#3##(1992-1#1)(2008-8#1)
of general manager##2##3##(1990-12#2)
of general medicine##2##3##(1996-3#1)(2007-7#1)
of general movements##2##3##(2006-10#2)
of general practice##5##3##(1990-3#1)(1990-5#1)(1997-4#1)(2007-2#1)(2008-1#1)
of general practitioners and##2##4##(1993-10#1)(2012-11#1)
of general practitioners in the##2##5##(1997-4#1)(2008-11#1)
of general practitioners in##4##4##(1994-3#1)(1997-4#1)(2008-11#1)(2008-3#1)
of general practitioners to##2##4##(2006-2#1)(2008-7#1)
of general practitioners##22##3##(1990-5#1)(1991-11#1)(1991-2#1)(1993-1#1)(1993-10#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1996-1#1)(1997-4#1)(1997-5#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-3#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-12#1)(2012-11#1)
of general relevance for##2##4##(1994-2#1)(1997-2#1)
of general surgery##5##3##(1992-10#1)(2006-10#1)(2006-7#1)(2007-3#1)(2008-4#1)
of general surgical##2##3##(1996-2#1)(2007-11#1)
of general transcription##2##3##(1994-3#1)(2007-12#1)
of general utility in##2##4##(1997-4#1)(2006-7#1)
of general utility##4##3##(1990-5#1)(1994-8#1)(1997-4#1)(2006-7#1)
of general validity##2##3##(2007-11#1)(2008-11#1)
of general##194##2##(1990-11#2)(1990-12#5)(1990-3#1)(1990-5#4)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#4)(1992-1#2)(1992-10#1)(1992-11#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-3#2)(1993-4#1)(1993-6#1)(1994-11#3)(1994-2#1)(1994-3#3)(1994-8#1)(1994-9#1)(1995-11#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-6#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-2#1)(2005-11#3)(2005-12#1)(2005-9#1)(2006-10#13)(2006-2#1)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#1)(2006-9#2)(2007-11#8)(2007-12#6)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#5)(2008-12#4)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#2)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#4)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#4)
of generalized anxiety disorder (GAD)##2##5##(2007-4#1)(2013-1#1)
of generalized anxiety disorder##4##4##(2007-4#1)(2011-2#1)(2013-1#2)
of generalized atherosclerosis##2##3##(2005-10#1)(2008-1#1)
of generalized linear models##2##4##(1993-9#1)(2012-1#1)
of generalized seizures##4##3##(1990-3#1)(1990-9#1)(1991-8#1)(2008-12#1)
of generalized tonic-clonic seizures##2##4##(1992-11#1)(2005-10#1)
of generalized##29##2##(1990-3#1)(1990-9#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-5#1)(1993-9#1)(2005-10#2)(2007-4#1)(2007-7#1)(2008-1#2)(2008-12#1)(2008-2#3)(2008-6#1)(2009-8#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)
of generated##9##2##(1997-2#1)(2007-11#1)(2008-10#3)(2008-7#1)(2009-2#1)(2011-1#1)(2011-2#1)
of generating a##4##3##(2007-12#1)(2009-6#1)(2009-9#1)(2012-1#1)
of generating this##2##3##(1990-12#1)(2007-12#1)
of generating##49##2##(1990-12#1)(1991-11#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-5#1)(1995-6#1)(2005-8#1)(2007-11#2)(2007-12#8)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-1#1)(2013-8#1)
of generation of##4##3##(1995-8#1)(1996-12#1)(2007-12#1)(2008-10#1)
of generation##6##2##(1995-8#1)(1996-12#1)(2007-12#1)(2008-10#2)(2010-7#1)
of generator##2##2##(1997-6#1)(2008-10#1)
of generic medicines##4##3##(2011-1#4)
of generic names##2##3##(2013-7#2)
of generic##21##2##(1990-12#1)(1994-3#1)(1996-2#1)(2006-11#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-4#1)(2010-4#1)(2010-7#1)(2011-1#5)(2011-3#1)(2012-11#1)(2013-7#2)
of genes active in##2##4##(1996-2#1)(1997-8#1)
of genes and gene products##2##5##(2008-7#1)(2009-5#1)
of genes and gene##3##4##(1996-12#1)(2008-7#1)(2009-5#1)
of genes and the##2##4##(2007-12#1)(2009-8#1)
of genes and their##2##4##(1997-4#1)(2007-12#1)
of genes and##17##3##(1992-6#1)(1993-2#1)(1995-6#1)(1996-12#1)(1997-4#1)(1997-7#1)(2006-12#1)(2006-8#1)(2007-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2009-9#1)
of genes are involved in##2##5##(2006-10#1)(2012-2#1)
of genes are##6##3##(1997-7#1)(2006-10#1)(2008-9#1)(2009-8#1)(2012-12#1)(2012-2#1)
of genes as##2##3##(2009-12#1)(2013-7#1)
of genes associated with##6##4##(2008-10#2)(2010-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
of genes belonging to the##2##5##(1995-6#1)(2011-1#1)
of genes belonging to##3##4##(1995-6#1)(2006-2#1)(2011-1#1)
of genes by##3##3##(1991-7#1)(1997-4#1)(2008-7#1)
of genes cloned##2##3##(1991-9#1)(1993-9#1)
of genes coding for##3##4##(1997-8#1)(2006-8#1)(2012-2#1)
of genes coding##4##3##(1997-8#1)(2006-8#1)(2008-12#1)(2012-2#1)
of genes controlling##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
of genes encoding glycolytic enzymes##2##5##(1996-3#2)
of genes encoding heat-stable and heat-labile##2##6##(1990-9#1)(2005-11#1)
of genes encoding proteins involved in##2##6##(2010-2#1)(2012-3#1)
of genes encoding proteins##3##4##(1990-6#1)(2010-2#1)(2012-3#1)
of genes encoding##27##3##(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1993-5#1)(1994-11#1)(1994-3#1)(1995-1#1)(1996-12#2)(1996-3#2)(1997-4#2)(2005-11#1)(2005-12#1)(2006-12#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-2#1)(2012-2#1)(2012-3#1)
of genes expressed in##2##4##(2008-7#2)
of genes expressed##4##3##(2006-10#1)(2008-10#1)(2008-7#2)
of genes for resistance to##3##5##(2008-10#3)
of genes for##12##3##(1993-11#1)(1996-12#2)(1997-4#1)(2005-12#1)(2008-10#4)(2010-2#1)(2012-11#1)(2013-7#1)
of genes from##5##3##(1991-9#1)(1993-9#1)(2007-5#1)(2008-7#1)(2009-12#1)
of genes have been identified##2##5##(2008-4#1)(2010-9#1)
of genes have been##3##4##(2007-12#1)(2008-4#1)(2010-9#1)
of genes have##5##3##(2007-12#2)(2008-10#1)(2008-4#1)(2010-9#1)
of genes implicated in prostate carcinogenesis##2##6##(2008-6#2)
of genes implicated in##3##4##(2008-4#1)(2008-6#2)
of genes in a##3##4##(1995-2#1)(2011-2#1)(2013-1#1)
of genes in parallel##2##4##(2008-7#2)
of genes in the genome##2##5##(1995-8#1)(2009-10#1)
of genes in the##8##4##(1990-7#1)(1995-1#1)(1995-8#2)(2008-11#1)(2008-6#1)(2008-7#1)(2009-10#1)
of genes in various##2##4##(2008-10#1)(2011-3#1)
of genes in##31##3##(1990-11#1)(1990-5#1)(1990-7#1)(1990-9#1)(1993-4#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-8#2)(1996-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#4)(2009-10#1)(2011-2#1)(2011-3#1)(2012-3#3)(2013-1#3)
of genes including##2##3##(2008-10#1)(2013-1#1)
of genes into##2##3##(2007-12#1)(2008-4#1)
of genes involved in cell proliferation##2##6##(2011-2#1)(2012-2#1)
of genes involved in the##10##5##(1991-7#1)(1996-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-2#1)(2012-12#2)(2013-1#2)
of genes involved in##39##4##(1990-1#1)(1990-5#1)(1991-7#1)(1995-11#1)(1995-12#1)(1996-10#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#2)(2009-12#1)(2009-3#2)(2009-5#1)(2009-8#3)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#2)
of genes involved##41##3##(1990-1#1)(1990-5#1)(1991-7#1)(1995-11#1)(1995-12#1)(1996-10#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-8#3)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#2)
of genes is##4##3##(2006-10#1)(2007-11#1)(2008-4#1)(2008-7#1)
of genes of the##2##4##(2010-12#1)(2011-1#1)
of genes of##5##3##(1996-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
of genes on##2##3##(2008-4#1)(2008-8#1)
of genes regulated by##2##4##(1994-3#1)(2008-7#1)
of genes regulating##2##3##(2008-1#1)(2013-1#1)
of genes related to##7##4##(1991-9#1)(2008-7#2)(2008-9#1)(2010-11#1)(2010-12#1)(2010-5#1)
of genes relevant to##2##4##(2006-10#1)(2009-5#1)
of genes responsible for##2##4##(2011-1#1)(2011-10#1)
of genes that are of##2##5##(2008-7#1)(2010-7#1)
of genes that are##7##4##(1993-9#1)(1995-1#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-7#1)(2011-1#1)
of genes that control##2##4##(2008-1#1)(2008-8#1)
of genes that encode##4##4##(1992-2#1)(1992-8#1)(2008-4#1)(2012-3#1)
of genes that influence##2##4##(2007-10#1)(2008-10#1)
of genes that predispose to familial##2##6##(1993-10#1)(2009-10#1)
of genes that regulate##3##4##(2006-10#1)(2007-4#1)(2012-12#1)
of genes that##39##3##(1990-8#1)(1992-2#1)(1992-8#1)(1993-10#1)(1993-9#1)(1994-5#1)(1995-1#1)(1996-9#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-7#6)(2008-8#1)(2009-10#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#3)
of genes to##5##3##(1993-7#1)(2008-4#1)(2008-7#1)(2010-11#1)(2011-1#1)
of genes under##2##3##(2008-10#1)(2008-7#1)
of genes via##2##3##(1992-7#1)(1996-5#1)
of genes was##2##3##(1993-12#1)(2006-12#1)
of genes were##3##3##(2009-8#1)(2010-4#1)(2013-8#1)
of genes which are##2##4##(2006-5#1)(2012-12#1)
of genes which##5##3##(1993-9#1)(2006-5#1)(2008-5#1)(2009-5#1)(2012-12#1)
of genes whose##3##3##(1991-12#1)(1992-12#1)(2008-4#1)
of genes with##6##3##(1992-6#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)
of genes within the##2##4##(1990-11#1)(1992-5#1)
of genes within##3##3##(1990-11#1)(1992-5#1)(1994-3#1)
of genes##411##2##(1990-1#2)(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-12#2)(1991-7#3)(1991-8#1)(1991-9#4)(1992-12#1)(1992-2#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#4)(1994-11#2)(1994-12#2)(1994-3#4)(1994-5#1)(1994-8#3)(1994-9#1)(1995-1#3)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#5)(1995-8#9)(1996-10#1)(1996-12#7)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#2)(1996-9#2)(1997-4#7)(1997-6#3)(1997-7#4)(1997-8#3)(2005-11#2)(2005-12#3)(2005-8#1)(2006-10#6)(2006-12#6)(2006-2#2)(2006-5#3)(2006-8#3)(2007-10#2)(2007-11#3)(2007-12#6)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#6)(2008-10#21)(2008-11#8)(2008-12#1)(2008-2#4)(2008-4#18)(2008-5#8)(2008-6#3)(2008-7#42)(2008-8#13)(2008-9#8)(2009-10#4)(2009-12#4)(2009-2#1)(2009-3#2)(2009-5#8)(2009-6#1)(2009-8#10)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#5)(2010-2#4)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#6)(2011-10#1)(2011-2#8)(2011-3#2)(2012-1#2)(2012-11#1)(2012-12#11)(2012-2#6)(2012-3#11)(2013-1#10)(2013-7#3)(2013-8#4)
of genes/proteins##2##2##(2008-7#2)
of genetic adaptation##2##3##(2010-8#1)(2011-1#1)
of genetic algorithms (GA)##2##4##(2008-10#1)(2008-2#1)
of genetic algorithms##7##3##(1994-2#1)(2005-4#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)
of genetic alterations##2##3##(2008-11#1)(2011-2#1)
of genetic and acquired##2##4##(2010-10#1)(2013-8#1)
of genetic and environmental factors##6##5##(1990-6#1)(2005-11#1)(2006-12#1)(2009-10#1)(2010-10#1)(2012-2#1)
of genetic and environmental##10##4##(1990-6#1)(1997-5#1)(2005-11#1)(2005-8#1)(2006-12#1)(2008-1#1)(2009-10#2)(2010-10#1)(2012-2#1)
of genetic and epigenetic changes##2##5##(1992-3#1)(2011-2#1)
of genetic and epigenetic##3##4##(1992-3#1)(2007-11#1)(2011-2#1)
of genetic and molecular##2##4##(1993-3#1)(2012-2#1)
of genetic and phenotypic##2##4##(2008-10#1)(2010-12#1)
of genetic and physical##2##4##(1996-10#1)(2009-10#1)
of genetic and##31##3##(1990-6#1)(1992-3#1)(1993-3#1)(1996-10#1)(1997-5#2)(2005-11#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-4#1)(2008-7#1)(2009-10#3)(2009-3#1)(2010-10#2)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
of genetic association##5##3##(1997-5#1)(2012-3#4)
of genetic background of##2##4##(2008-1#1)(2011-12#1)
of genetic background##3##3##(2007-8#1)(2008-1#1)(2011-12#1)
of genetic changes##3##3##(1993-8#1)(1995-11#1)(2007-10#1)
of genetic control of##2##4##(1993-2#1)(2008-10#1)
of genetic correlations##2##3##(2008-8#2)
of genetic counseling and##2##4##(2008-1#1)(2008-3#1)
of genetic counseling##4##3##(2007-3#1)(2008-1#2)(2008-3#1)
of genetic data##2##3##(2008-7#1)(2008-9#1)
of genetic defects##3##3##(2005-12#1)(2007-9#1)(2011-1#1)
of genetic determinants of##2##4##(1993-9#1)(2010-12#1)
of genetic determinants##3##3##(1993-9#1)(1997-4#1)(2010-12#1)
of genetic differentiation among##5##4##(2008-10#5)
of genetic differentiation were##3##4##(2008-10#3)
of genetic differentiation##17##3##(2006-3#1)(2008-10#14)(2012-3#1)(2012-5#1)
of genetic disease##5##3##(1994-2#1)(1995-6#1)(2007-7#1)(2008-1#1)(2008-11#1)
of genetic disorders##4##3##(2008-11#1)(2008-6#1)(2008-7#1)(2013-1#1)
of genetic distances##2##3##(2008-10#1)(2008-5#1)
of genetic divergence##2##3##(1997-4#1)(2008-8#1)
of genetic diversity and##4##4##(2008-10#4)
of genetic diversity in the##2##5##(1997-3#1)(2012-3#1)
of genetic diversity in##5##4##(1997-3#1)(2008-5#1)(2010-10#1)(2011-1#1)(2012-3#1)
of genetic diversity may##2##4##(2008-10#1)(2013-1#1)
of genetic diversity within##2##4##(1997-8#1)(2008-10#1)
of genetic diversity##29##3##(1997-3#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#1)(2008-10#13)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-7#1)
of genetic effect##2##3##(1994-2#1)(2012-3#1)
of genetic engineering##4##3##(1991-7#1)(2005-11#1)(2008-8#1)(2011-2#1)
of genetic epidemiology##3##3##(2008-7#2)(2011-2#1)
of genetic events##3##3##(1993-2#1)(1994-12#1)(2007-5#1)
of genetic factors and the##2##5##(1997-8#1)(2013-7#1)
of genetic factors##10##3##(1990-12#1)(1994-2#1)(1997-5#1)(1997-8#1)(2007-2#1)(2008-4#1)(2009-4#1)(2009-5#1)(2013-7#1)(2013-8#1)
of genetic information##13##3##(1991-9#1)(1993-1#1)(1995-8#1)(1996-2#1)(1997-8#3)(2008-10#1)(2008-11#1)(2008-7#3)(2012-2#1)
of genetic instability##7##3##(2008-8#5)(2012-2#1)(2013-1#1)
of genetic isolation##2##3##(2008-5#1)(2008-9#1)
of genetic markers for##2##4##(1996-9#1)(2011-3#1)
of genetic markers##5##3##(1996-6#2)(1996-9#1)(2011-1#1)(2011-3#1)
of genetic material##3##3##(2006-5#1)(2008-10#1)(2008-7#1)
of genetic mechanisms##2##3##(2006-5#1)(2012-3#1)
of genetic mutations##2##3##(1991-10#1)(2010-11#1)
of genetic origin##4##3##(1990-2#1)(2008-8#1)(2009-4#1)(2013-1#1)
of genetic pathways##5##3##(2011-1#1)(2013-1#4)
of genetic polymorphism in drug##2##5##(1996-3#2)
of genetic polymorphism in##4##4##(1996-3#2)(1996-6#1)(2012-3#1)
of genetic polymorphism##8##3##(1996-3#2)(1996-6#1)(2006-6#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-3#1)
of genetic polymorphisms##6##3##(1996-6#1)(2005-10#1)(2008-5#1)(2008-8#1)(2010-2#2)
of genetic predisposition##3##3##(2006-10#1)(2012-2#2)
of genetic profiles for##2##4##(2008-11#1)(2010-7#1)
of genetic recombination##4##3##(1994-3#1)(2006-10#1)(2008-10#2)
of genetic regulation##3##3##(2007-10#1)(2008-10#1)(2008-2#1)
of genetic regulatory networks##3##4##(2007-12#1)(2008-7#2)
of genetic regulatory##5##3##(1997-4#1)(2007-12#1)(2008-11#1)(2008-7#2)
of genetic resistance##3##3##(2008-10#2)(2013-8#1)
of genetic risk##5##3##(1996-9#1)(2008-7#2)(2011-1#1)(2012-3#1)
of genetic stability##2##3##(2005-11#1)(2012-1#1)
of genetic structure##3##3##(2008-10#2)(2008-8#1)
of genetic studies of##2##4##(2007-10#1)(2012-2#1)
of genetic studies##3##3##(2007-10#1)(2012-2#2)
of genetic susceptibility##5##3##(2008-4#1)(2008-7#1)(2009-11#1)(2011-12#1)(2013-1#1)
of genetic techniques##2##3##(2006-10#1)(2007-7#1)
of genetic testing in##4##4##(2007-9#1)(2009-7#1)(2010-7#1)(2011-2#1)
of genetic testing##14##3##(1991-11#1)(1993-9#1)(1995-9#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-9#1)(2009-7#1)(2010-7#1)(2011-2#3)(2012-3#1)
of genetic testing]##2##3##(2012-1#1)(2012-2#1)
of genetic tests##5##3##(1997-8#1)(2008-10#2)(2008-4#1)(2011-3#1)
of genetic tools##2##3##(2008-8#1)(2011-1#1)
of genetic variability##12##3##(1996-12#1)(1996-6#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)
of genetic variance##3##3##(2008-8#1)(2013-8#2)
of genetic variants##3##3##(1996-11#1)(2010-12#1)(2012-2#1)
of genetic variation among##2##4##(2008-10#2)
of genetic variation at##2##4##(2008-8#1)(2009-12#1)
of genetic variation in##5##4##(2004-11#1)(2008-10#2)(2009-9#2)
of genetic variation##24##3##(1996-6#2)(2004-11#1)(2005-10#1)(2008-10#10)(2008-5#1)(2008-8#1)(2008-9#3)(2009-12#1)(2009-9#2)(2010-4#1)(2012-2#1)
of genetic##423##2##(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-11#2)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-3#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#4)(1994-3#3)(1994-4#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-6#4)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#7)(1996-8#1)(1996-9#2)(1997-3#3)(1997-4#3)(1997-5#5)(1997-8#9)(2004-11#1)(2004-12#1)(2005-10#3)(2005-11#4)(2005-12#1)(2005-4#1)(2005-7#1)(2005-8#3)(2006-10#7)(2006-11#1)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#5)(2007-2#2)(2007-3#4)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#6)(2008-10#65)(2008-11#12)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#9)(2008-5#9)(2008-6#2)(2008-7#22)(2008-8#22)(2008-9#12)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-7#1)(2009-9#2)(2010-10#3)(2010-11#1)(2010-12#5)(2010-2#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#10)(2011-12#2)(2011-2#11)(2011-3#2)(2012-1#7)(2012-11#1)(2012-12#1)(2012-2#15)(2012-3#13)(2012-5#1)(2013-1#11)(2013-7#3)(2013-8#6)
of genetically and##2##3##(2008-10#1)(2013-1#1)
of genetically distinct##2##3##(1996-4#1)(2005-8#1)
of genetically engineered herpes simplex viruses##2##6##(1995-2#2)
of genetically engineered##6##3##(1995-2#2)(2006-7#1)(2007-8#1)(2008-11#1)(2011-1#1)
of genetically epilepsy-prone rats##2##4##(1993-4#1)(1997-5#1)
of genetically epilepsy-prone##3##3##(1993-4#1)(1996-12#1)(1997-5#1)
of genetically modified animals##2##4##(2008-7#1)(2010-4#1)
of genetically modified crops##2##4##(2006-12#1)(2009-4#1)
of genetically modified mice##2##4##(2008-4#1)(2012-3#1)
of genetically modified##17##3##(1995-3#2)(1997-3#1)(2006-12#2)(2007-10#1)(2007-11#1)(2007-12#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-3#1)
of genetically##49##2##(1991-6#1)(1991-8#1)(1993-4#1)(1995-2#2)(1995-3#2)(1996-12#1)(1996-3#1)(1996-4#1)(1997-3#1)(1997-5#1)(2004-4#1)(2005-12#1)(2005-8#1)(2006-12#3)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#1)
of geneticists and##2##3##(2008-5#1)(2010-3#1)
of geneticists##3##2##(2007-9#1)(2008-5#1)(2010-3#1)
of genetics and##5##3##(2006-10#1)(2007-6#1)(2008-4#1)(2010-1#1)(2012-12#1)
of genetics in##5##3##(2005-11#1)(2006-10#1)(2008-12#1)(2008-7#1)(2013-8#1)
of genetics research##2##3##(2009-6#2)
of genetics##17##2##(1996-8#1)(2005-11#1)(2006-10#3)(2006-12#1)(2007-6#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2009-6#2)(2010-1#1)(2012-12#1)(2013-8#1)
of genic##2##2##(2010-3#1)(2011-12#1)
of geniculate##2##2##(1997-7#1)(2011-2#1)
of genistein and biochanin A##2##5##(1991-8#1)(2010-3#1)
of genistein on##3##3##(1993-3#1)(1997-7#1)(2010-10#1)
of genistein##18##2##(1991-8#1)(1992-12#1)(1992-8#2)(1993-3#1)(1993-7#1)(1997-7#3)(2008-11#1)(2010-10#1)(2010-3#2)(2012-12#1)(2012-2#4)
of genital herpes##10##3##(2007-12#3)(2008-10#6)(2010-6#1)
of genital infection##2##3##(2010-12#1)(2013-1#1)
of genital lesions##2##3##(1996-12#1)(2007-7#1)
of genital pathology##2##3##(1991-11#1)(1996-12#1)
of genital skin##2##3##(1991-3#2)
of genital warts##4##3##(1996-1#1)(2007-11#2)(2011-2#1)
of genital##44##2##(1990-12#1)(1991-11#1)(1991-3#2)(1991-6#1)(1992-2#1)(1994-2#1)(1995-11#1)(1996-1#1)(1996-12#3)(2006-5#1)(2007-11#2)(2007-12#6)(2007-4#1)(2007-7#2)(2008-10#7)(2008-4#1)(2009-10#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#4)
of genitourinary prolapse and stress incontinence##2##6##(2007-4#2)
of genitourinary##10##2##(1995-12#1)(1997-8#1)(2006-9#2)(2007-4#2)(2008-10#1)(2013-8#3)
of genome analysis##2##3##(2008-8#1)(2013-8#1)
of genome integrity##3##3##(2012-12#2)(2013-1#1)
of genome organization##2##3##(1992-12#1)(2010-3#1)
of genome sequences##3##3##(2008-7#1)(2009-5#1)(2013-8#1)
of genome size##2##3##(1997-2#1)(2008-8#1)
of genome structure and##2##4##(1994-6#1)(1996-10#1)
of genome structure##4##3##(1994-6#1)(1996-10#1)(2008-4#1)(2008-8#1)
of genome wide##2##3##(2010-2#1)(2010-3#1)
of genome##38##2##(1992-12#1)(1992-8#1)(1993-12#1)(1994-6#2)(1996-10#1)(1997-2#1)(1997-4#1)(1997-7#2)(2008-4#1)(2008-7#3)(2008-8#10)(2008-9#1)(2009-5#2)(2010-2#1)(2010-3#4)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#2)
of genome-wide association studies##4##4##(2009-12#2)(2011-2#1)(2012-2#1)
of genome-wide##10##2##(2008-7#1)(2009-12#4)(2011-2#3)(2012-2#1)(2012-3#1)
of genomes of##2##3##(2008-2#1)(2013-1#1)
of genomes##11##2##(1993-7#1)(1997-2#1)(2008-2#1)(2008-7#2)(2009-5#1)(2009-6#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
of genomic DNA and##9##4##(1990-12#2)(1992-3#1)(1993-12#1)(1994-8#1)(1994-9#1)(1997-7#1)(2008-4#1)(2008-5#1)
of genomic DNA from the##3##5##(1996-5#1)(1996-6#1)(2006-12#1)
of genomic DNA from##12##4##(1990-1#1)(1990-4#1)(1993-2#1)(1996-5#1)(1996-6#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-2#1)(2011-2#1)
of genomic DNA into##2##4##(1990-10#1)(2008-4#1)
of genomic DNA isolated from##2##5##(1990-9#1)(1994-8#1)
of genomic DNA of##3##4##(1993-12#1)(2008-10#1)(2008-9#1)
of genomic DNA##73##3##(1990-1#1)(1990-10#1)(1990-12#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-9#2)(1992-3#2)(1992-8#2)(1993-12#2)(1993-2#3)(1993-4#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-3#1)(1995-5#2)(1996-10#2)(1996-5#2)(1996-6#1)(1996-7#2)(1997-6#3)(1997-7#2)(2006-12#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#3)(2008-4#8)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-2#1)
of genomic RNA##2##3##(1992-9#1)(2008-10#1)
of genomic Southern##2##3##(1992-7#1)(1993-7#1)
of genomic alterations in lung cancer##2##6##(2012-12#2)
of genomic alterations##3##3##(2012-12#3)
of genomic analysis##2##3##(1997-2#1)(2008-7#1)
of genomic and##4##3##(1996-7#1)(2008-10#1)(2008-8#1)(2011-2#1)
of genomic clones##5##3##(1990-8#1)(1991-6#1)(1993-11#1)(1994-6#1)(2008-10#1)
of genomic data##6##3##(2008-7#2)(2010-3#1)(2011-1#1)(2011-2#1)(2011-3#1)
of genomic imprinting##3##3##(1993-2#1)(1996-3#1)(2009-2#1)
of genomic information##2##3##(2008-7#1)(2008-9#1)
of genomic instability and##2##4##(2008-8#2)
of genomic instability##5##3##(2008-8#3)(2010-2#1)(2013-1#1)
of genomic islands##2##3##(2012-2#2)
of genomic regions##2##3##(2008-10#1)(2008-7#1)
of genomic research##3##3##(2008-7#2)(2012-2#1)
of genomic sequence##4##3##(1993-2#1)(2008-11#1)(2010-7#1)(2012-2#1)
of genomic sequences##4##3##(1994-6#1)(2008-9#1)(2009-10#1)(2013-1#1)
of genomic stability##3##3##(1997-4#1)(2007-4#1)(2008-8#1)
of genomic structure and##2##4##(2010-3#2)
of genomic studies##2##3##(2007-12#1)(2010-8#1)
of genomic tools##2##3##(2008-11#1)(2010-10#1)
of genomic##167##2##(1990-1#1)(1990-10#1)(1990-12#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-2#1)(1991-6#1)(1991-9#2)(1992-12#1)(1992-3#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#5)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-3#1)(1995-5#2)(1996-10#2)(1996-11#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#3)(1997-2#1)(1997-4#1)(1997-6#3)(1997-7#3)(2005-11#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#11)(2008-11#6)(2008-2#3)(2008-4#12)(2008-5#1)(2008-6#1)(2008-7#13)(2008-8#8)(2008-9#3)(2009-10#1)(2009-2#2)(2009-5#2)(2009-8#1)(2010-10#1)(2010-2#2)(2010-3#5)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#5)(2013-1#2)(2013-8#1)
of genomics and##2##3##(2008-10#1)(2008-11#1)
of genomics on##2##3##(2005-9#1)(2006-10#1)
of genomics to##2##3##(2006-5#1)(2008-4#1)
of genomics##19##2##(2005-9#1)(2006-10#1)(2006-5#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#4)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2013-8#1)
of genotoxic##2##2##(1995-2#1)(2011-12#1)
of genotoxicity in##2##3##(1992-6#2)
of genotoxicity##5##2##(1992-6#2)(1996-1#1)(2008-8#1)(2013-1#1)
of genotoxins##2##2##(1990-8#1)(1993-9#1)
of genotype and slaughter weight##2##5##(2010-4#2)
of genotype and##3##3##(2008-8#1)(2010-4#2)
of genotype calls##2##3##(2009-8#2)
of genotype distribution##2##3##(2008-10#1)(2008-3#1)
of genotype on##4##3##(2008-10#1)(2010-2#2)(2011-1#1)
of genotype resistance and##2##4##(2008-10#2)
of genotype resistance##4##3##(2008-10#4)
of genotype##23##2##(2007-9#1)(2008-10#8)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-12#1)(2010-2#2)(2010-4#2)(2011-1#1)(2012-1#1)(2012-12#1)
of genotypes and##3##3##(1992-4#1)(2012-11#1)(2012-12#1)
of genotypes at##2##3##(2012-1#1)(2012-11#1)
of genotypes from##2##3##(2008-10#2)
of genotypes of##2##3##(2008-10#1)(2009-12#1)
of genotypes or##2##3##(2008-10#1)(2011-1#1)
of genotypes that##2##3##(2008-10#2)
of genotypes with##3##3##(2008-10#1)(2008-12#1)(2008-9#1)
of genotypes within##3##3##(2008-10#2)(2010-2#1)
of genotypes##35##2##(1992-4#1)(1995-2#1)(2008-10#15)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#1)
of genotypic diversity##9##3##(2008-10#8)(2013-1#1)
of genotypic##18##2##(2006-11#1)(2006-8#1)(2008-10#11)(2008-9#1)(2011-12#1)(2011-2#1)(2013-1#2)
of genotyping##4##2##(2008-4#2)(2009-8#1)(2012-1#1)
of gentamicin 2##2##3##(2010-3#2)
of gentamicin##9##2##(1990-4#1)(2006-8#1)(2008-10#2)(2010-3#4)(2011-2#1)
of gentamycin##8##2##(2007-12#1)(2008-10#5)(2013-8#2)
of gentian violet##2##3##(1994-5#1)(2013-7#1)
of gently##2##2##(1991-1#1)(1996-9#1)
of genuine##9##2##(1994-3#2)(1996-2#1)(1997-3#1)(2007-1#1)(2008-10#1)(2008-5#1)(2009-8#1)(2011-1#1)
of genus##9##2##(1994-3#1)(1997-4#1)(2005-11#1)(2007-11#1)(2008-4#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
of geochemical##4##2##(1994-6#1)(1996-4#1)(2007-5#2)
of geographic information##2##3##(2006-10#1)(2013-8#1)
of geographic isolation##3##3##(2006-10#1)(2008-1#1)(2010-8#1)
of geographic variation in##2##4##(2008-8#1)(2010-8#1)
of geographic variation##3##3##(2008-8#1)(2010-8#2)
of geographic##18##2##(1994-6#1)(2006-10#2)(2008-1#1)(2008-10#4)(2008-7#1)(2008-8#2)(2010-8#4)(2011-2#1)(2013-8#2)
of geographical location##2##3##(1993-2#1)(2008-10#1)
of geographical##9##2##(1993-2#1)(2006-8#1)(2008-10#1)(2008-4#1)(2008-8#2)(2010-11#1)(2011-2#2)
of geological samples##3##3##(2008-10#3)
of geological##8##2##(1996-4#1)(2007-9#1)(2008-10#4)(2008-12#1)(2009-6#1)
of geometric and##2##3##(2008-3#2)
of geometric isomers of carotenoids##3##5##(2010-2#3)
of geometric isomers of##4##4##(1997-3#1)(2010-2#3)
of geometric optics##2##3##(2008-2#1)(2008-3#1)
of geometric##20##2##(1995-11#1)(1996-4#1)(1997-3#1)(2007-12#2)(2008-2#2)(2008-3#5)(2008-8#1)(2009-9#1)(2010-2#3)(2010-8#1)(2013-1#1)(2013-7#1)
of geometrical optics##3##3##(2008-2#1)(2008-3#2)
of geometrical parameters of transpedicular##2##5##(2007-11#2)
of geometrical##15##2##(1995-11#1)(1997-8#1)(2006-7#1)(2007-11#2)(2007-8#1)(2008-2#3)(2008-3#4)(2009-3#1)(2009-7#1)
of geometrically##2##2##(2008-7#1)(2010-9#1)
of geophysical parameters from##3##4##(2008-2#2)(2008-3#1)
of geraniol##3##2##(2007-11#2)(2008-5#1)
of geraniums##2##2##(1991-4#1)(2008-10#1)
of geranylgeranyl pyrophosphate##4##3##(1995-1#4)
of gerbils##2##2##(1995-5#1)(1997-7#1)
of geriatric patients##3##3##(1990-11#1)(2007-12#1)(2013-8#1)
of geriatric##8##2##(1990-11#1)(1991-1#1)(1991-11#1)(1992-1#1)(2006-12#1)(2007-12#1)(2008-4#1)(2013-8#1)
of geriatrics##3##2##(1994-2#1)(2006-2#1)(2008-7#1)
of germ cell development##5##4##(2009-10#2)(2009-3#1)(2012-2#2)
of germ cell##12##3##(1994-7#1)(2006-5#1)(2008-12#2)(2008-6#1)(2009-10#2)(2009-3#1)(2012-2#4)
of germ cells##11##3##(1990-11#1)(1990-9#1)(2006-5#2)(2007-12#1)(2008-7#1)(2009-10#2)(2010-1#1)(2012-2#1)(2013-8#1)
of germ line p53 mutations##2##5##(1990-12#1)(1994-12#1)
of germ line##3##3##(1990-12#1)(1994-12#1)(2008-11#1)
of germ tubes##6##3##(2008-10#6)
of germ##34##2##(1990-11#1)(1990-12#1)(1990-9#1)(1994-12#1)(1994-7#1)(2006-5#3)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#4)(2009-3#1)(2010-1#1)(2012-2#5)(2013-8#1)
of germ-cell##3##2##(2006-10#1)(2006-9#1)(2008-10#1)
of germ-free##3##2##(1991-12#1)(1992-8#1)(2012-3#1)
of germanium by##3##3##(2008-10#3)
of germanium in botanical samples##2##5##(2008-10#2)
of germanium in##3##3##(2008-10#3)
of germanium##11##2##(2006-12#2)(2007-12#1)(2008-10#7)(2008-2#1)
of germinal centers##2##3##(1994-3#1)(2008-10#1)
of germinal##9##2##(1992-11#1)(1994-3#3)(1994-6#1)(1995-2#1)(2008-10#1)(2008-9#1)(2011-2#1)
of germinated conidia##4##3##(2008-10#4)
of germinated##8##2##(2008-10#6)(2008-5#2)
of germinating seeds##2##3##(2008-10#1)(2008-7#1)
of germinating##8##2##(1990-5#2)(2008-10#3)(2008-12#1)(2008-7#1)(2009-10#1)
of germination and##4##3##(2008-10#2)(2008-12#1)(2011-2#1)
of germination in##2##3##(2008-10#2)
of germination of sclerotia##2##4##(2008-10#2)
of germination of##6##3##(2008-10#3)(2008-12#1)(2008-5#2)
of germination was##3##3##(2008-10#2)(2012-2#1)
of germination##34##2##(1990-10#1)(2004-2#4)(2005-10#1)(2006-12#2)(2008-10#13)(2008-12#6)(2008-5#2)(2011-2#3)(2012-2#2)
of germination)##2##2##(2008-12#1)(2008-9#1)
of germline##7##2##(1990-11#1)(1996-12#1)(2007-12#2)(2008-9#1)(2011-2#1)(2013-7#1)
of germplasm resources##3##3##(2008-9#1)(2012-11#2)
of germplasm##5##2##(2008-12#1)(2008-9#1)(2012-11#3)
of gerontological##6##2##(2007-10#5)(2012-12#1)
of gestation and##8##3##(1993-12#2)(1993-4#1)(1995-10#1)(2007-11#1)(2008-1#1)(2008-5#1)(2012-3#1)
of gestation from##2##3##(1996-11#1)(1996-9#1)
of gestation in##3##3##(1992-5#1)(1995-1#1)(2008-11#1)
of gestation is##2##3##(2008-11#1)(2011-1#1)
of gestation to##2##3##(1990-5#1)(1995-8#1)
of gestation was##2##3##(1997-8#1)(2007-3#1)
of gestation with##7##3##(2007-7#1)(2012-2#2)(2013-1#4)
of gestation##93##2##(1990-11#1)(1990-2#2)(1990-5#1)(1991-3#1)(1992-5#1)(1992-6#1)(1993-12#6)(1993-4#1)(1993-5#2)(1993-6#1)(1994-12#1)(1994-6#2)(1995-1#4)(1995-10#1)(1995-5#1)(1995-8#1)(1996-11#2)(1996-12#4)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-4#1)(2007-1#2)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#2)(2007-7#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2009-9#2)(2010-12#1)(2010-2#2)(2010-6#1)(2011-1#5)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#8)
of gestation)##2##2##(1993-6#1)(1996-5#1)
of gestational age and##3##4##(1991-4#1)(2008-11#1)(2011-1#1)
of gestational age##9##3##(1991-4#3)(1992-12#1)(1996-12#1)(2008-11#2)(2009-4#1)(2011-1#1)
of gestational diabetes mellitus##3##4##(1992-12#1)(2008-1#1)(2008-3#1)
of gestational diabetes##6##3##(1992-12#1)(1996-11#2)(2008-1#1)(2008-3#1)(2013-1#1)
of gestational stress on##2##4##(2008-11#2)
of gestational stress##4##3##(2008-11#4)
of gestational##24##2##(1991-4#3)(1992-12#2)(1994-6#1)(1996-11#2)(1996-12#1)(1996-3#1)(2007-2#1)(2008-1#1)(2008-11#6)(2008-3#1)(2008-7#1)(2009-4#1)(2011-1#1)(2013-1#2)
of gestodene##3##2##(2011-3#3)
of getting a##2##3##(2007-12#1)(2010-5#1)
of getting##14##2##(1990-5#1)(1991-1#1)(1992-10#1)(1993-1#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-7#2)(2009-10#1)(2009-9#1)(2010-4#1)(2010-5#1)
of ghost##3##2##(2007-12#2)(2008-2#1)
of ghrelin and##2##3##(2008-12#1)(2008-3#1)
of ghrelin in##2##3##(2011-1#1)(2011-2#1)
of ghrelin##17##2##(2006-10#1)(2006-6#1)(2008-12#1)(2008-3#5)(2011-1#2)(2011-2#5)(2012-3#1)(2013-8#1)
of giant cell reparative##2##4##(2006-12#2)
of giant cell##8##3##(1993-10#1)(2005-8#1)(2006-10#1)(2006-12#3)(2008-6#1)(2009-3#1)
of giant intracranial aneurysms##2##4##(2008-7#1)(2012-12#1)
of giant intracranial##3##3##(2008-7#1)(2008-9#1)(2012-12#1)
of giant ovarian cysts##2##4##(2012-12#2)
of giant##56##2##(1990-10#1)(1990-12#1)(1990-4#1)(1991-6#2)(1991-9#1)(1992-10#1)(1993-10#1)(1995-11#1)(1995-5#2)(1995-7#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-12#4)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#2)(2008-7#6)(2008-9#1)(2009-3#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#2)
of gifts##3##2##(1997-4#1)(2008-12#1)(2008-5#1)
of gigahertz##2##2##(2007-12#2)
of gill lamellae##2##3##(2008-5#1)(2008-7#1)
of gill##3##2##(2008-5#1)(2008-7#1)(2012-1#1)
of gills##2##2##(1996-11#1)(2010-10#1)
of gilthead sea bream##3##4##(2009-5#1)(2010-8#2)
of gilthead##4##2##(1997-1#1)(2009-5#1)(2010-8#2)
of ginger##4##2##(2008-10#1)(2008-11#1)(2008-7#2)
of gingipains##2##2##(2008-4#2)
of gingiva is##2##3##(2010-4#1)(2013-7#1)
of gingiva##5##2##(2010-4#2)(2013-1#1)(2013-7#2)
of gingival enlargement##2##3##(2013-7#2)
of gingival fibroblasts from##2##4##(1996-11#2)
of gingival fluid##3##3##(2012-12#3)
of gingival recession##5##3##(2010-4#2)(2012-12#2)(2013-7#1)
of gingival##20##2##(1991-9#2)(1996-11#2)(2008-5#1)(2010-4#3)(2012-12#5)(2012-3#1)(2013-1#2)(2013-7#4)
of gingivitis##4##2##(1990-10#1)(2006-2#2)(2012-12#1)
of ginseng and Radix Aconiti Praeparata##4##6##(2012-3#4)
of ginseng and##5##3##(2012-3#5)
of ginseng leaves##2##3##(2008-10#2)
of ginseng total saponin##3##4##(2007-1#2)(2008-11#1)
of ginseng##17##2##(2007-1#2)(2008-10#7)(2008-11#1)(2012-3#7)
of ginsenoside##2##2##(2012-3#1)(2013-1#1)
of ginsenosides##4##2##(2007-1#2)(2008-11#2)
of giraffe##2##2##(2007-2#2)
of girls and##3##3##(2009-2#3)
of girls in##3##3##(2007-10#1)(2010-11#1)(2013-1#1)
of girls##20##2##(1990-2#1)(1995-6#1)(1996-11#1)(2006-7#1)(2007-10#2)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#2)(2009-10#1)(2009-2#3)(2009-5#1)(2009-7#1)(2010-11#1)(2012-1#1)(2013-1#1)
of girls'##2##2##(2007-12#1)(2010-7#1)
of given##8##2##(2006-10#2)(2007-8#1)(2008-10#2)(2008-3#2)(2008-7#1)
of giving birth and##2##4##(2004-3#1)(2010-12#1)
of giving birth##9##3##(2004-3#1)(2007-2#4)(2007-3#1)(2009-10#1)(2010-12#2)
of giving the##3##3##(2004-3#1)(2006-5#1)(2007-8#1)
of giving##21##2##(1994-3#1)(1995-2#1)(2004-3#2)(2006-10#1)(2006-5#1)(2007-2#4)(2007-3#1)(2007-8#1)(2008-12#1)(2008-2#2)(2009-10#1)(2009-4#1)(2010-12#2)(2012-3#2)
of gizzard myosin##2##3##(1990-3#1)(1993-8#1)
of glaA gene##2##3##(2008-9#2)
of glaA##3##2##(2008-8#1)(2008-9#2)
of glands in##2##3##(1997-1#1)(2007-12#1)
of glands##4##2##(1995-11#1)(1997-1#1)(2007-12#2)
of glandular and##2##3##(2010-4#1)(2012-1#1)
of glandular##7##2##(1991-9#1)(1997-6#1)(2008-5#1)(2010-4#1)(2011-2#2)(2012-1#1)
of glass and##4##3##(2005-11#1)(2008-10#2)(2008-4#1)
of glass beads##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
of glass electrodes##3##3##(2008-10#3)
of glass fiber##2##3##(2005-11#1)(2008-10#1)
of glass fibers##6##3##(2008-3#2)(2009-7#2)(2010-8#2)
of glass ionomer##2##3##(2010-3#1)(2011-2#1)
of glass samples##2##3##(2008-10#2)
of glass transition##2##3##(2006-10#1)(2008-9#1)
of glass with##2##3##(2007-11#2)
of glass wool##3##3##(2010-8#3)
of glass##56##2##(1990-8#1)(1992-1#1)(1995-3#1)(2005-11#2)(2006-10#1)(2007-11#2)(2007-12#3)(2008-10#23)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-9#1)(2009-7#2)(2010-3#1)(2010-8#7)(2011-2#1)
of glass-ionomer cements##2##3##(2004-9#2)
of glass-ionomer##5##2##(2004-9#2)(2009-7#1)(2013-1#1)(2013-8#1)
of glasses for##3##3##(2008-3#3)
of glasses##12##2##(1995-3#2)(2006-10#1)(2007-4#2)(2008-10#2)(2008-2#1)(2008-3#4)
of glassy carbon##3##3##(2008-10#3)
of glassy##6##2##(1991-3#1)(1995-3#1)(2008-10#4)
of glaucoma and##4##3##(2008-3#3)(2013-8#1)
of glaucoma in##4##3##(2007-2#1)(2008-7#2)(2012-3#1)
of glaucoma patients##3##3##(2009-8#1)(2009-9#1)(2013-8#1)
of glaucoma##27##2##(1990-11#1)(2007-11#1)(2007-2#2)(2008-3#3)(2008-5#1)(2008-7#2)(2009-5#1)(2009-8#3)(2009-9#1)(2011-2#4)(2011-7#1)(2012-3#4)(2013-8#3)
of glaucomatous damage##3##3##(2007-6#1)(2008-3#1)(2011-7#1)
of glaucomatous visual field##2##4##(2007-6#2)
of glaucomatous##5##2##(2007-6#3)(2008-3#1)(2011-7#1)
of glia are##2##3##(2008-7#2)
of glia cells##2##3##(2008-5#1)(2008-7#1)
of glia in##2##3##(2008-5#1)(2008-7#1)
of glia##17##2##(1994-5#2)(1996-1#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-7#9)(2008-9#1)
of gliadin##4##2##(1996-3#4)
of glial and neuronal##2##4##(1994-10#1)(1996-6#1)
of glial and##4##3##(1994-10#1)(1996-6#1)(2008-5#1)(2009-2#1)
of glial cell line-derived neurotrophic factor##2##6##(1995-8#1)(1996-1#1)
of glial cell##7##3##(1993-11#1)(1995-8#1)(1996-1#1)(2006-11#1)(2008-5#1)(2008-7#1)(2008-8#1)
of glial cells and##2##4##(1996-9#1)(2013-8#1)
of glial cells in##3##4##(2008-11#1)(2008-3#1)(2008-7#1)
of glial cells to##2##4##(1996-1#1)(2008-7#1)
of glial cells##13##3##(1996-1#1)(1996-8#1)(1996-9#1)(1997-4#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#3)(2010-12#2)(2013-8#1)
of glial fibrillary acidic protein (GFAP) and##2##7##(1997-3#1)(2010-12#1)
of glial fibrillary acidic protein (GFAP)##4##6##(1990-7#1)(1994-6#1)(1997-3#1)(2010-12#1)
of glial fibrillary acidic protein##6##5##(1990-7#1)(1991-3#1)(1993-11#1)(1994-6#1)(1997-3#1)(2010-12#1)
of glial neoplasms##3##3##(2008-9#1)(2011-2#2)
of glial processes##2##3##(1994-2#1)(2008-7#1)
of glial##43##2##(1990-7#1)(1991-3#1)(1993-11#2)(1994-10#1)(1994-2#2)(1994-6#1)(1995-10#1)(1995-8#1)(1996-1#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(2006-11#1)(2006-4#1)(2007-1#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#7)(2008-8#1)(2008-9#1)(2009-2#1)(2010-12#3)(2011-2#2)(2013-8#1)
of glibenclamide##8##2##(1990-3#1)(1992-3#1)(1994-3#3)(1996-9#1)(2007-7#1)(2008-8#1)
of gliclazide##5##2##(2011-1#5)
of glimepiride##2##2##(1994-8#1)(2011-1#1)
of glimepride decreased significantly##2##4##(2011-1#2)
of glimepride##9##2##(2011-1#9)
of glioblastoma cells##4##3##(1997-1#1)(2008-7#1)(2008-8#1)(2013-1#1)
of glioblastoma in##2##3##(2011-2#2)
of glioblastoma multiforme (GBM)##2##4##(2007-12#1)(2011-2#1)
of glioblastoma multiforme##10##3##(1995-4#1)(1995-9#1)(2007-12#1)(2008-12#1)(2008-7#1)(2011-2#2)(2011-3#1)(2013-1#2)
of glioblastoma stem-like cells##4##4##(2012-12#4)
of glioblastoma##29##2##(1995-4#1)(1995-9#1)(1997-1#1)(2007-12#1)(2008-12#1)(2008-7#3)(2008-8#1)(2010-12#2)(2011-12#1)(2011-2#5)(2011-3#2)(2012-11#2)(2012-12#4)(2012-3#1)(2013-1#3)
of glioma##14##2##(1991-10#2)(1993-3#1)(1995-1#1)(1997-7#2)(2007-10#1)(2011-1#1)(2011-11#2)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
of gliomas##5##2##(1991-10#1)(2005-10#1)(2006-10#1)(2007-1#1)(2008-5#1)
of glistening##2##2##(2008-2#2)
of global and regional##4##4##(2006-10#2)(2010-12#1)(2013-3#1)
of global and##8##3##(1996-5#1)(2006-10#2)(2008-2#1)(2009-8#1)(2010-12#1)(2011-1#1)(2013-3#1)
of global budgeting##2##3##(1993-1#1)(1994-2#1)
of global budgets##2##3##(1994-1#2)
of global cardiovascular risk##2##4##(2008-7#1)(2011-2#1)
of global cerebral##2##3##(1997-6#1)(1997-8#1)
of global climate change##2##4##(2008-10#1)(2008-11#1)
of global environmental change##2##4##(2006-5#1)(2013-8#1)
of global gene expression##3##4##(2007-12#1)(2008-7#1)(2010-2#1)
of global health##5##3##(2008-10#1)(2008-7#1)(2011-1#3)
of global ischemia##2##3##(1996-12#1)(2010-12#1)
of global postural reeducation in the treatment of temporomandibular disorder##2##10##(2013-1#2)
of global public health##2##4##(2011-1#2)
of global warming##5##3##(1992-3#1)(2007-9#2)(2008-12#1)(2008-8#1)
of global##110##2##(1990-3#1)(1990-6#1)(1990-8#1)(1991-4#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-1#1)(1994-1#2)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-5#4)(1996-9#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-5#2)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#4)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-2#1)(2009-4#1)(2009-8#1)(2010-12#3)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#9)(2011-2#5)(2012-1#3)(2012-12#2)(2012-2#1)(2013-1#5)(2013-3#1)(2013-7#1)(2013-8#3)
of global/local feature analysis##2##4##(1996-5#2)
of globalisation##2##2##(2008-12#1)(2012-2#1)
of globalization and##2##3##(2012-3#1)(2013-1#1)
of globalization##6##2##(2006-7#1)(2007-5#1)(2008-1#1)(2009-8#1)(2012-3#1)(2013-1#1)
of globin##3##2##(1990-8#1)(2008-8#1)(2008-9#1)
of globular proteins##10##3##(1991-4#2)(1992-5#1)(1995-1#1)(1995-4#2)(2005-11#2)(2008-7#1)(2011-2#1)
of globular##13##2##(1991-4#2)(1992-5#1)(1995-1#1)(1995-4#2)(2005-11#3)(2006-5#1)(2008-11#1)(2008-7#1)(2011-2#1)
of globule##2##2##(1997-4#1)(2008-10#1)
of globuli cells##2##3##(2007-12#2)
of glomerular disease in##4##4##(2007-7#2)(2007-8#1)(2008-1#1)
of glomerular disease##7##3##(2007-7#2)(2007-8#2)(2008-1#3)
of glomerular diseases in##2##4##(2008-1#2)
of glomerular diseases##5##3##(2007-7#1)(2008-1#3)(2012-2#1)
of glomerular filtration##2##3##(2011-2#1)(2012-2#1)
of glomerular lesions##2##3##(1993-2#2)
of glomerular##26##2##(1990-4#1)(1992-7#1)(1993-2#2)(1993-4#1)(1995-12#1)(1996-6#2)(2005-10#1)(2005-12#1)(2007-7#3)(2007-8#2)(2008-1#8)(2011-2#1)(2012-2#2)
of glomeruli##6##2##(1996-7#3)(2007-12#2)(2008-9#1)
of glomerulonephritides##2##2##(2008-1#1)(2010-4#1)
of glomerulonephritis in##7##3##(1993-6#1)(2007-7#2)(2008-1#4)
of glomerulonephritis##13##2##(1993-6#1)(1996-6#1)(2007-11#1)(2007-7#4)(2008-1#5)(2011-2#1)
of glomerulopathy##2##2##(2008-1#1)(2013-8#1)
of glomerulosclerosis##3##2##(1992-8#1)(1993-12#1)(2010-12#1)
of glossopharyngeal##2##2##(1992-3#1)(1995-6#1)
of gloves##7##2##(1996-11#1)(2005-8#1)(2009-5#2)(2012-2#3)
of glucagon at##2##3##(1994-8#1)(1996-2#1)
of glucagon binding##2##3##(1995-3#1)(1995-6#1)
of glucagon receptor mRNA##3##4##(1995-6#3)
of glucagon secretion and##2##4##(2007-5#1)(2010-11#1)
of glucagon secretion in##2##4##(1994-11#1)(2010-11#1)
of glucagon secretion##8##3##(1994-11#2)(2007-5#1)(2010-11#5)
of glucagon##28##2##(1990-3#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1992-9#1)(1994-11#2)(1994-8#1)(1995-3#3)(1995-6#6)(1996-2#2)(2005-8#1)(2007-5#1)(2010-11#5)(2012-2#1)
of glucagon-induced##2##2##(1994-8#1)(1996-2#1)
of glucagon-like peptide-1-(7-36) amide##2##4##(1996-12#2)
of glucoamylase 1##2##3##(1991-5#1)(1996-6#1)
of glucoamylase##8##2##(1991-5#3)(1993-5#1)(1996-6#2)(1996-7#1)(2008-8#1)
of glucocorticoid and mineralocorticoid##2##4##(1993-8#1)(2007-11#1)
of glucocorticoid and##5##3##(1993-8#1)(1994-2#1)(2007-11#2)(2008-4#1)
of glucocorticoid receptor (GR)##2##4##(1994-11#1)(1996-7#1)
of glucocorticoid receptor and##2##4##(1993-12#1)(1996-7#1)
of glucocorticoid receptor function by the##2##6##(1993-12#1)(1995-5#1)
of glucocorticoid receptor##16##3##(1990-11#1)(1990-2#1)(1993-12#3)(1994-11#2)(1994-2#1)(1995-5#1)(1995-7#1)(1996-12#1)(1996-7#2)(2005-8#1)(2008-4#1)(2012-1#1)
of glucocorticoid receptors in the##2##5##(1993-11#1)(2012-1#1)
of glucocorticoid receptors in##3##4##(1993-11#1)(2009-6#1)(2012-1#1)
of glucocorticoid receptors##6##3##(1991-1#1)(1991-12#1)(1993-11#1)(2005-8#1)(2009-6#1)(2012-1#1)
of glucocorticoid##44##2##(1990-11#1)(1990-2#1)(1991-1#1)(1991-12#1)(1992-12#1)(1993-11#2)(1993-12#3)(1993-4#1)(1993-7#1)(1993-8#1)(1994-11#5)(1994-2#2)(1994-5#1)(1995-12#1)(1995-5#1)(1995-7#1)(1996-12#1)(1996-7#2)(1997-4#1)(2005-3#2)(2005-8#2)(2006-10#4)(2007-11#2)(2008-4#2)(2009-6#1)(2011-1#1)(2012-1#2)
of glucocorticoid-induced osteoporosis##3##3##(2005-3#1)(2012-12#2)
of glucocorticoid-induced##5##2##(2005-3#2)(2008-6#1)(2012-12#2)
of glucocorticoids and##5##3##(1994-5#1)(1994-9#1)(1995-10#1)(2007-8#1)(2012-1#1)
of glucocorticoids in the treatment of##2##6##(2008-11#1)(2012-12#1)
of glucocorticoids in##5##3##(1994-11#1)(2007-11#1)(2008-11#1)(2008-8#1)(2012-12#1)
of glucocorticoids on##2##3##(2008-7#1)(2008-9#1)
of glucocorticoids##26##2##(1991-12#1)(1994-11#2)(1994-5#1)(1994-9#3)(1995-10#1)(1995-12#2)(1996-12#1)(2007-11#2)(2007-3#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2011-2#1)(2012-1#1)(2012-12#1)
of glucokinase in##2##3##(1990-7#1)(1997-4#1)
of glucokinase##9##2##(1990-7#6)(1997-4#3)
of gluconeogenesis in##2##3##(1991-3#1)(1994-8#1)
of gluconeogenesis##10##2##(1991-3#2)(1991-7#1)(1993-3#1)(1994-8#1)(1995-4#1)(1995-8#1)(2011-2#3)
of gluconic acid and sorbitol##2##5##(2008-6#2)
of gluconic acid##5##3##(2008-10#3)(2008-6#2)
of glucose 6-phosphate dehydrogenase##2##4##(2008-5#2)
of glucose 6-phosphate##4##3##(1992-11#1)(1994-12#1)(2008-5#2)
of glucose and ethanol##7##4##(1995-4#3)(2008-10#4)
of glucose and fructose##3##4##(1995-1#1)(2008-6#2)
of glucose and glutamine metabolism in hybridoma##2##7##(2008-11#2)
of glucose and glutamine metabolism##3##5##(2008-11#3)
of glucose and glutamine##7##4##(1994-5#1)(2008-11#6)
of glucose and insulin##3##4##(1991-2#1)(1992-3#1)(1996-11#1)
of glucose and its oligomers##2##5##(1996-1#2)
of glucose and its##3##4##(1990-7#1)(1996-1#2)
of glucose and urea##3##4##(2008-11#1)(2008-3#2)
of glucose and xylose##2##4##(2008-5#1)(2013-1#1)
of glucose and##54##3##(1990-7#1)(1991-2#1)(1992-3#1)(1993-12#1)(1994-10#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-4#3)(1995-8#1)(1996-1#2)(1996-11#1)(1996-4#1)(1996-5#1)(2007-2#1)(2007-8#1)(2008-10#9)(2008-11#7)(2008-3#2)(2008-5#2)(2008-6#3)(2008-7#3)(2009-3#2)(2010-10#1)(2010-7#1)(2011-2#2)(2013-1#2)(2013-8#1)
of glucose as##3##3##(1995-10#1)(1995-8#1)(2011-2#1)
of glucose by the##2##4##(2008-10#2)
of glucose by##7##3##(1991-5#1)(1992-6#1)(1997-3#1)(2008-10#3)(2008-5#1)
of glucose concentration##10##3##(1991-4#1)(1992-12#2)(1992-4#1)(2006-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-8#1)
of glucose consumption##2##3##(2008-5#1)(2008-7#1)
of glucose control##3##3##(1990-6#1)(2008-1#1)(2012-5#1)
of glucose drink##2##3##(2007-1#2)
of glucose for##2##3##(1995-8#1)(2008-10#1)
of glucose from##7##3##(1990-11#1)(1991-9#1)(1994-6#1)(1996-4#1)(1997-7#1)(2009-10#1)(2011-2#1)
of glucose grown##2##3##(1990-11#1)(2006-8#1)
of glucose homeostasis in##2##4##(1994-6#1)(2007-5#1)
of glucose homeostasis##16##3##(1990-3#1)(1991-7#1)(1994-2#1)(1994-6#1)(2007-5#1)(2008-1#5)(2008-4#3)(2011-1#1)(2011-2#2)
of glucose in a##2##4##(1991-5#1)(2008-3#1)
of glucose in the growth medium##2##6##(1991-10#1)(2009-10#1)
of glucose in the presence of##3##6##(1990-2#1)(2008-10#2)
of glucose in the range##2##5##(2008-10#2)
of glucose in the##14##4##(1990-2#1)(1991-10#1)(1994-8#1)(1997-3#1)(2007-8#1)(2008-10#6)(2009-10#1)(2013-8#2)
of glucose in##34##3##(1990-2#1)(1991-10#1)(1991-5#1)(1994-3#1)(1994-8#1)(1995-8#1)(1997-3#1)(2006-10#1)(2007-8#1)(2008-10#16)(2008-11#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-5#1)(2012-1#2)(2013-8#2)
of glucose into##3##3##(1990-11#1)(1997-7#1)(2006-9#1)
of glucose intolerance and/or insulin resistance as obligatory##2##8##(2008-3#2)
of glucose intolerance##4##3##(1995-7#1)(2005-10#1)(2008-3#2)
of glucose is##3##3##(1997-3#1)(2005-10#1)(2010-5#1)
of glucose isomerase##2##3##(2008-5#2)
of glucose levels in##2##4##(2007-8#1)(2008-10#1)
of glucose metabolism in##3##4##(1993-11#1)(2008-7#1)(2013-8#1)
of glucose metabolism##16##3##(1990-2#1)(1991-12#1)(1993-11#1)(1993-3#1)(1996-2#1)(1997-8#1)(2006-10#1)(2006-5#1)(2006-8#1)(2008-1#3)(2008-3#1)(2008-4#1)(2008-7#1)(2013-8#1)
of glucose molecules##2##3##(2007-8#1)(2008-10#1)
of glucose on the##2##4##(1992-9#1)(1997-4#1)
of glucose on##7##3##(1992-9#1)(1994-8#1)(1997-4#2)(2007-8#1)(2008-7#1)(2010-11#1)
of glucose oxidase (GOx)##2##4##(2008-10#2)
of glucose oxidase and##3##4##(2007-8#1)(2008-10#2)
of glucose oxidase##15##3##(2007-6#1)(2007-8#1)(2008-10#11)(2008-5#2)
of glucose oxidation##2##3##(1997-8#1)(2007-8#1)
of glucose phosphate isomerase##2##4##(1997-6#1)(2008-5#1)
of glucose phosphorylation##2##3##(1990-11#1)(1991-10#1)
of glucose sensors##4##3##(2008-1#2)(2009-11#2)
of glucose starvation##2##3##(2008-11#2)
of glucose to##10##3##(1991-7#1)(1995-8#4)(2008-1#1)(2008-10#2)(2013-1#2)
of glucose tolerance##6##3##(1995-11#1)(2008-1#2)(2008-4#1)(2008-7#1)(2011-2#1)
of glucose transport in##3##4##(1991-5#1)(1994-12#1)(2008-7#1)
of glucose transport##12##3##(1991-5#1)(1992-11#2)(1994-11#2)(1994-12#1)(1994-6#1)(1995-11#1)(2007-11#1)(2008-1#1)(2008-7#1)(2010-11#1)
of glucose transporter##8##3##(1990-8#1)(1991-3#1)(1991-4#1)(1993-8#1)(1994-3#1)(1995-11#1)(2008-11#2)
of glucose transporters in##2##4##(1990-2#2)
of glucose transporters##8##3##(1990-11#1)(1990-2#3)(1992-6#1)(1993-6#1)(1994-12#1)(2008-7#1)
of glucose uptake by##2##4##(1991-7#1)(2008-10#1)
of glucose uptake##7##3##(1991-4#1)(1991-7#1)(1993-2#1)(1996-12#1)(2006-10#1)(2008-10#1)(2008-11#1)
of glucose using##3##3##(1996-7#1)(2008-10#1)(2008-5#1)
of glucose utilization in##4##4##(1990-11#1)(1994-8#2)(2012-1#1)
of glucose utilization was (i)##2##5##(1997-8#2)
of glucose utilization##8##3##(1990-11#1)(1990-2#1)(1994-8#3)(1997-8#2)(2012-1#1)
of glucose was##11##3##(1990-11#1)(1992-4#1)(1994-6#1)(2007-8#1)(2008-10#6)(2008-6#1)
of glucose with##4##3##(1994-12#1)(2008-10#2)(2012-12#1)
of glucose##410##2##(1990-11#7)(1990-12#1)(1990-2#11)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#3)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#4)(1991-5#4)(1991-7#4)(1991-9#2)(1992-1#1)(1992-11#3)(1992-12#2)(1992-3#1)(1992-4#2)(1992-6#2)(1992-9#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#2)(1994-10#1)(1994-11#4)(1994-12#6)(1994-2#2)(1994-3#4)(1994-5#2)(1994-6#4)(1994-8#7)(1995-1#3)(1995-10#1)(1995-11#3)(1995-4#3)(1995-7#1)(1995-8#10)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#3)(1996-5#2)(1996-7#1)(1997-2#3)(1997-3#3)(1997-4#4)(1997-6#2)(1997-7#2)(1997-8#4)(2005-10#2)(2005-11#1)(2005-7#3)(2006-10#4)(2006-3#2)(2006-4#1)(2006-5#1)(2006-8#2)(2006-9#2)(2007-1#2)(2007-11#4)(2007-2#1)(2007-5#3)(2007-6#1)(2007-8#10)(2007-9#2)(2008-1#15)(2008-10#68)(2008-11#21)(2008-12#2)(2008-3#7)(2008-4#6)(2008-5#18)(2008-6#13)(2008-7#13)(2009-10#4)(2009-11#2)(2009-2#1)(2009-3#2)(2009-6#1)(2009-8#1)(2009-9#3)(2010-10#1)(2010-11#4)(2010-2#1)(2010-5#3)(2010-7#1)(2011-1#2)(2011-2#10)(2012-1#3)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#2)(2012-5#1)(2012-7#1)(2013-1#6)(2013-8#4)
of glucose-6-phosphatase mRNA##2##3##(1994-11#1)(1994-5#1)
of glucose-6-phosphatase##7##2##(1991-2#1)(1994-11#2)(1994-5#1)(1997-7#2)(2007-9#1)
of glucose-6-phosphate dehydrogenase and##2##4##(1991-5#1)(2008-11#1)
of glucose-6-phosphate dehydrogenase##8##3##(1991-5#2)(1995-12#1)(1995-6#2)(1996-9#1)(2007-12#1)(2008-11#1)
of glucose-6-phosphate##10##2##(1991-5#2)(1995-12#1)(1995-6#2)(1996-9#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)
of glucose-induced insulin secretion##2##4##(1991-10#1)(1995-10#1)
of glucose-induced##4##2##(1991-10#1)(1995-10#1)(2005-10#1)(2008-1#1)
of glucose-limited##2##2##(1995-4#1)(2008-6#1)
of glucose-mediated##2##2##(1997-2#2)
of glucose-sensitive##2##2##(1992-8#1)(1995-8#1)
of glucose-stimulated insulin release##2##4##(1996-6#1)(2008-11#1)
of glucose-stimulated insulin secretion##2##4##(1991-10#1)(2010-11#1)
of glucose-stimulated insulin##4##3##(1991-10#1)(1996-6#1)(2008-11#1)(2010-11#1)
of glucose-stimulated##5##2##(1991-10#1)(1996-6#1)(2008-11#2)(2010-11#1)
of glucosephosphate isomerase##2##3##(2008-5#2)
of glucosinolate hydrolysis products##2##4##(1997-2#1)(2008-10#1)
of glucosinolate##3##2##(1997-2#1)(2008-10#2)
of glucosinolates##2##2##(2004-2#1)(2008-10#1)
of glucosylceramide##3##2##(1990-5#1)(1994-3#1)(1996-9#1)
of glucuronidation##5##2##(1996-6#1)(2008-11#3)(2009-3#1)
of glucuronide##2##2##(1991-4#1)(1996-6#1)
of glue sniffing##2##3##(2007-7#2)
of glue##4##2##(1997-3#1)(2007-7#2)(2008-8#1)
of glutamate and GABA##2##4##(1991-10#1)(1994-2#1)
of glutamate and aspartate##2##4##(1991-3#1)(1995-6#1)
of glutamate and taurine##3##4##(1995-5#1)(1997-5#2)
of glutamate and##14##3##(1991-10#1)(1991-3#1)(1993-11#1)(1993-2#1)(1994-2#1)(1995-12#1)(1995-5#1)(1995-6#1)(1997-5#2)(2007-9#1)(2008-7#3)
of glutamate as##2##3##(1990-7#1)(2008-7#1)
of glutamate by##2##3##(1990-6#1)(2007-12#1)
of glutamate decarboxylase##5##3##(1996-5#2)(1996-9#2)(2007-11#1)
of glutamate dehydrogenase##4##3##(1994-3#1)(1995-11#1)(2008-4#2)
of glutamate from the##2##4##(1993-12#1)(2008-7#1)
of glutamate from##6##3##(1990-11#2)(1991-9#1)(1992-1#1)(1993-12#1)(2008-7#1)
of glutamate has been##2##4##(1992-8#1)(2011-2#1)
of glutamate in both##2##4##(1994-10#1)(2008-4#1)
of glutamate in the##8##4##(1991-11#1)(1991-3#1)(1992-11#1)(1994-2#1)(1996-1#1)(1996-10#1)(1997-8#1)(2007-9#1)
of glutamate in##18##3##(1990-11#1)(1990-12#2)(1991-11#1)(1991-3#1)(1992-11#1)(1994-10#1)(1994-2#1)(1996-1#1)(1996-10#1)(1997-4#1)(1997-8#1)(2007-9#1)(2008-11#1)(2008-4#1)(2009-4#1)(2012-1#1)(2012-12#1)
of glutamate on##2##3##(1995-12#1)(2008-11#1)
of glutamate receptor activity##2##4##(2008-1#2)
of glutamate receptor##14##3##(1990-2#1)(1990-8#1)(1993-9#2)(1994-11#1)(1995-5#1)(1996-1#1)(1996-3#1)(1996-5#2)(1996-9#1)(2008-1#2)(2008-7#1)
of glutamate receptors##17##3##(1991-3#1)(1994-8#1)(1995-5#1)(1996-8#2)(1997-2#1)(1997-6#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-3#1)(2009-3#1)(2012-12#4)(2012-2#1)
of glutamate release and##2##4##(1992-8#1)(2008-1#1)
of glutamate release##5##3##(1990-11#1)(1992-8#2)(1994-8#1)(2008-1#1)
of glutamate to##3##3##(1997-5#1)(1997-6#1)(2007-9#1)
of glutamate transporter##2##3##(1996-2#1)(1997-7#1)
of glutamate uptake and##2##4##(1997-8#1)(2008-11#1)
of glutamate uptake##5##3##(1990-11#1)(1990-12#2)(1997-8#1)(2008-11#1)
of glutamate##158##2##(1990-11#6)(1990-12#8)(1990-2#4)(1990-6#1)(1990-7#4)(1990-8#1)(1991-10#1)(1991-11#1)(1991-3#3)(1991-4#1)(1991-9#3)(1992-1#3)(1992-11#1)(1992-5#1)(1992-8#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#2)(1994-10#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-8#3)(1995-11#4)(1995-12#2)(1995-5#4)(1995-6#1)(1996-1#3)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#4)(1996-8#2)(1996-9#4)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#7)(1997-6#2)(1997-7#1)(1997-8#2)(2005-8#1)(2006-4#1)(2007-11#1)(2007-12#3)(2007-9#9)(2008-1#4)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#8)(2008-8#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-8#2)(2010-10#1)(2010-4#1)(2011-2#2)(2012-1#3)(2012-12#5)(2012-2#1)
of glutamate- and##2##3##(1991-4#1)(2008-7#1)
of glutamatergic neurons##2##3##(1990-7#1)(2009-8#1)
of glutamatergic neurotransmission##3##3##(1996-6#1)(2007-11#1)(2011-1#1)
of glutamatergic##15##2##(1990-7#1)(1991-5#1)(1991-9#1)(1994-10#1)(1996-6#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-7#2)(2009-8#1)(2011-1#1)
of glutamic acid (Glu)##2##4##(1991-5#1)(1994-6#1)
of glutamic acid and##2##4##(1992-3#1)(1994-2#1)
of glutamic acid by##2##4##(2008-10#2)
of glutamic acid on the oscillating##2##6##(2008-10#2)
of glutamic acid##18##3##(1990-5#1)(1991-5#1)(1991-8#1)(1992-3#1)(1994-2#3)(1994-6#1)(1996-12#1)(2008-10#6)(2011-2#1)(2013-1#1)(2013-8#1)
of glutamic##20##2##(1990-5#1)(1991-5#1)(1991-8#1)(1992-3#1)(1994-2#4)(1994-6#1)(1996-12#1)(2008-10#6)(2008-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
of glutaminase flux##2##3##(1990-3#2)
of glutaminase##7##2##(1990-3#3)(1997-1#1)(2007-12#1)(2008-11#2)
of glutamine and serine##2##4##(2008-11#2)
of glutamine and##3##3##(2008-11#3)
of glutamine at##2##3##(1990-8#1)(1994-9#1)
of glutamine in##5##3##(1993-9#3)(1995-3#1)(2008-11#1)
of glutamine synthetase in##2##4##(1992-12#1)(1996-12#1)
of glutamine synthetase##7##3##(1990-7#1)(1992-12#1)(1996-12#4)(1997-1#1)
of glutamine##43##2##(1990-3#3)(1990-7#2)(1990-8#1)(1991-5#1)(1991-7#1)(1992-12#1)(1993-8#2)(1993-9#3)(1994-11#1)(1994-9#1)(1995-3#1)(1996-12#4)(1996-7#2)(1997-1#1)(2005-10#1)(2006-10#1)(2008-11#16)(2013-8#1)
of glutaraldehyde##7##2##(1993-8#1)(2008-10#5)(2008-7#1)
of glutathione (GSH) and##3##4##(1991-9#1)(1994-2#1)(2008-10#1)
of glutathione (GSH)##7##3##(1990-2#1)(1991-9#1)(1994-2#1)(2008-10#2)(2008-7#1)(2010-2#1)
of glutathione S-transferase##9##3##(1991-1#1)(1992-3#1)(1992-6#1)(1995-12#1)(1995-6#1)(1995-8#1)(1997-7#1)(2008-12#1)(2013-1#1)
of glutathione S-transferases##2##3##(1990-2#1)(2006-10#1)
of glutathione and glutathione disulfide in human plasma and tobacco leaves##2##11##(2008-10#2)
of glutathione and##9##3##(1991-12#1)(1994-6#1)(1995-1#2)(2008-10#2)(2008-5#2)(2012-2#1)
of glutathione biosynthesis##2##3##(1992-7#1)(2009-10#1)
of glutathione by##2##3##(1990-3#1)(2013-1#1)
of glutathione depletion on the viability of##2##7##(1995-9#1)(2008-7#1)
of glutathione depletion##3##3##(1995-9#1)(1997-3#1)(2008-7#1)
of glutathione in neuron-rich##2##4##(1996-11#2)
of glutathione in the##2##4##(1994-5#1)(2008-5#1)
of glutathione in##7##3##(1992-8#1)(1994-5#1)(1996-11#2)(2008-10#2)(2008-5#1)
of glutathione on##2##3##(2008-11#1)(2012-2#1)
of glutathione peroxidase and glutathione reductase genes##3##7##(2013-1#3)
of glutathione peroxidase and glutathione reductase##5##6##(2013-1#5)
of glutathione peroxidase and##6##4##(1991-12#1)(2013-1#5)
of glutathione peroxidase in##3##4##(1990-5#1)(1994-6#2)
of glutathione peroxidase##16##3##(1990-4#1)(1990-5#1)(1991-12#2)(1991-9#1)(1993-8#2)(1994-6#2)(1995-8#1)(2008-10#1)(2013-1#5)
of glutathione reductase##8##3##(1992-1#2)(1994-3#1)(1995-3#4)(2011-2#1)
of glutathione s-transferase##2##3##(1991-6#1)(2012-2#1)
of glutathione synthesis and##2##4##(1992-7#2)
of glutathione synthesis##4##3##(1992-7#2)(1995-11#1)(2008-11#1)
of glutathione transferase##2##3##(1995-1#1)(1997-6#1)
of glutathione transferases##2##3##(1992-2#1)(1997-6#1)
of glutathione was##2##3##(1996-11#1)(2005-11#1)
of glutathione##119##2##(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1991-1#2)(1991-12#3)(1991-3#1)(1991-6#1)(1991-9#3)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#4)(1992-8#1)(1993-3#1)(1993-8#2)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#1)(1995-3#8)(1995-6#3)(1995-8#2)(1995-9#3)(1996-11#5)(1996-12#1)(1996-8#1)(1997-2#4)(1997-3#1)(1997-6#2)(1997-7#1)(2005-11#2)(2006-10#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#3)(2009-10#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-2#4)(2013-1#7)
of glutathione-S-transferase (GST) and##2##4##(1994-11#1)(2005-11#1)
of glutathione-S-transferase##4##2##(1994-11#1)(1995-2#1)(2005-11#1)(2013-7#1)
of glutathionylcobalamin (GSCbl)##2##3##(2008-10#2)
of gluten##3##2##(2006-2#1)(2008-10#1)(2011-2#1)
of glutinous##3##2##(2008-10#3)
of glyburide##6##2##(1991-12#1)(1994-2#5)
of glycaemic control in##2##4##(1992-9#1)(1995-2#1)
of glycaemic control##7##3##(1992-9#3)(1995-2#1)(1995-6#1)(1997-3#1)(2010-7#1)
of glycaemic##9##2##(1992-9#3)(1995-2#1)(1995-6#1)(1997-3#1)(2010-4#1)(2010-7#1)(2012-1#1)
of glycan##3##2##(2007-12#1)(2008-4#1)(2012-2#1)
of glycans##4##2##(2007-12#1)(2008-4#1)(2010-11#1)(2012-3#1)
of glycated albumin##3##3##(1993-6#1)(1995-1#1)(2009-11#1)
of glycated hemoglobin##3##3##(1996-2#1)(2006-6#1)(2011-2#1)
of glycated##11##2##(1991-5#1)(1993-6#3)(1995-1#1)(1996-2#1)(2006-6#1)(2007-2#1)(2009-11#1)(2011-2#1)(2012-1#1)
of glycation sites##2##3##(1992-12#1)(1995-1#1)
of glycation##9##2##(1992-12#1)(1992-7#1)(1994-6#1)(1995-1#4)(2007-2#2)
of glycemia##2##2##(2008-1#1)(2011-1#1)
of glycemic control##7##3##(1995-1#2)(2007-3#1)(2008-3#2)(2008-7#1)(2010-6#1)
of glycemic##12##2##(1995-1#2)(2007-3#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-11#2)(2010-6#1)(2012-5#1)
of glyceraldehyde 3-phosphate##3##3##(1992-1#2)(1992-8#1)
of glyceraldehyde##6##2##(1991-3#2)(1992-1#2)(1992-8#1)(2011-2#1)
of glyceraldehyde-3-phosphate dehydrogenase by##2##4##(1993-9#1)(1994-5#1)
of glyceraldehyde-3-phosphate dehydrogenase##3##3##(1993-9#2)(1994-5#1)
of glyceraldehyde-3-phosphate##4##2##(1990-7#1)(1993-9#2)(1994-5#1)
of glycerin##2##2##(2008-5#2)
of glycerol is##2##3##(1993-9#1)(2008-10#1)
of glycerol or##2##3##(2008-10#1)(2008-7#1)
of glycerol##21##2##(1990-5#1)(1991-12#1)(1991-8#1)(1992-7#1)(1993-3#1)(1993-9#2)(1994-11#1)(1994-12#1)(1995-4#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)
of glyceroplasmalopsychosine##2##2##(2009-10#2)
of glyceryl trinitrate##4##3##(1996-10#1)(2007-10#1)(2007-8#2)
of glyceryl##6##2##(1996-10#2)(2007-10#1)(2007-8#2)(2013-1#1)
of glycidol##3##2##(2008-9#3)
of glycine and GABA immunoreactivities##2##5##(1995-11#1)(1997-2#1)
of glycine and GABA##3##4##(1995-11#1)(1997-2#2)
of glycine and##13##3##(1991-10#1)(1994-6#1)(1994-9#1)(1995-11#1)(1997-2#3)(1997-7#1)(2006-10#4)(2008-10#1)
of glycine betaine##2##3##(2006-12#2)
of glycine by alanine at##2##5##(2008-10#2)
of glycine immunoreactivity##2##3##(1995-11#2)
of glycine in aqueous solutions of NaCl##2##7##(2006-10#2)
of glycine in aqueous##3##4##(2006-10#3)
of glycine in water +##2##5##(2006-10#2)
of glycine in##6##3##(2006-10#5)(2006-2#1)
of glycine on##2##3##(1995-3#2)
of glycine was##3##3##(1995-3#1)(1996-9#1)(1997-1#1)
of glycine were##2##3##(1990-7#1)(2006-10#1)
of glycine with an##2##4##(1991-6#1)(2006-10#1)
of glycine with##4##3##(1991-6#1)(2006-10#1)(2006-2#2)
of glycine##64##2##(1990-12#1)(1990-2#1)(1990-7#3)(1991-10#1)(1991-11#1)(1991-5#1)(1991-6#1)(1992-1#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-10#1)(1994-6#1)(1994-9#2)(1995-11#4)(1995-2#1)(1995-3#3)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-5#1)(1997-7#1)(2005-11#1)(2006-10#15)(2006-12#2)(2006-2#3)(2007-7#1)(2008-10#5)(2010-2#1)(2010-7#1)(2011-1#1)
of glycine- and GABA-immunoreactive##2##4##(1995-11#2)
of glycinebetaine##2##2##(1997-4#1)(2008-4#1)
of glycoconjugates in##2##3##(2012-1#2)
of glycoconjugates##9##2##(1993-7#1)(1995-2#1)(2007-8#1)(2008-4#2)(2010-11#1)(2011-2#1)(2012-1#2)
of glycogen and##3##3##(1994-3#1)(2007-12#1)(2008-7#1)
of glycogen metabolism##2##3##(1992-1#1)(2012-2#1)
of glycogen phosphorylase##4##3##(1991-11#2)(1992-5#2)
of glycogen synthase##6##3##(1995-8#1)(1996-2#1)(2008-1#2)(2011-1#1)(2012-2#1)
of glycogen##27##2##(1990-2#1)(1991-11#2)(1992-1#2)(1992-12#1)(1992-5#2)(1994-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-2#1)(1997-7#1)(2007-12#3)(2008-1#2)(2008-10#1)(2008-7#1)(2011-1#1)(2012-2#4)(2013-1#1)
of glycolate to glyoxylate##2##4##(1991-1#1)(1997-7#1)
of glycolate##4##2##(1991-1#2)(1997-7#1)(2008-8#1)
of glycolic acid in##2##4##(1991-1#1)(2008-5#1)
of glycolic acid##4##3##(1991-1#1)(2007-7#1)(2008-5#2)
of glycolic##5##2##(1991-1#1)(2007-7#1)(2008-5#3)
of glycolipid##4##2##(1990-4#1)(1992-1#1)(1993-9#1)(1996-9#1)
of glycolipids in##2##3##(1991-9#1)(1994-3#1)
of glycolipids##11##2##(1990-2#2)(1991-9#2)(1994-3#3)(1995-1#2)(2005-11#1)(2006-12#1)
of glycolysis and##3##3##(2007-6#1)(2010-12#1)(2010-7#1)
of glycolysis in##2##3##(1994-6#1)(2006-10#1)
of glycolysis##15##2##(1990-2#1)(1990-3#1)(1992-3#1)(1994-6#1)(1995-11#1)(1996-4#1)(1997-4#1)(1997-6#2)(2006-10#1)(2007-6#1)(2008-11#1)(2009-4#1)(2010-12#1)(2010-7#1)
of glycolytic flux##2##3##(1991-10#1)(2008-6#1)
of glycolytic oscillations##2##3##(1996-11#2)
of glycolytic##12##2##(1990-11#1)(1991-10#1)(1994-12#1)(1994-3#1)(1996-11#2)(1996-6#3)(2008-11#1)(2008-6#1)(2010-12#1)
of glyconanoparticles##2##2##(2008-8#2)
of glycopeptide 1##2##3##(1990-12#2)
of glycopeptides and##3##3##(1990-12#1)(1990-7#1)(2008-4#1)
of glycopeptides##7##2##(1990-12#1)(1990-7#1)(2008-3#1)(2008-4#3)(2010-11#1)
of glycophorin A##7##3##(1990-4#3)(1992-12#2)(1993-12#1)(2007-12#1)
of glycophorin##9##2##(1990-4#3)(1992-12#2)(1992-6#1)(1993-12#1)(1994-12#1)(2007-12#1)
of glycoprotein IIb/IIIa inhibitors##5##4##(2005-7#1)(2008-3#3)(2010-12#1)
of glycoprotein IIb/IIIa##6##3##(2005-7#1)(2008-3#4)(2010-12#1)
of glycoprotein##13##2##(1990-10#1)(1994-11#1)(1995-7#1)(1996-2#1)(2005-7#1)(2006-10#1)(2008-1#1)(2008-3#4)(2009-12#1)(2010-12#1)
of glycoproteins containing##2##3##(1990-12#1)(2008-4#1)
of glycoproteins with##2##3##(2008-1#1)(2008-7#1)
of glycoproteins##19##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-8#1)(1993-11#1)(1994-9#1)(1997-7#1)(2008-1#4)(2008-11#1)(2008-4#2)(2008-7#1)
of glycosaminoglycan##5##2##(1990-5#1)(1993-11#1)(1994-12#2)(1995-5#1)
of glycosaminoglycans and##4##3##(1995-5#1)(1997-5#1)(2007-11#1)(2011-1#1)
of glycosaminoglycans in##2##3##(1997-8#1)(2009-8#1)
of glycosaminoglycans##16##2##(1994-12#1)(1995-5#2)(1996-5#3)(1997-5#2)(1997-8#2)(2007-11#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-8#1)(2011-1#1)
of glycosidic##5##2##(1990-12#1)(1995-10#1)(1995-11#2)(1996-4#1)
of glycosphingolipid##3##2##(1992-1#1)(1995-1#1)(2007-7#1)
of glycosphingolipids##2##2##(1991-8#2)
of glycosyl hydrolase family##2##4##(1995-6#1)(2013-1#1)
of glycosyl hydrolases##2##3##(2006-8#2)
of glycosyl ureides by human intestinal brush border enzymes##2##9##(1997-8#2)
of glycosyl##9##2##(1990-12#1)(1995-6#1)(1996-10#1)(1997-8#2)(2006-8#2)(2009-8#1)(2013-1#1)
of glycosylated##11##2##(1990-12#1)(1991-2#1)(1992-12#2)(1994-9#1)(2006-12#3)(2008-8#1)(2010-11#1)(2013-1#1)
of glycosylation in the##2##4##(1991-1#1)(1992-12#1)
of glycosylation in##6##3##(1990-3#1)(1991-1#1)(1991-5#1)(1992-12#1)(1995-2#1)(2010-2#1)
of glycosylation of##2##3##(1990-12#1)(1993-1#1)
of glycosylation##27##2##(1990-12#1)(1990-3#1)(1990-7#2)(1991-1#2)(1991-5#2)(1992-12#1)(1992-6#1)(1993-1#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-2#2)(1996-8#3)(2008-11#5)(2008-4#1)(2010-2#1)(2011-2#1)
of glycosyltransferases##2##2##(1994-11#1)(2012-11#1)
of glycyrrhizic acid in##2##4##(2013-1#2)
of glycyrrhizic acid##4##3##(2013-1#4)
of glyoxalase I##4##3##(1991-12#1)(1991-5#1)(1995-9#2)
of glyphosate and aminomethylphosphonic acid##2##5##(2008-10#1)(2011-1#1)
of glyphosate and##3##3##(2008-10#2)(2011-1#1)
of glyphosate in##2##3##(2007-10#1)(2010-1#1)
of glyphosate was##2##3##(2008-10#1)(2010-1#1)
of glyphosate##12##2##(2007-10#2)(2008-10#4)(2010-1#3)(2010-2#1)(2011-1#2)
of goal##2##2##(2008-5#2)
of goals and objectives##2##4##(1990-12#1)(1991-12#1)
of goals and##7##3##(1990-12#1)(1991-12#1)(1996-12#1)(2006-8#1)(2007-5#1)(2008-2#1)(2008-5#1)
of goals##12##2##(1990-12#1)(1991-12#1)(1996-12#1)(2006-8#1)(2007-12#1)(2007-5#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-12#1)(2013-8#1)
of goat and sheep##2##4##(2008-12#1)(2010-4#1)
of goat##12##2##(1995-6#1)(2007-7#1)(2008-10#1)(2008-12#1)(2010-3#1)(2010-4#6)(2013-1#1)
of goats##2##2##(1996-12#1)(1997-5#1)
of goblet cells##3##3##(1994-11#1)(2008-5#1)(2010-8#1)
of goblet##4##2##(1994-11#2)(2008-5#1)(2010-8#1)
of goethite##2##2##(2005-11#2)
of going beyond##2##3##(2012-1#1)(2012-3#1)
of going##3##2##(2011-1#1)(2012-1#1)(2012-3#1)
of goiter##5##2##(2006-4#2)(2007-4#2)(2011-1#1)
of gold and palladium##2##4##(2010-4#2)
of gold and##4##3##(2006-5#1)(2008-10#1)(2010-4#2)
of gold at##2##3##(1994-5#2)
of gold by##3##3##(2007-12#1)(2008-10#2)
of gold in the##2##4##(1992-11#1)(2008-2#1)
of gold in##4##3##(1992-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
of gold nanoparticles with##3##4##(2005-11#1)(2007-8#2)
of gold nanoparticles##15##3##(2005-11#1)(2007-8#3)(2008-10#1)(2008-11#1)(2010-12#4)(2010-7#1)(2011-1#1)(2012-2#3)
of gold nanorods##2##3##(2007-4#1)(2013-1#1)
of gold nanoshells for##2##4##(2013-1#2)
of gold nanoshells with##2##4##(2013-1#2)
of gold nanoshells##4##3##(2013-1#4)
of gold on the##3##4##(2008-10#2)(2010-7#1)
of gold particles##3##3##(2007-12#1)(2008-5#1)(2008-9#1)
of gold sodium thiomalate in##2##5##(1994-5#1)(1995-3#1)
of gold sodium thiomalate##3##4##(1994-5#2)(1995-3#1)
of gold therapy##3##3##(1992-11#3)
of gold were studied##2##4##(1994-5#1)(2008-10#1)
of gold##89##2##(1991-9#1)(1992-11#5)(1994-10#1)(1994-5#7)(1995-3#1)(2005-11#1)(2005-4#1)(2006-2#1)(2006-5#1)(2007-12#4)(2007-4#1)(2007-8#4)(2008-10#20)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#1)(2009-2#1)(2010-12#4)(2010-4#5)(2010-5#1)(2010-7#2)(2011-1#2)(2012-12#1)(2012-2#4)(2013-1#8)
of gold(I)##2##2##(2008-5#2)
of gold(III)##3##2##(2008-10#1)(2008-5#2)
of gold(i)##3##2##(2008-5#3)
of golden hamsters##3##3##(1992-3#1)(1995-12#1)(2010-2#1)
of goldfilled##2##2##(2008-10#2)
of goldfish##4##2##(1994-11#1)(2010-2#2)(2011-2#1)
of gonad##3##2##(2007-3#1)(2008-3#1)(2009-11#1)
of gonadal development##2##3##(2007-3#1)(2010-8#1)
of gonadal steroids##3##3##(1995-5#1)(2006-10#1)(2008-4#1)
of gonadal##11##2##(1993-2#1)(1995-5#1)(2006-10#1)(2007-10#1)(2007-3#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-8#1)
of gonadotropes##2##2##(1995-10#2)
of gonadotrophic cells##5##3##(2007-3#5)
of gonadotrophins##2##2##(2007-11#1)(2011-1#1)
of gonadotrophs##2##2##(1994-6#2)
of gonadotropic hormones##2##3##(1990-9#1)(1992-11#1)
of gonadotropin secretion##2##3##(1993-5#1)(1996-4#1)
of gonadotropin##7##2##(1990-3#1)(1992-12#1)(1993-5#1)(1994-3#1)(1994-5#1)(1996-4#1)(1996-8#1)
of gonadotropin-releasing hormone (GnRH)##3##4##(1992-8#1)(1995-11#1)(1997-5#1)
of gonadotropin-releasing hormone##6##3##(1992-8#1)(1993-6#1)(1994-5#1)(1995-11#1)(1995-5#1)(1997-5#1)
of gonadotropin-releasing hormones##2##3##(1994-8#1)(1995-5#1)
of gonadotropin-releasing##8##2##(1992-8#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-5#2)(1997-5#1)
of gonadotropins##2##2##(1994-9#1)(2007-3#1)
of gonads##2##2##(2007-3#1)(2008-5#1)
of gonococcal urethritis##2##3##(2007-8#2)
of gonococcal##5##2##(1993-12#1)(1995-12#1)(2006-10#1)(2007-8#2)
of gonorrhoea##4##2##(1990-3#2)(1990-4#1)(2007-3#1)
of good and##5##3##(1996-5#1)(2007-11#1)(2007-7#1)(2009-2#1)(2010-10#1)
of good genes##2##3##(2008-8#1)(2013-1#1)
of good health##4##3##(2010-2#1)(2012-1#2)(2012-12#1)
of good nutrition##2##3##(2012-12#1)(2012-3#1)
of good quality and##2##4##(2008-10#2)
of good quality##9##3##(2007-6#1)(2008-10#2)(2008-11#2)(2008-7#2)(2009-6#1)(2010-4#1)
of good work##2##3##(2007-4#1)(2011-1#1)
of good working##2##3##(2008-4#1)(2010-4#1)
of good wound care##2##4##(2007-11#1)(2012-10#1)
of good wound##3##3##(2007-11#1)(2012-10#2)
of good##85##2##(1990-12#1)(1991-2#1)(1992-10#1)(1992-12#2)(1993-1#1)(1994-1#1)(1994-5#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-1#1)(2006-12#3)(2006-3#1)(2007-11#4)(2007-12#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#3)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#1)(2009-6#1)(2009-8#3)(2010-10#2)(2010-12#2)(2010-2#1)(2010-4#3)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-10#2)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#1)
of goods and##2##3##(1991-2#1)(2008-11#1)
of goods##5##2##(1991-2#1)(2005-5#1)(2008-10#2)(2008-11#1)
of goose##2##2##(1993-4#2)
of gophers##2##2##(2008-8#2)
of gorillas##2##2##(2007-2#1)(2009-10#1)
of gossypol was##2##3##(2008-8#2)
of gossypol were##2##3##(1990-11#2)
of gossypol##7##2##(1990-11#4)(1993-9#1)(2008-8#2)
of gout in##3##3##(2006-10#2)(2010-9#1)
of gout##17##2##(1990-11#1)(1991-8#1)(2006-10#8)(2007-11#3)(2010-4#2)(2010-9#1)(2011-2#1)
of governance##4##2##(1996-1#2)(2007-4#1)(2013-7#1)
of government and##4##3##(1996-3#1)(2008-9#1)(2012-3#2)
of government health services##2##4##(2012-3#2)
of government in##4##3##(1996-12#1)(1996-3#1)(2010-8#1)(2012-2#1)
of government intervention##2##3##(1990-9#1)(1995-1#1)
of government is##2##3##(2007-12#1)(2008-6#1)
of government##44##2##(1990-12#1)(1990-9#1)(1991-2#1)(1992-1#2)(1992-2#1)(1993-9#1)(1994-1#1)(1994-2#3)(1994-7#1)(1995-1#1)(1995-2#1)(1995-3#2)(1996-12#2)(1996-2#1)(1996-3#3)(1996-7#1)(2005-5#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#6)(2013-7#3)
of governments##2##2##(1995-3#1)(2012-3#1)
of gowns and gloves##3##4##(1992-10#3)
of gp120##10##2##(1994-9#4)(1995-2#1)(1996-1#1)(2008-12#3)(2013-1#1)
of gp130##3##2##(1996-5#1)(1996-9#1)(1997-7#1)
of gp160##2##2##(1994-8#2)
of gp18##2##2##(1990-5#2)
of gp41##9##2##(1994-12#5)(1995-3#1)(1997-4#1)(2011-3#1)(2013-8#1)
of gp60a and gp60b were##2##5##(1994-9#2)
of gp60a##3##2##(1994-9#3)
of gp75LNGFR##2##2##(1994-2#2)
of gpA##3##2##(1996-8#3)
of grade 1##4##3##(1994-2#1)(2008-4#1)(2011-2#1)(2013-8#1)
of grade 2##3##3##(2008-6#1)(2013-1#1)(2013-8#1)
of grade 3##2##3##(2008-5#1)(2013-8#1)
of grade 4 neutropenia##2##4##(2008-6#1)(2008-7#1)
of grade 4##3##3##(1990-10#1)(2008-6#1)(2008-7#1)
of grade IIIB##2##3##(2008-7#1)(2013-8#1)
of grade IIIC##2##3##(2013-8#2)
of grade IV##3##3##(2007-10#1)(2008-12#2)
of grade inflation##2##3##(2006-12#2)
of grade##28##2##(1990-10#1)(1991-5#1)(1994-2#1)(2006-12#2)(2007-10#1)(2007-2#1)(2008-12#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2011-2#1)(2013-1#1)(2013-8#9)
of graded exercise##2##3##(2008-4#2)
of graded##8##2##(1990-11#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-4#3)(2011-12#1)
of graded-index##2##2##(2008-2#1)(2008-3#1)
of gradient##5##2##(1990-9#1)(1997-4#1)(2008-3#1)(2008-5#1)(2010-2#1)
of gradient-enriched##2##2##(1997-3#2)
of gradient-index lenses with##2##4##(2008-3#2)
of gradient-index##4##2##(2008-2#1)(2008-3#3)
of gradients##2##2##(2008-2#2)
of gradual##2##2##(2008-11#1)(2010-8#1)
of gradually##3##2##(2006-3#1)(2012-2#1)(2013-1#1)
of graduate education##2##3##(2007-9#1)(2011-1#1)
of graduate medical education##6##4##(1991-8#2)(2007-4#2)(2008-11#1)(2011-2#1)
of graduate students##2##3##(1996-1#1)(2009-4#1)
of graduate##16##2##(1991-1#1)(1991-8#3)(1992-2#1)(1995-1#1)(1996-1#1)(1996-3#1)(2007-4#2)(2007-6#1)(2007-9#1)(2008-11#1)(2009-4#1)(2011-1#1)(2011-2#1)
of graduates and##2##3##(1996-3#1)(2007-4#1)
of graduates##11##2##(1991-2#1)(1991-8#1)(1996-1#1)(1996-3#1)(2007-12#2)(2007-4#1)(2007-9#1)(2012-3#3)
of graft and##3##3##(2007-11#1)(2008-4#1)(2009-9#1)
of graft failure##3##3##(1995-2#1)(2007-8#1)(2011-2#1)
of graft function##2##3##(1991-9#1)(1994-5#1)
of graft is##2##3##(1990-4#1)(2011-3#1)
of graft loss due to##2##5##(2007-11#1)(2013-1#1)
of graft loss##6##3##(2007-11#2)(2008-8#1)(2009-2#2)(2013-1#1)
of graft patency##2##3##(2007-8#2)
of graft rejection##2##3##(2005-12#1)(2008-5#1)
of graft versus host disease (GVHD)##2##6##(2007-11#2)
of graft versus host disease##4##5##(2007-11#3)(2012-12#1)
of graft vessel disease##2##4##(2007-8#2)
of graft##40##2##(1990-4#1)(1991-9#1)(1993-3#1)(1994-5#1)(1995-2#1)(1997-8#1)(2005-12#1)(2006-9#1)(2007-10#1)(2007-11#7)(2007-8#6)(2008-4#1)(2008-5#2)(2008-8#1)(2009-2#2)(2009-9#2)(2011-2#3)(2011-3#1)(2012-11#1)(2012-12#2)(2012-8#1)(2013-1#2)
of graft-versus-host disease##7##3##(1995-12#2)(1997-8#1)(2007-11#1)(2007-12#1)(2009-10#1)(2012-11#1)
of grafted##8##2##(2004-9#2)(2005-11#1)(2008-10#1)(2008-3#1)(2009-5#1)(2010-2#1)(2013-1#1)
of grafting##6##2##(1995-2#2)(1996-4#1)(2007-8#2)(2008-3#1)
of grafts in the##2##4##(1990-5#1)(1991-2#1)
of grafts in##3##3##(1990-5#1)(1991-2#1)(2011-3#1)
of grafts##16##2##(1990-5#1)(1991-2#1)(1993-12#1)(2005-10#1)(2006-10#1)(2007-11#2)(2007-8#3)(2008-1#2)(2008-6#2)(2009-2#1)(2011-3#1)
of grain boundaries##3##3##(1990-7#1)(2006-12#1)(2007-5#1)
of grain yield##2##3##(2008-10#1)(2013-8#1)
of grain##21##2##(1990-7#1)(1997-8#1)(2006-12#3)(2006-4#1)(2007-12#1)(2007-5#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#2)(2013-1#1)(2013-8#1)
of grains was##3##3##(1990-10#2)(2007-8#1)
of grains##8##2##(1990-10#3)(1990-12#1)(1994-3#1)(2007-8#1)(2008-12#1)(2010-1#1)
of gram negative##2##3##(1991-2#1)(2007-7#1)
of gram positive##2##3##(2007-7#1)(2008-12#1)
of gram##6##2##(1991-2#1)(1992-1#1)(2007-7#3)(2008-12#1)
of gram-negative bacteria##2##3##(2007-7#1)(2008-2#1)
of gram-negative to gram-positive bacteria##2##5##(2013-1#2)
of gram-negative##8##2##(2007-7#1)(2008-10#1)(2008-2#1)(2010-6#1)(2011-3#1)(2013-1#2)(2013-7#1)
of gram-positive and gram-negative##2##4##(2007-12#1)(2008-5#1)
of gram-positive##7##2##(2006-10#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-5#1)(2011-2#1)(2013-7#1)
of gramicidin##5##2##(1990-11#1)(1992-5#1)(1993-8#2)(1996-7#1)
of gramicidinS in##2##3##(1994-2#2)
of gramicidinS##3##2##(1994-2#3)
of granisetron##4##2##(1991-11#1)(2010-12#2)(2010-7#1)
of granite##2##2##(2008-1#1)(2008-10#1)
of grant writing##2##3##(2005-12#1)(2007-8#1)
of granular cell tumor##2##4##(2009-7#1)(2010-12#1)
of granular content##2##3##(2008-1#2)
of granular endoplasmic reticulum##2##4##(2008-7#1)(2012-11#1)
of granular sludge##2##3##(2013-1#2)
of granular##13##2##(1995-3#1)(2008-1#2)(2008-10#2)(2008-7#1)(2009-7#1)(2010-12#1)(2012-11#1)(2013-1#4)
of granularity##7##2##(2008-7#2)(2009-12#1)(2013-1#4)
of granulated##2##2##(2008-11#1)(2010-1#1)
of granulation tissue was##2##4##(2006-9#1)(2010-12#1)
of granulation tissue##6##3##(2005-8#1)(2006-9#2)(2007-8#2)(2010-12#1)
of granulation##7##2##(1991-8#1)(2005-8#1)(2006-9#2)(2007-8#2)(2010-12#1)
of granule cell##8##3##(1990-5#1)(1993-2#1)(1994-8#1)(1995-5#1)(1996-9#2)(2006-3#1)(2010-12#1)
of granule cells and##2##4##(1991-6#1)(1995-5#1)
of granule cells in##2##4##(1994-8#1)(2008-6#1)
of granule cells##8##3##(1991-3#1)(1991-6#1)(1994-8#1)(1995-5#1)(1995-7#1)(1997-5#1)(2008-6#1)(2010-12#1)
of granule##19##2##(1990-5#1)(1991-3#1)(1991-6#1)(1991-8#1)(1993-2#1)(1994-8#2)(1995-5#2)(1995-7#1)(1996-9#2)(1997-5#1)(2006-3#1)(2008-4#1)(2008-6#2)(2010-12#2)
of granule-cell##2##2##(1991-6#2)
of granules##4##2##(1990-5#1)(1995-5#1)(2010-11#1)(2013-1#1)
of granulocyte colony-stimulating factor in##2##5##(2008-11#2)
of granulocyte colony-stimulating factor##7##4##(1994-12#1)(2004-1#1)(2007-11#1)(2008-11#2)(2012-1#1)(2013-1#1)
of granulocyte##8##2##(1994-12#1)(2004-1#1)(2007-11#2)(2008-11#2)(2012-1#1)(2013-1#1)
of granulocyte-macrophage colony-stimulating factor##4##4##(1993-11#1)(1994-9#2)(2008-3#1)
of granulocyte-macrophage##5##2##(1993-11#1)(1993-3#1)(1994-9#2)(2008-3#1)
of granulocyte/macrophage##2##2##(2006-10#1)(2008-4#1)
of granulocytes and##4##3##(1990-12#1)(1990-3#1)(2006-7#1)(2011-2#1)
of granulocytes##8##2##(1990-12#1)(1990-3#1)(2006-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#2)
of granulocytic anaplasmosis##2##3##(2008-12#1)(2013-1#1)
of granulocytic##6##2##(2007-1#1)(2008-12#1)(2012-1#3)(2013-1#1)
of granuloma##3##2##(1996-12#1)(2005-11#1)(2008-4#1)
of granulomas##5##2##(1990-5#1)(1992-5#1)(2006-10#1)(2007-10#1)(2010-10#1)
of granulomatous inflammation##2##3##(2006-10#1)(2008-4#1)
of granulomatous##8##2##(2006-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#2)
of granulosa cell##2##3##(1995-12#1)(2012-1#1)
of granulosa cells##5##3##(1992-4#1)(1995-12#1)(1996-11#1)(1996-8#1)(2008-12#1)
of granulosa##8##2##(1992-4#1)(1995-12#2)(1996-11#2)(1996-8#1)(2008-12#1)(2012-1#1)
of grape black rot##3##4##(2008-10#3)
of grape##15##2##(2008-10#13)(2011-1#1)(2012-11#1)
of grapefruit juice##2##3##(2008-8#1)(2011-1#1)
of grapefruit##4##2##(2008-10#2)(2008-8#1)(2011-1#1)
of grapes and##2##3##(2010-5#1)(2012-11#1)
of grapes##10##2##(2008-10#6)(2008-8#1)(2010-5#1)(2012-11#1)(2013-1#1)
of grapevine and##2##3##(2008-10#1)(2010-9#1)
of grapevine downy mildew##2##4##(2008-10#2)
of grapevine leaves by##2##4##(2008-10#2)
of grapevine##14##2##(2008-10#11)(2010-9#3)
of grapevines##3##2##(2008-10#2)(2012-2#1)
of graphene##6##2##(2009-2#1)(2012-2#4)(2013-8#1)
of graphical models##3##3##(2010-10#1)(2010-2#2)
of graphical##7##2##(1994-3#1)(2010-10#1)(2010-2#2)(2012-2#1)(2013-1#2)
of graphics##2##2##(2008-6#1)(2011-1#1)
of graphite##7##2##(2005-4#2)(2007-8#1)(2008-10#2)(2010-2#1)(2012-2#1)
of graphitic layer##2##3##(2006-12#2)
of graphitic structure##2##3##(2006-12#2)
of graphitic##4##2##(2006-12#4)
of graphs##2##2##(1995-3#1)(2008-3#1)
of grass shrimp##2##3##(2010-4#2)
of grass##7##2##(2005-7#1)(2006-12#1)(2008-10#1)(2008-7#1)(2010-4#2)(2011-12#1)
of grass-fed##2##2##(2007-8#2)
of grasses and##3##3##(2008-10#1)(2008-8#2)
of grasses##7##2##(2007-3#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-8#2)
of grasshoppers##4##2##(2013-7#4)
of grassland##4##2##(2008-9#1)(2013-8#3)
of grating couplers##2##3##(2008-2#2)
of grating efficiency##2##3##(2008-2#2)
of grating##28##2##(1992-7#2)(2007-11#3)(2007-12#6)(2008-2#10)(2008-3#4)(2013-8#3)
of grating-assisted##4##2##(2007-12#2)(2008-3#2)
of gratings written##2##3##(2007-12#2)
of gratings##12##2##(2007-11#2)(2007-12#6)(2008-2#2)(2008-3#2)
of gratitude##4##2##(2008-12#2)(2012-11#2)
of grave##2##2##(1996-3#1)(1996-6#1)
of gravid##2##2##(2010-8#1)(2012-2#1)
of gravidas' knowledge##5##3##(1990-8#5)
of gravimetric##2##2##(1994-3#1)(2007-3#1)
of gravitational##3##2##(1995-12#1)(1996-5#1)(2013-8#1)
of gravity and##2##3##(2007-1#1)(2007-12#1)
of gravity is##2##3##(1995-5#1)(2007-6#1)
of gravity##18##2##(1994-2#1)(1995-5#1)(1997-5#2)(2006-10#1)(2006-11#1)(2007-1#1)(2007-12#2)(2007-6#2)(2007-9#1)(2008-11#1)(2008-2#3)(2008-3#1)(2010-10#1)
of gray leaf spot of maize##2##6##(2008-10#2)
of gray leaf spot of perennial ryegrass turf##2##8##(2008-10#2)
of gray leaf spot of##5##5##(2008-10#5)
of gray leaf spot##7##4##(2008-10#7)
of gray matter##3##3##(1997-5#1)(2008-11#1)(2009-9#1)
of gray mold disease##2##4##(1997-4#1)(2008-10#1)
of gray mold##4##3##(1997-4#1)(2008-10#3)
of gray##20##2##(1991-5#1)(1997-1#1)(1997-4#1)(1997-5#1)(2007-12#1)(2007-4#1)(2008-10#10)(2008-11#1)(2008-3#2)(2009-9#1)
of grazing on chemical soil properties and vegetation cover##2##9##(2008-12#2)
of grazing##7##2##(1996-12#2)(2005-7#1)(2008-12#2)(2010-2#1)(2013-7#1)
of great benefit for##3##4##(1990-8#1)(2007-8#1)(2008-4#1)
of great benefit##6##3##(1990-8#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-4#1)(2013-1#1)
of great clinical value##3##4##(1991-12#1)(2007-11#1)(2010-5#1)
of great concern##5##3##(1994-1#1)(2008-10#2)(2008-12#1)(2010-8#1)
of great diversity##2##3##(2007-12#1)(2008-10#1)
of great help in##2##4##(1997-2#1)(2006-7#1)
of great help##6##3##(1990-6#1)(1997-2#1)(2006-10#1)(2006-7#1)(2010-7#2)
of great importance for the##4##5##(2006-10#1)(2007-9#1)(2011-2#1)(2012-12#1)
of great importance for##14##4##(1991-2#1)(1992-12#1)(1993-5#1)(1996-11#1)(2006-10#1)(2006-12#1)(2007-9#1)(2008-2#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
of great importance in the##4##5##(1991-9#1)(1997-3#1)(2005-11#1)(2008-10#1)
of great importance in##14##4##(1991-9#1)(1997-1#1)(1997-3#1)(2005-11#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-5#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#2)
of great importance to##5##4##(2006-10#1)(2006-7#1)(2008-9#1)(2009-1#1)(2013-8#1)
of great importance##50##3##(1990-11#1)(1990-7#1)(1991-2#1)(1991-9#1)(1992-12#1)(1993-5#1)(1995-6#1)(1996-11#1)(1997-1#1)(1997-3#2)(1997-5#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-7#1)(2007-4#1)(2007-5#1)(2007-9#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-1#1)(2009-5#1)(2010-11#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#2)
of great interest because##3##4##(1990-7#1)(2011-2#1)(2013-1#1)
of great interest for many##2##5##(1992-11#1)(2012-1#1)
of great interest for##9##4##(1991-2#1)(1992-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-5#1)(2012-1#1)(2012-2#1)
of great interest in the##2##5##(2008-10#2)
of great interest in##4##4##(2007-12#1)(2008-10#2)(2009-5#1)
of great interest to##3##4##(2008-8#1)(2009-5#1)(2010-9#1)
of great interest##34##3##(1990-4#1)(1990-7#1)(1991-2#1)(1992-11#1)(1992-6#1)(1996-11#1)(2006-12#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-11#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
of great practical importance##2##4##(2008-8#1)(2010-7#1)
of great practical##4##3##(2008-10#1)(2008-2#1)(2008-8#1)(2010-7#1)
of great relevance for the##2##5##(2007-8#1)(2012-12#1)
of great relevance##5##3##(2006-10#1)(2007-8#1)(2010-7#1)(2012-12#1)(2012-2#1)
of great significance in the##2##5##(2005-10#1)(2008-10#1)
of great significance in##4##4##(2005-10#1)(2008-10#2)(2009-2#1)
of great significance##6##3##(2005-10#1)(2007-12#1)(2007-4#1)(2008-10#2)(2009-2#1)
of great use for##2##4##(2008-2#1)(2009-3#1)
of great use##4##3##(2007-7#1)(2008-2#1)(2009-3#1)(2012-2#1)
of great value for the##2##5##(1995-9#1)(1996-11#1)
of great value for##4##4##(1995-9#1)(1996-11#1)(2013-1#2)
of great value in the##4##5##(2005-5#1)(2006-7#1)(2007-8#1)(2009-8#1)
of great value in##8##4##(1991-6#1)(2005-5#1)(2006-7#1)(2007-8#2)(2009-8#1)(2010-4#1)(2013-8#1)
of great value##17##3##(1991-6#1)(1992-8#1)(1995-9#1)(1996-11#1)(2005-5#1)(2006-7#1)(2007-3#1)(2007-8#2)(2007-9#1)(2009-8#1)(2010-4#1)(2010-8#1)(2013-1#2)(2013-7#1)(2013-8#1)
of great##186##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-5#1)(1993-9#1)(1994-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-11#3)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(2005-10#1)(2005-11#1)(2005-5#1)(2006-10#6)(2006-11#6)(2006-12#3)(2006-2#1)(2006-4#2)(2006-7#3)(2007-11#2)(2007-12#4)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#3)(2008-10#21)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#7)(2008-8#2)(2008-9#3)(2009-1#1)(2009-2#3)(2009-3#1)(2009-5#4)(2009-8#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#5)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#4)(2013-1#9)(2013-7#1)(2013-8#5)
of greater importance##2##3##(1990-2#1)(1997-8#1)
of greater relevance##2##3##(2008-10#2)
of greater than 1##2##4##(1992-7#1)(2007-12#1)
of greater than 100##2##4##(1995-6#1)(2008-3#1)
of greater than 2##2##4##(1990-12#1)(2008-2#1)
of greater than 200##2##4##(1991-8#1)(2008-3#1)
of greater than 3##2##4##(2006-10#1)(2012-3#1)
of greater than 50%##2##4##(1990-3#1)(1991-7#1)
of greater than 80%##2##4##(1995-6#1)(2008-3#1)
of greater than 90%##2##4##(2007-11#1)(2008-3#1)
of greater than or equal to##2##6##(1990-4#1)(1991-9#1)
of greater than##34##3##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-5#1)(1992-7#1)(1994-12#1)(1995-6#2)(1997-4#2)(2006-10#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#7)(2011-2#1)(2012-2#1)(2012-3#1)
of greater thickness##2##3##(2008-10#1)(2008-3#1)
of greater trochanter##2##3##(2005-3#1)(2006-10#1)
of greater##82##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-5#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#1)(1997-4#2)(1997-8#1)(2004-12#1)(2005-3#1)(2006-10#3)(2006-7#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-5#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-11#1)(2009-7#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
of greatest concern##2##3##(2006-10#1)(2008-2#1)
of greatest interest##2##3##(1995-12#1)(2005-9#1)
of greatest##11##2##(1991-3#1)(1995-12#1)(1995-3#1)(2005-9#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-2#1)(2009-12#1)(2010-12#1)(2010-7#1)
of greatly##2##2##(1991-12#1)(1994-8#1)
of green and black tea##2##5##(2009-8#2)
of green and yellow vegetables##2##5##(2008-10#1)(2011-2#1)
of green and##4##3##(2008-10#1)(2009-8#2)(2011-2#1)
of green coffee##3##3##(1992-8#1)(1996-10#1)(2008-10#1)
of green fluorescent protein (GFP)##3##5##(2006-12#1)(2008-1#1)(2008-7#1)
of green fluorescent protein##12##4##(2005-8#1)(2006-12#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-7#4)
of green fluorescent##13##3##(2005-8#1)(2006-12#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-7#4)(2008-9#1)
of green mold##2##3##(2008-10#2)
of green plants##2##3##(1994-12#1)(1997-4#1)
of green tea catechins##2##4##(2008-11#1)(2013-7#1)
of green tea extract##2##4##(2009-11#2)
of green tea##12##3##(1992-7#2)(1993-9#2)(2008-10#1)(2008-11#1)(2009-11#3)(2009-5#1)(2009-8#1)(2013-7#1)
of green##63##2##(1991-5#1)(1992-5#1)(1992-7#2)(1992-8#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1996-10#1)(1997-4#1)(2005-8#1)(2006-12#1)(2007-11#3)(2007-12#1)(2007-8#2)(2008-1#3)(2008-10#10)(2008-11#5)(2008-4#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#3)(2009-5#1)(2009-8#3)(2010-6#1)(2011-12#2)(2011-2#3)(2012-2#1)(2013-7#1)
of green-yellow colour##2##3##(2011-2#2)
of greenhouse##6##2##(2007-9#1)(2008-10#3)(2008-12#1)(2012-2#1)
of greenhouse-grown##3##2##(2008-10#3)
of gregarious behaviour##2##3##(2012-2#2)
of gregarious##3##2##(2008-9#1)(2012-2#2)
of grey cast iron##4##4##(2008-10#4)
of grey matter##2##3##(1995-8#1)(2012-1#1)
of grey##12##2##(1990-4#1)(1995-8#1)(1996-12#1)(2005-11#1)(2008-10#4)(2009-11#1)(2010-8#2)(2012-1#1)
of grief and##3##3##(1990-10#2)(1993-3#1)
of grief##12##2##(1990-10#3)(1993-3#2)(1993-6#1)(1995-11#2)(2007-8#2)(2008-12#1)(2013-7#1)
of grinding tools##2##3##(1994-6#1)(2008-3#1)
of grinding##6##2##(1994-6#2)(2008-10#1)(2008-3#3)
of grip force control##3##4##(2013-1#3)
of grip strength##4##3##(1997-5#1)(2008-9#2)(2012-12#1)
of grip##8##2##(1997-5#1)(2008-9#3)(2012-12#1)(2013-1#3)
of groin##2##2##(1991-6#1)(2011-2#1)
of grooming##2##2##(2007-1#2)
of grooves##3##2##(2008-1#1)(2008-3#2)
of gross anatomical##2##3##(2008-10#1)(2008-7#1)
of gross fractures##2##3##(2007-4#2)
of gross national product##3##4##(1990-12#1)(1991-12#1)(1992-3#1)
of gross saponins of Tribulus terrestris##2##6##(2011-3#2)
of gross##31##2##(1990-12#1)(1990-8#1)(1991-12#2)(1991-2#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1994-2#1)(1997-6#1)(2007-1#1)(2007-4#2)(2007-7#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-2#1)(2011-2#1)(2011-3#2)(2013-8#1)
of ground beef##4##3##(2007-3#2)(2010-4#2)
of ground squirrel##2##3##(2008-8#2)
of ground squirrels##2##3##(1995-12#2)
of ground state##5##3##(1991-8#1)(1993-12#1)(1993-8#1)(2006-10#1)(2010-2#1)
of ground water##6##3##(2007-10#2)(2008-1#2)(2008-10#1)(2009-6#1)
of ground##29##2##(1991-2#1)(1991-8#1)(1993-12#1)(1993-8#1)(1995-12#2)(1996-7#1)(1997-5#1)(2006-10#1)(2007-10#2)(2007-3#2)(2008-1#2)(2008-10#3)(2008-3#2)(2008-7#1)(2008-8#2)(2009-6#1)(2010-2#1)(2010-4#2)(2012-12#1)(2013-1#1)
of ground-based##3##2##(2008-3#2)(2013-8#1)
of ground-glass##3##2##(2005-8#2)(2012-2#1)
of ground-state##2##2##(2008-2#1)(2008-3#1)
of groundnut oil on blood glucose##2##6##(2007-9#2)
of groundnut rosette disease##2##4##(2008-10#2)
of groundnut rosette##3##3##(2008-10#3)
of groundnut##13##2##(2007-10#3)(2007-9#2)(2008-10#8)
of groundwater of##2##3##(2007-10#2)
of groundwater##9##2##(1996-4#1)(2007-10#2)(2007-9#1)(2008-1#1)(2008-10#1)(2009-6#1)(2013-1#2)
of group 1 were##2##4##(2008-10#1)(2008-9#1)
of group 1##9##3##(1991-3#3)(2008-1#1)(2008-10#2)(2008-9#1)(2010-5#1)(2011-12#1)
of group 2##7##3##(1991-10#1)(1991-3#3)(2008-10#2)(2008-9#1)
of group A Streptococcus##2##4##(2007-8#1)(2009-9#1)
of group A and##2##4##(2007-9#1)(2012-2#1)
of group A##9##3##(1993-12#1)(2007-12#1)(2007-6#1)(2007-8#2)(2007-9#1)(2009-9#1)(2012-11#1)(2012-2#1)
of group B Streptococcus type III oligosaccharides##2##7##(1995-6#2)
of group B Streptococcus##3##4##(1995-6#2)(2006-10#1)
of group B beta-haemolytic streptococci##2##5##(2006-7#2)
of group B streptococcal infection##2##5##(2006-10#2)
of group B streptococcal##3##4##(1991-8#1)(2006-10#2)
of group B streptococcus##2##4##(2006-10#2)
of group B##13##3##(1991-8#1)(1995-6#2)(2006-10#5)(2006-7#2)(2008-11#1)(2008-5#1)(2012-2#1)
of group C was##2##4##(2007-8#1)(2013-8#1)
of group C##6##3##(1992-4#1)(2007-6#1)(2007-8#1)(2010-7#1)(2012-2#1)(2013-8#1)
of group F##2##3##(1997-2#2)
of group G##2##3##(1997-2#1)(2007-7#1)
of group I PLA2 mRNA##2##5##(1992-2#2)
of group I PLA2##3##4##(1992-2#3)
of group I isolates##2##4##(2008-10#2)
of group I metabotropic##3##4##(1996-12#2)(2009-3#1)
of group I ribozymes##2##4##(1996-8#2)
of group I##17##3##(1992-2#4)(1993-8#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-12#2)(1996-8#2)(1997-7#1)(2007-8#1)(2008-10#2)(2009-3#1)
of group II isolates##2##4##(2008-10#2)
of group II##10##3##(1994-12#2)(1994-9#1)(2007-8#1)(2008-10#5)(2008-8#1)
of group III##5##3##(1992-4#1)(2008-10#3)(2008-8#1)
of group and individual##3##4##(1995-12#1)(2008-11#1)(2010-7#1)
of group cognitive-behavioral##2##3##(2008-6#2)
of group differences##4##3##(1992-6#3)(1997-3#1)
of group formation##2##3##(2009-5#1)(2013-1#1)
of group living##2##3##(1995-8#1)(2012-2#1)
of group medical##4##3##(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)
of group size##2##3##(2008-8#2)
of group therapy##2##3##(2008-11#1)(2012-1#1)
of group##139##2##(1990-8#1)(1991-10#1)(1991-3#7)(1991-4#1)(1991-8#1)(1991-9#1)(1992-2#4)(1992-4#2)(1992-6#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-9#3)(1995-1#1)(1995-12#2)(1995-6#3)(1995-8#1)(1996-12#2)(1996-8#2)(1997-2#3)(1997-3#1)(1997-7#2)(2006-10#6)(2006-2#1)(2006-5#1)(2006-7#3)(2007-11#1)(2007-12#2)(2007-2#2)(2007-6#2)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#15)(2008-11#6)(2008-2#2)(2008-5#2)(2008-6#3)(2008-8#5)(2008-9#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#3)
of group-delay ripples##2##3##(2007-11#2)
of group-delay##3##2##(2007-11#2)(2008-3#1)
of group-velocity dispersion in##2##4##(2007-12#1)(2008-3#1)
of group-velocity dispersion##4##3##(2007-12#2)(2008-3#2)
of group-velocity##7##2##(2007-11#1)(2007-12#2)(2008-1#2)(2008-3#2)
of grouping and##3##3##(2008-4#1)(2009-5#1)(2012-2#1)
of grouping##6##2##(1992-3#1)(1995-2#1)(2008-4#1)(2009-5#1)(2010-7#1)(2012-2#1)
of groups A##2##3##(2007-8#1)(2008-10#1)
of groups I and II##4##5##(2008-10#4)
of groups I##5##3##(2008-10#5)
of groups in##2##3##(1994-9#1)(2009-1#1)
of groups of##7##3##(1990-3#1)(1995-2#1)(2006-5#1)(2008-10#2)(2009-4#1)(2010-12#1)
of groups##43##2##(1990-3#1)(1991-12#2)(1992-4#1)(1993-11#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-2#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-5#1)(2006-7#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-8#2)(2008-10#9)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-12#3)(2009-4#1)(2010-12#1)(2010-4#2)(2012-2#1)
of growing concern##4##3##(1990-5#1)(2005-11#1)(2007-12#1)(2008-8#1)
of growing importance for##2##4##(2007-10#1)(2012-3#1)
of growing importance##6##3##(1990-12#1)(2007-10#1)(2008-10#1)(2008-11#1)(2012-1#1)(2012-3#1)
of growing neurites##2##3##(1991-3#1)(1994-11#1)
of growing old##2##3##(2006-2#1)(2008-2#1)
of growing##37##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-3#1)(1994-11#1)(1996-1#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#7)(2008-11#4)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-11#1)(2012-1#1)(2012-12#1)(2012-3#1)
of growth and decreased##2##4##(1994-5#1)(2008-5#1)
of growth and development##6##4##(1996-11#1)(2006-10#1)(2008-11#1)(2009-8#1)(2010-8#1)(2011-1#1)
of growth and differentiation of##4##5##(1990-12#1)(1993-9#1)(1997-2#1)(2008-11#1)
of growth and differentiation##7##4##(1990-12#1)(1991-4#1)(1993-9#1)(1995-11#1)(1997-2#1)(2007-12#1)(2008-11#1)
of growth and reproduction##2##4##(1991-11#1)(1996-5#1)
of growth and shortening##3##4##(1992-5#1)(1995-1#2)
of growth and survival##3##4##(1991-3#2)(2013-1#1)
of growth and##50##3##(1990-12#1)(1991-1#1)(1991-11#1)(1991-3#2)(1991-4#1)(1992-5#1)(1993-9#1)(1994-5#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-7#1)(2005-8#1)(2006-10#2)(2007-12#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#4)(2013-1#3)(2013-8#1)
of growth arrest##6##3##(1995-2#1)(1996-10#1)(1997-3#1)(2007-10#1)(2008-11#1)(2009-5#1)
of growth at##3##3##(2006-12#2)(2008-11#1)
of growth by##5##3##(1991-10#1)(1994-10#1)(1994-8#1)(1995-2#1)(2008-8#1)
of growth charts##2##3##(2006-2#2)
of growth cone##3##3##(1994-11#3)
of growth cones##3##3##(1991-7#1)(1995-9#1)(1997-6#1)
of growth during##2##3##(2008-7#1)(2009-8#1)
of growth factor receptor##2##4##(1990-12#1)(1996-4#1)
of growth factor receptors##4##4##(1993-6#1)(2007-11#1)(2010-1#1)(2012-1#1)
of growth factor##16##3##(1990-12#2)(1992-9#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-3#1)(1996-4#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-1#1)(2012-1#1)(2012-11#1)(2012-12#1)
of growth factors and cytokines##2##5##(1994-3#1)(1994-9#1)
of growth factors and##7##4##(1992-8#1)(1994-3#1)(1994-5#1)(1994-9#1)(1997-8#1)(2008-1#1)(2008-9#1)
of growth factors by##2##4##(1993-11#1)(1994-10#1)
of growth factors in breast##2##5##(1990-12#1)(1996-4#1)
of growth factors in##6##4##(1990-12#1)(1993-8#1)(1996-4#1)(2007-12#1)(2008-8#1)(2012-12#1)
of growth factors may##2##4##(1995-3#1)(2008-5#1)
of growth factors such as##3##5##(1995-11#1)(2006-2#1)(2007-11#1)
of growth factors##47##3##(1990-12#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-3#1)(1996-12#1)(1996-4#2)(1996-5#1)(1997-8#1)(2005-7#1)(2006-2#1)(2007-11#3)(2007-12#2)(2007-9#1)(2008-1#2)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-8#2)
of growth hormone (GH) deficiency##2##5##(1996-10#1)(2008-4#1)
of growth hormone (GH) on##2##5##(2006-1#1)(2010-5#1)
of growth hormone (GH) secretion##2##5##(2006-1#1)(2006-9#1)
of growth hormone (GH)##13##4##(1991-1#1)(1995-10#1)(1996-10#1)(1997-5#1)(2006-1#2)(2006-9#2)(2008-3#1)(2008-4#1)(2010-5#1)(2013-1#1)(2013-7#1)
of growth hormone and prolactin##2##5##(1993-2#2)
of growth hormone and##4##4##(1993-2#2)(2008-6#1)(2010-8#1)
of growth hormone deficiency##3##4##(1997-8#1)(2007-11#2)
of growth hormone in the##3##5##(2006-1#1)(2007-11#1)(2013-1#1)
of growth hormone in##8##4##(1994-8#2)(2006-1#1)(2007-11#1)(2012-3#1)(2013-1#1)(2013-7#2)
of growth hormone receptor (GHR)##2##5##(2008-9#1)(2010-5#1)
of growth hormone receptor##4##4##(1993-2#1)(2008-9#2)(2010-5#1)
of growth hormone replacement##2##4##(1993-2#1)(1997-8#1)
of growth hormone therapy##2##4##(1996-12#1)(2012-2#1)
of growth hormone##46##3##(1990-12#1)(1990-8#2)(1991-1#2)(1992-6#1)(1993-2#4)(1994-8#3)(1995-10#1)(1996-10#1)(1996-12#1)(1997-5#1)(1997-8#2)(2006-1#3)(2006-6#1)(2006-9#2)(2007-11#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#2)(2009-2#1)(2010-5#3)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#3)
of growth hormone-releasing factor##2##4##(1990-2#1)(1991-9#1)
of growth in##10##3##(1990-12#2)(1992-2#1)(1993-9#1)(1994-3#1)(1994-5#1)(1997-1#1)(2004-10#1)(2008-10#1)(2013-7#1)
of growth inhibition##6##3##(1990-5#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-5#1)
of growth is##2##3##(1993-11#1)(2008-7#1)
of growth of human##2##4##(1992-9#1)(2008-10#1)
of growth of the##2##4##(1994-5#1)(2011-2#1)
of growth of##19##3##(1990-12#1)(1990-7#2)(1992-9#1)(1994-10#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-9#1)(1996-3#1)(1997-1#1)(2005-10#1)(2007-5#1)(2008-10#2)(2008-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
of growth on##4##3##(1995-4#1)(2006-5#1)(2008-10#1)(2010-12#1)
of growth or##3##3##(2007-12#1)(2008-10#1)(2010-8#1)
of growth phase##2##3##(1991-12#1)(2005-11#1)
of growth rate and##2##4##(1994-3#1)(2010-8#1)
of growth rate on##2##4##(1994-2#1)(2012-2#1)
of growth rate##8##3##(1994-2#1)(1994-3#1)(2007-11#2)(2007-12#1)(2008-11#1)(2010-8#1)(2012-2#1)
of growth rates##5##3##(1991-11#2)(2008-10#1)(2008-8#2)
of growth stimulatory##2##3##(2008-6#1)(2008-7#1)
of growth temperature##2##3##(2011-2#2)
of growth under##2##3##(1993-9#1)(2008-10#1)
of growth was not##2##4##(1995-1#1)(2008-8#1)
of growth was##5##3##(1995-1#1)(1995-4#1)(2008-5#1)(2008-8#1)(2011-12#1)
of growth were##7##3##(1992-5#1)(2004-4#1)(2008-11#3)(2010-8#1)(2013-7#1)
of growth##360##2##(1990-10#1)(1990-12#10)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#2)(1991-1#5)(1991-10#1)(1991-11#3)(1991-12#1)(1991-3#2)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-2#4)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#3)(1994-1#1)(1994-10#3)(1994-11#6)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#5)(1994-6#1)(1994-7#1)(1994-8#10)(1994-9#2)(1995-1#4)(1995-10#1)(1995-11#4)(1995-12#1)(1995-2#4)(1995-3#3)(1995-4#3)(1995-8#2)(1995-9#2)(1996-10#2)(1996-11#1)(1996-12#2)(1996-3#3)(1996-4#3)(1996-5#2)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-10#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-1#4)(2006-10#2)(2006-12#2)(2006-2#3)(2006-5#2)(2006-6#1)(2006-8#2)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#15)(2007-12#6)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#14)(2008-11#15)(2008-12#2)(2008-3#1)(2008-4#6)(2008-5#9)(2008-6#7)(2008-7#8)(2008-8#7)(2008-9#5)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#5)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-5#5)(2010-7#1)(2010-8#6)(2011-1#5)(2011-12#1)(2011-2#11)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#8)(2013-7#6)(2013-8#4)
of growth-arrest genes##2##3##(1992-12#2)
of gsa1##2##2##(1995-3#2)
of guanethidine##5##2##(1990-7#1)(1991-11#2)(1995-12#1)(1997-4#1)
of guanidine chloride##3##3##(1990-10#3)
of guanidine hydrochloride and##2##4##(1993-2#1)(1995-3#1)
of guanidine hydrochloride with the##2##5##(1993-3#2)
of guanidine hydrochloride with##4##4##(1993-3#3)(1993-6#1)
of guanidine hydrochloride##14##3##(1991-5#1)(1992-6#2)(1993-2#1)(1993-3#5)(1993-6#1)(1995-3#1)(1995-5#3)
of guanidine x HCl##2##4##(2008-4#2)
of guanidine##20##2##(1990-10#3)(1991-5#1)(1992-6#3)(1993-2#1)(1993-3#5)(1993-6#1)(1995-3#1)(1995-5#3)(2008-4#2)
of guanine and##4##3##(1992-7#1)(1994-8#1)(1997-1#1)(2008-11#1)
of guanine at the##2##4##(2006-12#1)(2008-10#1)
of guanine bases##2##3##(1990-5#2)
of guanine in the presence of##2##6##(2008-10#2)
of guanine in the##4##4##(1992-9#1)(2006-12#1)(2008-10#2)
of guanine in##6##3##(1992-9#1)(1997-4#1)(2006-12#1)(2008-10#3)
of guanine nucleotide binding proteins##2##5##(1992-7#1)(1993-3#1)
of guanine nucleotide exchange factors##2##5##(1995-3#2)
of guanine nucleotide exchange##5##4##(1991-11#1)(1994-8#1)(1995-3#2)(2006-12#1)
of guanine nucleotide##12##3##(1990-5#1)(1990-8#1)(1991-11#1)(1992-11#1)(1992-7#2)(1993-3#1)(1994-8#1)(1995-3#2)(1996-5#1)(2006-12#1)
of guanine nucleotide-binding##3##3##(1993-7#1)(1995-3#2)
of guanine nucleotides on the##2##5##(1990-5#2)
of guanine nucleotides on##4##4##(1990-5#2)(1991-1#1)(1992-11#1)
of guanine nucleotides with the##3##5##(1991-5#1)(1995-5#2)
of guanine nucleotides##11##3##(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-5#1)(1992-11#1)(1993-6#1)(1995-3#1)(1995-5#2)
of guanine##51##2##(1990-5#5)(1990-7#2)(1990-8#2)(1991-1#1)(1991-11#1)(1991-5#1)(1992-11#2)(1992-7#3)(1992-9#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-8#3)(1995-3#5)(1995-5#2)(1996-5#1)(1997-1#1)(1997-4#1)(1997-7#1)(2006-12#4)(2007-3#1)(2007-8#1)(2008-10#9)(2008-11#1)
of guanosine 5'-O-(3-thiotriphosphate) (GTP gamma S)##2##6##(1990-6#1)(1992-11#1)
of guanosine and##2##3##(1997-8#1)(2009-12#1)
of guanosine triphosphate (GTP)##2##4##(1991-9#1)(2008-7#1)
of guanosine triphosphate##3##3##(1991-9#1)(2008-7#1)(2009-12#1)
of guanosine##21##2##(1990-6#1)(1991-9#1)(1992-10#1)(1992-11#1)(1994-12#1)(1994-9#1)(1995-8#1)(1997-8#1)(2007-11#1)(2007-9#1)(2008-4#6)(2008-7#1)(2009-12#3)(2010-10#1)
of guanylate cyclase in##4##4##(1990-5#2)(1991-10#2)
of guanylate cyclase##13##3##(1990-11#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-10#2)(1991-9#1)(1992-11#1)(1993-6#1)(1995-2#1)(1997-4#1)(2006-10#1)
of guanylate##15##2##(1990-11#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-10#2)(1991-4#1)(1991-9#1)(1992-11#1)(1993-6#1)(1995-2#1)(1997-4#2)(2006-10#1)
of guanylin##4##2##(1994-12#1)(1994-9#3)
of guanylyl cyclase##7##3##(1990-11#2)(1995-2#1)(1995-3#1)(1996-1#1)(2008-4#2)
of guanylyl##8##2##(1990-11#2)(1995-2#1)(1995-3#1)(1996-1#1)(2008-4#3)
of guest molecules##2##3##(2006-12#1)(2010-12#1)
of guest##4##2##(2006-12#1)(2008-10#1)(2010-12#2)
of guidance and##3##3##(2008-11#1)(2008-12#2)
of guidance##7##2##(2007-1#1)(2007-11#1)(2008-11#1)(2008-12#2)(2008-5#1)(2011-1#1)
of guide##3##2##(2007-12#1)(2011-2#2)
of guided modes##3##3##(2007-11#1)(2007-12#2)
of guided waves##4##3##(2007-12#2)(2008-1#1)(2008-2#1)
of guided##11##2##(2007-11#1)(2007-12#5)(2008-1#1)(2008-2#1)(2012-3#2)(2013-1#1)
of guided-mode resonance filters##2##4##(2008-3#2)
of guided-wave##5##2##(2007-12#2)(2008-1#1)(2008-2#2)
of guideline development##3##3##(2006-2#1)(2008-7#1)(2008-8#1)
of guideline##8##2##(2006-2#1)(2007-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2013-1#3)
of guidelines and##3##3##(1992-2#1)(2008-7#1)(2009-4#1)
of guidelines for##3##3##(1994-7#1)(2008-7#1)(2013-1#1)
of guidelines in##2##3##(1994-3#1)(2010-11#1)
of guidelines to##2##3##(1996-6#1)(2008-1#1)
of guidelines##21##2##(1992-10#1)(1992-2#1)(1994-1#1)(1994-3#2)(1994-7#1)(1996-3#2)(1996-4#1)(1996-6#1)(2006-2#1)(2007-4#1)(2008-1#1)(2008-7#2)(2008-9#1)(2009-4#1)(2010-11#2)(2011-2#1)(2013-1#1)
of guiding principles##2##3##(2007-10#1)(2008-11#1)
of guiding##7##2##(2007-10#1)(2007-12#1)(2008-11#2)(2008-9#1)(2011-2#1)(2012-1#1)
of guilt##2##2##(1992-2#1)(2012-12#1)
of guilty##2##2##(2011-2#1)(2012-2#1)
of guinea pig celiac ganglion##2##5##(1991-5#2)
of guinea pig ileum##2##4##(1991-5#1)(1995-12#1)
of guinea pig liver transglutaminase##2##5##(1992-8#1)(1995-2#1)
of guinea pig liver##3##4##(1992-8#1)(1995-2#1)(1995-3#1)
of guinea pig spermatozoa##2##4##(2008-8#2)
of guinea pig##24##3##(1991-2#1)(1991-3#1)(1991-5#3)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-7#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1997-3#1)(1997-7#1)(2008-8#3)(2013-1#1)
of guinea pigs##4##3##(1994-8#1)(1995-12#1)(2008-7#1)(2011-1#1)
of guinea##28##2##(1991-2#1)(1991-3#1)(1991-5#3)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1997-3#1)(1997-7#1)(2008-7#1)(2008-8#3)(2011-1#1)(2013-1#1)
of guinea-pig##13##2##(1990-10#1)(1990-5#1)(1990-7#2)(1991-9#1)(1992-1#1)(1993-11#1)(1993-3#1)(1994-5#1)(1997-4#1)(1997-7#1)(2008-2#1)(2009-12#1)
of guinea-pigs##2##2##(1990-7#1)(1995-12#1)
of gum tragacanth##3##3##(2012-11#3)
of gum##6##2##(1995-3#1)(2008-5#1)(2012-11#4)
of gummy##3##2##(2008-10#1)(2012-3#1)(2013-8#1)
of gun##2##2##(1995-2#1)(2011-2#1)
of gunshot residues##2##3##(2013-7#2)
of gunshot wounds##2##3##(2008-9#1)(2013-7#1)
of gunshot##5##2##(2008-8#1)(2008-9#1)(2013-7#3)
of guppies from##2##3##(2008-8#1)(2012-3#1)
of gustatory##6##2##(1992-11#2)(2008-11#1)(2008-2#1)(2009-10#1)(2010-2#1)
of gut bacteria##2##3##(2006-8#1)(2011-1#1)
of gut##13##2##(1990-12#1)(2005-10#1)(2006-10#4)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
of gutta-percha##2##2##(1991-3#1)(2009-8#1)
of gynecologic malignancy##2##3##(1991-3#1)(2013-8#1)
of gynecologic tumors##2##3##(1993-10#1)(2011-1#1)
of gynecologic##10##2##(1991-3#1)(1992-3#1)(1993-10#1)(1993-3#1)(2007-3#1)(2007-8#1)(2011-1#2)(2012-3#1)(2013-8#1)
of gynecological##3##2##(2010-11#1)(2011-1#2)
of gypsum application on##2##4##(2008-12#2)
of gypsum##4##2##(2008-12#4)
of gypsy##2##2##(2008-9#2)
of gyrase##3##2##(1994-12#1)(1994-9#2)
of gyration##15##2##(1992-7#2)(1994-9#1)(1996-11#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-5#1)(2007-7#1)(2008-2#2)(2008-3#2)(2008-9#1)
of h-TR beta 1 to##2##5##(1991-2#1)(1996-4#1)
of h-TR beta 1##6##4##(1991-2#1)(1993-8#2)(1996-4#3)
of hASCs##3##2##(2012-5#1)(2012-6#2)
of hBD-2 mRNA##2##3##(2008-11#2)
of hBM-MSCs##2##2##(2009-12#2)
of hBMSCs on the regenerated A##2##6##(2008-5#2)
of hBMSCs##4##2##(2008-5#3)(2013-7#1)
of hCDCs##2##2##(2012-12#2)
of hCG##14##2##(1990-5#1)(1992-12#1)(1992-7#1)(1993-12#3)(1993-6#1)(1994-5#1)(1996-11#1)(1996-12#1)(2006-5#1)(2010-10#2)(2011-2#1)
of hCaT1##2##2##(2008-11#2)
of hDRS##3##2##(1994-12#3)
of hESC##6##2##(2008-11#2)(2008-9#4)
of hESCs and##2##3##(2009-3#1)(2009-4#1)
of hESCs##4##2##(2008-1#1)(2009-3#1)(2009-4#2)
of hEp##3##2##(1993-12#2)(1993-6#1)
of hFF##2##2##(1994-2#2)
of hFGF-10##2##2##(2011-3#2)
of hFH##5##2##(1993-9#5)
of hFIX protein##3##3##(2008-8#2)(2008-9#1)
of hFIX##8##2##(2008-8#5)(2008-9#3)
of hFSH-beta##2##2##(1990-4#2)
of hGH##2##2##(1992-6#1)(2008-11#1)
of hGR C638S##2##3##(1995-10#2)
of hHSP90##2##2##(1994-3#2)
of hIAPP##2##2##(1994-8#2)
of hIK1##3##2##(2008-8#3)
of hIL-6 and##2##3##(2008-8#2)
of hIL-6##9##2##(1992-8#2)(2008-11#4)(2008-8#3)
of hIL-6R (V106-P322)##3##3##(2008-8#3)
of hIL-6R with##2##3##(2008-8#2)
of hIL-6R##5##2##(2008-8#5)
of hKLK2##2##2##(1993-6#2)
of hMLH1##3##2##(2008-4#3)
of hMSCs cultured on the##2##5##(2008-5#2)
of hMSCs cultured##3##3##(2008-11#1)(2008-5#2)
of hMSCs in the presence of FGF-2##2##7##(2008-11#2)
of hMSCs in##4##3##(2008-11#2)(2008-5#1)(2012-12#1)
of hMSCs##16##2##(2008-11#5)(2008-5#4)(2010-8#3)(2012-11#2)(2012-12#2)
of hMSH2##2##2##(1995-6#2)
of hMss4##2##2##(1995-8#2)
of hSIM2##2##2##(1996-6#2)
of hTERT overexpressed endothelial##2##4##(2009-8#2)
of hTERT transcription##2##3##(2008-11#2)
of hTERT##8##2##(2008-11#4)(2009-8#3)(2010-8#1)
of hTERT-immortalized cells##2##3##(2008-11#2)
of hTGF alpha##5##3##(1995-2#5)
of hTNF-alpha##2##2##(1994-3#2)
of hTR##2##2##(1991-6#2)
of hTg mRNA##2##3##(1991-7#2)
of hWRS is##2##3##(1993-6#2)
of hWRS##5##2##(1993-6#5)
of haFGF##2##2##(1991-2#2)
of habitat change##2##3##(2008-8#2)
of habitat fragmentation##2##3##(2008-8#1)(2012-1#1)
of habitat in the##2##4##(2008-8#1)(2008-9#1)
of habitat patches##7##3##(2006-5#1)(2007-9#1)(2008-8#3)(2008-9#2)
of habitat saturation##2##3##(2008-8#2)
of habitat selection##2##3##(2008-8#2)
of habitat structure##2##3##(2008-8#1)(2013-7#1)
of habitat##34##2##(2006-5#1)(2007-9#1)(2008-5#1)(2008-8#21)(2008-9#5)(2010-10#1)(2010-2#1)(2010-8#1)(2012-1#1)(2013-7#1)
of habitats##7##2##(2007-10#1)(2007-5#1)(2007-6#1)(2008-4#1)(2008-8#1)(2010-3#1)(2012-2#1)
of habits##2##2##(1992-8#1)(2008-5#1)
of habitual##3##2##(1992-12#1)(2008-11#2)
of habituation to##3##3##(1994-3#1)(2008-11#1)(2009-8#1)
of habituation##6##2##(1994-3#1)(1997-2#1)(2007-8#1)(2008-11#1)(2009-8#1)(2013-7#1)
of haem##7##2##(1992-6#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1996-7#1)(1997-7#1)
of haemagglutination##2##2##(1997-8#1)(2010-4#1)
of haemagglutinin##2##2##(2007-11#1)(2008-4#1)
of haematological malignancies##3##3##(2007-11#2)(2013-1#1)
of haematological##6##2##(2006-6#1)(2007-11#2)(2009-3#1)(2009-5#1)(2013-1#1)
of haematology##4##2##(2005-10#2)(2007-4#1)(2012-1#1)
of haematoma##5##2##(1990-10#1)(2006-9#1)(2007-7#1)(2008-7#1)(2008-8#1)
of haematuria##4##2##(2007-7#3)(2011-12#1)
of haemodialysis##4##2##(1995-7#1)(2006-6#1)(2008-12#1)(2011-12#1)
of haemodynamic##4##2##(1990-11#1)(2006-10#2)(2011-1#1)
of haemoglobin (Hb)##2##3##(2010-5#1)(2012-12#1)
of haemoglobin F##2##3##(1990-11#2)
of haemoglobin at the##2##4##(1993-1#1)(2010-5#1)
of haemoglobin in##2##3##(1991-5#2)
of haemoglobin variants##2##3##(1996-6#1)(2008-6#1)
of haemoglobin##27##2##(1990-11#3)(1990-3#1)(1991-5#4)(1991-9#1)(1993-1#1)(1994-8#1)(1996-6#1)(1997-2#1)(1997-6#3)(1997-7#1)(2007-2#1)(2008-6#1)(2010-5#3)(2011-1#2)(2012-12#1)(2013-1#2)
of haemoglobin-based##2##2##(2005-7#1)(2006-10#1)
of haemoglobinopathies##3##2##(1992-5#1)(1993-9#2)
of haemolysis##5##2##(1992-5#1)(1994-8#1)(2008-10#1)(2009-10#1)(2009-4#1)
of haemolytic anaemia##2##3##(2006-6#1)(2011-12#1)
of haemolytic##5##2##(1992-1#1)(1997-2#1)(2006-6#1)(2011-12#1)(2011-2#1)
of haemophilia##3##2##(1992-10#1)(2005-7#2)
of haemopoietic cells##2##3##(1991-5#1)(2008-11#1)
of haemopoietic##4##2##(1991-5#1)(2007-11#2)(2008-11#1)
of haemoptysis##5##2##(2006-6#2)(2008-4#1)(2010-10#1)(2010-2#1)
of haemorrhage##8##2##(1991-11#1)(1992-6#1)(1995-4#1)(1996-6#2)(1996-9#1)(2006-6#1)(2008-7#1)
of haemorrhages##2##2##(1990-9#1)(2010-12#1)
of haemorrhagic enteritis##2##3##(2011-2#2)
of haemorrhagic##7##2##(1990-3#1)(1995-7#1)(1997-3#1)(2007-11#1)(2009-2#1)(2011-2#2)
of haemostasis##3##2##(1992-12#1)(2006-10#2)
of haemostatic##4##2##(1993-2#1)(2007-8#1)(2007-9#1)(2008-7#1)
of hafnium##2##2##(2006-12#1)(2008-10#1)
of hagfishes##2##2##(2012-2#2)
of hair and##3##3##(2008-10#1)(2008-5#2)
of hair care products##2##4##(2008-5#2)
of hair cells##2##3##(1993-9#1)(2013-1#1)
of hair fibres##2##3##(2008-5#2)
of hair follicle##2##3##(1990-6#1)(2010-3#1)
of hair in##3##3##(2008-5#2)(2009-7#1)
of hair is##2##3##(2008-5#1)(2011-1#1)
of hair loss##5##3##(2008-5#4)(2010-6#1)
of hair on##2##3##(2008-5#1)(2009-5#1)
of hair over##2##3##(2007-7#2)
of hair samples##2##3##(2008-5#1)(2013-1#1)
of hair shampoo##6##3##(2008-5#6)
of hair was##2##3##(2012-3#2)
of hair##83##2##(1990-6#1)(1990-8#2)(1993-9#1)(1996-12#2)(1996-3#1)(2006-12#3)(2007-12#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-5#37)(2008-7#2)(2008-9#2)(2009-5#2)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#2)
of hair)##2##2##(1991-4#1)(2008-12#1)
of hair-cell precursors##4##3##(2012-12#4)
of hair-cell##5##2##(2012-12#4)(2012-2#1)
of hairless##3##2##(1990-6#1)(1992-8#1)(1994-6#1)
of hairpin ribozymes with##2##4##(1996-7#2)
of hairpin##5##2##(1991-5#1)(1993-12#1)(1996-7#2)(2011-1#1)
of hairs##5##2##(2008-5#2)(2011-2#2)(2013-8#1)
of hairy cell leukemia##3##4##(1992-11#1)(1992-6#2)
of hairy##6##2##(1992-11#1)(1992-6#3)(2007-1#1)(2008-8#1)
of half of the##2##4##(2008-10#1)(2009-3#1)
of half##7##2##(1990-6#1)(1992-8#1)(2008-10#3)(2009-3#1)(2013-8#1)
of half-amidase and imidase##2##4##(2005-11#2)
of half-amidase##4##2##(2005-11#4)
of half-life##3##2##(2007-8#1)(2008-7#1)(2008-8#1)
of half-lives##2##2##(1996-4#1)(2005-8#1)
of half-site##2##2##(1993-9#1)(1994-5#1)
of halide##5##2##(1990-8#1)(1994-5#1)(2008-10#3)
of halides##2##2##(2008-10#2)
of halitosis##2##2##(1997-4#1)(2006-2#1)
of hallucinations and delusions##3##4##(1997-8#3)
of hallucinations##4##2##(1997-8#3)(2007-7#1)
of hallucinogenic plants in plant mixtures##2##6##(2008-12#2)
of hallux valgus deformity with primary medial collateral ligamentous insufficiency##2##10##(2012-2#2)
of hallux valgus deformity##3##4##(2012-2#3)
of hallux valgus##5##3##(2008-12#1)(2009-10#1)(2012-2#3)
of halo nevi##3##3##(2011-2#3)
of halo##5##2##(2008-2#1)(2011-2#3)(2012-2#1)
of halo-traction##2##2##(2009-3#2)
of haloacetic acids##2##3##(2008-10#1)(2008-9#1)
of haloacetic##3##2##(2008-10#2)(2008-9#1)
of halogenated alkenes##2##3##(1993-3#2)
of halogenated aromatic compounds##3##4##(2004-4#3)
of halogenated by-products##3##3##(2007-8#1)(2008-10#2)
of halogenated pyrimidines##2##3##(1994-4#1)(2008-9#1)
of halogenated##18##2##(1992-11#1)(1993-12#1)(1993-3#2)(1994-4#1)(2004-4#3)(2007-8#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-9#1)
of halogenation##2##2##(2007-7#1)(2010-12#1)
of halogenoalkyl##2##2##(2008-4#2)
of haloperidol on##2##3##(1997-7#2)
of haloperidol##18##2##(1990-2#3)(1991-6#1)(1992-5#2)(1992-9#1)(1993-7#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-5#1)(1997-7#3)(2008-10#1)(2008-6#1)(2011-1#1)
of haloperidol-induced catalepsy##2##3##(1996-10#1)(2012-2#1)
of halophilic##3##2##(2006-10#1)(2011-2#2)
of halorhodopsin##2##2##(1994-5#1)(2006-10#1)
of halos##2##2##(2008-2#2)
of halothane and##2##3##(1990-2#1)(2007-9#1)
of halothane##11##2##(1990-2#1)(1991-2#1)(1991-7#2)(1992-9#1)(1995-3#2)(2006-4#1)(2007-9#3)
of halter##2##2##(2005-10#2)
of halting##2##2##(1997-1#1)(2010-8#1)
of hammerhead ribozymes##2##3##(2006-12#2)
of hamster##12##2##(1990-8#1)(1992-7#1)(1993-12#2)(1993-4#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-9#1)(2008-11#1)
of hamsters to##3##3##(1994-2#1)(2006-8#2)
of hamsters were##3##3##(1992-3#2)(1996-9#1)
of hamsters##8##2##(1992-3#2)(1994-2#1)(1996-3#1)(1996-9#2)(2006-8#2)
of hamstring tendon##2##3##(2009-6#1)(2013-1#1)
of hamstring##8##2##(2008-11#1)(2009-5#1)(2009-6#1)(2012-2#1)(2013-1#4)
of hand and##4##3##(1994-9#1)(2008-6#1)(2011-2#1)(2012-2#1)
of hand containment/massage##2##3##(2008-10#2)
of hand hygiene guidelines and protocols##2##6##(2011-2#2)
of hand hygiene##5##3##(2005-8#1)(2008-12#1)(2011-2#2)(2012-3#1)
of hand movements##2##3##(1992-9#1)(2008-11#1)
of hand sensory function##2##4##(2012-1#2)
of hand washing##6##3##(2011-1#6)
of hand##47##2##(1991-6#1)(1992-3#1)(1992-9#1)(1994-9#1)(1995-12#1)(2005-8#1)(2007-10#1)(2007-12#1)(2007-8#3)(2008-10#3)(2008-11#1)(2008-12#4)(2008-5#1)(2008-6#1)(2008-9#3)(2009-6#1)(2010-1#1)(2011-1#6)(2011-2#4)(2012-1#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
of handedness in##2##3##(1994-6#1)(2007-12#1)
of handedness##5##2##(1992-9#1)(1994-6#1)(1994-8#1)(1997-8#1)(2007-12#1)
of handheld##2##2##(2007-2#1)(2008-9#1)
of handling and fixation processes on##2##6##(2008-3#2)
of handling and##3##3##(2008-3#2)(2008-9#1)
of handling##22##2##(1992-10#1)(1992-11#1)(2008-1#1)(2008-10#4)(2008-3#5)(2008-4#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#4)
of handover forms##5##3##(2012-11#5)
of hands and feet##2##4##(1996-12#1)(2008-2#1)
of hands and##4##3##(1994-11#1)(1996-12#1)(2008-2#1)(2012-12#1)
of hands##7##2##(1994-11#2)(1996-12#1)(2007-7#1)(2008-2#1)(2009-5#1)(2012-12#1)
of hantavirus##5##2##(1991-11#1)(1993-7#1)(2008-10#3)
of haploid##9##2##(1991-12#1)(1992-1#1)(1993-12#1)(1994-11#1)(2005-11#1)(2007-12#1)(2008-10#2)(2012-12#1)
of haplotype variation##2##3##(2008-6#2)
of haplotype##5##2##(2008-10#1)(2008-6#2)(2009-5#1)(2011-2#1)
of haplotypes##3##2##(2008-10#3)
of haplotypic##2##2##(2008-10#1)(2008-9#1)
of hapten and bovine serum albumin##2##6##(2008-11#2)
of hapten##6##2##(1997-3#1)(2008-11#5)
of hapten-specific##2##2##(1992-8#1)(2005-11#1)
of haptic##3##2##(2007-5#2)(2012-1#1)
of haptoglobin##2##2##(2005-7#1)(2009-3#1)
of harboring##2##2##(2008-10#1)(2012-2#1)
of hard X-rays##2##3##(2006-4#1)(2006-5#1)
of hard and soft tissue##2##5##(2007-12#1)(2008-2#1)
of hard and soft##4##4##(1991-2#1)(2007-12#1)(2008-10#1)(2008-2#1)
of hard and##5##3##(1991-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2011-2#1)
of hard boundaries and an##2##5##(2008-8#2)
of hard metal disease##3##4##(1994-6#3)
of hard metal workers##6##4##(1994-6#6)
of hard metal##22##3##(1994-6#21)(2005-8#1)
of hard metals##4##3##(1994-6#3)(2005-11#1)
of hard tissues##3##3##(2008-5#1)(2011-1#1)(2013-1#1)
of hard##56##2##(1991-2#1)(1993-1#1)(1993-12#1)(1994-6#24)(1996-4#1)(1997-2#1)(2005-11#1)(2005-8#1)(2006-4#1)(2006-5#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#3)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#1)
of hardiness##2##2##(2012-1#1)(2013-7#1)
of hardness in##2##3##(2008-10#1)(2010-8#1)
of hardness##6##2##(2004-9#1)(2008-10#1)(2008-5#1)(2010-8#1)(2013-8#2)
of hardship##2##2##(2007-12#1)(2008-10#1)
of hardware and software##2##4##(1996-12#1)(2012-12#1)
of hardware and##4##3##(1996-12#1)(2007-12#1)(2011-2#1)(2012-12#1)
of hardware##6##2##(1996-12#1)(2007-12#1)(2008-2#2)(2011-2#1)(2012-12#1)
of hares##3##2##(2013-1#3)
of harm or benefit##2##4##(2008-7#1)(2008-9#1)
of harm reduction##5##3##(1997-5#1)(2008-7#1)(2012-11#2)(2012-3#1)
of harm##7##2##(1997-5#1)(2008-7#2)(2008-9#1)(2012-11#2)(2012-3#1)
of harmane and##2##3##(2006-10#1)(2008-10#1)
of harmane with the##2##4##(2006-10#2)
of harmane##6##2##(2006-10#4)(2008-10#2)
of harmful effects##2##3##(2008-11#1)(2008-7#1)
of harmful side effects##2##4##(1991-6#1)(2005-11#1)
of harmful##14##2##(1991-6#1)(2005-11#2)(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-6#1)(2010-11#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-8#1)
of harmonic##3##2##(2007-12#1)(2007-8#1)(2011-12#1)
of harpagoside##4##2##(2007-1#4)
of harpin##4##2##(2008-10#1)(2008-8#2)(2011-1#1)
of harsh##3##2##(2008-1#1)(2008-9#1)(2009-7#1)
of harvest time##3##3##(2008-7#1)(2013-1#2)
of harvest##5##2##(1994-11#1)(2006-12#1)(2008-7#1)(2013-1#2)
of harvested##2##2##(2008-10#2)
of harvesting##4##2##(2007-3#1)(2007-8#1)(2008-12#1)(2013-1#1)
of hatching##6##2##(1996-9#1)(2008-5#3)(2008-8#1)(2013-1#1)
of hatchling##2##2##(2008-8#1)(2009-4#1)
of haustoria##2##2##(2008-10#2)
of haustorial##2##2##(2008-10#2)
of having a baby with congenital anomalies##2##7##(2008-11#2)
of having a good##2##4##(1992-10#1)(2012-3#1)
of having a mentor during their first practice placement##2##9##(2008-11#2)
of having a usual source of##2##6##(1995-12#1)(2008-10#1)
of having a##31##3##(1990-9#1)(1992-10#1)(1992-3#1)(1995-12#1)(1996-1#1)(1997-2#1)(1997-5#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#4)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-12#3)(2011-2#1)(2012-3#1)(2013-1#1)
of having an##8##3##(1990-5#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-6#1)(2011-2#1)(2012-1#1)(2013-1#1)
of having at least one##2##5##(2012-12#1)(2013-1#1)
of having its##2##3##(2008-2#1)(2009-6#1)
of having more than one##2##5##(1992-9#1)(1997-2#1)
of having more##3##3##(1992-9#1)(1997-2#1)(2011-2#1)
of having multiple##2##3##(2011-2#1)(2013-7#1)
of having no##4##3##(1992-4#1)(2006-4#3)
of having sex while symptomatic##3##5##(2007-7#3)
of having sex##4##3##(2007-7#3)(2013-1#1)
of having the##4##3##(1992-5#1)(2008-7#1)(2009-4#1)(2012-2#1)
of having##107##2##(1990-5#1)(1990-9#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-2#1)(1995-12#2)(1996-1#1)(1997-2#2)(1997-5#1)(1997-8#1)(2005-7#1)(2006-10#2)(2006-4#3)(2006-8#1)(2007-12#4)(2007-2#1)(2007-7#7)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#1)(2009-6#2)(2010-10#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#2)
of hay fever##2##3##(1992-3#2)
of hazardous chemicals##4##3##(2008-2#1)(2008-9#2)(2010-7#1)
of hazardous materials##2##3##(2008-10#1)(2009-10#1)
of hazardous wastes##3##3##(2007-10#3)
of hazardous##20##2##(1996-5#1)(2006-3#1)(2007-10#3)(2008-10#4)(2008-2#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-7#1)(2012-12#2)(2012-2#1)
of hazards and risks##2##4##(2008-9#2)
of hazards and##3##3##(2006-2#1)(2008-9#2)
of hazards##5##2##(1995-5#1)(2006-2#1)(2008-11#1)(2008-9#2)
of hazmat##2##2##(2009-10#2)
of hcp##2##2##(1990-12#1)(1995-3#1)
of he##7##2##(2007-2#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-8#1)(2011-1#1)
of head and neck cancer patients##3##6##(2008-5#3)
of head and neck cancer##18##5##(1992-10#1)(1993-4#1)(1993-9#1)(1995-6#4)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-5#4)(2010-12#1)(2013-1#2)
of head and neck cancers##3##5##(1992-10#1)(2008-5#1)(2010-4#1)
of head and neck squamous cell##2##6##(2009-9#1)(2013-8#1)
of head and neck tumors##2##5##(2009-11#1)(2011-2#1)
of head and neck##43##4##(1990-12#1)(1992-10#2)(1993-4#1)(1993-9#1)(1995-6#4)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2008-1#2)(2008-2#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#2)(2013-1#3)(2013-8#3)
of head and##44##3##(1990-12#1)(1992-10#2)(1993-4#1)(1993-9#1)(1995-6#4)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2008-1#2)(2008-2#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#2)(2013-1#3)(2013-8#3)
of head blight##2##3##(2008-10#2)
of head concussions##2##3##(2010-1#2)
of head injuries in##2##4##(2005-10#1)(2007-4#1)
of head injuries##4##3##(1992-6#1)(2005-10#1)(2007-4#1)(2013-1#1)
of head injury##10##3##(2005-9#1)(2006-10#2)(2006-4#1)(2007-4#2)(2010-8#1)(2012-3#1)(2013-1#2)
of head movement##2##3##(1990-5#1)(2008-9#1)
of head segmentation##2##3##(2007-12#2)
of head structures##2##3##(1990-11#1)(2007-12#1)
of head trauma##2##3##(2008-7#1)(2013-7#1)
of head##89##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1992-10#2)(1992-6#1)(1993-4#1)(1993-9#1)(1994-7#1)(1995-12#1)(1995-6#4)(1996-12#1)(1997-4#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-4#5)(2008-1#2)(2008-10#2)(2008-2#2)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-9#1)(2010-1#2)(2010-12#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#4)
of head-down tilt##2##3##(1993-1#2)
of head-mounted##2##2##(2008-3#2)
of head-neck##2##2##(2007-1#2)
of headache and migraine in##2##5##(2007-3#2)
of headache and migraine##3##4##(2007-3#3)
of headache and##4##3##(2007-3#3)(2008-9#1)
of headache##30##2##(1994-6#1)(1994-9#1)(1996-9#1)(2004-12#6)(2004-3#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-2#1)(2007-3#6)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2013-1#1)(2013-8#1)
of headaches and##2##3##(2006-9#1)(2009-4#1)
of headaches##8##2##(2006-8#2)(2006-9#1)(2008-4#3)(2008-6#1)(2009-4#1)
of headgroup##2##2##(1990-7#1)(1992-1#1)
of heads##4##2##(1996-2#2)(2006-5#1)(2011-2#1)
of headspace solid phase microextraction##2##5##(2007-8#1)(2008-10#1)
of headspace solid phase##3##4##(2007-8#1)(2008-10#1)(2010-4#1)
of headspace volume##2##3##(2008-10#2)
of headspace##9##2##(2007-8#2)(2008-10#5)(2010-4#1)(2011-2#1)
of healing in##2##3##(1992-10#1)(2012-2#1)
of healing##18##2##(1992-10#2)(1996-2#1)(1997-3#1)(2004-9#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-8#1)
of health IT##9##3##(2011-2#1)(2013-1#8)
of health administration education##3##4##(1991-12#1)(1993-2#1)(1996-3#1)
of health administration programs##2##4##(1990-12#1)(1993-2#1)
of health administration##10##3##(1990-12#2)(1991-12#1)(1993-2#5)(1996-1#1)(1996-3#1)
of health and disease##6##4##(1992-5#1)(1993-11#1)(2008-3#1)(2010-10#1)(2012-2#2)
of health and healing##2##4##(2008-1#1)(2008-12#1)
of health and health##3##4##(2011-1#2)(2011-2#1)
of health and safety in##3##5##(1995-3#3)
of health and social services##2##5##(1994-1#1)(2008-1#1)
of health and social##5##4##(1992-3#1)(1994-1#1)(2005-8#1)(2008-1#1)(2011-1#1)
of health and well-being##4##4##(2008-2#1)(2008-7#1)(2011-2#1)(2012-12#1)
of health and wellness##2##4##(2008-12#1)(2012-12#1)
of health and##45##3##(1990-3#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-3#1)(1992-5#1)(1993-11#1)(1994-1#1)(1994-2#1)(1995-3#3)(1995-8#1)(2004-12#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-12#1)(2010-10#1)(2010-2#1)(2011-1#4)(2011-2#2)(2012-12#3)(2012-2#3)(2013-7#1)
of health are##2##3##(2008-1#1)(2008-12#1)
of health behavior##2##3##(2009-10#1)(2011-1#1)
of health behaviors##2##3##(2009-10#1)(2013-1#1)
of health belief##2##3##(1990-8#1)(2011-1#1)
of health benefits##3##3##(1996-5#1)(2008-12#1)(2008-7#1)
of health care and the##2##5##(1993-12#1)(2006-8#1)
of health care and##6##4##(1993-1#1)(1993-12#1)(1995-2#1)(2005-7#1)(2006-8#1)(2007-8#1)
of health care are##2##4##(1991-3#1)(1992-3#1)
of health care can##2##4##(1994-3#1)(2012-11#1)
of health care costs##10##4##(1990-12#2)(1992-2#1)(1994-12#1)(1994-2#2)(1995-1#1)(1996-3#1)(2009-4#1)(2011-1#1)
of health care delivery and financing##2##6##(1993-2#1)(1996-3#1)
of health care delivery systems##2##5##(1994-12#1)(1995-12#1)
of health care delivery##17##4##(1991-12#1)(1991-2#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1995-12#1)(1996-3#2)(2004-3#1)(2006-2#1)(2007-4#1)(2007-6#1)(2008-1#2)(2010-8#1)(2011-1#1)
of health care expenditure##2##4##(2013-7#2)
of health care expenditures in##3##5##(1992-1#1)(1997-1#1)(2010-1#1)
of health care expenditures##5##4##(1992-1#1)(1993-3#1)(1995-3#1)(1997-1#1)(2010-1#1)
of health care facilities in the##2##6##(1997-2#1)(2007-12#1)
of health care facilities##3##4##(1997-2#1)(2007-12#1)(2012-1#1)
of health care financing##2##4##(1990-12#1)(1991-3#1)
of health care for##3##4##(1991-3#1)(1994-3#2)
of health care in the United States##2##7##(1995-3#1)(2007-12#1)
of health care in the##7##5##(1995-3#1)(2007-12#1)(2008-1#3)(2013-1#1)(2013-8#1)
of health care in##18##4##(1992-1#1)(1993-2#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-3#1)(1997-1#1)(1997-4#1)(1997-8#1)(2007-10#1)(2007-12#1)(2008-1#3)(2008-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
of health care information##4##4##(1992-12#1)(1993-1#1)(1996-2#1)(2008-11#1)
of health care is##5##4##(1992-1#1)(1992-3#1)(1996-2#1)(2007-3#1)(2008-11#1)
of health care management##2##4##(1995-3#1)(1996-2#1)
of health care managers##2##4##(1995-12#1)(1995-2#1)
of health care networks##3##4##(1996-2#3)
of health care organizations##6##4##(1991-3#1)(1992-2#1)(1994-2#1)(1996-2#1)(1997-2#1)(2009-11#1)
of health care personnel##6##4##(1990-12#1)(1991-2#2)(2007-6#1)(2008-1#1)(2013-1#1)
of health care professionals in##3##5##(2004-10#1)(2005-7#1)(2010-4#1)
of health care professionals is##2##5##(2008-12#1)(2010-10#1)
of health care professionals##12##4##(1991-3#1)(1994-1#2)(1994-2#1)(2004-10#1)(2005-7#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-7#1)(2010-10#1)(2010-4#1)
of health care provider##2##4##(1994-1#1)(2007-2#1)
of health care providers in##3##5##(2007-6#1)(2009-4#1)(2010-4#1)
of health care providers##18##4##(1991-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-2#1)(1996-3#2)(1996-9#1)(1997-3#1)(2006-2#1)(2006-8#1)(2007-4#1)(2007-6#1)(2008-11#2)(2009-4#1)(2010-4#1)
of health care quality##7##4##(1994-1#2)(1994-12#1)(1996-1#1)(1996-3#1)(1997-3#1)(2005-9#1)
of health care reform##19##4##(1993-12#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#3)(1995-3#1)(1996-1#2)(1996-3#2)(1997-3#1)(2010-5#1)(2010-8#1)(2011-2#1)
of health care resources and##2##5##(1996-12#1)(2008-7#1)
of health care resources##9##4##(1996-12#1)(2007-7#1)(2008-1#2)(2008-7#2)(2008-8#1)(2011-2#1)(2012-3#1)
of health care services and##2##5##(1994-1#1)(2012-1#1)
of health care services in##2##5##(1995-1#1)(1995-2#1)
of health care services is##2##5##(1990-12#1)(1993-3#1)
of health care services provided##2##5##(1994-12#1)(1995-12#1)
of health care services to##2##5##(1990-12#1)(1995-3#1)
of health care services##33##4##(1990-12#3)(1991-12#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-2#1)(1997-1#1)(2006-8#1)(2008-2#1)(2008-5#1)(2010-3#1)(2012-1#1)(2012-12#1)
of health care should improve##2##5##(2006-6#1)(2010-1#1)
of health care spending##4##4##(1993-3#1)(1994-1#1)(1995-2#1)(2008-7#1)
of health care system##2##4##(1995-2#1)(2009-4#1)
of health care technology##2##4##(2007-4#1)(2008-11#1)
of health care to##7##4##(1994-3#2)(1995-12#1)(1997-3#1)(2006-2#1)(2006-8#1)(2008-4#1)
of health care will##2##4##(1994-12#1)(2008-7#1)
of health care within the##3##5##(1991-6#1)(2008-1#1)(2008-7#1)
of health care workers##8##4##(2005-2#1)(2006-2#1)(2008-11#1)(2010-11#2)(2010-3#1)(2012-2#2)
of health care##352##3##(1990-11#1)(1990-12#10)(1990-2#1)(1991-12#3)(1991-2#6)(1991-3#5)(1991-4#1)(1991-6#1)(1992-1#4)(1992-10#1)(1992-12#3)(1992-2#4)(1992-3#5)(1992-8#1)(1992-9#1)(1993-1#4)(1993-11#1)(1993-12#12)(1993-2#6)(1993-3#5)(1993-6#2)(1993-7#1)(1994-1#11)(1994-11#1)(1994-12#11)(1994-2#13)(1994-3#14)(1994-6#1)(1995-1#5)(1995-11#1)(1995-12#9)(1995-2#8)(1995-3#7)(1995-8#1)(1996-1#5)(1996-12#3)(1996-2#11)(1996-3#11)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#4)(1997-3#7)(1997-4#1)(1997-8#2)(2004-10#1)(2004-3#1)(2004-4#1)(2004-8#1)(2005-11#1)(2005-2#1)(2005-7#2)(2005-9#1)(2006-10#3)(2006-2#5)(2006-6#1)(2006-7#1)(2006-8#5)(2007-1#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-3#2)(2007-4#6)(2007-6#6)(2007-7#2)(2007-8#2)(2008-1#10)(2008-10#2)(2008-11#9)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#9)(2008-8#2)(2009-11#1)(2009-4#3)(2009-5#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#2)(2010-3#3)(2010-4#2)(2010-5#1)(2010-8#4)(2011-1#3)(2011-2#3)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#2)(2012-3#5)(2013-1#5)(2013-7#2)(2013-8#2)
of health care]##3##3##(1994-8#1)(1995-11#1)(2007-9#1)
of health centers and##2##4##(1996-9#1)(2008-10#1)
of health centers##3##3##(1996-9#1)(2008-10#1)(2008-11#1)
of health conditions##2##3##(2007-11#1)(2010-9#1)
of health consumers##2##3##(2008-1#1)(2008-11#1)
of health data##2##3##(1995-2#1)(2008-7#1)
of health disparities##4##3##(2010-2#1)(2011-1#2)(2013-1#1)
of health economic##3##3##(2007-9#1)(2013-8#2)
of health education and##2##4##(1997-6#1)(2010-12#1)
of health education##10##3##(1990-10#1)(1996-2#1)(1997-6#1)(2007-6#1)(2008-1#1)(2008-11#1)(2010-12#2)(2012-3#1)(2013-1#1)
of health expenditures##2##3##(1991-2#1)(1995-3#1)
of health facilities in##2##4##(2007-1#1)(2011-2#1)
of health facilities##6##3##(2007-1#1)(2007-3#1)(2007-7#1)(2011-2#1)(2012-11#1)(2012-3#1)
of health for##4##3##(2008-2#1)(2009-6#2)(2013-1#1)
of health in##5##3##(1993-1#1)(1993-2#1)(1994-4#1)(2008-1#1)(2010-8#1)
of health information systems##8##4##(1990-12#1)(2012-12#3)(2013-1#4)
of health information##26##3##(1990-12#2)(1995-12#1)(1995-3#1)(2007-12#1)(2008-5#1)(2009-5#1)(2012-1#1)(2012-12#5)(2012-3#1)(2013-1#11)(2013-7#1)
of health institutions##2##3##(1990-6#1)(1993-3#1)
of health insurance coverage##4##4##(1991-2#1)(1993-3#1)(2011-1#1)(2012-1#1)
of health insurance for##2##4##(1992-3#1)(2011-2#1)
of health insurance##18##3##(1991-2#1)(1992-3#2)(1993-3#1)(1993-9#1)(1994-4#1)(2005-12#1)(2008-11#2)(2008-7#2)(2009-5#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#1)
of health interventions##2##3##(1993-12#1)(2007-10#1)
of health is##2##3##(2008-1#1)(2013-1#1)
of health literacy##7##3##(2008-10#3)(2009-8#2)(2013-7#2)
of health maintenance organization##2##4##(1996-2#1)(1996-3#1)
of health maintenance##4##3##(1991-3#1)(1994-2#1)(1996-2#1)(1996-3#1)
of health management##3##3##(1994-12#1)(2012-12#2)
of health of the##3##4##(2006-8#1)(2007-7#1)(2011-2#1)
of health of##4##3##(1992-3#1)(2006-8#1)(2007-7#1)(2011-2#1)
of health on##2##3##(1995-2#1)(2011-1#1)
of health outcomes are##2##4##(2008-10#1)(2013-1#1)
of health outcomes##4##3##(2008-10#1)(2009-12#1)(2010-7#1)(2013-1#1)
of health personnel were##2##4##(1990-6#1)(1996-9#1)
of health personnel##5##3##(1990-12#1)(1990-5#1)(1990-6#1)(1996-9#1)(2007-7#1)
of health plan##3##3##(1995-2#1)(1997-3#1)(2007-2#1)
of health plans##3##3##(1996-12#1)(1997-3#1)(2013-8#1)
of health policy and##2##4##(2007-9#1)(2009-9#1)
of health policy in the##3##5##(1990-12#1)(1992-1#1)(1993-3#1)
of health policy in##4##4##(1990-12#1)(1992-1#1)(1993-3#1)(2008-7#1)
of health policy##10##3##(1990-12#1)(1992-1#1)(1993-3#1)(1994-12#1)(1994-2#1)(2007-6#1)(2007-9#1)(2008-7#1)(2009-9#1)(2010-5#1)
of health problems and##2##4##(1997-1#1)(2007-12#1)
of health problems##6##3##(1992-3#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)
of health professionals and##3##4##(2007-2#1)(2008-1#1)(2008-11#1)
of health professionals in##2##4##(1993-12#1)(2013-1#1)
of health professionals to##4##4##(1995-3#1)(2005-11#1)(2008-11#1)(2008-12#1)
of health professionals##22##3##(1992-1#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-3#1)(2005-11#1)(2006-9#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-4#1)(2010-3#1)(2011-1#1)(2013-1#2)
of health programmes##2##3##(2008-1#1)(2012-3#1)
of health promotion in##2##4##(2008-11#1)(2013-8#1)
of health promotion programs in##2##5##(1993-11#1)(2006-10#1)
of health promotion##13##3##(1990-10#1)(1993-1#1)(1993-11#1)(1993-8#1)(2006-10#1)(2006-7#1)(2008-11#2)(2009-6#1)(2010-5#1)(2011-1#1)(2012-1#1)(2013-8#1)
of health providers and health insurance underwriters##2##7##(1996-12#1)(1997-2#1)
of health providers##3##3##(1996-12#1)(1997-2#1)(2011-2#1)
of health psychology##3##3##(2010-2#1)(2013-1#2)
of health reform##6##3##(1994-1#1)(1994-3#1)(1996-1#1)(1996-3#2)(2008-4#1)
of health research##6##3##(1993-8#1)(1994-10#1)(2005-8#1)(2009-6#2)(2013-7#1)
of health researchers##2##3##(2005-7#1)(2006-9#1)
of health resources##2##3##(1990-12#1)(1997-2#1)
of health risk appraisal functions##2##5##(1995-8#2)
of health risk##7##3##(1995-11#1)(1995-8#2)(1996-8#1)(2010-12#1)(2010-2#1)(2012-1#1)
of health risks##2##3##(2009-10#1)(2009-12#1)
of health sector reform in##2##5##(2008-4#1)(2008-8#1)
of health sector##5##3##(2007-7#1)(2008-4#1)(2008-8#1)(2012-2#1)(2012-3#1)
of health service delivery##2##4##(1997-2#1)(2010-3#1)
of health service##9##3##(1991-2#1)(1993-2#1)(1997-2#1)(2008-7#1)(2008-8#1)(2010-3#1)(2012-2#1)(2013-8#2)
of health services administration##3##4##(1994-2#1)(1996-1#1)(1997-3#1)
of health services and##4##4##(1996-2#1)(2009-4#1)(2011-1#2)
of health services by##2##4##(1994-2#1)(2007-10#1)
of health services in##4##4##(1993-11#1)(2008-4#1)(2012-3#2)
of health services management##2##4##(1992-12#1)(1996-2#1)
of health services research##2##4##(1993-12#1)(2012-1#1)
of health services under##2##4##(1994-2#1)(2006-8#1)
of health services##71##3##(1991-4#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#6)(1994-12#1)(1994-2#4)(1994-3#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#3)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-10#2)(2007-2#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#8)
of health services]##2##3##(1990-5#1)(1992-11#1)
of health sites##2##3##(1996-12#2)
of health spending##4##3##(1991-2#1)(1992-12#1)(1996-2#1)(1997-3#1)
of health staff##2##3##(2007-11#1)(2008-10#1)
of health states##3##3##(1993-5#1)(2006-2#1)(2007-7#1)
of health status and##4##4##(1996-2#1)(1997-1#1)(2010-3#1)(2012-1#1)
of health status##15##3##(1991-4#1)(1992-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-1#2)(2007-6#1)(2008-6#1)(2008-7#1)(2010-3#1)(2012-1#1)
of health system##4##3##(1995-12#1)(2008-11#1)(2010-8#1)(2011-2#1)
of health systems##11##3##(1991-3#1)(1994-3#2)(1996-12#1)(2006-11#1)(2008-2#1)(2012-1#2)(2012-12#2)(2013-8#1)
of health technology##3##3##(2009-3#2)(2011-2#1)
of health work##2##3##(1991-6#1)(1992-2#1)
of health workers in the##2##5##(2008-2#1)(2010-8#1)
of health workers in##4##4##(1990-11#1)(1994-4#1)(2008-2#1)(2010-8#1)
of health workers may##2##4##(2012-3#1)(2013-1#1)
of health workers##14##3##(1990-11#2)(1992-1#1)(1994-4#1)(2006-9#1)(2007-12#1)(2008-2#2)(2010-8#1)(2012-3#4)(2013-1#1)
of health##933##2##(1990-10#2)(1990-11#3)(1990-12#21)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#2)(1990-8#2)(1991-12#4)(1991-2#12)(1991-3#9)(1991-4#5)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#8)(1992-10#1)(1992-11#1)(1992-12#6)(1992-2#7)(1992-3#12)(1992-4#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-1#8)(1993-11#5)(1993-12#16)(1993-2#15)(1993-3#11)(1993-5#1)(1993-6#10)(1993-7#1)(1993-8#2)(1993-9#2)(1994-1#13)(1994-10#1)(1994-11#1)(1994-12#16)(1994-2#20)(1994-3#20)(1994-4#5)(1994-6#3)(1994-8#1)(1994-9#1)(1995-1#6)(1995-11#3)(1995-12#11)(1995-2#12)(1995-3#15)(1995-8#4)(1995-9#1)(1996-1#10)(1996-12#9)(1996-2#19)(1996-3#15)(1996-5#2)(1996-8#2)(1996-9#4)(1997-1#8)(1997-2#10)(1997-3#13)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#3)(2004-10#1)(2004-12#1)(2004-3#1)(2004-4#1)(2004-8#2)(2005-10#2)(2005-11#2)(2005-12#1)(2005-2#1)(2005-6#1)(2005-7#3)(2005-8#3)(2005-9#1)(2006-10#7)(2006-11#1)(2006-2#6)(2006-6#4)(2006-7#3)(2006-8#7)(2006-9#3)(2007-1#2)(2007-10#4)(2007-11#5)(2007-12#8)(2007-2#7)(2007-3#4)(2007-4#7)(2007-6#10)(2007-7#9)(2007-8#3)(2007-9#3)(2008-1#27)(2008-10#14)(2008-11#23)(2008-12#13)(2008-2#9)(2008-3#2)(2008-4#9)(2008-5#4)(2008-6#2)(2008-7#23)(2008-8#9)(2008-9#1)(2009-10#5)(2009-11#1)(2009-12#3)(2009-3#3)(2009-4#8)(2009-5#3)(2009-6#5)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#6)(2010-11#2)(2010-12#4)(2010-2#8)(2010-3#7)(2010-4#4)(2010-5#5)(2010-7#2)(2010-8#8)(2010-9#3)(2011-1#29)(2011-2#24)(2012-1#13)(2012-11#7)(2012-12#21)(2012-2#11)(2012-3#26)(2013-1#41)(2013-7#8)(2013-8#9)
of health-care##2##2##(2010-8#1)(2011-1#1)
of health-related quality of life in##2##6##(2005-9#1)(2010-11#1)
of health-related quality of life##7##5##(2005-9#1)(2006-5#1)(2008-1#2)(2008-11#1)(2008-5#1)(2010-11#1)
of health-related##10##2##(1997-3#1)(2005-9#1)(2006-5#1)(2008-1#3)(2008-11#1)(2008-5#1)(2009-12#1)(2010-11#1)
of health-relevant##2##2##(2008-4#1)(2008-8#1)
of health-risk behaviors##2##3##(2010-5#1)(2010-7#1)
of healthcare and##2##3##(2006-5#2)
of healthcare costs##2##3##(1995-12#1)(2006-10#1)
of healthcare delivery##2##3##(2006-1#1)(2008-12#1)
of healthcare facilities##3##3##(1996-12#1)(1996-3#1)(2009-8#1)
of healthcare in##4##3##(2007-1#1)(2008-10#1)(2013-1#1)(2013-8#1)
of healthcare is##2##3##(2006-1#1)(2009-7#1)
of healthcare issues##2##3##(1990-12#1)(2010-1#1)
of healthcare organizations##3##3##(1994-12#1)(1995-2#1)(2007-1#1)
of healthcare practitioners on##2##4##(2008-9#2)
of healthcare practitioners##3##3##(2007-12#1)(2008-9#2)
of healthcare professionals##4##3##(1991-1#1)(2008-11#1)(2013-1#2)
of healthcare providers to##2##4##(1997-7#1)(2007-12#1)
of healthcare providers##5##3##(1997-7#1)(2007-12#1)(2010-5#1)(2013-1#2)
of healthcare quality and##2##4##(2007-5#1)(2013-1#1)
of healthcare quality##4##3##(2007-5#1)(2008-8#1)(2013-1#2)
of healthcare reform##3##3##(1993-12#2)(1995-1#1)
of healthcare resources##3##3##(2006-12#1)(2012-2#2)
of healthcare services##6##3##(1994-3#1)(1995-2#1)(2008-1#1)(2008-9#1)(2012-2#1)(2013-8#1)
of healthcare systems##3##3##(2009-3#1)(2010-3#1)(2012-2#1)
of healthcare workers in##3##4##(2012-12#1)(2013-1#2)
of healthcare workers##5##3##(2012-1#1)(2012-12#1)(2013-1#3)
of healthcare##105##2##(1990-12#1)(1991-1#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#2)(1994-12#2)(1994-3#1)(1995-1#4)(1995-12#2)(1995-2#4)(1996-12#1)(1996-2#2)(1996-3#2)(1996-7#1)(1997-7#1)(2005-10#1)(2006-1#2)(2006-10#2)(2006-12#1)(2006-5#3)(2006-6#1)(2007-1#2)(2007-12#8)(2007-5#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-7#1)(2008-8#1)(2008-9#4)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#2)(2011-7#1)(2012-1#1)(2012-12#3)(2012-2#4)(2013-1#18)(2013-8#3)
of healthy adult##2##3##(1990-2#1)(2007-1#1)
of healthy adults##2##3##(1990-6#1)(2008-5#1)
of healthy and diseased##3##4##(2008-10#2)(2013-1#1)
of healthy and##13##3##(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-6#1)(2012-1#1)(2012-12#1)(2013-1#2)
of healthy children aged##2##4##(1992-8#2)
of healthy children and##2##4##(2008-12#1)(2010-2#1)
of healthy children##11##3##(1992-8#2)(1995-2#2)(1996-1#1)(2007-11#1)(2007-7#1)(2008-12#1)(2008-5#1)(2009-4#1)(2010-2#1)
of healthy controls and##2##4##(1991-12#1)(1992-9#1)
of healthy controls##9##3##(1990-2#1)(1991-12#1)(1992-12#1)(1992-9#2)(1993-8#1)(2009-2#1)(2009-8#1)(2013-8#1)
of healthy donors##6##3##(1991-5#1)(1995-3#2)(2005-8#1)(2008-11#1)(2010-4#1)
of healthy host##2##3##(2008-10#2)
of healthy human##2##3##(1997-6#1)(2013-1#1)
of healthy humans##2##3##(1993-9#1)(2013-1#1)
of healthy individuals was##2##4##(1995-1#1)(2009-10#1)
of healthy individuals##14##3##(1990-12#1)(1995-1#2)(2007-11#1)(2007-7#1)(2008-10#2)(2008-7#2)(2009-10#1)(2010-2#1)(2011-2#2)(2012-12#1)
of healthy lifestyle##2##3##(2008-12#1)(2013-1#1)
of healthy men##2##3##(1990-10#1)(1992-3#1)
of healthy mothers##2##3##(2007-2#1)(2008-3#1)
of healthy people##3##3##(1990-7#1)(2011-12#1)(2012-3#1)
of healthy persons##2##3##(2006-8#1)(2007-8#1)
of healthy plants##2##3##(2008-10#2)
of healthy skin##2##3##(2008-5#1)(2009-4#1)
of healthy subjects and patients##2##5##(1993-11#1)(1996-12#1)
of healthy subjects and##4##4##(1993-11#1)(1996-12#1)(2008-12#1)(2010-12#1)
of healthy subjects##23##3##(1991-11#2)(1991-9#1)(1993-11#1)(1994-1#1)(1995-11#1)(1996-12#1)(1996-3#1)(2006-3#1)(2006-8#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-12#1)(2009-2#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-1#2)(2013-1#1)(2013-8#1)
of healthy tissue##2##3##(2008-10#1)(2011-2#1)
of healthy volunteers by##2##4##(2008-5#1)(2013-1#1)
of healthy volunteers##7##3##(1996-8#1)(2007-12#1)(2007-8#1)(2008-5#2)(2013-1#2)
of healthy women of the##2##5##(1993-2#1)(2013-8#1)
of healthy women##3##3##(1993-2#1)(1996-7#1)(2013-8#1)
of healthy young##2##3##(1990-12#1)(2012-1#1)
of healthy##177##2##(1990-10#1)(1990-12#2)(1990-2#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-5#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-2#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-3#2)(1995-1#2)(1995-11#1)(1995-2#2)(1995-3#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#3)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#23)(2008-11#8)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#10)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-2#2)(2009-4#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#4)(2010-4#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#4)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#5)
of hearing aid##3##3##(2011-12#1)(2013-1#2)
of hearing and balance##2##4##(1990-8#1)(2012-2#1)
of hearing and##4##3##(1990-12#1)(1990-8#1)(2011-2#1)(2012-2#1)
of hearing impairment##4##3##(2006-10#1)(2013-1#3)
of hearing loss##11##3##(1993-1#1)(1996-6#1)(2007-9#1)(2008-4#1)(2008-9#2)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
of hearing##44##2##(1990-12#3)(1990-8#1)(1993-1#1)(1994-9#2)(1996-6#1)(2006-10#1)(2006-3#1)(2007-9#2)(2008-1#1)(2008-4#2)(2008-9#4)(2010-4#1)(2011-12#2)(2011-2#10)(2012-2#3)(2013-1#9)
of hearing-impaired##2##2##(1995-1#1)(2013-1#1)
of heart and vessels##2##4##(2007-8#1)(2012-12#1)
of heart and##10##3##(1995-11#1)(1997-1#1)(2007-8#1)(2007-9#1)(2008-4#1)(2008-8#1)(2009-11#1)(2009-12#1)(2011-2#1)(2012-12#1)
of heart attack##4##3##(2008-3#2)(2010-12#1)(2013-7#1)
of heart damage##2##3##(1994-6#1)(2007-3#1)
of heart disease and##4##4##(1990-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
of heart disease in##3##4##(2007-10#1)(2008-1#1)(2011-1#1)
of heart disease##19##3##(1990-12#1)(1991-9#1)(1996-2#1)(2005-7#1)(2007-1#1)(2007-10#2)(2007-2#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-9#1)(2011-1#1)(2013-1#1)
of heart failure (HF)##6##4##(2008-10#1)(2010-12#1)(2010-6#1)(2011-2#2)(2013-8#1)
of heart failure and##7##4##(1990-3#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-4#1)(2012-3#1)
of heart failure are##2##4##(1990-3#1)(2005-10#1)
of heart failure in the##2##5##(1994-6#1)(2010-8#1)
of heart failure in##5##4##(1994-6#1)(2008-3#1)(2009-10#1)(2010-12#1)(2010-8#1)
of heart failure patients##2##4##(2007-5#1)(2010-11#1)
of heart failure symptoms##2##4##(2007-8#1)(2012-2#1)
of heart failure with##2##4##(2012-3#1)(2013-1#1)
of heart failure##76##3##(1990-3#2)(1991-9#1)(1992-6#1)(1994-6#1)(1994-7#2)(1996-6#2)(1996-9#1)(2005-10#4)(2005-12#1)(2005-7#2)(2006-4#1)(2006-6#1)(2007-1#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#6)(2008-4#2)(2008-5#2)(2008-7#4)(2009-10#5)(2009-4#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-6#5)(2010-8#3)(2011-2#3)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#1)
of heart failure]##5##3##(1992-9#1)(1994-7#1)(1994-8#1)(1996-6#1)(2008-10#1)
of heart function##2##3##(1995-12#1)(2013-1#1)
of heart rate (HR)##2##4##(1991-4#1)(2010-5#1)
of heart rate variability##11##4##(1991-4#1)(2006-12#1)(2006-9#1)(2008-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#1)
of heart rate##23##3##(1991-1#1)(1991-4#2)(1991-8#1)(1994-5#1)(1995-12#1)(1996-2#1)(2006-12#1)(2006-9#1)(2008-1#2)(2008-10#1)(2008-6#2)(2009-10#1)(2010-5#2)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#1)
of heart surgery##2##3##(1993-10#2)
of heart##182##2##(1990-12#1)(1990-3#2)(1991-1#2)(1991-4#3)(1991-5#1)(1991-8#3)(1991-9#2)(1992-2#1)(1992-6#1)(1992-9#1)(1993-10#2)(1993-12#1)(1993-9#1)(1994-5#1)(1994-6#2)(1994-7#3)(1994-8#1)(1995-11#2)(1995-12#2)(1995-2#1)(1996-10#1)(1996-2#2)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-10#4)(2005-12#1)(2005-7#3)(2006-10#1)(2006-12#2)(2006-4#2)(2006-6#1)(2006-9#1)(2007-1#3)(2007-10#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#6)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#9)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#1)(2009-10#6)(2009-11#2)(2009-12#1)(2009-4#1)(2010-10#2)(2010-11#3)(2010-12#3)(2010-2#1)(2010-5#3)(2010-6#5)(2010-8#4)(2010-9#1)(2011-1#4)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#7)(2013-1#9)(2013-7#1)(2013-8#2)
of heartburn##3##2##(1991-5#1)(2008-5#1)(2013-1#1)
of hearts##3##2##(2008-5#1)(2010-7#1)(2013-1#1)
of heat and##5##3##(1992-2#2)(1996-12#1)(2004-11#1)(2005-12#1)
of heat flow in##3##4##(2007-12#1)(2008-3#2)
of heat generation##2##3##(2007-12#1)(2008-2#1)
of heat in##2##3##(2006-12#1)(2013-1#1)
of heat is##2##3##(2006-12#1)(2011-1#1)
of heat on##4##3##(2007-12#1)(2008-3#1)(2013-1#1)(2013-8#1)
of heat resistance##2##3##(1994-8#1)(1997-6#1)
of heat shock gene expression and thermotolerance development in HT-29 cells##2##11##(1992-7#1)(1994-8#1)
of heat shock genes##2##4##(1990-11#1)(1994-8#1)
of heat shock protein (HSP)##3##5##(1994-11#1)(2008-7#1)(2013-1#1)
of heat shock protein 70##2##5##(1994-11#1)(2012-1#1)
of heat shock protein 90##2##5##(2005-10#1)(2012-1#1)
of heat shock protein with a molecular weight of 90 kDa##2##11##(2012-1#2)
of heat shock protein##19##4##(1991-8#1)(1994-11#4)(1994-8#3)(1995-5#1)(2005-10#1)(2008-7#1)(2010-12#1)(2011-12#1)(2012-1#4)(2012-2#1)(2013-1#1)
of heat shock proteins in the##3##6##(1994-11#2)(2012-3#1)
of heat shock proteins in##7##5##(1992-6#1)(1994-10#1)(1994-11#3)(2012-1#1)(2012-3#1)
of heat shock proteins##15##4##(1992-6#1)(1993-11#1)(1993-4#1)(1994-10#1)(1994-11#4)(2006-10#1)(2008-4#1)(2010-4#1)(2012-1#3)(2012-3#1)
of heat shock transcription factor (HSF)##2##6##(1995-11#1)(2009-8#1)
of heat shock transcription factor##3##5##(1994-11#1)(1995-11#1)(2009-8#1)
of heat shock transcription##4##4##(1994-11#1)(1995-11#1)(2009-8#2)
of heat shock##52##3##(1990-11#1)(1991-8#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-4#1)(1994-10#1)(1994-11#11)(1994-8#8)(1995-11#1)(1995-5#1)(1996-9#1)(2005-10#1)(2006-10#1)(2008-4#1)(2008-7#2)(2009-8#3)(2010-12#1)(2010-2#1)(2010-4#1)(2011-12#1)(2012-1#7)(2012-2#1)(2012-3#1)(2013-1#2)
of heat stress##8##3##(1992-1#1)(1994-11#1)(2008-12#3)(2010-7#1)(2012-2#2)
of heat transfer##2##3##(2008-10#2)
of heat treatment of rayon-based activated carbon fibers on the adsorption##2##11##(2005-11#2)
of heat treatment of##3##4##(1992-8#1)(2005-11#2)
of heat treatment##8##3##(1992-8#1)(2005-11#2)(2005-12#1)(2008-2#1)(2008-7#1)(2009-3#1)(2013-8#1)
of heat wave on##2##4##(2011-1#2)
of heat wave##3##3##(2011-1#3)
of heat##128##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-8#1)(1990-9#1)(1991-8#1)(1992-1#1)(1992-2#3)(1992-3#4)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-4#1)(1993-6#1)(1994-10#1)(1994-11#12)(1994-5#1)(1994-8#9)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#2)(1996-9#1)(1997-6#1)(2004-11#1)(2005-10#1)(2005-11#2)(2005-12#3)(2005-9#1)(2006-10#3)(2006-12#5)(2006-5#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#5)(2009-3#1)(2009-6#1)(2009-8#3)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#4)(2011-12#1)(2011-2#1)(2012-1#7)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#3)
of heat-inducible genes##2##3##(2009-8#2)
of heat-killed##2##2##(1994-5#1)(2008-10#1)
of heat-labile##3##2##(1992-6#1)(1995-2#1)(2005-11#1)
of heat-shock proteins##3##3##(1992-6#2)(1995-4#1)
of heat-shock##8##2##(1991-10#2)(1992-6#2)(1993-6#1)(1994-11#1)(1995-4#1)(2008-7#1)
of heat-treated##2##2##(1995-6#1)(1997-7#1)
of heated##6##2##(1990-3#1)(2006-10#2)(2006-12#1)(2008-3#1)(2009-6#1)
of heating and##3##3##(1990-9#1)(2008-10#2)
of heating in##3##3##(1990-2#1)(1994-5#1)(2008-10#1)
of heating temperature and##2##4##(2013-1#2)
of heating##16##2##(1990-2#2)(1990-9#1)(1994-5#1)(1994-9#1)(1995-6#1)(2006-12#1)(2007-8#1)(2008-10#5)(2008-2#1)(2013-1#2)
of heavy and light chain##3##5##(1991-8#1)(1994-9#1)(2008-4#1)
of heavy and##5##3##(1991-8#1)(1993-12#1)(1994-2#1)(1994-9#1)(2008-4#1)
of heavy chain and##2##4##(1991-5#1)(1994-3#1)
of heavy chain##6##3##(1990-5#1)(1991-5#1)(1994-3#3)(1997-9#1)
of heavy ion##2##3##(2006-8#1)(2009-8#1)
of heavy ions##2##3##(1995-2#1)(2008-7#1)
of heavy metal and##2##4##(2007-5#1)(2013-8#1)
of heavy metal ions from aqueous##2##6##(2008-10#2)
of heavy metal ions from##3##5##(1994-6#1)(2008-10#2)
of heavy metal ions in electroplate waste water##2##8##(2012-12#2)
of heavy metal ions in##4##5##(2008-10#2)(2012-12#2)
of heavy metal ions onto the##2##6##(2008-10#2)
of heavy metal ions onto##3##5##(2008-10#3)
of heavy metal ions##24##4##(1992-2#1)(1994-6#1)(2005-11#1)(2008-10#17)(2008-5#1)(2012-12#3)
of heavy metal pollution in##2##5##(2007-5#1)(2008-10#1)
of heavy metal##41##3##(1992-2#1)(1993-12#1)(1994-6#1)(1996-3#1)(1997-7#1)(2004-4#1)(2005-11#1)(2007-5#2)(2008-10#22)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#3)(2013-1#2)(2013-8#1)
of heavy metals by##2##4##(1995-3#1)(2008-10#1)
of heavy metals from##4##4##(2007-8#1)(2008-10#2)(2008-2#1)
of heavy metals in different tissues of##2##7##(2008-12#2)
of heavy metals in different##3##5##(2008-11#1)(2008-12#2)
of heavy metals in sediments##2##5##(2007-5#2)
of heavy metals in the##4##5##(1995-3#1)(2008-10#1)(2011-12#1)(2011-2#1)
of heavy metals in##21##4##(1995-3#1)(2007-5#2)(2007-8#1)(2008-10#8)(2008-11#1)(2008-12#2)(2009-6#2)(2010-11#1)(2011-12#1)(2011-2#1)(2013-8#1)
of heavy metals of##2##4##(2007-10#2)
of heavy metals on##2##4##(2008-10#1)(2008-5#1)
of heavy metals such as##2##5##(2007-10#1)(2008-4#1)
of heavy metals with##2##4##(2008-10#1)(2008-11#1)
of heavy metals##55##3##(1993-4#1)(1994-6#1)(1995-3#2)(2007-10#3)(2007-5#2)(2007-8#2)(2008-10#23)(2008-11#2)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#2)(2009-6#3)(2010-11#1)(2011-12#2)(2011-2#1)(2013-8#2)
of heavy##127##2##(1990-5#1)(1991-5#1)(1991-8#1)(1992-2#1)(1993-12#2)(1993-4#1)(1993-5#1)(1994-2#1)(1994-3#4)(1994-6#2)(1994-9#1)(1995-2#1)(1995-3#2)(1995-9#1)(1996-3#1)(1997-1#1)(1997-7#1)(1997-9#1)(2004-4#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-5#2)(2006-8#1)(2007-10#4)(2007-5#4)(2007-7#1)(2007-8#2)(2008-10#46)(2008-11#2)(2008-12#3)(2008-2#2)(2008-4#2)(2008-5#4)(2008-7#4)(2008-8#1)(2009-6#3)(2009-8#1)(2010-11#1)(2011-1#1)(2011-12#2)(2011-2#4)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#3)
of hedgehog##2##2##(1993-2#2)
of hegemonic##2##2##(2008-10#1)(2009-5#1)
of heifers to discriminate between##2##5##(2010-2#2)
of heifers##3##2##(2006-5#1)(2010-2#2)
of height functions##2##3##(2008-2#2)
of height##9##2##(2007-11#1)(2007-2#1)(2008-2#2)(2008-8#1)(2009-6#1)(2011-2#3)
of heightened##2##2##(2009-8#1)(2012-3#1)
of helical##12##2##(1993-6#2)(1997-2#4)(1997-4#1)(2005-10#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-6#1)
of helicase##2##2##(1994-5#1)(2010-7#1)
of helices 20 and##2##4##(1996-8#2)
of helices with##2##3##(1992-12#1)(1994-12#1)
of helices##11##2##(1991-6#1)(1992-12#2)(1993-3#2)(1994-12#1)(1994-6#1)(1994-8#1)(1996-8#2)(2008-5#1)
of helicobacter pylori##2##3##(2008-7#1)(2010-12#1)
of helicobacter##3##2##(2008-7#1)(2008-9#1)(2010-12#1)
of helium and##2##3##(2008-3#1)(2011-1#1)
of helium##4##2##(1991-12#1)(1992-9#1)(2008-3#1)(2011-1#1)
of helix 4##2##3##(1995-1#1)(2008-9#1)
of helix I##2##3##(1997-7#2)
of helix##19##2##(1990-11#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-5#1)(1994-9#1)(1995-1#1)(1996-8#1)(1997-4#4)(1997-7#3)(2006-11#1)(2008-2#1)(2008-5#1)(2008-9#1)
of helix-loop-helix##2##2##(1991-4#1)(1994-3#1)
of helminth infection##2##3##(2006-10#1)(2007-3#1)
of helminth parasites##3##3##(2007-3#1)(2011-1#2)
of helminth##9##2##(1997-7#1)(2006-10#1)(2007-12#1)(2007-3#3)(2011-1#2)(2012-2#1)
of helminthes##2##2##(2011-2#2)
of help for##2##3##(1992-5#1)(2008-4#1)
of help in##2##3##(1990-9#1)(2006-4#1)
of help##10##2##(1990-9#1)(1991-8#1)(1992-5#1)(1996-3#1)(2006-2#1)(2006-4#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-4#1)
of help-seeking##2##2##(2007-3#1)(2012-3#1)
of helper and##2##3##(1991-12#1)(2008-4#1)
of helper virus##2##3##(1990-5#1)(2008-10#1)
of helper##10##2##(1990-5#1)(1991-12#1)(1992-3#1)(1996-10#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-4#1)(2013-7#1)
of helping patients##2##3##(2005-7#1)(2009-6#1)
of helping##10##2##(1991-12#1)(1993-1#1)(2005-7#1)(2005-9#1)(2007-8#1)(2008-12#1)(2008-8#1)(2009-6#1)(2010-2#1)(2010-4#1)
of hemangioma##4##2##(2006-3#1)(2008-10#1)(2009-10#1)(2012-2#1)
of hemangiomas and##3##3##(1993-1#1)(2007-6#2)
of hemangiomas##4##2##(1993-1#1)(2007-6#3)
of hematite particles##2##3##(2005-11#2)
of hematite##3##2##(2005-11#3)
of hematocrit and##2##3##(2005-10#1)(2013-1#1)
of hematocrit##3##2##(2005-10#1)(2008-3#1)(2013-1#1)
of hematogenous##4##2##(1991-9#1)(1996-11#1)(2007-8#1)(2008-10#1)
of hematologic malignancy##2##3##(2010-12#1)(2012-2#1)
of hematologic##5##2##(2008-5#1)(2008-9#1)(2010-12#1)(2012-2#1)(2013-8#1)
of hematological malignancies##4##3##(2008-10#1)(2011-2#2)(2013-1#1)
of hematological##9##2##(2005-1#1)(2007-4#1)(2008-10#1)(2008-4#1)(2011-2#3)(2012-2#1)(2013-1#1)
of hematology##2##2##(2008-10#1)(2011-2#1)
of hematolymphoid##2##2##(1995-2#1)(2013-1#1)
of hematoma and##2##3##(1990-5#2)
of hematoma##3##2##(1990-5#2)(2007-10#1)
of hematophagous##2##2##(1995-1#1)(2008-4#1)
of hematopoiesis##8##2##(1990-12#1)(1996-10#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-8#1)(2010-11#1)
of hematopoietic and##3##3##(1995-2#1)(2008-9#1)(2012-12#1)
of hematopoietic cell proliferation##2##4##(2008-9#2)
of hematopoietic cells##9##3##(1995-3#2)(1996-2#1)(1997-7#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)
of hematopoietic cytokines##2##3##(2008-7#1)(2008-9#1)
of hematopoietic malignancies and##2##4##(1991-12#1)(2008-10#1)
of hematopoietic origin##4##3##(1995-3#3)(2008-11#1)
of hematopoietic progenitor cells##2##4##(2008-11#2)
of hematopoietic progenitors##5##3##(1993-6#1)(2008-11#2)(2010-8#1)(2011-2#1)
of hematopoietic stem cell transplantation##3##5##(2011-1#1)(2012-12#1)(2013-8#1)
of hematopoietic stem cell##4##4##(2009-10#1)(2011-1#1)(2012-12#1)(2013-8#1)
of hematopoietic stem cells (HSCs)##2##5##(2008-10#1)(2010-11#1)
of hematopoietic stem cells from##2##5##(2008-10#1)(2008-9#1)
of hematopoietic stem cells is##3##5##(1995-12#1)(2008-1#1)(2008-9#1)
of hematopoietic stem cells##16##4##(1995-1#1)(1995-12#2)(2007-8#2)(2008-1#1)(2008-10#3)(2008-5#1)(2008-9#3)(2010-11#2)(2012-12#1)
of hematopoietic stem##20##3##(1995-1#1)(1995-12#2)(2007-8#2)(2008-1#1)(2008-10#3)(2008-5#1)(2008-9#3)(2009-10#1)(2010-11#2)(2011-1#1)(2012-12#2)(2013-8#1)
of hematopoietic##59##2##(1990-12#1)(1991-12#1)(1991-7#1)(1993-6#1)(1993-8#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#5)(1996-2#1)(1997-7#1)(2006-12#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#7)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#9)(2009-10#1)(2009-7#1)(2010-11#2)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#5)(2013-8#1)
of hematoporphyrin##2##2##(2008-8#1)(2008-9#1)
of hematuria##11##2##(1993-2#1)(1996-12#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-2#4)(2007-7#1)
of heme B was oxidized##2##5##(1995-11#2)
of heme B##5##3##(1995-11#5)
of heme and##2##3##(2008-9#2)
of heme b##2##3##(1996-2#2)
of heme bL##3##3##(1997-3#3)
of heme binding##2##3##(1992-3#1)(1994-5#1)
of heme degradation##2##3##(1991-4#1)(1992-3#1)
of heme oxygenase##5##3##(1994-3#2)(1996-3#1)(2008-4#2)
of heme polymerase##2##3##(1993-8#2)
of heme site cooperativity##2##4##(1997-2#2)
of heme##52##2##(1990-8#1)(1991-10#1)(1991-4#2)(1991-7#1)(1992-3#2)(1992-4#1)(1993-8#3)(1994-3#4)(1994-5#2)(1994-8#5)(1995-1#1)(1995-11#6)(1996-2#2)(1996-3#2)(1997-2#2)(1997-3#4)(1997-4#2)(2006-9#1)(2007-11#1)(2008-10#1)(2008-4#3)(2008-9#3)(2010-1#1)(2010-12#1)
of heme-protein##2##2##(2008-10#2)
of hemerythrin##3##2##(1991-10#1)(1992-8#2)
of hemi-fusion in##2##3##(1991-5#2)
of hemiballismus##2##2##(2008-7#2)
of hemicellulose hydrolysate##2##3##(2008-6#2)
of hemicellulose hydrolysates##2##3##(2008-5#2)
of hemicellulose##4##2##(2008-5#2)(2008-6#2)
of hemicelluloses##8##2##(2008-5#8)
of hemifacial spasm##3##3##(2006-12#3)
of hemifacial##4##2##(2006-12#3)(2011-1#1)
of hemin##16##2##(1991-9#2)(1993-12#1)(1994-5#7)(2008-10#5)(2008-8#1)
of hemiparetic##2##2##(1994-1#1)(2007-11#1)
of hemispheric##4##2##(1994-2#1)(1996-5#1)(2007-7#1)(2007-9#1)
of hemispherical##2##2##(2008-10#1)(2008-2#1)
of hemochromatosis##2##2##(1991-4#1)(2007-2#1)
of hemocyanin##4##2##(2008-7#1)(2011-12#3)
of hemocytes##8##2##(2006-10#2)(2008-5#4)(2008-7#1)(2010-4#1)
of hemodialysis (HD)##2##3##(2008-1#1)(2011-2#1)
of hemodialysis facilities##2##3##(1991-12#2)
of hemodialysis patients##3##3##(1996-8#1)(2007-7#2)
of hemodialysis treatment##3##3##(2007-7#1)(2008-4#1)(2011-2#1)
of hemodialysis vascular access##3##4##(2007-7#1)(2008-4#1)(2012-1#1)
of hemodialysis##34##2##(1991-12#2)(1996-8#1)(2005-11#1)(2006-8#1)(2007-6#1)(2007-7#10)(2007-8#1)(2007-9#1)(2008-1#8)(2008-4#2)(2011-2#2)(2012-1#1)(2013-1#2)(2013-8#1)
of hemodynamic and##3##3##(1993-9#1)(2012-1#1)(2012-12#1)
of hemodynamic factors in##2##4##(2007-7#1)(2009-1#1)
of hemodynamic##19##2##(1990-8#1)(1991-9#1)(1993-9#1)(1994-3#1)(1997-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-6#2)(2008-8#1)(2009-1#1)(2009-3#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-3#1)
of hemodynamically significant##2##3##(2007-8#2)
of hemodynamically##4##2##(2007-8#4)
of hemodynamics and##2##3##(1995-6#1)(2008-1#1)
of hemodynamics##4##2##(1995-6#1)(1997-5#1)(2008-1#1)(2008-5#1)
of hemoglobin (Hb)##5##3##(1994-12#1)(2007-9#1)(2008-10#2)(2008-7#1)
of hemoglobin A0##2##3##(1990-8#2)
of hemoglobin A1c##3##3##(1996-9#1)(2012-5#2)
of hemoglobin S##2##3##(1991-8#1)(1994-11#1)
of hemoglobin and##4##3##(1990-8#1)(1994-9#1)(2008-1#1)(2008-2#1)
of hemoglobin by##2##3##(1994-9#1)(1997-1#1)
of hemoglobin concentration##3##3##(2007-8#1)(2008-3#1)(2011-1#1)
of hemoglobin from##2##3##(1991-6#1)(2010-11#1)
of hemoglobin have been##2##4##(1990-8#1)(1997-2#1)
of hemoglobin in##8##3##(1990-8#1)(1992-9#1)(1994-12#1)(2008-10#3)(2008-9#1)(2011-1#1)
of hemoglobin level##2##3##(2008-7#1)(2013-1#1)
of hemoglobin oxygen equilibrium curves##2##5##(1990-8#2)
of hemoglobin oxygenation##2##3##(1990-8#1)(2008-3#1)
of hemoglobin using##2##3##(2008-10#2)
of hemoglobin was##2##3##(1994-12#1)(2008-10#1)
of hemoglobin with##2##3##(1990-8#2)
of hemoglobin##89##2##(1990-10#2)(1990-11#1)(1990-7#1)(1990-8#16)(1990-9#1)(1991-1#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-4#1)(1992-9#3)(1993-6#2)(1993-8#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-8#3)(1994-9#4)(1995-5#1)(1996-9#1)(1997-1#2)(1997-2#4)(2006-8#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#11)(2008-2#1)(2008-3#2)(2008-7#3)(2008-9#1)(2009-3#2)(2010-11#1)(2011-1#2)(2012-12#1)(2012-5#2)(2013-1#1)(2013-8#2)
of hemoglobin-based##2##2##(2007-12#1)(2010-2#1)
of hemoglobinopathies##2##2##(1990-8#1)(1993-9#1)
of hemoglobinopathy##3##2##(2008-7#2)(2012-3#1)
of hemolymph##3##2##(1990-3#1)(1997-8#2)
of hemolysis##12##2##(1992-6#1)(1994-12#1)(1994-6#1)(1994-9#1)(2005-11#3)(2007-8#1)(2008-4#1)(2008-7#1)(2013-1#2)
of hemolytic disease of the newborn##2##6##(1992-12#1)(1993-6#1)
of hemolytic disease of the##3##5##(1992-12#1)(1993-6#1)(2010-11#1)
of hemophilia A##2##3##(1990-12#1)(1992-2#1)
of hemophilia B##2##3##(1993-6#1)(2008-8#1)
of hemophilia##4##2##(1990-12#1)(1992-2#1)(1993-6#1)(2008-8#1)
of hemophilic synovitis##2##3##(2009-2#2)
of hemopoiesis##3##2##(2012-1#2)(2013-1#1)
of hemopoietic cells##3##3##(1993-3#1)(1996-10#1)(1997-2#1)
of hemopoietic progenitor cells##2##4##(1990-7#1)(1994-5#1)
of hemopoietic stem cells##4##4##(1994-4#1)(2008-4#2)(2011-1#1)
of hemopoietic##11##2##(1990-7#1)(1993-3#1)(1994-4#1)(1994-5#1)(1995-1#1)(1996-10#1)(1997-2#1)(2008-4#2)(2010-12#1)(2011-1#1)
of hemoprotein##2##2##(1991-8#2)
of hemoproteins##2##2##(1997-7#1)(2010-12#1)
of hemoptysis##2##2##(1997-8#1)(2012-2#1)
of hemorrhage##15##2##(1990-11#1)(1990-5#1)(1996-9#1)(2005-8#1)(2006-10#2)(2006-2#1)(2007-10#1)(2007-9#2)(2008-7#1)(2009-8#1)(2012-3#2)(2013-1#1)
of hemorrhagic fever with renal syndrome##3##6##(2013-1#3)
of hemorrhagic fever with##4##4##(2010-12#1)(2013-1#3)
of hemorrhagic stroke##6##3##(2006-10#1)(2007-9#1)(2008-8#1)(2010-10#1)(2011-1#1)(2012-12#1)
of hemorrhagic##18##2##(1990-10#1)(1991-6#1)(2006-10#1)(2007-9#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#5)
of hemorrhoids##2##2##(1991-10#1)(2006-12#1)
of hemosiderin##2##2##(1992-6#1)(2010-12#1)
of hemostasis and##2##3##(2012-1#1)(2012-2#1)
of hemostasis##13##2##(1994-9#1)(2008-1#2)(2008-10#2)(2008-4#1)(2008-9#1)(2009-2#1)(2012-1#1)(2012-2#1)(2013-1#3)
of hemostatic variables##2##3##(2005-10#2)
of hemostatic##7##2##(1990-12#1)(2005-10#3)(2008-4#1)(2011-12#1)(2012-1#1)
of hen egg white lysozyme##3##5##(1994-8#1)(1997-2#1)(2009-5#1)
of hen egg white##4##4##(1994-8#1)(1996-5#1)(1997-2#1)(2009-5#1)
of hen lysozyme##2##3##(1995-8#1)(1997-4#1)
of hen##8##2##(1994-8#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-7#1)(2009-5#1)
of hens were##2##3##(2008-5#1)(2013-1#1)
of hens##5##2##(1991-11#1)(2008-5#2)(2013-1#2)
of heparan sulfate in##2##4##(1995-12#2)
of heparan sulfate proteoglycan and proteins occurs post-translationally##2##8##(1990-10#2)
of heparan sulfate proteoglycan and##3##5##(1990-10#2)(1995-8#1)
of heparan sulfate##11##3##(1990-10#2)(1990-5#1)(1992-5#1)(1995-12#2)(1995-5#1)(1995-8#1)(2009-12#3)
of heparan sulphate##2##3##(1993-6#1)(1996-8#1)
of heparan##14##2##(1990-10#2)(1990-5#1)(1992-5#1)(1992-9#1)(1993-6#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-8#1)(2009-12#3)
of heparin and dermatan sulfate##2##5##(1996-5#2)
of heparin and##6##3##(1995-4#1)(1996-5#2)(2006-10#1)(2006-12#1)(2007-10#1)
of heparin binding##4##3##(1990-12#1)(1992-10#1)(1996-1#1)(1997-4#1)
of heparin cofactor II##2##4##(1995-5#1)(2005-8#1)
of heparin in##6##3##(1990-11#2)(1992-10#2)(1994-8#1)(2008-10#1)
of heparin on##2##3##(1997-5#1)(2008-11#1)
of heparin or##2##3##(1990-12#1)(1993-6#1)
of heparin therapy##4##3##(1997-2#1)(2006-10#1)(2007-12#1)(2008-10#1)
of heparin to##7##3##(1992-10#1)(1993-6#1)(1994-4#1)(1995-2#1)(1997-5#1)(2008-11#1)(2009-4#1)
of heparin with##3##3##(1990-11#1)(1994-8#1)(2008-10#1)
of heparin##82##2##(1990-11#3)(1990-12#4)(1991-7#1)(1992-10#4)(1992-5#1)(1993-2#1)(1993-6#4)(1994-10#1)(1994-3#1)(1994-4#3)(1994-6#1)(1994-8#3)(1995-10#2)(1995-2#3)(1995-4#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-5#2)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-10#8)(2008-11#3)(2008-4#1)(2009-4#2)(2010-8#1)(2011-2#1)(2013-1#2)
of heparin-binding##2##2##(1991-4#1)(1997-1#1)
of heparin-derived oligosaccharides##2##3##(1995-4#2)
of heparin-induced extracorporeal lipoprotein apheresis##2##5##(2011-2#2)
of heparin-induced thrombocytopenia (HIT)##2##4##(2009-8#1)(2013-1#1)
of heparin-induced thrombocytopenia##5##3##(1995-4#1)(2007-12#1)(2009-8#1)(2011-2#1)(2013-1#1)
of heparin-induced##8##2##(1995-4#1)(2006-12#1)(2007-12#1)(2009-8#1)(2011-2#3)(2013-1#1)
of heparin-inserted PC liposomes##2##4##(1990-5#2)
of heparin-inserted##3##2##(1990-5#3)
of heparinized##2##2##(1990-8#1)(2011-2#1)
of hepatic GSH##2##3##(1990-3#1)(1996-9#1)
of hepatic MT##2##3##(1997-2#2)
of hepatic and extra-hepatic##2##4##(1992-11#1)(2008-1#1)
of hepatic and##6##3##(1992-11#1)(1992-9#1)(1995-3#1)(2004-11#1)(2008-1#1)(2008-10#1)
of hepatic blood##2##3##(1992-11#1)(2008-8#1)
of hepatic cell##2##3##(1995-3#1)(2008-11#1)
of hepatic cells##2##3##(1993-6#1)(2010-11#1)
of hepatic cholesterogenesis##2##3##(1990-7#1)(1991-10#1)
of hepatic cholesterol##3##3##(1994-11#1)(2007-8#1)(2012-2#1)
of hepatic cysts##3##3##(2007-8#3)
of hepatic damage##4##3##(1992-12#1)(1995-3#1)(1997-3#1)(2008-9#1)
of hepatic dysfunction##2##3##(2005-8#1)(2006-10#1)
of hepatic encephalopathy##5##3##(1990-4#1)(1996-4#1)(1997-5#2)(2006-10#1)
of hepatic epithelioid hemangioendothelioma##2##4##(2005-12#2)
of hepatic glucagon##2##3##(1994-11#2)
of hepatic glucose production##5##4##(1991-7#1)(1993-8#2)(1995-6#1)(2008-1#1)
of hepatic glucose##7##3##(1991-7#2)(1993-8#2)(1994-3#1)(1995-6#1)(2008-1#1)
of hepatic glucose-6-phosphatase and##2##4##(1991-9#1)(1994-5#1)
of hepatic glucose-6-phosphatase by##2##4##(1991-9#2)
of hepatic glucose-6-phosphatase##5##3##(1991-9#3)(1994-5#1)(2008-11#1)
of hepatic hydatidosis##2##3##(1990-4#1)(2013-8#1)
of hepatic injury and##2##4##(1997-3#1)(2006-10#1)
of hepatic injury##6##3##(1997-3#2)(2006-10#4)
of hepatic lesions##2##3##(1990-10#1)(2010-12#1)
of hepatic lipase on##2##4##(1991-10#1)(1996-8#1)
of hepatic lipase##6##3##(1991-10#1)(1991-8#1)(1994-8#2)(1996-8#2)
of hepatic metastases from colorectal cancer##2##6##(2006-10#2)
of hepatic metastases##5##3##(1992-11#1)(2006-10#2)(2008-7#1)(2008-8#1)
of hepatic microsomal##5##3##(1993-12#2)(1997-8#1)(2004-11#2)
of hepatic progenitor cells##2##4##(2006-10#1)(2013-1#1)
of hepatic stem##2##3##(2006-10#2)
of hepatic tumors induced by##2##5##(1991-10#1)(1996-11#1)
of hepatic tumors##7##3##(1991-10#1)(1994-6#1)(1996-11#1)(2006-6#1)(2008-12#1)(2012-11#2)
of hepatic##195##2##(1990-10#2)(1990-3#5)(1990-4#4)(1990-5#3)(1990-6#1)(1990-7#1)(1991-10#5)(1991-11#1)(1991-12#1)(1991-2#4)(1991-7#2)(1991-8#3)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#4)(1992-12#1)(1992-2#2)(1992-7#1)(1992-9#1)(1993-12#3)(1993-3#2)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#2)(1994-11#3)(1994-12#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#4)(1995-12#4)(1995-3#3)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-8#2)(1996-9#1)(1997-2#2)(1997-3#3)(1997-5#2)(1997-8#2)(2004-11#6)(2005-12#3)(2005-8#1)(2006-1#1)(2006-10#13)(2006-11#2)(2006-2#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-8#8)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#6)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#3)(2009-2#1)(2009-3#3)(2009-8#2)(2010-11#2)(2010-12#4)(2010-2#1)(2010-5#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#3)(2013-1#5)(2013-8#1)
of hepatitis A and##2##4##(2007-11#1)(2008-6#1)
of hepatitis A has##2##4##(2007-12#2)
of hepatitis A in##4##4##(2006-10#1)(2006-2#1)(2007-12#2)
of hepatitis A surveillance data##2##5##(2012-2#2)
of hepatitis A vaccine##2##4##(2007-11#1)(2007-2#1)
of hepatitis A virus (HAV)##2##5##(2012-12#2)
of hepatitis A virus##5##4##(2008-7#2)(2012-12#3)
of hepatitis A##25##3##(1994-8#1)(1995-4#1)(2006-10#4)(2006-2#1)(2007-11#2)(2007-12#6)(2007-2#1)(2008-6#1)(2008-7#2)(2011-1#1)(2012-12#3)(2012-2#2)
of hepatitis B and C##6##5##(1990-12#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-7#1)(2013-7#1)
of hepatitis B and hepatitis C##2##6##(2007-11#1)(2009-7#1)
of hepatitis B and##9##4##(1990-10#1)(1990-12#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-7#1)(2009-7#1)(2013-7#1)
of hepatitis B in##3##4##(2007-12#2)(2010-11#1)
of hepatitis B infection##4##4##(1996-3#1)(2007-6#3)
of hepatitis B surface antigen and##2##6##(2007-12#1)(2007-2#1)
of hepatitis B surface antigen##6##5##(1996-11#1)(1997-4#1)(2006-12#1)(2007-12#1)(2007-2#1)(2013-7#1)
of hepatitis B surface##8##4##(1996-11#1)(1997-4#1)(2006-12#1)(2007-12#2)(2007-2#1)(2008-8#1)(2013-7#1)
of hepatitis B vaccination##3##4##(1993-7#1)(2006-2#1)(2008-9#1)
of hepatitis B vaccine among##3##5##(2008-9#3)
of hepatitis B vaccine##6##4##(1990-6#1)(1995-3#1)(2007-7#1)(2008-9#3)
of hepatitis B vaccines##2##4##(2007-11#1)(2007-2#1)
of hepatitis B virus (HBV) infection##2##6##(1997-4#1)(2006-10#1)
of hepatitis B virus (HBV) replication##2##6##(2009-11#1)(2009-8#1)
of hepatitis B virus (HBV)##10##5##(1990-8#1)(1997-4#2)(2006-10#1)(2007-12#1)(2008-4#1)(2008-8#1)(2009-11#2)(2009-8#1)
of hepatitis B virus DNA##4##5##(1990-8#1)(1990-9#1)(2005-10#1)(2006-10#1)
of hepatitis B virus in##3##5##(1993-2#1)(2009-3#1)(2010-1#1)
of hepatitis B virus infection##6##5##(1991-9#1)(2007-11#1)(2007-8#1)(2008-5#1)(2012-2#2)
of hepatitis B virus surface antigen Pre-S1##2##7##(2008-8#2)
of hepatitis B virus surface antigen##4##6##(1991-9#1)(2008-8#3)
of hepatitis B virus##50##4##(1990-8#2)(1990-9#1)(1991-9#2)(1993-2#1)(1994-8#2)(1996-2#1)(1996-3#2)(1997-4#2)(1997-5#1)(2005-10#1)(2005-8#1)(2006-10#2)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#6)(2009-10#1)(2009-11#2)(2009-3#2)(2009-8#1)(2010-1#1)(2011-12#3)(2012-12#1)(2012-2#3)(2013-1#2)
of hepatitis B##94##3##(1990-10#1)(1990-12#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-9#2)(1993-2#1)(1993-7#1)(1994-8#2)(1995-3#1)(1996-11#1)(1996-2#1)(1996-3#4)(1996-4#1)(1997-4#3)(1997-5#1)(1997-7#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#1)(2007-11#4)(2007-12#6)(2007-2#2)(2007-6#3)(2007-7#4)(2007-8#1)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#7)(2008-9#4)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2011-12#3)(2012-12#1)(2012-2#3)(2013-1#3)(2013-7#4)
of hepatitis C in##3##4##(2007-7#1)(2008-1#1)(2010-11#1)
of hepatitis C on##2##4##(2006-10#1)(2008-1#1)
of hepatitis C viral##2##4##(1994-2#1)(2009-3#1)
of hepatitis C virus (HCV) infection##7##6##(2006-10#1)(2006-2#1)(2009-9#1)(2010-12#1)(2012-2#1)(2013-1#2)
of hepatitis C virus (HCV)##20##5##(1995-1#1)(1995-5#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-8#1)(2009-7#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#3)
of hepatitis C virus RNA##2##5##(1994-8#1)(2006-10#1)
of hepatitis C virus in##4##5##(1994-3#1)(2007-7#1)(2008-10#1)(2010-12#1)
of hepatitis C virus infection##6##5##(2006-10#2)(2007-2#1)(2012-2#2)(2013-1#1)
of hepatitis C virus is##2##5##(1995-5#1)(2006-10#1)
of hepatitis C virus##59##4##(1991-11#1)(1991-2#3)(1992-11#2)(1994-3#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-5#2)(1996-2#1)(1996-3#1)(2005-7#1)(2006-10#7)(2006-12#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-2#2)(2007-3#4)(2007-7#3)(2008-1#1)(2008-10#4)(2008-3#1)(2008-8#1)(2009-7#1)(2009-9#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-2#6)(2013-1#4)(2013-7#1)
of hepatitis C with##2##4##(2007-11#1)(2008-6#1)
of hepatitis C##86##3##(1991-11#1)(1991-2#3)(1992-1#1)(1992-11#2)(1992-2#1)(1992-5#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-7#4)(1994-8#1)(1995-1#1)(1995-5#2)(1995-9#1)(1996-2#1)(1996-3#1)(2005-7#1)(2006-10#8)(2006-12#1)(2006-2#1)(2006-4#1)(2007-11#2)(2007-2#2)(2007-3#4)(2007-7#5)(2008-1#5)(2008-10#4)(2008-3#2)(2008-6#1)(2008-8#2)(2009-3#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#6)(2013-1#4)(2013-7#2)
of hepatitis E in The Netherlands]##2##6##(1992-10#2)
of hepatitis E##4##3##(1992-10#2)(2006-2#1)(2007-7#1)
of hepatitis and##2##3##(2007-3#1)(2010-6#1)
of hepatitis is##2##3##(2008-5#1)(2009-9#1)
of hepatitis##231##2##(1990-10#2)(1990-12#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-2#3)(1991-4#1)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#2)(1992-2#1)(1992-5#1)(1993-2#2)(1993-7#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-7#4)(1994-8#4)(1995-1#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-9#1)(1996-11#1)(1996-2#2)(1996-3#7)(1996-4#1)(1997-4#3)(1997-5#1)(1997-7#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#17)(2006-12#2)(2006-2#4)(2006-4#1)(2006-6#2)(2006-7#1)(2007-11#9)(2007-12#12)(2007-2#6)(2007-3#5)(2007-6#3)(2007-7#11)(2007-8#1)(2008-1#5)(2008-10#5)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#9)(2008-9#4)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#3)(2009-4#1)(2009-7#3)(2009-8#1)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#3)(2011-2#1)(2012-12#5)(2012-2#11)(2013-1#7)(2013-7#6)
of hepatitis-B##2##2##(1991-9#1)(1993-7#1)
of hepatitis-C##2##2##(1991-9#1)(2009-5#1)
of hepatobiliary##6##2##(2006-10#1)(2007-9#1)(2008-3#1)(2008-5#1)(2009-4#1)(2011-2#1)
of hepatoblastoma##3##2##(2011-1#3)
of hepatocarcinogenesis##5##2##(1991-9#1)(2006-10#1)(2009-8#1)(2010-12#1)(2011-2#1)
of hepatocarcinoma##2##2##(2010-1#1)(2013-1#1)
of hepatocellular cancer##3##3##(2006-9#1)(2012-3#1)(2013-1#1)
of hepatocellular carcinoma (HCC)##13##4##(1993-7#1)(2005-8#1)(2006-10#2)(2008-10#1)(2008-3#1)(2008-5#2)(2009-8#1)(2010-12#2)(2013-1#1)(2013-7#1)
of hepatocellular carcinoma and##2##4##(2004-11#1)(2013-8#1)
of hepatocellular carcinoma from##2##4##(2008-4#1)(2010-7#1)
of hepatocellular carcinoma in a##3##5##(1993-2#1)(2011-2#1)(2013-8#1)
of hepatocellular carcinoma in patients with chronic hepatitis B##2##9##(2009-11#1)(2010-12#1)
of hepatocellular carcinoma in patients with##4##6##(2006-10#1)(2006-6#1)(2009-11#1)(2010-12#1)
of hepatocellular carcinoma in##10##4##(1992-9#1)(1993-2#1)(2006-10#1)(2006-2#1)(2006-6#1)(2009-11#1)(2010-12#1)(2011-2#2)(2013-8#1)
of hepatocellular carcinoma with##3##4##(2006-10#1)(2008-5#1)(2009-3#1)
of hepatocellular carcinoma##63##3##(1992-7#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-7#1)(1994-10#1)(1994-12#1)(1995-4#1)(2004-11#1)(2005-8#1)(2006-10#7)(2006-2#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#4)(2008-8#1)(2009-11#2)(2009-2#1)(2009-3#1)(2009-8#3)(2010-12#6)(2010-7#2)(2011-2#3)(2012-12#2)(2013-1#1)(2013-7#2)(2013-8#7)
of hepatocellular damage and##2##4##(1993-2#1)(1995-7#1)
of hepatocellular##71##2##(1992-7#1)(1992-9#1)(1993-1#1)(1993-2#2)(1993-7#1)(1994-10#1)(1994-12#1)(1995-3#1)(1995-4#1)(1995-7#1)(2004-11#1)(2005-12#1)(2005-8#1)(2006-10#7)(2006-2#1)(2006-6#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#4)(2008-8#1)(2009-11#2)(2009-2#1)(2009-3#1)(2009-8#3)(2010-12#6)(2010-7#2)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#3)(2013-8#7)
of hepatocyte cytoplasmic vacuolization in##2##5##(2008-9#2)
of hepatocyte cytoplasmic vacuolization were increased in males##2##8##(2008-9#2)
of hepatocyte cytoplasmic vacuolization##4##4##(2008-9#4)
of hepatocyte growth factor (HGF)##3##5##(1994-3#1)(2008-11#1)(2011-1#1)
of hepatocyte growth factor gene##2##5##(1990-11#1)(2008-11#1)
of hepatocyte growth factor mRNA in##2##6##(1991-5#1)(1992-7#1)
of hepatocyte growth factor##11##4##(1990-11#1)(1991-5#1)(1992-12#1)(1992-7#1)(1994-3#1)(2008-1#1)(2008-11#3)(2011-1#1)(2013-1#1)
of hepatocyte growth##12##3##(1990-11#1)(1991-5#1)(1992-12#1)(1992-7#1)(1994-3#1)(1994-8#1)(2008-1#1)(2008-11#3)(2011-1#1)(2013-1#1)
of hepatocyte transplantation##3##3##(2010-11#3)
of hepatocyte##34##2##(1990-11#1)(1990-9#1)(1991-5#1)(1992-12#1)(1992-7#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1996-2#1)(2005-7#1)(2006-10#1)(2008-1#1)(2008-11#5)(2008-4#1)(2008-7#1)(2008-9#9)(2010-11#3)(2011-1#1)(2013-1#1)
of hepatocytes and##5##3##(1993-3#1)(2008-11#3)(2008-3#1)
of hepatocytes from##3##3##(1991-12#1)(1994-11#1)(1996-5#1)
of hepatocytes in##9##3##(1991-5#1)(1994-6#4)(1994-8#1)(2006-10#1)(2008-11#1)(2010-12#1)
of hepatocytes to##2##3##(1994-11#1)(1994-8#1)
of hepatocytes was##2##3##(1994-11#1)(2008-6#1)
of hepatocytes with the##2##4##(1992-3#1)(1996-2#1)
of hepatocytes with##7##3##(1992-3#1)(1994-11#3)(1996-11#1)(1996-2#1)(2008-10#1)
of hepatocytes##53##2##(1990-3#1)(1990-5#1)(1991-12#1)(1991-5#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-3#1)(1994-11#11)(1994-6#4)(1994-8#2)(1995-3#1)(1996-11#1)(1996-2#1)(1996-5#2)(1997-4#2)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#8)(2008-3#1)(2008-4#2)(2008-6#2)(2009-10#1)(2009-2#1)(2010-12#1)(2012-2#1)(2013-1#1)
of hepatology##2##2##(2005-6#1)(2006-10#1)
of hepatoma cell invasion##2##4##(2008-11#2)
of hepatoma cells in vitro##2##5##(1991-5#1)(2009-6#1)
of hepatoma cells in##5##4##(1991-5#1)(2008-11#3)(2009-6#1)
of hepatoma cells##10##3##(1991-5#1)(1992-9#1)(2008-11#6)(2008-4#1)(2009-6#1)
of hepatoma##14##2##(1991-5#1)(1992-9#1)(2008-11#8)(2008-2#1)(2008-4#1)(2009-6#1)(2013-8#1)
of hepatopancreas and testis from##2##5##(2010-4#2)
of hepatopancreas##3##2##(1997-4#1)(2010-4#2)
of hepatoprotective##3##2##(2007-1#1)(2010-2#1)(2012-1#1)
of hepatorenal syndrome##3##3##(1996-6#1)(2006-8#1)(2008-12#1)
of hepatorenal##4##2##(1992-8#1)(1996-6#1)(2006-8#1)(2008-12#1)
of hepatotoxic##4##2##(1991-2#2)(2009-11#1)(2012-3#1)
of hepatotoxicity##6##2##(1995-3#2)(1996-12#1)(1997-3#1)(2006-10#1)(2008-7#1)
of hepatotoxins##3##2##(2005-7#3)
of hepcidin isoforms##4##3##(2010-12#4)
of hepcidin##6##2##(2010-12#5)(2012-12#1)
of hepoxilin A3##6##3##(1990-12#1)(1990-9#1)(1994-9#4)
of hepoxilin##8##2##(1990-12#1)(1990-9#2)(1994-9#5)
of her body##4##3##(1991-3#1)(1995-3#1)(2007-12#2)
of her body's##2##3##(2007-2#2)
of her disease##4##3##(1996-12#1)(1997-3#1)(2006-10#1)(2012-2#1)
of her experiences##2##3##(1991-3#1)(1996-4#1)
of her fingers##2##3##(2006-10#1)(2013-7#1)
of her first##2##3##(1995-4#1)(2008-6#1)
of her heart##2##3##(2006-12#1)(2010-9#1)
of her illness##2##3##(2006-10#1)(2008-1#1)
of her left knee##2##4##(2006-10#2)
of her left##6##3##(1990-8#1)(1996-3#1)(1996-8#1)(2006-10#2)(2008-12#1)
of her lower##2##3##(2008-9#1)(2013-1#1)
of her right##14##3##(1991-12#1)(1992-3#1)(1996-3#1)(2006-10#1)(2006-7#4)(2007-11#1)(2008-12#1)(2008-5#1)(2009-4#1)(2009-8#1)(2010-3#1)
of her symptoms##9##3##(2006-10#1)(2007-8#1)(2008-5#1)(2008-7#4)(2013-1#1)(2013-8#1)
of her upper##4##3##(2006-4#1)(2008-5#1)(2013-1#2)
of her work##3##3##(2011-1#2)(2011-2#1)
of her##136##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-8#1)(1991-12#2)(1991-3#3)(1991-6#1)(1992-3#1)(1992-9#2)(1993-2#1)(1993-3#1)(1994-4#1)(1994-7#1)(1995-10#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-12#3)(1996-3#4)(1996-4#1)(1996-6#2)(1996-8#1)(1997-1#1)(1997-3#2)(1997-8#1)(2004-12#1)(2005-11#1)(2006-10#14)(2006-12#1)(2006-2#1)(2006-4#1)(2006-7#6)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#8)(2007-7#3)(2007-8#3)(2008-1#2)(2008-12#2)(2008-5#4)(2008-6#1)(2008-7#4)(2008-9#2)(2009-1#1)(2009-3#2)(2009-4#7)(2009-8#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-11#1)(2012-2#4)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#3)
of her-2/neu##2##2##(2008-10#1)(2008-11#1)
of herb##3##2##(2008-10#2)(2012-3#1)
of herbaceous##2##2##(2008-10#1)(2013-8#1)
of herbage##2##2##(2010-2#1)(2012-2#1)
of herbal compounds##2##3##(2009-12#1)(2009-3#1)
of herbal medicine##3##3##(2006-8#2)(2013-7#1)
of herbal medicines##5##3##(2006-8#3)(2010-3#1)(2011-2#1)
of herbal products##5##3##(2005-11#1)(2006-10#1)(2008-10#2)(2013-1#1)
of herbal shampoos##2##3##(2008-5#2)
of herbal teas##2##3##(2005-11#1)(2012-2#1)
of herbal##33##2##(2005-11#2)(2006-10#1)(2006-8#6)(2007-8#2)(2008-10#4)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2009-12#2)(2009-3#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
of herbicide##4##2##(2007-5#1)(2008-10#1)(2008-11#1)(2009-6#1)
of herbicides in##2##3##(2007-8#1)(2008-10#1)
of herbicides##9##2##(1996-3#2)(2007-8#3)(2008-10#4)
of herbimycin A##3##3##(1990-11#1)(1993-8#1)(1996-2#1)
of herbivore##2##2##(2008-8#1)(2008-9#1)
of herbivore-induced##2##2##(1990-11#1)(2008-9#1)
of herbivores##4##2##(2008-8#2)(2008-9#2)
of herbivorous insects##2##3##(2008-8#2)
of herbivorous##3##2##(2008-8#3)
of herbivory on##5##3##(1995-8#1)(2008-8#2)(2008-9#2)
of herbivory##12##2##(1995-8#3)(2007-3#2)(2008-8#4)(2008-9#3)
of herbs and##2##3##(2007-11#1)(2009-12#1)
of herbs##6##2##(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#2)(2009-12#1)
of herds with##2##3##(1992-5#1)(2012-1#1)
of hereditary breast cancer##2##4##(1995-12#1)(2004-2#1)
of hereditary breast##3##3##(1995-12#1)(2004-2#1)(2011-2#1)
of hereditary cancer##2##3##(2011-2#2)
of hereditary colorectal##2##3##(2009-12#1)(2012-1#1)
of hereditary diseases##2##3##(1990-3#1)(2007-3#1)
of hereditary disorders##2##3##(1994-11#1)(2008-3#1)
of hereditary hemochromatosis and##2##4##(2007-6#1)(2010-12#1)
of hereditary hemochromatosis##4##3##(2004-11#1)(2007-6#2)(2010-12#1)
of hereditary hemorrhagic telangiectasia##2##4##(2008-1#1)(2010-6#1)
of hereditary##41##2##(1990-3#1)(1990-4#1)(1994-11#1)(1995-12#2)(1996-11#1)(1997-3#1)(1997-7#3)(2004-11#1)(2004-2#1)(2006-10#2)(2006-4#2)(2007-3#1)(2007-6#2)(2007-7#2)(2007-8#1)(2008-1#3)(2008-3#1)(2009-12#1)(2009-2#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-2#7)(2012-1#1)(2012-3#1)(2013-1#1)
of heredity##4##2##(1995-6#1)(2009-12#1)(2011-1#1)(2013-7#1)
of heritability##5##2##(1997-7#1)(2008-10#1)(2009-4#1)(2012-1#1)(2012-3#1)
of heritable##2##2##(2006-12#1)(2010-10#1)
of hermaphrodites##4##2##(2007-12#2)(2008-5#1)(2008-9#1)
of hermaphroditism in animals##2##4##(2008-8#2)
of hermaphroditism##7##2##(2006-7#2)(2007-12#1)(2008-8#3)(2009-2#1)
of hernia formation##2##3##(2010-12#1)(2010-8#1)
of hernia is##2##3##(1990-5#1)(2008-12#1)
of hernia##9##2##(1990-5#1)(2008-12#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
of hernias##4##2##(2008-7#1)(2008-8#1)(2011-1#2)
of herniated disc##2##3##(1991-8#1)(2007-1#1)
of herniated##5##2##(1990-5#1)(1990-9#1)(1991-8#1)(1993-9#1)(2007-1#1)
of herniation##11##2##(1991-9#1)(1995-11#1)(2006-7#2)(2007-8#2)(2008-7#2)(2009-4#1)(2011-2#1)(2012-12#1)
of heroin addicts##3##3##(1991-12#1)(1996-1#2)
of heroin and its metabolites##2##5##(2008-8#2)
of heroin##15##2##(1991-12#1)(1996-1#2)(1996-11#1)(1996-5#1)(1997-7#1)(2006-8#3)(2008-11#1)(2008-8#5)
of herpes simplex virus DNA polymerase##2##6##(1995-2#2)
of herpes simplex virus in##2##5##(2009-4#1)(2010-6#1)
of herpes simplex virus type 1 (HSV-1)##2##7##(2007-12#1)(2012-2#1)
of herpes simplex virus type 1##4##6##(1995-7#1)(2007-12#2)(2012-2#1)
of herpes simplex virus type##5##5##(1991-9#1)(1995-7#1)(2007-12#2)(2012-2#1)
of herpes simplex virus type-1##3##5##(1990-7#1)(1994-9#1)(1995-3#1)
of herpes simplex virus##18##4##(1990-12#1)(1990-7#1)(1991-9#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-7#1)(2005-7#1)(2006-10#3)(2007-12#3)(2009-4#1)(2010-6#1)(2012-2#1)
of herpes simplex virus-1 (HSV-1)##2##5##(1990-11#1)(1994-11#1)
of herpes simplex virus-1##4##4##(1990-11#2)(1994-11#1)(2007-7#1)
of herpes simplex##27##3##(1990-11#2)(1990-12#1)(1990-7#1)(1991-9#1)(1994-11#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-7#1)(1996-2#1)(1996-6#1)(2005-7#1)(2006-10#3)(2007-12#3)(2007-2#1)(2007-7#1)(2009-4#2)(2010-1#1)(2010-6#1)(2012-2#1)
of herpes virus infection##2##4##(2008-5#1)(2009-2#1)
of herpes virus##3##3##(2008-5#1)(2009-2#2)
of herpes zoster##5##3##(2005-12#2)(2006-12#1)(2007-7#1)(2008-7#1)
of herpes##39##2##(1990-11#2)(1990-12#1)(1990-7#1)(1991-4#1)(1991-9#1)(1994-11#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-7#1)(1996-2#1)(1996-6#1)(2005-12#2)(2005-7#1)(2006-10#3)(2006-12#1)(2007-12#3)(2007-2#1)(2007-7#3)(2008-5#1)(2008-7#2)(2009-2#2)(2009-4#2)(2010-1#1)(2010-6#1)(2012-2#1)
of herpesvirus infection##2##3##(2008-5#1)(2012-3#1)
of herpesvirus of turkeys##2##4##(2013-8#2)
of herpesvirus##10##2##(1991-2#1)(1996-2#1)(1997-6#1)(2008-5#2)(2012-3#1)(2013-8#4)
of herpesviruses##2##2##(2008-5#1)(2013-8#1)
of herpetic##2##2##(1990-4#1)(2008-7#1)
of herveline D##2##3##(2007-1#2)
of heteroaromatic##3##2##(1997-2#1)(2008-5#2)
of heterochromatic##4##2##(1991-5#1)(2009-3#3)
of heterochromatin##3##2##(2008-12#3)
of heterocycles and##2##3##(2006-12#1)(2008-11#1)
of heterocyclic amines##3##3##(1993-9#1)(1997-2#1)(2008-10#1)
of heterocyclic##20##2##(1992-1#2)(1993-9#1)(1995-2#2)(1995-3#1)(1997-2#1)(1997-3#1)(2005-8#2)(2006-12#1)(2007-11#2)(2008-10#1)(2008-5#4)(2008-7#1)(2009-12#1)
of heterodyne##6##2##(2007-11#2)(2008-2#2)(2008-3#2)
of heterogeneity among##2##3##(1992-8#1)(2008-9#1)
of heterogeneity between##2##3##(1994-8#1)(2008-12#1)
of heterogeneity in##2##3##(1991-8#1)(1994-8#1)
of heterogeneity of the##3##4##(2008-10#2)(2008-8#1)
of heterogeneity of##5##3##(1994-2#1)(2008-10#3)(2008-8#1)
of heterogeneity or##2##3##(1996-12#1)(2006-10#1)
of heterogeneity##25##2##(1991-8#1)(1992-8#1)(1994-2#1)(1994-8#2)(1996-12#1)(1996-3#1)(1997-6#1)(2005-11#1)(2006-10#1)(2008-10#10)(2008-12#2)(2008-4#1)(2008-8#1)(2008-9#1)
of heterogeneous bead behavior##2##4##(2008-7#2)
of heterogeneous nuclear ribonucleoprotein##3##4##(1992-7#1)(2008-8#2)
of heterogeneous nuclear##4##3##(1992-7#1)(1994-8#1)(2008-8#2)
of heterogeneous systems##2##3##(2008-2#1)(2010-8#1)
of heterogeneous##32##2##(1990-12#1)(1990-3#1)(1992-6#1)(1992-7#1)(1994-8#1)(1995-6#2)(2006-12#1)(2008-1#1)(2008-10#4)(2008-2#4)(2008-3#1)(2008-6#2)(2008-7#3)(2008-8#3)(2010-8#1)(2012-1#2)(2012-2#3)
of heterogenous##2##2##(2008-7#1)(2010-8#1)
of heterologous antigens##4##3##(1990-3#2)(1990-9#1)(1995-5#1)
of heterologous genes##6##3##(1991-9#1)(1993-4#1)(1994-12#2)(1997-4#1)(2008-5#1)
of heterologous protein##2##3##(2008-11#1)(2008-7#1)
of heterologous proteins from##3##4##(1992-2#1)(1994-11#2)
of heterologous proteins##7##3##(1992-2#1)(1994-11#2)(1997-4#2)(2006-11#1)(2008-7#1)
of heterologous##30##2##(1990-12#1)(1990-3#2)(1990-9#1)(1991-9#1)(1992-2#1)(1993-3#1)(1993-4#1)(1993-7#1)(1994-11#3)(1994-12#2)(1994-6#1)(1995-3#1)(1995-5#2)(1996-12#1)(1997-4#3)(2006-11#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#1)(2013-1#1)
of heterologously expressed##2##3##(2008-4#2)
of heteropagus##3##2##(2012-2#1)(2013-1#2)
of heterophils from all VILK##2##5##(2008-5#2)
of heterophils in the##3##4##(2007-6#1)(2008-5#2)
of heterophils##7##2##(2007-6#1)(2008-5#6)
of heteroplasmy##4##2##(2012-3#2)(2013-8#2)
of heterosexual transmission in##2##4##(1991-2#1)(1993-3#1)
of heterosexual##9##2##(1991-2#3)(1991-3#1)(1993-3#1)(2006-10#1)(2006-7#1)(2009-5#1)(2012-2#1)
of heterosis in rice##4##4##(2008-4#2)(2008-8#2)
of heterosis##6##2##(2008-4#3)(2008-8#2)(2009-10#1)
of heterotopic bone formation##2##4##(2007-12#1)(2010-12#1)
of heterotopic bone##3##3##(2007-11#1)(2007-12#1)(2010-12#1)
of heterotopic ossification and##2##4##(2007-12#1)(2012-12#1)
of heterotopic ossification##6##3##(1994-8#2)(2007-11#1)(2007-12#1)(2012-12#2)
of heterotopic pancreas##3##3##(1997-8#1)(2011-12#1)(2013-7#1)
of heterotopic##15##2##(1991-4#1)(1994-8#2)(1995-2#1)(1997-8#1)(2007-11#2)(2007-12#2)(2008-11#1)(2010-12#1)(2011-12#1)(2012-12#2)(2013-7#1)
of heterotrimeric G proteins##7##4##(1995-3#1)(1995-6#2)(1995-8#1)(1996-5#1)(2006-10#1)(2008-7#1)
of heterotrimeric##10##2##(1992-2#1)(1994-3#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-4#1)(1996-5#1)(2006-10#1)(2008-7#1)
of heterotrophic organisms##2##3##(2006-12#1)(2009-4#1)
of heterotrophic##7##2##(2006-12#1)(2009-10#1)(2009-4#1)(2013-1#2)(2013-7#2)
of heterozygosity loss##2##3##(1994-12#1)(1997-5#1)
of heterozygosity on chromosome##2##4##(1990-9#1)(1996-11#1)
of heterozygosity on##3##3##(1990-9#2)(1996-11#1)
of heterozygosity were##2##3##(1990-9#1)(2009-5#1)
of heterozygosity##28##2##(1990-5#1)(1990-6#1)(1990-9#5)(1993-11#1)(1994-12#2)(1994-6#1)(1995-12#1)(1996-11#2)(1997-2#1)(1997-5#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-2#1)(2009-5#2)(2010-9#1)(2011-1#1)(2012-3#2)
of heterozygotes in##2##3##(1991-9#1)(2008-10#1)
of heterozygotes##6##2##(1991-9#1)(1995-2#1)(1996-6#1)(2008-10#2)(2008-6#1)
of heterozygous familial hypercholesterolemia##5##4##(1993-9#5)
of heterozygous##13##2##(1993-9#6)(1995-2#1)(1995-5#1)(2008-2#1)(2009-5#1)(2013-1#3)
of heuristic algorithms##2##3##(2010-2#2)
of heuristic##3##2##(2007-8#1)(2010-2#2)
of heuristics##3##2##(1996-12#1)(2006-7#1)(2008-2#1)
of hexacyanoferrate(III)##4##2##(2008-10#3)(2010-4#1)
of hexadecane##3##2##(2005-11#3)
of hexadecyltrimethylammonium##3##2##(2005-11#2)(2008-10#1)
of hexagonal array illumination##2##4##(2007-11#2)
of hexagonal ice##2##3##(2007-12#2)
of hexagonal##12##2##(1991-5#1)(2006-12#1)(2007-11#2)(2007-12#4)(2008-2#2)(2008-3#1)(2010-2#1)
of hexagons##2##2##(1995-8#1)(2007-12#1)
of hexahydro-1##2##2##(2008-10#2)
of hexamethyldisiloxane##2##2##(2008-10#1)(2008-3#1)
of hexane##5##2##(2007-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-5#1)
of hexanoic acid with##2##4##(2013-7#2)
of hexanoic acid##4##3##(2013-7#4)
of hexaploid wheat##4##3##(2006-12#3)(2008-5#1)
of hexaploid##7##2##(2006-12#3)(2008-10#1)(2008-5#1)(2010-8#2)
of hexapod##2##2##(2007-12#2)
of hexavalent chromium##12##3##(2006-5#1)(2008-10#7)(2008-12#2)(2011-2#1)(2013-1#1)
of hexavalent##14##2##(2006-3#1)(2006-5#1)(2008-10#8)(2008-12#2)(2011-2#1)(2013-1#1)
of hexokinase##12##2##(1990-2#1)(1991-11#2)(1991-7#2)(1992-4#2)(1993-11#1)(1994-12#1)(1994-8#1)(2008-10#1)(2008-3#1)
of hexosaminidase##3##2##(1992-3#2)(1994-3#1)
of hexose phosphates##2##3##(1995-4#1)(2012-1#1)
of hexose##4##2##(1995-1#1)(1995-4#1)(2010-2#1)(2012-1#1)
of hfMSC##4##2##(2008-1#4)
of hfNSCs in##2##3##(2009-10#2)
of hiatal hernia##2##3##(2006-2#1)(2011-2#1)
of hiatal##3##2##(2006-2#1)(2011-2#2)
of hiatus hernia##3##3##(1996-9#1)(2007-8#2)
of hibernating##2##2##(1997-6#1)(2006-2#1)
of hiccups##2##2##(2006-10#2)
of hidden Markov models##3##4##(2008-4#2)(2009-3#1)
of hidden##15##2##(1993-8#1)(1995-5#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#2)(2009-3#1)(2010-6#1)(2010-9#1)(2012-3#1)(2013-1#2)
of hierarchical structures##2##3##(2012-2#2)
of hierarchical##15##2##(1995-4#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-6#1)(2009-11#1)(2009-5#1)(2010-10#1)(2010-3#1)(2012-1#1)(2012-2#2)
of hierarchically composed##2##3##(1996-5#2)
of hierarchically##6##2##(1996-12#1)(1996-5#2)(2008-11#1)(2010-1#1)(2010-4#1)
of hierarchy##2##2##(1993-2#1)(1995-9#1)
of high HIV##2##3##(2010-5#1)(2012-3#1)
of high M(r)##2##3##(1994-2#1)(2008-3#1)
of high affinity (KD = 0##2##6##(1993-6#1)(1994-11#1)
of high affinity (Kd##2##4##(1993-11#1)(1995-12#1)
of high affinity binding sites##4##5##(1990-5#1)(1992-9#1)(1993-3#1)(1994-2#1)
of high affinity binding##5##4##(1990-5#1)(1992-9#1)(1993-3#1)(1994-2#1)(1995-3#1)
of high affinity receptors##2##4##(1991-4#1)(1992-4#1)
of high affinity##28##3##(1990-11#1)(1990-2#1)(1990-5#1)(1991-11#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-2#1)(1994-9#1)(1995-12#2)(1995-3#2)(2006-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)
of high altitude##3##3##(1992-2#1)(2007-7#1)(2008-3#1)
of high amounts of##2##4##(1991-5#1)(1994-11#1)
of high and low affinity binding sites##2##7##(1990-5#2)
of high and low doses of##2##6##(1991-3#2)
of high and low##19##4##(1990-3#1)(1990-5#2)(1991-3#2)(1991-7#1)(1995-3#1)(1995-7#1)(1997-8#1)(2005-1#1)(2006-10#1)(2006-7#2)(2007-11#1)(2008-10#1)(2009-12#1)(2011-2#1)(2013-1#2)
of high and##23##3##(1990-3#1)(1990-5#2)(1991-3#2)(1991-7#1)(1995-3#1)(1995-7#1)(1997-8#1)(2005-1#1)(2005-4#1)(2006-10#1)(2006-7#2)(2007-11#2)(2008-10#2)(2008-8#1)(2009-12#1)(2011-2#1)(2013-1#2)
of high avidity##2##3##(1990-2#1)(1994-8#1)
of high blood pressure and##3##5##(2008-3#1)(2008-4#1)(2011-2#1)
of high blood pressure##11##4##(1992-6#1)(1993-2#1)(1994-6#1)(2007-9#1)(2008-10#2)(2008-3#2)(2008-4#1)(2010-4#1)(2011-2#1)
of high blood##13##3##(1992-6#1)(1993-2#1)(1994-6#1)(2007-9#1)(2008-10#2)(2008-3#3)(2008-4#1)(2010-4#1)(2011-1#1)(2011-2#1)
of high cell density##2##4##(2008-11#2)
of high cell##3##3##(2008-11#3)
of high complexity##2##3##(2008-2#1)(2013-1#1)
of high concentration of##5##4##(1990-2#1)(1995-3#1)(2008-10#1)(2008-5#1)(2013-1#1)
of high concentration##8##3##(1990-2#1)(1995-3#1)(2007-8#1)(2008-10#2)(2008-5#1)(2011-1#1)(2013-1#1)
of high concentrations of copper##2##5##(2007-5#1)(2008-10#1)
of high concentrations of glucose##3##5##(1994-3#1)(2008-11#1)(2008-4#1)
of high concentrations of##20##4##(1990-11#1)(1990-12#2)(1991-1#1)(1992-4#1)(1994-2#1)(1994-3#2)(1994-9#1)(1997-6#1)(2007-5#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#1)(2009-6#1)
of high conductance##2##3##(1992-11#1)(1997-5#1)
of high contrast##2##3##(2008-1#1)(2008-3#1)
of high cost##2##3##(2008-10#1)(2008-11#1)
of high degree##3##3##(2011-1#2)(2012-3#1)
of high density lipoprotein (HDL)##2##5##(2012-2#2)
of high density lipoprotein##4##4##(1997-4#1)(2010-5#1)(2012-2#2)
of high density lipoproteins (HDL)##3##5##(1991-8#1)(1993-9#1)(2008-7#1)
of high density lipoproteins##4##4##(1991-8#1)(1993-9#1)(2008-7#1)(2013-1#1)
of high density##17##3##(1990-5#1)(1991-10#1)(1991-8#1)(1993-2#1)(1993-9#1)(1996-3#1)(1997-4#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-12#1)(2010-5#1)(2012-1#1)(2012-2#2)(2013-1#1)
of high dimensional##2##3##(2008-10#1)(2010-7#1)
of high dose intravenous##2##4##(2005-11#1)(2007-11#1)
of high dose##9##3##(1995-4#1)(1996-8#1)(2005-11#1)(2006-10#1)(2007-11#2)(2008-11#1)(2008-5#1)(2008-6#1)
of high doses of##12##4##(1990-5#1)(1992-9#1)(1995-2#1)(1996-10#1)(1997-3#1)(1997-6#2)(2006-10#3)(2006-2#1)(2008-10#1)
of high doses##15##3##(1990-5#1)(1992-9#1)(1993-4#1)(1995-2#2)(1996-10#1)(1997-3#1)(1997-6#2)(2006-10#3)(2006-2#1)(2008-10#1)(2010-8#1)
of high frequency stimulation of the##2##6##(1997-7#2)
of high frequency ventilation##2##4##(1994-6#2)
of high frequency##8##3##(1994-6#2)(1997-7#2)(2006-11#1)(2007-12#1)(2011-2#1)(2013-1#1)
of high gain##2##3##(2007-12#1)(2008-2#1)
of high glucose##9##3##(1991-4#1)(1992-6#1)(1994-2#2)(1994-3#1)(1995-3#1)(1996-11#1)(2011-2#1)(2012-5#1)
of high grade##5##3##(1992-1#2)(2007-11#1)(2008-6#1)(2013-8#1)
of high hydrostatic pressure##2##4##(1990-2#1)(1992-1#1)
of high incidence of##2##4##(2007-7#1)(2012-12#1)
of high incidence##3##3##(2007-7#1)(2012-12#1)(2013-8#1)
of high ionic strength##3##4##(2005-11#1)(2008-10#1)(2008-2#1)
of high level##3##3##(2008-11#1)(2010-5#1)(2012-3#1)
of high levels of##23##4##(1990-10#2)(1990-8#1)(1992-7#1)(1992-9#1)(1993-3#1)(1994-3#1)(1995-8#1)(1996-1#1)(1997-4#1)(2004-8#1)(2006-5#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-2#1)(2011-1#1)
of high mobility group##2##4##(1990-3#1)(1995-3#1)
of high molecular weight HA##2##5##(1994-11#2)
of high molecular weight##21##4##(1990-12#2)(1991-9#1)(1992-3#1)(1994-11#2)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-4#1)(1996-7#1)(1997-8#2)(2008-10#2)(2008-5#2)(2010-11#2)
of high molecular##22##3##(1990-12#2)(1991-9#1)(1992-3#1)(1994-11#2)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-4#1)(1996-7#1)(1997-8#2)(2007-8#1)(2008-10#2)(2008-5#2)(2010-11#2)
of high morbidity and mortality##2##5##(1990-12#1)(2006-10#1)
of high morbidity##3##3##(1990-12#1)(2006-10#2)
of high myopia##2##3##(1991-2#1)(2013-8#1)
of high optical##2##3##(2008-2#1)(2010-4#1)
of high or##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
of high pH##2##3##(2005-12#1)(2010-11#1)
of high performance liquid chromatography (HPLC)##3##6##(2008-10#3)
of high performance liquid chromatography##4##5##(2006-12#1)(2008-10#3)
of high performance liquid##5##4##(2006-12#1)(2008-10#3)(2013-8#1)
of high performance##6##3##(2006-12#1)(2008-10#3)(2008-7#1)(2013-8#1)
of high power##2##3##(1994-2#1)(2011-1#1)
of high precision##3##3##(2008-3#1)(2008-5#1)(2013-1#1)
of high pressure liquid chromatography##4##5##(1991-10#1)(2008-6#3)
of high pressure liquid##5##4##(1991-10#1)(2005-8#1)(2008-6#3)
of high pressure##8##3##(1991-10#1)(2005-12#1)(2005-8#1)(2006-10#1)(2008-6#3)(2012-2#1)
of high priority in##2##4##(2006-6#1)(2009-3#1)
of high priority##4##3##(2006-6#1)(2008-10#1)(2009-3#1)(2012-3#1)
of high purity and##2##4##(1990-10#1)(2008-10#1)
of high purity arsenic through##2##5##(2008-10#2)
of high purity##10##3##(1990-10#1)(2004-9#1)(2008-10#6)(2008-11#1)(2008-6#1)
of high quality##22##3##(1993-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(2005-8#1)(2006-2#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)(2010-8#1)(2011-1#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
of high rate of##2##4##(2007-8#1)(2008-1#1)
of high relative humidity##3##4##(2008-10#3)
of high relative##4##3##(1991-2#1)(2008-10#3)
of high relevance##2##3##(2006-10#1)(2006-11#1)
of high resolution mass spectrometry##2##5##(2008-10#1)(2008-11#1)
of high resolution##10##3##(1991-10#1)(1993-9#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-3#1)(2010-12#1)(2010-6#1)(2011-12#1)
of high risk HPV##3##4##(2011-1#1)(2011-2#1)(2013-1#1)
of high risk and complicated pregnancies##2##6##(2011-1#2)
of high risk and##3##4##(2007-5#1)(2011-1#2)
of high risk patients##2##4##(2006-10#2)
of high risk##20##3##(1991-8#1)(1994-3#1)(1995-1#1)(2006-10#2)(2007-12#2)(2007-5#1)(2008-10#1)(2008-7#1)(2009-5#1)(2011-1#3)(2011-2#1)(2012-3#2)(2013-1#3)
of high salt##3##3##(1990-12#1)(2008-10#1)(2008-11#1)
of high sample##2##3##(1992-11#1)(2007-8#1)
of high school##3##3##(2008-1#1)(2010-4#1)(2013-1#1)
of high sensitive##2##3##(2010-4#1)(2013-1#1)
of high sensitivity##8##3##(1997-1#1)(2005-11#1)(2008-10#3)(2008-3#1)(2008-6#1)(2011-2#1)
of high socioeconomic status##2##4##(1990-2#1)(2013-8#1)
of high socioeconomic##3##3##(1990-2#1)(2007-7#1)(2013-8#1)
of high spatial resolution##2##4##(2008-3#1)(2012-1#1)
of high spectral##2##3##(2007-12#1)(2008-2#1)
of high speed##3##3##(2007-12#1)(2008-10#1)(2011-1#1)
of high temperature and##3##4##(2007-3#1)(2008-10#1)(2011-1#1)
of high temperature on##4##4##(1992-1#1)(2008-10#1)(2008-7#1)(2009-4#1)
of high temperature##11##3##(1992-1#1)(1992-12#1)(1992-7#1)(2007-10#1)(2007-3#1)(2008-10#3)(2008-7#1)(2009-4#1)(2011-1#1)
of high throughput##3##3##(2007-11#1)(2008-10#1)(2008-11#1)
of high titre##3##3##(1995-4#1)(2007-8#1)(2008-11#1)
of high##608##2##(1990-10#4)(1990-11#2)(1990-12#10)(1990-2#6)(1990-3#2)(1990-5#6)(1990-8#1)(1991-1#1)(1991-10#3)(1991-11#3)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#1)(1991-7#2)(1991-8#5)(1991-9#3)(1992-1#5)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#3)(1992-7#2)(1992-9#3)(1993-11#5)(1993-12#2)(1993-2#3)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#3)(1994-11#6)(1994-2#6)(1994-3#7)(1994-5#2)(1994-6#3)(1994-8#3)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#3)(1995-3#8)(1995-4#2)(1995-7#3)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#4)(2004-10#1)(2004-8#1)(2004-9#1)(2005-1#1)(2005-11#8)(2005-12#2)(2005-4#2)(2005-7#2)(2005-8#4)(2006-10#13)(2006-11#2)(2006-12#2)(2006-2#3)(2006-5#1)(2006-6#3)(2006-7#2)(2007-1#2)(2007-10#1)(2007-11#13)(2007-12#11)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#4)(2007-8#9)(2007-9#1)(2008-1#4)(2008-10#70)(2008-11#19)(2008-12#2)(2008-2#18)(2008-3#19)(2008-4#5)(2008-5#11)(2008-6#9)(2008-7#12)(2008-8#11)(2008-9#3)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#1)(2009-6#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#3)(2010-2#3)(2010-4#9)(2010-5#5)(2010-6#3)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#19)(2011-12#1)(2011-2#13)(2011-3#2)(2012-1#4)(2012-12#6)(2012-2#6)(2012-3#9)(2012-5#1)(2012-7#1)(2013-1#19)(2013-7#3)(2013-8#12)
of high- and low-voltage pulse combinations for gene electrotransfer in muscle##2##11##(2009-10#2)
of high- and##7##3##(1990-11#1)(1993-4#1)(1997-4#1)(2007-11#1)(2008-8#1)(2009-10#2)
of high-##9##2##(1990-11#1)(1993-4#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-8#1)(2009-10#2)(2012-2#1)
of high-Mr caldesmon by protein kinase C##2##7##(1990-3#2)
of high-Mr caldesmon##3##3##(1990-3#3)
of high-Tc superconductors##3##3##(1992-8#1)(1995-11#2)
of high-affinity GTPase activity##2##4##(1990-3#1)(1995-7#1)
of high-affinity binding sites for##3##5##(1993-12#1)(1993-9#1)(1994-11#1)
of high-affinity binding sites##4##4##(1993-12#1)(1993-9#1)(1994-11#1)(1996-2#1)
of high-affinity oligonucleotide binding sites to a structured RNA target##2##10##(2008-4#2)
of high-affinity##24##2##(1990-3#2)(1990-7#1)(1991-2#1)(1991-3#2)(1991-4#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-10#1)(1995-11#1)(1995-7#1)(1996-10#1)(1996-2#1)(1996-5#1)(2008-4#2)(2009-7#1)(2012-1#1)
of high-aspect-ratio##2##2##(2007-12#1)(2009-11#1)
of high-average-power##2##2##(2007-12#1)(2008-3#1)
of high-capacity##2##2##(2007-12#2)
of high-density lipoprotein (HDL) cholesterol##2##5##(2005-10#1)(2008-6#1)
of high-density lipoprotein (HDL)##3##4##(2005-10#1)(2008-6#2)
of high-density lipoprotein##7##3##(2005-10#1)(2008-6#2)(2009-11#1)(2009-2#1)(2011-2#1)(2012-12#1)
of high-density lipoproteins##2##3##(1991-7#1)(2006-6#1)
of high-density##14##2##(1991-7#1)(1996-4#1)(2005-10#1)(2006-6#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-11#1)(2009-2#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
of high-dose cisplatin##3##3##(1990-12#1)(1992-8#2)
of high-dose##19##2##(1990-12#1)(1991-2#1)(1991-3#2)(1992-8#3)(1993-12#1)(1993-9#1)(1996-3#2)(1996-6#1)(2006-10#2)(2007-11#1)(2008-7#2)(2011-2#1)(2012-2#1)
of high-efficiency##3##2##(2008-1#1)(2008-2#1)(2013-8#1)
of high-energy photons##2##3##(2007-8#1)(2009-11#1)
of high-energy pulses by##2##4##(2007-11#2)
of high-energy trauma##3##3##(2009-3#1)(2009-9#1)(2010-11#1)
of high-energy##28##2##(1993-5#1)(1995-1#1)(2006-4#1)(2006-5#1)(2007-11#4)(2007-12#4)(2007-8#2)(2007-9#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-9#1)(2009-11#1)(2009-3#1)(2009-9#1)(2010-11#1)(2011-2#1)
of high-fat##2##2##(1991-2#1)(2010-12#1)
of high-fidelity##3##2##(2007-11#1)(2007-12#1)(2008-7#1)
of high-flow priapism in##2##4##(2008-10#2)
of high-frequency electrical##2##3##(1996-3#1)(2010-8#1)
of high-frequency oscillatory ventilation##2##4##(2006-10#1)(2012-2#1)
of high-frequency##16##2##(1991-3#1)(1992-12#1)(1992-9#2)(1994-6#1)(1996-3#1)(2005-11#2)(2006-10#1)(2007-12#2)(2007-4#1)(2008-2#1)(2010-3#1)(2010-8#1)(2012-2#1)
of high-grade dysplasia in##2##4##(1996-8#1)(2009-4#1)
of high-grade dysplasia##5##3##(1996-8#1)(2006-10#1)(2007-6#1)(2009-4#2)
of high-grade glioma##2##3##(2011-2#1)(2013-1#1)
of high-grade gliomas##4##3##(2013-7#3)(2013-8#1)
of high-grade##27##2##(1992-5#2)(1996-8#1)(1997-7#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-6#2)(2008-10#2)(2008-3#1)(2008-6#2)(2009-4#2)(2011-2#2)(2013-1#3)(2013-7#3)(2013-8#2)
of high-intensity laser##2##3##(2007-11#1)(2008-2#1)
of high-intensity pulsed##2##3##(2008-2#2)
of high-intensity##17##2##(2007-11#1)(2007-12#5)(2008-1#1)(2008-2#4)(2008-7#1)(2011-2#1)(2012-1#2)(2013-7#2)
of high-level##4##2##(1991-2#1)(2008-10#1)(2008-11#1)(2013-7#1)
of high-molecular##3##2##(1990-8#1)(2008-2#1)(2008-8#1)
of high-molecular-weight genomic DNA##2##4##(2008-4#1)(2010-2#1)
of high-molecular-weight polycyclic aromatic##2##4##(2011-1#2)
of high-molecular-weight##6##2##(1996-11#2)(2008-4#1)(2010-2#1)(2011-1#2)
of high-numerical-aperture##2##2##(2007-12#1)(2008-3#1)
of high-order harmonics##3##3##(2007-11#1)(2007-12#2)
of high-order rainbows##2##3##(2008-2#2)
of high-order##8##2##(2007-11#1)(2007-12#5)(2008-2#2)
of high-output##2##2##(1993-3#1)(2008-8#1)
of high-performance capillary electrophoresis (HPCE)##2##5##(1996-12#1)(1996-5#1)
of high-performance capillary electrophoresis##4##4##(1992-1#1)(1996-12#2)(1996-5#1)
of high-performance capillary##5##3##(1992-1#1)(1996-12#2)(1996-5#1)(2008-10#1)
of high-performance liquid chromatographic##4##4##(1990-8#1)(1992-2#1)(1996-6#1)(1997-2#1)
of high-performance liquid chromatography (HPLC)##2##5##(2008-10#2)
of high-performance liquid chromatography in##2##5##(1990-8#2)
of high-performance liquid chromatography to the study of biogenic amine-related enzymes##2##11##(1991-5#2)
of high-performance liquid chromatography to the study of##3##8##(1991-5#3)
of high-performance liquid chromatography with##2##5##(1992-2#1)(1997-2#1)
of high-performance liquid chromatography##11##4##(1990-2#1)(1990-8#2)(1991-5#3)(1992-2#1)(1997-2#1)(2008-10#3)
of high-performance liquid##16##3##(1990-2#1)(1990-8#3)(1991-5#3)(1992-2#2)(1996-6#1)(1997-2#2)(2008-10#4)
of high-performance##28##2##(1990-2#1)(1990-8#3)(1991-5#4)(1992-1#1)(1992-2#2)(1996-12#2)(1996-5#1)(1996-6#1)(1997-2#2)(2007-12#1)(2008-10#6)(2008-7#2)(2010-10#1)(2010-12#1)
of high-permittivity##2##2##(2008-3#2)
of high-power femtosecond pulses##2##4##(2007-12#1)(2008-3#1)
of high-power laser pulses in##2##5##(2007-12#2)
of high-power##13##2##(2007-11#1)(2007-12#6)(2008-1#1)(2008-2#1)(2008-3#3)(2012-11#1)
of high-pressure structural##2##3##(2011-2#2)
of high-pressure##8##2##(2006-4#2)(2007-11#1)(2007-3#1)(2008-3#1)(2011-2#3)
of high-purity##3##2##(2008-10#1)(2008-4#1)(2008-5#1)
of high-quality research##2##3##(1993-12#1)(2008-11#1)
of high-quality##31##2##(1992-2#2)(1993-12#1)(2005-7#1)(2006-12#1)(2006-4#1)(2006-5#2)(2007-2#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-11#1)
of high-refractive-index##2##2##(2007-11#1)(2008-2#1)
of high-repetition-rate##3##2##(2007-12#3)
of high-resolution computed tomography (HRCT)##3##5##(2005-8#2)(2011-2#1)
of high-resolution structural information##2##4##(1990-8#1)(2010-5#1)
of high-resolution##23##2##(1990-12#1)(1990-8#1)(1991-6#1)(1996-4#1)(1996-5#1)(1997-6#1)(2004-9#1)(2005-8#2)(2006-12#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#5)(2008-7#1)(2009-9#1)(2010-5#1)(2011-2#1)
of high-risk HPV types##2##4##(2007-10#1)(2007-12#1)
of high-risk HPV##6##3##(1997-7#2)(2007-10#1)(2007-12#1)(2010-7#1)(2011-2#1)
of high-risk groups##3##3##(2006-10#1)(2009-11#1)(2010-8#1)
of high-risk infants##3##3##(2008-11#3)
of high-risk patients in##2##4##(1993-9#1)(2008-6#1)
of high-risk patients##8##3##(1993-9#1)(2006-10#1)(2007-7#1)(2008-3#1)(2008-6#1)(2009-5#1)(2013-1#2)
of high-risk##45##2##(1993-3#2)(1993-4#1)(1993-9#1)(1995-1#1)(1996-9#1)(1997-6#1)(1997-7#2)(2006-10#3)(2006-2#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-11#3)(2008-3#1)(2008-6#1)(2009-11#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#8)(2012-11#1)(2012-2#1)(2013-1#5)
of high-school##3##2##(2010-12#1)(2010-5#1)(2011-2#1)
of high-sensitivity##5##2##(2007-12#1)(2008-2#1)(2008-9#1)(2009-4#1)(2010-4#1)
of high-spatial-frequency##2##2##(2007-12#2)
of high-speed##8##2##(1993-2#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)(2012-1#1)
of high-spin##2##2##(1994-8#1)(2007-12#1)
of high-temperature##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
of high-throughput screening##2##3##(2008-10#2)
of high-throughput##15##2##(2008-10#2)(2008-11#1)(2008-7#4)(2009-4#2)(2009-8#2)(2012-3#3)(2013-8#1)
of high-voltage##3##2##(2007-8#1)(2008-1#1)(2008-2#1)
of high-volume##3##2##(2008-5#1)(2009-8#1)(2013-1#1)
of high-yield##3##2##(1992-11#1)(2005-11#2)
of higher alpha-olefins##2##3##(2007-11#2)
of higher concentration##2##3##(2008-2#1)(2011-1#1)
of higher concentrations of##3##4##(1996-4#1)(2008-8#1)(2009-9#1)
of higher concentrations##5##3##(1990-12#1)(1996-4#1)(2008-10#1)(2008-8#1)(2009-9#1)
of higher doses##3##3##(1997-8#1)(2008-11#1)(2008-5#1)
of higher education for##2##4##(2008-12#2)
of higher education##7##3##(2007-4#1)(2007-9#1)(2008-12#2)(2009-2#1)(2011-2#2)
of higher eukaryotes##3##3##(1993-11#1)(2006-10#1)(2008-8#1)
of higher level##2##3##(2008-12#1)(2008-4#1)
of higher levels of##6##4##(1993-11#1)(1996-6#1)(2008-11#2)(2008-8#1)(2009-11#1)
of higher order##3##3##(1994-7#1)(2010-3#1)(2012-2#1)
of higher organisms##4##3##(2006-2#1)(2008-11#1)(2009-12#1)(2009-2#1)
of higher plant##4##3##(1994-12#1)(1994-8#1)(1995-2#1)(2008-11#1)
of higher plants and##2##4##(1993-9#1)(1995-8#1)
of higher plants##8##3##(1990-3#1)(1993-3#1)(1993-9#2)(1995-8#2)(1996-12#1)(1997-4#1)
of higher quality than##2##4##(2006-5#1)(2011-1#1)
of higher taxa##3##3##(1991-6#2)(2008-1#1)
of higher vertebrates##5##3##(1991-9#2)(1996-7#1)(2008-7#1)(2009-2#1)
of higher##134##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#3)(1990-5#1)(1991-3#1)(1991-6#2)(1991-7#1)(1991-9#2)(1992-12#3)(1993-11#2)(1993-3#3)(1993-9#3)(1994-12#1)(1994-3#1)(1994-7#1)(1994-8#1)(1995-2#2)(1995-6#3)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-8#1)(2005-12#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-5#1)(2007-11#5)(2007-12#3)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#4)(2008-2#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#4)(2009-8#1)(2009-9#2)(2010-10#1)(2010-3#1)(2010-5#1)(2010-8#3)(2011-1#3)(2011-2#8)(2012-11#1)(2012-2#5)(2012-3#3)(2012-5#2)(2013-1#3)(2013-7#1)(2013-8#1)
of higher-order lights##2##3##(2008-2#2)
of higher-order modes##2##3##(2007-12#1)(2008-3#1)
of higher-order structure of##2##4##(2006-10#1)(2012-2#1)
of higher-order##22##2##(1994-8#1)(2006-10#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-11#2)(2008-2#7)(2008-3#4)(2012-2#1)
of highest##13##2##(1990-11#1)(1990-9#1)(2008-10#2)(2008-2#1)(2008-9#1)(2009-10#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#1)
of highlighting##2##2##(2007-4#1)(2008-7#1)
of highly absorbing black appliqués##2##5##(2008-3#2)
of highly active antiretroviral therapy (HAART) has##3##7##(2008-3#2)(2010-12#1)
of highly active antiretroviral therapy (HAART)##8##6##(2008-3#2)(2009-5#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-2#2)
of highly active antiretroviral therapy for##2##6##(2006-10#1)(2007-12#1)
of highly active antiretroviral therapy##17##5##(2004-9#1)(2005-10#1)(2006-10#3)(2007-11#2)(2007-12#1)(2008-3#2)(2008-5#1)(2009-5#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-2#2)
of highly active##20##3##(2004-9#1)(2005-10#1)(2006-10#3)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2009-5#1)(2009-7#1)(2010-12#1)(2011-2#2)(2012-2#2)
of highly aggressive and##2##4##(2010-3#1)(2012-1#1)
of highly and##2##3##(2008-10#1)(2008-8#1)
of highly birefringent##4##3##(2007-12#1)(2008-2#3)
of highly branched##3##3##(2006-12#1)(2007-12#1)(2008-5#1)
of highly complex##3##3##(2006-10#1)(2007-2#1)(2009-5#1)
of highly concentrated##2##3##(2008-3#1)(2008-9#1)
of highly conserved##5##3##(1990-9#1)(1994-2#1)(1995-6#1)(2010-7#1)(2013-1#1)
of highly crystalline##2##3##(2006-12#1)(2008-5#1)
of highly differentiated##2##3##(2008-11#1)(2013-1#1)
of highly dispersive##2##3##(2007-11#1)(2008-3#1)
of highly effective##7##3##(2008-1#1)(2008-4#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
of highly efficient nonlinear##2##4##(2007-12#2)
of highly efficient##15##3##(2007-11#3)(2007-12#7)(2008-10#1)(2008-2#2)(2008-3#1)(2013-8#1)
of highly functionalised##2##3##(2007-11#1)(2009-10#1)
of highly heterogeneous##2##3##(2008-10#1)(2008-6#1)
of highly hydrophilic##2##3##(2006-5#1)(2013-8#1)
of highly metastatic##2##3##(1996-9#1)(2008-8#1)
of highly nonlinear##3##3##(2007-11#3)
of highly ordered##3##3##(2008-12#1)(2009-11#1)(2010-4#1)
of highly potent##3##3##(1991-1#1)(2005-10#1)(2009-4#1)
of highly purified##7##3##(1990-11#1)(1990-3#1)(1991-8#1)(1993-3#1)(1995-6#1)(1996-5#1)(1996-8#1)
of highly qualified##2##3##(2008-1#1)(2008-2#1)
of highly reactive##4##3##(1991-9#1)(2006-2#1)(2008-1#1)(2008-3#1)
of highly reflective##2##3##(2008-2#1)(2008-3#1)
of highly resistant##2##3##(2008-10#1)(2013-1#1)
of highly scattering media##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
of highly scattering##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
of highly selective##2##3##(1995-3#1)(2008-10#1)
of highly sensitive and##2##4##(2006-10#1)(2008-3#1)
of highly sensitive##9##3##(1991-5#1)(2006-10#1)(2007-5#1)(2008-10#1)(2008-3#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#1)
of highly specific##5##3##(1990-2#1)(1991-10#1)(2005-9#1)(2008-7#1)(2011-3#1)
of highly susceptible##2##3##(1990-6#1)(2008-10#1)
of highly toxic##2##3##(2009-10#1)(2010-7#1)
of highly##226##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-5#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-3#1)(1993-12#2)(1993-3#1)(1993-5#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-2#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-4#2)(1997-6#2)(1997-7#1)(2004-9#1)(2005-10#2)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#6)(2006-12#3)(2006-2#1)(2006-5#2)(2007-11#15)(2007-12#19)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#5)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#11)(2008-3#15)(2008-4#3)(2008-5#7)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#5)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#4)(2010-7#5)(2011-1#1)(2011-2#6)(2011-3#1)(2012-1#3)(2012-2#6)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#3)
of hilar and mediastinal lymph nodes##2##6##(2007-8#1)(2010-11#1)
of hilar lymphadenopathy##2##3##(2007-7#1)(2011-2#1)
of hilar##6##2##(2006-10#1)(2007-7#1)(2007-8#1)(2010-11#1)(2011-2#1)(2012-2#1)
of himD##2##2##(1995-2#2)
of hind leg##3##3##(1997-2#1)(2007-12#2)
of hind##5##2##(1997-2#1)(2007-12#2)(2010-12#1)(2010-3#1)
of hindered##2##2##(2006-12#1)(2009-3#1)
of hindfoot##3##2##(2008-8#1)(2012-2#1)(2012-3#1)
of hindpaw##2##2##(1991-11#1)(2008-4#1)
of hinge##2##2##(2007-12#1)(2009-9#1)
of hip and knee##3##4##(2011-2#2)(2012-2#1)
of hip and##5##3##(2006-8#1)(2008-11#1)(2011-2#2)(2012-2#1)
of hip arthroplasty##2##3##(2012-2#1)(2013-1#1)
of hip dysplasia##2##3##(2007-11#1)(2007-8#1)
of hip fracture in the##2##5##(2005-3#2)
of hip fracture in##3##4##(1990-9#1)(2005-3#2)
of hip fracture##11##3##(1990-9#1)(1993-11#1)(2005-3#2)(2008-7#1)(2009-9#1)(2010-10#3)(2013-1#2)
of hip fractures in elderly women##2##6##(1993-11#1)(2008-8#1)
of hip fractures in the##2##5##(2005-3#1)(2011-2#1)
of hip fractures in##4##4##(1993-11#1)(2005-3#1)(2008-8#1)(2011-2#1)
of hip fractures##7##3##(1993-11#4)(2005-3#1)(2008-8#1)(2011-2#1)
of hip injuries##3##3##(2006-11#1)(2007-4#1)(2008-8#1)
of hip joint##8##3##(1990-1#1)(2006-8#1)(2007-11#3)(2007-7#1)(2007-8#1)(2009-4#1)
of hip joints##3##3##(1993-5#2)(2013-1#1)
of hip motion##3##3##(2007-11#1)(2007-7#1)(2010-4#1)
of hip posture on##2##4##(2006-11#2)
of hip##80##2##(1990-1#1)(1990-9#1)(1993-11#6)(1993-5#2)(1993-9#1)(1995-9#1)(2005-3#3)(2006-10#1)(2006-11#5)(2006-3#1)(2006-8#2)(2007-11#7)(2007-4#1)(2007-6#1)(2007-7#13)(2007-8#3)(2008-11#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-4#1)(2009-9#1)(2010-10#3)(2010-12#1)(2010-4#2)(2010-9#1)(2011-12#1)(2011-2#5)(2012-2#2)(2013-1#5)(2013-7#4)
of hippocampal 5-HT1A receptors##2##4##(1993-3#1)(1994-2#1)
of hippocampal 5-HT1A##3##3##(1993-3#1)(1994-2#2)
of hippocampal CA1##4##3##(1996-1#1)(2008-11#1)(2009-12#1)(2011-2#1)
of hippocampal CA3##2##3##(1995-8#1)(1997-4#1)
of hippocampal and cortical##2##4##(1996-5#2)
of hippocampal astrocytes##2##3##(1997-2#1)(2009-3#1)
of hippocampal cholinergic activity##2##4##(1993-9#2)
of hippocampal cholinergic##4##3##(1993-9#2)(1996-12#1)(1996-6#1)
of hippocampal formation and amygdaloidal complex##3##6##(2005-10#3)
of hippocampal formation##7##3##(1992-7#1)(2005-10#6)
of hippocampal function##3##3##(1993-9#1)(2007-8#2)
of hippocampal interneurons##2##3##(2008-4#1)(2011-2#1)
of hippocampal long-term potentiation##2##4##(1993-2#1)(1993-5#1)
of hippocampal neuronal##2##3##(1993-12#1)(1994-11#1)
of hippocampal neurons in vivo##2##5##(2009-12#2)
of hippocampal neurons to##2##4##(1993-12#1)(1994-11#1)
of hippocampal neurons##10##3##(1992-7#1)(1993-12#1)(1994-11#2)(2008-4#1)(2008-8#1)(2009-12#3)(2012-3#1)
of hippocampal nitric oxide##2##4##(1993-12#2)
of hippocampal slices##6##3##(1993-4#2)(1995-2#1)(1996-5#1)(1997-5#1)(2008-4#1)
of hippocampal synaptic plasticity##3##4##(1993-12#1)(2008-7#1)(2009-8#1)
of hippocampal##83##2##(1991-2#1)(1991-3#1)(1991-5#2)(1992-7#2)(1992-9#1)(1993-11#2)(1993-12#5)(1993-2#4)(1993-3#2)(1993-4#2)(1993-5#2)(1993-6#1)(1993-9#5)(1994-11#5)(1994-2#2)(1994-3#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-8#2)(1996-1#2)(1996-10#1)(1996-12#1)(1996-5#3)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(2005-10#6)(2007-8#2)(2008-11#1)(2008-4#3)(2008-7#1)(2008-8#1)(2009-12#4)(2009-3#1)(2009-8#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
of hippocampus##8##2##(1990-11#1)(1991-6#1)(1994-2#1)(1996-11#1)(1996-3#1)(1996-5#1)(2008-12#2)
of hirsutism##3##2##(2007-11#1)(2008-1#1)(2008-3#1)
of hirudin in##2##3##(2007-11#1)(2008-10#1)
of hirudin is##2##3##(2007-11#2)
of hirudin##13##2##(1991-6#1)(1993-3#1)(1996-8#1)(2007-11#9)(2008-10#1)
of hirulog-1##2##2##(1990-7#2)
of his HIV status##3##4##(1995-6#1)(1996-11#1)(2010-12#1)
of his career##2##3##(2007-9#1)(2008-5#1)
of his chest##2##3##(2006-4#1)(2008-11#1)
of his children##2##3##(2006-2#1)(2011-1#1)
of his coarctation of aorta##2##5##(2007-8#2)
of his contemporaries##2##3##(1991-6#1)(2007-1#1)
of his death##2##3##(2009-10#1)(2009-7#1)
of his disease##3##3##(2006-12#1)(2013-1#2)
of his face and##2##4##(2007-8#1)(2010-6#1)
of his family##3##3##(2011-2#2)(2012-12#1)
of his head##2##3##(2011-2#1)(2013-8#1)
of his left##4##3##(2006-12#1)(2007-8#1)(2009-1#2)
of his life and##2##4##(2007-8#1)(2008-11#1)
of his life##5##3##(2006-1#1)(2007-8#1)(2008-11#1)(2008-7#1)(2012-3#1)
of his lower##3##3##(2008-7#1)(2011-1#1)(2011-2#1)
of his neurological##2##3##(2008-7#1)(2011-2#1)
of his or her##4##4##(2004-10#1)(2006-11#1)(2006-12#1)(2010-2#1)
of his or##5##3##(2004-10#1)(2006-11#1)(2006-12#1)(2008-11#1)(2010-2#1)
of his own##2##3##(1990-3#1)(1995-5#1)
of his patients##3##3##(1991-7#1)(1993-11#1)(2006-4#1)
of his right lower leg##2##5##(2008-6#2)
of his right##4##3##(2006-10#1)(2008-6#2)(2011-1#1)
of his sister##2##3##(1997-1#2)
of his symptoms##4##3##(2007-6#1)(2010-1#1)(2011-2#1)(2012-2#1)
of his time##5##3##(1990-5#1)(1994-3#1)(2004-3#1)(2006-4#1)(2009-2#1)
of his work##4##3##(2007-5#1)(2008-12#1)(2009-2#1)(2009-3#1)
of his##189##2##(1990-3#3)(1990-5#1)(1990-8#2)(1990-9#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-7#2)(1992-5#1)(1992-6#1)(1993-10#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-3#4)(1994-4#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#2)(1995-6#2)(1996-11#1)(1996-12#2)(1996-6#2)(1996-9#2)(1997-1#3)(1997-5#1)(2004-10#1)(2004-3#2)(2005-12#1)(2006-1#1)(2006-10#5)(2006-11#2)(2006-12#7)(2006-2#2)(2006-4#5)(2006-6#1)(2006-7#4)(2007-1#1)(2007-10#1)(2007-12#4)(2007-4#1)(2007-5#2)(2007-6#2)(2007-8#7)(2007-9#3)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#4)(2008-7#7)(2008-8#2)(2008-9#2)(2009-1#2)(2009-10#1)(2009-2#2)(2009-3#1)(2009-7#2)(2009-9#1)(2010-1#4)(2010-10#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#7)(2011-12#1)(2011-2#13)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#1)
of his/her##12##2##(1992-1#1)(1992-12#1)(1993-1#1)(2007-6#1)(2007-8#2)(2009-4#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
of histamine H1 receptors in##2##5##(1991-12#1)(1991-6#1)
of histamine H1-receptors in##2##4##(1991-1#2)
of histamine and methacholine##2##4##(1996-5#2)
of histamine and##10##3##(1992-7#2)(1993-12#1)(1994-5#1)(1995-3#1)(1996-5#2)(2005-7#1)(2007-1#1)(2008-4#1)
of histamine in the##3##4##(1992-1#1)(1995-12#1)(2009-6#1)
of histamine in##8##3##(1992-1#2)(1992-7#3)(1995-12#1)(2008-10#1)(2009-6#1)
of histamine is##2##3##(1994-2#1)(1997-1#1)
of histamine on the##3##4##(1994-2#1)(1996-12#1)(2007-7#1)
of histamine on##8##3##(1993-6#1)(1994-2#1)(1995-12#1)(1995-7#1)(1996-12#1)(1996-5#1)(2007-7#1)(2008-12#1)
of histamine receptors##2##3##(1996-12#2)
of histamine to##2##3##(1991-12#1)(1992-4#1)
of histamine were##2##3##(1990-7#1)(1996-5#1)
of histamine##62##2##(1990-7#1)(1991-1#2)(1991-12#3)(1991-5#1)(1991-6#1)(1992-1#2)(1992-4#1)(1992-7#6)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#5)(1994-5#2)(1994-6#1)(1995-12#2)(1995-3#1)(1995-7#1)(1996-12#4)(1996-5#4)(1997-1#1)(2005-7#1)(2006-10#1)(2007-1#3)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-12#3)(2008-4#1)(2009-6#2)(2011-2#1)(2012-2#1)
of histamine-induced##2##2##(1994-8#1)(2008-5#1)
of histaminergic##4##2##(2006-10#1)(2007-1#2)(2012-12#1)
of histidine ammonia-lyase##2##3##(1994-5#1)(1994-6#1)
of histidine and its metabolites##2##5##(2008-10#2)
of histidine and##4##3##(1990-12#1)(2006-12#1)(2008-10#2)
of histidine are##2##3##(1990-5#1)(2008-10#1)
of histidine by##2##3##(2008-10#1)(2010-5#1)
of histidine decarboxylase##3##3##(1992-6#1)(1997-1#1)(2008-1#1)
of histidine in##4##3##(1995-3#1)(2007-8#1)(2008-10#1)(2010-5#1)
of histidine residues and sulfhydryl groups in the function of the##2##11##(1992-6#2)
of histidine residues and sulfhydryl groups in the##3##8##(1992-6#3)
of histidine residues##9##3##(1991-7#1)(1992-2#1)(1992-6#3)(1992-8#2)(1994-5#2)
of histidine##44##2##(1990-12#1)(1990-5#1)(1991-7#1)(1992-2#1)(1992-4#1)(1992-6#4)(1992-7#1)(1992-8#2)(1994-11#1)(1994-5#4)(1994-6#1)(1994-8#1)(1995-3#1)(1997-1#1)(2006-12#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-3#1)(2008-8#1)(2010-5#7)(2012-2#1)(2013-1#1)(2013-8#1)
of histidine-tail fusion proteins##2##4##(2008-4#2)
of histidines##2##2##(1990-2#1)(1995-3#1)
of histiocytic necrotizing lymphadenitis (Kikuchi's disease)##2##6##(1991-3#1)(1991-9#1)
of histiocytic##5##2##(1991-3#1)(1991-9#1)(2008-9#2)(2012-12#1)
of histocompatibility##3##2##(2008-1#1)(2008-4#2)
of histogenesis##2##2##(1996-6#1)(2006-12#1)
of histograms of##2##3##(2006-12#1)(2007-10#1)
of histologic features##2##3##(1992-4#1)(2011-2#1)
of histologic findings##3##3##(2007-2#1)(2009-3#2)
of histologic verification##2##3##(1991-2#2)
of histologic##14##2##(1991-2#2)(1991-9#1)(1992-4#1)(1993-8#1)(1994-12#1)(2004-2#1)(2007-2#2)(2009-3#2)(2009-4#1)(2011-2#1)(2012-12#1)
of histological and##3##3##(2008-4#1)(2008-5#1)(2008-6#1)
of histological diagnosis##2##3##(2007-12#1)(2013-8#1)
of histological examination in the diagnosis of##2##7##(2005-11#1)(2007-8#1)
of histological examination of##2##4##(2008-1#1)(2008-10#1)
of histological examination##5##3##(2005-11#1)(2006-5#1)(2007-8#1)(2008-1#1)(2008-10#1)
of histological##24##2##(1991-6#1)(1994-2#1)(1997-8#1)(2005-11#2)(2006-4#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-3#1)(2009-7#1)(2010-4#1)(2011-2#2)(2013-8#1)
of histologically proven##3##3##(1997-8#1)(2008-7#1)(2011-1#1)
of histologically##11##2##(1993-7#1)(1993-9#1)(1994-1#2)(1997-8#1)(2008-2#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-11#1)
of histology##5##2##(2006-2#1)(2007-9#1)(2008-5#1)(2010-10#1)(2011-2#1)
of histone H1##2##3##(1991-10#1)(1994-9#1)
of histone H2A##4##3##(1991-6#1)(2008-3#2)(2008-7#1)
of histone H2AX##3##3##(2008-9#2)(2009-5#1)
of histone H2B##3##3##(1994-12#1)(1995-7#2)
of histone H3##5##3##(1990-12#1)(1992-8#1)(1997-2#1)(2008-9#1)(2013-1#1)
of histone acetylation##3##3##(1990-12#1)(1991-2#1)(1996-8#1)
of histone deacetylase 8##2##4##(2009-12#2)
of histone deacetylase inhibitors as##2##5##(2007-10#1)(2007-11#1)
of histone deacetylase inhibitors##4##4##(2007-10#1)(2007-11#1)(2011-1#1)(2012-2#1)
of histone deacetylase##12##3##(2006-9#1)(2007-10#2)(2007-11#1)(2009-12#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)
of histone deacetylation##2##3##(2008-7#1)(2013-8#1)
of histone gene##2##3##(1990-5#1)(2008-7#1)
of histone genes##2##3##(1990-5#1)(1997-1#1)
of histone methylation##2##3##(1992-5#1)(2013-1#1)
of histone modifications##2##3##(2009-8#1)(2011-2#1)
of histone octamers##2##3##(1994-8#1)(1996-11#1)
of histone proteins##2##3##(1991-6#1)(2011-1#1)
of histone##59##2##(1990-12#3)(1990-5#2)(1990-8#1)(1991-10#1)(1991-2#1)(1991-6#3)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-7#2)(1996-11#1)(1996-8#1)(1997-1#1)(1997-2#1)(2006-9#1)(2007-10#2)(2007-11#1)(2008-10#2)(2008-3#2)(2008-7#3)(2008-9#3)(2009-12#2)(2009-5#2)(2009-8#1)(2009-9#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-2#2)(2013-1#2)(2013-8#1)
of histones H2B##2##3##(1995-7#2)
of histones H3 and H4 in##2##6##(1992-5#1)(2007-10#1)
of histones H3 and##3##4##(1992-5#1)(1992-8#1)(2007-10#1)
of histones from##2##3##(1995-2#1)(1995-7#1)
of histones in##3##3##(1990-2#1)(1995-7#1)(2013-8#1)
of histones##20##2##(1990-2#1)(1991-5#1)(1991-6#1)(1992-5#2)(1992-8#1)(1995-1#1)(1995-2#2)(1995-7#6)(1996-5#1)(2007-10#1)(2013-1#1)(2013-8#2)
of histopathologic##6##2##(1993-3#1)(2005-8#1)(2008-1#1)(2008-5#1)(2011-2#2)
of histopathological changes##2##3##(2007-6#1)(2007-7#1)
of histopathological examination of##2##4##(2011-1#1)(2011-12#1)
of histopathological examination##3##3##(2011-1#1)(2011-12#1)(2012-3#1)
of histopathological##7##2##(2007-6#1)(2007-7#1)(2011-1#1)(2011-12#1)(2012-2#1)(2012-3#2)
of histopathology##5##2##(1997-4#1)(2005-12#1)(2007-7#2)(2008-10#1)
of histoplasma panniculitis##2##3##(2006-10#2)
of histoplasmosis##2##2##(2006-10#1)(2007-7#1)
of historic##8##2##(2006-7#1)(2008-10#2)(2008-2#3)(2008-3#1)(2013-1#1)
of historical##17##2##(1996-6#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-5#1)(2012-2#1)
of history and##3##3##(2008-4#1)(2011-1#1)(2012-3#1)
of history of##5##3##(1997-8#1)(2006-10#1)(2011-2#2)(2013-1#1)
of history##23##2##(1995-2#1)(1997-8#1)(2006-10#2)(2006-8#1)(2007-12#1)(2007-2#2)(2007-5#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-11#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
of hit compounds##2##3##(2013-1#2)
of hitherto##2##2##(1991-3#1)(1996-12#1)
of hnRNP##3##2##(1994-3#1)(2008-8#2)
of hnRNPA1##2##2##(1995-6#2)
of hoarding in##2##3##(2008-9#1)(2011-2#1)
of holding##4##2##(1993-12#2)(2007-8#1)(2010-8#1)
of holes of##2##3##(2006-4#1)(2008-3#1)
of holes##8##2##(2006-4#1)(2007-11#1)(2007-12#3)(2008-3#3)
of holistic care##6##3##(2007-12#1)(2008-11#4)(2008-4#1)
of holistic##12##2##(2007-12#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-4#1)(2009-11#1)(2009-8#1)(2010-7#1)
of hollow spheres##2##3##(2005-11#1)(2007-11#1)
of hollow waveguides##2##3##(2008-3#2)
of hollow##10##2##(1993-4#1)(2005-11#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-9#1)(2013-1#1)
of holo##4##2##(1994-2#3)(2008-11#1)
of holoenzyme##3##2##(1994-9#1)(1997-7#2)
of hologram formation are##2##4##(2008-1#1)(2008-2#1)
of hologram formation in dichromated gelatin##2##6##(2008-2#2)
of hologram formation##6##3##(2008-1#1)(2008-2#5)
of hologram##11##2##(2007-11#2)(2008-1#1)(2008-2#7)(2008-3#1)
of holograms of##2##3##(2007-11#1)(2007-12#1)
of holograms##14##2##(2007-11#2)(2007-12#4)(2008-2#3)(2008-3#5)
of holographic data storage##2##4##(2008-1#1)(2008-2#1)
of holographic data##3##3##(2007-12#1)(2008-1#1)(2008-2#1)
of holographic gratings in##2##4##(2007-12#1)(2008-2#1)
of holographic gratings##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
of holographic images##2##3##(2008-2#2)
of holographic interferometry##2##3##(2007-12#1)(2008-2#1)
of holographic optical elements##4##4##(2008-2#3)(2008-3#1)
of holographic recording in##2##4##(2007-12#1)(2008-2#1)
of holographic recording##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
of holographic##27##2##(2007-11#1)(2007-12#7)(2008-1#1)(2008-2#13)(2008-3#5)
of holography##5##2##(2008-2#3)(2008-3#2)
of holoprosencephaly##2##2##(1996-12#1)(2012-3#1)
of homatropine methylbromide##2##3##(2008-10#2)
of home and##4##3##(2008-2#2)(2013-1#2)
of home birth##2##3##(2007-2#2)
of home care and##2##4##(1992-2#1)(2009-4#1)
of home care##13##3##(1991-3#3)(1992-2#1)(1992-3#1)(1995-2#2)(1997-3#1)(2009-4#2)(2010-8#1)(2011-2#1)(2012-2#1)
of home health care##7##4##(1993-1#1)(1995-3#4)(1996-12#1)(1997-2#1)
of home health services##4##4##(1995-3#4)
of home health##16##3##(1990-12#2)(1993-1#1)(1994-2#1)(1995-3#10)(1996-12#1)(1997-2#1)
of home injuries##3##3##(2013-1#3)
of home visits##2##3##(2012-2#1)(2012-3#1)
of home##59##2##(1990-12#2)(1991-1#1)(1991-2#1)(1991-3#3)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-2#1)(1995-12#1)(1995-2#3)(1995-3#10)(1996-12#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-2#2)(2007-7#2)(2008-2#2)(2008-5#1)(2008-8#1)(2009-4#2)(2009-6#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#5)
of home-based##5##2##(1995-12#2)(2007-12#1)(2008-10#1)(2008-3#1)
of home-made##3##2##(1991-9#2)(2008-10#1)
of homeless##4##2##(2006-8#2)(2008-4#1)(2012-3#1)
of homelessness##3##2##(2005-8#1)(2007-12#1)(2009-11#1)
of homeobox genes##2##3##(1990-11#1)(1995-8#1)
of homeopathic##4##2##(1994-2#1)(2007-4#1)(2008-10#2)
of homeopathy##6##2##(1994-2#2)(1997-6#2)(2008-10#2)
of homeostasis in##3##3##(2007-9#1)(2008-3#1)(2012-3#1)
of homeostasis system##2##3##(2013-1#2)
of homeostasis##13##2##(1993-6#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
of homeostatic##4##2##(2006-12#1)(2008-1#1)(2012-3#1)(2013-7#1)
of homes##3##2##(1992-3#1)(1995-2#2)
of homework##4##2##(2008-6#1)(2009-11#2)(2012-12#1)
of homicidal behavior among##2##4##(1996-5#2)
of homicidal behavior##4##3##(1996-5#4)
of homicidal##5##2##(1996-5#4)(2008-5#1)
of homicide victims were killed##2##5##(1992-5#2)
of homicide victims##3##3##(1992-5#2)(2004-3#1)
of homicide##4##2##(1992-5#2)(2004-3#1)(2011-12#1)
of homicides##4##2##(1992-5#1)(1993-3#1)(1993-5#2)
of homo- and##3##3##(1992-12#1)(2006-12#1)(2008-10#1)
of homocysteate in##2##3##(1994-2#1)(1995-12#1)
of homocysteine and##2##3##(2005-10#1)(2008-10#1)
of homocysteine concentration##2##3##(2013-1#2)
of homocysteine in plasma##2##4##(1992-9#2)
of homocysteine in##5##3##(1992-4#1)(1992-9#2)(1994-11#1)(2013-1#1)
of homocysteine metabolism##2##3##(2004-11#1)(2008-3#1)
of homocysteine with##2##3##(2005-10#1)(2013-1#1)
of homocysteine##37##2##(1992-1#1)(1992-4#2)(1992-9#3)(1994-11#3)(1997-2#1)(2004-11#1)(2005-10#2)(2008-1#1)(2008-10#6)(2008-3#6)(2008-7#1)(2008-8#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#5)
of homodimer##4##2##(1993-11#1)(2007-6#3)
of homoeopathic##2##2##(2007-8#2)
of homoeopathy##2##2##(1997-6#2)
of homogenate##3##2##(1992-2#1)(1994-3#1)(2010-2#1)
of homogenates of##2##3##(1993-6#1)(1996-6#1)
of homogenates##3##2##(1991-3#1)(1993-6#1)(1996-6#1)
of homogeneity in the##2##4##(2006-5#1)(2011-2#1)
of homogeneity in##4##3##(2006-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
of homogeneity of##3##3##(1997-2#1)(2008-10#1)(2008-3#1)
of homogeneity##15##2##(1992-6#1)(1997-2#1)(1997-4#1)(1997-5#3)(2006-11#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
of homogeneous and heterogeneous##2##4##(1995-5#1)(2010-12#1)
of homogeneous and##4##3##(1995-5#1)(2007-12#2)(2010-12#1)
of homogeneous spheres##2##3##(2008-2#2)
of homogeneous##19##2##(1992-10#1)(1994-5#1)(1995-5#1)(1996-4#1)(1997-5#1)(2006-12#1)(2007-12#2)(2007-8#2)(2008-10#1)(2008-2#5)(2008-3#1)(2010-12#1)(2012-12#1)
of homogenous##5##2##(1995-1#1)(1995-8#1)(2006-6#1)(2007-4#1)(2008-2#1)
of homologated##2##2##(2006-12#2)
of homologies with##2##3##(1992-3#1)(1996-10#1)
of homologous and non-homologous##2##4##(1994-6#1)(2010-8#1)
of homologous and##3##3##(1994-6#1)(1995-3#1)(2010-8#1)
of homologous blood##6##3##(1990-2#1)(1992-3#1)(1996-9#2)(2007-9#1)(2010-12#1)
of homologous recombination##5##3##(1990-10#1)(1993-11#1)(1994-8#1)(2008-11#1)(2008-4#1)
of homologous sequences##3##3##(1992-4#1)(1993-2#1)(2008-7#1)
of homologous##38##2##(1990-10#1)(1990-2#1)(1992-3#1)(1992-4#2)(1992-6#2)(1993-11#1)(1993-2#1)(1993-6#1)(1993-9#2)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-5#1)(1996-9#2)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-8#1)
of homologs##3##2##(2006-10#1)(2008-10#1)(2008-4#1)
of homologues of the##2##4##(1991-2#1)(2006-12#1)
of homologues##4##2##(1991-2#1)(1997-7#1)(2006-10#1)(2006-12#1)
of homology between the##3##4##(1995-11#1)(2008-10#1)(2010-7#1)
of homology between##6##3##(1990-7#1)(1993-2#1)(1994-12#1)(1995-11#1)(2008-10#1)(2010-7#1)
of homology in the##2##4##(1994-11#1)(1995-12#1)
of homology in##4##3##(1992-12#1)(1994-11#1)(1995-12#1)(2008-4#1)
of homology is##2##3##(1993-2#1)(2008-7#1)
of homology to other##2##4##(1992-8#1)(1993-6#1)
of homology to the##5##4##(1993-12#1)(1993-6#1)(1994-9#1)(1995-8#1)(1997-6#1)
of homology to##12##3##(1991-5#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#2)(1994-9#1)(1995-8#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-6#1)
of homology with the##4##4##(1990-11#1)(1992-1#1)(1993-11#1)(1993-9#1)
of homology with##13##3##(1990-11#1)(1990-2#1)(1991-7#1)(1992-1#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-5#1)(1995-5#1)(1996-12#1)(2008-9#1)(2011-1#1)
of homology##54##2##(1990-11#1)(1990-2#1)(1990-4#2)(1990-7#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-8#2)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-6#4)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-4#1)(2010-7#1)(2011-1#1)(2012-2#1)
of homophobia in##3##3##(2006-7#1)(2008-12#2)
of homophobia##4##2##(2006-7#1)(2008-12#3)
of homosexual and bisexual men##2##5##(2013-7#2)
of homosexual and bisexual##3##4##(2005-10#1)(2013-7#2)
of homosexual##6##2##(2005-10#1)(2007-12#1)(2008-5#1)(2011-2#1)(2013-7#2)
of homozygotes##2##2##(1995-2#1)(1997-8#1)
of homozygous##12##2##(1991-11#1)(1993-12#1)(1993-9#1)(1995-2#1)(1996-3#1)(1997-7#1)(2007-10#1)(2008-10#2)(2008-5#1)(2011-2#1)(2013-8#1)
of honesty##3##2##(1996-12#1)(2009-4#1)(2010-10#1)
of honey and##2##3##(2008-10#2)
of honey bee##2##3##(2007-2#1)(2009-5#1)
of honey bees##2##3##(1991-2#2)
of honey to##2##3##(2008-10#1)(2013-8#1)
of honey with##3##3##(2008-10#2)(2011-2#1)
of honey##16##2##(1991-2#2)(2007-2#1)(2008-10#6)(2008-7#1)(2009-5#1)(2011-2#2)(2012-12#1)(2013-8#2)
of honeybee behaviour##2##3##(2008-7#2)
of honeybee##4##2##(2007-2#1)(2008-10#1)(2008-7#2)
of honeybees##4##2##(1992-3#1)(2008-10#1)(2008-7#1)(2013-8#1)
of honokiol and magnolol in##3##5##(2008-10#3)
of honokiol and magnolol##4##4##(2008-10#4)
of hookups and romantic##2##4##(2013-1#2)
of hookups##3##2##(2013-1#3)
of hop powdery mildew##3##4##(2008-10#3)
of hop stunt viroid##2##4##(2008-10#2)
of hop##5##2##(2008-10#5)
of hope and expectancy##2##4##(2008-11#2)
of hope and##4##3##(2008-11#2)(2009-8#1)(2012-3#1)
of hope##13##2##(1997-5#1)(2006-10#1)(2007-7#1)(2008-11#2)(2008-4#1)(2009-8#2)(2010-10#2)(2010-8#1)(2010-9#1)(2012-3#1)
of horizontal gene transfer##2##4##(1994-8#2)
of horizontal transfer##2##3##(2006-8#1)(2012-12#1)
of horizontal transmission##3##3##(2010-12#1)(2012-3#2)
of horizontal violence##4##3##(2007-8#4)
of horizontal##22##2##(1991-1#1)(1993-12#1)(1994-3#1)(1994-8#2)(2006-8#1)(2007-8#4)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2009-6#1)(2010-12#1)(2012-12#1)(2012-3#2)
of horizontally##3##2##(1994-3#1)(1994-7#1)(2011-1#1)
of hormesis in##4##3##(2008-7#4)
of hormesis##11##2##(2008-7#10)(2010-12#1)
of hormetic##2##2##(2008-7#2)
of hormonal contraception##2##3##(2005-1#1)(2009-12#1)
of hormonal therapy in##2##4##(2010-12#1)(2013-1#1)
of hormonal therapy##4##3##(1993-5#1)(2008-3#1)(2010-12#1)(2013-1#1)
of hormonal treatment##2##3##(2008-10#1)(2008-6#1)
of hormonal##30##2##(1990-6#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-6#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-4#1)(1995-8#1)(1996-5#1)(2005-1#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-1#1)(2008-10#2)(2008-3#2)(2008-6#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-12#1)(2012-2#1)(2013-1#2)
of hormonally##2##2##(2008-11#1)(2008-4#1)
of hormone and receptor molecules##2##5##(2008-1#2)
of hormone and##4##3##(1995-11#1)(2008-1#2)(2009-10#1)
of hormone receptors##4##3##(1990-5#1)(1992-11#1)(2007-6#1)(2008-9#1)
of hormone release##2##3##(1994-11#1)(2008-5#1)
of hormone replacement therapy (HRT)##3##5##(2008-5#1)(2010-12#1)(2013-8#1)
of hormone replacement therapy in the##2##6##(1993-11#1)(2006-6#1)
of hormone replacement therapy in##3##5##(1993-11#1)(2006-6#1)(2012-3#1)
of hormone replacement therapy##13##4##(1993-11#1)(1994-9#1)(1996-11#1)(1997-5#2)(2006-10#2)(2006-6#1)(2008-5#2)(2010-12#1)(2012-3#1)(2013-8#1)
of hormone therapy##4##3##(2004-2#1)(2007-10#1)(2008-11#2)
of hormone##51##2##(1990-11#1)(1990-5#1)(1990-9#1)(1991-11#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-2#1)(1993-6#1)(1994-11#2)(1994-9#1)(1995-11#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-5#2)(1997-7#2)(2004-2#1)(2006-10#4)(2006-6#1)(2007-10#1)(2007-5#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-5#3)(2008-9#1)(2009-10#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
of hormone-dependent cancers##2##3##(2008-10#1)(2008-2#1)
of hormone-dependent##4##2##(1993-1#1)(2007-11#1)(2008-10#1)(2008-2#1)
of hormone-independent prostate cancer##2##4##(2007-6#2)
of hormone-independent##3##2##(1997-7#1)(2007-6#2)
of hormone-inducible expression of##2##4##(1995-1#2)
of hormone-refractory##2##2##(1992-4#1)(2008-7#1)
of hormone-related##3##2##(1990-6#1)(1995-9#1)(2009-8#1)
of hormones and growth factors##2##5##(1991-10#1)(1993-12#1)
of hormones and the##3##4##(2009-4#1)(2012-2#1)(2013-7#1)
of hormones and their##2##4##(1992-8#1)(2010-9#1)
of hormones and##12##3##(1991-10#1)(1992-8#1)(1993-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-9#1)(2012-2#1)(2013-7#1)
of hormones in##3##3##(2007-11#1)(2008-8#1)(2010-5#1)
of hormones on the##2##4##(1990-8#1)(1994-11#1)
of hormones on##3##3##(1990-8#1)(1993-6#1)(1994-11#1)
of hormones that##2##3##(2010-9#1)(2013-7#1)
of hormones##37##2##(1990-8#1)(1991-10#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-11#1)(1996-11#1)(1997-2#1)(1997-4#2)(2006-10#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#4)(2009-4#2)(2009-8#1)(2010-3#2)(2010-5#1)(2010-9#2)(2011-2#1)(2012-2#2)(2013-7#2)
of horse chestnut##2##3##(2008-5#2)
of horse heart##4##3##(1990-8#1)(1994-5#2)(1996-9#1)
of horse liver alcohol dehydrogenase##2##5##(1992-8#1)(1995-3#1)
of horse spermatozoa##3##3##(2006-5#3)
of horse##23##2##(1990-5#1)(1990-8#2)(1991-7#1)(1992-12#1)(1992-8#1)(1994-5#2)(1995-10#1)(1995-3#1)(1996-9#1)(2006-5#4)(2008-10#1)(2008-4#1)(2008-5#2)(2012-1#1)(2012-12#3)
of horseradish peroxidase (HRP) and##2##5##(2008-10#2)
of horseradish peroxidase (HRP)##9##4##(1992-9#1)(2008-10#7)(2008-4#1)
of horseradish peroxidase##30##3##(1990-2#1)(1990-4#4)(1990-7#1)(1991-9#2)(1992-7#1)(1992-8#1)(1992-9#2)(1994-2#1)(1994-5#1)(1994-6#1)(1995-7#1)(1997-2#1)(2008-10#10)(2008-4#1)(2009-2#2)
of horseradish##32##2##(1990-2#1)(1990-4#4)(1990-7#1)(1991-9#2)(1992-7#1)(1992-8#1)(1992-9#2)(1994-2#1)(1994-5#1)(1994-6#1)(1995-7#1)(1997-2#1)(2007-8#1)(2008-10#10)(2008-4#2)(2009-2#2)
of horses##3##2##(1992-8#1)(2012-3#1)(2013-1#1)
of hospice##5##2##(1990-10#1)(1994-12#1)(1995-12#1)(2004-8#1)(2010-2#1)
of hospital acquired infections##2##4##(1995-9#2)
of hospital acquired pneumonia and##2##5##(2008-10#1)(2010-12#1)
of hospital acquired##4##3##(1995-9#2)(2008-10#1)(2010-12#1)
of hospital administration##2##3##(1990-12#1)(1991-12#1)
of hospital admission for##3##4##(2007-10#1)(2010-4#2)
of hospital admission##6##3##(2007-10#1)(2008-3#1)(2009-6#1)(2010-4#2)(2012-12#1)
of hospital admissions##5##3##(1992-5#1)(1997-8#1)(2007-10#1)(2007-5#1)(2010-9#1)
of hospital and##6##3##(1991-12#1)(1995-3#1)(1997-3#1)(2008-11#1)(2011-2#1)(2013-1#1)
of hospital beds##6##3##(1990-6#1)(1997-6#1)(2011-7#1)(2013-8#3)
of hospital cardiac arrest##3##4##(1996-6#3)
of hospital care and##2##4##(1994-2#1)(2008-8#1)
of hospital care##13##3##(1990-12#1)(1990-7#1)(1991-3#4)(1992-3#1)(1994-2#2)(1994-3#1)(2006-2#1)(2008-8#2)
of hospital discharge##2##3##(2007-11#1)(2008-8#1)
of hospital efficiency##2##3##(2006-8#1)(2013-8#1)
of hospital effluents##2##3##(2013-1#2)
of hospital emergency services##2##4##(1993-11#1)(1993-4#1)
of hospital employees##2##3##(1992-3#1)(2008-12#1)
of hospital governing boards##2##4##(1991-1#1)(1991-12#1)
of hospital infections##4##3##(1990-6#1)(2007-8#2)(2013-1#1)
of hospital information systems##2##4##(1993-12#1)(1994-3#1)
of hospital information##3##3##(1993-12#1)(1994-3#1)(2012-3#1)
of hospital management##2##3##(1992-3#1)(1993-3#1)
of hospital medical records##3##4##(1996-3#1)(2008-6#2)
of hospital medical##5##3##(1994-1#1)(1996-3#1)(2008-6#2)(2011-2#1)
of hospital outpatient##3##3##(1991-2#1)(1992-12#1)(1996-2#1)
of hospital patients##2##3##(2006-1#1)(2006-4#1)
of hospital performance##2##3##(1995-1#1)(2007-12#1)
of hospital security##3##3##(1991-12#1)(1993-2#1)(1996-12#1)
of hospital services in##2##4##(1991-2#1)(1993-2#1)
of hospital services##6##3##(1990-12#1)(1991-1#1)(1991-2#1)(1993-2#1)(1993-6#1)(2012-3#1)
of hospital stay##49##3##(1991-12#3)(1992-12#1)(1992-2#1)(1992-5#2)(1994-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#3)(2007-8#6)(2007-9#1)(2008-1#2)(2008-3#1)(2010-12#1)(2011-11#2)(2011-2#5)(2012-2#2)(2013-1#5)(2013-8#2)
of hospital technologists##2##3##(1992-1#2)
of hospital treatment in##2##4##(2006-10#1)(2008-8#1)
of hospital##208##2##(1990-11#1)(1990-12#6)(1990-6#2)(1990-7#1)(1991-1#2)(1991-11#1)(1991-12#8)(1991-2#3)(1991-3#6)(1992-1#3)(1992-12#2)(1992-2#2)(1992-3#5)(1992-5#3)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#4)(1993-4#1)(1993-6#1)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#4)(1994-5#1)(1995-1#2)(1995-3#1)(1995-4#1)(1995-8#1)(1995-9#2)(1996-1#6)(1996-12#2)(1996-2#4)(1996-3#2)(1996-6#3)(1996-8#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-1#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#4)(2007-11#3)(2007-12#3)(2007-2#4)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#9)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#2)(2008-7#2)(2008-8#4)(2009-6#1)(2010-12#2)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-11#2)(2011-2#9)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#14)(2013-8#8)
of hospital-acquired infection##2##3##(2012-2#1)(2013-1#1)
of hospital-acquired##4##2##(2006-10#1)(2008-10#1)(2012-2#1)(2013-1#1)
of hospital-based##3##2##(1991-1#1)(1991-3#1)(1996-1#1)
of hospitalisation and the##2##4##(2007-11#1)(2011-2#1)
of hospitalisation and##5##3##(2007-11#1)(2008-1#1)(2008-11#1)(2011-12#1)(2011-2#1)
of hospitalisation was##2##3##(1991-9#1)(1996-2#1)
of hospitalisation##13##2##(1991-9#1)(1994-5#1)(1996-2#2)(1996-8#1)(2007-11#2)(2008-1#1)(2008-11#2)(2011-12#1)(2011-2#1)(2013-8#1)
of hospitalisations##2##2##(2007-1#1)(2007-11#1)
of hospitalised##3##2##(2011-2#3)
of hospitalists##2##2##(2008-3#2)
of hospitalization and death##2##4##(1995-2#1)(2007-8#1)
of hospitalization and high##2##4##(2008-11#1)(2011-2#1)
of hospitalization and##13##3##(1992-2#1)(1994-2#1)(1995-2#2)(1996-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2011-1#1)(2011-2#1)(2013-8#1)
of hospitalization for##3##3##(1995-12#1)(2006-5#1)(2008-11#1)
of hospitalization in##4##3##(2007-7#1)(2013-1#2)(2013-8#1)
of hospitalization of patients##2##4##(1992-3#1)(2011-1#1)
of hospitalization resulting from##2##4##(2006-10#1)(2006-8#1)
of hospitalization was##3##3##(1991-12#1)(2007-4#1)(2007-7#1)
of hospitalization were##2##3##(1993-12#1)(2013-1#1)
of hospitalization##74##2##(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-12#2)(1995-2#3)(1996-2#1)(1996-3#1)(1996-6#1)(1997-6#1)(2005-1#2)(2006-10#1)(2006-2#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-7#4)(2007-8#5)(2008-10#2)(2008-11#4)(2008-12#1)(2008-7#1)(2010-12#2)(2010-9#1)(2011-1#3)(2011-2#5)(2012-12#1)(2013-1#10)(2013-8#5)
of hospitalizations and##4##3##(1995-1#1)(2007-8#1)(2008-11#1)(2012-3#1)
of hospitalizations for##3##3##(1995-12#1)(2008-11#1)(2008-3#1)
of hospitalizations##8##2##(1995-1#1)(1995-12#1)(2007-8#1)(2008-11#2)(2008-3#1)(2012-3#1)(2013-1#1)
of hospitalized children##6##3##(1991-1#2)(1991-2#1)(2011-2#1)(2013-1#2)
of hospitalized intubated patients##2##4##(2010-10#2)
of hospitalized patients##6##3##(2004-3#1)(2005-11#1)(2006-7#1)(2007-8#1)(2009-4#1)(2010-2#1)
of hospitalized##21##2##(1990-6#1)(1991-1#2)(1991-2#1)(1993-12#1)(1994-12#1)(2004-3#1)(2005-11#1)(2006-7#1)(2007-10#1)(2007-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-10#2)(2010-2#1)(2011-2#1)(2013-1#2)(2013-8#1)
of hospitals and##3##3##(1992-3#1)(1995-7#1)(1997-1#1)
of hospitals are##3##3##(1993-3#1)(1995-1#1)(1997-1#1)
of hospitals in Isfahan##2##4##(2010-8#2)
of hospitals in##6##3##(1993-12#1)(1994-2#1)(2007-5#1)(2010-8#2)(2013-1#1)
of hospitals serving##2##3##(1991-6#1)(1992-2#1)
of hospitals that##2##3##(2008-3#1)(2012-12#1)
of hospitals to##5##3##(1990-12#2)(1992-2#1)(1996-3#1)(2008-11#1)
of hospitals with##3##3##(1990-6#1)(2008-8#1)(2011-2#1)
of hospitals##51##2##(1990-12#2)(1990-6#2)(1990-9#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-12#3)(1992-2#2)(1992-3#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-8#1)(1994-1#1)(1994-2#2)(1994-3#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-2#1)(1996-3#2)(1997-1#2)(1997-2#1)(2007-5#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-8#1)(2010-8#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
of hospitals'##2##2##(1994-2#1)(1995-2#1)
of host DNA##2##3##(2008-10#2)
of host and parasite##2##4##(2008-8#2)
of host and pathogen##3##4##(2008-10#2)(2008-9#1)
of host and##6##3##(1991-12#1)(2008-10#2)(2008-8#2)(2008-9#1)
of host cell##2##3##(2008-10#2)
of host cells by##2##4##(2007-7#1)(2012-1#1)
of host cells with##3##4##(1995-2#1)(2006-4#1)(2008-10#1)
of host cells##14##3##(1991-12#1)(1995-2#1)(2006-4#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-9#1)(2012-1#4)(2013-1#1)
of host cytoplasm##2##3##(2008-10#2)
of host defense##7##3##(1996-11#1)(2008-10#2)(2010-9#1)(2013-1#3)
of host diversity on##4##4##(2008-10#4)
of host diversity##6##3##(2008-10#6)
of host functions##2##3##(2008-9#1)(2013-1#1)
of host genetics##3##3##(2012-2#1)(2013-8#2)
of host genotype in##2##4##(2008-10#2)
of host genotype##4##3##(2008-10#4)
of host genotypes on##2##4##(2008-10#2)
of host genotypes##4##3##(2008-10#4)
of host immune response##2##4##(2006-10#1)(2012-3#1)
of host immunity and##2##4##(2007-11#1)(2008-8#1)
of host immunity##3##3##(2007-11#1)(2008-8#1)(2010-12#1)
of host insects##2##3##(2010-12#2)
of host phenology##2##3##(2008-10#2)
of host plant infection by##2##5##(2008-10#2)
of host plant##6##3##(2008-10#5)(2009-8#1)
of host plants in##2##4##(2008-5#1)(2009-8#1)
of host plants with##2##4##(2008-10#2)
of host plants##16##3##(2007-12#2)(2008-10#10)(2008-5#1)(2009-8#1)(2010-10#1)(2012-11#1)
of host preference##2##3##(2008-10#1)(2008-7#1)
of host range##2##3##(2008-10#1)(2008-11#1)
of host resistance and##3##4##(2008-10#2)(2008-8#1)
of host resistance to##2##4##(2006-10#1)(2009-10#1)
of host resistance##15##3##(2006-10#1)(2008-10#9)(2008-8#3)(2009-10#1)(2012-11#1)
of host response to##2##4##(2008-10#1)(2011-1#1)
of host specialization##3##3##(2008-10#2)(2008-9#1)
of host species##8##3##(2008-10#5)(2008-5#1)(2008-8#1)(2011-1#1)
of host tissue##4##3##(2008-10#4)
of host tissues and##3##4##(1994-5#1)(2007-7#1)(2008-10#1)
of host tissues##4##3##(1994-5#1)(2007-7#1)(2008-10#1)(2013-1#1)
of host traits##2##3##(2008-8#1)(2012-3#1)
of host##185##2##(1991-12#2)(1991-9#1)(1993-4#1)(1994-5#1)(1995-2#1)(1995-9#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-4#1)(2005-7#2)(2006-10#2)(2006-4#1)(2007-11#3)(2007-12#2)(2007-7#3)(2008-1#2)(2008-10#94)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#10)(2008-9#7)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#5)(2010-10#1)(2010-12#4)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#4)(2012-11#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#8)(2013-8#2)
of host-diversity effects##3##3##(2008-10#3)
of host-guest complexation##2##3##(2008-10#1)(2010-12#1)
of host-guest##3##2##(2008-10#1)(2010-12#2)
of host-parasite associations##2##3##(2008-8#1)(2012-3#1)
of host-parasite##5##2##(2008-10#1)(2008-8#3)(2012-3#1)
of host-pathogen interactions has##2##4##(2008-9#1)(2013-1#1)
of host-pathogen interactions##8##3##(2007-11#1)(2008-10#1)(2008-9#2)(2010-12#1)(2013-1#3)
of host-pathogen##9##2##(2005-11#1)(2007-11#1)(2008-10#1)(2008-9#2)(2010-12#1)(2013-1#3)
of host-specific virulence in##2##4##(2008-10#2)
of host-specific##5##2##(1995-12#1)(2008-10#3)(2009-8#1)
of hosts and##3##3##(2008-1#1)(2008-9#1)(2013-1#1)
of hosts##16##2##(1992-1#1)(1994-3#1)(1996-12#1)(2006-8#1)(2008-1#1)(2008-10#3)(2008-9#2)(2009-5#1)(2011-2#2)(2012-2#1)(2013-1#2)
of hot flashes in men##2##5##(2008-7#2)
of hot flashes in##4##4##(2008-7#4)
of hot flashes##12##3##(2008-7#11)(2009-5#1)
of hot peppers##2##3##(1990-7#1)(1995-11#1)
of hot spots##3##3##(2008-3#1)(2010-7#1)(2011-2#1)
of hot##26##2##(1990-7#1)(1991-8#1)(1992-12#1)(1992-6#1)(1995-11#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-3#1)(2008-7#11)(2009-5#1)(2010-12#1)(2010-7#1)(2011-2#2)
of hot-carrier luminescence from##2##4##(2007-12#2)
of hourly##2##2##(2008-11#1)(2008-3#1)
of hours of continuous##2##4##(2008-10#2)
of hours work##2##3##(1990-3#1)(1991-6#1)
of hours##28##2##(1990-3#3)(1991-5#1)(1991-6#1)(1993-1#1)(1993-10#1)(1993-3#1)(1995-9#1)(1997-3#1)(1997-5#2)(2004-7#4)(2006-7#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-10#6)(2009-12#1)(2011-2#1)
of house dust##2##3##(1995-6#1)(2012-12#1)
of house flies##2##3##(2011-12#2)
of house##8##2##(1995-3#1)(1995-6#1)(2007-11#1)(2008-2#1)(2011-12#2)(2012-12#2)
of household labor##3##3##(2008-5#1)(2011-2#2)
of household##15##2##(1993-6#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-7#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-2#1)(2013-1#1)
of households in the SM district##2##6##(2012-3#2)
of households in the##3##4##(2006-10#1)(2012-3#2)
of households in##4##3##(2006-10#1)(2012-3#3)
of households that##2##3##(2007-7#1)(2008-9#1)
of households were##2##3##(2008-2#1)(2013-1#1)
of households with##4##3##(2006-4#1)(2007-11#1)(2007-6#1)(2011-2#1)
of households##23##2##(1991-12#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-2#1)(2007-6#2)(2007-7#2)(2008-2#1)(2008-9#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-3#4)(2013-1#3)(2013-7#1)
of housekeeping genes##2##3##(1991-12#1)(2011-1#1)
of housekeeping##3##2##(1991-12#1)(1993-5#1)(2011-1#1)
of houses##2##2##(2007-6#1)(2013-8#1)
of housework##2##2##(2008-5#1)(2011-2#1)
of housing##3##2##(1992-7#1)(2011-2#1)(2012-12#1)
of how HCV##2##3##(2006-10#1)(2008-11#1)
of how a##6##3##(1993-3#1)(1993-9#1)(1995-6#1)(2007-2#1)(2007-8#1)(2008-7#1)
of how and where##2##4##(2008-4#1)(2013-7#1)
of how and why##4##4##(2006-7#1)(2007-12#1)(2008-9#1)(2009-5#1)
of how and##6##3##(2006-7#1)(2007-12#1)(2008-4#1)(2008-9#1)(2009-5#1)(2013-7#1)
of how best to##2##4##(2005-7#1)(2006-10#1)
of how cells##3##3##(1992-12#1)(2006-6#1)(2008-4#1)
of how electronic##2##3##(2008-11#1)(2008-7#1)
of how health##2##3##(1994-12#1)(1997-3#1)
of how it##4##3##(2008-4#2)(2008-9#1)(2012-12#1)
of how one##2##3##(1996-3#1)(2011-2#1)
of how peripheral##2##3##(2006-10#1)(2009-10#1)
of how relevant##2##3##(2008-1#1)(2011-1#1)
of how stress##2##3##(2009-8#1)(2012-2#1)
of how the differences##2##4##(2008-10#1)(2010-7#1)
of how the##50##3##(1990-11#1)(1990-9#1)(1992-10#1)(1993-1#1)(1993-6#1)(1994-12#1)(1995-12#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-10#2)(2006-5#1)(2006-7#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#2)(2009-5#1)(2010-10#1)(2010-7#2)(2011-1#2)(2011-3#1)(2012-1#1)(2012-3#1)(2013-1#2)
of how these##20##3##(1991-9#1)(1995-9#1)(1997-2#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2011-2#1)(2012-12#1)
of how they are##2##4##(1990-4#1)(2008-9#1)
of how they##8##3##(1990-4#1)(1992-11#1)(1995-1#1)(1995-10#1)(2005-7#1)(2006-2#1)(2008-11#1)(2008-9#1)
of how this##7##3##(1997-1#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-11#1)
of how to best##2##4##(2012-2#2)
of how to deal with##2##5##(1993-2#1)(2010-2#1)
of how to develop##2##4##(1993-2#1)(2007-4#1)
of how to do##2##4##(2006-10#1)(2008-2#1)
of how to go about##2##5##(2008-11#1)(2008-9#1)
of how to manage##3##4##(1995-12#2)(2006-9#1)
of how to provide##2##4##(1995-9#1)(2012-12#1)
of how to##39##3##(1993-2#3)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#2)(1995-9#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-7#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-4#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-9#1)(2009-2#1)(2009-4#1)(2010-2#1)(2010-3#1)(2012-12#1)(2012-2#3)(2012-3#1)
of how we##3##3##(2006-12#1)(2008-7#1)(2012-12#1)
of how well the##3##4##(1990-11#1)(2008-4#1)(2008-5#1)
of how well##5##3##(1990-11#1)(2008-4#1)(2008-5#1)(2009-9#1)(2011-12#1)
of how##325##2##(1990-11#3)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-1#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#1)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-6#1)(1995-8#2)(1995-9#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-7#2)(1997-8#1)(2005-11#2)(2005-7#3)(2005-8#1)(2006-10#14)(2006-11#2)(2006-12#3)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#2)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#9)(2007-2#3)(2007-3#1)(2007-4#3)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#12)(2008-11#18)(2008-12#4)(2008-2#8)(2008-3#6)(2008-4#14)(2008-5#3)(2008-6#1)(2008-7#11)(2008-8#9)(2008-9#18)(2009-10#2)(2009-12#2)(2009-2#3)(2009-3#3)(2009-4#3)(2009-5#3)(2009-6#2)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#4)(2011-1#5)(2011-12#2)(2011-2#8)(2011-3#1)(2012-1#4)(2012-12#7)(2012-2#4)(2012-3#4)(2013-1#14)(2013-7#1)
of hrp##2##2##(2008-10#2)
of hrp40 are##2##3##(1994-3#2)
of hrp40 in wild-type##2##4##(1994-3#2)
of hrp40##6##2##(1994-3#6)
of hsCRP##2##2##(2011-2#2)
of hsa-let-7g##3##2##(2008-1#3)
of hsp 28##5##3##(1995-3#5)
of hsp##9##2##(1995-3#5)(2008-5#4)
of hsp-reactive lymphocytes in##2##4##(1995-2#2)
of hsp-reactive lymphocytes##3##3##(1995-2#3)
of hsp25##2##2##(1992-11#1)(1993-6#1)
of hsp27##7##2##(1991-2#3)(1992-5#2)(2008-5#2)
of hsp60 in##2##3##(1994-11#2)
of hsp60##6##2##(1994-11#5)(1995-3#1)
of hsp70 in##5##3##(1992-6#1)(1994-11#3)(1995-7#1)
of hsp70 mRNA##2##3##(1992-6#2)
of hsp70 proteins##2##3##(1994-11#2)
of hsp70##17##2##(1992-6#3)(1994-11#11)(1995-7#2)(2012-12#1)
of hsp70RY##2##2##(1994-8#2)
of hsp90##2##2##(2008-4#2)
of htau protein##2##3##(1997-4#2)
of htau##3##2##(1997-4#3)
of huge##7##2##(2007-10#1)(2008-11#1)(2008-7#2)(2012-1#1)(2013-7#1)(2013-8#1)
of hugin##3##2##(2008-9#3)
of hull and hull-less soybean flour##2##6##(2012-2#2)
of hull##4##2##(2008-8#2)(2012-2#2)
of human 15-lipoxygenase##2##3##(1995-5#2)
of human Alu##2##3##(1995-2#2)
of human B and T lymphoblastoid cells##2##7##(1990-12#1)(1990-8#1)
of human B cell##3##4##(2008-11#1)(2008-4#1)(2008-8#1)
of human B cells##3##4##(1990-8#1)(1991-9#1)(2008-4#1)
of human B lymphocytes##2##4##(1992-8#1)(1995-5#1)
of human B##10##3##(1990-12#1)(1990-8#2)(1991-9#1)(1992-8#1)(1995-5#1)(2008-11#1)(2008-4#2)(2008-8#1)
of human B-cell progenitors##2##4##(1995-2#2)
of human C##2##3##(2006-8#1)(2008-4#1)
of human CD4##3##3##(1990-11#1)(1996-10#1)(2008-4#1)
of human CGRP on##3##4##(1997-5#3)
of human CGRP##5##3##(1991-8#1)(1997-5#4)
of human Cu##7##3##(1997-2#5)(1997-8#2)
of human Cu/Zn superoxide dismutase (SOD1)##2##6##(1994-6#1)(1996-5#1)
of human Cu/Zn superoxide dismutase##4##5##(1994-6#2)(1996-5#1)(2005-11#1)
of human Cu/Zn##5##3##(1994-6#2)(1996-10#1)(1996-5#1)(2005-11#1)
of human DNA helicase II##2##5##(1997-7#2)
of human DNA##12##3##(1991-9#1)(1993-3#1)(1994-12#1)(1994-9#1)(1996-6#1)(1997-4#1)(1997-7#3)(2008-12#1)(2008-5#1)(2008-8#1)
of human DPSCs##4##3##(2012-12#4)
of human ES cells##2##4##(2008-9#2)
of human ES##3##3##(2008-1#1)(2008-9#2)
of human FSH##2##3##(1991-3#1)(1991-8#1)
of human GMP synthetase##2##4##(1995-3#2)
of human IDE##2##3##(1994-12#2)
of human IL-2##2##3##(1995-8#1)(2008-4#1)
of human IL-6##3##3##(1994-3#1)(2008-8#2)
of human IgG##3##3##(1996-12#1)(1996-8#1)(2008-10#1)
of human MBP##3##3##(1997-2#3)
of human MDR1 P-glycoprotein##3##4##(1994-8#1)(1995-10#1)(1996-8#1)
of human MK##2##3##(1991-4#2)
of human NK cells##2##4##(2008-4#1)(2008-8#1)
of human NK##4##3##(2008-4#3)(2008-8#1)
of human P-glycoprotein##4##3##(1994-11#2)(2013-1#2)
of human RAD52 confers##2##4##(1995-6#2)
of human RPA##2##3##(1994-11#2)
of human S100##2##3##(1991-2#1)(1993-5#1)
of human SOD1##2##3##(1994-6#2)
of human Schwann cells##2##4##(1995-2#2)
of human T cell leukemia virus##2##6##(1996-5#1)(2012-12#1)
of human T cell##11##4##(1992-7#1)(1994-3#1)(1995-12#2)(1996-5#1)(1997-2#1)(2008-11#3)(2008-4#1)(2012-12#1)
of human T cells##5##4##(1991-2#1)(1995-1#1)(2007-11#1)(2008-11#1)(2008-4#1)
of human T##20##3##(1991-2#1)(1992-7#1)(1992-8#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-12#2)(1996-5#1)(1997-2#1)(2007-11#1)(2008-11#4)(2008-4#3)(2012-12#1)
of human T-cell leukemia virus type I##2##7##(1991-12#1)(1995-3#1)
of human T-cell leukemia virus##3##5##(1991-12#1)(1995-3#1)(2012-12#1)
of human T-cell##4##3##(1991-12#1)(1993-6#1)(1995-3#1)(2012-12#1)
of human T-lymphocytes##3##3##(1992-9#1)(2008-11#2)
of human T-lymphotropic viruses##2##4##(1991-12#1)(1994-4#1)
of human TFIID##2##3##(1990-6#1)(1992-5#1)
of human activity and##2##4##(1993-4#1)(2007-3#1)
of human activity##4##3##(1993-4#1)(2007-3#1)(2008-5#1)(2013-1#1)
of human acute##2##3##(2005-10#1)(2006-10#1)
of human adenovirus##5##3##(2013-8#5)
of human adipocytes##2##3##(2013-1#2)
of human adipose-derived stem cells##3##5##(2012-12#3)
of human adrenal capillary endothelial##2##5##(1991-1#2)
of human adrenal##4##3##(1991-1#2)(1995-12#2)
of human aging##4##3##(1992-7#1)(2008-11#1)(2009-8#2)
of human aldose reductase##2##4##(1992-2#2)
of human alpha##3##3##(1991-12#1)(1994-6#1)(1997-8#1)
of human alpha-CGRP [8-37] (30 nmol/kg/min)##2##6##(1990-9#2)
of human alpha-CGRP [8-37]##4##4##(1990-9#4)
of human alpha-CGRP##7##3##(1990-9#7)
of human alpha-N-acetylgalactosaminidase##2##3##(1991-3#2)
of human alpha-fetoprotein##2##3##(1997-6#1)(2008-8#1)
of human amniotic##2##3##(1990-4#1)(2013-8#1)
of human amylin##2##3##(1992-2#1)(2007-11#1)
of human anatomy##2##3##(1997-1#1)(2005-12#1)
of human and animal##7##4##(1994-6#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-7#1)
of human and bovine##5##4##(1990-7#1)(1992-2#1)(1997-4#1)(1997-5#1)(2006-11#1)
of human and mouse##7##4##(1994-9#1)(1997-7#1)(2006-11#1)(2008-4#2)(2010-2#1)(2013-1#1)
of human and murine cells##2##5##(1991-4#1)(1992-2#1)
of human and murine interleukin##3##5##(1993-8#1)(2008-4#2)
of human and murine##15##4##(1990-12#1)(1991-4#1)(1992-12#1)(1992-2#2)(1992-7#1)(1993-2#1)(1993-8#1)(1994-11#1)(1995-6#1)(2007-4#1)(2008-4#3)(2013-1#1)
of human and porcine##2##4##(1995-1#2)
of human and rat##6##4##(1990-2#1)(1993-4#2)(1993-8#1)(1994-3#1)(1996-5#1)
of human and rodent##2##4##(1994-6#1)(2008-4#1)
of human and##67##3##(1990-12#1)(1990-2#1)(1990-7#2)(1991-4#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#3)(1992-7#2)(1993-2#1)(1993-4#2)(1993-5#1)(1993-8#2)(1994-11#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-1#3)(1995-12#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-5#1)(2006-11#2)(2007-11#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-12#2)(2008-3#1)(2008-4#6)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-2#2)(2010-5#1)(2012-1#1)(2012-2#2)(2013-1#3)(2013-8#1)
of human angiogenin##6##3##(1990-9#2)(1994-9#3)(1997-7#1)
of human antibodies##2##3##(1995-12#1)(1995-7#1)
of human antibody in CHO cells##2##6##(2008-11#2)
of human antibody##3##3##(2008-11#2)(2010-12#1)
of human apoB##2##3##(1994-9#2)
of human apohemoglobin##2##3##(1994-3#2)
of human apolipoprotein E##2##4##(1991-6#1)(1993-3#1)
of human apolipoprotein##8##3##(1991-12#1)(1991-6#1)(1993-3#1)(1993-8#1)(1994-9#1)(1995-1#2)(1995-8#1)
of human articular chondrocytes##2##4##(2007-11#1)(2008-11#1)
of human articular##3##3##(1991-10#1)(2007-11#1)(2008-11#1)
of human atherosclerosis##2##3##(1997-8#1)(2010-9#1)
of human axillary##2##3##(2006-12#2)
of human behavior##5##3##(2006-6#1)(2008-11#1)(2009-4#1)(2011-1#2)
of human behaviour##2##3##(1996-12#1)(2006-6#1)
of human being##2##3##(2010-8#1)(2013-1#1)
of human beings##5##3##(2008-1#1)(2008-12#1)(2012-2#2)(2013-1#1)
of human beta 1 thyroid hormone receptor##2##7##(1993-8#2)
of human beta##4##3##(1993-8#2)(2008-1#1)(2010-2#1)
of human beta-endorphin##2##3##(1990-5#2)
of human blood serum##2##4##(1991-3#1)(2008-3#1)
of human blood##18##3##(1990-7#2)(1990-8#1)(1991-3#1)(1993-3#2)(1994-8#1)(2005-8#1)(2006-10#1)(2006-5#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#1)(2012-12#1)
of human body##5##3##(2007-11#1)(2008-10#1)(2008-7#1)(2011-1#1)(2013-7#1)
of human bone cells##2##4##(1991-3#1)(1994-6#1)
of human bone marrow derived mesenchymal stem cells##2##8##(2008-5#2)
of human bone marrow mesenchymal stem cells (MSCs)##2##8##(2008-11#2)
of human bone marrow mesenchymal stem cells##4##7##(2008-11#3)(2012-1#1)
of human bone marrow mesenchymal##5##5##(2008-11#3)(2012-1#2)
of human bone marrow stromal cells##2##6##(2008-5#1)(2009-4#1)
of human bone marrow##11##4##(2008-11#3)(2008-5#3)(2008-9#1)(2009-4#1)(2012-1#3)
of human bone##15##3##(1991-3#1)(1991-5#1)(1994-6#1)(2008-11#3)(2008-5#3)(2008-9#1)(2009-3#1)(2009-4#1)(2012-1#3)
of human brain tumors##2##4##(1990-4#1)(2008-5#1)
of human brain##22##3##(1990-12#1)(1990-4#1)(1991-1#1)(1991-5#1)(1992-8#2)(1993-4#2)(1994-2#1)(1994-7#1)(1997-2#2)(1997-6#2)(2007-1#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2013-1#1)
of human breast cancer and##2##5##(1993-1#1)(1994-2#1)
of human breast cancer cell##3##5##(2008-11#2)(2008-6#1)
of human breast cancer cells##5##5##(1991-8#1)(1994-8#1)(1995-1#1)(2007-11#1)(2012-3#1)
of human breast cancer##16##4##(1991-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(2007-11#1)(2008-11#2)(2008-6#1)(2009-9#1)(2012-3#2)
of human breast carcinoma##2##4##(1993-6#2)
of human breast##24##3##(1990-10#1)(1990-7#1)(1991-8#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1996-10#1)(2007-11#1)(2008-11#2)(2008-3#1)(2008-6#1)(2009-9#1)(2011-2#1)(2012-3#2)
of human cDNA for the##2##5##(1991-7#1)(1994-8#1)
of human cDNA##4##3##(1991-7#2)(1994-8#1)(1997-2#1)
of human cDNAs##2##3##(1994-12#1)(1996-4#1)
of human cadaver##2##3##(2006-11#1)(2007-4#1)
of human cancer cells and##2##5##(2008-11#1)(2008-4#1)
of human cancer cells##4##4##(2008-11#2)(2008-4#1)(2012-1#1)
of human cancer##15##3##(1990-11#2)(1994-3#1)(1997-4#1)(2007-10#1)(2008-1#1)(2008-11#4)(2008-4#2)(2008-7#1)(2012-1#1)(2013-1#1)
of human cancers##18##3##(1990-8#1)(1992-4#1)(1995-1#1)(1995-8#1)(1997-7#1)(2006-8#1)(2007-11#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-7#2)(2012-12#2)(2013-1#3)
of human carbonic anhydrase II##6##5##(1990-8#1)(1994-11#3)(1997-4#2)
of human carbonic##7##3##(1990-8#1)(1993-4#1)(1994-11#3)(1997-4#2)
of human carcinoma##3##3##(1992-3#1)(1992-9#1)(1996-4#1)
of human casein##2##3##(1993-11#1)(1994-3#1)
of human cell lines##3##4##(1994-8#1)(2008-11#2)
of human cell types##2##4##(2007-9#1)(2009-3#1)
of human cell##7##3##(1994-8#1)(1995-8#1)(1996-2#1)(2007-9#1)(2008-11#2)(2009-3#1)
of human cells and##2##4##(1993-9#1)(2007-11#1)
of human cells to##2##4##(1993-3#1)(1996-12#1)
of human cells##14##3##(1990-8#1)(1992-11#1)(1993-3#1)(1993-4#1)(1993-9#1)(1995-6#1)(1996-12#1)(1997-3#2)(1997-7#1)(2007-11#1)(2008-11#1)(2012-12#2)
of human cerebellum and##2##4##(1991-12#1)(1993-9#1)
of human cervical cancer##2##4##(2008-8#1)(2013-1#1)
of human chondrocytes##3##3##(2007-11#1)(2008-11#2)
of human choriogonadotropin (hCG)##2##4##(1990-5#1)(1994-12#1)
of human chorionic gonadotrophin##2##4##(1996-8#1)(2009-6#1)
of human chorionic gonadotropin (hCG)##5##5##(1991-7#1)(1992-8#1)(1994-8#1)(1996-11#1)(2005-7#1)
of human chorionic gonadotropin##9##4##(1991-7#1)(1992-8#1)(1993-6#1)(1994-8#1)(1995-8#1)(1996-11#1)(1997-4#1)(2005-7#1)(2010-12#1)
of human chorionic##11##3##(1991-7#1)(1992-8#1)(1993-6#1)(1994-8#1)(1995-8#1)(1996-11#1)(1996-8#1)(1997-4#1)(2005-7#1)(2009-6#1)(2010-12#1)
of human chromosome 7##2##4##(1996-6#2)
of human chromosome##9##3##(1990-4#1)(1990-6#1)(1994-3#1)(1995-11#1)(1996-2#1)(1996-6#2)(1997-8#1)(2008-7#1)
of human chromosomes##2##3##(2007-11#2)
of human class IV##2##4##(1994-8#2)
of human class##3##3##(1994-8#3)
of human clinical##3##3##(2005-6#1)(2007-7#1)(2012-12#1)
of human cloning##5##3##(2005-7#1)(2009-4#4)
of human coagulation factor##3##4##(2007-8#2)(2008-9#1)
of human colon cancer##2##4##(1994-8#1)(1997-4#1)
of human colon carcinoma##2##4##(1990-10#1)(2010-12#1)
of human colon##7##3##(1990-10#1)(1994-8#1)(1997-4#1)(1997-7#1)(2008-11#1)(2008-3#1)(2010-12#1)
of human colonic##2##3##(1993-9#1)(1994-9#1)
of human copper##2##3##(2008-12#1)(2010-11#1)
of human cortical##2##3##(1997-6#1)(2009-7#1)
of human cytochrome P450##2##4##(2008-10#1)(2013-1#1)
of human cytochrome P450IA1##2##4##(1990-10#2)
of human cytochrome##6##3##(1990-10#2)(1994-8#1)(1995-8#1)(2008-10#1)(2013-1#1)
of human cytomegalovirus (HCMV)##4##4##(1993-8#1)(1996-12#1)(1997-3#1)(2013-1#1)
of human cytomegalovirus##9##3##(1991-4#1)(1993-12#1)(1993-8#2)(1996-12#1)(1997-3#1)(1997-4#1)(2006-10#1)(2013-1#1)
of human cytosolic purine 5'-nucleotidase##2##5##(1994-11#2)
of human cytosolic##3##3##(1994-11#2)(1996-5#1)
of human dermal fibroblasts##3##4##(1990-5#1)(2008-11#2)
of human dermal##5##3##(1990-5#1)(1994-8#2)(2008-11#2)
of human development and##3##4##(1993-12#1)(2009-3#1)(2010-5#1)
of human development##5##3##(1993-12#2)(2006-3#1)(2009-3#1)(2010-5#1)
of human dihydrolipoamide dehydrogenase##2##4##(1995-6#2)
of human diploid##4##3##(1990-9#1)(1994-5#2)(1997-1#1)
of human disease##27##3##(1991-12#2)(1993-8#1)(1994-5#1)(2006-10#1)(2007-12#2)(2008-11#1)(2008-4#9)(2008-7#2)(2008-9#1)(2009-3#1)(2010-2#1)(2010-3#1)(2010-4#1)(2012-12#1)(2013-1#2)
of human diseased##2##3##(2010-8#1)(2013-1#1)
of human diseases characterized by##2##5##(2005-8#1)(2012-12#1)
of human diseases including##3##4##(1993-3#1)(2007-11#1)(2010-4#1)
of human diseases such as##2##5##(2007-7#2)
of human diseases##18##3##(1993-3#1)(1995-2#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-7#3)(2007-9#1)(2008-4#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#1)
of human disorders##3##3##(2007-11#1)(2008-4#1)(2011-2#1)
of human donor##2##3##(1992-7#1)(2005-7#1)
of human drug safety##2##4##(2008-8#2)
of human drug##5##3##(2008-10#1)(2008-8#3)(2010-11#1)
of human embryonic stem cell research##2##6##(2007-3#1)(2008-9#1)
of human embryonic stem cells (hESCs)##3##6##(2008-9#2)(2009-4#1)
of human embryonic stem cells to##2##6##(2008-11#1)(2008-9#1)
of human embryonic stem cells##13##5##(2008-1#1)(2008-11#5)(2008-9#4)(2009-4#1)(2012-12#1)(2012-3#1)
of human embryonic stem##17##4##(2007-3#1)(2008-1#1)(2008-11#5)(2008-8#1)(2008-9#6)(2009-4#1)(2012-12#1)(2012-3#1)
of human embryonic##18##3##(1994-12#1)(2007-3#1)(2008-1#1)(2008-11#5)(2008-8#1)(2008-9#6)(2009-4#1)(2012-12#1)(2012-3#1)
of human embryos##2##3##(1991-9#1)(2012-11#1)
of human endometrial stromal cells##2##5##(1994-9#2)
of human endometrial##4##3##(1994-9#3)(2013-1#1)
of human endometrium##6##3##(1994-9#3)(2006-10#2)(2010-12#1)
of human endothelial cells by##2##5##(1990-9#1)(1994-8#1)
of human endothelial cells##7##4##(1990-9#1)(1994-8#1)(1994-9#1)(1996-6#1)(1997-7#1)(2004-9#2)
of human endothelial##8##3##(1990-9#2)(1994-8#1)(1994-9#1)(1996-6#1)(1997-7#1)(2004-9#2)
of human enterovirus 71##3##4##(2010-1#1)(2013-8#2)
of human eosinophils##2##3##(1994-8#1)(2008-4#1)
of human epidermal growth factor##3##5##(1990-2#1)(2009-9#1)(2013-1#1)
of human epidermal keratinocyte##2##4##(1993-11#1)(2008-1#1)
of human epidermal keratinocytes##2##4##(1991-10#1)(1992-2#1)
of human epidermal##7##3##(1990-2#1)(1991-10#1)(1992-2#1)(1993-11#1)(2008-1#1)(2009-9#1)(2013-1#1)
of human epithelial cells##2##4##(1990-2#1)(1994-3#1)
of human error##2##3##(2007-4#1)(2012-12#1)
of human erythrocyte membranes##3##4##(1990-4#1)(2008-8#1)(2009-8#1)
of human erythrocyte##6##3##(1990-4#1)(1991-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-8#1)
of human erythrocytes and##3##4##(1990-8#1)(1991-5#1)(2006-8#1)
of human erythrocytes##17##3##(1990-8#2)(1991-3#1)(1991-5#3)(1992-12#1)(1992-4#1)(1992-9#1)(1995-6#2)(1997-1#2)(1997-6#2)(2006-8#1)(2008-2#1)
of human erythroleukemia##2##3##(1990-2#1)(1994-6#1)
of human esophageal##2##3##(1992-8#1)(2012-2#1)
of human evolution##2##3##(1991-11#1)(2012-2#1)
of human existence##3##3##(2008-2#1)(2009-6#1)(2010-12#1)
of human experience##2##3##(2006-3#1)(2011-1#1)
of human exposure to##5##4##(1990-12#1)(1992-3#1)(2006-7#1)(2008-8#1)(2009-3#1)
of human exposure##7##3##(1990-12#1)(1992-3#1)(2006-7#1)(2008-8#1)(2009-3#1)(2010-5#1)(2013-1#1)
of human eye##2##3##(2008-2#1)(2008-3#1)
of human factor IX mutant##2##5##(2008-9#2)
of human factor IX##3##4##(1995-10#1)(2008-9#2)
of human factor##6##3##(1995-1#1)(1995-10#1)(1995-6#1)(2007-11#1)(2008-9#2)
of human faecal bacteria##2##4##(2006-8#2)
of human fetal bone marrow##2##5##(2008-4#1)(2008-9#1)
of human fetal thymus##2##4##(2008-4#1)(2009-9#1)
of human fetal##17##3##(1992-5#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-5#1)(1997-2#1)(2008-11#1)(2008-4#3)(2008-9#2)(2009-10#2)(2009-9#1)(2012-12#2)
of human fetus##3##3##(1991-10#1)(1991-4#1)(1992-7#1)
of human fibrin##2##3##(1992-5#1)(1994-3#1)
of human fibrinogen##2##3##(1991-1#1)(2005-11#1)
of human fibroblast##4##3##(1993-6#1)(1997-4#1)(2008-12#1)(2008-5#1)
of human fibroblasts##5##3##(1990-5#1)(1991-8#1)(1994-3#1)(1995-2#1)(2013-1#1)
of human fibrosarcoma##2##3##(2008-11#1)(2011-2#1)
of human foetal liver Zn-metallothioneins##2##5##(2008-10#2)
of human follistatin##2##3##(1991-8#2)
of human gastric cancer##2##4##(1993-4#1)(2013-7#1)
of human gastric cathepsin E##2##5##(1990-4#2)
of human gastric##7##3##(1990-4#2)(1991-2#1)(1992-4#1)(1993-4#1)(1995-8#1)(2013-7#1)
of human gastrointestinal##3##3##(1997-7#1)(2007-12#1)(2008-11#1)
of human genes##7##3##(1997-1#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)
of human genetic disease##2##4##(1990-8#1)(2008-8#1)
of human genetic##3##3##(1990-8#1)(2008-8#1)(2012-1#1)
of human genetics##3##3##(2005-11#1)(2008-2#1)(2008-8#1)
of human genome##3##3##(2006-11#1)(2007-8#1)(2010-7#1)
of human genomic DNA revealed##2##5##(1994-3#1)(2008-9#1)
of human genomic DNA##4##4##(1991-6#1)(1993-6#1)(1994-3#1)(2008-9#1)
of human genomic##5##3##(1991-6#1)(1993-6#1)(1994-3#1)(2008-9#1)(2012-1#1)
of human gestation##2##3##(1996-10#1)(2011-2#1)
of human gingival fibroblasts##2##4##(1991-9#2)
of human glioma##3##3##(1994-5#3)
of human globin gene##2##4##(1990-8#1)(1993-2#1)
of human granulocytic anaplasmosis##4##4##(2008-9#1)(2013-1#3)
of human growth hormone##3##4##(1990-4#1)(1997-2#1)(2008-8#1)
of human growth##5##3##(1990-4#1)(1997-2#1)(2007-11#1)(2008-8#1)(2009-7#1)
of human hair and##2##4##(2008-10#2)
of human hair keratins##4##4##(2008-5#1)(2012-11#3)
of human hair##16##3##(2006-12#1)(2008-10#2)(2008-5#7)(2011-1#2)(2012-11#3)(2012-12#1)
of human head##2##3##(2007-4#1)(2008-5#1)
of human health and disease##2##5##(2008-4#1)(2011-1#1)
of human health and##4##4##(2008-4#1)(2008-8#1)(2011-1#1)(2013-8#1)
of human health or##2##4##(1993-9#1)(2011-2#1)
of human health##11##3##(1991-2#1)(1993-9#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
of human heart##5##3##(1997-2#1)(2008-10#2)(2009-10#1)(2010-12#1)
of human hematopoietic progenitor##2##4##(2008-11#2)
of human hematopoietic##8##3##(1990-9#1)(1995-12#1)(2008-11#6)
of human hemoglobin A##2##4##(1993-6#1)(1994-9#1)
of human hemoglobin##5##3##(1990-8#2)(1993-6#1)(1994-9#2)
of human hepatocellular carcinoma##2##4##(2009-6#1)(2011-2#1)
of human hepatocellular##3##3##(2009-6#1)(2011-2#2)
of human hepatoma cell line##2##5##(2008-8#1)(2012-3#1)
of human hepatoma##6##3##(1992-9#1)(1995-2#1)(2008-11#1)(2008-8#2)(2012-3#1)
of human hydatidosis##2##3##(2011-1#1)(2012-2#1)
of human immune cells##2##4##(2008-11#1)(2008-4#1)
of human immune##5##3##(1995-5#1)(2006-10#1)(2008-11#1)(2008-4#1)(2013-1#1)
of human immunodeficiency virus (HIV) in##2##6##(1991-6#1)(1991-7#1)
of human immunodeficiency virus (HIV) infection and##2##7##(1992-2#1)(2008-2#1)
of human immunodeficiency virus (HIV) infection##10##6##(1990-3#1)(1992-2#1)(1994-12#1)(1996-4#1)(1996-9#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-5#1)
of human immunodeficiency virus (HIV)##19##5##(1990-11#1)(1990-3#1)(1990-9#1)(1991-6#1)(1991-7#1)(1992-2#2)(1994-12#1)(1996-4#1)(1996-9#1)(2006-10#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-2#1)(2008-5#1)(2010-2#1)
of human immunodeficiency virus (HIV-1)##3##5##(1992-5#1)(1992-9#1)(2009-8#1)
of human immunodeficiency virus and other##3##6##(1997-1#2)(2008-8#1)
of human immunodeficiency virus infection##6##5##(1990-12#1)(1991-3#1)(1995-1#1)(2005-10#2)(2007-11#1)
of human immunodeficiency virus type 1 (HIV-1) is##2##8##(1993-9#1)(1997-1#1)
of human immunodeficiency virus type 1 (HIV-1)##12##7##(1991-2#1)(1992-11#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-1#1)(1996-1#1)(1996-11#1)(1997-1#1)(2007-11#1)(2008-2#1)
of human immunodeficiency virus type 1 in##2##7##(1992-6#1)(1994-2#1)
of human immunodeficiency virus type 1 reverse transcriptase##2##8##(1991-2#1)(1996-7#1)
of human immunodeficiency virus type 1##23##6##(1991-1#1)(1991-2#2)(1992-11#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-2#2)(1994-8#2)(1995-1#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-7#1)(1997-1#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-2#1)
of human immunodeficiency virus type##25##5##(1991-1#1)(1991-2#2)(1992-11#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-2#2)(1994-8#2)(1995-1#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-7#2)(1997-1#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-2#1)
of human immunodeficiency virus type-1##3##5##(1990-2#1)(1992-2#1)(1993-12#1)
of human immunodeficiency virus##76##4##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-2#3)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-8#3)(1995-1#3)(1995-2#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-4#2)(1996-7#2)(1996-9#1)(1997-1#4)(1997-3#1)(2005-10#2)(2006-10#1)(2007-11#6)(2007-12#1)(2008-1#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
of human immunodeficiency virus-1##3##4##(1992-8#1)(2007-11#1)(2008-11#1)
of human immunodeficiency viruses##2##4##(1990-5#1)(2008-9#1)
of human immunodeficiency##85##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-2#3)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-8#3)(1995-1#3)(1995-2#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-4#2)(1996-7#2)(1996-9#1)(1997-1#4)(1997-3#1)(2005-10#3)(2006-10#1)(2006-7#1)(2007-11#8)(2007-12#1)(2008-1#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
of human immunoglobulin##5##3##(1997-8#1)(2008-4#1)(2008-5#2)(2009-9#1)
of human individuals to##2##4##(1994-3#1)(1995-3#1)
of human indoleamine##2##3##(1992-11#1)(1996-7#1)
of human induced##2##3##(2012-12#1)(2013-1#1)
of human inflammatory bowel disease##2##5##(2006-10#2)
of human inflammatory##5##3##(2006-10#3)(2011-2#1)(2012-1#1)
of human influenza##6##3##(1994-8#3)(2008-9#1)(2009-5#2)
of human insulin##6##3##(1991-8#1)(1994-2#1)(1996-7#2)(1997-4#1)(2007-11#1)
of human interferon-alpha-encoding##2##3##(1993-5#2)
of human interleukin##3##3##(1991-7#1)(1992-12#1)(2008-4#1)
of human interleukin-6 (hIL-6)##2##4##(1992-8#1)(2008-8#1)
of human interleukin-6##5##3##(1992-11#1)(1992-8#2)(2008-8#2)
of human intestinal##7##3##(1990-2#1)(1992-11#1)(1995-12#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-1#1)
of human invariant##2##3##(2008-4#1)(2010-7#1)
of human keratinocyte##2##3##(1996-6#1)(2008-11#1)
of human keratinocytes with##2##4##(1994-12#1)(1996-6#1)
of human keratinocytes##7##3##(1990-5#1)(1992-9#1)(1994-12#1)(1996-6#3)(2008-11#1)
of human kidney##4##3##(1990-2#1)(1991-9#1)(1996-2#1)(2010-12#1)
of human lactotransferrin##4##3##(1992-9#4)
of human language##9##3##(1997-8#1)(2007-3#1)(2010-5#2)(2012-1#2)(2012-12#2)(2012-2#1)
of human leukemia##3##3##(1991-10#1)(1996-11#1)(2008-7#1)
of human leukocyte antigen##3##4##(1996-11#2)(1997-4#1)
of human leukocyte elastase (HLE)##3##5##(1991-2#1)(1991-4#1)(1994-9#1)
of human leukocyte elastase##10##4##(1991-2#1)(1991-4#2)(1994-11#1)(1994-9#3)(1995-7#2)(2008-5#1)
of human leukocyte##15##3##(1991-2#1)(1991-4#2)(1993-11#1)(1994-11#1)(1994-9#3)(1995-7#2)(1996-11#2)(1997-4#1)(2008-5#1)(2010-6#1)
of human life##7##3##(2006-2#1)(2006-7#1)(2007-10#1)(2008-5#1)(2008-9#1)(2010-8#1)(2013-1#1)
of human lipoprotein lipase##2##4##(1994-11#1)(1995-3#1)
of human liver UDP-glucuronosyltransferase cDNA##2##5##(2008-11#2)
of human liver cells##2##4##(1993-7#1)(2008-9#1)
of human liver cytochrome P-450##2##5##(1990-12#1)(1993-4#1)
of human liver cytochrome##3##4##(1990-12#2)(1993-4#1)
of human liver microsomes##2##4##(1990-5#1)(1994-3#1)
of human liver##22##3##(1990-1#1)(1990-10#1)(1990-12#2)(1990-5#1)(1991-12#1)(1991-3#2)(1991-5#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-9#1)(2008-11#3)(2008-9#1)(2010-2#1)(2012-12#1)
of human lung adenocarcinoma##3##4##(2008-9#1)(2012-11#1)(2013-1#1)
of human lung cancer##4##4##(1990-5#1)(2005-10#1)(2005-8#1)(2008-8#1)
of human lung##12##3##(1990-5#1)(1991-10#1)(1991-9#1)(1992-7#1)(1996-2#1)(2005-10#1)(2005-8#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-11#1)(2013-1#1)
of human lymphocyte##4##3##(1991-5#1)(1992-12#1)(1992-6#2)
of human lymphocytes to##2##4##(1992-12#1)(1994-12#1)
of human lymphocytes##11##3##(1992-12#2)(1994-12#1)(1994-9#1)(1996-11#1)(1997-4#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
of human lymphoid cell lines##2##5##(1990-8#1)(1993-7#1)
of human lymphoid cells##2##4##(1994-2#1)(1995-12#1)
of human lymphoid##4##3##(1990-8#1)(1993-7#1)(1994-2#1)(1995-12#1)
of human lysosomal##3##3##(1991-8#1)(1995-6#1)(1996-1#1)
of human lysozyme##7##3##(1991-8#3)(1992-9#3)(1995-3#1)
of human mAbs that##2##4##(2010-1#2)
of human mGluR1b##2##3##(1995-12#2)
of human macrophages##3##3##(1990-3#1)(1992-7#1)(2012-1#1)
of human malaria##5##3##(1991-2#1)(2006-10#1)(2010-12#1)(2011-1#1)(2012-2#1)
of human male##2##3##(2009-10#1)(2013-8#1)
of human malignancies##5##3##(1993-9#1)(1994-10#1)(2008-11#1)(2010-12#1)(2011-2#1)
of human malignant tumor cells##2##5##(1993-9#2)
of human malignant##4##3##(1993-9#2)(1995-2#1)(2008-4#1)
of human mammary##3##3##(1990-7#1)(1993-11#1)(2008-4#1)
of human melanocytes##3##3##(1993-5#2)(1995-2#1)
of human melanoma cells##3##4##(1992-1#1)(2008-10#1)(2009-4#1)
of human melanoma##10##3##(1991-5#1)(1992-1#1)(1994-6#1)(1995-8#2)(2008-10#1)(2008-11#2)(2008-8#1)(2009-4#1)
of human mesenchymal stem cells in##2##6##(2008-5#1)(2012-1#1)
of human mesenchymal stem cells##6##5##(2008-11#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-7#1)
of human metabolism##2##3##(2005-9#1)(2008-5#1)
of human milk##5##3##(1991-10#1)(1997-6#1)(2007-1#1)(2008-10#1)(2012-2#1)
of human mitochondrial tRNA(Leu(UUR))##2##4##(2008-8#2)
of human mitochondrial##5##3##(1991-9#1)(1997-1#1)(1997-2#1)(2008-8#2)
of human monoclonal antibodies##3##4##(1992-7#1)(2008-11#2)
of human monoclonal antibody##4##4##(2008-11#4)
of human monoclonal##8##3##(1992-7#1)(2008-11#6)(2010-12#1)
of human monocytes##4##3##(1991-4#2)(1991-7#1)(1992-1#1)
of human monocytes/macrophages##2##3##(1992-6#1)(2008-4#1)
of human monocytoid and CD4+ lymphoid cells##2##7##(1994-6#2)
of human morbidity and mortality##2##5##(2009-9#1)(2011-2#1)
of human mtDNA##2##3##(1992-12#1)(2010-12#1)
of human myometrium##3##3##(1993-1#1)(1993-12#1)(1994-8#1)
of human natural killer cell##2##5##(1994-5#1)(2008-4#1)
of human natural killer cells##4##5##(1990-12#3)(1994-9#1)
of human natural killer##7##4##(1990-12#3)(1994-5#1)(1994-9#1)(2008-4#2)
of human nature##3##3##(2006-7#2)(2011-1#1)
of human nebulin##2##3##(2008-6#2)
of human neural##2##3##(2008-11#2)
of human neuroblastoma cells in##2##5##(1992-1#1)(1994-3#1)
of human neuroblastoma cells##3##4##(1991-9#1)(1992-1#1)(1994-3#1)
of human neuroblastoma##5##3##(1991-9#1)(1992-1#2)(1994-3#1)(2007-11#1)
of human neuroblastomas##3##3##(1991-9#1)(2011-1#2)
of human neurodegenerative disorders##2##4##(2004-12#1)(2006-4#1)
of human neurodegenerative##3##3##(1994-5#1)(2004-12#1)(2006-4#1)
of human neutrophil elastase##2##4##(1992-3#1)(2005-8#1)
of human neutrophil##5##3##(1992-3#1)(1994-11#1)(1995-10#1)(2005-8#1)(2007-12#1)
of human neutrophils with##2##4##(1990-10#1)(1993-6#1)
of human neutrophils##11##3##(1990-10#1)(1990-11#1)(1990-8#1)(1991-7#1)(1992-12#1)(1993-6#1)(1994-12#1)(1994-3#1)(1996-5#1)(2008-1#1)(2010-2#1)
of human nitric oxide synthase##2##5##(1992-6#1)(1995-12#1)
of human nuclear##2##3##(1991-7#1)(1994-5#1)
of human obesity##4##3##(2006-8#1)(2007-11#1)(2008-3#1)(2009-2#1)
of human occupants##2##3##(2007-4#1)(2008-9#1)
of human occupation##2##3##(2008-8#1)(2010-5#1)
of human or animal origin##2##5##(2007-8#1)(2008-11#1)
of human or mouse##2##4##(2008-4#2)
of human or##8##3##(1991-7#1)(1992-7#1)(1993-12#1)(1995-1#1)(2007-8#1)(2008-11#1)(2008-4#2)
of human origin##10##3##(1990-2#2)(1992-12#1)(1994-12#1)(1997-5#1)(2005-11#1)(2008-5#2)(2008-8#1)(2009-2#1)
of human osteoblast-like osteosarcoma cell##2##5##(1992-8#2)
of human osteoblast-like##5##3##(1992-4#1)(1992-8#2)(2008-11#1)(2012-2#1)
of human osteoblasts##4##3##(1993-3#1)(2006-5#1)(2008-11#1)(2008-5#1)
of human ovarian cancer##2##4##(1993-9#1)(2013-7#1)
of human ovarian carcinoma##2##4##(1993-9#1)(2010-10#1)
of human ovarian##7##3##(1990-9#1)(1991-5#1)(1993-8#1)(1993-9#2)(2010-10#1)(2013-7#1)
of human pancreatic##5##3##(1994-11#1)(1996-7#1)(2006-10#1)(2010-11#2)
of human papilloma virus (HPV)##2##5##(1991-2#1)(2008-3#1)
of human papilloma virus##4##4##(1990-7#1)(1991-2#1)(2007-8#1)(2008-3#1)
of human papillomavirus (HPV) infection##4##5##(1992-2#1)(1992-3#1)(2011-2#1)(2012-2#1)
of human papillomavirus (HPV)##8##4##(1990-10#1)(1992-2#1)(1992-3#1)(1992-9#1)(2010-12#1)(2011-2#2)(2012-2#1)
of human papillomavirus and##2##4##(2006-10#1)(2013-8#1)
of human papillomavirus infection##4##4##(2008-4#1)(2010-5#1)(2010-7#1)(2013-1#1)
of human papillomavirus type 16##3##5##(1990-5#2)(1995-2#1)
of human papillomavirus type##4##4##(1990-10#1)(1990-5#2)(1995-2#1)
of human papillomavirus##26##3##(1990-10#2)(1990-5#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-2#1)(1995-2#1)(2006-10#2)(2007-12#1)(2008-4#2)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
of human papillomaviruses##2##3##(1997-7#1)(2010-12#1)
of human parainfluenza viruses##2##4##(2007-11#2)
of human parathyroid hormone##3##4##(1990-10#1)(1991-6#2)
of human parathyroid##4##3##(1990-10#1)(1991-6#2)(2008-11#1)
of human parturition##2##3##(1996-12#1)(2007-11#1)
of human patients##2##3##(1992-4#1)(2008-11#1)
of human performance##2##3##(2006-6#1)(2007-5#1)
of human peripheral blood cells##4##5##(1990-3#1)(1996-2#2)(2008-4#1)
of human peripheral blood lymphocytes (PBL)##2##6##(1995-12#1)(2008-11#1)
of human peripheral blood lymphocytes##6##5##(1992-5#1)(1995-12#2)(2008-11#2)(2008-9#1)
of human peripheral blood mononuclear cells (PBMC)##2##7##(1992-12#1)(2008-11#1)
of human peripheral blood mononuclear cells##3##6##(1992-12#1)(2008-11#1)(2008-9#1)
of human peripheral blood##18##4##(1990-11#1)(1990-3#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1994-11#1)(1995-12#2)(1996-2#2)(2008-11#3)(2008-4#1)(2008-9#3)
of human peripheral myelin##2##4##(1991-10#1)(1992-7#1)
of human peripheral##22##3##(1990-11#1)(1990-3#1)(1991-10#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1994-11#1)(1995-12#2)(1996-2#2)(1996-3#1)(2008-11#3)(2008-4#1)(2008-9#3)
of human perturbations##2##3##(2008-10#2)
of human placenta and##2##4##(1990-2#1)(1990-7#1)
of human placenta by##2##4##(1992-2#1)(1993-11#1)
of human placenta nuclei##2##4##(1992-12#2)
of human placenta##10##3##(1990-2#1)(1990-7#1)(1991-1#1)(1992-12#2)(1992-2#1)(1992-8#2)(1993-11#1)(1994-11#1)
of human placental ribonuclease##2##4##(1991-2#2)
of human placental##11##3##(1990-12#1)(1990-3#1)(1990-9#1)(1991-2#3)(1991-4#1)(1991-5#1)(1993-12#1)(1994-3#1)(2010-12#1)
of human plasma fibronectin##3##4##(1991-4#2)(1995-5#1)
of human plasma##23##3##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-3#1)(1991-4#2)(1991-8#1)(1992-5#1)(1993-11#1)(1993-12#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-3#2)(1996-7#1)(1997-8#2)(2005-12#1)(2007-11#1)(2008-10#2)
of human plasminogen##4##3##(1990-12#1)(1993-8#2)(2008-4#1)
of human platelet##3##3##(1992-1#1)(1992-3#1)(2006-10#1)
of human platelets##13##3##(1990-10#1)(1990-5#2)(1990-9#1)(1991-8#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-6#2)(1995-3#1)(1997-7#1)(2012-1#1)
of human pluripotent stem cells##2##5##(2009-3#2)
of human pluripotent##3##3##(2009-3#2)(2012-12#1)
of human polymorphonuclear leukocyte##2##4##(1991-7#1)(1993-8#1)
of human polymorphonuclear##4##3##(1990-8#1)(1991-7#1)(1993-6#1)(1993-8#1)
of human populations##4##3##(1997-4#1)(2008-2#1)(2012-12#1)(2012-3#1)
of human preadipocytes to##2##4##(2008-5#2)
of human preadipocytes##3##3##(2008-5#3)
of human prefrontal##2##3##(1994-8#1)(1997-5#1)
of human presence##2##3##(2008-11#1)(2008-8#1)
of human prevalence of S##2##5##(2008-8#2)
of human primary##2##3##(1994-9#1)(2008-5#1)
of human prion disease##2##4##(1996-12#1)(2010-12#1)
of human prostaglandin##2##3##(1994-5#1)(1994-8#1)
of human prostate cancer cells##2##5##(1991-8#1)(2011-2#1)
of human prostate cancer##4##4##(1991-8#1)(2008-4#1)(2009-5#1)(2011-2#1)
of human prostate##5##3##(1991-8#1)(2008-4#1)(2009-5#2)(2011-2#1)
of human protein C##2##4##(1995-2#2)
of human protein##3##3##(1994-2#1)(1995-2#2)
of human pyruvate dehydrogenase complex##2##5##(1994-8#1)(1995-1#1)
of human quadrupedalism##2##3##(2011-1#2)
of human recombinant IFN-γ##3##4##(2011-2#1)(2012-3#2)
of human recombinant and bovine brain##2##6##(1993-4#2)
of human recombinant##18##3##(1991-3#1)(1991-7#1)(1992-2#1)(1992-8#4)(1993-4#2)(1993-6#1)(1993-9#1)(1994-11#1)(2006-9#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#2)
of human red##2##3##(1990-11#1)(1997-8#1)
of human renal##2##3##(1991-11#1)(1992-8#1)
of human renin##3##3##(1990-7#1)(1992-5#1)(1993-6#1)
of human research##3##3##(2006-8#1)(2007-11#1)(2009-4#1)
of human resident cardiac stem cells##2##6##(2012-12#2)
of human resource##3##3##(1995-3#2)(2011-1#1)
of human resources##10##3##(1993-2#1)(1994-1#1)(2005-5#1)(2008-10#1)(2008-11#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
of human respiratory##2##3##(2010-1#1)(2013-1#1)
of human retinal##3##3##(1992-8#1)(1993-3#1)(2007-11#1)
of human retroviral replication##2##4##(1995-2#2)
of human retroviral##3##3##(1995-2#3)
of human rhinovirus##2##3##(2013-8#2)
of human rights##4##3##(1991-3#1)(1995-11#2)(2005-11#1)
of human salivary##3##3##(1990-12#1)(1994-12#1)(2011-2#1)
of human sebocytes in vitro##2##5##(2010-3#2)
of human serum albumin (HSA) onto colloidal TiO2##2##8##(2005-11#2)
of human serum albumin (HSA)##6##5##(2005-11#2)(2008-10#4)
of human serum albumin##13##4##(1991-9#1)(1994-9#1)(1996-11#1)(1996-12#1)(2005-11#3)(2006-11#1)(2008-10#5)
of human serum and urine##2##5##(2008-10#2)
of human serum and##3##4##(2008-10#2)(2010-12#1)
of human serum butyrylcholinesterase##3##4##(1990-3#2)(1992-12#1)
of human serum vitamin D binding protein##2##7##(1991-7#2)
of human serum##30##3##(1990-3#2)(1990-6#1)(1991-10#1)(1991-3#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-7#1)(1994-3#1)(1994-9#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-3#1)(2005-11#3)(2005-8#1)(2006-11#1)(2008-10#7)(2008-4#1)(2010-12#1)
of human sex##3##3##(1990-9#1)(2008-4#2)
of human skeletal muscle##5##4##(1990-11#2)(1995-2#1)(2008-11#1)(2008-6#1)
of human skin and##3##4##(1996-4#1)(2008-3#1)(2010-7#1)
of human skin fibroblasts and##2##5##(1993-12#1)(2008-5#1)
of human skin fibroblasts##6##4##(1993-11#1)(1993-12#1)(1994-3#1)(2008-2#1)(2008-5#1)(2008-7#1)
of human skin in vivo##5##5##(2007-12#1)(2008-3#1)(2008-5#3)
of human skin is##3##4##(1992-6#2)(2008-5#1)
of human skin##32##3##(1992-6#2)(1993-11#1)(1993-12#1)(1994-3#1)(1995-3#1)(1996-4#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#11)(2008-6#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
of human social##6##3##(1992-12#5)(2008-8#1)
of human society##2##3##(2006-7#1)(2008-12#1)
of human solid tumors##2##4##(1991-10#1)(1992-10#1)
of human spaceflight##2##3##(2012-3#2)
of human sperm protamines##3##4##(1990-7#2)(1994-6#1)
of human sperm##7##3##(1990-7#2)(1990-9#2)(1992-1#1)(1994-6#1)(2011-1#1)
of human sperms##3##3##(2009-5#2)(2009-6#1)
of human stem cell research##2##5##(2008-11#1)(2008-9#1)
of human stem##3##3##(2005-8#1)(2008-11#1)(2008-9#1)
of human studies##4##3##(2007-11#2)(2013-1#2)
of human subject##2##3##(2006-8#1)(2007-11#1)
of human subjects to##3##4##(2006-5#2)(2008-7#1)
of human subjects##12##3##(1990-4#1)(2005-7#1)(2006-11#1)(2006-5#3)(2007-11#1)(2007-12#1)(2007-4#2)(2008-5#1)(2008-7#1)
of human substantia nigra##2##4##(1991-9#2)
of human suffering##3##3##(1992-6#1)(2005-10#1)(2011-1#1)
of human telomerase catalytic subunit##4##5##(2012-1#4)
of human telomerase##8##3##(2008-11#3)(2008-9#1)(2012-1#4)
of human thymidine kinase##3##4##(1991-4#1)(1992-11#2)
of human thyroid##3##3##(1993-9#1)(1994-11#1)(1994-6#1)
of human thyrotropin receptor possess thyroid stimulating activities##2##8##(1991-12#1)(1991-9#1)
of human thyrotropin receptor##3##4##(1991-12#2)(1991-9#1)
of human thyrotropin##5##3##(1991-12#2)(1991-9#1)(1992-7#2)
of human tissue inhibitor of##2##5##(1990-8#1)(1994-8#1)
of human tissue plasminogen activator##2##5##(1991-9#2)
of human tissue##10##3##(1990-8#1)(1991-9#2)(1993-3#1)(1994-8#1)(1996-11#1)(2006-3#1)(2008-4#1)(2008-8#1)(2009-4#1)
of human tissues in the pediatric age range##2##8##(2006-11#1)(2007-4#1)
of human tissues##15##3##(1994-10#1)(1995-10#1)(1997-6#2)(2006-11#1)(2007-11#2)(2007-4#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-1#1)(2013-1#1)
of human topoisomerase II beta in##2##6##(1995-6#2)
of human toxocarosis##2##3##(2011-2#2)
of human transferrin##2##3##(1997-4#1)(2008-7#1)
of human transforming growth factor##3##5##(1990-8#1)(2008-8#2)
of human trypsin 1##3##4##(1996-6#3)
of human trypsin##4##3##(1992-11#1)(1996-6#3)
of human tumor antigens recognized by##2##6##(2008-4#2)
of human tumor antigens##3##4##(2008-4#3)
of human tumor cells##6##4##(1990-10#2)(1991-9#1)(1993-4#1)(2008-11#1)(2008-6#1)
of human tumor##15##3##(1990-10#2)(1991-9#1)(1993-4#1)(1994-9#1)(2008-11#1)(2008-4#3)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2013-7#1)
of human tumors##10##3##(1990-6#1)(2005-10#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-12#2)
of human tumour necrosis factor##2##5##(1994-3#2)
of human tumour##3##3##(1992-10#1)(1994-3#2)
of human tumours##3##3##(1994-10#1)(2007-11#2)
of human type I##2##4##(1995-3#1)(2008-5#1)
of human umbilical artery##2##4##(1994-3#1)(1995-3#1)
of human umbilical cord##2##4##(2008-11#1)(2012-12#1)
of human umbilical vein endothelial cells (HUVEC)##2##7##(1994-8#1)(2008-9#1)
of human umbilical vein endothelial cells (HUVECs)##2##7##(1995-2#1)(2008-10#1)
of human umbilical vein endothelial cells##8##6##(1991-5#1)(1994-8#1)(1994-9#2)(1995-2#1)(2008-10#1)(2008-9#1)(2011-2#1)
of human umbilical vein##9##4##(1991-5#1)(1993-7#1)(1994-8#1)(1994-9#2)(1995-2#1)(2008-10#1)(2008-9#1)(2011-2#1)
of human umbilical##14##3##(1991-5#1)(1993-7#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
of human urinary##3##3##(1990-12#1)(1993-2#1)(2010-12#1)
of human urine and##2##4##(2008-10#2)
of human vascular endothelial growth##2##5##(1997-7#1)(2008-8#1)
of human vascular smooth muscle##2##5##(1994-9#1)(2012-12#1)
of human vascular##4##3##(1994-9#1)(1997-7#1)(2008-8#1)(2012-12#1)
of human versican##2##3##(1994-12#2)
of human viral##3##3##(1993-11#1)(1994-12#1)(2010-11#1)
of human vision##2##3##(2006-10#1)(2008-3#1)
of human volunteers##2##3##(2008-5#2)
of human##2433##2##(1990-1#1)(1990-10#15)(1990-11#12)(1990-12#23)(1990-2#14)(1990-3#8)(1990-4#10)(1990-5#16)(1990-6#6)(1990-7#15)(1990-8#20)(1990-9#20)(1991-1#9)(1991-10#10)(1991-11#5)(1991-12#14)(1991-2#18)(1991-3#18)(1991-4#17)(1991-5#20)(1991-6#8)(1991-7#20)(1991-8#18)(1991-9#30)(1992-1#7)(1992-10#3)(1992-11#14)(1992-12#24)(1992-2#19)(1992-3#9)(1992-4#6)(1992-5#9)(1992-6#11)(1992-7#16)(1992-8#28)(1992-9#19)(1993-1#2)(1993-11#20)(1993-12#16)(1993-2#7)(1993-3#13)(1993-4#15)(1993-5#7)(1993-6#18)(1993-7#4)(1993-8#19)(1993-9#18)(1994-1#1)(1994-10#6)(1994-11#26)(1994-12#27)(1994-2#14)(1994-3#30)(1994-4#1)(1994-5#19)(1994-6#22)(1994-7#1)(1994-8#44)(1994-9#38)(1995-1#17)(1995-10#7)(1995-11#7)(1995-12#24)(1995-2#28)(1995-3#27)(1995-5#10)(1995-6#18)(1995-7#5)(1995-8#18)(1996-1#3)(1996-10#7)(1996-11#12)(1996-12#9)(1996-2#12)(1996-3#7)(1996-4#9)(1996-5#9)(1996-6#12)(1996-7#10)(1996-8#6)(1996-9#4)(1997-1#12)(1997-2#25)(1997-3#5)(1997-4#25)(1997-5#10)(1997-6#16)(1997-7#22)(1997-8#10)(1997-9#2)(2004-11#1)(2004-12#2)(2004-7#1)(2004-9#3)(2005-10#10)(2005-11#9)(2005-12#3)(2005-5#2)(2005-6#1)(2005-7#9)(2005-8#6)(2005-9#3)(2006-10#29)(2006-11#10)(2006-12#8)(2006-2#2)(2006-3#4)(2006-4#3)(2006-5#5)(2006-6#6)(2006-7#7)(2006-8#10)(2006-9#1)(2007-1#3)(2007-10#4)(2007-11#43)(2007-12#15)(2007-2#2)(2007-3#3)(2007-4#10)(2007-5#3)(2007-7#7)(2007-8#8)(2007-9#4)(2008-1#19)(2008-10#42)(2008-11#99)(2008-12#10)(2008-2#12)(2008-3#18)(2008-4#88)(2008-5#61)(2008-6#10)(2008-7#25)(2008-8#55)(2008-9#45)(2009-1#1)(2009-10#7)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#8)(2009-4#15)(2009-5#9)(2009-6#5)(2009-7#15)(2009-8#7)(2009-9#9)(2010-1#4)(2010-10#5)(2010-11#5)(2010-12#23)(2010-2#10)(2010-3#4)(2010-4#3)(2010-5#9)(2010-6#4)(2010-7#9)(2010-8#6)(2010-9#3)(2011-1#33)(2011-12#1)(2011-2#34)(2011-3#1)(2012-1#26)(2012-11#7)(2012-12#44)(2012-2#25)(2012-3#18)(2012-7#1)(2013-1#55)(2013-7#8)(2013-8#24)
of human-SCID chimeric##2##3##(2008-4#2)
of human-human hybridoma##2##3##(2008-11#2)
of human-human##3##2##(2008-11#3)
of humanangiopoietin-1##2##2##(2008-8#2)
of humanity##3##2##(2008-11#1)(2008-5#1)(2008-7#1)
of humanized##2##2##(1997-2#1)(2008-10#1)
of humankind##2##2##(2007-9#1)(2011-1#1)
of humans and animals##5##4##(1991-8#1)(1993-2#1)(2008-11#1)(2008-5#1)(2011-2#1)
of humans and mice##2##4##(2008-10#1)(2012-2#1)
of humans and other mammals##2##5##(1995-8#1)(2011-2#1)
of humans and other##3##4##(1991-8#1)(1995-8#1)(2011-2#1)
of humans and##20##3##(1991-8#2)(1992-11#1)(1993-12#1)(1993-2#1)(1995-8#1)(2004-4#3)(2006-7#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#2)(2011-2#3)(2012-2#1)
of humans or##2##3##(2010-4#1)(2012-1#1)
of humans to##6##3##(1992-3#1)(1993-3#1)(1994-5#1)(2007-3#1)(2008-7#1)(2011-2#1)
of humans with##4##3##(1994-3#1)(2008-5#1)(2012-2#1)(2013-8#1)
of humans##62##2##(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-3#2)(1995-8#1)(1996-11#4)(1997-1#1)(1997-5#2)(2004-4#3)(2005-8#1)(2006-7#1)(2007-12#1)(2007-3#4)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-10#1)(2009-4#1)(2010-12#2)(2010-4#1)(2011-2#5)(2012-1#1)(2012-2#5)(2013-7#1)(2013-8#2)
of humans'##2##2##(2009-3#1)(2011-1#1)
of humeral##6##2##(2007-11#1)(2007-8#2)(2008-12#1)(2009-3#1)(2012-2#1)
of humerus in##2##3##(2010-11#1)(2012-2#1)
of humerus##6##2##(2007-11#1)(2009-2#2)(2010-11#1)(2011-12#1)(2012-2#1)
of humic acid##7##3##(2008-10#6)(2013-8#1)
of humic acids (HA)##3##4##(2008-10#3)
of humic acids##9##3##(2008-10#9)
of humic and fulvic##2##4##(2008-10#1)(2008-3#1)
of humic compounds present in the##2##6##(2008-10#2)
of humic compounds##4##3##(2008-10#4)
of humic substances (HS)##2##4##(2008-10#2)
of humic substances were##2##4##(1992-5#1)(2008-10#1)
of humic substances##12##3##(1992-5#4)(2005-11#1)(2008-10#7)
of humic##39##2##(1992-5#4)(2005-11#1)(2008-10#32)(2008-3#1)(2013-8#1)
of humid##2##2##(1994-3#1)(2010-7#1)
of humidity on the##2##4##(2008-10#2)
of humidity on##4##3##(1992-4#1)(2008-10#3)
of humidity were##2##3##(2008-10#2)
of humidity##10##2##(1992-4#1)(2008-10#6)(2008-2#1)(2008-3#1)(2012-2#1)
of hummingbird##2##2##(2008-8#1)(2008-9#1)
of humor for##2##3##(2008-10#2)
of humor##8##2##(2008-10#4)(2008-12#1)(2010-7#1)(2011-2#2)
of humoral and cellular##4##4##(1997-3#1)(2006-10#1)(2007-9#1)(2008-4#1)
of humoral defense##2##3##(1994-8#1)(2008-11#1)
of humoral immune response##3##4##(1997-8#1)(2012-1#1)(2012-2#1)
of humoral immune##4##3##(1997-8#1)(2008-10#1)(2012-1#1)(2012-2#1)
of humoral immunity##9##3##(1993-12#1)(1995-12#1)(1996-10#2)(1997-6#1)(2007-2#1)(2008-4#1)(2008-7#1)(2011-1#1)
of humoral##23##2##(1991-5#1)(1993-12#2)(1993-3#1)(1994-8#1)(1995-12#1)(1996-10#2)(1997-3#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2011-1#1)(2012-1#1)(2012-2#1)
of humour##2##2##(2008-11#1)(2011-1#1)
of hundreds of thousands of##3##5##(2005-11#1)(2008-7#1)(2009-9#1)
of hundreds of##19##3##(1991-9#1)(1995-1#1)(2005-11#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-9#1)(2010-5#1)(2013-8#2)
of hundreds##20##2##(1991-9#1)(1995-1#1)(2005-11#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-11#1)(2009-9#1)(2010-5#1)(2013-8#2)
of hunger and satiety##3##4##(2009-12#1)(2012-1#2)
of hunger##4##2##(2009-12#2)(2012-1#2)
of hus1+##3##2##(1997-4#3)
of husbandry parameters on the##3##5##(2008-11#3)
of husbandry##4##2##(2008-11#3)(2008-3#1)
of hyaline cartilage##3##3##(2005-12#1)(2008-5#1)(2013-8#1)
of hyaline##6##2##(1991-8#1)(1994-6#1)(2005-12#1)(2007-8#1)(2008-5#1)(2013-8#1)
of hyaline-like##2##2##(2007-11#1)(2012-12#1)
of hyaluronan (HA)##2##3##(2005-8#1)(2013-7#1)
of hyaluronan and##2##3##(2007-3#1)(2013-7#1)
of hyaluronan in##2##3##(1993-6#1)(2011-1#1)
of hyaluronan synthase##2##3##(1994-2#1)(2007-12#1)
of hyaluronan##20##2##(1993-6#2)(1994-11#1)(1994-2#1)(2005-8#1)(2007-12#1)(2007-3#3)(2008-10#2)(2010-12#1)(2011-1#6)(2013-7#2)
of hyaluronic acid (HA)##3##4##(2008-10#1)(2008-11#1)(2011-12#1)
of hyaluronic acid##11##3##(2006-4#1)(2007-7#1)(2008-10#2)(2008-11#1)(2010-10#1)(2011-12#1)(2012-2#1)(2013-1#3)
of hyaluronic##12##2##(2006-4#1)(2006-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2010-10#1)(2011-12#1)(2012-2#1)(2013-1#3)
of hyaluronidase##2##2##(2008-10#1)(2010-12#1)
of hybrid and parental##2##4##(2008-12#2)
of hybrid and##5##3##(1991-4#1)(2008-12#2)(2008-3#1)(2008-8#1)
of hybrid goats##2##3##(2010-4#2)
of hybrid imaging##2##3##(2008-6#1)(2012-2#1)
of hybrid molecular nanosomal compositions##2##5##(2010-12#2)
of hybrid poplar##2##3##(2008-10#1)(2008-5#1)
of hybrid##45##2##(1990-10#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-4#1)(1991-5#1)(1994-12#1)(1995-10#1)(1995-5#2)(1995-8#2)(2005-11#1)(2006-10#1)(2008-10#3)(2008-12#2)(2008-3#4)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-12#4)(2010-3#1)(2010-4#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
of hybridization and##3##3##(2008-8#1)(2010-4#1)(2012-3#1)
of hybridization between the##3##4##(2008-10#1)(2010-8#1)(2012-3#1)
of hybridization between##4##3##(2008-10#1)(2010-3#1)(2010-8#1)(2012-3#1)
of hybridization in##2##3##(2008-8#1)(2012-3#1)
of hybridization##25##2##(1990-2#1)(1993-3#1)(1993-9#2)(1994-3#1)(1995-3#1)(1996-12#1)(1996-7#1)(1997-6#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2010-3#1)(2010-4#1)(2010-8#1)(2012-3#4)(2013-1#1)
of hybridoma and##6##3##(1994-11#5)(2008-11#1)
of hybridoma cell##3##3##(1994-11#1)(2008-11#1)(2012-3#1)
of hybridoma cells in##2##4##(1994-2#1)(2008-11#1)
of hybridoma cells##10##3##(1994-11#1)(1994-2#1)(1994-5#1)(2008-11#7)
of hybridoma culture##2##3##(1990-12#1)(2008-11#1)
of hybridoma cultures##2##3##(1991-11#1)(2008-11#1)
of hybridoma##28##2##(1990-12#1)(1991-11#1)(1992-8#1)(1994-11#7)(1994-2#1)(1994-5#3)(1997-4#1)(2008-11#12)(2012-3#1)
of hybridomas produced against cell surface antigens##2##7##(1992-8#2)
of hybridomas secreting##2##3##(1991-2#1)(1992-8#1)
of hybridomas##12##2##(1991-2#1)(1992-7#1)(1992-8#4)(2008-11#3)(2008-4#3)
of hybrids between the##2##4##(2008-9#1)(2010-10#1)
of hybrids between##3##3##(2008-9#2)(2010-10#1)
of hybrids with##2##3##(1995-8#1)(2013-1#1)
of hybrids##11##2##(1995-8#1)(1996-6#1)(2008-10#5)(2008-9#2)(2010-10#1)(2013-1#1)
of hydantoins##2##2##(1994-9#2)
of hydatid cyst of the##3##5##(1991-5#1)(2008-12#1)(2008-3#1)
of hydatid cyst of##4##4##(1991-5#1)(2007-7#1)(2008-12#1)(2008-3#1)
of hydatid cyst##9##3##(1991-10#2)(1991-5#1)(2007-7#2)(2008-12#2)(2008-3#1)(2010-11#1)
of hydatid cysts##2##3##(1991-8#1)(2006-5#1)
of hydatid disease##7##3##(2006-5#1)(2007-2#1)(2007-7#1)(2008-7#1)(2011-2#2)(2013-1#1)
of hydatid##21##2##(1991-10#2)(1991-5#1)(1991-8#1)(2006-5#2)(2007-2#1)(2007-6#2)(2007-7#3)(2008-12#3)(2008-3#1)(2008-7#1)(2010-11#1)(2011-2#2)(2013-1#1)
of hydatidiform##2##2##(2007-8#1)(2012-2#1)
of hydatidosis##3##2##(2010-12#1)(2011-1#1)(2011-2#1)
of hydrated##9##2##(1991-9#1)(1992-7#1)(2006-10#2)(2006-4#2)(2008-10#1)(2011-1#1)(2011-12#1)
of hydrating##2##2##(2007-8#1)(2008-5#1)
of hydration and##2##3##(2008-5#1)(2012-12#1)
of hydration free energy##2##4##(2006-10#1)(2012-11#1)
of hydration free##3##3##(2006-10#1)(2010-2#1)(2012-11#1)
of hydration of the##3##4##(1995-5#1)(1997-7#1)(2008-5#1)
of hydration of##5##3##(1995-11#1)(1995-5#1)(1997-7#1)(2005-11#1)(2008-5#1)
of hydration water##2##3##(2008-10#1)(2010-9#1)
of hydration##22##2##(1991-11#1)(1995-1#1)(1995-11#1)(1995-5#1)(1997-7#1)(2004-9#1)(2005-11#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-5#3)(2008-7#1)(2010-2#1)(2010-9#1)(2012-11#1)(2012-12#3)(2013-8#1)
of hydraulic##4##2##(2008-10#1)(2008-8#1)(2009-8#1)(2013-1#1)
of hydrazine and phenylhydrazine in##2##5##(2008-10#2)
of hydrazine and phenylhydrazine##4##4##(2008-10#4)
of hydrazine and##7##3##(2008-10#7)
of hydrazine at##3##3##(2008-10#3)
of hydrazine by##2##3##(2008-10#2)
of hydrazine in##7##3##(2008-10#6)(2010-5#1)
of hydrazine with##3##3##(2008-10#2)(2013-1#1)
of hydrazine##33##2##(1996-5#1)(2008-10#28)(2008-11#1)(2010-5#2)(2013-1#1)
of hydrazine-intercalated kaolinite##2##3##(2005-11#2)
of hydride transfer##3##3##(1990-5#2)(1994-11#1)
of hydride##6##2##(1990-5#2)(1994-11#1)(1997-7#1)(2008-10#2)
of hydrocarbon chains##3##3##(1991-2#2)(2008-11#1)
of hydrocarbon##10##2##(1990-3#1)(1991-2#2)(1992-7#3)(2006-12#1)(2008-11#1)(2011-1#1)(2012-2#1)
of hydrocarbons and organochlorine compounds##2##5##(1991-8#2)
of hydrocarbons and##5##3##(1991-8#3)(1992-3#1)(1992-5#1)
of hydrocarbons by##2##3##(2008-10#1)(2011-1#1)
of hydrocarbons from##5##3##(1991-4#2)(2008-10#2)(2008-6#1)
of hydrocarbons in##4##3##(2006-12#1)(2008-10#2)(2008-11#1)
of hydrocarbons##27##2##(1991-2#1)(1991-4#2)(1991-8#3)(1992-3#2)(1992-5#1)(2005-12#1)(2006-12#1)(2007-3#1)(2007-9#1)(2008-10#10)(2008-11#1)(2008-6#2)(2011-1#1)
of hydrocephalus and##2##3##(2006-4#1)(2008-7#1)
of hydrocephalus##12##2##(2005-10#2)(2006-12#1)(2006-4#2)(2006-8#2)(2008-5#1)(2008-7#3)(2011-2#1)
of hydrochloric acid (HCl)##2##4##(2007-8#1)(2008-10#1)
of hydrochloric acid##10##3##(1990-2#1)(2005-11#1)(2007-8#1)(2008-10#7)
of hydrochloric##12##2##(1990-2#1)(2005-11#1)(2007-8#1)(2008-10#9)
of hydrochlorothiazide and indapamide on##2##5##(2011-2#2)
of hydrochlorothiazide in##3##3##(2008-10#2)(2011-3#1)
of hydrochlorothiazide with##2##3##(2008-10#1)(2011-2#1)
of hydrochlorothiazide##12##2##(1996-9#1)(2008-10#5)(2011-2#3)(2011-3#2)(2012-1#1)
of hydrocortisone and##3##3##(2007-11#2)(2010-12#1)
of hydrocortisone##7##2##(1991-3#1)(1994-11#1)(2007-11#2)(2010-12#1)(2011-3#1)(2012-3#1)
of hydrocyclone##2##2##(2008-11#1)(2012-3#1)
of hydrodynamic##6##2##(1995-11#1)(1995-2#1)(2007-10#1)(2008-10#1)(2008-2#1)(2011-2#1)
of hydrodynamics##2##2##(1992-1#1)(2007-10#1)
of hydrofluoric acid##4##3##(2008-10#3)(2013-1#1)
of hydrofluoric##5##2##(2008-10#4)(2013-1#1)
of hydrogel##5##2##(2005-11#2)(2008-10#1)(2008-5#1)(2009-12#1)
of hydrogels##7##2##(2005-11#1)(2008-5#1)(2008-8#2)(2009-9#1)(2010-10#1)(2013-7#1)
of hydrogen and##2##3##(2007-12#1)(2008-3#1)
of hydrogen bond##3##3##(1991-10#1)(2008-8#1)(2012-3#1)
of hydrogen bonding interactions##2##4##(2009-12#1)(2010-7#1)
of hydrogen bonding with##2##4##(1993-11#1)(2010-4#1)
of hydrogen bonding##10##3##(1991-1#1)(1992-9#1)(1993-11#1)(2005-11#1)(2008-10#1)(2008-4#1)(2009-12#1)(2009-3#1)(2010-4#1)(2010-7#1)
of hydrogen bonds to##2##4##(1995-11#1)(1996-5#1)
of hydrogen bonds##11##3##(1991-7#1)(1995-11#1)(1995-8#1)(1996-4#1)(1996-5#1)(1997-1#2)(2005-11#1)(2008-10#2)(2013-7#1)
of hydrogen desorption via the##2##5##(2008-10#2)
of hydrogen desorption##3##3##(2008-10#3)
of hydrogen from##2##3##(1991-3#1)(2008-6#1)
of hydrogen gas on the plasma##2##6##(2008-10#2)
of hydrogen gas##6##3##(1997-7#1)(2008-10#3)(2008-2#1)(2010-7#1)
of hydrogen ion##4##3##(1993-12#1)(2008-10#3)
of hydrogen ions##6##3##(2007-12#1)(2008-10#4)(2012-1#1)
of hydrogen peroxide (H(2)O(2))##4##4##(2008-10#3)(2009-8#1)
of hydrogen peroxide (H2O2)##4##4##(1994-10#1)(1995-3#1)(1997-1#1)(2008-4#1)
of hydrogen peroxide and##14##4##(1990-3#1)(1992-7#1)(2007-10#1)(2008-10#9)(2008-8#1)(2010-2#1)
of hydrogen peroxide at##3##4##(2008-10#3)
of hydrogen peroxide by##3##4##(2008-10#2)(2011-2#1)
of hydrogen peroxide formed##2##4##(1990-1#1)(2008-10#1)
of hydrogen peroxide in rainwater##4##5##(2008-10#4)
of hydrogen peroxide in snow##2##5##(2008-10#2)
of hydrogen peroxide in the##4##5##(2008-10#4)
of hydrogen peroxide in##16##4##(1996-5#1)(2008-10#15)
of hydrogen peroxide on##2##4##(2005-11#1)(2008-10#1)
of hydrogen peroxide using##3##4##(2008-10#2)(2008-5#1)
of hydrogen peroxide was##3##4##(1994-3#1)(2008-10#2)
of hydrogen peroxide with##4##4##(1991-9#1)(1996-2#1)(2008-10#2)
of hydrogen peroxide##101##3##(1990-1#1)(1990-3#1)(1991-5#1)(1991-9#3)(1992-11#3)(1992-7#1)(1994-10#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-1#1)(2005-11#3)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#67)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-8#1)
of hydrogen peroxide)##2##3##(2008-10#1)(2013-1#1)
of hydrogen storage materials##2##4##(2010-4#2)
of hydrogen sulfide (H2S)##2##4##(2006-8#1)(2007-12#1)
of hydrogen sulfide on##2##4##(2005-11#1)(2013-8#1)
of hydrogen sulfide##11##3##(2005-11#4)(2006-8#1)(2007-12#2)(2008-10#2)(2011-1#1)(2013-8#1)
of hydrogen was##3##3##(1993-2#1)(2008-10#2)
of hydrogen with##2##3##(2006-4#1)(2007-12#1)
of hydrogen##207##2##(1990-1#1)(1990-3#1)(1991-1#1)(1991-10#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#3)(1992-11#3)(1992-12#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-10#1)(1994-2#1)(1994-3#3)(1994-5#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-2#2)(1996-4#1)(1996-5#2)(1996-7#1)(1997-1#3)(1997-7#2)(2005-11#10)(2006-4#1)(2006-8#6)(2007-10#1)(2007-11#1)(2007-12#6)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#95)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#4)(2008-6#4)(2008-7#1)(2008-8#2)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#4)(2010-7#3)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#1)(2012-8#1)(2013-1#1)(2013-7#1)(2013-8#1)
of hydrogen-bonding##2##2##(1993-11#1)(2008-10#1)
of hydrogen-loaded##3##2##(2007-12#3)
of hydrogenase##3##2##(1990-11#1)(1992-3#1)(1994-11#1)
of hydrogenases##4##2##(1994-5#2)(2006-8#2)
of hydrolase##2##2##(1992-6#1)(2008-7#1)
of hydrolysis and##2##3##(1990-11#1)(1994-5#1)
of hydrolysis of these##2##4##(2007-6#1)(2009-2#1)
of hydrolysis of this##2##4##(1992-5#1)(2008-11#1)
of hydrolysis of##21##3##(1990-11#1)(1990-4#1)(1990-5#1)(1992-11#1)(1992-12#1)(1992-5#2)(1992-7#1)(1993-6#2)(1994-11#1)(1994-5#1)(2005-12#1)(2007-6#1)(2008-11#1)(2008-5#2)(2008-6#1)(2009-2#1)(2009-4#1)(2010-8#1)
of hydrolysis were##2##3##(2008-10#1)(2008-5#1)
of hydrolysis##47##2##(1990-11#2)(1990-4#1)(1990-5#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-5#2)(1992-7#1)(1993-6#3)(1994-11#1)(1994-3#1)(1994-5#2)(1994-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(2005-12#1)(2007-6#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-5#4)(2008-6#1)(2008-8#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
of hydrolytic enzymes that##2##4##(1992-3#1)(2012-2#1)
of hydrolytic enzymes##3##3##(1992-3#1)(2005-7#1)(2012-2#1)
of hydrolytic##5##2##(1990-4#1)(1992-3#1)(2005-7#1)(2010-9#1)(2012-2#1)
of hydrolytically degradable##2##3##(2010-10#1)(2010-2#1)
of hydrolytically##3##2##(1991-4#1)(2010-10#1)(2010-2#1)
of hydrolyzable metal ions##2##4##(2005-11#2)
of hydrolyzed potato##2##3##(2008-5#1)(2010-4#1)
of hydrolyzed##5##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)
of hydrometra##2##2##(1993-1#2)
of hydronephrosis##3##2##(2008-10#2)(2008-4#1)
of hydroperoxides##5##2##(1990-5#2)(1995-2#1)(1996-5#1)(2009-7#1)
of hydrophilic compounds##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
of hydrophilic##27##2##(1990-8#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-6#2)(1995-8#1)(1997-1#1)(2005-11#2)(2005-9#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2012-12#1)(2013-8#1)
of hydrophobic amino acids##3##4##(1994-3#1)(2010-12#2)
of hydrophobic and##3##3##(1990-12#1)(1995-4#1)(1995-6#1)
of hydrophobic interaction##3##3##(2008-10#2)(2013-1#1)
of hydrophobic materials##2##3##(2006-1#2)
of hydrophobic molecules##2##3##(2005-11#2)
of hydrophobic residues##4##3##(1992-6#1)(1994-5#1)(1994-9#1)(1995-3#1)
of hydrophobic sites##2##3##(1990-5#1)(1994-9#1)
of hydrophobic surface##2##3##(1991-2#1)(1992-6#1)
of hydrophobic surfaces##4##3##(1992-12#1)(1995-3#2)(1997-4#1)
of hydrophobic##59##2##(1990-12#1)(1990-5#2)(1991-2#1)(1992-12#1)(1992-6#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-9#3)(1995-3#3)(1995-4#2)(1995-6#2)(1996-1#2)(1996-7#1)(1997-4#1)(1997-6#1)(2005-11#7)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#1)(2008-10#5)(2008-5#1)(2008-8#1)(2009-2#1)(2009-9#1)(2010-12#4)(2010-2#2)(2010-4#1)(2012-2#1)(2013-1#2)
of hydrophobicity and##3##3##(1991-11#1)(1991-5#1)(1996-8#1)
of hydrophobicity of##2##3##(1993-3#1)(2008-7#1)
of hydrophobicity##12##2##(1990-2#1)(1991-10#1)(1991-11#1)(1991-5#1)(1991-8#1)(1992-11#1)(1993-3#1)(1996-8#1)(2008-5#2)(2008-7#1)(2011-1#1)
of hydropneumothorax with##2##3##(2008-7#1)(2012-2#1)
of hydroquinone in the##2##4##(2006-12#1)(2008-10#1)
of hydroquinone in##7##3##(2006-12#1)(2008-10#6)
of hydroquinone##21##2##(2006-12#3)(2008-10#15)(2008-5#1)(2008-6#1)(2011-1#1)
of hydrostatic pressure and temperature##2##5##(2008-2#1)(2008-3#1)
of hydrostatic pressure##6##3##(1991-10#1)(2006-10#1)(2008-2#1)(2008-3#3)
of hydrostatic##7##2##(1991-10#1)(2006-10#2)(2008-2#1)(2008-3#3)
of hydrothermal##3##2##(1996-2#1)(2007-7#1)(2008-10#1)
of hydrous##2##2##(2005-11#2)
of hydroxamic##2##2##(2008-10#1)(2008-5#1)
of hydroxide##7##2##(1991-7#1)(1994-8#1)(1997-3#1)(2008-10#4)
of hydroxo##2##2##(2005-11#1)(2008-10#1)
of hydroxy groups##2##3##(1992-7#1)(2008-10#1)
of hydroxy##6##2##(1992-7#1)(1993-4#1)(1995-8#1)(1996-6#1)(2007-11#1)(2008-10#1)
of hydroxyapatite (HA)##2##3##(2004-9#1)(2008-12#1)
of hydroxyapatite##19##2##(1990-8#1)(2004-9#6)(2007-5#2)(2008-12#1)(2008-5#3)(2009-7#4)(2010-1#1)(2013-8#1)
of hydroxyapatite-sol##2##2##(2004-9#2)
of hydroxybenzene##2##2##(2010-12#2)
of hydroxychloroquine##4##2##(2006-10#1)(2012-12#1)(2013-1#2)
of hydroxyeicosatetraenoic acids##2##3##(1991-2#1)(1993-9#1)
of hydroxyfarrerol##2##2##(1990-12#2)
of hydroxyl and##3##3##(2007-11#1)(2008-10#1)(2009-3#1)
of hydroxyl free radical##2##4##(1997-3#1)(2008-10#1)
of hydroxyl groups##3##3##(1996-6#1)(2008-10#2)
of hydroxyl radical from##2##4##(1991-9#1)(1992-3#1)
of hydroxyl radical in##3##4##(1991-9#1)(1996-2#1)(2008-10#1)
of hydroxyl radical with##2##4##(2008-9#2)
of hydroxyl radical##11##3##(1991-9#2)(1992-3#1)(1995-1#1)(1996-2#1)(1997-8#1)(2008-10#3)(2008-9#2)
of hydroxyl radicals (##2##4##(1991-9#1)(1995-12#1)
of hydroxyl radicals in##2##4##(1994-2#1)(2008-10#1)
of hydroxyl radicals##13##3##(1990-12#1)(1991-9#1)(1994-2#1)(1995-1#3)(1995-12#1)(1996-6#1)(1997-8#1)(2008-10#3)(2008-4#1)
of hydroxyl##38##2##(1990-12#1)(1990-9#1)(1991-9#3)(1992-3#1)(1994-2#1)(1994-6#1)(1995-1#4)(1995-12#1)(1995-6#1)(1996-2#1)(1996-6#2)(1997-3#1)(1997-8#2)(2007-11#1)(2007-12#1)(2008-10#11)(2008-3#1)(2008-4#1)(2008-9#2)(2009-3#1)
of hydroxylamine hydrochloride##2##3##(2008-10#2)
of hydroxylamine##5##2##(1992-7#1)(1994-11#1)(1997-6#1)(2008-10#2)
of hydroxylase##2##2##(1995-10#1)(2013-1#1)
of hydroxylated PCBs##2##3##(2009-3#2)
of hydroxylated##5##2##(1996-3#1)(2006-12#1)(2009-3#2)(2010-5#1)
of hydroxylation##2##2##(1992-11#1)(1994-8#1)
of hydroxyproline##5##2##(1992-12#1)(1992-8#1)(1995-1#1)(1995-2#1)(2011-2#1)
of hydroxypropylmethylcellulose and ethyl cellulose##2##5##(2010-5#2)
of hydroxysteroid##2##2##(1991-3#1)(1995-12#1)
of hydroxyurea##5##2##(1990-2#2)(1994-11#2)(1995-8#1)
of hydrozoan##2##2##(2010-2#1)(2010-6#1)
of hydrozoans##3##2##(2010-2#3)
of hygiene and##3##3##(2011-1#1)(2012-12#1)(2013-1#1)
of hygiene##9##2##(1994-5#1)(2009-4#4)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
of hygroscopic##3##2##(1994-12#1)(2008-5#1)(2013-1#1)
of hypaphorine##2##2##(2008-10#2)
of hyper##2##2##(2006-11#1)(2009-5#1)
of hyper- and##2##3##(2007-11#1)(2009-2#1)
of hyper-autofluorescence##2##2##(2012-12#2)
of hyperactivity and##2##3##(1996-6#1)(2008-2#1)
of hyperactivity##6##2##(1994-5#1)(1996-6#1)(2008-2#1)(2011-2#1)(2013-7#2)
of hyperacute##3##2##(2011-2#2)(2011-3#1)
of hyperalgesia##6##2##(1993-12#3)(1996-5#1)(2005-7#1)(2006-10#1)
of hyperandrogenic##3##2##(2008-1#3)
of hyperandrogenism##3##2##(2008-4#3)
of hyperbaric oxygen##2##3##(2008-8#1)(2009-3#1)
of hyperbaric##3##2##(2008-8#1)(2009-3#1)(2012-12#1)
of hyperbilirubinemia in##3##3##(2008-11#2)(2008-7#1)
of hypercalcaemia##4##2##(1990-9#1)(1992-10#1)(1997-3#1)(2011-1#1)
of hypercalcemia##5##2##(1991-12#1)(2005-3#1)(2008-1#1)(2008-6#2)
of hypercapnia##2##2##(2006-10#1)(2012-12#1)
of hypercapnic respiratory##2##3##(1990-10#1)(1997-4#1)
of hypercholesterolaemia and##2##3##(2006-12#1)(2013-8#1)
of hypercholesterolaemia##4##2##(1994-7#1)(2006-12#1)(2008-8#1)(2013-8#1)
of hypercholesterolemia and##2##3##(2006-5#1)(2010-10#1)
of hypercholesterolemia in##3##3##(1991-6#1)(1997-1#1)(2008-1#1)
of hypercholesterolemia was##2##3##(2006-7#1)(2011-2#1)
of hypercholesterolemia##20##2##(1991-12#1)(1991-2#2)(1991-6#2)(1993-9#1)(1995-9#1)(1996-12#1)(1997-1#2)(2006-5#2)(2006-7#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-8#2)(2010-10#1)(2011-2#1)
of hypercholesterolemia]##3##2##(1991-3#1)(1996-2#1)(1996-4#1)
of hypercoagulation##2##2##(2007-10#1)(2008-4#1)
of hypercortisolism##2##2##(1995-12#2)
of hyperemesis gravidarum##3##3##(1996-8#3)
of hyperexcitability##2##2##(2006-12#2)
of hyperfine##3##2##(1991-9#1)(1993-8#1)(2008-3#1)
of hyperfractionated##2##2##(1993-9#1)(1995-4#1)
of hyperglycaemia##3##2##(1996-12#1)(2007-11#1)(2008-1#1)
of hyperglycemia in##5##3##(2006-10#1)(2007-8#1)(2008-1#1)(2008-3#1)(2013-1#1)
of hyperglycemia on##2##3##(2008-1#1)(2010-7#1)
of hyperglycemia##24##2##(1991-7#1)(1993-2#1)(1994-6#1)(2005-10#1)(2006-10#1)(2007-8#1)(2008-1#6)(2008-11#1)(2008-3#4)(2010-10#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-2#1)(2013-1#1)
of hyperglycemic##2##2##(1994-2#1)(2010-11#1)
of hyperhomocysteinemia in##3##3##(2007-10#2)(2008-1#1)
of hyperhomocysteinemia with##2##3##(2008-3#2)
of hyperhomocysteinemia##13##2##(2007-10#2)(2008-1#1)(2008-3#10)
of hypericin and##2##3##(2012-12#1)(2013-8#1)
of hypericin##6##2##(2007-11#1)(2008-8#1)(2009-3#2)(2012-12#1)(2013-8#1)
of hyperimmune##6##2##(2007-11#2)(2008-8#4)
of hyperimmunes in##2##3##(2007-11#2)
of hyperimmunes##4##2##(2007-11#4)
of hyperinsulinaemia and##2##3##(1991-1#1)(2008-1#1)
of hyperinsulinaemia##3##2##(1991-1#1)(2008-1#2)
of hyperinsulinemia##4##2##(1990-7#1)(2007-5#1)(2008-3#1)(2011-2#1)
of hyperkalemia##2##2##(2007-7#1)(2008-5#1)
of hyperkeratosis##2##2##(2007-7#1)(2008-9#1)
of hyperkinetic disorder##2##3##(2006-10#1)(2008-4#1)
of hyperkinetic##4##2##(1990-9#1)(1991-8#1)(2006-10#1)(2008-4#1)
of hyperlipidaemia##5##2##(1990-2#2)(1993-9#1)(2007-11#1)(2008-11#1)
of hyperlipidemia and##3##3##(1993-9#1)(2006-10#1)(2008-4#1)
of hyperlipidemia##10##2##(1990-4#1)(1992-11#1)(1993-9#1)(1995-11#2)(2005-9#1)(2006-10#1)(2008-4#1)(2008-9#1)(2010-8#1)
of hyperlipoproteinaemias##2##2##(1990-9#2)
of hyperosmotic##2##2##(2008-11#2)
of hyperparathyroidism##6##2##(1996-9#1)(1997-6#1)(2005-12#2)(2010-12#1)(2013-1#1)
of hyperphosphatemia in patients##2##4##(2005-9#1)(2010-6#1)
of hyperpigmentation##3##2##(2008-5#2)(2012-12#1)
of hyperplasia and##2##3##(1996-4#2)
of hyperplasia##6##2##(1994-9#1)(1996-4#2)(2006-6#1)(2011-2#1)(2012-1#1)
of hyperpolarization-activated##2##2##(2012-2#2)
of hyperpolarized##3##2##(2006-1#1)(2012-1#2)
of hyperprolactinemia was##2##3##(2008-7#1)(2010-10#1)
of hyperprolactinemia##6##2##(2006-9#2)(2008-7#1)(2010-10#1)(2011-1#2)
of hyperreactive##3##2##(1990-8#1)(1994-12#2)
of hypersensitive##4##2##(1990-4#1)(1992-7#1)(1992-9#1)(2008-10#1)
of hypersensitivity reactions##2##3##(2008-8#2)
of hypersensitivity to##5##3##(1990-12#1)(1996-10#1)(2008-11#1)(2011-1#2)
of hypersensitivity##11##2##(1990-12#1)(1994-6#1)(1996-10#1)(2006-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#2)(2011-1#2)
of hypertension after##2##3##(1991-11#1)(2008-1#1)
of hypertension among##2##3##(2008-1#1)(2013-1#1)
of hypertension and atherosclerosis##2##4##(1996-8#1)(2008-7#1)
of hypertension and hyperlipidemia##2##4##(1994-5#1)(2008-1#1)
of hypertension and its##3##4##(1996-9#1)(2008-11#1)(2010-4#1)
of hypertension and renal##2##4##(1992-5#1)(2007-9#1)
of hypertension and##31##3##(1990-2#2)(1992-4#1)(1992-5#1)(1992-8#1)(1994-5#1)(1996-12#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#1)(2006-10#1)(2007-7#3)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#3)(2010-2#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)
of hypertension are##2##3##(2011-2#1)(2012-12#1)
of hypertension as an##2##4##(2008-8#1)(2012-2#1)
of hypertension as##4##3##(2007-7#1)(2008-8#1)(2012-2#1)(2013-1#1)
of hypertension in an urban##2##5##(2008-11#2)
of hypertension in diabetes##2##4##(1990-1#1)(2008-1#1)
of hypertension in different##2##4##(2008-1#1)(2008-11#1)
of hypertension in older adults##2##5##(1992-6#1)(1996-3#1)
of hypertension in older##3##4##(1992-6#1)(1995-10#1)(1996-3#1)
of hypertension in patients with##2##5##(2008-1#1)(2010-4#1)
of hypertension in patients##4##4##(1993-8#1)(2007-7#1)(2008-1#1)(2010-4#1)
of hypertension in renal##2##4##(1996-6#1)(2008-4#1)
of hypertension in the elderly]##5##5##(1990-2#1)(1992-6#2)(1992-8#1)(1993-3#1)
of hypertension in the##11##4##(1990-2#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-3#1)(1997-5#1)(2008-7#1)(2009-9#1)(2013-8#1)
of hypertension in this##2##4##(2008-1#1)(2011-1#1)
of hypertension in utero##2##4##(1993-2#1)(2009-8#1)
of hypertension in##49##3##(1990-1#1)(1990-2#1)(1991-6#1)(1992-6#4)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-10#2)(1996-3#1)(1996-6#2)(1996-9#1)(1997-3#1)(1997-5#1)(1997-6#1)(2006-1#1)(2007-7#2)(2008-1#7)(2008-11#7)(2008-4#2)(2008-7#1)(2009-8#1)(2009-9#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
of hypertension increases with##2##4##(2008-5#1)(2013-1#1)
of hypertension increases##3##3##(2008-5#1)(2013-1#1)(2013-8#1)
of hypertension is a##2##4##(1996-9#1)(2013-1#1)
of hypertension is##6##3##(1993-12#1)(1996-9#1)(2006-7#1)(2008-11#2)(2013-1#1)
of hypertension on the##2##4##(1990-2#1)(1991-11#1)
of hypertension on##5##3##(1990-2#1)(1991-11#1)(2008-1#1)(2008-7#1)(2010-4#1)
of hypertension was investigated##2##4##(1990-11#1)(1997-6#1)
of hypertension was##13##3##(1990-11#1)(1994-12#1)(1997-6#2)(2005-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-1#1)(2013-1#4)
of hypertension with##5##3##(2009-7#1)(2009-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
of hypertension##260##2##(1990-1#1)(1990-11#2)(1990-12#1)(1990-2#5)(1990-3#1)(1990-6#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#2)(1992-4#2)(1992-5#1)(1992-6#4)(1992-8#11)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#4)(1993-3#2)(1993-8#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#2)(1995-10#2)(1995-11#1)(1995-12#1)(1996-12#2)(1996-3#1)(1996-6#3)(1996-8#1)(1996-9#7)(1997-2#1)(1997-3#4)(1997-5#2)(1997-6#4)(1997-8#2)(2004-10#1)(2004-12#1)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#1)(2006-9#1)(2007-1#3)(2007-7#7)(2007-8#4)(2007-9#3)(2008-1#25)(2008-10#2)(2008-11#21)(2008-3#3)(2008-4#4)(2008-5#1)(2008-7#10)(2008-8#4)(2009-1#3)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#3)(2010-12#5)(2010-2#1)(2010-4#8)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-12#4)(2012-2#3)(2013-1#17)(2013-8#3)
of hypertension-related##3##2##(2005-6#1)(2007-8#1)(2012-12#1)
of hypertensive and##2##3##(2006-12#1)(2008-10#1)
of hypertensive disorders##3##3##(1990-6#2)(2008-4#1)
of hypertensive parents##3##3##(2013-8#3)
of hypertensive patients was##2##4##(2007-7#1)(2008-7#1)
of hypertensive patients##14##3##(1990-12#1)(1991-2#2)(1991-3#1)(1992-8#1)(2005-7#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#1)
of hypertensive rats##2##3##(1990-7#1)(1997-2#1)
of hypertensive##39##2##(1990-12#1)(1990-6#2)(1990-7#2)(1991-2#2)(1991-3#1)(1992-8#1)(1996-3#1)(1997-2#1)(1997-8#1)(2005-7#1)(2006-10#3)(2006-12#1)(2007-10#1)(2007-3#1)(2007-7#1)(2008-1#4)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#3)
of hypertensives##3##2##(1990-4#1)(1997-2#1)(2005-12#1)
of hyperthermia##8##2##(1994-10#1)(1994-4#1)(1996-10#1)(1996-3#1)(2007-11#2)(2008-11#1)(2010-12#1)
of hyperthyroid animals##2##3##(1991-9#2)
of hyperthyroid rats##2##3##(1990-8#2)
of hyperthyroid##4##2##(1990-8#2)(1991-9#2)
of hyperthyroidism on##2##3##(1990-8#1)(2007-9#1)
of hyperthyroidism##7##2##(1990-8#1)(2007-5#2)(2007-8#2)(2007-9#1)(2012-12#1)
of hypertonic saline on##2##4##(1993-12#1)(2012-12#1)
of hypertonic saline##12##3##(1991-3#1)(1992-7#1)(1993-12#4)(2006-12#1)(2008-5#1)(2008-9#1)(2009-10#1)(2012-12#2)
of hypertonic solutions##3##3##(1996-9#3)
of hypertonic##19##2##(1991-3#1)(1992-7#1)(1992-8#1)(1993-12#4)(1995-8#1)(1995-9#1)(1996-9#3)(2006-12#1)(2008-5#1)(2008-9#1)(2009-10#1)(2011-1#1)(2012-12#2)
of hypertriglyceridemia was##2##3##(2008-3#1)(2012-12#1)
of hypertriglyceridemia##8##2##(1991-8#1)(2006-7#1)(2008-3#1)(2012-12#1)(2013-1#4)
of hypertriglyceridemic patients##2##3##(1991-8#1)(1994-3#1)
of hypertrophic cardiomyopathy##2##3##(1997-7#1)(2008-4#1)
of hypertrophic growth##2##3##(1992-8#1)(1994-12#1)
of hypertrophic scarring in##2##4##(1991-2#2)
of hypertrophic scarring##3##3##(1991-2#2)(2006-12#1)
of hypertrophic##18##2##(1991-2#2)(1992-8#1)(1992-9#2)(1994-12#1)(1997-7#1)(2006-12#1)(2007-5#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#2)(2011-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
of hypertrophy##3##2##(1990-3#1)(1991-4#1)(2008-7#1)
of hyperuricemia and##2##3##(2007-7#1)(2008-7#1)
of hyperuricemia##5##2##(2007-7#1)(2008-5#1)(2008-7#3)
of hypervariable##2##2##(1992-11#1)(2011-2#1)
of hyperventilation##3##2##(1991-12#1)(2006-10#1)(2012-3#1)
of hyphae in##2##3##(2007-7#1)(2008-5#1)
of hyphae of##2##3##(2008-10#2)
of hyphae##16##2##(1997-4#1)(2007-7#1)(2008-10#8)(2008-5#1)(2009-3#1)(2010-10#1)(2010-2#1)(2011-1#2)
of hyphal growth##3##3##(1997-4#1)(2008-10#2)
of hyphal##10##2##(1997-4#1)(2008-10#7)(2009-3#1)(2009-8#1)
of hypnosis##4##2##(2009-9#4)
of hypnotic analgesia##2##3##(2010-2#2)
of hypnotic drugs##2##3##(1993-10#1)(2006-10#1)
of hypnotic##7##2##(1993-10#1)(2006-10#1)(2007-5#1)(2007-6#2)(2010-2#2)
of hypnotics##4##2##(1993-10#2)(1996-9#1)(2013-1#1)
of hypo- and##3##3##(1991-8#1)(1997-5#1)(2008-4#1)
of hypo-##4##2##(1991-8#2)(1997-5#1)(2008-4#1)
of hypo-and hyperthyroid##2##3##(1995-7#2)
of hypoalbuminemia##2##2##(2006-7#1)(2007-7#1)
of hypobaric hypoxia##2##3##(1996-12#2)
of hypocalcaemia##2##2##(1997-8#1)(2008-1#1)
of hypocalcemia and hypophosphatemia in malignancy##2##6##(1991-8#2)
of hypocalcemia##5##2##(1991-8#2)(2007-8#1)(2011-2#2)
of hypochlorite and##2##3##(2008-10#2)
of hypochlorite##8##2##(2007-7#1)(2008-10#7)
of hypocotyl##3##2##(1995-8#1)(2008-9#1)(2009-10#1)
of hypocrellin##2##2##(2008-8#2)
of hypodermic needles##2##3##(2005-7#1)(2013-8#1)
of hypoglycaemia awareness##3##3##(1991-8#1)(1994-7#2)
of hypoglycaemia during##2##3##(1991-8#1)(2011-1#1)
of hypoglycaemia##12##2##(1991-8#4)(1994-7#2)(1995-9#1)(2005-7#1)(2006-1#1)(2011-1#3)
of hypoglycemia can##2##3##(1997-2#1)(2007-5#1)
of hypoglycemia during##2##3##(2009-4#1)(2010-2#1)
of hypoglycemia in##2##3##(2007-9#1)(2010-6#1)
of hypoglycemia was##2##3##(1991-10#1)(2007-5#1)
of hypoglycemia##26##2##(1990-5#1)(1990-8#1)(1991-10#3)(1996-11#2)(1997-2#1)(1997-4#1)(2006-1#1)(2006-6#1)(2007-12#1)(2007-5#3)(2007-8#1)(2007-9#1)(2008-5#1)(2009-4#3)(2010-2#1)(2010-6#2)(2011-1#1)(2012-12#1)
of hypoglycemic symptoms##2##3##(1992-8#2)
of hypoglycemic##5##2##(1992-8#2)(2013-1#3)
of hypogonadal##2##2##(2008-1#1)(2008-3#1)
of hypointense##2##2##(2007-11#1)(2012-2#1)
of hypokalaemia##4##2##(1996-6#1)(2007-9#3)
of hypolipidemic drugs##2##3##(1995-6#1)(2010-12#1)
of hypolipidemic##3##2##(1995-6#1)(1996-8#1)(2010-12#1)
of hypomania##2##2##(1995-11#1)(2004-3#1)
of hyponatraemia##5##2##(1993-7#1)(2006-4#2)(2008-7#1)(2008-8#1)
of hyponatremia and##2##3##(2009-11#1)(2011-2#1)
of hyponatremia##4##2##(1990-9#1)(1996-7#1)(2009-11#1)(2011-2#1)
of hypoosmotic##2##2##(1992-1#1)(2008-11#1)
of hypoparathyroidism##4##2##(1997-8#1)(2012-1#1)(2013-8#2)
of hypopharyngeal##2##2##(2008-1#1)(2013-8#1)
of hypophosphatasia##3##2##(1992-7#1)(2009-11#2)
of hypophosphorylated##2##2##(1991-1#1)(2008-11#1)
of hypophysectomized##2##2##(1995-12#1)(1995-8#1)
of hypophysis##2##2##(2009-2#1)(2009-8#1)
of hypopituitarism##2##2##(2008-7#1)(2013-1#1)
of hypoplastic##2##2##(2007-8#1)(2010-6#1)
of hypospadia##4##2##(2013-1#4)
of hypospadias surgery##2##3##(2008-10#1)(2009-5#1)
of hypospadias will be##2##4##(2009-10#1)(2009-5#1)
of hypospadias##18##2##(2006-10#1)(2008-10#3)(2009-10#5)(2009-5#9)
of hypospadiology##2##2##(2009-5#2)
of hypotension and##3##3##(2005-7#1)(2006-10#1)(2009-12#1)
of hypotension in##4##3##(2006-10#1)(2008-1#1)(2011-12#1)(2011-2#1)
of hypotension##18##2##(1995-6#2)(2005-10#2)(2005-7#1)(2006-10#2)(2008-1#1)(2008-4#1)(2009-12#1)(2010-12#1)(2011-12#5)(2011-2#1)(2012-3#1)
of hypotensive episodes in##2##4##(1991-9#1)(2008-1#1)
of hypotensive episodes##5##3##(1991-9#1)(2007-7#1)(2008-1#3)
of hypothalamic CRF##2##3##(1993-7#1)(1995-12#1)
of hypothalamic CRH neurons##2##4##(1995-12#2)
of hypothalamic CRH##3##3##(1995-12#3)
of hypothalamic corticotropin-releasing factor neurons##2##5##(1993-7#1)(1994-2#1)
of hypothalamic growth hormone-releasing##2##4##(1991-9#1)(1995-5#1)
of hypothalamic##29##2##(1991-11#1)(1991-9#1)(1992-3#1)(1993-12#2)(1993-5#2)(1993-7#2)(1994-10#1)(1994-2#2)(1994-5#1)(1995-10#1)(1995-12#5)(1995-5#2)(1995-9#1)(1996-12#1)(1997-5#1)(1997-6#2)(2008-10#1)(2008-4#1)(2012-2#1)
of hypothalamic-pituitary function##2##3##(1991-2#1)(2008-4#1)
of hypothermia and##3##3##(1994-4#1)(2006-10#1)(2011-12#1)
of hypothermia in##2##3##(2006-10#1)(2013-7#1)
of hypothermia##25##2##(1993-12#1)(1993-8#1)(1994-4#1)(1994-5#2)(1995-3#1)(1996-12#1)(1997-1#1)(2004-8#1)(2005-8#1)(2006-10#5)(2007-10#2)(2008-8#3)(2008-9#1)(2010-12#1)(2010-9#1)(2011-12#1)(2013-7#1)
of hypothermic circulatory arrest##2##4##(2007-8#1)(2010-6#1)
of hypothermic##4##2##(1995-12#1)(2007-8#2)(2010-6#1)
of hypotheses regarding the##2##4##(2010-2#1)(2010-6#1)
of hypotheses##7##2##(1990-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-2#1)(2010-6#1)
of hypothesis##3##2##(1991-2#1)(1993-1#1)(2011-2#1)
of hypothesized##5##2##(2008-12#1)(2008-4#1)(2008-8#1)(2013-1#2)
of hypothetical##6##2##(1993-12#1)(1997-3#1)(2008-10#2)(2008-3#1)(2011-1#1)
of hypothyroid and hyperthyroid##2##4##(1995-7#1)(2007-8#1)
of hypothyroid##3##2##(1995-7#1)(2007-8#1)(2008-4#1)
of hypothyroidism and##3##3##(1996-8#1)(2006-10#1)(2008-4#1)
of hypothyroidism in##2##3##(2008-4#1)(2011-1#1)
of hypothyroidism##13##2##(1996-5#1)(1996-8#1)(2006-10#1)(2008-4#2)(2008-6#2)(2010-10#1)(2011-1#1)(2011-2#2)(2013-1#2)
of hypotonic##2##2##(1992-9#1)(1993-12#1)
of hypovirulence##7##2##(2008-10#5)(2008-9#2)
of hypovirulent isolate##2##3##(2008-10#2)
of hypovirulent##3##2##(2008-10#3)
of hypoxanthine and xanthine in late-gestation human amniotic fluid by reversed-phase high-performance liquid chromatography##2##14##(1990-11#2)
of hypoxanthine##8##2##(1990-11#3)(1991-12#1)(1991-2#1)(1994-8#1)(1995-1#1)(2011-1#1)
of hypoxemia and##2##3##(1993-3#1)(2012-2#1)
of hypoxemia##10##2##(1991-8#1)(1991-9#1)(1993-3#1)(2007-8#2)(2008-1#1)(2008-4#1)(2010-8#1)(2012-2#2)
of hypoxia and reoxygenation##2##4##(1990-7#1)(2007-9#1)
of hypoxia and##4##3##(1990-7#1)(2007-9#1)(2008-4#1)(2011-2#1)
of hypoxia in##2##3##(1993-6#1)(2005-9#1)
of hypoxia on the##2##4##(2009-9#1)(2013-1#1)
of hypoxia on##5##3##(1990-7#1)(1994-5#1)(2009-9#1)(2011-1#1)(2013-1#1)
of hypoxia##27##2##(1990-6#1)(1990-7#3)(1992-9#1)(1993-2#2)(1993-6#1)(1994-2#2)(1994-3#1)(1994-5#1)(1996-12#2)(2005-9#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-4#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#3)
of hypoxia-induced apoptosis##2##3##(2007-9#1)(2012-12#1)
of hypoxia-induced##3##2##(2007-9#1)(2012-12#1)(2013-1#1)
of hypoxia-inducible##2##2##(2010-5#1)(2012-12#1)
of hypoxic exposure##3##3##(2008-4#1)(2012-1#2)
of hypoxic##14##2##(1992-1#1)(1993-6#1)(1994-9#1)(2006-1#1)(2006-4#1)(2006-6#1)(2008-4#1)(2008-8#1)(2009-9#1)(2010-8#2)(2012-1#2)(2013-1#1)
of hypusine##3##2##(1992-7#2)(1994-3#1)
of hysterectomy and##2##3##(1995-12#1)(2010-12#1)
of hysterectomy with##2##3##(2010-12#1)(2013-1#1)
of hysterectomy##11##2##(1994-2#1)(1995-1#1)(1995-12#1)(1996-2#2)(2004-10#1)(2006-4#1)(2010-12#2)(2012-3#1)(2013-1#1)
of hysteresis in##2##3##(1992-9#1)(2008-7#1)
of hysteresis##4##2##(1990-8#1)(1992-9#1)(2005-11#1)(2008-7#1)
of hysteria##3##2##(2006-3#1)(2010-12#1)(2011-1#1)
of hysterical paralyses##2##3##(2006-3#2)
of hysterical##4##2##(1992-5#1)(2006-3#2)(2012-3#1)
of hysteroscopic##4##2##(1992-1#1)(1996-2#2)(2007-8#1)
of i##21##2##(1992-1#1)(1992-3#2)(1992-7#2)(1992-8#1)(1993-7#1)(1993-8#1)(1995-12#1)(1995-5#2)(1996-2#1)(1997-2#1)(1997-4#2)(2005-10#1)(2007-7#1)(2008-1#2)(2008-4#1)(2008-7#1)
of iNOS and##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
of iNOS gene##2##3##(2011-2#2)
of iNOS in##2##3##(2006-8#1)(2008-8#1)
of iNOS mRNA##2##3##(1993-8#1)(1995-12#1)
of iNOS may##3##3##(2011-1#1)(2012-2#2)
of iNOS##18##2##(1993-8#1)(1995-12#1)(1996-12#3)(1997-7#1)(2006-8#1)(2008-10#1)(2008-8#2)(2008-9#1)(2011-1#1)(2011-2#3)(2012-2#3)
of iNOSox##3##2##(1997-4#3)
of iNPH##2##2##(2013-8#2)
of iPads##6##2##(2013-1#6)
of iatrogenic complications##4##3##(1993-10#1)(1996-3#2)(2007-9#1)
of iatrogenic##25##2##(1993-10#2)(1996-3#4)(2006-10#1)(2006-11#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#2)(2008-7#2)(2009-5#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-7#2)
of ibandronic acid on##3##4##(2011-2#2)(2013-8#1)
of ibandronic acid##4##3##(2011-2#3)(2013-8#1)
of ibogaine##8##2##(1991-6#2)(1996-10#2)(1997-2#3)(1997-5#1)
of ibotenate##3##2##(1991-9#2)(1996-3#1)
of ibotenic acid##3##3##(1993-3#1)(1993-5#1)(1993-6#1)
of ibuprofen in pharmaceutical preparations##2##5##(2008-10#2)
of ibuprofen in##7##3##(1997-8#2)(2008-10#5)
of ibuprofen##21##2##(1990-6#3)(1991-3#1)(1993-11#1)(1997-8#4)(2005-9#1)(2008-10#6)(2008-5#1)(2010-5#1)(2012-12#3)
of ibutilide##4##2##(1993-3#4)
of ice crystals##4##3##(2007-11#2)(2008-3#2)
of ice##16##2##(1991-8#1)(1994-5#1)(2005-11#1)(2007-11#2)(2007-4#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#6)
of ice-like water##2##3##(2008-5#2)
of ice-like##3##2##(2008-5#3)
of iconic##2##2##(2010-5#2)
of icosahedral##2##2##(1995-2#1)(2008-10#1)
of idazoxan on##2##3##(1993-11#2)
of idazoxan##6##2##(1991-3#1)(1993-11#2)(1993-12#1)(1997-4#2)
of ideal body##2##3##(2006-7#1)(2007-12#1)
of ideal geometric representations of knots##2##6##(2006-4#2)
of ideal values##2##3##(2008-2#1)(2009-10#1)
of ideal##17##2##(2006-10#3)(2006-4#2)(2006-7#1)(2007-12#2)(2008-2#1)(2008-3#1)(2009-10#1)(2009-9#1)(2010-3#1)(2010-8#2)(2011-2#1)(2013-1#1)
of ideas and##2##3##(1996-1#1)(2005-6#1)
of ideas in##2##3##(2006-1#1)(2012-3#1)
of ideas that##2##3##(2009-3#1)(2010-7#1)
of ideas##19##2##(1991-1#1)(1995-5#1)(1996-1#1)(1997-3#1)(2005-6#1)(2006-1#1)(2006-10#1)(2006-3#2)(2008-1#1)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-7#1)(2012-1#1)(2012-3#1)
of ideas)##2##2##(2006-3#1)(2012-1#1)
of identical and##2##3##(2008-10#1)(2008-8#1)
of identical molecular##2##3##(1990-12#1)(1990-6#1)
of identical sequence##3##3##(1995-8#1)(1996-7#1)(1997-7#1)
of identical spheres##2##3##(2008-2#2)
of identical subunits##3##3##(1994-11#1)(1994-8#1)(1996-5#1)
of identical##41##2##(1990-10#1)(1990-12#1)(1990-4#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-4#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-7#1)(1997-9#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-5#1)(2013-1#1)
of identification and##5##3##(2008-10#3)(2009-10#1)(2009-8#1)
of identification is##2##3##(2010-4#1)(2013-8#1)
of identification of the##3##4##(2005-10#1)(2006-3#1)(2008-3#1)
of identification of##4##3##(1993-6#1)(2005-10#1)(2006-3#1)(2008-3#1)
of identification rate##2##3##(2013-8#2)
of identification##25##2##(1992-10#1)(1992-6#1)(1993-6#1)(1994-9#1)(1995-6#1)(2005-10#2)(2006-3#1)(2008-10#4)(2008-3#2)(2008-5#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-8#3)
of identified barriers##2##3##(2008-11#1)(2011-1#1)
of identified neurons in##2##4##(1996-12#1)(2008-11#1)
of identified neurons##5##3##(1996-12#1)(1997-3#1)(2007-12#1)(2008-11#1)(2012-2#1)
of identified proteins in##2##4##(2008-9#1)(2010-2#1)
of identified proteins##3##3##(2008-9#1)(2010-2#1)(2013-8#1)
of identified##25##2##(1990-7#1)(1991-3#1)(1992-1#1)(1992-8#1)(1996-12#1)(1996-9#1)(1997-3#1)(1997-6#1)(2004-2#1)(2006-9#1)(2007-11#1)(2007-12#3)(2007-6#1)(2008-11#2)(2008-9#1)(2009-5#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
of identifying additional##2##3##(2012-2#2)
of identifying and##2##3##(1996-5#1)(2006-10#1)
of identifying appropriate##2##3##(2006-6#1)(2013-8#1)
of identifying genes##2##3##(2008-4#1)(2008-9#1)
of identifying patients##3##3##(1993-5#1)(2013-1#2)
of identifying the##15##3##(1995-8#1)(2004-12#1)(2005-11#1)(2006-3#1)(2006-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-11#1)(2010-12#1)(2012-2#1)
of identifying those##2##3##(1993-9#1)(1994-12#1)
of identifying with the family##2##5##(2012-2#2)
of identifying with the##3##4##(2011-2#1)(2012-2#2)
of identifying##74##2##(1990-6#1)(1993-5#1)(1993-9#3)(1994-12#1)(1995-8#2)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-8#2)(2004-12#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-6#2)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-2#6)(2012-3#1)(2013-1#7)(2013-8#1)
of identity and##2##3##(2007-2#1)(2012-12#1)
of identity development##4##3##(2004-12#1)(2012-12#3)
of identity in##2##3##(2008-8#1)(2012-12#1)
of identity with##2##3##(1992-11#1)(1996-10#1)
of identity##35##2##(1991-2#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#1)(1994-12#1)(1996-10#2)(1996-2#1)(1996-8#1)(1997-2#1)(2004-12#1)(2007-2#1)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-7#2)(2010-1#1)(2012-12#7)(2012-2#2)(2013-7#1)
of idiopathic acute##2##3##(2006-10#1)(2013-1#1)
of idiopathic adhesive capsulitis##2##4##(2008-8#2)
of idiopathic interstitial pneumonia (IIP)##3##5##(2005-8#3)
of idiopathic interstitial pneumonia##7##4##(2005-8#3)(2010-12#2)(2012-12#2)
of idiopathic megacolon##2##3##(2013-1#2)
of idiopathic panuveitis##2##3##(2006-10#2)
of idiopathic pulmonary arterial hypertension##2##5##(2008-10#1)(2010-10#1)
of idiopathic pulmonary arterial##3##4##(2008-10#2)(2010-10#1)
of idiopathic pulmonary fibrosis##3##4##(2005-8#1)(2010-12#1)(2012-12#1)
of idiopathic pulmonary fibrosis]##2##4##(2010-12#2)
of idiopathic pulmonary##9##3##(2005-8#1)(2008-10#2)(2010-10#1)(2010-12#4)(2012-12#1)
of idiopathic scoliosis according to##2##5##(2007-7#2)
of idiopathic scoliosis has##2##4##(2007-11#1)(2007-8#1)
of idiopathic scoliosis is##3##4##(2007-8#3)
of idiopathic scoliosis##24##3##(2007-11#3)(2007-7#9)(2007-8#11)(2012-2#1)
of idiopathic##89##2##(1990-9#1)(1991-8#1)(1992-2#1)(1993-11#1)(1993-12#2)(1997-8#2)(2005-10#2)(2005-6#1)(2005-7#1)(2005-8#4)(2006-10#7)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-3#2)(2007-7#11)(2007-8#13)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#3)(2010-10#2)(2010-12#6)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#4)(2012-2#1)(2013-1#4)(2013-7#1)
of idiosyncratic##4##2##(1990-3#1)(2008-10#1)(2008-4#1)(2012-11#1)
of idler##2##2##(2007-11#1)(2007-12#1)
of iduronic##3##2##(1990-11#1)(1994-3#1)(1995-3#1)
of ifenprodil##4##2##(1996-2#2)(1997-3#2)
of ifosfamide and##2##3##(2008-6#2)
of ifosfamide##13##2##(1994-3#4)(2008-6#9)
of ignorance##3##2##(2007-6#1)(2009-10#1)(2010-4#1)
of ileal##12##2##(1990-3#2)(1991-9#1)(1992-8#2)(1993-11#1)(2004-12#1)(2006-10#1)(2007-9#1)(2008-7#1)(2012-12#1)(2013-1#1)
of ileum##7##2##(1991-3#1)(2008-10#2)(2008-12#3)(2009-5#1)
of iliofemoral vein thrombosis##2##4##(1997-8#2)
of iliofemoral##3##2##(1997-8#2)(2007-8#1)
of iliopsoas bursitis##3##3##(2006-10#3)
of ill health##2##3##(1997-3#1)(2006-10#1)
of ill##6##2##(1993-1#1)(1994-3#1)(1997-3#1)(1997-8#1)(2006-10#1)(2008-8#1)
of ill-conditioned##2##2##(2008-10#1)(2008-2#1)
of illegal drugs##2##3##(1991-8#1)(1996-6#1)
of illegal##4##2##(1991-8#1)(1996-6#1)(2008-10#1)(2013-1#1)
of illegitimate transcripts##2##3##(1991-7#2)
of illicit drug abuse##3##4##(2006-8#3)
of illicit drug use in patients##3##6##(2006-8#2)(2013-8#1)
of illicit drug use##7##4##(2006-7#1)(2006-8#4)(2009-5#1)(2013-8#1)
of illicit drug##12##3##(1997-2#1)(2006-7#1)(2006-8#7)(2008-10#1)(2009-5#1)(2013-8#1)
of illicit drugs##8##3##(1996-10#1)(1996-4#1)(2006-8#2)(2008-10#1)(2012-2#1)(2013-7#1)(2013-8#1)
of illicit##25##2##(1991-12#1)(1996-10#1)(1996-4#1)(1997-2#1)(2006-7#1)(2006-8#9)(2008-10#5)(2009-5#1)(2012-2#2)(2013-7#1)(2013-8#2)
of illiterate##2##2##(2009-9#1)(2011-12#1)
of illness and death##3##4##(1993-12#1)(2007-12#1)(2010-12#1)
of illness and treatment##2##4##(1996-1#1)(2012-3#1)
of illness and##18##3##(1990-12#2)(1992-2#1)(1993-12#3)(1994-2#1)(1995-4#1)(1996-1#2)(2005-10#1)(2006-9#1)(2007-12#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
of illness during##2##3##(1995-9#1)(1996-3#1)
of illness for a##2##4##(2006-8#1)(2010-10#1)
of illness for##3##3##(2006-8#1)(2009-3#1)(2010-10#1)
of illness have##2##3##(2006-10#1)(2010-1#1)
of illness in##8##3##(1991-4#1)(1993-12#1)(1993-3#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-5#1)(2011-2#1)
of illness is##2##3##(1993-2#1)(1995-5#1)
of illness of##2##3##(2007-2#1)(2010-9#1)
of illness or##2##3##(2007-11#1)(2012-2#1)
of illness was##3##3##(2005-8#1)(2008-3#1)(2011-11#1)
of illness which##2##3##(2007-2#1)(2011-2#1)
of illness##116##2##(1990-12#2)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#3)(1993-12#5)(1993-2#1)(1993-3#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-11#3)(1995-2#1)(1995-4#2)(1995-5#1)(1995-9#1)(1996-1#3)(1996-3#3)(1996-8#2)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#1)(2004-3#2)(2004-7#1)(2005-10#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#4)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2009-3#2)(2009-6#1)(2009-7#3)(2010-1#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-11#2)(2011-2#6)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#2)
of illnesses##12##2##(1991-3#1)(2006-10#3)(2008-4#1)(2008-7#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#2)
of illumination and reflection##2##4##(2008-2#1)(2008-3#1)
of illumination and##3##3##(2008-2#1)(2008-3#2)
of illumination by##4##3##(1997-2#1)(2008-2#2)(2008-3#1)
of illumination##21##2##(1994-3#1)(1997-2#1)(2007-12#3)(2008-2#5)(2008-3#7)(2008-9#3)(2011-1#1)
of illusions##2##2##(2012-11#1)(2012-2#1)
of illusory contours##2##3##(2008-9#2)
of illusory##4##2##(2007-12#1)(2008-9#3)
of illustration##7##2##(2008-10#2)(2008-11#1)(2010-8#4)
of iloprost##8##2##(1994-12#1)(2007-8#1)(2008-7#3)(2011-2#3)
of image acquisition and##2##4##(2007-11#1)(2010-2#1)
of image analysis##3##3##(2008-1#1)(2008-2#1)(2008-4#1)
of image and##2##3##(2004-9#1)(2012-2#1)
of image contrast##3##3##(2008-2#1)(2008-3#2)
of image data##7##3##(2008-1#1)(2008-2#1)(2008-9#3)(2009-9#1)(2010-6#1)
of image formation##6##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
of image processing##8##3##(2008-2#3)(2008-3#2)(2008-6#1)(2008-9#2)
of image quality##4##3##(1996-2#1)(1997-8#1)(2008-2#1)(2008-3#1)
of image reconstruction in##2##4##(2007-11#1)(2008-3#1)
of image reconstruction##3##3##(2007-11#1)(2008-3#1)(2008-7#1)
of image recovery##2##3##(2008-2#2)
of image sources##2##3##(2008-2#2)
of image##93##2##(1991-12#1)(1992-9#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-8#1)(2004-11#1)(2004-9#1)(2005-12#1)(2006-4#1)(2007-11#4)(2007-12#2)(2008-1#2)(2008-12#1)(2008-2#30)(2008-3#15)(2008-4#3)(2008-6#2)(2008-7#1)(2008-9#8)(2009-11#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#2)(2012-2#1)(2013-1#3)
of image-guided surgery and##2##4##(2006-10#1)(2012-2#1)
of image-guided surgery##4##3##(2006-10#1)(2009-12#2)(2012-2#1)
of image-guided##7##2##(2006-10#1)(2006-2#1)(2009-12#2)(2011-1#1)(2012-12#1)(2012-2#1)
of imagery)##2##2##(2013-8#2)
of images and video##2##4##(1997-8#1)(2008-6#1)
of images and##5##3##(1997-8#1)(2007-12#1)(2008-6#2)(2010-7#1)
of images are##2##3##(2006-8#1)(2008-2#1)
of images from##2##3##(2006-5#1)(2008-2#1)
of images in##3##3##(1991-2#1)(2008-3#2)
of images is##2##3##(2008-2#1)(2012-2#1)
of images obtained##3##3##(2008-5#1)(2008-7#1)(2011-1#1)
of images of the##2##4##(2008-10#1)(2008-2#1)
of images of##9##3##(1997-8#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2012-2#1)
of images reconstructed##2##3##(2008-2#1)(2008-3#1)
of images taken##3##3##(2008-2#1)(2008-3#1)(2010-4#1)
of images that##2##3##(2008-2#1)(2010-4#1)
of images with##4##3##(2008-2#3)(2008-3#1)
of images##72##2##(1991-2#1)(1997-8#3)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#24)(2008-3#12)(2008-5#3)(2008-6#2)(2008-7#1)(2009-2#1)(2010-4#2)(2010-7#1)(2010-9#1)(2011-1#1)(2012-11#1)(2012-2#2)(2013-1#5)
of imagination and##2##3##(1992-3#1)(2011-2#1)
of imagination##3##2##(1992-3#1)(2008-5#1)(2011-2#1)
of imagined##2##2##(1991-1#1)(2013-8#1)
of imaging and##5##3##(1997-6#1)(2007-4#1)(2008-3#2)(2009-11#1)
of imaging biological samples##2##4##(2008-2#1)(2008-4#1)
of imaging characteristics of##2##4##(2007-10#1)(2012-2#1)
of imaging data##2##3##(2005-8#2)
of imaging fiber bundles##2##4##(2008-3#2)
of imaging findings and##2##4##(2006-7#1)(2013-1#1)
of imaging in##6##3##(2007-11#1)(2007-5#1)(2008-9#1)(2009-4#2)(2010-5#1)
of imaging methods##2##3##(2008-12#1)(2012-2#1)
of imaging of##2##3##(2007-12#1)(2012-12#1)
of imaging services##2##3##(1995-12#1)(2007-4#1)
of imaging studies##6##3##(2006-10#1)(2007-4#2)(2007-7#1)(2007-8#1)(2012-11#1)
of imaging systems##3##3##(2007-12#1)(2009-9#1)(2012-2#1)
of imaging techniques in##3##4##(2007-5#1)(2008-2#1)(2008-3#1)
of imaging techniques##9##3##(1995-5#1)(2005-9#1)(2006-8#1)(2007-5#1)(2008-2#1)(2008-3#1)(2009-10#2)(2012-12#1)
of imaging tests##2##3##(2005-9#1)(2010-6#1)
of imaging the##4##3##(2007-11#2)(2008-2#1)(2012-2#1)
of imaging these##2##3##(2008-4#1)(2011-2#1)
of imaging##109##2##(1994-1#1)(1995-10#1)(1995-12#1)(1995-5#1)(1997-6#1)(2005-8#2)(2005-9#2)(2006-10#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-4#13)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#10)(2008-3#13)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#2)(2009-11#1)(2009-4#4)(2009-9#2)(2010-10#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#9)(2012-3#1)(2013-1#1)(2013-8#1)
of imatinib mesylate##2##3##(2006-6#1)(2009-4#1)
of imatinib resistance##2##3##(2008-1#1)(2012-12#1)
of imatinib##10##2##(2006-6#1)(2008-1#1)(2009-3#2)(2009-4#1)(2010-6#1)(2011-2#2)(2012-12#2)
of imazalil##2##2##(2008-10#2)
of imbalances##2##2##(2005-10#1)(2008-1#1)
of imidazo[4##2##2##(1997-2#2)
of imidazole derivatives##3##3##(2008-10#3)
of imidazole##12##2##(1990-9#1)(1993-3#1)(1994-5#4)(2008-10#6)
of imidazoline binding##2##3##(2005-7#2)
of imines##4##2##(2006-4#2)(2010-5#2)
of imipenem##2##2##(1993-5#1)(2006-12#1)
of imipramine and##3##3##(1990-5#2)(1996-1#1)
of imipramine##9##2##(1990-5#4)(1994-2#1)(1996-1#2)(2008-10#1)(2012-12#1)
of imiquimod##3##2##(2007-11#2)(2010-12#1)
of immature T cells##2##4##(2008-5#1)(2010-6#1)
of immature and##2##3##(2008-10#1)(2008-4#1)
of immature##30##2##(1990-11#1)(1992-12#1)(1994-10#1)(1994-11#1)(1995-3#1)(1995-5#2)(1996-2#1)(1997-9#1)(2007-12#1)(2007-7#2)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#5)(2008-7#2)(2008-8#1)(2009-7#1)(2010-6#1)(2012-12#1)(2013-7#1)
of immaturity of the##2##4##(2006-6#1)(2011-12#1)
of immaturity##3##2##(1995-3#1)(2006-6#1)(2011-12#1)
of immediate and delayed##2##4##(2006-10#1)(2012-7#1)
of immediate and##4##3##(1997-4#1)(2006-10#1)(2009-7#1)(2012-7#1)
of immediate early genes following##2##5##(1995-5#2)
of immediate early genes##9##4##(1993-6#1)(1994-12#2)(1994-8#1)(1995-11#1)(1995-5#2)(1996-1#1)(1997-8#1)
of immediate early##10##3##(1993-6#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-5#2)(1996-1#1)(1997-8#1)
of immediate hypersensitivity##2##3##(2008-10#1)(2013-1#1)
of immediate loading##2##3##(2008-4#1)(2010-12#1)
of immediate##40##2##(1990-3#1)(1990-5#1)(1992-8#1)(1993-6#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-5#3)(1996-1#1)(1997-4#1)(1997-8#1)(2005-12#1)(2006-10#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#2)(2009-10#1)(2009-2#1)(2009-7#1)(2010-1#1)(2010-12#1)(2012-11#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#4)
of immediate-early genes##5##3##(1993-4#1)(1994-9#1)(1996-12#1)(1997-3#1)(2008-7#1)
of immediately loaded single##2##4##(2008-4#1)(2013-1#1)
of immediately loaded##4##3##(2008-4#1)(2011-7#1)(2013-1#2)
of immediately##5##2##(2008-3#1)(2008-4#1)(2011-7#1)(2013-1#2)
of immense##3##2##(2005-11#1)(2008-4#1)(2009-4#1)
of immersion in##4##3##(2004-9#1)(2005-11#1)(2008-5#2)
of immersion##5##2##(2004-9#1)(2005-11#1)(2008-5#2)(2013-7#1)
of immigrant##12##2##(1992-5#1)(2005-10#1)(2006-12#1)(2008-11#1)(2008-8#2)(2009-3#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
of immigrants from##2##3##(1996-6#1)(1997-8#1)
of immigrants##11##2##(1992-1#1)(1993-3#1)(1993-9#1)(1995-5#1)(1996-6#1)(1997-2#1)(1997-8#1)(2008-8#1)(2008-9#1)(2010-7#2)
of immigration and##3##3##(1996-11#1)(2008-10#1)(2010-7#1)
of immigration##11##2##(1992-8#1)(1996-11#1)(2005-10#1)(2006-10#1)(2006-7#3)(2008-10#1)(2010-12#1)(2010-7#1)(2013-8#1)
of imminent##2##2##(1991-4#1)(2008-7#1)
of immiscible##2##2##(1993-5#1)(2006-12#1)
of immobilisation##2##2##(2008-10#2)
of immobilised##3##2##(1995-10#1)(2008-10#2)
of immobility and##2##3##(1995-5#1)(2007-11#1)
of immobility##6##2##(1995-5#1)(2007-11#2)(2007-9#3)
of immobilization##17##2##(1995-12#2)(1997-2#1)(2005-11#2)(2007-11#1)(2007-8#2)(2008-10#4)(2009-2#1)(2009-3#1)(2009-5#1)(2012-1#1)(2013-7#1)
of immobilized DNA##2##3##(2008-10#2)
of immobilized and##2##3##(2008-10#1)(2012-1#1)
of immobilized antibody##2##3##(1990-12#1)(2007-8#1)
of immobilized enzymes##3##3##(1992-11#1)(2006-10#2)
of immobilized granulocyte colony-stimulating factor##3##5##(2012-1#3)
of immobilized granulocyte##4##3##(2012-1#4)
of immobilized human plasminogen##2##4##(1993-8#2)
of immobilized human##3##3##(1993-8#3)
of immobilized hyaluronidase##2##3##(2010-12#2)
of immobilized nanometer TiO(2) for##2##5##(2008-10#2)
of immobilized oligonucleotides##2##3##(2012-1#2)
of immobilized protein##2##3##(2008-10#1)(2009-2#1)
of immobilized##56##2##(1990-12#1)(1990-5#1)(1992-11#2)(1993-8#3)(1994-11#2)(1994-5#1)(1995-3#2)(2004-9#1)(2005-11#1)(2006-10#2)(2006-9#1)(2007-8#2)(2008-10#21)(2008-11#1)(2008-12#1)(2008-4#2)(2009-2#2)(2010-11#1)(2010-12#2)(2012-1#7)
of immortalised##2##2##(2008-11#2)
of immortalized##4##2##(1996-1#1)(2008-11#2)(2012-1#1)
of immune activation##3##3##(1995-2#1)(1995-7#1)(2005-8#1)
of immune adaptation##2##3##(2008-1#2)
of immune and##4##3##(1996-11#1)(2006-10#1)(2007-2#1)(2013-7#1)
of immune cell##5##3##(2007-11#2)(2008-10#1)(2008-9#1)(2010-3#1)
of immune cells in the##2##5##(2006-8#1)(2012-3#1)
of immune cells in##3##4##(2006-8#1)(2008-9#1)(2012-3#1)
of immune cells to##2##4##(2008-3#1)(2011-2#1)
of immune cells##23##3##(1991-2#1)(1992-12#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-11#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-9#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
of immune complex glomerulonephritis##2##4##(2008-1#1)(2008-4#1)
of immune complex##6##3##(1996-5#1)(1997-8#1)(2006-4#2)(2008-1#1)(2008-4#1)
of immune complexes in##2##4##(1992-7#1)(2012-3#1)
of immune complexes##10##3##(1990-12#2)(1991-2#1)(1992-7#2)(1995-4#1)(2008-10#1)(2010-4#1)(2010-5#1)(2012-3#1)
of immune defects##2##3##(1996-10#1)(2013-8#1)
of immune defense against##2##4##(2008-4#1)(2008-8#1)
of immune defense##3##3##(2008-4#1)(2008-8#2)
of immune deficiency##2##3##(1993-8#1)(2009-4#1)
of immune dysfunction##2##3##(1990-11#1)(1991-9#1)
of immune dysregulation##2##3##(2006-10#1)(2007-2#1)
of immune function##11##3##(1991-1#1)(1995-12#1)(2006-1#1)(2007-11#2)(2008-10#2)(2008-4#2)(2008-9#1)(2011-1#1)
of immune functions##6##3##(1993-12#1)(1994-11#1)(1994-9#1)(1995-12#1)(2006-6#1)(2007-2#1)
of immune mechanisms##2##3##(2006-10#1)(2013-1#1)
of immune privilege in the##2##5##(2010-1#2)
of immune privilege##4##3##(2010-1#4)
of immune regulation##3##3##(2007-5#1)(2008-12#1)(2011-2#1)
of immune response and##2##4##(2011-1#1)(2012-12#1)
of immune response in##3##4##(1994-6#1)(2010-12#1)(2013-7#1)
of immune response to##3##4##(2006-10#1)(2008-4#1)(2009-3#1)
of immune response##16##3##(1992-9#1)(1994-6#2)(1996-4#1)(1997-8#1)(2006-10#2)(2007-7#1)(2008-4#1)(2009-3#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
of immune responses and##2##4##(1991-12#1)(2008-4#1)
of immune responses to##3##4##(2008-10#1)(2008-4#1)(2011-2#1)
of immune responses##17##3##(1991-12#1)(1992-6#1)(1992-7#1)(1994-8#1)(2006-5#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-4#2)(2009-10#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
of immune responsiveness##2##3##(1994-5#1)(1996-4#1)
of immune status##2##3##(2007-2#1)(2011-1#1)
of immune stimulating##2##3##(2008-10#1)(2008-4#1)
of immune suppression and##2##4##(1993-11#1)(2006-10#1)
of immune suppression##3##3##(1993-11#1)(2006-10#1)(2008-5#1)
of immune system##8##3##(2006-6#1)(2007-11#1)(2009-1#1)(2011-1#2)(2012-1#1)(2013-1#1)(2013-7#1)
of immune tolerance##6##3##(1995-1#1)(2006-10#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
of immune##197##2##(1990-11#1)(1990-12#2)(1991-1#1)(1991-12#2)(1991-2#2)(1991-9#2)(1992-10#1)(1992-12#1)(1992-6#1)(1992-7#3)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#2)(1995-12#3)(1995-2#2)(1995-4#1)(1995-7#1)(1996-10#3)(1996-11#2)(1996-4#2)(1996-5#1)(1997-8#2)(2003-11#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#8)(2006-4#2)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#12)(2007-12#1)(2007-2#4)(2007-5#2)(2007-7#2)(2007-8#2)(2008-1#6)(2008-10#10)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#10)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-8#1)(2010-1#5)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#7)(2011-12#1)(2011-2#4)(2012-1#3)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#8)(2013-7#6)(2013-8#3)
of immune-competent cells##2##3##(2006-10#1)(2006-2#1)
of immune-mediated ductopenic biliary diseases##2##5##(2006-2#2)
of immune-mediated hemolytic anemia##2##4##(1992-3#1)(1996-4#1)
of immune-mediated inflammatory diseases (IMID)##2##5##(2011-2#2)
of immune-mediated inflammatory diseases##6##4##(2011-2#6)
of immune-mediated inflammatory##8##3##(2008-10#1)(2011-2#6)(2012-1#1)
of immune-mediated##17##2##(1992-3#2)(1996-4#1)(2006-2#2)(2007-11#1)(2007-3#1)(2008-10#1)(2011-2#6)(2012-1#1)(2013-1#1)(2013-7#1)
of immunisation##3##2##(1997-3#1)(2006-4#1)(2009-5#1)
of immunity are##2##3##(2011-1#1)(2012-3#1)
of immunity in##4##3##(2005-9#1)(2007-11#1)(2007-8#1)(2009-12#1)
of immunity to##7##3##(1995-1#1)(2005-9#2)(2006-10#1)(2006-7#1)(2008-1#1)(2011-1#1)
of immunity##29##2##(1990-8#1)(1992-10#1)(1993-3#1)(1995-1#1)(2005-9#4)(2006-10#3)(2006-7#1)(2007-11#2)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-1#1)(2010-9#1)(2011-1#2)(2012-3#1)
of immunization and##2##3##(2008-10#1)(2010-12#1)
of immunization in##2##3##(1992-1#1)(2009-5#1)
of immunization with##4##3##(1992-6#1)(1995-5#1)(2008-12#1)(2011-2#1)
of immunization##27##2##(1992-1#3)(1992-10#2)(1992-6#1)(1992-8#1)(1995-5#2)(1996-12#2)(2006-10#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-12#2)(2011-2#1)(2013-1#2)
of immunizations##6##2##(1995-5#2)(1996-12#2)(2013-1#2)
of immunized animals##3##3##(1992-8#1)(1995-2#1)(2011-2#1)
of immunized mice##3##3##(2005-11#1)(2007-2#1)(2008-4#1)
of immunized##8##2##(1992-8#1)(1995-2#3)(2005-11#1)(2007-2#1)(2008-4#1)(2011-2#1)
of immunizing##4##2##(1996-1#1)(1996-12#2)(2006-10#1)
of immunoassay##2##2##(1994-10#1)(2008-11#1)
of immunoassays##3##2##(2008-12#1)(2008-4#1)(2011-1#1)
of immunoblot analyses##2##3##(1990-7#1)(1991-12#1)
of immunoblot##3##2##(1990-12#1)(1990-7#1)(1991-12#1)
of immunochemical##2##2##(1990-1#1)(1996-4#1)
of immunocompetent##2##2##(2008-4#1)(2013-8#1)
of immunocomplex##2##2##(1990-8#1)(2008-10#1)
of immunocompromised patients##3##3##(2011-2#1)(2013-1#1)(2013-8#1)
of immunocompromised##5##2##(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
of immunocontraceptives##3##2##(2007-11#3)
of immunocytes##2##2##(1995-12#1)(2007-12#1)
of immunocytochemical detection of##2##4##(1990-8#1)(2011-2#1)
of immunocytochemical##3##2##(1990-8#1)(1996-11#1)(2011-2#1)
of immunodeficiency and##4##3##(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)
of immunodeficiency virus##2##3##(2006-7#1)(2007-2#1)
of immunodeficiency viruses##2##3##(1991-5#1)(1992-12#1)
of immunodeficiency##16##2##(1991-5#2)(1992-12#1)(1995-2#1)(1996-11#1)(2005-11#1)(2006-7#1)(2007-12#1)(2007-2#4)(2008-10#1)(2008-11#1)(2008-4#1)(2012-12#1)
of immunodepression##4##2##(1991-5#3)(2013-1#1)
of immunodominant##2##2##(1997-7#2)
of immunofluorescence in##2##3##(2007-7#2)
of immunofluorescence##5##2##(2007-7#5)
of immunofluorescent##2##2##(2008-10#1)(2010-2#1)
of immunogenic regions in human##2##5##(1990-8#2)
of immunogenic##9##2##(1990-12#1)(1990-8#2)(1992-9#2)(1995-8#1)(2010-12#2)(2011-1#1)
of immunogenicity##9##2##(1990-12#1)(1995-5#2)(2007-11#1)(2008-10#4)(2013-8#1)
of immunoglobulin (Ig)##2##3##(2011-1#1)(2012-12#1)
of immunoglobulin A (IgA)##2##4##(2006-10#1)(2008-10#1)
of immunoglobulin A##5##3##(1990-8#1)(1994-12#1)(2006-10#1)(2008-10#2)
of immunoglobulin E (IgE)##2##4##(1995-2#1)(2009-2#1)
of immunoglobulin E##4##3##(1995-2#1)(2009-2#3)
of immunoglobulin G (IgG)##3##4##(1990-7#1)(2006-10#1)(2012-3#1)
of immunoglobulin G with affinity for##2##6##(1993-8#2)
of immunoglobulin G##12##3##(1990-7#1)(1991-3#1)(1993-8#2)(2006-10#1)(2008-1#1)(2008-4#3)(2008-7#1)(2009-9#1)(2012-3#1)
of immunoglobulin M and##2##4##(1995-3#1)(2008-4#1)
of immunoglobulin M##5##3##(1995-3#2)(1996-8#1)(2008-4#2)
of immunoglobulin and##2##3##(1995-1#1)(2012-12#1)
of immunoglobulin heavy chain##4##4##(1990-11#1)(1995-3#1)(2007-12#1)(2008-11#1)
of immunoglobulin light chain amyloidosis##2##5##(2010-4#2)
of immunoglobulin light##3##3##(1997-1#1)(2010-4#2)
of immunoglobulin variable##2##3##(1992-7#1)(2008-4#1)
of immunoglobulin##58##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-3#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-3#3)(1995-1#1)(1995-2#2)(1995-3#3)(1996-8#1)(1997-1#1)(2006-10#2)(2007-12#1)(2007-2#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#10)(2008-7#1)(2009-2#3)(2009-9#1)(2010-4#2)(2011-1#1)(2012-12#2)(2012-3#1)
of immunoglobulins and##6##3##(1995-12#1)(2007-2#2)(2008-11#1)(2008-4#1)(2008-5#1)
of immunoglobulins in##2##3##(2007-2#1)(2012-1#1)
of immunoglobulins##20##2##(1990-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-8#2)(1997-8#1)(2007-11#1)(2007-2#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-1#4)
of immunogold##3##2##(1997-6#1)(2006-12#1)(2007-12#1)
of immunohistochemical analysis##2##3##(1997-5#1)(2013-1#1)
of immunohistochemical and##3##3##(1992-11#1)(1996-9#1)(2008-5#1)
of immunohistochemical staining##3##3##(1991-9#1)(1994-7#1)(1996-12#1)
of immunohistochemical##15##2##(1991-4#1)(1991-9#1)(1992-11#1)(1994-7#1)(1995-11#1)(1996-12#2)(1996-9#1)(1997-5#1)(1997-8#1)(2007-11#1)(2007-2#1)(2008-5#1)(2008-8#1)(2013-1#1)
of immunohistochemistry and the##2##4##(2006-10#1)(2009-8#1)
of immunohistochemistry and##5##3##(2005-7#1)(2005-8#1)(2006-10#1)(2008-6#1)(2009-8#1)
of immunohistochemistry in##2##3##(2008-12#1)(2010-8#1)
of immunohistochemistry##15##2##(1991-8#1)(1993-12#1)(1997-3#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-9#1)(2008-12#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-8#2)(2012-3#1)
of immunolabelled##2##2##(1991-9#1)(1997-2#1)
of immunologic tolerance##3##3##(1994-3#2)(2012-1#1)
of immunologic##15##2##(1991-12#1)(1994-3#2)(1995-5#2)(1997-8#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-3#1)(2009-6#1)(2009-8#1)(2012-1#1)
of immunological and##3##3##(1996-2#1)(1996-4#1)(1997-7#1)
of immunological response##2##3##(2010-12#1)(2012-2#1)
of immunological tolerance##3##3##(2008-1#2)(2012-1#1)
of immunological##41##2##(1990-4#1)(1990-8#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-3#1)(1995-10#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#6)(2007-12#1)(2007-5#1)(2008-1#2)(2010-12#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
of immunologically##2##2##(2008-4#1)(2012-3#1)
of immunology and physiology of the##2##6##(2008-11#2)
of immunology and##6##3##(2006-7#1)(2007-11#1)(2007-8#1)(2008-11#2)(2012-3#1)
of immunology##8##2##(2006-7#1)(2007-11#1)(2007-8#1)(2008-11#3)(2011-1#1)(2012-3#1)
of immunomodulating##2##2##(1991-5#1)(2006-10#1)
of immunomodulator##2##2##(1996-4#1)(2007-2#1)
of immunomodulators##2##2##(1990-12#1)(2007-8#1)
of immunomodulatory##7##2##(1991-5#1)(2006-10#1)(2006-11#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#1)
of immunopositive cells in##2##4##(1993-12#1)(2008-4#1)
of immunopositive cells##3##3##(1993-12#1)(2008-4#1)(2008-6#1)
of immunopositive##4##2##(1993-12#1)(2008-4#1)(2008-6#2)
of immunoprecipitated##3##2##(1990-7#1)(1992-8#1)(1996-5#1)
of immunopurified##2##2##(1992-8#1)(1994-3#1)
of immunoreaction##2##2##(1993-2#1)(1996-12#1)
of immunoreactions##2##2##(2007-8#1)(2008-10#1)
of immunoreactive (ir-) CNP in##2##5##(1991-3#1)(1991-8#1)
of immunoreactive (ir-)##6##3##(1990-10#2)(1991-3#1)(1991-5#1)(1991-8#1)(1993-11#1)
of immunoreactive big endothelin-1##3##4##(1990-7#3)
of immunoreactive cells##3##3##(1990-4#1)(1997-8#1)(2010-12#1)
of immunoreactive human##2##3##(1991-8#1)(1991-9#1)
of immunoreactive interleukin-1 beta##2##4##(1996-11#2)
of immunoreactive##48##2##(1990-10#4)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#6)(1991-3#2)(1991-5#2)(1991-8#5)(1991-9#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-7#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-5#1)(1996-11#3)(1997-2#2)(1997-5#1)(1997-8#1)(2005-7#1)(2007-12#3)(2008-6#1)(2010-12#1)(2013-1#1)
of immunoreactivity for the##2##4##(1995-11#1)(1997-2#1)
of immunoreactivity for##3##3##(1995-11#1)(1996-9#1)(1997-2#1)
of immunoreactivity in##3##3##(1992-8#1)(1996-4#1)(2008-6#1)
of immunoreactivity of##3##3##(1990-3#1)(1990-5#1)(1993-11#1)
of immunoreactivity##18##2##(1990-2#1)(1990-3#1)(1990-5#1)(1991-8#1)(1992-8#1)(1993-11#2)(1993-3#1)(1994-10#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-7#1)(2008-6#1)
of immunoregulatory##3##2##(2005-11#1)(2006-10#1)(2008-4#1)
of immunosine##5##2##(2004-12#5)
of immunostained##2##2##(1995-11#1)(1995-5#1)
of immunostaining##3##2##(1995-12#2)(1997-3#1)
of immunostimulatory##2##2##(2009-3#1)(2013-1#1)
of immunosuppressants and##2##3##(2006-10#1)(2010-12#1)
of immunosuppressants##6##2##(2006-10#1)(2007-11#1)(2008-11#1)(2010-10#1)(2010-12#1)(2012-11#1)
of immunosuppressed##3##2##(2007-12#1)(2012-11#2)
of immunosuppression and##3##3##(2007-8#1)(2008-5#1)(2011-2#1)
of immunosuppression on the##2##4##(2008-5#2)
of immunosuppression was##2##3##(2007-7#1)(2008-4#1)
of immunosuppression##24##2##(1991-3#1)(1993-11#1)(1995-2#1)(1996-12#1)(2007-11#3)(2007-7#1)(2007-8#3)(2008-10#5)(2008-4#2)(2008-5#4)(2011-2#1)(2013-1#1)
of immunosuppressive agents##5##3##(1994-5#1)(2007-11#3)(2008-5#1)
of immunosuppressive drugs in##2##4##(1993-11#1)(2010-4#1)
of immunosuppressive drugs##13##3##(1993-11#1)(2007-11#2)(2007-7#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-3#1)(2010-4#1)(2011-2#1)(2011-3#1)
of immunosuppressive medication##2##3##(2007-11#1)(2010-12#1)
of immunosuppressive medications##4##3##(2006-10#3)(2010-6#1)
of immunosuppressive therapy##8##3##(1994-5#1)(2006-10#1)(2007-11#1)(2008-3#1)(2010-10#1)(2010-12#1)(2011-2#2)
of immunosuppressive treatment##5##3##(1991-11#1)(1992-1#1)(2007-11#1)(2010-12#1)(2012-3#1)
of immunosuppressive##48##2##(1991-11#1)(1992-1#1)(1993-11#1)(1994-5#2)(1995-1#1)(2006-10#4)(2007-11#12)(2007-7#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2010-10#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-3#1)(2013-8#1)
of immunotherapeutic##2##2##(2007-11#2)
of immunotherapies##2##2##(2008-5#1)(2011-1#1)
of immunotherapy for##2##3##(2006-7#1)(2007-11#1)
of immunotherapy or##2##3##(1991-9#1)(2008-1#1)
of immunotherapy##13##2##(1991-6#1)(1991-9#1)(1992-11#1)(1994-12#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-11#1)(2010-7#1)(2012-1#1)(2012-2#1)
of immunotoxic##2##2##(2008-10#2)
of immunotoxicity##8##2##(2008-10#8)
of immunotoxicology##2##2##(2008-10#2)
of impact and##3##3##(2008-2#1)(2008-8#1)(2012-3#1)
of impact are##2##3##(2008-2#2)
of impact in##2##3##(2012-3#1)(2013-7#1)
of impact of##2##3##(2011-1#1)(2012-2#1)
of impact on##3##3##(2007-1#1)(2012-2#1)(2013-1#1)
of impact##40##2##(1995-3#1)(1997-5#8)(2005-10#1)(2006-11#3)(2006-3#1)(2007-1#1)(2007-4#3)(2007-5#2)(2008-2#4)(2008-5#1)(2008-7#1)(2008-8#2)(2010-8#1)(2011-1#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#2)
of impacted canines##2##3##(2008-7#1)(2013-1#1)
of impacted primary##2##3##(2012-12#2)
of impacted teeth in children##2##5##(2007-12#2)
of impacted teeth##7##3##(1990-2#1)(2007-12#6)
of impacted##21##2##(1990-2#1)(1991-3#1)(2006-12#1)(2007-12#9)(2008-7#2)(2009-3#1)(2010-12#1)(2012-12#3)(2013-1#2)
of impaction##3##2##(2007-12#1)(2008-12#1)(2009-3#1)
of impactor##2##2##(1994-12#1)(2006-11#1)
of impacts on##2##3##(2007-7#1)(2007-9#1)
of impacts##9##2##(1995-6#1)(1997-5#2)(2007-7#1)(2007-9#2)(2008-10#1)(2012-2#1)(2013-1#1)
of impaired fasting glucose##2##4##(2008-3#1)(2008-7#1)
of impaired fasting##4##3##(2008-3#1)(2008-7#1)(2011-2#2)
of impaired glucose tolerance##7##4##(1993-8#1)(1995-12#1)(2006-6#1)(2008-1#1)(2008-7#1)(2012-11#1)(2012-3#1)
of impaired glucose##9##3##(1993-8#1)(1995-12#1)(2006-6#1)(2007-5#1)(2008-1#1)(2008-7#2)(2012-11#1)(2012-3#1)
of impaired sperm##2##3##(1992-12#1)(2013-8#1)
of impaired##38##2##(1991-7#1)(1992-12#2)(1993-11#1)(1993-12#1)(1993-8#1)(1994-11#2)(1994-5#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(2005-1#1)(2006-10#2)(2006-4#1)(2006-6#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#2)(2013-8#1)
of impairment and##3##3##(1991-1#1)(1991-12#1)(2009-4#1)
of impairment was##2##3##(2009-9#1)(2011-1#1)
of impairment##28##2##(1991-1#2)(1991-12#1)(1991-2#1)(1992-1#1)(1993-11#1)(1995-3#1)(2004-3#1)(2006-10#1)(2006-2#2)(2006-8#2)(2008-6#1)(2008-7#1)(2009-2#1)(2009-4#1)(2009-9#6)(2010-7#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
of impairments and##2##3##(2007-7#1)(2008-12#1)
of impairments##6##2##(2007-7#1)(2008-12#1)(2009-1#1)(2009-4#2)(2010-9#1)
of impedance cardiography##2##3##(2006-11#1)(2009-1#1)
of impedance##6##2##(2006-11#1)(2008-7#1)(2009-1#1)(2011-1#1)(2012-1#2)
of impending##9##2##(1995-1#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-8#2)(2008-8#1)(2011-1#2)
of imperfect##4##2##(2008-2#1)(2008-3#2)(2012-3#1)
of impetigo##2##2##(1997-5#1)(2008-5#1)
of impingement and##2##3##(2006-12#1)(2009-12#1)
of impingement##4##2##(2006-12#1)(2009-12#1)(2011-2#2)
of implant placement##3##3##(2011-1#1)(2012-2#1)(2013-1#1)
of implant removal##2##3##(2008-8#1)(2012-2#1)
of implant users##2##3##(2008-9#2)
of implant##23##2##(1993-2#1)(2004-9#2)(2007-11#3)(2007-7#1)(2007-8#1)(2008-11#1)(2008-8#1)(2008-9#5)(2010-10#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#2)(2013-1#1)
of implantable devices##3##3##(2009-11#3)
of implantable medical devices##3##4##(2008-4#1)(2008-5#1)(2010-5#1)
of implantable medical##5##3##(2008-4#1)(2008-5#1)(2010-5#1)(2012-3#2)
of implantable##19##2##(2004-9#2)(2005-12#1)(2006-9#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#4)(2010-5#1)(2010-8#1)(2012-3#2)
of implantation and##2##3##(1996-4#1)(2008-5#1)
of implantation of rat##2##4##(2012-1#2)
of implantation of the##2##4##(1992-1#1)(2008-6#1)
of implantation of##8##3##(1992-1#1)(2005-1#1)(2007-8#1)(2008-12#1)(2008-6#1)(2012-1#3)
of implantation sites##2##3##(1996-12#1)(2008-9#1)
of implantation##29##2##(1991-6#2)(1992-1#1)(1994-9#2)(1996-12#1)(1996-4#1)(2005-1#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)(2010-10#1)(2010-6#1)(2011-2#2)(2012-1#3)(2012-2#1)(2012-3#1)
of implanted children##2##3##(2008-9#2)
of implanted##14##2##(1992-3#1)(1994-11#1)(1997-6#1)(2004-9#1)(2006-4#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2012-3#1)
of implantees##2##2##(2008-9#2)
of implanting##3##2##(1992-5#1)(2008-10#1)(2009-5#1)
of implants in the##2##4##(2007-12#1)(2010-5#1)
of implants in##4##3##(2007-12#1)(2008-11#1)(2010-5#1)(2013-1#1)
of implants is##3##3##(2007-11#1)(2007-7#1)(2011-1#1)
of implants made of##2##4##(2007-11#2)
of implants##27##2##(1996-3#1)(2007-11#11)(2007-12#2)(2007-7#1)(2008-11#1)(2008-4#2)(2009-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-11#2)(2013-1#2)
of implementation and##4##3##(1995-3#1)(2007-10#1)(2007-12#1)(2008-2#1)
of implementation intentions##2##3##(2010-2#1)(2010-3#1)
of implementation of the##2##4##(2008-1#1)(2008-2#1)
of implementation of##13##3##(1995-3#1)(2008-1#1)(2008-2#2)(2008-5#1)(2009-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#3)
of implementation##42##2##(1992-2#1)(1993-3#3)(1995-3#2)(1996-1#1)(1997-2#1)(2005-8#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-6#1)(2010-2#1)(2010-3#2)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#6)
of implementing a##7##3##(1992-2#1)(1996-3#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-2#1)(2012-3#1)
of implementing the##10##3##(1991-12#1)(1996-1#1)(1997-3#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-10#1)
of implementing##41##2##(1991-1#1)(1991-12#1)(1992-2#1)(1992-3#1)(1994-9#1)(1996-1#1)(1996-3#1)(1997-1#2)(1997-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-5#1)(2007-9#1)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-9#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
of implications for##3##3##(1994-2#1)(2005-2#1)(2007-4#1)
of implicit and explicit attitudes toward##2##6##(2007-12#1)(2010-2#1)
of implicit awareness##2##3##(2008-9#2)
of implicit##11##2##(2006-7#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-9#2)(2009-12#1)(2009-4#1)(2010-2#3)
of import##3##2##(1995-2#1)(2008-1#1)(2008-8#1)
of importance for the##11##4##(1991-9#1)(1992-12#1)(1994-11#1)(1994-3#1)(1995-4#1)(1996-5#2)(1997-7#1)(2007-11#1)(2008-2#1)(2010-3#1)
of importance for##22##3##(1991-9#1)(1992-1#1)(1992-12#2)(1994-11#1)(1994-3#1)(1995-4#1)(1995-5#1)(1996-5#2)(1997-7#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)(2010-3#1)(2010-7#1)
of importance from##2##3##(1994-1#1)(2008-10#1)
of importance in the##12##4##(1990-11#1)(1990-12#1)(1992-12#1)(1992-3#1)(1992-9#1)(1995-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-5#1)(2010-12#1)
of importance in##30##3##(1990-11#1)(1990-12#2)(1990-7#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-9#1)(1993-5#1)(1994-12#1)(1995-10#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#2)(2010-10#1)(2010-12#1)(2011-2#1)(2013-8#1)
of importance of##2##3##(2007-12#1)(2010-10#1)
of importance since##2##3##(1994-8#1)(2008-3#1)
of importance that##2##3##(1996-12#1)(2011-2#1)
of importance to forensic##2##4##(1995-6#2)
of importance to##10##3##(1992-9#1)(1993-11#1)(1995-6#2)(2005-11#1)(2005-8#1)(2007-2#1)(2008-10#1)(2012-2#1)(2012-3#1)
of importance when##2##3##(2008-2#1)(2011-1#1)
of importance##94##2##(1990-1#1)(1990-11#1)(1990-12#3)(1990-7#1)(1990-9#1)(1991-9#1)(1992-1#1)(1992-12#3)(1992-3#2)(1992-4#2)(1992-6#3)(1992-9#2)(1993-11#1)(1993-5#1)(1993-7#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#2)(1996-5#2)(1997-7#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#5)(2008-5#5)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
of important crops##2##3##(2008-10#2)
of important factors##3##3##(1996-12#1)(2005-10#1)(2011-2#1)
of important functions##3##3##(2012-2#1)(2013-1#2)
of important image##3##3##(2008-2#1)(2013-1#2)
of important questions##4##3##(1990-10#1)(2006-10#1)(2008-7#1)(2009-6#1)
of important structural##2##3##(2008-7#1)(2008-9#1)
of important##89##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-4#1)(1991-1#1)(1991-3#1)(1991-4#1)(1992-11#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-3#2)(2004-12#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-12#1)(2007-10#1)(2007-11#4)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#9)(2008-11#1)(2008-2#4)(2008-3#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#1)(2009-6#2)(2009-9#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-8#3)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
of imported falciparum malaria cases of Nantong City##2##8##(2012-3#2)
of imported falciparum malaria##5##4##(2011-12#2)(2012-3#3)
of imported infections##2##3##(2007-2#2)
of imported proteins##2##3##(2005-8#2)
of imported##17##2##(2005-5#1)(2005-8#2)(2006-10#1)(2007-2#3)(2011-1#2)(2011-12#3)(2011-2#1)(2012-3#3)(2013-8#1)
of imposex##3##2##(2004-4#2)(2010-5#1)
of impregnated bednets##2##3##(2006-4#1)(2007-2#1)
of impressions##3##2##(2007-9#1)(2010-2#2)
of imprint cytology##2##3##(2007-10#1)(2013-8#1)
of imprinted genes##4##3##(1993-2#1)(1996-10#1)(1996-3#1)(2008-7#1)
of imprinted##6##2##(1993-2#1)(1996-10#1)(1996-3#1)(2008-10#1)(2008-7#2)
of imprinting##3##2##(1992-9#1)(2008-6#1)(2010-12#1)
of improper##6##2##(1991-12#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-9#1)
of improved access and##2##4##(1995-1#2)
of improved diagnostic##3##3##(2006-10#3)
of improved pain##2##3##(2008-10#1)(2010-3#1)
of improved physical function##2##4##(2007-11#1)(2007-7#1)
of improved quality of##2##4##(1993-2#1)(2005-10#1)
of improved results##2##3##(2005-12#1)(2008-5#1)
of improved##65##2##(1990-12#1)(1992-11#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-5#1)(1994-9#1)(1995-1#2)(1995-8#1)(1997-8#1)(2005-10#1)(2005-12#1)(2005-7#2)(2006-10#4)(2006-11#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-6#2)(2007-7#1)(2008-10#2)(2008-11#3)(2008-12#7)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#6)(2012-3#1)(2012-4#1)
of improvement and##2##3##(2005-8#1)(2008-6#1)
of improvement in the##3##4##(1996-9#1)(2006-8#1)(2008-10#1)
of improvement in##16##3##(1995-3#1)(1996-2#1)(1996-9#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)(2013-1#3)
of improvement of##7##3##(1995-2#1)(2005-8#1)(2006-10#1)(2007-8#2)(2010-12#1)(2011-2#1)
of improvement was##5##3##(1991-4#1)(2007-8#1)(2008-10#2)(2008-9#1)
of improvement with##2##3##(1992-10#1)(2007-9#1)
of improvement##54##2##(1991-2#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-10#1)(1994-1#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-8#1)(2005-8#3)(2006-10#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#4)
of improvements in##8##3##(1990-12#1)(1997-3#1)(2008-11#2)(2008-5#1)(2010-10#1)(2010-12#1)(2012-1#1)
of improvements##12##2##(1990-12#1)(1994-12#1)(1997-3#1)(1997-4#1)(2008-11#2)(2008-4#1)(2008-5#1)(2010-10#1)(2010-12#1)(2012-1#2)
of improving optical poling efficiency##2##5##(2007-11#2)
of improving patient##4##3##(2006-10#1)(2010-3#1)(2010-4#1)(2010-8#1)
of improving the quality of life##2##6##(2005-3#1)(2006-6#1)
of improving the quality of##4##5##(2005-3#1)(2006-6#1)(2008-11#1)(2010-12#1)
of improving the##27##3##(1990-2#1)(1992-11#1)(1994-5#1)(1995-7#1)(1996-12#2)(1996-6#1)(1997-1#1)(1997-3#1)(2004-12#1)(2005-3#1)(2006-10#1)(2006-6#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-2#1)(2011-7#1)(2012-1#1)
of improving their##2##3##(2007-4#1)(2012-3#1)
of improving##79##2##(1990-2#2)(1992-11#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-7#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(2004-12#1)(2004-9#1)(2005-3#1)(2005-8#1)(2006-10#4)(2006-12#2)(2006-6#2)(2006-7#1)(2007-1#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#2)(2008-10#6)(2008-11#2)(2008-2#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-7#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
of impulse##5##2##(1991-10#1)(1991-5#2)(1993-11#1)(2008-1#1)
of impulses and##2##3##(1992-5#1)(2007-11#1)
of impulses##5##2##(1991-6#1)(1992-5#1)(2006-12#1)(2007-10#1)(2007-11#1)
of impulsive aggression and##2##4##(2009-10#2)
of impulsive aggression##3##3##(2009-10#3)
of impulsive##10##2##(2008-3#1)(2008-4#1)(2009-10#3)(2010-6#2)(2013-1#1)(2013-7#2)
of impulsiveness##2##2##(2008-10#1)(2010-12#1)
of impulsivity##9##2##(1996-3#1)(2008-6#1)(2010-12#2)(2010-6#2)(2013-7#3)
of impurities in##5##3##(2007-8#2)(2008-10#2)(2013-7#1)
of impurities of##3##3##(2007-8#1)(2008-10#1)(2013-7#1)
of impurities##17##2##(2005-11#1)(2007-8#3)(2008-10#6)(2008-11#1)(2008-7#1)(2010-7#1)(2013-7#2)(2013-8#2)
of impurity##5##2##(2005-11#1)(2008-7#2)(2010-7#1)(2013-8#1)
of imputation was##2##3##(2012-1#2)
of imputation##8##2##(2012-1#8)
of in silico##2##3##(2011-2#1)(2013-8#1)
of in situ TS##2##4##(1995-7#2)
of in situ bioremediation##2##4##(2004-4#2)
of in situ end##2##4##(1994-10#1)(1995-3#1)
of in situ hybridization##5##4##(1993-7#1)(1995-2#1)(1995-7#1)(1997-2#1)(2010-1#1)
of in situ measurements##2##4##(2008-2#1)(2008-3#1)
of in situ##55##3##(1990-12#1)(1991-9#1)(1992-4#3)(1992-8#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-7#3)(1996-11#2)(1996-3#1)(1997-2#2)(2004-4#2)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-1#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#1)
of in the##3##3##(1992-2#1)(2004-12#1)(2008-3#1)
of in utero exposure to##2##5##(1997-8#1)(2008-8#1)
of in utero##6##3##(1990-12#1)(1991-1#1)(1997-8#1)(2007-11#1)(2007-5#1)(2008-8#1)
of in vitro activated##2##4##(2008-9#1)(2013-1#1)
of in vitro and in vivo##8##6##(1991-5#1)(1992-8#1)(1997-2#1)(2007-7#1)(2007-8#1)(2008-5#3)
of in vitro and##9##4##(1991-5#1)(1992-8#1)(1997-2#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-5#3)
of in vitro antifungal##3##4##(2008-5#2)(2010-5#1)
of in vitro culture##3##4##(2008-5#3)
of in vitro development##2##4##(1996-2#1)(2009-12#1)
of in vitro fertilization and##3##5##(1997-5#1)(2010-7#1)(2013-1#1)
of in vitro fertilization##6##4##(1991-11#1)(1995-8#1)(1997-5#1)(2010-7#1)(2012-2#1)(2013-1#1)
of in vitro glycated HDL##2##5##(1995-1#2)
of in vitro studies on##2##5##(2008-11#1)(2012-2#1)
of in vitro studies##9##4##(1991-3#1)(1995-4#1)(1997-2#1)(2007-11#2)(2008-11#2)(2008-4#1)(2012-2#1)
of in vitro susceptibility tests##2##5##(1992-5#2)
of in vitro systems##2##4##(2008-1#1)(2008-10#1)
of in vitro tests##3##4##(1992-5#1)(2008-10#1)(2008-5#1)
of in vitro transcription of##2##5##(1991-12#1)(1994-2#1)
of in vitro transcription##3##4##(1991-12#1)(1994-2#1)(1997-6#1)
of in vitro##125##3##(1990-11#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-9#1)(1992-11#2)(1992-5#4)(1992-7#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-1#3)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-4#2)(1995-8#1)(1996-11#5)(1996-2#1)(1996-4#1)(1997-1#1)(1997-2#2)(1997-5#2)(1997-6#3)(1997-8#2)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#5)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#2)(2008-4#7)(2008-5#14)(2008-8#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#3)(2012-2#3)(2012-3#1)(2012-6#1)(2013-1#4)
of in vivo activity##3##4##(1993-4#1)(1996-5#1)(2007-6#1)
of in vivo and in vitro##4##6##(1994-8#1)(1995-3#1)(2007-12#1)(2008-10#1)
of in vivo confocal##2##4##(2008-2#1)(2013-1#1)
of in vivo human skin##3##5##(2007-11#1)(2007-12#2)
of in vivo measurements##3##4##(1993-9#1)(2008-7#1)(2011-1#1)
of in vivo##84##3##(1990-4#2)(1991-10#1)(1991-12#2)(1991-5#1)(1991-9#2)(1992-11#1)(1992-8#1)(1993-4#2)(1993-9#1)(1994-3#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-3#1)(1995-6#3)(1995-7#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-5#1)(2004-12#1)(2005-7#1)(2005-8#1)(2006-5#1)(2007-1#1)(2007-11#4)(2007-12#3)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-12#4)(2009-5#3)(2009-9#1)(2010-11#1)(2010-9#2)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
of in vivo-passaged##2##3##(2008-4#1)(2008-5#1)
of in##292##2##(1990-11#1)(1990-12#2)(1990-4#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#2)(1991-9#4)(1992-11#3)(1992-2#1)(1992-4#3)(1992-5#4)(1992-7#1)(1992-8#3)(1993-11#1)(1993-3#1)(1993-4#2)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#5)(1995-10#1)(1995-12#2)(1995-2#3)(1995-3#5)(1995-4#2)(1995-6#3)(1995-7#4)(1995-8#1)(1996-11#8)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#5)(1997-5#4)(1997-6#3)(1997-8#4)(2004-12#2)(2004-4#2)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-5#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#7)(2007-11#8)(2007-12#5)(2007-2#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#18)(2008-11#9)(2008-12#1)(2008-2#8)(2008-3#4)(2008-4#14)(2008-5#16)(2008-6#3)(2008-7#6)(2008-8#3)(2008-9#4)(2009-12#6)(2009-5#3)(2009-6#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#4)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#2)(2011-2#5)(2012-1#3)(2012-11#3)(2012-12#1)(2012-2#5)(2012-3#3)(2012-6#1)(2013-1#6)(2013-7#1)(2013-8#2)
of in-ambulance##2##2##(2010-8#2)
of in-center hemodialysis##2##3##(1996-2#1)(2010-5#1)
of in-depth##2##2##(2011-1#1)(2012-3#1)
of in-fiber##2##2##(2008-1#1)(2008-3#1)
of in-flight##2##2##(1991-2#1)(2008-2#1)
of in-home##3##2##(1991-2#1)(1995-3#1)(2010-2#1)
of in-hospital mortality##2##3##(2006-7#1)(2008-3#1)
of in-hospital pediatric cardiac arrest##2##5##(2007-3#2)
of in-hospital##10##2##(2006-7#1)(2007-3#2)(2007-8#1)(2008-3#1)(2008-6#1)(2010-12#1)(2011-2#1)(2013-1#2)
of in-house##3##2##(2008-10#3)
of in-line fiber-optic##2##3##(2008-2#2)
of in-line##6##2##(2007-12#3)(2007-8#1)(2008-2#2)
of in-patient##2##2##(1991-9#1)(2011-2#1)
of in-patients##3##2##(1993-1#1)(2009-10#1)(2011-2#1)
of in-phase##4##2##(1997-8#2)(2007-12#1)(2009-3#1)
of in-plane and out-of-plane##2##4##(2008-3#2)
of in-plane displacements##2##3##(2008-2#2)
of in-plane##8##2##(2007-11#1)(2008-2#3)(2008-3#3)(2009-7#1)
of in-situ##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
of in-stent restenosis##6##3##(2008-12#1)(2008-5#3)(2008-6#2)
of in-stent##9##2##(2008-12#1)(2008-5#3)(2008-6#2)(2009-5#1)(2011-2#2)
of in-vacuum undulators##2##3##(2006-4#2)
of in-vacuum##3##2##(2006-4#3)
of in-vitro##6##2##(1990-12#1)(1991-3#1)(2006-8#1)(2007-4#1)(2008-1#1)(2008-10#1)
of in-water##2##2##(2008-2#2)
of inactivated enzyme##2##3##(1992-9#1)(1997-4#1)
of inactivated poliovirus vaccine (IPV)##2##5##(1997-1#1)(2004-12#1)
of inactivated vaccine##3##3##(1991-3#1)(1996-12#1)(2007-2#1)
of inactivated vaccines##2##3##(2006-10#1)(2008-5#1)
of inactivated virus##3##3##(1991-12#1)(2008-1#1)(2008-4#1)
of inactivated##16##2##(1990-4#1)(1991-12#1)(1991-3#1)(1992-9#1)(1994-5#1)(1996-12#1)(1997-1#1)(1997-4#1)(1997-6#1)(2004-12#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-4#1)(2008-5#1)(2009-5#1)
of inactivating##3##2##(1993-11#1)(1994-9#1)(1996-4#1)
of inactivation and##3##3##(1990-5#1)(1991-2#1)(1995-12#1)
of inactivation are##2##3##(1993-11#1)(1993-12#1)
of inactivation in##2##3##(1995-1#1)(1995-2#1)
of inactivation of RDPR##2##4##(1993-11#2)
of inactivation of##10##3##(1991-2#2)(1991-3#1)(1993-11#2)(1994-12#1)(1994-3#1)(1994-8#1)(2006-3#1)(2008-8#1)
of inactivation##35##2##(1990-3#1)(1990-5#2)(1991-2#3)(1991-3#1)(1991-8#1)(1992-12#2)(1993-11#5)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-12#1)(1995-2#3)(1995-6#1)(1997-4#1)(2006-3#1)(2008-8#3)
of inactive##9##2##(1990-12#1)(1992-12#1)(1992-9#1)(1994-8#1)(1996-5#1)(1996-7#1)(2008-2#1)(2008-8#1)(2012-3#1)
of inadequacy##3##2##(1993-3#1)(2007-8#1)(2013-1#1)
of inadequate analgesia##2##3##(1993-4#1)(2006-8#1)
of inadequate##32##2##(1991-2#1)(1992-9#1)(1993-3#2)(1993-4#1)(1994-3#1)(1994-6#1)(1996-2#1)(2004-1#1)(2004-12#1)(2005-8#1)(2006-6#2)(2006-8#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#2)(2008-9#1)(2009-4#1)(2010-2#1)(2011-10#1)(2012-2#1)(2013-1#2)
of inadequately##2##2##(2008-8#1)(2010-12#1)
of inadvertent##3##2##(2009-11#1)(2012-3#1)(2013-1#1)
of inaperisone hydrochloride (inaperisone)##2##4##(1992-3#2)
of inaperisone##4##2##(1992-3#4)
of inappropriate ADH secretion##2##4##(1990-12#1)(1991-5#1)
of inappropriate antidiuretic hormone secretion##3##5##(2006-4#1)(2006-6#1)(2011-2#1)
of inappropriate antidiuretic hormone##6##4##(2006-4#1)(2006-6#1)(2009-5#2)(2009-8#1)(2011-2#1)
of inappropriate secretion of antidiuretic##3##5##(1994-3#1)(2008-1#1)(2009-10#1)
of inappropriate use##4##3##(2005-12#3)(2007-4#1)
of inappropriate##27##2##(1990-11#1)(1990-12#1)(1990-3#1)(1991-5#1)(1994-3#1)(1996-1#1)(2005-11#1)(2005-12#3)(2005-7#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-6#1)(2009-10#1)(2009-5#2)(2009-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
of inattention##2##2##(2008-2#1)(2008-8#1)
of inborn errors of metabolism##3##5##(2007-3#2)(2008-4#1)
of inborn errors##4##3##(2007-3#2)(2008-4#2)
of inbred lines##3##3##(2008-5#3)
of inbred mice##2##3##(1994-8#1)(2006-2#1)
of inbred##7##2##(1992-5#1)(1994-8#1)(2006-2#1)(2008-5#3)(2008-8#1)
of inbreds##2##2##(2008-10#2)
of inbreeding and##2##3##(2009-5#1)(2012-3#1)
of inbreeding depression##3##3##(2008-8#2)(2008-9#1)
of inbreeding##12##2##(2008-12#1)(2008-8#2)(2008-9#4)(2009-5#2)(2012-3#3)
of incapacity##2##2##(1990-12#1)(1990-4#1)
of incarcerated women##2##3##(1996-7#1)(2009-11#1)
of incarcerated##5##2##(1996-7#1)(2008-11#1)(2009-11#2)(2011-1#1)
of incarceration of##3##3##(2008-12#2)(2009-11#1)
of incarceration##5##2##(2008-12#2)(2008-3#1)(2009-11#1)(2012-1#1)
of incentive##3##2##(1991-12#1)(2007-4#1)(2012-1#1)
of incentives to##3##3##(1994-3#1)(2010-10#1)(2012-3#1)
of incentives##8##2##(1990-12#1)(1993-3#1)(1994-3#1)(1996-12#1)(2010-10#2)(2012-3#2)
of incest in Palau##2##4##(2008-1#2)
of incest in##3##3##(2008-1#3)
of incest##6##2##(1996-5#1)(2008-1#5)
of incidence and mortality##3##4##(1991-6#1)(1992-12#1)(2012-1#1)
of incidence and severity##2##4##(2008-10#2)
of incidence and##23##3##(1991-6#1)(1992-12#1)(2005-10#1)(2006-7#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#7)(2008-7#1)(2008-8#1)(2009-5#1)(2010-7#1)(2011-2#1)(2012-1#1)
of incidence in##3##3##(2008-2#2)(2008-9#1)
of incidence is##3##3##(1991-3#1)(2007-12#1)(2008-3#1)
of incidence of the##6##4##(1990-8#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-2#1)(2008-3#1)
of incidence of##23##3##(1990-11#1)(1990-12#1)(1990-8#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-2#7)(2008-3#4)
of incidence on##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
of incidence with the##2##4##(2008-3#2)
of incidence with##5##3##(2008-2#2)(2008-3#3)
of incidence##126##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-2#2)(1991-3#1)(1991-6#2)(1992-12#2)(1995-5#2)(1997-7#1)(2005-10#1)(2006-7#5)(2006-8#1)(2007-11#3)(2007-12#10)(2007-2#1)(2008-1#2)(2008-10#13)(2008-2#31)(2008-3#34)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#2)(2010-7#2)(2011-2#3)(2012-1#1)
of incident beam##3##3##(2008-2#2)(2008-3#1)
of incident cases##3##3##(1992-8#2)(1993-10#1)
of incident light##10##3##(2007-12#2)(2008-2#3)(2008-3#4)(2012-12#1)
of incident pump power##4##4##(2007-11#1)(2007-12#2)(2008-1#1)
of incident##36##2##(1992-8#2)(1993-10#1)(2005-10#1)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#6)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#10)(2008-7#1)(2010-12#1)(2012-12#2)
of incidental##9##2##(2007-9#1)(2008-7#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
of incidentally discovered##2##3##(1991-4#2)
of incidentally identified##2##3##(2005-12#1)(2010-9#1)
of incidentally##4##2##(1991-4#2)(2005-12#1)(2010-9#1)
of incidents##5##2##(2007-2#3)(2011-2#1)(2012-12#1)
of incipient scoliosis##2##3##(2007-8#2)
of incipient##9##2##(1993-4#1)(1995-10#1)(1996-4#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-9#1)(2013-8#1)
of incision##3##2##(2010-9#1)(2012-12#1)(2013-1#1)
of incisional##5##2##(2007-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)
of included studies were##2##4##(2013-1#2)
of included studies##4##3##(2008-10#1)(2013-1#2)(2013-8#1)
of included##7##2##(2008-10#1)(2010-4#1)(2011-2#2)(2013-1#2)(2013-8#1)
of including a##2##3##(1992-2#1)(2008-8#1)
of including##20##2##(1992-2#1)(1994-3#1)(1997-6#1)(2005-7#1)(2006-3#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-9#1)(2013-1#1)
of inclusion bodies in##2##4##(2008-10#1)(2009-3#1)
of inclusion bodies##4##3##(1992-5#1)(1996-7#1)(2008-10#1)(2009-3#1)
of inclusion complex##3##3##(1996-2#1)(2005-4#1)(2007-8#1)
of inclusion complexes of##2##4##(2004-12#1)(2008-5#1)
of inclusion complexes##4##3##(2004-12#1)(2008-10#2)(2008-5#1)
of inclusion##20##2##(1992-5#1)(1994-9#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(2004-12#1)(2005-11#1)(2005-4#1)(2006-8#1)(2007-8#1)(2008-10#3)(2008-5#1)(2009-12#2)(2009-3#1)(2012-3#2)
of inclusions##4##2##(2008-10#3)(2008-3#1)
of incoherent bright and dark##2##5##(2007-12#2)
of incoherent light##2##3##(2007-11#1)(2007-12#1)
of incoherent##9##2##(2007-11#1)(2007-12#5)(2008-2#1)(2008-3#2)
of income for##2##3##(2012-12#1)(2013-1#1)
of income to##2##3##(2008-8#1)(2013-1#1)
of income##20##2##(1992-12#1)(1993-2#1)(1994-1#1)(1995-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-2#2)(2010-8#2)(2012-12#2)(2013-1#2)
of incoming##7##2##(1990-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-7#1)
of incompatibility##7##2##(2005-10#3)(2007-2#1)(2008-10#1)(2008-11#1)(2009-12#1)
of incompatible##2##2##(1993-6#1)(2008-10#1)
of incompetence##2##2##(1995-5#1)(2011-1#1)
of incomplete combustion##4##3##(1996-11#1)(1996-12#3)
of incomplete lineage sorting##2##4##(2010-6#2)
of incomplete resistance##4##3##(2008-10#4)
of incomplete##23##2##(1990-9#1)(1992-9#1)(1994-6#1)(1995-2#1)(1996-11#1)(1996-12#3)(2006-12#1)(2006-3#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-8#1)(2010-2#1)(2010-6#2)(2011-2#1)(2012-3#1)(2013-1#1)
of incompletely occluded aneurysms##2##4##(2013-1#2)
of incompletely occluded##3##3##(2013-1#3)
of incompletely spliced viral##2##4##(1994-8#1)(1996-4#1)
of incompletely##5##2##(1994-8#1)(1996-4#1)(2013-1#3)
of incompressible##2##2##(1992-1#1)(2009-2#1)
of incongruence##3##2##(2007-8#2)(2010-6#1)
of incontinence in##3##3##(2007-10#1)(2011-2#2)
of incontinence##7##2##(2006-10#2)(2006-9#1)(2007-10#1)(2011-2#2)(2013-1#1)
of inconveniences##2##2##(2007-8#1)(2008-1#1)
of incorporated##5##2##(1991-12#1)(1994-12#1)(1996-2#1)(2008-10#2)
of incorporating an##2##3##(2008-10#1)(2010-4#1)
of incorporating the##5##3##(1994-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2012-3#1)
of incorporating##16##2##(1994-12#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-4#1)(2009-3#1)(2009-4#1)(2010-2#2)(2010-4#1)(2011-2#1)(2012-3#1)
of incorporation into##2##3##(2008-11#1)(2008-6#1)
of incorporation of the##2##4##(1996-7#1)(2008-4#1)
of incorporation of##15##3##(1991-12#1)(1994-10#1)(1995-3#1)(1995-4#1)(1996-7#3)(1997-1#1)(1997-8#1)(2005-9#1)(2006-3#2)(2008-1#1)(2008-4#1)(2011-2#1)
of incorporation##19##2##(1991-12#1)(1994-10#1)(1995-3#1)(1995-4#1)(1996-7#4)(1997-1#1)(1997-8#1)(2005-9#1)(2006-3#2)(2008-1#1)(2008-11#1)(2008-4#2)(2008-6#1)(2011-2#1)
of incorrect##3##2##(2008-3#1)(2008-6#1)(2008-7#1)
of incoupling##2##2##(2008-3#2)
of increase in mortality rate##2##5##(2008-9#2)
of increase in##19##3##(1990-12#1)(1990-7#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-9#1)(1995-12#2)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2012-2#1)
of increase is##2##3##(2008-10#1)(2008-7#1)
of increase of the##3##4##(1993-1#1)(1996-1#2)
of increase of##10##3##(1993-1#1)(1993-12#1)(1996-1#2)(2008-10#2)(2008-8#3)(2012-12#1)
of increase##42##2##(1990-12#1)(1990-7#2)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#3)(1993-6#1)(1994-9#1)(1995-12#2)(1996-1#2)(2006-10#1)(2007-10#1)(2007-8#1)(2007-9#3)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-8#1)(2011-2#2)(2012-12#1)(2012-2#1)
of increased ICP##2##3##(2005-10#1)(2006-11#1)
of increased activity##2##3##(1997-7#1)(2006-10#1)
of increased awareness and##2##4##(1994-1#1)(2007-7#1)
of increased awareness##3##3##(1994-1#1)(2007-7#1)(2009-4#1)
of increased bleeding##3##3##(2008-8#2)(2013-1#1)
of increased blood##3##3##(2006-10#1)(2011-1#1)(2013-1#1)
of increased bone##2##3##(2008-6#1)(2008-7#1)
of increased energy##2##3##(2006-2#1)(2010-9#1)
of increased expression of##3##4##(1993-7#1)(1994-3#1)(2008-9#1)
of increased expression##4##3##(1993-7#1)(1994-3#1)(1995-8#1)(2008-9#1)
of increased intracranial pressure##4##4##(1992-11#1)(2008-1#1)(2008-12#1)(2008-7#1)
of increased levels of##2##4##(1992-5#1)(2008-1#1)
of increased lipid##2##3##(2007-9#1)(2008-7#1)
of increased liver enzyme##2##4##(2010-2#2)
of increased liver##5##3##(1990-3#1)(2010-2#2)(2012-3#2)
of increased metabolic##2##3##(2008-11#1)(2010-12#1)
of increased mortality##4##3##(1994-7#1)(1997-6#1)(2007-8#1)(2012-2#1)
of increased numbers of##3##4##(1996-4#1)(1997-4#1)(2006-5#1)
of increased patient##2##3##(2007-3#1)(2011-1#1)
of increased physical activity##2##4##(2011-2#1)(2012-2#1)
of increased risk##2##3##(1994-2#1)(2007-8#1)
of increased sensitivity of##2##4##(1991-1#1)(2007-6#1)
of increased signal##2##3##(2006-10#1)(2008-6#1)
of increased susceptibility##2##3##(2007-12#1)(2012-1#1)
of increased uptake of##2##4##(1992-11#1)(1996-8#1)
of increased urinary##2##3##(1991-12#1)(1991-8#1)
of increased##188##2##(1990-3#1)(1990-4#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-5#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-10#1)(1993-5#1)(1993-7#2)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-7#1)(1995-1#2)(1995-11#2)(1995-2#1)(1995-4#1)(1995-7#1)(1995-8#3)(1996-4#1)(1996-8#1)(1996-9#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(2004-11#1)(2004-4#1)(2005-10#2)(2005-7#1)(2005-8#1)(2006-10#8)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#5)(2008-11#3)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#6)(2008-7#7)(2008-8#5)(2008-9#5)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#3)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#9)(2012-3#5)(2013-1#6)(2013-7#4)(2013-8#2)
of increases and decreases in##2##5##(2009-10#1)(2011-2#1)
of increases in##9##3##(1994-8#1)(1996-5#1)(2005-10#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-10#1)(2009-4#1)(2013-8#1)
of increases##11##2##(1994-8#1)(1996-5#1)(2005-10#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-10#1)(2009-10#1)(2009-4#1)(2011-2#1)(2013-8#1)
of increasing access to##2##4##(2011-1#1)(2011-2#1)
of increasing age##3##3##(1995-12#1)(1996-5#1)(2008-7#1)
of increasing amounts of##5##4##(1992-5#1)(1993-3#1)(1993-9#1)(2008-10#1)(2008-5#1)
of increasing complexity##2##3##(2008-11#1)(2012-2#1)
of increasing concentrations of##5##4##(1991-7#1)(1992-12#1)(1993-4#1)(1995-3#1)(2008-5#1)
of increasing concern##3##3##(1996-3#1)(2009-5#1)(2012-12#1)
of increasing dietary##2##3##(2013-1#2)
of increasing importance##4##3##(2008-10#1)(2008-5#1)(2008-7#2)
of increasing incidence of##2##4##(2007-12#1)(2013-8#1)
of increasing incidence##4##3##(1992-9#1)(2007-12#1)(2011-2#1)(2013-8#1)
of increasing interest in##3##4##(2005-8#1)(2007-8#1)(2008-8#1)
of increasing interest to##2##4##(2006-10#1)(2008-9#1)
of increasing interest##8##3##(2005-8#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-5#1)
of increasing numbers of##2##4##(2006-12#1)(2008-1#1)
of increasing prevalence##2##3##(1991-12#1)(1994-8#1)
of increasing severity##4##3##(1990-9#1)(1996-11#1)(1997-2#1)(2010-7#1)
of increasing the number##2##4##(2008-2#1)(2010-3#1)
of increasing the response##3##4##(1991-1#1)(2008-5#1)(2008-6#1)
of increasing the##28##3##(1990-2#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-2#1)(1992-3#1)(1995-12#1)(1997-2#1)(2005-7#1)(2007-11#3)(2008-10#3)(2008-2#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-11#1)(2009-4#1)(2010-3#1)
of increasing##151##2##(1990-2#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-4#2)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-3#1)(1995-6#2)(1996-11#2)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#2)(1997-6#2)(2004-4#1)(2005-1#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-6#1)(2005-7#1)(2005-8#2)(2006-10#4)(2006-12#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#2)(2008-2#6)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#3)(2009-11#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#4)(2012-8#1)(2013-1#2)(2013-7#1)(2013-8#1)
of increasingly large##3##3##(2010-12#1)(2013-1#2)
of increasingly##15##2##(1992-11#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-11#2)(2008-2#2)(2008-4#1)(2008-7#1)(2010-12#1)(2013-1#4)
of incremental flux##4##3##(2011-2#4)
of incremental##8##2##(2007-12#1)(2007-9#1)(2010-12#1)(2011-2#5)
of increments##2##2##(1992-12#1)(1993-9#1)
of incubating##2##2##(2007-12#1)(2008-10#1)
of incubation and the##2##4##(2005-11#1)(2009-3#1)
of incubation and##9##3##(1994-11#1)(2005-11#1)(2006-3#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-3#1)(2013-8#1)
of incubation at##5##3##(1991-2#1)(1992-8#1)(1994-5#1)(2006-5#1)(2008-10#1)
of incubation for##2##3##(2005-11#1)(2006-8#1)
of incubation in the##2##4##(1990-12#1)(2008-8#1)
of incubation in##4##3##(1990-12#1)(1996-4#1)(1997-4#1)(2008-8#1)
of incubation of##4##3##(1990-5#1)(1992-8#1)(1997-2#1)(2008-11#1)
of incubation temperature##3##3##(2008-10#1)(2011-2#2)
of incubation time on the##3##5##(1991-7#1)(2005-11#1)(2006-12#1)
of incubation time on##4##4##(1991-7#1)(2005-11#1)(2006-12#1)(2008-5#1)
of incubation time##12##3##(1991-7#1)(1992-12#1)(1995-5#1)(2005-11#1)(2006-12#2)(2008-10#2)(2008-12#1)(2008-5#3)
of incubation to##2##3##(2005-11#1)(2008-5#1)
of incubation with##10##3##(1991-5#1)(1993-12#1)(1994-11#1)(1997-2#1)(2006-8#1)(2008-10#1)(2008-11#1)(2009-3#1)(2009-6#1)(2013-8#1)
of incubation##137##2##(1990-11#1)(1990-12#2)(1990-5#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-7#2)(1992-1#1)(1992-12#6)(1992-3#1)(1992-8#4)(1992-9#1)(1993-11#1)(1993-12#5)(1993-2#2)(1993-4#4)(1994-11#3)(1994-12#1)(1994-3#2)(1994-5#2)(1994-8#2)(1994-9#6)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-4#2)(1996-6#1)(1997-2#2)(1997-3#1)(1997-4#1)(2004-9#1)(2005-11#5)(2006-10#1)(2006-12#2)(2006-3#2)(2006-5#2)(2006-8#3)(2006-9#1)(2007-12#1)(2007-2#2)(2007-9#1)(2008-10#12)(2008-11#8)(2008-12#1)(2008-3#1)(2008-5#6)(2008-7#2)(2008-8#3)(2009-3#3)(2009-6#1)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#5)(2013-8#3)
of incubation)##2##2##(1993-12#1)(1995-1#1)
of indapamide on contractile responses##2##5##(1993-11#2)
of indapamide##3##2##(1993-11#2)(2011-2#1)
of indentation##3##2##(2008-10#1)(2009-7#1)(2009-9#1)
of indenter##2##2##(2009-7#1)(2009-9#1)
of independence and##5##3##(1991-2#1)(1996-2#1)(1996-5#1)(2005-5#1)(2006-10#1)
of independence between the##2##4##(1996-2#1)(1996-7#1)
of independence between##3##3##(1996-2#1)(1996-5#1)(1996-7#1)
of independence in##3##3##(1992-12#1)(2007-9#1)(2009-12#1)
of independence##18##2##(1991-2#1)(1992-12#1)(1993-6#1)(1995-12#1)(1996-2#3)(1996-5#2)(1996-7#1)(2005-5#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-12#1)(2011-2#1)
of independent component analysis (ICA)##2##5##(2008-2#1)(2010-8#1)
of independent component analysis##3##4##(2008-2#1)(2008-7#1)(2010-8#1)
of independent genetic##2##3##(2008-10#1)(2012-3#1)
of independent identically distributed random variables##2##6##(2008-2#1)(2009-4#1)
of independent studies##3##3##(1996-6#1)(2008-11#1)(2008-2#1)
of independent variables##3##3##(2005-11#1)(2007-9#1)(2008-5#1)
of independent walking##2##3##(1993-12#2)
of independent##56##2##(1990-12#1)(1993-12#2)(1993-9#1)(1994-2#1)(1994-3#1)(1995-8#2)(1996-1#1)(1996-6#2)(1996-8#3)(1997-2#2)(1997-8#1)(2005-11#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-8#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
of independently##6##2##(1993-12#2)(1996-5#1)(2006-6#1)(2008-10#1)(2011-12#1)
of indeterminate##8##2##(1994-4#1)(1994-6#1)(2006-2#1)(2007-3#1)(2008-1#1)(2009-3#1)(2010-12#1)(2012-12#1)
of indeterminates##2##2##(2007-3#2)
of index modulation##2##3##(2008-3#2)
of index patients##2##3##(1996-6#2)
of index##20##2##(1992-9#2)(1996-3#4)(1996-6#2)(2007-11#3)(2007-12#1)(2007-7#1)(2008-3#4)(2008-8#1)(2010-7#1)(2011-1#1)
of indication for##2##3##(2006-10#1)(2013-1#1)
of indication##8##2##(1997-4#1)(2006-10#1)(2006-2#1)(2006-6#3)(2010-8#1)(2013-1#1)
of indications for such##2##4##(1991-6#1)(2006-10#1)
of indications for##8##3##(1991-6#1)(1992-4#1)(2006-10#1)(2007-11#2)(2007-6#1)(2008-3#1)(2008-7#1)
of indications##25##2##(1990-9#1)(1991-6#1)(1992-4#1)(1993-3#1)(1996-3#1)(1997-4#2)(2005-5#1)(2006-10#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-6#1)(2007-8#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-12#1)(2010-7#1)
of indicator information##2##3##(1997-1#2)
of indicator##10##2##(1990-12#1)(1991-2#1)(1997-1#3)(2008-10#2)(2008-9#1)(2009-4#1)(2012-2#1)
of indicators and##2##3##(2008-11#1)(2013-8#1)
of indicators of##5##3##(1996-2#1)(2007-1#1)(2008-12#1)(2011-2#1)(2013-1#1)
of indicators that##2##3##(2010-11#1)(2012-12#1)
of indicators##30##2##(1990-8#1)(1994-2#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-3#2)(2007-1#1)(2007-12#1)(2007-3#2)(2007-4#1)(2008-11#3)(2008-12#1)(2008-8#1)(2009-4#2)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#4)(2012-3#2)(2013-1#1)(2013-8#1)
of indices##7##2##(1995-2#1)(1995-6#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2011-1#1)
of indigenous medicines##5##3##(2012-2#4)(2013-1#1)
of indigenous##25##2##(1993-3#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2009-6#1)(2010-1#1)(2011-1#1)(2012-2#5)(2013-1#4)
of indigenously##2##2##(2007-12#1)(2008-11#1)
of indigent patients##2##3##(2008-11#1)(2008-12#1)
of indigent##3##2##(1996-3#1)(2008-11#1)(2008-12#1)
of indigo carmine##2##3##(2008-10#2)
of indirect##20##2##(1994-2#1)(1995-12#1)(1995-2#1)(2006-3#1)(2006-6#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-8#1)(2010-7#1)(2011-1#1)(2012-1#1)
of indirectly##2##2##(2008-8#1)(2010-11#1)
of indiscriminate##2##2##(2008-12#1)(2013-8#1)
of indium in high purity antimony by electrothermal atomic absorption##2##10##(2008-10#2)
of indium in##4##3##(2008-10#4)
of indium tin oxide (ITO)##3##5##(2007-12#1)(2007-8#1)(2008-2#1)
of indium tin oxide films##2##5##(2008-2#1)(2008-3#1)
of indium tin oxide##5##4##(2007-12#1)(2007-8#1)(2008-2#2)(2008-3#1)
of indium tin##6##3##(1995-3#1)(2007-12#1)(2007-8#1)(2008-2#2)(2008-3#1)
of indium##15##2##(1995-3#1)(2007-12#2)(2007-8#1)(2008-10#8)(2008-2#2)(2008-3#1)
of individual amino acid##2##4##(1993-8#1)(1997-4#1)
of individual amino acids##2##4##(1991-12#1)(1995-5#1)
of individual amino##4##3##(1991-12#1)(1993-8#1)(1995-5#1)(1997-4#1)
of individual and collective##2##4##(2008-9#1)(2009-8#1)
of individual and##6##3##(1995-1#1)(2008-10#1)(2008-9#1)(2009-11#1)(2009-8#1)(2012-1#1)
of individual animals##2##3##(2008-12#1)(2010-12#1)
of individual cases##3##3##(2006-3#1)(2007-11#1)(2012-1#1)
of individual cation-DNA complexes##2##4##(1995-7#2)
of individual cells##11##3##(2008-1#1)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#1)(2009-9#1)(2010-10#1)(2011-1#1)
of individual chemical##2##3##(1995-6#1)(2008-10#1)
of individual components of the##2##5##(2008-3#1)(2008-4#1)
of individual components##4##3##(2008-10#2)(2008-3#1)(2008-4#1)
of individual compounds##4##3##(2008-10#2)(2008-4#1)(2008-6#1)
of individual defect nanoclusters##2##4##(2007-12#2)
of individual defect##3##3##(2007-12#3)
of individual differences in##3##4##(2008-11#1)(2008-5#1)(2012-1#1)
of individual differences##6##3##(2004-3#1)(2008-11#1)(2008-5#1)(2010-2#1)(2011-12#1)(2012-1#1)
of individual drugs##2##3##(2007-1#1)(2013-1#1)
of individual elements##2##3##(2005-11#1)(2008-10#1)
of individual enzymes##3##3##(1996-5#1)(2008-2#1)(2010-3#1)
of individual erythrocytes##2##3##(2008-2#2)
of individual fibers##2##3##(2007-12#1)(2010-8#1)
of individual genes##5##3##(1995-8#1)(2008-11#2)(2008-7#1)(2010-2#1)
of individual health##4##3##(1990-12#1)(1996-6#1)(2010-1#2)
of individual human##2##3##(1995-3#1)(2008-8#1)
of individual ion##2##3##(1992-9#1)(2013-8#1)
of individual isolates##2##3##(2008-10#1)(2011-2#1)
of individual measurements##2##3##(2008-10#1)(2008-3#1)
of individual members in##2##4##(2007-3#1)(2008-4#1)
of individual members##3##3##(1997-7#1)(2007-3#1)(2008-4#1)
of individual molecular species of##2##5##(1992-2#1)(1995-8#1)
of individual molecules##3##3##(2008-7#2)(2012-1#1)
of individual negotiator##2##3##(1992-2#2)
of individual neurons##2##3##(1995-11#1)(1996-12#1)
of individual particles##3##3##(1995-8#1)(2008-2#1)(2008-3#1)
of individual patient##2##3##(1993-1#1)(2008-4#1)
of individual patients may be##2##5##(1991-3#1)(1997-5#1)
of individual patients with##2##4##(1996-7#1)(2010-12#1)
of individual patients##13##3##(1991-3#1)(1993-1#1)(1996-4#1)(1996-7#1)(1997-5#1)(2005-8#1)(2008-11#1)(2008-2#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#2)
of individual phases of##2##4##(1992-9#1)(1995-1#1)
of individual plants##3##3##(2008-10#3)
of individual pulses##2##3##(2007-12#2)
of individual quanta##2##3##(1997-7#1)(2007-10#1)
of individual research##2##3##(2008-1#1)(2012-12#1)
of individual residues##3##3##(1993-6#1)(1995-4#1)(1996-7#1)
of individual risk##3##3##(2009-7#1)(2012-2#1)(2013-8#1)
of individual sites##2##3##(1990-8#1)(1997-2#1)
of individual species in##2##4##(1997-2#1)(2008-10#1)
of individual species##6##3##(1995-8#1)(1997-2#1)(2008-10#1)(2008-6#1)(2009-8#1)(2012-3#1)
of individual steps in the##2##5##(1990-7#1)(2008-1#1)
of individual subunits##2##3##(1997-1#1)(1997-3#1)
of individual susceptibility to##2##4##(2007-4#1)(2010-7#1)
of individual susceptibility##3##3##(1994-6#1)(2007-4#1)(2010-7#1)
of individual symptoms##2##3##(2006-10#1)(2008-3#1)
of individual transcripts##2##3##(1997-6#1)(1997-8#1)
of individual trees##2##3##(2008-5#1)(2011-12#1)
of individual types of##2##4##(2006-4#1)(2008-4#1)
of individual variability##3##3##(2009-2#2)(2009-9#1)
of individual variation##3##3##(1990-7#1)(2008-8#2)
of individual volunteers##2##3##(1993-12#1)(1994-3#1)
of individual##407##2##(1990-10#2)(1990-12#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#2)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#4)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#3)(1993-11#1)(1993-12#3)(1993-4#1)(1993-6#3)(1993-8#2)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#3)(1994-9#4)(1995-1#3)(1995-11#1)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#3)(1995-8#4)(1995-9#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#2)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#5)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#3)(2004-10#1)(2004-3#1)(2005-10#1)(2005-11#2)(2005-4#1)(2005-8#2)(2006-1#1)(2006-10#4)(2006-2#1)(2006-3#2)(2006-4#2)(2006-5#1)(2006-6#2)(2006-7#1)(2007-1#3)(2007-10#1)(2007-11#4)(2007-12#11)(2007-3#1)(2007-4#4)(2007-7#1)(2007-8#3)(2008-1#7)(2008-10#46)(2008-11#17)(2008-12#2)(2008-2#13)(2008-3#10)(2008-4#14)(2008-5#7)(2008-6#5)(2008-7#7)(2008-8#9)(2008-9#8)(2009-11#1)(2009-12#4)(2009-2#3)(2009-3#3)(2009-4#2)(2009-7#3)(2009-8#2)(2009-9#6)(2010-1#2)(2010-10#2)(2010-12#3)(2010-2#3)(2010-3#1)(2010-6#1)(2010-7#3)(2010-8#4)(2011-1#6)(2011-12#3)(2011-2#6)(2012-1#8)(2012-12#3)(2012-2#9)(2012-3#6)(2013-1#8)(2013-7#3)(2013-8#4)
of individualized##5##2##(1995-5#1)(2005-10#1)(2006-10#1)(2007-10#1)(2009-8#1)
of individualizing##2##2##(2007-9#1)(2008-3#1)
of individually##3##2##(1992-4#1)(1995-10#1)(2007-11#1)
of individuals and the##3##4##(2007-9#1)(2008-7#1)(2010-4#1)
of individuals and their##3##4##(1993-9#1)(2008-1#1)(2011-1#1)
of individuals and##18##3##(1993-3#1)(1993-9#1)(1997-3#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2010-4#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
of individuals are##3##3##(1997-4#1)(2008-9#1)(2009-11#1)
of individuals at risk##4##4##(1997-5#1)(2010-4#1)(2011-2#1)(2012-2#1)
of individuals at##6##3##(1997-5#1)(2008-10#1)(2008-2#1)(2010-4#1)(2011-2#1)(2012-2#1)
of individuals diagnosed with##2##4##(2008-3#1)(2010-11#1)
of individuals for##3##3##(1995-3#1)(2007-1#1)(2011-12#1)
of individuals from##5##3##(1991-8#1)(1994-1#1)(1994-6#1)(1996-12#1)(2008-12#1)
of individuals in##7##3##(1991-2#1)(1994-12#1)(2008-5#1)(2008-9#1)(2010-7#1)(2011-2#1)(2013-8#1)
of individuals infected with##2##4##(2008-12#1)(2010-12#1)
of individuals of##8##3##(1993-9#1)(2007-3#3)(2008-10#1)(2013-7#3)
of individuals receiving##3##3##(1996-3#1)(2011-2#1)(2013-7#1)
of individuals suffering from##2##4##(2010-1#1)(2011-2#1)
of individuals that##3##3##(2007-7#1)(2008-8#2)
of individuals to##5##3##(1996-12#1)(1996-3#1)(2006-3#1)(2010-6#1)(2012-1#1)
of individuals were##2##3##(2008-10#1)(2008-8#1)
of individuals who are##3##4##(2007-8#2)(2010-11#1)
of individuals who have##2##4##(2007-11#1)(2009-5#1)
of individuals who##14##3##(1995-3#1)(1997-6#1)(2005-10#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-8#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-5#1)(2012-3#1)(2013-1#1)
of individuals with Down syndrome##3##5##(2010-4#3)
of individuals with FXS##2##4##(2010-4#2)
of individuals with a##3##4##(1995-12#1)(2008-2#1)(2010-11#1)
of individuals with autism##4##4##(2007-8#1)(2009-4#2)(2013-1#1)
of individuals with disabilities##2##4##(1994-2#1)(2010-2#1)
of individuals with early##2##4##(2011-1#1)(2012-3#1)
of individuals with familial##3##4##(1995-1#1)(2006-10#1)(2009-10#1)
of individuals with schizophrenia or other psychotic illnesses##4##8##(2011-2#4)
of individuals with schizophrenia##5##4##(2009-9#1)(2011-2#4)
of individuals with similar##2##4##(2008-10#1)(2010-4#1)
of individuals with##79##3##(1990-4#1)(1992-1#1)(1994-12#3)(1994-2#2)(1994-5#1)(1995-1#1)(1995-12#1)(1997-1#2)(1997-3#2)(2004-10#1)(2006-10#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#4)(2009-12#1)(2009-4#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#3)(2010-4#7)(2010-5#1)(2011-1#1)(2011-2#9)(2012-2#4)(2012-3#3)(2013-1#2)(2013-8#1)
of individuals within##2##3##(2008-10#1)(2008-8#1)
of individuals worldwide##5##3##(2006-1#1)(2007-11#1)(2007-2#1)(2008-8#1)(2013-1#1)
of individuals would##3##3##(1991-2#1)(2009-10#1)(2013-7#1)
of individuals##257##2##(1990-3#1)(1990-4#1)(1991-2#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#1)(1993-3#1)(1993-9#3)(1994-1#1)(1994-11#1)(1994-12#4)(1994-2#2)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#3)(1996-1#1)(1996-12#3)(1996-3#3)(1997-1#3)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#3)(2004-10#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#5)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#3)(2007-3#6)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#11)(2008-12#6)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#16)(2008-9#3)(2009-10#5)(2009-11#1)(2009-12#2)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#5)(2010-2#4)(2010-4#11)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#17)(2012-1#3)(2012-12#2)(2012-2#9)(2012-3#6)(2013-1#11)(2013-7#7)(2013-8#6)
of individuals'##3##2##(2007-9#1)(2008-9#1)(2009-12#1)
of indocarbocyanine##2##2##(1990-3#2)
of indocyanine green##3##3##(1992-2#1)(2007-8#1)(2008-2#1)
of indole-3-acetic acid (IAA)##2##4##(2006-10#2)
of indole-3-acetic acid##6##3##(1995-1#2)(2006-10#4)
of indole-3-acetic##8##2##(1995-1#2)(2006-10#4)(2008-10#2)
of indoleamine-2##3##2##(1993-12#1)(2010-12#2)
of indoles and##2##3##(1997-2#1)(2013-8#1)
of indoles##4##2##(1993-11#1)(1995-12#1)(1997-2#1)(2013-8#1)
of indolizines##2##2##(2007-11#1)(2009-7#1)
of indomethacin in##2##3##(1992-8#1)(2008-10#1)
of indomethacin on the uptake##2##5##(1990-11#1)(1991-7#1)
of indomethacin on the##3##4##(1990-11#1)(1991-7#1)(1997-6#1)
of indomethacin on##4##3##(1990-11#1)(1991-7#1)(1994-8#1)(1997-6#1)
of indomethacin##27##2##(1990-11#1)(1990-2#1)(1991-1#1)(1991-7#2)(1992-8#1)(1994-8#2)(1996-11#1)(1997-6#3)(2008-10#6)(2008-5#2)(2010-1#1)(2010-2#3)(2011-1#1)(2012-2#1)(2013-7#1)
of indoor air##7##3##(1992-4#4)(1994-9#1)(2008-10#1)(2010-5#1)
of indoor and outdoor airborne fungi##2##6##(2008-5#2)
of indoor and outdoor##5##4##(2008-10#1)(2008-5#3)(2010-5#1)
of indoor pollution##2##3##(2008-10#2)
of indoor restaurant##2##3##(2007-11#2)
of indoor##18##2##(1992-4#5)(1994-9#2)(2007-11#2)(2008-10#4)(2008-5#3)(2010-5#2)
of induced abortion##11##3##(1991-6#2)(1991-8#7)(1992-2#1)(2012-11#1)
of induced abortions##3##3##(2013-1#3)
of induced phenotypes##2##3##(1995-11#2)
of induced protection##2##3##(2007-2#1)(2008-7#1)
of induced resistance is##2##4##(2008-10#2)
of induced resistance##11##3##(2007-12#1)(2008-10#10)
of induced sputum##2##3##(2008-3#1)(2008-8#1)
of induced systemic resistance##3##4##(2008-10#3)
of induced##64##2##(1990-8#1)(1991-1#2)(1991-3#2)(1991-6#2)(1991-8#7)(1992-2#1)(1993-3#1)(1994-2#1)(1995-11#3)(1997-1#1)(2005-11#3)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#3)(2008-8#3)(2008-9#3)(2010-5#1)(2011-1#1)(2012-11#1)(2013-1#3)
of inducer##9##2##(1991-8#2)(1992-12#1)(1995-2#1)(1995-8#1)(1996-6#1)(2008-6#1)(2008-7#1)(2012-2#1)
of inducers of##2##3##(1992-2#1)(2007-11#1)
of inducible NO-synthase in##2##4##(1995-12#2)
of inducible NO-synthase##3##3##(1995-12#3)
of inducible nitric oxide synthase (iNOS) in##2##7##(1997-6#1)(2008-4#1)
of inducible nitric oxide synthase (iNOS)##3##6##(1996-12#1)(1997-6#1)(2008-4#1)
of inducible nitric oxide synthase mRNA in##2##7##(1995-12#1)(1997-6#1)
of inducible nitric oxide synthase##12##5##(1995-12#1)(1996-12#2)(1997-6#3)(2006-2#1)(2008-4#1)(2008-5#1)(2009-9#1)(2010-12#1)(2011-12#1)
of inducible nitric oxide##13##4##(1995-12#1)(1996-12#2)(1997-6#3)(2006-2#1)(2008-4#1)(2008-5#1)(2009-9#1)(2010-12#1)(2011-12#1)(2013-1#1)
of inducible##25##2##(1994-11#1)(1994-8#2)(1995-12#4)(1996-12#3)(1997-4#1)(1997-6#3)(2006-2#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-12#1)(2013-1#1)
of inducing a##6##3##(1990-9#1)(2006-10#1)(2008-10#2)(2008-4#1)(2008-8#1)
of inducing the##3##3##(2005-10#1)(2007-8#1)(2008-7#1)
of inducing##38##2##(1990-11#1)(1990-4#1)(1990-9#1)(1991-1#1)(1991-12#1)(1992-12#1)(1992-7#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-9#1)(1997-4#1)(1997-7#1)(2004-8#1)(2005-10#1)(2006-10#2)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-8#1)
of induction and##2##3##(2006-8#1)(2007-9#1)
of induction are##2##3##(2007-2#1)(2007-6#1)
of induction by##2##3##(1995-2#1)(1997-1#1)
of induction chemotherapy##4##3##(1990-6#1)(1991-10#1)(2008-10#1)(2009-8#1)
of induction of##16##3##(1990-3#1)(1993-4#1)(1994-8#1)(1995-6#1)(1996-10#1)(1996-5#1)(1997-7#1)(2005-10#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-8#2)(2009-6#1)
of induction##53##2##(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-10#1)(1992-4#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-2#3)(1994-8#1)(1995-2#2)(1995-6#1)(1996-10#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-7#2)(2004-1#1)(2005-10#1)(2006-10#2)(2006-8#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-7#1)(2008-8#3)(2008-9#1)(2009-6#1)(2009-8#2)(2011-2#2)(2012-1#1)(2013-8#2)
of inductive##6##2##(1994-12#1)(2005-1#1)(2006-8#1)(2008-11#1)(2008-7#1)(2011-1#1)
of inductively coupled plasma atomic##2##5##(2008-10#2)
of inductively coupled plasma mass spectrometry##2##6##(2008-10#2)
of inductively coupled plasma##7##4##(2007-12#1)(2008-10#5)(2013-8#1)
of inductively coupled##8##3##(2004-9#1)(2007-12#1)(2008-10#5)(2013-8#1)
of industrial applications##2##3##(2008-9#1)(2009-8#1)
of industrial effluents##2##3##(2007-10#1)(2009-6#1)
of industrial fermentation##2##3##(2012-3#2)
of industrial hygiene and##2##4##(2012-12#2)
of industrial products##2##3##(2011-2#1)(2012-3#1)
of industrial waste##4##3##(2008-10#1)(2008-5#2)(2011-12#1)
of industrial##44##2##(1991-4#1)(1994-11#1)(1994-3#1)(1996-1#1)(1996-6#1)(1997-6#1)(2004-4#1)(2005-11#1)(2006-12#1)(2007-10#2)(2007-6#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-3#3)(2013-1#2)(2013-8#1)
of industrialized countries##2##3##(1994-2#1)(2010-2#1)
of industrialized nations##2##3##(2011-1#1)(2012-2#1)
of industrialized##5##2##(1994-2#1)(2008-10#1)(2010-2#1)(2011-1#1)(2012-2#1)
of industrially##4##2##(2005-11#1)(2008-7#1)(2011-1#1)(2012-12#1)
of industries##4##2##(2006-6#1)(2008-10#1)(2008-12#1)(2012-1#1)
of industry##7##2##(1994-12#1)(1996-2#1)(2006-5#1)(2008-10#2)(2008-5#1)(2008-8#1)
of indwelling##4##2##(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)
of ineffective##5##2##(1996-3#1)(2007-11#1)(2008-7#1)(2010-5#1)(2011-2#1)
of inefficiency##2##2##(2010-8#1)(2013-8#1)
of inelastic##6##2##(1992-5#1)(2008-2#2)(2008-3#1)(2009-4#1)(2009-9#1)
of inequalities##3##2##(2007-7#1)(2011-2#1)(2012-2#1)
of inequality##4##2##(2008-9#1)(2010-8#1)(2011-2#2)
of inequity##2##2##(2007-7#1)(2009-4#1)
of inert##2##2##(2008-10#2)
of inertia##4##2##(2007-1#2)(2012-1#1)(2012-2#1)
of inertial confinement fusion##3##4##(1991-9#1)(2008-3#2)
of inertial terms##2##3##(2005-11#2)
of inertial##6##2##(1991-9#1)(2005-11#2)(2008-3#2)(2010-8#1)
of inexpensive##6##2##(1991-9#1)(1994-9#1)(2008-10#1)(2009-5#1)(2011-1#1)(2011-2#1)
of infancy was##3##3##(2006-10#1)(2008-10#2)
of infancy##23##2##(1995-8#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#4)(2009-12#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-2#6)(2013-1#1)(2013-8#2)
of infant feeding information##2##4##(2007-2#2)
of infant feeding##3##3##(2007-2#2)(2012-2#1)
of infant health##3##3##(1993-3#1)(1994-3#2)
of infant massage##2##3##(2008-10#2)
of infant mortality and##2##4##(2012-3#1)(2013-1#1)
of infant mortality##8##3##(1997-6#1)(2007-2#1)(2009-10#1)(2009-4#1)(2009-5#1)(2012-1#1)(2012-3#1)(2013-1#1)
of infant obesity]##2##3##(2012-2#1)(2013-7#1)
of infant##42##2##(1990-12#1)(1990-8#3)(1992-2#2)(1993-3#1)(1994-3#2)(1994-7#1)(1995-3#1)(1997-6#1)(2006-10#3)(2006-6#2)(2006-8#1)(2007-2#3)(2007-8#1)(2008-10#2)(2008-12#2)(2008-4#1)(2008-6#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-4#1)(2011-1#2)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)
of infant's##2##2##(1990-12#1)(2011-1#1)
of infantile asthma##2##3##(1996-6#1)(2005-11#1)
of infantile trigger thumb##2##4##(2006-3#2)
of infantile##13##2##(1994-8#1)(1996-6#1)(2005-11#1)(2006-3#2)(2007-2#1)(2007-6#1)(2008-7#1)(2010-7#2)(2011-1#1)(2012-12#1)(2012-2#1)
of infants aged##4##3##(1997-4#1)(2006-10#1)(2006-2#1)(2007-2#1)
of infants and children with##5##5##(1991-12#1)(1995-6#1)(2006-10#1)(2008-4#1)(2011-12#1)
of infants and children##12##4##(1991-12#1)(1995-3#1)(1995-6#1)(2005-11#1)(2006-10#2)(2008-11#1)(2008-4#2)(2009-4#1)(2010-7#1)(2011-12#1)
of infants and young children##5##5##(2007-7#1)(2010-5#2)(2013-1#2)
of infants and##20##3##(1991-12#2)(1992-12#1)(1995-3#1)(1995-6#1)(2005-11#1)(2006-10#2)(2007-7#1)(2008-11#1)(2008-4#2)(2009-4#1)(2010-12#1)(2010-5#2)(2010-7#1)(2011-12#1)(2013-1#2)
of infants at##2##3##(1992-7#1)(1994-4#1)
of infants born at##2##4##(2009-5#1)(2012-2#1)
of infants born to mothers from the##2##7##(2006-8#2)
of infants born##7##3##(2006-10#1)(2006-8#2)(2007-12#1)(2007-2#1)(2009-5#1)(2012-2#1)
of infants from##2##3##(1993-2#1)(2012-1#1)
of infants in the##2##4##(2006-10#1)(2006-12#1)
of infants in##6##3##(2006-10#1)(2006-12#1)(2007-9#2)(2010-4#1)(2013-1#1)
of infants is##2##3##(1991-7#1)(2007-8#1)
of infants under##2##3##(1992-7#1)(1993-12#1)
of infants was##3##3##(2006-10#1)(2010-4#1)(2011-1#1)
of infants were##3##3##(2007-7#1)(2011-1#1)(2013-1#1)
of infants who were##2##4##(2006-8#1)(2009-4#1)
of infants with##8##3##(1994-6#2)(1995-6#1)(2005-11#2)(2006-10#1)(2008-5#1)(2011-1#1)
of infants##82##2##(1990-2#1)(1991-12#2)(1991-2#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-7#3)(1993-12#1)(1993-2#1)(1994-4#1)(1994-6#4)(1995-3#1)(1995-4#1)(1995-6#2)(1996-3#1)(1997-4#1)(2005-11#3)(2006-10#10)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#4)(2007-12#1)(2007-2#2)(2007-7#3)(2007-8#1)(2007-9#2)(2008-11#1)(2008-4#3)(2008-5#1)(2008-6#1)(2009-4#2)(2009-5#2)(2010-12#1)(2010-4#2)(2010-5#2)(2010-7#1)(2011-1#5)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#5)
of infants'##2##2##(2006-12#1)(2009-12#1)
of infarct size##2##3##(1996-9#2)
of infarct volume##2##3##(1994-5#1)(2007-10#1)
of infarct##6##2##(1994-5#1)(1996-9#2)(2007-10#1)(2007-9#1)(2008-4#1)
of infarcted##2##2##(1996-6#1)(2012-12#1)
of infarction in the##5##4##(1993-10#1)(2007-10#2)(2007-9#2)
of infarction in##7##3##(1993-10#1)(2007-10#2)(2007-9#2)(2008-7#1)(2012-2#1)
of infarction of the##2##4##(1990-2#1)(2007-10#1)
of infarction was##2##3##(1993-11#1)(2007-9#1)
of infarction##24##2##(1990-2#2)(1990-5#1)(1990-6#1)(1990-9#1)(1992-7#1)(1993-10#1)(1993-11#2)(1997-8#2)(2007-10#3)(2007-9#7)(2008-7#1)(2012-2#2)
of infected and susceptible roots over time##3##7##(2008-10#3)
of infected and##8##3##(1991-6#1)(1994-9#1)(2008-10#4)(2008-9#1)(2011-1#1)
of infected cell##3##3##(1991-1#1)(2008-11#1)(2008-9#1)
of infected cells and##2##4##(2007-11#1)(2009-5#1)
of infected cells in##2##4##(2007-10#1)(2009-7#1)
of infected cells##26##3##(1990-3#1)(1990-7#1)(1991-7#2)(1994-5#1)(1996-4#1)(1997-3#2)(1997-4#3)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-4#3)(2008-5#2)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
of infected chickens##2##3##(2008-5#2)
of infected cultures##3##3##(2008-4#1)(2008-9#2)
of infected fish from##2##4##(2010-8#2)
of infected fruit in##3##4##(2008-10#3)
of infected fruit##6##3##(2008-10#6)
of infected individuals is##3##4##(2007-12#1)(2008-3#1)(2008-4#1)
of infected individuals##6##3##(1992-12#1)(2006-10#1)(2007-12#1)(2008-3#1)(2008-4#1)(2012-12#1)
of infected leaf##2##3##(2008-10#2)
of infected leaves##4##3##(2008-10#4)
of infected maize##2##3##(2005-11#1)(2008-10#1)
of infected mice##4##3##(1996-12#1)(2008-4#1)(2010-12#1)(2012-2#1)
of infected necrosis##2##3##(2006-10#1)(2008-5#1)
of infected patients##2##3##(1993-5#1)(2009-11#1)
of infected persons and##2##4##(2006-2#1)(2008-10#1)
of infected persons##3##3##(2006-2#1)(2008-10#1)(2013-8#1)
of infected plant##3##3##(2008-10#3)
of infected plants in##3##4##(2008-10#3)
of infected plants##12##3##(2007-9#1)(2008-10#11)
of infected pollen##2##3##(2008-10#2)
of infected potato##4##3##(2008-10#4)
of infected red blood cells##2##5##(2008-5#2)
of infected roots##2##3##(2008-10#2)
of infected ticks##2##3##(1996-11#1)(2011-2#1)
of infected tissue##5##3##(2008-10#3)(2008-8#1)(2008-9#1)
of infected wounds##2##3##(2008-10#1)(2010-12#1)
of infected##176##2##(1990-3#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-6#2)(1991-7#2)(1992-12#1)(1993-12#1)(1993-5#1)(1993-9#2)(1994-5#1)(1994-7#1)(1994-9#2)(1996-11#1)(1996-12#2)(1996-4#1)(1997-3#2)(1997-4#4)(1997-6#1)(2005-11#1)(2006-10#3)(2006-2#2)(2006-5#1)(2006-6#1)(2006-8#2)(2007-10#2)(2007-11#4)(2007-12#2)(2007-2#1)(2007-7#1)(2007-9#2)(2008-10#64)(2008-11#5)(2008-3#1)(2008-4#8)(2008-5#8)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#6)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-12#4)(2010-8#2)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#2)
of infecting##8##2##(1991-11#1)(1995-2#1)(2007-2#1)(2008-10#4)(2011-3#1)
of infection (0##2##3##(2006-2#1)(2007-10#1)
of infection (MOI)##6##3##(1995-1#1)(2007-3#1)(2008-11#4)
of infection above##2##3##(1997-1#1)(2012-12#1)
of infection acquired in##2##4##(1993-12#1)(2005-8#1)
of infection acquired##3##3##(1993-12#1)(2005-8#1)(2007-2#1)
of infection after##6##3##(1991-2#1)(2007-9#1)(2008-4#1)(2008-6#1)(2009-9#1)(2011-2#1)
of infection and clinical##4##4##(1991-8#1)(2006-10#1)(2007-12#1)(2010-8#1)
of infection and disease##2##4##(1994-10#1)(2005-7#1)
of infection and for##2##4##(2011-1#1)(2012-12#1)
of infection and inflammation##2##4##(2013-1#2)
of infection and precancerous lesions##3##5##(2011-3#3)
of infection and the##5##4##(1995-1#1)(2008-10#1)(2008-8#1)(2009-5#1)(2012-12#1)
of infection and##56##3##(1991-8#1)(1994-10#1)(1994-11#1)(1995-1#1)(1997-4#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#3)(2012-1#1)(2012-12#5)(2012-2#3)(2013-1#2)
of infection are##7##3##(2005-10#1)(2005-12#1)(2007-11#1)(2007-7#1)(2012-12#1)(2013-1#2)
of infection as##3##3##(2006-10#1)(2008-6#1)(2011-2#1)
of infection at##3##3##(2008-10#1)(2008-5#1)(2009-8#1)
of infection but##2##3##(2006-6#1)(2011-1#1)
of infection by the human immunodeficiency virus (HIV)##2##8##(1990-9#1)(2006-8#1)
of infection by the##3##4##(1990-9#1)(2006-8#1)(2007-2#1)
of infection by##25##3##(1990-9#1)(1991-6#1)(1995-5#1)(2006-8#1)(2007-12#1)(2007-2#2)(2008-10#10)(2009-2#1)(2009-8#1)(2011-12#1)(2012-12#1)(2012-2#2)(2013-1#2)
of infection can be##3##4##(1997-1#1)(2009-2#1)(2009-9#1)
of infection caused by##4##4##(2007-11#1)(2007-12#1)(2008-10#1)(2010-10#1)
of infection control##3##3##(1993-2#1)(2006-8#1)(2008-11#1)
of infection courts##2##3##(2008-10#2)
of infection decreases##2##3##(1994-6#1)(2011-1#1)
of infection for##13##3##(1991-7#1)(2006-10#2)(2008-10#3)(2008-4#2)(2008-7#2)(2008-8#1)(2012-12#1)(2013-1#1)
of infection from##3##3##(2006-10#1)(2007-7#1)(2007-8#1)
of infection hyphae from##2##4##(2008-10#1)(2012-2#1)
of infection in a##4##4##(1992-6#2)(1996-8#1)(2007-11#1)
of infection in both##2##4##(2008-10#2)
of infection in humans##2##4##(1996-6#1)(2008-10#1)
of infection in patients##2##4##(1990-4#1)(2012-2#1)
of infection in the##10##4##(1991-6#1)(2006-10#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-5#1)(2011-2#2)(2013-1#1)
of infection in these##2##4##(2007-7#1)(2008-7#1)
of infection in##56##3##(1990-4#2)(1991-6#1)(1992-6#2)(1993-8#1)(1994-6#1)(1994-9#1)(1996-6#1)(1996-8#1)(2005-7#1)(2006-10#4)(2007-11#1)(2007-12#5)(2007-7#2)(2008-10#13)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-5#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#3)
of infection is the##3##4##(1991-3#1)(2007-12#1)(2008-10#1)
of infection is##14##3##(1991-3#1)(1996-4#1)(2006-10#3)(2007-12#2)(2007-3#1)(2008-10#3)(2011-1#1)(2011-12#1)(2012-2#1)
of infection may be##2##4##(2006-10#1)(2007-8#1)
of infection of the##4##4##(1992-11#1)(1994-11#1)(1997-3#1)(2009-6#1)
of infection of##17##3##(1992-11#1)(1994-11#1)(1997-3#1)(2006-8#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-8#1)(2009-6#1)(2011-1#1)(2011-12#1)(2012-2#1)
of infection on##6##3##(2006-6#1)(2008-12#1)(2008-7#1)(2010-5#1)(2010-8#1)(2013-1#1)
of infection or##11##3##(1991-2#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-10#1)(2008-10#1)(2011-2#2)(2012-1#1)(2013-1#2)
of infection should##2##3##(1995-2#1)(2008-7#1)
of infection that##2##3##(2009-5#1)(2013-7#1)
of infection through##5##3##(2008-10#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-12#1)
of infection to##2##3##(2008-10#1)(2008-5#1)
of infection type##2##3##(2008-10#2)
of infection was##10##3##(1990-8#1)(1992-12#1)(2007-7#1)(2008-10#3)(2008-12#1)(2009-6#1)(2012-12#2)
of infection were generally##2##4##(1993-10#1)(2008-10#1)
of infection were observed##3##4##(2007-1#1)(2008-10#1)(2012-2#1)
of infection were similar##2##4##(2007-7#1)(2008-10#1)
of infection were##14##3##(1993-10#1)(2007-1#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-7#2)(2012-12#2)(2012-2#1)
of infection with an##2##4##(2008-11#1)(2011-2#1)
of infection with human immunodeficiency virus##2##6##(1991-2#1)(2009-12#1)
of infection with this organism##2##5##(1992-10#1)(2006-8#1)
of infection with##24##3##(1991-2#1)(1992-10#1)(1992-11#1)(1992-8#1)(1993-8#1)(1995-5#1)(1996-6#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-9#1)(2011-2#3)(2012-11#1)
of infection##532##2##(1990-2#1)(1990-3#1)(1990-4#3)(1990-8#1)(1990-9#1)(1991-2#3)(1991-3#2)(1991-6#2)(1991-7#1)(1991-8#3)(1992-10#2)(1992-11#2)(1992-12#2)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-12#3)(1993-2#2)(1993-8#2)(1994-10#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#3)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-5#2)(1995-8#1)(1996-11#1)(1996-12#3)(1996-3#1)(1996-4#1)(1996-6#2)(1996-8#1)(1997-1#5)(1997-3#2)(1997-4#3)(1997-6#2)(2004-9#2)(2005-10#3)(2005-11#1)(2005-12#1)(2005-7#4)(2005-8#6)(2005-9#2)(2006-10#22)(2006-12#1)(2006-2#4)(2006-4#1)(2006-5#1)(2006-6#4)(2006-8#8)(2007-1#1)(2007-10#5)(2007-11#7)(2007-12#14)(2007-2#10)(2007-3#2)(2007-6#1)(2007-7#20)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#94)(2008-11#13)(2008-12#6)(2008-2#2)(2008-4#12)(2008-5#9)(2008-6#4)(2008-7#17)(2008-8#11)(2008-9#4)(2009-1#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#4)(2009-6#4)(2009-8#2)(2009-9#5)(2010-10#2)(2010-11#1)(2010-12#4)(2010-3#2)(2010-5#2)(2010-6#3)(2010-8#5)(2011-1#9)(2011-10#1)(2011-12#5)(2011-2#22)(2011-3#4)(2012-1#2)(2012-11#1)(2012-12#19)(2012-2#16)(2012-3#8)(2013-1#21)(2013-7#1)(2013-8#4)
of infection)##4##2##(2007-11#1)(2008-5#1)(2011-3#2)
of infection-related##2##2##(2008-4#1)(2012-12#1)
of infections and malignancies##2##4##(1996-8#1)(2007-11#1)
of infections and##6##3##(1990-6#1)(1995-3#1)(1996-8#1)(2007-11#1)(2007-7#1)(2011-2#1)
of infections are caused by##2##5##(2007-12#1)(2011-12#1)
of infections are##3##3##(2007-12#1)(2011-12#1)(2013-8#1)
of infections at##2##3##(2008-10#2)
of infections by##4##3##(2009-9#2)(2010-12#1)(2012-2#1)
of infections caused by##10##4##(1990-8#3)(2006-10#1)(2006-8#1)(2007-9#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
of infections due to##2##4##(2006-7#1)(2012-2#1)
of infections due##3##3##(2006-7#1)(2008-3#1)(2012-2#1)
of infections following##2##3##(1993-1#1)(2008-8#1)
of infections in a##3##4##(1993-5#2)(2006-10#1)
of infections in patients with##2##5##(2007-11#2)
of infections in patients##3##4##(1990-12#1)(2007-11#2)
of infections in##16##3##(1990-12#2)(1992-6#1)(1993-5#2)(2005-8#1)(2006-10#1)(2007-11#3)(2008-1#1)(2008-10#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-2#1)
of infections is##2##3##(2009-2#1)(2011-2#1)
of infections may##2##3##(2007-10#1)(2008-10#1)
of infections of the##2##4##(2006-10#1)(2010-12#1)
of infections of##4##3##(1991-8#1)(2006-10#1)(2010-12#2)
of infections or##2##3##(1994-11#1)(2007-11#1)
of infections such as##2##4##(2008-11#1)(2008-7#1)
of infections with##6##3##(1995-8#1)(1996-11#1)(2006-10#2)(2007-7#1)(2008-8#1)
of infections##104##2##(1990-12#4)(1990-2#1)(1990-6#2)(1990-8#3)(1991-8#1)(1992-11#1)(1992-2#1)(1992-6#2)(1993-1#1)(1993-5#2)(1994-11#1)(1994-6#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-8#1)(1997-2#2)(1997-5#1)(2005-8#1)(2006-10#6)(2006-12#1)(2006-4#2)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#10)(2007-12#2)(2007-2#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#3)(2009-9#2)(2010-12#3)(2010-5#3)(2011-12#1)(2011-2#6)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#3)
of infectious RNA##2##3##(1996-4#1)(2008-10#1)
of infectious agents in##2##4##(1991-11#1)(2008-6#1)
of infectious agents##9##3##(1991-11#1)(1996-12#1)(1997-6#1)(2006-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2010-4#1)(2012-1#1)
of infectious and##5##3##(1997-8#1)(2008-1#1)(2008-4#1)(2010-2#1)(2010-7#1)
of infectious arthritis##3##3##(2006-10#2)(2007-11#1)
of infectious bronchitis virus (IBV)##9##5##(1997-3#1)(1997-6#2)(2008-5#6)
of infectious bronchitis virus in##2##5##(1997-6#1)(2008-5#1)
of infectious bronchitis virus isolated##3##5##(2008-5#3)
of infectious bronchitis virus##21##4##(1992-10#1)(1992-5#1)(1996-11#1)(1997-3#2)(1997-6#4)(2008-5#12)
of infectious bursal disease virus##5##5##(2005-7#1)(2008-5#2)(2012-2#2)
of infectious complications after##3##4##(2006-10#2)(2011-2#1)
of infectious complications in##4##4##(2006-10#2)(2007-7#1)(2008-1#1)
of infectious complications##11##3##(1990-8#1)(1991-12#1)(1994-4#1)(2006-10#4)(2007-7#1)(2008-1#1)(2011-2#2)
of infectious coryza in##2##4##(1997-3#1)(2008-5#1)
of infectious coryza##5##3##(1997-3#1)(2008-5#4)
of infectious diarrhoea##2##3##(2010-4#2)
of infectious disease in##2##4##(1991-3#1)(2010-2#1)
of infectious disease##15##3##(1991-3#1)(1993-9#1)(1995-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-12#1)(2010-2#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
of infectious diseases and##3##4##(2008-7#1)(2012-3#1)(2013-8#1)
of infectious diseases such as##3##5##(1991-4#1)(2008-3#1)(2011-2#1)
of infectious diseases##40##3##(1990-6#1)(1991-4#1)(1993-10#1)(1994-6#2)(1995-9#1)(1996-11#2)(2006-10#3)(2006-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#4)(2008-7#1)(2009-6#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#2)
of infectious intestinal##3##3##(1996-3#2)(2006-10#1)
of infectious laryngotracheitis virus (ILTV)##2##5##(2013-8#2)
of infectious laryngotracheitis virus##4##4##(2013-8#4)
of infectious laryngotracheitis##5##3##(2013-8#5)
of infectious markers##2##3##(1991-3#1)(2007-7#1)
of infectious organisms can be##2##5##(2008-9#1)(2012-3#1)
of infectious pancreatic necrosis virus##2##5##(2009-5#1)(2012-3#1)
of infectious salmon anaemia virus (ISAV)##2##6##(2009-6#2)
of infectious sinusitis##2##3##(1993-5#2)
of infectious sources##2##3##(2012-3#2)
of infectious viral##2##3##(1991-10#1)(2008-9#1)
of infectious virus##5##3##(2008-5#2)(2012-2#2)(2013-8#1)
of infectious##184##2##(1990-2#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-4#1)(1992-10#1)(1992-3#1)(1992-5#1)(1993-10#1)(1993-5#2)(1993-9#1)(1994-12#1)(1994-4#1)(1994-6#2)(1995-4#1)(1995-8#1)(1995-9#1)(1996-11#3)(1996-12#1)(1996-3#2)(1996-4#4)(1997-3#4)(1997-6#5)(1997-7#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-10#14)(2006-8#1)(2007-1#1)(2007-11#6)(2007-12#3)(2007-2#2)(2007-7#4)(2008-1#3)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#6)(2008-5#21)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-2#1)(2009-5#1)(2009-6#3)(2010-2#4)(2010-3#1)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#9)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#9)(2012-3#7)(2013-8#9)
of infective diseases##2##3##(2008-1#1)(2009-5#1)
of infective endocarditis##10##3##(2005-12#1)(2006-10#2)(2006-6#1)(2007-7#1)(2008-4#1)(2009-8#1)(2010-9#1)(2011-2#1)(2013-8#1)
of infective insects##2##3##(2008-10#2)
of infective##28##2##(1991-11#1)(2005-12#1)(2005-7#1)(2006-10#4)(2006-4#1)(2006-6#1)(2007-7#2)(2008-1#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#2)(2009-5#1)(2009-8#1)(2010-9#1)(2011-2#3)(2012-2#1)(2013-8#1)
of infectivity of##2##3##(1997-4#1)(2008-10#1)
of infectivity##6##2##(1996-6#1)(1997-4#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-2#1)
of inference##4##2##(2008-3#1)(2008-7#1)(2008-8#1)(2013-1#1)
of inferences##2##2##(2005-11#1)(2011-1#1)
of inferior competitors##2##3##(2008-8#2)
of inferior eyelid##4##3##(2007-11#4)
of inferior pancreaticoduodenal artery##2##4##(2008-7#2)
of inferior vena cava##3##4##(2008-7#2)(2013-1#1)
of inferior##20##2##(1997-5#1)(1997-6#1)(2007-11#4)(2007-12#1)(2007-3#1)(2007-7#1)(2008-2#3)(2008-7#4)(2008-8#2)(2008-9#1)(2013-1#1)
of inferring##6##2##(1995-3#1)(2006-10#1)(2006-4#1)(2007-3#1)(2008-10#1)(2008-2#1)
of infertile couples who##2##4##(2009-4#1)(2013-8#1)
of infertile men##4##3##(1990-9#1)(2008-10#2)(2008-12#1)
of infertile##11##2##(1990-9#1)(1996-12#1)(2007-10#1)(2008-10#2)(2008-12#4)(2009-4#1)(2013-8#1)
of infertility and##3##3##(2004-10#1)(2005-7#1)(2006-7#1)
of infertility in##2##3##(2005-8#1)(2012-2#1)
of infertility##23##2##(1991-11#1)(1991-12#1)(1991-3#1)(1994-12#1)(1995-7#1)(1996-12#1)(2004-10#2)(2005-7#1)(2005-8#1)(2006-7#1)(2007-11#1)(2008-3#1)(2009-2#1)(2010-8#4)(2011-1#1)(2012-2#1)(2013-8#3)
of infestation by##2##3##(2008-10#1)(2012-12#1)
of infestation for##2##3##(2011-2#2)
of infestation##11##2##(1996-12#1)(2007-2#1)(2008-10#3)(2008-12#1)(2011-2#2)(2012-12#3)
of infested##5##2##(2008-10#3)(2008-12#1)(2011-2#1)
of infiltrating CD3+ T cells##2##5##(2007-8#2)
of infiltrating##7##2##(1991-2#1)(1992-8#1)(1993-9#1)(2007-5#1)(2007-8#2)(2008-5#1)
of infiltration of##2##3##(2007-11#1)(2012-12#1)
of infiltration##6##2##(1994-9#1)(1995-4#1)(1996-8#1)(2007-11#1)(2007-7#1)(2012-12#1)
of infiltrative##2##2##(2009-2#1)(2012-2#1)
of infinite##5##2##(1991-6#1)(1997-7#1)(2005-11#1)(2008-11#1)(2008-3#1)
of infirmary##4##2##(2008-10#4)
of inflamed##3##2##(1992-7#1)(1994-9#1)(2008-10#1)
of inflammation (e##2##3##(2008-3#1)(2008-4#1)
of inflammation and immune##2##4##(1991-12#1)(1994-11#1)
of inflammation and tissue##2##4##(1992-11#1)(2008-7#1)
of inflammation and##32##3##(1990-5#1)(1991-12#1)(1992-10#1)(1992-11#1)(1992-9#1)(1993-11#2)(1994-11#1)(1995-3#1)(1997-1#1)(2006-10#3)(2006-12#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
of inflammation are##2##3##(1995-4#1)(2011-2#1)
of inflammation in the##4##4##(2005-10#1)(2005-8#1)(2012-2#2)
of inflammation in##13##3##(2005-10#1)(2005-8#1)(2006-12#1)(2007-10#1)(2008-3#2)(2008-7#1)(2008-8#2)(2010-2#1)(2012-2#2)(2013-7#1)
of inflammation into##2##3##(2005-11#1)(2009-4#1)
of inflammation is##2##3##(1993-12#1)(2009-10#1)
of inflammation may##2##3##(2006-10#1)(2008-1#1)
of inflammation on##2##3##(2006-3#1)(2006-5#1)
of inflammation or##5##3##(1992-6#1)(2006-10#1)(2006-7#1)(2007-7#1)(2008-5#1)
of inflammation versus##2##3##(2007-8#2)
of inflammation with##2##3##(2006-10#1)(2008-3#1)
of inflammation##142##2##(1990-2#1)(1990-4#1)(1990-5#2)(1991-12#1)(1991-2#1)(1992-10#1)(1992-11#2)(1992-4#1)(1992-6#1)(1992-7#2)(1992-9#2)(1993-11#2)(1993-12#1)(1993-2#3)(1993-4#1)(1994-11#2)(1994-12#1)(1995-3#1)(1995-4#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-5#1)(2005-10#2)(2005-11#1)(2005-8#1)(2006-10#9)(2006-12#2)(2006-2#2)(2006-3#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#5)(2008-10#5)(2008-3#5)(2008-4#7)(2008-5#5)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#2)(2009-4#1)(2009-6#2)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#3)(2010-2#2)(2010-8#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#8)(2013-7#3)(2013-8#2)
of inflammation-induced##2##2##(2006-10#1)(2008-5#1)
of inflammation-related##2##2##(2009-6#1)(2013-1#1)
of inflammatory and autoimmune diseases##2##5##(2008-12#1)(2010-4#1)
of inflammatory and infectious##2##4##(2013-1#1)(2013-8#1)
of inflammatory and##16##3##(1994-9#1)(2007-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2012-2#2)(2013-1#2)(2013-8#1)
of inflammatory arthritis##5##3##(2004-9#1)(2006-10#3)(2007-10#1)
of inflammatory bowel disease (IBD)##9##5##(2005-6#1)(2006-10#5)(2008-11#1)(2009-9#1)(2010-12#1)
of inflammatory bowel disease in##4##5##(2006-10#1)(2008-4#1)(2012-11#2)
of inflammatory bowel disease##51##4##(1991-8#1)(2005-12#1)(2005-6#1)(2005-8#1)(2006-10#23)(2006-2#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-4#1)(2009-6#2)(2009-9#2)(2010-12#6)(2010-2#1)(2011-1#1)(2012-11#3)(2013-8#1)
of inflammatory bowel disease]##5##4##(1997-3#1)(2012-11#4)
of inflammatory bowel diseases##6##4##(1996-2#2)(2008-12#1)(2011-1#2)(2011-12#1)
of inflammatory bowel diseases]##2##4##(2006-2#1)(2008-4#1)
of inflammatory bowel##64##3##(1991-8#1)(1996-2#2)(1997-3#1)(2005-12#1)(2005-6#1)(2005-8#1)(2006-10#23)(2006-2#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-7#1)(2009-4#1)(2009-6#2)(2009-9#2)(2010-12#6)(2010-2#1)(2011-1#3)(2011-12#1)(2012-11#7)(2013-8#1)
of inflammatory cell##2##3##(1991-5#1)(2010-6#1)
of inflammatory cells and##3##4##(2006-10#1)(2010-12#1)(2012-12#1)
of inflammatory cells in the##4##5##(1997-8#1)(2008-10#1)(2008-3#1)(2012-2#1)
of inflammatory cells in##5##4##(1997-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2012-2#1)
of inflammatory cells##20##3##(1990-8#1)(1992-2#1)(1992-5#1)(1993-4#1)(1996-12#1)(1997-8#1)(2004-9#1)(2005-8#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#1)(2009-10#1)(2010-12#1)(2012-12#1)(2012-2#1)
of inflammatory changes##2##3##(2007-11#2)
of inflammatory complications##2##3##(2007-11#1)(2013-1#1)
of inflammatory conditions##8##3##(2005-6#1)(2005-8#1)(2007-12#1)(2008-11#1)(2010-12#1)(2012-3#1)(2013-1#2)
of inflammatory cytokine##4##3##(1991-8#2)(2008-5#1)(2009-2#1)
of inflammatory cytokines##8##3##(2006-4#1)(2007-11#3)(2008-1#1)(2008-10#1)(2009-10#1)(2011-1#1)
of inflammatory disease##4##3##(1992-4#1)(1993-11#1)(2008-8#1)(2012-12#1)
of inflammatory diseases of##3##4##(1995-12#1)(2010-4#1)(2012-3#1)
of inflammatory diseases##15##3##(1995-12#1)(2005-8#1)(2007-2#1)(2008-10#1)(2008-12#2)(2010-1#1)(2010-12#1)(2010-4#1)(2011-1#2)(2012-12#2)(2012-3#1)(2013-1#1)
of inflammatory disorders##2##3##(2005-8#1)(2007-11#1)
of inflammatory joint diseases##2##4##(2010-5#2)
of inflammatory lesions of##2##4##(2006-8#1)(2010-5#1)
of inflammatory lesions##5##3##(1991-3#1)(2006-8#1)(2008-12#1)(2010-5#1)(2011-2#1)
of inflammatory markers##5##3##(2005-10#1)(2008-1#2)(2008-3#1)(2008-5#1)
of inflammatory mediators and##5##4##(2008-12#1)(2008-4#1)(2013-1#3)
of inflammatory mediators such as##2##5##(1996-5#1)(2011-2#1)
of inflammatory mediators that##2##4##(2007-11#1)(2008-7#1)
of inflammatory mediators##21##3##(1996-5#1)(2004-11#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-11#2)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#3)(2009-11#1)(2010-2#1)(2011-2#1)(2013-1#4)
of inflammatory myopathies##5##3##(2009-9#5)
of inflammatory myositis##2##3##(2006-10#2)
of inflammatory or##2##3##(1995-5#1)(2008-7#1)
of inflammatory pain##10##3##(1996-3#2)(2005-7#4)(2006-10#3)(2006-12#1)
of inflammatory periimplant##2##3##(2011-12#2)
of inflammatory proteins##2##3##(1997-3#1)(2006-9#1)
of inflammatory reaction##2##3##(2012-1#1)(2013-1#1)
of inflammatory reactions##2##3##(2006-9#1)(2010-12#1)
of inflammatory responses##4##3##(1992-3#1)(2008-10#1)(2008-8#1)(2012-3#1)
of inflammatory skin##3##3##(2007-11#1)(2007-7#1)(2008-3#1)
of inflammatory tissue##2##3##(1994-5#1)(2006-10#1)
of inflammatory##280##2##(1990-6#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-8#5)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#2)(1997-3#2)(1997-8#1)(2004-11#1)(2004-12#1)(2004-9#2)(2005-10#1)(2005-11#3)(2005-12#1)(2005-6#2)(2005-7#6)(2005-8#6)(2006-10#37)(2006-12#1)(2006-2#4)(2006-4#1)(2006-8#3)(2006-9#2)(2007-10#3)(2007-11#13)(2007-12#1)(2007-2#3)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#6)(2008-10#5)(2008-11#2)(2008-12#6)(2008-3#7)(2008-4#6)(2008-5#6)(2008-7#10)(2008-8#2)(2009-1#2)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#3)(2009-6#2)(2009-8#1)(2009-9#7)(2010-1#1)(2010-10#2)(2010-12#12)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#4)(2010-6#3)(2011-1#8)(2011-12#3)(2011-2#3)(2012-1#1)(2012-11#7)(2012-12#4)(2012-2#6)(2012-3#3)(2013-1#14)(2013-7#1)(2013-8#3)
of inflation##3##2##(1992-9#1)(1996-3#1)(2006-8#1)
of infliximab in##8##3##(2006-10#1)(2007-11#2)(2009-6#1)(2009-8#1)(2010-12#1)(2011-2#2)
of infliximab therapy in##2##4##(2008-8#1)(2010-12#1)
of infliximab therapy##5##3##(2006-10#1)(2008-8#1)(2010-12#2)(2012-3#1)
of infliximab was##2##3##(2007-11#1)(2008-8#1)
of infliximab##26##2##(2006-10#5)(2007-11#6)(2007-12#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-6#1)(2009-8#1)(2010-12#3)(2011-2#3)(2012-3#2)
of inflorescence architecture##2##3##(1996-2#2)
of inflorescence##3##2##(1996-2#2)(2009-5#1)
of inflow##3##2##(1997-3#1)(2008-7#1)(2009-7#1)
of influence of##12##3##(2005-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-7#1)
of influence##32##2##(1990-12#1)(1996-1#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-5#5)(2008-6#1)(2008-8#2)(2010-10#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
of influences on##2##3##(2008-6#1)(2010-1#1)
of influences##5##2##(1997-1#1)(2005-8#1)(2007-4#1)(2008-6#1)(2010-1#1)
of influencing the##3##3##(1994-2#1)(1994-8#1)(2007-11#1)
of influencing##7##2##(1994-10#1)(1994-2#1)(1994-8#1)(1995-3#1)(2007-11#1)(2010-10#1)(2012-2#1)
of influential##7##2##(1996-12#1)(2005-4#1)(2008-10#4)(2008-9#1)
of influenza A and B##2##5##(2008-5#1)(2011-1#1)
of influenza A in##2##4##(1992-2#1)(2007-12#1)
of influenza A infection##2##4##(2011-1#1)(2011-2#1)
of influenza A virus##11##4##(1990-11#2)(1992-9#1)(1995-5#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
of influenza A viruses##5##4##(1992-9#2)(1996-6#1)(2013-1#1)(2013-8#1)
of influenza A##28##3##(1990-11#2)(1992-2#2)(1992-6#1)(1992-9#3)(1995-5#1)(1996-6#1)(2007-12#1)(2008-5#1)(2008-9#1)(2010-4#1)(2011-1#4)(2011-2#4)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#2)
of influenza A(H1N1)##2##3##(1994-9#1)(2011-2#1)
of influenza A(H3N2) viruses##2##4##(2013-8#2)
of influenza A(H3N2)##4##3##(1994-9#1)(2013-8#3)
of influenza B##4##3##(1997-2#1)(2010-1#1)(2011-2#2)
of influenza and##5##3##(1991-8#1)(1993-5#1)(1996-11#1)(2005-8#1)(2009-4#1)
of influenza have##2##3##(2009-9#1)(2011-2#1)
of influenza hemagglutinin##2##3##(1993-3#1)(2012-2#1)
of influenza in##5##3##(1996-6#1)(2008-4#1)(2008-5#1)(2009-5#1)(2012-3#1)
of influenza or##2##3##(1997-7#1)(2010-12#1)
of influenza pandemic##2##3##(2010-4#1)(2011-2#1)
of influenza vaccination in##2##4##(2008-3#1)(2009-12#1)
of influenza vaccination##5##3##(2005-11#1)(2007-12#1)(2008-3#1)(2009-12#1)(2011-2#1)
of influenza vaccine in##2##4##(1991-8#1)(1996-1#1)
of influenza vaccine##4##3##(1991-8#1)(1996-1#3)
of influenza vaccines##2##3##(2007-8#1)(2009-12#1)
of influenza virus and##2##4##(2013-7#1)(2013-8#1)
of influenza virus infections##3##4##(2006-10#1)(2007-1#1)(2008-5#1)
of influenza virus##19##3##(1990-5#2)(1992-2#1)(1993-6#2)(1995-5#1)(1997-2#1)(2004-2#1)(2006-10#2)(2007-1#2)(2008-5#1)(2010-12#1)(2012-3#2)(2013-7#1)(2013-8#2)
of influenza viruses in humans##2##5##(2011-2#2)
of influenza viruses in##6##4##(2011-2#2)(2013-1#3)(2013-8#1)
of influenza viruses##7##3##(2011-2#2)(2013-1#4)(2013-8#1)
of influenza##121##2##(1990-11#2)(1990-5#2)(1991-3#1)(1991-8#2)(1992-2#3)(1992-6#1)(1992-9#3)(1993-3#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-9#2)(1995-10#1)(1995-5#4)(1996-1#3)(1996-11#1)(1996-6#3)(1997-2#2)(1997-4#1)(1997-7#1)(2004-11#1)(2004-2#1)(2005-11#1)(2005-8#1)(2006-10#3)(2007-1#2)(2007-11#1)(2007-12#4)(2007-8#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-9#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-4#3)(2010-7#2)(2011-1#4)(2011-2#16)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#9)(2013-7#2)(2013-8#8)
of influenza-like illness##2##3##(2013-1#2)
of influenza-like##3##2##(1996-12#1)(2013-1#2)
of influx##2##2##(1990-2#1)(1997-5#1)
of informal##6##2##(1992-1#1)(2007-2#1)(2008-12#1)(2009-5#1)(2012-11#1)(2013-1#1)
of informants##2##2##(1994-1#1)(2011-2#1)
of informatics##3##2##(2011-1#1)(2013-1#2)
of information about the##7##4##(1996-2#1)(2004-2#1)(2008-4#1)(2009-4#1)(2011-2#2)(2013-7#1)
of information about##25##3##(1992-7#1)(1993-2#2)(1995-12#2)(1995-5#1)(1996-11#1)(1996-2#1)(2004-2#1)(2007-5#2)(2007-9#1)(2008-1#1)(2008-2#1)(2008-4#3)(2008-7#1)(2009-10#1)(2009-4#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-7#1)
of information among##2##3##(1996-12#1)(2012-1#1)
of information and communication technologies##3##5##(2004-10#1)(2011-1#1)(2012-12#1)
of information and communication##4##4##(1996-4#1)(2004-10#1)(2011-1#1)(2012-12#1)
of information and experience##2##4##(2005-10#1)(2009-5#1)
of information and##26##3##(1990-11#1)(1990-12#1)(1993-2#1)(1993-4#1)(1994-1#1)(1994-12#1)(1996-11#1)(1996-4#1)(2004-10#1)(2005-10#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)
of information are##6##3##(1991-5#1)(1992-8#1)(1995-12#1)(1997-7#1)(2008-12#1)(2011-2#1)
of information as##2##3##(1997-6#1)(2007-6#1)
of information available to##2##4##(1997-3#1)(2008-11#1)
of information available##9##3##(1991-2#1)(1995-12#1)(1995-3#1)(1997-3#2)(2006-12#1)(2008-11#1)(2008-4#1)(2013-7#1)
of information between##8##3##(1992-11#1)(1992-12#1)(1996-2#1)(2008-11#1)(2008-2#1)(2008-5#1)(2012-11#1)(2013-1#1)
of information by##2##3##(1996-11#1)(2010-5#1)
of information can be##3##4##(2006-10#1)(2008-3#1)(2010-5#1)
of information concerning the##2##4##(2006-5#1)(2008-6#1)
of information concerning##8##3##(1991-2#3)(2006-5#1)(2008-6#1)(2010-11#1)(2010-3#1)(2013-8#1)
of information contained##2##3##(1992-3#1)(2008-7#1)
of information exchange##3##3##(1996-2#1)(2013-1#2)
of information extraction##3##3##(2008-7#1)(2013-1#2)
of information flow in##2##4##(2010-8#1)(2012-2#1)
of information for##9##3##(1997-3#1)(2006-2#1)(2007-5#1)(2007-8#1)(2008-8#1)(2008-9#1)(2011-12#1)(2012-3#1)(2013-1#1)
of information from different##2##4##(1996-2#1)(2011-2#1)
of information from one##2##4##(2007-12#1)(2011-12#1)
of information from the##6##4##(1994-6#1)(2005-10#1)(2008-2#1)(2011-2#1)(2012-12#2)
of information from##19##3##(1992-12#1)(1994-2#1)(1994-6#1)(1996-2#1)(2005-10#1)(2006-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#2)
of information gathered##4##3##(1993-3#1)(2006-7#1)(2007-3#1)(2008-8#1)
of information generated##3##3##(1993-12#1)(2009-5#1)(2010-2#1)
of information in consumer##2##4##(1997-3#2)
of information in the literature##2##5##(1992-2#1)(2008-1#1)
of information in the##6##4##(1992-2#1)(2005-6#1)(2008-1#1)(2008-4#1)(2009-4#1)(2013-1#1)
of information in##17##3##(1992-2#2)(1993-2#1)(1993-6#1)(1995-1#1)(1995-2#1)(1997-3#2)(2005-6#1)(2008-1#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
of information is##9##3##(1990-10#1)(1993-3#1)(1994-3#1)(2007-12#1)(2008-10#2)(2008-7#2)(2012-1#1)
of information needed##3##3##(1997-1#1)(2008-4#1)(2008-6#1)
of information on the##11##4##(1996-3#1)(1997-3#1)(2006-10#1)(2007-12#3)(2008-3#1)(2009-5#1)(2012-12#1)(2012-2#2)
of information on##29##3##(1991-11#1)(1991-5#1)(1994-3#1)(1996-3#1)(1997-3#3)(1997-8#1)(2006-10#1)(2006-6#1)(2007-12#3)(2007-3#1)(2008-10#1)(2008-3#2)(2008-8#1)(2009-5#1)(2010-11#1)(2010-7#2)(2012-12#1)(2012-2#4)(2012-3#2)
of information processing##3##3##(1993-5#1)(2006-3#1)(2012-12#1)
of information provided by the##3##5##(1992-12#1)(1996-1#1)(2008-10#1)
of information provided by##5##4##(1992-12#1)(1996-1#1)(2008-10#1)(2008-11#1)(2012-2#1)
of information regarding the##2##4##(1995-12#1)(2006-10#1)
of information regarding##7##3##(1995-12#1)(2005-7#1)(2006-10#2)(2013-1#2)(2013-8#1)
of information relative to##2##4##(2008-4#1)(2008-7#1)
of information resources##2##3##(2008-11#1)(2008-7#1)
of information retrieval##2##3##(1994-8#1)(2008-8#1)
of information systems (IS)##2##4##(1993-12#1)(1996-1#1)
of information systems to##2##4##(1996-12#1)(2012-11#1)
of information systems##7##3##(1993-12#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-3#1)(2011-1#1)(2012-11#1)
of information technologies##3##3##(2010-8#2)(2013-1#1)
of information technology in##5##4##(1993-2#1)(2007-4#1)(2008-10#2)(2008-7#1)
of information technology solutions##2##4##(2007-4#2)
of information technology##14##3##(1993-2#2)(1996-3#1)(2007-4#3)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2011-1#2)(2013-1#1)
of information that can be##3##5##(2008-12#1)(2008-4#2)
of information that is##3##4##(1992-9#1)(2006-1#1)(2010-12#1)
of information that##11##3##(1992-9#1)(1995-12#2)(2006-1#1)(2008-12#1)(2008-4#2)(2008-7#1)(2010-10#1)(2010-12#1)(2012-12#1)
of information theoretical quantities##2##4##(1997-8#2)
of information through##2##3##(2007-3#1)(2010-2#1)
of information to the##4##4##(1990-2#1)(1991-10#1)(2006-3#1)(2011-2#1)
of information to##15##3##(1990-2#1)(1991-10#1)(1991-3#1)(2006-10#1)(2006-2#1)(2006-3#2)(2006-7#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-4#1)(2010-11#1)(2011-10#1)(2011-2#1)
of information used##2##3##(1994-2#1)(1997-3#1)
of information was##4##3##(1997-1#1)(2006-10#1)(2008-10#1)(2011-1#1)
of information with##2##3##(1994-5#1)(2008-2#1)
of information##401##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#4)(1991-3#2)(1991-5#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-2#6)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#2)(1993-9#1)(1994-1#2)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#3)(1995-1#2)(1995-12#10)(1995-2#3)(1995-3#3)(1995-5#1)(1996-1#3)(1996-11#3)(1996-12#4)(1996-2#5)(1996-3#6)(1996-4#1)(1997-1#2)(1997-2#1)(1997-3#14)(1997-6#1)(1997-7#2)(1997-8#3)(2004-10#1)(2004-2#1)(2005-10#2)(2005-6#2)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#7)(2006-12#1)(2006-2#3)(2006-3#4)(2006-5#3)(2006-6#1)(2006-7#3)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#8)(2007-2#2)(2007-3#4)(2007-4#4)(2007-5#4)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#4)(2008-10#9)(2008-11#11)(2008-12#2)(2008-2#7)(2008-3#10)(2008-4#15)(2008-5#2)(2008-6#3)(2008-7#16)(2008-8#5)(2008-9#4)(2009-10#4)(2009-11#1)(2009-4#4)(2009-5#3)(2009-7#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#8)(2011-1#13)(2011-10#1)(2011-12#2)(2011-2#11)(2012-1#2)(2012-11#2)(2012-12#8)(2012-2#9)(2012-3#3)(2013-1#25)(2013-7#3)(2013-8#5)
of information)##2##2##(2008-7#1)(2012-2#1)
of informational##5##2##(1992-12#1)(1996-4#1)(1997-3#1)(2007-11#1)(2008-4#1)
of informative##4##2##(1990-9#1)(2010-12#1)(2012-1#2)
of informed consent and##3##4##(2007-11#1)(2007-2#1)(2009-8#1)
of informed consent for##3##4##(1997-6#1)(2012-1#1)(2012-11#1)
of informed consent in##4##4##(2007-5#1)(2008-12#1)(2008-9#1)(2012-1#1)
of informed consent is##2##4##(2006-3#1)(2008-7#1)
of informed consent on##2##4##(2012-1#1)(2012-12#1)
of informed consent##29##3##(1993-2#3)(1996-11#1)(1997-6#1)(2006-3#2)(2006-8#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-5#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-8#2)(2010-2#1)(2012-1#4)(2012-11#1)(2012-12#1)
of informed consent?##2##3##(1993-1#1)(2009-8#1)
of informed##32##2##(1993-1#1)(1993-2#3)(1996-11#1)(1996-12#1)(1997-6#1)(2006-3#2)(2006-8#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-5#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-8#3)(2010-2#1)(2012-1#4)(2012-11#1)(2012-12#1)
of informing##5##2##(1994-2#1)(1996-11#1)(1996-4#1)(2008-8#1)(2009-9#1)
of infrared (IR)##2##3##(2007-12#1)(2008-3#1)
of infrared and##2##3##(1997-7#1)(2007-12#1)
of infrared electroabsorption spectroscopy##2##4##(2006-12#2)
of infrared femtosecond laser pulses##3##5##(2007-12#3)
of infrared spectra##2##3##(2007-12#1)(2008-10#1)
of infrared spectroscopy##3##3##(2008-10#2)(2010-4#1)
of infrared##30##2##(1997-7#1)(2006-12#3)(2007-11#1)(2007-12#6)(2008-10#5)(2008-2#4)(2008-3#8)(2010-4#1)(2013-8#1)
of infrastructure##4##2##(2007-12#1)(2007-7#1)(2008-11#1)(2008-7#1)
of infringement##2##2##(2007-2#1)(2009-11#1)
of infused##3##2##(1993-4#1)(1996-12#1)(2008-5#1)
of infusion of##3##3##(1990-4#1)(2008-7#1)(2010-7#1)
of infusion##10##2##(1990-4#1)(1995-10#1)(1995-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-7#1)(2011-2#1)
of ingested##6##2##(1992-12#1)(1995-4#1)(2006-10#2)(2007-2#1)(2008-5#1)
of ingestion of##5##3##(2004-11#1)(2007-1#1)(2009-4#1)(2010-2#1)(2010-9#1)
of ingestion##10##2##(2004-11#1)(2007-1#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-2#2)(2010-9#1)(2012-12#1)
of ingredients##6##2##(2008-5#5)(2011-1#1)
of ingroup##2##2##(2008-11#1)(2012-3#1)
of ingrowth##2##2##(2008-3#1)(2010-12#1)
of inguinal hernia in children##2##5##(2008-12#2)
of inguinal hernia##6##3##(1994-11#1)(2008-12#3)(2011-2#1)(2012-12#1)
of inguinal##11##2##(1990-6#1)(1993-9#1)(1994-11#1)(1996-9#1)(2008-12#3)(2009-5#2)(2011-2#1)(2012-12#1)
of inhabitants##4##2##(1993-8#1)(1994-5#2)(2006-4#1)
of inhalation flow rate on the##2##6##(1997-2#2)
of inhalation flow rate##4##4##(1994-2#1)(1997-2#3)
of inhalation sedation with##2##4##(2011-12#2)
of inhalation sedation##3##3##(2011-12#3)
of inhalation##15##2##(1994-2#1)(1994-5#1)(1997-2#5)(2005-10#1)(2006-7#1)(2008-10#2)(2011-12#3)(2012-12#1)
of inhaled cocaine##2##3##(2013-8#2)
of inhaled corticosteroid##2##3##(1996-1#1)(2007-11#1)
of inhaled corticosteroids in patients with##2##6##(2006-5#1)(2011-2#1)
of inhaled corticosteroids in##4##4##(2005-11#1)(2006-10#1)(2006-5#1)(2011-2#1)
of inhaled corticosteroids##10##3##(2005-11#2)(2006-10#1)(2006-5#1)(2007-11#2)(2008-5#1)(2009-1#1)(2011-2#1)(2013-8#1)
of inhaled insulin##2##3##(2008-8#2)
of inhaled nitric oxide in##2##5##(1994-7#1)(2008-12#1)
of inhaled nitric oxide##4##4##(1994-7#1)(2006-10#2)(2008-12#1)
of inhaled particles##2##3##(1992-3#1)(1997-1#1)
of inhaled##42##2##(1991-12#1)(1992-3#1)(1993-8#3)(1994-12#1)(1994-7#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-1#3)(2005-11#2)(2005-8#2)(2006-10#5)(2006-5#1)(2007-11#6)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#3)(2009-1#1)(2010-5#1)(2011-2#1)(2013-8#3)
of inherent optical properties##2##4##(2008-2#1)(2008-3#1)
of inherent optical##3##3##(2008-2#2)(2008-3#1)
of inherent##15##2##(1991-2#1)(1994-2#1)(2006-6#1)(2006-7#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#1)(2013-1#2)
of inherently faster##2##3##(2008-10#1)(2008-5#1)
of inherently##4##2##(2008-10#2)(2008-2#1)(2008-5#1)
of inheritance in##2##3##(1990-7#1)(2013-1#1)
of inheritance is##3##3##(1996-3#1)(1997-3#1)(2011-2#1)
of inheritance of##5##3##(1993-5#1)(1996-12#1)(2008-11#2)(2008-5#1)
of inheritance suggests##2##3##(2006-10#1)(2006-7#1)
of inheritance##38##2##(1990-7#1)(1992-5#1)(1992-7#1)(1993-2#1)(1993-5#1)(1993-7#1)(1994-8#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-5#1)(2006-10#1)(2006-7#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-4#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
of inherited and##2##3##(1997-5#1)(2008-6#1)
of inherited arrhythmias in##2##4##(2009-5#2)
of inherited arrhythmias##3##3##(2009-5#3)
of inherited disorders of##3##4##(2007-2#3)
of inherited disorders##4##3##(1991-11#1)(2007-2#3)
of inherited##28##2##(1990-5#1)(1991-11#1)(1991-5#1)(1991-9#1)(1993-5#1)(1997-5#1)(1997-7#1)(2005-10#1)(2007-2#3)(2007-4#1)(2007-7#2)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#1)(2009-5#3)(2010-12#2)(2011-1#1)(2012-11#1)(2013-7#1)
of inheriting##4##2##(1997-3#1)(1997-7#2)(2008-8#1)
of inhibin B##2##3##(2012-1#2)
of inhibin subunits##2##3##(2008-8#2)
of inhibin##6##2##(1994-3#1)(1996-8#1)(2008-8#2)(2012-1#2)
of inhibited enzyme##2##3##(1995-1#1)(1995-6#1)
of inhibited##8##2##(1992-10#1)(1995-1#2)(1995-6#1)(1997-7#1)(2006-10#1)(2006-5#1)(2009-10#1)
of inhibiting the##9##3##(1990-12#1)(1994-9#1)(1996-1#1)(2005-10#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2012-2#1)
of inhibiting##28##2##(1990-12#1)(1991-2#1)(1991-9#1)(1992-12#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-7#1)(1996-1#1)(1996-4#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-4#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2009-2#1)(2012-2#2)(2012-3#1)
of inhibition and##4##3##(1991-8#1)(1993-3#1)(1995-1#1)(2006-3#1)
of inhibition being##2##3##(1990-6#1)(1991-9#1)
of inhibition by the##3##4##(1991-12#1)(1991-2#1)(1992-8#1)
of inhibition by these##2##4##(1991-2#1)(1992-6#1)
of inhibition by##7##3##(1990-3#1)(1991-12#1)(1991-2#2)(1992-6#1)(1992-8#1)(1994-12#1)
of inhibition depended on the##2##5##(1991-2#1)(1992-8#1)
of inhibition depended##3##3##(1991-2#1)(1992-3#1)(1992-8#1)
of inhibition from##2##3##(2008-1#1)(2010-7#1)
of inhibition in##5##3##(1991-2#1)(1992-3#1)(2008-12#1)(2008-7#2)
of inhibition is##3##3##(1990-11#1)(1992-8#1)(2008-5#1)
of inhibition of both##3##4##(1991-8#1)(1994-11#1)(2008-4#1)
of inhibition of the##7##4##(1992-6#1)(1993-12#1)(1995-11#1)(2005-10#1)(2008-10#1)(2009-4#1)(2011-2#1)
of inhibition of ubiquitin-proteasome pathway on human##2##7##(2008-9#2)
of inhibition of##57##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1991-1#1)(1991-2#2)(1991-4#1)(1991-8#2)(1991-9#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-8#1)(1994-11#3)(1994-3#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#2)(1996-10#1)(1996-12#2)(1996-5#1)(1997-1#1)(1997-3#1)(1997-5#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#1)(2010-12#1)(2011-2#2)
of inhibition on##2##3##(1995-6#1)(2008-11#1)
of inhibition was##10##3##(1990-10#1)(1992-6#1)(1994-3#1)(1995-7#1)(1996-10#1)(1996-4#1)(1997-7#1)(2010-1#1)(2010-3#1)(2011-2#1)
of inhibition were##2##3##(1994-8#1)(1995-3#1)
of inhibition##134##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#6)(1991-4#1)(1991-5#1)(1991-8#3)(1991-9#4)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#5)(1992-8#3)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-1#5)(1995-11#2)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#2)(1995-7#1)(1996-1#2)(1996-10#2)(1996-12#2)(1996-4#1)(1996-5#4)(1996-7#1)(1997-1#1)(1997-3#1)(1997-5#2)(1997-7#1)(2004-11#1)(2005-10#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#3)(2008-7#5)(2008-8#2)(2008-9#2)(2009-4#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-7#1)(2011-2#5)(2012-2#1)(2013-1#1)
of inhibitor and##4##3##(1991-2#1)(1992-12#1)(1993-8#1)(1994-8#1)
of inhibitor binding##3##3##(1993-3#1)(1994-8#1)(2012-12#1)
of inhibitor of apoptosis##3##4##(2008-11#2)(2009-3#1)
of inhibitor of##4##3##(2008-11#2)(2009-3#1)(2011-3#1)
of inhibitor##27##2##(1990-7#1)(1990-8#1)(1991-2#1)(1992-12#2)(1992-9#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-6#2)(1996-5#1)(1996-6#1)(1996-7#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-3#1)(2011-3#1)(2012-12#2)
of inhibitors act##2##3##(1993-11#1)(1994-8#1)
of inhibitors and##2##3##(2007-7#1)(2013-1#1)
of inhibitors for##2##3##(2008-7#1)(2011-1#1)
of inhibitors from##3##3##(2008-10#1)(2011-1#2)
of inhibitors in the samples##2##5##(2013-1#1)(2013-8#1)
of inhibitors in the##3##4##(2008-10#1)(2013-1#1)(2013-8#1)
of inhibitors of the##4##4##(1993-8#1)(2005-8#1)(2006-6#1)(2008-7#1)
of inhibitors of##18##3##(1990-7#1)(1991-5#1)(1993-11#1)(1993-8#1)(1995-8#1)(1997-4#2)(2005-7#1)(2005-8#1)(2006-6#1)(2007-11#1)(2007-5#1)(2008-4#1)(2008-7#1)(2009-8#1)(2013-1#3)
of inhibitors on##3##3##(1993-9#1)(2008-4#1)(2011-3#1)
of inhibitors to##2##3##(2008-11#1)(2008-4#1)
of inhibitors with##2##3##(1995-1#1)(2006-9#1)
of inhibitors##56##2##(1990-5#1)(1990-7#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-11#3)(1993-8#1)(1993-9#1)(1994-8#1)(1995-1#2)(1995-8#1)(1997-4#2)(1997-5#1)(2005-7#2)(2005-8#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#6)(2008-7#2)(2008-8#1)(2009-8#1)(2011-1#3)(2011-3#1)(2012-12#2)(2012-2#2)(2013-1#7)(2013-8#1)
of inhibitory action of eosin Y##3##6##(2008-8#3)
of inhibitory action of##4##4##(2008-10#1)(2008-8#3)
of inhibitory activity##3##3##(1991-8#1)(1997-8#2)
of inhibitory avoidance learning##3##4##(1996-1#3)
of inhibitory avoidance##4##3##(1996-1#3)(1997-2#1)
of inhibitory interneurons##3##3##(1991-6#2)(2008-11#1)
of inhibitory postsynaptic##2##3##(1995-2#1)(2011-2#1)
of inhibitory processes##2##3##(2012-3#1)(2013-1#1)
of inhibitory synapses##2##3##(2007-10#1)(2009-8#1)
of inhibitory##43##2##(1990-3#1)(1991-6#2)(1991-8#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-6#3)(1996-1#3)(1997-2#1)(1997-3#1)(1997-8#2)(2005-9#1)(2006-10#2)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#4)(2009-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)
of inhomogeneities##4##2##(1996-4#1)(2008-2#1)(2008-3#2)
of inhomogeneity of##2##3##(2008-2#1)(2013-7#1)
of inhomogeneous##12##2##(1996-4#1)(2008-2#6)(2008-3#5)
of initial amplitude##3##3##(1995-12#1)(1996-1#2)
of initial and##2##3##(2005-11#1)(2013-1#1)
of initial cell##3##3##(1991-9#1)(1994-10#1)(2008-5#1)
of initial conditions##2##3##(2008-10#1)(2013-8#1)
of initial diagnosis##3##3##(2007-11#2)(2008-11#1)
of initial disturbances##2##3##(2008-2#2)
of initial dose in##2##4##(1994-12#1)(2010-6#1)
of initial epidemic conditions##2##4##(2008-10#2)
of initial inocula##2##3##(2008-10#2)
of initial inoculum##2##3##(2008-10#2)
of initial presentation and##3##4##(2006-4#1)(2008-6#1)(2012-3#1)
of initial presentation##4##3##(2006-4#1)(2008-5#1)(2008-6#1)(2012-3#1)
of initial treatment##2##3##(2008-2#1)(2010-12#1)
of initial##98##2##(1991-9#1)(1992-11#1)(1992-2#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-1#3)(1996-12#1)(1996-9#1)(2004-9#1)(2005-10#2)(2005-11#3)(2005-5#1)(2006-10#2)(2006-4#1)(2006-7#2)(2006-8#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#13)(2008-11#2)(2008-2#4)(2008-4#1)(2008-5#8)(2008-6#5)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-6#2)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
of initially##7##2##(1993-12#2)(1993-9#1)(1996-8#2)(2007-8#1)(2008-10#1)
of initiated hepatocytes##3##3##(1994-6#3)
of initiating and##2##3##(2006-5#1)(2010-7#1)
of initiating##15##2##(1991-9#1)(1992-9#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-8#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
of initiation and##5##3##(1994-8#1)(1996-5#1)(2007-4#1)(2009-4#1)(2009-6#1)
of initiation complexes##2##3##(1994-12#2)
of initiation of the##2##4##(1992-11#1)(2011-1#1)
of initiation of##13##3##(1990-10#1)(1990-3#1)(1991-6#1)(1992-11#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-7#1)(2011-1#2)(2012-2#1)(2012-3#1)
of initiation##29##2##(1990-10#1)(1990-3#1)(1991-6#1)(1992-11#1)(1993-11#1)(1994-12#2)(1994-3#1)(1994-8#1)(1996-5#1)(1996-6#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-4#1)(2009-6#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-8#1)
of initiatives##2##2##(1995-1#1)(2013-1#1)
of initiator##3##2##(1991-7#1)(2008-10#1)(2009-10#1)
of injectable##4##2##(1993-8#1)(2005-7#1)(2007-8#1)(2008-11#1)
of injectate##2##2##(2006-12#1)(2006-8#1)
of injected sample##2##3##(1991-5#1)(2008-10#1)
of injected##14##2##(1990-5#1)(1991-5#2)(1991-9#2)(1993-11#1)(1996-1#1)(2007-11#1)(2008-10#3)(2012-12#1)(2012-2#1)(2013-1#1)
of injecting drug##2##3##(2006-10#1)(2007-7#1)
of injecting the##2##3##(1995-2#1)(2010-8#1)
of injecting##11##2##(1990-12#1)(1993-12#1)(1995-2#2)(2006-10#1)(2007-7#1)(2008-11#1)(2008-3#1)(2010-8#2)(2013-8#1)
of injection ampicilin and injection gentamicin##3##6##(2013-1#3)
of injection drug use##2##4##(2007-4#1)(2010-12#1)
of injection drug users in##2##5##(2007-12#1)(2012-1#1)
of injection drug users##4##4##(2007-12#1)(2007-4#1)(2012-1#2)
of injection drug##6##3##(2007-12#1)(2007-4#2)(2010-12#1)(2012-1#2)
of injection of##7##3##(1997-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-7#1)(2012-1#1)(2013-1#1)
of injection##52##2##(1990-5#1)(1991-8#1)(1992-6#1)(1993-1#1)(1994-4#1)(1994-6#1)(1995-5#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-3#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#2)(2008-1#2)(2008-10#5)(2008-11#3)(2008-4#2)(2008-7#3)(2009-10#3)(2010-12#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#2)(2012-1#4)(2013-1#5)(2013-8#1)
of injections in##2##3##(1996-3#1)(1997-5#1)
of injections##6##2##(1994-8#1)(1996-3#1)(1997-5#1)(2007-11#1)(2011-2#1)(2013-8#1)
of injured and##2##3##(2007-4#1)(2010-1#1)
of injured articular and growth plate cartilage##2##7##(2008-1#2)
of injured cells##2##3##(2008-10#2)
of injured peripheral nerves##2##4##(2008-7#1)(2011-2#1)
of injured tissue by##2##4##(1996-3#1)(2009-3#1)
of injured##26##2##(1990-9#1)(1991-11#1)(1991-3#2)(1992-9#1)(1993-4#1)(1996-3#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-7#1)(2009-3#1)(2010-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
of injuries among##2##3##(1992-6#1)(2006-11#1)
of injuries and##5##3##(1996-6#1)(2007-8#1)(2008-6#1)(2010-8#1)(2012-2#1)
of injuries associated with electrical events##2##6##(1994-5#2)
of injuries during##3##3##(1990-6#1)(2007-8#1)(2013-1#1)
of injuries from##2##3##(1992-6#1)(2007-12#1)
of injuries in##3##3##(1991-12#1)(2007-11#1)(2012-2#1)
of injuries that##2##3##(2007-12#1)(2010-3#1)
of injuries to the##3##4##(2006-11#1)(2007-11#1)(2008-4#1)
of injuries to##5##3##(2006-11#1)(2007-11#1)(2007-4#1)(2008-4#1)(2013-1#1)
of injuries##42##2##(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1992-2#1)(1992-6#2)(1994-5#2)(1996-6#1)(1996-7#1)(1997-2#1)(2005-9#1)(2006-11#2)(2006-8#1)(2007-1#1)(2007-11#5)(2007-12#2)(2007-4#1)(2007-8#2)(2008-2#1)(2008-4#2)(2008-6#1)(2009-2#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#4)(2013-8#1)
of injuries]##2##2##(1990-6#1)(1992-2#1)
of injurious##3##2##(1996-9#1)(2007-4#1)(2009-4#1)
of injury and the##3##4##(2006-3#1)(2007-4#1)(2010-1#1)
of injury and##15##3##(1992-3#1)(1995-6#1)(1997-3#1)(2005-10#2)(2006-3#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2010-1#1)(2010-11#1)(2011-2#1)
of injury from##3##3##(2007-4#2)(2011-2#1)
of injury has##3##3##(1991-3#1)(2011-12#1)(2012-12#1)
of injury in the##3##4##(1994-2#1)(2006-11#1)(2007-4#1)
of injury in##11##3##(1992-6#1)(1994-2#1)(1995-11#1)(1997-6#1)(2006-10#1)(2006-11#1)(2007-4#1)(2008-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
of injury is##2##3##(2009-6#1)(2012-2#1)
of injury risk##3##3##(2006-11#2)(2007-4#1)
of injury that##4##3##(1992-4#1)(1992-6#1)(2013-1#2)
of injury to be##2##4##(2007-11#1)(2008-5#1)
of injury to the##6##4##(1992-7#1)(1993-9#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-8#1)
of injury to##12##3##(1992-7#1)(1993-9#1)(2007-1#1)(2007-11#2)(2007-4#1)(2007-8#2)(2008-10#1)(2008-5#1)(2013-1#2)
of injury was##7##3##(1992-6#2)(2006-11#1)(2006-5#1)(2008-12#2)(2012-2#1)
of injury were##4##3##(2007-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
of injury with##2##3##(1996-6#1)(2007-8#1)
of injury##170##2##(1990-4#1)(1990-6#1)(1991-10#2)(1991-3#1)(1992-3#1)(1992-4#1)(1992-6#6)(1992-7#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-2#1)(1995-11#2)(1995-2#1)(1995-3#2)(1995-6#2)(1996-5#1)(1996-6#1)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#4)(2005-10#2)(2005-8#1)(2006-10#5)(2006-11#5)(2006-2#1)(2006-3#4)(2006-4#1)(2006-5#2)(2006-8#2)(2006-9#1)(2007-1#4)(2007-10#1)(2007-11#6)(2007-12#3)(2007-3#2)(2007-4#9)(2007-6#1)(2007-7#5)(2007-8#4)(2008-10#2)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#6)(2009-10#3)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#3)(2010-1#2)(2010-11#1)(2011-1#1)(2011-12#2)(2011-2#5)(2012-1#1)(2012-12#5)(2012-2#6)(2012-3#2)(2013-1#16)(2013-8#2)
of inkjet-printed##3##2##(2005-11#2)(2010-11#1)
of inks##2##2##(2008-10#2)
of inland##2##2##(2013-8#2)
of innate and adaptive immune mechanisms##2##6##(2009-8#1)(2010-12#1)
of innate and adaptive immune responses##3##6##(2005-10#1)(2007-12#1)(2013-8#1)
of innate and adaptive immune##5##5##(2005-10#1)(2007-12#1)(2009-8#1)(2010-12#1)(2013-8#1)
of innate and adaptive##6##4##(2005-10#1)(2007-12#1)(2009-10#1)(2009-8#1)(2010-12#1)(2013-8#1)
of innate defense##2##3##(2006-10#1)(2012-2#1)
of innate immune responses##3##4##(2008-4#1)(2011-1#1)(2013-8#1)
of innate immune##8##3##(2006-10#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
of innate immunity and##3##4##(2008-7#1)(2008-9#1)(2011-1#1)
of innate immunity in##3##4##(2006-10#1)(2008-4#1)(2009-8#1)
of innate immunity##14##3##(2005-11#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-3#1)
of innate##36##2##(2003-11#1)(2005-10#1)(2005-11#1)(2006-10#3)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#2)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
of inner and outer##3##4##(2005-11#2)(2007-12#1)
of inner cell mass##2##4##(2006-5#1)(2013-8#1)
of inner dynein arms within flagella##2##6##(1997-4#2)
of inner ear##3##3##(2011-1#1)(2012-2#1)(2013-1#1)
of inner##17##2##(1990-11#1)(1990-7#1)(1997-4#2)(2005-11#2)(2006-5#1)(2007-12#2)(2008-11#1)(2008-5#2)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
of innervating##2##2##(1992-3#1)(2007-12#1)
of innervation and##2##3##(1991-11#1)(1992-6#1)
of innervation of the##3##4##(1995-9#1)(1996-3#1)(1996-6#1)
of innervation##6##2##(1991-11#1)(1992-6#1)(1994-12#1)(1995-9#1)(1996-3#1)(1996-6#1)
of innocent##2##2##(1993-9#1)(1995-6#1)
of innovation in##2##3##(2009-7#1)(2010-5#1)
of innovation##12##2##(1991-1#1)(1994-12#1)(1995-1#1)(2006-12#1)(2007-12#1)(2007-4#1)(2008-9#1)(2009-7#1)(2010-5#1)(2011-1#3)
of innovations in##2##3##(2006-10#1)(2013-8#1)
of innovations##7##2##(2006-10#1)(2008-11#1)(2010-10#2)(2013-8#3)
of innovative##16##2##(1991-12#1)(1994-7#1)(1995-8#1)(2005-11#1)(2005-8#1)(2006-4#1)(2007-4#1)(2008-11#1)(2008-5#1)(2010-12#2)(2010-3#2)(2010-4#1)(2011-2#1)(2013-1#1)
of inocula##2##2##(2008-10#2)
of inoculated leaves##4##3##(2008-10#4)
of inoculated plants##4##3##(2008-10#4)
of inoculated##18##2##(2006-10#1)(2008-10#15)(2008-12#1)(2008-5#1)
of inoculation on the##2##4##(2008-10#1)(2008-5#1)
of inoculation was##2##3##(2008-10#1)(2013-1#1)
of inoculation##29##2##(1992-2#1)(2005-9#1)(2007-8#1)(2008-10#19)(2008-11#1)(2008-5#5)(2013-1#1)
of inoculum and##6##3##(2008-10#4)(2008-5#1)(2009-6#1)
of inoculum density##5##3##(2008-10#5)
of inoculum for##8##3##(2008-10#8)
of inoculum in##4##3##(2008-10#4)
of inoculum of##2##3##(2008-10#2)
of inoculum sources##2##3##(2008-10#2)
of inoculum was##4##3##(2006-8#1)(2008-10#3)
of inoculum##61##2##(2006-8#1)(2008-10#57)(2008-11#1)(2008-5#1)(2009-6#1)
of inoculum-substrate##3##2##(2009-6#3)
of inoperable##6##2##(1990-6#1)(1990-8#1)(1993-7#1)(2006-2#1)(2009-5#1)(2013-1#1)
of inorganic As(III)##2##3##(2008-10#2)
of inorganic and alkylmercury##2##4##(2008-10#2)
of inorganic and methyl mercury in##2##6##(2008-10#2)
of inorganic and organic mercury##2##5##(2008-10#2)
of inorganic and organic##10##4##(2005-4#1)(2008-10#6)(2011-2#1)(2013-7#1)(2013-8#1)
of inorganic and##15##3##(1994-6#1)(2005-4#1)(2008-10#10)(2011-2#1)(2013-7#1)(2013-8#1)
of inorganic anions in##2##4##(1996-11#1)(2008-10#1)
of inorganic anions##4##3##(1996-11#1)(2007-8#1)(2008-10#2)
of inorganic arsenic in##3##4##(2008-10#3)
of inorganic arsenic species in##2##5##(2008-10#2)
of inorganic arsenic species##4##4##(2008-10#4)
of inorganic arsenic using##2##4##(2008-10#2)
of inorganic arsenic##19##3##(1995-11#1)(2008-10#16)(2010-10#1)(2011-12#1)
of inorganic cations##4##3##(1995-4#1)(2008-10#3)
of inorganic compounds##2##3##(2008-3#1)(2008-7#1)
of inorganic ions in##2##4##(2008-10#1)(2012-2#1)
of inorganic ions##5##3##(2005-4#1)(2008-10#3)(2012-2#1)
of inorganic mercury##5##3##(1993-12#1)(2008-10#4)
of inorganic nickel compounds in##2##5##(2008-10#2)
of inorganic oxyanions of As##2##5##(2008-10#2)
of inorganic phosphate (Pi)##3##4##(1993-12#1)(1995-11#1)(2010-8#1)
of inorganic phosphate##9##3##(1992-12#1)(1993-12#2)(1994-8#1)(1995-11#2)(2008-10#1)(2008-5#1)(2010-8#1)
of inorganic phosphorus in##3##4##(2007-8#2)(2008-10#1)
of inorganic salts##8##3##(1991-5#1)(1991-9#1)(1994-5#1)(2005-11#2)(2008-10#2)(2008-11#1)
of inorganic selenium##3##3##(2008-10#3)
of inorganic selenium(IV)##3##3##(2008-10#3)
of inorganic species##2##3##(2008-10#1)(2008-7#1)
of inorganic##134##2##(1991-12#1)(1991-5#1)(1991-9#1)(1992-12#1)(1993-12#3)(1993-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#4)(1995-3#2)(1995-4#1)(1996-11#1)(1997-6#1)(2005-11#4)(2005-4#6)(2007-8#3)(2008-10#73)(2008-11#2)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#2)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#2)
of inorganics##3##2##(2007-8#2)(2008-10#1)
of inosine##14##2##(1991-3#2)(1995-1#3)(2005-11#1)(2007-11#1)(2008-10#7)
of inositol 1##27##3##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-5#1)(1992-11#2)(1992-5#1)(1993-6#1)(1993-7#1)(1993-8#2)(1994-3#1)(1995-11#1)(1997-4#1)(2007-9#1)(2008-8#1)(2012-12#2)(2012-3#1)(2013-1#1)
of inositol mono-##4##3##(1990-10#1)(1990-7#2)(1994-12#1)
of inositol monophosphates and##2##4##(1997-4#2)
of inositol monophosphates##3##3##(1997-4#3)
of inositol phosphate metabolism##2##4##(1993-5#1)(1997-4#1)
of inositol phosphate##4##3##(1993-5#1)(1995-3#1)(1997-2#1)(1997-4#1)
of inositol phosphates (IPs)##2##4##(1990-10#1)(1996-8#1)
of inositol phosphates in##3##4##(1990-9#1)(1993-6#1)(1995-5#1)
of inositol phosphates was##2##4##(1990-12#1)(1993-6#1)
of inositol phosphates##25##3##(1990-10#2)(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-2#2)(1991-5#1)(1992-11#1)(1993-6#4)(1994-10#1)(1994-2#3)(1995-5#1)(1996-8#1)(2008-4#2)
of inositol phospholipids##5##3##(1990-3#1)(1990-4#1)(1992-1#1)(1993-12#1)(2008-4#1)
of inositol polyphosphates##2##3##(1992-2#1)(1997-4#1)
of inositol tetrakisphosphate##2##3##(1990-5#1)(1997-1#1)
of inositol trisphosphate and##2##4##(1991-2#1)(1994-10#1)
of inositol trisphosphate##11##3##(1990-8#3)(1991-12#1)(1991-2#1)(1993-3#2)(1993-6#1)(1994-10#1)(1995-3#1)(2006-10#1)
of inositol##100##2##(1990-10#4)(1990-11#2)(1990-12#1)(1990-3#3)(1990-4#1)(1990-5#3)(1990-7#5)(1990-8#7)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#3)(1991-2#5)(1991-5#2)(1992-1#1)(1992-11#3)(1992-2#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#6)(1993-7#1)(1993-8#3)(1993-9#1)(1994-10#3)(1994-12#1)(1994-2#3)(1994-3#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#6)(2005-6#1)(2006-10#1)(2007-9#1)(2008-11#1)(2008-4#4)(2008-8#1)(2012-12#2)(2012-3#1)(2013-1#1)
of inpatient care was##2##4##(1992-1#1)(2006-12#1)
of inpatient care##5##3##(1992-1#1)(1992-2#1)(1993-12#1)(2006-12#1)(2009-4#1)
of inpatient diabetes##2##3##(2009-11#2)
of inpatient hospital##2##3##(1992-2#1)(1994-3#1)
of inpatient psychiatric treatment##2##4##(1991-2#1)(1992-2#1)
of inpatient psychiatric##4##3##(1991-2#2)(1992-2#1)(2006-9#1)
of inpatient treatment##5##3##(1990-12#2)(1993-2#1)(1995-11#1)(1997-8#1)
of inpatient##29##2##(1990-12#2)(1991-1#1)(1991-2#2)(1992-1#1)(1992-12#1)(1992-2#3)(1993-12#1)(1993-2#2)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#1)(1997-8#1)(2006-12#1)(2006-9#1)(2007-3#1)(2008-6#1)(2009-11#3)(2009-4#1)(2010-12#1)(2010-8#1)(2011-2#1)
of inpatients treated for##2##4##(2010-9#2)
of inpatients with##2##3##(2008-11#1)(2013-8#1)
of inpatients##9##2##(1995-2#1)(2006-2#1)(2007-7#1)(2008-1#1)(2008-11#1)(2009-4#1)(2010-9#2)(2013-8#1)
of input and##2##3##(2008-2#1)(2008-9#1)
of input data##4##3##(2008-2#1)(2008-6#1)(2013-1#2)
of input from##3##3##(1992-7#1)(1996-5#1)(2006-10#1)
of input images##2##3##(2007-12#1)(2008-3#1)
of input light##2##3##(2007-12#2)
of input noise##2##3##(2008-2#2)
of input power##2##3##(2007-11#1)(2007-12#1)
of input variables##2##3##(2008-10#1)(2009-3#1)
of input##45##2##(1991-3#1)(1992-7#2)(1993-2#1)(1996-5#1)(1997-4#1)(2006-10#1)(2007-11#2)(2007-12#9)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#8)(2008-3#6)(2008-6#1)(2008-9#1)(2009-3#1)(2012-2#2)(2012-3#1)(2013-1#2)
of input-output##2##2##(2008-2#1)(2008-8#1)
of inputs can be##2##4##(2007-8#1)(2008-3#1)
of inputs to##2##3##(1994-8#1)(2006-10#1)
of inputs##9##2##(1991-11#1)(1994-8#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-8#1)(2013-8#1)
of inquiry and##3##3##(2008-12#1)(2013-1#2)
of inquiry##8##2##(1996-2#1)(2005-12#1)(2008-12#2)(2008-8#2)(2013-1#2)
of insanity defense##2##3##(2010-9#2)
of insanity##6##2##(2004-12#1)(2009-10#1)(2010-9#3)(2011-1#1)
of insect cell cultures##2##4##(2008-2#2)
of insect cell##6##3##(1994-8#1)(1994-9#1)(2008-11#2)(2008-2#2)
of insect cells and##3##4##(1995-1#1)(2008-11#1)(2008-2#1)
of insect cells with##2##4##(2008-11#1)(2008-2#1)
of insect cells##10##3##(1991-11#1)(1993-6#1)(1994-10#1)(1995-1#1)(2008-11#4)(2008-2#2)
of insect flight muscle in##2##5##(1996-11#2)
of insect flight muscle##3##4##(1996-11#3)
of insect herbivores##2##3##(2011-2#1)(2013-7#1)
of insect pests##2##3##(2008-5#1)(2011-2#1)
of insect pheromones##2##3##(2008-10#2)
of insect vectors of##2##4##(2007-7#1)(2008-10#1)
of insect##57##2##(1991-10#1)(1991-11#1)(1991-5#1)(1993-6#1)(1994-10#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-11#3)(1997-4#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#5)(2007-7#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-2#4)(2008-4#1)(2008-5#3)(2008-8#3)(2008-9#2)(2010-4#1)(2011-12#1)(2011-2#4)(2013-7#1)
of insect-plant##2##2##(2008-1#1)(2009-6#1)
of insecticidal##2##2##(1994-2#1)(2005-11#1)
of insecticide resistance##3##3##(1990-6#1)(2008-8#1)(2011-2#1)
of insecticide##13##2##(1990-3#1)(1990-6#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-4#2)(2007-2#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-12#1)
of insecticides##9##2##(1997-7#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
of insects and are##2##4##(1995-11#1)(2007-12#1)
of insects and##5##3##(1995-11#1)(2007-12#3)(2011-12#1)
of insects in##3##3##(2007-12#2)(2010-6#1)
of insects is##2##3##(2007-12#1)(2012-3#1)
of insects##30##2##(1995-11#1)(1996-5#1)(2005-10#1)(2006-12#1)(2007-12#8)(2007-6#3)(2008-10#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2010-10#1)(2010-12#1)(2010-6#1)(2011-12#2)(2012-3#1)
of insecurity##2##2##(2010-5#1)(2011-2#1)
of insemination##5##2##(2006-5#5)
of insensitivity in##2##3##(2008-10#2)
of insensitivity##4##2##(2008-10#4)
of insert##2##2##(1993-11#1)(2008-3#1)
of inserting a##3##3##(1996-4#1)(2008-10#1)(2008-11#1)
of insertion and##3##3##(2007-1#1)(2008-10#1)(2010-7#1)
of insertion loss##3##3##(2007-11#1)(2008-3#2)
of insertion of a##2##4##(1991-10#1)(1997-3#1)
of insertion of##5##3##(1991-10#1)(1997-3#1)(2006-10#1)(2007-8#1)(2010-7#1)
of insertion##25##2##(1990-3#1)(1991-10#1)(1995-2#1)(1995-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-9#1)(2010-12#1)(2010-7#6)(2012-2#1)
of insight and##2##3##(2008-7#1)(2013-8#1)
of insight into##2##3##(1997-8#1)(2012-2#1)
of insight##4##2##(1997-8#1)(2008-7#1)(2012-2#1)(2013-8#1)
of insights##2##2##(2009-2#1)(2013-1#1)
of insoluble exopolysaccharide##2##3##(2008-6#2)
of insoluble fibrils##2##3##(2008-8#1)(2011-2#1)
of insoluble surfactant##2##3##(2005-11#2)
of insoluble##27##2##(1991-11#1)(1991-6#2)(1993-8#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#1)(2005-11#5)(2008-10#2)(2008-4#3)(2008-5#1)(2008-6#3)(2008-8#1)(2011-2#2)(2013-1#1)
of insolubles in##2##3##(2008-10#2)
of insomnia and associated##2##4##(2012-1#2)
of insomnia and##4##3##(2007-6#2)(2012-1#2)
of insomnia##20##2##(1991-1#1)(1994-6#1)(2007-2#1)(2007-6#5)(2008-5#3)(2008-7#2)(2011-2#1)(2012-1#3)(2013-1#3)
of inspection##4##2##(2005-5#2)(2007-12#1)(2008-10#1)
of inspiration##5##2##(1996-2#1)(2006-11#1)(2007-12#1)(2008-12#1)(2012-3#1)
of inspiratory##6##2##(1994-10#2)(1995-3#1)(1997-4#1)(2013-1#1)(2013-7#1)
of inspired##2##2##(1992-2#1)(2007-2#1)
of instabilities##2##2##(2007-12#1)(2008-5#1)
of instability and##2##3##(2009-1#1)(2013-1#1)
of instability of the##4##4##(2005-7#1)(2007-11#2)(2007-12#1)
of instability of##5##3##(2005-7#1)(2007-11#2)(2007-12#1)(2008-6#1)
of instability##19##2##(1995-2#1)(1996-4#1)(2005-11#1)(2005-7#1)(2006-9#1)(2007-11#3)(2007-12#2)(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-1#1)(2010-12#1)(2012-3#1)(2013-1#1)
of installing##3##2##(2008-7#1)(2009-12#2)
of instances##4##2##(2006-10#1)(2006-2#1)(2010-12#1)(2012-1#1)
of instant##2##2##(2008-1#1)(2008-11#1)
of instantaneous##5##2##(1996-6#1)(2007-12#1)(2008-10#1)(2012-12#1)(2013-1#1)
of institutional##16##2##(1990-12#1)(1991-1#2)(1991-2#1)(1991-6#1)(1993-1#1)(1996-12#1)(1997-3#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
of institutionalization and##2##3##(2008-7#1)(2009-4#1)
of institutionalization##5##2##(1992-12#1)(1994-6#1)(2008-7#1)(2009-4#1)(2009-9#1)
of institutionalized##5##2##(1991-6#1)(1994-12#1)(1997-3#1)(2006-8#1)(2011-2#1)
of institutions and##2##3##(2008-12#1)(2008-4#1)
of institutions for##2##3##(1995-5#1)(2007-5#1)
of institutions##14##2##(1993-12#2)(1993-2#1)(1995-12#1)(1995-5#1)(2007-5#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-4#1)(2010-12#1)(2012-12#1)(2013-1#2)
of instruction to##2##3##(1993-3#1)(2005-12#1)
of instruction##12##2##(1992-12#1)(1993-12#2)(1993-3#1)(1994-6#1)(1997-5#1)(2005-12#1)(2007-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#1)
of instructions for##2##3##(2007-5#1)(2012-12#1)
of instructions##4##2##(2007-5#1)(2008-11#1)(2008-8#1)(2012-12#1)
of instrument damage##3##3##(2006-6#3)
of instrument##14##2##(2006-12#1)(2006-6#4)(2007-5#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#1)(2009-9#1)
of instrumental and##7##3##(2008-10#4)(2008-4#1)(2008-5#1)(2012-12#1)
of instrumental##22##2##(1991-6#1)(2007-8#1)(2008-10#8)(2008-3#5)(2008-4#2)(2008-5#2)(2008-8#1)(2012-12#1)(2012-3#1)
of instrumentation and##4##3##(2005-4#1)(2008-10#1)(2011-2#1)(2013-1#1)
of instrumentation##12##2##(2004-2#1)(2005-4#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-2#1)(2010-11#1)(2011-2#1)(2013-1#1)
of instruments and##4##3##(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#1)
of instruments for##2##3##(2006-2#1)(2006-6#1)
of instruments used##3##3##(2007-5#1)(2008-5#1)(2013-8#1)
of instruments##23##2##(1990-4#1)(1996-4#1)(2005-9#1)(2006-2#1)(2006-6#3)(2007-11#1)(2007-5#1)(2007-8#3)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-4#1)(2012-2#1)(2013-8#2)
of insufficient##9##2##(1997-8#1)(2006-2#1)(2009-7#1)(2009-8#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-2#1)
of insufflation##3##2##(2006-6#2)(2012-3#1)
of insulating##2##2##(2008-11#1)(2008-2#1)
of insulin +##2##3##(1991-12#1)(1993-6#1)
of insulin action##5##3##(1993-8#1)(1994-8#1)(1995-1#1)(1996-2#1)(2009-12#1)
of insulin analogs##2##3##(1992-7#1)(2012-2#1)
of insulin analogues##4##3##(1992-3#1)(2006-1#1)(2007-11#2)
of insulin and IGF-1 receptors##2##5##(1994-11#2)
of insulin and IGF-1##4##4##(1994-11#3)(2008-9#1)
of insulin and glucagon##3##4##(1994-11#1)(2007-5#1)(2008-3#1)
of insulin and glucose##3##4##(1990-8#2)(1994-3#1)
of insulin and its receptor##2##5##(1994-11#1)(2011-1#1)
of insulin and##23##3##(1990-10#1)(1990-8#2)(1991-12#1)(1991-5#1)(1992-3#1)(1994-11#5)(1994-2#1)(1994-3#1)(1994-6#1)(1996-7#1)(2007-10#1)(2007-5#1)(2008-11#1)(2008-3#2)(2008-9#1)(2010-11#1)(2011-1#1)
of insulin by##5##3##(1990-11#1)(1996-11#1)(1997-4#2)(2008-8#1)
of insulin exocytosis##2##3##(2010-11#2)
of insulin granule##2##3##(2010-11#2)
of insulin growth##2##3##(2007-7#1)(2007-8#1)
of insulin in both##2##4##(2011-1#1)(2013-1#1)
of insulin in solution##2##4##(1991-7#1)(1992-7#1)
of insulin in the##5##4##(1990-11#1)(1995-12#1)(2007-8#1)(2008-3#1)(2011-1#1)
of insulin in##17##3##(1990-11#1)(1990-5#1)(1991-2#1)(1991-7#1)(1992-7#1)(1995-12#1)(2007-8#1)(2008-1#2)(2008-3#2)(2010-11#1)(2010-4#1)(2011-1#3)(2013-1#1)
of insulin infusion##2##3##(2008-3#2)
of insulin is##2##3##(1990-11#1)(2007-8#1)
of insulin loaded##2##3##(2010-1#1)(2010-12#1)
of insulin mRNA##2##3##(1995-10#1)(1997-4#1)
of insulin mediators##2##3##(1992-4#1)(1992-7#1)
of insulin on insulin##2##4##(2010-11#1)(2011-12#1)
of insulin on the##4##4##(1991-7#1)(1995-6#1)(1996-2#1)(1996-8#1)
of insulin on##10##3##(1991-7#1)(1994-3#1)(1994-9#1)(1995-6#1)(1996-2#1)(1996-8#1)(2008-1#1)(2009-10#1)(2010-11#1)(2011-12#1)
of insulin or##2##3##(1991-6#1)(1995-6#1)
of insulin preRNA##3##3##(1997-4#3)
of insulin producing##3##3##(2012-11#2)(2013-8#1)
of insulin pump therapy in##2##5##(2008-1#2)
of insulin pump therapy##3##4##(2008-1#3)
of insulin pump##4##3##(2008-1#3)(2008-7#1)
of insulin receptor gene##2##4##(1991-1#1)(1994-12#1)
of insulin receptor kinase in##2##5##(1993-12#1)(1995-3#1)
of insulin receptor kinase##5##4##(1993-12#3)(1994-5#1)(1995-3#1)
of insulin receptor substrate 1 (IRS1)##2##6##(1994-12#2)
of insulin receptor substrate-1##3##4##(1996-5#1)(1997-7#1)(2013-1#1)
of insulin receptor##22##3##(1991-1#1)(1992-10#1)(1993-12#3)(1994-11#2)(1994-12#3)(1994-2#2)(1994-5#2)(1995-3#1)(1996-5#1)(1997-1#1)(1997-7#1)(2006-10#1)(2008-3#1)(2010-11#1)(2013-1#1)
of insulin receptors##4##3##(1993-7#1)(1994-5#1)(1994-6#1)(2008-1#1)
of insulin release##3##3##(1990-12#2)(2010-11#1)
of insulin resistance (HOMA-IR)##2##4##(2008-3#1)(2011-1#1)
of insulin resistance and diabetes##3##5##(2008-12#1)(2008-3#1)(2012-2#1)
of insulin resistance and hyperinsulinemia##2##5##(1990-2#1)(2006-1#1)
of insulin resistance and the##2##5##(2008-1#1)(2012-2#1)
of insulin resistance and type 2 diabetes##5##7##(2007-8#1)(2008-1#1)(2009-4#1)(2010-12#1)(2011-1#1)
of insulin resistance and##23##4##(1990-2#1)(2005-7#1)(2005-8#1)(2006-1#1)(2007-8#2)(2008-1#3)(2008-12#1)(2008-3#4)(2009-4#1)(2010-12#2)(2011-1#2)(2012-2#3)(2013-1#1)
of insulin resistance as##2##4##(2005-10#1)(2008-1#1)
of insulin resistance in##10##4##(2005-10#1)(2005-8#1)(2008-1#3)(2008-3#3)(2011-2#1)(2012-5#1)
of insulin resistance syndrome##3##4##(2005-10#1)(2008-3#1)(2013-1#1)
of insulin resistance syndrome?##2##4##(2006-9#1)(2008-3#1)
of insulin resistance##88##3##(1990-2#1)(1996-5#1)(2005-1#1)(2005-10#4)(2005-7#1)(2005-8#2)(2006-1#2)(2006-10#1)(2006-9#1)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#14)(2008-12#1)(2008-3#23)(2008-5#1)(2008-6#1)(2008-9#1)(2009-1#1)(2009-4#1)(2010-10#1)(2010-12#3)(2010-8#1)(2011-1#8)(2011-2#1)(2012-2#4)(2012-5#2)(2013-1#4)(2013-7#1)
of insulin resistance]##2##3##(1991-6#1)(2005-1#1)
of insulin secretion and##5##4##(1997-3#1)(1997-7#1)(2009-12#1)(2010-10#1)(2011-1#1)
of insulin secretion by##4##4##(1992-11#1)(1995-12#1)(1997-4#1)(2008-4#1)
of insulin secretion in pancreatic##2##5##(1996-2#1)(2013-1#1)
of insulin secretion in##3##4##(1995-8#1)(1996-2#1)(2013-1#1)
of insulin secretion##28##3##(1990-12#1)(1991-10#1)(1992-11#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-5#3)(1997-3#1)(1997-4#4)(1997-7#1)(2008-1#1)(2008-11#1)(2008-4#2)(2009-12#1)(2010-10#1)(2010-11#2)(2011-1#2)(2013-1#1)
of insulin secretory##3##3##(2010-10#2)(2010-4#1)
of insulin sensitivity and lipid##2##5##(2007-9#1)(2011-1#1)
of insulin sensitivity and##3##4##(2007-9#1)(2011-1#1)(2011-2#1)
of insulin sensitivity##6##3##(2007-9#1)(2008-1#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
of insulin signaling##3##3##(2005-10#1)(2008-1#1)(2013-1#1)
of insulin stimulation##4##3##(1991-1#1)(1991-5#1)(2008-11#1)(2008-6#1)
of insulin therapy in##2##4##(2007-5#1)(2011-1#1)
of insulin therapy##12##3##(1992-3#1)(1993-12#4)(2007-3#1)(2007-5#3)(2009-11#1)(2011-1#2)
of insulin to##7##3##(1991-5#1)(1992-4#1)(1994-3#1)(2008-3#2)(2009-11#1)(2011-12#1)
of insulin was##5##3##(1994-3#1)(2006-6#1)(2007-8#1)(2008-9#1)(2013-8#1)
of insulin with##3##3##(1992-3#1)(2007-8#1)(2010-12#1)
of insulin##414##2##(1990-10#2)(1990-11#6)(1990-12#6)(1990-2#1)(1990-5#3)(1990-7#1)(1990-8#2)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#2)(1991-5#4)(1991-6#2)(1991-7#2)(1992-10#1)(1992-11#1)(1992-3#6)(1992-4#2)(1992-6#1)(1992-7#3)(1993-11#1)(1993-12#7)(1993-4#1)(1993-6#4)(1993-7#1)(1993-8#1)(1994-11#11)(1994-12#3)(1994-2#4)(1994-3#8)(1994-4#1)(1994-5#3)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-12#2)(1995-3#1)(1995-5#4)(1995-6#2)(1995-8#3)(1996-10#1)(1996-11#3)(1996-2#3)(1996-3#1)(1996-5#6)(1996-7#1)(1996-8#2)(1997-1#1)(1997-3#1)(1997-4#12)(1997-7#2)(2005-1#2)(2005-10#6)(2005-7#1)(2005-8#4)(2006-1#3)(2006-10#4)(2006-6#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-3#3)(2007-5#5)(2007-7#2)(2007-8#11)(2007-9#1)(2008-1#30)(2008-10#1)(2008-11#7)(2008-12#1)(2008-3#36)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#6)(2008-9#9)(2009-1#1)(2009-10#1)(2009-11#4)(2009-12#2)(2009-2#1)(2009-4#1)(2009-8#2)(2009-9#2)(2010-1#3)(2010-10#6)(2010-11#18)(2010-12#7)(2010-4#3)(2010-8#1)(2011-1#27)(2011-12#2)(2011-2#4)(2012-11#2)(2012-12#2)(2012-2#6)(2012-4#1)(2012-5#2)(2013-1#12)(2013-7#2)(2013-8#3)
of insulin)##2##2##(1990-8#1)(1997-2#1)
of insulin-dependent diabetes in the##2##5##(1994-12#1)(2008-4#1)
of insulin-dependent diabetes mellitus (IDDM)##2##5##(1994-8#1)(2007-5#1)
of insulin-dependent diabetes mellitus##7##4##(1992-6#2)(1993-11#1)(1994-7#1)(1994-8#1)(2007-5#1)(2010-11#1)
of insulin-dependent diabetes##11##3##(1992-6#2)(1993-11#2)(1994-12#1)(1994-7#1)(1994-8#1)(2007-5#1)(2008-1#1)(2008-4#1)(2010-11#1)
of insulin-dependent##15##2##(1991-2#2)(1992-6#2)(1992-8#2)(1993-11#2)(1994-12#1)(1994-7#1)(1994-8#1)(2007-5#1)(2008-1#1)(2008-4#1)(2010-11#1)
of insulin-induced##2##2##(1990-10#1)(2008-3#1)
of insulin-like growth factor 1##2##5##(2008-9#2)
of insulin-like growth factor I (IGF-I)##2##6##(1996-5#1)(2006-9#1)
of insulin-like growth factor I##3##5##(1994-8#1)(1996-5#1)(2006-9#1)
of insulin-like growth factor II##3##5##(1990-9#1)(1992-3#2)
of insulin-like growth factor binding protein-1##2##6##(1992-6#1)(1993-1#1)
of insulin-like growth factor binding##4##5##(1992-6#1)(1993-1#1)(1993-6#1)(1996-4#1)
of insulin-like growth factor##14##4##(1990-9#1)(1992-3#2)(1992-6#1)(1993-1#1)(1993-6#1)(1994-8#1)(1996-4#1)(1996-5#1)(2006-9#1)(2008-4#1)(2008-6#1)(2008-9#2)
of insulin-like growth factor-1##4##4##(2007-10#1)(2009-8#1)(2011-12#1)(2013-8#1)
of insulin-like growth factor-I (IGF-I) and##3##6##(1995-10#2)(1997-5#1)
of insulin-like growth factor-I (IGF-I)##4##5##(1995-10#2)(1997-5#2)
of insulin-like growth factor-I##7##4##(1992-6#1)(1994-6#1)(1995-10#2)(1997-5#2)(2010-1#1)
of insulin-like growth factors##2##4##(2010-5#1)(2012-1#1)
of insulin-like growth##27##3##(1990-9#1)(1992-3#2)(1992-6#2)(1993-1#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-10#2)(1996-4#1)(1996-5#1)(1997-5#2)(2006-9#1)(2007-10#1)(2008-4#1)(2008-6#1)(2008-9#2)(2009-8#1)(2010-1#1)(2010-5#1)(2011-12#1)(2012-1#1)(2013-8#1)
of insulin-like##31##2##(1990-9#1)(1992-3#2)(1992-6#2)(1993-1#1)(1993-6#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-10#2)(1996-4#1)(1996-5#1)(1996-7#1)(1997-5#2)(2006-11#1)(2006-9#1)(2007-10#1)(2008-4#1)(2008-6#1)(2008-9#2)(2009-8#1)(2010-1#1)(2010-4#1)(2010-5#1)(2011-12#1)(2012-1#1)(2013-8#1)
of insulin-producing##3##2##(1994-8#1)(2007-5#1)(2008-1#1)
of insulin-responsive glucose transporter (GLUT4)##2##5##(1994-11#2)
of insulin-stimulated##2##2##(1992-6#1)(1994-11#1)
of insulinoma##7##2##(1997-4#1)(1997-5#1)(2007-5#1)(2007-8#1)(2008-2#1)(2009-4#1)(2012-2#1)
of insulitis##4##2##(1997-4#1)(2008-4#2)(2010-11#1)
of insults##5##2##(2005-8#1)(2008-11#1)(2008-5#1)(2008-9#2)
of insurance benefits##2##3##(1996-5#1)(1997-5#1)
of insurance contract##3##3##(1992-1#3)
of insurance##24##2##(1991-3#1)(1992-1#5)(1992-9#1)(1993-2#1)(1993-3#1)(1995-1#1)(1996-1#1)(1996-3#2)(1996-5#1)(1997-5#1)(1997-8#4)(2008-5#1)(2009-11#1)(2010-2#1)(2011-1#1)(2013-8#1)
of insurers##2##2##(1992-3#1)(2008-10#1)
of intact 125I-ET-1##2##3##(1990-3#2)
of intact BAC DNA for##2##5##(2008-4#2)
of intact and##2##3##(1994-10#1)(2008-11#1)
of intact cells of##2##4##(1996-1#1)(1996-6#1)
of intact cells##5##3##(1992-8#1)(1993-9#1)(1994-8#1)(1996-1#1)(1996-6#1)
of intact chromogranin A##2##4##(1993-8#2)
of intact hepatocytes##2##3##(1990-12#1)(1991-10#1)
of intact mitochondria##2##3##(1991-5#1)(1997-2#1)
of intact plants##2##3##(2008-10#1)(2008-9#1)
of intact rats##2##3##(1992-3#1)(1994-10#1)
of intact type VI collagen microfibrils##2##6##(1993-3#2)
of intact type##3##3##(1992-5#1)(1993-3#2)
of intact##97##2##(1990-12#1)(1990-3#2)(1990-7#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-11#2)(1992-3#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#2)(1994-10#3)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#1)(1995-2#1)(1995-5#3)(1995-7#2)(1996-1#1)(1996-11#1)(1996-12#3)(1996-3#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#4)(2008-7#2)(2008-9#3)(2009-10#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
of intake and##3##3##(2008-10#1)(2008-12#1)(2009-2#1)
of intake of##4##3##(1990-8#1)(2008-1#1)(2012-1#1)(2012-2#1)
of intake##19##2##(1990-10#1)(1990-8#1)(1991-12#1)(1993-11#1)(1997-8#3)(2005-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2009-2#2)(2009-4#2)(2010-2#1)(2012-1#1)(2012-2#1)
of integer##3##2##(1992-9#1)(2008-2#2)
of integral imaging##2##3##(2007-11#2)
of integral membrane proteins##7##4##(1990-5#1)(1990-6#1)(1992-12#1)(1993-11#1)(1995-1#1)(2008-4#2)
of integral photography##2##3##(2007-12#1)(2008-3#1)
of integral##16##2##(1990-5#1)(1990-6#1)(1992-12#1)(1993-11#1)(1995-1#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#2)(2009-7#1)(2010-12#1)(2010-7#1)(2012-1#1)
of integrants##2##2##(1993-11#1)(1996-4#1)
of integrase##3##2##(1997-1#1)(2008-1#1)(2011-1#1)
of integrate-and-fire neurons##3##3##(2008-2#3)
of integrated KT##4##3##(2011-1#4)
of integrated care##2##3##(2012-3#2)
of integrated delivery systems##3##4##(1996-1#1)(1996-2#1)(1996-3#1)
of integrated delivery##4##3##(1996-1#1)(1996-2#1)(1996-3#1)(2010-8#1)
of integrated health care delivery##2##5##(1996-1#1)(2008-1#1)
of integrated health care##4##4##(1994-1#1)(1995-12#1)(1996-1#1)(2008-1#1)
of integrated health##5##3##(1994-1#1)(1995-12#1)(1996-1#1)(2007-9#1)(2008-1#1)
of integrated optical##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
of integrated pest management strategies##2##5##(2008-9#1)(2011-2#1)
of integrated pest management##5##4##(1997-7#1)(2008-10#2)(2008-9#1)(2011-2#1)
of integrated services##4##3##(2008-2#4)
of integrated systems##2##3##(1992-12#1)(1997-3#1)
of integrated vector management##3##4##(2008-8#2)(2013-1#1)
of integrated##67##2##(1990-7#1)(1990-9#1)(1992-12#1)(1993-12#2)(1994-1#2)(1994-3#1)(1995-12#1)(1996-1#2)(1996-2#1)(1996-3#4)(1997-3#2)(1997-7#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#8)(2008-3#5)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-8#2)(2011-1#7)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#1)
of integrating the##2##3##(1991-10#1)(2012-3#1)
of integrating##22##2##(1991-10#1)(1994-4#1)(1995-4#1)(1997-2#1)(2005-8#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#2)(2008-7#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#2)
of integration and##2##3##(2008-10#1)(2008-2#1)
of integration being##2##3##(2007-11#1)(2008-3#1)
of integration by homologous##2##4##(1990-5#1)(2008-10#1)
of integration of##9##3##(1990-9#1)(1993-11#1)(2006-8#1)(2007-7#1)(2008-11#1)(2008-2#2)(2008-5#1)(2011-1#1)
of integration sites##2##3##(1997-3#1)(2011-2#1)
of integration##31##2##(1990-4#1)(1990-5#1)(1990-9#1)(1991-9#1)(1993-11#1)(1995-2#1)(1995-8#1)(1997-3#2)(2006-8#1)(2007-11#2)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#2)(2011-2#1)(2013-7#1)
of integrative approaches to couple therapy##2##6##(2012-2#2)
of integrative##4##2##(1997-6#1)(2012-2#3)
of integrin clusters in##2##4##(2010-10#2)
of integrin clusters##4##3##(2010-10#4)
of integrin expression##2##3##(1994-12#1)(2010-7#1)
of integrin receptors##2##3##(1991-9#1)(1995-6#1)
of integrin subunits##2##3##(1994-10#1)(1995-6#1)
of integrin##25##2##(1991-9#1)(1992-11#1)(1994-10#1)(1994-12#3)(1995-6#2)(1996-2#1)(2008-1#2)(2008-11#1)(2008-5#1)(2009-7#1)(2009-8#1)(2010-10#5)(2010-6#1)(2010-7#1)(2011-1#2)(2012-12#1)
of integrin-mediated##3##2##(1993-11#1)(1994-10#1)(2010-1#1)
of integrins##8##2##(1991-9#1)(1994-12#1)(1997-6#1)(2006-1#1)(2007-11#1)(2009-1#1)(2010-1#1)(2012-2#1)
of integrity of##4##3##(2007-7#1)(2008-10#2)(2008-4#1)
of integrity##7##2##(2007-7#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-9#2)
of inteins##2##2##(2013-1#2)
of intellectual functioning##3##3##(1997-8#1)(2006-3#1)(2008-2#1)
of intellectual property protection##3##4##(2008-6#3)
of intellectual property rights##4##4##(2008-6#1)(2012-3#3)
of intellectual property##8##3##(1994-3#1)(2008-6#4)(2012-3#3)
of intellectual##18##2##(1993-3#1)(1994-3#1)(1997-8#1)(2006-10#1)(2006-3#1)(2008-1#1)(2008-2#1)(2008-6#4)(2008-7#1)(2010-4#2)(2012-2#1)(2012-3#3)
of intelligence in##2##3##(1992-8#1)(2012-12#1)
of intelligence##12##2##(1992-8#2)(2004-12#1)(2004-3#1)(2007-3#1)(2010-2#4)(2012-12#1)(2012-3#1)(2013-7#1)
of intelligent cryosubstrates##2##3##(2006-2#2)
of intelligent##5##2##(2006-2#2)(2013-8#3)
of intense debate##2##3##(2010-12#1)(2010-3#1)
of intense femtosecond pulses in##2##5##(2007-12#1)(2008-1#1)
of intense femtosecond##3##3##(2007-12#2)(2008-1#1)
of intense investigation##8##3##(1995-6#1)(2006-2#1)(2008-11#1)(2008-6#1)(2008-7#2)(2009-12#1)(2013-7#1)
of intense laser pulses##2##4##(1995-5#1)(2007-12#1)
of intense research in recent##2##5##(2008-1#1)(2008-9#1)
of intense research##9##3##(2005-1#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-7#1)(2010-9#1)(2011-1#1)
of intense study##2##3##(2006-10#1)(2008-9#1)
of intense transmission##2##3##(2006-4#1)(2008-8#1)
of intense tunable##2##3##(2006-4#1)(2008-1#1)
of intense ultrabroadband optical pulses##2##5##(2007-12#2)
of intense##67##2##(1992-2#1)(1992-3#1)(1993-12#1)(1993-8#1)(1995-11#1)(1995-5#1)(1995-6#1)(2005-1#1)(2005-10#1)(2005-7#1)(2006-10#3)(2006-2#1)(2006-4#4)(2006-8#1)(2007-11#1)(2007-12#13)(2007-8#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-12#1)(2009-3#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
of intensely immunostained##2##3##(1996-4#1)(1997-3#1)
of intensely##5##2##(1990-11#1)(1996-4#1)(1997-2#1)(1997-3#1)(2008-3#1)
of intensification##2##2##(2004-2#1)(2012-1#1)
of intensified IFADIC##2##3##(2008-6#2)
of intensified insulin##2##3##(1994-7#1)(2006-1#1)
of intensified##6##2##(1991-3#1)(1994-7#1)(2006-1#1)(2008-6#2)(2009-2#1)
of intensities of##3##3##(1992-12#1)(1994-12#1)(2008-10#1)
of intensity and pleasantness##3##4##(2012-12#3)
of intensity and##5##3##(2007-11#1)(2008-3#1)(2012-12#3)
of intensity data##2##3##(2007-12#1)(2008-3#1)
of intensity fluctuations of##2##4##(2008-3#1)(2013-1#1)
of intensity fluctuations##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
of intensity modulated##2##3##(2008-6#1)(2013-8#1)
of intensity noise in##2##4##(2007-12#1)(2008-3#1)
of intensity of##3##3##(2007-12#1)(2008-3#1)(2008-9#1)
of intensity variations##2##3##(2007-12#1)(2008-2#1)
of intensity##51##2##(1991-2#1)(1992-9#1)(1995-12#2)(1995-5#1)(2007-11#5)(2007-12#7)(2008-1#1)(2008-10#1)(2008-2#7)(2008-3#12)(2008-6#1)(2008-9#2)(2009-5#1)(2011-2#1)(2012-12#5)(2013-1#1)(2013-8#2)
of intensity-dependent polarization##2##3##(2007-12#1)(2008-1#1)
of intensity-modulated laser diodes##2##4##(2008-3#2)
of intensive care therapy##2##4##(1996-9#2)
of intensive care unit (ICU)##2##5##(2007-8#1)(2013-8#1)
of intensive care unit patients##5##5##(2006-10#2)(2009-11#1)(2009-9#1)(2012-2#1)
of intensive care unit##10##4##(2006-10#3)(2007-8#1)(2008-4#1)(2009-11#1)(2009-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
of intensive care##20##3##(1990-11#1)(1990-2#1)(1995-1#1)(1996-9#3)(2006-10#4)(2007-11#1)(2007-8#1)(2008-4#1)(2009-11#1)(2009-4#1)(2009-9#1)(2012-2#1)(2013-1#1)(2013-8#2)
of intensive focus##2##3##(2008-5#1)(2010-11#1)
of intensive insulin therapy##2##4##(2007-6#1)(2011-1#1)
of intensive research##6##3##(1990-6#1)(2005-10#1)(2006-12#1)(2007-5#1)(2008-8#1)(2012-2#1)
of intensive treatment##2##3##(1993-9#1)(2012-2#1)
of intensive vs##3##3##(2007-1#3)
of intensive##61##2##(1990-11#1)(1990-2#1)(1990-6#1)(1993-9#1)(1994-11#1)(1995-1#1)(1996-9#3)(2005-10#1)(2005-7#1)(2006-10#4)(2006-12#1)(2007-1#4)(2007-11#3)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#1)(2009-9#1)(2010-11#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#3)
of intensively##2##2##(2010-12#1)(2013-8#1)
of intent##3##2##(1996-3#1)(2008-4#1)(2008-5#1)
of intention to##2##3##(2006-9#1)(2010-2#1)
of intention##6##2##(2006-3#2)(2006-4#1)(2006-9#1)(2010-2#1)(2012-3#1)
of intentional and##2##3##(1996-11#1)(2009-10#1)
of intentional##7##2##(1996-11#1)(2007-7#1)(2008-1#1)(2008-11#1)(2009-10#1)(2009-12#1)(2010-2#1)
of intentions##5##2##(1997-3#1)(2010-2#4)
of inter and##2##3##(1996-7#1)(2008-7#1)
of inter##4##2##(1996-7#1)(2008-10#1)(2008-7#1)(2012-3#1)
of inter- and##3##3##(1992-3#1)(2008-9#1)(2010-2#1)
of interacting genes##2##3##(2004-12#1)(2007-11#1)
of interacting phenotypes##4##3##(2008-8#4)
of interacting proteins##3##3##(1990-12#1)(1992-3#1)(2008-1#1)
of interacting sites##2##3##(1992-9#1)(1996-5#1)
of interacting species##2##3##(1997-2#1)(2013-8#1)
of interacting with the##4##4##(1992-2#1)(1994-11#1)(1995-5#1)(2013-1#1)
of interacting with##7##3##(1991-4#1)(1992-2#2)(1994-11#1)(1995-5#1)(2008-11#1)(2013-1#1)
of interacting##33##2##(1990-12#1)(1990-8#1)(1991-4#1)(1991-6#1)(1992-2#2)(1992-3#1)(1992-9#1)(1994-11#1)(1994-5#1)(1995-5#1)(1996-5#1)(1997-2#1)(2004-12#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#4)(2009-9#1)(2010-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
of interaction among##3##3##(2005-4#1)(2008-11#1)(2010-6#1)
of interaction and the##2##4##(2006-8#1)(2009-12#1)
of interaction and##3##3##(2006-8#1)(2009-12#1)(2012-3#1)
of interaction between the##6##4##(1994-3#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-5#1)
of interaction between##28##3##(1990-11#1)(1990-2#1)(1991-9#1)(1992-2#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-10#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-11#2)(2006-10#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-4#1)(2010-3#1)(2012-2#1)
of interaction indices versus effects##2##5##(2009-12#2)
of interaction of the##2##4##(1991-6#1)(1994-9#1)
of interaction of##14##3##(1991-6#1)(1992-6#1)(1993-6#1)(1994-8#1)(1994-9#2)(1995-3#1)(2007-5#1)(2008-10#3)(2008-7#1)(2009-8#1)(2011-2#1)
of interaction was##4##3##(1995-6#1)(1996-8#2)(2008-10#1)
of interaction with the##3##4##(1996-5#1)(2008-11#1)(2008-7#1)
of interaction with##9##3##(1990-4#1)(1995-3#1)(1996-5#2)(2006-9#1)(2008-11#1)(2008-7#2)(2008-9#1)
of interaction##107##2##(1990-11#2)(1990-2#2)(1990-4#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-10#1)(1996-5#2)(1996-8#2)(1997-1#1)(1997-2#4)(1997-8#1)(2005-11#3)(2005-4#1)(2006-10#2)(2006-2#1)(2006-8#1)(2006-9#1)(2007-12#3)(2007-5#2)(2007-8#2)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#5)(2008-5#3)(2008-7#9)(2008-8#2)(2008-9#2)(2009-12#3)(2009-4#2)(2009-8#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#2)
of interactions among##2##3##(1994-9#1)(2009-12#1)
of interactions between the##7##4##(1990-5#1)(2005-11#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-1#1)(2012-2#1)
of interactions between##28##3##(1990-5#1)(1992-12#1)(1992-6#1)(1992-9#1)(2005-11#3)(2006-10#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-12#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
of interactions in##3##3##(2005-11#1)(2007-12#1)(2012-2#1)
of interactions of##5##3##(1991-9#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-5#1)
of interactions that##4##3##(1990-9#1)(2007-10#1)(2008-9#1)(2009-7#1)
of interactions with other##3##4##(2007-8#1)(2013-1#2)
of interactions with the##2##4##(2008-10#1)(2008-4#1)
of interactions with##12##3##(1993-1#1)(1997-3#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-4#2)(2008-7#1)(2009-12#1)(2013-1#2)
of interactions##75##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-8#1)(1994-9#1)(1996-11#1)(1997-3#2)(2005-11#7)(2006-10#3)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#3)(2009-12#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#2)(2011-1#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
of interactive##7##2##(1993-7#1)(2007-10#1)(2008-4#1)(2008-7#2)(2012-1#1)(2012-3#1)
of interactivity##3##2##(2006-6#1)(2008-7#1)(2010-4#1)
of intercalated##2##2##(1997-8#1)(2005-11#1)
of intercellular adhesion molecule 1 (ICAM-1)##2##6##(1995-5#1)(2009-9#1)
of intercellular adhesion##5##3##(1993-11#1)(1995-5#2)(2009-9#1)(2010-1#1)
of intercellular communication##2##3##(2008-7#1)(2013-8#1)
of intercellular signaling##2##3##(2007-12#1)(2008-4#1)
of intercellular spaces##2##3##(2008-10#1)(2008-7#1)
of intercellular##19##2##(1993-11#1)(1993-3#1)(1995-5#2)(1997-6#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-10#1)(2009-9#1)(2010-1#1)(2013-8#1)
of interchangeability##2##2##(1990-2#1)(2013-1#1)
of intercondylar##2##2##(2011-1#1)(2012-2#1)
of interconnected regions##2##3##(2008-4#1)(2008-6#1)
of interconnected##9##2##(2008-11#1)(2008-2#2)(2008-4#1)(2008-6#1)(2009-12#1)(2010-4#1)(2012-2#2)
of interconnecting##2##2##(2008-5#1)(2009-5#1)
of interconnections in##2##3##(2004-9#2)
of intercostal tube##2##3##(2007-8#1)(2010-2#1)
of intercostal##4##2##(2006-1#1)(2007-8#2)(2010-2#1)
of intercourse##3##2##(2006-10#3)
of interdental##2##2##(2012-12#1)(2013-7#1)
of interdigitated##2##2##(2007-12#1)(2008-10#1)
of interdisciplinary##10##2##(2006-7#2)(2007-7#1)(2008-8#1)(2010-11#1)(2010-2#1)(2012-12#3)(2013-1#1)
of interest (e##2##3##(2008-11#1)(2008-4#1)
of interest (the##2##3##(2008-2#1)(2008-7#1)
of interest analysis##3##3##(2008-10#1)(2008-11#1)(2012-12#1)
of interest and a##2##4##(2008-11#1)(2008-2#1)
of interest and for##2##4##(1996-7#1)(1997-4#1)
of interest and has##2##4##(1992-3#1)(2013-7#1)
of interest and the##2##4##(2008-1#1)(2008-4#1)
of interest and##28##3##(1992-3#1)(1996-7#1)(1997-4#2)(2007-11#1)(2007-4#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-9#2)(2009-4#1)(2009-6#1)(2012-3#2)(2013-1#2)(2013-7#1)
of interest are discussed##3##4##(2008-11#1)(2010-8#1)(2013-8#1)
of interest are not##2##4##(2007-4#1)(2010-11#1)
of interest are##22##3##(1991-12#1)(1991-5#1)(1994-11#1)(1994-5#1)(2006-10#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-9#2)(2010-11#1)(2010-8#1)(2013-8#1)
of interest as##6##3##(2007-11#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-2#1)(2011-2#1)
of interest because of##6##4##(1992-2#1)(2010-5#1)(2011-1#1)(2011-2#3)
of interest because##15##3##(1990-8#1)(1992-2#1)(2005-11#1)(2008-5#1)(2010-5#1)(2011-1#1)(2011-2#9)
of interest before##2##3##(2008-9#1)(2011-2#1)
of interest but##2##3##(2007-4#1)(2011-2#1)
of interest by##5##3##(2006-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-2#1)
of interest can be##8##4##(1992-8#1)(1993-9#1)(1996-6#2)(2008-2#1)(2008-4#1)(2008-7#1)(2012-2#1)
of interest can##11##3##(1992-8#1)(1993-9#1)(1996-6#2)(1997-8#1)(2008-2#1)(2008-4#2)(2008-7#1)(2009-12#1)(2012-2#1)
of interest for an##2##4##(2008-2#1)(2008-3#1)
of interest for further##3##4##(1991-5#1)(1997-5#1)(2008-5#1)
of interest for many##3##4##(2008-1#1)(2008-3#1)(2009-10#1)
of interest for the##6##4##(2006-10#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-12#1)(2013-8#1)
of interest for their##2##4##(1993-9#1)(2008-1#1)
of interest for##41##3##(1991-5#1)(1992-9#1)(1993-9#1)(1994-9#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-5#2)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#4)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#1)(2011-2#2)(2013-8#1)
of interest from the##2##4##(2005-10#1)(2008-4#1)
of interest from##6##3##(1995-1#1)(2005-10#1)(2008-2#1)(2008-4#3)
of interest has##2##3##(1994-2#1)(2008-10#1)
of interest have been##2##4##(2008-4#2)
of interest in a##3##4##(2008-4#2)(2008-9#1)
of interest in developing##3##4##(2007-7#1)(2009-12#1)(2012-3#1)
of interest in medical##6##4##(2012-11#4)(2013-1#2)
of interest in the##12##4##(1992-9#1)(2004-9#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-4#1)(2013-1#1)
of interest in these##2##4##(2007-11#1)(2008-11#1)
of interest in this##2##4##(2006-10#1)(2009-10#1)
of interest in##65##3##(1991-6#1)(1992-9#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2004-9#1)(2005-8#1)(2006-10#3)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#3)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-11#4)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#1)
of interest include##2##3##(2006-10#1)(2007-7#1)
of interest into##5##3##(2006-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#1)
of interest is expressed as a##3##6##(2008-2#2)(2008-9#1)
of interest is prepared and##2##5##(2008-4#2)
of interest is the##5##4##(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#2)
of interest is##35##3##(1994-11#1)(1994-2#2)(1994-6#1)(1994-8#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#10)(2008-5#1)(2008-7#2)(2008-9#3)(2012-2#2)
of interest on##6##3##(1995-8#1)(1997-2#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)
of interest over##2##3##(2004-9#1)(2008-9#1)
of interest since##2##3##(1996-11#1)(2008-10#1)
of interest such as##3##4##(1990-8#1)(2008-10#1)(2008-9#1)
of interest that##3##3##(2008-11#1)(2011-1#1)(2012-1#1)
of interest to determine whether##4##5##(1991-6#1)(1992-3#1)(1994-9#1)(2008-4#1)
of interest to determine##5##4##(1991-6#1)(1992-3#1)(1994-9#1)(2008-4#1)(2008-8#1)
of interest to investigate the##2##5##(1993-11#1)(2011-12#1)
of interest to investigate##3##4##(1993-11#1)(2011-12#1)(2013-1#1)
of interest to researchers##3##4##(2005-8#1)(2007-2#1)(2011-1#1)
of interest to the history and culture of health##2##9##(2009-10#2)
of interest to the##8##4##(2006-10#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-10#2)
of interest to understand the##2##5##(2008-10#1)(2008-7#1)
of interest to##70##3##(1990-2#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-3#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-5#1)(1994-3#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#3)
of interest using##2##3##(2008-10#1)(2008-11#1)
of interest was##4##3##(1996-4#1)(2008-10#1)(2008-7#1)(2008-8#1)
of interest were##12##3##(1990-6#1)(1996-6#1)(1997-3#1)(1997-5#1)(2005-8#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-2#1)(2012-2#1)
of interest when##2##3##(2007-10#1)(2012-2#1)
of interest will##2##3##(1997-4#1)(2008-8#1)
of interest with a##3##4##(1996-12#1)(2008-4#2)
of interest with##6##3##(1994-8#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-4#2)
of interest##666##2##(1990-11#1)(1990-2#1)(1990-6#2)(1990-8#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-8#3)(1992-9#4)(1993-11#2)(1993-12#2)(1993-3#2)(1993-5#1)(1993-7#1)(1993-9#2)(1994-1#1)(1994-11#2)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#5)(1996-7#1)(1996-8#2)(1997-2#2)(1997-3#2)(1997-4#6)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#3)(2004-9#3)(2005-10#2)(2005-11#4)(2005-7#1)(2005-8#4)(2006-10#12)(2006-12#5)(2006-2#2)(2006-5#4)(2006-8#1)(2007-10#2)(2007-11#9)(2007-12#8)(2007-2#1)(2007-4#6)(2007-5#5)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#3)(2008-1#9)(2008-10#43)(2008-11#33)(2008-12#4)(2008-2#32)(2008-3#27)(2008-4#57)(2008-5#10)(2008-6#4)(2008-7#21)(2008-8#15)(2008-9#33)(2009-10#6)(2009-11#1)(2009-12#5)(2009-2#1)(2009-3#1)(2009-4#7)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#2)(2010-2#8)(2010-3#1)(2010-4#1)(2010-5#6)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#47)(2011-12#2)(2011-2#19)(2011-3#4)(2012-1#6)(2012-11#7)(2012-12#5)(2012-2#11)(2012-3#13)(2013-1#23)(2013-7#2)(2013-8#5)
of interest)##2##2##(2008-11#1)(2008-4#1)
of interested##5##2##(1993-1#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-7#1)
of interesting##8##2##(1997-4#1)(2005-7#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2013-1#2)
of interests and activities##2##4##(2010-2#1)(2013-1#1)
of interests and##3##3##(2009-10#1)(2010-2#1)(2013-1#1)
of interests##9##2##(1992-1#1)(1993-7#1)(1996-11#2)(2008-12#1)(2009-10#1)(2010-2#1)(2012-11#1)(2013-1#1)
of interexaminer agreement##3##3##(1997-8#3)
of interface phenomena in##2##4##(2005-11#2)
of interface roughness##2##3##(2008-2#1)(2008-3#1)
of interface##12##2##(1997-6#1)(2005-11#2)(2007-6#2)(2008-10#1)(2008-2#2)(2008-3#1)(2012-2#2)(2013-8#1)
of interfaces##2##2##(1992-6#1)(2008-10#1)
of interfacial tension##2##3##(2005-11#2)
of interfacial water##2##3##(2010-9#1)(2012-1#1)
of interfacial##19##2##(1990-8#1)(1992-12#1)(1993-6#1)(1997-4#1)(2005-11#7)(2008-10#1)(2008-3#3)(2009-5#1)(2010-9#1)(2012-1#1)(2012-2#1)
of interference and##2##3##(1994-3#1)(2013-1#1)
of interference between##3##3##(2007-11#1)(2008-3#1)(2009-5#1)
of interference by##3##3##(1992-7#1)(2008-10#1)(2008-2#1)
of interference effects##2##3##(2008-1#1)(2008-3#1)
of interference fringes##5##3##(2008-2#1)(2008-3#4)
of interference from##4##3##(2007-12#1)(2008-10#2)(2010-6#1)
of interference is##2##3##(2008-10#1)(2008-5#1)
of interference of##3##3##(1990-12#1)(2007-12#1)(2008-6#1)
of interference screws for soft tissue##2##6##(2013-1#2)
of interference was observed##2##4##(2007-12#1)(2008-10#1)
of interference##46##2##(1990-12#1)(1992-7#1)(1994-3#1)(2005-11#1)(2006-3#1)(2006-4#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#10)(2008-2#3)(2008-3#8)(2008-5#2)(2008-6#1)(2008-7#1)(2009-5#1)(2010-6#1)(2013-1#5)(2013-7#1)(2013-8#2)
of interferences from##4##3##(2007-8#1)(2008-10#3)
of interferences in##2##3##(2008-10#2)
of interferences was##3##3##(2008-10#3)
of interferences##25##2##(2005-4#1)(2007-8#1)(2008-10#23)
of interferent##2##2##(2008-10#2)
of interferents##5##2##(2008-10#5)
of interfering ions on##2##4##(2008-10#2)
of interfering ions were##2##4##(2008-10#2)
of interfering ions##13##3##(2008-10#13)
of interfering peaks##3##3##(1990-6#1)(1997-2#2)
of interfering species##3##3##(2008-10#1)(2008-2#2)
of interfering substances##2##3##(2008-10#2)
of interfering##32##2##(1990-6#1)(1990-9#1)(1993-3#1)(1994-3#1)(1997-2#2)(2007-8#1)(2008-10#22)(2008-2#2)(2013-1#1)
of interferogram##4##2##(2006-12#1)(2008-3#1)(2013-8#2)
of interferograms##6##2##(2008-2#3)(2008-3#3)
of interferometer##2##2##(2007-12#1)(2008-2#1)
of interferometric##12##2##(2007-12#2)(2008-2#5)(2008-3#5)
of interferon (IFN)##2##3##(1993-2#1)(2013-7#1)
of interferon (IFN)-gamma##3##3##(1994-8#1)(1996-12#1)(2008-11#1)
of interferon alpha and##2##4##(1997-3#1)(2006-2#1)
of interferon alpha##5##3##(1992-2#1)(1997-3#1)(1997-5#1)(2006-2#1)(2009-10#1)
of interferon alpha-2a##2##3##(2008-5#2)
of interferon and nitric oxide##2##5##(2008-5#2)
of interferon and##4##3##(2008-5#2)(2008-7#1)(2009-11#1)
of interferon for##2##3##(2006-2#1)(2007-11#1)
of interferon gamma##4##3##(1994-10#1)(2007-10#1)(2007-11#1)(2013-1#1)
of interferon gamma-1b##3##3##(2007-2#3)
of interferon response##2##3##(2008-11#1)(2012-3#1)
of interferon therapy##4##3##(2006-10#1)(2006-2#1)(2009-3#1)(2012-1#1)
of interferon##52##2##(1990-8#1)(1991-8#1)(1992-2#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-8#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-5#2)(1997-3#1)(1997-4#1)(1997-5#1)(2006-10#2)(2006-2#4)(2007-1#1)(2007-10#1)(2007-11#7)(2007-2#3)(2008-11#2)(2008-5#4)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-3#1)(2010-11#1)(2012-1#1)(2012-3#3)(2013-1#2)(2013-7#1)
of interferon-alpha (IFN-alpha)##2##3##(1996-2#1)(2005-11#1)
of interferon-alpha and##2##3##(1996-2#1)(2008-6#1)
of interferon-alpha in##2##3##(1997-5#1)(2007-4#1)
of interferon-alpha##10##2##(1992-11#1)(1993-2#1)(1996-2#2)(1997-5#1)(2005-11#1)(2007-11#2)(2007-4#1)(2008-6#1)
of interferon-alpha-2a##4##2##(2007-11#4)
of interferon-alpha-2b##2##2##(2007-11#2)
of interferon-alpha-n1 in##2##3##(2007-11#2)
of interferon-based therapy##2##3##(2007-11#1)(2009-7#1)
of interferon-beta##9##2##(1994-6#1)(2008-11#8)
of interferon-beta-1a##2##2##(2007-11#2)
of interferon-gamma (IFN-gamma) and##2##4##(2008-11#1)(2008-4#1)
of interferon-gamma (IFN-gamma)##6##3##(1993-12#1)(1994-6#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-9#1)
of interferon-gamma (IFNgamma) in##2##4##(2008-10#2)
of interferon-gamma##17##2##(1990-8#1)(1993-12#1)(1993-6#1)(1994-6#2)(1995-2#1)(1996-10#1)(1997-7#1)(2007-2#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-9#1)
of intergenerational transmission##2##3##(2010-12#1)(2010-2#1)
of intergenerational##4##2##(2008-5#1)(2009-7#1)(2010-12#1)(2010-2#1)
of interhemispheric##2##2##(1997-6#1)(1997-8#1)
of interictal epileptiform activities##3##4##(2004-11#3)
of interictal epileptiform##4##3##(2004-11#4)
of interictal##7##2##(1990-5#1)(1995-12#1)(1996-6#1)(2004-11#4)
of interim##2##2##(1996-6#1)(2007-2#1)
of interlaboratory##4##2##(1996-8#2)(2008-10#2)
of interlayer##2##2##(1991-9#1)(2008-2#1)
of interleukin (IL)-10##2##3##(2007-11#1)(2008-5#1)
of interleukin (IL)-11##2##3##(1994-12#1)(2006-10#1)
of interleukin (IL)-1beta##2##3##(2008-12#1)(2008-6#1)
of interleukin 1 and 6 in##2##6##(1991-8#2)
of interleukin 1 and##3##4##(1991-8#3)
of interleukin 1 beta on##3##5##(1994-10#1)(1994-2#2)
of interleukin 1 beta##5##4##(1994-10#1)(1994-2#3)(1997-5#1)
of interleukin 1##10##3##(1990-11#1)(1991-8#3)(1992-11#1)(1994-10#1)(1994-2#3)(1997-5#1)
of interleukin 2 (IL-2) to##2##5##(1994-5#1)(2008-4#1)
of interleukin 2 receptor##2##4##(1990-6#1)(1992-6#1)
of interleukin 2##8##3##(1990-6#2)(1992-6#1)(1994-3#1)(1994-5#1)(2008-11#2)(2008-4#1)
of interleukin 6 (IL-6) in##2##5##(1995-2#1)(1997-7#1)
of interleukin 6 (IL-6)##4##4##(1990-7#1)(1994-5#1)(1995-2#1)(1997-7#1)
of interleukin 6##6##3##(1990-7#1)(1992-9#1)(1994-5#1)(1995-2#1)(1997-7#1)(2008-4#1)
of interleukin 7 (IL-7)##2##4##(2008-11#2)
of interleukin 7##4##3##(2008-11#3)(2008-4#1)
of interleukin 8##2##3##(1994-5#1)(1995-6#1)
of interleukin##46##2##(1990-11#1)(1990-6#2)(1990-7#1)(1991-8#3)(1992-11#1)(1992-6#1)(1992-9#1)(1994-10#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#3)(1994-8#1)(1995-2#1)(1995-6#1)(1997-5#1)(1997-7#1)(2006-10#2)(2007-11#1)(2007-9#1)(2008-11#6)(2008-12#1)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#1)(2012-3#1)(2013-1#1)
of interleukin-1 (IL-1)##5##3##(1991-8#1)(1992-9#1)(1995-6#1)(2006-10#1)(2009-9#1)
of interleukin-1 alpha##2##3##(1992-8#1)(1994-6#1)
of interleukin-1 and tumor necrosis factor-alpha##2##6##(1997-5#2)
of interleukin-1 and##4##3##(1997-5#3)(2012-2#1)
of interleukin-1 beta##3##3##(1990-10#1)(1996-3#2)
of interleukin-1 on pulmonary##2##4##(1992-6#2)
of interleukin-1 on##4##3##(1990-10#1)(1990-12#1)(1992-6#2)
of interleukin-1##24##2##(1990-10#2)(1990-12#1)(1991-8#1)(1992-3#1)(1992-6#3)(1992-8#1)(1992-9#1)(1994-2#1)(1994-3#1)(1994-6#2)(1995-6#1)(1996-3#2)(1997-5#3)(2006-10#1)(2006-9#1)(2009-9#1)(2012-2#1)
of interleukin-10##6##2##(1994-12#1)(1996-10#1)(2007-11#2)(2008-4#1)(2011-1#1)
of interleukin-12 (IL-12)##2##3##(1997-7#1)(2008-11#1)
of interleukin-12 in the##2##4##(1996-10#2)
of interleukin-12 in##6##3##(1996-10#6)
of interleukin-12 on##2##3##(1996-10#2)
of interleukin-12 receptors##2##3##(1996-10#1)(1997-2#1)
of interleukin-12##19##2##(1996-10#16)(1997-2#1)(1997-7#1)(2008-11#1)
of interleukin-13##2##2##(2008-4#1)(2009-8#1)
of interleukin-17##2##2##(2007-11#1)(2012-3#1)
of interleukin-2 (IL-2)##2##3##(1993-6#1)(2007-11#1)
of interleukin-2 and##2##3##(1994-6#1)(2007-11#1)
of interleukin-2 by##2##3##(1990-5#1)(1994-9#1)
of interleukin-2 in##3##3##(1990-6#1)(2007-11#2)
of interleukin-2 receptor alpha chain##2##5##(1994-9#2)
of interleukin-2##19##2##(1990-5#1)(1990-6#1)(1991-12#1)(1991-7#1)(1992-4#1)(1993-6#2)(1994-10#1)(1994-6#2)(1994-9#3)(1997-8#1)(2007-11#4)(2012-2#1)
of interleukin-21##2##2##(2008-4#2)
of interleukin-3##4##2##(1990-9#1)(1993-12#1)(1996-10#1)(1996-5#1)
of interleukin-4 (IL-4)##2##3##(1992-5#1)(2009-12#1)
of interleukin-4##3##2##(1992-1#1)(1992-5#1)(2009-12#1)
of interleukin-6 (IL-6) and##2##4##(2008-11#1)(2008-8#1)
of interleukin-6 (IL-6) was##3##4##(1992-4#1)(2007-8#1)(2012-3#1)
of interleukin-6 (IL-6)##12##3##(1992-12#1)(1992-4#1)(1994-3#2)(1994-6#1)(1997-8#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-8#1)(2012-3#1)
of interleukin-6##22##2##(1992-12#1)(1992-4#1)(1992-8#1)(1993-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-12#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-11#1)(2008-8#2)(2009-4#1)(2009-8#1)(2012-3#1)
of interleukin-8##4##2##(1991-1#1)(1993-6#1)(2009-3#1)(2012-12#1)
of interleukins##3##2##(1991-12#1)(1991-8#1)(1992-12#1)
of interlipid##2##2##(1991-7#1)(1992-1#1)
of interlobular##3##2##(2004-11#1)(2007-11#1)(2012-12#1)
of intermediate (alpha##3##3##(1994-8#3)
of intermediate density##4##3##(1992-3#3)(1994-8#1)
of intermediate filament##3##3##(1991-9#1)(1997-2#1)(2012-12#1)
of intermediate filaments##2##3##(2008-1#1)(2009-10#1)
of intermediate forms##2##3##(1990-12#1)(2010-6#1)
of intermediate grade##2##3##(1990-3#1)(2008-5#1)
of intermediate products##2##3##(2008-11#1)(2010-4#1)
of intermediate##56##2##(1990-12#2)(1990-3#2)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-3#3)(1993-3#1)(1994-6#1)(1994-8#5)(1995-10#2)(1995-4#1)(1995-7#1)(1995-8#1)(1996-8#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-3#1)(2006-8#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#2)(2009-10#2)(2010-4#1)(2010-6#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
of intermediates (alpha +CN-beta) (alpha##2##5##(1994-8#2)
of intermediates in##2##3##(1991-4#1)(2008-10#1)
of intermediates of##3##3##(1990-5#1)(1992-6#1)(2005-4#1)
of intermediates##20##2##(1990-5#2)(1990-8#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-6#1)(1992-9#1)(1994-6#1)(1994-8#2)(1995-4#1)(1997-2#1)(2005-4#1)(2008-10#3)(2008-4#1)(2009-2#1)(2011-1#1)
of intermittency##2##2##(1990-7#1)(2007-12#1)
of intermittent fever##2##3##(2011-2#1)(2012-2#1)
of intermittent##23##2##(1993-7#1)(1993-9#1)(1995-12#1)(1997-3#1)(1997-4#2)(1997-7#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2009-3#2)(2009-9#1)(2010-1#1)(2010-12#1)(2011-2#3)(2012-2#1)(2013-8#1)
of intermolecular interactions##4##3##(1995-3#1)(2008-10#1)(2010-4#1)(2013-7#1)
of intermolecular##16##2##(1993-6#1)(1993-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(2005-11#1)(2006-10#1)(2006-12#2)(2008-10#2)(2010-4#1)(2011-1#1)(2012-12#1)(2013-7#1)
of internal Ca2+ stores does not##2##6##(1991-12#1)(1995-3#1)
of internal Ca2+ stores##3##4##(1991-12#1)(1995-3#2)
of internal Ca2+##5##3##(1990-7#1)(1991-12#1)(1995-3#3)
of internal and external##6##4##(1990-10#1)(1991-2#1)(1995-4#1)(2008-1#1)(2009-10#1)(2013-1#1)
of internal and##7##3##(1990-10#1)(1991-2#1)(1995-4#1)(2008-1#2)(2009-10#1)(2013-1#1)
of internal carotid artery stenosis##2##5##(2007-9#1)(2013-1#1)
of internal carotid artery##6##4##(1991-10#1)(2007-9#1)(2008-3#1)(2013-1#2)(2013-8#1)
of internal carotid##7##3##(1991-10#1)(1996-9#1)(2007-9#1)(2008-3#1)(2013-1#2)(2013-8#1)
of internal consistency##4##3##(2008-3#1)(2009-12#1)(2010-2#1)(2010-8#1)
of internal contents##2##3##(1991-4#2)
of internal derangement##2##3##(2007-12#1)(2011-12#1)
of internal disc disruption##2##4##(2006-8#2)
of internal dose##2##3##(2010-2#2)
of internal fields in##2##4##(2008-2#2)
of internal fixation##3##3##(2006-3#1)(2007-11#1)(2012-2#1)
of internal jugular vein##2##4##(2007-7#1)(2010-2#1)
of internal jugular##3##3##(2007-7#2)(2010-2#1)
of internal malignancy##2##3##(2007-7#2)
of internal mammary sentinel lymph##2##5##(2008-8#2)
of internal marketing to the##2##5##(2008-12#2)
of internal mechanisms##2##3##(1996-4#1)(2007-8#1)
of internal medicine##5##3##(1990-10#3)(1990-12#1)(1990-6#1)
of internal medicine]##2##3##(1990-10#1)(1997-7#1)
of internal organs##4##3##(2007-8#2)(2010-7#1)(2012-3#1)
of internal radiation##2##3##(2008-4#1)(2012-2#1)
of internal resorption##2##3##(2007-2#2)
of internal standard##6##3##(1996-8#1)(2008-10#5)
of internal standards##2##3##(2008-10#2)
of internal structures##3##3##(1994-8#1)(2006-12#1)(2008-12#1)
of internal transcribed spacer (ITS)##2##5##(2008-10#2)
of internal transcribed spacer##3##4##(2005-9#1)(2008-10#2)
of internal transcribed##4##3##(2005-9#1)(2008-10#3)
of internal##157##2##(1990-10#5)(1990-11#1)(1990-12#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-4#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#1)(1993-11#1)(1994-11#1)(1994-3#2)(1994-8#1)(1995-3#4)(1995-4#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-7#1)(2005-5#1)(2005-9#1)(2006-12#1)(2006-3#1)(2006-7#2)(2006-8#3)(2006-9#1)(2007-11#4)(2007-12#1)(2007-2#2)(2007-4#3)(2007-7#4)(2007-8#4)(2007-9#2)(2008-1#4)(2008-10#17)(2008-11#1)(2008-12#4)(2008-2#3)(2008-3#7)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#1)(2009-5#1)(2010-2#5)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#5)(2013-8#2)
of internalization of##4##3##(1995-2#1)(2007-12#2)(2008-5#1)
of internalization##7##2##(1995-2#1)(2006-7#2)(2007-12#2)(2007-8#1)(2008-5#1)
of internalized##5##2##(1994-12#1)(1994-6#1)(1994-8#1)(1997-7#1)(2011-1#1)
of internalizing problems##2##3##(2010-4#1)(2010-6#1)
of internalizing##3##2##(2008-12#1)(2010-4#1)(2010-6#1)
of internally displaced##2##3##(1991-4#1)(2013-1#1)
of internally##7##2##(1991-4#1)(1994-8#1)(2005-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#1)
of international concern##2##3##(2008-1#2)
of international health##2##3##(2008-5#1)(2012-2#1)
of international importance##2##3##(1997-8#1)(2013-7#1)
of international literature##2##3##(1992-10#1)(2006-11#1)
of international normalized##2##3##(1990-12#1)(2010-12#1)
of international scientific##3##3##(2007-8#1)(2009-7#1)(2012-12#1)
of international teleradiology##2##3##(2007-4#2)
of international travel and##2##4##(2006-10#1)(2007-12#1)
of international travel##3##3##(2006-10#1)(2006-4#1)(2007-12#1)
of international##46##2##(1990-12#1)(1991-8#1)(1992-10#1)(1993-12#1)(1993-2#2)(1997-8#1)(2005-5#1)(2006-10#5)(2006-11#1)(2006-4#2)(2007-11#1)(2007-12#1)(2007-4#2)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-12#1)(2008-5#1)(2008-9#2)(2009-4#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
of internet##3##2##(2007-12#1)(2012-2#2)
of interneurons##3##2##(1990-5#1)(1997-3#2)
of internists##2##2##(1992-10#1)(1997-4#1)
of interobserver variability##3##3##(1991-12#1)(2008-3#1)(2009-11#1)
of interoceptive##2##2##(1992-10#1)(2012-2#1)
of interpartner conflict##2##3##(2009-9#2)
of interpersonal distress##3##3##(2011-1#3)
of interpersonal power##3##3##(2008-9#3)
of interpersonal relationships##2##3##(2006-10#1)(2012-3#1)
of interpersonal##20##2##(2005-9#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-11#1)(2008-11#1)(2008-9#4)(2009-8#1)(2009-9#1)(2010-1#1)(2011-1#3)(2012-12#1)(2012-3#3)
of interphase##6##2##(1990-3#1)(1990-6#1)(1997-3#1)(2008-1#2)(2008-4#1)
of interpixel cross talk##3##4##(2008-2#2)(2008-3#1)
of interpolation##2##2##(2007-10#1)(2008-8#1)
of interpretation and##2##3##(1993-12#1)(1994-6#1)
of interpretation of##5##3##(1992-12#1)(1994-12#1)(2008-11#1)(2008-4#1)(2010-2#1)
of interpretation##12##2##(1991-12#1)(1991-9#1)(1992-12#1)(1993-12#1)(1994-12#1)(1994-6#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-12#1)(2010-2#1)
of interpretative##2##2##(2007-4#1)(2008-5#1)
of interpreters##3##2##(2007-9#1)(2013-8#2)
of interpreting the##4##3##(2007-12#1)(2008-10#1)(2009-12#1)(2009-6#1)
of interpreting##9##2##(1992-2#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-12#1)(2009-5#1)(2009-6#1)
of interprofessional collaboration##2##3##(2008-12#1)(2013-1#1)
of interprofessional##4##2##(2008-11#2)(2008-12#1)(2013-1#1)
of interrelated##2##2##(1995-12#1)(2011-12#1)
of interrelation##2##2##(2008-3#1)(2011-1#1)
of interrogation##2##2##(2011-2#2)
of interrupting##3##2##(1992-12#1)(1992-2#1)(2011-2#1)
of interruption of##4##3##(1995-2#1)(2007-8#1)(2008-10#1)(2011-2#1)
of intersex##4##2##(2008-10#3)(2012-3#1)
of intersexual##3##2##(2006-7#1)(2008-8#1)(2008-9#1)
of intersexuality##2##2##(2006-7#1)(2008-5#1)
of interspecies##3##2##(1991-9#1)(1993-8#1)(2013-1#1)
of interspecific competition##7##3##(2007-4#2)(2007-7#1)(2008-8#3)(2012-2#1)
of interspecific hybridization was##2##4##(2008-9#2)
of interspecific hybridization##5##3##(2008-10#1)(2008-9#4)
of interspecific##18##2##(1990-9#1)(2007-4#2)(2007-7#1)(2008-10#2)(2008-6#1)(2008-8#3)(2008-9#7)(2012-2#1)
of interstitial cells of Cajal##2##5##(2006-10#1)(2008-6#1)
of interstitial collagenase##2##3##(1994-12#1)(1994-3#1)
of interstitial ectopic pregnancy##2##4##(2004-10#1)(2009-6#1)
of interstitial lung disease and##2##5##(1994-6#2)
of interstitial lung disease in##2##5##(2008-8#1)(2011-2#1)
of interstitial lung disease rather than##2##6##(2006-10#2)
of interstitial lung disease##11##4##(1994-6#4)(2006-10#3)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)
of interstitial lung diseases##3##4##(2005-8#1)(2007-11#1)(2012-11#1)
of interstitial lung##15##3##(1991-12#1)(1994-6#4)(2005-8#1)(2006-10#3)(2007-11#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-11#1)(2012-12#1)
of interstitial pneumonia##3##3##(2007-2#1)(2010-12#2)
of interstitial##35##2##(1991-12#1)(1991-8#1)(1992-1#1)(1994-12#1)(1994-3#1)(1994-6#4)(1996-12#2)(2004-10#1)(2005-10#1)(2005-8#1)(2006-10#4)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-12#4)(2011-2#1)(2012-11#1)(2012-12#2)
of interstrand##3##2##(1992-3#1)(1992-6#1)(2008-5#1)
of intersubunit##3##2##(1991-10#1)(1993-9#1)(1995-1#1)
of intersymbol interference##2##3##(2007-11#1)(2008-3#1)
of intertrochanteric nonunion##2##3##(2009-3#2)
of intertrochanteric##4##2##(2007-8#1)(2009-3#2)(2013-8#1)
of interval cancers##2##3##(1996-11#1)(2004-2#1)
of interval##6##2##(1995-1#1)(1996-11#1)(1997-7#1)(2004-2#1)(2008-4#2)
of intervening##6##2##(1990-3#1)(1992-2#1)(1994-2#1)(2007-2#1)(2008-2#1)(2011-1#1)
of intervention and##5##3##(1991-6#1)(2007-12#1)(2007-6#1)(2008-7#1)(2011-2#1)
of intervention for##4##3##(2006-10#1)(2006-7#1)(2009-5#1)(2009-9#1)
of intervention in##5##3##(1990-12#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-10#1)
of intervention strategies##2##3##(2007-12#1)(2011-3#1)
of intervention studies##3##3##(1992-9#1)(2005-10#2)
of intervention with##2##3##(2008-4#1)(2011-1#1)
of intervention##72##2##(1990-12#3)(1991-12#1)(1991-6#1)(1992-5#1)(1992-9#1)(1994-1#1)(1994-2#1)(1994-4#1)(1995-1#1)(1996-1#1)(1997-2#2)(2004-3#1)(2005-10#2)(2006-10#1)(2006-7#1)(2007-12#2)(2007-2#2)(2007-6#2)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-7#1)(2011-1#4)(2011-11#1)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
of interventional pain management##11##4##(2006-7#4)(2006-8#7)
of interventional pain##13##3##(2006-7#4)(2006-8#9)
of interventional radiology##3##3##(2007-4#1)(2012-2#2)
of interventional techniques in the management of chronic pain based on the current state of the art and science of interventional pain management##2##23##(2006-8#2)
of interventional techniques##3##3##(2006-7#1)(2006-8#2)
of interventional therapy##2##3##(1993-10#1)(2007-9#1)
of interventional##37##2##(1991-3#1)(1993-10#1)(1994-3#1)(1995-11#1)(1997-3#1)(2006-10#5)(2006-6#1)(2006-7#5)(2006-8#12)(2007-4#2)(2007-9#2)(2012-2#2)(2012-3#2)(2013-8#1)
of interventions and##2##3##(2012-2#1)(2013-1#1)
of interventions are##3##3##(2007-2#1)(2008-11#1)(2011-2#1)
of interventions for##7##3##(1997-2#1)(2008-10#1)(2008-7#1)(2011-2#2)(2013-1#1)(2013-7#1)
of interventions in##4##3##(1996-3#1)(2006-8#1)(2009-1#1)(2011-11#1)
of interventions that##3##3##(2008-6#1)(2010-4#1)(2011-2#1)
of interventions to improve##2##4##(2007-12#1)(2010-8#1)
of interventions to reduce##3##4##(2008-10#1)(2011-11#1)(2012-1#1)
of interventions to##10##3##(2007-11#1)(2007-12#1)(2008-10#1)(2009-5#1)(2010-8#1)(2011-11#1)(2011-2#3)(2012-1#1)
of interventions##60##2##(1990-6#1)(1993-3#1)(1994-9#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-11#2)(2011-2#9)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#3)
of intervertebral disc##7##3##(2005-10#2)(2006-10#1)(2006-8#1)(2007-11#2)(2007-7#1)
of intervertebral discs##3##3##(2006-7#1)(2007-11#1)(2007-8#1)
of intervertebral##15##2##(2005-10#3)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#3)(2007-7#2)(2007-8#3)(2008-9#1)
of interview data and##2##4##(2005-12#1)(2013-1#1)
of interview data##4##3##(2005-12#1)(2008-3#1)(2013-1#2)
of interview##6##2##(2005-12#1)(2008-3#1)(2011-8#1)(2013-1#3)
of interviews with##4##3##(1993-4#1)(1994-2#1)(1996-3#1)(2012-3#1)
of interviews##7##2##(1991-12#1)(1993-4#1)(1994-2#1)(1996-12#1)(1996-3#1)(2008-2#1)(2012-3#1)
of intestinal absorption##2##3##(2006-10#1)(2007-8#1)
of intestinal and##3##3##(1990-2#1)(1994-11#1)(2013-8#1)
of intestinal bacteria##4##3##(2006-5#1)(2008-11#2)(2008-8#1)
of intestinal brush-border##2##3##(1994-11#1)(2008-1#1)
of intestinal calcium##2##3##(1992-12#1)(1996-5#1)
of intestinal cells##2##3##(1994-11#1)(2012-1#1)
of intestinal continuity##2##3##(1991-6#1)(2011-11#1)
of intestinal damage##2##3##(1993-11#2)
of intestinal disorders##2##3##(2008-12#1)(2009-6#1)
of intestinal endometriosis##2##3##(2011-2#2)
of intestinal epithelial cells##3##4##(1990-12#1)(1992-3#1)(2006-10#1)
of intestinal epithelial##4##3##(1990-12#1)(1992-3#1)(1995-3#1)(2006-10#1)
of intestinal failure##2##3##(2006-10#2)
of intestinal immunity##2##3##(1991-9#1)(2006-10#1)
of intestinal inflammation and##2##4##(2008-10#1)(2009-8#1)
of intestinal inflammation##9##3##(2006-10#3)(2006-8#1)(2008-10#2)(2008-4#1)(2009-8#1)(2011-2#1)
of intestinal ischemia##2##3##(1992-8#1)(2013-1#1)
of intestinal lipomatosis##2##3##(2006-2#2)
of intestinal metaplasia and dysplasia##2##5##(2006-10#2)
of intestinal metaplasia##5##3##(1997-1#1)(2006-10#4)
of intestinal motility##2##3##(2005-11#1)(2006-10#1)
of intestinal mucosa from##2##4##(1992-11#1)(2006-8#1)
of intestinal mucosal##2##3##(1995-12#1)(2012-1#1)
of intestinal obstruction##11##3##(1990-5#1)(1993-10#1)(2007-2#1)(2008-12#3)(2009-7#1)(2009-8#1)(2013-1#3)
of intestinal occlusion##3##3##(1990-3#1)(1990-5#1)(1990-6#1)
of intestinal parasites##9##3##(1996-12#1)(1997-3#1)(2006-10#3)(2006-12#1)(2009-10#1)(2011-1#1)(2012-3#1)
of intestinal parasitic infection##2##4##(2011-1#1)(2012-3#1)
of intestinal parasitic##3##3##(2007-12#1)(2011-1#1)(2012-3#1)
of intestinal parasitosis among##2##4##(2012-3#2)
of intestinal permeability##3##3##(1990-2#1)(2005-12#1)(2006-10#1)
of intestinal protozoa##3##3##(2009-10#3)
of intestinal smooth muscle##2##4##(1990-7#1)(1993-3#1)
of intestinal##165##2##(1990-12#1)(1990-2#5)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#3)(1991-12#1)(1991-6#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#3)(1992-8#1)(1993-10#2)(1993-11#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#3)(1994-5#1)(1994-6#1)(1994-8#3)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-12#2)(1996-2#1)(1996-4#2)(1996-5#2)(1996-6#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#3)(2005-12#1)(2006-10#22)(2006-12#1)(2006-2#4)(2006-5#3)(2006-8#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#5)(2008-4#3)(2008-5#2)(2008-8#2)(2009-1#1)(2009-10#4)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-5#1)(2011-1#2)(2011-11#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#5)(2013-8#2)
of intestine##5##2##(1993-2#1)(2008-11#1)(2008-5#1)(2012-3#2)
of intestines##4##2##(1993-9#1)(1997-8#1)(2012-3#1)(2013-1#1)
of intimal hyperplasia##2##3##(2006-6#1)(2007-8#1)
of intimal thickening##2##3##(1995-12#1)(2005-12#1)
of intimal##7##2##(1995-12#1)(1995-2#1)(1996-2#1)(1997-8#1)(2005-12#1)(2006-6#1)(2007-8#1)
of intimate partner violence (IPV)##3##5##(2008-12#1)(2009-5#2)
of intimate partner violence##10##4##(2008-12#2)(2008-4#2)(2009-5#3)(2010-2#1)(2012-12#2)
of intimate##11##2##(2007-12#1)(2008-12#2)(2008-4#2)(2009-5#3)(2010-2#1)(2012-12#2)
of intolerance##4##2##(1990-3#1)(2006-4#1)(2006-7#1)(2010-12#1)
of intonation##5##2##(2009-2#1)(2010-10#3)(2013-8#1)
of intoxication##5##2##(1996-5#1)(2007-7#1)(2008-10#1)(2009-4#1)(2010-1#1)
of intoxications##2##2##(2005-10#2)
of intra - articular##2##4##(2007-11#1)(2008-12#1)
of intra operative##2##3##(2010-7#1)(2012-2#1)
of intra##7##2##(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-12#1)(2010-7#1)(2012-2#1)
of intra- and extracellular##3##4##(1990-4#1)(1997-1#1)(1997-2#1)
of intra- and inter-day##2##4##(2012-12#1)(2012-3#1)
of intra- and intermolecular hydrogen bonding##2##6##(2008-10#2)
of intra- and intermolecular##4##4##(2007-11#1)(2008-10#2)(2010-2#1)
of intra- and##12##3##(1990-4#1)(1992-3#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-7#1)(2010-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
of intra-abdominal malignancies##2##3##(1992-12#2)
of intra-abdominal##8##2##(1990-10#1)(1992-12#2)(1996-8#1)(2006-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
of intra-alveolar##2##2##(1996-12#1)(2006-10#1)
of intra-aortic balloon##2##3##(2006-12#1)(2010-5#1)
of intra-arterial calcium##2##3##(1997-5#1)(2007-5#1)
of intra-arterial##7##2##(1997-3#1)(1997-5#1)(2007-10#1)(2007-5#1)(2007-9#1)(2008-1#1)(2013-7#1)
of intra-articular##10##2##(2006-10#1)(2007-11#2)(2007-7#1)(2011-1#1)(2012-2#1)(2013-1#4)
of intra-assay##2##2##(1995-1#1)(2008-10#1)
of intra-day and inter-day##2##4##(2007-8#1)(2008-10#1)
of intra-family##2##2##(2008-9#1)(2010-8#1)
of intra-individual level and variability##2##5##(2007-12#2)
of intra-operative##11##2##(1995-9#1)(1996-1#1)(1997-8#1)(2007-8#2)(2008-3#1)(2008-9#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
of intra-uterine##2##2##(1996-12#1)(2007-9#1)
of intraabdominal##2##2##(1992-10#1)(1994-5#1)
of intraaortic balloon counterpulsation in patients##2##6##(2008-3#1)(2009-4#1)
of intraaortic balloon##4##3##(2008-3#1)(2009-4#1)(2010-7#1)(2010-8#1)
of intraaortic##5##2##(2008-3#1)(2008-8#1)(2009-4#1)(2010-7#1)(2010-8#1)
of intracanal##2##2##(2008-7#1)(2013-1#1)
of intracapsular##2##2##(2007-12#1)(2007-3#1)
of intracardiac##5##2##(1992-8#1)(1995-6#1)(2007-8#3)
of intracavitary##3##2##(1994-4#1)(1994-7#1)(2007-1#1)
of intracavity##8##2##(2007-11#3)(2007-12#4)(2008-3#1)
of intracellular ATP##3##3##(1994-10#2)(2008-11#1)
of intracellular Ca(2+) concentration in##2##5##(2008-11#1)(2008-4#1)
of intracellular Ca(2+) concentration##3##4##(2008-11#1)(2008-4#1)(2010-2#1)
of intracellular Ca(2+)##10##3##(2007-10#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-8#2)(2010-2#1)(2012-3#1)
of intracellular Ca2+ in the##2##5##(1991-12#1)(1993-3#1)
of intracellular Ca2+ in##5##4##(1990-3#1)(1991-12#1)(1992-8#1)(1993-3#1)(1994-3#1)
of intracellular Ca2+##24##3##(1990-12#1)(1990-2#1)(1990-3#4)(1991-12#1)(1991-2#1)(1991-6#3)(1992-1#1)(1992-12#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-6#2)(1994-8#1)(1996-12#1)(1996-2#1)(1997-6#1)(2008-9#1)
of intracellular MIF in##4##4##(2009-6#4)
of intracellular MIF##5##3##(2009-6#5)
of intracellular ROS##2##3##(2008-11#2)
of intracellular amino##2##3##(1990-12#2)
of intracellular cAMP##5##3##(1990-12#1)(1993-6#1)(1997-8#1)(2008-11#1)(2010-12#1)
of intracellular calcium and##2##4##(1993-5#1)(1994-2#1)
of intracellular calcium by##3##4##(1990-11#1)(1993-7#1)(2010-5#1)
of intracellular calcium concentration ([Ca2+]i)##2##5##(1995-12#1)(1997-7#1)
of intracellular calcium concentration##4##4##(1995-12#1)(1995-8#1)(1997-7#1)(2006-10#1)
of intracellular calcium in##3##4##(1993-9#1)(1994-3#1)(2010-5#1)
of intracellular calcium levels##2##4##(1995-7#1)(2010-5#1)
of intracellular calcium stores##2##4##(1994-8#1)(2007-10#1)
of intracellular calcium##27##3##(1990-11#1)(1990-8#2)(1992-2#1)(1993-5#1)(1993-7#1)(1993-9#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-7#1)(1995-8#1)(1997-7#1)(2006-10#1)(2007-10#1)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-5#3)
of intracellular cyclic AMP (cAMP)##3##5##(1991-8#1)(1996-6#1)(2008-10#1)
of intracellular cyclic AMP##4##4##(1991-2#1)(1991-8#1)(1996-6#1)(2008-10#1)
of intracellular effectors##2##3##(2007-12#1)(2010-2#1)
of intracellular enzymes##2##3##(2007-9#1)(2008-5#1)
of intracellular flux analysis##2##4##(2008-7#2)
of intracellular flux##4##3##(2008-7#4)
of intracellular free Ca2+##4##4##(1993-4#1)(1996-10#1)(1997-8#1)(2008-9#1)
of intracellular free calcium levels##3##5##(1995-11#3)
of intracellular free calcium##5##4##(1994-6#1)(1995-11#3)(2008-4#1)
of intracellular free##12##3##(1990-8#1)(1993-11#1)(1993-4#1)(1994-6#1)(1995-11#3)(1996-10#1)(1997-8#1)(2008-4#1)(2008-5#1)(2008-9#1)
of intracellular glutathione##3##3##(1992-5#1)(1995-3#1)(2010-12#1)
of intracellular histamine##2##3##(1992-4#1)(2008-11#1)
of intracellular ions##2##3##(1991-11#1)(2008-4#1)
of intracellular lactate dehydrogenase (LDH)##2##5##(2008-11#2)
of intracellular levels of##3##4##(1990-8#1)(1992-11#1)(2007-11#1)
of intracellular mechanisms##2##3##(2006-10#1)(2010-12#1)
of intracellular membrane##2##3##(1992-11#1)(1994-3#1)
of intracellular metabolites##2##3##(1994-9#1)(2012-3#1)
of intracellular organelles by flow cytometry##2##6##(2007-8#1)(2008-9#1)
of intracellular organelles##8##3##(1994-6#1)(2004-11#1)(2007-8#2)(2008-1#2)(2008-7#1)(2008-9#1)
of intracellular pH##5##3##(1990-2#1)(1992-12#1)(1993-2#1)(2008-9#1)(2010-8#1)
of intracellular pathogens##2##3##(1995-2#1)(1996-10#1)
of intracellular proteins##3##3##(1994-11#1)(2008-11#1)(2008-8#1)
of intracellular reactive oxygen species (ROS)##2##6##(2008-9#1)(2009-8#1)
of intracellular signaling pathways##3##4##(2008-11#1)(2008-7#1)(2009-12#1)
of intracellular signaling##7##3##(1994-12#1)(1994-8#1)(1997-4#1)(2008-11#1)(2008-7#1)(2009-12#1)(2012-12#1)
of intracellular signalling##2##3##(1994-9#1)(2012-12#1)
of intracellular signals##2##3##(1997-6#1)(2008-9#1)
of intracellular sodium##2##3##(1990-11#1)(1994-3#1)
of intracellular stores##2##3##(1992-3#1)(2007-10#1)
of intracellular trafficking of##2##4##(2011-2#1)(2013-1#1)
of intracellular trafficking##3##3##(2011-2#1)(2012-12#1)(2013-1#1)
of intracellular transport##2##3##(2007-12#1)(2013-1#1)
of intracellular##278##2##(1990-11#2)(1990-12#4)(1990-2#4)(1990-3#5)(1990-4#1)(1990-5#4)(1990-7#1)(1990-8#7)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#4)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#3)(1994-10#2)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#6)(1994-6#6)(1994-8#5)(1994-9#2)(1995-1#1)(1995-11#4)(1995-12#1)(1995-2#2)(1995-3#1)(1995-7#1)(1995-8#3)(1996-10#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#2)(2004-11#4)(2006-10#3)(2006-11#1)(2006-7#1)(2007-1#1)(2007-10#4)(2007-11#2)(2007-12#3)(2007-6#1)(2007-8#3)(2007-9#3)(2008-1#5)(2008-10#5)(2008-11#17)(2008-3#2)(2008-4#9)(2008-5#4)(2008-7#12)(2008-8#5)(2008-9#10)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#6)(2009-8#4)(2009-9#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-5#3)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#5)(2012-12#5)(2012-2#2)(2012-3#5)(2013-1#3)(2013-8#2)
of intracellularly##3##2##(1992-7#1)(1993-12#1)(1994-2#1)
of intracerebral hemorrhage##5##3##(2005-12#1)(2007-10#2)(2007-9#1)(2012-3#1)
of intracerebral##16##2##(1993-12#1)(1993-4#1)(1994-5#1)(2005-12#1)(2006-10#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-9#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-3#1)
of intracerebroventricular##3##2##(1992-3#1)(1997-4#1)(2009-6#1)
of intracerebroventricularly (i##2##3##(1992-3#2)
of intrachromosomal##4##2##(1990-5#1)(1996-2#1)(2010-12#1)(2012-3#1)
of intracochlear trauma##2##3##(2012-2#2)
of intracoronary##3##2##(1994-11#1)(2007-8#1)(2012-1#1)
of intracorporeal##3##2##(2009-6#1)(2011-1#2)
of intracortical##2##2##(1992-7#1)(1995-11#1)
of intracranial aneurysm##3##3##(1995-5#1)(2007-10#1)(2011-2#1)
of intracranial aneurysms##8##3##(1997-3#1)(2006-10#1)(2007-9#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-9#1)(2011-2#1)
of intracranial arterial##2##3##(1996-2#1)(1997-6#1)
of intracranial atherosclerosis##2##3##(2008-12#1)(2008-8#1)
of intracranial atherosclerotic##2##3##(2006-11#2)
of intracranial germ cell tumor##2##5##(2007-12#2)
of intracranial germ cell tumors##2##5##(2013-1#2)
of intracranial germ cell##4##4##(2007-12#2)(2013-1#2)
of intracranial haemorrhage and##2##4##(1992-6#1)(2007-11#1)
of intracranial haemorrhage in##2##4##(1997-6#1)(2008-7#1)
of intracranial haemorrhage##6##3##(1992-6#1)(1997-6#1)(2007-11#2)(2008-7#1)(2011-2#1)
of intracranial neoplasms##2##3##(1996-5#1)(2013-1#1)
of intracranial pressure##4##3##(1991-11#1)(1996-9#1)(2005-10#1)(2012-2#1)
of intracranial vasculature##2##3##(2012-2#2)
of intracranial##72##2##(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-6#1)(1993-11#1)(1993-12#2)(1994-8#2)(1995-5#1)(1995-9#1)(1996-2#2)(1996-5#1)(1996-9#1)(1997-3#1)(1997-5#2)(1997-6#4)(2005-10#1)(2006-1#1)(2006-10#1)(2006-11#3)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-4#2)(2007-6#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-7#1)(2009-9#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#3)(2013-7#2)
of intracranially##2##2##(1993-11#1)(2007-11#1)
of intractable malignant ascites##2##4##(2005-4#2)
of intractable nausea and vomiting##3##5##(2013-8#3)
of intractable pain##2##3##(2005-7#1)(2006-2#1)
of intractable##16##2##(2005-4#2)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-7#1)(2007-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#3)
of intracystic##2##2##(1992-2#1)(1994-7#1)
of intracytoplasmic sperm injection##3##4##(2006-10#3)
of intracytoplasmic##8##2##(1992-6#1)(2006-10#3)(2007-12#1)(2008-5#2)(2008-7#1)
of intradiscal steroids##2##3##(2009-5#2)
of intradiscal##3##2##(2006-8#1)(2009-5#2)
of intraductal##2##2##(2006-10#1)(2009-2#1)
of intradural spinal##2##3##(2011-2#1)(2012-3#1)
of intradural##5##2##(2007-11#1)(2009-5#1)(2011-2#1)(2012-3#2)
of intrafamilial##2##2##(1997-3#1)(2007-3#1)
of intragenic##2##2##(1995-1#1)(1995-6#1)
of intraguild predation and stage structure##2##6##(2008-8#2)
of intrahepatic biliary##2##3##(1990-3#1)(2009-2#1)
of intrahepatic cholangiocarcinoma##2##3##(2008-8#1)(2010-12#1)
of intrahepatic cholestasis##2##3##(1995-1#1)(2005-10#1)
of intrahepatic##11##2##(1990-3#1)(1995-1#1)(1996-9#2)(2005-10#1)(2007-5#1)(2008-4#1)(2008-8#1)(2009-2#1)(2010-12#1)(2012-12#1)
of intrahippocampal##3##2##(1993-12#2)(1993-3#1)
of intralacustrine##2##2##(1996-6#1)(2010-8#1)
of intralesional steroid##2##3##(2007-7#1)(2010-12#1)
of intralesional##3##2##(2007-7#2)(2010-12#1)
of intraluminal brachytherapy##2##3##(1993-2#1)(2007-11#1)
of intraluminal##5##2##(1993-2#1)(2007-11#1)(2007-8#1)(2011-2#1)(2012-3#1)
of intramedullary##7##2##(1992-10#1)(2006-12#1)(2007-11#3)(2012-2#1)(2012-3#1)
of intramembranous particles##2##3##(1990-4#1)(1992-6#1)
of intramembranous##4##2##(1990-10#1)(1990-4#1)(1992-6#1)(2011-2#1)
of intramolecular##14##2##(1992-11#1)(1993-11#1)(1994-11#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-1#2)(1997-6#1)(2005-11#1)(2005-4#1)(2006-5#1)(2008-10#1)
of intramuscular botulinum toxin##2##4##(2007-7#1)(2008-8#1)
of intramuscular fat##2##3##(2010-4#2)
of intramuscular injection of##2##4##(1990-6#1)(2013-7#1)
of intramuscular##14##2##(1990-6#1)(2007-11#2)(2007-7#1)(2008-8#1)(2010-2#1)(2010-4#4)(2010-5#1)(2012-11#1)(2012-12#1)(2013-7#1)
of intramyocardial##2##2##(2007-8#1)(2009-3#1)
of intranasal##3##2##(2007-10#1)(2009-11#1)(2010-12#1)
of intraneuronal##2##2##(1990-7#1)(1992-3#1)
of intranodal##3##2##(1996-9#1)(2007-6#1)(2008-4#1)
of intranuclear##4##2##(2007-12#1)(2007-8#1)(2010-3#2)
of intraocular pressure (IOP)##3##4##(2008-3#1)(2010-8#1)(2013-1#1)
of intraocular pressure##5##3##(1996-8#1)(2008-3#1)(2008-7#1)(2010-8#1)(2013-1#1)
of intraocular##11##2##(1996-8#1)(2007-3#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-8#1)(2011-1#2)(2013-1#1)
of intraoperative blood##3##3##(1994-3#2)(2006-7#1)
of intraoperative cytology##2##3##(2013-8#2)
of intraoperative hemolysis##2##3##(2012-3#2)
of intraoperative photodynamic therapy##2##4##(2007-8#1)(2011-1#1)
of intraoperative radiotherapy##2##3##(1994-7#1)(2011-2#1)
of intraoperative##47##2##(1990-3#1)(1990-6#1)(1992-10#1)(1992-2#1)(1992-6#1)(1993-10#1)(1994-3#2)(1994-7#1)(2006-10#3)(2006-12#1)(2006-6#2)(2006-7#2)(2007-8#6)(2008-10#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#3)(2013-7#1)(2013-8#2)
of intraoral##5##2##(1993-1#1)(2007-12#1)(2007-8#1)(2008-6#1)(2012-3#1)
of intraosseous schwannoma##2##3##(2009-3#2)
of intraosseous##4##2##(2008-11#1)(2009-3#3)
of intraparenchymal##5##2##(2005-12#1)(2006-12#1)(2007-10#1)(2008-7#1)(2011-1#1)
of intrapartum antimicrobial prophylaxis##2##4##(2006-10#2)
of intrapartum##3##2##(2006-10#2)(2006-2#1)
of intrapelvic##2##2##(2006-7#1)(2009-3#1)
of intraperitoneal administration of##2##4##(1995-12#1)(2012-1#1)
of intraperitoneal chemotherapy##2##3##(1990-4#1)(2006-6#1)
of intraperitoneal injection of##2##4##(1991-3#1)(2012-11#1)
of intraperitoneal##15##2##(1990-4#2)(1990-5#1)(1991-3#1)(1995-12#2)(2006-10#1)(2006-6#1)(2007-2#1)(2008-1#1)(2008-10#1)(2010-11#1)(2010-12#1)(2012-1#1)(2012-11#1)
of intrapleural##2##2##(2007-8#1)(2012-1#1)
of intrapulmonary##2##2##(2008-1#1)(2009-3#1)
of intraretinal##2##2##(2011-7#1)(2012-12#1)
of intraspecific variation##3##3##(2008-10#1)(2008-8#1)(2012-2#1)
of intraspecific##10##2##(1995-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-2#1)(2012-2#1)
of intraspinal##2##2##(1997-3#1)(2007-8#1)
of intrasynovial##3##2##(2006-3#3)
of intratesticular##2##2##(2008-4#1)(2011-5#1)
of intrathecal##14##2##(1990-2#1)(1991-7#1)(1991-9#1)(1992-8#1)(1993-4#1)(1997-8#2)(2006-10#1)(2006-12#3)(2006-7#1)(2007-12#1)(2012-12#1)
of intrathoracic meningocele##2##3##(2007-8#2)
of intrathoracic##10##2##(1990-12#1)(1993-5#1)(2007-11#1)(2007-8#4)(2012-2#3)
of intratumoral##2##2##(2008-5#1)(2011-2#1)
of intrauterine contraceptive device##4##4##(2007-12#1)(2007-7#1)(2013-1#2)
of intrauterine contraceptive##5##3##(2007-12#1)(2007-7#1)(2011-1#1)(2013-1#2)
of intrauterine device##2##3##(1992-4#1)(2006-7#1)
of intrauterine devices##3##3##(1993-12#2)(2007-7#1)
of intrauterine##21##2##(1990-9#1)(1991-2#1)(1992-4#1)(1993-12#2)(1996-12#1)(1996-5#2)(2005-7#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-7#2)(2008-1#1)(2010-8#1)(2011-1#1)(2013-1#3)
of intravascular catheters##2##3##(1991-8#1)(1994-5#1)
of intravascular##17##2##(1991-8#1)(1993-2#1)(1994-5#1)(1996-6#1)(1996-9#1)(2005-10#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-6#1)(2009-2#1)(2010-12#2)(2010-5#1)(2012-3#2)
of intravenous (IV)##2##3##(2012-12#1)(2012-2#1)
of intravenous and oral##2##4##(2008-6#1)(2012-12#1)
of intravenous clomipramine##2##3##(2005-7#1)(2013-8#1)
of intravenous cyclophosphamide##3##3##(2008-1#2)(2010-6#1)
of intravenous digital subtraction angiography##2##5##(1993-8#2)
of intravenous drug use##2##4##(1996-11#1)(2007-12#1)
of intravenous drug##5##3##(1993-3#1)(1995-9#1)(1996-11#1)(2007-12#1)(2009-2#1)
of intravenous drugs##2##3##(2006-10#2)
of intravenous fluid##2##3##(2006-10#1)(2012-3#1)
of intravenous immunoglobulin in##2##4##(2007-11#1)(2007-2#1)
of intravenous immunoglobulin##8##3##(1991-6#1)(2006-10#1)(2007-11#3)(2007-2#2)(2012-3#1)
of intravenous immunoglobulins##3##3##(1997-2#1)(2007-2#1)(2007-8#1)
of intravenous infusion##3##3##(1992-7#1)(2007-10#1)(2012-3#1)
of intravenous iron saccharate##2##4##(2007-7#2)
of intravenous iron##3##3##(2007-7#2)(2010-12#1)
of intravenous lidocaine##2##3##(2009-4#1)(2012-2#1)
of intravenous morphine##2##3##(1997-2#1)(2009-6#1)
of intravenous or##2##3##(1996-7#1)(2008-4#1)
of intravenous rt-PA##3##3##(2005-8#1)(2007-10#2)
of intravenous thrombolysis##2##3##(2007-10#2)
of intravenous tissue plasminogen activator##2##5##(2007-9#1)(2008-8#1)
of intravenous vitamin##2##3##(1997-7#1)(2010-8#1)
of intravenous##95##2##(1990-7#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-7#1)(1993-1#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-5#1)(1995-1#1)(1995-8#1)(1995-9#1)(1996-11#2)(1996-7#1)(1997-2#2)(1997-7#1)(2005-7#1)(2005-8#1)(2006-10#6)(2006-11#1)(2006-4#1)(2007-10#6)(2007-11#6)(2007-12#2)(2007-2#5)(2007-7#2)(2007-8#2)(2007-9#4)(2008-1#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#3)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#2)(2013-8#1)
of intravenously administered##2##3##(1990-12#1)(2008-5#1)
of intravenously##6##2##(1990-12#1)(1991-9#1)(1992-6#1)(1993-11#1)(2008-5#1)(2010-8#1)
of intraventricular hemorrhage and post hemorrhagic hydrocephalus##2##7##(2011-2#2)
of intraventricular hemorrhage and##3##4##(2008-5#1)(2011-2#2)
of intraventricular hemorrhage##4##3##(2006-10#1)(2008-5#1)(2011-2#2)
of intraventricular##8##2##(1994-10#1)(2006-10#1)(2007-10#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#2)
of intravesical chemotherapy##2##3##(2008-1#1)(2011-2#1)
of intravesical##5##2##(1991-11#1)(2007-4#1)(2007-9#1)(2008-1#1)(2011-2#1)
of intravesicular##3##2##(1991-4#1)(1996-2#1)(2007-7#1)
of intravital microscopy##2##3##(2006-9#1)(2008-9#1)
of intravital##3##2##(2006-9#1)(2008-9#1)(2012-1#1)
of intravitreal Ranibizumab##2##3##(2013-1#2)
of intravitreal bevacizumab##3##3##(2009-8#1)(2011-2#1)(2012-12#1)
of intravitreal injection of##3##4##(2008-1#1)(2012-3#1)(2013-8#1)
of intravitreal##10##2##(2008-1#1)(2009-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
of intrinsic and extrinsic##3##4##(1991-3#1)(1997-6#1)(2006-10#1)
of intrinsic and##4##3##(1991-3#1)(1992-8#1)(1997-6#1)(2006-10#1)
of intrinsic fluorescence##3##3##(1991-4#1)(1992-6#1)(1995-5#1)
of intrinsic linear birefringence##2##4##(2008-2#2)
of intrinsic lung disease##3##4##(2006-10#3)
of intrinsic skin aging##2##4##(2008-5#2)
of intrinsic skin##3##3##(2008-5#3)
of intrinsic##54##2##(1990-5#1)(1990-8#1)(1991-3#1)(1991-4#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-8#3)(1995-11#2)(1995-12#1)(1995-4#1)(1995-5#2)(1996-6#1)(1997-3#1)(1997-6#1)(2004-4#1)(2005-11#1)(2006-10#7)(2006-3#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
of intrinsically##2##2##(1993-11#1)(2006-11#1)
of introduced##12##2##(1994-3#1)(2005-8#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
of introducing a##4##3##(2008-10#1)(2008-11#2)(2008-3#1)
of introducing laparoscopically assisted vaginal hysterectomy##2##6##(1996-2#2)
of introducing optical##2##3##(2008-2#1)(2008-3#1)
of introducing the##2##3##(2008-10#1)(2008-11#1)
of introducing##26##2##(1990-4#1)(1996-2#2)(1996-8#1)(1997-4#1)(2007-7#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-3#4)(2008-7#1)(2008-8#2)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
of introduction of the##2##4##(1991-9#1)(2008-10#1)
of introduction of##5##3##(1991-9#1)(1994-7#1)(2008-10#1)(2011-2#1)(2012-1#1)
of introduction##12##2##(1991-9#1)(1994-7#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)
of introgression##4##2##(2008-8#1)(2009-2#2)(2010-10#1)
of intron 19##2##3##(1997-5#1)(2011-1#1)
of intron 5##3##3##(1993-3#1)(1993-4#2)
of intron##13##2##(1991-1#1)(1992-10#1)(1993-3#1)(1993-4#2)(1994-9#1)(1995-8#2)(1997-5#2)(2008-8#1)(2011-1#1)(2012-12#1)
of introns in the##2##4##(1992-3#1)(1995-8#1)
of introns in##3##3##(1991-12#1)(1992-3#1)(1995-8#1)
of introns##11##2##(1991-12#1)(1991-5#1)(1992-3#1)(1992-7#1)(1993-11#2)(1995-8#1)(1997-5#1)(2008-7#1)(2009-10#1)(2009-5#1)
of introspection##3##2##(1993-2#1)(2008-6#1)(2012-3#1)
of intrusion##2##2##(2007-4#1)(2010-2#1)
of intubation##2##2##(2007-9#1)(2010-7#1)
of intussusception##3##2##(1990-10#1)(2005-12#1)(2008-8#1)
of inulin##6##2##(1990-3#1)(1992-1#1)(1995-2#1)(2006-2#1)(2008-10#1)(2011-1#1)
of inulinase##2##2##(2008-6#1)(2011-1#1)
of invading##6##2##(1990-2#1)(1995-12#1)(2006-10#1)(2007-9#1)(2008-10#1)(2013-7#1)
of invagination##3##2##(2006-10#1)(2013-8#2)
of invalid##2##2##(2008-1#1)(2008-2#1)
of invalidity##2##2##(1990-8#1)(2005-10#1)
of invariant chain##4##3##(1995-11#1)(1995-8#2)(2009-9#1)
of invariant##7##2##(1994-10#1)(1995-11#1)(1995-8#2)(2007-12#1)(2008-4#1)(2009-9#1)
of invasion and##2##3##(2007-10#1)(2012-12#1)
of invasion of##5##3##(1991-12#1)(1995-12#1)(2006-6#1)(2007-6#1)(2013-8#1)
of invasion to##2##3##(1994-9#1)(2006-10#1)
of invasion##38##2##(1990-9#1)(1991-12#1)(1992-6#1)(1993-4#1)(1994-9#2)(1995-12#1)(2004-10#1)(2006-10#3)(2006-6#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-5#6)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#2)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
of invasive BC##2##3##(1992-8#1)(2013-8#1)
of invasive aspergillosis##7##3##(2007-12#1)(2008-3#1)(2008-7#2)(2009-3#2)(2010-12#1)
of invasive bladder cancer##4##4##(1993-9#2)(2013-8#2)
of invasive breast##4##3##(1993-11#1)(2012-12#1)(2013-1#2)
of invasive cancer##4##3##(1992-3#2)(2009-11#1)(2011-2#1)
of invasive candidiasis##2##3##(2005-8#1)(2011-2#1)
of invasive carcinoma##5##3##(1990-6#1)(1993-10#1)(1994-2#1)(1997-5#1)(2011-2#1)
of invasive cervical cancer##3##4##(1991-9#2)(1992-8#1)
of invasive cervical resorption##2##4##(2013-1#2)
of invasive cervical##6##3##(1991-9#2)(1992-8#1)(2006-10#1)(2013-1#2)
of invasive diagnostic methods##2##4##(2010-2#1)(2011-2#1)
of invasive disease in##2##4##(2009-5#1)(2011-1#1)
of invasive disease##4##3##(2008-11#1)(2009-5#1)(2011-1#1)(2012-12#1)
of invasive diseases##2##3##(2009-5#1)(2012-12#1)
of invasive ductal##3##3##(1995-4#1)(2012-12#2)
of invasive fungal infections among##2##5##(2006-10#1)(2008-8#1)
of invasive fungal infections in patients with##2##7##(2008-7#1)(2012-2#1)
of invasive fungal infections##11##4##(2006-10#3)(2007-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#2)(2012-2#1)
of invasive fungal##12##3##(2006-10#3)(2007-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#2)(2012-2#1)(2013-1#1)
of invasive group A streptococcal##2##5##(1990-8#1)(2007-12#1)
of invasive infections##3##3##(1996-12#1)(1997-2#1)(2010-12#1)
of invasive listeriosis##2##3##(2013-1#1)(2013-7#1)
of invasive lobular breast##2##4##(2004-2#1)(2007-6#1)
of invasive lobular carcinoma##2##4##(1996-3#1)(2007-11#1)
of invasive lobular##4##3##(1996-3#1)(2004-2#1)(2007-11#1)(2007-6#1)
of invasive meningococcal disease##3##4##(2007-12#1)(2008-11#2)
of invasive meningococcal##4##3##(2007-12#1)(2008-11#2)(2010-10#1)
of invasive mycoses##3##3##(2007-7#1)(2010-12#1)(2012-12#1)
of invasive pneumococcal##2##3##(2011-2#1)(2012-12#1)
of invasive procedures in##3##4##(2005-12#1)(2013-1#2)
of invasive procedures##7##3##(1996-2#1)(2005-12#1)(2006-10#2)(2007-4#1)(2013-1#2)
of invasive species science##2##4##(2013-7#2)
of invasive species##3##3##(2013-7#3)
of invasive##132##2##(1990-6#1)(1990-8#1)(1991-7#1)(1991-9#2)(1992-3#2)(1992-8#2)(1993-10#1)(1993-11#1)(1993-9#3)(1994-2#3)(1995-4#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-2#1)(1997-3#2)(1997-5#1)(2004-1#1)(2004-2#1)(2005-12#1)(2005-7#1)(2005-8#2)(2006-10#8)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#3)(2008-10#1)(2008-11#6)(2008-12#1)(2008-3#3)(2008-4#2)(2008-7#4)(2008-8#1)(2009-10#1)(2009-11#1)(2009-3#2)(2009-5#3)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#8)(2012-12#10)(2012-2#1)(2012-3#1)(2013-1#12)(2013-7#4)(2013-8#3)
of invasively##2##2##(1997-4#1)(2009-4#1)
of invasiveness of##2##3##(1990-6#1)(2007-7#1)
of invasiveness##7##2##(1990-6#1)(2006-6#3)(2007-7#1)(2008-8#1)(2013-8#1)
of inverse agonism##2##3##(2008-1#1)(2008-5#1)
of inverse##6##2##(1996-3#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-8#1)
of inversion##6##2##(1996-2#1)(2006-5#1)(2008-3#2)(2009-4#1)(2013-1#1)
of inversions##3##2##(2008-4#1)(2013-1#2)
of invertase##6##2##(2008-10#2)(2008-12#1)(2008-7#3)
of invertebrate and##2##3##(2006-11#1)(2007-10#1)
of invertebrate carcasses##4##3##(2004-11#4)
of invertebrate##11##2##(2004-11#5)(2006-11#1)(2006-5#1)(2007-10#1)(2009-4#1)(2009-6#1)(2011-12#1)
of invertebrates and##2##3##(2009-6#1)(2011-12#1)
of invertebrates##7##2##(1990-5#1)(2006-10#1)(2007-5#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-12#1)
of inverted papilloma##2##3##(1993-4#1)(2010-7#1)
of inverted##7##2##(1993-4#1)(1997-2#1)(2006-10#1)(2007-4#1)(2008-3#1)(2010-7#1)(2013-1#1)
of inverting the##2##3##(2008-3#2)
of inverting##4##2##(2008-2#1)(2008-3#2)(2010-11#1)
of investigated##6##2##(2007-7#1)(2008-10#2)(2008-12#1)(2009-2#1)(2012-3#1)
of investigating and##2##3##(2008-2#1)(2008-4#1)
of investigating the##6##3##(1991-2#1)(1993-11#1)(1995-3#1)(2005-11#1)(2008-8#1)(2013-8#1)
of investigating their##2##3##(1994-8#1)(2012-3#1)
of investigating##23##2##(1990-5#1)(1991-2#1)(1993-11#1)(1993-7#1)(1994-8#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-4#1)(2005-11#1)(2005-8#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
of investigation and##3##3##(1992-12#1)(1993-11#1)(2008-3#1)
of investigation for##4##3##(1993-8#1)(1995-11#1)(2007-2#1)(2011-1#1)
of investigation have##2##3##(2008-5#1)(2012-2#1)
of investigation in the##4##4##(1992-1#1)(2006-1#1)(2009-6#1)(2010-2#1)
of investigation in##8##3##(1991-3#1)(1992-1#1)(2004-12#1)(2006-1#1)(2008-3#1)(2009-6#1)(2010-2#1)(2012-2#1)
of investigation is##2##3##(2006-10#1)(2011-2#1)
of investigation of the##3##4##(2005-10#1)(2008-10#1)(2010-12#1)
of investigation of##7##3##(1997-4#1)(2005-10#1)(2008-10#1)(2008-11#1)(2010-12#2)(2012-2#1)
of investigation or##2##3##(2006-8#1)(2008-3#1)
of investigation that##2##3##(2006-2#1)(2008-4#1)
of investigation##63##2##(1991-11#2)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-8#1)(1995-11#1)(1995-9#1)(1996-3#1)(1996-6#2)(1997-4#2)(2004-12#1)(2005-10#1)(2006-1#1)(2006-10#4)(2006-2#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-12#2)(2010-2#1)(2011-1#2)(2011-2#2)(2012-2#4)(2012-7#1)(2013-1#3)(2013-8#1)
of investigational agents##2##3##(2005-7#1)(2008-1#1)
of investigational##4##2##(2005-7#1)(2007-11#1)(2008-1#1)(2009-4#1)
of investigations and##2##3##(2007-7#1)(2008-4#1)
of investigations into##3##3##(2007-1#1)(2007-9#1)(2008-10#1)
of investigations of##3##3##(1996-1#1)(2006-2#1)(2008-10#1)
of investigations##19##2##(1992-2#1)(1992-8#1)(1996-1#1)(2006-2#2)(2007-1#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-10#1)(2012-12#1)
of investigative and##3##3##(1995-5#1)(2006-10#1)(2010-9#1)
of investigative##4##2##(1995-5#1)(2006-10#1)(2007-9#1)(2010-9#1)
of investigator##2##2##(2005-11#1)(2009-4#1)
of investigators##11##2##(1994-3#1)(1995-3#1)(2005-9#1)(2006-10#2)(2006-9#1)(2007-7#2)(2008-1#1)(2008-5#1)(2010-6#1)
of investing in##2##3##(2004-12#1)(2008-8#1)
of investment in##4##3##(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#1)
of investment##6##2##(1996-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#1)
of inveterate##2##2##(2007-11#2)
of invited##3##2##(2005-8#1)(2008-10#1)(2009-10#1)
of involucrin##2##2##(2008-5#1)(2011-1#1)
of involuntary##5##2##(1995-1#1)(1995-2#1)(2006-5#1)(2007-3#1)(2011-2#1)
of involutional##2##2##(1993-7#1)(2005-1#1)
of involved lymph nodes##2##4##(1993-9#1)(2007-8#1)
of involved##16##2##(1993-3#1)(1993-9#1)(1995-10#3)(2004-2#1)(2006-8#1)(2007-10#1)(2007-8#4)(2008-10#1)(2010-3#1)(2011-2#1)(2013-7#1)
of involvement and##2##3##(2007-8#1)(2012-3#1)
of involvement in offending##2##4##(2009-7#2)
of involvement in##8##3##(1990-8#1)(1997-7#1)(2007-11#1)(2007-2#1)(2007-8#1)(2009-7#2)(2013-7#1)
of involvement of other organs##2##5##(1992-5#1)(2007-6#1)
of involvement of the##6##4##(1997-8#2)(2006-10#2)(2009-8#1)(2013-1#1)
of involvement of##17##3##(1992-5#1)(1992-6#1)(1995-2#1)(1995-4#1)(1997-1#1)(1997-8#2)(2006-10#2)(2006-8#1)(2007-6#3)(2008-7#1)(2009-8#1)(2011-2#1)(2013-1#1)
of involvement was##2##3##(2011-2#1)(2012-2#1)
of involvement##44##2##(1990-12#1)(1990-8#1)(1992-5#1)(1992-6#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#3)(2005-2#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-6#3)(2007-7#1)(2007-8#2)(2008-12#1)(2008-7#1)(2009-7#3)(2009-8#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
of involving service users##2##4##(2008-12#2)
of involving##6##2##(1997-7#1)(2008-12#3)(2011-2#2)
of inward current##2##3##(1992-12#1)(2008-8#1)
of inward##4##2##(1992-12#1)(1994-9#1)(1996-5#1)(2008-8#1)
of iodate and sulphate in##3##5##(2008-10#3)
of iodate and##6##3##(2008-10#6)
of iodate in##3##3##(2008-10#3)
of iodate##13##2##(2008-10#13)
of iodide and perchlorate##2##4##(2007-8#2)
of iodide at##3##3##(2007-8#2)(2008-10#1)
of iodide by the##2##4##(2007-8#1)(2008-10#1)
of iodide by##4##3##(2007-8#1)(2008-10#3)
of iodide concentration##2##3##(2008-10#2)
of iodide in##7##3##(1990-9#1)(2007-8#1)(2008-10#5)
of iodide ion##4##3##(2008-10#4)
of iodide on##2##3##(2008-10#2)
of iodide oxidation##3##3##(2007-8#1)(2008-10#2)
of iodide was##2##3##(2008-10#2)
of iodide##38##2##(1990-9#1)(1996-2#1)(2007-8#8)(2008-10#28)
of iodinated##3##2##(2008-10#2)(2012-12#1)
of iodine and bromine with two new macrocycle diamides##2##9##(2008-10#2)
of iodine and hardness##2##4##(2008-5#2)
of iodine and##6##3##(2007-8#1)(2008-10#2)(2008-5#2)(2013-1#1)
of iodine deficiency##6##3##(1995-5#1)(2006-10#1)(2007-11#1)(2011-1#1)(2012-1#1)(2013-1#1)
of iodine in##4##3##(2008-10#1)(2011-12#1)(2012-1#1)(2012-3#1)
of iodine nutrition in##2##4##(2006-4#2)
of iodine supplementation in##2##4##(2012-1#1)(2012-3#1)
of iodine supplementation##4##3##(2006-4#1)(2012-1#1)(2012-3#2)
of iodine using##2##3##(2008-10#2)
of iodine was##2##3##(2006-8#1)(2007-11#1)
of iodine##44##2##(1993-4#1)(1995-5#1)(1996-11#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-4#3)(2006-8#1)(2007-11#3)(2007-8#1)(2008-10#13)(2008-3#1)(2008-4#1)(2008-5#2)(2009-12#1)(2011-1#1)(2011-12#1)(2012-1#3)(2012-3#3)(2013-1#3)
of iodine-doped##3##2##(2005-11#2)(2012-2#1)
of iodized salt##4##3##(2006-10#2)(2013-1#2)
of iodized##6##2##(1997-8#1)(2006-10#2)(2007-2#1)(2013-1#2)
of iododeoxyuridine##3##2##(1994-11#1)(1995-6#2)
of ion associates of##3##4##(2008-10#3)
of ion associates##6##3##(2008-10#6)
of ion association of##2##4##(2008-10#2)
of ion association##5##3##(2008-10#5)
of ion channel##8##3##(1992-6#2)(1993-9#1)(1995-8#2)(2008-8#1)(2010-8#1)(2012-3#1)
of ion channels in##2##4##(2008-8#1)(2009-12#1)
of ion channels##19##3##(1990-4#1)(1990-5#1)(1997-4#1)(1997-5#1)(2005-7#1)(2006-12#1)(2006-2#1)(2008-3#1)(2008-4#1)(2008-8#8)(2008-9#1)(2009-12#1)
of ion chromatography##4##3##(1993-2#1)(2007-8#1)(2008-10#2)
of ion currents##2##3##(1992-9#1)(2004-11#1)
of ion exchange equilibrium constants##3##5##(2008-10#3)
of ion exchange##5##3##(2008-10#5)
of ion exchanger##2##3##(2007-8#1)(2008-10#1)
of ion mobility spectrometry##3##4##(2008-10#3)
of ion pairing##2##3##(2008-11#1)(2008-5#1)
of ion pairs##4##3##(2008-10#4)
of ion permeation##3##3##(2006-10#1)(2007-3#2)
of ion selective electrodes##3##4##(2008-10#2)(2008-6#1)
of ion transport in##2##4##(1996-2#1)(2009-5#1)
of ion transport##3##3##(1996-2#1)(2006-10#1)(2009-5#1)
of ion uptake##2##3##(1990-9#1)(1997-7#1)
of ion##93##2##(1990-4#1)(1990-5#1)(1990-9#1)(1991-4#1)(1992-6#2)(1992-9#1)(1993-2#1)(1993-9#1)(1994-12#1)(1995-8#2)(1996-11#1)(1996-2#1)(1996-4#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-11#1)(2005-4#2)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-12#2)(2007-3#3)(2007-8#2)(2008-10#36)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#10)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-3#1)
of ion-exchange chromatography##4##3##(1990-12#1)(1992-12#1)(2007-8#1)(2008-10#1)
of ion-exchange##11##2##(1990-12#1)(1991-12#1)(1992-12#1)(1996-8#1)(2005-11#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-4#1)(2013-1#1)
of ion-exchanged##2##2##(2007-12#1)(2008-2#1)
of ion-exchanger##2##2##(2008-10#2)
of ion-pair flow injection with piezoelectric detection##2##7##(2008-10#2)
of ion-pair##5##2##(2005-4#1)(2008-10#4)
of ion-selective electrode##2##3##(2008-10#2)
of ion-selective electrodes (ISEs)##5##4##(2008-10#3)(2010-2#1)(2013-7#1)
of ion-selective electrodes##8##3##(2008-10#6)(2010-2#1)(2013-7#1)
of ion-selective##10##2##(2008-10#8)(2010-2#1)(2013-7#1)
of ionene##2##2##(2008-10#2)
of ionic and hydrophobic interactions##2##5##(2008-5#1)(2012-2#1)
of ionic channels##2##3##(1995-8#1)(1996-7#1)
of ionic conditions##2##3##(1990-7#1)(1996-5#1)
of ionic currents##2##3##(1994-2#1)(1995-12#1)
of ionic liquid##4##3##(2008-10#1)(2009-3#1)(2010-4#1)(2013-1#1)
of ionic liquids##4##3##(2010-5#2)(2010-7#1)(2012-1#1)
of ionic species##3##3##(2005-11#1)(2008-10#2)
of ionic strength and##3##4##(1992-9#1)(2008-10#2)
of ionic strength on the##2##5##(2005-11#1)(2008-10#1)
of ionic strength##15##3##(1991-11#1)(1992-9#1)(1993-6#2)(2005-11#3)(2005-9#1)(2007-8#1)(2008-10#6)
of ionic surfactants##3##3##(2005-11#3)
of ionic##54##2##(1990-7#2)(1991-11#1)(1992-9#1)(1993-6#2)(1994-2#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-5#2)(1996-7#1)(2005-10#1)(2005-11#10)(2005-9#1)(2006-1#1)(2006-5#1)(2007-5#1)(2007-8#1)(2008-10#12)(2008-3#1)(2008-5#2)(2009-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2012-1#1)(2012-2#1)(2013-1#2)
of ionised##3##2##(1990-11#2)(2008-6#1)
of ionising##2##2##(1994-4#1)(2012-2#1)
of ionizable compounds##2##3##(1993-4#1)(2008-10#1)
of ionizable##3##2##(1991-7#1)(1993-4#1)(2008-10#1)
of ionization of the##3##4##(2005-11#1)(2006-10#2)
of ionization of##4##3##(2005-11#2)(2006-10#2)
of ionization##12##2##(2005-11#3)(2006-10#5)(2007-11#1)(2007-12#2)(2008-8#1)
of ionized##4##2##(1993-11#1)(1993-2#1)(1995-1#1)(2013-1#1)
of ionizing radiation and##4##4##(1990-7#1)(2007-10#1)(2008-11#1)(2008-7#1)
of ionizing radiation are##2##4##(2008-7#1)(2013-1#1)
of ionizing radiation in##2##4##(1997-8#1)(2008-6#1)
of ionizing radiation that##2##4##(2008-7#2)
of ionizing radiation##27##3##(1990-7#1)(1994-7#1)(1997-8#1)(2007-10#1)(2007-4#2)(2008-11#1)(2008-6#1)(2008-7#7)(2008-8#5)(2009-10#1)(2011-1#1)(2012-1#1)(2013-1#4)
of ionizing##32##2##(1990-7#1)(1990-8#1)(1994-7#1)(1997-8#1)(2007-10#1)(2007-4#2)(2008-11#2)(2008-6#1)(2008-7#8)(2008-8#5)(2009-10#1)(2011-1#2)(2012-1#1)(2013-1#5)
of ionophore##5##2##(1992-4#1)(2008-10#4)
of ionophores##2##2##(1990-12#1)(1992-4#1)
of ionotropic glutamate receptors##3##4##(1995-11#2)(1995-12#1)
of ionotropic glutamate##4##3##(1993-12#1)(1995-11#2)(1995-12#1)
of ionotropic receptor##2##3##(1993-11#1)(2008-7#1)
of ionotropic##7##2##(1993-11#1)(1993-12#1)(1995-11#2)(1995-12#1)(2008-7#2)
of ions and##8##3##(1995-1#1)(1995-5#1)(2005-10#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-6#1)(2010-5#1)
of ions by##2##3##(1991-3#1)(2005-11#1)
of ions down their electrochemical gradient##2##6##(2005-7#1)(2008-8#1)
of ions from##3##3##(2005-11#1)(2008-1#1)(2010-3#1)
of ions in the##5##4##(2005-11#2)(2008-10#3)
of ions in##8##3##(2005-11#2)(2008-1#1)(2008-10#4)(2009-10#1)
of ions is##3##3##(2006-4#1)(2008-5#1)(2010-7#1)
of ions per cluster##2##4##(2007-12#2)
of ions per##3##3##(2005-11#1)(2007-12#2)
of ions##55##2##(1990-7#1)(1991-3#1)(1995-1#1)(1995-5#1)(1996-4#1)(2005-10#1)(2005-11#10)(2005-4#1)(2005-7#1)(2006-4#2)(2007-12#2)(2008-1#2)(2008-10#15)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#1)(2010-3#1)(2010-5#2)(2010-7#1)(2012-2#2)
of iontophoresis##3##2##(2009-6#2)(2011-2#1)
of iontophoretic application of##2##4##(1992-9#1)(1997-7#1)
of iontophoretic##4##2##(1992-9#1)(1993-12#1)(1997-7#1)(2008-5#1)
of iprodione##4##2##(2008-10#4)
of ipsilateral recurrence##2##3##(1990-12#1)(1991-11#1)
of ipsilateral##14##2##(1990-12#1)(1990-6#1)(1991-11#1)(1992-8#1)(1995-11#2)(1996-1#1)(2005-10#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-8#1)(2013-1#1)
of ir-CNP##2##2##(1991-3#1)(1991-8#1)
of ir-ET##5##2##(1990-10#5)
of ir-atrial##2##2##(1991-3#1)(1991-5#1)
of iran##5##2##(2007-2#1)(2012-2#2)(2013-1#2)
of irbesartan##2##2##(2005-7#1)(2006-6#1)
of iridium oxide##2##3##(2008-10#2)
of iridium##10##2##(2008-10#10)
of iridophores in##3##3##(2008-5#3)
of irinotecan and##2##3##(2005-8#1)(2008-8#1)
of irinotecan##6##2##(2005-11#2)(2005-8#1)(2008-8#3)
of iris##3##2##(2006-11#1)(2008-10#1)(2008-8#1)
of iron (Fe)##2##3##(2008-10#1)(2013-1#1)
of iron (II)##3##3##(2008-10#2)(2009-9#1)
of iron (III)##6##3##(2008-10#5)(2013-8#1)
of iron acquisition##2##3##(1997-2#1)(2011-2#1)
of iron and copper##2##4##(2008-10#2)
of iron and manganese##2##4##(2008-10#2)
of iron and nickel##3##4##(2008-10#3)
of iron and ruthenium##2##4##(2008-10#2)
of iron and the##2##4##(1995-3#1)(2012-1#1)
of iron and zinc in the human hair with##2##9##(2008-10#2)
of iron and zinc in##3##5##(2008-10#3)
of iron and zinc##6##4##(2007-10#1)(2008-10#5)
of iron and##40##3##(1990-3#1)(1990-9#1)(1995-3#2)(1996-2#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-8#2)(2008-10#23)(2008-8#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
of iron as##4##3##(2008-10#4)
of iron by the##2##4##(1992-1#1)(2008-10#1)
of iron by##6##3##(1992-1#1)(2006-10#1)(2008-10#4)
of iron chelation##2##3##(1995-2#1)(2008-3#1)
of iron containing##2##3##(2008-11#2)
of iron content in##2##4##(2008-10#2)
of iron deficiency anaemia in##2##5##(2007-8#1)(2012-2#1)
of iron deficiency anaemia##5##4##(1993-2#2)(1993-5#1)(2007-8#1)(2012-2#1)
of iron deficiency anemia##2##4##(1991-6#1)(2013-7#1)
of iron deficiency in the##2##5##(1994-6#1)(2006-4#1)
of iron deficiency in##3##4##(1994-6#1)(2006-10#1)(2006-4#1)
of iron deficiency##12##3##(1991-6#1)(1993-2#2)(1993-5#1)(1994-6#1)(2005-10#1)(2006-10#1)(2006-4#2)(2007-8#1)(2012-2#1)(2013-7#1)
of iron depletion##2##3##(2009-8#2)
of iron enrichment##2##3##(1996-5#2)
of iron for##2##3##(1996-5#1)(2008-10#1)
of iron from##6##3##(1992-4#1)(2008-10#4)(2008-5#1)
of iron homeostasis##3##3##(1996-5#1)(2008-3#1)(2010-12#1)
of iron in milk##2##4##(2008-10#2)
of iron in natural##2##4##(2008-10#2)
of iron in seawater##3##4##(2007-8#2)(2008-10#1)
of iron in tap and##2##5##(2008-10#2)
of iron in the##15##4##(1991-10#2)(1993-2#1)(1996-5#2)(1996-9#1)(1997-8#1)(2006-2#1)(2008-10#5)(2012-11#1)(2013-8#1)
of iron in water samples##3##5##(2008-10#3)
of iron in water##4##4##(2007-10#1)(2008-10#3)
of iron in##45##3##(1991-10#2)(1993-2#1)(1996-5#2)(1996-9#1)(1997-8#1)(2006-2#1)(2007-10#1)(2007-6#1)(2007-8#2)(2008-10#28)(2012-11#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
of iron is##3##3##(1992-8#1)(2005-10#1)(2008-10#1)
of iron metabolism##7##3##(1992-5#1)(1993-11#1)(1995-2#1)(2006-9#1)(2008-10#1)(2012-12#1)(2013-8#1)
of iron meteorites##2##3##(1992-2#2)
of iron mobilization from##2##4##(1992-6#2)
of iron nanoparticles##2##3##(2006-12#1)(2009-2#1)
of iron on the##2##4##(1994-6#1)(2008-10#1)
of iron on##5##3##(1994-6#1)(2004-2#2)(2008-10#2)
of iron or copper##2##4##(1992-4#2)
of iron or##4##3##(1992-4#2)(1997-5#1)(2008-10#1)
of iron overload and##2##4##(2005-10#2)
of iron overload##5##3##(1996-6#1)(2005-10#2)(2008-3#1)(2012-2#1)
of iron oxide nanoparticles##2##4##(2008-10#1)(2009-2#1)
of iron oxide##5##3##(2006-5#1)(2008-10#1)(2008-11#1)(2009-2#1)(2009-6#1)
of iron phthalocyanine and its derivatives##2##6##(2010-5#2)
of iron phthalocyanine##3##3##(2008-10#1)(2010-5#2)
of iron reduction##4##3##(1992-6#1)(2006-8#2)(2009-8#1)
of iron regulatory proteins##2##4##(1996-4#2)
of iron regulatory##3##3##(1995-6#1)(1996-4#2)
of iron state on##2##4##(2004-9#2)
of iron stores in##2##4##(2008-1#1)(2008-3#1)
of iron stores##3##3##(2007-7#1)(2008-1#1)(2008-3#1)
of iron supplementation in##2##4##(2007-11#1)(2012-12#1)
of iron to##3##3##(1990-4#1)(2008-10#2)
of iron uptake##5##3##(1995-11#2)(1996-6#1)(2004-2#1)(2009-8#1)
of iron was##2##3##(2008-10#2)
of iron##293##2##(1990-3#2)(1990-4#1)(1990-7#1)(1990-9#1)(1991-10#2)(1991-11#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-2#2)(1992-4#3)(1992-5#1)(1992-6#3)(1992-8#2)(1993-11#2)(1993-2#4)(1993-5#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#2)(1995-3#4)(1995-6#4)(1996-2#4)(1996-4#2)(1996-5#7)(1996-6#2)(1996-7#2)(1996-9#1)(1997-2#2)(1997-5#1)(1997-7#1)(1997-8#1)(2004-2#3)(2004-9#3)(2005-10#4)(2005-11#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#4)(2006-5#2)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#3)(2007-6#1)(2007-7#1)(2007-8#6)(2008-1#1)(2008-10#108)(2008-11#3)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#4)(2009-6#1)(2009-8#5)(2009-9#1)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#4)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#6)(2012-2#10)(2012-3#2)(2013-1#4)(2013-7#5)(2013-8#6)
of iron's##4##2##(2006-12#1)(2012-2#3)
of iron(II) and##4##3##(2008-10#3)(2008-5#1)
of iron(II) tris-(1##3##3##(2008-10#3)
of iron(II)##13##2##(2007-8#1)(2008-10#10)(2008-5#2)
of iron(III) and copper(II) and of iron(III) and palladium(II)##3##9##(2008-10#3)
of iron(III) and iron(II) in##2##5##(2008-10#2)
of iron(III) and iron(II)##3##4##(2008-10#3)
of iron(III) and titanium(IV)##3##4##(2008-10#3)
of iron(III) and total iron by sequential injection analysis##2##9##(2008-10#2)
of iron(III) and total iron##3##5##(2008-10#3)
of iron(III) and vanadium(V) using 8-quinolinol derivatives##2##7##(2008-10#2)
of iron(III) and##17##3##(2008-10#17)
of iron(III)##39##2##(1996-2#1)(2007-11#1)(2007-3#1)(2008-10#36)
of iron)##2##2##(2008-10#2)
of iron-anthracycline complexes with##2##4##(1993-6#2)
of iron-containing##2##2##(1992-7#1)(2004-9#1)
of iron-deficiency anaemia##3##3##(1994-6#1)(2009-10#2)
of iron-deficiency anemia (IDA)##2##4##(2006-10#2)
of iron-deficiency anemia##4##3##(2006-10#4)
of iron-deficiency##9##2##(1994-6#1)(1996-10#1)(1996-4#1)(2006-10#4)(2009-10#2)
of iron-sulfur centers in##2##4##(1992-3#2)
of iron-sulfur centers##5##3##(1992-3#4)(1993-11#1)
of iron-sulfur##7##2##(1992-3#4)(1993-11#1)(1996-7#1)(2008-11#1)
of irradiance##5##2##(2008-2#1)(2008-3#4)
of irradiated plus anti-asialo GM1 pretreated##2##6##(1994-2#2)
of irradiated##18##2##(1993-9#1)(1994-2#2)(1995-2#1)(1996-11#1)(1997-4#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-4#1)(2012-12#2)
of irradiation and##3##3##(1991-1#1)(2008-10#1)(2010-4#1)
of irradiation in the##2##4##(2006-12#1)(2008-6#1)
of irradiation in##4##3##(1994-7#1)(2006-12#1)(2008-6#2)
of irradiation time##2##3##(1996-6#1)(2008-5#1)
of irradiation##29##2##(1990-9#1)(1991-1#1)(1994-7#1)(1996-5#1)(1996-6#1)(2006-12#1)(2008-10#8)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#4)(2008-9#2)(2010-4#1)(2011-2#2)
of irrational beliefs##3##3##(2010-5#3)
of irrationality##3##2##(2010-5#3)
of irreducible inguinal##2##3##(2009-6#2)
of irregular##12##2##(1991-7#1)(2005-11#1)(2008-10#2)(2008-5#1)(2009-7#2)(2010-10#1)(2011-1#2)(2012-2#1)(2013-1#1)
of irregularly shaped##2##3##(2008-10#1)(2010-12#1)
of irrelevant##6##2##(1995-1#1)(1995-5#2)(2009-1#1)(2009-8#1)(2013-8#1)
of irresponsible##2##2##(1996-2#1)(1997-6#1)
of irreversible protein denaturation##2##4##(1991-2#1)(2006-10#1)
of irreversible##18##2##(1990-7#1)(1991-1#1)(1991-11#1)(1991-2#1)(1994-12#1)(1995-7#1)(1996-7#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-12#2)(2012-2#1)(2013-1#2)
of irreversibly##3##2##(1991-2#1)(2005-11#1)(2007-12#1)
of irrigation water##3##3##(2008-10#2)(2008-12#1)
of irrigation##7##2##(2008-10#5)(2008-12#2)
of irritability##2##2##(2006-11#1)(2013-8#1)
of irritable bowel syndrome (IBS)##3##5##(1997-6#1)(2006-10#1)(2008-3#1)
of irritable bowel syndrome in##2##5##(2007-2#1)(2013-1#1)
of irritable bowel syndrome##9##4##(1997-6#2)(2006-10#1)(2006-4#1)(2007-2#1)(2008-3#1)(2008-4#1)(2010-6#1)(2013-1#1)
of irritable bowel##10##3##(1997-6#2)(2006-10#1)(2006-4#1)(2007-2#1)(2008-3#1)(2008-4#1)(2010-6#1)(2013-1#2)
of irritable##11##2##(1990-8#1)(1997-6#2)(2006-10#1)(2006-4#1)(2007-2#1)(2008-3#1)(2008-4#1)(2010-6#1)(2013-1#2)
of irritant##2##2##(2006-10#1)(2008-5#1)
of irritating##2##2##(1990-10#1)(2008-5#1)
of irritation##6##2##(1992-3#1)(1992-4#1)(2008-10#1)(2008-5#3)
of is##4##2##(1992-1#1)(2007-9#1)(2008-6#1)(2011-2#1)
of isatin##7##2##(1997-3#2)(2005-8#2)(2007-11#1)(2008-11#1)(2011-1#1)
of ischaemia##9##2##(1993-7#1)(1996-6#1)(2006-6#1)(2007-8#2)(2007-9#2)(2008-7#1)(2013-8#1)
of ischaemia-reperfusion##2##2##(2007-9#1)(2012-2#1)
of ischaemic heart disease (IHD) in##2##6##(1994-2#1)(2005-1#1)
of ischaemic heart disease (IHD)##3##5##(1994-2#1)(2005-1#1)(2006-6#1)
of ischaemic heart disease and##3##5##(1990-6#1)(1991-11#1)(1995-12#1)
of ischaemic heart disease##10##4##(1990-4#2)(1990-6#1)(1990-9#1)(1991-11#1)(1991-3#1)(1994-2#1)(1995-12#1)(2005-1#1)(2006-6#1)
of ischaemic postconditioning##2##3##(2013-7#2)
of ischaemic stroke##7##3##(1993-7#1)(2006-10#1)(2008-8#4)(2012-2#1)
of ischaemic##29##2##(1990-4#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-3#1)(1993-7#1)(1994-2#1)(1995-12#1)(1997-1#2)(1997-8#1)(2005-1#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-8#5)(2012-2#2)(2013-7#2)
of ischemia and##4##3##(2005-8#1)(2006-10#1)(2007-9#1)(2008-2#1)
of ischemia in##2##3##(1996-9#1)(1997-7#1)
of ischemia reperfusion injury##2##4##(2006-10#1)(2010-1#1)
of ischemia##54##2##(1991-11#1)(1991-8#1)(1991-9#1)(1993-12#1)(1993-2#1)(1994-10#4)(1994-2#1)(1994-3#1)(1994-5#4)(1995-12#3)(1996-7#1)(1996-9#2)(1997-1#5)(1997-6#1)(1997-7#2)(1997-8#2)(2005-7#1)(2005-8#2)(2006-10#5)(2007-8#1)(2007-9#6)(2008-10#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-7#1)(2010-1#1)(2010-11#1)
of ischemia)##2##2##(2008-3#1)(2009-12#1)
of ischemic brain injury##3##4##(2005-8#1)(2007-10#1)(2007-9#1)
of ischemic brain##4##3##(1994-2#1)(2005-8#1)(2007-10#1)(2007-9#1)
of ischemic cerebral##2##3##(2007-10#1)(2012-11#1)
of ischemic cerebrovascular##2##3##(2005-1#1)(2005-10#1)
of ischemic colitis##5##3##(1990-6#1)(2009-6#1)(2010-12#1)(2013-1#2)
of ischemic events##3##3##(2005-10#1)(2007-10#1)(2011-2#1)
of ischemic heart disease (IHD)##4##5##(2008-3#2)(2012-3#1)(2013-1#1)
of ischemic heart disease and##6##5##(1990-9#2)(1991-3#1)(1997-8#1)(2008-10#1)(2008-8#1)
of ischemic heart disease the##2##5##(2006-6#1)(2008-10#1)
of ischemic heart disease##31##4##(1990-9#2)(1991-3#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-6#1)(1996-9#1)(1997-8#2)(2006-6#1)(2007-10#1)(2008-10#3)(2008-3#3)(2008-8#1)(2010-11#1)(2010-12#2)(2010-6#2)(2010-8#2)(2011-2#2)(2012-3#2)(2013-1#1)
of ischemic heart disease]##2##4##(1995-11#1)(2012-3#1)
of ischemic heart##35##3##(1990-9#2)(1991-3#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-6#1)(1996-9#1)(1997-8#2)(2006-6#1)(2007-10#1)(2008-10#3)(2008-3#4)(2008-8#1)(2010-11#1)(2010-12#2)(2010-6#2)(2010-8#2)(2011-2#2)(2012-3#3)(2013-1#2)
of ischemic injury in##2##4##(2007-9#2)
of ischemic injury to##2##4##(2005-10#1)(2008-6#1)
of ischemic injury##8##3##(1997-2#1)(2005-10#1)(2007-9#4)(2008-6#1)(2012-1#1)
of ischemic myocardial##2##3##(1996-9#1)(2010-8#1)
of ischemic nephropathy##3##3##(2006-10#1)(2007-7#1)(2007-8#1)
of ischemic postconditioning##2##3##(2013-1#1)(2013-7#1)
of ischemic preconditioning in##2##4##(1996-9#1)(2007-8#1)
of ischemic preconditioning##11##3##(1996-9#6)(2006-10#1)(2007-8#1)(2010-12#2)(2013-7#1)
of ischemic stroke among##5##4##(2010-12#1)(2011-1#4)
of ischemic stroke and##3##4##(2007-10#1)(2007-9#2)
of ischemic stroke caused by##2##5##(2007-10#1)(2008-12#1)
of ischemic stroke in young adults##2##6##(2011-1#1)(2012-3#1)
of ischemic stroke in##7##4##(2007-10#1)(2010-12#1)(2011-1#4)(2012-3#1)
of ischemic stroke patients##3##4##(2007-10#1)(2007-9#1)(2008-3#1)
of ischemic stroke##44##3##(2005-12#1)(2007-10#13)(2007-9#6)(2008-12#2)(2008-3#1)(2009-12#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#11)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)
of ischemic strokes##4##3##(2007-10#2)(2008-5#1)(2008-7#1)
of ischemic##161##2##(1990-6#1)(1990-9#2)(1991-3#2)(1993-10#1)(1993-4#1)(1993-8#1)(1994-10#1)(1994-2#2)(1994-3#1)(1995-11#1)(1995-3#1)(1995-6#2)(1995-7#1)(1996-10#1)(1996-5#1)(1996-9#11)(1997-2#1)(1997-8#2)(2005-1#1)(2005-10#4)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-6#1)(2007-10#22)(2007-7#1)(2007-8#3)(2007-9#11)(2008-1#1)(2008-10#3)(2008-12#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2010-11#2)(2010-12#9)(2010-2#1)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#4)(2011-1#11)(2011-2#6)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#7)(2013-7#2)
of island##4##2##(1996-6#1)(2008-1#1)(2008-8#1)(2011-2#1)
of islands##2##2##(2012-3#1)(2013-8#1)
of islet amyloid polypeptide (IAPP)##2##5##(1992-7#1)(1995-10#1)
of islet amyloid polypeptide (amylin)##2##5##(1992-6#1)(1995-10#1)
of islet amyloid polypeptide##5##4##(1992-1#1)(1992-6#1)(1992-7#1)(1995-10#2)
of islet amyloid##7##3##(1992-1#1)(1992-12#1)(1992-6#1)(1992-7#1)(1994-8#1)(1995-10#2)
of islet antigens##2##3##(2007-5#1)(2008-4#1)
of islet cell##8##3##(1991-3#1)(1992-6#2)(1996-5#2)(1997-5#1)(2005-7#1)(2008-1#1)
of islet cells##2##3##(1992-6#1)(1994-3#1)
of islet progenitor cells##2##4##(2008-1#2)
of islet##38##2##(1990-12#1)(1991-3#1)(1991-6#2)(1992-1#1)(1992-12#1)(1992-6#4)(1992-7#1)(1994-3#1)(1994-8#1)(1995-10#2)(1996-5#2)(1997-4#1)(1997-5#1)(1997-8#1)(2005-7#2)(2007-11#3)(2007-5#4)(2008-1#3)(2008-4#1)(2010-10#2)(2010-11#2)(2012-12#1)
of islets from##2##3##(2010-11#2)
of islets isolated from##3##4##(2010-11#3)
of islets##15##2##(1995-11#1)(1995-8#1)(2007-5#1)(2008-4#1)(2010-11#11)
of iso##2##2##(1992-8#1)(2012-12#1)
of iso-##2##2##(2012-12#2)
of isochromatics##2##2##(2008-2#1)(2008-3#1)
of isocitrate dehydrogenase##2##3##(1990-8#1)(2006-10#1)
of isocitrate lyase##3##3##(1991-7#1)(1992-7#1)(1995-4#1)
of isocitrate##6##2##(1990-5#1)(1990-8#1)(1991-7#1)(1992-7#1)(1995-4#1)(2006-10#1)
of isoclinics and isochromatics##2##4##(2008-2#1)(2008-3#1)
of isoclinics##3##2##(2008-2#1)(2008-3#2)
of isocorydione##2##2##(2012-3#2)
of isoelectric##3##2##(1997-8#1)(2008-4#1)(2012-12#1)
of isoflavone aglycones##2##3##(2008-10#1)(2013-1#1)
of isoflavone##3##2##(2008-10#2)(2013-1#1)
of isoflavones##6##2##(1991-8#1)(2007-1#1)(2010-3#2)(2011-2#1)(2013-1#1)
of isoflavonoids##2##2##(2011-1#1)(2012-12#1)
of isoflurane##8##2##(1996-1#1)(2007-2#1)(2007-9#6)
of isoform##2##2##(1995-3#1)(2010-7#1)
of isoforms and##2##3##(1993-3#1)(2008-7#1)
of isoforms of the##3##4##(1994-8#1)(1996-2#1)(2005-8#1)
of isoforms of##4##3##(1994-8#1)(1995-11#1)(1996-2#1)(2005-8#1)
of isoforms##11##2##(1993-3#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-3#1)(1996-2#1)(1997-3#1)(2005-8#1)(2008-10#1)(2008-7#1)
of isofraxidin and fumaric acid in##2##6##(2008-10#2)
of isogenic##3##2##(1995-6#1)(1997-4#1)(2006-8#1)
of isoindolo[1##2##2##(1994-9#2)
of isokinetic##2##2##(2007-10#1)(2007-8#1)
of isolate EN-4##2##3##(2008-10#2)
of isolate##13##2##(2008-10#11)(2008-9#1)(2011-2#1)
of isolated and##2##3##(1992-1#1)(2010-12#1)
of isolated cardiac##2##3##(1990-2#1)(2004-11#1)
of isolated cells##7##3##(1991-2#1)(1994-12#1)(2007-2#2)(2008-11#3)
of isolated coronary##2##3##(2007-8#1)(2012-3#1)
of isolated guinea pig##4##4##(1991-2#2)(1995-3#1)(1997-7#1)
of isolated hepatocytes##3##3##(1990-11#1)(1992-3#1)(1994-8#1)
of isolated mitochondria##3##3##(1991-7#1)(1996-5#1)(1997-4#1)
of isolated outer hair cells##2##5##(1995-3#1)(2009-9#1)
of isolated outer##3##3##(1990-5#1)(1995-3#1)(2009-9#1)
of isolated pancreatic##2##3##(2010-1#1)(2013-1#1)
of isolated rat heart mitochondria##2##5##(1992-11#2)
of isolated rat hepatocytes##2##4##(1991-7#1)(2012-12#1)
of isolated rat liver##2##4##(1994-6#1)(2013-1#1)
of isolated rat##13##3##(1991-10#1)(1991-7#1)(1991-8#1)(1992-11#2)(1994-6#1)(1996-6#1)(1997-7#1)(2008-4#1)(2010-12#1)(2010-5#1)(2012-12#1)(2013-1#1)
of isolated rat-liver##2##3##(1990-8#1)(1992-4#1)
of isolated sarcolemma##2##3##(1991-2#1)(2007-9#1)
of isolated segments##2##3##(1995-12#1)(1996-12#1)
of isolated smooth muscle##3##4##(1991-12#1)(2008-8#2)
of isolated splenic##2##3##(1991-10#1)(2007-8#1)
of isolated strips of##2##4##(1990-7#1)(1997-5#1)
of isolated toxigenic C##2##4##(2011-2#2)
of isolated##169##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#2)(1990-4#3)(1990-5#3)(1990-7#1)(1990-8#1)(1991-1#2)(1991-10#2)(1991-12#1)(1991-2#4)(1991-3#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-1#1)(1992-11#3)(1992-12#1)(1992-3#1)(1992-4#3)(1992-5#2)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#2)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-5#3)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#2)(1997-7#2)(2004-10#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-2#3)(2007-4#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#3)(2008-4#7)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-5#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#3)(2013-8#4)
of isolates and a##2##4##(2008-10#1)(2008-5#1)
of isolates as##2##3##(2008-10#2)
of isolates at##2##3##(2008-10#1)(2011-1#1)
of isolates belonging to group I##2##6##(2008-10#2)
of isolates belonging to##4##4##(2008-10#4)
of isolates from each##3##4##(2008-10#3)
of isolates from the##2##4##(2008-10#2)
of isolates from##20##3##(2005-11#2)(2007-7#1)(2008-10#15)(2008-12#1)(2013-1#1)
of isolates in the##3##4##(2008-10#3)
of isolates in##9##3##(1990-6#1)(1991-8#2)(2008-10#6)
of isolates of the pathogen##2##5##(2008-10#2)
of isolates of the##6##4##(2008-10#5)(2013-8#1)
of isolates of this##2##4##(2008-10#1)(2008-9#1)
of isolates of##22##3##(1997-3#2)(2006-8#1)(2007-7#1)(2008-10#12)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
of isolates resistant to##2##4##(1991-12#1)(2008-10#1)
of isolates sampled from##2##4##(2008-10#2)
of isolates that##2##3##(2008-10#2)
of isolates to artichoke and cotton##2##6##(2008-10#2)
of isolates to##5##3##(2008-10#3)(2011-1#1)(2011-2#1)
of isolates was##2##3##(2005-11#1)(2008-10#1)
of isolates were HSV-1##2##4##(2007-12#2)
of isolates were identified##2##4##(2008-10#2)
of isolates were##10##3##(2007-12#2)(2008-10#6)(2008-5#1)(2011-2#1)
of isolates within##2##3##(2008-10#2)
of isolates##137##2##(1990-6#1)(1991-12#1)(1991-8#2)(1996-7#1)(1997-3#2)(2005-11#3)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#2)(2008-10#92)(2008-12#1)(2008-5#5)(2008-7#1)(2008-9#1)(2010-4#1)(2011-1#3)(2011-2#6)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#1)
of isolating##10##2##(1990-9#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-8#1)(2009-12#1)(2010-9#1)
of isolation and purification##2##4##(2008-10#2)
of isolation and##4##3##(2008-10#3)(2008-9#1)
of isolation by distance##2##4##(2009-2#1)(2011-2#1)
of isolation of##12##3##(1997-6#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-5#1)(2010-4#1)(2012-2#1)
of isolation were##2##3##(2007-7#1)(2008-9#1)
of isolation##32##2##(1991-7#1)(1992-6#1)(1993-12#1)(1994-8#1)(1997-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-9#3)(2009-12#1)(2009-2#1)(2009-5#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-2#1)
of isolations##2##2##(2007-10#1)(2008-5#1)
of isoleucyl-tRNA synthetase##2##3##(1994-9#2)
of isoleucyl-tRNA##3##2##(1994-9#3)
of isomeric##12##2##(1991-9#1)(1992-12#2)(1993-4#1)(1996-2#1)(1996-5#2)(2006-1#1)(2008-10#4)
of isomerization##3##2##(1993-11#1)(1994-8#1)(1995-3#1)
of isomers##4##2##(1990-8#1)(1994-5#1)(1996-5#1)(2008-11#1)
of isometric knee extension strength##2##5##(2007-10#2)
of isometric quadriceps muscle strengthening exercise##2##6##(2011-2#2)
of isometric##8##2##(2007-10#2)(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2011-2#2)
of isoniazid in##7##3##(1993-7#1)(1997-7#1)(2005-12#4)(2008-10#1)
of isoniazid tablets##2##3##(2008-10#2)
of isoniazid were##2##3##(2005-12#2)
of isoniazid##24##2##(1991-11#1)(1993-7#3)(1997-3#1)(1997-7#1)(2005-12#7)(2007-11#1)(2008-10#8)(2008-11#1)(2008-7#1)
of isonorargemonine##2##2##(2007-1#2)
of isoprene and##2##3##(1996-2#1)(2011-1#1)
of isoprenoid compounds such as##2##5##(1994-11#2)
of isoprenoid compounds##3##3##(1994-11#3)
of isoprenoid lipids##2##3##(1994-3#1)(2008-5#1)
of isoprenoid##7##2##(1994-11#3)(1994-3#2)(2008-5#1)(2012-2#1)
of isoprenylated proteins##2##3##(1994-3#2)
of isoproterenol##10##2##(1992-3#3)(1992-6#1)(1996-12#1)(2006-9#1)(2008-10#3)(2011-2#1)
of isoproterenol-induced##2##2##(1993-6#1)(1995-5#1)
of isoproterenol-stimulated##2##2##(1992-3#1)(1994-8#1)
of isoproturon##5##2##(2008-10#5)
of isosbestic##3##2##(2006-12#3)
of isosorbide dinitrate##2##3##(1996-9#1)(2008-10#1)
of isosteric##3##2##(1993-6#1)(2006-12#1)(2008-7#1)
of isothermal adsorption##2##3##(1997-2#1)(2005-12#1)
of isothermal##3##2##(1997-2#1)(2005-12#1)(2008-3#1)
of isotonic##2##2##(1992-6#1)(1995-3#1)
of isotope##6##2##(1991-3#1)(1992-3#1)(2005-10#1)(2008-10#1)(2008-4#1)(2012-1#1)
of isotopic##5##2##(1992-5#1)(1993-10#1)(2008-10#3)
of isotopically enriched##2##3##(2008-4#1)(2012-3#1)
of isotopically labeled##2##3##(1992-12#1)(1993-11#1)
of isotopically##7##2##(1991-3#1)(1992-12#1)(1993-11#1)(2008-11#1)(2008-4#1)(2009-12#1)(2012-3#1)
of isotopomer models is##2##4##(2008-7#2)
of isotopomer##3##2##(2008-7#3)
of isotretinoin##5##2##(2007-11#1)(2009-6#1)(2010-5#2)(2011-1#1)
of isotropic and anisotropic##2##4##(2008-2#1)(2008-3#1)
of isotropic and##3##3##(2008-2#1)(2008-3#2)
of isotropic scattering coefficients##2##4##(2007-12#1)(2008-2#1)
of isotropic scattering##3##3##(2007-12#1)(2008-2#2)
of isotropic##10##2##(1991-5#1)(2007-12#1)(2008-2#4)(2008-3#4)
of isozyme H1##3##3##(1990-2#3)
of isozyme I##2##3##(1991-2#2)
of isozyme##7##2##(1990-2#4)(1991-2#3)
of isozymes I and II##4##5##(1991-2#2)(1994-9#2)
of isozymes I##5##3##(1991-2#2)(1994-9#3)
of isozymes III and IV##2##5##(1994-9#2)
of isozymes##11##2##(1991-2#2)(1991-4#1)(1994-12#1)(1994-9#5)(2008-10#2)
of isradipine##3##2##(1993-10#3)
of issues and##3##3##(1995-3#1)(2008-1#1)(2010-4#1)
of issues related to##6##4##(1997-2#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-7#1)(2013-1#1)
of issues that##4##3##(1991-3#1)(2008-11#1)(2008-12#1)(2008-4#1)
of issues##34##2##(1991-3#1)(1992-11#1)(1992-3#1)(1994-12#1)(1995-3#1)(1996-1#1)(1997-1#2)(1997-2#1)(1997-8#1)(2004-12#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#2)(2008-7#2)(2009-11#1)(2009-4#1)(2010-4#1)(2010-6#1)(2013-1#2)
of isthmus-dependent atrial flutter##2##4##(2006-9#2)
of isthmus-dependent##3##2##(2006-9#3)
of it by##2##3##(1993-4#1)(2008-10#1)
of it in##3##3##(2006-12#1)(2009-2#1)(2011-2#1)
of it to##4##3##(2008-10#2)(2013-1#2)
of it##60##2##(1990-11#1)(1990-6#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-3#1)(1993-4#1)(1994-12#2)(1995-2#1)(1995-5#1)(1996-3#2)(1996-6#1)(1997-8#1)(2004-4#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-12#3)(2007-7#1)(2007-9#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)
of it's##3##2##(2007-11#1)(2008-12#1)(2009-2#1)
of itch##3##2##(2005-11#1)(2008-5#1)(2010-8#1)
of itching##11##2##(1996-11#4)(2007-2#2)(2007-7#2)(2008-1#2)(2012-12#1)
of item##9##2##(2007-12#1)(2008-12#1)(2008-4#1)(2012-1#1)(2012-2#5)
of item-writing##2##2##(2008-12#2)
of items and##2##3##(1990-3#1)(2006-8#1)
of items in##3##3##(2008-1#1)(2012-2#2)
of items with##2##3##(2010-11#1)(2010-2#1)
of items##25##2##(1990-3#1)(1993-12#1)(2006-5#2)(2006-6#1)(2006-8#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-1#1)(2010-11#2)(2010-2#1)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#2)
of iterative##5##2##(2008-3#3)(2008-5#1)(2008-9#1)
of itraconazole in##2##3##(2007-8#1)(2010-12#1)
of itraconazole##7##2##(2007-8#1)(2008-1#1)(2008-5#1)(2010-12#4)
of its 1-(2-pyridylazo)-2-naphthol##2##3##(2008-10#2)
of its DNA##2##3##(2008-11#1)(2011-2#1)
of its N-terminal##2##3##(1991-8#1)(2008-7#1)
of its SH2 domains##2##4##(1997-6#2)
of its ability to##19##4##(1991-9#1)(1992-9#1)(1993-6#1)(1994-5#1)(1995-6#2)(1996-2#1)(1997-5#1)(1997-7#1)(2005-11#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2010-5#1)(2012-2#1)
of its ability##20##3##(1991-9#1)(1992-9#1)(1993-6#1)(1994-5#1)(1995-6#2)(1996-2#2)(1997-5#1)(1997-7#1)(2005-11#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2010-5#1)(2012-2#1)
of its accuracy##2##3##(1994-2#1)(1995-1#1)
of its action##3##3##(1992-5#1)(1992-6#1)(2007-11#1)
of its activation##3##3##(1990-4#1)(1991-2#1)(2008-5#1)
of its active site##2##4##(1992-3#1)(1992-6#1)
of its active##4##3##(1992-3#1)(1992-6#1)(2008-11#1)(2008-5#1)
of its activity after##2##4##(1995-6#1)(2007-12#1)
of its activity##17##3##(1990-11#1)(1990-3#1)(1991-5#1)(1993-12#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-12#1)(1997-1#1)(2006-8#1)(2007-12#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-6#1)
of its aggregation##2##3##(1990-12#1)(1995-8#1)
of its amino acid##3##4##(1991-2#1)(1997-8#1)(2008-10#1)
of its analogs##4##3##(1990-5#1)(1991-5#1)(1994-12#2)
of its anatomical##2##3##(1994-5#1)(2008-10#1)
of its apparent##2##3##(1995-12#1)(2010-4#1)
of its applicability##2##3##(2008-2#1)(2012-3#1)
of its application to##4##4##(1991-2#1)(2007-11#1)(2007-12#1)(2007-4#1)
of its application##6##3##(1991-2#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-2#1)(2010-5#1)
of its applications##2##3##(1990-12#1)(2006-6#1)
of its aromatic##2##3##(1990-5#1)(2006-3#1)
of its associated##4##3##(2007-5#1)(2011-2#1)(2012-12#2)
of its basic##2##3##(2008-3#1)(2008-5#1)
of its behavior##2##3##(2008-8#1)(2009-5#1)
of its binding to##3##4##(1991-9#1)(1993-8#1)(2009-12#1)
of its binding##7##3##(1990-2#1)(1991-9#1)(1993-8#1)(1994-12#1)(1995-2#1)(2009-12#1)(2012-2#1)
of its biological activity##3##4##(1990-2#1)(2008-10#1)(2011-2#1)
of its biological##8##3##(1990-2#1)(1993-6#1)(1997-1#1)(2008-10#1)(2008-5#2)(2008-7#1)(2011-2#1)
of its biosynthetic pathway##2##4##(1994-12#1)(2009-8#1)
of its blood##2##3##(2009-2#1)(2010-12#1)
of its cDNA##5##3##(1991-10#1)(1992-4#1)(1993-3#1)(1995-3#1)(1997-7#1)
of its catalytic##4##3##(1990-5#1)(1996-7#2)(2007-10#1)
of its cause##3##3##(2005-9#1)(2006-2#1)(2006-6#1)
of its cell##3##3##(1990-8#1)(2008-11#1)(2008-5#1)
of its central##4##3##(1992-11#1)(2006-10#1)(2009-2#1)(2009-8#1)
of its circulating##2##3##(2008-7#1)(2010-10#1)
of its citizens##2##3##(1995-9#1)(2007-8#1)
of its clinical##12##3##(2005-8#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-12#1)(2013-8#1)
of its complementary##2##3##(1991-5#1)(2008-8#1)
of its complicated##2##3##(2011-2#1)(2012-2#1)
of its component##2##3##(1997-1#1)(2008-3#1)
of its components and##2##4##(1990-11#1)(2008-4#1)
of its components had already##2##5##(2008-5#2)
of its components##13##3##(1990-11#1)(1990-4#1)(2007-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2009-12#1)(2009-5#1)
of its concentration##5##3##(2007-8#1)(2008-10#4)
of its congeners##3##3##(1993-1#1)(1996-8#1)(1997-1#1)
of its constituent##2##3##(1990-7#1)(1992-11#1)
of its constituents##2##3##(2008-11#1)(2011-2#1)
of its corresponding##3##3##(1997-2#1)(2010-2#2)
of its critical surface tension##2##5##(2008-5#2)
of its critical##4##3##(2008-10#1)(2008-5#2)(2012-1#1)
of its current##2##3##(2006-12#1)(2008-10#1)
of its cytosolic##2##3##(1991-3#1)(1993-11#1)
of its density##2##3##(1993-2#1)(2008-10#1)
of its derivative##3##3##(2005-12#1)(2008-10#2)
of its derivatives##5##3##(1991-7#1)(1997-5#1)(2007-11#1)(2008-10#2)
of its detection in##2##4##(2009-6#1)(2012-1#1)
of its development##5##3##(1992-1#1)(2006-6#2)(2008-11#1)(2008-12#1)
of its diameter##2##3##(2006-6#1)(2013-1#1)
of its diffraction pattern##2##4##(2008-3#2)
of its dimensions##2##3##(2008-2#1)(2013-1#1)
of its disorders##2##3##(1995-5#1)(2006-10#1)
of its distribution and##2##4##(2008-10#2)
of its domain##3##3##(1995-6#1)(2013-1#2)
of its effect on##5##4##(1993-9#1)(1994-3#2)(1995-2#1)(2008-10#1)
of its effect##6##3##(1993-9#1)(1994-3#2)(1995-2#1)(1995-6#1)(2008-10#1)
of its effectiveness in##2##4##(1993-1#1)(2008-11#1)
of its effectiveness##3##3##(1993-1#1)(2007-11#1)(2008-11#1)
of its effects on##6##4##(1994-6#1)(1995-7#1)(2005-11#1)(2008-12#1)(2008-3#1)(2012-12#1)
of its effects##7##3##(1994-6#1)(1995-12#1)(1995-7#1)(2005-11#1)(2008-12#1)(2008-3#1)(2012-12#1)
of its efficacy and safety##2##5##(2008-3#1)(2008-4#1)
of its efficacy and##4##4##(2006-8#1)(2008-3#1)(2008-4#1)(2008-8#1)
of its efficacy in##2##4##(2007-3#1)(2012-1#1)
of its efficacy##8##3##(2006-8#1)(2007-3#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2012-1#1)
of its electrochemical##2##3##(2008-10#2)
of its employees##3##3##(1992-3#1)(1996-12#1)(2013-8#1)
of its enzymatic##3##3##(1995-8#1)(1997-8#1)(2010-1#1)
of its ethyl xanthate complex onto naphthalene##2##7##(2008-10#2)
of its etiology##3##3##(1991-2#1)(1992-3#1)(2006-11#1)
of its evident##2##3##(1990-5#1)(2006-10#1)
of its evolution##3##3##(1992-2#1)(2005-11#1)(2008-4#1)
of its existence##2##3##(1992-2#1)(2013-1#1)
of its expression##7##3##(1990-11#1)(1991-11#1)(1996-10#1)(1996-5#1)(1997-4#1)(2008-8#2)
of its extracellular##2##3##(1993-6#1)(2008-6#1)
of its failure##2##3##(1990-6#1)(2008-2#1)
of its fast##2##3##(2008-3#1)(2008-7#1)
of its favorable##2##3##(1992-11#1)(1996-9#1)
of its first##4##3##(1990-11#1)(2006-11#1)(2007-7#1)(2009-2#1)
of its five##2##3##(1997-2#1)(2010-12#1)
of its fluorescence##2##3##(2007-8#1)(2008-10#1)
of its formation##2##3##(2008-10#1)(2011-2#1)
of its function##8##3##(1990-7#1)(1992-9#1)(1993-6#1)(1994-9#1)(1995-2#1)(1996-5#1)(2008-7#1)(2009-8#1)
of its functional##2##3##(2008-4#1)(2013-1#1)
of its functions##3##3##(2006-10#1)(2008-6#1)(2010-8#1)
of its future##2##3##(2005-1#1)(2008-9#1)
of its gene expression##2##4##(1992-12#1)(1996-11#1)
of its gene##10##3##(1990-4#1)(1991-7#1)(1992-12#1)(1994-3#1)(1994-8#1)(1996-11#1)(1996-5#1)(2007-6#1)(2009-3#1)(2010-10#1)
of its genes##2##3##(2007-12#1)(2007-6#1)
of its genome##4##3##(2008-10#1)(2008-7#1)(2011-1#1)(2012-3#1)
of its genomic##2##3##(1996-4#1)(2005-11#1)
of its geographic range##2##4##(2007-1#1)(2010-10#1)
of its geographic##3##3##(2007-1#1)(2008-10#1)(2010-10#1)
of its good##2##3##(1992-12#1)(2008-2#1)
of its growth suppression##2##4##(1995-2#1)(2008-11#1)
of its growth##4##3##(1995-2#1)(2008-11#1)(2008-4#1)(2012-2#1)
of its high affinity##2##4##(1991-2#1)(1991-6#1)
of its high##23##3##(1991-11#1)(1991-2#2)(1991-6#1)(1992-6#1)(1995-3#1)(1995-7#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)
of its host plant##3##4##(2004-2#1)(2009-8#2)
of its host##7##3##(1995-2#1)(2004-2#1)(2008-9#1)(2009-8#2)(2011-1#1)(2011-2#1)
of its human##3##3##(1996-10#1)(1997-7#1)(2008-2#1)
of its hydrolysis##2##3##(2008-10#2)
of its impact on the##2##5##(2009-7#1)(2013-1#1)
of its impact on##3##4##(1992-4#1)(2009-7#1)(2013-1#1)
of its implementation##4##3##(1992-12#1)(1994-3#1)(2011-1#1)(2013-1#1)
of its incidence##2##3##(1990-3#1)(2010-5#1)
of its influence on##3##4##(2007-9#1)(2008-10#1)(2008-2#1)
of its inhibition of##2##4##(1992-6#1)(1997-2#1)
of its inhibition##3##3##(1992-6#1)(1994-12#1)(1997-2#1)
of its inhibitory##2##3##(1990-11#1)(1994-11#1)
of its initial value##2##4##(1993-6#1)(2008-4#1)
of its initial##5##3##(1993-6#1)(2004-9#1)(2008-10#1)(2008-4#1)(2012-2#1)
of its initiation##2##3##(1995-5#1)(2008-10#1)
of its interaction with##7##4##(1991-9#1)(1992-8#1)(1994-8#1)(1995-2#1)(2007-2#1)(2010-4#1)(2012-8#1)
of its interaction##8##3##(1991-9#1)(1992-8#1)(1994-8#1)(1995-2#1)(2007-2#1)(2008-8#1)(2010-4#1)(2012-8#1)
of its interactions##2##3##(1991-10#1)(1997-2#1)
of its intrinsic##2##3##(2010-7#1)(2013-1#1)
of its involvement in the##2##5##(2008-5#1)(2010-12#1)
of its involvement##3##3##(1996-2#1)(2008-5#1)(2010-12#1)
of its isolated##3##3##(1993-8#1)(2011-2#2)
of its kind in the##2##5##(2007-8#1)(2012-2#1)
of its kind in##5##4##(1990-3#1)(1996-3#1)(2007-8#1)(2008-8#1)(2012-2#1)
of its kind##12##3##(1990-3#1)(1996-3#1)(1996-5#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-12#1)(2012-2#1)
of its length##3##3##(1990-5#1)(2007-12#1)(2013-1#1)
of its life##2##3##(2009-7#1)(2009-8#1)
of its ligands##3##3##(1990-11#1)(1992-12#1)(1997-3#1)
of its local##2##3##(1995-11#1)(2008-2#1)
of its location##2##3##(2008-5#1)(2010-8#1)
of its long arm##2##4##(1997-4#1)(2008-12#1)
of its long##4##3##(1991-9#1)(1997-4#1)(2006-9#1)(2008-12#1)
of its low##4##3##(1991-10#1)(2008-2#1)(2009-10#1)(2011-1#1)
of its mRNA##8##3##(1991-5#1)(1992-11#1)(1993-4#1)(1994-11#1)(1995-2#1)(1996-2#1)(1997-5#1)(2008-9#1)
of its main metabolites##2##4##(1995-11#1)(2007-8#1)
of its main##4##3##(1995-11#1)(2005-6#1)(2007-12#1)(2007-8#1)
of its major##3##3##(2008-11#1)(2011-3#1)(2012-2#1)
of its malignant##2##3##(1996-6#1)(2010-11#1)
of its mammalian##2##3##(1990-5#1)(2008-5#1)
of its manufacture##2##3##(2008-10#1)(2008-3#1)
of its many##3##3##(1992-3#1)(2008-5#1)(2008-9#1)
of its maximal##2##3##(1990-12#1)(1992-12#1)
of its mechanism is##2##4##(1994-3#1)(2013-8#1)
of its mechanism of action##2##5##(1995-5#1)(2008-11#1)
of its mechanism##5##3##(1994-3#1)(1995-11#1)(1995-5#1)(2008-11#1)(2013-8#1)
of its medical##2##3##(1995-2#1)(1996-11#1)
of its members##9##3##(1992-2#1)(1996-1#1)(1996-3#1)(2007-4#1)(2009-2#1)(2009-8#1)(2011-2#2)(2012-3#1)
of its metabolism##4##3##(1994-12#1)(2007-9#1)(2008-5#1)(2008-6#1)
of its metabolites##3##3##(1990-3#1)(1996-6#1)(2008-4#1)
of its mobility##2##3##(1993-8#1)(2008-10#1)
of its molecular weight##2##4##(1992-6#1)(2008-7#1)
of its molecular##4##3##(1991-8#1)(1992-6#1)(2006-8#1)(2008-7#1)
of its more##3##3##(1991-6#1)(1992-2#1)(2005-9#1)
of its multiple##2##3##(1991-2#1)(2008-2#1)
of its native##3##3##(1995-2#1)(2007-9#1)(2011-2#1)
of its negative##3##3##(1994-9#1)(2007-12#1)(2013-7#1)
of its neighboring##2##3##(1993-8#1)(2008-10#1)
of its normal##2##3##(1990-2#1)(1990-5#1)
of its occurrence##4##3##(2006-5#1)(2011-2#3)
of its optical##2##3##(2006-12#1)(2008-1#1)
of its original activity after##2##5##(2007-8#1)(2008-10#1)
of its original activity##4##4##(1997-7#1)(2007-8#1)(2008-10#1)(2008-5#1)
of its original##7##3##(1992-10#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-8#1)
of its own##19##3##(1991-10#1)(1991-11#1)(1991-3#1)(1991-5#2)(1992-11#1)(1992-12#1)(1994-12#1)(1994-8#1)(1995-2#1)(2006-12#1)(2007-11#1)(2007-4#2)(2008-10#1)(2008-2#1)(2008-6#1)(2011-1#1)(2011-12#1)
of its oxidation##3##3##(2008-10#2)(2011-1#1)
of its parameters##4##3##(1993-9#1)(2008-10#1)(2008-2#1)(2013-1#1)
of its parents are##2##4##(2008-10#1)(2008-12#1)
of its particular##4##3##(1997-4#1)(2007-3#1)(2008-2#1)(2008-5#1)
of its pathophysiology##3##3##(2006-7#1)(2007-12#1)(2009-8#1)
of its pattern##2##3##(2008-1#1)(2010-12#1)
of its performance##3##3##(2006-6#1)(2008-3#2)
of its pharmacological##3##3##(2007-11#1)(2007-2#1)(2009-7#1)
of its phosphorylation##2##3##(1990-11#1)(1994-9#1)
of its physical##2##3##(2010-12#1)(2012-2#1)
of its physiological##2##3##(2008-10#1)(2011-1#1)
of its pivotal role in##2##5##(2007-4#1)(2011-12#1)
of its pivotal##3##3##(1995-8#1)(2007-4#1)(2011-12#1)
of its poor##2##3##(1991-8#1)(2010-12#1)
of its population##2##3##(1997-5#1)(2006-7#1)
of its possible##4##3##(1991-3#1)(1994-6#1)(2006-10#1)(2012-3#1)
of its potential as a##2##5##(2008-1#1)(2008-5#1)
of its potential to##2##4##(2008-10#1)(2012-2#1)
of its potential##16##3##(1996-2#1)(2006-12#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-10#1)(2012-1#1)(2012-2#1)(2013-1#1)
of its practical use##2##4##(2008-2#1)(2008-4#1)
of its precursor##2##3##(1991-7#1)(1995-4#1)
of its presence in##3##4##(2008-4#1)(2008-8#1)(2009-10#1)
of its presence##4##3##(2008-4#1)(2008-8#1)(2009-10#1)(2009-8#1)
of its presentation##2##3##(1991-11#1)(2008-5#1)
of its prevalence##3##3##(2008-6#1)(2011-2#1)(2013-8#1)
of its primary##3##3##(1993-12#1)(2006-5#1)(2012-1#1)
of its principal##2##3##(2008-10#1)(2008-3#1)
of its problems##3##3##(1993-11#1)(1994-9#1)(1997-2#1)
of its processing##2##3##(1992-8#1)(2012-12#1)
of its product##2##3##(1990-11#1)(2011-2#1)
of its products##2##3##(1997-8#1)(2008-10#1)
of its promoter##3##3##(1992-11#1)(1992-4#1)(1994-9#1)
of its properties##5##3##(2008-10#1)(2008-3#1)(2008-5#1)(2010-1#1)(2013-8#1)
of its proposed##2##3##(2008-12#1)(2010-12#1)
of its propyl side chain and carried ring alkoxyl substituents that favor##2##12##(2006-3#2)
of its protein##4##3##(1992-12#1)(1992-6#1)(1995-8#1)(2010-5#1)
of its proteins##2##3##(2008-1#1)(2012-2#1)
of its putative##3##3##(1990-5#1)(2011-12#1)(2011-2#1)
of its rarity and##3##4##(2007-11#1)(2007-8#1)(2011-1#1)
of its rarity##8##3##(2007-11#1)(2007-7#1)(2007-8#1)(2008-12#1)(2010-11#1)(2010-7#1)(2011-1#1)(2012-3#1)
of its reaction with##2##4##(1996-5#1)(2008-10#1)
of its reactive##2##3##(1995-7#1)(2009-3#1)
of its receptor##8##3##(1990-7#1)(1992-9#1)(1994-5#2)(1996-5#1)(1997-6#1)(2009-3#1)(2012-1#1)
of its receptors##3##3##(1994-2#1)(2008-8#2)
of its reference##2##3##(2007-12#1)(2012-2#1)
of its related##3##3##(2005-9#1)(2010-9#1)(2013-7#1)
of its relative##2##3##(2012-3#1)(2013-8#1)
of its relevance to##2##4##(2006-10#1)(2013-7#1)
of its resistance##2##3##(1997-4#1)(2008-10#1)
of its results##2##3##(2007-11#1)(2010-6#1)
of its role in maintaining##2##5##(2010-6#1)(2011-2#1)
of its role in the##3##5##(2005-10#1)(2006-4#1)(2008-10#1)
of its role in##12##4##(1991-12#1)(1994-10#1)(2005-10#1)(2005-11#1)(2006-4#1)(2007-12#1)(2008-10#1)(2009-11#1)(2010-6#1)(2011-2#1)(2013-1#2)
of its role##14##3##(1990-5#1)(1991-12#1)(1994-10#1)(2005-10#1)(2005-11#1)(2006-4#1)(2007-12#1)(2008-10#1)(2009-11#1)(2009-8#1)(2010-6#1)(2011-2#1)(2013-1#2)
of its second##2##3##(1992-6#1)(2008-4#1)
of its secondary##2##3##(1990-5#1)(2005-6#1)
of its sensitivity to##2##4##(1991-8#1)(2007-12#1)
of its sensitivity##3##3##(1991-8#1)(2007-12#1)(2008-9#1)
of its sequence##4##3##(1991-2#1)(1997-4#2)(1997-6#1)
of its services##2##3##(1995-12#1)(2005-5#1)
of its severe##2##3##(1992-9#1)(2006-6#1)
of its short##2##3##(2007-5#1)(2008-10#1)
of its side chain##2##4##(1993-11#1)(2007-12#1)
of its side effects##2##4##(2008-7#1)(2013-1#1)
of its side##4##3##(1993-11#1)(2007-12#1)(2008-7#1)(2013-1#1)
of its side-chain##2##3##(1993-2#1)(1995-5#1)
of its significant##2##3##(2010-7#1)(2011-2#1)
of its simpler##2##3##(2006-11#1)(2007-3#1)
of its simplicity and##3##4##(1996-7#1)(2005-8#1)(2007-7#1)
of its simplicity##6##3##(1991-10#1)(1996-7#1)(2005-8#1)(2007-11#1)(2007-7#1)(2007-8#1)
of its size##3##3##(1996-2#1)(2004-9#1)(2007-8#1)
of its specific##6##3##(1991-2#2)(1996-3#1)(2008-10#2)(2013-7#1)
of its specificity##2##3##(1990-12#1)(1992-9#1)
of its speed and##2##4##(1990-5#1)(2008-4#1)
of its structural homology to##2##5##(1993-3#1)(1993-8#1)
of its structural##5##3##(1992-5#1)(1993-3#1)(1993-8#1)(2008-7#1)(2009-12#1)
of its structure##5##3##(1990-7#1)(1994-3#1)(1997-7#2)(2012-2#1)
of its substrate##3##3##(1994-9#1)(2005-11#1)(2008-7#1)
of its sulfhydryl##2##3##(1992-8#1)(2008-9#1)
of its surface is##2##4##(1991-7#1)(2012-2#1)
of its surface##5##3##(1991-7#1)(1995-2#1)(2007-12#1)(2011-1#1)(2012-2#1)
of its synthesis##2##3##(1992-12#1)(1995-3#1)
of its target cells##2##4##(1993-12#1)(2008-5#1)
of its target##5##3##(1993-12#1)(1994-3#1)(2008-5#1)(2012-12#2)
of its technical##2##3##(1990-9#1)(2009-5#1)
of its therapeutic##3##3##(2007-11#1)(2008-5#1)(2009-3#1)
of its total##2##3##(2008-10#2)
of its transcript##2##3##(1991-5#1)(1992-5#1)
of its transcriptional regulation##2##4##(1992-5#1)(2008-9#1)
of its translocation##2##3##(1992-6#1)(1993-9#1)
of its treatment##3##3##(2005-1#2)(2009-6#1)
of its two##3##3##(1997-6#1)(2006-12#1)(2007-12#1)
of its use as a##2##5##(2008-11#1)(2008-2#1)
of its use by##2##4##(1994-6#1)(2004-10#1)
of its use in the##3##5##(2007-11#2)(2013-8#1)
of its use in##13##4##(2007-11#6)(2008-1#1)(2008-3#1)(2008-8#1)(2009-9#1)(2012-11#1)(2012-2#1)(2013-8#1)
of its use##27##3##(1993-3#1)(1994-6#1)(2004-10#1)(2006-10#1)(2006-8#1)(2007-11#6)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-9#1)(2012-11#1)(2012-2#1)(2013-8#1)
of its usefulness##3##3##(2007-8#1)(2008-2#1)(2009-4#1)
of its value##2##3##(1996-12#1)(2008-2#1)
of its variants##2##3##(1991-8#1)(2012-1#1)
of its various##3##3##(1991-5#1)(2006-10#1)(2010-7#1)
of its vector##4##3##(2006-4#1)(2008-10#2)(2008-8#1)
of its very##2##3##(2010-12#1)(2011-2#1)
of its volatile##2##3##(2007-12#1)(2008-10#1)
of its weight##3##3##(1993-3#1)(2008-5#1)(2008-9#1)
of its##1581##2##(1990-10#2)(1990-11#12)(1990-12#9)(1990-2#5)(1990-3#7)(1990-4#8)(1990-5#14)(1990-6#3)(1990-7#12)(1990-8#3)(1990-9#1)(1991-1#3)(1991-10#5)(1991-11#9)(1991-12#3)(1991-2#12)(1991-3#3)(1991-4#2)(1991-5#11)(1991-6#3)(1991-7#5)(1991-8#8)(1991-9#10)(1992-1#6)(1992-10#4)(1992-11#8)(1992-12#11)(1992-2#7)(1992-3#7)(1992-4#3)(1992-5#7)(1992-6#11)(1992-7#2)(1992-8#7)(1992-9#5)(1993-1#3)(1993-11#4)(1993-12#8)(1993-2#3)(1993-3#4)(1993-4#3)(1993-6#7)(1993-7#1)(1993-8#7)(1993-9#8)(1994-1#1)(1994-10#3)(1994-11#4)(1994-12#15)(1994-2#7)(1994-3#10)(1994-5#7)(1994-6#5)(1994-7#1)(1994-8#5)(1994-9#12)(1995-1#5)(1995-10#1)(1995-11#6)(1995-12#5)(1995-2#15)(1995-3#8)(1995-4#1)(1995-5#8)(1995-6#8)(1995-7#3)(1995-8#8)(1995-9#2)(1996-1#3)(1996-10#4)(1996-11#4)(1996-12#8)(1996-2#7)(1996-3#6)(1996-4#2)(1996-5#11)(1996-6#2)(1996-7#5)(1996-8#6)(1996-9#3)(1997-1#5)(1997-2#10)(1997-3#3)(1997-4#9)(1997-5#5)(1997-6#8)(1997-7#10)(1997-8#5)(2003-11#1)(2004-10#1)(2004-11#1)(2004-12#2)(2004-2#1)(2004-9#2)(2005-1#3)(2005-10#1)(2005-11#12)(2005-12#1)(2005-5#2)(2005-6#2)(2005-7#2)(2005-8#4)(2005-9#3)(2006-1#1)(2006-10#16)(2006-11#6)(2006-12#17)(2006-2#5)(2006-3#5)(2006-4#5)(2006-5#3)(2006-6#11)(2006-7#4)(2006-8#6)(2006-9#2)(2007-1#2)(2007-10#5)(2007-11#37)(2007-12#35)(2007-2#2)(2007-3#7)(2007-4#10)(2007-5#4)(2007-6#4)(2007-7#8)(2007-8#16)(2007-9#10)(2008-1#13)(2008-10#120)(2008-11#35)(2008-12#16)(2008-2#31)(2008-3#40)(2008-4#25)(2008-5#54)(2008-6#14)(2008-7#25)(2008-8#28)(2008-9#25)(2009-1#2)(2009-10#8)(2009-11#4)(2009-12#6)(2009-2#14)(2009-3#4)(2009-4#5)(2009-5#6)(2009-6#5)(2009-7#7)(2009-8#21)(2009-9#4)(2010-1#4)(2010-10#5)(2010-11#3)(2010-12#12)(2010-2#4)(2010-3#1)(2010-4#5)(2010-5#8)(2010-6#5)(2010-7#11)(2010-8#6)(2010-9#5)(2011-1#16)(2011-12#6)(2011-2#47)(2011-3#1)(2012-1#11)(2012-11#3)(2012-12#13)(2012-2#32)(2012-3#18)(2012-8#1)(2013-1#31)(2013-7#11)(2013-8#19)
of itself##8##2##(1990-12#1)(1991-4#1)(1995-2#2)(2008-1#1)(2008-3#1)(2009-4#1)(2011-2#1)
of iv##3##2##(1997-1#2)(2005-7#1)
of ivabradine##2##2##(2008-1#2)
of ivermectin##3##2##(1993-10#2)(2005-7#1)
of ixodid##2##2##(2011-1#2)
of jack bean##2##3##(1990-10#1)(1993-6#1)
of jasmonic acid and##2##4##(2008-10#2)
of jasmonic acid##4##3##(1992-8#1)(2008-10#2)(2009-8#1)
of jaundice##9##2##(1990-8#1)(1991-5#1)(1993-7#2)(1995-3#1)(2006-2#1)(2007-7#1)(2010-9#1)(2012-2#1)
of jaw##6##2##(2007-7#1)(2008-10#2)(2008-7#1)(2012-2#2)
of jejunal##9##2##(1990-5#1)(1990-9#1)(1991-12#2)(1994-6#1)(2005-10#1)(2006-2#1)(2008-7#1)(2013-1#1)
of jejunum##3##2##(1990-9#1)(1996-4#1)(2010-5#1)
of jelly##2##2##(1992-8#1)(2008-8#1)
of jet lag##2##3##(1997-6#2)
of jet##6##2##(1993-6#1)(1997-6#2)(2008-11#1)(2008-4#1)(2011-1#1)
of jitter##2##2##(2007-11#1)(2007-12#1)
of job and##3##3##(1994-6#1)(1997-2#1)(2012-2#1)
of job burnout##2##3##(2008-9#1)(2010-12#1)
of job functions##2##3##(1993-12#2)
of job insecurity##2##3##(2009-10#2)
of job satisfaction##6##3##(1993-2#1)(1994-5#1)(2006-1#1)(2007-4#1)(2008-11#1)(2008-7#1)
of job strain##3##3##(2008-10#3)
of job stress##2##3##(1996-2#1)(2012-1#1)
of job##30##2##(1991-12#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-5#1)(1994-6#1)(1995-2#1)(1996-2#1)(1997-2#1)(2006-1#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-7#1)(2008-9#2)(2009-10#2)(2009-5#1)(2009-9#1)(2010-12#1)(2012-1#1)(2012-2#1)
of job-related##2##2##(2008-12#1)(2010-10#1)
of job-sharing at administrative levels##2##5##(1992-12#2)
of jobs##3##2##(2009-9#3)
of jogging on mental well-being and seasonal mood##2##8##(1991-8#2)
of jogging##4##2##(1991-8#4)
of joining##2##2##(2007-11#1)(2008-2#1)
of joint application of##2##4##(2008-5#2)
of joint attention##3##3##(2008-11#1)(2010-10#1)(2012-1#1)
of joint function##3##3##(1996-6#1)(2007-12#1)(2010-3#1)
of joint pain##3##3##(1992-4#1)(1997-3#1)(2006-10#1)
of joint prostheses##2##3##(1991-5#1)(2009-7#1)
of joint replacement##2##3##(2011-2#2)
of joint surface##2##3##(2006-3#1)(2007-11#1)
of joint tissues##2##3##(2007-11#1)(2011-1#1)
of joint ventures##5##3##(1993-1#1)(2007-1#1)(2008-11#3)
of joint##61##2##(1990-6#1)(1991-5#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-1#2)(1993-3#1)(1995-2#2)(1996-11#1)(1996-6#1)(1997-3#1)(2005-3#1)(2006-10#4)(2006-11#1)(2006-3#1)(2006-7#1)(2007-1#2)(2007-11#8)(2007-12#2)(2007-5#1)(2007-7#1)(2008-11#4)(2008-12#2)(2008-2#2)(2008-5#2)(2009-2#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-3#1)(2013-1#2)(2013-8#1)
of joints and##5##3##(1992-5#1)(2006-10#1)(2007-11#1)(2008-1#1)(2011-2#1)
of joints that##2##3##(2007-12#1)(2012-2#1)
of joints##18##2##(1992-11#1)(1992-5#1)(1996-2#1)(1997-5#1)(2006-10#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-6#1)(2010-3#1)(2011-2#2)(2012-2#1)
of journal##2##2##(2007-10#1)(2008-12#1)
of journals and##3##3##(2006-3#1)(2009-10#1)(2012-2#1)
of journals##4##2##(1991-8#1)(2006-3#1)(2009-10#1)(2012-2#1)
of joy##3##2##(2009-10#2)(2012-11#1)
of judgment and##3##3##(1993-2#1)(2008-6#2)
of judgment##5##2##(1993-2#1)(2008-11#1)(2008-6#2)(2010-7#1)
of judicial##4##2##(2007-10#1)(2007-4#1)(2011-2#1)(2012-3#1)
of jugular venous oxygen saturation##2##5##(2006-10#1)(2006-7#1)
of jugular venous##3##3##(2006-10#1)(2006-7#2)
of jugular##4##2##(2006-10#1)(2006-7#2)(2011-1#1)
of jump##2##2##(1995-2#1)(2009-1#1)
of jun##4##2##(1991-12#2)(1991-2#1)(1991-3#1)
of junD was##2##3##(1996-12#2)
of junD##3##2##(1996-12#3)
of junctional##2##2##(1990-3#1)(1997-9#1)
of junior doctors##2##3##(1990-3#1)(2010-12#1)
of junior high school##2##4##(2009-5#1)(2010-12#1)
of junior##7##2##(1990-12#1)(1990-3#1)(1994-11#1)(2009-5#1)(2010-12#3)
of just a few##2##4##(1993-5#1)(2011-2#1)
of just one##7##3##(1993-11#1)(1995-2#1)(2008-7#1)(2010-6#1)(2010-7#1)(2010-8#1)(2013-8#1)
of just##17##2##(1992-6#1)(1993-11#1)(1993-5#1)(1995-2#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-8#1)
of justice and##4##3##(2009-9#1)(2011-2#1)(2012-2#2)
of justice##9##2##(1996-5#1)(2005-8#1)(2006-7#1)(2008-8#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-2#2)
of justification##2##2##(2009-9#1)(2012-2#1)
of juvenile dermatomyositis##2##3##(2006-10#1)(2007-7#1)
of juvenile hormone##3##3##(2008-7#1)(2008-8#1)(2008-9#1)
of juvenile lemon sharks Negaprion brevirostris##2##6##(2010-8#2)
of juvenile rainbow trout##2##4##(2010-8#2)
of juvenile rheumatoid##2##3##(2007-11#1)(2007-12#1)
of juvenile tilapia (Oreochromis niloticus)##2##5##(2007-3#1)(2013-7#1)
of juvenile walleye pollock Theragra chalcogramma##2##6##(2010-8#2)
of juvenile##45##2##(1992-6#2)(1992-9#1)(1994-8#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#2)(2007-7#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-12#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-8#9)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
of juveniles##8##2##(2004-4#1)(2007-5#1)(2008-10#3)(2008-5#1)(2008-9#2)
of k##7##2##(1995-2#2)(1996-7#1)(2008-2#1)(2008-3#1)(2009-9#1)(2010-2#1)
of k5##2##2##(1997-1#2)
of kDNA##2##2##(2010-2#2)
of kMts##2##2##(1997-6#2)
of kainate##4##2##(1991-5#1)(1994-2#1)(1995-11#1)(1997-1#1)
of kainic acid##9##3##(1990-4#2)(1991-4#3)(1992-8#1)(1995-5#1)(1995-7#1)(2010-10#1)
of kainic##10##2##(1990-4#2)(1991-4#3)(1992-8#1)(1995-5#1)(1995-7#1)(1997-8#1)(2010-10#1)
of kala-azar##3##2##(1996-8#1)(2004-10#1)(2008-7#1)
of kallikrein##5##2##(1991-5#2)(1991-8#1)(1992-2#2)
of kanamycin resistance##3##3##(2008-10#3)
of kanamycin##4##2##(2008-10#3)(2008-7#1)
of kaolinite dispersions##3##3##(2005-11#3)
of kaolinite##8##2##(2005-11#8)
of kappa opioid receptors##2##4##(1993-12#1)(1997-2#1)
of kappa##8##2##(1992-8#1)(1993-12#2)(1995-11#1)(1995-8#1)(1997-2#1)(2006-10#1)(2008-3#1)
of kappa- but not##2##4##(1990-7#1)(1996-12#1)
of kappa-##3##2##(1990-7#1)(1991-1#1)(1996-12#1)
of kappa-carrageenan##2##2##(2008-6#1)(2008-7#1)
of kappa-carrageenan-based##2##2##(2010-4#2)
of kappa-opioid receptors##2##3##(1990-2#1)(1993-3#1)
of kappa-opioid##5##2##(1990-2#1)(1993-3#1)(1995-3#1)(1997-2#2)
of karyotype##3##2##(2008-11#1)(2008-12#1)(2008-5#1)
of karyotypic##2##2##(2007-10#1)(2012-3#1)
of katE##2##2##(1997-5#2)
of kawasaki disease##2##3##(2011-2#1)(2012-12#1)
of kcat##6##2##(1990-7#2)(1993-6#1)(1994-9#1)(1995-11#1)(1996-7#1)
of kcat/Km##2##2##(1994-8#1)(1995-10#1)
of keeping mothers and their babies together##2##7##(2007-2#2)
of keeping mothers and##3##4##(2007-2#2)(2008-6#1)
of keeping##9##2##(1991-2#1)(2006-7#1)(2007-12#1)(2007-2#2)(2008-2#1)(2008-6#1)(2010-4#1)(2013-8#1)
of keloid##5##2##(2007-7#2)(2012-2#3)
of keloids##3##2##(2010-8#1)(2012-12#1)(2012-2#1)
of kenkey##6##2##(1997-4#6)
of kepone in seawater##2##4##(2012-12#2)
of kepone##4##2##(2012-12#4)
of keratin##14##2##(1991-12#1)(1997-7#1)(2007-9#1)(2008-11#1)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-11#2)(2012-3#1)
of keratinized##2##2##(1990-3#2)
of keratinocyte differentiation##4##3##(1994-3#1)(2008-11#1)(2008-5#2)
of keratinocyte##9##2##(1992-2#1)(1994-3#2)(1996-6#1)(2008-11#1)(2008-5#2)(2010-12#1)(2013-8#1)
of keratinocytes and##2##3##(2008-5#1)(2010-3#1)
of keratinocytes##12##2##(1996-6#1)(2006-12#1)(2008-4#2)(2008-5#4)(2010-3#2)(2012-8#1)(2013-8#1)
of keratinophilic##3##2##(2012-11#1)(2013-1#2)
of keratins##2##2##(2008-5#1)(2012-11#1)
of keratoconus##2##2##(2005-11#1)(2011-1#1)
of keratoglobus lesions in##2##4##(2008-5#2)
of keratomycosis by##2##3##(2007-7#1)(2009-8#1)
of keratomycosis##4##2##(2007-7#1)(2009-8#2)(2012-12#1)
of keratosis##2##2##(2011-2#2)
of keratotic##2##2##(1995-5#1)(2007-11#1)
of kernel density clustering for##2##5##(2008-7#2)
of kernel##7##2##(2008-10#4)(2008-3#1)(2008-7#2)
of kernels infected##2##3##(2008-10#2)
of kernels##6##2##(2008-10#4)(2008-3#2)
of kernicterus##4##2##(1990-1#2)(1990-8#1)(2009-1#1)
of kerosene##4##2##(2006-7#1)(2008-10#1)(2008-11#2)
of ketamine and##4##3##(2008-10#1)(2009-6#1)(2013-1#2)
of ketamine as an##2##4##(2006-10#2)
of ketamine for##2##3##(1996-8#1)(2006-4#1)
of ketamine in##8##3##(2007-2#1)(2009-5#2)(2010-2#1)(2011-2#3)(2012-2#1)
of ketamine##32##2##(1996-8#2)(2006-10#3)(2006-4#2)(2007-2#4)(2008-10#2)(2009-5#4)(2009-6#1)(2010-2#1)(2010-7#1)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#3)
of ketanserin##3##2##(1991-4#1)(1995-3#1)(2013-7#1)
of ketoacidosis##3##2##(2006-1#2)(2009-6#1)
of ketoconazole and MK 571##2##5##(2007-11#2)
of ketoconazole##8##2##(2007-11#2)(2007-7#3)(2008-11#2)(2011-2#1)
of ketone bodies##2##3##(2008-5#1)(2011-2#1)
of ketone##3##2##(2008-5#2)(2011-2#1)
of ketones##4##2##(2007-11#2)(2008-12#1)(2010-7#1)
of ketoprofen##6##2##(1992-11#1)(1994-3#1)(2008-10#2)(2011-1#1)(2012-3#1)
of ketorolac in##2##3##(1990-2#1)(2008-10#1)
of ketorolac was##2##3##(2008-10#2)
of ketorolac##8##2##(1990-2#3)(2008-10#5)
of ketotifen##3##2##(2010-2#2)(2010-6#1)
of key amino##2##3##(2006-11#1)(2011-2#1)
of key articles were searched##5##5##(2012-12#5)
of key articles##8##3##(2012-12#8)
of key components##3##3##(1996-2#1)(2008-5#1)(2010-2#1)
of key elements##3##3##(2008-10#1)(2012-1#1)(2012-3#1)
of key enzymes in##2##4##(2008-10#1)(2011-2#1)
of key enzymes involved in##3##5##(1990-2#1)(2008-11#1)(2011-2#1)
of key enzymes##8##3##(1990-2#1)(2005-11#2)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#2)
of key factors##2##3##(1990-12#1)(2008-3#1)
of key genes##3##3##(2006-10#1)(2009-8#1)(2013-7#1)
of key importance in##2##4##(1994-8#1)(2006-10#1)
of key importance##5##3##(1994-8#2)(2006-10#1)(2008-2#1)(2008-3#1)
of key inflammatory##2##3##(2006-2#1)(2013-1#1)
of key informants##3##3##(2010-8#1)(2012-11#1)(2013-1#1)
of key metabolic##3##3##(1994-8#1)(2008-11#1)(2009-4#1)
of key molecules##3##3##(2008-1#1)(2008-5#1)(2013-1#1)
of key personnel##2##3##(1990-10#1)(2008-10#1)
of key phospholipid synthesis##2##4##(2011-2#2)
of key regulatory proteins##3##4##(2008-2#1)(2008-4#1)(2009-8#1)
of key regulatory##4##3##(2008-2#1)(2008-4#1)(2009-3#1)(2009-8#1)
of key signalling##2##3##(2008-4#1)(2009-5#1)
of key stakeholders##2##3##(1991-1#1)(1991-3#1)
of key structural##2##3##(2009-12#1)(2012-2#1)
of key##129##2##(1990-10#1)(1990-12#1)(1990-2#1)(1991-1#1)(1991-3#2)(1992-8#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-8#3)(1995-12#1)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-9#1)(1997-7#1)(2005-11#2)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2007-12#5)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#7)(2008-7#2)(2008-8#4)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-8#2)(2009-9#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#4)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#10)(2012-2#3)(2012-3#1)(2013-1#9)(2013-7#2)
of keyword##2##2##(2010-12#2)
of khat chewing##3##3##(2006-8#3)
of khat##4##2##(2006-8#4)
of khebab##2##2##(2007-2#2)
of kidney allografts##3##3##(1995-11#1)(1995-2#2)
of kidney biopsy##2##3##(1996-6#1)(2008-1#1)
of kidney cancer##2##3##(2008-6#1)(2011-2#1)
of kidney damage##3##3##(1990-2#1)(1990-4#1)(1992-3#1)
of kidney disease##6##3##(2007-7#1)(2008-1#2)(2008-7#1)(2011-11#1)(2013-1#1)
of kidney diseases in##2##4##(2007-2#1)(2008-1#1)
of kidney diseases##3##3##(2007-2#1)(2008-1#2)
of kidney dysfunction##2##3##(2007-8#1)(2013-1#1)
of kidney failure##2##3##(2007-8#1)(2011-2#1)
of kidney function##5##3##(1992-12#1)(2011-11#1)(2011-12#1)(2012-2#1)(2013-7#1)
of kidney in##4##3##(1997-8#1)(2008-12#2)(2008-4#1)
of kidney stones##4##3##(2006-9#1)(2008-12#1)(2010-12#1)(2013-8#1)
of kidney transplant patients##2##4##(1994-5#1)(2007-8#1)
of kidney transplant##6##3##(1994-5#1)(2007-8#2)(2008-5#1)(2010-12#1)(2013-1#1)
of kidney##87##2##(1990-2#1)(1990-4#1)(1991-11#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#2)(1996-6#1)(1997-1#1)(1997-8#1)(2004-11#2)(2006-6#1)(2006-9#1)(2007-2#4)(2007-5#1)(2007-7#1)(2007-8#6)(2008-1#6)(2008-10#1)(2008-12#5)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#2)(2009-2#3)(2010-11#1)(2010-12#3)(2010-4#1)(2011-1#2)(2011-11#2)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#4)(2013-7#2)(2013-8#2)
of kidneys from##2##3##(2006-10#1)(2011-2#1)
of kidneys##9##2##(1997-8#1)(2006-10#2)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#1)
of killed##2##2##(2008-1#1)(2010-2#1)
of killer##3##2##(1994-10#1)(2007-11#2)
of killing##5##2##(1990-12#1)(1993-12#1)(1995-2#1)(2006-12#1)(2008-11#1)
of kilojoules) diet##2##3##(1991-2#2)
of kilometers##5##2##(1991-8#1)(2007-12#2)(2008-10#1)(2008-9#1)
of kin selection and##2##4##(2009-4#1)(2010-4#1)
of kin selection##5##3##(2006-7#2)(2008-8#1)(2009-4#1)(2010-4#1)
of kin##7##2##(1993-6#1)(2006-4#1)(2006-7#2)(2008-8#1)(2009-4#1)(2010-4#1)
of kinase C##2##3##(1991-1#1)(1992-12#1)
of kinase activity##3##3##(1993-8#1)(1996-5#1)(2009-3#1)
of kinase inhibitors##2##3##(1993-11#1)(2008-5#1)
of kinase##11##2##(1990-4#1)(1991-1#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-8#1)(1996-5#1)(2008-5#2)(2009-3#1)(2012-12#1)
of kinases##6##2##(1993-2#1)(2005-7#1)(2006-10#2)(2008-10#2)
of kindergarten##3##2##(1997-3#1)(2008-11#1)(2012-12#1)
of kindled##4##2##(1991-5#1)(1991-6#1)(1997-5#2)
of kindling##5##2##(1992-9#1)(1993-12#1)(1993-2#1)(1994-2#1)(1997-2#1)
of kinematic focusing was##2##4##(2008-10#2)
of kinematic focusing##3##3##(2008-10#3)
of kinematic##7##2##(1993-3#1)(1996-4#1)(2006-11#1)(2008-10#3)(2012-1#1)
of kinesitherapy complemented by thermotherapy##2##5##(2007-8#2)
of kinesitherapy in##2##3##(2007-11#1)(2007-8#1)
of kinesitherapy##6##2##(2007-11#2)(2007-8#4)
of kinetic and thermodynamic##2##4##(2008-4#1)(2010-9#1)
of kinetic and##5##3##(1990-8#1)(1995-10#1)(2008-4#1)(2008-8#1)(2010-9#1)
of kinetic constants##2##3##(1992-7#1)(1993-6#1)
of kinetic equations##2##3##(2008-10#1)(2010-9#1)
of kinetic experiments##2##3##(1994-3#1)(2008-4#1)
of kinetic models##2##3##(1991-5#1)(2006-10#1)
of kinetic parameters of##2##4##(1990-11#1)(1997-2#1)
of kinetic parameters##6##3##(1990-11#1)(1991-5#1)(1992-8#1)(1995-12#1)(1997-2#1)(2008-7#1)
of kinetic##37##2##(1990-11#1)(1990-6#1)(1990-8#1)(1991-5#2)(1991-7#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-10#2)(1995-12#1)(1995-6#1)(1996-10#1)(1997-2#1)(2006-10#4)(2007-4#2)(2007-6#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-9#2)
of kinetically-hindered##2##2##(2008-10#2)
of kinetics##3##2##(1993-2#1)(1994-11#1)(2008-5#1)
of kinetochores##2##2##(2008-8#2)
of kinin##4##2##(1990-1#1)(1996-5#1)(2006-10#1)(2007-11#1)
of kinins##3##2##(1990-12#1)(2006-10#2)
of kisspeptins##2##2##(2009-6#1)(2011-12#1)
of knee OA##2##3##(1992-3#2)
of knee and ankle##2##4##(2009-4#1)(2012-2#1)
of knee and##5##3##(1995-8#1)(2006-11#2)(2009-4#1)(2012-2#1)
of knee evaluation##2##3##(2013-1#2)
of knee flexion##5##3##(2007-7#1)(2009-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
of knee joint sarcomas##2##4##(2008-7#2)
of knee joint##7##3##(1994-12#1)(2007-8#1)(2008-1#1)(2008-7#3)(2012-1#1)
of knee joints##3##3##(2007-11#1)(2011-1#1)(2011-2#1)
of knee osteoarthritis##6##3##(2006-10#1)(2007-5#1)(2010-12#1)(2011-1#2)(2013-1#1)
of knee pain##3##3##(2006-10#2)(2011-1#1)
of knee prostheses##2##3##(2007-8#2)
of knee surgery##2##3##(2007-8#2)
of knee##58##2##(1992-3#2)(1994-12#1)(1995-3#1)(1995-8#1)(2006-10#3)(2006-11#2)(2007-1#1)(2007-10#1)(2007-11#7)(2007-2#1)(2007-4#3)(2007-5#2)(2007-7#1)(2007-8#5)(2008-1#1)(2008-5#2)(2008-7#3)(2009-3#1)(2009-4#1)(2010-12#1)(2011-1#4)(2011-2#4)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#5)
of knees##4##2##(2007-7#1)(2008-5#1)(2012-2#1)(2013-1#1)
of knockout mice deficient in##2##5##(2006-10#1)(2008-4#1)
of knockout mice##4##3##(2005-8#1)(2006-10#1)(2008-2#1)(2008-4#1)
of knockout##5##2##(2005-8#1)(2006-10#1)(2006-11#1)(2008-2#1)(2008-4#1)
of knot##2##2##(1995-1#1)(2008-2#1)
of knots##3##2##(2006-4#3)
of knowing##7##2##(1993-3#1)(1997-3#1)(1997-6#1)(2007-2#2)(2008-1#1)(2008-12#1)
of knowledge about HIV##2##4##(2005-10#1)(2012-12#1)
of knowledge about the##11##4##(1993-10#1)(1996-11#1)(2004-10#1)(2007-1#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-11#1)(2010-5#1)(2011-2#1)
of knowledge about##31##3##(1991-2#1)(1992-6#1)(1993-10#1)(1994-11#1)(1994-2#1)(1996-11#1)(2004-10#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
of knowledge across##2##3##(2008-11#1)(2010-12#1)
of knowledge and experience##2##4##(2007-6#1)(2008-1#1)
of knowledge and skills##3##4##(2006-12#1)(2009-6#1)(2011-2#1)
of knowledge and the##2##4##(2007-11#1)(2007-4#1)
of knowledge and##35##3##(1990-6#1)(1991-9#1)(1993-12#1)(1995-2#2)(1995-6#1)(1996-2#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#2)
of knowledge for##4##3##(2008-11#1)(2008-2#2)(2009-4#1)
of knowledge from the##3##4##(1994-6#1)(1997-8#1)(2008-11#1)
of knowledge has##2##3##(1990-10#1)(1994-5#1)
of knowledge in the##5##4##(1997-8#1)(2006-12#1)(2011-2#1)(2013-1#2)
of knowledge in##14##3##(1997-8#2)(2006-12#1)(2006-9#1)(2007-4#1)(2008-10#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-11#1)(2013-1#4)
of knowledge is##3##3##(1991-9#1)(2009-8#1)(2012-1#1)
of knowledge of the##6##4##(2007-12#1)(2007-3#1)(2008-10#1)(2008-8#1)(2009-4#1)(2013-1#1)
of knowledge of##20##3##(1990-3#1)(1993-2#1)(1995-11#1)(2005-1#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)
of knowledge on the##5##4##(1990-8#1)(1995-11#1)(2007-11#1)(2008-10#1)(2008-11#1)
of knowledge on##14##3##(1990-8#1)(1995-11#1)(1995-9#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-7#1)
of knowledge regarding the##8##4##(2007-11#3)(2008-12#1)(2010-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
of knowledge regarding##13##3##(2007-11#3)(2008-12#1)(2009-6#1)(2009-8#1)(2010-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
of knowledge that##2##3##(2012-1#1)(2013-8#1)
of knowledge to##5##3##(1996-6#1)(2010-7#1)(2011-12#1)(2011-2#2)
of knowledge transfer##2##3##(2006-12#1)(2008-11#1)
of knowledge translation##3##3##(2008-12#1)(2011-1#2)
of knowledge with different##2##4##(2011-1#2)
of knowledge with##3##3##(2011-1#2)(2013-8#1)
of knowledge##233##2##(1990-10#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-9#2)(1992-11#1)(1992-6#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-8#5)(2004-10#2)(2005-1#1)(2005-10#3)(2005-8#1)(2005-9#1)(2006-10#6)(2006-12#5)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#6)(2007-12#4)(2007-2#4)(2007-3#1)(2007-4#3)(2007-5#3)(2007-6#2)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#13)(2008-12#6)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#5)(2009-10#1)(2009-11#1)(2009-4#2)(2009-6#2)(2009-8#3)(2010-1#1)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#11)(2011-12#1)(2011-2#13)(2012-1#4)(2012-11#3)(2012-12#5)(2012-2#6)(2012-3#3)(2013-1#16)(2013-7#2)(2013-8#3)
of known amounts of##2##4##(2008-10#2)
of known and putative##2##4##(1991-3#1)(2011-2#1)
of known and##5##3##(1991-3#1)(2007-12#1)(2011-2#1)(2012-3#1)(2013-7#1)
of known bacterial##2##3##(2008-7#2)
of known composition##2##3##(2008-10#1)(2008-3#1)
of known concentration##2##3##(2008-10#2)
of known genes##3##3##(1994-12#1)(1995-5#1)(2010-3#1)
of known glutathionylated proteins##2##4##(2009-10#2)
of known index##2##3##(1993-9#1)(2008-3#1)
of known or suspected##3##4##(1991-12#1)(2004-11#1)(2008-1#1)
of known or##6##3##(1991-12#1)(1994-9#1)(2004-11#1)(2008-1#1)(2008-10#1)(2008-4#1)
of known risk factors##2##4##(2006-8#1)(2010-11#1)
of known sequence##2##3##(1990-7#1)(2008-10#1)
of known shape##2##3##(2008-2#1)(2008-3#1)
of known structure and##2##4##(1994-6#1)(2008-4#1)
of known structure##4##3##(1992-12#1)(1994-6#1)(2008-4#2)
of known three-dimensional##4##3##(1992-1#1)(1994-2#1)(1994-8#1)(2008-7#1)
of known##150##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-7#1)(1991-10#2)(1991-12#3)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#3)(1992-12#1)(1992-7#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-3#1)(1995-5#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(2004-11#1)(2004-7#1)(2005-12#1)(2006-10#1)(2006-5#1)(2006-8#2)(2007-10#2)(2007-11#4)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#18)(2008-11#4)(2008-2#8)(2008-3#8)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#1)(2009-10#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#1)(2010-11#2)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-2#2)(2012-3#2)(2013-7#2)
of koilocytes##2##2##(2008-4#1)(2011-2#1)
of kojic acid##4##3##(2008-5#2)(2012-12#2)
of kolkata##2##2##(2009-10#2)
of komaroviquinone##2##2##(2009-5#2)
of kraft lignin##5##3##(2005-11#5)
of kraft##6##2##(2005-11#6)
of kringle 1 + 2 + 3##3##7##(1990-5#3)
of kringle 1##4##3##(1990-5#4)
of kringle##5##2##(1990-5#4)(2008-8#1)
of kynurenic acid##7##3##(1992-3#2)(1993-7#1)(1996-3#4)
of kynurenine##2##2##(1992-3#1)(1996-3#1)
of kyphotic##2##2##(2007-11#1)(2012-2#1)
of l##2##2##(2008-2#1)(2011-12#1)
of l- and##3##3##(1993-2#1)(2008-10#2)
of l-2-HGA##3##2##(2008-10#3)
of l-2-hydroxyglutaric acid##2##3##(2008-10#2)
of l-2-hydroxyglutaric##3##2##(2008-10#3)
of l-ascorbic acid in##3##4##(2008-10#3)
of l-ascorbic acid##14##3##(2008-10#14)
of l-carnitine##4##2##(2008-10#4)
of l-carnosine##2##2##(2011-1#2)
of l-cysteine and glutathione##3##4##(2008-10#3)
of l-cysteine and##7##3##(2008-10#7)
of l-cysteine##18##2##(2008-10#18)
of l-cystine##2##2##(2008-10#2)
of l-dT##2##2##(2008-4#2)
of l-glutamate##5##2##(2008-10#5)
of l-histidine##3##2##(2008-10#3)
of l-malic acid with alkaline metals##2##6##(2008-10#2)
of l-phenylalanine##3##2##(2008-10#3)
of l-tyrosine##4##2##(2008-10#4)
of lab##3##2##(1994-8#1)(2008-1#1)(2010-8#1)
of label##10##2##(1990-12#1)(1992-12#1)(1992-9#1)(1994-9#1)(1995-12#1)(1997-8#1)(2008-7#2)(2008-8#1)(2011-2#1)
of labeled and unlabeled##2##4##(2008-2#1)(2008-4#1)
of labeled neurons##2##3##(1996-9#1)(2009-2#1)
of labeled peptides##2##3##(1990-7#1)(2009-12#1)
of labeled polypeptides##2##3##(1994-11#2)
of labeled##59##2##(1990-12#1)(1990-7#1)(1990-9#2)(1991-1#1)(1991-9#1)(1992-8#1)(1993-3#3)(1993-9#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-9#2)(1997-1#7)(1997-3#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#9)(2008-5#1)(2009-12#1)(2009-2#2)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#6)
of labeling of the##2##4##(1990-11#1)(1997-3#1)
of labeling of##3##3##(1990-11#1)(1995-11#1)(1997-3#1)
of labeling was##3##3##(1994-5#1)(1994-8#1)(1997-2#1)
of labeling##18##2##(1990-11#1)(1990-2#1)(1991-8#1)(1994-5#1)(1994-8#1)(1995-11#2)(1996-4#1)(1997-2#1)(1997-3#2)(2007-8#1)(2008-2#1)(2008-4#2)(2008-7#1)(2009-9#1)(2013-1#1)
of labelled cells##4##3##(1992-10#1)(1994-12#1)(1995-12#1)(2007-9#1)
of labelled lactic acid##2##4##(1996-9#2)
of labelled##25##2##(1990-11#1)(1990-12#3)(1990-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-9#2)(1997-5#1)(1997-6#1)(1997-8#2)(2006-12#1)(2007-9#2)(2008-7#1)
of labelling in the##2##4##(1992-10#1)(1993-9#1)
of labelling##10##2##(1990-3#1)(1990-8#1)(1992-10#2)(1993-9#1)(1995-2#1)(2008-7#1)(2010-4#1)(2010-7#1)(2012-11#1)
of labels and##2##3##(1992-3#1)(2007-8#1)
of labels##13##2##(1992-3#1)(1994-3#1)(1994-6#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-4#2)(2011-1#1)(2013-1#2)
of labia##2##2##(2007-10#1)(2008-10#1)
of labial##3##2##(2006-10#1)(2006-4#1)(2007-12#1)
of labile Cu(2+) in fresh waters##2##6##(2008-10#2)
of labile##13##2##(1991-1#2)(2007-12#1)(2007-8#2)(2008-10#5)(2008-4#1)(2009-3#1)(2013-7#1)
of labor and birth##2##4##(2008-6#1)(2010-9#1)
of labor and delivery on fibrinolysis##2##6##(1994-6#2)
of labor and delivery##3##4##(1994-6#3)
of labor and##6##3##(1994-6#4)(2008-6#1)(2010-9#1)
of labor at term##2##4##(1994-6#1)(2009-2#1)
of labor in the##4##4##(2006-2#1)(2007-2#1)(2008-12#1)(2008-9#1)
of labor in##7##3##(2006-2#1)(2007-2#1)(2008-12#1)(2008-8#3)(2008-9#1)
of labor##47##2##(1991-6#3)(1994-2#2)(1994-6#8)(1994-9#1)(1995-1#1)(1996-1#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-2#7)(2008-11#2)(2008-12#1)(2008-6#3)(2008-8#6)(2008-9#1)(2009-2#1)(2010-9#1)(2011-2#1)(2013-1#3)
of laboratories##11##2##(1993-6#1)(1994-12#1)(1994-6#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#1)(2009-4#1)
of laboratory and##3##3##(2007-11#1)(2008-11#1)(2010-5#1)
of laboratory animals and to##3##5##(2008-10#1)(2008-4#2)
of laboratory animals##8##3##(1993-8#1)(2006-10#1)(2008-10#2)(2008-4#4)
of laboratory automation and other resources##2##6##(2008-10#2)
of laboratory automation and##3##4##(2008-10#3)
of laboratory conditions##2##3##(1996-12#1)(2013-8#1)
of laboratory data##2##3##(1995-4#1)(2012-2#1)
of laboratory diagnosis##2##3##(2008-7#1)(2012-3#1)
of laboratory examinations##2##3##(1990-12#1)(2008-1#1)
of laboratory experiments##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
of laboratory findings##2##3##(1994-12#1)(2007-1#1)
of laboratory investigations##2##3##(2008-11#1)(2008-7#1)
of laboratory medicine##9##3##(1993-6#1)(1994-12#4)(1995-5#3)(2008-5#1)
of laboratory methods##2##3##(2005-7#1)(2008-1#1)
of laboratory mice##2##3##(1990-12#1)(2008-4#1)
of laboratory or##2##3##(1994-12#1)(2011-2#1)
of laboratory rats##2##3##(1991-10#1)(1992-12#1)
of laboratory results##2##3##(2007-9#1)(2012-12#1)
of laboratory rodents##2##3##(2005-8#1)(2008-4#1)
of laboratory services##2##3##(1993-2#1)(1994-3#1)
of laboratory staff##2##3##(2005-12#1)(2012-2#1)
of laboratory strains of##2##4##(2010-12#1)(2012-3#1)
of laboratory strains##3##3##(2010-12#1)(2012-3#2)
of laboratory studies##2##3##(2008-9#1)(2010-8#1)
of laboratory techniques##2##3##(2008-7#1)(2013-1#1)
of laboratory testing##5##3##(1994-12#1)(2006-10#1)(2008-10#1)(2008-9#1)(2013-1#1)
of laboratory tests are##2##4##(1997-5#1)(2008-7#1)
of laboratory tests##11##3##(1991-2#1)(1994-12#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-3#1)(1997-5#1)(2005-11#1)(2005-5#1)(2008-7#1)(2009-4#1)
of laboratory##111##2##(1990-12#2)(1990-9#1)(1991-10#1)(1991-2#1)(1991-8#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#9)(1994-3#1)(1994-6#1)(1995-4#1)(1995-5#3)(1996-1#1)(1996-12#1)(1996-2#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#2)(1997-5#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#2)(2006-10#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#3)(2008-3#2)(2008-4#7)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#5)(2009-4#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#2)
of laboratory-confirmed##2##2##(2012-1#1)(2013-1#1)
of labour and epidural##2##4##(2004-10#2)
of labour and##3##3##(2004-10#2)(2013-1#1)
of labour in##6##3##(1992-1#1)(1995-4#1)(2007-7#1)(2008-10#1)(2009-7#1)(2011-1#1)
of labour is##3##3##(1992-1#1)(1994-8#2)
of labour##28##2##(1992-1#3)(1993-4#2)(1993-8#1)(1994-8#2)(1995-4#1)(1996-12#1)(2004-10#4)(2006-2#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-7#1)(2010-3#1)(2011-1#2)(2012-12#1)(2013-1#1)(2013-8#1)
of lacZ expression##2##3##(1995-6#1)(1997-8#1)
of lacZ gene##3##3##(1991-7#1)(1991-8#1)(1996-3#1)
of lacZ##16##2##(1990-5#2)(1991-7#1)(1991-8#1)(1991-9#1)(1993-12#3)(1995-6#1)(1996-3#1)(1997-1#1)(1997-4#3)(1997-8#1)(2009-12#1)
of laccase and 0##2##4##(2008-5#2)
of laccase##6##2##(1992-12#1)(2005-11#1)(2008-10#2)(2008-5#2)
of lack of##14##3##(1995-11#1)(1996-3#1)(1997-2#1)(1997-6#1)(2004-10#1)(2005-11#1)(2006-4#1)(2006-9#1)(2007-12#1)(2007-8#1)(2008-5#1)(2009-12#1)(2011-2#1)(2013-8#1)
of lacking##7##2##(1990-10#1)(2008-10#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-8#2)
of lacquer##3##2##(2004-12#2)(2008-10#1)
of lacrimal gland##2##3##(2007-1#1)(2013-8#1)
of lacrimal##3##2##(1994-7#1)(2007-1#1)(2013-8#1)
of lactase##6##2##(1992-11#4)(2012-12#1)(2013-1#1)
of lactate accumulation##2##3##(2008-10#1)(2008-11#1)
of lactate and##3##3##(1994-9#1)(2008-11#1)(2012-3#1)
of lactate dehydrogenase (LDH) in##2##5##(1996-11#1)(2010-4#1)
of lactate dehydrogenase (LDH) into the##2##6##(1995-11#1)(1995-3#1)
of lactate dehydrogenase (LDH)##9##4##(1991-10#1)(1992-8#1)(1994-11#1)(1995-11#1)(1995-3#1)(1996-11#1)(1996-4#1)(2010-4#1)(2013-1#1)
of lactate dehydrogenase and##2##4##(1992-5#1)(1992-8#1)
of lactate dehydrogenase in##3##4##(1995-11#1)(2010-4#1)(2013-8#1)
of lactate dehydrogenase##22##3##(1990-5#1)(1991-10#1)(1992-11#1)(1992-5#1)(1992-7#1)(1992-8#2)(1993-12#2)(1994-11#1)(1995-11#3)(1995-3#1)(1996-11#1)(1996-4#1)(2008-10#1)(2008-7#1)(2010-4#2)(2013-1#1)(2013-8#1)
of lactate in whole##2##4##(2008-10#2)
of lactate production from##2##4##(1990-11#1)(1991-5#1)
of lactate production##5##3##(1990-11#1)(1991-5#3)(1992-4#1)
of lactate##48##2##(1990-11#1)(1990-5#1)(1991-1#2)(1991-10#1)(1991-5#3)(1992-11#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#2)(1993-12#2)(1994-11#2)(1994-9#2)(1995-11#3)(1995-3#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-9#1)(2006-8#2)(2007-7#1)(2008-10#5)(2008-11#4)(2008-7#1)(2009-8#1)(2010-4#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
of lactating cows##2##3##(2004-11#1)(2007-8#1)
of lactating goats##2##3##(1992-3#1)(2010-2#1)
of lactating mothers##2##3##(1992-7#1)(2008-8#1)
of lactating##9##2##(1990-7#1)(1992-3#1)(1992-7#1)(1994-6#1)(1996-6#1)(2004-11#1)(2007-8#1)(2008-8#1)(2010-2#1)
of lactation and##2##3##(1997-6#1)(2011-2#1)
of lactation in pinnipeds##2##4##(2008-9#2)
of lactation in##3##3##(1992-5#1)(2008-9#2)
of lactation##16##2##(1992-5#2)(1992-7#1)(1995-12#1)(1996-8#1)(1997-6#1)(2007-2#1)(2008-9#3)(2010-2#1)(2011-2#1)(2012-1#3)(2012-2#1)
of lactic acid bacteria##7##4##(2007-8#1)(2008-11#5)(2012-2#1)
of lactic acid by##2##4##(2008-6#2)
of lactic acid from cheese whey##4##6##(2008-5#2)(2008-6#2)
of lactic acid produced##2##4##(2008-6#2)
of lactic acid to##4##4##(2008-5#1)(2008-6#1)(2012-2#2)
of lactic acid##34##3##(2004-8#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#5)(2008-5#3)(2008-6#13)(2008-7#1)(2012-2#3)(2013-1#1)
of lactic acidosis##6##3##(1994-4#1)(2005-10#1)(2007-11#3)(2009-8#1)
of lactic and##2##3##(2008-5#2)
of lactic dehydrogenase##3##3##(1990-5#2)(1990-7#1)
of lactic##47##2##(1990-5#2)(1990-7#1)(1994-4#1)(2004-8#1)(2005-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#5)(2008-5#5)(2008-6#14)(2008-7#1)(2009-8#1)(2012-2#3)(2013-1#1)
of lactobacilli##5##2##(1994-6#1)(2006-10#1)(2007-8#1)(2009-9#1)(2012-2#1)
of lactobacillus##3##2##(2008-12#1)(2009-9#1)(2012-2#1)
of lactocepin I##2##3##(2005-12#2)
of lactoferrin##8##2##(1990-7#1)(1994-12#1)(1996-5#5)(2008-10#1)
of lactogenic##2##2##(1995-11#1)(1997-6#1)
of lactone##2##2##(2006-12#2)
of lactose and##2##3##(2008-10#1)(2008-11#1)
of lactose##4##2##(1995-1#1)(2008-10#2)(2008-11#1)
of lactotransferrin##2##2##(1992-9#2)
of lacunar infarct in patients without hypertension##2##7##(2007-10#2)
of lacunar infarcts##4##3##(2007-10#3)(2007-9#1)
of lacunar##7##2##(2007-10#6)(2007-9#1)
of lacustrine##3##2##(2008-5#3)
of lag##5##2##(2008-11#1)(2011-2#4)
of lake##3##2##(2005-11#1)(2012-3#1)(2013-8#1)
of lakes##2##2##(1991-8#1)(2008-5#1)
of lamb meat##3##3##(2010-4#3)
of lamb##6##2##(1994-4#1)(1997-4#1)(2010-4#4)
of lambda =##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
of lambda DNA##2##3##(1994-11#2)
of lambda phage##2##3##(1994-12#1)(1995-8#1)
of lambda plasmid##3##3##(1994-11#3)
of lambda repressor##2##3##(1991-6#1)(1995-8#1)
of lambda were##2##3##(2010-2#2)
of lambda##24##2##(1990-5#1)(1991-6#1)(1992-2#2)(1992-5#1)(1992-6#1)(1994-11#5)(1994-12#1)(1995-8#2)(1996-6#1)(1997-1#1)(1997-8#1)(2007-12#1)(2008-2#2)(2008-3#1)(2010-2#3)
of lambda-DNA##3##2##(2008-8#3)
of lambda-cyhalothrin in tea and soil were##2##7##(2011-1#2)
of lambda-cyhalothrin residue##2##3##(2011-1#2)
of lambda-cyhalothrin##4##2##(2011-1#4)
of lambdaN gene expression##2##4##(2008-8#1)(2008-9#1)
of lambdaN gene##10##3##(2008-8#8)(2008-9#2)
of lambdaN##11##2##(2008-8#9)(2008-9#2)
of lambdacyhalothrin##2##2##(2005-8#1)(2008-8#1)
of lambs fed##2##3##(2008-12#1)(2010-4#1)
of lambs##9##2##(1994-7#1)(1996-12#1)(2005-7#2)(2006-5#1)(2008-10#1)(2008-12#1)(2010-4#2)
of lamellae in the##2##4##(2008-7#2)
of lamellae##6##2##(2008-7#5)(2013-1#1)
of lamellar##9##2##(1990-5#2)(1991-2#1)(1995-8#1)(1996-11#2)(1997-6#1)(2006-10#1)(2009-3#1)
of lamellipodia##2##2##(1995-6#2)
of lamellipodial and filopodial##2##4##(1994-11#2)
of lamellulae between##3##3##(2010-10#3)
of lameness and##2##3##(1994-9#1)(1997-3#1)
of lameness##4##2##(1994-9#1)(1997-3#2)(2005-7#1)
of lamin A##2##3##(1990-11#2)
of lamin##3##2##(1990-11#2)(2011-2#1)
of lamina propria##3##3##(2008-11#1)(2009-2#1)(2011-2#1)
of lamina##6##2##(1993-2#1)(1995-6#1)(1997-3#1)(2008-11#1)(2009-2#1)(2011-2#1)
of laminar##3##2##(1991-11#1)(1993-12#1)(2010-9#1)
of laminin 332##3##3##(2013-8#3)
of laminin##18##2##(1990-7#2)(1991-2#1)(1992-5#1)(1994-5#1)(1994-9#1)(1995-5#1)(1995-6#3)(1996-11#1)(1996-8#1)(1997-4#1)(2012-2#2)(2013-8#3)
of laminin-1##2##2##(1995-5#2)
of laminin-5##3##2##(1995-5#1)(2008-11#1)(2008-5#1)
of laminitis##4##2##(1992-10#2)(1997-5#2)
of lamins A and C##4##5##(1992-12#4)
of lamins A##5##3##(1992-12#4)(1992-5#1)
of lamins A/C##2##3##(1992-5#2)
of lamins##7##2##(1992-12#4)(1992-5#3)
of lamivudine##5##2##(2007-12#1)(2008-5#1)(2009-8#3)
of lamotrigine##3##2##(1997-3#2)(2010-2#1)
of lamprey spinal neurons##2##4##(1992-8#2)
of lamprey##3##2##(1992-8#2)(1996-9#1)
of lancets##2##2##(2012-12#2)
of land and##4##3##(1993-4#1)(2008-3#3)
of land crabs##2##3##(2008-5#2)
of land plants and##2##4##(2010-6#1)(2012-2#1)
of land plants##6##3##(2007-9#1)(2009-6#2)(2010-6#1)(2012-2#1)(2013-1#1)
of land use change on soil##2##6##(2013-8#2)
of land use##3##3##(2008-8#1)(2013-8#2)
of land##24##2##(1993-4#1)(2006-10#1)(2007-9#2)(2008-10#1)(2008-12#2)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#2)(2009-4#1)(2009-6#2)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
of landmarks##4##2##(1993-2#1)(2010-8#1)(2012-12#2)
of landscape genetics##2##3##(2009-3#1)(2013-1#1)
of landscape structure##2##3##(2008-8#1)(2013-1#1)
of landscape##7##2##(2004-11#1)(2006-5#1)(2008-3#1)(2008-8#1)(2009-3#1)(2013-1#2)
of landscapes##2##2##(2008-2#1)(2008-8#1)
of language and##8##3##(2006-2#1)(2006-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2012-3#1)(2013-8#1)
of language development##2##3##(2005-7#1)(2008-9#1)
of language in##4##3##(1997-3#1)(2006-2#1)(2008-2#1)(2010-2#1)
of language is##2##3##(2006-3#1)(2012-2#1)
of language production##2##3##(2008-4#1)(2011-1#1)
of language##47##2##(1994-3#1)(1995-5#1)(1996-7#1)(1997-3#1)(2005-10#1)(2005-7#1)(2006-2#3)(2006-3#3)(2006-5#1)(2007-1#1)(2007-4#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#2)(2010-2#2)(2010-5#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-11#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
of language-specific##2##2##(2010-2#1)(2010-8#1)
of lanosterol 14##2##3##(1991-5#1)(1992-3#1)
of lanosterol##3##2##(1991-5#1)(1992-3#2)
of lansoprazole in daily practice##2##5##(2008-11#2)
of lansoprazole##4##2##(2008-11#4)
of lanthanide ions##2##3##(2008-10#1)(2012-12#1)
of lanthanide##10##2##(2005-11#1)(2007-10#1)(2008-10#5)(2008-3#1)(2012-12#2)
of lanthanides in##4##3##(2007-8#2)(2008-10#2)
of lanthanides##20##2##(2007-8#4)(2008-10#13)(2008-3#3)
of lanthanoids(III)##3##2##(2008-10#3)
of lanthanum chloride##2##3##(1992-11#1)(1992-4#1)
of lanthanum##10##2##(1992-11#1)(1992-4#1)(1997-2#1)(2005-4#1)(2008-10#3)(2008-7#1)(2008-9#1)(2010-6#1)
of laparoscopic and##2##3##(2010-12#1)(2011-1#1)
of laparoscopic cholecystectomy##5##3##(1993-5#1)(2006-10#1)(2008-10#1)(2008-12#1)(2012-3#1)
of laparoscopic hysterectomy##2##3##(2010-3#1)(2013-1#1)
of laparoscopic interventions##2##3##(2006-6#1)(2012-2#1)
of laparoscopic myomectomy##3##3##(1993-3#1)(2006-6#2)
of laparoscopic nephrectomy##2##3##(2009-3#1)(2011-2#1)
of laparoscopic oophorectomy##2##3##(2004-2#2)
of laparoscopic procedures##3##3##(2004-2#1)(2006-10#1)(2006-6#1)
of laparoscopic resection##2##3##(2011-2#1)(2012-12#1)
of laparoscopic sleeve gastrectomy##2##4##(2013-1#2)
of laparoscopic surgery for##3##4##(2006-10#1)(2012-11#1)(2013-1#1)
of laparoscopic surgery in##3##4##(2008-3#1)(2008-5#1)(2012-1#1)
of laparoscopic surgery##16##3##(1993-12#1)(2004-2#1)(2006-10#3)(2007-5#1)(2007-9#1)(2008-3#2)(2008-5#1)(2010-12#1)(2012-1#1)(2012-11#1)(2013-1#3)
of laparoscopic techniques in urology]##2##5##(2013-7#2)
of laparoscopic techniques##5##3##(2004-2#1)(2008-10#1)(2011-2#1)(2013-7#2)
of laparoscopic##72##2##(1990-6#1)(1991-6#1)(1992-5#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1994-2#1)(1994-3#1)(1995-1#2)(2004-2#5)(2006-10#5)(2006-6#8)(2007-5#2)(2007-9#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#2)(2009-3#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#5)
of laparoscopically assisted vaginal hysterectomy and##2##6##(1994-2#1)(2011-2#1)
of laparoscopically assisted vaginal hysterectomy##4##5##(1993-12#1)(1994-2#2)(2011-2#1)
of laparoscopy and##6##3##(1996-3#1)(2004-2#1)(2006-6#2)(2008-3#1)(2009-2#1)
of laparoscopy for##5##3##(2010-1#1)(2010-8#2)(2011-2#1)(2012-2#1)
of laparoscopy in##3##3##(2008-3#1)(2011-2#1)(2012-2#1)
of laparoscopy##24##2##(1993-3#2)(1996-1#1)(1996-3#2)(2004-2#2)(2006-6#2)(2008-3#2)(2009-2#1)(2010-1#1)(2010-8#2)(2011-2#6)(2012-2#3)
of laparotomy and##2##3##(1996-1#1)(2012-3#1)
of laparotomy##4##2##(1990-2#1)(1996-1#1)(2012-3#1)(2013-8#1)
of lapatinib##2##2##(2008-5#2)
of large DNA fragments##2##4##(1997-2#1)(2013-8#1)
of large DNA##6##3##(1997-2#1)(2008-11#1)(2008-2#1)(2008-4#1)(2013-8#2)
of large RNAs##2##3##(2008-4#2)
of large amount of##3##4##(2008-10#3)
of large amounts of##23##4##(1990-2#1)(1990-3#1)(1991-3#1)(1992-12#1)(1994-8#1)(1995-6#1)(1995-8#1)(1997-4#1)(2005-11#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-10#1)
of large amounts##24##3##(1990-2#1)(1990-3#1)(1991-10#1)(1991-3#1)(1992-12#1)(1994-8#1)(1995-6#1)(1995-8#1)(1997-4#1)(2005-11#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-10#1)
of large and giant##3##4##(2010-9#1)(2011-2#1)(2013-7#1)
of large and small vessel##2##5##(1997-8#1)(2007-10#1)
of large and small##5##4##(1995-12#1)(1997-8#1)(2007-10#1)(2008-7#1)(2010-11#1)
of large and##12##3##(1995-12#1)(1995-6#1)(1997-8#1)(2007-10#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-11#1)(2010-9#1)(2011-2#1)(2013-7#1)
of large areas##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
of large arteries##3##3##(2007-9#1)(2008-7#1)(2010-4#1)
of large blood vessels##2##4##(2011-2#2)
of large bone substitutes##2##4##(2008-5#2)
of large bowel cancer##6##4##(1990-7#3)(1991-6#3)
of large bowel##10##3##(1990-7#3)(1991-6#4)(2006-6#2)(2012-3#1)
of large cell##3##3##(2006-6#1)(2008-11#1)(2009-8#1)
of large clinical trials##2##4##(2007-1#1)(2009-2#1)
of large datasets##2##3##(2008-7#1)(2010-9#1)
of large defects##2##3##(1997-7#1)(2011-2#1)
of large doses of##2##4##(1990-9#1)(2008-8#1)
of large doses##5##3##(1990-9#1)(2006-8#2)(2008-8#1)(2012-1#1)
of large ensembles of##2##4##(2009-8#2)
of large events##2##3##(1996-4#2)
of large excess of##2##4##(2008-10#2)
of large fines##2##3##(1993-3#1)(2007-4#1)
of large insert##2##3##(2008-4#2)
of large libraries of##2##4##(2007-8#1)(2010-12#1)
of large molecules##4##3##(2005-8#1)(2008-5#1)(2010-12#1)(2012-2#1)
of large neurons##2##3##(1991-3#1)(1996-6#1)
of large numbers of samples##3##5##(2008-10#1)(2008-2#1)(2008-9#1)
of large numbers of##27##4##(1991-6#1)(1992-2#1)(1992-8#1)(1993-10#1)(1993-9#1)(1994-6#2)(1995-1#1)(1996-12#1)(2006-10#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#2)(2011-1#1)(2011-2#1)(2012-1#1)
of large optical##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
of large particles##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
of large pedigrees##2##3##(1996-5#1)(2012-3#1)
of large populations##3##3##(1994-3#1)(1996-12#1)(2005-7#1)
of large proteins##3##3##(1994-8#1)(2008-1#1)(2008-4#1)
of large quantities of protein##2##5##(2008-11#2)
of large quantities of##11##4##(1991-10#1)(1991-9#1)(1996-5#1)(1997-3#1)(1997-4#1)(2008-11#3)(2008-7#1)(2012-12#1)(2012-3#1)
of large quantities##13##3##(1991-10#1)(1991-9#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-11#1)(2008-11#3)(2008-7#1)(2012-12#1)(2012-3#1)
of large sample##3##3##(1995-9#1)(2008-10#1)(2012-2#1)
of large scale clinical trials##2##5##(1992-4#1)(2007-11#1)
of large scale##8##3##(1992-4#1)(1996-11#1)(1997-6#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-6#1)(2011-2#1)
of large series of##2##4##(1995-1#1)(2008-10#1)
of large series##3##3##(1995-1#1)(2006-11#1)(2008-10#1)
of large sets of##3##4##(2008-11#1)(2008-4#1)(2008-7#1)
of large simulators##2##3##(2006-10#2)
of large size##3##3##(2007-8#1)(2008-4#1)(2012-2#1)
of large studies##2##3##(1994-6#1)(2007-8#1)
of large tumor##3##3##(1995-2#1)(2007-6#1)(2010-12#1)
of large tumors##2##3##(2007-7#1)(2010-8#1)
of large vessels##3##3##(1997-8#1)(2010-4#1)(2010-9#1)
of large volumes of##4##4##(2005-8#1)(2008-10#1)(2009-7#1)(2011-12#1)
of large volumes##6##3##(1990-12#1)(2005-8#1)(2008-10#1)(2008-3#1)(2009-7#1)(2011-12#1)
of large##418##2##(1990-10#1)(1990-12#5)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#3)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#3)(1991-5#2)(1991-6#6)(1991-8#4)(1991-9#3)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#6)(1994-8#3)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#4)(1995-7#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-4#4)(1996-5#4)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#5)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2005-11#1)(2005-7#2)(2005-8#2)(2006-10#10)(2006-11#1)(2006-12#4)(2006-2#1)(2006-6#3)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#9)(2007-12#11)(2007-3#1)(2007-4#5)(2007-6#1)(2007-7#3)(2007-8#8)(2007-9#4)(2008-1#3)(2008-10#27)(2008-11#12)(2008-12#1)(2008-2#11)(2008-3#19)(2008-4#18)(2008-5#12)(2008-6#4)(2008-7#16)(2008-8#8)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#4)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#3)(2009-9#2)(2010-10#3)(2010-11#1)(2010-12#7)(2010-4#2)(2010-6#1)(2010-8#1)(2010-9#4)(2011-1#6)(2011-12#1)(2011-2#10)(2012-1#5)(2012-11#1)(2012-12#2)(2012-2#6)(2012-3#5)(2013-1#8)(2013-7#2)(2013-8#5)
of large-area##2##2##(2006-12#1)(2008-2#1)
of large-bowel##2##2##(1993-9#2)
of large-cell##2##2##(1990-3#1)(2007-2#1)
of large-diameter##2##2##(2008-2#2)
of large-mode holey and conventional fibers##2##6##(2007-12#2)
of large-scale##24##2##(1990-3#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-6#3)(2008-7#2)(2010-2#1)(2012-2#2)(2013-1#4)
of large-sized##2##2##(1992-10#1)(2012-1#1)
of largely##2##2##(1993-8#1)(1996-3#1)
of larger particles##3##3##(1995-3#1)(2004-9#1)(2008-2#1)
of larger size##4##3##(2007-11#1)(2008-10#1)(2012-3#1)(2013-8#1)
of larger than##2##3##(2008-10#1)(2012-3#1)
of larger##39##2##(1991-11#2)(1991-2#1)(1991-4#1)(1991-7#1)(1994-12#1)(1994-6#1)(1995-3#1)(1997-1#1)(1997-2#1)(1997-5#1)(2004-9#1)(2005-7#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-8#2)(2008-9#2)(2009-5#1)(2010-8#1)(2011-2#2)(2012-3#2)(2013-8#2)
of larvae##27##2##(2004-11#1)(2007-11#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-12#2)(2008-6#4)(2008-8#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-8#5)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
of larval Japanese##3##3##(2008-6#1)(2010-8#2)
of larval and##3##3##(2010-8#1)(2012-12#2)
of larval development##3##3##(2007-5#1)(2008-6#1)(2008-7#1)
of larval growth##2##3##(2007-5#1)(2008-7#1)
of larval inhibition##2##3##(1996-12#2)
of larval##41##2##(1991-11#1)(1991-5#2)(1992-1#1)(1993-9#1)(1996-12#2)(2007-12#2)(2007-5#3)(2008-10#2)(2008-11#1)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#2)(2010-11#1)(2010-8#6)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-3#1)
of larvivorous##2##2##(2007-10#1)(2007-11#1)
of laryngeal cancer##2##3##(1992-9#1)(2008-7#1)
of laryngeal cancer]##2##3##(2008-7#1)(2013-1#1)
of laryngeal carcinoma##3##3##(1997-8#2)(2011-2#1)
of laryngeal lesion##2##3##(1990-6#1)(2012-3#1)
of laryngeal lesions##2##3##(2008-5#2)
of laryngeal lipoma##4##3##(2011-2#4)
of laryngeal##35##2##(1990-6#2)(1990-8#1)(1991-12#1)(1992-9#1)(1995-9#1)(1997-8#3)(2007-9#1)(2008-2#1)(2008-5#5)(2008-7#2)(2008-8#1)(2009-11#1)(2011-2#6)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#2)
of laryngectomy##2##2##(2012-2#2)
of laryngomalacia##3##2##(1996-1#1)(2013-8#2)
of laryngotracheal##2##2##(2005-10#1)(2009-2#1)
of larynx was##2##3##(2010-7#2)
of larynx##8##2##(1996-6#2)(2007-9#1)(2010-7#4)(2013-1#1)
of laser Raman spectroscopy##2##4##(1990-5#1)(1991-6#1)
of laser ablation##5##3##(2006-12#1)(2007-12#1)(2008-10#3)
of laser activation of##2##4##(2007-1#1)(2012-3#1)
of laser activation##3##3##(2007-1#1)(2012-3#2)
of laser and##2##3##(2008-2#2)
of laser beam##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
of laser beams in##3##4##(2008-2#1)(2008-3#2)
of laser beams##10##3##(2007-11#2)(2008-2#5)(2008-3#3)
of laser capture microdissection (LCM)##2##5##(2007-10#1)(2009-8#1)
of laser capture microdissection##3##4##(2007-10#1)(2008-2#1)(2009-8#1)
of laser diodes##5##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
of laser energy##8##3##(2005-4#1)(2006-12#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-2#1)(2008-3#1)
of laser excitation##2##3##(1990-5#1)(2013-7#1)
of laser frequency##2##3##(2007-12#1)(2008-1#1)
of laser irradiation at##2##4##(2008-10#1)(2008-2#1)
of laser irradiation##4##3##(2008-10#1)(2008-2#1)(2009-2#1)(2013-8#1)
of laser light scattered by##2##5##(2008-2#2)
of laser light##11##3##(1994-3#1)(2007-11#1)(2007-8#2)(2008-2#2)(2008-3#4)(2008-5#1)
of laser parameters and staining on##2##6##(2011-1#2)
of laser parameters##3##3##(2008-3#1)(2011-1#2)
of laser power##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
of laser propagation in##2##4##(2008-3#2)
of laser propagation##3##3##(2008-2#1)(2008-3#2)
of laser pulses##7##3##(2007-11#2)(2008-1#1)(2008-10#1)(2008-2#3)
of laser radiation on##3##4##(2008-4#2)(2013-1#1)
of laser radiation##7##3##(2008-2#4)(2008-4#2)(2013-1#1)
of laser speckle##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
of laser system##2##3##(2008-3#1)(2010-1#1)
of laser therapy##2##3##(2007-8#1)(2008-10#1)
of laser treatment for##2##4##(1990-6#1)(2009-11#1)
of laser treatment##4##3##(1990-6#1)(2008-1#1)(2008-10#1)(2009-11#1)
of laser welding##2##3##(2008-3#1)(2012-2#1)
of laser##167##2##(1990-12#1)(1990-5#2)(1990-6#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-9#1)(1994-2#1)(1994-3#1)(1995-4#1)(2005-10#1)(2005-4#1)(2006-10#1)(2006-12#4)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#11)(2007-12#18)(2007-8#6)(2007-9#1)(2008-1#3)(2008-10#12)(2008-12#1)(2008-2#37)(2008-3#36)(2008-4#2)(2008-5#1)(2009-11#1)(2009-2#1)(2009-4#2)(2009-8#1)(2010-1#1)(2010-8#1)(2011-1#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
of laser-assisted##3##2##(2007-12#1)(2008-10#1)(2012-3#1)
of laser-cooled atoms##2##3##(2007-11#1)(2007-12#1)
of laser-cooled##4##2##(1992-3#1)(2007-11#1)(2007-12#2)
of laser-excited##2##2##(1994-2#1)(2008-2#1)
of laser-heated##2##2##(2008-2#1)(2008-3#1)
of laser-induced breakdown in##3##4##(2008-2#1)(2008-3#2)
of laser-induced breakdown##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
of laser-induced fluorescence##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
of laser-induced potentials##3##3##(2012-1#3)
of laser-induced thermal##2##3##(2008-2#1)(2008-3#1)
of laser-induced##29##2##(1990-7#1)(1991-2#1)(2005-4#1)(2007-11#1)(2007-12#6)(2008-10#1)(2008-2#7)(2008-3#7)(2011-2#1)(2012-1#3)
of laser-optical##2##2##(2008-2#2)
of lasers and##3##3##(2007-6#1)(2008-12#1)(2008-2#1)
of lasers by##2##3##(2008-3#2)
of lasers for##2##3##(1993-3#1)(1994-6#1)
of lasers in dentistry##2##4##(1993-3#2)
of lasers in##3##3##(1993-3#2)(2008-3#1)
of lasers is##2##3##(2004-2#1)(2008-3#1)
of lasers with##2##3##(1995-11#1)(2008-3#1)
of lasers##18##2##(1993-12#1)(1993-3#3)(1994-6#1)(1995-11#1)(2004-2#1)(2007-6#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#6)(2008-9#1)
of lasing of##2##3##(2007-12#1)(2008-2#1)
of lasing wavelength##2##3##(2008-3#2)
of lasing##8##2##(2007-12#2)(2008-2#3)(2008-3#3)
of last decade##2##3##(2008-10#1)(2011-2#1)
of last##11##2##(1991-11#1)(1992-6#1)(1996-5#1)(1997-2#1)(2007-6#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-1#1)
of last-names##2##2##(2012-12#2)
of late IFN-α##2##3##(2012-1#2)
of late and early cobblestone area-forming cells in the##2##9##(2008-4#2)
of late blight##8##3##(2008-10#7)(2008-8#1)
of late complications##4##3##(2007-8#1)(2011-2#2)(2012-12#1)
of late diagnosis##2##3##(1996-2#1)(2008-1#1)
of late effects##2##3##(2010-11#2)
of late gene transcription and##2##5##(1997-3#1)(1997-4#1)
of late gene##3##3##(1997-3#2)(1997-4#1)
of late onset##9##3##(1990-2#1)(1990-5#1)(1997-3#1)(2006-10#2)(2006-2#1)(2007-7#1)(2009-9#1)(2010-11#1)
of late potentials##4##3##(1996-4#2)(2006-9#1)(2010-12#1)
of late presentation for HIV care in Northern Greece during the##2##11##(2013-1#2)
of late replication##2##3##(1997-4#2)
of late sequelae##3##3##(1992-10#1)(2004-1#1)(2006-11#1)
of late stage##3##3##(2008-11#2)(2013-1#1)
of late stent thrombosis##3##4##(2007-11#1)(2009-1#2)
of late##117##2##(1990-2#1)(1990-3#1)(1990-5#1)(1991-2#1)(1992-10#1)(1992-5#1)(1993-1#1)(1993-10#1)(1993-3#1)(1993-5#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#3)(1996-8#1)(1997-3#3)(1997-4#3)(1997-6#1)(2004-1#2)(2005-12#2)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#2)(2006-9#1)(2007-11#5)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#4)(2009-1#2)(2009-12#1)(2009-2#3)(2009-9#1)(2010-11#3)(2010-12#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#1)
of late-arising##3##2##(2008-9#3)
of late-life proactivity##2##3##(2007-12#2)
of late-onset##2##2##(1995-11#1)(2008-7#1)
of latency##4##2##(1997-3#1)(2006-10#2)(2008-8#1)
of latent fingerprints##3##3##(1997-2#1)(2010-8#2)
of latent infection and##2##4##(2008-10#2)
of latent infection in##2##4##(2006-10#1)(2008-10#1)
of latent infection were##2##4##(2008-10#2)
of latent infection##17##3##(2006-10#2)(2008-10#15)
of latent infections##2##3##(2008-10#2)
of latent period##2##3##(2008-10#2)
of latent tuberculosis infection##2##4##(2007-12#1)(2011-1#1)
of latent variables##2##3##(1997-4#1)(2008-10#1)
of latent##62##2##(1990-9#3)(1991-12#1)(1991-3#1)(1992-5#1)(1993-9#1)(1994-2#1)(1995-3#3)(1995-5#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-10#25)(2008-5#2)(2008-8#1)(2009-2#1)(2010-3#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-7#2)
of latent-period##2##2##(2008-10#2)
of later reading##2##3##(2011-12#1)(2012-2#1)
of later##14##2##(1991-12#1)(1995-1#1)(1995-8#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-8#1)(2008-12#1)(2011-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
of later-stage##3##2##(2011-2#3)
of lateral and##4##3##(2007-12#1)(2008-9#1)(2009-11#1)(2010-8#1)
of lateral curvature##3##3##(2007-11#1)(2007-7#1)(2008-11#1)
of lateral hypothalamic##3##3##(1991-2#1)(1996-1#2)
of lateral ligament##4##3##(1993-3#1)(2007-11#3)
of lateral line placodes##2##4##(1995-8#2)
of lateral load and external twist on polarization-mode dispersion##2##9##(2007-12#2)
of lateral margin compromise##2##4##(2013-8#2)
of lateral medulla##2##3##(2006-10#1)(2012-2#1)
of lateral root##3##3##(2009-8#2)(2011-12#1)
of lateral row knotless##2##4##(2010-7#2)
of lateral row##3##3##(2010-7#3)
of lateral##74##2##(1991-11#2)(1991-2#1)(1991-4#1)(1993-3#2)(1994-2#1)(1995-5#2)(1995-7#1)(1995-8#2)(1996-1#2)(1996-2#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#6)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#3)(2010-11#1)(2010-5#1)(2010-7#3)(2010-8#2)(2011-12#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#3)
of laterality in##2##3##(2007-12#1)(2008-1#1)
of laterality##10##2##(1994-8#3)(2007-12#2)(2008-1#1)(2012-12#4)
of lateralization and##2##3##(1992-11#2)
of lateralization##6##2##(1992-11#2)(1992-9#1)(1994-8#2)(1997-8#1)
of lateralized##4##2##(1994-8#1)(1996-6#2)(2012-2#1)
of latex agglutination##2##3##(2006-12#1)(2007-7#1)
of latex particles with##2##4##(1990-12#1)(2006-2#1)
of latex particles##10##3##(1990-12#2)(2005-11#4)(2006-2#1)(2008-10#2)(2010-6#1)
of latex spheres##3##3##(2006-2#1)(2007-11#1)(2008-3#1)
of latex##23##2##(1990-12#2)(1994-3#1)(2005-11#6)(2006-12#1)(2006-2#2)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-9#1)(2010-6#1)
of lathosterol##3##2##(1992-6#3)
of latissimus dorsi and serratus anterior##2##6##(2007-8#1)(2011-2#1)
of latissimus dorsi##3##3##(1990-9#1)(2007-8#1)(2011-2#1)
of lattice##4##2##(1991-6#1)(2006-4#1)(2008-2#1)(2012-2#1)
of laughter##3##2##(2008-10#1)(2010-7#2)
of launched pump power##2##4##(2007-12#1)(2008-3#1)
of launching##8##2##(2007-2#1)(2008-2#1)(2010-12#6)
of lauric acid##2##3##(1994-3#1)(1995-3#1)
of lauric##3##2##(1994-12#1)(1994-3#1)(1995-3#1)
of law and##2##3##(2005-7#1)(2007-10#1)
of law##13##2##(1990-5#1)(1991-1#1)(1991-10#1)(1995-1#1)(2005-7#1)(2005-8#1)(2006-8#1)(2006-9#1)(2007-10#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
of laws##2##2##(2008-10#1)(2012-3#1)
of lawsuits##3##2##(1992-2#1)(2008-11#1)(2008-7#1)
of laxatives##3##2##(1991-8#2)(2013-1#1)
of lay##4##2##(1993-1#1)(1994-4#1)(2005-11#1)(2008-5#1)
of layer 4##2##3##(1995-12#2)
of layer II/III##2##3##(1991-3#1)(1997-2#1)
of layer IV##2##3##(1997-3#1)(1997-6#1)
of layer##14##2##(1990-7#1)(1991-3#1)(1995-12#2)(1995-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-10#1)(2008-3#2)(2008-5#1)(2012-2#1)(2013-1#1)
of layered niobate##2##3##(2008-10#2)
of layered##6##2##(2005-11#1)(2008-10#3)(2008-2#1)(2009-7#1)
of layers in##3##3##(2007-11#1)(2008-3#2)
of layers of##6##3##(2007-12#1)(2008-12#4)(2008-3#1)
of layers##24##2##(1990-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#4)(2008-2#2)(2008-3#10)(2012-2#1)
of laying hens##4##3##(2008-3#1)(2013-1#3)
of ld##3##2##(1990-8#3)
of leaching of##3##3##(2007-10#2)(2008-10#1)
of leaching##6##2##(2007-10#2)(2008-10#2)(2008-11#1)(2008-4#1)
of lead (II) and mercury (II)##2##6##(2008-10#2)
of lead (Pb) in##3##4##(2007-10#2)(2008-10#1)
of lead (Pb) on##2##4##(1995-3#1)(2008-10#1)
of lead (Pb)##6##3##(1995-3#1)(2007-10#2)(2008-10#3)
of lead acetate##3##3##(1997-4#1)(2012-2#1)(2013-8#1)
of lead and cadmium in##2##5##(2008-10#2)
of lead and cadmium##3##4##(2008-10#3)
of lead and copper##4##4##(2008-10#4)
of lead and iron##3##4##(2007-8#3)
of lead and mercury in##2##5##(2008-10#2)
of lead and tin##3##4##(2008-10#3)
of lead and##21##3##(2007-8#3)(2008-1#1)(2008-10#16)(2008-5#1)
of lead as##2##3##(1992-3#1)(2008-10#1)
of lead at##3##3##(1995-3#2)(2008-1#1)
of lead by##7##3##(1992-3#1)(2008-10#5)(2013-8#1)
of lead compounds identified##2##4##(2008-10#1)(2009-4#1)
of lead compounds##3##3##(2007-6#1)(2008-10#1)(2009-4#1)
of lead concentration##2##3##(2008-10#2)
of lead exposure##7##3##(1991-11#1)(1992-6#1)(1993-6#2)(1995-11#1)(1997-4#2)
of lead fracture##2##3##(2010-10#2)
of lead from##4##3##(1992-3#1)(2008-10#1)(2011-2#2)
of lead in blood##2##4##(2008-10#2)
of lead in dialysis concentrates##2##5##(2008-10#2)
of lead in different##2##4##(2007-10#1)(2008-10#1)
of lead in human saliva##3##5##(2008-10#3)
of lead in man and the environment in##2##8##(1992-3#2)
of lead in saliva##2##4##(2008-10#2)
of lead in the presence of##2##6##(2008-10#2)
of lead in the##7##4##(1993-9#1)(1996-3#1)(1997-4#1)(2008-10#4)
of lead in tinplate by##2##5##(2005-4#2)
of lead in water samples##3##5##(2008-10#3)
of lead in water##4##4##(2008-10#4)
of lead in wine samples##2##5##(2008-10#2)
of lead in##68##3##(1992-12#1)(1992-3#2)(1993-9#4)(1996-3#2)(1997-4#1)(2004-4#1)(2005-4#2)(2007-10#1)(2008-10#52)(2012-12#1)(2013-8#1)
of lead ions##2##3##(2008-10#2)
of lead is##3##3##(2006-12#1)(2008-10#2)
of lead nitrate##3##3##(1995-6#1)(1997-2#1)(2008-11#1)
of lead on the##5##4##(1995-11#1)(1995-3#1)(1997-2#3)
of lead on##7##3##(1995-11#1)(1995-3#3)(1997-2#3)
of lead onto the##2##4##(2008-10#2)
of lead oxide##2##3##(2007-12#1)(2008-10#1)
of lead salts##2##3##(2008-10#2)
of lead using##3##3##(2008-10#3)
of lead was##4##3##(1992-3#1)(2008-10#2)(2011-2#1)
of lead were##5##3##(2008-10#4)(2011-1#1)
of lead with##6##3##(2008-10#6)
of lead##231##2##(1991-11#1)(1992-12#1)(1992-3#6)(1992-6#1)(1993-6#4)(1993-9#6)(1994-9#1)(1995-11#3)(1995-3#7)(1995-6#1)(1996-3#3)(1996-4#1)(1997-2#5)(1997-4#9)(2004-4#1)(2005-4#2)(2005-7#1)(2006-12#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#137)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-4#1)(2010-10#2)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#6)
of lead(II) from##3##3##(2008-10#3)
of lead(II) in##3##3##(2008-10#3)
of lead(II) were##2##3##(2008-10#2)
of lead(II) with##4##3##(2008-10#4)
of lead(II)##26##2##(2008-10#25)(2013-7#1)
of lead-acid batteries##2##3##(2008-10#2)
of leaded gasoline##2##3##(1994-3#1)(2008-3#1)
of leader##4##2##(1991-4#1)(1991-9#1)(1993-1#1)(2008-8#1)
of leaders##5##2##(1993-3#1)(1995-12#1)(1995-2#2)(1996-3#1)
of leaders'##2##2##(2009-5#2)
of leadership and##4##3##(1995-1#1)(1997-3#1)(2005-12#1)(2011-2#1)
of leadership in##4##3##(1993-12#1)(1996-3#3)
of leadership is##2##3##(1991-2#1)(2008-1#1)
of leadership##22##2##(1991-2#1)(1991-3#1)(1992-2#3)(1992-5#1)(1993-12#1)(1994-1#1)(1995-1#1)(1996-1#1)(1996-3#4)(1997-3#1)(2005-12#1)(2008-1#2)(2008-12#1)(2008-6#1)(2010-3#1)(2011-2#1)
of leading to##2##3##(2008-1#1)(2010-3#1)
of leading##8##2##(1994-3#1)(2006-10#1)(2008-1#2)(2008-3#1)(2008-7#1)(2010-3#1)(2011-1#1)
of leaf and flower blight##2##5##(2008-10#2)
of leaf and##3##3##(1990-10#1)(2008-10#2)
of leaf area##6##3##(2008-10#4)(2008-7#2)
of leaf blast##3##3##(2008-10#3)
of leaf blight##4##3##(2008-10#4)
of leaf blotch##2##3##(2008-10#2)
of leaf colonization##3##3##(2008-10#3)
of leaf extracts##2##3##(2008-10#1)(2009-10#1)
of leaf hairs##2##3##(2008-10#2)
of leaf infection##2##3##(2008-10#2)
of leaf necrosis##2##3##(2004-4#2)
of leaf nitrogen##2##3##(2008-10#1)(2012-5#1)
of leaf rust resistance gene##2##5##(2008-10#2)
of leaf rust resistance genes##3##5##(2008-10#3)
of leaf rust resistance##7##4##(2008-10#7)
of leaf rust##9##3##(2008-10#9)
of leaf samples##2##3##(2008-10#1)(2008-12#1)
of leaf scald disease##2##4##(2008-10#2)
of leaf spot##6##3##(2008-10#6)
of leaf spots##2##3##(2008-10#2)
of leaf tissue##2##3##(2008-10#2)
of leaf wetness and temperature##2##5##(2008-10#2)
of leaf wetness and##3##4##(2008-10#3)
of leaf wetness was##3##4##(2008-10#3)
of leaf wetness##12##3##(2008-10#12)
of leaf##106##2##(1990-10#1)(1993-9#1)(2004-4#2)(2006-12#1)(2007-1#3)(2007-3#2)(2007-6#1)(2008-10#76)(2008-11#1)(2008-12#2)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2011-10#1)(2012-12#2)(2012-5#2)
of leafhopper##2##2##(2008-10#1)(2013-8#1)
of leaflets with##2##3##(2008-10#2)
of leaflets##8##2##(2004-9#1)(2008-10#7)
of leakage current##3##3##(2012-3#3)
of leakage##8##2##(1997-7#1)(2005-9#1)(2007-1#1)(2007-11#2)(2012-3#3)
of leaking##3##2##(2008-4#2)(2011-12#1)
of lean beef##3##3##(2010-4#3)
of lean body mass##2##4##(1995-3#1)(2007-11#1)
of lean##11##2##(1995-3#1)(2006-2#1)(2007-11#1)(2008-3#1)(2010-4#3)(2012-2#3)(2013-8#1)
of learned##7##2##(1991-1#1)(1996-7#1)(2008-4#2)(2008-8#2)(2011-2#1)
of learner-centered development##2##3##(1992-12#2)
of learners in the##2##4##(2008-11#1)(2012-1#1)
of learners##6##2##(2007-7#1)(2008-11#3)(2012-1#1)(2013-1#1)
of learning activities##2##3##(2008-12#1)(2010-8#1)
of learning and memory are##2##5##(1993-9#1)(1995-5#1)
of learning and memory in##3##5##(1997-6#1)(2008-9#1)(2009-8#1)
of learning and memory##21##4##(1991-2#1)(1993-9#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-6#2)(1997-7#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#2)
of learning and performance##2##4##(2007-9#1)(2012-1#1)
of learning and##31##3##(1991-2#1)(1993-9#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-6#2)(1997-7#1)(2007-1#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#4)
of learning as##2##3##(2006-8#1)(2008-12#1)
of learning automata##4##3##(2008-2#4)
of learning contracts##3##3##(2008-11#3)
of learning disability##4##3##(2004-10#2)(2008-11#2)
of learning from##3##3##(2008-2#1)(2013-1#2)
of learning in##7##3##(1994-3#1)(2007-1#1)(2007-7#1)(2008-11#2)(2008-4#1)(2013-1#1)
of learning new##2##3##(1994-2#1)(2008-9#1)
of learning resources##3##3##(2008-11#3)
of learning to##3##3##(2007-2#1)(2012-3#1)(2013-1#1)
of learning##117##2##(1991-2#2)(1992-11#1)(1992-8#1)(1993-9#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-6#2)(1997-7#3)(2004-10#2)(2005-8#1)(2006-2#1)(2006-7#2)(2006-8#1)(2007-1#2)(2007-12#2)(2007-2#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#24)(2008-12#5)(2008-2#7)(2008-4#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#3)(2009-8#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#5)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#2)
of least squares##3##3##(2008-10#1)(2008-2#2)
of least##11##2##(2007-8#1)(2008-10#1)(2008-2#5)(2008-3#1)(2008-8#2)(2011-1#1)
of least-squares##2##2##(2008-2#1)(2008-3#1)
of leather##2##2##(2008-10#2)
of leaves and fruits##3##4##(2008-12#3)
of leaves and roots##4##4##(2008-10#3)(2009-10#1)
of leaves and##12##3##(2006-12#1)(2008-10#5)(2008-12#4)(2008-8#1)(2009-10#1)
of leaves from##2##3##(2008-10#2)
of leaves of##8##3##(2008-10#3)(2010-12#1)(2010-3#1)(2011-1#1)(2011-3#1)(2012-2#1)
of leaves were##2##3##(2008-12#1)(2012-2#1)
of leaves with##3##3##(2008-10#3)
of leaves##53##2##(2006-12#2)(2008-10#34)(2008-12#6)(2008-5#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-3#1)(2012-2#2)(2012-9#1)
of leaving the##3##3##(1992-2#1)(2008-11#1)(2008-3#1)
of leaving##7##2##(1992-2#1)(1993-10#1)(1993-8#1)(2004-10#1)(2008-11#1)(2008-3#1)(2009-12#1)
of lecithin##5##2##(1991-6#2)(1992-2#1)(1993-3#1)(2010-2#1)
of lecithin-cholesterol acyl transferase (LCAT)##2##5##(1995-1#2)
of lectin reactive AFPs##2##4##(1993-1#2)
of lectin##4##2##(1991-9#1)(1993-1#2)(2008-10#1)
of lectins##3##2##(1995-11#1)(1997-7#1)(2008-4#1)
of lecturer##2##2##(2008-11#2)
of lectures##5##2##(1993-11#1)(1994-12#1)(1994-9#1)(2010-11#1)(2012-2#1)
of leech##2##2##(2007-7#1)(2012-12#1)
of leek rust##2##3##(2008-10#2)
of leek##5##2##(2008-10#5)
of leflunomide##6##2##(2006-10#4)(2007-11#1)(2012-12#1)
of left and right##6##4##(1997-8#1)(2006-12#1)(2007-8#1)(2010-12#2)(2011-2#1)
of left anterior descending artery##3##5##(2007-8#2)(2008-11#1)
of left anterior descending##4##4##(2007-8#2)(2008-11#1)(2013-1#1)
of left anterior fascicle block##2##5##(2008-7#2)
of left anterior##6##3##(2007-8#2)(2008-11#1)(2008-7#2)(2013-1#1)
of left atrial myxoma##2##4##(1997-8#1)(2008-7#1)
of left atrial thrombus##6##4##(1997-1#4)(2005-12#1)(2010-12#1)
of left atrial##10##3##(1993-12#1)(1997-1#4)(1997-8#1)(2005-12#1)(2008-7#1)(2010-12#1)(2012-2#1)
of left atrium##2##3##(2009-10#1)(2013-8#1)
of left bundle branch block##3##5##(1993-8#2)(2010-12#1)
of left cardiac##2##3##(1993-3#1)(2008-9#1)
of left coronary artery##2##4##(2007-8#1)(2013-8#1)
of left coronary##4##3##(1994-11#1)(2007-8#2)(2013-8#1)
of left forearm##2##3##(2007-4#1)(2008-5#1)
of left heart##2##3##(2007-8#1)(2011-2#1)
of left internal mammary artery##2##5##(2007-8#1)(2011-2#1)
of left internal##4##3##(2007-8#2)(2011-2#1)(2012-2#1)
of left main coronary artery (LMCA)##2##6##(2011-1#1)(2013-8#1)
of left main coronary artery##4##5##(2009-12#1)(2009-5#1)(2011-1#1)(2013-8#1)
of left main coronary##5##4##(2008-3#1)(2009-12#1)(2009-5#1)(2011-1#1)(2013-8#1)
of left main##6##3##(2008-3#1)(2009-12#1)(2009-5#2)(2011-1#1)(2013-8#1)
of left renal##2##3##(2008-11#1)(2010-11#1)
of left superior##2##3##(2007-8#2)
of left ventricle failure##4##4##(2006-6#4)
of left ventricle in##4##4##(2006-6#1)(2007-7#1)(2007-8#1)(2013-1#1)
of left ventricle##14##3##(2006-6#6)(2007-7#1)(2007-8#1)(2008-4#1)(2008-7#3)(2011-1#1)(2013-1#1)
of left ventricular (LV)##5##4##(1993-12#1)(2007-8#1)(2009-10#1)(2011-2#1)(2012-12#1)
of left ventricular dilatation##2##4##(1990-1#1)(2006-2#1)
of left ventricular dysfunction##7##4##(1993-2#1)(2005-10#1)(2005-7#1)(2006-10#1)(2008-2#1)(2008-3#1)(2009-1#1)
of left ventricular end-diastolic##2##4##(1996-10#1)(2008-12#1)
of left ventricular failure##2##4##(2005-8#1)(2010-5#1)
of left ventricular free wall##2##5##(2007-8#1)(2011-2#1)
of left ventricular function in##2##5##(1992-9#1)(2012-2#1)
of left ventricular function##5##4##(1992-9#1)(1993-8#1)(2007-9#1)(2008-8#1)(2012-2#1)
of left ventricular hypertrophy##5##4##(1990-5#2)(1991-6#1)(2009-1#1)(2011-2#1)
of left ventricular mass and##2##5##(1990-5#1)(2005-12#1)
of left ventricular mass##4##4##(1990-5#3)(2005-12#1)
of left ventricular outflow tract##2##5##(2011-1#1)(2012-2#1)
of left ventricular restoration##2##4##(2007-8#2)
of left ventricular systolic dysfunction##2##5##(1997-3#1)(2010-11#1)
of left ventricular systolic function##2##5##(2008-11#1)(2009-4#1)
of left ventricular systolic##4##4##(1997-3#1)(2008-11#1)(2009-4#1)(2010-11#1)
of left ventricular##66##3##(1990-1#1)(1990-5#5)(1991-6#1)(1991-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-8#2)(1995-6#1)(1996-10#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-1#2)(2005-10#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-9#1)(2007-8#5)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-1#3)(2009-10#1)(2009-4#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#1)
of left##179##2##(1990-1#1)(1990-5#5)(1991-5#1)(1991-6#1)(1991-8#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#5)(1994-11#1)(1995-6#1)(1996-10#1)(1996-6#1)(1997-1#4)(1997-3#3)(1997-6#1)(1997-8#3)(2005-1#2)(2005-10#1)(2005-12#2)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-6#6)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#4)(2007-8#19)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#12)(2008-8#4)(2008-9#4)(2009-1#3)(2009-10#2)(2009-12#1)(2009-4#2)(2009-5#2)(2010-11#2)(2010-12#4)(2010-3#2)(2010-5#1)(2010-7#1)(2011-1#5)(2011-2#10)(2012-12#3)(2012-2#11)(2012-3#1)(2013-1#3)(2013-8#3)
of left- and##3##3##(2006-11#1)(2008-7#1)(2010-12#1)
of left-sided##2##2##(2010-12#1)(2013-1#1)
of left-ventricular##2##2##(1991-6#1)(2010-12#1)
of leg and back pain disorders##2##6##(2008-12#2)
of leg and##3##3##(2007-7#1)(2008-12#2)
of leg motoneurons in##2##4##(2007-12#2)
of leg##22##2##(1990-6#1)(1992-12#1)(1993-12#1)(1995-2#1)(2006-12#2)(2007-12#5)(2007-4#2)(2007-7#1)(2007-8#1)(2008-12#2)(2008-6#2)(2009-1#1)(2012-1#1)(2013-8#1)
of legal abortions##4##3##(1991-11#1)(1992-2#1)(1996-11#2)
of legal##16##2##(1990-3#1)(1991-11#1)(1991-2#1)(1992-2#1)(1994-6#1)(1996-11#2)(1996-4#1)(1997-1#1)(2006-1#1)(2007-3#1)(2008-1#1)(2008-7#2)(2010-2#1)(2012-2#1)
of legalization##2##2##(2010-12#1)(2011-1#1)
of legalizing##2##2##(1995-4#1)(2010-12#1)
of legdh1##2##2##(1997-2#2)
of legged locomotion that are##2##5##(2007-12#2)
of legged locomotion##3##3##(2007-12#3)
of legged##4##2##(2007-12#4)
of legionellosis##2##2##(1990-9#1)(1997-1#1)
of legislation##8##2##(1991-3#1)(1993-10#1)(1994-1#1)(1995-9#1)(2006-2#1)(2007-10#1)(2008-6#1)(2010-5#1)
of legislative and##2##3##(1992-1#1)(2006-6#1)
of legislative##3##2##(1992-1#1)(2006-6#1)(2009-4#1)
of legitimate##2##2##(1991-1#1)(2009-7#1)
of legs##6##2##(1995-2#2)(2008-12#1)(2008-5#1)(2009-10#1)(2010-7#1)
of legume##4##2##(2008-10#2)(2012-11#2)
of legumes##2##2##(2006-3#1)(2008-10#1)
of leguminous cover crop pollens##2##5##(2008-6#2)
of leiomyoma of the##4##4##(1992-6#1)(2006-9#1)(2012-2#1)(2013-7#1)
of leiomyoma##8##2##(1992-6#1)(1996-12#1)(2006-6#1)(2006-9#1)(2007-7#1)(2010-2#1)(2012-2#1)(2013-7#1)
of leiomyosarcoma of the##5##4##(1991-9#1)(1993-10#2)(2008-5#2)
of leiomyosarcoma of##7##3##(1991-9#1)(1993-10#2)(2007-11#1)(2008-5#2)(2008-7#1)
of leiomyosarcoma##14##2##(1991-9#2)(1993-10#2)(1994-10#1)(2007-11#1)(2008-5#2)(2008-6#5)(2008-7#1)
of leishmania##4##2##(2007-2#1)(2007-7#1)(2009-5#1)(2012-2#1)
of leishmaniasis##8##2##(1995-12#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-5#1)(2012-12#1)(2013-1#1)
of leisure##4##2##(2006-8#2)(2009-3#1)(2011-1#1)
of leisure-time physical activity was##2##5##(2011-1#1)(2011-2#1)
of leisure-time physical activity##4##4##(2005-10#1)(2011-1#2)(2011-2#1)
of lemon##2##2##(2008-10#1)(2013-1#1)
of length and##2##3##(2008-2#1)(2009-12#1)
of length density##2##3##(2011-2#2)
of length of##10##3##(1993-12#1)(1994-10#1)(1995-10#1)(2005-12#1)(2007-10#1)(2008-10#2)(2008-2#1)(2011-12#1)(2012-3#1)
of length to##3##3##(2007-3#1)(2011-1#2)
of length variation##2##3##(1991-12#1)(2008-5#1)
of length##28##2##(1990-7#1)(1991-12#1)(1993-12#1)(1994-10#1)(1994-6#1)(1994-9#1)(1995-10#1)(1996-12#1)(2005-12#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-2#3)(2008-4#1)(2008-5#2)(2008-9#1)(2009-12#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-3#1)
of lengthening##11##2##(2007-11#1)(2007-8#10)
of lengths##2##2##(2007-12#1)(2009-7#1)
of lens aberrations##2##3##(2007-12#1)(2008-3#1)
of lens opacification##2##3##(2006-8#1)(2011-1#1)
of lens##20##2##(1990-9#1)(1992-7#2)(2006-8#1)(2007-12#3)(2008-2#1)(2008-3#6)(2008-5#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-2#1)
of lenses##10##2##(2005-11#1)(2007-11#1)(2008-1#1)(2008-2#2)(2008-3#4)(2013-1#1)
of lensing##3##2##(2008-2#2)(2008-3#1)
of lenticular##2##2##(1991-12#1)(1992-7#1)
of lentiviral vectors##2##3##(2008-2#1)(2008-4#1)
of lentiviral##3##2##(2008-2#1)(2008-4#1)(2010-12#1)
of lepidopteran##2##2##(2006-12#1)(2007-12#1)
of lepidopterous##2##2##(2007-6#1)(2011-1#1)
of lepirudin##7##2##(2007-11#4)(2009-8#3)
of lepromatous leprosy##3##3##(2009-5#1)(2011-2#2)
of leprosy cases##4##3##(1995-9#2)(2009-5#2)
of leprosy in##2##3##(2007-7#1)(2009-7#1)
of leprosy patients##7##3##(2007-7#2)(2008-3#2)(2009-5#1)(2011-2#1)(2012-12#1)
of leprosy##45##2##(1990-5#1)(1993-7#1)(1995-6#1)(1995-9#3)(2006-10#4)(2007-6#1)(2007-7#14)(2007-8#1)(2008-3#3)(2008-8#1)(2009-5#7)(2009-7#1)(2011-2#3)(2012-12#4)
of leptin in##4##3##(2006-10#1)(2006-2#1)(2008-4#1)(2008-9#1)
of leptin on##2##3##(1996-2#1)(2008-8#1)
of leptin to##2##3##(1997-4#1)(2008-4#1)
of leptin##29##2##(1996-2#3)(1997-4#3)(2006-1#1)(2006-10#5)(2006-2#2)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#3)(2008-8#1)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
of leptomeningeal##2##2##(1996-1#1)(2012-2#1)
of leptospirosis in##7##3##(1991-8#1)(1992-8#1)(2005-7#1)(2007-7#3)(2007-8#1)
of leptospirosis##16##2##(1991-8#1)(1992-8#1)(2005-7#6)(2006-10#1)(2007-7#4)(2007-8#1)(2008-9#2)
of lercanidipine hydrochloride##3##3##(2010-12#3)
of lesbian and gay parents##2##5##(2012-2#2)
of lesbian and gay##3##4##(1992-1#1)(2012-2#2)
of lesbian and##4##3##(1992-1#1)(2008-12#1)(2012-2#2)
of lesbian##6##2##(1992-1#1)(2008-12#2)(2009-7#1)(2012-2#2)
of lesion and##2##3##(2007-7#1)(2011-1#1)
of lesion are##2##3##(1990-4#1)(2008-6#1)
of lesion area##4##3##(1994-5#1)(2007-10#1)(2008-10#2)
of lesion density##3##3##(2008-10#3)
of lesion development##2##3##(1992-12#1)(2008-10#1)
of lesion expansion##3##3##(2008-10#3)
of lesion in##3##3##(1996-9#1)(2006-12#1)(2007-8#1)
of lesion of##2##3##(2008-8#1)(2013-1#1)
of lesion was##2##3##(2005-1#1)(2007-7#1)
of lesion##35##2##(1990-4#1)(1991-5#1)(1992-12#1)(1994-5#1)(1996-9#2)(2005-1#1)(2006-12#1)(2007-10#5)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#9)(2008-6#1)(2008-8#2)(2010-11#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
of lesion-induced##2##2##(1992-10#1)(1997-2#1)
of lesioning##2##2##(1993-2#1)(1993-6#1)
of lesions and##9##3##(1993-5#1)(1994-11#1)(2005-7#1)(2006-2#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-4#1)(2011-2#1)
of lesions associated with##2##4##(1994-11#1)(2007-3#1)
of lesions but##2##3##(2005-7#2)
of lesions caused by##4##4##(2008-10#3)(2012-3#1)
of lesions in the##5##4##(1991-1#1)(1992-10#1)(2007-7#1)(2008-11#1)(2010-8#1)
of lesions in##8##3##(1991-1#1)(1992-10#1)(2006-8#1)(2007-7#1)(2007-8#2)(2008-11#1)(2010-8#1)
of lesions of the##10##4##(1992-4#1)(1993-10#1)(1993-9#1)(1994-2#1)(1994-3#2)(2004-11#1)(2007-8#1)(2009-2#2)
of lesions of##13##3##(1992-1#1)(1992-11#1)(1992-4#1)(1993-10#1)(1993-9#1)(1994-2#1)(1994-3#2)(2004-11#1)(2006-10#1)(2007-8#1)(2009-2#2)
of lesions that##4##3##(1992-8#1)(2008-1#1)(2008-10#1)(2012-2#1)
of lesions to##2##3##(1994-6#1)(2013-8#1)
of lesions were##3##3##(2006-10#1)(2008-5#1)(2008-7#1)
of lesions within##2##3##(2006-5#1)(2008-10#1)
of lesions##114##2##(1991-1#1)(1991-2#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-4#1)(1992-6#2)(1992-8#1)(1993-10#1)(1993-5#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-6#2)(1994-9#1)(1996-12#1)(1997-3#1)(1997-6#2)(2004-11#1)(2005-7#4)(2006-10#2)(2006-12#1)(2006-2#3)(2006-5#1)(2006-6#2)(2006-8#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#4)(2007-8#4)(2008-1#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#7)(2008-6#4)(2008-7#3)(2008-8#1)(2009-2#3)(2009-4#1)(2009-5#1)(2010-12#3)(2010-8#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
of less extensive##4##3##(2008-6#1)(2008-7#1)(2012-12#2)
of less importance##3##3##(1992-1#1)(2007-10#1)(2008-7#1)
of less invasive surgical##2##4##(2008-8#1)(2011-2#1)
of less invasive##4##3##(2006-6#1)(2007-5#1)(2008-8#1)(2011-2#1)
of less significance##2##3##(2006-1#1)(2008-11#1)
of less than 0##17##4##(1992-7#1)(1995-1#1)(2008-10#6)(2008-2#3)(2008-3#5)(2008-5#1)
of less than 1 nm##2##5##(2008-3#2)
of less than 1##18##4##(1991-4#1)(1995-11#1)(2006-1#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#6)(2008-5#1)(2011-2#1)
of less than 1%##5##4##(2008-10#1)(2008-2#1)(2008-3#3)
of less than 10 ps##2##5##(2007-12#1)(2008-3#1)
of less than 10##15##4##(1996-12#1)(2006-10#1)(2006-5#1)(2007-12#3)(2007-2#1)(2008-10#1)(2008-12#1)(2008-3#3)(2008-5#1)(2011-2#1)(2013-8#1)
of less than 10%##6##4##(1996-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-5#1)
of less than 100##7##4##(1991-3#1)(1996-6#1)(2008-10#1)(2008-3#2)(2011-2#1)(2012-2#1)
of less than 2 cm##2##5##(1990-9#1)(1997-4#1)
of less than 2 nm##2##5##(2005-11#1)(2008-3#1)
of less than 2##12##4##(1990-2#1)(1990-9#1)(1997-4#1)(2005-11#1)(2006-2#1)(2008-10#3)(2008-3#3)(2013-1#1)
of less than 2%##6##4##(2007-6#1)(2008-10#2)(2008-3#2)(2012-1#1)
of less than 20##4##4##(1994-3#1)(2007-12#1)(2008-2#1)(2008-3#1)
of less than 200##2##4##(2008-10#1)(2008-9#1)
of less than 3##4##4##(1992-11#1)(2008-10#1)(2008-2#1)(2010-4#1)
of less than 3%##2##4##(2007-12#1)(2008-2#1)
of less than 30##3##4##(1997-2#1)(1997-3#1)(2008-10#1)
of less than 30%##3##4##(2007-8#1)(2008-5#2)
of less than 300##3##4##(2007-11#1)(2008-3#2)
of less than 4##2##4##(2008-10#1)(2008-2#1)
of less than 40##3##4##(2008-8#1)(2011-12#1)(2013-1#1)
of less than 5##5##4##(1990-3#1)(1991-9#1)(1995-5#1)(2005-8#1)(2008-10#1)
of less than 5% for both migration##2##7##(2008-10#2)
of less than 5% for##3##5##(2008-10#3)
of less than 5%##5##4##(1990-12#1)(2008-10#3)(2011-2#1)
of less than 50##4##4##(2004-11#1)(2007-8#1)(2008-3#1)(2011-1#1)
of less than 6 months##2##5##(2006-8#1)(2007-7#1)
of less than 6##6##4##(1992-6#1)(1994-7#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-2#1)
of less than 7##4##4##(2007-11#1)(2007-2#1)(2008-4#1)(2008-6#1)
of less than 70##2##4##(2008-1#2)
of less than 9%##2##4##(1996-11#1)(2008-3#1)
of less than a##2##4##(2008-2#1)(2009-4#1)
of less than approximately##4##4##(2008-11#1)(2008-3#1)(2008-5#1)(2010-4#1)
of less than or equal to##3##6##(1991-6#1)(1992-2#1)(1992-9#1)
of less than##202##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-8#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-11#1)(1996-12#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2004-11#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-8#4)(2007-10#1)(2007-11#3)(2007-12#10)(2007-2#2)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#7)(2008-10#32)(2008-11#3)(2008-12#1)(2008-2#15)(2008-3#38)(2008-4#2)(2008-5#9)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
of less##246##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-11#1)(1996-12#2)(1996-4#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2004-11#1)(2005-11#2)(2005-8#1)(2006-1#2)(2006-10#4)(2006-11#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#4)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#11)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#7)(2008-10#35)(2008-11#5)(2008-12#2)(2008-2#17)(2008-3#40)(2008-4#2)(2008-5#9)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2010-4#6)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#4)(2012-2#2)(2013-1#3)(2013-8#1)
of less-thans##2##2##(2008-10#2)
of lesser mealworm##4##3##(2004-11#1)(2011-2#3)
of lesser##7##2##(1991-9#1)(2004-11#1)(2007-4#1)(2011-2#3)(2013-1#1)
of lessons##5##2##(2004-7#1)(2007-10#1)(2008-12#1)(2011-2#1)(2012-3#1)
of let-60 ras##2##3##(1990-11#2)
of let-7##3##2##(2008-7#1)(2012-12#2)
of lethal##15##2##(1990-4#1)(1995-12#4)(1995-4#1)(1996-12#1)(1996-9#1)(1997-1#2)(2007-2#1)(2008-1#1)(2008-11#1)(2012-12#1)(2012-3#1)
of lethality##5##2##(1996-12#2)(2005-10#1)(2008-5#1)(2009-2#1)
of lethally irradiated mice##4##4##(1995-12#1)(2008-5#2)(2008-9#1)
of lethargy##2##2##(2008-7#2)
of letrozole in##4##3##(1996-8#1)(2012-12#3)
of letrozole##8##2##(1996-8#3)(2012-12#5)
of letter spacing##2##3##(2008-1#2)
of letter##6##2##(2008-1#4)(2008-4#1)(2008-7#1)
of letters##10##2##(1990-8#1)(2007-12#1)(2008-1#1)(2008-11#1)(2009-2#4)(2013-1#2)
of lettuce (Lactuca sativa)##3##4##(2008-10#1)(2012-2#2)
of lettuce and##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
of lettuce downy mildew##3##4##(2008-10#3)
of lettuce drop##4##3##(2008-10#4)
of lettuce##20##2##(2008-10#15)(2008-5#1)(2012-2#3)(2013-1#1)
of leucine and##3##3##(1991-12#1)(2008-11#2)
of leucine##17##2##(1990-8#1)(1991-12#2)(1992-1#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-9#1)(1995-11#2)(1995-6#1)(2008-11#2)
of leucine-rich##3##2##(2009-6#1)(2012-1#2)
of leucocytes##4##2##(1991-8#1)(1992-9#1)(1994-11#1)(2008-5#1)
of leucopenia##2##2##(2007-11#1)(2011-2#1)
of leucovorin and##2##3##(1991-4#1)(2008-10#1)
of leucovorin##3##2##(1991-4#1)(1995-5#1)(2008-10#1)
of leucyl aminopeptidase##3##3##(1991-2#3)
of leukaemia cases##2##3##(1997-8#2)
of leukaemia##7##2##(1992-5#1)(1993-2#1)(1995-4#1)(1997-8#2)(2009-3#1)(2013-1#1)
of leukaemic##3##2##(2007-11#2)(2013-7#1)
of leukemia cell lines##2##4##(2009-7#1)(2012-3#1)
of leukemia cell##4##3##(2008-9#1)(2009-7#1)(2011-1#1)(2012-3#1)
of leukemia cells##4##3##(1991-5#1)(1991-9#1)(2011-2#2)
of leukemia was##2##3##(2008-11#1)(2008-4#1)
of leukemia##28##2##(1991-5#1)(1991-9#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-9#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-9#1)(2009-7#1)(2010-6#2)(2011-1#1)(2011-2#7)(2012-3#1)
of leukemias##2##2##(1990-10#1)(2007-11#1)
of leukemic blasts##2##3##(2008-1#1)(2012-12#1)
of leukemic patients##2##3##(2007-2#1)(2008-9#1)
of leukemic##11##2##(2005-10#1)(2007-2#1)(2008-1#2)(2008-11#1)(2008-5#1)(2008-9#1)(2010-6#2)(2012-12#1)(2013-7#1)
of leukoaraiosis and##3##3##(2007-10#1)(2007-9#2)
of leukoaraiosis##7##2##(2007-10#5)(2007-9#2)
of leukocidin##3##2##(1992-4#3)
of leukocyte activation##2##3##(1997-8#1)(2009-6#1)
of leukocyte adhesion##2##3##(1996-2#1)(2005-8#1)
of leukocyte cell surface antigen CD38##2##6##(1996-5#2)
of leukocyte count##2##3##(2007-10#2)
of leukocyte removal##2##3##(2005-12#2)
of leukocyte##26##2##(1990-12#1)(1991-5#1)(1992-4#2)(1993-9#1)(1994-9#1)(1996-2#1)(1996-5#2)(1996-9#1)(1997-8#1)(2005-12#3)(2005-8#1)(2007-10#2)(2007-11#1)(2007-4#1)(2007-9#1)(2008-3#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)
of leukocyte-platelet aggregates##2##3##(2008-9#2)
of leukocytes and##8##3##(2006-6#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-5#2)(2012-2#1)(2013-1#1)
of leukocytes in the##2##4##(1992-12#1)(2008-1#1)
of leukocytes in##4##3##(1992-12#1)(1992-7#1)(2006-6#1)(2008-1#1)
of leukocytes into the##3##4##(1994-2#1)(2007-8#1)(2010-2#1)
of leukocytes through##2##3##(2008-10#1)(2008-11#1)
of leukocytes to endothelium##2##4##(1992-12#1)(1995-2#1)
of leukocytes to the##2##4##(2008-3#1)(2013-8#1)
of leukocytes to##4##3##(1992-12#1)(1995-2#1)(2008-3#1)(2013-8#1)
of leukocytes##38##2##(1991-5#1)(1991-8#2)(1992-12#2)(1992-7#1)(1993-6#1)(1994-2#1)(1995-2#1)(1995-7#2)(1997-3#1)(2005-10#1)(2005-12#1)(2006-6#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#3)(2010-2#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
of leukocytic##2##2##(2012-11#1)(2012-3#1)
of leukocytoclastic vasculitis##4##3##(1992-8#2)(2007-7#1)(2007-8#1)
of leukoencephalopathy##2##2##(2012-2#2)
of leukomalacia##4##2##(1992-7#4)
of leukopenia##2##2##(1990-10#1)(1993-2#1)
of leukotriene B4 (LTB4)##2##4##(1991-5#1)(1995-7#1)
of leukotriene receptor antagonists##2##4##(1996-2#1)(2008-1#1)
of leukotriene##8##2##(1990-8#1)(1991-5#1)(1995-1#1)(1995-7#1)(1996-2#1)(2007-11#1)(2008-1#1)(2008-11#1)
of leukotrienes in##2##3##(1993-11#1)(2008-1#1)
of leukotrienes##7##2##(1990-7#1)(1993-11#2)(1994-8#1)(1995-3#1)(2007-11#1)(2008-1#1)
of leupeptin##2##2##(1994-3#1)(1995-9#1)
of leuprolide acetate##3##3##(2004-1#2)(2008-5#1)
of leuprolide##4##2##(2004-1#3)(2008-5#1)
of levamisole##2##2##(2008-1#2)
of level observed with cognate beta2m)##2##6##(1997-9#2)
of level of##3##3##(1990-10#1)(2007-9#1)(2008-10#1)
of level##7##2##(1990-10#1)(1997-9#2)(2006-8#1)(2007-9#1)(2008-10#1)(2008-6#1)
of levels of##9##3##(1995-5#1)(1996-10#1)(1996-2#1)(1996-3#1)(2007-10#1)(2008-10#1)(2008-4#1)(2009-4#1)(2012-3#1)
of levels##13##2##(1995-5#1)(1996-10#1)(1996-2#1)(1996-3#1)(2006-8#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2009-4#1)(2012-3#1)
of levodopa in the##4##4##(2008-7#2)(2008-8#2)
of levodopa in##7##3##(2008-7#3)(2008-8#4)
of levodopa were##2##3##(1997-5#1)(2008-7#1)
of levodopa##32##2##(1994-10#2)(1997-5#1)(2008-10#2)(2008-11#2)(2008-7#10)(2008-8#14)(2013-8#1)
of levodropropizine in##2##3##(1991-2#2)
of levofloxacin in the treatment of##2##6##(2006-8#2)
of levofloxacin in the##3##4##(2006-8#2)(2010-11#1)
of levofloxacin in##8##3##(2006-8#2)(2008-10#4)(2010-11#2)
of levofloxacin versus##2##3##(2008-11#1)(2008-7#1)
of levofloxacin##17##2##(2006-8#3)(2008-10#5)(2008-11#2)(2008-7#1)(2010-11#4)(2011-1#1)(2011-2#1)
of levonorgestrel and ethinyloestradiol##2##4##(2007-8#2)
of levonorgestrel##6##2##(2007-8#2)(2008-10#4)
of lexical and##3##3##(2009-2#1)(2013-1#2)
of lexical##11##2##(1991-2#3)(2008-2#1)(2009-2#1)(2009-7#1)(2013-1#4)(2013-8#1)
of liability##7##2##(1992-2#1)(1993-1#1)(1993-2#1)(1994-1#1)(1996-3#1)(1997-1#1)(2007-4#1)
of liberated##4##2##(1990-8#1)(1991-9#1)(2008-3#1)(2010-3#1)
of libraries and##2##3##(1997-4#1)(2005-7#1)
of libraries##8##2##(1995-10#1)(1995-2#1)(1996-3#1)(1997-2#1)(1997-4#2)(2005-7#1)(2010-12#1)
of library##6##2##(1995-2#1)(1995-3#1)(2008-11#1)(2008-9#1)(2010-12#1)(2012-2#1)
of licensed##2##2##(1990-12#1)(2005-10#1)
of lichen amyloidosis##2##3##(2011-1#2)
of lichen planus##4##3##(1990-5#1)(1991-2#1)(2007-7#1)(2009-6#1)
of lichen sclerosus##7##3##(2005-11#6)(2012-1#1)
of lichen striatus##3##3##(2007-11#1)(2007-8#2)
of lichen##21##2##(1990-5#1)(1991-2#1)(1993-11#1)(2005-11#7)(2007-11#1)(2007-7#1)(2007-8#3)(2009-6#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#1)
of lichens##4##2##(2008-10#1)(2008-8#2)(2010-6#1)
of licking##3##2##(1990-7#1)(2013-7#2)
of lidamycin##2##2##(2008-9#1)(2012-3#1)
of lidar return signals for##2##5##(2008-2#2)
of lidar return signals##3##4##(2008-2#3)
of lidar signals##3##3##(2008-2#1)(2008-3#2)
of lidar systems##2##3##(2008-2#1)(2008-3#1)
of lidar##23##2##(2007-12#1)(2008-2#13)(2008-3#9)
of lidocaine and##2##3##(2007-10#1)(2012-12#1)
of lidocaine on##2##3##(2006-12#1)(2012-12#1)
of lidocaine##25##2##(1990-9#4)(1991-3#1)(1993-12#2)(1996-10#1)(2006-12#2)(2006-8#1)(2007-10#1)(2007-3#1)(2008-10#1)(2008-9#4)(2012-12#4)(2012-2#3)
of life (QOL)##28##3##(1994-12#1)(1995-10#1)(1995-2#1)(1995-4#1)(2004-3#1)(2005-3#1)(2006-11#2)(2006-12#1)(2006-2#1)(2006-9#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-7#3)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-2#2)
of life (QoL)##18##3##(2004-1#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#2)
of life a##2##3##(1996-11#1)(2013-1#1)
of life after surgery##3##4##(1995-8#1)(2007-8#1)(2012-1#1)
of life after##14##3##(1994-6#1)(1995-8#1)(2005-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)
of life among patients##2##4##(2009-12#1)(2011-2#1)
of life among##12##3##(1993-1#2)(2006-10#1)(2008-7#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-5#1)(2011-12#1)(2011-2#2)(2013-8#1)
of life and death##6##4##(1991-11#1)(1993-11#2)(2006-2#1)(2007-2#1)(2011-9#1)
of life and health##4##4##(1991-12#1)(2009-5#1)(2011-1#1)(2012-2#1)
of life and neuropsychological##2##4##(1994-7#1)(2005-11#1)
of life and psychological##3##4##(2008-6#1)(2008-9#1)(2009-11#1)
of life and social##3##4##(1992-1#1)(2007-10#1)(2011-2#1)
of life and the##9##4##(1990-3#1)(1996-9#1)(2007-11#1)(2007-8#1)(2008-1#1)(2009-12#1)(2011-12#1)(2012-12#1)(2013-8#1)
of life and they##2##4##(2008-5#1)(2013-8#1)
of life and to##4##4##(2006-2#1)(2010-1#1)(2010-12#1)(2013-8#1)
of life and toxicity of##2##5##(2011-2#1)(2012-1#1)
of life and##138##3##(1990-3#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-5#1)(1992-7#1)(1993-11#2)(1993-12#1)(1994-11#1)(1994-12#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-6#1)(1996-9#2)(1997-4#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-12#2)(2006-2#3)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#3)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#2)(2007-4#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#5)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#6)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#3)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#2)(2011-1#2)(2011-12#5)(2011-2#11)(2011-9#1)(2012-1#3)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#4)
of life are##3##3##(1996-7#1)(1997-5#1)(2006-10#1)
of life as##7##3##(1996-12#1)(2005-10#1)(2005-7#1)(2005-9#1)(2008-6#1)(2008-7#1)(2010-12#1)
of life assessment in##3##4##(1990-3#1)(1994-2#1)(2008-6#1)
of life by##4##3##(2007-11#1)(2007-7#1)(2008-5#2)
of life can be##2##4##(2006-10#1)(2008-1#1)
of life data##6##3##(1996-12#4)(2004-1#1)(2008-7#1)
of life decisions##4##3##(2012-12#4)
of life due to##4##4##(2007-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
of life during the##2##4##(2006-12#1)(2006-7#1)
of life during##6##3##(1990-2#2)(2006-12#1)(2006-7#1)(2008-9#2)
of life following##4##3##(2006-11#1)(2006-9#2)(2007-11#1)
of life for patients##8##4##(2007-10#1)(2007-12#1)(2008-7#1)(2010-12#1)(2010-7#2)(2011-1#1)(2012-3#1)
of life for##39##3##(1990-4#1)(1991-7#1)(1992-5#1)(1994-5#1)(1995-1#2)(1995-12#1)(2005-10#1)(2006-2#2)(2006-7#1)(2007-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-7#2)(2009-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#2)(2012-12#2)(2012-3#1)
of life has##4##3##(1996-1#1)(2008-7#1)(2009-11#1)(2010-11#1)
of life have##3##3##(2005-10#1)(2008-10#2)
of life history traits##2##4##(2009-10#1)(2010-6#1)
of life history##9##3##(2008-8#4)(2009-10#3)(2010-6#1)(2010-8#1)
of life improves##2##3##(2009-12#1)(2011-3#1)
of life in children with##5##5##(2008-7#1)(2009-3#1)(2012-2#3)
of life in children##7##4##(2007-7#1)(2008-2#1)(2008-7#1)(2009-3#1)(2012-2#3)
of life in different##4##4##(2008-4#1)(2008-6#1)(2010-6#2)
of life in elderly patients##2##5##(1996-7#1)(2013-1#1)
of life in elderly##4##4##(1996-7#1)(2007-12#1)(2008-7#1)(2013-1#1)
of life in long-term##2##4##(1993-3#1)(2007-1#1)
of life in patients with brain##2##6##(2006-12#2)
of life in patients with chronic obstructive##2##7##(2007-11#1)(2008-4#1)
of life in patients with chronic##3##6##(2007-11#1)(2008-4#1)(2011-2#1)
of life in patients with##25##5##(2005-6#1)(2006-10#2)(2006-12#2)(2006-5#1)(2007-11#2)(2007-8#1)(2008-12#1)(2008-4#1)(2008-7#2)(2009-7#2)(2009-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#3)
of life in patients##27##4##(1991-6#1)(2005-6#1)(2006-10#2)(2006-12#2)(2006-5#1)(2007-11#2)(2007-8#1)(2008-12#1)(2008-4#1)(2008-7#3)(2009-7#2)(2009-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#3)
of life in terms of##2##5##(2009-4#1)(2010-3#1)
of life in the patients##3##5##(1993-6#1)(2011-2#1)(2012-11#1)
of life in the##15##4##(1993-6#1)(1994-6#1)(2006-10#1)(2006-7#1)(2007-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#2)(2011-2#3)(2012-11#1)(2012-2#1)
of life in type 2 diabetes##2##6##(2006-2#1)(2012-1#1)
of life in##134##3##(1990-2#1)(1991-6#2)(1992-11#1)(1992-6#1)(1992-7#2)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-6#1)(1995-10#2)(1995-12#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-4#2)(2005-6#1)(2005-9#1)(2006-10#5)(2006-12#3)(2006-2#1)(2006-5#1)(2006-7#2)(2007-1#2)(2007-11#5)(2007-12#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#3)(2008-2#2)(2008-4#3)(2008-6#3)(2008-7#8)(2009-11#2)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-11#2)(2010-3#1)(2010-6#3)(2010-7#1)(2011-1#6)(2011-12#1)(2011-2#14)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#7)(2012-3#1)(2013-1#8)(2013-8#4)
of life indices##2##3##(2007-7#1)(2009-11#1)
of life is##17##3##(1995-1#1)(1996-11#1)(1996-9#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-7#2)(2007-8#2)(2008-10#1)(2010-10#1)(2010-7#1)(2011-2#1)(2013-1#1)
of life issues in##2##4##(2007-12#1)(2008-3#1)
of life issues##4##3##(2006-2#1)(2006-7#1)(2007-12#1)(2008-3#1)
of life itself##2##3##(2008-4#1)(2008-7#1)
of life measures##3##3##(1992-10#2)(2008-3#1)
of life of the##19##4##(1990-9#1)(1993-11#1)(1994-4#1)(2006-6#2)(2007-11#3)(2007-7#1)(2008-5#1)(2010-1#1)(2010-11#1)(2010-7#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
of life of##76##3##(1990-10#2)(1990-12#1)(1990-9#1)(1991-6#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-3#1)(1994-4#1)(1995-10#1)(1996-2#1)(1997-4#1)(2004-7#1)(2005-3#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-6#2)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-4#4)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-7#2)(2011-1#2)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#1)
of life on##3##3##(2008-12#1)(2008-6#1)(2013-8#1)
of life or##2##3##(1995-12#1)(2006-9#1)
of life quality##3##3##(2007-11#2)(2008-1#1)
of life satisfaction##2##3##(2007-10#1)(2010-9#1)
of life science##2##3##(2008-10#1)(2011-1#1)
of life span in##2##4##(1991-8#1)(1994-5#1)
of life span##7##3##(1991-4#1)(1991-8#1)(1994-5#1)(1994-6#1)(1995-6#1)(2008-9#1)(2010-8#1)
of life table##2##3##(1995-3#2)
of life the##2##3##(2007-8#1)(2012-2#1)
of life threatening##3##3##(1994-6#1)(2007-2#1)(2008-3#1)
of life to##5##3##(1992-10#1)(1993-12#1)(2006-10#1)(2009-12#1)(2011-2#1)
of life using the##2##4##(2007-3#1)(2013-1#1)
of life using##3##3##(2007-3#1)(2010-3#1)(2013-1#1)
of life was assessed##2##4##(2007-1#1)(2010-5#1)
of life was##20##3##(1990-12#1)(1992-10#1)(1993-1#1)(1995-6#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-7#2)(2009-10#1)(2009-12#1)(2009-7#1)(2010-5#1)(2011-2#3)
of life were briefly##2##4##(1997-5#1)(2005-4#1)
of life were##8##3##(1997-5#1)(2005-4#1)(2006-10#1)(2008-4#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-1#1)
of life when the##2##4##(2008-7#1)(2012-12#1)
of life when##4##3##(2006-10#1)(2008-7#1)(2010-12#1)(2012-12#1)
of life with##10##3##(1993-1#1)(1995-3#1)(2006-1#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-4#1)(2009-6#1)(2011-1#1)
of life##1318##2##(1990-1#1)(1990-10#3)(1990-11#1)(1990-12#5)(1990-2#3)(1990-3#2)(1990-4#2)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#2)(1991-11#2)(1991-12#3)(1991-2#4)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#5)(1991-7#2)(1991-8#5)(1991-9#2)(1992-1#2)(1992-10#5)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#6)(1992-6#2)(1992-7#8)(1992-8#2)(1993-1#6)(1993-10#1)(1993-11#6)(1993-12#7)(1993-2#3)(1993-3#5)(1993-4#1)(1993-5#2)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#5)(1994-3#3)(1994-4#3)(1994-5#3)(1994-6#6)(1994-7#2)(1994-9#1)(1995-1#4)(1995-10#6)(1995-11#1)(1995-12#4)(1995-2#4)(1995-3#4)(1995-4#3)(1995-5#2)(1995-6#4)(1995-8#6)(1995-9#3)(1996-1#3)(1996-10#1)(1996-11#4)(1996-12#5)(1996-2#5)(1996-3#7)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#5)(1996-9#6)(1997-1#4)(1997-2#2)(1997-3#4)(1997-4#5)(1997-5#3)(1997-7#1)(1997-8#4)(2004-1#5)(2004-10#1)(2004-3#2)(2004-7#1)(2005-1#1)(2005-10#9)(2005-11#2)(2005-3#3)(2005-4#2)(2005-6#1)(2005-7#3)(2005-8#5)(2005-9#4)(2006-1#9)(2006-10#40)(2006-11#6)(2006-12#17)(2006-2#15)(2006-3#1)(2006-4#7)(2006-5#3)(2006-6#7)(2006-7#13)(2006-8#13)(2006-9#15)(2007-1#3)(2007-10#7)(2007-11#46)(2007-12#16)(2007-2#9)(2007-3#3)(2007-4#3)(2007-5#2)(2007-6#3)(2007-7#29)(2007-8#33)(2007-9#5)(2008-1#17)(2008-10#21)(2008-11#11)(2008-12#14)(2008-2#8)(2008-3#12)(2008-4#22)(2008-5#22)(2008-6#20)(2008-7#65)(2008-8#12)(2008-9#12)(2009-1#2)(2009-10#9)(2009-11#11)(2009-12#15)(2009-2#3)(2009-3#4)(2009-4#5)(2009-5#7)(2009-6#4)(2009-7#8)(2009-8#3)(2009-9#5)(2010-1#4)(2010-10#9)(2010-11#8)(2010-12#20)(2010-2#4)(2010-3#6)(2010-4#2)(2010-5#7)(2010-6#6)(2010-7#12)(2010-8#13)(2010-9#4)(2011-1#38)(2011-12#13)(2011-2#78)(2011-3#3)(2011-7#1)(2011-9#1)(2012-1#18)(2012-11#3)(2012-12#37)(2012-2#29)(2012-3#16)(2013-1#46)(2013-7#7)(2013-8#29)
of life'##4##2##(1995-3#1)(1996-2#1)(2010-10#1)(2012-2#1)
of life)##7##2##(1995-8#1)(1996-3#1)(2007-11#1)(2008-1#1)(2009-4#1)(2010-11#1)(2010-5#1)
of life-history theory##2##3##(2006-10#1)(2008-8#1)
of life-history variation##2##3##(2008-8#2)
of life-history##11##2##(2006-10#1)(2008-8#8)(2008-9#1)(2010-8#1)
of life-long learning##2##3##(2008-11#2)
of life-long neurogenesis in the decapod crustacean brain##2##8##(2007-12#2)
of life-long##6##2##(1996-2#1)(2007-12#2)(2007-7#1)(2008-11#2)
of life-sustaining treatment##2##3##(1991-2#1)(2010-4#1)
of life-threatening fungal infections##2##4##(2008-3#1)(2012-1#1)
of life-threatening infections##2##3##(2005-9#1)(2011-1#1)
of life-threatening##16##2##(1994-6#1)(1996-4#1)(2005-9#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-2#1)(2009-6#1)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#1)
of life?##2##2##(2009-10#1)(2010-3#1)
of life]##8##2##(1994-3#1)(2006-6#1)(2007-3#1)(2008-2#1)(2008-4#1)(2009-10#1)(2012-1#1)(2012-2#1)
of lifelong##3##2##(1994-12#1)(2007-4#1)(2007-8#1)
of lifespan##2##2##(2009-5#2)
of lifestyle and##4##3##(2008-6#1)(2009-10#1)(2011-2#1)(2012-2#1)
of lifestyle behaviors##2##3##(2013-8#2)
of lifestyle diseases##2##3##(2008-1#2)
of lifestyle##19##2##(1993-2#1)(2005-8#1)(2007-2#1)(2008-1#4)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
of lifetime and##2##3##(2006-10#1)(2008-9#1)
of lifetime reproductive success##2##4##(2008-9#2)
of lifetime sex partners##2##4##(2008-12#2)
of lifetime##10##2##(2005-10#1)(2006-10#1)(2007-11#1)(2008-12#2)(2008-9#3)(2009-5#1)(2012-3#1)
of lifetimes##3##2##(1991-12#1)(1994-9#1)(1995-5#1)
of ligament##2##2##(2009-3#1)(2012-2#1)
of ligaments##5##2##(1995-8#1)(2006-10#1)(2008-5#1)(2009-3#1)(2009-4#1)
of ligand and##3##3##(1991-7#1)(2008-10#1)(2008-3#1)
of ligand binding and##4##4##(1995-12#1)(1996-5#1)(2006-10#1)(2008-4#1)
of ligand binding to the##2##5##(1996-12#1)(2010-2#1)
of ligand binding to##6##4##(1990-5#1)(1992-9#1)(1993-8#1)(1995-3#1)(1996-12#1)(2010-2#1)
of ligand binding##18##3##(1990-5#1)(1990-8#2)(1992-9#1)(1993-8#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1996-12#1)(1996-5#1)(2006-10#1)(2008-4#1)(2010-2#1)(2011-1#1)
of ligand concentration##3##3##(1992-7#1)(1992-8#1)(1994-11#1)
of ligand discrimination##2##3##(1994-9#1)(1996-5#1)
of ligand for##2##3##(1995-3#1)(2008-10#1)
of ligand in##3##3##(1994-11#1)(1995-10#1)(2008-10#1)
of ligand recognition by##2##4##(1997-1#1)(2008-1#1)
of ligand recognition##3##3##(1997-1#1)(2006-12#1)(2008-1#1)
of ligand structure##2##3##(2008-10#2)
of ligand##81##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-8#3)(1991-2#1)(1991-3#1)(1991-7#1)(1992-12#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#2)(1994-11#4)(1994-12#2)(1994-5#1)(1994-9#2)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#2)(1996-11#1)(1996-12#1)(1996-5#2)(1996-7#2)(1997-1#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-3#1)(2008-1#1)(2008-10#13)(2008-3#2)(2008-4#5)(2008-7#1)(2009-8#1)(2010-2#1)(2010-5#2)(2010-7#1)(2011-1#1)(2012-2#1)(2013-7#1)
of ligand-gated##2##2##(1990-2#1)(1996-2#1)
of ligand-macromolecule interactions##2##3##(1997-2#2)
of ligand-receptor##4##2##(1991-3#1)(1996-8#1)(2007-3#1)(2007-8#1)
of ligands and##6##3##(1991-10#1)(1992-10#1)(2008-4#1)(2008-5#1)(2010-2#1)(2012-3#1)
of ligands bound to##2##4##(2006-12#1)(2008-5#1)
of ligands by##10##3##(1996-11#3)(1996-4#2)(2007-8#2)(2008-4#1)(2008-9#1)(2009-3#1)
of ligands for##3##3##(1994-6#1)(1995-3#1)(2008-10#1)
of ligands in##3##3##(2007-10#1)(2008-10#1)(2009-3#1)
of ligands that##3##3##(1996-11#1)(2007-9#1)(2012-3#1)
of ligands to the##2##4##(1993-6#1)(2008-10#1)
of ligands to##6##3##(1992-7#1)(1993-6#1)(1995-8#1)(1996-6#1)(2008-10#1)(2011-2#1)
of ligands which##2##3##(1994-12#1)(1995-6#1)
of ligands##58##2##(1990-4#1)(1990-5#1)(1991-10#1)(1992-10#1)(1992-5#1)(1992-7#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#5)(1996-2#1)(1996-4#2)(1996-6#1)(1996-7#1)(1997-6#2)(1997-7#1)(2006-12#1)(2007-10#1)(2007-8#2)(2007-9#1)(2008-10#8)(2008-4#3)(2008-5#2)(2008-8#1)(2008-9#1)(2009-3#2)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#2)
of ligated##4##2##(1996-6#1)(1997-2#1)(2008-4#1)(2008-9#1)
of light absorption by##2##4##(2006-10#1)(2008-2#1)
of light absorption##4##3##(2006-10#1)(2008-2#2)(2008-3#1)
of light adaptation##4##3##(1990-2#1)(1991-12#1)(2006-8#2)
of light and heavy##2##4##(1993-8#1)(2008-10#1)
of light and##24##3##(1990-2#1)(1991-10#1)(1992-2#1)(1993-8#1)(1995-12#1)(2007-12#2)(2008-10#4)(2008-2#3)(2008-3#4)(2008-9#1)(2009-8#3)(2011-12#1)(2013-1#1)
of light are##2##3##(2007-11#1)(2007-8#1)
of light at the##3##4##(2007-12#1)(2007-8#1)(2008-2#1)
of light at##9##3##(2007-12#2)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-9#1)
of light backscattered from turbid media##2##6##(2007-12#2)
of light beams##6##3##(2007-11#2)(2008-2#2)(2008-3#2)
of light between##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
of light by a##2##4##(2008-2#1)(2008-3#1)
of light by##13##3##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#8)
of light chain##5##3##(1991-3#2)(1993-12#1)(2008-11#1)(2013-8#1)
of light chains##5##3##(1993-9#2)(1995-1#1)(1996-6#1)(2011-2#1)
of light delivery##3##3##(2008-2#1)(2008-7#2)
of light during##3##3##(1991-2#1)(2008-2#2)
of light emission from##2##4##(1996-8#1)(2008-2#1)
of light exposure and##2##4##(1990-10#1)(2008-5#1)
of light exposure##9##3##(1990-10#1)(1990-11#1)(1995-12#1)(1996-2#3)(2008-5#2)(2012-12#1)
of light for##6##3##(1990-7#1)(2005-7#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-9#1)
of light from a##2##4##(2007-12#1)(2008-3#1)
of light from an##2##4##(2007-12#1)(2008-10#1)
of light from the##4##4##(2007-12#2)(2008-2#2)
of light from##17##3##(2007-12#8)(2008-10#1)(2008-2#5)(2008-3#2)(2008-9#1)
of light harvesting##2##3##(1995-6#1)(2009-7#1)
of light has##3##3##(1997-5#1)(2008-3#2)
of light in a##3##4##(2007-12#2)(2008-2#1)
of light in the visible##2##5##(2006-7#1)(2008-3#1)
of light in the##8##4##(1990-5#1)(2006-7#1)(2007-12#1)(2008-2#2)(2008-3#3)
of light in##22##3##(1990-5#1)(1997-5#1)(2006-7#1)(2007-12#5)(2008-1#1)(2008-2#7)(2008-3#3)(2009-8#1)(2012-2#1)(2013-7#1)
of light incident##2##3##(2007-12#1)(2008-3#1)
of light intensity on##3##4##(2007-10#2)(2008-8#1)
of light intensity##9##3##(2006-3#1)(2007-10#2)(2007-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)
of light into a##2##4##(2008-3#1)(2009-11#1)
of light into##4##3##(2008-2#2)(2008-3#1)(2009-11#1)
of light is##6##3##(1997-6#1)(2007-12#3)(2008-3#1)(2011-2#1)
of light leaf spot##3##4##(2008-10#3)
of light microscopy##5##3##(2008-10#1)(2008-4#1)(2008-9#1)(2009-2#1)(2009-4#1)
of light on the##3##4##(1990-11#1)(1994-10#1)(2008-3#1)
of light on##7##3##(1990-11#1)(1993-12#1)(1994-10#1)(1995-6#1)(2007-1#1)(2008-10#1)(2008-3#1)
of light or##3##3##(1992-8#1)(1994-2#2)
of light over##2##3##(2007-11#1)(2007-12#1)
of light patterns##2##3##(2007-11#1)(2008-2#1)
of light pillars##3##3##(2008-2#3)
of light propagating in##3##4##(2008-1#1)(2008-2#1)(2008-3#1)
of light propagating##6##3##(2007-12#1)(2008-1#1)(2008-2#3)(2008-3#1)
of light propagation##6##3##(2007-11#1)(2007-12#1)(2008-3#3)(2009-5#1)
of light pulses##2##3##(2006-12#1)(2007-12#1)
of light quality and##2##4##(2004-2#1)(2008-10#1)
of light scattered by a##2##5##(2007-1#1)(2008-2#1)
of light scattered by##8##4##(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#3)
of light scattered from a##5##5##(2007-12#1)(2008-1#1)(2008-3#3)
of light scattered from##11##4##(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#6)
of light scattered into##2##4##(2007-11#1)(2007-12#1)
of light scattered##25##3##(1990-8#1)(2007-1#1)(2007-11#2)(2007-12#5)(2008-1#2)(2008-2#5)(2008-3#9)
of light scattering by##8##4##(2007-11#1)(2008-2#5)(2008-3#2)
of light scattering from##6##4##(2008-2#3)(2008-3#3)
of light scattering to##2##4##(2007-11#1)(2008-2#1)
of light scattering##33##3##(1993-7#2)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#12)(2008-3#13)(2008-9#1)
of light source##3##3##(2005-4#1)(2007-12#1)(2012-12#1)
of light that passed through##2##5##(2008-3#1)(2010-2#1)
of light that##6##3##(2007-12#2)(2008-3#3)(2010-2#1)
of light therapy##2##3##(1996-2#2)
of light through a##4##4##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
of light through the##5##4##(2007-12#1)(2008-2#1)(2008-3#3)
of light through##13##3##(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#6)(2008-7#1)
of light to the##2##4##(1997-6#1)(2008-4#1)
of light to##3##3##(1997-6#1)(2008-2#1)(2008-4#1)
of light transmitted##3##3##(2008-2#1)(2008-3#2)
of light transport in##2##4##(2008-2#1)(2008-3#1)
of light transport##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
of light was##2##3##(2006-10#1)(2008-7#1)
of light waves##3##3##(2007-11#1)(2007-12#2)
of light with##8##3##(2007-12#3)(2008-2#1)(2008-3#2)(2008-7#1)(2010-8#1)
of light within the##3##4##(2008-2#1)(2008-3#2)
of light##459##2##(1990-10#2)(1990-11#2)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#2)(1991-12#1)(1991-2#3)(1991-3#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-8#2)(1993-12#2)(1993-3#3)(1993-7#3)(1993-8#2)(1993-9#4)(1994-10#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-6#2)(1996-1#1)(1996-2#5)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-5#2)(1997-6#2)(1997-7#1)(2004-2#1)(2005-4#1)(2005-7#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-3#1)(2006-7#1)(2006-8#2)(2007-1#2)(2007-10#3)(2007-11#22)(2007-12#63)(2007-3#1)(2007-8#4)(2007-9#2)(2008-1#8)(2008-10#33)(2008-11#4)(2008-2#80)(2008-3#96)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#9)(2008-8#2)(2008-9#10)(2009-11#2)(2009-2#1)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#6)(2010-12#2)(2010-2#1)(2010-8#3)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#3)
of light-absorbing##3##2##(2005-7#1)(2008-10#1)(2008-3#1)
of light-beam propagation in##2##4##(2007-12#1)(2008-3#1)
of light-beam##3##2##(2007-12#1)(2008-3#2)
of light-dark##3##2##(1991-12#1)(2008-5#1)(2009-10#1)
of light-driven##2##2##(1992-6#1)(2007-12#1)
of light-emitting diodes##4##3##(2007-11#1)(2008-3#2)(2011-1#1)
of light-emitting##5##2##(2007-11#1)(2008-3#2)(2011-1#1)(2012-12#1)
of light-induced absorption##2##3##(2007-12#2)
of light-induced autofluorescence##2##3##(2007-12#2)
of light-induced reflectivity##3##3##(2007-11#3)
of light-induced##14##2##(1994-2#2)(1994-9#1)(2007-11#3)(2007-12#5)(2008-1#1)(2008-2#1)(2008-3#1)
of light-scattering##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
of lighting##3##2##(2008-3#1)(2008-6#2)
of lightweight and##2##3##(2006-5#1)(2011-2#1)
of lignified##2##2##(2008-10#1)(2008-5#1)
of lignin and##2##3##(2008-10#1)(2013-8#1)
of lignin monomers##2##3##(2008-11#2)
of lignin peroxidase##6##3##(1990-2#1)(1997-4#2)(2008-5#1)(2008-6#2)
of lignin##23##2##(1990-2#2)(1990-4#1)(1997-4#2)(2006-3#1)(2008-10#5)(2008-11#2)(2008-5#2)(2008-6#3)(2009-8#2)(2009-9#1)(2011-1#1)(2013-8#1)
of lignin-degrading##4##2##(1990-4#1)(2008-5#3)
of lignocaine##5##2##(2005-7#1)(2006-10#3)(2013-7#1)
of lignocellulose##4##2##(2005-12#1)(2008-11#1)(2008-7#1)(2011-1#1)
of lignocellulosic biomass##4##3##(2008-5#1)(2008-6#3)
of lignocellulosic##5##2##(2008-5#1)(2008-6#3)(2011-1#1)
of lignoceric acid##3##3##(1994-6#3)
of likelihood##2##2##(1993-5#1)(2011-2#1)
of likely##5##2##(1996-3#1)(1997-6#1)(1997-7#1)(2009-11#1)(2011-12#1)
of limb and##2##3##(1992-9#1)(2010-11#1)
of limb lengthening##3##3##(2007-8#3)
of limb muscle##2##3##(2006-11#1)(2011-12#1)
of limb observations##2##3##(2007-9#2)
of limb sparing##2##3##(2006-6#2)
of limb##34##2##(1991-11#1)(1992-11#1)(1992-9#2)(1993-9#1)(1994-11#2)(1994-8#1)(2006-11#2)(2006-4#1)(2006-6#3)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#3)(2007-9#4)(2009-3#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-12#1)(2011-2#2)(2011-3#2)
of limbal stem cell deficiency##2##5##(2012-12#2)
of limbal stem cells##3##4##(2008-1#3)
of limbal stem##5##3##(2008-1#3)(2012-12#2)
of limbal##7##2##(2008-1#4)(2009-8#1)(2012-12#2)
of limbic##7##2##(1992-8#1)(1995-12#1)(1997-5#1)(2005-10#1)(2008-5#1)(2008-6#1)(2008-7#1)
of limbs and##4##3##(2006-11#1)(2007-11#1)(2007-8#1)(2010-12#1)
of limbs##10##2##(1990-9#1)(1996-3#1)(2006-11#1)(2006-4#1)(2007-11#2)(2007-8#1)(2008-9#1)(2010-12#1)(2012-12#1)
of limit of detection##2##4##(2008-10#2)
of limit##4##2##(1995-5#1)(2008-10#2)(2008-3#1)
of limitation##4##2##(1996-5#1)(2007-10#1)(2007-12#1)(2008-10#1)
of limitations in the##2##4##(1996-11#1)(2008-3#1)
of limitations in##6##3##(1992-5#1)(1996-11#1)(2006-10#1)(2006-11#1)(2008-3#1)(2011-1#1)
of limitations on##2##3##(1996-5#1)(2007-12#1)
of limitations##16##2##(1992-5#1)(1996-11#1)(1996-12#1)(1996-5#2)(1996-6#2)(2006-10#1)(2006-11#1)(2006-2#1)(2007-12#1)(2008-11#2)(2008-3#1)(2011-1#1)(2011-2#1)
of limited benefit##2##3##(2006-10#1)(2007-7#1)
of limited resection for##2##4##(1994-12#1)(2012-1#1)
of limited resection##3##3##(1994-12#2)(2012-1#1)
of limited resources##8##3##(1990-2#1)(1997-2#1)(2005-5#1)(2006-10#1)(2007-4#1)(2008-7#1)(2009-6#1)(2012-12#1)
of limited success##2##3##(2007-9#1)(2011-2#1)
of limited surgery##3##3##(1990-12#1)(1992-8#1)(2008-6#1)
of limited use##4##3##(2006-2#1)(2008-10#2)(2008-7#1)
of limited value because##2##4##(1995-3#1)(2008-5#1)
of limited value in##3##4##(1992-12#1)(1995-12#1)(2008-7#1)
of limited value##10##3##(1992-12#1)(1994-4#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-2#1)(2008-1#1)(2008-5#1)(2008-7#1)
of limited##75##2##(1990-12#1)(1990-2#1)(1991-12#1)(1992-10#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-8#1)(1994-12#2)(1994-4#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-2#3)(2005-5#2)(2006-10#3)(2006-2#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#3)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-1#1)(2009-6#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
of limiting amounts of##3##4##(1994-3#1)(1996-3#1)(2008-4#1)
of limiting dilution##3##3##(1993-12#1)(1993-7#1)(1994-3#1)
of limiting membrane##2##3##(2007-9#2)
of limiting the##4##3##(2008-1#1)(2008-3#1)(2008-8#1)(2012-3#1)
of limiting##23##2##(1993-12#1)(1993-7#1)(1994-3#2)(1995-1#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-6#1)(2007-6#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)
of limits of detection##2##4##(2008-10#2)
of limits##3##2##(2008-10#2)(2011-1#1)
of limonene##3##2##(2008-5#3)
of lin-12##2##2##(1994-12#2)
of lindane and DDT##2##4##(1994-3#2)
of lindane##8##2##(1990-3#1)(1994-3#3)(1997-2#3)(1997-3#1)
of linden##2##2##(2006-12#2)
of line 30-4##2##3##(2008-10#2)
of line##11##2##(1990-12#1)(1992-7#1)(1995-5#1)(2005-8#1)(2008-10#4)(2008-3#1)(2009-12#1)(2013-8#1)
of lineage##3##2##(1992-3#1)(2008-10#1)(2011-2#1)
of lineage-specific##2##2##(2008-9#1)(2011-2#1)
of lineages##3##2##(2006-2#1)(2008-10#1)(2008-9#1)
of linear DNA##3##3##(1990-5#1)(1993-11#1)(1995-1#1)
of linear alkylbenzene sulfonates##3##4##(2008-10#3)
of linear and angular##2##4##(2007-1#1)(2008-5#1)
of linear and circular##3##4##(1994-8#1)(2007-12#2)
of linear and nonlinear##2##4##(1994-7#1)(2008-3#1)
of linear and##9##3##(1994-7#1)(1994-8#1)(2007-1#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)
of linear equality constraints##2##4##(2008-2#2)
of linear equations that##2##4##(2008-2#1)(2008-3#1)
of linear equations##4##3##(2008-2#1)(2008-3#2)(2008-7#1)
of linear models and##2##4##(2008-3#1)(2009-9#1)
of linear models##4##3##(1992-6#1)(2008-3#1)(2009-4#1)(2009-9#1)
of linear polarization##2##3##(2008-3#2)
of linear programming##2##3##(2008-2#1)(2008-7#1)
of linear range##2##3##(2008-10#2)
of linear regression##6##3##(2008-10#4)(2011-1#1)(2012-3#1)
of linear response##3##3##(2008-10#3)
of linear systems##2##3##(2007-12#2)
of linear ubiquitin chains##2##4##(2012-3#2)
of linear##106##2##(1990-5#1)(1990-9#2)(1991-12#2)(1991-9#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-2#1)(1994-7#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-9#1)(1996-11#1)(1996-4#1)(1996-8#1)(1997-6#1)(1997-7#1)(2005-11#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-9#2)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#10)(2008-3#13)(2008-5#1)(2008-7#6)(2008-8#3)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-6#2)(2011-1#4)(2012-1#1)(2012-3#4)(2013-1#2)(2013-7#1)
of linearity of##2##3##(2008-10#2)
of linearity##21##2##(1996-2#1)(2008-10#12)(2008-2#1)(2009-8#1)(2010-2#2)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
of linearly birefringent##2##3##(2007-12#2)
of linearly chirped##2##3##(2007-12#2)
of linearly polarized light##5##4##(2007-11#2)(2008-2#2)(2008-3#1)
of linearly polarized##7##3##(2007-11#3)(2008-2#3)(2008-3#1)
of linearly##15##2##(2007-11#3)(2007-12#5)(2008-2#3)(2008-3#3)(2009-12#1)
of lines in the##3##4##(2008-2#2)(2008-3#1)
of lines of##4##3##(1995-3#1)(2007-8#1)(2010-4#1)(2013-7#1)
of lines##17##2##(1991-2#1)(1995-3#1)(1996-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#4)(2008-3#3)(2008-5#1)(2010-4#1)(2013-7#1)
of linewidth##2##2##(2007-11#1)(2007-12#1)
of linezolid and##3##3##(2006-8#2)(2007-12#1)
of linezolid in the presence of##3##6##(2008-10#3)
of linezolid in##5##3##(2007-7#1)(2008-10#3)(2008-3#1)
of linezolid##15##2##(2006-8#4)(2007-12#1)(2007-7#1)(2008-10#4)(2008-3#2)(2008-4#1)(2009-6#1)(2010-10#1)
of lingual##4##2##(1994-12#1)(1995-6#1)(1995-9#1)(2007-11#1)
of linguistic and##2##3##(2010-5#1)(2013-8#1)
of linguistic##9##2##(1993-9#1)(1994-6#1)(2007-3#1)(2010-2#3)(2010-5#1)(2012-1#1)(2013-8#1)
of link nurses##2##3##(2008-11#2)
of link##5##2##(1992-6#2)(2008-11#2)(2008-7#1)
of linkage between##2##3##(1997-5#2)
of linkage disequilibrium (LD)##2##4##(2007-5#1)(2010-5#1)
of linkage disequilibrium##10##3##(1996-5#1)(2006-1#1)(2007-5#1)(2008-10#2)(2010-5#1)(2012-1#1)(2012-12#1)(2012-3#2)
of linkage group##2##3##(1996-9#1)(2006-12#1)
of linkage information##2##3##(2012-3#2)
of linkage mapping##2##3##(2008-5#1)(2011-2#1)
of linkage specificity##2##3##(1991-9#2)
of linkage to the##2##4##(1992-10#1)(1996-5#1)
of linkage to##4##3##(1992-10#1)(1996-5#1)(1997-5#1)(2008-5#1)
of linkage##40##2##(1990-3#1)(1990-8#4)(1991-5#1)(1991-9#2)(1992-10#1)(1994-12#1)(1996-5#3)(1996-9#1)(1997-5#3)(2006-1#1)(2006-10#1)(2006-12#1)(2007-5#1)(2008-10#2)(2008-11#3)(2008-5#3)(2009-4#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#5)
of linkages##3##2##(1997-2#1)(2007-12#1)(2008-12#1)
of linked##8##2##(1991-3#1)(1994-9#1)(2006-9#1)(2007-11#1)(2008-10#2)(2008-12#1)(2011-2#1)
of linker##5##2##(1991-12#1)(1994-9#1)(1997-4#1)(2006-12#1)(2008-7#1)
of linkers##2##2##(2008-4#2)
of linking##6##2##(1990-9#1)(1991-8#1)(2008-10#1)(2008-7#1)(2009-7#1)(2009-8#1)
of links between##5##3##(2004-9#1)(2013-1#4)
of links##10##2##(2004-9#1)(2008-2#1)(2008-4#1)(2012-12#1)(2013-1#6)
of linoleic acid (18##2##4##(1991-7#1)(2006-12#1)
of linoleic acid and##2##4##(1996-4#1)(2009-6#1)
of linoleic acid in##2##4##(1994-5#1)(2008-5#1)
of linoleic acid monoepoxides##2##4##(1992-8#2)
of linoleic acid##19##3##(1990-12#1)(1990-7#1)(1991-10#1)(1991-7#1)(1992-8#3)(1994-5#1)(1996-4#1)(1996-8#1)(1997-5#1)(2006-11#1)(2006-12#1)(2006-9#1)(2008-11#2)(2008-12#1)(2008-5#1)(2009-6#1)
of linoleic and##2##3##(1994-2#1)(1997-2#1)
of linoleic##22##2##(1990-12#1)(1990-7#1)(1991-10#1)(1991-7#1)(1992-8#3)(1994-2#1)(1994-5#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-5#1)(2006-11#1)(2006-12#1)(2006-9#1)(2008-11#2)(2008-12#1)(2008-5#1)(2009-6#2)
of lip##2##2##(2007-7#1)(2012-12#1)
of lipL32 gene##2##3##(2010-12#2)
of lipase activity##7##3##(1991-5#1)(2008-10#1)(2010-10#5)
of lipase in E##2##4##(1996-5#2)
of lipase inhibitor##2##3##(2005-11#2)
of lipase purified from human pancreatic juice##2##7##(1992-7#1)(1996-7#1)
of lipase##24##2##(1991-12#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-7#1)(1995-2#2)(1996-5#2)(1996-7#2)(1996-9#1)(1997-4#1)(2005-11#2)(2006-8#1)(2008-10#1)(2008-5#1)(2010-10#5)
of lipase-catalyzed##2##2##(2008-5#1)(2008-7#1)
of lipases##6##2##(1993-2#1)(1995-3#1)(2008-7#1)(2008-8#3)
of lipid A##5##3##(1990-5#2)(1991-12#1)(1992-5#1)(2011-2#1)
of lipid and lipoprotein##2##4##(2008-6#1)(2009-7#1)
of lipid and##5##3##(1990-3#1)(1993-11#1)(2008-3#1)(2008-6#1)(2009-7#1)
of lipid bilayer##2##3##(2006-10#1)(2008-9#1)
of lipid bilayers is##2##4##(1995-10#1)(1997-5#1)
of lipid bilayers##6##3##(1992-6#2)(1995-10#2)(1997-5#1)(2005-11#1)
of lipid components##2##3##(1992-12#1)(1997-6#1)
of lipid composition on the relaxivity of##2##7##(1990-2#2)
of lipid disorders##2##3##(1993-1#1)(2007-8#1)
of lipid droplets##4##3##(2007-12#2)(2007-9#1)(2009-3#1)
of lipid homeostasis##3##3##(1997-4#1)(2008-2#1)(2008-3#1)
of lipid hydroperoxides##7##3##(1992-11#2)(1995-2#2)(1996-11#1)(2008-5#1)(2013-1#1)
of lipid in##2##3##(1994-3#1)(2006-9#1)
of lipid isomerisation##2##3##(1990-3#1)(1994-10#1)
of lipid lowering diets##2##4##(1997-7#1)(2008-4#1)
of lipid lowering drugs##2##4##(2008-11#2)
of lipid lowering##6##3##(1991-7#1)(1997-7#1)(2008-11#2)(2008-4#1)(2011-11#1)
of lipid management##2##3##(2008-3#1)(2013-8#1)
of lipid mediators##2##3##(1992-11#1)(2007-8#1)
of lipid membranes##4##3##(1990-11#1)(1996-1#1)(2008-1#1)(2008-11#1)
of lipid metabolism in##4##4##(2008-3#1)(2008-9#1)(2011-2#1)(2013-1#1)
of lipid metabolism##13##3##(1992-10#1)(2008-1#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#5)
of lipid metabolism]##2##3##(1990-2#1)(1994-3#1)
of lipid molecules##2##3##(1990-11#1)(2006-10#1)
of lipid oxidation##3##3##(1997-2#1)(1997-5#1)(2005-8#1)
of lipid peroxidation (LPO)##4##4##(2006-6#2)(2010-4#1)(2013-1#1)
of lipid peroxidation and protein oxidation##2##6##(1995-1#2)
of lipid peroxidation and##7##4##(1995-1#3)(2007-8#1)(2009-12#1)(2010-12#1)(2011-2#1)
of lipid peroxidation at##2##4##(1997-8#1)(2006-12#1)
of lipid peroxidation by##4##4##(1993-2#1)(1995-6#2)(2011-2#1)
of lipid peroxidation can##2##4##(2007-8#1)(2009-5#1)
of lipid peroxidation in the##2##5##(1991-4#1)(2012-1#1)
of lipid peroxidation in##8##4##(1990-10#1)(1991-4#1)(1992-3#1)(1996-6#1)(1996-8#1)(1997-8#2)(2012-1#1)
of lipid peroxidation products and##2##5##(2008-8#1)(2010-4#1)
of lipid peroxidation products in the##2##6##(1994-8#1)(1997-8#1)
of lipid peroxidation products##6##4##(1994-8#1)(1997-8#1)(2008-1#1)(2008-8#1)(2009-8#1)(2010-4#1)
of lipid peroxidation was##3##4##(2008-4#1)(2008-7#1)(2008-8#1)
of lipid peroxidation with##2##4##(1995-1#1)(2008-10#1)
of lipid peroxidation##74##3##(1990-10#1)(1990-4#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-3#2)(1993-2#3)(1994-3#4)(1994-6#1)(1994-8#2)(1995-1#8)(1995-12#2)(1995-3#1)(1995-6#2)(1996-2#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-8#6)(2005-12#1)(2005-7#1)(2006-12#1)(2006-6#2)(2007-1#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#4)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-4#2)(2010-7#1)(2011-2#2)(2012-1#2)(2013-1#1)
of lipid peroxidation)##2##3##(1997-7#1)(2008-6#1)
of lipid peroxide##2##3##(2005-8#1)(2008-5#1)
of lipid peroxides in##3##4##(1990-5#2)(2013-1#1)
of lipid peroxides##7##3##(1990-5#2)(1996-8#1)(2004-4#1)(2008-5#2)(2013-1#1)
of lipid profile##2##3##(1996-9#1)(2006-10#1)
of lipid rafts in##4##4##(2005-7#1)(2008-11#1)(2010-5#2)
of lipid rafts##9##3##(2005-7#1)(2008-11#2)(2009-8#1)(2010-5#2)(2011-1#2)(2011-2#1)
of lipid therapy##2##3##(2006-5#2)
of lipid transfer##2##3##(2009-8#1)(2010-7#1)
of lipid vesicles##3##3##(1991-9#1)(2005-11#1)(2012-12#1)
of lipid##255##2##(1990-10#1)(1990-11#2)(1990-2#4)(1990-3#4)(1990-4#2)(1990-5#4)(1990-7#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#3)(1992-12#1)(1992-3#4)(1992-5#1)(1992-6#3)(1993-1#1)(1993-11#1)(1993-2#3)(1993-3#2)(1993-9#2)(1994-10#1)(1994-11#5)(1994-12#1)(1994-2#1)(1994-3#6)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#9)(1995-10#2)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-1#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#6)(2004-4#1)(2005-11#3)(2005-12#1)(2005-7#4)(2005-8#2)(2006-10#4)(2006-12#1)(2006-2#1)(2006-5#6)(2006-6#3)(2006-8#1)(2006-9#1)(2007-1#1)(2007-12#2)(2007-6#1)(2007-8#5)(2007-9#1)(2008-1#5)(2008-10#4)(2008-11#7)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#5)(2008-6#5)(2008-7#6)(2008-8#4)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-12#3)(2010-3#1)(2010-4#6)(2010-5#3)(2010-7#2)(2010-9#1)(2011-1#3)(2011-11#1)(2011-2#6)(2012-1#2)(2012-12#1)(2013-1#9)(2013-8#1)
of lipid-lowering drugs##2##3##(2006-5#1)(2013-1#1)
of lipid-lowering therapies is##2##4##(2006-5#2)
of lipid-lowering therapies##7##3##(2006-5#7)
of lipid-lowering therapy##3##3##(2008-3#2)(2009-4#1)
of lipid-lowering##14##2##(2005-10#1)(2006-5#8)(2008-3#2)(2009-4#1)(2013-1#2)
of lipid-protein##3##2##(1990-2#1)(1990-5#1)(1993-9#1)
of lipids and proteins##3##4##(2008-7#1)(2008-8#1)(2009-8#1)
of lipids and##17##3##(1990-8#1)(1991-11#1)(1994-12#1)(1995-10#1)(1995-4#1)(1995-8#1)(1996-9#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-4#1)(2012-12#1)
of lipids as##2##3##(1991-3#1)(2006-2#1)
of lipids between##2##3##(1994-11#1)(2010-7#1)
of lipids extracted from##2##4##(1990-3#1)(1997-3#1)
of lipids in the##2##4##(1993-1#1)(1997-7#1)
of lipids in##7##3##(1991-4#1)(1993-1#1)(1994-2#1)(1996-8#1)(1997-7#1)(2008-5#1)(2008-8#1)
of lipids into##2##3##(1992-9#1)(2007-12#1)
of lipids such as##2##4##(1993-9#1)(2011-2#1)
of lipids were##2##3##(1990-2#1)(2010-8#1)
of lipids with##3##3##(1995-2#1)(2009-2#1)(2012-12#1)
of lipids##71##2##(1990-2#2)(1990-3#1)(1990-8#1)(1991-11#2)(1991-3#2)(1991-4#1)(1991-7#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-6#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#1)(1995-1#3)(1995-10#1)(1995-2#2)(1995-4#1)(1995-8#1)(1996-8#2)(1996-9#1)(1997-3#1)(1997-7#1)(2005-11#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-5#1)(2009-7#2)(2009-8#2)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#2)
of lipoamide dehydrogenase deficiency##2##4##(1996-12#2)
of lipoamide dehydrogenase##6##3##(1990-12#1)(1992-1#1)(1996-12#4)
of lipoamide##7##2##(1990-12#2)(1992-1#1)(1996-12#4)
of lipocortin 1##2##3##(1993-4#1)(1994-11#1)
of lipodystrophy##3##2##(2006-9#1)(2007-12#1)(2009-2#1)
of lipofuscin in the##2##4##(1995-3#1)(2011-2#1)
of lipofuscin in##3##3##(1995-3#2)(2011-2#1)
of lipofuscin##8##2##(1992-2#1)(1994-6#1)(1995-3#3)(1995-6#1)(2011-2#1)(2012-12#1)
of lipogenesis and##2##3##(1994-6#1)(2012-2#1)
of lipogenesis##4##2##(1991-12#1)(1994-6#1)(2010-4#1)(2012-2#1)
of lipoid##2##2##(2008-5#1)(2011-2#1)
of lipolysis##6##2##(1991-10#2)(1991-12#1)(1996-2#1)(1997-7#1)(2008-3#1)
of lipoma##5##2##(1990-12#1)(1990-3#1)(2008-6#1)(2012-1#1)(2013-1#1)
of lipomas##2##2##(1993-9#1)(2011-2#1)
of lipopeptides##3##2##(1994-2#1)(2011-1#2)
of lipoperoxidation##5##2##(2006-8#1)(2008-10#2)(2008-11#1)(2013-1#1)
of lipophilic cationic##2##3##(1996-8#1)(2008-10#1)
of lipophilic cations##2##3##(1996-1#2)
of lipophilic##19##2##(1992-1#1)(1992-6#1)(1996-1#2)(1996-5#1)(1996-8#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-5#4)(2012-11#2)
of lipophilicity##3##2##(1996-4#1)(2005-10#1)(2006-12#1)
of lipopolysaccharide (LPS)##9##3##(1990-5#1)(1991-8#1)(1992-8#1)(1992-9#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2009-12#1)
of lipopolysaccharide and##2##3##(1991-2#1)(1992-9#1)
of lipopolysaccharide##27##2##(1990-2#2)(1990-5#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#3)(1994-9#1)(1995-12#2)(1996-12#5)(1997-2#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-12#1)
of lipopolysaccharide-induced prostaglandin H synthase-2##2##5##(1993-3#2)
of lipopolysaccharides##2##2##(1995-12#1)(1996-5#1)
of lipoprotein (a)##3##3##(1991-12#1)(2008-4#1)(2011-2#1)
of lipoprotein lipase (LPL)##2##4##(2008-11#1)(2008-7#1)
of lipoprotein lipase##12##3##(1991-12#1)(1991-2#1)(1994-2#1)(1997-4#4)(2008-11#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#1)
of lipoprotein metabolism in##3##4##(1990-8#1)(2008-6#2)
of lipoprotein##32##2##(1990-8#3)(1991-12#2)(1991-2#1)(1991-7#1)(1992-12#1)(1994-10#1)(1994-2#1)(1995-5#1)(1996-3#1)(1996-4#2)(1997-1#1)(1997-2#1)(1997-4#5)(2005-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
of lipoprotein(a)##5##2##(1993-12#1)(1993-2#1)(1993-9#1)(1995-2#1)(1996-12#1)
of lipoproteins with heparan sulfate##2##5##(1997-4#2)
of lipoproteins##12##2##(1993-11#1)(1993-9#1)(1994-3#1)(1995-5#1)(1995-8#1)(1996-5#1)(1997-4#3)(2010-12#1)(2012-2#1)(2013-1#1)
of liposarcoma in##2##3##(1991-10#1)(2007-2#1)
of liposarcoma##5##2##(1991-10#1)(1992-10#1)(2007-2#2)(2008-6#1)
of liposomal amphotericin B##2##4##(2008-4#1)(2008-5#1)
of liposomal and##2##3##(1992-6#1)(2005-11#1)
of liposomal##17##2##(1991-3#1)(1991-4#1)(1991-7#1)(1992-6#1)(1994-12#1)(1995-2#1)(1995-5#3)(2005-11#2)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)
of liposome##6##2##(1991-9#1)(1992-6#1)(1996-1#1)(2006-10#1)(2008-10#2)
of liposomes and the##2##4##(1990-11#1)(2008-8#1)
of liposomes and##6##3##(1990-11#1)(1997-1#2)(2005-11#1)(2008-10#1)(2008-8#1)
of liposomes by peritoneal macrophages##2##5##(1992-6#2)
of liposomes by##6##3##(1991-4#1)(1992-6#5)
of liposomes containing##3##3##(1990-11#1)(1994-3#1)(2005-11#1)
of liposomes during##2##3##(1996-1#2)
of liposomes in the##2##4##(2007-8#1)(2008-5#1)
of liposomes in##4##3##(1990-2#1)(1991-9#1)(2007-8#1)(2008-5#1)
of liposomes on##2##3##(1990-2#1)(2008-5#1)
of liposomes using##2##3##(2007-10#1)(2008-10#1)
of liposomes with##3##3##(1990-3#1)(1991-4#1)(1997-3#1)
of liposomes##51##2##(1990-11#3)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#1)(1991-4#3)(1991-9#1)(1992-6#7)(1992-8#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-1#2)(1996-2#1)(1997-1#2)(1997-3#1)(2005-11#4)(2007-10#1)(2007-8#1)(2008-10#8)(2008-5#3)(2008-8#2)
of lipoxins##3##2##(1991-5#2)(2012-12#1)
of lipoxygenase##11##2##(1990-7#1)(1991-2#1)(1991-4#2)(1992-12#2)(1992-3#1)(1994-9#1)(2008-11#2)(2011-10#1)
of lipstick with##2##3##(2008-5#1)(2012-12#1)
of lipstick##6##2##(2008-5#4)(2011-2#1)(2012-12#1)
of liquefied##4##2##(2008-6#1)(2009-10#1)(2013-1#1)(2013-7#1)
of liquid L-dopa/carbidopa in##2##4##(2008-7#2)
of liquid L-dopa/carbidopa##3##3##(2008-7#3)
of liquid and##4##3##(1991-4#1)(2005-11#1)(2008-10#1)(2008-3#1)
of liquid chromatographic##2##3##(1990-7#1)(1997-8#1)
of liquid chromatography with##2##4##(2008-10#1)(2010-4#1)
of liquid crystal##3##3##(2007-12#1)(2008-10#1)(2009-2#1)
of liquid crystalline##2##3##(1996-1#1)(2008-5#1)
of liquid crystals##4##3##(2007-11#1)(2007-12#1)(2008-10#2)
of liquid drops##3##3##(2005-11#3)
of liquid fraction##2##3##(2008-3#1)(2008-6#1)
of liquid in##2##3##(2007-11#1)(2008-2#1)
of liquid ion exchange##2##4##(2008-10#1)(2009-6#1)
of liquid nitrogen##3##3##(1995-11#1)(2007-12#1)(2008-8#1)
of liquid water in the##3##5##(2007-11#2)(2008-2#1)
of liquid water##11##3##(2007-11#3)(2007-9#2)(2008-2#2)(2008-3#4)
of liquid##88##2##(1990-7#1)(1991-4#1)(1992-5#2)(1995-11#2)(1995-3#1)(1996-1#1)(1996-3#1)(1997-8#1)(2005-11#6)(2006-12#1)(2006-4#1)(2007-11#7)(2007-12#5)(2007-9#2)(2008-10#16)(2008-2#9)(2008-3#11)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2009-2#1)(2009-6#1)(2010-12#1)(2010-4#2)(2010-7#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
of liquid-crystal panels##2##3##(2008-2#1)(2008-3#1)
of liquid-crystal televisions##2##3##(2008-2#2)
of liquid-crystal##11##2##(2007-12#1)(2008-2#6)(2008-3#3)(2012-2#1)
of liquid-crystalline##2##2##(1994-8#1)(1996-4#1)
of liquid-liquid extraction##3##3##(2008-10#2)(2008-5#1)
of liquid-phase##3##2##(2007-12#1)(2007-8#1)(2010-7#1)
of liquid/liquid interface##2##3##(2007-8#2)
of liquid/liquid interfacial##2##3##(2007-8#2)
of liquid/liquid##4##2##(2007-8#4)
of liquids and##2##3##(2005-11#1)(2006-12#1)
of liquids into##2##3##(1990-3#1)(2008-10#1)
of liquids with##2##3##(2008-10#1)(2008-2#1)
of liquids##16##2##(1990-3#1)(1994-2#1)(2005-11#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#3)(2008-7#1)
of liquor##2##2##(1992-1#1)(2013-1#1)
of liquorice##2##2##(1996-12#2)
of lisinopril##5##2##(1990-2#1)(1993-3#3)(2011-1#1)
of list length##3##3##(1993-3#1)(2008-6#2)
of list##4##2##(1993-3#1)(2008-6#2)(2008-9#1)
of listed##2##2##(1996-11#1)(2004-12#1)
of listening to##4##3##(2008-11#1)(2013-1#3)
of listening##5##2##(2008-11#1)(2012-2#1)(2013-1#3)
of listeriolysin O by##3##4##(1996-12#3)
of listeriolysin O##5##3##(1996-12#5)
of listeriosis##3##2##(2012-2#1)(2013-1#1)(2013-7#1)
of literacy##2##2##(1994-7#1)(2007-12#1)
of literature and clinical##2##4##(2008-7#2)
of literature and##7##3##(2007-2#1)(2008-11#1)(2008-7#2)(2009-10#1)(2010-7#1)(2011-2#1)
of literature data##2##3##(2008-10#1)(2009-5#1)
of literature exists##2##3##(2007-3#1)(2008-4#1)
of literature focusing##2##3##(2011-1#1)(2012-1#1)
of literature in##2##3##(2006-2#1)(2008-11#1)
of literature is##3##3##(2007-12#1)(2010-11#1)(2010-8#1)
of literature on the##7##4##(1992-8#1)(2006-10#1)(2008-6#1)(2008-8#1)(2009-5#1)(2012-12#1)(2012-2#1)
of literature on##13##3##(1992-8#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-5#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
of literature regarding##4##3##(2006-10#1)(2008-8#1)(2012-2#2)
of literature shows that##2##4##(1990-3#1)(2010-1#1)
of literature suggests##2##3##(2008-11#1)(2008-5#1)
of literature##138##2##(1990-10#1)(1990-3#1)(1991-12#1)(1992-5#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-6#1)(1996-5#1)(2005-11#1)(2005-12#1)(2005-9#1)(2006-10#5)(2006-2#3)(2006-5#2)(2007-1#2)(2007-11#6)(2007-12#2)(2007-2#1)(2007-3#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#5)(2008-12#4)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#4)(2008-7#3)(2008-8#3)(2009-1#1)(2009-10#1)(2009-4#2)(2009-5#4)(2009-6#4)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#3)(2011-2#2)(2012-1#3)(2012-12#5)(2012-2#7)(2012-3#4)(2013-1#10)(2013-7#2)(2013-8#2)
of literature]##8##2##(1996-8#1)(2006-6#1)(2009-5#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-3#2)
of lithiasis##5##2##(1990-5#1)(1991-3#1)(1997-8#1)(2008-10#1)(2011-2#1)
of lithium and a##2##4##(2007-11#1)(2012-12#1)
of lithium and##9##3##(1991-8#1)(1992-8#2)(1997-4#1)(2007-11#1)(2008-10#1)(2008-5#2)(2012-12#1)
of lithium in the##2##4##(1994-8#2)
of lithium in##5##3##(1991-6#2)(1994-8#2)(2008-10#1)
of lithium ions##3##3##(2008-10#2)(2008-2#1)
of lithium niobate##2##3##(2007-11#1)(2008-3#1)
of lithium traces##2##3##(2008-10#2)
of lithium##51##2##(1990-4#1)(1990-7#1)(1991-6#4)(1991-8#2)(1992-2#1)(1992-8#2)(1994-2#1)(1994-8#2)(1996-1#1)(1996-12#1)(1996-5#2)(1997-4#1)(2006-9#1)(2007-11#2)(2008-10#15)(2008-2#3)(2008-3#1)(2008-5#3)(2009-8#1)(2010-4#1)(2010-5#1)(2010-7#1)(2012-12#3)
of lithocholate and its glucuronide and sulfate##2##7##(1991-1#2)
of lithocholate and##3##3##(1991-1#3)
of lithocholate##4##2##(1991-1#4)
of lithocholate-glucuronide and sulfate##2##4##(1991-1#2)
of lithocholate-glucuronide##3##2##(1991-1#3)
of lithocholic acid##3##3##(1993-11#1)(1996-7#2)
of lithographic infrared antennas##2##4##(2008-2#1)(2008-3#1)
of lithographic##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
of lithographically##2##2##(2008-2#1)(2008-7#1)
of lithotripter##2##2##(2008-11#2)
of litterfall##2##2##(2007-5#1)(2008-5#1)
of litters##3##2##(1994-6#2)(2008-10#1)
of little practical##2##3##(2008-3#1)(2009-2#1)
of little value in the##2##5##(1991-2#1)(2006-10#1)
of little value##4##3##(1991-2#1)(1994-6#1)(2006-10#1)(2008-5#1)
of little##21##2##(1991-2#1)(1994-6#1)(1997-8#1)(2006-10#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-2#2)(2009-6#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
of live A##2##3##(2008-9#1)(2013-8#1)
of live ND vaccine in killed-in-oil vaccine##2##7##(2005-9#2)
of live adults##2##3##(2011-2#2)
of live and##2##3##(1996-9#1)(2008-5#1)
of live attenuated##2##3##(2008-11#1)(2010-8#1)
of live bacterial##3##3##(1994-11#1)(2009-8#2)
of live biological##3##3##(2007-11#1)(2008-3#1)(2010-4#1)
of live births##3##3##(1991-3#2)(2006-8#1)
of live born children##2##4##(2006-8#2)
of live born##3##3##(1995-5#1)(2006-8#2)
of live cardiomyocytes##2##3##(2008-3#1)(2011-1#1)
of live cells and##2##4##(2008-7#1)(2009-6#1)
of live cells##7##3##(2008-11#2)(2008-7#1)(2008-9#2)(2009-6#1)(2011-1#1)
of live sperm##3##3##(2008-12#1)(2008-3#2)
of live weight##2##3##(2010-4#2)
of live##68##2##(1990-6#1)(1991-3#2)(1992-4#1)(1994-11#1)(1994-2#1)(1995-5#1)(1995-6#1)(1996-9#1)(2005-10#1)(2005-11#1)(2005-9#3)(2006-5#1)(2006-7#1)(2006-8#3)(2007-11#1)(2007-3#3)(2008-10#3)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#4)(2009-5#1)(2009-6#3)(2009-8#2)(2010-4#3)(2010-8#3)(2011-1#3)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
of live-born##2##2##(2009-3#1)(2010-2#1)
of livedo racemosa##2##3##(1993-1#2)
of liver allograft rejection##2##4##(1995-2#1)(2007-11#1)
of liver and kidney##3##4##(1990-12#1)(2008-9#1)(2009-10#1)
of liver and##14##3##(1990-12#1)(1990-2#1)(1991-7#1)(1994-9#1)(1995-9#1)(1997-1#1)(1997-4#3)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#1)(2011-2#1)
of liver cancer##2##3##(2007-11#1)(2012-3#1)
of liver cell##5##3##(2005-10#1)(2006-10#1)(2008-11#1)(2009-8#1)(2012-1#1)
of liver cells##4##3##(1994-12#1)(1996-5#1)(2009-3#1)(2009-8#1)
of liver cirrhosis##7##3##(1991-10#1)(1995-4#1)(2006-9#1)(2009-8#1)(2011-1#1)(2011-12#1)(2012-2#1)
of liver damage##5##3##(1990-10#1)(2009-8#2)(2010-12#1)(2013-8#1)
of liver disease in##4##4##(2007-7#1)(2008-1#1)(2009-9#1)(2011-2#1)
of liver disease##26##3##(1991-10#1)(1995-3#1)(1995-4#1)(1996-8#1)(2004-11#2)(2005-10#1)(2006-10#1)(2006-2#3)(2007-12#1)(2007-7#2)(2008-1#2)(2009-8#1)(2009-9#2)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
of liver diseases in##2##4##(2008-1#1)(2009-4#1)
of liver diseases##8##3##(1995-4#1)(2005-10#2)(2005-6#1)(2006-2#1)(2008-1#2)(2009-4#1)
of liver enzymes##2##3##(2008-1#1)(2008-3#1)
of liver fibrosis and##3##4##(2012-12#1)(2013-1#1)(2013-8#1)
of liver fibrosis in chronic##2##5##(2006-6#1)(2010-12#1)
of liver fibrosis in##5##4##(2006-6#2)(2010-12#1)(2012-12#1)(2013-1#1)
of liver fibrosis is##2##4##(2012-12#1)(2013-8#1)
of liver fibrosis##18##3##(1997-7#1)(2006-2#1)(2006-6#2)(2009-8#1)(2010-12#2)(2011-12#1)(2012-12#5)(2013-1#3)(2013-8#2)
of liver fluke infection##2##4##(2008-12#2)
of liver fluke##3##3##(2006-10#1)(2008-12#2)
of liver from##2##3##(1994-2#1)(1997-8#1)
of liver function tests##2##4##(1992-2#1)(2007-7#1)
of liver function##7##3##(1992-12#2)(1992-2#1)(1992-5#1)(1995-11#1)(2007-7#1)(2013-8#1)
of liver functions##4##3##(1996-12#1)(2006-2#1)(2008-11#2)
of liver in##3##3##(2010-11#1)(2012-3#1)(2013-8#1)
of liver inflammation##2##3##(1996-9#1)(2012-12#1)
of liver injury during obstructive jaundice##2##6##(2008-4#2)
of liver injury##8##3##(1996-11#1)(1996-9#1)(1997-8#1)(2006-10#2)(2008-4#2)(2012-2#1)
of liver lesions##2##3##(1997-2#1)(2008-7#1)
of liver macrophages##2##3##(1995-5#2)
of liver metastases and##2##4##(2006-6#1)(2008-7#1)
of liver metastases from##2##4##(1995-4#1)(2006-10#1)
of liver metastases of unknown origin##3##6##(2006-10#3)
of liver metastases of##4##4##(2006-10#3)(2010-12#1)
of liver metastases##17##3##(1995-4#1)(1997-6#1)(2006-10#4)(2006-6#3)(2008-7#4)(2008-8#1)(2010-12#2)(2013-1#1)
of liver metastasis from##2##4##(1993-10#1)(2006-10#1)
of liver metastasis##3##3##(1993-10#1)(2006-10#1)(2009-3#1)
of liver microsomal##3##3##(1991-6#1)(1996-2#1)(1997-7#1)
of liver microsomes##2##3##(1992-9#1)(1994-6#1)
of liver of##2##3##(2010-11#1)(2013-1#1)
of liver or##3##3##(1992-7#1)(1993-8#1)(1995-11#1)
of liver regeneration and##2##4##(1994-8#1)(2006-10#1)
of liver regeneration##7##3##(1991-5#1)(1992-4#1)(1994-8#1)(2006-10#1)(2008-8#3)
of liver resection##2##3##(1995-9#1)(2008-3#1)
of liver specific functions##2##4##(2008-11#2)
of liver surgery##2##3##(2008-8#2)
of liver tissue##5##3##(1992-6#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-3#1)
of liver toxicity in##2##4##(1993-12#1)(2005-8#1)
of liver transplant##3##3##(2007-11#1)(2007-12#1)(2007-2#1)
of liver transplantation##7##3##(1993-3#1)(2004-11#1)(2006-2#1)(2007-11#1)(2007-2#1)(2009-8#2)
of liver tumors##6##3##(1990-6#1)(2006-6#4)(2008-10#1)
of liver##308##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-2#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#4)(1995-5#2)(1995-6#3)(1995-9#2)(1996-11#2)(1996-12#1)(1996-2#2)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#4)(1997-6#2)(1997-7#3)(1997-8#4)(2004-11#3)(2004-4#1)(2005-10#5)(2005-6#1)(2005-8#1)(2006-10#13)(2006-2#10)(2006-6#10)(2006-8#2)(2006-9#1)(2007-11#4)(2007-12#2)(2007-2#3)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#2)(2008-1#5)(2008-10#5)(2008-11#5)(2008-12#4)(2008-3#10)(2008-4#4)(2008-6#1)(2008-7#5)(2008-8#8)(2008-9#2)(2009-10#2)(2009-11#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#12)(2009-9#2)(2010-11#2)(2010-12#16)(2010-2#1)(2010-7#1)(2011-1#1)(2011-12#3)(2011-2#7)(2012-1#1)(2012-12#8)(2012-2#6)(2012-3#4)(2013-1#11)(2013-8#7)
of liver-derived##2##2##(1995-2#2)
of liver-specific##3##2##(1990-11#1)(2008-11#1)(2008-7#1)
of liver/bone/kidney alkaline phosphatase was##2##5##(1993-11#2)
of liver/bone/kidney##3##2##(1993-11#3)
of livers##3##2##(1991-6#1)(1994-6#1)(2006-8#1)
of livestock diseases in##2##4##(2006-10#1)(2010-1#1)
of livestock production##2##3##(2011-2#2)
of livestock##13##2##(1990-3#1)(1997-7#1)(2004-11#1)(2005-5#1)(2006-10#1)(2009-2#1)(2010-1#1)(2011-2#6)
of living and##3##3##(2007-8#1)(2008-5#1)(2010-9#1)
of living animals##5##3##(2008-10#1)(2008-9#1)(2009-2#1)(2009-4#2)
of living biological##2##3##(2007-12#1)(2012-1#1)
of living cells and##4##4##(2007-11#1)(2008-1#1)(2008-11#1)(2009-7#1)
of living cells is##2##4##(2008-3#1)(2008-7#1)
of living cells##21##3##(1992-5#2)(1993-6#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#2)(2008-1#3)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#2)(2009-7#1)(2010-12#1)(2011-1#1)
of living donor kidney transplantation##2##5##(2011-2#2)
of living donor##9##3##(2006-10#1)(2009-2#2)(2009-8#1)(2011-2#4)(2013-8#1)
of living donors##4##3##(1995-2#1)(2006-10#1)(2008-12#1)(2011-2#1)
of living donors]##2##3##(2011-2#2)
of living has##2##3##(2007-11#1)(2008-11#1)
of living in a disrupted situation as partner to a##2##10##(2009-5#2)
of living in a##4##4##(1992-3#1)(2004-12#1)(2009-5#2)
of living in##6##3##(1992-3#1)(1993-1#1)(2004-12#1)(2009-5#2)(2011-2#1)
of living organisms##4##3##(1992-11#1)(2009-5#1)(2009-8#1)(2010-11#1)
of living systems##2##3##(2008-1#1)(2012-2#1)
of living tissue##2##3##(1997-5#1)(2011-1#1)
of living tissues##3##3##(2006-6#1)(2007-8#1)(2012-2#1)
of living with##4##3##(2008-12#1)(2008-2#1)(2010-10#1)(2013-1#1)
of living##116##2##(1991-12#2)(1991-3#1)(1992-11#1)(1992-3#1)(1992-5#3)(1993-1#2)(1993-11#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-10#1)(1995-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-11#1)(2004-12#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-6#2)(2006-7#3)(2007-11#3)(2007-12#3)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#5)(2008-10#7)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#3)(2009-7#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#12)(2012-1#1)(2012-11#1)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
of living'##2##2##(2008-12#1)(2010-9#1)
of living-donor kidney transplantation]##4##4##(2011-2#4)
of living-donor kidney##5##3##(2011-2#5)
of lizards##5##2##(1991-5#1)(2008-7#1)(2010-3#2)(2011-2#1)
of lm mice##2##3##(2008-10#2)
of ln##3##2##(1997-2#1)(2005-11#1)(2006-10#1)
of load##11##2##(1993-12#1)(1993-5#2)(2006-11#2)(2007-1#1)(2007-4#1)(2010-3#1)(2012-2#1)(2013-1#2)
of load-bearing bone##2##3##(2009-7#2)
of loaded##5##2##(1996-4#1)(2006-9#1)(2008-10#3)
of loading and##3##3##(2005-11#1)(2008-10#2)
of loading rate on##3##4##(2007-4#3)
of loading rate##4##3##(2007-4#4)
of loading##30##2##(1996-5#1)(2005-11#1)(2005-4#1)(2006-11#3)(2007-4#13)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#4)(2009-7#1)(2009-9#1)
of lobar and segmental##2##4##(2008-5#1)(2012-2#1)
of lobar##3##2##(2008-2#1)(2008-5#1)(2012-2#1)
of lobbying##2##2##(1996-3#1)(2007-9#1)
of lobster##3##2##(1990-2#2)(1996-9#1)
of lobule VII##3##3##(1994-2#3)
of local adaptation##2##3##(2012-7#2)
of local anaesthetic##5##3##(1991-6#1)(2006-10#2)(2008-3#1)(2011-1#1)
of local anaesthetics##7##3##(1990-11#1)(1997-3#1)(2006-10#2)(2008-3#1)(2010-7#1)(2013-7#1)
of local and imported##3##4##(2006-1#2)(2008-10#1)
of local and regional##2##4##(2008-8#1)(2011-12#1)
of local and systemic##5##4##(1991-8#1)(1995-5#1)(2008-10#1)(2011-2#1)(2012-2#1)
of local and##19##3##(1991-8#1)(1995-5#1)(1996-1#1)(1996-5#1)(2006-1#2)(2007-4#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-6#1)(2008-8#2)(2011-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
of local anesthesia patients##2##4##(1996-12#2)
of local anesthesia##3##3##(1996-12#2)(2009-5#1)
of local anesthetic##9##3##(1995-3#1)(2006-10#1)(2006-7#1)(2006-8#3)(2007-10#1)(2012-3#1)(2013-1#1)
of local anesthetics##6##3##(1993-1#1)(2006-10#1)(2006-8#2)(2007-2#1)(2009-3#1)
of local bone##2##3##(2008-8#1)(2009-10#1)
of local circuit##2##3##(1991-10#1)(1995-11#1)
of local control in##2##4##(1992-10#1)(1994-4#1)
of local control##5##3##(1991-4#1)(1992-10#1)(1994-4#1)(2008-6#2)
of local environmental##2##3##(2008-10#1)(2010-6#1)
of local flaps to##2##4##(2009-9#1)(2011-12#1)
of local government##2##3##(2007-7#1)(2013-1#1)
of local habitats##2##3##(2008-8#2)
of local health##4##3##(1993-3#1)(2007-3#1)(2008-1#1)(2012-3#1)
of local immune##2##3##(2006-10#1)(2007-2#1)
of local infection##3##3##(2005-10#1)(2006-10#1)(2009-4#1)
of local infections##2##3##(2008-4#1)(2008-5#1)
of local inflammation##4##3##(1994-11#1)(2006-6#1)(2012-12#1)(2013-1#1)
of local interactions##3##3##(1995-4#1)(1997-2#1)(2008-7#1)
of local or distant##3##4##(1990-6#1)(1991-9#1)(2006-12#1)
of local or##5##3##(1990-6#2)(1991-9#1)(2006-12#1)(2007-8#1)
of local origin##3##3##(1991-8#1)(2008-10#2)
of local patients##2##3##(2007-8#1)(2008-1#1)
of local planes##2##3##(2008-2#2)
of local political##2##3##(1997-3#1)(2006-8#1)
of local populations##2##3##(2008-10#1)(2010-1#1)
of local recidives and##2##4##(2006-6#1)(2012-3#1)
of local recurrence and distant##2##5##(2007-12#1)(2010-3#1)
of local recurrence and##4##4##(2007-12#1)(2008-11#1)(2010-12#1)(2010-3#1)
of local recurrence or##3##4##(1993-11#1)(2007-12#1)(2008-6#1)
of local recurrence was##2##4##(2008-6#1)(2011-1#1)
of local recurrence##22##3##(1993-11#1)(1993-4#1)(2006-9#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#7)(2010-12#1)(2010-3#2)(2011-1#1)(2011-2#1)(2013-1#2)
of local recurrences after##2##4##(2006-6#1)(2007-5#1)
of local recurrences##5##3##(1991-9#1)(2006-6#1)(2007-5#1)(2008-6#1)(2012-12#1)
of local relapse##2##3##(2007-12#1)(2008-6#1)
of local relapses##2##3##(1990-3#2)
of local therapy##4##3##(2004-1#1)(2008-6#1)(2011-12#1)(2011-2#1)
of local trauma##2##3##(2007-2#1)(2007-5#1)
of local treatment##2##3##(2008-11#1)(2009-2#1)
of local wheat##2##3##(2008-10#1)(2013-8#1)
of local##318##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-10#2)(1991-4#2)(1991-6#1)(1991-8#3)(1991-9#3)(1992-10#2)(1992-12#1)(1992-4#1)(1993-1#2)(1993-11#2)(1993-3#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-2#2)(1994-4#1)(1994-5#1)(1995-11#2)(1995-3#1)(1995-4#1)(1995-5#4)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-5#2)(1997-6#2)(2004-1#1)(2004-2#1)(2005-10#1)(2005-12#2)(2006-1#2)(2006-10#11)(2006-12#1)(2006-4#3)(2006-6#3)(2006-7#1)(2006-8#8)(2006-9#2)(2007-10#2)(2007-11#7)(2007-12#6)(2007-2#5)(2007-3#2)(2007-4#4)(2007-5#2)(2007-7#1)(2007-8#5)(2008-1#7)(2008-10#15)(2008-11#6)(2008-12#6)(2008-2#7)(2008-3#9)(2008-4#5)(2008-5#3)(2008-6#16)(2008-7#6)(2008-8#12)(2008-9#4)(2009-10#3)(2009-12#2)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#4)(2010-1#2)(2010-12#3)(2010-3#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#4)(2011-2#7)(2011-3#1)(2011-9#1)(2012-1#1)(2012-12#3)(2012-2#8)(2012-3#6)(2012-7#2)(2013-1#9)(2013-7#3)(2013-8#4)
of local-regional##3##2##(1991-4#1)(1992-12#1)(2009-3#1)
of localisation##2##2##(1993-9#1)(2006-10#1)
of localised##4##2##(2007-11#2)(2007-7#1)(2013-7#1)
of localization in the##2##4##(2007-11#1)(2007-12#1)
of localization of##6##3##(1991-3#1)(1995-5#1)(2008-10#1)(2010-8#1)(2012-12#2)
of localization##12##2##(1991-11#1)(1991-3#1)(1995-5#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-3#1)(2010-8#1)(2012-12#2)
of localized folate##2##3##(1992-9#2)
of localized optical modes##2##4##(2007-12#2)
of localized prostate cancer##3##4##(1995-4#1)(2005-8#1)(2013-1#1)
of localized##45##2##(1990-12#1)(1991-9#1)(1992-7#1)(1992-9#2)(1993-3#1)(1995-2#1)(1995-4#2)(1997-3#1)(1997-7#1)(2005-11#1)(2005-8#1)(2007-12#5)(2007-3#1)(2007-7#3)(2007-9#1)(2008-10#2)(2008-3#2)(2008-9#1)(2009-4#2)(2009-8#1)(2010-3#1)(2010-6#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#3)
of localizing##2##2##(2007-12#1)(2009-8#1)
of locally advanced NSCLC##3##4##(2007-8#2)(2008-10#1)
of locally advanced breast cancer with##2##6##(1991-8#1)(1994-2#1)
of locally advanced breast cancer##7##5##(1991-8#3)(1993-11#1)(1994-2#1)(1996-4#1)(2007-5#1)
of locally advanced breast##8##4##(1991-8#3)(1993-11#1)(1994-2#1)(1996-4#1)(2007-5#1)(2008-9#1)
of locally advanced esophageal cancer##2##5##(2009-3#1)(2009-5#1)
of locally advanced head and neck cancer##2##7##(1990-6#1)(1993-9#1)
of locally advanced head and neck##3##6##(1990-6#1)(1993-9#1)(1995-9#1)
of locally advanced##24##3##(1990-12#1)(1990-6#2)(1991-8#3)(1992-3#2)(1993-11#1)(1993-9#1)(1994-2#1)(1995-8#1)(1995-9#1)(1996-4#1)(1997-7#1)(2007-5#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-12#1)
of locally recurrent##3##3##(2008-6#2)(2012-1#1)
of locally##48##2##(1990-12#1)(1990-6#3)(1991-8#3)(1992-3#3)(1992-9#1)(1993-11#1)(1993-9#1)(1994-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-4#2)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-2#2)(2008-6#2)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-1#1)(2013-1#1)
of locating the##3##3##(1993-1#1)(2008-2#2)
of locating##4##2##(1993-1#1)(2008-2#3)
of location and##4##3##(1994-4#1)(1994-8#1)(1997-2#1)(2008-7#1)
of location shift##2##3##(1996-3#2)
of location theory##2##3##(1996-1#2)
of location##17##2##(1994-4#1)(1994-8#1)(1995-11#1)(1996-1#3)(1996-3#2)(1996-5#1)(1997-2#1)(1997-8#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2009-6#1)
of location-specific##2##2##(1996-6#1)(2013-1#1)
of locations##5##2##(1995-12#1)(2007-5#2)(2008-10#1)(2008-5#1)
of loci##7##2##(1994-3#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2012-3#1)
of locked##2##2##(2008-4#1)(2008-9#1)
of locking##2##2##(2009-3#1)(2012-3#1)
of loco-regional##5##2##(1990-12#1)(1990-3#1)(1992-6#1)(2006-6#1)(2008-6#1)
of locomotion and##2##3##(1993-6#1)(1996-1#1)
of locomotion in##2##3##(1993-3#1)(1995-5#1)
of locomotion##12##2##(1991-1#1)(1991-5#1)(1993-3#2)(1993-6#2)(1995-5#1)(1996-1#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-9#1)
of locomotor activity##11##3##(1992-3#2)(1994-2#1)(1995-10#1)(1996-1#1)(1996-9#1)(1997-2#1)(1997-5#1)(2008-5#1)(2012-2#1)(2013-1#1)
of locomotor sensitization##2##3##(1993-3#1)(2011-2#1)
of locomotor##24##2##(1992-12#1)(1992-3#2)(1993-3#2)(1994-2#2)(1994-3#1)(1994-6#1)(1995-10#1)(1996-1#1)(1996-9#1)(1997-2#2)(1997-5#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
of locoregional and systemic##2##4##(2006-6#1)(2012-12#1)
of locoregional##11##2##(1993-11#1)(1996-10#1)(2006-10#1)(2006-6#4)(2007-12#1)(2012-12#1)(2012-2#2)
of locus coeruleus##3##3##(1992-9#1)(1993-2#1)(1993-7#1)
of locus of control and social support##2##7##(1996-2#2)
of locus##7##2##(1992-1#1)(1992-9#1)(1993-2#1)(1993-7#1)(1996-2#2)(2008-10#1)
of locust##2##2##(1991-10#1)(1991-5#1)
of lodgepole pine##2##3##(2013-1#2)
of log 5##2##3##(2008-10#1)(2008-5#1)
of log P##2##3##(2005-10#2)
of log##13##2##(1991-9#2)(1992-3#1)(1995-3#1)(1995-6#1)(2005-10#2)(2007-11#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-5#1)
of log-normal##2##2##(2006-12#1)(2007-12#1)
of logging##2##2##(2008-3#1)(2008-5#1)
of logical##2##2##(2007-12#1)(2008-7#1)
of logistic regression##5##3##(1997-8#1)(2007-8#1)(2008-11#1)(2009-5#1)(2013-8#1)
of logistic##8##2##(1992-9#1)(1997-8#1)(2005-7#1)(2007-8#1)(2008-11#1)(2009-4#1)(2009-5#1)(2013-8#1)
of logistical problems##2##3##(1993-2#1)(2008-11#1)
of logistical##3##2##(1993-2#1)(2007-8#1)(2008-11#1)
of lola##4##2##(2012-12#4)
of lometrexol in plasma##2##4##(1996-8#2)
of lometrexol##4##2##(1996-8#4)
of loneliness##6##2##(2007-11#1)(2009-12#1)(2010-12#1)(2011-2#1)(2013-8#2)
of long acting##3##3##(1993-2#1)(2006-10#1)(2008-1#1)
of long bone fractures##2##4##(2007-11#2)
of long bone##6##3##(2007-11#4)(2010-6#1)(2013-1#1)
of long bones and##2##4##(2007-5#1)(2007-7#1)
of long bones##14##3##(1993-10#1)(2007-11#5)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-7#1)(2009-1#1)(2009-9#1)(2013-1#1)
of long chain acyl-ACP##2##4##(1995-6#2)
of long chain fatty acids##3##5##(1994-11#1)(1994-9#1)(2008-10#1)
of long chain fatty##4##4##(1993-8#1)(1994-11#1)(1994-9#1)(2008-10#1)
of long chain##9##3##(1993-8#1)(1994-11#1)(1994-9#1)(1995-6#3)(2008-10#1)(2009-6#1)(2010-4#1)
of long duration##11##3##(1991-2#1)(1992-10#1)(1996-12#1)(2007-7#3)(2007-8#1)(2008-3#1)(2008-7#1)(2013-1#2)
of long filamentous##2##3##(1991-12#1)(2011-2#1)
of long single-mode##2##3##(2007-12#2)
of long standing##4##3##(1996-2#1)(1997-1#1)(2008-4#1)(2012-2#1)
of long term##28##3##(1991-12#2)(1993-10#1)(1994-12#1)(1994-6#1)(2006-7#1)(2006-9#1)(2007-11#7)(2007-12#1)(2007-2#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#3)
of long wavelength##2##3##(2006-4#1)(2011-7#1)
of long##136##2##(1990-7#1)(1990-9#1)(1991-12#4)(1991-2#1)(1991-8#1)(1992-10#1)(1993-10#2)(1993-2#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-6#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#2)(1997-1#1)(1997-4#1)(1997-5#4)(1997-6#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-4#1)(2006-7#1)(2006-9#1)(2007-11#17)(2007-12#10)(2007-2#2)(2007-5#1)(2007-7#7)(2007-8#3)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#7)(2009-1#1)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#3)(2011-7#1)(2012-2#1)(2013-1#8)(2013-7#1)
of long-acting##6##2##(1996-11#1)(2006-1#1)(2006-10#1)(2009-6#1)(2013-1#1)(2013-8#1)
of long-chain acyl-CoA##2##3##(1994-8#1)(1997-4#1)
of long-chain fatty acids##5##4##(1990-4#1)(1990-5#1)(2008-3#1)(2008-4#1)(2008-5#1)
of long-chain fatty##6##3##(1990-4#1)(1990-5#1)(1995-3#1)(2008-3#1)(2008-4#1)(2008-5#1)
of long-chain##15##2##(1990-4#1)(1990-5#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-5#1)(1997-4#1)(2005-11#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-1#2)
of long-distance##7##2##(1991-5#1)(2007-12#1)(2008-10#3)(2010-8#1)(2012-3#1)
of long-form PDGF-A chain##4##4##(1995-2#4)
of long-lasting##5##2##(1993-2#1)(1996-10#1)(1997-6#1)(2005-7#1)(2008-4#1)
of long-lived##8##2##(1992-6#1)(1994-5#1)(1995-12#1)(1995-8#1)(1996-3#1)(2008-3#1)(2012-2#1)(2012-5#1)
of long-period fiber gratings in B/Ge codoped fiber##2##8##(2007-12#2)
of long-period fiber gratings##8##4##(2007-11#3)(2007-12#3)(2008-3#2)
of long-period gratings##2##3##(2007-11#2)
of long-period##13##2##(2007-11#6)(2007-12#4)(2008-10#1)(2008-3#2)
of long-range##12##2##(1991-6#1)(1995-10#1)(1995-5#1)(1995-7#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-8#1)(2012-3#1)
of long-ranging##2##2##(1992-9#1)(2006-5#1)
of long-standing pain at the tumour site##2##7##(2008-6#2)
of long-standing##9##2##(1990-12#1)(1992-9#1)(2006-7#1)(2007-10#1)(2008-6#2)(2008-8#1)(2009-10#1)(2012-2#1)
of long-term administration of##5##4##(1991-12#1)(1995-3#1)(2008-10#1)(2008-5#1)(2009-8#1)
of long-term and##2##3##(1995-12#1)(2010-12#1)
of long-term care facilities##2##4##(1996-2#1)(2011-2#1)
of long-term care##19##3##(1990-12#1)(1992-3#4)(1993-12#1)(1994-2#1)(1995-3#4)(1996-2#1)(2006-3#1)(2008-1#1)(2008-2#1)(2011-2#1)(2012-1#1)(2012-12#2)
of long-term clinical##2##3##(1996-9#1)(2013-1#1)
of long-term complications##3##3##(1993-9#1)(2007-3#1)(2008-7#1)
of long-term depression##3##3##(1995-11#1)(1997-7#1)(2012-2#1)
of long-term disability for##3##4##(2005-8#1)(2013-1#2)
of long-term efficacy##2##3##(2005-11#1)(2009-8#1)
of long-term exposure to##2##4##(2004-4#1)(2006-12#1)
of long-term follow-up##3##3##(2006-10#1)(2009-12#1)(2012-2#1)
of long-term high##2##3##(2008-5#1)(2009-4#1)
of long-term management of##2##4##(2007-8#1)(2011-2#1)
of long-term management##3##3##(1996-7#1)(2007-8#1)(2011-2#1)
of long-term memory##7##3##(1992-11#1)(1994-2#1)(1994-5#1)(1995-6#1)(2006-3#1)(2007-8#1)(2013-1#1)
of long-term monitoring##2##3##(2008-3#1)(2008-9#1)
of long-term mortality##2##3##(2007-10#1)(2012-2#1)
of long-term outcome in##2##4##(1995-2#1)(2007-7#1)
of long-term outcome##4##3##(1992-12#1)(1995-2#1)(2007-7#1)(2008-11#1)
of long-term outcomes##2##3##(2008-9#1)(2009-8#1)
of long-term potentiation (LTP) in the##3##6##(1990-5#1)(1995-3#1)(2008-7#1)
of long-term potentiation (LTP) in##5##5##(1990-5#1)(1991-3#1)(1995-3#1)(1996-5#1)(2008-7#1)
of long-term potentiation (LTP) was##2##5##(1995-12#2)
of long-term potentiation (LTP)##13##4##(1990-5#1)(1991-3#1)(1991-6#1)(1995-12#3)(1995-3#1)(1996-1#1)(1996-5#1)(1996-6#1)(1997-4#1)(2008-7#1)(2011-2#1)
of long-term potentiation in the rat##2##6##(1990-5#1)(1994-2#1)
of long-term potentiation in the##7##5##(1990-4#1)(1990-5#1)(1994-2#1)(1995-12#2)(1997-1#1)(2008-7#1)
of long-term potentiation in##10##4##(1990-4#1)(1990-5#1)(1992-3#1)(1994-2#1)(1995-12#2)(1997-1#1)(1997-4#1)(1997-8#1)(2008-7#1)
of long-term potentiation##32##3##(1990-4#1)(1990-5#3)(1991-12#1)(1991-3#2)(1991-6#1)(1991-8#1)(1992-3#1)(1994-2#3)(1995-12#5)(1995-3#1)(1996-1#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-4#3)(1997-8#1)(2008-1#1)(2008-7#2)(2011-2#1)
of long-term results of##2##4##(1996-12#1)(2007-9#1)
of long-term results##4##3##(1993-10#1)(1996-12#1)(2007-9#1)(2008-3#1)
of long-term sleep deprivation##2##4##(1991-10#2)
of long-term survival##8##3##(1996-12#1)(1997-3#1)(2006-10#1)(2007-12#1)(2007-9#1)(2011-2#2)(2011-3#1)
of long-term survivors##3##3##(2007-8#1)(2010-11#1)(2010-3#1)
of long-term treatment##6##3##(1992-9#1)(1995-1#1)(1995-12#1)(2008-3#1)(2010-6#1)(2013-1#1)
of long-term##218##2##(1990-12#3)(1990-3#1)(1990-4#4)(1990-5#3)(1991-10#2)(1991-12#2)(1991-3#2)(1991-6#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#5)(1992-6#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-2#6)(1994-5#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#7)(1995-2#1)(1995-3#6)(1995-5#2)(1995-6#1)(1995-7#1)(1996-1#2)(1996-12#3)(1996-2#1)(1996-5#2)(1996-6#2)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#3)(1997-7#2)(1997-8#1)(2004-4#1)(2005-1#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-12#2)(2006-2#2)(2006-3#2)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-12#4)(2007-2#1)(2007-3#2)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#4)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#3)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#9)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#10)(2013-7#1)(2013-8#1)
of long-term-care##2##2##(1996-12#1)(2008-5#1)
of longer duration##8##3##(1996-5#1)(2005-1#1)(2006-10#1)(2007-2#1)(2008-11#1)(2008-5#2)(2008-7#1)
of longer latency##2##3##(1993-12#1)(2010-8#1)
of longer pulse duration##2##4##(2009-8#2)
of longer##29##2##(1991-12#1)(1992-3#1)(1993-12#1)(1994-8#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-8#1)(2004-1#1)(2005-1#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#2)(2009-6#1)(2009-8#2)(2010-11#1)(2010-8#1)(2012-3#1)
of longer-term##2##2##(2006-10#1)(2008-12#1)
of longevity in##2##3##(1995-6#1)(2008-7#1)
of longevity##8##2##(1991-10#1)(1992-11#1)(1995-6#1)(2006-11#1)(2008-7#1)(2009-5#1)(2010-3#1)(2012-2#1)
of longissimus dorsi muscle##2##4##(2010-4#2)
of longitudinal axons##2##3##(2008-2#2)
of longitudinal data##5##3##(1993-9#1)(1994-6#1)(1996-12#1)(1997-8#1)(2011-1#1)
of longitudinal##25##2##(1992-3#1)(1993-9#1)(1994-6#1)(1995-4#1)(1996-11#1)(1996-12#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-6#1)(2006-9#2)(2008-10#1)(2008-2#3)(2008-3#2)(2008-8#1)(2009-7#1)(2009-8#1)(2010-2#1)(2011-1#2)(2012-1#1)
of longterm##2##2##(2007-2#1)(2010-5#1)
of lonidamine##3##2##(1991-2#1)(1993-11#1)(1994-4#1)
of looking##5##2##(1994-2#1)(2008-4#1)(2009-8#1)(2010-4#1)(2011-1#1)
of loop electrosurgical excision procedure##2##5##(2006-10#2)
of loop##15##2##(1992-11#1)(1992-3#1)(1992-4#1)(1994-9#1)(1995-1#1)(1997-7#1)(2004-10#1)(2006-10#2)(2008-2#1)(2008-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
of loops and##2##3##(1990-5#1)(1991-6#1)
of loops##4##2##(1990-5#1)(1991-6#1)(1994-11#1)(1994-9#1)
of loose##4##2##(2006-6#1)(2007-11#1)(2008-5#1)(2008-8#1)
of loosely##4##2##(2006-10#1)(2008-10#1)(2009-12#1)(2012-3#1)
of lopinavir and ritonavir in human##2##6##(2011-3#2)
of lorazepam and##2##3##(2008-1#1)(2008-10#1)
of lorazepam##5##2##(2008-1#1)(2008-10#4)
of lordosis##4##2##(1993-6#3)(2007-7#1)
of losartan##5##2##(1995-11#1)(1997-7#1)(2011-2#3)
of losing the##2##3##(1992-5#1)(1994-1#1)
of losing##13##2##(1991-4#1)(1991-8#1)(1992-5#1)(1994-1#1)(1995-12#1)(1996-11#1)(2007-12#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-8#1)(2009-9#1)
of loss and##2##3##(2007-11#1)(2008-12#1)
of loss in##2##3##(2008-3#1)(2008-8#1)
of loss of consciousness##3##4##(1992-6#1)(1996-6#1)(2008-11#1)
of loss of heterozygosity on##2##5##(1990-9#2)
of loss of heterozygosity##5##4##(1990-9#4)(2012-3#1)
of loss of##27##3##(1990-4#1)(1990-9#4)(1991-11#1)(1991-9#1)(1992-1#1)(1992-6#1)(1994-12#1)(1994-3#1)(1994-8#1)(1996-6#1)(2005-11#1)(2006-4#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-5#1)(2010-9#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
of loss##48##2##(1990-4#1)(1990-9#4)(1991-11#1)(1991-9#1)(1992-1#1)(1992-6#1)(1993-3#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(2005-11#1)(2006-4#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#3)(2009-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-12#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
of losses in##2##3##(2008-10#1)(2008-3#1)
of losses##5##2##(1993-12#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
of lossless##2##2##(2008-2#2)
of lost##13##2##(1991-2#1)(1992-6#1)(2007-6#3)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-10#1)(2011-2#3)
of loteprednol etabonate##2##3##(2007-11#2)
of louse##3##2##(1996-12#1)(2004-4#1)(2010-2#1)
of lovastatin therapy##2##3##(1991-7#1)(2005-8#1)
of lovastatin##21##2##(1991-2#2)(1991-7#5)(1992-11#1)(1992-5#1)(1992-8#1)(1993-9#2)(1994-8#2)(1994-9#1)(2005-8#1)(2006-5#2)(2008-7#2)(2012-11#1)
of love##3##2##(1990-12#1)(1993-10#1)(2009-12#1)
of low (0##2##3##(1991-11#1)(1995-10#1)
of low LDL-C with##2##4##(2012-6#2)
of low LDL-C##3##3##(2012-6#3)
of low LET radiation##8##4##(2008-7#8)
of low SES##2##3##(2011-1#2)
of low abundance##3##3##(1990-8#1)(1997-2#1)(2008-4#1)
of low affinity binding sites##2##5##(1990-5#1)(1992-4#1)
of low affinity##5##3##(1990-5#1)(1991-1#1)(1991-2#1)(1992-4#1)(1995-5#1)
of low amounts of##6##4##(1996-5#1)(2008-10#2)(2008-6#1)(2010-5#1)(2011-1#1)
of low and high##5##4##(1992-11#1)(1995-11#1)(2008-10#1)(2011-2#1)(2013-8#1)
of low and##7##3##(1992-11#1)(1994-11#1)(1995-11#1)(2007-11#1)(2008-10#1)(2011-2#1)(2013-8#1)
of low attenuation with##2##4##(2006-5#1)(2012-2#1)
of low attenuation##4##3##(2006-5#1)(2007-8#2)(2012-2#1)
of low back and##3##4##(2006-8#1)(2007-6#1)(2008-12#1)
of low back pain (LBP)##2##5##(2010-12#1)(2010-9#1)
of low back pain and##4##5##(2006-8#3)(2010-1#1)
of low back pain are##2##5##(2006-8#1)(2007-8#1)
of low back pain in##3##5##(2009-4#2)(2010-10#1)
of low back pain is##2##5##(2006-8#2)
of low back pain with##2##5##(2006-11#1)(2006-8#1)
of low back pain##42##4##(1993-11#3)(1993-6#1)(2006-11#1)(2006-8#18)(2007-11#2)(2007-6#1)(2007-8#4)(2008-12#2)(2009-4#2)(2009-5#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-9#2)(2012-12#1)(2013-8#1)
of low back##47##3##(1993-11#3)(1993-6#1)(2006-11#1)(2006-8#21)(2007-11#2)(2007-6#2)(2007-8#4)(2008-12#3)(2009-4#2)(2009-5#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-9#2)(2012-12#1)(2013-8#1)
of low birth weight infants##2##5##(1993-3#1)(2006-12#1)
of low birth weight##10##4##(1991-12#1)(1992-2#1)(1993-1#1)(1993-3#1)(1993-6#1)(1995-12#1)(2006-12#1)(2007-7#1)(2008-11#1)(2008-9#1)
of low blood##4##3##(2006-10#1)(2007-11#1)(2009-4#1)(2013-1#1)
of low concentration of##3##4##(2005-11#1)(2010-5#1)(2011-1#1)
of low concentration##6##3##(1991-12#1)(2005-11#1)(2008-10#2)(2010-5#1)(2011-1#1)
of low concentrations of##9##4##(1992-7#1)(1994-9#1)(1997-3#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-7#1)
of low concentrations##13##3##(1992-7#1)(1994-2#1)(1994-9#1)(1997-3#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-7#1)(2013-8#1)
of low contrast detectability##2##4##(2012-1#2)
of low contrast##5##3##(2012-1#5)
of low copy number targets##2##5##(1996-11#2)
of low copy number##3##4##(1994-10#1)(1996-11#2)
of low copy##4##3##(1994-10#1)(1996-11#2)(2008-8#1)
of low cost##2##3##(2006-10#1)(2008-10#1)
of low current measurement systems for biomedical applications##2##8##(2013-7#2)
of low current##4##3##(2013-7#4)
of low density lipoprotein (LDL) receptors##3##6##(1990-11#1)(1993-9#1)(1995-8#1)
of low density lipoprotein (LDL) to##2##6##(1991-5#1)(2004-11#1)
of low density lipoprotein (LDL)##11##5##(1990-11#1)(1991-5#1)(1992-5#1)(1993-9#2)(1994-9#1)(1995-1#1)(1995-8#1)(1996-5#1)(1997-2#1)(2004-11#1)
of low density lipoprotein oxidation##2##5##(1997-8#1)(2011-2#1)
of low density lipoprotein##19##4##(1990-11#1)(1991-12#1)(1991-5#1)(1992-2#1)(1992-5#1)(1993-9#2)(1994-9#1)(1995-1#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-8#1)(2004-11#1)(2005-8#1)(2008-8#1)(2010-8#1)(2011-2#1)
of low density lipoproteins (LDL)##6##5##(1991-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1996-5#1)(2011-2#1)
of low density lipoproteins by##2##5##(1991-11#1)(1991-5#1)
of low density lipoproteins##14##4##(1991-11#2)(1991-5#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-5#2)(1995-8#1)(1996-5#2)(2011-2#1)
of low density##37##3##(1990-11#1)(1991-11#3)(1991-12#1)(1991-5#3)(1992-2#1)(1992-5#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-3#1)(1994-9#1)(1995-1#1)(1995-5#2)(1995-8#2)(1996-5#3)(1997-1#1)(1997-2#1)(1997-8#1)(2004-11#1)(2004-9#1)(2005-8#1)(2006-2#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#2)
of low dielectric##4##3##(1994-8#1)(2008-10#3)
of low dose exposures##2##4##(2008-7#2)
of low dose##13##3##(2006-10#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-7#4)(2009-4#1)(2011-1#1)(2012-1#2)(2012-2#1)
of low doses of ionizing##2##5##(2011-1#1)(2013-1#1)
of low doses of radiation due to##2##7##(1996-3#2)
of low doses of radiation##4##5##(1996-3#2)(2008-7#2)
of low doses of##16##4##(1990-5#1)(1993-1#1)(1993-4#1)(1994-5#2)(1996-3#2)(1997-5#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2011-1#1)(2013-1#2)
of low dozes of ionizing radiation on##2##7##(2008-8#2)
of low dozes of##3##4##(2008-8#3)
of low energy##4##3##(1992-9#1)(1993-5#1)(2005-4#2)
of low fertility##3##3##(2008-10#1)(2009-10#1)(2010-8#1)
of low folate levels##2##4##(2008-7#2)
of low frequency##3##3##(1992-3#1)(1993-8#1)(2011-2#1)
of low glycemic index foods##2##5##(2006-10#2)
of low grade malignancy##2##4##(1996-9#1)(2010-7#1)
of low grade##6##3##(1996-9#1)(2008-6#1)(2009-8#1)(2010-7#2)(2012-2#1)
of low income families##2##4##(1991-3#1)(1997-4#1)
of low income##6##3##(1991-3#1)(1994-12#1)(1995-12#1)(1997-4#1)(2008-9#1)(2010-12#1)
of low ionic strength##4##4##(1993-3#1)(1994-5#1)(2010-12#1)(2011-2#1)
of low level vancomycin resistance in##2##6##(2007-7#2)
of low level##7##3##(1995-3#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
of low levels of##15##4##(1993-4#1)(1996-8#1)(2006-12#1)(2006-6#1)(2008-10#7)(2008-11#1)(2008-5#1)(2011-2#2)
of low levels##17##3##(1993-4#1)(1996-8#1)(2006-12#1)(2006-6#1)(2007-2#1)(2008-10#8)(2008-11#1)(2008-5#1)(2011-2#2)
of low malignancy tumor nests##2##5##(2008-5#2)
of low malignancy##4##3##(1992-4#1)(1995-11#1)(2008-5#2)
of low malignant potential##2##4##(2011-1#1)(2013-1#1)
of low micromolar concentrations of##2##5##(1994-2#1)(1995-11#1)
of low molecular mass GTP-binding proteins##2##6##(1991-11#1)(1993-6#1)
of low molecular mass##5##4##(1990-4#1)(1991-11#1)(1993-6#1)(1994-12#1)(2008-10#1)
of low molecular weight GTP-binding proteins##2##6##(1992-8#2)
of low molecular weight heparin##4##5##(1995-5#1)(2005-10#1)(2007-7#1)(2008-7#1)
of low molecular weight heparins##5##5##(1994-7#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-2#1)
of low molecular weight iron##2##5##(1996-9#1)(2009-9#1)
of low molecular weight organic acids in soil solution##2##9##(2008-10#2)
of low molecular weight##37##4##(1990-11#1)(1990-7#1)(1991-5#1)(1992-8#3)(1994-12#2)(1994-3#1)(1994-5#2)(1994-7#1)(1995-2#1)(1995-5#1)(1996-9#1)(1997-2#1)(2004-9#1)(2005-10#1)(2005-7#2)(2006-10#2)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-7#2)(2009-9#1)(2010-11#1)(2011-2#1)
of low molecular##42##3##(1990-11#1)(1990-4#1)(1990-7#1)(1991-11#1)(1991-5#1)(1992-8#3)(1993-6#1)(1994-12#3)(1994-3#1)(1994-5#2)(1994-7#1)(1995-2#1)(1995-5#1)(1996-9#1)(1997-2#1)(2004-9#1)(2005-10#1)(2005-7#2)(2006-10#2)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-7#2)(2009-9#1)(2010-11#1)(2011-2#1)
of low numbers of##4##4##(2008-10#2)(2008-9#1)(2011-12#1)
of low or high##2##4##(1996-1#1)(2012-3#1)
of low pH##9##3##(1990-2#1)(1990-5#1)(1991-5#1)(1992-11#1)(1992-7#1)(1994-8#3)(2006-8#1)
of low pathogenicity##2##3##(1996-4#1)(2008-5#1)
of low power##4##3##(2008-5#1)(2011-2#1)(2012-3#2)
of low redox potential##3##4##(2008-10#3)
of low resistance##4##3##(2008-10#3)(2010-2#1)
of low rewards##2##3##(2012-1#2)
of low risk##4##3##(2004-10#1)(2007-7#1)(2008-10#1)(2008-5#1)
of low serum##3##3##(1995-3#1)(2005-12#1)(2009-4#1)
of low solubility##2##3##(1997-1#1)(2008-10#1)
of low spatial##2##3##(2007-12#1)(2008-3#1)
of low temperature##9##3##(2004-11#1)(2005-4#1)(2008-10#2)(2008-8#1)(2010-12#1)(2011-2#1)(2012-4#1)(2013-1#1)
of low temperatures##2##3##(2007-11#1)(2008-10#1)
of low to##2##3##(1994-11#1)(2008-5#1)
of low virulence##2##3##(2006-10#1)(2007-11#1)
of low viscosity##3##3##(2008-8#2)(2009-7#1)
of low vision among schoolchildren in Kibaha##2##7##(2010-8#2)
of low vision among##4##4##(2010-8#4)
of low vision##9##3##(2007-3#1)(2010-8#7)(2011-2#1)
of low vitamin B12##2##4##(1990-3#1)(2010-1#1)
of low vitamin D##2##4##(2012-2#1)(2013-7#1)
of low vitamin##4##3##(1990-3#1)(2010-1#1)(2012-2#1)(2013-7#1)
of low weight##2##3##(1997-5#1)(2008-8#1)
of low##551##2##(1990-11#4)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#6)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#6)(1991-12#4)(1991-2#2)(1991-3#1)(1991-5#5)(1991-7#1)(1991-8#1)(1992-11#2)(1992-2#2)(1992-3#2)(1992-4#2)(1992-5#1)(1992-7#2)(1992-8#5)(1992-9#2)(1993-1#2)(1993-11#3)(1993-12#1)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#4)(1993-7#2)(1993-8#3)(1993-9#3)(1994-10#1)(1994-11#4)(1994-12#4)(1994-2#2)(1994-3#5)(1994-5#6)(1994-7#1)(1994-8#5)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#2)(1995-3#3)(1995-5#4)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#3)(1996-11#2)(1996-12#3)(1996-3#2)(1996-4#1)(1996-5#4)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#5)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#1)(2004-10#1)(2004-11#2)(2004-9#4)(2005-10#1)(2005-11#6)(2005-12#2)(2005-4#3)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#10)(2006-11#1)(2006-12#4)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#4)(2006-8#22)(2007-10#4)(2007-11#12)(2007-12#6)(2007-2#3)(2007-3#3)(2007-4#1)(2007-6#4)(2007-7#7)(2007-8#9)(2007-9#2)(2008-1#3)(2008-10#59)(2008-11#6)(2008-12#4)(2008-2#5)(2008-3#6)(2008-4#2)(2008-5#9)(2008-6#4)(2008-7#23)(2008-8#12)(2008-9#6)(2009-10#1)(2009-11#3)(2009-2#2)(2009-4#6)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#8)(2010-2#3)(2010-5#2)(2010-7#2)(2010-8#11)(2010-9#2)(2011-1#11)(2011-12#1)(2011-2#14)(2012-1#10)(2012-12#3)(2012-2#6)(2012-3#4)(2012-4#1)(2012-6#5)(2013-1#11)(2013-7#6)(2013-8#9)
of low- and##6##3##(1992-7#2)(1993-3#1)(2007-12#1)(2008-2#1)(2010-8#1)
of low-LET radiation##4##3##(2008-7#4)
of low-abundance##3##2##(2008-4#1)(2012-1#1)(2012-12#1)
of low-affinity##4##2##(1990-3#2)(1990-7#1)(2008-4#1)
of low-angle elastic light-scattering data##2##5##(2008-2#2)
of low-calorie##2##2##(1995-3#1)(2013-7#1)
of low-carbohydrate##3##2##(2008-3#2)(2008-5#1)
of low-coherence gating##2##3##(2007-12#2)
of low-coherence##13##2##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#7)
of low-contrast##2##2##(2005-11#1)(2008-1#1)
of low-cost##8##2##(1996-12#1)(2007-11#2)(2007-9#1)(2008-3#3)(2010-9#1)
of low-density lipoprotein (LDL)##4##4##(1995-12#1)(1996-3#1)(2008-3#1)(2013-1#1)
of low-density lipoprotein cholesterol##3##4##(1991-2#1)(2009-10#1)(2011-2#1)
of low-density lipoprotein##13##3##(1990-7#1)(1991-2#1)(1995-10#1)(1995-12#1)(1996-3#1)(1997-1#1)(2006-12#1)(2008-3#1)(2009-10#1)(2010-12#1)(2011-2#2)(2013-1#1)
of low-density lipoproteins and##2##4##(1991-2#1)(2006-6#1)
of low-density lipoproteins##3##3##(1991-2#1)(1995-12#1)(2006-6#1)
of low-density##18##2##(1990-7#1)(1991-2#2)(1995-10#1)(1995-12#3)(1996-3#1)(1997-1#1)(2006-12#1)(2006-6#1)(2008-3#1)(2009-10#1)(2010-12#1)(2011-2#2)(2013-1#2)
of low-dose aspirin##3##3##(1993-7#1)(2007-7#1)(2010-9#1)
of low-dose diuretic therapy##2##4##(1996-9#2)
of low-dose diuretic##3##3##(1996-9#3)
of low-dose diuretics##2##3##(1996-9#2)
of low-dose radiation##3##3##(2007-4#1)(2008-7#1)(2012-2#1)
of low-dose##29##2##(1993-12#1)(1993-7#1)(1994-6#1)(1996-9#5)(2006-6#1)(2007-4#1)(2007-7#3)(2007-8#1)(2008-11#1)(2008-3#2)(2008-7#2)(2009-4#4)(2009-9#1)(2010-12#1)(2010-9#1)(2011-12#1)(2012-2#2)
of low-dose-rate##2##2##(2008-7#2)
of low-energy##7##2##(1992-3#1)(1993-4#1)(1993-8#1)(1994-5#1)(2007-11#1)(2007-7#1)(2008-8#1)
of low-fat frankfurters enriched with n-3##2##6##(2010-4#2)
of low-fat##4##2##(2005-8#1)(2010-4#3)
of low-field strength##2##3##(2008-4#2)
of low-frequency fluctuations and stabilization of##2##6##(2007-12#2)
of low-frequency fluctuations##4##3##(2007-12#4)
of low-frequency##12##2##(1990-5#1)(1992-9#1)(2007-12#5)(2008-2#2)(2008-3#2)(2010-3#1)
of low-grade gliomas in children##2##5##(2006-12#2)
of low-grade gliomas in##3##4##(2006-12#3)
of low-grade gliomas##5##3##(2006-12#5)
of low-grade##15##2##(1990-12#1)(1994-7#1)(2006-10#1)(2006-12#6)(2007-8#1)(2008-7#1)(2010-12#2)(2011-12#1)(2012-12#1)
of low-income##6##2##(2007-12#1)(2010-6#2)(2013-1#3)
of low-intensity microwave##2##3##(2012-1#2)
of low-intensity##7##2##(2006-6#1)(2007-12#1)(2008-2#1)(2010-4#1)(2012-1#2)(2012-2#1)
of low-level##8##2##(1990-5#1)(1994-6#1)(1995-8#1)(2007-2#1)(2007-8#1)(2008-4#1)(2008-6#1)(2011-1#1)
of low-loss##3##2##(2008-2#1)(2008-3#2)
of low-mass##2##2##(1995-11#1)(2007-8#1)
of low-molecular-mass heparins##2##3##(1993-7#2)
of low-molecular-mass##4##2##(1993-7#2)(1996-8#1)(1997-3#1)
of low-molecular-weight heparin and##2##4##(1995-6#1)(2007-10#1)
of low-molecular-weight##9##2##(1991-8#1)(1992-11#1)(1995-6#1)(2005-11#2)(2007-10#1)(2007-8#1)(2008-10#1)(2008-3#1)
of low-power laser in the##2##5##(2011-2#2)
of low-power laser##3##3##(2011-2#3)
of low-power##6##2##(2007-12#2)(2008-2#1)(2011-2#3)
of low-resolution##2##2##(2008-2#1)(2008-3#1)
of low-risk patients##2##3##(2007-8#1)(2008-3#1)
of low-risk##3##2##(2007-8#1)(2008-3#1)(2013-1#1)
of low-speed##2##2##(2007-4#1)(2012-1#1)
of low-spin##3##2##(1991-2#1)(1997-7#1)(2008-9#1)
of low-temperature##4##2##(2006-6#1)(2007-12#1)(2008-10#1)(2008-6#1)
of low-threshold##6##2##(1993-9#3)(2007-11#1)(2008-1#1)(2008-2#1)
of low-usage codons##2##3##(1991-8#2)
of low-volume##2##2##(1991-9#1)(2008-10#1)
of low-weight##3##2##(1991-4#1)(2008-10#1)(2008-8#1)
of lower affinity##3##3##(1990-2#1)(1995-2#1)(2008-7#1)
of lower amplitude##2##3##(1992-1#1)(1994-11#1)
of lower and##3##3##(1991-9#1)(2005-11#1)(2011-2#1)
of lower esophageal sphincter##2##4##(1992-9#1)(2013-8#1)
of lower extremity arteries##4##4##(2007-8#3)(2009-2#1)
of lower extremity##15##3##(1996-3#1)(2006-10#2)(2006-11#1)(2007-7#2)(2007-8#4)(2008-8#1)(2009-2#1)(2009-3#1)(2010-11#1)(2012-2#1)
of lower jaw##2##3##(1993-12#1)(2013-1#1)
of lower levels of##2##4##(1993-1#1)(2008-10#1)
of lower limb fractures##2##4##(2007-11#1)(2007-4#1)
of lower limb##11##3##(2007-11#2)(2007-4#1)(2007-7#1)(2008-7#1)(2009-9#1)(2010-4#1)(2011-1#1)(2012-1#2)(2012-2#1)
of lower limbs##4##3##(2007-8#2)(2009-7#1)(2010-9#1)
of lower pole##3##3##(2006-9#1)(2007-10#1)(2008-10#1)
of lower reproductive tract infections##2##5##(2007-3#1)(2011-1#1)
of lower reproductive tract##3##4##(1996-12#1)(2007-3#1)(2011-1#1)
of lower respiratory tract infection##2##5##(2008-7#1)(2010-10#1)
of lower respiratory tract infections##3##5##(1991-12#1)(2010-12#1)(2010-5#1)
of lower respiratory tract##8##4##(1991-12#1)(1996-9#1)(2007-9#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-5#1)(2012-12#1)
of lower respiratory##9##3##(1991-12#1)(1994-2#1)(1996-9#1)(2007-9#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-5#1)(2012-12#1)
of lower socioeconomic##3##3##(2011-2#2)(2013-1#1)
of lower than##2##3##(1996-2#1)(2008-10#1)
of lower ureteric stones##2##4##(2007-6#2)
of lower urinary tract##5##4##(2006-9#1)(2011-2#1)(2012-12#1)(2013-8#2)
of lower urinary##6##3##(2006-9#1)(2007-7#1)(2011-2#1)(2012-12#1)(2013-8#2)
of lower##130##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-7#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-4#1)(1995-12#1)(1995-2#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-9#1)(1997-7#1)(2005-11#2)(2006-10#3)(2006-11#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-10#2)(2007-11#3)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#3)(2007-7#5)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-6#3)(2008-7#7)(2008-8#1)(2008-9#2)(2009-2#1)(2009-3#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#7)(2012-1#2)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#4)
of lowered##3##2##(2006-8#1)(2007-12#1)(2012-1#1)
of lowering blood pressure##2##4##(1992-8#1)(2007-10#1)
of lowering blood##3##3##(1992-8#1)(1996-4#1)(2007-10#1)
of lowering##9##2##(1992-8#1)(1996-4#1)(2006-8#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-4#1)(2013-8#1)
of lowest##2##2##(2008-10#1)(2011-2#1)
of lowest-order##2##2##(2007-11#1)(2008-3#1)
of lowland##2##2##(1993-9#1)(2008-10#1)
of loxiglumide##3##2##(1991-2#2)(2006-2#1)
of loxoprofen##2##2##(2013-8#2)
of lubricating oil##4##3##(2005-4#3)(2008-10#1)
of lubricating##5##2##(2004-4#1)(2005-4#3)(2008-10#1)
of lucerne##2##2##(2007-8#1)(2010-4#1)
of luciferase activity in##3##4##(1994-9#1)(2004-4#1)(2008-11#1)
of luciferase activity##5##3##(1994-9#2)(1996-4#1)(2004-4#1)(2008-11#1)
of luciferase enzyme##2##3##(1994-9#1)(2008-10#1)
of luciferase##17##2##(1990-1#1)(1990-7#2)(1994-9#3)(1996-11#1)(1996-4#1)(1997-4#1)(2004-4#1)(2008-10#2)(2008-11#3)(2008-9#2)
of lucigenin##5##2##(2008-10#5)
of lukF##3##2##(1992-4#3)
of lumbar and##2##3##(2007-11#2)
of lumbar disc disease##3##4##(2007-8#2)(2008-12#1)
of lumbar disc herniation##3##4##(2007-1#1)(2008-12#2)
of lumbar disc##7##3##(2007-1#1)(2007-8#2)(2008-12#3)(2013-8#1)
of lumbar discopathy##3##3##(2007-8#3)
of lumbar disk prolapse##2##4##(1990-10#1)(1997-2#1)
of lumbar disk##3##3##(1990-10#1)(1997-2#1)(2009-3#1)
of lumbar facet joint pain in##3##6##(2006-7#1)(2006-8#2)
of lumbar facet joint pain##6##5##(2006-7#1)(2006-8#5)
of lumbar facet joint##9##4##(2006-7#1)(2006-8#8)
of lumbar interlaminar and transforaminal epidural injections##2##7##(2009-5#2)
of lumbar lordosis##3##3##(2007-7#1)(2009-2#2)
of lumbar pain##3##3##(2005-10#1)(2006-3#2)
of lumbar spinal stenosis##2##4##(2006-7#1)(2008-8#1)
of lumbar spinal##5##3##(2006-7#1)(2006-8#1)(2008-12#1)(2008-8#1)(2012-3#1)
of lumbar spine##8##3##(2006-10#1)(2008-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
of lumbar spondylolysis##3##3##(2007-7#3)
of lumbar sympathetic##2##3##(2006-7#2)
of lumbar vertebrae##2##3##(2008-5#1)(2011-2#1)
of lumbar vertebral##2##3##(2008-12#1)(2008-2#1)
of lumbar zygapophyseal joint##2##4##(2006-8#2)
of lumbar##71##2##(1990-10#1)(1993-1#1)(1995-9#1)(1997-2#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-3#2)(2006-7#5)(2006-8#11)(2007-1#1)(2007-11#2)(2007-7#6)(2007-8#5)(2008-11#1)(2008-12#5)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-2#2)(2009-3#1)(2009-5#3)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
of lumbo-sacral##2##2##(2007-11#1)(2008-12#1)
of lumbosacral degenerative##2##3##(2008-7#2)
of lumbosacral##9##2##(1993-7#1)(1996-12#1)(2005-10#1)(2006-8#1)(2008-12#1)(2008-7#2)(2009-11#1)(2011-1#1)
of lumi##2##2##(1994-11#2)
of luminal##9##2##(1990-2#1)(1990-4#1)(1990-6#1)(2006-10#2)(2008-10#1)(2008-3#1)(2008-8#1)(2009-12#1)
of luminance##3##2##(1996-2#1)(2007-1#1)(2008-2#1)
of luminescence##3##2##(2008-10#2)(2008-7#1)
of luminescent##5##2##(2007-11#1)(2008-10#3)(2010-12#1)
of luminol and##2##3##(2008-10#2)
of luminol with hydrogen peroxide catalyzed by##3##7##(2008-10#3)
of luminol with hydrogen peroxide in##2##6##(2008-10#2)
of luminol with hydrogen peroxide##6##5##(2008-10#6)
of luminol with##11##3##(1991-5#1)(2008-10#10)
of luminol##23##2##(1991-5#3)(2008-10#20)
of luminol-dependent chemiluminescence##2##3##(1991-11#1)(2008-4#1)
of luminol-hydrogen##2##2##(2008-10#2)
of lunar##2##2##(2008-3#1)(2013-8#1)
of lung adenocarcinoma##4##3##(2008-9#3)(2013-8#1)
of lung and##6##3##(2007-9#1)(2008-12#1)(2009-9#1)(2010-10#1)(2011-1#1)(2011-3#1)
of lung cancer among smokers and non-smokers in##2##8##(2010-2#1)(2011-2#1)
of lung cancer among##3##4##(2010-2#1)(2011-2#2)
of lung cancer and mesothelioma##2##5##(1991-12#1)(2010-5#1)
of lung cancer and##8##4##(1990-10#1)(1991-12#1)(1992-6#1)(1996-9#1)(2010-5#1)(2011-2#2)(2012-2#1)
of lung cancer by##2##4##(1995-9#1)(2011-2#1)
of lung cancer in non-smokers##2##5##(2011-2#2)
of lung cancer in##11##4##(1990-12#1)(1991-2#1)(1991-4#1)(1993-8#1)(1996-7#1)(2007-11#1)(2008-12#1)(2008-7#2)(2011-2#2)
of lung cancer is##3##4##(2007-8#1)(2008-11#1)(2010-9#1)
of lung cancer patients##6##4##(1996-9#2)(2008-11#1)(2008-5#1)(2010-8#1)(2012-2#1)
of lung cancer risk factors##2##5##(2011-2#2)
of lung cancer risk##3##4##(1990-12#1)(2011-2#2)
of lung cancer with advanced##2##5##(2007-8#2)
of lung cancer with##4##4##(2007-8#2)(2012-2#2)
of lung cancer##87##3##(1990-10#1)(1990-12#4)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-7#1)(1995-9#1)(1996-7#1)(1996-9#5)(2004-1#2)(2006-12#1)(2007-11#1)(2007-6#1)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#4)(2008-7#4)(2008-8#1)(2009-7#1)(2010-2#1)(2010-5#3)(2010-8#5)(2010-9#1)(2011-1#1)(2011-2#11)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#4)(2013-1#2)(2013-8#2)
of lung cancer]##2##3##(2008-11#1)(2012-2#1)
of lung carcinoma##3##3##(1994-12#1)(2008-1#1)(2008-9#1)
of lung cavities##2##3##(2010-8#2)
of lung disease in##3##4##(1994-6#1)(2006-8#1)(2012-3#1)
of lung disease##9##3##(1992-9#1)(1994-6#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-9#1)(2012-3#1)
of lung disorders##2##3##(1994-6#1)(2008-7#1)
of lung function and reflex activity on the success of patient-triggered ventilation##2##12##(1994-4#2)
of lung function and##3##4##(1994-4#2)(2007-11#1)
of lung function has##2##4##(1991-4#1)(1997-3#1)
of lung function in##2##4##(1997-3#1)(2006-5#1)
of lung function##18##3##(1991-2#1)(1991-4#1)(1992-6#1)(1994-4#2)(1997-3#2)(2005-11#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-11#2)(2008-4#1)(2009-6#1)(2010-12#1)(2011-12#1)
of lung injuries##2##3##(1994-6#1)(2007-2#1)
of lung injury##6##3##(1991-9#1)(2005-8#1)(2006-10#2)(2011-2#2)
of lung involvement##4##3##(1991-2#1)(1997-3#1)(2005-8#1)(2007-12#1)
of lung membrane AC##2##4##(1991-1#2)
of lung metastases##8##3##(1990-2#1)(1990-6#1)(1992-6#1)(1994-12#1)(1995-10#1)(2008-6#3)
of lung metastasis##3##3##(2005-8#1)(2011-1#1)(2013-1#1)
of lung neoplasms]##2##3##(1990-10#2)
of lung or kidney##2##4##(1991-5#1)(2006-10#1)
of lung parenchyma##2##3##(2011-2#1)(2013-7#1)
of lung pathology##2##3##(1997-2#1)(2008-9#1)
of lung tissue in patients with##2##6##(1991-12#1)(2013-1#1)
of lung tissue##5##3##(1991-12#1)(2008-7#1)(2008-8#1)(2013-1#2)
of lung transplantation##7##3##(1993-2#1)(1996-6#1)(2006-10#1)(2011-3#3)(2012-2#1)
of lung tumor##3##3##(1994-3#1)(2004-1#1)(2013-7#1)
of lung tumors##2##3##(2008-11#1)(2012-12#1)
of lung volume reduction surgery##2##5##(2006-10#1)(2010-5#1)
of lung volume reduction##3##4##(2006-10#2)(2010-5#1)
of lung volume##4##3##(2006-10#2)(2010-5#1)(2011-1#1)
of lung##249##2##(1990-10#3)(1990-11#1)(1990-12#4)(1990-2#1)(1990-6#1)(1991-1#3)(1991-10#2)(1991-12#4)(1991-2#3)(1991-4#2)(1991-5#1)(1991-9#2)(1992-1#1)(1992-3#2)(1992-6#3)(1992-9#4)(1993-12#1)(1993-2#1)(1993-8#2)(1993-9#2)(1994-12#3)(1994-3#3)(1994-4#2)(1994-6#3)(1994-7#1)(1995-10#1)(1995-3#1)(1995-9#1)(1996-6#1)(1996-7#1)(1996-9#5)(1997-2#2)(1997-3#3)(1997-4#1)(2004-1#3)(2005-11#3)(2005-8#4)(2006-10#12)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#9)(2007-9#2)(2008-1#5)(2008-10#5)(2008-11#6)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#6)(2009-11#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#4)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#16)(2011-3#7)(2012-1#1)(2012-12#5)(2012-2#8)(2012-3#2)(2013-1#10)(2013-7#3)(2013-8#3)
of lungs and##2##3##(2007-12#1)(2009-5#1)
of lungs##5##2##(2007-12#1)(2009-5#1)(2012-3#1)(2013-1#2)
of lupane triterpenes on##3##4##(2008-11#3)
of lupane triterpenes##4##3##(2008-11#4)
of lupin##3##2##(2008-10#2)(2009-8#1)
of lupine##2##2##(2008-5#2)
of lupus erythematosus##7##3##(1991-12#1)(2007-11#1)(2007-7#3)(2012-3#1)(2013-1#1)
of lupus nephritis in##2##4##(2007-9#1)(2008-10#1)
of lupus nephritis##10##3##(2006-10#1)(2007-7#1)(2007-9#1)(2008-1#4)(2008-10#1)(2011-1#1)(2013-1#1)
of lupus##29##2##(1990-11#1)(1991-12#1)(2005-11#1)(2006-10#7)(2007-11#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
of lupus-like##2##2##(1993-3#1)(2006-10#1)
of luteal##4##2##(1992-1#1)(1992-9#1)(2008-5#1)(2009-4#1)
of lutein##5##2##(1993-12#1)(2008-12#1)(2010-4#3)
of luteinizing hormone and follicle-stimulating hormone##2##6##(2006-9#1)(2012-12#1)
of luteinizing hormone##7##3##(1991-4#1)(1995-1#1)(1995-2#2)(1995-3#1)(2006-9#1)(2012-12#1)
of luteinizing hormone-releasing hormone##3##4##(1993-1#2)(1995-12#1)
of luteinizing##10##2##(1991-4#1)(1993-1#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(2006-9#1)(2012-12#1)
of luxS in##2##3##(2010-12#2)
of lying##2##2##(2010-10#1)(2013-1#1)
of lymph node cells of mice immunized with##2##8##(1997-4#2)
of lymph node metastasis in##2##5##(2011-2#2)
of lymph node metastasis##9##4##(1990-10#1)(2007-6#1)(2009-12#1)(2010-7#1)(2011-2#3)(2012-1#1)(2013-1#1)
of lymph node##23##3##(1990-10#1)(1990-9#1)(1991-10#1)(1997-4#2)(2007-3#1)(2007-6#2)(2008-1#1)(2008-10#1)(2008-4#1)(2009-12#1)(2009-9#1)(2010-12#2)(2010-7#1)(2011-2#3)(2012-1#2)(2013-1#1)(2013-7#1)
of lymph nodes and##3##4##(1992-2#1)(1995-2#1)(2010-8#1)
of lymph nodes in##2##4##(2005-1#1)(2007-6#1)
of lymph nodes##16##3##(1992-2#1)(1995-2#1)(1996-9#1)(2005-1#1)(2006-8#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
of lymph##45##2##(1990-10#1)(1990-9#1)(1991-10#1)(1992-2#1)(1995-2#1)(1996-9#1)(1997-4#2)(2005-1#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-6#4)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-8#2)(2009-12#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-7#2)(2010-8#2)(2011-2#4)(2012-1#2)(2012-3#1)(2013-1#2)(2013-7#1)
of lymph-node metastases##2##3##(1991-7#1)(2006-6#1)
of lymph-node##3##2##(1991-7#1)(2006-6#2)
of lymphadenectomy##7##2##(1990-3#1)(2006-10#1)(2006-9#1)(2007-8#3)(2010-12#1)
of lymphadenopathy in##2##3##(2011-1#2)
of lymphadenopathy##9##2##(1991-12#1)(1997-8#1)(2007-12#1)(2010-12#1)(2011-1#4)(2012-2#1)
of lymphatic filariasis##2##3##(2006-10#1)(2007-8#1)
of lymphatic spread of##2##4##(1990-8#1)(2006-10#1)
of lymphatic spread##3##3##(1990-8#1)(2006-10#1)(2006-9#1)
of lymphatic##17##2##(1990-8#1)(1997-7#1)(2005-12#1)(2006-10#2)(2006-9#1)(2007-8#1)(2008-11#1)(2008-5#2)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#1)
of lymphedema##4##2##(2009-3#1)(2010-2#2)(2011-1#1)
of lymphoblastoid cell lines##2##4##(1993-9#1)(1996-6#1)
of lymphoblastoid cell##3##3##(1993-12#1)(1993-9#1)(1996-6#1)
of lymphoblasts with##2##3##(1997-6#2)
of lymphoblasts##3##2##(1997-6#3)
of lymphocele##2##2##(2008-1#2)
of lymphocyte activation or##2##4##(2008-4#1)(2008-9#1)
of lymphocyte activation##4##3##(1991-10#1)(1992-7#1)(2008-4#1)(2008-9#1)
of lymphocyte function##2##3##(2008-5#1)(2012-12#1)
of lymphocyte proliferation##5##3##(1993-12#1)(1995-12#1)(1997-4#1)(2006-10#1)(2007-2#1)
of lymphocyte subsets##2##3##(2007-12#1)(2008-10#1)
of lymphocyte##35##2##(1990-12#1)(1991-10#2)(1991-5#1)(1991-9#2)(1992-12#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-2#1)(1995-12#1)(1995-8#1)(1996-3#1)(1997-4#1)(1997-8#1)(2004-12#2)(2006-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-1#2)(2012-12#1)
of lymphocytes and##8##3##(1992-12#1)(1992-9#1)(1994-6#1)(1996-5#1)(2005-7#1)(2006-6#1)(2008-12#1)(2011-2#1)
of lymphocytes from##3##3##(2008-4#1)(2008-5#2)
of lymphocytes in the elderly##2##5##(1995-8#2)
of lymphocytes in the##7##4##(1990-12#1)(1991-9#1)(1995-8#2)(1996-3#1)(2006-10#1)(2008-5#1)
of lymphocytes in##9##3##(1990-12#1)(1991-5#1)(1991-9#1)(1995-8#2)(1996-3#1)(2006-10#1)(2008-11#1)(2008-5#1)
of lymphocytes isolated from##2##4##(1995-2#1)(2007-1#1)
of lymphocytes to##2##3##(2008-4#1)(2008-8#1)
of lymphocytes were##3##3##(1990-8#1)(2008-2#1)(2011-2#1)
of lymphocytes##74##2##(1990-12#2)(1990-5#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-5#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-4#1)(1993-7#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#5)(1996-12#2)(1996-3#1)(1996-5#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-6#2)(2007-1#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#4)(2008-4#8)(2008-5#4)(2008-7#2)(2008-8#1)(2009-2#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-1#4)(2012-12#1)
of lymphocytic##3##2##(1993-7#2)(1997-2#1)
of lymphoid cells of##2##4##(1991-3#1)(2008-5#1)
of lymphoid cells##10##3##(1991-3#1)(1993-7#1)(2006-10#1)(2007-8#1)(2008-4#4)(2008-5#2)
of lymphoid follicles##2##3##(2009-4#1)(2009-8#1)
of lymphoid organs##2##3##(2008-4#1)(2012-1#1)
of lymphoid tissues##4##3##(2008-10#4)
of lymphoid##36##2##(1990-8#1)(1991-3#1)(1991-9#1)(1993-7#1)(1995-1#1)(1995-3#2)(1995-6#1)(1997-3#1)(2006-10#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#4)(2008-4#7)(2008-5#3)(2008-7#1)(2008-9#1)(2009-4#1)(2009-8#2)(2012-1#1)(2013-8#2)
of lymphokine activated killer (LAK)##2##5##(1996-9#1)(2007-11#1)
of lymphokine mRNA and##2##4##(1992-7#2)
of lymphokine##5##2##(1992-7#2)(1996-9#1)(2007-11#1)(2008-4#1)
of lymphokine-activated killer cells##3##4##(1993-3#1)(2008-4#2)
of lymphokines##3##2##(1990-7#1)(2008-5#2)
of lymphoma in the##2##4##(2006-4#1)(2009-1#1)
of lymphoma##11##2##(1990-11#1)(1992-12#1)(1996-11#1)(2006-4#1)(2006-7#1)(2007-6#1)(2009-1#2)(2010-7#1)(2011-2#1)(2012-1#1)
of lymphomas##4##2##(2005-10#1)(2006-9#1)(2007-11#1)(2008-10#1)
of lymphomononuclear##2##2##(1994-3#1)(2010-10#1)
of lymphopoietic##2##2##(1995-12#1)(2009-2#1)
of lymphoproliferative disorders##3##3##(1992-2#1)(1992-8#1)(2008-5#1)
of lymphoproliferative##4##2##(1992-2#1)(1992-8#1)(2008-4#1)(2008-5#1)
of lynestrenol##2##2##(1992-2#2)
of lyophilized cells##2##3##(2008-10#2)
of lyophilized##5##2##(2006-1#1)(2008-10#2)(2008-7#1)(2010-4#1)
of lysate from##2##3##(1991-6#2)
of lysed##3##2##(1992-4#1)(2008-11#2)
of lysergic acid diethylamide (LSD)##2##5##(1997-7#1)(2008-10#1)
of lysine and arginine##2##4##(1995-2#1)(2011-2#1)
of lysine and tryptophan##2##4##(2006-4#1)(2012-2#1)
of lysine and##6##3##(1994-3#1)(1995-2#1)(2006-4#1)(2008-10#1)(2011-2#1)(2012-2#1)
of lysine residue##3##3##(1991-6#2)(1994-9#1)
of lysine residues in##3##4##(1991-6#1)(1995-1#1)(1997-2#1)
of lysine residues of##2##4##(1994-9#1)(1995-2#1)
of lysine residues##8##3##(1990-4#1)(1991-6#1)(1992-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-6#1)(1997-2#1)
of lysine was##2##3##(1996-8#1)(2008-5#1)
of lysine##44##2##(1990-4#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-8#2)(1992-6#1)(1992-7#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-8#1)(1997-2#1)(1997-4#1)(2004-12#1)(2006-4#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-5#6)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)
of lysine-ketoglutarate reductase##3##3##(1994-3#3)
of lysing##2##2##(1994-5#1)(2013-1#1)
of lysinoalanine was##2##3##(1992-6#2)
of lysis of##5##3##(1990-12#4)(1996-4#1)
of lysis##10##2##(1990-11#1)(1990-12#4)(1996-4#1)(2005-9#1)(2008-10#1)(2008-2#1)(2008-8#1)
of lysoPI##5##2##(1991-7#5)
of lysophosphatidic acid##4##3##(1991-2#2)(1994-12#1)(1996-9#1)
of lysophosphatidylcholine in intact##2##4##(1990-2#2)
of lysophosphatidylcholine##6##2##(1990-2#2)(1990-4#2)(1995-6#1)(2008-8#1)
of lysophosphatidylinositol##2##2##(1990-8#1)(1991-7#1)
of lysosomal cholesterol to the##2##5##(1996-8#2)
of lysosomal cholesterol##3##3##(1996-8#3)
of lysosomal enzymes##4##3##(1990-4#1)(1991-8#1)(1995-6#1)(1996-3#1)
of lysosomal origin##3##3##(1993-1#2)(1996-3#1)
of lysosomal proteins##2##3##(1992-2#1)(1995-6#1)
of lysosomal storage disease##2##4##(2007-7#1)(2010-8#1)
of lysosomal storage diseases##2##4##(1996-4#2)
of lysosomal storage##4##3##(1996-4#2)(2007-7#1)(2010-8#1)
of lysosomal##28##2##(1990-4#1)(1990-5#1)(1991-7#2)(1991-8#1)(1992-2#1)(1992-9#1)(1993-1#2)(1993-8#2)(1994-11#1)(1995-6#2)(1996-3#2)(1996-4#2)(1996-8#3)(2006-6#1)(2007-7#2)(2007-8#1)(2010-8#1)(2012-1#1)(2013-7#1)
of lysosomes##2##2##(1992-2#1)(2008-1#1)
of lysozyme and##6##3##(1995-4#1)(2008-5#1)(2008-7#2)(2009-3#1)(2011-2#1)
of lysozyme from##2##3##(2008-10#2)
of lysozyme in##2##3##(1992-8#1)(2008-10#1)
of lysozyme##28##2##(1991-8#1)(1992-8#1)(1994-12#1)(1995-4#1)(1995-8#1)(1996-7#1)(1996-8#1)(1997-5#1)(1997-7#2)(2006-1#1)(2006-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#4)(2009-3#2)(2011-2#2)(2013-8#1)
of lysyl##3##2##(1991-1#1)(1995-3#1)(2008-5#1)
of lytic##7##2##(1994-5#1)(2006-1#1)(2008-10#2)(2008-6#1)(2013-1#2)
of m values##2##3##(1997-2#2)
of m##7##2##(1994-5#1)(1997-2#2)(2005-11#1)(2008-2#1)(2013-8#2)
of m-ABS##2##2##(1994-9#2)
of m-CPP##2##2##(1990-2#2)
of m-aminophenol##2##2##(2008-10#2)
of m-axis sapphire##2##3##(2008-3#2)
of m-calpain with##2##3##(1995-5#2)
of m-calpain##3##2##(1994-3#1)(1995-5#2)
of m-chlorophenylbiguanide##3##2##(1997-5#3)
of m-nisoldipine##2##2##(2011-3#2)
of m-toluate##2##2##(2004-4#2)
of m/z##2##2##(1997-3#1)(2010-11#1)
of m2 receptor gene##2##4##(1995-3#2)
of m2 receptor mRNA##2##4##(1995-3#2)
of m2 receptor##4##3##(1995-3#4)
of m2##6##2##(1995-3#5)(1996-3#1)
of m7Gua##3##2##(1994-5#3)
of mAMSA and CPT##2##4##(1994-8#2)
of mAb##7##2##(1997-4#1)(1997-7#1)(2005-10#3)(2008-11#2)
of mAbs##5##2##(1993-6#1)(1993-8#1)(1994-12#1)(1996-12#1)(2008-11#1)
of mES cells##2##3##(2008-11#2)
of mGlu##2##2##(1995-12#1)(2008-7#1)
of mGluR agonists and antagonists##2##5##(2008-3#2)
of mGluR1 alpha##2##3##(1995-12#2)
of mGluR5##5##2##(1992-11#1)(1994-3#2)(1996-12#1)(1997-5#1)
of mGluRs in##3##3##(1995-12#2)(2008-3#1)
of mKv1##3##2##(1996-10#3)
of mMOR##3##2##(1995-6#3)
of mPGES-1 in the##3##4##(2012-2#3)
of mPGES-1 in##4##3##(2012-2#4)
of mPGES-1##5##2##(2012-2#5)
of mRNA 3' of the A site codon##2##8##(2006-11#2)
of mRNA accumulation##2##3##(1990-12#1)(2009-8#1)
of mRNA and protein expression##2##5##(1995-3#1)(2011-1#1)
of mRNA and protein##3##4##(1993-6#1)(1995-3#1)(2011-1#1)
of mRNA and##12##3##(1990-5#1)(1990-7#1)(1991-9#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-3#1)(1995-6#1)(2006-12#1)(2009-12#1)(2011-1#1)
of mRNA by##3##3##(1992-10#1)(2008-2#1)(2008-9#1)
of mRNA coding for##2##4##(1990-3#1)(1992-12#1)
of mRNA encoding##7##3##(1990-8#2)(1991-10#1)(1992-6#1)(1994-5#1)(1996-12#2)
of mRNA expression of##4##4##(1990-12#1)(1996-2#1)(1997-6#1)(2005-10#1)
of mRNA expression##11##3##(1990-12#1)(1992-11#1)(1994-9#1)(1995-12#1)(1996-2#1)(1996-5#1)(1997-6#1)(2005-10#1)(2008-10#1)(2008-2#1)(2008-4#1)
of mRNA for both##2##4##(1990-8#1)(1992-3#1)
of mRNA for the##8##4##(1991-10#1)(1992-5#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-8#1)(2008-4#2)
of mRNA for##29##3##(1990-8#1)(1991-10#1)(1992-3#1)(1992-5#1)(1992-8#1)(1994-12#1)(1994-8#3)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-7#1)(1997-2#1)(1997-7#1)(1997-8#2)(2007-8#2)(2008-4#3)(2009-9#1)
of mRNA from rat liver##2##5##(1993-6#1)(1995-2#1)
of mRNA from rat##3##4##(1993-6#1)(1995-2#1)(1997-2#1)
of mRNA from the##2##4##(1994-8#1)(2008-7#1)
of mRNA from##9##3##(1991-2#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-2#1)(1997-2#1)(2008-7#1)
of mRNA in the##4##4##(1990-7#1)(1994-11#1)(1997-5#1)(2008-7#1)
of mRNA in##12##3##(1990-7#1)(1991-5#1)(1991-9#1)(1992-8#1)(1993-11#1)(1994-11#1)(1997-4#1)(1997-5#1)(2008-7#1)(2010-11#1)(2013-1#2)
of mRNA level##3##3##(1997-8#1)(2008-4#1)(2009-8#1)
of mRNA levels of##3##4##(1991-4#1)(1991-9#1)(1997-8#1)
of mRNA levels##5##3##(1991-4#1)(1991-9#1)(1996-11#1)(1996-2#1)(1997-8#1)
of mRNA of the##2##4##(1995-12#1)(1997-8#1)
of mRNA of##5##3##(1993-11#1)(1995-12#1)(1996-2#1)(1997-8#1)(2008-8#1)
of mRNA transcription##4##3##(1990-3#1)(1996-10#1)(2007-11#1)(2007-12#1)
of mRNA transcripts##4##3##(1990-7#1)(2006-12#2)(2009-10#1)
of mRNA was##2##3##(1994-9#1)(2008-7#1)
of mRNA were##4##3##(1995-11#1)(1996-7#1)(1997-8#1)(2008-12#1)
of mRNA##177##2##(1990-10#2)(1990-11#1)(1990-12#4)(1990-3#2)(1990-5#3)(1990-7#5)(1990-8#3)(1991-10#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#2)(1993-11#3)(1993-12#1)(1993-4#1)(1993-5#2)(1993-6#2)(1993-9#1)(1994-11#2)(1994-12#4)(1994-3#1)(1994-5#3)(1994-8#6)(1994-9#3)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#4)(1995-3#3)(1995-5#1)(1995-6#3)(1995-8#1)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#5)(1996-5#1)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#7)(2005-10#2)(2006-11#2)(2006-12#5)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-4#9)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-8#3)(2009-9#1)(2010-11#2)(2011-1#3)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
of mRNAs encoding the##3##4##(1994-2#1)(1995-2#1)(2008-7#1)
of mRNAs encoding##9##3##(1990-8#1)(1994-2#1)(1995-2#1)(2008-11#2)(2008-7#1)(2011-2#1)(2012-12#2)
of mRNAs for##11##3##(1990-8#1)(1993-4#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-9#1)(1996-12#1)(1997-2#1)(2008-8#3)
of mRNAs from##3##3##(1996-12#1)(2008-10#1)(2012-2#1)
of mRNAs that are translated on##2##6##(1992-3#2)
of mRNAs which##2##3##(1991-9#1)(1993-4#1)
of mRNAs##52##2##(1990-6#1)(1990-8#2)(1991-9#1)(1992-11#1)(1992-3#2)(1992-8#1)(1993-4#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1995-2#2)(1995-9#1)(1996-12#3)(1997-1#1)(1997-2#2)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-2#3)(2008-7#1)(2008-8#4)(2008-9#1)(2009-8#1)(2010-11#2)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#2)(2013-8#1)
of mSERT gene expression##2##4##(1996-12#2)
of mSERT##3##2##(1996-12#3)
of mTERT##2##2##(2008-11#2)
of mTOR inhibitors##6##3##(2008-5#3)(2010-12#1)(2013-1#2)
of mTOR signaling##3##3##(2009-12#1)(2010-3#1)(2011-2#1)
of mTOR##22##2##(2008-12#1)(2008-5#3)(2009-12#3)(2009-7#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#2)(2011-2#3)(2013-1#4)
of macaque##3##2##(1991-11#1)(1994-2#1)(1997-8#1)
of macaques with##2##3##(1995-8#1)(1997-3#1)
of macaques##8##2##(1992-11#1)(1992-9#1)(1993-2#1)(1994-2#1)(1995-8#1)(1997-3#2)(2008-4#1)
of macerated##2##2##(1995-9#1)(2008-10#1)
of machine learning##4##3##(2008-5#1)(2008-7#1)(2010-2#1)(2011-2#1)
of machine vision##4##3##(1997-8#1)(2007-11#2)(2008-3#1)
of machine##9##2##(1997-8#1)(2007-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-2#1)
of machinery##2##2##(2008-11#1)(2012-12#1)
of machines##5##2##(1995-1#1)(2006-9#1)(2008-4#1)(2009-6#1)(2012-2#1)
of macro and##2##3##(1993-7#1)(2008-7#1)
of macro##7##2##(1991-2#1)(1993-7#1)(2006-5#2)(2008-10#2)(2008-7#1)
of macro- and micronutrients##2##4##(2007-3#1)(2008-10#1)
of macro- and##3##3##(2007-3#1)(2008-10#1)(2008-12#1)
of macro-organisms##2##2##(2007-11#1)(2011-12#1)
of macroalgae##3##2##(2007-5#2)(2008-5#1)
of macrobenthos##2##2##(2006-6#2)
of macrocycle##4##2##(2008-10#4)
of macrocycles##3##2##(2006-12#1)(2008-10#2)
of macrocyclic lactones##2##3##(2006-12#2)
of macrocyclic##6##2##(1996-2#1)(1997-2#1)(2006-12#3)(2007-11#1)
of macrokinetic##3##2##(2008-7#3)
of macrolide##4##2##(2005-7#1)(2007-12#1)(2007-7#1)(2008-10#1)
of macrolides##11##2##(2005-7#2)(2006-10#4)(2006-11#4)(2007-11#1)
of macromolecular structures##2##3##(1990-8#1)(2008-4#1)
of macromolecular substrate##2##3##(1995-8#2)
of macromolecular##19##2##(1990-8#1)(1991-11#1)(1993-3#1)(1994-5#1)(1995-1#1)(1995-8#2)(1997-7#1)(2005-4#1)(2005-7#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-4#1)(2009-10#1)(2009-5#1)(2012-3#1)
of macromolecule##3##2##(2008-1#1)(2008-4#1)(2010-10#1)
of macromolecules and macromolecular##2##4##(2008-4#1)(2011-1#1)
of macromolecules and##3##3##(2008-4#1)(2011-1#1)(2012-3#1)
of macromolecules in##2##3##(1995-7#1)(2006-10#1)
of macromolecules##23##2##(1995-7#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-8#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-4#5)(2008-6#1)(2008-7#1)(2009-4#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of macronutrients##5##2##(2007-8#1)(2008-10#1)(2008-3#2)(2008-5#1)
of macroparasites##2##2##(2008-9#2)
of macrophage activation syndrome##2##4##(1993-11#1)(2006-10#1)
of macrophage activation##3##3##(1990-11#1)(1993-11#1)(2006-10#1)
of macrophage colony-stimulating factor##2##4##(1992-8#1)(1995-8#1)
of macrophage immune responses##2##4##(2007-11#2)
of macrophage immune##3##3##(2007-11#3)
of macrophage infiltration in##2##4##(1991-9#2)
of macrophage infiltration##3##3##(1991-9#2)(2007-11#1)
of macrophage migration inhibitory factor (MIF)##2##6##(1997-5#1)(2012-2#1)
of macrophage migration inhibitory factor##4##5##(1997-5#1)(2011-12#1)(2012-2#1)(2013-8#1)
of macrophage progenitors##2##3##(1990-5#1)(1991-6#1)
of macrophage##37##2##(1990-11#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-8#1)(1993-11#1)(1993-6#1)(1995-10#2)(1995-8#2)(1996-5#2)(1997-5#1)(2003-11#1)(2006-10#1)(2007-11#5)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2011-12#1)(2012-12#1)(2012-2#2)(2013-8#1)
of macrophages and##7##3##(1991-5#1)(1995-6#1)(2006-9#1)(2008-10#3)(2012-1#1)
of macrophages in the##2##4##(1995-1#1)(2008-11#1)
of macrophages in##3##3##(1995-1#1)(2008-11#1)(2011-1#1)
of macrophages that##2##3##(1996-10#1)(2008-4#1)
of macrophages to##3##3##(2008-4#2)(2008-8#1)
of macrophages via##2##3##(1991-12#1)(2007-11#1)
of macrophages were##2##3##(1990-12#1)(2007-9#1)
of macrophages with##5##3##(1994-9#2)(1995-2#1)(2008-4#2)
of macrophages##56##2##(1990-12#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-2#1)(1992-7#1)(1993-3#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-6#2)(2004-12#1)(2006-10#1)(2006-9#2)(2007-11#2)(2007-9#1)(2008-10#4)(2008-11#1)(2008-4#9)(2008-5#1)(2008-8#3)(2009-6#1)(2010-12#2)(2011-1#1)(2012-1#1)(2013-1#4)
of macropores##3##2##(2004-9#1)(2007-8#1)(2008-6#1)
of macroporous##3##2##(2008-11#2)(2011-1#1)
of macroprolactinemia##2##2##(2006-9#2)
of macroscopic haematuria##2##3##(1995-5#2)
of macroscopic objects##2##3##(2007-12#1)(2008-7#1)
of macroscopic##21##2##(1993-4#1)(1994-3#1)(1995-5#2)(1996-8#1)(2005-7#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#2)(2008-4#2)(2008-7#2)(2012-2#2)(2013-1#1)(2013-7#2)
of macroscopically##2##2##(2008-3#1)(2013-1#1)
of macrosomia##3##2##(1996-11#1)(2008-1#2)
of macrovascular##2##2##(1997-2#1)(2008-1#1)
of macular carotenoid pigments##2##4##(2007-11#2)
of macular degeneration##5##3##(2011-2#5)
of macular edema##2##3##(2008-1#1)(2012-12#1)
of macular pigments##2##3##(2012-12#2)
of macular##18##2##(2006-11#1)(2007-11#3)(2008-1#1)(2011-2#7)(2012-12#3)(2013-1#3)
of macules##2##2##(2011-2#2)
of made up women##2##4##(2008-5#2)
of made up##3##3##(2008-5#3)
of madness and##2##3##(2008-2#1)(2009-10#1)
of madness##4##2##(2008-2#1)(2009-10#1)(2009-7#1)(2013-8#1)
of mae1##2##2##(1997-6#2)
of magainin 2 amide##3##4##(1990-2#1)(1992-10#1)(1995-11#1)
of magainin##5##2##(1990-2#2)(1992-10#2)(1995-11#1)
of magic##2##2##(2006-4#1)(2008-8#1)
of magnesium and calcium##2##4##(2008-10#1)(2008-5#1)
of magnesium and##6##3##(1992-7#1)(1994-5#1)(2007-11#1)(2008-10#2)(2008-5#1)
of magnesium as##2##3##(1997-1#1)(2008-6#1)
of magnesium chloride##2##3##(1995-12#1)(2008-4#1)
of magnesium in different types of##2##6##(2008-10#2)
of magnesium in##7##3##(2008-10#7)
of magnesium ion##2##3##(1991-2#1)(1995-1#1)
of magnesium ions on the##2##5##(1994-5#1)(2008-10#1)
of magnesium ions on##3##4##(1994-5#1)(2008-10#2)
of magnesium ions##4##3##(1994-5#1)(2008-10#2)(2008-4#1)
of magnesium sulfate##2##3##(2007-12#1)(2011-1#1)
of magnesium sulphate (MgSO4) in the treatment of eclampsia##2##9##(2012-2#2)
of magnesium sulphate##6##3##(2006-10#1)(2008-7#1)(2012-2#2)(2013-8#2)
of magnesium were##2##3##(2008-10#2)
of magnesium with##3##3##(2007-8#1)(2008-10#1)(2008-5#1)
of magnesium##64##2##(1990-11#1)(1991-2#1)(1991-6#1)(1992-7#1)(1994-5#3)(1995-1#1)(1995-12#1)(1995-3#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-8#2)(2006-10#2)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#4)(2007-9#1)(2008-10#22)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#2)
of magnetic and##4##3##(2005-11#1)(2008-4#1)(2008-5#1)(2009-2#1)
of magnetic beads##5##3##(2007-12#2)(2008-10#2)(2010-11#1)
of magnetic domains##3##3##(2007-9#2)(2008-3#1)
of magnetic field on##4##4##(2008-10#1)(2008-8#1)(2011-2#1)(2012-1#1)
of magnetic field##8##3##(2006-10#1)(2007-11#1)(2008-10#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
of magnetic fields on##2##4##(1990-7#1)(2008-8#1)
of magnetic fields##4##3##(1990-7#1)(2007-12#1)(2008-2#1)(2008-8#1)
of magnetic flux##2##3##(1995-10#1)(2006-4#1)
of magnetic nanoparticles in##3##4##(2012-11#2)(2012-2#1)
of magnetic nanoparticles##8##3##(2006-5#1)(2012-11#6)(2012-2#1)
of magnetic resonance (MR)##2##4##(2007-7#1)(2011-2#1)
of magnetic resonance angiography##2##4##(2006-10#1)(2008-12#1)
of magnetic resonance images##2##4##(1996-7#1)(2010-8#1)
of magnetic resonance imaging (MRI) in##2##6##(2008-4#1)(2008-7#1)
of magnetic resonance imaging (MRI)##3##5##(2008-4#1)(2008-7#1)(2010-12#1)
of magnetic resonance imaging and##8##5##(1994-7#1)(2006-3#1)(2007-10#1)(2007-4#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
of magnetic resonance imaging in the##4##6##(1991-5#1)(2008-4#1)(2008-8#1)(2010-12#1)
of magnetic resonance imaging in##7##5##(1991-5#1)(1997-5#1)(2006-10#1)(2007-4#1)(2008-4#1)(2008-8#1)(2010-12#1)
of magnetic resonance imaging of##2##5##(1994-7#1)(2008-7#1)
of magnetic resonance imaging to##2##5##(2007-4#1)(2012-3#1)
of magnetic resonance imaging##28##4##(1991-5#1)(1994-7#2)(1996-2#1)(1997-5#1)(2006-10#1)(2006-3#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-4#3)(2008-4#2)(2008-7#5)(2008-8#1)(2008-9#1)(2010-12#2)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
of magnetic resonance spectroscopy##4##4##(1990-2#1)(2006-12#2)(2009-4#1)
of magnetic resonance##56##3##(1990-2#1)(1990-6#1)(1991-5#2)(1992-10#1)(1992-3#1)(1993-11#2)(1993-5#1)(1994-7#2)(1994-8#1)(1996-11#1)(1996-2#1)(1996-7#1)(1997-5#1)(2004-9#1)(2005-12#1)(2006-10#2)(2006-12#2)(2006-3#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-4#4)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#7)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#2)(2010-8#1)(2011-12#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
of magnetic##102##2##(1990-2#1)(1990-6#1)(1990-7#1)(1991-5#2)(1992-10#1)(1992-3#1)(1992-9#1)(1993-11#2)(1993-5#1)(1994-7#2)(1994-8#1)(1995-10#1)(1996-11#1)(1996-2#1)(1996-7#1)(1997-5#1)(2004-9#1)(2005-11#1)(2005-12#1)(2006-10#3)(2006-12#2)(2006-3#1)(2006-4#2)(2006-5#3)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-4#4)(2007-7#1)(2007-9#2)(2008-10#6)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#8)(2008-8#3)(2008-9#1)(2009-2#1)(2009-4#1)(2009-7#2)(2010-11#1)(2010-12#3)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-11#7)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
of magnetically##3##2##(1992-3#1)(2009-11#1)(2009-6#1)
of magnetite##5##2##(1992-1#2)(2004-9#2)(2005-11#1)
of magneto-optic##3##2##(2008-3#3)
of magneto-optical##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
of magnetoencephalography (MEG)##2##3##(2006-10#1)(2012-12#1)
of magnitude and a##3##4##(2007-8#1)(2008-10#2)
of magnitude and the##5##4##(1997-1#1)(2008-10#3)(2008-3#1)
of magnitude and##14##3##(1997-1#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#2)(2012-2#1)(2013-8#1)
of magnitude as##11##3##(1990-3#1)(1991-2#1)(1992-6#2)(1993-3#1)(1994-11#1)(2005-11#1)(2007-11#3)(2008-11#1)
of magnitude better than those of##2##6##(1997-1#1)(2010-4#1)
of magnitude by##6##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-11#1)(2010-5#1)
of magnitude compared to##2##4##(2008-5#1)(2013-8#1)
of magnitude compared##3##3##(2008-2#1)(2008-5#1)(2013-8#1)
of magnitude faster than##4##4##(1994-11#1)(1995-10#1)(1995-2#1)(2007-9#1)
of magnitude faster##7##3##(1994-11#1)(1995-10#1)(1995-2#1)(2007-12#1)(2007-9#1)(2008-3#1)(2010-6#1)
of magnitude for##6##3##(1991-5#1)(1995-5#1)(2007-12#3)(2008-10#1)
of magnitude from##5##3##(1995-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
of magnitude greater than that of##4##6##(1995-6#1)(2007-12#1)(2008-1#1)(2010-9#1)
of magnitude greater than that##5##5##(1995-6#1)(2007-12#1)(2008-1#1)(2008-3#1)(2010-9#1)
of magnitude greater than the##2##5##(2007-12#1)(2008-3#1)
of magnitude greater than##7##4##(1995-6#1)(2007-12#2)(2008-1#1)(2008-3#2)(2010-9#1)
of magnitude greater##9##3##(1995-2#1)(1995-6#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#2)(2010-9#1)
of magnitude higher than in##3##5##(1992-4#1)(1994-11#1)(2007-12#1)
of magnitude higher than that of the##4##7##(2007-12#2)(2008-10#1)(2008-7#1)
of magnitude higher than that of##6##6##(1992-8#1)(2007-12#3)(2008-10#1)(2008-7#1)
of magnitude higher than that##7##5##(1992-8#1)(2007-12#3)(2008-10#2)(2008-7#1)
of magnitude higher than those##4##5##(1990-7#1)(1991-5#1)(2008-10#1)(2012-2#1)
of magnitude higher than##21##4##(1990-7#1)(1991-5#1)(1992-4#1)(1992-8#1)(1994-11#1)(1995-11#1)(1995-8#1)(1996-5#1)(2006-4#1)(2007-11#1)(2007-12#5)(2008-10#4)(2008-7#1)(2012-2#1)
of magnitude higher when the##2##5##(2007-12#1)(2011-2#1)
of magnitude higher##27##3##(1990-7#1)(1991-5#1)(1992-4#1)(1992-8#1)(1994-11#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-5#1)(1997-6#1)(2006-4#1)(2007-11#1)(2007-12#6)(2008-10#4)(2008-7#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
of magnitude in the##4##4##(1990-12#1)(2007-12#1)(2008-2#1)(2008-3#1)
of magnitude in##11##3##(1990-12#1)(1990-5#1)(1997-8#1)(2007-12#1)(2007-3#1)(2008-2#2)(2008-3#2)(2009-11#1)(2010-8#1)
of magnitude increase in##2##4##(2008-2#1)(2008-3#1)
of magnitude larger than the##3##5##(2007-11#1)(2008-2#1)(2011-1#1)
of magnitude larger than##14##4##(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-9#1)(2010-8#1)(2011-1#1)(2013-8#1)
of magnitude larger##15##3##(1996-11#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-9#1)(2010-8#1)(2011-1#1)(2013-8#1)
of magnitude less favorable over the##2##6##(1997-2#2)
of magnitude less than the##2##5##(2008-11#1)(2008-2#1)
of magnitude less than##5##4##(1997-4#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-6#1)
of magnitude less##11##3##(1995-12#1)(1997-2#2)(1997-4#2)(2008-11#1)(2008-2#1)(2008-3#2)(2009-6#1)(2012-1#1)
of magnitude lower than that of##4##6##(1990-11#1)(1996-12#1)(2007-11#1)(2010-2#1)
of magnitude lower than that##5##5##(1990-11#1)(1996-12#1)(1996-5#1)(2007-11#1)(2010-2#1)
of magnitude lower than the frequency of##2##7##(1995-8#2)
of magnitude lower than the##3##5##(1995-8#2)(2008-10#1)
of magnitude lower than those##3##5##(1990-7#1)(2008-10#1)(2009-3#1)
of magnitude lower than##18##4##(1990-11#1)(1990-7#1)(1991-7#2)(1995-8#2)(1996-12#1)(1996-5#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-3#1)(2010-2#1)
of magnitude lower##22##3##(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-7#2)(1995-8#2)(1996-12#1)(1996-5#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-3#1)(2010-2#1)
of magnitude more efficient than##3##5##(2007-12#1)(2008-10#1)(2010-12#1)
of magnitude more efficient##4##4##(1995-8#1)(2007-12#1)(2008-10#1)(2010-12#1)
of magnitude more potent##2##4##(1990-7#1)(1992-3#1)
of magnitude more sensitive to##2##5##(2008-2#1)(2008-8#1)
of magnitude more sensitive##5##4##(2006-3#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-8#1)
of magnitude more##13##3##(1990-7#1)(1991-4#1)(1992-3#1)(1995-8#1)(2006-3#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-12#1)
of magnitude of##16##3##(1990-3#1)(1993-3#1)(1995-8#1)(1996-7#1)(1997-8#1)(2005-11#1)(2006-1#1)(2007-12#1)(2008-10#3)(2008-3#3)(2008-8#1)(2012-3#1)
of magnitude over##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
of magnitude relative to##4##4##(1994-5#1)(1994-8#1)(1995-2#1)(2008-10#1)
of magnitude slower than##2##4##(1991-1#1)(2008-10#1)
of magnitude smaller than##5##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-9#1)
of magnitude smaller##6##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-9#1)(2013-1#1)
of magnitude than that##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
of magnitude than##5##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
of magnitude was##2##3##(2007-11#1)(2008-10#1)
of magnitude were##3##3##(2007-12#1)(2008-2#1)(2013-8#1)
of magnitude when the##2##4##(2006-4#1)(2008-10#1)
of magnitude when##4##3##(2006-4#1)(2008-10#3)
of magnitude with the##2##4##(2005-11#1)(2009-2#1)
of magnitude with##8##3##(2005-11#1)(2008-1#1)(2008-10#4)(2009-11#1)(2009-2#1)
of magnitude within##2##3##(2007-11#1)(2008-10#1)
of magnitude##342##2##(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#3)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#2)(1991-4#1)(1991-5#4)(1991-7#2)(1992-3#1)(1992-4#1)(1992-6#3)(1992-8#1)(1993-3#2)(1993-8#1)(1994-11#4)(1994-2#1)(1994-3#2)(1994-5#3)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#5)(1996-11#2)(1996-12#1)(1996-4#1)(1996-5#2)(1996-7#2)(1996-8#1)(1997-1#3)(1997-2#4)(1997-4#7)(1997-6#2)(1997-8#2)(2004-11#1)(2005-11#6)(2005-12#1)(2006-1#1)(2006-10#1)(2006-3#1)(2006-4#3)(2007-11#16)(2007-12#36)(2007-3#1)(2007-8#3)(2007-9#1)(2008-1#6)(2008-10#65)(2008-11#5)(2008-12#1)(2008-2#20)(2008-3#31)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#3)(2009-11#4)(2009-12#2)(2009-2#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#4)(2012-3#3)(2013-1#1)(2013-8#5)
of magnitude)##5##2##(1995-2#1)(1995-5#1)(2007-11#1)(2008-10#2)
of magnolol##2##2##(2011-2#2)
of mail##2##2##(1990-12#1)(1995-12#1)
of main and##2##3##(2008-10#1)(2011-1#1)
of main##16##2##(1994-2#1)(1995-12#1)(1996-5#1)(2006-8#1)(2007-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#2)(2011-2#1)(2013-1#3)
of mainly##13##2##(1991-7#2)(1996-9#1)(2004-4#1)(2005-8#1)(2006-3#1)(2007-3#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-9#1)(2010-8#1)
of mainstream##4##2##(2007-11#1)(2008-11#1)(2008-7#1)(2013-1#1)
of maintained##2##2##(2008-10#1)(2009-8#1)
of maintaining a##3##3##(1992-3#1)(2008-10#1)(2012-3#1)
of maintaining and##3##3##(1990-12#1)(1992-6#1)(1997-2#1)
of maintaining##24##2##(1990-12#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-9#1)(1995-12#1)(1996-3#1)(1997-2#1)(2006-10#1)(2007-3#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#2)
of maintenance and repair##2##4##(2008-7#2)
of maintenance intravenous##2##3##(2008-1#2)
of maintenance of##2##3##(1991-8#1)(2013-1#1)
of maintenance therapy##4##3##(1991-2#1)(2008-4#1)(2012-2#2)
of maintenance##25##2##(1991-2#1)(1991-8#1)(1995-1#1)(1996-2#1)(1996-6#1)(2006-9#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-9#1)(2010-2#1)(2011-1#1)(2012-2#3)(2013-1#1)(2013-8#2)
of maize (Zea mays##2##4##(2008-5#1)(2012-2#1)
of maize (Zea##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
of maize amylose##2##3##(2013-8#2)
of maize and wheat##2##4##(2006-4#2)
of maize and##4##3##(2006-4#2)(2008-10#1)(2008-8#1)
of maize genotypes##2##3##(2008-10#2)
of maize in##2##3##(2008-10#1)(2012-2#1)
of maize seedlings##2##3##(2008-10#1)(2009-8#1)
of maize streak virus (MSV)##2##5##(2008-10#2)
of maize streak##3##3##(2008-10#3)
of maize with##3##3##(2008-10#2)(2008-5#1)
of maize##76##2##(1990-4#2)(1991-10#1)(1994-8#1)(1996-5#1)(2005-11#1)(2006-12#1)(2006-4#2)(2007-6#1)(2008-10#38)(2008-12#6)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#4)(2009-8#1)(2010-10#2)(2012-12#1)(2012-2#2)(2013-8#3)
of major adverse cardiac events##2##5##(2008-11#1)(2010-12#1)
of major and minor elements of##2##6##(2008-10#2)
of major and minor##6##4##(1990-9#1)(1997-2#1)(2008-10#2)(2010-12#1)(2011-2#1)
of major bleeding##5##3##(2007-10#1)(2007-11#1)(2008-3#1)(2008-8#1)(2010-12#1)
of major clinical##3##3##(2006-6#1)(2008-5#1)(2010-5#1)
of major complications and##2##4##(2006-2#2)
of major complications##10##3##(2006-2#4)(2006-8#1)(2007-8#1)(2008-9#1)(2010-3#1)(2011-2#1)(2013-1#1)
of major components of##2##4##(2011-3#2)
of major components##5##3##(2010-5#1)(2011-3#2)(2012-2#1)(2013-8#1)
of major concern##7##3##(2006-10#1)(2006-8#1)(2008-10#1)(2008-7#1)(2011-2#2)(2013-7#1)
of major constituents##5##3##(1993-9#1)(2007-5#3)(2008-10#1)
of major depression##8##3##(1995-12#1)(1996-2#1)(1996-7#2)(2004-3#1)(2008-7#1)(2008-9#1)(2011-2#1)
of major depressive disorder##3##4##(1991-2#1)(2008-8#1)(2011-2#1)
of major depressive##7##3##(1991-2#1)(2008-8#1)(2010-6#2)(2011-1#1)(2011-2#1)(2013-8#1)
of major flavor components in##2##5##(2005-12#2)
of major gene##3##3##(1996-6#1)(2013-8#2)
of major genes##3##3##(2008-10#2)(2012-11#1)
of major groove##2##3##(1992-3#1)(1994-8#1)
of major histocompatibility class##2##4##(1995-12#1)(2011-1#1)
of major histocompatibility complex (MHC) molecules##2##6##(1994-6#1)(1995-8#1)
of major histocompatibility complex (MHC)##4##5##(1993-9#1)(1994-6#1)(1995-8#1)(2008-10#1)
of major histocompatibility complex class II##3##6##(1990-12#1)(1993-6#1)(2008-10#1)
of major histocompatibility complex class##5##5##(1990-12#1)(1993-6#1)(1993-9#1)(2008-10#1)(2013-1#1)
of major histocompatibility complex##12##4##(1990-12#1)(1993-6#1)(1993-9#2)(1994-6#1)(1995-8#3)(2008-10#2)(2010-8#1)(2013-1#1)
of major histocompatibility##15##3##(1990-12#1)(1993-6#2)(1993-9#2)(1994-6#1)(1995-12#1)(1995-8#3)(2008-10#2)(2010-8#1)(2011-1#1)(2013-1#1)
of major importance for the##2##5##(1991-2#1)(2008-11#1)
of major importance for##5##4##(1991-2#1)(1991-6#1)(1997-2#1)(2008-11#1)(2012-2#1)
of major importance in the##3##5##(1995-7#1)(2007-6#1)(2010-8#1)
of major importance in##9##4##(1991-8#1)(1992-10#1)(1994-6#1)(1995-7#1)(2007-6#1)(2008-11#1)(2008-5#1)(2010-8#1)(2011-2#1)
of major importance to##2##4##(2009-10#1)(2011-2#1)
of major importance##22##3##(1991-2#1)(1991-6#1)(1991-8#1)(1992-10#1)(1994-6#1)(1995-7#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-6#1)(2008-1#1)(2008-11#2)(2008-5#2)(2009-10#1)(2009-12#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#1)
of major interest in##2##4##(1993-4#1)(1996-12#1)
of major interest##4##3##(1993-4#1)(1996-12#1)(2007-1#1)(2008-7#1)
of major lower limb##2##4##(2008-7#1)(2013-7#1)
of major medical##2##3##(2008-4#1)(2011-12#1)
of major mental disorders##2##4##(2006-8#1)(2009-8#1)
of major palm creases##2##4##(2010-12#2)
of major resistance genes##2##4##(2008-10#2)
of major risk factors for##2##5##(2005-3#1)(2008-8#1)
of major salivary glands##2##4##(2010-12#1)(2013-1#1)
of major trauma##3##3##(1990-6#1)(1990-9#1)(2006-10#1)
of major vascular##2##3##(2007-10#1)(2008-1#1)
of major##232##2##(1990-12#1)(1990-3#1)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-2#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-4#1)(1993-6#2)(1993-7#1)(1993-9#5)(1994-1#1)(1994-11#1)(1994-6#2)(1994-8#2)(1995-12#2)(1995-2#2)(1995-7#1)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#2)(1996-7#2)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(2004-3#1)(2005-12#3)(2005-3#1)(2005-8#1)(2006-10#3)(2006-2#4)(2006-4#2)(2006-6#1)(2006-8#4)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#5)(2008-10#23)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#3)(2008-7#7)(2008-8#4)(2008-9#3)(2009-10#1)(2009-12#1)(2009-4#2)(2009-8#2)(2010-1#1)(2010-12#9)(2010-3#2)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#10)(2011-3#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#9)(2013-7#3)(2013-8#5)
of making a##4##3##(1992-12#1)(1993-12#1)(1996-11#1)(2012-12#1)
of making experimental##2##3##(2010-12#2)
of making it##2##3##(1995-3#1)(2011-2#1)
of making the##4##3##(2008-8#2)(2010-4#1)(2011-2#1)
of making##33##2##(1992-12#1)(1993-12#1)(1994-2#1)(1995-3#1)(1996-11#1)(1997-2#1)(2005-11#1)(2006-10#1)(2007-11#4)(2007-12#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-6#1)(2010-12#3)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#2)
of malabsorption##5##2##(1990-3#1)(2006-2#3)(2012-2#1)
of malachite##2##2##(2007-8#1)(2008-10#1)
of malaise##2##2##(2009-3#1)(2013-1#1)
of malaria and its##2##4##(2007-2#1)(2011-2#1)
of malaria and the##2##4##(2006-2#1)(2009-6#1)
of malaria and##10##3##(2006-10#1)(2006-2#2)(2006-4#1)(2007-2#1)(2007-4#1)(2008-11#1)(2008-2#1)(2009-6#1)(2011-2#1)
of malaria as well as##3##5##(2008-10#1)(2008-2#2)
of malaria by##4##3##(2007-2#2)(2008-3#1)(2011-12#1)
of malaria cases##5##3##(2008-8#2)(2011-2#1)(2012-12#2)
of malaria control in##2##4##(2006-4#1)(2008-2#1)
of malaria control##7##3##(1997-4#1)(2006-4#2)(2008-2#1)(2008-8#1)(2012-3#2)
of malaria diagnosis##5##3##(2005-8#1)(2007-2#1)(2012-12#3)
of malaria during##2##3##(1993-8#1)(2007-8#1)
of malaria epidemic situation after malaria basically eliminated in Wujin District##2##11##(2012-3#2)
of malaria epidemic##3##3##(2012-3#3)
of malaria from##2##3##(1991-5#1)(2007-2#1)
of malaria has been##2##4##(2007-12#1)(2008-3#1)
of malaria in the##8##4##(2006-2#2)(2006-4#1)(2008-4#1)(2011-1#1)(2012-12#2)(2012-3#1)
of malaria in##28##3##(1990-3#1)(1991-5#1)(2005-8#1)(2006-10#1)(2006-2#5)(2006-4#1)(2007-2#4)(2007-8#1)(2008-2#1)(2008-4#2)(2011-1#1)(2011-2#1)(2012-12#6)(2012-3#2)
of malaria on the##4##4##(2005-8#2)(2011-2#1)(2013-8#1)
of malaria on##5##3##(2005-8#2)(2008-8#1)(2011-2#1)(2013-8#1)
of malaria parasite##4##3##(2006-10#1)(2006-2#1)(2012-12#1)(2012-2#1)
of malaria parasites##4##3##(1994-11#1)(2006-10#1)(2007-2#1)(2007-7#1)
of malaria patients in##3##4##(2008-2#1)(2008-3#2)
of malaria patients##4##3##(2008-2#1)(2008-3#2)(2012-12#1)
of malaria should be##2##4##(2008-2#1)(2011-12#1)
of malaria should##3##3##(2007-2#1)(2008-2#1)(2011-12#1)
of malaria that##2##3##(2007-12#1)(2012-12#1)
of malaria transmission##4##3##(2006-10#1)(2008-8#3)
of malaria treatment##2##3##(2008-3#2)
of malaria vectors##2##3##(2008-8#1)(2012-12#1)
of malaria##172##2##(1990-12#1)(1990-3#1)(1991-5#3)(1992-12#1)(1992-5#1)(1993-8#3)(1994-11#1)(1997-4#1)(2005-8#10)(2006-10#16)(2006-2#9)(2006-4#14)(2007-1#1)(2007-11#1)(2007-12#4)(2007-2#18)(2007-4#1)(2007-6#2)(2007-7#4)(2007-8#4)(2008-10#1)(2008-11#1)(2008-2#10)(2008-3#7)(2008-4#6)(2008-8#10)(2009-6#1)(2010-6#1)(2011-1#1)(2011-12#3)(2011-2#6)(2012-12#18)(2012-2#1)(2012-3#9)(2013-8#1)
of malaria-related##2##2##(2006-10#1)(2008-4#1)
of malaria]##2##2##(1997-2#1)(2012-12#1)
of malarial infections##2##3##(2006-2#1)(2008-4#1)
of malarial##8##2##(1990-9#1)(1996-11#1)(2006-10#1)(2006-2#2)(2008-4#1)(2012-3#1)(2013-1#1)
of malate dehydrogenase##4##3##(1992-7#1)(1993-11#1)(1997-8#1)(2008-10#1)
of malate##9##2##(1991-3#1)(1992-1#1)(1992-7#1)(1993-11#1)(1997-6#3)(1997-8#1)(2008-10#1)
of malathion##7##2##(2005-8#1)(2008-10#1)(2009-6#4)(2013-1#1)
of male CBA##2##3##(1995-2#1)(2010-12#1)
of male Filipino seafarers##3##4##(2011-2#3)
of male Sprague-Dawley##2##3##(1992-1#1)(1995-3#1)
of male Wistar rats##3##4##(1991-5#1)(1994-2#1)(2004-11#1)
of male adults##2##3##(1991-5#1)(1996-11#1)
of male and female Wistar rats##2##6##(1990-4#1)(1993-9#1)
of male and female haploinsufficient p16(Ink4a)/p19(Arf) mice##2##7##(2008-9#2)
of male and female haploinsufficient##3##5##(2008-9#3)
of male and female##33##4##(1990-12#1)(1990-4#1)(1993-1#1)(1993-2#1)(1993-9#2)(1994-10#1)(2004-2#1)(2005-10#1)(2006-1#1)(2006-3#1)(2006-5#2)(2007-1#1)(2007-12#2)(2008-12#2)(2008-5#2)(2008-8#2)(2008-9#5)(2009-4#1)(2010-2#1)(2010-8#2)(2012-2#1)(2012-3#1)
of male and##34##3##(1990-12#1)(1990-4#1)(1993-1#1)(1993-2#1)(1993-9#2)(1994-10#1)(2004-2#1)(2005-10#1)(2006-1#1)(2006-3#1)(2006-5#2)(2007-1#1)(2007-12#2)(2008-12#2)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#5)(2009-4#1)(2010-2#1)(2010-8#2)(2012-2#1)(2012-3#1)
of male animals##2##3##(1992-11#1)(2008-9#1)
of male breast cancer##4##4##(1990-2#1)(1997-7#2)(2011-2#1)
of male breast cancers##2##4##(2007-2#2)
of male breast##6##3##(1990-2#1)(1997-7#2)(2007-2#2)(2011-2#1)
of male factor infertility##2##4##(2007-10#1)(2008-1#1)
of male factor##3##3##(2006-10#1)(2007-10#1)(2008-1#1)
of male fertility##3##3##(1991-11#1)(2008-3#1)(2013-8#1)
of male fitness##2##3##(2008-9#2)
of male gender##2##3##(2007-10#1)(2011-2#1)
of male infertility and##3##4##(2006-10#1)(2009-10#2)
of male infertility##7##3##(2006-10#2)(2008-12#1)(2009-10#2)(2009-5#1)(2011-1#1)
of male killing##2##3##(2008-8#2)
of male lambs##2##3##(2008-12#1)(2010-2#1)
of male menopause##2##3##(2008-7#2)
of male mice##4##3##(1990-6#1)(2008-9#1)(2009-9#1)(2011-1#1)
of male or female##2##4##(2006-7#1)(2008-9#1)
of male patients with##4##4##(1996-3#1)(2006-10#2)(2012-3#1)
of male patients##5##3##(1990-8#1)(1996-3#1)(2006-10#2)(2012-3#1)
of male rat sexual behavior##2##5##(1991-2#2)
of male rat##4##3##(1990-4#1)(1991-2#2)(1993-8#1)
of male rats##13##3##(1991-10#1)(1992-12#1)(1992-3#1)(1993-7#2)(1994-10#1)(1994-6#1)(1994-8#1)(1995-2#1)(2008-11#2)(2010-5#1)(2012-2#1)
of male sex pheromone##2##4##(2007-12#2)
of male sex##4##3##(2007-12#2)(2007-7#1)(2008-12#1)
of male sexual behaviour##2##4##(1994-2#1)(1994-6#1)
of male sexual##8##3##(1994-2#2)(1994-6#1)(1995-12#1)(2009-5#1)(2009-9#1)(2012-3#2)
of male subfertility##2##3##(1991-11#1)(2006-10#1)
of male subjects##2##3##(1993-1#1)(2012-3#1)
of male##237##2##(1990-12#1)(1990-2#1)(1990-4#3)(1990-6#3)(1990-8#2)(1991-10#1)(1991-11#2)(1991-2#2)(1991-5#3)(1991-6#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#2)(1993-1#2)(1993-2#1)(1993-7#2)(1993-8#4)(1993-9#4)(1994-10#2)(1994-12#1)(1994-2#4)(1994-5#2)(1994-6#2)(1994-8#1)(1995-12#2)(1995-2#3)(1995-3#3)(1996-11#4)(1996-3#1)(1996-6#1)(1997-2#2)(1997-7#3)(1997-8#1)(2004-11#3)(2004-2#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#8)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-12#8)(2007-2#4)(2007-3#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#6)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#6)(2008-7#3)(2008-8#10)(2008-9#12)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#4)(2011-1#4)(2011-2#10)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#8)(2013-1#8)(2013-7#2)(2013-8#3)
of male-male##2##2##(2008-5#1)(2008-8#1)
of male-specific##4##2##(1997-4#1)(2007-12#1)(2008-4#2)
of male-to-male##2##2##(1996-12#1)(2012-3#1)
of male-typical##2##2##(1991-8#1)(1994-2#1)
of maleic hydrazide##4##3##(2008-10#4)
of maleic##5##2##(2007-11#1)(2008-10#4)
of males and 5##2##4##(1994-6#1)(2011-1#1)
of males and females were##2##5##(2007-5#1)(2008-9#1)
of males and females##10##4##(1996-8#1)(1997-6#1)(2007-5#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-4#1)(2010-8#1)
of males and##29##3##(1994-6#3)(1996-8#1)(1997-6#1)(1997-7#1)(2006-8#1)(2007-5#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#6)(2009-4#1)(2010-8#2)(2011-1#3)(2011-2#1)(2012-12#3)(2013-7#1)
of males at##3##3##(2008-9#2)(2009-4#1)
of males in##3##3##(1990-2#1)(1997-7#1)(2007-2#1)
of males of##2##3##(2007-12#1)(2008-5#1)
of males that##2##3##(2008-6#1)(2009-6#1)
of males was##2##3##(1991-10#1)(2008-10#1)
of males were##4##3##(1995-5#1)(2008-11#1)(2008-5#1)(2008-9#1)
of males##98##2##(1990-2#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-6#1)(1993-8#1)(1994-6#5)(1995-1#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-5#1)(1997-6#1)(1997-7#2)(2005-8#1)(2006-10#3)(2006-7#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#5)(2008-6#2)(2008-8#7)(2008-9#20)(2009-4#2)(2009-6#1)(2009-9#4)(2010-8#3)(2011-1#4)(2011-2#4)(2012-12#3)(2012-2#2)(2013-1#1)(2013-7#1)
of malformation##2##2##(2005-11#1)(2008-3#1)
of malformations in##2##3##(1997-1#1)(2008-10#1)
of malformations##9##2##(1990-8#1)(1997-1#1)(2005-11#1)(2006-2#1)(2007-6#1)(2008-10#1)(2009-5#1)(2011-2#1)(2012-3#1)
of malformed##6##2##(1993-3#2)(1995-2#2)(1996-12#1)(2008-3#1)
of malfunctioning##2##2##(2007-7#1)(2007-8#1)
of malic acid##2##3##(2008-10#2)
of malic enzyme and glucose-6-phosphate dehydrogenase##2##6##(1990-3#2)
of malic enzyme were##2##4##(1990-3#1)(1996-7#1)
of malic enzyme##5##3##(1990-3#3)(1996-7#2)
of malic##8##2##(1990-3#3)(1996-7#2)(2008-10#3)
of malignancies in##2##3##(2008-5#1)(2010-9#1)
of malignancies of##3##3##(1990-6#1)(2007-11#2)
of malignancies##25##2##(1990-6#1)(1994-5#1)(1997-4#1)(1997-5#1)(2005-7#1)(2006-10#1)(2007-11#5)(2007-3#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-3#1)(2010-4#1)(2010-9#1)(2012-2#2)(2013-7#1)
of malignancy and##6##3##(1993-8#1)(1997-6#1)(2008-10#1)(2008-2#2)(2013-1#1)
of malignancy by##2##3##(1990-3#1)(1994-12#1)
of malignancy has##2##3##(1995-6#1)(2009-5#1)
of malignancy in##8##3##(1990-10#1)(1990-2#1)(1997-2#1)(2008-6#1)(2010-11#1)(2011-12#2)(2013-8#1)
of malignancy of the##2##4##(1990-6#1)(2006-9#1)
of malignancy was##3##3##(1990-2#1)(1990-3#1)(1992-4#1)
of malignancy were##4##3##(1991-10#1)(1997-1#1)(2011-1#1)(2012-12#1)
of malignancy##93##2##(1990-10#1)(1990-2#5)(1990-3#2)(1990-6#2)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-2#2)(1992-4#1)(1993-10#1)(1993-8#1)(1994-12#2)(1995-6#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-6#1)(2004-1#1)(2005-11#1)(2005-12#1)(2005-3#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-7#2)(2011-1#5)(2011-12#2)(2011-2#3)(2012-12#4)(2012-2#2)(2013-1#4)(2013-8#5)
of malignant and##5##3##(1991-4#1)(1995-12#1)(2008-1#1)(2010-11#1)(2013-8#1)
of malignant biliary obstruction##2##4##(2006-10#1)(2010-12#1)
of malignant biliary##4##3##(1992-1#1)(2006-10#1)(2008-12#1)(2010-12#1)
of malignant bone##2##3##(2008-6#1)(2011-2#1)
of malignant brain tumors##2##4##(1990-9#1)(1993-4#1)
of malignant cell##2##3##(2005-11#1)(2011-2#1)
of malignant cells and##2##4##(2010-1#1)(2011-1#1)
of malignant cells to##2##4##(2008-11#1)(2011-2#1)
of malignant cells##13##3##(1990-11#1)(1995-6#1)(1997-7#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-3#1)(2010-1#2)(2010-3#1)(2011-1#1)(2011-2#1)
of malignant change in##2##4##(1990-10#1)(2008-7#1)
of malignant cutaneous##2##3##(2011-2#1)(2013-7#1)
of malignant degeneration##3##3##(1990-11#1)(2011-2#1)(2012-2#1)
of malignant disease##12##3##(1990-12#1)(1991-4#1)(1992-2#1)(1992-8#1)(1994-4#1)(1996-11#1)(2006-10#1)(2007-11#1)(2009-5#1)(2010-12#1)(2012-1#1)(2013-1#1)
of malignant diseases##4##3##(1992-10#1)(1992-2#1)(2008-1#1)(2011-1#1)
of malignant effusions##2##3##(1990-12#1)(2005-12#1)
of malignant fibrous histiocytoma##3##4##(1991-12#1)(2007-12#1)(2008-6#1)
of malignant gastric outlet obstruction##4##5##(2006-10#1)(2012-2#3)
of malignant gastric outlet##5##4##(2006-10#1)(2007-5#1)(2012-2#3)
of malignant gastric##6##3##(2006-10#1)(2007-5#1)(2011-1#1)(2012-2#3)
of malignant glioma##4##3##(1993-9#1)(2006-12#2)(2008-5#1)
of malignant gliomas##5##3##(1990-4#1)(1993-9#1)(1994-12#1)(2007-1#1)(2008-12#1)
of malignant hyperthermia##2##3##(1997-3#1)(2006-10#1)
of malignant lesions of the##2##5##(2006-2#1)(2012-3#1)
of malignant lesions##5##3##(1995-9#1)(2006-2#1)(2012-3#1)(2013-8#2)
of malignant lymphoma##10##3##(1992-3#1)(2006-4#1)(2007-3#1)(2008-1#2)(2008-10#1)(2008-9#2)(2009-8#2)
of malignant melanoma in##2##4##(2011-2#2)
of malignant melanoma of the##2##5##(2012-12#1)(2012-2#1)
of malignant melanoma to##2##4##(2006-12#1)(2007-5#1)
of malignant melanoma##15##3##(2006-12#2)(2007-10#1)(2007-11#3)(2007-5#2)(2007-8#1)(2011-2#4)(2012-12#1)(2012-2#1)
of malignant mesothelioma in##2##4##(1991-12#1)(2008-8#1)
of malignant mesothelioma is##2##4##(2007-8#1)(2010-12#1)
of malignant mesothelioma##9##3##(1991-12#2)(1991-2#1)(1997-7#1)(2007-8#1)(2008-8#1)(2010-1#1)(2010-12#1)(2012-2#1)
of malignant neoplasms##3##3##(1993-9#1)(2008-4#1)(2013-8#1)
of malignant obstructive##2##3##(2007-5#2)
of malignant plasma##2##3##(2012-12#2)
of malignant pleural effusions##2##4##(1991-6#1)(2008-1#1)
of malignant pleural mesothelioma in##2##5##(2010-9#1)(2011-2#1)
of malignant pleural mesothelioma##11##4##(1992-12#2)(1995-2#1)(1997-5#1)(2007-8#4)(2008-2#1)(2010-9#1)(2011-2#1)
of malignant pleural##14##3##(1991-6#1)(1992-12#2)(1995-2#1)(1997-5#1)(2007-8#4)(2008-1#1)(2008-2#1)(2010-9#1)(2011-2#1)(2012-12#1)
of malignant potential##2##3##(1994-2#1)(2010-7#1)
of malignant process##3##3##(2007-11#1)(2008-1#1)(2013-1#1)
of malignant transformation in##2##4##(2006-10#1)(2008-7#1)
of malignant transformation##19##3##(1991-9#1)(2006-10#1)(2006-12#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#1)(2009-12#1)(2009-8#2)(2011-2#1)(2012-12#2)(2013-1#2)
of malignant tumors##7##3##(1991-9#1)(1996-9#1)(2008-4#1)(2010-1#1)(2010-2#1)(2011-2#2)
of malignant tumors]##2##3##(1993-2#1)(2013-1#1)
of malignant tumour##4##3##(2006-6#1)(2008-6#1)(2008-9#2)
of malignant tumours in##3##4##(1994-4#2)(2010-9#1)
of malignant tumours##7##3##(1994-4#2)(2009-5#2)(2010-7#1)(2010-9#1)(2011-3#1)
of malignant##241##2##(1990-10#2)(1990-11#2)(1990-12#3)(1990-4#1)(1990-5#1)(1990-6#2)(1990-9#2)(1991-11#1)(1991-12#3)(1991-2#2)(1991-4#3)(1991-6#1)(1991-9#2)(1992-1#1)(1992-10#2)(1992-12#2)(1992-2#2)(1992-3#1)(1992-8#1)(1993-10#3)(1993-2#1)(1993-4#1)(1993-6#2)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-4#3)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-11#2)(1996-4#2)(1996-9#1)(1997-3#1)(1997-5#3)(1997-7#2)(2005-10#1)(2005-11#2)(2005-12#2)(2006-10#7)(2006-12#5)(2006-2#1)(2006-4#2)(2006-6#2)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#5)(2007-7#2)(2007-8#10)(2008-1#8)(2008-10#1)(2008-11#2)(2008-12#3)(2008-2#1)(2008-4#7)(2008-5#4)(2008-6#4)(2008-7#4)(2008-8#2)(2008-9#5)(2009-12#1)(2009-3#2)(2009-5#4)(2009-8#4)(2010-1#4)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-9#2)(2011-1#4)(2011-2#17)(2011-3#1)(2012-1#2)(2012-12#7)(2012-2#11)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#6)
of malnourished##2##2##(1992-9#1)(2013-1#1)
of malnutrition and its##2##4##(2011-1#1)(2012-2#1)
of malnutrition and##9##3##(1993-6#1)(2006-6#1)(2007-7#1)(2010-9#1)(2011-1#3)(2012-12#1)(2012-2#1)
of malnutrition in the##2##4##(2007-7#1)(2012-12#1)
of malnutrition in##7##3##(1991-3#1)(2007-2#2)(2007-7#2)(2012-12#2)
of malnutrition was##3##3##(2007-7#3)
of malnutrition##32##2##(1990-4#1)(1991-3#1)(1993-6#1)(1995-2#1)(2005-12#1)(2006-10#3)(2006-2#1)(2006-6#1)(2007-2#2)(2007-7#7)(2010-9#1)(2011-1#3)(2011-2#2)(2012-12#4)(2012-2#3)
of malocclusion##2##2##(2012-12#2)
of malonaldehyde##3##2##(1990-8#2)(1992-8#1)
of malonate##2##2##(1994-5#1)(2008-10#1)
of malonates##2##2##(2008-11#2)
of malondialdehyde (MDA)##7##3##(2005-12#1)(2007-9#1)(2008-12#1)(2008-6#1)(2008-7#2)(2012-2#1)
of malondialdehyde and##2##3##(1993-2#1)(2009-6#1)
of malondialdehyde##19##2##(1990-4#1)(1993-2#1)(1994-11#1)(1997-7#1)(2005-12#1)(2005-7#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-6#2)(2009-8#1)(2010-9#1)(2012-2#1)(2013-1#1)
of malonyl-CoA in the##2##4##(1995-6#2)
of malonyl-CoA##6##2##(1991-7#2)(1995-6#4)
of malpractice##9##2##(1990-9#1)(1995-1#1)(1995-12#2)(1997-2#1)(2007-4#4)
of malt##2##2##(2008-6#1)(2009-5#1)
of maltodextrin##3##2##(2007-11#2)(2008-10#1)
of maltol##5##2##(2008-10#4)(2008-4#1)
of maltose##8##2##(1992-12#1)(1994-12#2)(1996-11#2)(1996-2#1)(2005-11#1)(2011-2#1)
of maltotriose##3##2##(1990-12#2)(1992-12#1)
of maltreatment##7##2##(2008-9#5)(2009-8#1)(2012-3#1)
of maltreatment)##2##2##(1995-3#1)(2006-3#1)
of mammal##2##2##(1997-2#1)(2008-5#1)
of mammalia##2##2##(1994-12#1)(2008-8#1)
of mammalian GnRH##2##3##(1995-5#2)
of mammalian H+-ATP synthase##2##4##(1997-2#2)
of mammalian PKC##3##3##(1993-11#2)(1994-8#1)
of mammalian SRP54##2##3##(1996-5#2)
of mammalian adenosine##2##3##(1991-2#1)(1991-5#1)
of mammalian cell culture##2##4##(2008-11#2)
of mammalian cell cultures##3##4##(2008-11#3)
of mammalian cell proliferation##2##4##(1996-5#1)(2006-10#1)
of mammalian cell##13##3##(1994-11#1)(1994-9#1)(1996-5#1)(2006-10#1)(2008-11#5)(2008-2#2)(2008-4#1)(2010-11#1)
of mammalian cells and##4##4##(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)
of mammalian cells by##3##4##(2008-11#1)(2010-10#1)(2011-2#1)
of mammalian cells to##3##4##(1994-11#1)(1994-8#1)(2009-2#1)
of mammalian cells using##2##4##(2008-11#1)(2011-1#1)
of mammalian cells with##3##4##(1990-3#2)(1994-11#1)
of mammalian cells##45##3##(1990-3#2)(1991-5#1)(1991-8#1)(1991-9#1)(1993-6#1)(1994-11#3)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-11#12)(2008-2#3)(2008-4#2)(2008-5#2)(2009-2#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#2)
of mammalian central##2##3##(1990-5#1)(1990-7#1)
of mammalian development##3##3##(1990-11#1)(1996-12#1)(1996-5#1)
of mammalian embryos##2##3##(2012-1#1)(2012-12#1)
of mammalian evolution##3##3##(1992-12#1)(1992-8#1)(2008-8#1)
of mammalian genes##2##3##(2007-12#1)(2008-4#1)
of mammalian mitochondrial##3##3##(1995-11#1)(2005-8#2)
of mammalian species##2##3##(1996-6#1)(2008-8#1)
of mammalian sperm##2##3##(1993-6#1)(2008-9#1)
of mammalian systems##2##3##(1994-3#1)(2008-10#1)
of mammalian tissue##3##3##(1996-9#1)(2008-11#1)(2008-5#1)
of mammalian tissues##2##3##(2008-1#1)(2008-5#1)
of mammalian##186##2##(1990-11#2)(1990-3#3)(1990-5#2)(1990-7#3)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-5#2)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#4)(1992-8#2)(1993-11#3)(1993-6#5)(1993-9#1)(1994-11#5)(1994-12#2)(1994-2#3)(1994-3#3)(1994-5#2)(1994-8#2)(1994-9#4)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#2)(1995-8#2)(1996-10#1)(1996-12#3)(1996-4#2)(1996-5#6)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-7#3)(1997-8#1)(2005-8#2)(2006-10#1)(2006-5#3)(2007-12#2)(2008-1#3)(2008-10#2)(2008-11#23)(2008-2#7)(2008-4#5)(2008-5#8)(2008-7#4)(2008-8#6)(2008-9#3)(2009-2#1)(2009-5#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#5)(2013-1#1)
of mammals and##7##3##(1997-4#1)(2008-4#1)(2008-5#2)(2009-10#1)(2009-2#1)(2009-5#1)
of mammals##28##2##(1990-11#1)(1990-5#1)(1993-4#1)(1993-5#1)(1993-6#2)(1994-5#1)(1995-11#2)(1997-4#1)(2007-1#1)(2008-4#2)(2008-5#4)(2009-10#1)(2009-2#1)(2009-5#2)(2010-3#2)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#2)
of mammary adenocarcinoma##3##3##(1992-2#1)(1995-8#1)(2012-1#1)
of mammary carcinoma##3##3##(1993-4#1)(1993-7#1)(1993-9#1)
of mammary epithelial cells##2##4##(1990-7#1)(1993-2#1)
of mammary epithelial##3##3##(1990-7#1)(1993-11#1)(1993-2#1)
of mammary gland##4##3##(1997-6#1)(2005-6#1)(2008-9#1)(2013-1#1)
of mammary preneoplasia##2##3##(1995-9#2)
of mammary tumors##7##3##(1991-7#1)(1992-9#3)(1993-7#2)(1995-9#1)
of mammary##36##2##(1990-7#1)(1991-11#1)(1991-7#1)(1992-1#1)(1992-2#1)(1992-9#5)(1993-11#2)(1993-2#1)(1993-4#1)(1993-7#3)(1993-9#1)(1994-3#1)(1994-5#2)(1995-8#1)(1995-9#3)(1997-6#2)(1997-7#1)(2004-11#1)(2005-6#1)(2008-9#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
of mammographic##2##2##(2004-1#1)(2008-10#1)
of mammography increased##2##3##(1990-12#1)(2004-2#1)
of mammography screening##2##3##(2006-10#2)
of mammography##13##2##(1990-12#1)(1991-4#1)(1991-8#1)(1995-8#1)(2004-2#2)(2005-9#1)(2006-10#4)(2007-4#1)(2010-8#1)
of man and##4##3##(1991-6#2)(1994-3#1)(1997-2#1)
of man in##2##3##(2006-1#1)(2006-9#1)
of man made mounds were##2##5##(2008-12#2)
of man##20##2##(1990-3#1)(1991-6#2)(1993-5#1)(1994-3#1)(1995-2#1)(1997-1#1)(1997-2#1)(1997-5#1)(2006-1#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-6#1)(2007-7#2)(2008-12#2)(2010-7#2)
of man-made objects##2##3##(1997-8#1)(2008-8#1)
of man-made##5##2##(1991-6#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-8#1)
of managed care and##6##4##(1994-12#1)(1994-3#1)(1996-1#1)(1997-1#1)(2005-11#1)(2008-11#1)
of managed care in##4##4##(1994-3#1)(1997-1#1)(1997-2#1)(2008-6#1)
of managed care on the##2##5##(1992-3#1)(2007-9#1)
of managed care on##5##4##(1992-3#1)(1994-3#1)(1997-1#1)(2006-10#1)(2007-9#1)
of managed care options available to Medicare##2##7##(1991-3#1)(1995-12#1)
of managed care options##4##4##(1991-3#1)(1995-12#1)(1997-3#1)(2012-2#1)
of managed care organizations (MCOs)##3##5##(1994-1#1)(1996-2#1)(1997-2#1)
of managed care organizations##4##4##(1994-1#1)(1996-1#1)(1996-2#1)(1997-2#1)
of managed care plans##9##4##(1994-1#2)(1994-3#1)(1995-12#3)(1996-12#2)(1997-2#1)
of managed care programs##3##4##(1995-12#1)(1995-2#1)(2008-11#1)
of managed care##62##3##(1991-3#2)(1992-2#1)(1992-3#2)(1993-12#1)(1994-1#3)(1994-12#1)(1994-3#5)(1995-1#1)(1995-12#5)(1995-2#2)(1995-3#1)(1996-1#4)(1996-12#5)(1996-2#2)(1996-3#3)(1997-1#4)(1997-2#6)(1997-3#3)(2005-11#2)(2006-10#1)(2006-5#1)(2007-8#1)(2007-9#1)(2008-11#3)(2008-6#1)(2012-2#1)
of managed competition in##2##4##(1994-3#1)(1997-2#1)
of managed competition##6##3##(1994-3#4)(1995-12#1)(1997-2#1)
of managed##76##2##(1991-3#3)(1992-2#1)(1992-3#2)(1993-12#2)(1994-1#3)(1994-12#1)(1994-3#9)(1995-1#2)(1995-12#6)(1995-2#2)(1995-3#1)(1996-1#5)(1996-12#5)(1996-2#2)(1996-3#3)(1997-1#4)(1997-2#7)(1997-3#3)(2004-4#1)(2005-11#2)(2006-10#1)(2006-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-6#1)(2011-2#1)(2012-2#1)(2012-9#1)
of management and##4##3##(2007-4#1)(2007-7#1)(2008-6#1)(2009-4#1)
of management are##4##3##(2006-10#1)(2006-2#1)(2008-7#2)
of management development##4##3##(1994-1#2)(1996-3#2)
of management in##2##3##(2006-8#1)(2007-11#1)
of management is##2##3##(1990-8#1)(1992-1#1)
of management of the##2##4##(2007-8#2)
of management of##21##3##(1991-4#1)(1993-1#1)(1993-9#1)(1994-9#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2011-2#2)(2012-2#5)(2013-1#1)
of management practices to##2##4##(2008-10#1)(2013-7#1)
of management practices##3##3##(1993-1#1)(2008-10#1)(2013-7#1)
of management strategies##3##3##(2007-3#1)(2008-1#1)(2008-3#1)
of management that##2##3##(1992-12#1)(1993-3#1)
of management training for##2##4##(1991-2#1)(1993-1#1)
of management##93##2##(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#2)(1991-2#1)(1991-4#1)(1992-1#2)(1992-12#1)(1993-1#3)(1993-3#1)(1993-9#1)(1994-1#4)(1994-3#1)(1994-9#2)(1996-1#2)(1996-3#4)(2005-8#1)(2006-10#2)(2006-2#1)(2006-4#2)(2006-8#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#5)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2009-4#1)(2010-6#2)(2010-7#1)(2011-2#5)(2012-11#2)(2012-2#8)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
of managerial##3##2##(1994-1#1)(2007-4#1)(2009-8#1)
of managers about the##2##4##(2012-3#2)
of managers and##4##3##(1993-1#1)(2006-5#1)(2012-12#1)(2012-3#1)
of managers##11##2##(1993-1#1)(1995-1#1)(1996-3#1)(1997-1#1)(1997-2#1)(2006-5#1)(2008-1#1)(2012-12#1)(2012-3#3)
of managing and##2##3##(1994-2#1)(2012-3#1)
of managing##25##2##(1994-2#1)(1994-3#1)(1995-12#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-3#1)(2012-8#1)(2013-1#1)(2013-8#1)
of mancozeb in##2##3##(2008-10#1)(2008-8#1)
of mancozeb##6##2##(2008-10#3)(2008-8#3)
of mandatory##7##2##(1994-12#1)(1997-3#1)(2006-11#1)(2007-12#1)(2009-11#1)(2012-12#1)(2013-1#1)
of mandible##2##2##(2012-2#2)
of mandibular anterior alveolus##2##4##(2011-12#2)
of mandibular anterior##3##3##(2007-10#1)(2011-12#2)
of mandibular condylar##2##3##(2007-7#2)
of mandibular distraction##2##3##(2007-12#1)(2010-2#1)
of mandibular##14##2##(1996-5#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-7#3)(2010-2#1)(2011-1#1)(2011-12#2)(2012-12#1)(2012-2#1)
of manganese (II)##4##3##(2008-10#4)
of manganese and##8##3##(1990-11#1)(2008-10#5)(2008-5#1)(2013-1#1)
of manganese in blood##2##4##(2006-8#2)
of manganese in urine##2##4##(2008-10#2)
of manganese in##17##3##(2006-8#2)(2008-10#13)(2008-8#1)(2011-1#1)
of manganese ions##2##3##(1990-2#1)(2008-10#1)
of manganese on##2##3##(2008-10#1)(2010-7#1)
of manganese oxide##3##3##(2008-10#3)
of manganese peroxidase (MnP)##3##4##(1994-12#1)(2005-12#1)(2008-7#1)
of manganese peroxidase were obtained in##2##6##(2008-5#2)
of manganese peroxidase##8##3##(1994-12#2)(2005-12#1)(2008-5#3)(2008-7#2)
of manganese to##2##3##(2010-7#2)
of manganese was##2##3##(2008-10#2)
of manganese##73##2##(1990-11#2)(1990-2#1)(1992-6#1)(1993-4#1)(1994-12#2)(2005-11#1)(2005-12#1)(2006-8#2)(2008-10#46)(2008-5#5)(2008-7#2)(2008-8#1)(2010-7#4)(2011-1#2)(2013-1#2)
of manganese(II) chloride##2##3##(2011-1#2)
of manganese(II) ions##2##3##(2008-10#2)
of manganese(II) was##3##3##(2008-10#3)
of manganese(II)##18##2##(2007-11#1)(2008-10#14)(2008-3#1)(2011-1#2)
of manganese(IV)##4##2##(2008-10#4)
of mango##6##2##(2008-10#6)
of mangrove wetland##4##3##(2013-8#4)
of mangrove##9##2##(2008-5#3)(2013-8#6)
of mania and##2##3##(1995-5#1)(2009-8#1)
of mania##3##2##(1995-5#1)(1996-7#1)(2009-8#1)
of manic symptoms##2##3##(2005-7#1)(2013-8#1)
of manic##4##2##(1994-8#1)(2005-7#1)(2012-3#1)(2013-8#1)
of manifest disease##2##3##(1993-11#1)(1997-3#1)
of manifest##7##2##(1992-7#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-6#1)(1997-3#1)(2005-12#1)
of manifestation##2##2##(2010-7#1)(2013-1#1)
of manifestations##4##2##(2006-10#1)(2006-6#1)(2007-8#1)(2009-2#1)
of manipulating##3##2##(1991-11#1)(1994-8#1)(2007-9#1)
of manipulation of##2##3##(1993-1#1)(2012-1#1)
of manipulation techniques##2##3##(1993-2#1)(2009-12#1)
of manipulation##12##2##(1993-1#1)(1993-2#1)(1995-5#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#1)(2011-12#1)(2012-1#1)
of manipulations that##2##3##(2008-11#1)(2008-2#1)
of manipulations##6##2##(2008-11#1)(2008-2#2)(2008-4#1)(2010-7#1)(2011-2#1)
of manipulative therapy##2##3##(2008-12#2)
of mankind##4##2##(1991-11#1)(2006-10#1)(2006-12#1)(2006-9#1)
of mannanase activity were##2##4##(2008-6#2)
of mannanase##7##2##(2005-12#4)(2008-6#3)
of mannide monooleate##3##3##(2004-12#3)
of mannitol has##2##3##(2008-10#2)
of mannitol was##2##3##(2008-10#1)(2011-2#1)
of mannitol##14##2##(1990-9#1)(1995-12#1)(2006-4#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-7#1)
of mannose and##2##3##(1990-11#1)(1994-9#1)
of mannose##4##2##(1990-11#1)(1994-9#2)(2004-8#1)
of mannostatin A##2##3##(1990-10#2)
of manpower##2##2##(2010-10#1)(2011-1#1)
of mantle cell lymphoma (MCL)##2##5##(2009-1#1)(2010-11#1)
of mantle cell lymphoma##4##4##(2008-7#1)(2009-1#1)(2010-11#2)
of mantle cell##5##3##(2008-7#1)(2009-1#1)(2010-11#2)(2012-2#1)
of mantle##9##2##(1993-2#2)(1993-7#2)(2008-7#1)(2009-1#1)(2010-11#2)(2012-2#1)
of manual therapy or##2##4##(2007-11#1)(2012-3#1)
of manual therapy##4##3##(2007-11#1)(2008-12#1)(2012-2#1)(2012-3#1)
of manual##19##2##(1991-3#1)(1993-12#2)(1993-8#1)(2007-1#1)(2007-11#1)(2007-5#1)(2008-11#2)(2008-12#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2012-2#1)(2012-3#2)(2013-1#2)
of manufactory##2##2##(2008-10#2)
of manufacture##2##2##(1997-6#1)(2012-12#1)
of manufactured##4##2##(2008-10#1)(2010-12#2)(2013-1#1)
of manufacturing workers##4##3##(2010-8#4)
of manufacturing##11##2##(2008-11#1)(2008-2#1)(2008-3#3)(2008-8#1)(2010-8#4)(2012-2#1)
of manuka##2##2##(2012-1#1)(2012-3#1)
of manure is##2##3##(2008-5#2)
of manure##9##2##(2008-10#1)(2008-5#7)(2010-5#1)
of manuscripts##4##2##(2005-7#1)(2007-10#2)(2012-3#1)
of many a##2##3##(2006-12#1)(2007-11#1)
of many age-related diseases##2##4##(2008-10#1)(2012-11#1)
of many aspects of##7##4##(1993-12#1)(2006-10#1)(2007-6#1)(2008-11#1)(2008-5#1)(2008-6#1)(2012-12#1)
of many available##2##3##(1996-9#1)(2006-10#1)
of many bacterial##2##3##(1990-11#1)(2008-8#1)
of many biological##3##3##(1994-2#1)(2006-10#1)(2008-5#1)
of many cancers##4##3##(2005-8#1)(2006-8#1)(2008-7#1)(2012-2#1)
of many cell types and##2##5##(1992-8#1)(1995-12#1)
of many cell types##6##4##(1992-8#1)(1993-6#1)(1995-12#1)(2008-1#1)(2008-11#2)
of many cellular proteins##2##4##(1994-10#1)(2008-5#1)
of many cellular##5##3##(1993-6#1)(1994-10#1)(2008-5#1)(2009-4#1)(2009-5#1)
of many chronic lung diseases##2##5##(2010-9#1)(2012-12#1)
of many chronic##3##3##(1994-3#1)(2010-9#1)(2012-12#1)
of many clinical trials##2##4##(2007-10#1)(2008-9#1)
of many clinical##3##3##(2007-10#1)(2008-9#1)(2010-3#1)
of many common##4##3##(1990-8#1)(1991-12#1)(1991-9#1)(2008-10#1)
of many congenital anomalies##2##4##(2008-11#2)
of many countries##2##3##(1990-12#1)(2009-7#1)
of many different##6##3##(2006-2#1)(2006-8#1)(2006-9#1)(2010-8#1)(2011-2#1)(2011-3#1)
of many disease##2##3##(2007-6#1)(2008-9#1)
of many diseases including##2##4##(2008-10#1)(2010-4#1)
of many diseases##10##3##(1991-11#1)(2008-10#2)(2008-5#1)(2009-2#1)(2010-4#1)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
of many drugs and##2##4##(1992-8#1)(1994-8#1)
of many drugs##4##3##(1992-8#1)(1994-8#1)(2006-10#1)(2008-8#1)
of many eating##2##3##(1993-12#1)(2008-4#1)
of many economically important plants##2##5##(2008-10#2)
of many essential##3##3##(2006-8#1)(2007-11#1)(2008-7#1)
of many factors##3##3##(2007-7#1)(2008-5#1)(2011-2#1)
of many foods##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
of many forms of##2##4##(1990-9#1)(2008-8#1)
of many genes##9##3##(1990-6#1)(1997-2#1)(1997-4#1)(2007-8#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-4#1)(2012-3#1)
of many health care organizations##2##5##(1994-12#1)(1996-1#1)
of many human cancers##2##4##(1996-4#1)(2012-12#1)
of many human diseases##2##4##(2006-10#1)(2009-8#1)
of many human##7##3##(1996-4#1)(2006-10#1)(2008-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
of many important##3##3##(1996-8#1)(2008-3#1)(2009-6#1)
of many malignancies##3##3##(2010-12#2)(2013-1#1)
of many mammalian##2##3##(2008-9#1)(2012-1#1)
of many medical##3##3##(2008-8#1)(2011-2#1)(2012-2#1)
of many models##2##3##(2008-2#1)(2008-8#1)
of many molecular##2##3##(2008-2#1)(2010-12#1)
of many more##2##3##(2008-5#1)(2013-8#1)
of many new##3##3##(2006-12#1)(2008-1#1)(2009-2#1)
of many novel##2##3##(1997-4#1)(2006-6#1)
of many of its##2##4##(2009-2#1)(2011-2#1)
of many of the##12##4##(1991-7#1)(2006-2#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-3#1)(2010-8#1)(2013-8#1)
of many of these##12##4##(1994-12#1)(2006-8#1)(2006-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
of many of##28##3##(1991-7#1)(1994-12#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2009-2#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
of many organisms##2##3##(2008-8#1)(2010-12#1)
of many organs##2##3##(2008-5#1)(2009-4#1)
of many other##9##3##(1990-4#1)(1991-6#1)(2008-1#1)(2008-10#2)(2009-12#1)(2009-7#1)(2009-8#1)(2010-4#1)
of many patients and##2##4##(1994-3#1)(2010-4#1)
of many patients##5##3##(1994-3#1)(2007-12#1)(2007-2#1)(2009-2#1)(2010-4#1)
of many proteins##2##3##(1995-7#1)(2008-4#1)
of many publications##4##3##(1992-3#1)(2007-6#1)(2007-8#1)(2008-12#1)
of many researchers##3##3##(2005-10#1)(2008-10#1)(2013-1#1)
of many services##2##3##(2006-12#1)(2008-5#1)
of many small##3##3##(1992-11#1)(1992-8#1)(2007-12#1)
of many species##4##3##(2007-12#1)(2009-9#1)(2013-1#1)(2013-7#1)
of many studies##3##3##(2008-7#1)(2010-12#1)(2013-7#1)
of many such##3##3##(1991-12#1)(2008-7#1)(2008-9#1)
of many thousands of##2##4##(2007-12#1)(2012-3#1)
of many tissue types##2##4##(1993-6#1)(2008-11#1)
of many types of##2##4##(1993-12#1)(2011-1#1)
of many types##3##3##(1991-5#1)(1993-12#1)(2011-1#1)
of many vertebrates##2##3##(1993-6#1)(2008-9#1)
of many years##2##3##(1993-6#1)(2007-11#1)
of many years'##2##3##(1990-3#1)(1996-12#1)
of many##449##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#3)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-4#3)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#3)(1992-5#4)(1992-8#3)(1993-11#1)(1993-12#3)(1993-6#5)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#3)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-5#3)(1995-7#1)(1995-8#1)(1996-1#3)(1996-10#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#5)(1997-5#1)(1997-6#2)(1997-8#1)(2005-10#1)(2005-11#3)(2005-7#2)(2005-8#4)(2006-10#13)(2006-11#1)(2006-12#4)(2006-2#2)(2006-4#1)(2006-6#1)(2006-8#5)(2006-9#3)(2007-10#2)(2007-11#8)(2007-12#13)(2007-2#4)(2007-3#1)(2007-6#3)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#8)(2008-10#39)(2008-11#12)(2008-12#3)(2008-2#10)(2008-3#11)(2008-4#16)(2008-5#13)(2008-6#5)(2008-7#8)(2008-8#15)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#5)(2009-4#2)(2009-5#3)(2009-6#3)(2009-7#5)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#9)(2010-2#2)(2010-3#3)(2010-4#5)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#12)(2011-3#3)(2011-7#1)(2012-1#3)(2012-11#3)(2012-12#8)(2012-2#7)(2012-3#3)(2012-4#1)(2013-1#13)(2013-7#5)(2013-8#4)
of map##5##2##(1991-3#1)(1993-9#1)(1996-2#1)(1997-8#1)(2007-12#1)
of mapped##3##2##(1996-10#1)(2005-12#1)(2006-5#1)
of mapping the##2##3##(2007-11#1)(2008-1#1)
of mapping##7##2##(1995-8#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-8#2)
of marble industry effluent on##2##5##(2008-12#2)
of marble##3##2##(2008-1#1)(2008-12#2)
of marbling##2##2##(2010-4#2)
of mares##4##2##(1994-7#1)(2006-5#2)(2012-2#1)
of marginal##11##2##(2005-7#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-6#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-1#1)
of marihuana##2##2##(1992-8#1)(2012-2#1)
of marijuana##14##2##(1996-11#1)(1996-5#1)(1997-8#1)(2006-8#1)(2007-11#1)(2008-1#3)(2009-7#1)(2010-7#1)(2012-1#1)(2012-11#1)(2013-8#2)
of marijuana-only##2##2##(2013-8#2)
of marine algae from##2##4##(2008-11#2)
of marine animals##2##3##(2012-2#2)
of marine constituents in coastal waters##2##6##(2008-2#2)
of marine constituents in##3##4##(2008-2#3)
of marine constituents##4##3##(2008-2#3)(2008-3#1)
of marine invertebrates##2##3##(1996-2#1)(2008-9#1)
of marine mammals##2##3##(2008-10#2)
of marine microorganisms##2##3##(2008-9#1)(2011-1#1)
of marine natural products ma'edamines A##2##6##(2013-1#2)
of marine natural products##3##4##(2009-2#1)(2013-1#2)
of marine origin##3##3##(2004-4#1)(2007-9#1)(2012-2#1)
of marine phytoplankton##2##3##(2008-3#2)
of marine sediments##3##3##(2008-10#2)(2011-2#1)
of marine##51##2##(1994-2#1)(1996-2#1)(2004-4#1)(2007-5#3)(2007-9#2)(2008-10#7)(2008-11#4)(2008-2#3)(2008-3#4)(2008-9#3)(2009-10#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#2)(2012-2#3)(2013-1#4)
of marital##5##2##(1991-12#1)(2007-12#1)(2007-8#1)(2011-2#1)(2012-1#1)
of maritime##2##2##(2008-3#1)(2011-2#1)
of marked##19##2##(1991-1#1)(1991-10#1)(1992-4#1)(1993-12#1)(1994-9#1)(1996-12#1)(1997-4#1)(1997-6#1)(2004-11#1)(2006-3#1)(2007-10#1)(2008-10#2)(2008-11#2)(2011-2#2)(2013-8#2)
of markedly elevated##2##3##(1997-1#1)(2006-6#1)
of markedly##3##2##(1992-6#1)(1997-1#1)(2006-6#1)
of marker##10##2##(1990-1#1)(1992-5#1)(1993-11#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-8#1)
of marker-assisted selection##2##3##(2008-10#1)(2008-5#1)
of markers and##2##3##(1993-11#1)(2010-6#1)
of markers for##4##3##(2005-3#1)(2010-12#1)(2011-2#1)(2012-11#1)
of markers in##4##3##(2005-11#1)(2008-10#2)(2008-5#1)
of markers of##12##3##(1990-3#1)(1991-12#1)(1991-5#1)(1994-12#1)(2006-6#1)(2007-8#1)(2008-11#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-8#2)
of markers was##4##3##(1994-3#1)(2007-1#1)(2008-10#1)(2008-9#1)
of markers##38##2##(1990-3#1)(1991-12#1)(1991-5#1)(1993-11#2)(1993-9#1)(1994-12#1)(1994-3#1)(1996-9#1)(1997-5#2)(2005-11#1)(2005-3#1)(2006-6#1)(2007-1#1)(2007-10#2)(2007-3#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#2)
of market entry##3##3##(1990-12#1)(1991-3#1)(2008-11#1)
of market forces##2##3##(1997-7#1)(2010-5#1)
of market##17##2##(1990-12#1)(1991-3#1)(1994-2#3)(1996-3#1)(1997-2#1)(1997-7#1)(2005-5#1)(2006-4#1)(2008-11#1)(2008-7#1)(2009-9#1)(2010-5#1)(2012-3#2)(2013-1#1)
of market-oriented##2##2##(1994-1#1)(1995-2#1)
of marketed and investigational##2##4##(2005-7#1)(2009-12#1)
of marketed formulation##3##3##(2010-2#1)(2010-5#1)(2012-2#1)
of marketed##12##2##(2005-7#1)(2008-10#1)(2009-12#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#1)(2011-2#2)(2012-2#1)
of marketing and##2##3##(2008-12#1)(2011-2#1)
of marketing strategies##2##3##(2005-8#1)(2008-11#1)
of marketing##12##2##(1990-12#3)(1993-12#1)(1997-1#1)(2005-8#1)(2008-11#1)(2008-12#1)(2010-12#1)(2011-2#3)
of markets##2##2##(1997-1#1)(2006-10#1)
of marking##5##2##(2007-8#1)(2007-9#1)(2008-11#1)(2010-8#1)(2013-7#1)
of marks##3##2##(2008-9#2)(2013-8#1)
of marriage in##3##3##(2008-11#1)(2008-8#1)(2008-9#1)
of marriage##14##2##(2006-4#1)(2007-2#1)(2007-7#1)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#2)(2011-2#1)(2012-2#2)
of married couples##2##3##(1996-9#1)(2010-8#1)
of married##7##2##(1991-8#1)(1994-6#1)(1996-9#1)(2007-11#1)(2007-2#1)(2010-2#1)(2010-8#1)
of marrow##8##2##(1990-12#1)(1991-11#2)(1993-2#1)(1995-12#2)(2008-4#1)(2008-6#1)
of marsupial and##2##3##(2008-8#1)(2008-9#1)
of masculinity##4##2##(2008-11#1)(2009-5#3)
of mask##5##2##(1997-3#1)(2008-2#2)(2011-1#1)(2012-2#1)
of masked##2##2##(2009-9#1)(2010-5#1)
of masking##4##2##(2008-10#3)(2012-2#1)
of masks##3##2##(1996-3#1)(2007-9#1)(2008-2#1)
of maspin##3##2##(1995-6#3)
of mass and##3##3##(2006-5#1)(2011-2#1)(2013-1#1)
of mass balances##2##3##(2008-10#1)(2008-7#1)
of mass effect and##2##4##(2006-7#1)(2012-12#1)
of mass lesions##3##3##(2006-5#2)(2007-8#1)
of mass production##5##3##(2008-10#1)(2008-12#1)(2008-2#2)(2010-10#1)
of mass ratios##2##3##(2005-11#1)(2008-10#1)
of mass screening##2##3##(1994-11#1)(1995-4#1)
of mass spectra##4##3##(2008-10#1)(2008-4#1)(2010-5#1)(2011-2#1)
of mass spectrometers##2##3##(2008-4#1)(2008-6#1)
of mass spectrometry in##2##4##(2010-4#1)(2013-1#1)
of mass spectrometry to##2##4##(2008-7#1)(2010-7#1)
of mass spectrometry##8##3##(1994-12#1)(2008-10#1)(2008-7#1)(2010-4#1)(2010-7#1)(2013-1#2)(2013-8#1)
of mass spectrometry-based##3##3##(2008-10#1)(2009-4#1)(2010-5#1)
of mass transfer##3##3##(2005-11#1)(2008-10#1)(2008-6#1)
of mass transport##2##3##(2007-12#1)(2011-2#1)
of mass##78##2##(1990-7#1)(1991-3#1)(1992-3#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-4#1)(1996-5#1)(1997-5#1)(2004-7#1)(2005-11#2)(2006-2#1)(2006-5#3)(2006-7#1)(2006-8#1)(2007-12#1)(2007-4#2)(2007-8#2)(2008-1#2)(2008-10#12)(2008-12#1)(2008-2#2)(2008-4#2)(2008-6#2)(2008-7#2)(2008-9#2)(2009-3#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-5#3)(2010-7#1)(2011-1#2)(2011-2#6)(2012-12#3)(2012-2#1)(2013-1#6)(2013-8#2)
of massage on##3##3##(2008-12#1)(2009-3#1)(2011-12#1)
of massage therapy##3##3##(2006-10#1)(2008-11#1)(2010-6#1)
of massage##10##2##(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#2)(2009-3#1)(2010-6#1)(2011-12#2)(2011-2#1)
of masses##2##2##(2012-12#1)(2013-1#1)
of masseter##3##2##(1993-12#1)(2010-6#1)(2011-12#1)
of massive ascites##2##3##(2007-12#2)
of massive bleeding from##2##4##(2006-6#1)(2008-3#1)
of massive bleeding##3##3##(2006-6#1)(2008-3#1)(2011-12#1)
of massive##27##2##(1990-3#1)(1992-5#2)(1996-3#1)(1996-7#1)(2006-6#2)(2006-9#1)(2007-10#1)(2007-12#4)(2007-5#3)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
of mast cell activation##2##4##(2008-4#1)(2008-7#1)
of mast cell granules##2##4##(1991-8#1)(2008-1#1)
of mast cell##11##3##(1991-8#1)(1997-2#1)(2004-12#1)(2008-1#4)(2008-4#2)(2008-7#1)(2011-2#1)
of mast cells and##3##4##(1991-10#1)(2008-7#1)(2013-8#1)
of mast cells containing##2##4##(2011-2#1)(2012-1#1)
of mast cells in the##2##5##(1995-12#1)(2011-2#1)
of mast cells in##7##4##(1995-12#1)(2006-10#1)(2008-5#1)(2011-2#3)(2012-1#1)
of mast cells is##2##4##(2009-6#1)(2011-2#1)
of mast cells with##3##4##(1997-7#1)(2011-2#2)
of mast cells##36##3##(1991-10#1)(1992-3#1)(1995-12#2)(1996-5#1)(1997-7#3)(2006-10#2)(2006-12#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-9#1)(2009-6#1)(2010-12#2)(2011-2#10)(2012-1#3)(2013-8#1)
of mast fruiting##2##3##(2008-5#1)(2008-9#1)
of mast seeding##2##3##(2008-8#2)
of mast##53##2##(1991-10#1)(1991-8#1)(1992-3#1)(1995-12#2)(1996-5#1)(1997-2#1)(1997-7#3)(2004-12#1)(2005-8#1)(2006-10#2)(2006-12#1)(2008-1#4)(2008-4#5)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-6#2)(2010-12#2)(2011-2#11)(2012-1#3)(2013-8#1)
of mast-cell##2##2##(1996-8#1)(2009-6#1)
of mastectomy##3##2##(1994-2#1)(2012-3#2)
of masticatory##5##2##(1990-6#1)(1996-2#1)(1996-8#1)(2009-8#1)(2013-1#1)
of mastitis in##3##3##(2009-2#3)
of mastocytes##3##2##(1991-11#3)
of mastoid##4##2##(1996-12#1)(2006-12#1)(2008-6#1)(2008-9#1)
of mastoparan X##3##3##(1991-9#3)
of mastoparan##4##2##(1991-9#3)(1997-1#1)
of matched##7##2##(1991-7#1)(1997-8#2)(2007-8#1)(2008-4#1)(2011-1#1)(2013-1#1)
of matching##10##2##(1993-9#1)(1995-1#1)(1995-9#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
of mate choice##2##3##(2006-5#1)(2010-8#1)
of mate recognition##4##3##(2008-8#2)(2008-9#2)
of mate##9##2##(2006-5#1)(2007-12#2)(2008-8#3)(2008-9#2)(2010-8#1)
of material and##3##3##(1995-2#1)(2008-3#1)(2008-4#1)
of material deposited in the##2##5##(1994-2#1)(1995-12#1)
of material flow systems##3##4##(1997-6#1)(2008-11#2)
of material from##3##3##(1994-2#1)(2008-3#2)
of material in##2##3##(2008-8#1)(2010-2#1)
of material properties##2##3##(2006-11#1)(2009-7#1)
of material removal##2##3##(2008-3#2)
of material##61##2##(1990-5#1)(1992-2#1)(1992-6#1)(1994-2#3)(1995-12#1)(1995-2#1)(1997-6#1)(2005-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2007-11#3)(2007-12#3)(2007-3#1)(2007-8#3)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#6)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-7#2)(2010-11#2)(2010-2#1)(2010-8#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)
of materials and##6##3##(1990-4#1)(1992-4#1)(2008-2#1)(2008-4#1)(2008-7#1)(2012-2#1)
of materials in the##2##4##(2008-2#1)(2013-1#1)
of materials in##6##3##(2007-8#1)(2008-2#1)(2010-12#1)(2011-2#2)(2013-1#1)
of materials is also##2##4##(2008-2#1)(2010-9#1)
of materials of##2##3##(1992-1#1)(2009-4#1)
of materials science##2##3##(1992-2#1)(2011-11#1)
of materials that##3##3##(2007-8#1)(2008-3#1)(2010-4#1)
of materials used in##2##4##(2008-10#2)
of materials used##3##3##(2008-10#2)(2013-1#1)
of materials with##4##3##(2008-2#1)(2008-3#3)
of materials##74##2##(1990-4#1)(1990-8#1)(1991-3#1)(1992-1#1)(1992-2#3)(1992-4#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-8#1)(2005-10#1)(2005-12#1)(2006-11#1)(2006-2#1)(2006-5#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-8#4)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-4#2)(2010-9#1)(2011-11#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
of maternal HIV infection in##2##5##(1991-6#2)
of maternal HIV-1##2##3##(1991-6#1)(1996-2#1)
of maternal acculturation##2##3##(2009-7#2)
of maternal allergen##2##3##(2009-9#2)
of maternal and infant##2##4##(1991-5#1)(2007-9#1)
of maternal and perinatal##2##4##(1996-12#1)(2013-8#1)
of maternal and##10##3##(1991-5#1)(1995-2#1)(1996-12#1)(2007-9#1)(2008-9#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
of maternal behavior##4##3##(1990-12#1)(1992-9#1)(2011-2#1)(2012-12#1)
of maternal blood##2##3##(1992-1#1)(1996-9#1)
of maternal buspirone treatment on##2##5##(1996-4#2)
of maternal concentrations (n = 7)##2##6##(2011-2#2)
of maternal death in##3##4##(2007-7#2)(2010-12#1)
of maternal depressed mood##2##4##(2008-12#1)(2010-2#1)
of maternal diabetes##2##3##(1996-11#2)
of maternal factors##3##3##(1994-11#1)(2008-11#1)(2010-3#1)
of maternal gene products##2##4##(2007-12#1)(2007-8#1)
of maternal health##4##3##(1994-3#1)(2008-3#1)(2012-2#1)(2013-1#1)
of maternal hypotension##2##3##(1993-4#1)(2006-10#1)
of maternal mRNAs##2##3##(1993-6#1)(2007-12#1)
of maternal mortality##9##3##(1994-3#1)(1996-3#1)(2004-10#1)(2007-2#2)(2008-3#1)(2011-1#1)(2012-12#1)(2013-1#1)
of maternal prenatal smoking on##2##5##(2007-2#2)
of maternal serum##2##3##(1990-9#1)(1992-9#1)
of maternal tissue concentrations##2##4##(2011-2#2)
of maternal transmission##2##3##(1996-9#1)(1997-7#1)
of maternal zidovudine##2##3##(1996-2#1)(2007-2#1)
of maternal##118##2##(1990-12#1)(1990-9#2)(1991-5#1)(1991-6#3)(1992-1#1)(1992-12#3)(1992-2#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-4#3)(1993-6#1)(1993-7#1)(1994-11#1)(1994-3#3)(1995-2#1)(1995-8#1)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#3)(1996-9#2)(1997-7#2)(2004-10#1)(2006-10#4)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#7)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-7#5)(2009-9#3)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#4)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
of maternally derived##2##3##(1997-3#1)(2008-5#1)
of maternally inherited##2##3##(1993-1#1)(2008-9#1)
of maternally##6##2##(1993-1#1)(1997-3#1)(2007-8#2)(2008-5#1)(2008-9#1)
of maternity care##7##3##(2007-2#4)(2010-8#1)(2012-3#2)
of maternity##10##2##(2007-12#1)(2007-2#5)(2010-8#2)(2012-3#2)
of mates for##2##3##(2008-8#1)(2008-9#1)
of mates##6##2##(2008-8#4)(2008-9#2)
of mathematic models##2##3##(2012-2#2)
of mathematical and##2##3##(2008-12#1)(2009-5#1)
of mathematical modeling##3##3##(2008-11#2)(2009-5#1)
of mathematical models that##2##4##(2006-10#1)(2011-2#1)
of mathematical models##5##3##(2006-10#2)(2008-7#1)(2008-8#1)(2011-2#1)
of mathematical##16##2##(2006-10#2)(2007-8#1)(2008-11#4)(2008-12#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#2)(2011-1#1)(2011-2#1)
of mathematically##2##2##(2008-3#2)
of mathematics##6##2##(1992-2#1)(2006-5#1)(2008-12#1)(2009-11#1)(2012-1#1)(2013-8#1)
of mating and##4##3##(2008-10#2)(2008-8#1)(2008-9#1)
of mating behavior##3##3##(1992-8#1)(1996-4#1)(2008-5#1)
of mating between relatives##2##4##(2012-3#2)
of mating partners##2##3##(2008-8#2)
of mating strategies##3##3##(2006-10#2)(2008-8#1)
of mating type genes##2##4##(2008-10#2)
of mating type##5##3##(2008-10#5)
of mating types##5##3##(2008-10#5)
of mating##38##2##(1990-11#1)(1991-5#1)(1992-8#1)(1992-9#1)(1994-2#1)(1996-4#1)(2006-10#2)(2008-10#12)(2008-2#1)(2008-5#4)(2008-8#5)(2008-9#3)(2009-6#1)(2010-8#1)(2012-3#3)
of mating-type##3##2##(1994-12#1)(2008-10#1)(2012-3#1)
of matings##4##2##(2008-10#2)(2008-8#1)(2013-1#1)
of matric water##2##3##(2008-7#2)
of matrices##9##2##(1997-8#1)(2008-10#4)(2008-11#3)(2009-4#1)
of matrilysin in vascular endothelial cells##2##6##(1997-7#2)
of matrine in rat plasma##2##5##(2008-10#2)
of matrine in##4##3##(2008-10#3)(2011-1#1)
of matrine##6##2##(2008-10#5)(2011-1#1)
of matrix can be##2##4##(2008-10#1)(2013-8#1)
of matrix can##3##3##(2008-10#1)(2008-9#1)(2013-8#1)
of matrix components can##2##4##(2007-8#2)
of matrix components##4##3##(2007-8#4)
of matrix effect##3##3##(2007-10#1)(2008-10#1)(2011-1#1)
of matrix effects##5##3##(2008-10#5)
of matrix elements##8##3##(2008-10#6)(2008-2#2)
of matrix interferences##2##3##(2008-10#2)
of matrix metalloproteases (MMPs)##3##4##(2007-8#1)(2008-5#2)
of matrix metalloproteases##5##3##(2007-8#1)(2008-5#3)(2012-2#1)
of matrix metalloproteinase##6##3##(1997-2#1)(2006-9#1)(2008-9#1)(2010-12#1)(2013-1#2)
of matrix metalloproteinase-13 mRNA##2##4##(2006-9#2)
of matrix metalloproteinase-2##3##3##(2013-1#1)(2013-7#2)
of matrix metalloproteinase-8 and interleukin-1beta in gingival fluid samples##2##9##(2012-12#2)
of matrix metalloproteinase-8 and interleukin-1beta##3##5##(2012-12#3)
of matrix metalloproteinase-9##2##3##(2006-6#1)(2007-10#1)
of matrix metalloproteinases (MMP)##2##4##(1997-4#1)(2010-12#1)
of matrix metalloproteinases 7 and 9 and##2##7##(2010-12#2)
of matrix metalloproteinases 7 and 9##3##6##(2010-12#3)
of matrix metalloproteinases and their inhibitors##2##6##(2008-1#1)(2008-9#1)
of matrix metalloproteinases and##4##4##(1994-2#1)(2006-10#1)(2008-1#1)(2008-9#1)
of matrix metalloproteinases by##2##4##(1990-7#1)(1994-3#1)
of matrix metalloproteinases##18##3##(1990-7#1)(1994-2#1)(1994-3#1)(1997-4#1)(2006-10#1)(2006-11#1)(2007-1#2)(2008-1#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#2)(2010-12#4)
of matrix modifiers##2##3##(2005-4#2)
of matrix of##2##3##(2008-10#1)(2012-2#1)
of matrix##109##2##(1990-7#1)(1990-9#1)(1991-2#1)(1992-2#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-5#1)(1997-2#1)(1997-4#1)(2005-11#1)(2005-4#5)(2006-10#1)(2006-11#1)(2006-6#1)(2006-9#4)(2007-1#2)(2007-10#2)(2007-12#1)(2007-3#1)(2007-8#6)(2008-1#2)(2008-10#28)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-8#3)(2008-9#3)(2009-5#2)(2010-12#6)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
of matter in##2##3##(1990-3#1)(2007-9#1)
of matter under##2##3##(1996-5#1)(2007-11#1)
of matter##14##2##(1990-3#1)(1993-4#1)(1996-5#2)(1997-6#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-9#2)(2008-10#2)(2012-2#2)
of maturation and##2##3##(2006-5#1)(2010-11#1)
of maturation in##2##3##(1991-4#1)(2013-1#1)
of maturation of##6##3##(1993-3#1)(2008-10#3)(2008-5#1)(2009-2#1)
of maturation##17##2##(1991-4#1)(1993-3#1)(1994-9#1)(1995-2#1)(2006-11#1)(2006-5#1)(2007-12#1)(2008-10#3)(2008-5#2)(2008-9#1)(2009-2#1)(2010-11#1)(2012-2#1)(2013-1#1)
of mature 17 kDa##2##4##(1990-12#2)
of mature IL-1 beta##3##4##(1992-4#1)(1995-2#1)(1995-8#1)
of mature T cells##2##4##(1992-4#1)(1996-8#1)
of mature T##3##3##(1992-4#1)(1996-8#1)(2010-1#1)
of mature adipocytes##2##3##(2008-11#1)(2010-6#1)
of mature alpha##2##3##(1991-10#1)(1995-1#1)
of mature and immature##2##4##(2011-1#1)(2012-1#1)
of mature and##4##3##(1991-11#1)(2006-5#1)(2011-1#1)(2012-1#1)
of mature cells##3##3##(1992-1#1)(2007-9#1)(2008-7#1)
of mature fat##2##3##(1990-12#1)(2013-8#1)
of mature human##3##3##(1990-6#1)(1995-5#1)(2008-4#1)
of mature males##2##3##(1995-2#1)(2008-5#1)
of mature mitochondrial aspartate aminotransferase##2##5##(1994-6#2)
of mature pollen##2##3##(2009-10#1)(2009-12#1)
of mature pseudothecia##2##3##(2008-10#2)
of mature rat##2##3##(1991-2#1)(1991-7#1)
of mature teratoma##2##3##(2008-7#2)
of mature##109##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-6#1)(1990-7#3)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-4#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#3)(1994-6#2)(1994-9#4)(1995-1#3)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-3#1)(1996-8#2)(1997-1#1)(2005-10#1)(2006-12#2)(2006-5#1)(2007-11#2)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#6)(2008-12#2)(2008-4#1)(2008-5#6)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#2)
of matured##4##2##(1990-7#1)(2008-11#1)(2008-9#1)(2013-1#1)
of maturing thymocytes##2##3##(1991-12#1)(1992-5#1)
of maturing##3##2##(1991-12#1)(1992-5#1)(2006-12#1)
of maturity of the##2##4##(2007-1#1)(2008-7#1)
of maturity of##3##3##(2007-1#1)(2008-10#1)(2008-7#1)
of maturity##10##2##(1994-3#1)(2007-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-9#1)(2010-8#1)
of maxi-K+ channel##2##3##(1994-5#2)
of maxi-K+##3##2##(1994-5#3)
of maxilla##2##2##(2008-9#1)(2010-2#1)
of maxillary deformities##2##3##(1991-4#2)
of maxillary sensilla styloconica##2##4##(2008-8#2)
of maxillary sinus##4##3##(2008-5#1)(2008-9#2)(2011-2#1)
of maxillary##25##2##(1991-4#2)(2007-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-7#1)(2010-12#1)(2011-12#1)(2011-2#3)(2011-7#1)(2012-2#2)(2013-1#6)
of maxillofacial infections##3##3##(2007-12#3)
of maxillofacial##11##2##(2007-12#6)(2008-6#2)(2008-9#1)(2012-12#2)
of maxillomandibular fixation##3##3##(2007-12#1)(2013-1#2)
of maxima and minima##2##4##(2008-2#1)(2008-3#1)
of maxima##6##2##(1995-5#1)(2008-2#1)(2008-3#1)(2008-9#3)
of maximal force##2##3##(1996-5#1)(2011-1#1)
of maximal##17##2##(1990-2#1)(1994-11#1)(1994-2#1)(1995-10#1)(1995-11#1)(1995-6#1)(1995-9#1)(1996-5#1)(1997-4#1)(2005-8#1)(2007-5#1)(2008-5#2)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#1)
of maximally##2##2##(2005-7#1)(2008-10#1)
of maximizing the##2##3##(2008-2#1)(2009-10#1)
of maximizing##3##2##(2008-2#1)(2008-8#1)(2009-10#1)
of maximum likelihood is##2##4##(2008-2#1)(2008-3#1)
of maximum likelihood##4##3##(1992-2#1)(2008-2#1)(2008-3#1)(2008-9#1)
of maximum oxygen uptake##2##4##(2013-8#2)
of maximum species##2##3##(1995-6#1)(2009-5#1)
of maximum temperature##2##3##(2008-10#1)(2011-1#1)
of maximum tumor##2##3##(1990-5#1)(2007-1#1)
of maximum##69##2##(1990-5#1)(1992-11#1)(1992-2#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-8#1)(1995-1#1)(1995-3#2)(1995-6#1)(1996-3#2)(1996-8#1)(1997-1#1)(1997-2#1)(2005-11#2)(2007-1#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#15)(2008-11#5)(2008-2#4)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-5#1)(2010-2#1)(2010-6#1)(2011-1#1)(2013-1#3)(2013-8#3)
of maximum-likelihood##2##2##(1993-4#1)(2012-1#1)
of mdx##4##2##(1995-12#2)(2012-3#2)
of meals per day##2##4##(1994-6#1)(2013-8#1)
of meals##6##2##(1994-6#1)(2007-1#1)(2008-4#2)(2013-1#1)(2013-8#1)
of mealybug wilt of pineapple##2##5##(2008-10#2)
of mealybug##6##2##(2008-10#3)(2011-12#3)
of mean age##7##3##(1994-3#1)(1995-4#1)(2006-7#1)(2008-1#1)(2008-7#1)(2010-12#1)(2013-8#1)
of mean arterial pressure##2##4##(1992-7#1)(1995-12#1)
of mean arterial##3##3##(1992-3#1)(1992-7#1)(1995-12#1)
of mean changes##2##3##(1992-12#1)(1992-9#1)
of mean force for##2##4##(2008-10#1)(2012-11#1)
of mean force##8##3##(1997-8#1)(2005-11#3)(2006-10#1)(2007-3#1)(2008-10#1)(2012-11#1)
of mean normal##2##3##(1990-2#1)(1990-8#1)
of mean number of##2##4##(1994-4#1)(2013-1#1)
of mean phenotypes##2##3##(2008-8#1)(2010-8#1)
of mean squared##2##3##(1995-9#1)(2008-2#1)
of mean values##2##3##(2008-2#1)(2008-5#1)
of mean volumes##2##3##(2012-12#2)
of mean##64##2##(1990-2#1)(1990-7#1)(1990-8#1)(1991-10#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-8#1)(1995-12#1)(1995-4#1)(1995-9#1)(1996-9#1)(1997-8#1)(2004-10#1)(2005-10#1)(2005-11#3)(2005-8#1)(2006-10#1)(2006-7#1)(2007-3#1)(2008-1#1)(2008-10#8)(2008-2#6)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-5#1)(2013-1#2)(2013-8#1)
of mean-field##2##2##(1992-9#1)(2008-2#1)
of meaning and##3##3##(2004-3#1)(2008-12#1)(2008-7#1)
of meaning##8##2##(1995-1#1)(2004-3#1)(2006-7#1)(2008-12#1)(2008-2#1)(2008-7#1)(2012-2#1)(2012-3#1)
of meaningful##6##2##(1991-1#1)(2006-6#1)(2006-9#1)(2008-12#1)(2008-8#1)(2012-11#1)
of meanings##2##2##(2006-3#1)(2012-2#1)
of means and##3##3##(2011-2#1)(2013-1#2)
of means of##2##3##(1994-12#1)(2008-11#1)
of means##11##2##(1991-8#1)(1992-6#1)(1992-8#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2011-2#1)(2013-1#2)
of measles and##3##3##(2006-2#1)(2012-12#2)
of measles epidemics##2##3##(1995-5#1)(1996-12#1)
of measles virus##2##3##(1991-5#1)(1997-6#1)
of measles##23##2##(1991-5#1)(1992-7#1)(1994-3#1)(1995-3#2)(1995-5#2)(1996-12#2)(1997-6#1)(2006-2#2)(2006-4#1)(2007-11#2)(2007-2#1)(2008-1#2)(2009-5#1)(2012-12#3)(2013-1#1)
of measles-specific##2##2##(2008-12#2)
of measurable##6##2##(1990-12#1)(1991-2#1)(1997-2#1)(2007-12#1)(2008-2#1)(2010-9#1)
of measure##2##2##(2008-9#1)(2013-8#1)
of measured and##2##3##(2008-3#2)
of measured##23##2##(1990-9#1)(1996-8#1)(1997-1#1)(2006-11#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#4)(2009-7#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-3#1)(2013-1#1)
of measurement and##7##3##(1992-5#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)
of measurement data##3##3##(2008-11#2)(2008-2#1)
of measurement error and temporal variability##2##6##(1992-9#2)
of measurement error in##5##4##(1997-4#1)(2008-3#1)(2009-12#1)(2010-2#1)(2010-7#1)
of measurement error##16##3##(1992-9#2)(1993-5#2)(1993-9#1)(1996-8#1)(1997-4#1)(2008-3#3)(2008-7#1)(2009-12#1)(2010-11#1)(2010-2#2)(2010-7#1)
of measurement errors##3##3##(1996-8#1)(2010-2#1)(2010-3#1)
of measurement for##2##3##(1990-9#1)(2008-10#1)
of measurement in##2##3##(2008-7#1)(2013-1#1)
of measurement is##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
of measurement methods##2##3##(1992-6#1)(2012-12#1)
of measurement of the##4##4##(2007-11#1)(2007-12#1)(2007-7#1)(2008-3#1)
of measurement of##17##3##(1990-2#1)(1991-9#1)(1996-5#1)(2005-3#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-3#3)(2008-4#2)(2008-7#1)(2010-8#1)(2013-1#1)(2013-8#1)
of measurement results##2##3##(2008-10#1)(2008-2#1)
of measurement sensitivity##2##3##(2008-3#2)
of measurement##107##2##(1990-2#1)(1990-9#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-6#2)(1992-9#2)(1993-3#1)(1993-5#2)(1993-9#1)(1994-7#1)(1996-12#1)(1996-2#2)(1996-5#2)(1996-8#2)(1997-2#1)(1997-4#1)(2005-3#1)(2005-8#1)(2006-10#1)(2007-11#2)(2007-12#3)(2007-7#2)(2008-10#11)(2008-11#3)(2008-2#8)(2008-3#19)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#5)(2009-10#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#3)(2013-1#6)(2013-8#1)
of measurement)##2##2##(2010-7#1)(2011-2#1)
of measurements and##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#1)
of measurements at different##2##4##(1993-6#1)(2012-2#1)
of measurements at##3##3##(1993-6#1)(2008-10#1)(2012-2#1)
of measurements from##2##3##(2008-3#2)
of measurements in##5##3##(1996-3#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-8#1)
of measurements made##2##3##(2008-9#2)
of measurements of##11##3##(1997-6#1)(2007-12#2)(2008-2#3)(2008-3#4)(2008-5#1)
of measurements taken##3##3##(1995-12#1)(2008-2#1)(2012-1#1)
of measurements was##4##3##(1994-1#1)(2008-10#2)(2011-2#1)
of measurements were##3##3##(1996-7#1)(2008-10#1)(2011-2#1)
of measurements with a##2##4##(2008-2#2)
of measurements##74##2##(1993-6#2)(1994-1#1)(1994-11#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-7#1)(1997-6#1)(2005-11#2)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#4)(2007-5#1)(2008-10#17)(2008-11#1)(2008-2#11)(2008-3#10)(2008-5#2)(2008-8#2)(2008-9#3)(2009-11#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
of measures are##2##3##(2008-12#1)(2012-12#1)
of measures for##3##3##(2006-2#1)(2008-10#1)(2008-6#1)
of measures of##2##3##(2008-9#1)(2013-7#1)
of measures to##2##3##(2007-12#1)(2007-8#1)
of measures##16##2##(1992-1#1)(1993-1#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-9#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)
of measuring and##3##3##(2006-2#1)(2008-11#1)(2012-12#1)
of measuring blood pressure in##2##5##(2007-3#1)(2012-12#1)
of measuring blood##3##3##(2007-3#1)(2008-3#1)(2012-12#1)
of measuring optical##2##3##(2007-11#1)(2007-12#1)
of measuring productivity in the##2##5##(1991-11#1)(1991-12#1)
of measuring productivity##4##3##(1991-11#1)(1991-12#2)(1992-3#1)
of measuring quality of life##2##5##(1992-10#1)(2007-7#1)
of measuring the##18##3##(1995-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-2#5)(2008-3#2)(2008-4#3)(2008-7#1)(2011-1#1)(2013-1#1)
of measuring##95##2##(1990-2#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-8#1)(1992-10#1)(1992-11#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#1)(1995-1#1)(1995-10#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#2)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-3#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#15)(2008-3#13)(2008-4#5)(2008-5#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
of meat and bone meal##2##5##(2008-10#2)
of meat and##6##3##(1991-5#1)(2008-10#4)(2010-4#1)
of meat from##4##3##(2010-4#4)
of meat inspection##2##3##(2005-5#2)
of meat products and##2##4##(2008-10#1)(2010-4#1)
of meat products##6##3##(1994-5#1)(2008-10#3)(2010-4#2)
of meat quality##2##3##(2010-2#1)(2010-4#1)
of meat safety##2##3##(2005-5#2)
of meat##44##2##(1991-11#1)(1991-5#2)(1994-5#1)(2005-5#4)(2007-3#1)(2008-10#11)(2009-4#1)(2010-2#2)(2010-4#19)(2012-12#1)(2013-1#1)
of mebendazole##3##2##(2008-10#3)
of mechanical allodynia##2##3##(1993-4#1)(2009-12#1)
of mechanical and##5##3##(2005-10#1)(2008-2#1)(2009-12#1)(2012-1#1)(2012-2#1)
of mechanical blood##2##3##(2008-7#1)(2012-3#1)
of mechanical circulatory support##3##4##(2007-8#1)(2008-11#1)(2011-2#1)
of mechanical complications##2##3##(2007-11#1)(2013-8#1)
of mechanical efficacy of##2##4##(2007-11#2)
of mechanical forces##4##3##(2008-11#2)(2009-8#1)(2013-8#1)
of mechanical ileus##2##3##(1997-8#1)(2008-8#1)
of mechanical injuries##2##3##(1993-11#1)(2006-11#1)
of mechanical loading##3##3##(1994-6#1)(2009-8#1)(2010-9#1)
of mechanical properties of##3##4##(2004-9#1)(2009-8#1)(2013-8#1)
of mechanical properties##8##3##(2004-9#2)(2008-3#1)(2009-7#1)(2009-8#1)(2012-2#1)(2013-8#2)
of mechanical stress##4##3##(2007-9#1)(2010-4#1)(2011-1#2)
of mechanical ventilation and##2##4##(2006-10#1)(2012-12#1)
of mechanical ventilation is##2##4##(1993-10#1)(2005-8#1)
of mechanical ventilation##16##3##(1993-10#1)(2005-8#3)(2006-10#4)(2006-4#1)(2007-8#1)(2008-6#1)(2008-8#1)(2010-6#1)(2012-12#1)(2013-8#2)
of mechanical##114##2##(1990-4#1)(1991-5#1)(1993-10#1)(1993-11#1)(1993-4#1)(1994-6#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-8#1)(2004-11#1)(2004-9#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#3)(2006-10#4)(2006-11#2)(2006-12#1)(2006-4#1)(2006-6#1)(2007-10#4)(2007-11#6)(2007-6#4)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#1)(2008-6#3)(2008-7#1)(2008-8#3)(2009-12#2)(2009-5#1)(2009-7#2)(2009-8#5)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#7)
of mechanically##12##2##(1991-11#1)(1996-11#1)(2006-10#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-3#2)(2010-12#1)
of mechanism in biology has##2##5##(2012-2#2)
of mechanism in biology##3##4##(2012-2#3)
of mechanism##12##2##(1997-4#1)(2006-4#2)(2008-8#1)(2009-2#1)(2009-4#1)(2012-2#6)
of mechanism-based##3##2##(1992-3#1)(2007-11#1)(2008-3#1)
of mechanisms by which##2##4##(2008-6#1)(2008-9#1)
of mechanisms involved in##3##4##(1997-3#1)(2008-9#1)(2009-12#1)
of mechanisms of##10##3##(1991-8#1)(2006-10#2)(2006-6#1)(2007-10#1)(2008-10#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
of mechanisms such as##2##4##(2007-5#1)(2009-11#1)
of mechanisms that##4##3##(1990-2#1)(2006-10#1)(2011-12#1)(2012-12#1)
of mechanisms underlying##3##3##(1997-2#1)(2009-9#1)(2012-2#1)
of mechanisms##51##2##(1990-2#1)(1990-3#1)(1990-8#2)(1991-8#1)(1993-9#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-6#1)(2007-10#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#4)(2013-1#2)
of mechanistic##8##2##(2007-12#1)(2009-8#1)(2010-6#1)(2010-9#1)(2011-1#1)(2012-2#2)(2013-1#1)
of mechanosensory##2##2##(2007-12#1)(2012-11#1)
of mechanotherapy##3##2##(2008-12#3)
of mechanotransduction##3##2##(2007-12#1)(2011-1#1)(2012-12#1)
of medaka##2##2##(2009-7#2)
of media and regulatory##2##4##(2008-11#2)
of media and##3##3##(2008-11#3)
of media containing##2##3##(1991-9#1)(1996-9#1)
of media for##3##3##(1995-12#1)(2007-11#1)(2008-12#1)
of media on##2##3##(2007-8#1)(2008-11#1)
of media reports on##2##4##(2008-11#1)(2012-3#1)
of media##38##2##(1991-9#1)(1992-12#1)(1992-4#1)(1993-8#1)(1993-9#1)(1995-12#1)(1996-11#1)(1996-9#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#3)(2008-11#9)(2008-12#3)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-1#1)(2012-2#1)(2012-3#1)
of medial septal##2##3##(1992-8#1)(1996-12#1)
of medial temporal##2##3##(2004-11#1)(2008-11#1)
of medial##24##2##(1992-5#1)(1992-8#1)(1992-9#1)(1995-3#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-3#1)(2004-11#1)(2006-10#1)(2006-8#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)(2012-2#2)(2013-1#2)
of medialis dorsalis##2##3##(1994-6#2)
of median nerve and##2##4##(2011-12#2)
of median nerve##5##3##(2011-12#4)(2012-2#1)
of median##15##2##(1992-5#2)(2006-6#1)(2007-11#1)(2007-8#2)(2008-5#2)(2009-8#1)(2011-12#4)(2012-2#1)(2013-8#1)
of mediastinal lymph nodes##2##4##(1997-8#1)(2004-1#1)
of mediastinal lymphadenopathy in postresection lung cancer patients##2##8##(2007-6#2)
of mediastinal lymphadenopathy##3##3##(2007-6#3)
of mediastinal structures##2##3##(2010-7#1)(2012-2#1)
of mediastinal tumors##2##3##(1992-8#1)(2011-2#1)
of mediastinal##16##2##(1991-8#1)(1992-8#1)(1996-3#1)(1997-8#1)(2004-1#1)(2007-6#3)(2007-8#1)(2009-8#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)
of mediastinitis##4##2##(2007-8#3)(2013-1#1)
of mediastinoscopy##3##2##(2007-6#2)(2007-8#1)
of mediated##3##2##(1991-3#1)(1991-9#2)
of mediating the##5##3##(1992-9#1)(1993-7#1)(2008-10#3)
of mediating##13##2##(1990-12#1)(1992-9#1)(1993-7#1)(1995-3#1)(1996-10#1)(1996-4#1)(2008-10#3)(2008-4#1)(2009-7#1)(2010-1#1)(2010-8#1)
of mediation##4##2##(1994-1#1)(2006-1#1)(2008-2#1)(2009-2#1)
of mediator production##2##3##(1991-8#1)(1994-11#1)
of mediator##6##2##(1991-8#1)(1992-7#1)(1994-11#2)(1995-11#1)(2008-10#1)
of mediators of##4##3##(1991-10#1)(2006-10#1)(2010-3#1)(2012-3#1)
of mediators such as##3##4##(1992-2#1)(2005-10#1)(2011-2#1)
of mediators##10##2##(1991-10#1)(1992-2#1)(2005-10#1)(2005-8#1)(2006-10#1)(2008-7#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-3#1)
of medical and mental health records##5##6##(1991-12#3)(1992-3#2)
of medical and non-medical##2##4##(1994-12#1)(2011-2#1)
of medical and nursing##4##4##(1991-12#1)(1996-6#1)(2007-2#1)(2012-11#1)
of medical and pharmacy claims##2##5##(2009-6#1)(2009-9#1)
of medical and psychosocial##2##4##(2006-12#1)(2010-3#1)
of medical and social##3##4##(1994-12#1)(2005-10#1)(2007-12#1)
of medical and surgical care##2##5##(1993-12#1)(2008-11#1)
of medical and surgical##11##4##(1993-12#1)(2005-7#1)(2007-1#1)(2007-10#2)(2007-8#1)(2008-11#1)(2008-9#1)(2010-6#1)(2011-2#1)(2013-1#1)
of medical and##41##3##(1991-12#4)(1991-4#1)(1991-6#1)(1992-3#2)(1993-12#1)(1993-2#1)(1994-12#2)(1994-3#1)(1996-6#1)(1997-1#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#2)
of medical applications##2##3##(2008-12#1)(2008-5#1)
of medical audit##2##3##(1994-12#1)(2008-4#1)
of medical care are##2##4##(2010-3#1)(2011-2#1)
of medical care in the##2##5##(1994-11#1)(1997-1#1)
of medical care in##4##4##(1994-11#1)(1997-1#1)(2007-7#1)(2013-8#1)
of medical care##33##3##(1990-12#1)(1991-12#2)(1991-2#1)(1991-4#1)(1992-2#2)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-10#1)(1996-12#1)(1997-1#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-3#1)(2011-12#1)(2011-2#5)(2013-1#2)(2013-8#2)
of medical centers##3##3##(2007-3#1)(2007-9#2)
of medical complications##4##3##(1990-4#1)(2006-1#1)(2006-10#1)(2006-11#1)
of medical concepts##3##3##(2012-3#1)(2013-1#2)
of medical conditions##2##3##(2008-10#1)(2010-4#1)
of medical consultation##2##3##(1991-6#1)(2006-10#1)
of medical consultations in##2##4##(1990-12#1)(1993-6#1)
of medical costs and##2##4##(2010-5#1)(2010-8#1)
of medical costs##4##3##(1994-12#1)(2010-5#1)(2010-8#1)(2011-1#1)
of medical counseling##2##3##(1993-10#2)
of medical data##4##3##(1993-3#1)(2012-2#1)(2013-1#2)
of medical decision##2##3##(1993-6#1)(2006-8#1)
of medical device##4##3##(2009-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
of medical devices and##2##4##(2006-10#1)(2008-3#1)
of medical devices is##3##4##(2011-2#1)(2013-1#2)
of medical devices##10##3##(2005-10#1)(2006-10#1)(2007-11#1)(2008-11#2)(2008-3#1)(2010-6#1)(2011-2#1)(2013-1#2)
of medical diagnostic##2##3##(1996-7#1)(2010-6#1)
of medical disorders##3##3##(1996-6#1)(2012-12#1)(2012-2#1)
of medical education and##2##4##(2008-11#1)(2010-11#1)
of medical education##11##3##(1990-12#1)(1991-2#1)(1992-6#2)(1994-12#1)(2007-4#1)(2008-11#3)(2010-11#2)
of medical emergencies in India##2##5##(1995-12#1)(2009-4#1)
of medical emergencies in##3##4##(1995-12#1)(2009-4#1)(2010-9#1)
of medical emergencies##6##3##(1995-12#1)(2008-1#2)(2008-4#1)(2009-4#1)(2010-9#1)
of medical entomology and##2##4##(2010-1#2)
of medical entomology in##3##4##(2010-1#3)
of medical entomology##9##3##(2010-1#9)
of medical equipment##3##3##(2008-11#1)(2010-8#1)(2013-1#1)
of medical ethics and##2##4##(2010-8#1)(2011-2#1)
of medical ethics##5##3##(2005-12#1)(2007-11#1)(2008-7#1)(2010-8#1)(2011-2#1)
of medical factors##2##3##(1997-5#1)(2008-11#1)
of medical goods##2##3##(2007-8#2)
of medical grade##2##3##(2010-8#2)
of medical graduates##4##3##(1992-1#1)(1994-12#2)(2009-10#1)
of medical history##3##3##(1993-8#1)(1995-5#1)(2009-2#1)
of medical imaging and radiation therapy##2##6##(1990-12#2)
of medical imaging and##3##4##(1990-12#2)(1996-1#1)
of medical imaging##8##3##(1990-12#2)(1996-1#1)(2005-8#1)(2007-4#1)(2007-5#1)(2009-10#1)(2012-2#1)
of medical importance##3##3##(2006-10#1)(2008-5#1)(2011-1#1)
of medical information##4##3##(1993-12#1)(2007-3#1)(2010-12#1)(2012-2#1)
of medical intervention##2##3##(1992-5#1)(2011-1#1)
of medical invalidity##2##3##(1993-3#2)
of medical journals##2##3##(1995-9#1)(2007-12#1)
of medical knowledge##3##3##(1991-11#1)(1993-10#1)(2011-2#1)
of medical librarianship##2##3##(1995-1#1)(2005-12#1)
of medical malpractice claims##2##4##(2004-1#1)(2012-3#1)
of medical malpractice##4##3##(1996-12#1)(1997-1#1)(2004-1#1)(2012-3#1)
of medical management in##2##4##(2009-4#2)
of medical management##6##3##(1992-9#1)(1993-5#1)(2009-4#3)(2010-8#1)
of medical necessity##5##3##(2006-8#3)(2011-2#2)
of medical or##2##3##(2010-7#1)(2013-1#1)
of medical ozone##2##3##(2007-10#1)(2007-11#1)
of medical patients##2##3##(1992-6#1)(2006-10#1)
of medical personnel##4##3##(1992-3#1)(1994-6#1)(2006-2#1)(2009-7#1)
of medical practice in##3##4##(1992-3#1)(2007-4#2)
of medical practice##13##3##(1990-6#1)(1991-12#1)(1992-3#1)(1993-10#1)(1993-3#3)(1997-3#1)(2006-12#1)(2007-4#3)(2013-7#1)
of medical practices##2##3##(1990-12#1)(1995-3#1)
of medical problems##2##3##(2012-12#1)(2012-3#1)
of medical procedures and##3##4##(1992-2#1)(1996-3#1)(2008-8#1)
of medical procedures##6##3##(1992-2#1)(1995-12#1)(1996-3#1)(2008-4#1)(2008-8#1)(2011-2#1)
of medical products##3##3##(2006-6#2)(2013-1#1)
of medical professional liability insurance##2##5##(1993-1#1)(2009-9#1)
of medical professional liability##3##4##(1993-1#1)(2009-9#1)(2011-1#1)
of medical professionals##2##3##(1995-6#1)(1996-9#1)
of medical record##3##3##(2007-12#2)(2008-5#1)
of medical records and##4##4##(1994-3#2)(2013-1#1)(2013-8#1)
of medical records from##2##4##(2009-4#1)(2013-8#1)
of medical records of##3##4##(2007-9#1)(2008-1#1)(2013-1#1)
of medical records##18##3##(1992-5#1)(1993-1#1)(1994-11#1)(1994-3#2)(1997-3#1)(2007-9#1)(2008-1#1)(2008-6#2)(2009-4#1)(2010-4#1)(2013-1#3)(2013-8#3)
of medical rehabilitation##3##3##(2007-11#2)(2013-1#1)
of medical research##3##3##(2007-6#1)(2008-12#1)(2009-3#1)
of medical resources and##3##4##(1994-3#1)(1996-2#1)(2010-7#1)
of medical resources##6##3##(1992-2#1)(1994-3#1)(1996-12#1)(1996-2#1)(2010-7#1)(2010-8#1)
of medical risk##3##3##(1990-4#1)(2006-6#1)(2012-11#1)
of medical robotics##2##3##(2006-6#1)(2007-5#1)
of medical school##2##3##(1991-3#1)(2012-3#1)
of medical schools##5##3##(1991-6#1)(2008-5#1)(2009-6#1)(2011-2#1)(2013-1#1)
of medical science##3##3##(2006-8#1)(2007-12#1)(2013-8#1)
of medical sciences##4##3##(2007-7#1)(2008-12#1)(2011-2#2)
of medical screening##2##3##(1995-12#1)(2008-9#1)
of medical services##14##3##(1991-2#1)(1993-3#1)(1995-3#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#2)(1997-3#1)(2006-12#1)(2007-4#1)(2007-6#1)(2010-5#1)
of medical specialists in##3##4##(1991-12#1)(1995-12#1)(2008-7#1)
of medical specialists##4##3##(1991-12#1)(1995-12#1)(2008-7#2)
of medical staff credentialing##4##4##(1993-1#1)(1993-12#3)
of medical staff##12##3##(1991-2#1)(1992-1#1)(1993-1#1)(1993-12#5)(1994-1#1)(2007-8#1)(2008-12#1)(2010-9#1)
of medical structures##2##3##(2009-4#2)
of medical students and##3##4##(2007-7#1)(2008-7#1)(2013-8#1)
of medical students towards communication skills learning##2##7##(2008-8#2)
of medical students towards##3##4##(2008-8#2)(2009-7#1)
of medical students##14##3##(1991-2#1)(1992-6#1)(2006-10#1)(2007-4#1)(2007-7#1)(2008-7#1)(2008-8#2)(2009-7#1)(2011-2#1)(2013-1#1)(2013-8#3)
of medical students'##2##3##(2011-2#1)(2013-1#1)
of medical technologies##2##3##(1990-12#1)(2005-11#1)
of medical technology##6##3##(1990-12#1)(1992-1#1)(1996-12#2)(2010-8#1)(2011-12#1)
of medical therapies##2##3##(2011-2#2)
of medical therapy for##3##4##(2007-11#1)(2008-3#2)
of medical therapy##8##3##(2005-10#1)(2006-10#2)(2007-11#1)(2008-3#2)(2009-9#1)(2010-8#1)
of medical training##5##3##(1994-6#1)(1995-9#1)(2012-2#1)(2013-1#2)
of medical treatment and##3##4##(2008-4#1)(2008-5#1)(2011-2#1)
of medical treatment in##3##4##(1993-11#1)(2006-10#1)(2009-4#1)
of medical treatment##19##3##(1990-4#1)(1993-11#1)(1993-5#1)(1996-12#2)(1996-9#1)(1997-5#1)(2006-10#1)(2006-8#2)(2007-1#1)(2007-6#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-4#1)(2011-12#1)(2011-2#1)(2013-1#1)
of medical treatments##2##3##(2005-12#1)(2009-9#1)
of medical waste##2##3##(2008-2#2)
of medical wastes##4##3##(1991-4#4)
of medical##566##2##(1990-10#1)(1990-12#8)(1990-4#3)(1990-6#1)(1991-11#1)(1991-12#11)(1991-2#7)(1991-3#1)(1991-4#6)(1991-6#4)(1992-1#4)(1992-12#1)(1992-2#5)(1992-3#7)(1992-5#3)(1992-6#5)(1992-9#3)(1993-1#3)(1993-10#6)(1993-11#1)(1993-12#8)(1993-2#1)(1993-3#8)(1993-5#3)(1993-6#2)(1993-8#2)(1994-1#1)(1994-11#3)(1994-12#9)(1994-2#2)(1994-3#6)(1994-6#3)(1994-8#1)(1994-9#1)(1995-1#3)(1995-10#3)(1995-12#5)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#1)(1995-9#4)(1996-1#2)(1996-12#11)(1996-2#6)(1996-3#3)(1996-6#5)(1996-7#1)(1996-9#2)(1997-1#5)(1997-3#3)(1997-4#1)(1997-5#3)(1997-8#2)(2004-1#1)(2004-7#1)(2005-1#1)(2005-10#5)(2005-11#3)(2005-12#4)(2005-4#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#12)(2006-11#2)(2006-12#5)(2006-2#2)(2006-4#2)(2006-6#6)(2006-7#1)(2006-8#7)(2007-1#3)(2007-10#5)(2007-11#8)(2007-12#7)(2007-2#3)(2007-3#2)(2007-4#9)(2007-5#2)(2007-6#3)(2007-7#4)(2007-8#5)(2007-9#4)(2008-1#6)(2008-10#2)(2008-11#11)(2008-12#7)(2008-2#3)(2008-3#5)(2008-4#5)(2008-5#5)(2008-6#3)(2008-7#9)(2008-8#5)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#10)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#4)(2010-1#13)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#12)(2010-9#4)(2011-1#6)(2011-12#4)(2011-2#31)(2012-11#5)(2012-12#3)(2012-2#10)(2012-3#12)(2013-1#34)(2013-7#3)(2013-8#12)
of medicalization##2##2##(1995-6#1)(2008-5#1)
of medically##11##2##(1990-9#1)(2006-11#2)(2007-11#1)(2007-4#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-3#1)(2012-12#2)
of medicaments##3##2##(1993-1#1)(2010-2#1)(2011-1#1)
of medication administration##4##3##(2008-2#1)(2011-1#1)(2013-1#2)
of medication and##6##3##(1996-3#1)(2006-10#1)(2006-12#1)(2007-12#1)(2011-2#1)(2012-3#1)
of medication errors and##4##4##(2010-8#1)(2011-1#3)
of medication errors##9##3##(2008-7#1)(2010-8#1)(2011-1#5)(2011-2#2)
of medication for##2##3##(1994-7#1)(2010-10#1)
of medication in##3##3##(2007-8#1)(2008-6#1)(2011-1#1)
of medication management##4##3##(2007-12#1)(2012-12#3)
of medication##79##2##(1990-5#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-7#1)(1995-9#1)(1996-1#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-4#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-7#3)(2007-8#1)(2008-1#2)(2008-12#2)(2008-2#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-5#4)(2009-9#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#10)(2011-2#11)(2012-12#4)(2012-3#1)(2013-1#5)
of medication-related##3##2##(2006-3#1)(2011-1#1)(2013-8#1)
of medications and##6##3##(1996-1#1)(2005-8#1)(2008-5#1)(2010-11#2)(2010-2#1)
of medications are##2##3##(2007-11#1)(2008-8#1)
of medications containing##2##3##(2006-4#1)(2007-9#1)
of medications for##2##3##(1993-9#1)(2008-8#1)
of medications in##3##3##(2005-9#1)(2008-3#1)(2008-8#1)
of medications used in##2##4##(2008-8#1)(2010-12#1)
of medications used##4##3##(2006-9#1)(2008-8#1)(2010-12#1)(2010-2#1)
of medications##41##2##(1993-9#1)(1995-11#1)(1996-1#1)(2004-9#1)(2005-6#1)(2005-8#1)(2005-9#1)(2006-12#1)(2006-4#1)(2006-9#2)(2007-11#3)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#5)(2009-4#1)(2010-11#2)(2010-12#1)(2010-2#2)(2011-2#2)(2013-1#4)
of medicinal chemistry##3##3##(2005-7#1)(2005-8#2)
of medicinal plants in##3##4##(2007-11#1)(2010-6#1)(2011-2#1)
of medicinal plants with##2##4##(2008-4#1)(2011-2#1)
of medicinal plants##15##3##(2007-11#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#3)(2009-10#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-2#1)
of medicinal products##3##3##(2008-8#1)(2010-3#1)(2013-7#1)
of medicinal##29##2##(2005-7#1)(2005-8#2)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#4)(2008-8#1)(2009-10#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)
of medicine and surgery##2##4##(1991-6#1)(2012-2#1)
of medicine and##7##3##(1991-6#1)(1992-3#1)(2006-3#1)(2006-9#1)(2010-1#1)(2010-7#1)(2012-2#1)
of medicine are##4##3##(1997-5#1)(2013-1#3)
of medicine in the##2##4##(2008-7#1)(2009-5#1)
of medicine in##11##3##(1994-5#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2011-2#1)(2012-12#1)
of medicine is##4##3##(2007-7#1)(2008-7#1)(2010-1#1)(2013-1#1)
of medicine over the last##2##5##(2006-6#1)(2007-8#1)
of medicine that##3##3##(2005-10#1)(2012-3#1)(2013-8#1)
of medicine use##2##3##(2008-11#1)(2010-9#1)
of medicine was##2##3##(2010-12#1)(2011-1#1)
of medicine##135##2##(1990-10#1)(1990-2#1)(1991-1#2)(1991-12#1)(1991-2#3)(1991-5#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-10#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#2)(1994-12#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-2#1)(1996-1#1)(1997-1#1)(1997-5#1)(1997-6#1)(2004-11#2)(2005-10#1)(2006-10#3)(2006-3#1)(2006-4#2)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#2)(2007-11#1)(2007-2#1)(2007-4#7)(2007-5#3)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#6)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#2)(2009-5#1)(2009-7#1)(2010-1#2)(2010-12#3)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#2)
of medicine]##6##2##(1995-3#1)(1996-3#1)(1997-5#1)(2005-1#1)(2006-6#1)(2013-1#1)
of medicines and##2##3##(2011-1#2)
of medicines in a##4##4##(2008-11#2)(2011-1#1)(2011-2#1)
of medicines in government facilities##2##5##(2012-3#2)
of medicines in##9##3##(2008-1#1)(2008-11#2)(2009-2#1)(2011-1#1)(2011-2#1)(2012-3#3)
of medicines information##2##3##(2008-8#2)
of medicines##33##2##(1992-2#1)(1993-7#1)(1996-11#1)(1996-3#1)(2005-8#1)(2006-2#2)(2008-1#1)(2008-11#5)(2008-8#5)(2009-2#1)(2009-3#1)(2011-1#3)(2011-2#2)(2012-3#3)(2013-1#2)(2013-8#3)
of medico-legal certification##2##3##(2009-4#2)
of medico-legal##7##2##(2005-12#1)(2009-4#4)(2010-1#1)(2011-12#1)
of medieval##3##2##(2007-10#1)(2007-5#1)(2008-7#1)
of medigap##4##2##(1991-2#1)(1992-2#2)(1997-3#1)
of meditation training##2##3##(2008-11#2)
of meditation##4##2##(2008-11#3)(2010-2#1)
of medium and large##2##4##(2008-5#1)(2009-12#1)
of medium and##6##3##(2005-4#1)(2006-2#1)(2007-3#1)(2008-11#1)(2008-5#1)(2009-12#1)
of medium chain##2##3##(1992-7#1)(2012-2#1)
of medium components##3##3##(1994-2#1)(2007-12#1)(2008-11#1)
of medium or##2##3##(1992-1#1)(2006-9#1)
of medium to##2##3##(2007-12#1)(2008-4#1)
of medium was##2##3##(2008-11#1)(2011-1#1)
of medium##48##2##(1990-7#1)(1991-11#1)(1991-8#1)(1992-1#1)(1992-6#1)(1992-7#1)(1993-12#1)(1994-2#1)(1995-4#1)(1996-2#1)(2005-4#1)(2006-2#1)(2006-7#1)(2006-9#2)(2007-11#2)(2007-12#2)(2007-3#1)(2008-10#3)(2008-11#13)(2008-12#2)(2008-3#2)(2008-4#3)(2008-5#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
of medium- and##2##3##(2007-12#1)(2012-1#1)
of medium-sized##2##2##(1996-8#1)(2013-7#1)
of medroxyprogesterone acetate (MPA)##2##4##(1992-6#1)(1995-10#1)
of medroxyprogesterone acetate on##2##4##(1991-10#1)(1992-6#1)
of medroxyprogesterone acetate##6##3##(1991-10#1)(1992-6#2)(1993-2#1)(1995-10#1)(2005-6#1)
of medulla oblongata##2##3##(2011-2#2)
of medulla##3##2##(2010-12#1)(2011-2#2)
of medullar##2##2##(2009-5#1)(2012-12#1)
of medullary thyroid##3##3##(1990-9#1)(1991-2#1)(2008-7#1)
of medullary##6##2##(1990-9#1)(1991-2#1)(1996-5#1)(1997-5#1)(2008-7#1)(2008-8#1)
of medullasin##3##2##(1991-7#3)
of medulloblastoma##5##2##(1993-9#1)(2006-8#2)(2008-7#1)(2009-1#1)
of meeting the##3##3##(2006-10#1)(2008-5#1)(2012-2#1)
of meeting##7##2##(2006-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#1)
of meetings##3##2##(2006-10#1)(2008-7#1)(2010-8#1)
of mefenacet##4##2##(2008-10#4)
of mefenamic acid##4##3##(2012-2#4)
of mefenamic##5##2##(2012-2#5)
of mefenoxam sensitivity was##2##4##(2008-10#2)
of mefenoxam##3##2##(2008-10#3)
of mefloquine for malaria prophylaxis##2##5##(2011-2#2)
of mefloquine on the mechanical activity of the mouse isolated rectal smooth muscle##2##13##(2008-4#2)
of mefloquine##6##2##(1996-8#1)(2008-4#2)(2011-2#3)
of megacolon##2##2##(1993-6#1)(1994-12#1)
of megakaryocytes##3##2##(2005-12#1)(2008-8#1)(2012-12#1)
of megakaryocytopoiesis##2##2##(2007-11#2)
of megakaryopoiesis##2##2##(2005-12#1)(2011-2#1)
of megavoltage##2##2##(2008-6#1)(2012-12#1)
of megsin##2##2##(2008-7#2)
of meibomian gland##2##3##(2006-11#1)(2012-2#1)
of meibomian##4##2##(2006-11#1)(2007-1#2)(2012-2#1)
of meiosis I and##2##4##(2007-12#1)(2012-2#1)
of meiosis and##2##3##(2010-3#1)(2012-2#1)
of meiosis in starfish oocytes##2##5##(1994-8#2)
of meiosis##16##2##(1994-12#2)(1994-8#4)(1995-11#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-2#2)(2013-8#1)
of meiosis-specific##4##2##(1995-8#2)(2011-2#1)(2012-3#1)
of meiotic maturation##4##3##(1992-11#1)(1994-8#2)(2007-12#1)
of meiotic prophase##3##3##(1990-8#1)(2007-12#2)
of meiotic telomeres##2##3##(2011-2#2)
of meiotic##14##2##(1990-8#1)(1992-11#1)(1993-7#1)(1994-8#2)(2006-5#1)(2007-12#3)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#2)
of melamine##2##2##(2008-10#1)(2013-1#1)
of melancholia and##3##3##(1995-12#1)(2008-12#2)
of melanin synthesis in##2##4##(2008-5#1)(2008-8#1)
of melanin synthesis##4##3##(2008-5#1)(2008-8#2)(2012-12#1)
of melanin##14##2##(1991-10#1)(1991-7#1)(1992-2#1)(1992-8#1)(1996-9#1)(2008-3#1)(2008-5#2)(2008-8#3)(2008-9#1)(2012-12#1)(2013-1#1)
of melanin-concentrating hormone##4##3##(1993-5#4)
of melanocortin receptors##3##3##(1994-10#1)(1996-12#1)(2008-5#1)
of melanocortin##4##2##(1994-10#1)(1996-12#1)(2008-5#1)(2010-5#1)
of melanocortins##4##2##(1993-5#2)(1994-10#2)
of melanocyte##2##2##(2008-5#1)(2008-9#1)
of melanocyte-stimulating hormone##2##3##(1993-5#1)(2008-6#1)
of melanocytes and##2##3##(1990-10#1)(1997-7#1)
of melanocytes##10##2##(1990-10#1)(1997-7#1)(2006-12#1)(2007-7#2)(2008-5#2)(2008-8#1)(2009-3#1)(2011-2#1)
of melanogenesis##6##2##(1993-5#1)(1994-12#1)(2007-7#2)(2008-5#1)(2013-1#1)
of melanoma and##2##3##(2008-9#1)(2010-7#1)
of melanoma cells to##4##4##(1992-1#1)(2009-4#2)(2012-3#1)
of melanoma cells##13##3##(1990-5#1)(1991-2#1)(1992-1#1)(1994-2#2)(1994-5#1)(2007-10#1)(2008-8#2)(2009-4#2)(2012-3#2)
of melanoma in##2##3##(2006-4#1)(2007-11#1)
of melanoma is##4##3##(1995-4#1)(2007-11#2)(2009-3#1)
of melanoma metastatic to the##3##5##(2007-4#3)
of melanoma of the##2##4##(2010-9#1)(2012-2#1)
of melanoma patients with##2##4##(1991-5#1)(2005-11#1)
of melanoma patients##6##3##(1991-5#1)(1996-11#2)(2005-10#1)(2005-11#1)(2007-10#1)
of melanoma was##2##3##(1996-9#1)(2013-8#1)
of melanoma##56##2##(1990-5#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-12#1)(1994-2#2)(1994-5#1)(1995-4#1)(1996-11#2)(1996-9#1)(2005-10#1)(2005-11#2)(2006-4#1)(2007-10#2)(2007-11#7)(2007-4#3)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
of melanomas##3##2##(1995-8#3)
of melanophores##2##2##(1992-3#1)(2008-5#1)
of melanosomes##2##2##(2008-1#1)(2008-8#1)
of melanotic##2##2##(2005-5#1)(2012-2#1)
of melanotrope cells##3##3##(1993-5#3)
of melanotrope##5##2##(1993-5#5)
of melanotropic peptides##2##3##(1993-5#2)
of melanotropic##3##2##(1993-5#2)(1995-2#1)
of melatonin against formaldehyde-induced##2##4##(2008-8#2)
of melatonin against##3##3##(1996-3#1)(2008-8#2)
of melatonin and its derivatives##2##5##(2008-10#2)
of melatonin and its##3##4##(2008-10#3)
of melatonin and##11##3##(1991-12#1)(1992-8#2)(1994-5#1)(1996-6#2)(2008-10#3)(2008-8#1)(2011-2#1)
of melatonin at##4##3##(1992-3#2)(1995-3#1)(2008-3#1)
of melatonin binding##2##3##(1993-11#1)(1995-12#1)
of melatonin by##2##3##(1994-5#1)(2008-10#1)
of melatonin in the##4##4##(1991-12#1)(1995-11#1)(1995-3#1)(2008-11#1)
of melatonin in##12##3##(1991-12#1)(1994-8#1)(1995-11#2)(1995-3#2)(1996-2#1)(2007-8#1)(2008-10#1)(2008-11#2)(2009-12#1)
of melatonin is##3##3##(1994-5#1)(2008-4#1)(2013-7#1)
of melatonin on the dopamine-glutamate interaction in the anterior hypothalamus##2##10##(1995-11#2)
of melatonin on##10##3##(1990-5#1)(1991-12#1)(1991-7#1)(1994-8#1)(1995-11#4)(1996-2#1)(2010-12#1)
of melatonin receptor##2##3##(1996-2#1)(1997-2#1)
of melatonin receptors##3##3##(1992-8#1)(1995-12#1)(2013-7#1)
of melatonin synthesis##2##3##(1994-10#1)(2008-5#1)
of melatonin was##2##3##(1992-3#1)(2008-10#1)
of melatonin##70##2##(1990-5#1)(1991-12#3)(1991-2#1)(1991-7#1)(1992-3#3)(1992-8#4)(1993-11#2)(1994-10#1)(1994-5#3)(1994-8#2)(1994-9#2)(1995-11#6)(1995-12#2)(1995-3#4)(1995-7#1)(1995-9#1)(1996-1#1)(1996-2#3)(1996-3#2)(1996-6#2)(1997-2#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#3)(2009-12#1)(2010-12#1)(2011-2#2)(2012-1#1)(2013-7#3)
of melittin is##2##3##(1991-7#1)(1992-6#1)
of melittin on##5##3##(1990-11#1)(1991-7#1)(1997-6#1)(2008-10#2)
of melittin##26##2##(1990-11#3)(1990-4#2)(1991-7#7)(1991-9#2)(1992-6#4)(1994-2#1)(1994-3#1)(1997-6#3)(2008-10#3)
of melon##6##2##(1994-12#1)(2008-10#5)
of meloxicam##7##2##(2006-10#4)(2008-11#3)
of melphalan##3##2##(2009-8#1)(2011-3#2)
of melting##2##2##(2008-10#1)(2008-4#1)
of memantine in##2##3##(1992-8#1)(2009-3#1)
of memantine##12##2##(1992-8#3)(1996-10#3)(2008-4#1)(2009-3#5)
of member satisfaction##2##3##(1996-3#2)
of member##3##2##(1996-2#1)(1996-3#2)
of members and chairs##2##4##(2009-4#2)
of members and##3##3##(1996-3#1)(2009-4#2)
of members in##2##3##(2007-6#1)(2011-1#1)
of members of the Association for##2##6##(1994-3#2)
of members of the family##2##5##(2008-10#1)(2008-6#1)
of members of the##21##4##(1992-11#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-3#2)(1996-2#1)(1997-6#1)(1997-8#1)(2006-5#1)(2007-8#1)(2008-10#2)(2008-6#1)(2008-9#2)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
of members of##23##3##(1992-11#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-3#2)(1996-2#1)(1997-6#1)(1997-8#1)(2006-5#1)(2007-8#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-9#3)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
of members##34##2##(1992-11#1)(1994-3#3)(1994-5#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#2)(1996-2#2)(1996-3#1)(1997-6#1)(1997-8#1)(2006-5#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-6#2)(2008-7#1)(2008-9#3)(2009-4#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
of membership##4##2##(2007-2#2)(2009-2#1)(2012-1#1)
of membrane additives##2##3##(1991-2#1)(2008-10#1)
of membrane adsorption##2##3##(2008-7#1)(2010-5#1)
of membrane and cytosolic##2##4##(1991-2#1)(2008-1#1)
of membrane and##4##3##(1991-2#1)(1993-8#1)(2008-1#1)(2008-10#1)
of membrane bound##5##3##(1992-11#1)(1992-12#1)(1994-8#1)(1995-2#1)(2007-8#1)
of membrane cholesterol##3##3##(1991-5#1)(2008-8#1)(2011-1#1)
of membrane components##3##3##(1992-11#1)(2009-10#1)(2011-1#1)
of membrane composition and##2##4##(2008-10#2)
of membrane composition##4##3##(2008-10#4)
of membrane curvature##2##3##(1990-12#1)(2011-1#1)
of membrane damage##2##3##(2009-6#2)
of membrane fatty##3##3##(2011-1#2)(2011-2#1)
of membrane fluidity##6##3##(1991-5#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#1)(2006-2#1)
of membrane fraction##2##3##(1991-5#1)(1993-12#1)
of membrane from##2##3##(1990-4#1)(1996-9#1)
of membrane fusion##4##3##(1990-11#2)(1991-1#1)(1995-8#1)
of membrane immunoglobulin##3##3##(1994-9#2)(1995-6#1)
of membrane lipid biophysical properties##2##5##(2008-9#2)
of membrane lipid biophysical##3##4##(2008-9#3)
of membrane lipid##7##3##(1997-1#1)(1997-7#1)(2008-3#1)(2008-9#4)
of membrane lipids##7##3##(1991-5#1)(2005-12#1)(2008-3#1)(2008-8#2)(2009-6#1)(2013-1#1)
of membrane permeability##2##3##(2009-2#2)
of membrane permeabilization##2##3##(1994-2#1)(1997-7#1)
of membrane phosphoinositides##2##3##(1992-7#1)(1996-2#1)
of membrane phospholipids##2##3##(1991-5#1)(1993-9#1)
of membrane potential and##2##4##(1997-1#1)(2008-8#1)
of membrane potential##15##3##(1990-2#1)(1990-8#1)(1991-4#1)(1992-3#1)(1992-5#1)(1992-8#1)(1997-1#1)(2005-11#1)(2008-10#1)(2008-8#3)(2008-9#2)(2009-2#1)
of membrane protein##11##3##(1990-2#2)(1990-5#3)(1992-6#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-1#1)
of membrane proteins and##4##4##(2006-2#1)(2008-11#1)(2008-8#2)
of membrane proteins in##3##4##(1990-4#1)(1994-8#1)(2008-10#1)
of membrane proteins into the##2##5##(1992-12#1)(2012-1#1)
of membrane proteins into##3##4##(1992-12#1)(2008-4#1)(2012-1#1)
of membrane proteins with##2##4##(1990-5#1)(2007-12#1)
of membrane proteins##38##3##(1990-10#1)(1990-3#1)(1990-4#1)(1990-5#2)(1992-1#2)(1992-11#2)(1992-12#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-7#1)(1996-5#1)(2006-2#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-4#3)(2008-7#2)(2008-8#3)(2011-1#3)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
of membrane receptor##2##3##(1992-1#1)(2008-6#1)
of membrane structure##2##3##(1994-8#1)(2009-8#1)
of membrane surfaces##2##3##(2008-6#2)
of membrane transport##3##3##(1990-7#1)(1990-8#1)(2007-9#1)
of membrane vesicles with##2##4##(1994-8#1)(1997-8#1)
of membrane vesicles##3##3##(1991-9#1)(1994-8#1)(1997-8#1)
of membrane voltage and##2##4##(1990-2#1)(1996-10#1)
of membrane was##2##3##(1991-5#1)(2007-12#1)
of membrane with##2##3##(1992-6#1)(2008-5#1)
of membrane##246##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#5)(1990-3#2)(1990-4#3)(1990-5#5)(1990-7#2)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#2)(1991-2#2)(1991-4#1)(1991-5#7)(1991-9#1)(1992-1#4)(1992-11#6)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#5)(1994-9#3)(1995-1#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#5)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-9#1)(1997-1#4)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2005-11#9)(2005-12#1)(2006-2#2)(2007-11#1)(2007-12#3)(2007-3#1)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#16)(2008-11#3)(2008-3#2)(2008-4#5)(2008-5#2)(2008-6#4)(2008-7#5)(2008-8#14)(2008-9#8)(2009-10#2)(2009-2#5)(2009-3#1)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#10)(2011-12#1)(2011-2#4)(2012-1#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
of membrane-associated (NiFe) and (NiFeSe) hydrogenases of Desulfovibrio vulgaris##2##9##(1990-8#2)
of membrane-associated##8##2##(1990-8#2)(1990-9#1)(1991-5#1)(1993-12#1)(1993-8#1)(1994-3#1)(2008-4#1)
of membrane-bound Na+##2##3##(1993-3#2)
of membrane-bound alkaline phosphatase##2##4##(2004-11#2)
of membrane-bound guanylyl cyclase##2##4##(2008-5#2)
of membrane-bound##22##2##(1990-11#1)(1990-2#1)(1991-5#2)(1992-4#2)(1993-3#2)(1994-12#1)(1996-11#1)(1996-8#1)(1997-1#3)(1997-7#1)(2004-11#2)(2005-7#1)(2006-12#1)(2008-4#1)(2008-5#2)
of membrane-permeable##2##2##(1995-6#1)(1996-1#1)
of membranes and##3##3##(1990-11#1)(2007-12#1)(2008-10#1)
of membranes at##3##3##(1990-12#1)(1996-12#1)(2010-3#1)
of membranes by##2##3##(1992-8#1)(1997-7#1)
of membranes for##2##3##(2008-10#1)(2008-4#1)
of membranes in response to##2##5##(1996-8#2)
of membranes of##2##3##(1990-12#1)(1997-6#1)
of membranes showed##2##3##(1996-8#1)(2006-10#1)
of membranes with##4##3##(1990-3#1)(1992-7#1)(1993-6#1)(2013-1#1)
of membranes##51##2##(1990-11#2)(1990-12#2)(1990-3#1)(1990-4#1)(1990-8#1)(1991-9#2)(1992-2#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-10#1)(1995-3#1)(1996-12#1)(1996-8#3)(1997-6#1)(1997-7#1)(2004-10#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-12#1)(2008-10#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-6#1)(2010-3#1)(2011-1#1)(2012-3#1)(2013-1#2)
of membranolytic##2##2##(1991-9#1)(2005-11#1)
of membranoproliferative glomerulonephritis##3##3##(2007-2#2)(2007-7#1)
of membranoproliferative##4##2##(2007-2#2)(2007-7#2)
of membranous nephropathy##2##3##(1992-7#1)(2008-1#1)
of membranous##7##2##(1992-7#1)(2007-7#1)(2008-1#1)(2008-5#1)(2010-6#2)(2011-2#1)
of memories##5##2##(2008-11#1)(2008-4#1)(2010-8#1)(2011-1#2)
of memory B cells##2##4##(1996-11#1)(2009-8#1)
of memory T cells##7##4##(1991-2#4)(1995-12#1)(2006-10#1)(2008-1#1)
of memory and attention##2##4##(1991-5#1)(1991-6#1)
of memory and##5##3##(1991-5#1)(1991-6#1)(2008-2#1)(2008-7#1)(2012-1#1)
of memory cells##2##3##(1995-12#1)(2010-8#1)
of memory consolidation##3##3##(1994-2#2)(1996-1#1)
of memory decline##2##3##(2006-10#1)(2013-1#1)
of memory dysfunction##2##3##(1993-12#2)
of memory for##3##3##(2007-8#1)(2008-2#1)(2008-4#1)
of memory formation##5##3##(1993-11#2)(1993-12#1)(1994-3#1)(2006-10#1)
of memory impairment in##2##4##(2006-4#1)(2009-10#1)
of memory impairment##3##3##(1994-6#1)(2006-4#1)(2009-10#1)
of memory in##5##3##(1992-10#1)(2005-7#1)(2006-10#1)(2007-8#1)(2008-6#1)
of memory performance##3##3##(2006-3#1)(2008-12#1)(2008-7#1)
of memory processes##3##3##(2009-10#2)(2011-1#1)
of memory processing##3##3##(1994-2#2)(2008-2#1)
of memory reparation##2##3##(2013-7#2)
of memory##100##2##(1990-10#1)(1990-9#1)(1991-1#1)(1991-2#4)(1991-4#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-9#1)(1993-11#3)(1993-12#3)(1994-10#1)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#3)(1996-1#1)(1996-11#1)(1996-2#1)(2005-7#1)(2006-10#5)(2006-3#1)(2006-4#2)(2006-5#1)(2007-12#1)(2007-8#9)(2008-1#1)(2008-11#1)(2008-12#2)(2008-2#6)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#4)(2009-8#1)(2010-8#2)(2011-1#6)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#7)(2013-8#2)
of men aged##4##3##(1993-9#1)(1997-2#1)(2008-7#1)(2012-3#1)
of men and women in the##4##6##(1992-6#1)(2007-7#1)(2010-12#1)(2010-8#1)
of men and women in##5##5##(1992-6#1)(2007-7#2)(2010-12#1)(2010-8#1)
of men and women##25##4##(1990-9#1)(1992-6#1)(1994-11#1)(1994-5#1)(1995-12#1)(1996-6#1)(2004-11#1)(2004-3#1)(2006-1#2)(2007-12#3)(2007-7#2)(2008-3#1)(2009-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-8#1)
of men and##38##3##(1990-9#1)(1992-6#1)(1993-12#3)(1994-11#1)(1994-5#1)(1995-12#1)(1996-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-3#1)(2006-1#2)(2006-7#1)(2007-11#1)(2007-12#3)(2007-7#2)(2008-1#2)(2008-3#1)(2008-8#1)(2009-11#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-8#2)
of men in the##3##4##(1997-2#1)(2008-1#1)(2011-2#1)
of men in##10##3##(1997-2#1)(2006-7#2)(2008-1#1)(2008-10#1)(2008-2#2)(2009-5#2)(2011-2#1)
of men undergoing##2##3##(2010-10#2)
of men was##2##3##(1997-2#1)(2004-11#1)
of men who have sex with men##3##7##(2009-5#1)(2011-1#2)
of men who##5##3##(2006-7#1)(2009-5#1)(2010-10#1)(2011-1#2)
of men with##8##3##(1991-6#1)(2005-7#1)(2006-9#1)(2007-11#1)(2007-7#2)(2009-9#1)(2013-7#1)
of men##106##2##(1990-9#1)(1991-6#1)(1991-9#1)(1992-6#1)(1993-12#3)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#2)(1995-12#1)(1996-5#4)(1996-6#1)(1997-2#3)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2004-11#4)(2004-3#1)(2005-7#1)(2006-1#2)(2006-10#3)(2006-2#1)(2006-7#4)(2006-9#3)(2007-11#3)(2007-12#3)(2007-7#4)(2007-8#1)(2008-1#4)(2008-10#2)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-5#8)(2009-9#1)(2010-10#4)(2010-12#2)(2010-4#1)(2010-8#2)(2011-1#3)(2011-2#5)(2012-1#1)(2012-3#2)(2013-7#1)(2013-8#3)
of men's##6##2##(1993-10#1)(2007-12#2)(2010-12#2)(2011-2#1)
of menarche was##3##3##(2006-4#1)(2013-1#2)
of menarche##6##2##(2006-4#1)(2008-1#1)(2011-2#1)(2013-1#3)
of menin in##6##3##(2010-2#6)
of menin##11##2##(2008-11#1)(2010-2#10)
of meningeal hemangiopericytoma##2##3##(2008-6#2)
of meningeal involvement##2##3##(2008-7#1)(2013-1#1)
of meningeal irritation##2##3##(2009-11#1)(2013-1#1)
of meningeal melanocytoma##4##3##(1992-11#2)(2008-7#1)(2012-2#1)
of meningeal##10##2##(1992-11#2)(2008-6#2)(2008-7#2)(2009-11#1)(2012-2#1)(2013-1#2)
of meningioma invasion into the dura mater##2##7##(2007-12#2)
of meningioma##12##2##(1992-11#1)(2007-12#7)(2010-11#2)(2011-2#1)(2012-2#1)
of meningiomas##4##2##(2007-12#3)(2011-2#1)
of meningitis and##3##3##(2005-10#1)(2007-2#1)(2009-3#1)
of meningitis caused by##3##4##(1992-11#1)(2007-12#1)(2009-11#1)
of meningitis in##4##3##(1992-8#1)(1993-12#1)(2008-7#1)(2013-7#1)
of meningitis##30##2##(1991-2#1)(1992-11#1)(1992-8#1)(1993-12#2)(2004-12#2)(2005-10#1)(2005-7#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#1)(2008-12#1)(2008-7#3)(2008-9#3)(2009-11#1)(2009-3#1)(2010-12#1)(2011-2#2)(2013-7#1)
of meningococcal disease in##3##4##(2007-2#1)(2012-12#1)(2013-8#1)
of meningococcal disease##15##3##(1991-6#1)(1991-8#1)(1993-9#4)(2005-7#1)(2007-12#1)(2007-2#1)(2009-9#1)(2012-12#4)(2013-8#1)
of meningococcal infection##2##3##(1991-8#1)(2013-1#1)
of meningococcal meningitis##3##3##(1991-6#2)(2010-1#1)
of meningococcal##24##2##(1990-12#1)(1991-6#3)(1991-8#2)(1993-9#4)(2005-7#1)(2006-10#1)(2007-12#1)(2007-2#1)(2009-9#2)(2010-1#1)(2010-10#1)(2012-12#4)(2013-1#1)(2013-8#1)
of meningoencephalitis in##3##3##(1993-7#1)(2009-10#2)
of meningoencephalitis##8##2##(1993-7#2)(2009-10#2)(2010-12#3)(2012-12#1)
of meniscal##7##2##(1993-11#2)(1996-11#2)(2006-6#1)(2010-4#2)
of menopausal symptoms##2##3##(2008-4#1)(2011-1#1)
of menopausal##4##2##(1991-12#1)(2008-4#1)(2010-6#1)(2011-1#1)
of menopause##7##2##(1993-11#1)(1994-12#1)(2007-1#1)(2007-6#1)(2013-8#3)
of menopause-related symptoms##2##3##(2007-2#1)(2012-2#1)
of menopause-related##3##2##(2007-2#1)(2012-2#2)
of menorrhagia with tranexamic acid##2##5##(1993-9#2)
of menorrhagia##5##2##(1991-11#1)(1993-9#2)(1997-3#1)(2008-8#1)
of menstrual cycle##5##3##(1995-12#1)(2012-1#1)(2012-2#3)
of menstrual migraine##3##3##(2008-3#3)
of menstrual##12##2##(1993-5#1)(1995-12#1)(2008-10#1)(2008-3#4)(2008-9#1)(2012-1#1)(2012-2#3)
of menstruation##6##2##(1991-9#1)(2006-4#1)(2008-11#1)(2008-4#2)(2011-2#1)
of mental and behavioral##2##4##(1996-12#1)(1997-1#1)
of mental and##5##3##(1993-12#1)(1996-12#1)(1997-1#1)(2008-12#1)(2011-2#1)
of mental disorders in primary##3##5##(1996-12#1)(2007-2#2)
of mental disorders in##6##4##(1996-12#1)(2004-12#1)(2006-8#1)(2007-2#2)(2009-2#1)
of mental disorders##21##3##(1996-12#1)(2004-12#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-2#3)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#2)
of mental distress##2##3##(2007-9#1)(2012-3#1)
of mental health and##8##4##(1996-12#1)(1997-2#1)(2007-2#1)(2008-2#1)(2009-10#1)(2011-2#1)(2013-8#2)
of mental health care##7##4##(1994-1#1)(1995-1#1)(2006-9#1)(2007-3#1)(2010-5#2)(2012-11#1)
of mental health disorders##3##4##(2008-1#1)(2008-11#1)(2012-1#1)
of mental health issues in##2##5##(2008-12#2)
of mental health nurses in##2##5##(2010-5#1)(2011-1#1)
of mental health nurses##3##4##(2007-3#1)(2010-5#1)(2011-1#1)
of mental health nursing##6##4##(2007-3#2)(2008-11#2)(2008-12#1)(2009-6#1)
of mental health problems##3##4##(2010-11#1)(2012-12#1)(2013-1#1)
of mental health professionals and##2##5##(1990-2#1)(2008-2#1)
of mental health professionals##7##4##(1990-2#1)(1993-8#1)(1994-1#3)(2008-11#1)(2008-2#1)
of mental health service##2##4##(2008-2#1)(2011-1#1)
of mental health services and##2##5##(2007-3#1)(2011-2#1)
of mental health services in##3##5##(2008-11#1)(2008-2#2)
of mental health services##17##4##(1994-1#2)(1996-12#1)(1996-3#3)(2007-3#1)(2008-11#1)(2008-2#5)(2011-2#1)(2013-1#3)
of mental health treatment##2##4##(1995-1#1)(2004-12#1)
of mental health workers and##2##5##(2008-2#2)
of mental health workers##3##4##(2008-2#3)
of mental health##90##3##(1990-2#1)(1992-1#1)(1992-12#1)(1992-3#2)(1993-2#1)(1993-8#1)(1994-1#7)(1995-1#3)(1996-12#2)(1996-3#3)(1997-2#1)(1997-5#1)(1997-8#1)(2004-12#1)(2005-8#1)(2006-9#1)(2007-2#1)(2007-3#6)(2008-1#1)(2008-11#5)(2008-12#3)(2008-2#13)(2009-10#1)(2009-6#1)(2010-11#3)(2010-2#1)(2010-4#1)(2010-5#4)(2011-1#3)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#3)
of mental healthcare##2##3##(1992-1#1)(2009-4#1)
of mental illness and the##2##5##(2009-7#1)(2012-3#1)
of mental illness and##7##4##(2008-4#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-7#3)
of mental illness in##2##4##(1993-5#1)(2013-7#1)
of mental illness##25##3##(1993-5#1)(2005-7#1)(2007-12#1)(2008-12#4)(2008-2#1)(2008-4#3)(2009-7#1)(2011-1#3)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#5)(2013-8#1)
of mental illnesses##4##3##(2009-5#1)(2010-7#1)(2011-1#1)(2012-2#1)
of mental impairment##5##3##(1990-3#5)
of mental processes##2##3##(1992-9#1)(2013-8#1)
of mental retardation and##2##4##(1995-2#1)(2006-4#1)
of mental retardation in##2##4##(1993-5#1)(2006-4#1)
of mental retardation##12##3##(1992-2#3)(1992-5#1)(1993-5#1)(1995-2#1)(1996-3#1)(2006-4#2)(2007-3#1)(2009-5#1)(2012-1#1)
of mental##195##2##(1990-2#1)(1990-3#5)(1991-8#1)(1992-1#2)(1992-12#1)(1992-2#3)(1992-3#2)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#2)(1993-8#1)(1994-1#7)(1995-1#3)(1995-11#1)(1995-2#1)(1996-12#4)(1996-3#4)(1996-4#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#1)(2004-12#2)(2005-7#1)(2005-8#1)(2006-10#2)(2006-4#3)(2006-5#1)(2006-8#1)(2006-9#4)(2007-12#1)(2007-2#4)(2007-3#7)(2007-6#1)(2007-9#1)(2008-1#1)(2008-11#6)(2008-12#8)(2008-2#16)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#4)(2010-7#1)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#11)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#7)(2013-7#5)(2013-8#9)
of mentally ill##5##3##(1990-2#1)(1992-3#1)(1996-9#1)(2008-2#1)(2009-7#1)
of mentally##8##2##(1990-2#1)(1992-3#1)(1994-7#1)(1996-1#1)(1996-9#1)(2006-6#1)(2008-2#1)(2009-7#1)
of menthofuran (II)##2##3##(1990-12#2)
of menthol cigarette##2##3##(2011-1#2)
of menthol##4##2##(1994-6#2)(2011-1#2)
of mentioned##2##2##(2005-10#1)(2008-10#1)
of mentoring relationships##2##3##(2008-12#1)(2009-9#1)
of mentoring##10##2##(2008-12#1)(2009-4#7)(2009-9#2)
of mentorship##3##2##(2008-11#2)(2008-6#1)
of meperidine##5##2##(2007-2#3)(2011-2#2)
of mephenesin and diclofenac diethylamine were found to be##2##9##(2010-2#2)
of mephenesin and diclofenac diethylamine##5##5##(2010-2#5)
of mequitazine and the IS##2##5##(2008-10#2)
of mequitazine##4##2##(2008-10#4)
of mercapto##2##2##(1997-1#1)(2008-8#1)
of mercaptoethanol##2##2##(1991-1#1)(1991-7#1)
of mercaptosuccinic acid##2##3##(2013-7#2)
of merchant##2##2##(1991-12#1)(2008-11#1)
of mercuric chloride##3##3##(1993-4#1)(2008-7#2)
of mercuric##5##2##(1993-4#1)(2006-12#1)(2008-3#1)(2008-7#2)
of mercury and tin##3##4##(2008-3#3)
of mercury and##9##3##(1995-3#1)(2007-11#1)(2008-10#3)(2008-3#3)(2013-1#1)
of mercury by atomic absorption spectrometry##2##6##(2008-10#2)
of mercury by##7##3##(1990-3#1)(2007-8#1)(2008-10#5)
of mercury film##2##3##(2008-10#2)
of mercury from coal##3##4##(2008-6#3)
of mercury from##12##3##(1995-6#3)(2008-10#6)(2008-6#3)
of mercury in agroindustrial samples by##2##6##(2008-10#2)
of mercury in the##3##4##(2008-10#2)(2013-1#1)
of mercury in##26##3##(1993-9#2)(1995-6#2)(2008-10#20)(2011-2#1)(2013-1#1)
of mercury ions##2##3##(2008-10#2)
of mercury porosimetry data##2##4##(2005-11#2)
of mercury species##5##3##(2008-10#5)
of mercury vapour##4##3##(1993-4#1)(1995-6#1)(2008-10#2)
of mercury was##3##3##(1993-4#2)(2008-10#1)
of mercury with##3##3##(2008-10#3)
of mercury##117##2##(1990-3#1)(1992-11#1)(1993-4#5)(1993-6#1)(1993-9#5)(1995-3#1)(1995-6#7)(2005-11#5)(2007-11#1)(2007-8#1)(2008-10#76)(2008-3#3)(2008-6#4)(2010-5#2)(2011-2#1)(2013-1#3)
of mercury(II) and lead(II) in##2##5##(2008-10#2)
of mercury(II) and lead(II)##3##4##(2008-10#3)
of mercury(II) and##4##3##(2008-10#4)
of mercury(II) by##5##3##(2008-10#5)
of mercury(II) in##2##3##(2008-10#2)
of mercury(II) ions##2##3##(2008-10#2)
of mercury(II) with##2##3##(2008-10#2)
of mercury(II)##24##2##(2008-10#24)
of mercy##3##2##(1993-5#1)(1994-3#1)(2008-6#1)
of mergers on health maintenance organization##2##6##(1997-1#2)
of mergers##4##2##(1997-1#3)(2007-4#1)
of merit and##3##3##(2008-10#3)
of merit are##4##3##(2008-10#3)(2008-2#1)
of merit for##6##3##(2007-12#2)(2008-10#1)(2008-7#1)(2011-2#1)(2013-7#1)
of merit of the##9##4##(2007-12#1)(2008-10#8)
of merit of##11##3##(2007-12#3)(2008-10#8)
of merit such as limit of detection##2##7##(2008-10#2)
of merit##62##2##(1996-3#1)(1996-5#1)(2007-11#4)(2007-12#9)(2007-8#2)(2008-10#29)(2008-2#4)(2008-3#6)(2008-7#1)(2010-11#1)(2010-5#1)(2011-2#1)(2013-7#2)
of merits in##2##3##(2008-10#2)
of merits##4##2##(2008-10#4)
of merocyanine 540##3##3##(1996-1#1)(1997-1#2)
of meropenem##4##2##(2008-3#1)(2008-7#1)(2012-12#2)
of mersalyl##2##2##(1991-2#1)(1994-8#1)
of mesaconate##2##2##(2013-8#2)
of mesalazine (5-ASA) in##2##4##(2006-2#2)
of mesalazine##6##2##(2006-2#2)(2007-11#2)(2010-11#2)
of mesangial cells##4##3##(1990-2#1)(1993-8#1)(1995-11#1)(2011-2#1)
of mesangial proliferative##2##3##(2006-7#1)(2007-7#1)
of mesangial##7##2##(1990-2#1)(1993-8#1)(1995-11#1)(1996-6#1)(2006-7#1)(2007-7#1)(2011-2#1)
of mesencephalic##4##2##(1993-6#1)(1995-11#1)(1996-10#1)(2008-7#1)
of mesenchymal and##3##3##(2007-12#2)(2010-6#1)
of mesenchymal cell##2##3##(1994-5#1)(2012-12#1)
of mesenchymal cells##4##3##(2008-11#1)(2010-12#1)(2012-12#2)
of mesenchymal origin##7##3##(1996-4#1)(1997-7#1)(2007-8#1)(2010-3#1)(2011-2#1)(2012-12#2)
of mesenchymal stem cells (MSC)##2##5##(2008-5#2)
of mesenchymal stem cells (MSCs)##4##5##(2008-1#1)(2008-5#1)(2010-2#1)(2010-8#1)
of mesenchymal stem cells from##4##5##(2007-11#1)(2008-9#2)(2012-2#1)
of mesenchymal stem cells in##4##5##(2008-1#1)(2012-1#1)(2012-12#2)
of mesenchymal stem cells##30##4##(2007-11#1)(2008-1#2)(2008-5#5)(2008-9#3)(2010-12#3)(2010-2#1)(2010-8#1)(2012-1#6)(2012-12#5)(2012-2#1)(2012-3#1)(2012-7#1)
of mesenchymal stem##31##3##(2007-11#1)(2008-1#2)(2008-11#1)(2008-5#5)(2008-9#3)(2010-12#3)(2010-2#1)(2010-8#1)(2012-1#6)(2012-12#5)(2012-2#1)(2012-3#1)(2012-7#1)
of mesenchymal stromal cells##3##4##(2012-1#2)(2012-3#1)
of mesenchymal##58##2##(1991-2#1)(1993-10#1)(1994-5#1)(1996-4#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#4)(2008-5#5)(2008-9#3)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#8)(2012-12#11)(2012-2#1)(2012-3#2)(2012-7#1)
of mesenchyme##5##2##(2008-5#4)(2010-6#1)
of mesenteric and##2##3##(1991-5#1)(1992-6#1)
of mesenteric ischaemia##2##3##(2007-8#1)(2008-10#1)
of mesenteric lymphatic vessels##2##4##(2010-12#2)
of mesenteric##14##2##(1990-6#1)(1991-5#1)(1992-6#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-12#2)(2011-12#2)
of mesentery##2##2##(2009-8#1)(2010-12#1)
of mesh##7##2##(2007-8#1)(2008-10#1)(2011-2#2)(2013-1#3)
of mesna from##2##3##(2008-10#2)
of mesna##6##2##(2008-10#6)
of meso- and##3##3##(1990-5#1)(2008-7#1)(2013-1#1)
of meso-2##3##2##(1992-12#2)(1995-3#1)
of meso-erythritol and L-erythrulose in fermentation broth##3##7##(2012-12#3)
of meso-tetraphenylporphine tetrasulphonate##2##3##(1992-2#2)
of mesoderm##2##2##(1991-5#1)(1997-4#1)
of mesodermal##6##2##(2008-5#1)(2012-12#3)(2012-7#1)(2013-1#1)
of mesolimbic dopamine##4##3##(1993-12#1)(1993-6#1)(1994-2#1)(1996-10#1)
of mesolimbic##6##2##(1991-1#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-2#1)(1996-10#1)
of mesopause##2##2##(1993-2#1)(2008-3#1)
of mesophase pitch##2##3##(2009-2#2)
of mesophilic##2##2##(2006-8#1)(2010-4#1)
of mesoporous materials##2##3##(2006-12#1)(2008-10#1)
of mesoporous##7##2##(2005-11#1)(2006-12#2)(2008-10#1)(2009-2#1)(2010-4#1)(2011-1#1)
of mesoscopic##4##2##(1993-3#1)(2008-11#3)
of mesospheric##2##2##(1993-2#1)(2008-2#1)
of mesostructured##3##2##(2006-12#2)(2008-10#1)
of mesothelial cells##4##3##(2010-9#1)(2013-1#3)
of mesothelial##5##2##(2010-9#1)(2012-2#1)(2013-1#3)
of mesothelioma is##2##3##(1991-12#1)(2010-9#1)
of mesothelioma##8##2##(1991-12#6)(1997-5#1)(2010-9#1)
of message framing##2##3##(2012-1#2)
of message##6##2##(1991-3#1)(1995-8#1)(2007-12#1)(2012-1#2)(2012-2#1)
of messages and##2##3##(2008-3#1)(2012-11#1)
of messages##9##2##(2006-11#1)(2007-12#2)(2007-9#1)(2008-3#1)(2009-6#1)(2010-11#1)(2011-2#1)(2012-11#1)
of messenger RNA (mRNA)##3##4##(1994-8#1)(2006-12#1)(2008-4#1)
of messenger RNA for##2##4##(1991-7#1)(1993-7#1)
of messenger RNA##9##3##(1990-7#1)(1991-7#1)(1992-8#1)(1993-7#1)(1994-8#1)(1995-9#1)(2006-12#1)(2008-1#1)(2008-4#1)
of messenger RNAs##2##3##(1996-8#1)(2010-9#1)
of messenger ribonucleic##2##3##(1992-9#1)(2013-8#1)
of messenger##16##2##(1990-7#1)(1991-7#1)(1992-8#1)(1992-9#1)(1993-7#1)(1994-8#1)(1995-9#1)(1996-8#1)(1997-2#1)(2006-11#1)(2006-12#1)(2008-1#1)(2008-4#2)(2010-9#1)(2013-8#1)
of metE expression##3##3##(1992-1#3)
of meta-analyses##2##2##(2006-3#1)(2010-5#1)
of meta-analysis and the##2##4##(1996-6#1)(2010-11#1)
of meta-analysis and##4##3##(1992-2#1)(1996-6#1)(2010-11#1)(2011-12#1)
of meta-analysis##10##2##(1992-2#1)(1996-6#3)(1996-8#1)(2007-7#1)(2008-10#1)(2008-6#1)(2010-11#1)(2011-12#1)
of metabolic abnormalities##4##3##(2006-10#1)(2008-11#1)(2008-3#2)
of metabolic activation and##2##4##(1996-11#1)(2011-1#1)
of metabolic activation##3##3##(1996-11#1)(1996-12#1)(2011-1#1)
of metabolic activity##3##3##(1991-5#1)(1992-3#1)(2007-8#1)
of metabolic and cardiovascular##2##4##(2010-2#1)(2013-1#1)
of metabolic and hormonal##3##4##(1994-12#1)(2008-3#1)(2013-7#1)
of metabolic and physiologic##2##4##(2008-5#1)(2012-1#1)
of metabolic and##13##3##(1994-12#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-10#1)(2010-2#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
of metabolic bone##2##3##(2005-3#1)(2007-3#1)
of metabolic changes in##3##4##(1996-2#1)(2007-12#1)(2012-2#1)
of metabolic changes##4##3##(1996-2#1)(2007-12#1)(2010-11#1)(2012-2#1)
of metabolic compartmentation##2##3##(2012-2#2)
of metabolic complications in renal transplant recipients is##2##8##(2008-3#2)
of metabolic control analysis##2##4##(1990-7#2)
of metabolic control##5##3##(1990-7#2)(2007-11#1)(2008-3#1)(2012-4#1)
of metabolic disorders in##2##4##(2008-12#1)(2008-3#1)
of metabolic disorders##5##3##(1997-4#1)(2008-12#1)(2008-3#1)(2008-4#1)(2010-8#1)
of metabolic engineering##3##3##(1994-11#1)(2007-6#1)(2012-11#1)
of metabolic fluxes##4##3##(2006-12#1)(2007-6#1)(2008-11#1)(2013-1#1)
of metabolic functions##2##3##(2008-10#2)
of metabolic networks##3##3##(2006-10#2)(2007-9#1)
of metabolic origin##2##3##(2007-8#1)(2011-2#1)
of metabolic parameters and##2##4##(2009-2#1)(2012-5#1)
of metabolic pathways##10##3##(2006-10#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#3)(2009-3#1)(2009-8#1)(2010-7#1)
of metabolic profiling##2##3##(2010-11#2)
of metabolic reactions##2##3##(2008-7#2)
of metabolic risk factors##2##4##(1996-4#1)(2008-3#1)
of metabolic stress##4##3##(2007-5#1)(2010-12#1)(2012-1#2)
of metabolic syndrome (MS)##4##4##(2008-3#3)(2011-1#1)
of metabolic syndrome and its components in##2##7##(2008-3#1)(2013-1#1)
of metabolic syndrome and its##3##5##(2008-3#2)(2013-1#1)
of metabolic syndrome and##7##4##(2008-3#5)(2013-1#2)
of metabolic syndrome in overweight##2##5##(2012-12#2)
of metabolic syndrome in##12##4##(2008-3#6)(2009-6#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
of metabolic syndrome was##4##4##(2008-3#3)(2012-12#1)
of metabolic syndrome with##2##4##(2008-3#1)(2009-11#1)
of metabolic syndrome##61##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#35)(2008-4#1)(2008-7#1)(2009-11#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#2)(2012-12#4)(2012-2#2)(2013-1#6)(2013-7#1)
of metabolic syndrome]##2##3##(2008-10#1)(2008-5#1)
of metabolic##181##2##(1990-7#3)(1990-8#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-11#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-8#1)(1996-9#3)(1997-4#1)(2005-10#1)(2005-3#1)(2006-10#5)(2006-12#2)(2007-11#1)(2007-12#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#2)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#45)(2008-4#2)(2008-5#3)(2008-7#10)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#4)(2010-12#3)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#2)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#6)(2012-4#1)(2012-5#1)(2013-1#11)(2013-7#2)(2013-8#1)
of metabolically##9##2##(1990-11#1)(1992-9#1)(1994-2#1)(1996-11#1)(2008-11#1)(2008-4#2)(2013-1#1)(2013-8#1)
of metabolism in##2##3##(1995-12#1)(2006-6#1)
of metabolism##34##2##(1991-12#1)(1992-1#1)(1993-9#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-8#2)(2006-2#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-3#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#2)(2013-7#1)(2013-8#2)
of metabolite##5##2##(1993-3#1)(1997-5#1)(2007-11#1)(2008-8#1)(2009-8#1)
of metabolites and##3##3##(2007-6#1)(2008-12#1)(2013-8#1)
of metabolites by##2##3##(1993-8#1)(2010-5#1)
of metabolites from the##2##4##(2007-12#1)(2010-5#1)
of metabolites from##3##3##(2007-12#1)(2010-11#1)(2010-5#1)
of metabolites in a##3##4##(2008-6#1)(2009-3#1)(2010-5#1)
of metabolites in##9##3##(1994-11#1)(2004-11#1)(2008-10#2)(2008-6#1)(2009-3#1)(2010-11#1)(2010-5#1)(2012-3#1)
of metabolites of##4##3##(1990-2#1)(1991-12#1)(1996-5#1)(2012-3#1)
of metabolites that##2##3##(2010-12#1)(2012-1#1)
of metabolites##49##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-6#1)(1993-12#1)(1993-8#1)(1994-11#2)(1996-12#1)(1996-3#1)(1996-5#2)(1997-8#1)(2004-11#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-3#4)(2010-11#3)(2010-12#1)(2010-5#3)(2011-2#2)(2012-1#2)(2012-3#4)(2013-8#1)
of metabolomics##7##2##(2007-11#2)(2009-3#1)(2010-11#1)(2010-5#1)(2012-2#2)
of metabonomics##3##2##(2010-11#3)
of metabotropic glutamate receptors##4##4##(1992-9#1)(1995-11#1)(2008-3#2)
of metabotropic glutamate##6##3##(1992-9#1)(1995-11#1)(1995-12#1)(1996-5#1)(2008-3#2)
of metabotropic receptors##2##3##(1992-12#1)(2008-4#1)
of metabotropic##9##2##(1992-12#1)(1992-9#1)(1993-11#1)(1995-11#1)(1995-12#1)(1996-5#1)(2008-3#2)(2008-4#1)
of metacarpophalangeal##2##2##(2006-3#1)(2008-9#1)
of metacentric chromosomes##2##3##(2008-12#2)
of metacentric##3##2##(2008-12#2)(2010-3#1)
of metachronous##3##2##(2008-3#1)(2013-1#2)
of metal Pd##2##3##(2008-10#2)
of metal and##2##3##(1990-7#1)(2008-9#1)
of metal atoms##2##3##(1996-2#1)(2006-4#1)
of metal binding##4##3##(2007-8#1)(2008-3#1)(2010-11#2)
of metal cations##5##3##(1995-2#1)(1997-4#1)(2008-10#3)
of metal chelator##4##3##(2012-11#4)
of metal complexation##2##3##(1996-2#1)(1997-8#1)
of metal complexes containing##2##4##(2008-5#2)
of metal complexes having##2##4##(2008-5#1)(2010-5#1)
of metal complexes of##4##4##(2008-3#1)(2008-5#3)
of metal complexes##14##3##(2005-11#1)(2008-10#2)(2008-3#4)(2008-5#6)(2010-5#1)
of metal concentration##4##3##(2004-4#1)(2008-10#1)(2008-2#1)(2008-5#1)
of metal concentrations##2##3##(2008-10#1)(2008-2#1)
of metal content##3##3##(2008-10#2)(2010-11#1)
of metal deposited##2##3##(2008-10#1)(2008-7#1)
of metal distributions in##2##4##(2010-11#2)
of metal in##2##3##(1990-7#1)(2008-10#1)
of metal incorporation##2##3##(2008-10#1)(2008-5#1)
of metal ion solution##2##4##(2008-10#2)
of metal ion##17##3##(1994-11#1)(1997-2#1)(2008-10#13)(2008-5#1)(2010-11#1)
of metal ions Cu(II) and##2##5##(2008-10#2)
of metal ions and##6##4##(2008-10#5)(2008-3#1)
of metal ions by##3##4##(2008-10#3)
of metal ions from##4##4##(2008-10#4)
of metal ions in the##3##5##(2008-10#3)
of metal ions in##13##4##(1997-7#1)(2008-10#12)
of metal ions is##2##4##(2008-10#2)
of metal ions on the##7##5##(1993-4#1)(2008-10#6)
of metal ions on##8##4##(1993-4#1)(2008-10#6)(2008-3#1)
of metal ions to the##2##5##(2008-1#1)(2008-10#1)
of metal ions to##4##4##(2005-11#1)(2008-1#1)(2008-10#2)
of metal ions using##4##4##(2008-10#4)
of metal ions was##3##4##(1991-4#1)(2008-10#2)
of metal ions were##4##4##(2008-10#4)
of metal ions with##3##4##(2008-10#3)
of metal ions##91##3##(1991-3#1)(1991-4#1)(1993-4#1)(1994-6#1)(1997-7#1)(2005-11#1)(2007-8#1)(2008-1#2)(2008-10#76)(2008-3#3)(2008-5#1)(2008-7#1)(2011-1#1)
of metal nanoparticles##3##3##(2007-12#1)(2009-2#1)(2010-4#1)
of metal species##2##3##(2008-10#2)
of metal to##2##3##(2008-10#1)(2008-11#1)
of metal uptake##2##3##(2008-10#1)(2008-6#1)
of metal with##2##3##(2007-8#1)(2008-7#1)
of metal##241##2##(1990-7#2)(1990-9#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-5#1)(1993-4#1)(1994-11#1)(1994-6#1)(1995-2#1)(1996-2#2)(1996-8#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2004-4#2)(2005-11#5)(2006-10#1)(2006-12#3)(2006-4#1)(2006-5#1)(2007-12#2)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#134)(2008-11#2)(2008-2#5)(2008-3#12)(2008-5#11)(2008-6#1)(2008-7#4)(2008-9#1)(2009-2#1)(2009-3#1)(2010-11#8)(2010-4#2)(2010-5#3)(2010-8#1)(2011-1#1)(2012-1#2)(2012-11#6)(2012-12#1)(2013-8#2)
of metal-based##4##2##(2008-10#1)(2008-5#1)(2010-5#1)(2012-3#1)
of metal-binding##2##2##(2008-10#1)(2010-11#1)
of metal-containing##2##2##(2010-11#2)
of metal-enhanced##2##2##(2007-12#1)(2009-12#1)
of metal-induced##2##2##(1990-4#1)(1996-4#1)
of metal-stripe subwavelength period gratings##2##5##(2008-3#2)
of metallic and##2##3##(2012-1#1)(2012-12#1)
of metallic cobalt##2##3##(1994-6#2)
of metallic films##2##3##(2008-2#2)
of metallic impurities in##3##4##(2008-10#1)(2008-3#1)(2010-7#1)
of metallic ions##2##3##(2008-10#2)
of metallic nanoparticles##3##3##(2006-12#1)(2008-10#1)(2008-7#1)
of metallic particles##2##3##(2007-12#1)(2008-6#1)
of metallic silver##2##3##(2008-10#1)(2011-2#1)
of metallic structures##2##3##(2008-3#1)(2008-7#1)
of metallic##42##2##(1991-12#1)(1994-6#2)(1996-2#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-2#5)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#4)(2009-2#1)(2010-3#1)(2010-7#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
of metalloprotease##2##2##(1995-1#1)(2012-3#1)
of metalloproteases##6##2##(1994-12#1)(1994-5#1)(2006-6#1)(2008-4#1)(2008-7#1)(2011-2#1)
of metalloproteinase 2##2##3##(2010-1#1)(2010-12#1)
of metalloproteinase##10##2##(1990-8#2)(1991-8#1)(1992-6#2)(2008-5#1)(2008-9#1)(2010-1#1)(2010-12#1)(2012-1#1)
of metalloproteinases and their inhibitor##2##5##(1992-6#1)(2010-12#1)
of metalloproteinases and their##3##4##(1992-6#1)(2009-4#1)(2010-12#1)
of metalloproteinases and##4##3##(1992-6#1)(2007-11#1)(2009-4#1)(2010-12#1)
of metalloproteinases##23##2##(1990-10#1)(1990-12#1)(1990-7#2)(1991-7#3)(1992-11#1)(1992-6#1)(1992-9#2)(1994-5#2)(1994-9#1)(1996-1#2)(1997-4#1)(2006-9#1)(2007-11#1)(2008-4#1)(2009-4#1)(2010-12#1)(2013-1#1)
of metalloproteins##6##2##(1990-5#1)(1995-5#1)(2008-10#1)(2010-11#3)
of metallothionein (MT)##4##3##(2008-10#4)
of metallothionein by##4##3##(1991-5#4)
of metallothionein in##2##3##(2008-10#2)
of metallothionein isoforms##3##3##(2008-10#3)
of metallothionein proteins##2##3##(2008-10#2)
of metallothionein##32##2##(1990-5#3)(1991-5#4)(1992-6#1)(1993-12#2)(1997-2#2)(1997-3#1)(2007-12#1)(2008-10#15)(2008-11#1)(2008-3#1)(2013-1#1)
of metallothioneins (MTs)##2##3##(2008-10#2)
of metallothioneins by##2##3##(2008-10#2)
of metallothioneins##11##2##(1990-5#1)(2006-12#1)(2008-10#8)(2008-5#1)
of metals and anions##2##4##(2008-10#2)
of metals and##7##3##(1996-3#1)(2004-4#1)(2008-10#5)
of metals at##2##3##(2008-10#2)
of metals from sediment##2##4##(2008-10#2)
of metals from##7##3##(2008-10#7)
of metals in lubricating##2##4##(2008-10#2)
of metals in solution##2##4##(2008-10#2)
of metals in the##3##4##(2008-10#2)(2011-12#1)
of metals in used lubricating oils##2##6##(2008-10#2)
of metals in##26##3##(1995-2#1)(2005-10#1)(2008-10#19)(2008-2#1)(2010-11#2)(2011-12#1)(2011-2#1)
of metals on##4##3##(1990-4#1)(1994-6#1)(2005-10#1)(2008-5#1)
of metals such as##2##4##(1997-2#1)(2008-10#1)
of metals was##2##3##(2008-10#2)
of metals with##3##3##(2007-12#1)(2008-10#2)
of metals##80##2##(1990-4#1)(1994-6#1)(1995-2#1)(1996-3#1)(1997-2#1)(2004-4#1)(2005-10#2)(2005-4#1)(2007-12#2)(2008-10#53)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2010-11#3)(2010-2#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
of metameric##2##2##(1996-3#1)(2008-7#1)
of metamorphic##3##2##(1990-5#1)(1997-6#1)(2012-3#1)
of metamorphosis##4##2##(1994-9#1)(1997-4#1)(2008-5#1)(2008-8#1)
of metaphase chromosomes##6##3##(1990-3#1)(1994-6#1)(1996-6#1)(2008-1#1)(2008-5#1)(2008-9#1)
of metaphase##9##2##(1990-3#1)(1994-6#1)(1995-6#1)(1996-6#1)(1997-3#1)(2008-1#1)(2008-5#2)(2008-9#1)
of metaphorical##2##2##(2012-2#2)
of metaphyseal##2##2##(2009-2#1)(2009-4#1)
of metapopulation##3##2##(2007-9#1)(2008-8#2)
of metapopulations##4##2##(2008-8#4)
of metarhodopsin II##2##3##(1990-6#1)(1994-11#1)
of metarhodopsin##3##2##(1990-6#1)(1994-11#2)
of metastable##3##2##(1992-8#1)(1997-7#1)(2006-10#1)
of metastasectomy for##2##3##(2010-5#1)(2012-1#1)
of metastasectomy##3##2##(2010-5#1)(2012-1#1)(2012-2#1)
of metastases and##4##3##(1991-10#1)(1994-12#1)(2008-6#1)(2011-1#1)
of metastases at##3##3##(2007-8#1)(2009-10#1)(2010-3#1)
of metastases in##4##3##(1991-5#1)(1995-10#1)(2007-11#1)(2008-7#1)
of metastases to the##4##4##(2006-2#1)(2007-11#1)(2007-7#1)(2009-10#1)
of metastases to##6##3##(1990-8#1)(2006-2#1)(2007-11#2)(2007-7#1)(2009-10#1)
of metastases##46##2##(1990-12#1)(1990-6#1)(1990-8#1)(1991-10#2)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1993-10#1)(1994-12#1)(1995-10#1)(1995-2#1)(1996-3#1)(2006-10#1)(2006-2#1)(2006-9#2)(2007-10#1)(2007-11#6)(2007-7#1)(2007-8#2)(2008-1#2)(2008-3#1)(2008-6#3)(2008-7#2)(2009-10#2)(2010-3#3)(2011-1#1)(2012-2#2)(2013-8#1)
of metastasis and##3##3##(2005-6#1)(2008-9#1)(2012-3#1)
of metastasis in##3##3##(1993-8#1)(2005-10#1)(2006-9#1)
of metastasis of the##2##4##(2006-2#1)(2012-12#1)
of metastasis of##3##3##(2006-2#1)(2012-12#1)(2012-3#1)
of metastasis or##2##3##(2007-8#1)(2013-8#1)
of metastasis to lung##2##4##(2008-8#2)
of metastasis to##3##3##(2007-11#1)(2008-8#2)
of metastasis was##3##3##(2005-10#1)(2008-6#1)(2011-1#1)
of metastasis##49##2##(1990-6#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-8#1)(2005-10#2)(2005-6#1)(2006-2#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#4)(2007-6#1)(2007-8#1)(2008-1#2)(2008-5#1)(2008-6#2)(2008-8#3)(2008-9#1)(2009-3#2)(2010-3#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
of metastatic HCC##2##3##(2009-8#1)(2011-2#1)
of metastatic bone disease##2##4##(2012-3#2)
of metastatic bone##6##3##(2007-11#3)(2012-1#1)(2012-3#2)
of metastatic breast cancer##4##4##(1992-10#1)(2009-8#3)
of metastatic breast##5##3##(1992-10#1)(2007-4#1)(2009-8#3)
of metastatic cancer##3##3##(1993-1#1)(2008-7#1)(2009-3#1)
of metastatic carcinoma##2##3##(2007-5#1)(2008-4#1)
of metastatic cells of##2##4##(1990-2#1)(1991-10#1)
of metastatic cells##4##3##(1990-2#2)(1991-10#1)(2008-4#1)
of metastatic colorectal cancer##3##4##(2008-7#1)(2009-12#1)(2012-2#1)
of metastatic colorectal##6##3##(2008-7#1)(2009-12#1)(2010-12#1)(2012-1#2)(2012-2#1)
of metastatic deposits##2##3##(1992-6#1)(2010-11#1)
of metastatic disease and##2##4##(2008-7#1)(2010-9#1)
of metastatic disease to the##3##5##(1990-12#1)(2006-8#1)(2008-1#1)
of metastatic disease was##3##4##(2007-11#1)(2007-3#1)(2008-6#1)
of metastatic disease##21##3##(1990-12#1)(1997-6#1)(2005-11#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-3#1)(2008-1#2)(2008-3#1)(2008-6#3)(2008-7#2)(2010-9#1)(2011-1#1)(2012-2#2)
of metastatic dissemination##2##3##(2009-3#1)(2012-2#1)
of metastatic gestational choriocarcinoma##2##4##(2007-10#2)
of metastatic hepatocellular carcinoma after treatment with thymostimulin##2##8##(1990-2#2)
of metastatic involvement of##2##4##(2006-8#1)(2010-11#1)
of metastatic lesions##2##3##(1991-7#1)(2010-3#1)
of metastatic lymph##2##3##(2010-12#1)(2012-12#1)
of metastatic melanoma##5##3##(2007-11#2)(2009-3#1)(2010-7#1)(2010-9#1)
of metastatic renal cell carcinoma##6##5##(1990-2#1)(1994-12#1)(2006-8#1)(2009-11#1)(2010-12#1)(2011-1#1)
of metastatic renal cell##7##4##(1990-2#1)(1994-12#1)(2006-8#1)(2009-11#2)(2010-12#1)(2011-1#1)
of metastatic renal##8##3##(1990-2#1)(1994-12#1)(2006-8#1)(2007-4#1)(2009-11#2)(2010-12#1)(2011-1#1)
of metastatic spinal##2##3##(1993-9#1)(2006-2#1)
of metastatic spread to##2##4##(1994-12#1)(2007-6#1)
of metastatic spread##6##3##(1991-2#1)(1994-12#1)(2007-6#1)(2008-1#1)(2008-6#1)(2009-9#1)
of metastatic tumor##2##3##(2007-11#1)(2007-12#1)
of metastatic tumors##8##3##(2006-10#1)(2006-2#1)(2007-11#3)(2008-1#1)(2009-5#1)(2011-1#1)
of metastatic##133##2##(1990-12#1)(1990-2#5)(1991-10#1)(1991-2#1)(1991-4#1)(1991-7#2)(1991-8#1)(1992-10#4)(1992-2#1)(1992-6#1)(1993-1#1)(1993-7#3)(1993-9#1)(1994-12#2)(1994-4#1)(1994-5#1)(1996-11#1)(1996-4#1)(1996-6#1)(1997-6#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-2#2)(2006-6#1)(2006-8#3)(2006-9#1)(2007-10#2)(2007-11#13)(2007-12#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#5)(2008-10#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#6)(2008-7#4)(2009-11#4)(2009-12#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-8#4)(2009-9#1)(2010-11#2)(2010-12#5)(2010-3#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#4)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#6)(2012-3#2)
of metatarsal##2##2##(2009-6#1)(2010-3#1)
of metatarsus adductus##2##3##(2012-2#2)
of metazoan##2##2##(2007-12#2)
of meteoric##3##2##(1993-2#2)(2007-7#1)
of meteorological##4##2##(1996-3#1)(2008-10#1)(2008-2#1)(2013-1#1)
of metered dose inhalers##3##4##(1992-2#2)(1993-2#1)
of metered dose##4##3##(1992-2#2)(1992-3#1)(1993-2#1)
of metformin hydrochloride in bulk##3##5##(2010-2#2)(2010-5#1)
of metformin hydrochloride in##4##4##(2010-2#2)(2010-5#2)
of metformin hydrochloride using##2##4##(2011-1#1)(2012-2#1)
of metformin hydrochloride##11##3##(2010-2#4)(2010-5#3)(2011-1#2)(2012-2#1)(2013-1#1)
of metformin in##8##3##(1995-8#2)(2005-1#1)(2008-10#1)(2008-3#2)(2009-6#1)(2012-3#1)
of metformin is##2##3##(1994-8#1)(2012-3#1)
of metformin on##4##3##(1994-8#1)(2005-8#1)(2010-4#2)
of metformin##41##2##(1994-8#3)(1995-8#2)(2005-1#1)(2005-8#2)(2008-1#2)(2008-10#2)(2008-3#4)(2009-6#2)(2010-2#4)(2010-4#2)(2010-5#3)(2011-1#3)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#2)
of methacrylate##2##2##(2007-11#1)(2008-5#1)
of methadone and##3##3##(2009-4#3)
of methadone base in##2##4##(2010-5#2)
of methadone base##3##3##(2010-5#3)
of methadone in##2##3##(2008-7#1)(2010-5#1)
of methadone##12##2##(2007-2#3)(2008-7#1)(2009-4#3)(2010-5#4)(2012-12#1)
of methadone-maintained##2##2##(2007-8#1)(2010-2#1)
of methamidophos in##2##3##(2008-10#1)(2013-8#1)
of methamidophos##4##2##(2008-10#3)(2013-8#1)
of methamphetamine and amphetamine in##3##5##(2007-8#3)
of methamphetamine and prescription drug use##2##6##(2013-1#2)
of methamphetamine and##7##3##(1996-10#1)(2005-8#1)(2007-8#3)(2013-1#2)
of methamphetamine on##3##3##(1996-10#3)
of methamphetamine##34##2##(1990-8#2)(1991-1#3)(1993-3#4)(1995-3#1)(1996-10#11)(1996-7#1)(1997-5#2)(1997-8#1)(2005-8#1)(2007-8#3)(2008-10#1)(2010-5#1)(2013-1#2)(2013-8#1)
of methamphetamine-induced##2##2##(1996-7#1)(2012-2#1)
of methane and##2##3##(2008-10#1)(2008-3#1)
of methane at##2##3##(2007-12#1)(2008-1#1)
of methane by##2##3##(2007-12#1)(2008-3#1)
of methane in a##2##4##(2008-3#1)(2008-6#1)
of methane in##3##3##(2008-3#1)(2008-6#1)(2013-1#1)
of methane monooxygenase##2##3##(1991-12#2)
of methane yield##2##3##(2007-12#1)(2009-6#1)
of methane##36##2##(1991-12#2)(2004-9#1)(2007-12#6)(2007-6#1)(2008-1#2)(2008-10#5)(2008-2#6)(2008-3#7)(2008-6#3)(2009-6#1)(2010-5#1)(2013-1#1)
of methane-air##2##2##(2008-3#2)
of methanogenesis##2##2##(2006-3#1)(2006-8#1)
of methanogenic##2##2##(2006-5#1)(2006-8#1)
of methanol and ethanol##3##4##(2006-10#1)(2008-10#2)
of methanol and##8##3##(2006-10#1)(2006-8#1)(2008-10#5)(2011-1#1)
of methanol extract of Aegle marmelos##3##6##(2012-2#3)
of methanol extract of##4##4##(2012-2#3)(2012-3#1)
of methanol in the##3##4##(1996-5#1)(2005-11#2)
of methanol in##6##3##(1996-5#2)(2005-11#2)(2008-10#2)
of methanol to##2##3##(2007-11#1)(2008-7#1)
of methanol versus water##2##4##(2006-8#2)
of methanol was##2##3##(1996-5#1)(2008-10#1)
of methanol with##2##3##(2007-8#1)(2010-12#1)
of methanol##71##2##(1992-12#1)(1995-3#1)(1996-5#7)(1996-8#1)(1997-8#1)(2005-11#3)(2005-12#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-8#3)(2007-11#1)(2007-8#1)(2008-10#29)(2008-2#3)(2008-5#2)(2008-6#1)(2008-7#2)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-2#3)(2012-3#1)(2013-8#1)
of methanol-0##3##2##(1993-2#1)(2005-12#1)(2011-3#1)
of methanol-water (70##2##3##(2011-2#1)(2012-12#1)
of methanol-water##7##2##(2005-12#1)(2008-10#4)(2011-2#1)(2012-12#1)
of methanol/water##2##2##(2008-10#1)(2008-5#1)
of methanolic extract##2##3##(2010-3#1)(2011-2#1)
of methanolic##4##2##(2010-3#1)(2011-2#1)(2012-11#1)(2013-1#1)
of methaqualone##4##2##(2008-10#4)
of methemoglobin##3##2##(1990-8#1)(2010-4#1)(2013-8#1)
of methicillin resistant Staphylococcus aureus (MRSA)##3##6##(1996-7#1)(2005-8#1)(2007-7#1)
of methicillin resistant Staphylococcus aureus##6##5##(1996-7#2)(2005-8#1)(2007-7#1)(2007-8#1)(2009-7#1)
of methicillin resistant##7##3##(1996-7#2)(2005-8#1)(2007-7#1)(2007-8#2)(2009-7#1)
of methicillin##8##2##(1996-7#2)(2005-8#2)(2007-7#1)(2007-8#2)(2009-7#1)
of methicillin-resistant Staphylococcus aureus (MRSA)##5##5##(1994-7#1)(2007-12#1)(2007-7#1)(2008-10#1)(2011-2#1)
of methicillin-resistant Staphylococcus aureus in##2##5##(2007-12#1)(2008-10#1)
of methicillin-resistant Staphylococcus aureus##14##4##(1993-5#1)(1994-7#1)(2007-12#5)(2007-7#1)(2008-10#2)(2009-5#1)(2010-6#1)(2011-2#1)(2012-2#1)
of methicillin-resistant##18##2##(1993-5#1)(1994-7#2)(1996-4#1)(2006-12#1)(2007-12#5)(2007-7#1)(2008-10#2)(2008-3#1)(2009-5#1)(2010-6#1)(2011-2#1)(2012-2#1)
of methimazole##3##2##(1997-8#1)(2011-2#1)(2012-12#1)
of methionine metabolism##2##3##(2006-8#1)(2007-11#1)
of methionine##25##2##(1991-10#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-6#1)(1994-11#2)(1994-9#1)(2005-11#2)(2006-8#1)(2007-11#2)(2007-3#1)(2008-10#2)(2008-11#2)(2008-4#1)(2009-10#1)(2010-8#3)(2011-2#1)(2013-1#1)
of methionyl adenylate formation##2##4##(1994-9#2)
of methionyl adenylate##4##3##(1994-9#4)
of methionyl-tRNA synthetase##2##3##(1994-11#1)(1994-9#1)
of method accuracy##2##3##(2008-10#2)
of method and##3##3##(2007-8#1)(2008-10#1)(2008-7#1)
of method of##2##3##(1996-5#1)(2012-3#1)
of method##23##2##(1990-8#2)(1990-9#1)(1994-6#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-5#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-7#1)(2011-1#1)(2012-3#2)
of methodological approaches##2##3##(2006-5#1)(2009-9#1)
of methodological difficulties##2##3##(1992-1#1)(2008-6#1)
of methodological problems##2##3##(1992-11#1)(2008-6#1)
of methodological##13##2##(1992-1#1)(1992-11#1)(1992-3#1)(1995-5#1)(1997-1#1)(2005-5#1)(2006-5#1)(2008-1#1)(2008-6#2)(2009-9#1)(2012-3#2)
of methodologies for##2##3##(2008-10#1)(2013-1#1)
of methodologies to determine##2##4##(2008-10#1)(2013-8#1)
of methodologies to##3##3##(1992-7#1)(2008-10#1)(2013-8#1)
of methodologies##11##2##(1992-7#1)(1992-9#1)(1995-5#1)(2005-8#2)(2008-10#3)(2009-4#1)(2013-1#1)(2013-8#1)
of methodology##12##2##(1990-11#1)(1990-3#1)(1991-12#1)(1994-6#1)(1996-1#1)(1997-1#1)(2005-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-3#1)
of methods and approaches##2##4##(2005-5#1)(2007-5#1)
of methods and##5##3##(1994-6#1)(2005-5#1)(2007-5#1)(2008-10#1)(2013-1#1)
of methods applied##2##3##(2006-6#1)(2009-5#1)
of methods based on##4##4##(2008-7#1)(2010-11#1)(2013-1#2)
of methods exist for##2##4##(2009-7#1)(2010-2#1)
of methods exist##3##3##(2008-4#1)(2009-7#1)(2010-2#1)
of methods for the determination of##2##6##(2008-10#1)(2008-11#1)
of methods for the##5##4##(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-5#1)
of methods for##25##3##(1992-4#1)(1994-6#1)(1995-2#1)(1995-9#1)(1996-2#1)(2005-10#2)(2005-11#1)(2006-10#1)(2007-11#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-4#4)(2008-7#1)(2008-9#1)(2010-5#1)(2012-2#1)(2012-3#1)
of methods from##2##3##(2008-5#1)(2011-1#1)
of methods have been##3##4##(2008-10#1)(2008-4#1)(2009-10#1)
of methods have##4##3##(2008-10#1)(2008-2#1)(2008-4#1)(2009-10#1)
of methods in##2##3##(2006-4#1)(2008-10#1)
of methods is##3##3##(2006-6#1)(2008-10#1)(2013-1#1)
of methods of##7##3##(1990-12#1)(2007-2#1)(2007-7#2)(2008-7#1)(2012-11#1)(2013-1#1)
of methods that##4##3##(2008-4#1)(2008-7#1)(2008-9#1)(2010-1#1)
of methods to investigate##2##4##(2006-12#1)(2010-2#1)
of methods to##16##3##(1993-3#1)(1995-1#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-9#2)(2009-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2012-3#1)(2013-1#4)
of methods used##3##3##(2007-11#1)(2008-1#1)(2008-5#1)
of methods##109##2##(1990-12#1)(1992-4#1)(1993-3#1)(1994-6#2)(1995-1#2)(1995-2#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-6#1)(2005-10#3)(2005-11#1)(2005-5#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#5)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#9)(2008-5#3)(2008-7#5)(2008-9#6)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-12#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#9)
of methotrexate (MTX) in##2##4##(1990-8#1)(1995-7#1)
of methotrexate (MTX)##4##3##(1990-8#1)(1992-8#1)(1994-11#1)(1995-7#1)
of methotrexate (Mtx)##3##3##(2008-10#2)(2011-2#1)
of methotrexate and##4##3##(1990-12#1)(1993-12#1)(1995-8#1)(2010-3#1)
of methotrexate in rheumatoid##3##4##(1993-11#1)(1997-1#2)
of methotrexate in##7##3##(1990-8#1)(1992-12#1)(1993-11#1)(1997-1#2)(2006-10#2)
of methotrexate##38##2##(1990-12#1)(1990-3#1)(1990-8#2)(1991-2#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-11#1)(1995-4#1)(1995-7#1)(1995-8#3)(1997-1#2)(2005-8#1)(2006-10#4)(2007-10#1)(2007-11#2)(2008-10#4)(2008-11#4)(2010-3#2)(2011-2#1)(2012-2#1)
of methoxy##2##2##(2008-10#1)(2008-11#1)
of methyl 3-O-beta-D-glucopyranosyl-beta-D-glucopyranoside (methyl beta-D-laminarabioside)##2##5##(1992-12#2)
of methyl 4##3##3##(1991-7#1)(1996-5#1)(2007-11#1)
of methyl acrylate##2##3##(2008-10#1)(2010-8#1)
of methyl and##2##3##(2007-8#1)(2013-1#1)
of methyl bromide in##2##4##(2006-3#1)(2008-10#1)
of methyl bromide##4##3##(2006-3#1)(2008-10#3)
of methyl coenzyme M reductase##2##5##(1997-6#2)
of methyl ester##3##3##(2007-10#1)(2008-10#2)
of methyl esters##3##3##(2008-10#1)(2008-6#1)(2009-8#1)
of methyl group##2##3##(2007-11#1)(2008-3#1)
of methyl linoleate in micelles##2##5##(1995-2#2)
of methyl methacrylate (MMA)##3##4##(2005-12#1)(2008-1#1)(2010-4#1)
of methyl methacrylate##5##3##(2005-12#1)(2008-1#1)(2008-3#2)(2010-4#1)
of methyl orange##4##3##(2008-10#3)(2009-11#1)
of methyl parathion##2##3##(1994-5#1)(2005-11#1)
of methyl prednisolone acetate##3##4##(2010-2#3)
of methyl prednisolone##4##3##(2010-2#3)(2010-4#1)
of methyl red##2##3##(2010-5#2)
of methyl tert-butyl ether##2##4##(2008-12#2)
of methyl yellow##2##3##(2008-10#2)
of methyl##77##2##(1990-10#1)(1991-7#1)(1991-9#1)(1992-12#4)(1992-3#2)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#2)(1995-4#1)(1996-4#1)(1996-5#3)(1996-9#1)(1997-3#1)(1997-6#3)(2005-10#1)(2005-11#1)(2005-12#1)(2006-12#1)(2006-3#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#18)(2008-11#1)(2008-12#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-8#1)(2010-2#3)(2010-4#2)(2010-5#2)(2010-8#1)(2012-2#1)(2013-1#1)
of methyl-β-cyclodextrin##4##2##(2011-2#4)
of methylamine##4##2##(1990-2#1)(2008-10#2)(2008-11#1)
of methylamphetamine and related compounds##2##5##(2008-10#2)
of methylamphetamine##3##2##(2008-10#3)
of methylated##12##2##(1991-8#1)(1992-11#1)(1992-7#1)(1995-5#1)(1996-2#1)(2007-8#4)(2009-12#1)(2010-10#1)(2010-11#1)
of methylation analysis##2##3##(1991-12#1)(1992-12#1)
of methylation in the##2##4##(1992-9#1)(2010-12#1)
of methylation in##4##3##(1990-12#1)(1992-9#1)(1997-4#1)(2010-12#1)
of methylation of the##2##4##(1997-4#1)(2013-8#1)
of methylation of##6##3##(1990-9#1)(1997-4#1)(2006-12#1)(2008-7#2)(2013-8#1)
of methylation on the##2##4##(1991-2#1)(1994-5#1)
of methylation##31##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-10#2)(1991-12#1)(1991-2#1)(1992-12#1)(1992-9#1)(1994-5#1)(1995-10#1)(1997-4#4)(2006-12#2)(2007-11#2)(2008-10#1)(2008-4#2)(2008-7#2)(2009-12#1)(2010-12#2)(2010-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
of methylcobalamin##2##2##(2006-12#1)(2010-1#1)
of methylcoenzyme M##3##3##(1991-1#3)
of methylcytosine##2##2##(1992-8#1)(2009-3#1)
of methyldopa and dopamine##3##4##(2008-10#3)
of methyldopa##5##2##(2008-10#5)
of methylene blue (MB) with##2##5##(2008-10#2)
of methylene blue (MB)##8##4##(2008-10#8)
of methylene blue and##2##4##(2008-10#2)
of methylene blue on##2##4##(2005-12#1)(2009-6#1)
of methylene blue##21##3##(2005-12#1)(2007-7#1)(2008-10#12)(2008-3#1)(2008-4#1)(2008-9#1)(2009-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
of methylene chloride##2##3##(2008-10#1)(2008-2#1)
of methylene groups##3##3##(2005-11#2)(2008-10#1)
of methylene##28##2##(2005-11#2)(2005-12#2)(2007-7#1)(2008-10#15)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
of methylenebis(phosphonate)##2##2##(2008-4#2)
of methylenedioxymethamphetamine##2##2##(1990-5#2)
of methylenetetrahydrofolate##2##2##(1995-7#1)(2012-3#1)
of methylglyoxal##5##2##(2006-5#2)(2008-11#3)
of methylhydrazine##2##2##(1996-5#1)(2011-1#1)
of methylmercury and inorganic mercury##2##5##(2008-10#2)
of methylmercury##7##2##(1990-2#1)(2008-10#5)(2010-5#1)
of methylphenidate have##2##3##(1995-11#1)(2006-12#1)
of methylphenidate hydrochloride##2##3##(1995-11#2)
of methylphenidate##14##2##(1995-11#4)(1997-8#2)(2006-12#3)(2008-9#2)(2010-9#1)(2012-2#2)
of methylprednisolone##4##2##(1991-7#1)(1996-11#1)(2007-7#1)(2008-12#1)
of methylxanthine-containing beverages##2##3##(1990-6#2)
of methylxanthines##2##2##(1991-12#1)(1991-5#1)
of meticulous##2##2##(1992-11#1)(2013-8#1)
of metmyoglobin##2##2##(1991-9#1)(2006-1#1)
of metoclopramide on##2##3##(1990-9#2)
of metoclopramide##18##2##(1990-9#2)(2008-10#12)(2008-7#1)(2012-12#3)
of metoprolol##3##2##(1997-7#1)(2006-6#1)(2008-10#1)
of metrifonate##7##2##(1993-2#1)(1996-12#3)(2008-10#3)
of metrology##2##2##(2008-3#1)(2013-8#1)
of metronidazole and##3##3##(1997-4#1)(2006-8#1)(2007-11#1)
of metronidazole in##2##3##(2008-10#1)(2011-2#1)
of metronidazole##18##2##(1997-4#2)(1997-7#1)(2006-8#1)(2007-11#1)(2008-10#9)(2011-2#4)
of metropolitan##2##2##(1994-3#1)(2011-2#1)
of mevalonate metabolism##3##3##(1991-1#3)
of mevalonate##6##2##(1991-1#3)(1994-3#1)(1995-12#1)(2005-3#1)
of mgn2a##2##2##(1992-10#2)
of miR-122##3##2##(2006-12#3)
of miR-143 in lung cancer##2##5##(2013-8#2)
of miR-143##3##2##(2013-8#3)
of miR-218##2##2##(2011-2#2)
of miR-541 in##2##3##(2013-1#2)
of miR-541##3##2##(2013-1#3)
of miR399s##2##2##(2009-8#2)
of miRNA in##2##3##(2008-11#1)(2013-1#1)
of miRNA##8##2##(2008-11#1)(2010-11#1)(2010-5#1)(2011-2#3)(2012-12#1)(2013-1#1)
of miRNAs in##5##3##(2008-1#1)(2010-11#1)(2011-2#1)(2012-2#2)
of miRNAs is a##2##4##(2012-2#1)(2013-1#1)
of miRNAs to##2##3##(2009-8#2)
of miRNAs##25##2##(2007-12#2)(2008-1#1)(2008-11#3)(2008-7#1)(2009-5#1)(2009-8#2)(2010-11#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#5)(2013-1#1)(2013-8#2)
of mianserin##3##2##(1991-5#1)(2008-6#2)
of mice after##3##3##(1990-12#1)(2006-8#1)(2010-12#1)
of mice and guinea pigs##2##5##(1995-12#1)(2008-4#1)
of mice and rats##5##4##(1990-8#1)(1993-3#1)(1996-9#1)(2008-10#1)(2008-5#1)
of mice and##15##3##(1990-7#1)(1990-8#1)(1991-12#1)(1992-1#1)(1992-7#1)(1993-3#1)(1995-1#1)(1995-12#1)(1996-9#1)(2007-3#1)(2008-10#1)(2008-4#2)(2008-5#1)(2010-11#1)
of mice at##4##3##(1995-12#1)(1996-2#1)(1996-6#1)(2010-12#1)
of mice bearing##6##3##(1992-3#2)(1992-5#1)(1992-9#1)(1996-3#1)(2012-2#1)
of mice carrying##3##3##(1990-5#1)(2009-9#1)(2011-1#1)
of mice euthanized by##2##4##(2012-2#2)
of mice exposed to##2##4##(1994-6#1)(2008-9#1)
of mice fed##5##3##(1994-11#1)(2006-10#1)(2006-2#1)(2006-8#2)
of mice for##2##3##(2008-7#1)(2013-8#1)
of mice given##2##3##(1994-6#1)(1997-8#1)
of mice has##2##3##(1995-11#1)(1996-6#1)
of mice in##2##3##(1995-5#1)(2008-11#1)
of mice infected with##2##4##(2006-8#1)(2010-12#1)
of mice intoxicated with bromobenzene##2##5##(1992-3#2)
of mice on##2##3##(1997-6#1)(2008-12#1)
of mice that##6##3##(1993-12#1)(1994-5#1)(2008-4#1)(2008-8#1)(2011-1#1)(2011-2#1)
of mice to##6##3##(1997-3#1)(2006-10#1)(2008-4#1)(2008-8#3)
of mice treated with##2##4##(1996-12#1)(2013-8#1)
of mice treated##3##3##(1995-2#1)(1996-12#1)(2013-8#1)
of mice was significantly##2##4##(1993-3#1)(1996-3#1)
of mice was##7##3##(1990-12#1)(1992-8#1)(1993-3#1)(1996-3#1)(1996-9#1)(2008-5#1)(2008-9#1)
of mice were##8##3##(1991-12#1)(1992-1#1)(1994-3#1)(2007-2#1)(2008-10#1)(2008-9#2)(2012-2#1)
of mice with a##3##4##(1994-8#1)(1995-12#1)(2011-2#1)
of mice with recombinant mouse##2##5##(1995-1#2)
of mice with the##4##4##(1991-7#2)(1993-9#1)(1995-1#1)
of mice with##41##3##(1990-2#1)(1991-5#1)(1991-7#2)(1992-7#3)(1992-8#1)(1993-9#1)(1994-8#1)(1995-1#3)(1995-12#1)(1995-2#1)(1995-5#1)(1996-10#2)(1996-4#1)(1996-6#1)(1997-3#1)(2005-11#1)(2007-12#1)(2008-12#1)(2008-4#3)(2008-7#2)(2008-9#1)(2009-6#2)(2010-10#1)(2010-12#2)(2011-1#1)(2011-2#2)(2011-3#1)(2013-1#2)
of mice##219##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#3)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-10#2)(1991-11#2)(1991-12#6)(1991-5#1)(1991-7#2)(1991-9#1)(1992-1#3)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#2)(1992-7#4)(1992-8#2)(1992-9#1)(1993-12#2)(1993-3#2)(1993-5#3)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#3)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#4)(1995-11#1)(1995-12#4)(1995-2#4)(1995-3#1)(1995-5#2)(1996-10#3)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#3)(1996-9#2)(1997-2#5)(1997-3#2)(1997-4#2)(1997-6#1)(1997-8#3)(2005-11#1)(2005-7#2)(2006-10#2)(2006-11#1)(2006-2#2)(2006-8#4)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#6)(2008-11#5)(2008-12#4)(2008-4#14)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#7)(2009-10#1)(2009-2#2)(2009-5#1)(2009-6#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#5)(2010-5#1)(2011-1#4)(2011-2#3)(2011-3#1)(2012-2#6)(2012-3#1)(2013-1#5)(2013-8#4)
of micellar electrokinetic chromatography (MEKC)##2##5##(1994-9#1)(1997-8#1)
of micellar shape on##4##4##(2012-11#4)
of micellar shape##6##3##(2012-11#6)
of micellar##15##2##(1994-9#1)(1997-8#1)(2005-11#2)(2008-10#5)(2012-11#6)
of micelle##2##2##(1993-11#1)(2005-11#1)
of micelles of##3##3##(1990-5#1)(1994-9#1)(2005-11#1)
of micelles##8##2##(1990-5#1)(1994-9#1)(1997-4#1)(2005-11#4)(2009-7#1)
of micellization##13##2##(2005-11#13)
of miconazole nitrate##2##3##(2010-5#2)
of miconazole##6##2##(1997-2#1)(2006-10#1)(2010-5#4)
of micro carcinomas##3##3##(2013-8#3)
of micro total analysis##2##4##(2007-8#1)(2008-10#1)
of micro##14##2##(2005-4#1)(2007-8#1)(2008-10#5)(2008-4#1)(2012-3#1)(2013-1#2)(2013-8#3)
of micro- and##5##3##(2006-2#2)(2007-12#1)(2008-4#1)(2008-7#1)
of micro-optical elements##2##3##(2008-3#2)
of micro-optical objects##2##3##(2008-3#2)
of micro-optical##5##2##(2008-3#5)
of micro-optics##3##2##(2008-3#3)
of micro-organisms##6##2##(2005-11#2)(2006-8#2)(2008-2#1)(2008-3#1)
of microRNA expression##2##3##(2010-4#2)
of microRNA##6##2##(2009-3#1)(2010-4#3)(2010-5#1)(2010-7#1)
of microRNA-218##2##2##(2011-2#2)
of microRNAs (miRNAs)##2##3##(2008-10#1)(2011-2#1)
of microRNAs in##2##3##(2007-10#1)(2012-11#1)
of microRNAs##7##2##(2007-10#1)(2008-10#1)(2010-3#1)(2010-7#2)(2011-2#1)(2012-11#1)
of microalbuminuria and##2##3##(1995-10#1)(2010-4#1)
of microalbuminuria in patients with##2##5##(1992-10#1)(2007-12#1)
of microalbuminuria in##4##3##(1991-6#1)(1992-10#1)(2007-12#1)(2010-4#1)
of microalbuminuria is##2##3##(2005-12#1)(2010-4#1)
of microalbuminuria with##4##3##(2010-4#4)
of microalbuminuria##17##2##(1991-6#1)(1992-10#1)(1995-10#1)(2005-12#1)(2007-11#1)(2007-12#1)(2010-4#11)
of microangiopathic##2##2##(1996-11#1)(2006-1#1)
of microarray analysis##2##3##(2008-11#1)(2009-10#1)
of microarray data##12##3##(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#6)(2010-3#1)(2012-12#1)
of microarray experiments##6##3##(2006-12#1)(2008-2#1)(2008-4#1)(2008-7#2)(2009-10#1)
of microarray gene expression data##2##5##(2008-7#1)(2012-3#1)
of microarray image analysis##2##4##(2006-10#2)
of microarray technology##4##3##(2006-10#1)(2008-7#2)(2012-12#1)
of microarray##39##2##(2006-10#4)(2006-12#1)(2006-5#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-4#3)(2008-7#15)(2009-10#3)(2010-1#1)(2010-12#1)(2010-3#1)(2012-12#2)(2012-3#1)
of microarrays as##2##3##(2008-7#2)
of microarrays for##3##3##(2007-12#1)(2008-7#1)(2010-4#1)
of microarrays##14##2##(2006-5#1)(2007-12#1)(2008-10#3)(2008-7#8)(2010-4#1)
of microbes that##3##3##(2007-12#1)(2008-4#1)(2011-1#1)
of microbes##19##2##(2006-10#2)(2007-12#2)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#2)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)
of microbial activity##2##3##(2008-10#2)
of microbial biofilms##3##3##(2008-9#1)(2011-1#2)
of microbial communities##6##3##(2008-10#3)(2011-2#1)(2012-12#1)(2012-3#1)
of microbial community##2##3##(2007-12#1)(2008-10#1)
of microbial contamination of##2##4##(2012-2#1)(2013-8#1)
of microbial contamination##5##3##(1997-4#2)(2008-5#1)(2012-2#1)(2013-8#1)
of microbial degradation of##2##4##(2006-3#1)(2006-8#1)
of microbial extracellular glycolipids##2##4##(2008-11#2)
of microbial flora##2##3##(2008-10#1)(2008-5#1)
of microbial growth##2##3##(2011-2#1)(2013-1#1)
of microbial invasion##2##3##(1993-2#1)(2008-5#1)
of microbial pathogens##8##3##(1995-1#1)(2007-12#1)(2008-10#2)(2008-4#2)(2010-4#1)(2011-1#1)
of microbial polyester##2##3##(2008-5#2)
of microbial populations in##2##4##(2008-11#1)(2008-8#1)
of microbial resistance##2##3##(2008-5#1)(2012-12#1)
of microbial viability##3##3##(2008-9#2)(2013-8#1)
of microbial##98##2##(1990-9#1)(1992-11#1)(1992-5#1)(1993-2#1)(1995-1#1)(1996-5#1)(1997-4#4)(1997-8#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-6#1)(2008-10#12)(2008-11#8)(2008-4#3)(2008-5#6)(2008-7#1)(2008-8#1)(2008-9#5)(2009-11#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#1)(2011-1#6)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#2)
of microbially##2##2##(2008-10#2)
of microbiological##5##2##(1994-3#1)(2007-7#1)(2008-5#1)(2008-7#2)
of microbiology and##4##3##(1992-12#1)(2007-12#1)(2008-10#2)
of microbiology##11##2##(1992-12#1)(2005-11#1)(2007-12#2)(2008-10#2)(2008-9#2)(2010-12#1)(2011-11#1)(2013-1#1)
of microbodies##3##2##(2008-10#3)
of microbubbles##2##2##(2008-8#1)(2013-1#1)
of microcapsule##2##2##(2008-11#2)
of microcapsules##2##2##(2008-5#2)
of microcarrier cultures##2##3##(1994-11#1)(2008-11#1)
of microcarrier##5##2##(1994-11#1)(2008-11#3)(2012-3#1)
of microcarriers##2##2##(1994-11#1)(2008-11#1)
of microcavities##2##2##(2007-11#1)(2007-12#1)
of microcephaly##2##2##(1997-3#2)
of microchannel formation##2##3##(2008-3#2)
of microchannel structure##2##3##(2008-10#2)
of microchannel##8##2##(2008-10#3)(2008-2#2)(2008-3#3)
of microchip CE##2##3##(2008-10#2)
of microchip##4##2##(2008-10#3)(2013-8#1)
of microcirculation and##2##3##(2008-5#1)(2010-1#1)
of microcirculation##3##2##(2006-8#1)(2008-5#1)(2010-1#1)
of microcirculatory##3##2##(1997-2#1)(2008-1#1)(2009-10#1)
of microcracks##3##2##(2008-7#1)(2009-7#2)
of microcrystalline cellulose##3##3##(2008-6#1)(2010-2#1)(2013-1#1)
of microcrystalline##6##2##(2008-2#1)(2008-6#1)(2009-2#1)(2010-2#1)(2011-2#1)(2013-1#1)
of microcrystals in##2##3##(1994-2#1)(2006-10#1)
of microcrystals##5##2##(1994-2#2)(2006-10#1)(2008-10#2)
of microcystin-LR in surface water##2##5##(2008-10#2)
of microcystin-LR##3##2##(2008-10#2)(2012-2#1)
of microcystins##7##2##(2007-8#1)(2008-10#5)(2010-5#1)
of microdamage##3##2##(2006-5#1)(2008-6#2)
of microdialysis##11##2##(1991-5#1)(1996-12#1)(2007-8#1)(2007-9#3)(2008-10#1)(2008-8#4)
of microdroplets##3##2##(2008-2#3)
of microelectromechanical##2##2##(2007-12#1)(2008-3#1)
of microelements##2##2##(2008-10#2)
of microemulsions##2##2##(2008-10#1)(2012-2#1)
of microencapsulated##5##2##(2005-7#1)(2007-8#1)(2010-5#1)(2010-7#1)(2011-2#1)
of microfabrication##2##2##(1991-11#1)(2010-9#1)
of microfibrillar-associated protein 4##2##4##(2012-2#2)
of microfibrils##2##2##(2008-5#1)(2012-2#1)
of microfilament##2##2##(1993-8#1)(2009-10#1)
of microfilaments in##2##3##(1990-8#2)
of microfilaments##3##2##(1990-8#2)(1994-8#1)
of microfluidic devices##4##3##(2005-11#1)(2008-10#1)(2008-11#1)(2011-2#1)
of microfluidic##12##2##(2005-11#1)(2008-10#5)(2008-11#2)(2008-3#2)(2011-2#2)
of microfluidics##2##2##(2008-10#1)(2008-11#1)
of microglandular##2##2##(2006-10#1)(2011-2#1)
of microglia and##3##3##(1994-12#1)(2007-1#1)(2007-11#1)
of microglia in denervated neuropil##3##5##(1997-3#3)
of microglia in##7##3##(1997-3#3)(2008-6#1)(2008-7#2)(2012-12#1)
of microglia were##2##3##(1993-4#1)(1995-6#1)
of microglia##23##2##(1993-4#1)(1994-12#1)(1995-3#1)(1995-6#1)(1997-3#3)(2007-1#1)(2007-11#4)(2007-12#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2012-12#5)
of microglial activation##4##3##(1996-12#1)(2007-11#1)(2008-7#1)(2008-8#1)
of microglial cells##2##3##(1995-6#1)(2008-4#1)
of microglial function##2##3##(2008-4#1)(2008-7#1)
of microglial##14##2##(1995-3#1)(1995-6#1)(1996-12#1)(2007-11#1)(2008-4#6)(2008-5#1)(2008-7#2)(2008-8#1)
of microgratings##2##2##(2007-11#1)(2007-12#1)
of microgravity on##2##3##(2008-4#1)(2008-8#1)
of microhematuria##3##2##(1997-7#1)(2007-2#2)
of microinjected##2##2##(1990-5#1)(1994-12#1)
of microinvasive disease and##2##4##(2004-10#2)
of microlenses with##2##3##(2007-12#1)(2008-3#1)
of microlenses##6##2##(2007-12#1)(2008-2#1)(2008-3#4)
of micromachined##2##2##(2007-11#1)(2008-3#1)
of micromechanical tunneling##2##3##(2008-3#2)
of micromechanical##3##2##(2008-3#3)
of micrometer-sized polymer##2##3##(2008-10#1)(2008-3#1)
of micrometer-sized##4##2##(2007-11#1)(2008-10#1)(2008-3#1)(2010-11#1)
of micrometers##10##2##(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#3)
of micromolar amounts of##2##4##(1992-2#1)(1995-1#1)
of micromolar concentrations of##2##4##(1996-12#1)(2008-11#1)
of micromolar##7##2##(1991-1#1)(1992-2#1)(1995-1#1)(1996-12#1)(2006-1#1)(2008-10#1)(2008-11#1)
of micron sized##2##3##(2008-10#2)
of micron##4##2##(1995-10#1)(2008-10#3)
of microneedles by##2##3##(2011-1#2)
of microneedles##3##2##(2009-11#1)(2011-1#2)
of micronized##2##2##(1994-2#1)(2008-5#1)
of micronucleated erythrocytes in male and female##2##7##(2008-9#2)
of micronucleated erythrocytes in##4##4##(2008-8#1)(2008-9#3)
of micronucleated erythrocytes##10##3##(2008-8#1)(2008-9#9)
of micronucleated##13##2##(1996-12#1)(2008-10#1)(2008-8#1)(2008-9#10)
of micronuclei##4##2##(1993-8#1)(1996-2#1)(2007-11#1)(2008-9#1)
of micronutrient adequacy##2##3##(2008-12#2)
of micronutrient deficiencies##2##3##(2005-10#1)(2006-10#1)
of micronutrient supplements##2##3##(2006-10#2)
of micronutrient##13##2##(1995-7#1)(2005-10#3)(2006-10#5)(2008-1#1)(2008-12#2)(2008-5#1)
of micronutrients in##2##3##(2008-10#1)(2013-8#1)
of micronutrients##8##2##(2008-10#2)(2010-6#1)(2011-2#1)(2012-12#1)(2013-8#3)
of microorganism##3##2##(2006-6#1)(2008-10#1)(2010-8#1)
of microorganisms and the##2##4##(2008-11#1)(2011-2#1)
of microorganisms and##4##3##(2005-11#1)(2008-11#1)(2011-2#1)(2013-1#1)
of microorganisms at##2##3##(2008-5#1)(2012-3#1)
of microorganisms have been##2##4##(1997-7#1)(2011-1#1)
of microorganisms in##7##3##(2008-11#1)(2008-6#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)
of microorganisms to##2##3##(2008-7#1)(2012-1#1)
of microorganisms under##2##3##(2008-7#1)(2013-8#1)
of microorganisms were isolated from the##2##6##(2007-7#1)(2008-5#1)
of microorganisms were##4##3##(2007-7#1)(2008-2#1)(2008-5#2)
of microorganisms##76##2##(1990-3#1)(1991-3#1)(1991-9#1)(1994-11#1)(1994-2#1)(1996-12#1)(1997-7#1)(2005-11#3)(2005-12#1)(2006-10#2)(2006-2#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-6#2)(2007-7#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#12)(2008-6#1)(2008-7#2)(2008-9#2)(2009-2#1)(2010-4#1)(2010-9#1)(2011-1#4)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#2)
of microporous##3##2##(2005-11#2)(2006-4#1)
of microprism-type##3##2##(2008-2#2)(2008-3#1)
of microprisms##2##2##(2008-3#2)
of micropropagated cranberry plants##2##4##(2008-10#2)
of micropropagated##4##2##(2008-10#3)(2009-8#1)
of microroughness##2##2##(2008-1#1)(2008-3#1)
of microsatellite markers in##4##4##(1994-6#1)(2006-2#1)(2006-5#1)(2008-5#1)
of microsatellite markers##6##3##(1994-6#1)(2006-2#1)(2006-5#1)(2008-10#1)(2008-5#2)
of microsatellite primers##2##3##(2008-10#1)(2008-5#1)
of microsatellite##15##2##(1994-6#1)(1996-11#1)(1997-1#1)(2006-2#1)(2006-5#1)(2008-10#2)(2008-5#3)(2008-7#1)(2008-9#1)(2010-7#1)(2010-8#1)(2013-8#1)
of microsatellites##8##2##(1994-11#1)(1994-3#1)(1996-12#1)(1997-6#1)(2008-10#2)(2010-7#1)(2012-3#1)
of microscale##6##2##(2006-12#1)(2008-2#1)(2008-3#1)(2010-2#1)(2012-11#1)(2013-1#1)
of microsclerotia of V##2##4##(2008-10#2)
of microsclerotia was##2##3##(2008-10#2)
of microsclerotia##12##2##(2008-10#12)
of microscope##3##2##(2007-12#1)(2011-2#2)
of microscopic haematuria##2##3##(1991-3#2)
of microscopic objects##3##3##(2008-3#3)
of microscopic##23##2##(1991-3#2)(1992-5#1)(2005-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#5)(2008-5#2)(2008-8#1)(2010-7#1)(2011-2#1)(2012-2#2)
of microscopists##2##2##(2011-2#1)(2012-12#1)
of microscopy##8##2##(2007-8#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-9#1)(2011-2#1)
of microseconds##3##2##(1995-1#1)(2007-12#1)(2008-2#1)
of microsomal cytochrome P450##2##4##(1994-9#1)(1995-10#1)
of microsomal cytochrome##5##3##(1990-8#2)(1991-11#1)(1994-9#1)(1995-10#1)
of microsomal glutathione##2##3##(1994-9#1)(1995-7#1)
of microsomal membranes##3##3##(1994-3#1)(1994-8#1)(1995-8#1)
of microsomal##30##2##(1990-8#2)(1991-11#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#3)(1995-10#2)(1995-3#2)(1995-6#1)(1995-7#2)(1995-8#1)(1996-3#1)(1997-7#1)(2008-4#1)(2012-2#1)
of microsomes from##2##3##(1992-9#1)(1995-10#1)
of microsomes were##2##3##(1993-3#1)(1994-8#1)
of microsomes with##5##3##(1990-7#1)(1991-7#1)(1993-8#1)(1994-2#1)(1994-6#1)
of microsomes##13##2##(1990-7#1)(1991-7#1)(1992-9#2)(1993-3#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-3#1)(1995-6#1)(1996-2#1)
of microspheres and##2##3##(2007-12#1)(2011-2#1)
of microspheres was##2##3##(2010-5#1)(2013-1#1)
of microspheres##10##2##(2007-11#2)(2007-12#2)(2008-10#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
of microsporidia##2##2##(2007-7#1)(2009-5#1)
of microstructural##2##2##(1996-9#1)(2009-7#1)
of microstructure##4##2##(2007-12#2)(2008-3#1)(2013-1#1)
of microstructured##3##2##(2006-2#2)(2007-11#1)
of microstructures##4##2##(1994-2#1)(2004-9#1)(2008-3#2)
of microsurgery##4##2##(1995-7#1)(2009-5#1)(2011-2#2)
of microsurgical##3##2##(2006-3#1)(2009-5#1)(2011-2#1)
of microteaching##5##2##(2008-11#5)
of microtiter##3##2##(1992-7#1)(1994-9#1)(2008-4#1)
of microtitre wells##2##3##(1994-9#2)
of microtitre##3##2##(1994-9#3)
of microtubular##2##2##(1991-5#1)(2012-2#1)
of microtubule assembly##3##3##(1991-5#1)(1994-12#1)(2008-11#1)
of microtubule bundles##2##3##(2007-10#2)
of microtubule dynamic instability##2##4##(1995-1#2)
of microtubule dynamics##2##3##(1995-1#1)(2008-7#1)
of microtubule##18##2##(1991-5#2)(1994-12#1)(1995-1#4)(2006-12#1)(2007-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2009-10#2)(2009-8#1)(2012-2#1)
of microtubule-associated protein 2##2##4##(1994-12#1)(1995-7#1)
of microtubule-associated protein##3##3##(1994-12#1)(1995-7#1)(1995-8#1)
of microtubule-associated proteins##3##3##(1991-4#1)(1993-8#1)(2011-1#1)
of microtubule-associated##7##2##(1991-4#1)(1993-8#1)(1994-12#1)(1995-7#1)(1995-8#1)(2009-10#1)(2011-1#1)
of microtubules and##2##3##(1992-8#1)(2008-1#1)
of microtubules by##2##3##(1994-11#1)(1994-8#1)
of microtubules in the##3##4##(2008-1#1)(2008-10#1)(2008-7#1)
of microtubules in##5##3##(1995-1#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)
of microtubules is##2##3##(1994-8#1)(1995-1#1)
of microtubules with##2##3##(1991-9#1)(1995-2#1)
of microtubules##39##2##(1990-8#1)(1991-4#1)(1991-9#1)(1992-8#2)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#3)(1995-1#2)(1995-2#1)(1997-4#2)(2003-11#1)(2004-12#2)(2006-10#4)(2007-12#4)(2008-1#2)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-7#1)(2012-2#1)
of microvascular complications##3##3##(2005-10#1)(2007-8#1)(2011-1#1)
of microvascular decompression##3##3##(2011-1#1)(2012-3#1)(2013-1#1)
of microvascular disease##3##3##(2007-10#1)(2008-1#1)(2009-11#1)
of microvascular##14##2##(2004-9#1)(2005-10#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-9#1)(2009-10#1)(2009-11#1)(2011-1#2)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
of microvesicles##2##2##(1997-3#1)(2008-4#1)
of microvessels##4##2##(1994-12#1)(1994-8#1)(2005-8#1)(2011-1#1)
of microvilli##6##2##(2007-6#1)(2008-12#2)(2008-6#1)(2009-10#1)(2009-8#1)
of microwave and##2##3##(2006-6#1)(2007-8#1)
of microwave digestion##4##3##(2008-10#4)
of microwave energy##2##3##(2008-10#2)
of microwave irradiation##3##3##(2007-10#1)(2007-11#1)(2010-12#1)
of microwave radiation##2##3##(2007-12#1)(2008-10#1)
of microwave##29##2##(1994-10#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-8#1)(2008-10#10)(2008-12#2)(2008-3#1)(2008-7#1)(2009-12#1)(2010-12#1)(2013-8#1)
of microwave-accelerated##2##2##(2007-11#1)(2009-12#1)
of microwave-assisted extraction##5##3##(2007-8#1)(2008-10#4)
of microwave-assisted##6##2##(2007-8#1)(2008-10#5)
of microwaves##4##2##(1996-7#1)(2008-10#3)
of mid molecule parathyroid hormone##2##5##(1991-3#2)
of mid##4##2##(1991-3#2)(2008-5#1)(2011-2#1)
of mid-IR##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
of mid-infrared molecular spectroscopy##2##4##(2010-12#2)
of mid-infrared##9##2##(2007-11#1)(2007-12#5)(2008-3#1)(2010-12#2)
of midazolam and##6##3##(1996-6#1)(2006-4#1)(2012-12#1)(2012-2#2)(2013-7#1)
of midazolam in##3##3##(1996-8#2)(1997-2#1)
of midazolam##19##2##(1990-8#1)(1994-2#1)(1996-6#2)(1996-8#2)(1997-2#4)(1997-7#2)(2006-4#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-7#1)
of midbrain##5##2##(1995-12#1)(1997-1#1)(2006-7#1)(2007-10#1)(2009-2#1)
of midcarpal##2##2##(2008-9#1)(2012-2#1)
of middle age##3##3##(2008-4#1)(2011-2#2)
of middle cerebral artery##3##4##(1997-8#1)(2006-4#1)(2007-10#1)
of middle cerebral##5##3##(1997-8#1)(2006-4#1)(2007-10#1)(2007-9#1)(2012-3#1)
of middle ear effusion and serum##2##6##(2008-10#2)
of middle ear##5##3##(1993-8#1)(2008-10#2)(2012-12#1)(2013-1#1)
of middle phalangeal##2##3##(2006-3#1)(2009-5#1)
of middle##25##2##(1993-8#1)(1994-1#2)(1995-2#1)(1995-6#1)(1997-8#1)(2005-9#1)(2006-3#1)(2006-4#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#2)(2008-4#1)(2009-5#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#1)
of middle-aged and elderly##3##4##(2005-3#1)(2011-12#2)
of middle-aged##7##2##(1990-2#1)(2005-3#1)(2006-7#1)(2008-7#2)(2011-12#2)
of midecamycin producing strain##2##4##(2008-8#2)
of midface##2##2##(2007-12#1)(2012-12#1)
of midfacial##2##2##(2007-12#1)(2011-2#1)
of midgut##6##2##(2007-12#1)(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#2)
of midlife##2##2##(2006-7#1)(2007-9#1)
of midline brain##2##3##(1996-12#1)(2011-2#1)
of midline neuropils in##2##4##(2007-12#2)
of midline shift##2##3##(2007-12#1)(2008-7#1)
of midline##8##2##(1996-12#1)(2007-12#3)(2008-7#2)(2011-2#1)(2012-12#1)
of midsagittal##2##2##(1995-5#2)
of midwifery##6##2##(1996-12#1)(2008-12#1)(2012-1#1)(2013-1#3)
of midwives and##2##3##(2009-10#1)(2010-12#1)
of midwives reporting##2##3##(2007-7#2)
of midwives##9##2##(1990-6#1)(2006-9#1)(2007-7#2)(2008-12#1)(2009-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
of mifepristone##3##2##(1993-8#1)(1996-12#1)(2013-1#1)
of mighty morphing##2##3##(2007-12#2)
of migraine and the##2##4##(2008-5#1)(2009-9#1)
of migraine and##5##3##(1996-1#1)(2008-3#1)(2008-5#1)(2009-9#1)(2011-1#1)
of migraine are##3##3##(2007-10#1)(2008-9#1)(2012-2#1)
of migraine attacks##7##3##(2004-12#2)(2007-10#1)(2008-9#2)(2013-1#2)
of migraine aura##2##3##(2004-12#2)
of migraine in##2##3##(1994-11#1)(2004-12#1)
of migraine is##4##3##(2007-2#1)(2008-9#1)(2012-2#2)
of migraine pathophysiology##2##3##(2008-9#2)
of migraine patients##3##3##(2009-9#2)(2013-1#1)
of migraine with##2##3##(2004-12#1)(2008-6#1)
of migraine##68##2##(1990-7#2)(1992-10#2)(1994-11#1)(1996-1#1)(1996-9#1)(2004-12#10)(2005-7#2)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-9#13)(2009-9#8)(2010-2#5)(2011-1#2)(2012-2#6)(2013-1#3)
of migraine-associated vertigo##2##3##(2011-1#2)
of migraine]##2##2##(1993-4#1)(1994-4#1)
of migraineurs##3##2##(1996-3#2)(2010-9#1)
of migrant farmworkers##2##3##(2007-1#1)(2008-12#1)
of migrant##6##2##(1997-8#1)(2006-5#1)(2007-1#1)(2008-12#1)(2008-8#1)(2012-2#1)
of migrants##12##2##(1992-8#1)(1997-4#1)(1997-8#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-8#1)(2010-5#1)(2010-8#1)(2013-1#2)
of migrated##3##2##(2008-3#1)(2008-7#1)(2012-12#1)
of migrating cells##2##3##(2008-11#2)
of migrating##6##2##(2008-11#2)(2008-8#1)(2010-6#1)(2011-1#1)(2012-3#1)
of migration and##3##3##(2006-6#1)(2010-8#2)
of migration in##5##3##(1991-8#1)(1992-6#1)(2007-9#1)(2008-9#1)(2010-2#1)
of migration of##7##3##(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2013-1#2)
of migration on##2##3##(1991-4#1)(2008-8#1)
of migration rate in##2##4##(2008-8#2)
of migration rate##4##3##(2008-8#4)
of migration times and peak areas##2##6##(2008-10#2)
of migration times and##4##4##(2008-10#4)
of migration times##6##3##(2008-10#6)
of migration to##2##3##(2007-8#1)(2008-1#1)
of migration##47##2##(1990-12#1)(1991-4#1)(1991-8#1)(1992-2#1)(1992-6#1)(1993-10#1)(1993-6#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#9)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#8)(2008-9#1)(2010-2#2)(2010-8#3)(2011-2#3)(2013-1#3)
of migratory behaviour##2##3##(2008-3#1)(2010-8#1)
of migratory birds##3##3##(1995-3#1)(1997-4#1)(2009-8#1)
of migratory##15##2##(1995-3#2)(1997-4#1)(2008-2#3)(2008-3#2)(2008-8#1)(2009-8#1)(2009-9#1)(2010-8#2)(2011-2#2)
of milacemide##3##2##(1994-8#1)(1995-7#2)
of mild and moderate##2##4##(1996-9#1)(1997-8#1)
of mild and##3##3##(1996-9#1)(1997-8#1)(2005-7#1)
of mild cognitive impairment##5##4##(2008-2#1)(2009-10#1)(2009-2#1)(2011-2#1)(2013-8#1)
of mild hypothermia##2##3##(1992-7#1)(2007-10#1)
of mild to moderate##4##4##(1991-9#1)(1994-8#1)(2008-7#1)(2008-8#1)
of mild to##6##3##(1991-9#1)(1994-8#1)(2006-6#1)(2008-5#1)(2008-7#1)(2008-8#1)
of mild##64##2##(1990-12#1)(1990-2#1)(1991-11#1)(1991-9#1)(1992-1#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-8#1)(2005-10#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#2)(2006-6#1)(2007-10#4)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#2)(2009-10#2)(2009-2#1)(2010-12#1)(2010-2#1)(2011-2#3)(2012-11#1)(2012-2#2)(2012-3#1)(2013-8#3)
of mild-to-moderate##2##2##(1990-3#1)(1993-12#1)
of mildewed##2##2##(2008-10#2)
of mildly##3##2##(1993-1#1)(1996-2#1)(1996-6#1)
of miliary tuberculosis##3##3##(2008-4#1)(2012-2#1)(2012-3#1)
of military orthopaedics##2##3##(2007-8#2)
of military service##8##3##(2005-11#1)(2011-2#1)(2013-1#6)
of military##18##2##(1996-12#1)(2004-7#2)(2005-11#1)(2007-4#1)(2007-8#2)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#7)
of milk and##7##3##(1993-9#1)(2005-3#1)(2007-7#2)(2007-8#1)(2008-10#1)(2012-2#1)
of milk in##2##3##(1993-9#1)(2011-2#1)
of milk replacers##2##3##(2010-2#2)
of milk was##2##3##(2007-8#1)(2008-5#1)
of milk##37##2##(1992-11#1)(1992-12#1)(1992-3#1)(1993-9#2)(2005-3#1)(2007-7#2)(2007-8#3)(2008-10#9)(2008-11#1)(2008-12#1)(2008-5#4)(2010-2#2)(2011-2#1)(2012-1#3)(2012-2#3)(2013-1#2)
of milligram amounts of##2##4##(1992-12#1)(2008-11#1)
of milligram quantities of##2##4##(1994-5#2)
of milligram##4##2##(1992-12#1)(1994-5#2)(2008-11#1)
of milligrams or even##2##4##(2004-4#1)(2008-11#1)
of milligrams##4##2##(2004-4#1)(2008-10#2)(2008-11#1)
of millimeter##2##2##(2008-3#1)(2013-7#1)
of millimeters per second##2##4##(2007-12#2)
of millimeters##4##2##(2007-12#3)(2008-3#1)
of millimolar##3##2##(1993-3#1)(1994-3#1)(2009-8#1)
of millions of people##2##4##(2008-2#1)(2013-8#1)
of millions of##9##3##(1991-2#1)(1993-6#1)(2007-6#1)(2007-9#2)(2008-10#2)(2008-2#1)(2013-8#1)
of millions##10##2##(1991-2#1)(1993-6#1)(2007-6#1)(2007-9#2)(2008-10#3)(2008-2#1)(2013-8#1)
of milliseconds##3##2##(1991-9#1)(2007-12#1)(2008-2#1)
of milnacipran and olanzapine##2##4##(2008-6#2)
of milnacipran##4##2##(2008-6#3)(2011-1#1)
of mimicking##4##2##(1995-2#1)(2009-11#1)(2010-9#1)(2012-2#1)
of mimicry evolution##2##3##(2012-3#2)
of mimicry##3##2##(2012-3#3)
of mimosine##4##2##(2008-10#4)
of mind and##4##3##(2005-12#1)(2008-11#2)(2013-1#1)
of mind in##5##3##(2006-2#2)(2006-4#1)(2008-7#1)(2012-1#1)
of mind##33##2##(1993-5#1)(1993-8#1)(1994-2#1)(2005-12#2)(2006-2#9)(2006-3#2)(2006-4#1)(2008-11#3)(2008-12#2)(2008-7#1)(2009-4#1)(2010-12#1)(2010-2#1)(2011-12#1)(2012-1#2)(2013-1#3)(2013-8#1)
of mindfulness##3##2##(2008-11#1)(2012-2#1)(2013-1#1)
of mindfulness-based##3##2##(2013-1#3)
of mineral acids##2##3##(2008-10#2)
of mineral and##2##3##(1992-2#1)(2006-6#1)
of mineral elements##3##3##(2005-4#2)(2012-3#1)
of mineral feed additives based on##2##6##(2008-10#2)
of mineral matter##2##3##(2005-11#2)
of mineral metabolism##2##3##(2007-8#1)(2008-8#1)
of mineral soil##2##3##(1996-3#2)
of mineral##44##2##(1991-11#1)(1991-12#1)(1992-2#1)(1996-3#3)(2005-11#5)(2005-4#3)(2006-6#3)(2007-8#2)(2008-10#9)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-7#2)(2011-12#1)(2012-2#2)(2012-3#1)
of mineralization##5##2##(2008-10#3)(2008-12#1)(2012-6#1)
of mineralized tissue##2##3##(2005-10#1)(2013-1#1)
of mineralized##5##2##(1990-4#1)(2005-10#1)(2007-8#1)(2008-11#1)(2013-1#1)
of mineralocorticoid##3##2##(1995-12#1)(1997-1#1)(2008-4#1)
of minerals##6##2##(1997-4#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-5#2)
of mini##2##2##(2011-12#1)(2012-11#1)
of mini-white##2##2##(2012-3#2)
of miniature##6##2##(1992-12#1)(1994-11#1)(1996-2#1)(2008-10#2)(2008-4#1)
of miniaturization##3##2##(2006-5#1)(2008-10#1)(2010-6#1)
of miniaturized##3##2##(2007-8#1)(2008-10#2)
of minidose aspirin on renal##2##5##(2006-10#2)
of minidose##3##2##(1990-12#1)(2006-10#2)
of minima##2##2##(2008-2#1)(2012-2#1)
of minimal change##2##3##(2007-7#1)(2008-1#1)
of minimal invasive##2##3##(1995-9#1)(2007-8#1)
of minimal residual disease in##2##5##(1995-12#1)(2012-12#1)
of minimal residual disease##5##4##(1995-12#1)(2007-11#1)(2010-2#1)(2012-12#2)
of minimal##28##2##(1991-6#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-4#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-8#1)(2008-9#2)(2010-2#1)(2010-7#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#1)
of minimally invasive surgery in the##3##6##(2004-2#1)(2007-8#1)(2008-7#1)
of minimally invasive surgery##13##4##(2004-2#1)(2006-10#3)(2006-6#2)(2006-8#1)(2007-8#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
of minimally invasive surgical techniques##2##5##(2007-9#1)(2008-8#1)
of minimally invasive techniques and##2##5##(2007-5#1)(2007-8#1)
of minimally invasive techniques##6##4##(2006-5#1)(2007-5#1)(2007-8#1)(2008-11#1)(2012-12#2)
of minimally invasive##40##3##(2004-2#1)(2006-1#1)(2006-10#5)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-5#2)(2007-8#6)(2007-9#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-9#1)(2011-2#2)(2012-12#6)(2012-3#2)
of minimized##2##2##(1991-7#1)(2011-1#1)
of minimizing##9##2##(1997-7#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-4#1)(2013-1#1)
of minimum##9##2##(2006-8#1)(2007-12#1)(2008-2#2)(2008-7#1)(2009-6#1)(2010-3#1)(2011-1#1)(2013-1#1)
of mining activities##3##3##(2007-10#2)(2008-12#1)
of mining##7##2##(2007-10#2)(2007-9#1)(2008-12#2)(2008-5#1)(2013-1#1)
of mink##2##2##(1990-12#2)
of minocycline##7##2##(1997-8#1)(2007-10#2)(2008-5#2)(2008-7#1)(2010-5#1)
of minor complications##3##3##(2007-8#1)(2009-3#1)(2013-8#1)
of minor effect##2##3##(2008-10#2)
of minor groove##3##3##(1996-3#1)(2008-4#2)
of minor importance##6##3##(1990-1#1)(1990-11#1)(1991-11#1)(2005-11#1)(2008-10#1)(2008-11#1)
of minor salivary glands##2##4##(1990-6#1)(1991-9#1)
of minor salivary##6##3##(1990-6#1)(1991-9#1)(2013-1#4)
of minor veins##2##3##(2008-10#2)
of minor##58##2##(1990-1#1)(1990-11#1)(1990-4#1)(1990-6#1)(1991-11#1)(1991-9#1)(1992-3#1)(1992-6#2)(1993-12#2)(1993-9#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-5#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#1)(2005-11#1)(2007-11#1)(2007-8#3)(2008-10#8)(2008-11#2)(2008-4#2)(2009-3#2)(2010-12#1)(2010-3#1)(2011-2#2)(2012-3#5)(2013-1#6)(2013-8#3)
of minorities##4##2##(1991-8#1)(1994-12#1)(1997-2#1)(2013-1#1)
of minority health care##2##4##(1997-2#2)
of minority##10##2##(1994-12#1)(1997-2#3)(2006-10#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#1)
of minors##6##2##(1991-8#1)(1994-2#2)(1996-1#1)(2006-7#1)(2008-10#1)
of minute ventilation##2##3##(2007-9#1)(2012-3#1)
of minute##7##2##(1990-8#1)(1995-3#1)(1997-6#1)(2007-12#1)(2007-9#1)(2008-11#1)(2012-3#1)
of minutes##10##2##(1990-2#1)(1993-12#1)(1993-3#1)(1994-11#1)(1996-5#1)(2005-8#1)(2006-3#1)(2007-11#1)(2008-2#1)(2008-3#1)
of mirror neurons##2##3##(2008-11#1)(2009-4#1)
of mirror##17##2##(2006-6#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-9#1)(2009-4#1)(2010-2#1)(2011-1#1)(2012-12#4)
of mirrors##9##2##(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#4)
of mirtazapine on the##2##4##(2012-2#2)
of mirtazapine on##5##3##(2010-12#1)(2012-2#3)(2013-7#1)
of mirtazapine##9##2##(2010-12#3)(2012-2#5)(2013-7#1)
of misalignment between##2##3##(2008-2#1)(2008-3#1)
of misalignment##11##2##(2008-2#1)(2008-3#10)
of misalignments##2##2##(2008-2#1)(2008-3#1)
of misbehaviour##4##2##(2012-12#4)
of miscarriage##2##2##(2008-4#1)(2010-12#1)
of misclassification##6##2##(1992-6#1)(1995-6#1)(1996-7#1)(2008-10#1)(2011-2#1)(2012-1#1)
of misdiagnosis##3##2##(2007-11#1)(2008-11#1)(2008-7#1)
of misfolded##2##2##(1997-2#1)(2013-1#1)
of misidentification of##2##3##(2007-5#1)(2008-10#1)
of misidentification##4##2##(2006-3#1)(2007-5#1)(2008-10#1)(2008-11#1)
of misinformation##2##2##(1993-1#1)(2006-7#1)
of misleading##6##2##(2004-10#1)(2008-11#2)(2008-12#1)(2012-2#1)(2013-8#1)
of mismatch responses##2##3##(2012-1#2)
of mismatch##6##2##(1995-12#1)(2008-2#1)(2012-1#2)(2012-12#1)(2013-1#1)
of mismatched grating pairs##2##4##(2008-2#2)
of mismatched##7##2##(1991-7#1)(1993-11#1)(2007-12#1)(2008-2#2)(2010-11#2)
of mismatches##5##2##(1994-9#1)(1995-12#3)(1996-4#1)
of misoprostol##6##2##(1995-8#4)(1996-12#1)(2007-2#1)
of misreporting##4##2##(2012-1#4)
of missed diagnosis##2##3##(1995-8#1)(2008-12#1)
of missed opportunities##2##3##(1996-12#1)(2008-9#1)
of missed##7##2##(1995-8#1)(1996-12#1)(2008-12#1)(2008-8#2)(2008-9#1)(2012-2#1)
of missing anterior teeth##2##4##(2008-6#2)
of missing data for##2##4##(2007-10#1)(2012-2#1)
of missing data##12##3##(1994-9#1)(1995-12#1)(2007-10#2)(2008-2#1)(2012-1#2)(2012-12#3)(2012-2#2)
of missing teeth##3##3##(2008-9#1)(2012-2#1)(2013-1#1)
of missing values##4##3##(1994-5#1)(1995-6#1)(2012-1#1)(2013-1#1)
of missing##36##2##(1993-8#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-8#2)(1997-8#1)(2006-1#2)(2006-3#1)(2007-10#2)(2007-3#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#3)(2008-9#1)(2009-9#1)(2010-8#1)(2012-1#3)(2012-12#3)(2012-2#3)(2013-1#2)(2013-7#1)
of missing-data in image sequences##2##5##(2008-2#2)
of mission##4##2##(1993-12#1)(1994-1#2)(1995-12#1)
of mistake##2##2##(2006-5#1)(2007-3#1)
of mites in##2##3##(1993-6#1)(2011-2#1)
of mites##3##2##(1993-6#1)(2008-8#1)(2011-2#1)
of mithramycin##4##2##(1991-4#1)(1993-9#1)(1995-1#2)
of mitochondria and##9##3##(1990-4#1)(1993-9#1)(1996-9#1)(2006-12#1)(2007-12#1)(2008-12#1)(2012-2#2)(2013-1#1)
of mitochondria from##4##3##(1992-11#1)(1994-5#1)(2008-1#1)(2008-10#1)
of mitochondria in the##2##4##(2007-5#1)(2008-7#1)
of mitochondria in##7##3##(1994-12#1)(2007-5#1)(2008-1#1)(2008-7#2)(2010-12#1)(2012-11#1)
of mitochondria isolated from##3##4##(1994-3#1)(2005-8#1)(2013-1#1)
of mitochondria with##2##3##(1994-8#1)(1996-2#1)
of mitochondria##60##2##(1990-3#1)(1990-4#1)(1991-7#1)(1992-11#2)(1992-4#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-8#8)(2006-10#1)(2006-12#1)(2007-10#4)(2007-12#3)(2007-5#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-6#1)(2010-12#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
of mitochondrial ATPase##3##3##(1995-3#2)(1997-6#1)
of mitochondrial DNA (mtDNA)##4##4##(2005-8#2)(2009-11#1)(2009-8#1)
of mitochondrial DNA in##2##4##(1995-12#1)(2008-8#1)
of mitochondrial DNA##20##3##(1991-1#1)(1991-10#1)(1994-10#1)(1995-12#1)(1996-9#1)(2005-8#2)(2007-10#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-11#1)(2009-8#1)(2010-8#1)(2013-8#1)
of mitochondrial aldehyde dehydrogenase##2##4##(1996-9#2)
of mitochondrial alpha-tocopherol##2##3##(2005-8#2)
of mitochondrial and##2##3##(2008-6#1)(2010-3#1)
of mitochondrial aspartate aminotransferase##3##4##(1990-12#1)(1994-6#2)
of mitochondrial beta-oxidation##2##3##(1992-4#1)(1995-3#1)
of mitochondrial biogenesis##2##3##(2008-1#1)(2012-3#1)
of mitochondrial cristae##2##3##(2008-12#2)
of mitochondrial cytochrome c oxidase##2##5##(2005-8#1)(2008-6#1)
of mitochondrial cytochrome c##3##4##(2005-8#1)(2008-6#1)(2013-8#1)
of mitochondrial cytochrome##6##3##(1995-10#1)(1997-3#1)(2005-8#2)(2008-6#1)(2013-8#1)
of mitochondrial diseases##3##3##(1993-12#1)(2005-8#1)(2008-10#1)
of mitochondrial dysfunction##8##3##(1994-10#1)(2007-2#2)(2007-8#2)(2008-1#1)(2008-8#1)(2011-12#1)
of mitochondrial electron##2##3##(1995-2#1)(2005-8#1)
of mitochondrial function by##2##4##(1996-5#1)(1997-1#1)
of mitochondrial function##6##3##(1994-5#1)(1996-5#1)(1997-1#1)(2008-7#2)(2013-1#1)
of mitochondrial gene expression##3##4##(1996-5#1)(2005-8#2)
of mitochondrial gene##4##3##(1996-5#1)(2005-8#2)(2010-3#1)
of mitochondrial genomes##2##3##(2010-3#1)(2010-6#1)
of mitochondrial matrix##2##3##(1990-2#2)
of mitochondrial membrane potential##8##4##(1993-11#2)(2008-1#1)(2008-10#2)(2008-9#2)(2011-2#1)
of mitochondrial membrane##10##3##(1993-11#2)(1997-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-9#2)(2011-2#1)
of mitochondrial membranes##2##3##(1994-11#1)(2010-12#1)
of mitochondrial metabolism##2##3##(2008-1#1)(2011-1#1)
of mitochondrial origin##2##3##(1992-11#1)(2010-4#1)
of mitochondrial oxidative phosphorylation##3##4##(1994-12#3)
of mitochondrial permeability transition (MPT)##2##5##(2005-7#1)(2008-11#1)
of mitochondrial permeability transition##5##4##(1997-6#1)(2005-7#1)(2008-11#2)(2010-12#1)
of mitochondrial protein##4##3##(1990-8#1)(1994-12#3)
of mitochondrial proteins##3##3##(1992-7#1)(2005-8#2)
of mitochondrial proteolytic enzymes##2##4##(2005-8#2)
of mitochondrial proteolytic##3##3##(2005-8#3)
of mitochondrial proton leak##2##4##(1994-12#1)(1994-8#1)
of mitochondrial respiration##5##3##(1990-5#2)(2007-10#2)(2008-7#1)
of mitochondrial respiratory function##2##4##(1993-12#1)(2008-10#1)
of mitochondrial respiratory##3##3##(1993-12#1)(2005-8#1)(2008-10#1)
of mitochondrial structure##3##3##(2005-8#2)(2012-3#1)
of mitochondrial targeted drugs##2##4##(2008-1#2)
of mitochondrial targeted##3##3##(2008-1#3)
of mitochondrial translation##2##3##(1995-6#1)(2008-7#1)
of mitochondrial##192##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-11#4)(1992-12#1)(1992-2#2)(1992-4#1)(1992-7#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-10#2)(1994-11#2)(1994-12#7)(1994-3#2)(1994-5#2)(1994-6#3)(1994-8#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-6#3)(1996-12#1)(1996-2#1)(1996-5#3)(1996-8#1)(1996-9#6)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#3)(1997-6#5)(2005-7#1)(2005-8#30)(2006-12#3)(2007-10#4)(2007-2#2)(2007-8#2)(2008-1#7)(2008-10#8)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#2)(2009-11#1)(2009-8#2)(2010-12#3)(2010-3#3)(2010-4#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-3#3)(2013-1#3)(2013-8#2)
of mitochondrially##3##2##(1996-3#1)(2005-8#1)(2013-8#1)
of mitogen##4##2##(1991-10#1)(1996-2#1)(2006-5#1)(2012-1#1)
of mitogen-activated protein kinase (MAPK)##2##5##(1995-3#1)(2012-3#1)
of mitogen-activated protein kinase in##3##5##(1992-8#1)(1993-8#1)(1995-1#1)
of mitogen-activated protein kinase##10##4##(1992-8#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-5#1)(1996-8#1)(2012-3#1)
of mitogen-activated protein kinases##3##4##(2008-5#1)(2012-2#1)(2013-1#1)
of mitogen-activated protein##14##3##(1992-8#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-3#2)(1995-6#1)(1996-5#1)(1996-8#1)(2008-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
of mitogenic activity##2##3##(2005-11#1)(2008-11#1)
of mitogenic signals##3##3##(1994-5#1)(1995-6#1)(1996-5#1)
of mitogenic##6##2##(1992-6#1)(1994-5#1)(1995-6#1)(1996-5#1)(2005-11#1)(2008-11#1)
of mitogens##2##2##(1990-12#1)(1996-1#1)
of mitomycin C (MMC)##3##4##(1996-6#1)(1997-7#1)(2008-11#1)
of mitomycin C##13##3##(1990-2#1)(1991-4#1)(1992-3#1)(1996-6#3)(1997-7#2)(2007-3#2)(2008-11#1)(2008-4#1)(2012-2#1)
of mitomycin##15##2##(1990-2#1)(1991-12#1)(1991-4#1)(1992-3#1)(1996-6#4)(1997-7#2)(2007-3#2)(2008-11#1)(2008-4#1)(2012-2#1)
of mitoplasts##2##2##(1997-1#2)
of mitoses##3##2##(1992-6#1)(1993-10#1)(2012-1#1)
of mitosis and##3##3##(1996-4#1)(2008-9#1)(2009-3#1)
of mitosis in##2##3##(1991-6#1)(1995-6#1)
of mitosis##14##2##(1991-6#2)(1992-6#1)(1994-10#1)(1994-3#1)(1995-6#1)(1996-4#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-3#1)
of mitotic and##2##3##(1990-8#1)(2010-3#1)
of mitotic cells##4##3##(1994-9#1)(2008-4#1)(2008-9#2)
of mitotic chromosomes##4##3##(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)
of mitotic cyclins##2##3##(1996-4#1)(1997-6#1)
of mitotic figures##2##3##(2008-5#1)(2008-6#1)
of mitotic progression##2##3##(1994-8#1)(2007-11#1)
of mitotic recombination##2##3##(1995-9#1)(1996-7#1)
of mitotic##25##2##(1990-4#1)(1990-6#1)(1990-8#1)(1993-12#1)(1994-8#1)(1994-9#1)(1995-9#2)(1996-4#1)(1996-7#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-9#3)(2010-3#1)
of mitotically##2##2##(1991-9#1)(2008-9#1)
of mitoxantrone on##2##3##(1991-6#1)(1993-3#1)
of mitoxantrone##7##2##(1991-12#1)(1991-6#2)(1993-3#2)(2012-3#2)
of mitral aortic intervalvular fibrosa##2##5##(2010-7#2)
of mitral aortic intervalvular##3##4##(2010-7#3)
of mitral cells##5##3##(1995-5#2)(2012-2#2)(2013-1#1)
of mitral regurgitation##3##3##(1990-6#1)(1995-6#1)(2010-11#1)
of mitral valve repair##2##4##(2007-9#1)(2009-10#1)
of mitral valve##6##3##(1990-9#1)(1996-8#1)(2007-9#1)(2009-10#1)(2009-4#1)(2011-2#1)
of mitral##20##2##(1990-6#1)(1990-9#1)(1995-5#2)(1995-6#1)(1996-8#1)(2006-10#1)(2007-9#1)(2009-10#2)(2009-4#1)(2010-11#1)(2010-12#1)(2010-7#3)(2011-2#1)(2012-2#2)(2013-1#1)
of mitral/tufted##3##2##(1996-7#1)(1997-7#1)(2009-12#1)
of mitten##2##2##(2010-4#2)
of mivacurium in##2##3##(2008-10#2)
of mixed connective tissue disease##2##5##(1991-11#1)(2006-10#1)
of mixed infections##3##3##(2008-10#2)(2008-5#1)
of mixed marriages##2##3##(2010-4#2)
of mixed micelles and##2##4##(1990-2#1)(2008-5#1)
of mixed micelles##3##3##(1990-2#1)(1996-4#1)(2008-5#1)
of mixed monolayers##3##3##(1990-2#2)(2008-10#1)
of mixed##91##2##(1990-2#4)(1990-4#1)(1991-11#1)(1992-4#1)(1992-7#1)(1993-9#1)(1994-6#1)(1995-1#1)(1996-4#1)(1996-5#1)(1997-8#1)(2004-3#1)(2005-1#2)(2005-11#3)(2005-4#3)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#21)(2008-11#1)(2008-12#2)(2008-2#2)(2008-5#3)(2008-6#1)(2008-7#1)(2009-11#2)(2010-1#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#2)
of mixed-chain phosphatidylcholines##3##3##(1990-7#3)
of mixed-mode##2##2##(2013-8#2)
of mixed-phase##3##2##(1996-8#3)
of mixes##3##2##(2008-10#2)(2011-2#1)
of mixing the reagents##3##4##(2008-10#2)(2008-3#1)
of mixing the##4##3##(2007-12#1)(2008-10#2)(2008-3#1)
of mixing##17##2##(1997-2#1)(2004-9#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#2)(2008-8#2)(2010-8#1)(2011-12#1)
of mixture design on##2##4##(2008-10#2)
of mixture of##2##3##(2008-10#1)(2008-5#1)
of mixture##12##2##(2008-10#5)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2009-4#1)
of mixtures and##2##3##(2004-4#1)(2008-10#1)
of mixtures in##3##3##(2008-10#3)
of mixtures of three##2##4##(2008-10#2)
of mixtures of##20##3##(1990-12#1)(1992-5#1)(1993-8#1)(2004-9#1)(2005-11#1)(2007-11#1)(2008-10#10)(2008-2#1)(2008-6#1)(2008-7#1)(2010-5#1)
of mixtures were##2##3##(2008-10#1)(2013-8#1)
of mixtures with##2##3##(2008-10#2)
of mixtures##39##2##(1990-12#1)(1992-5#1)(1993-8#1)(2004-4#1)(2004-9#1)(2005-11#1)(2007-1#1)(2007-11#1)(2008-10#23)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-3#1)(2010-5#1)(2013-8#1)
of mizolastine##2##2##(2007-11#2)
of mleS##2##2##(1997-6#2)
of mobile elements##2##3##(2008-8#1)(2010-3#1)
of mobile phase and##2##4##(2008-10#1)(2011-1#1)
of mobile phase composition##2##4##(2005-12#1)(2008-10#1)
of mobile phase variables##4##4##(2008-10#4)
of mobile phase##21##3##(1996-8#1)(1997-3#1)(2005-12#1)(2008-10#14)(2008-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
of mobile phone##4##3##(2009-9#1)(2011-2#2)(2012-3#1)
of mobile##45##2##(1992-5#1)(1996-8#1)(1997-3#1)(2005-12#1)(2007-12#1)(2007-9#1)(2008-10#17)(2008-12#1)(2008-5#1)(2008-8#2)(2009-10#2)(2009-3#1)(2009-9#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#2)
of mobility and##5##3##(1994-2#1)(2007-7#1)(2008-2#1)(2009-3#1)(2011-12#1)
of mobility in##3##3##(2006-6#1)(2007-8#1)(2010-9#1)
of mobility##24##2##(1993-12#1)(1994-2#1)(1997-4#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-7#1)(2009-3#1)(2010-10#1)(2010-9#2)(2011-12#7)(2013-1#1)
of mobilization##2##2##(1997-4#1)(2012-12#1)
of mobilizations##2##2##(2012-2#2)
of modal##7##2##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#1)
of modalities##3##2##(2007-9#1)(2008-5#1)(2008-9#1)
of modality usage##2##3##(1995-12#2)
of modality##3##2##(1995-12#2)(2008-3#1)
of mode of##2##3##(2004-12#1)(2013-1#1)
of mode##10##2##(2004-12#1)(2007-11#2)(2007-12#3)(2008-3#3)(2013-1#1)
of mode-locked laser##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
of mode-locked lasers##5##3##(2007-11#3)(2007-12#2)
of mode-locked##8##2##(2007-11#4)(2007-12#3)(2008-2#1)
of model compounds##3##3##(1990-12#1)(2008-10#1)(2011-1#1)
of model development##2##3##(2008-7#1)(2013-8#1)
of model drug compounds##2##4##(2007-2#2)
of model membranes##2##3##(1994-12#1)(2009-7#1)
of model misspecification and##2##4##(1994-5#1)(1997-3#1)
of model misspecification##3##3##(1992-9#1)(1994-5#1)(1997-3#1)
of model organisms##2##3##(2008-9#1)(2009-5#1)
of model parameters##8##3##(1997-8#1)(2008-2#1)(2008-7#1)(2009-4#1)(2013-1#3)(2013-8#1)
of model predictions##2##3##(2007-4#1)(2008-5#1)
of model selection##4##3##(2006-5#1)(2008-2#1)(2010-2#1)(2011-1#1)
of model systems##2##3##(2008-4#1)(2008-6#1)
of model##85##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#1)(1991-5#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-8#2)(1997-2#1)(1997-3#1)(1997-8#1)(2005-11#2)(2006-5#3)(2007-11#1)(2007-12#2)(2007-2#2)(2007-4#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-2#1)(2011-1#3)(2011-2#1)(2012-2#3)(2013-1#4)(2013-8#4)
of modeled and measured##2##4##(2008-2#1)(2008-3#1)
of modeled##5##2##(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#2)
of modeling and##3##3##(2008-7#1)(2012-3#1)(2013-1#1)
of modeling techniques##2##3##(2008-8#1)(2011-1#1)
of modeling##23##2##(1990-2#1)(2006-5#3)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-7#1)(2008-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
of modelling##8##2##(1996-2#1)(2005-5#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-1#1)(2013-8#1)
of models for the##4##4##(1994-9#1)(2007-9#1)(2008-2#1)(2008-8#1)
of models for##12##3##(1991-12#1)(1994-5#1)(1994-9#1)(2007-10#1)(2007-9#1)(2008-2#2)(2008-8#1)(2009-9#1)(2011-2#1)(2013-1#2)
of models have##2##3##(1990-5#1)(2007-11#1)
of models is##4##3##(2006-1#1)(2007-8#1)(2008-4#1)(2008-7#1)
of models of##6##3##(1993-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-9#1)
of models that##2##3##(1995-6#1)(2006-10#1)
of models used##2##3##(2008-10#1)(2012-2#1)
of models were##2##3##(2007-12#1)(2008-10#1)
of models which##2##3##(1994-3#1)(1997-8#1)
of models with##3##3##(2008-10#1)(2009-3#2)
of models##60##2##(1990-5#1)(1991-12#1)(1991-6#1)(1992-4#1)(1993-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1997-8#1)(2006-1#1)(2006-10#3)(2007-10#2)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#5)(2009-3#2)(2009-9#1)(2010-1#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#2)
of moderate and severe##4##4##(1993-6#1)(2007-7#1)(2008-1#1)(2008-3#1)
of moderate and##6##3##(1993-6#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-3#1)(2012-11#1)
of moderate atmospheric refractive-index turbulence##2##5##(2008-3#2)
of moderate intensity##3##3##(1990-12#1)(1995-10#1)(1995-8#1)
of moderate or severe##3##4##(1990-3#1)(1991-11#1)(2010-11#1)
of moderate or vigorous physical##2##5##(2010-11#1)(2011-1#1)
of moderate or##7##3##(1990-3#1)(1991-11#1)(2008-7#1)(2010-11#2)(2011-1#1)(2012-1#1)
of moderate severity##2##3##(1993-6#1)(2008-6#1)
of moderate to moderately severe pain##2##6##(1996-7#1)(2008-5#1)
of moderate to severe acute pain##2##6##(2011-1#2)
of moderate to severe cancer pain##3##6##(2008-3#2)(2008-7#1)
of moderate to severe##15##4##(2005-6#1)(2007-2#1)(2007-7#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-8#2)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)
of moderate to##17##3##(1996-7#1)(2005-6#1)(2007-2#1)(2007-7#1)(2008-3#2)(2008-5#3)(2008-7#1)(2009-8#2)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)
of moderate##62##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-11#1)(1991-3#1)(1991-5#1)(1992-9#1)(1993-6#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-8#1)(1996-7#1)(1997-8#1)(2005-10#1)(2005-6#1)(2006-10#2)(2006-3#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#3)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#5)(2008-5#3)(2008-6#1)(2008-7#3)(2009-5#2)(2009-8#2)(2010-11#2)(2011-1#3)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-8#1)
of moderate-size##2##2##(1996-4#2)
of moderate-to-severe##3##2##(1990-3#1)(2008-1#1)(2010-5#1)
of moderated##2##2##(2009-11#1)(2010-2#1)
of moderately high##2##3##(2008-10#1)(2008-7#1)
of moderately##11##2##(1997-6#1)(2005-10#1)(2005-11#1)(2007-7#1)(2008-10#3)(2008-7#1)(2009-3#1)(2011-2#1)(2012-1#1)
of modern biology##4##3##(2006-2#1)(2008-2#2)(2008-4#1)
of modern clinical##2##3##(2007-11#1)(2013-8#1)
of modern composites##2##3##(2012-1#1)(2013-1#1)
of modern evolutionary##2##3##(1991-8#1)(2012-12#1)
of modern human##3##3##(2011-2#3)
of modern humans##6##3##(1995-11#1)(1996-4#1)(1997-4#1)(2007-3#1)(2008-8#1)(2011-2#1)
of modern medicine##3##3##(1991-11#1)(2007-11#1)(2008-6#1)
of modern methods of##2##4##(2011-1#1)(2011-2#1)
of modern societies##2##3##(2005-10#1)(2009-2#1)
of modern techniques##3##3##(2005-10#1)(2007-8#1)(2013-1#1)
of modern technology##3##3##(2008-10#1)(2008-4#1)(2011-2#1)
of modern times##2##3##(1990-6#1)(2007-8#1)
of modern##108##2##(1990-12#1)(1990-2#1)(1990-6#2)(1991-11#1)(1991-12#1)(1991-4#1)(1991-8#1)(1992-2#1)(1992-6#1)(1994-4#1)(1994-5#1)(1995-11#1)(1995-4#1)(1996-4#1)(1997-1#1)(1997-4#2)(2005-1#1)(2005-10#2)(2005-12#1)(2005-5#1)(2005-8#1)(2006-2#2)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-3#2)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2009-2#5)(2009-5#1)(2009-7#3)(2009-8#1)(2010-10#1)(2010-4#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#11)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2012-9#1)(2013-1#4)(2013-7#1)(2013-8#2)
of modernity##4##2##(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)
of modes##13##2##(1990-5#1)(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#3)(2011-2#2)(2012-1#1)
of modest##5##2##(1997-5#1)(2005-11#1)(2007-12#1)(2008-9#1)(2012-3#1)
of modifiable##5##2##(1990-7#1)(1997-1#1)(2007-9#1)(2008-2#1)(2011-2#1)
of modification of the##2##4##(1992-5#1)(2008-11#1)
of modification of##5##3##(1991-2#1)(1992-5#1)(1996-5#1)(2008-11#1)(2009-2#1)
of modification##10##2##(1990-5#1)(1991-2#1)(1992-5#1)(1992-7#1)(1995-3#1)(1996-5#1)(2008-10#1)(2008-11#1)(2009-2#1)(2013-8#1)
of modifications in##2##3##(1996-6#1)(2008-6#1)
of modifications##6##2##(1994-9#1)(1996-6#1)(2007-12#1)(2008-6#1)(2011-2#1)(2012-12#1)
of modified &quot##2##3##(2011-2#2)
of modified electrodes##3##3##(2008-10#3)
of modified nucleosides##3##3##(1992-1#1)(1993-8#1)(1993-9#1)
of modified nucleotides##2##3##(2008-4#1)(2008-8#1)
of modified oligonucleotides##2##3##(2006-12#1)(2007-11#1)
of modified proteins##2##3##(2008-10#1)(2009-5#1)
of modified radical##2##3##(2008-10#1)(2009-2#1)
of modified test##2##3##(2011-2#2)
of modified##81##2##(1990-11#1)(1990-8#1)(1991-5#1)(1992-1#1)(1992-2#2)(1992-6#1)(1993-8#2)(1993-9#1)(1994-3#1)(1994-7#1)(1994-8#2)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-8#1)(2005-11#3)(2005-7#1)(2006-12#2)(2006-2#1)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#11)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#5)(2008-8#2)(2008-9#1)(2009-2#2)(2009-5#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#7)(2012-11#2)(2012-2#1)(2013-1#3)(2013-8#1)
of modifier and##2##3##(2008-10#2)
of modifier##6##2##(2008-10#6)
of modifiers##3##2##(2008-10#2)(2012-3#1)
of modifying the##4##3##(1994-5#1)(2006-10#1)(2007-11#1)(2013-8#1)
of modifying##12##2##(1991-8#1)(1994-5#1)(1995-11#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-4#2)(2012-1#1)(2012-12#2)(2013-8#1)
of modular##6##2##(1990-1#1)(2007-11#1)(2008-11#1)(2009-9#1)(2011-1#1)(2011-12#1)
of modularity##6##2##(2008-11#1)(2011-12#2)(2013-1#2)(2013-7#1)
of modulated##4##2##(1995-8#1)(2007-11#1)(2008-3#2)
of modulating the##3##3##(1994-2#1)(1996-2#1)(2008-11#1)
of modulating##11##2##(1990-2#1)(1991-4#1)(1992-4#1)(1994-2#1)(1996-2#1)(2005-8#1)(2008-11#1)(2009-2#1)(2009-9#1)(2010-12#1)(2011-2#1)
of modulation and##4##3##(2008-2#1)(2008-3#1)(2013-1#2)
of modulation frequency##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
of modulation of the##2##4##(2007-11#1)(2011-2#1)
of modulation of##9##3##(1991-9#1)(1992-1#1)(1994-3#1)(2007-11#2)(2007-12#1)(2011-2#2)(2012-1#1)
of modulation##25##2##(1991-9#1)(1992-1#1)(1994-3#1)(1994-8#1)(2007-11#3)(2007-12#5)(2008-10#1)(2008-2#4)(2008-3#3)(2011-2#2)(2012-1#1)(2013-1#2)
of modulational instability##3##3##(2007-11#1)(2007-12#1)(2008-1#1)
of modulators of##2##3##(2006-10#1)(2008-5#1)
of module##3##2##(2008-11#1)(2008-12#1)(2013-1#1)
of moiré fringes in##2##4##(2008-3#2)
of moiré fringes##3##3##(2008-2#1)(2008-3#2)
of moiré##6##2##(2008-2#4)(2008-3#2)
of moist##3##2##(2005-11#1)(2008-10#2)
of moisture in##7##3##(2006-12#3)(2008-10#3)(2008-5#1)
of moisture occurrence##2##3##(2008-10#2)
of moisture on##2##3##(2008-10#2)
of moisture periods##2##3##(2008-10#2)
of moisture##22##2##(1996-2#1)(2006-12#4)(2008-10#13)(2008-5#1)(2008-6#1)(2010-4#1)(2012-2#1)
of moisturizers will##2##3##(2006-12#2)
of moisturizers##4##2##(2006-12#3)(2008-5#1)
of molar##4##2##(1992-5#1)(2008-10#2)(2010-12#1)
of molding##2##2##(2007-8#1)(2008-5#1)
of molds##3##2##(2008-3#1)(2008-7#1)(2010-12#1)
of molecular MRI##2##3##(2010-9#2)
of molecular analysis##2##3##(2011-2#1)(2012-3#1)
of molecular and genetic##3##4##(2006-10#1)(2007-12#1)(2012-3#1)
of molecular and morphological##2##4##(1992-12#1)(2008-7#1)
of molecular and##13##3##(1991-2#1)(1992-12#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-11#1)(2012-3#1)
of molecular biological techniques##3##4##(2008-11#2)(2008-4#1)
of molecular biological##5##3##(1990-12#1)(2008-11#2)(2008-4#1)(2008-9#1)
of molecular biology and##3##4##(1993-9#1)(1994-3#1)(2008-4#1)
of molecular biology in veterinary parasitology##2##6##(1997-7#2)
of molecular biology in##4##4##(1997-3#1)(1997-7#2)(2011-2#1)
of molecular biology techniques##2##4##(1997-7#1)(2006-10#1)
of molecular biology to##2##4##(1995-9#1)(1997-7#1)
of molecular biology##29##3##(1990-11#1)(1991-11#1)(1993-9#1)(1994-3#1)(1995-6#1)(1995-9#1)(1997-3#1)(1997-7#5)(2006-10#2)(2007-11#1)(2007-7#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-12#1)(2011-2#3)(2012-12#1)
of molecular changes and##2##4##(1992-12#1)(2009-4#1)
of molecular chaperones and##3##4##(1995-4#1)(2008-1#1)(2008-7#1)
of molecular chaperones##10##3##(1994-11#2)(1995-4#3)(2008-1#1)(2008-4#1)(2008-7#3)
of molecular components##2##3##(2010-9#1)(2012-12#1)
of molecular concentration##2##3##(1992-8#1)(2011-1#1)
of molecular data##3##3##(1992-12#1)(2008-10#2)
of molecular descriptors##4##3##(2007-11#2)(2007-8#1)(2008-10#1)
of molecular determinants##2##3##(2007-10#1)(2007-11#1)
of molecular diagnostic##4##3##(2006-10#1)(2011-1#1)(2013-1#2)
of molecular diversity##3##3##(1995-7#1)(2007-12#2)
of molecular dynamics simulations (MD)##2##5##(1990-8#1)(2009-5#1)
of molecular dynamics simulations##5##4##(1990-8#1)(1992-6#1)(1993-11#1)(1995-3#1)(2009-5#1)
of molecular dynamics##9##3##(1990-8#1)(1992-6#1)(1993-11#1)(1993-8#1)(1995-3#1)(2007-6#1)(2008-7#1)(2009-5#1)(2011-2#1)
of molecular events in##2##4##(1990-4#1)(2006-10#1)
of molecular events##4##3##(1990-4#1)(2005-11#1)(2006-10#1)(2008-11#1)
of molecular evolution##9##3##(1992-12#1)(1994-8#1)(1997-6#3)(2007-12#1)(2008-11#1)(2010-4#1)(2013-1#1)
of molecular forms##2##3##(1990-8#1)(1992-7#1)
of molecular function##3##3##(2007-6#1)(2008-2#1)(2008-4#1)
of molecular genetic techniques to##2##5##(1997-4#1)(2008-9#1)
of molecular genetic##7##3##(1997-4#1)(2006-10#1)(2007-7#1)(2008-4#1)(2008-9#2)(2011-2#1)
of molecular genetics##4##3##(2007-4#1)(2007-9#1)(2012-3#1)(2013-1#1)
of molecular hydrogen##3##3##(1995-2#2)(2007-12#1)
of molecular imaging in##2##4##(2008-2#1)(2010-1#1)
of molecular imaging##8##3##(2008-2#2)(2009-10#2)(2010-1#1)(2010-12#2)(2011-1#1)
of molecular interactions##2##3##(2008-9#1)(2010-10#1)
of molecular iodine##2##3##(2007-12#1)(2010-6#1)
of molecular ions##2##3##(1996-8#1)(2008-10#1)
of molecular layer of the cerebellar cortex##2##7##(1991-11#1)(1994-2#1)
of molecular marker##2##3##(2008-10#1)(2011-2#1)
of molecular markers for##5##4##(1997-8#1)(2007-7#1)(2007-9#1)(2008-10#2)
of molecular markers in##2##4##(2008-5#1)(2011-2#1)
of molecular markers##17##3##(1997-7#1)(1997-8#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-10#6)(2008-5#2)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#1)
of molecular mass##11##3##(1990-3#2)(1990-5#1)(1990-7#1)(1991-4#2)(1993-7#1)(1994-9#1)(1995-1#1)(1997-7#1)(2006-8#1)
of molecular mechanisms of##4##4##(2005-7#1)(2009-6#1)(2012-12#1)(2012-2#1)
of molecular mechanisms##6##3##(1994-11#1)(2005-7#1)(2009-6#1)(2012-12#1)(2012-2#2)
of molecular medicine##5##3##(1991-11#1)(2007-3#1)(2007-8#1)(2008-5#1)(2009-11#1)
of molecular modulation##2##3##(1994-9#1)(2007-12#1)
of molecular orientation##3##3##(2004-9#1)(2008-10#1)(2008-2#1)
of molecular oxidative damage##2##4##(1995-6#2)
of molecular oxygen##7##3##(1994-11#1)(1996-11#1)(2006-12#1)(2007-9#1)(2008-10#1)(2008-3#2)
of molecular pathways##3##3##(2008-7#1)(2009-5#1)(2010-10#1)
of molecular recognition and##2##4##(2008-3#1)(2008-7#1)
of molecular recognition by##2##4##(2006-12#1)(2012-3#1)
of molecular recognition##8##3##(1993-7#1)(2006-12#2)(2008-10#1)(2008-3#1)(2008-7#1)(2009-3#1)(2012-3#1)
of molecular replacement##2##3##(1997-5#1)(2008-8#1)
of molecular scattering##2##3##(2008-2#1)(2008-3#1)
of molecular self-assembly##2##3##(2013-8#2)
of molecular size##4##3##(1991-4#1)(1993-4#1)(2007-11#1)(2008-10#1)
of molecular species##7##3##(1990-8#2)(1997-1#1)(1997-2#1)(2008-11#1)(2008-3#2)
of molecular systems##2##3##(1991-3#1)(2010-12#1)
of molecular techniques to##2##4##(1991-5#1)(2006-10#1)
of molecular techniques##7##3##(1991-5#1)(2006-10#1)(2007-11#1)(2007-8#1)(2009-8#1)(2011-2#1)(2012-2#1)
of molecular tools and##2##4##(2009-10#1)(2010-10#1)
of molecular tools##3##3##(2009-10#1)(2010-10#1)(2011-1#1)
of molecular transport##2##3##(2010-7#1)(2011-1#1)
of molecular variance (AMOVA) revealed##2##5##(2008-10#2)
of molecular variance (AMOVA)##3##4##(2008-10#2)(2008-12#1)
of molecular variance revealed that##3##5##(2008-10#3)
of molecular variance##17##3##(2008-10#14)(2008-12#1)(2011-2#2)
of molecular variation##2##3##(2008-10#2)
of molecular weight of##2##4##(2005-11#1)(2008-10#1)
of molecular weight profile##2##4##(2007-8#2)
of molecular weight##20##3##(1990-2#1)(1990-3#1)(1991-1#1)(1991-10#1)(1993-3#2)(1993-4#1)(1997-8#1)(2005-11#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#2)(2013-1#1)
of molecular weights##8##3##(1994-12#1)(1997-6#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-10#1)
of molecular##407##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#4)(1991-1#1)(1991-10#1)(1991-11#3)(1991-2#1)(1991-3#1)(1991-4#3)(1991-5#1)(1991-9#2)(1992-10#1)(1992-12#4)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#3)(1993-4#4)(1993-6#2)(1993-7#3)(1993-8#1)(1993-9#1)(1994-11#5)(1994-12#1)(1994-2#2)(1994-3#3)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-2#3)(1995-3#2)(1995-4#3)(1995-6#4)(1995-7#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#5)(1997-7#7)(1997-8#3)(2004-9#1)(2005-11#3)(2005-7#1)(2005-8#2)(2006-10#12)(2006-11#1)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#10)(2007-12#12)(2007-3#2)(2007-4#1)(2007-6#4)(2007-7#3)(2007-8#5)(2007-9#5)(2008-1#3)(2008-10#49)(2008-11#10)(2008-12#2)(2008-2#8)(2008-3#8)(2008-4#7)(2008-5#7)(2008-6#2)(2008-7#14)(2008-8#6)(2008-9#6)(2009-10#5)(2009-11#4)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#5)(2010-11#1)(2010-12#9)(2010-2#2)(2010-4#1)(2010-6#2)(2010-7#2)(2010-9#3)(2011-1#6)(2011-2#17)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#2)
of molecularly based##3##3##(2005-10#3)
of molecularly imprinted##4##3##(2005-12#2)(2008-10#2)
of molecularly targeted##2##3##(2005-10#1)(2010-12#1)
of molecularly##9##2##(2005-10#4)(2005-12#2)(2008-10#2)(2010-12#1)
of molecule##6##2##(1996-1#1)(1996-11#1)(2005-4#1)(2007-9#1)(2008-10#1)(2013-8#1)
of molecules and##5##3##(1993-4#1)(1996-8#1)(2006-2#1)(2006-5#1)(2008-7#1)
of molecules are##3##3##(1994-9#1)(2008-2#1)(2008-4#1)
of molecules between##2##3##(2008-1#1)(2011-2#1)
of molecules in the##3##4##(2006-10#1)(2008-3#1)(2008-5#1)
of molecules in##7##3##(1992-7#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-3#2)(2008-5#1)
of molecules of##7##3##(1990-12#1)(1993-8#1)(1995-8#1)(2008-11#1)(2009-6#1)(2010-6#1)(2012-1#1)
of molecules on##2##3##(1990-6#1)(2008-3#1)
of molecules or##2##3##(2008-7#1)(2010-7#1)
of molecules such as##3##4##(2007-5#1)(2008-4#1)(2009-9#1)
of molecules that can##2##4##(2006-2#1)(2008-5#1)
of molecules that##6##3##(2006-2#1)(2008-5#2)(2008-7#1)(2009-9#1)(2010-11#1)
of molecules with##8##3##(1990-3#2)(1995-2#1)(2008-1#1)(2008-10#2)(2010-12#1)(2010-7#1)
of molecules##87##2##(1990-12#2)(1990-3#2)(1990-4#1)(1990-6#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-3#1)(1992-7#1)(1993-4#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-9#2)(1995-2#1)(1995-8#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-2#2)(2006-5#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#5)(2008-7#4)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#2)(2011-2#1)(2012-1#2)
of moles##4##2##(1994-5#1)(2004-12#1)(2006-12#1)(2012-2#1)
of mollusks##6##2##(2006-10#1)(2007-3#2)(2011-2#3)
of molsidomine on##2##3##(1990-11#1)(1991-5#1)
of molsidomine##5##2##(1990-11#1)(1990-6#3)(1991-5#1)
of molten##6##2##(1995-4#1)(2005-11#3)(2006-4#1)(2009-6#1)
of molybdate##8##2##(1990-11#2)(1992-3#1)(2006-8#2)(2008-10#3)
of molybdenum and tungsten##3##4##(2007-11#1)(2008-10#2)
of molybdenum and##7##3##(1991-3#1)(2007-11#1)(2008-10#5)
of molybdenum by##2##3##(2008-10#2)
of molybdenum determination was##2##4##(2008-10#2)
of molybdenum in seawater##2##4##(2008-10#2)
of molybdenum in##12##3##(2008-10#12)
of molybdenum particles##2##3##(1991-3#2)
of molybdenum was##2##3##(2008-10#2)
of molybdenum with##3##3##(2008-10#3)
of molybdenum##45##2##(1991-3#3)(1992-12#1)(1992-3#1)(2007-11#1)(2008-10#38)(2008-2#1)
of molybdenum(VI)##6##2##(2008-10#6)
of molybdenyl##2##2##(2008-10#2)
of molybdophosphate##2##2##(2008-10#2)
of molybdopterin##5##2##(1992-12#2)(1994-9#3)
of moment##2##2##(1996-11#1)(2008-2#1)
of momentum##4##2##(1992-7#1)(2006-11#1)(2007-6#1)(2013-1#1)
of mometasone furoate/formoterol##2##3##(2012-3#2)
of monatomic##2##2##(1995-5#1)(2004-9#1)
of monensin and chloramphenicol##2##4##(2008-5#2)
of monensin##4##2##(1991-1#1)(2008-5#3)
of money and##2##3##(2007-4#1)(2013-8#1)
of money##9##2##(1990-4#1)(2004-7#1)(2006-10#1)(2007-12#1)(2007-4#2)(2008-7#1)(2013-1#1)(2013-8#1)
of monitor##6##2##(2004-9#6)
of monitored##3##2##(2006-10#1)(2007-7#1)(2010-2#1)
of monitoring and##3##3##(1993-2#1)(1997-2#1)(2008-10#1)
of monitoring by##2##3##(2008-10#1)(2009-7#1)
of monitoring of qualitative content of##2##6##(2013-1#2)
of monitoring of##3##3##(2008-10#1)(2013-1#2)
of monitoring the##11##3##(1994-9#1)(1997-2#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2013-8#1)
of monitoring##53##2##(1992-10#1)(1992-11#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#1)(1994-7#1)(1994-9#1)(1995-3#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-2#2)(2004-2#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-10#1)(2009-6#1)(2009-7#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
of monkey##8##2##(1990-12#1)(1992-12#1)(1992-6#1)(1993-4#1)(1997-2#3)(2009-5#1)
of monkeys with##2##3##(2008-10#1)(2013-8#1)
of monkeys##11##2##(1990-10#1)(1991-11#1)(1992-5#1)(1995-12#1)(1997-2#1)(2004-4#1)(2005-11#1)(2008-10#1)(2009-8#1)(2010-12#1)(2013-8#1)
of mono- and diacylglycerol##2##4##(1991-9#2)
of mono- and disubstituted##2##4##(1993-4#1)(2009-9#1)
of mono- and sesquiterpenes in##2##5##(2008-10#2)
of mono- and##16##3##(1991-7#1)(1991-9#2)(1993-4#1)(1996-5#1)(2006-12#2)(2008-10#6)(2009-4#1)(2009-9#1)(2010-11#1)
of mono-##23##2##(1991-7#1)(1991-9#2)(1993-4#1)(1995-8#1)(1996-5#1)(1996-6#1)(2005-12#1)(2006-12#2)(2007-6#1)(2008-10#8)(2008-11#1)(2009-4#1)(2009-9#1)(2010-11#1)
of mono-THF##2##2##(2007-1#2)
of mono-and##2##2##(1994-3#1)(2006-10#1)
of mono-dispersed##2##2##(2008-5#1)(2010-5#1)
of monoadducts##2##2##(1992-11#1)(1992-6#1)
of monoamine oxidase (MAO)##2##4##(1991-12#1)(1995-11#1)
of monoamine oxidase A##2##4##(1991-12#1)(1997-5#1)
of monoamine oxidase##7##3##(1991-12#2)(1993-4#1)(1995-11#1)(1996-5#1)(1997-5#1)(2010-9#1)
of monoamine##12##2##(1990-5#1)(1991-12#2)(1992-7#1)(1993-4#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-5#1)(2010-9#1)
of monoaminergic##3##2##(1995-12#1)(2008-6#1)(2009-2#1)
of monoamines##2##2##(1997-5#1)(2006-10#1)
of monoarthritis##2##2##(1992-11#1)(2013-8#1)
of monobromobenzoic acids##2##3##(2008-10#2)
of monochromatic##3##2##(2006-4#1)(2008-2#2)
of monochromator##3##2##(2008-2#1)(2008-3#2)
of monoclinic##2##2##(1993-12#1)(2008-10#1)
of monoclonal and polyclonal##2##4##(1994-3#1)(1997-3#1)
of monoclonal antibodies (MoAbs)##2##4##(1990-7#1)(1993-1#1)
of monoclonal antibodies (mAb)##3##4##(2005-9#1)(2008-4#1)(2011-2#1)
of monoclonal antibodies against human##4##5##(1991-2#1)(1992-1#1)(1996-10#1)(2008-4#1)
of monoclonal antibodies against##15##4##(1991-2#1)(1992-1#1)(1992-4#1)(1992-7#1)(1992-8#1)(1994-9#1)(1995-12#1)(1996-10#1)(1996-5#1)(2007-8#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-8#1)
of monoclonal antibodies and##4##4##(1991-6#1)(2008-10#1)(2008-4#1)(2013-7#1)
of monoclonal antibodies for##4##4##(1992-8#1)(2008-2#1)(2008-4#1)(2012-3#1)
of monoclonal antibodies in##3##4##(1993-6#1)(2008-11#1)(2012-1#1)
of monoclonal antibodies recognizing##3##4##(1993-9#1)(1994-9#1)(2008-10#1)
of monoclonal antibodies specific for##2##5##(1993-9#1)(2008-4#1)
of monoclonal antibodies that##4##4##(1991-2#1)(1991-5#1)(1996-12#1)(2008-4#1)
of monoclonal antibodies to##4##4##(1990-12#1)(1991-2#1)(2007-11#1)(2010-12#1)
of monoclonal antibodies##83##3##(1990-12#3)(1990-6#1)(1990-7#1)(1991-2#4)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-4#1)(1992-7#2)(1992-8#3)(1993-1#1)(1993-11#1)(1993-6#2)(1993-9#2)(1994-5#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#2)(1996-1#2)(1996-10#1)(1996-12#1)(1996-5#1)(1997-3#3)(2005-9#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#8)(2008-2#1)(2008-4#9)(2008-8#3)(2008-9#4)(2009-8#1)(2010-12#2)(2011-2#3)(2012-1#1)(2012-3#1)(2013-7#1)
of monoclonal antibody 4-4-20##2##4##(1991-8#2)
of monoclonal antibody against##3##4##(2008-11#3)
of monoclonal antibody production##3##4##(1994-2#1)(2008-11#2)
of monoclonal antibody##30##3##(1990-12#2)(1991-5#1)(1991-8#2)(1992-6#1)(1992-7#2)(1994-2#2)(1996-5#1)(1997-7#1)(2005-10#2)(2008-10#2)(2008-11#11)(2008-4#2)(2008-8#1)
of monoclonal gammopathy##3##3##(1992-12#1)(2008-1#2)
of monoclonal or##2##3##(1993-2#1)(2008-5#1)
of monoclonal##136##2##(1990-12#5)(1990-6#1)(1990-7#1)(1991-2#4)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#4)(1992-8#4)(1993-1#1)(1993-11#1)(1993-2#1)(1993-6#2)(1993-9#3)(1994-2#2)(1994-3#3)(1994-5#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#2)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-3#4)(1997-7#1)(2005-10#2)(2005-9#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#4)(2008-10#5)(2008-11#19)(2008-2#1)(2008-4#11)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#5)(2009-8#2)(2010-12#3)(2011-2#3)(2012-1#1)(2012-3#1)(2013-7#1)
of monocrotophos and dichlrovos##2##4##(2008-5#2)
of monocrotophos and##4##3##(1992-11#1)(2008-5#3)
of monocrotophos##5##2##(1992-11#2)(2008-5#3)
of monocrystalline##2##2##(2004-9#1)(2008-10#1)
of monocular deprivation##7##3##(1992-3#1)(1994-3#5)(1994-8#1)
of monocular##8##2##(1992-3#1)(1994-3#5)(1994-8#2)
of monocyte and##2##3##(2011-2#1)(2012-1#1)
of monocyte chemoattractant protein-1##3##4##(1996-9#1)(2006-9#1)(2013-1#1)
of monocyte chemoattractant##6##3##(1991-10#1)(1994-8#2)(1996-9#1)(2006-9#1)(2013-1#1)
of monocyte chemotactic protein-1##3##4##(1993-4#3)
of monocyte chemotactic##4##3##(1991-9#1)(1993-4#3)
of monocyte##18##2##(1991-10#1)(1991-7#1)(1991-9#1)(1992-2#1)(1993-4#3)(1994-8#3)(1996-9#1)(2006-9#1)(2007-9#1)(2008-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
of monocyte-derived##3##2##(1992-12#1)(1995-8#1)(2008-5#1)
of monocyte/macrophage##3##2##(1991-10#1)(1994-2#1)(2007-12#1)
of monocytes and T-lymphocytes##2##4##(1996-9#1)(2008-10#1)
of monocytes and##4##3##(1996-9#1)(1997-8#1)(2007-8#1)(2008-10#1)
of monocytes by##2##3##(1994-3#1)(1994-8#1)
of monocytes from normal##2##4##(1990-12#2)
of monocytes##27##2##(1990-11#1)(1990-12#3)(1991-10#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-12#1)(1994-3#2)(1994-8#1)(1995-12#2)(1995-6#1)(1996-9#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-4#1)(2010-4#1)(2012-12#2)(2013-1#1)
of monocytic differentiation##2##3##(1992-6#1)(1997-7#1)
of monocytic##7##2##(1992-6#1)(1993-11#1)(1996-10#1)(1997-7#1)(2012-1#2)(2013-1#1)
of monodisperse##5##2##(1996-2#1)(2005-11#1)(2010-4#1)(2010-5#1)(2012-2#1)
of monodispersed##3##2##(2005-11#1)(2007-12#1)(2008-3#1)
of monoester##2##2##(2005-12#2)
of monofluorinated##2##2##(2006-12#1)(2009-1#1)
of monofunctional adducts##3##3##(1992-11#1)(2008-5#2)
of monolayer##5##2##(1990-4#1)(1992-12#1)(1996-8#1)(2008-11#1)(2008-9#1)
of monolayers of##3##3##(1991-9#1)(1994-3#1)(2005-11#1)
of monolayers##6##2##(1991-9#1)(1994-12#1)(1994-3#1)(1996-12#1)(2005-11#1)(2008-3#1)
of monolingual##4##2##(2009-10#4)
of monolithic columns with##2##4##(2005-12#1)(2008-10#1)
of monolithic##8##2##(2005-12#1)(2008-10#3)(2008-3#1)(2008-7#1)(2009-7#1)(2013-8#1)
of monomer and##2##3##(2008-10#1)(2008-4#1)
of monomer##8##2##(1994-9#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2010-2#1)
of monomeric IgD##2##3##(1995-12#2)
of monomeric##24##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1994-9#3)(1995-12#2)(1995-3#1)(1997-1#1)(1997-2#1)(1997-6#2)(2004-8#1)(2008-10#2)(2008-5#2)(2008-7#2)(2010-4#1)(2013-1#1)
of monomers##11##2##(1990-11#2)(1991-10#1)(1991-7#1)(1994-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#2)(2009-11#1)
of mononuclear cell##2##3##(2007-11#1)(2012-1#1)
of mononuclear cells from##4##4##(1992-3#1)(2008-11#1)(2008-4#1)(2008-9#1)
of mononuclear cells##11##3##(1992-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-9#2)(2009-10#1)(2012-1#1)
of mononuclear fraction cells from autologous bone marrow##2##8##(2012-1#2)
of mononuclear##22##2##(1992-3#1)(1995-12#1)(2005-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#2)(2008-9#2)(2009-10#1)(2009-11#1)(2010-5#1)(2012-1#6)
of mononucleosis syndrome##2##3##(2011-2#2)
of mononucleosis##3##2##(2007-2#1)(2011-2#2)
of monooxygenase##2##2##(1994-6#1)(2008-11#1)
of monophyletic##3##2##(1995-11#1)(2007-12#1)(2008-8#1)
of monosaccharides##5##2##(1990-11#1)(1993-11#2)(2008-10#1)(2008-6#1)
of monosomy##2##2##(1991-3#1)(2012-3#1)
of monospecific##4##2##(1990-2#1)(1990-6#1)(1992-2#1)(2008-9#1)
of monostotic fibrous dysplasia##2##4##(2009-3#2)
of monostotic##3##2##(2006-10#1)(2009-3#2)
of monosubstituted##3##2##(2007-11#1)(2008-12#1)(2011-1#1)
of monoterpene hydrocarbons##3##3##(2008-11#3)
of monoterpenes and##2##3##(2013-1#1)(2013-8#1)
of monoterpenes##4##2##(2008-10#1)(2008-12#1)(2013-1#1)(2013-8#1)
of monotherapy##3##2##(2007-11#2)(2010-3#1)
of monounsaturated fatty acids##3##4##(1990-2#1)(2010-4#2)
of monovalent cations##4##3##(1990-7#1)(1991-9#1)(1994-9#1)(2008-8#1)
of monovalent##10##2##(1990-7#1)(1991-4#1)(1991-9#1)(1992-12#1)(1994-5#1)(1994-9#1)(2008-10#3)(2008-8#1)
of monozygotic##6##2##(2008-6#1)(2008-7#3)(2010-8#1)(2011-1#1)
of monsoon##3##2##(2007-10#3)
of montelukast in##2##3##(2008-1#2)
of montelukast sodium and bambuterol hydrochloride##2##6##(2010-2#2)
of montelukast##4##2##(2008-1#2)(2010-2#2)
of monthly##7##2##(2007-7#1)(2008-1#1)(2008-3#1)(2011-2#1)(2012-12#1)(2013-1#2)
of months of##2##3##(1997-2#1)(2008-7#1)
of months##5##2##(1990-2#1)(1991-8#1)(1997-2#1)(2008-1#1)(2008-7#1)
of montmorillonite##2##2##(2005-11#2)
of mood and anxiety disorders##3##5##(2009-4#2)(2009-9#1)
of mood and##9##3##(1996-7#1)(2008-5#1)(2009-4#2)(2009-9#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
of mood disorder##3##3##(2004-3#1)(2009-4#1)(2012-2#1)
of mood disorders and##6##4##(1992-8#1)(2004-3#1)(2008-7#2)(2010-2#1)(2012-2#1)
of mood disorders##19##3##(1992-8#2)(1996-7#1)(2004-3#2)(2008-4#1)(2008-7#7)(2009-4#1)(2010-12#1)(2010-2#2)(2012-2#1)(2013-8#1)
of mood stabilizers##2##3##(2005-7#1)(2012-2#1)
of mood##44##2##(1991-6#1)(1991-8#1)(1992-8#3)(1996-7#2)(2004-3#3)(2005-7#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#7)(2009-4#4)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#2)(2011-2#1)(2012-12#1)(2012-2#5)(2013-8#5)
of moonshine##2##2##(1993-6#2)
of moose (Alces alces)##2##4##(2010-5#2)
of moral judgments##2##3##(2007-5#1)(2008-11#1)
of moral understanding##2##3##(2010-12#2)
of moral##21##2##(1991-2#2)(1992-3#1)(1993-9#1)(2005-7#1)(2006-12#1)(2006-7#1)(2007-4#1)(2007-5#1)(2008-11#3)(2009-6#2)(2009-7#1)(2010-12#2)(2012-11#1)(2012-2#1)(2013-8#2)
of morality##5##2##(1991-2#1)(2008-11#2)(2011-2#1)(2012-2#1)
of morbid obesity##5##3##(1993-3#1)(2006-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
of morbid##9##2##(1992-8#1)(1993-3#1)(1994-11#1)(1994-12#1)(2004-3#1)(2006-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
of morbidity after##2##3##(2012-3#1)(2013-1#1)
of morbidity among##2##3##(2008-7#1)(2009-12#1)
of morbidity and mortality among##9##5##(1992-5#1)(1996-8#1)(2006-6#1)(2007-11#1)(2008-1#2)(2008-8#1)(2010-8#1)(2010-9#1)
of morbidity and mortality and##4##5##(2006-10#1)(2008-11#1)(2008-3#1)(2012-12#1)
of morbidity and mortality due to##3##6##(2007-2#1)(2007-9#1)(2013-8#1)
of morbidity and mortality for##2##5##(1995-12#1)(2008-4#1)
of morbidity and mortality in patients with##4##7##(2006-6#1)(2009-8#1)(2010-12#1)(2010-9#1)
of morbidity and mortality in patients##6##6##(2006-6#1)(2008-3#1)(2009-8#1)(2010-12#1)(2010-9#1)(2012-12#1)
of morbidity and mortality in the##9##6##(1992-4#1)(1993-5#1)(2007-2#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2013-8#1)
of morbidity and mortality in##35##5##(1991-12#1)(1992-4#1)(1993-3#1)(1993-5#1)(2006-10#2)(2006-2#2)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#2)(2010-12#2)(2010-4#1)(2010-9#1)(2011-11#1)(2011-2#1)(2012-12#2)(2013-7#1)(2013-8#1)
of morbidity and mortality of the##2##6##(2007-12#1)(2011-2#1)
of morbidity and mortality worldwide##8##5##(2005-11#1)(2009-11#1)(2009-12#1)(2010-11#1)(2011-2#3)(2012-12#1)
of morbidity and mortality##104##4##(1990-5#2)(1990-8#1)(1991-12#1)(1992-4#1)(1992-5#1)(1993-3#1)(1993-5#1)(1993-6#1)(1995-12#1)(1996-8#1)(2005-10#1)(2005-11#1)(2006-10#9)(2006-2#2)(2006-4#1)(2006-6#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#3)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#5)(2008-4#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-12#2)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#1)(2010-9#2)(2011-11#1)(2011-2#6)(2012-12#6)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
of morbidity and##114##3##(1990-5#2)(1990-8#1)(1991-12#1)(1992-4#1)(1992-5#2)(1993-3#1)(1993-5#1)(1993-6#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-8#1)(2005-10#1)(2005-11#1)(2006-10#9)(2006-2#2)(2006-4#1)(2006-6#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#3)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#6)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#6)(2008-4#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-12#2)(2009-6#1)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#2)(2010-9#2)(2011-11#1)(2011-2#6)(2012-12#6)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
of morbidity in##12##3##(2004-11#1)(2006-10#2)(2007-8#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
of morbidity is##2##3##(2006-3#1)(2007-6#1)
of morbidity of##2##3##(2009-2#1)(2012-12#1)
of morbidity##155##2##(1990-5#2)(1990-8#1)(1991-12#1)(1991-2#1)(1992-4#1)(1992-5#2)(1993-3#1)(1993-5#1)(1993-6#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-8#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-5#1)(2006-10#12)(2006-2#2)(2006-3#1)(2006-4#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#3)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#7)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#3)(2009-2#1)(2009-6#1)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-11#1)(2011-2#7)(2012-11#1)(2012-12#10)(2012-2#8)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#4)
of more accurate##4##3##(2005-12#1)(2008-11#1)(2008-3#1)(2008-5#1)
of more active##2##3##(2006-10#2)
of more advanced##2##3##(2006-2#1)(2012-12#1)
of more aggressive##3##3##(2006-12#1)(2008-8#1)(2009-3#1)
of more and more##2##4##(2008-10#1)(2009-10#1)
of more blood##2##3##(2008-1#2)
of more clinically##2##3##(2006-10#1)(2008-5#1)
of more complex relationships##2##4##(1997-6#1)(2007-6#1)
of more complex##7##3##(1992-3#1)(1993-11#1)(1997-6#1)(2007-12#1)(2007-6#1)(2008-6#1)(2011-2#1)
of more comprehensive data##2##4##(1992-2#1)(2008-1#1)
of more detailed##2##3##(1996-3#1)(2012-11#1)
of more effective treatment##2##4##(2008-1#1)(2009-6#1)
of more effective##19##3##(1993-11#1)(1993-12#1)(1993-8#1)(1997-3#1)(2005-7#1)(2006-10#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-4#1)(2009-12#1)(2009-6#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
of more efficient and##2##4##(2008-1#1)(2010-12#1)
of more efficient##4##3##(2006-5#1)(2008-1#1)(2008-10#1)(2010-12#1)
of more frequent##4##3##(1993-5#1)(2005-8#1)(2008-9#1)(2011-2#1)
of more general##5##3##(1993-11#1)(1995-11#1)(2007-9#1)(2008-10#1)(2008-2#1)
of more intensive chemotherapy##2##4##(2004-1#1)(2011-2#1)
of more intensive##3##3##(2004-1#1)(2011-2#2)
of more or less##2##4##(1992-9#1)(2007-11#1)
of more potent and##2##4##(2005-11#1)(2008-5#1)
of more potent##6##3##(1994-5#1)(2005-11#1)(2008-4#1)(2008-5#1)(2012-2#2)
of more powerful##4##3##(1996-9#1)(2007-4#1)(2008-1#1)(2008-3#1)
of more precise##2##3##(1996-12#1)(2009-12#1)
of more rapid and##2##4##(2006-6#1)(2009-4#1)
of more rapid##3##3##(2006-6#1)(2009-4#1)(2009-9#1)
of more recent##3##3##(2005-8#1)(2006-11#1)(2008-2#1)
of more rigorous##2##3##(2008-3#1)(2010-5#1)
of more robust##2##3##(2008-10#1)(2008-2#1)
of more selective##2##3##(1995-11#1)(2007-8#1)
of more sensitive##3##3##(2009-3#1)(2011-2#2)
of more serious##3##3##(1991-3#1)(2008-2#1)(2011-1#1)
of more severe##5##3##(2007-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
of more sophisticated##2##3##(1991-12#1)(2011-2#1)
of more species##2##3##(2008-10#2)
of more than 0##2##4##(1993-4#1)(1996-5#1)
of more than 1##10##4##(1993-6#1)(1994-2#1)(1995-5#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)
of more than 10 dB##2##5##(2007-12#2)
of more than 10##7##4##(1993-5#1)(1995-6#1)(2006-5#1)(2007-12#2)(2007-2#1)(2012-2#1)
of more than 10(5)##2##4##(2007-12#1)(2008-7#1)
of more than 100 different##2##5##(2008-7#1)(2011-2#1)
of more than 100##6##4##(1996-3#1)(2008-10#1)(2008-7#2)(2010-7#1)(2011-2#1)
of more than 100%##2##4##(1994-2#1)(2007-11#1)
of more than 1000##4##4##(1995-5#1)(2007-12#1)(2007-8#1)(2008-2#1)
of more than 150##2##4##(2008-11#1)(2011-2#1)
of more than 2 orders of magnitude##2##7##(2007-12#2)
of more than 2##8##4##(1990-10#1)(1991-9#1)(1993-9#1)(2006-10#1)(2007-12#2)(2008-10#2)
of more than 20 years##3##5##(2006-10#1)(2008-7#1)(2012-2#1)
of more than 20##9##4##(1995-9#1)(2006-10#1)(2006-2#1)(2007-9#1)(2008-7#2)(2009-5#1)(2009-9#1)(2012-2#1)
of more than 200##2##4##(2007-11#1)(2008-10#1)
of more than 250##2##4##(1996-5#1)(2008-3#1)
of more than 3##3##4##(1994-2#1)(2008-10#1)(2011-2#1)
of more than 30 years##2##5##(1996-11#1)(2007-8#1)
of more than 30##14##4##(1990-12#1)(1991-2#1)(1996-11#1)(2007-12#3)(2007-8#2)(2008-10#2)(2008-11#1)(2009-8#1)(2009-9#1)(2010-10#1)
of more than 30%##3##4##(1996-4#1)(2008-10#1)(2008-2#1)
of more than 40##5##4##(2007-12#2)(2008-10#1)(2012-1#1)(2012-12#1)
of more than 40% in##2##5##(2008-11#1)(2008-8#1)
of more than 40%##3##4##(2008-11#1)(2008-2#1)(2008-8#1)
of more than 400##3##4##(1992-2#1)(2008-1#1)(2009-6#1)
of more than 5##8##4##(2004-11#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-2#1)(2008-7#1)(2008-8#1)
of more than 50##6##4##(1993-2#1)(1997-3#1)(2006-6#2)(2007-12#1)(2008-10#1)
of more than 50% of##2##5##(1990-12#1)(2008-5#1)
of more than 50%##4##4##(1990-12#1)(2007-8#1)(2008-5#1)(2008-6#1)
of more than 500##2##4##(1993-2#1)(2008-8#1)
of more than 6 orders of magnitude##2##7##(1994-11#1)(2007-12#1)
of more than 6##5##4##(1992-2#1)(1994-11#1)(2007-12#2)(2012-12#1)
of more than 60##2##4##(1993-10#1)(1994-9#1)
of more than 600##2##4##(2007-12#2)
of more than 7##3##4##(1996-9#1)(2004-11#1)(2007-7#1)
of more than 70##2##4##(2007-12#1)(2008-7#1)
of more than 700##2##4##(1992-11#1)(2007-7#1)
of more than 80%##5##4##(1995-2#1)(2007-12#1)(2008-2#1)(2008-5#1)(2011-12#1)
of more than 90%##3##4##(1997-1#1)(2008-10#1)(2013-7#1)
of more than a##3##4##(1991-11#1)(2008-10#1)(2012-2#1)
of more than eight##2##4##(1990-2#1)(1995-7#1)
of more than four##3##4##(1990-12#1)(1992-11#1)(2011-2#1)
of more than half of the##2##6##(1990-7#1)(2008-10#1)
of more than one##27##4##(1990-11#1)(1990-4#1)(1991-2#1)(1991-9#1)(1993-3#2)(1994-11#1)(1994-3#1)(1994-6#1)(1996-2#1)(1997-5#1)(2006-8#1)(2007-2#1)(2008-10#7)(2008-2#2)(2008-5#2)(2008-7#1)(2012-2#1)(2013-8#1)
of more than six##2##4##(2009-10#1)(2011-1#1)
of more than ten##2##4##(1990-2#1)(2007-3#1)
of more than three##5##4##(1992-8#1)(1992-9#1)(1993-7#2)(2008-5#1)
of more than two##2##4##(2007-12#1)(2008-3#1)
of more than##227##3##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#2)(1990-4#1)(1990-7#2)(1991-11#1)(1991-2#2)(1991-9#2)(1992-11#2)(1992-2#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#2)(1993-9#1)(1994-11#2)(1994-2#3)(1994-3#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#3)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-8#1)(2004-11#2)(2005-6#1)(2006-10#4)(2006-2#2)(2006-5#1)(2006-6#2)(2006-8#1)(2007-11#4)(2007-12#26)(2007-2#4)(2007-3#2)(2007-4#1)(2007-7#6)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#25)(2008-11#3)(2008-12#1)(2008-2#11)(2008-3#3)(2008-5#6)(2008-6#1)(2008-7#10)(2008-8#4)(2009-10#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#6)(2013-1#3)(2013-7#1)(2013-8#3)
of more value than##2##4##(1996-5#1)(1996-9#1)
of more vigorous##2##3##(2010-10#2)
of more virulent##2##3##(2008-9#2)
of more vulnerable##2##3##(2008-9#1)(2011-1#1)
of more##423##2##(1990-10#1)(1990-11#1)(1990-12#5)(1990-2#2)(1990-4#1)(1990-7#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-9#2)(1992-11#3)(1992-2#3)(1992-3#2)(1992-5#1)(1992-7#2)(1992-8#1)(1992-9#2)(1993-10#1)(1993-11#4)(1993-12#3)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-2#3)(1995-5#2)(1995-6#1)(1995-7#1)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#4)(1996-9#4)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-1#1)(2004-11#2)(2005-11#2)(2005-12#1)(2005-3#1)(2005-6#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#10)(2006-11#1)(2006-12#1)(2006-2#4)(2006-5#2)(2006-6#5)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#7)(2007-12#30)(2007-2#6)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#8)(2007-8#6)(2007-9#4)(2008-1#11)(2008-10#36)(2008-11#8)(2008-12#4)(2008-2#18)(2008-3#8)(2008-4#4)(2008-5#10)(2008-6#4)(2008-7#11)(2008-8#5)(2008-9#4)(2009-10#4)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#3)(2010-10#3)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#3)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#17)(2012-1#2)(2012-11#2)(2012-12#5)(2012-2#11)(2013-1#5)(2013-7#1)(2013-8#4)
of more-complex##2##2##(2008-3#2)
of morin##2##2##(1997-8#1)(2008-10#1)
of morin-Al(3+) complex##2##3##(2008-10#2)
of morphemes##2##2##(2009-9#1)(2012-1#1)
of morphine (10##2##3##(1995-5#1)(1997-2#1)
of morphine and beta-endorphin##3##4##(1992-3#3)
of morphine and##8##3##(1990-2#1)(1992-3#3)(1994-2#1)(1995-6#1)(2008-10#1)(2008-8#1)
of morphine did not##2##4##(2008-4#1)(2008-7#1)
of morphine in the##2##4##(1995-12#1)(1997-2#1)
of morphine in tolerant rats##2##5##(1996-2#2)
of morphine in##11##3##(1991-1#2)(1995-12#1)(1996-2#2)(1997-2#2)(2007-2#1)(2008-10#2)(2008-3#1)
of morphine into the##2##4##(1990-7#1)(1993-12#1)
of morphine is presented##2##4##(1995-11#1)(2008-10#1)
of morphine is##4##3##(1991-1#1)(1995-11#1)(2008-10#1)(2008-3#1)
of morphine on##11##3##(1990-2#2)(1994-2#1)(1995-12#1)(1996-12#3)(1996-2#1)(2007-11#1)(2008-10#1)(2008-12#1)
of morphine sulfate##4##3##(1993-12#1)(1993-9#1)(1996-2#2)
of morphine tolerance##5##3##(1991-1#1)(1991-8#4)
of morphine was##3##3##(1990-7#1)(1991-3#1)(2006-12#1)
of morphine were##3##3##(1995-11#2)(2008-12#1)
of morphine##106##2##(1990-10#1)(1990-2#3)(1990-7#2)(1990-8#1)(1991-1#7)(1991-3#2)(1991-6#2)(1991-8#4)(1992-3#3)(1992-5#2)(1993-11#2)(1993-12#6)(1993-9#1)(1994-10#1)(1994-2#3)(1995-11#3)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#6)(1996-2#12)(1996-5#1)(1996-8#1)(1997-2#3)(2006-10#1)(2006-12#1)(2007-11#3)(2007-2#3)(2008-10#9)(2008-11#1)(2008-12#6)(2008-3#3)(2008-4#4)(2008-7#2)(2008-8#1)(2009-4#1)
of morphine-exposed##2##2##(1994-10#2)
of morphine-induced##2##2##(1991-3#1)(1997-2#1)
of morphogenesis##4##2##(1993-12#1)(1996-3#1)(2007-9#1)(2008-7#1)
of morphogenetic##3##2##(1990-8#1)(1994-9#1)(2009-8#1)
of morphogenic##2##2##(2009-8#1)(2012-2#1)
of morphologic and##3##3##(1993-12#1)(1996-7#1)(2008-10#1)
of morphologic##8##2##(1990-8#1)(1992-12#1)(1993-12#1)(1996-7#1)(2008-10#1)(2010-9#1)(2011-2#2)
of morphological alterations##2##3##(1990-5#1)(1997-2#1)
of morphological and biochemical##5##4##(1992-11#1)(1996-5#1)(2009-9#1)(2012-2#1)(2013-1#1)
of morphological and molecular evolution##2##5##(1992-12#1)(2012-2#1)
of morphological and##13##3##(1992-11#1)(1992-12#1)(1996-5#1)(2007-2#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-2#3)(2013-1#1)
of morphological changes##3##3##(1990-7#1)(2006-6#1)(2011-1#1)
of morphological characters##2##3##(2010-8#1)(2013-1#1)
of morphological data##3##3##(1992-12#1)(1993-6#1)(2009-10#1)
of morphological traits##2##3##(2008-10#1)(2008-8#1)
of morphological variation##2##3##(2013-1#2)
of morphological##57##2##(1990-5#1)(1990-7#1)(1992-11#1)(1992-12#3)(1992-5#3)(1993-6#1)(1994-8#1)(1996-5#1)(1997-2#1)(1997-8#1)(2006-11#1)(2006-5#1)(2006-6#4)(2006-9#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#2)(2009-9#1)(2010-12#1)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#4)
of morphologically and##2##3##(1990-12#1)(2008-7#1)
of morphologically distinct##2##3##(1995-2#1)(2008-10#1)
of morphologically normal##3##3##(1993-5#1)(2011-2#2)
of morphologically##15##2##(1990-10#1)(1990-12#1)(1992-6#1)(1993-5#1)(1995-2#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#2)(2011-2#3)
of morphology and##3##3##(2007-9#1)(2008-3#1)(2009-12#1)
of morphology##15##2##(1997-4#1)(2004-9#2)(2007-11#1)(2007-2#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-3#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-8#1)(2012-12#1)
of morphology-dependent resonances##2##3##(2007-12#1)(2008-3#1)
of morphometric##2##2##(2008-4#1)(2012-12#1)
of morphospecies##2##2##(2008-6#2)
of morphotype##6##2##(2008-10#6)
of mortality among##4##3##(2007-8#1)(2008-6#2)(2009-6#1)
of mortality and morbidity in##4##5##(2009-9#1)(2011-2#2)(2012-2#1)
of mortality and morbidity##14##4##(1994-11#1)(2004-1#1)(2006-8#1)(2006-9#1)(2009-10#1)(2009-9#1)(2010-12#1)(2011-2#3)(2012-1#2)(2012-2#2)
of mortality and##25##3##(1994-11#1)(2004-1#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-12#2)(2011-2#4)(2012-1#2)(2012-2#4)(2013-7#1)(2013-8#1)
of mortality at##2##3##(2008-8#1)(2012-3#1)
of mortality by##3##3##(2008-1#1)(2012-12#1)(2012-2#1)
of mortality causes##3##3##(2005-10#2)(2012-2#1)
of mortality during##2##3##(2008-10#1)(2013-1#1)
of mortality from##5##3##(1990-10#1)(1990-9#1)(1993-3#1)(1996-9#1)(2011-2#1)
of mortality in patients##3##4##(1993-9#1)(2006-6#1)(2011-2#1)
of mortality in the##2##4##(2008-1#1)(2011-2#1)
of mortality in##25##3##(1990-9#1)(1993-9#1)(1997-4#1)(2006-6#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-6#1)(2010-7#1)(2011-2#6)(2012-2#3)(2013-1#4)
of mortality is##4##3##(1994-11#1)(1995-8#1)(2008-10#1)(2011-2#1)
of mortality of##4##3##(2008-5#1)(2012-2#3)
of mortality or##3##3##(2008-5#2)(2012-3#1)
of mortality rate##4##3##(1995-3#1)(1995-8#1)(2008-5#1)(2008-8#1)
of mortality was##5##3##(2007-2#1)(2007-7#1)(2008-10#1)(2010-7#1)(2013-8#1)
of mortality when##2##3##(2008-7#1)(2008-8#1)
of mortality##151##2##(1990-10#1)(1990-9#2)(1991-3#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-3#1)(1993-9#1)(1994-11#2)(1994-5#1)(1995-3#2)(1995-8#2)(1996-12#1)(1996-9#2)(1997-4#1)(1997-6#1)(2004-1#1)(2004-11#1)(2005-10#2)(2005-8#2)(2006-10#7)(2006-12#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-10#2)(2007-11#4)(2007-2#2)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#3)(2008-3#2)(2008-5#6)(2008-6#2)(2008-7#7)(2008-8#6)(2008-9#2)(2009-10#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-12#2)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#17)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#13)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#4)
of mosaic symptoms##2##3##(2008-10#2)
of mosaic##7##2##(1991-5#1)(1996-3#1)(2007-11#1)(2008-10#2)(2012-11#2)
of mosaicism in##2##3##(1996-12#2)
of mosaicism##4##2##(1996-12#3)(2012-3#1)
of mosquito control##2##3##(2006-4#1)(2007-5#1)
of mosquito larvae in##3##4##(2007-11#2)(2013-1#1)
of mosquito larvae##4##3##(2007-10#1)(2007-11#2)(2013-1#1)
of mosquito##19##2##(1990-3#1)(1994-6#1)(2006-4#4)(2007-10#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-6#2)(2008-7#1)(2008-8#1)(2010-1#1)(2013-1#1)(2013-8#2)
of mosquitoes (Diptera##4##3##(2006-4#1)(2013-1#3)
of mosquitoes in the##2##4##(2007-2#1)(2008-3#1)
of mosquitoes in##5##3##(2007-11#1)(2007-2#1)(2008-3#2)(2013-1#1)
of mosquitoes##24##2##(1995-1#1)(2004-11#2)(2005-8#1)(2006-4#1)(2007-11#2)(2007-2#1)(2007-6#1)(2008-11#3)(2008-3#2)(2008-7#1)(2008-8#1)(2010-1#1)(2011-1#1)(2012-12#1)(2013-1#5)
of moss##3##2##(2006-12#1)(2008-10#1)(2010-2#1)
of mossy fiber##2##3##(1991-8#1)(1996-3#1)
of mossy fibers##2##3##(1993-6#1)(2009-6#1)
of mossy fibre##3##3##(1995-11#1)(2012-2#2)
of mossy##7##2##(1991-8#1)(1993-6#1)(1995-11#1)(1996-3#1)(2009-6#1)(2012-2#2)
of most affected##2##3##(2004-11#1)(2009-10#1)
of most cancer##2##3##(2007-3#1)(2009-11#1)
of most cancers##2##3##(1990-12#1)(2007-10#1)
of most cases##2##3##(2008-3#1)(2011-1#1)
of most commercial##2##3##(2008-10#1)(2008-3#1)
of most common##4##3##(1995-4#1)(2008-10#1)(2010-12#1)(2011-2#1)
of most complex diseases##2##4##(2012-3#2)
of most eukaryotic##2##3##(1990-6#1)(2008-1#1)
of most genes##2##3##(2007-12#1)(2008-10#1)
of most health##2##3##(1992-1#1)(2012-3#1)
of most interfering substances##2##4##(2008-10#2)
of most of the##30##4##(1990-12#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-7#1)(1995-9#1)(1996-11#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-7#1)(2006-12#2)(2006-4#1)(2006-7#1)(2007-1#2)(2007-12#1)(2007-7#1)(2008-10#5)(2008-4#1)(2009-7#1)(2012-12#1)(2013-1#1)
of most of these genes##2##5##(2008-8#1)(2008-9#1)
of most of these##8##4##(1991-10#1)(1995-10#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-8#1)(2008-9#1)(2010-12#1)
of most of##41##3##(1990-12#1)(1991-10#1)(1991-8#1)(1993-8#1)(1994-11#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-7#1)(1995-9#1)(1996-11#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-7#2)(2006-12#2)(2006-4#1)(2006-7#1)(2007-1#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
of most plant##2##3##(2004-4#1)(2008-8#1)
of most species##2##3##(1996-6#1)(2009-5#1)
of most##208##2##(1990-11#1)(1990-12#3)(1990-2#2)(1990-6#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-7#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-4#1)(1995-5#1)(1995-7#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-3#2)(1996-4#1)(1996-6#3)(1996-7#1)(1996-8#2)(1997-1#1)(1997-4#1)(1997-7#2)(1997-8#1)(2004-11#2)(2004-12#1)(2004-4#2)(2006-1#1)(2006-10#3)(2006-12#3)(2006-2#2)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#4)(2007-1#3)(2007-10#2)(2007-11#4)(2007-12#8)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#21)(2008-11#6)(2008-12#3)(2008-2#3)(2008-3#4)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#4)(2009-10#1)(2009-11#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#2)(2010-12#2)(2010-4#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#6)(2011-10#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#5)(2012-3#4)(2012-5#1)(2013-1#2)(2013-7#2)(2013-8#2)
of mostly##4##2##(1993-5#1)(2007-2#1)(2008-11#1)(2009-11#1)
of mother and child##3##4##(1994-6#1)(1994-9#1)(2008-4#1)
of mother and##10##3##(1990-12#3)(1993-6#1)(1994-6#1)(1994-9#1)(2007-2#3)(2008-4#1)
of mother##25##2##(1990-12#3)(1990-9#1)(1991-2#2)(1993-6#1)(1994-6#1)(1994-9#1)(1996-2#2)(2004-11#1)(2004-4#1)(2007-2#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2011-1#1)(2013-1#2)
of mother's##3##2##(1994-12#1)(2009-7#1)(2010-7#1)
of mother-infant##2##2##(1995-9#1)(2007-2#1)
of mother-to-child transmission of##9##4##(1990-9#1)(2007-2#1)(2009-4#4)(2009-7#1)(2012-2#2)
of mother-to-child transmission##14##3##(1990-9#1)(2006-10#1)(2007-2#1)(2007-7#1)(2009-4#7)(2009-7#1)(2012-2#2)
of mother-to-child##16##2##(1990-9#1)(2006-10#1)(2007-2#1)(2007-7#1)(2009-4#8)(2009-7#2)(2012-2#2)
of mothers and##7##3##(2007-5#1)(2008-9#1)(2009-11#2)(2009-4#2)(2013-1#1)
of mothers of children with##4##5##(1996-1#2)(2008-9#1)(2010-1#1)
of mothers of substance-dependent patients##2##5##(2011-1#2)
of mothers of##10##3##(1996-1#2)(2008-2#1)(2008-9#1)(2010-1#1)(2011-1#5)
of mothers regarding##3##3##(2007-2#1)(2007-7#1)(2007-9#1)
of mothers visited by##2##4##(2011-1#2)
of mothers who##3##3##(1990-10#1)(1990-9#1)(2007-1#1)
of mothers with##13##3##(1990-12#1)(2007-10#1)(2007-2#1)(2008-2#1)(2008-3#1)(2009-11#1)(2011-1#5)(2012-12#1)(2013-8#1)
of mothers##60##2##(1990-10#1)(1990-12#1)(1990-9#1)(1993-3#1)(1996-1#2)(2006-10#1)(2007-1#1)(2007-10#2)(2007-2#4)(2007-5#1)(2007-7#2)(2007-9#3)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-9#3)(2009-11#3)(2009-4#2)(2010-1#1)(2010-10#1)(2011-1#14)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
of mothers' confidence to care for children assisted with tracheostomy##2##10##(2012-2#2)
of mothers'##6##2##(2006-2#1)(2007-9#1)(2008-7#1)(2009-7#1)(2012-2#2)
of motifs in##4##3##(1995-8#1)(1996-4#1)(2008-7#1)(2010-2#1)
of motifs##12##2##(1995-8#2)(1996-4#1)(2007-6#1)(2008-4#2)(2008-7#1)(2010-2#1)(2010-7#2)(2012-2#2)
of motile cells##2##3##(2006-5#1)(2008-1#1)
of motile spermatozoa##2##3##(2006-5#1)(2009-4#1)
of motile##11##2##(1994-6#1)(2006-12#1)(2006-5#4)(2008-1#1)(2008-10#1)(2008-5#1)(2009-4#1)(2012-2#1)
of motilin##7##2##(1992-2#5)(1994-10#1)(1994-11#1)
of motility and##2##3##(2008-11#1)(2008-7#1)
of motility##14##2##(1990-6#1)(1993-7#1)(1993-9#1)(1994-6#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-7#5)(2009-6#2)
of motion and proprioception##2##4##(2010-12#2)
of motion and##20##3##(1991-2#1)(1992-3#1)(1993-11#1)(1996-3#1)(1997-8#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-4#1)(2007-7#2)(2008-2#2)(2008-8#1)(2009-1#1)(2010-12#2)(2011-2#1)(2012-1#2)
of motion are##2##3##(1992-2#1)(2007-12#1)
of motion at the##4##4##(2006-6#1)(2007-11#1)(2008-7#1)(2012-1#1)
of motion blurred images##2##4##(2008-6#2)
of motion blurred##3##3##(2008-2#1)(2008-6#2)
of motion events##5##3##(2008-4#4)(2010-2#1)
of motion has##2##3##(2007-12#1)(2008-8#1)
of motion in the##8##4##(2005-1#2)(2007-7#4)(2007-8#1)(2008-2#1)
of motion in##20##3##(2005-1#2)(2006-10#1)(2006-12#1)(2007-11#3)(2007-7#5)(2007-8#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-8#1)(2010-3#1)(2013-1#1)
of motion is##5##3##(1997-6#1)(2005-11#1)(2007-12#1)(2008-9#1)(2010-12#1)
of motion of the##10##4##(1993-9#1)(2007-11#1)(2007-12#1)(2007-8#3)(2009-5#1)(2011-2#2)(2013-1#1)
of motion of##15##3##(1992-2#1)(1993-9#1)(1996-2#1)(2007-11#1)(2007-12#2)(2007-8#4)(2009-5#1)(2011-2#2)(2013-1#2)
of motion perception##2##3##(1992-9#1)(1997-8#1)
of motion sensitivity##2##3##(2012-3#2)
of motion types##2##3##(2008-2#1)(2008-3#1)
of motion vision in##2##4##(1995-5#2)
of motion##188##2##(1991-12#1)(1991-2#1)(1992-1#1)(1992-2#3)(1992-3#1)(1992-9#2)(1993-11#1)(1993-9#1)(1995-5#2)(1996-2#1)(1996-3#1)(1997-6#2)(1997-8#4)(2005-1#2)(2005-11#1)(2006-10#3)(2006-12#3)(2006-3#3)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#11)(2007-12#5)(2007-4#1)(2007-7#12)(2007-8#10)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#10)(2008-2#11)(2008-3#7)(2008-4#7)(2008-6#4)(2008-7#2)(2008-8#8)(2008-9#7)(2009-1#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#9)(2012-1#6)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#12)(2013-7#1)
of motional##2##2##(1990-3#1)(2007-10#1)
of motions##3##2##(1991-2#1)(1994-9#1)(2009-2#1)
of motivation and##3##3##(2009-3#2)(2013-1#1)
of motivation##13##2##(1993-6#2)(1996-7#2)(2006-2#2)(2009-3#2)(2011-12#3)(2013-1#2)
of motivation-related behavior##2##3##(2008-4#2)
of motivational beliefs##2##3##(2010-1#2)
of motivational readiness for physical activity##3##6##(2008-4#3)
of motivational##12##2##(2006-3#1)(2008-11#1)(2008-12#1)(2008-4#3)(2008-6#1)(2008-9#1)(2010-1#2)(2011-2#1)(2013-1#1)
of motoneuron##2##2##(1992-7#1)(2007-12#1)
of motoneurones##2##2##(1996-2#1)(1996-3#1)
of motoneurons##6##2##(1991-3#1)(1995-1#2)(1996-11#1)(1996-6#1)(1996-9#1)
of motor activity##5##3##(1992-9#1)(1993-10#1)(1993-2#1)(1994-6#1)(1996-12#1)
of motor and sensory##3##4##(2006-3#2)(2009-3#1)
of motor and##6##3##(2006-3#2)(2007-8#1)(2009-3#1)(2012-12#2)
of motor complications##4##3##(2008-7#1)(2010-12#3)
of motor control##3##3##(2008-11#1)(2012-1#2)
of motor coordination##2##3##(1997-5#1)(2008-4#1)
of motor disability##2##3##(2008-7#2)
of motor fluctuation##2##3##(2013-1#2)
of motor fluctuations##2##3##(1994-10#1)(2008-11#1)
of motor function and##3##4##(1993-5#1)(1995-5#1)(1996-9#1)
of motor function in##2##4##(2006-10#1)(2013-7#1)
of motor function##12##3##(1990-5#1)(1993-5#1)(1995-1#1)(1995-5#1)(1996-9#1)(1997-2#1)(2006-10#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
of motor imagery##3##3##(2012-1#2)(2013-7#1)
of motor learning##2##3##(2008-4#1)(2012-1#1)
of motor nerves##2##3##(2007-12#1)(2008-9#1)
of motor neuron disease##2##4##(1992-1#1)(2006-4#1)
of motor neuron##8##3##(1992-1#1)(1997-8#1)(2006-4#1)(2008-6#2)(2008-7#2)(2012-2#1)
of motor neurone diseases##2##4##(1995-12#2)
of motor neurone##4##3##(1995-12#2)(1996-5#2)
of motor neurons in##2##4##(1996-6#1)(1997-8#1)
of motor neurons##7##3##(1990-5#2)(1996-6#2)(1997-8#1)(2008-9#1)(2010-12#1)
of motor performance##3##3##(1995-10#1)(2011-2#1)(2012-1#1)
of motor recovery##2##3##(2010-2#1)(2012-1#1)
of motor skills in##2##4##(2009-10#1)(2012-1#1)
of motor skills##3##3##(2009-10#1)(2012-1#2)
of motor units in##2##4##(1993-9#1)(1996-5#1)
of motor units##4##3##(1993-9#1)(1996-5#1)(2013-1#1)(2013-8#1)
of motor vehicle##2##3##(1992-3#1)(2012-12#1)
of motor##114##2##(1990-5#3)(1992-1#1)(1992-3#1)(1992-9#4)(1993-10#1)(1993-2#2)(1993-5#1)(1993-9#1)(1994-10#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-12#3)(1995-5#1)(1996-12#1)(1996-5#3)(1996-6#2)(1996-9#1)(1997-2#1)(1997-5#2)(1997-8#2)(2006-10#6)(2006-3#2)(2006-4#1)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#3)(2008-6#3)(2008-7#9)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-12#4)(2010-2#1)(2011-2#1)(2011-8#1)(2012-1#11)(2012-12#3)(2012-2#3)(2013-1#6)(2013-7#4)(2013-8#3)
of motorcycle##2##2##(2007-1#1)(2012-12#1)
of moulds##2##2##(2008-5#2)
of mountain##3##2##(1993-9#1)(2013-1#1)(2013-8#1)
of mounting##8##2##(2006-8#1)(2007-11#1)(2007-5#1)(2008-6#1)(2010-12#1)(2012-1#1)(2013-1#2)
of mouse B16 melanoma##2##4##(1991-5#1)(2008-5#1)
of mouse ES cell##2##4##(2008-1#1)(2012-2#1)
of mouse ES cells##3##4##(2008-1#2)(2008-9#1)
of mouse ES##5##3##(2008-1#3)(2008-9#1)(2012-2#1)
of mouse IgG protein##2##4##(2008-10#2)
of mouse IgG##3##3##(2008-10#3)
of mouse L cells##3##4##(1990-2#2)(1991-4#1)
of mouse L##4##3##(1990-2#2)(1991-4#2)
of mouse N-ras##2##3##(1992-9#2)
of mouse T cell receptor##2##5##(2008-4#2)
of mouse T cell##3##4##(2008-4#3)
of mouse T##4##3##(2008-4#4)
of mouse TGF-beta receptor genes##2##5##(1997-2#2)
of mouse Ugt1##2##3##(1994-8#2)
of mouse alpha-amylase##2##3##(1997-6#2)
of mouse and human class I##2##6##(1995-7#2)
of mouse and human##15##4##(1990-11#1)(1992-11#1)(1993-8#1)(1994-11#1)(1995-7#2)(1997-7#1)(2008-2#1)(2008-4#6)(2009-4#1)
of mouse and rat##2##4##(1995-5#1)(2007-11#1)
of mouse and##17##3##(1990-11#1)(1992-11#1)(1993-8#1)(1994-11#1)(1995-5#1)(1995-7#2)(1997-7#1)(2007-11#1)(2008-2#1)(2008-4#6)(2009-4#1)
of mouse blastocysts##2##3##(2006-5#1)(2008-11#1)
of mouse bone marrow##2##4##(2008-11#1)(2008-9#1)
of mouse brain##8##3##(1992-5#2)(1992-6#1)(1992-8#2)(1993-8#1)(1995-11#1)(1996-2#1)
of mouse calpastatin##2##3##(2008-11#2)
of mouse cerebellar##2##3##(1996-1#1)(2008-4#1)
of mouse chromosome 2##2##4##(1997-1#2)
of mouse chromosome##8##3##(1993-2#1)(1995-2#1)(1996-10#1)(1997-1#2)(1997-2#1)(2008-7#2)
of mouse colon##2##3##(1993-5#2)
of mouse embryonic fibroblasts##4##4##(1994-12#1)(2008-2#2)(2008-9#1)
of mouse embryonic##6##3##(1994-12#1)(2008-11#1)(2008-2#2)(2008-9#2)
of mouse embryos##2##3##(1992-11#1)(1996-5#1)
of mouse erythroleukemia##2##3##(1992-8#1)(2008-9#1)
of mouse hepatoma Hca-F cells##2##5##(2012-3#2)
of mouse hybridoma cells in##2##5##(1994-2#1)(2008-11#1)
of mouse islets with##2##4##(1995-7#1)(2013-1#1)
of mouse islets##3##3##(1995-7#1)(2008-1#1)(2013-1#1)
of mouse kidney##2##3##(1990-2#1)(1996-5#1)
of mouse lactate##2##3##(1990-4#2)
of mouse liver##4##3##(2008-10#2)(2008-9#1)(2013-1#1)
of mouse lymphocytes##2##3##(1992-5#1)(2008-4#1)
of mouse macrophages to##2##4##(1995-2#1)(2008-4#1)
of mouse macrophages##3##3##(1991-6#1)(1995-2#1)(2008-4#1)
of mouse mammary tumor virus##2##5##(1994-11#1)(1994-7#1)
of mouse mammary tumor virus-long terminal repeat##2##7##(1993-12#2)
of mouse mammary tumor##4##4##(1993-12#2)(1994-11#1)(1994-7#1)
of mouse mammary##6##3##(1991-12#1)(1991-7#1)(1993-12#2)(1994-11#1)(1994-7#1)
of mouse melanoma##2##3##(2008-11#2)
of mouse models##2##3##(2008-11#1)(2008-4#1)
of mouse monoclonal antibodies##4##4##(1996-5#1)(1997-6#1)(2008-5#1)(2011-1#1)
of mouse monoclonal##5##3##(1991-12#1)(1996-5#1)(1997-6#1)(2008-5#1)(2011-1#1)
of mouse neurons##3##3##(1994-2#1)(2011-1#1)(2012-2#1)
of mouse serum##3##3##(1990-12#1)(2007-11#1)(2010-12#1)
of mouse small##2##3##(2008-11#1)(2008-4#1)
of mouse spinal cord##3##4##(1991-10#1)(1995-11#1)(2008-11#1)
of mouse thymic##2##3##(2008-8#2)
of mouse thymus##2##3##(1990-3#1)(2008-4#1)
of mouse tissues##2##3##(1991-6#1)(2008-11#1)
of mouse uroplakin II gene##2##5##(1995-1#2)
of mouse##253##2##(1990-11#6)(1990-12#1)(1990-2#4)(1990-3#2)(1990-4#2)(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-4#3)(1991-5#2)(1991-6#4)(1991-7#4)(1991-9#2)(1992-11#4)(1992-5#3)(1992-6#2)(1992-7#2)(1992-8#5)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#3)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#4)(1993-8#3)(1994-11#5)(1994-12#2)(1994-2#5)(1994-3#1)(1994-5#1)(1994-7#1)(1994-8#3)(1994-9#3)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#4)(1995-5#2)(1995-6#1)(1995-7#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#3)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#5)(1997-4#3)(1997-5#4)(1997-6#4)(1997-7#5)(2006-11#2)(2006-5#1)(2007-11#2)(2007-12#1)(2008-1#4)(2008-10#6)(2008-11#15)(2008-2#5)(2008-3#1)(2008-4#27)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#7)(2009-4#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
of mouse-human hybridomas##2##3##(2008-11#2)
of mouse-mouse hybridoma##2##3##(1994-2#1)(1994-5#1)
of mouth##10##2##(1997-2#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-5#1)(2009-4#2)(2010-2#1)(2010-8#1)(2013-1#1)
of mouth-opening##2##2##(2008-5#2)
of movement and##9##3##(1991-1#1)(1993-2#1)(1997-3#1)(2007-11#2)(2007-8#1)(2012-1#3)
of movement are##2##3##(1990-5#1)(2008-6#1)
of movement direction##2##3##(1992-10#1)(2012-2#1)
of movement disorders or##2##4##(2006-12#1)(2008-7#1)
of movement disorders##4##3##(2006-12#1)(2006-4#1)(2008-7#1)(2013-7#1)
of movement in##8##3##(1996-4#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-6#1)
of movement is##4##3##(2007-7#1)(2008-8#1)(2011-12#1)(2013-8#1)
of movement of the##6##4##(1994-1#1)(2007-11#2)(2007-8#1)(2012-1#2)
of movement of##13##3##(1991-5#2)(1994-1#1)(1995-11#1)(2007-11#2)(2007-8#1)(2008-10#1)(2011-12#2)(2012-1#2)(2012-2#1)
of movement##109##2##(1990-2#1)(1990-5#2)(1991-1#1)(1991-5#2)(1992-10#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#2)(1994-1#1)(1994-3#1)(1995-11#1)(1996-4#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-8#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#9)(2007-12#1)(2007-2#4)(2007-7#8)(2007-8#12)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#2)(2008-6#3)(2008-7#3)(2008-8#3)(2009-3#1)(2010-3#2)(2010-6#2)(2011-12#4)(2012-1#6)(2012-12#1)(2012-2#6)(2013-1#2)(2013-7#2)(2013-8#1)
of movement-induced dose reduction##2##4##(2009-8#2)
of movements at the##2##4##(1991-9#1)(2012-2#1)
of movements of##2##3##(2007-12#1)(2010-8#1)
of movements##12##2##(1991-9#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-2#1)(2010-8#2)(2012-1#1)(2012-2#1)(2012-3#1)
of moving and##3##3##(2008-11#1)(2012-11#2)
of moving from##3##3##(2007-11#1)(2011-2#1)(2012-1#1)
of moving gratings in a##2##5##(2008-2#2)
of moving gratings##6##3##(2008-2#3)(2008-3#3)
of moving objects##8##3##(2007-9#1)(2008-2#3)(2008-3#3)(2011-2#1)
of moving surfaces##3##3##(2007-12#1)(2008-3#2)
of moving##45##2##(1990-4#1)(1993-5#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-6#2)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#7)(2008-3#10)(2008-5#3)(2008-8#1)(2009-3#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-3#1)(2013-8#1)
of moxibustion##2##2##(2012-3#1)(2013-1#1)
of moxidectin##4##2##(1993-10#1)(2007-6#3)
of moxifloxacin##4##2##(2006-8#2)(2013-7#2)
of moyamoya disease in the United States##2##7##(2006-11#2)
of moyamoya disease in the##4##5##(2006-11#2)(2007-10#2)
of moyamoya disease##9##3##(2006-11#6)(2007-10#2)(2012-12#1)
of mrf-1##2##2##(2008-6#2)
of mrgA##2##2##(1995-8#2)
of mrr##3##2##(2008-11#3)
of mt##2##2##(1993-2#1)(1996-7#1)
of mtDNA analysis##2##3##(2005-8#2)
of mtDNA haplotypes##3##3##(2008-10#2)(2010-8#1)
of mtDNA in rho0 cells##2##5##(2005-8#2)
of mtDNA in##5##3##(1995-11#1)(2005-8#2)(2008-8#1)(2009-11#1)
of mtDNA mutations##2##3##(1991-1#1)(2010-12#1)
of mtDNA type##2##3##(1997-4#2)
of mtDNA with##4##3##(1991-10#3)(1993-12#1)
of mtDNA##35##2##(1991-1#1)(1991-10#3)(1993-12#1)(1994-11#1)(1995-11#3)(1995-7#2)(1996-2#1)(1997-2#1)(1997-4#2)(2005-8#5)(2008-10#2)(2008-12#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#2)
of mtRNA##2##2##(1991-4#2)
of mtRNA(Leu(M)) was##2##3##(2008-8#2)
of mu and delta opioid receptors in##2##7##(2009-7#2)
of mu and delta##3##4##(2009-7#3)
of mu and##6##3##(1990-5#1)(1991-1#1)(2008-10#1)(2009-7#3)
of mu opioid##2##3##(1995-7#1)(1996-2#1)
of mu##17##2##(1990-2#1)(1990-5#1)(1991-1#1)(1991-5#3)(1993-2#1)(1995-7#1)(1996-2#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-2#1)(2009-7#4)
of mu(a) and mu(s)'##2##4##(2008-3#2)
of mu(a)##3##2##(2007-12#1)(2008-3#2)
of mu- and delta-opioid receptors##2##5##(1991-9#1)(1996-2#1)
of mu- and kappa-opioid receptor mRNAs in the##2##8##(1994-2#2)
of mu- and kappa-opioid receptors##2##5##(1990-7#2)
of mu- and kappa-opioid##4##4##(1990-7#2)(1994-2#2)
of mu- and##7##3##(1990-7#2)(1991-9#1)(1994-2#2)(1995-12#1)(1996-2#1)
of mu-##8##2##(1990-7#2)(1991-9#1)(1994-2#2)(1995-12#2)(1996-2#1)
of mu-calpain##4##2##(1992-1#3)(1994-3#1)
of mu-opioid receptors##3##3##(1996-2#1)(1997-2#2)
of mu-opioid##5##2##(1993-3#1)(1996-2#2)(1997-2#2)
of much debate##3##3##(2008-11#1)(2012-12#1)(2013-7#1)
of much higher##4##3##(1996-8#1)(2007-11#1)(2008-3#1)(2008-7#1)
of much less importance##2##4##(2006-10#1)(2009-6#1)
of much less##3##3##(2006-10#1)(2009-6#2)
of much of the##2##4##(1995-1#1)(2005-8#1)
of much of##3##3##(1990-5#1)(1995-1#1)(2005-8#1)
of much research in##2##4##(2008-11#1)(2009-6#1)
of much research##3##3##(2008-10#1)(2008-11#1)(2009-6#1)
of much##28##2##(1990-5#1)(1990-9#1)(1993-1#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-8#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#4)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#3)(2012-12#1)(2013-1#2)(2013-7#1)
of mucin in the##2##4##(1992-5#1)(2011-1#1)
of mucin##8##2##(1992-11#1)(1992-5#1)(1993-11#1)(1993-8#1)(2005-7#1)(2006-6#1)(2007-7#1)(2011-1#1)
of mucin&quot##2##2##(2005-12#2)
of mucinous material##2##3##(2006-6#1)(2010-6#1)
of mucinous ovarian cystomas of intestinal##2##6##(1990-2#2)
of mucinous##9##2##(1990-2#2)(1996-3#1)(2005-12#1)(2006-6#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-6#1)
of mucins and##2##3##(1992-11#1)(1992-4#1)
of mucins##4##2##(1992-11#1)(1992-4#1)(1994-9#1)(2007-1#1)
of mucociliary##2##2##(1991-9#1)(2005-11#1)
of mucocutaneous manifestations##2##3##(2010-9#2)
of mucocutaneous##6##2##(1994-4#1)(2007-12#1)(2010-6#1)(2010-9#3)
of mucormycosis##7##2##(2009-6#2)(2010-10#1)(2011-2#4)
of mucosa and##2##3##(2005-11#1)(2007-4#1)
of mucosa##7##2##(1997-1#1)(2005-11#1)(2006-10#2)(2007-4#1)(2011-1#1)(2013-8#1)
of mucosa-associated lymphoid tissue (MALT)##3##5##(2006-11#1)(2009-8#2)
of mucosa-associated lymphoid tissue##6##4##(2006-11#1)(2009-5#1)(2009-7#1)(2009-8#3)
of mucosal damage and##2##4##(2006-10#1)(2009-6#1)
of mucosal immune responses##2##4##(2006-10#1)(2012-1#1)
of mucosal immunity##2##3##(2006-10#1)(2008-5#1)
of mucosal inflammation##2##3##(2005-7#1)(2012-2#1)
of mucosal prolapse##3##3##(2006-6#1)(2008-8#1)(2013-1#1)
of mucosal tolerance##2##3##(1996-10#2)
of mucosal ulceration##2##3##(1996-12#1)(2007-11#1)
of mucosal##43##2##(1990-9#1)(1991-3#1)(1991-8#2)(1992-8#1)(1993-11#4)(1994-2#1)(1996-10#3)(1996-12#1)(2005-12#1)(2005-7#3)(2006-10#6)(2006-6#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#4)(2008-8#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#1)
of mucositis is##2##3##(2008-3#1)(2008-7#1)
of mucositis##4##2##(2007-11#1)(2008-3#1)(2008-7#2)
of mucous membranes##2##3##(1994-6#1)(2005-7#1)
of mucus##6##2##(1992-5#1)(1995-2#1)(1996-7#1)(2005-11#1)(2006-10#1)(2007-2#1)
of mud##2##2##(2007-5#1)(2012-3#1)
of mug l(-1)##3##3##(2008-10#3)
of mug##4##2##(2008-10#4)
of mulberry anthracnose##2##3##(2008-10#2)
of mulberry##3##2##(2008-10#3)
of mulch##2##2##(2008-10#2)
of multi-agent##2##2##(2010-2#1)(2010-3#1)
of multi-component##3##2##(2008-10#2)(2010-4#1)
of multi-detector##3##2##(2008-7#1)(2011-2#2)
of multi-dimensional##3##2##(1996-12#1)(1997-2#1)(2012-2#1)
of multi-domain##2##2##(2011-1#1)(2013-8#1)
of multi-drug resistant##3##3##(2005-12#1)(2007-6#1)(2011-1#1)
of multi-drug##8##2##(2005-12#1)(2005-7#1)(2007-6#1)(2011-1#1)(2013-1#4)
of multi-faceted##2##2##(1997-2#1)(2012-3#1)
of multi-institutional##2##2##(2006-10#1)(2010-5#1)
of multi-level##2##2##(1996-12#1)(2007-8#1)
of multi-resistant##2##2##(1995-8#1)(2007-2#1)
of multi-traumatized patients##2##3##(1992-3#2)
of multi-unit##2##2##(1996-12#2)
of multicellular##8##2##(1991-11#1)(1992-9#1)(2008-10#1)(2008-7#1)(2009-12#1)(2009-6#1)(2010-3#1)(2011-2#1)
of multicenter clinical##2##3##(2011-2#2)
of multicenter##3##2##(2006-7#1)(2011-2#2)
of multicentric##8##2##(1991-12#1)(2005-12#1)(2006-10#1)(2006-2#1)(2007-7#1)(2008-9#1)(2013-7#2)
of multichannel##6##2##(1997-6#1)(2007-12#2)(2008-2#1)(2008-3#1)(2009-2#1)
of multicistronic expression##2##3##(2008-11#2)
of multicommutation##3##2##(2008-10#3)
of multicomponent systems##2##3##(2007-12#1)(2008-11#1)
of multicomponent##12##2##(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-10#1)(2013-8#2)
of multicomponents in##2##3##(2007-8#1)(2013-8#1)
of multicopper oxidases##2##3##(2008-10#1)(2012-2#1)
of multicultural training to##2##4##(2004-12#2)
of multicultural training##3##3##(2004-12#3)
of multicultural##5##2##(2004-12#5)
of multidentate##2##2##(1996-8#1)(2006-3#1)
of multidetector CT##2##3##(2008-7#1)(2010-9#1)
of multidetector##4##2##(2007-4#1)(2007-8#1)(2008-7#1)(2010-9#1)
of multidimensional data##2##3##(2008-10#1)(2009-8#1)
of multidimensional scaling##2##3##(1995-5#1)(2013-7#1)
of multidimensional##13##2##(1995-5#1)(1997-2#1)(2008-10#2)(2008-2#2)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#1)(2012-1#1)(2012-3#1)(2013-7#1)
of multidisciplinary care##2##3##(1996-1#1)(2012-8#1)
of multidisciplinary##11##2##(1996-1#2)(2008-10#1)(2008-12#1)(2008-9#1)(2010-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#1)
of multidrug resistance (MDR)##2##4##(1990-8#1)(2012-3#1)
of multidrug resistance in##4##4##(2005-10#1)(2007-10#1)(2008-11#1)(2010-2#1)
of multidrug resistance##15##3##(1990-2#1)(1990-8#1)(1993-9#1)(1994-7#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-5#1)(2005-10#1)(2007-10#1)(2008-11#2)(2010-2#1)(2012-3#2)
of multidrug resistant##10##3##(1994-3#1)(1996-3#1)(2008-11#2)(2008-8#1)(2009-2#1)(2009-5#1)(2012-1#1)(2012-2#1)(2013-8#1)
of multidrug##29##2##(1990-2#1)(1990-8#1)(1991-8#1)(1993-9#1)(1994-3#1)(1994-7#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-5#1)(2005-10#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-11#4)(2008-8#1)(2009-2#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-8#1)
of multidrug-resistant cells##2##3##(1993-9#1)(1996-7#1)
of multidrug-resistant tuberculosis (MDR-TB)##2##4##(1991-8#1)(2010-10#1)
of multidrug-resistant tuberculosis##6##3##(1991-8#2)(1996-3#1)(2007-11#1)(2009-4#1)(2010-10#1)
of multidrug-resistant##14##2##(1991-8#2)(1993-9#1)(1994-7#1)(1995-6#1)(1996-3#1)(1996-7#1)(2005-7#1)(2006-10#1)(2007-11#1)(2009-4#1)(2010-10#1)(2010-6#1)(2011-2#1)
of multielemental analysis in##2##4##(2008-10#2)
of multielemental analysis##3##3##(2008-10#3)
of multifactorial diseases##2##3##(2008-3#1)(2012-2#1)
of multifactorial##4##2##(1990-3#1)(2008-3#1)(2009-9#1)(2012-2#1)
of multifocal##8##2##(1997-1#1)(2004-2#1)(2006-10#1)(2006-6#1)(2007-7#1)(2009-3#2)(2009-9#1)
of multifunctional##9##2##(1991-9#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-3#1)
of multigene metabolic engineering##2##4##(2008-11#2)
of multigene##3##2##(2006-4#1)(2008-11#2)
of multilamellar vesicles##2##3##(1991-9#1)(2006-10#1)
of multilamellar##3##2##(1991-9#1)(2006-10#2)
of multilayer coatings##3##3##(2008-2#2)(2010-4#1)
of multilayer formation##3##3##(2005-11#2)(2008-10#1)
of multilayer mirrors##2##3##(2008-2#2)
of multilayer neural networks##2##4##(2008-2#1)(2010-8#1)
of multilayer##21##2##(2005-11#2)(2007-12#1)(2008-10#4)(2008-2#6)(2008-3#6)(2010-4#1)(2010-8#1)
of multilayered##4##2##(2007-12#1)(2008-12#2)(2008-2#1)
of multilayers##2##2##(1995-10#1)(2007-12#1)
of multilevel diffractive##2##3##(2007-12#2)
of multilevel##11##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#2)
of multilingual##2##2##(2008-7#1)(2008-9#1)
of multilocus correlation##7##3##(2008-10#7)
of multilocus structure of populations##2##5##(2008-10#2)
of multilocus##17##2##(2005-10#1)(2008-10#14)(2008-9#1)(2012-3#1)
of multimedia##3##2##(2008-2#1)(2010-7#1)(2013-8#1)
of multimeric proteins##2##3##(1996-11#2)
of multimeric##3##2##(1996-11#2)(2007-11#1)
of multimodal therapy##4##3##(2007-12#1)(2010-12#1)(2010-3#2)
of multimodal##10##2##(1993-6#1)(2006-10#1)(2007-12#1)(2008-10#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-3#2)(2012-2#1)
of multimodality##5##2##(2006-10#1)(2006-7#1)(2008-2#1)(2009-11#1)(2010-5#1)
of multimode fibers##2##3##(2008-2#1)(2008-3#1)
of multimode##14##2##(2007-11#1)(2007-12#2)(2008-2#6)(2008-3#5)
of multimorbidity##6##2##(2013-1#6)
of multinational##3##2##(2007-4#1)(2008-5#1)(2010-3#1)
of multinucleated giant cells##2##4##(1995-5#1)(2009-3#1)
of multinucleated##5##2##(1990-9#2)(1991-1#1)(1995-5#1)(2009-3#1)
of multiorgan##4##2##(1990-6#1)(1997-3#1)(2007-11#1)(2008-12#1)
of multiparameter##2##2##(2008-9#2)
of multiparametric##2##2##(2008-1#1)(2008-4#1)
of multipass ultrashort-pulse laser amplifiers##2##5##(2008-2#2)
of multipayer agreements##3##3##(2007-4#3)
of multiphoton fluorescence##4##3##(2007-12#2)(2008-9#1)(2009-4#1)
of multiphoton##9##2##(2007-12#4)(2008-9#2)(2009-4#2)(2011-1#1)
of multiplanar##2##2##(2008-3#1)(2011-2#1)
of multiple Z-tests##3##3##(1993-6#3)
of multiple analytes##3##3##(2007-11#1)(2008-3#1)(2010-5#1)
of multiple and##4##3##(1993-10#1)(2008-10#1)(2008-4#1)(2008-6#1)
of multiple beams in##2##4##(2007-12#1)(2008-2#1)
of multiple beams##4##3##(2007-12#1)(2008-2#3)
of multiple biomarkers##2##3##(2012-1#1)(2013-1#1)
of multiple births##2##3##(1995-6#2)
of multiple burials of sclerotia##2##5##(2008-10#2)
of multiple cell types##4##4##(2006-10#1)(2010-4#3)
of multiple cell##7##3##(2006-10#1)(2008-5#1)(2008-8#1)(2010-4#3)(2012-2#1)
of multiple cholesterol##2##3##(2006-10#2)
of multiple copies of##2##4##(1993-5#1)(2011-2#1)
of multiple copies##3##3##(1993-5#1)(1994-3#1)(2011-2#1)
of multiple cutaneous##2##3##(2007-10#1)(2012-3#1)
of multiple data##2##3##(2008-7#1)(2013-1#1)
of multiple defense##2##3##(2008-10#2)
of multiple diseases##6##3##(2008-10#1)(2012-12#1)(2013-1#4)
of multiple drugs##6##3##(1990-8#1)(2006-8#1)(2009-11#1)(2010-11#1)(2012-11#2)
of multiple endocrine neoplasia##2##4##(1990-3#1)(2013-1#1)
of multiple endocrine##3##3##(1990-3#1)(2009-4#1)(2013-1#1)
of multiple endogenous##2##3##(2010-6#1)(2012-12#1)
of multiple exposures##2##3##(1993-4#2)
of multiple failure time data##2##5##(1997-4#2)
of multiple field##2##3##(2008-10#1)(2008-3#1)
of multiple foci##2##3##(2007-11#1)(2008-10#1)
of multiple forms of##6##4##(1990-7#1)(1991-5#1)(1994-12#1)(1994-9#1)(2007-8#1)(2009-12#1)
of multiple gene##4##3##(1997-7#1)(2008-5#1)(2008-7#1)(2012-3#1)
of multiple genes involved in##2##5##(1995-8#1)(2010-12#1)
of multiple genes##7##3##(1992-12#1)(1994-9#1)(1995-8#1)(2006-5#1)(2008-11#1)(2008-9#1)(2010-12#1)
of multiple genetic and environmental factors##2##6##(2005-8#1)(2008-7#1)
of multiple genetic and##3##4##(2005-8#1)(2008-7#1)(2009-6#1)
of multiple genetic##6##3##(2005-8#1)(2008-7#1)(2009-6#1)(2010-9#1)(2012-3#1)(2013-8#1)
of multiple growth factors##2##4##(1993-7#1)(2006-11#1)
of multiple hydatid cysts##2##4##(2008-7#2)
of multiple indicators##2##3##(1995-8#1)(2010-11#1)
of multiple infections##2##3##(1997-4#1)(2008-9#1)
of multiple injuries##2##3##(1992-6#1)(2005-8#1)
of multiple internal##2##3##(2008-11#1)(2008-9#1)
of multiple isoforms of##3##4##(1994-6#1)(1996-8#1)(2007-12#1)
of multiple isoforms##4##3##(1994-6#1)(1996-5#1)(1996-8#1)(2007-12#1)
of multiple layers of##2##4##(2009-5#1)(2009-6#1)
of multiple layers##3##3##(2007-12#1)(2009-5#1)(2009-6#1)
of multiple lesions in##2##4##(2005-12#1)(2013-1#1)
of multiple lesions##5##3##(2005-12#1)(2007-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
of multiple light scattering##2##4##(2008-2#1)(2008-3#1)
of multiple light##3##3##(2008-2#1)(2008-3#2)
of multiple linear regression##3##4##(2008-10#3)
of multiple malignancies##3##3##(2013-1#2)(2013-8#1)
of multiple measurements##2##3##(1994-9#1)(2007-12#1)
of multiple measures##2##3##(2008-5#1)(2008-8#1)
of multiple mechanisms##3##3##(2005-8#1)(2007-12#1)(2008-10#1)
of multiple medical##2##3##(2006-7#1)(2007-8#1)
of multiple medications##5##3##(2008-4#1)(2008-5#1)(2009-4#1)(2013-1#2)
of multiple meningiomas##2##3##(2008-10#1)(2008-8#1)
of multiple metabolic##2##3##(1996-8#1)(2011-1#1)
of multiple molecular##2##3##(1996-6#1)(2009-5#1)
of multiple myeloma (MM)##3##4##(2008-1#2)(2010-12#1)
of multiple myeloma and##2##4##(1991-12#1)(2012-2#1)
of multiple myeloma by##2##4##(1991-5#1)(2008-7#1)
of multiple myeloma##22##3##(1991-12#1)(1991-5#1)(1992-10#1)(2005-12#1)(2007-12#1)(2007-8#1)(2008-1#4)(2008-3#2)(2008-7#2)(2009-4#1)(2010-12#3)(2012-12#2)(2012-2#1)(2013-8#1)
of multiple myeloma]##3##3##(2008-1#3)
of multiple nodules and##2##4##(2006-6#1)(2010-6#1)
of multiple nodules##4##3##(2006-6#3)(2010-6#1)
of multiple objects##3##3##(2008-3#3)
of multiple organ failure##5##4##(1996-3#1)(2006-6#1)(2007-8#1)(2008-3#1)(2012-1#1)
of multiple organ##9##3##(1996-3#2)(2005-8#1)(2006-6#1)(2007-8#1)(2008-3#1)(2008-8#1)(2012-1#1)(2012-2#1)
of multiple parallel synthesis##2##4##(2008-10#2)
of multiple phase##2##3##(1993-2#1)(2007-12#1)
of multiple populations of##2##4##(1990-7#1)(2012-2#1)
of multiple populations##3##3##(1990-7#1)(2008-9#1)(2012-2#1)
of multiple positive##2##3##(2013-7#2)
of multiple pregnancies##2##3##(1997-2#1)(2008-11#1)
of multiple primary melanomas##2##4##(2007-8#2)
of multiple primary##4##3##(2007-8#2)(2011-2#2)
of multiple protein##2##3##(1991-11#1)(1996-2#1)
of multiple proteins##3##3##(1993-8#1)(2009-7#1)(2010-11#1)
of multiple quantitative##2##3##(2008-9#1)(2013-8#1)
of multiple rare variants##2##4##(2012-3#2)
of multiple rare##5##3##(2012-3#5)
of multiple reflecting surfaces##2##4##(2008-3#2)
of multiple reflection##2##3##(2007-12#1)(2008-3#1)
of multiple reflections##2##3##(2007-12#1)(2008-3#1)
of multiple reversals##2##3##(1990-7#1)(2007-12#1)
of multiple rotational Raman##2##4##(2007-11#2)
of multiple scattering by##2##4##(2008-2#1)(2008-3#1)
of multiple scattering on##3##4##(2008-2#1)(2008-3#2)
of multiple scattering##15##3##(2007-11#1)(2008-2#6)(2008-3#7)(2013-8#1)
of multiple sclerosis (MS) patients##2##5##(2010-2#1)(2012-3#1)
of multiple sclerosis (MS)##10##4##(1994-7#1)(2006-12#2)(2007-11#1)(2010-2#1)(2012-3#3)(2013-1#1)(2013-7#1)
of multiple sclerosis has##2##4##(2007-11#2)
of multiple sclerosis have been##2##5##(2007-11#2)
of multiple sclerosis have##3##4##(2007-11#2)(2012-2#1)
of multiple sclerosis in##2##4##(2006-12#2)
of multiple sclerosis patients##2##4##(1997-3#1)(2007-11#1)
of multiple sclerosis with##2##4##(2007-11#1)(2009-10#1)
of multiple sclerosis##42##3##(1990-12#1)(1991-12#1)(1991-6#1)(1991-8#1)(1994-7#1)(1994-9#1)(1995-12#1)(1997-3#2)(2005-7#1)(2006-12#4)(2007-11#13)(2008-8#1)(2009-10#1)(2010-12#1)(2010-2#1)(2012-2#3)(2012-3#5)(2013-1#2)(2013-7#1)
of multiple sequence alignment##3##4##(1994-8#1)(2008-4#2)
of multiple sequence##4##3##(1994-8#1)(1994-9#1)(2008-4#2)
of multiple sex##2##3##(1993-6#1)(2011-2#1)
of multiple signaling pathways##4##4##(2007-3#2)(2011-2#1)(2013-7#1)
of multiple species of##4##4##(1991-10#1)(1991-7#1)(2008-3#1)(2008-5#1)
of multiple species##8##3##(1991-10#1)(1991-7#1)(1994-2#1)(1995-6#1)(2008-3#2)(2008-5#1)(2009-8#1)
of multiple spectral lines##2##4##(2007-12#2)
of multiple squamous cell papilloma of the forestomach in##2##9##(2008-9#2)
of multiple tests##3##3##(1993-6#1)(2010-2#2)
of multiple tissues##3##3##(1996-10#1)(2008-7#1)(2010-3#1)
of multiple trauma##2##3##(2008-12#1)(2012-12#1)
of multiple treatment##2##3##(1991-1#1)(2009-2#1)
of multiple types of##4##4##(2007-12#1)(2012-2#1)(2013-1#2)
of multiple vertebral hemangiomas##2##4##(2009-3#1)(2012-2#1)
of multiple##652##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-7#4)(1990-8#3)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#3)(1991-6#2)(1991-7#3)(1991-8#3)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1993-1#2)(1993-10#1)(1993-12#2)(1993-2#1)(1993-4#3)(1993-5#2)(1993-6#5)(1993-7#2)(1993-8#2)(1993-9#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#2)(1994-8#3)(1994-9#7)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#5)(1995-8#3)(1996-1#2)(1996-10#1)(1996-12#2)(1996-2#3)(1996-3#4)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#5)(1997-4#5)(1997-5#3)(1997-7#2)(2003-11#1)(2005-1#1)(2005-11#1)(2005-12#2)(2005-7#2)(2005-8#4)(2006-1#1)(2006-10#11)(2006-11#2)(2006-12#6)(2006-2#1)(2006-5#2)(2006-6#4)(2006-7#4)(2006-8#3)(2006-9#1)(2007-10#4)(2007-11#24)(2007-12#24)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#3)(2007-7#5)(2007-8#11)(2008-1#12)(2008-10#35)(2008-11#10)(2008-12#4)(2008-2#21)(2008-3#35)(2008-4#20)(2008-5#10)(2008-6#3)(2008-7#16)(2008-8#12)(2008-9#15)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#6)(2009-5#2)(2009-6#4)(2009-7#1)(2009-8#5)(2009-9#3)(2010-10#1)(2010-11#7)(2010-12#12)(2010-2#3)(2010-3#1)(2010-4#4)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#10)(2011-12#4)(2011-2#9)(2012-1#8)(2012-11#3)(2012-12#14)(2012-2#19)(2012-3#24)(2013-1#24)(2013-7#5)(2013-8#8)
of multiple-beam##4##2##(2008-2#3)(2008-3#1)
of multiple-choice##2##2##(2005-10#1)(2009-4#1)
of multiple-drug##2##2##(2006-11#1)(2007-6#1)
of multiple-organ system failure##2##4##(2006-10#2)
of multiple-scattering##3##2##(2006-4#1)(2008-2#1)(2008-3#1)
of multiplex PCR products##3##4##(2008-10#2)(2008-9#1)
of multiplex PCR##4##3##(2008-10#3)(2008-9#1)
of multiplex real-time##2##3##(2007-12#1)(2008-10#1)
of multiplex##10##2##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-9#1)(2012-2#2)
of multiplexed##3##2##(2008-11#1)(2008-3#1)(2008-9#1)
of multiplexing##3##2##(2007-12#1)(2007-8#1)(2008-2#1)
of multiplication and##2##3##(2008-10#2)
of multiplication##3##2##(2008-10#2)(2009-2#1)
of multiplicity of##2##3##(1996-11#1)(2008-4#1)
of multiply scattered light##4##4##(2007-12#1)(2008-2#3)
of multiply scattered photons##2##4##(2007-12#1)(2008-3#1)
of multiply scattered##9##3##(2007-12#4)(2008-2#4)(2008-3#1)
of multiply##15##2##(2007-12#4)(2008-1#1)(2008-2#5)(2008-3#2)(2008-4#1)(2008-9#1)(2009-10#1)
of multipole##2##2##(2007-11#1)(2007-12#1)
of multipotent##7##2##(1995-1#1)(2005-8#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-12#1)(2012-4#1)
of multiprofessional##2##2##(1997-8#1)(2012-3#1)
of multiprotein complexes##2##3##(2008-4#1)(2010-2#1)
of multipurpose solutions##2##3##(2005-11#2)
of multiresistant Gram-positive##2##3##(2008-3#2)
of multiresistant bacteria##2##3##(2009-5#1)(2012-1#1)
of multiresistant##7##2##(2007-7#1)(2008-3#2)(2009-5#1)(2012-1#1)(2012-3#2)
of multisite##2##2##(1995-10#1)(1995-3#1)
of multislice spiral CT##2##4##(2005-8#2)
of multislice spiral##3##3##(2005-8#2)(2013-7#1)
of multislice##5##2##(2005-8#2)(2008-7#1)(2012-12#1)(2013-7#1)
of multispecies competition##2##3##(2008-8#2)
of multispecies##3##2##(2008-8#3)
of multispectral images##2##3##(2008-2#2)
of multispectral##4##2##(2008-10#1)(2008-2#3)
of multistage##3##2##(2007-12#1)(2008-10#1)(2011-2#1)
of multistep##3##2##(2008-10#1)(2008-3#1)(2010-10#1)
of multisubunit##6##2##(1995-10#1)(1996-8#1)(2008-2#2)(2008-4#1)(2010-7#1)
of multitherapy vs##2##3##(1994-6#2)
of multivalent##5##2##(2006-10#1)(2007-12#3)(2009-2#1)
of multivariable##4##2##(1994-5#2)(2007-11#1)(2009-12#1)
of multivariate analysis##3##3##(2006-12#1)(2008-10#2)
of multivariate calibration methods##2##4##(2008-1#2)
of multivariate calibration##3##3##(2008-1#2)(2008-10#1)
of multivariate data analysis##3##4##(2008-10#2)(2012-1#1)
of multivariate data##4##3##(2008-10#2)(2008-6#1)(2012-1#1)
of multivariate techniques##2##3##(2008-11#1)(2008-3#1)
of multivariate##31##2##(1992-6#1)(1993-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-11#1)(2006-12#1)(2007-10#1)(2008-1#2)(2008-10#14)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-1#1)(2012-1#2)
of multivessel##2##2##(2007-8#2)
of multiwall carbon nanotubes##3##4##(2008-10#3)
of multiwalled carbon nanotubes##4##4##(2008-10#1)(2009-3#1)(2010-12#2)
of multiwavelength##7##2##(2005-4#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)
of mummy##3##2##(2008-10#3)
of mumps virus##3##3##(2010-1#2)(2013-7#1)
of mumps##7##2##(1997-6#1)(2007-2#1)(2010-1#2)(2010-12#1)(2011-1#1)(2013-7#1)
of mung bean seedlings##2##4##(2008-9#2)
of mung bean##3##3##(2008-10#1)(2008-9#2)
of municipal##7##2##(1992-11#1)(1992-3#1)(1995-11#1)(1997-4#1)(2008-2#1)(2009-6#1)(2011-2#1)
of municipalities##4##2##(2008-9#2)(2011-1#1)(2012-12#1)
of mupirocin##2##2##(1991-8#1)(2013-7#1)
of muraglitazar##2##2##(2010-4#2)
of mural##4##2##(1992-9#1)(2008-7#1)(2012-12#2)
of murexide##3##2##(2008-10#3)
of murine Hoxa-7##3##3##(1997-4#3)
of murine ST2##2##3##(1992-12#2)
of murine Smad5##2##3##(2008-8#2)
of murine and human##5##4##(1991-5#1)(1992-2#1)(1995-2#1)(2008-4#1)(2010-6#1)
of murine and##6##3##(1991-5#1)(1992-2#1)(1995-12#1)(1995-2#1)(2008-4#1)(2010-6#1)
of murine cortical##2##3##(1995-12#1)(1995-7#1)
of murine erythroid##2##3##(2008-8#2)
of murine erythroleukemia cells##5##4##(1991-2#1)(1991-6#2)(1991-8#1)(1993-6#1)
of murine erythroleukemia##6##3##(1991-2#2)(1991-6#2)(1991-8#1)(1993-6#1)
of murine fibroblasts##3##3##(1994-12#1)(1996-8#1)(2008-6#1)
of murine hematopoietic stem cells##2##5##(1994-3#1)(2008-4#1)
of murine hematopoietic##3##3##(1994-3#1)(1997-4#1)(2008-4#1)
of murine hybridoma##2##3##(2008-11#2)
of murine macrophages##8##3##(1992-1#1)(1992-9#1)(1994-9#1)(2008-4#5)
of murine model##2##3##(2008-9#1)(2009-9#1)
of murine monoclonal##2##3##(1990-9#1)(2008-10#1)
of murine origin##2##3##(1991-9#1)(1992-1#1)
of murine peritoneal##2##3##(1992-7#1)(2008-8#1)
of murine spleen cells##2##4##(1994-3#1)(2007-11#1)
of murine tumor##2##3##(1990-12#1)(1992-8#1)
of murine##123##2##(1990-12#2)(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-2#2)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-7#4)(1992-8#1)(1992-9#1)(1993-3#4)(1993-4#2)(1993-5#1)(1993-6#2)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#4)(1995-1#1)(1995-12#2)(1995-2#3)(1995-3#3)(1995-5#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-4#7)(1997-6#1)(1997-7#2)(2005-8#1)(2006-10#2)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#4)(2008-4#15)(2008-6#1)(2008-8#7)(2008-9#2)(2009-9#1)(2010-12#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
of muscarine##3##2##(1995-7#1)(1996-3#2)
of muscarinic M2##4##3##(1995-12#4)
of muscarinic acetylcholine##2##3##(1990-4#1)(1995-3#1)
of muscarinic and nicotinic##2##4##(2004-12#1)(2012-1#1)
of muscarinic receptor subtypes##4##4##(1994-9#1)(1996-3#3)
of muscarinic receptor##6##3##(1991-5#1)(1994-9#1)(1995-12#1)(1996-3#3)
of muscarinic receptors can##2##4##(1996-10#1)(1996-12#1)
of muscarinic receptors##7##3##(1990-10#2)(1993-2#1)(1996-10#2)(1996-12#1)(1996-3#1)
of muscarinic##30##2##(1990-10#2)(1990-4#2)(1991-5#1)(1991-9#2)(1993-12#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#5)(1995-3#1)(1996-10#2)(1996-12#1)(1996-3#4)(1997-5#2)(2004-12#1)(2012-1#1)
of muscimol on##2##3##(1991-1#1)(1993-11#1)
of muscimol to##2##3##(1993-11#2)
of muscimol##9##2##(1991-1#2)(1993-11#3)(1993-12#2)(1993-7#1)(1994-10#1)
of muscle MEPs##2##3##(2006-12#2)
of muscle activation##4##3##(1993-9#2)(2006-11#2)
of muscle activity##2##3##(2012-1#1)(2012-12#1)
of muscle afferents##2##3##(1992-8#1)(2005-10#1)
of muscle and##2##3##(1990-3#1)(2012-2#1)
of muscle biopsy##4##3##(1994-8#1)(1996-6#1)(2006-4#1)(2008-7#1)
of muscle cell##3##3##(1994-12#1)(1996-3#1)(2012-2#1)
of muscle cells##9##3##(1992-3#2)(1994-3#1)(2008-10#1)(2009-3#1)(2009-9#4)
of muscle contraction##5##3##(1990-6#1)(1997-4#2)(2006-5#1)(2011-2#1)
of muscle contractions##4##3##(1991-11#1)(1994-8#2)(2008-3#1)
of muscle disease##2##3##(2006-10#1)(2012-3#1)
of muscle enzymes##2##3##(2006-10#1)(2006-4#1)
of muscle fatigue##2##3##(1993-11#1)(2010-8#1)
of muscle fiber motion##2##4##(2011-1#2)
of muscle fibers##5##3##(1994-11#1)(1995-12#1)(2008-3#1)(2011-2#1)(2012-3#1)
of muscle fibres##3##3##(1993-7#1)(2005-1#1)(2013-1#1)
of muscle flap closure##2##4##(2012-2#2)
of muscle function##3##3##(2009-5#1)(2010-8#1)(2011-2#1)
of muscle glycogen##2##3##(1994-12#1)(2008-1#1)
of muscle involvement##2##3##(2006-10#2)
of muscle membrane cytoskeleton##2##4##(1993-4#2)
of muscle pain##2##3##(1994-2#2)
of muscle relaxants##3##3##(2006-10#2)(2013-7#1)
of muscle spindles in##2##4##(1992-9#2)
of muscle spindles##4##3##(1992-9#2)(1996-9#2)
of muscle stem##2##3##(2008-1#1)(2009-3#1)
of muscle strength and functional ability##2##6##(2007-2#2)
of muscle strength and##3##4##(2007-2#2)(2012-2#1)
of muscle strength in the shoulder rotators##2##7##(2007-7#2)
of muscle strength##7##3##(2007-2#3)(2007-7#3)(2012-2#1)
of muscle tension and##2##4##(1994-2#2)
of muscle tension##4##3##(1994-11#1)(1994-2#2)(2006-11#1)
of muscle tissue##3##3##(1990-6#1)(2008-3#1)(2012-3#1)
of muscle to##4##3##(1990-8#1)(1992-3#1)(2009-5#1)(2010-12#1)
of muscle tone##7##3##(1991-5#2)(1995-2#4)(2007-4#1)
of muscle was##2##3##(2010-4#1)(2011-2#1)
of muscle weakness##4##3##(1997-8#1)(2006-8#1)(2007-7#1)(2012-3#1)
of muscle##175##2##(1990-3#1)(1990-6#2)(1990-8#2)(1991-11#1)(1991-2#1)(1991-5#3)(1991-7#1)(1992-3#3)(1992-4#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#1)(1993-4#2)(1993-7#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#4)(1994-3#1)(1994-8#3)(1995-12#3)(1995-2#5)(1995-5#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#5)(1997-4#2)(1997-6#2)(1997-8#1)(2004-11#1)(2005-1#1)(2005-10#7)(2005-11#1)(2006-10#8)(2006-11#6)(2006-12#2)(2006-4#2)(2006-5#1)(2006-8#1)(2007-11#3)(2007-12#3)(2007-2#3)(2007-4#1)(2007-7#4)(2007-8#3)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#4)(2009-5#2)(2009-6#1)(2009-9#5)(2010-12#1)(2010-4#3)(2010-8#2)(2011-1#2)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#6)(2012-3#7)(2013-1#2)(2013-7#1)(2013-8#1)
of muscles and##3##3##(1994-5#1)(2007-12#1)(2010-4#1)
of muscles of the##2##4##(1996-9#1)(2013-1#1)
of muscles##22##2##(1990-5#2)(1990-6#1)(1993-12#1)(1994-5#1)(1995-9#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-5#1)(2008-9#1)(2010-12#2)(2010-4#1)(2010-9#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
of muscular dystrophy##2##3##(1997-3#1)(2008-7#1)
of muscular tissue##2##3##(2007-10#1)(2010-5#1)
of muscular##26##2##(1990-5#1)(1990-6#1)(1994-4#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-12#3)(2008-6#1)(2008-7#2)(2009-2#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#2)
of muscularity##6##2##(2007-12#6)
of musculocutaneous##2##2##(2007-9#1)(2011-12#1)
of musculoskeletal conditions##2##3##(2008-3#1)(2012-2#1)
of musculoskeletal discomfort##2##3##(1996-9#2)
of musculoskeletal disorders##3##3##(1997-3#1)(2007-4#1)(2009-3#1)
of musculoskeletal injuries##3##3##(2008-12#1)(2008-6#1)(2008-7#1)
of musculoskeletal pain##3##3##(2007-6#1)(2008-12#2)
of musculoskeletal soft tissue infection##2##5##(2006-4#2)
of musculoskeletal symptoms##10##3##(2006-10#6)(2006-2#1)(2008-3#1)(2008-7#1)(2013-7#1)
of musculoskeletal##32##2##(1996-9#2)(1997-3#1)(2006-10#8)(2006-2#1)(2006-4#2)(2007-4#1)(2007-6#1)(2007-7#1)(2008-12#4)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-3#1)(2009-5#1)(2012-2#1)(2013-1#1)(2013-7#1)
of mushroom##8##2##(2007-12#1)(2008-10#2)(2008-12#1)(2008-5#2)(2010-11#1)(2011-2#1)
of mushrooms##3##2##(1994-9#1)(2010-10#1)(2011-2#1)
of music after cochlear implantation##2##5##(2008-9#2)
of music on pain for home-dwelling persons with dementia##2##9##(2010-8#2)
of music on the##2##4##(1991-12#1)(2007-6#1)
of music on##12##3##(1991-12#2)(2007-6#2)(2008-5#1)(2008-9#1)(2010-3#1)(2010-8#2)(2011-1#2)(2013-7#1)
of music therapists##2##3##(1991-12#2)
of music therapy and other##2##5##(1993-2#2)
of music therapy##4##3##(1993-2#2)(2007-6#1)(2009-3#1)
of music##33##2##(1991-12#4)(1993-2#2)(2007-6#7)(2008-5#1)(2008-9#6)(2009-3#1)(2010-3#2)(2010-8#4)(2011-1#3)(2012-2#1)(2013-7#1)(2013-8#1)
of musical experience##2##3##(2008-11#2)
of musical instruments##2##3##(2008-9#2)
of musical##9##2##(2008-11#3)(2008-9#2)(2012-2#4)
of musk odorants##3##3##(2006-12#3)
of muskmelon##2##2##(2008-10#2)
of mussel##2##2##(2008-10#2)
of mussels and##2##3##(2008-4#1)(2008-9#1)
of mussels##5##2##(2007-5#1)(2008-10#2)(2008-4#1)(2008-9#1)
of mutacin B-Ny266##2##3##(1997-6#2)
of mutacin##4##2##(1997-6#2)(2006-1#2)
of mutagenesis##4##2##(1991-8#1)(1995-8#1)(2011-1#1)(2013-8#1)
of mutagenic process##3##3##(2008-10#3)
of mutagenic##8##2##(1994-12#1)(1995-6#1)(1997-3#1)(2008-10#4)(2009-9#1)
of mutant alleles##4##3##(1993-3#1)(1995-8#1)(1995-9#1)(2008-10#1)
of mutant alpha1-AT Z##2##4##(1996-5#2)
of mutant and wild-type##2##4##(1990-3#1)(1997-3#1)
of mutant and##4##3##(1990-3#1)(1996-5#1)(1997-3#1)(2013-1#1)
of mutant enzymes##3##3##(1992-6#1)(1994-9#1)(1995-6#1)
of mutant mice##8##3##(1991-6#1)(1994-2#1)(2008-10#1)(2008-8#4)(2009-4#1)
of mutant mouse##2##3##(1995-6#1)(2010-3#1)
of mutant mtDNA##2##3##(1990-10#1)(1997-2#1)
of mutant or null p53 cells##2##6##(2007-9#2)
of mutant p53 in##2##4##(1991-2#1)(2009-4#1)
of mutant p53##5##3##(1990-12#1)(1991-2#1)(1991-5#1)(2009-4#2)
of mutant proteins##2##3##(1990-5#1)(1995-3#1)
of mutant strain##2##3##(2008-12#1)(2013-1#1)
of mutant##84##2##(1990-10#1)(1990-12#4)(1990-3#2)(1990-5#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-3#1)(1992-6#1)(1993-3#1)(1994-2#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-3#1)(1995-6#4)(1995-8#3)(1995-9#1)(1996-2#1)(1996-4#3)(1996-5#3)(1996-8#1)(1997-1#3)(1997-2#2)(1997-3#2)(1997-6#1)(2005-11#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-12#2)(2007-9#2)(2008-10#7)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#5)(2009-10#1)(2009-3#1)(2009-4#3)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
of mutants and##3##3##(1990-11#1)(2006-12#1)(2008-1#1)
of mutants by##2##3##(1993-4#1)(2008-9#1)
of mutants of##2##3##(1995-9#1)(2008-8#1)
of mutants was##2##3##(1995-2#1)(2008-10#1)
of mutants with##3##3##(1995-2#1)(2007-11#1)(2007-12#1)
of mutants##27##2##(1990-11#1)(1990-7#1)(1993-4#1)(1994-10#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-6#1)(1995-9#1)(1996-3#1)(1997-6#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-8#3)(2008-9#2)(2012-11#1)(2012-3#1)
of mutated genes##2##3##(1991-11#1)(2010-12#1)
of mutated##18##2##(1991-11#1)(1992-6#1)(1994-8#1)(1995-5#1)(1995-8#1)(1997-4#1)(1997-7#1)(2005-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
of mutating##2##2##(1997-7#1)(2010-5#1)
of mutation and cancer##2##4##(1991-9#2)
of mutation and##4##3##(1991-9#2)(2010-4#1)(2010-6#1)
of mutation because##2##3##(1995-6#1)(2010-9#1)
of mutation in##2##3##(1994-9#1)(2011-2#1)
of mutation of##4##3##(1997-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
of mutation##30##2##(1990-8#1)(1991-9#2)(1992-12#1)(1992-2#1)(1994-9#1)(1995-6#1)(1995-8#2)(1997-7#1)(2005-12#1)(2006-10#1)(2006-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-6#2)(2010-9#1)(2011-2#3)(2012-2#1)(2013-1#1)
of mutation-selection##2##2##(2008-1#2)
of mutational##3##2##(2012-12#2)(2012-2#1)
of mutations affecting##2##3##(1990-5#1)(1992-12#1)
of mutations and##4##3##(1991-10#1)(1993-9#1)(1995-8#1)(1996-2#1)
of mutations at the##3##4##(1990-7#1)(1995-9#1)(1997-3#1)
of mutations at##4##3##(1990-7#1)(1995-9#1)(1997-3#1)(2008-7#1)
of mutations causing##2##3##(1993-6#1)(2008-3#1)
of mutations in either the##2##5##(1995-8#1)(2008-9#1)
of mutations in the gene for##2##6##(2008-7#2)
of mutations in the gene##4##5##(1997-3#1)(2008-4#1)(2008-7#2)
of mutations in the##12##4##(1990-8#1)(1993-11#1)(1993-9#1)(1995-1#1)(1997-3#1)(1997-4#1)(2008-4#1)(2008-6#1)(2008-7#2)(2010-12#1)(2012-2#1)
of mutations in##32##3##(1990-11#1)(1990-8#2)(1991-9#1)(1993-11#2)(1993-9#1)(1994-12#1)(1995-1#1)(1995-8#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(2006-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-12#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
of mutations involving##2##3##(1992-10#1)(1997-6#1)
of mutations resulting##2##3##(2006-11#1)(2008-5#1)
of mutations that##4##3##(1990-5#1)(1995-8#1)(2008-4#1)(2010-7#1)
of mutations##78##2##(1990-11#1)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-10#1)(1991-9#1)(1992-10#1)(1992-12#1)(1993-11#2)(1993-6#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-8#4)(1995-9#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#3)(1997-4#2)(1997-6#1)(2004-2#1)(2006-11#2)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#3)(2009-12#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#2)
of mutual aid##2##3##(1996-3#2)
of mutual incoherence of the##2##5##(2006-4#1)(2008-3#1)
of mutual information##2##3##(1996-6#1)(2008-2#1)
of mutual respect and##2##4##(1991-3#1)(2008-12#1)
of mutual##17##2##(1990-8#1)(1991-3#1)(1992-2#1)(1996-3#2)(1996-6#2)(2006-4#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
of mutualism##2##2##(2008-8#2)
of mutuality##2##2##(1997-8#1)(2008-2#1)
of mutually##3##2##(2007-12#2)(2008-9#1)
of muzzle##2##2##(1997-6#2)
of my##19##2##(1991-2#1)(1992-12#1)(1996-2#1)(2005-7#1)(2005-9#1)(2006-11#1)(2006-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-10#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#2)
of myalgia##2##2##(2009-5#2)
of myasthenia gravis patients and##2##5##(1996-4#2)
of myasthenia gravis##8##3##(1991-9#1)(1996-4#3)(2010-11#1)(2012-3#2)(2013-7#1)
of myasthenia##10##2##(1991-9#1)(1996-4#3)(2007-8#2)(2010-11#1)(2012-3#2)(2013-7#1)
of myc##5##2##(1991-10#1)(1991-9#4)
of mycelia##4##2##(2008-10#3)(2012-3#1)
of mycelial growth##3##3##(2005-11#1)(2008-10#2)
of mycelial##5##2##(2005-11#1)(2008-10#4)
of mycelium in##2##3##(2008-10#2)
of mycelium##8##2##(1994-8#1)(2008-10#7)
of mycetoma##2##2##(2007-7#1)(2008-5#1)
of mycobacteria##9##2##(1991-5#1)(1996-10#1)(1997-4#1)(2007-7#1)(2008-4#2)(2010-12#1)(2011-1#1)(2011-2#1)
of mycobacterial infection##3##3##(2008-1#1)(2008-4#1)(2013-8#1)
of mycobacterial infections##5##3##(2005-7#1)(2005-9#2)(2011-2#1)(2013-1#1)
of mycobacterial##14##2##(1997-4#1)(2005-7#1)(2005-9#2)(2008-1#1)(2008-12#1)(2008-4#2)(2008-7#2)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
of mycobacterium tuberculosis in vivo##2##5##(2010-12#2)
of mycobacterium tuberculosis in##3##4##(2010-12#3)
of mycobacterium##4##2##(2010-12#3)(2013-1#1)
of mycolic acids##2##3##(2008-9#2)
of mycoparasitism##2##2##(2008-10#2)
of mycophenolate mofetil##3##3##(1996-8#1)(2007-11#1)(2007-7#1)
of mycophenolate##4##2##(1996-8#2)(2007-11#1)(2007-7#1)
of mycophenolic acid##3##3##(1993-11#1)(2007-11#2)
of mycoplasma contamination in cell cultures##2##6##(2008-11#2)
of mycoplasma contamination##5##3##(1992-7#1)(2008-11#3)(2008-9#1)
of mycoplasma##8##2##(1991-9#1)(1992-7#1)(1993-11#2)(2008-11#3)(2008-9#1)
of mycoplasmas##4##2##(2008-11#3)(2010-9#1)
of mycorrhizal fungal##2##3##(2004-4#2)
of mycorrhizal##7##2##(2004-4#4)(2006-5#1)(2008-12#1)(2011-1#1)
of mycoses##2##2##(2008-5#1)(2009-7#1)
of mycosis fungoides##5##3##(2007-8#2)(2010-6#2)(2011-2#1)
of mycosis##7##2##(2007-7#1)(2007-8#2)(2008-5#1)(2010-6#2)(2011-2#1)
of mycotic##3##2##(2005-10#1)(2008-5#2)
of mycotoxin##2##2##(2008-10#2)
of mycotoxins in##2##3##(2008-10#1)(2010-7#1)
of mycotoxins##8##2##(1993-3#1)(1995-3#1)(2008-10#2)(2008-8#1)(2010-7#3)
of myelin basic protein and##2##5##(2005-7#1)(2007-11#1)
of myelin basic protein in electrolyte solutions##2##7##(1991-7#2)
of myelin basic protein##15##4##(1991-10#1)(1991-12#1)(1991-7#8)(1993-8#1)(1994-8#1)(2005-7#2)(2007-11#1)
of myelin in the##2##4##(2009-6#2)
of myelin proteins##4##3##(1990-7#1)(1992-12#3)
of myelin##33##2##(1990-7#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-7#8)(1992-12#3)(1993-8#1)(1994-8#1)(1997-2#1)(1997-4#1)(2005-7#3)(2007-10#1)(2007-11#2)(2008-7#2)(2009-6#3)(2010-12#1)(2012-1#1)(2012-3#1)
of myelinated fibres##3##3##(1991-10#1)(1994-6#1)(1997-5#1)
of myelinated##5##2##(1991-10#1)(1992-12#1)(1994-6#1)(1997-4#1)(1997-5#1)
of myelinating cells##2##3##(2008-7#2)
of myelinating##4##2##(2006-1#1)(2008-7#3)
of myelination##9##2##(1994-6#1)(1996-5#4)(2006-6#1)(2008-5#2)(2008-7#1)
of myelodysplastic syndrome##2##3##(2008-5#1)(2013-1#1)
of myelodysplastic syndromes##3##3##(2008-3#1)(2010-1#1)(2010-11#1)
of myelodysplastic##6##2##(1990-11#1)(2008-3#1)(2008-5#1)(2010-1#1)(2010-11#1)(2013-1#1)
of myeloid cells in##2##4##(2012-1#1)(2013-8#1)
of myeloid cells##6##3##(1994-9#1)(1995-2#1)(2008-10#1)(2008-4#1)(2012-1#1)(2013-8#1)
of myeloid neoplasms with##2##4##(2011-2#2)
of myeloid neoplasms##3##3##(2011-2#3)
of myeloid progenitor cells##4##4##(1994-5#1)(1997-7#1)(2006-1#1)(2011-1#1)
of myeloid##27##2##(1990-12#1)(1992-6#1)(1992-8#1)(1993-7#1)(1994-5#1)(1994-9#1)(1995-2#1)(1997-7#1)(2005-7#1)(2006-1#1)(2007-11#2)(2008-10#1)(2008-4#4)(2011-1#1)(2011-2#6)(2012-1#2)(2013-8#1)
of myeloma cells##4##3##(2008-1#1)(2011-1#1)(2011-2#1)(2013-1#1)
of myeloma##11##2##(1995-8#1)(2008-1#4)(2008-3#1)(2009-4#1)(2011-1#1)(2011-2#1)(2013-1#2)
of myelopathy##2##2##(2005-10#1)(2008-12#1)
of myeloperoxidase##3##2##(1990-9#1)(1992-8#1)(2012-2#1)
of myelopoiesis##3##2##(1996-5#1)(2008-4#2)
of myeloproliferative disorders##2##3##(2008-10#1)(2012-12#1)
of myelosuppression##2##2##(1995-6#1)(1997-7#1)
of myenteric plexus##2##3##(1995-5#2)
of myenteric##4##2##(1995-5#2)(1996-4#1)(2006-10#1)
of myiasis in##2##3##(2008-2#1)(2010-3#1)
of myiasis##6##2##(2008-2#3)(2010-3#1)(2010-8#1)(2013-1#1)
of mylohyoid muscle##2##3##(2012-1#2)
of myo-inositol 1##2##3##(1990-5#1)(1996-2#1)
of myoD##2##2##(1992-5#2)
of myoblasts##7##2##(1996-4#1)(1997-1#1)(2004-11#1)(2008-11#2)(2008-4#2)
of myocardial cell apoptosis##5##4##(2007-8#5)
of myocardial contractility##4##3##(1990-2#1)(1997-8#1)(2013-1#2)
of myocardial damage##6##3##(1994-6#1)(2006-6#1)(2007-8#2)(2007-9#1)(2011-2#1)
of myocardial depression##2##3##(1993-12#1)(2008-7#1)
of myocardial disease##2##3##(2007-8#1)(2013-8#1)
of myocardial dysfunction##2##3##(2010-5#2)
of myocardial energetics in##2##4##(2010-8#2)
of myocardial function##5##3##(1993-12#1)(2010-5#3)(2011-2#1)
of myocardial gene expression in##2##5##(2009-12#1)(2010-6#1)
of myocardial hypertrophy##3##3##(1993-8#1)(1997-1#1)(2008-10#1)
of myocardial infarction (MI) in##2##5##(2009-5#1)(2011-1#1)
of myocardial infarction (MI)##3##4##(2008-10#1)(2009-5#1)(2011-1#1)
of myocardial infarction and stroke##3##5##(2007-9#1)(2009-9#2)
of myocardial infarction and##11##4##(1990-2#1)(1992-8#1)(1993-12#2)(1996-8#1)(1997-8#1)(2007-9#1)(2009-9#2)(2011-12#1)(2011-2#1)
of myocardial infarction by reducing##2##5##(1991-6#1)(2007-11#1)
of myocardial infarction in##4##4##(1990-6#1)(1991-6#1)(1994-2#1)(2009-12#1)
of myocardial infarction##54##3##(1990-2#1)(1990-5#1)(1990-6#1)(1991-3#2)(1991-6#2)(1992-8#1)(1993-12#2)(1993-7#1)(1994-2#1)(1994-4#4)(1995-2#1)(1995-6#2)(1996-8#1)(1997-8#1)(2005-8#2)(2006-10#2)(2006-2#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-7#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-4#2)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
of myocardial injury and##3##4##(1995-6#1)(2010-1#1)(2010-8#1)
of myocardial injury##8##3##(1992-10#1)(1995-6#2)(2008-4#2)(2008-6#1)(2010-1#1)(2010-8#1)
of myocardial ischemia and##2##4##(2008-1#1)(2008-10#1)
of myocardial ischemia##15##3##(1990-11#1)(1993-12#1)(1996-9#1)(1997-8#1)(2006-10#3)(2008-1#2)(2008-10#2)(2008-3#1)(2008-7#1)(2010-9#1)(2012-2#1)
of myocardial necrosis##2##3##(1990-12#1)(2011-2#1)
of myocardial performance##2##3##(2011-2#1)(2012-2#1)
of myocardial perfusion in##2##4##(2011-2#1)(2013-8#1)
of myocardial perfusion##4##3##(2009-10#1)(2010-12#1)(2011-2#1)(2013-8#1)
of myocardial progenitor##2##3##(2012-12#2)
of myocardial protection##6##3##(1991-3#1)(1996-9#1)(2007-8#3)(2013-1#1)
of myocardial revascularization##3##3##(1993-12#1)(2005-1#1)(2009-4#1)
of myocardial scar##2##3##(2009-10#2)
of myocardial segments##2##3##(1992-5#1)(2010-5#1)
of myocardial stunning##3##3##(1991-3#3)
of myocardial viability with##2##4##(2008-10#1)(2009-10#1)
of myocardial viability##7##3##(1992-5#1)(2008-10#1)(2009-10#2)(2010-5#1)(2010-9#1)(2012-2#1)
of myocardial##179##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#2)(1990-6#1)(1991-1#1)(1991-3#8)(1991-6#2)(1992-10#1)(1992-5#2)(1992-8#1)(1993-12#7)(1993-7#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-4#4)(1994-6#1)(1995-2#1)(1995-6#4)(1996-8#1)(1996-9#7)(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#3)(2005-1#1)(2005-7#1)(2005-8#2)(2006-10#5)(2006-2#2)(2006-6#3)(2006-7#1)(2006-8#1)(2007-11#2)(2007-3#1)(2007-4#1)(2007-8#13)(2007-9#2)(2008-1#3)(2008-10#6)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#4)(2009-10#5)(2009-12#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-4#2)(2010-5#7)(2010-6#1)(2010-8#5)(2010-9#4)(2011-1#2)(2011-12#1)(2011-2#8)(2012-1#1)(2012-12#4)(2012-2#6)(2013-1#4)(2013-7#1)(2013-8#4)
of myocardin##2##2##(2012-12#2)
of myocardiopathy##2##2##(1994-6#2)
of myocarditis##7##2##(1994-7#2)(2008-4#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
of myocardium protection##2##3##(2007-8#2)
of myocardium##12##2##(1990-5#1)(1996-9#1)(2006-6#1)(2006-9#1)(2007-8#3)(2008-10#1)(2011-1#2)(2012-2#1)(2013-7#1)
of myocytes##3##2##(1994-12#1)(1997-4#1)(2008-1#1)
of myoepithelial cells##2##3##(1994-12#1)(2012-3#1)
of myoepithelial##4##2##(1994-12#1)(2007-5#1)(2012-3#1)(2013-8#1)
of myofascial pain##2##3##(2006-8#1)(2008-12#1)
of myofascial trigger points##2##4##(2007-6#1)(2008-12#1)
of myofascial trigger##3##3##(2007-6#1)(2008-12#1)(2013-1#1)
of myofascial##6##2##(2006-8#1)(2007-6#1)(2008-12#2)(2009-1#1)(2013-1#1)
of myofibrils##3##2##(1994-3#1)(2008-7#1)(2010-8#1)
of myofibroblastic##2##2##(2012-2#2)
of myofibroblasts are##2##3##(2009-3#1)(2012-12#1)
of myofibroblasts in##2##3##(2012-12#2)
of myofibroblasts##11##2##(2009-3#2)(2009-8#2)(2012-12#7)
of myofibroma##2##2##(2011-1#1)(2012-2#1)
of myogenesis##4##2##(1996-5#2)(2010-4#2)
of myogenic factors##2##3##(1995-6#2)
of myogenic precursor cells##5##4##(1995-8#4)(2006-11#1)
of myogenic##12##2##(1994-2#1)(1995-6#2)(1995-8#4)(1996-5#1)(2006-11#1)(2006-4#1)(2008-11#1)(2009-5#1)
of myogenin expression##3##3##(1992-3#1)(1994-2#2)
of myogenin mRNA##2##3##(1994-2#1)(1996-5#1)
of myogenin##10##2##(1992-3#5)(1994-2#4)(1996-5#1)
of myoglobin (Mb)##2##3##(1994-11#1)(2008-10#1)
of myoglobin and##2##3##(1992-3#1)(1993-6#1)
of myoglobin##19##2##(1990-2#1)(1991-4#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-6#8)(1994-11#2)(1994-12#1)(1994-4#1)(1994-9#1)(2008-10#1)
of myoinositol##4##2##(1992-4#1)(2008-7#1)(2008-8#2)
of myointima##2##2##(2006-6#2)
of myoma##3##2##(2009-2#3)
of myometrial invasion##2##3##(1994-9#1)(2011-2#1)
of myometrial##6##2##(1991-1#1)(1993-1#1)(1994-3#2)(1994-9#1)(2011-2#1)
of myometrium##3##2##(2008-8#1)(2010-12#2)
of myopathy##3##2##(2006-4#1)(2008-10#1)(2009-11#1)
of myopia and##2##3##(2008-3#1)(2013-8#1)
of myopia progression##2##3##(2012-12#2)
of myopia##10##2##(2008-3#1)(2012-12#8)(2013-8#1)
of myosin II##2##3##(1995-8#2)
of myosin heavy##2##3##(1991-9#1)(2008-4#1)
of myosin light chain kinase##5##5##(1990-5#1)(1991-2#1)(1992-5#1)(1992-6#1)(1995-12#1)
of myosin light chain phosphorylation in##2##6##(1990-9#1)(1991-3#1)
of myosin light chain##9##4##(1990-5#1)(1990-9#1)(1991-2#1)(1991-3#1)(1992-5#1)(1992-6#1)(1995-12#1)(1997-4#1)(1997-7#1)
of myosin light##10##3##(1990-5#1)(1990-9#1)(1991-2#1)(1991-3#1)(1992-5#1)(1992-6#1)(1995-12#1)(1997-4#1)(1997-7#2)
of myosin on##3##3##(1992-4#1)(1996-5#2)
of myosin subfragment 1 (S-1)##2##5##(1994-3#1)(1996-5#1)
of myosin subfragment 1##7##4##(1991-4#2)(1994-3#1)(1994-5#1)(1994-8#1)(1996-5#2)
of myosin subfragment-1 with##2##4##(1992-3#1)(1995-3#1)
of myosin with##2##3##(1993-9#1)(1997-4#1)
of myosin##51##2##(1990-5#2)(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-9#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-6#2)(1993-9#2)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-11#2)(1996-2#2)(1996-4#1)(1996-5#7)(1996-8#1)(1996-9#1)(1997-4#4)(1997-7#2)(2008-11#1)(2008-4#1)(2008-5#1)(2012-2#1)
of myositis and##2##3##(1992-11#1)(2006-10#1)
of myositis ossificans##2##3##(1992-2#2)
of myositis##11##2##(1992-11#1)(1992-2#2)(1992-8#1)(2006-10#3)(2010-12#1)(2012-2#1)(2013-1#2)
of myotonic dystrophy##3##3##(2004-11#1)(2008-7#2)
of myotubes##3##2##(1995-5#1)(2010-10#2)
of myristic acid##4##3##(1990-10#1)(2008-10#3)
of myristic##5##2##(1990-10#1)(2008-10#4)
of myrosinase##2##2##(1990-12#2)
of myxedema coma##3##3##(2010-7#3)
of myxoid and##2##3##(2008-6#1)(2010-6#1)
of myxoid##3##2##(2008-6#2)(2010-6#1)
of n =##6##3##(2007-11#1)(2008-2#2)(2008-3#1)(2011-1#2)
of n and k##4##4##(2008-2#2)(2008-3#2)
of n was##2##3##(1994-8#1)(2008-2#1)
of n##30##2##(1991-7#1)(1991-9#1)(1994-8#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#9)(2008-7#3)(2008-9#1)(2009-12#1)(2010-7#1)(2011-1#2)
of n(2)##5##2##(2007-11#3)(2008-2#2)
of n(c)##3##2##(2008-3#3)
of n-3 PUFA##5##3##(2007-8#3)(2011-2#1)(2013-1#1)
of n-3 PUFAs on CVD##4##5##(2013-1#4)
of n-3 PUFAs on##5##4##(2013-1#5)
of n-3 PUFAs##13##3##(2013-1#13)
of n-3 and n-6##2##4##(1991-2#1)(2008-12#1)
of n-3 fatty acids on##3##5##(1991-7#2)(2012-12#1)
of n-3 fatty acids##9##4##(1990-4#2)(1991-7#2)(1997-1#1)(2007-9#1)(2012-12#2)(2013-1#1)
of n-3 fatty##10##3##(1990-4#3)(1991-7#2)(1997-1#1)(2007-9#1)(2012-12#2)(2013-1#1)
of n-3 highly unsaturated fatty##2##5##(2008-7#1)(2010-8#1)
of n-3##33##2##(1990-4#3)(1991-2#1)(1991-7#2)(1997-1#1)(2007-8#3)(2007-9#1)(2008-12#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-12#2)(2013-1#15)(2013-8#1)
of n-6##3##2##(2007-8#1)(2010-4#1)(2013-1#1)
of n-alcohol##2##2##(1990-11#1)(1994-2#1)
of n-alkane##2##2##(1991-9#1)(2005-11#1)
of n-alkanes##3##2##(2005-11#2)(2013-8#1)
of n-anthroyloxy fatty acids##2##4##(1997-1#2)
of n-butanol##2##2##(2008-10#2)
of n-butylamine##2##2##(2008-10#2)
of n-decane##3##2##(2005-11#1)(2005-12#1)(2008-10#1)
of n-fatty##2##2##(1997-8#2)
of n-hexadecane##2##2##(1994-11#2)
of n-hexane and##2##3##(2007-11#1)(2008-10#1)
of n-hexane##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
of n-hexanethiolate##2##2##(2007-12#2)
of nAChR##3##2##(1995-11#1)(2007-8#1)(2010-8#1)
of nAChRs##4##2##(1994-2#3)(2011-1#1)
of nNOS##6##2##(1995-8#2)(1996-12#2)(2011-2#2)
of nabumetone in##2##3##(1990-6#1)(1990-7#1)
of nabumetone##3##2##(1990-6#1)(1990-7#2)
of nafion##3##2##(2008-10#3)
of nail##8##2##(1990-9#1)(2006-12#1)(2007-7#3)(2008-8#1)(2011-2#1)(2012-2#1)
of nails##2##2##(2008-5#1)(2011-2#1)
of naive T cells##2##4##(1996-10#1)(2005-10#1)
of naive human##2##3##(1995-12#1)(1996-10#1)
of naive##8##2##(1994-11#1)(1994-2#1)(1995-12#1)(1996-10#2)(2005-10#1)(2008-11#2)
of nalbuphine and fentanyl as intravenous##2##6##(1993-1#2)
of nalbuphine during##3##3##(1992-5#3)
of nalbuphine##9##2##(1990-6#1)(1992-5#5)(1993-1#2)(1993-8#1)
of naled##2##2##(2007-5#1)(2008-10#1)
of nalidixic acid##6##3##(2008-10#4)(2008-5#1)(2012-2#1)
of naloxone##7##2##(1991-2#1)(1991-6#1)(1992-5#1)(1995-6#2)(1996-10#1)(1996-2#1)
of naltrexone##7##2##(1991-1#2)(1997-2#2)(1997-8#2)(2008-2#1)
of named##3##2##(2007-11#1)(2008-10#1)(2008-7#1)
of names##4##2##(1993-8#1)(2006-10#1)(2008-10#1)(2008-7#1)
of naming##4##2##(2006-7#2)(2010-12#1)(2010-2#1)
of nano-scale##2##2##(2009-11#1)(2012-2#1)
of nano-sized##3##2##(2006-2#1)(2009-5#2)
of nanobiotechnology##4##2##(2005-7#1)(2008-11#1)(2009-4#1)(2012-12#1)
of nanocapsules##2##2##(2006-5#1)(2013-1#1)
of nanoclusters##2##2##(2008-10#2)
of nanocomposites##4##2##(2010-4#2)(2010-7#1)(2012-7#1)
of nanocrystal##2##2##(2006-12#1)(2009-2#1)
of nanocrystalline Ce(1-x)Ln(x)O(2-x/2-delta) (Ln = Yb##2##6##(2010-4#2)
of nanocrystalline Y2O3##2##3##(2005-11#2)
of nanocrystalline##7##2##(2005-11#2)(2006-12#1)(2007-9#1)(2010-4#2)(2012-2#1)
of nanocrystals##4##2##(2007-11#1)(2008-10#1)(2009-2#1)(2010-4#1)
of nanodevices##2##2##(2008-7#1)(2009-2#1)
of nanofibers##3##2##(2008-5#2)(2009-5#1)
of nanogram amounts of##2##4##(1996-9#1)(2008-10#1)
of nanogram quantities of iron(II) tris-(1##2##6##(2008-10#2)
of nanogram quantities of##3##4##(1997-3#1)(2008-10#2)
of nanogram quantities##4##3##(1997-3#1)(2008-10#3)
of nanogram##10##2##(1996-9#1)(1997-3#1)(2008-10#7)(2008-4#1)
of nanomaterial##3##2##(2008-10#2)(2008-8#1)
of nanomaterials##14##2##(2006-12#1)(2007-8#2)(2007-9#1)(2008-7#1)(2010-12#1)(2010-7#5)(2012-11#2)(2012-12#1)
of nanomedicine##3##2##(2011-2#3)
of nanometer##2##2##(2009-11#1)(2010-5#1)
of nanometers in##2##3##(2005-11#1)(2007-12#1)
of nanometers##8##2##(1990-7#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2010-4#1)(2012-1#1)
of nanometres##4##2##(2006-2#1)(2008-7#2)(2010-8#1)
of nanometric displacement##2##3##(2007-12#2)
of nanoparticle DDS##2##3##(2007-11#2)
of nanoparticle imaging probes##2##4##(2009-12#2)
of nanoparticle##14##2##(2007-11#2)(2008-10#1)(2008-11#1)(2008-7#1)(2009-12#3)(2010-12#1)(2010-7#1)(2010-9#2)(2011-2#1)(2012-2#1)
of nanoparticle-based##2##2##(2007-11#1)(2010-1#1)
of nanoparticles and microparticles##3##4##(2007-12#2)(2008-4#1)
of nanoparticles and##7##3##(2007-12#2)(2008-4#1)(2008-7#3)(2012-2#1)
of nanoparticles in##8##3##(2006-2#1)(2007-8#1)(2008-6#1)(2009-2#2)(2009-3#1)(2010-7#1)(2013-1#1)
of nanoparticles is##2##3##(2009-2#1)(2010-7#1)
of nanoparticles that##4##3##(2008-7#2)(2011-1#1)(2011-2#1)
of nanoparticles with a##2##4##(2005-7#1)(2008-3#1)
of nanoparticles with##3##3##(2005-7#1)(2008-3#1)(2010-7#1)
of nanoparticles##48##2##(2005-11#1)(2005-7#1)(2006-2#1)(2007-11#1)(2007-12#3)(2007-8#4)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#9)(2008-8#1)(2009-11#1)(2009-2#3)(2009-3#2)(2009-4#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#3)(2011-1#3)(2011-2#2)(2012-2#1)(2012-6#1)(2013-1#1)
of nanopores##3##2##(2009-2#1)(2010-5#1)(2012-2#1)
of nanoporous##2##2##(2008-5#1)(2009-2#1)
of nanorose##2##2##(2011-1#2)
of nanoscale##13##2##(2006-12#1)(2007-12#2)(2007-2#1)(2008-4#1)(2009-2#1)(2009-6#1)(2010-12#1)(2010-7#2)(2012-2#1)(2013-1#2)
of nanoscopic##2##2##(2006-2#1)(2010-4#1)
of nanosecond pulses##2##3##(2007-12#1)(2008-1#1)
of nanosecond##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
of nanoseconds##6##2##(1991-2#1)(1994-8#1)(2008-1#1)(2008-2#2)(2009-2#1)
of nanosensors##3##2##(2008-10#3)
of nanosized##7##2##(2005-11#2)(2008-10#2)(2008-5#1)(2008-7#1)(2013-1#1)
of nanostructured##6##2##(2005-11#1)(2006-5#1)(2007-9#1)(2008-10#1)(2009-11#1)(2010-11#1)
of nanostructures in##2##3##(2010-12#1)(2011-2#1)
of nanostructures##11##2##(1991-11#1)(2006-12#2)(2007-9#1)(2008-7#3)(2010-12#1)(2010-7#1)(2011-2#1)(2012-1#1)
of nanotechnology and##2##3##(2008-10#1)(2010-12#1)
of nanotechnology in##2##3##(2008-9#1)(2010-12#1)
of nanotechnology patent applications##2##4##(2010-12#2)
of nanotechnology##22##2##(1991-11#1)(2008-10#2)(2008-11#3)(2008-7#4)(2008-9#1)(2010-12#8)(2010-5#1)(2010-7#1)(2011-2#1)
of nanotube##5##2##(2006-2#1)(2008-10#1)(2008-7#2)(2010-8#1)
of nanotubes##8##2##(2005-11#1)(2008-10#4)(2008-7#1)(2010-2#1)(2010-7#1)
of nanowire##2##2##(2008-7#2)
of nanowires (NWs)##2##3##(2008-7#2)
of nanowires##6##2##(2008-7#3)(2009-11#2)(2012-2#1)
of naphthalene and##3##3##(1996-11#1)(2008-11#1)(2011-2#1)
of naphthalene##9##2##(1994-9#1)(1996-11#1)(2007-11#1)(2008-10#2)(2008-11#2)(2011-12#1)(2011-2#1)
of naphthol##2##2##(2008-10#2)
of naphthyl##2##2##(2008-10#1)(2011-2#1)
of naphthyltetrahydroisoquinoline alkaloids##2##3##(1994-12#2)
of naproxen in##2##3##(2008-10#1)(2010-5#1)
of naproxen is##2##3##(2007-12#1)(2008-10#1)
of naproxen##19##2##(1995-3#1)(2006-10#2)(2007-12#1)(2008-10#11)(2008-11#2)(2010-5#2)
of narcolepsy##5##2##(2007-6#2)(2008-8#3)
of narcotic##4##2##(1991-11#1)(1996-12#1)(2006-8#1)(2008-4#1)
of narcotics##2##2##(1992-8#1)(2007-9#1)
of naringin##2##2##(1996-8#2)
of narrative##4##2##(1996-3#1)(2005-12#1)(2008-5#1)(2009-7#1)
of narratives of illness##2##4##(1996-3#1)(2011-2#1)
of narratives##5##2##(1996-3#1)(2008-12#1)(2011-2#1)(2013-1#2)
of narrow band##3##3##(2007-7#1)(2007-8#1)(2011-1#1)
of narrow##10##2##(2006-6#1)(2007-12#3)(2007-7#1)(2007-8#1)(2009-11#1)(2011-1#1)(2012-11#2)
of narrow-band##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
of narrow-bandwidth##2##2##(2007-12#2)
of narrowband##3##2##(1992-3#1)(2007-11#1)(2009-6#1)
of narrowing##2##2##(1993-6#1)(2007-10#1)
of nasal cancer##3##3##(1992-10#3)
of nasal cavity##2##3##(2009-2#1)(2013-8#1)
of nasal obstruction##2##3##(2006-12#1)(2012-2#1)
of nasal polyps##2##3##(1991-4#1)(2013-8#1)
of nasal spray##3##3##(2007-2#1)(2013-1#2)
of nasal##31##2##(1991-4#1)(1992-10#3)(1993-11#2)(1993-2#2)(1996-9#1)(1997-4#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#4)
of nasally inhaled##2##3##(2013-1#2)
of nasally##3##2##(1993-11#1)(2013-1#2)
of nascent##14##2##(1991-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-3#1)(1996-4#2)(1996-6#1)(1997-4#2)(1997-5#1)(2008-10#1)(2008-8#1)(2008-9#1)
of nasogastric##2##2##(2005-12#1)(2007-8#1)
of nasolabial##2##2##(2008-5#1)(2011-12#1)
of nasopharyngeal cancer##3##3##(2008-8#2)(2010-3#1)
of nasopharyngeal carcinoma##5##3##(1991-8#1)(1993-9#1)(1997-7#1)(2006-12#1)(2011-2#1)
of nasopharyngeal##12##2##(1991-8#1)(1993-9#1)(1997-7#1)(2006-12#1)(2007-5#1)(2008-8#2)(2010-3#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
of nasopharynx##4##2##(1993-9#1)(2011-12#3)
of natal##3##2##(2006-5#2)(2008-8#1)
of national AIDS##2##3##(1996-11#1)(2008-10#1)
of national Veterinary Services##2##4##(2005-5#2)
of national and international organizations##2##5##(1994-12#1)(2010-12#1)
of national and international##6##4##(1994-12#1)(1997-7#1)(2006-6#1)(2008-1#1)(2009-1#1)(2010-12#1)
of national and##7##3##(1994-12#1)(1995-9#1)(1997-7#1)(2006-6#1)(2008-1#1)(2009-1#1)(2010-12#1)
of national data##3##3##(1997-3#1)(2007-12#1)(2011-1#1)
of national health expenditures##2##4##(1991-2#1)(1992-3#1)
of national health##7##3##(1991-2#1)(1992-3#1)(1993-9#1)(1996-1#1)(2007-4#1)(2007-6#1)(2008-11#1)
of national institutes of health stroke scale##2##7##(2012-11#2)
of national public health surveillance##2##5##(1997-3#1)(2008-1#1)
of national standards##3##3##(1993-1#1)(1996-2#1)(2008-12#1)
of national##68##2##(1990-12#1)(1990-6#1)(1991-11#1)(1991-2#1)(1992-3#2)(1993-1#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-3#2)(1997-7#1)(1997-8#1)(2005-5#3)(2006-4#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-9#1)(2009-1#1)(2009-3#2)(2009-7#1)(2010-12#2)(2010-3#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-11#2)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
of nationalism##5##2##(2008-2#1)(2011-1#3)(2012-2#1)
of nations##3##2##(2006-10#1)(2012-2#1)(2013-7#1)
of native AVF in##2##4##(2007-7#2)
of native AVF##3##3##(2007-7#3)
of native TAA##2##3##(1992-2#2)
of native and denatured##3##4##(1990-5#1)(2008-10#2)
of native and##18##3##(1990-2#1)(1990-5#2)(1992-11#1)(1994-11#1)(1994-5#1)(1995-2#1)(1996-6#1)(1997-7#2)(2005-11#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)
of native arteries##2##3##(2011-2#2)
of native arteriovenous fistulas in##2##5##(2007-7#2)
of native arteriovenous fistulas##3##4##(2007-7#3)
of native coarctation##2##3##(2008-4#2)
of native cytochrome##2##3##(1992-12#1)(1997-4#1)
of native enzyme##6##3##(1993-8#1)(1994-11#1)(1995-6#4)
of native glucagon##2##3##(2008-8#1)(2011-2#1)
of native human insulin##2##4##(1991-7#1)(1992-6#1)
of native human##3##3##(1991-7#1)(1992-6#1)(2008-4#1)
of native kidneys##2##3##(1995-2#1)(2008-1#1)
of native populations##2##3##(2008-10#2)
of native protein##5##3##(1990-7#1)(1992-8#1)(1993-11#1)(1997-4#1)(2009-5#1)
of native species##2##3##(2008-8#1)(2013-7#1)
of native zinc-containing##2##3##(1995-5#2)
of native##140##2##(1990-2#1)(1990-4#2)(1990-5#2)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-7#3)(1991-9#3)(1992-11#1)(1992-12#2)(1992-2#3)(1992-6#1)(1992-8#2)(1993-11#2)(1993-12#1)(1993-8#2)(1993-9#1)(1994-11#5)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#6)(1994-9#1)(1995-10#1)(1995-2#5)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#4)(1996-10#2)(1996-2#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#3)(2004-9#1)(2005-11#1)(2007-12#2)(2007-7#9)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-4#5)(2008-5#8)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#6)(2009-10#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-2#1)(2011-2#5)(2012-2#1)(2013-7#1)
of natriuretic peptide genes##2##4##(1990-8#1)(1997-4#1)
of natriuretic peptide##9##3##(1990-7#1)(1990-8#1)(1992-11#1)(1995-2#1)(1995-5#1)(1997-4#1)(2009-5#2)(2010-12#1)
of natriuretic peptides##6##3##(1994-8#2)(2009-5#4)
of natriuretic##15##2##(1990-7#1)(1990-8#1)(1992-11#1)(1994-8#2)(1995-2#1)(1995-5#1)(1997-4#1)(2009-5#6)(2010-12#1)
of natural CB based on##2##5##(1997-8#2)
of natural and synthetic antioxidants##2##5##(2008-3#1)(2012-1#1)
of natural and synthetic##7##4##(1993-12#1)(1994-8#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-1#1)
of natural and##19##3##(1990-2#1)(1992-11#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-8#1)(2005-12#1)(2006-12#2)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2012-1#1)(2012-3#1)
of natural antibodies##3##3##(1992-1#1)(1994-11#1)(1997-9#1)
of natural antisense transcripts##2##4##(2006-11#2)
of natural bone##2##3##(2007-8#1)(2009-7#1)
of natural compounds##4##3##(1994-11#1)(2004-2#1)(2009-3#1)(2012-2#1)
of natural disasters##6##3##(2012-1#1)(2013-1#5)
of natural disturbance##3##3##(2006-6#1)(2010-10#2)
of natural enemies##6##3##(1994-6#1)(2008-8#3)(2008-9#1)(2013-8#1)
of natural evolution##2##3##(1991-12#1)(1997-6#1)
of natural fluids##2##3##(2008-10#2)
of natural health products##2##4##(2008-10#2)
of natural history##2##3##(2004-11#1)(2011-7#1)
of natural human##3##3##(1990-5#1)(2007-11#1)(2008-11#1)
of natural humic##2##3##(2008-10#2)
of natural images##2##3##(2007-12#1)(2008-6#1)
of natural increase##3##3##(2008-8#1)(2011-2#2)
of natural infections##2##3##(2008-10#1)(2008-5#1)
of natural killer (NK) cells from##2##6##(2008-4#2)
of natural killer (NK) cells##5##5##(2007-11#1)(2008-4#2)(2010-7#1)(2013-1#1)
of natural killer (NK)##6##4##(2007-11#1)(2008-4#2)(2008-9#1)(2010-7#1)(2013-1#1)
of natural killer cell##2##4##(2008-4#2)
of natural killer cells and##2##5##(1992-4#1)(1995-3#1)
of natural killer cells##6##4##(1992-4#1)(1995-2#1)(1995-3#1)(1996-12#1)(2007-12#1)(2010-7#1)
of natural killer##15##3##(1992-4#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-4#4)(2008-9#1)(2010-7#2)(2013-1#1)
of natural medicinal materials##2##4##(2005-10#2)
of natural or synthetic##3##4##(2006-12#1)(2012-12#2)
of natural or##6##3##(2006-12#1)(2008-10#1)(2008-4#1)(2012-12#2)(2013-1#1)
of natural organic matter (NOM)##3##5##(1992-5#1)(2008-10#1)(2008-11#1)
of natural organic matter##5##4##(1992-5#1)(2008-10#3)(2008-11#1)
of natural organic##7##3##(1992-5#1)(2005-11#1)(2008-10#4)(2008-11#1)
of natural origin##2##3##(2005-10#1)(2008-10#1)
of natural plant##2##3##(2008-8#1)(2011-1#1)
of natural polymers##3##3##(2008-10#2)(2008-5#1)
of natural populations and##2##4##(2008-10#2)
of natural populations of##5##4##(2007-12#1)(2008-10#1)(2008-9#1)(2012-12#1)(2012-3#1)
of natural populations##9##3##(2007-12#1)(2008-10#3)(2008-9#2)(2011-12#1)(2012-12#1)(2012-3#1)
of natural product##4##3##(2007-11#1)(2008-10#1)(2008-11#1)(2010-7#1)
of natural products and##3##4##(2009-10#1)(2009-2#1)(2010-12#1)
of natural products##14##3##(1997-4#1)(2005-8#1)(2006-10#1)(2006-12#2)(2007-7#2)(2008-10#1)(2009-10#1)(2009-2#1)(2010-12#2)(2010-2#2)
of natural proteins##3##3##(2006-12#1)(2010-9#1)(2013-8#1)
of natural resistance##2##3##(2008-10#2)
of natural resources##2##3##(2007-5#1)(2008-1#1)
of natural rotenone##3##3##(1996-9#3)
of natural samples##3##3##(1994-8#1)(2008-10#1)(2011-2#1)
of natural selection in##4##4##(2008-11#2)(2010-4#1)(2012-3#1)
of natural selection on##2##4##(2008-9#2)
of natural selection##17##3##(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#2)(2010-4#2)(2010-5#1)(2012-12#2)(2012-3#4)
of natural shampoos##2##3##(2008-5#2)
of natural systems##3##3##(2006-10#1)(2008-8#1)(2010-12#1)
of natural tooth##2##3##(2008-7#1)(2012-2#1)
of natural water##7##3##(1991-8#1)(2008-10#6)
of natural waters and##2##4##(2008-10#2)
of natural waters##8##3##(2008-10#5)(2008-2#1)(2008-3#2)
of natural##318##2##(1990-2#1)(1990-5#2)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-11#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-7#1)(1996-9#4)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#3)(1997-9#1)(2004-11#1)(2004-2#1)(2004-4#3)(2005-10#3)(2005-11#4)(2005-12#1)(2005-8#1)(2006-10#3)(2006-11#2)(2006-12#6)(2006-3#1)(2006-5#1)(2006-6#2)(2006-7#2)(2007-1#1)(2007-11#5)(2007-12#5)(2007-2#3)(2007-3#3)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#59)(2008-11#10)(2008-12#2)(2008-2#11)(2008-3#5)(2008-4#8)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#8)(2008-9#7)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-7#1)(2010-10#2)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#2)(2010-7#3)(2010-8#1)(2010-9#3)(2011-1#5)(2011-12#1)(2011-2#8)(2011-7#1)(2012-1#6)(2012-12#6)(2012-2#6)(2012-3#7)(2013-1#10)(2013-8#5)
of naturalistic##2##2##(2006-7#1)(2009-4#1)
of naturally acquired##2##3##(2005-10#1)(2011-1#1)
of naturally infected##6##3##(1992-11#1)(2008-10#5)
of naturally occurring large presecretory proteins##2##6##(1994-11#2)
of naturally occurring species in##2##5##(2008-10#1)(2008-7#1)
of naturally occurring##36##3##(1991-6#1)(1992-11#1)(1992-6#2)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-8#1)(1996-7#1)(1997-4#3)(1997-7#1)(2004-2#1)(2004-9#1)(2006-12#1)(2008-10#6)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
of naturally processed##2##3##(1990-8#1)(2008-4#1)
of naturally##54##2##(1990-8#1)(1991-6#1)(1992-11#2)(1992-6#2)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-7#1)(1997-4#3)(1997-7#2)(2004-2#1)(2004-9#1)(2005-10#1)(2006-12#1)(2007-7#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-3#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
of naturalness##2##2##(2010-4#1)(2013-7#1)
of nature and##5##3##(2008-11#1)(2008-4#1)(2009-10#1)(2009-2#1)(2013-1#1)
of nature##33##2##(1992-3#1)(1994-3#1)(1997-6#1)(2006-10#2)(2006-12#2)(2006-4#1)(2006-7#1)(2007-8#2)(2008-11#1)(2008-12#7)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2010-11#1)(2010-12#1)(2012-2#3)(2013-1#1)
of nature's##4##2##(1997-6#1)(2006-10#1)(2006-7#1)(2010-5#1)
of naturopathy##2##2##(1991-2#1)(2010-3#1)
of nausea and vomiting##8##4##(1990-12#1)(1991-11#1)(1994-10#1)(2008-7#4)(2011-12#1)
of nausea and##9##3##(1990-12#1)(1991-11#1)(1994-10#1)(2006-8#1)(2008-7#4)(2011-12#1)
of nausea##15##2##(1990-12#1)(1991-11#1)(1994-10#1)(2006-8#1)(2008-5#1)(2008-7#4)(2008-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
of navicular disease##2##3##(1993-7#2)
of navigation system##2##3##(2009-4#2)
of navigation##6##2##(2006-6#1)(2007-12#1)(2007-8#1)(2009-4#2)(2013-1#1)
of naïve T cells##2##4##(2008-1#1)(2008-4#1)
of naïve T##3##3##(2008-1#1)(2008-4#1)(2010-2#1)
of naïve##9##2##(2008-1#1)(2008-4#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-2#1)(2012-11#1)(2012-12#1)(2013-8#1)
of ncRNAs##6##2##(2008-1#2)(2008-4#2)(2012-3#2)
of near infrared reflectance##2##4##(1995-1#1)(2010-4#1)
of near infrared##4##3##(1995-1#1)(2008-10#2)(2010-4#1)
of near##12##2##(1995-1#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-7#1)(2009-9#1)(2010-4#1)(2011-2#1)
of near-field optical##5##3##(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#1)
of near-field##17##2##(2007-11#1)(2007-12#5)(2008-1#1)(2008-2#3)(2008-3#6)(2009-11#1)
of near-infrared (NIR)##3##3##(2008-1#1)(2008-10#1)(2008-3#1)
of near-infrared fluorescent##2##3##(2007-11#2)
of near-infrared light##2##3##(2008-2#1)(2010-7#1)
of near-infrared spectroscopy##7##3##(1997-6#4)(2007-10#1)(2008-10#2)
of near-infrared##23##2##(1997-6#4)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#4)(2008-2#1)(2008-3#5)(2009-12#1)(2010-4#1)(2010-7#1)
of near-isogenic lines##2##3##(2008-10#1)(2012-11#1)
of near-physiological##2##2##(1990-3#1)(2008-9#1)
of nearby##7##2##(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-3#1)(2012-12#1)
of nearly 15%##2##3##(2008-10#1)(2011-2#1)
of nearly 20##3##3##(1996-1#1)(2007-11#1)(2008-3#1)
of nearly 30 years##2##4##(1993-10#1)(2008-4#1)
of nearly all##6##3##(1991-4#1)(1995-1#1)(2006-4#1)(2006-5#1)(2008-10#1)(2011-3#1)
of nearly homogeneous##2##3##(2008-2#1)(2008-4#1)
of nearly transform-limited##2##3##(2007-11#1)(2007-12#1)
of nearly##46##2##(1990-9#1)(1991-4#1)(1993-10#1)(1993-12#1)(1994-10#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-5#1)(1997-5#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-11#3)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#4)(2008-4#2)(2008-6#1)(2008-7#1)(2009-10#1)(2010-8#1)(2011-2#3)(2011-3#1)
of nearshore##4##2##(2009-2#1)(2010-8#1)(2013-8#2)
of neat##3##2##(1994-3#1)(2006-10#1)(2008-5#1)
of nebivolol##2##2##(2010-2#1)(2010-3#1)
of nebulization##2##2##(1993-2#1)(1996-3#1)
of nebulized insulin was##2##4##(1996-3#2)
of nebulized insulin##3##3##(1996-3#3)
of nebulized##5##2##(1993-2#1)(1996-1#1)(1996-3#3)
of nebulizers##3##2##(1995-3#1)(1997-1#1)(2013-8#1)
of necessary##5##2##(1995-12#1)(2006-6#1)(2008-1#1)(2008-10#1)(2010-4#1)
of necessity##7##2##(1990-12#1)(2006-10#1)(2006-4#1)(2008-5#1)(2008-9#1)(2011-2#2)
of neck anatomy##2##3##(2010-11#1)(2010-9#1)
of neck and##2##3##(2006-11#1)(2013-1#1)
of neck infections##3##3##(2008-8#1)(2008-9#1)(2010-12#1)
of neck injuries##3##3##(2007-4#3)
of neck muscle strength along the##2##6##(2007-1#2)
of neck muscle##4##3##(2007-1#3)(2007-4#1)
of neck pain##9##3##(1993-3#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-7#3)(2008-7#1)(2009-5#1)
of neck##37##2##(1993-3#1)(2006-11#1)(2006-4#2)(2006-8#1)(2007-1#4)(2007-11#1)(2007-4#4)(2007-7#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2009-5#1)(2010-11#1)(2010-12#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#3)(2013-1#2)(2013-8#1)
of necroses##2##2##(2006-6#1)(2008-1#1)
of necrosis and##7##3##(1994-6#1)(2006-10#1)(2008-10#2)(2008-6#1)(2011-2#1)(2013-1#1)
of necrosis in##2##3##(2007-7#1)(2012-3#1)
of necrosis of the##2##4##(2008-6#1)(2011-2#1)
of necrosis of##3##3##(2008-6#2)(2011-2#1)
of necrosis##31##2##(1990-12#1)(1991-2#1)(1991-3#1)(1992-6#1)(1992-9#1)(1994-6#1)(1995-7#1)(1996-9#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-6#3)(2011-2#3)(2012-3#2)(2013-1#1)
of necrotic core and dense calcium##2##6##(2011-1#2)
of necrotic core##3##3##(2010-12#1)(2011-1#2)
of necrotic leaf tissue##2##4##(2008-10#2)
of necrotic lesions##4##3##(1997-6#1)(2008-10#3)
of necrotic##18##2##(1997-6#1)(1997-7#1)(2005-10#1)(2008-10#8)(2010-12#1)(2011-1#2)(2011-2#3)(2013-1#1)
of necrotizing enterocolitis in##2##4##(2011-2#1)(2012-2#1)
of necrotizing enterocolitis##3##3##(1997-7#1)(2011-2#1)(2012-2#1)
of necrotizing fasciitis##5##3##(1990-8#1)(1992-3#1)(2007-12#2)(2013-8#1)
of necrotizing soft tissue infections##2##5##(2009-3#2)
of necrotizing##14##2##(1990-8#1)(1992-3#1)(1997-7#1)(2006-10#1)(2007-12#2)(2008-10#1)(2009-1#1)(2009-3#2)(2011-2#1)(2012-2#2)(2013-8#1)
of nectar on microbial antagonists##2##5##(2008-10#2)
of nectar production##3##3##(2009-8#1)(2013-8#2)
of nectar##7##2##(1991-8#1)(2008-10#2)(2008-8#1)(2009-8#1)(2013-8#2)
of need and##2##3##(2010-9#1)(2012-2#1)
of need for##3##3##(1990-9#1)(2009-10#1)(2010-3#1)
of need to##2##3##(2005-3#1)(2011-2#1)
of need##16##2##(1990-11#1)(1990-9#1)(2005-3#1)(2005-7#1)(2006-5#1)(2007-7#1)(2008-11#1)(2008-9#1)(2009-10#1)(2010-1#1)(2010-3#2)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
of needed##3##2##(2005-7#1)(2007-4#1)(2008-10#1)
of needle pain##3##3##(2008-11#3)
of needle##11##2##(1993-10#2)(1993-11#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#3)(2012-2#1)
of needles and##3##3##(1994-4#1)(2007-5#1)(2013-1#1)
of needles##7##2##(1992-9#1)(1994-4#1)(2007-5#1)(2007-7#1)(2013-1#3)
of needlestick injuries and other##2##5##(2007-7#1)(2011-2#1)
of needlestick injuries##3##3##(2006-5#1)(2007-7#1)(2011-2#1)
of needs and##2##3##(1994-3#1)(2007-6#1)
of needs##13##2##(1990-11#1)(1993-1#1)(1994-3#1)(1997-3#1)(2005-11#1)(2005-7#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-6#1)(2008-10#1)(2008-4#1)
of negative affect##5##3##(2006-2#1)(2008-11#1)(2008-5#1)(2009-11#2)
of negative affectivity##2##3##(2010-6#2)
of negative air ions##2##4##(1997-6#2)
of negative and##2##3##(1990-3#1)(2009-9#1)
of negative binomial##2##3##(2008-6#1)(2011-12#1)
of negative charge##2##3##(1995-10#1)(2005-11#1)
of negative charges in##2##4##(1993-3#1)(1997-8#1)
of negative charges##4##3##(1993-3#1)(1994-2#1)(1997-8#2)
of negative emotions##2##3##(2008-11#1)(2010-11#1)
of negative health outcomes##3##4##(2009-12#1)(2010-10#1)(2012-1#1)
of negative outcomes##2##3##(2007-8#1)(2013-8#1)
of negative phototropism##3##3##(2008-9#3)
of negative pressure##2##3##(1994-4#1)(2007-8#1)
of negative regulation by the##2##5##(1993-2#1)(2012-12#1)
of negative reports##2##3##(1992-8#1)(1997-5#1)
of negative symptoms##4##3##(1997-8#1)(2008-6#1)(2012-2#2)
of negative##89##2##(1990-3#1)(1990-8#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-4#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-6#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-5#2)(1997-6#2)(1997-8#4)(2005-11#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-12#5)(2007-4#1)(2007-7#2)(2007-8#3)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-9#5)(2009-11#7)(2009-12#3)(2009-5#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#3)(2012-12#2)(2012-2#2)(2013-7#1)(2013-8#1)
of negatively charged Al-citrate##2##4##(2008-10#2)
of negatively charged phospholipids##2##4##(1994-2#1)(1995-8#1)
of negatively charged vesicles##2##4##(1994-2#1)(1997-6#1)
of negatively charged##16##3##(1991-8#1)(1992-12#1)(1994-2#3)(1994-3#1)(1995-8#1)(1996-8#1)(1997-6#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-8#1)(2013-8#1)
of negatively##19##2##(1990-5#1)(1991-8#1)(1992-12#1)(1994-2#3)(1994-3#1)(1995-8#1)(1996-8#1)(1997-1#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-8#1)(2013-8#1)
of neglect##4##2##(1995-12#1)(1996-2#1)(2007-3#1)(2007-8#1)
of neglected##5##2##(2008-5#3)(2011-2#1)(2012-2#1)
of negligence in##2##3##(2004-12#1)(2008-10#1)
of negligence##5##2##(1991-7#1)(1992-2#1)(1995-12#1)(2004-12#1)(2008-10#1)
of negligible##4##2##(2007-12#1)(2008-3#2)(2012-2#1)
of negotiated##2##2##(1991-3#1)(2008-2#1)
of negotiating##3##2##(1992-3#1)(1996-3#1)(2012-3#1)
of negotiations##2##2##(1991-10#1)(1996-5#1)
of neighborhood disadvantage##2##3##(2009-7#2)
of neighborhood##9##2##(2007-10#1)(2008-11#1)(2009-7#2)(2009-9#5)
of neighboring protein##2##3##(1996-7#1)(1997-1#1)
of neighboring##14##2##(1990-1#1)(1991-11#1)(1993-7#1)(1996-7#1)(1997-1#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-6#1)(2009-8#1)(2012-2#1)
of neighbors##4##2##(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
of neighbouring##3##2##(1996-2#1)(2008-1#1)(2008-10#1)
of neither##7##2##(1991-9#1)(1995-3#1)(1996-10#1)(1996-8#1)(1997-8#1)(2005-8#1)(2008-9#1)
of nematic liquid-crystal (LC)##2##4##(2007-12#1)(2008-3#1)
of nematic##6##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)
of nematode##9##2##(1990-6#1)(1993-6#1)(2006-10#1)(2007-12#2)(2008-10#3)(2009-3#1)
of nematode-trapping fungi was##2##4##(2008-10#2)
of nematode-trapping fungi##4##3##(2008-10#4)
of nematodes that had fed on##2##6##(2008-10#2)
of nematodes that had##3##4##(2008-10#2)(2009-3#1)
of nematodes that##5##3##(2008-10#4)(2009-3#1)
of nematodes##20##2##(2007-12#2)(2007-3#2)(2007-7#1)(2008-10#12)(2008-12#1)(2009-3#2)
of neoadjuvant chemotherapy##5##3##(2006-6#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-7#1)
of neoadjuvant exemestane##2##3##(2007-11#2)
of neoadjuvant therapy##4##3##(2007-8#1)(2010-12#2)(2013-8#1)
of neoadjuvant##16##2##(2006-10#1)(2006-6#1)(2007-11#3)(2007-8#1)(2010-12#2)(2010-3#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
of neoangiogenesis##2##2##(2012-1#1)(2012-12#1)
of neocortex##3##2##(1991-3#1)(1991-5#1)(1993-12#1)
of neocortical neurons have##2##4##(1997-5#1)(2008-11#1)
of neocortical neurons##3##3##(1995-6#1)(1997-5#1)(2008-11#1)
of neocortical##11##2##(1992-12#2)(1994-3#1)(1995-6#1)(1997-5#1)(2007-9#1)(2008-11#4)(2010-7#1)
of neocuproine##2##2##(2008-10#2)
of neodymium##2##2##(2008-10#1)(2008-3#1)
of neointima formation in the##2##5##(2005-7#1)(2007-8#1)
of neointima formation in##3##4##(2005-7#1)(2007-8#2)
of neointima formation##5##3##(1992-9#2)(2005-7#1)(2007-8#2)
of neoliberal##2##2##(2013-1#2)
of neomycin##2##2##(1994-11#2)
of neonatal and##3##3##(1991-1#1)(2010-12#1)(2011-2#1)
of neonatal candidiasis##2##3##(2009-9#2)
of neonatal care##4##3##(1993-6#1)(2006-1#1)(2006-2#2)
of neonatal follow-up##2##3##(2008-11#2)
of neonatal intensive care units##2##5##(1991-2#1)(2008-11#1)
of neonatal intensive care##6##4##(1991-2#1)(1994-12#1)(2008-11#4)
of neonatal intercostal catheters##2##4##(2006-4#2)
of neonatal lupus##2##3##(2006-10#1)(2010-6#1)
of neonatal mouse calvaria##2##4##(1990-11#1)(1993-8#1)
of neonatal mouse##3##3##(1990-11#1)(1993-8#1)(2008-8#1)
of neonatal rat##3##3##(1992-8#1)(1994-11#1)(1996-5#1)
of neonatal rats was##2##4##(1992-2#1)(1993-12#1)
of neonatal rats##5##3##(1992-2#1)(1992-9#1)(1993-12#1)(1993-2#1)(1996-3#1)
of neonatal screening##3##3##(2007-11#2)(2007-3#1)
of neonatal sepsis##4##3##(2006-1#1)(2008-5#1)(2009-12#1)(2011-2#1)
of neonatal septicaemia in a tertiary care hospital of##2##9##(2007-7#2)
of neonatal septicaemia##3##3##(2007-7#3)
of neonatal septicemia##2##3##(2007-7#1)(2010-2#1)
of neonatal##100##2##(1990-11#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-9#1)(1992-10#2)(1992-2#1)(1992-5#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-2#2)(1993-5#6)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-3#2)(2004-10#1)(2006-1#2)(2006-10#4)(2006-2#2)(2006-4#2)(2006-5#1)(2006-8#1)(2007-11#2)(2007-2#2)(2007-3#3)(2007-7#4)(2008-10#1)(2008-11#8)(2008-5#1)(2008-8#1)(2009-12#1)(2009-9#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#2)(2011-1#5)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
of neonatally##2##2##(1994-3#2)
of neonate##6##2##(2004-11#1)(2008-5#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-3#1)
of neonates and##3##3##(1994-6#1)(2008-1#1)(2008-11#1)
of neonates in##2##3##(1991-9#1)(1996-6#1)
of neonates with##4##3##(2006-10#2)(2008-11#1)(2013-1#1)
of neonates##14##2##(1991-1#1)(1991-9#1)(1993-1#1)(1994-6#1)(1996-6#1)(2006-10#2)(2007-5#1)(2008-1#1)(2008-11#3)(2012-2#1)(2013-1#1)
of neoplasia in##2##3##(1992-9#1)(2008-12#1)
of neoplasia##16##2##(1990-9#2)(1992-9#1)(1995-2#1)(2006-10#2)(2007-2#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#2)
of neoplasm in##2##3##(1992-2#1)(2011-2#1)
of neoplasm##5##2##(1992-2#1)(1993-3#1)(2007-11#1)(2011-2#1)(2012-11#1)
of neoplasmatic disease##2##3##(2007-11#2)
of neoplasmatic##3##2##(2007-11#2)(2007-8#1)
of neoplasms of the##2##4##(2008-8#1)(2010-2#1)
of neoplasms which##2##3##(1992-8#1)(2011-2#1)
of neoplasms##17##2##(1992-8#2)(1995-11#1)(2008-5#1)(2008-8#1)(2008-9#3)(2010-2#2)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-1#1)
of neoplastic cells and##4##4##(1990-4#1)(1990-8#1)(2006-11#1)(2010-3#1)
of neoplastic cells in##2##4##(1992-6#1)(2011-2#1)
of neoplastic cells##11##3##(1990-10#1)(1990-4#1)(1990-8#1)(1992-6#1)(1997-1#1)(2006-10#1)(2006-11#1)(2010-3#1)(2011-2#2)(2012-2#1)
of neoplastic changes##3##3##(1992-3#1)(1993-2#1)(2007-7#1)
of neoplastic disease##5##3##(1994-9#1)(1996-1#1)(2005-8#1)(2007-11#2)
of neoplastic diseases##3##3##(1990-12#1)(2008-11#1)(2011-2#1)
of neoplastic lesions in##2##4##(2011-12#1)(2012-1#1)
of neoplastic lesions##3##3##(2011-12#2)(2012-1#1)
of neoplastic tissues##2##3##(2008-5#2)
of neoplastic transformation in vitro##4##5##(2008-7#4)
of neoplastic transformation in##6##4##(2008-7#5)(2012-12#1)
of neoplastic transformation##9##3##(1992-2#1)(2006-11#1)(2008-7#6)(2012-12#1)
of neoplastic##54##2##(1990-10#1)(1990-12#1)(1990-4#1)(1990-8#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1993-2#1)(1994-9#1)(1995-7#1)(1996-1#1)(1997-1#1)(1997-5#1)(2005-8#1)(2006-10#2)(2006-11#2)(2006-12#1)(2007-11#4)(2007-2#1)(2007-7#1)(2007-8#1)(2008-11#3)(2008-4#2)(2008-5#3)(2008-7#6)(2008-9#1)(2009-2#1)(2010-12#1)(2010-3#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)
of neopterin concentrations##2##3##(1990-2#1)(2012-2#1)
of neopterin##10##2##(1990-2#1)(1992-12#1)(1994-9#1)(1996-12#1)(2008-10#1)(2009-12#1)(2012-2#4)
of neostigmine and ketamine##2##4##(2011-12#2)
of neostigmine##8##2##(2007-12#1)(2008-10#4)(2011-12#3)
of neostriatal cyclic##2##3##(1990-5#2)
of neostriatal dopamine##2##3##(1993-12#1)(1993-3#1)
of neostriatal##5##2##(1990-5#3)(1993-12#1)(1993-3#1)
of neosynthesized##2##2##(1990-7#1)(1996-2#1)
of neotropical##4##2##(2008-5#2)(2010-1#1)(2013-7#1)
of neovascular AMD##2##3##(2009-8#1)(2011-7#1)
of neovascular age-related macular##3##4##(2011-7#2)(2013-1#1)
of neovascular##7##2##(1990-7#1)(2008-10#1)(2009-8#1)(2011-7#3)(2013-1#1)
of neovascularisation##2##2##(1996-12#1)(2007-11#1)
of neovascularization##4##2##(1993-9#2)(1995-1#1)(2010-11#1)
of nephrectomy##2##2##(2007-7#1)(2011-2#1)
of nephritis##2##2##(1996-9#1)(2009-12#1)
of nephrolithiasis##5##2##(2008-10#1)(2008-12#2)(2011-2#1)(2012-12#1)
of nephrologists##3##2##(2007-7#2)(2008-10#1)
of nephrology and##2##3##(2007-7#2)
of nephrology##3##2##(1991-11#1)(2007-7#2)
of nephropathy in##4##3##(1991-4#1)(2008-1#2)(2011-1#1)
of nephropathy##16##2##(1991-4#1)(1995-10#1)(1996-12#1)(2005-10#2)(2007-1#1)(2007-7#1)(2008-1#5)(2008-9#2)(2011-1#1)(2012-1#1)
of nephrosclerosis##3##2##(1990-7#1)(2008-1#2)
of nephrosis##3##2##(1996-6#1)(2008-5#1)(2009-6#1)
of nephrotic syndrome and##2##4##(1992-5#1)(2007-11#1)
of nephrotic syndrome in##4##4##(1991-1#1)(2007-11#1)(2007-8#2)
of nephrotic syndrome##12##3##(1991-1#1)(1992-5#1)(1995-6#1)(1996-6#2)(2006-10#1)(2006-7#1)(2007-11#2)(2007-8#2)(2009-4#1)
of nephrotic##13##2##(1991-1#1)(1992-5#1)(1995-6#1)(1996-6#2)(2006-10#1)(2006-7#1)(2007-11#2)(2007-8#2)(2008-5#1)(2009-4#1)
of nephrotoxic drugs##4##3##(1994-6#1)(2006-8#1)(2010-7#1)(2013-7#1)
of nephrotoxic##5##2##(1994-6#1)(2006-10#1)(2006-8#1)(2010-7#1)(2013-7#1)
of nephrotoxicity##3##2##(1996-12#1)(2007-11#1)(2007-8#1)
of neplanocin##3##2##(1994-9#1)(2008-11#2)
of nerisopam##4##2##(1996-3#4)
of neritic-benthonic##4##2##(2007-5#4)
of nerve and##2##3##(1992-3#1)(2005-10#1)
of nerve block##2##3##(2007-7#1)(2012-2#1)
of nerve cell death##2##4##(1996-12#1)(2009-10#1)
of nerve cell##8##3##(1991-12#1)(1992-12#1)(1994-6#2)(1995-3#1)(1996-12#2)(2009-10#1)
of nerve cells##7##3##(1994-11#1)(1995-11#1)(1995-8#1)(1997-1#1)(2008-11#1)(2008-7#2)
of nerve compression##3##3##(1993-12#1)(2007-7#1)(2008-9#1)
of nerve damage##2##3##(1991-3#1)(2012-2#1)
of nerve endings##2##3##(1991-9#1)(1995-7#1)
of nerve fibers##2##3##(1994-5#1)(2006-8#1)
of nerve growth factor (NGF) and##2##6##(1991-12#1)(1994-3#1)
of nerve growth factor (NGF) to##2##6##(1993-11#1)(1996-1#1)
of nerve growth factor (NGF)##11##5##(1991-12#1)(1992-7#1)(1993-11#1)(1993-4#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-12#1)(1997-6#1)(2008-11#1)(2008-4#1)
of nerve growth factor##27##4##(1991-12#1)(1992-7#1)(1993-11#2)(1993-12#1)(1993-4#1)(1993-5#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1996-1#1)(1996-12#2)(1996-3#3)(1997-6#1)(1997-8#1)(2008-11#3)(2008-4#2)(2012-1#1)
of nerve growth##28##3##(1991-12#1)(1992-7#1)(1993-11#2)(1993-12#1)(1993-4#1)(1993-5#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1996-1#1)(1996-12#2)(1996-3#3)(1997-6#1)(1997-8#1)(2008-11#3)(2008-4#2)(2012-1#1)
of nerve injury##6##3##(2006-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-5#1)
of nerve regeneration##3##3##(1993-5#1)(2006-9#1)(2011-2#1)
of nerve root##2##3##(2007-11#1)(2008-1#1)
of nerve stimulation##3##3##(1990-10#1)(1990-11#1)(1996-9#1)
of nerve##92##2##(1990-10#1)(1990-11#1)(1990-7#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-9#1)(1992-12#1)(1992-3#3)(1992-7#1)(1993-11#3)(1993-12#2)(1993-4#1)(1993-5#2)(1994-11#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-11#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-12#4)(1996-3#4)(1996-9#1)(1997-1#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#4)(2008-12#1)(2008-4#3)(2008-7#4)(2008-9#5)(2009-10#1)(2009-5#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#4)
of nerves and##3##3##(2008-7#1)(2009-5#1)(2012-12#1)
of nerves##7##2##(2006-1#1)(2007-1#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
of nervous and##2##3##(2011-2#1)(2013-1#1)
of nervous system##3##3##(1993-5#1)(1997-6#1)(2010-3#1)
of nervous tissue##5##3##(1990-5#1)(2006-7#1)(2007-11#1)(2009-8#1)(2010-12#1)
of nervous##14##2##(1990-3#1)(1990-5#1)(1993-5#1)(1994-10#2)(1997-6#1)(2006-7#1)(2007-11#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#1)(2013-1#1)
of nest##2##2##(2008-5#1)(2009-10#1)
of nested##7##2##(1994-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2011-2#1)
of nestin and vimentin was##2##5##(2007-9#1)(2009-2#1)
of nestin in##2##3##(2007-9#2)
of nestin##4##2##(2007-9#3)(2009-2#1)
of nesting females##2##3##(2007-3#2)
of nesting##5##2##(2007-3#2)(2008-5#1)(2008-6#1)(2008-9#1)
of nestling##2##2##(1993-2#1)(1994-3#1)
of nests##7##2##(2007-3#3)(2007-5#1)(2008-5#1)(2008-9#1)(2010-7#1)
of net charge##3##3##(1991-10#1)(2008-4#2)
of net photosynthesis rate##2##4##(2008-10#1)(2008-12#1)
of net photosynthesis##3##3##(2007-1#1)(2008-10#1)(2008-12#1)
of net present value##3##4##(2007-4#2)(2008-6#1)
of net##25##2##(1990-2#1)(1991-10#1)(1991-8#1)(1992-3#1)(1994-3#1)(1995-6#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-4#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#2)
of network##19##2##(1990-5#1)(1992-3#1)(2005-11#1)(2007-1#1)(2008-1#1)(2008-2#3)(2008-7#2)(2008-9#1)(2009-10#1)(2010-1#1)(2010-2#1)(2011-2#1)(2013-7#2)(2013-8#2)
of networking##3##2##(2008-10#1)(2008-2#2)
of networks of##2##3##(2007-12#1)(2008-7#1)
of networks##9##2##(1994-11#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-8#1)(2011-2#1)
of neural activity in the##2##5##(1991-9#1)(2008-4#1)
of neural activity in##3##4##(1991-9#1)(2008-11#1)(2008-4#1)
of neural activity##6##3##(1991-2#1)(1991-9#1)(1995-5#1)(2008-11#2)(2008-4#1)
of neural and##5##3##(1996-8#1)(2008-4#1)(2008-8#1)(2010-1#1)(2011-12#1)
of neural blockade and##2##4##(2006-7#2)
of neural blockade##4##3##(2006-7#2)(2006-8#2)
of neural cell adhesion molecule##2##5##(1991-11#1)(1994-8#1)
of neural cell adhesion##3##4##(1991-11#1)(1994-8#1)(2010-12#1)
of neural cells##7##3##(1990-6#1)(1995-12#1)(2005-8#1)(2007-2#2)(2008-8#1)(2009-6#1)
of neural circuits##4##3##(2008-1#1)(2008-11#1)(2008-9#1)(2012-3#1)
of neural codes##2##3##(2008-11#2)
of neural coding##3##3##(2008-1#1)(2008-11#2)
of neural crest cell##2##4##(1997-6#1)(2006-11#1)
of neural crest cells##2##4##(2012-2#2)
of neural crest origin##2##4##(1996-4#1)(2006-9#1)
of neural crest##10##3##(1996-4#1)(1997-6#1)(2006-11#2)(2006-9#1)(2011-1#1)(2012-12#2)(2012-2#2)
of neural development##2##3##(1995-2#1)(2010-1#1)
of neural differentiation##6##3##(1990-11#2)(1990-8#1)(1994-3#1)(1996-4#1)(2008-10#1)
of neural dynamics##3##3##(2008-11#1)(2012-2#1)(2013-8#1)
of neural markers##2##3##(1990-8#1)(2008-1#1)
of neural network##5##3##(2008-10#3)(2008-2#1)(2010-8#1)
of neural networks##9##3##(1991-6#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-7#1)(2013-7#1)
of neural organization##2##3##(1991-11#2)
of neural origin##2##3##(1993-12#1)(2011-2#1)
of neural populations##3##3##(1994-2#1)(2009-8#1)(2012-1#1)
of neural precursor cells##3##4##(1995-11#1)(2005-10#1)(2013-1#1)
of neural precursors##2##3##(2007-12#2)
of neural progenitor cells in##2##5##(2012-2#1)(2012-3#1)
of neural responses##4##3##(2008-11#2)(2008-7#1)(2008-9#1)
of neural stem cell##2##4##(2008-1#1)(2008-7#1)
of neural stem cells (NSCs)##2##5##(2008-1#1)(2012-12#1)
of neural stem cells##11##4##(1994-11#3)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#1)(2012-1#1)(2012-12#1)
of neural stem##13##3##(1994-11#3)(2008-1#3)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2012-1#1)(2012-12#1)
of neural structures##6##3##(1991-1#1)(1994-10#1)(2005-9#1)(2006-8#1)(2007-8#1)(2012-2#1)
of neural tissue##4##3##(1991-10#1)(1991-2#1)(1995-8#1)(2008-11#1)
of neural tube defects in##2##5##(2007-11#1)(2009-10#1)
of neural tube defects with##2##5##(1993-2#1)(2012-12#1)
of neural tube defects##8##4##(1993-2#1)(2004-10#1)(2007-11#2)(2009-10#1)(2010-12#1)(2012-1#1)(2012-12#1)
of neural tube##10##3##(1993-2#1)(2004-10#1)(2007-11#2)(2009-10#1)(2009-4#1)(2010-1#1)(2010-12#1)(2012-1#1)(2012-12#1)
of neural##168##2##(1990-11#2)(1990-5#1)(1990-6#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#4)(1991-2#2)(1991-6#2)(1991-9#1)(1993-12#1)(1993-2#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#3)(1995-11#2)(1995-12#4)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-4#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-6#1)(2004-10#1)(2005-10#2)(2005-8#1)(2005-9#1)(2006-11#3)(2006-7#3)(2006-8#4)(2006-9#1)(2007-11#2)(2007-12#4)(2007-2#2)(2007-8#1)(2008-1#6)(2008-10#8)(2008-11#16)(2008-2#5)(2008-4#5)(2008-7#7)(2008-8#2)(2008-9#4)(2009-10#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#2)(2010-1#3)(2010-12#2)(2010-2#1)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#2)(2012-1#4)(2012-12#4)(2012-2#5)(2012-3#5)(2013-1#1)(2013-7#2)(2013-8#3)
of neural-crest cells##2##3##(1996-3#2)
of neural-crest##3##2##(1996-3#3)
of neurally##2##2##(1990-5#1)(2010-2#1)
of neuraminidase inhibitors in##2##4##(2007-12#2)
of neuraminidase##5##2##(1991-9#2)(1996-7#1)(2007-12#2)
of neuraxial anesthesia##2##3##(2005-12#1)(2013-8#1)
of neuraxial steroids##6##3##(2006-8#6)
of neuraxial##10##2##(2005-12#2)(2006-8#7)(2013-8#1)
of neuregulin 1##2##3##(2007-12#2)
of neurite outgrowth and##3##4##(1995-11#1)(1995-6#1)(2008-11#1)
of neurite outgrowth by##3##4##(1996-1#1)(1996-5#2)
of neurite outgrowth is##2##4##(1992-11#1)(1996-5#1)
of neurite outgrowth##14##3##(1990-8#1)(1991-2#1)(1992-11#1)(1995-11#3)(1995-6#2)(1996-1#1)(1996-5#3)(2008-11#1)(2008-5#1)
of neurite##18##2##(1990-7#2)(1990-8#1)(1991-2#1)(1992-11#1)(1995-11#3)(1995-6#2)(1995-9#1)(1996-1#1)(1996-5#3)(2008-11#2)(2008-5#1)
of neurites from##2##3##(1996-3#1)(2005-7#1)
of neurites in##3##3##(1991-1#1)(1995-11#1)(2007-10#1)
of neurites##16##2##(1991-1#2)(1991-3#1)(1995-11#1)(1996-3#3)(1996-9#4)(2005-7#1)(2007-10#1)(2008-10#1)(2008-5#1)(2009-10#1)
of neuritic dystrophy##2##3##(2012-2#2)
of neuritic plaques and neurofibrillary tangles##2##6##(1993-11#2)
of neuritic plaques and##3##4##(1992-12#1)(1993-11#2)
of neuritic plaques##5##3##(1992-12#1)(1993-11#3)(1996-2#1)
of neuritic##8##2##(1992-12#1)(1993-11#3)(1996-2#1)(1996-3#1)(2012-2#2)
of neuroAIDS##2##2##(2007-11#2)
of neuroactive##5##2##(1992-8#1)(1995-12#1)(1995-5#1)(1997-5#1)(2008-7#1)
of neuroanatomical connection data##3##4##(1995-5#3)
of neuroanatomical##4##2##(1995-5#3)(2008-4#1)
of neurobehavioral##5##2##(1992-4#1)(1996-12#4)
of neurobiological##3##2##(2008-5#1)(2009-4#1)(2011-2#1)
of neurobiology and##3##3##(2012-2#3)
of neurobiology##4##2##(2009-7#1)(2012-2#3)
of neuroblast##2##2##(1990-8#1)(2007-12#1)
of neuroblastoma and##2##3##(2006-10#1)(2011-1#1)
of neuroblastoma cell lines##2##4##(1995-5#1)(2011-2#1)
of neuroblastoma cells##3##3##(1993-3#1)(1994-10#1)(1994-3#1)
of neuroblastoma##13##2##(1990-4#1)(1990-8#1)(1993-3#1)(1994-10#1)(1994-3#1)(1995-5#1)(1996-4#1)(2006-10#1)(2011-1#1)(2011-2#4)
of neuroblastomas##2##2##(1990-8#1)(2011-1#1)
of neuroblasts##4##2##(2007-12#4)
of neurochemicals##2##2##(2006-5#1)(2008-4#1)
of neurocognitive##4##2##(1996-8#1)(2006-3#1)(2010-2#1)(2011-1#1)
of neurocysticercosis##2##2##(2007-2#1)(2008-7#1)
of neurodegeneration in Parkinson's disease##2##5##(1995-6#1)(2008-11#1)
of neurodegeneration in##4##3##(1995-12#1)(1995-6#1)(2008-11#2)
of neurodegeneration##15##2##(1993-11#1)(1993-2#1)(1995-12#1)(1995-6#1)(1996-8#1)(2005-7#1)(2008-11#3)(2008-7#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-8#2)
of neurodegenerative and##3##3##(2008-3#1)(2008-4#1)(2009-3#1)
of neurodegenerative diseases and##3##4##(1994-5#1)(2008-11#1)(2012-12#1)
of neurodegenerative diseases##13##3##(1994-5#1)(1997-7#1)(2005-8#1)(2006-4#1)(2008-11#2)(2008-4#1)(2008-8#1)(2009-10#1)(2010-10#1)(2012-12#3)
of neurodegenerative disorders and##2##4##(1994-11#1)(2005-8#1)
of neurodegenerative disorders##5##3##(1994-11#1)(2005-8#1)(2007-11#1)(2009-5#1)(2013-8#1)
of neurodegenerative##33##2##(1994-11#1)(1994-5#1)(1997-7#1)(2005-8#4)(2006-4#1)(2007-11#2)(2008-1#1)(2008-11#5)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-10#1)(2012-1#1)(2012-12#3)(2013-1#2)(2013-8#1)
of neurodevelopment##2##2##(2006-9#1)(2008-11#1)
of neurodevelopmental##4##2##(2006-9#1)(2008-6#1)(2011-2#1)(2012-3#1)
of neuroendocrine cell##2##3##(1992-8#1)(2013-1#1)
of neuroendocrine cells##2##3##(1990-8#1)(2012-1#1)
of neuroendocrine origin##4##3##(1990-8#1)(1994-3#1)(1997-7#1)(2008-1#1)
of neuroendocrine tumors##7##3##(1993-12#1)(1995-7#1)(2011-2#2)(2012-3#1)(2013-1#2)
of neuroendocrine##32##2##(1990-11#1)(1990-8#2)(1991-1#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-3#1)(1995-7#1)(1996-2#1)(1996-4#1)(1997-7#2)(2008-1#2)(2008-11#1)(2008-5#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#1)
of neuroendocrinology##2##2##(1991-5#1)(2005-8#1)
of neurofibrillary tangles of##2##4##(1992-8#1)(2004-12#1)
of neurofibrillary tangles##6##3##(1991-1#2)(1992-3#1)(1992-8#1)(2004-12#1)(2008-7#1)
of neurofibrillary##7##2##(1991-1#2)(1992-3#1)(1992-8#1)(1995-10#1)(2004-12#1)(2008-7#1)
of neurofibromatosis type 1 (NF1) gene##2##6##(1991-5#1)(1992-8#1)
of neurofibromatosis type 1##4##4##(1991-5#1)(1992-8#2)(2008-6#1)
of neurofibromatosis##14##2##(1991-5#1)(1992-8#2)(1997-3#3)(2007-8#1)(2008-6#1)(2011-2#2)(2012-3#1)(2013-7#3)
of neurofibromatosis]##2##2##(1991-3#1)(1997-3#1)
of neurofibromin##5##2##(1992-8#2)(1994-12#1)(1995-7#1)(2008-7#1)
of neurofilament proteins##3##3##(1995-12#1)(1995-5#1)(1996-12#1)
of neurofilament##7##2##(1995-12#1)(1995-5#1)(1996-12#4)(1996-8#1)
of neurofilaments in##3##3##(1990-3#1)(1991-12#1)(1995-12#1)
of neurofilaments##7##2##(1990-3#2)(1991-12#1)(1991-8#1)(1991-9#2)(1995-12#1)
of neurogenesis in##3##3##(1996-5#1)(2007-12#1)(2008-7#1)
of neurogenesis##12##2##(1994-11#1)(1996-5#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-7#2)(2008-9#1)(2010-9#1)(2011-2#1)(2012-2#1)
of neurogenic induction##2##3##(2012-1#1)(2012-7#1)
of neurogenic##8##2##(2007-12#1)(2007-8#2)(2009-2#1)(2012-1#2)(2012-7#2)
of neurohormonal##4##2##(2006-1#1)(2008-10#1)(2008-3#1)(2008-4#1)
of neurohospitalists##2##2##(2011-1#2)
of neurohumoral##5##2##(2005-10#1)(2006-10#3)(2008-10#1)
of neurohypophyseal##2##2##(1993-4#1)(2007-12#1)
of neuroimaging and##2##3##(2009-9#1)(2012-12#1)
of neuroimaging data##2##3##(2008-2#1)(2009-9#1)
of neuroimaging##10##2##(2008-2#1)(2008-8#1)(2008-9#1)(2009-9#3)(2010-2#1)(2010-9#2)(2012-12#1)
of neuroinflammation##2##2##(2008-8#2)
of neuroinflammatory##3##2##(2012-2#1)(2013-1#2)
of neuroinvasive Borrelia##2##3##(2012-2#2)
of neurokinin A##2##3##(1994-2#1)(1997-4#1)
of neurokinin B##2##3##(1995-5#2)
of neurokinin##5##2##(1994-2#1)(1995-5#2)(1996-3#1)(1997-4#1)
of neuroleptic##7##2##(1992-12#1)(2007-6#1)(2008-1#1)(2012-2#1)(2012-3#3)
of neuroleptics##4##2##(1995-12#1)(1996-5#1)(1996-7#1)(2006-8#1)
of neurologic deficit##3##3##(1992-12#1)(1995-4#1)(2006-10#1)
of neurologic deficits##4##3##(2008-3#2)(2008-7#1)(2011-2#1)
of neurologic disease##2##3##(1996-12#1)(2007-11#1)
of neurologic function##2##3##(1992-6#1)(2013-8#1)
of neurologic involvement##2##3##(2006-11#1)(2011-1#1)
of neurologic symptoms##2##3##(2006-10#1)(2007-11#1)
of neurologic##23##2##(1992-12#1)(1992-6#1)(1993-2#1)(1995-4#1)(1996-12#1)(1997-3#1)(1997-5#1)(2006-10#4)(2006-11#1)(2007-10#1)(2007-11#2)(2008-3#2)(2008-7#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
of neurological and##8##3##(1990-4#1)(2005-10#1)(2005-12#1)(2006-5#1)(2007-8#1)(2008-1#2)(2011-1#1)
of neurological complications##3##3##(2006-10#1)(2010-8#1)(2011-12#1)
of neurological deficit##4##3##(1996-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
of neurological deficits##4##3##(1996-9#1)(2007-8#1)(2007-9#1)(2008-7#1)
of neurological deterioration##2##3##(2007-10#1)(2011-1#1)
of neurological disease##5##3##(1991-8#1)(1995-12#1)(1996-11#1)(2008-4#1)(2012-3#1)
of neurological diseases and##2##4##(2006-7#1)(2008-1#1)
of neurological diseases##6##3##(1993-8#1)(1996-1#1)(2006-7#1)(2008-1#1)(2009-8#1)(2011-2#1)
of neurological disorders##6##3##(1994-10#1)(1997-8#1)(2007-11#1)(2008-7#1)(2008-8#1)(2011-1#1)
of neurological disturbances##3##3##(1997-3#1)(2008-4#2)
of neurological dysfunction##3##3##(2007-11#1)(2013-1#2)
of neurological function##7##3##(1991-9#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-2#1)(2007-11#1)
of neurological impairment##2##3##(1991-11#1)(1992-7#1)
of neurological impairments##2##3##(2007-11#1)(2008-5#1)
of neurological signs##2##3##(2006-6#1)(2007-12#1)
of neurological status##2##3##(2006-7#1)(2007-11#1)
of neurological symptoms##5##3##(2005-1#1)(2007-11#1)(2008-12#1)(2008-8#1)(2012-2#1)
of neurological##84##2##(1990-4#1)(1991-10#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-7#2)(1993-8#1)(1994-10#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-8#1)(2005-1#1)(2005-10#1)(2005-12#1)(2006-10#2)(2006-11#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-9#1)(2007-10#1)(2007-11#11)(2007-12#1)(2007-8#4)(2007-9#1)(2008-1#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#2)(2009-8#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)
of neurologically impaired##3##3##(2010-7#2)(2012-1#1)
of neurologically##4##2##(1997-2#1)(2010-7#2)(2012-1#1)
of neurologists##2##2##(2008-7#1)(2012-3#1)
of neuromediators##4##2##(2008-10#4)
of neuromodulation##3##2##(2006-12#1)(2006-8#1)(2011-1#1)
of neuromodulators##2##2##(2007-8#1)(2008-11#1)
of neuromodulatory##4##2##(1995-2#1)(2008-3#1)(2008-6#1)(2008-7#1)
of neuromotor##3##2##(1995-6#1)(2006-10#1)(2008-6#1)
of neuromuscular abnormalities##2##3##(1990-8#1)(2012-1#1)
of neuromuscular blockade##4##3##(1993-1#1)(2006-10#1)(2010-7#1)(2012-12#1)
of neuromuscular blocking##3##3##(2006-10#1)(2007-9#1)(2010-11#1)
of neuromuscular disease##2##3##(1997-4#1)(2009-3#1)
of neuromuscular diseases##2##3##(2008-7#1)(2012-3#1)
of neuromuscular junction##2##3##(2012-3#2)
of neuromuscular##24##2##(1990-8#1)(1993-1#1)(1993-9#1)(1995-9#1)(1996-9#1)(1997-4#1)(2006-10#3)(2006-8#1)(2007-9#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-11#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-3#5)
of neuromusculoskeletal##3##2##(2007-11#1)(2008-12#1)(2009-3#1)
of neuron body and synaptosome##2##5##(1991-1#1)(1991-2#1)
of neuron in##2##3##(1994-10#1)(1994-2#1)
of neuron specific enolase##3##4##(1990-2#2)(1997-7#1)
of neuron##17##2##(1990-2#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1993-11#1)(1993-12#1)(1994-10#2)(1994-2#2)(1994-3#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#1)
of neuron-enriched cultures##3##3##(1993-2#3)
of neuron-glia interactions##2##3##(2008-7#1)(2013-8#1)
of neuron-glia##4##2##(2006-1#1)(2008-7#2)(2013-8#1)
of neuron-specific enolase (NSE)##2##4##(1993-7#1)(2011-2#1)
of neuron-specific enolase in##2##4##(1996-1#1)(2011-2#1)
of neuron-specific enolase##6##3##(1990-6#1)(1993-7#1)(1996-1#1)(1996-4#1)(2011-2#2)
of neuron-specific##9##2##(1990-6#1)(1993-7#1)(1994-8#1)(1995-5#1)(1996-1#1)(1996-4#1)(2007-10#1)(2011-2#2)
of neuronal Nogo-A##2##3##(2007-10#2)
of neuronal activities##2##3##(1992-11#1)(2008-4#1)
of neuronal activity within##2##4##(1992-8#1)(2008-11#1)
of neuronal activity##10##3##(1991-10#1)(1991-6#1)(1992-8#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-7#1)(2008-11#1)(2008-4#1)(2009-8#1)
of neuronal and glial##2##4##(1994-11#1)(1996-9#1)
of neuronal and##5##3##(1994-11#1)(1994-6#1)(1996-9#1)(2007-11#1)(2013-1#1)
of neuronal calcium##2##3##(1991-11#1)(1994-2#1)
of neuronal cell bodies##6##4##(1994-10#1)(1996-11#1)(1996-6#1)(1997-3#1)(1997-5#1)(1997-8#1)
of neuronal cell##7##3##(1994-10#1)(1996-11#1)(1996-6#1)(1997-3#1)(1997-5#1)(1997-8#1)(2006-3#1)
of neuronal cells##7##3##(1992-12#1)(1995-1#1)(1995-12#1)(1996-3#1)(1996-6#1)(2008-11#1)(2009-10#1)
of neuronal circuits##3##3##(1991-5#1)(1997-4#1)(2008-9#1)
of neuronal damage##5##3##(1991-11#3)(1995-7#1)(1997-2#1)
of neuronal death##3##3##(1996-1#1)(2005-8#1)(2008-7#1)
of neuronal degeneration##3##3##(1995-3#1)(2008-11#1)(2008-4#1)
of neuronal development##2##3##(1994-12#1)(2011-1#1)
of neuronal differentiation##8##3##(1991-11#1)(1992-3#1)(1994-2#1)(1996-4#1)(1996-5#1)(2008-10#1)(2008-4#1)(2012-12#1)
of neuronal excitability##3##3##(2008-5#1)(2008-6#1)(2008-8#1)
of neuronal excitation##2##3##(1997-8#1)(2005-8#1)
of neuronal function##2##3##(1997-3#1)(2008-7#1)
of neuronal functions##2##3##(2008-8#1)(2013-1#1)
of neuronal gene expression##3##4##(2008-4#3)
of neuronal growth##2##3##(1994-5#1)(1996-7#1)
of neuronal injury##4##3##(1991-9#1)(1996-1#1)(1996-9#1)(2008-4#1)
of neuronal loss in##2##4##(1991-6#1)(2008-7#1)
of neuronal loss##5##3##(1991-6#1)(1995-5#1)(2008-7#3)
of neuronal migration##4##3##(1995-5#1)(2007-9#2)(2008-11#1)
of neuronal morphology##3##3##(1994-5#1)(1997-6#2)
of neuronal nicotinic acetylcholine receptors##3##5##(1995-11#3)
of neuronal nicotinic##4##3##(1995-11#3)(1997-7#1)
of neuronal nitric oxide synthase##3##5##(1993-6#1)(1995-5#1)(2006-11#1)
of neuronal origin##3##3##(1996-8#2)(2007-8#1)
of neuronal polarization##2##3##(1996-9#2)
of neuronal populations##3##3##(2008-11#1)(2008-4#1)(2010-2#1)
of neuronal processes##2##3##(1990-2#1)(1992-7#1)
of neuronal properties##2##3##(1993-2#1)(2009-8#1)
of neuronal responses##4##3##(1991-1#1)(1991-6#1)(1996-3#1)(1996-7#1)
of neuronal soma##2##3##(1990-7#1)(1991-1#1)
of neuronal somata##3##3##(1995-12#3)
of neuronal susceptibility##2##3##(1990-7#2)
of neuronal systems##2##3##(1991-3#1)(1994-2#1)
of neuronal tissue##2##3##(2006-5#2)
of neuronal viability##2##3##(1996-12#1)(2008-7#1)
of neuronal##203##2##(1990-2#1)(1990-5#1)(1990-7#5)(1991-1#2)(1991-10#1)(1991-11#6)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#3)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-7#2)(1992-8#1)(1993-2#3)(1993-5#1)(1993-6#1)(1994-10#3)(1994-11#3)(1994-12#1)(1994-2#4)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#1)(1995-1#2)(1995-11#5)(1995-12#7)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#1)(1995-7#2)(1995-8#2)(1996-1#4)(1996-11#1)(1996-12#2)(1996-3#5)(1996-4#2)(1996-5#2)(1996-6#3)(1996-7#3)(1996-8#2)(1996-9#5)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#3)(2004-11#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-11#1)(2006-12#1)(2006-3#2)(2006-5#2)(2007-10#2)(2007-11#4)(2007-12#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#11)(2008-3#1)(2008-4#13)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#4)(2010-12#3)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#4)(2013-7#1)
of neuronal-type NO synthase I##2##5##(1997-6#2)
of neuronavigation##2##2##(2005-5#1)(2010-3#1)
of neurone##2##2##(1996-1#1)(2008-11#1)
of neurones in the##3##4##(1990-7#1)(1996-1#1)(1997-7#1)
of neurones in##6##3##(1990-7#1)(1995-12#2)(1996-1#2)(1997-7#1)
of neurones recorded##2##3##(1995-11#1)(1996-5#1)
of neurones##21##2##(1990-7#1)(1991-2#1)(1991-8#1)(1993-2#1)(1995-11#3)(1995-12#3)(1995-8#1)(1996-1#6)(1996-5#1)(1997-7#1)(1997-8#1)(2008-11#1)
of neurons and astrocytes##2##4##(1996-6#1)(2008-7#1)
of neurons and glia is##2##5##(2007-10#1)(2008-7#1)
of neurons and glia##3##4##(1995-12#1)(2007-10#1)(2008-7#1)
of neurons and glial cells##3##5##(1993-12#1)(2008-1#1)(2009-2#1)
of neurons and muscles##4##4##(1993-12#1)(2007-12#3)
of neurons and##24##3##(1993-12#2)(1994-10#1)(1995-12#1)(1996-2#2)(1996-6#1)(1997-2#1)(1997-7#1)(2006-11#1)(2007-10#1)(2007-12#3)(2008-1#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-2#1)
of neurons by##3##3##(1995-3#1)(1996-3#1)(2009-8#1)
of neurons during##2##3##(1991-3#1)(1994-12#1)
of neurons from##5##3##(1991-5#1)(1993-2#1)(2008-2#2)(2008-4#1)
of neurons in many##2##4##(1990-8#1)(2007-10#1)
of neurons in the central nervous system##2##7##(1993-3#1)(1996-10#1)
of neurons in the cerebral cortex##2##6##(1996-12#1)(2007-8#1)
of neurons in the network##2##5##(2012-2#2)
of neurons in the spinal##2##5##(1990-4#1)(1996-6#1)
of neurons in the##37##4##(1990-4#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-10#1)(1993-11#1)(1993-3#1)(1994-2#2)(1994-8#1)(1995-3#1)(1996-10#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-7#1)(2005-10#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-8#1)(2012-2#3)(2012-3#2)
of neurons in##54##3##(1990-4#1)(1990-5#1)(1990-8#2)(1991-11#1)(1991-2#1)(1991-3#1)(1992-10#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-7#2)(1994-2#2)(1994-5#1)(1994-8#1)(1995-3#1)(1996-10#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#2)(1997-1#1)(1997-2#1)(1997-7#1)(2005-10#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#3)(2012-3#2)
of neurons is##3##3##(2007-10#1)(2008-2#2)
of neurons of the##2##4##(1996-10#1)(2010-12#1)
of neurons of##6##3##(1996-10#1)(2009-8#1)(2010-12#3)(2013-7#1)
of neurons that are##2##4##(1995-8#1)(1996-9#1)
of neurons that##9##3##(1991-7#1)(1995-8#1)(1996-3#1)(1996-9#1)(1997-6#1)(2007-12#1)(2007-9#1)(2008-11#1)(2012-2#1)
of neurons to##9##3##(1990-10#1)(1992-5#1)(1992-7#1)(1993-11#1)(1994-11#1)(1996-2#1)(1996-3#1)(2008-4#1)(2010-4#1)
of neurons was##4##3##(1991-11#1)(1991-12#1)(1995-9#1)(2006-5#1)
of neurons were labeled in##2##5##(1990-11#1)(1997-3#1)
of neurons were##8##3##(1990-11#1)(1993-2#1)(1994-5#1)(1995-11#1)(1995-5#1)(1997-3#1)(2013-1#1)(2013-7#1)
of neurons with##7##3##(1993-11#1)(1994-5#1)(1996-12#1)(1996-9#1)(1997-3#1)(2012-2#1)(2013-7#1)
of neurons within the##2##4##(1991-9#1)(2008-2#1)
of neurons##238##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-4#2)(1990-5#2)(1990-7#2)(1990-8#3)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-7#1)(1992-8#4)(1993-11#3)(1993-12#4)(1993-2#6)(1993-3#1)(1993-6#1)(1993-7#2)(1994-10#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#4)(1994-6#1)(1994-8#2)(1995-10#1)(1995-11#3)(1995-12#2)(1995-3#3)(1995-5#2)(1995-6#2)(1995-7#2)(1995-8#2)(1995-9#2)(1996-10#4)(1996-11#1)(1996-12#5)(1996-2#4)(1996-3#8)(1996-4#1)(1996-5#2)(1996-6#4)(1996-9#4)(1997-1#1)(1997-2#2)(1997-3#3)(1997-5#1)(1997-6#2)(1997-7#2)(2005-10#1)(2006-11#1)(2006-5#1)(2007-10#4)(2007-11#1)(2007-12#6)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#1)(2008-11#13)(2008-2#8)(2008-4#7)(2008-5#3)(2008-7#7)(2008-8#6)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#3)(2009-8#8)(2010-12#4)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#7)(2012-3#2)(2013-1#3)(2013-7#6)(2013-8#2)
of neuropathic pain and##2##4##(2008-1#2)
of neuropathic pain in patients with##2##6##(2008-7#1)(2011-1#1)
of neuropathic pain in the rat##2##6##(2008-4#2)
of neuropathic pain in##8##4##(2005-9#1)(2006-12#1)(2008-4#3)(2008-7#2)(2011-1#1)
of neuropathic pain sensation through microglial##2##6##(2008-4#2)
of neuropathic pain that##2##4##(2005-9#1)(2008-4#1)
of neuropathic pain##55##3##(1993-4#4)(1996-5#2)(1997-3#1)(2005-9#2)(2006-10#2)(2006-12#4)(2006-3#2)(2007-12#3)(2007-7#1)(2008-1#5)(2008-12#1)(2008-4#8)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#9)(2009-12#1)(2010-7#1)(2011-1#2)(2012-3#1)(2013-7#1)
of neuropathic##64##2##(1991-2#1)(1993-12#1)(1993-4#4)(1996-5#2)(1997-3#1)(2005-9#2)(2006-10#2)(2006-12#5)(2006-3#2)(2006-8#1)(2007-12#3)(2007-7#1)(2008-1#6)(2008-10#1)(2008-12#1)(2008-4#8)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#9)(2009-12#1)(2010-3#1)(2010-7#1)(2011-1#2)(2012-3#1)(2013-7#1)
of neuropathologic##4##2##(1995-7#1)(2011-2#2)(2013-7#1)
of neuropathy and nephropathy##2##4##(2007-5#1)(2012-2#1)
of neuropathy and##3##3##(2007-5#1)(2012-2#2)
of neuropathy as##2##3##(1993-12#1)(2012-2#1)
of neuropathy##20##2##(1991-10#1)(1993-12#3)(1996-5#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-5#1)(2008-1#2)(2008-6#1)(2008-8#1)(2009-11#1)(2011-2#1)(2012-12#1)(2012-2#4)
of neuropeptide Y (NPY) in##2##5##(1990-2#1)(1996-1#1)
of neuropeptide Y (NPY)##9##4##(1990-2#1)(1991-6#1)(1993-7#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-9#1)(1997-2#1)(1997-5#1)
of neuropeptide Y (NPY)-immunoreactive##2##4##(1992-9#1)(1997-4#1)
of neuropeptide Y and##3##4##(1990-2#1)(1995-12#1)(1996-12#1)
of neuropeptide Y in##2##4##(1995-11#1)(1996-1#1)
of neuropeptide Y##29##3##(1990-2#2)(1991-2#1)(1991-6#1)(1991-8#2)(1992-9#1)(1993-12#1)(1993-7#1)(1995-11#4)(1995-12#4)(1995-3#2)(1996-1#2)(1996-12#1)(1996-9#2)(1997-2#1)(1997-4#2)(1997-5#2)
of neuropeptide Y-(2-36)##2##3##(1996-12#2)
of neuropeptide##38##2##(1990-2#2)(1991-2#2)(1991-6#1)(1991-8#2)(1992-9#3)(1993-12#1)(1993-7#1)(1994-10#1)(1995-11#4)(1995-12#4)(1995-3#2)(1996-1#2)(1996-12#3)(1996-9#2)(1997-2#1)(1997-4#2)(1997-5#3)(2005-10#1)(2006-10#1)
of neuropeptides and##4##3##(1993-2#1)(2008-8#1)(2009-12#1)(2013-1#1)
of neuropeptides in the##2##4##(1995-5#1)(2010-5#1)
of neuropeptides in##4##3##(1995-5#1)(1997-4#1)(2010-5#1)(2013-8#1)
of neuropeptides##22##2##(1992-11#1)(1992-9#1)(1993-2#1)(1994-10#5)(1994-8#1)(1995-5#1)(1996-3#1)(1997-4#1)(2006-10#1)(2007-2#2)(2008-10#1)(2008-4#1)(2008-8#1)(2009-12#1)(2010-5#1)(2013-1#1)(2013-8#1)
of neuropil##4##2##(1997-3#1)(2008-5#1)(2012-3#2)
of neuroprotection against the##2##4##(2007-9#1)(2010-8#1)
of neuroprotection##12##2##(1996-12#1)(2006-10#3)(2007-9#2)(2008-1#1)(2008-2#2)(2010-8#1)(2013-1#1)(2013-8#1)
of neuroprotective agents##6##3##(1993-1#1)(2007-9#3)(2008-7#2)
of neuroprotective##13##2##(1991-11#1)(1993-1#1)(1996-10#1)(2007-10#1)(2007-9#3)(2008-1#1)(2008-2#1)(2008-7#2)(2008-8#1)(2012-1#1)
of neuropsychiatric SLE##2##3##(1997-5#2)
of neuropsychiatric disease##2##3##(2008-4#2)
of neuropsychiatric diseases##2##3##(2011-1#1)(2012-2#1)
of neuropsychiatric disorders##7##3##(1996-8#1)(2005-10#1)(2008-12#1)(2008-8#1)(2010-9#2)(2011-1#1)
of neuropsychiatric##20##2##(1996-8#1)(1997-5#2)(1997-8#1)(2005-10#1)(2007-11#1)(2007-6#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-8#2)(2010-9#2)(2011-1#3)(2012-1#1)(2012-2#1)
of neuropsychological functioning and decline over time in dementia##2##9##(2008-7#2)
of neuropsychological functioning##3##3##(2005-10#1)(2008-7#2)
of neuropsychological impairment##3##3##(1991-1#1)(1995-9#1)(2008-9#1)
of neuropsychological rehabilitation for##2##4##(2007-11#2)
of neuropsychological research##2##3##(1994-5#1)(2005-11#1)
of neuropsychological test##2##3##(1996-11#1)(2008-7#1)
of neuropsychological##21##2##(1991-1#1)(1991-2#1)(1994-5#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-8#1)(2005-10#1)(2005-11#2)(2007-1#1)(2007-11#4)(2007-9#1)(2008-11#1)(2008-7#3)(2008-9#1)
of neuroradiological##2##2##(2006-4#1)(2008-7#1)
of neuroreceptor imaging##2##3##(2011-1#2)
of neuroscience##10##2##(1992-3#1)(2005-8#2)(2006-4#1)(2008-4#1)(2011-2#2)(2013-1#1)(2013-7#2)
of neurosciences##3##2##(2008-12#1)(2009-10#1)(2012-2#1)
of neurosecretory cells which stained with##2##6##(2008-5#2)
of neurosecretory cells##3##3##(2008-5#3)
of neurosecretory##5##2##(1990-5#2)(2008-5#3)
of neurosurgeons##4##2##(1996-3#1)(2006-12#2)(2007-1#1)
of neurosurgery in##2##3##(1990-9#1)(2011-2#1)
of neurosurgery##7##2##(1990-9#2)(2007-10#1)(2008-9#1)(2009-7#1)(2011-2#1)(2013-8#1)
of neurosurgical complications##3##3##(2012-3#3)
of neurosurgical patients##4##3##(2006-10#3)(2008-11#1)
of neurosurgical##8##2##(2006-10#3)(2007-10#1)(2008-11#1)(2012-3#3)
of neurosyphilis##2##2##(1993-2#1)(2010-3#1)
of neurotensin##8##2##(1993-3#2)(1994-3#1)(1995-2#1)(1996-2#2)(1997-7#2)
of neurotensin-induced phosphoinositide##2##3##(1996-6#2)
of neuroticism##10##2##(2007-12#1)(2008-11#2)(2008-6#5)(2009-4#1)(2010-12#1)
of neurotoxic##3##2##(1995-3#1)(2008-1#1)(2011-9#1)
of neurotoxicity from##2##3##(1997-5#1)(2008-3#1)
of neurotoxicity##10##2##(1991-1#1)(1991-3#1)(1992-8#1)(1995-12#1)(1996-9#1)(1997-5#1)(2006-12#1)(2008-3#1)(2008-8#1)(2012-2#1)
of neurotransmission##4##2##(1997-3#1)(2007-12#1)(2008-8#1)(2012-2#1)
of neurotransmitter receptors##5##3##(1991-11#1)(1993-8#1)(1994-2#1)(1996-8#1)(2008-1#1)
of neurotransmitter release was##2##4##(1990-2#1)(2008-5#1)
of neurotransmitter release##11##3##(1990-2#1)(1990-7#1)(1993-6#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-12#2)(1997-1#1)(2008-5#1)(2008-7#1)
of neurotransmitter##23##2##(1990-2#1)(1990-7#2)(1991-11#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-12#2)(1996-8#1)(1997-1#1)(2006-1#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)
of neurotransmitters in##2##3##(1994-2#1)(1995-12#1)
of neurotransmitters such as##2##4##(2008-10#1)(2012-2#1)
of neurotransmitters##18##2##(1990-11#2)(1991-12#2)(1992-11#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-5#1)(2006-4#1)(2007-10#1)(2008-1#1)(2008-10#1)(2012-2#1)
of neurotrophic factor##4##3##(1991-3#1)(2008-11#1)(2009-10#1)(2013-1#1)
of neurotrophic factors##8##3##(1996-3#1)(2005-7#1)(2008-11#2)(2008-7#2)(2013-1#2)
of neurotrophic keratopathy##4##3##(2005-11#2)(2006-11#2)
of neurotrophic##23##2##(1991-3#2)(1996-3#3)(1996-9#1)(2005-11#2)(2005-7#1)(2006-11#2)(2008-11#3)(2008-5#1)(2008-7#2)(2009-10#2)(2009-3#1)(2013-1#3)
of neurotrophin genes in the brain of senescence-accelerated mouse##2##9##(1994-5#2)
of neurotrophin receptors##2##3##(1996-12#1)(1996-3#1)
of neurotrophin##12##2##(1994-5#2)(1996-1#1)(1996-12#2)(1996-3#4)(1996-5#1)(2007-10#1)(2008-5#1)
of neurotrophin-3 (NT-3)##2##3##(2008-5#1)(2009-4#1)
of neurotrophin-3 during the formation of##2##6##(1996-3#2)
of neurotrophin-3 during##3##3##(1996-3#3)
of neurotrophin-3##5##2##(1996-3#3)(2008-5#1)(2009-4#1)
of neurotrophins and their receptors in the rat pituitary gland##2##10##(1995-11#2)
of neurotrophins and their receptors in the##3##7##(1995-11#2)(1996-12#1)
of neurotrophins and their receptors in##4##6##(1995-11#2)(1996-12#1)(2008-5#1)
of neurotrophins and##7##3##(1995-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(2008-5#1)(2008-9#1)
of neurotrophins in##5##3##(1994-8#1)(1996-3#2)(1996-6#1)(2008-7#1)
of neurotrophins##18##2##(1993-6#1)(1993-9#1)(1994-8#1)(1995-11#2)(1996-12#2)(1996-2#1)(1996-3#5)(1996-6#1)(2008-5#1)(2008-7#2)(2008-9#1)
of neurovascular##4##2##(2008-7#1)(2008-8#1)(2009-5#1)(2013-1#1)
of neutral alpha-glucosidase##3##3##(1996-1#3)
of neutral and##6##3##(1994-9#1)(2008-10#1)(2008-11#2)(2009-4#1)(2013-1#1)
of neutral endopeptidase##2##3##(1990-5#2)
of neutral hydrogen##2##3##(1997-2#2)
of neutral lipids##2##3##(1996-5#1)(2010-5#1)
of neutral red##4##3##(1996-4#1)(2008-10#2)(2008-11#1)
of neutral taurine##2##3##(1994-12#2)
of neutral##64##2##(1990-5#2)(1991-4#1)(1992-1#1)(1992-11#1)(1993-2#1)(1993-3#2)(1994-12#2)(1994-9#2)(1996-1#3)(1996-2#1)(1996-4#2)(1996-5#1)(1997-2#2)(1997-7#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-3#6)(2008-6#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-5#3)(2011-1#1)(2013-1#4)(2013-8#1)
of neutralisation##2##2##(2005-7#1)(2008-10#1)
of neutralising antibodies##2##3##(2007-11#2)
of neutralising##3##2##(2007-11#3)
of neutralization of the##2##4##(1994-3#1)(2008-10#1)
of neutralization##4##2##(1994-3#1)(2004-9#1)(2008-10#1)(2010-1#1)
of neutralizing antibodies##4##3##(1995-2#1)(1997-4#1)(2007-10#1)(2013-1#1)
of neutralizing antibody##5##3##(1995-5#3)(1996-10#1)(2008-5#1)
of neutralizing##15##2##(1995-2#2)(1995-5#3)(1996-10#1)(1997-4#1)(1997-6#1)(2007-10#1)(2008-10#3)(2008-5#2)(2013-1#1)
of neutron##3##2##(1994-3#1)(1995-11#1)(2008-10#1)
of neutropenia##9##2##(1996-12#1)(2007-11#2)(2007-2#1)(2008-6#1)(2008-7#4)
of neutropenic patients##2##3##(2005-8#1)(2006-10#1)
of neutropenic##7##2##(2005-8#1)(2006-10#1)(2007-12#1)(2008-6#2)(2008-7#1)(2012-3#1)
of neutrophil NADPH oxidase##2##4##(1991-5#1)(1996-2#1)
of neutrophil cathepsin G##2##4##(1996-7#2)
of neutrophil collagenase##3##3##(1992-5#3)
of neutrophil elastase##4##3##(1994-5#2)(1995-2#1)(2008-5#1)
of neutrophil granules##2##3##(1990-5#2)
of neutrophil membranes##2##3##(1991-2#2)
of neutrophil##39##2##(1990-5#2)(1991-1#1)(1991-12#1)(1991-2#3)(1991-5#1)(1992-1#1)(1992-5#3)(1993-1#1)(1993-3#1)(1994-5#2)(1994-8#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-7#2)(2006-2#1)(2008-11#5)(2008-4#1)(2008-5#1)(2009-6#1)(2010-5#1)(2011-1#3)(2012-1#1)(2012-3#3)
of neutrophils and##6##3##(1991-2#1)(1995-7#1)(2008-5#1)(2009-6#1)(2011-1#1)(2012-2#1)
of neutrophils by##4##3##(1991-2#1)(1992-3#1)(1994-3#1)(1995-7#1)
of neutrophils in the##2##4##(2006-4#1)(2012-3#1)
of neutrophils in##7##3##(1994-11#1)(2006-4#1)(2009-6#2)(2010-9#1)(2012-3#2)
of neutrophils was##2##3##(2007-9#1)(2010-12#1)
of neutrophils with##7##3##(1990-9#1)(1991-6#1)(1992-1#1)(1996-5#1)(2008-4#2)(2010-6#1)
of neutrophils##62##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#2)(1992-7#1)(1993-1#1)(1993-12#1)(1994-11#1)(1994-3#2)(1994-6#1)(1995-3#1)(1995-7#2)(1996-5#1)(2006-4#1)(2006-5#2)(2006-8#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-5#1)(2009-2#1)(2009-6#4)(2010-12#1)(2010-6#1)(2010-9#3)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)
of never##2##2##(1991-6#1)(2012-12#1)
of nevirapine##4##2##(2005-8#1)(2008-10#3)
of nevoid basal cell carcinoma syndrome##2##6##(2008-5#2)
of nevoid basal cell##3##4##(2007-4#1)(2008-5#2)
of nevoid##4##2##(2007-12#1)(2007-4#1)(2008-5#2)
of nevus cells##2##3##(2011-2#1)(2013-7#1)
of nevus##3##2##(2007-7#1)(2011-2#1)(2013-7#1)
of new 1##3##3##(1997-1#1)(2007-10#1)(2012-3#1)
of new 4beta-5-Fu-substituted 4'-demethylepipodophyllotoxin derivatives##2##5##(2007-11#2)
of new AHPs##2##3##(1994-3#2)
of new AIDS##2##3##(1991-11#1)(1993-9#1)
of new HIV infections##2##4##(1990-11#1)(2010-7#1)
of new HIV##4##3##(1990-11#1)(1996-12#1)(1996-6#1)(2010-7#1)
of new HIV-1##2##3##(1992-9#1)(2007-11#1)
of new Schiff bases##2##4##(2007-10#1)(2007-11#1)
of new active##2##3##(2007-11#1)(2012-12#1)
of new agents to##2##4##(2005-9#1)(2008-5#1)
of new agents##9##3##(2005-7#1)(2005-9#1)(2006-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-12#1)(2013-1#1)
of new anaesthetic##2##3##(2006-10#2)
of new analogues##2##3##(1992-6#1)(2011-2#1)
of new analytical##3##3##(2007-9#1)(2008-10#1)(2008-7#1)
of new and##18##3##(1994-9#1)(1995-3#1)(1996-11#1)(1997-4#1)(2005-8#1)(2006-11#1)(2007-10#2)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-11#2)(2011-2#1)(2012-11#1)
of new anti-HIV-1 drugs##2##4##(2011-3#2)
of new anticancer##5##3##(2008-1#1)(2008-5#3)(2008-8#1)
of new antimicrobial agents##2##4##(2006-10#1)(2008-7#1)
of new antimicrobial##5##3##(2005-8#1)(2006-10#2)(2008-10#1)(2008-7#1)
of new antiviral##3##3##(2006-10#1)(2007-11#1)(2008-11#1)
of new approaches to##2##4##(2005-6#1)(2010-12#1)
of new approaches##6##3##(1995-12#1)(2004-12#1)(2005-6#1)(2007-11#1)(2008-5#1)(2010-12#1)
of new areas##2##3##(1994-12#1)(2013-1#1)
of new assays##2##3##(2008-4#1)(2013-1#1)
of new blood vessels##5##4##(1993-9#1)(2007-11#1)(2008-1#1)(2010-9#1)(2013-8#1)
of new blood##6##3##(1993-9#1)(2007-11#1)(2008-1#1)(2010-9#1)(2013-8#2)
of new cardiac##2##3##(2008-3#2)
of new cases of##5##4##(1992-2#1)(2011-2#1)(2012-2#1)(2013-1#2)
of new cases##8##3##(1992-2#1)(1997-6#2)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#2)
of new catalysts##2##3##(2008-7#1)(2010-12#1)
of new catheters##2##3##(1994-11#1)(2011-2#1)
of new cell##3##3##(2008-11#1)(2009-8#1)(2010-2#1)
of new chemical entities##2##4##(2005-6#1)(2010-7#1)
of new chemical##6##3##(2005-6#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-7#1)
of new chiral##2##3##(2007-10#2)
of new clinical##6##3##(1995-5#1)(2006-10#1)(2008-10#1)(2009-1#1)(2009-4#1)(2011-12#1)
of new compounds##10##3##(1991-1#2)(1996-3#1)(1997-5#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-5#1)(2012-3#1)
of new concepts##3##3##(2006-10#1)(2008-2#1)(2012-3#1)
of new cosmetic##3##3##(2008-5#2)(2011-1#1)
of new data##8##3##(1996-8#1)(2006-10#1)(2007-8#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-8#1)
of new developments in##3##4##(2006-10#1)(2008-10#1)(2011-1#1)
of new developments##4##3##(2006-10#1)(2008-10#1)(2011-1#2)
of new devices##2##3##(2006-6#1)(2008-7#1)
of new diagnostic##3##3##(2006-10#1)(2010-11#1)(2011-1#1)
of new diethyl 1##2##4##(2012-3#2)
of new disability-pensioners##2##3##(1997-6#2)
of new doubly bridged morphinan derivatives##2##6##(2006-12#2)
of new drug development##3##4##(2005-8#1)(2012-11#1)(2013-1#1)
of new drug targets##3##4##(2005-7#1)(2008-7#1)(2010-12#1)
of new drug##9##3##(1991-10#1)(2005-7#1)(2005-8#1)(2008-10#1)(2008-7#1)(2010-12#2)(2012-11#1)(2013-1#1)
of new drugs and##6##4##(2006-6#3)(2007-11#1)(2008-3#1)(2008-5#1)
of new drugs are##2##4##(2008-12#1)(2011-2#1)
of new drugs for##4##4##(2005-8#1)(2005-9#1)(2006-12#1)(2006-4#1)
of new drugs or##2##4##(2010-12#1)(2011-2#1)
of new drugs to##2##4##(2006-12#1)(2008-9#1)
of new drugs##40##3##(1993-1#1)(1997-3#1)(2005-7#1)(2005-8#6)(2005-9#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#5)(2007-11#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#2)(2011-2#2)(2013-1#2)
of new features##2##3##(2008-10#1)(2008-3#1)
of new findings##3##3##(2006-1#1)(2010-7#1)(2012-2#1)
of new fluorescent##5##3##(2007-8#1)(2008-10#2)(2008-4#1)(2010-2#1)
of new food##3##3##(1993-12#1)(2008-4#1)(2011-2#1)
of new functions##3##3##(2008-1#1)(2012-1#1)(2012-3#1)
of new gene##2##3##(2005-8#1)(2009-10#1)
of new generation of##2##4##(2007-11#1)(2011-2#1)
of new generation##4##3##(2007-11#1)(2010-12#1)(2011-2#1)(2012-3#1)
of new genes##2##3##(2008-10#1)(2009-10#1)
of new genetic##2##3##(1995-12#1)(2008-4#1)
of new genotypes##2##3##(2008-10#1)(2011-2#1)
of new health##2##3##(2007-9#1)(2013-8#1)
of new imaging##3##3##(2006-12#1)(2008-2#1)(2013-1#1)
of new infections##4##3##(1995-9#1)(2008-10#1)(2008-5#1)(2009-4#1)
of new information##7##3##(1997-3#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-8#1)(2009-11#1)
of new intervention##2##3##(2005-1#1)(2012-2#1)
of new knowledge and##2##4##(2006-10#1)(2008-7#1)
of new knowledge##8##3##(1992-8#1)(2005-12#1)(2006-10#4)(2007-9#1)(2008-7#1)
of new lesions##4##3##(1991-8#1)(2007-11#1)(2008-10#1)(2008-5#1)
of new materials and##2##4##(2010-10#1)(2010-7#1)
of new materials for##3##4##(2009-8#1)(2013-1#2)
of new materials##6##3##(2008-7#1)(2009-8#1)(2010-10#1)(2010-7#1)(2013-1#2)
of new medical##2##3##(2007-4#1)(2011-2#1)
of new members of##2##4##(1994-6#1)(2011-1#1)
of new members##4##3##(1993-1#1)(1994-6#1)(1997-9#1)(2011-1#1)
of new membrane##2##3##(2008-7#1)(2009-8#1)
of new metabolic##2##3##(2008-3#1)(2010-12#1)
of new methods of##2##4##(2009-2#1)(2011-1#1)
of new methods##6##3##(1997-1#1)(1997-8#1)(2007-9#1)(2008-10#1)(2009-2#1)(2011-1#1)
of new models##3##3##(2008-11#1)(2008-9#1)(2012-2#1)
of new molecular##3##3##(2008-10#1)(2009-6#1)(2010-10#1)
of new molecules##5##3##(2008-1#1)(2010-11#1)(2011-3#1)(2012-12#2)
of new mouse##3##3##(2008-8#1)(2008-9#1)(2013-1#1)
of new niches##2##3##(2008-10#1)(2012-12#1)
of new or##2##3##(2007-11#1)(2008-11#1)
of new patients##3##3##(1994-2#1)(2006-8#1)(2012-3#1)
of new practices##2##3##(1993-3#1)(2008-2#1)
of new primary malignancies##3##4##(1991-8#3)
of new primary##4##3##(1991-8#4)
of new products for##2##4##(2005-8#1)(2010-12#1)
of new products##4##3##(2005-12#1)(2005-8#1)(2010-12#1)(2012-12#1)
of new prognostic##2##3##(2007-10#1)(2008-4#1)
of new proteins##3##3##(1990-12#1)(1997-6#1)(2008-10#1)
of new quantitative##2##3##(1997-6#1)(2011-1#1)
of new reagents and##2##4##(2008-7#1)(2012-12#1)
of new receptive fields##2##4##(1995-12#2)
of new research and##2##4##(2007-4#1)(2008-3#1)
of new risk factors##2##4##(2007-9#1)(2011-2#1)
of new scaffolding##2##3##(2010-10#1)(2011-1#1)
of new services##2##3##(1997-3#2)
of new sources of##2##4##(2007-8#1)(2008-11#1)
of new sources##3##3##(2007-8#1)(2008-11#1)(2009-5#1)
of new species##3##3##(2008-10#1)(2008-12#1)(2008-9#1)
of new strategies for##3##4##(2006-10#1)(2009-8#1)(2010-5#1)
of new strategies##9##3##(1997-8#1)(2006-10#1)(2007-6#1)(2008-11#1)(2008-6#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-10#1)
of new structures##3##3##(1994-10#1)(2007-7#1)(2010-2#1)
of new studies##3##3##(2005-8#1)(2006-4#1)(2008-10#1)
of new substances##3##3##(2007-11#1)(2008-10#1)(2011-3#1)
of new surgical and##2##4##(2008-6#1)(2009-2#1)
of new surgical techniques##4##4##(1994-6#1)(2006-10#1)(2007-11#1)(2007-8#1)
of new surgical##8##3##(1994-6#1)(2006-10#3)(2007-11#1)(2007-8#1)(2008-6#1)(2009-2#1)
of new systems##2##3##(2008-11#1)(2011-2#1)
of new tag sequences##2##4##(1997-3#2)
of new targeted therapies##2##4##(2007-4#1)(2008-6#1)
of new targets##4##3##(2008-11#1)(2008-5#1)(2009-12#1)(2013-7#1)
of new techniques##7##3##(1991-3#1)(2006-10#1)(2006-11#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)
of new technologies in##2##4##(1992-2#1)(2008-11#1)
of new technologies##17##3##(1992-2#1)(1994-5#1)(2006-2#1)(2006-6#1)(2008-10#1)(2008-11#3)(2008-7#3)(2009-12#1)(2012-3#2)(2013-1#3)
of new technology in##6##4##(2005-7#1)(2007-12#3)(2008-10#1)(2009-9#1)
of new technology##13##3##(2005-10#1)(2005-7#1)(2006-12#1)(2007-12#5)(2007-4#1)(2007-5#1)(2008-10#2)(2009-9#1)
of new therapeutic agents##3##4##(2005-7#1)(2008-4#2)
of new therapeutic approaches##3##4##(2006-10#1)(2007-11#1)(2008-1#1)
of new therapeutic modalities##5##4##(1992-3#1)(1997-6#1)(2005-11#1)(2007-7#1)(2011-1#1)
of new therapeutic strategies##4##4##(2007-8#1)(2008-4#2)(2008-6#1)
of new therapeutic##23##3##(1992-3#1)(1993-11#1)(1996-11#1)(1997-6#1)(2005-11#1)(2005-7#1)(2006-10#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#4)(2008-6#1)(2009-5#1)(2010-12#1)(2011-1#2)(2012-2#1)
of new therapies for##3##4##(2008-11#1)(2009-10#1)(2011-1#1)
of new therapies is##2##4##(2008-1#1)(2009-7#1)
of new therapies##20##3##(2005-11#1)(2005-7#1)(2005-8#1)(2007-10#1)(2007-2#2)(2008-1#1)(2008-11#3)(2008-6#1)(2008-8#2)(2009-10#1)(2009-7#1)(2010-12#1)(2011-1#2)(2011-2#1)(2013-8#1)
of new tools##3##3##(2007-11#1)(2008-12#1)(2010-5#1)
of new treatment modalities##3##4##(2006-10#1)(2007-9#1)(2011-2#1)
of new treatment options##2##4##(2006-10#1)(2010-12#1)
of new treatment strategies##3##4##(2007-1#1)(2008-9#1)(2013-8#1)
of new treatment##10##3##(2006-10#2)(2007-1#1)(2007-9#1)(2008-10#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
of new treatments##2##3##(2006-10#1)(2008-10#1)
of new types of##2##4##(2008-10#1)(2013-8#1)
of new vaccine##3##3##(2005-7#1)(2007-11#1)(2013-1#1)
of new vaccines##4##3##(2005-7#1)(2007-11#1)(2008-9#1)(2012-12#1)
of new varieties##2##3##(2008-12#1)(2008-8#1)
of new vertebral fractures##3##4##(1993-11#1)(2007-11#1)(2008-11#1)
of new virulence##2##3##(2012-2#1)(2013-8#1)
of new words##2##3##(2008-7#1)(2011-1#1)
of new##959##2##(1990-10#2)(1990-11#3)(1990-12#1)(1990-2#1)(1990-6#2)(1990-7#1)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#8)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#3)(1992-6#4)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#3)(1993-12#2)(1993-3#1)(1993-4#1)(1993-9#2)(1994-1#2)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#2)(1994-4#2)(1994-5#1)(1994-6#5)(1994-9#3)(1995-10#1)(1995-12#5)(1995-3#3)(1995-5#4)(1995-8#4)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#5)(1997-2#5)(1997-3#11)(1997-4#1)(1997-5#3)(1997-6#7)(1997-8#3)(1997-9#1)(2004-12#1)(2004-9#1)(2005-1#1)(2005-10#3)(2005-11#4)(2005-12#2)(2005-5#1)(2005-6#2)(2005-7#16)(2005-8#17)(2005-9#4)(2006-1#1)(2006-10#45)(2006-11#4)(2006-12#12)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#11)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#2)(2007-10#18)(2007-11#46)(2007-12#19)(2007-2#7)(2007-3#4)(2007-4#8)(2007-5#3)(2007-6#3)(2007-7#4)(2007-8#11)(2007-9#13)(2008-1#19)(2008-10#68)(2008-11#30)(2008-12#4)(2008-2#8)(2008-3#11)(2008-4#22)(2008-5#24)(2008-6#12)(2008-7#24)(2008-8#12)(2008-9#12)(2009-1#2)(2009-10#4)(2009-11#2)(2009-12#6)(2009-2#3)(2009-3#1)(2009-4#5)(2009-5#3)(2009-6#2)(2009-7#5)(2009-8#6)(2009-9#3)(2010-1#1)(2010-10#4)(2010-11#8)(2010-12#21)(2010-2#6)(2010-3#1)(2010-4#6)(2010-5#7)(2010-6#3)(2010-7#9)(2010-8#4)(2010-9#3)(2011-1#25)(2011-10#1)(2011-12#2)(2011-2#26)(2011-3#5)(2012-1#4)(2012-11#4)(2012-12#15)(2012-2#17)(2012-3#16)(2012-4#1)(2013-1#31)(2013-7#4)(2013-8#15)
of new-onset##4##2##(2004-12#1)(2007-8#1)(2008-3#1)(2013-8#1)
of newborn babies##2##3##(1991-6#1)(2006-8#1)
of newborn calves##3##3##(1994-7#2)(2010-2#1)
of newborn cells##2##3##(2008-11#1)(2012-2#1)
of newborn feeding ability##2##4##(2006-9#2)
of newborn hair Cd##3##4##(1993-4#3)
of newborn infants##6##3##(1993-5#1)(1994-6#2)(1995-2#1)(2010-12#1)(2012-12#1)
of newborn mice##5##3##(1991-5#1)(1993-2#1)(1994-2#1)(2006-5#1)(2008-7#1)
of newborn rats##5##3##(1991-5#1)(1991-9#1)(1995-12#1)(1996-8#1)(2012-1#1)
of newborn##45##2##(1990-11#1)(1990-5#1)(1991-12#1)(1991-5#2)(1991-6#1)(1991-9#1)(1993-2#1)(1993-4#3)(1993-5#1)(1994-2#1)(1994-3#1)(1994-6#3)(1994-7#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-3#1)(1996-8#1)(1997-4#1)(2006-5#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-9#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)
of newborns from##2##3##(2007-11#2)
of newborns is##2##3##(1994-7#1)(2008-8#1)
of newborns##21##2##(1992-11#1)(1992-4#2)(1993-4#1)(1994-6#1)(1994-7#1)(1996-10#1)(2006-7#2)(2007-11#3)(2007-9#2)(2008-4#1)(2008-8#1)(2009-8#1)(2012-1#2)(2012-3#1)(2013-8#1)
of newcomers##2##2##(2008-11#1)(2010-9#1)
of newer agents##2##3##(1996-9#1)(2013-1#1)
of newer drugs##2##3##(1995-10#1)(2008-8#1)
of newer techniques##3##3##(2011-1#1)(2011-2#2)
of newer##45##2##(1991-1#3)(1993-12#1)(1994-1#1)(1995-10#1)(1996-9#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-5#2)(2007-10#1)(2007-11#2)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-1#1)(2009-2#1)(2009-3#1)(2010-11#2)(2010-5#1)(2010-6#2)(2011-1#3)(2011-12#2)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
of newly added##2##3##(1995-6#1)(2013-8#1)
of newly developed##3##3##(1991-8#1)(2008-3#1)(2008-5#1)
of newly diagnosed acute##2##4##(2008-11#1)(2009-8#1)
of newly diagnosed cases##2##4##(2006-10#1)(2008-1#1)
of newly diagnosed hypertensive patients##2##5##(2013-1#2)
of newly diagnosed##13##3##(1991-2#1)(2006-10#1)(2008-1#3)(2008-11#1)(2008-5#1)(2009-8#2)(2013-1#4)
of newly discovered##3##3##(2006-10#1)(2009-5#1)(2011-2#1)
of newly eclosed##2##3##(2008-8#2)
of newly formed##6##3##(1996-5#1)(1997-2#1)(2008-10#1)(2009-3#1)(2009-8#1)(2012-1#1)
of newly generated##2##3##(1995-12#1)(1996-5#1)
of newly hatched##2##3##(2008-12#1)(2008-5#1)
of newly registered##2##3##(2007-7#1)(2008-11#1)
of newly synthesized ASA##2##4##(1993-11#2)
of newly synthesized apoE##2##4##(2004-11#2)
of newly synthesized protein##2##4##(1990-11#1)(1994-8#1)
of newly synthesized uracil nucleotides##2##5##(1990-4#2)
of newly synthesized##35##3##(1990-11#1)(1990-4#2)(1991-2#1)(1991-7#1)(1992-3#1)(1992-4#1)(1993-11#3)(1993-9#1)(1994-3#3)(1994-8#1)(1995-11#3)(1996-2#1)(1996-4#2)(1997-1#1)(1997-8#1)(2004-11#2)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2009-10#1)(2012-2#1)
of newly##93##2##(1990-11#1)(1990-4#2)(1991-2#3)(1991-7#1)(1991-8#1)(1992-3#1)(1992-4#1)(1993-11#3)(1993-12#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-3#3)(1994-8#1)(1995-11#3)(1995-12#1)(1995-6#1)(1996-2#1)(1996-4#2)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#1)(2004-11#2)(2004-9#1)(2005-7#1)(2006-10#2)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#2)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#3)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#4)(2013-8#2)
of newly-hatched##2##2##(2008-5#2)
of next generation sequencing##2##4##(2012-2#1)(2013-1#1)
of next generation##6##3##(2006-11#1)(2008-8#1)(2011-1#1)(2012-2#2)(2013-1#1)
of next##7##2##(2006-11#1)(2008-8#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
of next-generation sequencing##3##3##(2012-12#1)(2012-2#1)(2012-3#1)
of next-generation##5##2##(2008-10#1)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#1)
of ng ml(-1)##3##3##(2008-10#3)
of nia##2##2##(1993-6#2)
of niacin##4##2##(2005-9#1)(2006-5#1)(2008-7#2)
of nibbling and gorging dietary regimens on weight and lipid##2##10##(2008-12#2)
of niche##2##2##(1991-11#1)(2008-8#1)
of nickel and##10##3##(1990-2#1)(1994-5#1)(2008-10#7)(2008-6#1)
of nickel by##2##3##(2008-10#2)
of nickel hexacyanoferrate nanoparticles##2##4##(2007-8#2)
of nickel in natural waters##2##5##(2008-10#2)
of nickel in natural##4##4##(2008-10#4)
of nickel in some natural food samples##2##7##(2008-10#2)
of nickel in table salt and baking soda##2##8##(2008-10#2)
of nickel in the##3##4##(2008-10#3)
of nickel in##25##3##(2007-8#1)(2008-10#24)
of nickel ion##2##3##(2008-10#2)
of nickel on##2##3##(1995-3#1)(2007-6#1)
of nickel were##2##3##(2008-10#1)(2011-12#1)
of nickel with a##2##4##(2008-10#2)
of nickel within##2##3##(2008-10#2)
of nickel##82##2##(1990-2#3)(1990-9#1)(1994-5#1)(1995-3#2)(2005-4#1)(2007-10#3)(2007-6#2)(2007-8#5)(2008-10#56)(2008-3#1)(2008-6#2)(2008-7#1)(2011-12#4)
of nickel(II) in##3##3##(2008-10#3)
of nickel(II)##7##2##(2008-10#7)
of niclosamide##2##2##(2006-10#1)(2011-12#1)
of nicotinamide adenine dinucleotide (NADH)##2##5##(2005-8#1)(2008-10#1)
of nicotinamide adenine dinucleotide phosphate##2##5##(2011-2#2)
of nicotinamide adenine dinucleotide phosphate-diaphorase##2##5##(1995-5#2)
of nicotinamide adenine dinucleotide##8##4##(1995-5#2)(2005-8#1)(2006-12#1)(2008-10#1)(2011-2#2)(2012-11#1)
of nicotinamide##13##2##(1990-1#1)(1993-11#2)(1994-4#1)(1995-5#2)(2005-8#1)(2006-12#1)(2007-7#1)(2008-10#1)(2011-2#2)(2012-11#1)
of nicotine and its##2##4##(1993-2#2)
of nicotine and##5##3##(1993-2#3)(1995-1#1)(2013-8#1)
of nicotine dependence in##2##4##(2008-8#1)(2011-2#1)
of nicotine dependence##7##3##(2008-8#3)(2010-9#2)(2011-2#2)
of nicotine in the##2##4##(1990-7#1)(1994-2#1)
of nicotine into the##2##4##(1991-11#1)(1993-2#1)
of nicotine on##9##3##(1991-1#1)(1994-2#1)(1996-2#2)(2008-3#2)(2008-8#1)(2010-8#1)(2011-1#1)
of nicotine replacement therapy##4##4##(2008-6#1)(2012-3#2)(2013-1#1)
of nicotine replacement##8##3##(2008-6#1)(2012-3#2)(2013-1#5)
of nicotine was##3##3##(1994-2#1)(1996-2#1)(2008-8#1)
of nicotine withdrawal##3##3##(1995-12#2)(2006-2#1)
of nicotine##63##2##(1990-7#1)(1991-1#2)(1991-11#2)(1993-2#5)(1993-8#2)(1994-10#2)(1994-2#4)(1994-7#1)(1995-1#1)(1995-12#3)(1995-5#1)(1996-2#4)(1997-5#1)(2006-2#1)(2007-10#1)(2008-10#2)(2008-3#4)(2008-6#1)(2008-8#5)(2010-8#2)(2010-9#3)(2011-1#1)(2011-2#4)(2012-3#2)(2013-1#7)(2013-8#1)
of nicotine's##2##2##(1994-2#1)(2008-12#1)
of nicotinic acetylcholine receptor##6##4##(1994-2#1)(1996-10#1)(1997-1#1)(1997-5#1)(2008-8#2)
of nicotinic acetylcholine receptors##3##4##(1992-8#1)(1995-11#1)(1995-7#1)
of nicotinic acetylcholine##10##3##(1992-8#1)(1994-2#1)(1995-11#2)(1995-7#1)(1996-10#1)(1997-1#1)(1997-5#1)(2008-8#2)
of nicotinic acetylcholine-activated##2##3##(1994-2#2)
of nicotinic acid##3##3##(1994-4#1)(2008-5#1)(2013-1#1)
of nicotinic and muscarinic##2##4##(1992-3#1)(2006-10#1)
of nicotinic or##2##3##(1990-6#1)(2004-12#1)
of nicotinic receptor##3##3##(1996-12#1)(1997-5#1)(2008-8#1)
of nicotinic receptors##3##3##(1992-7#1)(1993-11#1)(1995-5#1)
of nicotinic##30##2##(1990-6#1)(1990-7#2)(1991-11#1)(1992-3#2)(1992-7#1)(1992-8#1)(1993-11#1)(1994-2#3)(1994-4#1)(1995-11#2)(1995-5#1)(1995-7#1)(1996-10#1)(1996-12#2)(1997-1#1)(1997-5#2)(2004-12#1)(2006-10#1)(2008-5#1)(2008-8#3)(2013-1#1)
of nifedipine (0##3##3##(1991-5#2)(1993-11#1)
of nifedipine in the##2##4##(1991-11#1)(2008-5#1)
of nifedipine in##4##3##(1991-11#1)(1993-12#1)(2008-5#1)(2011-2#1)
of nifedipine on##5##3##(1991-5#4)(1993-11#1)
of nifedipine##31##2##(1990-2#1)(1991-11#1)(1991-5#6)(1992-4#4)(1993-11#3)(1993-12#3)(1993-3#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-6#2)(1997-5#1)(1997-7#1)(2008-5#1)(2009-5#1)(2011-2#2)(2012-12#1)
of niflumic acid##2##3##(1990-11#1)(1990-5#1)
of night##5##2##(1997-6#1)(2010-7#1)(2011-12#3)
of nightly##3##2##(2007-1#1)(2008-10#1)(2010-10#1)
of nighttime##3##2##(1993-11#1)(2007-12#1)(2009-9#1)
of nigral##3##2##(1992-11#1)(2008-7#2)
of nigrostriatal DAergic neurons##3##4##(2013-7#3)
of nigrostriatal dopamine##2##3##(1996-12#1)(2008-11#1)
of nigrostriatal##9##2##(1993-5#1)(1995-12#1)(1996-12#1)(2006-8#1)(2008-11#2)(2013-7#3)
of nile blue sulphate##2##4##(2008-10#2)
of nimesulide##2##2##(2006-2#1)(2008-4#1)
of nimodipine##10##2##(1993-11#1)(1996-12#2)(1996-3#2)(1997-8#3)(2004-12#2)
of nine cases##2##3##(2008-7#2)
of nine different##3##3##(1990-5#1)(1992-12#1)(2007-4#1)
of nine genes##2##3##(1994-8#1)(2008-7#1)
of nine isolates##2##3##(1997-8#1)(2008-10#1)
of nine months##5##3##(2007-7#1)(2008-1#1)(2008-9#1)(2009-2#1)(2010-4#1)
of nine patients with##3##4##(1994-8#1)(2006-9#1)(2008-3#1)
of nine patients##8##3##(1994-8#1)(1996-4#2)(1997-6#1)(2006-9#1)(2008-3#1)(2008-5#1)(2012-2#1)
of nine selected##3##3##(2008-10#1)(2012-12#2)
of nine species of##4##4##(1997-2#1)(2008-10#1)(2008-11#1)(2013-7#1)
of nine species##5##3##(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2013-7#1)
of nine subjects##3##3##(1997-1#1)(2006-7#1)(2012-1#1)
of nine years##5##3##(1992-5#1)(2007-3#1)(2009-9#1)(2011-12#1)(2011-2#1)
of nine##129##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-8#4)(1995-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1997-1#1)(1997-2#3)(1997-5#1)(1997-6#2)(1997-8#2)(2005-11#1)(2005-12#1)(2006-10#2)(2006-11#2)(2006-7#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#27)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#3)(2008-7#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
of nines')##2##2##(2012-1#2)
of nineteen##4##2##(1993-2#1)(2008-12#1)(2011-2#1)(2013-1#1)
of nineteenth-century##2##2##(2005-12#1)(2012-2#1)
of ninth grade##2##3##(2007-10#1)(2007-9#1)
of niobium##4##2##(2005-11#1)(2008-10#2)(2008-5#1)
of niobium(V) oxide as a##2##5##(2008-10#2)
of nisin and##3##3##(2008-5#2)(2011-2#1)
of nisin##8##2##(1995-8#1)(1996-5#2)(2008-5#2)(2008-6#2)(2011-2#1)
of nitrate and chlorate in swimming pool water##2##8##(2008-10#2)
of nitrate and chlorate in##3##5##(2008-10#3)
of nitrate and nitrite in water and some fruit samples##3##10##(2008-10#3)
of nitrate and nitrite##6##4##(2008-10#6)
of nitrate and##16##3##(2004-4#1)(2007-12#1)(2008-10#13)(2008-11#1)
of nitrate from##2##3##(2008-10#2)
of nitrate in estuarine and coastal waters##2##7##(2008-10#2)
of nitrate in water##2##4##(2008-10#1)(2013-8#1)
of nitrate in##13##3##(2006-8#1)(2008-10#11)(2013-8#1)
of nitrate ions##2##3##(2008-10#2)
of nitrate reduced##2##3##(2007-6#2)
of nitrate reductase##2##3##(1997-2#1)(2008-10#1)
of nitrate to##6##3##(1991-8#1)(2008-10#5)
of nitrate tolerance##2##3##(1991-9#2)
of nitrate##63##2##(1991-11#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-6#1)(1997-2#1)(2004-4#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-6#2)(2008-10#43)(2008-11#4)(2009-5#1)(2013-8#1)
of nitrates and##2##3##(2008-10#1)(2008-3#1)
of nitrates##3##2##(2005-8#1)(2008-10#1)(2008-3#1)
of nitric acid and##2##4##(2008-10#2)
of nitric acid at##2##4##(2008-10#2)
of nitric acid solution##2##4##(2008-10#2)
of nitric acid##9##3##(2008-10#9)
of nitric and##2##3##(2008-10#2)
of nitric oxide (NO##2##4##(1994-5#1)(2008-6#1)
of nitric oxide (NO) and##4##5##(1996-8#1)(2007-12#1)(2008-10#2)
of nitric oxide (NO) from L-arginine##2##6##(1990-6#1)(1992-12#1)
of nitric oxide (NO) in##6##5##(1992-8#1)(2005-7#1)(2008-10#2)(2008-8#1)(2013-1#1)
of nitric oxide (NO) on##3##5##(1996-1#1)(1997-6#1)(2007-1#1)
of nitric oxide (NO) synthase in##2##6##(1992-7#1)(1995-11#1)
of nitric oxide (NO) synthase##5##5##(1992-7#1)(1992-9#1)(1995-11#1)(1995-12#1)(1997-5#1)
of nitric oxide (NO)##34##4##(1990-6#1)(1990-7#1)(1991-9#1)(1992-12#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-6#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-10#1)(1996-8#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-7#1)(2007-1#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-8#1)(2009-6#1)(2010-12#1)(2011-1#1)(2013-1#1)
of nitric oxide and sulfur dioxide##2##6##(2008-1#1)(2008-2#1)
of nitric oxide and##18##4##(1992-6#1)(1993-12#1)(1994-6#1)(1995-5#3)(1996-11#1)(1997-4#1)(2006-10#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2011-1#1)(2013-1#1)
of nitric oxide by##4##4##(1990-11#1)(1991-3#1)(1992-5#1)(1993-11#1)
of nitric oxide donors##2##4##(2007-10#1)(2008-5#1)
of nitric oxide for##3##4##(1994-2#1)(2006-10#1)(2008-10#1)
of nitric oxide from L-arginine##2##5##(1994-7#1)(2009-9#1)
of nitric oxide from##5##4##(1991-10#1)(1993-12#1)(1993-4#1)(1994-7#1)(2009-9#1)
of nitric oxide in the##5##5##(1991-10#1)(1992-8#1)(1993-6#1)(1995-6#1)(1996-5#1)
of nitric oxide in##18##4##(1991-10#1)(1992-8#1)(1993-6#1)(1993-9#1)(1995-6#1)(1996-5#1)(1997-8#1)(2004-12#1)(2005-8#1)(2006-11#1)(2006-2#1)(2008-10#2)(2008-2#1)(2009-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
of nitric oxide on the##2##5##(1993-3#1)(2010-12#1)
of nitric oxide on##7##4##(1993-12#1)(1993-3#2)(1994-7#1)(1997-6#1)(2007-1#1)(2010-12#1)
of nitric oxide produced in##2##5##(1994-5#1)(2008-2#1)
of nitric oxide production##5##4##(1996-5#1)(2006-10#2)(2011-1#1)(2012-1#1)
of nitric oxide release##2##4##(1993-6#1)(1996-10#1)
of nitric oxide synthase (NOS)##8##5##(1992-8#2)(1993-3#1)(1993-8#1)(1995-5#1)(1996-3#1)(2008-4#1)(2013-1#1)
of nitric oxide synthase activity in##2##6##(1993-3#1)(1995-5#1)
of nitric oxide synthase and##3##5##(1992-8#1)(1994-9#1)(1996-6#1)
of nitric oxide synthase in##5##5##(1992-7#2)(1993-6#1)(2005-12#1)(2008-5#1)
of nitric oxide synthase##32##4##(1992-7#2)(1992-8#3)(1992-9#1)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-9#1)(1995-12#2)(1995-5#2)(1996-10#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#2)(1997-8#1)(2004-12#1)(2005-12#1)(2008-4#1)(2008-5#1)(2013-1#1)
of nitric oxide synthases##2##4##(1995-11#1)(2009-4#1)
of nitric oxide synthesis##8##4##(1990-11#1)(1992-1#1)(1992-3#1)(1996-6#1)(2010-12#1)(2013-1#3)
of nitric oxide to##4##4##(1994-8#1)(1995-5#1)(1997-5#1)(2004-12#1)
of nitric oxide using polymer modified electrodes##2##7##(2008-10#2)
of nitric oxide using##3##4##(2008-10#3)
of nitric oxide with##2##4##(2008-10#1)(2008-3#1)
of nitric oxide##209##3##(1990-11#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-10#3)(1991-12#1)(1991-3#2)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-7#3)(1992-8#6)(1992-9#3)(1993-11#1)(1993-12#4)(1993-3#5)(1993-4#2)(1993-6#4)(1993-8#2)(1993-9#4)(1994-11#3)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#1)(1994-7#2)(1994-8#1)(1994-9#1)(1995-11#3)(1995-12#4)(1995-2#1)(1995-5#7)(1995-6#1)(1996-1#1)(1996-10#3)(1996-11#2)(1996-12#3)(1996-3#1)(1996-5#3)(1996-6#3)(1996-8#1)(1997-4#2)(1997-5#3)(1997-6#2)(1997-7#1)(1997-8#3)(2004-12#6)(2005-1#1)(2005-12#1)(2005-7#1)(2005-8#2)(2006-10#6)(2006-11#1)(2006-2#1)(2007-1#2)(2007-10#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#19)(2008-11#3)(2008-2#7)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-4#1)(2009-6#2)(2009-9#1)(2010-11#1)(2010-12#4)(2010-4#1)(2010-7#1)(2011-1#5)(2011-12#1)(2011-2#2)(2012-1#1)(2013-1#8)(2013-8#2)
of nitric oxide-induced##2##3##(1990-8#1)(2013-7#1)
of nitric##230##2##(1990-11#3)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#4)(1991-10#3)(1991-12#1)(1991-3#2)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-7#3)(1992-8#7)(1992-9#3)(1993-11#1)(1993-12#4)(1993-3#5)(1993-4#2)(1993-6#4)(1993-8#2)(1993-9#4)(1994-11#3)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#1)(1994-7#2)(1994-8#1)(1994-9#1)(1995-11#3)(1995-12#4)(1995-2#1)(1995-5#8)(1995-6#1)(1996-1#1)(1996-10#3)(1996-11#2)(1996-12#3)(1996-3#1)(1996-5#3)(1996-6#3)(1996-8#1)(1997-4#2)(1997-5#3)(1997-6#2)(1997-7#1)(1997-8#3)(2004-12#6)(2005-1#1)(2005-12#1)(2005-7#1)(2005-8#2)(2006-10#6)(2006-11#1)(2006-2#1)(2007-1#2)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#32)(2008-11#3)(2008-2#7)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#2)(2009-4#1)(2009-6#2)(2009-9#1)(2010-11#1)(2010-12#4)(2010-4#1)(2010-7#1)(2011-1#5)(2011-12#1)(2011-2#2)(2012-1#1)(2013-1#8)(2013-7#1)(2013-8#2)
of nitridation##2##2##(2013-8#2)
of nitrile##4##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)
of nitriles##3##2##(1996-2#1)(2007-6#1)(2009-6#1)
of nitrilimines and nitrile oxides with hydrazines##2##7##(2007-11#2)
of nitrite and citrulline##2##4##(1990-11#1)(2006-10#1)
of nitrite and nitrate in##11##5##(2008-10#11)
of nitrite and nitrate using##2##5##(2008-10#2)
of nitrite and nitrate was##2##5##(2008-10#2)
of nitrite and nitrate##23##4##(2005-8#1)(2008-10#22)
of nitrite and##33##3##(1990-11#1)(1990-7#1)(1995-2#1)(2005-8#1)(2006-10#2)(2008-10#27)
of nitrite based on its##3##5##(2008-10#3)
of nitrite by##5##3##(1994-3#1)(2008-10#4)
of nitrite in the##4##4##(2008-10#4)
of nitrite in##16##3##(2008-10#16)
of nitrite ion using##3##4##(2008-10#3)
of nitrite ion##11##3##(2008-10#11)
of nitrite on the##2##4##(2008-10#2)
of nitrite using##3##3##(2008-10#3)
of nitrite was##4##3##(1994-3#1)(2005-4#1)(2008-10#2)
of nitrite##120##2##(1990-11#1)(1990-7#2)(1990-8#1)(1992-7#1)(1992-9#1)(1993-6#1)(1994-3#3)(1995-2#1)(1996-11#1)(1997-4#1)(1997-7#2)(2005-4#2)(2005-8#1)(2006-10#2)(2006-3#1)(2007-3#2)(2007-8#1)(2008-10#95)(2008-11#1)
of nitrite-nitrogen was##2##3##(2008-10#2)
of nitrite-nitrogen##3##2##(2008-10#3)
of nitrites##7##2##(1992-5#1)(1992-7#1)(2005-8#1)(2007-10#2)(2008-10#1)(2008-11#1)
of nitro radical anions##2##4##(1995-6#1)(1997-4#1)
of nitro##7##2##(1990-11#2)(1993-11#1)(1995-6#1)(1997-4#1)(1997-8#1)(2008-10#1)
of nitro-organic explosives##2##3##(2008-10#2)
of nitroaniline isomers##4##3##(2008-10#4)
of nitroaniline##6##2##(2008-10#6)
of nitroaromatic compounds##2##3##(1990-9#1)(2008-10#1)
of nitroaromatic##7##2##(1990-9#1)(2008-10#6)
of nitrobenzene##2##2##(2008-10#1)(2008-11#1)
of nitroblue tetrazolium##4##3##(1993-1#1)(1996-3#1)(1997-8#1)(2005-8#1)
of nitrocellulose##2##2##(2006-8#1)(2008-4#1)
of nitrocompounds##3##2##(1995-8#3)
of nitroflavones##2##2##(1994-9#2)
of nitrofurantoin and its toxic metabolite##2##6##(2008-10#2)
of nitrofurantoin##3##2##(2008-10#3)
of nitrofurazone##3##2##(2012-2#3)
of nitrogen PRRS##3##3##(2008-3#3)
of nitrogen and methane##2##4##(2008-2#2)
of nitrogen and oxygen stable isotopes in##2##7##(2013-8#2)
of nitrogen and phosphorus##3##4##(2008-10#1)(2008-6#1)(2013-1#1)
of nitrogen and##11##3##(2005-11#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-6#1)(2013-1#2)(2013-8#2)
of nitrogen dioxide using##2##4##(2008-10#2)
of nitrogen dioxide##8##3##(1993-9#1)(2008-10#6)(2008-11#1)
of nitrogen for##2##3##(1994-10#1)(2005-11#1)
of nitrogen gas in the##2##5##(2007-12#2)
of nitrogen gas##3##3##(2007-12#2)(2008-10#1)
of nitrogen in##3##3##(2006-12#1)(2008-10#1)(2011-12#1)
of nitrogen intake##2##3##(1993-5#2)
of nitrogen molecules##2##3##(2008-1#1)(2008-3#1)
of nitrogen or##2##3##(1995-11#1)(2008-10#1)
of nitrogen oxides in##3##4##(2008-10#2)(2012-2#1)
of nitrogen oxides##4##3##(2008-10#3)(2012-2#1)
of nitrogen##86##2##(1990-12#1)(1990-8#1)(1991-11#1)(1993-5#2)(1993-9#1)(1994-10#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-3#2)(1996-6#1)(1997-6#1)(2005-11#6)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#6)(2008-1#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#2)(2009-6#1)(2010-4#2)(2011-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#6)
of nitrogen-15##3##2##(1995-2#2)(1995-3#1)
of nitrogen-containing##2##2##(2008-10#1)(2013-8#1)
of nitrogenase activity##4##3##(2006-3#3)(2008-6#1)
of nitrogenase##6##2##(1995-8#1)(2006-3#4)(2008-6#1)
of nitroglycerin##4##2##(1992-6#1)(1993-3#2)(2012-12#1)
of nitroprusside##2##2##(1992-6#1)(1995-12#1)
of nitrosamino acids##2##3##(1991-7#2)
of nitrosyl transfer##3##3##(1991-3#3)
of nitrosyl##4##2##(1991-3#3)(1992-3#1)
of nitrotyrosine##2##2##(2007-10#1)(2010-1#1)
of nitrous acid##2##3##(2008-10#2)
of nitrous oxide and##2##4##(2006-10#1)(2008-11#1)
of nitrous oxide in##2##4##(2006-10#2)
of nitrous oxide reductase##3##4##(1992-8#1)(1995-2#1)(2009-3#1)
of nitrous oxide##19##3##(1991-6#2)(1992-8#1)(1994-2#2)(1995-2#1)(2006-10#6)(2007-11#1)(2007-12#1)(2008-11#1)(2008-8#2)(2009-12#1)(2009-3#1)
of nitrous##21##2##(1991-6#2)(1992-8#1)(1994-2#2)(1995-2#1)(2006-10#6)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-8#2)(2009-12#1)(2009-3#1)
of nitroxide##2##2##(1994-3#1)(1995-10#1)
of nm23##2##2##(1993-8#1)(2005-10#1)
of no benefit in##2##4##(2006-2#1)(2011-2#1)
of no benefit##3##3##(2006-2#1)(2007-8#1)(2011-2#1)
of no clinical significance##2##4##(1996-9#1)(2010-12#1)
of no clinical##4##3##(1996-9#1)(1997-6#1)(2007-4#1)(2010-12#1)
of no routine interventions during birth##2##6##(2007-2#2)
of no significance##3##3##(1996-6#1)(2006-8#1)(2011-1#1)
of no treatment effect##2##4##(1993-9#1)(1997-2#1)
of no treatment##3##3##(1993-9#1)(1996-7#1)(1997-2#1)
of no use##2##3##(1990-12#1)(2008-10#1)
of no##59##2##(1990-10#1)(1990-11#1)(1990-12#1)(1991-4#1)(1992-11#1)(1992-8#1)(1993-9#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-6#1)(2005-11#1)(2005-12#1)(2006-2#1)(2006-8#1)(2007-12#2)(2007-2#2)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#2)
of nobiletin in rats##2##4##(2012-3#2)
of nobiletin##3##2##(2012-3#3)
of noble metal##3##3##(2007-8#2)(2008-10#1)
of noble metals##4##3##(1993-7#2)(2008-10#2)
of noble##9##2##(1993-7#2)(2007-8#2)(2008-10#4)(2012-2#1)
of nocardial##2##2##(2008-1#1)(2008-7#1)
of nocardiosis##2##2##(1995-7#1)(2006-10#1)
of nociception and##2##3##(1996-3#1)(2008-9#1)
of nociception##5##2##(1996-12#1)(1996-2#1)(1996-3#1)(2007-1#1)(2008-9#1)
of nociceptive information##2##3##(1993-7#1)(2008-9#1)
of nociceptive##17##2##(1990-7#1)(1991-3#1)(1991-8#1)(1993-7#3)(1993-9#1)(1994-2#1)(1996-3#1)(1997-2#1)(2006-12#1)(2008-4#1)(2008-9#2)(2009-11#1)(2009-12#1)(2010-9#1)
of nociceptor##2##2##(2006-12#1)(2009-3#1)
of nociceptors##3##2##(1993-12#1)(1995-12#1)(1996-3#1)
of nocturnal##5##2##(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#1)
of nodal metastasis##2##3##(2008-2#2)
of nodal##15##2##(1990-12#2)(2007-3#2)(2008-10#1)(2008-2#2)(2008-6#1)(2008-7#2)(2008-9#1)(2012-3#2)(2013-1#2)
of node##3##2##(2006-10#1)(2008-10#1)(2008-8#1)
of node-negative##2##2##(1992-10#1)(1995-4#1)
of node-positive##2##2##(1992-10#1)(1993-5#1)
of nodes##12##2##(1995-10#1)(2007-11#1)(2007-9#1)(2008-10#5)(2012-2#1)(2013-1#3)
of nodose##2##2##(2013-8#2)
of nodular fasciitis##3##3##(2006-4#2)(2007-7#1)
of nodular##9##2##(1990-10#1)(1993-9#1)(2006-4#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2012-12#1)
of nodulation##3##2##(1995-8#1)(2006-3#1)(2008-8#1)
of nodule##2##2##(2007-9#1)(2009-8#1)
of nodules##8##2##(2006-5#3)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-12#1)
of noise and##7##3##(2006-6#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-9#1)(2013-8#1)
of noise are##2##3##(2008-2#1)(2008-3#1)
of noise in the##5##4##(1997-3#1)(2007-12#1)(2008-2#2)(2010-10#1)
of noise in##13##3##(1997-3#1)(2006-10#2)(2007-11#1)(2007-12#2)(2008-1#2)(2008-2#3)(2008-3#1)(2010-10#1)
of noise is##2##3##(2007-12#1)(2008-9#1)
of noise on blood pressure##2##5##(2005-11#1)(2011-2#1)
of noise on human##2##4##(2008-1#2)
of noise on the##5##4##(2008-3#4)(2010-8#1)
of noise on##11##3##(2005-11#1)(2008-1#2)(2008-3#4)(2010-8#2)(2011-1#1)(2011-2#1)
of noise photons##3##3##(2008-3#3)
of noise##83##2##(1997-3#1)(2005-11#2)(2006-10#3)(2006-6#1)(2007-11#1)(2007-12#9)(2008-1#5)(2008-10#2)(2008-2#14)(2008-3#23)(2008-4#1)(2008-5#1)(2008-6#3)(2008-9#7)(2010-10#2)(2010-8#2)(2011-1#3)(2011-2#1)(2012-2#1)(2013-8#1)
of noise-induced hearing loss##2##4##(2009-5#2)
of noisy##2##2##(2008-3#1)(2010-5#1)
of nominal##4##2##(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#1)
of nominally pure##2##3##(2007-11#1)(2007-12#1)
of nominally##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
of non##30##2##(1990-2#1)(1994-2#1)(2005-3#1)(2005-7#1)(2007-12#1)(2007-5#3)(2007-7#5)(2008-10#3)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-4#2)(2011-2#4)(2012-12#1)(2012-2#1)
of non-##5##2##(2005-12#2)(2005-8#1)(2009-8#1)(2010-10#1)
of non-A##6##2##(1991-3#1)(1997-2#1)(2006-2#1)(2007-11#2)(2007-7#1)
of non-CFC MDIs##2##3##(1996-1#2)
of non-Hodgkin lymphoma##4##3##(1991-6#1)(2009-10#1)(2010-10#1)(2013-7#1)
of non-Hodgkin##5##2##(1991-6#1)(2009-10#1)(2010-10#1)(2012-2#1)(2013-7#1)
of non-Hodgkin's lymphoma##8##3##(1991-9#1)(2007-10#2)(2008-12#1)(2008-5#1)(2008-7#2)(2012-12#1)
of non-Hodgkin's lymphomas##4##3##(1993-7#1)(2007-10#1)(2007-3#1)(2009-8#1)
of non-Hodgkin's##14##2##(1991-9#1)(1993-1#1)(1993-7#1)(2007-10#3)(2007-3#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#2)(2009-8#1)(2012-12#1)
of non-Hodgkins lymphoma##2##3##(1993-9#1)(2010-9#1)
of non-Hodgkins##3##2##(1993-9#2)(2010-9#1)
of non-NMDA receptors in##2##4##(1992-8#1)(1994-2#1)
of non-NMDA##3##2##(1991-5#1)(1992-8#1)(1994-2#1)
of non-ST segment elevation##2##4##(2008-3#2)
of non-alcoholic fatty liver disease##2##5##(2012-2#1)(2013-1#1)
of non-alcoholic fatty##3##3##(2012-2#1)(2013-1#2)
of non-alcoholic steatohepatitis##2##3##(2005-12#1)(2008-9#1)
of non-alcoholic##6##2##(1990-11#1)(2005-12#1)(2008-9#1)(2012-2#1)(2013-1#2)
of non-alkaloidal natural compounds##2##4##(2006-12#2)
of non-allergic##3##2##(1996-3#2)(2011-1#1)
of non-attendance##2##2##(1992-2#2)
of non-blood contacting pneumatic ventricle assistance##2##6##(2012-3#2)
of non-bonded##2##2##(2008-10#1)(2012-12#1)
of non-cardiac##3##2##(2006-10#1)(2008-8#1)(2013-1#1)
of non-caseating##2##2##(2007-7#1)(2010-6#1)
of non-chromatographic##2##2##(1996-11#1)(2008-10#1)
of non-class-III beta-tubulin isoforms in neuronal##2##6##(1993-3#2)
of non-coding RNA##2##3##(2011-2#2)
of non-coding RNAs##3##3##(2007-10#1)(2008-1#2)
of non-coding regions##2##3##(1993-11#1)(1997-6#1)
of non-coding##7##2##(1993-11#1)(1997-6#1)(2007-10#1)(2008-1#2)(2011-2#2)
of non-cognate##2##2##(1997-5#1)(2008-7#1)
of non-colonial##2##2##(2008-5#2)
of non-communicable diseases##14##3##(2008-1#1)(2012-12#1)(2012-2#2)(2013-8#10)
of non-compliance##3##2##(2007-7#1)(2008-10#1)(2012-2#1)
of non-covalent##7##2##(1995-4#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-11#1)
of non-crop vegetation##2##3##(2013-8#2)
of non-crystalline##2##2##(1993-4#1)(2008-11#1)
of non-diabetic##2##2##(1990-6#1)(2008-1#1)
of non-enzymatic glycation of##2##4##(1993-8#1)(1997-2#1)
of non-enzymatic##5##2##(1992-7#1)(1993-8#1)(1997-2#1)(2010-8#1)(2013-1#1)
of non-esterified fatty acids in plasma##2##6##(1991-12#1)(1995-7#1)
of non-esterified fatty acids##4##4##(1990-4#1)(1991-1#1)(1991-12#1)(1995-7#1)
of non-esterified fatty##5##3##(1990-4#1)(1991-1#1)(1991-12#1)(1995-7#2)
of non-esterified##6##2##(1990-4#1)(1991-1#1)(1991-12#1)(1992-5#1)(1995-7#2)
of non-extractable residues##3##3##(2008-11#3)
of non-fucosylated##2##2##(2008-11#2)
of non-functional##3##2##(1992-8#1)(2008-5#1)(2009-11#1)
of non-functioning##3##2##(1994-5#1)(2007-8#1)(2010-10#1)
of non-heme##4##2##(1992-7#1)(1994-8#1)(2010-4#2)
of non-high##2##2##(1995-11#1)(2013-8#1)
of non-human primates##3##3##(1991-6#1)(1996-12#2)
of non-human##5##2##(1990-10#1)(1991-6#1)(1996-12#2)(2010-3#1)
of non-indigenous##2##2##(1991-12#1)(2008-12#1)
of non-inferiority##2##2##(2012-3#2)
of non-insulin dependent diabetes mellitus (NIDDM)##2##6##(2008-11#1)(2008-5#1)
of non-insulin dependent diabetes##6##4##(1997-3#2)(1997-8#1)(2008-11#1)(2008-5#2)
of non-insulin dependent##7##3##(1993-1#1)(1997-3#2)(1997-8#1)(2008-11#1)(2008-5#2)
of non-insulin-dependent diabetes mellitus##5##4##(1991-12#1)(1993-12#1)(1994-6#1)(1996-2#1)(2008-10#1)
of non-insulin-dependent diabetes##7##3##(1991-12#1)(1993-12#1)(1994-12#1)(1994-6#1)(1996-2#1)(2006-10#1)(2008-10#1)
of non-insulin-dependent##8##2##(1991-12#1)(1993-12#1)(1994-12#1)(1994-6#1)(1994-8#1)(1996-2#1)(2006-10#1)(2008-10#1)
of non-invasive breast cancer##2##4##(2013-1#2)
of non-invasive diagnostic##3##3##(1993-3#1)(2005-10#1)(2010-6#1)
of non-invasive imaging techniques##2##4##(2012-3#1)(2013-1#1)
of non-invasive##21##2##(1990-5#1)(1991-10#1)(1992-8#1)(1993-3#1)(1995-4#1)(1996-12#1)(1996-3#1)(1997-6#1)(2005-10#1)(2005-7#1)(2008-1#1)(2010-12#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)
of non-invasively##2##2##(1991-4#1)(2010-2#1)
of non-ionic detergents##2##3##(1994-9#1)(2008-10#1)
of non-ionic surfactant##3##3##(2008-10#3)
of non-ionic surfactants (NS)##2##4##(2008-10#2)
of non-ionic surfactants##5##3##(2008-10#5)
of non-ionic##12##2##(1991-11#1)(1994-9#1)(2008-10#10)
of non-irradiated##3##2##(1995-1#1)(1995-10#1)(2008-5#1)
of non-linear material behaviour##2##4##(2006-11#2)
of non-linear material##3##3##(2006-11#3)
of non-linear##9##2##(1996-12#1)(1997-4#1)(2006-11#4)(2008-10#1)(2008-7#1)(2013-1#1)
of non-lipid##2##2##(2008-10#1)(2010-4#1)
of non-malignant##6##2##(1995-9#1)(2006-6#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-8#1)
of non-mammalian vertebrates##2##3##(1992-1#2)
of non-metallic inclusions##2##3##(2008-10#2)
of non-metallic##3##2##(2008-10#3)
of non-metastatic LLC-C8 cells##2##4##(1993-7#2)
of non-metastatic##7##2##(1991-9#1)(1992-6#2)(1993-7#2)(2008-10#1)(2008-4#1)
of non-methane hydrocarbons##4##3##(2007-8#3)(2008-11#1)
of non-microbial salivary caries activity parameters and salivary biochemical indicators in predicting dental caries##2##14##(2012-12#2)
of non-modified##2##2##(1993-11#1)(2008-10#1)
of non-native##2##2##(1995-3#1)(2007-7#1)
of non-natural amino acids##2##4##(2008-1#1)(2013-8#1)
of non-natural##4##2##(1995-7#1)(2008-1#1)(2008-4#1)(2013-8#1)
of non-neoplastic##2##2##(2013-1#1)(2013-8#1)
of non-nucleoside##2##2##(1996-8#1)(2008-10#1)
of non-nutritive suck (NNS)##2##4##(2009-12#1)(2009-2#1)
of non-obese##2##2##(1994-3#1)(2013-1#1)
of non-operative##2##2##(2006-7#1)(2012-3#1)
of non-palpable breast cancer##3##4##(1995-10#1)(2004-2#2)
of non-palpable breast##4##3##(1993-5#1)(1995-10#1)(2004-2#2)
of non-parasitic##2##2##(2008-9#1)(2010-8#1)
of non-peer-reviewed##3##2##(2005-7#3)
of non-peptide##3##2##(1991-4#1)(2008-1#1)(2008-8#1)
of non-pharmacological therapy##2##3##(2010-12#1)(2012-3#1)
of non-pharmacological##5##2##(2006-6#1)(2008-1#1)(2010-12#1)(2012-3#2)
of non-physiological signs##2##3##(2006-8#2)
of non-physiological##3##2##(2006-8#3)
of non-polar and##2##3##(2006-10#1)(2013-8#1)
of non-polar gases in water##2##5##(2006-10#2)
of non-polar##10##2##(1995-4#1)(2006-10#6)(2008-10#2)(2013-8#1)
of non-polarized infrared##2##3##(2008-10#2)
of non-pregnant and pregnant##2##4##(1995-10#2)
of non-pregnant##5##2##(1993-12#1)(1995-10#2)(2009-9#1)(2010-3#1)
of non-prescription##2##2##(2008-9#1)(2013-1#1)
of non-protein##2##2##(2007-7#1)(2008-11#1)
of non-proteinogenic##2##2##(2010-12#2)
of non-radioactive##3##2##(1994-2#1)(1996-12#1)(2008-1#1)
of non-random##4##2##(1995-12#1)(1995-4#1)(2009-10#1)(2012-5#1)
of non-rare earth##2##3##(2005-4#2)
of non-responders##3##2##(1996-12#1)(2012-12#1)(2013-1#1)
of non-small cell lung cancer (NSCLC)##2##6##(2007-8#1)(2008-1#1)
of non-small cell lung cancer##13##5##(2005-8#1)(2007-11#1)(2007-5#1)(2007-8#3)(2008-1#2)(2008-4#1)(2008-5#1)(2013-1#2)(2013-8#1)
of non-small cell lung carcinoma##2##5##(1997-5#1)(2007-9#1)
of non-small cell lung##16##4##(1997-5#1)(2005-8#1)(2007-11#1)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-4#1)(2008-5#1)(2013-1#3)(2013-8#1)
of non-small##17##2##(1997-5#1)(2005-8#1)(2007-11#1)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-4#1)(2008-5#1)(2013-1#4)(2013-8#1)
of non-small-cell lung cancer (NSCLC)##3##5##(2005-12#1)(2009-5#1)(2011-12#1)
of non-small-cell lung##4##3##(2004-1#1)(2005-12#1)(2009-5#1)(2011-12#1)
of non-smokers##2##2##(1993-8#1)(2012-1#1)
of non-smoking##6##2##(1991-11#2)(2007-3#4)
of non-sodium##2##2##(2007-10#1)(2013-7#1)
of non-spatial##4##2##(1993-3#1)(1993-5#1)(1995-5#1)(1997-1#1)
of non-specific binding##2##3##(1992-7#1)(2008-10#1)
of non-specific##21##2##(1990-7#1)(1991-10#2)(1992-10#1)(1992-7#1)(1996-3#1)(1996-7#1)(2007-11#2)(2008-1#1)(2008-10#6)(2008-3#1)(2008-5#2)(2008-7#1)(2011-12#1)
of non-steady-state photoinduced electromotive force##2##5##(2007-12#2)
of non-sterile##2##2##(2009-5#1)(2012-2#1)
of non-steroid##3##2##(2007-11#2)(2007-7#1)
of non-steroidal anti-inflammatory drugs (NSAIDs) are##2##6##(2008-12#1)(2008-4#1)
of non-steroidal anti-inflammatory drugs (NSAIDs)##4##5##(2006-7#1)(2008-12#1)(2008-4#1)(2013-1#1)
of non-steroidal anti-inflammatory drugs##11##4##(1990-11#1)(1995-5#1)(2006-10#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-2#1)(2010-3#1)(2013-1#1)
of non-steroidal anti-inflammatory##12##3##(1990-11#1)(1993-11#1)(1995-5#1)(2006-10#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-2#1)(2010-3#1)(2013-1#1)
of non-supine##2##2##(2007-2#1)(2011-1#1)
of non-surgical##2##2##(1991-3#1)(1992-5#1)
of non-targeted##2##2##(2008-7#2)
of non-telomeric DSBs##2##3##(2010-2#2)
of non-toxic##4##2##(1993-6#2)(2011-2#1)(2013-8#1)
of non-transmissible##2##2##(1993-6#1)(2008-9#1)
of non-traumatic##4##2##(2007-7#1)(2008-1#1)(2012-2#1)(2013-8#1)
of non-treated##2##2##(2008-5#1)(2008-6#1)
of non-type 1 diabetes##2##4##(2008-1#1)(2008-4#1)
of non-uniform##2##2##(2004-9#1)(2008-10#1)
of non-union in##2##3##(2011-2#1)(2012-2#1)
of non-union##5##2##(2007-7#2)(2011-2#1)(2012-2#1)(2013-1#1)
of non-verbal##3##2##(1990-3#1)(2009-4#2)
of non-viral vectors for##2##4##(2008-5#1)(2012-3#1)
of non-viral##5##2##(1991-3#1)(1997-4#1)(2008-5#1)(2012-3#2)
of nonabsorbing##3##2##(2008-3#3)
of nonaccidental injury##3##3##(2009-3#3)
of nonadditive##2##2##(2006-8#1)(2008-8#1)
of nonadherence to medication##2##4##(2012-1#2)
of nonadherence to##5##3##(2008-3#1)(2008-4#1)(2011-2#1)(2012-1#2)
of nonadherence##9##2##(1992-12#1)(1994-3#1)(2008-3#2)(2008-4#1)(2011-2#1)(2012-1#3)
of nonadsorbing##3##2##(2005-11#3)
of nonagenarians##3##2##(2008-10#1)(2008-7#1)(2009-5#1)
of nonalcoholic steatohepatitis##3##3##(2006-10#1)(2006-2#1)(2010-12#1)
of nonalcoholic##4##2##(2006-10#1)(2006-2#1)(2010-12#1)(2011-1#1)
of nonaqueous capillary electrophoresis##3##4##(2008-10#3)
of nonaqueous capillary##4##3##(1996-5#1)(2008-10#3)
of nonaqueous##6##2##(1996-5#1)(2005-11#1)(2008-10#4)
of nonbilayer phase##2##3##(1997-7#2)
of nonbilayer##4##2##(1997-2#1)(1997-7#3)
of noncanonical##2##2##(2007-11#2)
of noncaseating##3##2##(2007-10#1)(2007-11#2)
of noncausal##2##2##(2012-3#2)
of nonclinical##2##2##(1994-2#1)(2013-7#1)
of noncoding RNA##2##3##(2006-10#1)(2013-7#1)
of noncoding##6##2##(1994-3#1)(1995-2#1)(2006-10#1)(2008-9#1)(2012-1#1)(2013-7#1)
of noncommunicating hydrocephalus##2##3##(2006-5#2)
of noncommunicating syringomyelia##3##3##(2006-5#3)
of noncommunicating##5##2##(2006-5#5)
of noncompliance with##2##3##(2006-5#1)(2007-6#1)
of noncompliance##8##2##(2006-5#3)(2007-11#4)(2007-6#1)
of nonconserved residues##2##3##(1993-11#1)(1994-9#1)
of noncontact##3##2##(2008-3#1)(2009-4#1)(2010-8#1)
of noncooperative##3##2##(1997-2#1)(2008-2#1)(2008-3#1)
of noncovalent interactions##2##3##(1992-4#1)(1996-11#1)
of noncovalent labeling##2##3##(2007-11#2)
of noncovalent##5##2##(1992-4#1)(1993-3#1)(1996-11#1)(2007-11#2)
of noncrossover##2##2##(1995-8#2)
of nondegenerate four-wave mixing##2##4##(2007-11#1)(2007-12#1)
of nondegenerate##5##2##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)
of nondiabetic controls##2##3##(1996-2#1)(2007-2#1)
of nondiffracting patterns and arrays##2##5##(2007-11#2)
of nondiffracting##3##2##(2007-11#3)
of none##2##2##(1997-4#1)(2007-4#1)
of noneconomic damages##5##3##(1991-1#2)(1992-1#3)
of noneconomic##6##2##(1991-1#3)(1992-1#3)
of nonenzymatic##2##2##(1994-9#1)(1996-5#1)
of nonequilibrium##3##2##(1992-8#1)(1993-6#1)(2008-3#1)
of nonesterified##3##2##(1991-12#1)(1992-4#2)
of nonexercised controls##2##3##(2008-10#2)
of nonfatal##2##2##(2007-10#2)
of nonfluorescent##3##2##(1997-7#1)(2006-12#1)(2007-11#1)
of nonfreezing water##2##3##(2005-11#2)
of nongenotoxic##2##2##(1990-8#2)
of nonglycosylated##2##2##(1990-3#1)(1991-9#1)
of nonhomologous DNA##3##3##(1993-2#1)(2008-10#2)
of nonhospital##3##2##(1991-12#1)(1995-3#2)
of nonhost##3##2##(2008-10#2)(2011-2#1)
of nonhuman##3##2##(1995-1#1)(2008-9#2)
of nonideal##2##2##(1995-7#1)(2008-2#1)
of nonidentical##2##2##(1997-6#1)(2007-12#1)
of nonimaging##3##2##(2008-2#1)(2008-3#2)
of nonindigenous##2##2##(2008-10#1)(2008-8#1)
of noninoculated##3##2##(2008-10#3)
of noninvasive cardiac##2##3##(2008-12#1)(2010-8#1)
of noninvasive diagnostic##3##3##(1991-3#1)(2007-4#1)(2009-10#1)
of noninvasive imaging##2##3##(2008-12#1)(2010-9#1)
of noninvasive positive pressure ventilation##2##5##(1997-4#1)(2008-1#1)
of noninvasive ventilation##4##3##(1997-4#3)(2013-8#1)
of noninvasive##21##2##(1991-3#1)(1993-11#1)(1997-4#5)(2005-11#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-12#2)(2009-1#1)(2009-10#1)(2009-4#1)(2010-8#1)(2010-9#1)(2013-8#2)
of nonionic and##2##3##(2005-11#2)
of nonionic microemulsion##2##3##(2005-4#1)(2008-10#1)
of nonionic surfactant##3##3##(2005-11#1)(2008-10#2)
of nonionic##14##2##(2005-11#8)(2005-4#1)(2007-4#1)(2008-10#4)
of nonirradiated##2##2##(1995-5#1)(2011-2#1)
of nonlinear gratings##2##3##(2007-12#2)
of nonlinear interactions##3##3##(2008-2#1)(2008-8#1)(2010-11#1)
of nonlinear optical crystals##2##4##(2007-12#1)(2008-2#1)
of nonlinear optical waveguides##2##4##(2008-2#1)(2008-3#1)
of nonlinear optical##13##3##(2007-11#1)(2007-12#2)(2008-2#7)(2008-3#3)
of nonlinear pulse##2##3##(2007-12#1)(2008-1#1)
of nonlinear techniques##2##3##(1997-2#1)(2012-2#1)
of nonlinear wave##2##3##(2007-11#1)(2008-3#1)
of nonlinear##72##2##(1993-9#1)(1994-10#1)(1996-4#2)(1997-2#1)(2006-10#1)(2007-11#9)(2007-12#18)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#12)(2008-3#9)(2008-7#4)(2008-8#1)(2009-12#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2012-1#1)(2012-2#2)(2013-1#1)
of nonlinearity is##3##3##(2007-12#1)(2008-2#2)
of nonlinearity to##2##3##(1996-3#1)(2008-2#1)
of nonlinearity##12##2##(1990-8#3)(1996-3#1)(2006-11#1)(2007-12#1)(2008-2#5)(2008-3#1)
of nonmalignant##2##2##(1990-12#1)(1996-7#1)
of nonmelanoma skin cancers##2##4##(2007-11#1)(2010-8#1)
of nonmelanoma skin##3##3##(2007-11#1)(2007-12#1)(2010-8#1)
of nonmelanotic##2##2##(2007-12#2)
of nonmetastatic##3##2##(2010-3#3)
of nonnative##4##2##(1993-11#2)(1995-8#1)(2008-8#1)
of nonneoplastic##3##2##(2008-9#1)(2011-1#2)
of nonoverlapping##4##2##(2007-12#1)(2008-2#1)(2009-11#1)(2009-3#1)
of nonoxinol-9##2##2##(2006-10#2)
of nonpalpable breast##2##3##(2008-7#2)
of nonpalpable##4##2##(1997-8#2)(2008-7#2)
of nonparametric##4##2##(1991-12#1)(2008-10#1)(2010-12#1)(2010-3#1)
of nonparaxial##3##2##(2007-11#1)(2007-12#2)
of nonpathogenic Fusarium oxysporum##3##4##(2008-10#3)
of nonpathogenic Fusarium##4##3##(2008-10#4)
of nonpathogenic##7##2##(2008-10#7)
of nonpecuniary##2##2##(1991-1#1)(1991-2#1)
of nonpeptide angiotensin II##2##4##(1991-5#1)(1993-4#1)
of nonpeptide##8##2##(1991-5#1)(1993-4#1)(1994-5#1)(1995-1#1)(1996-8#1)(1997-2#2)(2005-7#1)
of nonperiodic##2##2##(1995-5#1)(2008-3#1)
of nonpharmacologic##2##2##(2005-6#1)(2006-10#1)
of nonpharmacological##5##2##(2009-11#1)(2009-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
of nonpolar and polar surface##3##5##(1992-5#3)
of nonpolar gases##2##3##(1996-11#2)
of nonpolar molecules##2##3##(2010-2#2)
of nonpolar##18##2##(1990-11#1)(1990-7#1)(1992-5#4)(1993-6#1)(1995-2#1)(1995-8#1)(1996-11#2)(2005-11#3)(2008-10#1)(2009-4#1)(2010-2#2)
of nonpolyadenylated RNA##3##3##(2008-9#3)
of nonpregnant women##2##3##(1992-4#1)(1996-7#1)
of nonpregnant##3##2##(1990-11#1)(1992-4#1)(1996-7#1)
of nonprescription drugs##2##3##(2013-8#2)
of nonprescription##3##2##(2006-10#1)(2013-8#2)
of nonprofit organizations##2##3##(1991-12#1)(1995-2#1)
of nonprofit##8##2##(1991-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-2#1)(1997-1#1)(2008-11#2)
of nonprofits##3##2##(1994-2#1)(1995-3#2)
of nonpyramidal neurons in##2##4##(1990-7#1)(1997-6#1)
of nonrandom##4##2##(1991-11#1)(2006-2#1)(2008-4#1)(2010-12#1)
of nonresonant##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
of nonresponders##2##2##(1990-2#1)(2008-7#1)
of nonselective##2##2##(2008-9#1)(2009-10#1)
of nonsense mutations##2##3##(1990-3#1)(1994-10#1)
of nonsense##3##2##(1990-3#1)(1993-11#1)(1994-10#1)
of nonsmokers##2##2##(2010-2#2)
of nonspecific binding##4##3##(1994-9#1)(2008-10#1)(2008-4#1)(2008-7#1)
of nonspecific inflammatory##2##3##(1997-2#1)(2006-10#1)
of nonspecific nonsteroidal##2##3##(2006-10#1)(2007-8#1)
of nonspecific##26##2##(1990-12#1)(1991-2#1)(1991-5#1)(1992-6#1)(1992-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-2#1)(2006-10#3)(2006-2#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-4#2)(2008-7#1)(2009-6#1)(2011-1#1)(2012-12#1)
of nonspherical##3##2##(2008-2#1)(2008-3#2)
of nonsphericity##2##2##(2008-2#1)(2008-3#1)
of nonstationary##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
of nonsteroidal anti-inflammatory drug-induced gastrointestinal##2##5##(2006-10#2)
of nonsteroidal anti-inflammatory drugs (NSAIDs)##2##5##(2007-12#1)(2007-4#1)
of nonsteroidal anti-inflammatory drugs on##2##5##(2006-10#1)(2008-7#1)
of nonsteroidal anti-inflammatory drugs##9##4##(2006-10#4)(2007-12#1)(2007-2#1)(2007-4#1)(2008-7#1)(2012-12#1)
of nonsteroidal anti-inflammatory##12##3##(2006-10#6)(2007-12#1)(2007-2#1)(2007-4#1)(2008-7#1)(2008-9#1)(2012-12#1)
of nonsteroidal antiinflammatory drugs in##2##5##(1992-11#1)(1993-11#1)
of nonsteroidal antiinflammatory drugs##5##4##(1992-11#1)(1993-11#2)(2006-10#2)
of nonsteroidal##17##2##(1992-11#1)(1993-11#2)(2006-10#8)(2007-12#1)(2007-2#1)(2007-4#1)(2008-7#1)(2008-9#1)(2012-12#1)
of nonsurgical treatment##3##3##(2006-3#1)(2006-7#1)(2013-1#1)
of nonsurgical##5##2##(2006-3#1)(2006-7#1)(2006-8#1)(2008-4#1)(2013-1#1)
of nonsymmetrical##4##2##(1992-12#1)(2007-11#1)(2008-4#1)(2008-7#1)
of nontransformed cells##3##3##(1995-2#2)(1996-4#1)
of nontransformed##8##2##(1995-2#2)(1996-4#1)(1997-2#1)(2008-10#3)(2012-12#1)
of nontransgenic mice##2##3##(2007-10#2)
of nontransgenic##3##2##(2007-10#2)(2008-10#1)
of nontraversable##2##2##(2006-10#2)
of nontrivial##2##2##(1993-2#1)(2006-10#1)
of nontuberculous mycobacteria (NTM)##2##4##(2011-2#1)(2013-8#1)
of nontuberculous mycobacteria##4##3##(2007-12#1)(2011-2#1)(2013-8#2)
of nontuberculous mycobacterial disease##3##4##(2007-12#3)
of nontuberculous##8##2##(2007-12#5)(2011-2#1)(2013-8#2)
of nonulcer dyspepsia##5##3##(2006-10#5)
of nonuniform##4##2##(1995-4#1)(2007-11#1)(2008-2#1)(2008-3#1)
of nonuniformity##2##2##(2008-2#1)(2008-3#1)
of nonunion##3##2##(2006-3#1)(2009-10#1)(2013-1#1)
of nonvariceal upper gastrointestinal##2##4##(2006-10#1)(2008-9#1)
of nonverbal##4##2##(1996-2#2)(2005-10#1)(2012-3#1)
of nonvertebral fractures##2##3##(2006-10#2)
of nonviable cells##2##3##(2008-4#1)(2008-9#1)
of nonviable##4##2##(2008-4#2)(2008-9#1)(2010-6#1)
of nonvital##2##2##(2009-8#2)
of nonword##2##2##(2004-10#1)(2008-4#1)
of nonylphenol##2##2##(2008-10#2)
of nonzero##2##2##(2008-2#1)(2008-3#1)
of nootropic##5##2##(1990-3#1)(1990-7#2)(1995-3#1)(2008-5#1)
of noradrenaline (NA)##3##3##(1994-6#1)(1995-12#1)(1996-12#1)
of noradrenaline and adrenaline##3##4##(1990-7#1)(1994-2#1)(2008-10#1)
of noradrenaline and dopamine##5##4##(1990-8#1)(2008-10#3)(2008-7#1)
of noradrenaline and##8##3##(1990-7#1)(1990-8#1)(1994-2#1)(2008-10#4)(2008-7#1)
of noradrenaline in the##2##4##(1995-12#1)(1995-5#1)
of noradrenaline##30##2##(1990-2#1)(1990-7#3)(1990-8#1)(1991-2#1)(1992-11#1)(1992-8#2)(1993-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#6)(1995-5#1)(1995-9#1)(1996-10#2)(1996-12#1)(2008-10#4)(2008-7#1)(2009-5#1)
of noradrenergic function##2##3##(2004-10#1)(2008-6#1)
of noradrenergic neurons projecting to the diencephalon##2##7##(1994-2#2)
of noradrenergic neurons##3##3##(1994-2#3)
of noradrenergic##12##2##(1990-7#1)(1991-11#1)(1993-12#1)(1994-2#3)(1995-7#1)(1996-5#1)(1996-7#1)(2004-10#1)(2008-6#1)(2008-7#1)
of norbornadiene-tethered nitrile oxides##2##4##(2005-8#2)
of norcantharidin##2##2##(2011-3#2)
of norepinephrine (NE) by##2##4##(2005-4#1)(2008-10#1)
of norepinephrine (NE)##9##3##(1990-4#1)(1991-3#1)(1993-3#1)(1993-4#1)(1995-12#1)(1996-10#1)(1996-7#1)(2005-4#1)(2008-10#1)
of norepinephrine and##6##3##(1990-8#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-7#1)(2008-4#1)
of norepinephrine from##2##3##(1990-12#1)(1996-9#1)
of norepinephrine in the##2##4##(1990-5#1)(1991-10#1)
of norepinephrine in##3##3##(1990-5#1)(1991-10#1)(2005-4#1)
of norepinephrine into the##2##4##(1991-3#1)(1993-4#1)
of norepinephrine release##2##3##(1990-5#1)(2005-10#1)
of norepinephrine to##2##3##(1993-6#1)(1994-12#1)
of norepinephrine##37##2##(1990-12#1)(1990-4#1)(1990-5#2)(1990-8#1)(1991-10#1)(1991-3#2)(1991-6#1)(1992-7#1)(1993-3#1)(1993-4#2)(1993-6#2)(1994-12#2)(1994-2#1)(1995-12#2)(1995-3#1)(1996-10#1)(1996-7#2)(1996-9#1)(2005-10#4)(2005-4#2)(2008-10#2)(2008-2#1)(2008-4#1)(2013-1#1)(2013-8#1)
of norfloxacin##3##2##(1993-2#1)(2010-5#2)
of normal B cells##2##4##(1992-12#1)(1995-2#1)
of normal adult rats##2##4##(1995-11#1)(2008-6#1)
of normal adult##3##3##(1995-11#1)(2007-9#1)(2008-6#1)
of normal aging##6##3##(1991-12#1)(1993-11#2)(2007-2#1)(2008-7#1)(2012-3#1)
of normal and abnormal##7##4##(1990-10#1)(1995-2#1)(2006-10#1)(2008-4#1)(2010-8#3)
of normal and cancer##2##4##(1996-4#1)(2008-10#1)
of normal and cloned##2##4##(1991-12#1)(1992-7#1)
of normal and diabetic##2##4##(1991-10#1)(1991-3#1)
of normal and malignant human##2##5##(1992-7#1)(1996-10#1)
of normal and monocularly##2##4##(1995-11#2)
of normal and mutant##3##4##(1992-12#1)(1995-11#1)(1996-6#1)
of normal and neoplastic##4##4##(1990-2#1)(1990-7#1)(1992-3#1)(2009-2#1)
of normal and pathological##6##4##(1996-6#1)(2005-10#1)(2009-5#1)(2010-8#1)(2013-1#2)
of normal and##65##3##(1990-10#1)(1990-2#1)(1990-7#2)(1990-8#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-7#3)(1993-11#1)(1994-5#1)(1994-8#1)(1995-11#3)(1995-2#1)(1995-6#2)(1996-10#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-6#2)(1997-1#1)(1997-2#1)(2005-10#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-8#4)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#2)
of normal animals##3##3##(1992-10#1)(1993-2#1)(2013-7#1)
of normal anterior cruciate ligament (ACL) and##2##7##(1997-8#2)
of normal atlas and##2##4##(2013-1#2)
of normal bone marrow cells##2##5##(1990-5#1)(2011-2#1)
of normal bone marrow##3##4##(1990-5#1)(2008-6#1)(2011-2#1)
of normal bone##6##3##(1990-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)
of normal brain tissue##2##4##(1990-9#1)(2011-1#1)
of normal brain##5##3##(1990-9#1)(1994-6#1)(2006-12#1)(2011-1#2)
of normal breast##3##3##(1990-12#1)(1996-3#1)(2011-2#1)
of normal by##2##3##(1991-10#1)(2008-10#1)
of normal cell growth##2##4##(2007-2#1)(2008-11#1)
of normal cell##7##3##(1991-11#1)(1994-11#1)(1997-4#1)(2007-2#1)(2008-11#2)(2008-5#1)
of normal cells##5##3##(1991-10#1)(1991-2#1)(2008-11#2)(2009-10#1)
of normal cellular##2##3##(2006-7#1)(2008-2#1)
of normal children and##2##4##(1992-4#2)
of normal children##4##3##(1992-4#2)(1992-9#1)(2011-2#1)
of normal control##5##3##(1995-3#1)(1996-9#1)(2011-3#3)
of normal controls##5##3##(1991-7#1)(1992-8#1)(1996-12#1)(2009-9#1)(2012-3#1)
of normal development##2##3##(2009-5#1)(2012-12#1)
of normal donors##2##3##(1990-12#2)
of normal erythrocytes##2##3##(1992-6#1)(1997-1#1)
of normal function of##2##4##(1996-6#1)(2007-12#1)
of normal function##4##3##(1996-6#1)(2007-12#1)(2008-4#2)
of normal glucose##2##3##(2011-2#2)
of normal healthy##2##3##(1991-3#1)(1994-8#1)
of normal human cells##2##4##(1991-3#1)(2008-11#1)
of normal human epidermal keratinocytes##3##5##(1992-2#1)(2008-4#1)(2008-5#1)
of normal human keratinocytes##4##4##(2008-4#1)(2008-5#3)
of normal human lymphocytes##2##4##(1995-3#1)(1996-6#1)
of normal human skin##4##4##(2008-4#1)(2008-5#2)(2010-3#1)
of normal human##30##3##(1990-10#1)(1990-3#1)(1990-4#1)(1991-2#1)(1991-3#2)(1991-9#1)(1992-10#1)(1992-2#1)(1993-12#1)(1993-6#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-4#1)(1996-6#1)(2008-11#1)(2008-4#3)(2008-5#6)(2010-3#1)(2012-1#1)(2012-12#1)
of normal individuals and patients with##2##6##(1995-4#1)(1996-4#1)
of normal individuals and##4##4##(1995-4#1)(1996-11#1)(1996-4#1)(2011-2#1)
of normal individuals##9##3##(1995-4#1)(1996-11#1)(1996-3#1)(1996-4#1)(2007-2#2)(2008-9#1)(2011-2#2)
of normal infants##2##3##(1997-1#1)(2012-2#1)
of normal insulin##2##3##(1994-4#1)(2008-4#1)
of normal levels of##2##4##(1993-6#1)(2008-1#1)
of normal levels##3##3##(1993-6#1)(1996-5#1)(2008-1#1)
of normal liver##2##3##(1990-2#2)
of normal mammalian cells##2##4##(1990-5#1)(2008-11#1)
of normal marrow##3##3##(1992-6#1)(2013-1#2)
of normal mice##3##3##(1992-3#1)(1995-12#1)(1997-3#1)
of normal or##8##3##(1993-7#1)(1993-9#1)(1994-10#1)(1995-11#1)(2007-2#1)(2009-7#1)(2010-6#1)(2011-2#1)
of normal ovaries##2##3##(1992-12#2)
of normal persons##2##3##(2008-3#1)(2008-9#1)
of normal platelets##3##3##(1990-5#1)(2006-6#2)
of normal pressure hydrocephalus##2##4##(2007-9#2)
of normal rat kidney epithelial cells##2##6##(1991-8#2)
of normal rat kidney##6##4##(1991-12#2)(1991-2#1)(1991-8#3)
of normal rat liver##3##4##(1990-7#1)(1992-6#1)(1996-5#1)
of normal rat pituitary cells##2##5##(1992-6#2)
of normal rat##11##3##(1990-7#1)(1991-12#2)(1991-2#1)(1991-8#3)(1992-6#3)(1996-5#1)
of normal rats and##2##4##(1991-10#1)(2013-1#1)
of normal rats##3##3##(1990-7#1)(1991-10#1)(2013-1#1)
of normal renal##2##3##(2006-10#1)(2012-2#1)
of normal resting##2##3##(1995-12#1)(1996-2#1)
of normal saline##4##3##(2007-1#1)(2007-9#1)(2011-12#1)(2012-3#1)
of normal serum##4##3##(1990-2#1)(1992-7#1)(1997-2#1)(2012-3#1)
of normal skin##4##3##(1996-1#1)(2007-9#1)(2008-5#2)
of normal sleep##2##3##(2008-7#2)
of normal sperm was##2##4##(2008-5#1)(2009-5#1)
of normal sperm##5##3##(2008-12#1)(2008-5#3)(2009-5#1)
of normal subjects and##3##4##(1991-2#1)(1993-12#1)(2006-6#1)
of normal subjects##9##3##(1990-2#1)(1991-12#2)(1991-2#1)(1993-12#1)(1994-12#1)(2004-11#1)(2006-6#1)(2008-2#1)
of normal tissue##6##3##(2004-1#1)(2007-11#1)(2007-12#2)(2008-2#1)(2010-8#1)
of normal tissues##9##3##(1990-12#1)(1992-3#1)(1994-2#1)(1994-5#1)(2007-4#1)(2008-5#1)(2008-6#2)(2012-12#1)
of normal values##2##3##(2008-7#1)(2010-9#1)
of normal weight##3##3##(2006-8#2)(2011-2#1)
of normal##494##2##(1990-10#2)(1990-12#5)(1990-2#8)(1990-3#3)(1990-4#2)(1990-5#6)(1990-6#1)(1990-7#5)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#5)(1991-11#5)(1991-12#6)(1991-2#6)(1991-3#7)(1991-5#1)(1991-6#2)(1991-7#3)(1991-8#4)(1991-9#4)(1992-1#1)(1992-10#2)(1992-12#5)(1992-2#3)(1992-3#4)(1992-4#3)(1992-6#7)(1992-7#5)(1992-8#2)(1992-9#4)(1993-1#1)(1993-11#4)(1993-12#2)(1993-2#3)(1993-3#2)(1993-5#1)(1993-6#3)(1993-7#1)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#3)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#5)(1995-12#3)(1995-2#3)(1995-3#3)(1995-4#2)(1995-5#2)(1995-6#4)(1995-9#2)(1996-1#3)(1996-10#3)(1996-11#3)(1996-12#2)(1996-2#1)(1996-3#5)(1996-4#7)(1996-5#4)(1996-6#6)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#3)(2004-1#2)(2004-11#1)(2004-2#1)(2005-10#1)(2005-11#3)(2005-3#1)(2006-1#1)(2006-10#9)(2006-11#2)(2006-12#2)(2006-2#1)(2006-5#4)(2006-6#3)(2006-7#2)(2006-8#4)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#8)(2007-12#5)(2007-2#10)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#3)(2007-9#6)(2008-1#6)(2008-10#10)(2008-11#11)(2008-12#5)(2008-2#4)(2008-3#5)(2008-4#9)(2008-5#18)(2008-6#10)(2008-7#6)(2008-8#8)(2008-9#4)(2009-10#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#5)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-11#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-6#2)(2010-8#5)(2010-9#2)(2011-1#5)(2011-12#2)(2011-2#16)(2011-3#3)(2012-1#3)(2012-12#6)(2012-2#6)(2012-3#6)(2013-1#8)(2013-7#1)(2013-8#3)
of normal)##2##2##(1991-11#1)(1991-7#1)
of normalcy##2##2##(1996-10#1)(2010-7#1)
of normality##5##2##(1996-3#1)(1996-7#1)(1997-7#1)(2008-10#1)(2010-2#1)
of normalization of##3##3##(1996-9#1)(2008-2#1)(2010-7#1)
of normalization##5##2##(1996-9#1)(2008-2#1)(2008-7#2)(2010-7#1)
of normalized##3##2##(1990-10#1)(2008-2#1)(2008-7#1)
of normally developing##2##3##(1991-3#1)(2008-4#1)
of normally distributed##5##3##(1995-12#1)(1995-5#1)(2008-10#2)(2008-3#1)
of normally##17##2##(1991-3#1)(1993-5#1)(1993-7#1)(1995-12#1)(1995-5#1)(1996-1#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-7#1)
of normals##2##2##(2007-11#1)(2008-7#1)
of normative agency##2##3##(2012-2#2)
of normative##4##2##(2005-7#1)(2012-12#1)(2012-2#2)
of normativity##2##2##(2012-2#2)
of normocythemic##2##2##(2010-8#2)
of normotensive and##2##3##(1994-2#1)(2007-1#1)
of normotensive parents##2##3##(2013-8#2)
of normotensive##9##2##(1990-2#1)(1994-2#1)(2007-1#1)(2008-4#2)(2008-7#1)(2012-12#1)(2013-8#2)
of normothermic##3##2##(1992-7#1)(1996-12#1)(1996-9#1)
of normoxia##2##2##(1995-1#1)(1995-7#1)
of normoxic##3##2##(1992-1#1)(1992-10#1)(2009-9#1)
of norms##2##2##(1996-5#1)(2006-7#1)
of norovirus in##2##3##(2013-8#2)
of norovirus##3##2##(2013-8#3)
of noroviruses##2##2##(2009-3#1)(2010-12#1)
of norpseudoephedrine##2##2##(1992-2#1)(2007-8#1)
of north India##4##3##(2004-8#1)(2009-6#1)(2012-12#1)(2012-2#1)
of north east##2##3##(2008-12#1)(2012-2#1)
of north##10##2##(2004-8#1)(2008-11#1)(2008-12#1)(2009-6#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)
of north-western Nigeria##2##3##(2010-4#2)
of northeastern Brazil##2##3##(2012-12#1)(2013-8#1)
of northeastern##3##2##(2008-8#1)(2012-12#1)(2013-8#1)
of northern Ghana##3##3##(2006-4#3)
of northern India##2##3##(2007-12#1)(2007-7#1)
of northern Italy##4##3##(1991-5#1)(1993-2#2)(2012-7#1)
of northern and##2##3##(1990-12#1)(2012-12#1)
of northern##27##2##(1990-12#1)(1990-6#1)(1991-11#1)(1991-5#1)(1991-8#1)(1993-2#2)(1994-8#1)(2006-4#3)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-7#1)(2008-8#1)(2012-12#3)(2012-7#1)(2013-8#2)
of northwestern##3##2##(1993-4#1)(2010-6#1)(2012-12#1)
of noscapine##4##2##(2008-11#4)
of nose##5##2##(1990-9#2)(2007-9#1)(2008-7#1)(2013-8#1)
of nosocomial HIV infection##2##4##(1990-12#1)(2007-12#1)
of nosocomial RSV infection##2##4##(1992-10#2)
of nosocomial and zoonotic##2##4##(2010-4#2)
of nosocomial and##3##3##(2009-9#1)(2010-4#2)
of nosocomial infection##8##3##(1992-10#1)(1995-9#1)(2005-8#3)(2006-10#1)(2007-11#1)(2007-7#1)
of nosocomial infections in##5##4##(1990-6#1)(1994-4#1)(2008-11#1)(2008-5#1)(2013-1#1)
of nosocomial infections##14##3##(1990-6#1)(1991-4#1)(1991-7#1)(1994-4#1)(1996-12#1)(1996-9#1)(2007-12#1)(2008-11#1)(2008-5#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#2)
of nosocomial pneumonia##3##3##(1997-4#1)(2005-9#1)(2006-10#1)
of nosocomial##47##2##(1990-12#1)(1990-6#1)(1991-4#1)(1991-7#1)(1992-10#3)(1993-10#1)(1994-4#1)(1995-6#1)(1995-9#2)(1996-12#1)(1996-9#1)(1997-4#1)(2005-8#4)(2005-9#1)(2006-10#3)(2006-8#1)(2007-11#1)(2007-12#4)(2007-7#3)(2008-11#1)(2008-3#1)(2008-5#1)(2009-9#1)(2010-4#4)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
of not more than##2##4##(1990-2#1)(2008-10#1)
of not only##11##3##(1990-11#1)(1995-3#1)(2005-7#1)(2007-11#2)(2008-10#2)(2008-3#1)(2012-12#1)(2013-1#2)
of not requiring##2##3##(1990-8#1)(2012-3#1)
of not##32##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-2#1)(1991-6#1)(1995-3#1)(2005-7#1)(2006-2#1)(2006-7#1)(2007-11#2)(2007-2#1)(2007-7#2)(2007-8#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)(2009-1#1)(2009-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
of not-for-profit##2##2##(2005-11#2)
of note that##2##3##(1990-12#1)(1997-6#1)
of note##6##2##(1990-12#1)(1997-6#1)(2005-7#1)(2006-12#1)(2008-12#1)(2009-4#1)
of notes##4##2##(2013-1#4)
of notifiable diseases##2##3##(1997-3#2)
of notifiable##3##2##(1997-3#2)(2011-2#1)
of nouns##2##2##(1991-2#1)(2012-11#1)
of novalgin##4##2##(2008-10#4)
of novel 1##2##3##(2007-11#2)
of novel 5##2##3##(2011-2#2)
of novel DNA##2##3##(1995-6#1)(2007-11#1)
of novel agents##6##3##(2006-10#2)(2008-7#2)(2008-8#1)(2011-2#1)
of novel and##8##3##(1996-7#1)(2006-10#1)(2008-5#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
of novel anticancer##3##3##(2008-1#2)(2009-4#1)
of novel antipsychotic medication##2##4##(2004-3#2)
of novel antipsychotic medications##3##4##(2004-3#1)(2006-2#2)
of novel antipsychotic##5##3##(2004-3#3)(2006-2#2)
of novel approaches##5##3##(2004-4#1)(2005-8#1)(2007-6#1)(2008-5#1)(2013-8#1)
of novel arylpiperazines##2##3##(1992-3#2)
of novel benzimidazole##2##3##(1993-4#1)(2007-10#1)
of novel biocatalysts##2##3##(1991-8#1)(1995-3#1)
of novel biological##3##3##(2009-12#1)(2010-3#1)(2010-9#1)
of novel biomarkers##4##3##(2008-10#1)(2010-5#1)(2010-6#1)(2012-12#1)
of novel clinical##2##3##(2006-10#2)
of novel combinations##2##3##(2006-10#1)(2007-11#1)
of novel drug##5##3##(1990-9#1)(2005-8#1)(2007-10#1)(2012-1#1)(2013-1#1)
of novel drugs##2##3##(2008-4#1)(2009-12#1)
of novel forms of##3##4##(1991-6#1)(1995-12#1)(2006-10#1)
of novel genes and##3##4##(2008-10#1)(2008-7#2)
of novel genes##9##3##(1997-4#2)(2008-10#2)(2008-11#1)(2008-7#4)
of novel inhibitors of##2##4##(1992-6#1)(2013-1#1)
of novel inhibitors##3##3##(1992-6#1)(1994-2#1)(2013-1#1)
of novel medications##2##3##(2008-7#1)(2008-8#1)
of novel mutations##2##3##(2006-10#1)(2006-5#1)
of novel nucleoside##2##3##(2006-11#1)(2009-9#1)
of novel optical##4##3##(2007-11#1)(2008-1#1)(2008-2#1)(2008-7#1)
of novel proteins##2##3##(2006-10#1)(2009-10#1)
of novel synthetic##3##3##(2008-1#1)(2008-10#1)(2008-11#1)
of novel targeted##3##3##(2008-5#1)(2009-10#1)(2009-8#1)
of novel targets##2##3##(2005-6#1)(2013-1#1)
of novel techniques##3##3##(2006-8#1)(2008-10#1)(2011-2#1)
of novel technologies##2##3##(2006-10#1)(2011-1#1)
of novel therapeutic agents##3##4##(2005-8#1)(2008-6#1)(2009-8#1)
of novel therapeutic targets##2##4##(2008-7#1)(2008-9#1)
of novel therapeutic##12##3##(2005-8#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2011-1#1)(2012-12#1)(2012-2#1)
of novel therapies##3##3##(2006-12#1)(2008-4#1)(2010-4#1)
of novel vaccines##2##3##(2005-7#1)(2010-8#1)
of novel##349##2##(1990-7#1)(1990-9#1)(1991-1#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-4#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#2)(1995-11#2)(1995-12#2)(1995-3#2)(1995-6#1)(1996-10#1)(1996-2#1)(1996-7#1)(1997-4#3)(2004-3#3)(2004-4#1)(2005-11#2)(2005-6#1)(2005-7#8)(2005-8#6)(2006-10#20)(2006-11#2)(2006-12#4)(2006-2#2)(2006-5#2)(2006-8#3)(2006-9#1)(2007-10#5)(2007-11#21)(2007-12#3)(2007-6#1)(2007-8#5)(2008-1#14)(2008-10#19)(2008-11#9)(2008-2#4)(2008-3#7)(2008-4#3)(2008-5#13)(2008-6#4)(2008-7#15)(2008-8#9)(2008-9#4)(2009-1#1)(2009-10#4)(2009-11#2)(2009-12#5)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#3)(2009-8#4)(2009-9#3)(2010-10#1)(2010-11#3)(2010-12#7)(2010-3#2)(2010-4#4)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#10)(2011-3#3)(2011-7#1)(2011-9#1)(2012-1#3)(2012-12#10)(2012-2#4)(2012-3#3)(2013-1#14)(2013-7#3)(2013-8#3)
of novelty##2##2##(1993-11#1)(1994-6#1)
of noxious##6##2##(1994-12#1)(1996-7#1)(2007-1#1)(2008-4#1)(2008-7#1)(2012-2#1)
of npr##2##2##(1990-3#1)(1996-7#1)
of nsL-TP##4##2##(1990-4#1)(1991-11#2)(1994-12#1)
of nsLTP in the##2##4##(1991-3#2)
of nuclear DNA content##6##4##(1991-10#1)(1991-6#1)(1992-9#1)(1994-3#1)(2008-11#1)(2008-9#1)
of nuclear DNA have##2##4##(1997-4#1)(2008-7#1)
of nuclear DNA synthesis##2##4##(1991-8#1)(1994-5#1)
of nuclear DNA##25##3##(1991-10#1)(1991-6#1)(1991-8#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-4#3)(1994-3#1)(1994-5#3)(1996-1#1)(1997-4#1)(2005-8#2)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-3#1)(2011-2#1)
of nuclear NF-kappaB##2##3##(2006-10#2)
of nuclear Overhauser effects and##2##5##(1992-4#1)(1994-5#1)
of nuclear Overhauser enhancement##2##4##(1990-7#1)(1993-8#1)
of nuclear Overhauser##5##3##(1990-7#1)(1992-4#1)(1993-8#1)(1994-5#1)(1995-1#1)
of nuclear abnormalities##2##3##(2009-4#2)
of nuclear and cytoplasmic##3##4##(2008-2#2)(2011-2#1)
of nuclear and mitochondrial##3##4##(1996-12#1)(2012-2#1)(2013-1#1)
of nuclear and##8##3##(1991-10#1)(1992-8#1)(1996-12#1)(2008-2#2)(2011-2#1)(2012-2#1)(2013-1#1)
of nuclear envelope##3##3##(2008-5#1)(2008-8#1)(2008-9#1)
of nuclear extracts from##2##4##(1991-11#1)(2008-2#1)
of nuclear extracts##5##3##(1991-11#1)(1992-8#1)(1995-3#1)(2008-11#1)(2008-2#1)
of nuclear factor kappa B##5##5##(2007-8#1)(2008-3#1)(2010-10#1)(2011-1#2)
of nuclear factor##11##3##(1995-6#1)(2005-3#1)(2006-10#1)(2007-8#2)(2008-3#1)(2010-10#2)(2011-1#2)(2012-3#1)
of nuclear factor-kappa B##5##4##(1996-9#1)(2008-1#1)(2008-3#1)(2010-12#1)(2010-3#1)
of nuclear factor-kappaB##3##3##(2008-7#1)(2009-9#1)(2010-12#1)
of nuclear factor-κB##2##3##(2010-10#1)(2012-3#1)
of nuclear factors##4##3##(1991-10#1)(1992-11#1)(1996-11#1)(1996-4#1)
of nuclear fast red##2##4##(2008-10#2)
of nuclear genes##3##3##(1991-2#1)(2008-8#1)(2011-2#1)
of nuclear hormone receptors that##2##5##(2005-11#1)(2008-1#1)
of nuclear hormone receptors##3##4##(1995-3#1)(2005-11#1)(2008-1#1)
of nuclear hormone##4##3##(1995-3#1)(2005-11#2)(2008-1#1)
of nuclear lamina##5##3##(2007-12#1)(2008-8#4)
of nuclear mRNA export##2##4##(2006-12#1)(2010-11#1)
of nuclear mRNA##3##3##(2006-12#1)(2008-4#1)(2010-11#1)
of nuclear magnetic resonance##4##4##(1990-4#1)(1992-12#1)(2008-4#1)(2010-5#1)
of nuclear matrix##6##3##(1990-5#2)(1993-8#1)(2008-8#3)
of nuclear medicine##5##3##(2008-1#2)(2010-9#1)(2012-2#2)
of nuclear membrane dynamics##2##4##(2011-2#2)
of nuclear morphology##3##3##(1997-2#1)(2009-8#1)(2011-12#1)
of nuclear protein##2##3##(1991-3#1)(1997-6#1)
of nuclear proteins by##2##4##(2008-1#1)(2008-2#1)
of nuclear proteins from##2##4##(1992-11#2)
of nuclear proteins##16##3##(1990-7#2)(1990-9#1)(1991-3#1)(1992-11#3)(1992-8#1)(1994-8#1)(1996-4#1)(1997-2#2)(2008-1#3)(2008-2#1)
of nuclear quadrupole##2##3##(1995-5#1)(2012-12#1)
of nuclear rDNA##4##3##(1997-4#1)(2008-10#2)(2008-5#1)
of nuclear receptor ligands##3##4##(2008-9#3)
of nuclear receptor##5##3##(2006-11#1)(2008-9#3)(2011-2#1)
of nuclear receptors##4##3##(1994-12#1)(2006-2#1)(2008-10#1)(2008-5#1)
of nuclear ribosomal##3##3##(2008-12#1)(2008-5#1)(2010-3#1)
of nuclear spin##3##3##(1995-10#1)(2008-7#1)(2012-1#1)
of nuclear spins##3##3##(2008-7#2)(2012-2#1)
of nuclear structure##3##3##(1993-8#1)(1994-5#1)(1995-2#1)
of nuclear transcription factors##2##4##(1995-8#1)(2009-6#1)
of nuclear transfer##2##3##(2005-6#1)(2008-8#1)
of nuclear type II##2##4##(1991-6#2)
of nuclear##220##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#4)(1990-9#2)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-6#3)(1991-8#1)(1992-11#4)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#3)(1992-7#1)(1992-8#4)(1992-9#2)(1993-4#3)(1993-6#1)(1993-8#3)(1994-12#2)(1994-3#2)(1994-5#5)(1994-6#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-4#2)(1996-7#1)(1996-9#2)(1997-2#3)(1997-4#2)(1997-6#1)(2005-11#2)(2005-3#1)(2005-6#1)(2005-8#3)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-12#2)(2007-8#2)(2008-1#8)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#11)(2008-8#14)(2008-9#9)(2009-3#1)(2009-4#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#4)(2010-11#2)(2010-12#3)(2010-3#5)(2010-5#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#2)(2013-8#1)
of nuclear-coded subunits of##2##4##(1990-2#2)
of nuclear-encoded tRNAIle##2##3##(1996-7#2)
of nuclear-encoded##6##2##(1994-8#1)(1996-7#3)(1997-2#1)(2008-1#1)
of nuclease##4##2##(1991-5#1)(1995-1#1)(1995-4#1)(1997-2#1)
of nucleated cells##3##3##(1991-2#1)(1995-12#1)(2011-2#1)
of nucleated##4##2##(1991-2#1)(1995-12#1)(2007-12#1)(2011-2#1)
of nucleation and growth##2##4##(1997-4#1)(2008-3#1)
of nucleation##6##2##(1994-2#1)(1996-4#1)(1997-4#1)(2005-11#1)(2006-10#1)(2008-3#1)
of nuclei and nuclear membranes##2##5##(2008-1#2)
of nuclei and##3##3##(2008-1#2)(2008-10#1)
of nuclei in##2##3##(1995-3#1)(2012-1#1)
of nuclei of##2##3##(1991-2#1)(2008-11#1)
of nuclei with##2##3##(2008-7#2)
of nuclei##20##2##(1990-4#1)(1990-7#1)(1991-11#1)(1991-2#1)(1995-3#1)(2006-5#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2012-1#1)
of nucleic acid in##2##4##(2008-10#1)(2011-2#1)
of nucleic acid sequence##2##4##(1996-6#1)(2005-11#1)
of nucleic acid sequences##3##4##(1996-6#1)(2008-10#1)(2008-9#1)
of nucleic acid structure##4##4##(2008-4#4)
of nucleic acid##34##3##(1992-3#1)(1992-8#1)(1996-6#2)(1997-6#1)(2005-11#1)(2008-10#6)(2008-4#8)(2008-5#1)(2008-7#1)(2008-9#3)(2010-10#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#3)
of nucleic acids and protein##2##5##(2008-10#1)(2008-2#1)
of nucleic acids and proteins##2##5##(2008-2#1)(2012-12#1)
of nucleic acids and##5##4##(2006-5#1)(2008-10#1)(2008-2#2)(2012-12#1)
of nucleic acids by##3##4##(2008-10#3)
of nucleic acids from##2##4##(2008-11#1)(2008-6#1)
of nucleic acids has##2##4##(2008-10#1)(2008-4#1)
of nucleic acids in##5##4##(2008-10#3)(2008-3#1)(2008-5#1)
of nucleic acids into##2##4##(2007-3#1)(2008-9#1)
of nucleic acids is##6##4##(1990-4#1)(2008-2#1)(2008-4#2)(2008-9#1)(2011-2#1)
of nucleic acids to##2##4##(1994-3#1)(2010-10#1)
of nucleic acids was##2##4##(2008-10#2)
of nucleic acids were##2##4##(1995-8#1)(2008-5#1)
of nucleic acids##60##3##(1990-4#1)(1994-3#1)(1994-6#1)(1995-6#3)(1995-8#1)(1996-6#1)(1997-6#2)(2006-5#1)(2007-3#1)(2007-9#1)(2008-10#20)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#8)(2008-5#2)(2008-6#1)(2008-9#2)(2009-3#2)(2010-10#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
of nucleic##99##2##(1990-4#1)(1992-3#1)(1992-8#1)(1994-3#1)(1994-6#1)(1995-6#3)(1995-8#1)(1996-6#3)(1997-2#1)(1997-6#3)(2005-11#1)(2006-5#1)(2007-3#1)(2007-9#1)(2008-10#27)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#17)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-3#2)(2009-8#1)(2010-10#3)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#3)
of nucleobases##5##2##(1997-2#1)(2005-11#1)(2010-11#1)(2010-7#1)(2012-2#1)
of nucleobindin##2##2##(1992-8#1)(1994-3#1)
of nucleocytoplasmic transport##2##3##(2011-2#2)
of nucleocytoplasmic##3##2##(2008-9#1)(2011-2#2)
of nucleolar skeleton##3##3##(2008-8#3)
of nucleolar##7##2##(2007-12#1)(2008-2#1)(2008-8#4)(2011-2#1)
of nucleoli##2##2##(2011-12#1)(2013-1#1)
of nucleolin##3##2##(1991-10#3)
of nucleolus##5##2##(2008-10#1)(2008-12#1)(2008-8#3)
of nucleophagy##2##2##(2011-2#2)
of nucleophilic##4##2##(1994-12#1)(1997-8#1)(2006-12#1)(2010-12#1)
of nucleoplasmic##2##2##(2008-8#2)
of nucleoporins##2##2##(2011-2#2)
of nucleoprotein##2##2##(1996-3#1)(2012-3#1)
of nucleoside 2-deoxyribosyltransferase##2##3##(1995-6#2)
of nucleoside analogues##3##3##(2006-10#1)(2008-1#2)
of nucleoside diphosphates##2##3##(1997-7#1)(2008-7#1)
of nucleoside ligands##2##3##(1996-6#2)
of nucleoside mono- and diphosphites and phosphonates##2##7##(2008-3#2)
of nucleoside mono-##3##3##(2008-3#2)(2008-4#1)
of nucleoside triphosphates to##2##4##(1993-4#1)(2008-4#1)
of nucleoside triphosphates##3##3##(1993-4#1)(2008-4#2)
of nucleoside##26##2##(1993-4#1)(1994-8#1)(1995-3#1)(1995-6#2)(1996-4#1)(1996-6#2)(1997-7#1)(2006-10#1)(2008-1#2)(2008-3#2)(2008-4#8)(2008-5#1)(2008-7#1)(2009-12#1)(2011-2#1)
of nucleosides and bases##2##4##(2008-10#2)
of nucleosides and##3##3##(1993-12#1)(2008-10#2)
of nucleosides in##2##3##(1994-9#1)(2011-1#1)
of nucleosides to##2##3##(1995-12#1)(2006-3#1)
of nucleosides##13##2##(1992-3#1)(1993-12#1)(1994-9#1)(1995-1#1)(1995-12#1)(1997-8#1)(2006-3#2)(2008-10#2)(2008-4#1)(2010-4#1)(2011-1#1)
of nucleosomal##3##2##(1991-11#1)(1991-5#1)(1996-4#1)
of nucleosomes at##2##3##(2008-2#2)
of nucleosomes##15##2##(1990-12#2)(1990-8#1)(1993-6#2)(1994-6#1)(1995-6#1)(1996-2#1)(2008-2#2)(2008-8#3)(2012-12#2)
of nucleotide binding##2##3##(1991-2#1)(1994-6#1)
of nucleotide changes##2##3##(1990-11#1)(2008-10#1)
of nucleotide cyclases##3##3##(2008-7#3)
of nucleotide exchange##3##3##(1994-9#1)(2008-1#1)(2010-12#1)
of nucleotide excision repair##2##4##(1997-1#1)(2008-11#1)
of nucleotide hydrolysis##2##3##(2006-10#1)(2011-2#1)
of nucleotide or##2##3##(2008-4#1)(2008-9#1)
of nucleotide sequence of##2##4##(1992-4#1)(2008-8#1)
of nucleotide sequence##6##3##(1992-4#1)(1996-7#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-8#1)
of nucleotide sequences and##2##4##(1996-10#1)(2008-10#1)
of nucleotide sequences of the##2##5##(1994-8#1)(2008-6#1)
of nucleotide sequences##8##3##(1991-8#1)(1994-8#1)(1996-10#1)(2008-10#2)(2008-4#1)(2008-6#1)(2011-1#1)
of nucleotide substitution in the##2##5##(1991-2#1)(2008-6#1)
of nucleotide substitution##5##3##(1991-2#1)(2008-4#2)(2008-6#1)(2009-9#1)
of nucleotide substitutions##3##3##(1990-4#1)(2008-6#1)(2008-8#1)
of nucleotide##66##2##(1990-11#1)(1990-4#1)(1991-2#2)(1991-5#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-11#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-3#1)(1996-10#1)(1996-5#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-10#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-4#12)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#2)(2009-9#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
of nucleotides and##3##3##(1995-3#1)(1997-2#2)
of nucleotides from##3##3##(1990-7#1)(1994-6#1)(1996-6#1)
of nucleotides in the##2##4##(2008-4#2)
of nucleotides in##11##3##(1992-5#1)(1992-8#1)(1993-4#3)(1994-5#2)(2008-4#4)
of nucleotides to##2##3##(1993-11#1)(2008-11#1)
of nucleotides##42##2##(1990-5#1)(1990-7#2)(1991-7#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-4#3)(1994-5#2)(1994-6#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-2#2)(1997-4#2)(1997-7#1)(2008-1#1)(2008-11#4)(2008-2#2)(2008-4#10)
of nucleus accumbens##3##3##(1994-2#1)(1996-10#2)
of nucleus basalis lesions##2##4##(1990-5#2)
of nucleus basalis magnocellularis##5##4##(1991-9#1)(1993-12#2)(1994-12#1)(1996-9#1)
of nucleus basalis##8##3##(1990-5#2)(1991-9#1)(1992-10#1)(1993-12#2)(1994-12#1)(1996-9#1)
of nucleus pulposus of##2##4##(2007-7#1)(2010-9#1)
of nucleus pulposus##4##3##(2006-7#1)(2007-7#1)(2010-9#1)(2012-2#1)
of nucleus##23##2##(1990-5#2)(1991-9#1)(1992-10#2)(1993-12#2)(1993-5#1)(1994-10#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-10#2)(1996-9#1)(2006-7#1)(2007-7#1)(2008-5#1)(2008-8#3)(2010-9#1)(2012-2#1)
of nude mice##5##3##(1991-9#1)(1995-1#1)(2008-8#2)(2011-11#1)
of nude##6##2##(1991-9#1)(1995-1#1)(2008-8#2)(2008-9#1)(2011-11#1)
of null ellipsometry##2##3##(2008-3#2)
of null mutations##2##3##(2007-11#1)(2009-8#1)
of null##8##2##(1996-3#1)(2007-11#1)(2007-9#1)(2008-3#2)(2008-9#1)(2009-8#1)(2010-2#1)
of nulling##2##2##(2007-11#1)(2008-3#1)
of nulliparous##2##2##(2007-3#1)(2013-1#1)
of number density##2##3##(2008-3#1)(2013-1#1)
of number of cells##2##4##(1994-10#1)(1997-4#1)
of number of trials##2##4##(2008-5#1)(2013-8#1)
of number of##24##3##(1993-12#1)(1994-10#1)(1994-3#1)(1996-1#1)(1997-4#1)(2006-7#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2011-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
of number##29##2##(1993-12#1)(1994-10#1)(1994-3#1)(1996-1#1)(1997-4#1)(2006-7#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-1#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
of numbers and##2##3##(1996-4#1)(2010-9#1)
of numbers of##5##3##(1991-2#1)(1992-1#1)(2007-4#1)(2011-2#1)(2013-7#1)
of numbers##8##2##(1991-2#1)(1992-1#1)(1996-4#1)(2007-4#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-7#1)
of numerical and analytical##2##4##(2007-9#1)(2008-2#1)
of numerical and structural chromosomal##2##5##(2007-3#1)(2008-1#1)
of numerical and structural chromosome##2##5##(2008-4#1)(2008-9#1)
of numerical and structural##4##4##(2007-3#1)(2008-1#1)(2008-4#1)(2008-9#1)
of numerical and##7##3##(2006-11#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-9#1)
of numerical experiments##2##3##(2008-3#2)
of numerical models##2##3##(2007-4#1)(2008-2#1)
of numerical simulation of##2##4##(2007-12#1)(2008-3#1)
of numerical simulation##3##3##(2005-11#1)(2007-12#1)(2008-3#1)
of numerical simulations##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
of numerical##39##2##(1996-4#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-12#1)(2007-11#3)(2007-12#6)(2007-3#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#6)(2008-3#8)(2008-4#2)(2008-9#1)(2013-8#2)
of numerous clinical##2##3##(2006-10#1)(2007-11#1)
of numerous diseases##2##3##(1992-7#1)(2005-11#1)
of numerous other##4##3##(1995-1#1)(1996-5#1)(2008-10#1)(2008-2#1)
of numerous small##2##3##(2008-7#1)(2011-1#1)
of numerous virulence##2##3##(1995-2#1)(2007-12#1)
of numerous##91##2##(1991-11#1)(1991-5#1)(1992-12#1)(1992-5#1)(1992-7#1)(1993-2#2)(1993-6#1)(1994-11#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#2)(1995-8#1)(1996-3#1)(1996-5#2)(1997-3#1)(2005-10#3)(2005-11#1)(2005-8#2)(2005-9#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-12#1)(2009-2#2)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-7#1)
of nurse cells##3##3##(2007-12#3)
of nurse education and##2##4##(2008-12#2)
of nurse education##8##3##(2008-11#4)(2008-12#3)(2012-3#1)
of nurse educators are##2##4##(2008-11#1)(2012-3#1)
of nurse educators##3##3##(2006-5#1)(2008-11#1)(2012-3#1)
of nurse lecturers##2##3##(2008-11#2)
of nurse researchers##2##3##(2005-7#1)(2010-9#1)
of nurse##29##2##(1993-12#1)(2005-7#1)(2006-1#1)(2006-5#1)(2007-12#5)(2008-11#9)(2008-12#3)(2009-9#1)(2010-10#1)(2010-9#1)(2011-2#2)(2012-3#2)(2013-1#1)
of nurse's##2##2##(2008-12#1)(2011-1#1)
of nurse-delivered alcohol##2##3##(2012-11#2)
of nurse-delivered##4##2##(2012-11#4)
of nurses and##10##3##(1996-7#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#2)(2009-9#1)(2010-3#1)(2011-1#1)
of nurses for##3##3##(2008-11#1)(2013-1#2)
of nurses from##2##3##(2005-7#1)(2012-12#1)
of nurses in a##2##4##(2007-2#1)(2012-3#1)
of nurses in##10##3##(1991-11#1)(1991-2#1)(1995-9#1)(2007-2#1)(2008-11#1)(2008-7#1)(2010-10#1)(2012-12#1)(2012-3#1)(2013-1#1)
of nurses of the##2##4##(2008-10#1)(2012-12#1)
of nurses of##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
of nurses that##2##3##(2008-11#1)(2011-2#1)
of nurses to##7##3##(2006-1#1)(2007-3#1)(2007-9#1)(2008-11#2)(2012-3#2)
of nurses who##5##3##(2009-5#1)(2010-11#2)(2011-1#1)(2012-3#1)
of nurses working in a##2##5##(2007-10#1)(2011-2#1)
of nurses working in##3##4##(2006-1#1)(2007-10#1)(2011-2#1)
of nurses##92##2##(1990-2#1)(1991-11#1)(1991-2#2)(1992-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-3#1)(1996-7#1)(2005-7#2)(2005-9#1)(2006-1#3)(2006-2#1)(2007-10#2)(2007-2#2)(2007-3#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#12)(2008-12#5)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#3)(2010-11#4)(2010-3#3)(2010-4#1)(2011-1#3)(2011-2#4)(2012-12#4)(2012-3#5)(2013-1#7)(2013-8#4)
of nurses&quot##2##2##(1990-2#2)
of nurses' caring##2##3##(2007-10#2)
of nurses' perceptions##2##3##(2010-10#1)(2013-1#1)
of nurses'##12##2##(1993-12#1)(2005-10#1)(2007-10#2)(2008-11#1)(2008-12#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-12#1)(2013-1#1)(2013-8#1)
of nurses]##2##2##(1994-6#1)(2012-3#1)
of nursing activities##3##3##(1991-2#3)
of nursing administration##2##3##(1990-12#1)(2008-1#1)
of nursing advocacy##3##3##(2009-12#3)
of nursing and medical##2##4##(2004-10#1)(2010-3#1)
of nursing and midwifery##3##4##(2007-10#1)(2008-11#1)(2008-12#1)
of nursing and##17##3##(1997-6#1)(2004-10#1)(2005-12#1)(2007-10#1)(2008-11#5)(2008-12#2)(2009-7#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-11#1)(2012-3#1)
of nursing are##5##3##(2005-12#1)(2008-12#2)(2009-8#1)(2010-8#1)
of nursing as##3##3##(2008-1#2)(2008-11#1)
of nursing care and##2##4##(1991-3#1)(2007-10#1)
of nursing care in##3##4##(1990-2#1)(2012-12#1)(2012-3#1)
of nursing care of##2##4##(2008-11#1)(2012-3#1)
of nursing care will##2##4##(2007-9#1)(2012-3#1)
of nursing care##28##3##(1990-2#1)(1991-3#1)(1994-3#1)(1996-1#1)(2006-1#1)(2007-1#1)(2007-10#1)(2007-3#2)(2007-9#1)(2008-1#1)(2008-11#4)(2008-12#1)(2009-8#1)(2011-1#1)(2012-12#2)(2012-3#4)(2013-1#2)(2013-8#2)
of nursing care]##2##3##(2009-4#1)(2010-3#1)
of nursing diagnoses##3##3##(2011-2#1)(2013-1#2)
of nursing diagnosis are##2##4##(1990-2#2)
of nursing diagnosis##6##3##(1990-2#4)(2010-3#2)
of nursing education##7##3##(1996-3#1)(2006-10#1)(2008-11#2)(2008-12#1)(2010-3#1)(2011-2#1)
of nursing faculty##7##3##(2007-10#1)(2008-11#3)(2008-2#1)(2012-2#1)(2012-3#1)
of nursing graduates##2##3##(2005-12#1)(2012-3#1)
of nursing have been##2##4##(2007-11#1)(2011-2#1)
of nursing have##3##3##(2007-11#1)(2008-1#1)(2011-2#1)
of nursing home admission##2##4##(2010-12#1)(2011-1#1)
of nursing home capital##2##4##(1992-1#2)
of nursing home care##9##4##(1991-2#1)(1993-2#1)(1995-2#1)(1996-2#1)(1997-3#1)(2009-3#1)(2010-8#2)(2012-12#1)
of nursing home quality##2##4##(1996-2#1)(2010-11#1)
of nursing home residents##8##4##(1991-3#1)(1993-3#1)(1996-2#1)(2005-7#1)(2006-3#1)(2008-2#1)(2010-8#2)
of nursing home##40##3##(1990-5#3)(1991-2#1)(1991-3#3)(1992-1#2)(1993-2#1)(1993-3#1)(1994-12#3)(1994-2#3)(1995-2#2)(1996-2#3)(1997-2#1)(1997-3#2)(2005-7#1)(2006-3#1)(2008-11#2)(2008-2#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-8#4)(2011-1#1)(2011-2#1)(2012-12#1)
of nursing homes##10##3##(1991-1#1)(1996-6#6)(1997-1#1)(2008-12#1)(2012-12#1)
of nursing in the##2##4##(2006-10#1)(2012-3#1)
of nursing in##6##3##(2006-10#1)(2008-1#1)(2008-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
of nursing knowledge##3##3##(2008-11#1)(2008-12#2)
of nursing leadership in##2##4##(2008-1#1)(2012-3#1)
of nursing must##2##3##(2008-11#2)
of nursing practice in##3##4##(2007-10#1)(2008-4#1)(2010-5#1)
of nursing practice##11##3##(1997-7#1)(2004-10#1)(2007-10#1)(2007-3#1)(2008-11#4)(2008-12#1)(2008-4#1)(2010-5#1)
of nursing programmes##2##3##(2008-12#1)(2012-3#1)
of nursing research##5##3##(1996-1#1)(2008-12#1)(2010-9#3)
of nursing services##2##3##(2008-1#1)(2009-4#1)
of nursing staff##4##3##(1997-6#1)(2010-10#2)(2011-2#1)
of nursing students##9##3##(2006-5#1)(2007-10#2)(2008-11#2)(2008-12#3)(2012-12#1)
of nursing to##5##3##(1990-12#1)(2005-9#1)(2008-1#1)(2008-12#2)
of nursing work##3##3##(2004-10#2)(2008-9#1)
of nursing##275##2##(1990-12#3)(1990-2#9)(1990-5#3)(1991-1#1)(1991-11#1)(1991-2#5)(1991-3#4)(1992-1#2)(1993-2#1)(1993-3#1)(1994-12#3)(1994-2#3)(1994-3#4)(1994-9#1)(1995-2#2)(1996-1#2)(1996-2#3)(1996-3#1)(1996-6#6)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#3)(1997-7#2)(1997-8#1)(2004-10#4)(2005-12#6)(2005-7#1)(2005-8#1)(2005-9#2)(2006-1#2)(2006-10#2)(2006-12#3)(2006-2#3)(2006-3#1)(2006-5#4)(2007-1#1)(2007-10#9)(2007-11#1)(2007-3#3)(2007-8#2)(2007-9#1)(2008-1#13)(2008-11#39)(2008-12#27)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#3)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#3)(2010-10#3)(2010-11#1)(2010-12#2)(2010-3#6)(2010-5#1)(2010-7#2)(2010-8#5)(2010-9#3)(2011-1#4)(2011-2#11)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#1)(2012-3#10)(2013-1#4)(2013-8#6)
of nursing's##2##2##(2008-1#2)
of nursing]##2##2##(1993-8#1)(2007-3#1)
of nusap1##2##2##(2011-1#2)
of nut##2##2##(1995-3#1)(2008-10#1)
of nutrient intake##3##3##(2008-7#1)(2009-2#1)(2013-1#1)
of nutrient intakes##2##3##(1991-11#1)(2009-2#1)
of nutrient patches##2##3##(2008-11#2)
of nutrient##30##2##(1991-11#1)(1995-3#1)(2004-4#1)(2006-10#1)(2007-11#2)(2007-9#2)(2008-10#3)(2008-11#5)(2008-12#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-2#2)(2011-12#1)(2012-2#1)(2013-1#2)
of nutrient-rich##2##2##(2008-1#1)(2008-5#1)
of nutrients and a##2##4##(2008-11#1)(2012-2#1)
of nutrients and##9##3##(1994-11#1)(2007-11#1)(2007-5#1)(2007-6#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
of nutrients had##2##3##(2008-6#1)(2013-1#1)
of nutrients in the##2##4##(2007-7#1)(2008-9#1)
of nutrients in##6##3##(1992-9#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-9#1)
of nutrients is##3##3##(1992-2#1)(1996-7#1)(2006-2#1)
of nutrients on##2##3##(1997-4#1)(2012-1#1)
of nutrients or##3##3##(2007-3#1)(2007-7#1)(2008-11#1)
of nutrients to##4##3##(2005-3#1)(2008-11#1)(2008-3#1)(2008-9#1)
of nutrients##52##2##(1991-11#1)(1991-5#1)(1992-2#1)(1992-9#1)(1994-11#1)(1996-7#1)(1997-4#1)(2004-4#1)(2005-10#1)(2005-3#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2008-10#1)(2008-11#6)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-2#2)(2011-1#2)(2011-12#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#2)
of nutrigenomic##2##2##(2008-10#2)
of nutrigenomics##2##2##(2008-10#1)(2009-5#1)
of nutrition and lifestyle##2##4##(1996-8#1)(2011-2#1)
of nutrition and##8##3##(1994-3#1)(1996-8#2)(2006-10#1)(2008-10#1)(2010-4#1)(2011-2#1)(2012-12#1)
of nutrition care##5##3##(1994-3#4)(1997-3#1)
of nutrition education##3##3##(2005-3#3)
of nutrition for##3##3##(1996-8#1)(2007-2#1)(2008-10#1)
of nutrition in children##2##4##(2012-2#2)
of nutrition in the##2##4##(2005-10#1)(2008-4#1)
of nutrition in##6##3##(2005-10#2)(2008-12#1)(2008-4#1)(2012-2#2)
of nutrition information##2##3##(1991-3#2)
of nutrition intervention##2##3##(1995-2#1)(1995-3#1)
of nutrition on canine behaviour##2##5##(2008-12#2)
of nutrition support##2##3##(2005-10#2)
of nutrition therapy##3##3##(1995-3#1)(2005-10#1)(2012-12#1)
of nutrition##52##2##(1990-12#1)(1991-3#3)(1993-1#1)(1994-3#5)(1995-2#1)(1995-3#3)(1995-6#1)(1996-8#3)(1997-3#1)(2005-1#1)(2005-10#7)(2005-3#3)(2006-10#1)(2006-2#2)(2007-1#1)(2007-2#1)(2008-10#2)(2008-12#3)(2008-2#1)(2008-4#1)(2010-4#2)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#1)
of nutrition-related##2##2##(2008-1#1)(2012-1#1)
of nutritional assessment##2##3##(1993-3#1)(2011-2#1)
of nutritional deficiencies##3##3##(1995-3#1)(2007-7#1)(2008-10#1)
of nutritional deficiency##2##3##(1991-12#1)(2006-10#1)
of nutritional education##2##3##(2006-8#1)(2011-2#1)
of nutritional factors##3##3##(1994-5#1)(2004-11#1)(2010-12#1)
of nutritional health##2##3##(2006-6#1)(2012-1#1)
of nutritional intake##2##3##(1991-2#1)(2008-1#1)
of nutritional interventions##2##3##(2010-6#2)
of nutritional origin##4##3##(2012-2#4)
of nutritional status in##4##4##(2006-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
of nutritional status of##3##4##(2011-1#1)(2011-2#1)(2012-2#1)
of nutritional status should be##3##5##(2006-2#1)(2010-7#2)
of nutritional status##22##3##(1993-12#1)(1996-9#1)(1997-4#1)(2005-10#1)(2006-2#6)(2007-7#1)(2010-7#2)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
of nutritional supplementation##2##3##(2010-9#2)
of nutritional support##6##3##(2005-10#1)(2006-10#2)(2006-6#1)(2007-12#1)(2013-1#1)
of nutritional##77##2##(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-6#1)(1993-12#1)(1993-3#1)(1994-5#1)(1995-3#2)(1996-9#1)(1997-4#1)(2004-11#1)(2005-1#1)(2005-10#2)(2006-10#4)(2006-2#9)(2006-6#2)(2006-8#2)(2006-9#2)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#2)(2009-2#1)(2009-5#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#2)(2010-7#2)(2010-9#2)(2011-1#3)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#7)(2013-1#2)
of nutritionally##4##2##(2008-11#1)(2008-4#1)(2008-5#1)(2013-7#1)
of nutritionists##2##2##(1993-1#2)
of nutritive##3##2##(2007-8#1)(2008-9#1)(2012-1#1)
of nymphs and adults of##2##5##(2007-3#1)(2013-7#1)
of nymphs and adults##4##4##(2004-11#1)(2007-3#1)(2013-7#2)
of nymphs##7##2##(2004-11#4)(2007-3#1)(2013-7#2)
of nystagmus##3##2##(2008-7#1)(2009-5#2)
of o-##2##2##(2008-10#2)
of o-catechol##2##2##(2008-10#2)
of o-dianisidine##2##2##(2007-8#1)(2008-10#1)
of o-nitrophenol##3##2##(2009-3#3)
of o-phenylenediamine##2##2##(2008-10#2)
of oak##4##2##(2008-10#2)(2012-5#1)(2012-9#1)
of oat##7##2##(1990-12#1)(1990-5#1)(2008-10#3)(2008-5#1)(2008-9#1)
of oats as##2##3##(2008-12#2)
of oats##7##2##(1991-6#1)(2006-10#1)(2008-10#2)(2008-12#3)
of ob/ob and##2##3##(1996-2#1)(2012-1#1)
of obese Zucker rats##2##4##(1995-5#1)(1997-5#1)
of obese Zucker##3##3##(1995-5#1)(1997-4#1)(1997-5#1)
of obese children##4##3##(2008-7#2)(2010-8#2)
of obese individuals##2##3##(2011-2#1)(2012-2#1)
of obese pGDM##2##3##(2008-3#2)
of obese patients with##2##4##(2008-3#1)(2013-1#1)
of obese patients##3##3##(2006-2#1)(2008-3#1)(2013-1#1)
of obese rats##3##3##(1996-12#1)(1997-5#1)(2009-4#1)
of obese women##2##3##(2006-1#1)(2007-12#1)
of obese##27##2##(1995-5#1)(1995-6#1)(1996-12#2)(1997-4#1)(1997-5#2)(2006-1#1)(2006-2#2)(2007-12#1)(2007-7#1)(2008-3#5)(2008-7#2)(2009-4#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
of obesity among##5##3##(2005-9#1)(2006-1#1)(2008-11#1)(2012-3#1)(2013-8#1)
of obesity and cardiovascular##2##4##(2010-3#1)(2011-1#1)
of obesity and diabetes##4##4##(1991-3#1)(2005-8#1)(2008-6#1)(2010-12#1)
of obesity and its associated##2##5##(2007-11#1)(2012-12#1)
of obesity and its##4##4##(2007-11#1)(2010-9#1)(2012-12#1)(2012-2#1)
of obesity and overweight##2##4##(2006-12#1)(2006-2#1)
of obesity and related metabolic diseases##2##6##(2008-3#2)
of obesity and related metabolic##3##5##(2008-10#1)(2008-3#2)
of obesity and type 2 diabetes##2##6##(2008-1#1)(2008-3#1)
of obesity and##40##3##(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(2004-12#1)(2005-10#1)(2005-8#1)(2006-1#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-12#2)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)
of obesity are##3##3##(2006-1#1)(2006-2#2)
of obesity as##3##3##(2005-8#1)(2006-2#1)(2012-2#1)
of obesity for##2##3##(2007-12#1)(2011-1#1)
of obesity has increased##3##4##(2010-2#1)(2011-1#1)(2012-1#1)
of obesity has##8##3##(2006-10#1)(2009-5#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#2)(2012-1#1)
of obesity in children##2##4##(2006-1#2)
of obesity in the##8##4##(1993-11#1)(2006-10#1)(2006-2#1)(2007-3#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
of obesity in these##2##4##(2006-1#1)(2006-10#1)
of obesity in##23##3##(1993-11#1)(2006-1#3)(2006-10#2)(2006-2#1)(2007-11#1)(2007-3#2)(2008-1#4)(2009-11#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)
of obesity is##6##3##(1996-3#1)(2006-1#1)(2006-2#2)(2011-1#1)(2011-2#1)
of obesity on the psychometric##2##5##(2011-2#2)
of obesity on the##3##4##(2011-2#3)
of obesity on##9##3##(2007-2#1)(2010-3#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#1)
of obesity or undernutrition##2##4##(2008-7#2)
of obesity or##3##3##(2008-7#3)
of obesity should##2##3##(1996-1#1)(2006-2#1)
of obesity than##2##3##(2011-2#1)(2013-1#1)
of obesity that##3##3##(2008-10#2)(2008-9#1)
of obesity treatment##2##3##(1991-2#1)(2005-8#1)
of obesity was##7##3##(1997-1#1)(2007-11#1)(2007-8#1)(2008-3#1)(2012-2#2)(2013-7#1)
of obesity were##2##3##(1997-1#1)(2013-1#1)
of obesity with##4##3##(2006-1#1)(2006-2#1)(2012-12#1)(2012-2#1)
of obesity##193##2##(1991-2#1)(1991-3#2)(1991-6#1)(1991-7#1)(1991-8#1)(1993-11#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#2)(2004-12#1)(2005-10#1)(2005-8#4)(2005-9#1)(2006-1#10)(2006-10#7)(2006-12#1)(2006-2#11)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#1)(2007-2#2)(2007-3#2)(2007-8#1)(2008-1#13)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#15)(2008-4#6)(2008-5#6)(2008-6#1)(2008-7#4)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-9#2)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#8)(2011-2#12)(2012-1#7)(2012-12#4)(2012-2#14)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#2)
of obesity-related##2##2##(2008-1#1)(2011-1#1)
of obesity]##5##2##(1990-5#1)(2006-2#2)(2006-8#1)(2007-3#1)
of object and##3##3##(1997-8#1)(2007-12#1)(2008-2#1)
of object identification##2##3##(1997-8#2)
of object motion##2##3##(1996-1#1)(2012-1#1)
of object##19##2##(1993-3#1)(1996-1#1)(1997-8#5)(2007-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2009-2#1)(2009-4#1)(2011-1#1)(2012-1#3)
of object-adapted fringes##4##3##(2007-12#3)(2008-2#1)
of objective and subjective##3##4##(1991-6#1)(2008-7#1)(2011-1#1)
of objective and##4##3##(1991-6#1)(2008-7#1)(2009-7#1)(2011-1#1)
of objective clinical##3##3##(2006-8#2)(2007-7#1)
of objective criteria##4##3##(2005-5#1)(2006-3#1)(2008-10#2)
of objective##39##2##(1991-6#1)(1992-4#1)(1993-1#1)(1996-8#1)(2005-10#1)(2005-5#1)(2006-3#1)(2006-6#1)(2006-8#2)(2007-11#4)(2007-6#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#2)(2009-2#1)(2009-7#1)(2009-9#2)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#1)(2013-1#5)
of objectively##2##2##(1994-2#1)(2008-5#1)
of objectives##6##2##(1991-2#1)(1995-3#1)(1996-8#1)(2008-9#2)(2010-9#1)
of objectivity in##2##3##(2012-2#2)
of objectivity##3##2##(2012-12#1)(2012-2#2)
of objects and##7##3##(1997-8#2)(2007-8#1)(2008-2#2)(2008-4#1)(2010-5#1)
of objects from##3##3##(2008-2#1)(2008-3#2)
of objects hidden##2##3##(2007-12#1)(2008-2#1)
of objects in a##4##4##(1993-6#1)(2007-11#1)(2008-3#1)(2008-4#1)
of objects in##8##3##(1993-6#1)(1993-7#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-4#1)
of objects is##2##3##(1995-12#1)(2008-3#1)
of objects of##2##3##(2007-11#1)(2008-2#1)
of objects that##2##3##(2008-3#1)(2008-9#1)
of objects##67##2##(1990-12#1)(1990-3#1)(1992-2#1)(1993-12#1)(1993-6#2)(1993-7#1)(1995-12#2)(1995-8#3)(1997-5#1)(1997-8#6)(2006-8#1)(2007-11#4)(2007-12#2)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#9)(2008-3#11)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-2#1)
of obligate##6##2##(2006-8#2)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)
of oblique##3##2##(2007-1#1)(2007-12#1)(2008-2#1)
of obliquely incident##2##3##(2008-2#1)(2008-3#1)
of obliquely##6##2##(2008-2#3)(2008-3#1)(2008-5#2)
of obscure origin##2##3##(2008-7#1)(2009-8#1)
of obscure##9##2##(2006-10#2)(2006-7#1)(2006-8#1)(2008-7#2)(2009-8#1)(2012-12#1)(2012-2#1)
of observation and##2##3##(1991-10#1)(2011-1#1)
of observation are##2##3##(1992-8#1)(2008-2#1)
of observation as##2##3##(1990-5#1)(2012-3#1)
of observation in the##2##4##(1994-7#1)(2012-12#1)
of observation in##3##3##(1994-7#1)(2010-1#1)(2012-12#1)
of observation of##2##3##(1992-3#1)(1994-2#1)
of observation the##2##3##(1992-6#1)(1993-9#1)
of observation##36##2##(1990-5#2)(1990-8#1)(1991-10#1)(1991-12#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-9#1)(1994-2#1)(1994-7#1)(1995-2#1)(1996-3#1)(1997-7#1)(2006-10#2)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-5#1)(2008-8#1)(2009-6#1)(2010-1#1)(2010-3#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
of observation)##2##2##(2007-11#1)(2008-10#1)
of observational data##3##3##(2006-7#1)(2013-1#2)
of observational studies##3##3##(2006-10#1)(2009-4#1)(2011-1#1)
of observational##11##2##(2005-12#1)(2006-10#1)(2006-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-4#1)(2010-12#1)(2011-1#1)(2013-1#2)
of observations in##4##3##(2008-10#1)(2008-3#1)(2008-8#1)(2011-1#1)
of observations that##2##3##(1992-6#1)(1997-1#1)
of observations with##2##3##(2008-3#1)(2009-8#1)
of observations##27##2##(1992-6#1)(1993-7#1)(1994-6#1)(1996-2#1)(1996-8#1)(1997-1#1)(2006-10#1)(2006-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-3#1)
of observed data##2##3##(2013-1#1)(2013-8#1)
of observed##27##2##(1992-12#1)(1993-1#1)(1995-1#1)(1995-4#1)(1997-6#1)(2005-11#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-2#1)(2010-10#1)(2010-11#1)(2011-1#2)(2013-1#3)(2013-8#2)
of observer variation studies##2##4##(1991-9#2)
of observer variation##3##3##(1991-9#3)
of observer##5##2##(1991-9#3)(1993-1#2)
of observers##2##2##(2008-11#1)(2009-8#1)
of observing and##3##3##(2006-6#1)(2008-10#1)(2008-2#1)
of observing the##2##3##(1992-5#1)(2006-3#1)
of observing##11##2##(1992-5#1)(2006-3#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2010-10#1)(2013-8#1)
of obsessive compulsive disorder##2##4##(2007-10#1)(2012-2#1)
of obsessive-compulsive disorder (OCD)##7##4##(1995-11#1)(2006-9#1)(2007-6#2)(2008-1#1)(2008-6#1)(2012-2#1)
of obsessive-compulsive disorder in##2##4##(2008-11#1)(2012-12#1)
of obsessive-compulsive disorder##14##3##(1995-11#1)(2004-3#1)(2006-9#1)(2007-6#4)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
of obsessive-compulsive disorders##2##3##(2009-7#1)(2013-8#1)
of obsessive-compulsive##18##2##(1995-11#1)(2004-3#1)(2006-9#1)(2007-6#4)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#2)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
of obstacles##2##2##(2008-1#1)(2012-12#1)
of obstetric anaesthesia##3##3##(2006-10#3)
of obstetric care in##2##4##(2011-1#1)(2013-8#1)
of obstetric care##3##3##(2011-1#2)(2013-8#1)
of obstetric complications##2##3##(1996-8#1)(2008-2#1)
of obstetric##17##2##(1993-4#1)(1996-8#1)(2006-10#5)(2008-2#1)(2008-3#1)(2011-1#3)(2012-2#2)(2013-1#2)(2013-8#1)
of obstetrical##5##2##(1992-2#1)(1993-12#1)(1996-2#1)(2006-4#1)(2010-11#1)
of obstetrics in##2##3##(1991-6#1)(2013-8#1)
of obstetrics##3##2##(1991-6#1)(1994-6#1)(2013-8#1)
of obstructed##4##2##(1991-3#1)(1996-12#1)(2010-5#1)(2013-7#1)
of obstructing##2##2##(2008-5#1)(2012-1#1)
of obstruction##8##2##(1990-8#1)(1997-8#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2012-2#1)(2013-1#1)
of obstructive jaundice##7##3##(1991-3#1)(1991-9#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-4#1)(2008-3#1)
of obstructive lesions##2##3##(2010-6#1)(2012-3#1)
of obstructive lung disease in##2##5##(2008-6#1)(2010-3#1)
of obstructive lung disease##3##4##(1996-8#1)(2008-6#1)(2010-3#1)
of obstructive lung##4##3##(1996-8#1)(2008-6#2)(2010-3#1)
of obstructive sleep apnea##6##4##(2007-12#2)(2007-6#1)(2009-3#1)(2010-5#1)(2013-1#1)
of obstructive sleep##8##3##(2006-10#1)(2007-1#1)(2007-12#2)(2007-6#1)(2009-3#1)(2010-5#1)(2013-1#1)
of obstructive uropathy##3##3##(2007-7#1)(2008-1#1)(2008-10#1)
of obstructive##37##2##(1991-3#1)(1991-9#1)(1996-8#1)(1996-9#1)(1997-8#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#3)(2008-6#3)(2009-3#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
of obtained##2##2##(2008-10#1)(2013-1#1)
of obtaining a##5##3##(2006-10#1)(2008-10#1)(2008-6#1)(2008-9#1)(2012-12#1)
of obtaining access to##2##4##(2009-6#1)(2009-9#1)
of obtaining an##3##3##(2008-10#1)(2008-4#1)(2011-2#1)
of obtaining optical sectioning##2##4##(2008-1#2)
of obtaining the##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
of obtaining##53##2##(1990-12#1)(1991-12#1)(1991-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-8#1)(2006-10#2)(2006-6#1)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-9#1)(2008-1#2)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-6#2)(2009-9#1)(2010-11#2)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
of obtusifoliol##3##2##(1992-3#3)
of obvious##6##2##(2006-8#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-4#1)(2013-1#1)
of occipital condyles##2##3##(2013-1#2)
of occipital##7##2##(2006-7#1)(2008-7#2)(2011-2#1)(2013-1#3)
of occluded central venous##2##4##(2006-12#1)(2013-7#1)
of occluded##6##2##(1991-6#1)(2006-12#1)(2006-9#1)(2008-11#1)(2008-7#1)(2013-7#1)
of occluding##3##2##(1997-8#1)(2007-8#1)(2013-8#1)
of occlusal##6##2##(2009-7#1)(2010-3#1)(2010-6#2)(2011-2#1)(2013-8#1)
of occlusion##11##2##(1997-3#1)(2007-10#2)(2008-1#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-4#2)(2012-3#1)
of occlusive vascular disease##3##4##(1992-9#2)(2009-2#1)
of occlusive vascular##4##3##(1992-9#2)(1995-2#1)(2009-2#1)
of occlusive##7##2##(1990-11#1)(1992-9#2)(1995-2#1)(2007-9#1)(2008-5#1)(2009-2#1)
of occult blood in##3##4##(1993-6#1)(2009-1#1)(2010-12#1)
of occult papillary##2##3##(1990-6#2)
of occult##26##2##(1990-6#6)(1991-2#1)(1991-3#1)(1991-6#1)(1993-3#1)(1993-6#1)(1995-10#1)(2004-2#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-1#1)(2010-12#1)(2012-2#1)(2013-1#2)
of occupancy##3##2##(1990-12#1)(1990-8#1)(1995-2#1)
of occupants##2##2##(2006-11#2)
of occupation##3##2##(1996-8#1)(2010-9#1)(2011-1#1)
of occupational asthma##4##3##(1994-6#1)(2008-10#3)
of occupational asthma]##2##3##(1993-5#1)(1995-9#1)
of occupational cancer in Nepal##2##5##(2006-1#2)
of occupational disease incidence in Mexico##2##6##(2007-4#2)
of occupational disease##5##3##(2007-4#4)(2010-12#1)
of occupational diseases in##2##4##(1990-3#1)(1992-1#1)
of occupational diseases##5##3##(1990-3#1)(1992-1#1)(2007-4#1)(2010-9#1)(2011-1#1)
of occupational exposure and##2##4##(1994-6#1)(1996-2#1)
of occupational exposure to##12##4##(1990-8#2)(1993-6#1)(1994-6#2)(2006-5#1)(2007-10#1)(2007-7#2)(2008-3#1)(2008-9#1)(2009-7#1)
of occupational exposure was##2##4##(1994-6#1)(2007-7#1)
of occupational exposure##19##3##(1990-8#2)(1993-6#1)(1994-6#5)(1996-2#1)(2006-5#1)(2007-10#1)(2007-7#3)(2008-3#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-2#1)
of occupational health##7##3##(1991-6#1)(1993-6#1)(2008-11#1)(2010-12#1)(2011-1#1)(2012-2#2)
of occupational hygiene##2##3##(1994-6#1)(2008-10#1)
of occupational injury and ill-health##2##5##(2008-11#2)
of occupational lung##2##3##(1996-2#1)(2005-8#1)
of occupational medicine##2##3##(1995-6#1)(2011-2#1)
of occupational stress among##2##4##(2008-4#2)
of occupational stress on##4##4##(2010-12#3)(2012-2#1)
of occupational stress##6##3##(2008-4#2)(2010-12#3)(2012-2#1)
of occupational therapy##3##3##(2013-7#2)(2013-8#1)
of occupational##93##2##(1990-3#2)(1990-8#2)(1991-6#1)(1992-1#1)(1993-5#1)(1993-6#3)(1994-6#10)(1995-6#1)(1995-9#1)(1996-2#2)(2004-9#1)(2005-8#3)(2006-1#2)(2006-5#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-4#5)(2007-6#1)(2007-7#5)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#5)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-7#1)(2010-12#6)(2010-9#4)(2011-1#2)(2011-2#3)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#5)
of occupationally##3##2##(1992-4#1)(2007-12#1)(2011-2#1)
of occupied##3##2##(1991-1#1)(2008-8#2)
of occurrence and##2##3##(2008-12#1)(2009-10#1)
of occurrence for##2##3##(2007-5#2)
of occurrence in##3##3##(2007-6#2)(2011-2#1)
of occurrence of each##2##4##(2007-6#1)(2013-1#1)
of occurrence of the##5##4##(1993-9#1)(1996-3#1)(2007-12#1)(2009-8#1)(2011-2#1)
of occurrence of##25##3##(1991-9#1)(1992-8#1)(1993-8#1)(1993-9#1)(1996-3#1)(1996-4#3)(2007-12#1)(2007-6#2)(2007-7#1)(2008-10#2)(2008-11#1)(2009-6#1)(2009-8#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
of occurrence##54##2##(1991-9#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-3#1)(1996-3#1)(1996-4#3)(1997-4#1)(2007-12#1)(2007-3#2)(2007-5#3)(2007-6#4)(2007-7#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#3)(2009-10#1)(2009-6#1)(2009-8#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
of occurring##2##2##(2008-10#2)
of ocean color imagery##3##4##(2008-2#2)(2008-3#1)
of ocean color##16##3##(2008-2#9)(2008-3#7)
of ocean currents##2##3##(2007-5#1)(2009-2#1)
of ocean water##3##3##(2008-2#2)(2008-3#1)
of ocean##25##2##(1996-4#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-2#11)(2008-3#9)(2009-2#1)
of oceanic water##2##3##(2008-2#2)
of oceanic waters##3##3##(2008-3#3)
of oceanic##11##2##(1996-4#1)(2008-2#4)(2008-3#4)(2012-2#2)
of ochratoxin A##6##3##(1997-3#1)(2008-10#4)(2009-3#1)
of ocs##2##2##(1994-3#2)
of octa-O-acetylsucrose##2##2##(1991-12#2)
of octadecanethiol##2##2##(2007-12#1)(2008-10#1)
of octadecenedioic acid##2##3##(2008-5#2)
of octahedral##3##2##(2008-3#1)(2010-5#2)
of octanol##2##2##(2008-10#1)(2010-2#1)
of octanol-water partition coefficient##2##4##(2008-6#2)
of octopamine##5##2##(1994-2#3)(1995-5#2)
of octreotide and##3##3##(1994-8#2)(2004-9#1)
of octreotide in##2##3##(1991-11#1)(1992-4#1)
of octreotide on##2##3##(1994-10#1)(2005-10#1)
of octreotide##12##2##(1991-11#1)(1992-4#1)(1994-10#1)(1994-8#2)(1995-5#1)(1995-8#1)(1997-4#1)(2004-9#1)(2005-10#1)(2008-1#1)(2012-11#1)
of octyl glucoside##4##3##(1990-9#3)(1992-12#1)
of octyl methoxycinnamate##2##3##(2008-5#2)
of octyl##9##2##(1990-9#3)(1992-12#1)(2008-5#4)(2013-8#1)
of ocular abnormalities##2##3##(2011-12#2)
of ocular allergy##2##3##(2005-8#1)(2006-11#1)
of ocular blood##2##3##(2009-4#1)(2009-8#1)
of ocular disorders##2##3##(2007-12#1)(2008-4#1)
of ocular dominance plasticity##3##4##(1991-8#3)
of ocular dominance##4##3##(1991-8#3)(2008-11#1)
of ocular hypersensitivity##2##3##(2005-11#2)
of ocular inflammation##2##3##(2007-11#1)(2013-7#1)
of ocular melanoma##4##3##(2008-3#1)(2010-9#3)
of ocular or##2##3##(2008-8#1)(2009-2#1)
of ocular pathological changes in the##2##6##(2013-7#2)
of ocular surface##4##3##(2005-11#1)(2007-1#2)(2009-8#1)
of ocular tissues##3##3##(1992-11#1)(2007-11#2)
of ocular##49##2##(1991-11#1)(1991-2#1)(1991-8#3)(1992-11#1)(1995-12#1)(2005-11#4)(2005-8#1)(2006-11#1)(2007-1#2)(2007-11#3)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-2#4)(2009-4#1)(2009-8#4)(2010-11#1)(2010-9#3)(2011-1#3)(2011-12#2)(2013-7#4)(2013-8#2)
of oculocutaneous albinism##2##3##(1997-4#1)(2012-12#1)
of odd-numbered double bond##2##4##(1994-8#2)
of odds ratio##3##3##(1997-8#1)(2007-2#1)(2012-3#1)
of odontoblast##2##2##(2013-1#1)(2013-8#1)
of odontogenic origin##2##3##(2007-12#1)(2013-8#1)
of odontogenic##6##2##(2007-12#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-8#2)
of odontoid##2##2##(2006-7#2)
of odor##2##2##(1992-4#1)(2008-10#1)
of odorant##4##2##(2006-12#2)(2008-7#1)(2013-8#1)
of odorant-binding##2##2##(2007-12#2)
of odorants to##2##3##(1991-2#1)(2006-12#1)
of odorants##6##2##(1991-2#2)(2006-12#2)(2013-1#2)
of odour##2##2##(2007-12#1)(2008-5#1)
of odourless##3##2##(2006-12#1)(2008-5#2)
of odours##2##2##(1994-3#1)(2007-12#1)
of oedema##6##2##(2006-9#1)(2008-7#2)(2011-1#1)(2013-7#2)
of oesophageal adenocarcinoma##2##3##(1993-3#2)
of oesophageal reflux##2##3##(2005-1#1)(2006-8#1)
of oesophageal varices##4##3##(1995-9#1)(2009-8#2)(2013-1#1)
of oesophageal##18##2##(1992-5#1)(1993-2#1)(1993-3#2)(1995-9#1)(2005-1#1)(2006-6#2)(2006-8#1)(2008-1#1)(2008-11#3)(2008-7#1)(2008-9#1)(2009-8#2)(2013-1#1)
of oestrogen and##3##3##(1990-11#1)(1992-1#1)(2005-12#1)
of oestrogen receptor##2##3##(1992-1#1)(2004-2#1)
of oestrogen receptors##3##3##(2008-4#1)(2008-5#2)
of oestrogen##15##2##(1990-11#1)(1992-1#2)(2004-2#2)(2005-12#2)(2008-4#4)(2008-5#3)(2011-2#1)
of oestrogens in##3##3##(1990-6#1)(2005-12#1)(2008-4#1)
of oestrogens##6##2##(1990-6#1)(1994-2#1)(1994-6#1)(2005-12#2)(2008-4#1)
of oestrous##2##2##(1992-12#1)(2007-1#1)
of oestrus##2##2##(1994-7#1)(2005-7#1)
of of##8##2##(1992-1#1)(1996-6#1)(2007-10#1)(2007-7#1)(2008-5#1)(2011-2#1)(2013-1#2)
of off standard pods##2##4##(2008-12#2)
of off-axis##5##2##(2008-2#1)(2008-3#4)
of off-label##3##2##(2009-12#1)(2011-12#2)
of off-pump##2##2##(2007-8#2)
of offenders##6##2##(2008-11#1)(2008-6#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-3#1)
of offending behavior##2##3##(2008-12#2)
of offending drugs##2##3##(2007-11#1)(2007-8#1)
of offending##10##2##(1990-12#1)(2006-8#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-12#3)(2009-7#1)(2009-8#1)
of offering##5##2##(1990-12#1)(2008-2#1)(2009-10#1)(2010-8#1)(2011-12#1)
of office visits to##2##4##(2004-3#1)(2010-8#1)
of office visits##5##3##(1995-3#1)(2004-3#1)(2006-10#1)(2010-8#2)
of office-based##4##2##(2007-12#1)(2011-1#1)(2012-1#1)(2012-12#1)
of official##3##2##(2008-10#1)(2011-2#1)(2013-7#1)
of officials##2##2##(1990-4#1)(2012-1#1)
of offshore ecosystem health##3##4##(2013-8#3)
of offshore ecosystem##4##3##(2013-8#4)
of offshore##5##2##(1990-11#1)(2013-8#4)
of offspring at##2##3##(2008-9#2)
of offspring with##2##3##(1993-9#1)(2008-8#1)
of offspring##35##2##(1990-9#1)(1993-9#1)(1995-6#1)(1996-10#1)(1997-7#1)(2004-2#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#8)(2008-9#5)(2010-2#4)(2010-4#1)(2011-2#1)(2012-12#4)(2013-8#2)
of ofloxacin in##4##3##(2008-10#4)
of ofloxacin##12##2##(1990-2#1)(1995-6#2)(1996-2#1)(2008-10#7)(2009-4#1)
of often##2##2##(2007-7#1)(2010-8#1)
of oil and##3##3##(2006-3#1)(2008-10#1)(2013-1#1)
of oil flowers##2##3##(2006-12#2)
of oil for##2##3##(2008-10#1)(2009-3#1)
of oil inside##2##3##(2005-11#2)
of oil phase##2##3##(2008-5#2)
of oil##51##2##(1993-6#1)(1997-2#1)(2004-1#1)(2005-11#12)(2006-12#5)(2006-3#1)(2007-1#1)(2008-10#17)(2008-5#3)(2008-6#1)(2009-10#2)(2009-3#1)(2009-5#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
of oil-in-water##2##2##(1990-2#1)(2005-11#1)
of oil-soluble##2##2##(2005-11#2)
of oils and solidifying agents##2##5##(2008-5#2)
of oils and##4##3##(1992-4#1)(2007-7#1)(2008-5#2)
of oils##12##2##(1992-4#1)(1997-2#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#2)(2009-6#1)(2013-1#1)
of oilseed rape (Brassica##2##4##(2008-10#2)
of oilseed rape##6##3##(2008-10#6)
of oilseed##7##2##(2008-10#7)
of okadaic acid on##3##4##(1991-7#1)(1992-8#1)(1993-8#1)
of okadaic acid##9##3##(1991-7#1)(1992-8#2)(1993-7#2)(1993-8#1)(1994-2#1)(1995-5#1)(1996-5#1)
of olanzapine##3##2##(2004-3#1)(2006-12#1)(2010-2#1)
of old age##6##3##(1990-11#1)(1992-1#1)(1994-6#1)(2008-5#1)(2009-4#1)(2009-7#1)
of old and new##2##4##(1993-12#1)(1995-6#1)
of old and young##2##4##(2008-12#1)(2010-12#1)
of old and##5##3##(1993-12#1)(1995-6#1)(2008-12#1)(2010-12#1)(2011-2#1)
of old drugs##2##3##(2006-10#1)(2008-1#1)
of old mice##5##3##(1990-5#1)(1994-5#1)(1995-12#1)(1996-7#1)(2012-2#1)
of old people##5##3##(1990-11#1)(1990-8#1)(1992-1#1)(2007-11#1)(2008-7#1)
of old people's##2##3##(2010-6#2)
of old rats##3##3##(1994-6#1)(2010-7#2)
of old##53##2##(1990-11#2)(1990-4#1)(1990-5#1)(1990-8#1)(1991-12#1)(1992-1#2)(1992-12#1)(1992-3#1)(1993-12#1)(1994-5#1)(1994-6#2)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-5#1)(2005-7#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-6#2)(2010-7#4)(2011-2#1)(2012-11#2)(2012-2#1)(2013-1#1)
of older adults are##3##4##(1996-1#1)(2013-1#2)
of older adults in##2##4##(2008-5#1)(2012-12#1)
of older adults who##2##4##(2010-2#1)(2011-1#1)
of older adults##23##3##(1990-4#1)(1996-1#1)(2007-12#1)(2008-11#3)(2008-5#1)(2009-4#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#5)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
of older adults'##2##3##(2009-3#1)(2010-11#1)
of older children and##2##4##(1996-2#1)(2006-8#1)
of older children##3##3##(1996-2#1)(2006-8#1)(2008-3#1)
of older mothers##2##3##(1997-3#1)(2010-2#1)
of older patients with cancer##3##5##(2008-7#1)(2010-11#2)
of older patients with##6##4##(1992-9#1)(2008-7#1)(2010-10#1)(2010-11#2)(2013-1#1)
of older patients##14##3##(1990-12#1)(1992-9#1)(1995-10#2)(1996-3#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-11#2)(2010-6#1)(2011-12#1)(2013-1#2)
of older people during##2##4##(2013-8#2)
of older people in##2##4##(2010-10#1)(2011-2#1)
of older people##23##3##(1995-3#1)(2007-7#1)(2008-1#1)(2008-7#2)(2009-4#1)(2010-10#12)(2010-3#1)(2011-2#1)(2013-8#3)
of older persons in##3##4##(1997-2#1)(1997-3#1)(2010-10#1)
of older persons##6##3##(1990-12#1)(1997-2#1)(1997-3#1)(2008-3#1)(2010-10#2)
of older volunteers##2##3##(1996-3#1)(2008-3#1)
of older women##3##3##(1994-2#1)(2006-7#1)(2008-7#1)
of older##112##2##(1990-10#1)(1990-12#3)(1990-4#1)(1992-12#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-4#2)(1995-10#2)(1995-3#2)(1996-1#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-3#2)(2005-10#2)(2005-9#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#5)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#4)(2009-11#2)(2009-12#1)(2009-3#2)(2009-4#2)(2009-6#1)(2010-10#15)(2010-11#4)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#6)(2012-3#1)(2013-1#7)(2013-8#3)
of oleander##2##2##(2008-10#2)
of oleanolic acid##3##3##(2011-1#1)(2012-12#2)
of oleate in##2##3##(1992-8#2)
of oleate##7##2##(1990-8#1)(1992-8#3)(1993-9#1)(1994-8#2)
of oleate-type fatty compounds##2##4##(2009-3#2)
of olefin##2##2##(2007-10#1)(2007-9#1)
of olefins and##2##3##(2008-10#1)(2010-6#1)
of olefins##4##2##(2008-10#1)(2010-2#1)(2010-6#2)
of oleic acid (18##2##4##(2006-12#1)(2007-8#1)
of oleic acid and##2##4##(2005-11#1)(2010-7#1)
of oleic acid at##2##4##(2005-11#2)
of oleic acid on sillimanite##2##5##(2005-11#2)
of oleic acid on##4##4##(1992-2#1)(2005-11#3)
of oleic acid to##2##4##(1992-12#1)(1996-6#1)
of oleic acid##23##3##(1990-7#1)(1992-12#1)(1992-2#2)(1994-2#1)(1994-3#1)(1996-4#1)(1996-6#1)(2005-11#9)(2006-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-7#1)(2012-12#1)
of oleic and##2##3##(1994-8#1)(1996-4#1)
of oleic##29##2##(1990-2#2)(1990-7#1)(1991-5#1)(1992-12#1)(1992-2#2)(1994-2#1)(1994-3#1)(1994-8#1)(1996-4#2)(1996-6#1)(2005-11#9)(2006-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-7#1)(2012-12#1)(2013-1#1)
of olfactory ensheathing cells##2##4##(2008-7#2)
of olfactory epithelium##2##3##(1991-5#1)(1994-5#1)
of olfactory glomeruli in##2##4##(1992-5#1)(2007-12#1)
of olfactory interneurons in##2##4##(1990-5#2)
of olfactory learning##3##3##(1991-1#1)(1995-5#1)(2007-12#1)
of olfactory receptor neurons##2##4##(2007-12#2)
of olfactory sensilla##2##3##(2007-12#2)
of olfactory##35##2##(1990-5#2)(1991-1#1)(1991-2#4)(1991-5#1)(1992-5#1)(1992-8#2)(1993-6#2)(1994-5#1)(1995-12#2)(1995-5#1)(2006-12#2)(2006-5#1)(2007-12#9)(2008-4#1)(2008-7#2)(2012-2#3)
of oligo(dN)##3##2##(1991-12#3)
of oligodendrocyte progenitors##2##3##(2008-7#2)
of oligodendrocyte##5##2##(2008-7#4)(2010-12#1)
of oligodendrocytes##8##2##(1991-5#1)(1996-8#1)(2007-10#3)(2008-7#3)
of oligodendroglial##2##2##(2008-7#1)(2010-12#1)
of oligodendroglioma##4##2##(2005-10#1)(2011-1#3)
of oligodeoxynucleotides##3##2##(1990-11#1)(2008-10#1)(2008-4#1)
of oligodeoxyribonucleotide##3##2##(1990-11#1)(1991-9#1)(1993-3#1)
of oligodeoxyribonucleotides##7##2##(1991-9#2)(2008-4#5)
of oligodontia##2##2##(2008-5#1)(2011-1#1)
of oligomer##2##2##(1990-7#1)(1993-8#1)
of oligomeric##2##2##(2007-9#1)(2011-2#1)
of oligomers based##2##3##(1993-3#1)(2008-4#1)
of oligomers##7##2##(1990-11#1)(1991-5#1)(1993-3#2)(1995-11#1)(2006-10#1)(2008-4#1)
of oligomycin##4##2##(1995-1#2)(1997-4#2)
of oligonucleotide primers##2##3##(2008-4#1)(2008-5#1)
of oligonucleotide##15##2##(1993-11#1)(1995-5#1)(1995-7#1)(1996-11#1)(2008-10#3)(2008-4#6)(2008-5#2)
of oligonucleotide-carbohydrate conjugates are##2##4##(2006-12#2)
of oligonucleotide-carbohydrate conjugates##4##3##(2006-12#4)
of oligonucleotides and##4##3##(2008-4#2)(2010-1#1)(2011-1#1)
of oligonucleotides in##2##3##(1992-2#1)(1996-5#1)
of oligonucleotides##27##2##(1991-12#1)(1991-3#1)(1992-2#1)(1994-11#1)(1994-6#3)(1996-5#1)(1997-2#1)(1997-5#1)(2006-12#2)(2006-5#1)(2008-10#3)(2008-4#9)(2010-1#1)(2011-1#1)
of oligopeptides##3##2##(1990-12#1)(2007-8#2)
of oligopyrrole##2##2##(2008-10#2)
of oligoribonucleotides containing##3##3##(1991-11#1)(2008-4#2)
of oligosaccharide##15##2##(1990-7#2)(1992-9#1)(1993-11#1)(1993-3#1)(1994-11#3)(1994-8#2)(1994-9#1)(1995-5#1)(1997-4#2)(2008-12#1)
of oligosaccharides in##3##3##(1993-11#1)(1996-4#2)
of oligosaccharides obtained by##2##4##(1990-9#2)
of oligosaccharides on##2##3##(1990-10#1)(2008-4#1)
of oligosaccharides with##2##3##(1994-9#1)(1996-2#1)
of oligosaccharides##27##2##(1990-10#2)(1990-4#1)(1990-9#2)(1993-11#2)(1993-8#1)(1994-8#2)(1994-9#1)(1995-5#1)(1995-6#1)(1996-2#2)(1996-4#3)(1997-4#4)(2008-10#2)(2008-4#2)(2012-2#1)
of olive oil and##2##4##(2010-4#2)
of olive oil##7##3##(2008-10#1)(2010-12#1)(2010-4#3)(2012-2#2)
of olive##12##2##(2006-12#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-8#1)(2010-12#1)(2010-4#3)(2012-2#2)
of olmesartan medoxomil##2##3##(2008-11#2)
of omega##4##2##(1990-7#1)(1991-4#1)(1992-8#1)(2008-4#1)
of omega-3 fatty acids##3##4##(1990-2#1)(1990-5#1)(2007-11#1)
of omega-3 polyunsaturated fatty acids in the##2##7##(2006-7#1)(2007-8#1)
of omega-3 polyunsaturated fatty acids in##4##6##(2006-7#3)(2007-8#1)
of omega-3 polyunsaturated fatty acids##9##5##(2006-7#5)(2007-8#2)(2008-5#1)(2011-2#1)
of omega-3 supplementation in dialysis patients##2##6##(2007-8#2)
of omega-3##21##2##(1990-2#1)(1990-5#1)(2006-7#5)(2007-11#1)(2007-8#5)(2008-5#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-7#4)
of omega-3s##2##2##(2008-3#2)
of omega-6 fatty acids##2##4##(1990-5#1)(2012-1#1)
of omega-6##3##2##(1990-5#1)(2010-4#1)(2012-1#1)
of omega-conotoxin GVIA##3##3##(1993-7#1)(1994-9#2)
of omega-conotoxin##7##2##(1990-7#2)(1993-7#1)(1994-3#2)(1994-9#2)
of omental cakes is##2##4##(2012-2#2)
of omental cakes##3##3##(2012-2#3)
of omental##5##2##(2006-6#1)(2010-4#1)(2012-2#3)
of omentum##5##2##(2005-12#1)(2007-2#1)(2007-8#3)
of omeprasole and lansoprasole##3##4##(2008-8#3)
of omeprazole on##2##3##(1993-11#2)
of omeprazole##10##2##(1993-11#3)(1997-1#1)(2006-10#1)(2006-2#1)(2008-12#1)(2008-5#1)(2010-12#1)(2012-2#1)
of omethoate##2##2##(2008-10#2)
of omiganan##3##2##(2008-1#3)
of omitted##2##2##(1992-6#1)(2013-7#1)
of ommatidia##5##2##(2007-12#5)
of omnidirectional##2##2##(2008-3#2)
of omnivory##4##2##(2008-8#1)(2008-9#3)
of omphalocele with##2##3##(1997-3#1)(2010-8#1)
of on average##3##3##(2008-2#2)(2008-5#1)
of on pixels##2##3##(2008-3#2)
of on the##2##3##(2004-8#1)(2007-12#1)
of on##11##2##(1990-11#1)(2004-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-5#1)
of on-going##4##2##(1991-12#1)(2008-5#1)(2011-2#1)(2013-1#1)
of on-line instrumentation##2##3##(2008-10#2)
of on-line sample##3##3##(2008-10#3)
of on-line##18##2##(2006-5#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-7#1)(2010-4#1)
of on-orbit##3##2##(2008-3#3)
of on-site##2##2##(2008-10#1)(2008-4#1)
of once daily##2##3##(2008-5#1)(2010-5#1)
of once##5##2##(1997-3#1)(2007-11#1)(2008-2#1)(2008-5#1)(2010-5#1)
of once-daily##4##2##(1992-4#1)(1996-9#1)(2008-3#1)(2010-8#1)
of onchocerciasis##5##2##(1990-6#2)(1991-12#2)(2010-8#1)
of onco-antigens in serum##2##4##(2013-1#2)
of oncofetal##2##2##(1994-9#1)(1996-12#1)
of oncogene and##2##3##(1990-7#1)(2007-11#1)
of oncogene##5##2##(1990-11#1)(1990-7#1)(1996-12#1)(2007-11#1)(2008-11#1)
of oncogenes and##2##3##(1995-2#1)(1995-6#1)
of oncogenes in##5##3##(1996-7#1)(2008-11#3)(2008-3#1)
of oncogenes or##3##3##(2007-3#1)(2008-1#1)(2011-2#1)
of oncogenes##17##2##(1990-8#1)(1994-4#1)(1995-2#2)(1995-6#1)(1996-7#1)(2007-3#1)(2008-1#1)(2008-11#6)(2008-3#1)(2009-4#1)(2011-2#1)
of oncogenesis##2##2##(1992-2#1)(1994-10#1)
of oncogenic##8##2##(1994-8#1)(1995-2#1)(1996-1#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-1#1)(2013-1#1)
of oncogenicity##2##2##(1995-12#1)(2013-8#1)
of oncologic##3##2##(1991-2#1)(2009-2#1)(2011-1#1)
of oncological patients##3##3##(2006-6#3)
of oncological treatment##2##3##(2005-1#1)(2012-12#1)
of oncological##11##2##(1997-3#1)(2005-1#1)(2006-6#3)(2007-11#1)(2008-5#1)(2010-12#2)(2012-12#1)(2013-1#1)
of oncology and##3##3##(1991-3#1)(2010-7#1)(2012-3#1)
of oncology in##2##3##(2008-6#1)(2008-9#1)
of oncology patients##3##3##(1995-6#1)(1996-6#1)(2007-7#1)
of oncology##14##2##(1991-3#1)(1991-8#1)(1995-6#1)(1995-9#1)(1996-6#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-6#1)(2008-9#1)(2010-5#1)(2010-7#1)(2012-1#1)(2012-3#1)
of oncolytic viruses##2##3##(2013-1#1)(2013-8#1)
of oncolytic##6##2##(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
of oncomodulin##5##2##(1990-6#4)(1991-7#1)
of oncoproteins##2##2##(2007-11#1)(2011-2#1)
of ondansetron##7##2##(1994-4#1)(1995-9#1)(1996-2#2)(1996-8#1)(2008-7#1)(2011-12#1)
of one amino acid##3##4##(1996-6#1)(1997-4#1)(1997-7#1)
of one and a half##2##5##(1996-6#1)(2008-12#1)
of one and##5##3##(1996-6#1)(2008-10#1)(2008-12#1)(2008-6#1)(2010-11#1)
of one another##9##3##(1990-8#1)(1996-4#1)(2007-12#1)(2008-10#4)(2008-7#1)(2009-2#1)
of one aperture##2##3##(2007-11#1)(2008-3#1)
of one case]##13##3##(2007-4#1)(2012-3#1)(2013-1#5)(2013-8#6)
of one cell##2##3##(1997-3#1)(1997-8#1)
of one child##2##3##(2007-3#1)(2008-9#1)
of one class of##2##4##(1993-12#1)(2008-10#1)
of one copy of##3##4##(1997-2#1)(2008-7#1)(2012-3#1)
of one copy##4##3##(1997-2#1)(2007-11#1)(2008-7#1)(2012-3#1)
of one electron##3##3##(2008-10#2)(2008-4#1)
of one element##2##3##(2007-12#1)(2008-10#1)
of one eye##2##3##(1994-3#1)(1997-3#1)
of one form of##3##4##(2008-10#2)(2009-5#1)
of one form##4##3##(2008-10#2)(2008-4#1)(2009-5#1)
of one gene##4##3##(1990-11#1)(1992-6#1)(1994-8#1)(2008-10#1)
of one group##3##3##(1991-11#1)(2008-10#2)
of one half of the##2##5##(1992-9#1)(2008-2#1)
of one half##3##3##(1992-9#1)(1993-11#1)(2008-2#1)
of one hospital##2##3##(1990-9#1)(2007-8#1)
of one hundred and##5##4##(1995-10#1)(2007-10#1)(2007-3#1)(2007-6#1)(2012-2#1)
of one hundred patients##2##4##(2007-7#2)
of one hundred##8##3##(1995-10#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#2)(2012-2#1)
of one intron##2##3##(1995-2#1)(2008-10#1)
of one kidney##2##3##(2008-10#1)(2011-1#1)
of one laser##2##3##(2007-11#1)(2007-12#1)
of one layer of##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
of one layer##5##3##(2008-10#1)(2008-2#2)(2008-3#2)
of one left-sided##2##3##(2011-2#2)
of one leg##2##3##(1992-5#1)(2012-1#1)
of one lung##2##3##(2008-10#1)(2011-2#1)
of one main##3##3##(2007-12#1)(2008-7#2)
of one major##3##3##(1990-7#1)(1992-12#1)(2012-12#1)
of one million##3##3##(1994-3#1)(2008-10#1)(2008-7#1)
of one molecule##3##3##(1995-3#2)(2008-1#1)
of one month and##2##4##(1992-11#1)(2008-10#1)
of one month##11##3##(1990-2#1)(1992-11#1)(1993-6#1)(2006-8#1)(2007-1#1)(2008-10#2)(2008-9#1)(2010-1#1)(2011-1#1)(2013-1#1)
of one novel##3##3##(1990-7#1)(1994-12#1)(2008-12#1)
of one nucleotide##2##3##(1990-3#1)(1996-6#1)
of one of its##2##4##(1992-8#1)(2008-10#1)
of one of our most##2##5##(2008-11#1)(2008-5#1)
of one of the five##2##5##(1997-7#1)(2008-3#1)
of one of the four##2##5##(1990-6#1)(1994-8#1)
of one of the most##4##5##(1990-3#1)(1991-9#1)(1997-8#1)(2009-7#1)
of one of the two##7##5##(1992-3#1)(1992-9#1)(1997-2#1)(2007-12#1)(2008-2#1)(2008-3#1)(2012-12#1)
of one of the##85##4##(1990-11#1)(1990-3#1)(1990-4#1)(1990-6#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-12#1)(1992-3#1)(1992-9#1)(1993-5#1)(1993-6#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-10#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-3#1)(1996-5#2)(1997-2#2)(1997-7#2)(1997-8#1)(2005-11#1)(2006-12#2)(2007-11#1)(2007-12#7)(2007-8#1)(2008-10#8)(2008-11#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#2)(2009-1#1)(2009-4#2)(2009-7#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-3#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
of one of them##4##4##(1990-12#2)(2008-10#1)(2008-2#1)
of one of these genes##2##5##(1992-5#1)(1992-9#1)
of one of these##15##4##(1990-3#1)(1991-12#1)(1992-10#1)(1992-5#1)(1992-9#1)(1995-10#1)(2006-12#1)(2007-3#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#1)
of one of##116##3##(1990-11#1)(1990-12#3)(1990-3#2)(1990-4#1)(1990-6#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-5#1)(1993-6#1)(1994-12#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-10#2)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-3#1)(1996-5#2)(1997-2#2)(1997-7#2)(1997-8#1)(2005-11#1)(2006-12#3)(2007-11#1)(2007-12#7)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#8)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-4#2)(2009-7#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-3#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
of one or a few##3##5##(2007-12#1)(2008-10#1)(2008-7#1)
of one or both##4##4##(2005-11#1)(2009-9#1)(2012-12#1)(2013-1#1)
of one or more of the##5##6##(1992-6#1)(1996-2#1)(1997-4#2)(2008-11#1)
of one or more of##6##5##(1992-6#1)(1996-2#1)(1997-4#2)(2008-11#1)(2012-1#1)
of one or more##35##4##(1991-1#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-3#1)(1994-6#1)(1994-9#2)(1995-3#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-4#2)(2007-10#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-2#1)(2012-1#1)
of one or other##2##4##(1991-8#1)(2006-2#1)
of one or several##3##4##(1991-9#1)(2008-3#1)(2009-5#1)
of one or the other##2##5##(2008-7#1)(2009-12#1)
of one or two##10##4##(1990-4#1)(1992-10#1)(2004-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2013-1#2)
of one or##62##3##(1990-4#1)(1991-1#1)(1991-8#1)(1991-9#3)(1992-10#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-3#1)(1994-6#1)(1994-9#2)(1995-3#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-4#2)(2004-2#1)(2005-11#1)(2006-2#1)(2007-10#1)(2007-12#2)(2008-1#3)(2008-10#5)(2008-11#3)(2008-3#4)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#2)(2009-9#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#3)
of one pH unit##2##4##(1997-5#1)(2005-11#1)
of one pair of##2##4##(2008-12#1)(2010-7#1)
of one particular##2##3##(1996-12#1)(2010-11#1)
of one patient##4##3##(1994-6#1)(1995-9#1)(2009-4#1)(2010-12#1)
of one polarization##2##3##(2008-2#1)(2008-3#1)
of one polypeptide##2##3##(1992-8#1)(1993-2#1)
of one protein##4##3##(1990-5#1)(2006-10#1)(2008-4#2)
of one proton##3##3##(1996-2#1)(2006-10#1)(2008-10#1)
of one sample##2##3##(2008-10#1)(2008-3#1)
of one side##3##3##(1993-3#1)(2007-12#1)(2008-2#1)
of one single##2##3##(2007-8#1)(2008-10#1)
of one species##5##3##(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2013-1#1)
of one specific##5##3##(2007-12#1)(2007-4#1)(2008-5#1)(2008-7#1)(2013-8#1)
of one strand##2##3##(2008-2#1)(2008-4#1)
of one subunit##4##3##(1991-6#1)(1993-11#1)(1994-9#1)(1996-11#1)
of one such##13##3##(1990-6#1)(1991-1#1)(1991-7#1)(2006-6#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-7#1)(2012-12#1)
of one to three##2##4##(1991-4#1)(2007-7#1)
of one to##6##3##(1991-4#1)(1996-2#1)(1997-4#1)(2007-7#2)(2010-5#1)
of one transverse##2##3##(2007-11#1)(2007-12#1)
of one type of##4##4##(1993-12#1)(2007-12#1)(2008-10#1)(2013-8#1)
of one type##5##3##(1993-12#1)(2007-12#1)(2008-10#2)(2013-8#1)
of one variant##2##3##(2008-10#1)(2013-8#1)
of one wavelength##2##3##(2008-3#2)
of one week##3##3##(1991-6#1)(1994-2#1)(2004-9#1)
of one with##2##3##(1996-12#1)(2008-3#1)
of one year and##2##4##(1990-12#1)(2013-8#1)
of one year from##3##4##(1993-5#1)(2007-3#1)(2013-8#1)
of one year were##2##4##(1990-11#1)(1994-8#1)
of one year##33##3##(1990-11#1)(1990-12#1)(1991-12#1)(1991-4#1)(1993-5#1)(1994-6#1)(1994-8#1)(1996-1#1)(1996-6#1)(1996-8#1)(1997-6#1)(2007-11#1)(2007-3#4)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
of one##630##2##(1990-11#5)(1990-12#6)(1990-2#3)(1990-3#4)(1990-4#5)(1990-5#3)(1990-6#2)(1990-7#2)(1990-8#2)(1990-9#2)(1991-1#3)(1991-11#2)(1991-12#6)(1991-2#1)(1991-4#4)(1991-5#3)(1991-6#2)(1991-7#4)(1991-8#4)(1991-9#7)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#4)(1992-3#2)(1992-5#3)(1992-6#3)(1992-7#2)(1992-8#5)(1992-9#4)(1993-10#1)(1993-11#3)(1993-12#4)(1993-2#2)(1993-3#5)(1993-5#2)(1993-6#4)(1993-9#2)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#5)(1994-8#4)(1994-9#4)(1995-1#2)(1995-10#3)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#7)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#1)(1996-4#3)(1996-5#5)(1996-6#5)(1996-7#2)(1996-8#1)(1996-9#4)(1997-1#2)(1997-2#5)(1997-3#4)(1997-4#7)(1997-5#1)(1997-6#1)(1997-7#5)(1997-8#2)(2004-11#1)(2004-12#1)(2004-2#1)(2004-9#1)(2005-11#7)(2005-8#1)(2006-10#2)(2006-11#2)(2006-12#4)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#5)(2007-1#1)(2007-10#4)(2007-11#7)(2007-12#23)(2007-2#4)(2007-3#7)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#7)(2007-8#7)(2007-9#2)(2008-1#7)(2008-10#69)(2008-11#11)(2008-12#8)(2008-2#20)(2008-3#27)(2008-4#14)(2008-5#15)(2008-6#4)(2008-7#16)(2008-8#7)(2008-9#7)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#4)(2009-4#3)(2009-5#3)(2009-7#2)(2009-9#2)(2010-1#1)(2010-11#2)(2010-12#4)(2010-2#3)(2010-3#1)(2010-5#3)(2010-7#3)(2011-1#3)(2011-12#1)(2011-2#9)(2011-3#1)(2012-1#2)(2012-11#2)(2012-12#7)(2012-2#2)(2012-3#6)(2013-1#15)(2013-7#1)(2013-8#16)
of one's own##5##3##(2007-8#1)(2009-4#2)(2010-10#1)(2013-1#1)
of one's##23##2##(1994-2#2)(1994-6#1)(1996-5#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-4#3)(2009-5#1)(2010-10#1)(2010-2#1)(2010-6#1)(2010-8#1)(2012-2#1)(2013-1#1)
of one- and##3##3##(1996-8#1)(2006-12#1)(2007-11#1)
of one-day##3##2##(2007-2#2)(2008-5#1)
of one-dimensional and two-dimensional optical beams##2##6##(2008-1#2)
of one-dimensional##13##2##(1995-7#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-2#4)(2008-3#3)
of one-electron##2##2##(1995-6#1)(2006-3#1)
of one-photon##2##2##(2008-3#2)
of one-step##3##2##(2006-10#1)(2013-1#1)(2013-8#1)
of one-time##2##2##(2008-11#1)(2013-1#1)
of one-year##2##2##(1993-7#1)(1995-9#1)
of one-year-old children##2##3##(1993-1#2)
of one-year-old infants##3##3##(2009-2#3)
of one-year-old##6##2##(1993-1#2)(2009-2#3)(2009-8#1)
of onfFN##2##2##(1994-9#2)
of ongoing clinical trials##4##4##(2005-10#1)(2008-11#1)(2008-3#1)(2010-6#1)
of ongoing clinical##5##3##(2005-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-6#1)
of ongoing research##2##3##(1992-1#1)(2010-5#1)
of ongoing trials##3##3##(2005-10#1)(2008-3#1)(2013-8#1)
of ongoing##37##2##(1992-1#1)(1993-11#1)(1994-8#1)(1996-4#1)(1997-1#1)(1997-5#1)(1997-8#1)(2005-10#2)(2006-10#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#3)(2008-8#4)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2012-12#1)(2013-1#1)(2013-8#2)
of onion cells##2##3##(2007-11#1)(2007-12#1)
of onion yellows phytoplasma##3##4##(2008-10#3)
of onion##18##2##(1992-8#1)(2005-7#1)(2007-11#1)(2007-12#1)(2008-10#14)
of onium salt##4##3##(2008-10#4)
of online health##3##3##(2010-10#2)(2010-4#1)
of online information##2##3##(2006-2#1)(2011-2#1)
of online learning##2##3##(2006-1#1)(2008-12#1)
of online resources##2##3##(1994-12#1)(2008-11#1)
of online##19##2##(1991-2#1)(1994-12#1)(2006-1#1)(2006-2#2)(2008-10#2)(2008-11#2)(2008-12#1)(2010-10#3)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#1)
of only 0##12##3##(1997-1#1)(2007-10#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)(2012-12#2)
of only 1##3##3##(1994-2#1)(2008-10#2)
of only 10##2##3##(2007-12#1)(2013-8#1)
of only 2##2##3##(2008-10#1)(2010-3#1)
of only 200##2##3##(2007-12#1)(2008-1#1)
of only 24##2##3##(1994-12#1)(2011-1#1)
of only 3##4##3##(2008-10#2)(2008-8#1)(2011-1#1)
of only 4##2##3##(2008-2#2)
of only 6##2##3##(2007-12#1)(2008-9#1)
of only 7##2##3##(2007-12#1)(2008-2#1)
of only a few##7##4##(1990-12#1)(1997-8#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-7#1)
of only a single##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
of only a small##2##4##(1996-6#1)(2008-10#1)
of only a subset of##2##5##(1991-7#1)(1992-9#1)
of only a##18##3##(1990-12#1)(1991-3#1)(1991-7#1)(1992-9#1)(1996-6#1)(1997-8#1)(2007-12#4)(2008-10#2)(2008-2#3)(2008-3#2)(2008-7#1)
of only four##3##3##(1994-9#1)(1995-12#1)(2006-12#1)
of only limited##2##3##(2007-2#1)(2012-3#1)
of only minor##2##3##(1992-3#1)(2008-2#1)
of only one of##2##4##(2008-10#1)(2013-8#1)
of only one type of##2##5##(1991-9#1)(2007-12#1)
of only one##18##3##(1990-4#1)(1991-8#1)(1991-9#1)(1992-12#1)(2007-12#4)(2008-10#3)(2008-2#3)(2008-9#1)(2009-9#1)(2012-2#1)(2013-8#1)
of only six##2##3##(1990-5#1)(1995-3#1)
of only the first##3##4##(1996-6#1)(2008-5#1)(2011-2#1)
of only the##16##3##(1990-7#1)(1991-5#1)(1992-9#1)(1994-11#1)(1995-3#1)(1996-11#1)(1996-5#1)(1996-6#1)(2007-8#1)(2008-3#3)(2008-4#1)(2008-5#1)(2010-11#1)(2011-2#1)
of only those##2##3##(1990-2#1)(1992-3#1)
of only two##7##3##(1997-2#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-6#1)(2011-12#1)
of only water##2##3##(2008-10#1)(2010-6#1)
of only##179##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#2)(1990-4#2)(1990-5#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-9#2)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-3#3)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#2)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2007-10#2)(2007-12#22)(2007-2#1)(2007-3#3)(2007-7#1)(2007-8#5)(2008-1#2)(2008-10#20)(2008-2#15)(2008-3#9)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#3)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
of onset and##11##3##(1991-8#1)(1996-7#2)(1996-8#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-12#1)
of onset in##4##3##(1995-11#2)(2006-2#1)(2007-9#1)
of onset of symptoms##3##4##(1996-1#1)(2012-12#2)
of onset of the disease##2##5##(2007-11#1)(2008-1#1)
of onset of the##4##4##(1990-5#1)(1995-1#1)(2007-11#1)(2008-1#1)
of onset of##26##3##(1990-5#1)(1991-11#1)(1992-12#1)(1994-2#1)(1995-1#1)(1996-1#2)(1997-3#1)(2006-8#1)(2007-10#3)(2007-11#2)(2007-6#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-5#2)(2010-10#1)(2010-12#1)(2011-2#2)(2012-12#2)
of onset was##8##3##(1996-1#1)(1996-3#1)(1996-7#1)(2007-3#2)(2007-8#2)(2008-8#1)
of onset were##4##3##(1994-12#1)(1997-5#1)(2007-10#1)(2012-12#1)
of onset##91##2##(1990-12#1)(1990-5#1)(1991-11#1)(1991-8#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-11#3)(1995-8#1)(1996-1#3)(1996-10#1)(1996-2#1)(1996-3#1)(1996-7#3)(1996-8#1)(1997-3#1)(1997-5#2)(2006-10#3)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#5)(2007-11#3)(2007-3#2)(2007-6#2)(2007-7#2)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-7#2)(2010-10#1)(2010-12#3)(2010-2#2)(2011-2#4)(2012-11#1)(2012-12#5)(2012-2#1)(2013-7#3)
of onset)##2##2##(2008-8#2)
of ontogenic resistance to##2##4##(2008-10#2)
of ontogenic resistance##5##3##(2008-10#5)
of ontogenic##6##2##(2008-10#5)(2008-11#1)
of ontologies##5##2##(2008-7#3)(2013-1#2)
of ontology##6##2##(2008-7#2)(2013-1#4)
of onychomycoses##3##2##(1993-4#1)(1996-1#1)(2008-5#1)
of onychomycosis##9##2##(2007-7#4)(2008-3#2)(2008-5#1)(2011-2#2)
of onychophoran##3##2##(2007-12#3)
of oocyst##2##2##(2004-11#1)(2008-5#1)
of oocysts in##4##3##(1996-12#1)(2005-12#1)(2008-5#2)
of oocysts##12##2##(1996-12#3)(2004-11#1)(2005-12#3)(2007-12#1)(2007-2#1)(2008-5#3)
of oocyte tPA##2##3##(2008-8#2)
of oocyte##12##2##(1991-9#1)(1992-11#1)(1996-9#1)(1997-4#1)(2007-12#2)(2008-12#1)(2008-5#2)(2008-8#2)(2009-6#1)
of oocytes and##2##3##(2007-12#1)(2008-12#1)
of oocytes in##2##3##(2006-5#1)(2008-7#1)
of oocytes was##2##3##(2006-5#1)(2012-3#1)
of oocytes##26##2##(1991-10#2)(1995-12#1)(1996-10#1)(2006-5#8)(2007-12#1)(2008-12#3)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#2)(2012-3#1)(2013-1#4)
of oogenesis##7##2##(1994-3#1)(1996-7#1)(2007-12#3)(2008-9#1)(2009-10#1)
of oogonia##2##2##(2008-10#2)
of oospores in the##2##4##(2008-10#2)
of oospores in##5##3##(2008-10#5)
of oospores of##2##3##(2008-10#2)
of oospores##22##2##(2008-10#22)
of opaque microstructures in optically diffuse media##2##7##(2008-3#2)
of opaque##5##2##(2008-10#1)(2008-2#1)(2008-3#3)
of open access##2##3##(2006-10#1)(2007-4#1)
of open and##5##3##(2008-8#1)(2011-2#1)(2012-12#2)(2012-2#1)
of open fracture wounds##2##4##(2008-11#1)(2009-9#1)
of open fractures of the##2##5##(2009-9#1)(2013-8#1)
of open fractures##10##3##(2007-11#1)(2007-8#1)(2009-9#4)(2010-11#1)(2013-8#3)
of open heart surgery##2##4##(1993-10#1)(2012-2#1)
of open pollination##2##3##(2008-10#1)(2011-2#1)
of open reading frame##2##4##(2008-10#1)(2008-8#1)
of open reading frames##2##4##(1992-3#1)(1996-6#1)
of open reading##4##3##(1992-3#1)(1996-6#1)(2008-10#1)(2008-8#1)
of open reduction##2##3##(2008-4#1)(2009-3#1)
of open surgery##2##3##(2007-7#1)(2011-2#1)
of open tibial fractures##2##4##(2007-8#1)(2009-9#1)
of open tibial shaft fractures##2##5##(2009-9#2)
of open tibial##4##3##(2007-8#1)(2009-9#3)
of open tubular##2##3##(2008-10#2)
of open##71##2##(1991-2#1)(1991-6#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-10#1)(1993-8#1)(1995-12#1)(1995-9#1)(1996-6#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#2)(2009-8#1)(2009-9#9)(2010-11#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#4)
of open-heart surgery in##2##4##(1995-3#1)(2012-2#1)
of open-heart surgery##5##3##(1995-3#1)(1996-12#1)(2010-7#1)(2012-2#2)
of open-label##3##2##(2004-3#1)(2008-6#1)(2010-4#1)
of open-source software##2##3##(2007-4#2)
of opening##7##2##(1994-3#1)(1996-12#2)(2005-10#1)(2008-10#1)(2008-12#1)(2008-5#1)
of openings##5##2##(1990-2#1)(1992-9#2)(1994-2#1)(1997-1#1)
of openness##4##2##(2008-12#1)(2008-7#1)(2010-12#1)(2013-8#1)
of operable breast cancer##2##4##(1992-10#1)(1993-11#1)
of operable##4##2##(1992-10#1)(1993-11#1)(1996-1#1)(2007-8#1)
of operant##4##2##(1990-7#1)(2008-4#1)(2010-2#1)(2012-1#1)
of operated##3##2##(1990-10#1)(2007-11#1)(2009-5#1)
of operating a##2##3##(1991-12#1)(2008-9#1)
of operating conditions##5##3##(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-4#1)
of operating in a##2##4##(2007-11#1)(2008-10#1)
of operating in##5##3##(2007-11#2)(2007-4#1)(2008-10#1)(2008-2#1)
of operating parameters##3##3##(2008-10#2)(2012-3#1)
of operating room##3##3##(2006-10#1)(2006-6#1)(2011-2#1)
of operating##32##2##(1991-12#1)(1993-9#1)(1996-12#1)(1997-8#1)(2006-10#1)(2006-6#2)(2007-11#2)(2007-4#1)(2008-10#4)(2008-2#6)(2008-3#3)(2008-6#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
of operation and##12##3##(1990-2#1)(1991-4#1)(1992-9#1)(1993-2#1)(1995-9#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2011-1#1)
of operation at##3##3##(1992-11#1)(2008-3#1)(2010-1#1)
of operation has been##2##4##(2007-8#1)(2008-3#1)
of operation in##5##3##(1994-9#1)(2008-11#1)(2008-2#2)(2008-3#1)
of operation is##5##3##(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2011-2#1)
of operation of the##4##4##(1990-3#1)(2008-2#1)(2008-3#1)(2011-2#1)
of operation of##10##3##(1990-3#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-1#1)(2011-2#1)
of operation was##3##3##(1993-8#1)(2008-10#1)(2008-2#1)
of operation##84##2##(1990-2#1)(1990-3#3)(1991-11#1)(1991-4#1)(1992-10#1)(1992-11#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-8#1)(1994-2#2)(1994-9#1)(1995-9#1)(1997-2#1)(2004-1#1)(2004-12#1)(2004-9#1)(2005-11#1)(2005-4#1)(2006-5#3)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-5#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-2#8)(2008-3#9)(2008-7#1)(2010-1#2)(2011-1#1)(2011-2#3)(2013-1#1)
of operational research##2##3##(2007-12#1)(2008-2#1)
of operational##7##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-8#2)(2012-2#2)
of operationally##2##2##(1991-2#1)(2008-3#1)
of operations are##2##3##(1990-3#1)(2008-2#1)
of operations for##2##3##(2006-7#1)(2007-11#1)
of operations in##2##3##(2007-8#1)(2010-8#1)
of operations##19##2##(1990-12#1)(1990-3#1)(1990-5#1)(1992-9#1)(1996-1#1)(2006-7#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-2#2)(2008-9#2)(2010-1#1)(2010-8#2)(2012-11#1)
of operative anesthesia##2##3##(2010-2#2)
of operative approach##2##3##(2006-10#1)(2008-1#1)
of operative mortality##2##3##(2008-11#1)(2012-12#1)
of operative time##3##3##(2006-7#1)(2012-2#1)(2013-1#1)
of operative treatment of bone metastases to the knee##2##9##(2007-11#2)
of operative treatment of##3##4##(2007-11#3)
of operative treatment##13##3##(2007-11#9)(2007-7#2)(2008-3#2)
of operative##37##2##(1990-6#1)(1993-3#1)(2006-10#2)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#11)(2007-7#4)(2008-1#1)(2008-11#1)(2008-3#2)(2009-2#1)(2009-3#1)(2010-12#1)(2010-2#2)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)
of operator##2##2##(1992-4#1)(1996-11#1)
of ophthalmic segment##2##3##(2012-3#2)
of ophthalmic##8##2##(1993-8#1)(2008-10#1)(2011-1#1)(2012-3#3)(2013-1#1)(2013-8#1)
of ophthalmology##5##2##(1995-9#1)(2011-7#2)(2013-8#2)
of opiate dependence##3##3##(2007-11#2)(2011-1#1)
of opiate withdrawal##2##3##(1991-1#1)(1997-5#1)
of opiate##13##2##(1991-1#3)(1991-5#2)(1995-12#1)(1997-5#1)(2007-11#3)(2007-2#1)(2010-2#1)(2011-1#1)
of opiates and##2##3##(1991-1#1)(2006-12#1)
of opiates in the##2##4##(2008-3#1)(2012-3#1)
of opiates in##3##3##(1991-1#1)(2008-3#1)(2012-3#1)
of opiates on##2##3##(1995-7#2)
of opiates##12##2##(1991-1#3)(1995-7#2)(1996-5#1)(2006-12#1)(2007-11#2)(2008-3#1)(2012-3#2)
of opinion regarding the##2##4##(2007-8#1)(2008-11#1)
of opinion##9##2##(1990-9#1)(1991-12#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-5#1)(2012-11#2)(2013-8#1)
of opinions##5##2##(1990-12#1)(2005-10#1)(2006-8#1)(2012-12#1)(2012-2#1)
of opioid analgesia##2##3##(1990-7#1)(1995-5#1)
of opioid binding##5##3##(1991-5#1)(1993-7#1)(1995-7#3)
of opioid dependence##3##3##(2008-6#2)(2009-4#1)
of opioid peptides and##2##4##(1997-2#1)(2006-10#1)
of opioid peptides in##3##4##(1991-1#1)(1993-2#1)(1994-2#1)
of opioid peptides##9##3##(1991-1#1)(1993-2#1)(1994-2#1)(1995-6#1)(1996-2#1)(1997-2#1)(2006-10#1)(2009-12#1)(2009-7#1)
of opioid receptor agonists##2##4##(1995-12#1)(2009-7#1)
of opioid receptor##10##3##(1990-2#1)(1991-1#1)(1993-12#1)(1995-12#1)(1997-2#1)(1997-8#1)(2007-11#1)(2008-11#1)(2009-7#1)(2010-12#1)
of opioid receptors and##2##4##(2008-11#1)(2009-7#1)
of opioid receptors in the##4##5##(1996-12#1)(1997-7#1)(2008-11#2)
of opioid receptors in##7##4##(1993-6#1)(1996-12#1)(1997-7#1)(2008-11#3)(2009-7#1)
of opioid receptors##18##3##(1990-10#1)(1990-7#1)(1993-12#1)(1993-6#2)(1995-11#1)(1996-12#1)(1997-7#1)(2008-11#4)(2008-3#1)(2008-7#1)(2009-7#2)(2010-12#2)
of opioid tolerance and dependence##2##5##(1991-1#1)(2007-10#1)
of opioid tolerance and##3##4##(1991-1#1)(2007-10#1)(2007-11#1)
of opioid##81##2##(1990-10#1)(1990-2#1)(1990-7#2)(1991-1#6)(1991-5#2)(1993-12#2)(1993-2#1)(1993-6#2)(1993-7#1)(1994-10#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#6)(1996-12#2)(1996-2#2)(1997-2#3)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#6)(2006-12#2)(2007-10#1)(2007-11#4)(2007-2#2)(2008-11#6)(2008-3#1)(2008-6#2)(2008-7#1)(2009-12#1)(2009-4#1)(2009-7#4)(2010-12#3)(2012-1#2)(2012-11#2)(2013-1#1)
of opioids and other##2##4##(2010-2#1)(2011-2#1)
of opioids and##5##3##(1997-5#1)(2006-10#1)(2010-2#1)(2010-9#1)(2011-2#1)
of opioids at##2##3##(1990-2#1)(2008-7#1)
of opioids in##7##3##(1991-1#1)(2006-10#1)(2007-2#1)(2011-2#4)
of opioids like##2##3##(2008-7#1)(2009-7#1)
of opioids##34##2##(1990-2#1)(1991-1#2)(1995-12#1)(1995-5#1)(1995-6#1)(1997-5#1)(1997-6#2)(2006-10#9)(2006-12#1)(2007-2#1)(2008-3#1)(2008-7#2)(2009-7#1)(2010-2#3)(2010-9#1)(2011-2#5)(2012-3#1)
of opium poppy##4##3##(2008-10#4)
of opponens replacement in median nerve paralysis in leprosy##2##9##(2012-12#2)
of opportunistic infections and##2##4##(1993-8#1)(2010-12#1)
of opportunistic infections in##3##4##(2006-10#1)(2008-12#1)(2010-12#1)
of opportunistic infections##12##3##(1993-8#1)(1997-4#1)(2006-10#2)(2007-12#1)(2008-12#1)(2008-2#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-12#1)
of opportunistic parasitic##2##3##(2006-10#1)(2009-7#1)
of opportunistic##22##2##(1993-8#1)(1997-4#1)(2006-10#4)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-5#2)(2009-7#1)(2010-12#3)(2010-5#1)(2011-2#2)(2012-12#1)(2013-1#2)
of opportunities for##3##3##(2007-12#1)(2007-9#1)(2008-4#1)
of opportunities that##2##3##(1993-1#1)(2008-11#1)
of opportunities##8##2##(1993-1#1)(1993-3#1)(2006-11#1)(2007-12#1)(2007-9#2)(2008-11#1)(2008-4#1)
of opportunity for##9##3##(2007-11#1)(2008-3#1)(2009-10#3)(2010-6#1)(2010-7#1)(2010-8#1)(2013-1#1)
of opportunity##18##2##(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2009-10#3)(2009-4#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2012-1#1)(2013-1#1)
of opposing##4##2##(2006-2#1)(2008-11#1)(2008-3#1)(2010-10#1)
of opposite sign##4##3##(1995-6#1)(2007-11#1)(2007-12#1)(2008-3#1)
of opposite signs##2##3##(1990-3#1)(2007-11#1)
of opposite##13##2##(1990-3#1)(1990-8#1)(1995-6#1)(1996-2#1)(2005-11#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)
of oppositely charged polyelectrolytes##4##4##(2005-11#1)(2008-7#1)(2010-4#1)(2010-9#1)
of opposition##2##2##(2008-7#1)(2013-8#1)
of opsonisation##2##2##(1996-12#2)
of opsonized##2##2##(1991-6#1)(2008-10#1)
of opt-out##2##2##(2010-12#1)(2012-12#1)
of optic disc##2##3##(2007-6#1)(2012-2#1)
of optic nerve##4##3##(1996-3#2)(2008-5#1)(2010-5#1)
of optic##11##2##(1996-3#2)(2006-12#1)(2007-6#1)(2008-5#1)(2008-9#1)(2010-5#1)(2011-2#1)(2011-7#1)(2012-2#2)
of optical aberrations##2##3##(2007-12#1)(2008-3#1)
of optical activity##2##3##(1991-2#1)(2009-5#1)
of optical and##4##3##(2008-2#1)(2008-3#1)(2009-5#1)(2009-7#1)
of optical anisotropy##2##3##(2007-11#1)(2008-3#1)
of optical beams by##2##4##(2007-12#2)
of optical beams##6##3##(2007-12#4)(2008-2#2)
of optical bistability in a##2##5##(2007-12#2)
of optical coatings##3##3##(2007-12#1)(2008-3#2)
of optical coherence tomography (OCT)##5##5##(2007-12#1)(2008-1#1)(2010-12#1)(2010-2#1)(2011-7#1)
of optical coherence tomography images##3##5##(2007-11#1)(2011-1#2)
of optical coherence tomography in##2##5##(2007-3#1)(2011-7#1)
of optical coherence tomography##14##4##(2007-11#3)(2007-12#2)(2007-3#1)(2008-1#1)(2008-3#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-7#2)
of optical coherence##17##3##(2007-11#3)(2007-12#2)(2007-3#1)(2008-1#2)(2008-3#3)(2010-12#1)(2010-2#1)(2011-1#2)(2011-7#2)
of optical coherent transient true-time##2##5##(2007-12#2)
of optical coherent transient##4##4##(2007-12#4)
of optical communication##2##3##(2008-2#1)(2008-3#1)
of optical communications##2##3##(2007-12#1)(2008-3#1)
of optical components and##2##4##(2007-12#1)(2008-3#1)
of optical components with##2##4##(2008-3#2)
of optical components##11##3##(2007-12#1)(2008-2#5)(2008-3#5)
of optical constants and##2##4##(2008-2#2)
of optical constants of thin##3##5##(2008-2#2)(2008-3#1)
of optical constants of##6##4##(2007-12#1)(2008-2#2)(2008-3#3)
of optical constants##11##3##(2007-12#1)(2008-2#5)(2008-3#5)
of optical correlation##2##3##(2008-2#1)(2008-3#1)
of optical correlators##3##3##(2008-2#1)(2008-3#2)
of optical damage##2##3##(2008-3#2)
of optical data links##2##4##(2008-3#2)
of optical data storage##3##4##(2007-12#1)(2008-1#1)(2008-2#1)
of optical data##6##3##(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#2)
of optical density##2##3##(1994-2#1)(2008-2#1)
of optical depth##3##3##(2008-2#2)(2008-3#1)
of optical devices##7##3##(2007-11#2)(2008-2#2)(2008-3#2)(2008-9#1)
of optical disks with##2##4##(2008-2#1)(2008-3#1)
of optical disks##4##3##(2008-2#3)(2008-3#1)
of optical feedback##3##3##(2007-11#1)(2008-3#2)
of optical fiber##8##3##(2007-12#5)(2008-2#1)(2008-3#2)
of optical fibers and##5##4##(2006-4#1)(2007-11#1)(2008-2#1)(2008-3#2)
of optical fibers by##2##4##(2007-12#1)(2008-3#1)
of optical fibers##16##3##(2006-4#1)(2007-11#5)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#5)
of optical fields##2##3##(2007-11#1)(2008-3#1)
of optical filtering##2##3##(2008-2#1)(2008-9#1)
of optical filters##6##3##(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-9#1)
of optical flow##3##3##(1992-9#3)
of optical frequencies##2##3##(2007-12#2)
of optical frequency comb generators##2##5##(2007-12#1)(2008-3#1)
of optical frequency comb##3##4##(2007-12#2)(2008-3#1)
of optical frequency##6##3##(2007-12#4)(2008-3#2)
of optical glass material##2##4##(2008-3#2)
of optical glasses##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
of optical imaging##6##3##(1995-12#1)(1997-5#1)(2008-2#1)(2011-1#1)(2013-1#2)
of optical intensity##2##3##(2007-12#1)(2008-3#1)
of optical interconnections##2##3##(2008-3#2)
of optical limiting##2##3##(2007-11#1)(2007-12#1)
of optical links##2##3##(2008-2#2)
of optical loss##2##3##(2008-2#2)
of optical memory##4##3##(2007-12#2)(2008-3#2)
of optical near fields##2##4##(2007-12#2)
of optical parameters in general film-substrate systems##2##7##(2008-3#2)
of optical parameters in##3##4##(2008-3#3)
of optical parameters##6##3##(1990-8#1)(2006-2#1)(2008-3#4)
of optical parametric generation in##2##5##(2007-12#2)
of optical parametric##6##3##(2007-12#4)(2008-2#1)(2008-3#1)
of optical path length##2##4##(1997-6#1)(2008-10#1)
of optical path lengths##2##4##(2007-12#1)(2008-3#1)
of optical path##5##3##(1997-6#1)(2007-12#2)(2008-10#1)(2008-3#1)
of optical phase##5##3##(1993-8#1)(2007-12#3)(2008-3#1)
of optical power##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
of optical properties##10##3##(2007-12#1)(2008-2#3)(2008-3#5)(2010-4#1)
of optical pulse propagation in##2##5##(2007-12#2)
of optical pulse##4##3##(2007-12#4)
of optical pulses in a##2##5##(2007-11#1)(2007-12#1)
of optical pulses in##3##4##(2007-11#1)(2007-12#2)
of optical pulses##9##3##(2007-11#1)(2007-12#5)(2008-2#3)
of optical rectification and the##2##5##(2007-12#2)
of optical rectification##3##3##(2007-11#1)(2007-12#2)
of optical saturation##2##3##(2007-12#1)(2008-3#1)
of optical scattering##2##3##(2008-2#1)(2011-1#1)
of optical sensors based on##2##5##(2008-3#2)
of optical sensors##3##3##(2008-10#1)(2008-3#2)
of optical signals##3##3##(2007-11#1)(2008-2#1)(2012-2#1)
of optical solitons##5##3##(2007-11#1)(2007-12#4)
of optical sources##2##3##(2008-2#2)
of optical space code-division##2##4##(2008-2#2)
of optical spatial solitons in##2##5##(2007-12#2)
of optical spatial##3##3##(2007-12#2)(2008-2#1)
of optical surfaces##4##3##(2008-2#2)(2008-3#2)
of optical synchronization of chaotic external-cavity##2##6##(2007-12#2)
of optical synchronization of##3##4##(2007-11#1)(2007-12#2)
of optical systems##8##3##(2007-12#1)(2008-2#3)(2008-3#4)
of optical thickness##2##3##(2008-2#1)(2008-3#1)
of optical time-domain reflectometry##2##4##(2008-2#2)
of optical time-domain##3##3##(2008-2#3)
of optical transmission##6##3##(1997-6#1)(2005-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
of optical trapping##2##3##(2008-3#2)
of optical tweezers##2##3##(2006-9#1)(2007-11#1)
of optical vortices in##2##4##(2007-11#1)(2007-12#1)
of optical vortices##3##3##(2007-11#1)(2007-12#2)
of optical wave-front##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
of optical waveguide##4##3##(2007-11#1)(2007-12#3)
of optical waves##2##3##(2008-3#2)
of optical##425##2##(1990-8#1)(1991-2#1)(1991-7#1)(1992-9#3)(1993-8#1)(1994-2#1)(1995-12#1)(1996-5#1)(1997-5#2)(1997-6#4)(2005-11#2)(2006-12#2)(2006-2#1)(2006-4#1)(2006-9#1)(2007-11#33)(2007-12#99)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#6)(2008-10#8)(2008-11#1)(2008-2#89)(2008-3#130)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#4)(2009-11#1)(2009-5#3)(2009-7#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#5)(2011-2#1)(2011-7#2)(2011-9#1)(2012-2#2)(2013-1#2)(2013-8#1)
of optical-CT##2##2##(2007-1#2)
of optically active##10##3##(1996-5#1)(1997-7#1)(2006-12#1)(2007-12#3)(2008-3#1)(2008-7#2)(2009-10#1)
of optically amplified##2##3##(2007-12#1)(2008-2#1)
of optically pumped##4##3##(1993-6#1)(1994-2#1)(2008-3#1)(2008-7#1)
of optically thick##5##3##(2008-2#1)(2008-3#4)
of optically transparent##3##3##(2007-11#2)(2008-7#1)
of optically##37##2##(1990-8#1)(1991-5#1)(1993-6#1)(1994-2#1)(1996-5#1)(1997-7#1)(2006-12#1)(2007-11#3)(2007-12#5)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#11)(2008-7#4)(2009-10#1)(2011-1#1)
of optics and##2##3##(2008-2#1)(2008-3#1)
of optics in##4##3##(2007-11#1)(2008-3#3)
of optics##14##2##(2007-11#1)(2007-12#2)(2007-8#1)(2008-2#5)(2008-3#5)
of optimal binary##2##3##(2008-2#2)
of optimal focusing conditions##2##4##(2007-12#2)
of optimal therapeutic##2##3##(2010-10#1)(2012-12#1)
of optimal##54##2##(1990-7#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-3#1)(1995-2#1)(1996-10#1)(1996-2#2)(1997-4#1)(1997-6#1)(2004-12#1)(2005-8#1)(2006-5#1)(2006-6#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-11#1)(2008-2#6)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-12#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
of optimality##4##2##(1996-2#1)(2008-8#1)(2008-9#1)(2010-1#1)
of optimised##2##2##(2008-10#2)
of optimization of##2##3##(2008-10#1)(2013-1#1)
of optimization problems##2##3##(2007-9#1)(2008-2#1)
of optimization##9##2##(2006-5#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-2#1)(2010-12#1)(2013-1#1)
of optimized##11##2##(1993-6#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2009-2#1)(2011-2#1)(2012-12#1)
of optimizing the##3##3##(2006-6#1)(2008-2#2)
of optimizing##8##2##(1996-1#1)(2004-9#1)(2006-6#1)(2008-2#2)(2008-3#1)(2009-10#1)(2010-4#1)
of optimum pH##2##3##(1990-7#1)(1992-2#1)
of optimum##12##2##(1990-7#1)(1992-12#1)(1992-2#1)(1996-3#1)(1997-2#1)(2005-4#1)(2007-11#2)(2007-7#1)(2008-2#1)(2008-4#1)(2008-8#1)
of options and##2##3##(1992-1#1)(1994-1#1)
of options available for##2##4##(2007-9#1)(2008-5#1)
of options for##7##3##(1991-2#1)(1996-2#1)(2007-12#1)(2008-11#1)(2008-6#1)(2010-11#1)(2011-2#1)
of options##18##2##(1991-2#1)(1992-1#1)(1994-1#1)(1996-2#1)(2004-12#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-3#2)(2009-8#1)(2010-11#1)(2010-2#1)(2011-2#1)
of optode##2##2##(2008-10#2)
of optoelectronic devices by##2##4##(2007-12#2)
of optoelectronic devices##5##3##(2007-12#2)(2008-2#2)(2008-3#1)
of optoelectronic##17##2##(2007-12#4)(2008-2#8)(2008-3#4)(2010-4#1)
of optokinetic##3##2##(2008-4#1)(2008-8#1)(2011-2#1)
of or the##2##3##(1995-9#1)(2007-8#1)
of or##16##2##(1991-9#1)(1994-4#1)(1995-1#1)(1995-9#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-2#1)(2013-7#1)(2013-8#1)
of oral Candida albicans##2##4##(2007-7#1)(2010-8#1)
of oral Candida##5##3##(2007-7#1)(2008-5#1)(2010-8#1)(2012-2#2)
of oral HIV##2##3##(2006-8#2)
of oral administration of##8##4##(1992-8#1)(1993-11#2)(2007-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-5#1)
of oral administration##12##3##(1992-8#1)(1993-11#2)(1994-6#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#1)(2009-1#1)(2009-5#1)
of oral agents##2##3##(2010-5#1)(2010-6#1)
of oral and intravenous##3##4##(1991-12#1)(1997-3#1)(2013-7#1)
of oral and maxillofacial surgeons##2##5##(2007-12#2)
of oral and maxillofacial surgery patients##2##6##(2007-12#2)
of oral and maxillofacial surgery##4##5##(2007-12#4)
of oral and maxillofacial##6##4##(2007-12#6)
of oral and topical##2##4##(2006-10#1)(2007-7#1)
of oral and##20##3##(1991-12#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#6)(2007-2#1)(2007-7#1)(2007-9#1)(2008-8#1)(2010-10#1)(2012-12#1)(2012-3#1)(2013-7#1)
of oral antibiotics##2##3##(1994-8#1)(2011-1#1)
of oral anticoagulation##4##3##(1995-5#1)(1997-5#1)(2007-8#1)(2011-2#1)
of oral antifungal##2##3##(2007-8#1)(2008-3#1)
of oral azithromycin##2##3##(2006-2#1)(2007-7#1)
of oral calcium##3##3##(2005-7#2)(2013-8#1)
of oral cancer in##4##4##(1993-4#1)(2007-2#1)(2011-2#1)(2013-1#1)
of oral cancer##16##3##(1992-9#1)(1993-4#1)(2007-12#3)(2007-2#1)(2007-9#3)(2011-2#4)(2012-12#1)(2013-1#2)
of oral cancers and##2##4##(1992-8#1)(2011-1#1)
of oral cancers##4##3##(1992-8#2)(2005-11#1)(2011-1#1)
of oral candidiasis##4##3##(2006-8#3)(2008-5#1)
of oral care##2##3##(1997-4#1)(2012-2#1)
of oral cavity cancer##2##4##(2005-11#1)(2013-1#1)
of oral cavity##8##3##(2005-11#1)(2007-12#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-7#1)(2013-1#2)
of oral contraceptives during##2##4##(1990-9#1)(1991-6#1)
of oral contraceptives##15##3##(1990-10#1)(1990-11#3)(1990-6#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-4#1)(1993-9#1)(2008-11#2)
of oral corticosteroid therapy##2##4##(2008-1#1)(2008-11#1)
of oral corticosteroids##3##3##(2005-11#1)(2006-4#1)(2007-8#1)
of oral disease##4##3##(2006-8#1)(2012-2#2)(2013-8#1)
of oral diseases in##2##4##(2006-10#1)(2008-1#1)
of oral diseases##4##3##(1991-6#1)(2006-10#1)(2008-1#2)
of oral granisetron##3##3##(2010-12#3)
of oral health and##3##4##(2006-2#2)(2008-5#1)
of oral health care##4##4##(2006-2#1)(2006-8#2)(2012-3#1)
of oral health promotion##2##4##(2010-7#1)(2012-1#1)
of oral health##22##3##(1991-6#1)(2006-10#1)(2006-2#6)(2006-8#2)(2008-1#1)(2008-5#2)(2008-9#2)(2010-7#1)(2012-1#1)(2012-2#4)(2012-3#1)
of oral healthcare##2##3##(2006-2#1)(2008-1#1)
of oral hygiene##2##3##(2006-2#1)(2012-2#1)
of oral hypoglycemics##2##3##(1991-12#2)
of oral insulin##3##3##(2007-5#1)(2008-5#1)(2011-1#1)
of oral language and phonological awareness on##2##7##(2008-12#2)
of oral language##3##3##(2008-12#2)(2011-12#1)
of oral lesions##6##3##(2007-12#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
of oral lichen planus##4##4##(2008-4#2)(2012-2#1)(2013-1#1)
of oral lichen##5##3##(2008-4#3)(2012-2#1)(2013-1#1)
of oral malignancies##3##3##(1991-5#2)(2008-2#1)
of oral malodor##3##3##(2006-8#1)(2008-6#1)(2011-1#1)
of oral medications##2##3##(2010-2#1)(2010-7#1)
of oral metronidazole versus##2##4##(2006-10#2)
of oral midazolam##2##3##(2009-4#1)(2012-2#1)
of oral motor##2##3##(1993-12#2)
of oral mucositis##3##3##(2008-3#2)(2010-7#1)
of oral nutritional supplements##2##4##(1995-2#2)
of oral polio vaccine##2##4##(1994-9#1)(2007-10#1)
of oral polio##4##3##(1994-9#1)(2007-10#2)(2007-2#1)
of oral poliovirus vaccine##3##4##(1995-3#1)(1997-1#1)(2007-11#1)
of oral precancerous and cancerous##2##5##(1991-5#1)(2007-12#1)
of oral prednisolone##2##3##(2006-4#1)(2007-7#1)
of oral prednisone##2##3##(2006-10#2)
of oral presentations and##2##4##(2008-5#1)(2008-7#1)
of oral reading fluency##3##4##(2007-3#1)(2008-12#2)
of oral reading##4##3##(2007-3#1)(2008-12#2)(2008-4#1)
of oral submucous fibrosis##6##4##(2013-1#6)
of oral therapy##2##3##(2006-10#1)(2008-11#1)
of oral tissues##2##3##(1994-6#1)(2007-9#1)
of oral tolerance##9##3##(2006-10#5)(2008-11#4)
of oral##351##2##(1990-10#1)(1990-11#3)(1990-2#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#5)(1991-6#4)(1991-8#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#3)(1992-9#1)(1993-1#2)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-5#2)(1996-2#1)(1996-3#1)(1996-6#3)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#4)(2005-7#3)(2006-1#1)(2006-10#16)(2006-12#2)(2006-2#10)(2006-4#2)(2006-7#1)(2006-8#11)(2006-9#1)(2007-10#2)(2007-11#7)(2007-12#16)(2007-2#7)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#8)(2007-8#3)(2007-9#5)(2008-1#7)(2008-10#1)(2008-11#12)(2008-12#5)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#13)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#4)(2009-1#1)(2009-10#3)(2009-12#1)(2009-4#3)(2009-5#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#5)(2010-2#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#8)(2011-12#3)(2011-2#10)(2011-7#1)(2012-1#5)(2012-12#3)(2012-2#18)(2012-3#6)(2013-1#20)(2013-7#2)(2013-8#7)
of orally active##2##3##(1994-9#1)(2007-11#1)
of orally administered##6##3##(1995-5#1)(1996-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-12#1)
of orally effective##3##3##(1996-8#2)(2008-1#1)
of orally##14##2##(1994-9#1)(1995-5#1)(1996-10#1)(1996-8#3)(1997-3#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-2#1)(2012-12#1)
of orally-active non-peptide##2##3##(2005-7#2)
of orange juice##3##3##(2007-8#3)
of orbicularis oris muscle##2##4##(2012-12#2)
of orbit##6##2##(2005-4#1)(2009-2#1)(2009-9#1)(2010-11#2)(2013-1#1)
of orbital##12##2##(2006-12#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-11#1)(2011-1#3)(2012-12#1)(2012-2#1)(2013-7#1)
of orchard##3##2##(2008-10#3)
of orchitis##2##2##(1990-9#1)(2006-10#1)
of order of##6##3##(2006-10#1)(2006-12#1)(2008-5#4)
of order sets and##4##4##(2013-1#4)
of order sets##14##3##(2013-1#14)
of order statistics##2##3##(2011-1#2)
of order##38##2##(1992-1#1)(1996-5#2)(2006-10#1)(2006-12#1)(2006-3#1)(2007-11#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#5)(2008-8#1)(2011-1#3)(2011-2#1)(2013-1#17)
of ordered arrays of##2##4##(2008-7#2)
of ordered categorical##2##3##(1996-7#1)(1997-2#1)
of ordered helix##3##3##(1993-6#3)
of ordered##24##2##(1992-10#1)(1992-3#1)(1992-8#2)(1993-3#1)(1993-6#3)(1994-9#1)(1996-2#1)(1996-7#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-2#1)(2010-12#1)(2010-4#1)(2013-7#1)
of ordering and##3##3##(1992-3#1)(2013-1#2)
of ordering##4##2##(1992-3#1)(2013-1#3)
of orders##4##2##(2007-11#1)(2007-8#1)(2013-1#2)
of ordinal##6##2##(1994-8#1)(2008-10#4)(2008-9#1)
of ordinary##8##2##(1994-6#1)(2007-12#2)(2007-4#1)(2008-10#1)(2009-11#1)(2012-12#1)(2012-2#1)
of oregano##2##2##(2007-8#1)(2008-11#1)
of orexin neurons##4##3##(2010-10#4)
of organ donation##2##3##(2008-1#1)(2011-2#1)
of organ donors##3##3##(2006-10#2)(2010-11#1)
of organ failure and##2##4##(2007-11#1)(2013-1#1)
of organ failure##3##3##(2007-11#1)(2009-4#1)(2013-1#1)
of organ function##2##3##(1992-3#1)(2013-1#1)
of organ involvement##4##3##(2007-3#2)(2007-5#1)(2010-12#1)
of organ systems##3##3##(1993-10#1)(1997-1#1)(2008-10#1)
of organ transplant##3##3##(1997-2#1)(2005-9#1)(2007-11#1)
of organ transplantation##6##3##(1994-8#1)(1995-2#1)(1996-2#1)(2006-10#1)(2007-11#1)(2007-7#1)
of organ weights##2##3##(2008-10#1)(2013-8#1)
of organ##50##2##(1990-11#1)(1992-3#1)(1993-10#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-2#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-7#1)(2005-9#1)(2006-10#3)(2007-11#3)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#8)(2013-8#1)
of organ-specific##4##2##(1991-12#1)(1996-6#1)(2008-11#1)(2012-1#1)
of organellar##2##2##(1995-2#1)(2012-3#1)
of organelles##20##2##(1994-8#1)(1997-6#1)(2007-10#2)(2007-12#1)(2007-5#1)(2008-11#1)(2008-4#8)(2008-7#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-3#1)
of organic acid anhydrides##2##4##(1995-11#1)(1997-3#1)
of organic acids and##2##4##(2008-10#1)(2009-5#1)
of organic acids in liquid hot water pretreated##2##8##(2008-5#2)
of organic acids in urine##2##5##(1994-9#2)
of organic acids in##6##4##(1990-8#1)(1994-9#3)(2008-5#2)
of organic acids was##2##4##(1994-9#1)(2008-10#1)
of organic acids##18##3##(1990-8#1)(1993-9#1)(1994-9#4)(2004-8#1)(2006-12#1)(2008-10#5)(2008-5#2)(2008-7#1)(2009-5#1)(2012-11#1)
of organic additives##2##3##(1994-9#1)(2008-10#1)
of organic ammonium##2##3##(2008-10#2)
of organic and inorganic##9##4##(2005-12#1)(2007-8#1)(2008-10#3)(2008-7#1)(2013-8#3)
of organic and##11##3##(2005-12#1)(2007-10#1)(2007-8#1)(2008-10#4)(2008-7#1)(2013-8#3)
of organic anions##4##3##(1992-3#1)(2005-11#2)(2008-11#1)
of organic carbon##6##3##(2007-10#1)(2008-10#4)(2008-5#1)
of organic chemicals##2##3##(2008-10#1)(2013-1#1)
of organic chemistry##2##3##(1997-4#1)(2007-7#1)
of organic chlorine##2##3##(2004-4#1)(2008-10#1)
of organic compounds by##3##4##(2008-10#3)
of organic compounds from##3##4##(2008-10#3)
of organic compounds##20##3##(1992-7#1)(2007-11#1)(2007-8#1)(2008-10#15)(2008-7#1)(2013-1#1)
of organic contaminants in##3##4##(2004-4#1)(2008-10#2)
of organic contaminants##4##3##(2004-4#1)(2007-9#1)(2008-10#2)
of organic disease##4##3##(1992-11#1)(1993-8#1)(2007-6#1)(2008-4#1)
of organic dust##3##3##(1995-11#1)(1995-8#1)(2008-10#1)
of organic dye-doped##2##3##(2007-12#2)
of organic dyes##5##3##(1990-8#1)(2007-12#1)(2008-10#2)(2008-3#1)
of organic ions by##2##4##(1990-3#1)(2008-10#1)
of organic ligands##4##3##(2008-10#3)(2010-4#1)
of organic material##2##3##(1991-11#1)(1997-4#1)
of organic matter in##2##4##(2004-4#1)(2008-11#1)
of organic matter on##2##4##(2007-8#1)(2008-11#1)
of organic matter##17##3##(2004-4#2)(2005-12#1)(2006-12#1)(2007-3#1)(2007-8#3)(2008-10#2)(2008-11#3)(2008-12#2)(2010-5#1)(2012-2#1)
of organic modifier##5##3##(1990-6#3)(1997-3#1)(2008-10#1)
of organic modifiers##2##3##(1991-8#1)(1997-8#1)
of organic moieties##2##3##(2008-10#1)(2008-3#1)
of organic molecules##5##3##(2005-8#1)(2007-11#1)(2008-10#2)(2010-7#1)
of organic nitrates##2##3##(1992-6#1)(1994-2#1)
of organic phase##3##3##(2008-10#2)(2008-5#1)
of organic phosphorus##3##3##(1995-11#1)(2008-10#2)
of organic pollutants##4##3##(2008-10#2)(2008-5#1)(2010-5#1)
of organic reactions##2##3##(2008-5#1)(2012-2#1)
of organic silicon##2##3##(2008-10#2)
of organic small molecules##3##4##(2008-10#3)
of organic solvent and##4##4##(2008-10#4)
of organic solvent was used##2##5##(1996-9#1)(2008-10#1)
of organic solvent##14##3##(1996-9#1)(2008-10#12)(2012-12#1)
of organic solvents in##2##4##(2008-10#2)
of organic solvents##16##3##(2005-12#1)(2006-6#1)(2007-6#1)(2008-10#9)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
of organic substances##2##3##(1996-7#1)(2008-10#1)
of organic synthesis##2##3##(1997-4#1)(2008-10#1)
of organic thin films##3##4##(2008-3#3)
of organic##263##2##(1990-3#1)(1990-6#3)(1990-8#2)(1990-9#1)(1991-11#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-3#2)(1992-6#1)(1992-7#1)(1993-2#1)(1993-4#1)(1993-8#1)(1993-9#2)(1994-2#1)(1994-3#1)(1994-9#5)(1995-1#1)(1995-11#3)(1995-3#1)(1995-8#1)(1996-12#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-8#1)(2004-11#1)(2004-4#5)(2004-8#1)(2005-11#5)(2005-12#4)(2005-4#1)(2005-8#1)(2006-12#5)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#4)(2007-12#3)(2007-3#1)(2007-6#2)(2007-7#1)(2007-8#5)(2007-9#2)(2008-10#98)(2008-11#9)(2008-12#3)(2008-3#6)(2008-4#1)(2008-5#11)(2008-6#1)(2008-7#5)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-4#3)(2010-5#4)(2010-7#3)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#5)(2013-1#3)(2013-8#4)
of organics##2##2##(2008-10#1)(2011-1#1)
of organisational##3##2##(2005-11#1)(2007-10#1)(2008-12#1)
of organisations##3##2##(2007-2#2)(2013-1#1)
of organised dentistry##2##3##(2006-2#2)
of organised##4##2##(2006-2#2)(2011-1#2)
of organising##4##2##(2005-8#4)
of organism in##2##3##(2004-4#1)(2011-2#1)
of organism##7##2##(2004-4#1)(2005-7#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#2)
of organisms and##6##3##(1990-11#1)(2008-6#1)(2008-7#3)(2013-1#1)
of organisms in##4##3##(2006-11#1)(2008-10#1)(2008-8#1)(2009-8#1)
of organisms ranging from##2##4##(1992-5#1)(2008-8#1)
of organisms ranging##3##3##(1992-5#1)(2008-8#1)(2010-10#1)
of organisms such as##2##4##(2008-8#1)(2012-12#1)
of organisms that##2##3##(2006-5#1)(2009-4#1)
of organisms to##11##3##(1995-12#1)(2008-10#1)(2008-7#2)(2008-8#2)(2008-9#1)(2011-12#2)(2012-2#2)
of organisms##76##2##(1990-11#1)(1990-7#1)(1992-4#1)(1992-5#1)(1994-6#2)(1995-12#1)(1995-2#1)(1995-4#1)(1996-9#1)(1997-4#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-2#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#9)(2008-8#6)(2008-9#6)(2009-3#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-6#1)(2010-7#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#2)
of organization and##2##3##(2008-1#1)(2008-2#1)
of organization is##2##3##(2008-2#1)(2011-2#1)
of organization of services##3##4##(2008-2#3)
of organization of##6##3##(2008-2#3)(2008-7#1)(2011-1#1)(2013-1#1)
of organization##22##2##(1990-5#1)(1995-2#1)(1996-1#1)(2006-5#1)(2008-1#1)(2008-11#1)(2008-2#5)(2008-6#1)(2008-7#2)(2008-9#2)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
of organizational and##3##3##(1992-12#1)(1994-12#1)(2012-12#1)
of organizational commitment##2##3##(1996-1#1)(2007-5#1)
of organizational renewal##2##3##(1995-1#2)
of organizational##29##2##(1990-11#1)(1992-12#3)(1993-1#1)(1993-2#1)(1994-12#1)(1995-1#3)(1995-12#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-1#1)(2006-8#1)(2007-1#1)(2007-5#2)(2008-11#1)(2008-2#1)(2008-7#2)(2010-10#1)(2010-6#1)(2010-8#1)(2012-12#1)
of organizations and##2##3##(2007-2#1)(2008-2#1)
of organizations involved##2##3##(1994-12#1)(2007-5#1)
of organizations that##2##3##(1991-3#1)(1995-3#1)
of organizations##14##2##(1990-12#1)(1991-3#1)(1993-1#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(2007-12#1)(2007-2#2)(2007-5#1)(2008-2#2)(2012-3#1)
of organized##15##2##(1990-4#1)(1990-6#3)(1992-3#1)(1993-6#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-4#1)(2012-2#2)
of organizing##2##2##(1992-9#1)(2010-12#1)
of organochlorine pesticide##3##3##(1993-9#2)(2007-10#1)
of organochlorine pesticides from##2##4##(2007-7#1)(2008-10#1)
of organochlorine pesticides##7##3##(1997-4#1)(2007-7#2)(2007-8#1)(2008-10#3)
of organochlorine##14##2##(1993-9#4)(1997-4#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-8#1)
of organogenesis##3##2##(2008-7#1)(2008-9#2)
of organomercurials##3##2##(2008-10#3)
of organomercury and organotin compounds in##2##6##(2008-3#2)
of organometallic##4##2##(2007-12#1)(2008-10#1)(2009-9#1)(2012-3#1)
of organophosphate poisoning##2##3##(2006-4#1)(2012-2#1)
of organophosphate##4##2##(1992-10#1)(2006-4#1)(2010-2#1)(2012-2#1)
of organophosphates##4##2##(1994-5#1)(2008-10#1)(2008-6#1)(2009-3#1)
of organophosphonate##2##2##(2008-10#2)
of organophosphorous pesticides in##3##4##(2008-10#1)(2013-1#2)
of organophosphorous pesticides##4##3##(2008-10#2)(2013-1#2)
of organophosphorous##7##2##(1994-5#1)(2008-10#2)(2010-5#2)(2013-1#2)
of organophosphorus and carbamate pesticides##2##5##(2008-10#2)
of organophosphorus pesticides in water##5##5##(2008-10#5)
of organophosphorus pesticides##11##3##(2008-10#11)
of organophosphorus##17##2##(2008-10#16)(2008-5#1)
of organosilicon##2##2##(2006-12#1)(2008-5#1)
of organosulfur##3##2##(1992-5#1)(2008-1#2)
of organotin compounds##3##3##(2008-10#3)
of organotin in##2##3##(2008-10#2)
of organotin##6##2##(2008-10#6)
of organotin(IV)##2##2##(2008-3#1)(2012-2#1)
of organotins##3##2##(2008-10#3)
of organotypic##3##2##(1990-2#1)(1991-9#1)(2008-4#1)
of organs and tissues##7##4##(1991-3#1)(2005-11#1)(2006-10#1)(2006-11#2)(2007-5#1)(2011-1#1)
of organs and##8##3##(1991-2#1)(1991-3#1)(2005-11#1)(2006-10#1)(2006-11#2)(2007-5#1)(2011-1#1)
of organs during##5##3##(2006-6#1)(2012-12#4)
of organs for transplantation##3##4##(1991-11#1)(1991-3#1)(2006-10#1)
of organs for##5##3##(1991-11#1)(1991-3#1)(2006-10#1)(2007-7#1)(2008-1#1)
of organs from##3##3##(1992-4#1)(1993-2#1)(2011-2#1)
of organs of##2##3##(1993-9#1)(2009-2#1)
of organs or##4##3##(1996-12#1)(1997-6#1)(2011-1#1)(2013-8#1)
of organs##42##2##(1991-11#2)(1991-2#2)(1991-3#2)(1992-4#1)(1993-2#2)(1993-5#1)(1993-9#1)(1996-12#1)(1997-6#1)(2005-11#1)(2006-10#4)(2006-11#2)(2006-6#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#2)(2008-1#1)(2008-5#1)(2009-2#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#2)(2011-3#1)(2012-12#4)(2013-8#1)
of ori##3##2##(1994-11#2)(1996-7#1)
of oriLyt##4##2##(1997-3#4)
of oriental lacquer films##2##4##(2008-10#2)
of orientation and##3##3##(1991-9#1)(2008-10#1)(2008-8#1)
of orientation of##2##3##(1992-9#1)(2008-5#1)
of orientation selectivity##2##3##(2008-11#1)(2008-8#1)
of orientation tuning##2##3##(2008-11#2)
of orientation##19##2##(1991-9#1)(1992-9#1)(1996-11#1)(1997-7#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#4)(2009-5#2)(2012-2#1)
of orientational##3##2##(1992-1#1)(1994-11#1)(2007-12#1)
of orientations##5##2##(2007-9#1)(2008-2#2)(2008-3#1)(2012-2#1)
of oriented##4##2##(1990-4#1)(1992-7#1)(2008-3#1)(2009-11#1)
of orienting##2##2##(1992-7#1)(1994-1#1)
of origin and the##2##4##(2008-10#1)(2013-7#1)
of origin and##9##3##(1994-4#1)(2005-8#1)(2008-10#2)(2010-3#1)(2010-6#1)(2012-12#1)(2012-3#1)(2013-7#1)
of origin are##2##3##(1991-9#1)(2011-2#1)
of origin as##2##3##(2011-12#1)(2012-3#1)
of origin in the##2##4##(2008-11#1)(2008-2#1)
of origin in##6##3##(2008-10#1)(2008-11#2)(2008-2#1)(2013-1#2)
of origin of primary##2##4##(1990-7#1)(2008-6#1)
of origin of the##4##4##(1993-5#1)(2008-10#2)(2012-12#1)
of origin of##18##3##(1990-7#2)(1993-5#1)(1995-2#1)(2005-11#1)(2008-10#5)(2008-6#1)(2008-9#1)(2010-11#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#2)
of origin was##2##3##(1991-9#1)(2008-7#1)
of origin##100##2##(1990-6#1)(1990-7#2)(1991-9#2)(1992-11#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-4#1)(1995-2#1)(1996-9#1)(2005-10#2)(2005-11#1)(2005-5#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#29)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-6#1)(2010-9#1)(2011-12#2)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#8)(2013-1#8)(2013-7#2)
of original and##3##3##(1990-3#1)(2008-2#1)(2011-3#1)
of original articles##3##3##(2008-7#1)(2011-1#1)(2013-1#1)
of original##15##2##(1990-3#1)(1991-12#1)(1991-2#1)(1993-3#1)(2008-1#1)(2008-2#1)(2008-7#1)(2009-2#1)(2009-8#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#2)
of orlistat therapy on plasma concentrations of oxygenated##2##8##(2007-8#2)
of orlistat##4##2##(2007-8#2)(2008-3#1)(2008-5#1)
of ornamental plants##2##3##(2008-10#2)
of ornamental##3##2##(2008-10#2)(2011-2#1)
of ornithine aminotransferase activity by oxygen##2##6##(1994-12#2)
of ornithine aminotransferase by##2##4##(1991-2#2)
of ornithine aminotransferase##4##3##(1991-2#2)(1994-12#2)
of ornithine carbamoyl transferase##2##4##(2008-7#2)
of ornithine decarboxylase (ODC)##3##4##(1990-10#1)(1994-12#1)(1994-8#1)
of ornithine decarboxylase activity##4##4##(1992-9#1)(1997-8#2)(2008-10#1)
of ornithine decarboxylase in##2##4##(1990-10#1)(1991-11#1)
of ornithine decarboxylase##12##3##(1990-10#2)(1991-10#1)(1991-11#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1997-8#2)(2008-10#1)
of ornithine##24##2##(1990-10#2)(1991-10#1)(1991-11#1)(1991-2#2)(1992-5#1)(1992-9#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-8#1)(1996-7#3)(1997-8#2)(2008-10#1)(2008-7#3)(2009-8#1)
of orofacial clefts##5##3##(2009-10#5)
of orofacial granulomatosis##3##3##(2009-2#1)(2012-12#2)
of orofacial myofunctional therapy##3##4##(2008-10#3)
of orofacial##18##2##(2007-2#1)(2008-10#4)(2008-5#1)(2008-6#1)(2009-10#5)(2009-2#1)(2012-12#3)(2012-2#1)(2013-1#1)
of orogastric##3##2##(2008-5#1)(2010-7#2)
of oropharyngeal##11##2##(1996-2#3)(2006-2#1)(2007-12#1)(2008-5#1)(2008-8#2)(2010-7#3)
of orphan##5##2##(1996-5#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
of orphans##2##2##(1997-6#1)(2011-1#1)
of orthodontic treatment with##4##4##(2010-3#1)(2012-12#2)(2013-1#1)
of orthodontic treatment##8##3##(2007-12#1)(2009-7#1)(2010-2#1)(2010-3#1)(2012-12#3)(2013-1#1)
of orthodontic##14##2##(2007-12#2)(2009-7#2)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#2)(2012-12#3)(2013-1#2)
of orthodontics and##2##3##(2012-3#1)(2013-1#1)
of orthodontics##3##2##(2011-1#1)(2012-3#1)(2013-1#1)
of orthodoxy##2##2##(1991-12#1)(2007-10#1)
of orthogonal films##2##3##(2009-11#2)
of orthogonal polarization##3##3##(2007-12#2)(2008-3#1)
of orthogonal##14##2##(1990-5#1)(2007-12#6)(2008-11#1)(2008-2#2)(2008-3#1)(2009-11#2)(2009-12#1)
of orthographic##3##2##(2008-4#3)
of orthologous genes##2##3##(1997-4#1)(2010-10#1)
of orthologous##6##2##(1993-12#1)(1994-6#1)(1994-8#1)(1997-4#1)(2008-5#1)(2010-10#1)
of orthopaedic##12##2##(1990-2#1)(1996-3#1)(2004-9#2)(2007-10#1)(2007-11#2)(2007-8#2)(2008-12#1)(2011-2#1)(2013-1#1)
of orthopaedics##2##2##(2007-8#1)(2011-1#1)
of orthopedic surgery##5##3##(2011-2#5)
of orthopedic##15##2##(2006-10#1)(2007-11#1)(2007-8#1)(2009-3#2)(2010-3#1)(2010-6#1)(2011-12#1)(2011-2#6)(2013-1#1)
of orthopedics##3##2##(1997-6#1)(2007-11#2)
of orthophosphate and total phosphates##2##5##(2008-10#2)
of orthophosphate and total##4##4##(2008-10#4)
of orthophosphate in##4##3##(2008-10#4)
of orthophosphate##10##2##(2008-10#10)
of orthostatic##4##2##(1991-7#1)(2009-6#2)(2010-12#1)
of orthotic##7##2##(1993-3#1)(2007-11#2)(2007-8#2)(2009-10#1)(2010-3#1)
of orthotopic liver transplantation##3##4##(1991-11#1)(1993-3#1)(2004-11#1)
of orthotopic##4##2##(1991-11#1)(1993-3#1)(2004-11#1)(2008-5#1)
of oryzalin##3##2##(1997-8#3)
of os calcis##2##3##(2008-4#1)(2009-5#1)
of os##3##2##(2006-9#1)(2008-4#1)(2009-5#1)
of oscillating bubble systems##2##4##(2005-11#2)
of oscillating##6##2##(2005-11#2)(2007-12#2)(2007-8#1)(2011-2#1)
of oscillation##6##2##(1994-6#1)(1996-5#2)(2005-11#1)(2008-11#1)(2008-3#1)
of oscillations and complex dynamics##2##5##(2006-10#2)
of oscillations and##3##3##(2006-10#3)
of oscillations in##3##3##(2007-9#1)(2010-10#1)(2012-1#1)
of oscillations##17##2##(1990-8#2)(2005-11#1)(2006-10#6)(2007-9#1)(2008-2#1)(2008-7#3)(2008-8#1)(2010-10#1)(2012-1#1)
of oscillatory behavior##2##3##(2007-9#1)(2008-7#1)
of oscillatory##6##2##(2005-8#1)(2006-10#1)(2007-9#1)(2008-7#2)(2009-8#1)
of oseltamivir##2##2##(2005-10#1)(2013-1#1)
of osmium tetroxide##2##3##(2008-10#1)(2008-7#1)
of osmium##7##2##(2008-10#6)(2008-7#1)
of osmolality##2##2##(1995-10#1)(2008-11#1)
of osmolarity##3##2##(1991-11#1)(2008-11#2)
of osmolytes (polyols plus trehalose)##2##5##(2005-12#2)
of osmolytes##3##2##(2005-12#2)(2008-11#1)
of osmoregulatory##2##2##(2005-12#1)(2008-7#1)
of osmotic pressure##7##3##(2006-6#1)(2008-11#6)
of osmotic stress##2##3##(1992-8#1)(1994-12#1)
of osmotic##16##2##(1992-8#1)(1993-3#1)(1994-12#1)(1994-8#1)(2005-11#1)(2006-6#1)(2008-11#7)(2008-4#1)(2009-12#1)(2011-1#1)
of osmotin##2##2##(2008-10#1)(2008-8#1)
of osseointegrated##3##2##(2007-3#1)(2008-5#1)(2012-2#1)
of osseous tissue##3##3##(2005-1#1)(2007-7#2)
of osseous##10##2##(1991-1#1)(2005-1#1)(2007-7#2)(2007-8#1)(2008-1#1)(2009-3#1)(2010-12#1)(2010-3#1)(2013-1#1)
of ossification nucleus in the##2##5##(2009-2#2)
of ossification nucleus##3##3##(2009-2#3)
of ossification##5##2##(1996-6#1)(2005-3#1)(2009-2#3)
of osteoarthritic##2##2##(2006-12#1)(2008-11#1)
of osteoarthritis (OA)##3##3##(2005-8#1)(2007-11#1)(2012-1#1)
of osteoarthritis and the##2##4##(1993-11#1)(2007-11#1)
of osteoarthritis in the##2##4##(1993-11#1)(2007-8#1)
of osteoarthritis in##5##3##(1993-11#1)(2006-11#1)(2006-3#1)(2007-8#1)(2012-3#1)
of osteoarthritis of the knee##4##5##(2006-10#2)(2011-2#1)(2013-1#1)
of osteoarthritis of the##5##4##(1993-11#1)(2006-10#2)(2011-2#1)(2013-1#1)
of osteoarthritis of##6##3##(1993-11#1)(2006-10#2)(2008-5#1)(2011-2#1)(2013-1#1)
of osteoarthritis##38##2##(1993-11#3)(2005-8#1)(2006-10#5)(2006-11#1)(2006-3#1)(2007-11#6)(2007-7#1)(2007-8#3)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-7#1)(2011-1#4)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#2)
of osteoarthrosis##6##2##(2007-11#2)(2007-8#1)(2008-3#2)(2011-2#1)
of osteoarticular##2##2##(2007-8#1)(2008-6#1)
of osteoblast metabolism##2##3##(2008-11#2)
of osteoblast proliferation (UMR-106) by parathyroid##2##6##(1991-5#1)(1991-8#1)
of osteoblast proliferation##8##3##(1991-12#1)(1991-5#3)(1991-8#3)(2008-11#1)
of osteoblast##15##2##(1990-9#1)(1991-12#2)(1991-5#3)(1991-8#3)(1996-11#1)(2008-11#3)(2008-8#1)(2009-8#1)
of osteoblastic MC3T3-E1 cells##4##4##(1991-12#2)(1997-1#2)
of osteoblastic cells##4##3##(1993-8#2)(2008-11#2)
of osteoblastic##13##2##(1990-12#1)(1991-12#2)(1991-8#1)(1993-12#1)(1993-8#2)(1994-2#1)(1997-1#2)(2008-11#2)(2008-7#1)
of osteoblasts##12##2##(1990-11#1)(1993-12#1)(1997-1#1)(2005-1#1)(2008-11#1)(2008-5#4)(2010-2#1)(2013-1#2)
of osteocalcin by##2##3##(1990-2#2)
of osteocalcin expression##2##3##(1994-11#1)(2010-2#1)
of osteocalcin gene##3##3##(1997-6#1)(2012-11#2)
of osteocalcin synthesis in response to##2##6##(1990-2#2)
of osteocalcin synthesis##3##3##(1990-2#3)
of osteocalcin##24##2##(1990-2#7)(1991-3#1)(1992-1#1)(1993-3#1)(1994-11#1)(1994-2#1)(1996-12#3)(1997-6#1)(2006-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-2#2)(2012-11#2)
of osteochondrosis##2##2##(2007-11#2)
of osteoclast and osteoblast##2##4##(1991-12#1)(2007-8#1)
of osteoclast differentiation##2##3##(1993-8#1)(2011-2#1)
of osteoclast formation##2##3##(1990-9#1)(2010-10#1)
of osteoclast##11##2##(1990-2#1)(1990-9#1)(1991-12#1)(1993-8#1)(1993-9#1)(2005-3#1)(2007-8#1)(2009-3#1)(2010-10#1)(2011-2#2)
of osteoclast-like giant cells##3##4##(2012-3#3)
of osteoclast-like##5##2##(1990-9#2)(2012-3#3)
of osteoclastic bone resorption and##2##5##(1992-3#1)(2005-3#1)
of osteoclastic bone resorption##7##4##(1990-2#1)(1992-3#2)(1993-6#1)(1994-3#2)(2005-3#1)
of osteoclastic##9##2##(1990-2#1)(1992-3#2)(1993-6#1)(1994-3#2)(2005-3#1)(2008-11#1)(2008-5#1)
of osteoclasts and##3##3##(1992-7#1)(2005-1#1)(2011-2#1)
of osteoclasts in##3##3##(1990-9#1)(2006-4#1)(2010-10#1)
of osteoclasts##21##2##(1990-9#2)(1991-11#1)(1992-7#2)(1993-8#1)(1993-9#4)(1997-7#2)(2005-1#1)(2006-4#1)(2008-7#1)(2010-10#2)(2011-2#2)(2012-2#1)(2012-3#1)
of osteocytes##2##2##(2008-5#1)(2010-9#1)
of osteogenesis imperfecta##2##3##(2007-8#1)(2013-1#1)
of osteogenesis##5##2##(1993-9#1)(2007-8#1)(2008-5#1)(2008-8#1)(2013-1#1)
of osteogenic differentiation##3##3##(2008-11#1)(2009-4#1)(2012-1#1)
of osteogenic sarcoma of the##2##5##(1996-6#1)(2011-2#1)
of osteogenic sarcoma##3##3##(1996-6#1)(2007-8#1)(2011-2#1)
of osteogenic##13##2##(1993-9#1)(1996-6#1)(2007-8#1)(2008-11#5)(2009-4#1)(2011-2#2)(2012-1#1)(2012-2#1)
of osteoid osteoma##5##3##(2007-11#1)(2008-8#2)(2010-12#2)
of osteoid##8##2##(2007-11#2)(2008-6#1)(2008-8#2)(2010-12#2)(2010-9#1)
of osteolysis##2##2##(2013-1#2)
of osteolytic bone##2##3##(1992-10#1)(2008-7#1)
of osteolytic##6##2##(1992-10#1)(1997-6#1)(2007-11#1)(2008-6#1)(2008-7#1)(2013-1#1)
of osteoma cutis##2##3##(2005-11#1)(2010-6#1)
of osteomalacia##4##2##(1997-6#1)(2006-10#3)
of osteomyelitis defects##3##3##(2010-6#3)
of osteomyelitis in##2##3##(2008-7#1)(2010-6#1)
of osteomyelitis##19##2##(2007-8#1)(2008-7#1)(2009-6#1)(2010-6#15)(2012-2#1)
of osteonecrosis and##2##3##(1994-7#2)
of osteonecrosis of the jaw##3##5##(2008-1#1)(2008-7#2)
of osteonecrosis of the##4##4##(2008-1#1)(2008-7#2)(2009-3#1)
of osteonecrosis##6##2##(1994-7#2)(2008-1#1)(2008-7#2)(2009-3#1)
of osteopathic manipulative treatment##2##4##(2008-3#1)(2013-1#1)
of osteopathic medicine##2##3##(1991-8#1)(2007-12#1)
of osteopathic##4##2##(1991-8#1)(2007-12#1)(2008-3#1)(2013-1#1)
of osteopenia and osteoporosis##2##4##(2006-10#1)(2007-8#1)
of osteopenia and##3##3##(2006-10#1)(2007-8#2)
of osteopenia##4##2##(2006-10#2)(2007-8#2)
of osteopontin in##3##3##(1992-7#1)(2008-7#1)(2010-11#1)
of osteopontin##11##2##(1992-7#1)(1995-10#1)(2006-5#1)(2008-7#3)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#1)(2012-12#1)
of osteoporosis among##2##3##(1992-2#1)(2010-3#1)
of osteoporosis and its complications##2##5##(1992-2#2)
of osteoporosis and##14##3##(1992-2#3)(1993-11#1)(1994-7#1)(1994-9#1)(1996-6#1)(2005-1#1)(2005-3#1)(2007-11#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
of osteoporosis from##2##3##(2005-3#1)(2006-10#1)
of osteoporosis in the##5##4##(1996-6#1)(2006-10#1)(2007-7#1)(2008-8#1)(2010-3#1)
of osteoporosis in##20##3##(1993-11#1)(1995-9#1)(1996-6#1)(2005-7#1)(2006-10#1)(2007-11#2)(2007-7#3)(2008-7#4)(2008-8#1)(2010-3#3)(2011-1#1)(2013-1#1)
of osteoporosis is##7##3##(2005-3#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-7#1)(2010-3#1)(2013-1#1)
of osteoporosis or osteopenia##2##4##(2008-8#1)(2012-2#1)
of osteoporosis with##2##3##(1992-1#1)(2005-1#1)
of osteoporosis##132##2##(1990-11#1)(1991-11#3)(1992-1#2)(1992-2#4)(1993-11#12)(1993-7#1)(1994-7#1)(1994-9#1)(1995-4#1)(1995-9#1)(1996-11#1)(1996-6#3)(1997-6#4)(1997-7#1)(1997-8#1)(2004-11#1)(2005-1#5)(2005-3#9)(2005-7#2)(2006-10#6)(2006-8#1)(2007-11#9)(2007-7#4)(2007-8#7)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#3)(2008-4#4)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#1)(2009-3#1)(2010-3#10)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2012-12#5)(2012-2#2)(2013-1#5)(2013-8#1)
of osteoporotic bone##5##3##(1992-6#1)(2006-3#3)(2011-2#1)
of osteoporotic fractures##5##3##(1993-10#1)(2006-10#1)(2007-11#1)(2007-8#1)(2007-9#1)
of osteoporotic vertebral fractures##3##4##(1991-11#1)(2007-8#2)
of osteoporotic vertebral##5##3##(1991-11#1)(2007-11#1)(2007-8#3)
of osteoporotic##21##2##(1991-11#1)(1992-6#1)(1993-10#1)(2005-3#1)(2006-10#1)(2006-3#3)(2007-11#3)(2007-8#4)(2007-9#1)(2008-11#1)(2011-2#1)(2013-1#2)(2013-7#1)
of osteoprogenitor cells##2##3##(1992-1#1)(1996-11#1)
of osteoprotegerin (OPG) on##2##4##(2008-12#2)
of osteoprotegerin (OPG)##4##3##(2008-12#2)(2013-1#1)(2013-8#1)
of osteoprotegerin##9##2##(2007-8#1)(2008-12#2)(2011-12#3)(2013-1#2)(2013-8#1)
of osteosarcoma in the##2##4##(2010-3#1)(2013-1#1)
of osteosarcoma in##4##3##(2010-3#2)(2013-1#1)(2013-7#1)
of osteosarcoma is##2##3##(2008-6#1)(2010-3#1)
of osteosarcoma patients##2##3##(2010-3#2)
of osteosarcoma was##2##3##(2008-2#1)(2008-6#1)
of osteosarcoma##42##2##(1993-12#1)(1997-7#1)(2008-2#1)(2008-6#3)(2008-8#1)(2010-3#33)(2013-1#1)(2013-7#1)
of osteosynthesis##6##2##(1995-3#1)(2006-6#1)(2007-11#1)(2007-8#2)(2013-8#1)
of osteotomies##2##2##(1996-6#1)(2012-2#1)
of osteotomy of the proximal femur##2##6##(2007-7#2)
of osteotomy##4##2##(2007-7#2)(2007-8#2)
of ostriches (Struthio camelus)##3##4##(1996-8#1)(2008-5#1)(2013-1#1)
of ostriches##4##2##(1996-8#1)(2008-5#2)(2013-1#1)
of ota##2##2##(2007-7#2)
of other DNA##2##3##(2008-5#1)(2008-9#1)
of other DNA-binding##3##3##(1991-6#1)(1991-7#1)(1994-8#1)
of other OECD countries##2##4##(1993-2#1)(1996-3#1)
of other abnormalities##2##3##(1997-3#1)(2006-2#1)
of other adhesion molecules##2##4##(1992-11#2)
of other ages##2##3##(1996-12#1)(2013-1#1)
of other amino acids##2##4##(2008-10#1)(2013-1#1)
of other amino##3##3##(2008-10#2)(2013-1#1)
of other animals##4##3##(2007-9#1)(2008-4#2)(2008-8#1)
of other antiepileptic drugs##2##4##(1996-8#1)(2008-7#1)
of other areas of##2##4##(2006-10#1)(2007-2#1)
of other areas##3##3##(2006-10#1)(2007-2#1)(2007-8#1)
of other authors##6##3##(1990-2#1)(2005-1#1)(2007-3#1)(2007-8#1)(2008-5#1)(2013-8#1)
of other autoimmune##3##3##(1990-5#1)(2005-1#1)(2008-7#1)
of other bacteria was##2##4##(2008-10#2)
of other bacteria##3##3##(1995-8#1)(2008-10#2)
of other bacterial species##2##4##(1994-12#1)(2008-5#1)
of other bacterial##3##3##(1994-12#1)(2008-5#1)(2009-6#1)
of other begomoviruses##2##3##(2008-10#2)
of other blood##2##3##(1994-8#1)(2005-11#1)
of other cancers##3##3##(2009-12#1)(2011-2#1)(2011-3#1)
of other cations##5##3##(2008-10#5)
of other causes##5##3##(1992-10#1)(2006-10#1)(2007-8#1)(2012-2#1)(2013-1#1)
of other cell types##4##4##(1992-10#1)(1996-5#1)(2008-11#1)(2008-7#1)
of other cell##7##3##(1992-10#1)(1996-5#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-7#1)
of other cells##2##3##(1990-7#1)(2008-4#1)
of other centres##4##3##(1991-4#1)(2006-8#2)(2008-8#1)
of other chemotherapeutic agents##2##4##(2008-1#1)(2008-3#1)
of other closteroviruses##3##3##(2008-10#3)
of other coexisting##2##3##(2007-8#1)(2012-3#1)
of other common##3##3##(2005-11#1)(2008-10#2)
of other complications##2##3##(1992-2#1)(2006-2#1)
of other components of the##2##5##(2008-3#1)(2008-8#1)
of other components##6##3##(2006-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)
of other compounds##4##3##(2006-2#1)(2007-1#1)(2007-11#1)(2008-10#1)
of other conditions##6##3##(2007-11#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-2#1)
of other contaminants##2##3##(2008-10#2)
of other countries##5##3##(1990-6#1)(1993-6#1)(1994-2#1)(2007-2#1)(2009-6#1)
of other craniates##2##3##(1995-8#2)
of other cytokines##5##3##(1996-11#1)(1996-2#1)(2007-11#1)(2008-4#2)
of other data##2##3##(1994-12#1)(2008-3#1)
of other diseases can##2##4##(1992-6#1)(2010-8#1)
of other diseases in##2##4##(1993-12#1)(1997-7#1)
of other diseases such as##2##5##(2010-8#1)(2011-12#1)
of other diseases##12##3##(1992-6#1)(1993-12#1)(1997-3#1)(1997-7#2)(2006-10#1)(2007-2#1)(2008-7#2)(2010-8#2)(2011-12#1)
of other drugs##8##3##(1991-1#1)(1996-8#1)(2005-10#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-3#1)
of other environmental##2##3##(2009-8#1)(2010-2#1)
of other enzymes##4##3##(1991-4#1)(1992-4#1)(2005-7#1)(2011-1#1)
of other etiologies##2##3##(1990-9#1)(2007-8#1)
of other eukaryotic##2##3##(1992-4#1)(2008-4#1)
of other existing##2##3##(2008-3#1)(2009-12#1)
of other factors such as##2##5##(2008-5#2)
of other factors which##2##4##(2007-2#1)(2008-5#1)
of other factors##10##3##(1993-2#1)(1996-9#1)(2007-2#1)(2008-10#1)(2008-5#3)(2010-2#1)(2010-5#1)(2011-2#1)
of other forms of##2##4##(1993-9#1)(2010-6#1)
of other fungi##2##3##(2008-10#2)
of other genes in##2##4##(2008-6#1)(2008-7#1)
of other genes##11##3##(1992-10#1)(1993-2#1)(1994-3#1)(1995-11#1)(2008-4#2)(2008-6#1)(2008-7#2)(2009-4#1)(2009-8#1)
of other genetic##3##3##(1993-9#1)(2006-8#1)(2012-12#1)
of other groups of##3##4##(1995-12#1)(2008-6#1)(2011-1#1)
of other groups##4##3##(1995-12#1)(2008-6#1)(2011-1#1)(2012-3#1)
of other health##4##3##(1991-6#1)(2008-1#1)(2010-8#1)(2011-11#1)
of other human##2##3##(1997-6#1)(2010-4#1)
of other immune##3##3##(1991-12#1)(2008-4#1)(2010-5#1)
of other immunosuppressive##2##3##(2007-11#1)(2013-8#1)
of other influential##2##3##(2007-3#1)(2008-4#1)
of other inorganic##3##3##(2008-10#2)(2010-12#1)
of other investigators##3##3##(1990-3#1)(1994-8#1)(2008-4#1)
of other ions in the##3##5##(2008-10#2)(2008-6#1)
of other ions in##4##4##(2008-10#3)(2008-6#1)
of other ions##10##3##(1990-4#1)(2007-8#1)(2008-10#7)(2008-6#1)
of other isoforms##2##3##(1992-3#1)(2010-12#1)
of other known##9##3##(1990-2#1)(1990-9#1)(1991-2#2)(1995-2#1)(1997-2#1)(1997-6#1)(2008-5#1)(2010-6#1)
of other less##2##3##(2007-6#1)(2008-1#1)
of other local##2##3##(1996-9#1)(2012-12#1)
of other major##4##3##(1991-3#1)(1995-9#1)(2008-3#1)(2012-2#1)
of other males##2##3##(2008-8#1)(2009-6#1)
of other mammals##4##3##(1992-11#1)(1992-12#1)(1992-8#1)(1995-6#1)
of other materials##2##3##(1990-2#1)(2007-12#1)
of other mechanisms##2##3##(2008-1#1)(2008-4#1)
of other members of the family##3##6##(1993-11#1)(1994-8#1)(2008-10#1)
of other members of the##5##5##(1993-11#1)(1994-8#1)(1996-11#1)(2008-10#1)(2008-5#1)
of other members of##6##4##(1992-7#1)(1993-11#1)(1994-8#1)(1996-11#1)(2008-10#1)(2008-5#1)
of other members##7##3##(1992-7#1)(1993-11#1)(1994-8#1)(1996-11#1)(2006-7#1)(2008-10#1)(2008-5#1)
of other metal ions##8##4##(2008-10#8)
of other metal##9##3##(2008-10#9)
of other metals##3##3##(1996-7#1)(2008-10#2)
of other methods##3##3##(1990-3#1)(2007-10#1)(2007-8#1)
of other microbes##2##3##(2008-10#1)(2008-5#1)
of other microorganisms##2##3##(2005-7#1)(2008-10#1)
of other mitochondrial##2##3##(1993-2#1)(1994-11#1)
of other models##3##3##(1992-2#1)(2007-9#1)(2008-9#1)
of other molecular##2##3##(2011-2#2)
of other more common##2##4##(1991-6#1)(2013-1#1)
of other mutants##2##3##(1995-6#1)(2008-8#1)
of other natural##2##3##(2008-8#1)(2013-1#1)
of other neurons##2##3##(1997-3#1)(2008-11#1)
of other neurotransmitters##2##3##(1993-12#1)(2006-9#1)
of other new##2##3##(2005-12#1)(2009-2#1)
of other organisms##5##3##(1993-9#2)(1995-12#1)(2007-12#2)
of other organs##5##3##(1992-5#1)(2006-10#1)(2007-6#1)(2008-10#1)(2013-1#1)
of other oxidoreductases##2##3##(1996-6#1)(1997-4#1)
of other parameters##2##3##(2008-1#1)(2008-9#1)
of other people##3##3##(1997-8#1)(2008-6#1)(2009-6#1)
of other peptide##3##3##(1993-5#1)(1995-2#1)(2008-10#1)
of other plant##2##3##(2008-10#1)(2008-7#1)
of other plants##2##3##(2008-10#1)(2008-8#1)
of other possible##4##3##(1991-8#1)(1995-4#1)(2008-7#1)(2009-3#1)
of other potential##3##3##(2008-3#1)(2011-2#1)(2013-7#1)
of other protein##5##3##(1991-12#1)(1994-12#1)(1996-12#1)(1996-8#1)(2008-7#1)
of other proteins in##2##4##(1990-3#1)(1993-11#1)
of other proteins##11##3##(1990-12#1)(1990-3#1)(1993-11#1)(1993-6#1)(1994-11#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-4#2)
of other putative##2##3##(1992-9#1)(2008-8#1)
of other rare earths##2##4##(2008-10#2)
of other rare##3##3##(2008-10#2)(2008-2#1)
of other receptors##2##3##(1992-10#1)(2013-7#1)
of other recombinant##2##3##(2008-11#1)(2008-4#1)
of other relatives##2##3##(1997-3#1)(2011-1#1)
of other risk factors##5##4##(1990-9#1)(2005-10#2)(2007-2#1)(2008-7#1)
of other risk##6##3##(1990-9#1)(2005-10#2)(2007-2#1)(2008-7#1)(2010-4#1)
of other serine proteases##3##4##(1991-2#2)(2008-4#1)
of other serious##2##3##(2008-10#1)(2008-8#1)
of other similar##2##3##(1990-4#1)(2007-3#1)
of other sites##7##3##(1991-12#1)(1992-12#1)(1995-11#1)(1997-4#1)(2007-3#1)(2010-11#1)(2010-9#1)
of other small##4##3##(1991-1#1)(1993-11#1)(1997-4#1)(2008-8#1)
of other social##2##3##(2005-10#1)(2011-2#1)
of other somatic##2##3##(1993-5#1)(2005-7#1)
of other sources of##2##4##(1994-2#1)(2009-4#1)
of other species in##2##4##(2004-4#1)(2008-5#1)
of other species##20##3##(1991-12#1)(1992-1#1)(1993-6#1)(1993-8#1)(1993-9#1)(1996-11#1)(1997-2#1)(1997-3#1)(2004-4#1)(2007-1#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
of other steroids##2##3##(1994-9#1)(2007-11#1)
of other studies on##2##4##(1994-2#1)(2008-2#1)
of other studies##7##3##(1991-8#1)(1994-2#1)(2008-11#1)(2008-2#2)(2008-4#1)(2012-3#1)
of other subjects##2##3##(2008-10#2)
of other substances##5##3##(2006-9#1)(2008-10#4)
of other substrates##2##3##(1990-10#1)(1994-8#1)
of other symptoms##4##3##(1993-8#1)(2009-1#1)(2009-7#1)(2013-7#1)
of other systemic##2##3##(2006-10#1)(2008-11#1)
of other systems##2##3##(1992-3#1)(2008-7#1)
of other tissue##2##3##(2008-5#1)(2010-6#1)
of other tissues##5##3##(1994-8#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-6#1)
of other treatment##3##3##(1991-4#1)(2006-12#1)(2010-3#1)
of other tumors##2##3##(2007-4#1)(2012-1#1)
of other types of##5##4##(1994-2#1)(2006-5#1)(2007-11#1)(2008-6#1)(2010-12#1)
of other types##7##3##(1990-10#1)(1994-2#1)(2006-5#1)(2007-11#1)(2008-2#1)(2008-6#1)(2010-12#1)
of other viral##2##3##(1994-9#1)(2008-3#1)
of other workers##2##3##(1991-11#1)(2006-6#1)
of other##1001##2##(1990-1#1)(1990-10#4)(1990-11#5)(1990-12#4)(1990-2#8)(1990-3#7)(1990-4#4)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#7)(1991-1#4)(1991-10#3)(1991-11#2)(1991-12#5)(1991-2#7)(1991-3#3)(1991-4#5)(1991-5#2)(1991-6#6)(1991-7#2)(1991-8#4)(1991-9#2)(1992-1#3)(1992-10#4)(1992-11#6)(1992-12#5)(1992-2#7)(1992-3#6)(1992-4#3)(1992-5#1)(1992-6#6)(1992-7#2)(1992-8#3)(1992-9#2)(1993-1#2)(1993-11#3)(1993-12#6)(1993-2#6)(1993-3#2)(1993-5#2)(1993-6#6)(1993-7#1)(1993-8#4)(1993-9#7)(1994-1#1)(1994-11#2)(1994-12#8)(1994-2#5)(1994-3#5)(1994-5#3)(1994-6#2)(1994-8#7)(1994-9#7)(1995-1#4)(1995-11#5)(1995-12#5)(1995-2#7)(1995-3#7)(1995-4#3)(1995-5#3)(1995-6#5)(1995-7#2)(1995-8#4)(1995-9#1)(1996-1#4)(1996-10#2)(1996-11#4)(1996-12#5)(1996-2#3)(1996-3#4)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#4)(1996-8#6)(1996-9#5)(1997-1#2)(1997-2#8)(1997-3#6)(1997-4#7)(1997-5#3)(1997-6#4)(1997-7#3)(1997-8#5)(2004-12#1)(2004-3#1)(2004-4#1)(2004-9#1)(2005-1#2)(2005-10#5)(2005-11#7)(2005-12#2)(2005-3#1)(2005-4#1)(2005-7#9)(2005-8#3)(2005-9#2)(2006-1#1)(2006-10#14)(2006-12#7)(2006-2#5)(2006-4#2)(2006-5#1)(2006-6#4)(2006-7#3)(2006-8#8)(2006-9#4)(2007-1#4)(2007-10#7)(2007-11#14)(2007-12#17)(2007-2#7)(2007-3#6)(2007-4#4)(2007-6#4)(2007-7#3)(2007-8#10)(2007-9#5)(2008-1#11)(2008-10#137)(2008-11#12)(2008-12#3)(2008-2#15)(2008-3#22)(2008-4#26)(2008-5#25)(2008-6#11)(2008-7#21)(2008-8#20)(2008-9#11)(2009-1#1)(2009-10#1)(2009-12#7)(2009-2#1)(2009-3#2)(2009-4#5)(2009-5#1)(2009-6#4)(2009-7#4)(2009-8#6)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#9)(2010-2#6)(2010-3#2)(2010-4#3)(2010-5#5)(2010-6#5)(2010-8#7)(2010-9#2)(2011-1#10)(2011-11#1)(2011-12#1)(2011-2#19)(2011-3#2)(2012-1#4)(2012-12#10)(2012-2#15)(2012-3#14)(2013-1#10)(2013-7#6)(2013-8#9)
of others and the##2##4##(1996-5#1)(2011-2#1)
of others in##2##3##(2008-10#1)(2008-2#1)
of others is##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
of others to##2##3##(1997-8#1)(2005-10#1)
of others##48##2##(1990-11#1)(1990-5#1)(1991-2#1)(1991-7#1)(1993-6#1)(1994-1#1)(1995-10#1)(1995-3#2)(1996-3#1)(1996-5#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-12#4)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#6)(2008-2#2)(2008-9#3)(2009-10#1)(2009-6#1)(2009-9#2)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#1)
of others'##3##2##(1991-2#1)(2006-3#1)(2008-5#1)
of otherwise##12##2##(1994-8#1)(1995-12#1)(1997-1#1)(1997-2#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-8#1)(2008-9#1)
of otitis media in##2##4##(1991-3#1)(2008-7#1)
of otitis media##9##3##(1991-3#2)(1996-12#1)(1997-2#1)(2006-10#1)(2007-2#2)(2008-7#1)(2008-9#1)
of otitis##10##2##(1991-3#2)(1996-12#1)(1997-2#1)(2006-10#1)(2007-2#2)(2008-7#1)(2008-9#1)(2013-1#1)
of otogenic##2##2##(1991-4#1)(2008-7#1)
of otolith calcium carbonate##2##4##(2008-10#2)
of otolith##3##2##(2008-10#2)(2010-8#1)
of otosclerosis##2##2##(1991-11#1)(2013-1#1)
of ototoxicity##3##2##(2007-7#3)
of otter (Lutra lutra)##3##4##(1993-9#2)(2008-7#1)
of ouabain on##2##3##(1994-8#2)
of ouabain##6##2##(1991-4#1)(1994-8#2)(1995-1#1)(1997-1#1)(2008-8#1)
of our &quot##2##3##(2007-4#1)(2007-7#1)
of our 12 patients##2##4##(1997-3#1)(2008-6#1)
of our algorithm##3##3##(2007-9#1)(2008-2#1)(2010-4#1)
of our analysis##9##3##(1997-5#1)(2004-2#1)(2006-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2010-12#1)(2012-3#2)
of our approach by##2##4##(2009-8#1)(2012-3#1)
of our approach is that##3##5##(2008-2#1)(2008-8#1)(2009-8#1)
of our approach is##5##4##(2006-10#1)(2007-11#1)(2008-2#1)(2008-8#1)(2009-8#1)
of our approach##16##3##(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-6#1)(2008-8#2)(2009-12#1)(2009-8#2)(2010-8#1)(2012-2#1)(2012-3#2)
of our assumptions##2##3##(1993-12#1)(2008-9#1)
of our basic##2##3##(2006-7#1)(2013-1#1)
of our body##2##3##(2008-1#1)(2013-1#1)
of our case study##2##4##(1991-12#1)(1991-3#1)
of our case##8##3##(1991-12#1)(1991-3#1)(2007-10#1)(2009-3#1)(2012-2#1)(2013-1#3)
of our cases##7##3##(1990-3#1)(1995-4#1)(2007-12#1)(2007-7#2)(2007-8#1)(2010-5#1)
of our clinical##6##3##(1997-2#1)(2007-10#1)(2007-4#1)(2008-5#1)(2009-10#1)(2013-1#1)
of our collaborators##3##3##(1995-2#1)(2013-1#2)
of our combined experience##2##4##(1991-12#1)(2008-8#1)
of our comparative##2##3##(1994-11#1)(2008-10#1)
of our computerized##3##3##(1990-3#1)(1994-3#2)
of our country##2##3##(2010-1#1)(2011-2#1)
of our current knowledge about##2##5##(1994-6#1)(2008-4#1)
of our current knowledge##4##4##(1994-6#1)(2008-1#1)(2008-11#1)(2008-4#1)
of our current understanding of##3##5##(2006-9#1)(2009-12#1)(2012-1#1)
of our current##13##3##(1994-6#1)(1996-2#1)(2006-4#1)(2006-9#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-12#1)(2011-1#1)(2012-1#1)(2013-8#2)
of our data with##2##4##(2008-10#1)(2008-12#1)
of our data##8##3##(1991-2#1)(1991-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-12#1)
of our efforts##3##3##(1993-3#1)(2007-8#1)(2008-10#1)
of our experience is##2##4##(2004-9#1)(2008-1#1)
of our experience##14##3##(1991-2#1)(1993-10#1)(1993-8#1)(1994-6#1)(2004-9#1)(2006-10#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-7#1)(2008-9#1)(2011-2#2)
of our experience]##3##3##(1990-4#1)(1991-3#1)(2012-2#1)
of our experimental results and##2##5##(1997-4#1)(2006-4#1)
of our experimental##3##3##(1997-4#1)(2006-4#1)(2013-7#1)
of our experiments##4##3##(1997-8#1)(2010-8#1)(2013-1#2)
of our exploratory##2##3##(2008-5#2)
of our field##3##3##(2007-4#1)(2010-4#1)(2012-11#1)
of our findings##15##3##(1990-6#1)(1992-3#1)(1995-7#1)(1996-11#1)(1997-1#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-4#2)(2009-8#1)(2010-12#1)(2010-9#1)(2012-2#1)(2013-1#1)
of our first##4##3##(1997-1#1)(2008-3#1)(2008-9#1)(2012-12#1)
of our four##2##3##(2009-10#1)(2012-2#1)
of our group##2##3##(2010-1#1)(2010-3#1)
of our health care system##3##5##(1997-2#1)(2008-1#1)(2008-4#1)
of our health care##4##4##(1994-1#1)(1997-2#1)(2008-1#1)(2008-4#1)
of our health##5##3##(1994-1#1)(1995-3#1)(1997-2#1)(2008-1#1)(2008-4#1)
of our hospital##6##3##(2006-4#1)(2007-3#1)(2010-9#1)(2013-1#3)
of our hypothesis##2##3##(1997-8#1)(2006-8#1)
of our individual##2##3##(2008-10#1)(2011-2#1)
of our institution##2##3##(2006-11#1)(2007-8#1)
of our interest##2##3##(1994-12#1)(2010-7#1)
of our investigation##10##3##(2005-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-12#1)(2011-2#1)
of our investigations##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
of our knowledge about##5##4##(1997-8#1)(2007-8#1)(2008-7#1)(2010-5#1)(2011-2#1)
of our knowledge in##2##4##(2005-7#1)(2006-2#1)
of our knowledge of the##3##5##(2006-12#1)(2007-11#1)(2008-4#1)
of our knowledge of##7##4##(2006-12#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-4#1)(2012-12#1)(2012-2#1)
of our knowledge##96##3##(1990-10#1)(1991-9#1)(1992-6#1)(1994-12#1)(1995-5#1)(1996-2#1)(1996-7#1)(1997-8#1)(2005-7#1)(2006-12#1)(2006-2#1)(2007-11#6)(2007-12#3)(2007-2#2)(2007-5#1)(2007-7#5)(2007-8#3)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#6)(2008-4#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#8)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#2)
of our major##2##3##(2008-5#1)(2009-12#1)
of our measurements##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
of our method for the##2##5##(1991-2#1)(2008-3#1)
of our method is##2##4##(2007-12#1)(2012-3#1)
of our method##13##3##(1991-2#1)(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#3)(2008-6#1)(2012-3#1)(2013-1#1)
of our methodology##5##3##(2004-11#1)(2008-3#2)(2013-1#2)
of our methods##4##3##(1993-5#1)(2012-1#1)(2013-1#2)
of our model##9##3##(1993-4#1)(1993-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)(2013-1#1)
of our modern##2##3##(2006-12#1)(2012-2#1)
of our most##3##3##(2008-11#1)(2008-5#1)(2012-3#1)
of our new##4##3##(2010-10#1)(2010-12#1)(2012-3#1)(2013-1#1)
of our optical##2##3##(2007-11#1)(2008-2#1)
of our original##4##3##(2007-8#2)(2008-10#1)(2010-6#1)
of our own##16##3##(1990-12#1)(1991-2#1)(1993-3#1)(1997-1#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-1#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
of our paper was to##2##5##(2007-7#1)(2008-1#1)
of our paper##4##3##(2006-3#1)(2007-7#1)(2007-8#1)(2008-1#1)
of our patient##8##3##(1994-11#1)(2009-10#1)(2010-10#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#2)
of our patients and##2##4##(2013-1#1)(2013-8#1)
of our patients had##3##4##(2007-2#1)(2007-3#1)(2007-8#1)
of our patients in##2##4##(2007-7#1)(2010-2#1)
of our patients presented with##2##5##(2007-2#1)(2010-5#1)
of our patients presented##3##4##(2007-2#1)(2007-7#1)(2010-5#1)
of our patients with##6##4##(1993-11#1)(1996-3#1)(2006-10#1)(2007-7#2)(2008-8#1)
of our patients##45##3##(1990-6#2)(1990-9#1)(1991-3#1)(1992-2#1)(1992-5#1)(1993-11#1)(1994-7#2)(1996-3#1)(2006-10#2)(2006-3#1)(2006-6#1)(2007-2#3)(2007-3#1)(2007-7#6)(2007-8#4)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#3)(2013-8#1)
of our population##4##3##(1995-12#1)(2008-11#1)(2010-1#1)(2013-1#1)
of our predictions##2##3##(1992-3#1)(1997-2#1)
of our preliminary study##2##4##(2006-6#1)(2013-1#1)
of our present knowledge##2##4##(1990-10#1)(1991-4#1)
of our present##4##3##(1990-10#1)(1990-12#1)(1991-4#1)(2007-10#1)
of our previous in vitro##2##5##(2012-2#2)
of our previous research##2##4##(2008-3#1)(2012-3#1)
of our previous study of##2##5##(2007-8#1)(2011-1#1)
of our previous##15##3##(1992-12#1)(1994-8#1)(1995-7#1)(1996-5#1)(1997-2#2)(1997-5#1)(2007-8#2)(2008-10#1)(2008-3#1)(2011-1#1)(2012-2#2)(2012-3#1)
of our previously##2##3##(1995-11#1)(2012-3#1)
of our primary##2##3##(2008-7#1)(2013-8#1)
of our procedure##2##3##(1997-2#1)(2010-1#1)
of our profession##6##3##(1993-12#1)(1994-12#1)(1995-1#1)(2008-4#1)(2008-5#1)(2012-2#1)
of our professional##2##3##(2008-6#1)(2012-3#1)
of our program##3##3##(1994-9#1)(2007-4#1)(2011-2#1)
of our project##2##3##(2008-2#1)(2010-8#1)
of our proposal##4##3##(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#1)
of our proposed##5##3##(2007-12#1)(2008-2#2)(2012-1#1)(2012-3#1)
of our prospective study was to##2##6##(1997-8#1)(2007-9#1)
of our recent studies##2##4##(2010-2#1)(2011-2#1)
of our recent work##4##4##(1994-11#1)(2005-10#1)(2007-5#1)(2013-8#1)
of our recent##10##3##(1994-11#1)(2005-10#1)(2006-6#1)(2007-5#1)(2008-8#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-8#1)
of our renal##2##3##(2008-1#2)
of our research on##2##4##(2011-1#1)(2013-1#1)
of our research was to assess##2##6##(2007-7#2)
of our research was to evaluate the effectiveness of##2##9##(2007-7#1)(2007-8#1)
of our research was to evaluate the##4##7##(2007-11#1)(2007-7#1)(2007-8#2)
of our research was to evaluate##6##6##(1996-9#1)(2007-11#1)(2007-7#2)(2007-8#2)
of our research was to##15##5##(1990-5#1)(1990-6#1)(1996-9#1)(2007-11#1)(2007-7#6)(2007-8#4)(2013-1#1)
of our research was##16##4##(1990-5#1)(1990-6#1)(1996-9#1)(2007-11#1)(2007-7#6)(2007-8#5)(2013-1#1)
of our research##25##3##(1990-5#1)(1990-6#1)(1994-5#1)(1996-9#1)(2006-6#1)(2007-11#1)(2007-7#7)(2007-8#5)(2008-12#1)(2008-2#1)(2011-1#2)(2011-2#1)(2013-1#2)
of our results and##2##4##(2007-12#1)(2011-1#1)
of our results for##3##4##(2008-2#1)(2013-1#2)
of our results in##2##4##(1993-4#1)(2010-2#1)
of our results is that##2##5##(1991-12#1)(1994-5#1)
of our results on the##2##5##(2005-11#1)(2011-2#1)
of our results##17##3##(1990-4#1)(1991-12#1)(1993-4#1)(1994-5#1)(1997-6#1)(1997-8#1)(2005-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#2)
of our retrospective study##2##4##(2007-7#1)(2013-1#1)
of our review##2##3##(1992-5#1)(2006-6#1)
of our sample##2##3##(2008-11#1)(2011-2#1)
of our samples##3##3##(2008-10#1)(2008-12#1)(2008-2#1)
of our scheme##2##3##(2007-12#1)(2009-5#1)
of our scientific##2##3##(1993-6#1)(2012-1#1)
of our screening program##2##4##(2007-11#1)(2008-10#1)
of our series##2##3##(2007-7#1)(2007-8#1)
of our setup##3##3##(2007-12#1)(2008-2#2)
of our simulation##3##3##(1990-8#1)(2010-12#1)(2010-8#1)
of our society##3##3##(1995-11#1)(2005-10#1)(2007-8#1)
of our specialty##2##3##(2007-4#2)
of our structural##2##3##(1991-9#1)(2012-12#1)
of our studies##6##3##(1994-6#1)(1995-1#1)(2006-6#1)(2008-12#1)(2008-4#1)(2008-5#1)
of our study is that##2##5##(2009-6#1)(2013-8#1)
of our study is to##11##5##(2006-6#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-6#1)(2009-3#1)(2011-2#1)(2011-7#1)(2013-1#1)(2013-7#1)
of our study is##15##4##(2006-6#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-11#2)(2008-6#1)(2009-3#1)(2009-6#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
of our study show##3##4##(2008-1#1)(2008-11#1)(2008-3#1)
of our study showed that##2##5##(2008-7#1)(2011-2#1)
of our study suggest that##2##5##(1992-12#1)(2008-8#1)
of our study suggest##4##4##(1992-12#1)(2007-2#1)(2008-8#1)(2011-1#1)
of our study was to assess the effectiveness##2##8##(2006-6#1)(2007-7#1)
of our study was to assess the##13##7##(2006-6#1)(2007-3#1)(2007-7#5)(2007-8#2)(2007-9#2)(2013-1#1)(2013-8#1)
of our study was to assess##17##6##(2006-6#1)(2007-3#1)(2007-7#8)(2007-8#3)(2007-9#2)(2013-1#1)(2013-8#1)
of our study was to compare the##6##7##(2007-7#2)(2007-8#1)(2007-9#1)(2013-1#1)(2013-8#1)
of our study was to compare##9##6##(2007-7#3)(2007-8#3)(2007-9#1)(2013-1#1)(2013-8#1)
of our study was to estimate the##2##7##(2008-7#1)(2013-8#1)
of our study was to estimate##3##6##(2007-7#1)(2008-7#1)(2013-8#1)
of our study was to evaluate a##2##7##(2007-7#1)(2007-8#1)
of our study was to evaluate the effectiveness of##3##9##(2007-7#2)(2007-8#1)
of our study was to evaluate the##15##7##(1991-3#1)(1997-8#2)(2006-11#1)(2006-6#1)(2007-7#6)(2007-8#2)(2011-2#1)(2012-3#1)
of our study was to evaluate##23##6##(1991-3#1)(1997-8#3)(2006-11#1)(2006-6#1)(2007-7#9)(2007-8#5)(2008-7#1)(2011-2#1)(2012-3#1)
of our study was to examine the##4##7##(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)
of our study was to examine##5##6##(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
of our study was to investigate the##4##7##(2006-10#1)(2006-11#1)(2006-8#1)(2008-4#1)
of our study was to investigate whether##2##7##(2010-7#1)(2013-7#1)
of our study was to investigate##8##6##(1995-6#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-1#1)(2008-4#1)(2010-7#1)(2013-7#1)
of our study was to##94##5##(1991-3#1)(1993-12#1)(1995-6#1)(1997-8#3)(2004-9#1)(2006-10#2)(2006-11#2)(2006-6#2)(2006-8#1)(2007-1#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#23)(2007-8#14)(2007-9#3)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-7#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-3#2)(2012-6#1)(2013-1#4)(2013-7#1)(2013-8#3)
of our study was##96##4##(1990-5#1)(1991-3#1)(1993-12#1)(1995-6#1)(1997-8#3)(2004-9#1)(2006-10#2)(2006-11#2)(2006-6#2)(2006-8#1)(2007-1#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#23)(2007-8#15)(2007-9#3)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-7#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-3#2)(2012-6#1)(2013-1#4)(2013-7#1)(2013-8#3)
of our study were##4##4##(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
of our study##152##3##(1990-5#1)(1991-3#2)(1992-12#1)(1993-12#1)(1993-8#1)(1995-6#1)(1997-8#3)(2004-9#1)(2006-10#2)(2006-11#3)(2006-6#3)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#24)(2007-8#15)(2007-9#6)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-6#2)(2010-7#2)(2011-1#5)(2011-2#10)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#4)(2012-6#1)(2013-1#7)(2013-7#2)(2013-8#4)
of our system##4##3##(2008-2#2)(2008-6#1)(2011-1#1)
of our technique##2##3##(2008-10#1)(2008-5#1)
of our test##2##3##(1997-4#1)(2009-2#1)
of our theoretical##4##3##(2007-9#1)(2008-2#1)(2008-3#2)
of our time##3##3##(1994-8#1)(2010-4#1)(2011-2#1)
of our treatment approach##2##4##(2008-3#1)(2009-6#1)
of our treatment##4##3##(1990-9#1)(2007-8#1)(2008-3#1)(2009-6#1)
of our understanding of the##3##5##(2007-8#1)(2008-11#1)(2012-11#1)
of our understanding of##9##4##(2006-11#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-9#1)(2009-8#1)(2012-11#1)(2012-3#1)
of our understanding##10##3##(1994-10#1)(2006-11#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-9#1)(2009-8#1)(2012-11#1)(2012-3#1)
of our work is##4##4##(2006-6#1)(2012-2#1)(2013-1#2)
of our work was to study the##2##7##(1997-7#1)(2005-11#1)
of our work was to##3##5##(1997-7#1)(2005-11#1)(2008-5#1)
of our work##12##3##(1997-7#1)(2005-10#1)(2005-11#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-5#1)(2009-9#1)(2012-2#1)(2013-1#2)
of our##974##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-3#3)(1990-4#2)(1990-5#2)(1990-6#4)(1990-8#1)(1990-9#3)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#4)(1991-3#6)(1991-4#2)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#2)(1992-12#2)(1992-2#4)(1992-3#2)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#3)(1993-5#2)(1993-6#1)(1993-8#4)(1994-1#2)(1994-10#1)(1994-11#4)(1994-12#5)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#4)(1994-7#2)(1994-8#2)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#4)(1995-2#3)(1995-3#2)(1995-4#2)(1995-5#3)(1995-6#1)(1995-7#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#8)(1997-3#4)(1997-4#4)(1997-5#3)(1997-6#4)(1997-7#1)(1997-8#9)(2004-11#1)(2004-2#2)(2004-9#2)(2005-10#5)(2005-11#3)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#13)(2006-11#5)(2006-12#6)(2006-2#1)(2006-3#2)(2006-4#4)(2006-5#1)(2006-6#11)(2006-7#2)(2006-8#2)(2006-9#2)(2007-1#2)(2007-10#6)(2007-11#17)(2007-12#26)(2007-2#7)(2007-3#5)(2007-4#7)(2007-5#6)(2007-6#2)(2007-7#53)(2007-8#45)(2007-9#11)(2008-1#17)(2008-10#28)(2008-11#19)(2008-12#7)(2008-2#39)(2008-3#36)(2008-4#7)(2008-5#16)(2008-6#15)(2008-7#24)(2008-8#18)(2008-9#10)(2009-1#2)(2009-10#4)(2009-12#6)(2009-2#2)(2009-3#2)(2009-4#7)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#8)(2009-9#3)(2010-1#5)(2010-10#2)(2010-11#2)(2010-12#9)(2010-2#8)(2010-3#2)(2010-4#10)(2010-5#4)(2010-6#5)(2010-7#5)(2010-8#7)(2010-9#3)(2011-1#18)(2011-12#3)(2011-2#32)(2011-7#1)(2012-1#7)(2012-11#4)(2012-12#11)(2012-2#27)(2012-3#19)(2012-6#1)(2013-1#63)(2013-7#4)(2013-8#13)
of out of hours##3##4##(1990-3#1)(2004-7#2)
of out of##4##3##(1990-3#1)(2004-7#2)(2006-10#1)
of out-of-focus##2##2##(2007-12#1)(2008-2#1)
of out-of-hospital cardiac arrest##4##4##(1992-5#1)(1993-8#1)(1997-7#1)(2007-7#1)
of out-of-phase##2##2##(1997-7#1)(2007-9#1)
of out-of-plane##5##2##(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#1)
of out-of-pocket##2##2##(2006-8#1)(2011-1#1)
of out-of-school##2##2##(2007-3#1)(2010-8#1)
of out-patient pulmonary rehabilitation##3##4##(2011-2#3)
of out-patient##5##2##(1990-2#1)(2008-1#1)(2011-2#3)
of outbreaks of##5##3##(1992-10#1)(2007-12#1)(2008-5#1)(2008-8#1)(2010-4#1)
of outbreaks##20##2##(1992-1#1)(1992-10#1)(1993-5#1)(1996-3#2)(1997-3#1)(2007-12#1)(2008-5#1)(2008-6#1)(2008-8#3)(2009-2#2)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-2#1)
of outcome comparing##2##3##(2006-10#1)(2012-2#1)
of outcome events##2##3##(2007-10#1)(2008-8#1)
of outcome from##2##3##(2006-10#1)(2006-2#1)
of outcome in a##2##4##(2008-4#1)(2013-1#1)
of outcome in##7##3##(1990-9#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-4#1)(2009-10#1)(2013-1#1)
of outcome measures in##3##4##(2007-11#1)(2010-12#1)(2011-12#1)
of outcome measures##10##3##(1996-1#1)(1996-3#2)(2007-11#2)(2008-11#2)(2008-12#1)(2010-12#1)(2011-12#1)
of outcome of##6##3##(1990-9#1)(1996-11#1)(2008-11#1)(2008-6#2)(2011-2#1)
of outcome research##2##3##(1993-1#1)(2012-1#1)
of outcome variables##2##3##(1993-9#1)(2006-2#1)
of outcome was##2##3##(2007-3#1)(2011-2#1)
of outcome with##2##3##(1992-10#1)(2007-12#1)
of outcome##72##2##(1990-9#2)(1992-10#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-2#1)(1995-4#2)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#2)(2006-10#5)(2006-2#2)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#3)(2008-11#4)(2008-12#1)(2008-4#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-9#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#2)
of outcomes and##4##3##(1995-12#1)(2007-12#1)(2009-2#1)(2012-2#1)
of outcomes assessment##2##3##(1996-3#1)(2007-12#1)
of outcomes associated with##2##4##(2007-12#1)(2009-5#1)
of outcomes information##2##3##(1996-1#1)(1996-2#1)
of outcomes management##2##3##(1993-3#1)(1994-11#1)
of outcomes of##3##3##(2009-2#1)(2011-2#1)(2012-2#1)
of outcomes research in##2##4##(2008-8#1)(2008-9#1)
of outcomes research##6##3##(1994-11#2)(1994-12#1)(2006-5#1)(2008-8#1)(2008-9#1)
of outcomes when##2##3##(2008-2#1)(2009-4#1)
of outcomes##41##2##(1992-6#1)(1993-3#1)(1994-11#3)(1994-12#1)(1995-12#1)(1996-1#1)(1996-2#2)(1996-3#1)(2006-10#2)(2006-3#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-6#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-2#2)(2009-4#1)(2009-5#1)(2010-11#2)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#3)
of outcrossing##4##2##(2007-12#1)(2008-10#2)(2008-9#1)
of outdoor aeroallergens##2##3##(2008-5#2)
of outdoor##4##2##(2007-4#1)(2008-5#3)
of outer and inner##2##4##(2008-2#1)(2008-3#1)
of outer hair cells##2##4##(1995-10#1)(1995-3#1)
of outer membrane protein##2##4##(1996-5#1)(2007-2#1)
of outer membrane##4##3##(1996-5#1)(2006-8#1)(2007-2#1)(2008-12#1)
of outer##17##2##(1990-6#1)(1991-2#1)(1992-9#1)(1994-11#1)(1995-10#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-5#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)
of outflow##2##2##(1991-11#1)(2011-2#1)
of outgroup##2##2##(2012-3#2)
of outgrowth##3##2##(1991-3#1)(2011-2#2)
of outlet##2##2##(2007-2#1)(2013-7#1)
of outlier data##3##3##(2008-10#3)
of outlier##7##2##(1993-9#1)(2008-10#5)(2009-8#1)
of outliers##4##2##(1991-12#1)(2008-10#3)
of outpatient care##2##3##(1993-12#1)(1994-3#1)
of outpatient chemotherapy##2##3##(2010-2#2)
of outpatient commitment##4##3##(2006-5#4)
of outpatient mental health##2##4##(2008-6#1)(2009-7#1)
of outpatient orthopedic surgery##2##4##(2006-10#2)
of outpatient pulmonary##2##3##(2010-12#2)
of outpatient services##6##3##(1993-2#1)(1994-12#1)(1995-3#1)(2006-5#1)(2007-11#1)(2011-7#1)
of outpatient##45##2##(1991-3#1)(1992-1#1)(1993-12#3)(1993-2#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#1)(2006-10#3)(2006-5#5)(2007-11#1)(2007-3#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-6#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-12#3)(2010-2#4)(2010-5#1)(2011-7#1)(2012-2#1)
of outpatients##8##2##(1993-11#1)(1996-3#1)(2006-8#1)(2007-8#1)(2010-12#1)(2011-2#1)(2012-12#2)
of output coupling##2##3##(2007-12#1)(2008-3#1)
of output power in the##2##5##(2007-12#2)
of output power##11##3##(2007-11#2)(2007-12#5)(2008-2#3)(2011-1#1)
of output variables##2##3##(1992-2#1)(2009-12#1)
of output##28##2##(1992-2#1)(1993-3#1)(1994-12#1)(2005-11#1)(2007-11#2)(2007-12#9)(2008-11#2)(2008-2#4)(2008-3#3)(2008-4#2)(2009-12#1)(2011-1#1)
of outputs##2##2##(2007-7#1)(2009-4#1)
of outside##5##2##(1996-12#1)(1996-3#1)(2007-11#1)(2007-8#1)(2008-5#1)
of outsourcing##2##2##(2008-1#1)(2012-3#1)
of outstanding importance##2##3##(2006-10#1)(2006-6#1)
of outstanding##7##2##(1995-11#1)(2006-10#1)(2006-6#1)(2007-3#1)(2007-8#1)(2010-7#1)(2012-2#1)
of outward##3##2##(1994-2#1)(2007-12#1)(2009-2#1)
of ova##5##2##(1996-12#2)(2006-5#1)(2007-1#1)(2013-1#1)
of oval cells##5##3##(2006-10#1)(2008-10#1)(2009-4#3)
of oval##8##2##(2006-10#1)(2007-2#1)(2008-10#1)(2008-5#1)(2009-4#3)(2013-8#1)
of ovalbumin##3##2##(2004-12#1)(2005-10#1)(2008-10#1)
of ovarian activity##2##3##(2008-12#1)(2008-3#1)
of ovarian and##3##3##(1995-11#1)(1997-8#1)(2010-12#1)
of ovarian cancer patients##2##4##(1991-4#1)(1992-9#1)
of ovarian cancer##28##3##(1990-12#1)(1990-4#1)(1990-5#2)(1991-4#1)(1991-6#1)(1992-12#1)(1992-9#1)(1993-9#5)(1994-6#1)(1994-9#1)(1996-11#1)(2008-1#1)(2008-2#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-8#4)
of ovarian carcinoma##6##3##(1991-8#1)(1995-5#1)(2010-7#1)(2010-9#1)(2013-1#2)
of ovarian carcinoma]##2##3##(1993-9#1)(2005-11#1)
of ovarian fibromatosis/massive ovarian oedema##3##5##(2008-6#3)
of ovarian hormones##2##3##(1994-4#1)(2008-2#1)
of ovarian masses##4##3##(1992-12#1)(1996-1#3)
of ovarian steroid hormones##2##4##(1995-10#1)(2006-10#1)
of ovarian tissue##2##3##(1995-11#1)(2010-12#1)
of ovarian tumor##3##3##(2007-12#1)(2008-4#1)(2008-5#1)
of ovarian tumors##3##3##(1990-6#1)(1994-7#1)(2012-2#1)
of ovarian tumours##2##3##(2012-3#1)(2013-8#1)
of ovarian##95##2##(1990-10#2)(1990-12#1)(1990-4#1)(1990-5#3)(1990-6#1)(1991-4#2)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#2)(1992-9#1)(1993-9#6)(1994-4#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-5#1)(1996-1#3)(1996-11#1)(1996-12#1)(1997-3#1)(1997-8#1)(2004-10#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#5)(2008-5#2)(2008-6#3)(2009-7#1)(2010-12#3)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#2)(2013-8#7)
of ovariectomized female##3##3##(1991-11#1)(1992-8#1)(1993-6#1)
of ovariectomized rats##3##3##(1993-4#1)(1994-11#1)(1997-5#1)
of ovariectomized##8##2##(1991-11#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-4#1)(1993-6#1)(1994-11#1)(1997-5#1)
of ovariectomy##2##2##(2007-1#1)(2008-5#1)
of ovaries##3##2##(1993-2#1)(1995-2#1)(2006-5#1)
of ovary##6##2##(2008-10#1)(2011-1#1)(2013-1#4)
of over 0##2##3##(1997-6#1)(2013-1#1)
of over 100##3##3##(1995-10#1)(1996-8#1)(2008-10#1)
of over 200##2##3##(2007-11#1)(2008-10#1)
of over 30##3##3##(1993-2#1)(2010-3#1)(2011-2#1)
of over 3000##3##3##(1990-9#1)(2004-2#1)(2004-4#1)
of over 4##2##3##(1997-6#1)(2008-1#1)
of over 50##2##3##(1993-6#1)(2010-2#1)
of over 50%##3##3##(2007-7#2)(2008-3#1)
of over 60##2##3##(2010-3#1)(2011-2#1)
of over 65##2##3##(1995-3#1)(2009-8#1)
of over 90##2##3##(2008-4#1)(2009-5#1)
of over 90%##4##3##(2008-7#1)(2012-11#1)(2013-1#2)
of over 98%##2##3##(2008-3#1)(2010-2#1)
of over the counter##2##4##(1996-3#1)(2008-7#1)
of over two##2##3##(2005-12#1)(2008-10#1)
of over##83##2##(1990-2#1)(1990-9#1)(1991-11#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-6#2)(1994-3#2)(1994-7#2)(1995-10#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-8#2)(1997-5#1)(1997-6#3)(2004-2#1)(2004-4#1)(2005-12#1)(2005-6#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#5)(2009-5#1)(2009-8#2)(2010-10#1)(2010-2#3)(2010-3#4)(2010-7#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)
of over-expression##3##2##(1994-12#1)(2008-11#2)
of over-the-counter##3##2##(2009-2#1)(2010-8#1)(2010-9#1)
of overactive bladder in##2##4##(2008-10#1)(2011-1#1)
of overactive bladder##4##3##(2008-10#1)(2008-12#1)(2008-9#1)(2011-1#1)
of overall complications and##2##4##(2013-1#2)
of overall satisfaction and##3##4##(2007-8#1)(2008-8#2)
of overall satisfaction##4##3##(1996-3#1)(2007-8#1)(2008-8#2)
of overall service quality##3##4##(1995-3#3)
of overall success##2##3##(2012-12#2)
of overall survival##4##3##(1991-4#1)(1997-6#1)(2010-3#1)(2011-2#1)
of overall##49##2##(1991-2#1)(1991-4#1)(1992-1#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-7#1)(1995-3#3)(1996-12#1)(1996-3#1)(1996-7#1)(1997-5#1)(1997-6#1)(2004-3#1)(2006-7#1)(2007-10#1)(2007-12#4)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-8#1)(2010-3#1)(2010-4#2)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#3)
of overcoming##6##2##(1995-3#1)(2008-10#1)(2008-11#2)(2011-1#1)(2013-8#1)
of overdiagnosis##3##2##(2013-1#3)
of overdominance##2##2##(2008-10#2)
of overdose##3##2##(1991-8#1)(2012-2#1)(2013-1#1)
of overdosing##2##2##(1996-9#2)
of overexpressing##4##2##(1991-5#1)(1994-11#1)(1997-1#1)(1997-4#1)
of overexpression of##8##3##(1992-12#1)(1993-5#1)(1995-6#1)(2005-7#1)(2008-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
of overexpression##9##2##(1992-12#1)(1993-5#1)(1995-6#1)(2005-7#1)(2008-11#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
of overhead##3##2##(1991-3#1)(2008-10#1)(2008-3#1)
of overhydration##2##2##(2007-11#1)(2010-1#1)
of overjet and overbite##2##4##(2010-2#1)(2012-12#1)
of overlap between##3##3##(1991-11#1)(2007-12#1)(2008-4#1)
of overlap in##3##3##(1991-4#1)(2008-9#1)(2010-4#1)
of overlap##17##2##(1991-11#1)(1991-4#1)(1992-11#1)(1994-3#1)(1995-12#1)(1995-8#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-12#2)(2008-12#2)(2008-4#1)(2008-9#1)(2009-4#1)(2010-4#1)
of overlapped##3##2##(2008-10#1)(2010-8#1)(2011-1#1)
of overlapping genes in bacteriophage T4##2##6##(1997-7#2)
of overlapping peaks##3##3##(2008-10#3)
of overlapping thin collimation images##2##5##(2006-4#2)
of overlapping transcripts##2##3##(2006-11#1)(2008-7#1)
of overlapping##26##2##(1990-9#1)(1991-5#1)(1992-12#1)(1993-8#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-9#1)(1997-7#2)(2006-11#1)(2006-4#2)(2008-10#6)(2008-2#2)(2008-7#2)(2010-2#1)(2011-2#1)
of overload##2##2##(1990-9#1)(2012-3#1)
of overnight##2##2##(2005-11#1)(2011-2#1)
of overpotential##2##2##(2008-10#2)
of overproduction##2##2##(1997-4#1)(2008-6#1)
of overt and##2##3##(2008-10#1)(2009-4#1)
of overt disease##2##3##(1997-8#1)(2006-9#1)
of overt##14##2##(1990-3#1)(1997-8#1)(2006-2#1)(2006-9#1)(2007-8#1)(2008-10#1)(2009-1#1)(2009-11#1)(2009-4#4)(2011-11#1)(2011-2#1)
of overtraining##5##2##(1993-2#2)(2008-5#1)(2012-1#2)
of overtreatment and##2##3##(2005-11#1)(2007-12#1)
of overuse injuries##2##3##(2008-7#1)(2009-6#1)
of overuse##6##2##(1994-3#2)(2008-7#1)(2009-6#2)(2011-2#1)
of overweight among##2##3##(2008-3#1)(2009-9#1)
of overweight and hypertension among rural and urban school going children##2##11##(2012-2#2)
of overweight and obese##3##4##(2006-2#1)(2006-6#1)(2013-8#1)
of overweight and obesity among children and adolescents in##2##9##(2006-1#2)
of overweight and obesity among children##3##6##(2006-1#3)
of overweight and obesity among##7##5##(2006-1#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
of overweight and obesity are##2##5##(2006-1#1)(2012-2#1)
of overweight and obesity in Turkey##2##6##(2008-3#2)
of overweight and obesity in##8##5##(2006-1#1)(2006-10#1)(2008-3#2)(2011-1#2)(2012-12#1)(2012-3#1)
of overweight and obesity was##2##5##(2011-1#1)(2012-12#1)
of overweight and obesity##25##4##(2006-1#5)(2006-10#2)(2006-8#1)(2008-3#2)(2011-1#4)(2011-2#1)(2012-12#4)(2012-2#4)(2012-3#2)
of overweight and##37##3##(2006-1#5)(2006-10#2)(2006-2#1)(2006-6#1)(2006-8#1)(2008-3#6)(2009-9#1)(2011-1#5)(2011-2#1)(2012-12#4)(2012-2#7)(2012-3#2)(2013-8#1)
of overweight children##2##3##(2006-1#1)(2013-1#1)
of overweight in##4##3##(1993-9#1)(2009-9#2)(2011-2#1)
of overweight##61##2##(1990-9#1)(1993-9#1)(2006-1#9)(2006-10#2)(2006-2#1)(2006-6#1)(2006-8#1)(2007-12#2)(2008-10#2)(2008-3#10)(2009-8#1)(2009-9#6)(2011-1#5)(2011-2#3)(2012-12#4)(2012-2#8)(2012-3#2)(2013-1#1)(2013-8#1)
of overwhelming##3##2##(2007-5#1)(2008-4#1)(2010-2#1)
of overwintering##5##2##(2008-10#3)(2008-8#1)(2011-2#1)
of ovigerous females##3##3##(2013-7#3)
of ovine##9##2##(1992-3#1)(1993-12#1)(1994-8#1)(1995-8#1)(1996-12#1)(1997-3#1)(1997-6#1)(2010-12#1)(2011-1#1)
of oviposition##6##2##(2004-11#1)(2007-12#2)(2009-6#1)(2009-9#1)(2011-2#1)
of ovulation and##2##3##(1992-4#1)(2011-1#1)
of ovulation##8##2##(1992-12#1)(1992-4#2)(1992-7#1)(2007-11#1)(2007-9#1)(2008-9#1)(2011-1#1)
of ovules##3##2##(1993-10#1)(2008-5#1)(2009-12#1)
of own##5##2##(1992-6#1)(1993-12#1)(1996-6#1)(1997-8#1)(2009-7#1)
of ownership and##2##3##(1995-2#1)(2008-12#1)
of ownership of##2##3##(1993-2#1)(2008-10#1)
of ownership##7##2##(1993-2#1)(1995-2#2)(2004-9#1)(2008-10#1)(2008-12#1)(2008-7#1)
of oxalate and##2##3##(1990-12#1)(2008-10#1)
of oxalate##24##2##(1990-10#1)(1990-12#2)(1992-6#1)(1994-12#3)(1995-7#2)(2006-10#1)(2008-10#11)(2012-2#3)
of oxalic acid in urine##3##5##(1990-8#1)(2008-10#2)
of oxalic acid##10##3##(1990-8#1)(2008-10#3)(2009-8#3)(2012-2#1)(2013-1#2)
of oxaliplatin##4##2##(1990-5#1)(2008-3#2)(2008-5#1)
of oxaloacetate##3##2##(1991-4#3)
of oxazepam##3##2##(2008-6#3)
of oxazolo[3##2##2##(2007-11#2)
of oxazolone##2##2##(2011-3#1)(2013-1#1)
of oxidant stress##5##3##(1994-3#2)(1994-6#2)(1995-1#1)
of oxidant##15##2##(1994-3#2)(1994-6#2)(1995-1#1)(1995-3#1)(1995-6#1)(1996-8#1)(2007-10#1)(2008-10#3)(2010-5#1)(2010-7#2)
of oxidants##3##2##(1991-9#1)(2008-1#1)(2008-10#1)
of oxidase activation##3##3##(1991-2#1)(1992-7#1)(1993-12#1)
of oxidase activity##2##3##(1992-3#1)(2008-5#1)
of oxidase##7##2##(1991-2#1)(1992-3#1)(1992-7#1)(1993-12#1)(2008-10#2)(2008-5#1)
of oxidation agent##2##3##(2008-10#2)
of oxidation by##2##3##(1995-6#1)(2008-10#1)
of oxidation is##2##3##(2008-10#2)
of oxidation of##15##3##(1990-5#1)(1991-1#1)(1991-7#1)(1992-12#1)(1993-4#1)(1994-5#1)(1995-6#1)(1996-7#1)(2008-10#5)(2008-12#1)(2013-1#1)
of oxidation products of##2##4##(1990-7#1)(2008-10#1)
of oxidation products##5##3##(1990-4#2)(1990-7#1)(2008-10#2)
of oxidation##42##2##(1990-4#2)(1990-5#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-7#1)(1992-12#1)(1993-4#1)(1994-5#1)(1995-6#2)(1996-5#3)(1996-7#1)(1997-8#1)(2005-8#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-2#1)(2010-5#1)(2013-1#1)
of oxidation-reduction reactions##2##3##(1992-12#1)(2008-10#1)
of oxidative DNA damage in##2##5##(1994-6#1)(2008-10#1)
of oxidative DNA damage##3##4##(1994-6#1)(2008-10#1)(2010-3#1)
of oxidative coupling reactions for##2##5##(2008-10#1)(2011-1#1)
of oxidative damage of##2##4##(2008-10#1)(2008-4#1)
of oxidative damage to##4##4##(1997-5#1)(1997-6#1)(2008-1#1)(2013-8#1)
of oxidative damage##15##3##(1991-9#1)(1997-4#2)(1997-5#1)(1997-6#1)(2006-12#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-5#1)(2013-8#1)
of oxidative metabolism##2##3##(1997-8#1)(2008-10#1)
of oxidative modification of proteins##3##5##(2008-1#1)(2008-4#2)
of oxidative modification of##6##4##(2008-1#1)(2008-10#1)(2008-4#2)(2009-8#1)(2010-12#1)
of oxidative modification##7##3##(2008-1#2)(2008-10#1)(2008-4#2)(2009-8#1)(2010-12#1)
of oxidative phosphorylation and##2##4##(1996-9#1)(2008-7#1)
of oxidative phosphorylation in##2##4##(1994-12#1)(2007-10#1)
of oxidative phosphorylation was##2##4##(1994-12#1)(1997-7#1)
of oxidative phosphorylation##17##3##(1990-8#2)(1991-2#1)(1994-12#4)(1995-7#1)(1996-9#2)(1997-7#1)(2005-8#1)(2007-10#1)(2008-7#2)(2012-3#1)(2013-8#1)
of oxidative reactions##3##3##(2008-10#1)(2010-12#1)(2010-4#1)
of oxidative stress and antioxidant##3##5##(2009-8#1)(2010-8#1)(2012-12#1)
of oxidative stress and##9##4##(1995-3#1)(2008-10#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-8#1)(2012-12#2)(2013-8#1)
of oxidative stress in patients with##2##6##(2007-9#1)(2011-1#1)
of oxidative stress in their##2##5##(2008-11#1)(2013-8#1)
of oxidative stress in##19##4##(1990-4#1)(1996-3#1)(1996-5#1)(1997-2#1)(2007-9#1)(2008-1#1)(2008-11#2)(2009-12#1)(2009-6#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
of oxidative stress is##4##4##(2006-8#1)(2007-8#1)(2007-9#1)(2008-5#1)
of oxidative stress markers##3##4##(2011-1#1)(2012-5#1)(2013-1#1)
of oxidative stress on##5##4##(1991-9#1)(1994-10#1)(1995-6#1)(2007-1#1)(2008-5#1)
of oxidative stress responses##2##4##(1991-11#1)(2008-7#1)
of oxidative stress##92##3##(1990-4#1)(1991-11#1)(1991-9#1)(1994-10#1)(1994-6#1)(1995-3#1)(1995-6#2)(1996-3#1)(1996-5#1)(1997-2#2)(1997-6#1)(2005-1#1)(2005-10#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#10)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#3)(2009-11#2)(2009-12#2)(2009-5#1)(2009-6#2)(2009-8#2)(2010-12#2)(2010-3#1)(2010-4#4)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#1)(2012-1#2)(2012-12#2)(2012-5#1)(2013-1#2)(2013-8#4)
of oxidative##163##2##(1990-4#1)(1990-5#1)(1990-8#2)(1991-11#1)(1991-2#1)(1991-9#2)(1992-5#1)(1994-10#1)(1994-11#1)(1994-12#4)(1994-5#1)(1994-6#2)(1994-8#1)(1995-12#1)(1995-3#2)(1995-6#2)(1995-7#1)(1996-1#1)(1996-3#1)(1996-5#1)(1996-9#2)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-12#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-8#1)(2007-9#3)(2008-1#7)(2008-10#9)(2008-11#3)(2008-3#3)(2008-4#4)(2008-5#11)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#4)(2009-10#3)(2009-11#2)(2009-12#3)(2009-3#1)(2009-5#2)(2009-6#2)(2009-8#5)(2010-12#4)(2010-3#3)(2010-4#7)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#5)(2011-2#3)(2012-1#2)(2012-12#2)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#6)
of oxidatively damaged cells##2##4##(1995-2#2)
of oxidatively damaged##4##3##(1995-2#3)(1997-6#1)
of oxidatively modified low density##2##5##(1995-2#1)(2005-7#1)
of oxidatively modified##3##3##(1995-2#1)(2005-7#1)(2010-12#1)
of oxidatively##8##2##(1995-2#4)(1997-6#1)(2005-7#1)(2008-7#1)(2010-12#1)
of oxide surfaces with##2##4##(2005-11#1)(2007-5#1)
of oxide##5##2##(2005-11#1)(2006-12#1)(2007-5#1)(2008-10#1)(2008-3#1)
of oxidised LDL##2##3##(1997-2#1)(2005-7#1)
of oxidised##5##2##(1996-8#2)(1997-2#1)(2005-7#2)
of oxidising##2##2##(1997-2#1)(2008-10#1)
of oxidizable##7##2##(2008-10#7)
of oxidized LDL in##2##4##(1991-2#1)(1996-2#1)
of oxidized LDL##5##3##(1991-2#1)(1991-7#1)(1996-2#1)(2005-8#1)(2009-10#1)
of oxidized and reduced##5##4##(1992-6#1)(1992-9#1)(1994-8#1)(2004-11#1)(2008-4#1)
of oxidized fibrinogen##2##3##(2010-12#2)
of oxidized glutathione##2##3##(1991-9#1)(2012-12#1)
of oxidized low-density lipoprotein##2##4##(1995-6#1)(1996-2#1)
of oxidized##45##2##(1990-8#1)(1991-2#1)(1991-7#2)(1991-9#1)(1992-1#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-5#3)(1994-8#2)(1995-6#1)(1996-2#2)(1996-5#2)(1997-5#1)(2004-11#1)(2005-11#2)(2005-8#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-5#2)(2009-8#1)(2010-12#4)(2012-1#1)(2012-12#1)(2013-1#1)
of oxidizing##6##2##(1992-9#1)(2007-8#1)(2008-1#1)(2008-10#1)(2010-5#1)(2011-1#1)
of oxime- and methyloxime-containing flavone##2##5##(2006-12#2)
of oxolinic acid residues in baked##2##6##(2005-12#2)
of oxolinic acid##4##3##(2005-12#2)(2008-10#2)
of oxotremorine##3##2##(1991-2#1)(1993-12#2)
of oxy-##2##2##(1991-2#1)(2007-10#1)
of oxybutynin##4##2##(1997-5#1)(2008-3#3)
of oxychlorine species##4##3##(2008-10#4)
of oxycodone##4##2##(2007-2#1)(2008-3#3)
of oxyethylene##3##2##(1990-3#1)(2005-11#1)(2008-10#1)
of oxygen affinity##2##3##(1990-8#2)
of oxygen and the##3##4##(1993-6#1)(2006-10#1)(2008-10#1)
of oxygen and##16##3##(1990-10#1)(1993-6#1)(1995-12#1)(1996-6#1)(2005-10#1)(2006-10#2)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-6#1)(2013-1#1)
of oxygen at##2##3##(2008-2#1)(2013-7#1)
of oxygen binding to the##2##5##(1990-8#1)(1993-8#1)
of oxygen binding to##3##4##(1990-8#2)(1993-8#1)
of oxygen by##3##3##(1996-11#1)(1997-1#1)(1997-6#1)
of oxygen consumption and##2##4##(2008-4#1)(2009-6#1)
of oxygen consumption during##2##4##(2008-10#1)(2008-3#1)
of oxygen consumption in the##2##5##(1997-1#1)(1997-6#1)
of oxygen consumption in##3##4##(1997-1#1)(1997-6#1)(2008-7#1)
of oxygen consumption##13##3##(1990-3#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-11#2)
of oxygen demand##2##3##(2008-6#2)
of oxygen deprivation##3##3##(1992-3#1)(2007-9#1)(2008-10#1)
of oxygen equilibrium curves##2##4##(1990-8#2)
of oxygen evolution##7##3##(1994-12#4)(2007-10#1)(2008-6#1)(2010-5#1)
of oxygen free radicals in##5##5##(1991-9#1)(1992-12#1)(1994-10#1)(1994-2#1)(1996-9#1)
of oxygen free radicals##7##4##(1991-9#1)(1992-12#1)(1993-4#1)(1994-10#1)(1994-2#1)(1996-9#1)(2008-4#1)
of oxygen free##8##3##(1991-9#1)(1992-12#1)(1993-4#1)(1994-10#1)(1994-2#1)(1996-9#1)(1997-1#1)(2008-4#1)
of oxygen in the##3##4##(1996-6#1)(2006-10#1)(2008-3#1)
of oxygen in##8##3##(1995-8#1)(1996-6#1)(2006-10#2)(2007-8#1)(2008-10#2)(2008-3#1)
of oxygen is##2##3##(2008-10#1)(2008-5#1)
of oxygen limitation##2##3##(2005-11#1)(2008-6#1)
of oxygen on##3##3##(1995-3#1)(2008-10#1)(2008-3#1)
of oxygen partial pressure on##2##5##(2008-11#2)
of oxygen radicals and##2##4##(1993-8#1)(1994-3#1)
of oxygen radicals##7##3##(1991-9#1)(1993-8#1)(1994-11#1)(1994-3#3)(2006-8#1)
of oxygen reduction##2##3##(1990-7#1)(1995-11#1)
of oxygen saturation##4##3##(1993-1#1)(2007-1#1)(2011-1#1)(2013-8#1)
of oxygen tension##3##3##(1991-8#1)(1994-3#1)(2008-7#1)
of oxygen therapy##3##3##(2007-6#1)(2008-8#2)
of oxygen to##7##3##(1991-9#1)(1995-2#1)(2008-10#1)(2008-3#2)(2009-8#1)(2012-2#1)
of oxygen transfer##3##3##(1994-2#2)(2008-6#1)
of oxygen uptake and carbon dioxide production rates##2##8##(2008-11#2)
of oxygen uptake and carbon dioxide##5##6##(2008-11#5)
of oxygen uptake in##2##4##(1991-1#1)(2008-12#1)
of oxygen uptake reserve##5##4##(2013-8#5)
of oxygen uptake##19##3##(1991-1#1)(1995-1#1)(2008-11#6)(2008-12#1)(2008-5#2)(2010-12#1)(2013-8#7)
of oxygen was##2##3##(1991-10#1)(2006-3#1)
of oxygen with##4##3##(1995-11#1)(2007-12#1)(2008-10#1)(2009-2#1)
of oxygen##220##2##(1990-10#2)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#7)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#4)(1992-12#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#2)(1994-10#2)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#5)(1994-6#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#3)(1995-8#1)(1996-11#1)(1996-12#2)(1996-6#2)(1996-9#1)(1997-1#5)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#3)(2005-7#5)(2006-10#5)(2006-11#1)(2006-12#1)(2006-3#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-6#1)(2007-8#4)(2007-9#1)(2008-10#28)(2008-11#9)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#2)(2008-5#6)(2008-6#7)(2008-7#5)(2008-8#2)(2008-9#2)(2009-2#2)(2009-3#3)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#10)
of oxygen-17##3##2##(1990-5#3)
of oxygen-derived free radicals##6##4##(1990-4#1)(2008-10#1)(2010-10#1)(2010-3#3)
of oxygen-evolving##2##2##(1996-10#1)(2008-8#1)
of oxygen-glucose deprivation##2##3##(1994-2#1)(1996-1#1)
of oxygenated and##2##3##(2007-8#1)(2011-1#1)
of oxygenated haemoglobin##2##3##(1997-6#2)
of oxygenated##6##2##(1997-6#2)(2007-8#2)(2008-12#1)(2011-1#1)
of oxygenation##8##2##(1990-8#1)(1995-5#1)(1995-9#1)(1997-2#1)(2005-7#1)(2008-11#1)(2008-8#1)(2012-3#1)
of oxyhaemoglobin##2##2##(1997-6#2)
of oxyhemoglobin##5##2##(1990-8#1)(1992-11#1)(1994-2#1)(1995-5#1)(1997-2#1)
of oxysterols##2##2##(1996-5#2)
of oxytetracycline and metronidazole##2##4##(1996-6#2)
of oxytetracycline##4##2##(1996-6#2)(2008-10#1)(2013-8#1)
of oxytocin and##2##3##(1994-11#1)(1997-4#1)
of oxytocin##13##2##(1991-2#1)(1992-11#1)(1993-4#1)(1994-10#1)(1994-11#1)(1994-6#1)(1994-9#1)(1996-11#1)(1997-4#2)(1997-7#1)(1997-8#1)(2008-4#1)
of ozonated oil##2##3##(2013-8#2)
of ozonation##4##2##(1994-8#1)(2005-12#1)(2008-10#2)
of ozone and##2##3##(2004-4#1)(2008-3#1)
of ozone as##3##3##(2008-10#2)(2011-1#1)
of ozone in##4##3##(2007-12#1)(2008-10#2)(2008-11#1)
of ozone is##2##3##(1992-8#1)(2008-10#1)
of ozone on##3##3##(1992-3#1)(1997-2#1)(2008-5#1)
of ozone profiles obtained##2##4##(2008-2#1)(2008-3#1)
of ozone profiles##3##3##(2008-2#2)(2008-3#1)
of ozone treatment##2##3##(2005-11#1)(2008-10#1)
of ozone with##2##3##(1992-8#1)(2008-10#1)
of ozone##45##2##(1991-5#1)(1991-9#2)(1992-3#4)(1992-4#1)(1992-8#3)(1997-2#1)(2004-4#1)(2005-11#1)(2007-11#2)(2007-12#1)(2008-10#10)(2008-11#1)(2008-2#3)(2008-3#7)(2008-5#1)(2009-4#1)(2010-12#1)(2011-1#1)(2012-2#2)(2013-8#1)
of ozonized##2##2##(2005-11#2)
of p##13##2##(1996-2#1)(1997-8#1)(2005-10#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-11#1)(2013-1#1)
of p-NF-kBp65 (Ser 536)##3##4##(2010-3#3)
of p-NF-kBp65##4##2##(2010-3#4)
of p-chloroamphetamine in##2##3##(1991-8#1)(1996-10#1)
of p-chloroamphetamine##3##2##(1991-8#2)(1996-10#1)
of p-cresol##4##2##(2008-10#1)(2011-2#3)
of p-nitrobenzyl C-functionalized diethylenetriamine pentaacetic acids##2##6##(1997-5#2)
of p-nitrophenol##4##2##(1991-5#1)(1994-3#1)(1994-8#1)(2005-11#1)
of p-nitrophenyl picolinate##2##3##(2005-11#2)
of p-nitrophenyl##4##2##(1991-4#1)(1995-10#1)(2005-11#2)
of p-phenylenediamine##2##2##(2008-10#2)
of p-polarized##2##2##(2007-12#1)(2008-2#1)
of p-substituted N-phenylsulfonylbenzamides##2##3##(2007-11#2)
of p-toluenesulfonic acid##2##3##(2008-5#1)(2009-9#1)
of p110delta##3##2##(1997-4#3)
of p125FAK##5##2##(1994-9#5)
of p130##4##2##(1994-12#4)
of p130Cas##2##2##(2011-1#2)
of p150Glued##2##2##(1995-2#2)
of p16 and##2##3##(2009-1#1)(2012-2#1)
of p16##5##2##(1997-7#1)(2008-9#1)(2009-1#1)(2011-2#1)(2012-2#1)
of p16INK4a and##2##3##(1997-7#1)(2011-1#1)
of p16INK4a##4##2##(1996-4#1)(1997-7#2)(2011-1#1)
of p185HER2-overexpressing##2##2##(1995-2#2)
of p185neu##4##2##(1994-9#4)
of p190rho guanosine triphosphatase-activating protein##2##5##(1996-2#2)
of p20##3##2##(1996-10#1)(1996-5#2)
of p21 in##2##3##(1996-5#1)(1997-7#1)
of p21 protein##2##3##(1991-12#1)(2003-11#1)
of p21##12##2##(1991-12#2)(1994-9#1)(1996-5#4)(1997-7#2)(2003-11#1)(2005-10#1)(2010-2#1)
of p21ras activity##2##3##(1992-12#1)(1993-4#1)
of p21ras##7##2##(1992-12#3)(1993-4#1)(1994-12#2)(1995-11#1)
of p21ras-GTP##2##2##(1993-4#1)(1994-12#1)
of p24##2##2##(1992-11#1)(1997-4#1)
of p27 protein##2##3##(2007-6#2)
of p27##7##2##(2007-12#2)(2007-6#3)(2011-2#1)(2012-12#1)
of p31##2##2##(1997-6#2)
of p33##2##2##(1996-5#2)
of p33CDK2##3##2##(1995-2#1)(1997-1#2)
of p34##2##2##(1994-8#2)
of p34cdc2 kinase in##2##4##(1994-9#2)
of p34cdc2##16##2##(1990-11#4)(1991-1#2)(1993-11#3)(1993-9#1)(1994-9#3)(1997-6#3)
of p38 MAP kinase##2##4##(1996-5#1)(2008-7#1)
of p38 and##2##3##(1996-3#1)(1996-5#1)
of p38##9##2##(1995-3#1)(1996-3#1)(1996-5#2)(2008-7#2)(2010-12#1)(2011-2#1)(2013-8#1)
of p38α##2##2##(2012-12#1)(2012-3#1)
of p42 and p44 mitogen-activated protein##2##6##(1994-12#2)
of p45 in vitro##2##4##(1995-3#1)(1996-5#1)
of p45##8##2##(1995-3#2)(1996-2#2)(1996-5#4)
of p47-phox and p67-phox##2##4##(1990-11#1)(1993-8#1)
of p50##2##2##(1994-8#1)(1997-3#1)
of p53 and NF-B##2##4##(2010-10#2)
of p53 and##13##3##(1993-8#1)(1993-9#1)(1994-7#1)(1995-6#1)(2003-11#1)(2006-6#1)(2008-9#1)(2010-10#2)(2011-2#2)(2013-1#2)
of p53 as##2##3##(1993-3#1)(1997-4#1)
of p53 expression##2##3##(1994-7#1)(2012-1#1)
of p53 gene mutation##2##4##(1991-10#2)
of p53 gene##3##3##(1991-10#2)(2008-10#1)
of p53 in the##2##4##(1992-12#1)(2012-1#1)
of p53 in##14##3##(1992-12#1)(1993-9#1)(1995-8#3)(1997-4#1)(1997-7#1)(2008-6#1)(2008-9#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
of p53 is##3##3##(1990-8#1)(1993-3#1)(1994-2#1)
of p53 mRNA##2##3##(1990-9#1)(1993-4#1)
of p53 may##2##3##(1994-12#1)(2009-5#1)
of p53 on##2##3##(1993-9#1)(2012-1#1)
of p53 or##2##3##(1994-12#1)(2010-10#1)
of p53 protein and##2##4##(1995-10#1)(2003-11#1)
of p53 protein expression##2##4##(2006-12#1)(2008-7#1)
of p53 protein##16##3##(1992-3#1)(1995-10#2)(1995-2#1)(1996-1#3)(2003-11#1)(2005-12#2)(2006-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-2#1)
of p53 that##2##3##(1990-9#1)(1995-6#1)
of p53 were##2##3##(1993-9#1)(2011-2#1)
of p53##135##2##(1990-8#3)(1990-9#2)(1991-10#2)(1991-5#2)(1992-12#4)(1992-3#1)(1993-12#2)(1993-3#2)(1993-4#1)(1993-8#1)(1993-9#8)(1994-12#5)(1994-2#2)(1994-5#1)(1994-7#2)(1994-8#2)(1994-9#1)(1995-10#2)(1995-2#2)(1995-6#3)(1995-8#6)(1995-9#1)(1996-1#3)(1996-10#2)(1997-4#4)(1997-7#3)(2003-11#3)(2005-12#3)(2006-10#2)(2006-12#1)(2006-6#1)(2007-11#2)(2007-8#3)(2008-1#1)(2008-10#6)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-10#4)(2010-12#2)(2010-2#1)(2011-2#7)(2012-1#3)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
of p53-mediated##3##2##(1994-12#1)(1996-10#1)(1997-7#1)
of p55 TNFR##3##3##(1996-5#3)
of p55##4##2##(1991-1#1)(1996-5#3)
of p55/GDI##2##2##(1993-8#2)
of p56lck from##2##3##(1993-3#1)(1994-3#1)
of p56lck##6##2##(1991-11#1)(1993-3#1)(1994-12#2)(1994-3#1)(1994-9#1)
of p60v-src##4##2##(1990-11#1)(1990-9#3)
of p63##2##2##(1993-8#1)(2011-2#1)
of p65 NF-kappa B##2##4##(1995-3#1)(1995-6#1)
of p65##9##2##(1994-8#1)(1994-9#1)(1995-3#3)(1995-6#4)
of p66##2##2##(1992-8#1)(1995-3#1)
of p68##4##2##(1990-2#2)(1991-8#2)
of p72syk in platelets##2##4##(1992-6#1)(1994-12#1)
of p72syk in##3##3##(1992-6#1)(1994-12#2)
of p72syk##13##2##(1992-6#3)(1993-11#3)(1994-12#6)(1994-5#1)
of p75##3##2##(1995-8#2)(2005-8#1)
of p80##2##2##(1992-3#1)(1994-8#1)
of p85##2##2##(1994-6#1)(1997-4#1)
of p95vav##4##2##(1995-3#4)
of p97##2##2##(1991-9#2)
of p97pos##3##2##(1991-9#3)
of pAB##2##2##(1992-5#2)
of pAT112##2##2##(1991-9#2)
of pBPAB##2##2##(1994-3#2)
of pBR322##5##2##(1990-11#1)(1990-5#1)(1991-7#1)(1997-2#1)(2004-12#1)
of pCIS7##2##2##(1990-9#2)
of pDC##2##2##(2011-1#2)
of pDNA##2##2##(2013-1#2)
of pDNA-IL-10##2##2##(2007-12#2)
of pH (5##2##3##(1997-1#1)(2008-10#1)
of pH 2 and##2##4##(1990-8#2)
of pH 2##10##3##(1990-8#2)(2008-10#8)
of pH 3##5##3##(1996-12#1)(2007-8#1)(2008-10#3)
of pH 4##8##3##(1990-5#1)(1996-5#1)(1997-4#3)(2008-10#2)(2012-9#1)
of pH 5##10##3##(1991-3#1)(1992-8#1)(1994-11#1)(1997-3#1)(2005-4#1)(2007-8#1)(2008-10#4)
of pH 6##6##3##(1990-8#2)(1995-2#1)(2006-1#1)(2008-10#1)(2011-2#1)
of pH 7##7##3##(1990-9#1)(1991-7#1)(2007-8#1)(2008-10#4)
of pH 8##8##3##(1990-8#1)(1992-4#1)(1996-5#1)(1997-3#1)(2008-10#2)(2011-1#1)(2012-12#1)
of pH and PIP2 gating in##2##6##(2008-8#2)
of pH and ionic strength##5##5##(1991-4#1)(1993-11#1)(2008-7#1)(2009-2#1)(2013-1#1)
of pH and of##2##4##(2008-10#2)
of pH and salt concentration##2##5##(1997-5#1)(2008-4#1)
of pH and sodium chloride on##2##6##(1990-8#2)
of pH and temperature##6##4##(1990-8#1)(1995-2#1)(1995-8#1)(2008-10#2)(2008-5#1)
of pH and the concentration of##2##6##(1996-5#1)(2008-10#1)
of pH and the##3##4##(1995-8#1)(1996-5#1)(2008-10#1)
of pH and##43##3##(1990-8#3)(1991-4#1)(1992-5#1)(1993-11#1)(1993-4#1)(1995-2#1)(1995-8#2)(1996-12#1)(1996-5#1)(1997-3#1)(1997-5#1)(2006-8#2)(2007-10#2)(2007-8#1)(2008-10#13)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2010-5#1)(2013-1#1)(2013-8#1)
of pH change##2##3##(1994-9#1)(2008-10#1)
of pH from 2##2##4##(1994-8#1)(2008-10#1)
of pH from 6##2##4##(2008-10#1)(2008-8#1)
of pH from##7##3##(1994-6#1)(1994-8#1)(2008-10#4)(2008-8#1)
of pH has been##2##4##(2008-10#1)(2008-8#1)
of pH has##3##3##(2008-10#2)(2008-8#1)
of pH in the##7##4##(1991-12#1)(1991-4#1)(1991-5#1)(1997-7#1)(2005-11#1)(2008-10#2)
of pH in##15##3##(1991-12#1)(1991-4#1)(1991-5#1)(1997-7#1)(2005-11#1)(2007-12#1)(2008-10#6)(2008-5#1)(2008-8#1)(2010-8#1)
of pH is##2##3##(2008-8#1)(2008-9#1)
of pH of the##3##4##(2008-10#3)
of pH of##6##3##(2008-10#6)
of pH on the##8##4##(1990-6#1)(2008-10#3)(2008-5#2)(2008-8#1)(2011-2#1)
of pH on##16##3##(1990-6#1)(1991-5#2)(1992-7#1)(1994-6#1)(2008-10#5)(2008-5#3)(2008-6#1)(2008-8#1)(2011-2#1)
of pH to##2##3##(1994-8#1)(2008-4#1)
of pH values##7##3##(1992-8#2)(1996-4#1)(2005-11#1)(2008-10#3)
of pH with##3##3##(2005-11#1)(2007-10#1)(2008-10#1)
of pH##261##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#10)(1990-9#1)(1991-12#1)(1991-3#3)(1991-4#3)(1991-5#4)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#3)(1993-11#2)(1993-4#1)(1994-11#2)(1994-3#1)(1994-6#2)(1994-8#4)(1994-9#1)(1995-2#3)(1995-5#1)(1995-8#2)(1996-12#2)(1996-4#1)(1996-5#3)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#4)(1997-4#3)(1997-5#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-11#5)(2005-4#2)(2006-1#1)(2006-8#2)(2007-10#3)(2007-12#1)(2007-8#5)(2008-10#124)(2008-11#1)(2008-4#2)(2008-5#11)(2008-6#1)(2008-7#1)(2008-8#8)(2008-9#2)(2009-2#1)(2009-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-9#1)(2013-1#2)(2013-8#1)
of pH-dependence of##2##3##(2008-8#2)
of pH-dependent##2##2##(1992-8#1)(1997-7#1)
of pH-metric##3##2##(1996-2#1)(2008-10#2)
of pH-sensitive##3##2##(1997-1#1)(2008-10#1)(2013-7#1)
of pHi##3##2##(1994-11#1)(1994-6#2)
of pI##2##2##(1990-10#1)(1992-7#1)
of pIGFBP-4##3##2##(1991-12#3)
of pK##4##2##(1990-8#1)(1991-9#1)(2005-11#1)(2008-9#1)
of pK(a) values##2##3##(2008-10#2)
of pK(a)##4##2##(2008-10#3)(2009-9#1)
of pKa values##3##3##(1994-9#1)(1995-11#1)(2007-11#1)
of pKa##6##2##(1992-7#1)(1994-9#1)(1995-11#2)(1996-8#1)(2007-11#1)
of pMIRY-type plasmids##2##3##(1991-8#2)
of pMIRY-type##3##2##(1991-8#3)
of pMLZ-4##2##2##(1993-2#2)
of pO(2)##2##2##(2006-7#1)(2008-11#1)
of pOCs into##2##3##(2008-11#2)
of pOCs##4##2##(2008-11#4)
of pR490##4##2##(1991-7#4)
of pRB##5##2##(1993-6#1)(1995-2#1)(1996-2#1)(2008-11#1)(2013-1#1)
of pRNA##3##2##(1995-6#1)(2010-5#2)
of pRT-9##2##2##(1994-6#2)
of pRb##2##2##(1997-7#1)(2008-6#1)
of pS2##2##2##(1990-2#1)(1995-9#1)
of pSK6##2##2##(1992-9#2)
of pVAX1hsp60##2##2##(2009-5#2)
of pacemaker##4##2##(1997-1#1)(2008-4#2)(2012-2#1)
of pacemakers and##2##3##(2010-5#1)(2011-2#1)
of pacemakers##5##2##(1994-11#1)(2006-9#1)(2008-4#1)(2010-5#1)(2011-2#1)
of pacifier##3##2##(2007-10#2)(2009-6#1)
of pacing##2##2##(2006-9#2)
of packaged SFV##2##3##(2008-4#2)
of packaged##6##2##(2007-12#1)(2008-4#4)(2013-1#1)
of packaging##5##2##(1990-3#1)(1994-3#1)(2008-4#1)(2010-4#2)
of packed##6##2##(1993-8#1)(1994-6#1)(2008-10#1)(2009-5#1)(2010-8#1)(2013-1#1)
of packets##2##2##(2008-2#2)
of packing of the##2##4##(1990-2#1)(2005-11#1)
of packing##6##2##(1990-2#1)(1995-7#1)(1996-4#2)(2005-11#1)(2007-8#1)
of paclitaxel and##2##3##(1997-1#1)(2012-3#1)
of paclitaxel with##2##3##(1996-10#1)(1997-4#1)
of paclitaxel##21##2##(1995-8#1)(1996-10#1)(1997-1#1)(1997-4#3)(2005-11#3)(2007-3#1)(2008-3#1)(2008-7#1)(2009-4#2)(2009-8#1)(2010-11#2)(2012-11#2)(2012-3#1)(2013-8#1)
of pacu##2##2##(2008-7#2)
of paediatric Cushing's disease##2##4##(2006-9#2)
of paediatric anaesthesia##3##3##(2006-10#3)
of paediatric cochlear implant##2##4##(2008-9#1)(2011-1#1)
of paediatric cochlear implantation##3##4##(2008-9#3)
of paediatric cochlear##5##3##(2008-9#4)(2011-1#1)
of paediatric patients with##2##4##(2012-3#1)(2013-1#1)
of paediatric patients##8##3##(1994-3#1)(2006-10#3)(2007-9#1)(2008-7#1)(2012-3#1)(2013-1#1)
of paediatric rotavirus gastroenteritis##2##4##(2007-11#2)
of paediatric urology##3##3##(2008-10#3)
of paediatric##52##2##(1994-3#1)(1997-4#1)(2005-11#1)(2006-10#7)(2006-2#1)(2006-4#1)(2006-9#2)(2007-11#3)(2007-4#2)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#9)(2008-7#1)(2008-9#4)(2009-7#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
of paediatrics##2##2##(2010-3#1)(2010-5#1)
of pages##2##2##(2008-3#1)(2012-12#1)
of paid and##2##3##(2011-2#2)
of paid##3##2##(1995-2#1)(2011-2#2)
of pain after##5##3##(1991-5#1)(2006-10#1)(2006-12#1)(2006-8#1)(2008-9#1)
of pain among##3##3##(2007-11#1)(2008-3#1)(2010-12#1)
of pain and a##2##4##(2006-10#1)(2009-9#1)
of pain and anxiety##4##4##(1995-9#1)(2011-1#2)(2012-2#1)
of pain and depression##3##4##(2008-10#1)(2013-1#2)
of pain and disability##5##4##(2006-10#1)(2007-11#1)(2008-9#2)(2012-12#1)
of pain and fever##2##4##(2008-10#1)(2011-1#1)
of pain and function##3##4##(2010-9#3)
of pain and improvement in##2##5##(2007-11#1)(2007-2#1)
of pain and improvement##3##4##(2007-11#1)(2007-2#1)(2008-9#1)
of pain and other symptoms##2##5##(2006-10#1)(2012-3#1)
of pain and symptoms##2##4##(2005-10#1)(2013-1#1)
of pain and the##4##4##(2006-10#1)(2006-11#2)(2013-7#1)
of pain and##69##3##(1995-9#1)(1996-7#1)(1997-3#1)(1997-5#1)(2005-10#1)(2006-10#7)(2006-11#3)(2006-12#3)(2006-3#2)(2006-8#1)(2007-11#5)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#4)(2008-7#2)(2008-8#1)(2008-9#4)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-9#3)(2011-1#4)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#1)
of pain are##2##3##(2007-2#1)(2007-5#1)
of pain as a##2##4##(1993-9#1)(2008-6#1)
of pain as##3##3##(1993-9#1)(2007-8#1)(2008-6#1)
of pain assessment##3##3##(2007-12#1)(2008-11#2)
of pain associated with##12##4##(1992-2#1)(1993-2#1)(1996-7#1)(2005-8#1)(2006-10#3)(2007-11#3)(2008-1#1)(2010-1#1)
of pain at##2##3##(2006-8#1)(2008-7#1)
of pain before##2##3##(2007-11#1)(2008-7#1)
of pain behavior##2##3##(2006-12#1)(2006-8#1)
of pain behaviour by##2##4##(2008-11#2)
of pain by the##2##4##(1990-6#1)(1994-2#1)
of pain by##3##3##(1990-6#2)(1994-2#1)
of pain can be##2##4##(1991-11#1)(2008-4#1)
of pain can##3##3##(1991-11#1)(2007-12#1)(2008-4#1)
of pain care##2##3##(2010-7#2)
of pain caused by##2##4##(1993-9#1)(2006-6#1)
of pain conditions##3##3##(1996-7#1)(2006-8#1)(2009-7#1)
of pain control##3##3##(2006-10#2)(2007-11#1)
of pain during##4##3##(1990-3#1)(2006-10#1)(2007-12#1)(2007-2#1)
of pain experience##2##3##(2006-12#1)(2012-2#1)
of pain experienced##3##3##(2007-5#1)(2010-11#1)(2011-2#1)
of pain for##3##3##(1993-12#1)(2008-9#1)(2013-1#1)
of pain generation##2##3##(2006-7#1)(2006-8#1)
of pain has been##3##4##(2006-10#1)(2006-12#1)(2006-6#1)
of pain has##5##3##(2006-10#2)(2006-12#1)(2006-6#1)(2009-4#1)
of pain in MS##2##4##(2008-8#2)
of pain in childhood##2##4##(2008-11#2)
of pain in osteoarthritis##2##4##(2007-11#1)(2011-1#1)
of pain in patients with##3##5##(2008-12#1)(2009-9#1)(2010-6#1)
of pain in the back##3##5##(2006-8#3)
of pain in the elderly##2##5##(2007-12#1)(2008-5#1)
of pain in the##20##4##(1990-2#1)(1990-5#1)(1996-2#1)(1996-4#1)(2006-10#2)(2006-8#5)(2007-12#2)(2007-8#1)(2007-9#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-1#1)
of pain in this##2##4##(2006-10#1)(2008-5#1)
of pain in##50##3##(1990-2#1)(1990-5#1)(1991-11#2)(1991-5#1)(1994-9#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-8#1)(2005-10#1)(2006-10#3)(2006-12#1)(2006-8#6)(2007-11#2)(2007-12#3)(2007-2#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#4)(2008-9#1)(2009-1#1)(2009-12#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-7#1)
of pain intensity was##2##4##(2006-12#2)
of pain is highly##2##4##(1996-7#1)(2008-9#1)
of pain is##10##3##(1996-7#2)(2006-12#1)(2006-3#1)(2006-8#1)(2007-10#1)(2008-11#1)(2008-9#1)(2009-5#1)(2012-2#1)
of pain management##9##3##(1996-7#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-2#1)(2009-12#1)(2010-1#1)(2010-11#1)(2012-2#1)
of pain mechanisms##2##3##(2006-10#1)(2008-8#1)
of pain medications##2##3##(1996-7#1)(2008-7#1)
of pain of##2##3##(2004-2#1)(2007-12#1)
of pain on pressure##2##4##(1990-9#1)(1992-5#1)
of pain on##5##3##(1990-9#2)(1992-5#2)(2006-11#1)
of pain perception##2##3##(2009-3#1)(2010-11#1)
of pain relief and improvement##2##5##(2006-7#1)(2010-10#1)
of pain relief and##3##4##(2006-7#1)(2007-11#1)(2010-10#1)
of pain relief is##2##4##(2006-10#1)(2008-7#1)
of pain relief##17##3##(1990-6#1)(2006-10#4)(2006-7#1)(2006-8#1)(2007-11#2)(2007-2#2)(2007-7#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-10#1)
of pain scales##2##3##(1996-7#1)(2008-5#1)
of pain should be##3##4##(2006-10#1)(2006-11#1)(2008-4#1)
of pain therapy##2##3##(2006-10#1)(2006-6#1)
of pain treatment##2##3##(1996-2#1)(2012-2#1)
of pain was achieved in##2##5##(1995-9#1)(2008-6#1)
of pain was the##2##4##(2013-1#1)(2013-8#1)
of pain was##7##3##(1995-9#1)(2007-11#1)(2007-8#1)(2008-6#1)(2008-7#1)(2013-1#1)(2013-8#1)
of pain were##3##3##(1993-2#1)(2007-3#1)(2010-3#1)
of pain when##2##3##(2006-7#1)(2006-8#1)
of pain with##3##3##(1997-6#1)(2006-7#1)(2007-8#1)
of pain##465##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#4)(1990-6#3)(1990-8#1)(1990-9#2)(1991-11#3)(1991-2#1)(1991-3#1)(1991-5#2)(1992-2#3)(1992-3#1)(1992-5#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-8#1)(1993-9#2)(1994-2#2)(1994-9#1)(1995-12#1)(1995-5#1)(1995-9#3)(1996-1#1)(1996-12#1)(1996-2#7)(1996-4#2)(1996-7#14)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-12#2)(2004-2#1)(2005-10#2)(2005-11#1)(2005-7#3)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#36)(2006-11#6)(2006-12#20)(2006-2#1)(2006-3#5)(2006-6#7)(2006-7#6)(2006-8#22)(2007-10#1)(2007-11#34)(2007-12#12)(2007-2#11)(2007-3#1)(2007-5#5)(2007-6#1)(2007-7#4)(2007-8#11)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#14)(2008-12#7)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#4)(2008-7#16)(2008-8#10)(2008-9#17)(2009-1#1)(2009-12#5)(2009-2#1)(2009-3#3)(2009-4#4)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#6)(2010-2#3)(2010-3#2)(2010-4#1)(2010-6#4)(2010-7#3)(2010-8#2)(2010-9#4)(2011-1#7)(2011-12#1)(2011-2#5)(2012-11#1)(2012-12#4)(2012-2#12)(2012-3#4)(2013-1#11)(2013-7#3)(2013-8#4)
of painful bone##2##3##(2006-6#1)(2012-2#1)
of painful chronic pancreatitis##2##4##(2006-10#2)
of painful conditions##3##3##(2006-10#1)(2006-8#1)(2013-1#1)
of painful diabetic neuropathy##2##4##(2008-4#2)
of painful##32##2##(1990-5#1)(1992-5#1)(2006-10#3)(2006-6#1)(2006-8#2)(2007-11#3)(2007-5#1)(2008-10#2)(2008-12#1)(2008-4#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-9#1)(2010-12#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)
of painfull##2##2##(2007-11#2)
of painless swelling in the##2##5##(2005-12#1)(2008-12#1)
of painless##9##2##(1990-6#1)(2005-12#1)(2006-10#1)(2007-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-2#1)(2013-1#1)
of paint##2##2##(2007-12#1)(2012-1#1)
of painted##3##2##(1990-10#1)(2007-12#2)
of paints##2##2##(2007-12#1)(2008-10#1)
of pair##2##2##(1995-12#1)(2010-3#1)
of pair-wise##2##2##(2008-12#1)(2010-8#1)
of paired helical filaments##4##4##(1991-3#1)(1995-11#1)(1995-8#1)(2004-12#1)
of paired##12##2##(1990-9#1)(1991-3#1)(1995-11#1)(1995-8#1)(1996-11#1)(2004-12#1)(2007-12#1)(2007-7#1)(2008-11#1)(2010-12#1)(2010-8#1)(2012-3#1)
of paired-pulse inhibition##2##3##(1996-10#1)(1997-5#1)
of paired-pulse##3##2##(1996-10#1)(1997-5#2)
of pairing and##2##3##(2008-2#1)(2008-7#1)
of pairing##4##2##(2008-2#2)(2008-5#1)(2008-7#1)
of pairings##3##2##(2008-10#1)(2009-11#2)
of pairs of##9##3##(1995-6#1)(1996-12#1)(1996-5#1)(1996-7#1)(2008-10#2)(2008-3#1)(2010-2#1)(2011-2#1)
of pairwise residue correlations##2##4##(1995-8#2)
of pairwise##9##2##(1991-9#1)(1995-8#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)
of palanosetron (0##2##3##(2011-12#2)
of palanosetron##3##2##(2011-12#3)
of palatal##2##2##(2009-8#1)(2013-1#1)
of pale eggs##2##3##(2008-8#2)
of pale##3##2##(2008-8#2)(2010-4#1)
of paleoamygdala##3##2##(2009-2#3)
of palladium and##4##3##(2007-11#1)(2008-10#2)(2008-11#1)
of palladium by##2##3##(2008-10#2)
of palladium chloride and trimethoxysilane##2##5##(2007-11#2)
of palladium in##7##3##(2007-11#1)(2007-8#1)(2008-10#5)
of palladium is##2##3##(2007-11#1)(2007-8#1)
of palladium matrix modification##2##4##(1991-12#2)
of palladium with##2##3##(2008-10#2)
of palladium##32##2##(1991-12#3)(2007-11#9)(2007-8#2)(2008-10#17)(2008-11#1)
of palladium(II) and##3##3##(2008-10#3)
of palladium(II) from##3##3##(2008-10#3)
of palladium(II) in##2##3##(2008-10#2)
of palladium(II) with##6##3##(2008-10#6)
of palladium(II)##23##2##(2007-8#2)(2008-10#21)
of palliation of##2##3##(2006-6#1)(2008-12#1)
of palliation##6##2##(2006-6#1)(2007-10#2)(2008-12#1)(2008-5#1)(2010-12#1)
of palliative care##9##3##(2006-4#2)(2008-4#1)(2010-10#1)(2010-7#2)(2011-2#1)(2012-3#2)
of palliative medicine##2##3##(2012-3#2)
of palliative radiation therapy##2##4##(2008-7#2)
of palliative radiotherapy alone or combined with surgery##2##8##(2007-11#2)
of palliative radiotherapy##8##3##(2007-11#3)(2007-6#3)(2008-10#2)
of palliative treatment in##2##4##(1993-6#1)(1996-12#1)
of palliative##24##2##(1990-11#1)(1993-6#1)(1996-12#1)(2006-4#2)(2007-11#3)(2007-6#3)(2008-10#2)(2008-4#1)(2008-7#2)(2010-10#1)(2010-7#2)(2011-2#1)(2012-3#4)
of pallidal##3##2##(1993-12#1)(1994-2#1)(2005-10#1)
of palm creases##3##3##(2010-12#3)
of palm oil diets##2##4##(2009-5#2)
of palm oil##4##3##(2008-12#1)(2008-5#1)(2009-5#2)
of palm trees##3##3##(2007-3#2)(2012-12#1)
of palm##15##2##(2007-3#2)(2008-10#1)(2008-12#1)(2008-5#4)(2009-5#2)(2010-12#4)(2012-12#1)
of palmar##5##2##(2005-11#1)(2006-4#1)(2007-1#1)(2008-10#1)(2012-1#1)
of palmitate bound to##2##4##(1995-3#2)
of palmitate##9##2##(1990-4#1)(1991-10#1)(1994-12#1)(1995-3#3)(1996-2#1)(2008-5#1)(2010-10#1)
of palmitic acid on##3##4##(2008-5#2)(2010-12#1)
of palmitic acid##7##3##(1995-8#1)(1996-8#1)(2008-5#3)(2009-6#1)(2010-12#1)
of palmitic and##2##3##(1993-9#1)(1994-8#1)
of palmitic saturated fatty acid in##2##6##(2013-1#2)
of palmitic saturated fatty acid##4##5##(2013-1#4)
of palmitic##15##2##(1993-9#1)(1994-8#1)(1995-8#1)(1996-8#1)(2008-5#3)(2009-6#2)(2010-12#1)(2011-2#1)(2013-1#4)
of palmitoyl-CoA##2##2##(1990-5#2)
of palmitoylcarnitine##2##2##(1991-2#2)
of palpable breast masses##2##4##(1990-10#1)(2006-9#1)
of palpable breast##6##3##(1990-10#1)(1995-10#1)(2006-1#3)(2006-9#1)
of palpable##10##2##(1990-10#1)(1995-10#1)(1996-12#1)(2006-1#3)(2006-10#1)(2006-5#1)(2006-9#1)(2007-8#1)
of pamidronate##4##2##(2005-3#1)(2006-10#1)(2007-11#1)(2012-12#1)
of pan masala##2##3##(1992-8#2)
of pancreas and##2##3##(1992-6#1)(2008-3#1)
of pancreas disease##2##3##(1994-7#2)
of pancreas were##2##3##(2008-3#1)(2012-3#1)
of pancreas##26##2##(1991-10#1)(1992-4#1)(1992-6#1)(1994-7#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-3#4)(2008-7#2)(2008-8#1)(2010-12#2)(2012-2#1)(2012-3#7)(2013-1#1)
of pancreatic OPN##2##3##(2010-11#2)
of pancreatic RNase##2##3##(1990-10#1)(2005-8#1)
of pancreatic acinar cell##3##4##(1992-8#1)(1997-7#1)(2006-10#1)
of pancreatic acinar##4##3##(1992-4#1)(1992-8#1)(1997-7#1)(2006-10#1)
of pancreatic and gastric cancer##2##5##(1997-7#2)
of pancreatic and##4##3##(1997-7#2)(2007-5#1)(2010-5#1)
of pancreatic beta-cells in##2##4##(2007-5#1)(2008-12#1)
of pancreatic beta-cells##6##3##(1996-2#1)(2005-1#1)(2007-5#1)(2008-12#1)(2009-3#1)(2012-3#1)
of pancreatic cancer and##2##4##(1990-9#1)(2008-3#1)
of pancreatic cancer cells##2##4##(2013-1#2)
of pancreatic cancer in##5##4##(1995-5#1)(2006-10#2)(2008-3#1)(2013-1#1)
of pancreatic cancer##29##3##(1990-6#4)(1990-9#1)(1991-2#1)(1992-4#1)(1994-3#1)(1995-5#2)(1997-7#1)(2006-10#6)(2008-3#5)(2008-9#1)(2009-5#1)(2011-2#1)(2013-1#4)
of pancreatic cancer]##3##3##(1990-11#1)(1990-9#2)
of pancreatic cancers##2##3##(2005-12#1)(2013-1#1)
of pancreatic carcinoma##3##3##(1994-6#1)(2008-1#1)(2010-12#1)
of pancreatic cells##2##3##(2008-9#1)(2010-11#1)
of pancreatic cysts##2##3##(2012-3#2)
of pancreatic disease##3##3##(1993-5#1)(2006-10#1)(2007-5#1)
of pancreatic diseases##3##3##(2006-10#1)(2006-6#1)(2012-3#1)
of pancreatic endocrine##2##3##(1992-7#1)(2011-2#1)
of pancreatic exocrine secretion##6##4##(2006-10#6)
of pancreatic exocrine##7##3##(1991-5#1)(2006-10#6)
of pancreatic function##2##3##(2006-10#2)
of pancreatic injury##2##3##(2005-10#1)(2010-12#1)
of pancreatic insufficiency##2##3##(1991-2#2)
of pancreatic islet##9##3##(1990-8#1)(1995-7#1)(2008-1#1)(2008-2#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-9#1)
of pancreatic islets##8##3##(1990-8#1)(1992-5#1)(1996-6#1)(2005-7#1)(2008-11#1)(2009-3#1)(2010-10#1)(2010-11#1)
of pancreatic malignancies##2##3##(1991-3#1)(1992-2#1)
of pancreatic malignancy##2##3##(2005-12#1)(2013-8#1)
of pancreatic neoplasm##2##3##(2007-4#1)(2012-2#1)
of pancreatic neoplasms##2##3##(2012-2#2)
of pancreatic pseudocysts##4##3##(1991-8#2)(2005-10#1)(2010-12#1)
of pancreatic secretion##6##3##(1992-8#1)(2006-10#3)(2006-6#1)(2008-7#1)
of pancreatic secretory trypsin inhibitor##2##5##(1990-12#1)(1990-3#1)
of pancreatic secretory trypsin##3##4##(1990-12#1)(1990-3#1)(1996-6#1)
of pancreatic β-cells##2##3##(2010-10#1)(2010-11#1)
of pancreatic##176##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#2)(1990-6#4)(1990-8#2)(1990-9#3)(1991-11#1)(1991-2#3)(1991-3#2)(1991-5#1)(1991-8#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#2)(1994-3#1)(1994-6#1)(1995-3#1)(1995-5#2)(1995-7#1)(1996-2#1)(1996-6#2)(1997-7#4)(2004-12#1)(2005-1#1)(2005-10#3)(2005-11#1)(2005-12#2)(2005-7#1)(2005-8#2)(2006-10#28)(2006-6#2)(2006-8#2)(2007-2#1)(2007-4#1)(2007-5#5)(2007-8#2)(2008-1#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#6)(2008-7#3)(2008-9#2)(2009-3#2)(2009-5#1)(2010-10#3)(2010-11#7)(2010-12#6)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#5)(2012-3#4)(2013-1#10)(2013-7#4)(2013-8#2)
of pancreatitis and pancreatic carcinoma##2##5##(2006-10#2)
of pancreatitis and##5##3##(1993-5#1)(2006-10#2)(2007-2#1)(2013-7#1)
of pancreatitis in##2##3##(1993-7#1)(2006-6#1)
of pancreatitis is##2##3##(2006-6#2)
of pancreatitis with a##2##4##(2006-6#1)(2012-12#1)
of pancreatitis##32##2##(1990-3#1)(1993-5#1)(1993-7#2)(1994-7#1)(1996-8#1)(1996-9#1)(2005-10#1)(2006-10#5)(2006-2#1)(2006-6#8)(2007-2#2)(2009-2#1)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#2)
of pandemic (H1N1) 2009##2##4##(2011-2#1)(2012-1#1)
of pandemic influenza##3##3##(2010-5#1)(2011-2#2)
of pandemic spread##4##3##(2008-10#4)
of pandemic##14##2##(2008-10#4)(2010-5#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2013-1#1)
of paneer##2##2##(2007-8#2)
of panel##2##2##(2006-4#1)(2007-2#1)
of panic and##2##3##(1990-11#1)(2012-2#1)
of panic disorder##6##3##(1995-11#1)(2005-7#1)(2008-3#2)(2012-2#2)
of panic##11##2##(1990-11#1)(1992-2#1)(1995-11#1)(2005-10#1)(2005-7#1)(2007-9#1)(2008-3#2)(2012-2#3)
of panicle and shoot blight of pistachio##2##7##(2008-10#2)
of panicle and shoot blight severity##2##6##(2008-10#2)
of panicle and shoot blight##5##5##(2008-10#5)
of panicle and##6##3##(2008-10#5)(2008-12#1)
of panicle blast##4##3##(2008-10#4)
of panicle##11##2##(2008-10#9)(2008-12#2)
of panniculitis##3##2##(2007-7#1)(2012-12#2)
of panoramic##2##2##(2007-5#1)(2008-12#1)
of panthenol##7##2##(2008-5#7)
of pantropical##2##2##(2010-6#2)
of pap smear##3##3##(2006-10#1)(2011-2#2)
of pap##5##2##(2006-10#2)(2011-2#3)
of papain##3##2##(1990-4#1)(1994-12#1)(2008-4#1)
of papaverine##6##2##(1994-3#1)(2006-11#1)(2008-10#4)
of paper disc##2##3##(1994-11#2)
of paper is##2##3##(2008-3#1)(2013-1#1)
of paper to##2##3##(2008-3#2)
of paper##23##2##(1991-3#1)(1994-11#2)(2006-12#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#6)(2008-9#2)(2009-6#1)(2012-2#1)(2013-1#4)
of papers from##3##3##(2008-3#1)(2008-7#1)(2011-2#1)
of papers in this##2##4##(2007-11#1)(2010-7#1)
of papers on the##2##4##(2009-10#1)(2009-3#1)
of papers presented at the##11##5##(2008-10#9)(2008-2#1)(2010-3#1)
of papers published in the##3##5##(2008-10#1)(2008-5#2)
of papers published##5##3##(2006-10#1)(2008-10#1)(2008-5#2)(2013-1#1)
of papers that##3##3##(2006-10#1)(2008-2#1)(2008-5#1)
of papers##46##2##(1990-12#2)(1991-5#1)(2006-10#4)(2007-11#1)(2007-3#1)(2008-10#20)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#1)(2009-10#1)(2009-3#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
of papillae and##2##3##(1991-3#1)(2008-10#1)
of papillae##5##2##(1991-3#1)(2008-10#4)
of papillary calculi##2##3##(1995-8#2)
of papillary muscle##2##3##(2009-5#1)(2012-2#1)
of papillary thyroid carcinoma##5##4##(1990-4#1)(2007-11#1)(2009-5#2)(2013-8#1)
of papillary##13##2##(1990-4#1)(1995-5#2)(1995-8#2)(2006-12#1)(2007-11#1)(2007-8#1)(2009-5#3)(2012-2#1)(2013-8#1)
of papilledema##2##2##(2008-5#1)(2009-8#1)
of papillomas in##2##3##(2010-7#1)(2013-1#1)
of papillomas per##2##3##(1990-5#1)(1992-8#1)
of papillomas##10##2##(1990-5#3)(1992-8#1)(2008-9#1)(2010-7#3)(2013-1#2)
of papillomavirus##2##2##(1992-2#1)(2008-9#1)
of para-Cl-phenylazo-R-acid##3##2##(2008-10#3)
of para-substituted##2##2##(1994-5#1)(2008-10#1)
of parabens##5##2##(2007-8#3)(2008-10#2)
of parabolic##2##2##(2005-10#1)(2009-9#1)
of parabrachial##2##2##(1992-10#1)(2009-10#1)
of paracetamol and##5##3##(1990-10#1)(2008-10#2)(2008-4#1)(2010-12#1)
of paracetamol from##2##3##(2005-11#1)(2008-10#1)
of paracetamol in pharmaceutical formulations##3##5##(2008-10#3)
of paracetamol in##11##3##(2008-10#11)
of paracetamol##37##2##(1990-10#1)(1995-7#1)(1997-5#1)(2005-11#2)(2006-10#1)(2007-2#1)(2007-8#1)(2008-10#25)(2008-4#1)(2010-12#1)(2012-2#1)(2013-1#1)
of paracoccidioidomycosis##2##2##(2007-7#1)(2008-5#1)
of paracrine factors##2##3##(1994-9#1)(2008-9#1)
of paracrine##6##2##(1992-12#1)(1993-8#1)(1994-9#1)(2006-7#1)(2008-9#1)(2013-1#1)
of paradigms##3##2##(1995-4#1)(2006-4#1)(2013-8#1)
of paradoxical sleep##4##3##(1992-10#2)(1993-2#1)(1996-8#1)
of paradoxical##7##2##(1992-10#3)(1993-2#1)(1996-8#1)(2008-1#1)(2013-1#1)
of paraffin-embedded##3##2##(1994-12#1)(2008-10#1)(2008-11#1)
of parafoveal##3##2##(1992-7#2)(2009-5#1)
of paraganglioma##2##2##(2011-2#1)(2012-2#1)
of paragangliomas##2##2##(1996-8#1)(2005-10#1)
of parallel and concurrent architectures##2##5##(2008-2#2)
of parallel and##3##3##(1991-3#1)(2008-2#2)
of parallel beta-sheet##2##3##(1994-8#1)(2009-5#1)
of parallel fiber##2##3##(1991-11#1)(2008-3#1)
of parallel foils##2##3##(2006-5#2)
of parallel search##2##3##(2008-1#1)(2008-2#1)
of parallel##37##2##(1991-11#1)(1991-3#1)(1993-11#1)(1993-6#1)(1994-5#1)(1994-8#1)(1996-12#1)(2005-11#2)(2006-5#2)(2007-12#2)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#7)(2008-3#2)(2008-8#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)
of parallelism##4##2##(2008-3#2)(2010-8#1)(2013-1#1)
of paralogous##2##2##(2008-8#1)(2012-2#1)
of paralogs##2##2##(2008-8#1)(2009-6#1)
of paralysis##4##2##(1991-1#1)(2006-10#1)(2007-3#1)(2012-12#1)
of paralytic shellfish poisoning##2##4##(1994-12#2)
of paralytic##5##2##(1990-5#1)(1994-12#2)(1997-1#1)(1997-8#1)
of paramagnetic##7##2##(1990-5#1)(1991-7#2)(1994-5#1)(1997-8#1)(2006-10#1)(2007-11#1)
of paramecia##3##2##(1992-6#1)(2008-5#2)
of paramedic diagnosis of stroke##2##5##(2007-9#2)
of paramedics##2##2##(2005-10#1)(2012-2#1)
of parameter estimates##4##3##(1992-8#1)(1996-12#1)(2008-10#1)(2010-2#1)
of parameter estimation##2##3##(2008-10#1)(2009-12#1)
of parameter values and##3##4##(1994-2#1)(2008-3#2)
of parameter values##14##3##(1994-2#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-5#1)(2008-10#2)(2008-3#3)(2008-8#2)(2008-9#1)(2010-2#1)
of parameter##24##2##(1992-8#1)(1994-2#1)(1996-12#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-5#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-8#3)(2008-9#1)(2009-12#1)(2010-2#2)(2010-6#1)
of parameters affecting##2##3##(2008-10#1)(2010-6#1)
of parameters and##3##3##(1994-6#1)(2007-6#1)(2008-10#1)
of parameters for##4##3##(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)
of parameters in the##2##4##(1995-9#1)(2010-8#1)
of parameters involved##2##3##(2006-12#1)(2008-10#1)
of parameters is##3##3##(2008-2#1)(2008-5#1)(2008-9#1)
of parameters of the##4##4##(2006-10#1)(2008-10#1)(2008-3#1)(2013-1#1)
of parameters of##7##3##(1994-6#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-4#1)(2013-1#1)
of parameters such as##4##4##(1996-5#1)(2008-1#1)(2008-3#2)
of parameters that##3##3##(1997-8#1)(2008-3#1)(2009-8#1)
of parameters##76##2##(1991-3#1)(1994-3#1)(1994-6#2)(1995-6#1)(1995-9#1)(1996-3#1)(1996-5#1)(1997-8#1)(2005-1#1)(2005-11#2)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#8)(2008-3#11)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-4#1)(2009-8#1)(2010-11#1)(2010-2#2)(2010-6#1)(2010-8#2)(2010-9#1)(2012-12#2)(2013-1#1)(2013-8#1)
of parametric##17##2##(1995-8#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-11#5)(2007-12#8)
of paramount importance for##2##4##(2007-8#1)(2008-7#1)
of paramount importance in##6##4##(1994-12#1)(2004-11#1)(2007-7#1)(2009-9#1)(2010-12#1)(2010-2#1)
of paramount importance to##11##4##(1991-5#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-2#2)(2010-11#1)(2011-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
of paramount importance##27##3##(1990-10#1)(1991-5#1)(1994-12#1)(1996-2#1)(1997-7#1)(2004-11#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-7#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
of paramount interest##2##3##(2010-2#1)(2011-1#1)
of paramount##30##2##(1990-10#1)(1991-5#1)(1994-12#1)(1996-2#1)(1997-7#1)(2004-11#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-7#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2011-1#2)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
of paramyosin within##2##3##(2006-10#2)
of paranasal aspergilloma##2##3##(2008-5#2)
of paranasal sinuses##2##3##(2009-2#1)(2011-1#1)
of paranasal##6##2##(2008-5#2)(2008-7#1)(2009-2#1)(2011-1#1)(2013-1#1)
of paraneoplastic syndromes##4##3##(1997-7#1)(2009-3#2)(2009-5#1)
of paraneoplastic##6##2##(1996-11#1)(1997-7#1)(2009-3#2)(2009-5#1)(2013-7#1)
of paranoid schizophrenia##3##3##(1997-8#2)(2012-2#1)
of paranoid##4##2##(1997-8#2)(2007-5#1)(2012-2#1)
of paraoesophageal lymph nodes in##2##5##(2005-1#2)
of paraoesophageal lymph nodes##4##4##(2005-1#4)
of paraoxon##9##2##(1991-7#1)(2008-10#6)(2012-11#2)
of paraoxonase 1##2##3##(2009-12#1)(2009-2#1)
of paraoxonase##5##2##(1995-9#1)(1996-3#2)(2009-12#1)(2009-2#1)
of paraparesis##4##2##(2009-4#2)(2013-1#2)
of paraplantaricin C7##2##3##(2007-12#2)
of paraplegia##2##2##(2008-7#1)(2009-4#1)
of paraquat in human##2##4##(2008-10#2)
of paraquat in##6##3##(2008-10#6)
of paraquat was##2##3##(1993-3#1)(2008-10#1)
of paraquat##17##2##(1993-3#1)(1995-7#2)(2008-10#13)(2012-2#1)
of parasitaemia and##2##3##(2005-8#1)(2006-10#1)
of parasitaemia##8##2##(1994-11#1)(1995-9#1)(2005-8#2)(2006-10#1)(2007-8#1)(2008-4#1)(2010-12#1)
of parasite biology##2##3##(2005-8#1)(2006-10#1)
of parasite growth##2##3##(2006-10#1)(2012-3#1)
of parasite life-history##2##3##(2006-10#1)(2008-8#1)
of parasite resistance##2##3##(2009-6#2)
of parasite virulence##6##3##(2008-8#6)
of parasite##36##2##(1992-9#1)(1994-11#2)(1994-12#1)(2005-8#1)(2005-9#1)(2006-10#6)(2006-4#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-4#3)(2008-5#1)(2008-8#9)(2008-9#1)(2009-5#1)(2009-6#3)(2011-2#1)(2012-3#1)
of parasite-mediated##2##2##(2009-2#1)(2012-3#1)
of parasitemia and##2##3##(2012-2#2)
of parasites and the##2##4##(1997-7#1)(2006-4#1)
of parasites and##4##3##(1997-7#2)(2006-4#1)(2008-9#1)
of parasites in the##3##4##(1996-3#1)(2006-10#1)(2007-8#1)
of parasites in##10##3##(1994-11#1)(1996-3#1)(1997-7#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
of parasites is##2##3##(2007-3#1)(2011-2#1)
of parasites was##2##3##(2007-11#1)(2012-2#1)
of parasites were##2##3##(2006-4#1)(2011-2#1)
of parasites##38##2##(1992-2#1)(1994-11#1)(1996-3#1)(1997-7#6)(2006-10#3)(2006-4#2)(2007-1#1)(2007-11#1)(2007-3#2)(2007-8#1)(2008-4#1)(2008-8#4)(2008-9#2)(2010-3#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)
of parasitic diseases##4##3##(2010-12#1)(2011-2#2)(2012-12#1)
of parasitic species##2##3##(2006-10#2)
of parasitic##16##2##(2006-10#3)(2006-5#2)(2007-12#2)(2009-6#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-8#1)
of parasitism in##4##3##(2008-6#1)(2008-8#3)
of parasitism##14##2##(2006-10#1)(2008-10#2)(2008-6#3)(2008-8#7)(2009-3#1)
of parasitized##4##2##(1990-2#1)(1992-6#1)(1997-1#1)(2012-12#1)
of parasitoids##4##2##(2007-6#1)(2008-9#1)(2010-2#1)(2011-12#1)
of parasitological##2##2##(2006-10#1)(2008-8#1)
of parasitology##3##2##(2010-1#2)(2010-3#1)
of parastomal hernias##2##3##(2011-2#2)
of parasympathetic activity##2##3##(2008-7#1)(2013-8#1)
of parasympathetic##4##2##(1992-6#1)(1997-8#1)(2008-7#1)(2013-8#1)
of parathormone##3##2##(2008-1#1)(2008-7#1)(2010-7#1)
of parathyroid adenoma##2##3##(2009-7#2)
of parathyroid adenomas##3##3##(1991-11#1)(2008-10#1)(2009-7#1)
of parathyroid hormone (1-84)##2##4##(1994-6#2)
of parathyroid hormone (PTH##3##4##(1993-12#1)(2008-8#1)(2012-3#1)
of parathyroid hormone (PTH)##8##4##(1992-6#1)(1994-11#1)(2009-3#1)(2009-7#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-8#1)
of parathyroid hormone##19##3##(1990-6#1)(1991-8#1)(1992-6#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-6#2)(2007-8#1)(2008-10#1)(2008-8#1)(2009-3#1)(2009-7#1)(2010-2#2)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
of parathyroid hormone-related peptide in##2##5##(1993-3#1)(1997-6#1)
of parathyroid hormone-related peptide##3##4##(1993-3#1)(1994-3#1)(1997-6#1)
of parathyroid hormone-related protein (PTHrP)##3##5##(1991-8#1)(1994-7#1)(1996-1#1)
of parathyroid hormone-related##6##3##(1991-8#1)(1993-3#1)(1994-3#1)(1994-7#1)(1996-1#1)(1997-6#1)
of parathyroid##36##2##(1990-10#1)(1990-6#1)(1991-11#1)(1991-8#2)(1992-6#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-7#1)(1996-1#1)(1997-6#1)(2007-8#2)(2008-10#2)(2008-8#1)(2009-3#1)(2009-7#4)(2010-2#3)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
of paratuberculosis##2##2##(2010-12#2)
of parenchyma cells##2##3##(2008-10#1)(2012-5#1)
of parenchymal##9##2##(1991-11#1)(1992-8#1)(1993-4#1)(1996-4#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-8#1)(2011-1#1)
of parent and##5##3##(1990-12#2)(2008-9#1)(2009-12#1)(2012-3#1)
of parent drug##3##3##(1996-3#1)(2010-11#2)
of parent involvement##2##3##(1991-3#1)(2012-2#1)
of parent monitoring##3##3##(2010-9#3)
of parent##31##2##(1990-12#2)(1991-3#1)(1992-8#1)(1995-1#1)(1995-11#1)(1996-3#1)(1996-7#1)(2005-11#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-11#2)(2010-5#1)(2010-9#3)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-8#2)
of parent-adolescent##3##2##(2009-7#1)(2012-12#1)(2013-1#1)
of parent-child##3##2##(2009-11#1)(2009-12#1)(2012-12#1)
of parent-rated##2##2##(2006-3#1)(2012-2#1)
of parental and##2##3##(1995-6#1)(2008-9#1)
of parental behavior##2##3##(1991-1#1)(1993-3#1)
of parental care in##2##4##(2008-4#1)(2008-8#1)
of parental care##4##3##(2008-4#1)(2008-8#2)(2008-9#1)
of parental cells##2##3##(1992-11#1)(1996-6#1)
of parental death##2##3##(2010-8#1)(2011-1#1)
of parental investment##4##3##(2008-8#1)(2008-9#3)
of parental monitoring##4##3##(2010-2#4)
of parental stress and##2##4##(2012-2#2)
of parental stress##3##3##(1990-12#1)(2012-2#2)
of parental##58##2##(1990-12#1)(1990-5#1)(1991-1#1)(1992-11#1)(1993-3#1)(1994-2#1)(1995-1#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-3#4)(1996-6#2)(1997-6#1)(2005-12#1)(2006-8#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-8#3)(2008-9#6)(2009-10#1)(2009-12#1)(2009-7#2)(2010-1#1)(2010-11#1)(2010-2#4)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#1)
of parenteral iron##3##3##(2005-10#2)(2008-5#1)
of parenteral nutrition##6##3##(1993-5#1)(2005-10#2)(2008-11#1)(2011-2#1)(2013-1#1)
of parenteral##18##2##(1993-5#1)(1995-9#1)(2004-12#1)(2005-10#4)(2007-11#1)(2007-7#1)(2008-11#1)(2008-5#1)(2009-1#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
of parenterally##3##2##(1993-3#1)(2006-6#1)(2013-7#1)
of parenthood##3##2##(2007-2#1)(2007-3#1)(2009-4#1)
of parenting stress##3##3##(2007-10#1)(2007-8#2)
of parenting##8##2##(1995-2#1)(2007-10#1)(2007-8#2)(2009-9#2)(2010-1#1)(2012-11#1)
of parents and children##2##4##(2009-10#2)
of parents and peers##2##4##(1990-2#2)
of parents and teachers##2##4##(2011-2#1)(2012-12#1)
of parents and the##2##4##(2007-6#1)(2009-10#1)
of parents and##16##3##(1990-2#2)(2006-10#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-10#3)(2009-7#1)(2011-2#1)(2012-12#1)
of parents as##2##3##(1993-1#1)(2008-2#1)
of parents for##2##3##(1992-2#1)(2010-4#1)
of parents from##2##3##(2006-4#1)(2008-3#1)
of parents in##3##3##(2008-8#1)(2009-4#1)(2012-12#1)
of parents of children with##2##5##(1992-2#1)(1993-3#1)
of parents of##6##3##(1992-2#1)(1993-3#1)(1994-3#1)(1996-12#1)(2004-10#1)(2012-12#1)
of parents towards##2##3##(1991-8#2)
of parents were##2##3##(2006-12#2)
of parents who##4##3##(1994-2#2)(1994-3#1)(2011-2#1)
of parents with a##2##4##(2006-8#1)(2013-1#1)
of parents with children##2##4##(2005-12#1)(2012-12#1)
of parents with##8##3##(2005-12#1)(2006-8#1)(2006-9#1)(2007-3#1)(2012-12#1)(2013-1#3)
of parents##74##2##(1990-2#2)(1991-12#1)(1991-8#2)(1992-2#3)(1992-3#1)(1993-1#1)(1993-3#1)(1994-2#2)(1994-3#2)(1996-12#1)(2004-10#1)(2005-12#1)(2005-6#1)(2005-7#1)(2006-10#1)(2006-12#4)(2006-3#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#3)(2009-10#3)(2009-4#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#1)
of parents'##8##2##(1990-12#1)(1994-3#1)(2008-9#1)(2010-1#2)(2010-3#1)(2010-6#1)(2012-12#1)
of parents)##2##2##(2009-7#1)(2013-7#1)
of parents/guardians##3##2##(2008-9#1)(2010-9#2)
of paresthesia##2##2##(1990-11#1)(2006-10#1)
of parietal cells##2##3##(1997-1#1)(2012-2#1)
of parietal##5##2##(1992-10#1)(1997-1#1)(2009-2#1)(2010-12#1)(2012-2#1)
of parity##8##2##(2007-10#1)(2007-3#1)(2007-4#1)(2008-8#1)(2009-5#3)(2010-8#1)
of parkinsonian##5##2##(1993-11#1)(2008-12#1)(2008-7#2)(2012-2#1)
of parkinsonism and##4##3##(1997-2#2)(2008-7#2)
of parkinsonism##9##2##(1997-2#2)(2008-11#2)(2008-7#5)
of parliament and##2##3##(1995-3#1)(2013-8#1)
of paromomycin##2##2##(2007-6#2)
of parotid masses##2##3##(1992-10#2)
of parotid##7##2##(1992-10#3)(1993-10#1)(1996-6#1)(2008-11#1)(2009-4#1)
of paroxetine##5##2##(1991-5#1)(1996-1#1)(1997-3#2)(2008-8#1)
of paroxysmal atrial fibrillation##4##4##(2006-9#2)(2007-8#1)(2007-9#1)
of paroxysmal positional vertigo##3##4##(2008-4#3)
of paroxysmal supraventricular##2##3##(1995-6#2)
of paroxysmal##16##2##(1992-3#1)(1995-6#2)(2006-2#1)(2006-9#2)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#3)(2009-10#2)
of parsimony##2##2##(2008-4#1)(2012-1#1)
of parsley cells##2##3##(1992-11#1)(1997-4#1)
of parsley plastocyanin##2##3##(1994-5#2)
of parsley##5##2##(1992-11#1)(1994-5#2)(1997-4#1)(1997-7#1)
of part of the##5##4##(1993-9#1)(1995-2#1)(2008-10#1)(2008-2#1)(2008-5#1)
of part of##9##3##(1992-11#1)(1993-9#1)(1995-2#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2013-7#1)
of part##11##2##(1992-11#1)(1993-9#1)(1995-2#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2013-7#1)
of parthenin hormesis##2##3##(2008-7#2)
of parthenin##3##2##(2008-7#3)
of parthenium dermatitis##3##3##(2007-8#3)
of parthenogenesis##2##2##(2008-9#1)(2010-3#1)
of parthenogenetic lizards##2##3##(2010-3#2)
of parthenogenetic##3##2##(2010-3#3)
of partial and##2##3##(2006-4#1)(2008-11#1)
of partial anomalous pulmonary venous connection##2##6##(2007-8#1)(2010-9#1)
of partial bone resection procedure##2##5##(2007-11#2)
of partial cDNA fragments##2##4##(1994-6#2)
of partial cDNA##4##3##(1992-11#1)(1993-12#1)(1994-6#2)
of partial coherence##4##3##(2007-12#1)(2007-9#1)(2008-2#1)(2008-3#1)
of partial hospitalization##3##3##(1991-1#2)(1992-1#1)
of partial least squares (PLS)##2##5##(2008-10#2)
of partial least squares##4##4##(2008-10#3)(2008-3#1)
of partial least-squares##2##3##(2007-11#1)(2008-3#1)
of partial resistance in##4##4##(2008-10#4)
of partial resistance to##2##4##(2008-10#2)
of partial resistance were##2##4##(2008-10#2)
of partial resistance##13##3##(2008-10#13)
of partial##101##2##(1990-2#2)(1990-5#1)(1990-6#1)(1991-1#2)(1991-5#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-2#2)(1993-12#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-6#2)(1996-2#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#6)(2007-12#3)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#20)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-2#1)(2010-7#1)(2010-9#1)(2011-2#4)(2012-1#1)(2012-2#3)(2013-1#3)(2013-8#2)
of partial-response##2##2##(2008-3#2)
of partially coherent anisotropic GSM beams##2##6##(2007-11#2)
of partially coherent beams that##2##5##(2007-12#1)(2008-3#1)
of partially coherent beams##5##4##(2007-11#2)(2007-12#2)(2008-3#1)
of partially coherent fields##4##4##(2007-11#1)(2007-12#3)
of partially coherent##16##3##(2007-11#6)(2007-12#7)(2008-3#3)
of partially polarized beams##2##4##(2008-3#2)
of partially polarized light##3##4##(2007-11#1)(2008-3#2)
of partially polarized##5##3##(2007-11#1)(2008-3#4)
of partially purified##8##3##(1990-11#2)(1990-7#1)(1991-11#1)(1991-4#1)(1992-12#1)(1993-9#1)(1995-11#1)
of partially resistant##3##3##(2008-10#3)
of partially##54##2##(1990-11#2)(1990-2#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-4#1)(1992-1#1)(1992-12#2)(1993-9#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-3#2)(1996-3#1)(1997-1#1)(1997-2#1)(2005-11#1)(2006-10#1)(2007-11#7)(2007-12#8)(2007-9#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#8)(2008-8#1)(2010-2#1)
of participant##6##2##(2007-7#1)(2008-10#1)(2009-11#1)(2009-4#1)(2012-1#1)(2012-2#1)
of participants and##3##3##(1991-4#1)(2010-3#1)(2012-12#1)
of participants at##2##3##(2008-11#1)(2008-5#1)
of participants had a##2##4##(2009-3#2)
of participants had##7##3##(2006-3#1)(2008-12#1)(2008-8#1)(2009-3#2)(2012-12#1)(2013-8#1)
of participants in an##2##4##(1990-12#1)(2010-12#1)
of participants in the##2##4##(1994-3#1)(2010-3#1)
of participants in##5##3##(1990-12#1)(1994-3#1)(2009-6#1)(2010-12#1)(2010-3#1)
of participants indicated##2##3##(2006-7#1)(2008-8#1)
of participants reported##4##3##(2009-3#1)(2011-1#1)(2011-12#1)(2012-12#1)
of participants to##2##3##(1996-3#1)(2007-11#1)
of participants was##10##3##(1995-9#1)(2004-10#1)(2006-8#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
of participants with##4##3##(2006-7#1)(2007-12#1)(2012-12#1)(2012-2#1)
of participants##82##2##(1990-12#1)(1991-4#1)(1994-3#1)(1995-1#1)(1995-9#1)(1996-3#1)(2004-10#1)(2006-10#1)(2006-3#1)(2006-7#4)(2006-8#4)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-7#3)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#3)
of participants'##3##2##(2009-11#1)(2012-2#2)
of participating in a##2##4##(2008-3#1)(2009-5#1)
of participating in##5##3##(1991-4#1)(2007-5#1)(2008-3#1)(2009-5#1)(2010-3#1)
of participating##14##2##(1991-4#1)(1995-12#2)(1997-1#1)(2006-10#1)(2007-2#1)(2007-5#1)(2008-3#1)(2009-5#1)(2009-8#1)(2010-3#1)(2012-3#2)(2013-1#1)
of participation by##2##3##(1996-11#1)(2008-10#1)
of participation from##2##3##(2008-12#1)(2010-1#1)
of participation in the##4##4##(1990-2#1)(1993-2#1)(1997-2#1)(2012-2#1)
of participation in##17##3##(1990-2#1)(1993-2#1)(1996-2#1)(1997-2#2)(2006-2#1)(2007-10#2)(2008-11#1)(2008-3#1)(2008-7#2)(2009-5#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
of participation of##3##3##(1996-12#1)(2007-5#2)
of participation##38##2##(1990-2#1)(1992-1#1)(1993-2#1)(1994-12#1)(1995-2#2)(1996-11#1)(1996-12#1)(1996-2#1)(1997-2#2)(2006-2#1)(2007-10#2)(2007-11#2)(2007-5#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#2)(2009-5#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-3#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
of participatory##3##2##(1994-6#1)(2008-2#2)
of particle and##2##3##(1990-7#1)(1993-2#1)
of particle capture##3##3##(2008-9#3)
of particle matter##2##3##(2008-3#2)
of particle position##2##3##(2008-3#1)(2009-9#1)
of particle removal from silicon wafer##2##6##(2005-11#2)
of particle scattering##2##3##(1994-3#1)(2008-3#1)
of particle size and##8##4##(2005-11#1)(2008-10#2)(2008-2#2)(2008-3#1)(2009-2#1)(2011-2#1)
of particle size distribution##2##4##(2005-11#1)(2010-12#1)
of particle size was##2##4##(1996-8#1)(2008-10#1)
of particle size##28##3##(1990-8#1)(1992-3#2)(1993-6#1)(1996-8#1)(2005-11#3)(2008-10#8)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#1)(2009-2#1)(2010-12#1)(2011-2#1)(2013-8#1)
of particle sizing##3##3##(1992-3#1)(2008-2#1)(2008-3#1)
of particle##71##2##(1990-7#1)(1990-8#1)(1991-3#1)(1992-3#3)(1993-2#1)(1993-6#1)(1994-3#1)(1996-8#1)(2005-11#8)(2006-12#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-2#7)(2008-3#16)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-2#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of particle-size distribution##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
of particles and##6##3##(1993-9#1)(1996-12#1)(2005-11#2)(2008-10#1)(2008-2#1)
of particles as##2##3##(2005-11#1)(2008-3#1)
of particles in the##3##4##(1991-12#1)(2008-10#2)
of particles in##8##3##(1991-12#1)(1992-3#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-4#1)
of particles of##3##3##(1997-3#1)(2009-4#1)(2011-2#1)
of particles that are##2##4##(1990-6#1)(2008-3#1)
of particles that##5##3##(1990-6#1)(1991-11#1)(2006-2#1)(2007-8#1)(2008-3#1)
of particles was##3##3##(1996-8#1)(2005-11#1)(2008-5#1)
of particles with##5##3##(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
of particles##74##2##(1990-12#2)(1990-6#1)(1991-11#1)(1991-12#1)(1992-3#2)(1993-5#1)(1993-9#1)(1994-3#2)(1996-12#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-10#1)(2005-11#7)(2006-12#1)(2006-2#2)(2007-12#4)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-2#8)(2008-3#13)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-4#2)(2010-11#1)(2011-2#2)(2012-2#1)
of particular clinical##2##3##(2007-11#1)(2008-6#1)
of particular concern in##4##4##(1991-4#1)(2008-10#1)(2008-3#1)(2012-3#1)
of particular concern##11##3##(1991-3#1)(1991-4#1)(1996-1#1)(2005-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2012-3#1)(2013-1#1)
of particular elements##3##3##(2008-10#2)(2010-5#1)
of particular importance for the##2##5##(2006-9#1)(2008-2#1)
of particular importance for##4##4##(1995-4#1)(1996-3#1)(2006-9#1)(2008-2#1)
of particular importance in the##2##5##(1993-3#1)(1994-9#1)
of particular importance in##7##4##(1992-5#1)(1993-3#1)(1994-9#1)(2006-10#1)(2007-2#1)(2008-6#1)(2013-1#1)
of particular importance##23##3##(1990-2#1)(1991-8#1)(1992-4#1)(1992-5#1)(1993-3#1)(1994-9#1)(1995-12#1)(1995-4#1)(1996-3#1)(1997-7#1)(1997-8#1)(2004-12#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-2#1)(2008-2#1)(2008-6#1)(2008-9#1)(2011-2#2)(2013-1#1)
of particular interest because the##2##5##(2008-2#1)(2008-7#1)
of particular interest because they##2##5##(1996-12#1)(2008-10#1)
of particular interest because##8##4##(1990-12#1)(1995-3#1)(1996-12#1)(2006-2#1)(2008-10#2)(2008-2#1)(2008-7#1)
of particular interest for##11##4##(1995-6#1)(2007-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#2)(2011-1#1)(2013-1#1)(2013-8#1)
of particular interest in##2##4##(2006-9#1)(2012-1#1)
of particular interest is##2##4##(1991-9#1)(2008-3#1)
of particular interest since the##2##5##(1992-8#1)(2008-4#1)
of particular interest since they##2##5##(1992-8#1)(1997-6#1)
of particular interest since##8##4##(1991-12#1)(1992-8#2)(1997-6#2)(1997-8#1)(2008-4#1)(2011-2#1)
of particular interest to the##3##5##(2006-10#1)(2008-8#1)(2013-8#1)
of particular interest to##10##4##(1992-8#1)(1993-12#2)(2005-8#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-8#1)(2008-9#1)(2013-8#1)
of particular interest##57##3##(1990-12#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-8#3)(1993-12#2)(1993-3#1)(1995-3#2)(1995-6#1)(1996-12#1)(1997-1#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#2)
of particular neural##2##3##(1990-11#1)(2008-11#1)
of particular relevance for##2##4##(2007-12#1)(2012-3#1)
of particular relevance in##2##4##(2008-11#1)(2013-8#1)
of particular relevance to##2##4##(1994-8#1)(2008-1#1)
of particular relevance##7##3##(1994-8#1)(2007-12#1)(2008-1#1)(2008-11#1)(2010-2#1)(2012-3#1)(2013-8#1)
of particular significance##4##3##(1992-8#1)(1996-6#1)(2006-10#1)(2008-10#1)
of particular species##2##3##(2008-12#1)(2010-12#1)
of particular types of##2##4##(2008-5#1)(2012-12#1)
of particular value##2##3##(1994-8#1)(2012-3#1)
of particular##164##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#2)(1991-12#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-4#1)(1992-5#1)(1992-8#6)(1992-9#1)(1993-12#3)(1993-3#2)(1994-11#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#2)(1995-3#2)(1995-4#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-6#3)(1997-7#2)(1997-8#2)(2004-12#1)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-9#2)(2007-11#5)(2007-12#3)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#6)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#5)(2009-11#1)(2009-7#2)(2009-8#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#6)(2013-8#3)
of particularly##7##2##(1991-11#1)(1991-4#1)(1992-6#1)(1997-7#1)(2008-4#1)(2008-7#1)(2009-11#1)
of particulate air pollution##2##4##(1997-1#1)(2012-12#1)
of particulate evidence##2##3##(2012-2#2)
of particulate lead##2##3##(1993-9#2)
of particulate matter##5##3##(2007-8#1)(2008-10#2)(2008-6#1)(2008-9#1)
of particulate##21##2##(1992-3#1)(1993-11#1)(1993-9#2)(1994-9#1)(1996-3#1)(1997-1#1)(1997-7#1)(2004-4#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-9#2)(2012-12#1)(2012-2#2)
of particulates and##2##3##(2008-3#1)(2012-2#1)
of partition coefficient##2##3##(2005-10#1)(2011-2#1)
of partition coefficients##5##3##(2008-10#5)
of partition##8##2##(2005-10#1)(2008-10#5)(2008-3#1)(2011-2#1)
of partitioned##2##2##(2008-10#1)(2008-3#1)
of partitioning##5##2##(1990-5#2)(1992-12#1)(2007-8#1)(2008-5#1)
of partly##2##2##(2008-10#1)(2011-1#1)
of partners of HIV positive##2##5##(2007-12#2)
of partners##12##2##(1994-12#1)(1996-1#2)(2007-12#2)(2011-2#1)(2012-11#1)(2012-3#4)(2013-1#1)
of partners'##3##2##(1996-1#1)(2009-9#1)(2010-9#1)
of partnership##8##2##(1991-3#1)(1992-1#3)(1995-12#1)(2008-2#2)(2008-9#1)
of partnerships##4##2##(1994-2#1)(1995-1#1)(1997-2#1)(2012-2#1)
of parts in##2##3##(2008-3#2)
of parts of the##3##4##(1990-7#1)(1992-12#1)(2007-12#1)
of parts of##5##3##(1990-7#1)(1992-12#1)(2006-10#1)(2007-12#1)(2008-9#1)
of parts per##3##3##(2008-10#1)(2008-3#2)
of parts##14##2##(1990-7#1)(1992-12#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-3#4)(2008-9#1)(2009-5#1)(2009-8#1)(2012-2#2)
of parturition##4##2##(1992-1#1)(1994-2#1)(1996-11#1)(2006-5#1)
of parvalbumin##2##2##(1994-8#1)(1995-1#1)
of parvovirus B19 infection##3##4##(2006-10#1)(2013-1#2)
of parvovirus B19##5##3##(1996-7#1)(2006-10#1)(2012-12#1)(2013-1#2)
of parvovirus##6##2##(1991-6#1)(1996-7#1)(2006-10#1)(2012-12#1)(2013-1#2)
of passage##8##2##(1990-11#1)(1992-11#2)(1997-3#2)(2007-6#1)(2008-12#1)(2012-1#1)
of passerine##2##2##(2006-5#1)(2007-2#1)
of passing##5##2##(1993-9#1)(2004-12#1)(2008-10#1)(2008-2#1)(2008-9#1)
of passive Q switching##2##4##(2008-3#2)
of passive avoidance##4##3##(1991-4#1)(1991-5#1)(1994-5#1)(1997-6#1)
of passive transbilayer drug movement##2##5##(1996-5#2)
of passive##32##2##(1990-2#1)(1991-4#1)(1991-5#1)(1994-2#1)(1994-5#1)(1995-3#1)(1996-3#1)(1996-5#2)(1997-5#1)(1997-6#1)(1997-7#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#5)(2010-10#1)(2011-1#1)(2012-1#1)
of passively##2##2##(1994-6#1)(2007-12#1)
of past and##2##3##(2007-12#1)(2008-11#1)
of past experience##2##3##(2009-10#1)(2013-7#1)
of past history##2##3##(1990-3#1)(2007-12#1)
of past month alcohol use##4##5##(2009-12#4)
of past research##2##3##(2007-6#1)(2012-2#1)
of past##34##2##(1990-12#1)(1990-3#1)(1993-12#1)(1993-4#1)(1995-12#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-6#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#4)(2009-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-9#3)(2013-1#1)(2013-7#1)
of pastoral##2##2##(2008-12#1)(2009-10#1)
of pasture and##2##3##(2010-4#2)
of pasture##3##2##(2010-2#1)(2010-4#2)
of patch occupancy are##2##4##(2008-8#1)(2008-9#1)
of patch occupancy##5##3##(2008-8#3)(2008-9#2)
of patch pipets##3##3##(2008-4#3)
of patch##13##2##(2004-12#1)(2008-10#1)(2008-4#3)(2008-8#3)(2008-9#2)(2010-2#1)(2012-12#2)
of patches and##2##3##(2008-10#1)(2008-11#1)
of patches has##2##3##(2008-8#1)(2008-9#1)
of patches##13##2##(2008-10#2)(2008-11#1)(2008-8#6)(2008-9#4)
of patchiness##3##2##(2007-9#1)(2008-10#2)
of patchy##2##2##(2008-8#1)(2008-9#1)
of patella##2##2##(2008-12#1)(2012-12#1)
of patellar##4##2##(2007-7#2)(2009-3#1)(2010-9#1)
of patello-femoral##2##2##(2007-1#1)(2007-8#1)
of patellofemoral pain syndrome##2##4##(1996-3#1)(2008-12#1)
of patellofemoral pain##3##3##(1996-3#1)(2007-6#1)(2008-12#1)
of patency##2##2##(2007-7#1)(2007-8#1)
of patent applications##2##3##(2007-2#1)(2010-12#1)
of patent ductus arteriosus##2##4##(2007-8#1)(2009-10#1)
of patent foramen ovale##2##4##(2007-8#1)(2012-2#1)
of patent rights##2##3##(2005-7#1)(2010-7#1)
of patent##17##2##(1992-10#1)(2005-7#2)(2005-8#1)(2007-2#1)(2007-8#3)(2008-1#3)(2009-10#1)(2010-12#1)(2010-7#2)(2011-3#1)(2012-2#1)
of patented##2##2##(2010-7#1)(2012-2#1)
of patents##5##2##(2008-1#3)(2009-11#2)
of paternal care##2##3##(2008-8#2)
of paternal inheritance##2##3##(2008-8#2)
of paternal##7##2##(2007-7#1)(2008-8#4)(2008-9#1)(2010-9#1)
of paternally derived deletions##2##4##(1997-3#2)
of paternity by##2##3##(1993-7#1)(2007-12#1)
of paternity##15##2##(1990-3#2)(1991-7#3)(1993-7#2)(2006-5#1)(2007-12#1)(2008-12#1)(2008-8#3)(2008-9#1)(2010-9#1)
of path analysis##2##3##(2008-9#1)(2012-1#1)
of path##5##2##(1997-6#1)(2007-12#1)(2008-2#1)(2008-9#1)(2012-1#1)
of pathogen DNA in##2##4##(2008-10#2)
of pathogen DNA present in##3##5##(2008-10#3)
of pathogen DNA##10##3##(2008-10#10)
of pathogen colonization in the##2##5##(1990-9#1)(2008-10#1)
of pathogen colonization##4##3##(1990-9#1)(2008-10#2)(2009-12#1)
of pathogen evolution##2##3##(2008-10#1)(2013-1#1)
of pathogen growth##3##3##(2008-10#3)
of pathogen inoculum##2##3##(2008-10#2)
of pathogen virulence##2##3##(2008-10#1)(2008-9#1)
of pathogen##49##2##(1990-9#1)(2006-5#1)(2008-10#41)(2008-3#1)(2008-9#1)(2009-12#1)(2009-2#1)(2013-1#2)
of pathogen-derived resistance##2##3##(2008-10#2)
of pathogenesis and##8##3##(2005-8#1)(2006-2#1)(2008-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
of pathogenesis in##3##3##(2007-12#1)(2009-8#1)(2013-8#1)
of pathogenesis of##7##3##(1992-3#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2013-1#2)
of pathogenesis##33##2##(1990-6#1)(1992-3#1)(1994-2#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#3)(2013-8#1)
of pathogenesis-related (PR) genes##3##4##(2008-10#3)
of pathogenesis-related (PR)##4##3##(2008-10#4)
of pathogenesis-related genes##3##3##(2008-10#1)(2011-10#2)
of pathogenesis-related##9##2##(2008-10#7)(2011-10#2)
of pathogenetic##2##2##(2009-7#1)(2011-2#1)
of pathogenic Leptospira##2##3##(2008-9#2)
of pathogenic T cells##2##4##(1991-12#1)(2013-1#1)
of pathogenic and nonpathogenic##2##4##(2008-10#2)
of pathogenic and##5##3##(2008-10#3)(2008-9#1)(2010-5#1)
of pathogenic bacteria##4##3##(1990-8#1)(1996-8#1)(2007-12#1)(2011-12#1)
of pathogenic fungi and bacteria##5##5##(2008-5#5)
of pathogenic fungi##9##3##(2008-10#3)(2008-5#5)(2009-2#1)
of pathogenic isolates from##2##4##(2008-10#2)
of pathogenic microorganisms##4##3##(1994-11#1)(1994-5#1)(2008-11#1)(2008-9#1)
of pathogenic viruses##2##3##(2006-7#1)(2008-7#1)
of pathogenic##54##2##(1990-12#1)(1990-8#1)(1991-12#1)(1992-2#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1996-8#1)(2006-7#1)(2007-12#1)(2007-5#1)(2008-10#13)(2008-11#1)(2008-5#8)(2008-7#1)(2008-9#6)(2009-2#1)(2009-6#1)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#1)
of pathogenicity and##2##3##(2007-12#1)(2008-10#1)
of pathogenicity of##2##3##(2007-7#1)(2008-12#1)
of pathogenicity##13##2##(1995-6#1)(2007-12#1)(2007-6#1)(2007-7#2)(2008-10#7)(2008-12#1)
of pathogens and their##2##4##(1994-3#1)(2011-2#1)
of pathogens and##7##3##(1991-10#1)(1994-3#1)(2006-12#1)(2009-10#1)(2009-3#1)(2009-8#1)(2011-2#1)
of pathogens from##3##3##(2007-9#1)(2008-10#1)(2013-1#1)
of pathogens in##5##3##(1996-8#1)(2008-10#3)(2010-11#1)
of pathogens including##2##3##(2006-10#1)(2011-2#1)
of pathogens is##2##3##(2006-10#1)(2008-10#1)
of pathogens such as##2##4##(1992-2#1)(2010-11#1)
of pathogens that##3##3##(2008-10#1)(2008-8#1)(2009-6#1)
of pathogens to##3##3##(2008-10#2)(2009-2#1)
of pathogens##54##2##(1991-10#1)(1992-2#1)(1994-3#2)(1996-8#1)(2006-10#3)(2006-12#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#21)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
of pathognomonic##2##2##(1990-2#1)(2009-10#1)
of pathologic bone##2##3##(2009-3#1)(2010-10#1)
of pathologic conditions##2##3##(1994-8#1)(2007-12#1)
of pathologic##27##2##(1990-3#1)(1990-6#1)(1990-8#1)(1994-8#1)(2006-10#1)(2006-2#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#2)(2009-4#1)(2010-10#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
of pathological DST##2##3##(1994-11#2)
of pathological brain##2##3##(2006-8#1)(2009-8#1)
of pathological changes in the##3##5##(2007-11#1)(2012-1#1)(2013-1#1)
of pathological changes in##5##4##(2005-1#1)(2007-11#2)(2012-1#1)(2013-1#1)
of pathological changes##9##3##(1990-11#1)(1991-6#1)(2005-1#1)(2007-11#3)(2012-1#2)(2013-1#1)
of pathological conditions##7##3##(1997-6#1)(2005-1#1)(2005-11#1)(2005-7#1)(2006-8#1)(2008-4#1)(2012-1#1)
of pathological events##2##3##(2006-8#1)(2008-4#1)
of pathological fracture##6##3##(2007-11#6)
of pathological fractures in##3##4##(2007-11#3)
of pathological fractures##9##3##(2007-11#9)
of pathological gambling in##2##4##(2012-12#1)(2013-8#1)
of pathological gambling##5##3##(1992-6#1)(2008-11#1)(2012-12#2)(2013-8#1)
of pathological processes##3##3##(2006-8#1)(2007-9#1)(2010-11#1)
of pathological##72##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-6#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-11#2)(1995-1#1)(1995-5#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-1#2)(2005-11#1)(2005-7#1)(2006-10#2)(2006-8#4)(2007-11#21)(2007-9#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-7#1)(2012-1#4)(2012-12#4)(2013-1#1)(2013-8#1)
of pathologies##14##2##(1991-4#1)(1996-9#1)(2006-12#1)(2008-7#1)(2009-5#2)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
of pathology and##3##3##(1992-10#1)(2007-2#1)(2011-2#1)
of pathology for##2##3##(2006-8#1)(2008-10#1)
of pathology in the##3##4##(1995-10#1)(2009-9#1)(2011-1#1)
of pathology##33##2##(1992-10#2)(1995-10#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-7#1)(2006-10#1)(2006-8#4)(2007-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
of pathomorphological##2##2##(2008-4#1)(2012-1#1)
of pathophysiologic##5##2##(2005-7#1)(2006-10#1)(2007-10#1)(2007-9#1)(2013-7#1)
of pathophysiological conditions##2##3##(1995-12#1)(2006-2#1)
of pathophysiological##9##2##(1992-7#1)(1995-12#1)(1997-4#1)(2006-10#1)(2006-2#2)(2008-2#1)(2008-5#1)(2010-11#1)
of pathophysiology and##5##3##(2005-10#1)(2006-4#2)(2013-1#2)
of pathophysiology of##3##3##(2005-1#1)(2006-10#1)(2008-9#1)
of pathophysiology##14##2##(1995-3#1)(2005-1#1)(2005-10#1)(2006-10#2)(2006-4#2)(2007-6#1)(2007-8#1)(2008-9#1)(2010-2#1)(2013-1#3)
of pathotypes with##2##3##(2008-10#2)
of pathotypes##3##2##(2008-10#3)
of pathway##7##2##(2006-12#1)(2007-9#1)(2009-5#1)(2009-6#1)(2010-11#2)(2012-1#1)
of pathways and##2##3##(2008-7#1)(2013-8#1)
of pathways in##2##3##(2009-10#1)(2010-11#1)
of pathways of##2##3##(1990-8#1)(2010-12#1)
of pathways##20##2##(1990-8#1)(1994-11#1)(1995-4#1)(2007-7#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2011-2#1)(2013-8#1)
of patient adherence to##3##4##(1993-9#1)(2006-12#1)(2010-8#1)
of patient adherence##4##3##(1993-9#1)(2006-12#1)(2008-3#1)(2010-8#1)
of patient advocacy##2##3##(2008-10#1)(2008-2#1)
of patient age##2##3##(2009-10#1)(2010-2#1)
of patient and family##3##4##(2007-11#1)(2010-2#1)(2012-1#1)
of patient and##10##3##(1993-5#1)(1995-2#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-6#2)(2008-8#1)(2010-2#1)(2012-1#1)
of patient autonomy##2##3##(1991-2#1)(1992-3#1)
of patient care and##4##4##(2006-1#1)(2006-2#1)(2009-8#1)(2012-11#1)
of patient care in##2##4##(2008-7#1)(2012-3#1)
of patient care##35##3##(1991-12#1)(1993-2#1)(1993-3#2)(1994-1#1)(1997-1#2)(1997-3#1)(2005-11#1)(2005-12#1)(2006-1#3)(2006-10#2)(2006-2#2)(2007-10#1)(2007-12#1)(2008-11#3)(2008-5#1)(2008-7#1)(2009-8#1)(2010-8#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#1)
of patient characteristics##2##3##(2006-1#1)(2011-12#1)
of patient compliance##4##3##(1993-11#1)(1993-9#1)(1996-3#1)(2011-2#1)
of patient concerns##2##3##(2006-10#1)(2010-8#1)
of patient cooperation##4##3##(1992-3#1)(2006-10#1)(2007-8#1)(2011-12#1)
of patient data on the Internet##2##6##(2006-6#2)
of patient data##9##3##(1994-3#1)(2006-6#2)(2008-10#1)(2008-12#1)(2013-1#4)
of patient dose##3##3##(2008-3#2)(2012-12#1)
of patient doses##3##3##(1992-3#1)(2008-3#2)
of patient education##5##3##(1991-3#1)(1993-2#1)(2006-9#1)(2010-12#2)
of patient factors##5##3##(2008-10#1)(2008-11#1)(2009-3#1)(2013-1#2)
of patient focused restructuring##2##4##(1993-12#2)
of patient focused##4##3##(1993-12#2)(1994-2#1)(1996-2#1)
of patient groups##3##3##(2007-9#1)(2008-12#1)(2012-2#1)
of patient health##2##3##(2007-12#2)
of patient information and##2##4##(2011-1#1)(2012-2#1)
of patient information leaflets##2##4##(2010-5#1)(2012-3#1)
of patient information##10##3##(1993-3#1)(2007-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#2)
of patient injury##2##3##(2007-4#1)(2010-9#1)
of patient is##2##3##(1991-5#1)(2006-1#1)
of patient management##2##3##(2007-11#1)(2007-7#1)
of patient monitoring##2##3##(1993-11#1)(2006-1#1)
of patient needs##2##3##(2006-1#1)(2013-1#1)
of patient outcomes##6##3##(1993-2#1)(2006-8#1)(2008-1#1)(2010-10#1)(2013-1#2)
of patient participation##2##3##(2004-1#1)(2006-1#1)
of patient perceptions##2##3##(1995-2#1)(2007-8#1)
of patient position##2##3##(1993-7#1)(2008-3#1)
of patient positioning##2##3##(1993-7#1)(2008-9#1)
of patient records##3##3##(2006-10#1)(2008-7#2)
of patient risk##2##3##(1995-9#1)(2010-2#1)
of patient satisfaction and##3##4##(1996-1#1)(1997-1#1)(2006-11#1)
of patient satisfaction with##2##4##(1996-3#1)(2012-12#1)
of patient satisfaction##18##3##(1993-4#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-1#3)(1996-3#3)(1997-1#1)(2006-11#1)(2007-2#1)(2008-10#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
of patient selection##3##3##(2006-12#1)(2006-6#1)(2008-3#1)
of patient serum##2##3##(1997-4#2)
of patient setup##4##3##(2012-12#4)
of patient status##2##3##(1997-2#1)(2013-1#1)
of patient survival##3##3##(1995-2#1)(2008-5#1)(2010-12#1)
of patient symptoms##2##3##(1993-10#1)(2010-12#1)
of patient with##8##3##(2007-11#1)(2007-8#1)(2007-9#1)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
of patient##292##2##(1990-12#1)(1990-3#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#4)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#4)(1993-3#4)(1993-4#1)(1993-5#1)(1993-7#3)(1993-9#2)(1994-1#1)(1994-12#2)(1994-2#3)(1994-3#3)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#1)(1995-9#1)(1996-1#3)(1996-2#2)(1996-3#6)(1996-7#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#2)(2004-1#1)(2004-2#1)(2004-7#1)(2005-11#1)(2005-12#2)(2005-7#1)(2006-1#8)(2006-10#8)(2006-11#1)(2006-12#5)(2006-2#2)(2006-4#1)(2006-5#2)(2006-6#4)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#7)(2007-12#7)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#3)(2008-1#4)(2008-10#5)(2008-11#4)(2008-12#4)(2008-2#2)(2008-3#8)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#7)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#4)(2010-2#3)(2010-4#1)(2010-5#2)(2010-8#6)(2010-9#2)(2011-1#3)(2011-12#3)(2011-2#12)(2012-1#3)(2012-11#3)(2012-12#9)(2012-2#5)(2012-3#5)(2013-1#28)(2013-8#2)
of patient's##13##2##(1991-12#1)(1995-9#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
of patient- and##5##3##(2008-3#1)(2008-7#2)(2010-8#1)(2011-2#1)
of patient-based##3##2##(1994-3#3)
of patient-centered care##2##3##(2012-12#1)(2013-8#1)
of patient-controlled epidural analgesia##3##4##(1993-4#2)(2013-7#1)
of patient-controlled##4##2##(1993-4#2)(2009-6#1)(2013-7#1)
of patient-focused care##3##3##(1994-1#1)(1996-1#1)(1997-3#1)
of patient-reported##3##2##(1995-2#1)(2008-9#1)(2013-1#1)
of patient-satisfaction##2##2##(2010-8#1)(2013-8#1)
of patient-specific##6##2##(2008-12#1)(2008-5#1)(2009-3#1)(2011-2#2)(2012-12#1)
of patients (average improvement##3##4##(2008-9#3)
of patients (follow-up##2##3##(2005-9#2)
of patients (n =##5##4##(2007-8#1)(2008-6#2)(2008-7#1)(2012-3#1)
of patients (p&amp##2##3##(2013-7#2)
of patients 1##2##3##(1995-2#1)(2007-11#1)
of patients achieved a##2##4##(2008-5#1)(2012-3#1)
of patients achieved##6##3##(1993-2#1)(2007-3#1)(2008-5#2)(2008-8#1)(2012-3#1)
of patients achieving complete remission##2##5##(2007-3#1)(2012-2#1)
of patients achieving##5##3##(2007-3#1)(2010-8#2)(2012-2#1)(2013-1#1)
of patients admitted for##2##4##(1997-7#1)(2008-3#1)
of patients admitted to the##2##5##(2011-2#1)(2012-3#1)
of patients admitted to##8##4##(1990-10#1)(2005-8#1)(2006-8#2)(2007-7#1)(2008-7#1)(2011-2#1)(2012-3#1)
of patients admitted with##4##4##(1995-9#1)(2007-10#1)(2008-3#1)(2008-7#1)
of patients admitted##14##3##(1990-10#1)(1995-9#1)(1997-7#1)(2005-8#1)(2006-8#2)(2007-10#1)(2007-7#1)(2008-3#2)(2008-7#2)(2011-2#1)(2012-3#1)
of patients affected by##13##4##(1990-5#1)(1990-6#1)(1991-9#1)(2006-2#1)(2006-6#2)(2008-1#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#2)
of patients affected with##3##4##(1990-11#1)(1992-2#1)(1993-6#1)
of patients affected##17##3##(1990-11#1)(1990-5#1)(1990-6#1)(1991-9#1)(1992-2#1)(1993-6#1)(2006-2#1)(2006-6#3)(2008-1#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#2)
of patients after 10##2##4##(2005-8#1)(2007-11#1)
of patients after AMI##2##4##(2006-8#2)
of patients after a##2##4##(2006-10#2)
of patients after an##2##4##(1991-11#1)(1993-8#1)
of patients after radical##2##4##(1990-10#1)(2008-4#1)
of patients after treatment##2##4##(2007-11#1)(2009-3#1)
of patients after##26##3##(1990-10#1)(1991-11#1)(1993-6#1)(1993-8#1)(2005-8#2)(2006-10#4)(2006-8#3)(2007-11#3)(2007-8#2)(2008-1#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-7#1)(2011-2#1)(2013-8#1)
of patients aged##3##3##(2011-1#1)(2011-11#1)(2012-3#1)
of patients and controls##2##4##(1994-8#1)(2011-1#1)
of patients and family##2##4##(2005-7#1)(2007-8#1)
of patients and in the##2##5##(1992-10#1)(1992-5#1)
of patients and in##3##4##(1992-10#1)(1992-5#1)(2010-5#1)
of patients and physicians##2##4##(1994-2#1)(2012-1#1)
of patients and the##7##4##(1991-4#1)(2004-1#1)(2006-10#1)(2006-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
of patients and their families##3##5##(2007-8#1)(2010-2#1)(2012-2#1)
of patients and their##7##4##(2007-4#1)(2007-8#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-2#1)
of patients and to##2##4##(2008-1#1)(2008-8#1)
of patients and volunteers##2##4##(1992-3#2)
of patients and##75##3##(1990-11#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-10#1)(1992-3#2)(1992-5#1)(1993-6#1)(1993-9#2)(1994-2#1)(1994-8#1)(1995-2#1)(1996-2#2)(1996-7#1)(1997-8#1)(2004-1#1)(2005-5#1)(2005-6#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-6#2)(2006-7#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
of patients and/or##2##3##(2008-11#2)
of patients are intolerant##2##4##(2009-3#1)(2010-12#1)
of patients are##20##3##(1991-4#1)(1993-12#1)(1993-9#1)(1995-11#1)(2005-10#1)(2006-6#2)(2007-8#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-12#1)(2011-2#2)(2012-2#1)
of patients as##6##3##(1994-10#1)(1996-12#1)(2007-7#1)(2007-8#1)(2009-2#1)(2009-5#1)
of patients at high risk of##2##6##(1993-1#1)(2008-7#1)
of patients at high risk##3##5##(1993-1#1)(2004-11#1)(2008-7#1)
of patients at risk for##4##5##(1997-3#1)(2006-10#1)(2012-2#1)(2013-1#1)
of patients at risk of##6##5##(1992-12#1)(2007-12#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-12#1)
of patients at risk##13##4##(1992-12#1)(1997-3#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-3#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
of patients at the##3##4##(2006-10#1)(2007-11#1)(2010-3#1)
of patients at##30##3##(1992-12#2)(1993-1#1)(1997-3#1)(2004-11#1)(2005-10#1)(2005-8#1)(2006-10#2)(2007-11#2)(2007-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#1)
of patients attending a##2##4##(2008-3#1)(2011-1#1)
of patients attending##3##3##(2008-3#2)(2011-1#1)
of patients before##5##3##(1991-2#1)(2007-11#1)(2008-10#1)(2012-12#1)(2012-2#1)
of patients being##4##3##(2006-8#1)(2006-9#1)(2007-11#1)(2011-1#1)
of patients belonged to##2##4##(1996-12#1)(1997-8#1)
of patients benefit from##2##4##(2007-11#1)(2010-11#1)
of patients benefit##3##3##(2007-11#1)(2008-6#1)(2010-11#1)
of patients between##2##3##(1990-10#1)(2011-2#1)
of patients born in the corresponding months in the comparison years##2##11##(2004-11#2)
of patients born in the##3##5##(2004-11#3)
of patients born##4##3##(2004-11#4)
of patients by a##3##4##(1996-12#1)(2007-11#1)(2007-8#1)
of patients by##10##3##(1990-3#1)(1995-9#1)(1996-12#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-8#1)(2012-1#1)(2013-1#1)
of patients can be##5##4##(1990-12#1)(1992-3#1)(1997-3#1)(2006-1#1)(2008-8#1)
of patients can##8##3##(1990-12#1)(1992-3#1)(1997-3#1)(2006-1#1)(2008-8#1)(2010-1#1)(2010-12#1)(2012-11#1)
of patients could##2##3##(1997-8#1)(2007-7#1)
of patients develop##4##3##(2010-12#1)(2012-3#1)(2013-1#2)
of patients developed##3##3##(1996-1#1)(2007-11#1)(2008-6#1)
of patients diagnosed with tinea versicolor treated at##2##8##(2011-2#2)
of patients diagnosed with##10##4##(2006-5#1)(2006-8#2)(2008-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)
of patients did##2##3##(2007-3#1)(2012-12#1)
of patients died##2##3##(2011-2#1)(2012-2#1)
of patients discharged from##3##4##(1996-12#1)(2006-8#1)(2007-7#1)
of patients do not##4##4##(2005-11#1)(2010-12#1)(2011-2#1)(2013-7#1)
of patients during the first##2##5##(1990-6#1)(2007-11#1)
of patients during the##3##4##(1990-6#1)(2007-11#1)(2012-1#1)
of patients during##4##3##(1990-6#1)(2007-11#2)(2012-1#1)
of patients eligible for the##2##5##(1997-8#1)(2008-3#1)
of patients entering##2##3##(1994-5#1)(1996-6#1)
of patients evaluated in##2##4##(2007-6#1)(2010-11#1)
of patients examined##2##3##(2008-4#1)(2010-12#1)
of patients experience##3##3##(2007-12#1)(2008-3#1)(2010-11#1)
of patients experienced##5##3##(2008-10#1)(2009-11#1)(2010-12#1)(2012-3#1)(2013-1#1)
of patients experiencing##4##3##(1994-2#1)(2006-8#2)(2008-7#1)
of patients exposed to##3##4##(1996-9#1)(1997-2#1)(2005-8#1)
of patients for acute stroke##2##5##(2007-9#2)
of patients for surgical treatment##2##5##(2006-6#1)(2008-9#1)
of patients for whom##4##4##(1995-11#1)(1996-1#1)(2006-10#1)(2013-1#1)
of patients for##28##3##(1990-8#1)(1992-9#1)(1993-8#1)(1994-2#1)(1995-11#1)(1995-4#1)(1996-1#1)(2005-7#1)(2006-10#2)(2006-6#1)(2006-9#1)(2007-12#1)(2007-7#1)(2007-9#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-11#2)(2012-12#1)(2013-1#2)
of patients found##2##3##(2009-6#2)
of patients from all##2##4##(2007-8#1)(2010-8#1)
of patients from the##3##4##(1990-3#1)(1995-1#1)(2007-3#1)
of patients from##13##3##(1990-3#1)(1991-11#1)(1993-1#1)(1995-1#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-12#1)
of patients group##2##3##(2013-1#2)
of patients had a successful result##2##6##(2009-3#2)
of patients had a##6##4##(1992-9#1)(2007-7#2)(2009-3#2)(2012-2#1)
of patients had acute##2##4##(2005-10#1)(2009-10#1)
of patients had at least##2##5##(1994-2#1)(2012-3#1)
of patients had steroid##2##4##(2007-8#2)
of patients had##51##3##(1990-2#1)(1991-12#1)(1992-10#1)(1992-3#1)(1992-9#1)(1993-5#1)(1994-2#1)(1994-3#1)(1995-2#1)(2005-10#1)(2006-11#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-7#5)(2007-8#4)(2007-9#1)(2008-11#2)(2008-4#2)(2008-6#2)(2008-7#1)(2009-10#1)(2009-3#2)(2010-12#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)
of patients has been##2##4##(2005-8#1)(2007-11#1)
of patients has resulted in##2##5##(2006-10#1)(2012-2#1)
of patients has##4##3##(2005-8#1)(2006-10#1)(2007-11#1)(2012-2#1)
of patients have a##2##4##(2007-8#1)(2012-2#1)
of patients have been##3##4##(1995-4#1)(2007-11#1)(2008-8#1)
of patients have to##2##4##(1996-2#1)(2010-12#1)
of patients have##18##3##(1990-6#1)(1995-4#1)(1996-2#1)(2005-8#1)(2006-1#1)(2006-10#1)(2007-11#2)(2007-8#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#2)(2012-2#1)(2012-3#1)
of patients having##6##3##(2004-1#1)(2007-11#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-2#1)
of patients hospitalised for##2##4##(2008-6#1)(2013-7#1)
of patients hospitalized for##3##4##(1997-3#1)(2008-7#1)(2012-12#1)
of patients hospitalized##5##3##(1997-3#1)(2007-8#1)(2008-7#1)(2012-12#2)
of patients improved##3##3##(2006-8#1)(2007-8#1)(2010-8#1)
of patients in a##6##4##(1992-4#1)(1994-12#1)(1995-3#1)(2004-3#1)(2008-3#1)(2012-1#1)
of patients in accordance with the##2##6##(2007-8#1)(2013-1#1)
of patients in an##3##4##(1991-11#1)(1992-12#1)(2009-4#1)
of patients in both groups##2##5##(1994-5#1)(2012-2#1)
of patients in remission##2##4##(1992-3#1)(2012-3#1)
of patients in the control group reported that they would make that choice##2##13##(2010-4#2)
of patients in the control group were diagnosed with old septal deviation##2##12##(2011-2#2)
of patients in the control group##5##6##(2010-4#2)(2011-2#3)
of patients in the emergency department##2##6##(2008-3#1)(2012-2#1)
of patients in the intervention group reported that they would choose to##2##12##(2010-4#2)
of patients in the##36##4##(1990-2#1)(1991-7#1)(1992-12#2)(2004-1#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-7#3)(2007-9#2)(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-3#1)(2010-4#4)(2010-6#1)(2010-7#1)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#1)
of patients in this group##2##5##(2007-8#1)(2011-2#1)
of patients in this##4##4##(2005-7#1)(2007-8#1)(2008-6#1)(2011-2#1)
of patients in whom##4##4##(2007-7#1)(2008-7#1)(2009-6#1)(2010-12#1)
of patients in##96##3##(1990-2#1)(1991-11#1)(1991-7#1)(1992-12#3)(1992-3#1)(1992-4#1)(1994-12#2)(1994-5#1)(1994-7#1)(1995-3#1)(2004-1#1)(2004-3#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-6#1)(2006-7#1)(2006-8#5)(2007-11#2)(2007-6#1)(2007-7#4)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#2)(2008-7#6)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#4)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#11)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)
of patients included##2##3##(2006-9#1)(2008-8#1)
of patients indicated##2##3##(2006-8#2)
of patients infected by the##2##5##(1992-10#1)(1996-11#1)
of patients infected with##2##4##(2006-11#1)(2012-1#1)
of patients infected##4##3##(1992-10#1)(1996-11#1)(2006-11#1)(2012-1#1)
of patients into##3##3##(1992-3#1)(2008-7#1)(2013-8#1)
of patients irradiated due to bone metastases##3##7##(2007-11#3)
of patients is warranted##2##4##(2007-3#1)(2008-6#1)
of patients is##18##3##(1992-5#1)(1995-7#1)(2005-5#1)(2007-2#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-6#2)(2008-7#1)(2008-8#1)(2011-2#2)(2013-1#1)
of patients likely to benefit from##2##6##(2008-3#1)(2009-2#1)
of patients lost##2##3##(2012-12#1)(2013-8#1)
of patients may##4##3##(1995-2#1)(2006-5#1)(2008-6#1)(2013-8#1)
of patients more than##3##4##(1992-10#1)(1992-2#1)(2007-8#1)
of patients must##2##3##(1997-5#1)(2007-12#1)
of patients need##2##3##(2007-2#1)(2011-2#1)
of patients needed##2##3##(2010-10#1)(2012-2#1)
of patients of##5##3##(1992-8#1)(1995-3#1)(2006-10#1)(2013-1#2)
of patients on hemodialysis##2##4##(2008-1#1)(2013-1#1)
of patients on long-term##2##4##(2004-11#1)(2006-8#1)
of patients on maintenance hemodialysis##2##5##(2008-1#2)
of patients on the##6##4##(2006-4#1)(2008-7#1)(2013-8#4)
of patients on##22##3##(1995-6#1)(2004-11#1)(2005-10#1)(2006-4#1)(2006-8#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-7#1)(2010-12#3)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#4)
of patients one##2##3##(1990-8#1)(1990-9#1)
of patients operated by the##3##5##(2006-6#1)(2007-7#2)
of patients operated by##4##4##(1993-11#1)(2006-6#1)(2007-7#2)
of patients operated on for##3##5##(1990-9#1)(1991-9#1)(1993-10#1)
of patients operated##11##3##(1990-9#1)(1991-9#1)(1992-6#1)(1993-10#1)(1993-11#1)(2006-12#1)(2006-6#1)(2007-7#2)(2009-10#1)(2013-8#1)
of patients or##2##3##(2007-7#1)(2012-2#1)
of patients over the age of##2##6##(2011-2#2)
of patients over the##3##4##(2007-8#1)(2011-2#2)
of patients over##6##3##(2005-7#1)(2007-11#1)(2007-8#1)(2011-2#3)
of patients per year##3##4##(1990-8#1)(2006-10#1)(2007-11#1)
of patients per##4##3##(1990-8#1)(2006-10#1)(2007-11#1)(2011-1#1)
of patients present with##5##4##(2006-10#1)(2007-11#1)(2010-12#3)
of patients presented with##2##4##(2008-4#1)(2011-2#1)
of patients presented##6##3##(1997-8#1)(2008-4#2)(2011-2#2)(2013-1#1)
of patients presenting to the##2##5##(2008-3#2)
of patients presenting to##3##4##(2006-8#1)(2008-3#2)
of patients presenting with##9##4##(2007-1#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-7#2)(2011-1#1)(2011-2#1)
of patients presenting##14##3##(1995-11#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-3#2)(2008-7#2)(2011-1#1)(2011-2#1)
of patients previously##3##3##(2007-5#1)(2008-10#1)(2008-5#1)
of patients prior##2##3##(2009-8#1)(2011-2#1)
of patients progressing to##2##4##(2008-1#2)
of patients ranged##2##3##(2005-12#1)(2007-7#1)
of patients received##6##3##(2006-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)
of patients receiving adjuvant##3##4##(1994-6#1)(2007-10#1)(2008-7#1)
of patients receiving filgrastim##2##4##(2008-7#2)
of patients receiving##30##3##(1990-8#1)(1993-7#1)(1994-6#1)(1995-3#1)(1996-12#1)(2004-1#1)(2004-2#1)(2006-1#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#7)(2009-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2013-8#2)
of patients referred for##2##4##(1993-3#1)(2010-5#1)
of patients referred to##2##4##(2010-8#2)
of patients referred##5##3##(1993-3#1)(2007-7#1)(2010-5#1)(2010-8#2)
of patients remains##2##3##(2008-6#1)(2012-1#1)
of patients reported##5##3##(2007-8#1)(2008-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
of patients required##2##3##(2007-8#1)(2012-2#1)
of patients requiring##10##3##(1995-2#1)(2005-10#1)(2006-10#3)(2007-11#2)(2010-10#1)(2010-5#1)(2011-2#1)
of patients respectively##5##3##(2006-6#2)(2007-7#3)
of patients responded to##2##4##(2007-11#2)
of patients responded##3##3##(2007-11#2)(2013-1#1)
of patients resulted##2##3##(2009-2#1)(2013-1#1)
of patients said they had##2##5##(2009-6#2)
of patients said##3##3##(2009-6#3)
of patients scheduled##2##3##(2006-12#1)(2013-1#1)
of patients seeking medical##2##4##(1991-4#1)(2007-11#1)
of patients seeking treatment##2##4##(2008-3#1)(2012-2#1)
of patients seeking##4##3##(1991-4#1)(2007-11#1)(2008-3#1)(2012-2#1)
of patients seen##2##3##(2007-2#2)
of patients selected for##2##4##(2006-2#1)(2013-1#1)
of patients should##3##3##(1993-10#2)(2009-12#1)
of patients showed##2##3##(1996-4#1)(2008-3#1)
of patients starting##2##3##(2007-12#1)(2010-8#1)
of patients still##5##3##(1993-9#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-8#1)
of patients studied##2##3##(2005-1#1)(2007-7#1)
of patients submitted to##4##4##(1993-9#1)(2008-10#1)(2010-1#1)(2013-8#1)
of patients suffering from acute##2##5##(2007-8#1)(2009-6#1)
of patients suffering from rheumatoid arthritis##4##6##(1993-3#1)(1997-5#2)(2013-1#1)
of patients suffering from##27##4##(1990-4#1)(1991-11#1)(1991-4#1)(1992-9#1)(1993-11#1)(1993-3#1)(1995-3#1)(1996-9#1)(1997-5#2)(1997-6#1)(2005-9#2)(2006-6#2)(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-6#1)(2011-2#1)(2011-3#1)(2012-1#1)(2013-1#1)
of patients suffering with##2##4##(2006-8#1)(2007-8#1)
of patients suffering##29##3##(1990-4#1)(1991-11#1)(1991-4#1)(1992-9#1)(1993-11#1)(1993-3#1)(1995-3#1)(1996-9#1)(1997-5#2)(1997-6#1)(2005-9#2)(2006-6#2)(2006-8#1)(2007-11#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-6#1)(2011-2#1)(2011-3#1)(2012-1#1)(2013-1#1)
of patients surviving##2##3##(2006-10#1)(2012-1#1)
of patients taking##2##3##(2008-11#1)(2008-5#1)
of patients that are##2##4##(2008-12#1)(2012-12#1)
of patients that had##2##4##(2006-8#1)(2013-8#1)
of patients that##13##3##(1995-12#1)(2006-1#1)(2006-2#1)(2006-8#1)(2007-8#1)(2008-12#1)(2010-12#1)(2011-1#1)(2012-12#2)(2013-7#2)(2013-8#1)
of patients the##4##3##(1990-1#1)(2004-11#1)(2007-11#1)(2008-1#1)
of patients these##2##3##(2008-5#1)(2012-12#1)
of patients to be##2##4##(2010-12#1)(2011-1#1)
of patients to the##2##4##(1991-11#1)(2008-8#1)
of patients to##21##3##(1991-11#1)(1993-9#1)(1994-2#1)(1994-6#1)(2005-9#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-7#3)(2008-8#1)(2010-1#1)(2010-12#1)(2010-9#1)(2011-1#1)(2013-1#1)
of patients transplanted##2##3##(1991-9#1)(2010-5#1)
of patients treated at##2##4##(2008-5#1)(2008-7#1)
of patients treated by##4##4##(1992-9#1)(2007-7#1)(2008-10#1)(2010-2#1)
of patients treated for##3##4##(1993-8#1)(1994-5#1)(2009-5#1)
of patients treated in##3##4##(2010-5#1)(2012-2#1)(2013-1#1)
of patients treated with the##2##5##(2007-11#1)(2007-8#1)
of patients treated with##26##4##(1990-3#1)(1990-6#1)(1995-1#1)(1995-2#1)(1996-9#1)(2004-1#1)(2005-10#2)(2007-10#1)(2007-11#3)(2007-8#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-6#1)(2010-5#1)(2011-2#3)(2013-1#3)(2013-8#1)
of patients treated##52##3##(1990-3#1)(1990-6#1)(1991-9#1)(1992-9#1)(1993-8#1)(1994-5#1)(1995-1#1)(1995-2#1)(1996-9#1)(2004-1#1)(2005-10#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#5)(2007-7#2)(2007-8#3)(2008-10#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-5#2)(2011-2#4)(2012-2#3)(2013-1#4)(2013-8#1)
of patients under##6##3##(1990-5#1)(1993-2#1)(1996-2#1)(1996-9#1)(2008-10#1)(2013-1#1)
of patients undergoing laparoscopic##2##4##(2010-11#1)(2013-8#1)
of patients undergoing spinal##2##4##(2012-12#1)(2012-3#1)
of patients undergoing surgery for##2##5##(2006-10#1)(2006-12#1)
of patients undergoing surgery##4##4##(1991-8#1)(2006-10#1)(2006-12#1)(2008-8#1)
of patients undergoing total hip##2##5##(2007-8#1)(2011-2#1)
of patients undergoing treatment with##2##5##(2006-8#1)(2008-10#1)
of patients undergoing##47##3##(1991-5#1)(1991-8#1)(1992-3#1)(1994-5#1)(1996-4#1)(2006-10#6)(2006-11#2)(2006-12#1)(2006-8#2)(2006-9#1)(2007-11#2)(2007-5#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-2#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
of patients underwent##5##3##(1990-10#1)(1990-5#1)(1992-2#1)(2006-6#1)(2008-6#1)
of patients using##2##3##(2004-3#1)(2013-1#1)
of patients was##26##3##(1990-11#1)(1990-5#1)(1990-8#1)(1992-2#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-3#1)(1996-12#1)(2005-10#1)(2006-6#1)(2007-11#4)(2007-2#1)(2007-7#1)(2007-8#1)(2009-6#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-8#1)
of patients were able to##2##5##(2006-2#1)(2008-7#1)
of patients were alive##2##4##(1991-10#1)(2007-11#1)
of patients were seen in##2##5##(1996-1#1)(2007-7#1)
of patients were seen##3##4##(1996-1#1)(2006-2#1)(2007-7#1)
of patients were##57##3##(1990-1#1)(1990-2#1)(1991-10#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-2#1)(1992-5#1)(1994-2#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(2004-10#1)(2006-2#3)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#3)(2007-10#1)(2007-11#1)(2007-7#5)(2007-8#4)(2007-9#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#2)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#5)(2013-1#1)(2013-8#1)
of patients when##2##3##(2007-9#1)(2008-12#1)
of patients where the##2##4##(1994-4#1)(2009-2#1)
of patients who are at##3##5##(1994-12#1)(2008-7#1)(2013-1#1)
of patients who are not##2##5##(2012-3#1)(2013-1#1)
of patients who are##17##4##(1993-3#1)(1994-12#1)(1995-1#1)(1995-12#1)(2006-10#1)(2006-9#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-6#1)(2008-7#1)(2011-12#1)(2012-3#1)(2013-1#2)
of patients who can##4##4##(2007-10#1)(2007-9#1)(2009-8#1)(2013-1#1)
of patients who develop##2##4##(2006-10#1)(2007-9#1)
of patients who developed##2##4##(2007-8#1)(2013-8#1)
of patients who did not##2##5##(1992-11#1)(2009-9#1)
of patients who died##4##4##(1991-8#1)(1994-7#1)(2008-7#1)(2010-2#1)
of patients who experience##3##4##(2008-1#1)(2008-7#1)(2009-2#1)
of patients who had been##2##5##(1991-5#1)(2009-6#1)
of patients who had received##3##5##(1997-5#1)(2004-2#1)(2007-2#1)
of patients who had##20##4##(1991-10#1)(1991-5#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-3#1)(1997-5#1)(2004-2#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-4#1)(2010-7#1)(2011-2#2)
of patients who have been##2##5##(2008-12#1)(2008-3#1)
of patients who have undergone##4##5##(1990-9#1)(2004-12#1)(2010-6#1)(2012-12#1)
of patients who have##19##4##(1990-9#1)(1992-1#1)(2004-12#1)(2006-9#3)(2007-12#5)(2007-8#1)(2007-9#1)(2008-12#1)(2008-3#1)(2010-6#1)(2012-12#1)(2012-3#1)(2013-8#1)
of patients who might benefit from##2##6##(1990-12#1)(2008-8#1)
of patients who present with##4##5##(2007-7#1)(2008-3#1)(2008-5#1)(2009-11#1)
of patients who present##5##4##(2007-11#1)(2007-7#1)(2008-3#1)(2008-5#1)(2009-11#1)
of patients who presented with##2##5##(2005-9#1)(2006-8#1)
of patients who presented##5##4##(1990-3#1)(2005-9#1)(2006-8#1)(2011-2#1)(2013-1#1)
of patients who received##6##4##(1995-4#1)(2005-6#2)(2008-7#1)(2008-9#1)(2012-3#1)
of patients who require##2##4##(2006-9#1)(2007-8#1)
of patients who required##2##4##(1993-2#1)(2008-7#1)
of patients who showed##2##4##(2011-2#1)(2013-8#1)
of patients who suffer from##2##5##(2007-5#1)(2010-5#1)
of patients who suffer##4##4##(2006-10#1)(2007-10#1)(2007-5#1)(2010-5#1)
of patients who survived##3##4##(1993-2#2)(2007-8#1)
of patients who undergo##2##4##(2007-8#1)(2013-1#1)
of patients who underwent a##2##5##(2007-10#1)(2011-12#1)
of patients who underwent##12##4##(2006-8#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-6#1)(2010-11#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
of patients who were admitted##3##5##(2007-10#1)(2008-3#1)(2012-2#1)
of patients who were##13##4##(1991-2#1)(1993-12#1)(1997-2#1)(2007-10#3)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2011-1#1)(2012-2#2)
of patients who will##3##4##(2007-11#1)(2012-3#1)(2013-7#1)
of patients who##159##3##(1990-12#1)(1990-3#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#1)(1994-12#2)(1994-3#1)(1994-7#1)(1995-1#1)(1995-12#1)(1995-4#1)(1995-5#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-12#1)(2004-2#1)(2005-6#3)(2005-9#1)(2006-10#4)(2006-2#1)(2006-5#1)(2006-8#3)(2006-9#5)(2007-10#6)(2007-11#3)(2007-12#5)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#10)(2007-9#5)(2008-1#3)(2008-10#1)(2008-12#1)(2008-3#5)(2008-5#1)(2008-6#3)(2008-7#8)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#6)(2013-1#6)(2013-7#1)(2013-8#5)
of patients whose##9##3##(1997-5#1)(2006-2#1)(2006-9#1)(2008-4#1)(2011-2#2)(2012-3#1)(2013-8#2)
of patients will develop##2##4##(2007-8#1)(2009-3#1)
of patients will##11##3##(1996-12#1)(2007-8#1)(2008-5#2)(2008-6#1)(2009-1#1)(2009-3#1)(2010-12#1)(2010-5#1)(2010-8#1)(2012-2#1)
of patients with ACS##2##4##(2006-6#1)(2008-3#1)
of patients with AD##2##4##(2011-1#1)(2012-2#1)
of patients with AIDS and##2##5##(1996-11#1)(2011-2#1)
of patients with AIDS##6##4##(1994-4#1)(1996-11#1)(2006-10#1)(2008-5#2)(2011-2#1)
of patients with AMD##2##4##(2005-7#1)(2011-2#1)
of patients with ARDS##2##4##(2005-8#1)(2009-6#1)
of patients with Alzheimer disease##2##5##(1995-1#1)(2008-8#1)
of patients with Alzheimer##3##4##(1995-1#1)(2008-8#2)
of patients with Alzheimer's Disease (AD)##2##6##(1993-12#1)(2011-2#1)
of patients with Alzheimer's disease (AD) and##2##7##(1991-3#1)(2008-1#1)
of patients with Alzheimer's disease (AD)##5##6##(1991-3#1)(1995-3#1)(2008-1#1)(2008-7#1)(2012-2#1)
of patients with Alzheimer's disease and##2##6##(1991-1#1)(1996-1#1)
of patients with Alzheimer's disease##13##5##(1990-9#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-9#1)(1992-12#1)(1995-3#1)(1996-1#1)(2006-1#1)(2008-1#1)(2008-7#1)(2009-6#1)(2012-2#1)
of patients with Alzheimer's##15##4##(1990-9#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-9#1)(1992-12#1)(1993-12#1)(1995-3#1)(1996-1#1)(2006-1#1)(2008-1#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-2#1)
of patients with Barrett esophagus##4##5##(2006-10#4)
of patients with Barrett's##2##4##(2011-12#1)(2013-1#1)
of patients with CAD##2##4##(1996-1#1)(2006-9#1)
of patients with CD##2##4##(2008-4#1)(2012-2#1)
of patients with CIN##2##4##(1990-12#1)(2006-10#1)
of patients with CNS##2##4##(2008-7#2)
of patients with COPD##5##4##(2006-9#1)(2009-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
of patients with CRF##3##4##(2007-7#1)(2008-1#1)(2009-2#1)
of patients with Crohn's disease##2##5##(2007-11#1)(2010-12#1)
of patients with ESRD##3##4##(2007-7#1)(2007-8#2)
of patients with FTD##2##4##(2008-4#1)(2008-9#1)
of patients with GBS##2##4##(2007-11#2)
of patients with Graves' disease##4##5##(1990-8#3)(1994-11#1)
of patients with Graves'##6##4##(1990-8#3)(1994-11#1)(2008-7#1)(2009-2#1)
of patients with HCC##3##4##(1993-7#2)(2008-10#1)
of patients with HCV##3##4##(1994-8#1)(2006-2#1)(2012-12#1)
of patients with HD##2##4##(2008-7#1)(2011-2#1)
of patients with HF##2##4##(2010-6#1)(2013-1#1)
of patients with HIV infection##2##5##(2007-11#1)(2008-8#1)
of patients with HIV##3##4##(2007-11#1)(2008-5#1)(2008-8#1)
of patients with HIV/AIDS##2##4##(2007-12#1)(2007-7#1)
of patients with Hodgkin's disease (HD)##2##6##(1997-7#1)(2008-1#1)
of patients with Hodgkin's disease##3##5##(1997-7#2)(2008-1#1)
of patients with MM##2##4##(1996-9#1)(2010-4#1)
of patients with MRSA infections##2##5##(2011-2#2)
of patients with MRSA##3##4##(2011-2#3)
of patients with MS##3##4##(1990-12#1)(2006-12#1)(2008-10#1)
of patients with NSCLC##3##4##(2004-1#1)(2007-4#1)(2012-3#1)
of patients with PD##5##4##(2006-4#1)(2006-9#1)(2007-5#1)(2008-11#2)
of patients with Parkinson##2##4##(2013-8#2)
of patients with Parkinson's disease##6##5##(1991-5#1)(1993-11#1)(1994-2#1)(2012-1#2)(2013-1#1)
of patients with RA##4##4##(2006-10#1)(2008-7#1)(2012-3#2)
of patients with SAH is##2##5##(1995-11#1)(2007-10#1)
of patients with SAH##3##4##(1995-11#1)(2007-10#1)(2008-7#1)
of patients with STS##2##4##(2008-6#2)
of patients with T-cell##2##4##(2007-2#1)(2008-5#1)
of patients with T1D##2##4##(2007-5#2)
of patients with a diagnosis of##3##6##(2007-10#1)(2012-2#2)
of patients with a high probability##2##6##(2005-10#1)(2007-11#1)
of patients with a high##3##5##(1990-3#1)(2005-10#1)(2007-11#1)
of patients with a history of##2##6##(1997-1#1)(2008-9#1)
of patients with a neuromuscular disorder in this group had a successful result##2##13##(2009-3#2)
of patients with a##42##4##(1990-1#1)(1990-11#1)(1990-3#1)(1991-10#1)(1991-8#1)(1991-9#1)(1992-2#2)(1993-11#1)(1996-1#1)(1996-7#1)(1997-1#1)(1997-7#1)(2005-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#4)(2007-3#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#3)(2009-3#2)(2012-2#3)(2013-1#1)(2013-8#1)
of patients with abnormal##3##4##(1994-9#1)(2006-1#1)(2011-2#1)
of patients with active##5##4##(2008-7#1)(2011-1#1)(2012-2#3)
of patients with acute chest pain##2##6##(2008-3#2)
of patients with acute coronary syndrome##2##6##(2008-3#2)
of patients with acute coronary syndromes##3##6##(2008-3#2)(2011-1#1)
of patients with acute coronary##7##5##(2006-6#1)(2008-3#4)(2011-1#1)(2013-8#1)
of patients with acute myocardial infarction (AMI)##2##7##(1997-6#1)(2013-1#1)
of patients with acute myocardial infarction##8##6##(1990-3#1)(1992-9#1)(1997-6#1)(2008-10#1)(2008-3#1)(2011-1#1)(2013-1#2)
of patients with acute pancreatitis##3##5##(2006-6#1)(2006-7#1)(2009-2#1)
of patients with acute stroke##2##5##(1994-6#1)(2010-11#1)
of patients with acute##37##4##(1990-3#1)(1992-5#1)(1992-9#1)(1993-7#1)(1994-6#1)(1997-6#1)(2006-10#2)(2006-6#2)(2006-7#2)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#9)(2008-5#1)(2009-2#1)(2010-11#1)(2011-1#3)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#2)
of patients with advanced breast cancer##3##6##(1991-6#1)(1993-12#1)(2006-11#1)
of patients with advanced breast##4##5##(1991-6#1)(1993-12#1)(2006-11#1)(2011-2#1)
of patients with advanced##15##4##(1990-8#1)(1991-6#1)(1993-12#1)(1995-8#1)(1997-6#1)(2004-1#1)(2006-10#1)(2006-11#1)(2007-11#1)(2008-1#1)(2008-6#2)(2008-7#1)(2011-12#1)(2011-2#1)
of patients with an##4##4##(1992-8#1)(1993-3#1)(1997-7#1)(2008-7#1)
of patients with and without##3##5##(1990-4#1)(2006-2#1)(2012-3#1)
of patients with aneurysmal##2##4##(2006-11#1)(2007-10#1)
of patients with asthma##4##4##(1993-1#1)(1996-2#1)(1996-7#1)(2012-2#1)
of patients with benign##5##4##(1991-5#1)(1992-5#1)(1992-9#1)(1995-3#1)(2006-8#1)
of patients with biliary##2##4##(1994-6#1)(2006-2#1)
of patients with bipolar disorder##3##5##(2005-6#1)(2012-3#2)
of patients with bipolar##4##4##(2005-10#1)(2005-6#1)(2012-3#2)
of patients with bone sarcomas##2##5##(2008-6#1)(2011-1#1)
of patients with bone##3##4##(2008-6#1)(2011-1#2)
of patients with breast cancer and##2##6##(2007-11#1)(2007-6#1)
of patients with breast cancer##8##5##(1990-1#1)(1990-8#1)(1993-1#1)(1996-6#1)(2004-2#1)(2007-11#1)(2007-6#1)(2013-1#1)
of patients with breast##9##4##(1990-1#1)(1990-8#1)(1993-1#1)(1996-6#1)(2004-2#1)(2007-1#1)(2007-11#1)(2007-6#1)(2013-1#1)
of patients with cancer and##2##5##(1993-9#1)(2008-7#1)
of patients with cancer is##2##5##(2007-8#1)(2008-2#1)
of patients with cancer of the stomach##5##7##(1991-2#1)(2008-7#4)
of patients with cancer of the##7##6##(1990-9#1)(1991-2#1)(1991-8#1)(2008-7#4)
of patients with cancer receiving##2##5##(2008-7#2)
of patients with cancer##22##4##(1990-9#1)(1991-2#1)(1991-8#1)(1993-9#1)(1996-11#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-7#13)(2012-3#1)
of patients with carcinoid##2##4##(1993-11#1)(2013-1#1)
of patients with carcinoma##2##4##(1995-8#1)(2009-3#1)
of patients with cardiac##2##4##(2006-10#1)(2012-2#1)
of patients with cardiovascular disease##2##5##(2006-10#1)(2011-2#1)
of patients with cardiovascular##4##4##(2006-10#1)(2010-4#1)(2011-2#1)(2013-1#1)
of patients with carotid stenosis##2##5##(2006-10#1)(2010-11#1)
of patients with carotid##3##4##(2006-10#1)(2006-11#1)(2010-11#1)
of patients with cerebral##2##4##(2006-2#1)(2006-4#1)
of patients with cerebrovascular bleedings##2##5##(1992-4#2)
of patients with cerebrovascular##4##4##(1992-4#2)(2006-7#1)(2007-10#1)
of patients with cervical spine##2##5##(2007-11#2)
of patients with cervical##4##4##(2005-9#1)(2007-11#2)(2007-4#1)
of patients with chest pain##3##5##(2008-3#2)(2012-2#1)
of patients with chronic HBV##3##5##(2009-11#1)(2011-12#1)(2012-3#1)
of patients with chronic heart failure##2##6##(2008-7#1)(2011-1#1)
of patients with chronic hepatitis C virus infection##2##8##(2006-10#1)(2011-2#1)
of patients with chronic hepatitis C##5##6##(1994-8#1)(2006-10#1)(2007-11#1)(2008-8#1)(2011-2#1)
of patients with chronic hepatitis##6##5##(1994-8#1)(2006-10#1)(2007-11#1)(2008-8#1)(2009-11#1)(2011-2#1)
of patients with chronic kidney##3##5##(2008-4#1)(2008-5#1)(2012-2#1)
of patients with chronic liver##2##5##(1990-10#1)(2009-2#1)
of patients with chronic low back pain##4##7##(2006-8#3)(2008-10#1)
of patients with chronic myeloid##2##5##(1996-2#1)(2006-6#1)
of patients with chronic myeloproliferative diseases and##2##7##(2008-4#2)
of patients with chronic neck##2##5##(2006-8#1)(2010-12#1)
of patients with chronic obstructive pulmonary disease (COPD)##2##8##(2007-3#1)(2011-2#1)
of patients with chronic obstructive pulmonary disease##4##7##(2007-3#1)(2008-4#1)(2011-2#2)
of patients with chronic pain##5##5##(2007-12#1)(2007-2#1)(2008-4#1)(2008-9#1)(2012-3#1)
of patients with chronic pancreatitis##2##5##(2005-10#1)(2006-6#1)
of patients with chronic periodontitis##2##5##(2010-4#1)(2012-3#1)
of patients with chronic renal failure (CRF)##2##7##(2007-7#2)
of patients with chronic renal failure##3##6##(2007-7#2)(2008-1#1)
of patients with chronic##67##4##(1990-10#1)(1992-10#1)(1994-11#1)(1994-8#1)(1996-2#1)(2005-10#1)(2006-10#2)(2006-6#2)(2006-7#2)(2006-8#6)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#6)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#2)(2009-2#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-2#1)(2012-3#3)(2013-1#2)
of patients with cirrhosis of##2##5##(2006-6#1)(2012-3#1)
of patients with cirrhosis##4##4##(2006-10#1)(2006-6#1)(2008-4#1)(2012-3#1)
of patients with colorectal cancer##2##5##(2008-10#1)(2009-12#1)
of patients with colorectal##4##4##(1992-8#1)(2008-10#1)(2009-12#1)(2012-1#1)
of patients with combined##2##4##(2006-8#1)(2012-1#1)
of patients with complete##3##4##(2004-2#1)(2007-11#1)(2007-7#1)
of patients with complex##2##4##(2006-12#1)(2012-12#1)
of patients with complicated##4##4##(1991-6#1)(2008-10#1)(2008-3#1)(2012-12#1)
of patients with congenital heart disease##2##6##(2012-1#1)(2012-2#1)
of patients with congenital heart##3##5##(2010-12#1)(2012-1#1)(2012-2#1)
of patients with congestive heart failure##3##6##(1993-9#1)(2010-11#1)(2012-3#1)
of patients with connective tissue##2##5##(2012-1#1)(2012-2#1)
of patients with coronary artery disease##5##6##(1990-3#1)(1995-6#1)(1996-1#1)(2007-8#1)(2010-5#1)
of patients with coronary artery##6##5##(1990-3#1)(1995-6#1)(1996-1#1)(2007-8#1)(2008-1#1)(2010-5#1)
of patients with coronary disease##3##5##(1993-3#1)(1993-9#1)(1995-11#1)
of patients with coronary heart disease##2##6##(1990-8#1)(2008-7#1)
of patients with coronary##13##4##(1990-3#1)(1990-8#1)(1993-3#1)(1993-9#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-5#1)(2007-8#1)(2008-1#1)(2008-7#1)(2010-5#1)
of patients with cystic fibrosis##2##5##(1991-12#1)(2006-10#1)
of patients with degeneration disease##2##5##(2007-8#2)
of patients with degenerative arthritis##2##5##(2006-3#1)(2008-8#1)
of patients with dementia##3##4##(1996-11#1)(2008-1#1)(2013-8#1)
of patients with diabetes mellitus##5##5##(1991-8#1)(2006-6#1)(2008-1#1)(2008-10#1)(2013-1#1)
of patients with diabetes##13##4##(1991-8#1)(1996-11#1)(2006-6#1)(2007-10#1)(2008-1#3)(2008-10#1)(2008-8#2)(2013-1#1)(2013-8#2)
of patients with diabetic##3##4##(2007-8#1)(2008-1#1)(2011-1#1)
of patients with diagnosis of##2##5##(2008-12#1)(2011-2#1)
of patients with different##4##4##(1991-2#1)(1996-2#1)(1997-2#1)(2012-3#1)
of patients with diffuse##2##4##(2009-8#1)(2013-8#1)
of patients with disease##2##4##(2010-12#1)(2013-8#1)
of patients with dyslipidemia##2##4##(1990-5#1)(2013-8#1)
of patients with early##3##4##(2007-10#1)(2008-5#1)(2011-2#1)
of patients with eating##2##4##(2007-7#1)(2013-1#1)
of patients with elevated##2##4##(2005-12#1)(2008-10#1)
of patients with end-stage renal disease (ESRD)##2##7##(2007-7#2)
of patients with end-stage renal disease##3##6##(2007-7#2)(2008-1#1)
of patients with end-stage renal##4##5##(2007-1#1)(2007-7#2)(2008-1#1)
of patients with end-stage##5##4##(2007-1#1)(2007-2#1)(2007-7#2)(2008-1#1)
of patients with epilepsy##3##4##(1997-8#1)(2010-2#1)(2011-2#1)
of patients with esophageal##2##4##(1993-7#1)(2009-3#1)
of patients with extensive##2##4##(2004-1#1)(2010-5#1)
of patients with familial##6##4##(1992-12#1)(1993-9#1)(1996-3#1)(1996-5#1)(2007-10#1)(2013-8#1)
of patients with focal##3##4##(1997-3#1)(1997-8#1)(2007-8#1)
of patients with fulminant hepatic failure##2##6##(1990-10#1)(2006-10#1)
of patients with functional##3##4##(1992-8#1)(2006-10#1)(2008-7#1)
of patients with gastric##2##4##(1990-2#1)(2010-12#1)
of patients with gastroenteritis##2##4##(1990-6#1)(2008-7#1)
of patients with glioblastoma##3##4##(1994-4#1)(2008-11#1)(2010-9#1)
of patients with head injuries##2##5##(1990-3#1)(1996-8#1)
of patients with head injury##2##5##(1996-9#1)(2006-2#1)
of patients with head##5##4##(1990-3#1)(1994-6#1)(1996-8#1)(1996-9#1)(2006-2#1)
of patients with heart failure##2##5##(1993-2#1)(2006-9#1)
of patients with hematologic##2##4##(2007-12#1)(2008-7#1)
of patients with heparin-induced thrombocytopenia##3##5##(2006-10#1)(2007-11#1)(2009-8#1)
of patients with hepatic##2##4##(2006-6#1)(2009-3#1)
of patients with hepatitis##2##4##(2006-10#1)(2007-11#1)
of patients with high##7##4##(1991-7#1)(2008-6#1)(2012-2#1)(2013-1#1)(2013-8#3)
of patients with high-grade##2##4##(2008-6#2)
of patients with human immunodeficiency virus##2##6##(1996-2#1)(2010-12#1)
of patients with hypertension and##2##5##(2007-11#1)(2011-2#1)
of patients with hypertension##3##4##(2007-1#1)(2007-11#1)(2011-2#1)
of patients with idiopathic##5##4##(1990-8#1)(1991-5#1)(1995-2#1)(2013-1#2)
of patients with impaired##2##4##(1990-1#1)(2006-10#1)
of patients with increased##2##4##(1992-11#1)(2013-1#1)
of patients with inflammatory bowel##2##5##(2006-10#1)(2008-11#1)
of patients with inflammatory##5##4##(1992-12#1)(1993-10#1)(2006-10#1)(2008-11#1)(2008-4#1)
of patients with injuries to the cervical and thoracic spine##2##10##(2007-11#2)
of patients with insulin##3##4##(1990-9#1)(2011-1#2)
of patients with ischemic heart disease##2##6##(1996-9#1)(1997-6#1)
of patients with ischemic stroke##3##5##(2007-10#2)(2007-9#1)
of patients with ischemic##7##4##(1996-9#1)(1997-6#1)(2006-7#1)(2007-10#2)(2007-9#1)(2008-3#1)
of patients with juvenile##2##4##(2007-11#1)(2010-12#1)
of patients with kidney##2##4##(2008-6#1)(2010-12#1)
of patients with late-onset##2##4##(1996-7#1)(2005-8#1)
of patients with left##3##4##(1996-1#1)(2005-10#1)(2008-6#1)
of patients with leukemia##2##4##(1992-3#1)(2008-1#1)
of patients with limited##2##4##(2009-8#1)(2011-1#1)
of patients with liver disease##2##5##(2006-10#1)(2009-4#1)
of patients with liver##6##4##(2006-10#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-4#1)
of patients with localized disease##2##5##(2010-3#2)
of patients with localized##3##4##(2010-3#2)(2011-2#1)
of patients with low##6##4##(2006-10#1)(2007-11#1)(2007-8#1)(2010-8#2)(2013-8#1)
of patients with lower limb arterial occlusive disease for endovascular treatment of the iliac arteries##2##15##(2005-10#2)
of patients with lower##3##4##(2005-10#2)(2006-9#1)
of patients with lung cancer##3##5##(1990-4#1)(2007-6#1)(2012-1#1)
of patients with lung##4##4##(1990-4#1)(2007-6#1)(2009-4#1)(2012-1#1)
of patients with malignancies##2##4##(2007-4#1)(2012-3#1)
of patients with malignant brain tumors##2##6##(2006-7#1)(2008-7#1)
of patients with malignant##8##4##(1990-6#1)(1995-9#1)(1997-2#1)(2004-10#1)(2006-7#1)(2008-7#1)(2010-5#1)(2012-3#1)
of patients with metastatic RCC##2##5##(2010-12#2)
of patients with metastatic disease##5##5##(1990-11#1)(2007-11#1)(2008-6#1)(2010-3#2)
of patients with metastatic melanoma##2##5##(2007-11#2)
of patients with metastatic renal##2##5##(2007-11#1)(2008-6#1)
of patients with metastatic##14##4##(1990-1#1)(1990-11#1)(1994-8#1)(2007-11#4)(2007-5#1)(2008-6#2)(2010-12#2)(2010-3#2)
of patients with moderate and##2##5##(2007-10#1)(2013-8#1)
of patients with moderate##6##4##(1991-7#1)(2006-10#1)(2007-10#1)(2008-5#1)(2010-5#1)(2013-8#1)
of patients with multiple brain metastases##3##6##(2006-7#3)
of patients with multiple myeloma##3##5##(2005-1#1)(2008-1#1)(2011-1#1)
of patients with multiple sclerosis##5##5##(1991-12#1)(1991-8#2)(2007-11#1)(2012-1#1)
of patients with multiple##17##4##(1990-9#1)(1991-12#1)(1991-8#2)(2005-1#1)(2006-7#4)(2007-11#1)(2008-1#1)(2009-3#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)
of patients with muscular##2##4##(2012-2#1)(2012-3#1)
of patients with myelodysplastic##2##4##(2006-10#1)(2008-5#1)
of patients with myocardial infarction##5##5##(2008-7#1)(2011-1#1)(2012-1#3)
of patients with neural##2##4##(2010-5#1)(2012-1#1)
of patients with non##2##4##(2008-8#1)(2012-2#1)
of patients with non-Hodgkin's##3##4##(1992-6#1)(2008-7#1)(2010-12#1)
of patients with normal##4##4##(2007-11#1)(2007-12#1)(2008-10#1)(2009-5#1)
of patients with obstructive##2##4##(1997-4#1)(2008-5#1)
of patients with one or##2##5##(2011-11#1)(2013-1#1)
of patients with osteoarthritis##2##4##(2007-11#1)(2007-8#1)
of patients with osteosarcoma##2##4##(2010-3#2)
of patients with other##3##4##(1990-3#1)(1993-7#1)(2008-1#1)
of patients with ovarian neoplasms##2##5##(1994-2#1)(2010-12#1)
of patients with ovarian##4##4##(1994-2#1)(1996-10#1)(2006-10#1)(2010-12#1)
of patients with paranoid schizophrenia##2##5##(1997-8#1)(2007-7#1)
of patients with peritoneal##2##4##(2010-12#2)
of patients with pituitary##3##4##(2009-2#1)(2011-2#1)(2013-8#1)
of patients with poor##2##4##(2007-7#2)
of patients with positive##5##4##(1992-3#1)(2007-2#1)(2011-1#1)(2012-12#1)(2012-2#1)
of patients with posterior##2##4##(2006-8#1)(2008-1#1)
of patients with primary biliary cirrhosis##3##6##(1992-9#1)(1994-2#1)(2007-11#1)
of patients with primary##14##4##(1991-2#1)(1992-8#2)(1992-9#1)(1994-2#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-2#3)(2008-10#1)(2010-12#1)(2013-1#1)
of patients with progressive##3##4##(1992-8#2)(1995-10#1)
of patients with prophylactic filters##3##5##(2011-2#3)
of patients with psoriasis##2##4##(2007-7#1)(2012-2#1)
of patients with pulmonary##6##4##(1992-2#1)(2006-8#1)(2008-1#1)(2008-7#1)(2010-11#1)(2010-12#1)
of patients with recurrent##3##4##(1993-2#1)(2005-11#1)(2008-1#1)
of patients with reflex sympathetic dystrophy##2##6##(1992-3#1)(2008-7#1)
of patients with refractory##4##4##(1996-1#1)(2006-3#1)(2007-11#1)(2011-1#1)
of patients with renal cell cancer##2##6##(2006-10#1)(2012-1#1)
of patients with renal cell##3##5##(2006-10#1)(2006-9#1)(2012-1#1)
of patients with renal##10##4##(1990-12#1)(1996-2#1)(2006-10#2)(2006-9#1)(2007-12#1)(2007-7#1)(2009-11#1)(2012-1#1)(2012-3#1)
of patients with rheumatic##2##4##(2006-10#1)(2007-11#1)
of patients with rheumatoid arthritis (RA)##3##6##(2006-10#1)(2007-11#1)(2008-8#1)
of patients with rheumatoid arthritis##7##5##(1993-1#1)(2006-10#3)(2007-11#1)(2008-8#1)(2010-12#1)
of patients with schizophrenia##5##4##(1991-9#1)(1995-5#1)(1997-8#1)(2006-12#1)(2012-3#1)
of patients with scleroderma##2##4##(1992-8#1)(2008-10#1)
of patients with severe acute##2##5##(1992-3#1)(2013-1#1)
of patients with severe mental##2##5##(1992-2#1)(1993-1#1)
of patients with severe sepsis##4##5##(2007-7#1)(2009-6#3)
of patients with severe##18##4##(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#1)(1995-5#1)(1997-1#1)(2006-10#2)(2007-7#1)(2008-5#1)(2008-6#1)(2009-6#3)(2009-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
of patients with significant##2##4##(2007-3#1)(2010-12#1)
of patients with skin##5##4##(2007-10#1)(2007-11#1)(2007-7#1)(2008-12#1)(2012-2#1)
of patients with small cell##2##5##(2009-1#1)(2013-8#1)
of patients with soft tissue sarcomas##2##6##(2008-6#2)
of patients with spinal cord##2##5##(1991-6#1)(2007-8#1)
of patients with spinal##3##4##(1991-6#1)(2007-8#1)(2008-10#1)
of patients with stage##2##4##(2008-11#1)(2008-6#1)
of patients with stroke##5##4##(2007-10#2)(2012-11#1)(2013-1#2)
of patients with suspected ACS##2##5##(2008-3#2)
of patients with suspected or##2##5##(2007-11#1)(2012-2#1)
of patients with suspected##13##4##(1990-6#1)(1991-4#1)(1995-6#1)(2007-11#1)(2007-4#1)(2008-3#3)(2010-10#1)(2011-1#1)(2012-12#1)(2012-2#2)
of patients with symptomatic##3##4##(1993-2#1)(2008-8#1)(2009-8#1)
of patients with syringomyelia##2##4##(2005-8#1)(2006-5#1)
of patients with systemic lupus erythematosus (SLE)##2##7##(1990-12#1)(1994-3#1)
of patients with systemic lupus erythematosus##3##6##(1990-12#1)(1994-3#1)(2010-11#1)
of patients with systemic sclerosis##2##5##(2008-8#1)(2011-12#1)
of patients with systemic##5##4##(1990-12#1)(1994-3#1)(2008-8#1)(2010-11#1)(2011-12#1)
of patients with the##10##4##(1990-12#1)(1991-3#1)(2004-11#1)(2005-8#1)(2006-8#1)(2007-10#1)(2008-5#1)(2008-6#1)(2010-9#1)(2011-1#1)
of patients with these disorders##2##5##(2005-6#1)(2013-1#1)
of patients with these##7##4##(1995-5#1)(2005-6#1)(2005-7#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
of patients with this disease##3##5##(1996-3#1)(2007-11#1)(2008-6#1)
of patients with this disorder##3##5##(1993-11#1)(2006-10#1)(2007-4#1)
of patients with this##15##4##(1993-11#1)(1996-3#1)(1996-7#1)(2006-10#2)(2007-11#1)(2007-4#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-2#1)(2011-2#2)(2012-12#1)(2012-2#1)
of patients with traumatic##4##4##(2006-10#1)(2007-11#1)(2009-2#1)(2011-2#1)
of patients with tumors##2##4##(1990-10#1)(2007-8#1)
of patients with type 2 DM##2##6##(2008-8#1)(2010-10#1)
of patients with type 2 diabetes##5##6##(2006-9#1)(2010-10#1)(2011-1#1)(2012-1#1)(2012-12#1)
of patients with type 2##8##5##(2006-9#1)(2007-1#1)(2008-8#1)(2010-10#2)(2011-1#1)(2012-1#1)(2012-12#1)
of patients with type II diabetes mellitus and##2##8##(1996-1#1)(2006-6#1)
of patients with type II diabetes mellitus##3##7##(1996-1#2)(2006-6#1)
of patients with type II diabetes##5##6##(1996-1#2)(1996-11#1)(2005-8#1)(2006-6#1)
of patients with type##16##4##(1992-3#1)(1996-1#2)(1996-11#1)(1996-9#1)(2005-8#1)(2006-6#1)(2006-9#1)(2007-1#1)(2008-8#1)(2010-10#2)(2011-1#1)(2012-1#2)(2012-12#1)
of patients with unexplained##2##4##(2006-10#1)(2008-11#1)
of patients with unilateral##2##4##(2007-10#1)(2007-7#1)
of patients with unstable angina##3##5##(1990-12#1)(2007-11#1)(2012-1#1)
of patients with unstable##5##4##(1990-12#1)(2006-8#1)(2007-11#1)(2008-3#1)(2012-1#1)
of patients with upper##3##4##(2006-9#1)(2008-9#1)(2010-3#1)
of patients with various##3##4##(1993-2#1)(2006-9#1)(2011-2#1)
of patients with very##2##4##(1990-12#1)(2006-10#1)
of patients with##1380##3##(1990-1#5)(1990-10#6)(1990-11#4)(1990-12#8)(1990-2#1)(1990-3#7)(1990-4#2)(1990-5#1)(1990-6#3)(1990-7#2)(1990-8#7)(1990-9#6)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#2)(1991-2#4)(1991-3#2)(1991-4#3)(1991-5#4)(1991-6#4)(1991-7#2)(1991-8#6)(1991-9#6)(1992-1#3)(1992-10#3)(1992-11#1)(1992-12#6)(1992-2#5)(1992-3#7)(1992-4#2)(1992-5#3)(1992-6#1)(1992-7#2)(1992-8#10)(1992-9#4)(1993-1#6)(1993-10#4)(1993-11#9)(1993-12#2)(1993-2#5)(1993-3#4)(1993-4#1)(1993-5#1)(1993-7#6)(1993-8#4)(1993-9#8)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#4)(1994-3#4)(1994-4#5)(1994-6#4)(1994-7#1)(1994-8#3)(1994-9#1)(1995-1#4)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#2)(1995-3#5)(1995-5#4)(1995-6#3)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#10)(1996-10#1)(1996-11#7)(1996-12#1)(1996-2#6)(1996-3#7)(1996-4#2)(1996-5#3)(1996-6#2)(1996-7#6)(1996-8#1)(1996-9#5)(1997-1#5)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#5)(1997-7#7)(1997-8#10)(2004-1#5)(2004-10#1)(2004-11#2)(2004-12#1)(2004-2#2)(2004-3#1)(2005-1#2)(2005-10#8)(2005-11#4)(2005-12#1)(2005-6#3)(2005-7#3)(2005-8#8)(2005-9#2)(2006-1#3)(2006-10#62)(2006-11#8)(2006-12#6)(2006-2#8)(2006-3#2)(2006-4#2)(2006-5#3)(2006-6#21)(2006-7#16)(2006-8#18)(2006-9#12)(2007-1#4)(2007-10#23)(2007-11#60)(2007-12#10)(2007-2#18)(2007-3#3)(2007-4#7)(2007-5#6)(2007-6#3)(2007-7#32)(2007-8#29)(2007-9#7)(2008-1#28)(2008-10#17)(2008-11#9)(2008-12#6)(2008-2#2)(2008-3#27)(2008-4#16)(2008-5#23)(2008-6#22)(2008-7#41)(2008-8#25)(2008-9#14)(2009-1#3)(2009-10#1)(2009-11#5)(2009-12#2)(2009-2#11)(2009-3#7)(2009-4#4)(2009-5#2)(2009-6#6)(2009-7#2)(2009-8#6)(2009-9#4)(2010-10#7)(2010-11#10)(2010-12#29)(2010-2#2)(2010-3#8)(2010-4#5)(2010-5#6)(2010-6#4)(2010-7#2)(2010-8#6)(2010-9#6)(2011-1#31)(2011-11#1)(2011-12#7)(2011-2#49)(2011-7#1)(2012-1#23)(2012-11#2)(2012-12#18)(2012-2#34)(2012-3#29)(2012-6#1)(2013-1#49)(2013-7#6)(2013-8#25)
of patients within the##2##4##(2005-11#1)(2006-12#1)
of patients within##6##3##(2005-11#1)(2006-12#1)(2006-6#1)(2007-7#1)(2010-7#1)(2012-1#1)
of patients without##9##3##(1990-3#1)(2006-6#1)(2006-8#2)(2007-10#3)(2008-10#1)(2013-8#1)
of patients would be##2##4##(1991-11#1)(2010-8#1)
of patients would##3##3##(1991-11#1)(2004-10#1)(2010-8#1)
of patients##3293##2##(1990-1#7)(1990-10#14)(1990-11#9)(1990-12#11)(1990-2#5)(1990-3#14)(1990-4#5)(1990-5#8)(1990-6#9)(1990-7#2)(1990-8#14)(1990-9#9)(1991-1#2)(1991-10#5)(1991-11#15)(1991-12#5)(1991-2#6)(1991-3#9)(1991-4#10)(1991-5#7)(1991-6#6)(1991-7#4)(1991-8#11)(1991-9#12)(1992-1#6)(1992-10#9)(1992-11#2)(1992-12#11)(1992-2#20)(1992-3#19)(1992-4#4)(1992-5#7)(1992-6#6)(1992-7#2)(1992-8#12)(1992-9#8)(1993-1#9)(1993-10#9)(1993-11#13)(1993-12#11)(1993-2#12)(1993-3#9)(1993-4#1)(1993-5#6)(1993-6#3)(1993-7#7)(1993-8#9)(1993-9#17)(1994-10#2)(1994-11#4)(1994-12#6)(1994-2#12)(1994-3#7)(1994-4#7)(1994-5#5)(1994-6#9)(1994-7#3)(1994-8#6)(1994-9#2)(1995-1#8)(1995-10#1)(1995-11#9)(1995-12#7)(1995-2#15)(1995-3#10)(1995-4#6)(1995-5#5)(1995-6#5)(1995-7#2)(1995-8#2)(1995-9#4)(1996-1#17)(1996-10#1)(1996-11#9)(1996-12#11)(1996-2#16)(1996-3#9)(1996-4#7)(1996-5#3)(1996-6#5)(1996-7#7)(1996-8#1)(1996-9#12)(1997-1#8)(1997-2#6)(1997-3#9)(1997-4#4)(1997-5#7)(1997-6#7)(1997-7#8)(1997-8#18)(2004-1#10)(2004-10#5)(2004-11#9)(2004-12#2)(2004-2#4)(2004-3#3)(2005-1#5)(2005-10#23)(2005-11#6)(2005-12#3)(2005-5#3)(2005-6#8)(2005-7#9)(2005-8#20)(2005-9#8)(2006-1#7)(2006-10#119)(2006-11#17)(2006-12#17)(2006-2#19)(2006-3#5)(2006-4#6)(2006-5#10)(2006-6#54)(2006-7#20)(2006-8#69)(2006-9#25)(2007-1#6)(2007-10#49)(2007-11#145)(2007-12#29)(2007-2#29)(2007-3#10)(2007-4#11)(2007-5#15)(2007-6#9)(2007-7#100)(2007-8#106)(2007-9#36)(2008-1#59)(2008-10#40)(2008-11#35)(2008-12#17)(2008-2#9)(2008-3#59)(2008-4#33)(2008-5#47)(2008-6#61)(2008-7#104)(2008-8#54)(2008-9#27)(2009-1#5)(2009-10#5)(2009-11#9)(2009-12#4)(2009-2#20)(2009-3#23)(2009-4#9)(2009-5#11)(2009-6#19)(2009-7#5)(2009-8#11)(2009-9#8)(2010-1#4)(2010-10#13)(2010-11#22)(2010-12#64)(2010-2#11)(2010-3#17)(2010-4#13)(2010-5#19)(2010-6#8)(2010-7#10)(2010-8#22)(2010-9#8)(2011-1#63)(2011-11#2)(2011-12#11)(2011-2#153)(2011-3#2)(2011-7#2)(2012-1#35)(2012-11#4)(2012-12#42)(2012-2#79)(2012-3#70)(2012-6#1)(2013-1#126)(2013-7#16)(2013-8#58)
of patients' characteristics##2##3##(2010-8#2)
of patients' knowledge##2##3##(2008-10#1)(2008-3#1)
of patients' rights##2##3##(2005-7#1)(2013-8#1)
of patients' samples##3##3##(1994-6#3)
of patients' satisfaction with##2##4##(1997-5#1)(2008-8#1)
of patients'##50##2##(1991-10#1)(1992-5#1)(1994-6#3)(1997-2#1)(1997-5#3)(1997-8#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-2#2)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-8#3)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-3#2)(2013-1#3)(2013-8#2)
of patients)##3##2##(2006-10#1)(2007-8#1)(2009-12#1)
of pattern formation in##2##4##(2007-12#1)(2009-8#1)
of pattern formation##5##3##(2007-12#3)(2007-9#1)(2009-8#1)
of pattern recognition receptors##3##4##(2008-1#1)(2010-12#1)(2010-8#1)
of pattern recognition##9##3##(2008-1#1)(2008-10#1)(2008-11#1)(2009-3#2)(2010-12#1)(2010-8#1)(2012-2#2)
of pattern separation##2##3##(1991-6#1)(2008-11#1)
of pattern##21##2##(1991-6#1)(2006-1#1)(2007-12#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-5#2)(2009-3#2)(2009-8#1)(2010-12#1)(2010-8#1)(2012-2#2)
of patterned##3##2##(1994-2#1)(1995-5#1)(2008-3#1)
of patterning##2##2##(2008-10#2)
of patterns of de-escalation##2##4##(2009-7#2)
of patterns of##14##3##(2006-10#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2009-4#1)(2009-7#2)(2013-1#1)
of patterns that##2##3##(2007-12#1)(2007-9#1)
of patterns##27##2##(1995-8#1)(2006-10#2)(2007-12#3)(2007-9#3)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#4)(2009-4#1)(2009-7#2)(2010-9#1)(2012-12#1)(2013-1#3)
of patulin and##2##3##(2008-10#2)
of pauciarticular##2##2##(2006-10#2)
of pavement##2##2##(2008-5#2)
of paw preference in a##2##5##(1992-9#1)(1994-8#1)
of paw preference##4##3##(1992-9#3)(1994-8#1)
of paw withdrawal##2##3##(1996-5#1)(2008-5#1)
of paw##6##2##(1992-9#3)(1994-8#1)(1996-5#1)(2008-5#1)
of paxillin and##3##3##(1994-9#1)(1996-12#1)(1997-7#1)
of paxillin##11##2##(1994-9#1)(1996-12#1)(1996-5#4)(1997-4#1)(1997-7#3)(2012-12#1)
of pay for performance##2##4##(1996-3#1)(2007-4#1)
of payers##2##2##(1990-12#1)(1994-12#1)
of paying##3##2##(2007-12#1)(2010-8#1)(2012-3#1)
of payment for outpatient##2##4##(1995-2#1)(1997-1#1)
of payment for##6##3##(1991-3#1)(1994-3#1)(1995-1#1)(1995-2#1)(1997-1#1)(2005-12#1)
of payment reform##3##3##(1993-12#1)(1994-1#1)(1997-1#1)
of payment systems##3##3##(1990-12#2)(2010-8#1)
of payment##21##2##(1990-12#2)(1991-3#2)(1992-12#1)(1993-12#1)(1994-1#1)(1994-3#3)(1995-1#1)(1995-2#1)(1995-5#1)(1996-12#1)(1997-1#3)(1997-2#1)(2005-12#1)(2006-10#1)(2010-8#1)
of pazopanib and RT patients and##2##6##(2013-1#2)
of pazufloxacin mesilate##2##3##(2011-2#2)
of pea is presented##2##4##(2008-5#2)
of pea is##3##3##(2008-5#2)(2009-8#1)
of pea##14##2##(1993-8#1)(2008-10#5)(2008-5#5)(2008-8#2)(2009-8#1)
of peace##2##2##(1993-1#1)(2008-3#1)
of peach fruit##4##3##(2008-10#4)
of peach rust##2##3##(2008-10#2)
of peach##17##2##(2008-10#16)(2011-12#1)
of peak 3##3##3##(1996-6#2)(2008-10#1)
of peak acceleration and##2##4##(1993-7#1)(2010-2#1)
of peak area##3##3##(2005-12#1)(2008-10#2)
of peak current is##2##4##(2008-10#2)
of peak current was##2##4##(2008-10#2)
of peak current##6##3##(2008-10#6)
of peak experiences##3##3##(2013-8#3)
of peak expiratory flow rate##2##5##(2007-1#1)(2007-2#1)
of peak height##4##3##(2007-8#1)(2008-10#3)
of peak inspiratory pressure##2##4##(2005-11#1)(2006-10#1)
of peak intensity##2##3##(2007-12#1)(2008-2#1)
of peak levels##2##3##(1992-9#2)
of peak oxygen consumption##2##4##(2007-10#1)(2007-8#1)
of peak oxygen##3##3##(2007-10#1)(2007-8#1)(2013-8#1)
of peak potential##3##3##(2008-10#2)(2009-3#1)
of peak power##5##3##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)
of peak##63##2##(1990-11#1)(1991-10#1)(1992-9#2)(1993-11#1)(1993-7#1)(1996-5#1)(1996-6#2)(2005-11#2)(2005-12#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#1)(2007-6#1)(2007-8#4)(2008-1#1)(2008-10#18)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-2#1)(2010-3#2)(2013-1#2)(2013-8#5)
of peak-shaped models##2##3##(2007-12#2)
of peaks in##2##3##(1993-2#1)(2012-1#1)
of peaks representing##2##3##(1996-9#2)
of peaks which##2##3##(1990-7#1)(1996-9#1)
of peaks##22##2##(1990-2#1)(1990-7#2)(1993-2#1)(1994-9#1)(1996-5#1)(1996-6#1)(1996-9#4)(1997-8#1)(2005-11#1)(2007-1#1)(2007-5#1)(2008-10#3)(2008-3#1)(2010-11#1)(2011-1#1)(2012-1#1)
of peanut (Arachis hypogaea)##3##4##(2008-10#3)
of peanut and##2##3##(1996-8#1)(2009-2#1)
of peanut shells##2##3##(2008-5#2)
of peanut##11##2##(1990-10#1)(1996-8#1)(2008-10#5)(2008-5#3)(2009-2#1)
of pear and apple##6##4##(2008-10#6)
of pear##13##2##(2008-10#13)
of pearl millet##2##3##(2008-10#2)
of peat##4##2##(2008-10#3)(2008-8#1)
of peatlands##2##2##(2008-8#2)
of pecks##3##2##(2008-6#3)
of pectin##5##2##(1990-4#1)(2007-8#2)(2008-10#1)(2010-5#1)
of pectolytic enzymes##2##3##(1997-2#1)(2008-10#1)
of pectolytic##3##2##(1997-2#2)(2008-10#1)
of pectoralis minor##3##3##(2010-9#1)(2013-1#2)
of pectus excavatum in young##2##5##(2007-8#2)
of pectus excavatum in##3##4##(2007-8#3)
of pectus excavatum##4##3##(2007-8#4)
of pectus##6##2##(2007-8#6)
of pedagogical##2##2##(2010-4#1)(2011-2#1)
of pedal edema##3##3##(2010-2#3)
of pedal##7##2##(1997-8#2)(2010-2#3)(2011-3#2)
of pedestrian##2##2##(2006-11#1)(2012-12#1)
of pedestrians##3##2##(2006-11#1)(2007-4#2)
of pediatric abdominal surgical emergencies in##2##6##(2011-2#2)
of pediatric abdominal##4##3##(2007-1#2)(2011-2#2)
of pediatric and adolescent patients with##2##6##(2005-10#1)(2010-3#1)
of pediatric and adolescent##3##4##(2005-10#1)(2010-3#1)(2013-8#1)
of pediatric and##4##3##(2005-10#1)(2010-3#1)(2012-2#1)(2013-8#1)
of pediatric asthma##3##3##(2007-5#1)(2010-8#1)(2012-2#1)
of pediatric cardiac##2##3##(2007-3#1)(2013-1#1)
of pediatric centers to Italian Society of Neonatology recommendations on prevention of respiratory syncytial virus infection##2##16##(2006-8#2)
of pediatric cochlear##2##3##(2010-9#1)(2011-1#1)
of pediatric hospitals##2##3##(1994-1#1)(2008-11#1)
of pediatric liver disease##3##4##(2006-10#3)
of pediatric liver##6##3##(1995-2#2)(1996-1#1)(2006-10#3)
of pediatric nursing##2##3##(1994-1#1)(2011-2#1)
of pediatric patient##3##3##(1994-1#2)(2012-2#1)
of pediatric patients and##2##4##(1994-2#1)(2009-10#1)
of pediatric patients with##2##4##(2006-10#1)(2009-12#1)
of pediatric patients##6##3##(1994-2#1)(2006-10#1)(2009-10#1)(2009-12#1)(2010-1#1)(2012-2#1)
of pediatric population##2##3##(2011-2#1)(2012-12#1)
of pediatric radiology##2##3##(2007-4#2)
of pediatric renal length##2##4##(2008-10#2)
of pediatric renal##4##3##(1991-2#1)(2007-7#1)(2008-10#2)
of pediatric trauma##3##3##(2006-10#3)
of pediatric traumatic macular##2##4##(2012-12#1)(2013-7#1)
of pediatric traumatic##3##3##(2010-5#1)(2012-12#1)(2013-7#1)
of pediatric##135##2##(1991-2#1)(1992-12#1)(1992-5#1)(1992-8#1)(1994-1#4)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-1#2)(1997-8#1)(2005-10#4)(2005-7#1)(2006-10#14)(2006-12#1)(2006-3#1)(2006-8#3)(2007-1#4)(2007-10#1)(2007-11#1)(2007-12#5)(2007-3#3)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#3)(2008-9#4)(2009-10#1)(2009-12#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#4)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#7)(2012-11#1)(2012-12#7)(2012-2#6)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#2)
of pediatricians##2##2##(2006-10#1)(2012-3#1)
of pediatrics in Norway##2##4##(1993-1#2)
of pediatrics in##3##3##(1993-1#3)
of pediatrics##9##2##(1991-3#1)(1993-1#4)(2006-9#3)(2007-10#1)
of pedicle##3##2##(2007-5#1)(2010-8#1)(2013-8#1)
of peer group##2##3##(2009-7#1)(2009-8#1)
of peer review##7##3##(1990-8#1)(1991-1#2)(1996-11#1)(2006-1#1)(2007-1#1)(2007-4#1)
of peer victimization##6##3##(2007-12#3)(2008-12#1)(2008-4#1)(2013-7#1)
of peer##25##2##(1990-8#1)(1991-1#2)(1996-11#1)(2005-10#1)(2006-1#1)(2006-6#1)(2007-1#1)(2007-12#3)(2007-4#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-7#3)(2009-8#1)(2010-4#1)(2012-2#1)(2013-1#2)(2013-7#1)
of peer-reviewed studies##2##3##(2005-7#1)(2010-9#1)
of peer-reviewed##5##2##(2005-7#1)(2006-10#1)(2007-4#1)(2008-6#1)(2010-9#1)
of peers##2##2##(2006-9#1)(2012-11#1)
of pefloxacin##2##2##(1993-2#2)
of pegfilgrastim##2##2##(2005-11#1)(2008-7#1)
of pegylated interferon and ribavirin##2##5##(2005-11#1)(2010-12#1)
of pegylated interferon and##3##4##(2005-11#1)(2010-12#2)
of pegylated interferon##5##3##(2005-11#1)(2006-10#1)(2010-12#2)(2011-12#1)
of pegylated##7##2##(2005-11#1)(2006-10#1)(2010-12#2)(2010-2#2)(2011-12#1)
of peled##2##2##(2008-12#2)
of pellet##5##2##(2008-10#4)(2008-7#1)
of pellets##11##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#7)(2010-4#1)
of pelvic endometriosis##5##3##(1992-1#1)(1995-2#1)(2009-6#1)(2011-1#1)(2013-1#1)
of pelvic floor##5##3##(2006-8#1)(2006-9#1)(2007-4#1)(2010-12#1)(2011-2#1)
of pelvic fracture##4##3##(2006-11#2)(2013-8#2)
of pelvic inflammatory##2##3##(2008-11#1)(2011-1#1)
of pelvic lymph nodes##2##4##(1991-9#1)(2011-2#1)
of pelvic lymph##3##3##(1991-9#1)(2007-8#1)(2011-2#1)
of pelvic malignancies##2##3##(2007-4#1)(2008-7#1)
of pelvic obliquity##2##3##(2012-1#1)(2012-2#1)
of pelvic organs##2##3##(1996-3#1)(2008-12#1)
of pelvic osteotomy##2##3##(2007-8#1)(2008-10#1)
of pelvic##48##2##(1991-1#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#1)(1995-2#1)(1996-3#1)(2006-11#3)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-4#2)(2007-7#2)(2007-8#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-5#2)(2009-6#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
of pelvic-peritoneal tuberculosis##3##3##(2008-10#3)
of pelvimetry##4##2##(1994-4#4)
of pelvis##2##2##(2006-11#1)(2012-1#1)
of pemphigus vulgaris##5##3##(1992-12#1)(2007-7#3)(2013-8#1)
of pemphigus##8##2##(1992-12#1)(2007-7#6)(2013-8#1)
of pencil##2##2##(1991-9#1)(2010-9#1)
of pendimethalin residue (0##2##4##(2011-1#2)
of pendimethalin##7##2##(2008-11#1)(2011-1#6)
of penetrating cardiac injuries##3##4##(2007-8#2)(2008-1#1)
of penetrating injuries##2##3##(2007-3#1)(2007-7#1)
of penetrating##17##2##(1992-2#1)(1992-3#1)(2006-4#1)(2007-3#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-10#1)(2011-1#2)
of penetration into the##2##4##(2007-10#1)(2008-5#1)
of penetration into##3##3##(2007-10#1)(2008-5#2)
of penetration of the##5##4##(1990-10#1)(1990-3#1)(1991-2#1)(2008-1#1)(2008-10#1)
of penetration of##11##3##(1990-10#1)(1990-3#3)(1991-2#1)(2006-12#1)(2008-1#1)(2008-10#3)(2008-5#1)
of penetration##28##2##(1990-10#1)(1990-3#3)(1991-2#2)(2004-12#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#10)(2008-3#1)(2008-5#3)(2010-2#1)(2013-1#1)
of penguins##3##2##(1993-9#2)(2008-5#1)
of penicillamine##4##2##(1992-5#2)(2008-10#2)
of penicillin G acylase##3##4##(2006-9#1)(2012-11#2)
of penicillin G and##2##4##(1990-9#1)(2008-12#1)
of penicillin G##12##3##(1990-9#1)(1992-11#1)(1992-2#1)(1994-8#1)(2005-12#1)(2006-9#1)(2008-10#2)(2008-12#1)(2012-11#2)(2013-8#1)
of penicillin V##2##3##(1994-9#1)(2006-8#1)
of penicillin acylase from Escherichia coli##2##6##(1990-11#2)
of penicillin##33##2##(1990-11#2)(1990-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-8#1)(1994-8#1)(1994-9#1)(1996-12#1)(1996-4#1)(2005-12#2)(2005-7#1)(2006-8#1)(2006-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#5)(2012-11#2)(2012-12#1)(2012-2#1)(2013-8#2)
of penicillin-G##3##2##(1996-1#3)
of penicillin-resistant S##2##3##(2012-2#2)
of penicillin-resistant##5##2##(1991-12#1)(1993-5#1)(2007-11#1)(2012-2#2)
of penicillins##3##2##(1990-6#1)(1992-2#2)
of penile fracture##4##3##(2008-10#2)(2008-7#1)(2011-1#1)
of penile##8##2##(2006-10#1)(2008-1#1)(2008-10#3)(2008-7#1)(2010-2#1)(2011-1#1)
of penis##4##2##(2007-5#1)(2007-9#1)(2013-1#2)
of penoscrotal hypospadia##4##3##(2013-1#4)
of penoscrotal##5##2##(2008-10#1)(2013-1#4)
of pentachlorophenol and its##2##4##(1990-11#2)
of pentachlorophenol in##2##3##(2008-10#2)
of pentachlorophenol##5##2##(1990-11#2)(2008-10#2)(2009-3#1)
of pentaerythritol triacrylate##3##3##(2008-9#3)
of pentaerythritol##4##2##(2008-3#1)(2008-9#3)
of pentagastrin on##2##3##(1993-6#2)
of pentagastrin##4##2##(1993-6#4)
of pentamidine##6##2##(1993-2#4)(2008-10#2)
of pentane on water##2##4##(2008-3#2)
of pentane##3##2##(2008-3#3)
of pentasaccharide repeating units having the following structure##2##8##(1995-11#1)(1995-4#1)
of pentavalent antimony##2##3##(2008-10#2)
of pentavalent##5##2##(2008-10#2)(2009-6#3)
of pentobarbital##4##2##(1990-7#2)(1991-3#1)(1992-4#1)
of pentobarbitone##2##2##(1995-12#1)(2008-12#1)
of pentose##2##2##(1992-12#1)(2006-12#1)
of pentoxifylline in##3##3##(2008-1#1)(2008-10#1)(2010-6#1)
of pentoxifylline##4##2##(2008-1#1)(2008-10#2)(2010-6#1)
of pentoxyverine##3##2##(2008-10#3)
of pentylenetetrazole##2##2##(1995-12#1)(2010-3#1)
of people affected by##2##4##(2008-5#1)(2012-3#1)
of people affected##3##3##(2008-5#1)(2012-3#1)(2013-1#1)
of people are##4##3##(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#1)
of people dying##2##3##(2012-12#2)
of people for##2##3##(1993-5#1)(2008-1#1)
of people have##2##3##(2005-10#1)(2006-9#1)
of people in the##5##4##(1995-6#1)(1996-1#1)(2008-5#1)(2011-2#1)(2013-8#1)
of people in##10##3##(1995-6#1)(1996-1#1)(2006-10#1)(2006-7#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#2)(2013-8#1)
of people infected with the##2##5##(1990-5#1)(1996-9#1)
of people infected with##3##4##(1990-5#1)(1991-6#1)(1996-9#1)
of people interviewed in##2##4##(2007-2#2)
of people interviewed##4##3##(2007-2#4)
of people living in##5##4##(2007-1#1)(2007-2#1)(2007-7#1)(2010-5#2)
of people living with HIV##3##5##(2007-9#1)(2009-10#1)(2013-8#1)
of people living with HIV/AIDS (PLWHA)##2##6##(2010-8#1)(2012-12#1)
of people living with HIV/AIDS##4##5##(2006-2#1)(2010-8#1)(2012-12#2)
of people living with##10##4##(2006-2#1)(2007-11#1)(2007-9#1)(2009-10#1)(2010-12#1)(2010-8#2)(2012-12#2)(2013-8#1)
of people living##16##3##(2006-2#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-4#1)(2009-10#1)(2010-12#1)(2010-5#2)(2010-8#2)(2012-12#2)(2013-8#1)
of people suffering from##4##4##(1992-3#1)(1997-4#1)(2010-8#1)(2011-1#1)
of people suffering of##2##4##(2008-2#2)
of people suffering##6##3##(1992-3#1)(1997-4#1)(2008-2#2)(2010-8#1)(2011-1#1)
of people that##2##3##(1996-1#1)(2009-4#1)
of people to##2##3##(2006-7#1)(2011-2#1)
of people were##2##3##(2006-2#1)(2009-12#1)
of people who have##3##4##(1995-1#1)(2006-10#1)(2008-2#1)
of people who##15##3##(1991-8#1)(1992-1#1)(1992-3#1)(1993-2#1)(1995-1#1)(1996-12#1)(2006-10#1)(2006-7#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-7#1)(2012-2#1)(2013-1#2)
of people whose##2##3##(1991-10#1)(2010-7#1)
of people with AIDS and##2##5##(1995-6#2)
of people with AIDS##3##4##(1995-6#2)(1996-2#1)
of people with a##2##4##(2008-9#1)(2012-1#1)
of people with dementia in##3##5##(2011-1#1)(2011-2#1)(2013-8#1)
of people with dementia##4##4##(2008-6#1)(2011-1#1)(2011-2#1)(2013-8#1)
of people with diabetes mellitus##2##5##(2011-2#1)(2012-12#1)
of people with diabetes##3##4##(2011-2#1)(2012-12#1)(2012-3#1)
of people with disabilities##5##4##(1996-1#2)(2010-2#2)(2011-2#1)
of people with mental health problems##2##6##(2008-2#1)(2011-1#1)
of people with mental##4##4##(2008-2#2)(2011-1#1)(2012-3#1)
of people with severe mental disorders##5##6##(2008-2#5)
of people with severe mental illness##4##6##(2008-2#4)
of people with severe mental##9##5##(2008-2#9)
of people with##48##3##(1994-2#1)(1995-11#1)(1995-6#2)(1996-1#2)(1996-2#1)(1997-1#1)(2007-7#1)(2008-11#1)(2008-2#12)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-11#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
of people##179##2##(1990-5#1)(1991-10#3)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-2#1)(1993-5#1)(1994-2#4)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#3)(1995-9#1)(1996-1#4)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-4#1)(2005-10#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#3)(2006-7#4)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-2#9)(2007-7#2)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#19)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#3)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#4)(2011-1#6)(2011-2#13)(2012-1#2)(2012-12#6)(2012-2#3)(2012-3#4)(2013-1#6)(2013-8#4)
of pepF##2##2##(1994-12#2)
of pepO##2##2##(1993-3#2)
of pepper mild mottle virus##2##5##(1997-6#2)
of pepper plants##2##3##(2008-10#2)
of pepper##10##2##(1997-6#2)(2008-10#8)
of peppermint oil##2##3##(2012-2#2)
of pepsin##4##2##(1990-2#2)(1992-12#1)(1996-5#1)
of pepsinogen secretion##2##3##(1995-8#1)(1997-1#1)
of pepsinogen##3##2##(1995-8#1)(1997-1#1)(2007-8#1)
of pepstatin##2##2##(1990-6#1)(1991-6#1)
of peptic ulcer associated with##2##5##(1990-6#1)(2007-2#1)
of peptic ulcer disease##11##4##(1995-4#1)(1996-2#1)(1997-1#2)(2006-10#6)(2006-2#1)
of peptic ulcer##17##3##(1990-6#1)(1992-10#1)(1995-4#1)(1996-2#1)(1997-1#2)(2006-10#6)(2006-2#1)(2007-2#1)(2007-9#1)(2011-1#2)
of peptic ulcers##2##3##(1991-11#1)(1995-3#1)
of peptic##20##2##(1990-6#1)(1991-11#1)(1992-10#1)(1995-3#1)(1995-4#1)(1996-2#1)(1997-1#3)(2006-10#6)(2006-2#1)(2007-2#1)(2007-9#1)(2011-1#2)
of peptidase##2##2##(1991-3#1)(2008-5#1)
of peptidases in##3##3##(2008-4#3)
of peptidases##5##2##(1992-5#1)(2006-12#1)(2008-4#3)
of peptide C28W##2##3##(1992-3#2)
of peptide and##3##3##(1990-8#1)(1994-11#1)(2010-1#1)
of peptide antibiotics##2##3##(2006-8#1)(2008-5#1)
of peptide binding to##3##4##(1993-3#1)(2007-6#2)
of peptide binding##4##3##(1993-3#1)(1995-8#1)(2007-6#2)
of peptide fragments##7##3##(1990-7#1)(1991-2#1)(1991-7#1)(1992-12#1)(1993-6#2)(2011-12#1)
of peptide hormones and##2##4##(2008-4#1)(2012-12#1)
of peptide hormones##4##3##(1990-5#1)(2006-10#1)(2008-4#1)(2012-12#1)
of peptide ligands##3##3##(2008-4#2)(2012-2#1)
of peptide mass##2##3##(2008-4#1)(2008-7#1)
of peptide nucleic acids##2##4##(2008-4#2)
of peptide##102##2##(1990-10#1)(1990-12#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#3)(1991-12#1)(1991-2#1)(1991-4#3)(1991-7#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1993-11#1)(1993-3#2)(1993-6#2)(1993-8#2)(1994-10#2)(1994-11#2)(1994-2#1)(1994-9#4)(1995-12#1)(1995-3#2)(1995-8#1)(1996-11#1)(1996-4#1)(1996-5#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#3)(2006-8#1)(2007-6#3)(2008-10#3)(2008-3#1)(2008-4#17)(2008-5#3)(2008-7#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-12#1)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#1)
of peptide-HLA binding##2##3##(1997-2#2)
of peptide-MHC##2##2##(2008-4#2)
of peptidergic##3##2##(1992-8#1)(2008-7#1)(2013-8#1)
of peptides Lys-Glu-Asp-Gly and Ala-Glu-Asp-Gly##2##5##(2012-1#2)
of peptides after##2##3##(1994-5#1)(2008-4#1)
of peptides and proteins##6##4##(1991-3#1)(1995-2#1)(1997-4#1)(2008-11#1)(2008-4#2)
of peptides and##10##3##(1991-12#1)(1991-3#1)(1995-2#1)(1997-4#1)(2008-11#1)(2008-2#1)(2008-4#4)
of peptides as##2##3##(1990-5#1)(2006-10#1)
of peptides derived from the##4##5##(1990-5#1)(1992-12#1)(1994-6#1)(1995-6#1)
of peptides derived from##5##4##(1990-5#1)(1990-7#1)(1992-12#1)(1994-6#1)(1995-6#1)
of peptides from the##2##4##(1994-9#1)(1995-3#1)
of peptides from##4##3##(1993-12#1)(1994-9#1)(1995-3#1)(1996-1#1)
of peptides generated by enzymatic##2##5##(1993-12#1)(1996-2#1)
of peptides generated by##3##4##(1993-12#1)(1993-4#1)(1996-2#1)
of peptides generated##4##3##(1993-12#1)(1993-4#1)(1996-2#1)(2008-9#1)
of peptides in##4##3##(1992-2#1)(1994-12#1)(1994-9#1)(2008-4#1)
of peptides obtained from##2##4##(1992-8#1)(1994-8#1)
of peptides obtained##3##3##(1991-8#1)(1992-8#1)(1994-8#1)
of peptides of the##3##4##(1990-11#1)(1992-5#1)(1995-12#1)
of peptides of##4##3##(1990-11#1)(1992-12#1)(1992-5#1)(1995-12#1)
of peptides on##2##3##(1992-2#1)(2008-4#1)
of peptides or##3##3##(1995-2#2)(2008-4#1)
of peptides produced by##3##4##(1993-8#1)(2008-4#1)(2008-9#1)
of peptides that##4##3##(1992-9#1)(1995-1#1)(2006-11#1)(2009-5#1)
of peptides to##4##3##(1990-11#1)(1991-5#1)(2005-11#1)(2008-4#1)
of peptides under 1 kDa in size##2##7##(2008-11#2)
of peptides was##3##3##(1992-3#1)(1995-3#1)(2007-8#1)
of peptides with the##2##4##(1990-6#1)(1994-10#1)
of peptides with##5##3##(1990-6#1)(1992-2#1)(1994-10#1)(1997-2#1)(2013-8#1)
of peptides##121##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#3)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-12#2)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-12#2)(1995-2#3)(1995-3#6)(1995-6#2)(1996-1#1)(1996-2#1)(1997-2#4)(1997-4#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#15)(2008-5#2)(2008-7#1)(2008-9#4)(2009-12#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-1#2)(2013-1#1)(2013-8#2)
of peptidic##4##2##(1992-8#1)(1992-9#2)(1995-11#1)
of peptidomimetics##2##2##(2012-3#1)(2013-1#1)
of peptidyl-dipeptidase A and carboxypeptidase N##2##6##(2008-8#2)
of per capita##3##3##(1997-3#1)(2009-4#1)(2012-2#1)
of per##7##2##(1993-12#1)(1997-3#1)(2006-5#1)(2009-4#1)(2012-12#1)(2012-2#1)(2012-3#1)
of peracarids##2##2##(2008-5#2)
of perceived discrimination##2##3##(2008-12#1)(2010-7#1)
of perceived exertion (RPE)##5##4##(2006-10#1)(2013-1#1)(2013-7#1)(2013-8#2)
of perceived exertion##11##3##(2006-10#1)(2010-9#1)(2012-12#2)(2013-1#1)(2013-7#2)(2013-8#4)
of perceived friend##2##3##(2009-7#1)(2013-1#1)
of perceived norms##2##3##(2011-1#1)(2013-1#1)
of perceived parental##2##3##(2004-11#1)(2009-7#1)
of perceived quality##2##3##(1996-3#1)(2008-11#1)
of perceived social support##2##4##(2010-1#1)(2010-7#1)
of perceived support##2##3##(2010-1#1)(2010-2#1)
of perceived##54##2##(1990-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#2)(1996-5#1)(1997-8#1)(2004-11#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-9#2)(2009-7#2)(2010-1#2)(2010-10#1)(2010-2#2)(2010-3#2)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#3)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#4)
of perceiving##2##2##(2009-8#1)(2013-8#1)
of percent##5##2##(1993-2#1)(2008-10#3)(2008-2#1)
of percentage of##2##3##(2007-9#1)(2008-3#1)
of percentage##8##2##(1991-2#1)(1996-12#1)(2007-9#1)(2008-3#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
of perception and##3##3##(1994-12#1)(2007-8#1)(2012-2#1)
of perception of##3##3##(2007-6#1)(2009-4#1)(2011-2#1)
of perception##13##2##(1991-2#2)(1994-12#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-4#1)(2009-4#1)(2011-2#1)(2012-2#2)
of perceptions and##3##3##(2008-1#1)(2012-2#1)(2013-1#1)
of perceptions of##2##3##(2007-2#1)(2013-8#1)
of perceptions##12##2##(2006-7#1)(2007-2#1)(2008-1#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#2)
of perceptual and##2##3##(2007-8#1)(2008-11#1)
of perceptual disorder##2##3##(2007-5#2)
of perceptual learning##2##3##(2010-5#2)
of perceptual##13##2##(1995-5#1)(2007-12#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-11#2)(2008-9#1)(2009-4#1)(2010-5#2)(2012-11#1)
of perceptually##2##2##(2008-2#1)(2012-2#1)
of perchlorate (ClO4-)##2##3##(2007-8#2)
of perchlorate in##17##3##(2007-8#11)(2008-10#6)
of perchlorate##38##2##(2007-8#23)(2008-10#15)
of perchloric acid##5##3##(1990-5#1)(1991-1#2)(1996-6#1)(2012-1#1)
of perchloric##7##2##(1990-5#1)(1991-1#2)(1993-11#1)(1996-6#1)(2008-10#1)(2012-1#1)
of percutaneous coronary intervention (PCI)##4##5##(2006-7#1)(2008-11#1)(2010-7#1)(2013-8#1)
of percutaneous coronary intervention for unprotected left main##2##8##(2009-12#2)
of percutaneous coronary intervention##8##4##(2006-7#1)(2007-8#1)(2008-11#1)(2009-12#3)(2010-7#1)(2013-8#1)
of percutaneous coronary interventions##5##4##(2006-10#1)(2007-8#1)(2008-6#1)(2009-5#1)(2011-2#1)
of percutaneous coronary##13##3##(2006-10#1)(2006-7#1)(2007-8#2)(2008-11#1)(2008-6#1)(2009-12#3)(2009-5#1)(2010-7#1)(2011-2#1)(2013-8#1)
of percutaneous disc decompression using##2##5##(2006-8#2)
of percutaneous endoscopic gastrostomy##3##4##(1992-5#1)(1997-3#2)
of percutaneous laser disc decompression (PLDD)##2##6##(2007-8#2)
of percutaneous radial artery##2##4##(1990-8#2)
of percutaneous radiofrequency (RF)##2##4##(2006-12#1)(2010-12#1)
of percutaneous radiofrequency##3##3##(2006-12#1)(2008-8#1)(2010-12#1)
of percutaneous tracheostomy in##2##4##(2006-10#1)(2008-2#1)
of percutaneous tracheostomy##3##3##(2006-10#2)(2008-2#1)
of percutaneous treatment of##2##4##(2008-3#1)(2010-5#1)
of percutaneous treatment##3##3##(2006-10#1)(2008-3#1)(2010-5#1)
of percutaneous##61##2##(1990-8#2)(1992-5#1)(1993-11#1)(1995-11#2)(1996-12#1)(1996-3#1)(1997-3#2)(2004-12#1)(2005-10#1)(2006-10#4)(2006-12#2)(2006-6#3)(2006-7#1)(2006-8#3)(2007-11#2)(2007-8#4)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#4)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#3)(2010-5#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-8#1)
of percutaneously##2##2##(2006-6#1)(2009-10#1)
of perennial and##2##3##(2008-5#1)(2013-1#1)
of perennial ryegrass turf##3##4##(2008-10#3)
of perennial ryegrass##9##3##(2008-10#9)
of perennial##15##2##(2008-10#10)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#1)
of perfect##5##2##(1997-7#1)(2007-11#1)(2008-10#2)(2009-10#1)
of perfectionism##2##2##(2007-12#2)
of perfectionistic self-presentation##2##3##(2007-12#2)
of perfectly##3##2##(2006-3#1)(2008-3#1)(2008-4#1)
of perforated colonic##2##3##(1993-9#2)
of perforated##8##2##(1993-10#1)(1993-6#2)(1993-9#2)(2005-12#1)(2006-10#1)(2008-8#1)
of perforation of the##2##4##(2007-8#1)(2008-3#1)
of perforation of##3##3##(1991-9#1)(2007-8#1)(2008-3#1)
of perforation##11##2##(1991-9#1)(1997-2#1)(2007-5#1)(2007-8#1)(2008-3#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-2#2)
of perforators##2##2##(2011-3#1)(2013-1#1)
of perforin##4##2##(1993-3#2)(1994-5#1)(2011-2#1)
of performance and##8##3##(1995-2#1)(1996-3#1)(1996-9#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-2#1)
of performance feedback##3##3##(2007-10#3)
of performance in children##2##4##(2005-10#1)(2008-9#1)
of performance in the##4##4##(1990-10#1)(2007-5#1)(2009-1#1)(2010-12#1)
of performance in##9##3##(1990-10#1)(1995-12#1)(1996-12#1)(2005-10#1)(2007-5#1)(2008-4#1)(2008-9#1)(2009-1#1)(2010-12#1)
of performance indicators##3##3##(1992-12#1)(1994-2#1)(2009-4#1)
of performance measurement##2##3##(1996-2#1)(2008-4#1)
of performance measures##4##3##(1992-11#1)(1995-12#2)(2008-6#1)
of performance of##7##3##(1990-10#1)(1996-9#1)(1997-8#1)(2007-8#1)(2008-2#1)(2008-4#1)(2011-2#1)
of performance on##5##3##(1990-3#1)(1993-2#1)(1995-12#1)(2008-7#1)(2012-12#1)
of performance testing##2##3##(2013-7#2)
of performance that##2##3##(2008-3#2)
of performance traits##2##3##(2012-1#2)
of performance was##2##3##(1993-12#1)(2008-3#1)
of performance##92##2##(1990-10#3)(1990-11#1)(1990-3#1)(1991-5#1)(1992-11#2)(1992-12#2)(1993-12#1)(1993-2#1)(1993-5#1)(1994-12#1)(1994-2#2)(1994-3#3)(1995-12#4)(1995-2#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-9#2)(1997-8#1)(2005-10#2)(2005-11#1)(2006-10#1)(2006-5#1)(2007-10#4)(2007-12#1)(2007-5#1)(2007-8#2)(2008-10#4)(2008-11#2)(2008-12#3)(2008-2#7)(2008-3#6)(2008-4#3)(2008-6#2)(2008-7#2)(2008-9#2)(2009-1#1)(2009-11#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-1#3)(2012-12#1)(2012-3#1)(2013-7#2)(2013-8#1)
of performing a##5##3##(2006-12#1)(2006-6#1)(2006-9#1)(2008-4#1)(2013-1#1)
of performing an##2##3##(1993-10#1)(2009-3#1)
of performing the##5##3##(1992-6#1)(2007-12#1)(2007-2#1)(2008-2#1)(2010-8#1)
of performing##53##2##(1990-10#1)(1991-10#1)(1991-3#1)(1992-3#1)(1992-6#1)(1993-10#1)(1994-9#1)(1995-1#1)(2006-10#1)(2006-12#1)(2006-6#3)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-8#4)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#6)(2008-3#1)(2008-4#1)(2008-7#4)(2008-9#1)(2009-2#1)(2009-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
of perfumes##2##2##(2008-5#2)
of perfusate osmolarity on##2##4##(1990-3#2)
of perfusate was##2##3##(1993-3#1)(2011-2#1)
of perfusate##5##2##(1990-3#2)(1993-3#1)(2009-4#1)(2011-2#1)
of perfused##8##2##(1990-3#1)(1994-6#1)(1996-10#2)(1997-2#2)(2007-9#1)(2008-11#1)
of perfusion in##2##3##(2007-10#1)(2008-7#1)
of perfusion##17##2##(1990-6#1)(1992-2#3)(1992-6#1)(1993-3#1)(1994-2#1)(1995-6#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-6#1)(2008-7#1)(2010-12#1)(2011-3#1)
of pergolide##3##2##(2008-7#3)
of peri-implant mucositis##4##3##(2012-11#2)(2012-12#2)
of peri-implant##6##2##(2012-11#2)(2012-12#2)(2012-2#1)(2013-1#1)
of peri-implantitis##5##2##(2007-12#1)(2012-11#1)(2013-1#3)
of peri-operative##2##2##(2007-8#1)(2011-12#1)
of perianal##2##2##(1997-8#1)(2007-8#1)
of periapical##5##2##(2008-5#1)(2011-12#2)(2011-2#1)(2013-1#1)
of pericapillary##2##2##(1995-1#1)(2012-1#1)
of pericardial disease##2##3##(2006-10#1)(2007-3#1)
of pericardial effusion##2##3##(2007-8#1)(2010-5#1)
of pericardial fluid##2##3##(2007-8#2)
of pericardial thymic cyst##2##4##(2007-8#2)
of pericardial##14##2##(2006-10#1)(2007-3#1)(2007-8#10)(2009-10#1)(2010-5#1)
of pericarditis and##2##3##(2006-10#2)
of pericarditis##5##2##(2006-10#2)(2006-12#1)(2009-10#1)(2011-2#1)
of pericardium##3##2##(2004-9#2)(2013-1#1)
of perichondrium##2##2##(2007-11#2)
of pericytes##3##2##(1993-3#1)(2008-1#2)
of perikaryal##3##2##(2007-9#2)(2008-7#1)
of perimembranous##3##2##(2008-4#1)(2010-6#1)(2013-1#1)
of perinatal care for##2##4##(1990-9#1)(2013-1#1)
of perinatal care##3##3##(1990-9#1)(2007-2#1)(2013-1#1)
of perinatal education##2##3##(2007-2#2)
of perinatal morbidity##3##3##(2006-1#1)(2011-12#2)
of perinatal mortality in##3##4##(2011-12#1)(2012-12#2)
of perinatal mortality##6##3##(1990-9#1)(2008-7#1)(2011-12#2)(2012-12#2)
of perinatal##31##2##(1990-11#1)(1990-9#2)(1991-6#1)(1992-4#1)(1992-8#1)(1994-2#1)(1994-6#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-7#1)(2006-1#1)(2006-6#1)(2007-2#4)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2011-12#4)(2012-12#2)(2012-2#1)(2013-1#1)
of perinatally##2##2##(2007-7#1)(2009-7#1)
of perindopril in##2##3##(2005-10#1)(2008-1#1)
of perindopril##3##2##(2005-10#1)(2008-1#1)(2013-8#1)
of perineal##4##2##(1993-6#1)(2010-2#2)(2011-2#1)
of perineural invasion##2##3##(2006-9#1)(2011-1#1)
of perineural##3##2##(2006-9#1)(2008-1#1)(2011-1#1)
of perineuronal##2##2##(2013-8#2)
of period##2##2##(2007-12#1)(2011-1#1)
of periodate and iodate##4##4##(2008-10#4)
of periodate with 1-(3##2##4##(2008-10#2)
of periodate##11##2##(2008-10#10)(2008-8#1)
of periodic arrays##2##3##(2008-3#2)
of periodic forcing##2##3##(2007-12#1)(2007-9#1)
of periodic nonlinearity##3##3##(2008-3#3)
of periodic pulse trains##2##4##(2007-12#1)(2008-3#1)
of periodic##40##2##(1990-8#1)(1993-2#1)(1995-11#3)(2006-10#2)(2006-7#1)(2007-11#5)(2007-12#8)(2007-9#1)(2008-10#2)(2008-2#3)(2008-3#8)(2008-4#1)(2008-7#1)(2009-2#1)(2012-12#1)(2013-8#1)
of periodical##5##2##(1995-10#1)(1996-12#1)(2005-11#1)(2007-5#1)(2008-9#1)
of periodically poled KTiOPO(4)##3##4##(2007-12#3)
of periodically poled LiNbO(3)##2##4##(2007-12#2)
of periodically poled lithium niobate##4##5##(2007-11#1)(2007-12#3)
of periodically poled##11##3##(2007-11#1)(2007-12#9)(2008-3#1)
of periodically##15##2##(2007-11#3)(2007-12#10)(2008-2#1)(2008-3#1)
of periodicity and##2##3##(2008-2#1)(2009-2#1)
of periodontal disease##14##3##(1997-4#1)(2005-3#1)(2006-2#1)(2006-8#1)(2007-2#1)(2008-4#1)(2008-9#1)(2010-4#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#2)
of periodontal diseases##8##3##(1994-3#1)(2006-8#1)(2008-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
of periodontal therapy##3##3##(2012-12#1)(2012-3#1)(2013-7#1)
of periodontal##38##2##(1994-3#1)(1995-11#1)(1995-8#1)(1997-4#1)(2005-3#1)(2006-2#4)(2006-8#2)(2007-12#2)(2007-2#1)(2008-1#1)(2008-2#1)(2008-4#2)(2008-9#1)(2010-4#1)(2011-1#1)(2011-12#1)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#2)(2013-7#2)(2013-8#3)
of periodontics##2##2##(2004-3#1)(2013-7#1)
of periodontitis##6##2##(2010-4#2)(2012-3#2)(2013-8#2)
of periodontium##4##2##(2012-3#4)
of periods of##2##3##(2008-6#1)(2008-7#1)
of periods##3##2##(2007-11#1)(2008-6#1)(2008-7#1)
of perioperative care##3##3##(2010-2#1)(2012-2#2)
of perioperative complications##3##3##(2007-8#1)(2009-5#1)(2013-1#1)
of perioperative myocardial##2##3##(1990-12#1)(2006-10#1)
of perioperative risk##3##3##(2007-12#1)(2009-5#1)(2011-2#1)
of perioperative stroke##2##3##(1997-8#1)(2006-7#1)
of perioperative##42##2##(1990-12#1)(1991-3#1)(1997-8#1)(2005-10#1)(2006-1#1)(2006-10#9)(2006-11#1)(2006-7#1)(2007-12#2)(2007-4#1)(2007-8#3)(2008-8#1)(2009-5#3)(2009-7#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#2)
of periosteal##2##2##(2008-5#1)(2008-6#1)
of periosteum##3##2##(2007-11#2)(2012-12#1)
of periosteum-derived cells##2##3##(1993-9#1)(2012-12#1)
of peripartum cardiomyopathy##2##3##(2008-11#1)(2013-8#1)
of peripheral BDZ receptors##2##4##(2008-6#2)
of peripheral T cells##2##4##(1993-12#1)(1995-1#1)
of peripheral and central##3##4##(1992-2#1)(2007-12#1)(2008-1#1)
of peripheral arterial disease in##4##5##(1997-2#1)(2008-8#1)(2011-2#2)
of peripheral arterial disease##9##4##(1990-11#1)(1997-2#1)(2005-10#1)(2008-8#2)(2009-4#1)(2011-2#2)(2012-2#1)
of peripheral arterial##11##3##(1990-11#1)(1996-3#1)(1997-2#1)(2005-10#1)(2008-8#3)(2009-4#1)(2011-2#2)(2012-2#1)
of peripheral blood EPCs##2##4##(2007-11#2)
of peripheral blood cells##2##4##(2007-12#1)(2008-10#1)
of peripheral blood dilution##2##4##(2008-11#2)
of peripheral blood gene expression##2##5##(2008-10#2)
of peripheral blood leukocytes##2##4##(1996-12#1)(2010-12#1)
of peripheral blood lymphocytes from##2##5##(1991-12#1)(1994-6#1)
of peripheral blood lymphocytes##9##4##(1991-12#2)(1992-2#1)(1994-6#1)(1995-12#1)(2007-8#1)(2008-9#1)(2012-1#1)(2013-8#1)
of peripheral blood mononuclear cells (PBMC)##4##6##(1995-2#1)(1996-9#1)(2006-8#1)(2010-12#1)
of peripheral blood mononuclear cells##10##5##(1995-2#1)(1995-3#2)(1995-7#1)(1996-3#1)(1996-9#1)(1997-2#1)(2006-8#1)(2008-7#1)(2010-12#1)
of peripheral blood revealed##3##4##(1992-11#1)(2013-1#2)
of peripheral blood samples##2##4##(1997-7#1)(2008-9#1)
of peripheral blood stem cells##2##5##(2008-1#2)
of peripheral blood stem##3##4##(2008-1#2)(2011-2#1)
of peripheral blood##48##3##(1991-10#1)(1991-12#2)(1992-11#1)(1992-2#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-7#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-7#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#3)(2010-12#2)(2010-9#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
of peripheral inputs##2##3##(1994-10#1)(2005-10#1)
of peripheral lung tumors##2##4##(2007-8#1)(2010-12#1)
of peripheral lung##3##3##(2007-8#1)(2010-12#1)(2013-7#1)
of peripheral lymphadenopathy##2##3##(2006-7#1)(2008-5#1)
of peripheral lymphocytes##2##3##(2007-1#1)(2010-4#1)
of peripheral myelin##2##3##(1991-10#1)(1992-7#1)
of peripheral nerve injuries##2##4##(2007-10#2)
of peripheral nerve injury##3##4##(1994-5#1)(2005-10#1)(2006-11#1)
of peripheral nerve lesions##2##4##(2011-1#1)(2011-2#1)
of peripheral nerve##17##3##(1994-5#1)(1995-12#1)(1995-5#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-10#2)(2008-11#1)(2008-7#2)(2008-9#1)(2011-1#3)(2011-2#1)
of peripheral nerves in##2##4##(1992-8#1)(2008-9#1)
of peripheral nerves##12##3##(1992-8#1)(1992-9#1)(1994-11#1)(1995-12#1)(2006-12#3)(2007-11#1)(2008-7#1)(2008-9#2)(2013-8#1)
of peripheral neuropathy and##3##4##(1990-8#1)(2007-7#1)(2008-8#1)
of peripheral neuropathy occurrence in HIV-1 infected patients##2##8##(2008-11#2)
of peripheral neuropathy occurrence in HIV-1 infected##3##7##(2008-11#3)
of peripheral neuropathy##14##3##(1990-8#1)(1996-2#1)(1996-3#1)(1997-1#1)(2006-6#1)(2006-8#1)(2007-7#1)(2008-11#4)(2008-8#2)(2012-3#1)
of peripheral pulmonary lesions##3##4##(2010-8#3)
of peripheral##187##2##(1990-11#1)(1990-8#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-2#3)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#1)(1994-10#2)(1994-11#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-12#4)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-7#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-6#1)(1997-7#1)(2004-3#1)(2005-10#3)(2006-10#3)(2006-11#1)(2006-12#4)(2006-6#2)(2006-7#1)(2006-8#5)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#3)(2007-2#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#4)(2008-11#8)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#7)(2008-8#6)(2008-9#6)(2009-4#1)(2009-8#1)(2010-12#6)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#3)(2013-8#3)
of peripherally##4##2##(1992-9#1)(1994-6#2)(2007-7#1)
of periplasmic##2##2##(1991-11#1)(1996-10#1)
of periportal##2##2##(1991-12#1)(2008-8#1)
of periprosthetic femoral fractures##2##4##(2011-2#1)(2013-1#1)
of periprosthetic fractures##2##3##(2007-7#1)(2011-2#1)
of periprosthetic##5##2##(2007-11#1)(2007-7#1)(2011-2#2)(2013-1#1)
of perirectal##2##2##(1990-3#1)(1991-12#1)
of perirenal##2##2##(2010-4#2)
of peristaltic##3##2##(2007-9#1)(2008-10#1)(2008-7#1)
of peritoneal and##2##3##(1995-9#1)(2012-2#1)
of peritoneal carcinosis##2##3##(1990-4#2)
of peritoneal catheter##2##3##(2011-2#1)(2012-12#1)
of peritoneal cells to##3##4##(1991-12#1)(1997-2#1)(2008-10#1)
of peritoneal cells##4##3##(1991-12#2)(1997-2#1)(2008-10#1)
of peritoneal dialysis catheter##2##4##(2007-7#1)(2013-7#1)
of peritoneal dialysis fluid by##2##5##(2008-5#2)
of peritoneal dialysis##14##3##(2007-12#4)(2007-7#2)(2008-10#2)(2008-5#2)(2011-12#1)(2011-2#2)(2013-7#1)
of peritoneal exudate##2##3##(1991-12#1)(2010-2#1)
of peritoneal fluid##3##3##(2005-7#2)(2008-1#1)
of peritoneal macrophages##4##3##(1991-12#1)(1991-6#1)(1995-9#1)(1997-2#1)
of peritoneal membrane##2##3##(2007-12#1)(2007-7#1)
of peritoneal metastases##2##3##(2008-1#2)
of peritoneal##60##2##(1990-4#2)(1991-12#4)(1991-6#1)(1993-6#2)(1994-8#1)(1995-9#2)(1997-2#2)(2005-7#2)(2006-6#2)(2007-12#8)(2007-7#4)(2008-1#4)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#2)(2010-12#2)(2010-2#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)
of peritoneum##2##2##(1993-6#1)(2006-6#1)
of peritonitis in##3##3##(2007-7#2)(2008-12#1)
of peritonitis were##3##3##(2008-4#2)(2011-2#1)
of peritonitis##19##2##(1992-5#1)(2007-12#1)(2007-7#3)(2008-10#1)(2008-12#2)(2008-4#5)(2011-2#6)
of peritumoral edema##3##3##(2007-12#3)
of peritumoral##4##2##(2006-8#1)(2007-12#3)
of perivascular##2##2##(1993-4#1)(2010-12#1)
of periwinkle yellows##2##3##(2005-11#2)
of permanent access##2##3##(2007-7#2)
of permanent and##3##3##(2008-7#1)(2010-6#1)(2011-2#1)
of permanent teeth##6##3##(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
of permanent tooth germs##2##4##(2009-3#2)
of permanent##43##2##(1990-1#1)(1990-8#1)(1992-5#1)(1994-3#1)(1996-11#1)(1996-2#1)(1996-9#1)(2005-9#1)(2006-2#2)(2006-5#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-7#6)(2007-8#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-3#2)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
of permanganate##4##2##(2008-10#4)
of permeability and##2##3##(1993-11#1)(2005-11#1)
of permeability of##2##3##(2005-11#1)(2008-1#1)
of permeability transition##2##3##(1997-6#1)(2008-10#1)
of permeability##10##2##(1990-11#1)(1993-11#1)(1994-2#1)(1997-6#1)(2005-11#4)(2008-1#1)(2008-10#1)
of permeabilized##3##2##(1992-7#1)(1994-9#1)(2012-11#1)
of permeabilizing##2##2##(2006-6#1)(2009-10#1)
of permeant##2##2##(2008-4#1)(2008-5#1)
of permeation##3##2##(2005-11#2)(2008-5#1)
of permethrin##4##2##(1997-5#1)(2004-11#2)(2010-2#1)
of permethylated##3##2##(1991-9#1)(1992-3#2)
of pernicious anemia##3##3##(2012-3#1)(2013-1#2)
of peroneal##2##2##(2009-5#1)(2013-8#1)
of peroral##2##2##(1997-2#1)(2007-2#1)
of peroxidase activity##4##3##(1991-8#3)(2008-10#1)
of peroxidase##10##2##(1991-8#3)(1991-9#1)(1994-2#1)(2008-10#5)
of peroxidases##4##2##(1992-12#1)(1992-3#1)(2008-10#2)
of peroxidation##4##2##(1990-10#1)(1990-11#2)(2008-10#1)
of peroxide value in##2##4##(2008-10#2)
of peroxide##8##2##(1990-5#1)(1995-3#1)(1995-8#1)(2008-10#5)
of peroxides in##2##3##(1995-8#2)
of peroxidizing##2##2##(1994-6#2)
of peroxisomal 3-ketoacyl-CoA thiolase##2##4##(1991-12#1)(1992-7#1)
of peroxisomal beta-oxidation activity in cultured human skin fibroblasts##3##9##(1992-4#3)
of peroxisomal beta-oxidation system##2##4##(1992-4#1)(1994-6#1)
of peroxisomal beta-oxidation##6##3##(1990-2#1)(1992-4#4)(1994-6#1)
of peroxisomal bifunctional enzyme##3##4##(1992-4#1)(1992-5#2)
of peroxisomal disorders##2##3##(1992-4#1)(1993-8#1)
of peroxisomal fatty acid##2##4##(1992-4#1)(1994-6#1)
of peroxisomal##23##2##(1990-2#2)(1991-12#1)(1992-4#9)(1992-5#2)(1992-6#1)(1992-7#1)(1993-8#3)(1994-6#2)(1996-7#1)(2008-1#1)
of peroxisome biogenesis##3##3##(1993-12#2)(2007-8#1)
of peroxisome proliferation in##3##4##(1992-8#1)(1995-3#1)(2009-8#1)
of peroxisome proliferation##7##3##(1992-8#1)(1993-9#1)(1995-3#2)(2009-8#3)
of peroxisome proliferator##2##3##(1995-3#1)(2008-7#1)
of peroxisome proliferator-activated receptor##2##4##(2010-10#1)(2013-8#1)
of peroxisome proliferator-activated##4##3##(2010-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
of peroxisome##21##2##(1992-2#1)(1992-8#2)(1993-12#2)(1993-9#1)(1995-12#1)(1995-3#3)(1995-9#1)(2007-8#1)(2008-7#1)(2009-8#4)(2010-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
of peroxisomes and mitochondria##3##4##(2009-10#3)
of peroxisomes and##5##3##(1993-9#1)(2009-10#3)(2009-8#1)
of peroxisomes in##3##3##(1995-3#1)(2007-8#1)(2009-8#1)
of peroxisomes##13##2##(1992-2#1)(1993-9#2)(1995-3#1)(1997-7#1)(2007-8#1)(2009-10#3)(2009-8#4)
of peroxy radicals##2##3##(1993-12#1)(1997-5#1)
of peroxynitrate##2##2##(2010-5#2)
of peroxynitrite in the##2##4##(1994-9#1)(2008-10#1)
of peroxynitrite in##4##3##(1994-9#1)(2004-12#1)(2008-10#2)
of peroxynitrite on##2##3##(2008-10#2)
of peroxynitrite##23##2##(1994-9#3)(1997-7#1)(2004-12#4)(2008-10#11)(2010-5#4)
of perpetrators##2##2##(2009-5#2)
of perpetual##2##2##(2008-1#1)(2012-2#1)
of perpetuation of##2##3##(2006-10#1)(2011-1#1)
of perphenazine in##4##3##(2008-10#4)
of perphenazine using##2##3##(2008-10#2)
of perphenazine##12##2##(2008-10#12)
of persecution##3##2##(1996-6#1)(2008-6#2)
of perseverative errors##2##3##(1996-8#1)(2006-3#1)
of perseverative##4##2##(1994-3#1)(1996-8#1)(2006-3#1)(2012-1#1)
of persistence with##2##3##(2009-6#2)
of persistence##9##2##(1995-5#1)(1997-6#1)(2006-9#1)(2007-12#1)(2008-11#1)(2008-5#1)(2009-6#2)(2012-3#1)
of persistent TD##2##3##(2010-12#2)
of persistent arterial duct##4##4##(1992-10#1)(1993-2#1)(2012-12#2)
of persistent infection##4##3##(1994-8#1)(1997-6#1)(2008-11#1)(2008-4#1)
of persistent left superior vena cava##2##6##(2011-2#1)(2012-2#1)
of persistent low back pain##3##5##(2006-12#1)(2006-8#1)(2009-5#1)
of persistent or recurrent##2##4##(2006-5#1)(2010-12#1)
of persistent organic pollutants##3##4##(2004-4#1)(2008-10#1)(2008-7#1)
of persistent pain##9##3##(1996-3#2)(2007-1#1)(2008-3#1)(2008-7#5)
of persistent symptoms##2##3##(2008-3#1)(2008-8#1)
of persistent##87##2##(1990-5#1)(1992-10#2)(1992-11#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-5#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-3#2)(1997-5#1)(1997-6#1)(2004-12#1)(2004-4#1)(2005-7#1)(2006-12#2)(2006-5#1)(2006-8#1)(2007-1#2)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#3)(2009-10#1)(2009-5#2)(2009-8#1)(2010-12#6)(2011-1#1)(2011-2#5)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#2)
of persistently high##2##3##(2006-10#1)(2013-1#1)
of persistently##3##2##(2006-10#1)(2006-9#1)(2013-1#1)
of persisting##4##2##(1996-12#1)(1997-7#1)(2006-9#1)(2010-11#1)
of person##8##2##(2004-10#1)(2007-12#1)(2010-4#1)(2012-1#3)(2012-12#2)
of person-centered medicine##2##3##(2012-12#2)
of personal and collective##3##4##(2005-10#1)(2008-9#1)(2011-3#1)
of personal and professional values##2##5##(2008-1#1)(2011-2#1)
of personal and professional##4##4##(1994-3#1)(2007-5#1)(2008-1#1)(2011-2#1)
of personal and social##2##4##(2009-8#1)(2012-3#1)
of personal and##13##3##(1992-4#1)(1994-3#1)(1994-6#1)(2005-10#1)(2007-5#1)(2008-1#1)(2008-12#1)(2008-9#1)(2009-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
of personal care products##2##4##(2008-5#2)
of personal care##4##3##(2008-5#3)(2011-1#1)
of personal characteristics##3##3##(1995-12#1)(2007-12#1)(2011-2#1)
of personal cleansing##3##3##(2008-5#3)
of personal computers##2##3##(1993-12#1)(1994-3#1)
of personal genomics##2##3##(2009-5#2)
of personal growth##3##3##(2007-9#2)(2010-4#1)
of personal health information##2##4##(2007-10#1)(2010-5#1)
of personal health##4##3##(1997-2#1)(2007-10#1)(2010-1#1)(2010-5#1)
of personal protection##2##3##(2006-12#1)(2008-2#1)
of personal protective##3##3##(2008-12#1)(2009-12#1)(2010-4#1)
of personal reflection##2##3##(2008-11#1)(2008-12#1)
of personal responsibility for##2##4##(2005-10#1)(2009-5#1)
of personal risk##2##3##(1997-5#1)(2013-1#1)
of personal##87##2##(1990-3#2)(1991-4#1)(1992-4#1)(1992-9#1)(1993-12#1)(1994-3#2)(1994-6#2)(1995-12#1)(1996-1#1)(1997-2#1)(1997-5#1)(2005-10#3)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#1)(2008-11#5)(2008-12#3)(2008-2#3)(2008-5#6)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#6)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#3)(2010-5#3)(2011-1#3)(2011-2#2)(2011-3#1)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#4)
of personality and##7##3##(1994-2#1)(2007-11#1)(2007-12#1)(2008-3#1)(2010-12#2)(2011-1#1)
of personality disorders in##4##4##(1991-1#2)(2009-10#1)(2012-12#1)
of personality disorders##7##3##(1991-1#2)(2005-7#2)(2006-9#1)(2009-10#1)(2012-12#1)
of personality in##2##3##(2010-12#1)(2013-1#1)
of personality on stress responses and##2##6##(2012-1#2)
of personality resilience##2##3##(2007-12#2)
of personality traits##6##3##(2004-11#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
of personality vulnerability to alcoholism##2##5##(2007-8#2)
of personality##45##2##(1991-1#2)(1994-2#1)(2004-11#1)(2004-8#1)(2005-7#2)(2006-9#3)(2007-1#2)(2007-11#1)(2007-12#3)(2007-8#2)(2008-2#1)(2008-3#2)(2008-5#3)(2008-9#1)(2009-10#1)(2009-5#1)(2010-12#6)(2011-1#3)(2011-2#2)(2012-1#3)(2012-12#2)(2013-1#2)
of personalized medicine and##2##4##(2010-10#2)
of personalized medicine##8##3##(2008-1#1)(2008-10#1)(2008-6#1)(2009-3#1)(2010-10#2)(2010-5#1)(2011-1#1)
of personalized##10##2##(2008-1#1)(2008-10#2)(2008-6#1)(2009-3#1)(2009-4#1)(2010-10#2)(2010-5#1)(2011-1#1)
of personally familiar faces##2##4##(2009-4#2)
of personally familiar##3##3##(2008-1#1)(2009-4#2)
of personally##4##2##(2007-2#1)(2008-1#1)(2009-4#2)
of personhood##2##2##(2007-3#1)(2013-7#1)
of personnel and##2##3##(1993-3#1)(2012-2#1)
of personnel in##2##3##(1996-12#1)(2005-5#1)
of personnel to##2##3##(1990-11#1)(2011-1#1)
of personnel##20##2##(1990-11#1)(1990-12#2)(1992-9#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-2#1)(1996-12#1)(2005-5#1)(2006-12#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-12#1)(2011-1#2)(2012-2#2)
of persons dying of##3##4##(1990-12#3)
of persons experiencing a##2##4##(1995-11#1)(2007-12#1)
of persons from##3##3##(1996-11#1)(1996-3#1)(2009-9#1)
of persons in##2##3##(1990-4#1)(2007-8#1)
of persons living##3##3##(1994-3#1)(2008-6#2)
of persons of##3##3##(1994-2#1)(2008-10#1)(2009-2#1)
of persons suffering from##2##4##(1996-1#1)(2007-8#1)
of persons who##6##3##(1993-7#1)(2007-10#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
of persons with AIDS##3##4##(1990-11#1)(1991-8#1)(1993-1#1)
of persons with aphasia##3##4##(2012-2#1)(2012-3#2)
of persons with burnout##2##4##(2011-2#2)
of persons with chronic##2##4##(1994-4#1)(1997-1#1)
of persons with dementia##3##4##(1992-3#1)(2007-11#1)(2011-2#1)
of persons with diabetes##2##4##(2008-1#1)(2011-2#1)
of persons with disabilities##3##4##(1997-2#1)(2007-10#1)(2009-6#1)
of persons with##44##3##(1990-11#1)(1990-4#1)(1990-5#2)(1991-8#1)(1992-3#1)(1993-1#1)(1994-4#1)(1995-3#2)(1995-6#1)(1996-3#1)(1997-1#2)(1997-2#1)(2005-7#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-6#1)(2009-7#1)(2011-2#4)(2012-1#2)(2012-2#2)(2012-3#2)(2013-1#1)
of persons without##2##3##(1991-9#1)(2011-2#1)
of persons##95##2##(1990-11#1)(1990-12#3)(1990-4#2)(1990-5#2)(1991-11#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-7#1)(1993-1#1)(1993-7#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-4#1)(1995-11#2)(1995-3#2)(1995-6#2)(1996-1#1)(1996-11#1)(1996-3#2)(1997-1#2)(1997-2#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#4)(2007-11#2)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-6#2)(2008-7#3)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#1)(2011-12#1)(2011-2#7)(2012-1#2)(2012-2#4)(2012-3#3)(2013-1#2)
of perspective##7##2##(1996-2#1)(1997-8#1)(2007-11#1)(2008-11#2)(2008-12#1)(2008-9#1)
of perspectives##4##2##(1993-7#1)(2008-11#1)(2011-12#1)(2013-8#1)
of perspiration##2##2##(2008-5#2)
of persuasion and##2##3##(1997-7#1)(2009-11#1)
of persuasion##5##2##(1997-7#1)(2009-11#1)(2010-1#2)(2011-2#1)
of persulfate##2##2##(2011-12#2)
of pertinent##4##2##(2006-10#1)(2008-11#1)(2008-2#1)(2010-7#1)
of perturbation of##2##3##(2008-10#1)(2011-2#1)
of perturbation##4##2##(2007-12#1)(2008-10#1)(2008-4#1)(2011-2#1)
of perturbations##5##2##(2008-10#2)(2008-3#2)(2009-5#1)
of pertussis and##3##3##(1990-9#1)(2005-11#1)(2010-12#1)
of pertussis toxin##5##3##(1991-1#1)(1991-3#1)(1993-11#2)(1996-5#1)
of pertussis vaccine##3##3##(1993-6#1)(1995-5#1)(2007-11#1)
of pertussis vaccines##3##3##(1995-5#3)
of pertussis##20##2##(1990-9#2)(1991-1#1)(1991-3#1)(1993-11#2)(1993-6#1)(1995-5#4)(1996-5#1)(2005-11#1)(2007-11#2)(2007-12#1)(2010-12#4)
of perycriptal fibroblasts##2##3##(2007-6#2)
of pest##5##2##(2006-12#1)(2008-10#3)(2011-2#1)
of pesticide are##2##3##(2008-10#2)
of pesticide exposure##2##3##(2005-11#2)
of pesticide mixtures on##2##4##(1996-4#2)
of pesticide residues in food of plant origin in Milan##2##10##(2013-8#2)
of pesticide residues in##4##4##(2008-10#1)(2011-2#1)(2013-8#2)
of pesticide##25##2##(1995-6#1)(1996-3#1)(1996-4#2)(2005-11#3)(2005-3#1)(2007-5#1)(2008-10#11)(2011-2#3)(2013-8#2)
of pesticides and##3##3##(1994-3#1)(2008-10#1)(2008-12#1)
of pesticides in the##3##4##(2007-5#1)(2008-10#1)(2008-6#1)
of pesticides in##10##3##(1990-9#1)(2007-5#1)(2008-10#6)(2008-11#1)(2008-6#1)
of pesticides is##2##3##(2008-10#1)(2011-1#1)
of pesticides was##2##3##(2008-10#2)
of pesticides##37##2##(1990-9#1)(1991-6#1)(1994-3#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-10#19)(2008-11#3)(2008-12#1)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#2)
of pests##10##2##(2008-10#6)(2011-12#1)(2011-2#2)(2013-8#1)
of pet dogs##2##3##(2008-8#1)(2013-1#1)
of pet food to##2##4##(2010-4#2)
of pet food##4##3##(2010-4#4)
of pet##7##2##(2008-8#1)(2010-2#1)(2010-4#4)(2013-1#1)
of petal##2##2##(2006-12#1)(2008-10#1)
of pethidine was##2##3##(1993-7#2)
of pethidine##5##2##(1993-7#4)(2006-7#1)
of petroleum ether##4##3##(2008-8#2)(2010-5#1)(2013-8#1)
of petroleum##10##2##(2004-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#2)(2010-5#1)(2012-12#1)(2013-8#1)
of petrous bone##2##3##(2011-2#2)
of petrous##6##2##(2006-12#1)(2011-2#5)
of petty corruption##2##3##(2012-3#2)
of petty##3##2##(2005-9#1)(2012-3#2)
of phage T4##2##3##(1990-12#1)(1995-12#1)
of phage T7##2##3##(1992-2#1)(1993-3#1)
of phage antibodies##2##3##(2008-10#1)(2008-4#1)
of phage based##2##3##(2011-12#2)
of phage display##3##3##(2006-10#1)(2008-4#1)(2009-6#1)
of phage lambda DNA replication##2##5##(1995-2#2)
of phage lambda DNA##5##4##(1990-11#2)(1995-2#2)(1997-4#1)
of phage lambda##8##3##(1990-11#2)(1990-3#1)(1992-4#1)(1994-12#1)(1995-2#2)(1997-4#1)
of phage therapy##7##3##(2008-4#2)(2012-2#4)(2013-1#1)
of phage##51##2##(1990-11#2)(1990-12#1)(1990-3#2)(1990-9#1)(1992-2#2)(1992-4#1)(1993-3#1)(1994-12#2)(1995-12#1)(1995-2#3)(1995-7#1)(1997-4#2)(2006-10#2)(2008-10#2)(2008-4#6)(2008-9#1)(2009-6#1)(2010-4#1)(2011-1#1)(2011-12#5)(2012-2#6)(2013-1#7)
of phages##5##2##(2007-8#1)(2009-2#1)(2011-12#1)(2012-2#1)(2013-1#1)
of phagocyte##2##2##(2006-10#1)(2008-9#1)
of phagocytes##4##2##(1996-9#2)(2006-10#1)(2012-12#1)
of phagocytic cells##6##3##(1991-10#1)(1997-3#3)(2006-10#1)(2008-5#1)
of phagocytic processes##2##3##(2008-1#1)(2008-10#1)
of phagocytic##12##2##(1991-10#1)(1995-5#1)(1997-3#3)(2006-10#1)(2007-2#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)
of phagocytosis and##2##3##(1994-3#1)(2008-1#1)
of phagocytosis by##2##3##(1993-6#1)(2008-9#1)
of phagocytosis of##4##3##(1990-8#1)(1993-6#1)(1994-5#1)(2010-2#1)
of phagocytosis##18##2##(1990-12#1)(1990-8#1)(1993-4#1)(1993-6#4)(1994-3#1)(1994-5#1)(1994-6#3)(2006-10#1)(2008-1#1)(2008-6#1)(2008-9#1)(2010-2#2)
of phagosomes##3##2##(1991-10#1)(1996-9#1)(2008-7#1)
of phalangeal##2##2##(1994-6#1)(2009-5#1)
of phalloidin##3##2##(1990-5#2)(1993-11#1)
of phantom##3##2##(2006-6#1)(2008-3#1)(2011-2#1)
of pharaonis hR in##2##4##(1994-5#2)
of pharaonis hR##3##3##(1994-5#3)
of pharma sense and pharma think##2##6##(2004-12#2)
of pharma sense and##3##4##(2004-12#3)
of pharma##5##2##(2004-12#4)(2009-9#1)
of pharmaceutical agents and##2##4##(2005-3#1)(2007-11#1)
of pharmaceutical agents##3##3##(2005-3#1)(2007-11#1)(2008-1#1)
of pharmaceutical and##3##3##(1990-9#1)(2008-3#1)(2009-4#1)
of pharmaceutical care##3##3##(2010-3#1)(2012-1#1)(2012-12#1)
of pharmaceutical companies##3##3##(2005-8#1)(2008-5#1)(2011-1#1)
of pharmaceutical development##2##3##(2008-8#1)(2012-2#1)
of pharmaceutical drugs##2##3##(2007-11#1)(2012-2#1)
of pharmaceutical effluent##3##3##(2009-6#3)
of pharmaceutical formulations##5##3##(2008-10#5)
of pharmaceutical industry##3##3##(2008-10#1)(2012-2#1)(2012-3#1)
of pharmaceutical interest by##2##4##(1996-5#1)(2008-10#1)
of pharmaceutical interest##7##3##(1996-5#2)(1997-6#1)(2005-11#1)(2008-10#3)
of pharmaceutical preparations##3##3##(2008-10#3)
of pharmaceutical product##2##3##(1997-1#1)(2011-2#1)
of pharmaceutical products##6##3##(1995-1#1)(1997-2#1)(2006-11#1)(2008-10#1)(2008-7#1)(2013-8#1)
of pharmaceutical proteins##2##3##(1994-5#1)(2006-11#1)
of pharmaceutical research##3##3##(2005-7#1)(2007-3#1)(2008-10#1)
of pharmaceutical residues in##2##4##(2008-10#2)
of pharmaceutical residues##4##3##(2008-10#4)
of pharmaceutical services at ward level in a teaching hospital##2##10##(2010-3#2)
of pharmaceutical services at ward level##3##6##(2010-3#3)
of pharmaceutical tablets##2##3##(2011-1#2)
of pharmaceutical##85##2##(1990-9#1)(1994-5#1)(1995-1#2)(1995-11#1)(1996-5#3)(1997-1#1)(1997-2#1)(1997-6#1)(2004-12#2)(2005-11#1)(2005-3#1)(2005-7#2)(2005-8#1)(2006-11#2)(2006-2#1)(2007-11#3)(2007-3#1)(2007-7#1)(2008-1#2)(2008-10#24)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-4#1)(2009-5#1)(2009-6#3)(2010-12#1)(2010-2#2)(2010-3#4)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#2)
of pharmaceutically##2##2##(2005-11#1)(2010-2#1)
of pharmaceuticals containing##2##3##(2008-10#2)
of pharmaceuticals in##3##3##(2008-10#2)(2013-1#1)
of pharmaceuticals##25##2##(1993-12#1)(1994-5#1)(1996-3#1)(2005-8#1)(2007-8#1)(2008-10#13)(2010-3#2)(2010-6#1)(2012-11#1)(2012-2#1)(2013-1#2)
of pharmacies that##2##3##(2011-1#2)
of pharmacies##4##2##(2011-1#4)
of pharmacist##4##2##(2006-3#1)(2008-1#1)(2010-3#1)(2011-1#1)
of pharmacists##9##2##(2008-1#1)(2011-1#4)(2011-2#1)(2013-1#1)(2013-8#2)
of pharmacists'##2##2##(2011-1#2)
of pharmacodynamic##2##2##(1992-8#1)(2010-8#1)
of pharmacoeconomics##3##2##(2006-5#3)
of pharmacoepidemiology##2##2##(2008-11#2)
of pharmacogenetic studies##2##3##(1994-10#1)(2005-9#1)
of pharmacogenetic##4##2##(1994-10#1)(2005-9#1)(2008-11#1)(2008-9#1)
of pharmacogenetics and##3##3##(2008-10#2)(2008-4#1)
of pharmacogenetics##8##2##(2005-9#1)(2008-10#3)(2008-4#2)(2008-8#2)
of pharmacogenomic##4##2##(2008-8#1)(2009-2#1)(2009-5#2)
of pharmacogenomics in##2##3##(2008-10#1)(2010-8#1)
of pharmacogenomics##8##2##(2008-10#2)(2008-8#2)(2009-5#1)(2010-8#1)(2011-1#1)(2013-8#1)
of pharmacognostic drugs##3##3##(2005-10#3)
of pharmacokinetic and pharmacodynamic##2##4##(2006-10#1)(2008-8#1)
of pharmacokinetic##10##2##(1995-2#1)(1995-4#1)(2004-12#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-7#1)(2010-2#1)(2011-1#1)
of pharmacokinetics and pharmacodynamics##2##4##(1996-10#1)(2006-8#1)
of pharmacokinetics and##3##3##(1996-10#1)(2006-10#1)(2006-8#1)
of pharmacokinetics##4##2##(1996-10#1)(2006-10#1)(2006-8#1)(2008-1#1)
of pharmacologic agents in##2##4##(2007-10#1)(2007-9#1)
of pharmacologic agents##5##3##(2006-10#2)(2007-10#1)(2007-9#1)(2008-2#1)
of pharmacologic##15##2##(1994-7#1)(1996-7#1)(1996-9#1)(2006-10#3)(2007-10#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2012-12#1)(2012-2#1)(2012-3#1)
of pharmacological activities##2##3##(2012-11#1)(2013-1#1)
of pharmacological agents##5##3##(1993-7#1)(1994-10#1)(1995-5#1)(2008-3#1)(2009-12#1)
of pharmacological and##6##3##(1992-6#1)(2006-1#1)(2007-9#1)(2008-11#1)(2009-4#1)(2009-7#1)
of pharmacological interest##3##3##(1995-6#1)(2007-10#1)(2009-8#1)
of pharmacological interventions##2##3##(1995-3#1)(2013-8#1)
of pharmacological properties##2##3##(2007-11#1)(2009-10#1)
of pharmacological therapies##3##3##(1993-11#1)(2011-1#1)(2011-12#1)
of pharmacological therapy##2##3##(2005-10#1)(2010-12#1)
of pharmacological treatment##5##3##(2007-11#1)(2008-9#1)(2010-2#1)(2011-2#1)(2013-1#1)
of pharmacological treatments##3##3##(2006-10#1)(2008-3#1)(2009-7#1)
of pharmacological##52##2##(1992-6#1)(1993-11#1)(1993-7#1)(1994-10#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(2005-10#1)(2005-8#2)(2006-1#2)(2006-10#4)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#2)(2009-7#2)(2009-8#2)(2010-12#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#1)(2013-1#2)(2013-7#1)(2013-8#1)
of pharmacologically active catechins in##2##5##(2008-10#2)
of pharmacologically active##5##3##(1992-5#1)(1995-1#1)(2006-12#1)(2008-10#2)
of pharmacologically##7##2##(1992-5#1)(1993-8#1)(1995-1#1)(1997-5#1)(2006-12#1)(2008-10#2)
of pharmacology and##3##3##(1990-11#1)(2008-11#2)
of pharmacology##7##2##(1990-11#1)(2008-11#2)(2008-12#2)(2008-3#1)(2010-6#1)
of pharmacotherapeutic agents##2##3##(2007-9#1)(2008-1#1)
of pharmacotherapies##3##2##(2008-2#1)(2008-3#1)(2013-1#1)
of pharmacotherapy and##2##3##(2008-2#1)(2011-12#1)
of pharmacotherapy for##3##3##(2006-9#1)(2008-2#1)(2013-1#1)
of pharmacotherapy in the##2##4##(2008-4#1)(2011-1#1)
of pharmacotherapy##12##2##(2005-7#1)(2006-9#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-12#1)(2013-1#2)
of pharmacovigilance##5##2##(2008-11#4)(2008-8#1)
of pharmacy education##2##3##(2010-3#1)(2011-1#1)
of pharmacy in##2##3##(2008-1#1)(2010-3#1)
of pharmacy services##2##3##(2008-10#1)(2013-1#1)
of pharmacy##14##2##(2008-1#1)(2008-10#1)(2009-12#1)(2010-3#4)(2011-1#2)(2011-2#4)(2013-1#1)
of pharyngitis##2##2##(2007-3#1)(2007-7#1)
of phase 1##2##3##(1997-6#1)(2008-11#1)
of phase I##5##3##(1993-6#1)(1995-12#1)(2007-11#1)(2008-1#1)(2011-2#1)
of phase II and III##2##5##(2008-5#1)(2009-11#1)
of phase II##8##3##(1995-12#1)(1997-8#1)(2007-7#1)(2008-5#2)(2009-11#1)(2009-3#1)(2010-6#1)
of phase and amplitude##2##4##(2007-11#1)(2008-2#1)
of phase and##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
of phase change on reflection##2##5##(2007-11#1)(2008-2#1)
of phase change##5##3##(2007-11#2)(2008-2#1)(2012-2#2)
of phase changes##4##3##(2008-2#4)
of phase conjugation##2##3##(2008-1#1)(2008-2#1)
of phase correction##2##3##(2007-12#2)
of phase dislocations##2##3##(2007-11#1)(2008-2#1)
of phase diversity##3##3##(2008-2#1)(2008-3#2)
of phase errors##3##3##(2008-2#2)(2008-3#1)
of phase gratings##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
of phase jump##2##3##(2008-3#2)
of phase levels of a Talbot array illuminator##2##8##(2008-3#2)
of phase levels of a##3##5##(2008-3#3)
of phase levels##6##3##(2008-2#1)(2008-3#5)
of phase matching and##2##4##(2007-12#1)(2008-3#1)
of phase matching##4##3##(2007-12#2)(2008-3#2)
of phase mismatch##2##3##(2007-11#1)(2007-12#1)
of phase objects##4##3##(2008-3#4)
of phase separation during##3##4##(2004-9#2)(2008-7#1)
of phase separation##5##3##(2004-9#2)(2008-10#1)(2008-3#1)(2008-7#1)
of phase shift##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
of phase singularities in##2##4##(2007-11#1)(2008-1#1)
of phase unwrapping##2##3##(2008-1#1)(2008-3#1)
of phase##134##2##(1991-9#1)(1992-3#1)(1993-6#1)(1995-12#2)(1996-5#1)(1997-6#1)(1997-8#1)(2004-9#2)(2005-11#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-11#14)(2007-12#16)(2007-7#1)(2008-1#4)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#24)(2008-3#35)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-2#1)(2010-4#2)(2010-6#1)(2011-2#1)(2012-2#3)
of phase-change##3##2##(2008-3#3)
of phase-conjugate mirrors during##2##4##(2008-2#2)
of phase-conjugate mirrors with two interaction regions##2##7##(2007-12#2)
of phase-conjugate mirrors##4##3##(2007-12#2)(2008-2#2)
of phase-conjugate##8##2##(2007-12#4)(2008-1#1)(2008-2#2)(2008-3#1)
of phase-encoded##2##2##(2007-11#1)(2008-2#1)
of phase-locked##2##2##(2007-11#1)(2008-3#1)
of phase-matched##4##2##(2007-12#2)(2008-1#1)(2008-3#1)
of phase-modulated light##2##3##(2007-11#1)(2008-3#1)
of phase-modulated##4##2##(1997-6#1)(2007-11#2)(2008-3#1)
of phase-only##2##2##(2008-3#2)
of phase-separated##2##2##(1994-5#1)(2008-10#1)
of phase-shift##3##2##(2007-12#1)(2008-3#2)
of phase-shifted##2##2##(2008-3#2)
of phase-shifting interferometry##5##3##(2007-12#2)(2008-3#3)
of phase-shifting##10##2##(2007-11#2)(2007-12#2)(2008-3#6)
of phase-stepping##2##2##(2007-12#1)(2008-3#1)
of phased-array antennas##2##3##(2007-12#1)(2008-3#1)
of phases##5##2##(1992-1#1)(2008-10#2)(2008-4#1)(2012-2#1)
of phasic##4##2##(1997-4#1)(2011-2#3)
of phenanthrene##7##2##(1992-7#1)(1994-5#2)(2008-11#3)(2008-9#1)
of phenazopyridine hydrochloride##2##3##(2008-10#2)
of phencyclidine (PCP)##2##3##(1991-1#2)
of phencyclidine##4##2##(1991-1#2)(1991-2#1)(2012-12#1)
of phenethyl alcohol##3##3##(2008-5#3)
of phenobarbital and phenytoin##2##4##(2008-10#2)
of phenobarbital and##4##3##(1994-8#1)(1997-3#1)(2008-10#2)
of phenobarbital##18##2##(1991-10#1)(1993-11#2)(1994-8#1)(1997-3#3)(1997-5#5)(2007-8#1)(2008-10#3)(2008-6#2)
of phenol and catechol##2##4##(2008-10#2)
of phenol and chlorophenols from##2##5##(2012-1#2)
of phenol and the##2##4##(2005-11#1)(2008-3#1)
of phenol and##14##3##(1996-11#1)(2005-11#2)(2005-4#3)(2008-10#4)(2008-3#1)(2008-8#1)(2012-1#2)
of phenol compounds##2##3##(1990-9#1)(2008-10#1)
of phenol derivatives##2##3##(2007-8#1)(2008-10#1)
of phenol in transformer##2##4##(2008-10#2)
of phenol in water##2##4##(2008-10#2)
of phenol in##10##3##(1995-11#1)(2005-11#1)(2006-8#1)(2008-10#6)(2008-8#1)
of phenol is##2##3##(2008-10#2)
of phenol to##3##3##(2006-12#1)(2006-8#2)
of phenol transformation##2##3##(2006-8#2)
of phenol under##2##3##(2006-8#2)
of phenol##64##2##(1990-12#1)(1990-9#1)(1992-6#1)(1994-10#1)(1994-2#1)(1995-11#1)(1996-11#1)(1996-6#2)(1997-2#2)(1997-8#1)(2005-11#6)(2005-4#3)(2006-12#2)(2006-8#8)(2007-8#1)(2008-10#25)(2008-11#1)(2008-3#1)(2008-8#3)(2012-1#2)
of phenolic acids was##2##4##(2008-10#2)
of phenolic acids##7##3##(2006-8#1)(2007-8#2)(2008-10#3)(2008-6#1)
of phenolic and##2##3##(2006-8#1)(2012-2#1)
of phenolic antioxidants##3##3##(2008-10#3)
of phenolic compounds and##4##4##(2008-10#3)(2010-4#1)
of phenolic compounds as natural antioxidants##2##6##(2008-10#2)
of phenolic compounds by##2##4##(2008-10#2)
of phenolic compounds in river water##2##6##(2008-10#2)
of phenolic compounds in##5##4##(2008-10#5)
of phenolic compounds##28##3##(1990-12#1)(2008-10#21)(2008-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#2)
of phenolic##53##2##(1990-12#1)(1992-9#1)(2006-8#2)(2007-11#1)(2007-8#2)(2008-10#32)(2008-11#1)(2008-5#3)(2008-6#1)(2008-9#1)(2009-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#1)
of phenolics##8##2##(2007-12#1)(2008-10#3)(2011-2#2)(2012-1#1)(2012-2#1)
of phenology##2##2##(2008-10#1)(2008-5#1)
of phenols and polyphenols##3##4##(2008-10#3)
of phenols and##8##3##(1994-9#1)(2008-10#7)
of phenols by##2##3##(2008-10#2)
of phenols from##3##3##(2007-8#1)(2008-10#2)
of phenols is##2##3##(1994-5#1)(2008-6#1)
of phenols using##2##3##(2008-10#2)
of phenols##30##2##(1994-5#2)(1994-9#2)(2006-12#1)(2007-8#1)(2008-10#22)(2008-6#1)(2013-1#1)
of phenomena##7##2##(1991-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2011-1#1)
of phenomenological##5##2##(2007-10#1)(2007-3#1)(2008-3#1)(2012-1#1)(2013-8#1)
of phenomenology##2##2##(1995-12#1)(1997-3#1)
of phenophases##2##2##(2012-6#2)
of phenothiazine derivatives##7##3##(2008-10#7)
of phenothiazines in##2##3##(2008-10#2)
of phenothiazines##4##2##(2008-10#4)
of phenotype and##3##3##(1991-9#2)(2008-11#1)
of phenotype##9##2##(1991-9#2)(1995-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)
of phenotypes from##2##3##(1990-8#1)(2008-7#1)
of phenotypes##15##2##(1990-8#1)(1994-2#2)(1995-8#1)(1997-2#1)(2008-10#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2010-3#1)
of phenotypic and genotypic##3##4##(2008-10#2)(2012-3#1)
of phenotypic data##2##3##(2008-8#1)(2010-2#1)
of phenotypic plasticity##4##3##(2008-8#1)(2008-9#1)(2009-6#1)(2012-2#1)
of phenotypic selection##2##3##(2008-8#2)
of phenotypic specialization##2##3##(2008-8#1)(2008-9#1)
of phenotypic tests##2##3##(2011-2#1)(2012-2#1)
of phenotypic variance##4##3##(2008-10#2)(2008-8#2)
of phenotypic variation in##2##4##(1996-8#1)(2013-8#1)
of phenotypic variation##4##3##(1996-8#1)(2008-10#1)(2012-3#1)(2013-8#1)
of phenotypic##41##2##(1991-5#1)(1995-11#1)(1996-3#1)(1996-8#1)(1996-9#1)(2007-7#1)(2008-10#6)(2008-7#1)(2008-8#10)(2008-9#2)(2009-4#1)(2009-5#1)(2009-6#2)(2010-2#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
of phenotypically##3##2##(1993-3#1)(2010-4#1)(2013-8#1)
of phenotyping##2##2##(2008-2#1)(2012-4#1)
of phenoxyl free##2##3##(2008-10#2)
of phenoxyl radicals##2##3##(2008-10#2)
of phenoxyl##6##2##(2008-10#4)(2008-8#2)
of phentolamine##6##2##(1990-5#3)(1997-5#2)(2007-7#1)
of phenyl##9##2##(1990-12#1)(1991-2#1)(2006-12#1)(2007-1#1)(2010-2#3)(2010-7#1)(2011-1#1)
of phenylalanine ammonia lyase##2##4##(2008-10#2)
of phenylalanine ammonia-lyase##2##3##(1995-8#1)(2008-10#1)
of phenylalanine and##2##3##(1994-6#1)(1994-9#1)
of phenylalanine in##2##3##(1993-6#1)(1993-9#1)
of phenylalanine residues##2##3##(1990-3#1)(2009-3#1)
of phenylalanine##18##2##(1990-3#1)(1990-8#1)(1992-6#1)(1993-6#4)(1993-9#1)(1994-6#1)(1994-9#1)(1995-8#1)(2008-10#5)(2009-3#1)(2010-2#1)
of phenylalkylamine derivatives in##2##4##(1992-2#2)
of phenylanthranilic acids##2##3##(1993-4#2)
of phenylephrine hydrochloride##5##3##(2008-10#4)(2008-7#1)
of phenylephrine on##3##3##(1990-12#1)(1991-3#1)(2012-3#1)
of phenylephrine##15##2##(1990-12#1)(1991-3#1)(1994-3#1)(1994-6#1)(1997-5#1)(1997-7#1)(2007-10#1)(2008-10#5)(2008-7#1)(2011-2#1)(2012-3#1)
of phenylglyoxal##2##2##(1993-3#1)(1997-1#1)
of phenylglyoxal-mediated##2##2##(1990-3#2)
of phenylhydrazine##2##2##(1991-1#1)(2010-8#1)
of phenylmercury##4##2##(2008-10#4)
of phenylpropanoid##4##2##(1992-11#1)(2006-10#1)(2008-10#2)
of phenylpropanolamine and methoxamine##2##4##(2008-10#2)
of phenylsulfonyl##2##2##(2007-11#2)
of phenylurea##2##2##(2008-10#2)
of phenytoin and##4##3##(1990-12#1)(1995-12#1)(1995-7#2)
of phenytoin in##6##3##(1990-12#1)(1994-2#1)(2007-7#1)(2008-10#2)(2008-11#1)
of phenytoin on the##2##4##(2008-11#2)
of phenytoin were##3##3##(1994-2#2)(2008-11#1)
of phenytoin##31##2##(1990-12#3)(1991-3#1)(1994-2#4)(1995-12#1)(1995-7#4)(1997-5#2)(2007-7#2)(2008-10#3)(2008-11#8)(2008-7#2)(2013-8#1)
of pheochromocytoma and##5##3##(1991-10#2)(1992-2#1)(1995-7#1)(2009-1#1)
of pheochromocytoma##12##2##(1991-10#2)(1992-2#1)(1995-7#2)(1996-12#2)(1997-8#1)(2006-8#1)(2006-9#1)(2009-1#2)
of pheophorbide a##2##3##(1996-11#2)
of pheophytin##2##2##(2008-8#1)(2008-9#1)
of pheromone##6##2##(1990-11#1)(1992-5#1)(1995-1#1)(2006-4#1)(2009-7#1)(2012-12#1)
of phi X174##3##3##(1991-5#2)(1995-2#1)
of phi##8##2##(1991-5#2)(1993-9#1)(1995-10#2)(1995-2#1)(2008-2#1)(2008-3#1)
of philosophers##2##2##(2005-11#1)(2012-2#1)
of philosophy##2##2##(1996-1#1)(2006-3#1)
of phimosis##2##2##(2006-8#1)(2008-10#1)
of phlD##6##2##(2008-10#6)
of phlD(+)##2##2##(2008-10#2)
of phlD+ pseudomonads in##2##4##(2008-10#2)
of phlebitis##2##2##(2013-1#2)
of phlebotomine sand flies##2##4##(2012-12#2)
of phlebotomine sandflies##2##3##(2007-6#2)
of phlebotomine##4##2##(2007-6#2)(2012-12#2)
of phloem cells##3##3##(2008-10#2)(2008-11#1)
of phloem##7##2##(2008-10#4)(2008-11#2)(2009-8#1)
of phloretin across##2##3##(1997-1#2)
of phloretin##3##2##(1991-2#1)(1997-1#2)
of phloroglucinol containing natural products##2##5##(2006-9#2)
of phoborhodopsin##2##2##(1991-7#2)
of phomactin A##2##3##(2008-6#2)
of phomopsis leaf blight of strawberry##2##6##(2008-10#2)
of phone##2##2##(1991-3#1)(2012-2#1)
of phonetic##2##2##(2012-1#1)(2012-12#1)
of phonological awareness and semantic intervention on word-learning##2##8##(2011-1#2)
of phonological awareness and##4##4##(2008-12#2)(2011-1#2)
of phonological awareness##6##3##(2007-9#1)(2008-12#3)(2011-1#2)
of phonological##18##2##(2006-8#1)(2007-9#1)(2008-11#1)(2008-12#3)(2008-4#3)(2008-9#2)(2009-10#1)(2010-2#1)(2011-1#2)(2012-1#1)(2012-12#1)(2013-7#1)
of phonon##2##2##(2008-2#2)
of phonons##2##2##(2006-10#1)(2007-11#1)
of phonophoresis with ketoprofen in the treatment of##2##8##(2007-7#2)
of phonophoresis with ketoprofen in##3##5##(2007-7#3)
of phonophoresis##5##2##(2007-7#5)
of phonotactic probability##3##3##(2008-9#3)
of phorbol 12-myristate 13-acetate##2##4##(1994-6#1)(1996-5#1)
of phorbol 12-myristate##3##3##(1994-6#1)(1995-5#1)(1996-5#1)
of phorbol dibutyrate##3##3##(1990-11#1)(1990-2#1)(1990-7#1)
of phorbol ester on cell growth inhibition by transforming growth factor beta 1##2##13##(1990-8#2)
of phorbol ester on##4##4##(1990-8#2)(1995-5#1)(1995-6#1)
of phorbol ester##11##3##(1990-8#2)(1990-9#1)(1992-7#1)(1992-8#1)(1992-9#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-5#1)(2008-11#1)
of phorbol esters on##3##4##(1990-12#1)(1992-4#1)(2010-12#1)
of phorbol esters##8##3##(1990-10#1)(1990-12#1)(1992-12#1)(1992-4#2)(1992-5#1)(1994-11#1)(2010-12#1)
of phorbol myristate acetate##3##4##(1994-8#1)(2004-12#1)(2005-8#1)
of phorbol##32##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-7#1)(1990-8#2)(1990-9#1)(1992-12#1)(1992-4#2)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-6#1)(1994-8#2)(1995-5#3)(1995-6#1)(1995-8#1)(1996-5#2)(2004-12#1)(2005-8#1)(2008-11#1)(2010-12#1)
of phoresy##3##2##(2008-4#3)
of phosducin##8##2##(1994-9#8)
of phosphatase##11##2##(1990-3#1)(1990-4#1)(1992-8#1)(1995-3#3)(1996-5#1)(1997-6#1)(2004-4#1)(2007-3#1)(2012-3#1)
of phosphatases and##2##3##(1997-6#1)(2008-7#1)
of phosphatases##5##2##(1990-12#1)(1992-8#1)(1995-12#1)(1997-6#1)(2008-7#1)
of phosphate and organic##2##4##(2008-10#1)(2008-5#1)
of phosphate and silicate using molybdenum blue##2##7##(2008-10#2)
of phosphate and silicate##3##4##(2008-10#3)
of phosphate and##14##3##(1991-8#1)(1994-9#1)(1996-7#1)(1997-1#1)(2008-10#6)(2008-5#1)(2010-2#1)(2012-1#1)(2012-12#1)
of phosphate buffer (pH 7##2##5##(1990-8#1)(2007-8#1)
of phosphate buffer##6##3##(1990-8#1)(1992-2#1)(2007-8#1)(2008-10#2)(2010-2#1)
of phosphate esters##3##3##(1991-4#1)(1993-8#1)(1994-11#1)
of phosphate from##4##3##(1995-8#1)(2006-6#1)(2008-4#2)
of phosphate groups##3##3##(1992-9#1)(1994-9#1)(1995-1#1)
of phosphate in hydroponic nutrient solutions##2##6##(2008-10#2)
of phosphate in hydroponic nutrient##3##5##(2008-10#3)
of phosphate in marine waters##2##5##(2008-10#2)
of phosphate in natural water##2##5##(2008-10#2)
of phosphate in##15##3##(1990-5#1)(1990-8#1)(2008-10#10)(2010-2#3)
of phosphate ion in##2##4##(2008-10#2)
of phosphate ion##3##3##(2008-10#3)
of phosphate ions##2##3##(2006-9#1)(2008-10#1)
of phosphate release##2##3##(2008-4#1)(2008-7#1)
of phosphate to the##2##4##(2008-10#2)
of phosphate transport##2##3##(1990-8#2)
of phosphate was##3##3##(1990-9#1)(1994-9#1)(2008-10#1)
of phosphate were##3##3##(1990-4#1)(1994-12#1)(2006-10#1)
of phosphate##104##2##(1990-10#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-8#5)(1990-9#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-9#5)(1995-1#1)(1995-8#1)(1996-7#2)(1997-1#1)(1997-5#1)(1997-6#3)(2006-10#4)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#43)(2008-4#3)(2008-5#1)(2008-7#1)(2010-2#6)(2010-8#1)(2012-1#1)(2012-12#1)
of phosphate/mol##2##2##(1996-5#1)(2008-5#1)
of phosphates##7##2##(1993-6#1)(1994-9#1)(1996-2#1)(2006-5#1)(2008-10#2)(2008-5#1)
of phosphates)##3##2##(1994-9#3)
of phosphatidic acid (PA)##2##4##(1991-5#1)(1997-8#1)
of phosphatidic acid##8##3##(1990-8#1)(1991-5#1)(1994-3#4)(1997-8#1)(2011-1#1)
of phosphatidyl inositol##2##3##(1991-11#1)(1992-12#1)
of phosphatidyl##4##2##(1991-11#1)(1992-12#1)(1997-1#1)(1997-6#1)
of phosphatidylcholine (PC) and phosphatidylethanolamine (PE)##2##6##(1994-12#1)(2008-8#1)
of phosphatidylcholine (PC) and##3##4##(1993-3#1)(1994-12#1)(2008-8#1)
of phosphatidylcholine (PC)##9##3##(1991-5#1)(1991-9#1)(1993-3#1)(1993-8#1)(1994-12#1)(1997-1#1)(2006-10#1)(2008-10#1)(2008-8#1)
of phosphatidylcholine and phosphatidylethanolamine##2##4##(1990-2#1)(2007-11#1)
of phosphatidylcholine and##6##3##(1990-2#1)(1990-7#1)(1992-4#1)(1994-6#1)(1994-8#1)(2007-11#1)
of phosphatidylcholine bilayers##2##3##(1992-3#2)
of phosphatidylcholine hydroperoxide##3##3##(1996-3#2)(1996-5#1)
of phosphatidylcholine in##4##3##(1992-2#1)(2008-10#3)
of phosphatidylcholine synthesis##4##3##(1995-3#4)
of phosphatidylcholine##47##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-3#5)(1995-5#1)(1996-1#1)(1996-3#2)(1996-5#2)(1997-1#2)(2006-10#3)(2007-11#1)(2008-10#6)(2008-8#2)(2009-12#1)
of phosphatidylcholines and##2##3##(1994-12#1)(1997-1#1)
of phosphatidylcholines##4##2##(1994-12#1)(1996-5#1)(1997-1#1)(1997-2#1)
of phosphatidylethanol##3##2##(1990-9#1)(1994-3#1)(1996-4#1)
of phosphatidylethanolamine (PE)##2##3##(1995-10#1)(2012-2#1)
of phosphatidylethanolamine and##2##3##(1990-7#1)(1997-7#1)
of phosphatidylethanolamine by##2##3##(1995-5#1)(2006-10#1)
of phosphatidylethanolamine on##2##3##(1990-5#1)(2012-2#1)
of phosphatidylethanolamine##15##2##(1990-2#1)(1990-5#1)(1990-7#1)(1994-8#1)(1995-10#1)(1995-5#2)(1996-1#1)(1997-7#1)(2006-10#1)(2008-8#3)(2012-2#2)
of phosphatidylglycerol##4##2##(1993-8#1)(1993-9#1)(2008-8#2)
of phosphatidylinositide##2##2##(1992-6#1)(1997-6#1)
of phosphatidylinositol (PI)##6##3##(1992-6#1)(1993-6#1)(1994-12#1)(1994-5#1)(1995-10#1)(1995-3#1)
of phosphatidylinositol 3' kinase##2##4##(1990-11#1)(1996-2#1)
of phosphatidylinositol 3-kinase (PI 3-kinase)##2##5##(1995-8#1)(2008-11#1)
of phosphatidylinositol 3-kinase##10##3##(1993-6#1)(1994-6#1)(1995-6#3)(1995-8#1)(1996-5#1)(2008-11#1)(2008-3#2)
of phosphatidylinositol 4##5##3##(1990-3#1)(1990-9#1)(1992-1#1)(1992-12#1)(1997-1#1)
of phosphatidylinositol 4-phosphate##2##3##(1993-8#1)(1997-8#1)
of phosphatidylinositol##46##2##(1990-11#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-7#2)(1991-8#3)(1992-1#1)(1992-12#1)(1992-6#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-3#2)(1995-6#4)(1995-8#1)(1996-2#2)(1996-5#2)(1997-1#1)(1997-2#1)(1997-8#2)(2008-11#3)(2008-3#2)(2008-4#1)(2008-8#1)(2009-12#1)(2010-11#1)(2013-1#1)
of phosphatidylinositol-specific phospholipase##3##3##(1991-7#1)(2008-4#1)(2008-8#1)
of phosphatidylserine and##7##3##(1990-11#2)(1990-12#2)(1991-4#1)(1992-9#1)(1993-8#1)
of phosphatidylserine at the##2##4##(2003-11#1)(2008-8#1)
of phosphatidylserine bilayers and their interactions with the local anesthetic tetracaine##2##11##(1990-2#2)
of phosphatidylserine in the##2##4##(1991-4#1)(1994-8#1)
of phosphatidylserine on the cell surface##2##6##(1995-2#1)(1997-1#1)
of phosphatidylserine on the##3##4##(1995-2#1)(1997-1#1)(2008-1#1)
of phosphatidylserine##24##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-5#1)(1991-4#3)(1992-10#1)(1992-9#1)(1993-8#1)(1994-8#3)(1995-2#1)(1997-1#1)(1997-6#1)(2003-11#1)(2008-1#1)(2008-11#1)(2008-8#2)
of phosphenes##2##2##(2010-6#1)(2011-1#1)
of phosphine##6##2##(2008-10#1)(2009-3#1)(2010-5#1)(2011-2#3)
of phosphinegold(I) thiolates##2##3##(2008-3#1)(2008-5#1)
of phosphite##3##2##(2008-10#3)
of phospho-specific antibodies##2##3##(2008-1#1)(2010-12#1)
of phosphocitrate##2##2##(1990-8#2)
of phosphocreatine##4##2##(1990-11#1)(1993-2#1)(1993-4#1)(1994-8#1)
of phosphodiester bond##3##3##(1990-2#1)(1996-7#2)
of phosphodiester##6##2##(1990-2#1)(1993-11#1)(1996-7#2)(2006-12#2)
of phosphodiesterase type##2##3##(2008-5#1)(2011-2#1)
of phosphodiesterase##6##2##(1992-12#1)(2005-8#1)(2008-3#2)(2008-5#1)(2011-2#1)
of phosphodiesters##2##2##(1991-9#1)(1993-11#1)
of phosphoenolpyruvate carboxykinase##5##3##(1991-4#1)(1991-6#1)(1994-8#1)(1995-6#1)(1997-3#1)
of phosphoenolpyruvate with##2##3##(1994-5#1)(1995-2#1)
of phosphoenolpyruvate##9##2##(1990-4#1)(1991-4#1)(1991-6#1)(1994-5#2)(1994-8#1)(1995-2#1)(1995-6#1)(1997-3#1)
of phosphofructokinase (PFK)##2##3##(1990-12#1)(1994-6#1)
of phosphofructokinase##12##2##(1990-12#1)(1990-3#2)(1991-2#3)(1994-3#1)(1994-6#1)(1995-2#1)(1997-2#3)
of phosphoinositide hydrolysis by##4##4##(1990-2#1)(1993-7#1)(1994-6#2)
of phosphoinositide hydrolysis##11##3##(1990-2#1)(1990-9#1)(1993-11#2)(1993-7#1)(1994-6#5)(1997-1#1)
of phosphoinositide##19##2##(1990-2#1)(1990-9#1)(1992-4#1)(1993-11#3)(1993-12#1)(1993-7#1)(1994-6#5)(1994-9#1)(1995-8#1)(1996-2#3)(1997-1#1)
of phosphoinositides on##2##3##(1992-12#1)(2010-9#1)
of phosphoinositides##5##2##(1990-3#1)(1992-12#1)(1995-10#1)(1997-4#1)(2010-9#1)
of phospholamban##5##2##(1992-11#1)(1993-3#2)(1994-3#2)
of phospholipase A##3##3##(1993-1#1)(1995-5#1)(2013-7#1)
of phospholipase A(2) and##3##4##(2007-11#1)(2008-11#2)
of phospholipase A(2)##5##3##(2007-11#1)(2008-11#3)(2011-2#1)
of phospholipase A2 (PLA2)##2##4##(1991-5#1)(1995-6#1)
of phospholipase A2 activity##2##4##(1991-5#1)(1995-1#1)
of phospholipase A2 and##3##4##(1996-2#2)(2012-2#1)
of phospholipase A2 by##3##4##(1991-2#1)(1994-11#2)
of phospholipase A2 in##4##4##(1990-4#1)(1992-5#1)(1992-7#1)(1994-3#1)
of phospholipase A2##29##3##(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#2)(1992-11#1)(1992-5#1)(1992-7#1)(1994-11#2)(1994-3#1)(1994-5#4)(1995-1#1)(1995-6#1)(1996-2#2)(1997-6#2)(2006-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
of phospholipase C (PLC)##6##4##(1991-1#1)(1991-10#1)(1992-11#1)(1994-12#1)(1994-8#1)(2008-4#1)
of phospholipase C and protein kinase C##2##7##(2008-11#2)
of phospholipase C and##4##4##(1990-7#1)(2008-11#3)
of phospholipase C by##2##4##(1992-9#1)(1995-5#1)
of phospholipase C##33##3##(1990-10#2)(1990-3#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-7#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-12#3)(1994-8#1)(1995-2#1)(1995-5#4)(1996-6#1)(1997-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#1)(2012-2#1)
of phospholipase C-gamma 1##5##4##(1990-11#1)(1995-6#3)(1997-4#1)
of phospholipase C-gamma##8##3##(1990-11#1)(1991-2#1)(1994-6#1)(1995-3#1)(1995-6#3)(1997-4#1)
of phospholipase Cgamma##2##3##(1996-5#1)(2008-10#1)
of phospholipase D (PLD)##4##4##(1990-7#1)(1990-9#1)(1995-3#1)(1995-8#1)
of phospholipase D and##4##4##(1991-6#1)(1993-3#1)(1995-3#1)(1996-9#1)
of phospholipase D in##7##4##(1990-7#1)(1993-3#1)(1995-8#1)(1996-5#2)(1997-3#1)(2010-9#1)
of phospholipase D##20##3##(1990-7#2)(1990-9#2)(1991-10#1)(1991-6#1)(1993-3#3)(1995-3#2)(1995-5#1)(1995-8#2)(1996-5#2)(1996-9#1)(1997-2#1)(1997-3#1)(2010-9#1)
of phospholipase activity##2##3##(1995-8#2)
of phospholipase##108##2##(1990-10#2)(1990-11#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#4)(1990-8#1)(1990-9#2)(1991-1#2)(1991-10#2)(1991-2#2)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-5#2)(1992-7#2)(1992-9#2)(1993-1#1)(1993-3#3)(1993-6#1)(1994-11#3)(1994-12#5)(1994-3#1)(1994-5#4)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#3)(1995-5#6)(1995-6#4)(1995-8#4)(1996-2#3)(1996-5#3)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(2006-8#1)(2007-11#1)(2008-10#2)(2008-11#6)(2008-3#1)(2008-4#1)(2010-9#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
of phospholipases A##2##3##(1995-5#2)
of phospholipases##4##2##(1994-3#1)(1995-5#2)(2008-1#1)
of phospholipid and##2##3##(1991-4#1)(1992-11#1)
of phospholipid bilayers##4##3##(1990-2#1)(1991-4#1)(1995-10#1)(2008-11#1)
of phospholipid exchange between##2##4##(1993-11#2)
of phospholipid membranes##2##3##(1990-2#1)(1991-2#1)
of phospholipid molecules##3##3##(1990-5#1)(2005-11#1)(2008-9#1)
of phospholipid precursors and##2##4##(1990-5#1)(2011-2#1)
of phospholipid synthesis##2##3##(1995-6#1)(2011-2#1)
of phospholipid translocation##2##3##(1994-5#1)(2011-1#1)
of phospholipid turnover##2##3##(1992-4#2)
of phospholipid vesicles##5##3##(1991-2#1)(1991-8#1)(1992-10#1)(1994-8#1)(1996-7#1)
of phospholipid##54##2##(1990-11#2)(1990-2#2)(1990-4#1)(1990-5#3)(1990-9#1)(1991-10#1)(1991-2#2)(1991-4#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-6#1)(1993-11#2)(1993-8#3)(1993-9#1)(1994-12#2)(1994-5#2)(1994-8#2)(1995-10#1)(1995-6#2)(1996-1#2)(1996-7#1)(2005-11#2)(2006-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-12#1)
of phospholipids and##6##3##(1990-2#1)(1992-3#1)(1993-6#1)(1996-11#1)(2005-11#1)(2013-7#1)
of phospholipids between##2##3##(1991-4#1)(1993-9#1)
of phospholipids in the##2##4##(2008-10#1)(2012-12#1)
of phospholipids in##6##3##(1990-11#1)(1991-1#1)(1993-3#1)(1994-12#1)(2008-10#1)(2012-12#1)
of phospholipids on the reconstitution##2##5##(1995-8#2)
of phospholipids on the##3##4##(1995-8#3)
of phospholipids with##4##3##(1993-11#1)(1994-12#1)(1995-5#2)
of phospholipids##46##2##(1990-11#1)(1990-2#2)(1990-5#2)(1991-1#1)(1991-4#2)(1992-3#1)(1992-6#2)(1993-11#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-5#2)(1995-8#3)(1996-11#1)(1996-8#1)(1997-1#1)(1997-4#1)(2004-11#1)(2005-11#1)(2006-9#1)(2008-10#3)(2008-11#3)(2008-5#2)(2008-8#3)(2009-7#1)(2009-8#1)(2012-12#1)(2013-7#1)
of phosphonate##2##2##(1992-5#1)(2008-10#1)
of phosphonic acids##2##3##(1995-11#2)
of phosphonoacetate##2##2##(1992-4#1)(2008-4#1)
of phosphopeptides##10##2##(1993-11#1)(1996-2#2)(2010-7#2)(2012-12#1)(2013-8#4)
of phosphoprotein phosphatases##2##3##(1997-6#2)
of phosphoprotein##4##2##(1991-9#1)(1997-6#3)
of phosphoproteins##3##2##(1995-3#1)(1995-6#1)(2010-9#1)
of phosphoramidite and##2##3##(2008-4#2)
of phosphoramidite##3##2##(2008-4#3)
of phosphoramidites##4##2##(2008-4#4)
of phosphoramidon##11##2##(1991-6#2)(1991-7#1)(1992-7#5)(1995-1#3)
of phosphoramidon-sensitive##2##2##(1991-4#1)(1992-6#1)
of phosphorescence##3##2##(2008-10#3)
of phosphoric acid##4##3##(2008-10#4)
of phosphorothioate analogues of##2##4##(1990-11#1)(1991-9#1)
of phosphorothioate##7##2##(1990-11#1)(1991-9#1)(1993-3#1)(1995-12#1)(1996-8#1)(2007-1#1)(2008-4#1)
of phosphorous##3##2##(2004-9#1)(2007-11#1)(2008-10#1)
of phosphorus (P)##2##3##(2008-10#1)(2008-5#1)
of phosphorus and##4##3##(1991-7#1)(2007-6#1)(2008-12#2)
of phosphorus by##4##3##(2008-10#4)
of phosphorus can##2##3##(2008-10#1)(2008-4#1)
of phosphorus in soil and sediment##3##6##(2008-10#3)
of phosphorus in##7##3##(2008-10#6)(2008-11#1)
of phosphorus is##3##3##(2004-9#1)(2008-10#2)
of phosphorus species##5##3##(2008-10#5)
of phosphorus##50##2##(1991-7#2)(2004-9#1)(2007-6#1)(2007-8#1)(2008-10#32)(2008-11#1)(2008-12#3)(2008-4#2)(2008-5#1)(2010-4#1)(2011-10#2)(2013-1#3)
of phosphorus-containing##2##2##(2004-9#1)(2010-7#1)
of phosphoryl transfer##3##3##(1990-5#1)(1995-3#1)(1996-5#1)
of phosphorylase a##2##3##(1994-12#2)
of phosphorylase b##4##3##(1990-8#1)(1994-12#2)(1995-3#1)
of phosphorylase kinase in##2##4##(1995-3#1)(1997-7#1)
of phosphorylase kinase##8##3##(1990-8#3)(1994-9#2)(1995-3#2)(1997-7#1)
of phosphorylase##15##2##(1990-8#4)(1994-12#5)(1994-9#2)(1995-3#3)(1997-7#1)
of phosphorylated and##2##3##(2008-9#1)(2009-12#1)
of phosphorylated proteins##2##3##(1995-8#1)(2008-4#1)
of phosphorylated##29##2##(1990-5#2)(1990-7#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-8#1)(1994-9#1)(1995-1#2)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(2006-12#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-9#4)(2009-12#3)(2011-1#1)
of phosphorylating and##2##3##(1991-12#1)(1994-12#1)
of phosphorylating##6##2##(1991-12#1)(1993-11#1)(1993-12#1)(1994-12#1)(1995-3#1)(1997-6#1)
of phosphorylation and##5##3##(1990-4#1)(1992-3#2)(1995-6#1)(2009-8#1)
of phosphorylation by##3##3##(1993-6#1)(1996-5#1)(1997-2#1)
of phosphorylation in##8##3##(1990-3#1)(1992-6#1)(1994-11#1)(1995-1#1)(1995-10#1)(1995-8#1)(1996-4#1)(2008-8#1)
of phosphorylation of the##6##4##(1990-4#1)(1990-5#1)(1992-11#2)(1996-5#1)(2013-1#1)
of phosphorylation of##22##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-7#1)(1992-11#2)(1992-5#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-12#1)(1996-5#1)(1997-6#1)(2011-2#1)(2013-1#1)
of phosphorylation on the##2##4##(1991-10#1)(1997-2#1)
of phosphorylation on##3##3##(1991-10#1)(1997-2#1)(2008-11#1)
of phosphorylation sites##2##3##(1995-10#1)(2008-8#1)
of phosphorylation was##2##3##(1990-7#1)(1992-3#1)
of phosphorylation##69##2##(1990-12#1)(1990-2#1)(1990-3#3)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#1)(1991-10#1)(1991-2#5)(1991-7#1)(1991-8#3)(1992-11#2)(1992-3#3)(1992-5#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-5#1)(1994-8#2)(1995-1#1)(1995-10#3)(1995-12#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-4#1)(1996-5#2)(1997-2#2)(1997-6#1)(1997-7#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-8#3)(2009-8#1)(2011-2#1)(2013-1#1)
of phosphoserine##2##2##(2008-5#2)
of phosphoserines##2##2##(2008-5#2)
of phosphosilicate##3##2##(2007-12#3)
of phosphotyrosine in##2##3##(1992-10#1)(2005-7#1)
of phosphotyrosine motifs##2##3##(1996-5#2)
of phosphotyrosine##10##2##(1990-7#1)(1992-10#1)(1992-8#1)(1994-11#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-5#2)(2005-7#1)
of photic information to the##2##5##(1997-5#2)
of photic information##3##3##(1994-2#1)(1997-5#2)
of photo##2##2##(2008-10#1)(2008-2#1)
of photo-induced##4##2##(1994-5#2)(2004-4#2)
of photoacoustic##9##2##(1994-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2011-1#1)(2011-7#2)
of photoactivated##3##2##(1997-7#1)(2008-1#1)(2008-10#1)
of photoactivation##2##2##(1990-5#1)(2010-2#1)
of photoaffinity labeling##3##3##(1991-9#1)(1995-3#2)
of photoaffinity##4##2##(1991-9#1)(1995-3#2)(1996-8#1)
of photoaged skin and##2##4##(2008-5#1)(2011-2#1)
of photoaged skin##3##3##(2008-5#2)(2011-2#1)
of photoageing##2##2##(2008-5#2)
of photoaging##5##2##(1991-6#1)(1992-6#2)(2008-5#1)(2011-2#1)
of photobleaching##2##2##(2008-1#2)
of photocarcinogenesis##4##2##(1996-11#4)
of photocatalyst##2##2##(2008-10#2)
of photocatalytic##2##2##(2008-10#2)
of photochemical##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
of photochemically induced fluorescence##2##4##(2008-10#2)
of photochemically induced##3##3##(1995-6#1)(2008-10#2)
of photochemically##4##2##(1994-11#1)(1995-6#1)(2008-10#2)
of photochemotherapy##2##2##(1992-6#2)
of photoconductive antennas##2##3##(2008-2#2)
of photoconductive##4##2##(2007-12#1)(2008-2#2)(2010-7#1)
of photodamage##2##2##(1991-7#1)(2008-5#1)
of photodamaged lysosomes##2##3##(1997-1#2)
of photodamaged##3##2##(1997-1#2)(2008-5#1)
of photodecomposition##2##2##(1997-6#1)(2007-11#1)
of photodegradation##7##2##(1997-6#1)(2004-12#1)(2008-10#5)
of photodetectors##3##2##(2007-12#1)(2008-2#1)(2012-12#1)
of photodynamic therapy (PDT) in##3##5##(2008-5#1)(2009-4#1)(2012-3#1)
of photodynamic therapy (PDT)##6##4##(2007-8#1)(2008-5#3)(2009-4#1)(2012-3#1)
of photodynamic therapy and##2##4##(2009-4#1)(2011-11#1)
of photodynamic therapy in the treatment of##2##7##(2007-11#1)(2012-12#1)
of photodynamic therapy in##4##4##(2007-11#1)(2008-5#1)(2012-12#1)(2012-3#1)
of photodynamic therapy##16##3##(1992-8#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-5#4)(2008-8#1)(2009-4#2)(2011-11#1)(2012-12#1)(2012-2#1)(2012-3#2)
of photodynamic##21##2##(1990-11#1)(1992-8#1)(2005-7#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-5#5)(2008-8#1)(2009-4#2)(2011-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
of photoelastic fringe patterns##3##4##(2008-2#2)(2008-3#1)
of photoelastic fringe##4##3##(2008-2#2)(2008-3#2)
of photoelastic##6##2##(2007-11#1)(2008-2#3)(2008-3#2)
of photoexcited##2##2##(1992-6#1)(2007-12#1)
of photographic##4##2##(2008-10#1)(2008-2#2)(2012-12#1)
of photographs of##2##3##(2009-4#1)(2010-10#1)
of photographs##4##2##(2007-8#1)(2009-4#1)(2010-10#1)(2012-12#1)
of photography##2##2##(2008-2#1)(2008-8#1)
of photoinduced charge-transfer between##2##4##(2007-11#2)
of photoinduced damage##2##3##(2007-12#2)
of photoinduced molecular polar alignment##2##5##(2007-12#2)
of photoinduced##18##2##(1995-5#1)(2007-11#5)(2007-12#9)(2007-8#2)(2008-1#1)
of photoinhibition##7##2##(1990-5#1)(1991-7#1)(1995-8#4)(2007-3#1)
of photoinitiators##2##2##(2007-11#1)(2010-4#1)
of photolabeled##3##2##(1992-5#1)(1993-8#1)(1996-8#1)
of photolesions##3##2##(1992-6#3)
of photolithography and##2##3##(2008-2#1)(2008-3#1)
of photoluminescence##3##2##(2007-11#2)(2008-10#1)
of photolysis##4##2##(1992-6#1)(1994-11#1)(2008-3#2)
of photolyzed##2##2##(1990-10#1)(1995-1#1)
of photometric quantities##2##3##(2008-3#2)
of photometric##3##2##(2008-3#3)
of photon absorption##2##3##(2006-6#1)(2008-3#1)
of photon correlation##4##3##(1990-3#1)(2008-2#3)
of photon counting##2##3##(2007-11#1)(2008-3#1)
of photon density waves##3##4##(2008-3#3)
of photon density##5##3##(2007-11#1)(2008-3#4)
of photon echoes and##2##4##(2007-12#2)
of photon energy##3##3##(2006-5#1)(2006-6#1)(2007-11#1)
of photon migration##4##3##(2007-12#2)(2008-2#2)
of photon##38##2##(1990-3#1)(1995-8#1)(1997-6#1)(2006-4#1)(2006-5#2)(2006-6#2)(2007-11#4)(2007-12#9)(2008-2#7)(2008-3#8)(2010-10#1)(2010-11#1)
of photon-echo##2##2##(2007-12#2)
of photonic crystal##5##3##(2007-11#2)(2007-12#2)(2008-3#1)
of photonic crystals##2##3##(2005-11#1)(2007-11#1)
of photonic wire structure##2##4##(2007-11#2)
of photonic##19##2##(1992-3#1)(2005-11#1)(2007-11#9)(2007-12#4)(2008-2#1)(2008-3#2)(2008-7#1)
of photonic-crystal##2##2##(2007-11#2)
of photons in##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2008-6#1)
of photons inside the##2##4##(2008-3#2)
of photons with##3##3##(2007-12#1)(2008-3#2)
of photons##25##2##(1991-2#1)(2006-3#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-2#7)(2008-3#9)(2008-4#1)(2008-6#1)
of photoperiod on testicular##2##4##(2009-5#2)
of photoperiod##6##2##(2008-11#1)(2008-7#2)(2009-5#2)(2012-11#1)
of photoperiodic##2##2##(1995-11#1)(2009-6#1)
of photopheresis##3##2##(1991-12#2)(1992-6#1)
of photopolymer##4##2##(2007-12#2)(2008-9#2)
of photopolymerization##2##2##(2008-2#1)(2008-3#1)
of photoproducts was##2##3##(1990-8#1)(2008-10#1)
of photoproducts##4##2##(1990-8#1)(1996-11#2)(2008-10#1)
of photoprotection##2##2##(2008-5#1)(2011-2#1)
of photoreactive##2##2##(1990-5#1)(1994-8#1)
of photoreceptor cells and##3##4##(2007-12#3)
of photoreceptor cells##6##3##(1990-11#1)(2007-12#4)(2008-7#1)
of photoreceptor degeneration##2##3##(1990-11#1)(2011-1#1)
of photoreceptor outer segments##2##4##(2008-7#1)(2012-12#1)
of photoreceptor outer##3##3##(2008-7#2)(2012-12#1)
of photoreceptor##17##2##(1990-11#2)(1995-10#1)(1995-7#1)(1996-2#1)(2007-12#4)(2008-7#3)(2011-1#1)(2012-12#3)(2012-3#1)
of photoreceptors in the##2##4##(1991-10#1)(2009-8#1)
of photoreceptors##5##2##(1991-10#1)(1996-2#2)(2008-7#1)(2009-8#1)
of photorefractive crystals##3##3##(2007-12#2)(2008-2#1)
of photorefractive holograms##2##3##(2008-2#1)(2008-3#1)
of photorefractive##17##2##(1990-4#1)(2007-12#8)(2008-1#1)(2008-2#2)(2008-3#5)
of photoresist##3##2##(2008-10#1)(2008-3#2)
of photorhodopsin##2##2##(2006-3#1)(2006-6#1)
of photosensitive##2##2##(2008-3#2)
of photosensitivity in##2##3##(2007-11#1)(2007-12#1)
of photosensitivity##4##2##(1991-10#1)(1993-12#1)(2007-11#1)(2007-12#1)
of photosensitization##3##2##(1991-5#1)(1997-1#1)(2008-8#1)
of photosensitized##2##2##(2006-12#1)(2008-8#1)
of photosensitizer##4##2##(2008-2#1)(2009-3#1)(2009-4#1)(2012-2#1)
of photosensitizers in##2##3##(1992-7#1)(1993-11#1)
of photosensitizers##3##2##(1992-7#2)(1993-11#1)
of photosynthesis in##2##3##(2007-9#1)(2008-10#1)
of photosynthesis##13##2##(1993-12#2)(1996-12#1)(2004-11#2)(2006-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-10#1)(2012-12#1)(2012-7#1)
of photosynthetic bacteria##3##3##(1991-3#1)(2008-8#2)
of photosynthetic electron transport to photorespiration##2##6##(2008-8#2)
of photosynthetic##15##2##(1991-3#1)(1992-12#1)(1994-5#1)(1997-4#2)(2006-12#1)(2007-12#1)(2008-10#2)(2008-8#4)(2008-9#1)(2013-8#1)
of photosynthetically active radiation##3##4##(2008-10#2)(2008-3#1)
of photosynthetically active##4##3##(2008-10#2)(2008-3#2)
of photosystem I##4##3##(1991-1#1)(1994-12#2)(2008-7#1)
of photosystem II (PS II)##2##5##(1994-12#1)(1995-8#1)
of photosystem II##18##3##(1990-8#1)(1992-3#1)(1994-12#2)(1994-8#3)(1995-8#4)(1996-10#1)(1996-4#1)(1997-4#2)(1997-7#1)(2008-11#1)(2009-2#1)
of photosystem##23##2##(1990-8#1)(1991-1#2)(1992-3#1)(1994-12#4)(1994-8#3)(1995-8#4)(1996-10#1)(1996-4#1)(1997-4#2)(1997-7#1)(2008-11#1)(2008-7#1)(2009-2#1)
of photosystem-II##2##2##(1990-5#2)
of phototherapy##4##2##(1992-4#1)(1997-6#1)(2008-11#1)(2008-3#1)
of photothermal##3##2##(2008-10#1)(2008-3#1)(2011-1#1)
of phototype##2##2##(2008-5#2)
of phr3##2##2##(1991-12#2)
of phrenic nerve##2##3##(1994-10#1)(2013-1#1)
of phthalate esters in cosmetics##2##5##(2008-5#2)
of phthalate esters##3##3##(2008-5#3)
of phthalate##6##2##(2008-10#2)(2008-5#4)
of phthalates##2##2##(2008-10#2)
of phthalic acid##3##3##(2005-11#2)(2008-10#1)
of phthalocyanine##3##2##(1993-8#1)(2005-4#1)(2008-10#1)
of phthalocyanines##3##2##(1993-8#1)(1994-12#1)(2008-10#1)
of phycoerythrin##3##2##(2008-4#1)(2008-8#2)
of phycoerythrobilins on##2##3##(2008-8#2)
of phycoerythrocyanin##2##2##(1990-9#1)(2008-8#1)
of phycourobilin##2##2##(2008-3#1)(2008-8#1)
of phyllodes tumour##2##3##(2011-2#2)
of phyllodes##3##2##(1996-6#1)(2011-2#2)
of phylogenetic analyses##2##3##(2008-10#1)(2008-8#1)
of phylogenetic analysis based on##2##5##(2008-10#1)(2013-7#1)
of phylogenetic analysis##3##3##(2005-11#1)(2008-10#1)(2013-7#1)
of phylogenetic relationships##3##3##(1996-4#1)(2008-5#1)(2008-8#1)
of phylogenetic trees##4##3##(1991-5#2)(2008-1#1)(2008-8#1)
of phylogenetic##31##2##(1991-5#3)(1991-6#1)(1992-1#1)(1995-3#1)(1996-4#1)(2005-11#1)(2006-5#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#7)(2009-5#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-7#1)
of phylogenetically##6##2##(1993-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)
of phylogenies##2##2##(2010-5#1)(2012-3#1)
of phylogeny##4##2##(1994-5#2)(2008-7#1)(2010-3#1)
of phylotypes##2##2##(2011-1#2)
of physical abuse##3##3##(2010-7#1)(2011-2#1)(2012-3#1)
of physical activity and the##2##5##(2009-6#1)(2012-12#1)
of physical activity and##4##4##(2008-7#1)(2009-6#1)(2010-5#1)(2012-12#1)
of physical activity at##3##4##(1991-9#1)(2004-10#1)(2013-1#1)
of physical activity in##2##4##(2012-12#1)(2013-1#1)
of physical activity may##2##4##(2010-3#1)(2012-2#1)
of physical activity on brain health##2##6##(2013-1#2)
of physical activity on##7##4##(2005-10#1)(2007-12#1)(2012-12#1)(2013-1#4)
of physical activity##57##3##(1991-9#2)(1995-8#1)(1997-3#1)(2004-10#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-11#5)(2010-3#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-11#1)(2011-2#2)(2012-12#6)(2012-2#2)(2013-1#13)(2013-8#8)
of physical aggression##2##3##(2008-2#2)
of physical and biological##3##4##(1994-5#1)(2008-10#1)(2008-3#1)
of physical and chemical properties##4##5##(2007-6#1)(2009-11#1)(2010-11#1)(2013-8#1)
of physical and chemical##7##4##(2007-6#1)(2008-10#3)(2009-11#1)(2010-11#1)(2013-8#1)
of physical and emotional##3##4##(2005-8#1)(2007-8#1)(2009-8#1)
of physical and mental##3##4##(1996-9#1)(2011-1#1)(2012-1#1)
of physical and psychological##3##4##(2009-7#1)(2010-2#1)(2010-6#1)
of physical and verbal/emotional abuse in schools in Lebanon is##2##10##(2013-1#2)
of physical and##33##3##(1991-2#1)(1991-6#1)(1994-5#1)(1995-1#1)(1995-4#1)(1996-4#1)(1996-9#1)(2005-8#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-5#1)(2009-11#2)(2009-7#3)(2009-8#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#3)(2013-8#2)
of physical barriers##2##3##(2008-10#2)
of physical dependence##3##3##(2008-3#1)(2008-8#2)
of physical disability##2##3##(2008-6#1)(2010-7#1)
of physical evidence##2##3##(2008-10#2)
of physical examination and##3##4##(2006-10#1)(2008-8#1)(2011-2#1)
of physical examination##7##3##(1990-10#1)(1994-4#1)(2006-10#1)(2007-2#1)(2008-8#1)(2010-8#1)(2011-2#1)
of physical exercise in##3##4##(1996-2#1)(1996-9#1)(2010-12#1)
of physical exercise##11##3##(1993-6#2)(1995-6#1)(1996-2#1)(1996-9#1)(2006-9#1)(2007-9#1)(2008-3#1)(2010-12#1)(2011-1#2)
of physical forces##3##3##(2007-3#1)(2008-11#1)(2010-9#1)
of physical function##5##3##(1994-4#1)(2006-10#1)(2006-7#1)(2007-10#1)(2010-11#1)
of physical functioning##4##3##(2006-10#1)(2006-12#1)(2013-7#2)
of physical medicine##3##3##(2007-10#1)(2008-12#2)
of physical or##3##3##(2007-11#1)(2007-9#1)(2011-1#1)
of physical parameters##5##3##(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#1)
of physical properties of##2##4##(1991-7#1)(2008-5#1)
of physical properties##3##3##(1991-7#1)(2008-5#1)(2011-2#1)
of physical responses##2##3##(2007-11#1)(2007-6#1)
of physical restraints##3##3##(2010-10#3)
of physical symptoms##2##3##(1992-2#1)(2011-12#1)
of physical therapists##3##3##(1993-12#1)(2008-8#1)(2011-2#1)
of physical therapy and##2##4##(2006-8#1)(2010-3#1)
of physical therapy in##2##4##(1993-3#1)(2008-7#1)
of physical therapy intervention##2##4##(2006-10#1)(2008-6#1)
of physical therapy students##3##4##(1995-3#2)(2011-2#1)
of physical therapy treatment of##2##5##(1992-3#1)(2008-12#1)
of physical therapy##23##3##(1991-3#1)(1992-3#1)(1993-3#1)(1995-3#2)(1996-1#1)(2006-1#1)(2006-10#1)(2006-8#1)(2008-11#2)(2008-12#2)(2008-6#1)(2008-7#3)(2009-2#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
of physical training on##3##4##(2005-1#1)(2013-8#2)
of physical training##6##3##(1990-12#1)(2005-1#1)(2013-1#2)(2013-8#2)
of physical##264##2##(1990-10#1)(1990-12#2)(1990-8#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#2)(1991-9#2)(1992-12#1)(1992-2#2)(1992-3#1)(1993-12#1)(1993-3#2)(1993-6#2)(1993-9#1)(1994-3#1)(1994-4#2)(1994-5#1)(1995-1#2)(1995-3#2)(1995-4#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-10#1)(2005-1#2)(2005-10#2)(2005-11#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#6)(2006-12#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#5)(2007-12#4)(2007-2#1)(2007-3#1)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#11)(2008-11#4)(2008-12#9)(2008-2#7)(2008-3#5)(2008-4#4)(2008-5#6)(2008-6#4)(2008-7#7)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#3)(2009-2#2)(2009-4#2)(2009-6#1)(2009-7#3)(2009-8#3)(2010-10#3)(2010-11#8)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#7)(2011-11#1)(2011-12#1)(2011-2#12)(2012-1#4)(2012-11#1)(2012-12#7)(2012-2#4)(2012-3#2)(2013-1#18)(2013-7#3)(2013-8#13)
of physically adsorbed##3##3##(1996-11#1)(2005-11#1)(2008-7#1)
of physically##11##2##(1990-7#1)(1995-2#1)(1996-11#1)(2005-11#1)(2006-10#1)(2008-7#1)(2008-9#1)(2009-12#2)(2012-1#1)(2012-12#1)
of physician P4P##2##3##(2008-4#2)
of physician and##3##3##(2007-11#1)(2008-1#1)(2011-1#1)
of physician assistants##2##3##(2007-4#2)
of physician behavior##2##3##(1995-2#1)(2010-10#1)
of physician entrepreneurship##3##3##(2007-4#3)
of physician leaders##2##3##(1994-1#1)(2008-11#1)
of physician payment reform##2##4##(1994-1#2)
of physician performance##4##3##(1996-3#1)(2013-1#3)
of physician services##2##3##(1993-12#1)(1995-12#1)
of physician with##2##3##(1993-3#1)(2008-8#1)
of physician##56##2##(1991-1#1)(1991-12#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-1#5)(1994-3#1)(1995-12#3)(1995-2#1)(1995-3#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-4#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-4#7)(2007-9#4)(2008-1#1)(2008-11#1)(2008-4#2)(2008-8#1)(2010-10#3)(2010-11#1)(2011-1#1)(2012-2#1)(2013-1#5)
of physician's##3##2##(1992-6#2)(2004-10#1)
of physician-patient reciprocity##2##3##(2005-12#2)
of physician-patient##3##2##(2005-12#2)(2009-5#1)
of physician-related##2##2##(1993-10#1)(2008-1#1)
of physician-specific health care data##3##5##(1994-2#3)
of physician-specific##4##2##(1994-2#4)
of physicians and hospitals##5##4##(1992-11#1)(1992-12#1)(1993-12#1)(1994-1#1)(1997-5#1)
of physicians and nurses to##2##5##(1993-2#1)(2008-11#1)
of physicians and other##3##4##(1994-3#1)(1996-2#1)(1996-7#1)
of physicians and##21##3##(1990-5#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-3#1)(1995-1#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-5#1)(2006-9#1)(2007-8#1)(2008-11#1)(2010-11#1)
of physicians for##3##3##(1991-1#1)(1991-10#1)(2011-2#1)
of physicians from##2##3##(1994-3#1)(2009-3#1)
of physicians in the##3##4##(1996-12#1)(2006-1#1)(2007-3#1)
of physicians in##15##3##(1991-5#1)(1992-1#1)(1994-3#6)(1996-12#1)(2006-1#1)(2007-3#1)(2007-7#1)(2010-11#1)(2010-12#1)(2010-2#1)
of physicians is##2##3##(1991-3#1)(2006-2#1)
of physicians to provide##2##4##(1994-2#1)(2007-9#1)
of physicians to##9##3##(1994-1#2)(1994-2#1)(1995-1#1)(2006-8#1)(2007-4#1)(2007-9#1)(2008-4#1)(2012-2#1)
of physicians who##3##3##(2007-1#1)(2007-4#1)(2011-2#1)
of physicians with##4##3##(2007-1#1)(2007-9#1)(2008-8#2)
of physicians##118##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#3)(1991-4#1)(1991-5#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#2)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#3)(1994-1#4)(1994-2#2)(1994-3#8)(1994-8#1)(1995-1#3)(1995-11#1)(1995-12#1)(1996-1#2)(1996-12#2)(1996-2#3)(1996-3#2)(1996-7#1)(1997-5#1)(2005-8#1)(2006-1#3)(2006-2#1)(2006-5#1)(2006-8#3)(2006-9#1)(2007-1#2)(2007-11#1)(2007-3#2)(2007-4#4)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#2)(2008-8#3)(2009-2#1)(2009-3#2)(2010-1#2)(2010-11#3)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#3)(2010-9#3)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
of physicians' services##2##3##(1991-2#1)(2010-2#1)
of physicians'##15##2##(1991-2#1)(1991-3#2)(1992-12#1)(1993-3#1)(1994-1#1)(1995-12#1)(1995-2#1)(2007-9#1)(2010-2#1)(2010-9#2)(2011-1#1)(2011-2#2)
of physicists##3##2##(2007-9#3)
of physico-chemical##6##2##(1997-2#1)(2004-4#1)(2006-12#1)(2008-10#2)(2008-4#1)
of physicochemical parameters##3##3##(1996-5#1)(2008-10#1)(2012-2#1)
of physicochemical properties##2##3##(1996-11#1)(2013-1#1)
of physicochemical##10##2##(1992-7#1)(1996-11#1)(1996-5#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2012-1#1)(2012-2#1)(2013-1#1)
of physics##5##2##(1991-5#1)(1996-4#2)(2006-2#1)(2006-5#1)
of physiologic##12##2##(1990-2#1)(1995-8#1)(1997-4#1)(2006-10#2)(2008-7#1)(2009-9#1)(2010-7#1)(2012-3#1)(2013-1#3)
of physiological and biochemical##2##4##(1991-2#1)(2012-2#1)
of physiological and pathological##4##4##(2005-8#1)(2007-11#1)(2007-2#1)(2012-3#1)
of physiological and pathophysiological##2##4##(2008-1#1)(2008-5#1)
of physiological and##17##3##(1991-2#1)(1992-6#1)(1995-12#1)(1995-5#1)(2005-8#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-2#1)(2008-4#2)(2008-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
of physiological changes##2##3##(2008-8#1)(2008-9#1)
of physiological functions in##2##4##(1995-5#1)(2011-2#1)
of physiological functions##9##3##(1990-3#1)(1995-5#1)(2006-10#1)(2008-5#2)(2008-7#1)(2011-2#2)(2012-2#1)
of physiological importance##3##3##(1990-2#1)(1992-3#1)(1992-9#1)
of physiological measurements##2##3##(1997-6#1)(2012-3#1)
of physiological parameters##5##3##(1992-12#1)(1996-1#1)(1996-11#1)(2005-9#1)(2008-9#1)
of physiological processes in##2##4##(1993-11#1)(1993-5#1)
of physiological processes##7##3##(1993-11#1)(1993-5#1)(2005-7#1)(2008-11#1)(2009-4#1)(2011-1#1)(2012-12#1)
of physiological relevance##2##3##(1991-6#1)(2011-12#1)
of physiological responses##4##3##(1991-5#1)(2008-10#1)(2008-6#1)(2012-1#1)
of physiological saline##3##3##(1995-12#2)(2008-5#1)
of physiological thoracic kyphosis##2##4##(2007-11#2)
of physiological variables##2##3##(1993-11#1)(2005-10#1)
of physiological##103##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-2#1)(1993-5#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-5#3)(1996-1#2)(1996-11#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-6#1)(1997-7#1)(2005-10#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-5#1)(2006-6#1)(2007-11#5)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-4#3)(2008-5#8)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-8#2)(2010-12#1)(2011-1#2)(2011-12#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-7#1)(2013-8#1)
of physiologically based pharmacokinetic##2##4##(2010-2#1)(2013-7#1)
of physiologically relevant##2##3##(1994-8#1)(2011-2#1)
of physiologically##10##2##(1990-8#1)(1994-8#1)(2006-11#1)(2008-10#1)(2010-2#1)(2010-4#1)(2011-2#1)(2013-1#2)(2013-7#1)
of physiology and##2##3##(2008-4#2)
of physiology##10##2##(1997-6#1)(2007-8#1)(2008-1#1)(2008-4#2)(2009-11#1)(2012-2#3)(2013-8#1)
of physiotherapeutic provision for patients undergoing##2##6##(2012-12#2)
of physiotherapeutic##3##2##(2007-7#1)(2012-12#2)
of physiotherapists and##2##3##(1996-1#1)(1996-2#1)
of physiotherapists in##2##3##(1993-1#1)(2008-9#1)
of physiotherapists##6##2##(1993-1#1)(1994-3#1)(1996-1#1)(1996-2#1)(2008-9#1)(2009-7#1)
of physiotherapy in##3##3##(1992-2#1)(1993-3#2)
of physiotherapy students##2##3##(2008-1#1)(2012-12#1)
of physiotherapy##17##2##(1990-6#1)(1992-2#1)(1992-5#1)(1993-3#4)(1994-2#1)(1995-3#1)(2007-8#2)(2008-1#1)(2010-9#1)(2012-1#1)(2012-12#3)
of physostigmine##6##2##(1993-11#4)(1997-2#2)
of phytase##5##2##(2008-5#1)(2010-2#3)(2013-1#1)
of phytic acid on the##2##5##(1991-2#2)
of phytic acid##5##3##(1991-2#3)(1992-7#1)(2013-1#1)
of phytoalexins in##2##3##(1990-6#1)(2008-10#1)
of phytoalexins##3##2##(1990-6#1)(2008-10#2)
of phytochemicals and##2##3##(2006-10#1)(2013-1#1)
of phytochemicals##7##2##(2006-10#1)(2007-11#1)(2008-7#3)(2011-1#1)(2013-1#1)
of phytochrome action##2##3##(1990-5#2)
of phytochrome##6##2##(1990-12#3)(1990-5#2)(2008-7#1)
of phytoene##4##2##(1990-7#1)(1995-2#2)(2006-12#1)
of phytoestrogens##4##2##(2006-8#1)(2008-10#2)(2012-2#1)
of phytoextraction##2##2##(2008-2#2)
of phytohormones on growth and DHA production by Thraustochytrium##2##9##(2005-11#2)
of phytohormones##7##2##(1993-8#1)(2005-11#2)(2008-10#3)(2011-1#1)
of phytopathogenic fungi##3##3##(1990-6#1)(2006-10#1)(2008-5#1)
of phytopathogenic##8##2##(1990-6#1)(2006-10#2)(2007-7#1)(2008-10#3)(2008-5#1)
of phytophagous insects##2##3##(2008-5#1)(2008-9#1)
of phytophthora##2##2##(2008-10#2)
of phytoplankton biomass##2##3##(2007-5#2)
of phytoplankton blooms##2##3##(2008-3#1)(2008-8#1)
of phytoplankton##20##2##(2007-5#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#5)(2008-9#2)(2009-8#1)(2012-2#1)(2013-8#1)
of phytoplasma in the##2##4##(2008-10#2)
of phytoplasma in##6##3##(2008-10#6)
of phytoplasma##16##2##(2005-11#2)(2008-10#14)
of phytoplasmas in the##2##4##(2008-10#2)
of phytoplasmas in##3##3##(2008-10#3)
of phytoplasmas were##2##3##(2008-10#2)
of phytoplasmas##14##2##(2008-10#14)
of phytosphingosine##2##2##(1997-5#1)(2008-5#1)
of phytostanol##2##2##(2007-8#2)
of phytosterol##2##2##(2007-11#1)(2007-8#1)
of phytosterols on##2##3##(2007-8#2)
of phytosterols##4##2##(2006-12#1)(2007-8#3)
of phytotoxic##2##2##(2008-11#1)(2009-8#1)
of phytotoxins in##2##3##(2008-10#1)(2009-6#1)
of pi##4##2##(2007-12#1)(2008-3#2)(2008-8#1)
of pial##3##2##(1992-8#2)(1996-9#1)
of pica##3##2##(1992-4#1)(1995-11#1)(1996-11#1)
of pickup##2##2##(1996-1#1)(2006-11#1)
of picosecond pulses##5##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
of picosecond##12##2##(2007-11#2)(2007-12#5)(2008-1#1)(2008-2#2)(2008-3#2)
of picoseconds##3##2##(1994-5#1)(2008-3#2)
of picrate anions##2##3##(2008-10#2)
of picric acid##4##3##(2008-10#4)
of picrotoxin##4##2##(1995-12#1)(2008-8#1)(2012-1#2)
of picture##2##2##(2004-9#1)(2006-3#1)
of pieces of##2##3##(1994-3#1)(2008-2#1)
of piezoelectric immunosensors for##2##4##(2008-10#2)
of piezoelectric quartz crystal (PQC)##2##5##(2008-10#2)
of piezoelectric quartz crystal##4##4##(2008-10#4)
of piezoelectric quartz##5##3##(1990-8#1)(2008-10#4)
of piezoelectric##8##2##(1990-8#1)(2008-10#7)
of pig heart##2##3##(1990-12#1)(1991-2#1)
of pig liver##3##3##(1992-7#2)(1996-5#1)
of pig urinary bladder myosin##2##5##(1990-7#2)
of pig##29##2##(1990-12#2)(1990-7#2)(1991-12#2)(1991-2#2)(1991-4#1)(1992-7#2)(1993-3#2)(1994-9#1)(1995-6#1)(1996-5#1)(1997-1#1)(2006-6#1)(2007-9#1)(2008-12#1)(2008-3#2)(2008-5#1)(2010-4#3)(2011-1#2)(2013-1#1)
of pigbel was##2##3##(2006-2#2)
of pigbel##4##2##(2006-2#4)
of pigeon herpes virus (PHV)##2##5##(2008-5#2)
of pigeon intestinal##2##3##(2005-7#2)
of pigeon liver malic enzyme##2##5##(1996-7#2)
of pigeon##12##2##(1992-12#2)(1996-7#2)(1997-6#1)(2005-7#2)(2008-5#4)(2008-6#1)
of pigeons##4##2##(1990-11#1)(2011-2#3)
of pigeons'##2##2##(1994-2#1)(2012-12#1)
of piglets from##2##3##(1996-8#1)(2013-1#1)
of piglets##5##2##(1996-8#1)(2008-7#2)(2010-12#1)(2013-1#1)
of pigment epithelium-derived factor##2##4##(2010-3#2)
of pigment substitution on the electrochemical properties of Rhodobacter sphaeroides 601 reaction centers##2##13##(2008-8#2)
of pigment substitution##4##3##(2008-8#4)
of pigment##13##2##(1990-10#1)(1992-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#4)(2008-9#1)(2010-3#2)(2013-1#1)
of pigmentary##2##2##(2007-7#1)(2008-5#1)
of pigmentation##6##2##(2007-7#1)(2008-10#1)(2008-8#1)(2012-11#2)(2013-7#1)
of pigmented and wooden surfaces##2##5##(2008-10#2)
of pigmented skin##2##3##(1997-5#1)(2011-2#1)
of pigmented surfaces##2##3##(2008-10#2)
of pigmented##14##2##(1990-10#1)(1995-3#2)(1997-5#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-8#1)(2010-12#1)(2010-6#1)(2011-2#1)
of pigments and##2##3##(2008-10#2)
of pigments in##2##3##(1996-7#1)(2008-3#1)
of pigments##7##2##(1996-7#1)(2008-10#4)(2008-3#1)(2008-8#1)
of pigs and the##2##4##(2011-1#2)
of pigs in##2##3##(2011-2#1)(2013-8#1)
of pigs with##2##3##(2012-2#1)(2012-3#1)
of pigs##18##2##(1991-6#1)(1992-10#1)(1994-9#1)(1996-11#1)(1996-9#1)(2006-5#1)(2010-4#4)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
of pilE##2##2##(1993-12#2)
of pilimiction##2##2##(2009-7#2)
of pilocarpine##7##2##(1990-11#3)(1991-3#2)(1991-7#1)(1997-5#1)
of pilosebaceous##2##2##(1990-6#1)(2010-3#1)
of pilot studies##2##3##(2005-7#1)(2010-3#1)
of pilot##3##2##(1996-3#1)(2005-7#1)(2010-3#1)
of pilots and##3##3##(2007-2#1)(2012-2#2)
of pimozide##2##2##(1992-9#1)(1995-12#1)
of pin##2##2##(2008-5#1)(2010-12#1)
of pinch##2##2##(2006-3#1)(2012-1#1)
of pindolol##6##2##(1995-6#1)(1997-5#1)(2008-10#4)
of pine mistletoe##2##3##(2011-12#2)
of pine needles##2##3##(2007-8#2)
of pine##6##2##(2007-8#2)(2008-10#2)(2011-12#2)
of pineal peptide preparation##2##4##(1992-12#1)(1994-5#1)
of pineal##12##2##(1990-5#1)(1992-12#1)(1994-2#1)(1994-5#2)(1995-7#1)(1995-9#1)(1997-5#2)(2008-5#1)(2012-2#2)
of pineapple##6##2##(2008-10#4)(2012-2#1)(2013-1#1)
of pineocytoma##3##2##(2012-2#3)
of pinoresinol diglucoside##2##3##(2011-1#2)
of pioglitazone##5##2##(2008-3#3)(2012-3#1)(2013-1#1)
of pioneer cells##2##3##(2007-12#2)
of pioneer##5##2##(2006-8#1)(2007-12#3)(2013-1#1)
of pioneers##2##2##(1993-9#1)(2007-12#1)
of pipeline##2##2##(2008-5#2)
of piperidine##2##2##(1993-8#1)(2008-11#1)
of pirimicarb##4##2##(2007-8#3)(2008-10#1)
of piritrexim##3##2##(2005-8#3)
of piroxicam (PX) in##2##4##(2008-10#2)
of piroxicam##10##2##(1990-9#1)(1997-8#4)(2008-10#5)
of pistachio in California##2##4##(2008-10#2)
of pistachio in california##2##4##(2008-10#2)
of pistachio in##4##3##(2008-10#4)
of pistachio##10##2##(2008-10#10)
of pitch##3##2##(2008-2#1)(2009-2#1)(2013-8#1)
of pitfalls##4##2##(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)
of pituitary adenoma##3##3##(1996-11#1)(2007-12#1)(2013-8#1)
of pituitary adenomas##4##3##(1995-9#1)(2006-9#1)(2011-2#1)(2013-8#1)
of pituitary adenylate##2##3##(1994-10#1)(1997-8#1)
of pituitary apoplexy##3##3##(1994-5#1)(2011-2#2)
of pituitary cells##3##3##(1994-3#1)(1994-9#1)(1995-10#1)
of pituitary gland##3##3##(2006-12#1)(2006-9#1)(2013-8#1)
of pituitary hormone##7##3##(1995-12#1)(2007-12#6)
of pituitary hyperplasia##2##3##(2006-9#1)(2012-2#1)
of pituitary tumors##4##3##(2006-9#1)(2009-2#1)(2010-2#1)(2011-2#1)
of pituitary##51##2##(1991-8#1)(1992-12#1)(1992-2#1)(1993-5#2)(1994-10#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-9#3)(1996-11#2)(1997-1#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-9#5)(2007-1#1)(2007-12#7)(2009-1#1)(2009-2#1)(2009-4#1)(2010-2#1)(2011-2#5)(2012-2#1)(2013-8#5)
of pityriasis alba##2##3##(2007-7#2)
of pityriasis versicolor##3##3##(2007-7#1)(2008-5#2)
of pityriasis##6##2##(2007-7#3)(2008-5#2)(2011-2#1)
of pivotal importance##2##3##(2010-7#1)(2011-2#1)
of pivotal##7##2##(1990-3#1)(1996-5#1)(1997-8#1)(2009-4#1)(2010-7#1)(2011-2#1)(2013-1#1)
of pixel##8##2##(2006-5#1)(2007-12#1)(2008-2#4)(2008-3#2)
of pixels in the##4##4##(2008-2#1)(2008-3#2)(2008-5#1)
of pixels that##2##3##(2007-11#1)(2008-8#1)
of pixels##17##2##(2007-11#2)(2007-12#2)(2008-1#1)(2008-2#6)(2008-3#3)(2008-5#1)(2008-8#1)(2010-11#1)
of place of##3##3##(2007-7#1)(2013-1#2)
of place##12##2##(1994-3#1)(1995-10#3)(1996-1#1)(2007-7#1)(2008-11#3)(2013-1#3)
of placebo or##2##3##(2008-5#1)(2013-1#1)
of placebo patients##2##3##(1991-7#1)(2006-10#1)
of placebo##16##2##(1991-7#2)(1992-11#1)(1992-12#1)(2004-3#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-11#1)(2010-9#1)(2013-1#1)
of placebos##4##2##(1995-9#1)(2007-12#2)(2012-3#1)
of placement of##2##3##(2006-7#1)(2007-8#1)
of placement##4##2##(2006-6#1)(2006-7#1)(2007-8#1)(2010-7#1)
of placental mammals##3##3##(2006-5#3)
of placental steroids##2##3##(1992-1#2)
of placental##24##2##(1990-5#1)(1992-1#2)(1992-12#2)(1993-4#2)(1993-7#1)(1994-9#1)(1995-12#1)(1996-11#1)(1996-12#2)(2006-11#1)(2006-12#1)(2006-5#4)(2008-11#1)(2009-2#2)(2009-7#1)(2012-1#1)
of placentas##5##2##(2011-1#2)(2012-1#3)
of places##2##2##(2011-1#1)(2012-12#1)
of placing a##2##3##(2006-5#1)(2007-5#1)
of placing the##2##3##(1992-12#1)(2007-11#1)
of placing##9##2##(1991-3#1)(1992-12#1)(1993-6#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-5#1)(2012-1#1)(2013-1#1)
of plague##2##2##(2004-10#1)(2013-1#1)
of plain radiographs##2##3##(2007-7#2)
of plain radiography##2##3##(2010-6#1)(2011-2#1)
of plain##10##2##(1992-10#1)(2007-2#1)(2007-7#2)(2008-2#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#1)(2013-7#1)
of plan##4##2##(1994-2#1)(1997-3#2)(2007-2#1)
of planar lipid membranes##2##4##(1990-3#1)(1991-9#1)
of planar optical waveguides##2##4##(2007-12#2)
of planar waveguides##3##3##(2007-11#1)(2008-3#2)
of planar##24##2##(1990-3#1)(1991-10#1)(1991-9#1)(1994-3#1)(1995-11#1)(2007-11#2)(2007-12#6)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#4)(2008-6#1)(2010-5#1)(2012-2#1)
of plane mirrors##2##3##(2008-2#2)
of plane reflecting##2##3##(2008-2#2)
of plane warts##2##3##(2013-1#2)
of plane waves##3##3##(2007-9#1)(2008-3#2)
of plane##10##2##(2007-9#1)(2008-2#4)(2008-3#3)(2013-1#2)
of planes##3##2##(2007-12#1)(2009-10#1)(2010-8#1)
of plankton##3##2##(2007-9#1)(2013-8#2)
of planktonic##5##2##(2007-5#3)(2009-8#1)(2011-12#1)
of planned adolescent pregnancy##2##4##(2007-2#2)
of planned pregnancy##2##3##(2006-8#1)(2007-2#1)
of planned visits##3##3##(1992-3#2)(2012-2#1)
of planned##19##2##(1992-3#3)(1994-1#1)(2006-8#1)(2006-9#1)(2007-2#3)(2008-3#1)(2008-7#1)(2010-6#1)(2011-12#2)(2012-1#1)(2012-2#3)(2012-3#1)
of planning a##2##3##(2007-2#1)(2008-10#1)
of planning and##6##3##(1991-1#1)(1994-6#1)(1995-5#1)(2005-10#1)(2009-11#1)(2010-2#1)
of planning decisions##2##3##(2012-3#2)
of planning##30##2##(1991-1#1)(1991-3#1)(1991-4#1)(1993-1#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-5#1)(1996-3#1)(1997-3#1)(2005-10#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-8#1)(2009-10#1)(2009-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2012-3#2)
of plans##2##2##(1996-3#1)(2008-11#1)
of plant DNA##2##3##(2009-9#1)(2012-2#1)
of plant TFs##2##3##(2008-7#1)(2011-2#1)
of plant age##3##3##(2008-10#3)
of plant and animal##5##4##(2007-3#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)
of plant and##9##3##(2007-3#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-10#1)
of plant biology##4##3##(2007-12#1)(2008-7#1)(2008-9#1)(2012-1#1)
of plant cell walls##4##4##(2008-9#1)(2009-10#1)(2013-8#2)
of plant cell##8##3##(1997-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2013-8#3)
of plant cells by##2##4##(2008-11#1)(2009-8#1)
of plant cells to##2##4##(1997-8#1)(2009-8#1)
of plant cells##10##3##(1997-4#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#5)
of plant chromosomes##2##3##(2008-9#2)
of plant defence##2##3##(2006-5#1)(2011-1#1)
of plant defense reactions##2##4##(2008-10#2)
of plant defense##6##3##(2008-10#4)(2008-8#1)(2009-8#1)
of plant development##5##3##(2008-10#4)(2009-8#1)
of plant disease epidemics##6##4##(2007-9#1)(2008-10#5)
of plant disease##9##3##(2007-9#2)(2008-10#7)
of plant diseases##5##3##(2008-10#5)
of plant diversity##2##3##(2008-7#1)(2008-8#1)
of plant extracts on the##2##5##(2008-12#1)(2008-5#1)
of plant extracts##8##3##(2006-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#2)(2011-1#1)(2011-2#1)
of plant foods##2##3##(1991-11#1)(2012-12#1)
of plant gene expression##2##4##(1995-2#1)(2008-9#1)
of plant genes##3##3##(2006-12#1)(2008-7#1)(2012-2#1)
of plant growth regulators##2##4##(2008-10#1)(2008-12#1)
of plant growth##10##3##(2005-11#1)(2007-12#2)(2008-10#4)(2008-12#1)(2011-2#1)(2013-8#1)
of plant growth-promoting rhizobacteria (PGPR)##3##5##(2007-12#1)(2008-10#2)
of plant growth-promoting rhizobacteria##4##4##(2007-12#1)(2008-10#3)
of plant hormone##3##3##(2009-8#3)
of plant keratin intermediate##2##4##(2008-8#2)
of plant leaf##2##3##(2013-8#2)
of plant material##2##3##(2006-12#1)(2008-9#1)
of plant materials##3##3##(2005-10#1)(2008-10#2)
of plant or##2##3##(2008-1#1)(2008-7#1)
of plant origin##10##3##(1994-5#1)(1996-1#1)(2006-10#2)(2006-9#1)(2008-10#1)(2012-2#1)(2013-8#3)
of plant parts##2##3##(2004-4#1)(2010-1#1)
of plant pathogen##2##3##(2008-10#2)
of plant pathogens by##2##4##(2008-10#2)
of plant pathogens##17##3##(1994-3#1)(2008-10#16)
of plant polyphenols##2##3##(1996-1#1)(2009-8#1)
of plant populations##2##3##(1995-8#1)(2008-9#1)
of plant productivity##2##3##(2008-8#1)(2013-8#1)
of plant protection products##4##4##(2008-11#3)(2013-8#1)
of plant protoplasts##3##3##(2008-1#1)(2008-2#1)(2008-9#1)
of plant resistance##2##3##(2009-6#1)(2011-1#1)
of plant responses to##3##4##(2008-10#1)(2008-8#1)(2009-8#1)
of plant roots##4##3##(2008-10#3)(2009-8#1)
of plant samples##4##3##(2008-10#2)(2008-6#1)(2008-9#1)
of plant signalling##2##3##(2009-8#1)(2011-2#1)
of plant species##12##3##(1991-11#1)(2008-10#3)(2008-7#1)(2008-8#3)(2009-8#2)(2013-7#2)
of plant sterols in##2##4##(2009-4#2)
of plant tissue##5##3##(1991-8#1)(2007-3#1)(2008-10#2)(2008-9#1)
of plant tissues##2##3##(2004-11#1)(2013-7#1)
of plant vacuoles##2##3##(1991-2#1)(1994-8#1)
of plant viral##2##3##(2008-9#2)
of plant viruses by##2##4##(2008-10#2)
of plant viruses##14##3##(2005-8#1)(2008-10#9)(2008-9#3)(2010-10#1)
of plant water##2##3##(2008-10#1)(2009-8#1)
of plant##305##2##(1990-11#1)(1990-6#1)(1991-11#3)(1991-2#2)(1991-8#1)(1992-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#2)(1996-4#1)(1996-5#2)(1997-4#3)(1997-8#1)(2004-11#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-4#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#6)(2006-5#1)(2006-9#1)(2007-10#1)(2007-12#7)(2007-3#3)(2007-8#2)(2007-9#3)(2008-1#2)(2008-10#95)(2008-11#6)(2008-12#4)(2008-2#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#12)(2008-8#18)(2008-9#21)(2009-10#4)(2009-4#2)(2009-6#4)(2009-8#27)(2009-9#1)(2010-1#1)(2010-10#1)(2011-1#4)(2011-10#2)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#6)(2012-3#1)(2012-6#1)(2013-7#3)(2013-8#13)
of plant-associated microbes##2##3##(2008-10#2)
of plant-derived##6##2##(1996-2#1)(2006-12#1)(2008-10#2)(2010-2#1)(2012-12#1)
of plant-herbivore##2##2##(2008-8#1)(2008-9#1)
of plant-made pharmaceuticals##2##3##(2006-12#2)
of plant-made##4##2##(2006-12#4)
of plant-parasitic nematodes##2##3##(2008-10#2)
of plant-pathogenic##2##2##(2008-10#2)
of plant-specific##2##2##(1997-4#1)(2006-12#1)
of plant-virus##2##2##(2008-10#2)
of plantar##6##2##(2006-10#1)(2008-7#1)(2009-10#1)(2010-11#1)(2010-3#1)(2012-2#1)
of planthoppers##2##2##(2008-10#2)
of planting##8##2##(2006-3#1)(2007-6#1)(2008-10#5)(2008-12#1)
of plants against##2##3##(1992-8#1)(1993-8#1)
of plants and animals##4##4##(1991-5#1)(1994-8#1)(2008-6#1)(2008-9#1)
of plants and##10##3##(1991-5#1)(1994-8#1)(2006-5#1)(2007-11#1)(2008-10#3)(2008-6#1)(2008-8#1)(2008-9#1)
of plants are##2##3##(2008-10#1)(2009-8#1)
of plants by##3##3##(1992-6#1)(2004-4#1)(2011-2#1)
of plants for##2##3##(2004-4#1)(2012-12#1)
of plants from##3##3##(2007-1#1)(2007-11#1)(2008-10#1)
of plants in the##5##4##(1994-6#1)(2008-10#3)(2010-7#1)
of plants in##7##3##(1994-6#1)(2008-10#4)(2008-12#1)(2010-7#1)
of plants inoculated##2##3##(2008-10#2)
of plants of##2##3##(1996-4#1)(2008-10#1)
of plants to##15##3##(1995-8#2)(2008-10#2)(2008-11#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-8#2)(2011-2#1)(2012-1#1)(2012-5#1)
of plants using##2##3##(2008-10#1)(2008-9#1)
of plants were##3##3##(2008-10#1)(2008-12#1)(2013-8#1)
of plants with##6##3##(2008-10#5)(2008-9#1)
of plants within##2##3##(2008-10#2)
of plants##129##2##(1991-5#1)(1991-7#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-6#2)(1994-8#1)(1995-8#2)(1996-4#1)(1996-8#1)(2004-4#2)(2006-11#1)(2006-12#2)(2006-3#1)(2006-5#1)(2007-1#1)(2007-11#2)(2007-12#2)(2008-10#54)(2008-11#3)(2008-12#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#5)(2009-10#2)(2009-2#2)(2009-6#1)(2009-8#7)(2010-12#1)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-5#1)(2013-7#2)(2013-8#4)
of plaque and##2##3##(2008-7#1)(2012-3#1)
of plaque burden##2##3##(2005-7#1)(2012-2#1)
of plaque enlargement##2##3##(2010-12#1)(2012-2#1)
of plaque rupture##2##3##(2005-7#1)(2006-10#1)
of plaque vulnerability##2##3##(2008-8#2)
of plaque##31##2##(1992-8#1)(1995-3#1)(1995-5#1)(2005-7#2)(2006-10#1)(2006-2#3)(2007-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2010-12#1)(2010-9#4)(2011-1#1)(2012-2#3)(2012-3#1)(2013-1#1)
of plaque-forming##2##2##(1992-1#1)(2013-8#1)
of plaques and##3##3##(1991-1#1)(2008-5#1)(2012-2#1)
of plaques in##2##3##(1990-7#1)(2013-7#1)
of plaques##15##2##(1990-5#1)(1990-7#1)(1991-1#1)(1991-10#1)(1992-11#1)(2007-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-4#1)(2013-7#1)(2013-8#1)
of plasma 7-dehydrocholesterol by##2##4##(1997-1#2)
of plasma CPB##3##3##(1996-5#3)
of plasma HDL-C##2##3##(1997-4#2)
of plasma Hp##2##3##(1995-7#2)
of plasma LCAT activity##2##4##(1991-7#1)(1995-6#1)
of plasma NEAC##2##3##(2012-12#2)
of plasma TF##2##3##(2005-12#2)
of plasma aldosterone##2##3##(1995-10#2)
of plasma amino acids##2##4##(1992-8#1)(1995-5#1)
of plasma and serum##2##4##(1995-1#1)(2005-8#1)
of plasma and urine amino##2##5##(1990-6#1)(1995-2#1)
of plasma and urine##3##4##(1990-6#1)(1995-2#1)(1997-3#1)
of plasma and##14##3##(1990-11#1)(1990-6#1)(1994-12#2)(1994-2#1)(1995-1#2)(1995-2#2)(1997-3#1)(2005-8#1)(2008-3#1)(2008-5#1)(2013-1#1)
of plasma cell##2##3##(2009-8#1)(2012-1#1)
of plasma cells in##2##4##(2008-1#1)(2008-9#1)
of plasma cells##3##3##(2008-1#1)(2008-9#2)
of plasma cholesterol##3##3##(1992-5#1)(1997-1#1)(1997-8#1)
of plasma concentrations of##2##4##(1991-1#1)(1994-8#1)
of plasma corticosterone##3##3##(1994-2#1)(1995-3#1)(2013-7#1)
of plasma cortisol##2##3##(2008-6#1)(2010-8#1)
of plasma diacyl-PC##2##3##(1994-12#2)
of plasma exchange##2##3##(1993-2#1)(2006-10#1)
of plasma fibrinogen##2##3##(1996-6#1)(2008-10#1)
of plasma free##2##3##(1990-4#1)(1990-5#1)
of plasma from##3##3##(1992-2#1)(1994-12#1)(2008-10#1)
of plasma gelsolin##2##3##(1992-8#1)(1996-7#1)
of plasma glucose##4##3##(1991-12#1)(1991-7#1)(1994-4#1)(2010-8#1)
of plasma homocysteine##4##3##(1991-12#1)(1992-9#1)(2005-10#1)(2008-3#1)
of plasma in##3##3##(1997-7#1)(2007-8#1)(2011-2#1)
of plasma jet##2##3##(2013-8#2)
of plasma leptin##2##3##(2008-3#1)(2011-2#1)
of plasma levels of##4##4##(1990-12#1)(1992-11#1)(1995-9#1)(2011-2#1)
of plasma levels##6##3##(1990-12#2)(1990-8#1)(1992-11#1)(1995-9#1)(2011-2#1)
of plasma lipids##2##3##(1996-11#1)(2007-2#1)
of plasma lipoproteins##2##3##(1997-2#1)(1997-8#1)
of plasma membrane H(+)-ATPase##2##4##(1993-6#1)(2009-8#1)
of plasma membrane and##2##4##(1990-2#1)(2008-4#1)
of plasma membrane receptors##3##4##(1992-12#1)(2006-10#1)(2008-4#1)
of plasma membrane##35##3##(1990-11#1)(1990-2#2)(1990-5#2)(1991-1#1)(1991-2#1)(1991-8#1)(1992-1#2)(1992-12#2)(1992-7#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-8#1)(1997-1#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-7#2)(2008-9#1)(2009-8#2)(2009-9#1)
of plasma membranes from##3##4##(1993-6#1)(1995-6#1)(2008-4#1)
of plasma membranes##11##3##(1991-1#1)(1991-5#1)(1993-6#1)(1994-9#1)(1995-11#1)(1995-6#1)(2008-10#1)(2008-11#2)(2008-4#2)
of plasma or lipoprotein fraction##2##5##(1990-8#2)
of plasma or##7##3##(1990-6#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#1)(1993-2#1)
of plasma phosphatidylcholine##2##3##(1995-8#2)
of plasma platelet-activating factor##2##4##(1997-7#2)
of plasma prekallikrein##5##3##(1991-2#1)(1991-8#2)(1993-12#2)
of plasma protein##2##3##(2008-10#1)(2011-1#1)
of plasma proteins##4##3##(1995-1#1)(2007-2#1)(2010-12#1)(2011-2#1)
of plasma renin##2##3##(2006-9#1)(2008-7#1)
of plasma samples obtained from##3##5##(1996-8#1)(1997-2#1)(2008-10#1)
of plasma samples##8##3##(1991-1#1)(1992-2#1)(1993-2#1)(1993-9#1)(1996-8#1)(1997-2#1)(2008-10#1)(2010-12#1)
of plasma to##2##3##(1993-3#1)(2008-9#1)
of plasma uracil##2##3##(1996-6#2)
of plasma uridine##7##3##(1996-6#7)
of plasma with##2##3##(1990-11#1)(1997-8#1)
of plasma##315##2##(1990-1#1)(1990-10#1)(1990-11#7)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#3)(1990-6#4)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#6)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#2)(1991-5#2)(1991-7#2)(1991-8#3)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#2)(1993-1#2)(1993-12#2)(1993-2#3)(1993-3#2)(1993-4#1)(1993-6#2)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#7)(1994-2#4)(1994-3#2)(1994-4#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#3)(1995-10#2)(1995-11#2)(1995-12#2)(1995-2#6)(1995-3#2)(1995-5#3)(1995-6#5)(1995-7#3)(1995-8#4)(1995-9#1)(1996-11#1)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#10)(1996-7#1)(1996-8#5)(1997-1#4)(1997-2#3)(1997-3#5)(1997-4#2)(1997-5#1)(1997-7#4)(1997-8#5)(2004-12#1)(2005-10#3)(2005-11#1)(2005-12#2)(2005-8#2)(2005-9#1)(2006-10#2)(2006-12#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#2)(2007-2#3)(2007-8#4)(2008-1#2)(2008-10#10)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#8)(2008-9#4)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#4)(2010-4#2)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#6)(2012-1#3)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
of plasma-deposited##3##2##(2008-2#3)
of plasma-derived##5##2##(1992-2#1)(1994-9#2)(2010-11#1)(2012-12#1)
of plasma-enhanced##2##2##(2008-2#1)(2008-3#1)
of plasmalemma##2##2##(1994-11#1)(2007-5#1)
of plasmalemmal##3##2##(1994-2#1)(1997-4#2)
of plasmalogens##2##2##(1996-7#1)(1997-4#1)
of plasmapheresis##5##2##(2006-10#1)(2010-12#1)(2013-1#2)(2013-8#1)
of plasmas##2##2##(2004-11#1)(2010-12#1)
of plasmatic##2##2##(1990-9#1)(2008-1#1)
of plasmepsin-4##2##2##(2012-2#2)
of plasmid DNA and##2##4##(2008-4#1)(2009-10#1)
of plasmid DNA into##4##4##(2008-11#2)(2008-2#1)(2008-4#1)
of plasmid DNA##27##3##(1992-2#1)(1994-3#2)(1996-6#1)(1997-6#1)(1997-8#2)(2004-12#1)(2008-10#4)(2008-11#8)(2008-2#1)(2008-4#2)(2008-8#2)(2009-10#1)(2011-2#1)
of plasmid and##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
of plasmid delivery##2##3##(2008-11#1)(2012-2#1)
of plasmid##57##2##(1990-4#1)(1990-9#4)(1991-8#1)(1992-2#1)(1993-12#2)(1994-12#1)(1994-3#3)(1994-9#1)(1995-8#3)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-8#2)(2004-12#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-11#12)(2008-2#2)(2008-3#1)(2008-4#2)(2008-8#2)(2009-10#1)(2011-2#1)(2012-2#1)
of plasmid-derived##3##2##(1997-1#3)
of plasmids containing##2##3##(1994-9#1)(1997-3#1)
of plasmids encoding##2##3##(1997-4#1)(2008-11#1)
of plasmids in##2##3##(1997-6#1)(2012-1#1)
of plasmids into##2##3##(1992-11#1)(2008-11#1)
of plasmids##20##2##(1992-11#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-9#2)(1995-1#1)(1995-8#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(2008-11#2)(2011-2#1)(2012-1#1)(2012-3#1)
of plasmin and##2##3##(1993-12#1)(2011-2#1)
of plasmin##7##2##(1990-11#1)(1993-12#1)(1995-2#1)(2008-6#1)(2011-2#2)(2013-8#1)
of plasminogen activation and##2##4##(1990-11#1)(1991-2#1)
of plasminogen activation by##3##4##(1997-2#3)
of plasminogen activation##6##3##(1990-11#1)(1991-2#1)(1997-2#4)
of plasminogen activator inhibitor-1 (PAI-1)##2##5##(1993-12#1)(1993-4#1)
of plasminogen activator inhibitor-1##6##4##(1992-2#1)(1993-12#1)(1993-4#1)(1997-1#1)(2005-7#1)(2008-4#1)
of plasminogen activator##9##3##(1990-11#1)(1992-2#1)(1993-12#1)(1993-4#1)(1994-3#1)(1997-1#1)(1997-2#1)(2005-7#1)(2008-4#1)
of plasminogen activators##2##3##(1992-6#2)
of plasminogen is##2##3##(1997-2#1)(2012-12#1)
of plasminogen to fibrin##2##4##(1990-11#1)(1991-7#1)
of plasminogen to##4##3##(1990-11#3)(1991-7#1)
of plasminogen##37##2##(1990-11#8)(1990-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-2#1)(1992-6#2)(1993-12#1)(1993-4#1)(1994-3#1)(1995-6#1)(1997-1#1)(1997-2#8)(1997-7#2)(2005-7#1)(2008-10#1)(2008-4#1)(2008-8#2)(2010-3#1)(2012-12#1)
of plasmodes##3##2##(2010-2#3)
of plasmon resonance##2##3##(2007-11#1)(2009-3#1)
of plasmon##4##2##(2007-11#1)(2007-12#1)(2007-8#1)(2009-3#1)
of plasmonic##2##2##(2007-11#1)(2008-7#1)
of plastic products##2##3##(2004-4#1)(2008-10#1)
of plastic surgery##5##3##(1991-4#1)(2010-8#2)(2013-1#2)
of plastic##22##2##(1990-10#1)(1991-4#1)(1994-10#1)(1995-9#1)(2004-4#1)(2005-8#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#3)(2008-6#1)(2008-8#1)(2009-2#1)(2010-8#3)(2013-1#2)
of plasticity are##3##3##(2006-5#1)(2008-11#1)(2008-8#1)
of plasticity in the##2##4##(2006-8#1)(2007-5#1)
of plasticity in##4##3##(2006-8#1)(2007-5#1)(2008-8#1)(2013-1#1)
of plasticity##15##2##(1995-11#1)(2006-5#1)(2006-8#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-8#6)(2009-3#1)(2009-6#1)(2013-1#1)
of plasticizer and##3##3##(2008-10#2)(2010-2#1)
of plasticizer##5##2##(2008-10#4)(2010-2#1)
of plasticizers##7##2##(1996-8#1)(2008-10#3)(2008-5#1)(2010-5#1)(2012-2#1)
of plastics##4##2##(1997-8#1)(2008-6#2)(2011-12#1)
of plastid##3##2##(1997-4#1)(2006-12#1)(2011-2#1)
of plastocyanin##4##2##(1993-11#1)(1996-9#1)(2006-10#1)(2009-10#1)
of platanus##2##2##(2013-8#2)
of plate and##2##3##(2007-11#1)(2010-8#1)
of plate##6##2##(1994-6#1)(2006-5#1)(2007-11#1)(2008-10#2)(2010-8#1)
of plateau##2##2##(1996-5#1)(2013-1#1)
of platelet GP##2##3##(1990-11#1)(2006-6#1)
of platelet activating factor (PAF)##2##5##(1991-5#1)(1991-8#1)
of platelet activating factor##3##4##(1991-5#2)(1991-8#1)
of platelet activation##5##3##(1990-5#1)(1994-3#1)(1997-7#1)(2008-7#1)(2012-11#1)
of platelet activity##2##3##(1995-12#1)(1997-7#1)
of platelet aggregation and##5##4##(1990-11#1)(1990-8#1)(1991-9#1)(1992-4#1)(1997-7#1)
of platelet aggregation by##6##4##(1995-12#3)(1996-12#1)(1997-7#1)(2008-5#1)
of platelet aggregation in response to##2##6##(2008-3#1)(2008-5#1)
of platelet aggregation in##4##4##(2006-6#1)(2007-7#1)(2008-3#1)(2008-5#1)
of platelet aggregation induced by##2##5##(1992-8#1)(2006-12#1)
of platelet aggregation##31##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-9#1)(1992-4#1)(1992-8#1)(1994-12#1)(1995-12#5)(1996-12#1)(1997-7#2)(2005-7#1)(2006-12#2)(2006-6#2)(2007-10#1)(2007-11#2)(2007-7#1)(2008-3#1)(2008-5#4)(2010-12#1)
of platelet alpha-granules##3##3##(1997-7#3)
of platelet cholesterol##2##3##(1992-12#1)(1997-7#1)
of platelet count##5##3##(2007-10#1)(2008-10#2)(2009-8#1)(2012-2#1)
of platelet derived growth factor##2##5##(1990-6#1)(1994-3#1)
of platelet factor 4##2##4##(1992-8#1)(1995-3#1)
of platelet factor##3##3##(1990-5#1)(1992-8#1)(1995-3#1)
of platelet function##4##3##(1991-12#1)(2005-9#1)(2008-1#1)(2008-11#1)
of platelet hemostasis##2##3##(2010-12#2)
of platelet hyperactivity in##2##4##(1997-7#1)(2010-12#1)
of platelet integrin##2##3##(1994-12#1)(1997-7#1)
of platelet membranes##2##3##(1995-11#1)(2007-10#1)
of platelet monoamine oxidase##2##4##(1995-1#1)(1995-8#1)
of platelet production##2##3##(2006-6#1)(2008-5#1)
of platelet suspensions##2##3##(1990-12#2)
of platelet thrombospondin 1##2##4##(1996-7#2)
of platelet##123##2##(1990-11#4)(1990-12#6)(1990-5#3)(1990-6#1)(1990-8#2)(1991-12#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-12#2)(1992-4#2)(1992-5#1)(1992-8#2)(1993-11#1)(1993-8#1)(1994-12#2)(1994-3#2)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#6)(1995-3#3)(1995-8#1)(1996-12#1)(1996-3#1)(1996-7#4)(1997-3#1)(1997-7#11)(2005-10#1)(2005-7#1)(2005-9#1)(2006-12#2)(2006-6#4)(2006-9#1)(2007-10#4)(2007-11#4)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-3#3)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-8#2)(2010-12#4)(2011-1#1)(2011-2#4)(2012-11#2)(2012-2#1)(2012-6#1)(2013-1#1)
of platelet-activating factor (PAF)##3##4##(1990-2#1)(1991-11#1)(1993-4#1)
of platelet-activating factor##9##3##(1990-2#3)(1990-7#1)(1991-11#1)(1991-5#1)(1993-4#1)(2007-9#1)(2008-3#1)
of platelet-derived growth factor (PDGF)##3##5##(1992-11#1)(1996-6#1)(2008-11#1)
of platelet-derived growth factor##8##4##(1990-7#1)(1992-11#1)(1995-11#1)(1995-3#2)(1996-6#2)(2008-11#1)
of platelet-derived growth##9##3##(1990-7#1)(1992-11#1)(1995-11#2)(1995-3#2)(1996-6#2)(2008-11#1)
of platelet-derived##12##2##(1990-12#1)(1990-7#1)(1991-9#1)(1992-11#1)(1995-11#2)(1995-3#2)(1996-11#1)(1996-6#2)(2008-11#1)
of platelet-leukocyte##2##2##(2006-6#2)
of platelet-rich plasma##4##3##(2006-6#1)(2010-4#1)(2012-12#2)
of platelet-rich##5##2##(1994-10#1)(2006-6#1)(2010-4#1)(2012-12#2)
of platelets and##9##3##(1990-9#1)(1991-12#1)(1994-10#1)(1994-12#1)(2008-11#1)(2008-4#1)(2010-12#1)(2011-1#1)(2012-3#1)
of platelets by##5##3##(1990-11#1)(1990-5#1)(1992-12#1)(2006-6#1)(2008-9#1)
of platelets from##4##3##(1990-11#2)(1992-12#1)(1992-8#1)
of platelets in the##3##4##(1990-5#1)(2007-11#1)(2012-12#1)
of platelets in##10##3##(1990-5#2)(1991-12#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-8#2)(2010-12#1)(2012-12#1)
of platelets on##2##3##(2006-6#1)(2008-11#1)
of platelets to##4##3##(1997-7#4)
of platelets with##6##3##(1990-12#1)(1990-5#1)(1992-12#1)(1992-8#1)(1993-11#1)(2011-2#1)
of platelets##67##2##(1990-11#4)(1990-12#1)(1990-5#6)(1990-9#1)(1991-12#2)(1992-1#1)(1992-12#3)(1992-5#2)(1992-6#1)(1992-8#3)(1993-11#1)(1993-6#1)(1994-10#1)(1994-12#2)(1994-9#1)(1997-2#1)(1997-7#7)(2006-6#6)(2007-11#1)(2007-9#2)(2008-1#1)(2008-11#2)(2008-4#1)(2008-8#4)(2008-9#3)(2009-8#1)(2010-12#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)
of plates##3##2##(1996-11#1)(2005-11#1)(2008-9#1)
of platform##3##2##(2008-10#1)(2011-12#1)(2012-12#1)
of platination##2##2##(1991-9#1)(1992-11#1)
of plating##5##2##(1990-4#1)(1994-3#1)(1994-5#1)(2008-11#1)(2011-1#1)
of platinum and palladium##6##4##(2008-10#6)
of platinum and ruthenium##3##4##(2008-10#3)
of platinum and##12##3##(2007-7#1)(2008-10#11)
of platinum complexes##3##3##(1991-10#1)(2008-1#2)
of platinum group elements##2##4##(2008-10#1)(2008-11#1)
of platinum group metals##5##4##(2008-10#5)
of platinum group##8##3##(2008-10#7)(2008-11#1)
of platinum nanoparticles##3##3##(2010-4#3)
of platinum with a##2##4##(2008-10#2)
of platinum with##3##3##(2008-10#3)
of platinum##59##2##(1990-5#1)(1990-6#1)(1991-10#2)(1992-8#1)(1993-8#1)(1994-6#1)(2006-2#1)(2007-7#1)(2008-1#2)(2008-10#39)(2008-11#2)(2008-5#2)(2009-4#1)(2010-11#1)(2010-4#3)
of platinum(II) complexes##2##3##(2008-5#1)(2013-1#1)
of platinum(II) with##4##3##(2008-10#4)
of platinum(II)##10##2##(2008-10#7)(2008-5#1)(2011-2#1)(2013-1#1)
of platinum(IV)##5##2##(2008-10#5)
of platinum-based##2##2##(2008-1#1)(2008-10#1)
of plausible##2##2##(2007-9#1)(2008-8#1)
of play behaviors##2##3##(1993-12#2)
of play in the##2##4##(2011-2#1)(2013-8#1)
of play in##5##3##(1993-12#1)(2008-9#2)(2011-2#1)(2013-8#1)
of play##23##2##(1991-3#1)(1992-9#4)(1993-12#5)(2005-7#1)(2007-11#3)(2008-12#1)(2008-9#2)(2009-9#2)(2011-2#2)(2012-12#1)(2013-8#1)
of pleasure##4##2##(1994-6#1)(2006-7#1)(2008-3#1)(2008-7#1)
of plenary##2##2##(2005-8#2)
of pleomorphic##7##2##(1991-12#1)(1992-1#1)(2005-7#1)(2007-5#1)(2008-7#1)(2008-8#1)(2010-12#1)
of pleomorphism and##2##3##(2008-6#2)
of pleural adhesions##4##3##(2007-8#4)
of pleural and##3##3##(1997-7#1)(2007-8#1)(2010-12#1)
of pleural effusion in##2##4##(2008-7#2)
of pleural effusion##12##3##(1997-4#1)(2006-7#1)(2007-7#1)(2008-1#1)(2008-7#3)(2013-1#5)
of pleural effusions##3##3##(1997-8#2)(2010-3#1)
of pleural empyema##3##3##(2007-8#2)(2012-2#1)
of pleural fluid and##2##4##(2007-12#1)(2010-10#1)
of pleural fluid##5##3##(1996-12#1)(2007-12#1)(2010-10#1)(2012-12#1)(2012-2#1)
of pleural mesothelioma##3##3##(1997-5#1)(2007-8#1)(2011-2#1)
of pleural tuberculosis##2##3##(1996-12#1)(1997-3#1)
of pleural##50##2##(1994-10#1)(1996-12#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#3)(2006-7#2)(2007-12#1)(2007-4#1)(2007-7#3)(2007-8#10)(2008-1#2)(2008-10#1)(2008-7#3)(2010-10#1)(2010-12#2)(2010-3#1)(2011-2#1)(2012-12#4)(2012-2#2)(2013-1#5)
of ploidy##8##2##(1992-2#1)(1993-1#1)(1995-4#1)(2006-12#1)(2009-8#1)(2010-3#3)
of plot##2##2##(1996-3#1)(2008-10#1)
of plots##7##2##(2008-10#4)(2008-12#1)(2008-8#2)
of plugs##2##2##(1995-5#1)(2008-4#1)
of plum##3##2##(2008-10#2)(2010-4#1)
of pluripotency##5##2##(2008-11#1)(2008-9#1)(2012-12#3)
of pluripotent hematopoietic stem cells##2##5##(1993-2#1)(2011-1#1)
of pluripotent stem cells##4##4##(2008-9#1)(2009-3#2)(2012-12#1)
of pluripotent##8##2##(1991-10#1)(1993-2#1)(2008-11#1)(2008-9#1)(2009-3#2)(2011-1#1)(2012-12#1)
of pluripotential##2##2##(2006-6#1)(2008-9#1)
of pluronic lecithin organogels##2##4##(2010-2#2)
of plus##2##2##(1997-2#1)(1997-6#1)
of plutonium##2##2##(2008-10#2)
of pluviosity and sun shine on sperm production and seminal characteristics of the fish Brycon henni (Pisces##2##17##(2008-5#2)
of pms##3##2##(1991-4#3)
of pneumadin into water-loaded##2##4##(1995-5#2)
of pneumadin into##3##3##(1995-5#3)
of pneumadin##4##2##(1995-5#4)
of pneumatic##2##2##(2008-10#2)
of pneumatosis intestinalis##3##3##(2012-2#3)
of pneumatosis##4##2##(2012-2#4)
of pneumococcal conjugate vaccines##2##4##(2011-2#1)(2012-12#1)
of pneumococcal disease##2##3##(2008-10#1)(2012-12#1)
of pneumococcal endocarditis##2##3##(1997-2#2)
of pneumococcal infections##3##3##(1995-3#1)(2007-11#1)(2012-12#1)
of pneumococcal meningitis##2##3##(1997-3#1)(2007-2#1)
of pneumococcal##18##2##(1990-9#1)(1991-3#1)(1995-3#4)(1997-2#2)(1997-3#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2011-2#2)(2012-12#3)
of pneumocoeles##5##2##(2012-2#5)
of pneumoconiosis##3##2##(1994-6#2)(1994-8#1)
of pneumoconiosis]##2##2##(2012-2#1)(2013-8#1)
of pneumocystis##2##2##(1990-6#1)(2013-8#1)
of pneumonia and##4##3##(1991-4#1)(2005-11#1)(2007-7#1)(2012-12#1)
of pneumonia in##4##3##(1996-9#1)(2005-11#1)(2009-4#1)(2010-12#1)
of pneumonia with##2##3##(1990-9#1)(2011-2#1)
of pneumonia##22##2##(1990-9#1)(1991-12#1)(1991-4#1)(1996-3#1)(1996-9#1)(2005-11#2)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-5#1)(2009-4#1)(2010-12#2)(2010-7#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#1)
of pneumonic##2##2##(2008-5#2)
of pneumoperitoneum##3##2##(2006-10#1)(2010-5#1)(2013-7#1)
of pneumothorax##8##2##(1990-3#1)(2006-10#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-7#1)
of podocyte##2##2##(2008-1#1)(2011-2#1)
of podocytes##5##2##(2007-12#1)(2007-9#1)(2008-1#2)(2009-2#1)
of podophyllotoxin and its##2##4##(2005-4#2)
of podophyllotoxin from##2##3##(2007-1#1)(2008-11#1)
of podophyllotoxin##9##2##(2005-4#2)(2007-1#3)(2008-11#4)
of podoplanin##3##2##(2011-2#1)(2013-1#2)
of pods##2##2##(2008-12#2)
of poikilothermic##4##2##(2008-7#3)(2008-9#1)
of point images##2##3##(2008-3#2)
of point mutations in##6##4##(1991-4#1)(1995-8#1)(1997-4#1)(2006-12#1)(2008-10#1)(2008-7#1)
of point mutations##14##3##(1991-4#2)(1991-5#1)(1994-9#1)(1995-1#1)(1995-8#3)(1997-4#1)(2006-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-1#1)
of point##27##2##(1991-4#2)(1991-5#1)(1993-3#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-7#1)(1995-8#4)(1997-4#1)(1997-6#1)(2006-12#1)(2008-10#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#1)(2010-11#1)(2011-1#1)(2012-2#2)
of pointing responses##2##3##(1993-7#2)
of pointing##7##2##(1993-5#2)(1993-7#2)(2008-2#1)(2008-3#2)
of points in the##3##4##(2008-2#2)(2008-3#1)
of points in##4##3##(2008-11#1)(2008-2#2)(2008-3#1)
of points of##4##3##(1995-3#1)(2008-2#1)(2008-3#1)(2008-6#1)
of points##23##2##(1993-1#1)(1995-3#1)(1997-6#1)(2004-1#1)(2007-11#2)(2008-11#3)(2008-2#6)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-2#1)
of poisoned##2##2##(2011-1#1)(2012-12#1)
of poisoning in##3##3##(2006-9#1)(2011-2#1)(2012-12#1)
of poisoning with##2##3##(2011-2#1)(2012-1#1)
of poisoning##13##2##(1990-9#1)(2005-11#1)(2006-2#2)(2006-9#1)(2007-7#1)(2008-12#1)(2008-3#1)(2011-2#2)(2012-1#1)(2012-12#2)
of poisonous mushrooms##2##3##(2008-5#1)(2011-2#1)
of poisonous##3##2##(1996-6#1)(2008-5#1)(2011-2#1)
of pokeweed antiviral protein##4##4##(1995-8#1)(1997-6#1)(2008-8#2)
of pokeweed##5##2##(1995-8#1)(1997-6#2)(2008-8#2)
of pol alpha##2##3##(1994-9#1)(1995-2#1)
of pol delta##3##3##(1994-8#1)(1994-9#1)(1995-2#1)
of pol##7##2##(1994-8#2)(1994-9#2)(1995-2#2)(2006-10#1)
of polar and nonpolar##2##4##(2008-10#1)(2013-8#1)
of polar and##4##3##(2008-10#2)(2012-3#1)(2013-8#1)
of polar compounds##2##3##(2005-11#1)(2013-8#1)
of polar stratospheric##2##3##(2008-2#1)(2008-3#1)
of polar surface##2##3##(1992-5#2)
of polar##27##2##(1990-11#1)(1992-5#2)(1992-6#1)(1993-2#2)(1996-11#1)(1997-6#1)(2005-11#2)(2005-12#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
of polarimetric##3##2##(2008-3#3)
of polarity##4##2##(1997-2#1)(2008-10#1)(2009-8#1)(2012-1#1)
of polarizability of##2##3##(2008-10#1)(2008-3#1)
of polarization and##7##3##(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#2)
of polarization are##2##3##(2008-2#2)
of polarization at the##2##4##(2008-2#2)
of polarization changing and##2##4##(2008-2#2)
of polarization for##4##3##(2007-12#1)(2008-3#3)
of polarization in##2##3##(2008-2#2)
of polarization is##3##3##(2007-12#1)(2008-3#2)
of polarization lidar##2##3##(2008-2#2)
of polarization mode dispersion (PMD) in spun fibers##2##8##(2007-11#2)
of polarization mode dispersion (PMD)##3##5##(2007-11#3)
of polarization mode dispersion##8##4##(2007-11#5)(2007-12#3)
of polarization of light##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
of polarization of the##8##4##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#3)
of polarization of##13##3##(2007-11#1)(2007-12#2)(2008-2#6)(2008-3#4)
of polarization on the##2##4##(2008-2#1)(2008-3#1)
of polarization rotation##2##3##(2008-2#1)(2008-3#1)
of polarization state##2##3##(2007-12#1)(2008-3#1)
of polarization##107##2##(1990-3#1)(2006-12#1)(2007-11#11)(2007-12#24)(2008-10#1)(2008-2#34)(2008-3#33)(2011-1#1)(2013-8#1)
of polarization-dependent##2##2##(2007-11#1)(2007-12#1)
of polarization-mode dispersion##2##3##(2007-11#1)(2008-3#1)
of polarization-selective##2##2##(2008-3#2)
of polarization-sensitive optical coherence tomography##5##5##(2007-11#2)(2007-12#2)(2008-3#1)
of polarization-sensitive##7##2##(2007-11#3)(2007-12#3)(2008-3#1)
of polarized absorption##2##3##(1997-4#1)(2008-3#1)
of polarized light##12##3##(2007-12#4)(2008-2#3)(2008-3#5)
of polarized##25##2##(1994-8#1)(1997-4#1)(2006-4#1)(2007-10#1)(2007-12#5)(2008-1#1)(2008-2#4)(2008-3#9)(2008-5#1)(2009-10#1)
of polarized-light##2##2##(2007-12#1)(2008-3#1)
of polarizers##2##2##(2007-11#1)(2008-1#1)
of polarizing activity##3##3##(1993-12#2)(2008-5#1)
of polarizing##5##2##(1993-12#3)(2008-2#1)(2008-5#1)
of polarographic##2##2##(2008-10#2)
of poled polymer##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
of poled##9##2##(2006-4#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#3)(2008-3#1)
of police force personnel##2##4##(2009-3#2)
of police##6##2##(1993-10#1)(1993-5#1)(2005-9#1)(2009-3#2)(2012-3#1)
of policies and programs##2##4##(2008-11#1)(2008-9#1)
of policies and##5##3##(2007-2#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-7#1)
of policies for##2##3##(1995-1#1)(2007-5#1)
of policies##14##2##(1993-12#1)(1995-1#1)(1996-1#2)(2007-2#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-7#1)(2008-9#2)(2010-7#1)(2012-2#2)
of policy and##2##3##(2008-6#1)(2013-8#1)
of policy makers##2##3##(2006-5#1)(2011-1#1)
of policy options##2##3##(1994-2#1)(2011-2#1)
of policy to##2##3##(2008-7#1)(2010-10#1)
of policy##30##2##(1990-12#1)(1992-1#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-7#1)(2006-5#1)(2007-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#4)(2009-4#1)(2010-10#2)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
of policy-relevant##2##2##(1995-1#1)(2008-11#1)
of polio in##2##3##(1994-9#1)(2008-8#1)
of polio vaccination##4##3##(2012-12#4)
of polio virus##2##3##(1992-6#1)(2008-8#1)
of polio##12##2##(1992-6#1)(1994-3#1)(1994-9#1)(2004-12#1)(2007-8#1)(2008-8#3)(2012-12#4)
of poliomyelitis##13##2##(1994-8#1)(1994-9#1)(1995-5#1)(1997-1#1)(2006-4#1)(2007-2#4)(2007-7#1)(2009-3#1)(2009-4#1)(2010-12#1)
of poliovirus vaccine##2##3##(2007-10#2)
of poliovirus##8##2##(1993-6#1)(1995-5#1)(2004-12#1)(2007-10#2)(2008-4#2)(2011-1#1)
of polish child orthopedics##2##4##(2007-8#2)
of polish orthopaedics##2##3##(2007-8#2)
of polish##8##2##(2007-8#8)
of polished##3##2##(2007-7#1)(2008-2#2)
of polishing##4##2##(1994-6#1)(2008-10#1)(2008-2#2)
of political activism##2##3##(1996-1#1)(2012-11#1)
of political and financial##2##4##(1996-2#1)(1997-1#1)
of political and social##2##4##(2010-4#1)(2013-1#1)
of political and##6##3##(1995-2#1)(1996-2#1)(1997-1#1)(2010-4#1)(2011-2#1)(2013-1#1)
of political science##2##3##(2008-1#1)(2011-1#1)
of political##20##2##(1995-2#1)(1996-1#1)(1996-2#1)(1997-1#1)(2006-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2009-4#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-3#2)(2013-1#1)
of pollen and##2##3##(1994-2#1)(2008-8#1)
of pollen discounting and##2##4##(2008-9#2)
of pollen grains##3##3##(2008-10#2)(2013-8#1)
of pollen limitation##2##3##(2008-8#1)(2008-9#1)
of pollen to##2##3##(2007-3#1)(2008-10#1)
of pollen transfer##2##3##(2008-8#2)
of pollen tube##3##3##(2009-10#1)(2009-12#1)(2009-8#1)
of pollen tubes##4##3##(2008-10#1)(2009-10#1)(2009-12#2)
of pollen##34##2##(1994-2#1)(1996-5#1)(2007-12#1)(2007-3#3)(2008-10#6)(2008-7#1)(2008-8#6)(2008-9#3)(2009-10#3)(2009-12#4)(2009-8#1)(2011-2#1)(2012-7#1)(2013-8#2)
of pollination##3##2##(2008-10#1)(2008-9#1)(2009-6#1)
of pollutant##8##2##(1992-3#1)(1992-4#1)(2004-4#1)(2008-11#2)(2012-2#2)(2013-1#1)
of pollutants from the##2##4##(2007-10#2)
of pollutants from##3##3##(2007-10#3)
of pollutants in a##2##4##(2008-10#2)
of pollutants in the##2##4##(2008-10#1)(2008-5#1)
of pollutants in##6##3##(2007-10#1)(2008-10#3)(2008-5#2)
of pollutants##20##2##(1991-3#1)(1994-3#1)(1995-11#1)(2004-4#1)(2007-10#4)(2008-10#9)(2008-5#2)(2009-6#1)
of polluted##4##2##(2008-10#1)(2009-6#1)(2012-2#2)
of pollution and##2##3##(2007-10#1)(2008-6#1)
of pollution in##4##3##(2007-10#1)(2009-6#1)(2013-8#2)
of pollution levels##2##3##(2008-10#1)(2012-12#1)
of pollution##23##2##(1990-8#1)(2004-4#1)(2006-3#1)(2007-10#5)(2007-5#3)(2008-10#4)(2008-11#2)(2008-6#1)(2009-6#1)(2011-12#1)(2012-12#1)(2013-8#2)
of pollution-mediated changes in mycorrhizal##2##5##(2004-4#2)
of poloxamer##2##2##(1994-5#1)(2005-11#1)
of poly (ADP-ribose) polymerase##4##4##(1991-10#1)(1994-6#2)(2011-2#1)
of poly##10##2##(1991-10#1)(1992-11#1)(1992-8#1)(1994-6#2)(2008-10#1)(2008-5#1)(2009-10#1)(2009-11#1)(2011-2#1)
of poly(A)+ RNA##2##3##(1995-3#1)(2008-2#1)
of poly(A)+##4##2##(1992-8#1)(1994-9#1)(1995-3#1)(2008-2#1)
of poly(ADP-ribose) polymerase##8##3##(1990-9#1)(1992-3#1)(1994-10#1)(1994-3#1)(1994-6#1)(2008-1#1)(2011-2#1)(2012-1#1)
of poly(ADP-ribose) synthetase in##2##4##(1993-6#2)
of poly(ADP-ribose) synthetase##3##3##(1993-6#3)
of poly(ADP-ribose)##14##2##(1990-9#1)(1992-3#1)(1993-6#3)(1994-10#1)(1994-3#1)(1994-6#1)(2006-12#1)(2008-1#3)(2011-2#1)(2012-1#1)
of poly(ADP-ribose)polymerase##2##2##(1991-12#1)(1994-10#1)
of poly(HPMA)-DTPA-(99m)Tc##2##2##(2013-7#2)
of poly(HPMA)-SPD-DTPA-(99m)Tc##3##2##(2013-7#3)
of poly(MMA)##2##2##(2008-5#2)
of poly(acrylic acid) and##2##4##(2010-4#1)(2013-1#1)
of poly(alpha-hydroxyacid)s##2##2##(1996-6#2)
of poly(butyl methacrylate)##2##3##(2005-11#2)
of poly(dA-dT)##3##2##(1992-5#3)
of poly(dG-dC)##2##2##(2006-10#2)
of poly(dimethylsiloxane)##2##2##(2007-8#1)(2008-10#1)
of poly(ethylene glycol) (PEG)##2##4##(1991-4#1)(2010-7#1)
of poly(ethylene glycol)##7##3##(1991-4#1)(2007-8#1)(2008-5#1)(2009-10#1)(2010-4#1)(2010-7#1)(2010-9#1)
of poly(ethylene glycol)-based##2##3##(2005-11#1)(2010-12#1)
of poly(ethylene oxide) (PEO)##2##4##(2008-10#1)(2008-5#1)
of poly(ethylene oxide)##5##3##(2005-11#2)(2008-10#1)(2008-5#2)
of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) block##2##7##(2005-11#2)
of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide)##3##5##(2005-11#3)
of poly(ethylene terephthalate) and##2##4##(2007-11#1)(2008-10#1)
of poly(ethylene terephthalate)##4##3##(2007-11#1)(2008-10#3)
of poly(ethylene##23##2##(1991-4#1)(2005-11#7)(2007-11#1)(2007-8#1)(2008-10#5)(2008-5#3)(2009-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-9#1)
of poly(maleic##2##2##(2005-11#1)(2008-10#1)
of poly(methacrylic acid)##2##3##(2006-10#2)
of poly(methyl methacrylate) (PMMA)##3##4##(2005-11#1)(2008-10#1)(2008-3#1)
of poly(methyl methacrylate)##4##3##(2005-11#1)(2008-1#1)(2008-10#1)(2008-3#1)
of poly(sodium##2##2##(2008-10#2)
of poly(vinyl alcohol) (PVA)##2##4##(2008-10#1)(2009-10#1)
of poly(vinyl##4##2##(2008-10#2)(2009-10#1)(2010-5#1)
of poly-3-hydroxybutyric acid##2##3##(2008-5#2)
of poly-L-lysine with##2##3##(1992-8#1)(2008-11#1)
of poly-L-lysine##4##2##(1992-8#1)(2008-10#1)(2008-11#2)
of polyacetylene##2##2##(2009-11#1)(2009-3#1)
of polyacrylamide##5##2##(1994-12#1)(1995-3#1)(2008-10#2)(2008-4#1)
of polyacrylic##3##2##(2005-11#2)(2008-10#1)
of polyadenylated##4##2##(1997-8#2)(2010-4#2)
of polyadenylation##4##2##(1995-3#1)(1997-2#1)(1997-4#1)(2010-4#1)
of polyamide##2##2##(2005-11#1)(2008-5#1)
of polyamine biosynthesis##3##3##(1991-10#1)(1992-1#1)(1992-9#1)
of polyamine metabolism##2##3##(1994-12#1)(2013-8#1)
of polyamine stimulation##2##3##(1993-4#2)
of polyamine##17##2##(1990-11#1)(1991-10#2)(1992-1#1)(1992-9#1)(1993-4#3)(1994-12#2)(1994-5#2)(1994-8#2)(1997-3#1)(1997-8#1)(2013-8#1)
of polyamine-deficient##4##2##(1990-10#1)(1994-8#2)(2009-6#1)
of polyamines and##4##3##(2008-10#2)(2008-7#1)(2008-8#1)
of polyamines in##4##3##(1994-11#1)(1996-12#1)(2008-10#1)(2010-4#1)
of polyamines on##2##3##(1993-4#1)(2008-11#1)
of polyamines were##3##3##(1994-11#1)(2008-10#2)
of polyamines##26##2##(1990-10#1)(1990-9#1)(1991-10#1)(1991-4#2)(1993-4#1)(1994-11#2)(1994-5#1)(1996-12#2)(1996-7#1)(1997-3#1)(2008-10#6)(2008-11#2)(2008-7#1)(2008-8#1)(2009-8#2)(2010-4#1)
of polyaniline (PANI)##2##3##(2005-11#1)(2008-10#1)
of polyaniline fiber##2##3##(2008-10#2)
of polyaniline films##4##3##(2005-11#2)(2007-8#1)(2008-10#1)
of polyaniline##16##2##(2005-11#4)(2007-8#1)(2008-10#6)(2008-7#2)(2010-4#1)(2011-2#2)
of polyanions##6##2##(1993-6#2)(2008-10#4)
of polyaromatic hydrocarbons##4##3##(1991-3#1)(2008-10#3)
of polyaromatic##5##2##(1991-3#1)(2008-10#4)
of polyarteritis nodosa##2##3##(1997-8#1)(2006-10#1)
of polyarteritis##3##2##(1990-9#1)(1997-8#1)(2006-10#1)
of polyatomic##2##2##(2008-10#2)
of polybrominated diphenyl ethers (PBDEs)##2##5##(2008-10#2)
of polybrominated diphenyl ethers##5##4##(2008-10#5)
of polybrominated##6##2##(2008-10#6)
of polycarbonate and##3##3##(2005-11#1)(2008-10#1)(2008-4#1)
of polycarbonate##6##2##(2004-9#1)(2005-11#1)(2006-2#1)(2008-10#1)(2008-2#1)(2008-4#1)
of polycations##2##2##(2006-10#1)(2010-4#1)
of polychaetes##2##2##(2007-5#1)(2008-5#1)
of polychlorinated biphenyls (PCBs)##3##4##(2007-10#1)(2008-10#2)
of polychlorinated biphenyls in##2##4##(2008-10#2)
of polychlorinated biphenyls##7##3##(1996-12#1)(2007-10#1)(2008-10#4)(2013-1#1)
of polychlorinated##10##2##(1994-10#1)(1996-12#1)(2007-10#1)(2008-10#5)(2008-8#1)(2013-1#1)
of polychromatic##4##2##(2007-12#1)(2008-4#1)(2008-9#2)
of polyclonal and monoclonal sequence-specific anti-phosphoamino acid antibodies##2##8##(2008-4#2)
of polyclonal and monoclonal##3##4##(2008-4#3)
of polyclonal and##5##3##(1990-10#1)(2008-4#4)
of polyclonal antisera##4##3##(1991-2#1)(2008-4#3)
of polyclonal immunoglobulin synthesis##3##4##(2008-4#3)
of polyclonal##24##2##(1990-10#1)(1990-6#1)(1991-2#1)(1991-7#1)(1995-2#2)(2007-5#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-4#12)(2012-1#1)
of polycrystalline##2##2##(2007-12#1)(2008-10#1)
of polycyclic aromatic compounds##2##4##(2008-10#2)
of polycyclic aromatic hydrocarbon##4##4##(1994-6#1)(1996-3#1)(2008-10#1)(2008-2#1)
of polycyclic aromatic hydrocarbons (PAHs) from##2##6##(2008-10#2)
of polycyclic aromatic hydrocarbons (PAHs) in airborne particulate matter##2##9##(2008-10#2)
of polycyclic aromatic hydrocarbons (PAHs) in##7##6##(2008-10#6)(2010-5#1)
of polycyclic aromatic hydrocarbons (PAHs)##13##5##(2008-10#12)(2010-5#1)
of polycyclic aromatic hydrocarbons and##3##5##(2008-10#2)(2008-11#1)
of polycyclic aromatic hydrocarbons by##3##5##(2008-10#3)
of polycyclic aromatic hydrocarbons from##2##5##(2008-10#2)
of polycyclic aromatic hydrocarbons in water samples##3##7##(2008-10#3)
of polycyclic aromatic hydrocarbons in water##4##6##(2008-10#4)
of polycyclic aromatic hydrocarbons in##9##5##(2008-10#8)(2008-2#1)
of polycyclic aromatic hydrocarbons using##2##5##(2008-10#2)
of polycyclic aromatic hydrocarbons##35##4##(2008-10#32)(2008-11#1)(2008-2#1)(2010-5#1)
of polycyclic aromatic##41##3##(1994-6#1)(1996-3#1)(2008-10#35)(2008-11#1)(2008-2#2)(2010-5#1)
of polycyclic##42##2##(1994-6#1)(1996-3#1)(2008-10#35)(2008-11#1)(2008-2#2)(2010-5#1)(2013-7#1)
of polycystic ovary syndrome (PCOS)##3##5##(2008-4#3)
of polycystic ovary syndrome##4##4##(2008-3#1)(2008-4#3)
of polycystic##6##2##(2008-3#2)(2008-4#4)
of polycythemia##2##2##(1990-12#1)(1993-9#1)
of polydisperse##3##2##(2005-11#1)(2007-12#1)(2008-3#1)
of polydispersity##3##2##(1995-2#1)(2005-11#1)(2012-11#1)
of polyelectrolyte##3##2##(2006-5#1)(2008-7#1)(2009-12#1)
of polyelectrolytes and ionic surfactants##2##5##(2005-11#2)
of polyelectrolytes and##4##3##(2005-11#2)(2006-12#1)(2009-11#1)
of polyelectrolytes##8##2##(2005-11#4)(2006-12#1)(2007-8#1)(2008-10#1)(2009-11#1)
of polyester containing cyanoazobenzene units in the side chain##2##9##(2007-12#2)
of polyester##7##2##(2005-11#3)(2007-12#2)(2008-3#2)
of polyethylene glycol (PEG)##3##4##(1992-11#1)(2008-10#2)
of polyethylene glycol##10##3##(1991-5#1)(1992-11#2)(1993-11#1)(1994-3#1)(2005-12#1)(2008-10#2)(2008-3#1)(2008-4#1)
of polyethylene glycols##2##3##(1997-6#1)(2004-12#1)
of polyethylene##20##2##(1990-4#1)(1991-5#1)(1992-11#2)(1993-11#1)(1994-3#1)(1997-6#1)(2004-12#1)(2004-9#1)(2005-12#2)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2009-3#1)(2013-1#1)
of polyethyleneglycol (PEG)##2##3##(2008-10#1)(2008-12#1)
of polyethyleneglycol##3##2##(1994-11#1)(2008-10#1)(2008-12#1)
of polyethyleneimine (PEI)##2##3##(2008-10#2)
of polyethyleneimine##4##2##(1997-1#1)(2008-10#3)
of polyethylenimine (PEI)##2##3##(2006-5#1)(2010-4#1)
of polygalacturonase##2##2##(1997-2#1)(2008-10#1)
of polygenic##2##2##(2008-7#1)(2013-1#1)
of polygonal##3##2##(2004-2#1)(2012-1#2)
of polyhedral##2##2##(2008-7#1)(2013-8#1)
of polyhydramnios##2##2##(1992-12#1)(2012-12#1)
of polyhydric phenols##2##3##(2008-10#2)
of polyhydroxy phenols##2##3##(2008-10#2)
of polylactic##2##2##(2009-6#1)(2009-7#1)
of polylactosaminoglycans##2##2##(1994-11#2)
of polylysine##4##2##(1992-4#1)(1995-6#1)(2005-11#2)
of polymer and##3##3##(2005-11#1)(2005-5#1)(2010-4#1)
of polymer beads##2##3##(2008-7#2)
of polymer brush-modified##2##3##(2010-7#2)
of polymer capsules##2##3##(2010-7#2)
of polymer chains##4##3##(2005-11#2)(2007-11#1)(2008-3#1)
of polymer film##3##3##(2008-10#3)
of polymer films##2##3##(2007-12#1)(2008-5#1)
of polymer in##2##3##(2005-11#1)(2011-2#1)
of polymer modified electrode##2##4##(2008-10#2)
of polymer modified stationary phases##2##5##(2005-12#2)
of polymer modified##4##3##(2005-12#2)(2008-10#2)
of polymer used##2##3##(2008-8#1)(2010-5#1)
of polymer waveguides on##2##4##(2006-2#2)
of polymer##72##2##(1991-3#1)(1991-7#1)(1991-8#1)(1994-10#1)(1994-2#1)(1996-12#1)(2004-9#1)(2005-11#7)(2005-12#3)(2005-5#1)(2006-2#3)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#15)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-4#3)(2010-5#2)(2010-7#5)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#2)
of polymer-based##5##2##(1990-12#1)(1991-3#1)(2008-10#1)(2010-10#1)(2010-12#1)
of polymer-supported##3##2##(1997-4#1)(2007-11#2)
of polymerase activity##2##3##(1994-4#1)(2008-4#1)
of polymerase chain reaction (PCR)##10##5##(1990-3#1)(1991-1#1)(1991-9#1)(1995-12#1)(2005-7#1)(2006-12#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-7#1)
of polymerase chain reaction and##2##5##(1991-1#1)(2008-10#1)
of polymerase chain reaction for the diagnosis of##2##8##(1996-11#1)(2007-8#1)
of polymerase chain reaction for##3##5##(1996-11#1)(2006-10#1)(2007-8#1)
of polymerase chain reaction##26##4##(1990-10#1)(1990-3#1)(1991-1#2)(1991-9#1)(1992-8#1)(1993-7#1)(1995-12#1)(1996-11#1)(1996-3#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#1)(2013-1#1)
of polymerase chain reaction-amplified##2##4##(1992-1#1)(2008-3#1)
of polymerase chain##31##3##(1990-10#1)(1990-3#1)(1991-1#2)(1991-9#1)(1992-1#1)(1992-8#1)(1993-7#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-3#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#3)(2013-1#1)
of polymerase##38##2##(1990-10#1)(1990-3#1)(1991-1#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-8#1)(1993-7#1)(1994-4#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-6#1)(1996-11#1)(1996-3#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#3)(2013-1#1)
of polymerases##3##2##(1991-9#1)(1997-1#1)(1997-6#1)
of polymeric galactoglucomannans##2##3##(2013-1#2)
of polymeric resin##2##3##(2008-10#2)
of polymeric##32##2##(1991-3#3)(1994-8#1)(1995-3#1)(1997-7#2)(2007-11#2)(2008-10#5)(2008-2#3)(2008-3#3)(2008-5#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-4#1)(2010-5#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
of polymerizable##2##2##(1992-8#1)(1994-8#1)
of polymerization##18##2##(1990-6#2)(1991-8#1)(1994-9#1)(1997-1#1)(1997-8#1)(2005-12#1)(2006-8#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-5#1)(2010-2#1)(2013-1#3)
of polymerizations##2##2##(1994-9#1)(2007-11#1)
of polymerized##2##2##(1994-3#1)(2013-8#1)
of polymers in solution##2##4##(2007-12#1)(2008-2#1)
of polymers in##3##3##(2007-12#1)(2008-2#1)(2010-10#1)
of polymers through##2##3##(2007-11#1)(2008-9#1)
of polymers##24##2##(1995-3#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#2)(2009-3#1)(2009-7#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#2)(2013-1#1)
of polymethacrylates##2##2##(2008-10#1)(2009-8#1)
of polymethyl methacrylate##2##3##(2007-12#1)(2008-5#1)
of polymethylmethacrylate##3##2##(2006-2#1)(2007-11#1)(2008-7#1)
of polymorphic N-acetyltransferase##2##3##(1993-3#1)(1995-9#1)
of polymorphic loci##4##3##(2008-10#3)(2008-9#1)
of polymorphic markers##4##3##(1996-3#1)(1997-8#1)(2008-10#1)(2011-1#1)
of polymorphic##23##2##(1990-5#1)(1990-7#1)(1993-3#1)(1994-8#1)(1995-9#1)(1996-3#1)(1997-8#1)(2005-10#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-8#1)(2008-9#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)
of polymorphism in##2##3##(1991-9#1)(2008-4#1)
of polymorphism than##2##3##(2008-10#1)(2008-5#1)
of polymorphism##10##2##(1991-9#1)(1996-10#1)(2008-10#2)(2008-12#2)(2008-4#1)(2008-5#2)(2010-3#1)
of polymorphisms in the##2##4##(2008-7#1)(2010-11#1)
of polymorphisms in##5##3##(2004-10#1)(2005-11#1)(2008-7#1)(2010-11#1)(2012-1#1)
of polymorphisms of the##3##4##(2005-11#1)(2010-10#1)(2012-2#1)
of polymorphisms of##4##3##(2005-11#1)(2010-10#1)(2010-6#1)(2012-2#1)
of polymorphisms##16##2##(1997-9#1)(2004-10#1)(2005-11#2)(2008-10#2)(2008-7#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
of polymorphonuclear cells##2##3##(1990-4#2)
of polymorphonuclear leucocytes##2##3##(1991-11#1)(1992-6#1)
of polymorphonuclear leukocytes (PMNs)##2##4##(1993-3#1)(2008-12#1)
of polymorphonuclear leukocytes##5##3##(1990-4#1)(1993-3#1)(2008-12#1)(2008-4#1)(2010-1#1)
of polymorphonuclear neutrophils##2##3##(1990-12#1)(2011-12#1)
of polymorphonuclear##13##2##(1990-12#2)(1990-4#3)(1991-11#1)(1992-6#1)(1993-3#1)(1995-7#1)(2008-12#1)(2008-4#1)(2010-1#1)(2011-12#1)
of polymyalgia rheumatica##3##3##(1994-9#1)(1995-4#1)(2008-7#1)
of polymyxins on the##2##4##(2008-10#2)
of polynomial##3##2##(2007-11#1)(2008-10#1)(2011-1#1)
of polynuclear aromatic hydrocarbons (PAHs)##2##5##(2008-10#2)
of polynuclear aromatic hydrocarbons in##2##5##(2008-10#2)
of polynuclear aromatic hydrocarbons##6##4##(1994-9#1)(2007-7#1)(2008-10#4)
of polynuclear##7##2##(1993-10#1)(1994-9#1)(2007-7#1)(2008-10#4)
of polynucleated PAM##2##3##(1993-8#2)
of polynucleotide phosphorylase##2##3##(1996-5#1)(1997-2#1)
of polyol##2##2##(1992-5#1)(2004-11#1)
of polyoxometalates##3##2##(2008-10#3)
of polyp##3##2##(2008-5#1)(2009-8#1)(2012-2#1)
of polypeptide chains##2##3##(1995-4#1)(2011-1#1)
of polypeptide##12##2##(1991-10#1)(1992-1#1)(1993-6#1)(1994-11#1)(1995-4#1)(1995-7#1)(1996-2#1)(1996-3#1)(1997-6#1)(2008-4#1)(2011-1#1)(2012-1#1)
of polypeptides that have##2##4##(1996-8#1)(2008-5#1)
of polypeptides that##3##3##(1991-3#1)(1996-8#1)(2008-5#1)
of polypeptides with##2##3##(1990-12#1)(2011-2#1)
of polypeptides##27##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-3#3)(1993-3#2)(1993-6#1)(1994-11#2)(1995-10#1)(1995-12#1)(1996-8#4)(1997-4#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)
of polypharmacy##4##2##(1991-8#1)(2005-6#1)(2010-4#2)
of polyphenol oxidase##5##3##(2008-10#5)
of polyphenol##6##2##(2008-10#5)(2009-12#1)
of polyphenolic compounds##2##3##(1992-9#1)(2008-10#1)
of polyphenols and##3##3##(2005-7#1)(2009-8#1)(2011-2#1)
of polyphenols in##4##3##(2008-10#2)(2009-12#1)(2009-3#1)
of polyphenols##18##2##(1996-1#1)(2005-7#1)(2008-10#5)(2008-7#1)(2009-12#3)(2009-3#2)(2009-8#1)(2010-2#1)(2011-2#1)(2012-12#2)
of polyphosphate##3##2##(1993-12#1)(1994-11#1)(1996-7#1)
of polyphosphates in##2##3##(1994-11#1)(2008-10#1)
of polyphosphates##5##2##(1994-11#2)(1996-5#1)(2008-10#2)
of polyphosphoinositides##2##2##(1990-3#1)(1993-6#1)
of polyploid##2##2##(1995-8#1)(2013-1#1)
of polypoid##4##2##(2008-1#1)(2009-2#1)(2011-12#1)(2013-1#1)
of polypoidal lesions in the nasal cavity##2##7##(2013-8#2)
of polypoidal lesions##3##3##(2013-8#3)
of polyposis##2##2##(1997-5#2)
of polyprenyl##2##2##(1993-4#2)
of polypropylene fiber liquid filtration membrane particles##2##7##(2012-3#2)
of polypropylene##5##2##(2005-11#1)(2010-7#1)(2012-3#3)
of polyps##5##2##(1996-12#1)(2008-1#1)(2010-2#1)(2011-2#2)
of polypyrrole##5##2##(2006-12#1)(2007-9#1)(2008-10#1)(2009-2#1)(2010-11#1)
of polyribosomal##2##2##(1990-10#2)
of polysaccharide##8##2##(1992-7#1)(1994-3#1)(2009-10#1)(2009-3#1)(2009-9#1)(2012-12#1)(2012-3#1)(2013-8#1)
of polysaccharides as##2##3##(1996-12#1)(1996-5#1)
of polysaccharides in##2##3##(2008-10#1)(2011-2#1)
of polysaccharides##6##2##(1996-12#1)(1996-5#1)(2008-10#1)(2008-2#1)(2011-2#2)
of polysialic acid##2##3##(2005-7#1)(2009-8#1)
of polysialic##3##2##(2005-7#1)(2009-8#2)
of polysorbate 80##2##3##(2006-4#1)(2007-1#1)
of polyspermy##3##2##(2006-5#1)(2008-8#2)
of polystyrene and##3##3##(2005-11#2)(2008-3#1)
of polystyrene beads##6##3##(1996-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2013-1#2)
of polystyrene latex spheres##3##4##(2008-3#3)
of polystyrene latex##4##3##(2007-12#1)(2008-3#3)
of polystyrene microspheres##5##3##(2007-1#1)(2007-12#2)(2008-2#1)(2008-3#1)
of polystyrene nanolatex##2##3##(2005-11#2)
of polystyrene spheres##3##3##(2008-3#3)
of polystyrene substrates##2##3##(2005-11#2)
of polystyrene##33##2##(1991-10#1)(1991-9#1)(1996-3#1)(2005-11#6)(2007-1#1)(2007-11#1)(2007-12#5)(2008-10#2)(2008-2#3)(2008-3#9)(2010-4#1)(2013-1#2)
of polysubstituted##4##2##(2007-11#1)(2008-3#1)(2009-11#1)(2009-5#1)
of polytetrafluoroethylene (PTFE)##2##3##(2007-7#1)(2008-10#1)
of polytheonamide B##2##3##(2010-12#2)
of polyunsaturated fat##2##3##(2010-4#1)(2011-1#1)
of polyunsaturated fatty acids (PUFA)##2##5##(1995-8#1)(1997-5#1)
of polyunsaturated fatty acids (PUFAs) in##2##6##(2008-10#1)(2010-4#1)
of polyunsaturated fatty acids (PUFAs)##3##5##(2008-10#1)(2008-5#1)(2010-4#1)
of polyunsaturated fatty acids in the##2##6##(1991-2#1)(2011-2#1)
of polyunsaturated fatty acids in##4##5##(1991-2#1)(2004-11#1)(2008-5#1)(2011-2#1)
of polyunsaturated fatty acids of##2##5##(1994-11#1)(2012-2#1)
of polyunsaturated fatty acids##18##4##(1990-2#1)(1991-12#1)(1991-2#1)(1994-11#1)(1995-2#1)(1995-8#1)(1996-9#1)(1997-5#1)(2004-11#1)(2008-10#2)(2008-5#2)(2010-4#2)(2011-2#1)(2012-2#2)
of polyunsaturated fatty##19##3##(1990-2#1)(1991-12#1)(1991-2#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-9#1)(1997-5#1)(2004-11#1)(2008-10#2)(2008-5#2)(2010-4#2)(2011-2#1)(2012-2#2)
of polyunsaturated##25##2##(1990-2#1)(1991-12#1)(1991-2#1)(1991-4#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-9#1)(1997-5#1)(1997-7#1)(2004-11#1)(2008-10#2)(2008-5#2)(2010-4#4)(2011-1#1)(2011-2#1)(2012-2#2)
of polyurethane coated##2##3##(2013-8#2)
of polyurethane coating##3##3##(2013-8#3)
of polyurethane##7##2##(2008-11#1)(2008-5#1)(2013-8#5)
of polyvalent##3##2##(1990-7#1)(2007-8#1)(2012-12#1)
of polyvinyl alcohol##4##3##(2006-9#1)(2008-10#3)
of polyvinyl chloride##2##3##(1996-8#2)
of polyvinyl pyrrolidone##2##3##(1990-12#1)(2008-5#1)
of polyvinyl##9##2##(1990-12#1)(1996-8#2)(2005-11#1)(2006-9#1)(2008-10#3)(2008-5#1)
of polyvinylpolypyrrolidone##2##2##(2008-5#2)
of pome##2##2##(2008-10#2)
of pomiferin##3##2##(2011-1#3)
of pontine##2##2##(1992-1#1)(2008-11#1)
of pooled data##2##3##(2004-3#1)(2009-11#1)
of pooled##8##2##(1990-12#1)(1996-8#2)(2004-3#1)(2005-7#1)(2008-10#1)(2009-11#1)(2012-3#1)
of pools##2##2##(1995-6#1)(2008-11#1)
of poor health##2##3##(2006-4#1)(2008-10#1)
of poor outcome##7##3##(2008-3#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-3#1)
of poor outcomes with##2##4##(2007-12#1)(2013-1#1)
of poor performance##2##3##(1992-10#1)(2012-12#1)
of poor prognosis##6##3##(1993-10#1)(2007-11#1)(2008-3#1)(2009-10#1)(2011-2#1)(2013-1#1)
of poor prognostic factors##2##4##(2008-6#1)(2013-1#1)
of poor quality##4##3##(1995-5#1)(1995-9#1)(1997-6#1)(2007-2#1)
of poor responders##2##3##(2010-3#1)(2011-1#1)
of poor##79##2##(1990-9#1)(1991-4#1)(1992-10#1)(1993-10#1)(1993-12#1)(1993-3#2)(1994-2#1)(1994-6#2)(1995-2#1)(1995-5#1)(1995-9#2)(1996-11#1)(1997-6#1)(2005-10#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-7#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#6)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#8)
of poorer##5##2##(1992-2#1)(2006-7#1)(2008-5#1)(2010-12#1)(2012-3#1)
of poorly differentiated##6##3##(1990-2#1)(1991-5#1)(2006-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
of poorly soluble compounds##3##4##(2008-5#3)
of poorly water-soluble##2##3##(2012-12#1)(2012-2#1)
of poorly##19##2##(1990-2#1)(1991-5#1)(1994-12#1)(1996-2#1)(2006-4#1)(2006-7#1)(2006-8#1)(2008-5#4)(2009-2#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
of poplar tree (Populus tremula L##2##6##(2006-11#2)
of poplar tree##3##3##(2006-11#3)
of poplar##7##2##(2006-11#3)(2008-10#2)(2011-2#2)
of popliteal lymph##2##3##(2008-11#1)(2008-5#1)
of popliteal##4##2##(1991-3#2)(2008-11#1)(2008-5#1)
of popular##9##2##(1993-1#1)(1995-2#1)(2005-9#1)(2007-12#1)(2007-6#1)(2007-7#1)(2009-10#1)(2010-2#1)(2011-2#1)
of popularity##2##2##(2012-12#1)(2013-7#1)
of population and##4##3##(1996-7#1)(2007-8#1)(2010-4#1)(2013-8#1)
of population bottlenecks##2##3##(1995-2#2)
of population data##2##3##(2008-10#1)(2008-12#1)
of population decline##2##3##(1995-3#1)(2008-10#1)
of population differentiation##2##3##(2008-10#2)
of population dynamics##3##3##(2008-10#1)(2010-8#1)(2013-8#1)
of population fluctuations##2##3##(2008-8#2)
of population genetics##5##3##(2008-8#3)(2009-2#1)(2009-5#1)
of population groups##4##3##(2006-2#1)(2006-7#1)(2008-10#1)(2010-9#1)
of population growth rate##2##4##(2008-8#1)(2010-8#1)
of population growth##9##3##(1991-3#1)(1994-7#1)(2004-11#1)(2006-12#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-8#1)
of population in##2##3##(2008-3#1)(2011-2#1)
of population increase##4##3##(2010-8#1)(2011-2#1)(2012-2#2)
of population regulation##3##3##(2008-8#3)
of population screening##2##3##(1990-6#1)(1996-8#1)
of population size##2##3##(2008-8#1)(2008-9#1)
of population stratification analysis on false-positive rates for common and rare variants##2##12##(2012-3#2)
of population stratification##3##3##(2012-3#3)
of population structure##8##3##(2008-10#3)(2008-9#3)(2012-3#1)(2013-1#1)
of population studies##2##3##(2008-1#1)(2010-9#1)
of population subdivision##3##3##(1997-4#1)(2008-10#1)(2009-2#1)
of population##118##2##(1990-6#1)(1991-3#2)(1994-3#1)(1994-7#2)(1995-12#1)(1995-2#2)(1995-3#1)(1996-12#1)(1996-7#1)(1996-8#2)(1997-3#1)(1997-4#1)(2004-11#2)(2006-10#1)(2006-12#1)(2006-2#2)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#16)(2008-9#10)(2009-2#2)(2009-5#1)(2009-7#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#2)(2013-8#4)
of population-based information##2##3##(2010-11#2)
of population-based##10##2##(1991-6#1)(1993-9#1)(1995-12#1)(1997-3#1)(2007-10#1)(2009-9#1)(2010-11#3)(2010-12#1)
of population-level##2##2##(2008-1#1)(2010-8#1)
of population-specific##3##2##(2008-10#1)(2009-9#1)(2012-3#1)
of populations and##4##3##(2006-10#1)(2008-7#1)(2011-12#1)(2011-2#1)
of populations as##2##3##(1995-12#2)
of populations from##5##3##(2008-10#4)(2008-9#1)
of populations in##3##3##(2005-11#1)(2008-8#1)(2008-9#1)
of populations into##2##3##(2008-8#1)(2013-1#1)
of populations is##2##3##(2008-9#1)(2010-8#1)
of populations of Phytophthora##2##4##(2008-10#2)
of populations of##14##3##(1991-12#1)(2004-4#1)(2007-5#1)(2008-10#7)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#1)
of populations on##2##3##(2008-9#1)(2013-7#1)
of populations##69##2##(1991-12#1)(1994-3#1)(1995-12#3)(1995-8#1)(1996-6#1)(1997-3#1)(2004-4#1)(2005-11#1)(2005-12#1)(2006-10#2)(2007-2#2)(2007-3#1)(2007-5#2)(2008-1#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#7)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
of porcelain##2##2##(2006-6#1)(2013-8#1)
of porcine Serpulina species##2##4##(1996-11#2)
of porcine and##2##3##(1991-6#1)(1991-8#1)
of porcine aortic##2##3##(1990-7#1)(2009-7#1)
of porcine big##3##3##(1990-12#1)(1990-2#2)
of porcine brain##2##3##(1991-2#1)(1994-3#1)
of porcine coronary arteries##3##4##(1997-8#1)(2009-5#1)(2011-1#1)
of porcine coronary artery##3##4##(1990-8#1)(2008-11#2)
of porcine coronary##6##3##(1990-8#1)(1997-8#1)(2008-11#2)(2009-5#1)(2011-1#1)
of porcine embryos##2##3##(1996-8#2)
of porcine liver in##2##4##(2006-6#1)(2009-7#1)
of porcine liver##4##3##(1994-12#2)(2006-6#1)(2009-7#1)
of porcine oocytes##4##3##(2006-5#2)(2013-1#2)
of porcine pancreatic alpha-amylase##4##4##(1990-9#2)(1992-12#2)
of porcine pancreatic elastase##2##4##(1991-3#2)
of porcine pancreatic phospholipase A2##2##5##(1991-2#1)(1992-5#1)
of porcine pancreatic##12##3##(1990-2#2)(1990-9#2)(1991-2#2)(1991-3#2)(1992-12#2)(1992-2#1)(1992-5#1)
of porcine reproductive and respiratory syndrome virus (PRRSV)##2##8##(1997-6#1)(2005-11#1)
of porcine reproductive and respiratory syndrome virus##3##7##(1997-6#1)(2005-11#2)
of porcine##97##2##(1990-11#1)(1990-12#1)(1990-2#6)(1990-7#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-2#5)(1991-3#2)(1991-6#1)(1991-8#2)(1992-12#4)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-12#5)(1994-2#1)(1994-3#1)(1995-12#2)(1995-3#1)(1995-8#2)(1996-11#2)(1996-12#3)(1996-5#1)(1996-8#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-5#2)(2006-6#1)(2007-4#1)(2008-11#6)(2008-5#3)(2009-4#2)(2009-5#1)(2009-7#2)(2010-2#1)(2010-4#2)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#8)
of pore diameter##2##3##(2004-9#1)(2005-12#1)
of pore sensitivity to##2##4##(2009-3#2)
of pore size and alkyl chain length##2##7##(1990-12#2)
of pore size and##4##4##(1990-12#2)(2008-2#1)(2008-4#1)
of pore size##8##3##(1990-12#2)(1990-8#1)(2004-9#1)(2005-11#1)(2008-2#1)(2008-4#1)(2008-5#1)
of pore structure##3##3##(2005-11#1)(2009-2#1)(2013-8#1)
of pore##17##2##(1990-12#2)(1990-8#1)(1994-2#1)(2004-9#2)(2005-11#2)(2005-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-2#1)(2009-3#2)(2013-8#1)
of pore-forming##3##2##(1994-2#2)(2008-8#1)
of pores##7##2##(1994-2#2)(2004-9#1)(2008-10#2)(2008-4#1)(2008-5#1)
of porin##3##2##(1990-8#2)(1994-8#1)
of porins##3##2##(1997-8#1)(2008-10#1)(2013-1#1)
of pork and pork products##2##5##(1994-5#1)(2010-4#1)
of pork##17##2##(1990-8#1)(1994-5#1)(2007-6#1)(2008-10#1)(2010-2#1)(2010-4#12)
of porogenic##2##2##(2005-12#1)(2013-8#1)
of porogens##2##2##(2008-10#2)
of porokeratosis##3##2##(2007-7#3)
of porosity##3##2##(2008-5#1)(2009-7#2)
of porous HA##2##3##(2008-5#2)
of porous materials##2##3##(2004-9#1)(2008-10#1)
of porous silicon##4##3##(2007-11#1)(2008-10#2)(2008-3#1)
of porous spherical silicon oxynitride##2##5##(2013-8#2)
of porous##31##2##(1990-6#1)(2004-9#2)(2005-11#3)(2007-11#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#3)(2009-7#1)(2010-7#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
of porphobilinogen##2##2##(1992-3#1)(1997-7#1)
of porphyrin fluorescence##2##3##(1991-5#2)
of porphyrin rings##2##3##(2005-4#1)(2008-9#1)
of porphyrin to##2##3##(2008-10#2)
of porphyrin##11##2##(1991-5#2)(1996-5#1)(2005-4#3)(2008-10#4)(2008-9#1)
of porphyrins in##2##3##(1991-5#1)(1996-1#1)
of porphyrins##6##2##(1991-5#1)(1992-9#1)(1993-12#1)(1995-4#1)(1996-1#1)(2008-10#1)
of port##4##2##(2007-7#2)(2007-8#2)
of port-wine##2##2##(1996-3#1)(2012-12#1)
of portable##7##2##(1994-2#2)(2007-8#1)(2008-5#1)(2010-7#1)(2010-8#1)(2011-2#1)
of portal hypertension##8##3##(2006-2#1)(2009-8#3)(2009-9#2)(2010-1#1)(2013-1#1)
of portal images##2##3##(2007-6#1)(2008-2#1)
of portal infusion of##2##4##(1993-12#2)
of portal thrombosis##2##3##(1990-3#1)(1990-8#1)
of portal vein##4##3##(2005-12#1)(2008-11#1)(2009-2#1)(2012-2#1)
of portal##25##2##(1990-3#1)(1990-8#1)(1993-12#2)(1993-5#1)(1993-9#1)(1995-9#1)(2005-12#1)(2006-10#1)(2006-2#1)(2007-6#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-2#2)(2009-8#3)(2009-9#2)(2010-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
of portals##4##2##(2008-10#4)
of portfolio development##2##3##(2008-11#2)
of portfolio##5##2##(1996-12#1)(2008-11#3)(2012-12#1)
of portfolios##5##2##(2008-11#4)(2012-12#1)
of posaconazole in the##2##4##(2008-5#1)(2010-11#1)
of posaconazole in##3##3##(2008-5#1)(2010-11#2)
of posaconazole##4##2##(2008-5#1)(2010-11#3)
of position of##2##3##(1996-12#1)(2007-11#1)
of position##13##2##(1992-8#1)(1993-11#1)(1994-8#1)(1996-12#1)(1996-9#1)(2006-11#1)(2007-11#1)(2007-4#1)(2008-12#1)(2008-2#1)(2008-3#2)(2010-3#1)
of position-sensitive##3##2##(2008-2#2)(2008-3#1)
of positional atrial##2##3##(2009-4#2)
of positional isomers##4##3##(1992-3#1)(1995-11#1)(1996-8#1)(2008-10#1)
of positional##8##2##(1992-3#1)(1995-11#1)(1995-5#1)(1996-8#1)(2007-12#1)(2008-10#1)(2009-4#2)
of positioning the##2##3##(2008-3#1)(2008-7#1)
of positioning##7##2##(1993-12#1)(2004-2#1)(2007-4#1)(2007-7#1)(2008-3#2)(2008-7#1)
of positions and##2##3##(1994-12#1)(2007-11#1)
of positions##5##2##(1993-5#1)(1994-12#1)(1995-9#1)(2007-11#1)(2008-2#1)
of positive WOM advocacy##2##4##(2008-8#2)
of positive WOM##3##3##(2008-8#3)
of positive affect##3##3##(2008-9#1)(2009-2#1)(2012-12#1)
of positive and negative affect##2##5##(2013-8#2)
of positive and negative symptoms##2##5##(2005-7#1)(2008-12#1)
of positive and negative##16##4##(1990-10#1)(1991-4#1)(1993-12#1)(1994-8#1)(1996-9#1)(2005-7#1)(2007-11#1)(2008-12#1)(2008-2#1)(2009-2#1)(2010-4#1)(2010-7#1)(2010-9#1)(2012-2#1)(2013-8#2)
of positive cases##4##3##(1990-6#1)(2006-2#1)(2012-12#1)(2013-8#1)
of positive cells##6##3##(1990-4#1)(1990-8#1)(1991-4#1)(1992-1#1)(1992-8#1)(1994-7#1)
of positive charge##4##3##(1994-10#1)(2005-11#1)(2008-10#1)(2012-12#1)
of positive charges##2##3##(1993-3#1)(1994-2#1)
of positive clones##3##3##(1990-8#1)(1994-8#1)(2008-8#1)
of positive emotion regulation##2##4##(2010-3#2)
of positive emotion##3##3##(2010-3#3)
of positive feedback##2##3##(2006-12#1)(2010-10#1)
of positive findings##3##3##(1990-4#1)(2008-10#1)(2012-2#1)
of positive or negative correlations##2##5##(2008-9#2)
of positive or negative##3##4##(2008-2#1)(2008-9#2)
of positive outcomes##2##3##(2006-12#1)(2007-7#1)
of positive quality of life##2##5##(2009-12#2)
of positive results##4##3##(1990-10#1)(1997-4#1)(2011-1#1)(2011-2#1)
of positive samples##7##3##(1996-12#1)(1997-6#1)(2011-2#1)(2012-12#1)(2013-8#3)
of positive selection##3##3##(2008-7#1)(2012-12#2)
of positive tests##2##3##(2006-2#1)(2011-2#1)
of positive words##2##3##(2007-12#1)(2008-6#1)
of positive##162##2##(1990-10#2)(1990-4#2)(1990-6#1)(1990-8#4)(1991-2#2)(1991-3#1)(1991-4#2)(1992-1#1)(1992-11#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-10#1)(1994-2#1)(1994-7#1)(1994-8#2)(1995-4#1)(1995-6#1)(1996-12#2)(1996-4#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-4#1)(1997-6#1)(2005-1#1)(2005-11#2)(2005-7#1)(2006-12#3)(2006-2#3)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#3)(2007-7#3)(2008-10#10)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#4)(2009-10#1)(2009-12#2)(2009-2#2)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#11)(2012-1#1)(2012-12#11)(2012-2#6)(2012-3#1)(2013-1#3)(2013-8#6)
of positive/negative cooperativity##2##3##(2010-7#2)
of positively and negatively valenced baby faces##2##7##(2011-2#2)
of positively charged amino acids##3##5##(1990-8#1)(1995-5#1)(2008-8#1)
of positively charged##12##3##(1990-11#1)(1990-8#1)(1992-6#1)(1994-9#1)(1995-5#1)(2005-11#2)(2007-8#1)(2008-10#2)(2008-8#1)(2011-1#1)
of positively##14##2##(1990-11#1)(1990-8#1)(1992-6#1)(1994-9#1)(1995-5#1)(2005-11#2)(2007-8#1)(2008-10#2)(2008-8#1)(2011-1#1)(2011-2#2)
of positivity##5##2##(1997-2#2)(2006-8#1)(2007-2#1)(2007-8#1)
of positron emission tomography study##2##5##(2006-11#1)(2008-8#1)
of positron emission tomography##6##4##(1995-11#1)(2004-1#1)(2006-10#1)(2006-11#1)(2006-2#1)(2008-8#1)
of positron emission##8##3##(1992-11#1)(1995-11#1)(2004-1#1)(2006-10#1)(2006-11#1)(2006-2#1)(2008-8#1)(2012-12#1)
of possibilities##2##2##(1994-12#1)(2009-4#1)
of possibility##4##2##(1990-12#1)(2008-10#1)(2010-5#1)(2010-7#1)
of possible acute##2##3##(2006-4#1)(2007-7#1)
of possible adulterations##2##3##(2007-1#1)(2011-2#1)
of possible adverse##2##3##(1991-2#1)(2010-12#1)
of possible bias##2##3##(1996-8#2)
of possible complications##3##3##(2008-7#1)(2008-9#1)(2013-1#1)
of possible diagnostic##2##3##(1996-3#1)(2008-3#1)
of possible errors##2##3##(2008-3#1)(2011-2#1)
of possible inhibitory##2##3##(1994-5#1)(2008-7#1)
of possible interactions between##3##4##(1996-6#1)(2007-9#1)(2012-1#1)
of possible interactions##4##3##(1991-3#1)(1996-6#1)(2007-9#1)(2012-1#1)
of possible models##2##3##(1995-8#1)(2008-5#1)
of possible side effects##2##4##(1993-8#1)(2006-10#1)
of possible situations##2##3##(2006-10#1)(2008-8#1)
of possible sources of##2##4##(1995-3#1)(2008-10#1)
of possible species##2##3##(1997-7#1)(2010-2#1)
of possible therapeutic options##2##4##(2006-2#1)(2012-12#1)
of possible treatment options##2##4##(1995-12#1)(2008-11#1)
of possible underlying##2##3##(2006-10#1)(2008-7#1)
of possible ways of##2##4##(1993-3#1)(2008-6#1)
of possible ways##3##3##(1993-3#1)(2008-10#1)(2008-6#1)
of possible##160##2##(1990-10#2)(1990-11#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-4#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-4#1)(1994-5#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#3)(1996-6#1)(1996-7#1)(1996-8#3)(1997-1#1)(1997-2#1)(1997-5#2)(1997-6#1)(1997-7#1)(2005-10#1)(2005-11#2)(2005-8#1)(2005-9#1)(2006-10#8)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#3)(2007-9#2)(2008-1#3)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#2)(2009-10#2)(2009-5#1)(2009-6#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
of possibly##3##2##(2008-10#2)(2009-9#1)
of post mortem alteration##2##4##(1996-9#2)
of post mortem##4##3##(1991-9#1)(1996-9#3)
of post operative##4##3##(2006-4#1)(2007-8#1)(2010-12#1)(2013-7#1)
of post transplant hypertension##3##4##(2008-1#3)
of post transplant##5##3##(2008-1#5)
of post##27##2##(1991-9#1)(1996-12#1)(1996-9#3)(2006-4#1)(2006-9#1)(2007-2#2)(2007-7#1)(2007-8#2)(2008-1#6)(2008-10#1)(2008-11#1)(2008-4#1)(2009-3#1)(2010-12#1)(2011-2#2)(2012-1#1)(2013-7#1)
of post-ESD ulcers##2##3##(2012-2#2)
of post-ESD##3##2##(2012-2#3)
of post-QQc cells##2##3##(2012-12#2)
of post-abortion##2##2##(1991-6#1)(2007-1#1)
of post-adolescent acne##2##3##(2008-5#2)
of post-angiography false aneurysms##2##4##(2007-3#2)
of post-genomic##3##2##(2008-10#1)(2008-7#1)(2010-4#1)
of post-intubation##2##2##(2007-8#1)(2013-1#1)
of post-menopausal bleeding##2##3##(2007-3#2)
of post-menopausal##3##2##(2007-3#2)(2008-11#1)
of post-mortem##4##2##(2008-7#1)(2009-12#1)(2009-3#1)(2010-4#1)
of post-natal##3##2##(1994-9#1)(1996-8#1)(2010-2#1)
of post-operative complications##2##3##(2007-8#1)(2009-10#1)
of post-operative pain##3##3##(1996-2#1)(2009-3#1)(2011-1#1)
of post-operative##19##2##(1991-5#1)(1996-2#1)(1997-7#1)(2007-11#1)(2007-8#9)(2008-5#1)(2008-6#1)(2009-10#1)(2009-3#1)(2011-1#2)
of post-partum##3##2##(1992-1#1)(1996-12#1)(2008-7#1)
of post-parturient haemoglobinuria in##2##4##(2005-7#2)
of post-parturient haemoglobinuria##3##3##(2005-7#3)
of post-prandial lipoprotein##2##3##(2008-6#2)
of post-prandial##3##2##(2008-6#3)
of post-processing##2##2##(2006-4#1)(2008-2#1)
of post-reaction operations##2##3##(2008-10#2)
of post-resting temperature##2##3##(2010-4#2)
of post-stroke##2##2##(2008-11#1)(2010-12#1)
of post-surgical##6##2##(1991-1#1)(2005-6#1)(2005-8#1)(2007-7#1)(2007-8#1)(2012-12#1)
of post-transcriptional##6##2##(1997-2#1)(2006-12#1)(2007-12#1)(2009-2#2)(2013-8#1)
of post-translational modification##3##3##(2009-7#1)(2011-1#1)(2012-3#1)
of post-translational modifications##5##3##(2008-11#1)(2008-4#1)(2009-5#1)(2009-9#1)(2010-9#1)
of post-translational##13##2##(1992-12#1)(1993-6#1)(2008-11#1)(2008-4#2)(2009-5#2)(2009-7#1)(2009-9#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
of post-translationally modified##4##3##(1997-2#1)(2009-7#1)(2010-2#1)(2011-1#1)
of post-transplant complications##2##3##(2008-1#2)
of post-transplant proteinuria##2##3##(2008-1#2)
of post-transplant##9##2##(2007-11#3)(2008-1#5)(2012-2#1)
of post-traumatic neuronal death##2##4##(1997-7#2)
of post-traumatic stress disorder##4##4##(2006-3#1)(2008-6#2)(2009-6#1)
of post-traumatic stress##7##3##(2006-3#1)(2008-6#2)(2009-6#1)(2012-1#1)(2012-12#1)(2013-8#1)
of post-traumatic##17##2##(1991-1#1)(1991-5#1)(1997-3#1)(1997-7#2)(2006-3#1)(2007-11#2)(2007-7#1)(2008-6#2)(2008-7#1)(2009-6#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-8#1)
of post-treatment##7##2##(1990-4#1)(1992-9#1)(2012-1#3)(2013-1#2)
of post-weaning individual housing on autonomic##2##6##(2013-8#2)
of post-weaning##3##2##(2012-3#1)(2013-8#2)
of postactivation potentiation##2##3##(2009-1#2)
of postal##4##2##(1997-6#2)(2006-5#1)(2013-8#1)
of postaxial polydactyly##2##3##(2010-4#2)
of postcoital##4##2##(1993-2#4)
of postconcussive##2##2##(2008-6#1)(2013-1#1)
of poster##2##2##(2005-8#1)(2006-10#1)
of posterior cerebral artery##3##4##(2007-9#1)(2011-1#2)
of posterior cingulate cortex##2##4##(1993-12#2)
of posterior circulation##4##3##(2006-11#1)(2008-7#1)(2012-2#1)(2013-8#1)
of posterior communicating artery##2##4##(2011-1#2)
of posterior composites in##2##4##(2009-2#2)
of posterior composites##5##3##(2009-2#5)
of posterior cortical##2##3##(2005-10#1)(2011-1#1)
of posterior fossa##4##3##(2006-5#3)(2012-12#1)
of posterior interosseous##2##3##(2006-3#2)
of posterior mediastinal##2##3##(2011-2#1)(2012-3#1)
of posterior parietal##4##3##(1992-9#1)(1993-2#1)(2008-4#1)(2009-10#1)
of posterior pituitary##3##3##(1995-12#1)(1997-8#2)
of posterior urethral disruption injuries##2##5##(2013-8#2)
of posterior##72##2##(1992-9#1)(1993-12#2)(1993-2#1)(1994-12#1)(1994-2#1)(1995-12#2)(1997-7#1)(1997-8#2)(2005-10#3)(2006-10#2)(2006-11#1)(2006-3#2)(2006-5#3)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-2#6)(2009-3#1)(2010-3#1)(2011-1#5)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#2)(2013-8#5)
of posteromedial tibial plateau##2##4##(2013-1#2)
of posters##2##2##(2008-10#1)(2013-1#1)
of postganglionic##4##2##(1995-12#1)(1995-6#1)(1996-12#1)(1997-5#1)
of postgraduate training##4##3##(1993-8#1)(1994-12#1)(1997-6#1)(2006-6#1)
of postgraduate##10##2##(1992-1#1)(1993-8#1)(1994-12#1)(1997-6#1)(2005-8#1)(2006-6#1)(2007-2#1)(2009-7#1)(2013-1#2)
of postharvest decay##2##3##(2008-10#2)
of postharvest pathogens##2##3##(2008-10#2)
of postharvest##11##2##(2008-10#11)
of postherpetic neuralgia##3##3##(1996-6#1)(2006-12#1)(2006-7#1)
of postinfarction ventricular septal rupture##2##5##(2007-8#2)
of postinfarction##3##2##(2007-8#3)
of postinfectious##2##2##(2008-4#1)(2011-2#1)
of postischemic##3##2##(1991-9#1)(1993-3#1)(1994-9#1)
of postlarvae##2##2##(2007-3#1)(2010-8#1)
of postmenopausal osteoporosis by##2##4##(2012-2#2)
of postmenopausal osteoporosis##15##3##(1993-11#1)(1995-11#1)(2005-3#1)(2007-11#2)(2008-3#3)(2008-8#3)(2012-2#4)
of postmenopausal patients##2##3##(2008-5#1)(2010-7#1)
of postmenopausal women receiving bone loss medications##2##7##(2011-1#2)
of postmenopausal women##10##3##(1994-12#1)(2005-3#1)(2006-10#1)(2008-5#2)(2008-7#1)(2010-12#1)(2011-1#3)
of postmenopausal##33##2##(1991-4#1)(1992-12#1)(1993-11#2)(1993-6#1)(1994-12#1)(1994-8#1)(1995-11#1)(2005-3#2)(2006-10#1)(2007-11#2)(2008-3#4)(2008-5#3)(2008-7#1)(2008-8#3)(2010-12#1)(2010-7#1)(2011-1#3)(2012-2#4)
of postmitotic##2##2##(1994-5#1)(1997-6#1)
of postmortal##2##2##(2011-2#2)
of postmortem##11##2##(1992-8#1)(1995-3#1)(1996-12#2)(2006-1#1)(2007-5#1)(2008-7#1)(2009-4#1)(2010-4#1)(2010-9#1)(2013-7#1)
of postnatal day##2##3##(1990-4#1)(1995-6#1)
of postnatal depression##2##3##(1997-3#1)(2007-9#1)
of postnatal development##3##3##(2008-4#1)(2009-2#2)
of postnatal life##3##3##(1997-6#3)
of postnatal mice##2##3##(1996-6#1)(1997-5#1)
of postnatal neovascularization and##2##4##(2012-12#2)
of postnatal stress on##2##4##(1993-2#2)
of postnatal transports##2##3##(1995-5#2)
of postnatal##30##2##(1990-4#1)(1992-12#1)(1993-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-5#1)(1997-6#3)(2007-9#1)(2008-4#3)(2009-10#1)(2009-2#2)(2010-12#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#2)
of postoperative acute##2##3##(2006-6#1)(2007-12#1)
of postoperative adjuvant##3##3##(1993-10#1)(1994-7#1)(1997-7#1)
of postoperative analgesia##7##3##(2006-10#2)(2007-11#1)(2008-8#1)(2010-7#1)(2011-12#1)(2013-7#1)
of postoperative complications and lethality##2##5##(2009-2#2)
of postoperative complications and##3##4##(2006-10#1)(2009-2#2)
of postoperative complications are##2##4##(2006-10#1)(2012-3#1)
of postoperative complications##14##3##(2006-10#3)(2007-7#1)(2007-8#5)(2009-2#2)(2011-2#1)(2011-3#1)(2012-3#1)
of postoperative death##2##3##(2007-8#1)(2010-6#1)
of postoperative deep vein thrombosis##2##5##(1990-12#1)(1997-5#1)
of postoperative deep##3##3##(1990-12#1)(1997-5#1)(2008-8#1)
of postoperative hypoxemia##2##3##(2007-8#2)
of postoperative ileus##3##3##(2010-2#2)(2010-4#1)
of postoperative infection##5##3##(1992-6#1)(2007-7#1)(2007-8#1)(2008-8#1)(2011-2#1)
of postoperative infections and##2##4##(1991-5#1)(2007-4#1)
of postoperative infections##4##3##(1990-11#1)(1991-5#1)(2007-12#1)(2007-4#1)
of postoperative infectious##2##3##(1991-4#1)(2006-10#1)
of postoperative irradiation in##2##4##(2008-6#2)
of postoperative nausea and vomiting after##2##6##(2011-12#1)(2012-12#1)
of postoperative nausea and vomiting##13##5##(2006-10#9)(2008-5#1)(2011-12#2)(2012-12#1)
of postoperative nausea and##14##4##(2006-10#10)(2008-5#1)(2011-12#2)(2012-12#1)
of postoperative neurological##2##3##(1992-5#1)(2006-10#1)
of postoperative pain and##2##4##(2006-10#1)(2012-12#1)
of postoperative pain##14##3##(2005-8#1)(2006-10#4)(2006-3#1)(2006-4#1)(2006-6#1)(2007-11#2)(2008-3#1)(2010-2#1)(2012-12#1)(2013-1#1)
of postoperative pulmonary##4##3##(1990-10#1)(2007-8#2)(2012-2#1)
of postoperative radiation therapy##2##4##(1994-10#1)(2008-7#1)
of postoperative radiotherapy##4##3##(1990-10#1)(2007-4#1)(2008-7#1)(2012-1#1)
of postoperative respiratory complications##3##4##(2006-10#2)(2009-5#1)
of postoperative respiratory##4##3##(2006-10#2)(2009-5#1)(2012-3#1)
of postoperative vomiting in##2##4##(2006-10#1)(2008-5#1)
of postoperative wound##2##3##(1994-2#1)(2007-8#1)
of postoperative##178##2##(1990-10#2)(1990-11#1)(1990-12#4)(1990-4#1)(1990-5#1)(1991-11#2)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-10#3)(1993-12#1)(1993-2#1)(1993-7#1)(1994-10#1)(1994-2#1)(1994-6#1)(1994-7#1)(1995-10#1)(1995-9#1)(1996-12#1)(1996-9#2)(1997-1#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-5#1)(2005-8#1)(2006-10#27)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#3)(2006-7#1)(2006-9#1)(2007-11#5)(2007-12#4)(2007-4#2)(2007-5#1)(2007-7#3)(2007-8#23)(2007-9#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#2)(2009-2#4)(2009-3#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-2#4)(2010-4#1)(2010-6#1)(2010-7#3)(2011-1#1)(2011-12#4)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#1)
of postpartum depression##5##3##(2007-2#1)(2010-1#1)(2013-1#3)
of postpartum fistulas##2##3##(1996-12#2)
of postpartum##20##2##(1992-2#1)(1996-12#3)(1996-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-10#2)(2007-11#1)(2007-2#3)(2010-1#1)(2010-8#1)(2013-1#3)(2013-8#1)
of postpartum-onset##2##2##(2004-3#2)
of postpneumonectomy syndrome##2##3##(2007-8#2)
of postpneumonectomy##4##2##(2007-3#1)(2007-8#3)
of postprandial##3##2##(1997-4#1)(2006-10#1)(2008-12#1)
of postradiation##2##2##(1993-2#1)(2006-6#1)
of postrenal##2##2##(2010-2#2)
of postresuscitation myocardial##2##3##(2008-3#2)
of poststroke##8##2##(2007-10#2)(2007-9#2)(2008-2#1)(2008-8#1)(2009-11#1)(2013-1#1)
of postsynaptic neurons##2##3##(1993-3#1)(2008-11#1)
of postsynaptic##12##2##(1990-9#1)(1991-9#1)(1993-3#1)(1994-10#1)(1994-2#1)(1995-12#1)(1996-6#1)(1997-5#1)(2007-10#1)(2007-11#1)(2008-11#2)
of posttranscriptional gene silencing##2##4##(2008-10#2)
of posttranscriptional##4##2##(2005-8#1)(2008-10#2)(2013-1#1)
of posttranslational modifications##3##3##(1995-5#1)(1995-7#1)(1997-7#1)
of posttranslational##4##2##(1992-6#1)(1995-5#1)(1995-7#1)(1997-7#1)
of posttransplantation##2##2##(2007-8#1)(2013-8#1)
of posttraumatic narcolepsy##2##3##(2007-6#2)
of posttraumatic stress disorder (PTSD)##3##5##(1995-11#1)(2005-10#1)(2013-7#1)
of posttraumatic stress disorder##5##4##(1995-11#1)(2005-10#1)(2009-9#1)(2013-7#2)
of posttraumatic stress##6##3##(1995-11#1)(2005-10#1)(2009-11#1)(2009-9#1)(2013-7#2)
of posttraumatic##15##2##(1995-11#1)(2005-10#1)(2006-5#1)(2007-12#2)(2007-6#2)(2007-7#1)(2008-8#1)(2009-11#1)(2009-9#1)(2010-3#1)(2013-7#2)(2013-8#1)
of postural and##2##3##(1993-9#1)(2008-7#1)
of postural control##2##3##(2006-3#1)(2012-12#1)
of postural##10##2##(1990-10#1)(1990-6#1)(1993-9#1)(2006-12#1)(2006-3#1)(2008-7#2)(2011-1#2)(2012-12#1)
of posture and##3##3##(2007-12#2)(2010-12#1)
of posture##10##2##(1991-4#1)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#2)(2010-12#1)(2012-3#1)(2013-1#1)
of potassium and##2##3##(1991-3#1)(1997-8#1)
of potassium bromide##2##3##(2008-10#2)
of potassium channels in##2##4##(1997-4#1)(2006-10#1)
of potassium channels##11##3##(1992-6#2)(1997-4#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-12#1)(2008-8#2)(2010-12#2)
of potassium chloride##4##3##(1990-2#1)(1991-9#1)(1995-12#1)(2007-9#1)
of potassium cyanide##2##3##(1996-3#1)(2011-1#1)
of potassium ferricyanide##4##3##(2008-10#3)(2009-9#1)
of potassium from the##2##4##(2008-10#1)(2010-1#1)
of potassium in##3##3##(1992-4#1)(2007-1#1)(2008-10#1)
of potassium iodate in##2##4##(2005-4#2)
of potassium iodide##6##3##(2007-7#2)(2007-8#1)(2008-10#2)(2010-12#1)
of potassium ion in##2##4##(2008-10#2)
of potassium ion##3##3##(2008-10#3)
of potassium ions in##3##4##(1994-12#1)(2007-9#1)(2008-10#1)
of potassium ions##6##3##(1991-9#1)(1994-12#1)(1995-1#1)(2007-9#1)(2008-10#2)
of potassium permanganate##5##3##(2007-7#1)(2008-10#1)(2009-5#3)
of potassium phosphate buffer##2##4##(2008-10#2)
of potassium phosphate##7##3##(2007-11#1)(2008-10#5)(2008-7#1)
of potassium##99##2##(1990-12#2)(1990-2#2)(1990-3#1)(1991-10#1)(1991-3#1)(1991-9#3)(1992-4#1)(1992-6#2)(1992-9#1)(1993-8#1)(1994-12#1)(1995-1#1)(1995-11#2)(1995-12#1)(1996-1#1)(1996-3#1)(1997-4#1)(1997-8#3)(2005-4#3)(2006-1#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#3)(2008-10#32)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#3)(2009-9#1)(2010-1#1)(2010-12#3)(2010-4#1)(2011-1#1)(2011-12#1)
of potato (cv##2##3##(2008-10#2)
of potato and tomato##4##4##(2008-10#4)
of potato and##5##3##(2008-10#5)
of potato caused by##2##4##(2008-10#2)
of potato cultivars##4##3##(2008-10#4)
of potato cvs##2##3##(2008-10#2)
of potato cyst nematode##2##4##(2008-10#1)(2009-3#1)
of potato cyst##3##3##(2008-10#2)(2009-3#1)
of potato in the##2##4##(2008-10#2)
of potato late blight##6##4##(2008-10#6)
of potato or tomato##2##4##(2008-10#2)
of potato or##3##3##(2008-10#3)
of potato starch with##2##4##(1991-12#1)(2006-12#1)
of potato stem rot##2##4##(2008-10#2)
of potato virus X (PVX)##3##5##(1995-2#2)(1997-3#1)
of potato virus X##4##4##(1995-2#2)(1997-3#1)(2010-9#1)
of potato virus y##2##4##(2008-10#2)
of potato virus##7##3##(1995-2#2)(1997-3#1)(2008-10#3)(2010-9#1)
of potato##66##2##(1991-12#1)(1993-12#2)(1995-2#2)(1997-3#1)(2006-12#1)(2008-10#55)(2008-5#1)(2008-9#1)(2009-3#1)(2010-9#1)
of potatoes##4##2##(2008-10#2)(2008-9#1)(2012-1#1)
of potencies##3##2##(1993-3#1)(1995-11#1)(1995-12#1)
of potency and##2##3##(1991-1#1)(2005-7#1)
of potency in##2##3##(1991-3#1)(1994-11#1)
of potency was##4##3##(1993-3#1)(1993-9#1)(1994-12#1)(1996-10#1)
of potency##36##2##(1990-2#2)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#3)(1995-1#2)(1995-12#4)(1995-6#1)(1995-7#1)(1996-10#1)(1996-12#3)(2005-7#1)(2007-11#1)(2007-2#1)(2009-12#1)(2010-12#1)(2013-1#1)
of potent and selective##2##4##(2008-4#1)(2008-5#1)
of potent and##4##3##(1994-9#1)(2008-11#1)(2008-4#1)(2008-5#1)
of potent##33##2##(1990-8#1)(1990-9#1)(1992-4#2)(1992-8#2)(1993-6#1)(1994-9#2)(1995-2#1)(1995-9#1)(1996-8#1)(1997-1#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-7#1)(2012-3#2)
of potential DNA##2##3##(2008-2#1)(2011-1#1)
of potential adverse effects##2##4##(2007-11#1)(2008-10#1)
of potential adverse##3##3##(2007-11#1)(2008-10#1)(2011-2#1)
of potential and##4##3##(1991-6#1)(2008-10#1)(2008-11#2)
of potential application##2##3##(2007-8#1)(2010-9#1)
of potential applications in##2##4##(2008-7#1)(2010-6#1)
of potential applications##6##3##(1990-3#1)(2008-7#1)(2009-10#1)(2010-6#1)(2012-12#2)
of potential benefit##3##3##(2006-9#1)(2008-5#2)
of potential benefits and risks##2##5##(1992-3#1)(1996-2#1)
of potential benefits##4##3##(1992-3#1)(1996-2#1)(2006-10#1)(2007-12#1)
of potential biomarkers##2##3##(2010-5#1)(2013-1#1)
of potential candidates##4##3##(1993-2#1)(1994-1#2)(2007-5#1)
of potential causes of##3##4##(2006-10#1)(2008-7#1)(2010-12#1)
of potential clinical importance##2##4##(1994-3#1)(2006-10#1)
of potential clinical##6##3##(1994-3#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-5#1)
of potential competitors##2##3##(1993-1#1)(2004-4#1)
of potential complications##4##3##(2005-10#1)(2006-10#1)(2007-6#1)(2013-8#1)
of potential concern##2##3##(1991-1#1)(2008-2#1)
of potential drug##3##3##(2008-4#1)(2009-4#1)(2011-1#1)
of potential energy##2##3##(1991-11#1)(2009-4#1)
of potential exposure##2##3##(2007-2#1)(2012-3#1)
of potential functional##2##3##(1995-6#1)(2010-4#1)
of potential importance to##2##4##(1996-5#1)(2008-7#1)
of potential importance##3##3##(1996-5#1)(2008-5#1)(2008-7#1)
of potential interest##3##3##(1996-8#1)(2008-5#2)
of potential interferences##2##3##(2008-10#2)
of potential interfering ions on the determination of##2##8##(2008-10#2)
of potential interfering ions##4##4##(2008-10#4)
of potential interfering##5##3##(2008-10#5)
of potential life##2##3##(1991-8#1)(2007-6#1)
of potential ligands##2##3##(1991-12#1)(1996-5#1)
of potential markers##2##3##(2008-10#1)(2010-12#1)
of potential mates##5##3##(2008-8#5)
of potential medical##2##3##(1993-3#1)(2010-2#1)
of potential of##3##3##(2007-10#1)(2008-10#1)(2008-8#1)
of potential pathogen##3##3##(2008-10#3)
of potential pathogens##2##3##(1994-6#1)(2007-12#1)
of potential research##2##3##(2007-4#1)(2010-2#1)
of potential risk factors##2##4##(1995-8#1)(1996-12#1)
of potential risk##4##3##(1995-8#1)(1996-12#1)(2008-10#1)(2008-4#1)
of potential snail-borne disease transmission##2##5##(2008-8#2)
of potential sources of##2##4##(2008-10#1)(2008-12#1)
of potential target##2##3##(1995-5#1)(2008-9#1)
of potential targets for##2##4##(2011-1#1)(2011-2#1)
of potential targets##3##3##(2009-9#1)(2011-1#1)(2011-2#1)
of potential therapeutic agents for##2##5##(2008-4#1)(2009-12#1)
of potential therapeutic##5##3##(1996-2#1)(2005-10#1)(2008-4#1)(2009-12#1)(2010-12#1)
of potential tyrosine##2##3##(1990-3#1)(2005-8#1)
of potential use as an##2##5##(1993-12#1)(1996-5#1)
of potential use in the##2##5##(2008-5#1)(2008-9#1)
of potential use in##5##4##(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-4#1)
of potential use##7##3##(1993-12#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-4#1)
of potential##287##2##(1990-10#1)(1990-12#1)(1990-3#3)(1990-6#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-1#2)(1994-3#2)(1994-6#1)(1994-8#2)(1995-1#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#3)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(2004-4#1)(2005-10#3)(2005-11#2)(2005-5#1)(2005-7#1)(2005-8#2)(2006-10#8)(2006-11#1)(2006-12#9)(2006-2#1)(2006-5#3)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#3)(2007-3#1)(2007-4#4)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#41)(2008-11#8)(2008-12#4)(2008-2#6)(2008-3#5)(2008-4#7)(2008-5#8)(2008-6#2)(2008-7#10)(2008-8#11)(2008-9#4)(2009-10#2)(2009-12#1)(2009-4#4)(2009-9#3)(2010-10#1)(2010-12#7)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#5)(2011-2#8)(2012-11#1)(2012-12#10)(2012-2#6)(2012-3#3)(2013-1#3)(2013-8#1)
of potentially confounding##2##3##(1997-4#1)(2006-10#1)
of potentially curable##2##3##(2008-7#1)(2011-2#1)
of potentially harmful##5##3##(1996-8#1)(2007-9#1)(2008-5#1)(2011-1#1)(2012-2#1)
of potentially important##4##3##(2008-11#1)(2008-6#1)(2013-1#2)
of potentially inappropriate##2##3##(1996-11#1)(2006-3#1)
of potentially lethal##2##3##(2007-10#1)(2012-2#1)
of potentially severe##2##3##(2010-1#1)(2011-3#1)
of potentially useful##4##3##(2010-1#1)(2011-1#1)(2012-12#2)
of potentially##59##2##(1991-1#1)(1991-4#1)(1993-11#1)(1994-5#1)(1995-4#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-8#2)(1997-4#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-3#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-3#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-5#1)(2009-8#1)(2010-1#2)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)
of potentials##2##2##(2008-10#2)
of potentiating##3##2##(1995-11#1)(1995-3#1)(2010-11#1)
of potentiation and##2##3##(1991-3#1)(2008-2#1)
of potentiation of##2##3##(1993-6#1)(2010-5#1)
of potentiation##6##2##(1991-3#1)(1993-6#1)(1995-12#1)(1995-3#1)(2008-2#1)(2010-5#1)
of potentiometric sensors##2##3##(2008-10#2)
of potentiometric titration##3##3##(2008-10#3)
of potentiometric titrations##3##3##(2008-10#2)(2008-3#1)
of potentiometric##17##2##(1996-2#1)(2008-10#14)(2008-3#1)(2010-5#1)
of potted apple trees##2##4##(2008-10#2)
of potted##3##2##(2008-10#3)
of pottery##3##2##(2007-8#2)(2008-10#1)
of potting mix##2##3##(2008-10#2)
of potting##6##2##(2008-10#6)
of potyvirus##3##2##(2008-10#3)
of potyviruses##2##2##(2008-10#2)
of poultry##6##2##(1990-8#1)(2008-5#3)(2008-8#1)(2011-2#1)
of poults##2##2##(1997-3#1)(1997-6#1)
of pound##2##2##(2004-1#1)(2005-9#1)
of poverty and##6##3##(1993-1#1)(2008-11#1)(2009-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
of poverty in##3##3##(2007-12#1)(2007-7#1)(2008-9#1)
of poverty##28##2##(1992-1#1)(1993-1#1)(2007-12#1)(2007-7#3)(2008-1#2)(2008-11#8)(2008-7#1)(2008-9#4)(2009-8#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
of powder##6##2##(1997-7#1)(2004-9#2)(2008-10#2)(2008-7#1)
of powdered##6##2##(2007-12#2)(2008-10#1)(2008-11#1)(2008-5#2)
of powdery mildew in##2##4##(2008-10#2)
of powdery mildew on##4##4##(2008-10#4)
of powdery mildew##16##3##(2008-10#16)
of powdery##19##2##(2008-10#18)(2010-4#1)
of power and##10##3##(1993-2#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-8#1)(2008-9#1)(2012-3#2)
of power at a##2##4##(2007-12#2)
of power at##10##3##(2007-11#1)(2007-12#5)(2008-2#1)(2008-3#2)(2013-8#1)
of power consumption##2##3##(2008-2#2)
of power from##5##3##(2006-7#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-5#1)
of power in a##2##4##(2007-12#2)
of power in##6##3##(1997-2#1)(2007-11#1)(2007-12#2)(2008-2#1)(2010-5#1)
of power of##3##3##(2008-10#1)(2008-3#1)(2009-3#1)
of power over##4##3##(2007-5#2)(2008-11#1)(2013-1#1)
of power##88##2##(1991-12#1)(1993-2#2)(1993-4#1)(1994-9#1)(1997-2#2)(1997-3#3)(2006-2#1)(2006-7#2)(2007-11#6)(2007-12#16)(2007-5#3)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#14)(2008-3#11)(2008-5#2)(2008-8#2)(2008-9#1)(2009-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#1)
of powered orthosis##2##3##(2012-1#2)
of powered##4##2##(2006-2#2)(2012-1#2)
of powerful computers##2##3##(1993-12#1)(2010-2#1)
of powerful##12##2##(1990-7#1)(1993-12#1)(2007-9#1)(2008-1#4)(2008-10#1)(2008-2#1)(2008-5#1)(2009-4#1)(2010-2#1)
of powers##2##2##(2008-2#1)(2008-3#1)
of pp185##4##2##(1992-10#2)(1995-3#2)
of pp38##2##2##(2013-8#2)
of pp60c-src from Y79 cells##2##5##(1991-7#2)
of pp60c-src from Y79##3##4##(1991-7#3)
of pp60c-src##9##2##(1990-12#2)(1991-7#3)(1992-11#1)(1994-6#1)(1995-6#2)
of pp64##5##2##(1990-3#5)
of pp76##5##2##(1995-3#5)
of ppANP mRNA-positive neurones##3##4##(1995-5#3)
of ppANP mRNA-positive##4##3##(1995-5#4)
of ppb##3##2##(2008-10#2)(2008-2#1)
of pph(3)##4##2##(2013-1#4)
of prC4##2##2##(1997-8#2)
of practical and##4##3##(2006-10#1)(2008-11#1)(2008-4#1)(2010-8#1)
of practical experience##2##3##(1994-3#1)(2007-2#1)
of practical importance##5##3##(1995-11#1)(2007-12#1)(2008-12#1)(2008-2#1)(2013-1#1)
of practical interest for##2##4##(2008-3#1)(2009-3#1)
of practical interest##3##3##(2008-2#1)(2008-3#1)(2009-3#1)
of practical nursing skills##2##4##(2008-11#2)
of practical samples##3##3##(2008-10#3)
of practical significance##3##3##(2005-11#1)(2008-10#1)(2008-3#1)
of practical skills##2##3##(1992-11#1)(2008-11#1)
of practical strategies##3##3##(1994-12#1)(2009-5#1)(2013-1#1)
of practical use of##2##4##(2011-1#1)(2012-1#1)
of practical use##3##3##(1996-5#1)(2011-1#1)(2012-1#1)
of practical value for##2##4##(2008-10#1)(2009-6#1)
of practical value##3##3##(2006-5#1)(2008-10#1)(2009-6#1)
of practical##45##2##(1992-11#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-4#1)(1995-11#1)(1996-5#1)(2005-11#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-1#2)
of practically all##2##3##(2010-9#1)(2012-12#1)
of practically##5##2##(2008-10#2)(2008-4#1)(2010-9#1)(2012-12#1)
of practice and##4##3##(1992-3#1)(2008-12#1)(2008-7#1)(2011-1#1)
of practice as##3##3##(2006-10#1)(2006-7#1)(2007-10#1)
of practice for##2##3##(2007-3#1)(2007-4#1)
of practice guidelines##5##3##(1993-12#1)(2007-4#2)(2013-1#2)
of practice in healthcare##2##4##(2008-12#1)(2011-2#1)
of practice in the##3##4##(2006-10#1)(2007-10#1)(2012-12#1)
of practice in##10##3##(2006-10#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
of practice learning##3##3##(2008-11#3)
of practice parameters##2##3##(1993-3#1)(1994-3#1)
of practice patterns##4##3##(1990-6#1)(2006-10#1)(2007-12#1)(2009-9#1)
of practice that##2##3##(2008-1#1)(2013-1#1)
of practice trials##2##3##(2006-10#1)(2009-10#1)
of practice##116##2##(1990-10#1)(1990-6#2)(1992-11#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-12#1)(1994-3#1)(1995-1#2)(1995-12#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#2)(2004-3#1)(2006-10#4)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#6)(2007-12#1)(2007-3#2)(2007-4#6)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#1)(2008-11#13)(2008-12#6)(2008-4#3)(2008-7#2)(2008-8#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-1#10)(2011-12#1)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#6)(2013-8#1)
of practice-based teaching##3##3##(2008-11#3)
of practices##8##2##(1990-2#1)(1996-3#1)(2005-10#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
of practicing physicians##3##3##(1996-1#1)(2006-10#1)(2007-9#1)
of practicing##7##2##(1993-12#1)(1996-1#1)(2006-10#1)(2007-9#1)(2010-11#1)(2010-5#2)
of practitioners and##2##3##(1994-12#1)(1997-4#1)
of practitioners is##2##3##(1991-3#1)(2006-10#1)
of practitioners##14##2##(1991-3#1)(1992-1#1)(1993-11#1)(1994-12#1)(1995-1#2)(1997-4#1)(2006-10#2)(2006-8#1)(2007-4#1)(2007-6#1)(2007-8#1)(2012-12#1)
of practolol with##2##3##(2005-4#2)
of practolol##3##2##(2005-4#3)
of prairie##2##2##(2008-9#2)
of pramipexole##6##2##(1996-8#5)(2013-8#1)
of praseodymium##6##2##(2008-10#6)
of pravastatin sodium##2##3##(1993-4#2)
of pravastatin##6##2##(1992-5#1)(1993-4#3)(2009-12#1)(2011-1#1)
of prayer##2##2##(1996-1#1)(2010-2#1)
of praziquantel##6##2##(1992-2#1)(1997-8#2)(2006-10#2)(2012-3#1)
of prazosin##6##2##(1990-12#4)(1991-3#1)(1991-6#1)
of pre- and post-synaptic##2##4##(1991-1#1)(2007-12#1)
of pre- and postnatal##3##4##(1992-7#1)(1993-3#1)(1997-8#1)
of pre- and postoperative pulmonary rehabilitation##2##6##(2012-12#2)
of pre- and postoperative##3##4##(2007-1#1)(2012-12#2)
of pre- and##17##3##(1991-1#1)(1991-5#1)(1992-7#1)(1993-3#1)(1995-12#1)(1996-3#1)(1997-8#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-9#1)(2012-12#2)(2012-2#1)(2012-3#1)
of pre-##19##2##(1991-1#1)(1991-5#1)(1992-7#1)(1993-3#1)(1995-12#1)(1996-3#1)(1997-8#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-9#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)
of pre-analytical##2##2##(2007-7#1)(2013-1#1)
of pre-beta-lactamase##3##2##(1992-3#3)
of pre-column derivatization##2##3##(1996-6#1)(2008-10#1)
of pre-column##3##2##(1996-6#1)(2008-10#2)
of pre-defined##2##2##(2010-2#1)(2012-1#1)
of pre-eclampsia is##2##3##(2008-4#1)(2011-1#1)
of pre-eclampsia##7##2##(1992-1#1)(1997-3#1)(2006-10#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
of pre-emptive##4##2##(1993-12#1)(2008-7#1)(2011-2#1)(2011-3#1)
of pre-end stage renal disease##2##5##(2008-1#2)
of pre-end stage renal##3##4##(2008-1#3)
of pre-existent##3##2##(1991-4#1)(2006-11#1)(2012-2#1)
of pre-existing β-cells##3##3##(2010-11#3)
of pre-existing##15##2##(1994-12#1)(1996-3#1)(1997-2#1)(2005-7#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2010-11#3)(2010-12#1)(2011-2#1)(2013-1#1)
of pre-formed##2##2##(1991-7#1)(1992-4#1)
of pre-heating##2##2##(2010-4#2)
of pre-hospital care##3##3##(2006-10#2)(2011-1#1)
of pre-hospital##4##2##(1991-9#1)(2006-10#2)(2011-1#1)
of pre-mRNA splicing by antisense RNA in vitro##3##8##(1991-9#3)
of pre-mRNA##6##2##(1991-9#5)(2010-11#1)
of pre-mRNAs##2##2##(1995-5#1)(2007-12#1)
of pre-natal##2##2##(2007-7#1)(2011-2#1)
of pre-operative##10##2##(1991-9#1)(1995-12#1)(1996-2#1)(1997-6#1)(2008-12#1)(2009-2#1)(2011-1#1)(2012-12#1)(2012-2#2)
of pre-packaging antimalarial drugs and counselling on compliance with##2##9##(2008-4#2)
of pre-pregnancy##3##2##(1990-9#1)(2004-10#1)(2011-1#1)
of pre-registration nursing##4##3##(2008-11#4)
of pre-registration##6##2##(2008-11#6)
of pre-school##3##2##(1991-10#1)(1996-1#1)(2008-9#1)
of pre-settlement##2##2##(2010-8#2)
of pre-tRNA(fMet)##2##2##(1995-6#2)
of pre-term delivery##3##3##(2006-10#2)(2007-1#1)
of pre-term##8##2##(1995-8#1)(2006-10#2)(2007-1#5)
of pre-travel##2##2##(2007-2#1)(2011-2#1)
of pre-treatment and##2##3##(1992-3#1)(2008-10#1)
of pre-treatment##8##2##(1992-3#1)(1996-12#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-1#2)(2013-1#1)
of preMBP##3##2##(1993-12#3)
of preactivated##2##2##(2008-10#2)
of preadipocyte##2##2##(1990-11#1)(2008-11#1)
of preadipocytes##2##2##(1992-9#1)(1994-12#1)
of preadipose cells##3##3##(1992-9#1)(1993-6#1)(1994-2#1)
of precancer##2##2##(2008-11#1)(2011-1#1)
of precancerous lesions##5##3##(1994-5#1)(2008-2#1)(2011-2#2)(2011-3#1)
of precancerous##8##2##(1992-8#1)(1994-5#1)(2008-2#1)(2008-7#1)(2010-11#1)(2011-2#2)(2011-3#1)
of preceding crop on wireworm (Coleoptera##2##6##(2011-2#2)
of preceding##3##2##(1995-2#1)(2011-2#2)
of precentral and mesial##2##4##(1993-9#2)
of preceptorship##2##2##(2008-11#2)
of prechordal plate##2##3##(2012-12#2)
of precious##4##2##(2006-10#1)(2008-10#3)
of precipitated##2##2##(2004-9#1)(2007-2#1)
of precipitates##2##2##(2007-9#1)(2008-5#1)
of precipitating##3##2##(2008-10#1)(2010-8#1)(2011-2#1)
of precipitation and##3##3##(2008-10#1)(2008-3#1)(2013-8#1)
of precipitation##15##2##(1997-6#2)(2006-11#1)(2007-2#1)(2008-10#9)(2008-3#1)(2013-8#1)
of precise##21##2##(1990-12#1)(1991-8#2)(1997-4#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-12#1)(2008-10#2)(2008-3#4)(2009-8#1)(2009-9#1)(2010-2#1)(2010-5#1)(2010-7#1)(2012-3#1)
of precisely##8##2##(1993-5#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-12#1)
of precision and##2##3##(2008-11#1)(2009-11#1)
of precision diagnostic##2##3##(2006-7#2)
of precision for##3##3##(2010-2#2)(2011-12#1)
of precision##25##2##(1994-11#1)(2006-3#1)(2006-7#2)(2007-11#1)(2008-10#7)(2008-11#1)(2008-2#2)(2009-11#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#2)(2010-8#1)(2011-1#1)(2011-12#2)
of preclinical and clinical studies##2##5##(2005-7#1)(2009-11#1)
of preclinical and clinical##7##4##(1993-11#1)(2005-7#1)(2007-11#1)(2009-11#1)(2010-12#1)(2012-1#1)(2012-3#1)
of preclinical animal##3##3##(2008-1#1)(2012-12#2)
of preclinical studies##6##3##(2005-11#1)(2005-7#1)(2012-12#4)
of preclinical##26##2##(1991-12#1)(1991-5#1)(1993-11#1)(1994-3#1)(2005-11#1)(2005-7#2)(2006-7#1)(2007-11#1)(2008-1#1)(2008-6#1)(2008-7#1)(2009-11#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-1#2)(2012-12#6)(2012-3#1)
of precompensation and postcompensation##2##4##(2007-12#2)
of preconcentration time##6##3##(2008-10#6)
of preconcentration##14##2##(2008-10#14)
of preconditioned##2##2##(2008-7#2)
of preconditioning in##2##3##(2006-10#1)(2013-7#1)
of preconditioning##5##2##(1996-9#1)(2006-10#2)(2008-7#1)(2013-7#1)
of precordial pain##2##3##(2008-10#1)(2008-7#1)
of precursor cells##7##3##(1990-5#1)(1994-3#1)(1995-1#1)(1995-8#1)(2007-8#2)(2012-1#1)
of precursor molecules##2##3##(1992-12#1)(2008-11#1)
of precursor protein##2##3##(1990-3#1)(2008-5#1)
of precursor proteins into##2##4##(1991-2#1)(1992-6#1)
of precursor proteins##4##3##(1991-2#2)(1992-6#1)(1994-8#1)
of precursor to##2##3##(1990-7#1)(2009-10#1)
of precursor##29##2##(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1991-2#2)(1992-11#1)(1992-12#1)(1992-6#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-6#1)(1995-8#1)(1997-6#1)(2007-8#3)(2008-11#1)(2008-4#1)(2008-5#1)(2009-10#2)(2009-6#1)(2012-1#1)(2012-2#1)(2013-8#1)
of precursors and##2##3##(2008-10#1)(2008-7#1)
of precursors of egg envelopes##2##5##(2007-12#2)
of precursors of##3##3##(2007-12#2)(2009-8#1)
of precursors##15##2##(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#1)(1995-2#1)(2006-3#1)(2007-12#2)(2008-10#1)(2008-4#1)(2008-7#3)(2009-8#1)(2010-1#1)
of predation and##2##3##(2008-9#2)
of predation on the##2##4##(2008-8#1)(2008-9#1)
of predation on##4##3##(2008-8#3)(2008-9#1)
of predation##12##2##(1991-11#1)(2008-8#6)(2008-9#4)(2010-8#1)
of predator##4##2##(2008-8#1)(2011-12#1)(2012-2#1)(2012-3#1)
of predator-prey interactions##2##3##(2008-8#1)(2008-9#1)
of predator-prey systems##2##3##(2008-8#2)
of predator-prey##4##2##(2008-8#3)(2008-9#1)
of predators and prey##2##4##(2008-8#2)
of predators in##3##3##(2007-3#1)(2008-8#2)
of predators that##2##3##(2008-8#2)
of predators##12##2##(2007-3#1)(2008-8#10)(2012-3#1)
of predictability##2##2##(1992-12#1)(2010-4#1)
of predictable##5##2##(1994-3#1)(2008-11#2)(2008-8#1)(2012-12#1)
of predicted##12##2##(1990-5#1)(1992-11#1)(1993-9#1)(1994-3#1)(1996-2#1)(2006-10#1)(2006-11#1)(2008-10#2)(2011-2#1)(2011-3#1)(2013-8#1)
of predicting the##6##3##(2007-8#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-7#1)
of predicting##24##2##(1993-4#1)(1994-6#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2009-7#1)(2009-8#1)(2010-8#1)(2010-9#1)(2012-2#1)(2013-1#3)
of prediction (RSEP)##3##3##(2008-10#3)
of prediction for##2##3##(1990-4#1)(2008-10#1)
of prediction methods##2##3##(1994-10#1)(1996-4#1)
of prediction of##4##3##(1997-2#1)(2009-2#1)(2012-7#1)(2013-8#1)
of prediction##38##2##(1990-4#1)(1994-10#1)(1996-4#2)(1997-2#1)(2005-12#1)(2006-12#1)(2008-10#22)(2008-2#1)(2008-7#1)(2009-2#1)(2010-8#1)(2011-1#2)(2012-2#1)(2012-7#1)(2013-8#1)
of predictions made##2##3##(1994-3#1)(2008-1#1)
of predictions##13##2##(1991-5#1)(1994-3#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-7#1)(2013-1#2)
of predictive ability##4##3##(1997-6#1)(2008-10#1)(2012-3#2)
of predictive accuracy##3##3##(1996-2#2)(2013-1#1)
of predictive models##3##3##(2011-2#1)(2013-1#2)
of predictive role##2##3##(2011-2#1)(2012-3#1)
of predictive validity##2##3##(1994-2#1)(2010-7#1)
of predictive value##2##3##(1994-2#1)(1997-8#1)
of predictive values##2##3##(1993-1#1)(2006-10#1)
of predictive##32##2##(1993-1#1)(1993-2#1)(1994-2#2)(1996-2#3)(1997-6#1)(1997-8#1)(2006-10#2)(2007-11#1)(2008-10#2)(2008-4#2)(2008-7#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#4)(2013-1#3)(2013-8#2)
of predictor variables##2##3##(1997-6#1)(2012-12#1)
of predictors for##3##3##(2006-10#2)(2007-8#1)
of predictors of##5##3##(1995-12#1)(2006-7#1)(2008-11#1)(2008-12#1)(2008-7#1)
of predictors##15##2##(1995-12#2)(1997-2#1)(2006-10#2)(2006-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-3#1)(2011-2#2)(2012-12#2)
of predisposing factors##5##3##(2006-3#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
of predisposing##7##2##(2006-3#1)(2010-1#1)(2011-2#2)(2012-12#2)(2012-3#1)
of predisposition##2##2##(2007-7#1)(2013-1#1)
of prednisolone and##3##3##(1991-12#1)(2008-1#1)(2013-8#1)
of prednisolone in##2##3##(1995-5#1)(2007-7#1)
of prednisolone##16##2##(1991-12#1)(1993-11#1)(1995-5#1)(2006-9#1)(2007-2#2)(2007-7#2)(2007-8#2)(2008-1#2)(2010-12#1)(2011-1#1)(2012-12#1)(2013-8#1)
of prednisone or##2##3##(2006-10#1)(2007-8#1)
of prednisone##7##2##(1992-5#1)(2006-10#2)(2007-11#1)(2007-8#2)(2008-7#1)
of predominance of##2##3##(2008-10#1)(2012-3#1)
of predominance##3##2##(1991-9#1)(2008-10#1)(2012-3#1)
of predominantly##9##2##(1990-10#1)(1996-1#1)(1996-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-7#1)(2009-7#1)(2012-3#1)
of predominately##2##2##(1997-8#1)(2007-11#1)
of preeclampsia and##4##3##(1996-11#1)(2008-11#2)(2010-8#1)
of preeclampsia##13##2##(1993-10#1)(1996-11#1)(1996-12#1)(2006-10#1)(2008-11#3)(2008-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)
of preeclamptic##2##2##(2007-9#1)(2008-10#1)
of preemergence damping-off##2##3##(2008-10#2)
of preemptive analgesia##3##3##(2006-10#3)
of preemptive##5##2##(2006-10#3)(2011-2#1)(2012-1#1)
of preexisting conditions##2##3##(1994-2#1)(2008-7#1)
of preexisting##10##2##(1994-2#1)(1996-11#1)(2004-1#1)(2007-1#1)(2007-7#1)(2008-10#2)(2008-7#1)(2009-5#1)(2010-12#1)
of preference and performance##2##4##(2008-8#2)
of preference and##4##3##(2006-2#1)(2008-8#3)
of preference for##2##3##(2008-2#1)(2009-4#1)
of preference##9##2##(1995-2#1)(2005-7#1)(2006-2#1)(2008-2#1)(2008-8#3)(2009-4#1)(2012-12#1)
of preferences for##3##3##(2007-12#1)(2008-3#1)(2012-3#1)
of preferences##5##2##(2007-12#1)(2008-3#1)(2008-9#1)(2012-2#1)(2012-3#1)
of preferential##5##2##(1991-6#1)(1992-7#1)(1997-2#1)(1997-7#1)(2005-11#1)
of preferred##5##2##(1992-6#1)(1994-7#1)(2007-6#2)(2013-1#1)
of preformed DAPs##2##3##(2010-5#2)
of preformed antifungal##2##3##(2008-10#2)
of preformed##11##2##(1992-8#1)(1995-2#1)(2007-11#1)(2008-10#3)(2008-4#1)(2009-12#1)(2010-5#2)(2012-1#1)
of prefrontal cortex##2##3##(2007-8#1)(2009-12#1)
of prefrontal cortical##2##3##(1995-12#1)(2006-4#1)
of prefrontal##10##2##(1995-12#2)(1996-7#1)(1997-2#1)(2006-4#1)(2007-8#1)(2008-11#2)(2009-12#1)(2012-12#1)
of pregnancies and##5##3##(2006-10#1)(2006-4#1)(2009-3#1)(2011-1#1)(2011-2#1)
of pregnancies in##2##3##(1990-5#1)(1993-7#1)
of pregnancies##25##2##(1990-5#1)(1991-3#1)(1992-10#1)(1993-7#1)(1995-6#1)(2005-10#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-3#1)(2008-3#1)(2008-4#1)(2009-3#1)(2011-1#1)(2011-2#6)(2013-1#4)
of pregnancy after##2##3##(1992-7#1)(2010-12#1)
of pregnancy and childbearing##2##4##(2007-7#1)(2012-12#1)
of pregnancy and in##2##4##(1993-12#1)(2006-10#1)
of pregnancy and labor##4##4##(2009-2#1)(2012-3#3)
of pregnancy and neonatal##2##4##(2009-6#1)(2012-12#1)
of pregnancy and the##2##4##(2007-2#1)(2010-8#1)
of pregnancy and##27##3##(1991-6#1)(1992-2#1)(1993-12#1)(1994-2#1)(1995-12#2)(1995-8#1)(1996-12#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-9#1)(2009-2#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#3)(2013-1#1)(2013-8#1)
of pregnancy are##3##3##(1990-2#1)(2010-6#1)(2011-1#1)
of pregnancy by##2##3##(2005-8#1)(2011-1#1)
of pregnancy complications##3##3##(2007-3#2)(2008-11#1)
of pregnancy for##2##3##(2004-10#1)(2008-7#1)
of pregnancy in the##3##4##(1990-2#1)(2005-10#1)(2007-11#1)
of pregnancy in##13##3##(1990-2#2)(1990-9#1)(1991-2#1)(1991-8#1)(1995-3#1)(2005-10#1)(2006-5#1)(2007-11#1)(2007-2#1)(2008-9#1)(2010-12#1)(2012-3#1)
of pregnancy induced hypertension##2##4##(2008-4#2)
of pregnancy is##2##3##(1993-11#1)(2008-2#1)
of pregnancy loss##2##3##(1994-9#1)(2007-3#1)
of pregnancy on##5##3##(1995-2#1)(2008-3#1)(2010-3#1)(2011-2#1)(2013-1#1)
of pregnancy or##8##3##(1996-7#1)(2007-10#1)(2007-8#1)(2008-12#1)(2009-9#1)(2010-8#1)(2012-3#1)(2013-8#1)
of pregnancy outcome in##2##4##(1992-2#1)(2011-1#1)
of pregnancy outcome##3##3##(1992-2#2)(2011-1#1)
of pregnancy outcomes##2##3##(2011-2#1)(2013-8#1)
of pregnancy to##2##3##(1994-2#1)(1995-8#1)
of pregnancy until##2##3##(2008-7#1)(2012-12#1)
of pregnancy was##3##3##(1993-3#1)(2006-5#1)(2012-3#1)
of pregnancy were##5##3##(1992-2#1)(1995-12#2)(2006-8#1)(2007-8#1)
of pregnancy when##2##3##(1994-3#1)(2007-2#1)
of pregnancy with##5##3##(1993-5#1)(1993-8#1)(2006-1#1)(2008-3#1)(2009-1#1)
of pregnancy##247##2##(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#2)(1990-6#3)(1990-9#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#3)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#4)(1992-2#8)(1992-3#2)(1992-4#1)(1992-5#2)(1992-7#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-8#1)(1994-2#3)(1994-3#3)(1994-9#3)(1995-1#2)(1995-12#6)(1995-2#2)(1995-3#1)(1995-6#3)(1995-8#4)(1995-9#1)(1996-12#5)(1996-4#3)(1996-7#2)(1996-9#1)(1997-4#1)(2004-10#3)(2005-10#1)(2005-8#1)(2006-1#1)(2006-10#8)(2006-12#1)(2006-5#3)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-2#5)(2007-3#4)(2007-6#1)(2007-7#2)(2007-8#6)(2007-9#3)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#4)(2008-7#3)(2008-9#5)(2009-1#3)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#3)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#4)(2011-1#8)(2011-2#10)(2012-1#2)(2012-12#6)(2012-2#2)(2012-3#13)(2013-1#3)(2013-7#1)(2013-8#6)
of pregnancy-associated cancer##2##3##(2013-1#2)
of pregnancy-associated##4##2##(2008-10#1)(2013-1#3)
of pregnancy-induced hypertension##7##3##(1990-3#1)(1990-6#3)(1994-3#1)(2010-10#1)(2012-2#1)
of pregnancy-induced##8##2##(1990-3#1)(1990-6#3)(1994-3#1)(2007-9#1)(2010-10#1)(2012-2#1)
of pregnant and lactating##3##4##(1990-11#2)(2011-2#1)
of pregnant and non-pregnant##4##4##(2008-4#3)(2010-6#1)
of pregnant and##7##3##(1990-11#2)(2008-4#3)(2010-6#1)(2011-2#1)
of pregnant females##3##3##(2008-7#1)(2013-7#2)
of pregnant patients##2##3##(1990-12#1)(2009-1#1)
of pregnant rats##6##3##(1994-11#1)(1995-10#1)(1996-10#1)(2007-1#1)(2010-12#1)(2013-1#1)
of pregnant women and their##2##5##(2007-8#1)(2012-2#1)
of pregnant women and##4##4##(1994-6#1)(2007-8#1)(2011-2#1)(2012-2#1)
of pregnant women in Iceland##2##5##(2006-7#2)
of pregnant women in##7##4##(1997-6#1)(2006-7#2)(2007-12#1)(2007-4#1)(2009-9#1)(2010-6#1)
of pregnant women##34##3##(1990-6#1)(1992-3#1)(1993-3#1)(1994-6#1)(1995-4#1)(1996-11#3)(1996-12#1)(1996-7#1)(1997-6#1)(2005-10#1)(2006-7#3)(2007-12#1)(2007-2#2)(2007-4#1)(2007-8#1)(2008-3#1)(2009-1#1)(2009-4#1)(2009-9#1)(2010-4#1)(2010-6#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
of pregnant##68##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-6#1)(1991-3#1)(1992-11#1)(1992-3#1)(1993-12#2)(1993-3#1)(1994-11#3)(1994-6#1)(1995-10#1)(1995-4#1)(1995-6#1)(1996-10#2)(1996-11#3)(1996-12#1)(1996-7#1)(1997-6#1)(2005-10#1)(2006-7#3)(2007-1#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-4#3)(2008-7#3)(2008-8#1)(2009-1#2)(2009-4#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#3)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#2)
of pregnenolone sulfate##6##3##(1990-10#2)(1996-2#2)(1997-1#2)
of pregnenolone was##2##3##(1990-3#1)(1995-10#1)
of pregnenolone##11##2##(1990-10#2)(1990-11#1)(1990-3#2)(1995-10#1)(1996-2#3)(1997-1#2)
of prehaustorial resistance to##2##4##(2008-10#2)
of prehaustorial##4##2##(2008-10#4)
of prehospital##8##2##(1990-12#1)(1993-1#1)(1994-4#1)(2005-9#1)(2007-7#1)(2008-3#3)
of preimplantation genetic diagnosis##2##4##(2008-4#1)(2012-3#1)
of preincubation##2##2##(1991-8#1)(1993-11#1)
of preinvasive##4##2##(2006-10#1)(2008-5#3)
of preirradiation##2##2##(1994-3#1)(2007-12#1)
of prekallikrein##2##2##(1991-8#1)(1996-5#1)
of preliminary experiments##2##3##(1997-7#1)(2007-11#1)
of preliminary##13##2##(1991-5#1)(1992-3#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#3)
of prelingually##2##2##(2008-9#2)
of preload##3##2##(2007-4#1)(2011-2#2)
of premalignant lesions##2##3##(2006-9#1)(2011-2#1)
of premalignant##4##2##(1992-3#1)(2006-9#1)(2007-11#1)(2011-2#1)
of premating isolation##2##3##(2008-8#1)(2008-9#1)
of premating##5##2##(2008-8#2)(2008-9#2)(2012-3#1)
of premature adrenarche##2##3##(2008-4#2)
of premature aging##4##3##(1992-9#1)(1994-5#1)(1996-4#1)(2008-8#1)
of premature and##2##3##(1991-12#1)(2006-7#1)
of premature atherosclerosis##6##3##(1995-4#1)(1997-2#3)(2008-11#2)
of premature cardiovascular##5##3##(2006-12#1)(2008-1#1)(2008-11#1)(2009-11#2)
of premature coronary artery disease##2##5##(1993-9#2)
of premature death##2##3##(2005-7#1)(2007-8#1)
of premature infant##2##3##(1994-3#1)(1997-2#1)
of premature infants with##3##4##(1990-11#1)(2012-2#2)
of premature infants##11##3##(1990-11#1)(1994-3#1)(2007-11#1)(2008-11#1)(2010-10#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-7#1)
of premature infants]##2##3##(1990-11#1)(2013-1#1)
of premature mortality##2##3##(1990-9#1)(2008-1#1)
of premature newborns##3##3##(2009-5#2)(2009-9#1)
of premature ovarian failure##2##4##(1996-2#1)(2013-8#1)
of premature##61##2##(1990-11#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-6#1)(1992-9#1)(1993-9#2)(1994-3#2)(1994-5#1)(1994-6#1)(1995-1#1)(1995-4#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-2#4)(2005-7#1)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-11#4)(2008-4#2)(2008-8#1)(2009-11#2)(2009-5#3)(2009-9#1)(2010-10#1)(2011-2#5)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#2)
of prematurity and##3##3##(1992-7#1)(2004-10#1)(2008-11#1)
of prematurity was##3##3##(1992-1#1)(1992-2#1)(2007-7#1)
of prematurity##21##2##(1991-9#2)(1992-1#1)(1992-2#1)(1992-7#1)(1993-2#1)(1994-3#1)(2004-10#1)(2007-2#1)(2007-7#1)(2008-11#1)(2011-1#6)(2012-12#1)(2012-2#1)(2013-1#2)
of premenopausal##4##2##(1994-12#1)(1994-2#1)(2007-5#1)(2012-12#1)
of premenstrual syndrome##2##3##(2006-7#1)(2008-5#1)
of premenstrual##4##2##(2006-7#1)(2007-7#1)(2008-5#2)
of premetamorphic##2##2##(1994-9#1)(2008-5#1)
of premixed##2##2##(2008-10#1)(2008-3#1)
of premorbid##2##2##(2007-11#1)(2007-6#1)
of prenatal alcohol exposure##4##4##(1991-1#1)(2006-3#1)(2008-11#1)(2011-2#1)
of prenatal alcohol##6##3##(1991-1#1)(2006-3#2)(2008-11#2)(2011-2#1)
of prenatal care and##4##4##(1992-2#1)(1993-3#1)(2005-10#2)
of prenatal care in##3##4##(1994-3#1)(2008-10#1)(2011-2#1)
of prenatal care on##2##4##(1993-3#1)(2008-9#1)
of prenatal care##22##3##(1992-2#2)(1993-3#5)(1994-3#2)(1995-12#2)(1995-2#1)(2005-10#2)(2008-1#3)(2008-10#2)(2008-9#1)(2011-2#2)
of prenatal cocaine##4##3##(1996-10#3)(1996-4#1)
of prenatal contraceptive counseling and##2##5##(2013-1#2)
of prenatal contraceptive counseling##3##4##(2013-1#3)
of prenatal development##3##3##(2007-11#1)(2012-3#2)
of prenatal diagnosis##2##3##(2006-10#1)(2011-2#1)
of prenatal exposure to##4##4##(1996-10#2)(2010-9#1)(2011-2#1)
of prenatal exposure##5##3##(1996-10#2)(2010-12#1)(2010-9#1)(2011-2#1)
of prenatal malnutrition##2##3##(1994-10#1)(2008-11#1)
of prenatal protein malnutrition##2##4##(1994-10#1)(2008-11#1)
of prenatal stress##2##3##(2008-2#2)
of prenatal treatment##2##3##(1990-3#1)(2011-2#1)
of prenatal##74##2##(1990-3#1)(1991-1#2)(1991-3#1)(1991-4#2)(1992-2#2)(1993-3#7)(1994-10#2)(1994-3#2)(1995-12#2)(1995-2#1)(1996-10#5)(1996-4#1)(1996-5#1)(1996-6#1)(1997-3#1)(2005-10#3)(2006-10#1)(2006-3#2)(2007-11#1)(2007-2#2)(2008-1#3)(2008-10#3)(2008-11#4)(2008-2#3)(2008-9#1)(2009-9#2)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
of prenatally##4##2##(2008-10#2)(2008-4#1)(2010-8#1)
of preneoplastic and neoplastic##2##4##(2007-6#1)(2013-7#1)
of preneoplastic lesions##2##3##(1991-6#1)(1992-4#1)
of preneoplastic##8##2##(1991-6#1)(1992-4#1)(1992-9#2)(2007-6#1)(2009-2#1)(2010-9#1)(2013-7#1)
of prenyl##3##2##(2009-11#3)
of prenylated carbene complexes##2##4##(2008-9#2)
of prenylated flavonoids##2##3##(2011-2#2)
of prenylated##5##2##(2008-5#1)(2008-9#2)(2011-2#2)
of prenyltransferases##3##2##(1993-4#1)(2008-8#1)(2011-2#1)
of preoperative and postoperative##2##4##(2007-11#1)(2011-7#1)
of preoperative chemotherapy##4##3##(2006-10#1)(2007-2#1)(2012-3#2)
of preoperative feeding##2##3##(2011-2#2)
of preoperative radiotherapy##2##3##(2006-10#1)(2007-4#1)
of preoperative serum##2##3##(2011-2#2)
of preoperative ultrasound staging and postoperative histopathological staging##2##8##(1990-9#1)(1993-5#1)
of preoperative ultrasound##3##3##(1990-9#1)(1993-5#1)(1996-1#1)
of preoperative##53##2##(1990-11#1)(1990-9#1)(1991-11#1)(1992-12#1)(1993-12#1)(1993-5#2)(1993-9#1)(1995-1#1)(1996-1#1)(2006-10#6)(2006-2#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-4#1)(2007-8#2)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-9#1)(2010-11#1)(2010-3#2)(2011-1#1)(2011-2#5)(2011-7#1)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
of prepaid##2##2##(1994-2#1)(1997-1#1)
of preparation and##5##3##(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)
of preparation for the##2##4##(1990-12#1)(2008-12#1)
of preparation for##4##3##(1990-12#1)(1997-7#1)(2007-8#1)(2008-12#1)
of preparation of##4##3##(1990-5#1)(2008-10#1)(2010-2#1)(2012-3#1)
of preparation##30##2##(1990-12#1)(1990-5#1)(1991-12#1)(1994-12#2)(1994-5#1)(1997-7#1)(2005-10#1)(2005-11#1)(2007-10#1)(2007-11#2)(2007-8#1)(2007-9#2)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#1)(2009-5#1)(2010-2#1)(2010-5#1)(2012-3#1)
of preparations of##4##3##(1990-7#1)(1991-5#1)(1996-1#1)(2013-1#1)
of preparations##9##2##(1990-12#1)(1990-7#1)(1991-5#1)(1994-10#1)(1996-1#1)(1996-5#1)(2004-12#1)(2008-5#1)(2013-1#1)
of preparative quantities of##2##4##(1995-6#2)
of preparative##6##2##(1990-11#1)(1990-8#1)(1995-6#2)(2007-8#1)(2008-10#1)
of prepared##4##2##(2008-10#3)(2012-3#1)
of preparedness##4##2##(2006-10#1)(2007-12#1)(2007-2#1)(2007-3#1)
of preparing a##3##3##(2008-10#2)(2011-1#1)
of preparing the##2##3##(2007-12#1)(2008-11#1)
of preparing##13##2##(1994-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#2)(2009-12#1)(2010-4#1)(2011-1#1)(2013-8#1)
of prepenetration##2##2##(2008-10#2)
of prepro##2##2##(1991-8#2)
of preproatrial natriuretic peptide##2##4##(1995-5#2)
of preprocessing##4##2##(2007-12#3)(2008-7#1)
of preproinsulin##2##2##(2007-5#1)(2010-11#1)
of prepubertal goat oocytes##2##4##(2006-5#2)
of prepubertal##4##2##(2006-5#2)(2013-1#2)
of preputial##2##2##(2008-10#1)(2013-1#1)
of preschool children in##2##4##(2005-9#1)(2013-1#1)
of preschool children##9##3##(2005-9#1)(2006-4#1)(2007-11#1)(2009-9#1)(2012-12#1)(2013-1#4)
of preschool##13##2##(2005-9#1)(2006-10#1)(2006-4#1)(2007-11#1)(2009-9#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#4)(2013-7#1)
of preschoolers##2##2##(1992-9#1)(2010-6#1)
of prescribed##4##2##(2012-3#1)(2013-1#3)
of prescribing##8##2##(2007-2#1)(2008-11#3)(2008-4#1)(2008-8#1)(2013-1#2)
of prescription antiplatelet##2##3##(2007-10#2)
of prescription controlled substances##3##4##(2006-8#3)
of prescription drug##5##3##(1995-1#3)(2009-4#1)(2011-2#1)
of prescription drugs are##2##4##(1992-5#1)(2013-8#1)
of prescription drugs##11##3##(1992-5#1)(1995-1#1)(1996-1#1)(2006-8#2)(2008-11#2)(2008-12#1)(2008-4#1)(2013-1#1)(2013-8#1)
of prescription medications is a##2##5##(2008-12#1)(2008-3#1)
of prescription medications##3##3##(2008-12#1)(2008-3#1)(2011-1#1)
of prescription##39##2##(1991-1#1)(1992-5#1)(1994-11#1)(1995-1#5)(1996-1#1)(2006-1#1)(2006-8#5)(2007-10#3)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#1)(2009-4#1)(2009-9#1)(2010-12#2)(2011-1#2)(2011-2#2)(2012-1#1)(2013-1#3)(2013-8#1)
of prescriptions##13##2##(1991-12#1)(1994-9#1)(1995-9#1)(1996-12#1)(2008-11#1)(2008-4#2)(2009-9#3)(2010-12#1)(2011-1#1)(2013-1#1)
of preselected##2##2##(1994-3#1)(2008-11#1)
of presence of##6##3##(2007-2#1)(2008-10#3)(2008-8#1)(2012-3#1)
of presence or absence of##3##5##(2008-6#1)(2009-5#1)(2011-2#1)
of presence or absence##4##4##(1997-4#1)(2008-6#1)(2009-5#1)(2011-2#1)
of presence##12##2##(1997-4#1)(2007-2#1)(2008-10#3)(2008-6#2)(2008-8#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-3#1)
of presenile##2##2##(1992-1#2)
of presenilin 1##2##3##(1997-5#2)
of presenilin##3##2##(1997-5#3)
of present study was to##4##5##(2008-12#1)(2011-2#1)(2012-12#1)(2013-7#1)
of present study##10##3##(2006-1#1)(2008-12#3)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
of present##30##2##(1991-6#1)(1993-6#1)(2006-1#1)(2006-8#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#4)(2008-3#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#1)
of presentation and##7##3##(1991-8#1)(1992-12#1)(1995-10#1)(2005-8#1)(2007-3#1)(2008-7#1)(2009-6#1)
of presentation in##2##3##(2007-2#1)(2007-7#1)
of presentation is##2##3##(2008-3#1)(2008-9#1)
of presentation of##12##3##(1990-9#1)(1991-12#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-1#2)(2008-4#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-3#1)
of presentation was##4##3##(2007-3#2)(2008-1#1)(2008-8#1)
of presentation##65##2##(1990-9#1)(1991-12#1)(1991-8#2)(1992-10#1)(1992-12#1)(1993-1#1)(1995-10#1)(1997-8#2)(2005-7#1)(2005-8#2)(2006-10#3)(2006-2#1)(2007-11#1)(2007-2#4)(2007-3#5)(2007-7#5)(2008-1#3)(2008-12#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#2)(2010-11#1)(2010-12#2)(2010-3#1)(2011-1#3)(2011-12#2)(2011-2#3)(2012-1#1)(2012-3#3)(2013-8#1)
of presentations and##3##3##(1991-12#1)(2008-7#1)(2009-8#1)
of presentations##55##2##(1991-12#1)(2005-8#3)(2005-9#1)(2006-2#1)(2008-1#1)(2008-11#45)(2008-7#1)(2009-8#1)(2012-2#1)
of presenting##9##2##(1990-9#1)(1991-6#1)(2005-10#1)(2006-5#1)(2007-7#1)(2007-9#1)(2009-8#1)(2012-1#1)(2013-1#1)
of presently available##2##3##(1991-2#1)(2011-2#1)
of presently##3##2##(1991-2#1)(2008-8#1)(2011-2#1)
of preservation of the##2##4##(1990-6#1)(2008-7#1)
of preservation of##4##3##(1990-6#1)(2007-9#1)(2008-7#1)(2013-1#1)
of preservation##6##2##(1990-6#1)(1991-6#1)(2006-2#1)(2007-9#1)(2008-7#1)(2013-1#1)
of preservative##2##2##(2008-5#1)(2011-2#1)
of preservatives##9##2##(1990-10#3)(2008-5#5)(2011-1#1)
of preserved##4##2##(2008-10#1)(2008-11#1)(2009-10#2)
of preserving the##2##3##(1991-10#1)(2008-1#1)
of preserving##9##2##(1991-10#1)(1996-3#1)(2007-1#1)(2008-1#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-2#2)
of prespore##2##2##(1993-6#2)
of pressure (COP)##2##3##(2010-12#1)(2010-9#1)
of pressure and temperature##6##4##(1992-1#1)(2008-10#1)(2008-2#2)(2008-3#2)
of pressure and##14##3##(1990-3#1)(1991-3#1)(1992-1#1)(1997-4#1)(2005-11#2)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-8#1)
of pressure at##3##3##(1992-3#1)(1995-1#1)(2008-10#1)
of pressure on the##5##4##(1991-10#1)(1991-2#1)(2006-10#2)(2009-9#1)
of pressure on##8##3##(1991-10#2)(1991-2#1)(2005-12#1)(2006-10#2)(2008-10#1)(2009-9#1)
of pressure sores##3##3##(1990-6#1)(1996-1#1)(2012-2#1)
of pressure ulcer##2##3##(2012-3#2)
of pressure##73##2##(1990-2#2)(1990-3#1)(1990-6#1)(1990-8#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#2)(1992-1#1)(1992-3#1)(1995-1#1)(1996-1#2)(1997-4#1)(2005-11#2)(2005-12#1)(2006-10#3)(2006-9#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#13)(2008-11#1)(2008-2#3)(2008-3#6)(2008-6#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#2)(2011-1#2)(2011-12#1)(2012-12#1)(2012-2#5)(2012-3#2)
of pressures##2##2##(2008-8#1)(2009-2#1)
of pressurized##3##2##(1992-3#1)(2008-10#2)
of prestalk cells into##2##4##(1993-6#1)(2008-8#1)
of prestalk cells##5##3##(1993-6#3)(1995-8#1)(2008-8#1)
of prestalk##6##2##(1993-6#3)(1995-8#2)(2008-8#1)
of presumed##12##2##(1992-3#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-7#2)(2006-10#2)(2006-2#1)(2007-7#1)(2008-4#1)(2012-3#1)
of presumptive##2##2##(1991-9#1)(1995-6#1)
of presynaptic function##2##3##(1995-11#1)(1997-7#1)
of presynaptic##16##2##(1990-2#2)(1992-12#1)(1992-5#1)(1992-9#1)(1993-3#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-7#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-5#1)
of pretectal neurons##2##3##(2008-8#2)
of pretectal##3##2##(1992-3#1)(2008-8#2)
of pretension##2##2##(2006-11#2)
of preterm birth##13##3##(2006-10#1)(2006-6#1)(2007-2#2)(2007-8#1)(2011-2#2)(2013-1#6)
of preterm delivery and##2##4##(1994-3#1)(2012-12#1)
of preterm delivery##8##3##(1994-3#1)(1996-11#1)(1996-9#3)(2011-1#1)(2012-12#1)(2012-3#1)
of preterm infants and##2##4##(1990-3#1)(2010-12#1)
of preterm infants##6##3##(1990-3#1)(1991-1#1)(2006-9#1)(2007-11#1)(2009-2#1)(2010-12#1)
of preterm labor##2##3##(2010-11#1)(2011-2#1)
of preterm labour##3##3##(2004-10#1)(2006-1#1)(2007-11#1)
of preterm neonates##4##3##(2007-11#4)
of preterm##40##2##(1990-11#1)(1990-3#1)(1991-1#1)(1993-3#1)(1994-3#1)(1996-11#1)(1996-9#3)(2004-10#1)(2006-1#1)(2006-10#1)(2006-6#2)(2006-9#1)(2007-11#7)(2007-2#2)(2007-8#1)(2009-2#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#6)
of pretibial##3##2##(2007-7#1)(2007-8#1)(2012-3#1)
of pretransfusion testing##3##3##(2011-1#3)
of pretransplant##3##2##(1994-5#1)(1995-2#1)(2011-2#1)
of pretreated##11##2##(1990-4#1)(1991-12#1)(1993-2#1)(2008-10#1)(2008-5#5)(2008-7#1)(2013-1#1)
of pretreatment and##2##3##(2011-2#1)(2013-1#1)
of pretreatment with##3##3##(1994-2#1)(1996-2#1)(1996-6#1)
of pretreatment##20##2##(1990-11#1)(1992-6#1)(1994-2#1)(1995-10#1)(1995-4#1)(1996-2#1)(1996-6#1)(2008-10#2)(2008-5#3)(2009-11#1)(2009-5#1)(2010-10#1)(2011-2#2)(2012-1#1)(2013-1#2)
of prevailing##3##2##(1992-5#1)(2006-2#1)(2008-7#1)
of prevalence of metabolic syndrome##2##5##(2008-3#1)(2010-12#1)
of prevalence of##13##3##(1995-9#1)(1996-6#1)(1997-5#1)(2006-4#1)(2007-7#2)(2008-10#2)(2008-3#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-3#1)
of prevalence was##2##3##(2006-4#1)(2007-2#1)
of prevalence##22##2##(1995-10#1)(1995-9#1)(1996-6#1)(1997-2#1)(1997-5#1)(2006-4#2)(2006-8#1)(2007-2#1)(2007-7#2)(2008-10#3)(2008-3#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-2#1)(2012-3#1)
of prevalent##8##2##(1997-6#1)(2005-10#1)(2010-10#1)(2011-1#1)(2011-2#2)(2013-1#2)
of preventable##6##2##(1994-9#1)(2005-10#1)(2010-9#2)(2011-1#1)(2011-2#1)
of preventative##4##2##(2007-10#1)(2007-6#1)(2008-10#2)
of preventing infarction##2##3##(1997-1#1)(1997-6#1)
of preventing or correcting##2##4##(2006-10#1)(2008-10#1)
of preventing or##4##3##(2006-10#2)(2007-12#1)(2008-10#1)
of preventing the##4##3##(1992-2#1)(2005-3#1)(2007-11#1)(2012-3#1)
of preventing##38##2##(1992-2#1)(1992-3#1)(1992-8#1)(1993-2#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-6#1)(2005-12#1)(2005-3#2)(2005-9#1)(2006-10#2)(2006-3#1)(2006-4#1)(2007-11#4)(2007-12#2)(2007-8#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-4#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
of prevention against##2##3##(1993-6#1)(2013-1#1)
of prevention and control##2##4##(2004-10#1)(2011-2#1)
of prevention and quarantine##2##4##(2012-2#2)
of prevention and treatment of##2##5##(2007-11#1)(2008-1#1)
of prevention and treatment##3##4##(2007-11#1)(2008-1#1)(2013-8#1)
of prevention and##13##3##(2004-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-3#1)(2008-9#1)(2010-12#2)(2011-2#1)(2012-2#2)(2013-8#1)
of prevention in##2##3##(1994-9#1)(2010-4#1)
of prevention of##5##3##(2007-7#2)(2010-6#1)(2012-2#1)(2013-1#1)
of prevention programs##2##3##(1993-3#1)(1997-2#1)
of prevention strategies##3##3##(1991-6#1)(2005-7#1)(2007-2#1)
of prevention##50##2##(1991-6#1)(1992-12#1)(1992-5#1)(1993-1#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-9#1)(1995-5#1)(1995-9#1)(1996-1#1)(1997-2#1)(2004-10#1)(2005-7#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#2)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
of preventive activities##3##3##(1993-11#1)(1993-3#1)(1997-3#1)
of preventive and therapeutic##2##4##(2005-1#1)(2008-4#1)
of preventive and##4##3##(2005-1#1)(2007-12#1)(2008-4#1)(2012-12#1)
of preventive care and##2##4##(1994-2#1)(2006-2#1)
of preventive care in##3##4##(2006-2#2)(2007-2#1)
of preventive care##7##3##(1994-2#2)(2006-2#4)(2007-2#1)
of preventive health##2##3##(2010-8#1)(2011-1#1)
of preventive interventions##2##3##(2006-7#1)(2007-9#1)
of preventive measures##7##3##(1991-12#1)(1994-4#1)(2007-1#1)(2007-2#1)(2008-8#1)(2011-12#1)(2012-3#1)
of preventive services##6##3##(1994-2#3)(1995-12#1)(1995-2#1)(2005-10#1)
of preventive strategies##2##3##(2009-4#1)(2010-9#1)
of preventive##52##2##(1991-12#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-2#5)(1994-4#2)(1995-12#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-3#1)(2005-1#1)(2005-10#1)(2006-2#5)(2006-5#2)(2006-7#1)(2007-1#1)(2007-12#3)(2007-2#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-4#1)(2009-6#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
of previous blood transfusions##2##4##(1991-3#1)(2008-1#1)
of previous cases##3##3##(2011-2#2)(2012-2#1)
of previous exposure to##2##4##(2005-8#1)(2009-8#1)
of previous findings##3##3##(1990-6#1)(1993-9#1)(2010-12#1)
of previous methods##2##3##(2008-10#1)(2010-12#1)
of previous reports##6##3##(1991-9#1)(2006-10#1)(2006-9#1)(2008-1#1)(2010-3#1)(2013-7#1)
of previous research##5##3##(2008-1#1)(2008-2#1)(2008-9#1)(2012-2#2)
of previous studies of##3##4##(1996-4#1)(2006-10#1)(2008-9#1)
of previous studies##16##3##(1990-12#1)(1990-8#1)(1991-10#1)(1991-2#1)(1994-10#1)(1994-5#1)(1996-4#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-12#1)(2011-2#1)
of previous trials##3##3##(1996-6#1)(2011-1#1)(2013-8#1)
of previous work in##2##4##(2009-2#1)(2010-8#1)
of previous work##5##3##(1992-9#1)(2008-10#1)(2009-2#1)(2010-8#1)(2012-1#1)
of previous##146##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-2#2)(1993-9#1)(1994-10#3)(1994-2#1)(1994-5#1)(1995-8#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-8#2)(2006-1#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#3)(2006-9#1)(2007-11#3)(2007-12#7)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#2)(2008-1#6)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-12#4)(2010-3#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
of previously cloned##2##3##(1990-11#1)(1991-9#1)
of previously described##3##3##(1993-12#1)(2005-7#1)(2009-10#1)
of previously determined##2##3##(1996-10#1)(2008-3#1)
of previously identified##3##3##(1995-11#1)(1996-10#1)(2009-5#1)
of previously known##4##3##(1990-3#1)(2008-10#1)(2008-3#1)(2008-9#1)
of previously published##10##3##(1991-2#1)(1993-11#1)(2005-8#2)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
of previously reported cases##2##4##(1996-3#1)(2008-5#1)
of previously reported##7##3##(1990-11#1)(1992-4#1)(1996-3#1)(2007-11#1)(2008-5#2)(2010-12#1)
of previously unknown##2##3##(2008-10#1)(2008-7#1)
of previously unrecognised##4##3##(1994-3#1)(2008-8#3)
of previously unreported##2##3##(2010-4#1)(2013-8#1)
of previously##75##2##(1990-11#4)(1990-3#1)(1991-2#1)(1991-9#1)(1992-4#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-3#1)(1996-10#2)(1996-12#1)(1996-3#1)(1996-7#1)(1997-1#2)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-11#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-5#1)(2010-10#1)(2010-12#3)(2010-4#2)(2011-1#2)(2012-3#1)(2013-8#1)
of previtellogenesis##2##2##(2007-12#2)
of prey and predators##2##4##(2008-8#2)
of prey and##3##3##(2007-2#1)(2008-8#2)
of prey##28##2##(1995-11#1)(2007-2#2)(2007-3#3)(2008-5#8)(2008-8#6)(2008-9#1)(2009-4#3)(2010-8#4)
of preys##4##2##(2006-12#2)(2007-3#2)
of priapism##3##2##(2011-1#3)
of price##4##2##(1993-12#1)(1995-1#1)(2008-7#1)(2013-8#1)
of pricing##3##2##(1993-1#1)(1995-1#1)(2008-12#1)
of primarily##3##2##(1993-7#1)(2006-11#1)(2009-11#1)
of primary AVF failure##3##4##(2010-4#3)
of primary As species in##2##5##(2008-10#2)
of primary B lymphocytes##2##4##(1991-2#2)
of primary B##3##3##(1991-2#2)(2008-9#1)
of primary GN##2##3##(2007-7#1)(2008-1#1)
of primary IgA deficiency##2##4##(2006-10#2)
of primary OSCC##2##3##(2010-7#2)
of primary Sjögren's syndrome##3##4##(1990-2#2)(2006-10#1)
of primary T cell##2##4##(1997-4#1)(2008-4#1)
of primary adult##2##3##(1995-8#1)(2013-1#1)
of primary afferent fibers##3##4##(1990-7#1)(1994-8#1)(2008-4#1)
of primary afferent##6##3##(1990-5#1)(1990-7#1)(1994-8#1)(2006-10#1)(2008-4#1)(2008-7#1)
of primary afferents##4##3##(1990-7#1)(1992-6#1)(1995-7#1)(1997-3#1)
of primary alcohols##2##3##(2006-12#1)(2007-11#1)
of primary aliphatic short-chain monoamines##2##5##(2008-10#2)
of primary amino groups##2##4##(2008-10#1)(2008-5#1)
of primary and interfering##2##4##(2008-10#2)
of primary and middle school students in four cities of China]##4##11##(2013-7#4)
of primary and recurrent##6##4##(1991-10#1)(1991-6#2)(1996-2#1)(2007-11#1)(2008-6#1)
of primary and secondary infection##8##5##(2008-10#8)
of primary and secondary prevention##4##5##(1990-12#1)(1996-12#1)(2006-2#1)(2010-2#1)
of primary and secondary##35##4##(1990-12#1)(1990-4#1)(1991-7#1)(1992-10#1)(1993-8#1)(1994-5#2)(1995-2#3)(1996-12#1)(1996-7#1)(2006-12#2)(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-2#1)(2008-5#1)(2009-7#1)(2010-2#1)(2011-2#3)(2011-3#1)(2012-3#1)(2013-1#1)
of primary and##56##3##(1990-12#1)(1990-4#1)(1991-10#1)(1991-6#2)(1991-7#1)(1992-10#1)(1992-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-5#2)(1995-2#3)(1996-12#1)(1996-2#1)(1996-7#1)(1997-1#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#10)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-2#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#4)
of primary biliary cirrhosis and##3##5##(2004-11#1)(2006-10#1)(2012-2#1)
of primary biliary cirrhosis##16##4##(1996-11#1)(2004-11#9)(2006-10#4)(2007-11#1)(2012-2#1)
of primary biodiversity data##2##4##(2012-3#2)
of primary bone lymphoma##2##4##(2007-5#2)
of primary bone tumors##2##4##(2008-2#1)(2009-3#1)
of primary bone##5##3##(2007-5#2)(2008-2#1)(2008-6#1)(2009-3#1)
of primary brain tumors##2##4##(2005-10#1)(2008-8#1)
of primary brain##3##3##(2005-10#1)(2007-10#1)(2008-8#1)
of primary breast cancer##3##4##(1991-12#1)(1991-8#1)(1996-4#1)
of primary cancer##2##3##(2008-5#1)(2011-1#1)
of primary cardiac##4##3##(1994-6#1)(2005-1#1)(2005-9#1)(2010-9#1)
of primary cardiovascular##2##3##(2008-11#1)(2008-3#1)
of primary care and##2##4##(1997-3#1)(2012-1#1)
of primary care health##2##4##(1993-6#1)(1994-9#1)
of primary care in the Czech Republic##2##7##(2006-8#2)
of primary care in the##5##5##(1995-3#1)(1996-9#1)(2006-8#3)
of primary care in##6##4##(1995-3#1)(1996-9#1)(2006-10#1)(2006-8#3)
of primary care physicians##5##4##(1996-9#1)(2006-10#1)(2007-9#2)(2008-12#1)
of primary care providers##3##4##(2007-6#1)(2010-12#1)(2011-1#1)
of primary care services##2##4##(2007-1#1)(2010-8#1)
of primary care##43##3##(1991-9#1)(1993-1#1)(1993-10#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#3)(1996-12#1)(1996-9#2)(1997-3#3)(2006-10#2)(2006-5#1)(2006-8#3)(2007-1#1)(2007-5#2)(2007-6#1)(2007-9#2)(2008-12#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#2)
of primary care]##7##3##(1992-1#1)(1993-10#1)(1994-11#2)(1994-6#1)(1995-6#1)(1997-5#1)
of primary caregivers of##2##4##(2007-11#1)(2010-8#1)
of primary cell cultures##3##4##(1996-1#1)(2008-10#1)(2008-11#1)
of primary cell##4##3##(1996-1#1)(2008-10#1)(2008-11#1)(2010-3#1)
of primary cells##2##3##(2008-11#1)(2010-3#1)
of primary central nervous system##2##5##(1991-6#1)(2005-9#1)
of primary chemotherapy on##2##4##(1996-4#1)(2008-9#1)
of primary cultured##3##3##(1993-6#1)(1994-5#1)(1996-2#1)
of primary cultures of##7##4##(1994-11#1)(1994-3#1)(1994-5#1)(1995-11#1)(2008-4#1)(2010-11#2)
of primary cultures##8##3##(1992-11#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-11#1)(2008-4#1)(2010-11#2)
of primary cutaneous##8##3##(1991-6#1)(1992-4#1)(2007-7#3)(2010-8#2)(2011-1#1)
of primary electron##3##3##(1991-7#1)(2007-5#1)(2008-8#1)
of primary endometrial##2##3##(1994-9#2)
of primary gallbladder carcinoma and##2##5##(2011-1#2)
of primary gastric##2##3##(1992-8#1)(2008-9#1)
of primary glomerulonephritis##2##3##(2007-7#1)(2008-1#1)
of primary health care (PHC)##2##5##(2006-2#1)(2007-2#1)
of primary health care##14##4##(1990-9#1)(1992-11#2)(1994-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-9#1)(2006-2#1)(2007-10#1)(2007-2#1)(2007-3#1)(2008-1#1)
of primary health care]##2##4##(1991-9#1)(1995-2#1)
of primary health##18##3##(1990-9#1)(1991-9#1)(1992-11#2)(1994-3#1)(1994-4#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-9#1)(2006-2#1)(2007-10#1)(2007-2#1)(2007-3#1)(2008-1#1)(2013-1#1)
of primary healthcare##2##3##(2010-11#2)
of primary human cells##2##4##(2008-11#2)
of primary human##6##3##(1997-4#1)(2008-1#1)(2008-11#3)(2013-1#1)
of primary hyperoxaluria type 1##2##5##(2007-12#1)(2009-3#1)
of primary hyperoxaluria type##4##4##(1995-12#2)(2007-12#1)(2009-3#1)
of primary hyperparathyroidism in##2##4##(2007-2#1)(2007-3#1)
of primary hyperparathyroidism##11##3##(1990-2#1)(1994-7#1)(1995-11#1)(2007-2#1)(2007-3#2)(2008-12#2)(2010-2#1)(2011-1#1)(2012-12#1)
of primary hyperparathyroidism]##2##3##(1990-9#1)(1995-11#1)
of primary hypothyroidism##2##3##(2010-10#1)(2012-2#1)
of primary immune responses##4##4##(2007-2#1)(2008-10#1)(2008-4#1)(2010-2#1)
of primary immune##5##3##(2007-11#1)(2007-2#1)(2008-10#1)(2008-4#1)(2010-2#1)
of primary immunodeficiencies##2##3##(2006-10#1)(2007-2#1)
of primary importance for##2##4##(2008-2#1)(2012-3#1)
of primary importance in##3##4##(1990-5#1)(1991-2#1)(1994-11#1)
of primary importance##8##3##(1990-5#1)(1991-2#1)(1992-3#1)(1994-11#1)(2006-5#1)(2008-2#1)(2009-5#1)(2012-3#1)
of primary infection by##2##4##(2008-10#2)
of primary infection##5##3##(1997-5#1)(2008-10#3)(2008-8#1)
of primary infections##2##3##(2007-2#1)(2008-10#1)
of primary inoculum##14##3##(2008-10#13)(2008-12#1)
of primary interest##2##3##(2005-6#1)(2010-2#1)
of primary intracerebral hemorrhage##3##4##(2007-10#3)
of primary intracranial##2##3##(2007-12#1)(2010-2#1)
of primary liver cancer##3##4##(1991-11#1)(1992-9#1)(2013-1#1)
of primary localised cutaneous amyloidosis##2##5##(2007-7#2)
of primary lung cancer##3##4##(1991-9#1)(1996-12#2)
of primary lung##4##3##(1991-9#1)(1992-3#1)(1996-12#2)
of primary malignant bone##2##4##(1993-10#1)(2011-2#1)
of primary malignant##4##3##(1993-10#1)(2007-7#1)(2008-6#1)(2011-2#1)
of primary melanoma##3##3##(1996-2#2)(2013-8#1)
of primary molars##2##3##(2008-12#1)(2012-2#1)
of primary mouse##3##3##(1990-7#1)(1991-2#1)(2009-10#1)
of primary nephrotic syndrome##2##4##(2007-11#2)
of primary non-Hodgkin's lymphoma of the##2##6##(2006-4#1)(2007-10#1)
of primary open angle glaucoma##2##5##(2010-3#1)(2012-2#1)
of primary open angle##3##4##(2010-3#1)(2011-2#1)(2012-2#1)
of primary or secondary##2##4##(2005-9#1)(2007-7#1)
of primary or##3##3##(1993-8#1)(2005-9#1)(2007-7#1)
of primary outcome##2##3##(1991-11#1)(2007-9#1)
of primary particles##7##3##(2005-11#2)(2008-10#1)(2008-3#3)(2010-4#1)
of primary percutaneous coronary intervention##3##5##(2008-3#2)(2013-1#1)
of primary percutaneous coronary##4##4##(2008-3#2)(2008-6#1)(2013-1#1)
of primary percutaneous##5##3##(2008-3#2)(2008-6#2)(2013-1#1)
of primary porcine hepatocytes##3##4##(2008-11#3)
of primary prevention are##2##4##(1996-12#1)(2007-11#1)
of primary prevention of cardiovascular disease##2##6##(2006-5#1)(2013-1#1)
of primary prevention of##3##4##(2006-5#1)(2010-4#1)(2013-1#1)
of primary prevention##15##3##(1992-12#1)(1994-6#1)(1995-3#1)(1996-12#1)(1996-3#1)(2005-10#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-8#1)(2010-4#3)(2011-2#1)(2013-1#1)
of primary producers##2##3##(2008-8#1)(2011-12#1)
of primary production##2##3##(1991-11#1)(2008-8#1)
of primary prophylaxis##2##3##(2005-10#1)(2009-8#1)
of primary prostate##2##3##(1992-8#1)(2008-4#1)
of primary psychopathy##3##3##(2009-9#3)
of primary radiocephalic##3##3##(2007-7#3)
of primary radiotherapy##3##3##(1990-10#1)(1992-3#1)(2005-5#1)
of primary rat hepatocytes##2##4##(2008-11#2)
of primary rat##3##3##(1993-3#1)(2008-11#2)
of primary resistance##3##3##(2008-5#1)(2010-5#1)(2013-1#1)
of primary retroperitoneal##4##3##(2008-6#1)(2009-5#3)
of primary school##6##3##(1991-10#1)(1993-6#1)(2006-8#2)(2007-2#1)(2009-12#1)
of primary schooling##2##3##(2008-4#1)(2009-9#1)
of primary schools##2##3##(2006-8#1)(2008-7#1)
of primary sclerosing cholangitis in##2##5##(2009-8#1)(2012-2#1)
of primary sclerosing cholangitis remains##2##5##(2004-11#1)(2006-10#1)
of primary sclerosing cholangitis##8##4##(2004-11#3)(2006-10#1)(2009-8#1)(2012-11#1)(2012-2#2)
of primary sensory neurons##3##4##(1991-10#1)(1996-3#1)(2008-6#1)
of primary sensory##5##3##(1991-10#1)(1994-2#1)(1996-3#1)(1997-8#1)(2008-6#1)
of primary spermatocytes##2##3##(2008-3#1)(2012-12#1)
of primary teeth##3##3##(2008-5#1)(2011-2#1)(2012-2#1)
of primary total hip replacement##2##5##(1996-11#1)(2013-1#1)
of primary total hip##3##4##(1996-11#1)(2011-2#1)(2013-1#1)
of primary total##4##3##(1996-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
of primary transnasal surgery##2##4##(2007-1#2)
of primary treatment##3##3##(1991-9#1)(2007-12#1)(2008-9#1)
of primary trisomics##3##3##(2009-12#3)
of primary tuberculosis##2##3##(2008-1#1)(2008-10#1)
of primary tumor##6##3##(2007-11#1)(2008-10#1)(2009-6#1)(2010-12#1)(2013-8#2)
of primary tumors##4##3##(1993-8#1)(2007-11#1)(2010-3#2)
of primary tumour##2##3##(2007-11#1)(2012-2#1)
of primary tumours##4##3##(1990-9#1)(2007-8#1)(2008-4#1)(2008-6#1)
of primary varicella##2##3##(2008-5#1)(2010-8#1)
of primary##647##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#6)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#3)(1990-9#4)(1991-10#3)(1991-11#4)(1991-12#2)(1991-2#6)(1991-5#1)(1991-6#6)(1991-7#3)(1991-8#1)(1991-9#4)(1992-1#1)(1992-10#2)(1992-11#4)(1992-12#2)(1992-2#2)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-10#3)(1993-2#1)(1993-3#4)(1993-6#5)(1993-8#3)(1994-11#4)(1994-2#1)(1994-3#4)(1994-4#1)(1994-5#5)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#3)(1995-11#4)(1995-12#3)(1995-2#5)(1995-3#2)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#5)(1996-10#1)(1996-11#2)(1996-12#6)(1996-2#6)(1996-3#2)(1996-4#2)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#3)(1997-1#1)(1997-3#4)(1997-4#4)(1997-5#2)(1997-7#2)(1997-8#2)(2004-10#1)(2004-11#12)(2005-1#2)(2005-10#5)(2005-11#3)(2005-12#1)(2005-5#1)(2005-6#1)(2005-8#1)(2005-9#3)(2006-10#15)(2006-12#3)(2006-2#2)(2006-4#1)(2006-5#5)(2006-6#3)(2006-7#2)(2006-8#7)(2007-1#3)(2007-10#6)(2007-11#13)(2007-12#6)(2007-2#9)(2007-3#4)(2007-4#1)(2007-5#7)(2007-6#1)(2007-7#17)(2007-8#6)(2007-9#4)(2008-1#6)(2008-10#49)(2008-11#20)(2008-12#5)(2008-2#5)(2008-3#10)(2008-4#10)(2008-5#9)(2008-6#12)(2008-7#7)(2008-8#10)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#4)(2009-4#1)(2009-5#5)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#5)(2010-10#1)(2010-11#6)(2010-12#6)(2010-2#6)(2010-3#7)(2010-4#8)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#6)(2010-9#1)(2011-1#10)(2011-12#1)(2011-2#14)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#7)(2012-2#16)(2012-3#8)(2013-1#21)(2013-7#6)(2013-8#7)
of primase##3##2##(1993-3#2)(1995-6#1)
of primate##12##2##(1990-12#2)(1990-3#1)(1990-8#1)(1992-2#1)(1995-11#1)(2006-1#1)(2008-1#2)(2008-11#1)(2008-9#2)
of primates##10##2##(1990-11#1)(1991-11#3)(1991-8#1)(1992-11#1)(1993-12#1)(1996-1#1)(2008-9#1)(2009-8#1)
of prime importance##6##3##(1992-12#1)(1993-10#1)(2006-12#1)(2008-10#1)(2008-9#2)
of prime##8##2##(1992-12#1)(1993-10#1)(1996-2#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-9#2)
of primed##2##2##(1996-2#1)(2013-1#1)
of primer##8##2##(1990-2#1)(1990-9#1)(1992-4#1)(1994-12#1)(2006-5#2)(2008-10#1)(2008-8#1)
of primers and probe##2##4##(2008-10#2)
of primers designed##3##3##(1994-5#1)(2005-11#1)(2013-8#1)
of primers specific for##2##4##(2007-12#1)(2008-5#1)
of primers that##4##3##(1993-12#1)(1993-6#1)(2008-10#1)(2008-5#1)
of primers were##2##3##(2008-10#1)(2011-2#1)
of primers##31##2##(1990-2#1)(1990-7#1)(1993-12#1)(1993-6#1)(1994-5#1)(1994-9#2)(1995-8#1)(1997-6#1)(2005-11#2)(2006-10#1)(2006-12#2)(2006-6#1)(2007-12#1)(2008-10#10)(2008-5#2)(2008-8#1)(2011-2#1)(2013-8#1)
of priming##2##2##(1992-7#1)(2008-10#1)
of primiparas##2##2##(1996-12#1)(2011-2#1)
of primitive##9##2##(1990-10#1)(1990-5#1)(1996-6#1)(1997-4#1)(2005-11#1)(2006-2#2)(2008-5#1)(2008-6#1)
of primordia##2##2##(2007-12#1)(2009-8#1)
of primordial germ cells##2##4##(2008-11#1)(2010-5#1)
of primordial##7##2##(1994-6#1)(1996-2#1)(2007-12#2)(2008-11#1)(2008-9#1)(2010-5#1)
of principal component analysis (PCA)##2##5##(2008-10#1)(2011-1#1)
of principal component analysis and##2##5##(2008-10#1)(2013-8#1)
of principal component analysis##7##4##(2007-8#1)(2008-10#2)(2010-5#1)(2011-1#1)(2013-8#2)
of principal component##9##3##(2007-8#1)(2008-10#3)(2008-11#1)(2010-5#1)(2011-1#1)(2013-8#2)
of principal components##4##3##(2007-8#1)(2008-10#1)(2010-7#1)(2012-3#1)
of principal sections##2##3##(2008-3#2)
of principal stratification to##2##4##(2009-9#2)
of principal sulcus and##2##4##(1993-2#2)
of principal##23##2##(1991-4#1)(1993-2#2)(2007-8#2)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#2)(2009-9#2)(2010-5#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-8#2)
of principle for##2##3##(2008-8#1)(2010-4#1)
of principle##10##2##(1997-5#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-8#2)(2009-4#1)(2010-4#1)(2012-1#1)
of principles of##6##3##(1993-12#1)(1997-7#1)(2004-10#1)(2007-7#1)(2008-4#1)(2009-2#1)
of principles##10##2##(1993-12#1)(1994-3#1)(1997-7#1)(2004-10#1)(2007-7#1)(2008-4#1)(2008-9#2)(2009-2#1)(2009-4#1)
of print development##2##3##(2010-8#2)
of print##5##2##(2009-10#1)(2009-9#1)(2010-8#2)(2013-1#1)
of printed paper surfaces##2##4##(2008-3#2)
of printed##4##2##(1996-1#1)(2006-12#1)(2008-3#2)
of printing##3##2##(2008-1#1)(2008-2#1)(2010-9#1)
of prion diseases##4##3##(1993-2#2)(1997-3#1)(2006-10#1)
of prion protein##3##3##(1997-5#1)(2008-11#1)(2008-5#1)
of prion##10##2##(1993-2#2)(1997-3#1)(1997-5#1)(2006-10#2)(2008-11#3)(2008-5#1)
of prior distributions##2##3##(1995-6#1)(2009-10#1)
of prior experience##2##3##(1992-12#1)(2013-1#1)
of prior information about the location and scale parameters##2##9##(1995-4#2)
of prior information##3##3##(1995-4#3)
of prior knowledge about##2##4##(1997-8#2)
of prior knowledge##5##3##(1997-8#4)(2010-6#1)
of prior studies##4##3##(1993-1#1)(2006-2#2)(2007-10#1)
of prior surgery##3##3##(2008-5#2)(2009-3#1)
of prior##58##2##(1990-11#1)(1990-7#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-9#3)(1994-1#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-4#3)(1995-6#1)(1995-8#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-8#6)(2005-7#1)(2006-2#2)(2007-10#1)(2007-8#1)(2007-9#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-10#2)(2009-3#1)(2010-12#1)(2010-3#1)(2010-6#1)(2012-12#2)(2013-1#4)
of priorities##3##2##(1991-2#1)(1996-8#1)(2006-9#1)
of priority##8##2##(1996-2#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-2#1)(2013-1#1)(2013-7#1)
of prisms##2##2##(2007-11#1)(2007-12#1)
of prison##3##2##(2012-1#2)(2012-11#1)
of pristinamycin##2##2##(2010-2#2)
of pristine##3##2##(2005-11#1)(2007-12#1)(2010-10#1)
of privacy in##2##3##(1997-5#1)(2007-2#1)
of privacy##6##2##(1995-12#1)(1996-5#1)(1997-5#1)(2007-2#1)(2008-10#1)(2012-12#1)
of private and public##2##4##(1996-1#1)(1997-3#1)
of private and##3##3##(1996-1#1)(1997-3#1)(2007-8#1)
of private health insurance##3##4##(1993-3#1)(1994-3#1)(2008-7#1)
of private health##4##3##(1993-3#1)(1994-3#1)(2008-7#1)(2012-1#1)
of private insurance##3##3##(1992-2#1)(1994-1#1)(2012-2#1)
of private medical##2##3##(2005-9#1)(2010-4#1)
of private sector##3##3##(1994-2#1)(1995-1#1)(1996-12#1)
of private##29##2##(1990-5#1)(1992-2#1)(1993-3#1)(1994-1#2)(1994-2#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-3#1)(1997-8#1)(2005-9#1)(2007-8#1)(2008-6#1)(2008-7#4)(2009-7#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-7#1)
of private-sector##3##2##(2005-5#1)(2006-10#1)(2007-4#1)
of prmt5 in##2##3##(2009-7#2)
of prmt5##3##2##(2009-7#3)
of pro##4##2##(1991-8#1)(2006-9#2)(2007-4#1)
of pro- and anti-inflammatory cytokines##6##5##(2006-10#3)(2011-1#1)(2012-1#1)(2013-7#1)
of pro- and anti-inflammatory##7##4##(2006-10#3)(2008-10#1)(2011-1#1)(2012-1#1)(2013-7#1)
of pro- and##11##3##(1992-1#1)(2006-10#4)(2008-10#1)(2009-12#2)(2011-1#1)(2012-1#1)(2013-7#1)
of pro-##12##2##(1992-1#1)(2006-10#4)(2008-10#1)(2009-12#2)(2010-9#1)(2011-1#1)(2012-1#1)(2013-7#1)
of pro-LPH##3##2##(1992-11#3)
of pro-UK in##2##3##(1990-12#2)
of pro-UK##7##2##(1990-12#7)
of pro-angiogenic##3##2##(2010-12#1)(2010-9#1)(2013-1#1)
of pro-apoptotic protein Bax##2##4##(2010-6#1)(2013-1#1)
of pro-apoptotic##3##2##(2008-10#1)(2010-6#1)(2013-1#1)
of pro-cathepsin D##2##3##(1990-9#2)
of pro-cathepsin##4##2##(1990-9#3)(1992-12#1)
of pro-inflammatory cytokines in##3##4##(2006-10#1)(2010-12#1)(2011-1#1)
of pro-inflammatory cytokines##14##3##(2005-10#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#2)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#2)(2012-2#1)
of pro-inflammatory mediators##7##3##(2006-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-12#1)
of pro-inflammatory##30##2##(1994-12#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-5#4)(2008-7#1)(2009-12#1)(2010-12#3)(2010-4#1)(2010-7#1)(2011-1#2)(2012-2#3)
of pro-opiomelanocortin mRNA##2##3##(2012-1#2)
of pro-opiomelanocortin##3##2##(1991-9#1)(2012-1#2)
of pro-oxidants##2##2##(1991-9#2)
of pro-urokinase##3##2##(1990-12#2)(1990-8#1)
of proCCK and its products##2##5##(1995-6#2)
of proMMP-1##3##2##(1990-12#1)(1997-2#2)
of proMMP-2 is##2##3##(1990-12#2)
of proMMP-2##5##2##(1990-12#2)(1993-11#3)
of proU##2##2##(1994-12#2)
of proactive coping in##2##4##(2010-3#2)
of proactive##3##2##(2008-8#1)(2010-3#2)
of proalbumin##4##2##(1990-8#1)(1991-3#1)(1992-12#1)(1993-2#1)
of proanthocyanidin##3##2##(2006-12#3)
of proapoptotic protein P53 and proliferation protein Ki-67##2##8##(2012-1#2)
of proapoptotic##4##2##(2008-11#1)(2012-1#2)(2012-12#1)
of probabilistic##4##2##(1991-6#1)(2005-10#1)(2010-8#1)(2012-1#1)
of probability of##3##3##(1996-6#2)(2012-3#1)
of probability##10##2##(1993-9#1)(1996-4#1)(1996-6#2)(1997-3#1)(2008-10#2)(2008-2#1)(2008-8#1)(2012-3#1)
of probable effects of##2##4##(2008-12#1)(2013-1#1)
of probable##11##2##(1991-4#1)(1992-11#1)(1993-12#2)(1994-5#1)(2008-12#1)(2008-2#1)(2008-3#1)(2012-1#2)(2013-1#1)
of probands##4##2##(2009-4#2)(2011-2#2)
of probe drugs##2##3##(2005-8#1)(2010-2#1)
of probe##20##2##(1991-7#1)(1992-1#1)(1996-7#1)(2005-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#2)(2008-4#3)(2008-9#1)(2009-4#1)(2010-2#1)(2012-2#2)
of probes and##3##3##(1993-11#1)(2008-10#1)(2012-3#1)
of probes in##2##3##(2007-8#1)(2008-9#1)
of probes##11##2##(1990-8#1)(1993-11#1)(1994-6#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-9#2)(2012-3#1)
of probing the##3##3##(1994-5#1)(1997-4#1)(2007-12#1)
of probing##6##2##(1994-5#1)(1997-4#1)(2007-12#2)(2008-10#1)(2010-7#1)
of probiotic##17##2##(2006-5#1)(2008-5#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2010-10#1)(2010-9#1)(2011-2#4)(2012-1#1)(2013-1#3)(2013-8#1)
of probiotics in health and disease##3##6##(2013-7#3)
of probiotics in inflammatory bowel##2##5##(2006-10#1)(2012-11#1)
of probiotics in##11##3##(2006-10#1)(2008-10#1)(2009-11#1)(2009-12#1)(2012-1#2)(2012-11#1)(2012-2#1)(2013-7#3)
of probiotics is##2##3##(2011-2#1)(2013-7#1)
of probiotics on##2##3##(2007-3#1)(2010-5#1)
of probiotics##29##2##(2006-10#2)(2006-12#2)(2007-3#1)(2008-10#2)(2008-4#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-5#1)(2011-2#3)(2012-1#6)(2012-11#1)(2012-2#2)(2013-7#5)
of problem behavior##4##3##(2006-3#1)(2008-12#1)(2009-9#2)
of problem behaviors were##2##4##(2008-12#2)
of problem behaviors##5##3##(1994-2#1)(1997-1#1)(2008-12#3)
of problem drinkers##2##3##(1994-2#1)(1995-5#1)
of problem drinking in##2##4##(1990-5#1)(1994-2#1)
of problem drinking##4##3##(1990-5#1)(1994-2#2)(2010-2#1)
of problem gambling##2##3##(2008-11#1)(2013-1#1)
of problem resolution##2##3##(1995-12#1)(1997-5#1)
of problem##29##2##(1990-5#1)(1994-2#4)(1995-12#1)(1995-5#1)(1996-1#1)(1997-1#1)(1997-5#1)(2006-3#3)(2006-5#1)(2008-11#1)(2008-12#6)(2008-2#1)(2008-7#2)(2009-9#2)(2010-2#1)(2012-12#1)(2013-1#1)
of problem-based learning##4##3##(1995-2#1)(2008-11#1)(2008-12#1)(2012-3#1)
of problematic##5##2##(2006-3#1)(2007-1#1)(2008-11#1)(2008-2#1)(2009-12#1)
of problems and##3##3##(2008-2#1)(2008-7#1)(2008-9#1)
of problems encountered##5##3##(1993-12#1)(2004-9#1)(2008-7#1)(2012-1#1)(2012-12#1)
of problems experienced##2##3##(2007-11#1)(2010-10#1)
of problems of##2##3##(1992-1#1)(2007-7#1)
of problems related to##4##4##(1994-10#1)(2008-10#1)(2008-2#1)(2010-11#1)
of problems with##2##3##(2004-9#1)(2012-2#1)
of problems##54##2##(1990-11#1)(1991-1#2)(1992-1#1)(1992-2#1)(1992-4#1)(1992-5#2)(1993-12#1)(1994-10#1)(1994-6#1)(1995-12#2)(1996-9#1)(2004-9#2)(2005-10#1)(2006-10#1)(2006-2#2)(2006-3#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-2#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
of procaine hydrochloride##8##3##(1992-5#1)(2008-10#7)
of procaine##13##2##(1992-5#1)(1993-9#2)(2005-4#2)(2006-7#1)(2008-10#7)
of procalcitonin in patients with##2##5##(1993-2#1)(2008-5#1)
of procalcitonin in the##3##4##(2008-5#1)(2013-1#2)
of procalcitonin in##6##3##(1993-2#1)(2008-5#2)(2013-1#3)
of procalcitonin##14##2##(1991-2#2)(1993-2#3)(2008-5#3)(2010-12#1)(2013-1#5)
of procathepsin E to cathepsin E##2##6##(1991-2#2)
of procathepsin E##3##3##(1991-2#3)
of procathepsin L##4##3##(1995-6#4)
of procathepsin##7##2##(1991-2#3)(1995-6#4)
of procedural complications##2##3##(2006-6#1)(2007-8#1)
of procedural pain##2##3##(1993-2#1)(2008-10#1)
of procedural##12##2##(1993-2#1)(1996-2#1)(2006-10#2)(2006-5#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-12#1)(2009-10#1)(2013-1#2)
of procedure##15##2##(1996-3#1)(1996-5#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-7#1)(2013-1#1)
of procedure-related##3##2##(1996-2#1)(2006-10#1)(2008-11#1)
of procedures and##4##3##(1994-3#1)(1995-12#1)(2009-8#1)(2011-2#1)
of procedures for##5##3##(1995-2#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-3#1)
of procedures have been##2##4##(2006-10#1)(2008-4#1)
of procedures in##2##3##(2008-3#1)(2010-12#1)
of procedures performed##5##3##(1995-2#1)(1995-3#1)(2004-2#1)(2011-2#1)(2013-1#1)
of procedures that are##2##4##(2006-10#1)(2008-4#1)
of procedures that##5##3##(2006-10#1)(2008-10#1)(2008-4#2)(2010-6#1)
of procedures to##7##3##(1992-7#1)(2006-10#1)(2006-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-2#1)
of procedures##51##2##(1992-7#1)(1993-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#2)(1995-3#1)(2004-2#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-12#1)(2008-3#2)(2008-4#5)(2008-8#1)(2008-9#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
of proceeding##3##2##(1995-2#1)(2008-10#2)
of proceedings##2##2##(1990-5#1)(2007-11#1)
of process or##2##3##(1995-12#1)(2013-1#1)
of process parameters##2##3##(2008-5#1)(2008-7#1)
of process streams##2##3##(2008-6#2)
of process##26##2##(1992-12#1)(1993-12#1)(1995-11#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-11#2)(2008-12#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2009-7#1)(2010-10#1)(2011-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
of processed##4##2##(1995-2#1)(2013-1#3)
of processes in##4##3##(1991-8#1)(2006-5#1)(2007-8#1)(2010-6#1)
of processes involved in##2##4##(1996-3#1)(2008-4#1)
of processes of##4##3##(1996-1#1)(1996-9#1)(2006-6#1)(2008-3#1)
of processes related to##2##4##(2009-5#1)(2013-8#1)
of processes that##3##3##(1991-3#1)(1997-5#1)(2010-7#1)
of processes underlying##2##3##(2006-10#1)(2007-8#1)
of processes##34##2##(1991-3#1)(1991-8#1)(1992-12#1)(1993-12#1)(1994-3#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-5#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-8#2)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-5#1)(2010-10#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#1)(2013-8#1)
of processing and##2##3##(2008-11#1)(2008-2#1)
of processing intermediates##2##3##(1994-11#1)(1996-4#1)
of processing is##3##3##(1997-4#1)(2007-12#1)(2008-10#1)
of processing of the##2##4##(1990-11#1)(2008-5#1)
of processing of##8##3##(1990-11#1)(1993-2#2)(1994-11#1)(1994-2#1)(1994-6#1)(2008-5#1)(2009-12#1)
of processing##60##2##(1990-11#1)(1991-2#1)(1991-3#1)(1993-12#1)(1993-2#2)(1994-11#4)(1994-2#1)(1994-6#2)(1995-2#1)(1995-8#1)(1996-4#1)(1997-4#2)(1997-7#1)(1997-8#1)(2004-9#2)(2005-5#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-4#1)(2011-12#1)(2012-1#2)(2012-12#3)(2012-2#2)(2013-1#2)(2013-7#1)
of processors##10##2##(2008-2#7)(2008-3#2)(2010-8#1)
of prochiral ketones##2##3##(2007-11#1)(2010-2#1)
of procholecystokinin##2##2##(1995-6#2)
of procoagulant##3##2##(1990-11#1)(1991-7#1)(2009-3#1)
of procolipase##4##2##(1991-8#1)(1995-5#3)
of procollagen III##2##3##(1991-2#2)
of procollagen##10##2##(1991-1#6)(1991-2#2)(1994-9#1)(1996-8#1)
of procurement##2##2##(1995-2#2)
of procuring##2##2##(1992-12#2)
of procyanidins##3##2##(2008-10#1)(2008-5#2)
of prodrug##2##2##(1994-11#1)(2009-3#1)
of prodrugs##2##2##(2008-5#2)
of produced water##4##3##(2013-1#4)
of produced##11##2##(2008-10#3)(2008-11#2)(2008-5#1)(2012-2#1)(2013-1#4)
of producing a##11##3##(1991-6#1)(1994-5#1)(1994-9#1)(2006-10#1)(2007-12#2)(2008-11#1)(2008-12#1)(2009-5#1)(2011-1#1)(2012-11#1)
of producing highly##2##3##(2008-4#1)(2012-2#1)
of producing smaller##2##3##(2008-1#1)(2008-8#1)
of producing systems##2##3##(1994-11#1)(2008-10#1)
of producing##73##2##(1990-11#2)(1990-5#1)(1991-3#1)(1991-6#1)(1991-9#2)(1992-3#1)(1992-5#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-5#2)(1994-9#1)(1996-5#1)(1997-4#1)(2005-12#1)(2005-6#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#8)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-1#1)
of product and##2##3##(1991-12#1)(1993-6#1)
of product application##2##3##(2008-5#2)
of product characteristics##2##3##(2008-5#1)(2012-3#1)
of product formation##5##3##(1991-5#2)(1992-11#2)(2008-10#1)
of product inhibition##2##3##(1994-8#1)(2008-7#1)
of product quality##2##3##(2008-10#1)(2012-2#1)
of product##47##2##(1991-12#1)(1991-5#2)(1991-9#1)(1992-11#2)(1992-3#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-8#1)(1997-8#1)(2006-10#2)(2007-11#2)(2008-10#6)(2008-11#3)(2008-4#1)(2008-5#7)(2008-7#3)(2008-8#1)(2009-11#1)(2009-2#1)(2010-9#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
of production and##7##3##(1994-6#1)(2005-7#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
of production medium##3##3##(2006-9#1)(2012-2#2)
of production of the##4##4##(1990-11#1)(1993-3#1)(2008-10#1)(2008-7#1)
of production of##19##3##(1990-11#1)(1990-12#1)(1992-5#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1995-3#1)(1996-5#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-7#1)(2009-9#1)(2012-2#1)
of production processes##2##3##(2005-5#1)(2013-8#1)
of production situations##2##3##(2008-10#2)
of production systems##3##3##(1997-4#1)(2010-4#1)(2013-8#1)
of production##61##2##(1990-11#1)(1990-12#1)(1992-5#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-3#1)(1996-5#2)(1997-4#2)(2005-11#1)(2005-3#1)(2005-4#1)(2005-5#1)(2005-7#1)(2006-10#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#3)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#2)(2013-8#3)
of productive##5##2##(1990-11#1)(1992-9#1)(2006-10#1)(2012-2#1)(2013-1#1)
of productivity in##3##3##(2007-11#1)(2008-9#1)(2010-5#1)
of productivity of##2##3##(2006-9#1)(2008-11#1)
of productivity##15##2##(2005-7#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-11#4)(2008-5#1)(2008-8#2)(2008-9#3)(2010-5#1)
of products and##5##3##(1991-12#1)(1992-2#1)(1996-12#1)(2008-9#1)(2012-2#1)
of products at##2##3##(1996-12#1)(2008-5#1)
of products containing##3##3##(2008-3#1)(2008-5#1)(2013-7#1)
of products formed##3##3##(1990-8#2)(1991-8#1)
of products from##2##3##(1991-11#1)(1997-8#1)
of products of##6##3##(1990-4#1)(1993-11#1)(2007-12#1)(2008-4#1)(2010-7#1)(2012-1#1)
of products that##2##3##(2008-10#1)(2008-5#1)
of products which##2##3##(1991-2#1)(2008-5#1)
of products with##2##3##(1995-11#1)(2007-6#1)
of products##60##2##(1990-4#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-7#1)(1997-8#1)(2005-8#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#8)(2008-6#3)(2008-9#1)(2009-5#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#2)(2013-7#1)
of professional boundaries and##2##4##(2008-12#1)(2009-9#1)
of professional confidence##4##3##(2008-11#2)(2008-12#2)
of professional development##2##3##(2007-4#1)(2013-8#1)
of professional knowledge##2##3##(2007-10#1)(2008-11#1)
of professional liability##3##3##(1991-5#1)(1992-2#1)(1993-3#1)
of professional practice##3##3##(2008-11#2)(2008-12#1)
of professional relationships##2##3##(2008-7#2)
of professional training##2##3##(2005-8#2)
of professional##58##2##(1990-5#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-2#1)(1993-2#1)(1993-3#1)(1993-6#1)(1995-1#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-3#3)(2004-11#1)(2005-8#2)(2006-10#1)(2007-10#1)(2007-11#1)(2007-4#4)(2007-9#1)(2008-10#1)(2008-11#9)(2008-12#5)(2008-3#1)(2008-7#3)(2008-9#2)(2009-3#1)(2009-9#1)(2011-2#1)(2012-6#1)(2013-1#2)(2013-7#2)(2013-8#2)
of professionalisation##2##2##(2007-11#1)(2008-7#1)
of professionalism##8##2##(1993-3#1)(2006-2#1)(2008-12#1)(2008-4#1)(2012-1#2)(2013-1#2)
of professionals##15##2##(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#1)(1997-8#1)(2004-11#1)(2006-5#1)(2008-10#2)(2008-12#1)(2008-2#3)(2012-2#1)(2013-1#1)
of professor##2##2##(2011-2#1)(2013-8#1)
of profile##2##2##(2008-5#1)(2011-2#1)
of profiles##3##2##(2007-6#1)(2008-2#1)(2008-3#1)
of profilin##3##2##(1990-3#2)(1994-8#1)
of profit##2##2##(2011-2#2)
of profound deafness##2##3##(2008-9#2)
of profound hearing loss##2##4##(2008-9#2)
of profound##10##2##(1995-7#1)(2006-12#1)(2008-9#7)(2013-1#1)
of profoundly hearing-impaired children##2##4##(2008-9#2)
of profoundly##4##2##(1990-8#1)(2008-9#3)
of progenitor cells and##2##4##(2007-3#1)(2008-11#1)
of progenitor cells from##3##4##(1991-10#1)(2008-11#2)
of progenitor cells##12##3##(1991-10#1)(1991-5#1)(2007-3#1)(2008-1#1)(2008-11#5)(2008-9#2)(2010-11#1)
of progenitor##14##2##(1991-10#1)(1991-5#1)(2007-3#1)(2008-1#1)(2008-11#6)(2008-5#1)(2008-9#2)(2010-11#1)
of progenitors in##2##3##(1991-10#1)(2008-4#1)
of progenitors##4##2##(1991-10#1)(1995-12#1)(2008-4#1)(2012-12#1)
of progeny budded virus##2##4##(1997-3#2)
of progeny from##4##3##(2008-10#1)(2008-7#1)(2012-1#1)(2013-8#1)
of progeny of##3##3##(2008-10#2)(2009-3#1)
of progeny##20##2##(1994-11#1)(1997-3#2)(2008-10#5)(2008-7#1)(2008-8#2)(2009-2#1)(2009-3#1)(2009-9#1)(2012-1#1)(2013-8#5)
of progeria##2##2##(2007-8#2)
of progesterone and##7##3##(1991-11#1)(1994-12#1)(1997-8#2)(2005-7#1)(2007-12#1)(2007-2#1)
of progesterone on the##2##4##(1997-8#1)(2008-8#1)
of progesterone particles dispersed in##2##5##(2005-11#2)
of progesterone receptor##5##3##(1993-11#1)(1995-3#1)(2007-10#1)(2008-11#2)
of progesterone receptors##3##3##(1993-2#1)(2007-10#1)(2013-8#1)
of progesterone to##4##3##(1990-11#1)(1994-9#1)(1997-8#2)
of progesterone##50##2##(1990-11#1)(1991-11#1)(1991-7#4)(1992-1#1)(1993-11#1)(1993-2#4)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#5)(1995-3#1)(1995-8#1)(1997-8#9)(2004-12#2)(2005-11#2)(2005-7#1)(2007-10#3)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2012-11#1)(2013-8#1)
of progestin##5##2##(1992-2#1)(1993-9#1)(2008-12#3)
of prognosis and##3##3##(2008-12#1)(2010-12#2)
of prognosis in##3##3##(1990-12#1)(2007-12#1)(2008-12#1)
of prognosis of##2##3##(1990-1#1)(2010-8#1)
of prognosis##15##2##(1990-1#2)(1990-12#1)(1992-8#1)(1995-10#1)(2005-10#1)(2007-12#1)(2008-12#2)(2009-5#1)(2010-11#1)(2010-12#2)(2010-8#1)(2012-3#1)
of prognostic factors and##2##4##(1994-12#1)(2006-6#1)
of prognostic factors in##4##4##(1991-10#2)(1991-11#1)(1995-8#1)
of prognostic factors##13##3##(1991-10#2)(1991-11#1)(1992-9#1)(1994-12#1)(1994-5#1)(1995-8#1)(2006-6#1)(2007-2#1)(2007-7#1)(2008-2#1)(2011-2#1)(2013-7#1)
of prognostic markers##2##3##(2006-10#1)(2010-12#1)
of prognostic models##3##3##(2009-11#1)(2013-1#2)
of prognostic significance##3##3##(1990-12#1)(1996-9#1)(2007-8#1)
of prognostic value in##2##4##(2006-6#1)(2011-2#1)
of prognostic value##6##3##(1990-8#1)(1996-9#1)(1997-8#1)(2006-6#1)(2008-1#1)(2011-2#1)
of prognostic##37##2##(1990-12#1)(1990-8#1)(1991-10#2)(1991-11#1)(1992-9#1)(1994-12#1)(1994-5#1)(1994-7#1)(1995-8#1)(1996-9#2)(1997-8#1)(2006-10#1)(2006-6#2)(2006-9#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-8#1)(2009-11#2)(2010-11#1)(2010-12#2)(2011-2#2)(2012-1#1)(2013-1#4)(2013-7#1)(2013-8#1)
of prognostically##2##2##(1995-5#1)(2012-3#1)
of program effectiveness##2##3##(1997-2#1)(2008-4#1)
of program evaluation##4##3##(1993-12#3)(2007-11#1)
of program focus##2##3##(1993-12#1)(1996-3#1)
of program in##2##3##(1993-2#1)(2011-2#1)
of program management##3##3##(1994-3#1)(1995-2#2)
of program##31##2##(1991-4#1)(1992-12#1)(1992-3#1)(1993-12#4)(1993-2#1)(1994-3#2)(1994-7#1)(1995-2#3)(1995-3#1)(1996-3#1)(1997-1#1)(1997-2#1)(2007-11#1)(2007-2#2)(2008-2#1)(2008-4#1)(2008-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-11#2)(2012-3#1)(2013-1#1)
of programmable compared with conventional valves##2##6##(2006-8#2)
of programmable##10##2##(2006-8#3)(2007-11#2)(2007-7#1)(2007-8#1)(2008-2#1)(2008-3#1)(2010-12#1)
of programmatic##4##2##(1997-3#1)(2012-11#2)(2012-12#1)
of programme##5##2##(1994-4#1)(2007-7#1)(2008-3#1)(2010-9#2)
of programmed cell death (PCD) in##2##6##(2007-8#1)(2008-10#1)
of programmed cell death (PCD)##3##5##(2007-8#1)(2008-10#2)
of programmed cell death and##3##5##(1991-11#1)(1995-1#1)(2009-8#1)
of programmed cell death by apoptosis##2##6##(1991-12#1)(1993-9#1)
of programmed cell death in##5##5##(1991-12#1)(2003-11#1)(2007-12#1)(2008-8#1)(2009-10#1)
of programmed cell death##25##4##(1991-11#3)(1991-12#3)(1991-3#1)(1993-9#2)(1994-9#1)(1995-1#2)(1996-5#1)(2003-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-4#1)(2008-8#2)(2009-10#1)(2009-8#1)(2011-2#1)
of programmed cell##26##3##(1991-11#3)(1991-12#3)(1991-3#1)(1993-9#2)(1994-9#1)(1995-1#2)(1996-5#1)(2003-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-4#1)(2008-8#2)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#1)
of programmed death##2##3##(2008-4#1)(2010-5#1)
of programmed##30##2##(1991-11#3)(1991-12#3)(1991-3#1)(1993-9#2)(1994-9#1)(1995-1#2)(1996-12#1)(1996-5#1)(2003-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-4#2)(2008-8#2)(2009-10#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)
of programmes##8##2##(1994-6#1)(2005-7#1)(2010-12#1)(2011-1#2)(2012-3#2)(2013-7#1)
of programming##4##2##(2008-3#1)(2008-9#3)
of programs for the##2##4##(1991-5#1)(1995-3#1)
of programs for##4##3##(1991-2#1)(1991-5#1)(1995-3#1)(2011-2#1)
of programs in##2##3##(1996-3#1)(2008-1#1)
of programs that##3##3##(2012-12#1)(2012-2#1)(2012-3#1)
of programs with##2##3##(1992-3#1)(2008-1#1)
of programs##28##2##(1991-1#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-8#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
of progress and##3##3##(2007-10#1)(2009-4#1)(2011-2#1)
of progress curves##2##3##(1990-5#1)(1997-6#1)
of progress in the##4##4##(1996-3#1)(2006-4#1)(2008-10#1)(2008-6#1)
of progress in##8##3##(1990-2#1)(1991-3#1)(1994-3#1)(1996-3#1)(2006-4#1)(2008-10#1)(2008-6#1)(2011-2#1)
of progress monitoring##3##3##(2011-2#3)
of progress of##2##3##(2006-12#1)(2008-10#1)
of progress towards##2##3##(2006-10#1)(2007-11#1)
of progress##32##2##(1990-2#1)(1990-5#1)(1990-9#1)(1991-3#1)(1993-1#1)(1994-3#1)(1996-3#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-4#1)(2009-5#1)(2011-2#5)(2012-2#1)
of progression and##3##3##(2008-3#1)(2009-12#1)(2013-8#1)
of progression in##4##3##(2008-9#1)(2011-1#1)(2013-8#2)
of progression may##2##3##(2008-1#1)(2010-4#1)
of progression of the##4##4##(1990-2#1)(2006-6#1)(2007-7#1)(2012-3#1)
of progression of##17##3##(1990-2#1)(1991-8#1)(1995-12#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-2#1)(2011-2#2)(2012-3#1)(2013-1#1)
of progression to##11##3##(1990-5#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-9#1)(2010-5#1)(2011-3#1)(2012-12#1)(2012-2#1)
of progression##52##2##(1990-2#1)(1990-5#1)(1991-8#1)(1994-7#1)(1995-12#1)(1995-8#1)(1997-7#1)(2005-7#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-2#1)(2007-6#1)(2007-7#5)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#2)(2009-11#2)(2009-12#1)(2009-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
of progressive and##4##3##(1993-9#1)(2008-2#1)(2010-12#1)(2011-2#1)
of progressive disease##7##3##(1992-12#1)(1995-5#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-6#1)(2010-9#1)
of progressive loss of##2##4##(1990-11#1)(2007-11#1)
of progressive renal##2##3##(2005-7#1)(2008-1#1)
of progressive systemic##2##3##(1991-3#1)(2012-2#1)
of progressive weakness##2##3##(2012-2#2)
of progressive##49##2##(1990-11#1)(1990-7#1)(1991-3#1)(1992-12#1)(1992-2#1)(1993-3#1)(1993-9#1)(1994-10#1)(1995-5#1)(1997-5#1)(2005-12#1)(2005-7#2)(2006-10#1)(2006-12#2)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-9#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#3)(2013-7#1)
of progressively##4##2##(1994-2#1)(2007-5#1)(2008-2#1)(2012-2#1)
of prohibited substances in##2##4##(2010-11#2)
of prohibited substances##3##3##(2010-11#2)(2010-7#1)
of prohormones and##2##3##(1991-1#1)(1993-5#1)
of prohormones##5##2##(1991-1#1)(1993-5#1)(2008-4#3)
of proinflammatory cytokine expression and##2##5##(2009-8#1)(2011-2#1)
of proinflammatory cytokine##3##3##(2008-6#1)(2009-8#1)(2011-2#1)
of proinflammatory cytokines and chemokines##2##5##(2006-10#1)(2008-4#1)
of proinflammatory cytokines and the##2##5##(2009-9#2)
of proinflammatory cytokines and##5##4##(2006-10#1)(2008-4#1)(2009-9#2)(2010-12#1)
of proinflammatory cytokines in##3##4##(2007-12#1)(2010-4#1)(2013-7#1)
of proinflammatory cytokines##27##3##(1995-2#1)(1996-4#1)(2006-10#3)(2007-11#4)(2007-12#1)(2007-9#1)(2008-1#1)(2008-11#5)(2008-4#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-7#1)
of proinflammatory mediators##2##3##(1994-8#1)(2010-1#1)
of proinflammatory proteins##2##3##(2006-10#1)(2013-1#1)
of proinflammatory##40##2##(1993-9#1)(1994-8#1)(1995-2#1)(1996-4#1)(2006-10#4)(2007-11#4)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-4#1)(2008-6#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-12#1)(2010-4#2)(2010-7#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-7#2)
of proinsulin##3##2##(1990-5#1)(1995-8#1)(2005-1#1)
of project##4##2##(2007-12#1)(2008-5#1)(2010-6#1)(2012-2#1)
of projected##3##2##(2007-12#1)(2007-7#1)(2008-2#1)
of projection##6##2##(1991-5#1)(1993-7#1)(2008-11#1)(2008-3#2)(2008-5#1)
of projections##10##2##(1992-7#1)(1995-10#1)(2006-10#3)(2007-12#1)(2009-8#1)(2010-12#1)(2011-1#2)
of projects##15##2##(1994-3#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-4#1)(1997-8#1)(2007-9#1)(2008-10#1)(2012-2#1)(2012-3#4)
of prokaryotes##2##2##(1996-8#1)(2010-4#1)
of prokaryotic and eukaryotic##3##4##(1990-5#1)(2008-10#1)(2008-11#1)
of prokaryotic##12##2##(1990-5#1)(1991-9#1)(1992-7#1)(1996-10#1)(1996-9#1)(2008-10#1)(2008-11#2)(2010-12#1)(2011-1#2)(2011-2#1)
of prolactin (PRL)##2##3##(1991-12#1)(1994-3#1)
of prolactin and##2##3##(1990-9#1)(2008-4#1)
of prolactin in amniotic fluid##2##5##(1993-12#2)
of prolactin in##6##3##(1991-2#1)(1992-2#1)(1992-9#1)(1993-12#2)(2008-12#1)
of prolactin receptor##2##3##(1994-3#1)(2008-4#1)
of prolactin secretion in##2##4##(1994-3#1)(1995-10#1)
of prolactin secretion##3##3##(1990-7#1)(1994-3#1)(1995-10#1)
of prolactin were##2##3##(1993-12#1)(2004-10#1)
of prolactin##24##2##(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#2)(1992-2#1)(1992-9#1)(1993-12#4)(1994-11#1)(1994-3#3)(1994-6#1)(1995-10#1)(2004-10#2)(2008-11#1)(2008-12#2)(2008-4#2)
of prolapse##4##2##(2007-4#1)(2008-12#2)(2013-1#1)
of prolidase##4##2##(1990-1#3)(1996-7#1)
of proliferating bile##2##3##(2006-10#2)
of proliferating cell nuclear antigen##6##5##(1994-9#2)(1995-8#1)(1997-6#1)(2013-1#2)
of proliferating cell##7##3##(1994-9#2)(1995-8#1)(1997-6#1)(2005-12#1)(2013-1#2)
of proliferating cells##6##3##(1995-2#3)(1996-4#1)(2008-9#2)
of proliferating##24##2##(1994-9#2)(1995-10#1)(1995-2#5)(1995-8#1)(1996-4#1)(1997-6#1)(2005-12#2)(2006-10#2)(2008-11#1)(2008-7#1)(2008-9#3)(2010-12#1)(2012-2#1)(2013-1#2)
of proliferation and apoptosis##2##4##(2008-11#1)(2012-1#1)
of proliferation and##13##3##(1991-5#1)(1993-11#1)(1993-9#1)(1996-4#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-1#1)(2012-3#1)(2013-1#2)
of proliferation control##2##3##(1994-3#1)(2008-11#1)
of proliferation in##3##3##(1995-2#1)(1995-6#1)(2008-5#1)
of proliferation markers##2##3##(1997-7#1)(2011-2#1)
of proliferation of##12##3##(1991-3#1)(1992-12#1)(1992-8#1)(1994-3#1)(1995-2#1)(1995-5#1)(1997-2#1)(2007-11#1)(2009-8#1)(2010-12#1)(2012-1#1)(2013-8#1)
of proliferation##49##2##(1990-8#1)(1991-3#2)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-8#2)(1993-11#1)(1993-9#2)(1994-3#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-4#1)(1997-2#1)(1997-7#2)(2006-10#2)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#3)(2008-4#2)(2008-5#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2011-2#1)(2012-1#3)(2012-3#1)(2013-1#3)(2013-8#1)
of proliferative activity in##2##4##(1994-8#1)(1995-12#1)
of proliferative activity##5##3##(1994-8#2)(1995-12#1)(2008-4#1)(2012-1#1)
of proliferative diabetic retinopathy (PDR)##2##5##(2008-1#2)
of proliferative diabetic##3##3##(2008-1#2)(2013-1#1)
of proliferative##21##2##(1990-9#1)(1994-8#3)(1995-1#1)(1995-12#1)(1997-7#1)(2007-6#1)(2008-1#2)(2008-11#1)(2008-4#3)(2008-7#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-12#1)(2012-1#1)(2013-1#1)
of proline by##2##3##(1990-5#1)(2011-1#1)
of proline dehydrogenase##3##3##(1996-2#3)
of proline in##4##3##(1991-12#1)(2008-10#3)
of proline residues in##2##4##(1990-10#1)(1991-3#1)
of proline with##2##3##(1990-5#2)
of proline##23##2##(1990-10#1)(1990-5#3)(1990-9#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-7#1)(1994-12#1)(1995-1#1)(1995-11#1)(1996-2#3)(1997-6#1)(2008-10#3)(2008-5#1)(2011-1#1)(2012-7#1)
of prolongation of##3##3##(1994-4#1)(1996-4#1)(2013-1#1)
of prolongation##4##2##(1991-10#1)(1994-4#1)(1996-4#1)(2013-1#1)
of prolonged courses of##3##4##(2008-5#1)(2008-6#1)(2009-8#1)
of prolonged formalin fixation##2##4##(2012-3#2)
of prolonged##39##2##(1990-4#1)(1991-12#1)(1992-9#1)(1993-5#1)(1995-11#1)(1995-12#3)(1995-8#1)(1995-9#1)(1997-2#1)(1997-6#1)(2006-8#1)(2007-11#1)(2007-8#3)(2008-10#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-8#1)(2010-3#1)(2011-2#4)(2012-12#2)(2012-3#3)(2013-1#1)(2013-7#1)
of prolonging life##2##3##(1994-6#1)(2008-11#1)
of prolonging##3##2##(1994-6#1)(1996-9#1)(2008-11#1)
of prolyl endopeptidase##3##3##(1991-2#3)
of prolyl peptides##3##3##(1990-5#3)
of prolyl##7##2##(1990-5#3)(1991-2#3)(2013-8#1)
of promegestone##3##2##(1992-2#3)
of promethazine hydrochloride using##2##4##(2008-10#2)
of promethazine hydrochloride##4##3##(2008-10#4)
of promethazine-HCl##3##2##(2008-10#3)
of prominent##12##2##(1994-2#1)(1995-5#1)(2006-6#1)(2006-7#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-8#1)(2012-11#1)
of promise##2##2##(2006-9#1)(2007-10#1)
of promising therapeutic##2##3##(2010-2#1)(2012-3#1)
of promising##14##2##(1991-3#1)(2005-8#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
of promoter CpG##2##3##(2007-10#1)(2008-7#1)
of promoter DNA##2##3##(2007-10#1)(2008-10#1)
of promoter activity##7##3##(1990-5#1)(1991-2#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-8#1)
of promoter and enhancer##2##4##(1992-6#1)(2008-1#1)
of promoter and##5##3##(1991-12#1)(1991-7#1)(1992-6#1)(2008-1#1)(2008-8#1)
of promoter elements##2##3##(1994-3#1)(2008-9#1)
of promoter hypermethylation##2##3##(2007-10#1)(2008-7#1)
of promoter pagC##2##3##(2005-11#2)
of promoter##32##2##(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-6#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-4#1)(1997-5#1)(1997-8#1)(2005-11#2)(2007-10#3)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-7#1)(2012-2#1)(2013-8#1)
of promoters and##2##3##(1997-4#1)(2008-11#1)
of promoters##11##2##(1992-2#1)(1993-11#1)(1995-2#1)(1996-7#1)(1996-8#1)(1997-4#1)(2005-4#1)(2006-12#1)(2008-1#1)(2008-11#1)(2008-7#1)
of promoting health and##2##4##(2008-9#1)(2012-3#1)
of promoting health##3##3##(2008-9#1)(2011-1#1)(2012-3#1)
of promoting the##3##3##(1990-2#1)(2007-11#1)(2011-2#1)
of promoting##23##2##(1990-2#1)(1993-6#1)(1993-9#1)(1994-8#1)(1995-4#1)(1996-10#1)(1996-3#1)(2005-9#1)(2007-11#2)(2007-2#1)(2007-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-10#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)
of prompt##3##2##(2008-1#1)(2008-3#1)(2008-7#1)
of pronase##2##2##(2006-12#1)(2008-10#1)
of prone##3##2##(1992-11#1)(1992-4#1)(2012-12#1)
of proofreading##2##2##(1994-11#2)
of proopiomelanocortin##2##2##(1993-5#2)
of propagating##6##2##(2006-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-2#1)(2012-2#1)
of propagation and##2##3##(2007-12#1)(2008-11#1)
of propagation of the##3##4##(2007-11#1)(2007-12#1)(2008-1#1)
of propagation of##9##3##(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)
of propagation through##3##3##(2007-12#2)(2008-2#1)
of propagation##27##2##(2006-12#1)(2007-11#2)(2007-12#9)(2008-1#3)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#3)(2008-5#2)
of propagule size##2##3##(2008-8#2)
of propagule##5##2##(2008-10#1)(2008-8#2)(2008-9#2)
of propagules in##3##3##(2008-10#3)
of propagules of F##2##4##(2008-10#2)
of propagules##8##2##(2008-10#7)(2008-8#1)
of propanal and##2##3##(1995-7#1)(2010-4#1)
of propanal oxidation by##2##4##(1995-7#2)
of propanal##4##2##(1995-7#3)(2010-4#1)
of propargylic##2##2##(2010-2#1)(2013-7#1)
of propellants##4##2##(1992-3#1)(1996-1#2)(2008-10#1)
of propensity##5##2##(1993-11#1)(2008-11#2)(2010-6#1)(2013-7#1)
of proper nuclear##2##3##(1995-3#1)(2011-2#1)
of proper treatment##3##3##(1993-5#1)(2007-11#1)(2008-1#1)
of proper##26##2##(1990-10#1)(1990-3#1)(1991-11#1)(1993-1#2)(1993-5#1)(1995-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#3)(2009-6#1)(2011-2#6)(2012-12#1)
of properdin##2##2##(1995-9#2)
of properly##5##2##(1991-12#1)(1993-2#1)(1997-4#1)(2008-2#1)(2008-4#1)
of properties and##2##3##(1993-1#1)(1996-2#1)
of properties of##6##3##(1992-12#1)(1996-7#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-8#1)
of properties##17##2##(1992-12#1)(1993-1#1)(1996-2#1)(1996-7#1)(2005-11#1)(2005-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)(2013-8#1)
of prophage##2##2##(1995-2#1)(2011-2#1)
of prophase##2##2##(2008-5#1)(2009-10#1)
of prophylactic antibiotics in##2##4##(2006-10#1)(2008-7#1)
of prophylactic antibiotics##5##3##(2006-10#1)(2007-12#1)(2008-7#2)(2009-5#1)
of prophylactic cholecystectomy##2##3##(1993-3#1)(2006-10#1)
of prophylactic intramuscular##2##3##(2011-12#2)
of prophylactic##34##2##(1990-6#1)(1993-3#1)(1994-2#2)(1994-6#1)(1995-9#1)(2006-10#2)(2006-9#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-3#2)(2008-7#5)(2008-8#1)(2009-5#1)(2010-11#1)(2010-7#2)(2011-1#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
of prophylaxis and##4##3##(1992-12#1)(2009-3#1)(2013-1#2)
of prophylaxis for##2##3##(1997-4#1)(2012-12#1)
of prophylaxis of##2##3##(2005-1#1)(2006-6#1)
of prophylaxis##20##2##(1992-12#1)(1993-10#1)(1993-5#1)(1993-7#1)(1997-4#1)(2005-1#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-7#1)(2008-8#2)(2009-3#1)(2011-2#2)(2012-12#1)(2013-1#3)
of propiconazole##3##2##(2008-10#3)
of propidium iodide (PI)##2##4##(2008-9#2)
of propidium iodide##4##3##(1992-8#1)(2008-9#3)
of propidium##8##2##(1992-3#3)(1992-8#1)(1997-3#1)(2008-9#3)
of propionibacteria##2##2##(2011-2#2)
of propionic acid methyl##2##4##(2008-7#2)
of propionic acid##8##3##(2006-8#5)(2008-7#2)(2011-2#1)
of propionic##10##2##(2006-8#5)(2008-7#2)(2011-2#1)(2013-1#2)
of propiverine and##3##3##(2008-10#3)
of propofol and##2##3##(1996-6#1)(2011-2#1)
of propofol in##2##3##(1990-6#1)(1992-8#1)
of propofol##15##2##(1990-3#1)(1990-6#1)(1992-6#1)(1992-8#2)(1995-3#2)(1996-6#1)(2006-10#3)(2011-2#2)(2013-7#1)(2013-8#1)
of propolis##10##2##(2006-8#2)(2008-10#3)(2008-11#4)(2011-2#1)
of proportional##2##2##(2008-10#1)(2010-2#1)
of proportions##2##2##(1994-6#1)(1995-5#1)
of proposed##17##2##(1992-9#1)(1993-2#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
of propositions##4##2##(1990-12#1)(2008-4#2)(2010-8#1)
of propranolol and##8##3##(1993-2#3)(1994-5#2)(2008-10#3)
of propranolol hydrochloride##2##3##(2004-12#2)
of propranolol on##4##3##(1996-5#1)(2008-9#1)(2012-2#2)
of propranolol##27##2##(1990-5#1)(1993-2#5)(1994-12#1)(1994-5#3)(1996-5#1)(2004-12#2)(2007-12#1)(2008-10#5)(2008-7#1)(2008-9#1)(2009-8#3)(2012-12#1)(2012-2#2)
of proprietary##2##2##(1992-12#1)(2009-2#1)
of proprioception##2##2##(1995-8#1)(2007-11#1)
of proprioceptive##4##2##(1990-6#1)(1995-8#1)(2012-1#2)
of proproteins##2##2##(1991-3#1)(1992-12#1)
of propylene oxide##3##3##(2008-6#3)
of propylene##8##2##(2007-11#3)(2007-7#1)(2008-5#1)(2008-6#3)
of propylthiouracil##2##2##(1995-3#1)(2006-10#1)
of prosaposin##4##2##(1990-11#1)(1991-4#3)
of prosocial##2##2##(2012-12#1)(2012-2#1)
of prosodic##6##2##(2008-4#2)(2009-10#1)(2009-2#1)(2010-9#2)
of prosody##7##2##(2008-9#1)(2009-2#1)(2010-9#5)
of prosome##2##2##(1997-7#2)
of prosopagnosia##5##2##(2009-4#5)
of prospective and retrospective##2##4##(2005-12#1)(2012-3#1)
of prospective cohort studies of##2##5##(2005-10#2)
of prospective cohort studies##3##4##(2005-10#2)(2008-8#1)
of prospective memory##2##3##(2008-1#1)(2013-7#1)
of prospective payment##4##3##(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)
of prospective studies have##2##4##(1997-6#1)(2012-3#1)
of prospective studies##6##3##(1990-10#1)(1997-6#1)(2005-10#2)(2007-2#1)(2012-3#1)
of prospective##30##2##(1990-10#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1995-2#1)(1996-3#1)(1997-6#1)(2005-10#4)(2005-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#3)(2008-8#1)(2009-12#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)
of prostacyclin and##3##3##(1991-12#1)(2006-10#2)
of prostacyclin production by##2##4##(1991-8#1)(1994-9#1)
of prostacyclin##18##2##(1991-12#1)(1991-2#1)(1991-5#3)(1991-8#2)(1992-1#1)(1992-6#1)(1993-12#1)(1994-3#1)(1994-9#2)(1995-11#2)(2006-10#2)(2008-11#1)
of prostaglandin D2##4##3##(1990-2#3)(1996-2#1)
of prostaglandin E1##3##3##(1990-11#1)(1991-8#1)(2005-7#1)
of prostaglandin E2 (PGE2) and##2##5##(1991-3#1)(2007-11#1)
of prostaglandin E2 (PGE2)##7##4##(1990-2#1)(1991-3#1)(1992-1#1)(1995-3#1)(1997-2#1)(1997-8#1)(2007-11#1)
of prostaglandin E2 and##2##4##(1992-4#1)(1996-2#1)
of prostaglandin E2 in##4##4##(1990-2#1)(1994-12#1)(1995-8#1)(1997-2#1)
of prostaglandin E2 on the intensity of##2##7##(1995-12#2)
of prostaglandin E2 production##2##4##(1992-1#2)
of prostaglandin E2 synthesis by##2##5##(1997-1#2)
of prostaglandin E2##23##3##(1990-2#2)(1990-4#1)(1991-3#1)(1992-1#3)(1992-4#2)(1994-12#1)(1995-12#3)(1995-3#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-1#2)(1997-2#2)(1997-8#1)(2007-11#1)
of prostaglandin H synthase##4##4##(1994-5#3)(1997-6#1)
of prostaglandin H synthase-2##3##4##(1993-3#3)
of prostaglandin H##8##3##(1993-3#3)(1994-5#4)(1997-6#1)
of prostaglandin endoperoxide synthase and##2##5##(1991-4#2)
of prostaglandin endoperoxide synthase-1##2##4##(1992-3#1)(1993-4#1)
of prostaglandin endoperoxide##4##3##(1991-4#2)(1992-3#1)(1993-4#1)
of prostaglandin synthesis in##2##4##(1990-12#2)
of prostaglandin synthesis##6##3##(1990-12#2)(1993-12#1)(1993-8#1)(1995-5#1)(2010-2#1)
of prostaglandin##63##2##(1990-11#1)(1990-12#3)(1990-2#5)(1990-4#1)(1990-8#1)(1991-3#1)(1991-4#3)(1991-7#1)(1991-8#1)(1992-1#3)(1992-3#1)(1992-4#2)(1993-12#2)(1993-3#4)(1993-4#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#4)(1995-12#3)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1997-1#3)(1997-2#2)(1997-6#1)(1997-8#1)(2005-1#1)(2005-11#1)(2005-7#1)(2006-5#1)(2007-11#1)(2008-7#1)(2009-8#1)(2010-2#1)
of prostaglandins (PGs)##2##3##(2008-11#1)(2008-7#1)
of prostaglandins and##3##3##(2006-10#1)(2008-4#1)(2008-8#1)
of prostaglandins in##4##3##(1991-1#1)(2006-10#2)(2008-10#1)
of prostaglandins##28##2##(1990-2#1)(1991-1#2)(1991-8#2)(1992-8#1)(1993-4#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-6#1)(1996-12#1)(1997-1#1)(2006-10#6)(2007-7#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#1)
of prostanoid synthesis##4##3##(1993-3#1)(1994-3#2)(2009-1#1)
of prostanoid##8##2##(1993-3#2)(1994-3#2)(2005-8#2)(2008-8#1)(2009-1#1)
of prostanoids and##3##3##(1992-1#1)(1992-3#1)(2008-8#1)
of prostanoids in##2##3##(1992-3#1)(2008-8#1)
of prostanoids##9##2##(1992-1#1)(1992-3#2)(1992-8#3)(1993-3#1)(2008-8#2)
of prostate biopsy##2##3##(2006-9#1)(2007-3#1)
of prostate cancer has been##2##5##(2006-10#1)(2007-3#1)
of prostate cancer has##5##4##(1996-2#1)(2006-10#2)(2007-3#1)(2011-1#1)
of prostate cancer in##7##4##(1994-12#1)(1995-9#1)(2007-3#1)(2009-5#2)(2010-1#1)(2011-2#1)
of prostate cancer is##2##4##(2011-2#1)(2013-1#1)
of prostate cancer patients##2##4##(1992-8#1)(2007-11#1)
of prostate cancer risk##3##4##(2012-12#3)
of prostate cancer screening##2##4##(2009-5#1)(2011-1#1)
of prostate cancer using##2##4##(2007-11#1)(2009-12#1)
of prostate cancer were##2##4##(2007-3#2)
of prostate cancer##81##3##(1991-8#1)(1992-11#1)(1992-8#1)(1994-12#1)(1995-4#1)(1995-9#3)(1996-2#1)(1997-7#2)(2005-10#1)(2005-7#1)(2006-10#5)(2006-9#10)(2007-1#1)(2007-11#3)(2007-3#4)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#2)(2009-12#1)(2009-5#5)(2010-1#1)(2010-12#3)(2010-8#1)(2011-1#2)(2011-2#8)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#3)
of prostate cancer]##3##3##(1991-9#1)(2009-2#1)(2012-12#1)
of prostate epithelial cells and##2##5##(2007-11#1)(2008-11#1)
of prostate gland##2##3##(2008-7#1)(2012-3#1)
of prostate in##2##3##(2009-4#1)(2012-3#1)
of prostate specific antigen (PSA)##2##5##(2009-2#1)(2011-2#1)
of prostate specific antigen##3##4##(2009-2#2)(2011-2#1)
of prostate specific##4##3##(2007-11#1)(2009-2#2)(2011-2#1)
of prostate tissue##2##3##(2008-9#1)(2011-1#1)
of prostate##119##2##(1991-8#2)(1991-9#1)(1992-11#1)(1992-8#1)(1994-12#3)(1995-4#1)(1995-8#1)(1995-9#3)(1996-11#1)(1996-2#1)(1997-7#2)(2005-10#1)(2005-7#1)(2006-10#5)(2006-9#12)(2007-1#1)(2007-11#6)(2007-3#5)(2007-6#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-11#1)(2009-12#2)(2009-2#4)(2009-4#1)(2009-5#5)(2010-1#2)(2010-12#3)(2010-8#1)(2011-1#5)(2011-2#11)(2012-1#1)(2012-12#6)(2012-2#1)(2012-3#4)(2013-1#5)(2013-8#3)
of prostate-specific antigen (PSA) screening##2##5##(2006-6#1)(2006-9#1)
of prostate-specific antigen (PSA)##4##4##(2006-10#1)(2006-6#1)(2006-9#1)(2008-9#1)
of prostate-specific antigen in##2##4##(1996-9#1)(2007-4#1)
of prostate-specific antigen##8##3##(1990-12#1)(1996-9#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-4#1)(2008-9#2)
of prostatic cancer##6##3##(1990-9#2)(1991-2#1)(1991-7#1)(1996-2#1)(2009-5#1)
of prostatic carcinoma##5##3##(1991-2#2)(1996-12#1)(2007-6#1)(2008-4#1)
of prostatic epithelial##2##3##(1990-7#1)(2008-11#1)
of prostatic fluid##2##3##(1991-2#1)(2012-12#1)
of prostatic urethral polyp##2##4##(2006-1#1)(2011-12#1)
of prostatic utricle##2##3##(2010-2#2)
of prostatic##30##2##(1990-7#1)(1990-9#2)(1991-2#5)(1991-7#1)(1996-12#1)(1996-2#1)(2006-1#1)(2007-6#5)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2009-5#1)(2010-2#2)(2011-1#1)(2011-12#1)(2012-12#2)
of prostatitis syndrome##2##3##(2008-10#2)
of prostatitis##6##2##(2006-8#1)(2008-10#3)(2008-6#2)
of prostheses and##3##3##(2004-9#1)(2008-1#1)(2011-2#1)
of prostheses to##2##3##(2011-2#1)(2013-1#1)
of prostheses##9##2##(2004-9#1)(2007-5#1)(2008-1#1)(2009-1#1)(2010-3#1)(2011-2#3)(2013-1#1)
of prosthesis##9##2##(1992-9#1)(2007-11#2)(2007-7#3)(2007-8#1)(2011-2#1)(2013-1#1)
of prosthetic joint##2##3##(2007-12#1)(2011-2#1)
of prosthetic materials##2##3##(1990-4#1)(2012-2#1)
of prosthetic##20##2##(1990-4#1)(1990-5#1)(1995-8#1)(2006-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-2#1)(2008-6#1)(2011-2#6)(2012-2#1)(2013-1#1)(2013-8#1)
of prostitutes##2##2##(1990-2#1)(1991-6#1)
of prostitution##3##2##(1990-12#1)(2008-10#1)(2009-7#1)
of prostratin##3##2##(1992-5#3)
of prosurvival##2##2##(2012-1#1)(2013-8#1)
of protamine##9##2##(1990-9#1)(1991-2#2)(1993-8#1)(1994-6#1)(1995-8#1)(2007-8#3)
of protease activity and##2##4##(1992-4#1)(2011-2#1)
of protease activity##3##3##(1992-4#1)(2011-2#2)
of protease inhibitors##11##3##(1991-2#2)(1992-6#1)(1995-5#1)(1995-9#1)(1996-7#1)(2007-11#2)(2008-8#1)(2009-4#2)
of protease nexin-2/amyloid beta-protein precursor##2##5##(1992-12#1)(1992-7#1)
of protease##25##2##(1991-2#2)(1991-4#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-6#2)(1992-7#1)(1994-12#1)(1995-1#1)(1995-5#1)(1995-9#1)(1996-7#1)(2005-7#1)(2007-11#2)(2008-10#1)(2008-4#1)(2008-8#1)(2009-4#2)(2011-2#3)
of proteases and##2##3##(1991-8#1)(1995-1#1)
of proteases##14##2##(1990-11#1)(1990-7#1)(1990-9#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-6#1)(1994-11#1)(1995-1#1)(1997-4#1)(2004-12#1)(2008-11#1)(2008-4#2)
of proteasome##4##2##(1996-9#1)(2008-4#1)(2012-3#1)(2013-8#1)
of protected amine-functionalised polymer beads##2##5##(2008-10#2)
of protected##10##2##(1997-4#1)(2004-2#1)(2008-10#4)(2008-4#4)
of protecting groups and##2##4##(2007-10#1)(2008-7#1)
of protecting groups##6##3##(1995-11#1)(1996-2#1)(2007-10#1)(2008-6#1)(2008-7#1)(2009-9#1)
of protecting##18##2##(1991-6#1)(1992-12#1)(1992-8#1)(1995-11#1)(1995-12#1)(1996-2#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#1)
of protection against##14##3##(1991-9#1)(1992-5#1)(1995-12#1)(1995-5#2)(2006-10#1)(2008-10#1)(2008-7#1)(2009-12#1)(2010-1#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
of protection and##4##3##(2007-10#1)(2007-2#1)(2009-12#1)(2011-2#1)
of protection appears##2##3##(1996-12#1)(1996-9#1)
of protection by##3##3##(1996-4#1)(2008-5#2)
of protection for##4##3##(1991-5#1)(2008-4#1)(2012-2#2)
of protection from##6##3##(1991-2#1)(1995-10#1)(2006-10#1)(2007-11#1)(2008-11#1)(2012-12#1)
of protection in##3##3##(1994-2#1)(1995-5#1)(1997-6#1)
of protection motivation theory##2##4##(2010-3#2)
of protection of##2##3##(1990-12#1)(2007-11#1)
of protection strategies##2##3##(2010-5#2)
of protection##79##2##(1990-10#1)(1990-12#1)(1990-6#1)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-5#1)(1993-7#1)(1994-11#1)(1994-2#2)(1995-10#1)(1995-12#1)(1995-5#5)(1996-12#1)(1996-4#1)(1996-9#2)(1997-6#1)(2006-10#3)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-3#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#6)(2008-7#1)(2008-8#1)(2009-12#2)(2010-1#1)(2010-12#1)(2010-3#2)(2010-5#2)(2011-2#3)(2012-12#2)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#1)
of protective T##2##3##(1997-4#1)(2009-4#1)
of protective antibodies##3##3##(1997-6#1)(2006-2#1)(2010-10#1)
of protective effects of##2##4##(2008-6#1)(2012-3#1)
of protective enzymes##2##3##(2008-12#1)(2011-2#1)
of protective immunity##6##3##(1996-10#1)(1997-3#1)(2007-11#1)(2011-2#3)
of protective mechanisms##2##3##(2008-5#1)(2009-3#1)
of protective serum antibody titres##2##5##(2008-5#2)
of protective##37##2##(1991-10#1)(1992-11#1)(1996-1#1)(1996-10#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-2#2)(2006-8#1)(2007-11#3)(2008-12#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-4#1)(2009-8#1)(2010-10#1)(2011-2#4)(2012-3#1)
of protein 1 in##4##4##(1991-9#4)
of protein 1##5##3##(1991-9#4)(1993-12#1)
of protein 4##4##3##(1994-12#2)(2006-10#1)(2010-5#1)
of protein A in##2##4##(1990-12#2)
of protein A##14##3##(1990-12#4)(1990-8#2)(1991-11#1)(1993-11#2)(1997-4#1)(2005-11#1)(2008-10#1)(2008-11#1)(2013-1#1)
of protein C activation##2##4##(1990-5#1)(1997-2#1)
of protein C precursor in the##2##6##(1995-1#2)
of protein C precursor##3##4##(1995-1#3)
of protein C##12##3##(1990-5#1)(1993-5#1)(1995-1#5)(1995-5#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-12#1)
of protein D##7##3##(1992-3#5)(1992-8#2)
of protein E##3##3##(2007-11#3)
of protein G##7##3##(1992-7#1)(1994-11#1)(1995-5#1)(2008-10#2)(2010-7#1)(2013-1#1)
of protein L##2##3##(1994-11#2)
of protein L7/L12##4##3##(1996-11#4)
of protein S to##2##4##(1992-12#2)
of protein S##9##3##(1992-12#4)(1993-5#3)(1994-3#1)(2007-2#1)
of protein S-nitrosylation##2##3##(2008-4#2)
of protein X##2##3##(1994-5#1)(1995-3#1)
of protein Z##2##3##(1997-4#2)
of protein Z)##2##3##(1997-4#2)
of protein adsorption##3##3##(2005-11#2)(2008-6#1)
of protein aggregates in##2##4##(2010-4#1)(2013-8#1)
of protein aggregates##5##3##(1994-11#1)(2008-1#1)(2010-4#1)(2013-8#2)
of protein and to##2##4##(2008-10#1)(2013-8#1)
of protein and##20##3##(1990-5#1)(1991-5#1)(1992-2#1)(1992-8#1)(1993-8#1)(1994-12#1)(1996-11#1)(1996-8#1)(2006-4#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
of protein based on##2##4##(2008-10#2)
of protein based##3##3##(2008-10#2)(2008-5#1)
of protein binding and##2##4##(1995-1#1)(2011-1#1)
of protein binding in##3##4##(1990-7#1)(1995-2#1)(1996-8#1)
of protein binding to##2##4##(1995-10#1)(1996-8#1)
of protein binding##11##3##(1990-6#1)(1990-7#1)(1995-1#1)(1995-10#1)(1995-2#1)(1996-8#2)(1997-5#1)(2008-4#1)(2008-7#1)(2011-1#1)
of protein biomarkers##2##3##(2008-10#1)(2010-11#1)
of protein biosynthesis##4##3##(1992-8#1)(2006-3#1)(2008-4#1)(2008-7#1)
of protein bound##2##3##(1993-4#1)(2013-8#1)
of protein by##3##3##(1994-5#1)(2008-10#2)
of protein carbonyls##3##3##(1995-6#1)(2010-4#2)
of protein coding##3##3##(2008-4#1)(2009-5#1)(2010-7#1)
of protein complexes##6##3##(1994-11#1)(1995-6#1)(2006-12#1)(2008-7#1)(2010-10#1)(2010-9#1)
of protein concentration##11##3##(1990-8#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#4)(2008-5#1)(2011-2#1)
of protein conformational##2##3##(1991-8#1)(1995-6#1)
of protein content in##2##4##(1992-8#1)(2008-10#1)
of protein content##5##3##(1992-8#1)(2007-3#1)(2008-10#1)(2012-12#2)
of protein crystal growth##2##4##(2006-10#1)(2008-4#1)
of protein crystal##3##3##(2006-10#2)(2008-4#1)
of protein crystallization##3##3##(2006-12#1)(2008-10#1)(2009-11#1)
of protein crystals##4##3##(1996-12#1)(2006-4#2)(2009-12#1)
of protein degradation##3##3##(1992-12#1)(1994-11#1)(2008-7#1)
of protein disulfide isomerase##5##4##(1990-7#1)(1993-6#2)(1995-3#1)(2013-1#1)
of protein disulfide##6##3##(1990-7#1)(1993-6#2)(1995-3#1)(1996-7#1)(2013-1#1)
of protein domain evolution##2##4##(2011-2#2)
of protein domain folds##2##4##(1995-4#1)(2008-4#1)
of protein domain##5##3##(1995-4#1)(2006-6#1)(2008-4#1)(2011-2#2)
of protein domains##3##3##(2011-1#1)(2012-12#2)
of protein engineering##4##3##(1994-8#1)(1995-4#1)(2009-2#1)(2011-2#1)
of protein evolution##3##3##(1991-12#1)(2008-7#2)
of protein expression in##4##4##(1995-5#1)(2008-11#1)(2008-5#1)(2010-2#1)
of protein expression##15##3##(1990-10#1)(1995-5#1)(2008-1#1)(2008-11#4)(2008-4#3)(2008-5#1)(2008-7#1)(2010-2#1)(2010-5#1)(2010-9#1)
of protein extracts##3##3##(2008-10#2)(2008-4#1)
of protein families##5##3##(2007-11#2)(2007-8#1)(2008-4#1)(2009-5#1)
of protein folding and##3##4##(1991-6#1)(2008-1#1)(2008-4#1)
of protein folding from the##2##5##(1991-4#1)(1992-5#1)
of protein folding from##3##4##(1991-4#2)(1992-5#1)
of protein folding##22##3##(1991-4#2)(1991-6#2)(1992-5#1)(1993-6#4)(1995-1#1)(1995-2#1)(1995-4#2)(1995-5#1)(1996-11#1)(1996-6#1)(1997-2#1)(2008-1#1)(2008-4#1)(2010-2#1)(2011-1#1)(2011-2#1)
of protein folds in##2##4##(2008-4#2)
of protein for##3##3##(1991-1#1)(1996-5#1)(1997-4#1)
of protein function##4##3##(2008-4#1)(2008-9#1)(2010-11#1)(2011-2#1)
of protein functional groups##2##4##(1997-2#1)(1997-6#1)
of protein gene##2##3##(1995-11#1)(2008-8#1)
of protein heat capacity##2##4##(2006-10#2)
of protein in the##4##4##(1990-5#1)(1997-8#1)(2004-9#1)(2008-2#1)
of protein in##10##3##(1990-3#1)(1990-5#1)(1994-2#1)(1997-8#1)(2004-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-4#1)
of protein intake##4##3##(2008-5#2)(2013-1#1)(2013-8#1)
of protein interaction##5##3##(2008-4#1)(2008-7#4)
of protein interactions in living cells##2##6##(2008-4#2)
of protein interactions in##4##4##(2008-1#1)(2008-4#3)
of protein interactions##10##3##(2007-8#1)(2008-1#1)(2008-2#1)(2008-4#6)(2012-2#1)
of protein isolates##2##3##(2011-2#2)
of protein kinase A (PKA)##3##5##(1996-11#1)(1996-8#1)(2008-10#1)
of protein kinase A##15##4##(1990-12#1)(1990-7#1)(1992-12#2)(1992-7#2)(1993-8#1)(1994-12#1)(1994-3#1)(1996-11#1)(1996-12#1)(1996-6#1)(1996-8#1)(2008-10#1)(2012-2#1)
of protein kinase C (PKC) and##6##6##(1991-9#1)(1992-9#1)(1993-8#1)(1995-3#1)(1997-6#1)(1997-7#1)
of protein kinase C (PKC) in the##2##7##(1991-9#1)(1996-5#1)
of protein kinase C (PKC) in##7##6##(1990-6#1)(1991-2#1)(1991-9#1)(1993-3#1)(1995-11#1)(1996-5#1)(2008-4#1)
of protein kinase C (PKC)##35##5##(1990-6#1)(1991-2#1)(1991-9#2)(1992-12#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-11#3)(1995-3#2)(1995-5#1)(1996-12#1)(1996-5#2)(1997-3#1)(1997-6#1)(1997-7#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-8#1)(2013-8#2)
of protein kinase C activation on##2##6##(1993-3#1)(1996-8#1)
of protein kinase C activation to##2##6##(1990-9#1)(1992-8#1)
of protein kinase C activation##7##5##(1990-11#1)(1990-9#1)(1992-8#1)(1993-3#2)(1996-8#1)(2008-11#1)
of protein kinase C activity by##2##6##(1993-12#1)(1994-12#1)
of protein kinase C activity in##5##6##(1991-4#1)(1993-4#2)(1993-8#1)(1994-11#1)
of protein kinase C activity##18##5##(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-4#2)(1992-1#1)(1993-12#1)(1993-4#2)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#3)
of protein kinase C alpha##2##5##(1994-5#1)(1995-11#1)
of protein kinase C and the##2##6##(1994-8#1)(1997-2#1)
of protein kinase C and##12##5##(1991-7#1)(1993-8#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-4#1)
of protein kinase C by##8##5##(1990-12#1)(1990-2#1)(1991-3#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-9#1)(2008-8#1)
of protein kinase C does not##2##6##(1990-8#1)(1991-2#1)
of protein kinase C down-regulation##2##5##(1990-11#1)(1992-9#1)
of protein kinase C from the##2##6##(1991-5#1)(1993-8#1)
of protein kinase C from##3##5##(1991-5#1)(1993-8#1)(1994-8#1)
of protein kinase C in mouse skin##2##7##(1990-11#2)
of protein kinase C in the##7##6##(1990-3#1)(1990-4#3)(1994-12#1)(1997-1#2)
of protein kinase C in##29##5##(1990-10#3)(1990-11#2)(1990-2#1)(1990-3#1)(1990-4#5)(1991-10#1)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#1)(1994-12#1)(1994-5#1)(1996-9#1)(1997-1#2)(2008-11#2)
of protein kinase C is##3##5##(1990-4#1)(1992-6#1)(1994-3#1)
of protein kinase C isoforms##3##5##(1990-6#1)(1994-12#1)(2011-2#1)
of protein kinase C isozymes in##2##6##(1993-8#1)(1994-2#1)
of protein kinase C isozymes##3##5##(1992-7#1)(1993-8#1)(1994-2#1)
of protein kinase C or by##2##6##(1990-4#1)(1991-7#1)
of protein kinase C or##4##5##(1990-4#1)(1991-3#1)(1991-7#1)(2010-12#1)
of protein kinase C substrates##3##5##(1992-9#1)(1993-9#1)(1996-5#1)
of protein kinase C subtypes##2##5##(1990-6#1)(1991-7#1)
of protein kinase C to the##4##6##(1990-4#1)(1991-5#1)(1991-8#2)
of protein kinase C to##6##5##(1990-4#2)(1991-5#1)(1991-8#2)(1994-5#1)
of protein kinase C was##2##5##(1990-11#1)(1992-8#1)
of protein kinase C were##3##5##(1990-2#1)(1990-4#1)(1990-9#1)
of protein kinase C with##4##5##(1993-6#1)(1994-5#1)(1995-2#1)(1995-8#1)
of protein kinase C##233##4##(1990-10#4)(1990-11#5)(1990-12#3)(1990-2#4)(1990-3#1)(1990-4#14)(1990-5#7)(1990-6#3)(1990-7#4)(1990-8#5)(1990-9#4)(1991-1#1)(1991-10#4)(1991-12#1)(1991-2#4)(1991-3#2)(1991-4#2)(1991-5#4)(1991-7#4)(1991-8#6)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#2)(1992-4#1)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#6)(1992-9#9)(1993-12#4)(1993-2#1)(1993-3#5)(1993-4#3)(1993-6#3)(1993-7#2)(1993-8#7)(1993-9#1)(1994-11#4)(1994-12#11)(1994-2#2)(1994-3#3)(1994-5#9)(1994-6#2)(1994-8#5)(1994-9#2)(1995-11#5)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-5#6)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#3)(2007-9#1)(2008-1#3)(2008-11#8)(2008-4#3)(2008-8#2)(2008-9#1)(2010-12#1)(2011-2#1)(2013-8#2)
of protein kinase activities##3##4##(1991-3#1)(1993-11#1)(2008-4#1)
of protein kinase activity##2##4##(1995-3#1)(1996-10#1)
of protein kinase inhibitors##2##4##(1990-8#1)(1994-11#1)
of protein kinase##279##3##(1990-10#4)(1990-11#5)(1990-12#5)(1990-2#4)(1990-3#1)(1990-4#14)(1990-5#7)(1990-6#3)(1990-7#6)(1990-8#6)(1990-9#4)(1991-1#1)(1991-10#4)(1991-12#2)(1991-2#5)(1991-3#3)(1991-4#2)(1991-5#4)(1991-7#4)(1991-8#6)(1991-9#4)(1992-1#1)(1992-11#1)(1992-12#4)(1992-4#1)(1992-5#1)(1992-6#5)(1992-7#3)(1992-8#6)(1992-9#9)(1993-11#1)(1993-12#5)(1993-2#3)(1993-3#5)(1993-4#3)(1993-6#3)(1993-7#2)(1993-8#8)(1993-9#1)(1994-11#5)(1994-12#12)(1994-2#2)(1994-3#4)(1994-5#10)(1994-6#2)(1994-8#6)(1994-9#2)(1995-11#5)(1995-12#1)(1995-2#1)(1995-3#5)(1995-5#2)(1995-6#1)(1995-8#2)(1996-10#1)(1996-11#2)(1996-12#2)(1996-5#6)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#3)(1997-6#3)(1997-7#3)(1997-8#1)(2006-9#2)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#9)(2008-4#5)(2008-8#2)(2008-9#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
of protein kinases at##2##4##(1990-6#1)(1996-10#1)
of protein kinases in the##2##5##(2008-11#1)(2012-3#1)
of protein kinases in##3##4##(1997-1#1)(2008-11#1)(2012-3#1)
of protein kinases that##3##4##(2008-1#1)(2008-2#1)(2013-1#1)
of protein kinases##24##3##(1990-6#1)(1991-11#1)(1991-8#1)(1993-12#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-2#1)(1996-10#2)(1996-2#1)(1996-8#1)(1996-9#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
of protein level in##2##4##(2008-7#1)(2009-4#1)
of protein level##5##3##(2008-11#1)(2008-12#1)(2008-7#1)(2009-4#1)(2012-3#1)
of protein linear molecular motors##2##5##(2009-12#2)
of protein malnutrition##2##3##(1990-4#1)(2008-8#1)
of protein mass##2##3##(2008-7#2)
of protein methylation##4##3##(1992-5#1)(2008-4#3)
of protein microarrays##2##3##(2007-8#1)(2013-1#1)
of protein modification##2##3##(2005-11#1)(2009-8#1)
of protein molecules##6##3##(1990-11#1)(1991-4#1)(1994-8#1)(1995-4#1)(2005-11#1)(2010-10#1)
of protein nuclear extracts##2##4##(2008-9#2)
of protein on##4##3##(1994-12#1)(2008-5#1)(2008-9#1)(2013-8#1)
of protein or mRNA##2##4##(1997-4#1)(2009-9#1)
of protein or##4##3##(1991-7#1)(1995-6#1)(1997-4#1)(2009-9#1)
of protein oxidation##3##3##(1995-6#1)(2008-4#1)(2010-4#1)
of protein p1##2##3##(1997-5#2)
of protein per##5##3##(1990-7#1)(1995-1#1)(2008-10#2)(2010-7#1)
of protein phosphatase 1##3##4##(1990-12#1)(1995-8#1)(1997-4#1)
of protein phosphatase 2A##3##4##(1994-9#2)(1995-8#1)
of protein phosphatase inhibitors##4##4##(1992-8#1)(1995-6#1)(2008-2#1)(2008-4#1)
of protein phosphatase type 1##3##5##(1991-7#1)(1992-8#1)(1995-8#1)
of protein phosphatase type##4##4##(1991-7#1)(1992-8#1)(1995-8#2)
of protein phosphatase##17##3##(1990-12#1)(1991-7#1)(1992-8#2)(1993-8#1)(1994-11#1)(1994-9#2)(1995-6#1)(1995-8#4)(1997-4#1)(2008-2#1)(2008-4#1)(2012-12#1)
of protein phosphatases 1 and 2A##4##6##(1992-12#2)(1994-2#1)(1997-8#1)
of protein phosphatases in the##2##5##(1994-2#1)(1995-6#1)
of protein phosphatases##11##3##(1990-12#1)(1992-12#2)(1992-8#2)(1994-2#2)(1995-11#1)(1995-6#1)(1997-8#1)(2013-7#1)
of protein phosphorylation##4##3##(1990-12#1)(1992-5#1)(1994-3#1)(1996-2#1)
of protein post-translational##2##3##(2009-6#1)(2010-12#1)
of protein production##2##3##(2008-11#1)(2012-3#1)
of protein secondary structure##4##4##(1990-12#1)(1991-11#1)(1994-9#1)(2008-10#1)
of protein secretion##2##3##(1994-9#1)(1997-3#1)
of protein sequence conservation##2##4##(1997-8#1)(2012-3#1)
of protein sequence databases##2##4##(2006-10#1)(2009-6#1)
of protein sequence##7##3##(1991-9#1)(1997-8#1)(2006-10#1)(2008-9#2)(2009-6#1)(2012-3#1)
of protein sequences##4##3##(2008-4#1)(2009-6#1)(2012-2#1)(2013-8#1)
of protein serine/threonine##3##3##(1994-11#1)(1995-8#1)(1997-6#1)
of protein solutions##3##3##(2006-10#1)(2008-4#2)
of protein spots##2##3##(2007-8#2)
of protein stability##5##3##(1993-3#1)(2008-4#3)(2010-2#1)
of protein structural##3##3##(2008-4#1)(2009-5#2)
of protein structure and function##2##5##(2010-12#1)(2011-1#1)
of protein structure and##4##4##(2008-4#1)(2010-12#1)(2011-1#1)(2012-3#1)
of protein structure##11##3##(1991-3#1)(1994-9#1)(1995-4#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)
of protein structures by##3##4##(1994-8#2)(2008-4#1)
of protein structures##6##3##(1994-8#2)(2008-4#2)(2009-5#1)(2013-1#1)
of protein synthesis and##4##4##(1990-10#1)(1990-7#1)(1991-6#1)(1993-9#1)
of protein synthesis are##2##4##(1995-6#2)
of protein synthesis by cycloheximide##3##5##(1991-10#1)(1992-8#1)(1995-8#1)
of protein synthesis by##5##4##(1991-10#1)(1992-11#1)(1992-8#1)(1994-6#1)(1995-8#1)
of protein synthesis in##6##4##(1991-6#2)(1994-6#1)(1996-11#1)(2008-11#1)(2010-12#1)
of protein synthesis when##2##4##(1997-2#1)(2006-11#1)
of protein synthesis##49##3##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#2)(1991-10#2)(1991-2#1)(1991-6#4)(1992-11#2)(1992-8#1)(1993-6#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-6#3)(1994-8#1)(1995-11#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#2)(2006-11#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-2#1)
of protein thiols##2##3##(1990-6#1)(1992-11#1)
of protein to DNA##2##4##(1991-11#1)(1994-12#1)
of protein to##5##3##(1991-11#1)(1992-2#1)(1994-12#1)(2006-10#1)(2013-1#1)
of protein translocation##3##3##(1993-8#2)(1994-3#1)
of protein turnover in##2##4##(2013-1#2)
of protein turnover##5##3##(1995-6#1)(2008-11#1)(2013-1#3)
of protein tyrosine kinase (PTK)##2##5##(1994-6#1)(2008-8#1)
of protein tyrosine kinase##3##4##(1994-6#1)(1994-9#1)(2008-8#1)
of protein tyrosine kinases##6##4##(1990-7#1)(1993-3#1)(1994-3#1)(1995-3#1)(1996-2#2)
of protein tyrosine phosphatase##3##4##(1993-3#1)(1994-6#1)(2008-8#1)
of protein tyrosine phosphatases##4##4##(1996-5#1)(1997-6#3)
of protein tyrosine phosphorylation##5##4##(1993-3#1)(1997-3#1)(2012-3#3)
of protein tyrosine##21##3##(1990-7#1)(1993-3#3)(1994-3#1)(1994-6#2)(1994-9#1)(1995-3#1)(1996-2#2)(1996-5#1)(1997-3#1)(1997-6#3)(2008-8#2)(2012-3#3)
of protein unfolding and##2##4##(1995-3#1)(1995-4#1)
of protein unfolding##4##3##(1995-1#1)(1995-3#1)(1995-4#1)(1997-2#1)
of protein using a##2##4##(2006-5#1)(2008-7#1)
of protein using##4##3##(2006-12#1)(2006-5#1)(2008-10#1)(2008-7#1)
of protein was##3##3##(1992-6#1)(2008-5#1)(2012-11#1)
of protein were##2##3##(1990-7#1)(2008-10#1)
of protein with##5##3##(1990-7#1)(1992-7#1)(2008-10#1)(2008-8#1)(2012-3#1)
of protein##1059##2##(1990-10#7)(1990-11#11)(1990-12#19)(1990-2#6)(1990-3#3)(1990-4#16)(1990-5#15)(1990-6#6)(1990-7#14)(1990-8#12)(1990-9#5)(1991-1#2)(1991-10#6)(1991-11#4)(1991-12#3)(1991-2#6)(1991-3#4)(1991-4#5)(1991-5#7)(1991-6#7)(1991-7#8)(1991-8#11)(1991-9#9)(1992-1#1)(1992-11#5)(1992-12#14)(1992-2#2)(1992-3#5)(1992-4#2)(1992-5#4)(1992-6#9)(1992-7#8)(1992-8#17)(1992-9#10)(1993-11#6)(1993-12#8)(1993-2#3)(1993-3#10)(1993-4#5)(1993-5#4)(1993-6#14)(1993-7#2)(1993-8#12)(1993-9#2)(1994-11#17)(1994-12#19)(1994-2#6)(1994-3#12)(1994-5#16)(1994-6#8)(1994-8#12)(1994-9#9)(1995-1#10)(1995-10#2)(1995-11#8)(1995-12#1)(1995-2#4)(1995-3#10)(1995-4#10)(1995-5#8)(1995-6#15)(1995-7#2)(1995-8#11)(1996-10#3)(1996-11#10)(1996-12#7)(1996-2#5)(1996-4#1)(1996-5#9)(1996-6#3)(1996-7#1)(1996-8#7)(1996-9#2)(1997-1#4)(1997-2#11)(1997-3#6)(1997-4#13)(1997-5#3)(1997-6#12)(1997-7#6)(1997-8#6)(2004-9#1)(2005-11#5)(2006-10#11)(2006-11#1)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#4)(2006-6#2)(2006-9#2)(2007-11#7)(2007-12#3)(2007-2#1)(2007-3#1)(2007-6#3)(2007-8#9)(2007-9#1)(2008-1#15)(2008-10#36)(2008-11#25)(2008-12#3)(2008-2#13)(2008-3#2)(2008-4#62)(2008-5#24)(2008-6#1)(2008-7#30)(2008-8#8)(2008-9#8)(2009-10#3)(2009-11#2)(2009-12#4)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#8)(2009-6#3)(2009-7#2)(2009-8#4)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#8)(2010-2#4)(2010-3#1)(2010-4#9)(2010-5#2)(2010-7#4)(2010-9#4)(2011-1#10)(2011-2#13)(2011-3#1)(2012-1#2)(2012-11#3)(2012-12#8)(2012-2#9)(2012-3#12)(2013-1#13)(2013-7#2)(2013-8#10)
of protein)##10##2##(1990-11#1)(1991-11#1)(1993-11#3)(1994-12#2)(1995-10#1)(1996-2#1)(2010-11#1)
of protein-based binding media##2##4##(2007-8#2)
of protein-bound##11##2##(1990-3#4)(1991-12#1)(1992-8#1)(1996-2#1)(1997-2#1)(2004-11#1)(2008-5#1)(2008-7#1)
of protein-coding##3##2##(1991-8#1)(1993-11#1)(2007-11#1)
of protein-doped##2##2##(2007-8#2)
of protein-energy malnutrition##2##3##(2006-2#1)(2006-9#1)
of protein-energy##4##2##(1996-9#2)(2006-2#1)(2006-9#1)
of protein-ligand binding##2##3##(2012-3#2)
of protein-ligand interactions##2##3##(2007-8#1)(2008-4#1)
of protein-ligand##6##2##(1995-11#1)(2006-10#1)(2007-8#1)(2008-4#1)(2012-3#2)
of protein-losing gastroenteropathy##2##3##(2006-4#2)
of protein-phospholipid##2##2##(1992-3#1)(1995-11#1)
of protein-protein and##3##3##(1992-9#1)(2008-1#1)(2008-2#1)
of protein-protein complexes##2##3##(1997-4#1)(2008-4#1)
of protein-protein interaction networks##2##4##(2008-4#2)
of protein-protein interaction##7##3##(1993-12#1)(1993-6#1)(2008-11#1)(2008-4#2)(2009-5#1)(2013-8#1)
of protein-protein interactions are##2##4##(2008-7#2)
of protein-protein interactions in real time##2##6##(2008-4#2)
of protein-protein interactions##24##3##(1990-6#1)(1992-10#1)(1997-1#1)(2005-7#1)(2006-10#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-4#10)(2008-7#3)(2009-5#1)(2010-10#1)
of protein-protein##38##2##(1990-6#1)(1992-10#1)(1992-9#1)(1993-12#1)(1993-6#1)(1997-1#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2008-1#3)(2008-11#2)(2008-2#2)(2008-4#13)(2008-7#3)(2009-5#2)(2010-10#1)(2013-8#1)
of protein-tyrosine kinase##2##3##(1990-3#1)(1992-8#1)
of protein-tyrosine kinases##4##3##(1992-8#1)(1994-3#1)(1994-9#1)(2008-1#1)
of protein-tyrosine phosphorylation##2##3##(1992-8#1)(1994-2#1)
of protein-tyrosine##9##2##(1990-3#1)(1992-8#3)(1994-2#1)(1994-3#1)(1994-9#1)(1995-3#1)(2008-1#1)
of proteinaceous binding media##3##4##(2008-10#3)
of proteinaceous glues##2##3##(2008-10#2)
of proteinaceous##10##2##(1997-6#1)(2005-11#1)(2007-12#1)(2008-10#6)(2008-7#1)
of proteinase inhibition##2##3##(1994-11#1)(1995-7#1)
of proteinase inhibitors##4##3##(1991-8#1)(1992-8#1)(1996-12#2)
of proteinase##10##2##(1990-5#1)(1991-8#1)(1992-8#1)(1994-11#1)(1995-7#1)(1996-12#2)(2005-8#1)(2007-7#1)(2008-4#1)
of proteinases and##2##3##(2008-11#1)(2013-1#1)
of proteinases in##2##3##(1996-2#2)
of proteinases##9##2##(1994-5#1)(1994-6#1)(1995-6#1)(1996-12#1)(1996-2#2)(2008-11#1)(2012-12#1)(2013-1#1)
of proteinkinase C##5##3##(1992-3#3)(2008-1#1)(2008-11#1)
of proteins (e##3##3##(1992-6#1)(2008-2#1)(2008-4#1)
of proteins across##2##3##(1992-12#1)(2009-8#1)
of proteins acting as##2##4##(2009-5#1)(2010-2#1)
of proteins after##2##3##(2008-11#1)(2010-3#1)
of proteins and lipids in##2##5##(1993-11#1)(2007-9#1)
of proteins and lipids##4##4##(1993-11#1)(2007-9#1)(2008-1#2)
of proteins and nucleic acids##2##5##(1995-2#1)(2008-6#1)
of proteins and peptides by capillary##2##6##(1996-5#1)(1997-2#1)
of proteins and peptides using##2##5##(1996-5#1)(2008-2#1)
of proteins and peptides##8##4##(1994-3#1)(1996-3#1)(1996-5#2)(1997-2#1)(2008-10#1)(2008-2#2)
of proteins and the##2##4##(1996-5#1)(2008-6#1)
of proteins and##45##3##(1992-11#1)(1992-6#1)(1993-11#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-11#1)(1996-3#1)(1996-5#3)(1997-2#2)(1997-4#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-7#1)(2011-2#1)(2012-6#1)(2013-1#2)(2013-7#1)(2013-8#1)
of proteins are##12##3##(1991-10#1)(1997-6#1)(2008-1#1)(2008-11#1)(2008-4#3)(2010-12#1)(2010-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
of proteins associated with##4##4##(1990-12#1)(2007-12#1)(2009-7#1)(2010-1#1)
of proteins at nanogram##2##4##(2008-10#2)
of proteins at##3##3##(2008-10#2)(2009-9#1)
of proteins based on the##2##5##(2008-10#2)
of proteins based on##3##4##(2008-10#2)(2011-3#1)
of proteins bearing the##2##4##(1990-6#1)(1995-3#1)
of proteins belonging to the family of receptors coupled to##2##10##(1991-2#2)
of proteins by the##3##4##(1996-12#1)(2006-5#1)(2008-10#1)
of proteins by##14##3##(1990-8#1)(1991-9#1)(1994-3#1)(1996-12#2)(1997-2#2)(1997-7#1)(2006-5#1)(2007-8#1)(2008-10#2)(2008-8#1)(2012-2#1)
of proteins can be##2##4##(1993-6#1)(2006-2#1)
of proteins can##4##3##(1993-6#1)(2006-2#1)(2008-10#1)(2008-4#1)
of proteins encoded by the##2##5##(1993-4#1)(1997-4#1)
of proteins encoded by##3##4##(1990-3#1)(1993-4#1)(1997-4#1)
of proteins for##2##3##(2008-1#1)(2009-3#1)
of proteins from the##4##4##(2005-11#1)(2008-1#1)(2008-6#2)
of proteins from whole-cell##4##4##(2008-2#1)(2008-4#3)
of proteins from##19##3##(1991-12#1)(1992-5#1)(1993-2#1)(1993-6#1)(1994-11#1)(2005-11#1)(2008-1#1)(2008-2#1)(2008-4#7)(2008-6#2)(2008-9#1)(2010-4#1)
of proteins has been##4##4##(1995-1#1)(1997-6#1)(2005-11#1)(2008-10#1)
of proteins has##7##3##(1995-1#1)(1997-6#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)
of proteins have##2##3##(2007-8#1)(2009-3#1)
of proteins having##2##3##(1994-12#1)(2008-11#1)
of proteins in cancer##2##4##(2011-2#1)(2012-12#1)
of proteins in cells##2##4##(2008-1#1)(2010-10#1)
of proteins in complex##2##4##(2008-1#1)(2008-4#1)
of proteins in human##3##4##(2008-10#2)(2008-4#1)
of proteins in solution##6##4##(1990-12#1)(1991-9#1)(1995-4#1)(2008-4#3)
of proteins in the range##2##5##(1995-2#1)(2008-10#1)
of proteins in the##13##4##(1990-3#1)(1990-7#1)(1992-12#1)(1994-12#1)(1995-2#1)(1996-1#1)(1997-3#1)(2008-10#3)(2008-4#1)(2009-8#1)(2013-8#1)
of proteins in##61##3##(1990-11#2)(1990-12#2)(1990-3#1)(1990-7#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-9#2)(1992-12#1)(1992-8#1)(1994-12#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-4#2)(1995-8#1)(1996-1#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-1#3)(2008-10#8)(2008-2#1)(2008-4#10)(2009-12#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#1)(2011-2#3)(2012-12#1)(2013-8#1)
of proteins including##4##3##(1997-4#1)(2008-11#1)(2010-12#1)(2012-2#1)
of proteins into the##2##4##(1994-11#1)(1995-1#1)
of proteins into##7##3##(1993-3#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-1#1)(2008-4#1)(2013-7#1)
of proteins involved in##8##4##(1993-6#1)(2008-1#1)(2008-10#1)(2008-4#2)(2011-1#3)
of proteins involved##9##3##(1993-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#2)(2011-1#3)
of proteins is a##3##4##(1995-3#1)(2008-1#1)(2008-4#1)
of proteins is found##2##4##(2006-12#2)
of proteins is##18##3##(1990-9#1)(1991-4#1)(1994-3#1)(1995-3#1)(2006-12#2)(2007-2#1)(2008-1#2)(2008-10#1)(2008-4#2)(2008-7#3)(2009-5#1)(2009-6#1)(2013-8#1)
of proteins mediating##2##3##(1994-9#1)(2010-12#1)
of proteins modified by##4##4##(2008-2#2)(2008-4#1)(2010-12#1)
of proteins of##7##3##(1991-10#1)(1991-12#1)(1993-8#1)(1994-5#1)(1997-1#2)(2011-2#1)
of proteins on a##2##4##(2008-7#1)(2013-8#1)
of proteins on the##3##4##(1990-8#1)(1995-1#1)(2008-10#1)
of proteins on##8##3##(1990-8#1)(1993-6#1)(1995-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-7#1)(2013-8#1)
of proteins onto##2##3##(2006-11#1)(2013-8#1)
of proteins or dimethyl sulfoxide##2##5##(2013-7#2)
of proteins or##6##3##(2007-12#1)(2008-4#2)(2008-9#1)(2013-7#2)
of proteins produced##2##3##(2006-10#1)(2008-10#1)
of proteins required for##3##4##(2007-12#1)(2009-6#1)(2012-12#1)
of proteins that are##7##4##(1991-5#1)(1995-2#1)(2008-4#2)(2008-7#1)(2010-6#1)(2013-1#1)
of proteins that can##2##4##(2008-2#1)(2009-6#1)
of proteins that have##4##4##(1994-6#1)(2006-5#1)(2009-7#1)(2011-2#1)
of proteins that##24##3##(1990-11#1)(1991-5#1)(1994-6#1)(1995-2#1)(1995-8#1)(2006-5#1)(2008-10#2)(2008-2#1)(2008-4#3)(2008-7#2)(2008-8#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
of proteins through##2##3##(2008-11#1)(2008-8#1)
of proteins to form##2##4##(1990-4#1)(2008-7#1)
of proteins to specific##2##4##(2009-5#1)(2012-7#1)
of proteins to##6##3##(1990-4#1)(2008-11#1)(2008-7#1)(2009-5#1)(2010-12#1)(2012-7#1)
of proteins under##2##3##(1993-5#1)(1995-8#1)
of proteins using the##2##4##(1990-12#1)(2008-10#1)
of proteins using##6##3##(1990-12#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)
of proteins was detected by##2##5##(2010-12#1)(2013-8#1)
of proteins was detected##3##4##(1997-6#1)(2010-12#1)(2013-8#1)
of proteins was##7##3##(1991-10#1)(1997-6#1)(2008-10#2)(2008-4#1)(2010-12#1)(2013-8#1)
of proteins were##6##3##(1990-12#1)(1994-12#1)(2008-10#3)(2008-4#1)
of proteins which are##2##4##(1991-9#1)(1994-12#1)
of proteins which##6##3##(1991-9#1)(1994-12#1)(1994-9#1)(1997-3#1)(2008-1#1)(2010-7#1)
of proteins with a##3##4##(2005-11#1)(2006-10#1)(2006-12#1)
of proteins with some heteropoly compounds##2##6##(2008-10#2)
of proteins with specific##3##4##(2007-6#1)(2008-1#1)(2008-2#1)
of proteins with##32##3##(1991-10#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-6#1)(1994-6#1)(1994-9#1)(1995-7#1)(1996-9#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-6#1)(2008-1#2)(2008-10#7)(2008-2#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-5#2)(2010-7#1)(2011-2#1)(2013-8#1)
of proteins within the##2##4##(2008-1#2)
of proteins within##7##3##(2008-1#2)(2008-4#2)(2008-7#1)(2008-9#1)(2009-12#1)
of proteins##601##2##(1990-10#1)(1990-11#3)(1990-12#5)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#2)(1991-10#5)(1991-11#1)(1991-12#3)(1991-2#2)(1991-4#3)(1991-5#3)(1991-9#5)(1992-1#1)(1992-11#1)(1992-12#3)(1992-3#3)(1992-4#1)(1992-5#3)(1992-6#4)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#2)(1993-5#3)(1993-6#7)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#4)(1994-3#5)(1994-5#3)(1994-6#3)(1994-8#4)(1994-9#6)(1995-1#3)(1995-12#1)(1995-2#10)(1995-3#3)(1995-4#4)(1995-6#1)(1995-7#4)(1995-8#5)(1996-1#1)(1996-10#2)(1996-11#3)(1996-12#5)(1996-2#2)(1996-3#1)(1996-5#5)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#11)(1997-3#3)(1997-4#6)(1997-5#1)(1997-6#4)(1997-7#4)(1997-8#1)(2005-10#2)(2005-11#4)(2006-10#9)(2006-11#1)(2006-12#7)(2006-2#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-11#4)(2007-12#6)(2007-2#1)(2007-6#2)(2007-8#8)(2007-9#2)(2008-1#21)(2008-10#48)(2008-11#12)(2008-2#17)(2008-4#72)(2008-5#11)(2008-6#6)(2008-7#24)(2008-8#5)(2008-9#7)(2009-11#1)(2009-12#3)(2009-3#3)(2009-4#1)(2009-5#6)(2009-6#6)(2009-7#3)(2009-8#7)(2009-9#3)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#9)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#7)(2011-1#6)(2011-2#14)(2011-3#2)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#1)(2012-6#1)(2012-7#1)(2013-1#7)(2013-7#5)(2013-8#13)
of proteinuria and##9##3##(1992-1#1)(1993-12#1)(2004-11#1)(2005-12#1)(2008-1#2)(2011-2#1)(2012-1#1)(2012-2#1)
of proteinuria in##3##3##(2007-11#1)(2008-1#1)(2012-12#1)
of proteinuria##25##2##(1992-1#1)(1993-12#2)(1995-2#1)(2004-11#1)(2005-12#1)(2006-7#2)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-5#2)(2008-8#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
of proteinuric##2##2##(1990-6#1)(2007-8#1)
of proteochondroitin##2##2##(1995-5#2)
of proteoglycan##3##2##(1990-5#1)(1994-5#1)(1994-9#1)
of proteoglycans and##2##3##(1997-8#1)(2007-11#1)
of proteoglycans##12##2##(1990-2#2)(1993-6#1)(1995-5#3)(1996-4#1)(1997-8#1)(2005-8#1)(2007-11#1)(2009-12#1)(2012-3#1)
of proteolipid##2##2##(2009-6#2)
of proteolysis##10##2##(1991-2#2)(1991-5#2)(1992-11#2)(1995-11#1)(1996-8#1)(2009-8#1)(2010-3#1)
of proteolytic activity##5##3##(1990-2#2)(2008-4#1)(2008-6#1)(2010-4#1)
of proteolytic enzymes##6##3##(1991-5#1)(2007-10#1)(2008-5#1)(2010-12#1)(2010-3#1)(2013-1#1)
of proteolytic fragments of##2##4##(1992-2#1)(1992-3#1)
of proteolytic profiles##2##3##(2012-12#2)
of proteolytic##24##2##(1990-11#1)(1990-2#2)(1991-5#2)(1992-2#1)(1992-3#1)(1992-8#1)(1994-8#1)(2006-12#1)(2007-10#1)(2008-4#1)(2008-5#1)(2008-6#2)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-12#2)(2013-1#1)
of proteome##5##2##(2008-4#1)(2008-7#1)(2009-5#2)(2010-2#1)
of proteomes##6##2##(2006-12#1)(2008-4#2)(2008-7#1)(2008-9#1)(2013-8#1)
of proteomic data##2##3##(2008-4#1)(2010-2#1)
of proteomic studies##4##3##(2010-12#2)(2010-2#1)(2013-8#1)
of proteomic##16##2##(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-2#2)(2011-1#1)(2013-1#1)(2013-8#2)
of proteomics data##2##3##(2008-7#2)
of proteomics in##2##3##(2009-6#1)(2012-2#1)
of proteomics##14##2##(2005-11#1)(2008-4#1)(2008-7#4)(2009-5#1)(2009-6#1)(2010-12#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
of proteosome-based vaccines##2##3##(1990-12#2)
of protexin##2##2##(2010-4#2)
of prothrombin activation##2##3##(1990-12#2)
of prothrombin conversion##2##3##(1994-3#1)(1994-8#1)
of prothrombin##8##2##(1990-12#4)(1994-3#1)(1994-8#2)(2007-7#1)
of prothrombinase##6##2##(1990-12#5)(1994-3#1)
of protistan##3##2##(2007-3#1)(2011-2#2)
of proto-oncogene c-fos##3##3##(1991-3#1)(1993-12#1)(1994-12#1)
of proto-oncogene induction##2##3##(1991-5#1)(1996-12#1)
of proto-oncogene##6##2##(1991-3#1)(1991-5#1)(1993-12#1)(1994-12#1)(1995-5#1)(1996-12#1)
of proto-oncogenes and##2##3##(1990-7#1)(2008-3#1)
of proto-oncogenes##5##2##(1990-7#1)(1992-9#1)(2008-3#1)(2008-7#1)(2011-2#1)
of protocatechuic acid##2##3##(2008-10#1)(2012-3#1)
of protocol biopsies and##2##4##(2007-8#2)
of protocol biopsies##3##3##(2007-8#3)
of protocol##10##2##(1995-1#1)(2007-8#3)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#2)(2013-8#1)
of protocols and##2##3##(2007-12#1)(2008-4#1)
of protocols for##6##3##(2008-4#4)(2008-9#1)(2012-3#1)
of protocols in##4##3##(1994-7#1)(2008-4#1)(2008-9#1)(2010-10#1)
of protocols is provided##2##4##(2008-4#1)(2008-9#1)
of protocols that##2##3##(2008-1#1)(2008-4#1)
of protocols##23##2##(1994-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#11)(2008-9#5)(2010-10#1)(2012-3#1)
of protoheme IX to##2##4##(1992-12#1)(1994-8#1)
of proton NMR##3##3##(1993-8#1)(1996-8#1)(2008-5#1)
of proton and##2##3##(1994-8#1)(2008-10#1)
of proton leak##2##3##(1990-8#2)
of proton pump inhibitor##2##4##(2009-11#1)(2012-2#1)
of proton pump inhibitors on##2##5##(2010-12#1)(2012-2#1)
of proton pump inhibitors##11##4##(2006-10#1)(2008-6#1)(2010-12#5)(2012-2#4)
of proton pump##15##3##(2006-10#1)(2006-2#1)(2006-6#1)(2008-6#1)(2009-11#1)(2010-12#5)(2012-2#5)
of proton release##4##3##(1997-6#4)
of proton resonances##2##3##(1990-7#1)(1996-7#1)
of proton transfer##3##3##(1992-3#1)(1995-10#1)(2011-1#1)
of proton uptake##2##3##(1994-9#1)(1995-5#1)
of proton##49##2##(1990-7#1)(1990-8#2)(1992-11#1)(1992-3#1)(1993-8#1)(1994-12#1)(1994-8#4)(1994-9#1)(1995-10#1)(1995-5#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-6#5)(2005-11#1)(2006-10#2)(2006-2#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-6#2)(2009-11#1)(2010-12#5)(2010-9#1)(2011-1#2)(2012-12#1)(2012-2#5)
of proton-exchanged##2##2##(2008-2#2)
of protonated##22##2##(1990-11#1)(1995-10#1)(1996-6#1)(2006-3#1)(2006-4#2)(2007-8#2)(2008-10#11)(2010-5#1)(2012-12#2)
of protonation constants##2##3##(2008-10#2)
of protonation of##4##3##(2005-11#1)(2008-10#3)
of protonation##11##2##(1990-5#1)(1996-2#1)(1997-7#1)(2005-11#2)(2008-10#6)
of protonophores##4##2##(1996-4#4)
of protons into##2##3##(2006-8#2)
of protons##18##2##(1990-2#1)(1990-3#1)(1991-12#1)(1991-2#1)(1991-9#1)(1993-3#2)(1994-9#1)(1996-1#1)(1996-7#1)(1997-4#1)(1997-5#1)(2006-8#2)(2008-10#2)(2011-1#1)(2013-1#1)
of protoplasts##4##2##(2008-8#1)(2008-9#2)(2010-2#1)
of protoporphyrin IX##3##3##(1996-9#2)(2012-3#1)
of protoporphyrin##6##2##(1990-1#1)(1990-3#1)(1996-9#3)(2012-3#1)
of protostomes and deuterostomes##2##4##(2007-12#2)
of prototype##3##2##(2008-10#1)(2012-1#1)(2013-1#1)
of prototypical##2##2##(2008-10#1)(2009-11#1)
of protozoa##3##2##(2008-12#1)(2009-10#1)(2012-12#1)
of protozoan##2##2##(2008-12#1)(2011-2#1)
of protruding##2##2##(1990-9#1)(2012-12#1)
of prourokinase##3##2##(2008-11#3)
of proven education##2##3##(2007-4#2)
of proven efficacy in##2##4##(2007-11#1)(2012-12#1)
of proven efficacy##3##3##(2006-8#1)(2007-11#1)(2012-12#1)
of proven##17##2##(1992-8#1)(2005-11#2)(2006-8#1)(2007-11#1)(2007-2#1)(2007-4#2)(2007-7#1)(2008-5#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-3#1)
of provider performance##2##3##(1995-3#1)(2013-1#1)
of provider##9##2##(1991-3#1)(1995-3#1)(1996-11#1)(1997-1#1)(1997-3#1)(2008-8#1)(2011-1#1)(2013-1#2)
of providers##17##2##(1991-10#1)(1992-1#1)(1993-12#1)(1994-1#2)(1994-12#1)(1996-1#1)(1996-12#1)(1997-3#2)(2006-8#3)(2011-2#1)(2013-1#3)
of providing a##13##3##(1990-12#1)(1991-11#1)(1996-3#1)(2004-11#1)(2004-3#1)(2005-10#1)(2007-12#1)(2008-2#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
of providing an##6##3##(2007-12#1)(2008-3#1)(2009-5#1)(2009-7#1)(2012-12#1)(2013-1#1)
of providing better##2##3##(2005-10#1)(2008-7#1)
of providing care to##4##4##(2006-1#1)(2008-11#1)(2008-6#1)(2010-4#1)
of providing care##7##3##(2006-1#1)(2006-12#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-4#1)(2011-2#1)
of providing detailed##2##3##(2008-5#1)(2011-1#1)
of providing high##2##3##(2008-11#1)(2008-2#1)
of providing information##2##3##(2005-11#1)(2008-4#1)
of providing more##2##3##(2010-10#1)(2012-3#1)
of providing the##2##3##(1997-1#1)(2008-1#1)
of providing##103##2##(1990-12#1)(1991-1#1)(1991-11#1)(1991-12#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#2)(1993-11#2)(1993-12#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(2004-11#1)(2004-3#1)(2005-10#2)(2005-11#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-10#3)(2007-11#1)(2007-12#5)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-5#2)(2009-7#2)(2010-10#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#5)(2011-3#1)(2012-1#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
of provincial##4##2##(1991-3#1)(2007-9#1)(2009-12#1)(2012-12#1)
of proviruses##2##2##(1991-5#1)(1995-8#1)
of provision##2##2##(1995-12#1)(2012-3#1)
of provisional restorations' deficiencies##2##4##(2012-2#2)
of provisional##9##2##(2005-5#1)(2007-3#2)(2010-2#2)(2012-2#3)(2012-7#1)
of provisions of##2##3##(1995-9#1)(2007-4#1)
of provisions##3##2##(1991-10#1)(1995-9#1)(2007-4#1)
of provocation##2##2##(2006-7#1)(2006-8#1)
of provocative##3##2##(2006-10#1)(2006-8#1)(2008-4#1)
of proximal and distal##2##4##(2006-6#1)(2009-2#1)
of proximal femur fractures in##2##5##(2007-11#1)(2009-3#1)
of proximal femur fractures##3##4##(2007-11#1)(2007-8#1)(2009-3#1)
of proximal femur##5##3##(2007-11#3)(2007-8#1)(2009-3#1)
of proximal humerus fractures##3##4##(2007-8#3)
of proximal humerus##5##3##(2007-8#4)(2009-4#1)
of proximal interphalangeal##2##3##(2008-12#1)(2008-9#1)
of proximal renal##2##3##(1990-8#1)(1991-8#1)
of proximal tubular##2##3##(1991-4#1)(1995-11#1)
of proximal##47##2##(1990-6#1)(1990-8#1)(1991-4#1)(1991-8#1)(1992-8#1)(1993-1#1)(1993-6#1)(1994-5#1)(1995-11#1)(1996-5#1)(2006-3#1)(2006-6#1)(2007-11#4)(2007-8#7)(2008-10#2)(2008-12#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2010-10#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-7#1)(2013-8#4)
of proximate composition##2##3##(2012-2#1)(2013-7#1)
of proximate##6##2##(2007-8#1)(2008-5#1)(2008-6#2)(2012-2#1)(2013-7#1)
of proximity##4##2##(2008-10#2)(2008-6#1)(2010-7#1)
of proxy respondents##2##3##(2011-1#2)
of proxy##4##2##(2011-1#4)
of prudent##2##2##(1990-12#1)(2008-6#1)
of prune##4##2##(2008-10#3)(2008-7#1)
of pruritic##2##2##(2007-7#1)(2008-3#1)
of pruritus and##3##3##(2005-7#1)(2006-10#1)(2007-2#1)
of pruritus is##2##3##(2004-11#1)(2007-8#1)
of pruritus##14##2##(2004-11#1)(2005-11#1)(2005-7#2)(2006-10#1)(2007-2#2)(2007-8#1)(2008-1#2)(2008-3#2)(2008-5#1)(2010-12#1)
of ps15##2##2##(1994-5#2)
of psbP##2##2##(1996-10#2)
of pseudarthrosis##4##2##(2006-8#2)(2007-11#2)
of pseudo cyst##2##3##(2008-5#2)
of pseudo##4##2##(2007-6#1)(2008-5#2)(2009-7#1)
of pseudo-nondiffracting beams by use of diffractive phase elements##2##9##(2008-2#2)
of pseudoaneurysm##3##2##(1991-3#1)(2007-8#1)(2008-12#1)
of pseudoaneurysms##2##2##(2008-4#1)(2008-7#1)
of pseudoarthrosis in the##2##4##(2007-7#1)(2009-3#1)
of pseudoarthrosis##7##2##(2007-7#1)(2007-8#2)(2008-4#2)(2009-3#2)
of pseudodipeptides##2##2##(2008-5#2)
of pseudoephedrine##8##2##(2008-10#4)(2010-4#4)
of pseudoislets##2##2##(2010-11#2)
of pseudomonic acid##5##3##(1994-9#2)(1996-8#3)
of pseudomyxoma peritonei##3##3##(2006-6#1)(2007-2#1)(2008-2#1)
of pseudophakic CME##2##3##(2012-12#2)
of pseudophakic##3##2##(2012-12#2)(2013-1#1)
of pseudopregnancy##3##2##(1992-9#1)(1995-6#2)
of pseudopregnant rat##2##3##(1997-6#1)(2008-9#1)
of pseudorabies virus##4##3##(1992-8#1)(1995-7#1)(1997-2#1)(2005-11#1)
of pseudosclerotia##9##2##(2008-10#9)
of pseudothecia and ascospores##2##4##(2008-10#2)
of pseudothecia and##4##3##(2008-10#4)
of pseudothecia on##2##3##(2008-10#2)
of pseudothecia was##3##3##(2008-10#3)
of pseudothecia##15##2##(2008-10#15)
of pseudothecial##2##2##(2008-10#2)
of pseudouridine (psi)##3##3##(1991-4#1)(1993-8#1)(1994-8#1)
of pseudouridine in human urine and serum##2##7##(1990-8#2)
of pseudouridine in##3##3##(1990-8#2)(1994-8#1)
of pseudouridine##8##2##(1990-8#2)(1991-4#1)(1992-3#2)(1993-8#1)(1994-8#2)
of pseudowords##2##2##(2008-4#1)(2010-7#1)
of pseudoxanthoma elasticum##2##3##(2006-10#2)
of psi##5##2##(1993-8#1)(1994-8#3)(1994-9#1)
of psilocin and psilocybin using flow injection analysis with acidic potassium permanganate and tris(2##2##14##(2008-10#2)
of psilocin and psilocybin##3##4##(2008-10#3)
of psilocybin in##3##3##(2008-10#3)
of psilocybin users##5##3##(2013-8#5)
of psilocybin was##2##3##(2008-10#2)
of psilocybin##13##2##(2008-10#5)(2013-8#8)
of psittacine beak and feather disease##3##6##(2008-5#2)(2012-2#1)
of psittacine birds##2##3##(2008-5#2)
of psittacine##6##2##(2008-5#5)(2012-2#1)
of psoralen photochemotherapy##2##3##(1992-6#1)(2007-8#1)
of psoralen##10##2##(1992-6#5)(1994-3#2)(2007-7#1)(2007-8#2)
of psoralens and##3##3##(1992-6#3)
of psoralens##8##2##(1992-6#8)
of psoriasis and psoriatic arthritis##3##5##(2006-10#2)(2008-5#1)
of psoriasis and##7##3##(2005-8#1)(2006-10#2)(2007-7#2)(2008-5#1)(2008-6#1)
of psoriasis in##3##3##(1997-8#1)(2007-11#1)(2008-6#1)
of psoriasis that##2##3##(1990-5#1)(2008-6#1)
of psoriasis vulgaris##4##3##(2007-7#1)(2007-8#3)
of psoriasis##58##2##(1990-5#1)(1990-6#1)(1991-12#1)(1993-11#1)(1993-8#1)(1995-5#2)(1997-8#2)(2005-11#4)(2005-8#1)(2006-10#2)(2007-11#4)(2007-7#5)(2007-8#6)(2008-1#4)(2008-12#2)(2008-5#5)(2008-6#5)(2009-11#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-3#1)(2013-7#1)
of psoriasis]##2##2##(1990-5#1)(2013-7#1)
of psoriatic arthritis (PsA)##2##4##(2006-10#1)(2008-3#1)
of psoriatic arthritis##6##3##(1990-6#1)(2006-10#2)(2008-3#3)
of psoriatic patients##2##3##(1993-8#1)(2011-2#1)
of psoriatic##9##2##(1990-6#1)(1993-8#1)(2006-10#2)(2008-3#3)(2009-11#1)(2011-2#1)
of psychiatric and neurological disorders##2##5##(1994-11#1)(2011-2#1)
of psychiatric and##4##3##(1990-3#1)(1994-11#1)(2011-2#2)
of psychiatric care##2##3##(2010-5#1)(2012-11#1)
of psychiatric comorbidity##2##3##(2008-6#1)(2013-1#1)
of psychiatric diseases##3##3##(1996-12#1)(2009-4#1)(2013-1#1)
of psychiatric disorder##3##3##(1993-7#1)(2007-11#1)(2011-1#1)
of psychiatric disorders and##2##4##(2007-11#1)(2008-9#1)
of psychiatric disorders in##3##4##(2005-9#1)(2007-1#1)(2011-12#1)
of psychiatric disorders##21##3##(1995-11#1)(1996-11#2)(1997-5#1)(2005-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-9#1)(2011-1#2)(2011-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
of psychiatric hospitals##2##3##(1992-3#1)(1993-12#1)
of psychiatric inpatients##2##3##(2009-2#1)(2009-4#1)
of psychiatric morbidity##2##3##(1993-5#1)(2012-3#1)
of psychiatric occupational therapy##2##4##(2012-1#2)
of psychiatric patients##12##3##(1992-1#1)(1996-3#1)(2006-6#1)(2006-9#1)(2007-1#1)(2008-6#2)(2009-7#2)(2011-2#1)(2012-2#2)
of psychiatric patients]##2##3##(2007-10#1)(2008-6#1)
of psychiatric research##3##3##(1992-8#1)(2011-1#2)
of psychiatric services##2##3##(2008-2#2)
of psychiatric symptoms in##4##4##(1996-3#1)(2009-12#1)(2010-12#1)(2011-2#1)
of psychiatric symptoms##9##3##(1996-3#1)(1997-1#1)(2004-3#2)(2009-12#1)(2010-12#1)(2011-2#1)(2013-8#2)
of psychiatric treatment##4##3##(1991-6#1)(1993-2#1)(2009-2#1)(2010-11#1)
of psychiatric##111##2##(1990-3#1)(1991-1#1)(1991-2#2)(1991-6#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-7#2)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#1)(1996-3#2)(1997-1#1)(1997-5#1)(1997-8#1)(2004-11#1)(2004-3#2)(2005-9#1)(2006-6#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#1)(2008-11#2)(2008-2#5)(2008-5#2)(2008-6#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-4#3)(2009-7#3)(2009-9#2)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#6)(2011-12#1)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#4)(2013-8#5)
of psychiatrists##2##2##(2005-7#1)(2006-8#1)
of psychiatry and##3##3##(1996-1#1)(2008-6#1)(2010-9#1)
of psychiatry in the##2##4##(2008-2#1)(2010-7#1)
of psychiatry in##7##3##(2006-9#1)(2008-2#1)(2009-10#1)(2010-7#1)(2011-7#1)(2012-2#2)
of psychiatry##27##2##(1991-3#1)(1992-8#2)(1993-1#1)(1996-1#1)(1996-12#1)(2006-9#3)(2008-2#3)(2008-6#1)(2008-7#1)(2009-10#1)(2009-2#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-7#2)(2012-2#4)(2013-8#1)
of psychoactive drugs##7##3##(1994-2#1)(2008-1#1)(2008-6#1)(2009-2#2)(2012-3#2)
of psychoactive substances##4##3##(2008-1#1)(2009-2#1)(2010-9#1)(2013-1#1)
of psychoactive##11##2##(1994-2#1)(2008-1#2)(2008-6#1)(2009-2#3)(2010-9#1)(2012-3#2)(2013-1#1)
of psychoanalysis##6##2##(2006-9#2)(2008-5#2)(2011-2#1)(2012-2#1)
of psychodermatology##3##2##(2013-7#3)
of psychoeducation##2##2##(2012-12#2)
of psychogenic##2##2##(1991-11#1)(2008-9#1)
of psychological and##4##3##(1993-7#1)(2008-1#1)(2008-4#1)(2010-12#1)
of psychological distress and##3##4##(2006-4#1)(2007-12#1)(2008-6#1)
of psychological distress##10##3##(2004-11#2)(2004-2#1)(2006-4#2)(2007-12#1)(2008-3#1)(2008-6#1)(2012-1#2)
of psychological factors##5##3##(1993-12#1)(1995-9#1)(2006-10#1)(2006-9#1)(2009-2#1)
of psychological stress on##2##4##(1993-7#1)(2008-6#1)
of psychological support##2##3##(2008-6#2)
of psychological symptoms##2##3##(2008-2#1)(2008-4#1)
of psychological techniques##2##3##(1993-8#1)(2012-2#1)
of psychological therapies##2##3##(2006-9#2)
of psychological##60##2##(1992-3#1)(1993-12#1)(1993-7#2)(1993-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(2004-11#2)(2004-2#1)(2006-10#3)(2006-2#1)(2006-3#1)(2006-4#2)(2006-7#1)(2006-8#1)(2006-9#4)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#5)(2008-7#1)(2009-10#1)(2009-2#1)(2009-7#1)(2010-12#2)(2011-1#2)(2011-2#5)(2012-1#2)(2012-2#2)
of psychologists as##2##3##(2008-12#2)
of psychologists who##2##3##(2008-12#1)(2008-3#1)
of psychologists##9##2##(2006-2#1)(2008-12#7)(2008-3#1)
of psychology as##3##3##(2008-11#1)(2008-12#2)
of psychology in##3##3##(2006-8#1)(2008-12#2)
of psychology##12##2##(1991-2#1)(2006-12#1)(2006-8#1)(2008-11#1)(2008-12#4)(2008-9#1)(2009-10#1)(2011-1#2)
of psychometric##4##2##(1990-6#1)(2009-12#1)(2010-2#1)(2013-8#1)
of psychomotor##4##2##(1996-10#1)(2006-10#1)(2007-11#1)(2008-1#1)
of psychopathological##3##2##(2008-9#1)(2011-2#1)(2012-12#1)
of psychopathology and##3##3##(1992-5#1)(2008-2#1)(2012-2#1)
of psychopathology in##2##3##(2008-7#1)(2011-2#1)
of psychopathology##21##2##(1992-5#1)(1996-11#1)(1997-8#1)(2006-3#2)(2006-8#1)(2007-12#1)(2007-7#1)(2008-2#1)(2008-7#1)(2009-10#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-5#1)(2013-1#1)(2013-8#2)
of psychopathy##3##2##(2009-12#1)(2010-12#1)(2012-2#1)
of psychopharmacologic##3##2##(2005-6#1)(2008-4#2)
of psychopharmacological##2##2##(1990-3#1)(2011-1#1)
of psychophysical##3##2##(1992-4#1)(2008-9#1)(2011-2#1)
of psychophysiologic##2##2##(2004-3#2)
of psychophysiological##2##2##(1992-4#1)(1995-12#1)
of psychoses##2##2##(1991-9#1)(1993-6#1)
of psychosis and##3##3##(1995-1#1)(1995-11#1)(2006-9#1)
of psychosis in##2##3##(1993-1#1)(2008-7#1)
of psychosis##23##2##(1992-12#1)(1993-1#1)(1995-1#1)(1995-11#1)(1996-7#1)(1997-2#1)(1997-5#1)(2005-8#1)(2006-3#1)(2006-9#1)(2007-6#3)(2007-7#2)(2008-11#1)(2008-7#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-11#1)
of psychosocial development##2##3##(2012-12#1)(2012-2#1)
of psychosocial factors at work##2##5##(2011-1#2)
of psychosocial factors in the##2##5##(2005-10#1)(2013-8#1)
of psychosocial factors##5##3##(2005-10#1)(2008-2#1)(2011-1#2)(2013-8#1)
of psychosocial intervention##3##3##(1992-3#1)(2007-12#1)(2008-2#1)
of psychosocial interventions##3##3##(1992-12#1)(2009-6#1)(2009-7#1)
of psychosocial##34##2##(1990-8#1)(1992-12#2)(1992-3#2)(1992-7#1)(1996-1#1)(2005-10#3)(2005-6#1)(2006-12#2)(2007-1#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-2#3)(2009-6#1)(2009-7#1)(2011-1#4)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#2)(2013-8#2)
of psychosocially focused##2##3##(2010-11#2)
of psychotherapeutic interventions##3##3##(2008-6#1)(2013-1#1)(2013-8#1)
of psychotherapeutic##7##2##(1995-6#1)(2008-6#1)(2009-10#2)(2013-1#2)(2013-8#1)
of psychotherapy and##2##3##(2009-12#2)
of psychotherapy##14##2##(1991-9#1)(1994-11#2)(2004-3#2)(2008-2#1)(2008-4#1)(2009-12#2)(2009-9#2)(2011-12#1)(2013-1#2)
of psychotic disorders##3##3##(2005-7#1)(2006-3#1)(2008-4#1)
of psychotic illness##2##3##(1995-11#1)(2011-2#1)
of psychotic symptoms in PTSD is##2##6##(2007-7#2)
of psychotic symptoms in PTSD##3##5##(2007-7#3)
of psychotic symptoms in##6##4##(2007-7#5)(2012-2#1)
of psychotic symptoms##11##3##(1997-8#1)(2007-7#5)(2010-12#1)(2012-1#1)(2012-12#1)(2012-2#2)
of psychotic##20##2##(1993-8#1)(1995-11#1)(1997-8#1)(2005-7#1)(2006-3#1)(2007-7#5)(2008-4#1)(2010-12#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#2)
of psychotic-like##2##2##(1995-11#1)(2012-1#1)
of psychotropic agents##2##3##(1995-12#1)(2005-9#1)
of psychotropic drugs in##4##4##(1992-10#1)(1994-3#1)(2007-8#1)(2009-7#1)
of psychotropic drugs##13##3##(1992-10#2)(1994-3#2)(1996-9#2)(2005-11#1)(2007-8#1)(2008-3#1)(2009-3#1)(2009-7#1)(2010-2#1)(2011-2#1)
of psychotropic medications is##2##4##(2005-9#1)(2007-11#1)
of psychotropic medications##3##3##(1996-9#1)(2005-9#1)(2007-11#1)
of psychotropic##21##2##(1992-10#2)(1992-2#1)(1994-3#3)(1995-12#1)(1996-9#3)(2005-11#1)(2005-9#2)(2007-11#1)(2007-8#1)(2008-3#1)(2009-3#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-3#1)
of psychotropics##6##2##(1994-3#1)(2008-4#1)(2013-8#4)
of psychrotrophic bacteria##2##3##(2011-2#2)
of ptc##3##2##(1994-3#2)(1997-6#1)
of pterin##3##2##(2006-12#3)
of pterygium##3##2##(2008-4#2)(2010-11#1)
of pthN##2##2##(2008-10#2)
of pts##4##2##(2006-6#2)(2007-11#1)(2010-3#1)
of pubertal##4##2##(2008-4#1)(2012-2#1)(2013-1#2)
of puberty and##4##3##(2006-10#2)(2008-2#1)(2008-4#1)
of puberty in##10##3##(2006-10#4)(2006-7#1)(2009-5#5)
of puberty##23##2##(1991-1#1)(2006-10#8)(2006-7#1)(2006-9#1)(2008-11#1)(2008-2#1)(2008-4#2)(2009-5#6)(2009-6#1)(2013-8#1)
of pubic hair##5##3##(2006-10#2)(2008-4#1)(2011-2#2)
of pubic##6##2##(2006-10#2)(2007-7#1)(2008-4#1)(2011-2#2)
of pubis##3##2##(1995-6#1)(2008-5#2)
of public and##3##3##(1996-3#1)(2008-3#1)(2011-2#1)
of public dental care for##2##5##(2008-9#2)
of public funding##2##3##(1991-12#1)(1994-2#1)
of public goods##3##3##(2008-10#2)(2012-3#1)
of public health activities##2##4##(1992-1#1)(1996-12#1)
of public health and a##2##5##(1994-1#1)(1997-3#1)
of public health and health##2##5##(2006-6#1)(2012-3#1)
of public health and medical care##2##6##(1995-2#2)
of public health and medicine##4##5##(1995-2#3)(2009-5#1)
of public health and##20##4##(1994-1#1)(1995-2#5)(1996-12#3)(1997-2#1)(1997-3#1)(2006-6#1)(2007-10#1)(2007-2#1)(2008-6#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of public health importance##6##4##(1994-7#1)(1997-3#1)(2007-7#1)(2008-7#1)(2010-1#1)(2011-2#1)
of public health in an##2##5##(1996-3#1)(1997-3#1)
of public health in##5##4##(1993-6#1)(1996-3#1)(1997-3#1)(2007-2#1)(2008-1#1)
of public health is##2##4##(1996-3#1)(2013-1#1)
of public health nurses and high-priority families in northern##2##9##(2010-9#2)
of public health nurses and high-priority families in##3##8##(2010-9#3)
of public health nurses##5##4##(1995-3#1)(1996-2#1)(2010-9#3)
of public health nutritionists employed in provincial and municipal/regional departments of health in Canada##2##14##(1993-1#1)(1993-2#1)
of public health nutritionists##3##4##(1993-1#1)(1993-2#2)
of public health officials##2##4##(2012-12#2)
of public health policy##2##4##(1993-2#1)(2013-1#1)
of public health practice##4##4##(1996-2#1)(1996-3#1)(1997-3#2)
of public health professionals##2##4##(2006-10#1)(2013-1#1)
of public health services##3##4##(1990-12#1)(1997-1#1)(2011-1#1)
of public health surveillance##4##4##(1997-3#3)(2008-7#1)
of public health to##2##4##(1997-2#1)(2008-7#1)
of public health##134##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-8#1)(1991-4#1)(1992-1#1)(1993-1#1)(1993-2#3)(1993-3#1)(1993-4#1)(1993-6#1)(1994-1#2)(1994-7#1)(1995-12#10)(1995-2#5)(1995-3#1)(1995-6#1)(1996-1#7)(1996-12#5)(1996-2#6)(1996-3#8)(1997-1#1)(1997-2#5)(1997-3#12)(2005-3#1)(2006-10#3)(2006-6#1)(2007-10#1)(2007-2#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#7)(2013-8#1)
of public involvement##3##3##(1996-12#1)(2008-7#2)
of public policies##2##3##(2012-2#1)(2013-1#1)
of public policy##3##3##(1996-3#1)(1996-4#1)(2008-12#1)
of public relations##6##3##(2008-12#6)
of public safety##2##3##(1991-3#1)(2012-11#1)
of public sector##3##3##(1995-3#1)(2007-11#1)(2008-11#1)
of public services##3##3##(2008-7#1)(2008-9#1)(2012-3#1)
of public##214##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-8#1)(1991-12#2)(1991-3#3)(1991-4#1)(1992-1#1)(1992-5#1)(1993-1#1)(1993-2#4)(1993-3#2)(1993-4#1)(1993-6#1)(1994-1#2)(1994-2#6)(1994-7#1)(1995-12#10)(1995-2#5)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#7)(1996-12#6)(1996-2#6)(1996-3#12)(1996-4#1)(1996-9#1)(1997-1#1)(1997-2#7)(1997-3#12)(2005-10#1)(2005-3#1)(2005-5#2)(2006-10#5)(2006-2#1)(2006-6#1)(2006-7#2)(2007-10#1)(2007-11#1)(2007-2#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#7)(2008-2#4)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#4)(2009-10#1)(2009-4#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-11#2)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#10)(2013-8#3)
of public-private partnership##3##3##(1995-3#1)(2006-10#2)
of publication of##2##3##(2008-3#1)(2010-12#1)
of publication##73##2##(1991-3#1)(1995-9#1)(1996-12#1)(2005-7#1)(2007-6#1)(2007-8#61)(2008-3#1)(2009-2#1)(2010-12#1)(2013-1#3)(2013-7#1)
of publications has##2##3##(2008-11#1)(2013-8#1)
of publications in##3##3##(2006-10#1)(2007-6#1)(2010-12#1)
of publications on this##2##4##(2008-8#1)(2008-9#1)
of publications on##7##3##(1994-3#1)(2005-9#1)(2006-10#1)(2007-8#1)(2008-8#2)(2008-9#1)
of publications reviewed##3##3##(2008-10#1)(2012-12#2)
of publications##37##2##(1992-2#1)(1994-3#1)(1995-2#1)(1996-5#1)(1997-5#1)(2005-7#1)(2005-9#1)(2006-10#3)(2006-11#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-8#2)(2008-9#1)(2009-2#2)(2009-3#1)(2009-9#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
of publicly available##2##3##(2008-4#1)(2012-3#1)
of publicly##4##2##(1991-3#1)(1992-2#1)(2008-4#1)(2012-3#1)
of published cases##3##3##(2006-10#1)(2006-9#1)(2012-12#1)
of published data##11##3##(1991-2#1)(1995-1#1)(2006-11#1)(2008-10#1)(2009-10#1)(2009-4#1)(2012-12#1)(2013-1#4)
of published evidence##2##3##(1996-9#1)(2005-10#1)
of published literature##7##3##(2004-12#1)(2007-11#1)(2008-6#1)(2008-9#1)(2009-10#1)(2012-3#1)(2013-8#1)
of published reports##4##3##(1995-9#1)(2006-12#1)(2008-2#1)(2012-12#1)
of published research##5##3##(2006-9#1)(2007-8#2)(2009-5#1)(2011-1#1)
of published studies##9##3##(2005-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
of published##78##2##(1991-2#1)(1991-4#1)(1992-1#1)(1993-2#1)(1995-1#1)(1995-3#1)(1995-9#2)(1996-9#1)(1997-1#2)(1997-4#1)(2004-12#1)(2005-10#1)(2005-7#2)(2006-10#3)(2006-11#2)(2006-12#1)(2006-9#2)(2007-11#4)(2007-8#3)(2008-10#6)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#4)(2009-10#2)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
of publishing##3##2##(2005-7#1)(2006-10#1)(2007-4#1)
of puerarin##2##2##(2012-12#1)(2012-2#1)
of puerperal##2##2##(2009-10#1)(2012-12#1)
of pufferfish##2##2##(2008-8#1)(2012-12#1)
of pull-out strength##3##3##(2007-11#2)(2013-1#1)
of pulling##2##2##(2007-12#1)(2008-12#1)
of pulmonary TA##2##3##(2006-10#2)
of pulmonary TB in children##2##5##(2011-2#2)
of pulmonary TB in##3##4##(2011-2#3)
of pulmonary TB##4##3##(2011-11#1)(2011-2#3)
of pulmonary adenocarcinoma##2##3##(1994-3#1)(2008-5#1)
of pulmonary adenomas##2##3##(1990-7#1)(2008-9#1)
of pulmonary and hepatic##2##4##(1992-9#1)(2011-1#1)
of pulmonary and##9##3##(1992-9#1)(1997-1#1)(2008-6#1)(2009-6#1)(2010-10#1)(2010-3#1)(2011-1#1)(2013-1#2)
of pulmonary arterial hypertension (PAH)##2##5##(2010-10#2)
of pulmonary arterial hypertension##6##4##(2007-11#1)(2008-4#1)(2010-10#3)(2013-1#1)
of pulmonary arterial##11##3##(1996-3#1)(2007-11#1)(2008-10#2)(2008-4#1)(2010-10#3)(2011-2#1)(2012-2#1)(2013-1#1)
of pulmonary arteries and##2##4##(2010-8#1)(2012-3#1)
of pulmonary arteries##4##3##(2008-1#2)(2010-8#1)(2012-3#1)
of pulmonary arteriovenous##2##3##(2007-8#1)(2008-4#1)
of pulmonary artery hypertension##2##4##(2007-11#1)(2007-9#1)
of pulmonary artery smooth muscle##2##5##(2010-12#1)(2012-2#1)
of pulmonary artery##15##3##(1993-12#2)(2006-10#2)(2007-11#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-4#1)(2010-12#1)(2012-2#1)(2013-1#3)
of pulmonary aspergillosis in##2##4##(2007-7#1)(2012-12#1)
of pulmonary aspergillosis##4##3##(2007-7#1)(2008-1#2)(2012-12#1)
of pulmonary blood flow evaluation##2##5##(2010-9#2)
of pulmonary blood flow##4##4##(2006-10#1)(2007-8#1)(2010-9#2)
of pulmonary capillaries##2##3##(1993-6#1)(2006-10#1)
of pulmonary coccidioidomycosis##3##3##(1993-5#1)(2007-12#2)
of pulmonary complications in##2##4##(1990-10#1)(2008-4#1)
of pulmonary complications##7##3##(1990-10#1)(1992-12#1)(1997-3#1)(2007-4#1)(2008-4#1)(2012-1#1)(2013-8#1)
of pulmonary disease in##3##4##(1997-3#1)(2006-10#1)(2007-12#1)
of pulmonary disease##5##3##(1997-3#1)(2006-10#1)(2007-12#1)(2007-6#1)(2011-2#1)
of pulmonary disorders##2##3##(2007-3#2)
of pulmonary embolism (PE)##3##4##(2007-8#1)(2008-3#1)(2010-8#1)
of pulmonary embolism##14##3##(1991-11#3)(1993-7#1)(2005-10#1)(2005-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-10#1)(2010-8#1)
of pulmonary fibrosis and##2##4##(2005-8#1)(2010-12#1)
of pulmonary fibrosis in##2##4##(1994-6#1)(2012-1#1)
of pulmonary fibrosis##9##3##(1994-6#1)(2005-8#1)(2010-12#1)(2012-1#3)(2012-12#1)(2012-2#2)
of pulmonary function and##2##4##(2006-10#1)(2011-2#1)
of pulmonary function tests##3##4##(1991-12#1)(2007-2#1)(2008-8#1)
of pulmonary function##10##3##(1991-12#1)(1992-5#1)(2005-11#1)(2006-10#2)(2007-2#1)(2008-8#1)(2011-2#1)(2011-3#1)(2012-3#1)
of pulmonary functions##2##3##(2007-8#1)(2012-2#1)
of pulmonary histoplasmosis##2##3##(2008-1#2)
of pulmonary hyalinizing granuloma##2##4##(2008-10#2)
of pulmonary hydatid##2##3##(2007-9#1)(2013-7#1)
of pulmonary hypertension##17##3##(2005-11#1)(2005-9#3)(2006-10#1)(2007-8#1)(2010-10#2)(2010-5#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)
of pulmonary infarction##2##3##(2007-8#2)
of pulmonary infection##3##3##(1991-11#1)(1995-7#1)(2007-7#1)
of pulmonary infections##2##3##(1997-1#1)(2006-10#1)
of pulmonary lesions##6##3##(2006-10#1)(2012-2#1)(2013-8#4)
of pulmonary metastases in osteosarcoma##2##5##(2010-3#2)
of pulmonary metastases##8##3##(1991-9#1)(1992-7#1)(2008-8#1)(2010-11#1)(2010-3#4)
of pulmonary metastasis from##3##4##(2008-6#1)(2012-1#1)(2013-7#1)
of pulmonary metastasis##6##3##(2008-6#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-7#1)
of pulmonary metastatic##2##3##(2008-7#1)(2012-1#1)
of pulmonary or##2##3##(2010-12#1)(2011-1#1)
of pulmonary origin##3##3##(1994-7#1)(2011-2#2)
of pulmonary rehabilitation##3##3##(1997-8#1)(2007-6#1)(2011-2#1)
of pulmonary surfactant##7##3##(1994-12#1)(1994-3#1)(1996-12#2)(1996-5#2)(2011-1#1)
of pulmonary thromboembolism##2##3##(2008-10#1)(2008-6#1)
of pulmonary tuberculosis in##2##4##(1995-3#1)(2011-2#1)
of pulmonary tuberculosis##9##3##(1995-2#1)(1995-3#1)(1997-3#1)(2007-4#1)(2007-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-7#1)
of pulmonary vascular##2##3##(2007-11#1)(2010-6#1)
of pulmonary vessels##2##3##(2008-1#1)(2012-3#1)
of pulmonary##271##2##(1990-10#3)(1990-3#2)(1990-7#1)(1991-11#4)(1991-12#1)(1991-4#1)(1991-9#1)(1992-11#2)(1992-12#2)(1992-2#3)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1994-10#1)(1994-12#1)(1994-3#2)(1994-6#2)(1994-7#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-7#1)(1996-12#3)(1996-3#1)(1996-5#2)(1997-1#2)(1997-2#1)(1997-3#4)(1997-4#1)(1997-8#1)(2005-10#2)(2005-11#2)(2005-7#1)(2005-8#2)(2005-9#3)(2006-10#18)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#5)(2007-2#1)(2007-3#2)(2007-4#2)(2007-6#2)(2007-7#6)(2007-8#11)(2007-9#3)(2008-1#9)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#4)(2008-7#3)(2008-8#3)(2008-9#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#8)(2010-11#1)(2010-12#4)(2010-3#6)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#2)(2010-9#4)(2011-1#4)(2011-11#1)(2011-2#17)(2011-3#1)(2012-1#7)(2012-11#1)(2012-12#4)(2012-2#11)(2012-3#5)(2013-1#12)(2013-7#4)(2013-8#5)
of pulp##8##2##(2004-4#1)(2008-10#1)(2008-3#1)(2008-6#1)(2012-2#1)(2013-8#3)
of pulpal##3##2##(1990-4#2)(2012-12#1)
of pulsar##2##2##(1990-6#1)(1993-6#1)
of pulse energy##2##3##(2007-12#2)
of pulse oximetry##5##3##(1993-1#1)(1993-7#1)(2006-10#2)(2010-9#1)
of pulse propagation in##2##4##(2007-11#2)
of pulse wave velocity##2##4##(2007-10#1)(2010-12#1)
of pulse width and chirp##2##5##(2007-12#1)(2008-1#1)
of pulse width and##3##4##(2007-12#2)(2008-1#1)
of pulse width##4##3##(2007-12#3)(2008-1#1)
of pulse##38##2##(1990-8#1)(1993-1#1)(1993-7#1)(1995-11#1)(2005-4#1)(2006-10#4)(2007-10#2)(2007-11#4)(2007-12#10)(2007-4#1)(2008-1#6)(2008-11#1)(2008-2#1)(2008-3#1)(2010-12#1)(2010-9#1)(2013-1#1)
of pulsed RF is##2##4##(2006-12#2)
of pulsed beams##2##3##(2007-12#2)
of pulsed field gel electrophoresis##3##5##(2011-2#1)(2012-3#2)
of pulsed laser##3##3##(2008-1#1)(2008-10#1)(2008-2#1)
of pulsed lasers##2##3##(1995-4#1)(2007-11#1)
of pulsed photoacoustics##2##3##(2008-3#2)
of pulsed##31##2##(1990-6#1)(1992-3#1)(1995-4#1)(1997-8#1)(2006-12#3)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#4)(2008-2#4)(2008-3#4)(2011-2#1)(2012-2#2)(2012-3#2)
of pulsed-field gel electrophoresis##2##4##(2008-11#1)(2013-1#1)
of pulses and##2##3##(2007-12#1)(2008-10#1)
of pulses in the##2##4##(2007-11#1)(2007-12#1)
of pulses transmitted##2##3##(2007-12#1)(2008-3#1)
of pulses with##2##3##(2007-12#2)
of pulses##23##2##(2006-5#2)(2007-11#1)(2007-12#12)(2008-1#1)(2008-10#2)(2008-3#3)(2012-2#2)
of pulverized##2##2##(2008-10#1)(2013-1#1)
of pumice##3##2##(2008-10#2)(2008-7#1)
of pump and##3##3##(2007-11#1)(2007-12#1)(2008-1#1)
of pump energy##2##3##(2007-11#1)(2008-3#1)
of pump power was##2##4##(2007-11#1)(2008-3#1)
of pump power##13##3##(2007-11#7)(2007-12#2)(2008-2#2)(2008-3#2)
of pump wavelengths##2##3##(2007-11#1)(2009-4#1)
of pump##38##2##(1997-4#1)(2006-10#1)(2007-11#13)(2007-12#8)(2008-1#3)(2008-10#2)(2008-2#3)(2008-3#6)(2009-4#1)
of pump-beam##2##2##(2008-2#1)(2008-3#1)
of pumping intensity##2##3##(2008-2#2)
of pumping##6##2##(2007-12#1)(2008-2#3)(2008-3#2)
of puncture##4##2##(1993-5#1)(2007-7#1)(2012-2#2)
of punishment##2##2##(2008-8#2)
of pupil##4##2##(2008-2#2)(2008-3#1)(2013-1#1)
of pupils##4##2##(1994-6#1)(2005-9#1)(2008-10#1)(2009-10#1)
of pups born##2##3##(1995-6#1)(2005-7#1)
of pups in##2##3##(2008-11#1)(2010-12#1)
of pups##8##2##(1991-2#2)(1995-6#1)(2005-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-12#1)
of pups' ultrasonic calls##2##4##(1992-9#2)
of purR##2##2##(2008-8#1)(2008-9#1)
of purchase and##2##3##(1992-12#1)(2010-12#1)
of purchase##4##2##(1992-12#1)(2010-12#1)(2012-2#1)(2013-1#1)
of purchasing##3##2##(1992-12#1)(1992-9#1)(2008-8#1)
of pure DNA##2##3##(1990-5#1)(2008-10#1)
of pure DPPC##2##3##(1990-3#1)(1995-10#1)
of pure alexia##3##3##(2008-4#3)
of pure and##8##3##(1994-5#1)(1996-5#1)(2006-3#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
of pure chlorophenols##3##3##(2008-10#3)
of pure curvature and twist##2##5##(2008-3#2)
of pure daidzin##2##3##(1996-4#2)
of pure extraction resin##2##4##(2008-10#2)
of pure laparoscopic hepatectomy for hepatocellular carcinoma##2##7##(2013-8#2)
of pure liquid water##2##4##(2008-2#1)(2008-3#1)
of pure marble trout##2##4##(2008-3#2)
of pure methyl##2##3##(2008-10#1)(2009-8#1)
of pure protein##3##3##(1991-5#1)(1991-7#1)(2006-10#1)
of pure rotational##3##3##(2007-12#2)(2008-2#1)
of pure standards##2##3##(1996-6#1)(1997-8#1)
of pure synthetic##3##3##(1991-4#1)(2008-10#1)(2010-2#1)
of pure water##14##3##(1997-6#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-2#6)(2008-3#4)
of pure##136##2##(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1991-3#3)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-10#1)(1994-5#1)(1995-10#1)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#3)(2005-7#1)(2006-10#2)(2006-12#1)(2006-3#1)(2007-11#2)(2007-12#5)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#10)(2008-3#15)(2008-4#7)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#2)(2009-4#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#4)(2013-7#1)(2013-8#2)
of purely temporal data##3##4##(2007-12#2)(2008-3#1)
of purely##8##2##(1992-12#1)(1992-5#1)(2007-12#4)(2007-3#1)(2008-3#1)
of purification of##3##3##(1992-4#1)(1994-12#1)(2008-11#1)
of purification##17##2##(1990-5#3)(1992-4#1)(1994-12#1)(1996-5#1)(1997-8#2)(2004-9#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-7#1)(2011-1#1)(2012-2#1)
of purified B##2##3##(1996-1#1)(2008-4#1)
of purified K1-antigen##2##3##(1990-4#2)
of purified MT##2##3##(2008-10#2)
of purified P2Y receptors##2##4##(2008-4#2)
of purified T cells and##2##5##(2004-12#1)(2007-11#1)
of purified alpha##2##3##(1991-12#1)(1993-8#1)
of purified beta-cells to##2##4##(1990-8#2)
of purified human placental##2##4##(1990-7#1)(1995-8#1)
of purified human##8##3##(1990-7#1)(1991-5#1)(1991-7#1)(1992-8#1)(1994-8#1)(1995-8#1)(1997-7#1)(2008-4#1)
of purified murine##2##3##(1990-2#1)(2007-2#1)
of purified nerve##2##3##(1990-7#1)(1993-11#1)
of purified protein derivative##2##4##(1997-2#1)(2006-2#1)
of purified protein kinase C##2##5##(1992-9#2)
of purified protein##5##3##(1992-9#2)(1997-2#1)(2006-2#1)(2008-2#1)
of purified proteins##4##3##(1994-5#1)(2008-4#1)(2009-10#1)(2009-9#1)
of purified recombinant##2##3##(1992-7#1)(2008-11#1)
of purified##135##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#4)(1990-5#1)(1990-7#3)(1990-8#2)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#3)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#3)(1993-11#6)(1993-12#3)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#4)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#3)(1994-9#4)(1995-1#1)(1995-2#1)(1995-3#2)(1995-6#2)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-1#3)(2008-10#8)(2008-11#3)(2008-2#1)(2008-4#11)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-2#2)(2012-2#1)
of purifying##5##2##(1991-11#1)(1992-1#1)(1993-11#1)(2008-10#1)(2008-4#1)
of purine and pyrimidine 2'##2##5##(1995-8#2)
of purine and pyrimidine bases##2##5##(1990-4#1)(2008-10#1)
of purine and pyrimidine##4##4##(1990-4#1)(1995-8#2)(2008-10#1)
of purine metabolism##3##3##(1992-8#1)(2007-11#1)(2012-1#1)
of purine mononucleotides##2##3##(2009-2#1)(2012-1#1)
of purine nucleoside phosphorylase##3##4##(1994-6#1)(1995-1#1)(2010-4#1)
of purine nucleosides##2##3##(2008-4#2)
of purine nucleotide##2##3##(1991-4#1)(1994-11#1)
of purine nucleotides##4##3##(1996-5#1)(2006-12#1)(2008-4#1)(2012-2#1)
of purine receptors##2##3##(2013-1#2)
of purine ribonucleosides##2##3##(2008-4#2)
of purine units##3##3##(2008-10#3)
of purine##38##2##(1990-4#1)(1991-4#1)(1992-8#1)(1994-11#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-8#2)(1996-5#3)(1997-1#2)(2006-12#3)(2007-11#1)(2008-10#4)(2008-4#6)(2008-8#1)(2008-9#2)(2009-2#1)(2010-4#1)(2012-1#2)(2012-2#1)(2013-1#2)
of purinergic signaling##5##3##(2008-4#2)(2008-5#1)(2013-8#2)
of purinergic system activity##2##4##(1991-5#2)
of purinergic##15##2##(1991-5#2)(1995-11#1)(2006-1#2)(2008-2#1)(2008-4#6)(2008-5#1)(2013-8#2)
of purines in##3##3##(1992-2#2)(2008-3#1)
of purines##9##2##(1992-2#2)(1995-12#1)(1996-5#1)(1997-2#1)(2006-12#1)(2008-3#1)(2008-8#1)(2013-8#1)
of purinoceptors##3##2##(1995-12#3)
of purity of##2##3##(2008-10#2)
of purity##4##2##(2008-10#3)(2010-8#1)
of purple##4##2##(1990-2#1)(1991-7#1)(1992-3#1)(2008-10#1)
of purported##2##2##(1991-2#1)(2012-1#1)
of purpose and##2##3##(2007-2#1)(2010-11#1)
of purpose##5##2##(1991-12#1)(1993-12#1)(2007-2#1)(2010-11#1)(2013-1#1)
of purposes including##2##3##(1991-7#1)(2012-12#1)
of purposes##6##2##(1991-7#1)(1996-1#1)(2008-4#1)(2010-12#1)(2012-12#1)(2012-3#1)
of purpurogallin##4##2##(1994-6#1)(2008-10#3)
of pursuing a##2##3##(2008-2#1)(2010-12#1)
of pursuing##5##2##(1997-2#1)(2008-2#1)(2008-9#1)(2010-12#1)(2012-2#1)
of pursuit eye movements##2##4##(1996-1#2)
of pursuit##5##2##(1993-2#2)(1996-1#2)(2006-6#1)
of purulent##2##2##(2005-10#1)(2011-2#1)
of pustules##5##2##(2008-10#5)
of putative anti-aging interventions##2##4##(2010-3#2)
of putative genes that##2##4##(1995-8#1)(1997-1#1)
of putative inhibitory##2##3##(1995-11#1)(2007-12#1)
of putative melatonin receptor antagonists##2##5##(1992-3#2)
of putative phosphorylation sites##2##4##(1992-8#1)(1994-11#1)
of putative regulatory##2##3##(1991-9#1)(1992-5#1)
of putative virus-resistant##2##3##(2008-10#2)
of putative##67##2##(1990-5#1)(1991-1#1)(1991-10#1)(1991-3#1)(1991-9#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-7#1)(1994-11#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(2006-10#2)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#2)(2009-10#2)(2010-12#1)(2010-3#2)(2010-9#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
of putrescine and tissue##2##4##(1994-11#2)
of putrescine and##3##3##(1994-11#2)(1994-9#1)
of putrescine##17##2##(1991-2#2)(1994-11#5)(1994-9#1)(1996-12#1)(2007-8#2)(2008-10#2)(2010-4#1)(2011-2#2)(2012-2#1)
of pycnidia##4##2##(2008-10#4)
of pyelonephritis and##2##3##(2011-2#2)
of pyelonephritis##5##2##(2009-1#1)(2011-2#3)(2013-1#1)
of pyloric##3##2##(1990-6#1)(1993-2#1)(2010-12#1)
of pyo-inflammatory complications##2##3##(2009-2#2)
of pyo-inflammatory##3##2##(2009-2#3)
of pyoderma gangrenosum is##2##4##(2007-7#1)(2007-8#1)
of pyoderma gangrenosum##5##3##(2007-7#3)(2007-8#1)(2013-1#1)
of pyoderma##6##2##(2007-7#4)(2007-8#1)(2013-1#1)
of pyogenic liver abscess##4##4##(2006-10#1)(2008-3#1)(2010-12#2)
of pyogenic liver##5##3##(2006-10#2)(2008-3#1)(2010-12#2)
of pyogenic meningitis##4##3##(2007-8#3)(2008-7#1)
of pyogenic##13##2##(1991-7#1)(2006-10#3)(2007-8#3)(2008-3#1)(2008-7#1)(2010-12#2)(2012-2#1)(2013-8#1)
of pyramid##3##2##(2008-2#1)(2013-1#2)
of pyramidal cell##2##3##(1994-5#1)(1997-7#1)
of pyramidal cells##6##3##(1991-5#2)(1995-3#1)(1996-3#1)(1997-5#1)(2007-8#1)
of pyramidal neurons##3##3##(1991-2#1)(2008-11#1)(2008-4#1)
of pyramidal tract##2##3##(2007-10#1)(2012-2#1)
of pyramidal##17##2##(1991-2#1)(1991-5#2)(1994-5#2)(1995-3#1)(1995-8#1)(1996-3#1)(1997-5#1)(1997-7#2)(2007-10#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-4#1)(2012-2#1)
of pyranine##2##2##(1993-3#1)(2008-11#1)
of pyrantel pamoate##2##3##(2008-10#2)
of pyrazinamide##2##2##(2007-7#1)(2012-2#1)
of pyrene and##4##3##(1990-5#1)(2005-11#1)(2008-10#2)
of pyrene in soils##2##4##(2011-12#2)
of pyrene in##4##3##(2005-11#1)(2011-12#3)
of pyrene##15##2##(1990-5#1)(1992-6#2)(1997-1#1)(2005-11#2)(2008-10#3)(2009-11#1)(2011-12#5)
of pyrene-PG##3##2##(1993-9#3)
of pyrene-labeled##3##2##(1992-5#2)(1993-9#1)
of pyrethroid##2##2##(2006-4#1)(2008-10#1)
of pyrethroids##2##2##(2008-10#1)(2011-12#1)
of pyrexia##2##2##(1991-3#1)(2007-7#1)
of pyridine and##3##3##(2006-12#1)(2007-3#1)(2008-10#1)
of pyridine derivatives##2##3##(2008-10#1)(2008-8#1)
of pyridine nucleotide##3##3##(1990-5#1)(1992-1#1)(1994-3#1)
of pyridine on##2##3##(1992-7#1)(1994-3#1)
of pyridine##22##2##(1990-1#1)(1990-11#1)(1990-5#1)(1992-1#1)(1992-7#1)(1994-3#4)(1996-2#2)(2005-11#1)(2006-12#1)(2007-11#1)(2007-3#1)(2008-10#4)(2008-3#1)(2008-8#1)(2013-1#1)
of pyridinium chloride##2##3##(2008-10#2)
of pyridinium##4##2##(1995-8#1)(1997-8#1)(2008-10#2)
of pyridoxal 5'-phosphate (PLP)##2##4##(1996-5#1)(2005-11#1)
of pyridoxal##4##2##(1995-6#1)(1996-5#1)(2005-11#1)(2013-1#1)
of pyridoxine hydrochloride##5##3##(2008-10#5)
of pyridoxine##6##2##(2008-10#5)(2013-1#1)
of pyridyl##2##2##(2008-5#2)
of pyrimethamine##6##2##(2008-10#3)(2008-2#1)(2008-4#2)
of pyrimidine##10##2##(1991-1#1)(1993-12#1)(1993-8#1)(1995-8#1)(2006-12#2)(2007-11#1)(2007-3#1)(2008-8#1)(2010-3#1)
of pyriproxyfen and buprofezin##2##4##(2012-12#2)
of pyriproxyfen##6##2##(2007-12#2)(2012-12#4)
of pyritinol dihydrochloride in##3##4##(2010-4#3)
of pyritinol dihydrochloride##4##3##(2010-4#4)
of pyrocatechol##2##2##(2008-10#2)
of pyrogallol and its##2##4##(2007-8#1)(2008-10#1)
of pyrogallol compounds##4##3##(2008-10#4)
of pyrogallol##11##2##(1994-3#1)(2007-8#1)(2008-10#9)
of pyrolusite##2##2##(2005-11#2)
of pyrolysis and atomization temperatures##3##5##(2008-10#3)
of pyrolysis and atomization##4##4##(2008-10#4)
of pyrolysis##7##2##(2008-10#6)(2010-3#1)
of pyrolytic carbon##2##3##(2008-9#1)(2010-8#1)
of pyrolytic##4##2##(2008-10#1)(2008-5#1)(2008-9#1)(2010-8#1)
of pyrophosphate hydrolysis and synthesis##2##5##(1990-12#2)
of pyrophosphate##7##2##(1990-12#4)(1991-7#1)(1995-3#1)(2011-1#1)
of pyrrole and##2##3##(2007-9#1)(2008-10#1)
of pyrrole##7##2##(1995-3#2)(2007-9#1)(2008-10#4)
of pyrrolizidine alkaloids in##2##4##(2007-1#1)(2012-12#1)
of pyrrolizidine alkaloids##4##3##(2007-1#2)(2010-6#1)(2012-12#1)
of pyrrolo[2##2##2##(1996-8#1)(2007-11#1)
of pyruvate and##3##3##(1990-7#1)(2010-12#1)(2011-2#1)
of pyruvate carboxylase##3##3##(1991-8#2)(1993-11#1)
of pyruvate decarboxylase##3##3##(1990-12#1)(2008-10#1)(2008-6#1)
of pyruvate dehydrogenase##3##3##(2005-8#2)(2010-12#1)
of pyruvate in##3##3##(2008-10#3)
of pyruvate kinase from##2##4##(1990-5#2)
of pyruvate kinase##8##3##(1990-5#3)(1991-3#1)(1991-8#1)(1994-11#1)(1995-12#1)(2008-7#1)
of pyruvate to##3##3##(1994-11#1)(1995-10#2)
of pyruvate##42##2##(1990-12#1)(1990-5#3)(1990-7#1)(1991-3#1)(1991-5#3)(1991-8#3)(1992-4#4)(1993-11#1)(1993-2#1)(1993-8#2)(1994-10#1)(1994-11#2)(1995-10#2)(1995-12#1)(1995-2#1)(2005-8#2)(2008-10#7)(2008-6#1)(2008-7#1)(2009-10#1)(2010-12#2)(2011-2#1)
of qRslx1##2##2##(2012-11#2)
of qi##2##2##(2008-10#2)
of quadrat size##3##3##(2008-10#3)
of quadrat##5##2##(2008-10#5)
of quadratic soliton##2##3##(2007-12#2)
of quadratic solitons##3##3##(2007-12#3)
of quadratic spatial solitons in periodically poled lithium niobate##2##9##(2007-12#2)
of quadratic spatial solitons##3##4##(2007-12#2)(2008-1#1)
of quadratic##10##2##(2007-11#1)(2007-12#7)(2008-1#1)(2008-8#1)
of quadriceps muscle##2##3##(2013-1#2)
of quadriceps##4##2##(2009-4#1)(2009-9#1)(2013-1#2)
of quadricuspid aortic valve##4##4##(2008-11#1)(2012-3#3)
of quadruplexes##2##2##(2007-9#2)
of quail##3##2##(1993-6#1)(1997-6#1)(2008-6#1)
of qualia##2##2##(2012-2#2)
of qualified nurses##2##3##(2008-11#1)(2008-12#1)
of qualified##9##2##(1992-1#1)(1997-8#1)(2005-5#1)(2007-4#1)(2007-9#1)(2008-11#2)(2008-12#1)(2012-3#1)
of qualitative and quantitative##7##4##(1994-6#1)(1996-12#1)(2007-1#1)(2007-12#1)(2008-10#1)(2011-1#1)(2013-1#1)
of qualitative and##8##3##(1994-6#1)(1996-12#1)(2007-1#1)(2007-12#1)(2008-10#1)(2009-6#1)(2011-1#1)(2013-1#1)
of qualitative content##3##3##(2009-6#1)(2013-1#2)
of qualitative data from##2##4##(2007-10#1)(2010-4#1)
of qualitative data##3##3##(2006-3#1)(2007-10#1)(2010-4#1)
of qualitative interviews with##2##4##(2008-2#1)(2009-4#1)
of qualitative methods##2##3##(1994-3#1)(2008-8#1)
of qualitative research and##2##4##(1997-3#1)(2012-3#1)
of qualitative research##5##3##(1997-3#2)(2008-11#1)(2012-12#1)(2012-3#1)
of qualitative##32##2##(1990-10#1)(1992-9#1)(1994-3#1)(1994-6#1)(1994-9#1)(1996-12#1)(1997-3#2)(2005-8#1)(2006-3#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2009-4#1)(2009-6#2)(2010-4#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#3)(2013-1#3)
of qualitatively##3##2##(1997-7#1)(2007-11#1)(2007-12#1)
of quality and##9##3##(1992-2#1)(1995-12#1)(1996-1#1)(1996-12#1)(2005-5#1)(2005-7#1)(2007-4#1)(2008-7#1)(2010-2#1)
of quality assessment##2##3##(1997-1#1)(2012-12#1)
of quality assurance and quality management##3##6##(2006-2#3)
of quality assurance in##2##4##(1996-12#1)(2010-12#1)
of quality assurance systems in##2##5##(1990-12#2)
of quality assurance systems##3##4##(1990-12#2)(1992-5#1)
of quality assurance to##2##4##(2005-5#1)(2010-7#1)
of quality assurance##20##3##(1990-12#2)(1992-11#1)(1992-5#1)(1993-3#2)(1996-12#1)(2005-11#1)(2005-5#3)(2006-2#5)(2008-4#1)(2008-5#1)(2010-12#1)(2010-7#1)
of quality care##4##3##(1992-3#1)(1994-2#1)(1994-3#1)(1997-3#1)
of quality circles##2##3##(2010-11#2)
of quality control and##3##4##(2007-12#1)(2008-10#1)(2011-3#1)
of quality control in##2##4##(2008-9#2)
of quality control of the##2##5##(2008-7#1)(2013-1#1)
of quality control problems##2##4##(1993-12#1)(2007-7#1)
of quality control##16##3##(1993-12#1)(1994-6#1)(1996-6#1)(2005-12#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-9#4)(2009-7#1)(2011-3#1)(2012-3#1)(2013-1#1)
of quality criteria##2##3##(1995-2#1)(2008-11#1)
of quality data##2##3##(2010-11#1)(2012-12#1)
of quality for##3##3##(1996-2#1)(1997-2#1)(2008-10#1)
of quality improvement##8##3##(1993-2#1)(1995-12#1)(1995-3#3)(1996-3#1)(1996-9#1)(2008-7#1)
of quality in the##2##4##(1994-12#1)(2008-10#1)
of quality in##7##3##(1994-12#1)(1996-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-9#1)(2012-2#1)
of quality indicators##5##3##(1996-9#1)(1997-3#2)(2008-7#1)(2011-1#1)
of quality management##8##3##(1995-3#1)(1996-3#1)(1997-3#1)(2010-4#2)(2010-9#1)(2013-1#1)(2013-8#1)
of quality measurement and##2##4##(1996-2#1)(2008-7#1)
of quality measurement##4##3##(1996-2#1)(1996-3#2)(2008-7#1)
of quality of care##8##4##(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
of quality of health care##2##5##(1994-3#1)(2008-7#1)
of quality of life (QOL)##2##5##(2011-12#2)
of quality of life and##4##5##(1995-8#1)(2008-11#1)(2010-3#1)(2013-1#1)
of quality of life in##9##5##(2007-1#1)(2007-7#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#1)
of quality of life of##2##5##(2009-1#1)(2011-2#1)
of quality of life##45##4##(1991-12#1)(1993-5#1)(1995-8#1)(1997-3#1)(2004-1#1)(2005-4#2)(2006-4#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2009-1#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
of quality of##62##3##(1991-12#1)(1993-5#1)(1994-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#2)(2004-1#1)(2005-4#2)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#6)(2009-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#5)(2012-1#2)(2012-2#4)(2012-3#1)(2013-1#2)
of quality should be##2##4##(1994-2#1)(1997-2#1)
of quality standards##2##3##(2008-3#1)(2011-1#1)
of quality were##2##3##(2012-12#1)(2012-3#1)
of quality##224##2##(1990-12#2)(1991-12#1)(1991-2#1)(1991-3#2)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-5#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-8#1)(1994-12#2)(1994-2#6)(1994-3#3)(1994-5#1)(1994-6#1)(1995-12#4)(1995-2#1)(1995-3#5)(1995-8#1)(1996-1#2)(1996-12#7)(1996-2#8)(1996-3#5)(1996-6#1)(1996-9#2)(1997-1#3)(1997-2#4)(1997-3#9)(2004-1#1)(2005-11#1)(2005-12#1)(2005-4#2)(2005-5#5)(2005-7#1)(2006-2#5)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-4#2)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#11)(2008-8#1)(2008-9#5)(2009-1#1)(2009-3#1)(2009-7#2)(2010-10#1)(2010-11#4)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#4)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#6)(2011-12#2)(2011-2#5)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#5)(2012-3#4)(2013-1#9)(2013-8#2)
of quality-of-life assessments in##2##4##(2006-12#1)(2007-11#1)
of quality-of-life##3##2##(2006-12#1)(2007-11#1)(2012-2#1)
of quanta##7##2##(1990-7#1)(1991-6#2)(1995-1#2)(1995-8#1)(2008-7#1)
of quantal release##2##3##(1990-2#1)(1995-8#1)
of quantal##6##2##(1990-2#1)(1995-8#2)(1997-3#2)(2010-2#1)
of quantification (10sigma)##2##3##(2008-10#2)
of quantification (LOQ) were##3##4##(2008-10#1)(2011-1#1)(2013-8#1)
of quantification (LOQ)##12##3##(1996-3#1)(2008-10#7)(2011-1#1)(2012-12#2)(2013-8#1)
of quantification and##6##3##(1997-3#1)(2008-10#3)(2008-5#1)(2010-2#1)
of quantification are##2##3##(1997-8#1)(2008-10#1)
of quantification for the##3##4##(2008-10#1)(2010-2#1)(2012-2#1)
of quantification for##5##3##(1996-8#1)(2008-10#2)(2010-2#1)(2012-2#1)
of quantification in##3##3##(2007-11#1)(2008-10#2)
of quantification is 5##2##4##(1993-2#1)(2008-5#1)
of quantification of##7##3##(1994-1#1)(1997-8#2)(2007-8#1)(2008-10#2)(2008-5#1)
of quantification was##15##3##(1992-2#2)(1996-6#2)(1996-8#2)(2005-12#1)(2008-10#2)(2008-5#1)(2010-2#1)(2011-2#2)(2012-12#1)(2013-1#1)
of quantification were##9##3##(1996-6#1)(1997-3#1)(1997-8#1)(2008-10#5)(2011-3#1)
of quantification##83##2##(1992-2#2)(1993-2#1)(1994-1#1)(1996-3#1)(1996-6#3)(1996-8#3)(1997-3#2)(1997-8#4)(2005-12#1)(2007-11#1)(2007-8#4)(2008-10#39)(2008-5#4)(2009-4#1)(2010-2#3)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#4)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
of quantifying the##7##3##(2008-10#2)(2008-3#1)(2008-4#2)(2010-9#1)(2011-2#1)
of quantifying##13##2##(1990-8#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-5#1)(2010-4#1)(2010-9#1)(2011-2#2)
of quantitating##3##2##(1992-7#1)(2008-4#2)
of quantitation (LOQ) for##2##4##(2008-10#1)(2011-2#1)
of quantitation (LOQ) of##4##4##(1992-8#1)(1996-8#1)(1997-3#1)(2007-8#1)
of quantitation (LOQ)##13##3##(1992-8#1)(1996-5#1)(1996-8#1)(1997-3#1)(2007-8#2)(2008-10#6)(2011-2#1)
of quantitation and##2##3##(2010-4#1)(2013-1#1)
of quantitation for##3##3##(2008-10#2)(2010-3#1)
of quantitation of 0##2##4##(1997-8#1)(2008-10#1)
of quantitation of##8##3##(1996-5#1)(1996-8#1)(1997-3#1)(1997-8#1)(2008-10#3)(2012-12#1)
of quantitation##44##2##(1992-8#1)(1993-2#2)(1996-3#1)(1996-5#3)(1996-8#2)(1997-3#6)(1997-8#1)(2007-8#2)(2008-10#19)(2010-3#2)(2010-4#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)
of quantitative analysis of##2##4##(2008-10#1)(2013-1#1)
of quantitative and qualitative##4##4##(1992-12#1)(2007-6#1)(2010-11#1)(2011-1#1)
of quantitative data##2##3##(2006-10#1)(2010-4#1)
of quantitative determination##2##3##(2008-10#1)(2011-2#1)
of quantitative genetic##2##3##(2008-8#1)(2009-5#1)
of quantitative host resistance##2##4##(2008-10#2)
of quantitative magnetic resonance (QMR)##2##5##(2010-8#2)
of quantitative phase microscopy##2##4##(2007-11#2)
of quantitative phase##3##3##(2007-11#2)(2007-12#1)
of quantitative resistance##3##3##(2008-10#1)(2009-10#1)(2011-10#1)
of quantitative results##2##3##(1997-2#1)(2005-12#1)
of quantitative structure-activity##3##3##(1992-4#1)(1993-4#1)(2008-5#1)
of quantitative trait Loci for fusarium head blight resistance in##2##10##(2008-10#2)
of quantitative trait Loci for resistance to southern leaf blight##2##10##(2008-10#2)
of quantitative trait Loci for##4##5##(2008-10#4)
of quantitative trait loci (QTL)##5##5##(2008-10#3)(2009-2#1)(2012-3#1)
of quantitative trait loci##8##4##(2008-10#4)(2009-10#1)(2009-2#1)(2012-1#1)(2012-3#1)
of quantitative trait##13##3##(2008-10#8)(2009-10#1)(2009-2#1)(2012-1#1)(2012-3#2)
of quantitative traits##2##3##(2008-10#1)(2012-3#1)
of quantitative##89##2##(1990-12#1)(1991-12#2)(1992-12#1)(1992-4#1)(1993-2#1)(1993-4#1)(1994-6#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-2#1)(1997-7#1)(2004-11#1)(2005-12#1)(2005-7#2)(2005-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#23)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-10#2)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#2)(2010-11#2)(2010-4#1)(2010-8#2)(2011-1#3)(2011-10#1)(2011-2#2)(2012-1#1)(2012-3#5)(2013-1#5)
of quantitatively##3##2##(2008-10#1)(2008-2#2)
of quantity##3##2##(2008-11#1)(2008-5#1)(2012-12#1)
of quantized kinoforms##3##3##(2008-2#3)
of quantized##5##2##(2008-2#3)(2008-3#2)
of quantum chemical##2##3##(2011-3#1)(2013-1#1)
of quantum chemistry##3##3##(2008-11#1)(2011-1#1)(2013-8#1)
of quantum dot blinking##2##4##(2010-2#2)
of quantum dot##7##3##(2007-2#1)(2010-2#3)(2011-2#3)
of quantum dots##4##3##(1994-5#1)(2007-2#1)(2008-10#1)(2009-12#1)
of quantum mechanics##4##3##(2007-9#1)(2008-5#1)(2010-2#1)(2012-2#1)
of quantum##42##2##(1992-12#1)(1993-5#1)(1994-5#2)(1995-2#1)(2006-10#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#3)(2009-12#1)(2009-9#1)(2010-12#1)(2010-2#4)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#2)(2013-1#1)(2013-8#1)
of quantum-limited timing jitter in##2##5##(2007-11#2)
of quantum-well##2##2##(1994-5#1)(2007-12#1)
of quarantine##5##2##(2008-10#2)(2008-5#3)
of quarter-wave##2##2##(2008-2#1)(2008-3#1)
of quartz crystal microbalance (QCM)##2##5##(2008-10#2)
of quartz crystal microbalance##3##4##(2008-10#3)
of quartz crystal##5##3##(2008-10#3)(2013-8#2)
of quartz from##2##3##(2013-8#2)
of quartz##19##2##(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-2#3)(2008-3#1)(2010-5#1)(2013-8#5)
of quasi##3##2##(2007-12#2)(2008-8#1)
of quasi-phase-matched##4##2##(2007-11#1)(2007-12#2)(2008-1#1)
of quaternary ammonium##5##3##(2008-10#2)(2010-4#1)(2013-7#2)
of quaternary##9##2##(1990-9#1)(1994-8#1)(2008-10#3)(2008-4#1)(2010-4#1)(2013-7#2)
of quenched##3##2##(1992-6#1)(2008-4#1)(2008-5#1)
of quenching##7##2##(2003-11#1)(2006-10#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)
of quercetin and kaempferol##2##4##(2007-1#1)(2008-5#1)
of quercetin and##5##3##(2007-1#3)(2008-10#1)(2008-5#1)
of quercetin##9##2##(1992-7#1)(2007-1#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)
of quercetin-induced##2##2##(1992-4#1)(1994-8#1)
of questing nymphs##2##3##(2004-11#2)
of questing##5##2##(2004-11#5)
of question##2##2##(2006-5#2)
of questionable value##2##3##(1995-11#1)(1997-3#1)
of questionable##6##2##(1995-11#1)(1997-3#1)(2008-1#1)(2008-7#1)(2011-2#2)
of questionnaire##4##2##(1996-1#1)(2007-7#1)(2012-12#1)(2013-1#1)
of questionnaires to##3##3##(1992-5#1)(1997-4#1)(2011-1#1)
of questionnaires##8##2##(1992-5#1)(1997-4#1)(2006-10#1)(2006-2#1)(2008-9#1)(2009-2#1)(2011-1#1)(2012-1#1)
of questions and##2##3##(1993-3#1)(2012-12#1)
of questions for##2##3##(1993-1#1)(2008-1#1)
of questions that##2##3##(2008-1#1)(2010-4#1)
of questions to##2##3##(1995-2#1)(2012-3#1)
of questions were##2##3##(2006-10#1)(2008-12#1)
of questions##30##2##(1993-1#1)(1993-2#1)(1993-3#1)(1995-2#1)(1997-2#1)(2005-4#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-8#1)(2007-3#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-11#2)(2010-4#1)(2010-9#1)(2012-12#1)(2012-3#1)(2013-1#2)
of queuine uptake in cultured human fibroblasts##2##7##(1990-8#2)
of queuine##5##2##(1990-8#5)
of quick##3##2##(1991-3#1)(2008-9#2)
of quickly##3##2##(2007-11#1)(2008-10#1)(2011-3#1)
of quiescence##2##2##(2006-10#1)(2008-10#1)
of quiescent lysates##2##3##(1994-8#2)
of quiescent##17##2##(1991-2#1)(1992-2#1)(1992-8#1)(1993-12#3)(1994-8#2)(1995-3#1)(1995-6#1)(1996-8#1)(1997-3#2)(2008-10#3)(2010-4#1)
of quinapril and hydrochlorothiazide##2##4##(2010-5#2)
of quinapril##3##2##(1995-3#1)(2010-5#2)
of quinidine##3##2##(1990-12#1)(1994-3#1)(1996-3#1)
of quinine and##2##3##(2006-8#1)(2008-10#1)
of quinine in##2##3##(2008-10#2)
of quinine##16##2##(2006-10#1)(2006-12#1)(2006-8#7)(2008-10#7)
of quinoline and##2##3##(2008-10#1)(2008-7#1)
of quinoline##6##2##(1995-5#1)(2008-10#1)(2008-12#3)(2008-7#1)
of quinolinic acid in##2##4##(1990-7#1)(1995-5#1)
of quinolinic acid##4##3##(1990-7#2)(1994-2#1)(1995-5#1)
of quinolinone##2##2##(2008-3#1)(2011-3#1)
of quinolone##3##2##(1994-9#1)(2008-5#1)(2012-3#1)
of quinolones in##4##3##(2006-10#2)(2007-8#2)
of quinolones is##2##3##(2008-10#1)(2008-5#1)
of quinolones##13##2##(1991-12#2)(2005-7#1)(2006-10#2)(2006-6#1)(2007-8#2)(2008-10#2)(2008-3#1)(2008-5#2)
of quinone hepatotoxicity##2##3##(2013-8#2)
of quinone##9##2##(1991-5#1)(1992-7#1)(1993-8#1)(1994-11#1)(1994-8#1)(2007-11#1)(2013-8#3)
of quinones##7##2##(1993-8#2)(2006-8#1)(2008-10#2)(2009-9#2)
of quinpirole##3##2##(1993-3#2)(1993-6#1)
of quisqualate##3##2##(1991-9#1)(1993-12#1)(1995-12#1)
of quisqualic acid##2##3##(1992-8#2)
of quite different##2##3##(2008-10#1)(2011-2#1)
of quite##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
of quitting##5##2##(1991-12#1)(2005-10#1)(2007-11#1)(2012-1#1)(2013-1#1)
of quorum sensing##2##3##(2010-10#1)(2013-1#1)
of quorum-quenching enzymes##2##3##(2008-9#2)
of r##4##2##(2008-10#3)(2008-2#1)
of r(2)=0##4##2##(2008-10#4)
of r(g)##2##2##(2008-10#2)
of r-HuEPO##3##2##(2007-7#1)(2008-1#2)
of r-[K4HPg]##2##2##(1993-8#2)
of r=0##2##2##(2005-12#2)
of rAAV##5##2##(2008-5#1)(2008-8#1)(2008-9#3)
of rCBF##4##2##(1995-5#2)(1996-5#2)
of rDNA from##2##3##(2008-10#2)
of rDNA repeats##2##3##(1993-11#1)(2008-5#1)
of rDNA transcription##2##3##(1993-3#1)(2008-2#1)
of rDNA##28##2##(1993-11#1)(1993-3#1)(1993-5#1)(1996-5#1)(2006-8#1)(2007-12#2)(2008-10#9)(2008-2#4)(2008-5#4)(2010-10#1)(2010-8#2)(2012-2#1)
of rEP3 receptor##2##3##(1993-7#2)
of rFVIIa##3##2##(2005-10#3)
of rFurin##3##2##(2008-11#3)
of rHGH##2##2##(2007-11#2)
of rHuEPO##4##2##(1995-1#3)(2008-5#1)
of rIL-2##7##2##(1990-12#2)(1991-8#1)(2007-11#4)
of rNG-hCGalpha with native hCGbeta##2##5##(1995-8#2)
of rNG-hCGalpha with##4##3##(1995-8#4)
of rNG-hCGalpha##6##2##(1995-8#6)
of rNT-3##2##2##(2008-8#2)
of rOAT##2##2##(1993-3#2)
of rPA##2##2##(2007-9#2)
of rPEA##2##2##(2008-10#2)
of rPlg##4##2##(1995-6#4)
of rQT3##2##2##(1990-8#2)
of rRNA gene##3##3##(2008-8#3)
of rRNA genes##4##3##(2006-10#1)(2008-5#1)(2008-8#2)
of rRNA##18##2##(1991-2#1)(1993-3#1)(1993-5#1)(1993-9#3)(1996-8#1)(1997-6#1)(2006-10#1)(2006-5#1)(2008-5#1)(2008-8#5)(2009-2#1)(2010-4#1)
of rTFA##2##2##(2012-2#2)
of rTMS as##2##3##(2010-3#1)(2012-2#1)
of rTMS in##3##3##(1996-1#1)(2012-2#2)
of rTMS##9##2##(1996-1#2)(2008-10#3)(2010-3#1)(2012-2#3)
of rTNF-alpha##2##2##(1994-8#2)
of rTNFalpha##3##2##(2007-11#3)
of rVIIa on##2##3##(2007-7#2)
of rVIIa##6##2##(1995-6#1)(2007-7#5)
of rab##3##2##(1992-8#1)(1993-8#2)
of rabbit IgG##6##3##(2008-10#6)
of rabbit aorta##2##3##(1992-6#1)(1997-5#1)
of rabbit aortic rings##2##4##(1992-1#1)(1997-2#1)
of rabbit aortic##4##3##(1991-5#1)(1992-1#1)(1997-2#1)(2009-5#1)
of rabbit corneal epithelial cells##3##5##(1992-11#3)
of rabbit fast##2##3##(1991-7#1)(1994-10#1)
of rabbit haemorrhagic disease virus##2##5##(2005-7#2)
of rabbit immunoglobulin##2##3##(2008-10#1)(2008-2#1)
of rabbit intestinal##2##3##(1992-6#2)
of rabbit muscle phosphofructokinase##3##4##(1990-8#1)(1991-2#1)(1997-2#1)
of rabbit muscle##6##3##(1990-8#1)(1991-2#1)(1992-11#1)(1992-4#1)(1994-5#1)(1997-2#1)
of rabbit peritoneal neutrophils##2##4##(1991-2#1)(1994-8#1)
of rabbit platelets##4##3##(1990-12#1)(1997-3#3)
of rabbit reticulocyte lysate##2##4##(1996-5#2)
of rabbit reticulocyte##4##3##(1990-2#1)(1995-5#1)(1996-5#2)
of rabbit retina##2##3##(2008-11#1)(2012-3#1)
of rabbit skeletal muscle##7##4##(1990-7#1)(1991-2#1)(1991-3#1)(1994-5#2)(1995-6#1)(2008-9#1)
of rabbit skeletal##8##3##(1990-7#1)(1991-2#1)(1991-3#1)(1991-4#1)(1994-5#2)(1995-6#1)(2008-9#1)
of rabbit small##2##3##(1990-11#1)(1991-12#1)
of rabbit spermatozoa##2##3##(2006-5#2)
of rabbit##108##2##(1990-11#2)(1990-12#4)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#3)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#5)(1992-12#2)(1992-2#1)(1992-4#1)(1992-6#4)(1992-8#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-5#3)(1994-6#1)(1994-8#2)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-2#2)(1997-3#3)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#2)(2005-7#2)(2005-9#2)(2006-5#2)(2007-11#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-5#1)(2008-9#4)(2009-5#2)(2010-4#1)(2010-9#1)(2012-12#1)(2012-2#1)(2012-3#1)
of rabbits in##3##3##(2007-4#1)(2010-12#1)(2013-1#1)
of rabbits to##2##3##(1990-4#1)(1990-5#1)
of rabbits with##8##3##(1995-5#1)(1996-12#1)(1996-2#1)(2005-10#1)(2008-10#2)(2008-8#1)(2012-1#1)
of rabbits##28##2##(1990-4#1)(1990-5#1)(1991-8#3)(1993-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(2004-9#1)(2005-10#1)(2005-12#2)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#2)(2012-1#1)(2013-1#1)
of rabeprazole in##2##3##(2008-10#1)(2008-5#1)
of rabeprazole##4##2##(2008-10#2)(2008-5#2)
of rabies in##4##3##(1993-8#1)(2007-10#1)(2007-12#1)(2012-3#1)
of rabies vaccine##4##3##(1996-8#2)(2007-11#2)
of rabies virus##3##3##(1995-2#2)(2008-11#1)
of rabies##21##2##(1991-12#3)(1993-8#1)(1995-2#3)(1996-4#1)(1996-8#2)(2005-7#2)(2007-10#1)(2007-11#3)(2007-12#1)(2008-11#1)(2012-12#1)(2012-3#2)
of rac 1 and rac 2##2##6##(1996-2#2)
of rac p21s is##2##4##(1993-8#2)
of rac p21s##5##3##(1993-8#5)
of rac##8##2##(1993-8#5)(1996-2#3)
of race 0##2##3##(2008-10#2)
of race 1 and race 2##2##6##(2008-10#2)
of race 1 isolates##2##4##(2008-10#2)
of race 1##8##3##(2008-10#8)
of race 2##3##3##(2008-10#3)
of race and ethnicity##2##4##(2010-9#1)(2011-2#1)
of race and gender on##3##5##(2007-10#2)(2008-3#1)
of race and gender##4##4##(2007-10#2)(2008-3#1)(2009-4#1)
of race and##6##3##(2007-10#2)(2008-3#1)(2009-4#1)(2010-9#1)(2011-2#1)
of race in##2##3##(2007-3#1)(2011-2#1)
of race or##2##3##(2008-5#1)(2009-5#1)
of race##39##2##(1991-1#1)(2007-10#2)(2007-3#2)(2007-4#1)(2007-9#1)(2008-10#18)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-9#1)(2011-2#2)(2012-12#1)
of race-change mutants and##2##4##(2008-10#2)
of race-change mutants##4##3##(2008-10#4)
of race-specific##2##2##(2008-10#2)
of race/ethnicity##2##2##(2011-2#1)(2013-1#1)
of racemic salbutamol##2##3##(2007-11#2)
of racemic##14##2##(1991-5#1)(1992-12#1)(1993-2#2)(1994-2#1)(1994-3#2)(1996-5#1)(1996-8#1)(1997-7#1)(2007-11#2)(2009-4#1)(2012-12#1)
of races 1##3##3##(2008-10#3)
of races 2 and##2##4##(2008-10#2)
of races 2##4##3##(2008-10#4)
of races 4 and##2##4##(2008-10#2)
of races in##2##3##(2008-10#2)
of races##18##2##(2008-10#18)
of rachis##4##2##(2008-10#4)
of racial and ethnic##2##4##(2008-5#1)(2010-2#1)
of racial and##3##3##(2008-5#1)(2008-7#1)(2010-2#1)
of racial categories in##2##4##(2008-12#2)
of racial differences##2##3##(1996-9#1)(2012-2#1)
of racial disparities in##2##4##(2010-3#1)(2013-1#1)
of racial disparities##4##3##(2010-3#2)(2012-12#1)(2013-1#1)
of racial##15##2##(1996-9#2)(2005-12#2)(2007-3#1)(2008-12#2)(2008-5#1)(2008-7#1)(2010-2#1)(2010-3#2)(2012-12#1)(2012-2#1)(2013-1#1)
of racism##3##2##(2006-7#1)(2009-7#2)
of raclopride##6##2##(2008-6#6)
of radial basis function neural networks##3##6##(2008-10#2)(2008-2#1)
of radial basis function##4##4##(2008-10#2)(2008-2#2)
of radial##25##2##(1995-5#1)(1996-12#1)(2006-11#1)(2006-3#2)(2006-4#1)(2007-11#1)(2007-6#3)(2007-7#1)(2008-10#4)(2008-2#2)(2008-7#2)(2009-5#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#1)
of radiance##3##2##(2008-2#1)(2008-3#2)
of radiation and##5##3##(2005-9#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-3#1)
of radiation are##2##3##(2008-7#2)
of radiation at##3##3##(2007-12#2)(2008-3#1)
of radiation can be##2##4##(2008-6#1)(2008-7#1)
of radiation can##5##3##(2008-6#1)(2008-7#4)
of radiation carcinogenesis##2##3##(2008-7#2)
of radiation damage##2##3##(2006-8#1)(2007-11#1)
of radiation delivered##2##3##(2008-6#1)(2008-7#1)
of radiation delivery##2##3##(2007-1#1)(2008-3#1)
of radiation dose##2##3##(2004-1#1)(2006-6#1)
of radiation exposure##5##3##(2006-8#1)(2008-12#1)(2008-7#1)(2010-12#1)(2012-1#1)
of radiation for##2##3##(2006-2#1)(2009-11#1)
of radiation from##3##3##(2007-12#1)(2008-3#2)
of radiation hormesis##3##3##(2008-7#2)(2013-1#1)
of radiation in a##2##4##(2007-12#2)
of radiation in the##2##4##(2007-12#1)(2008-7#1)
of radiation in##8##3##(2007-11#1)(2007-12#3)(2008-3#1)(2008-7#1)(2013-1#1)(2013-8#1)
of radiation is##3##3##(2008-7#3)
of radiation may##2##3##(2006-12#1)(2013-1#1)
of radiation of##2##3##(1990-9#1)(2008-3#1)
of radiation on##5##3##(1993-9#1)(1995-10#1)(2008-3#1)(2008-7#2)
of radiation oncology##2##3##(2007-4#1)(2008-6#1)
of radiation pressure##4##3##(2007-12#2)(2008-2#2)
of radiation protection for##2##4##(1993-12#1)(2008-12#1)
of radiation protection##9##3##(1993-12#1)(1994-12#1)(1996-6#2)(2006-5#1)(2008-12#2)(2008-7#1)(2012-2#1)
of radiation risk##2##3##(2008-7#2)
of radiation survey##2##3##(2012-2#2)
of radiation therapy and##2##4##(1991-2#1)(2011-1#1)
of radiation therapy for##2##4##(1994-6#1)(2006-9#1)
of radiation therapy in##3##4##(1992-4#1)(1994-12#1)(1994-6#1)
of radiation therapy on##2##4##(2004-1#1)(2008-7#1)
of radiation therapy##23##3##(1990-9#1)(1991-2#1)(1992-4#1)(1993-4#1)(1994-12#1)(1994-6#3)(1994-7#1)(1997-5#1)(2004-1#1)(2006-6#2)(2006-9#2)(2007-10#1)(2007-7#1)(2008-1#1)(2008-6#2)(2008-7#2)(2011-1#1)
of radiation through##2##3##(2008-3#2)
of radiation to the##2##4##(1993-9#1)(2006-8#1)
of radiation to##4##3##(1993-9#1)(2006-8#1)(2008-2#1)(2008-7#1)
of radiation treatment##3##3##(1996-12#1)(2011-2#1)(2012-1#1)
of radiation with##2##3##(2008-7#1)(2013-1#1)
of radiation##172##2##(1990-11#1)(1990-9#2)(1991-2#1)(1992-4#1)(1993-12#1)(1993-4#1)(1993-9#2)(1994-12#2)(1994-6#3)(1994-7#1)(1995-10#1)(1995-4#1)(1995-9#1)(1996-12#2)(1996-3#3)(1996-6#5)(1997-5#1)(2004-1#2)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-5#1)(2006-6#5)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#10)(2007-4#2)(2007-7#1)(2008-1#2)(2008-12#5)(2008-2#6)(2008-3#12)(2008-4#2)(2008-5#2)(2008-6#8)(2008-7#38)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-11#1)(2012-2#5)(2013-1#6)(2013-8#1)
of radiation-induced breast##2##3##(2008-7#1)(2013-8#1)
of radiation-induced necrosis and tumor recurrence##3##6##(2007-12#3)
of radiation-induced necrosis##4##3##(2007-12#4)
of radiation-induced##27##2##(1991-5#1)(1992-2#2)(1992-4#1)(1992-9#1)(1994-8#1)(1995-12#1)(1997-4#1)(2007-12#5)(2008-2#1)(2008-5#2)(2008-7#5)(2009-12#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-8#1)
of radiative transfer calculations##3##4##(2008-2#2)(2008-3#1)
of radiative transfer##6##3##(2008-2#2)(2008-3#4)
of radiative##9##2##(2006-4#1)(2008-2#4)(2008-3#4)
of radical generation##3##3##(1994-9#3)
of radical lymph node dissection in the##2##7##(2007-8#2)
of radical mastectomy##2##3##(1990-4#1)(2009-2#1)
of radical species##3##3##(1996-7#1)(2008-10#1)(2010-5#1)
of radical surgery in##2##4##(1992-4#1)(2013-7#1)
of radical surgery##7##3##(1990-10#1)(1990-9#1)(1991-4#1)(1992-4#1)(2008-6#1)(2010-5#1)(2013-7#1)
of radical surgical##2##3##(1990-6#1)(2007-11#1)
of radical therapy##2##3##(2008-5#1)(2012-2#1)
of radical##41##2##(1990-10#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-4#1)(1992-4#1)(1994-9#3)(1995-6#2)(1996-12#1)(1996-5#1)(1996-7#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-2#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-5#2)(2011-2#2)(2012-2#1)(2013-7#1)
of radicals##6##2##(1990-10#2)(1992-11#1)(2007-11#1)(2008-11#1)(2010-4#1)
of radicular pain##4##3##(2006-7#1)(2006-8#1)(2012-2#2)
of radicular##7##2##(1990-12#1)(1997-3#1)(2006-7#1)(2006-8#1)(2010-12#1)(2012-2#2)
of radiculopathy##4##2##(2006-8#1)(2007-8#2)(2012-3#1)
of radii##2##2##(2005-11#1)(2008-2#1)
of radio frequency##3##3##(2007-11#1)(2008-3#1)(2011-2#1)
of radio-iodinated##2##2##(1991-12#1)(2008-2#1)
of radioactive##25##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-6#1)(1991-9#1)(1992-4#1)(1992-8#1)(1992-9#1)(1994-10#1)(1994-9#2)(1995-2#1)(1996-5#2)(2007-5#1)(2008-10#3)(2008-4#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)
of radioactively##2##2##(1993-11#1)(2008-4#1)
of radioactivity from##2##3##(1994-6#1)(1995-8#1)
of radioactivity in the##3##4##(1994-3#1)(1995-1#1)(2008-2#1)
of radioactivity in##5##3##(1992-8#1)(1994-3#1)(1994-9#1)(1995-1#1)(2008-2#1)
of radioactivity into the##2##4##(1990-11#1)(2008-4#1)
of radioactivity into##3##3##(1990-11#1)(1994-3#1)(2008-4#1)
of radioactivity is##2##3##(1992-4#1)(1997-8#1)
of radioactivity retained##2##3##(1993-6#1)(1994-11#1)
of radioactivity##42##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-8#1)(1991-12#1)(1992-2#1)(1992-4#3)(1992-5#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-8#1)(1996-2#1)(1997-1#1)(1997-8#2)(2006-12#1)(2007-11#1)(2008-11#3)(2008-2#1)(2008-4#3)(2008-7#3)(2008-9#1)(2010-2#1)
of radiobiology##2##2##(2007-4#1)(2008-10#1)
of radiocaesium in##3##3##(1992-3#3)
of radiocaesium levels in##2##4##(1993-9#2)
of radiocaesium##8##2##(1992-3#4)(1992-6#1)(1993-9#3)
of radiofrequency ablation of##2##4##(2008-11#1)(2013-8#1)
of radiofrequency ablation##6##3##(2006-6#1)(2006-9#2)(2008-11#1)(2011-2#1)(2013-8#1)
of radiofrequency denervation in##2##4##(2006-8#2)
of radiofrequency heat##2##3##(2006-12#1)(2009-3#1)
of radiofrequency##23##2##(1991-6#1)(2006-12#6)(2006-6#1)(2006-8#3)(2006-9#2)(2008-10#2)(2008-11#1)(2009-3#1)(2010-3#1)(2010-5#1)(2011-2#3)(2013-8#1)
of radiographic##16##2##(1991-12#2)(1993-11#1)(1997-4#1)(2005-11#1)(2006-1#1)(2006-10#2)(2006-3#1)(2007-2#1)(2008-12#1)(2008-3#1)(2011-2#2)(2012-12#1)(2012-3#1)
of radiography and##2##3##(2009-9#1)(2012-3#1)
of radiography##5##2##(1993-1#1)(1996-2#1)(2007-7#1)(2009-9#1)(2012-3#1)
of radioimmunoassay##3##2##(1990-9#1)(1993-9#1)(2007-8#1)
of radioiodinated##7##2##(1990-7#1)(1992-10#2)(1992-2#1)(1994-8#1)(1995-6#1)(2008-4#1)
of radioiodine##2##2##(1991-10#1)(2008-4#1)
of radioisotope##3##2##(1991-9#1)(1992-2#1)(1996-11#1)
of radioisotopes and##3##3##(2007-11#1)(2008-2#2)
of radioisotopes##11##2##(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-4#3)(2008-9#2)(2012-2#1)
of radiolabel##5##2##(1991-12#1)(1991-2#1)(1991-3#1)(1992-9#1)(1993-6#1)
of radiolabeled T cells in mouse brain##2##7##(2010-2#2)
of radiolabeled lipid##2##3##(1997-1#2)
of radiolabeled precursor##2##3##(2008-10#1)(2008-4#1)
of radiolabeled##33##2##(1990-2#1)(1990-8#1)(1991-10#1)(1991-2#1)(1992-11#1)(1992-7#1)(1993-11#1)(1993-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-8#2)(1996-9#1)(1997-1#2)(2005-11#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#9)(2009-9#1)(2010-2#2)
of radiolabelled##13##2##(1990-1#1)(1990-11#1)(1990-12#1)(1992-8#1)(1992-9#1)(1994-3#1)(1996-2#2)(2004-11#1)(2007-11#2)(2008-11#1)(2008-7#1)
of radioligand binding##3##3##(1991-3#1)(1994-8#1)(1995-12#1)
of radioligand was##2##3##(1991-5#1)(1994-8#1)
of radioligand##6##2##(1991-3#1)(1991-5#1)(1994-8#2)(1995-12#1)(1996-5#1)
of radiologic practice##2##3##(2007-4#2)
of radiologic##4##2##(1996-2#1)(1997-4#1)(2007-4#2)
of radiological and##3##3##(2006-2#1)(2007-3#1)(2007-8#1)
of radiological examinations##2##3##(2004-2#1)(2013-1#1)
of radiological management##2##3##(1990-4#1)(2012-2#1)
of radiological signs##2##3##(2007-11#1)(2008-6#1)
of radiological##26##2##(1990-4#1)(1991-11#1)(1991-12#1)(1993-10#2)(1995-8#1)(2004-2#1)(2006-12#1)(2006-2#1)(2007-11#5)(2007-3#1)(2007-7#1)(2007-8#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
of radiologist##5##2##(2007-4#4)(2012-2#1)
of radiologists and##2##3##(1992-1#1)(2007-4#1)
of radiologists##7##2##(1992-1#1)(2007-4#5)(2012-2#1)
of radiology and##4##3##(1995-3#2)(2007-4#1)(2009-9#1)
of radiology departments##3##3##(1990-12#1)(1993-12#1)(1994-1#1)
of radiology in##2##3##(1993-10#1)(1995-3#1)
of radiology practices##2##3##(1993-3#2)
of radiology reports##2##3##(2012-2#2)
of radiology##47##2##(1990-12#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#1)(1993-1#2)(1993-10#1)(1993-12#1)(1993-3#3)(1994-1#1)(1995-1#1)(1995-2#1)(1995-3#3)(1996-2#2)(2007-4#19)(2008-6#1)(2009-4#1)(2009-9#3)(2012-2#3)
of radiometric##4##2##(2008-2#1)(2008-3#3)
of radionecrosis##3##2##(2011-1#3)
of radionuclide##4##2##(2007-11#4)
of radionuclides##6##2##(1992-4#1)(1993-8#1)(1995-12#1)(2007-11#1)(2008-10#1)(2008-3#1)
of radiopharmaceuticals##3##2##(1994-5#1)(2008-10#1)(2012-12#1)
of radiosurgery for##2##3##(2006-7#1)(2011-2#1)
of radiosurgery##6##2##(1995-12#1)(2006-11#1)(2006-7#1)(2008-7#2)(2011-2#1)
of radiotherapeutic##2##2##(1992-10#1)(1996-12#1)
of radiotherapy and chemotherapy in##2##5##(2012-1#1)(2013-1#1)
of radiotherapy and chemotherapy##4##4##(1997-6#2)(2012-1#1)(2013-1#1)
of radiotherapy and##8##3##(1995-11#1)(1995-9#1)(1997-6#2)(2008-6#1)(2008-7#1)(2012-1#1)(2013-1#1)
of radiotherapy for##5##3##(1992-10#1)(1995-9#1)(2007-11#1)(2012-2#2)
of radiotherapy in the treatment of##3##6##(1994-8#1)(2012-2#2)
of radiotherapy in the##5##4##(1994-8#1)(1995-9#1)(2007-10#1)(2012-2#2)
of radiotherapy in##12##3##(1994-8#1)(1995-9#1)(1996-12#1)(2006-6#2)(2007-10#1)(2007-11#1)(2007-4#1)(2008-10#1)(2010-3#1)(2012-2#2)
of radiotherapy is##2##3##(2006-7#1)(2009-1#1)
of radiotherapy of##2##3##(1990-10#1)(2006-7#1)
of radiotherapy on##2##3##(1995-8#1)(2007-8#1)
of radiotherapy plus##2##3##(1991-2#1)(2011-2#1)
of radiotherapy should be considered##2##5##(1997-3#1)(2007-10#1)
of radiotherapy to##2##3##(2007-11#2)
of radiotherapy treatments##2##3##(2007-11#1)(2009-5#1)
of radiotherapy##75##2##(1990-10#1)(1990-12#1)(1991-2#1)(1991-4#1)(1992-10#1)(1993-8#1)(1993-9#1)(1994-4#2)(1994-8#1)(1995-11#1)(1995-8#1)(1995-9#3)(1996-12#1)(1997-3#1)(1997-5#1)(1997-6#2)(2004-1#2)(2006-2#1)(2006-6#2)(2006-7#3)(2006-8#1)(2007-10#2)(2007-11#7)(2007-4#2)(2007-6#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#3)(2008-7#3)(2009-1#1)(2009-5#2)(2010-12#2)(2010-3#3)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#7)(2013-1#2)
of radiotoxicity##2##2##(1991-12#2)
of radiotracers##2##2##(2007-11#1)(2008-10#1)
of radish##10##2##(1990-3#1)(2008-10#9)
of radius##4##2##(2005-11#1)(2008-4#1)(2010-11#2)
of radon in##2##3##(1992-6#1)(1996-3#1)
of radon##8##2##(1991-11#1)(1992-6#1)(1996-3#2)(2008-1#2)(2008-7#2)
of raf##2##2##(1994-6#1)(2005-11#1)
of raft formation in##2##4##(2007-12#2)
of raft mussels##2##3##(2010-5#2)
of raft nanodomains##2##3##(2011-1#2)
of raft##6##2##(2007-12#2)(2010-5#2)(2011-1#2)
of rain##7##2##(2008-10#5)(2008-3#1)(2013-8#1)
of rainbow trout (Oncorhynchus mykiss Walbaum##2##6##(2008-7#2)
of rainbow trout (Oncorhynchus##3##4##(2008-7#3)
of rainbow trout (Oncorhynchuss mykiss) and##2##6##(2009-4#2)
of rainbow trout Oncorhynchus mykiss##4##5##(1992-12#1)(2010-8#2)(2012-3#1)
of rainbow trout##17##3##(1991-4#1)(1992-12#1)(1996-11#1)(1997-9#1)(2005-10#1)(2008-11#1)(2008-7#4)(2009-4#2)(2009-5#1)(2010-8#2)(2012-3#2)
of rainbow##19##2##(1991-4#1)(1992-12#1)(1996-11#1)(1997-9#1)(2005-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#4)(2009-4#2)(2009-5#1)(2010-8#2)(2012-3#2)
of rainbows##2##2##(2008-3#2)
of raindrops##2##2##(2008-3#2)
of rainfall in##2##3##(2008-10#1)(2010-2#1)
of rainfall##8##2##(2006-7#1)(2007-3#1)(2008-10#2)(2010-2#3)(2011-2#1)
of rainwater##3##2##(2008-10#3)
of rainy##2##2##(2005-8#1)(2008-10#1)
of raised ICP##7##3##(1996-9#1)(2008-7#2)(2010-5#4)
of raised intracranial##3##3##(1994-7#1)(2009-10#1)(2013-1#1)
of raised##16##2##(1994-3#1)(1994-7#1)(1995-12#1)(1996-9#1)(2008-7#2)(2009-10#1)(2010-5#5)(2010-8#1)(2012-3#1)(2013-1#2)
of raising children##2##3##(2007-3#1)(2009-12#1)
of raising the##2##3##(2008-11#1)(2010-7#1)
of raising##7##2##(1996-11#1)(2007-3#1)(2008-11#2)(2009-12#1)(2009-8#1)(2010-7#1)
of raloxifene##2##2##(2008-10#1)(2010-10#1)
of raltegravir##2##2##(2009-6#1)(2010-9#1)
of ram p25##2##3##(1992-11#2)
of ram##3##2##(1992-11#2)(2006-5#1)
of ramadan fasting on##4##4##(2012-3#4)
of ramets##2##2##(2008-5#1)(2008-9#1)
of ramified##2##2##(2007-12#2)
of ramipril and##2##3##(2010-12#1)(2010-3#1)
of ramipril##3##2##(2010-12#2)(2010-3#1)
of ramoplanin##5##2##(1995-2#1)(2006-5#4)
of ramsdellite##2##2##(2005-11#2)
of random DNA##5##3##(2007-8#5)
of random amplified polymorphic DNA (RAPD)##2##6##(2008-10#2)
of random amplified polymorphic DNA##4##5##(2008-10#4)
of random and##2##3##(2008-2#1)(2008-3#1)
of random coil##2##3##(2005-11#1)(2008-8#1)
of random errors in##3##4##(2008-3#1)(2008-7#1)(2009-5#1)
of random errors##5##3##(2008-10#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-12#1)
of random knots##3##3##(2006-4#3)
of random matrices##2##3##(1992-3#1)(2012-2#1)
of random noise##2##3##(2008-2#1)(2008-3#1)
of random peptides##2##3##(2008-4#1)(2009-2#1)
of random phase##2##3##(2008-3#2)
of random sequence##3##3##(1990-5#1)(1990-8#1)(1996-3#1)
of random sequences##3##3##(1993-6#2)(1995-8#1)
of random wave vectors##2##4##(2008-3#2)
of random##78##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-3#1)(1992-3#1)(1993-4#1)(1993-6#2)(1995-11#1)(1995-8#1)(1996-3#1)(1996-8#1)(1997-8#1)(2005-11#5)(2006-10#1)(2006-2#1)(2006-4#3)(2007-11#3)(2007-8#5)(2008-10#15)(2008-2#3)(2008-3#11)(2008-4#2)(2008-7#3)(2008-8#3)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-12#1)(2012-2#1)(2012-3#1)
of random-coil##2##2##(1997-2#1)(2009-2#1)
of randomisation##2##2##(2010-2#1)(2012-3#1)
of randomised controlled trials##3##4##(1993-8#1)(2006-9#1)(2010-12#1)
of randomised controlled##4##3##(1993-8#1)(2006-9#1)(2010-12#1)(2012-3#1)
of randomised##8##2##(1993-8#1)(1997-7#1)(2006-9#1)(2007-12#1)(2010-12#1)(2010-5#1)(2012-3#2)
of randomized clinical trials##6##4##(2006-10#1)(2007-10#1)(2008-10#1)(2009-7#1)(2010-6#1)(2012-3#1)
of randomized controlled trials##11##4##(2005-10#1)(2005-11#1)(2006-7#1)(2007-10#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-8#2)(2013-1#2)
of randomized controlled##12##3##(2005-10#1)(2005-11#1)(2006-7#1)(2007-10#1)(2007-4#1)(2007-7#2)(2008-11#1)(2008-8#2)(2013-1#2)
of randomized studies##2##3##(1997-3#1)(2007-8#1)
of randomized trials are##2##4##(2010-12#1)(2012-1#1)
of randomized trials##7##3##(1993-12#1)(2006-6#1)(2007-11#1)(2009-9#1)(2010-12#1)(2012-1#1)(2012-3#1)
of randomized##37##2##(1993-1#1)(1993-12#1)(1994-11#1)(1994-2#1)(1997-3#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#2)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-6#1)(2012-1#1)(2012-3#2)(2013-1#2)
of randomly distributed soot##2##4##(2008-3#2)
of randomly generated##3##3##(1995-6#1)(2013-1#2)
of randomly oriented##6##3##(1995-12#1)(2008-2#1)(2008-3#3)(2008-4#1)
of randomly selected##7##3##(1993-8#1)(2004-8#1)(2006-10#1)(2007-7#1)(2008-10#2)(2009-5#1)
of randomly##27##2##(1993-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-2#1)(2004-8#1)(2006-10#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#1)(2009-5#1)(2013-1#2)
of randomness##2##2##(2007-8#1)(2008-2#1)
of range expansion##2##3##(2006-5#1)(2010-6#1)
of range of motion##6##4##(2008-4#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-9#1)(2011-2#1)
of range##11##2##(2006-5#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#1)
of ranitidine in##6##3##(1990-12#2)(1992-11#1)(1995-3#1)(2013-8#2)
of ranitidine##16##2##(1990-12#2)(1991-5#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-8#1)(1993-6#2)(1995-3#1)(1997-8#1)(2008-11#1)(2013-8#3)
of rank##2##2##(1995-1#1)(2008-10#1)
of ranolazine in##4##3##(2005-8#4)
of ranolazine used in##2##4##(2005-8#2)
of ranolazine##8##2##(2005-8#7)(2009-12#1)
of rapamycin##30##2##(1993-11#3)(1994-6#1)(2006-10#1)(2006-5#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-12#4)(2010-7#1)(2011-2#2)(2013-1#5)(2013-7#2)
of rape##11##2##(1990-12#3)(2005-8#2)(2007-12#1)(2007-3#1)(2008-6#2)(2011-2#1)(2013-1#1)
of rapeseed oil##2##3##(2008-6#2)
of rapeseed proanthrocyanidin##2##3##(2011-1#2)
of rapeseed proteins##2##3##(2008-11#2)
of rapeseed##9##2##(1990-12#1)(2008-10#1)(2008-11#2)(2008-6#3)(2011-1#2)
of rapid and##5##3##(1994-12#1)(2007-11#1)(2008-10#2)(2013-1#1)
of rapid change in##2##4##(2008-3#1)(2013-1#1)
of rapid change##4##3##(1997-3#2)(2008-3#1)(2013-1#1)
of rapid changes in the##2##5##(2008-11#1)(2008-8#1)
of rapid development##2##3##(1996-11#1)(2006-7#1)
of rapid diagnostic##2##3##(2011-2#1)(2013-1#1)
of rapid evolution##2##3##(2008-7#1)(2010-8#1)
of rapid growth of##2##4##(1990-11#1)(1991-9#1)
of rapid growth##4##3##(1990-11#1)(1991-9#1)(2010-8#1)(2012-12#1)
of rapid increase##2##3##(1990-6#1)(2006-10#1)
of rapid screening of##2##4##(2007-11#1)(2008-8#1)
of rapid spread##2##3##(2008-10#1)(2008-9#1)
of rapid##95##2##(1990-11#2)(1990-6#1)(1991-6#1)(1991-9#1)(1992-1#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-6#1)(1996-11#1)(1996-12#1)(1997-3#2)(1997-4#1)(2005-8#1)(2006-10#6)(2006-7#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-4#1)(2007-8#5)(2008-1#2)(2008-10#9)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#8)(2008-8#7)(2008-9#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-4#1)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
of rapid-acting##2##2##(2007-11#2)
of rapidity##4##2##(1997-4#1)(2008-10#2)(2008-2#1)
of rapidly changing##2##3##(2006-10#1)(2008-2#1)
of rapidly convergent##2##3##(2007-12#1)(2008-2#1)
of rapidly evolving##2##3##(2010-5#1)(2013-8#1)
of rapidly progressive##2##3##(2007-7#1)(2013-7#1)
of rapidly##18##2##(1990-5#1)(1993-2#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#4)(2010-5#1)(2010-7#1)(2011-2#1)(2013-7#2)(2013-8#1)
of rare SNPs##2##3##(2012-3#2)
of rare alleles##4##3##(2012-3#4)
of rare but##2##3##(2009-6#1)(2011-2#1)
of rare conditions##2##3##(2012-1#1)(2012-3#1)
of rare congenital##2##3##(2010-2#1)(2010-6#1)
of rare earth elements and##3##5##(2005-4#1)(2008-10#2)
of rare earth elements##10##4##(2005-4#4)(2008-10#6)
of rare earth impurities in high purity##2##7##(2008-10#2)
of rare earth impurities in##3##5##(2005-4#1)(2008-10#2)
of rare earth impurities##4##4##(2005-4#1)(2008-10#3)
of rare earth##18##3##(2005-4#5)(2008-10#12)(2010-7#1)
of rare earths##4##3##(2008-10#4)
of rare genetic variants##3##4##(2012-3#3)
of rare genetic##4##3##(2012-3#4)
of rare restriction sites##3##4##(1990-5#2)(1994-12#1)
of rare restriction##4##3##(1990-5#2)(1994-12#2)
of rare side##2##3##(1991-3#2)
of rare species##2##3##(2007-5#1)(2008-12#1)
of rare variant##3##3##(2012-3#3)
of rare variants and##2##4##(2012-3#2)
of rare variants by##2##4##(2012-3#2)
of rare variants in##7##4##(2012-1#1)(2012-3#6)
of rare variants##33##3##(2012-1#1)(2012-3#32)
of rare##120##2##(1990-12#1)(1990-5#2)(1990-7#1)(1991-11#1)(1991-3#2)(1991-7#1)(1994-12#2)(1995-2#1)(1996-3#1)(1997-8#1)(2005-4#6)(2007-11#1)(2007-5#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#3)(2009-6#2)(2009-8#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#2)(2011-7#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-3#52)(2013-7#1)(2013-8#1)
of rare-earth##6##2##(2005-4#2)(2007-8#1)(2008-10#1)(2008-2#1)(2010-5#1)
of rare-earth-doped##2##2##(2007-12#2)
of rarely##3##2##(2006-6#1)(2007-7#1)(2012-1#1)
of rarer##2##2##(1996-9#1)(2008-6#1)
of ras mutations in##2##4##(1991-5#2)
of ras##10##2##(1990-11#1)(1991-5#2)(1991-8#1)(1992-11#1)(1992-5#1)(1993-6#1)(1993-9#1)(1994-12#1)(2005-11#1)
of ras-p21 and##2##3##(1993-3#1)(1995-9#1)
of ras-p21##3##2##(1993-3#2)(1995-9#1)
of ras-rBHK-IgG##2##2##(2008-11#2)
of rasagiline##2##2##(2008-5#2)
of rasburicase##3##2##(2008-7#3)
of rash##3##2##(2006-12#1)(2007-2#1)(2009-11#1)
of raster##2##2##(2007-12#1)(2008-3#1)
of rat CMECs to hypoxia##2##5##(2013-8#2)
of rat ECs##2##3##(1994-6#1)(1994-8#1)
of rat MSH2##2##3##(1997-1#2)
of rat adrenal nerve cells##2##5##(2008-11#2)
of rat adrenal##3##3##(1991-2#1)(2008-11#2)
of rat and bovine##2##4##(1991-2#1)(1994-8#1)
of rat and human##6##4##(1991-9#1)(1992-1#1)(1994-2#1)(1995-2#1)(1995-6#1)(2009-4#1)
of rat and mouse##5##4##(1990-8#1)(1991-6#1)(1991-8#2)(1994-12#1)
of rat and rabbit##2##4##(1991-6#1)(2012-1#1)
of rat and##19##3##(1990-8#1)(1991-2#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-3#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-2#1)(2008-11#1)(2009-4#1)(2012-1#1)
of rat aorta##3##3##(1990-12#1)(1991-5#1)(1993-3#1)
of rat aortic rings##3##4##(1990-11#1)(1994-2#2)
of rat aortic##6##3##(1990-11#1)(1990-12#1)(1991-9#1)(1994-2#2)(2008-4#1)
of rat ascites hepatoma##3##4##(1996-11#1)(2008-11#2)
of rat bone marrow##2##4##(1990-3#1)(1991-1#1)
of rat bone##3##3##(1990-3#1)(1991-1#1)(2009-7#1)
of rat brain tumors##2##4##(1994-3#2)
of rat brain##50##3##(1990-12#1)(1990-2#1)(1990-5#3)(1990-7#5)(1991-1#2)(1991-12#2)(1991-3#2)(1991-5#2)(1991-6#1)(1991-9#2)(1992-11#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#2)(1993-7#1)(1994-10#1)(1994-2#1)(1994-3#3)(1995-11#1)(1995-7#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-7#1)(2007-9#1)(2008-10#2)(2008-11#2)(2011-2#1)(2012-1#2)
of rat by##3##3##(1990-11#1)(1996-2#1)(2013-8#1)
of rat central##2##3##(1995-12#1)(1996-5#1)
of rat cerebellar##3##3##(1995-7#2)(1997-7#1)
of rat cerebral cortex##6##4##(1990-2#1)(1990-7#1)(1992-12#2)(1994-10#1)(1994-12#1)
of rat cerebral neurons##2##4##(1996-11#2)
of rat cerebral##8##3##(1990-2#1)(1990-7#1)(1992-12#2)(1994-10#1)(1994-12#1)(1996-11#2)
of rat cerebrum##2##3##(1991-1#1)(1994-6#1)
of rat collagen type I##2##5##(1990-11#2)
of rat cortical##4##3##(1990-4#1)(1993-12#1)(1996-9#1)(2008-4#1)
of rat duodenal##2##3##(1996-5#2)
of rat eccrine sweat gland##2##5##(1991-5#2)
of rat embryo##2##3##(1990-11#1)(1994-3#1)
of rat embryonic##3##3##(1994-12#1)(1997-6#1)(2012-1#1)
of rat frontal cortex##2##4##(1996-6#2)
of rat genomic##2##3##(1990-12#1)(2007-3#1)
of rat heart##7##3##(1990-7#1)(1991-10#2)(1991-8#1)(1993-9#1)(1994-5#1)(1994-6#1)
of rat hepatic and renal##2##5##(2008-10#1)(2009-6#1)
of rat hepatic##6##3##(1992-5#1)(1995-3#1)(2008-10#1)(2008-5#1)(2009-6#1)(2013-8#1)
of rat hepatocyte##2##3##(1993-3#1)(2008-11#1)
of rat hepatocytes and##2##4##(2004-11#1)(2008-11#1)
of rat hepatocytes##15##3##(1990-5#1)(1990-7#1)(1991-9#1)(1992-3#1)(1994-11#2)(1994-5#1)(1994-8#1)(1997-2#2)(2004-11#2)(2008-1#1)(2008-11#2)
of rat hepatoma cells##2##4##(1992-3#1)(2008-11#1)
of rat hepatoma##3##3##(1992-3#1)(2008-11#2)
of rat hindlimb##2##3##(1993-11#2)
of rat hippocampal neurons exposed to hydrogen peroxide##2##8##(1993-4#2)
of rat hippocampal neurons exposed to##3##6##(1993-4#2)(1995-6#1)
of rat hippocampal slices##8##4##(1990-7#1)(1992-3#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-8#2)(1997-5#1)
of rat hippocampal##16##3##(1990-7#1)(1992-3#1)(1993-4#2)(1994-2#1)(1995-12#1)(1995-3#1)(1995-6#2)(1996-1#2)(1996-8#2)(1997-5#1)(2008-4#1)(2008-7#1)
of rat hippocampus##9##3##(1990-2#1)(1990-7#1)(1991-3#1)(1991-6#1)(1992-1#1)(1995-12#1)(1997-2#1)(1997-5#1)(1997-6#1)
of rat hypothalamic##2##3##(1995-1#1)(1995-10#1)
of rat intestinal##2##3##(1991-12#1)(1992-9#1)
of rat kidney##7##3##(1992-3#1)(1992-5#1)(1993-3#1)(1994-9#2)(1995-1#1)(2010-12#1)
of rat liver H(+)-ATP synthase has been determined from a recombinant cDNA clone isolated by screening a rat liver cDNA library with a probe DNA##2##25##(1990-5#1)(1990-9#1)
of rat liver S-adenosylhomocysteinase##2##4##(1990-10#2)
of rat liver aryl sulphotransferase##2##5##(1993-2#2)
of rat liver aryl##3##4##(1993-12#1)(1993-2#2)
of rat liver cells##4##4##(1990-12#2)(1991-7#1)(2008-8#1)
of rat liver class theta glutathione S-transferase##2##7##(1991-12#2)
of rat liver microsomal glutathione transferase##2##6##(1995-7#2)
of rat liver microsomal##4##4##(1990-4#1)(1994-8#1)(1995-7#2)
of rat liver microsomes##3##4##(1992-7#1)(1994-8#1)(1996-2#1)
of rat liver mitochondria##2##4##(1994-11#1)(2005-8#1)
of rat liver mitochondrial##2##4##(1991-7#1)(1995-2#1)
of rat liver uricase##2##4##(1992-8#2)
of rat liver##78##3##(1990-10#2)(1990-12#2)(1990-2#2)(1990-3#3)(1990-4#3)(1990-5#3)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#5)(1991-3#2)(1991-7#2)(1991-8#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-7#1)(1992-8#3)(1993-12#3)(1993-2#2)(1993-4#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-5#3)(1994-8#6)(1994-9#3)(1995-1#2)(1995-12#1)(1995-2#1)(1995-7#2)(1996-2#1)(2005-8#1)(2006-2#1)(2008-10#2)(2008-2#1)(2008-8#1)(2009-8#1)
of rat lung##4##3##(1991-5#1)(1995-2#2)(2009-3#1)
of rat mammary##3##3##(1990-5#2)(1995-11#1)
of rat motor activity##2##4##(1993-2#2)
of rat motor##3##3##(1993-2#2)(2013-8#1)
of rat peripheral blood large granular lymphocytes (LGL)##2##8##(1990-12#2)
of rat peroxisomal 3-ketoacyl-CoA thiolase##2##5##(1991-12#1)(1992-7#1)
of rat pituitary##6##3##(1990-12#1)(1990-9#1)(1991-8#1)(1992-2#1)(1993-5#1)(1994-3#1)
of rat plasma##8##3##(1990-12#2)(1990-7#2)(1993-11#1)(1997-2#1)(1997-8#1)(2013-1#1)
of rat primary hepatocytes##2##4##(2008-11#2)
of rat primary##4##3##(1995-5#1)(1997-4#1)(2008-11#2)
of rat prolactin receptor##2##4##(1995-11#1)(2008-4#1)
of rat prolactin##4##3##(1994-11#2)(1995-11#1)(2008-4#1)
of rat renal##6##3##(1990-11#1)(1991-10#1)(1992-5#1)(1995-1#1)(1995-11#1)(2008-8#1)
of rat sensory neurons##2##4##(1990-7#1)(1995-2#1)
of rat skeletal muscle##7##4##(1991-5#1)(1993-12#1)(1993-3#1)(1996-3#1)(2008-2#1)(2008-9#1)(2011-2#1)
of rat skeletal##8##3##(1990-11#1)(1991-5#1)(1993-12#1)(1993-3#1)(1996-3#1)(2008-2#1)(2008-9#1)(2011-2#1)
of rat somatosensory##2##3##(1995-12#1)(2008-1#1)
of rat spleen##3##3##(1992-8#1)(1993-7#2)
of rat thymocytes##2##3##(1993-4#1)(1997-6#1)
of rat thyroid##2##3##(1991-12#1)(1992-2#1)
of rat tissues##2##3##(1990-12#1)(1993-5#1)
of rat urine##2##3##(1996-8#1)(2008-10#1)
of rat uterine##3##3##(1991-6#1)(1991-8#2)
of rat ventral prostate##2##4##(1990-7#1)(1995-6#1)
of rat visual cortex##2##4##(1996-3#2)
of rat##584##2##(1990-10#3)(1990-11#13)(1990-12#16)(1990-2#10)(1990-3#4)(1990-4#5)(1990-5#12)(1990-7#17)(1990-8#4)(1990-9#2)(1991-1#4)(1991-10#6)(1991-11#1)(1991-12#12)(1991-2#7)(1991-3#8)(1991-4#1)(1991-5#9)(1991-6#9)(1991-7#3)(1991-8#7)(1991-9#6)(1992-1#4)(1992-10#1)(1992-11#5)(1992-12#4)(1992-2#4)(1992-3#10)(1992-4#2)(1992-5#7)(1992-6#5)(1992-7#6)(1992-8#12)(1992-9#3)(1993-11#10)(1993-12#7)(1993-2#4)(1993-3#10)(1993-4#12)(1993-5#3)(1993-6#1)(1993-7#5)(1993-8#3)(1993-9#2)(1994-10#3)(1994-11#10)(1994-12#5)(1994-2#8)(1994-3#7)(1994-5#9)(1994-6#8)(1994-8#12)(1994-9#10)(1995-1#5)(1995-10#2)(1995-11#8)(1995-12#9)(1995-2#5)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#7)(1995-7#5)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#4)(1996-12#6)(1996-2#7)(1996-3#6)(1996-5#10)(1996-6#2)(1996-7#2)(1996-8#4)(1996-9#1)(1997-1#4)(1997-2#7)(1997-4#1)(1997-5#2)(1997-6#4)(1997-7#4)(1997-8#3)(2004-11#2)(2005-8#1)(2006-2#1)(2007-3#2)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#21)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#10)(2008-5#3)(2008-7#5)(2008-8#3)(2008-9#5)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#6)(2011-2#4)(2011-3#6)(2012-1#5)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#7)
of rat's##2##2##(1995-12#1)(2008-12#1)
of rate constants for##2##4##(1991-11#1)(2012-1#1)
of rate constants##6##3##(1991-11#1)(1992-6#1)(1994-12#1)(2008-2#1)(2008-4#1)(2012-1#1)
of rate equations##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
of rate isomorphy##4##3##(2008-8#4)
of rate##22##2##(1991-11#1)(1992-6#1)(1994-12#1)(1996-4#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#1)(2011-1#1)(2012-1#1)
of rate-limiting steps in the soybean lipoxygenase-1##2##7##(1995-10#2)
of rate-limiting##4##2##(1995-10#2)(2008-7#1)(2010-12#1)
of raters##2##2##(2010-12#1)(2012-3#1)
of rates of##8##3##(1992-12#1)(1994-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)
of rates##14##2##(1991-6#1)(1992-12#1)(1992-5#1)(1994-12#1)(1994-3#1)(1994-4#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)
of rather##5##2##(1991-6#1)(2007-11#1)(2008-2#1)(2008-7#1)(2009-6#1)
of rating##2##2##(1990-3#1)(2008-7#1)
of ratio##7##2##(2008-10#4)(2008-3#1)(2009-6#1)(2012-2#1)
of rational##12##2##(1990-10#1)(1991-12#1)(1992-9#1)(1994-11#1)(1995-5#1)(1996-3#1)(1997-3#1)(2006-10#1)(2006-7#2)(2006-9#1)(2008-4#1)
of rationing##5##2##(1993-3#1)(1993-7#1)(1996-8#1)(2006-5#1)(2008-7#1)
of rations##2##2##(2007-8#1)(2010-7#1)
of ratios of##2##3##(2008-10#1)(2013-1#1)
of ratios##4##2##(2008-10#2)(2011-1#1)(2013-1#1)
of ratites##2##2##(2013-1#2)
of rats (n =##4##4##(1993-6#1)(1997-8#1)(2007-10#2)
of rats and mice##3##4##(2006-10#1)(2008-7#2)
of rats and##5##3##(1994-6#1)(1996-10#1)(2006-10#1)(2008-7#2)
of rats are##2##3##(2008-4#2)
of rats at##4##3##(1996-5#1)(2006-1#1)(2008-12#1)(2008-3#1)
of rats bearing##3##3##(1993-8#3)
of rats by##6##3##(1991-10#1)(1993-12#1)(1997-8#1)(2008-10#1)(2009-2#1)(2013-1#1)
of rats carrying##3##3##(1990-2#1)(1990-4#2)
of rats during##2##3##(1992-3#1)(2013-1#1)
of rats exposed to##5##4##(1992-11#1)(1992-6#1)(1995-12#1)(1995-8#1)(1997-2#1)
of rats exposed##6##3##(1992-11#1)(1992-6#1)(1994-10#1)(1995-12#1)(1995-8#1)(1997-2#1)
of rats fed vitamin##2##4##(1993-12#1)(1994-5#1)
of rats fed##6##3##(1991-7#1)(1993-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(2013-1#1)
of rats following##5##3##(1991-3#1)(1993-2#2)(1994-10#1)(1994-6#1)
of rats from##4##3##(1991-5#1)(1993-11#1)(1993-3#1)(2008-10#1)
of rats given##2##3##(1993-2#1)(2009-3#1)
of rats in a##3##4##(1992-11#1)(2012-1#1)(2013-1#1)
of rats in##10##3##(1990-6#1)(1992-11#1)(1992-12#1)(1993-9#1)(1994-7#1)(2008-10#1)(2008-8#1)(2009-8#1)(2012-1#1)(2013-1#1)
of rats of different##2##4##(1997-1#1)(2012-1#1)
of rats on##3##3##(1992-9#1)(1994-3#1)(2008-10#1)
of rats prenatally exposed to ethanol##2##6##(1995-3#1)(2013-1#1)
of rats received##8##3##(1993-3#1)(1996-1#1)(2008-5#1)(2008-6#1)(2009-10#1)(2010-7#1)(2011-2#1)(2013-1#1)
of rats receiving##5##3##(1993-4#1)(1995-1#1)(1996-12#1)(1997-1#1)(1997-3#1)
of rats soon after##2##4##(1991-5#1)(1993-7#1)
of rats subjected to##3##4##(1995-7#1)(2007-9#1)(2013-7#1)
of rats that##3##3##(1990-5#1)(2009-5#2)
of rats to the##2##4##(1991-10#1)(1993-7#1)
of rats to##14##3##(1990-7#1)(1991-10#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-6#1)(1995-12#2)(2007-10#1)(2008-11#1)(2009-3#1)(2009-4#1)(2012-2#2)
of rats treated with##16##4##(1990-2#2)(1991-3#1)(1992-9#1)(1994-3#2)(1994-5#1)(1994-6#1)(1996-10#1)(1996-5#1)(2007-10#1)(2008-10#2)(2008-5#1)(2012-1#1)(2012-2#1)
of rats treated##17##3##(1990-2#2)(1991-3#1)(1992-9#1)(1994-3#2)(1994-5#1)(1994-6#1)(1996-10#1)(1996-5#1)(1997-2#1)(2007-10#1)(2008-10#2)(2008-5#1)(2012-1#1)(2012-2#1)
of rats was investigated##2##4##(1993-8#1)(1997-2#1)
of rats was##8##3##(1991-12#2)(1993-12#1)(1993-8#1)(1997-2#1)(1997-8#1)(2007-1#1)(2007-11#1)
of rats were fed##2##4##(1991-2#1)(1994-2#1)
of rats were##11##3##(1990-5#2)(1991-12#1)(1991-2#1)(1993-5#1)(1993-8#1)(1994-2#1)(1995-12#1)(2008-5#1)(2011-1#2)
of rats with a##5##4##(1991-2#2)(1993-3#2)(1996-9#1)
of rats with acute##2##4##(1992-9#1)(2013-8#1)
of rats with the glucocorticoid##2##5##(1991-6#1)(1997-7#1)
of rats with the##7##4##(1991-2#1)(1991-6#2)(1997-4#2)(1997-7#1)(1997-8#1)
of rats with##41##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-2#3)(1991-5#1)(1991-6#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-3#2)(1994-11#2)(1995-12#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-7#1)(1997-8#2)(2006-10#1)(2008-10#2)(2008-11#1)(2008-8#2)(2009-6#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
of rats##310##2##(1990-12#1)(1990-2#5)(1990-3#1)(1990-4#3)(1990-5#5)(1990-6#1)(1990-7#4)(1991-1#1)(1991-10#3)(1991-12#4)(1991-2#4)(1991-3#2)(1991-5#3)(1991-6#2)(1991-7#1)(1992-11#2)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#5)(1993-11#3)(1993-12#8)(1993-2#5)(1993-3#5)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#7)(1993-9#2)(1994-10#3)(1994-11#4)(1994-2#6)(1994-3#4)(1994-5#2)(1994-6#7)(1994-7#1)(1994-8#3)(1995-1#2)(1995-10#2)(1995-12#12)(1995-2#1)(1995-3#2)(1995-5#2)(1995-7#2)(1995-8#1)(1996-1#2)(1996-10#2)(1996-12#4)(1996-2#2)(1996-3#1)(1996-5#4)(1996-7#1)(1996-9#2)(1997-1#3)(1997-2#5)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#3)(1997-8#5)(2006-1#2)(2006-10#2)(2006-9#1)(2007-1#4)(2007-10#6)(2007-11#1)(2007-12#1)(2007-9#2)(2008-10#9)(2008-11#4)(2008-12#5)(2008-3#1)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#7)(2008-9#3)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#2)(2010-12#3)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#10)(2011-3#3)(2012-1#4)(2012-2#4)(2012-3#2)(2013-1#10)(2013-7#3)(2013-8#5)
of raw and cooked beef patties##2##6##(2010-4#2)
of raw and cooked##3##4##(2010-4#3)
of raw and##5##3##(2008-12#1)(2010-4#4)
of raw data measurements##2##4##(2008-10#2)
of raw data##5##3##(2005-11#1)(2008-10#2)(2008-2#1)(2012-12#1)
of raw material##3##3##(2008-6#1)(2011-2#2)
of raw materials in##2##4##(2006-12#1)(2012-3#1)
of raw materials used##2##4##(2008-10#2)
of raw materials##10##3##(2006-12#1)(2008-10#4)(2008-5#2)(2008-6#1)(2012-3#2)
of raw pork##6##3##(2010-2#5)(2010-4#1)
of raw##50##2##(1992-5#2)(1994-3#1)(1994-4#1)(1996-8#2)(2005-11#4)(2005-4#1)(2006-10#1)(2006-12#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#2)(2010-2#5)(2010-4#7)(2011-2#2)(2012-12#1)(2012-3#3)
of ray paths##2##3##(2008-2#1)(2008-3#1)
of ray tracing and##4##4##(2008-2#3)(2008-3#1)
of ray tracing##7##3##(2008-2#5)(2008-3#2)
of ray##14##2##(2008-2#9)(2008-3#5)
of rayon-based##3##2##(2005-11#3)
of rays in##2##3##(2007-11#1)(2013-7#1)
of rays##6##2##(1995-2#1)(2007-11#1)(2008-2#2)(2008-3#1)(2013-7#1)
of re-bleeding and##3##3##(2013-1#3)
of re-exposure to##2##3##(1993-12#1)(2012-2#1)
of re-resection##2##2##(2006-10#1)(2008-6#1)
of re-treatment##2##2##(2007-11#1)(2013-1#1)
of reGP63##2##2##(1993-11#2)
of reaching the recommended levels of HbA1c##2##7##(2011-2#2)
of reaching the##5##3##(1997-2#1)(2008-11#1)(2010-12#1)(2011-2#2)
of reaching##20##2##(1990-10#1)(1991-2#1)(1992-11#1)(1994-3#1)(1996-1#2)(1997-2#1)(2005-8#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)
of reacquisition##2##2##(2008-5#2)
of reactant##2##2##(2006-12#1)(2008-10#1)
of reactants##5##2##(1993-6#1)(2008-10#2)(2008-3#1)(2010-5#1)
of reacting##5##2##(1992-1#1)(1994-3#1)(1994-8#1)(1997-1#1)(2010-8#1)
of reaction and##2##3##(1991-11#1)(2008-10#1)
of reaction between##7##3##(1997-4#1)(1997-7#1)(2006-4#1)(2008-10#4)
of reaction conditions on##2##4##(2008-5#1)(2008-7#1)
of reaction conditions##8##3##(1993-4#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-12#1)
of reaction in##2##3##(2007-12#1)(2008-7#1)
of reaction intermediates##2##3##(1991-9#1)(2006-10#1)
of reaction mechanisms##2##3##(2007-8#1)(2008-7#1)
of reaction norms##2##3##(2008-8#2)
of reaction of the##2##4##(1994-11#1)(1994-5#1)
of reaction of##4##3##(1994-11#1)(1994-5#1)(2008-10#1)(2010-5#1)
of reaction parameters##2##3##(2008-6#1)(2011-2#1)
of reaction products##6##3##(1992-6#1)(1993-4#1)(2004-9#1)(2008-4#3)
of reaction rates##2##3##(2006-12#1)(2008-5#1)
of reaction time##5##3##(2007-5#1)(2008-10#2)(2008-8#1)(2013-1#1)
of reaction to##3##3##(1994-5#1)(2013-7#2)
of reaction was##3##3##(2008-10#3)
of reaction##87##2##(1990-3#1)(1991-11#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-6#1)(1993-4#2)(1994-11#1)(1994-3#1)(1994-5#2)(1994-6#1)(1995-10#1)(1995-5#1)(1996-5#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-4#1)(2007-11#4)(2007-12#1)(2007-5#3)(2007-8#3)(2008-10#20)(2008-11#1)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#3)(2009-10#1)(2009-12#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#1)
of reaction-diffusion equations##3##3##(2009-8#1)(2013-8#2)
of reaction-diffusion##4##2##(2008-9#1)(2009-8#1)(2013-8#2)
of reactions are##2##3##(2008-10#2)
of reactions catalyzed by##2##4##(1991-4#1)(2005-11#1)
of reactions of##2##3##(1992-9#1)(2008-10#1)
of reactions that##2##3##(2008-1#1)(2008-10#1)
of reactions##34##2##(1990-9#1)(1991-4#1)(1991-6#1)(1991-7#2)(1992-9#1)(1993-3#1)(1994-6#1)(1994-8#2)(1996-3#1)(2004-11#1)(2005-11#1)(2005-8#1)(2008-1#1)(2008-10#12)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)
of reactivation of##2##3##(1993-5#1)(2008-5#1)
of reactivation##3##2##(1990-5#1)(1993-5#1)(2008-5#1)
of reactive and##2##3##(2007-12#1)(2011-2#1)
of reactive arthritis##3##3##(1990-6#2)(2006-10#1)
of reactive blue 2##2##4##(1995-12#1)(2008-4#1)
of reactive carbonyl residues in##5##5##(2004-11#5)
of reactive dyes##2##3##(2008-1#1)(2008-10#1)
of reactive intermediates##3##3##(1995-7#2)(1996-12#1)
of reactive metabolites##2##3##(1991-1#1)(2005-7#1)
of reactive nitrogen intermediates in##2##5##(1992-7#1)(1996-11#1)
of reactive nitrogen intermediates##3##4##(1992-7#1)(1996-11#1)(2008-4#1)
of reactive nitrogen##4##3##(1992-7#2)(1996-11#1)(2008-4#1)
of reactive oxygen and##2##4##(2009-8#1)(2011-2#1)
of reactive oxygen intermediates##2##4##(1993-7#2)
of reactive oxygen species (ROS) and##2##6##(2010-5#1)(2010-7#1)
of reactive oxygen species (ROS) by##2##6##(1994-5#1)(2007-11#1)
of reactive oxygen species (ROS) has been##2##7##(1994-2#1)(2009-8#1)
of reactive oxygen species (ROS) in##5##6##(1992-12#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-12#1)
of reactive oxygen species (ROS)##35##5##(1992-12#1)(1994-11#1)(1994-2#1)(1994-5#1)(1996-9#1)(1997-4#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2009-12#2)(2009-5#1)(2009-8#4)(2010-5#1)(2010-7#1)(2011-2#5)(2012-12#2)(2013-8#1)
of reactive oxygen species and##6##5##(2006-2#1)(2008-4#3)(2011-1#1)(2013-8#1)
of reactive oxygen species by##5##5##(1992-6#1)(2006-10#1)(2008-10#1)(2009-3#1)(2010-1#1)
of reactive oxygen species in the##7##6##(1992-6#1)(1994-3#1)(2008-4#2)(2008-5#1)(2009-12#1)(2010-10#1)
of reactive oxygen species in##10##5##(1992-6#3)(1994-2#1)(1994-3#1)(2008-4#2)(2008-5#1)(2009-12#1)(2010-10#1)
of reactive oxygen species production##2##5##(2010-4#1)(2011-1#1)
of reactive oxygen species##92##4##(1990-11#1)(1991-9#2)(1992-12#2)(1992-6#5)(1992-7#1)(1993-12#1)(1993-4#1)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-5#1)(1996-9#1)(1997-4#2)(1997-6#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#2)(2007-11#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#8)(2008-5#4)(2008-8#1)(2009-10#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#5)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#4)(2011-2#5)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#3)
of reactive oxygen##103##3##(1990-11#1)(1991-6#1)(1991-9#2)(1992-12#2)(1992-6#5)(1992-7#1)(1993-12#2)(1993-4#1)(1993-6#1)(1993-7#2)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-5#2)(1995-8#1)(1996-9#1)(1997-4#2)(1997-6#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#2)(2007-10#1)(2007-11#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#9)(2008-5#4)(2008-8#1)(2009-10#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#6)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#4)(2011-2#6)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#3)
of reactive species by##2##4##(2008-10#1)(2008-11#1)
of reactive species is##2##4##(2008-10#1)(2008-11#1)
of reactive species##4##3##(2008-10#2)(2008-11#2)
of reactive##173##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#3)(1990-7#1)(1991-1#1)(1991-3#2)(1991-6#1)(1991-9#3)(1992-12#2)(1992-3#1)(1992-6#6)(1992-7#3)(1992-9#1)(1993-12#2)(1993-4#1)(1993-6#1)(1993-7#2)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-5#2)(1995-12#2)(1995-2#1)(1995-7#3)(1995-8#2)(1996-11#2)(1996-12#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-4#2)(1997-6#3)(2004-11#5)(2005-12#1)(2005-7#3)(2005-8#1)(2006-10#4)(2006-12#1)(2006-2#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#3)(2008-10#13)(2008-11#4)(2008-2#1)(2008-3#3)(2008-4#13)(2008-5#5)(2008-8#2)(2009-10#1)(2009-12#3)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#9)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#8)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#3)
of reactive-ion etching##2##3##(2008-3#2)
of reactivity in##3##3##(1995-8#2)(2005-8#1)
of reactivity of the##4##4##(1991-8#1)(1996-2#1)(1997-7#1)(2008-5#1)
of reactivity to##2##3##(2006-8#1)(2011-2#1)
of reactivity with##2##3##(1995-11#1)(1995-12#1)
of reactivity##21##2##(1991-7#1)(1991-8#2)(1991-9#1)(1992-8#1)(1992-9#1)(1993-3#1)(1995-11#1)(1995-12#1)(1995-8#4)(1996-2#1)(1997-7#1)(1997-8#1)(2005-8#1)(2006-8#1)(2007-11#1)(2008-5#1)(2011-2#1)
of reactor##4##2##(1990-9#1)(1994-11#1)(2008-10#1)(2008-6#1)
of readers##4##2##(2006-5#1)(2007-4#1)(2008-10#1)(2010-2#1)
of readily available##8##3##(1994-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#2)(2011-2#1)
of readily##11##2##(1993-2#1)(1994-8#1)(1995-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#2)(2011-2#1)(2013-8#1)
of readiness to change##2##4##(2007-9#1)(2008-11#1)
of readiness to##3##3##(2007-9#1)(2008-11#1)(2012-3#1)
of readiness##6##2##(2006-10#1)(2007-9#1)(2008-11#1)(2012-3#3)
of reading development##2##3##(2004-10#2)
of reading difficulties##3##3##(2007-9#2)(2008-4#1)
of reading in##2##3##(2008-4#1)(2008-9#1)
of reading instruction##2##3##(2004-10#1)(2008-12#1)
of reading##35##2##(1991-7#1)(1993-12#1)(1996-2#1)(1997-3#1)(2004-10#6)(2006-5#1)(2007-12#1)(2007-6#1)(2007-9#6)(2008-1#1)(2008-11#2)(2008-12#3)(2008-4#3)(2008-9#2)(2009-2#1)(2009-4#2)(2010-2#1)(2010-7#1)
of readmission or##2##3##(2011-2#1)(2013-1#1)
of readmission##8##2##(1992-6#2)(2006-10#1)(2009-7#2)(2011-2#2)(2013-1#1)
of readmissions##2##2##(1992-6#1)(2009-7#1)
of ready-to-eat vegetable##2##3##(1997-4#2)
of ready-to-eat##4##2##(1997-4#2)(2008-1#1)(2010-4#1)
of reagent and calibrator##2##4##(2008-10#2)
of reagent and##3##3##(2008-10#3)
of reagent concentrations##2##3##(1997-3#1)(2008-10#1)
of reagent##26##2##(1990-12#1)(1990-2#1)(1990-7#1)(1997-3#1)(2006-10#1)(2008-10#19)(2012-2#1)(2013-8#1)
of reagents and the##2##4##(2007-8#1)(2008-10#1)
of reagents and##10##3##(2007-8#1)(2008-10#6)(2008-5#1)(2008-9#2)
of reagents to##3##3##(2008-10#2)(2008-9#1)
of reagents used##2##3##(1992-3#1)(2008-9#1)
of reagents##38##2##(1992-3#1)(1993-11#1)(1994-3#1)(2006-12#1)(2007-8#3)(2008-10#16)(2008-4#4)(2008-5#2)(2008-9#5)(2009-8#1)(2012-2#1)(2013-1#2)
of real proteins##2##3##(1995-2#1)(1996-6#1)
of real sample analysis##3##4##(2008-10#3)
of real sample##6##3##(2008-10#6)
of real samples were##2##4##(2005-4#1)(2008-10#1)
of real samples##17##3##(1997-2#1)(2005-11#1)(2005-4#1)(2007-8#1)(2008-10#13)
of real time##4##3##(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
of real vapor sources##2##4##(2008-2#2)
of real water samples##2##4##(2008-10#2)
of real world##3##3##(2008-10#2)(2008-8#1)
of real##75##2##(1990-12#1)(1994-12#1)(1994-9#1)(1995-2#1)(1996-12#2)(1996-4#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-4#2)(2006-10#1)(2006-2#1)(2007-10#1)(2007-12#3)(2007-8#1)(2008-10#28)(2008-11#1)(2008-2#7)(2008-3#5)(2008-7#2)(2008-8#2)(2010-12#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#3)
of real-time PCR##4##3##(2007-10#1)(2007-8#1)(2008-7#1)(2011-2#1)
of real-time ultrasound guidance##2##4##(2008-1#1)(2012-2#1)
of real-time##35##2##(1996-1#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#2)(2007-8#1)(2008-1#3)(2008-10#1)(2008-2#5)(2008-3#4)(2008-6#2)(2008-7#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)
of real-world crashes##2##3##(2007-4#2)
of real-world##8##2##(1995-11#1)(2006-11#1)(2007-4#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
of realistic##12##2##(1996-4#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#3)(2010-10#1)(2012-2#1)
of reality##4##2##(1994-6#1)(1995-2#1)(2004-8#1)(2008-12#1)
of realization of the##2##4##(2008-2#1)(2012-1#1)
of realization##3##2##(1997-6#1)(2008-2#1)(2012-1#1)
of realized##3##2##(2008-10#1)(2010-11#1)(2010-6#1)
of realizing##4##2##(2007-12#1)(2008-10#2)(2008-3#1)
of rear bridges##2##3##(1996-11#2)
of rearing##5##2##(1990-10#1)(1994-6#1)(2007-12#2)(2008-5#1)
of rearranged##6##2##(1991-9#1)(1995-2#4)(2008-4#1)
of rearrangement##5##2##(1990-5#1)(1993-2#1)(1997-1#2)(2008-4#1)
of rearrangements##3##2##(1994-8#1)(2012-12#2)
of reasoning##6##2##(1990-3#2)(2004-12#1)(2009-12#1)(2009-3#1)(2012-11#1)
of reasons and##2##3##(2007-11#1)(2008-12#1)
of reasons for##3##3##(2007-11#1)(2009-2#1)(2013-8#1)
of reasons##26##2##(1990-5#1)(1993-6#1)(1995-12#1)(1996-9#1)(2005-7#1)(2006-1#1)(2007-11#3)(2007-4#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-4#2)(2011-1#2)(2013-8#1)
of rebleeding##3##2##(1997-3#1)(2007-10#1)(2008-7#1)
of rebound##2##2##(2004-3#1)(2006-4#1)
of reboxetine##2##2##(2011-1#1)(2011-2#1)
of recA##2##2##(1991-10#2)
of recA-like genes##2##3##(1995-6#2)
of recA-like##3##2##(1995-6#3)
of recF##2##2##(1991-10#1)(1995-8#1)
of recalcitrant##9##2##(2006-10#2)(2006-3#1)(2008-5#1)(2009-6#1)(2011-1#1)(2012-3#1)(2013-1#2)
of recall##9##2##(1994-8#1)(2004-2#2)(2008-2#1)(2008-8#1)(2010-1#1)(2010-4#1)(2013-1#2)
of recanalization##4##2##(1990-10#1)(1990-6#1)(1991-3#1)(1994-5#1)
of receiver operating characteristic##2##4##(1996-9#1)(2007-8#1)
of receiver operating##3##3##(1996-9#1)(2007-8#1)(2010-8#1)
of receiver##8##2##(1995-1#1)(1996-9#1)(2007-8#1)(2008-2#3)(2010-12#1)(2010-8#1)
of receivers##2##2##(2008-3#2)
of receiving a##2##3##(2008-8#1)(2012-2#1)
of receiving##6##2##(1992-12#1)(2007-12#1)(2007-7#1)(2008-8#1)(2010-2#1)(2012-2#1)
of recent University of British Columbia##2##6##(1993-3#2)
of recent advances in##3##4##(2009-5#1)(2012-12#1)(2013-8#1)
of recent advances##5##3##(1990-9#1)(2008-5#1)(2009-5#1)(2012-12#1)(2013-8#1)
of recent and##4##3##(1996-8#1)(2007-3#1)(2011-2#1)(2012-1#1)
of recent case##2##3##(2007-11#1)(2008-7#1)
of recent clinical trials##4##4##(2005-7#1)(2007-11#1)(2008-5#1)(2009-3#1)
of recent clinical##7##3##(1996-11#1)(2005-7#1)(2006-9#1)(2007-11#1)(2008-5#1)(2008-8#1)(2009-3#1)
of recent data##2##3##(2008-7#1)(2010-3#1)
of recent developments in##7##4##(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-3#1)(2011-2#1)
of recent developments##8##3##(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-3#1)(2011-2#1)
of recent evidence##3##3##(1992-9#2)(1996-3#1)
of recent experiments##3##3##(1991-3#1)(2004-12#1)(2007-11#1)
of recent findings##4##3##(1996-11#1)(2008-8#1)(2009-6#1)(2012-12#1)
of recent influenza##2##3##(1990-9#1)(1991-8#1)
of recent interest##2##3##(1997-7#1)(2006-10#1)
of recent investigations##2##3##(2006-10#1)(2008-11#1)
of recent literature##6##3##(1996-1#1)(2006-10#1)(2007-7#1)(2009-8#1)(2013-8#2)
of recent onset and##2##4##(1991-11#1)(2007-8#1)
of recent onset##5##3##(1991-11#1)(2007-5#2)(2007-8#1)(2013-1#1)
of recent papers##2##3##(2006-10#2)
of recent progress in##2##4##(1994-3#1)(2009-4#1)
of recent progress##4##3##(1994-3#1)(1996-11#1)(2007-11#1)(2009-4#1)
of recent publications##7##3##(1993-3#1)(2006-10#4)(2006-7#1)(2011-2#1)
of recent reports##3##3##(1991-4#1)(2008-3#1)(2009-5#1)
of recent research##5##3##(1991-2#1)(2005-1#1)(2009-4#1)(2010-2#1)(2011-1#1)
of recent smoking##2##3##(2008-8#2)
of recent species##3##3##(2007-12#1)(2008-9#2)
of recent studies have##4##4##(2006-10#2)(2006-7#1)(2011-2#1)
of recent studies in##2##4##(2008-3#1)(2010-7#1)
of recent studies on##2##4##(2009-8#1)(2010-12#1)
of recent studies suggest that##2##5##(1993-6#1)(1995-12#1)
of recent studies that##2##4##(2006-7#1)(2008-10#1)
of recent studies##22##3##(1993-6#1)(1995-12#1)(2006-10#3)(2006-7#2)(2006-8#1)(2006-9#1)(2008-1#1)(2008-10#2)(2008-3#2)(2009-2#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#2)
of recent surveys##2##3##(2006-10#1)(2008-9#1)
of recent therapeutic##2##3##(1993-2#1)(2005-7#1)
of recent trauma##2##3##(2006-7#1)(2007-7#1)
of recent trends in population redistribution##2##6##(2011-2#2)
of recent trends in##3##4##(1990-10#1)(2011-2#2)
of recent work##3##3##(2007-10#1)(2007-4#1)(2008-2#1)
of recent years##2##3##(1993-12#1)(2011-2#1)
of recent##207##2##(1990-10#1)(1990-11#1)(1990-6#1)(1990-9#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-9#3)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#2)(1993-8#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-11#4)(1996-3#1)(1996-8#2)(1996-9#1)(1997-3#2)(1997-6#1)(1997-7#1)(2004-12#1)(2005-1#1)(2005-7#3)(2006-1#1)(2006-10#18)(2006-2#2)(2006-5#2)(2006-7#4)(2006-8#2)(2006-9#3)(2007-10#1)(2007-11#7)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#6)(2008-11#4)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#8)(2008-7#3)(2008-8#5)(2008-9#4)(2009-2#4)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#8)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#4)
of recently completed##2##3##(1996-1#1)(2010-5#1)
of recently developed##4##3##(1991-1#1)(1993-9#1)(2008-11#1)(2011-2#1)
of recently diagnosed##2##3##(1994-12#1)(2010-12#1)
of recently published##3##3##(2006-10#1)(2008-11#1)(2011-2#1)
of recently##29##2##(1990-4#1)(1991-1#1)(1991-3#1)(1993-9#1)(1994-12#1)(1995-3#1)(1996-1#1)(2005-8#1)(2006-10#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-4#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#4)
of receptive field##3##3##(1990-4#1)(2008-11#1)(2008-8#1)
of receptive fields##2##3##(1991-11#1)(1995-12#1)
of receptive##7##2##(1990-4#1)(1991-11#1)(1995-12#1)(2005-8#1)(2007-9#1)(2008-11#1)(2008-8#1)
of receptor activation##4##3##(1990-2#1)(1992-9#1)(2007-8#1)(2008-5#1)
of receptor autophosphorylation##2##3##(1990-3#2)
of receptor binding and##3##4##(1993-3#1)(1994-11#1)(2008-4#1)
of receptor binding sites##2##4##(1990-12#1)(1995-11#1)
of receptor binding##8##3##(1990-12#1)(1992-9#1)(1993-3#1)(1994-11#1)(1995-11#1)(2007-8#1)(2008-4#1)(2010-8#1)
of receptor cells##2##3##(2007-12#1)(2012-2#1)
of receptor clustering##3##3##(1990-8#1)(1997-6#1)(2006-10#1)
of receptor desensitization##3##3##(2007-11#1)(2008-1#1)(2008-5#1)
of receptor expression in##2##4##(1994-11#1)(1994-3#1)
of receptor expression##6##3##(1991-3#1)(1994-11#1)(1994-3#1)(1996-5#1)(1997-5#1)(2010-11#1)
of receptor function##5##3##(1992-3#1)(1995-11#1)(1996-5#1)(2008-5#1)(2008-8#1)
of receptor gene##3##3##(1992-9#1)(2006-10#1)(2007-11#1)
of receptor ligands##2##3##(1993-11#1)(1994-12#1)
of receptor molecules##3##3##(1996-12#2)(2008-5#1)
of receptor protein##5##3##(1992-9#1)(1994-11#1)(1994-5#1)(2005-8#2)
of receptor signaling##3##3##(2008-4#1)(2012-2#2)
of receptor sites in##2##4##(1994-11#1)(1995-7#1)
of receptor sites##3##3##(1990-7#1)(1994-11#1)(1995-7#1)
of receptor subtypes##2##3##(1995-10#1)(2005-8#1)
of receptor tyrosine kinases##5##4##(1990-7#1)(1996-3#1)(2008-1#1)(2008-5#1)(2009-8#1)
of receptor tyrosine##6##3##(1990-7#1)(1994-9#1)(1996-3#1)(2008-1#1)(2008-5#1)(2009-8#1)
of receptor tyrosines##2##3##(1995-3#1)(1996-9#1)
of receptor##100##2##(1990-12#1)(1990-2#2)(1990-3#2)(1990-7#2)(1990-8#1)(1991-11#1)(1991-3#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#4)(1993-11#1)(1993-3#2)(1993-5#1)(1993-6#1)(1994-11#4)(1994-12#1)(1994-3#1)(1994-5#3)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#3)(1995-12#1)(1995-3#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-3#1)(1996-5#3)(1996-9#1)(1997-5#2)(1997-6#2)(1997-8#1)(2005-8#3)(2006-10#4)(2007-11#3)(2007-12#2)(2007-8#3)(2008-1#2)(2008-4#2)(2008-5#6)(2008-8#4)(2009-10#1)(2009-8#2)(2010-11#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-2#3)(2013-1#1)
of receptor-like##2##2##(2009-10#1)(2009-8#1)
of receptor-mediated endocytosis##2##3##(1990-7#1)(1994-6#1)
of receptor-mediated##9##2##(1990-10#1)(1990-2#1)(1990-7#1)(1993-3#1)(1993-7#1)(1994-11#2)(1994-6#1)(1995-3#1)
of receptor-selective##2##2##(1991-9#1)(2008-8#1)
of receptors and##4##3##(1994-9#1)(1995-11#1)(2006-10#2)
of receptors are##3##3##(1991-5#1)(1993-2#1)(2005-8#1)
of receptors as##2##3##(1994-2#1)(2005-8#1)
of receptors by##3##3##(1997-2#1)(2005-8#1)(2010-2#1)
of receptors coupled to##3##4##(1991-2#2)(1993-6#1)
of receptors expression##2##3##(2011-2#2)
of receptors for the##4##4##(1990-7#1)(1991-12#1)(1993-5#1)(1996-12#1)
of receptors for##11##3##(1990-7#2)(1991-12#2)(1993-5#1)(1994-3#1)(1996-12#1)(1996-4#1)(1996-5#1)(2006-6#1)(2008-4#1)
of receptors in the##2##4##(1990-7#1)(1996-5#1)
of receptors in##3##3##(1990-7#1)(1996-5#1)(2013-7#1)
of receptors that##4##3##(1991-2#1)(1995-8#1)(2008-1#1)(2008-5#1)
of receptors to the##2##4##(1992-9#1)(1994-5#1)
of receptors to##3##3##(1992-9#1)(1994-5#1)(2008-10#1)
of receptors##81##2##(1990-11#1)(1990-7#3)(1991-12#2)(1991-2#4)(1991-5#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-5#1)(1993-6#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-4#2)(1996-5#3)(1997-1#1)(1997-2#2)(1997-6#1)(2005-11#1)(2005-7#1)(2005-8#5)(2006-10#4)(2006-6#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#7)(2008-5#1)(2009-1#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-2#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
of recession##2##2##(2013-1#1)(2013-7#1)
of recessive enhancers##2##3##(2007-11#2)
of recessive##6##2##(1993-2#1)(1996-6#1)(2007-11#2)(2008-10#1)(2013-1#1)
of recipes##2##2##(1995-7#2)
of recipient##11##2##(1991-12#1)(1994-3#1)(1995-2#1)(1996-10#1)(1997-5#1)(2007-8#1)(2008-11#4)(2010-11#1)
of recipients and kidney donors##2##5##(2007-9#2)
of recipients and##3##3##(1996-2#1)(2007-9#2)
of recipients##6##2##(1995-2#2)(1996-2#1)(2007-9#2)(2011-2#1)
of reciprocal altruism##2##3##(2012-3#2)
of reciprocal and##3##3##(2007-12#1)(2008-5#1)(2009-7#1)
of reciprocal crosses##2##3##(1990-10#1)(2008-5#1)
of reciprocal##19##2##(1990-10#1)(1992-3#1)(1995-8#1)(1996-4#1)(1996-7#1)(2006-5#2)(2006-6#1)(2007-12#1)(2008-10#1)(2008-5#2)(2009-7#1)(2010-12#1)(2012-1#1)(2012-2#1)(2012-3#3)
of reciprocity##4##2##(1993-3#1)(2008-2#1)(2010-9#1)(2012-3#1)
of recirculation and##2##3##(1992-10#1)(1994-10#1)
of recirculation##6##2##(1991-11#1)(1992-10#1)(1993-2#2)(1994-10#2)
of recognition memory##5##3##(1993-3#1)(2007-12#1)(2008-6#2)(2009-10#1)
of recognition of##4##3##(1991-11#1)(1992-8#1)(2008-2#1)(2012-3#1)
of recognition##23##2##(1991-11#1)(1992-8#1)(1993-11#1)(1993-3#1)(1997-1#1)(2006-3#1)(2006-7#2)(2007-12#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-6#2)(2009-10#2)(2009-4#1)(2012-12#1)(2012-3#3)(2013-7#1)
of recognized##4##2##(1997-7#1)(2005-10#1)(2008-10#1)(2012-12#1)
of recognizing a##2##3##(1997-8#1)(2006-10#1)
of recognizing the##7##3##(1993-12#1)(2006-12#1)(2007-10#1)(2008-10#1)(2013-1#3)
of recognizing##22##2##(1993-12#2)(1994-3#1)(1995-2#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-12#2)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-6#1)(2009-4#1)(2009-7#1)(2010-11#1)(2011-1#1)(2012-1#1)(2013-1#3)
of recombinant CHO##3##3##(2008-11#3)
of recombinant Chinese hamster ovary##2##5##(2008-11#2)
of recombinant DNA technology##7##4##(2007-11#3)(2009-2#3)(2011-2#1)
of recombinant DNA##11##3##(1990-5#1)(1991-9#1)(2007-11#4)(2009-2#4)(2011-2#1)
of recombinant E##2##3##(1996-7#1)(2008-7#1)
of recombinant Escherichia coli##5##4##(1994-2#1)(1995-2#1)(2008-7#2)(2013-1#1)
of recombinant HSA##2##3##(2006-11#2)
of recombinant IGF-I##2##3##(2008-11#1)(2008-5#1)
of recombinant TF##2##3##(1995-6#1)(2005-12#1)
of recombinant adeno-associated virus##2##4##(1993-2#1)(2008-8#1)
of recombinant adeno-associated##4##3##(1993-2#1)(2008-4#2)(2008-8#1)
of recombinant adenoviruses##2##3##(1995-12#1)(2008-4#1)
of recombinant antibodies##4##3##(1992-7#1)(2008-10#1)(2008-4#1)(2013-8#1)
of recombinant antibody##3##3##(2008-11#3)
of recombinant antigens##2##3##(1997-7#1)(2007-11#1)
of recombinant bacteria##2##3##(2008-11#1)(2008-4#1)
of recombinant baculovirus-infected##2##3##(1993-12#1)(1995-2#1)
of recombinant baculoviruses##4##3##(2008-2#3)(2010-2#1)
of recombinant basic##2##3##(1994-12#1)(2008-5#1)
of recombinant chicken##2##3##(1991-3#1)(2008-11#1)
of recombinant coagulation factor VIIa##2##5##(2007-7#1)(2008-8#1)
of recombinant core##2##3##(1995-1#1)(1995-2#1)
of recombinant dTFIIA-S##2##3##(1994-9#2)
of recombinant factor VIIa##9##4##(2005-10#1)(2006-10#1)(2007-11#3)(2007-2#1)(2007-8#2)(2013-1#1)
of recombinant gene##2##3##(1990-12#1)(2008-11#1)
of recombinant genes and##2##4##(1990-9#1)(2011-1#1)
of recombinant genes##3##3##(1990-9#1)(1994-5#1)(2011-1#1)
of recombinant growth hormone on##2##5##(2005-12#1)(2008-9#1)
of recombinant growth##3##3##(1990-12#1)(2005-12#1)(2008-9#1)
of recombinant hepatitis B vaccine##2##5##(1994-4#1)(2005-12#1)
of recombinant hepatitis B##4##4##(1994-4#1)(2005-12#1)(2008-11#1)(2012-2#1)
of recombinant hirudin##7##3##(1990-11#1)(1993-3#1)(1994-2#2)(2007-11#1)(2013-8#2)
of recombinant human activated protein C##3##6##(2007-12#1)(2011-1#1)(2012-2#1)
of recombinant human bone morphogenetic##3##5##(2008-5#1)(2011-2#1)(2013-1#1)
of recombinant human coagulation factor##2##5##(2008-11#1)(2008-8#1)
of recombinant human erythropoietin##9##4##(1995-5#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-5#1)(2010-12#2)(2011-2#1)
of recombinant human fibroblast growth factor-2##2##6##(2006-9#2)
of recombinant human fibroblast growth##3##5##(2006-9#2)(2008-7#1)
of recombinant human glucagon was##3##5##(2008-8#3)
of recombinant human granulocyte colony-stimulating factor##2##6##(1991-9#1)(2012-3#1)
of recombinant human growth hormone##2##5##(1997-8#1)(2007-11#1)
of recombinant human haemoglobin##2##4##(2007-11#2)
of recombinant human keratinocyte growth factor##2##6##(1994-11#1)(2008-7#1)
of recombinant human protein C##2##5##(2008-12#2)
of recombinant human tumor necrosis factor##2##6##(1991-2#1)(1991-8#1)
of recombinant human tumour necrosis factor beta##2##7##(1997-1#2)
of recombinant human##72##3##(1990-11#1)(1990-12#2)(1990-5#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#1)(1993-12#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#3)(1996-11#1)(1997-1#2)(1997-8#1)(2005-10#1)(2006-11#1)(2006-9#4)(2007-11#3)(2007-12#2)(2007-7#1)(2008-1#1)(2008-11#7)(2008-12#2)(2008-5#2)(2008-7#5)(2008-8#4)(2010-12#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
of recombinant inbred (RI) lines##2##5##(2008-10#2)
of recombinant inbred lines##5##4##(2008-10#4)(2012-11#1)
of recombinant inbred##7##3##(2008-10#6)(2012-11#1)
of recombinant insulin##2##3##(1996-7#1)(2008-11#1)
of recombinant interferon##3##3##(1991-2#1)(2007-11#2)
of recombinant interferon-beta-1a##2##3##(2007-11#2)
of recombinant interleukin 2##2##4##(1990-12#1)(1995-12#1)
of recombinant interleukin-2##3##3##(1991-10#2)(2007-11#1)
of recombinant mammalian cell lines##2##5##(2008-11#2)
of recombinant mammalian##3##3##(2008-11#3)
of recombinant mouse##6##3##(1994-11#2)(1994-3#1)(1994-5#1)(2008-10#1)(2008-4#1)
of recombinant murine##2##3##(1995-2#1)(1996-10#1)
of recombinant plasmid##4##3##(1994-3#1)(2005-6#1)(2011-2#2)
of recombinant plasmids##3##3##(1990-9#1)(1991-7#1)(1994-2#1)
of recombinant protein in##3##4##(2008-1#1)(2008-11#2)
of recombinant protein is##3##4##(1993-2#1)(2005-11#1)(2008-11#1)
of recombinant protein pharmaceuticals##2##4##(2008-11#1)(2012-3#1)
of recombinant protein production in##2##5##(2008-11#1)(2008-7#1)
of recombinant protein was##2##4##(1990-3#1)(2008-11#1)
of recombinant protein##32##3##(1990-3#3)(1990-8#1)(1991-10#1)(1993-2#1)(1994-11#1)(1995-1#1)(2005-11#1)(2008-1#1)(2008-11#16)(2008-4#1)(2008-7#2)(2011-2#2)(2012-3#1)
of recombinant proteins and##2##4##(2008-11#1)(2008-4#1)
of recombinant proteins by##4##4##(1995-8#1)(2008-11#2)(2008-4#1)
of recombinant proteins for##4##4##(1997-4#1)(2008-11#3)
of recombinant proteins from##2##4##(1994-5#1)(2008-1#1)
of recombinant proteins in mammalian cells##2##6##(1992-12#1)(2007-6#1)
of recombinant proteins in the##2##5##(2008-11#2)
of recombinant proteins in##10##4##(1992-12#1)(2006-12#1)(2007-6#1)(2008-11#5)(2008-4#1)(2008-7#1)
of recombinant proteins produced##3##4##(1994-5#1)(2008-4#1)(2011-2#1)
of recombinant proteins using##3##4##(2008-11#1)(2008-2#1)(2008-4#1)
of recombinant proteins with##2##4##(2008-11#1)(2012-2#1)
of recombinant proteins##54##3##(1992-12#1)(1993-11#1)(1994-11#3)(1994-5#2)(1995-8#1)(1996-10#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-12#3)(2007-6#2)(2008-1#1)(2008-11#20)(2008-2#1)(2008-4#8)(2008-5#1)(2008-7#2)(2009-8#1)(2011-2#2)(2012-2#1)
of recombinant rabbit##2##3##(1991-7#2)
of recombinant rat DNA polymerase beta##2##6##(1990-5#2)
of recombinant rat##8##3##(1990-5#2)(1992-3#1)(2008-11#4)(2008-8#1)
of recombinant soluble and non-fusion angiogenesis inhibitor Kringle 5##2##9##(2012-12#2)
of recombinant soluble##3##3##(1997-7#1)(2012-12#2)
of recombinant strain##2##3##(2013-1#2)
of recombinant technology##2##3##(2006-9#1)(2007-11#1)
of recombinant tissue plasminogen activator##2##5##(2007-9#1)(2008-7#1)
of recombinant tumor necrosis##2##4##(1991-12#1)(1994-8#1)
of recombinant wild-type##2##3##(1992-9#1)(1995-6#1)
of recombinant zebrafish##2##3##(2010-5#2)
of recombinant##447##2##(1990-11#4)(1990-12#6)(1990-3#3)(1990-5#4)(1990-8#4)(1990-9#2)(1991-1#1)(1991-10#5)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-7#7)(1991-8#1)(1991-9#4)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-7#1)(1992-9#4)(1993-11#2)(1993-12#5)(1993-2#2)(1993-3#1)(1993-4#3)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#3)(1994-11#8)(1994-12#2)(1994-2#4)(1994-3#5)(1994-4#1)(1994-5#6)(1994-6#2)(1994-8#3)(1994-9#3)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#5)(1995-3#4)(1995-5#1)(1995-6#5)(1995-8#2)(1996-10#3)(1996-11#1)(1996-3#1)(1996-7#3)(1997-1#2)(1997-3#2)(1997-4#3)(1997-6#1)(1997-7#3)(1997-8#2)(2004-1#1)(2005-10#2)(2005-11#1)(2005-12#3)(2005-6#1)(2005-7#1)(2006-10#2)(2006-11#3)(2006-12#3)(2006-7#1)(2006-9#5)(2007-11#25)(2007-12#2)(2007-2#1)(2007-6#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#16)(2008-11#85)(2008-12#2)(2008-2#4)(2008-4#22)(2008-5#6)(2008-6#2)(2008-7#17)(2008-8#9)(2008-9#1)(2009-2#5)(2009-7#2)(2009-8#1)(2009-9#1)(2010-12#4)(2010-2#1)(2010-5#3)(2010-6#2)(2011-1#2)(2011-2#12)(2011-3#2)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#9)(2013-1#6)(2013-8#4)
of recombinantly expressed##3##3##(1995-2#1)(1996-9#1)(2008-4#1)
of recombinants and##2##3##(2008-10#1)(2008-2#1)
of recombinants##9##2##(1991-7#1)(1991-9#2)(1994-12#2)(1995-9#1)(2008-10#1)(2008-2#1)(2008-4#1)
of recombination and##6##3##(2008-10#4)(2009-10#1)(2013-8#1)
of recombination between##3##3##(1995-8#1)(2008-10#2)
of recombination events##3##3##(2006-10#2)(2006-12#1)
of recombination in the##3##4##(1991-8#1)(1993-12#1)(2008-5#1)
of recombination in##6##3##(1991-8#1)(1993-12#2)(2008-10#2)(2008-5#1)
of recombination##34##2##(1990-11#1)(1991-10#1)(1991-12#1)(1991-8#1)(1993-12#2)(1994-12#1)(1995-8#1)(2006-10#2)(2006-12#1)(2006-5#1)(2008-10#13)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-2#1)(2013-1#2)(2013-8#1)
of recombinational##2##2##(1993-12#1)(2008-8#1)
of recombined single chain insulin and##2##6##(2008-9#2)
of recombined single chain insulin##4##5##(2008-9#4)
of recombined##5##2##(2005-11#1)(2008-9#4)
of recommendation##2##2##(2008-12#1)(2012-12#1)
of recommendations are##2##3##(2012-3#1)(2013-8#1)
of recommendations for##5##3##(1993-12#1)(1996-6#1)(2007-7#1)(2008-8#1)(2008-9#1)
of recommendations that##3##3##(2007-10#1)(2007-9#1)(2008-11#1)
of recommendations to##4##3##(1997-3#1)(2008-3#1)(2010-12#1)(2010-8#1)
of recommendations##24##2##(1990-12#1)(1991-12#1)(1993-12#1)(1996-6#1)(1997-3#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#2)(2010-8#1)(2010-9#1)(2012-3#1)(2013-8#1)
of recommended##12##2##(1994-12#1)(1995-1#1)(1996-2#1)(1996-7#1)(2006-4#1)(2008-1#1)(2008-4#1)(2008-8#1)(2010-2#1)(2010-4#1)(2012-2#2)
of reconciling##3##2##(2011-12#1)(2012-12#1)(2013-8#1)
of reconstituted##11##2##(1991-4#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-5#1)(2008-8#4)(2009-8#1)
of reconstitution##4##2##(1992-6#1)(1994-12#1)(1994-9#1)(2009-8#1)
of reconstructed embryos##3##3##(2008-9#1)(2012-2#2)
of reconstructed epidermis##3##3##(2008-5#3)
of reconstructed##11##2##(2007-12#2)(2008-3#1)(2008-5#5)(2008-9#1)(2012-2#2)
of reconstructing##10##2##(2007-7#1)(2008-2#1)(2008-3#3)(2008-4#1)(2010-10#1)(2011-3#1)(2011-7#1)(2013-1#1)
of reconstruction after##4##3##(1996-3#1)(2006-10#1)(2006-6#2)
of reconstruction are##2##3##(2006-3#1)(2011-2#1)
of reconstruction of the##4##4##(1990-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
of reconstruction of##6##3##(1990-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
of reconstruction##32##2##(1990-3#1)(1990-9#1)(1996-3#1)(2006-10#1)(2006-3#1)(2006-6#2)(2007-11#2)(2007-12#3)(2008-2#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-9#2)(2010-6#1)(2011-1#1)(2011-2#7)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
of reconstructions##3##2##(2007-12#1)(2011-1#2)
of reconstructive options##2##3##(2006-3#1)(2013-8#1)
of reconstructive surgery in##2##4##(1993-11#1)(2008-4#1)
of reconstructive surgery##3##3##(1993-11#1)(2007-7#1)(2008-4#1)
of reconstructive##10##2##(1993-11#1)(2006-3#1)(2007-12#1)(2007-7#1)(2008-4#1)(2011-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
of recontamination##2##2##(1991-11#1)(2013-8#1)
of recordable##2##2##(2008-10#1)(2008-3#1)
of recorded data##2##3##(1993-3#1)(2007-12#1)
of recorded signals is##2##4##(2008-3#1)(2011-1#1)
of recorded##16##2##(1991-3#1)(1992-8#1)(1993-3#1)(1996-12#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#5)(2008-4#1)(2011-1#1)(2012-2#1)
of recording a##2##3##(2008-2#1)(2008-7#1)
of recording in##2##3##(2008-2#1)(2008-3#1)
of recording##25##2##(1995-11#1)(1997-8#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#7)(2008-3#5)(2008-7#1)(2011-1#2)
of records of##4##3##(2007-4#1)(2007-6#1)(2011-1#1)(2012-3#1)
of records##9##2##(1994-12#2)(2006-10#1)(2007-4#1)(2007-6#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
of recovered cells##4##3##(2006-8#3)(2008-4#1)
of recovered##14##2##(1993-3#1)(1996-12#1)(2006-5#1)(2006-8#3)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2012-2#1)
of recoveries##4##2##(2008-10#4)
of recoverin##3##2##(1992-2#2)(1995-6#1)
of recovering energy from##2##4##(2008-5#2)
of recovering##4##2##(1991-12#1)(2007-11#1)(2008-5#2)
of recovery after##2##3##(1994-6#1)(2012-1#1)
of recovery and time to standing were##2##7##(2013-1#2)
of recovery and##7##3##(1996-6#1)(2007-7#1)(2007-8#1)(2008-2#1)(2012-11#1)(2013-1#2)
of recovery are##2##3##(2005-4#1)(2010-3#1)
of recovery for##2##3##(2008-10#1)(2008-5#1)
of recovery from##12##3##(1992-9#1)(1994-6#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-6#1)(2008-8#2)(2009-6#1)(2010-3#2)(2012-11#1)
of recovery in##5##3##(1995-3#1)(2008-2#1)(2010-3#1)(2013-1#2)
of recovery is##6##3##(1993-5#1)(2005-4#1)(2008-2#2)(2008-7#2)
of recovery of the##3##4##(2008-10#1)(2008-7#1)(2009-9#1)
of recovery of##16##3##(1993-7#1)(1994-4#1)(2006-8#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-5#1)(2011-1#1)
of recovery showed##2##3##(1996-5#1)(2008-6#1)
of recovery was##6##3##(1991-2#1)(1991-3#1)(2008-10#2)(2008-12#1)(2012-3#1)
of recovery were not##2##4##(1994-8#1)(2012-3#1)
of recovery were##4##3##(1994-8#1)(2007-10#1)(2007-8#1)(2012-3#1)
of recovery##101##2##(1991-2#2)(1991-3#1)(1991-8#1)(1992-5#1)(1992-9#1)(1993-5#1)(1993-7#2)(1993-9#1)(1994-2#1)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-3#1)(1995-6#2)(1996-4#1)(1996-5#2)(1996-6#1)(2005-4#2)(2005-8#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-12#3)(2008-2#8)(2008-5#2)(2008-6#4)(2008-7#3)(2008-8#4)(2009-6#1)(2009-9#1)(2010-3#4)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#5)(2012-3#3)(2013-1#4)
of recreational sports##2##3##(2012-12#2)
of recreational##6##2##(2011-2#1)(2012-12#3)(2013-1#1)(2013-7#1)
of recrudescence##2##2##(2005-7#1)(2006-10#1)
of recruiting patients##2##3##(2008-11#1)(2010-5#1)
of recruiting##5##2##(1996-5#1)(2007-1#1)(2008-11#1)(2010-2#1)(2010-5#1)
of recruitment and##5##3##(1991-6#1)(1994-2#2)(2008-12#1)(2008-8#1)
of recruitment from##2##3##(1992-1#1)(2012-3#1)
of recruitment of##2##3##(1992-9#1)(2013-1#1)
of recruitment##17##2##(1990-2#1)(1991-6#1)(1992-1#1)(1992-9#1)(1994-2#2)(1994-4#1)(1995-1#2)(2007-4#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2012-3#1)(2013-1#1)
of recruits##3##2##(2007-3#1)(2007-5#2)
of rectal cancer with##2##4##(2007-4#1)(2013-8#1)
of rectal cancer##13##3##(1990-9#3)(1993-9#1)(1994-4#1)(2007-4#2)(2008-8#1)(2009-12#1)(2009-4#1)(2011-2#1)(2012-1#1)(2013-8#1)
of rectal dose-volume constraints##2##4##(2008-3#2)
of rectal ibuprofen was considerably lower##2##6##(2012-12#2)
of rectal mucosal prolapse and hemorrhoidal prolapse##2##7##(2013-1#2)
of rectal mucosal prolapse##5##4##(2013-1#5)
of rectal neoplasia##2##3##(2009-12#2)
of rectal polypoid lesions in dogs##2##6##(2013-1#2)
of rectal polypoid lesions in##4##5##(2013-1#4)
of rectal temperature##2##3##(1990-5#1)(1996-8#1)
of rectal##48##2##(1990-3#1)(1990-4#2)(1990-5#3)(1990-9#3)(1991-12#1)(1993-8#1)(1993-9#1)(1994-4#2)(1996-2#1)(1996-8#1)(2007-4#2)(2008-3#2)(2008-8#2)(2009-11#1)(2009-12#4)(2009-4#1)(2010-2#1)(2011-2#1)(2012-1#2)(2012-12#3)(2013-1#10)(2013-7#1)(2013-8#2)
of rectangular##5##2##(2006-5#1)(2008-2#1)(2010-1#1)(2012-1#1)(2013-1#1)
of rectum was##2##3##(2006-8#1)(2008-3#1)
of rectum##10##2##(1990-3#1)(2006-8#1)(2008-12#3)(2008-3#2)(2012-12#1)(2012-3#1)(2013-8#1)
of rectus femoris muscle##2##4##(2008-12#1)(2011-2#1)
of recurrence after surgical resection##2##5##(2010-3#1)(2013-1#1)
of recurrence after##6##3##(1991-11#1)(1993-9#1)(2010-12#1)(2010-3#1)(2012-12#1)(2013-1#1)
of recurrence and death##3##4##(2006-6#1)(2007-3#1)(2013-1#1)
of recurrence and metastasis##2##4##(2010-12#1)(2012-2#1)
of recurrence and the##2##4##(2007-10#1)(2012-3#1)
of recurrence and##13##3##(1995-8#1)(1996-6#1)(2006-6#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-2#1)(2008-6#1)(2009-7#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
of recurrence as##2##3##(2011-1#1)(2011-12#1)
of recurrence by##2##3##(2010-12#1)(2013-8#1)
of recurrence for##3##3##(1991-8#1)(1992-4#1)(2012-1#1)
of recurrence has been##2##4##(2006-10#1)(2011-2#1)
of recurrence in##3##3##(2007-11#2)(2011-2#1)
of recurrence of the##4##4##(2006-2#1)(2008-6#1)(2008-7#1)(2008-8#1)
of recurrence of##13##3##(2004-11#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2012-12#1)
of recurrence or##3##3##(2006-10#1)(2007-11#1)(2011-2#1)
of recurrence were##2##3##(2012-12#1)(2013-8#1)
of recurrence##102##2##(1990-1#1)(1990-4#1)(1990-8#1)(1991-11#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-4#1)(1993-1#1)(1993-9#2)(1994-2#1)(1994-8#1)(1995-8#1)(1996-11#1)(1996-6#1)(2004-11#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#3)(2006-9#1)(2007-10#1)(2007-11#4)(2007-2#1)(2007-3#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-5#4)(2008-6#6)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#2)(2009-7#1)(2010-11#1)(2010-12#4)(2010-3#3)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#3)(2013-8#3)
of recurrences and##3##3##(2008-7#1)(2009-10#1)(2012-2#1)
of recurrences for##2##3##(1994-1#1)(2008-10#1)
of recurrences of##3##3##(1996-12#1)(1997-4#1)(2008-1#1)
of recurrences##18##2##(1992-10#1)(1992-5#1)(1993-9#1)(1994-1#1)(1996-12#1)(1997-4#1)(1997-8#1)(2006-6#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-10#1)(2012-2#1)(2013-1#2)
of recurrent acute##2##3##(1995-4#1)(2013-8#1)
of recurrent and##3##3##(2006-10#1)(2007-11#1)(2007-12#1)
of recurrent aseptic##2##3##(1990-10#1)(2013-1#1)
of recurrent bleeding##5##3##(1996-11#2)(2007-8#3)
of recurrent disease after##2##4##(1994-5#1)(2010-5#1)
of recurrent disease##9##3##(1991-6#1)(1994-5#1)(2006-10#2)(2008-12#1)(2010-12#1)(2010-5#1)(2012-2#1)(2012-3#1)
of recurrent dislocation##2##3##(2009-3#1)(2011-12#1)
of recurrent epidermoid##2##3##(1992-10#1)(2011-2#1)
of recurrent episodes of##3##4##(1990-2#1)(1994-2#1)(2007-8#1)
of recurrent events##3##3##(1997-4#1)(2007-10#1)(2008-8#1)
of recurrent hepatitis##2##3##(2006-10#2)
of recurrent infection##4##3##(1992-11#1)(2007-8#1)(2008-8#1)(2011-2#1)
of recurrent infections##3##3##(2007-2#2)(2011-2#1)
of recurrent ischemic##2##3##(1993-2#1)(2007-10#1)
of recurrent oral##2##3##(2007-7#1)(2012-3#1)
of recurrent ovarian##2##3##(2007-7#1)(2011-1#1)
of recurrent pneumonia##2##3##(2007-2#1)(2007-8#1)
of recurrent primary##2##3##(2004-11#1)(2007-11#1)
of recurrent prostate cancer##3##4##(2006-10#1)(2013-1#2)
of recurrent respiratory##4##3##(1997-1#1)(2008-3#2)(2008-7#1)
of recurrent stroke##15##3##(2007-10#4)(2007-9#5)(2008-8#2)(2010-12#1)(2010-9#3)
of recurrent tumour##2##3##(1993-8#1)(2008-6#1)
of recurrent vertigo##3##3##(2012-3#3)
of recurrent##171##2##(1990-10#1)(1990-11#2)(1990-2#2)(1991-11#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-5#2)(1993-1#2)(1993-2#2)(1993-8#1)(1994-2#1)(1994-5#1)(1994-7#1)(1995-12#1)(1995-4#1)(1996-11#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(2004-11#2)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#8)(2006-2#1)(2006-4#1)(2006-7#2)(2007-1#1)(2007-10#7)(2007-11#2)(2007-12#3)(2007-2#3)(2007-7#4)(2007-8#11)(2007-9#5)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#4)(2008-6#6)(2008-7#4)(2008-8#7)(2008-9#3)(2009-12#1)(2009-3#2)(2009-4#1)(2009-8#3)(2010-12#3)(2010-2#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#8)(2013-1#6)(2013-8#3)
of recurring##5##2##(1991-3#1)(2005-7#1)(2007-10#1)(2007-8#1)(2011-2#1)
of recycled P##2##3##(2012-2#2)
of recycled##6##2##(2008-10#1)(2008-6#1)(2011-2#1)(2012-2#2)(2013-1#1)
of recycling##6##2##(1996-11#1)(1996-12#2)(1996-3#2)(2008-10#1)
of red and##2##3##(2006-11#1)(2009-4#1)
of red beds and##3##4##(2013-8#3)
of red beds##5##3##(2013-8#5)
of red blood cell##10##4##(1993-11#1)(1996-3#2)(2006-5#1)(2008-3#1)(2008-8#1)(2009-5#1)(2012-2#1)(2013-1#1)(2013-7#1)
of red blood cells (RBCs)##3##5##(1994-12#1)(1994-9#1)(2009-4#1)
of red blood cells and##2##5##(2010-12#1)(2012-12#1)
of red blood cells##21##4##(1990-12#1)(1992-11#1)(1994-12#1)(1994-2#1)(1994-6#2)(1994-8#1)(1994-9#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-12#2)(2010-5#1)(2011-12#1)(2012-12#1)(2012-3#2)(2013-1#1)
of red blood##31##3##(1990-12#1)(1992-11#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-6#2)(1994-8#1)(1994-9#1)(1996-3#2)(2006-5#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#2)(2010-5#1)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
of red cell##10##3##(1993-3#2)(1994-9#2)(1995-11#1)(1996-6#1)(2005-10#1)(2009-5#1)(2011-12#2)
of red cells in##2##4##(2005-10#1)(2006-6#1)
of red cells##3##3##(1992-12#1)(2005-10#1)(2006-6#1)
of red light##4##3##(1990-5#2)(2007-12#1)(2008-5#1)
of red mud##2##3##(2007-8#2)
of red pepper##2##3##(2004-11#1)(2012-3#1)
of red sea##2##3##(2007-5#2)
of red tilapia##2##3##(2008-12#2)
of red wine or resveratrol##2##5##(2011-2#2)
of red wine##14##3##(1995-3#1)(1996-1#1)(2008-10#3)(2008-7#5)(2009-3#2)(2011-2#2)
of red##105##2##(1990-12#1)(1990-3#1)(1990-5#2)(1992-11#2)(1992-12#1)(1993-11#1)(1993-2#1)(1993-3#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#3)(1995-11#1)(1995-3#1)(1996-1#1)(1996-3#2)(1996-6#1)(1997-4#2)(2004-11#1)(2005-10#2)(2005-7#1)(2005-8#1)(2006-11#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-5#2)(2007-8#3)(2008-10#6)(2008-11#1)(2008-12#5)(2008-2#1)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-3#2)(2009-4#2)(2009-5#2)(2010-12#2)(2010-5#1)(2011-1#1)(2011-12#3)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#5)
of redisplacement##3##2##(1991-9#1)(2011-2#2)
of redox mediator##2##3##(2008-10#2)
of redox reactions##3##3##(1995-1#1)(1997-2#1)(2008-10#1)
of redox##19##2##(1990-12#1)(1991-4#1)(1992-6#1)(1994-11#1)(1995-1#1)(1997-2#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-10#1)(2010-12#1)(2012-12#1)
of redox-active##4##2##(2006-2#1)(2008-10#1)(2009-10#2)
of reduced P##3##3##(1993-11#2)(2008-10#1)
of reduced and oxidized##2##4##(1991-4#1)(2011-1#1)
of reduced and##3##3##(1991-4#1)(1997-2#1)(2011-1#1)
of reduced cytochrome##2##3##(1991-2#1)(1994-8#1)
of reduced glutathione (GSH) in##2##5##(2008-10#2)
of reduced glutathione (GSH)##6##4##(1991-9#1)(2008-10#2)(2008-12#1)(2010-4#1)(2013-1#1)
of reduced glutathione in##2##4##(1994-5#1)(2008-10#1)
of reduced glutathione##14##3##(1990-12#1)(1991-9#1)(1992-7#1)(1994-5#1)(1994-6#1)(1997-1#2)(2005-12#1)(2008-10#3)(2008-12#1)(2010-4#1)(2013-1#1)
of reduced hemodynamic load##2##4##(2012-3#2)
of reduced inorganic##2##3##(2006-3#2)
of reduced nicotinamides##2##3##(1996-11#2)
of reduced phosphorus##2##3##(2008-10#2)
of reduced sensitivity to the##2##5##(1994-9#1)(2007-2#1)
of reduced sulfur compounds (RSC)##2##5##(2008-10#2)
of reduced sulfur compounds##4##4##(2008-10#4)
of reduced total##2##3##(2007-7#1)(2007-8#1)
of reduced##130##2##(1990-10#1)(1990-12#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-4#1)(1993-9#2)(1994-12#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-7#1)(1996-8#2)(1997-1#4)(1997-2#1)(1997-7#1)(2005-10#1)(2005-12#1)(2006-3#2)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#16)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#4)(2012-12#2)(2012-3#5)(2013-1#2)(2013-8#4)
of reduced-resolution##2##2##(2008-2#1)(2008-3#1)
of reducing agent##4##3##(1990-7#1)(1993-3#1)(1995-11#2)
of reducing agents##3##3##(1991-2#1)(1992-9#1)(2008-4#1)
of reducing equivalents##5##3##(1991-2#1)(2004-4#1)(2006-8#1)(2009-4#1)(2009-9#1)
of reducing maternal mortality##2##4##(2010-12#1)(2011-1#1)
of reducing power##3##3##(1993-12#1)(2008-7#1)(2010-11#1)
of reducing salt intake##2##4##(2013-1#2)
of reducing the number of##2##5##(1997-2#1)(2008-9#1)
of reducing the##24##3##(1997-2#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#2)
of reducing this##3##3##(2007-1#1)(2008-2#1)(2010-9#1)
of reducing##90##2##(1990-12#1)(1990-7#1)(1991-2#2)(1991-9#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-6#1)(1995-11#2)(1995-12#1)(1996-6#1)(1997-2#1)(2004-4#1)(2005-11#1)(2005-6#1)(2005-8#1)(2005-9#1)(2006-10#5)(2006-5#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-11#1)(2012-12#2)(2013-1#7)
of reductant##3##2##(1992-6#1)(1995-5#1)(2008-10#1)
of reductase##2##2##(1991-5#1)(1993-6#1)
of reduction and##3##3##(1991-9#1)(2008-10#1)(2011-2#1)
of reduction by##2##3##(1991-4#1)(2005-3#1)
of reduction for both##2##4##(1991-8#1)(1994-8#1)
of reduction in the##2##4##(2007-8#1)(2011-2#1)
of reduction in##12##3##(1990-2#1)(1995-3#1)(1996-2#1)(1996-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-3#1)
of reduction of the##5##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-8#1)
of reduction of##16##3##(1990-12#1)(1991-10#1)(1991-12#1)(1991-8#1)(1993-9#1)(1996-9#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#2)(2009-8#1)
of reduction was##3##3##(1994-3#1)(2007-8#1)(2008-10#1)
of reduction##53##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-8#2)(1991-9#1)(1992-8#1)(1993-4#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-2#1)(1996-5#1)(1996-9#2)(2005-3#1)(2006-3#2)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#3)(2008-10#10)(2008-2#2)(2008-3#3)(2008-9#1)(2009-7#1)(2009-8#1)(2011-2#2)(2012-3#1)(2013-8#2)
of reductionist##2##2##(2011-1#2)
of reductions in##5##3##(1996-12#1)(2007-11#1)(2008-3#1)(2010-2#1)(2012-1#1)
of reductive potential##2##3##(2008-11#2)
of reductive##9##2##(1992-3#1)(2006-8#1)(2008-10#3)(2008-11#3)(2011-1#1)
of redundancy##3##2##(2008-1#1)(2011-2#1)(2011-3#1)
of redundant##6##2##(1992-7#1)(2007-5#1)(2007-8#2)(2008-9#1)(2010-2#1)
of reed canarygrass##3##3##(2008-5#3)
of reed##5##2##(2008-5#5)
of reef##9##2##(2007-3#1)(2007-5#4)(2008-2#1)(2008-5#1)(2008-8#1)(2013-7#1)
of reelin expression##2##3##(2009-8#2)
of reelin##5##2##(2009-8#3)(2011-2#2)
of reengineering##4##2##(1994-12#1)(1995-1#1)(1995-3#1)(1997-3#1)
of refeeding syndrome##3##3##(2005-10#3)
of refeeding##7##2##(1996-1#2)(2005-10#3)(2008-3#1)(2008-7#1)
of reference and##6##3##(1993-11#3)(1997-8#1)(2007-11#1)(2008-3#1)
of reference compounds##3##3##(2008-10#1)(2008-5#1)(2010-11#1)
of reference for the##5##4##(1990-12#1)(1995-3#1)(2007-11#1)(2010-12#1)(2011-2#1)
of reference for##9##3##(1990-12#1)(1995-3#1)(2007-11#1)(2007-4#1)(2008-2#2)(2009-5#1)(2010-12#1)(2011-2#1)
of reference materials##4##3##(2008-10#4)
of reference memory##5##3##(1993-11#1)(1993-3#3)(1994-8#1)
of reference peak##2##3##(2007-8#2)
of reference plasmid##2##3##(1996-10#2)
of reference that##2##3##(1995-3#1)(2008-2#1)
of reference to##3##3##(1992-2#1)(1996-1#1)(2008-2#1)
of reference values for##2##4##(1996-12#1)(2007-12#1)
of reference values##4##3##(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#1)
of reference##92##2##(1990-12#2)(1990-2#1)(1991-1#1)(1992-10#1)(1992-2#2)(1993-10#1)(1993-11#4)(1993-3#3)(1993-6#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-3#2)(1996-1#1)(1996-10#4)(1996-12#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-11#1)(2005-5#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#3)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#3)(2008-2#8)(2008-3#2)(2008-5#2)(2008-7#2)(2009-11#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-11#1)(2010-12#3)(2010-4#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-2#1)(2012-3#3)(2013-8#1)
of references##7##2##(1991-3#1)(1991-4#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2013-8#1)
of referral for##2##3##(1991-6#1)(2007-5#1)
of referral of##4##3##(1990-12#1)(1992-12#1)(2007-7#1)(2012-2#1)
of referral to##2##3##(2007-4#1)(2010-8#1)
of referral##22##2##(1990-12#1)(1991-6#1)(1992-12#1)(1992-9#2)(2004-12#1)(2007-4#1)(2007-5#1)(2007-7#2)(2008-1#1)(2008-11#1)(2010-8#1)(2011-1#2)(2012-2#6)(2012-3#1)
of referrals##13##2##(1992-9#2)(1994-2#1)(1994-8#1)(1995-8#1)(1997-8#1)(2004-12#1)(2006-8#1)(2007-3#1)(2008-12#1)(2008-4#1)(2010-4#1)(2012-2#1)
of referred##3##2##(2006-12#2)(2008-1#1)
of referring physicians##2##3##(1991-1#1)(2007-8#1)
of referring##6##2##(1991-1#1)(2007-4#1)(2007-8#1)(2008-5#1)(2011-1#1)(2012-2#1)
of refined##10##2##(1994-5#1)(1996-2#6)(2006-10#1)(2008-6#1)(2012-1#1)
of refinements of##2##3##(1993-11#1)(2009-2#1)
of reflectance and path length to scattering variations##3##8##(2008-3#3)
of reflectance and##6##3##(2008-2#2)(2008-3#4)
of reflectance at##3##3##(1991-2#1)(2007-12#1)(2008-2#1)
of reflectance data##2##3##(2008-3#2)
of reflectance##26##2##(1991-2#1)(1995-12#1)(2007-12#2)(2008-10#5)(2008-2#5)(2008-3#10)(2008-8#1)(2010-5#1)
of reflectances##2##2##(2008-2#1)(2008-3#1)
of reflected light##2##3##(2008-10#1)(2008-2#1)
of reflected##7##2##(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#1)(2013-7#1)
of reflecting##2##2##(2006-6#1)(2008-10#1)
of reflection and reflective practice##3##5##(2008-11#3)
of reflection and##6##3##(2008-11#5)(2008-3#1)
of reflection as a##2##4##(2008-12#2)
of reflection as##3##3##(2008-11#1)(2008-12#2)
of reflection in##3##3##(2008-11#2)(2008-12#1)
of reflection on##2##3##(2009-10#1)(2013-1#1)
of reflection or##2##3##(2008-11#1)(2008-3#1)
of reflection##35##2##(2006-5#1)(2007-11#1)(2007-12#2)(2008-11#15)(2008-12#4)(2008-2#4)(2008-3#5)(2009-10#1)(2013-1#2)
of reflection-type##2##2##(2007-12#1)(2008-2#1)
of reflections##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
of reflective practice##3##3##(1997-4#1)(2008-11#1)(2012-12#1)
of reflective surfaces##2##3##(2007-12#1)(2008-2#1)
of reflective##17##2##(1997-4#1)(2007-12#2)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#3)(2010-4#1)(2012-12#1)(2013-1#1)
of reflectivity and roughness##2##4##(2008-3#2)
of reflectivity##8##2##(2007-11#3)(2008-2#1)(2008-3#4)
of reflex responses##2##3##(1993-12#1)(1995-8#1)
of reflex##3##2##(1992-11#1)(1993-12#1)(1995-8#1)
of reflow##2##2##(1991-9#1)(1993-3#1)
of reflux disease##5##3##(2005-1#2)(2006-2#1)(2011-2#2)
of reflux esophagitis##4##3##(2005-10#1)(2007-3#3)
of reflux##14##2##(1991-5#1)(2005-1#3)(2005-10#1)(2006-2#1)(2007-3#3)(2008-4#3)(2011-2#2)
of refluxing ureters##2##3##(2008-10#2)
of refluxing##3##2##(2008-10#3)
of reform##7##2##(1993-12#1)(1993-3#1)(1994-12#1)(1996-2#1)(2007-2#1)(2008-3#1)(2008-4#1)
of reforms##3##2##(1993-2#1)(1997-1#1)(2008-1#1)
of refraction and size##5##4##(2008-2#3)(2008-3#2)
of refraction and##12##3##(2007-12#1)(2008-2#7)(2008-3#4)
of refraction halos##2##3##(2008-2#2)
of refraction of##21##3##(2007-12#1)(2008-2#14)(2008-3#6)
of refraction through##2##3##(2007-11#1)(2008-3#1)
of refraction##104##2##(1991-9#1)(2006-12#1)(2007-1#1)(2007-11#7)(2007-12#9)(2008-1#1)(2008-2#46)(2008-3#37)(2008-7#1)
of refractive and##2##3##(2007-12#1)(2008-3#1)
of refractive errors##3##3##(2009-8#1)(2009-9#1)(2010-8#1)
of refractive index n(0)##2##4##(2008-3#2)
of refractive index##14##3##(2007-1#1)(2007-11#2)(2008-10#2)(2008-2#3)(2008-3#5)(2011-12#1)
of refractive indices##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2009-5#1)
of refractive surgery##2##3##(2007-1#1)(2007-3#1)
of refractive turbulence on ground-based verification of##2##7##(2008-3#2)
of refractive turbulence on##3##4##(2008-3#3)
of refractive turbulence##4##3##(2008-3#4)
of refractive##37##2##(2007-1#2)(2007-11#3)(2007-12#2)(2007-3#1)(2008-10#2)(2008-2#7)(2008-3#13)(2009-5#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-12#1)(2013-7#1)
of refractive-index change##2##3##(2008-3#2)
of refractive-index mismatch##2##3##(2008-2#1)(2008-3#1)
of refractive-index##8##2##(2007-11#1)(2008-1#1)(2008-2#2)(2008-3#4)
of refractoriness##4##2##(1992-8#1)(1993-12#1)(2013-1#2)
of refractory acute##2##3##(2007-11#1)(2012-2#1)
of refractory ascites by using a##2##6##(2007-12#2)
of refractory ascites##3##3##(2007-12#3)
of refractory rejection##3##3##(2007-11#3)
of refractory shock##2##3##(2013-8#2)
of refractory##46##2##(1991-2#1)(1991-3#1)(1991-9#1)(1996-12#1)(1996-5#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-11#4)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-3#2)(2009-5#1)(2009-7#1)(2010-12#2)(2010-2#1)(2010-5#2)(2011-2#3)(2012-2#2)(2012-3#1)(2013-8#5)
of refrigerated##2##2##(2007-3#1)(2013-7#1)
of refugees and asylum-seekers who##2##5##(1995-11#2)
of refugees##7##2##(1990-6#1)(1993-7#1)(1995-11#2)(2006-9#2)(2008-2#1)
of refusal##3##2##(1992-2#1)(2005-10#1)(2011-2#1)
of refuse##2##2##(1991-9#1)(2008-10#1)
of refusers##2##2##(1991-6#2)
of regenerate##3##2##(2007-11#2)(2008-8#1)
of regenerated tissue##2##3##(2008-1#1)(2008-5#1)
of regenerated##9##2##(1991-6#1)(1995-12#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-8#1)
of regenerating##8##2##(1990-2#1)(1992-4#1)(1994-2#1)(1995-3#1)(2008-1#1)(2008-10#1)(2012-2#1)(2013-8#1)
of regeneration of the##2##4##(1995-12#1)(2008-10#1)
of regeneration of##5##3##(1993-2#1)(1995-12#1)(2008-10#2)(2013-8#1)
of regeneration##13##2##(1992-7#1)(1993-2#1)(1993-3#1)(1994-2#1)(1995-12#1)(2007-12#1)(2008-1#1)(2008-10#2)(2012-2#1)(2013-8#3)
of regenerative medicine##9##3##(2007-1#1)(2008-1#1)(2008-11#2)(2008-4#1)(2012-12#2)(2013-1#1)(2013-7#1)
of regenerative##11##2##(2007-1#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-4#1)(2010-12#1)(2012-12#2)(2013-1#1)(2013-7#1)
of regimens##5##2##(1992-8#1)(1996-12#1)(1997-7#2)(2004-1#1)
of regio- and stereospecificity in##2##5##(1990-7#2)
of region of##2##3##(2005-10#1)(2010-8#1)
of region specific##2##3##(1991-3#1)(1994-12#1)
of region##7##2##(1991-3#1)(1994-12#1)(2005-10#1)(2007-4#1)(2008-11#1)(2008-6#1)(2010-8#1)
of regional anaesthesia in obstetrics##2##5##(2006-10#2)
of regional anaesthesia in##4##4##(2006-10#3)(2013-1#1)
of regional anaesthesia##7##3##(2006-10#5)(2013-1#2)
of regional anaesthetic techniques##2##4##(2006-10#2)
of regional and##4##3##(1996-12#1)(2006-10#2)(2010-2#1)
of regional anesthesia##8##3##(2006-10#5)(2008-8#1)(2012-2#1)(2012-3#1)
of regional brain##2##3##(2008-4#1)(2009-6#1)
of regional cerebral blood flow##5##5##(1992-8#1)(1993-2#1)(2007-9#1)(2008-2#1)(2012-12#1)
of regional cerebral##7##3##(1992-8#1)(1993-2#1)(1997-3#1)(2006-7#1)(2007-9#1)(2008-2#1)(2012-12#1)
of regional climate##2##3##(2007-8#1)(2008-9#1)
of regional differences##2##3##(2009-10#1)(2011-2#1)
of regional lymph node##4##4##(1995-10#1)(2006-10#1)(2008-6#1)(2010-12#1)
of regional lymph##5##3##(1995-10#1)(2006-10#1)(2008-6#1)(2010-12#1)(2010-8#1)
of regional myocardial performance##2##4##(1993-12#2)
of regional spread##3##3##(1990-4#2)(2008-10#1)
of regional systems##4##3##(1992-12#3)(1997-4#1)
of regional systolic##2##3##(2005-1#1)(2010-5#1)
of regional##97##2##(1990-12#1)(1990-2#1)(1990-4#2)(1990-9#2)(1992-12#4)(1992-8#1)(1993-12#2)(1993-2#1)(1993-4#2)(1994-5#1)(1995-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(2005-1#1)(2006-10#19)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#4)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-3#1)(2013-8#1)
of regions of##4##3##(1994-6#1)(2007-9#1)(2009-7#1)(2011-2#1)
of regions that##2##3##(1996-4#1)(2008-11#1)
of regions##17##2##(1991-5#1)(1991-6#1)(1991-8#1)(1993-3#1)(1994-6#1)(1996-4#1)(2005-5#1)(2007-9#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-6#1)(2009-12#1)(2009-7#1)(2011-2#1)
of register data##2##3##(1990-8#1)(1995-8#1)
of registered nurses (RNs)##2##4##(1991-2#1)(2010-11#1)
of registered nurses in##2##4##(2008-11#1)(2012-3#1)
of registered nurses##5##3##(1991-2#1)(2008-11#2)(2010-11#1)(2012-3#1)
of registered professional nurses##2##4##(2007-10#2)
of registered##14##2##(1991-2#1)(1996-3#1)(2006-8#1)(2007-10#2)(2007-5#1)(2008-11#3)(2008-9#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#1)
of registration accuracy of##2##4##(2006-12#2)
of registration of deaths##2##4##(2006-6#2)
of registration##10##2##(1990-3#1)(1993-12#1)(2006-12#4)(2006-6#3)(2008-11#1)
of regression coefficients for the##2##5##(2008-10#1)(2008-3#1)
of regression coefficients##4##3##(2008-10#1)(2008-3#1)(2012-3#2)
of regression models to##2##4##(2010-9#1)(2011-1#1)
of regression models##6##3##(1991-1#1)(1992-9#1)(1995-6#1)(1997-2#1)(2010-9#1)(2011-1#1)
of regression##19##2##(1991-1#2)(1992-9#1)(1995-4#1)(1995-6#1)(1996-12#1)(1997-2#1)(2006-6#1)(2008-10#3)(2008-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-8#2)
of regrowth##2##2##(1992-9#2)
of regular dialysis treatment##2##4##(2010-12#2)
of regular secondary structure##2##4##(1991-4#1)(1992-12#1)
of regular secondary structures##2##4##(2009-7#1)(2012-12#1)
of regular secondary##4##3##(1991-4#1)(1992-12#1)(2009-7#1)(2012-12#1)
of regular##43##2##(1990-4#2)(1991-4#1)(1992-12#2)(1993-3#1)(1995-11#1)(1995-12#1)(1995-9#1)(1996-6#1)(1996-8#1)(1997-4#1)(2005-5#1)(2007-11#1)(2007-12#3)(2007-3#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-7#2)(2010-12#2)(2010-3#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#2)(2013-8#2)
of regularization##2##2##(2008-3#1)(2008-6#1)
of regulated##7##2##(1992-12#1)(1994-9#1)(1996-5#1)(1997-6#1)(2007-3#1)(2008-10#1)(2009-7#1)
of regulating gene expression##2##4##(2007-12#1)(2008-4#1)
of regulating##14##2##(1995-3#1)(1996-10#1)(1997-5#1)(2005-11#1)(2007-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-1#1)(2012-11#2)(2012-2#2)
of regulation and##3##3##(1990-12#1)(2008-7#1)(2009-4#1)
of regulation for##2##3##(1997-6#1)(2005-10#1)
of regulation is##3##3##(1997-2#2)(2010-7#1)
of regulation of gene expression##2##5##(2008-7#1)(2013-8#1)
of regulation of the##4##4##(1991-3#1)(1993-2#1)(1994-3#1)(2008-4#1)
of regulation of##19##3##(1991-3#1)(1992-6#1)(1993-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(2007-11#1)(2008-11#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#1)(2013-8#1)
of regulation##50##2##(1990-12#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-6#1)(1993-2#1)(1993-5#1)(1994-12#2)(1994-3#1)(1994-6#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#1)(1997-2#2)(1997-6#2)(2005-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-11#2)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-7#1)(2013-1#1)(2013-8#1)
of regulations##5##2##(1995-5#1)(2007-11#1)(2007-4#1)(2008-11#2)
of regulator##6##2##(1990-7#1)(1997-2#2)(2005-11#1)(2007-10#1)(2008-11#1)
of regulators##3##2##(1990-4#1)(2008-12#1)(2009-8#1)
of regulatory T cell##2##4##(2007-5#1)(2013-7#1)
of regulatory T cells in##4##5##(2006-10#1)(2008-4#1)(2010-6#1)(2011-2#1)
of regulatory T cells##13##4##(2006-10#1)(2007-5#3)(2008-4#3)(2010-2#1)(2010-6#3)(2011-2#1)(2012-1#1)
of regulatory T##15##3##(2006-10#1)(2007-5#4)(2008-4#3)(2010-2#1)(2010-6#3)(2011-2#1)(2012-1#1)(2013-7#1)
of regulatory agencies##3##3##(2005-8#1)(2008-10#2)
of regulatory cytokines##2##3##(2007-2#1)(2007-9#1)
of regulatory elements##2##3##(1995-8#1)(2008-7#1)
of regulatory genes##5##3##(1994-11#1)(1994-8#1)(2008-10#1)(2008-9#1)(2012-2#1)
of regulatory molecules##3##3##(1990-8#1)(1990-9#1)(1995-12#1)
of regulatory networks##4##3##(2006-7#1)(2008-11#2)(2010-10#1)
of regulatory pathways##3##3##(2007-12#1)(2008-7#2)
of regulatory peptide##2##3##(1992-9#1)(2008-4#1)
of regulatory peptides##4##3##(1990-11#1)(1992-11#1)(1993-3#1)(2008-4#1)
of regulatory proteins and##2##4##(1997-2#1)(2012-12#1)
of regulatory proteins##7##3##(1997-2#1)(2008-4#1)(2008-9#1)(2009-3#1)(2012-1#1)(2012-12#1)(2013-7#1)
of regulatory regions##3##3##(1994-6#1)(1995-12#1)(2007-11#1)
of regulatory##85##2##(1990-11#1)(1990-8#2)(1990-9#2)(1991-9#1)(1992-11#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-6#2)(1994-8#1)(1995-12#2)(1995-8#1)(1996-10#1)(1996-2#1)(1997-2#2)(1997-4#1)(2005-5#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#5)(2007-9#1)(2008-10#5)(2008-11#3)(2008-4#6)(2008-7#6)(2008-9#2)(2009-11#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-6#3)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#2)
of regurgitation##2##2##(1993-10#1)(2006-10#1)
of rehabilitation after##3##3##(1995-5#1)(2006-4#1)(2007-11#1)
of rehabilitation and##4##3##(2007-10#1)(2007-11#1)(2007-8#1)(2008-11#1)
of rehabilitation in cases of##2##5##(2007-8#2)
of rehabilitation in##6##3##(2007-11#1)(2007-8#2)(2008-9#2)(2010-10#1)
of rehabilitation measures##2##3##(1991-5#1)(1995-5#1)
of rehabilitation of the##2##4##(2007-11#1)(2008-5#1)
of rehabilitation services##2##3##(2007-12#1)(2007-9#1)
of rehabilitation##64##2##(1991-5#1)(1993-6#1)(1993-7#1)(1995-5#5)(1996-3#1)(1997-3#1)(2006-4#2)(2006-5#1)(2006-8#3)(2007-10#1)(2007-11#10)(2007-12#1)(2007-7#1)(2007-8#13)(2007-9#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-12#2)(2009-4#1)(2009-8#1)(2010-10#2)(2010-9#1)(2011-2#2)(2012-12#2)(2013-1#2)
of reimbursement for##2##3##(1994-2#1)(2007-4#1)
of reimbursement##5##2##(1990-10#1)(1992-3#1)(1994-2#1)(2007-4#1)(2011-2#1)
of reindeer##3##2##(1990-8#2)(1992-4#1)
of reinforcement learning##2##3##(2011-1#1)(2012-2#1)
of reinforcement##17##2##(1990-2#1)(1993-6#2)(1994-3#1)(1996-10#1)(2005-10#1)(2006-7#2)(2008-10#1)(2008-5#1)(2009-7#1)(2010-10#1)(2011-1#1)(2012-2#1)(2013-7#3)
of reinforcers for##3##3##(2011-2#3)
of reinforcing##2##2##(2008-12#1)(2008-2#1)
of reinfusion drains##2##3##(2008-8#2)
of reinnervation##2##2##(2008-3#1)(2013-8#1)
of reintubation##6##2##(2013-8#6)
of rejected##2##2##(1995-5#1)(2011-3#1)
of rejection and##4##3##(1990-12#1)(2006-10#1)(2007-11#1)(2010-3#1)
of rejection episodes##4##3##(1990-11#1)(2006-5#1)(2007-11#2)
of rejection was##2##3##(2007-12#1)(2007-8#1)
of rejection##20##2##(1990-11#1)(1990-12#1)(1991-12#1)(1995-2#2)(1996-8#1)(1997-5#1)(2006-10#1)(2006-5#1)(2007-11#5)(2007-12#1)(2007-8#1)(2009-3#2)(2010-3#1)(2010-8#1)
of rejoining##3##2##(1997-1#3)
of relapse and##6##3##(1993-1#1)(1995-9#1)(2007-3#1)(2009-11#1)(2010-12#1)(2012-12#1)
of relapse following##2##3##(2009-5#1)(2010-2#1)
of relapse of##3##3##(2007-7#1)(2007-8#1)(2013-1#1)
of relapse##40##2##(1990-11#1)(1990-12#1)(1991-4#1)(1991-5#1)(1992-12#1)(1993-1#1)(1995-11#1)(1995-6#1)(1995-9#1)(1996-4#1)(1997-8#2)(2006-5#1)(2006-7#1)(2007-11#2)(2007-3#1)(2007-7#2)(2007-8#1)(2008-2#1)(2008-6#4)(2009-11#2)(2009-2#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#2)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)
of relapse-free##2##2##(1993-9#1)(1995-12#1)
of relapsed##8##2##(1995-9#1)(2008-5#3)(2010-12#2)(2010-4#2)
of relapses and##2##3##(1993-5#1)(2013-8#1)
of relapses##11##2##(1991-6#1)(1993-5#1)(2005-7#1)(2007-11#3)(2008-1#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
of relapsing polychondritis##2##3##(2006-10#2)
of relapsing##13##2##(1990-8#1)(1991-12#2)(1991-2#1)(1994-2#1)(2006-10#2)(2007-11#2)(2008-1#1)(2009-2#1)(2010-12#1)(2010-9#1)
of related diseases##3##3##(1994-7#1)(2011-1#2)
of related enzymes##2##3##(1994-8#1)(2013-8#1)
of related growth##2##3##(1994-12#1)(2010-8#1)
of related protein##2##3##(1990-8#1)(2008-9#1)
of related proteins##3##3##(1990-5#1)(1996-9#1)(2010-12#1)
of related sequences##2##3##(2005-10#1)(2008-4#1)
of related species sperms##2##4##(2008-9#2)
of related species##3##3##(2008-9#2)(2010-3#1)
of related substances##2##3##(2008-10#1)(2012-12#1)
of related symptoms##2##3##(1994-7#1)(2011-2#1)
of related##67##2##(1990-5#1)(1990-8#1)(1991-6#1)(1992-4#1)(1992-6#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-7#2)(1994-8#2)(1994-9#1)(1995-6#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-6#1)(2005-10#1)(2007-11#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-3#2)(2008-4#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-1#1)(2009-4#3)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
of relatedness and##3##3##(2009-10#1)(2010-2#1)(2010-4#1)
of relatedness##7##2##(2008-8#2)(2008-9#1)(2009-10#1)(2010-2#1)(2010-4#1)(2010-8#1)
of relating##8##2##(1993-1#1)(1993-2#1)(2005-8#1)(2008-10#1)(2008-3#1)(2010-7#1)(2013-1#1)(2013-8#1)
of relation between##2##3##(1990-9#1)(2004-12#1)
of relation##5##2##(1990-9#1)(1997-8#1)(2004-12#1)(2007-12#1)(2008-9#1)
of relational##9##2##(1992-3#1)(1993-2#1)(1993-6#1)(2007-5#1)(2010-4#2)(2010-8#1)(2011-1#1)(2012-12#1)
of relations among##2##3##(2008-9#1)(2010-2#1)
of relations between the##2##4##(2010-10#1)(2010-6#1)
of relations between##5##3##(2007-5#1)(2008-10#1)(2008-7#1)(2010-10#1)(2010-6#1)
of relations##10##2##(2006-2#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-2#1)(2010-6#1)
of relationship and##2##3##(2008-11#1)(2008-6#1)
of relationship between##2##3##(1991-6#1)(1996-12#1)
of relationship satisfaction##4##3##(2008-6#1)(2010-8#1)(2012-2#2)
of relationship##19##2##(1991-6#1)(1996-12#1)(1997-5#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-9#1)(2010-8#1)(2012-12#1)(2012-2#4)
of relationships among##4##3##(1992-3#1)(1997-2#1)(2013-1#2)
of relationships as##2##3##(2007-9#1)(2009-4#1)
of relationships between health##2##4##(1993-1#1)(1993-3#1)
of relationships between##9##3##(1991-2#1)(1992-3#1)(1993-1#1)(1993-3#1)(2008-10#2)(2008-4#1)(2008-5#1)(2013-8#1)
of relationships that##2##3##(1993-1#1)(2013-7#1)
of relationships with##3##3##(1995-2#1)(2009-7#1)(2011-1#1)
of relationships##36##2##(1991-2#1)(1992-3#2)(1993-1#2)(1993-3#1)(1995-2#1)(1997-2#1)(1997-6#1)(2006-3#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#2)(2010-1#1)(2011-1#1)(2013-1#8)(2013-7#1)(2013-8#1)
of relative fluorescence##3##3##(2005-8#1)(2008-10#1)(2008-3#1)
of relative humidity##6##3##(2008-10#3)(2008-2#2)(2008-5#1)
of relative importance##3##3##(2007-3#2)(2008-5#1)
of relative molecular mass 60##3##5##(1991-11#3)
of relative molecular mass##5##4##(1991-11#3)(1991-2#1)(1997-8#1)
of relative potency##2##3##(1995-12#1)(2008-5#1)
of relative response##2##3##(1994-9#1)(2011-2#1)
of relative risk##6##3##(1992-6#1)(1993-4#1)(1994-2#1)(1995-5#1)(1997-5#1)(2009-11#1)
of relative stability##2##3##(1991-4#1)(2012-9#1)
of relative standard deviation (R##5##5##(2007-8#1)(2008-10#4)
of relative standard deviation##9##4##(2007-8#2)(2008-1#1)(2008-10#6)
of relative value##2##3##(1991-2#1)(1992-3#1)
of relative##91##2##(1990-4#1)(1991-11#3)(1991-2#2)(1991-4#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-4#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#2)(1995-5#1)(1995-6#2)(1995-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-8#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-11#1)(2007-10#1)(2007-12#1)(2007-3#3)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#1)(2010-12#1)(2010-8#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-9#1)
of relatively high and##2##4##(1991-9#1)(2012-2#1)
of relatively high##5##3##(1990-12#1)(1991-9#1)(2005-11#1)(2012-2#1)(2013-1#1)
of relatively hydrophilic chemicals##2##4##(2008-11#2)
of relatively large##7##3##(1991-12#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-8#1)(2011-2#1)
of relatively low##6##3##(1990-12#1)(2005-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-6#1)
of relatively small##6##3##(1990-12#1)(1993-11#1)(1997-3#1)(1997-8#1)(2004-1#1)(2008-4#1)
of relatively young##2##3##(1996-7#1)(2006-8#1)
of relatively##46##2##(1990-12#3)(1990-4#1)(1991-12#1)(1991-9#1)(1992-9#1)(1993-11#1)(1993-7#1)(1994-2#1)(1995-12#1)(1996-1#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(2004-1#1)(2005-11#2)(2006-2#2)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#4)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
of relatives of the##2##4##(1990-11#1)(2011-2#1)
of relatives of##4##3##(1990-11#1)(2010-2#1)(2011-2#2)
of relatives with##3##3##(2011-2#2)(2013-7#1)
of relatives##11##2##(1990-11#1)(2009-11#1)(2009-6#1)(2010-2#1)(2011-2#5)(2012-12#1)(2013-7#1)
of relativistic##2##2##(1992-3#1)(2007-12#1)
of relativity##3##2##(1990-6#1)(1995-7#1)(2009-3#1)
of relaxation and##3##3##(2004-3#1)(2008-7#1)(2012-3#1)
of relaxation times##3##3##(1997-7#1)(2005-11#1)(2012-7#1)
of relaxation##15##2##(1991-12#2)(1991-9#1)(1997-4#1)(1997-7#1)(2004-3#1)(2005-11#1)(2007-2#1)(2008-11#1)(2008-2#2)(2008-7#1)(2012-2#1)(2012-3#1)(2012-7#1)
of relaxed selective constraint##2##4##(2011-2#2)
of relaxed##4##2##(1990-9#1)(1995-3#1)(2011-2#2)
of relaxin##3##2##(1995-8#1)(2005-7#2)
of relaxing##2##2##(1995-3#1)(1997-4#1)
of release and##2##3##(1995-5#1)(2008-3#1)
of release by##2##3##(1995-12#1)(2010-2#1)
of release of##23##3##(1990-10#1)(1990-11#1)(1991-2#1)(1991-7#1)(1992-3#1)(1992-6#1)(1993-5#1)(1994-6#1)(1996-6#1)(2004-12#1)(2005-11#1)(2006-8#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-4#2)(2010-8#4)(2011-2#2)
of release was##4##3##(1994-2#1)(2010-12#1)(2011-2#2)
of release##47##2##(1990-10#1)(1990-11#1)(1991-2#1)(1991-7#1)(1992-3#1)(1992-6#1)(1993-5#1)(1994-2#1)(1994-6#1)(1995-10#1)(1995-12#2)(1995-5#1)(1996-2#1)(1996-6#1)(2004-12#2)(2005-10#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-4#2)(2007-9#1)(2008-10#2)(2008-3#1)(2008-4#3)(2008-5#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-8#4)(2011-2#6)(2013-1#1)
of released alpha-tocopherol##2##3##(2009-8#2)
of released##19##2##(1991-10#1)(1992-6#1)(1992-7#1)(1993-3#1)(2005-12#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-4#4)(2009-8#3)(2010-8#1)(2011-2#2)
of releasing##8##2##(1992-9#1)(1994-3#1)(1994-6#1)(1997-4#1)(2006-8#1)(2008-11#2)(2008-8#1)
of relevance for##3##3##(1997-3#1)(2008-12#1)(2008-3#1)
of relevance in##4##3##(1990-8#1)(1991-1#1)(2006-10#1)(2007-2#1)
of relevance to the##6##4##(1992-12#1)(2005-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
of relevance to##14##3##(1992-12#1)(1996-5#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-9#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
of relevance##28##2##(1990-8#1)(1991-1#1)(1992-12#1)(1992-8#1)(1996-5#1)(1997-3#1)(1997-8#1)(2005-8#1)(2006-10#3)(2006-5#1)(2007-10#1)(2007-11#2)(2007-2#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-2#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
of relevant and##2##3##(2008-10#1)(2008-7#1)
of relevant articles for##2##4##(1994-3#1)(2013-8#1)
of relevant articles##3##3##(1994-3#1)(2007-8#1)(2013-8#1)
of relevant information##5##3##(1997-8#1)(2008-7#2)(2012-12#1)(2012-3#1)
of relevant literature##4##3##(2008-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
of relevant scientific##2##3##(1990-10#1)(2006-8#1)
of relevant##61##2##(1990-10#1)(1991-6#1)(1994-3#2)(1995-11#1)(1995-2#1)(1995-4#1)(1996-11#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-8#1)(2004-7#1)(2005-7#1)(2005-8#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-12#2)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#7)(2009-11#1)(2009-2#1)(2009-6#1)(2010-4#1)(2010-7#3)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2012-8#1)(2013-1#3)(2013-8#2)
of reliability and##3##3##(2008-1#1)(2012-1#1)(2012-2#1)
of reliability in the##2##4##(1991-6#1)(2007-4#1)
of reliability of##3##3##(1997-4#1)(2006-8#1)(2011-2#1)
of reliability##17##2##(1991-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-9#1)(1995-2#1)(1997-4#1)(2006-8#1)(2007-10#1)(2007-4#1)(2008-1#1)(2009-12#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)
of reliable and##2##3##(2010-4#1)(2013-8#1)
of reliable information##2##3##(2008-9#1)(2010-12#1)
of reliable##17##2##(1991-10#1)(1993-11#1)(1993-6#1)(1994-8#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-7#2)(2008-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2012-2#1)(2013-8#1)
of reliably##4##2##(1991-3#1)(2008-10#2)(2012-2#1)
of relief after the##2##4##(2006-12#1)(2007-7#1)
of relief##6##2##(1992-5#1)(1996-1#1)(2006-12#2)(2006-8#1)(2007-7#1)
of religion in##3##3##(2009-5#1)(2009-7#2)
of religion on##2##3##(2009-6#1)(2009-7#1)
of religion##8##2##(2008-12#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#3)
of religiosity##6##2##(2009-11#2)(2009-7#2)(2011-1#2)
of religious beliefs##3##3##(2010-2#1)(2012-12#2)
of religious involvement##2##3##(2009-5#1)(2010-10#1)
of religious##16##2##(1996-2#1)(1997-1#1)(2004-12#1)(2006-7#1)(2007-10#2)(2007-3#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-10#2)(2010-2#1)(2012-12#2)
of relocated##2##2##(2007-5#1)(2013-7#1)
of relocation##2##2##(2013-7#2)
of relying on##3##3##(2008-10#1)(2012-2#1)(2013-1#1)
of relying##4##2##(2006-2#1)(2008-10#1)(2012-2#1)(2013-1#1)
of remaining life##2##3##(2006-2#1)(2011-2#1)
of remaining patients##2##3##(1992-9#1)(2012-2#1)
of remaining##17##2##(1991-5#3)(1992-10#1)(1992-9#1)(1994-8#1)(1996-12#1)(2006-2#2)(2006-9#1)(2007-11#1)(2007-2#1)(2008-7#2)(2011-2#2)(2012-2#1)
of remarkable##6##2##(1996-4#1)(2008-1#1)(2008-12#1)(2008-7#1)(2010-3#1)(2011-12#1)
of remedies##2##2##(2007-4#1)(2008-3#1)
of remembering##2##2##(2011-2#2)
of remifentanil are##2##3##(2006-10#2)
of remifentanil for reducing##2##4##(2011-2#2)
of remifentanil for##3##3##(2006-10#1)(2011-2#2)
of remifentanil on arterial oxygenation during one-lung ventilation##2##8##(2011-2#2)
of remifentanil on##3##3##(2011-2#3)
of remifentanil##15##2##(2006-10#7)(2009-4#1)(2011-2#6)(2012-12#1)
of reminder##2##2##(2012-3#2)
of remission in##2##3##(2010-12#1)(2012-3#1)
of remission##19##2##(1990-10#1)(1990-11#2)(1990-2#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-4#1)(1992-2#1)(1994-6#1)(1996-8#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-8#1)(2010-12#1)(2010-4#1)(2010-6#1)(2012-3#1)
of remodeling are##2##3##(1993-10#1)(2005-8#1)
of remodeling##8##2##(1993-10#1)(2005-8#3)(2007-8#1)(2009-11#1)(2011-1#1)(2012-12#1)
of remote sensing of##2##4##(2008-2#1)(2008-3#1)
of remote sensing##4##3##(2008-2#2)(2008-3#1)(2008-8#1)
of remote##14##2##(1991-8#1)(2006-1#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-2#4)(2008-3#1)(2008-8#1)(2010-8#1)(2012-12#1)(2013-7#1)
of remote-sensing reflectance##2##3##(2008-3#2)
of remotely sensed##2##3##(2008-2#1)(2008-3#1)
of removable partial denture##2##4##(2012-1#1)(2012-2#1)
of removable partial##3##3##(2011-12#1)(2012-1#1)(2012-2#1)
of removal of the##3##4##(1993-2#1)(2008-3#1)(2008-4#1)
of removal of##10##3##(1993-12#1)(1993-2#1)(1994-8#1)(2004-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-5#1)
of removal##13##2##(1993-12#1)(1993-2#1)(1994-6#1)(1994-8#1)(2004-7#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-5#1)(2013-8#1)
of removed##4##2##(2007-7#1)(2011-2#3)
of removing all##2##3##(2006-9#1)(2008-10#1)
of removing the##6##3##(1992-12#1)(1992-3#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
of removing##17##2##(1992-12#1)(1992-3#1)(1993-10#1)(1993-2#1)(2006-10#1)(2006-9#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
of remyelination##5##2##(2008-12#2)(2008-7#3)
of renal abnormalities##2##3##(2006-8#1)(2008-1#1)
of renal allograft recipients##2##4##(1995-2#1)(2007-11#1)
of renal allograft##4##3##(1995-2#2)(2007-11#1)(2007-8#1)
of renal allografts in patients##2##5##(2007-8#1)(2008-8#1)
of renal allografts##4##3##(1995-2#1)(2007-8#1)(2008-8#1)(2012-12#1)
of renal and hepatic##2##4##(1995-1#1)(2008-8#1)
of renal and##3##3##(1995-1#1)(2007-8#1)(2008-8#1)
of renal arteries##3##3##(1993-8#1)(2008-12#1)(2008-7#1)
of renal artery stenosis##5##4##(2006-10#2)(2008-1#2)(2008-12#1)
of renal artery##7##3##(1994-9#1)(2006-10#3)(2008-1#2)(2008-12#1)
of renal biopsy##2##3##(2007-7#1)(2012-11#1)
of renal blood flow##2##4##(2005-12#1)(2007-8#1)
of renal cancer##5##3##(1993-9#2)(2007-11#1)(2008-7#1)(2009-11#1)
of renal cell cancer##2##4##(1993-11#1)(2008-1#1)
of renal cell carcinoma (RCC)##5##5##(2007-2#1)(2007-4#1)(2008-6#1)(2010-12#1)(2012-3#1)
of renal cell carcinoma and##3##5##(1992-8#1)(2010-12#1)(2011-12#1)
of renal cell carcinoma in##3##5##(1990-8#2)(2007-7#1)
of renal cell carcinoma##27##4##(1990-8#2)(1992-8#2)(1995-12#1)(2006-9#1)(2007-2#3)(2007-4#2)(2007-7#1)(2007-8#1)(2008-6#2)(2008-8#1)(2009-11#1)(2009-8#1)(2010-12#3)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
of renal cell##33##3##(1990-8#2)(1992-8#4)(1993-11#1)(1995-12#1)(2006-9#1)(2007-2#3)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-6#2)(2008-8#1)(2009-11#1)(2009-8#1)(2010-12#3)(2010-8#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
of renal colic using intracutaneous injection of sterile water##2##9##(2007-10#2)
of renal colic##8##3##(2006-7#3)(2007-10#2)(2008-1#3)
of renal cortical slices##2##4##(1994-3#1)(1997-2#1)
of renal cortical##3##3##(1994-3#1)(1997-2#1)(2012-12#1)
of renal damage in##2##4##(2005-10#2)
of renal damage##6##3##(1991-5#1)(1995-2#1)(2005-10#2)(2006-1#1)(2008-7#1)
of renal disease can##2##4##(2007-7#2)
of renal disease in##2##4##(2005-7#2)
of renal disease##15##3##(1996-12#1)(2005-10#1)(2005-7#2)(2007-7#2)(2007-8#2)(2008-1#3)(2008-7#1)(2009-6#1)(2011-12#1)(2012-12#1)
of renal diseases in children##2##5##(2007-7#1)(2008-4#1)
of renal diseases##8##3##(1997-5#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-4#1)(2013-1#1)
of renal dysfunction and##2##4##(2008-1#1)(2011-1#1)
of renal dysfunction##5##3##(1994-6#1)(2008-1#1)(2010-7#1)(2011-1#1)(2013-1#1)
of renal endothelial##2##3##(2012-12#2)
of renal failure and##3##4##(1990-4#1)(2008-1#1)(2008-4#1)
of renal failure in patients with##2##6##(1990-4#1)(2009-9#1)
of renal failure in##3##4##(1990-4#1)(1992-4#1)(2009-9#1)
of renal failure##42##3##(1990-2#1)(1990-4#5)(1990-8#1)(1992-4#2)(1995-12#1)(1995-2#1)(1995-5#1)(2005-12#1)(2005-7#1)(2006-10#2)(2007-11#1)(2007-3#2)(2007-7#3)(2008-1#5)(2008-4#5)(2008-7#1)(2009-9#3)(2011-2#1)(2012-2#1)(2013-1#4)
of renal fibrogenesis##2##3##(2012-12#2)
of renal fibrosis##3##3##(2011-2#1)(2012-12#2)
of renal function and##5##4##(2006-10#2)(2007-2#1)(2008-1#1)(2010-7#1)
of renal function in##5##4##(1996-1#1)(2005-10#1)(2006-10#1)(2009-8#1)(2012-2#1)
of renal function is##2##4##(2005-10#1)(2008-1#1)
of renal function may##2##4##(2008-1#1)(2010-12#1)
of renal function##43##3##(1990-6#1)(1992-4#1)(1992-8#1)(1995-11#1)(1995-2#1)(1996-1#1)(2005-10#4)(2006-10#5)(2006-7#1)(2007-1#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-1#4)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-7#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#2)
of renal functional##2##3##(2008-1#2)
of renal graft##2##3##(2007-11#1)(2009-5#1)
of renal impairment##7##3##(1993-12#1)(2008-1#1)(2008-8#1)(2013-1#4)
of renal injuries##2##3##(1990-9#1)(2012-2#1)
of renal injury##7##3##(1994-5#1)(2008-3#1)(2009-6#1)(2012-12#2)(2012-2#2)
of renal insufficiency and##2##4##(1990-9#1)(2011-2#1)
of renal insufficiency##9##3##(1990-5#1)(1990-9#1)(1993-5#1)(2005-10#1)(2005-7#1)(2007-7#2)(2007-8#1)(2011-2#1)
of renal involvement in##2##4##(1992-5#1)(2008-1#1)
of renal involvement##4##3##(1992-5#1)(2006-8#1)(2008-1#2)
of renal lesions##4##3##(2004-11#2)(2005-10#1)(2008-5#1)
of renal lithiasis##2##3##(1991-11#1)(2011-2#1)
of renal masses##3##3##(2008-6#1)(2012-2#2)
of renal metabolism##2##3##(1990-2#1)(1992-7#1)
of renal osteodystrophy##2##3##(2008-4#1)(2011-2#1)
of renal parenchyma is##2##4##(2006-7#1)(2006-9#1)
of renal parenchyma##4##3##(2006-7#1)(2006-9#1)(2008-1#1)(2012-12#1)
of renal replacement therapy in##4##5##(2008-1#1)(2008-3#1)(2008-8#1)(2010-4#1)
of renal replacement therapy##10##4##(2006-10#1)(2007-7#2)(2008-1#3)(2008-3#2)(2008-8#1)(2010-4#1)
of renal replacement##11##3##(2006-10#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-3#2)(2008-8#1)(2010-4#1)
of renal scarring##2##3##(2008-4#2)
of renal stones##3##3##(1994-12#1)(2008-10#1)(2011-2#1)
of renal transplant patients##2##4##(2009-10#1)(2010-7#1)
of renal transplant recipients##3##4##(1995-2#1)(2007-7#1)(2007-8#1)
of renal transplant##8##3##(1995-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2009-10#1)(2010-7#2)(2011-2#1)
of renal transplantation in patients with##2##6##(2007-8#1)(2013-1#1)
of renal transplantation in##6##4##(2006-10#1)(2007-7#1)(2007-8#1)(2008-4#2)(2013-1#1)
of renal transplantation##17##3##(1991-11#1)(1994-5#1)(2006-10#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#4)(2008-4#4)(2009-10#1)(2013-1#1)
of renal tubular##4##3##(1992-3#1)(2004-11#1)(2007-7#1)(2008-4#1)
of renal tubule dilatation in##2##5##(2008-9#2)
of renal tubule##5##3##(2008-9#5)
of renal tumor##4##3##(2007-7#1)(2008-10#2)(2010-10#1)
of renal##393##2##(1990-2#4)(1990-4#5)(1990-5#1)(1990-6#3)(1990-8#4)(1990-9#2)(1991-10#1)(1991-11#2)(1991-5#2)(1992-3#1)(1992-4#3)(1992-5#3)(1992-7#4)(1992-8#7)(1993-11#1)(1993-12#1)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-12#2)(1994-3#2)(1994-5#4)(1994-6#3)(1994-8#3)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#7)(1995-5#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-6#1)(1996-8#2)(1997-2#4)(1997-5#1)(1997-7#2)(2004-11#3)(2005-1#1)(2005-10#10)(2005-12#2)(2005-7#4)(2006-1#2)(2006-10#15)(2006-2#1)(2006-7#5)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#1)(2007-2#5)(2007-3#2)(2007-4#2)(2007-5#1)(2007-7#22)(2007-8#14)(2007-9#1)(2008-1#41)(2008-10#9)(2008-12#2)(2008-3#7)(2008-4#15)(2008-5#2)(2008-6#4)(2008-7#7)(2008-8#6)(2008-9#6)(2009-10#2)(2009-11#2)(2009-2#1)(2009-5#2)(2009-6#2)(2009-8#2)(2009-9#3)(2010-10#1)(2010-11#2)(2010-12#5)(2010-4#2)(2010-6#1)(2010-7#5)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#12)(2012-1#1)(2012-11#2)(2012-12#18)(2012-2#10)(2012-3#2)(2013-1#17)(2013-8#1)
of renal-cell##2##2##(1991-2#1)(2008-8#1)
of renalase##2##2##(2013-1#2)
of rendered##2##2##(1996-8#1)(2007-1#1)
of rendering##4##2##(1991-10#1)(1996-9#1)(2008-4#1)(2012-2#1)
of renewable resources##2##3##(2006-12#1)(2008-6#1)
of renin and aldosterone##2##4##(1992-7#1)(2012-1#1)
of renin and##4##3##(1992-7#1)(1995-9#1)(2012-1#1)(2013-1#1)
of renin in##2##3##(1990-7#1)(1996-5#1)
of renin is##2##3##(1990-5#1)(1995-9#1)
of renin mRNA##2##3##(1995-9#2)
of renin##21##2##(1990-11#1)(1990-5#2)(1990-7#2)(1990-8#2)(1991-8#1)(1992-7#1)(1994-2#1)(1995-9#5)(1996-5#1)(2007-8#1)(2008-1#1)(2012-1#1)(2013-1#2)
of renin-angiotensin system##2##3##(1996-3#1)(2012-3#1)
of renovascular hypertension##6##3##(1990-2#2)(1991-10#1)(2006-10#1)(2007-7#1)(2010-7#1)
of renovascular##7##2##(1990-2#2)(1991-10#1)(2006-10#1)(2007-7#2)(2010-7#1)
of reoperation for bleeding##3##4##(2007-8#3)
of reoperation with##2##3##(2012-3#2)
of reoperation##13##2##(2006-12#4)(2007-8#4)(2010-3#1)(2012-12#2)(2012-3#2)
of reorganization of##2##3##(2006-6#1)(2008-11#1)
of reorganization##3##2##(1997-3#1)(2006-6#1)(2008-11#1)
of repair##18##2##(1994-5#1)(1997-1#2)(2006-10#1)(2008-9#1)(2009-10#3)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#1)
of repairing##3##2##(2006-4#1)(2008-8#1)(2010-4#1)
of repeat motifs##2##3##(2007-6#1)(2012-2#1)
of repeat##16##2##(1990-3#1)(1993-11#1)(1993-6#1)(1994-3#1)(1995-11#1)(2004-10#1)(2007-3#1)(2007-6#2)(2007-8#1)(2008-11#1)(2008-8#1)(2010-11#1)(2011-1#2)(2012-2#1)
of repeatability at the##2##4##(2008-10#2)
of repeatability##5##2##(2008-10#4)(2012-12#1)
of repeated administration of##2##4##(1995-12#1)(1997-5#1)
of repeated contractions##2##3##(2005-1#2)
of repeated fasting/refeeding##2##3##(2012-3#2)
of repeated interventions##2##3##(2007-8#1)(2013-1#1)
of repeated measurements##3##3##(1990-8#1)(2008-10#2)
of repeated measures data##2##4##(1994-8#1)(1994-9#1)
of repeated measures##7##3##(1992-6#1)(1992-9#2)(1994-8#1)(1994-9#1)(1997-3#2)
of repeated restraint stress on platelet endothelial cell adhesion molecule-1##2##10##(2010-12#2)
of repeated sequence##2##3##(1992-6#1)(2008-8#1)
of repeated sequences##2##3##(1992-7#1)(1995-1#1)
of repeated testing##2##3##(1993-6#1)(2007-1#1)
of repeated##75##2##(1990-8#1)(1991-1#1)(1991-2#1)(1992-4#1)(1992-6#3)(1992-7#1)(1992-9#2)(1993-10#1)(1993-12#1)(1993-6#2)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#2)(1995-5#1)(1995-9#2)(1996-12#2)(1996-6#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(2004-12#1)(2005-1#2)(2005-10#1)(2007-1#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-12#1)(2009-3#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#4)(2013-1#3)(2013-7#1)
of repeating##5##2##(1995-11#1)(1995-2#1)(2008-9#1)(2012-12#2)
of repeats##8##2##(1991-12#1)(1995-8#1)(2007-6#3)(2008-7#1)(2008-8#1)(2011-2#1)
of repellents##2##2##(2004-11#1)(2008-2#1)
of reperfused##2##2##(2007-8#1)(2009-10#1)
of reperfusion and##2##3##(1996-12#1)(2007-8#1)
of reperfusion injury in##2##4##(1990-3#1)(2006-10#1)
of reperfusion injury to the##2##5##(1997-1#1)(2004-11#1)
of reperfusion injury##10##3##(1990-3#1)(1991-9#1)(1997-1#2)(2004-11#1)(2006-10#2)(2007-8#1)(2010-3#1)(2011-1#1)
of reperfusion treatment##2##3##(2008-10#1)(2008-3#1)
of reperfusion##41##2##(1990-3#2)(1991-9#1)(1992-7#1)(1994-3#1)(1994-5#2)(1995-12#1)(1995-6#1)(1995-7#1)(1996-12#2)(1996-5#2)(1996-9#2)(1997-1#2)(1997-6#1)(1997-8#1)(2004-11#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-8#4)(2007-9#2)(2008-10#3)(2008-3#2)(2010-3#1)(2010-7#2)(2011-1#1)(2013-1#1)
of repetition##4##2##(1996-4#1)(2008-3#1)(2010-4#1)(2010-7#1)
of repetitive DNA sequences##4##4##(1992-8#2)(2008-10#1)(2011-12#1)
of repetitive elements in##2##4##(2010-3#1)(2012-2#1)
of repetitive self-injury##2##3##(2008-11#2)
of repetitive sequences##2##3##(1991-6#1)(2010-3#1)
of repetitive thinking##4##3##(2010-8#4)
of repetitive transcranial magnetic stimulation##3##5##(2008-10#1)(2012-1#1)(2012-2#1)
of repetitive##35##2##(1990-11#1)(1990-7#1)(1991-6#1)(1992-8#2)(1995-11#1)(1996-3#1)(2006-10#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-8#5)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#3)
of repetitive-pulse##2##2##(2008-2#2)
of replacement of##4##3##(1997-4#1)(2008-10#1)(2010-4#1)(2012-12#1)
of replacement therapy with recombinant human##2##6##(2007-11#1)(2007-7#1)
of replacement therapy##4##3##(1997-1#1)(2007-11#2)(2007-7#1)
of replacement##15##2##(1990-11#1)(1991-6#1)(1997-1#1)(1997-4#1)(2004-11#1)(2005-9#1)(2007-11#3)(2007-7#2)(2007-8#1)(2008-10#1)(2010-4#1)(2012-12#1)
of replacing a##2##3##(2004-11#1)(2008-11#1)
of replacing the##2##3##(1990-12#1)(2008-11#1)
of replacing##11##2##(1990-12#1)(1992-3#1)(1996-11#1)(1996-3#1)(1997-2#1)(2004-11#1)(2006-7#1)(2008-10#1)(2008-11#2)(2013-1#1)
of replant##2##2##(2008-10#2)
of replantation##2##2##(2006-3#1)(2008-9#1)
of replica exchange##2##3##(2008-12#1)(2010-2#1)
of replicas of the Skylab 3600-line/mm concave grating with multilayer and gold coatings##2##13##(2008-2#2)
of replicas of the##3##4##(2007-11#1)(2008-2#2)
of replicas##4##2##(2007-11#1)(2008-2#2)(2008-5#1)
of replicate##9##2##(1993-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-9#1)(2012-3#2)
of replicating##3##2##(1994-8#1)(1995-2#1)(1997-5#1)
of replication and##3##3##(1992-12#1)(2008-5#1)(2008-7#1)
of replication from##2##3##(1997-6#1)(2006-10#1)
of replication in##4##3##(1994-12#1)(1996-7#1)(2008-8#1)(2013-1#1)
of replication of the##4##4##(1990-11#1)(1992-12#1)(1993-3#1)(1995-8#1)
of replication of##9##3##(1990-11#1)(1991-12#1)(1991-9#1)(1992-12#1)(1993-3#1)(1994-11#1)(1995-8#1)(1996-5#1)(2007-11#1)
of replication origins##2##3##(2008-7#2)
of replication stress##2##3##(2011-2#1)(2012-3#1)
of replication with##3##3##(1993-3#2)(1994-11#1)
of replication##66##2##(1990-11#2)(1990-3#1)(1990-5#1)(1991-12#1)(1991-9#1)(1992-12#4)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1994-11#2)(1994-12#2)(1995-1#3)(1995-12#2)(1995-2#3)(1995-3#3)(1995-5#1)(1995-8#1)(1996-10#1)(1996-5#1)(1996-6#1)(1996-7#3)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-12#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#1)
of replication-defective##3##2##(1994-3#1)(2008-11#1)(2008-4#1)
of replicative##2##2##(1997-7#1)(2012-3#1)
of repolarization##8##2##(1993-12#1)(2007-9#3)(2009-2#1)(2009-8#1)(2010-11#1)(2010-8#1)
of report##2##2##(1997-3#1)(2012-2#1)
of reportable##3##2##(1997-3#2)(2010-11#1)
of reported cases in##2##4##(2007-12#1)(2008-6#1)
of reported cases of##2##4##(2007-12#1)(2007-7#1)
of reported cases##10##3##(1991-2#1)(1992-5#1)(2006-10#1)(2007-12#2)(2007-7#1)(2008-11#1)(2008-6#1)(2010-12#1)(2013-1#1)
of reported side effects##2##4##(1993-2#1)(2006-10#1)
of reported##51##2##(1990-5#1)(1990-8#1)(1991-2#1)(1991-3#1)(1992-5#1)(1993-2#1)(1993-4#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-8#1)(2005-10#1)(2006-10#4)(2006-11#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-6#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#8)(2013-8#2)
of reporter gene expression##5##4##(1991-7#1)(1995-2#1)(2006-12#1)(2008-11#1)(2008-8#1)
of reporter gene##6##3##(1991-7#1)(1995-2#1)(2006-12#1)(2008-11#1)(2008-8#1)(2012-12#1)
of reporter genes##3##3##(1994-3#1)(2008-10#1)(2008-8#1)
of reporter##15##2##(1991-7#1)(1994-11#1)(1994-3#1)(1995-2#2)(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-8#2)(2010-7#1)(2012-12#1)(2012-2#1)
of reporting and##2##3##(2007-4#1)(2008-10#1)
of reporting of##3##3##(1996-3#1)(2008-10#1)(2012-3#1)
of reporting##19##2##(1990-12#3)(1990-9#1)(1993-9#1)(1996-3#1)(2007-4#1)(2008-10#2)(2009-4#1)(2009-5#2)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
of reports and##2##3##(2006-8#1)(2008-7#1)
of reports from##2##3##(1996-9#1)(2011-1#1)
of reports of##12##3##(1995-3#1)(1995-9#1)(1996-4#1)(1997-1#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-7#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-3#1)
of reports on##3##3##(2008-10#1)(2008-4#1)(2010-12#1)
of reports that##6##3##(1992-8#1)(1996-9#1)(2008-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
of reports to the##2##4##(1997-5#1)(2009-2#1)
of reports to##3##3##(1997-5#1)(2007-8#1)(2009-2#1)
of reports##55##2##(1990-7#1)(1992-8#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-4#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-5#1)(2004-9#1)(2005-7#1)(2006-10#3)(2006-8#2)(2007-11#1)(2007-8#4)(2008-10#2)(2008-11#3)(2008-4#2)(2008-5#2)(2008-7#3)(2008-9#2)(2009-12#1)(2009-2#1)(2009-6#1)(2010-12#3)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
of representation##3##2##(1992-4#1)(1997-8#1)(2011-1#1)
of representations##3##2##(1997-8#1)(2008-9#1)(2009-3#1)
of representative isolates##2##3##(2008-10#1)(2011-2#1)
of representative strains##2##3##(2008-10#1)(2008-4#1)
of representative##21##2##(1992-1#1)(1994-3#1)(1996-6#1)(1997-8#1)(2007-11#1)(2008-10#5)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-3#1)
of representatives of##3##3##(1994-1#2)(2005-7#1)
of representing##7##2##(1997-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-7#1)(2009-7#1)(2013-8#1)
of repression of the##2##4##(1990-8#1)(1997-1#1)
of repression of##3##3##(1990-8#1)(1996-4#1)(1997-1#1)
of repressive and sanitary institutions##2##5##(2009-7#2)
of repressor and##2##3##(1991-5#1)(2012-3#1)
of repressor##6##2##(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-4#1)(2012-3#1)
of reproducibility and##3##3##(2010-12#1)(2013-1#1)(2013-8#1)
of reproducibility##8##2##(1994-9#1)(2008-10#1)(2008-5#1)(2010-12#1)(2013-1#1)(2013-8#3)
of reproducible##5##2##(1996-8#1)(2008-10#2)(2008-2#1)(2012-3#1)
of reproducing##4##2##(2006-12#1)(2008-11#1)(2008-5#1)(2008-8#1)
of reproduction and##3##3##(1995-12#1)(2007-12#1)(2011-1#1)
of reproduction in##7##3##(1997-7#1)(2007-1#1)(2008-3#1)(2008-5#1)(2008-8#2)(2013-1#1)
of reproduction may##2##3##(2008-5#1)(2013-1#1)
of reproduction requires##2##3##(1991-6#1)(2008-9#1)
of reproduction##37##2##(1991-6#1)(1995-12#1)(1997-7#1)(2007-1#1)(2007-12#3)(2008-10#1)(2008-3#1)(2008-5#3)(2008-8#6)(2008-9#8)(2009-9#2)(2010-12#1)(2010-4#2)(2010-8#1)(2011-1#1)(2012-1#1)(2013-1#2)(2013-7#1)
of reproductive age are##2##4##(2008-3#2)
of reproductive age##20##3##(1994-9#1)(1995-5#1)(2004-1#1)(2005-8#1)(2006-4#1)(2008-3#3)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-11#1)(2012-12#1)(2012-3#1)(2013-7#1)
of reproductive and sexual health##3##5##(2008-11#1)(2008-6#2)
of reproductive and##5##3##(2006-10#1)(2008-11#1)(2008-6#2)(2010-3#1)
of reproductive biology##3##3##(2006-11#1)(2009-6#1)(2013-8#1)
of reproductive effort##6##3##(2008-8#5)(2008-9#1)
of reproductive function##4##3##(2006-10#2)(2006-5#1)(2009-6#1)
of reproductive health##3##3##(2007-4#1)(2008-1#2)
of reproductive isolation##6##3##(1994-3#1)(2008-8#5)
of reproductive organs##6##3##(2008-3#1)(2008-5#4)(2008-7#1)
of reproductive output##4##3##(2008-8#3)(2011-2#1)
of reproductive parasitism##2##3##(2008-9#1)(2010-8#1)
of reproductive partitioning##2##3##(2008-9#1)(2010-2#1)
of reproductive skew models##3##4##(2008-9#1)(2010-2#2)
of reproductive skew##6##3##(2008-8#3)(2008-9#1)(2010-2#2)
of reproductive status##2##3##(1994-4#1)(2007-3#1)
of reproductive structure##2##3##(2011-2#2)
of reproductive success##2##3##(2006-7#1)(2009-12#1)
of reproductive traits in the##2##5##(2008-8#1)(2010-10#1)
of reproductive traits of##3##4##(1996-11#1)(2012-12#2)
of reproductive traits##5##3##(1996-11#1)(2008-8#1)(2010-10#1)(2012-12#2)
of reproductive##112##2##(1990-10#1)(1991-1#1)(1992-12#2)(1992-2#1)(1992-4#1)(1994-3#1)(1994-4#1)(1994-9#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-4#1)(2004-1#1)(2004-11#1)(2005-7#3)(2005-8#1)(2006-10#3)(2006-11#1)(2006-4#1)(2006-5#3)(2006-7#1)(2007-1#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#5)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#17)(2008-9#4)(2009-12#2)(2009-5#1)(2009-6#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-8#4)(2011-1#3)(2011-2#9)(2012-11#1)(2012-12#7)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
of reprogramming##2##2##(2008-1#1)(2012-12#1)
of reptiles##5##2##(1992-8#1)(2008-4#1)(2010-3#3)
of reptilian##2##2##(2010-3#1)(2012-2#1)
of requests for##2##3##(1992-12#1)(1994-1#1)
of required##6##2##(1993-3#1)(1996-6#1)(2007-9#1)(2008-10#1)(2010-3#1)(2011-1#1)
of requirements for##2##3##(1990-2#1)(2008-1#1)
of requirements##6##2##(1990-2#1)(1994-3#1)(2007-3#1)(2007-8#1)(2008-1#1)(2009-11#1)
of requiring##4##2##(1996-1#1)(2008-3#1)(2009-2#1)(2013-1#1)
of rescue analgesics##2##3##(1992-3#1)(2010-7#1)
of rescue##8##2##(1992-3#1)(2005-7#1)(2005-8#1)(2007-9#1)(2008-5#2)(2008-8#1)(2010-7#1)
of research aimed at##2##4##(2008-1#1)(2008-2#1)
of research and development##6##4##(1995-8#1)(2006-7#1)(2007-11#2)(2007-12#1)(2012-11#1)
of research and education##2##4##(2007-8#1)(2008-7#1)
of research and practice##5##4##(2010-10#5)
of research and the##3##4##(1995-4#1)(2007-11#1)(2011-2#1)
of research and##27##3##(1990-6#1)(1994-3#1)(1995-4#1)(1995-8#1)(1996-12#1)(2005-12#1)(2006-7#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-7#1)(2010-10#5)(2011-1#1)(2011-2#1)(2011-7#1)(2012-11#1)(2012-2#1)(2013-8#1)
of research are##8##3##(1993-11#1)(1994-3#1)(1997-8#1)(2006-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2012-12#1)
of research areas##3##3##(1993-2#1)(2006-10#1)(2009-10#1)
of research at##2##3##(2007-7#1)(2010-2#1)
of research conducted in##2##4##(1993-1#1)(2009-2#1)
of research conducted##4##3##(1993-1#1)(2009-2#1)(2009-4#1)(2009-5#1)
of research design and##2##4##(1995-4#1)(2006-5#1)
of research design##3##3##(1995-4#1)(2006-10#1)(2006-5#1)
of research efforts##6##3##(2005-7#1)(2005-9#1)(2006-10#1)(2007-6#1)(2010-5#1)(2012-2#1)
of research ethics##6##3##(1996-11#1)(2007-10#1)(2007-12#1)(2008-9#1)(2009-4#2)
of research evidence by##2##4##(2008-7#1)(2009-2#1)
of research evidence to##2##4##(2008-11#1)(2008-12#1)
of research evidence##7##3##(2006-10#1)(2007-6#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-2#1)
of research findings##2##3##(2008-10#1)(2010-2#1)
of research for the##2##4##(2008-10#1)(2010-2#1)
of research for##4##3##(2006-10#1)(2008-10#1)(2008-3#1)(2010-2#1)
of research has been conducted##2##5##(2010-12#1)(2011-2#1)
of research has been done##3##5##(2013-1#2)(2013-8#1)
of research has been##7##4##(2007-9#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
of research has demonstrated##2##4##(1990-11#1)(2008-7#1)
of research has focused on##2##5##(2006-7#1)(2009-2#1)
of research has##16##3##(1990-11#1)(1997-1#1)(2006-7#2)(2007-9#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
of research have##2##3##(2007-8#1)(2008-6#1)
of research in primary##2##4##(1993-2#1)(1996-9#1)
of research in the area of##2##6##(2007-11#1)(2008-11#1)
of research in the area##3##5##(2005-11#1)(2007-11#1)(2008-11#1)
of research in the past##2##5##(2009-1#1)(2010-10#1)
of research in the##10##4##(1992-6#1)(1997-3#1)(2005-11#1)(2005-8#1)(2007-11#2)(2008-11#1)(2009-1#1)(2010-10#1)(2012-2#1)
of research in this area##4##5##(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
of research in this field##3##5##(2008-10#1)(2008-5#1)(2011-1#1)
of research in this##7##4##(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
of research in##44##3##(1990-12#1)(1991-6#1)(1992-6#1)(1993-2#1)(1994-2#1)(1994-4#1)(1995-3#1)(1996-9#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-5#1)(2008-9#1)(2009-1#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#3)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
of research into the##2##4##(2007-7#1)(2013-1#1)
of research into##9##3##(1993-6#1)(2007-7#1)(2009-4#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-1#3)
of research investigations##2##3##(2008-10#1)(2012-12#1)
of research involving##5##3##(2007-10#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-11#1)
of research is##9##3##(1990-8#1)(1997-1#1)(2006-10#1)(2007-2#1)(2008-11#2)(2008-7#1)(2009-9#1)(2012-1#1)
of research issues##2##3##(1992-12#1)(2013-1#1)
of research linking##2##3##(2010-2#1)(2010-7#1)
of research methodology##2##3##(1993-8#1)(1994-2#1)
of research on the##9##4##(1993-1#1)(2007-11#1)(2007-7#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-2#1)(2013-8#1)
of research on##24##3##(1993-1#1)(2004-12#1)(2005-11#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#2)(2010-12#1)(2010-2#1)(2013-1#1)(2013-8#1)
of research papers##2##3##(2008-5#1)(2011-1#1)
of research participants##2##3##(2007-12#1)(2009-4#1)
of research participation##3##3##(2009-4#2)(2009-9#1)
of research priorities for Australian critical care nurses##2##8##(2007-11#2)
of research priorities for critical care##2##6##(2007-11#2)
of research priorities for##4##4##(2007-11#4)
of research projects##2##3##(1997-1#1)(1997-3#1)
of research protocols##2##3##(1992-3#1)(2011-1#1)
of research results##4##3##(1992-12#1)(1993-6#1)(2008-8#1)(2011-2#1)
of research studies##3##3##(2008-3#1)(2010-12#1)(2010-8#1)
of research supervision##3##3##(2012-3#3)
of research that##16##3##(2008-10#2)(2008-11#2)(2008-2#1)(2008-7#1)(2009-10#1)(2009-4#3)(2010-12#1)(2010-7#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
of research to##4##3##(2005-7#1)(2007-4#1)(2008-11#2)
of research tools##2##3##(2008-4#1)(2010-2#1)
of research upon##2##3##(2006-8#1)(2008-5#1)
of research uptake##3##3##(2010-10#3)
of research which##2##3##(1996-11#1)(2009-9#1)
of research with the##2##4##(2010-12#1)(2012-2#1)
of research with##3##3##(1994-9#1)(2010-12#1)(2012-2#1)
of research within##2##3##(1997-3#1)(2008-5#1)
of research##399##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#1)(1990-8#1)(1991-12#1)(1991-6#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#2)(1993-11#1)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#1)(1994-2#2)(1994-3#2)(1994-4#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-4#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-7#1)(1996-9#1)(1997-1#6)(1997-3#4)(1997-6#1)(1997-8#1)(2004-12#2)(2005-11#3)(2005-12#1)(2005-7#5)(2005-8#1)(2005-9#1)(2006-10#10)(2006-2#2)(2006-5#2)(2006-6#2)(2006-7#3)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#19)(2007-12#6)(2007-2#2)(2007-4#4)(2007-6#2)(2007-7#7)(2007-8#4)(2007-9#3)(2008-1#5)(2008-10#8)(2008-11#18)(2008-12#5)(2008-2#6)(2008-3#3)(2008-4#7)(2008-5#8)(2008-6#3)(2008-7#12)(2008-8#4)(2008-9#4)(2009-1#2)(2009-10#5)(2009-12#1)(2009-2#6)(2009-4#19)(2009-5#2)(2009-8#1)(2009-9#6)(2010-1#1)(2010-10#11)(2010-11#6)(2010-12#7)(2010-2#7)(2010-3#2)(2010-4#4)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#11)(2011-2#8)(2011-3#1)(2011-7#1)(2012-1#4)(2012-11#1)(2012-12#10)(2012-2#17)(2012-3#5)(2013-1#14)(2013-7#3)(2013-8#6)
of researchers and clinicians##2##4##(2011-1#1)(2012-12#1)
of researchers and practitioners in##2##5##(2012-1#1)(2013-7#1)
of researchers and##7##3##(2006-10#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-7#1)
of researchers from##2##3##(2008-1#1)(2009-4#1)
of researchers have##2##3##(2006-10#1)(2008-10#1)
of researchers to##2##3##(2006-11#1)(2006-5#1)
of researchers who##2##3##(2008-4#1)(2009-3#1)
of researchers##31##2##(1991-4#1)(1993-2#1)(2006-10#2)(2006-11#1)(2006-5#2)(2007-8#1)(2007-9#5)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-4#3)(2009-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-7#1)
of researches in##2##3##(2012-2#1)(2013-7#1)
of researches of##2##3##(2007-11#1)(2013-8#1)
of researches##4##2##(2007-11#1)(2012-2#1)(2013-7#1)(2013-8#1)
of resectable##5##2##(1992-12#1)(2004-1#1)(2007-8#1)(2008-3#1)(2013-1#1)
of resected specimen##2##3##(2007-8#1)(2008-10#1)
of resected##10##2##(1995-9#2)(2007-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-12#1)(2013-1#2)
of resecting##2##2##(1997-6#1)(2008-4#1)
of resection for##2##3##(2005-12#1)(2009-10#1)
of resection of##2##3##(2007-8#1)(2011-2#1)
of resection was##4##3##(2005-12#1)(2006-12#1)(2012-12#2)
of resection##28##2##(1992-3#1)(1993-10#1)(1994-12#1)(1995-9#1)(2005-12#3)(2006-12#3)(2006-6#1)(2007-8#2)(2008-5#2)(2008-9#3)(2009-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2013-1#1)
of resective##2##2##(1993-10#1)(2008-5#1)
of reserpine in the##2##4##(2008-10#1)(2008-12#1)
of reserpine in##4##3##(2008-10#2)(2008-12#2)
of reserpine treatment##2##3##(1991-8#2)
of reserpine##17##2##(1990-2#2)(1991-8#2)(2007-3#3)(2008-10#5)(2008-12#4)(2012-2#1)
of reserve##3##2##(2007-12#1)(2010-12#1)(2012-1#1)
of reserves##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
of residence and##2##3##(1992-4#1)(1994-6#1)
of residence in the##2##4##(2008-8#1)(2010-12#1)
of residence in##7##3##(1995-5#1)(2004-4#1)(2008-8#1)(2010-12#2)(2010-8#2)
of residence##31##2##(1991-1#1)(1991-5#1)(1992-4#1)(1994-3#1)(1994-6#1)(1995-5#2)(1997-2#1)(2004-4#1)(2006-10#2)(2007-10#1)(2007-7#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#2)(2010-8#3)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
of residency##10##2##(1991-6#1)(1992-1#1)(1992-3#1)(1994-12#1)(1994-3#1)(1996-8#1)(2007-4#1)(2010-8#1)(2013-1#2)
of resident bacteria##2##3##(2008-5#2)
of resident peritoneal##2##3##(1997-2#1)(2008-12#1)
of resident##22##2##(1991-3#1)(1997-1#1)(1997-2#1)(2004-3#1)(2007-3#1)(2008-10#4)(2008-12#2)(2008-5#4)(2008-7#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-8#1)(2012-2#1)
of residential##8##2##(1991-10#1)(2005-9#1)(2009-9#1)(2010-3#2)(2012-12#1)(2013-1#1)(2013-8#1)
of residents and##4##3##(1997-1#2)(2007-4#1)(2012-3#1)
of residents in##4##3##(1992-2#1)(1994-3#1)(1996-9#1)(2006-7#1)
of residents who##2##3##(2011-2#2)
of residents##26##2##(1991-3#1)(1991-8#1)(1992-2#2)(1993-12#1)(1993-3#1)(1994-12#2)(1994-3#1)(1995-2#1)(1996-9#1)(1997-1#2)(2006-7#1)(2007-12#1)(2007-4#2)(2009-3#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-3#1)
of residents'##2##2##(2007-5#1)(2008-11#1)
of residual acetic acid##2##4##(2008-10#2)
of residual chlorine##2##3##(2008-10#2)
of residual confounding##3##3##(1992-9#2)(2012-12#1)
of residual disease##3##3##(2004-2#1)(2006-12#1)(2013-8#1)
of residual effects##2##3##(1994-5#1)(2008-10#1)
of residual hearing and##2##4##(2008-9#1)(2012-2#1)
of residual hearing##3##3##(2008-9#1)(2012-2#2)
of residual renal function##5##4##(2007-11#1)(2007-12#2)(2011-2#2)
of residual risk##2##3##(2012-2#2)
of residual stress##5##3##(2007-11#2)(2007-12#1)(2008-2#1)(2009-7#1)
of residual stresses##2##3##(2008-2#2)
of residual tooth structure and##2##5##(2013-8#2)
of residual yolk sac##3##4##(2008-12#3)
of residual##108##2##(1990-6#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-10#1)(1992-5#1)(1992-9#3)(1993-1#1)(1993-10#1)(1993-12#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-4#1)(1995-5#1)(1996-6#1)(1996-8#1)(2004-2#2)(2005-10#1)(2005-11#4)(2006-10#1)(2006-12#1)(2006-6#3)(2006-8#1)(2007-11#6)(2007-12#4)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#10)(2008-12#3)(2008-2#7)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-7#2)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#5)(2013-8#6)
of residuals##5##2##(1993-1#1)(1995-12#1)(2006-12#1)(2007-6#1)(2008-10#1)
of residue 161##3##3##(1995-5#3)
of residue 478##2##3##(1992-9#2)
of residue##19##2##(1990-8#1)(1991-4#1)(1992-3#1)(1992-9#2)(1994-11#2)(1995-10#1)(1995-5#4)(1996-11#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-4#1)
of residues at positions##2##4##(1994-3#1)(1994-5#1)
of residues from the##2##4##(1993-3#1)(1997-6#1)
of residues from##3##3##(1993-3#1)(1997-6#1)(2007-5#1)
of residues in##5##3##(1994-9#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-3#1)
of residues involved in##3##4##(1992-12#1)(1994-9#1)(2012-2#1)
of residues of##8##3##(1990-9#1)(1991-4#1)(1991-7#3)(1993-9#1)(2007-7#2)
of residues that are##2##4##(1995-10#1)(1996-7#1)
of residues##65##2##(1990-12#3)(1990-7#1)(1990-9#1)(1991-4#1)(1991-6#1)(1991-7#3)(1992-12#1)(1992-8#1)(1993-3#2)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#4)(1994-8#1)(1994-9#5)(1995-1#2)(1995-10#6)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-5#1)(1996-6#2)(1996-7#2)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-4#1)(2012-2#1)
of resilience##4##2##(2007-12#2)(2011-1#1)(2012-1#1)
of resilient personality##2##3##(2007-12#2)
of resilin is##2##3##(2007-12#2)
of resilin##4##2##(2007-12#4)
of resin composites##2##3##(2010-10#1)(2013-1#1)
of resin in##3##3##(2005-11#3)
of resin##17##2##(2004-9#1)(2005-11#5)(2005-4#1)(2008-10#5)(2008-3#1)(2009-8#1)(2010-10#1)(2012-2#1)(2013-1#1)
of resin-resin interfaces##2##3##(2008-12#2)
of resins##3##2##(2005-11#1)(2007-12#2)
of resistance against##6##3##(2006-12#1)(2008-1#1)(2008-10#3)(2008-8#1)
of resistance among##4##3##(2007-2#1)(2008-10#1)(2011-2#1)(2012-12#1)
of resistance and the##3##4##(1997-6#1)(2005-8#1)(2007-2#1)
of resistance and virulence##2##4##(2008-10#2)
of resistance and##12##3##(1995-6#1)(1997-6#1)(2005-8#1)(2007-2#1)(2008-10#7)(2013-1#1)
of resistance are##4##3##(1997-6#1)(2006-11#1)(2008-10#1)(2012-1#1)
of resistance by##4##3##(2008-1#1)(2008-10#1)(2011-2#2)
of resistance conferred by##2##4##(2008-10#2)
of resistance development##3##3##(2008-10#2)(2011-2#1)
of resistance displayed by the source plant##2##7##(2008-10#2)
of resistance during##2##3##(2005-8#1)(2008-10#1)
of resistance elicitors##4##3##(2008-10#4)
of resistance for##2##3##(2008-10#1)(2011-1#1)
of resistance genes##8##3##(2008-10#8)
of resistance in a##2##4##(2008-10#1)(2008-11#1)
of resistance in the##4##4##(2005-7#1)(2007-6#1)(2008-10#2)
of resistance in wheat to##2##5##(2008-10#1)(2011-2#1)
of resistance in##25##3##(1994-7#1)(1995-12#1)(1995-6#1)(2005-7#1)(2006-11#1)(2007-6#1)(2008-10#13)(2008-11#2)(2009-3#1)(2010-9#1)(2011-10#1)(2011-2#1)
of resistance into commercial##2##4##(2008-10#2)
of resistance into##3##3##(2008-10#3)
of resistance is##6##3##(2008-10#3)(2008-5#1)(2010-2#1)(2013-1#1)
of resistance loci##3##3##(2008-10#3)
of resistance mechanisms##3##3##(2006-10#1)(2007-7#1)(2008-10#1)
of resistance of##4##3##(2008-10#2)(2010-8#1)(2012-12#1)
of resistance rates##2##3##(2006-8#1)(2010-11#1)
of resistance responses##2##3##(2008-10#1)(2009-6#1)
of resistance to Aspergillus ear rot and aflatoxin production##2##9##(2008-10#2)
of resistance to Aspergillus ear rot and aflatoxin##3##8##(2008-10#3)
of resistance to FHB##2##4##(2008-10#2)
of resistance to STB##2##4##(2008-10#2)
of resistance to Sclerotinia##2##4##(2008-10#2)
of resistance to a##2##4##(1997-5#1)(2011-2#1)
of resistance to aflatoxin production##2##5##(2008-10#2)
of resistance to alkylating agents##2##5##(2008-11#2)
of resistance to both##2##4##(2008-4#1)(2011-2#1)
of resistance to different##2##4##(2008-5#1)(2010-4#1)
of resistance to fumonisin production and accumulation in grain##2##9##(2008-10#2)
of resistance to fumonisin##3##4##(2008-10#3)
of resistance to praziquantel##2##4##(2006-10#2)
of resistance to standard##2##4##(2006-4#1)(2011-2#1)
of resistance to the##13##4##(1990-7#1)(2005-9#1)(2006-10#2)(2007-11#2)(2007-7#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-12#1)(2013-8#1)
of resistance to therapy##2##4##(1995-2#1)(2012-3#1)
of resistance to this##3##4##(2006-8#1)(2008-10#1)(2008-11#1)
of resistance to three##2##4##(2008-10#1)(2011-1#1)
of resistance to##142##3##(1990-6#1)(1990-7#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-3#2)(1995-12#1)(1995-2#1)(1995-7#1)(1997-5#1)(1997-7#1)(2005-11#1)(2005-7#3)(2005-8#1)(2005-9#2)(2006-10#5)(2006-11#2)(2006-4#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-7#3)(2008-10#62)(2008-11#4)(2008-12#2)(2008-4#3)(2008-5#3)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#5)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#5)(2013-1#1)(2013-7#2)(2013-8#1)
of resistance was evaluated##2##4##(1995-7#1)(2008-10#1)
of resistance was##8##3##(1995-7#1)(2008-10#7)
of resistance were##6##3##(2006-8#1)(2008-10#4)(2013-8#1)
of resistance##357##2##(1990-6#1)(1990-7#1)(1992-8#2)(1993-12#2)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-3#2)(1994-7#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-6#2)(1995-7#2)(1997-5#2)(1997-6#5)(1997-7#1)(2004-11#1)(2005-11#1)(2005-7#4)(2005-8#4)(2005-9#2)(2006-10#9)(2006-11#6)(2006-12#1)(2006-4#2)(2006-5#1)(2006-8#4)(2006-9#1)(2007-11#2)(2007-2#3)(2007-6#1)(2007-7#5)(2008-1#4)(2008-10#173)(2008-11#9)(2008-12#3)(2008-4#4)(2008-5#6)(2008-7#3)(2008-8#6)(2008-9#3)(2009-11#3)(2009-2#3)(2009-3#4)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-10#1)(2011-12#2)(2011-2#14)(2011-3#2)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#4)(2013-7#2)(2013-8#3)
of resistance-associated##2##2##(2008-11#2)
of resistant S##2##3##(2012-2#2)
of resistant and susceptible##4##4##(2008-10#4)
of resistant and##5##3##(2008-10#5)
of resistant bacteria##2##3##(2008-5#1)(2013-1#1)
of resistant cultivars##8##3##(2008-10#8)
of resistant genotypes##4##3##(2008-10#4)
of resistant host##2##3##(2008-10#1)(2008-8#1)
of resistant hypertension##2##3##(2010-6#2)
of resistant isolates##6##3##(2006-4#1)(2008-10#5)
of resistant pathogens##2##3##(2005-11#1)(2006-10#1)
of resistant plants##3##3##(1991-7#1)(2008-10#2)
of resistant strains of##2##4##(2007-7#1)(2013-8#1)
of resistant strains##13##3##(1993-5#2)(2005-8#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-4#1)(2009-11#1)(2011-12#1)(2012-2#1)(2013-8#1)
of resistant variants##4##3##(1993-9#1)(2012-1#2)(2013-1#1)
of resistant##90##2##(1991-7#1)(1993-5#2)(1993-9#1)(1994-3#1)(1995-5#1)(1995-7#1)(1996-3#1)(1997-4#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#4)(2006-4#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#37)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#3)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#1)(2010-11#2)(2010-12#1)(2010-6#2)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#1)
of resistin and##3##3##(2008-1#2)(2008-10#1)
of resistin in##2##3##(2008-1#2)
of resistin##6##2##(2008-1#5)(2008-10#1)
of resistivity for antibiotics##3##4##(2010-8#3)
of resistivity##5##2##(1990-7#1)(2007-9#1)(2010-8#3)
of resolution and##5##3##(1991-7#1)(1993-9#1)(2008-3#2)(2009-5#1)
of resolution of##4##3##(1994-8#1)(2008-2#1)(2008-4#1)(2008-5#1)
of resolution##31##2##(1990-11#1)(1991-7#1)(1992-5#1)(1993-9#1)(1994-2#1)(1994-8#1)(1996-7#1)(2006-10#4)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-7#1)
of resolvase##2##2##(1993-3#1)(1994-3#1)
of resolving##5##2##(1991-8#1)(2008-10#1)(2008-2#2)(2008-3#1)
of resonance energy transfer##2##4##(1996-1#1)(2008-9#1)
of resonance interferometry##2##3##(2008-2#2)
of resonance light scattering (RLS)##2##5##(2008-10#1)(2008-3#1)
of resonance modes##2##3##(2008-1#1)(2008-3#1)
of resonance##15##2##(1992-12#1)(1993-3#1)(1996-1#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#3)(2008-9#1)(2012-2#1)
of resonances in##2##3##(1991-2#1)(1997-4#1)
of resonances##8##2##(1991-2#1)(1992-12#1)(1994-10#1)(1994-5#1)(1995-3#1)(1997-4#1)(2007-11#1)(2008-5#1)
of resonant enhancement##2##3##(1992-9#1)(2008-10#1)
of resonant##12##2##(1992-9#1)(1996-12#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#3)(2010-5#1)
of resonator##5##2##(2007-12#1)(2008-2#1)(2008-3#2)(2008-7#1)
of resonator-originated and external beam shaping##2##6##(2008-2#2)
of resonators##2##2##(2007-11#1)(2008-3#1)
of resorption villi##2##3##(2011-1#2)
of resorption##4##2##(2004-9#1)(2011-1#2)(2013-1#1)
of resource allocation##2##3##(1992-3#1)(2007-4#1)
of resource availability##4##3##(2008-8#3)(2008-9#1)
of resource capture##3##3##(2008-8#1)(2008-9#2)
of resource competition##4##3##(2007-7#1)(2008-8#2)(2008-9#1)
of resource patches##2##3##(2008-9#2)
of resource sharing##2##3##(1995-2#1)(2011-2#1)
of resource supply##2##3##(2008-8#2)
of resource use##3##3##(1993-12#1)(2007-10#1)(2008-9#1)
of resource utilization##2##3##(1994-3#1)(2009-2#1)
of resource##43##2##(1992-3#1)(1993-12#1)(1994-3#1)(1995-2#1)(2004-11#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-8#19)(2008-9#8)(2009-2#1)(2011-2#1)
of resources and##17##3##(1992-2#1)(1994-12#1)(1997-3#1)(2007-7#2)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#2)
of resources are##2##3##(1994-3#1)(2007-7#1)
of resources between##2##3##(2007-7#1)(2008-8#1)
of resources for the##3##4##(1996-4#1)(2006-9#1)(2012-12#1)
of resources for##8##3##(1996-4#1)(2006-10#1)(2006-9#1)(2011-1#1)(2012-11#1)(2012-12#2)(2012-3#1)
of resources in the##3##4##(1990-9#1)(2008-5#1)(2013-1#1)
of resources in##4##3##(1990-9#1)(2008-5#1)(2008-8#1)(2013-1#1)
of resources that##3##3##(2007-6#1)(2008-8#1)(2010-2#1)
of resources to a##2##4##(1990-12#1)(1994-12#1)
of resources to##6##3##(1990-12#1)(1994-12#1)(1995-3#1)(2008-9#2)(2013-1#1)
of resources used##3##3##(1997-4#1)(2007-2#1)(2008-8#1)
of resources was##2##3##(2007-8#1)(2012-2#1)
of resources##85##2##(1990-12#1)(1990-4#1)(1990-9#1)(1991-2#1)(1992-2#1)(1992-3#3)(1992-5#1)(1994-12#3)(1994-2#2)(1994-3#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-4#1)(1997-3#1)(1997-4#1)(1997-5#1)(2005-11#1)(2006-10#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#5)(2007-8#2)(2008-1#2)(2008-10#4)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#6)(2008-9#5)(2009-10#1)(2009-6#1)(2010-12#1)(2010-2#2)(2010-7#1)(2011-1#3)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)
of respect for autonomy in##2##5##(2005-7#2)
of respect for persons##4##4##(1992-3#1)(2007-11#1)(2007-12#2)
of respect for##6##3##(1992-3#1)(2005-7#2)(2007-11#1)(2007-12#2)
of respect##10##2##(1992-3#1)(1994-1#1)(2005-7#2)(2007-11#1)(2007-12#2)(2007-2#2)(2007-8#1)
of respective##10##2##(1991-12#1)(1993-11#1)(1994-6#1)(1995-12#1)(1997-6#1)(2005-4#1)(2008-10#1)(2008-11#2)(2011-2#1)
of respectively##2##2##(1996-9#1)(2007-8#1)
of respirable fibers##2##3##(1991-12#1)(2010-8#1)
of respirable size##2##3##(1991-12#1)(1996-1#1)
of respirable##5##2##(1991-12#2)(1996-1#1)(2008-3#1)(2010-8#1)
of respiration and thermoregulation##2##4##(2012-3#2)
of respiration and##6##3##(1994-12#2)(1996-6#1)(1997-8#1)(2012-3#2)
of respiration is##3##3##(1996-6#1)(2008-7#2)
of respiration##22##2##(1990-8#1)(1991-3#1)(1994-12#2)(1995-6#2)(1996-6#5)(1997-8#1)(2008-7#4)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#3)
of respiratory and##2##3##(2005-8#1)(2008-10#1)
of respiratory burst##2##3##(1994-3#1)(2012-2#1)
of respiratory chain inhibitors##2##4##(1994-8#1)(2006-8#1)
of respiratory chain##7##3##(1994-8#1)(1996-12#1)(1997-6#1)(2005-8#1)(2006-8#1)(2008-10#1)(2013-8#1)
of respiratory complications##3##3##(2006-12#1)(2008-12#1)(2008-4#1)
of respiratory control##2##3##(1990-10#1)(1995-7#1)
of respiratory disease in racehorses##2##5##(1996-9#2)
of respiratory disease in##4##4##(1996-9#2)(1997-1#1)(1997-6#1)
of respiratory disease##6##3##(1996-9#2)(1997-1#1)(1997-6#1)(2008-12#1)(2009-10#1)
of respiratory diseases##4##3##(1996-3#2)(2006-8#1)(2007-1#1)
of respiratory disorders##3##3##(2005-11#1)(2007-3#1)(2008-7#1)
of respiratory distress syndrome (RDS)##3##5##(1993-5#1)(2007-11#1)(2009-2#1)
of respiratory distress syndrome##7##4##(1992-2#1)(1993-5#2)(2006-2#1)(2007-11#1)(2009-2#1)(2009-6#1)
of respiratory distress##13##3##(1992-2#1)(1993-5#2)(1994-4#1)(2006-2#1)(2007-11#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-6#2)(2013-1#2)
of respiratory dyskinesia##2##3##(2012-3#2)
of respiratory epithelium and##2##4##(2012-3#2)
of respiratory epithelium##3##3##(1992-3#1)(2012-3#2)
of respiratory failure##6##3##(1991-6#1)(1996-3#1)(2006-10#1)(2008-2#1)(2009-5#1)(2011-2#1)
of respiratory function##5##3##(2005-8#1)(2010-9#1)(2012-11#1)(2013-1#2)
of respiratory illnesses##2##3##(2008-4#1)(2009-5#1)
of respiratory infection##2##3##(2012-2#2)
of respiratory infections will##2##4##(1991-12#1)(2006-10#1)
of respiratory infections##5##3##(1991-12#1)(2006-10#2)(2007-11#1)(2008-3#1)
of respiratory muscle##2##3##(1993-7#1)(2013-1#1)
of respiratory muscles and##2##4##(1991-6#1)(2012-3#1)
of respiratory muscles##4##3##(1990-10#1)(1991-6#1)(1997-3#1)(2012-3#1)
of respiratory pathogens##2##3##(1991-12#1)(2011-2#1)
of respiratory problems##2##3##(2010-5#1)(2012-1#1)
of respiratory symptoms in##2##4##(1995-8#1)(1996-3#1)
of respiratory symptoms##6##3##(1995-8#2)(1996-3#1)(2007-2#1)(2008-4#1)(2011-1#1)
of respiratory syncytial virus (RSV)##2##5##(2009-8#1)(2010-5#1)
of respiratory syncytial virus infection##3##5##(2006-8#2)(2010-10#1)
of respiratory syncytial virus##5##4##(2006-8#2)(2009-8#1)(2010-10#1)(2010-5#1)
of respiratory syncytial##6##3##(2006-8#2)(2007-3#1)(2009-8#1)(2010-10#1)(2010-5#1)
of respiratory syndromes##4##3##(2010-12#4)
of respiratory system##2##3##(2007-8#1)(2011-2#1)
of respiratory tract infection##2##4##(2005-7#1)(2010-12#1)
of respiratory tract infections##3##4##(1990-7#1)(1997-2#1)(2007-12#1)
of respiratory tract##8##3##(1990-7#1)(1992-6#1)(1997-2#1)(2005-7#1)(2007-12#1)(2008-5#2)(2010-12#1)
of respiratory##153##2##(1990-10#2)(1990-11#1)(1990-6#1)(1990-7#4)(1990-9#1)(1991-12#2)(1991-3#1)(1991-6#2)(1991-8#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-5#2)(1993-7#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-4#2)(1994-6#1)(1994-8#1)(1995-7#1)(1995-8#3)(1996-12#1)(1996-3#6)(1996-5#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#2)(2005-11#2)(2005-7#1)(2005-8#4)(2006-10#6)(2006-12#2)(2006-2#1)(2006-4#1)(2006-8#4)(2007-1#1)(2007-11#3)(2007-12#3)(2007-2#2)(2007-3#2)(2007-8#2)(2008-10#5)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#2)(2009-8#1)(2010-10#1)(2010-12#5)(2010-2#1)(2010-5#2)(2010-8#3)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#6)(2013-8#2)
of respondents experienced##2##3##(2009-10#1)(2012-12#1)
of respondents from##2##3##(1993-1#1)(1995-3#1)
of respondents had##3##3##(1993-1#1)(2007-9#1)(2008-12#1)
of respondents reported having##2##4##(2006-2#1)(2011-1#1)
of respondents reported##6##3##(1990-6#1)(2006-2#1)(2008-12#1)(2009-4#1)(2010-8#1)(2011-1#1)
of respondents reporting##2##3##(1993-9#1)(1996-3#1)
of respondents thought##2##3##(2007-12#1)(2012-3#1)
of respondents were##7##3##(1993-3#1)(2007-12#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-1#1)
of respondents##67##2##(1990-6#1)(1991-12#1)(1991-3#1)(1992-1#1)(1993-1#2)(1993-12#1)(1993-3#1)(1993-9#1)(1995-3#1)(1996-3#1)(1997-3#1)(1997-5#1)(2005-7#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-10#3)(2007-12#4)(2007-2#1)(2007-7#1)(2007-9#1)(2008-11#2)(2008-12#4)(2008-9#1)(2009-10#3)(2009-4#1)(2009-7#1)(2010-10#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#3)(2012-1#4)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#2)
of responder##2##2##(1994-3#1)(2012-2#1)
of responders and non-responders##2##4##(2006-8#1)(2010-12#1)
of responders is##2##3##(1996-12#1)(2009-10#1)
of responders to##2##3##(2006-10#1)(2009-6#1)
of responders##20##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-6#1)(1992-8#1)(1994-12#1)(1996-12#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-2#2)(2008-5#2)(2008-6#1)(2009-10#1)(2009-6#1)(2010-12#1)(2013-1#2)
of responding cells##3##3##(1992-12#1)(2008-2#2)
of responding to the##3##4##(2008-10#1)(2008-5#2)
of responding to##6##3##(2006-10#1)(2008-10#1)(2008-4#1)(2008-5#2)(2011-2#1)
of responding##23##2##(1991-7#1)(1992-10#1)(1992-11#1)(1992-12#1)(1993-6#1)(1996-10#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#7)(2011-2#1)(2012-2#1)
of response among##2##3##(1994-9#1)(1997-6#1)
of response and##9##3##(1990-10#1)(1991-2#1)(1992-10#1)(1996-5#1)(2008-10#1)(2009-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
of response categories##4##3##(2008-5#1)(2010-1#2)(2012-2#1)
of response inhibition##2##3##(1992-12#1)(2010-12#1)
of response is##3##3##(1991-7#1)(2006-10#1)(2008-10#1)
of response time##3##3##(2006-9#1)(2007-8#1)(2010-8#1)
of response times##4##3##(1995-4#1)(2006-9#1)(2010-3#2)
of response to interferon##2##4##(2006-10#1)(2009-8#1)
of response to neoadjuvant##3##4##(1993-11#1)(2008-12#1)(2010-7#1)
of response to the##2##4##(1995-2#1)(2008-10#1)
of response to therapy##3##4##(2010-11#1)(2011-2#1)(2012-12#1)
of response to these##2##4##(1990-12#1)(2010-12#1)
of response to treatment and##2##5##(2007-8#1)(2011-2#1)
of response to treatment##6##4##(2007-2#1)(2007-8#1)(2008-12#2)(2010-8#1)(2011-2#1)
of response to##49##3##(1990-12#1)(1990-8#1)(1992-7#4)(1993-11#1)(1995-10#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-3#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-12#3)(2008-2#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
of response was observed##2##4##(1990-6#1)(2007-8#1)
of response was##13##3##(1990-2#1)(1990-6#1)(1990-8#1)(1991-5#1)(1991-6#1)(1992-2#1)(1992-8#1)(1994-8#1)(1997-1#1)(2007-8#1)(2008-2#1)(2010-12#1)(2013-1#1)
of response were found##2##4##(1992-9#1)(2008-6#1)
of response were##4##3##(1992-9#1)(1993-2#1)(2007-11#1)(2008-6#1)
of response##146##2##(1990-10#3)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-7#4)(1992-8#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-6#2)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-8#1)(1996-11#1)(1996-12#3)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-6#1)(2005-4#1)(2006-10#5)(2006-12#1)(2006-4#1)(2006-7#1)(2006-9#3)(2007-10#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-8#4)(2007-9#1)(2008-10#11)(2008-12#4)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-1#3)(2010-11#1)(2010-12#5)(2010-3#3)(2010-7#1)(2010-8#2)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#6)(2013-7#2)(2013-8#2)
of responses at##2##3##(1994-10#1)(2008-12#1)
of responses by##2##3##(1994-2#1)(2008-8#1)
of responses in##7##3##(1991-3#1)(1992-4#1)(1994-10#1)(1995-8#1)(1996-8#1)(2006-10#1)(2008-11#1)
of responses increased significantly from##2##5##(2008-12#2)
of responses of##4##3##(1990-2#1)(1990-4#1)(2004-9#1)(2008-10#1)
of responses that##4##3##(1993-4#1)(2008-11#1)(2008-6#1)(2012-3#1)
of responses to the##5##4##(2007-12#1)(2008-10#1)(2009-3#1)(2012-12#2)
of responses to various##2##4##(1995-12#1)(2010-12#1)
of responses to##24##3##(1991-9#1)(1993-9#1)(1994-12#1)(1995-12#1)(1996-5#1)(1996-8#1)(2005-10#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#3)(2012-2#2)
of responses##68##2##(1990-2#1)(1990-4#1)(1991-2#1)(1991-3#2)(1991-9#1)(1992-4#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-10#2)(1994-12#1)(1994-2#2)(1994-8#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-5#1)(1996-8#2)(2004-9#1)(2005-10#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#7)(2008-11#7)(2008-12#3)(2008-6#1)(2008-8#1)(2008-9#2)(2009-12#2)(2009-3#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
of responsibilities and##2##3##(2006-8#1)(2008-1#1)
of responsibilities##8##2##(1992-10#1)(1995-12#1)(2006-8#2)(2008-1#1)(2008-7#1)(2012-3#2)
of responsibility and##2##3##(2007-10#1)(2008-11#1)
of responsibility for quality of care##2##6##(1991-12#1)(1996-2#1)
of responsibility for##6##3##(1990-10#1)(1991-12#1)(1995-12#1)(1996-2#1)(2008-7#1)(2009-5#1)
of responsibility in##2##3##(1997-2#1)(2011-2#1)
of responsibility to##2##3##(1996-1#1)(2012-1#1)
of responsibility##21##2##(1990-10#1)(1991-12#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#3)(1997-2#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-2#2)(2012-1#1)(2012-3#1)
of responsive cells##2##3##(1991-12#1)(1996-5#1)
of responsive##3##2##(1991-12#1)(1996-5#1)(2009-4#1)
of responsiveness to##2##3##(1995-12#1)(1995-2#1)
of responsiveness##6##2##(1991-1#1)(1991-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(2007-6#1)
of responsivity##2##2##(2008-2#2)
of rest##6##2##(2006-10#1)(2006-6#1)(2009-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
of rest/activity##2##2##(2008-6#2)
of restenosis after angioplasty##2##4##(1994-8#1)(2007-11#1)
of restenosis after##10##3##(1991-5#1)(1994-8#1)(1995-8#1)(1996-12#1)(1996-8#1)(2005-10#1)(2007-11#1)(2007-8#1)(2008-7#1)(2010-11#1)
of restenosis and##4##3##(2005-7#1)(2007-11#2)(2009-1#1)
of restenosis has been##2##4##(2008-12#1)(2010-5#1)
of restenosis has##3##3##(1994-11#1)(2008-12#1)(2010-5#1)
of restenosis##35##2##(1991-5#1)(1992-4#2)(1992-9#3)(1994-11#3)(1994-8#1)(1994-9#2)(1995-8#1)(1996-12#1)(1996-8#1)(2005-10#1)(2005-7#2)(2006-11#1)(2007-11#5)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-6#2)(2010-11#1)(2010-5#1)(2013-7#1)
of resting human##2##3##(1990-4#1)(1992-6#1)
of resting platelets##2##3##(1997-7#1)(2006-6#1)
of resting spores##2##3##(2008-10#2)
of resting##28##2##(1990-4#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-6#1)(1992-7#2)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-3#2)(1997-7#1)(2005-10#1)(2006-6#1)(2006-7#1)(2008-10#2)(2008-7#2)(2008-8#1)(2009-8#1)(2010-1#1)(2010-4#1)(2011-2#1)
of restless##2##2##(2007-2#1)(2013-8#1)
of restoration of##5##3##(1995-8#1)(2006-9#1)(2007-3#1)(2009-4#1)(2011-1#1)
of restoration##14##2##(1995-8#1)(2006-9#1)(2007-3#1)(2008-3#4)(2009-4#1)(2011-1#2)(2011-11#1)(2011-2#1)(2012-12#1)(2013-7#1)
of restorations##2##2##(2012-12#1)(2013-1#1)
of restorative##12##2##(2008-11#1)(2008-7#2)(2009-4#1)(2010-10#1)(2011-2#1)(2012-12#4)(2013-1#2)
of restored##3##2##(2008-2#1)(2011-2#1)(2013-1#1)
of restoring##7##2##(1994-7#1)(2007-10#1)(2007-11#1)(2008-7#1)(2009-4#1)(2011-1#1)(2012-1#1)
of restraint stress##2##3##(2007-11#1)(2012-1#1)
of restraint##9##2##(1991-12#1)(1995-12#1)(1996-10#1)(1997-2#2)(2007-11#1)(2007-4#1)(2008-7#1)(2012-1#1)
of restraints##3##2##(1996-3#1)(2004-12#1)(2008-7#1)
of restricted antibiotics##3##3##(2012-2#3)
of restricted##12##2##(1991-12#1)(1992-1#1)(1992-6#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-2#4)(2012-3#1)
of restriction and##2##3##(1995-6#1)(2006-8#1)
of restriction endonuclease##2##3##(2005-11#1)(2008-8#1)
of restriction enzyme##5##3##(1991-7#1)(1993-12#1)(2005-10#1)(2008-10#1)(2008-7#1)
of restriction enzyme-induced##2##3##(1993-9#1)(1994-7#1)
of restriction enzymes##2##3##(1994-12#1)(2008-4#1)
of restriction fragment length polymorphism (RFLP)##2##6##(1997-4#1)(2008-9#1)
of restriction fragment length polymorphism##4##5##(1997-4#1)(2008-10#1)(2008-4#1)(2008-9#1)
of restriction fragment length##5##4##(1996-5#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-9#1)
of restriction sites##3##3##(1994-12#1)(1996-2#1)(2008-11#1)
of restriction##28##2##(1991-7#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-12#3)(1994-7#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-4#1)(2005-10#1)(2005-11#1)(2006-6#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)
of restrictions##3##2##(1994-2#1)(2007-12#1)(2008-6#1)
of restrictive##4##2##(1990-4#1)(1990-9#1)(1991-12#2)
of restructured##2##2##(2006-10#1)(2010-4#1)
of restructuring##5##2##(1993-1#1)(1994-2#1)(1995-12#2)(2011-1#1)
of result##2##2##(2007-11#1)(2008-2#1)
of resultant##3##2##(1997-1#1)(2008-1#1)(2008-2#1)
of resulting##14##2##(1992-6#1)(1993-12#1)(1995-12#1)(1996-5#1)(2004-9#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-7#1)(2011-2#1)
of results and##4##3##(1991-8#1)(2007-5#1)(2007-7#1)(2012-2#1)
of results are discussed##2##4##(2005-8#1)(2009-9#1)
of results between##3##3##(2006-12#1)(2008-10#1)(2008-4#1)
of results by##2##3##(2007-2#1)(2012-3#1)
of results can##2##3##(2008-9#1)(2013-1#1)
of results for##2##3##(1990-5#1)(2008-10#1)
of results from a##5##4##(1990-9#1)(1997-5#1)(2008-2#1)(2008-5#2)
of results from different##4##4##(2008-2#2)(2008-4#1)(2011-12#1)
of results from the##2##4##(2008-10#1)(2008-11#1)
of results from this##2##4##(1997-4#1)(2010-8#1)
of results from##24##3##(1990-9#1)(1991-7#1)(1995-12#1)(1995-3#1)(1996-7#1)(1997-4#1)(1997-5#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-4#1)(2008-5#2)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
of results has##2##3##(2006-10#1)(2011-2#1)
of results in the##2##4##(2008-10#1)(2008-12#1)
of results in##7##3##(1996-5#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#2)
of results is##5##3##(2004-4#1)(2005-11#1)(2007-7#1)(2008-9#1)(2009-8#1)
of results obtained by##3##4##(2008-10#2)(2008-11#1)
of results obtained##14##3##(1995-2#1)(1996-4#1)(2005-11#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-12#1)(2013-1#1)
of results of the##2##4##(1990-2#1)(2008-10#1)
of results of treatment of##4##5##(2006-6#1)(2009-2#3)
of results of treatment##6##4##(2006-6#1)(2009-2#4)(2009-4#1)
of results of##16##3##(1990-2#1)(1994-11#1)(1995-4#1)(2006-12#1)(2006-6#1)(2008-10#1)(2009-2#7)(2009-3#1)(2009-4#1)(2010-12#1)
of results produced by##2##4##(2008-6#1)(2008-7#1)
of results reported##2##3##(2008-5#1)(2009-8#1)
of results to##3##3##(2008-3#1)(2008-8#1)(2012-3#1)
of results using##2##3##(1990-12#1)(2011-1#1)
of results was##3##3##(2006-10#1)(2008-10#2)
of results with##3##3##(2008-10#2)(2008-7#1)
of results##146##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-7#1)(1991-8#1)(1992-4#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-5#1)(2004-12#1)(2004-4#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-12#4)(2006-6#1)(2007-12#1)(2007-2#1)(2007-5#2)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#20)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-2#8)(2009-3#1)(2009-4#1)(2009-8#4)(2009-9#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#6)(2013-1#4)
of resurgence##2##2##(2007-9#1)(2012-12#1)
of resuscitation##14##2##(1994-6#1)(2006-10#5)(2007-3#1)(2008-11#1)(2008-3#2)(2010-12#1)(2010-8#1)(2012-2#2)
of resveratrol in##3##3##(2008-3#1)(2009-12#1)(2010-12#1)
of resveratrol on##2##3##(2009-12#1)(2012-4#1)
of resveratrol##16##2##(2007-1#1)(2008-10#5)(2008-3#1)(2009-12#2)(2010-12#2)(2011-2#3)(2012-4#1)(2013-1#1)
of ret proto-oncogene##3##3##(1990-4#3)
of ret##5##2##(1990-4#4)(1993-8#1)
of retail##3##2##(2008-11#1)(2010-4#1)(2011-1#1)
of retained foreign bodies##3##4##(2008-12#1)(2008-4#2)
of retained molecular orientation##2##4##(2004-9#2)
of retained placenta##3##3##(1996-11#2)(2006-5#1)
of retained wooden foreign bodies##2##5##(2010-5#2)
of retained##16##2##(1994-8#1)(1996-11#2)(2004-9#2)(2005-10#1)(2006-5#1)(2007-12#1)(2007-2#1)(2008-12#2)(2008-4#2)(2010-5#2)(2012-2#1)
of retaining##4##2##(1993-3#1)(2005-8#1)(2007-8#1)(2008-11#1)
of retardance for##2##3##(2007-12#1)(2008-3#1)
of retardation of##2##3##(1991-5#1)(1992-1#1)
of retardation##5##2##(1990-10#1)(1991-10#1)(1991-5#1)(1992-1#1)(2008-2#1)
of retarded##2##2##(1994-8#1)(2007-11#1)
of retention and elution##3##4##(2008-10#3)
of retention and##6##3##(1992-6#1)(2004-10#1)(2007-8#1)(2008-10#3)
of retention efficiency##2##3##(2007-8#1)(2008-10#1)
of retention is##2##3##(1993-4#1)(2008-10#1)
of retention of##3##3##(1995-2#1)(2008-10#1)(2008-11#1)
of retention times##5##3##(1990-12#1)(1997-8#1)(2007-8#1)(2008-10#1)(2013-1#1)
of retention##33##2##(1990-12#1)(1990-5#1)(1992-6#1)(1993-4#1)(1994-6#1)(1995-2#1)(1997-8#1)(2004-10#2)(2005-12#2)(2007-8#3)(2008-10#10)(2008-11#1)(2008-12#1)(2009-4#1)(2009-9#1)(2012-3#1)(2013-1#3)(2013-8#1)
of reteplase##4##2##(2006-4#1)(2007-11#3)
of rethrombosis##2##2##(1990-11#2)
of reticular##4##2##(1990-6#1)(1990-9#1)(1994-2#1)(2013-1#1)
of reticulate##4##2##(2008-8#2)(2010-3#1)(2013-7#1)
of reticulated platelets##4##3##(2006-6#3)(2008-9#1)
of reticulocyte##4##2##(1992-4#1)(1992-8#1)(2007-12#1)(2008-9#1)
of reticulocytes in##2##3##(2008-9#2)
of reticulocytes turning into##2##4##(2008-9#2)
of reticulocytes##6##2##(1993-2#1)(1996-2#1)(2008-9#4)
of reticuloendotheliosis virus (REV)##3##4##(2008-5#2)(2013-8#1)
of reticuloendotheliosis virus##4##3##(2008-5#2)(2013-8#2)
of retina##5##2##(1992-6#1)(2008-1#1)(2008-11#1)(2010-1#1)(2011-2#1)
of retinal birefringence##2##3##(2007-11#1)(2008-2#1)
of retinal cells##2##3##(1993-12#1)(1996-1#1)
of retinal degeneration##2##3##(2013-8#2)
of retinal ganglion cells (RGCs)##2##5##(1991-3#1)(2013-8#1)
of retinal ganglion cells##8##4##(1991-10#1)(1991-3#1)(1993-12#1)(2007-6#1)(2008-7#1)(2009-12#1)(2011-2#1)(2013-8#1)
of retinal neovascularization##2##3##(1995-1#1)(1997-7#1)
of retinal nerve fiber layer##4##5##(2007-3#2)(2012-12#1)(2013-1#1)
of retinal nerve##5##3##(2007-3#2)(2012-12#1)(2013-1#2)
of retinal neurons##3##3##(2008-8#3)
of retinal pathology##2##3##(2011-7#2)
of retinal pigment##2##3##(1990-3#1)(1996-1#1)
of retinal rod outer segments##2##5##(1992-6#1)(1993-4#1)
of retinal rod##4##3##(1990-2#1)(1992-6#2)(1993-4#1)
of retinal vascular##2##3##(2009-10#1)(2009-4#1)
of retinal vessels##2##3##(2006-10#1)(2008-3#1)
of retinal##69##2##(1990-2#1)(1990-3#1)(1991-10#2)(1991-3#1)(1992-3#1)(1992-6#2)(1993-12#2)(1993-4#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-6#1)(1995-9#1)(1996-1#2)(1996-5#2)(1996-9#1)(1997-7#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-6#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#4)(2009-8#1)(2010-5#1)(2011-1#3)(2011-2#2)(2011-7#2)(2011-9#1)(2012-12#3)(2013-1#3)(2013-8#3)
of retinitis pigmentosa##2##3##(2012-2#2)
of retinoblastoma gene##2##3##(1996-4#1)(1997-7#1)
of retinoblastoma##8##2##(1995-2#1)(1996-4#1)(1997-7#1)(2003-11#1)(2007-5#1)(2011-1#2)(2011-2#1)
of retinoic acid (RA)##6##4##(1990-6#1)(1992-1#1)(1993-9#1)(1994-6#1)(1995-9#1)(2006-12#1)
of retinoic acid and##3##4##(1995-10#1)(1995-11#1)(2011-1#1)
of retinoic acid in##2##4##(1990-6#1)(2007-11#1)
of retinoic acid nuclear receptors##2##5##(1991-2#2)
of retinoic acid on##4##4##(1993-3#1)(1994-11#1)(1994-9#1)(2008-11#1)
of retinoic acid receptor##3##4##(1991-9#2)(1995-3#1)
of retinoic acid receptors##2##4##(1995-8#2)
of retinoic acid synthesis##2##4##(1993-12#1)(1996-5#1)
of retinoic acid##28##3##(1990-6#2)(1991-2#2)(1991-9#2)(1992-1#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#3)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-3#1)(1995-8#2)(1995-9#1)(1996-5#1)(1996-8#1)(2006-12#1)(2007-11#1)(2008-11#1)(2011-1#1)
of retinoic acid-induced differentiation##2##4##(1992-12#1)(1997-7#1)
of retinoic##34##2##(1990-6#2)(1991-2#2)(1991-9#2)(1992-1#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#3)(1994-6#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-3#1)(1995-8#2)(1995-9#1)(1996-5#2)(1996-8#1)(1997-7#1)(2006-12#1)(2007-11#1)(2008-11#1)(2010-2#1)(2011-1#1)
of retinoid X receptor##3##4##(1994-8#1)(1995-8#1)(1996-8#1)
of retinoid X##4##3##(1993-3#1)(1994-8#1)(1995-8#1)(1996-8#1)
of retinoid##15##2##(1993-3#3)(1994-8#1)(1995-3#2)(1995-8#1)(1996-8#2)(2007-11#2)(2008-5#1)(2013-1#3)
of retinoids and cytokines##2##4##(1992-2#2)
of retinoids in##4##3##(1990-11#1)(1991-3#1)(1993-12#1)(1997-3#1)
of retinoids may be##3##4##(1994-6#1)(2007-11#1)(2008-4#1)
of retinoids##15##2##(1990-11#1)(1991-3#1)(1991-9#1)(1992-2#2)(1992-9#1)(1993-12#1)(1994-6#1)(1997-3#1)(2007-11#3)(2008-4#1)(2008-8#1)(2013-1#1)
of retinol and##3##3##(1991-5#1)(2009-6#2)
of retinol deficiency and curcumin##2##5##(1994-8#2)
of retinol in##3##3##(2008-5#2)(2008-8#1)
of retinol##22##2##(1991-5#1)(1994-12#2)(1994-8#2)(1996-5#1)(2006-10#2)(2008-5#11)(2008-8#1)(2009-6#2)
of retinol-binding protein##2##3##(1991-8#1)(1994-11#1)
of retinopathy in##2##3##(1991-8#1)(2008-2#1)
of retinopathy of prematurity in##2##5##(2011-1#2)
of retinopathy of prematurity##3##4##(2007-2#1)(2011-1#2)
of retinopathy##8##2##(1991-8#1)(1995-9#2)(2007-2#1)(2008-2#1)(2009-2#1)(2011-1#2)
of retinoyl-beta-glucuronides##2##2##(1996-8#2)
of retinula##2##2##(2007-12#2)
of retinyl palmitate and retinol in the skin of SKH-1 mice##2##11##(2008-8#2)
of retinyl palmitate and##5##4##(2008-8#5)
of retinyl palmitate in the##2##5##(2008-8#2)
of retinyl palmitate##8##3##(2008-8#8)
of retinyl##11##2##(1991-2#1)(2008-10#2)(2008-8#8)
of retired workers##2##3##(1993-1#2)
of retirement##4##2##(2007-4#1)(2007-9#1)(2009-12#2)
of retraction##2##2##(1996-1#1)(2007-12#1)
of retrieval of##3##3##(1993-12#1)(2008-3#2)
of retrieval##7##2##(1990-12#1)(1993-12#1)(1995-12#1)(2008-3#2)(2009-2#1)(2013-8#1)
of retrieved aerosol##2##3##(2008-2#1)(2008-3#1)
of retrieved##9##2##(2007-12#1)(2008-2#2)(2008-3#1)(2009-5#1)(2012-12#1)(2013-1#3)
of retrieving##4##2##(1993-2#1)(2008-2#2)(2008-3#1)
of retrocalcaneal##2##2##(2008-8#1)(2009-10#1)
of retrograde transport##3##3##(1991-8#1)(1995-8#1)(2008-1#1)
of retrograde##12##2##(1991-8#1)(1993-12#1)(1994-7#1)(1995-5#1)(1995-8#1)(2006-12#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-7#1)(2013-1#1)
of retrogradely labeled##2##3##(1994-12#1)(1995-6#1)
of retrogradely labelled##2##3##(1992-8#1)(1997-6#1)
of retrogradely##5##2##(1992-8#1)(1994-12#1)(1994-2#1)(1995-6#1)(1997-6#1)
of retropatellar##2##2##(2007-4#1)(2011-2#1)
of retroperitoneal laparoscopic##2##3##(2006-6#1)(2013-1#1)
of retroperitoneal lesions##2##3##(2011-2#2)
of retroperitoneal sarcomas##3##3##(2006-6#2)(2008-6#1)
of retroperitoneal##14##2##(1990-5#1)(1990-6#1)(1994-6#1)(1996-6#1)(2006-6#4)(2008-1#1)(2008-6#1)(2011-2#2)(2013-1#2)
of retroreflectors##2##2##(2008-3#2)
of retrospective data##3##3##(2006-5#2)(2007-8#1)
of retrospective study##2##3##(2008-11#1)(2012-3#1)
of retrospective##11##2##(2005-10#1)(2006-10#1)(2006-2#1)(2006-5#2)(2007-11#2)(2007-8#1)(2008-11#1)(2011-2#1)(2012-3#1)
of retrotransposons##2##2##(1995-8#1)(2006-12#1)
of retroviral vector##3##3##(2008-11#2)(2008-4#1)
of retroviral##10##2##(1990-11#1)(1994-8#1)(1995-3#1)(2008-11#3)(2008-4#4)
of retroviral-related antigens##2##3##(2007-6#2)
of retrovirus-mediated##2##2##(2010-12#1)(2012-2#1)
of retroviruses for##2##3##(2008-11#1)(2008-4#1)
of retroviruses##9##2##(1990-11#1)(1992-12#1)(1995-6#1)(1995-8#1)(2007-11#1)(2008-11#3)(2008-4#1)
of return to##4##3##(1992-1#1)(2007-1#1)(2008-4#1)(2011-1#1)
of return##20##2##(1992-1#1)(1992-12#1)(2006-10#1)(2007-1#1)(2007-4#2)(2007-9#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#1)
of return-to-zero##2##2##(2007-12#2)
of returned##3##2##(1994-11#1)(2005-11#1)(2008-3#1)
of returning to##3##3##(1991-12#1)(2008-12#1)(2008-8#1)
of returning##6##2##(1991-12#1)(2007-11#1)(2008-12#1)(2008-8#3)
of returns from##2##3##(1993-1#1)(1994-2#1)
of returns##3##2##(1993-1#1)(1994-2#1)(2008-3#1)
of reusable##2##2##(1992-12#1)(2011-2#1)
of reuse##2##2##(1992-3#1)(1994-11#1)
of revascularization of the##2##4##(1990-5#1)(2005-1#1)
of revascularization##7##2##(1990-5#1)(1997-1#1)(1997-6#1)(2005-1#1)(2007-8#2)(2009-12#1)
of revealing##5##2##(1990-4#1)(2008-3#1)(2008-9#1)(2012-1#2)
of revenue##3##2##(1991-1#1)(1996-3#1)(2007-1#1)
of revenues##2##2##(1992-3#1)(2010-8#1)
of reversal agents##2##3##(2007-2#2)
of reversal##5##2##(2007-12#1)(2007-2#2)(2008-11#1)(2008-2#1)
of reverse oblique##2##3##(2013-1#2)
of reverse transcriptase (RT)##2##4##(1996-7#1)(1997-2#1)
of reverse transcriptase##13##3##(1990-10#1)(1991-10#2)(1992-11#1)(1993-9#1)(1994-6#4)(1996-7#1)(1997-2#1)(1997-4#1)(2006-11#1)
of reverse transcriptase-polymerase chain##2##4##(1996-12#1)(1996-2#1)
of reverse transcription and##2##4##(1992-12#1)(1995-12#1)
of reverse transcription polymerase chain reaction##2##6##(2007-10#1)(2008-10#1)
of reverse transcription##6##3##(1991-10#1)(1992-12#1)(1995-12#1)(1997-6#1)(2007-10#1)(2008-10#1)
of reverse transcription-polymerase chain reaction##2##5##(1991-10#1)(1996-5#1)
of reverse transcription-polymerase chain##3##4##(1991-10#1)(1995-3#1)(1996-5#1)
of reverse##38##2##(1990-10#1)(1991-10#4)(1992-11#1)(1992-12#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-6#4)(1995-12#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#2)(1997-2#1)(1997-4#1)(1997-6#1)(2006-11#1)(2007-10#1)(2008-10#1)(2008-3#2)(2008-9#1)(2010-12#1)(2011-1#1)(2012-1#1)(2013-1#5)
of reverse-correlation##3##2##(2013-8#3)
of reversed micelles as##2##4##(2008-10#2)
of reversed micelles##6##3##(1990-5#1)(1995-3#1)(2005-11#2)(2008-10#2)
of reversed##11##2##(1990-12#1)(1990-5#3)(1995-3#1)(2005-11#2)(2007-8#1)(2008-10#2)(2012-1#1)
of reversed-phase HPLC##2##3##(1996-12#1)(1996-8#1)
of reversed-phase high-performance liquid chromatography and##2##6##(1996-5#1)(1996-6#1)
of reversed-phase high-performance liquid chromatography##5##5##(1996-5#2)(1996-6#1)(1997-2#1)(2008-10#1)
of reversed-phase liquid chromatography##2##4##(1990-6#1)(2013-8#1)
of reversed-phase##10##2##(1990-6#1)(1996-12#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-2#1)(2008-10#1)(2012-12#1)(2013-8#1)
of reversibility of##2##3##(1992-10#1)(2005-10#1)
of reversibility##6##2##(1992-10#1)(1992-5#1)(2005-10#1)(2008-10#3)
of reversible##15##2##(1990-7#1)(1990-9#1)(1995-10#1)(1995-12#1)(1995-7#1)(1997-2#1)(2005-1#2)(2007-10#1)(2008-10#1)(2008-7#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
of revertants##4##2##(1995-5#1)(1995-6#2)(2008-9#1)
of review##11##2##(1991-10#1)(2006-10#3)(2007-1#1)(2007-5#1)(2007-8#1)(2008-12#1)(2008-8#1)(2011-1#1)(2013-7#1)
of reviewed##2##2##(2008-10#1)(2008-11#1)
of reviewing##2##2##(1993-12#1)(2006-10#1)
of reviews##3##2##(2006-9#1)(2008-10#1)(2008-7#1)
of revising##2##2##(1991-2#1)(2007-6#1)
of revision THA in##2##4##(2013-1#2)
of revision THA##3##3##(2013-1#3)
of revision and##2##3##(2011-1#1)(2012-12#1)
of revision hip##2##3##(2007-7#1)(2011-2#1)
of revision surgery were good##2##5##(2007-7#2)
of revision surgery##4##3##(2007-7#3)(2012-3#1)
of revision##17##2##(2007-7#4)(2010-11#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#4)(2013-7#1)
of revolution that##2##3##(2008-2#1)(2008-3#1)
of revolution##5##2##(1991-7#1)(1993-3#1)(2008-2#2)(2008-3#1)
of revolutionary##2##2##(2008-8#1)(2009-7#1)
of reward and##4##3##(1994-8#1)(2008-7#1)(2010-2#1)(2013-8#1)
of reward##18##2##(1991-1#2)(1992-12#2)(1993-6#1)(1994-8#1)(1995-12#1)(1996-3#1)(1996-5#1)(2006-7#1)(2008-7#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-2#1)(2012-2#1)(2013-8#2)
of rewards##4##2##(1997-1#1)(2009-2#1)(2012-1#2)
of rh TNF##2##3##(1992-9#2)
of rh##4##2##(1992-9#2)(2005-10#1)(2012-3#1)
of rhAT III##2##3##(2008-7#2)
of rhBMP-2 induced periosteal cells##2##5##(2008-5#2)
of rhBMP-2##6##2##(2008-5#2)(2009-8#1)(2012-12#2)(2013-7#1)
of rhBMPs##2##2##(2008-8#2)
of rhG-CSF after##2##3##(1991-9#2)
of rhG-CSF##6##2##(1991-9#5)(2012-3#1)
of rhGH##3##2##(2007-11#3)
of rhIL-1 alpha##2##3##(1990-12#1)(1990-2#1)
of rhIL-4##3##2##(2006-11#3)
of rhIL-5##2##2##(1991-7#2)
of rhP2##2##2##(1995-12#2)
of rhPC##2##2##(2008-12#2)
of rhabdomere microvilli##3##3##(2009-10#3)
of rhabdomyolysis##6##2##(2008-1#2)(2009-11#1)(2011-2#2)(2013-8#1)
of rhabdomyosarcoma of the bladder##2##5##(2006-10#1)(2007-10#1)
of rhabdomyosarcoma of##3##3##(2006-10#1)(2007-10#1)(2010-11#1)
of rhabdomyosarcoma##8##2##(1991-4#1)(1993-9#1)(2006-10#1)(2007-10#1)(2008-6#3)(2010-11#1)
of rhamnose##2##2##(1993-11#2)
of rhein##5##2##(2008-10#1)(2010-3#4)
of rheological properties of##2##4##(2008-5#1)(2008-7#1)
of rheological##5##2##(2005-10#1)(2006-5#1)(2008-5#1)(2008-7#1)(2012-12#1)
of rheology##4##2##(2008-5#1)(2009-4#1)(2010-12#1)(2011-1#1)
of rhesus monkeys##3##3##(1995-2#1)(1996-1#1)(2010-2#1)
of rhesus##5##2##(1995-2#1)(1996-1#1)(2006-8#2)(2010-2#1)
of rheumatic carditis##2##3##(2011-2#2)
of rheumatic disease##6##3##(1993-3#1)(2006-10#3)(2007-11#1)(2008-7#1)
of rheumatic diseases##6##3##(1990-6#1)(1991-8#1)(1993-3#1)(2006-10#1)(2007-11#1)(2012-2#1)
of rheumatic fever##6##3##(1996-12#2)(1997-1#1)(2005-12#1)(2008-7#1)(2011-2#1)
of rheumatic heart disease##5##4##(2005-12#1)(2008-1#3)(2008-8#1)
of rheumatic heart##6##3##(2005-10#1)(2005-12#1)(2008-1#3)(2008-8#1)
of rheumatic mitral stenosis##2##4##(1995-6#1)(2010-7#1)
of rheumatic mitral##3##3##(1994-3#1)(1995-6#1)(2010-7#1)
of rheumatic patients##3##3##(1993-3#1)(1994-2#1)(2008-3#1)
of rheumatic##35##2##(1990-6#1)(1990-7#1)(1991-8#1)(1993-3#4)(1994-2#1)(1994-3#1)(1995-6#1)(1996-12#2)(1997-1#1)(2005-10#1)(2005-12#2)(2006-10#5)(2007-11#2)(2008-1#3)(2008-3#1)(2008-7#2)(2008-8#1)(2010-7#1)(2011-2#3)(2012-2#1)
of rheumatoid arthritis (RA) and##2##5##(2006-10#1)(2008-4#1)
of rheumatoid arthritis (RA)##8##4##(1993-3#1)(2006-10#2)(2008-3#2)(2008-4#1)(2011-2#1)(2012-3#1)
of rheumatoid arthritis and##6##4##(1992-3#1)(2006-10#1)(2007-11#1)(2009-1#1)(2009-7#1)(2013-1#1)
of rheumatoid arthritis in##3##4##(2006-10#1)(2011-1#1)(2012-2#1)
of rheumatoid arthritis is##6##4##(1990-6#1)(2007-11#4)(2008-3#1)
of rheumatoid arthritis patients##2##4##(2007-11#1)(2012-3#1)
of rheumatoid arthritis with##2##4##(2006-10#2)
of rheumatoid arthritis##76##3##(1990-6#3)(1991-10#1)(1991-8#1)(1992-11#2)(1992-3#1)(1993-3#2)(1994-12#1)(1995-6#1)(1996-9#1)(2005-10#1)(2006-10#14)(2006-4#1)(2007-11#17)(2007-7#1)(2008-3#6)(2008-4#1)(2008-5#3)(2008-8#1)(2009-1#1)(2009-7#1)(2010-1#1)(2010-4#3)(2011-1#1)(2011-2#1)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#1)
of rheumatoid arthritis]##5##3##(1991-11#1)(1992-10#1)(1993-5#1)(1994-6#1)(2012-2#1)
of rheumatoid factor (RF)##2##4##(2008-3#1)(2011-2#1)
of rheumatoid factor##6##3##(2006-4#2)(2008-3#1)(2008-4#1)(2011-2#2)
of rheumatoid##90##2##(1990-6#3)(1991-10#1)(1991-11#1)(1991-8#1)(1992-10#1)(1992-11#2)(1992-3#1)(1993-3#2)(1993-5#1)(1994-12#1)(1994-6#1)(1995-6#1)(1996-9#1)(2005-10#1)(2006-10#16)(2006-4#3)(2007-11#18)(2007-7#1)(2008-3#7)(2008-4#2)(2008-5#3)(2008-8#1)(2009-1#1)(2009-7#1)(2010-1#1)(2010-4#3)(2011-1#1)(2011-2#3)(2012-2#5)(2012-3#2)(2013-1#3)(2013-8#1)
of rheumatological##6##2##(1990-6#1)(2007-7#1)(2013-1#4)
of rheumatology##7##2##(1991-11#1)(2006-10#2)(2007-12#1)(2009-7#1)(2011-1#1)(2012-2#1)
of rhinitis##2##2##(2005-7#1)(2011-1#1)
of rhinogenic deafness##3##3##(2008-4#3)
of rhinolite##2##2##(2009-2#2)
of rhinosporidiosis##2##2##(2007-7#1)(2007-8#1)
of rhizobacteria##2##2##(2007-12#1)(2008-10#1)
of rhizobial##2##2##(2009-8#1)(2011-2#1)
of rhizoctonia##2##2##(2008-10#2)
of rhizomania in##2##3##(2008-10#2)
of rhizomania##6##2##(2008-10#6)
of rhizome##2##2##(2008-5#2)
of rhizosphere##2##2##(2008-10#2)
of rhizospheric##2##2##(2013-8#2)
of rhizoxin##2##2##(1991-7#2)
of rho A in the##2##5##(1992-12#1)(1994-11#1)
of rho GDS##2##3##(1992-5#2)
of rho p21 was##2##4##(1992-5#2)
of rho p21##4##3##(1992-1#1)(1992-5#3)
of rho##18##2##(1992-1#1)(1992-12#2)(1992-3#1)(1992-5#6)(1992-9#1)(1994-11#1)(2008-10#3)(2008-3#3)
of rhodamine 123##3##3##(1996-5#2)(2008-10#1)
of rhodamine 6G##2##3##(2008-10#2)
of rhodamine B##3##3##(2008-10#1)(2008-12#1)(2013-8#1)
of rhodamine##12##2##(1996-5#2)(2005-11#1)(2008-10#7)(2008-12#1)(2013-8#1)
of rhodium by##2##3##(2008-10#2)
of rhodium in different##2##4##(2008-10#2)
of rhodium in##4##3##(2008-10#4)
of rhodium##21##2##(2008-10#21)
of rhodium(III) has been##2##4##(2008-10#2)
of rhodium(III) in##3##3##(2008-10#3)
of rhodium(III)##9##2##(2008-10#9)
of rhodopsin and its##2##4##(1995-1#1)(1995-10#1)
of rhodopsin and##3##3##(1995-1#2)(1995-10#1)
of rhodopsin phosphorylation by##2##4##(1994-8#2)
of rhodopsin phosphorylation##3##3##(1994-8#2)(1995-1#1)
of rhodopsin##18##2##(1990-6#1)(1990-7#2)(1991-4#1)(1991-6#1)(1991-7#1)(1992-3#1)(1994-8#2)(1994-9#1)(1995-1#4)(1995-10#1)(2006-3#3)
of rhodopsin's##2##2##(2006-6#2)
of rhombic##2##2##(1997-7#1)(2009-7#1)
of rhythm disturbance##2##3##(1993-10#1)(2007-8#1)
of rhythm##3##2##(1993-10#1)(2007-8#1)(2008-10#1)
of rhythmic##3##2##(1992-10#1)(1996-9#1)(2012-12#1)
of rhythmical##2##2##(2007-8#1)(2008-8#1)
of rhythmically##2##2##(1993-2#1)(2008-3#1)
of rhythms##2##2##(2008-11#1)(2008-6#1)
of riNOS##2##2##(1994-11#2)
of rib##6##2##(2006-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2012-12#2)
of ribBP##2##2##(1994-9#2)
of ribavirin##5##2##(1990-10#1)(2007-11#1)(2008-10#3)
of riboflavin in beer by capillary##2##6##(2008-10#2)
of riboflavin in##7##3##(2008-10#5)(2008-9#1)(2012-2#1)
of riboflavin synthase##2##3##(1996-7#2)
of riboflavin##15##2##(1992-9#1)(1996-7#2)(2005-10#1)(2008-10#6)(2008-9#2)(2012-2#2)(2012-3#1)
of ribonuclease A##5##3##(1990-8#2)(1994-8#1)(1997-2#1)(2009-12#1)
of ribonuclease T1##4##3##(1992-10#1)(1992-4#1)(1994-2#1)(1997-7#1)
of ribonuclease##11##2##(1990-8#3)(1992-10#1)(1992-4#1)(1994-2#1)(1994-8#1)(1997-2#1)(1997-7#1)(2008-7#1)(2009-12#1)
of ribonucleoprotein##2##2##(1995-2#1)(1995-6#1)
of ribonucleoproteins##2##2##(1992-12#1)(2007-12#1)
of ribonucleosides to##3##3##(2008-4#3)
of ribonucleosides##5##2##(1997-2#1)(2006-3#1)(2008-4#3)
of ribonucleotide reductase and##3##4##(1991-2#2)(1996-7#1)
of ribonucleotide reductase from##3##4##(1991-5#1)(1992-4#1)(1995-10#1)
of ribonucleotide reductase##25##3##(1990-2#4)(1991-2#2)(1991-5#3)(1991-7#2)(1992-10#2)(1992-4#1)(1992-8#1)(1993-11#2)(1993-9#1)(1994-8#3)(1995-10#1)(1996-7#1)(1997-7#1)(2013-8#1)
of ribonucleotide##27##2##(1990-2#4)(1991-2#2)(1991-5#3)(1991-7#2)(1992-10#2)(1992-4#2)(1992-8#1)(1993-11#3)(1993-9#1)(1994-8#3)(1995-10#1)(1996-7#1)(1997-7#1)(2013-8#1)
of ribose##6##2##(1995-8#5)(2012-1#1)
of ribosomal DNA (rDNA)##4##4##(1996-5#1)(2008-4#1)(2008-5#1)(2008-9#1)
of ribosomal DNA##13##3##(1996-5#1)(2005-9#1)(2008-10#7)(2008-4#1)(2008-5#1)(2008-9#1)(2009-2#1)
of ribosomal RNA (rRNA)##2##4##(1993-11#1)(2011-2#1)
of ribosomal RNA##7##3##(1993-11#1)(2006-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
of ribosomal frameshifting##3##3##(1995-9#3)
of ribosomal protein genes##2##4##(2008-11#1)(2009-8#1)
of ribosomal protein##8##3##(1993-11#1)(1995-6#1)(1996-11#1)(2006-12#1)(2008-11#2)(2008-8#1)(2009-8#1)
of ribosomal proteins##2##3##(1994-12#1)(2008-8#1)
of ribosomal##38##2##(1993-11#2)(1993-12#1)(1994-12#1)(1995-6#1)(1995-9#3)(1996-11#1)(1996-5#1)(2005-10#1)(2005-9#1)(2006-12#2)(2007-11#1)(2008-10#8)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-2#1)(2009-8#1)(2010-11#1)(2011-1#2)(2011-2#1)
of ribosome and signal recognition particle##2##6##(1994-11#1)(1994-2#1)
of ribosome synthesis##2##3##(2006-12#1)(2011-12#1)
of ribosome##8##2##(1992-4#1)(1994-11#1)(1994-2#1)(1995-3#2)(2006-12#2)(2011-12#1)
of ribosomes##7##2##(1990-10#1)(1992-1#2)(1995-1#1)(2007-12#1)(2008-7#1)(2009-11#1)
of ribozymes##4##2##(1991-11#1)(2006-12#2)(2008-11#1)
of ribs##3##2##(2007-8#2)(2013-1#1)
of ribulose 1##3##3##(1991-9#1)(1997-1#1)(1997-6#1)
of ribulose##4##2##(1991-9#1)(1997-1#1)(1997-6#1)(2009-10#1)
of ribulose-1##3##2##(1992-3#1)(1993-12#1)(1994-8#1)
of rice (Oryza sativa L##2##5##(1992-8#1)(2008-10#1)
of rice (Oryza sativa ssp##2##5##(2006-12#1)(2009-10#1)
of rice (Oryza sativa##4##4##(1992-8#1)(2006-12#1)(2008-10#1)(2009-10#1)
of rice (Oryza##5##3##(1992-8#1)(2006-12#1)(2008-10#2)(2009-10#1)
of rice 5-enolpyruvylshikimate 3-phosphate synthase gene##2##6##(2008-9#2)
of rice and wheat##3##4##(2006-4#1)(2008-10#1)(2008-11#1)
of rice and##9##3##(2006-4#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-10#3)(2013-8#1)
of rice black-streaked dwarf virus##2##5##(2005-11#2)
of rice blast##5##3##(2008-10#5)
of rice bran wax as##2##5##(2010-2#2)
of rice bran##3##3##(2010-2#3)
of rice chromosome 1##2##4##(1996-10#2)
of rice chromosome 2##3##4##(1997-4#3)
of rice chromosome##7##3##(1996-10#3)(1997-4#3)(2009-10#1)
of rice chromosomes 4 and 7##2##6##(1997-2#2)
of rice chromosomes##6##3##(1996-12#2)(1997-2#2)(1997-4#1)(2008-8#1)
of rice dwarf##2##3##(2008-10#1)(2008-8#1)
of rice growth##4##3##(2007-8#2)(2008-10#1)(2008-9#1)
of rice panicle##2##3##(2008-10#1)(2008-12#1)
of rice paper##4##3##(2008-10#4)
of rice plant##2##3##(2008-10#1)(2009-8#1)
of rice plants##2##3##(1997-2#1)(2007-8#1)
of rice root##6##3##(2008-9#6)
of rice striped stem borer##2##5##(2009-8#2)
of rice to##3##3##(2008-10#3)
of rice with##2##3##(2006-4#1)(2008-10#1)
of rice##136##2##(1990-7#3)(1992-8#2)(1995-6#1)(1996-10#4)(1996-12#2)(1997-2#4)(1997-4#5)(2005-11#2)(2006-11#1)(2006-12#3)(2006-4#3)(2007-6#1)(2007-8#4)(2008-10#39)(2008-11#2)(2008-12#4)(2008-5#2)(2008-6#2)(2008-8#12)(2008-9#17)(2009-10#10)(2009-3#1)(2009-8#3)(2010-2#3)(2012-2#3)(2013-1#1)(2013-8#2)
of rich##2##2##(1992-5#1)(2004-8#1)
of richness##2##2##(2008-6#1)(2013-7#1)
of ricin and abrin##2##4##(1994-5#2)
of ricin and##3##3##(1990-11#1)(1994-5#2)
of ricin##8##2##(1990-11#1)(1991-2#1)(1993-11#1)(1994-5#2)(2010-4#1)(2012-11#2)
of rickets##5##2##(1994-11#1)(2008-1#3)(2011-1#1)
of rickettsial infection##2##3##(2006-2#2)
of rickettsial##6##2##(2006-2#4)(2007-7#1)(2008-4#1)
of rickettsiosis in##2##3##(2006-2#2)
of rickettsiosis##3##2##(2006-2#2)(2012-12#1)
of ridges##3##2##(2008-10#1)(2008-2#1)(2011-12#1)
of riding##2##2##(2007-1#1)(2009-1#1)
of rifalazil##2##2##(2008-5#2)
of rifampicin resistance##3##3##(2007-7#3)
of rifampicin##10##2##(1992-2#3)(2006-10#1)(2007-7#3)(2008-10#2)(2009-2#1)
of right and left##5##4##(1991-5#1)(2008-5#1)(2011-1#1)(2012-1#1)(2012-12#1)
of right answer##2##3##(1990-8#2)
of right atrial aneurysm##2##4##(2010-7#2)
of right atrial##3##3##(2010-7#2)(2012-2#1)
of right hand##2##3##(2007-8#1)(2012-1#1)
of right heart failure##2##4##(1997-4#1)(2012-12#1)
of right heart##3##3##(1997-4#1)(2010-7#1)(2012-12#1)
of right inferior temporal-occipital cortex##2##5##(1995-12#2)
of right or left##2##4##(2008-4#1)(2009-8#1)
of right to left##2##4##(2007-12#1)(2007-6#1)
of right to##3##3##(1994-2#1)(2007-12#1)(2007-6#1)
of right unilateral##2##3##(2010-7#1)(2012-2#1)
of right ventricle##2##3##(2008-7#1)(2011-2#1)
of right ventricular apical pacing on##2##6##(2006-9#2)
of right ventricular function##2##4##(1994-3#1)(2009-10#1)
of right ventricular outflow tract##2##5##(2012-1#1)(2012-2#1)
of right ventricular##16##3##(1993-8#2)(1994-3#2)(2006-9#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#2)(2009-2#1)(2010-10#1)(2010-6#1)(2012-1#1)(2012-2#1)
of right vertebral artery##2##4##(2012-1#2)
of right##82##2##(1990-6#1)(1990-8#2)(1991-5#1)(1991-8#1)(1992-10#1)(1993-8#2)(1994-2#1)(1994-3#2)(1995-1#1)(1995-12#2)(1996-5#1)(1997-4#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-9#3)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#1)(2008-8#1)(2009-10#2)(2009-2#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#4)(2011-1#2)(2011-12#4)(2011-2#4)(2012-1#5)(2012-12#2)(2012-2#5)(2013-8#2)
of right-sided facial##2##3##(2011-2#2)
of right-sided##6##2##(1990-11#1)(1990-3#1)(2009-6#1)(2011-2#2)(2012-1#1)
of righting##3##2##(1991-4#1)(1993-9#1)(2007-12#1)
of rights and##2##3##(2005-11#1)(2012-3#1)
of rights in African##2##4##(2012-3#2)
of rights in##5##3##(2009-4#1)(2012-3#4)
of rights##18##2##(1992-10#1)(2005-11#1)(2005-7#1)(2006-7#1)(2009-4#1)(2009-7#1)(2012-3#12)
of rigid endoscopes##3##3##(2006-6#2)(2011-1#1)
of rigid##17##2##(1992-9#1)(1995-4#1)(1996-5#1)(2005-11#1)(2006-11#1)(2006-3#1)(2006-6#2)(2006-8#1)(2007-4#1)(2007-9#1)(2008-5#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
of rigidity in##2##3##(1994-9#1)(2005-8#1)
of rigidity##5##2##(1994-9#1)(1995-1#1)(2005-8#1)(2009-7#1)(2013-8#1)
of rigor mortis##3##3##(1996-5#2)(2011-2#1)
of rigor##10##2##(1996-11#7)(1996-5#2)(2011-2#1)
of rigorous and##2##3##(1992-2#1)(2012-12#1)
of rigorous##6##2##(1992-2#1)(2006-5#1)(2007-9#1)(2008-11#1)(2009-4#1)(2012-12#1)
of riluzole##2##2##(1996-1#1)(2011-12#1)
of rinderpest in##2##3##(1990-3#1)(2011-2#1)
of rinderpest##4##2##(1990-3#1)(1992-8#1)(2011-2#2)
of ring size or an additional heteroatom##2##7##(1996-8#2)
of ring##16##2##(1993-1#1)(1994-11#1)(1994-5#1)(1996-8#2)(1997-3#1)(2006-10#2)(2007-11#1)(2008-10#4)(2010-12#1)(2011-12#1)(2013-7#1)
of rings##6##2##(1991-8#1)(1993-8#1)(2007-12#3)(2009-7#1)
of ripe##3##2##(2006-12#1)(2007-1#1)(2008-9#1)
of ripening##4##2##(2005-11#2)(2012-12#1)(2012-2#1)
of rise in##3##3##(1991-2#1)(1994-2#1)(2008-2#1)
of rise##7##2##(1991-2#1)(1994-2#1)(1994-3#1)(1997-8#1)(2007-10#1)(2008-2#1)(2009-6#1)
of rising##12##2##(1990-12#1)(1993-1#1)(1993-3#1)(1995-9#1)(2006-5#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-12#1)(2010-4#2)
of risk adjustment##2##3##(1995-2#1)(1995-3#1)
of risk analysis##3##3##(2005-5#1)(2008-11#1)(2009-7#1)
of risk and##7##3##(1997-3#1)(2008-6#1)(2009-4#1)(2012-12#1)(2013-1#2)(2013-7#1)
of risk are##2##3##(1997-5#1)(2009-12#1)
of risk assessment and##2##4##(2007-2#1)(2013-1#1)
of risk assessment##9##3##(2006-10#1)(2006-9#1)(2007-2#1)(2008-10#1)(2011-2#1)(2013-1#2)(2013-7#2)
of risk assessments##3##3##(2008-10#1)(2011-2#1)(2013-7#1)
of risk behaviors##4##3##(1995-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
of risk behaviour##3##3##(1996-1#2)(2012-12#1)
of risk control##3##3##(2009-10#1)(2013-1#2)
of risk exposure##2##3##(2005-8#1)(2010-7#1)
of risk factor##6##3##(1990-4#1)(2007-11#1)(2008-7#1)(2011-2#3)
of risk factors and##8##4##(1993-3#1)(2007-10#1)(2007-12#1)(2010-4#1)(2010-8#1)(2011-2#3)
of risk factors associated with##3##5##(2008-3#1)(2008-6#1)(2010-9#1)
of risk factors for chronic disease as health status adjusters##2##10##(1993-3#2)
of risk factors for chronic disease##3##6##(1993-3#2)(2005-10#1)
of risk factors for coronary heart disease##3##7##(2006-10#1)(2008-12#2)
of risk factors for coronary##4##5##(2006-10#1)(2006-9#1)(2008-12#2)
of risk factors for oral cancer##2##6##(2011-2#2)
of risk factors for##29##4##(1992-11#1)(1993-3#2)(1995-6#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-12#2)(2008-7#3)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
of risk factors in the##2##5##(2007-11#1)(2008-6#1)
of risk factors in##4##4##(2006-4#1)(2007-11#1)(2007-9#1)(2008-6#1)
of risk factors of##3##4##(1990-9#1)(2007-8#1)(2011-2#1)
of risk factors on##2##4##(1992-9#1)(2009-5#1)
of risk factors such as##2##5##(1991-9#1)(2009-4#1)
of risk factors that##2##4##(2008-8#1)(2009-6#1)
of risk factors to##3##4##(1992-4#1)(1997-6#1)(2007-10#1)
of risk factors which##2##4##(1993-9#1)(2008-11#1)
of risk factors##97##3##(1990-9#1)(1991-12#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-9#2)(1993-2#1)(1993-3#3)(1993-9#1)(1995-10#1)(1995-6#1)(1997-6#1)(1997-8#1)(2005-10#4)(2006-10#1)(2006-4#1)(2006-9#1)(2007-10#4)(2007-11#3)(2007-12#2)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-3#1)(2008-6#2)(2008-7#3)(2008-8#2)(2009-12#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#9)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#5)
of risk for##13##3##(1990-8#1)(1991-5#1)(1991-8#1)(1996-2#1)(2006-6#1)(2007-12#2)(2009-1#1)(2009-12#1)(2010-4#2)(2010-5#1)(2012-2#1)
of risk groups##4##3##(2005-11#1)(2011-2#3)
of risk in##4##3##(1994-2#1)(1997-8#1)(2007-8#1)(2010-12#1)
of risk is##2##3##(2008-5#1)(2010-2#1)
of risk management at##2##4##(1996-2#1)(2009-4#1)
of risk management##9##3##(1990-12#1)(1993-2#1)(1994-2#1)(1996-2#1)(2005-5#1)(2007-1#1)(2007-11#1)(2008-6#1)(2009-4#1)
of risk of the##2##4##(1990-5#1)(2009-2#1)
of risk of##11##3##(1990-5#1)(1991-7#1)(1991-9#1)(1995-9#1)(1997-3#1)(2005-10#1)(2007-9#1)(2008-1#1)(2009-2#1)(2009-5#1)(2012-12#1)
of risk or##2##3##(1997-3#1)(2008-3#1)
of risk patients##2##3##(1994-8#1)(2013-1#1)
of risk preference on alcohol##2##5##(2009-12#2)
of risk preference##3##3##(2009-12#3)
of risk to##2##3##(1991-12#1)(2012-3#1)
of risk tolerance##2##3##(2011-2#2)
of risk##274##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#4)(1992-4#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#4)(1993-3#3)(1993-8#1)(1993-9#5)(1994-2#2)(1994-8#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-9#1)(1996-1#2)(1996-2#2)(1996-7#1)(1997-3#6)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2005-10#6)(2005-11#1)(2005-5#2)(2005-7#1)(2005-8#1)(2006-10#4)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#6)(2007-11#5)(2007-12#7)(2007-2#3)(2007-7#3)(2007-8#4)(2007-9#3)(2008-1#2)(2008-10#7)(2008-11#4)(2008-12#4)(2008-3#2)(2008-5#1)(2008-6#4)(2008-7#8)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#7)(2009-2#1)(2009-4#6)(2009-5#4)(2009-6#2)(2009-7#3)(2009-9#1)(2010-11#1)(2010-12#5)(2010-2#3)(2010-4#3)(2010-5#1)(2010-7#2)(2010-8#5)(2010-9#3)(2011-1#3)(2011-11#1)(2011-2#21)(2012-1#2)(2012-12#9)(2012-2#5)(2012-3#3)(2013-1#16)(2013-7#6)(2013-8#6)
of risk-adjusted outcome##2##3##(2007-8#1)(2008-11#1)
of risk-adjusted##3##2##(1997-1#1)(2007-8#1)(2008-11#1)
of risk/benefit##2##2##(2007-11#1)(2011-2#1)
of risks and benefits##2##4##(2010-8#1)(2013-7#1)
of risks##15##2##(1994-6#1)(1996-3#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-4#1)(2009-4#2)(2010-8#1)(2011-2#2)(2013-1#2)(2013-7#2)
of risky sexual##3##3##(2011-2#1)(2013-1#1)(2013-8#1)
of risky##7##2##(2006-10#1)(2009-7#1)(2011-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
of risperidone##6##2##(1996-2#1)(1997-5#3)(2004-12#1)(2008-7#1)
of ritanserin##2##2##(1990-11#1)(1996-5#1)
of ritodrine hydrochloride##4##3##(2008-10#4)
of ritual##2##2##(1991-8#1)(2009-10#1)
of rituximab and##2##3##(2010-12#1)(2011-2#1)
of rituximab for##2##3##(2008-7#1)(2013-1#1)
of rituximab in autoimmune##2##4##(2010-12#1)(2010-4#1)
of rituximab in##7##3##(2010-12#2)(2010-4#1)(2012-2#1)(2013-1#3)
of rituximab##15##2##(2006-10#1)(2007-10#1)(2008-7#1)(2010-12#4)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#5)
of rivalry##2##2##(1992-3#1)(2008-11#1)
of rivals##2##2##(2007-9#1)(2009-6#1)
of rivanol##4##2##(2008-10#4)
of rivastigmine##5##2##(2004-3#2)(2011-2#3)
of river water and##2##4##(2008-10#2)
of river water##3##3##(2008-10#3)
of river##10##2##(1993-8#1)(1993-9#1)(2008-10#6)(2008-6#1)(2013-8#1)
of rivers where##2##3##(1990-6#1)(2008-5#1)
of rivers##3##2##(1990-6#1)(1993-9#1)(2008-5#1)
of rizatriptan##2##2##(2005-7#1)(2008-6#1)
of rmIL-12##3##2##(1996-10#3)
of rms roughness##4##3##(2008-2#4)
of rms##5##2##(2008-2#4)(2008-3#1)
of road traffic##6##3##(2008-10#1)(2008-4#1)(2008-8#1)(2010-11#3)
of road##9##2##(2007-4#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-4#1)(2010-11#3)(2013-8#1)
of roadside soils##2##3##(2008-10#2)
of roadside##4##2##(2008-10#3)(2013-1#1)
of roasted##2##2##(2006-12#1)(2008-10#1)
of robot##2##2##(2008-2#1)(2012-1#1)
of robot-assisted##4##2##(2011-3#1)(2012-1#2)(2013-7#1)
of robotic devices##2##3##(2012-1#1)(2013-1#1)
of robotic surgery##2##3##(2006-6#1)(2012-1#1)
of robotic technologies##2##3##(2007-5#1)(2012-1#1)
of robotic technology##2##3##(1994-6#1)(2007-5#1)
of robotic therapy##2##3##(2012-1#2)
of robotic##21##2##(1994-6#1)(2006-6#1)(2007-5#3)(2007-8#2)(2008-11#1)(2011-1#1)(2011-2#1)(2012-1#9)(2013-1#1)(2013-8#1)
of robotic-assisted laparoscopic##3##3##(2006-6#1)(2007-7#2)
of robotic-assisted##5##2##(2006-6#1)(2007-7#2)(2012-1#2)
of robotics##5##2##(1990-12#1)(2006-6#1)(2008-10#2)(2010-7#1)
of robots##6##2##(2007-12#1)(2007-5#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
of robust and##3##3##(2007-12#1)(2008-11#1)(2008-2#1)
of robust clinical data##2##4##(2009-10#1)(2010-6#1)
of robust##21##2##(1993-3#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-7#2)(2009-10#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#1)
of robustness##4##2##(2008-10#2)(2008-2#1)(2009-3#1)
of rock##2##2##(2008-10#1)(2013-8#1)
of rocks##3##2##(1996-4#1)(2008-10#1)(2008-3#1)
of rocuronium in##2##3##(2011-2#1)(2012-12#1)
of rocuronium##5##2##(2009-4#1)(2010-4#1)(2011-2#2)(2012-12#1)
of rod outer segment##2##4##(1993-4#1)(1996-5#1)
of rod outer segments##3##4##(1991-10#1)(1993-8#1)(2008-4#1)
of rod outer##5##3##(1991-10#1)(1993-4#1)(1993-8#1)(1996-5#1)(2008-4#1)
of rod##11##2##(1991-10#1)(1993-4#1)(1993-8#1)(1996-5#1)(1997-4#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2013-8#1)
of rodent and##2##3##(1993-7#1)(1995-7#1)
of rodent brain##2##3##(1991-12#1)(1997-7#1)
of rodent intestinal microsomes##2##4##(2010-2#2)
of rodent pest population##2##4##(2013-8#2)
of rodent##28##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#1)(1992-7#1)(1993-7#2)(1995-7#2)(1997-7#1)(2004-11#2)(2008-11#2)(2008-4#3)(2010-2#2)(2011-1#4)(2012-2#2)(2013-1#1)(2013-8#2)
of rodents##11##2##(1992-6#1)(1993-3#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-5#1)(2006-12#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-2#1)
of rods##3##2##(2009-3#1)(2012-12#2)
of rofecoxib##7##2##(2007-12#6)(2007-8#1)
of roflumilast##2##2##(2010-12#2)
of role conflict and##2##4##(1990-2#2)
of role conflict##3##3##(1990-2#3)
of role modelling##4##3##(2008-12#4)
of role##12##2##(1990-2#3)(2006-8#1)(2007-10#1)(2008-12#4)(2009-11#2)(2009-7#1)
of roles in##2##3##(1996-7#1)(2010-11#1)
of roles##16##2##(1990-12#1)(1991-3#1)(1994-4#1)(1996-7#1)(1997-3#1)(2007-1#1)(2007-4#1)(2007-9#2)(2008-1#1)(2008-11#1)(2009-8#1)(2010-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
of rolling circle plasmid pKYM##2##5##(1997-6#2)
of rolling##3##2##(1997-6#2)(2009-4#1)
of rolling-stock##2##2##(1991-12#2)
of roman age##2##3##(2008-10#2)
of roman##3##2##(2008-10#3)
of romantic disengagement##4##3##(2009-9#4)
of romantic relationship##2##3##(2006-7#1)(2009-9#1)
of romantic relationships in##2##4##(2009-9#1)(2010-8#1)
of romantic relationships##3##3##(2009-9#2)(2010-8#1)
of romantic##9##2##(2006-7#1)(2009-9#7)(2010-8#1)
of romifidine##2##2##(2012-3#1)(2013-1#1)
of room temperature##4##3##(2008-10#1)(2008-5#1)(2009-6#1)(2012-3#1)
of room##6##2##(2008-10#1)(2008-5#1)(2008-6#1)(2009-6#1)(2012-12#1)(2012-3#1)
of room-temperature ionic liquids##2##4##(2007-8#1)(2010-5#1)
of room-temperature##6##2##(1995-5#1)(2007-11#2)(2007-8#1)(2008-10#1)(2010-5#1)
of root and rhizome of Asarum heterotropoides Fr##2##8##(2005-12#2)
of root and rhizome##3##4##(2005-12#3)
of root and##6##3##(2005-12#3)(2008-10#2)(2008-12#1)
of root bark of##3##4##(2007-1#1)(2008-10#1)(2008-12#1)
of root canal##4##3##(1990-4#1)(2008-7#1)(2013-1#2)
of root canals##7##3##(2008-11#1)(2012-12#2)(2012-3#1)(2013-1#3)
of root cells##2##3##(2009-8#2)
of root colonization by##2##4##(2008-10#2)
of root colonization##3##3##(2008-10#3)
of root coverage are##2##4##(2013-1#1)(2013-7#1)
of root disease##2##3##(2008-10#2)
of root exudates from##2##4##(2008-10#1)(2013-8#1)
of root exudates##3##3##(2008-10#1)(2013-8#2)
of root hair##2##3##(2008-10#1)(2009-8#1)
of root infection##3##3##(2008-10#3)
of root necrosis##2##3##(2008-10#2)
of root pathogens##2##3##(2008-10#2)
of root rot##4##3##(2008-10#4)
of root samples##2##3##(2008-10#2)
of root surface biomodification##2##4##(2013-1#2)
of root##79##2##(1990-4#1)(1997-5#1)(2005-11#1)(2005-12#3)(2007-1#1)(2008-10#39)(2008-11#2)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#2)(2009-8#6)(2010-5#1)(2011-12#1)(2012-12#2)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#2)
of root-knot nematodes##2##3##(2008-10#2)
of root-knot##3##2##(2008-10#3)
of roots and##5##3##(2006-1#1)(2007-1#2)(2008-10#1)(2009-10#1)
of roots for##2##3##(2007-3#1)(2008-9#1)
of roots from##3##3##(2008-10#3)
of roots of##6##3##(2007-1#2)(2010-2#2)(2010-5#1)(2012-12#1)
of roots was##2##3##(2008-10#2)
of roots##29##2##(2006-1#1)(2007-1#4)(2007-3#1)(2008-10#13)(2008-5#1)(2008-9#1)(2009-10#2)(2010-2#2)(2010-5#1)(2012-1#2)(2012-12#1)
of ropinirole##5##2##(2005-7#1)(2008-7#2)(2010-2#2)
of ropivacaine in##2##3##(2006-10#1)(2010-12#1)
of ropivacaine##4##2##(2006-10#3)(2010-12#1)
of rosacea##2##2##(2006-12#1)(2013-1#1)
of rosiglitazone##4##2##(2008-11#1)(2008-3#1)(2010-4#1)(2010-7#1)
of rosmarinic acid##2##3##(2013-1#2)
of rotating constant magnetic field##2##5##(2008-8#2)
of rotating objects with##2##4##(2008-3#2)
of rotating the##2##3##(2008-3#2)
of rotating##8##2##(1992-3#1)(2008-2#1)(2008-3#4)(2008-8#2)
of rotation of the##7##4##(1997-8#1)(2006-4#1)(2007-12#1)(2008-3#2)(2009-8#1)(2012-1#1)
of rotation of##9##3##(1997-1#1)(1997-8#1)(2006-4#1)(2007-12#1)(2008-3#2)(2009-8#1)(2012-1#1)(2012-2#1)
of rotation rate##3##3##(1996-5#1)(1997-2#1)(2008-11#1)
of rotation##35##2##(1990-3#1)(1992-10#2)(1995-5#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-4#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-8#1)(2008-11#3)(2008-2#1)(2008-3#3)(2008-5#1)(2009-6#1)(2009-8#1)(2011-1#1)(2012-1#3)(2012-2#3)
of rotational mobility##2##3##(1990-4#1)(2008-4#1)
of rotational##13##2##(1990-4#1)(1991-5#1)(1991-7#1)(2007-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
of rotator cuff##5##3##(2006-10#1)(2007-11#2)(2009-9#1)(2012-2#1)
of rotavirus infection was##2##4##(2011-2#2)
of rotavirus infection##3##3##(2007-6#1)(2011-2#2)
of rotavirus infections##2##3##(2009-5#2)
of rotavirus##12##2##(2006-10#1)(2006-12#1)(2007-11#1)(2007-6#1)(2008-12#1)(2008-5#1)(2009-5#2)(2011-2#2)(2012-1#2)
of rotavirus-associated diarrhea##2##3##(2007-12#2)
of rotenone in##2##3##(1996-9#1)(2013-8#1)
of rotenone##9##2##(1994-12#1)(1994-8#1)(1995-3#1)(1996-9#3)(1997-6#1)(2011-1#1)(2013-8#1)
of rotifers##3##2##(2008-5#1)(2010-8#1)(2012-2#1)
of rotting##2##2##(2007-4#1)(2008-10#1)
of rough endoplasmic reticulum##4##4##(1992-6#2)(2008-7#2)
of rough microsomes##2##3##(1992-6#2)
of rough surfaces##7##3##(2008-2#3)(2008-3#4)
of rough##19##2##(1992-6#4)(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#5)(2008-3#5)(2008-7#2)
of roughly 1##2##3##(2008-10#1)(2008-7#1)
of roughly##6##2##(2007-9#1)(2008-10#2)(2008-7#2)(2011-2#1)
of roughness##2##2##(2006-12#1)(2008-3#1)
of round##11##2##(1991-3#1)(1997-4#3)(2007-12#1)(2007-8#1)(2008-2#1)(2008-5#1)(2008-6#1)(2012-12#1)(2012-3#1)
of routine health##2##3##(2009-6#1)(2010-9#1)
of routine interventions##2##3##(2008-9#1)(2011-2#1)
of routine transabdominal##2##3##(2008-7#2)
of routine wrist radiography##2##4##(2008-9#2)
of routine##50##2##(1990-6#1)(1991-11#1)(1991-12#1)(1992-6#1)(1993-1#1)(1994-1#1)(1994-6#1)(1995-2#1)(1996-12#1)(1997-3#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-2#2)(2006-9#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#3)(2008-9#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-8#2)
of routinely##6##2##(2008-6#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
of rows##4##2##(2007-9#1)(2008-10#1)(2010-6#1)(2013-8#1)
of roxarsone##3##2##(2010-11#3)
of rs12979860##2##2##(2012-12#1)(2013-1#1)
of rs2241766##2##2##(2011-1#2)
of rs266729##3##2##(2011-1#3)
of rt-PA use in##3##4##(2007-10#2)(2008-8#1)
of rt-PA use##4##3##(2007-10#3)(2008-8#1)
of rt-PA##6##2##(1993-2#1)(1997-8#1)(2007-10#3)(2008-8#1)
of rtN236T##3##2##(2013-1#3)
of rubidate##5##2##(2008-10#5)
of rubidium in##2##3##(2008-10#2)
of rubidium##5##2##(2007-12#1)(2008-10#3)(2008-3#1)
of rubisco##2##2##(1991-9#2)
of rubrerythrin##2##2##(1991-11#1)(1991-12#1)
of rudimentary##6##2##(1997-2#2)(2008-7#1)(2008-9#2)(2011-1#1)
of rules in##2##3##(1995-6#1)(2008-2#1)
of rules to##2##3##(2007-4#1)(2008-3#1)
of rules##17##2##(1990-11#1)(1995-6#1)(1996-3#1)(1997-8#1)(2005-10#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)(2013-1#4)
of ruling out##2##3##(2008-4#1)(2012-2#1)
of rumen bacteria##2##3##(2006-5#1)(2006-8#1)
of rumen##3##2##(2006-5#1)(2006-8#1)(2012-12#1)
of ruminal##2##2##(1991-12#1)(2006-8#1)
of ruminant##2##2##(2011-2#1)(2012-3#1)
of ruminants in##2##3##(1997-7#1)(2007-8#1)
of ruminants##8##2##(1996-10#1)(1997-7#2)(2006-10#1)(2006-8#1)(2007-8#1)(2011-1#1)(2013-1#1)
of ruminative thinking##3##3##(2008-8#1)(2012-1#2)
of running buffer##2##3##(2008-10#2)
of running##6##2##(1996-2#1)(2005-7#1)(2006-5#1)(2008-10#2)(2010-2#1)
of runoff##2##2##(2008-1#1)(2008-10#1)
of rupintrivir##2##2##(2008-10#2)
of rupture of pregnant uterus##2##5##(2008-7#2)
of rupture of the##5##4##(1992-2#1)(1994-7#1)(1996-1#1)(2005-7#1)(2012-2#1)
of rupture of##10##3##(1991-6#1)(1992-2#2)(1994-7#1)(1996-1#1)(2005-7#1)(2008-7#2)(2011-2#1)(2012-2#1)
of rupture##23##2##(1991-6#1)(1992-2#2)(1993-10#1)(1994-1#1)(1994-7#1)(1996-1#1)(2005-7#1)(2006-10#1)(2007-7#2)(2007-8#2)(2008-6#1)(2008-7#3)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
of ruptured cerebral##2##3##(1997-3#1)(2007-11#1)
of ruptured fetal membranes##4##4##(1993-1#2)(1996-9#2)
of ruptured intracranial aneurysms##2##4##(2006-7#1)(2008-7#1)
of ruptured intracranial##3##3##(2006-7#1)(2008-7#1)(2010-9#1)
of ruptured##18##2##(1990-5#1)(1993-1#2)(1996-9#2)(1997-3#1)(2006-10#1)(2006-4#2)(2006-7#1)(2007-11#1)(2007-3#1)(2008-7#2)(2010-5#2)(2010-9#1)(2013-8#1)
of rural and urban##3##4##(1994-2#1)(2010-3#1)(2011-11#1)
of rural areas##2##3##(2007-7#1)(2008-3#1)
of rural hospitals##2##3##(1992-12#1)(1993-2#1)
of rural##31##2##(1990-12#2)(1991-1#1)(1992-12#3)(1993-12#1)(1993-2#1)(1994-2#1)(1996-1#1)(1996-3#2)(1997-1#1)(1997-2#1)(2006-4#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-3#1)(2011-11#1)(2011-2#2)(2013-1#1)
of rust on leaves##2##4##(2008-10#2)
of rust on##4##3##(2008-10#4)
of rust##21##2##(2008-10#21)
of rusts##2##2##(2008-10#2)
of rutaecarpine##2##2##(1996-12#2)
of ruthenium and##3##3##(2008-10#3)
of ruthenium oxide materials##2##4##(2010-4#2)
of ruthenium oxide##3##3##(2006-12#1)(2010-4#2)
of ruthenium red##2##3##(1990-5#1)(2008-8#1)
of ruthenium##19##2##(1990-5#1)(2006-12#1)(2008-10#11)(2008-12#1)(2008-5#1)(2008-8#1)(2010-4#2)(2010-7#1)
of ruthenium(II)##2##2##(2008-10#2)
of rutile##8##2##(2005-11#2)(2007-12#2)(2008-1#1)(2008-3#3)
of rutin and##2##3##(2008-10#1)(2008-9#1)
of rutin in##4##3##(2008-10#4)
of rutin##18##2##(1997-8#1)(2008-10#12)(2008-6#1)(2008-9#1)(2010-12#3)
of ryanodine##6##2##(1990-2#2)(1991-3#1)(1992-1#1)(1992-3#1)(2010-11#1)
of rye##6##2##(2008-10#4)(2008-5#2)
of s and##2##3##(2008-3#2)
of s##9##2##(1993-7#2)(1997-7#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-3#3)
of s(x)##2##2##(2008-3#2)
of s(z)##2##2##(2008-3#2)
of s-adenosylmethionine##2##2##(2008-4#1)(2008-9#1)
of s-polarized##3##2##(2008-2#1)(2008-3#2)
of sFasL##2##2##(2008-8#1)(2010-12#1)
of sGC##2##2##(1997-2#1)(2008-8#1)
of sGFP418##2##2##(2009-10#2)
of sICAM-1 in##2##3##(1993-8#2)
of sICAM-1##3##2##(1993-8#3)
of sIL-1R I##2##3##(2008-10#2)
of sIL-1R##4##2##(1995-2#2)(2008-10#2)
of sIL-6R##2##2##(1994-2#1)(1997-7#1)
of sIgA##2##2##(2008-5#1)(2011-1#1)
of sIgM-mediated##2##2##(1992-9#2)
of sPLA2I and PGHS2##2##4##(1996-8#2)
of sPLA2I and##3##3##(1996-8#3)
of sPhoA##2##2##(1993-3#2)
of sRANKL##2##2##(2010-10#2)
of saGH gene##2##3##(2008-3#2)
of saccades##4##2##(1991-5#1)(1995-1#1)(1996-1#1)(2009-2#1)
of saccadic##3##2##(1991-10#1)(1993-12#1)(2006-7#1)
of saccharides##2##2##(1991-7#1)(2008-4#1)
of saccharin##2##2##(1995-12#1)(2008-5#1)
of sacral##5##2##(1993-12#1)(2006-9#1)(2007-9#2)(2010-9#1)
of sacrifice##2##2##(1991-11#1)(2008-1#1)
of sacrococcygeal teratoma##2##3##(2005-11#2)
of sacroiliac joint injections is##2##5##(2006-8#2)
of sacroiliac joint##7##3##(2005-10#1)(2006-8#6)
of sacroiliac joints in##2##4##(2011-2#2)
of sacroiliac##10##2##(2005-10#1)(2006-8#6)(2007-11#1)(2011-2#2)
of sacroiliitis##2##2##(2006-10#2)
of sadness##2##2##(2008-11#1)(2012-12#1)
of safe abortion##2##3##(2011-1#1)(2011-2#1)
of safe and effective##11##4##(2006-10#1)(2006-2#1)(2007-11#1)(2008-8#1)(2009-5#1)(2010-2#1)(2012-2#1)(2013-1#4)
of safe and##16##3##(2005-5#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-12#1)(2008-8#1)(2009-5#1)(2010-10#1)(2010-2#2)(2012-2#1)(2013-1#4)(2013-8#1)
of safe sex##2##3##(1997-6#2)
of safe use of##2##4##(2006-10#1)(2011-2#1)
of safe use##3##3##(2006-10#1)(2011-1#1)(2011-2#1)
of safe##37##2##(1995-1#1)(1997-6#2)(2005-10#1)(2005-5#1)(2006-10#3)(2006-2#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#2)(2010-10#1)(2010-12#1)(2010-2#2)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#2)
of safeguarding##2##2##(2007-11#1)(2013-1#1)
of safer##3##2##(2009-5#2)(2011-2#1)
of safety and efficacy##5##4##(2006-1#1)(2006-5#2)(2007-10#1)(2008-8#1)
of safety and##13##3##(1992-2#1)(1995-2#1)(2006-1#1)(2006-5#2)(2007-10#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
of safety data##5##3##(2008-11#2)(2008-8#1)(2010-5#1)(2012-3#1)
of safety equipment##2##3##(2007-3#1)(2012-3#1)
of safety issues##2##3##(2006-10#1)(2008-8#1)
of safety of##3##3##(2006-10#1)(2009-2#1)(2011-12#1)
of safety requirements##2##3##(2012-1#2)
of safety##58##2##(1991-2#1)(1992-2#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-3#1)(2005-11#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-5#3)(2006-8#1)(2006-9#1)(2007-10#2)(2007-3#1)(2008-1#2)(2008-11#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#2)(2009-2#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-3#2)(2013-1#4)
of saffron##5##2##(2007-8#2)(2008-10#2)(2008-12#1)
of safranal##2##2##(2007-8#2)
of sagittal synostosis##2##3##(1996-3#1)(2006-7#1)
of sagittal##5##2##(1996-3#1)(2006-7#2)(2007-9#1)(2011-12#1)
of said##2##2##(2009-11#1)(2011-1#1)
of saikosaponin c##3##3##(2008-11#3)
of salbutamol and##2##3##(1993-2#1)(2008-10#1)
of salbutamol in pharmaceutical products##2##5##(2008-10#2)
of salbutamol in pharmaceutical##3##4##(2008-10#3)
of salbutamol in##5##3##(2008-10#4)(2008-11#1)
of salbutamol sulphate and bromhexine hydrochloride##3##6##(2010-2#3)
of salbutamol with 4-aminoantipyrine##2##4##(2008-10#2)
of salbutamol##29##2##(1992-1#2)(1993-2#1)(1996-1#3)(1996-12#1)(1996-2#2)(2004-12#1)(2008-10#14)(2008-11#2)(2010-2#3)
of sales##2##2##(1990-12#1)(2005-7#1)
of salicylaldehyde##3##2##(2008-10#2)(2010-5#1)
of salicylate hydroxylase (PpG7) was##2##5##(1990-6#2)
of salicylate hydroxylase##3##3##(1990-6#3)
of salicylate in##3##3##(2008-10#3)
of salicylate##10##2##(1990-3#1)(1990-6#3)(1993-12#1)(2008-10#3)(2008-2#1)(2009-6#1)
of salicylic acid (SA)##3##4##(2008-10#3)
of salicylic acid and its derivatives##2##6##(1993-11#2)
of salicylic acid and its##3##5##(1993-11#3)
of salicylic acid and##4##4##(1993-11#3)(2008-5#1)
of salicylic acid in##4##4##(2007-8#1)(2008-10#3)
of salicylic acid##28##3##(1993-11#3)(1996-6#1)(2007-12#1)(2007-8#6)(2008-10#13)(2008-5#2)(2009-10#1)(2013-8#1)
of salicylic##29##2##(1993-11#3)(1996-6#1)(2007-12#1)(2007-8#6)(2008-10#14)(2008-5#2)(2009-10#1)(2013-8#1)
of salient##2##2##(2005-8#1)(2007-12#1)
of saline (0##3##3##(1994-10#1)(1997-4#1)(2011-2#1)
of saline in the##2##4##(1993-10#1)(2008-9#1)
of saline or##6##3##(1991-6#1)(1993-12#1)(1994-2#1)(2008-10#1)(2012-12#1)(2013-1#1)
of saline##34##2##(1990-7#2)(1991-12#1)(1991-6#1)(1993-10#4)(1993-12#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-3#1)(1997-2#1)(1997-4#2)(2006-5#2)(2006-9#2)(2008-1#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
of saline-treated##2##2##(1995-12#1)(1996-10#1)
of salinity on##2##3##(2004-2#2)
of salinity##10##2##(2004-2#2)(2008-12#1)(2008-2#1)(2008-3#2)(2009-8#1)(2011-12#2)(2013-7#1)
of saliva testing##3##3##(2007-2#3)
of saliva was##2##3##(1996-6#1)(2010-5#1)
of saliva##17##2##(1991-8#1)(1996-6#2)(2004-11#1)(2006-2#1)(2006-4#2)(2007-2#4)(2008-11#1)(2009-6#2)(2010-5#1)(2012-12#1)(2012-3#1)
of salivary gland tumours##4##4##(2010-12#1)(2012-2#3)
of salivary gland##13##3##(1991-11#1)(1992-5#1)(2004-11#1)(2006-4#1)(2007-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-7#1)(2012-2#3)(2012-3#1)
of salivary glands##5##3##(2007-12#1)(2008-4#1)(2008-8#1)(2011-2#2)
of salivary##33##2##(1990-6#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-5#2)(2004-11#1)(2006-4#1)(2007-12#2)(2007-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#2)(2010-12#4)(2010-5#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#2)
of salmeterol##2##2##(1996-2#2)
of salmon calcitonin##6##3##(1990-3#2)(1992-8#2)(2006-12#2)
of salmon##8##2##(1990-3#2)(1992-6#1)(1992-8#2)(2006-12#2)(2012-2#1)
of salmonella##3##2##(1996-3#2)(1997-3#1)
of salmonelloses##2##2##(1993-1#1)(1997-3#1)
of salmonellosis##3##2##(1991-3#1)(2006-10#1)(2011-2#1)
of salsalate##5##2##(2008-10#4)(2009-4#1)
of salt and##7##3##(1994-8#1)(1997-8#1)(2006-4#1)(2008-8#1)(2012-2#1)(2013-1#2)
of salt concentration##2##3##(1990-7#1)(2009-12#1)
of salt in##2##3##(2012-2#1)(2013-1#1)
of salt on the##2##4##(2005-11#1)(2010-4#1)
of salt restriction##2##3##(1991-9#1)(1995-9#1)
of salt split technique of immunofluorescence##2##6##(2007-7#2)
of salt stress##3##3##(2008-11#1)(2009-8#2)
of salt tolerant rice##2##4##(2008-12#2)
of salt tolerant##3##3##(2008-12#2)(2011-12#1)
of salt##59##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-9#1)(1993-6#1)(1993-9#1)(1994-8#1)(1995-6#1)(1995-9#1)(1996-8#1)(1997-8#1)(2005-11#2)(2006-10#3)(2006-12#1)(2006-4#2)(2007-11#2)(2007-2#2)(2007-7#2)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#3)(2010-4#1)(2011-12#1)(2012-2#3)(2013-1#7)(2013-8#1)
of salt-induced leaf##2##3##(2004-4#2)
of saltatory##2##2##(2008-12#1)(2010-8#1)
of salted##2##2##(2011-2#2)
of saltiness##2##2##(1990-9#1)(2010-4#1)
of salts on water##2##4##(2005-11#1)(2009-10#1)
of salts on##3##3##(2005-11#1)(2008-10#1)(2009-10#1)
of salts##11##2##(1990-2#1)(1991-5#1)(2005-11#1)(2006-10#1)(2008-10#4)(2009-10#1)(2009-6#1)(2009-8#1)
of salvage##4##2##(2006-9#1)(2007-5#1)(2008-1#1)(2013-1#1)
of salvation##2##2##(2008-4#1)(2008-5#1)
of salvia miltiorrhiza pretreatment##2##4##(2010-12#2)
of salvianolic##2##2##(2008-10#2)
of salvinorin A##5##3##(2008-7#1)(2009-2#3)(2009-3#1)
of salvinorin##6##2##(2008-7#1)(2009-2#3)(2009-3#2)
of samarium##3##2##(2008-10#3)
of same age##3##3##(2006-7#1)(2008-10#1)(2008-7#1)
of same##9##2##(1993-3#1)(2006-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
of same-sex##2##2##(2008-9#1)(2009-7#1)
of sample and eluent##3##4##(2008-10#3)
of sample and reagent##4##4##(2008-10#4)
of sample and reagents##5##4##(2008-10#4)(2010-7#1)
of sample and##23##3##(1992-2#1)(2007-7#1)(2008-10#20)(2010-7#1)
of sample and/or standard solution containing##2##6##(2008-10#2)
of sample collection##2##3##(1992-7#1)(2008-10#1)
of sample concentration##2##3##(1996-5#1)(2008-10#1)
of sample dilution##3##3##(1995-1#2)(2008-10#1)
of sample handling##2##3##(2008-10#2)
of sample is##5##3##(2007-8#1)(2008-10#4)
of sample matrix##5##3##(2008-10#5)
of sample or standard##2##4##(2008-10#2)
of sample or##3##3##(2008-10#3)
of sample preparation and##3##4##(2008-10#1)(2008-5#1)(2010-7#1)
of sample preparation for##2##4##(2008-1#1)(2008-4#1)
of sample preparation methods##3##4##(2008-10#2)(2012-12#1)
of sample preparation##20##3##(1994-12#1)(1994-9#2)(1996-7#1)(2005-11#1)(2008-1#1)(2008-10#7)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#1)(2010-7#1)(2012-12#1)
of sample pretreatment##4##3##(1992-2#1)(2005-4#1)(2008-10#2)
of sample processing##2##3##(2008-10#1)(2008-11#1)
of sample size##7##3##(1994-6#1)(1994-9#1)(1995-4#1)(1996-7#1)(2006-10#1)(2012-1#1)(2012-3#1)
of sample sizes##3##3##(1993-1#1)(2008-2#1)(2012-3#1)
of sample solution and eluent##3##5##(2008-10#3)
of sample solution and##5##4##(2008-10#5)
of sample solution gave a##2##5##(2008-10#2)
of sample solution is##3##4##(2008-10#3)
of sample solution were##2##4##(2008-10#2)
of sample solution##27##3##(2008-10#26)(2013-8#1)
of sample solutions##3##3##(2007-8#1)(2008-10#2)
of sample to##4##3##(2008-10#3)(2008-3#1)
of sample treatment##2##3##(2008-10#2)
of sample types##3##3##(2008-10#2)(2008-3#1)
of sample volume in##2##4##(2007-8#1)(2008-10#1)
of sample volume##5##3##(2007-8#1)(2008-10#4)
of sample volume)##4##3##(2008-10#4)
of sample was used and the L(D) was approximately##2##9##(2008-10#2)
of sample was##4##3##(2008-10#4)
of sample with a##2##4##(2008-10#2)
of sample with##5##3##(1990-11#1)(2008-10#4)
of sample##234##2##(1990-11#1)(1991-8#1)(1992-2#2)(1992-7#1)(1993-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#4)(1995-1#3)(1995-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(2004-11#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#11)(2008-1#1)(2008-10#146)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#4)(2009-10#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#4)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#2)
of sample)##2##2##(2008-10#2)
of sampled##5##2##(1991-3#1)(1992-1#1)(2006-12#1)(2008-10#1)(2008-2#1)
of samples and reagents##3##4##(1991-3#1)(2008-10#2)
of samples and the##3##4##(2008-10#2)(2008-7#1)
of samples and##16##3##(1991-3#1)(2005-4#1)(2006-12#1)(2007-2#1)(2008-10#8)(2008-7#2)(2013-1#2)
of samples are##5##3##(2008-10#2)(2009-11#1)(2011-1#1)(2011-2#1)
of samples before##2##3##(2008-10#1)(2008-2#1)
of samples by##5##3##(1996-12#1)(2008-10#3)(2008-3#1)
of samples collected in##2##4##(2011-2#2)
of samples collected##4##3##(2008-7#1)(2009-2#1)(2011-2#2)
of samples could be##2##4##(2008-10#2)
of samples for##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
of samples from##12##3##(1993-9#1)(1994-7#1)(1997-3#1)(2006-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2013-1#1)
of samples have##2##3##(2008-10#1)(2009-4#1)
of samples having##2##3##(2007-12#1)(2008-10#1)
of samples in a##4##4##(2008-10#1)(2008-11#1)(2008-3#1)(2010-11#1)
of samples in##11##3##(1990-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-2#1)(2010-11#1)(2011-2#2)(2012-2#1)
of samples into##2##3##(2008-10#1)(2008-9#1)
of samples is##3##3##(2008-10#3)
of samples obtained by##3##4##(1996-6#1)(2008-1#1)(2008-10#1)
of samples obtained##4##3##(1996-6#1)(1996-9#1)(2008-1#1)(2008-10#1)
of samples of##8##3##(1992-1#1)(2005-8#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-7#1)
of samples prepared##2##3##(2005-11#1)(2011-1#1)
of samples prior to##2##4##(2008-4#1)(2013-8#1)
of samples that##5##3##(2005-8#1)(2007-5#1)(2008-10#2)(2008-2#1)
of samples to##3##3##(1994-3#1)(2006-8#1)(2010-4#1)
of samples was carried out##2##5##(2007-8#1)(2008-10#1)
of samples was##8##3##(2007-8#1)(2008-10#7)
of samples were##9##3##(2007-10#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2013-8#2)
of samples which##2##3##(2006-8#1)(2009-5#1)
of samples with a##3##4##(2006-12#1)(2007-10#1)(2008-11#1)
of samples with##21##3##(1990-12#1)(1995-10#1)(1996-9#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2013-1#2)(2013-8#1)
of samples##239##2##(1990-12#2)(1991-3#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-9#2)(1994-3#1)(1994-7#1)(1995-10#1)(1996-12#1)(1996-6#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(2005-11#2)(2005-4#2)(2005-8#2)(2006-12#3)(2006-2#1)(2006-8#2)(2007-1#2)(2007-10#4)(2007-11#3)(2007-12#2)(2007-2#2)(2007-3#3)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#102)(2008-11#5)(2008-12#2)(2008-2#6)(2008-3#7)(2008-4#7)(2008-5#3)(2008-7#4)(2008-9#7)(2009-11#2)(2009-2#2)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2011-1#3)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#7)(2013-8#7)
of samples)##3##2##(2008-10#2)(2008-4#1)
of sampling and##4##3##(1992-12#1)(1995-7#1)(2008-10#1)(2012-3#1)
of sampling design##2##3##(2008-10#1)(2013-7#1)
of sampling is##2##3##(1994-6#1)(2008-10#1)
of sampling points##3##3##(2008-10#1)(2008-3#2)
of sampling techniques##2##3##(2008-10#2)
of sampling the##3##3##(1991-5#1)(2008-3#1)(2008-5#1)
of sampling units##5##3##(2008-10#4)(2011-2#1)
of sampling##64##2##(1991-5#1)(1992-12#1)(1992-2#1)(1994-11#1)(1994-6#2)(1995-7#1)(2006-12#1)(2006-4#1)(2007-12#1)(2007-6#1)(2008-10#29)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-4#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-7#2)
of samplings##2##2##(2008-10#2)
of sanA##2##2##(2008-9#2)
of sand flies##6##3##(2004-11#3)(2008-12#1)(2013-1#2)
of sand fly##2##3##(2008-12#1)(2012-2#1)
of sand##12##2##(2004-11#3)(2008-12#2)(2008-7#4)(2012-2#1)(2013-1#2)
of sandy soils##2##3##(2008-10#1)(2013-7#1)
of sandy##4##2##(2008-1#1)(2008-10#1)(2011-1#1)(2013-7#1)
of sanguinarine iminium form##2##4##(1994-11#2)
of sanguinarine iminium##3##3##(1994-11#3)
of sanguinarine##7##2##(1994-11#3)(2006-10#3)(2011-2#1)
of sanitary measures##2##3##(1994-3#1)(2008-8#1)
of sanitary##5##2##(1994-3#1)(2007-1#1)(2007-6#1)(2008-8#1)(2011-12#1)
of sap flow##2##3##(2008-5#2)
of sap##3##2##(2008-10#1)(2008-5#2)
of saphenous vein graft##6##4##(2007-8#3)(2008-12#1)(2009-5#1)(2012-2#1)
of saphenous vein##7##3##(2005-10#1)(2007-8#3)(2008-12#1)(2009-5#1)(2012-2#1)
of saphenous##10##2##(1994-2#1)(1995-11#1)(1996-5#1)(2005-10#1)(2007-8#3)(2008-12#1)(2009-5#1)(2012-2#1)
of saplings in the##2##4##(2008-5#1)(2008-9#1)
of saplings##5##2##(2008-5#3)(2008-9#1)(2012-9#1)
of saponin##5##2##(1995-8#1)(1997-2#4)
of saponin-skinned human muscle fibers##2##5##(1994-12#2)
of saponins##8##2##(1997-2#1)(1997-4#1)(2008-10#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
of sapphire##2##2##(2008-3#2)
of saprophytic##3##2##(2007-7#1)(2011-2#1)(2013-1#1)
of sapstain##3##2##(2008-10#3)
of saquinavir##2##2##(1995-9#1)(2004-12#1)
of sarafotoxin##2##2##(1992-12#1)(1994-11#1)
of sarcoidosis is##2##3##(2005-8#1)(2007-11#1)
of sarcoidosis patients##3##3##(2006-10#1)(2007-10#1)(2007-11#1)
of sarcoidosis##32##2##(1997-5#1)(2005-8#4)(2006-10#5)(2006-8#1)(2007-10#5)(2007-11#4)(2007-6#1)(2008-1#1)(2008-4#2)(2009-2#1)(2010-6#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)
of sarcolemmal##2##2##(1993-2#1)(2008-1#1)
of sarcoma arising in##2##4##(2008-6#1)(2013-7#1)
of sarcoma was##2##3##(2008-6#1)(2008-7#1)
of sarcoma##10##2##(1991-9#1)(1996-4#1)(2008-6#5)(2008-7#1)(2011-2#1)(2013-7#1)
of sarcomas##7##2##(2008-6#4)(2008-7#1)(2013-1#1)(2013-7#1)
of sarcomatoid carcinoma##2##3##(2012-12#2)
of sarcomatous##2##2##(1993-6#1)(2008-6#1)
of sarcoplasmic reticulum (SR)##2##4##(1991-2#1)(1993-12#1)
of sarcoplasmic reticulum Ca(2+)-ATPase##2##4##(1994-3#1)(2010-12#1)
of sarcoplasmic reticulum is##2##4##(1990-3#1)(1996-12#1)
of sarcoplasmic reticulum##23##3##(1990-11#2)(1990-2#1)(1990-3#2)(1990-7#2)(1991-2#2)(1991-8#1)(1991-9#2)(1992-11#2)(1993-12#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-12#1)(1997-7#1)(2010-12#1)
of sarcoplasmic##24##2##(1990-11#2)(1990-2#1)(1990-3#2)(1990-7#2)(1991-2#2)(1991-8#1)(1991-9#2)(1992-11#2)(1993-12#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-12#1)(1997-7#1)(2010-12#1)(2010-4#1)
of satRNA##2##2##(2008-10#2)
of satRNAs##2##2##(2008-10#2)
of satellite DNA##5##3##(1996-9#3)(2008-10#1)(2010-8#1)
of satellite RNA##2##3##(1990-7#1)(2008-10#1)
of satellite cells##4##3##(1993-3#1)(2008-7#1)(2009-3#2)
of satellite imagery over mountainous terrain##2##6##(2008-2#2)
of satellite images##2##3##(2008-2#2)
of satellite tobacco mosaic virus (STMV)##2##6##(2008-10#1)(2008-9#1)
of satellite tobacco mosaic virus##3##5##(2008-10#2)(2008-9#1)
of satellite##32##2##(1990-3#1)(1990-7#1)(1993-3#1)(1996-9#3)(2007-12#1)(2008-10#5)(2008-2#8)(2008-3#5)(2008-7#1)(2008-9#1)(2009-3#3)(2010-8#1)(2013-8#1)
of satellites in the##2##4##(2007-9#1)(2012-2#1)
of satellites##3##2##(2007-9#2)(2012-2#1)
of saterinone##5##2##(1990-12#5)
of satiety##2##2##(1991-8#1)(2004-12#1)
of satisfaction and##4##3##(1995-12#1)(2007-5#1)(2008-10#1)(2008-2#1)
of satisfaction was##2##3##(2006-4#1)(2012-2#1)
of satisfaction with the##6##4##(1990-10#1)(1993-12#1)(1994-8#1)(2007-7#1)(2008-11#1)(2013-8#1)
of satisfaction with##10##3##(1990-10#1)(1993-12#1)(1994-8#1)(1996-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-11#1)(2012-2#1)(2013-8#1)
of satisfaction##33##2##(1990-10#1)(1992-1#1)(1992-2#1)(1993-12#1)(1994-8#1)(1995-12#1)(1995-9#1)(1996-3#1)(2006-10#1)(2006-4#3)(2007-11#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-7#1)(2008-8#2)(2009-9#1)(2012-2#2)(2013-8#3)
of satisfactory##5##2##(1992-11#1)(1996-12#1)(2005-4#1)(2007-8#1)(2012-2#1)
of saturable##4##2##(1992-6#1)(1993-1#1)(1994-2#1)(2007-12#1)
of saturated aldehydes as lipid oxidation markers in washed turkey##2##10##(2010-4#2)
of saturated and trans##2##4##(2005-12#1)(2011-2#1)
of saturated fatty acids and cholesterol##3##6##(1992-8#2)(2004-11#1)
of saturated fatty acids in##3##5##(2005-12#1)(2006-12#2)
of saturated fatty acids is##2##5##(2006-12#1)(2008-12#1)
of saturated fatty acids##12##4##(1990-2#2)(1992-8#2)(2004-11#1)(2005-12#1)(2006-12#3)(2008-11#1)(2008-12#1)(2012-2#1)
of saturated##29##2##(1990-2#3)(1990-7#1)(1992-8#2)(1994-9#1)(2004-11#3)(2005-10#1)(2005-12#2)(2006-12#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2010-4#2)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
of saturating pump intensities minimizes the##2##6##(2008-3#2)
of saturating##8##2##(1990-10#1)(1995-11#1)(1995-8#1)(1996-9#1)(1997-2#1)(2008-3#2)(2008-8#1)
of saturation and##3##3##(1995-12#1)(2006-3#1)(2008-3#1)
of saturation in##2##3##(2008-3#1)(2010-10#1)
of saturation##24##2##(1990-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(2005-11#1)(2006-3#2)(2007-12#2)(2008-2#2)(2008-3#6)(2010-10#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#2)
of saudi arabia##4##3##(2008-1#3)(2012-2#1)
of saudi##5##2##(2007-7#1)(2008-1#3)(2012-2#1)
of sauna bathing##3##3##(2008-7#3)
of sauropsids##2##2##(2010-3#2)
of saving##2##2##(2006-2#1)(2008-2#1)
of savings for##2##3##(1991-1#1)(2013-8#1)
of savings##3##2##(1991-1#1)(1995-2#1)(2013-8#1)
of saw##3##2##(2006-9#1)(2008-12#1)(2008-8#1)
of sawdust##3##2##(2008-5#1)(2008-9#1)(2013-1#1)
of saxiphilin##4##2##(1994-3#4)
of scFv##4##2##(1994-12#2)(2008-10#1)(2008-4#1)
of scab on##2##3##(2008-10#2)
of scab##10##2##(2008-10#10)
of scabies##7##2##(1996-12#1)(2005-11#1)(2006-10#2)(2010-2#1)(2010-6#2)
of scaffold##3##2##(2010-9#1)(2012-11#1)(2012-2#1)
of scalar diffraction##3##3##(2008-3#3)
of scalar##7##2##(2007-12#2)(2008-2#1)(2008-3#4)
of scalding##2##2##(1991-12#2)
of scale cells in##2##4##(2007-9#2)
of scale cells##3##3##(2007-9#3)
of scale##24##2##(1991-2#1)(1992-2#1)(1994-3#1)(1996-1#1)(1997-1#1)(2006-2#1)(2007-12#2)(2007-8#1)(2007-9#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
of scaled##3##2##(2008-2#2)(2012-3#1)
of scales and##2##3##(2007-9#1)(2008-3#1)
of scales##15##2##(2006-12#1)(2007-12#1)(2007-9#3)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#3)
of scaling in##2##3##(1993-12#1)(1993-5#1)
of scaling##14##2##(1993-12#1)(1993-5#1)(2007-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#6)(2008-8#1)
of scalp##12##2##(1990-2#1)(1992-4#1)(1994-2#1)(2005-11#1)(2007-7#2)(2007-8#1)(2008-6#2)(2011-12#2)(2012-11#1)
of scan##3##2##(2005-11#1)(2006-4#1)(2008-10#1)
of scandium(III) and yttrium(III)##3##4##(2008-10#3)
of scanning calorimetry##2##3##(1993-11#1)(1997-2#1)
of scanning electron microscopy (SEM)##2##5##(2008-10#1)(2008-8#1)
of scanning electron microscopy##5##4##(2007-12#1)(2007-5#1)(2008-10#1)(2008-8#1)(2012-2#1)
of scanning electron##6##3##(2007-12#1)(2007-5#1)(2008-10#1)(2008-6#1)(2008-8#1)(2012-2#1)
of scanning the##2##3##(2006-7#1)(2008-3#1)
of scanning##27##2##(1993-11#1)(1995-11#1)(1997-2#1)(1997-7#1)(2006-7#1)(2007-12#3)(2007-5#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#6)(2008-6#1)(2008-7#2)(2008-8#1)(2011-1#1)(2012-2#1)
of scaphoid nonunions with##2##4##(2006-3#1)(2008-9#1)
of scaphoid##6##2##(2006-3#1)(2007-11#2)(2008-9#1)(2012-2#2)
of scapholunate##2##2##(2006-4#1)(2013-1#1)
of scar formation##2##3##(2006-7#1)(2008-9#1)
of scar tissue##2##3##(1997-3#1)(2013-7#1)
of scar##7##2##(1997-3#1)(2006-7#1)(2008-12#2)(2008-9#2)(2013-7#1)
of scarce resources##3##3##(2008-7#1)(2013-1#2)
of scarce##6##2##(2007-4#1)(2008-7#1)(2010-12#1)(2012-12#1)(2013-1#2)
of scarcity##2##2##(2008-12#1)(2011-2#1)
of scarring##10##2##(1991-12#1)(2004-2#1)(2007-7#1)(2008-4#2)(2011-1#1)(2012-11#1)(2012-12#1)(2013-1#2)
of scars##4##2##(1991-2#1)(2005-11#1)(2006-5#1)(2011-2#1)
of scatter##3##2##(1992-7#1)(2007-12#1)(2007-8#1)
of scattered laser light##2##4##(2008-2#1)(2008-3#1)
of scattered laser##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
of scattered light is##3##4##(2008-3#3)
of scattered light were##2##4##(2007-12#1)(2008-2#1)
of scattered light##14##3##(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#6)(2011-2#2)
of scattered radiation##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
of scattered##26##2##(1990-8#1)(2006-4#1)(2007-12#5)(2008-10#1)(2008-2#5)(2008-3#10)(2011-2#2)(2013-1#1)
of scatterer size##2##3##(2007-1#1)(2008-3#1)
of scatterer##4##2##(2007-1#1)(2008-2#1)(2008-3#2)
of scatterers on the##2##4##(2008-3#2)
of scatterers##9##2##(2007-12#1)(2008-2#3)(2008-3#5)
of scattering and absorption##4##4##(1997-6#1)(2007-11#1)(2008-3#2)
of scattering and##11##3##(1997-6#1)(2007-11#1)(2008-2#3)(2008-3#6)
of scattering at##2##3##(2008-2#1)(2008-3#1)
of scattering by##3##3##(2008-2#2)(2008-3#1)
of scattering centers in##2##4##(2008-2#1)(2008-3#1)
of scattering centers##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
of scattering coefficients##2##3##(2011-1#2)
of scattering from##2##3##(2006-10#1)(2011-1#1)
of scattering in a##2##4##(2008-2#1)(2008-3#1)
of scattering in##3##3##(2008-2#2)(2008-3#1)
of scattering layers in the##2##5##(2008-3#2)
of scattering media##4##3##(2007-12#1)(2008-3#3)
of scattering on the##2##4##(2008-3#2)
of scattering on##3##3##(2008-3#3)
of scattering particles##2##3##(2007-12#1)(2008-3#1)
of scattering##75##2##(1992-3#1)(1997-6#1)(2005-4#1)(2006-10#1)(2007-11#3)(2007-12#10)(2008-10#1)(2008-2#16)(2008-3#36)(2008-7#1)(2010-7#1)(2011-1#3)
of scavenger receptor##2##3##(1992-12#1)(1993-8#1)
of scavenger##6##2##(1992-12#2)(1993-6#1)(1993-8#3)
of scavenging##2##2##(2008-3#1)(2008-9#1)
of sceletal complications##2##3##(2007-11#2)
of scenarios##3##2##(2008-10#1)(2009-10#1)(2010-4#1)
of scene##6##2##(2008-2#1)(2008-3#1)(2008-4#1)(2010-2#1)(2011-2#1)(2012-2#1)
of scene-schema expectations##2##3##(2009-4#2)
of scent##2##2##(2007-12#1)(2009-6#1)
of scheduled##2##2##(1992-3#1)(2010-12#1)
of schemes##2##2##(2006-10#1)(2008-2#1)
of schistosomal portal##2##3##(2013-8#2)
of schistosome##3##2##(1996-12#1)(2010-12#1)(2011-12#1)
of schistosomiasis and##2##3##(2006-10#1)(2011-12#1)
of schistosomiasis control in##2##4##(2011-12#2)
of schistosomiasis control##5##3##(2011-12#3)(2012-3#2)
of schistosomiasis in a national##3##5##(2012-3#3)
of schistosomiasis in a##5##4##(1996-8#1)(2007-6#1)(2012-3#3)
of schistosomiasis in##21##3##(1994-3#1)(1996-8#1)(2006-10#1)(2007-6#1)(2008-8#1)(2011-12#9)(2012-3#7)
of schistosomiasis japonica##2##3##(2012-3#2)
of schistosomiasis transmission in##3##4##(2011-12#1)(2012-3#2)
of schistosomiasis transmission##5##3##(2006-10#2)(2011-12#1)(2012-3#2)
of schistosomiasis##64##2##(1993-8#1)(1994-3#2)(1996-12#2)(1996-8#1)(2006-10#10)(2007-6#1)(2007-7#2)(2008-4#1)(2008-8#4)(2010-12#1)(2011-12#20)(2012-1#1)(2012-3#18)
of schizophrenia and other##2##4##(1997-2#1)(2008-5#1)
of schizophrenia and schizophrenia spectrum disorders and##2##7##(2011-2#2)
of schizophrenia and schizophrenia spectrum disorders##3##6##(2011-2#3)
of schizophrenia and##26##3##(1991-4#1)(1995-1#1)(1996-8#1)(1997-2#3)(2005-6#1)(2005-7#3)(2005-8#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#2)(2010-11#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)
of schizophrenia genetics##2##3##(2012-11#2)
of schizophrenia has been##2##4##(2005-6#1)(2008-3#1)
of schizophrenia has##4##3##(1996-11#2)(2005-6#1)(2008-3#1)
of schizophrenia in the##8##4##(1995-11#1)(1997-2#2)(1997-8#1)(2006-12#1)(2008-8#1)(2011-1#2)
of schizophrenia in##10##3##(1995-11#1)(1996-5#1)(1997-2#2)(1997-8#2)(2006-12#1)(2008-8#1)(2011-1#2)
of schizophrenia is##3##3##(1990-11#1)(1993-9#1)(2008-2#1)
of schizophrenia or##3##3##(1995-11#1)(2008-3#1)(2008-6#1)
of schizophrenia patients##2##3##(2006-4#1)(2011-1#1)
of schizophrenia to##2##3##(1997-5#2)
of schizophrenia with##2##3##(2008-4#1)(2011-1#1)
of schizophrenia##149##2##(1990-11#1)(1991-4#1)(1991-9#1)(1993-6#1)(1993-9#1)(1995-1#3)(1995-11#3)(1995-12#3)(1995-3#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-11#3)(1996-3#2)(1996-5#2)(1996-7#2)(1996-8#3)(1997-2#7)(1997-5#2)(1997-8#5)(2004-11#1)(2004-12#1)(2004-3#2)(2005-10#2)(2005-6#4)(2005-7#9)(2005-8#2)(2006-12#1)(2006-3#1)(2006-4#1)(2006-8#1)(2006-9#5)(2007-1#1)(2007-3#1)(2007-8#2)(2008-1#3)(2008-2#2)(2008-3#2)(2008-4#7)(2008-5#1)(2008-6#5)(2008-8#3)(2008-9#1)(2009-12#1)(2009-7#3)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#14)(2011-12#1)(2011-2#9)(2012-11#3)(2012-12#3)(2012-2#5)
of schizophrenic patients##8##3##(1996-1#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-5#1)(2009-9#1)(2012-1#1)(2013-1#1)
of schizophrenic psychosis##2##3##(1996-2#1)(2007-1#1)
of schizophrenic symptoms##2##3##(1996-5#1)(1997-8#1)
of schizophrenic##20##2##(1995-11#1)(1995-4#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#3)(1997-5#1)(1997-8#2)(2007-1#2)(2008-11#1)(2009-9#1)(2011-1#1)(2012-1#1)(2013-1#1)
of schizophrenics and##2##3##(2006-3#1)(2010-2#1)
of schizophrenics##5##2##(1997-2#1)(2006-3#2)(2008-10#1)(2010-2#1)
of schizophreniform disorder##2##3##(1995-11#2)
of schizophreniform##3##2##(1995-11#2)(2004-12#1)
of schizophyllan##3##2##(1991-12#1)(2006-12#2)
of schizotypal personality##3##3##(1995-1#1)(1997-8#2)
of schizotypal##5##2##(1995-1#1)(1997-8#2)(2008-1#2)
of schizotypy##2##2##(1997-8#1)(2008-1#1)
of scholarly##4##2##(2010-12#1)(2010-4#1)(2012-12#1)(2012-3#1)
of school based##2##3##(2006-7#1)(2012-2#1)
of school children in##2##4##(2008-1#1)(2008-7#1)
of school children##6##3##(1992-8#1)(2006-8#1)(2007-1#1)(2008-1#1)(2008-7#1)(2012-2#1)
of school engagement##2##3##(2009-7#2)
of school going children##2##4##(2011-1#1)(2012-2#1)
of school health##2##3##(2008-10#1)(2009-8#1)
of school readiness##2##3##(2008-11#1)(2008-12#1)
of school teachers##2##3##(2005-9#1)(2012-2#1)
of school##45##2##(1991-6#1)(1992-8#1)(1993-1#1)(2005-9#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#4)(2008-2#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-7#7)(2009-8#1)(2009-9#1)(2010-1#3)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#1)
of school-age##3##2##(1991-2#2)(1993-12#1)
of school-aged children##3##3##(1992-5#1)(2008-9#1)(2010-5#1)
of school-based health centers##2##4##(2009-8#2)
of school-based##9##2##(1995-12#1)(2008-9#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-2#1)(2012-2#1)
of schoolchildren##8##2##(1990-3#2)(2005-8#1)(2006-10#3)(2011-1#1)(2013-1#1)
of schooling##8##2##(2007-7#2)(2008-6#1)(2009-2#1)(2010-3#2)(2011-1#1)(2013-1#1)
of schools##4##2##(1992-6#1)(2008-12#2)(2008-9#1)
of schwannoma##3##2##(2008-6#1)(2008-7#1)(2013-1#1)
of schwannomas##3##2##(2009-3#1)(2012-12#1)(2013-1#1)
of sciatic nerve##2##3##(1991-11#1)(2008-8#1)
of sciatic##3##2##(1991-11#1)(2006-2#1)(2008-8#1)
of sciatica##4##2##(1992-11#1)(2006-10#1)(2006-8#1)(2007-8#1)
of science and technology##3##4##(1994-12#1)(2006-12#1)(2010-12#1)
of science and##16##3##(1990-3#1)(1993-2#1)(1994-12#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-5#1)(2008-11#1)(2008-5#2)(2009-2#1)(2009-4#1)(2010-12#1)(2011-2#1)(2013-1#2)
of science in the##3##4##(2006-10#1)(2006-5#1)(2007-3#1)
of science in##5##3##(2006-10#1)(2006-5#1)(2007-3#2)(2010-11#1)
of science teachers##2##3##(2009-4#2)
of science was##2##3##(1991-6#1)(2012-2#1)
of science##69##2##(1990-12#1)(1990-3#1)(1991-6#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-11#2)(1997-8#1)(2006-10#2)(2006-12#1)(2006-4#3)(2006-5#1)(2006-6#1)(2006-7#2)(2007-10#2)(2007-11#1)(2007-3#2)(2007-5#2)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#3)(2009-3#1)(2009-4#5)(2009-6#2)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#5)(2013-1#9)
of science-based##2##2##(2008-6#1)(2008-7#1)
of sciences##2##2##(1997-3#1)(1997-4#1)
of scientific and##7##3##(1995-1#1)(1997-7#1)(2006-4#1)(2007-3#1)(2007-8#1)(2009-10#1)(2010-11#1)
of scientific applications##2##3##(2008-5#1)(2010-2#1)
of scientific articles##2##3##(2011-1#1)(2013-8#1)
of scientific data##2##3##(1991-5#1)(2008-7#1)
of scientific diffusion##2##3##(2006-5#2)
of scientific discovery##3##3##(1991-2#1)(2012-2#2)
of scientific evidence##5##3##(2006-4#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-8#1)
of scientific experience##2##3##(1992-6#1)(2007-11#1)
of scientific information and##2##4##(2008-7#1)(2012-3#1)
of scientific information##6##3##(2005-7#1)(2006-2#1)(2008-10#1)(2008-7#1)(2010-5#1)(2012-3#1)
of scientific inquiry##2##3##(1993-2#1)(2007-11#1)
of scientific interest##4##3##(2007-8#1)(2008-10#1)(2008-9#1)(2012-2#1)
of scientific knowledge##9##3##(1993-8#1)(2006-5#1)(2007-10#1)(2009-5#1)(2010-1#1)(2011-2#2)(2013-7#1)(2013-8#1)
of scientific literature##5##3##(1996-9#1)(2005-7#2)(2008-11#1)(2013-1#1)
of scientific maternity in##2##4##(2009-4#2)
of scientific medicine##2##3##(1997-6#1)(2009-11#1)
of scientific misconduct##2##3##(1991-1#1)(1993-7#1)
of scientific papers##2##3##(2007-3#1)(2012-3#1)
of scientific production##3##3##(2009-10#1)(2010-7#1)(2011-2#1)
of scientific publications in##2##4##(2005-8#1)(2012-12#1)
of scientific publications##4##3##(1992-6#1)(2005-8#1)(2010-7#1)(2012-12#1)
of scientific research##2##3##(2005-7#1)(2009-4#1)
of scientific##101##2##(1991-1#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-6#2)(1993-2#2)(1993-7#1)(1993-8#1)(1995-1#1)(1995-12#1)(1996-5#1)(1996-9#1)(1997-6#1)(1997-7#1)(2005-7#4)(2005-8#1)(2006-2#1)(2006-4#2)(2006-5#3)(2006-7#1)(2007-10#1)(2007-11#2)(2007-3#3)(2007-4#1)(2007-8#2)(2007-9#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#6)(2009-5#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-7#4)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#3)
of scientifically##4##2##(2008-6#1)(2009-4#2)(2011-2#1)
of scientists and##4##3##(2007-8#1)(2008-8#1)(2009-11#1)(2012-12#1)
of scientists who##3##3##(1993-12#1)(2013-1#2)
of scientists##23##2##(1990-2#1)(1993-12#1)(2006-5#1)(2006-7#1)(2007-2#1)(2007-8#1)(2007-9#2)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-6#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
of scimitar syndrome with##2##4##(2007-8#2)
of scimitar syndrome##3##3##(2007-8#3)
of scintigraphic##5##2##(2008-1#1)(2009-2#1)(2011-2#1)(2013-1#2)
of scintillation##2##2##(2006-8#1)(2008-3#1)
of scirtids##2##2##(2008-12#2)
of sclareol##2##2##(2007-11#2)
of scleractinian corals##2##3##(2008-5#1)(2011-2#1)
of sclerites and the##2##4##(2008-7#1)(2013-1#1)
of sclerites##4##2##(2008-7#2)(2013-1#2)
of scleroderma and##2##3##(1992-8#1)(2007-7#1)
of scleroderma renal##2##3##(2006-10#2)
of scleroderma##13##2##(1991-12#1)(1992-12#1)(1992-8#1)(1993-9#1)(2006-10#3)(2007-11#2)(2007-7#1)(2008-10#1)(2009-8#2)
of scleroderma-related pulmonary##2##3##(2012-2#2)
of sclerosis##2##2##(2007-8#1)(2011-2#1)
of sclerotia and the##2##4##(2008-10#2)
of sclerotia and##4##3##(2008-10#4)
of sclerotia in##3##3##(2008-10#3)
of sclerotia produced##2##3##(2008-10#2)
of sclerotia##30##2##(2008-10#30)
of sclerotial size##2##3##(2008-10#2)
of sclerotial##5##2##(2008-10#5)
of sclerotinia stem rot of##2##5##(2008-10#2)
of sclerotised##2##2##(2007-12#2)
of scoliosis and##2##3##(2007-8#1)(2012-2#1)
of scoliosis correction in the##2##5##(2007-7#2)
of scoliosis in##3##3##(2007-7#2)(2007-8#1)
of scoliosis to##2##3##(2007-7#2)
of scoliosis was##2##3##(2007-7#2)
of scoliosis##41##2##(1996-9#1)(2006-6#1)(2007-11#3)(2007-7#21)(2007-8#11)(2008-11#3)(2012-2#1)
of scoliosis]##2##2##(2007-7#2)
of scoliotic deformity##2##3##(2007-8#2)
of scoliotic##3##2##(2006-6#1)(2007-8#2)
of scope##4##2##(1997-1#2)(2012-12#2)
of scopolamine and its##2##4##(2008-10#2)
of scopolamine on##2##3##(1992-11#1)(1994-8#1)
of scopolamine##12##2##(1990-6#1)(1991-6#1)(1992-11#2)(1994-6#2)(1994-8#1)(2007-5#1)(2008-10#4)
of score##4##2##(2007-7#1)(2013-1#3)
of scored##3##2##(2007-8#2)(2008-7#1)
of scores of##2##3##(2006-9#1)(2008-10#1)
of scores##7##2##(2006-10#1)(2006-9#1)(2008-10#2)(2009-9#1)(2011-1#2)
of scoring systems##2##3##(2006-10#1)(2007-10#1)
of scoring##5##2##(1996-3#1)(2005-4#1)(2006-10#1)(2007-10#1)(2012-3#1)
of scorpion envenomation##2##3##(2009-6#2)
of scorpion##3##2##(1990-2#1)(2009-6#2)
of scrapie agent##2##3##(1996-6#2)
of scrapie in##4##3##(1993-8#3)(1995-5#1)
of scrapie##10##2##(1990-6#1)(1993-8#4)(1995-5#1)(1996-6#3)(2006-8#1)
of screen-detected cancer cases##2##4##(1995-12#2)
of screen-detected##5##2##(1991-6#1)(1995-12#2)(2004-2#1)(2011-1#1)
of screen-printed##2##2##(2008-10#2)
of screened women##2##3##(1992-6#1)(2011-1#1)
of screened##3##2##(1992-6#1)(1993-1#1)(2011-1#1)
of screening and##9##3##(2006-6#1)(2006-9#1)(2007-9#1)(2008-10#1)(2008-11#1)(2009-4#1)(2010-8#1)(2012-3#2)
of screening for colorectal cancer##2##5##(1996-11#1)(2006-2#1)
of screening for prostatic cancer##2##5##(1991-7#2)
of screening for the##2##4##(2006-10#1)(2007-10#1)
of screening for##17##3##(1990-6#3)(1991-7#2)(1993-3#1)(1994-2#1)(1996-11#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
of screening in##3##3##(1993-5#1)(2004-2#1)(2008-11#1)
of screening mammography in##2##4##(1995-4#1)(2007-4#1)
of screening mammography##4##3##(1995-4#1)(2007-4#1)(2008-10#1)(2008-6#1)
of screening methods##2##3##(2008-10#1)(2008-12#1)
of screening programmes for##2##4##(1991-4#1)(1995-12#1)
of screening programmes##3##3##(1991-4#1)(1995-12#1)(2011-1#1)
of screening programs##4##3##(1990-10#1)(1993-9#1)(2007-12#1)(2011-2#1)
of screening tests##4##3##(1991-3#1)(1992-4#1)(2008-11#2)
of screening with the##2##4##(2006-2#1)(2008-10#1)
of screening##93##2##(1990-10#1)(1990-2#1)(1990-6#3)(1991-3#1)(1991-4#1)(1991-7#2)(1992-10#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-5#1)(1993-9#3)(1994-2#1)(1995-11#1)(1995-12#2)(1995-4#1)(1995-9#2)(1996-11#1)(1996-12#1)(1997-4#1)(2004-2#1)(2005-11#2)(2006-10#3)(2006-2#2)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-12#4)(2007-4#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-5#2)(2010-8#2)(2011-1#3)(2011-2#3)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#1)
of screening]##2##2##(1993-10#1)(1993-6#1)
of screw and##2##3##(2009-3#2)
of screw##12##2##(2006-8#1)(2007-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#2)(2011-1#1)(2011-12#1)(2011-2#1)
of screws##3##2##(2007-11#1)(2009-3#1)(2012-12#1)
of scrotal##2##2##(1993-10#1)(2013-8#1)
of scrub typhus##2##3##(2008-4#1)(2013-1#1)
of scrutiny##4##2##(1992-12#1)(2006-10#2)(2013-1#1)
of scs1/lcb2 mutant cells##2##4##(1997-3#2)
of scuba diving##3##3##(1990-8#1)(1994-7#2)
of sea stars##2##3##(2007-5#2)
of sea surface directional reflectance##2##5##(2008-2#2)
of sea surface##5##3##(2008-2#4)(2012-2#1)
of sea urchin sperm flagella##2##5##(1991-2#2)
of sea urchin##11##3##(1990-10#1)(1990-2#1)(1991-2#2)(1996-10#1)(1996-5#1)(1997-4#1)(2008-4#1)(2008-6#1)(2009-7#1)(2012-2#1)
of sea urchins##2##3##(1994-11#1)(1997-4#1)
of sea water##6##3##(2007-10#1)(2008-10#4)(2008-5#1)
of sea##29##2##(1990-10#1)(1990-2#1)(1991-10#1)(1991-2#2)(1992-5#1)(1994-11#1)(1996-10#1)(1996-5#1)(1997-4#2)(2007-10#1)(2007-5#2)(2008-10#4)(2008-2#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2012-2#2)
of seafarers##2##2##(2011-2#2)
of seafood##4##2##(2008-2#1)(2010-9#1)(2012-1#1)(2013-7#1)
of seagrass##3##2##(2007-5#2)(2011-2#1)
of seagrasses##2##2##(2007-5#1)(2011-2#1)
of search results##2##3##(1990-12#1)(2008-4#1)
of search##10##2##(1990-12#1)(2006-6#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-3#2)(2010-8#2)(2010-9#1)
of searching##7##2##(1994-3#1)(1995-3#1)(1996-1#1)(2008-11#1)(2008-7#1)(2008-8#2)
of season and##3##3##(2007-8#1)(2008-3#1)(2008-5#1)
of season of##2##3##(1996-8#1)(2006-4#1)
of season##10##2##(1995-11#1)(1996-8#1)(2004-11#1)(2006-4#2)(2007-8#2)(2008-3#1)(2008-5#1)(2010-2#1)
of seasonal affective disorder (SAD)##2##5##(1996-1#1)(2010-8#1)
of seasonal allergic rhinitis##3##4##(2007-11#2)(2011-2#1)
of seasonal allergic##4##3##(2007-11#3)(2011-2#1)
of seasonal##20##2##(1996-1#1)(1997-5#1)(2007-11#3)(2007-2#1)(2007-9#2)(2008-12#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
of seasonality##2##2##(2008-9#1)(2011-2#1)
of seat belt##2##3##(2006-11#1)(2009-4#1)
of seat##5##2##(2006-11#3)(2009-4#1)(2010-5#1)
of seatbelts##2##2##(1997-6#1)(2008-10#1)
of seawater is##2##3##(2008-3#2)
of seawater samples##3##3##(2008-10#3)
of seawater##28##2##(2007-10#1)(2007-8#3)(2008-10#14)(2008-2#3)(2008-3#6)(2008-4#1)
of seaweed##9##2##(2007-8#1)(2008-5#1)(2010-4#5)(2011-12#2)
of seaweeds##4##2##(2006-12#1)(2008-10#1)(2010-4#2)
of sebaceous gland##2##3##(2007-7#1)(2008-5#1)
of sebaceous glands##6##3##(2008-5#1)(2009-2#1)(2010-3#4)
of sebaceous##11##2##(2007-7#1)(2008-5#2)(2008-8#1)(2009-2#1)(2010-3#5)(2012-3#1)
of sebocytes##2##2##(2010-3#2)
of seborrheic keratosis##2##3##(2007-8#1)(2011-2#1)
of seborrheic##3##2##(2007-8#1)(2010-8#1)(2011-2#1)
of sebum##9##2##(2008-5#4)(2010-3#2)(2010-5#3)
of secnidazole##3##2##(1997-3#3)
of second and third##2##4##(1993-1#1)(2007-11#1)
of second and##5##3##(1991-12#1)(1993-1#1)(1995-8#1)(2007-11#1)(2011-1#1)
of second generation##6##3##(1990-2#1)(1997-3#1)(2007-7#1)(2009-10#1)(2013-1#2)
of second group##2##3##(2012-3#2)
of second harmonic##3##3##(2007-12#1)(2008-10#1)(2009-7#1)
of second messengers and##2##4##(1990-3#1)(2013-1#1)
of second messengers##5##3##(1990-3#1)(1991-3#1)(1991-8#1)(2009-8#1)(2013-1#1)
of second opinions##3##3##(2011-12#3)
of second to##2##3##(1993-12#1)(2008-1#1)
of second##49##2##(1990-2#1)(1990-3#1)(1991-12#1)(1991-3#1)(1991-8#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#1)(1995-11#1)(1995-8#1)(1995-9#1)(1996-5#2)(1997-3#1)(2006-12#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-12#3)(2011-2#2)(2012-3#2)(2013-1#5)(2013-8#1)
of second-generation tyrosine kinase inhibitors##2##5##(2009-3#2)
of second-generation##8##2##(2005-8#1)(2006-5#1)(2008-7#1)(2009-3#2)(2010-12#1)(2011-2#1)(2012-2#1)
of second-harmonic (SH)##2##3##(2007-12#2)
of second-harmonic generation (SHG) in##2##5##(2007-12#1)(2008-3#1)
of second-harmonic generation (SHG)##4##4##(2007-12#2)(2008-3#2)
of second-harmonic generation frequency-resolved optical gating##2##6##(2007-12#2)
of second-harmonic generation in##2##4##(2007-11#1)(2008-1#1)
of second-harmonic generation with##2##4##(2007-12#1)(2008-2#1)
of second-harmonic generation##19##3##(2007-11#2)(2007-12#12)(2008-1#1)(2008-2#1)(2008-3#3)
of second-harmonic light##2##3##(2007-11#1)(2008-2#1)
of second-harmonic##28##2##(2007-11#3)(2007-12#19)(2008-1#1)(2008-2#2)(2008-3#3)
of second-order PMD##2##3##(2007-11#1)(2007-12#1)
of second-order nonlinear##2##3##(2007-12#1)(2008-1#1)
of second-order nonlinearity and##2##4##(2007-12#1)(2008-1#1)
of second-order##12##2##(1997-7#1)(2007-11#3)(2007-12#3)(2007-8#1)(2008-1#2)(2008-3#1)(2011-1#1)
of secondarily##2##2##(2008-9#1)(2010-6#1)
of secondary alcohols##4##3##(2005-8#1)(2007-11#1)(2008-8#1)(2010-5#1)
of secondary and tertiary structure##2##5##(1990-7#1)(1995-5#1)
of secondary and tertiary##4##4##(1990-7#1)(1994-5#1)(1995-5#1)(2005-11#1)
of secondary and##5##3##(1990-7#1)(1994-5#1)(1995-5#1)(2004-1#1)(2005-11#1)
of secondary and/or tertiary##2##4##(1992-6#1)(2006-4#1)
of secondary bacterial infections##2##4##(2007-11#1)(2008-12#1)
of secondary bacterial##3##3##(2007-11#1)(2008-12#1)(2013-1#1)
of secondary caries##3##3##(2013-1#2)(2013-7#1)
of secondary conidia##3##3##(2008-10#3)
of secondary contamination##2##3##(1992-6#1)(2008-4#1)
of secondary hyperparathyroidism##5##3##(1991-11#1)(1991-8#1)(2008-3#1)(2009-4#1)(2012-12#1)
of secondary hypertension##5##3##(1990-1#1)(2006-10#1)(2008-12#1)(2011-2#2)
of secondary importance for##2##4##(2007-8#1)(2008-5#1)
of secondary importance##3##3##(2006-11#1)(2007-8#1)(2008-5#1)
of secondary infection##2##3##(2008-10#2)
of secondary inoculum##3##3##(2008-10#3)
of secondary lesions##3##3##(1991-10#1)(1993-8#1)(2006-10#1)
of secondary metabolite##2##3##(2007-11#1)(2008-10#1)
of secondary metabolites in##3##4##(2006-12#1)(2008-7#1)(2008-9#1)
of secondary metabolites##7##3##(2006-12#1)(2007-7#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#1)(2012-3#1)
of secondary prevention##4##3##(1993-3#1)(2006-5#1)(2011-3#1)(2013-1#1)
of secondary products##2##3##(2008-10#1)(2008-11#1)
of secondary school students##2##4##(2012-12#1)(2013-8#1)
of secondary school##3##3##(2008-10#1)(2012-12#1)(2013-8#1)
of secondary sporidia##2##3##(2008-10#2)
of secondary structural elements##3##4##(1990-7#1)(1993-11#1)(1995-5#1)
of secondary structural##4##3##(1990-7#1)(1992-1#1)(1993-11#1)(1995-5#1)
of secondary structure and##2##4##(1992-2#1)(2011-2#1)
of secondary structure from##2##4##(1993-6#1)(1994-11#1)
of secondary structure in##2##4##(1995-2#1)(1997-4#1)
of secondary structure##16##3##(1990-4#1)(1990-5#1)(1992-2#1)(1992-4#1)(1993-6#2)(1994-11#1)(1994-12#1)(1995-2#1)(1995-4#2)(1997-4#1)(1997-6#1)(2008-4#1)(2008-8#1)(2011-2#1)
of secondary structures of##2##4##(2008-5#1)(2012-2#1)
of secondary structures##10##3##(1990-5#1)(1991-2#1)(1993-3#1)(1995-11#1)(1995-8#1)(2007-9#2)(2008-5#1)(2008-6#1)(2012-2#1)
of secondary syphilis##6##3##(1993-3#1)(2005-11#1)(2007-2#1)(2012-3#1)(2013-1#2)
of secondary tumors##2##3##(1993-8#1)(2008-10#1)
of secondary##201##2##(1990-1#1)(1990-12#2)(1990-4#1)(1990-5#2)(1990-7#2)(1991-10#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-2#2)(1992-4#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#2)(1993-8#3)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#2)(1995-4#2)(1995-5#2)(1995-8#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#2)(2004-1#1)(2005-10#1)(2005-11#4)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#2)(2007-10#2)(2007-11#7)(2007-12#3)(2007-2#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#25)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#5)(2011-3#1)(2011-8#1)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#3)(2013-1#9)(2013-7#2)(2013-8#2)
of seconds at##2##3##(1994-5#1)(2008-10#1)
of seconds##6##2##(1992-2#1)(1994-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2011-1#1)
of secreted human##2##3##(1997-2#1)(1997-4#1)
of secreted protein##2##3##(1997-4#1)(2008-10#1)
of secreted proteins is##2##4##(1995-8#1)(2008-9#1)
of secreted proteins##8##3##(1990-3#1)(1993-11#1)(1994-3#1)(1995-8#1)(1996-3#1)(1997-3#1)(2008-4#1)(2008-9#1)
of secreted uPA-IgG##2##3##(1997-4#2)
of secreted##26##2##(1990-3#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-3#2)(1995-8#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-4#4)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-9#1)(2009-6#1)
of secretin##3##2##(1993-11#1)(2006-10#1)(2009-7#1)
of secretion and##2##3##(1992-4#1)(2006-10#1)
of secretion of##6##3##(1991-6#1)(1992-3#2)(2008-11#2)(2008-6#1)
of secretion##32##2##(1990-3#2)(1990-6#1)(1990-8#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-3#2)(1992-4#2)(1992-8#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-8#3)(1997-2#1)(1997-4#1)(2006-10#3)(2007-12#1)(2008-11#3)(2008-6#1)(2008-7#1)(2010-11#1)(2010-3#1)
of secretions##5##2##(1995-8#1)(1997-1#2)(2008-9#2)
of secretory IgA##4##3##(1990-12#1)(1991-3#1)(2006-10#1)(2010-12#1)
of secretory cells##3##3##(1993-11#1)(2007-12#1)(2008-7#1)
of secretory granule##3##3##(2010-11#3)
of secretory granules##3##3##(1995-8#1)(1997-7#1)(2010-11#1)
of secretory proteins##4##3##(1991-5#1)(1992-6#1)(1994-2#1)(1994-8#1)
of secretory vesicles##2##3##(2008-11#2)
of secretory##35##2##(1990-12#1)(1991-3#2)(1991-5#2)(1992-4#1)(1992-6#1)(1993-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-5#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-4#1)(2007-12#4)(2007-2#1)(2008-11#3)(2008-5#1)(2008-7#2)(2010-11#4)(2010-12#1)(2011-2#1)(2012-1#1)
of section##2##2##(1995-11#1)(2010-7#1)
of sectioning##2##2##(2008-1#1)(2008-4#1)
of sections##6##2##(1992-12#1)(1995-6#1)(1997-6#1)(1997-8#1)(2007-11#2)
of sectors##2##2##(1994-9#1)(2012-12#1)
of secure##2##2##(2006-12#1)(2008-11#1)
of securing##5##2##(1997-8#1)(2007-7#1)(2007-8#1)(2010-7#1)(2011-1#1)
of security##8##2##(1991-3#1)(1992-12#1)(2006-6#2)(2007-12#1)(2008-2#1)(2010-7#1)(2013-1#1)
of sedation and analgesia##3##4##(2006-10#1)(2008-8#2)
of sedation and##5##3##(2006-10#1)(2008-8#2)(2010-4#1)(2012-2#1)
of sedation in##2##3##(2010-12#2)
of sedation##18##2##(2006-10#2)(2006-8#1)(2007-11#1)(2008-8#5)(2009-6#1)(2010-12#2)(2010-4#1)(2010-7#1)(2012-2#2)(2013-8#2)
of sedative##2##2##(2008-8#2)
of sedatives##2##2##(2006-10#1)(2009-6#1)
of sedentary##2##2##(2006-10#1)(2008-5#1)
of sediment samples##2##3##(2008-10#2)
of sediment##11##2##(2006-6#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-5#2)(2012-1#2)
of sedimentary##2##2##(2007-5#1)(2007-7#1)
of sedimentation of##3##3##(1990-12#1)(2008-1#2)
of sedimentation##7##2##(1990-12#1)(2006-10#1)(2007-9#1)(2008-1#2)(2008-7#2)
of sediments and##2##3##(2008-5#2)
of sediments in##2##3##(2006-8#1)(2007-5#1)
of sediments##7##2##(2006-8#1)(2007-5#1)(2008-10#3)(2008-5#2)
of seed coat pigmentation##3##4##(2012-11#3)
of seed coat##5##3##(2012-11#3)(2013-8#2)
of seed development##3##3##(1994-3#1)(2008-12#2)
of seed diffusate##2##3##(2008-5#2)
of seed dispersal##5##3##(2006-5#3)(2008-12#1)(2008-9#1)
of seed dormancy##2##3##(2004-2#1)(2009-10#1)
of seed extract##3##3##(2012-2#3)
of seed from##2##3##(1995-7#1)(2008-10#1)
of seed germination##3##3##(2004-2#1)(2008-7#1)(2011-12#1)
of seed infection##5##3##(2008-10#5)
of seed meal##2##3##(2008-10#2)
of seed plant##2##3##(2008-8#2)
of seed predators##3##3##(2008-5#1)(2013-1#2)
of seed##68##2##(1993-9#1)(1994-3#2)(1995-7#1)(2004-2#2)(2006-12#4)(2006-5#4)(2008-10#19)(2008-12#7)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#1)(2009-6#1)(2011-12#2)(2012-11#3)(2012-2#3)(2013-1#4)(2013-8#3)
of seed-transmitted endophytes##2##3##(2008-8#2)
of seed-transmitted##3##2##(2008-10#1)(2008-8#2)
of seedborne##4##2##(2008-10#4)
of seeded atomic Rb##2##4##(2008-2#2)
of seeded##4##2##(2006-12#1)(2008-2#2)(2008-3#1)
of seeding of##2##3##(2008-10#1)(2008-6#1)
of seeding##8##2##(1991-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#2)(2011-2#2)
of seedling##5##2##(2006-5#1)(2008-10#3)(2008-12#1)
of seedlings of##2##3##(2007-3#1)(2008-10#1)
of seedlings##13##2##(2007-3#1)(2008-10#10)(2008-5#1)(2008-9#1)
of seeds and##2##3##(2007-7#1)(2008-5#1)
of seeds by##2##3##(2008-5#2)
of seeds from##3##3##(2006-12#1)(2008-5#1)(2012-3#1)
of seeds of##6##3##(2008-10#2)(2008-12#2)(2008-8#1)(2013-7#1)
of seeds or##2##3##(2008-10#1)(2008-9#1)
of seeds##32##2##(2006-12#3)(2007-7#1)(2008-10#4)(2008-12#7)(2008-5#5)(2008-8#3)(2008-9#4)(2009-12#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-7#1)
of seeing##7##2##(1996-1#1)(1997-3#1)(2007-9#1)(2008-3#1)(2008-7#1)(2008-8#1)(2013-7#1)
of seeking##7##2##(1990-4#1)(2008-3#1)(2008-7#1)(2010-10#1)(2011-1#1)(2012-11#1)(2012-12#1)
of seemingly unrelated##2##3##(2011-1#1)(2011-2#1)
of seemingly##4##2##(1993-3#1)(2007-9#1)(2011-1#1)(2011-2#1)
of segment##8##2##(1992-12#1)(1994-8#1)(2007-12#1)(2008-10#3)(2008-3#1)(2011-2#1)
of segmental patterns##2##3##(2006-5#2)
of segmental##12##2##(1995-5#1)(2005-10#1)(2006-5#2)(2007-7#2)(2008-1#1)(2008-8#1)(2009-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
of segmentation and##2##3##(1992-9#1)(2006-5#1)
of segmentation gene expression##3##4##(2009-4#3)
of segmentation of##2##3##(1992-7#1)(2008-10#1)
of segmentation##14##2##(1991-8#1)(1992-7#1)(1992-9#1)(2006-5#2)(2008-10#1)(2008-2#3)(2008-8#1)(2009-4#3)(2010-8#1)
of segmented composite filtering##2##4##(2008-3#2)
of segmented##5##2##(2008-3#3)(2008-6#1)(2009-6#1)
of segments in##2##3##(2006-10#1)(2008-10#1)
of segments of the##2##4##(2008-10#1)(2008-3#1)
of segments of##4##3##(2007-12#1)(2008-10#2)(2008-3#1)
of segments was##2##3##(1992-11#1)(2009-5#1)
of segments without##2##3##(1997-1#1)(2007-7#1)
of segments##20##2##(1992-11#1)(1992-5#1)(1997-1#1)(2006-10#2)(2006-5#1)(2007-12#4)(2007-7#2)(2007-8#1)(2007-9#2)(2008-10#3)(2008-3#1)(2009-5#1)
of segregating##2##2##(2008-10#2)
of segregation##6##2##(2008-10#4)(2008-3#1)(2011-2#1)
of seismic##3##2##(1996-4#2)(2009-6#1)
of seismicity in##2##3##(1996-4#2)
of seismicity##7##2##(1996-4#7)
of seizure activity##4##3##(1990-5#1)(1991-3#1)(1996-1#1)(1997-3#1)
of seizure and##2##3##(2008-5#1)(2013-1#1)
of seizure disorders##2##3##(1997-3#1)(2007-10#1)
of seizure in##4##3##(1996-1#1)(2007-2#2)(2008-8#1)
of seizure##18##2##(1990-5#1)(1991-3#1)(1993-4#1)(1996-1#2)(1997-3#2)(2004-11#1)(2007-10#1)(2007-12#1)(2007-2#2)(2008-5#1)(2008-8#1)(2009-8#1)(2010-11#1)(2012-12#1)(2013-1#1)
of seizures and##2##3##(2009-3#1)(2010-7#1)
of seizures in##2##3##(2008-11#1)(2008-8#1)
of seizures induced by##2##4##(1996-3#2)
of seizures was##2##3##(1996-1#1)(2011-1#1)
of seizures##32##2##(1992-9#1)(1993-3#1)(1994-2#1)(1996-1#2)(1996-3#3)(1997-3#1)(2004-11#1)(2006-4#2)(2007-2#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-3#2)(2009-8#2)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#1)(2013-1#1)(2013-8#1)
of select metals##2##3##(2008-10#2)
of select##12##2##(1996-2#1)(2005-10#1)(2006-10#1)(2006-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2009-11#1)(2010-10#1)(2013-1#1)
of selectable##2##2##(1991-6#1)(2008-10#1)
of selected PCBs##2##3##(2008-11#2)
of selected amino##2##3##(1995-8#1)(2008-5#1)
of selected biological##3##3##(2007-8#2)(2009-7#1)
of selected clinical##2##3##(2012-3#1)(2013-1#1)
of selected diseases##2##3##(1993-12#1)(1996-6#1)
of selected drugs##4##3##(1996-5#1)(1996-7#2)(2007-11#1)
of selected factors##2##3##(2007-7#1)(2011-2#1)
of selected findings##2##3##(1990-8#1)(1994-12#1)
of selected genes##4##3##(2007-11#1)(2008-10#1)(2009-8#1)(2010-2#1)
of selected markers##3##3##(1990-11#1)(2006-6#1)(2008-5#1)
of selected metals##2##3##(1993-9#1)(2008-10#1)
of selected patients with##2##4##(1990-11#1)(2006-2#1)
of selected patients##4##3##(1990-11#1)(1990-6#1)(2006-2#1)(2008-8#1)
of selected physical##2##3##(1991-2#1)(2007-7#1)
of selected variables##2##3##(2008-10#1)(2010-3#1)
of selected##174##2##(1990-11#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-9#3)(1994-1#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-9#1)(1997-2#1)(1997-4#3)(1997-6#1)(2004-4#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-5#4)(2006-6#1)(2007-10#4)(2007-11#6)(2007-12#3)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#6)(2008-1#3)(2008-10#22)(2008-11#4)(2008-3#2)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#3)(2009-7#2)(2009-8#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-12#2)(2011-2#5)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#6)(2013-1#1)(2013-7#2)(2013-8#3)
of selectin##2##2##(1993-8#1)(2008-3#1)
of selecting a##2##3##(1995-12#1)(2009-9#1)
of selecting and##2##3##(2008-7#1)(2010-8#1)
of selecting##15##2##(1995-12#1)(1996-3#1)(1997-4#1)(2006-2#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-9#1)(2010-8#1)
of selectins##2##2##(2008-3#1)(2011-1#1)
of selection and amplification##2##4##(1997-2#1)(2008-4#1)
of selection and##12##3##(1991-11#1)(1995-4#1)(1995-8#1)(1997-2#1)(2008-1#1)(2008-4#1)(2008-8#4)(2010-8#1)(2012-3#1)
of selection bias##4##3##(1997-5#2)(2007-10#1)(2012-3#1)
of selection for resistance##3##4##(2008-10#3)
of selection for##7##3##(1997-4#1)(2008-10#3)(2008-2#1)(2008-8#2)
of selection in##3##3##(1995-2#1)(1995-8#1)(2012-3#1)
of selection of##6##3##(1990-8#1)(2008-10#1)(2011-1#2)(2011-3#1)(2012-1#1)
of selection on##7##3##(2008-11#1)(2008-8#4)(2008-9#2)
of selection with##2##3##(2008-9#1)(2013-8#1)
of selection##84##2##(1990-3#1)(1990-8#1)(1991-11#1)(1991-7#1)(1992-2#1)(1995-2#2)(1995-4#1)(1995-7#1)(1995-8#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#2)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-2#1)(2008-4#4)(2008-5#1)(2008-8#22)(2008-9#4)(2009-8#1)(2010-4#2)(2010-8#1)(2011-1#4)(2011-3#1)(2012-1#1)(2012-3#4)(2013-1#2)(2013-8#1)
of selective adrenergic##2##3##(1991-3#2)
of selective and nonselective media##2##5##(2008-12#2)
of selective and nonselective##3##4##(2008-10#1)(2008-12#2)
of selective attention##2##3##(1996-3#1)(2005-10#1)
of selective axonal hypotrophy##2##4##(1996-5#2)
of selective brain cooling on the expression of##2##8##(2010-1#2)
of selective dorsal rhizotomy##2##4##(2005-10#1)(2006-10#1)
of selective inhibition of##2##4##(1997-7#1)(2012-2#1)
of selective inhibitors##3##3##(1994-8#1)(2009-5#1)(2010-12#1)
of selective ligands##3##3##(1995-11#1)(1997-5#1)(2009-7#1)
of selective mapping##4##3##(2013-1#4)
of selective muscarinic##2##3##(1994-3#1)(1995-12#1)
of selective protein##4##3##(1992-12#1)(1993-9#1)(1994-10#1)(1994-3#1)
of selective serotonin reuptake inhibitor (SSRI)##2##6##(2008-3#1)(2009-6#1)
of selective serotonin reuptake inhibitors (SSRIs)##4##6##(2005-9#1)(2006-4#1)(2008-11#1)(2008-6#1)
of selective serotonin reuptake inhibitors##10##5##(1996-1#1)(1997-8#3)(2005-9#1)(2006-4#1)(2007-7#1)(2008-11#1)(2008-6#1)(2008-8#1)
of selective serotonin reuptake##12##4##(1996-1#1)(1997-8#3)(2005-9#1)(2006-4#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-6#1)
of selective vulnerability##3##3##(1990-2#1)(1995-12#1)(1996-9#1)
of selective##116##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-11#2)(1991-2#1)(1991-3#4)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-6#1)(1993-11#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-3#3)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#3)(1996-1#1)(1996-3#3)(1996-5#2)(1996-6#2)(1996-9#1)(1997-5#3)(1997-7#1)(1997-8#3)(2005-10#2)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-4#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#3)(2008-1#2)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#2)(2009-7#2)(2010-1#2)(2010-12#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#4)
of selectively##6##2##(1994-11#1)(1997-6#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-5#1)
of selectivity and##5##3##(2008-10#4)(2008-5#1)
of selectivity coefficients of##2##4##(2008-10#2)
of selectivity coefficients##4##3##(2008-10#4)
of selectivity for##5##3##(1997-2#1)(2005-7#1)(2008-10#2)(2008-11#1)
of selectivity in the##3##4##(1993-4#1)(1995-2#1)(2008-10#1)
of selectivity in##5##3##(1990-5#1)(1993-4#1)(1995-2#1)(2008-10#1)(2008-5#1)
of selectivity is##2##3##(2005-11#1)(2008-2#1)
of selectivity##35##2##(1990-5#1)(1990-9#1)(1993-3#1)(1993-4#2)(1995-2#1)(1997-1#2)(1997-2#1)(2005-11#1)(2005-7#1)(2007-8#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2012-12#1)
of selenite (Se(IV))##2##3##(2008-10#2)
of selenite##14##2##(1992-7#3)(1993-12#2)(2008-10#9)
of selenium (IV) in##2##4##(2008-10#2)
of selenium (IV)##4##3##(2008-10#4)
of selenium and alpha-tocopherol##2##4##(1994-3#2)
of selenium and##4##3##(1994-3#2)(2008-10#2)
of selenium by##2##3##(2008-10#2)
of selenium deficiency##3##3##(1992-4#1)(1992-5#1)(1996-11#1)
of selenium in the##4##4##(2007-4#1)(2008-10#2)(2012-2#1)
of selenium in water and##2##5##(2008-10#2)
of selenium in water##3##4##(2008-10#3)
of selenium in##20##3##(1992-11#1)(2007-4#1)(2008-10#17)(2012-2#1)
of selenium is##5##3##(2008-10#5)
of selenium species##3##3##(2008-10#3)
of selenium supplementation##2##3##(1991-1#1)(1992-4#1)
of selenium treatment##2##3##(2008-7#2)
of selenium##78##2##(1991-1#2)(1992-11#1)(1992-4#2)(1992-5#2)(1993-3#1)(1994-3#2)(1996-11#1)(1996-7#1)(2007-4#1)(2007-7#1)(2008-10#47)(2008-6#2)(2008-7#5)(2009-3#1)(2009-8#1)(2010-11#2)(2012-2#2)(2013-1#1)(2013-8#3)
of selenium(IV) and molybdenum(VI)##2##4##(2008-10#2)
of selenium(IV) and##7##3##(2008-10#7)
of selenium(IV)##13##2##(2008-10#13)
of selenium-containing##3##2##(1991-1#1)(2008-10#1)(2008-8#1)
of selenium-deficient rats##2##3##(1990-12#1)(1996-11#1)
of selenium-deficient##4##2##(1990-12#1)(1992-11#2)(1996-11#1)
of selenoamino acids in##2##4##(2008-10#2)
of selenoamino acids##3##3##(2008-10#3)
of selenocysteine##2##2##(1990-4#1)(2012-2#1)
of selenoprotein mRNA##2##3##(2012-2#2)
of selenoprotein##4##2##(2012-2#4)
of selenoproteins##2##2##(1992-5#1)(2010-11#1)
of selenospecies##3##2##(2008-10#3)
of self and others##2##4##(2008-11#1)(2008-12#1)
of self and##7##3##(1990-8#1)(2007-12#1)(2008-11#3)(2008-12#1)(2008-9#1)
of self harm##3##3##(2007-3#2)(2011-2#1)
of self monitoring of##2##4##(1997-3#1)(2008-10#1)
of self monitoring##4##3##(1997-3#1)(2008-10#3)
of self reported hematuria or dysuria##2##6##(2007-2#2)
of self reported hematuria##3##4##(2007-2#3)
of self##41##2##(1990-8#1)(1991-11#1)(1993-12#1)(1997-3#1)(1997-4#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-3#2)(2007-9#1)(2008-10#4)(2008-11#8)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-2#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-12#1)(2013-8#1)
of self- and##2##3##(1995-8#1)(2013-1#1)
of self-administered##2##2##(2006-10#1)(2013-1#1)
of self-administration##4##2##(2007-11#1)(2008-4#1)(2011-2#2)
of self-annealed##2##2##(1995-12#2)
of self-antigens##3##2##(2006-5#1)(2008-10#1)(2012-1#1)
of self-assembled monolayers (SAMs)##2##4##(2008-10#1)(2010-4#1)
of self-assembled monolayers##6##3##(2006-12#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-4#2)
of self-assembled##14##2##(1991-11#1)(1995-3#1)(2006-12#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-7#2)(2009-11#2)(2009-2#2)(2010-4#2)
of self-assembly of##2##3##(2008-3#1)(2013-8#1)
of self-assembly##3##2##(2008-3#1)(2008-7#1)(2013-8#1)
of self-association##2##2##(1990-8#1)(1997-4#1)
of self-awareness##3##2##(2008-1#1)(2008-11#1)(2013-1#1)
of self-care to##3##3##(2007-9#2)(2008-12#1)
of self-care##8##2##(2007-9#2)(2008-12#1)(2008-3#1)(2010-2#1)(2011-1#2)(2013-8#1)
of self-concept##3##2##(2008-12#2)(2010-3#1)
of self-control##5##2##(2008-12#3)(2011-1#1)(2013-7#1)
of self-deception##2##2##(1992-2#1)(2006-3#1)
of self-defense##2##2##(2008-10#2)
of self-development##3##2##(2008-5#3)
of self-diffraction##2##2##(2007-11#1)(2007-12#1)
of self-directed work teams##3##4##(1993-12#3)
of self-directed##5##2##(1993-12#3)(1993-2#1)(1996-2#1)
of self-efficacy##3##2##(2007-10#1)(2011-1#1)(2012-3#1)
of self-esteem##5##2##(2009-2#1)(2009-5#3)(2013-1#1)
of self-expanding##3##2##(1990-8#1)(2008-12#1)(2010-12#1)
of self-fertilization##3##2##(2008-8#1)(2008-9#2)
of self-focus##2##2##(2008-2#1)(2010-10#1)
of self-focusing in a hollow waveguide##2##6##(2007-12#2)
of self-focusing in##3##3##(2007-12#3)
of self-focusing of##2##3##(1994-10#1)(2007-11#1)
of self-focusing##7##2##(1994-10#1)(2007-11#1)(2007-12#5)
of self-harming behaviors##2##3##(2006-7#2)
of self-harming##3##2##(2006-7#3)
of self-healing##2##2##(2006-5#1)(2010-7#1)
of self-help groups in##2##4##(1996-3#1)(2008-4#1)
of self-help groups##4##3##(1996-3#2)(2008-4#2)
of self-help##7##2##(1994-1#1)(1996-3#4)(2008-4#2)
of self-improvement##2##2##(1997-1#1)(2007-12#1)
of self-induced##2##2##(2007-12#1)(2010-9#1)
of self-injection locking##2##3##(2007-12#2)
of self-injurious behavior##3##3##(2006-7#1)(2009-10#1)(2012-2#1)
of self-made capsules##2##3##(2012-3#2)
of self-made##3##2##(2012-3#3)
of self-management plans##2##3##(2006-5#2)
of self-management##4##2##(1993-12#1)(2006-5#2)(2012-12#1)
of self-medication##4##2##(2007-7#3)(2007-8#1)
of self-monitoring of blood glucose (SMBG)##2##6##(2008-8#1)(2009-11#1)
of self-monitoring##4##2##(2008-11#2)(2008-8#1)(2009-11#1)
of self-organization in the##2##4##(2008-3#1)(2008-8#1)
of self-organization in##3##3##(2008-3#1)(2008-8#1)(2008-9#1)
of self-organization##10##2##(1996-4#1)(2006-10#1)(2006-3#2)(2008-3#1)(2008-8#1)(2008-9#2)(2009-5#1)(2013-8#1)
of self-organized##2##2##(2007-9#1)(2008-7#1)
of self-paced##2##2##(1991-3#1)(1996-1#1)
of self-phase modulation and##3##4##(2007-11#1)(2007-12#1)(2008-1#1)
of self-phase modulation##4##3##(2007-11#2)(2007-12#1)(2008-1#1)
of self-pumped phase conjugation##2##4##(2008-2#2)
of self-pumped phase##3##3##(2008-2#3)
of self-reactive##2##2##(1991-11#1)(2011-1#1)
of self-reference##4##2##(2008-11#2)(2008-9#2)
of self-referral in##2##3##(2007-4#2)
of self-referral##5##2##(2007-4#5)
of self-regulation##4##2##(2008-7#1)(2009-4#1)(2012-3#1)(2013-7#1)
of self-renewal and differentiation##2##4##(2006-7#1)(2009-3#1)
of self-renewal and##5##3##(2006-7#1)(2008-11#1)(2009-3#1)(2013-1#2)
of self-renewal##12##2##(1993-2#1)(2006-7#1)(2008-1#1)(2008-11#3)(2009-12#1)(2009-3#1)(2010-11#1)(2013-1#3)
of self-renewing##2##2##(2008-1#1)(2013-1#1)
of self-repair##2##2##(2008-5#2)
of self-replication##2##2##(1991-3#1)(2008-10#1)
of self-report##2##2##(2010-6#1)(2010-8#1)
of self-reported health status##3##4##(1992-9#1)(1995-12#1)(2008-10#1)
of self-reported health##4##3##(1992-9#1)(1993-1#1)(1995-12#1)(2008-10#1)
of self-reported##18##2##(1990-9#1)(1992-9#1)(1993-1#1)(1994-6#1)(1995-1#1)(1995-12#1)(1996-3#1)(2008-10#1)(2008-6#1)(2009-7#2)(2010-12#1)(2011-1#1)(2011-12#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
of self-reporting##2##2##(2010-2#2)
of self-serving##2##2##(2008-6#1)(2010-2#1)
of self-steepening and space-time focusing##2##5##(2007-12#2)
of self-stimulation##3##2##(1990-10#1)(1994-2#1)(1994-3#1)
of self-tolerance##2##2##(2005-11#1)(2012-3#1)
of self-trapped##3##2##(2007-11#2)(2007-12#1)
of self-trapping of##2##3##(2007-12#2)
of self-written waveguides##2##3##(2007-11#1)(2007-12#1)
of selfing##6##2##(2008-10#1)(2008-8#1)(2008-9#2)(2013-1#2)
of selfishness##5##2##(2008-9#4)(2010-2#1)
of sellar##2##2##(2007-1#1)(2011-2#1)
of semantic and##2##3##(2008-2#1)(2009-2#1)
of semantic errors##2##3##(2008-4#2)
of semantic knowledge##3##3##(1996-7#1)(2007-8#1)(2009-2#1)
of semantic##16##2##(1996-7#2)(2007-4#1)(2007-8#1)(2008-2#1)(2008-4#3)(2009-2#3)(2012-2#3)(2013-1#2)
of semen##17##2##(2006-5#5)(2006-8#1)(2007-12#1)(2008-12#2)(2009-4#1)(2009-6#1)(2010-12#1)(2010-7#1)(2012-3#1)(2013-8#3)
of semi-purified##2##2##(1994-12#1)(1996-11#1)
of semi-structured interviews with##3##4##(2008-12#1)(2008-6#1)(2009-10#1)
of semi-structured interviews##4##3##(2008-12#1)(2008-6#1)(2009-10#1)(2009-12#1)
of semi-structured##7##2##(1995-1#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2013-1#1)
of semicarbazide and hydrazine##4##4##(2008-10#4)
of semicarbazide##6##2##(2008-10#6)
of semicircular##2##2##(2008-3#1)(2013-1#1)
of semiconducting and metallic##3##4##(2009-6#1)(2010-7#2)
of semiconducting##6##2##(2008-10#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-7#2)
of semiconductor laser##2##3##(2007-12#2)
of semiconductor lasers##2##3##(2007-11#1)(2008-2#1)
of semiconductor nanocrystals##2##3##(2007-12#2)
of semiconductor optical##2##3##(2007-12#1)(2008-1#1)
of semiconductor##17##2##(2006-12#1)(2007-11#2)(2007-12#8)(2008-1#1)(2008-2#1)(2008-7#3)(2009-10#1)
of seminal fluid##2##3##(1997-8#1)(2011-2#1)
of seminal gamma-GTP##2##3##(1995-11#2)
of seminal vesicle##2##3##(1992-2#1)(2008-11#1)
of seminal##17##2##(1990-5#1)(1991-12#1)(1992-2#1)(1994-3#1)(1995-11#3)(1997-8#1)(2005-10#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#3)(2013-8#1)
of seminars##2##2##(2005-8#1)(2011-1#1)
of seminiferous tubules##2##3##(1995-6#1)(2013-8#1)
of seminiferous##3##2##(1990-9#1)(1995-6#1)(2013-8#1)
of semiparametric##3##2##(2008-11#1)(2010-7#1)(2010-8#1)
of semiselective##2##2##(2008-10#2)
of semisolid##2##2##(2008-10#1)(2008-5#1)
of semisynthetic penicillins##2##3##(2008-10#2)
of semisynthetic##4##2##(1993-8#1)(2008-10#2)(2009-12#1)
of senS##2##2##(1993-6#2)
of senecionine##3##2##(1991-7#3)
of senescence and##2##3##(2008-8#1)(2010-2#1)
of senescence in##6##3##(1997-7#1)(2008-3#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-3#1)
of senescence##21##2##(1991-4#1)(1994-5#1)(1997-7#1)(2006-12#3)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-4#1)(2009-5#2)(2009-8#1)(2010-2#1)(2011-2#1)(2012-3#2)
of senescent cell antigen##2##4##(1994-5#2)
of senescent cell##3##3##(1994-5#3)
of senescent cells##2##3##(1995-1#1)(1997-7#1)
of senescent##8##2##(1991-4#1)(1994-5#3)(1995-1#1)(1997-7#1)(2006-12#1)(2008-5#1)
of senile dementia in##2##4##(1991-9#2)
of senile dementia of the Alzheimer type##2##7##(1993-11#1)(1994-5#1)
of senile dementia##4##3##(1991-9#2)(1993-11#1)(1994-5#1)
of senile plaques in##3##4##(1990-7#1)(1993-3#1)(2012-12#1)
of senile plaques##6##3##(1990-7#1)(1992-12#1)(1993-3#1)(1995-10#1)(2008-7#1)(2012-12#1)
of senile##14##2##(1990-7#1)(1991-9#2)(1992-1#1)(1992-12#1)(1993-11#1)(1993-3#1)(1994-5#1)(1995-10#1)(2006-8#1)(2006-9#1)(2008-7#1)(2011-2#1)(2012-12#1)
of senior citizens in the##2##5##(1993-5#1)(2005-1#1)
of senior citizens##5##3##(1993-5#1)(2005-1#3)(2008-7#1)
of senior management##2##3##(1993-1#1)(1995-3#1)
of senior physicians##2##3##(1992-1#1)(1993-6#1)
of senior##20##2##(1992-1#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-2#2)(1995-3#1)(2005-1#3)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-5#1)(2012-3#1)(2013-7#1)
of seniors##7##2##(2005-1#1)(2006-2#2)(2008-9#1)(2010-8#2)(2011-2#1)
of sensation and##2##3##(2009-3#1)(2010-3#1)
of sensation##6##2##(1990-3#1)(1990-5#1)(2007-7#1)(2008-1#1)(2009-3#1)(2010-3#1)
of sense and antisenseabp transgenic tobacco##2##6##(2008-8#2)
of sense and##3##3##(2006-11#1)(2008-8#2)
of sense of##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
of sense##9##2##(1990-2#1)(1993-11#1)(1996-3#1)(2006-11#1)(2008-10#1)(2008-7#1)(2008-8#2)(2013-1#1)
of sensilla basiconica##2##3##(2007-12#2)
of sensilla##7##2##(2007-12#7)
of sensing molecules##2##3##(2008-10#1)(2013-8#1)
of sensing##12##2##(2007-12#1)(2007-9#1)(2008-10#4)(2008-3#2)(2008-9#1)(2009-2#1)(2010-6#1)(2013-8#1)
of sensitisation##4##2##(1990-11#1)(1996-1#1)(1997-2#1)(2008-7#1)
of sensitised##2##2##(1994-11#1)(1997-2#1)
of sensitive and resistant##2##4##(1992-2#1)(2010-5#1)
of sensitive and##5##3##(1992-2#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-5#1)
of sensitive detection of##2##4##(2008-10#1)(2012-2#1)
of sensitive detection##3##3##(2005-8#1)(2008-10#1)(2012-2#1)
of sensitive skin##3##3##(2008-5#3)
of sensitive##22##2##(1992-2#1)(1994-8#1)(1995-6#1)(1996-1#1)(2005-8#1)(2007-1#1)(2007-9#1)(2008-10#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-9#2)(2010-5#1)(2010-8#1)(2012-2#1)(2013-8#1)
of sensitivities##6##2##(1994-12#1)(1995-8#1)(2008-10#3)(2009-4#1)
of sensitivity and reproducibility##2##4##(2008-10#1)(2008-4#1)
of sensitivity and selectivity##4##4##(2008-10#4)
of sensitivity and specificity in##3##5##(1996-8#1)(1997-6#1)(2008-4#1)
of sensitivity and specificity##9##4##(1990-12#1)(1993-3#1)(1996-8#1)(1997-6#2)(2007-12#1)(2007-2#1)(2008-4#1)(2011-2#1)
of sensitivity and##24##3##(1990-12#1)(1992-2#1)(1993-3#1)(1994-6#1)(1996-11#1)(1996-8#1)(1997-3#1)(1997-6#2)(2007-12#1)(2007-2#1)(2008-10#8)(2008-4#3)(2008-5#1)(2011-2#1)
of sensitivity for the##2##4##(2008-10#2)
of sensitivity for##7##3##(1992-2#1)(1996-5#1)(1996-8#1)(2008-10#4)
of sensitivity in the##2##4##(2008-3#1)(2009-9#1)
of sensitivity in##5##3##(1991-12#1)(1993-2#1)(2008-10#1)(2008-3#1)(2009-9#1)
of sensitivity of the##4##4##(1996-9#1)(1997-1#1)(2008-10#1)(2010-10#1)
of sensitivity of##10##3##(1990-10#1)(1993-9#1)(1996-9#1)(1997-1#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-10#1)
of sensitivity to the##5##4##(1992-7#1)(1992-8#1)(2005-9#1)(2007-11#1)(2008-10#1)
of sensitivity to##24##3##(1990-11#1)(1990-12#2)(1990-5#1)(1990-7#1)(1992-7#1)(1992-8#1)(1994-12#1)(1995-10#1)(2004-4#1)(2005-9#1)(2007-11#1)(2007-3#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-5#1)(2011-12#1)(2013-1#1)
of sensitivity was##2##3##(2008-10#2)
of sensitivity##105##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#1)(1992-2#2)(1992-7#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-10#1)(1996-11#2)(1996-5#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#3)(1997-8#1)(2004-4#1)(2005-9#1)(2006-10#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#38)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#3)(2008-9#1)(2009-9#1)(2010-10#1)(2011-12#1)(2011-2#3)(2012-2#1)(2012-8#1)(2013-1#1)
of sensitization to the##2##4##(1993-6#1)(1996-10#1)
of sensitization to##4##3##(1991-11#1)(1993-6#1)(1996-10#2)
of sensitization##13##2##(1991-11#1)(1991-5#2)(1993-6#1)(1993-8#1)(1995-2#1)(1996-10#2)(2006-8#1)(2008-10#3)(2009-8#1)
of sensitized##3##2##(1992-12#1)(1995-2#2)
of sensitizing##5##2##(1996-3#1)(1997-2#2)(2008-10#1)(2008-11#1)
of sensor and##2##3##(2008-2#1)(2012-3#1)
of sensor errors##6##3##(2009-9#6)
of sensor response##2##3##(2008-10#1)(2008-7#1)
of sensor##22##2##(2008-10#10)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-9#7)(2012-3#1)
of sensorimotor reflexes##2##3##(1992-12#2)
of sensorimotor##4##2##(1992-12#2)(1993-9#1)(1996-1#1)
of sensors and##4##3##(2007-9#1)(2008-10#2)(2012-2#1)
of sensors are##2##3##(2008-10#2)
of sensors for##2##3##(2007-9#1)(2008-10#1)
of sensors that##2##3##(2007-12#1)(2008-10#1)
of sensors##18##2##(2007-12#1)(2007-9#2)(2008-10#12)(2009-6#1)(2010-4#1)(2012-2#1)
of sensory and##3##3##(1997-7#1)(2007-12#1)(2008-10#1)
of sensory axons##2##3##(1995-2#1)(2013-1#1)
of sensory cells##3##3##(2007-12#2)(2011-2#1)
of sensory fibers##2##3##(1996-3#1)(2007-1#1)
of sensory function##2##3##(1993-12#1)(2012-1#1)
of sensory information##2##3##(1993-2#1)(1996-6#1)
of sensory input##6##3##(1995-11#1)(1995-12#1)(1996-5#1)(1996-7#1)(1997-8#1)(2009-12#1)
of sensory nerve##4##3##(1990-11#1)(2006-8#1)(2007-11#1)(2013-8#1)
of sensory nerves##5##3##(1992-11#1)(1992-6#2)(1996-3#1)(2007-11#1)
of sensory neurons##16##3##(1990-7#1)(1991-10#1)(1993-12#1)(1994-8#1)(1996-3#9)(2007-11#1)(2007-12#1)(2008-7#1)
of sensory processing##3##3##(1991-3#1)(2009-12#1)(2013-8#1)
of sensory stimulation##3##3##(1993-12#1)(2006-7#1)(2008-11#1)
of sensory stimuli##2##3##(2013-1#2)
of sensory##99##2##(1990-10#1)(1990-11#3)(1990-4#1)(1990-7#1)(1991-10#1)(1991-3#1)(1991-4#1)(1992-11#1)(1992-4#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-12#6)(1993-2#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-3#16)(1996-5#1)(1996-6#1)(1996-7#1)(1997-7#1)(1997-8#3)(2006-10#2)(2006-5#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#7)(2007-8#2)(2008-10#2)(2008-11#2)(2008-3#2)(2008-6#1)(2008-7#1)(2009-12#3)(2009-8#2)(2010-4#4)(2011-2#1)(2012-1#3)(2012-2#1)(2013-1#5)(2013-8#3)
of sentence processing##3##3##(2008-11#2)(2012-3#1)
of sentence##7##2##(2007-4#1)(2008-11#2)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
of sentences##2##2##(2012-3#1)(2013-7#1)
of sentential complements##2##3##(2006-2#2)
of sentinel infective events##2##4##(2011-2#2)
of sentinel lymph node##4##4##(2010-1#1)(2011-2#1)(2013-8#2)
of sentinel lymph nodes##4##4##(2008-8#2)(2011-1#1)(2013-8#1)
of sentinel lymph##8##3##(2008-8#2)(2010-1#1)(2011-1#1)(2011-2#1)(2013-8#3)
of sentinel node biopsy##4##4##(2005-8#1)(2007-12#1)(2010-7#2)
of sentinel node##5##3##(2005-8#1)(2007-12#1)(2010-7#2)(2010-8#1)
of sentinel##19##2##(2005-8#1)(2007-12#1)(2007-7#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#3)(2012-3#1)(2013-8#3)
of separate and##2##3##(1997-2#1)(2011-1#1)
of separate components in##2##4##(2005-8#1)(2008-10#1)
of separate##28##2##(1990-7#1)(1992-1#1)(1994-1#1)(1995-11#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-8#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-1#1)
of separated##6##2##(1990-6#1)(1991-3#1)(1996-5#1)(2007-8#1)(2008-10#2)
of separating the##2##3##(2005-11#1)(2008-3#1)
of separating##14##2##(1996-11#1)(1996-6#1)(1997-6#2)(2004-8#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#2)
of separation and##7##3##(1996-5#1)(1997-8#1)(2005-4#1)(2008-10#2)(2008-5#1)(2010-2#1)
of separation as##2##3##(1996-5#1)(2008-10#1)
of separation between##2##3##(1997-2#1)(2013-7#1)
of separation of##5##3##(1997-7#1)(2008-10#2)(2008-12#1)(2008-6#1)
of separation techniques##2##3##(2008-4#1)(2008-7#1)
of separation##32##2##(1993-1#1)(1996-5#3)(1997-2#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-4#1)(2008-10#11)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#1)(2010-2#1)(2013-7#1)(2013-8#1)
of separations##3##2##(1996-5#1)(2005-11#1)(2008-10#1)
of sepsis after##2##3##(2008-8#1)(2008-9#1)
of sepsis and septic shock##3##5##(2006-10#2)(2007-12#1)
of sepsis and##6##3##(2006-10#2)(2007-12#1)(2007-7#1)(2010-12#1)(2013-1#1)
of sepsis in children##2##4##(2007-5#1)(2013-1#1)
of sepsis in the##2##4##(2011-2#1)(2012-2#1)
of sepsis in##9##3##(2007-11#1)(2007-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
of sepsis is##2##3##(2009-6#1)(2011-2#1)
of sepsis management are##2##4##(2011-2#2)
of sepsis management##3##3##(2011-2#3)
of sepsis##45##2##(1991-3#2)(2006-10#3)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#2)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-6#2)(2010-11#2)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#9)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
of septal neurons##2##3##(1994-5#2)
of septal##5##2##(1993-12#1)(1994-5#2)(2008-11#1)(2011-2#1)
of septic arthritis caused by L##2##6##(2006-10#2)
of septic arthritis##7##3##(2006-10#3)(2010-12#1)(2010-3#1)(2013-8#2)
of septic shock##11##3##(1994-8#1)(1996-3#1)(2005-7#1)(2006-4#1)(2007-12#1)(2008-1#1)(2009-8#1)(2011-1#1)(2011-2#3)
of septic spondylodiscitis##2##3##(2006-10#2)
of septic##31##2##(1994-8#1)(1996-3#1)(2005-10#1)(2005-7#1)(2006-10#5)(2006-2#1)(2006-4#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-7#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-12#2)(2013-8#3)
of septicaemia##5##2##(1990-8#1)(1995-11#1)(1996-9#1)(2007-7#2)
of septicemia##3##2##(2007-7#2)(2011-2#1)
of septohippocampal##2##2##(1991-3#1)(2013-8#1)
of sequelae of##2##3##(2008-3#1)(2009-9#1)
of sequelae##4##2##(2007-11#1)(2008-3#1)(2008-4#1)(2009-9#1)
of sequence alignments##3##3##(1994-11#1)(1994-6#1)(2006-10#1)
of sequence analysis##3##3##(1995-8#1)(2008-2#1)(2008-4#1)
of sequence annotation or##2##4##(2008-7#2)
of sequence comparisons##2##3##(1993-2#1)(2008-8#1)
of sequence conservation and##2##4##(1993-9#1)(1994-6#1)
of sequence conservation between##2##4##(2008-7#1)(2012-3#1)
of sequence conservation##8##3##(1992-11#1)(1993-9#1)(1994-6#2)(2008-7#2)(2012-3#2)
of sequence data##9##3##(1995-7#1)(1997-2#1)(2008-4#1)(2008-7#2)(2010-6#1)(2012-3#3)
of sequence divergence##4##3##(2008-10#3)(2013-1#1)
of sequence diversity##3##3##(1992-11#1)(1996-3#1)(2008-10#1)
of sequence homology between##2##4##(1992-2#1)(1993-11#1)
of sequence homology to##3##4##(1992-12#1)(1993-3#1)(1995-3#1)
of sequence homology##11##3##(1990-7#1)(1990-9#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-3#1)(1995-3#1)(1995-8#1)(2008-10#1)
of sequence identity with##2##4##(1994-12#1)(1995-11#1)
of sequence identity##5##3##(1990-5#1)(1992-2#1)(1992-8#1)(1994-12#1)(1995-11#1)
of sequence information##3##3##(1995-8#1)(2008-4#2)
of sequence motifs##2##3##(1996-4#1)(1996-7#1)
of sequence or##2##3##(1995-7#1)(2007-6#1)
of sequence similarities##2##3##(1992-6#1)(1994-6#1)
of sequence similarity to##2##4##(1992-11#1)(1994-8#1)
of sequence similarity##8##3##(1990-12#1)(1992-11#1)(1994-8#1)(2008-4#3)(2008-9#1)(2009-5#1)
of sequence variants in##3##4##(1996-11#1)(2008-4#2)
of sequence variants##9##3##(1992-2#1)(1996-11#1)(2008-10#5)(2008-4#2)
of sequence##114##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-9#1)(1992-11#3)(1992-12#2)(1992-2#3)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#4)(1994-8#2)(1995-11#2)(1995-3#1)(1995-6#1)(1995-7#2)(1995-8#3)(1996-11#1)(1996-3#1)(1996-4#3)(1996-6#1)(1996-7#2)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#2)(2006-10#2)(2007-6#1)(2008-10#12)(2008-2#1)(2008-4#11)(2008-7#8)(2008-8#1)(2008-9#1)(2009-5#1)(2010-6#1)(2011-1#2)(2012-2#1)(2012-3#5)(2013-1#1)(2013-8#2)
of sequence-specific DNA-binding proteins##3##4##(1991-5#1)(1993-12#1)(2008-4#1)
of sequence-specific##10##2##(1991-5#1)(1991-8#1)(1992-3#1)(1992-8#2)(1993-12#1)(1996-11#1)(2008-4#3)
of sequenced##7##2##(1994-11#2)(1994-12#1)(1997-6#1)(2008-7#2)(2009-6#1)
of sequences and##4##3##(2006-6#1)(2008-10#1)(2009-5#1)(2011-2#1)
of sequences from##5##3##(1996-12#1)(1997-4#1)(2007-3#1)(2008-10#1)(2008-4#1)
of sequences in##2##3##(1997-6#1)(2010-7#1)
of sequences is##2##3##(1995-8#1)(2008-4#1)
of sequences of the##2##4##(2008-10#2)
of sequences of##5##3##(1991-2#1)(2008-10#3)(2008-7#1)
of sequences with##2##3##(2007-8#1)(2008-3#1)
of sequences##45##2##(1990-3#1)(1991-2#1)(1991-9#1)(1992-6#1)(1993-12#1)(1993-5#1)(1994-12#1)(1995-8#1)(1996-12#1)(1996-7#1)(1997-4#2)(1997-6#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-3#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-4#4)(2008-7#2)(2009-5#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
of sequencing data##2##3##(2007-1#1)(2012-3#1)
of sequencing targets##2##3##(2008-10#2)
of sequencing##14##2##(1991-7#1)(1995-7#1)(1996-10#1)(1997-4#1)(2007-1#1)(2008-10#2)(2009-10#1)(2011-1#2)(2012-3#3)(2013-8#1)
of sequential injection analysis##5##4##(2008-10#5)
of sequential injection systems##2##4##(2008-10#2)
of sequential injection with##2##4##(2008-10#2)
of sequential injection##10##3##(2008-10#10)
of sequential trials##2##3##(1995-12#1)(1997-2#1)
of sequential##37##2##(1990-11#1)(1990-6#1)(1991-9#1)(1994-9#1)(1995-12#2)(1996-11#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-6#1)(2007-5#1)(2007-8#1)(2008-10#16)(2008-12#1)(2008-5#1)(2009-9#1)(2012-2#2)
of sequentially implanted children##2##4##(2012-2#2)
of sequentially##4##2##(1992-9#1)(1997-6#1)(2012-2#2)
of sequestered##2##2##(1990-5#1)(1994-8#1)
of sequestering##4##2##(1992-8#1)(2006-10#1)(2008-10#1)(2008-11#1)
of sera from##2##3##(1994-11#1)(2008-11#1)
of sera##6##2##(1992-8#1)(1994-11#1)(1994-3#1)(2007-8#1)(2008-10#1)(2008-11#1)
of serial##27##2##(1990-12#1)(1990-5#1)(1993-11#1)(1994-3#1)(1997-5#1)(2005-10#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#3)(2009-3#1)(2010-1#1)(2013-1#2)
of serially##2##2##(2008-10#1)(2008-4#1)
of sericin##3##2##(2008-11#3)
of series##3##2##(2005-10#1)(2007-5#1)(2008-10#1)
of serine 129##2##3##(1994-11#2)
of serine and threonine residues in##2##6##(1991-3#1)(2006-9#1)
of serine and threonine residues##4##5##(1991-10#1)(1991-3#1)(1992-7#1)(2006-9#1)
of serine and##8##3##(1991-10#1)(1991-3#1)(1992-12#1)(1992-7#1)(2006-9#1)(2008-10#2)(2008-4#1)
of serine phosphorylation for##2##4##(1995-3#2)
of serine phosphorylation##3##3##(1995-3#3)
of serine protease inhibitors##2##4##(1995-1#1)(1997-7#1)
of serine protease##6##3##(1991-2#1)(1994-6#2)(1995-1#1)(1997-7#1)(2008-5#1)
of serine proteases and##2##4##(1991-2#1)(2008-4#1)
of serine proteases##11##3##(1991-2#3)(1991-3#1)(1991-6#1)(1994-8#1)(1995-2#1)(1995-5#1)(2008-4#2)(2008-9#1)
of serine proteinases##8##3##(1991-5#1)(1991-8#1)(1992-6#1)(1993-11#1)(1993-3#1)(1996-9#1)(2012-3#2)
of serine##67##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#4)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-6#2)(1992-7#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#5)(1994-5#3)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#4)(1995-5#1)(1995-8#1)(1996-9#1)(1997-1#2)(1997-7#1)(2006-8#1)(2006-9#1)(2008-10#5)(2008-4#4)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)(2012-3#2)
of serine-143##2##2##(1994-5#2)
of serine/threonine and tyrosine protein phosphatases##2##6##(2013-7#2)
of serine/threonine kinases##2##3##(1993-3#1)(1995-2#1)
of serine/threonine protein kinases##4##4##(1993-6#1)(1994-9#1)(1995-6#1)(2006-5#1)
of serine/threonine protein##5##3##(1990-8#1)(1993-6#1)(1994-9#1)(1995-6#1)(2006-5#1)
of serine/threonine##11##2##(1990-8#1)(1993-3#1)(1993-6#1)(1994-9#1)(1995-2#1)(1995-6#1)(1997-6#1)(2006-5#1)(2009-9#1)(2013-7#2)
of serious adverse events##4##4##(2005-7#1)(2008-3#1)(2008-5#1)(2008-8#1)
of serious adverse##8##3##(2005-10#1)(2005-7#1)(2007-2#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-8#1)(2013-8#1)
of serious complications##8##3##(2006-10#2)(2006-4#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-7#1)(2011-2#1)
of serious diseases##3##3##(2009-9#1)(2012-12#2)
of serious hypoglycemia##2##3##(1994-6#2)
of serious illness##3##3##(1995-3#1)(2006-8#1)(2008-11#1)
of serious infections##6##3##(1990-8#1)(2005-8#1)(2008-5#1)(2009-11#1)(2009-9#1)(2011-2#1)
of serious infectious##2##3##(1994-9#1)(2006-10#1)
of serious side effects##5##4##(1993-11#1)(1995-5#1)(2008-10#1)(2008-7#1)(2011-2#1)
of serious thoracic##2##3##(2012-12#2)
of serious##80##2##(1990-5#1)(1990-8#1)(1991-9#1)(1992-11#1)(1992-2#2)(1992-3#1)(1993-11#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-3#1)(1995-5#1)(1996-6#1)(1997-2#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#5)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-11#2)(2009-2#1)(2009-6#1)(2009-9#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
of seriousness##2##2##(1991-6#1)(2010-12#1)
of sermorelin##2##2##(2007-11#2)
of seroconversion##5##2##(1990-3#1)(1997-6#1)(2007-2#2)(2007-7#1)
of serogroup B meningococcal disease in##3##6##(1992-10#3)
of serogroup B meningococcal disease##5##5##(1992-10#5)
of serogroup B meningococcal##6##4##(1992-10#6)
of serogroup B##8##3##(1992-10#6)(2012-12#2)
of serogroup##14##2##(1992-10#6)(2007-12#1)(2008-10#2)(2009-5#1)(2011-2#1)(2012-12#3)
of serogroups of Neisseria meningitidis##2##5##(2007-12#2)
of serologic##2##2##(2006-10#1)(2008-10#1)
of serological and##2##3##(1995-12#1)(2008-10#1)
of serological markers of##2##4##(2007-12#1)(2008-12#1)
of serological markers##3##3##(2007-12#1)(2008-12#1)(2008-5#1)
of serological tests##3##3##(1997-3#1)(2007-8#1)(2011-2#1)
of serological##16##2##(1993-1#2)(1993-3#1)(1994-5#1)(1995-12#1)(1996-12#1)(1996-7#2)(1997-3#1)(2005-7#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)
of serologically##5##2##(1990-12#1)(1997-6#1)(2006-10#1)(2007-12#1)(2012-2#1)
of seronegative##2##2##(1993-1#1)(2008-9#1)
of seropositive dogs##2##3##(2011-2#2)
of seropositive##5##2##(1996-7#1)(2007-7#1)(2011-2#2)(2012-3#1)
of seropositivity was##2##3##(1996-3#1)(2007-7#1)
of seropositivity##7##2##(1991-11#2)(1995-1#1)(1996-3#1)(2006-10#1)(2007-7#1)(2010-6#1)
of serotonergic##14##2##(1992-11#1)(1992-3#1)(1993-3#1)(1994-11#1)(1996-1#1)(1996-3#1)(1996-5#1)(2005-9#1)(2006-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-8#1)
of serotonin (5-HT) and##2##4##(1992-1#1)(1996-4#1)
of serotonin (5-HT) in##3##4##(1993-3#1)(1996-10#1)(2008-6#1)
of serotonin (5-HT) on##2##4##(1993-12#1)(1997-5#1)
of serotonin (5-HT)##13##3##(1992-1#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-3#1)(1996-10#1)(1996-4#1)(1997-5#1)(2006-10#1)(2007-12#1)(2008-6#1)(2008-8#2)
of serotonin (5-hydroxytryptamine##5##3##(1995-12#2)(1996-12#1)(1996-7#1)(2012-12#1)
of serotonin (5HT)##2##3##(1993-7#1)(2008-6#1)
of serotonin and##3##3##(1990-7#1)(1997-3#1)(2008-2#1)
of serotonin antiserum##2##3##(1995-12#2)
of serotonin in the pineal##2##5##(1990-5#2)
of serotonin in the##4##4##(1990-5#2)(1995-12#1)(2006-12#1)
of serotonin in##6##3##(1990-5#2)(1995-12#1)(2006-12#2)(2008-8#1)
of serotonin on##4##3##(1990-5#2)(1996-12#1)(2010-12#1)
of serotonin organelles##2##3##(1990-12#2)
of serotonin receptors in##2##4##(2010-5#1)(2012-2#1)
of serotonin receptors##3##3##(2005-8#1)(2010-5#1)(2012-2#1)
of serotonin transport##2##3##(1996-12#2)
of serotonin##82##2##(1990-12#3)(1990-5#4)(1990-7#2)(1991-5#1)(1992-1#2)(1992-11#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-12#3)(1993-3#2)(1993-7#1)(1994-11#1)(1995-11#2)(1995-12#8)(1996-10#1)(1996-12#4)(1996-4#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-5#1)(2005-10#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#7)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2009-5#1)(2009-8#1)(2010-12#2)(2010-5#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-8#1)
of serotype 1##2##3##(2008-5#1)(2013-8#1)
of serotype##7##2##(2006-8#2)(2007-8#1)(2008-5#2)(2011-2#1)(2013-8#1)
of serotypes 1##3##3##(1996-12#2)(1997-6#1)
of serotypes##5##2##(1996-12#3)(1997-6#1)(2007-11#1)
of serous cystadenoma##5##3##(2012-11#1)(2012-2#4)
of serous##10##2##(1992-2#1)(2008-12#1)(2010-12#1)(2010-9#1)(2012-11#1)(2012-12#1)(2012-2#4)
of serovars##2##2##(1992-12#1)(2005-7#1)
of serrated polyps##2##3##(2009-12#2)
of serrated##3##2##(2009-12#3)
of sertraline##3##2##(2007-8#1)(2012-12#2)
of serum 25-hydroxyvitamin D##2##4##(2008-1#1)(2011-2#1)
of serum ALT##3##3##(2007-11#2)(2009-11#1)
of serum IgE##2##3##(2011-1#1)(2013-1#1)
of serum IgG##3##3##(1991-3#1)(2011-1#1)(2012-12#1)
of serum KM01##2##3##(1995-4#2)
of serum NSE##2##3##(1990-6#1)(1996-1#1)
of serum PG##2##3##(2007-8#2)
of serum TSH##2##3##(2011-12#1)(2013-8#1)
of serum albumin in the##2##5##(2008-7#2)
of serum albumin##10##3##(1991-3#1)(1992-9#1)(1993-12#1)(1994-8#1)(1995-12#2)(2008-10#1)(2008-7#2)(2011-2#1)
of serum alkaline phosphatase##2##4##(1995-1#1)(2007-11#1)
of serum amylase##2##3##(1993-12#1)(2012-2#1)
of serum amyloid A##2##4##(1991-12#1)(1995-3#1)
of serum and##21##3##(1990-2#1)(1992-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#1)(1997-3#1)(1997-7#1)(2005-12#1)(2005-8#1)(2008-1#1)(2008-11#3)(2008-5#1)(2009-11#1)(2011-1#1)
of serum antibodies##4##3##(2005-11#1)(2008-10#1)(2008-4#2)
of serum antibody to##2##4##(1991-12#1)(1995-5#1)
of serum antibody##3##3##(1991-12#1)(1995-12#1)(1995-5#1)
of serum calcium##5##3##(1994-7#1)(2005-3#1)(2007-7#1)(2008-6#1)(2013-1#1)
of serum carcinoembryonic antigen##3##4##(1995-10#1)(2005-10#1)(2012-1#1)
of serum cholesterol was##2##4##(1991-6#1)(2008-10#1)
of serum cholesterol##7##3##(1991-6#2)(1992-6#1)(1993-10#1)(2008-10#1)(2008-5#1)(2013-8#1)
of serum complement##2##3##(1997-2#2)
of serum cortisol##3##3##(2006-9#1)(2011-2#2)
of serum creatinine levels##3##4##(1990-6#1)(2007-2#2)
of serum creatinine##5##3##(1990-12#1)(1990-6#1)(1994-12#1)(2007-2#2)
of serum cystatin C##2##4##(2011-11#2)
of serum cytokines##2##3##(2006-4#1)(2008-10#1)
of serum deprivation##2##3##(1992-11#1)(2007-6#1)
of serum electrolytes##3##3##(1996-6#1)(2012-2#2)
of serum enzymes##3##3##(1990-6#1)(1994-3#2)
of serum ferritin##3##3##(1996-3#1)(2008-10#1)(2009-8#1)
of serum free thyroxine##2##4##(2008-6#1)(2012-3#1)
of serum free##4##3##(2008-6#1)(2009-10#1)(2011-1#1)(2012-3#1)
of serum from the##2##4##(1992-12#1)(1995-2#1)
of serum from##4##3##(1992-12#1)(1995-2#1)(2008-10#1)(2008-11#1)
of serum glucose##3##3##(2008-11#1)(2010-7#1)(2012-12#1)
of serum growth factors##3##4##(1990-3#1)(1992-12#1)(1994-11#1)
of serum growth##4##3##(1990-3#1)(1991-1#1)(1992-12#1)(1994-11#1)
of serum immunoglobulin##3##3##(1990-8#1)(2007-7#1)(2009-7#1)
of serum in the##3##4##(1991-5#1)(2008-1#1)(2008-11#1)
of serum in##8##3##(1991-5#1)(1992-3#1)(1992-6#1)(1996-2#1)(2008-1#1)(2008-11#3)
of serum iron##2##3##(1996-2#1)(2007-2#1)
of serum laminin P1##2##4##(1996-8#2)
of serum leptin##2##3##(2008-3#1)(2011-1#1)
of serum level##2##3##(1997-5#1)(2008-8#1)
of serum lipid##3##3##(1995-1#1)(2008-9#1)(2011-2#1)
of serum lipids##3##3##(1994-12#1)(1996-2#1)(2007-7#1)
of serum magnesium##2##3##(2011-2#2)
of serum malondialdehyde##2##3##(2009-6#1)(2010-12#1)
of serum markers of##2##4##(1993-2#1)(2012-12#1)
of serum markers##3##3##(1991-12#1)(1993-2#1)(2012-12#1)
of serum melatonin##4##3##(1992-8#3)(2008-3#1)
of serum neutralizing##2##3##(1992-6#1)(1992-8#1)
of serum on the uptake of##2##6##(1992-6#2)
of serum on the##3##4##(1992-6#3)
of serum on##4##3##(1992-6#3)(2008-11#1)
of serum or##6##3##(1991-10#1)(1992-12#1)(1992-2#1)(1992-4#1)(1994-11#1)(2008-11#1)
of serum parathormone##2##3##(2007-7#2)
of serum protein##2##3##(1992-6#1)(2008-3#1)
of serum proteins in##5##4##(1992-6#1)(1993-12#2)(1996-6#1)(2013-8#1)
of serum proteins##16##3##(1990-1#1)(1990-11#2)(1991-10#1)(1991-12#1)(1992-6#2)(1993-12#2)(1993-9#1)(1996-11#2)(1996-6#1)(1997-5#1)(2013-8#2)
of serum samples##4##3##(1990-12#1)(2007-2#2)(2008-10#1)
of serum sickness##3##3##(1997-8#2)(2007-5#1)
of serum sodium concentration##2##4##(2010-1#2)
of serum sodium##3##3##(2006-1#1)(2010-1#2)
of serum ss2-microglobulin##2##3##(2007-3#2)
of serum testosterone##3##3##(1996-11#1)(2004-1#1)(2012-12#1)
of serum total and##2##4##(1990-10#1)(1993-10#1)
of serum total cholesterol##3##4##(1993-12#1)(1997-1#1)(2010-10#1)
of serum total##9##3##(1990-10#1)(1993-10#1)(1993-12#1)(1995-12#1)(1997-1#1)(2007-2#1)(2010-10#1)(2012-12#2)
of serum triglycerides##2##3##(1992-6#2)
of serum tumor markers##2##4##(1994-7#1)(2007-3#1)
of serum tumor##3##3##(1994-7#1)(2007-3#2)
of serum was##3##3##(1995-12#1)(1997-3#1)(2008-10#1)
of serum were##4##3##(1992-1#1)(1993-2#1)(2008-7#2)
of serum##400##2##(1990-1#2)(1990-10#1)(1990-11#4)(1990-12#4)(1990-2#5)(1990-3#1)(1990-4#1)(1990-6#3)(1990-8#3)(1991-1#1)(1991-10#4)(1991-12#8)(1991-2#4)(1991-3#9)(1991-5#3)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#4)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#4)(1992-6#13)(1992-7#1)(1992-8#6)(1992-9#1)(1993-10#2)(1993-11#2)(1993-12#13)(1993-2#4)(1993-6#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#4)(1994-12#2)(1994-3#3)(1994-7#2)(1994-8#2)(1995-1#3)(1995-10#1)(1995-12#6)(1995-2#6)(1995-3#5)(1995-4#2)(1995-5#3)(1995-9#1)(1996-1#1)(1996-11#4)(1996-2#8)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#4)(1996-7#1)(1996-8#3)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#2)(1997-7#2)(1997-8#3)(2004-1#1)(2004-11#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-3#1)(2005-4#1)(2005-8#3)(2006-1#2)(2006-10#2)(2006-2#1)(2006-4#6)(2006-5#1)(2006-6#1)(2006-9#2)(2007-10#1)(2007-11#7)(2007-2#7)(2007-3#5)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#4)(2008-1#6)(2008-10#12)(2008-11#21)(2008-3#5)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#3)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2010-1#5)(2010-10#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#6)(2011-11#2)(2011-12#2)(2011-2#10)(2012-1#2)(2012-11#1)(2012-12#8)(2012-2#7)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#6)
of serum-derived##2##2##(1990-7#1)(2008-11#1)
of serum-free cell##2##3##(1992-11#1)(1997-3#1)
of serum-free culture##2##3##(1994-5#1)(2007-6#1)
of serum-free media##2##3##(2008-11#2)
of serum-free produced##2##3##(2008-11#2)
of serum-free##10##2##(1992-11#1)(1994-5#1)(1997-3#1)(2007-6#1)(2008-11#5)(2012-12#1)
of service among##3##3##(1995-2#1)(2012-3#2)
of service and##5##3##(1992-3#1)(1994-3#1)(1995-3#1)(1997-1#1)(2008-4#1)
of service delivery##7##3##(1992-12#2)(1994-2#2)(1995-1#1)(2010-2#1)(2011-1#1)
of service integration##2##3##(2008-2#1)(2012-3#1)
of service needs##2##3##(2013-8#2)
of service providers##4##3##(1993-1#1)(1995-1#1)(2012-3#2)
of service provision##4##3##(1996-1#1)(1996-2#1)(1996-3#1)(2005-5#1)
of service quality##6##3##(1993-12#2)(1994-2#1)(1995-2#1)(1997-3#1)(2008-8#1)
of service to##3##3##(1990-10#1)(1995-1#1)(2008-11#1)
of service user##3##3##(2008-12#2)(2012-11#1)
of service users and##2##4##(2008-11#1)(2009-6#1)
of service users##6##3##(2008-11#1)(2008-12#2)(2009-6#2)(2012-3#1)
of service was##2##3##(2007-1#1)(2010-8#1)
of service##104##2##(1990-10#1)(1990-12#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#2)(1993-12#2)(1994-1#2)(1994-2#6)(1994-3#1)(1995-1#4)(1995-2#2)(1995-3#3)(1996-1#4)(1996-12#1)(1996-2#4)(1996-3#4)(1997-1#1)(1997-3#2)(2005-5#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-9#1)(2008-11#2)(2008-12#4)(2008-2#3)(2008-3#2)(2008-4#2)(2008-8#2)(2009-6#3)(2010-2#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#8)(2013-1#6)(2013-8#12)
of services a##2##3##(1992-3#1)(1994-1#1)
of services across##2##3##(2004-12#1)(2008-2#1)
of services and the##3##4##(1991-2#1)(1993-1#1)(2006-8#1)
of services and##13##3##(1991-2#1)(1993-1#1)(1993-2#1)(1993-3#1)(2006-8#1)(2008-1#2)(2008-2#2)(2010-6#1)(2012-2#1)(2012-3#2)
of services by##4##3##(1994-12#1)(1996-1#1)(2007-12#1)(2008-2#1)
of services delivered##2##3##(1997-3#1)(2012-3#1)
of services for the elderly##2##5##(1991-3#1)(2008-2#1)
of services for the##4##4##(1991-3#1)(1997-2#1)(2008-2#2)
of services for##7##3##(1991-3#1)(1995-3#1)(1997-2#1)(2008-2#3)(2010-8#1)
of services in##4##3##(1992-3#1)(2004-12#1)(2008-2#2)
of services is##3##3##(1991-2#1)(1992-12#1)(2008-8#1)
of services of a##2##4##(1995-3#1)(1995-9#1)
of services offered by##2##4##(1996-12#1)(2006-7#1)
of services offered##5##3##(1994-2#1)(1996-12#1)(2006-7#1)(2008-2#2)
of services provided to##2##4##(1995-3#1)(2010-5#1)
of services provided##6##3##(1992-12#1)(1992-2#1)(1995-3#2)(2010-5#1)(2013-1#1)
of services required##2##3##(1997-3#1)(2009-6#1)
of services to people with mental##2##6##(2008-2#1)(2011-1#1)
of services to the##2##4##(2004-12#1)(2009-6#1)
of services to##10##3##(1991-3#1)(1997-8#1)(2004-12#1)(2008-1#1)(2008-11#1)(2008-2#2)(2009-6#1)(2011-1#1)(2012-12#1)
of services were##2##3##(1996-1#1)(2012-2#1)
of services##140##2##(1990-12#1)(1990-2#1)(1991-1#1)(1991-12#2)(1991-2#4)(1991-3#3)(1992-12#4)(1992-2#3)(1992-3#2)(1993-1#1)(1993-2#2)(1993-3#1)(1994-1#3)(1994-12#2)(1994-2#3)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-9#1)(1996-1#6)(1996-12#1)(1996-2#6)(1996-3#2)(1997-1#2)(1997-2#4)(1997-3#3)(1997-8#2)(2004-12#3)(2005-5#1)(2005-8#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-4#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-2#23)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#2)(2009-7#2)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#3)(2012-1#1)(2012-11#3)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#1)(2013-7#1)
of serving##3##2##(1990-12#1)(1994-12#1)(1996-8#1)
of sesame oil substitution##2##4##(2007-9#2)
of sesame oil##6##3##(2007-9#6)
of sesquiterpene##4##2##(2007-1#2)(2008-8#2)
of sesquiterpenes##2##2##(2011-10#1)(2013-8#1)
of sessile##3##2##(1992-6#1)(2005-11#1)(2008-8#1)
of sessions##8##2##(2005-7#1)(2005-8#1)(2006-9#1)(2009-9#1)(2010-8#1)(2013-8#3)
of set##4##2##(2008-11#1)(2013-7#3)
of setae on the##2##4##(2007-12#2)
of setae##6##2##(2007-12#3)(2008-4#1)(2013-1#2)
of setal##2##2##(2013-1#2)
of setting up##4##3##(2007-8#1)(2008-1#1)(2008-11#1)(2013-7#1)
of setting##6##2##(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-9#1)(2013-7#1)
of settings and##3##3##(1994-2#1)(2008-11#1)(2009-9#1)
of settings##12##2##(1992-1#1)(1994-2#1)(1996-8#1)(2004-3#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-11#1)(2009-9#1)(2012-12#1)(2013-8#2)
of settlement in##2##3##(2008-8#1)(2011-2#1)
of settlement##5##2##(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#2)
of setup uncertainties##2##3##(1993-9#1)(1995-4#1)
of setup##3##2##(1993-9#1)(1995-4#1)(2012-12#1)
of seven EST clones##2##4##(2008-10#2)
of seven amino##2##3##(1994-12#1)(1994-2#1)
of seven cases##7##3##(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(2006-8#1)(2008-7#1)(2011-1#1)
of seven commercial##2##3##(2008-5#1)(2008-7#1)
of seven compounds in##2##4##(2011-1#1)(2012-3#1)
of seven compounds##3##3##(2008-5#1)(2011-1#1)(2012-3#1)
of seven days##2##3##(1995-4#1)(2006-10#1)
of seven different##4##3##(1992-6#1)(1995-6#1)(2008-10#1)(2008-5#1)
of seven exons##3##3##(1991-12#1)(1991-9#1)(1997-2#1)
of seven field trials##2##4##(2008-10#2)
of seven genes##2##3##(1991-8#1)(1996-6#1)
of seven human##6##3##(1994-3#1)(1995-3#1)(1996-4#1)(2007-4#1)(2008-3#1)(2008-5#1)
of seven months##2##3##(2005-12#1)(2007-2#1)
of seven patients who underwent##2##5##(2006-6#1)(2012-12#1)
of seven patients who##3##4##(2006-6#1)(2007-7#1)(2012-12#1)
of seven patients with##5##4##(1991-12#1)(1993-3#1)(1995-4#1)(2008-3#1)(2008-7#1)
of seven patients##11##3##(1991-12#1)(1993-3#1)(1995-4#1)(2004-10#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-7#1)(2012-12#2)
of seven populations from##2##4##(2008-10#1)(2008-8#1)
of seven populations##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
of seven replicates##5##3##(2008-10#5)
of seven sites##2##3##(1995-8#1)(2008-9#1)
of seven species##2##3##(2007-7#1)(2008-5#1)
of seven##163##2##(1990-10#1)(1990-2#1)(1990-4#2)(1990-7#2)(1990-8#2)(1991-12#4)(1991-2#2)(1991-6#1)(1991-8#1)(1991-9#3)(1992-2#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-12#2)(1993-3#2)(1993-4#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-4#2)(1995-6#1)(1995-7#1)(1995-8#2)(1996-2#1)(1996-4#2)(1996-5#1)(1996-6#1)(1997-2#3)(1997-4#2)(1997-7#1)(2004-10#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#36)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#11)(2008-7#3)(2008-8#3)(2008-9#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-3#1)(2011-1#4)(2011-12#2)(2011-2#2)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#3)(2013-8#2)
of seven- to##2##3##(1996-11#1)(2006-10#1)
of sevenless##4##2##(1991-12#1)(1992-1#2)(1994-12#1)
of seventeen##4##2##(1993-9#1)(2008-3#1)(2008-4#1)(2011-2#1)
of seventh##3##2##(2010-9#1)(2011-12#1)(2011-2#1)
of several alternative##2##3##(2008-4#1)(2008-5#1)
of several analytes##2##3##(2008-10#2)
of several assays##2##3##(1993-2#1)(2010-7#1)
of several attachment##2##3##(2012-5#2)
of several autoimmune##2##3##(2006-5#1)(2010-12#1)
of several bacteria##3##3##(1996-4#1)(2005-7#1)(2008-10#1)
of several basic##2##3##(2008-4#1)(2013-8#1)
of several cancers##2##3##(2006-6#1)(2011-2#1)
of several cell functions##2##4##(1994-6#1)(2006-2#1)
of several cell types##3##4##(2006-10#1)(2008-11#1)(2008-4#1)
of several cell##6##3##(1994-6#1)(2006-10#1)(2006-2#1)(2008-11#2)(2008-4#1)
of several cellular proteins##4##4##(1990-12#1)(1992-8#1)(1994-6#1)(1994-9#1)
of several cellular##5##3##(1990-12#1)(1992-8#1)(1994-6#1)(1994-9#1)(2008-8#1)
of several chemotherapeutic agents##2##4##(1997-7#1)(2010-3#1)
of several chronic##2##3##(2009-3#1)(2011-1#1)
of several classes of##3##4##(1994-9#1)(2007-12#1)(2008-5#1)
of several clinical##5##3##(1994-12#1)(1996-3#1)(2008-3#1)(2008-5#1)(2011-1#1)
of several common##2##3##(1991-12#1)(2008-10#1)
of several commonly used##3##4##(2008-3#2)(2008-6#1)
of several components of##2##4##(2008-10#1)(2012-3#1)
of several components##8##3##(2006-2#1)(2007-4#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#1)(2012-3#1)
of several compounds##4##3##(1995-8#1)(2005-8#1)(2008-10#2)
of several core##2##3##(2008-10#1)(2012-3#1)
of several cytokines##3##3##(1991-4#2)(2010-12#1)
of several days##2##3##(2006-10#1)(2008-10#1)
of several different##17##3##(1990-3#1)(1994-11#1)(1995-2#1)(1996-8#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)
of several diseases##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
of several disorders##2##3##(2006-2#1)(2008-12#1)
of several distinct##5##3##(1992-5#1)(1993-6#1)(1996-1#1)(1996-4#1)(2008-10#1)
of several enzyme##2##3##(1991-5#1)(2008-10#1)
of several enzymes##5##3##(1990-12#1)(1994-3#1)(2008-10#1)(2008-7#1)(2012-12#1)
of several epidemics##2##3##(2008-12#1)(2012-2#1)
of several experimental##4##3##(2005-11#1)(2008-10#3)
of several factors on the##2##5##(1992-3#1)(2008-5#1)
of several factors##8##3##(1990-8#1)(1992-3#1)(2006-2#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-5#1)
of several families of##2##4##(1993-8#1)(2008-8#1)
of several forms##2##3##(1991-3#1)(2010-11#1)
of several functional##2##3##(2009-5#1)(2012-1#1)
of several genes in##2##4##(2008-11#1)(2008-8#1)
of several genes involved in##2##5##(1995-2#1)(2008-10#1)
of several genes##9##3##(1991-5#1)(1994-3#1)(1994-9#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-2#1)
of several growth factors##3##4##(1992-12#1)(1995-11#1)(2006-10#1)
of several hours##3##3##(1993-3#1)(1994-11#1)(2011-2#1)
of several human##8##3##(1990-2#1)(1990-5#1)(1997-8#1)(2007-11#1)(2008-11#1)(2008-8#2)(2010-12#1)
of several hundred meters##2##4##(2008-2#1)(2008-3#1)
of several hundred##12##3##(1990-8#1)(1993-12#1)(1994-9#1)(1997-6#1)(2007-11#2)(2008-10#3)(2008-2#1)(2008-3#2)
of several important factors##4##4##(2008-10#4)
of several important##9##3##(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)
of several independent##2##3##(1991-12#1)(2008-7#1)
of several inflammatory diseases##2##4##(1995-12#1)(1995-7#1)
of several inflammatory##3##3##(1995-12#1)(1995-7#1)(2009-10#1)
of several ions##2##3##(2008-10#2)
of several isoforms##2##3##(1992-2#1)(2009-8#1)
of several key enzymes##2##4##(2004-11#1)(2008-5#1)
of several key##6##3##(1996-11#1)(1997-2#1)(2004-11#1)(2008-5#1)(2009-7#1)(2011-2#1)
of several kinds of##7##4##(1993-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-10#1)
of several known##2##3##(2008-10#1)(2013-1#1)
of several lysosomal pro-enzymes##2##4##(1990-9#2)
of several mammalian##3##3##(1993-11#1)(2008-10#1)(2008-11#1)
of several mechanisms##2##3##(2008-10#1)(2008-8#1)
of several members of the##3##5##(1992-3#1)(1996-3#1)(2008-11#1)
of several members of##4##4##(1992-3#1)(1996-3#1)(1997-7#1)(2008-11#1)
of several metals##3##3##(2005-4#1)(2008-10#2)
of several methods##2##3##(1996-12#1)(2006-10#1)
of several micrometers##2##3##(2007-12#1)(2008-2#1)
of several minimally invasive##2##4##(2006-7#1)(2013-1#1)
of several mixtures##3##3##(2008-10#3)
of several model##2##3##(2007-8#1)(2008-10#1)
of several months##2##3##(1992-11#1)(2007-11#1)
of several natural##2##3##(1995-3#1)(2008-10#1)
of several neuropsychiatric##2##3##(2008-1#1)(2013-8#1)
of several neurotransmitters and##2##4##(2006-10#1)(2008-7#1)
of several new classes of##2##5##(2008-1#1)(2008-3#1)
of several new##3##3##(2008-1#1)(2008-3#1)(2010-5#1)
of several novel##3##3##(1990-8#1)(1994-5#1)(2009-11#1)
of several of the##6##4##(1996-2#1)(2007-4#1)(2008-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
of several of these##4##4##(2006-10#1)(2008-10#1)(2008-7#1)(2012-3#1)
of several of##14##3##(1992-3#1)(1996-2#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-12#3)(2012-2#2)(2012-3#2)
of several oncogenic##2##3##(1995-2#1)(2012-12#1)
of several orders of##2##4##(2008-10#1)(2008-3#1)
of several organ systems##2##4##(1990-8#1)(1994-10#1)
of several organic##2##3##(1993-12#1)(2008-10#1)
of several organs##3##3##(2008-10#1)(2010-10#1)(2010-11#1)
of several other##9##3##(1991-12#1)(1991-9#1)(1993-2#1)(1995-4#1)(2005-8#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-9#1)
of several parameters##3##3##(1997-7#1)(2008-10#2)
of several partial reactions##2##4##(1993-4#1)(1995-3#1)
of several pathological##2##3##(2005-8#1)(2012-3#1)
of several polar##2##3##(1996-5#2)
of several polypeptides##2##3##(1991-10#1)(2006-3#1)
of several potential##4##3##(1993-12#1)(2007-12#1)(2008-5#1)(2008-7#1)
of several previously##4##3##(1990-10#1)(1992-6#1)(1994-3#1)(2007-12#1)
of several protein##2##3##(1994-5#1)(2008-11#1)
of several proteins in##2##4##(1994-12#1)(2006-10#1)
of several proteins##8##3##(1991-5#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-6#1)(2006-10#1)(2008-10#1)(2011-12#1)
of several recent studies##3##4##(2008-3#1)(2009-5#1)(2011-2#1)
of several recent##6##3##(2006-10#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-5#1)(2011-2#1)
of several recombinant##2##3##(2006-2#1)(2008-10#1)
of several reference##2##3##(2006-12#1)(2008-10#1)
of several research groups##2##4##(2005-7#1)(2010-10#1)
of several sizes##2##3##(1993-9#1)(2008-10#1)
of several sources of##2##4##(1990-2#1)(2008-1#1)
of several species##7##3##(1996-7#1)(1997-2#1)(2005-10#1)(2007-3#1)(2008-10#2)(2009-5#1)
of several specific##3##3##(1990-4#1)(1996-3#1)(2005-6#1)
of several strains of##2##4##(2008-10#1)(2008-9#1)
of several structural##2##3##(1993-1#1)(2010-5#1)
of several studies##9##3##(1993-12#1)(2006-10#3)(2009-5#1)(2013-8#4)
of several substances##3##3##(2008-10#2)(2010-5#1)
of several supermodes##2##3##(2007-12#1)(2008-1#1)
of several surfactants##2##3##(1996-1#1)(2008-10#1)
of several techniques##4##3##(1992-12#1)(2008-3#1)(2008-4#1)(2009-9#1)
of several tens of##5##4##(2007-11#1)(2007-12#2)(2008-3#1)(2008-7#1)
of several thousand##2##3##(2008-2#1)(2008-3#1)
of several trace##2##3##(2008-10#1)(2008-2#1)
of several transcription##2##3##(1996-5#1)(2011-1#1)
of several trials##2##3##(2007-11#1)(2008-11#1)
of several tumour suppressor genes##2##5##(2008-7#2)
of several types of##11##4##(1990-6#1)(2005-8#1)(2007-12#2)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-10#2)(2009-7#1)
of several types##13##3##(1990-6#1)(2005-8#1)(2006-8#1)(2007-12#2)(2007-7#1)(2008-11#2)(2008-2#1)(2008-3#1)(2009-10#2)(2009-7#1)
of several variables##6##3##(1995-3#1)(2008-10#4)(2009-8#1)
of several varieties of##2##4##(2008-10#1)(2011-2#1)
of several vascular diseases##2##4##(2009-10#2)
of several viral##2##3##(1995-2#1)(2005-8#1)
of several weeks to##2##4##(2006-10#1)(2008-10#1)
of several weeks##3##3##(1993-3#1)(2006-10#1)(2008-10#1)
of several##859##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#4)(1990-5#3)(1990-6#1)(1990-7#3)(1990-8#6)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#4)(1991-4#5)(1991-5#4)(1991-6#1)(1991-7#3)(1991-8#3)(1991-9#6)(1992-1#1)(1992-11#3)(1992-12#6)(1992-2#2)(1992-3#5)(1992-5#2)(1992-6#1)(1992-8#5)(1992-9#3)(1993-1#3)(1993-11#2)(1993-12#6)(1993-2#3)(1993-3#4)(1993-4#3)(1993-5#1)(1993-6#4)(1993-8#3)(1993-9#5)(1994-10#2)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#4)(1994-5#3)(1994-6#7)(1994-8#1)(1994-9#7)(1995-11#3)(1995-12#2)(1995-2#8)(1995-3#8)(1995-4#1)(1995-5#1)(1995-6#5)(1995-7#1)(1995-8#2)(1996-1#3)(1996-10#3)(1996-11#3)(1996-12#5)(1996-2#2)(1996-3#7)(1996-4#4)(1996-5#6)(1996-7#4)(1996-8#2)(1997-1#3)(1997-2#3)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#6)(2004-11#1)(2004-12#1)(2004-3#2)(2004-9#2)(2005-10#1)(2005-11#5)(2005-12#1)(2005-4#2)(2005-6#1)(2005-7#3)(2005-8#6)(2006-1#1)(2006-10#24)(2006-11#1)(2006-12#6)(2006-2#8)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#16)(2007-12#22)(2007-2#2)(2007-3#2)(2007-4#4)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#8)(2007-9#3)(2008-1#10)(2008-10#149)(2008-11#26)(2008-12#7)(2008-2#23)(2008-3#35)(2008-4#14)(2008-5#18)(2008-6#5)(2008-7#18)(2008-8#14)(2008-9#10)(2009-1#1)(2009-10#7)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#3)(2009-5#8)(2009-6#1)(2009-7#4)(2009-8#3)(2009-9#3)(2010-1#2)(2010-10#4)(2010-11#3)(2010-12#8)(2010-2#6)(2010-3#1)(2010-4#1)(2010-5#4)(2010-7#3)(2011-1#5)(2011-12#3)(2011-2#13)(2012-1#4)(2012-11#1)(2012-12#6)(2012-2#10)(2012-3#10)(2012-5#2)(2013-1#10)(2013-8#8)
of severe OM to##2##4##(2008-7#2)
of severe acute asthma##2##4##(1992-10#2)
of severe acute pancreatitis and##2##5##(2005-10#1)(2008-3#1)
of severe acute pancreatitis has##2##5##(2008-3#2)
of severe acute pancreatitis##8##4##(2005-10#2)(2006-6#1)(2008-3#5)
of severe acute respiratory syndrome##4##5##(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)
of severe acute##17##3##(1992-10#2)(2005-10#2)(2006-4#1)(2006-6#2)(2007-12#1)(2008-10#1)(2008-3#5)(2008-5#1)(2008-7#1)(2013-7#1)
of severe adverse##2##3##(2006-8#1)(2007-9#1)
of severe anaemia##3##3##(2006-2#2)(2012-1#1)
of severe and##8##3##(1990-8#1)(1994-11#1)(1996-11#1)(2006-10#1)(2006-6#1)(2006-8#1)(2012-12#2)
of severe aortic##3##3##(2007-8#3)
of severe asthma##2##3##(2005-8#1)(2012-2#1)
of severe atenolol##2##3##(2007-7#2)
of severe back pain##2##4##(2006-8#1)(2012-12#1)
of severe chest pain##2##4##(2007-8#1)(2013-7#1)
of severe chest##3##3##(2006-10#1)(2007-8#1)(2013-7#1)
of severe chronic##2##3##(2007-8#1)(2008-3#1)
of severe combined##2##3##(1994-2#1)(1995-8#1)
of severe complications##4##3##(1993-5#1)(2006-10#1)(2011-2#2)
of severe congenital##2##3##(2006-10#1)(2008-7#1)
of severe disability##2##3##(2007-9#1)(2011-2#1)
of severe disease in##2##4##(2010-12#1)(2011-1#1)
of severe disease##4##3##(2006-6#1)(2010-12#1)(2011-1#1)(2011-2#1)
of severe fibrosis##2##3##(2008-3#1)(2013-8#1)
of severe food insecurity##5##4##(2011-1#5)
of severe head injury##2##4##(2008-7#1)(2013-8#1)
of severe headache##4##3##(1992-2#1)(2006-1#1)(2006-10#1)(2008-7#1)
of severe heart failure##3##4##(2007-7#1)(2007-8#1)(2008-4#1)
of severe human##2##3##(2008-4#1)(2008-8#1)
of severe hypotension##2##3##(1990-8#1)(2013-1#1)
of severe idiopathic##2##3##(1992-5#1)(2010-12#1)
of severe infections##2##3##(2008-3#1)(2008-5#1)
of severe injury##2##3##(2005-11#1)(2009-6#1)
of severe malaria in##2##4##(2007-2#2)
of severe malaria##3##3##(2007-2#2)(2008-2#1)
of severe mental##2##3##(2008-2#1)(2012-11#1)
of severe morbidity##2##3##(2006-10#1)(2012-2#1)
of severe neurological##2##3##(2006-10#1)(2008-7#1)
of severe pain and##3##4##(2005-7#1)(2008-12#1)(2011-1#1)
of severe pain##6##3##(1993-5#1)(2005-7#1)(2008-12#1)(2011-1#1)(2012-12#1)(2012-3#1)
of severe pulmonary##7##3##(2006-10#2)(2007-10#1)(2008-10#1)(2008-11#2)(2008-4#1)
of severe respiratory distress syndrome##2##5##(1992-2#1)(1994-6#1)
of severe respiratory##4##3##(1992-2#1)(1994-6#1)(2010-9#1)(2012-2#1)
of severe sepsis and##2##4##(2007-12#1)(2011-2#1)
of severe sepsis in##2##4##(2011-2#1)(2012-2#1)
of severe sepsis##10##3##(2007-12#4)(2008-8#1)(2009-6#1)(2011-2#2)(2012-2#1)(2013-1#1)
of severe side effects##2##4##(2006-10#1)(2006-6#1)
of severe systemic##2##3##(2006-10#1)(2006-8#1)
of severe thoracic scoliosis##4##4##(2009-3#4)
of severe thoracic##5##3##(2006-4#1)(2009-3#4)
of severe toxicity##2##3##(1990-12#1)(1992-4#1)
of severe traumatic brain injury##3##5##(2006-4#1)(2006-7#1)(2008-9#1)
of severe##358##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#2)(1990-8#2)(1991-1#1)(1991-11#3)(1991-3#3)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#3)(1992-11#1)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-10#3)(1993-2#2)(1993-4#1)(1993-5#5)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-4#1)(1995-5#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-3#1)(2005-10#3)(2005-11#2)(2005-7#1)(2005-8#1)(2006-1#3)(2006-10#19)(2006-12#2)(2006-2#3)(2006-4#7)(2006-5#1)(2006-6#5)(2006-7#1)(2006-8#10)(2007-1#2)(2007-10#2)(2007-11#8)(2007-12#10)(2007-2#4)(2007-4#1)(2007-5#1)(2007-7#7)(2007-8#12)(2007-9#3)(2008-1#5)(2008-10#3)(2008-11#4)(2008-12#3)(2008-2#8)(2008-3#11)(2008-4#6)(2008-5#7)(2008-6#3)(2008-7#9)(2008-8#6)(2008-9#4)(2009-10#1)(2009-3#4)(2009-5#1)(2009-6#4)(2009-7#1)(2009-9#2)(2010-10#1)(2010-12#9)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#4)(2010-8#1)(2010-9#2)(2011-1#10)(2011-12#1)(2011-2#14)(2012-1#3)(2012-11#2)(2012-12#11)(2012-2#11)(2012-3#6)(2013-1#13)(2013-7#4)(2013-8#7)
of severed##4##2##(1991-10#1)(1997-4#1)(2008-11#1)(2008-9#1)
of severely##6##2##(1995-1#1)(1997-8#1)(2006-10#1)(2008-10#2)(2013-1#1)
of severity levels##2##3##(2007-2#2)
of severity of##12##3##(1994-12#1)(1995-4#1)(1996-3#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-1#1)(2013-1#1)
of severity##40##2##(1992-3#1)(1993-5#1)(1994-1#1)(1994-12#2)(1994-5#1)(1994-7#1)(1995-4#1)(1996-3#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#4)(2007-6#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
of sevoflurane and##2##3##(2007-9#2)
of sevoflurane##5##2##(2006-10#1)(2007-9#3)(2012-3#1)
of sewage sludge disposal##2##4##(1997-4#2)
of sewage sludge##10##3##(1997-4#7)(2007-12#1)(2008-11#1)(2008-12#1)
of sewage##14##2##(1992-6#1)(1997-4#7)(2005-11#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-12#1)(2013-1#1)
of sex allocation##2##3##(2008-8#1)(2008-9#1)
of sex and age##2##4##(2007-11#1)(2011-2#1)
of sex and##13##3##(1990-2#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-11#2)(2008-5#2)(2009-1#1)(2009-9#2)(2010-2#1)(2011-2#1)
of sex chromosomal##3##3##(1990-3#1)(2013-1#2)
of sex chromosome evolution##3##4##(2010-5#3)
of sex chromosome##8##3##(2005-10#1)(2007-12#1)(2008-12#1)(2010-3#1)(2010-5#3)(2012-3#1)
of sex chromosomes and##2##4##(2010-3#2)
of sex chromosomes##11##3##(1995-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-3#7)
of sex determination are##2##4##(2007-12#1)(2010-3#1)
of sex determination##6##3##(1995-11#2)(2005-10#1)(2007-12#1)(2010-3#1)(2012-12#1)
of sex determining##2##3##(1995-11#1)(2010-3#1)
of sex differences in the##2##5##(1997-7#1)(2006-10#1)
of sex differences in##8##4##(1996-5#1)(1997-7#1)(2006-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#1)
of sex education##3##3##(1990-9#1)(1993-8#1)(2006-7#1)
of sex hormones on##3##4##(1996-4#2)(2007-9#1)
of sex hormones##9##3##(1996-4#2)(1997-5#1)(2007-1#1)(2007-9#2)(2008-11#1)(2008-7#1)(2010-6#1)
of sex in##3##3##(1990-11#1)(1997-7#1)(2008-10#1)
of sex is##2##3##(1997-7#1)(2009-2#1)
of sex on##3##3##(1994-7#1)(1997-7#1)(2012-12#1)
of sex or##2##3##(1995-3#1)(2009-9#1)
of sex pheromone##4##3##(1992-1#1)(2008-10#3)
of sex steroids in##2##4##(1995-12#1)(2011-1#1)
of sex steroids on##2##4##(1993-5#1)(1997-6#1)
of sex steroids##12##3##(1990-11#1)(1992-6#1)(1993-5#1)(1995-12#1)(1996-4#1)(1997-6#1)(2005-3#1)(2007-2#1)(2008-3#1)(2009-6#1)(2009-7#1)(2011-1#1)
of sex work##2##3##(2012-3#2)
of sex workers' rights##2##4##(2012-3#2)
of sex##149##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-9#3)(1991-3#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-7#1)(1995-11#5)(1995-12#1)(1995-3#1)(1995-6#1)(1996-3#1)(1996-4#4)(1996-5#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#4)(2004-10#1)(2005-10#2)(2005-3#1)(2006-10#1)(2006-7#3)(2007-1#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#2)(2007-9#2)(2008-10#6)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-1#2)(2009-11#1)(2009-2#2)(2009-4#3)(2009-6#1)(2009-7#2)(2009-9#3)(2010-10#1)(2010-2#1)(2010-3#11)(2010-5#3)(2010-6#1)(2011-1#4)(2011-12#1)(2011-2#1)(2012-12#5)(2012-2#1)(2012-3#13)(2013-1#5)
of sex-determining##3##2##(2010-3#2)(2010-5#1)
of sex-linked##3##2##(2008-7#1)(2012-3#2)
of sex-specific##6##2##(1995-8#1)(1997-5#1)(2007-6#1)(2008-11#1)(2010-6#2)
of sexting##3##2##(2013-1#3)
of sexual abuse##17##3##(1992-2#1)(1993-5#1)(1996-11#2)(2005-8#1)(2006-2#1)(2007-3#1)(2007-7#1)(2009-9#4)(2010-10#3)(2010-4#1)(2012-1#1)
of sexual addiction and##2##4##(2007-7#2)
of sexual and reproductive health rights##2##6##(2012-3#2)
of sexual and reproductive health##6##5##(1995-9#1)(1996-12#1)(2012-12#1)(2012-3#3)
of sexual and reproductive rights##2##5##(2012-3#2)
of sexual and reproductive##8##4##(1995-9#1)(1996-12#1)(2012-12#1)(2012-3#5)
of sexual and##11##3##(1995-9#1)(1996-12#1)(1997-7#1)(2008-9#1)(2012-12#1)(2012-3#6)
of sexual assault and##2##4##(2007-12#1)(2008-6#1)
of sexual assault##8##3##(2007-12#1)(2008-12#2)(2008-6#2)(2009-5#2)(2010-12#1)
of sexual behavior and##2##4##(2008-4#1)(2011-2#1)
of sexual behavior in##2##4##(2007-7#1)(2013-1#1)
of sexual behavior##8##3##(1992-12#1)(2007-7#1)(2008-4#1)(2011-2#3)(2012-1#1)(2013-1#1)
of sexual debut##2##3##(1990-9#1)(2011-1#1)
of sexual development##4##3##(1995-6#1)(2008-5#1)(2010-8#1)(2011-2#1)
of sexual differentiation##4##3##(1997-3#1)(1997-5#1)(2006-10#2)
of sexual dimorphism in##3##4##(1995-6#1)(2008-8#1)(2012-3#1)
of sexual dimorphism##6##3##(1995-6#1)(2007-3#1)(2008-8#3)(2012-3#1)
of sexual dysfunction##5##3##(2006-9#1)(2008-6#1)(2010-12#1)(2011-2#1)(2012-3#1)
of sexual exhaustion##2##3##(1994-6#2)
of sexual function##3##3##(2006-9#1)(2008-1#1)(2012-1#1)
of sexual harassment##2##3##(1996-3#1)(2006-5#1)
of sexual health##4##3##(1995-4#1)(2010-9#2)(2012-3#1)
of sexual identity##2##3##(2008-10#1)(2009-7#1)
of sexual initiation##2##3##(2012-1#1)(2012-3#1)
of sexual maturity##2##3##(2008-5#1)(2013-7#1)
of sexual minority##2##3##(2008-12#2)
of sexual network##3##3##(2010-2#3)
of sexual networks##3##3##(2010-2#3)
of sexual orientation##3##3##(2008-12#1)(2012-2#1)(2013-1#1)
of sexual partner##2##3##(2008-5#1)(2012-2#1)
of sexual populations##2##3##(1990-11#1)(2013-1#1)
of sexual recombination##6##3##(2008-10#6)
of sexual reproduction in##2##4##(2010-12#1)(2012-3#1)
of sexual reproduction of##2##4##(2008-10#2)
of sexual reproduction##13##3##(2008-10#4)(2008-5#1)(2008-9#2)(2009-5#1)(2010-12#1)(2012-3#3)(2013-1#1)
of sexual risk##5##3##(2008-4#1)(2009-8#2)(2011-2#1)(2012-3#1)
of sexual selection in##2##4##(1995-2#1)(2008-8#1)
of sexual selection on males##2##5##(2008-8#2)
of sexual selection on##4##4##(2008-8#3)(2010-8#1)
of sexual selection##20##3##(1995-2#2)(2008-5#1)(2008-8#10)(2008-9#2)(2009-9#1)(2010-8#1)(2012-3#2)(2013-1#1)
of sexual signalling##3##3##(2009-9#3)
of sexual violence##5##3##(2006-7#4)(2010-3#1)
of sexual##203##2##(1990-11#1)(1990-6#1)(1990-9#1)(1992-12#1)(1992-2#2)(1992-9#1)(1993-5#1)(1993-9#1)(1994-2#1)(1994-6#2)(1995-12#1)(1995-2#2)(1995-4#1)(1995-6#2)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-3#2)(1997-5#1)(1997-7#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-5#1)(2006-7#7)(2006-9#2)(2007-12#3)(2007-3#2)(2007-5#1)(2007-7#4)(2008-1#1)(2008-10#13)(2008-12#7)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#17)(2008-9#10)(2009-4#2)(2009-5#3)(2009-7#2)(2009-8#2)(2009-9#8)(2010-10#3)(2010-12#3)(2010-2#7)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#3)(2011-2#7)(2012-1#4)(2012-12#3)(2012-2#2)(2012-3#18)(2013-1#7)(2013-7#3)
of sexuality in##3##3##(1992-10#1)(2008-10#1)(2012-3#1)
of sexuality##11##2##(1992-10#1)(1996-9#1)(1997-7#2)(2007-7#1)(2008-1#1)(2008-10#1)(2009-5#1)(2010-8#1)(2012-3#2)
of sexually abused children##3##4##(2008-2#2)(2010-10#1)
of sexually abused##4##3##(1990-11#1)(2008-2#2)(2010-10#1)
of sexually active##2##3##(2007-11#1)(2007-3#1)
of sexually selected traits##3##4##(2008-9#1)(2012-3#2)
of sexually transmitted disease##3##4##(1995-4#1)(1996-12#1)(2008-4#1)
of sexually transmitted diseases such as##2##6##(2009-10#1)(2010-2#1)
of sexually transmitted diseases##13##4##(1991-12#2)(1991-5#1)(1992-2#1)(1994-3#1)(1996-6#1)(1997-3#1)(1997-7#2)(2006-10#1)(2009-10#1)(2009-12#1)(2010-2#1)
of sexually transmitted infections (STI)##3##5##(2007-3#1)(2011-2#1)(2012-3#1)
of sexually transmitted infections in##2##5##(2007-12#2)
of sexually transmitted infections##8##4##(2007-12#2)(2007-3#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of sexually transmitted##28##3##(1991-12#2)(1991-5#1)(1992-2#1)(1994-3#1)(1995-11#1)(1995-4#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-7#2)(2006-10#1)(2007-12#3)(2007-3#1)(2008-4#1)(2009-10#1)(2009-12#1)(2010-2#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
of sexually##50##2##(1990-11#1)(1991-12#2)(1991-5#1)(1992-2#1)(1993-5#1)(1993-7#1)(1994-3#1)(1995-11#1)(1995-4#1)(1996-12#1)(1996-6#1)(1996-8#2)(1997-3#1)(1997-7#3)(2006-10#1)(2007-11#1)(2007-12#4)(2007-3#2)(2008-10#1)(2008-2#2)(2008-4#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#1)(2010-10#1)(2010-2#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#2)
of sfGFP-TEV##2##2##(2010-2#2)
of sgcD##2##2##(2008-9#2)
of sgk##4##2##(1997-4#1)(2008-8#3)
of shadow##2##2##(2006-12#1)(2008-3#1)
of shadows in##2##3##(2006-6#1)(2008-3#1)
of shadows##3##2##(2006-6#1)(2008-3#1)(2008-6#1)
of shaft of##2##3##(2007-11#1)(2011-12#1)
of shaft##4##2##(2007-11#2)(2011-12#1)(2011-2#1)
of shaking##2##2##(2008-10#1)(2013-1#1)
of shallow water##2##3##(2007-5#1)(2008-5#1)
of shallow##7##2##(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-11#1)(2011-2#1)
of shallow-water bathymetry##2##3##(2008-2#1)(2008-3#1)
of shallow-water##3##2##(2007-5#1)(2008-2#1)(2008-3#1)
of sham##2##2##(1995-11#1)(2013-1#1)
of sham-operated##2##2##(1994-8#1)(2008-5#1)
of shame##3##2##(1997-7#1)(2008-1#2)
of shampoo##8##2##(2008-10#1)(2008-5#7)
of shampooing##2##2##(2008-10#1)(2008-5#1)
of shape and##2##3##(2005-11#1)(2007-12#1)
of shape components##2##3##(2008-2#2)
of shape memory alloys##3##4##(2006-6#2)(2008-2#1)
of shape memory##5##3##(2006-6#2)(2008-2#2)(2008-5#1)
of shape##18##2##(1995-8#1)(1996-11#1)(2005-11#1)(2006-11#1)(2006-6#2)(2007-12#1)(2008-2#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)
of shapes##5##2##(2007-8#1)(2008-6#2)(2009-10#1)(2009-8#1)
of shaping##2##2##(2005-11#1)(2008-1#1)
of shared care##3##3##(2008-2#1)(2013-1#2)
of shared##19##2##(1990-7#1)(1992-2#1)(1994-12#1)(1994-9#1)(1995-1#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#2)(2013-8#1)
of shareholders##2##2##(1994-1#1)(2007-3#1)
of sharing in##2##3##(1995-3#1)(2012-12#1)
of sharing##7##2##(1995-3#1)(2007-9#1)(2008-10#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
of sharp boundaries##2##3##(2008-3#1)(2012-12#1)
of sharp##9##2##(2005-8#1)(2007-11#1)(2008-2#1)(2008-3#4)(2009-4#1)(2012-12#1)
of shaving on axillary##2##4##(2008-5#2)
of shaving on##3##3##(2008-5#3)
of shaving##6##2##(2008-5#6)
of shear for##2##3##(1997-6#1)(2011-2#1)
of shear in##2##3##(2011-2#2)
of shear stress on##3##4##(1993-11#1)(2008-11#1)(2009-12#1)
of shear stress##6##3##(1993-11#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-12#1)(2010-1#1)
of shear##14##2##(1993-11#1)(1997-6#1)(2006-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-5#2)(2009-12#1)(2010-1#1)(2011-2#3)
of shearing##2##2##(2005-11#1)(2013-1#1)
of sheath blight##4##3##(2008-10#4)
of sheath##5##2##(2008-10#5)
of shedding of revertant virus##2##5##(1995-5#2)
of shedding of##3##3##(1995-5#2)(1997-6#1)
of shedding##6##2##(1995-5#2)(1997-6#1)(2012-3#1)(2013-8#2)
of sheep and goats in##2##5##(1997-5#1)(2011-2#1)
of sheep and goats##4##4##(1997-5#1)(2007-3#1)(2008-12#1)(2011-2#1)
of sheep and##5##3##(1992-1#1)(1997-5#1)(2007-3#1)(2008-12#1)(2011-2#1)
of sheep by##2##3##(1991-8#1)(1993-8#1)
of sheep liver##2##3##(2008-5#2)
of sheep meat##2##3##(2010-4#1)(2013-1#1)
of sheep to##2##3##(1996-12#1)(2011-1#1)
of sheep##28##2##(1991-8#1)(1992-1#2)(1993-8#1)(1996-12#2)(1997-5#3)(1997-6#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-4#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
of sheets of##2##3##(2005-7#1)(2006-11#1)
of shell##4##2##(2004-9#1)(2010-4#1)(2011-2#2)
of shellfish##3##2##(1997-4#2)(2013-7#1)
of shells##2##2##(2005-11#1)(2006-5#1)
of shift of tumor position##2##5##(2009-11#2)
of shift work on##2##4##(2010-7#2)
of shift work##4##3##(2010-7#3)(2011-2#1)
of shift##7##2##(2007-12#1)(2009-11#2)(2010-7#3)(2011-2#1)
of shifting##6##2##(1992-2#1)(1994-2#1)(2006-4#1)(2008-3#2)(2008-4#1)
of shifts in the##2##4##(2012-1#1)(2012-6#1)
of shifts in##5##3##(2008-9#1)(2012-1#2)(2012-6#1)(2013-8#1)
of shiga toxin##3##3##(2008-8#3)
of shigella##2##2##(2006-10#1)(2007-11#1)
of shikonin##2##2##(1994-11#2)
of shoaling behaviour##2##3##(2008-11#2)
of shock and##3##3##(2009-8#1)(2011-1#1)(2013-1#1)
of shock waves##3##3##(1994-5#2)(2007-11#1)
of shock##21##2##(1992-5#1)(1993-10#1)(1994-5#2)(1996-6#1)(2006-10#4)(2006-6#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#3)(2009-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
of shock-wave##2##2##(2008-10#1)(2008-2#1)
of shockwave##3##2##(1992-5#1)(2013-1#2)
of shoot##5##2##(2006-12#1)(2007-3#1)(2008-10#1)(2013-1#2)
of shoots and roots##4##4##(2007-8#1)(2008-10#2)(2008-12#1)
of shoots and##5##3##(2007-8#1)(2008-10#3)(2008-12#1)
of shoots in##2##3##(1991-11#1)(2008-12#1)
of shoots##14##2##(1991-11#1)(2004-4#1)(2007-8#1)(2008-10#7)(2008-12#2)(2009-8#1)(2011-2#1)
of shoots)##3##2##(2008-10#1)(2013-1#2)
of shorebirds##3##2##(2013-7#3)
of short DNA fragments##2##4##(2008-10#1)(2012-3#1)
of short DNA##4##3##(2008-10#1)(2008-11#1)(2012-1#1)(2012-3#1)
of short and long##3##4##(2006-10#1)(2008-11#1)(2012-12#1)
of short and##5##3##(2006-10#2)(2008-11#1)(2010-5#1)(2012-12#1)
of short bowel syndrome##3##4##(1991-12#1)(1993-5#1)(2008-10#1)
of short bowel##4##3##(1991-12#1)(1993-5#1)(2008-10#2)
of short chain fatty acids##2##5##(1990-6#1)(2009-3#1)
of short duration and##2##4##(2008-11#1)(2008-9#1)
of short duration##9##3##(1990-10#1)(1990-2#1)(1992-5#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-9#1)
of short fragments of##2##4##(1993-5#1)(2008-4#1)
of short fragments##3##3##(1993-5#1)(1993-6#1)(2008-4#1)
of short oligonucleotides##2##3##(2008-10#1)(2008-4#1)
of short peptides##3##3##(1997-4#1)(2013-1#2)
of short protein coding regions##2##5##(1996-12#2)
of short pulses##4##3##(1991-8#1)(2007-11#1)(2007-12#1)(2008-2#1)
of short reads##2##3##(2012-2#1)(2012-3#1)
of short stature##8##3##(1993-6#1)(2007-11#1)(2007-8#1)(2011-1#1)(2012-2#2)(2013-1#2)
of short##114##2##(1990-10#1)(1990-11#2)(1990-2#2)(1990-6#2)(1991-12#1)(1991-3#1)(1991-8#1)(1992-5#1)(1992-9#1)(1993-4#1)(1993-5#2)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#2)(1994-9#1)(1995-11#1)(1996-12#3)(1997-4#1)(2006-10#3)(2006-11#1)(2006-12#1)(2007-11#3)(2007-12#8)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#4)(2008-3#1)(2008-4#6)(2008-5#5)(2008-7#3)(2008-9#2)(2009-10#3)(2009-3#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#5)(2013-7#1)
of short- and long-range##2##4##(1991-11#1)(1997-5#1)
of short- and long-term##2##4##(1994-5#1)(1995-8#1)
of short- and##5##3##(1991-11#1)(1994-5#1)(1995-8#1)(1997-5#1)(2008-10#1)
of short-##7##2##(1991-11#1)(1994-5#1)(1995-8#1)(1997-5#1)(2007-8#1)(2007-9#1)(2008-10#1)
of short-acting##4##2##(2006-10#1)(2007-11#1)(2009-9#1)(2012-3#1)
of short-chain alcohol dehydrogenases##2##4##(1995-1#1)(1995-5#1)
of short-chain fatty acid##2##4##(2008-5#1)(2011-2#1)
of short-chain fatty##3##3##(2008-5#1)(2011-2#1)(2012-1#1)
of short-chain##11##2##(1990-12#1)(1990-4#1)(1990-8#1)(1991-5#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-5#1)(2008-5#1)(2011-2#1)(2012-1#1)
of short-distance##2##2##(2008-10#1)(2011-2#1)
of short-lived proteins##4##3##(1992-12#1)(2004-11#3)
of short-lived##11##2##(1992-12#2)(1994-2#1)(2004-11#3)(2007-11#1)(2007-4#1)(2008-10#1)(2009-9#1)(2011-12#1)
of short-pulse##3##2##(2007-11#3)
of short-range##2##2##(2006-10#1)(2008-11#1)
of short-stay hospital##2##3##(1991-1#1)(1991-3#1)
of short-term and##2##3##(2008-1#1)(2012-2#1)
of short-term efficacy of##2##4##(1991-2#1)(2011-2#1)
of short-term memory##4##3##(1992-11#1)(2007-8#2)(2013-7#1)
of short-term oral administration of propranolol on tear secretion in##2##10##(2012-2#2)
of short-term synaptic##2##3##(1997-5#1)(2008-6#1)
of short-term##43##2##(1990-6#1)(1991-10#1)(1991-2#1)(1992-11#1)(1992-9#2)(1993-10#1)(1993-4#1)(1993-7#1)(1993-9#1)(1994-11#1)(1995-12#3)(1995-6#1)(1996-9#2)(1997-5#2)(2006-10#1)(2006-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-8#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2012-5#1)(2013-7#2)
of short-wavelength##3##2##(2007-11#1)(2008-1#1)(2008-3#1)
of shortening the##2##3##(2007-8#1)(2012-12#1)
of shortening##6##2##(1993-9#1)(2007-7#1)(2007-8#3)(2012-12#1)
of shorter##8##2##(1992-2#1)(1994-11#1)(1995-2#1)(2005-9#1)(2007-9#1)(2008-10#1)(2008-7#2)
of shortness of breath##2##4##(2008-1#1)(2013-8#1)
of shot fabric##2##3##(2008-3#2)
of shot fabrics##3##3##(2008-3#3)
of shot noise##2##3##(1995-10#1)(2008-3#1)
of shot##8##2##(1995-10#1)(2008-2#1)(2008-3#6)
of shoulder abduction##3##3##(2007-7#1)(2010-7#1)(2012-1#1)
of shoulder and elbow##3##4##(2007-8#1)(2012-1#2)
of shoulder and##4##3##(1997-8#1)(2007-8#1)(2012-1#2)
of shoulder dislocations##2##3##(2007-3#2)
of shoulder dystocia##4##3##(2004-10#4)
of shoulder function##3##3##(2008-9#3)
of shoulder injuries in elite soccer##3##6##(2013-1#3)
of shoulder injuries in##4##4##(2013-1#4)
of shoulder muscles##2##3##(2012-2#2)
of shoulder pain##5##3##(2006-8#3)(2007-10#1)(2008-8#1)
of shoulder pathology##2##3##(2006-12#1)(2009-3#1)
of shoulder##45##2##(1990-3#1)(1997-8#1)(2004-10#4)(2006-11#2)(2006-12#1)(2006-8#4)(2007-10#1)(2007-11#3)(2007-3#2)(2007-4#3)(2007-7#1)(2007-8#3)(2008-10#1)(2008-8#1)(2008-9#4)(2009-3#1)(2010-7#2)(2012-1#3)(2012-2#2)(2013-1#5)
of showing##4##2##(1996-12#1)(1996-9#1)(2008-10#1)(2013-8#1)
of shrimp##2##2##(2007-3#1)(2011-12#1)
of shrimps##2##2##(2008-8#1)(2013-7#1)
of shrinkage##3##2##(2005-11#2)(2010-10#1)
of shunt##4##2##(1991-11#1)(2006-5#1)(2006-8#2)
of shunts##2##2##(2007-8#2)
of shuttle box##2##3##(1994-6#2)
of shuttle##4##2##(1994-6#2)(1997-4#1)(2008-8#1)
of siRNA##8##2##(2008-1#2)(2008-2#1)(2009-3#1)(2010-12#1)(2012-2#2)(2012-3#1)
of siRNAs##2##2##(2009-3#1)(2012-3#1)
of sialic acid metabolites##2##4##(2010-12#2)
of sialic acid on the viscosity of canine tracheal mucin##2##10##(1994-11#2)
of sialic acid residues##3##4##(1992-12#1)(1994-12#2)
of sialic acid##17##3##(1990-12#2)(1990-5#1)(1992-12#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-6#1)(1995-12#1)(1995-3#2)(2008-11#1)(2010-12#3)
of sialic##18##2##(1990-12#2)(1990-5#1)(1992-12#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-6#1)(1995-12#1)(1995-3#2)(2008-11#2)(2010-12#3)
of sialidase##3##2##(1993-4#1)(1996-3#1)(2008-11#1)
of sialoglycoconjugates##3##2##(1990-12#1)(1992-11#1)(1996-3#1)
of sialolithiasis##4##2##(1992-5#1)(2008-10#1)(2011-2#2)
of sialyl##2##2##(1995-1#1)(1997-8#1)
of sialylated and##2##3##(1997-7#1)(2008-7#1)
of sialylated##6##2##(1993-4#1)(1997-4#1)(1997-7#1)(2006-12#1)(2008-7#1)(2012-3#1)
of sibling species##2##3##(2008-10#1)(2013-7#1)
of sibling##6##2##(2008-10#5)(2013-7#1)
of siblings about##2##3##(2010-9#2)
of siblings##12##2##(1993-7#1)(2004-11#4)(2006-10#2)(2007-7#1)(2008-8#1)(2010-9#2)(2013-1#1)
of siboglinids##2##2##(2009-8#2)
of sibutramine and citalopram##3##4##(2012-3#3)
of sibutramine##4##2##(2011-2#1)(2012-3#3)
of sicca symptoms in##3##4##(2006-10#3)
of sicca##4##2##(2006-10#3)(2006-4#1)
of sick children##2##3##(1994-6#1)(2005-7#1)
of sick leave##5##3##(1990-4#3)(1991-8#1)(2008-7#1)
of sick##10##2##(1990-4#4)(1991-8#1)(1994-6#1)(2005-7#1)(2008-3#1)(2008-7#1)(2009-7#1)
of sickle cell disease (SCD)##2##5##(2007-3#1)(2007-7#1)
of sickle cell disease##6##4##(1991-6#1)(1992-3#1)(2007-3#2)(2007-7#1)(2012-12#1)
of sickle cell##17##3##(1991-6#1)(1992-3#1)(1992-6#1)(1996-6#1)(2005-7#1)(2005-9#1)(2006-10#1)(2007-3#4)(2007-7#1)(2012-12#2)(2013-1#2)(2013-8#1)
of sickle##20##2##(1991-6#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-9#1)(1996-6#2)(2005-7#1)(2005-9#1)(2006-10#1)(2007-3#4)(2007-7#1)(2012-12#2)(2013-1#2)(2013-8#1)
of sickness##2##2##(1992-1#1)(1997-6#1)
of sickness-related absences##2##3##(2007-10#2)
of sickness-related##3##2##(2007-10#3)
of side chains##7##3##(1990-2#1)(1992-3#1)(1997-7#2)(2005-11#1)(2008-11#1)(2010-7#1)
of side effects after##2##4##(2006-8#1)(2011-2#1)
of side effects and##7##4##(1997-1#1)(2006-8#1)(2007-11#1)(2007-6#1)(2008-3#2)(2008-6#1)
of side effects associated with##2##5##(1997-8#1)(2007-6#1)
of side effects of##5##4##(1991-6#1)(1993-1#1)(2007-11#1)(2012-2#1)(2013-8#1)
of side effects was##2##4##(1993-2#1)(2010-4#1)
of side effects##48##3##(1991-11#1)(1991-6#1)(1991-7#1)(1993-1#1)(1993-2#2)(1993-4#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-3#1)(2006-10#1)(2006-8#4)(2007-11#2)(2007-12#1)(2007-6#7)(2007-8#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#3)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
of side impact##4##3##(2006-11#2)(2007-4#2)
of side population cells##2##4##(2010-6#2)
of side##65##2##(1990-2#1)(1991-11#1)(1991-6#1)(1991-7#1)(1992-3#1)(1993-1#1)(1993-2#2)(1993-4#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2004-3#1)(2005-11#1)(2006-10#1)(2006-11#2)(2006-8#4)(2007-11#2)(2007-12#1)(2007-4#2)(2007-6#7)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#3)(2009-11#1)(2009-7#1)(2010-4#1)(2010-6#2)(2010-7#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#2)
of side-chain##7##2##(1990-10#1)(1991-10#1)(1992-8#1)(1994-5#1)(1994-9#1)(2005-4#1)(2010-7#1)
of side-effects##11##2##(1990-1#1)(1994-4#1)(1997-1#1)(2006-10#1)(2007-8#1)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#3)
of sideband generation##2##3##(2007-11#1)(2007-12#1)
of sideband##3##2##(2007-11#1)(2007-12#2)
of sidebands##2##2##(2007-12#2)
of siderophore##2##2##(2013-1#2)
of sieve pores##2##3##(2008-11#1)(2009-8#1)
of sieve##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
of sight of their optics##2##5##(2008-2#1)(2008-3#1)
of sight of##3##3##(2008-2#1)(2008-3#2)
of sight##12##2##(2007-12#1)(2008-2#4)(2008-3#5)(2008-6#1)(2009-4#1)
of sight)##2##2##(1994-8#1)(2008-3#1)
of sigma 70##2##3##(1990-3#1)(1990-8#1)
of sigma ligands on##3##4##(1994-5#3)
of sigma ligands##6##3##(1993-11#1)(1994-5#5)
of sigma receptor ligands##2##4##(1996-10#1)(1996-12#1)
of sigma##13##2##(1990-3#1)(1990-8#1)(1993-11#1)(1994-3#1)(1994-5#5)(1995-12#1)(1996-10#1)(1996-12#1)(1996-3#1)
of sigma-1 receptors##2##3##(2008-3#2)
of sigmoid colon##5##3##(2008-12#2)(2009-6#1)(2012-1#1)(2012-12#1)
of sigmoid##9##2##(1994-10#1)(2008-12#2)(2009-1#1)(2009-6#1)(2010-12#1)(2010-8#1)(2012-1#1)(2012-12#1)
of sign-out##2##2##(2011-1#2)
of signal and idler##5##4##(2007-12#3)(2008-2#2)
of signal generation##2##3##(2008-11#1)(2009-8#1)
of signal intensities##2##3##(2008-2#1)(2013-8#1)
of signal intensity##3##3##(2009-11#2)(2013-1#1)
of signal levels##2##3##(2008-2#1)(2009-4#1)
of signal peptidase##2##3##(1994-12#1)(2008-10#1)
of signal peptides##3##3##(1994-11#1)(1997-6#1)(2008-10#1)
of signal processing##3##3##(2007-7#1)(2008-3#1)(2012-12#1)
of signal sequences##4##3##(1990-3#1)(1995-6#2)(1996-8#1)
of signal transducer##3##3##(1995-2#1)(2008-10#1)(2011-1#1)
of signal transducers and activators of transcription##2##7##(2009-3#1)(2011-12#1)
of signal transducing##2##3##(1993-8#1)(1996-5#1)
of signal transduction and##5##4##(1997-2#1)(2003-11#1)(2006-12#1)(2008-11#2)
of signal transduction events##2##4##(1994-6#1)(1994-9#1)
of signal transduction mediated by##2##5##(1993-6#1)(1994-9#1)
of signal transduction networks##2##4##(2006-10#1)(2009-5#1)
of signal transduction pathway##2##4##(2008-7#1)(2011-3#1)
of signal transduction pathways##5##4##(1994-5#1)(1997-4#1)(2007-11#1)(2008-8#1)(2008-9#1)
of signal transduction##31##3##(1993-6#3)(1994-5#1)(1994-6#1)(1994-9#2)(1995-2#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-4#1)(2003-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#2)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
of signal transmission##2##3##(2007-11#1)(2008-11#1)
of signal with##2##3##(2007-8#1)(2008-3#1)
of signal##113##2##(1990-11#1)(1990-3#1)(1993-6#3)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-5#2)(1996-8#3)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2003-11#1)(2006-10#1)(2006-12#1)(2007-11#4)(2007-12#8)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#5)(2008-2#6)(2008-3#10)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#3)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-8#4)(2010-7#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
of signal-to-noise ratio is##2##4##(2008-3#2)
of signal-to-noise ratio##4##3##(2007-12#1)(2008-3#3)
of signal-to-noise##8##2##(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#3)(2008-8#1)
of signaling by##2##3##(1997-6#1)(2008-9#1)
of signaling cascades##3##3##(2008-7#2)(2009-3#1)
of signaling events##6##3##(1997-4#1)(1997-6#1)(2006-4#1)(2008-4#1)(2010-4#1)(2011-2#1)
of signaling molecules##5##3##(2009-12#1)(2009-4#1)(2010-11#1)(2013-1#1)(2013-8#1)
of signaling pathways##11##3##(1994-12#1)(1995-6#1)(2008-1#1)(2008-8#1)(2009-8#2)(2011-2#2)(2012-12#2)(2013-8#1)
of signaling##49##2##(1992-7#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-6#2)(2005-7#1)(2006-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#4)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#4)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#4)(2012-12#4)(2012-2#2)(2013-1#2)(2013-8#2)
of signalling by##2##3##(2006-10#1)(2012-12#1)
of signalling events##2##3##(1997-7#1)(2008-1#1)
of signalling pathways##5##3##(1994-4#1)(1996-2#1)(2007-8#1)(2008-1#1)(2010-3#1)
of signalling##18##2##(1994-4#1)(1996-2#1)(1997-7#1)(2006-10#2)(2006-11#1)(2007-8#1)(2008-1#2)(2009-6#1)(2009-7#1)(2009-9#2)(2010-3#1)(2011-2#1)(2012-12#3)
of signals from the plasma membrane##2##6##(1995-2#1)(1996-10#1)
of signals from##6##3##(1995-2#1)(1996-10#1)(2008-3#2)(2008-4#1)(2008-8#1)
of signals in##5##3##(1992-3#1)(1997-7#1)(2008-1#1)(2008-2#2)
of signals to##2##3##(2008-3#1)(2008-4#1)
of signals##37##2##(1991-5#1)(1992-3#1)(1994-10#1)(1994-12#2)(1995-2#1)(1996-10#1)(1996-7#1)(1996-8#1)(1997-5#1)(1997-7#1)(2005-10#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#4)(2008-4#3)(2008-8#5)(2008-9#1)(2009-9#1)(2010-8#2)(2012-12#2)
of signature chemicals##2##3##(2008-10#2)
of signature##6##2##(2008-10#2)(2008-9#1)(2013-1#3)
of signatures##2##2##(2008-10#1)(2008-7#1)
of significance and##4##3##(1995-4#1)(1997-2#1)(2013-1#2)
of significance for the##2##4##(1990-11#1)(2013-8#1)
of significance for##4##3##(1990-11#1)(2010-9#1)(2013-8#2)
of significance in the##3##4##(1996-11#1)(2008-8#1)(2011-1#1)
of significance in##8##3##(1990-7#1)(1991-3#1)(1994-8#1)(1996-11#1)(2008-5#1)(2008-8#1)(2011-1#1)(2013-8#1)
of significance to##4##3##(1992-2#1)(1996-5#1)(2006-8#1)(2008-8#1)
of significance was##2##3##(2007-10#1)(2008-10#1)
of significance##38##2##(1990-11#1)(1990-7#1)(1991-3#1)(1992-2#1)(1994-8#1)(1995-2#1)(1995-4#2)(1996-11#1)(1996-2#1)(1996-5#1)(1997-2#1)(2006-1#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#2)(2009-7#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#4)
of significant CAD##2##3##(2012-2#2)
of significant amounts of##6##4##(1990-5#1)(1993-11#1)(1996-5#1)(2007-7#1)(2008-7#1)(2009-10#1)
of significant association##2##3##(1997-4#1)(2008-10#1)
of significant changes##2##3##(1992-12#1)(1994-10#1)
of significant clinical##2##3##(2008-9#1)(2009-10#1)
of significant differences between##3##4##(2005-4#1)(2007-5#1)(2008-2#1)
of significant differences in##4##4##(1997-4#1)(1997-6#1)(2008-2#1)(2010-8#1)
of significant differences##10##3##(1997-4#1)(1997-6#1)(2005-4#1)(2007-5#1)(2008-12#1)(2008-2#2)(2010-1#1)(2010-8#1)(2013-1#1)
of significant importance##3##3##(1993-3#1)(1994-9#1)(2008-10#1)
of significant interest##3##3##(2005-7#1)(2008-7#1)(2011-2#1)
of significant numbers of##2##4##(2006-9#1)(2008-10#1)
of significant perioperative##2##3##(2007-8#1)(2007-9#1)
of significant potential##3##3##(1993-11#1)(1995-2#1)(2010-6#1)
of significant quantities of##2##4##(1990-5#1)(2005-11#1)
of significant relevance##2##3##(2005-11#1)(2008-10#1)
of significant renal##2##3##(2008-10#1)(2011-2#1)
of significant tumor##2##3##(2011-2#2)
of significant##138##2##(1990-12#1)(1990-5#2)(1991-11#1)(1991-3#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-7#1)(1993-11#2)(1993-3#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-4#2)(1997-5#1)(1997-6#1)(2005-10#2)(2005-11#3)(2005-4#1)(2005-7#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#1)(2006-9#3)(2007-11#5)(2007-12#1)(2007-2#2)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#18)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#2)(2009-10#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#2)(2010-12#1)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#7)(2013-8#2)
of significantly different##2##3##(1993-11#1)(2008-10#1)
of significantly##12##2##(1991-12#1)(1992-3#1)(1993-11#1)(1994-4#1)(1995-1#1)(2006-10#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-8#1)(2012-2#1)
of signs and symptoms of##3##5##(2005-8#1)(2013-1#2)
of signs and symptoms##13##4##(1991-10#1)(1991-2#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-7#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-3#1)(2013-1#3)
of signs of##6##3##(1995-3#1)(2006-6#1)(2009-8#1)(2011-2#1)(2013-1#2)
of signs##24##2##(1991-10#1)(1991-2#1)(1993-2#1)(1995-3#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-2#1)(2007-7#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#5)
of silane##3##2##(2005-11#1)(2008-12#2)
of sildenafil citrate##4##3##(2008-10#4)
of sildenafil##9##2##(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#4)(2010-5#2)
of silencing##4##2##(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
of silent ischemia##2##3##(1990-2#1)(1991-7#1)
of silent myocardial##3##3##(1990-3#1)(1991-7#1)(2012-2#1)
of silent##16##2##(1990-2#1)(1990-3#1)(1991-7#2)(1995-11#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-12#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-8#1)(2012-2#2)(2012-3#1)
of silica and##3##3##(1991-8#1)(2007-11#1)(2010-7#1)
of silica fume produced by zircon desilication##2##7##(2008-10#2)
of silica gel and##2##4##(2008-10#2)
of silica gel##14##3##(2007-12#1)(2007-8#1)(2008-10#11)(2013-8#1)
of silica gels##2##3##(2008-10#1)(2010-4#1)
of silica glass##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
of silica in##3##3##(2005-12#1)(2008-10#2)
of silica microspheres##2##3##(2007-11#1)(2013-8#1)
of silica modified with##2##4##(2008-10#2)
of silica nanospheres##2##3##(2008-10#2)
of silica nanostructures##2##3##(2009-2#2)
of silica surface##2##3##(2008-10#2)
of silica with##2##3##(2008-10#1)(2008-3#1)
of silica##72##2##(1991-8#1)(1993-8#1)(1997-2#1)(2005-11#5)(2005-12#1)(2007-11#5)(2007-12#4)(2007-8#1)(2008-10#30)(2008-2#6)(2008-3#3)(2008-5#1)(2009-2#2)(2009-7#2)(2009-8#1)(2010-4#2)(2010-7#2)(2012-12#1)(2013-8#3)
of silica-ERT phase##4##3##(2008-10#4)
of silica-ERT##5##2##(2008-10#5)
of silica-based##2##2##(1996-8#1)(2008-10#1)
of silicate based##2##3##(2008-10#2)
of silicate##6##2##(2008-10#5)(2010-9#1)
of silicic acid##6##3##(2005-11#6)
of silicic##8##2##(2005-11#8)
of silicon (Si) in##2##4##(2008-10#2)
of silicon (Si)##5##3##(2008-10#5)
of silicon and germanium containing pyridine oxime O-ethers##2##8##(2008-3#2)
of silicon and##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
of silicon atoms##2##3##(2007-12#1)(2010-12#1)
of silicon by##2##3##(2008-10#2)
of silicon dioxide##2##3##(1992-7#1)(2010-12#1)
of silicon in##5##3##(2008-10#5)
of silicon nanowires##3##3##(2008-7#1)(2010-3#2)
of silicon on##2##3##(2008-10#1)(2008-9#1)
of silicon oxide##2##3##(2008-3#1)(2008-7#1)
of silicon photodiode##3##3##(2008-2#1)(2008-3#2)
of silicon##68##2##(1992-7#1)(1995-5#1)(2005-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#20)(2008-2#6)(2008-3#13)(2008-5#2)(2008-7#2)(2008-9#1)(2010-1#1)(2010-12#2)(2010-3#2)(2010-4#1)(2011-2#1)(2012-11#2)(2012-12#1)(2013-1#1)
of silicone gel-filled##2##3##(1992-2#1)(1996-3#1)
of silicone rubber##3##3##(2004-9#1)(2007-11#1)(2008-11#1)
of silicone##19##2##(1992-2#1)(1996-3#1)(2004-9#2)(2005-11#2)(2007-11#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-9#2)(2009-6#1)(2010-10#1)(2012-2#1)
of silicosis##3##2##(2009-12#1)(2012-2#2)
of siliqua##3##2##(2011-12#3)
of siliquae##2##2##(2013-8#2)
of silk fibroin##3##3##(2008-5#1)(2012-8#2)
of silk##15##2##(2007-12#4)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#6)(2012-8#2)
of silkworm hemolymph on the expression of##2##7##(1997-8#2)
of silkworm##3##2##(1997-8#2)(2012-2#1)
of silkwormAttacus ricini##2##3##(2008-8#2)
of silver NMR##2##3##(2008-5#2)
of silver and##5##3##(1992-12#1)(1997-8#1)(2007-12#1)(2008-3#1)(2012-2#1)
of silver at##2##3##(2007-8#1)(2008-10#1)
of silver in##11##3##(2005-11#1)(2007-8#2)(2008-10#7)(2010-4#1)
of silver ion##2##3##(2007-8#1)(2008-10#1)
of silver ions onto##4##4##(2008-10#4)
of silver ions##9##3##(2008-10#8)(2008-3#1)
of silver nanoparticles synthesized##2##4##(2005-11#1)(2010-1#1)
of silver nanoparticles##11##3##(2005-11#2)(2007-12#1)(2008-3#1)(2009-3#2)(2010-1#2)(2010-11#1)(2011-2#2)
of silver nanostructures##2##3##(2005-11#1)(2010-11#1)
of silver nitrate##4##3##(2005-11#2)(2007-11#1)(2013-1#1)
of silver or##2##3##(2008-10#1)(2010-6#1)
of silver picrate##2##3##(2008-10#2)
of silver staining##2##3##(2008-7#1)(2010-1#1)
of silver was##3##3##(2008-10#3)
of silver were##2##3##(2008-10#2)
of silver##108##2##(1992-12#3)(1992-8#1)(1993-11#1)(1997-5#1)(1997-8#2)(2004-4#1)(2005-11#12)(2007-11#1)(2007-12#5)(2007-8#6)(2008-10#39)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#6)(2008-7#2)(2009-2#2)(2009-3#2)(2010-1#3)(2010-11#2)(2010-4#1)(2010-6#1)(2011-2#4)(2012-2#2)(2013-1#2)
of silver(I)##8##2##(2008-10#8)
of silyl##2##2##(2008-4#1)(2009-5#1)
of silymarin##2##2##(2010-11#1)(2010-12#1)
of simazine and##2##3##(2008-10#2)
of simazine in##2##3##(2008-10#2)
of simazine was##2##3##(2008-10#1)(2008-2#1)
of simazine##7##2##(2008-10#6)(2008-2#1)
of simian immunodeficiency virus##2##4##(1993-9#1)(1995-2#1)
of simian virus 40 large##2##5##(1990-6#1)(2008-11#1)
of simian virus 40##3##4##(1990-6#1)(1997-7#1)(2008-11#1)
of simian virus##4##3##(1990-6#1)(1997-1#1)(1997-7#1)(2008-11#1)
of simian##9##2##(1990-6#1)(1992-8#1)(1993-3#1)(1993-9#1)(1995-2#1)(1997-1#1)(1997-7#1)(2008-11#1)(2012-12#1)
of similar Mr##2##3##(1990-9#1)(1991-1#1)
of similar affinities##2##3##(1994-2#1)(1996-7#1)
of similar age##3##3##(1992-8#1)(2012-3#1)(2013-1#1)
of similar ages##3##3##(1996-7#1)(2007-11#1)(2008-5#1)
of similar amounts of##2##4##(1993-6#1)(2007-2#1)
of similar cases##5##3##(2006-7#1)(2007-8#1)(2008-12#1)(2008-9#1)(2012-12#1)
of similar compounds##2##3##(1990-12#1)(2010-5#1)
of similar experiments##2##3##(1992-9#1)(2008-8#1)
of similar intensity##2##3##(1997-5#1)(2008-10#1)
of similar magnitude and##2##4##(1990-7#1)(1997-4#1)
of similar magnitude to that##2##5##(1992-8#1)(2008-1#1)
of similar magnitude##5##3##(1990-7#1)(1992-8#1)(1997-4#1)(2008-1#1)(2008-10#1)
of similar mass##3##3##(1995-1#1)(2008-8#1)(2008-9#1)
of similar molecular mass##3##4##(1990-10#1)(1990-11#1)(1993-12#1)
of similar molecular weight##2##4##(1990-11#1)(1995-11#1)
of similar molecular##5##3##(1990-10#1)(1990-11#2)(1993-12#1)(1995-11#1)
of similar programs##2##3##(2006-10#1)(2007-3#1)
of similar size and##2##4##(1996-3#1)(2008-10#1)
of similar size##10##3##(1993-12#1)(1993-9#1)(1994-6#1)(1996-2#1)(1996-3#1)(2008-10#2)(2008-12#1)(2008-2#1)(2010-2#1)
of similar structure##6##3##(1993-2#1)(2008-10#4)(2012-3#1)
of similar##145##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-7#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-10#1)(1992-12#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-1#1)(1995-11#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-7#4)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(2005-10#2)(2005-11#1)(2005-5#2)(2005-8#1)(2005-9#1)(2006-10#6)(2006-4#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#3)(2008-10#18)(2008-11#2)(2008-12#2)(2008-2#7)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)
of similarities between##2##3##(2008-4#1)(2011-1#1)
of similarities to##2##3##(2007-8#1)(2008-3#1)
of similarities##8##2##(2006-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2011-1#1)(2013-1#1)
of similarity among##3##3##(2008-10#2)(2008-2#1)
of similarity between##6##3##(1990-11#1)(1993-2#1)(2008-10#1)(2010-5#1)(2011-2#1)(2012-12#1)
of similarity factor##2##3##(2010-3#2)
of similarity in their##2##4##(2006-12#1)(2008-10#1)
of similarity in##3##3##(2005-8#1)(2006-12#1)(2008-10#1)
of similarity of##2##3##(1997-1#1)(2012-1#1)
of similarity to the##2##4##(1992-12#1)(1994-8#1)
of similarity to##8##3##(1992-11#1)(1992-12#1)(1992-8#1)(1994-8#1)(1995-12#1)(1996-8#1)(2005-6#1)(2008-10#1)
of similarity with##4##3##(1991-9#1)(1994-3#1)(2004-12#1)(2008-10#1)
of similarity##50##2##(1990-11#2)(1991-2#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-2#2)(1993-9#1)(1994-3#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-8#1)(1997-1#1)(1997-7#1)(2004-12#1)(2005-6#1)(2005-8#1)(2006-12#2)(2007-8#2)(2008-10#9)(2008-2#1)(2008-4#4)(2008-8#1)(2010-3#2)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
of similarly treated##2##3##(2007-11#1)(2008-3#1)
of similarly##4##2##(1997-7#1)(2007-11#1)(2008-3#1)(2008-7#1)
of simple and##7##3##(1992-7#1)(2005-9#1)(2006-10#1)(2007-1#1)(2010-4#1)(2012-1#1)(2012-2#1)
of simple bromophenols in##2##4##(2008-10#2)
of simple cells##4##3##(1996-2#1)(2008-11#1)(2008-8#2)
of simple linear##2##3##(1993-6#1)(2008-3#1)
of simple methods for##2##4##(2008-4#1)(2013-1#1)
of simple methods##3##3##(2008-2#1)(2008-4#1)(2013-1#1)
of simple models##2##3##(1996-6#1)(2008-8#1)
of simple sequence repeats in the##2##6##(1996-8#1)(2007-6#1)
of simple sequence repeats in##3##5##(1996-8#1)(2007-6#1)(2012-2#1)
of simple sequence repeats##5##4##(1996-8#1)(2007-6#2)(2008-7#1)(2012-2#1)
of simple sugars##2##3##(2006-10#1)(2008-10#1)
of simple warm##2##3##(2007-8#2)
of simple##124##2##(1991-9#1)(1992-10#1)(1992-12#2)(1992-7#1)(1992-9#1)(1993-6#1)(1994-11#1)(1995-11#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-7#1)(2005-4#1)(2005-9#1)(2006-10#8)(2006-2#1)(2006-4#2)(2006-5#1)(2006-7#2)(2007-1#1)(2007-12#3)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#4)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#14)(2008-3#6)(2008-4#8)(2008-5#4)(2008-7#2)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
of simple-cell receptive##2##3##(2008-8#2)
of simpler##4##2##(1992-6#1)(2008-2#1)(2009-4#1)(2010-2#1)
of simplicity and##3##3##(2008-10#2)(2008-3#1)
of simplicity##12##2##(2007-11#2)(2008-10#7)(2008-2#1)(2008-3#2)
of simplified##4##2##(1994-3#1)(1995-6#1)(2005-4#1)(2008-7#1)
of simplifying##3##2##(2008-5#1)(2011-2#1)(2012-1#1)
of simply##2##2##(2008-4#1)(2012-3#1)
of simulated and experimental##2##4##(2008-2#1)(2008-3#1)
of simulated annealing##2##3##(2008-2#1)(2008-3#1)
of simulated atmospheric##2##3##(2008-2#1)(2008-3#1)
of simulated microgravity on nitric oxide##2##6##(2008-9#2)
of simulated microgravity on##3##4##(2008-9#3)
of simulated microgravity##4##3##(2008-9#4)
of simulated phenotypes##2##3##(2012-3#2)
of simulated##28##2##(1990-12#1)(1996-7#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#3)(2008-8#1)(2008-9#4)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-3#2)(2012-5#1)
of simulating the##2##3##(1994-3#1)(2008-2#1)
of simulating##8##2##(1994-3#1)(2006-11#1)(2007-4#2)(2008-11#1)(2008-2#1)(2008-7#1)(2010-12#1)
of simulation and##4##3##(2006-11#1)(2007-12#1)(2008-3#2)
of simulation data##2##3##(1991-5#1)(2012-3#1)
of simulation in##3##3##(2008-10#1)(2008-11#1)(2009-4#1)
of simulation results##2##3##(2008-3#2)
of simulation##28##2##(1991-5#1)(1996-7#1)(2006-11#1)(2006-2#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#5)(2008-7#1)(2009-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-8#2)
of simulation-based##4##2##(2008-6#1)(2010-8#1)(2012-2#1)(2013-8#1)
of simulations and##2##3##(2007-12#1)(2009-12#1)
of simulations of##3##3##(2008-3#3)
of simulations with##2##3##(2008-12#1)(2008-3#1)
of simulations##14##2##(2007-12#1)(2007-9#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#6)(2008-9#1)(2009-12#1)
of simulators##4##2##(2009-4#1)(2011-1#1)(2011-2#2)
of simultaneous degradation of##2##4##(2008-10#1)(2008-7#1)
of simultaneous determination of##4##4##(2005-4#1)(2008-10#3)
of simultaneous measurement of##2##4##(2007-11#1)(2008-3#1)
of simultaneous measurements##2##3##(2008-3#2)
of simultaneous##46##2##(1992-8#1)(1994-9#1)(1995-5#2)(1996-3#1)(1997-1#1)(2005-12#1)(2005-4#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#4)(2008-10#9)(2008-2#1)(2008-3#6)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#1)
of simultaneously recording##2##3##(2007-12#1)(2008-3#1)
of simultaneously##12##2##(1995-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#3)(2011-1#1)(2011-2#1)(2012-2#1)
of simvastatin on##2##3##(1991-1#1)(2008-12#1)
of simvastatin##9##2##(1991-1#1)(1991-12#1)(1991-6#1)(1997-6#1)(2008-12#3)(2008-4#2)
of sinefungin##2##2##(1995-8#2)
of single DNA molecules##2##4##(2006-10#1)(2006-2#1)
of single DNA##3##3##(2006-10#1)(2006-2#1)(2008-9#1)
of single amino acid##3##4##(1991-8#1)(1994-2#1)(2008-10#1)
of single and combined##2##4##(1991-12#1)(1993-3#1)
of single and multiple##6##4##(1990-3#1)(1994-3#1)(1994-9#1)(2007-10#1)(2008-2#1)(2011-1#1)
of single and##15##3##(1990-3#1)(1991-12#1)(1993-3#1)(1994-3#1)(1994-9#1)(1997-2#1)(2007-10#1)(2008-2#2)(2008-8#1)(2008-9#1)(2011-1#2)(2012-1#1)(2013-8#1)
of single cell##2##3##(2007-11#1)(2008-8#1)
of single cells and##2##4##(1995-11#1)(2008-9#1)
of single cells from##3##4##(1995-5#1)(2008-2#1)(2009-2#1)
of single cells in##2##4##(2008-1#1)(2008-7#1)
of single cells##17##3##(1992-8#1)(1994-3#1)(1995-11#1)(1995-5#1)(2007-3#1)(2008-1#1)(2008-2#1)(2008-7#6)(2008-9#1)(2009-12#1)(2009-2#1)(2012-11#1)
of single chain##4##3##(1990-11#1)(1994-3#1)(1994-9#1)(2008-3#1)
of single channel##2##3##(1990-9#1)(2012-3#1)
of single components##2##3##(1996-4#1)(2008-10#1)
of single crystalline##2##3##(2007-9#1)(2011-1#1)
of single crystals##2##3##(2006-5#1)(2008-10#1)
of single doses##2##3##(2004-12#1)(2008-5#1)
of single gene##3##3##(1991-9#1)(2008-8#1)(2012-3#1)
of single mandibular molars##2##4##(2013-1#2)
of single molecule##3##3##(2010-2#1)(2010-7#2)
of single molecules by##2##4##(2007-11#1)(2007-12#1)
of single molecules on##2##4##(2007-12#1)(2009-4#1)
of single molecules##10##3##(2007-11#2)(2007-12#4)(2008-7#3)(2009-4#1)
of single nanoparticles##2##3##(2010-7#2)
of single neurons##5##3##(1995-6#1)(1996-12#1)(1997-3#1)(2007-8#1)(2009-5#1)
of single nucleotide polymorphism##4##4##(2008-7#2)(2011-1#1)(2013-8#1)
of single nucleotide polymorphisms (SNPs)##4##5##(2005-8#1)(2008-10#2)(2011-2#1)
of single nucleotide polymorphisms and mutations##2##6##(2005-8#1)(2008-7#1)
of single nucleotide polymorphisms##9##4##(2005-8#2)(2007-3#1)(2008-10#3)(2008-7#1)(2009-8#1)(2011-2#1)
of single nucleotide##13##3##(2005-8#2)(2007-3#1)(2008-10#3)(2008-7#3)(2009-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
of single or multiple##2##4##(2006-7#1)(2011-1#1)
of single or##4##3##(2006-7#1)(2008-9#2)(2011-1#1)
of single particles##2##3##(1994-10#1)(2008-10#1)
of single photon emission computed##2##5##(1994-1#1)(2008-2#1)
of single quantum dots##2##4##(2007-12#1)(2010-2#1)
of single strand breaks##2##4##(1993-12#1)(1995-10#1)
of single strand conformation polymorphism##2##5##(1992-2#1)(2008-8#1)
of single strand##4##3##(1992-2#1)(1993-12#1)(1995-10#1)(2008-8#1)
of single stranded##2##3##(1996-11#1)(2008-3#1)
of single tumor cells##2##4##(2011-2#1)(2012-12#1)
of single unit##2##3##(1995-11#1)(2008-4#1)
of single versus multiple##4##4##(2008-10#3)(2011-1#1)
of single walled carbon##2##4##(2010-8#2)
of single##249##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-9#2)(1991-11#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-7#2)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-4#2)(1994-8#2)(1994-9#2)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-5#3)(1995-6#1)(1995-7#3)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#3)(2004-11#1)(2004-12#1)(2005-11#2)(2005-8#3)(2006-10#5)(2006-12#3)(2006-2#3)(2006-5#1)(2006-7#2)(2007-10#1)(2007-11#9)(2007-12#8)(2007-3#2)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#22)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#7)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#12)(2008-8#4)(2008-9#5)(2009-12#3)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#2)(2010-2#3)(2010-4#1)(2010-6#1)(2010-7#8)(2010-8#3)(2011-1#6)(2011-12#1)(2011-2#4)(2012-1#4)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#4)
of single- and##2##3##(1994-11#1)(2008-2#1)
of single-##5##2##(1994-11#1)(2006-11#1)(2008-2#2)(2008-4#1)
of single-agent therapy##2##3##(2008-7#1)(2009-6#1)
of single-agent##4##2##(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)
of single-band##4##2##(2008-2#1)(2008-3#3)
of single-base##2##2##(2008-10#1)(2008-2#1)
of single-cell suspensions of##2##4##(2008-4#1)(2008-9#1)
of single-cell##4##2##(1997-4#1)(2008-4#1)(2008-9#1)(2010-10#1)
of single-chain tPA##2##3##(2008-5#2)
of single-chain variable##2##3##(2008-10#2)
of single-chain##7##2##(2008-10#3)(2008-4#2)(2008-5#2)
of single-channel##3##2##(1992-11#1)(1994-12#1)(2007-12#1)
of single-charge##2##2##(2007-11#1)(2007-12#1)
of single-copy genes##2##3##(1991-5#1)(2008-4#1)
of single-copy sequences##3##3##(2008-4#1)(2008-5#1)(2008-9#1)
of single-copy##7##2##(1991-5#1)(1994-12#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-9#1)
of single-crystal##4##2##(2006-12#1)(2006-4#1)(2008-2#2)
of single-cycle terahertz pulses##2##4##(2007-12#2)
of single-cycle##3##2##(2007-12#3)
of single-dose##3##2##(1997-5#1)(2007-12#1)(2012-12#1)
of single-electron reduction##2##3##(1995-8#2)
of single-electron##3##2##(1995-8#2)(1996-5#1)
of single-fraction unidirectional##2##3##(2007-3#2)
of single-fraction##3##2##(2007-3#2)(2008-7#1)
of single-frequency##12##2##(2007-11#1)(2007-12#6)(2008-1#2)(2008-2#1)(2008-3#2)
of single-layer##2##2##(2007-12#1)(2008-3#1)
of single-mode fibers##7##3##(2007-12#5)(2008-2#1)(2008-3#1)
of single-mode optical fibers##3##4##(2008-2#1)(2008-3#2)
of single-mode optical##6##3##(2008-2#3)(2008-3#3)
of single-mode output##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
of single-mode waveguides##3##3##(2007-12#2)(2007-8#1)
of single-mode##36##2##(2007-11#4)(2007-12#11)(2007-8#1)(2008-2#9)(2008-3#10)(2008-7#1)
of single-molecule fluorescence##2##3##(2007-12#1)(2008-2#1)
of single-molecule##4##2##(2007-12#1)(2008-2#1)(2011-12#1)(2012-1#1)
of single-nucleotide polymorphisms (SNPs)##4##4##(2012-3#3)(2013-1#1)
of single-nucleotide polymorphisms##7##3##(2008-10#1)(2012-3#4)(2013-1#2)
of single-pass##3##2##(2007-12#2)(2008-2#1)
of single-photon and two-photon##2##4##(2008-3#2)
of single-photon##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
of single-pulse##2##2##(2007-12#1)(2008-3#1)
of single-scattering##3##2##(2008-2#1)(2008-3#2)
of single-shot##6##2##(2007-11#1)(2008-3#4)(2011-1#1)
of single-site##2##2##(1996-11#1)(1997-2#1)
of single-spore##2##2##(2008-10#2)
of single-strand##3##2##(1996-6#1)(1997-1#1)(2006-10#1)
of single-stranded DNA##7##3##(1990-3#1)(1994-12#1)(1996-7#2)(2006-12#1)(2008-10#1)(2008-9#1)
of single-stranded RNA##2##3##(2011-1#1)(2012-12#1)
of single-stranded##24##2##(1990-3#1)(1990-4#1)(1991-4#1)(1991-7#2)(1992-2#1)(1992-8#1)(1992-9#1)(1994-12#1)(1994-6#2)(1996-10#1)(1996-11#1)(1996-7#2)(2006-12#2)(2008-10#3)(2008-9#1)(2010-7#1)(2011-1#1)(2012-12#1)
of single-walled carbon nanotubes (SWNTs) in##2##6##(2006-12#1)(2008-7#1)
of single-walled carbon nanotubes (SWNTs)##3##5##(2006-12#1)(2008-7#2)
of single-walled carbon nanotubes##13##4##(2006-12#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-7#6)(2010-7#1)
of single-walled carbon##15##3##(2006-12#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-7#7)(2009-2#1)(2010-7#1)
of single-walled##16##2##(2006-12#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-7#7)(2009-2#1)(2010-7#1)
of singlet oxygen and##4##4##(1993-12#1)(2008-5#1)(2008-8#2)
of singlet oxygen formation##2##4##(1992-12#2)
of singlet oxygen##19##3##(1990-1#1)(1990-11#3)(1992-12#2)(1993-12#1)(1994-10#1)(1996-7#1)(2008-10#1)(2008-3#1)(2008-5#4)(2008-8#3)(2010-4#1)
of singlet##21##2##(1990-1#1)(1990-11#3)(1992-12#2)(1993-12#1)(1994-10#1)(1996-7#1)(2008-10#1)(2008-3#1)(2008-5#4)(2008-8#3)(2010-4#2)(2010-5#1)
of singly and##2##3##(1990-6#1)(1996-7#1)
of singly protonated##2##3##(1996-7#2)
of singly resonant##2##3##(2007-11#1)(2007-12#1)
of singly##10##2##(1990-6#1)(1993-11#1)(1994-11#1)(1996-7#3)(2007-11#1)(2007-12#1)(2008-2#1)(2009-12#1)
of singular value decomposition##2##4##(1990-8#1)(2008-2#1)
of singular##6##2##(1990-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2009-7#1)(2013-1#1)
of sinoatrial blocks##2##3##(1996-3#2)
of sinonasal symptoms##2##3##(2011-2#2)
of sinonasal##7##2##(2007-2#2)(2008-3#1)(2011-2#2)(2012-1#1)(2012-2#1)
of sinus rhythm##6##3##(2006-10#1)(2008-7#1)(2010-12#2)(2012-3#2)
of sinus##13##2##(2005-7#1)(2006-10#1)(2007-12#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-12#2)(2012-1#1)(2012-3#2)(2013-1#1)
of sinusitis##5##2##(1993-2#1)(2007-2#1)(2008-7#1)(2012-8#1)(2013-8#1)
of sinusoidal##9##2##(1995-2#1)(1996-5#1)(1997-7#1)(2006-10#1)(2008-2#1)(2008-3#3)(2008-8#1)
of sires##2##2##(2010-4#1)(2012-2#1)
of sirolimus in##2##3##(2007-8#2)
of sirolimus##6##2##(2006-5#1)(2007-8#2)(2008-11#1)(2013-1#2)
of sisomicin cream##2##3##(2007-7#2)
of sister chromatid##3##3##(1992-9#1)(1997-7#2)
of sister##6##2##(1992-12#1)(1992-9#1)(1997-7#2)(2007-12#1)(2009-2#1)
of site 1##3##3##(1990-5#2)(2013-1#1)
of site and##2##3##(2006-5#1)(2008-7#1)
of site##15##2##(1990-5#3)(1991-6#1)(1992-6#1)(1994-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-7#1)(2010-8#1)(2013-1#2)
of site-directed mutagenesis##6##3##(1990-12#1)(1990-7#1)(1991-10#1)(1993-6#1)(1993-8#1)(1997-4#1)
of site-directed##10##2##(1990-12#1)(1990-7#1)(1991-10#1)(1993-6#1)(1993-8#1)(1995-10#1)(1995-2#1)(1995-3#1)(1997-4#1)(2008-11#1)
of site-specific recombinases##2##3##(2008-11#2)
of site-specific recombination##2##3##(2007-12#1)(2011-12#1)
of site-specific##17##2##(1990-3#1)(1990-8#1)(1995-1#1)(1996-7#1)(1997-4#1)(2007-12#3)(2008-10#1)(2008-11#2)(2008-5#1)(2008-9#1)(2009-3#1)(2010-4#1)(2011-1#1)(2011-12#1)
of sites for##4##3##(1991-5#1)(1991-6#1)(1992-3#1)(1995-3#1)
of sites of##6##3##(1990-11#1)(1991-2#1)(1994-12#1)(1995-8#1)(2008-4#1)(2008-8#1)
of sites that##2##3##(1994-6#1)(1997-4#1)
of sites with##3##3##(1990-7#1)(1991-2#1)(1994-2#1)
of sites##39##2##(1990-10#1)(1990-11#1)(1990-7#3)(1990-8#1)(1991-2#2)(1991-5#1)(1991-6#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-6#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-3#1)(1995-8#2)(1997-2#1)(1997-4#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)(2012-5#1)
of sitosterol##2##2##(2006-10#2)
of sitting##4##2##(2007-7#2)(2010-3#2)
of situation##6##2##(1996-1#1)(1996-9#1)(2007-12#1)(2009-6#1)(2010-4#1)(2012-12#1)
of situational##3##2##(2007-12#1)(2008-12#1)(2009-7#1)
of situations in which##2##4##(1996-12#1)(2008-4#1)
of situations##16##2##(1990-5#1)(1994-8#1)(1996-12#1)(1996-3#1)(2005-11#1)(2006-4#1)(2006-9#1)(2008-11#1)(2008-2#3)(2008-4#1)(2008-9#1)(2010-1#1)(2010-11#1)(2011-2#1)
of six and##3##3##(1996-12#1)(2008-10#2)
of six animals##3##3##(1996-12#1)(2008-7#1)(2009-5#1)
of six cases##5##3##(1993-3#1)(2005-9#1)(2007-2#1)(2007-7#1)(2008-9#1)
of six cell lines##2##4##(1990-4#2)
of six chicken respiratory##2##4##(2013-8#2)
of six cycles##3##3##(2006-12#1)(2008-6#1)(2011-2#1)
of six different##5##3##(1991-5#1)(2004-7#1)(2006-5#1)(2008-6#1)(2008-7#1)
of six human pancreatic cancer cell lines##2##7##(1991-2#2)
of six human##4##3##(1990-4#1)(1991-2#2)(1992-8#1)
of six identical##2##3##(1992-12#1)(1996-5#1)
of six monoclonal antibodies##3##4##(1992-1#1)(1994-8#1)(2011-12#1)
of six months of##3##4##(2010-4#2)(2013-1#1)
of six months##15##3##(1990-12#1)(1990-5#2)(1991-12#1)(1997-4#1)(2004-9#1)(2007-2#1)(2007-7#2)(2008-4#1)(2008-6#1)(2010-4#2)(2013-1#1)(2013-8#1)
of six new##3##3##(1990-4#1)(2009-12#1)(2013-1#1)
of six or##2##3##(2006-12#1)(2008-2#1)
of six patients with##3##4##(2008-7#2)(2013-1#1)
of six patients##8##3##(1991-3#1)(1996-12#1)(1996-4#1)(2007-2#1)(2007-8#1)(2008-7#2)(2013-1#1)
of six phenols and related compounds##2##6##(2008-10#2)
of six phenols##3##3##(1990-9#1)(2008-10#2)
of six phenothiazine derivatives##2##4##(2008-10#2)
of six prisms##4##3##(2007-12#2)(2008-3#2)
of six pyrethroids##2##3##(2008-10#2)
of six randomly selected##2##4##(2008-5#1)(2013-1#1)
of six rats##2##3##(1993-7#1)(2007-1#1)
of six samples##3##3##(2008-10#3)
of six species of##2##4##(2008-5#1)(2013-1#1)
of six trials##2##3##(2008-10#1)(2008-3#1)
of six vineyards##2##3##(2008-10#2)
of six weeks##3##3##(2009-6#1)(2012-3#1)(2013-7#1)
of six years##5##3##(1991-2#1)(1993-1#1)(2007-7#1)(2008-9#1)(2011-2#1)
of six##285##2##(1990-11#2)(1990-12#2)(1990-4#4)(1990-5#2)(1990-9#2)(1991-12#4)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#3)(1992-12#2)(1992-2#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#3)(1993-6#2)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-11#1)(1996-12#6)(1996-2#2)(1996-3#3)(1996-4#2)(1996-5#4)(1996-6#1)(1997-1#1)(1997-4#6)(1997-7#1)(2004-7#1)(2004-9#1)(2005-4#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#2)(2006-5#2)(2007-1#4)(2007-10#1)(2007-12#7)(2007-2#10)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#8)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#48)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#14)(2008-6#7)(2008-7#5)(2008-8#3)(2008-9#4)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-2#2)(2010-4#3)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#8)(2013-7#2)(2013-8#6)
of six)##2##2##(2004-1#2)
of sixteen##8##2##(1991-6#1)(1996-2#1)(1996-5#1)(1997-2#1)(2005-4#2)(2006-5#1)(2007-10#1)
of sixty isolated strains##2##4##(2012-2#2)
of sixty##5##2##(1990-12#1)(2008-1#1)(2011-2#1)(2012-2#2)
of sixty-seven##3##2##(1992-10#1)(1996-3#1)(2007-10#1)
of size 1##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
of size and shape##3##4##(1994-8#1)(2008-5#1)(2010-7#1)
of size and##8##3##(1994-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-7#1)(2013-8#1)
of size distribution##2##3##(2008-3#1)(2008-9#1)
of size exclusion chromatography##3##4##(2008-10#3)
of size inequality##2##3##(2008-8#2)
of size of the##2##4##(2004-9#1)(2011-2#1)
of size of##3##3##(2004-9#1)(2011-2#1)(2013-7#1)
of size or##3##3##(2006-6#1)(2007-12#1)(2011-2#1)
of size parameters##2##3##(2007-11#1)(2008-2#1)
of size variation##3##3##(2008-8#2)(2013-1#1)
of size##63##2##(1991-11#1)(1991-9#1)(1993-1#1)(1993-2#1)(1993-4#1)(1994-8#1)(1995-12#1)(1995-4#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-8#1)(2004-9#1)(2005-11#2)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-8#8)(2008-9#1)(2009-11#1)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#6)(2013-1#1)(2013-7#1)(2013-8#1)
of size-abundance relationships among free-living animals##2##6##(2008-9#2)
of size-dependent##2##2##(2005-11#1)(2008-8#1)
of size-exclusion chromatography##2##3##(2008-10#1)(2008-4#1)
of sizes##4##2##(1991-11#1)(2005-11#1)(2008-7#1)(2012-11#1)
of sizzled expression##4##3##(2012-12#4)
of sizzled##6##2##(2012-12#6)
of skeletal and##3##3##(2009-7#1)(2010-7#1)(2012-3#1)
of skeletal complications and##2##4##(2007-11#1)(2008-7#1)
of skeletal complications##3##3##(2007-11#2)(2008-7#1)
of skeletal disease##2##3##(2007-11#2)
of skeletal events##2##3##(2010-4#2)
of skeletal metastases##3##3##(2007-11#2)(2008-7#1)
of skeletal metastasis##2##3##(1994-7#1)(2007-11#1)
of skeletal muscle sarcoplasmic reticulum##2##5##(1991-8#1)(1992-7#1)
of skeletal muscle##36##3##(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-7#1)(1993-12#2)(1993-2#2)(1993-3#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-2#1)(1996-7#1)(1997-6#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-11#2)(2008-1#2)(2008-5#2)(2009-3#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#3)
of skeletal muscles in##2##4##(1996-5#1)(2012-1#1)
of skeletal muscles##8##3##(1991-10#1)(1991-9#1)(1995-12#1)(1995-2#1)(1996-5#1)(2008-5#1)(2012-1#2)
of skeletal myoblasts##3##3##(1993-12#1)(2008-1#1)(2009-9#1)
of skeletal##96##2##(1990-11#1)(1990-5#1)(1991-10#1)(1991-2#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-12#5)(1993-2#2)(1993-3#2)(1993-4#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-7#1)(1995-12#1)(1995-2#2)(1996-5#1)(1996-7#1)(1997-4#1)(1997-6#1)(2006-10#3)(2006-11#2)(2006-4#1)(2006-9#1)(2007-11#10)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-7#1)(2011-1#4)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#4)
of skeletal-related events##2##3##(2008-7#1)(2013-7#1)
of skeleton##3##2##(2008-1#2)(2008-2#1)
of skepticism##2##2##(2007-12#1)(2009-1#1)
of skew rays through metal light pipes##2##7##(2008-3#2)
of skew rays##3##3##(2007-12#1)(2008-3#2)
of skew##7##2##(2007-12#1)(2008-3#2)(2008-8#4)
of skill acquisition##3##3##(1994-2#1)(2011-1#2)
of skill in##2##3##(1992-11#1)(2008-11#1)
of skill##8##2##(1992-11#1)(1994-2#1)(2006-10#1)(2006-9#1)(2008-11#1)(2011-1#2)(2011-2#1)
of skilled attendance##2##3##(2011-1#2)
of skilled nursing##2##3##(1992-1#1)(1992-2#1)
of skilled##10##2##(1992-1#1)(1992-2#1)(1992-9#1)(2007-8#1)(2008-4#1)(2008-7#1)(2010-1#1)(2010-12#1)(2011-1#2)
of skills and##3##3##(1994-12#1)(1995-4#1)(2008-7#1)
of skills for##3##3##(1990-12#1)(2006-10#1)(2006-6#1)
of skills of##2##3##(2011-2#1)(2012-3#1)
of skills training in##3##4##(2005-7#3)
of skills training##4##3##(2005-7#4)
of skills##22##2##(1990-12#1)(1994-12#2)(1995-4#1)(1996-3#1)(2005-7#4)(2006-10#2)(2006-6#2)(2007-12#1)(2008-11#2)(2008-7#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
of skin ageing##3##3##(2008-5#3)
of skin aging##3##3##(2008-5#2)(2009-9#1)
of skin ailments##2##3##(2006-12#1)(2008-5#1)
of skin and subcutaneous tissue##2##5##(2011-12#1)(2013-1#1)
of skin and##16##3##(1991-9#1)(1992-2#1)(1995-12#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-8#1)(2008-3#3)(2008-5#1)(2010-9#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
of skin barrier##2##3##(2008-5#2)
of skin biopsies##5##3##(1991-5#1)(2007-2#1)(2007-8#2)(2012-2#1)
of skin cancer in organ transplant recipients##3##7##(2007-11#3)
of skin cancer in##5##4##(2007-11#5)
of skin cancer is##3##4##(2007-11#1)(2011-2#2)
of skin cancer##16##3##(1991-6#1)(1994-5#1)(1994-7#1)(2007-11#7)(2007-12#3)(2011-2#2)(2012-12#1)
of skin cancers and##2##4##(2007-12#1)(2011-2#1)
of skin cancers##7##3##(2007-11#1)(2007-12#2)(2008-12#1)(2008-5#1)(2011-2#2)
of skin care##3##3##(2008-5#3)
of skin cells##2##3##(2008-4#1)(2008-5#1)
of skin color##2##3##(2008-5#2)
of skin colour##5##3##(1996-7#3)(2008-5#2)
of skin damage caused by##2##5##(2006-12#1)(2011-2#1)
of skin damage##3##3##(2006-12#1)(2008-5#1)(2011-2#1)
of skin diseases at##2##4##(2007-2#1)(2011-2#1)
of skin diseases##14##3##(2006-12#2)(2006-2#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#5)(2011-1#1)(2011-2#2)
of skin disorders in##2##4##(2006-4#1)(2007-7#1)
of skin disorders##3##3##(2006-4#1)(2007-7#1)(2008-5#1)
of skin dryness##3##3##(2008-5#3)
of skin exposure to##2##4##(1994-6#1)(2008-5#1)
of skin fibroblast##2##3##(1990-3#1)(2008-2#1)
of skin fibroblasts from##2##4##(1990-3#1)(2007-3#1)
of skin fibroblasts##11##3##(1990-3#3)(1993-9#1)(1996-3#1)(2007-3#2)(2008-2#1)(2008-5#2)(2008-7#1)
of skin hydration in##2##4##(2008-5#2)
of skin hydration##5##3##(2008-10#1)(2008-5#3)(2010-8#1)
of skin improvement##2##3##(2008-5#2)
of skin in##5##3##(1990-2#1)(1995-11#1)(1996-12#1)(2008-5#2)
of skin irritation##3##3##(2008-10#1)(2008-5#2)
of skin is##3##3##(2008-5#3)
of skin lesions at the site of application##3##8##(2008-9#3)
of skin lesions in##2##4##(2006-4#1)(2011-1#1)
of skin lesions when##2##4##(2011-1#2)
of skin lesions##22##3##(1990-6#1)(1992-10#2)(1993-12#1)(1996-11#1)(2006-4#1)(2007-8#3)(2008-9#4)(2009-4#1)(2010-6#1)(2011-1#4)(2011-2#1)(2012-2#1)(2012-3#1)
of skin markers##2##3##(2013-1#2)
of skin melanoma in##2##4##(1994-12#1)(2011-2#1)
of skin metastases in##2##4##(1991-6#2)
of skin metastases##3##3##(1991-6#2)(2008-6#1)
of skin of##3##3##(2007-7#2)(2008-5#1)
of skin physiology##3##3##(1997-8#1)(2008-5#2)
of skin pigmentation##2##3##(2008-5#1)(2008-9#1)
of skin sensitization##3##3##(2007-8#1)(2008-5#2)
of skin sensitizers##3##3##(2007-8#3)
of skin surface##5##3##(2008-5#4)(2010-8#1)
of skin that##2##3##(2007-7#1)(2011-2#1)
of skin tissue##2##3##(2009-11#1)(2013-8#1)
of skin to the##2##4##(2007-8#1)(2008-5#1)
of skin to##4##3##(2007-8#1)(2008-5#2)(2010-8#1)
of skin tone##2##3##(2008-11#2)
of skin tumours##2##3##(1997-4#1)(2005-11#1)
of skin ulcers##2##3##(1992-10#1)(2011-1#1)
of skin with a scar##2##5##(2009-9#2)
of skin with##6##3##(1992-2#1)(1992-8#2)(2008-5#1)(2009-9#2)
of skin##302##2##(1990-2#1)(1990-3#4)(1990-5#1)(1990-6#1)(1991-3#1)(1991-5#1)(1991-6#3)(1991-8#1)(1991-9#1)(1992-10#3)(1992-2#2)(1992-8#4)(1992-9#2)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-7#3)(1997-4#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#8)(2006-2#1)(2006-4#2)(2006-8#1)(2007-11#10)(2007-12#6)(2007-2#4)(2007-3#3)(2007-7#13)(2007-8#14)(2007-9#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#3)(2008-5#89)(2008-6#2)(2008-7#4)(2008-9#7)(2009-11#1)(2009-2#1)(2009-4#1)(2009-9#4)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#7)(2011-12#2)(2011-2#11)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#4)(2013-7#2)(2013-8#3)
of skinned##2##2##(1993-3#1)(1994-12#1)
of skull base tumors##2##4##(2005-5#1)(2006-6#1)
of skull base##9##3##(2005-5#1)(2006-12#4)(2006-6#3)(2013-7#1)
of skull thickness variations on human head dynamic impact responses##2##10##(2007-4#2)
of skull thickness##3##3##(2007-11#1)(2007-4#2)
of skull##23##2##(1996-6#1)(2005-5#1)(2006-12#4)(2006-6#4)(2007-11#1)(2007-4#2)(2008-7#2)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)
of skylight polarization##3##3##(2008-2#3)
of skylight##8##2##(2008-2#6)(2008-3#2)
of slab##2##2##(2008-3#2)
of slash and##2##3##(2008-10#1)(2010-7#1)
of slaughter##4##2##(1994-7#1)(2010-4#3)
of slaughtered pigs##3##3##(1991-8#1)(2010-4#1)(2011-2#1)
of slavery##3##2##(2008-7#3)
of slaves in##2##3##(2008-8#1)(2009-4#1)
of slaves##3##2##(2008-8#1)(2009-4#2)
of sleep EEG##2##3##(2009-8#1)(2010-8#1)
of sleep and dreaming##2##4##(2008-11#2)
of sleep and its##3##4##(2008-12#1)(2009-8#1)(2010-3#1)
of sleep and sleep loss##2##5##(2008-12#1)(2008-6#1)
of sleep and##12##3##(1990-7#1)(1993-11#1)(2007-6#1)(2008-11#2)(2008-12#2)(2008-6#1)(2009-8#1)(2010-3#1)(2013-1#2)
of sleep apnea##4##3##(2006-10#2)(2007-6#1)(2009-4#1)
of sleep behind the wheel##3##5##(2012-12#3)
of sleep deprivation##6##3##(1996-1#3)(1996-9#1)(2011-2#1)(2013-1#1)
of sleep disordered breathing in##2##5##(2006-10#2)
of sleep disordered breathing##5##4##(2006-10#2)(2007-12#1)(2008-9#1)(2010-2#1)
of sleep disorders##5##3##(1993-2#1)(1993-5#1)(2007-6#1)(2008-11#1)(2013-7#1)
of sleep disturbances in children##2##5##(2006-10#2)
of sleep disturbances in##4##4##(2006-10#3)(2008-7#1)
of sleep in##4##3##(1997-7#1)(2010-12#2)(2013-1#1)
of sleep loss##2##3##(1995-12#1)(2013-1#1)
of sleep onset##2##3##(1990-5#1)(1996-7#1)
of sleep stages##2##3##(2010-8#2)
of sleep##81##2##(1990-5#1)(1990-7#1)(1992-1#3)(1993-11#1)(1993-2#1)(1993-5#2)(1994-8#1)(1995-12#2)(1996-1#4)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-7#1)(2006-10#9)(2007-1#1)(2007-12#2)(2007-6#7)(2008-11#3)(2008-12#4)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-7#1)(2009-8#4)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#3)(2011-2#1)(2012-12#7)(2013-1#6)(2013-7#1)
of sleep-disordered breathing##2##3##(2007-12#1)(2007-6#1)
of sleep-related breathing disorders##4##4##(2006-10#1)(2007-12#3)
of sleep-related##6##2##(2006-10#1)(2007-1#1)(2007-12#3)(2007-6#1)
of sleeping sickness##3##3##(2006-10#1)(2007-6#1)(2008-2#1)
of sleeping##6##2##(1992-11#1)(1994-2#1)(1996-8#1)(2006-10#1)(2007-6#1)(2008-2#1)
of slice##5##2##(1995-5#1)(1997-2#1)(2006-4#1)(2007-3#1)(2008-11#1)
of slices with##3##3##(1990-10#1)(1991-9#1)(1996-1#1)
of slices##5##2##(1990-10#1)(1991-9#1)(1996-1#1)(1996-9#1)(2013-1#1)
of slide##2##2##(2008-11#1)(2010-3#1)
of slides##6##2##(2005-10#1)(2005-8#1)(2006-2#1)(2008-4#3)
of sliding##7##2##(1993-3#1)(1995-3#1)(1996-4#2)(2006-10#1)(2011-2#2)
of slight##6##2##(1993-5#1)(1996-6#1)(2006-2#1)(2007-2#1)(2008-11#1)(2013-1#1)
of slightly different##2##3##(2007-11#1)(2008-2#1)
of slightly less##2##3##(1992-3#1)(2008-3#1)
of slightly##12##2##(1992-3#1)(2007-11#1)(2008-10#1)(2008-2#5)(2008-3#2)(2008-5#2)
of slip on##2##3##(1996-4#2)
of slip##6##2##(1996-4#5)(2005-11#1)
of slipped capital femoral epiphysis##2##5##(2007-8#1)(2008-8#1)
of slipped##3##2##(2007-8#1)(2008-8#2)
of slits##2##2##(2008-2#1)(2008-3#1)
of slope and##2##3##(1995-4#1)(2008-10#1)
of slope##7##2##(1990-11#1)(1995-4#1)(1997-5#1)(2008-10#2)(2008-3#1)(2009-4#1)
of slopes##3##2##(1993-6#2)(2008-10#1)
of slow and##2##3##(1996-8#1)(2007-9#1)
of slow growth##2##3##(1991-11#1)(1997-3#1)
of slow sleep and##2##4##(1992-10#1)(1993-2#1)
of slow sleep##3##3##(1992-10#1)(1993-2#2)
of slow wave##3##3##(1992-10#1)(1993-11#1)(1996-3#1)
of slow##34##2##(1991-11#1)(1991-3#1)(1991-9#1)(1992-10#2)(1992-3#1)(1993-10#1)(1993-11#1)(1993-2#2)(1993-8#1)(1994-9#1)(1995-1#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-6#2)(2004-1#1)(2006-1#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-7#2)(2010-4#1)(2012-1#1)(2012-2#1)(2013-7#1)
of slow-release##2##2##(1992-5#1)(2006-7#1)
of slower##4##2##(1991-12#1)(1994-6#1)(2005-11#1)(2013-1#1)
of slowly##8##2##(1992-9#1)(1995-1#1)(2006-1#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-7#1)(2012-3#1)
of sludge flocs##9##3##(2005-11#9)
of sludge in##2##3##(2004-4#1)(2008-5#1)
of sludge##19##2##(2004-4#2)(2005-11#10)(2007-10#1)(2008-11#1)(2008-12#4)(2008-5#1)
of slurries of##2##3##(2006-8#1)(2008-10#1)
of slurries##3##2##(2006-8#1)(2008-10#2)
of slurry##4##2##(2008-10#4)
of smad##2##2##(2005-8#2)
of small (&lt##5##3##(2007-12#1)(2008-3#1)(2008-7#1)(2010-12#1)(2012-3#1)
of small GTP-binding proteins##7##4##(1991-10#1)(1992-1#1)(1992-3#1)(1993-6#1)(1994-6#1)(1997-1#1)(2008-6#1)
of small GTP-binding##8##3##(1991-10#1)(1992-1#1)(1992-3#1)(1993-6#2)(1994-6#1)(1997-1#1)(2008-6#1)
of small RNA##2##3##(2008-2#1)(2010-5#1)
of small RNAs that##2##4##(2009-3#1)(2013-8#1)
of small RNAs##7##3##(2007-10#1)(2008-2#2)(2008-9#1)(2009-3#2)(2013-8#1)
of small amounts of##14##4##(1990-2#1)(1990-5#1)(1993-6#1)(2005-11#2)(2006-10#2)(2008-10#5)(2008-11#1)(2008-8#1)
of small amounts##16##3##(1990-2#1)(1990-5#1)(1991-2#1)(1993-6#1)(1994-2#1)(2005-11#2)(2006-10#2)(2008-10#5)(2008-11#1)(2008-8#1)
of small amplitude##5##3##(1990-2#1)(2008-10#2)(2008-2#1)(2008-3#1)
of small and large##3##4##(1993-12#1)(2005-10#1)(2008-5#1)
of small and medium##3##4##(2006-10#1)(2008-10#1)(2012-12#1)
of small and##9##3##(1993-12#1)(2005-10#1)(2006-10#1)(2007-4#2)(2008-10#1)(2008-5#1)(2012-12#1)(2013-1#1)
of small animal##2##3##(1996-12#1)(2009-8#1)
of small animals##5##3##(2007-12#2)(2010-12#1)(2010-7#1)(2011-1#1)
of small biological##2##3##(2008-11#1)(2008-8#1)
of small blood vessels##2##4##(2007-9#1)(2009-11#1)
of small bowel disorders in##2##5##(2012-2#2)
of small bowel ischemia##2##4##(2005-10#2)
of small bowel mesenteric volvulus##2##5##(2009-4#2)
of small bowel obstruction##4##4##(2006-10#1)(2007-8#1)(2008-12#2)
of small bowel resection##2##4##(2008-10#1)(2010-12#1)
of small bowel transplantation##3##4##(2006-10#3)
of small bowel##32##3##(1991-12#1)(1991-9#1)(1995-12#1)(1996-8#1)(1997-8#1)(2005-10#2)(2006-10#7)(2006-2#1)(2007-8#2)(2008-10#1)(2008-12#3)(2008-6#1)(2009-2#1)(2009-4#2)(2010-12#3)(2012-12#1)(2012-2#2)(2012-3#1)
of small cell carcinoma##3##4##(1992-12#1)(1992-4#1)(2009-3#1)
of small cell lung cancer##7##5##(1992-10#2)(1993-12#1)(1994-3#1)(2009-1#2)(2010-8#1)
of small cell##12##3##(1990-10#1)(1992-10#2)(1992-12#1)(1992-4#1)(1993-12#1)(1994-3#1)(1997-4#1)(2009-1#2)(2009-3#1)(2010-8#1)
of small children##2##3##(1993-5#1)(2008-9#1)
of small deformations##2##3##(2005-11#1)(2008-3#1)
of small diameter##2##3##(2006-12#1)(2008-2#1)
of small doses of##4##4##(1991-3#1)(1997-7#1)(2006-9#1)(2007-7#1)
of small grains##2##3##(2008-10#2)
of small intestinal##18##3##(1990-11#1)(1991-9#1)(1994-9#1)(1996-6#1)(1997-3#1)(2006-10#4)(2006-8#1)(2006-9#1)(2007-9#1)(2008-5#1)(2012-2#1)(2013-1#4)
of small intestine in##2##4##(2007-2#1)(2007-8#1)
of small intestine##9##3##(1991-4#1)(1995-12#1)(1997-3#1)(2007-2#1)(2007-8#1)(2008-8#1)(2009-2#2)(2012-2#1)
of small liquid##3##3##(2005-11#2)(2007-8#1)
of small lymphocytes and##2##4##(1991-8#1)(1997-6#1)
of small lymphocytes with##2##4##(1997-6#2)
of small lymphocytes##5##3##(1991-8#1)(1997-6#3)(2009-2#1)
of small mammals##3##3##(1996-6#1)(2012-2#2)
of small molecule inhibitors of##2##5##(2005-6#1)(2005-7#1)
of small molecule inhibitors##4##4##(2005-6#1)(2005-7#1)(2009-9#1)(2010-12#1)
of small molecule##14##3##(2005-11#1)(2005-12#1)(2005-6#1)(2005-7#1)(2007-3#1)(2008-10#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-7#1)(2012-12#1)(2013-8#1)
of small molecules that##2##4##(2009-9#1)(2012-3#1)
of small molecules to##2##4##(2007-8#1)(2008-4#1)
of small molecules##18##3##(1990-11#1)(1990-12#1)(1996-11#1)(2007-12#1)(2007-8#2)(2008-4#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-7#3)(2011-2#3)(2012-3#1)
of small monovalent cations##2##4##(1994-12#2)
of small neurons##2##3##(1995-6#1)(1996-6#1)
of small numbers of##2##4##(1992-7#1)(1993-7#1)
of small objects##2##3##(1995-11#1)(2008-3#1)
of small or##2##3##(1993-8#1)(2008-2#1)
of small organic molecules##3##4##(1996-5#1)(2009-11#2)
of small particle##2##3##(2008-5#1)(2013-8#1)
of small particles##3##3##(2005-11#1)(2008-2#1)(2009-5#1)
of small peptides and##3##4##(1990-11#2)(1990-12#1)
of small peptides##4##3##(1990-11#2)(1990-12#1)(2008-4#1)
of small phosphorus-containing compounds by capillary electrophoresis##2##7##(2008-10#2)
of small populations of##2##4##(1991-8#1)(2010-12#1)
of small populations##3##3##(1991-8#1)(2008-9#1)(2010-12#1)
of small quantities of##3##4##(2008-10#2)(2008-5#1)
of small quantities##4##3##(2005-11#1)(2008-10#2)(2008-5#1)
of small remote islands##3##4##(2013-8#3)
of small rodents##2##3##(1991-3#1)(2008-10#1)
of small scatterers##3##3##(2008-3#3)
of small size##4##3##(2006-2#1)(2008-4#1)(2010-11#1)(2013-8#1)
of small solutes##4##3##(1993-11#2)(2011-2#2)
of small studies##2##3##(1995-12#1)(2008-6#1)
of small synthetic substrates##2##4##(1993-3#2)
of small time dispersion and nonparaxiality##2##6##(2008-1#2)
of small tissue##2##3##(2008-10#2)
of small to large##3##4##(1992-5#1)(2008-10#1)(2009-5#1)
of small to##5##3##(1990-8#1)(1992-5#1)(2004-11#1)(2008-10#1)(2009-5#1)
of small unilamellar vesicles##2##4##(1990-2#1)(2006-10#1)
of small vesicles##2##3##(2007-12#2)
of small vessels##3##3##(1993-10#1)(2006-8#1)(2009-3#1)
of small volume##2##3##(2007-8#1)(2008-10#1)
of small##441##2##(1990-10#2)(1990-11#5)(1990-12#5)(1990-2#3)(1990-5#4)(1990-6#2)(1990-7#2)(1990-8#2)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#3)(1991-4#1)(1991-6#3)(1991-8#4)(1991-9#4)(1992-1#1)(1992-10#3)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-5#3)(1993-6#5)(1993-7#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#2)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#2)(1996-1#1)(1996-11#3)(1996-12#2)(1996-4#1)(1996-5#1)(1996-6#4)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#5)(1997-7#3)(1997-8#2)(2004-11#1)(2004-9#2)(2005-10#3)(2005-11#14)(2005-12#1)(2005-6#1)(2005-7#2)(2005-9#1)(2006-10#20)(2006-11#1)(2006-12#2)(2006-2#3)(2006-5#1)(2006-7#1)(2006-8#3)(2006-9#2)(2007-10#2)(2007-11#5)(2007-12#11)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#7)(2007-9#3)(2008-1#4)(2008-10#30)(2008-11#4)(2008-12#4)(2008-2#11)(2008-3#21)(2008-4#7)(2008-5#8)(2008-6#5)(2008-7#4)(2008-8#7)(2008-9#6)(2009-1#3)(2009-10#1)(2009-11#5)(2009-12#1)(2009-2#4)(2009-3#4)(2009-4#4)(2009-5#3)(2009-7#2)(2009-8#5)(2009-9#2)(2010-1#1)(2010-11#3)(2010-12#11)(2010-2#4)(2010-3#2)(2010-5#1)(2010-6#2)(2010-7#5)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#5)(2013-1#10)(2013-7#1)(2013-8#8)
of small- and##2##3##(2006-10#1)(2008-9#1)
of small-##3##2##(2006-10#1)(2007-12#1)(2008-9#1)
of small-angle##2##2##(2008-10#1)(2012-1#1)
of small-artery##2##2##(2007-10#2)
of small-bowel##4##2##(2008-12#1)(2008-3#1)(2008-9#1)(2013-1#1)
of small-cell cancer##2##3##(2012-12#2)
of small-cell lung cancer##3##4##(2004-1#2)(2005-11#1)
of small-cell##5##2##(2004-1#2)(2005-11#1)(2012-12#2)
of small-diameter##5##2##(1990-7#1)(1991-2#2)(1996-3#1)(2008-10#1)
of small-molecule inhibitors of##2##4##(1997-4#1)(2008-1#1)
of small-molecule##8##2##(1997-4#1)(2004-12#1)(2008-1#1)(2008-4#1)(2010-11#2)(2010-12#1)(2010-4#1)
of small-scale##7##2##(1994-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)
of small-sized##2##2##(1994-10#1)(2013-1#1)
of smaller##32##2##(1991-1#1)(1994-11#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-4#1)(1997-3#1)(1997-5#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#3)(2012-12#3)
of smallpox in##5##3##(1993-12#1)(1993-6#3)(2009-9#1)
of smallpox##10##2##(1993-12#1)(1993-6#4)(1994-3#1)(1994-9#1)(2007-5#1)(2008-1#1)(2009-9#1)
of smart##5##2##(2006-2#1)(2008-8#3)(2009-7#1)
of smcR##2##2##(2007-12#2)
of smears##3##2##(1990-8#1)(2008-1#1)(2011-2#1)
of smell##10##2##(2006-12#1)(2007-8#1)(2007-9#2)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#3)
of smells##2##2##(2012-2#2)
of smoke on##2##3##(1991-4#1)(2011-12#1)
of smoke##8##2##(1991-4#1)(1992-5#1)(1996-12#3)(2010-2#1)(2010-7#1)(2011-12#1)
of smoke-dried meat##2##3##(1992-5#2)
of smoked##2##2##(1991-1#1)(2008-3#1)
of smokeless tobacco##2##3##(1991-8#1)(2008-4#1)
of smokers among##3##3##(1991-4#2)(1994-11#1)
of smokers in the##2##4##(1991-5#1)(2008-10#1)
of smokers in##5##3##(1991-5#1)(1994-5#1)(2008-10#1)(2009-5#1)(2013-1#1)
of smokers was##3##3##(1991-10#1)(1994-5#1)(2011-2#1)
of smokers##27##2##(1990-4#1)(1991-10#1)(1991-4#3)(1991-5#1)(1991-8#1)(1991-9#1)(1992-9#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-5#2)(1996-9#1)(2007-12#1)(2008-10#2)(2009-5#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
of smoking among women##2##4##(1991-11#2)
of smoking among##7##3##(1991-11#3)(1991-4#1)(2006-2#1)(2007-3#1)(2009-7#1)
of smoking and alcohol##2##4##(2005-11#1)(2013-1#1)
of smoking and the##2##4##(1995-6#1)(2011-1#1)
of smoking and##13##3##(1992-6#1)(1995-6#1)(1997-8#1)(2005-11#1)(2006-2#1)(2006-7#1)(2007-2#1)(2009-5#1)(2011-1#2)(2013-1#3)
of smoking are##2##3##(2008-7#1)(2011-2#1)
of smoking as well as##2##5##(2006-8#1)(2008-8#1)
of smoking as##3##3##(2006-8#1)(2008-8#1)(2011-2#1)
of smoking cessation in##3##4##(2010-2#2)(2012-2#1)
of smoking cessation on##2##4##(1995-3#1)(2010-2#1)
of smoking cessation##13##3##(1995-3#1)(1997-4#1)(2008-11#1)(2008-8#1)(2010-2#5)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
of smoking during pregnancy##2##4##(1995-6#1)(1997-7#1)
of smoking habit##2##3##(2007-10#1)(2008-1#1)
of smoking habits##3##3##(1990-2#1)(1994-6#1)(1996-3#1)
of smoking in##6##3##(1991-9#1)(1993-5#1)(1995-6#1)(2006-1#1)(2007-8#1)(2008-10#1)
of smoking is##2##3##(1991-4#1)(1994-6#1)
of smoking mothers##5##3##(1990-5#1)(1991-11#2)(1991-4#1)(2007-2#1)
of smoking on##7##3##(1990-6#1)(1995-6#1)(2005-9#1)(2007-10#1)(2009-11#2)(2012-3#1)
of smoking was##7##3##(1991-8#1)(1996-3#1)(2006-2#1)(2007-7#1)(2011-2#2)(2012-1#1)
of smoking were##6##3##(1996-3#1)(2010-11#1)(2010-2#2)(2010-9#1)(2012-1#1)
of smoking##126##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#2)(1990-9#1)(1991-1#1)(1991-11#5)(1991-12#1)(1991-4#3)(1991-8#1)(1991-9#3)(1992-3#1)(1992-6#1)(1993-5#1)(1994-6#4)(1995-3#1)(1995-6#5)(1996-3#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#2)(2005-11#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-2#3)(2006-5#1)(2006-7#2)(2006-8#1)(2007-10#2)(2007-12#1)(2007-2#2)(2007-3#5)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#3)(2008-8#6)(2009-11#2)(2009-5#2)(2009-7#1)(2010-10#1)(2010-11#2)(2010-2#11)(2010-9#2)(2011-1#4)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
of smoking-related lung##2##3##(2005-8#1)(2013-1#1)
of smoking-related##3##2##(2005-8#2)(2013-1#1)
of smooth endoplasmic reticulum##3##4##(2006-5#1)(2007-12#1)(2008-5#1)
of smooth faults##2##3##(1996-4#2)
of smooth muscle and##3##4##(1991-12#1)(1996-4#1)(2008-7#1)
of smooth muscle calponin##2##4##(1990-9#1)(2008-6#1)
of smooth muscle cell proliferation##2##5##(2008-10#1)(2008-7#1)
of smooth muscle cell##4##4##(1995-12#1)(1995-3#1)(2008-10#1)(2008-7#1)
of smooth muscle cells from##2##5##(1990-9#1)(1997-2#1)
of smooth muscle cells is##2##5##(1992-9#1)(2008-4#1)
of smooth muscle cells##20##4##(1990-9#1)(1991-7#1)(1992-12#1)(1992-9#1)(1993-8#2)(1995-11#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#2)(2006-6#1)(2008-11#1)(2008-4#3)(2008-7#2)(2012-1#1)
of smooth muscle in##2##4##(1990-10#1)(1997-5#1)
of smooth muscle myosin light chain kinase##6##7##(1990-4#2)(1990-8#1)(1991-2#1)(1992-5#1)(1992-9#1)
of smooth muscle myosin light chain##7##6##(1990-4#2)(1990-8#2)(1991-2#1)(1992-5#1)(1992-9#1)
of smooth muscle myosin##8##4##(1990-4#2)(1990-8#2)(1991-2#1)(1991-5#1)(1992-5#1)(1992-9#1)
of smooth muscle##58##3##(1990-10#1)(1990-4#2)(1990-8#2)(1990-9#2)(1991-12#1)(1991-2#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-5#2)(1992-9#4)(1993-6#1)(1993-8#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-5#1)(1997-7#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-6#1)(2008-7#4)(2008-8#2)(2010-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
of smooth pursuit eye##2##4##(1996-1#1)(1996-8#1)
of smooth##70##2##(1990-10#1)(1990-3#1)(1990-4#2)(1990-8#2)(1990-9#2)(1991-12#1)(1991-2#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-5#2)(1992-9#4)(1993-6#1)(1993-8#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-1#2)(1996-10#1)(1996-3#1)(1996-4#4)(1996-5#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-5#1)(1997-7#1)(2006-5#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2010-2#1)(2012-1#1)(2012-2#2)(2012-3#1)
of smoothing##4##2##(1994-11#1)(2008-10#2)(2008-2#1)
of smoothness##2##2##(2008-3#1)(2011-2#1)
of snRNA##2##2##(1996-4#1)(2006-12#1)
of snail##6##2##(1994-6#1)(1995-5#1)(2008-12#1)(2008-8#1)(2011-12#1)(2012-3#1)
of snails##5##2##(2006-10#1)(2008-12#4)
of snake##7##2##(2008-12#1)(2008-7#1)(2008-8#2)(2009-6#1)(2009-7#1)(2010-3#1)
of snakebite and##2##3##(2009-6#2)
of snakebite cases##2##3##(2012-2#2)
of snakebite##5##2##(2005-8#1)(2009-6#2)(2012-2#2)
of snakebites##2##2##(2007-6#1)(2009-6#1)
of snakes##2##2##(1996-12#1)(2012-2#1)
of sneaking##2##2##(2010-8#2)
of snoRNA##2##2##(2008-8#1)(2010-11#1)
of snoring and mild##3##4##(2007-12#3)
of snoring and##5##3##(2005-10#1)(2007-12#3)(2007-6#1)
of snoring##7##2##(2005-10#1)(2007-12#3)(2007-6#1)(2009-4#1)(2011-2#1)
of snow molds##2##3##(2008-10#2)
of snow##8##2##(1993-3#2)(2008-10#2)(2008-2#1)(2008-3#2)(2013-8#1)
of snuff##2##2##(1991-6#1)(1991-8#1)
of snus and##2##3##(2012-12#2)
of snus##6##2##(2012-12#6)
of so many##2##3##(1992-2#1)(2008-7#1)
of so##4##2##(1992-2#1)(2008-7#1)(2009-4#1)(2012-2#1)
of so-called &quot##3##3##(1990-6#1)(1991-2#1)(1991-3#1)
of so-called##13##2##(1990-6#1)(1991-2#1)(1991-3#1)(1992-3#1)(1993-1#1)(1995-5#1)(1996-6#1)(2006-10#2)(2006-12#1)(2006-8#1)(2009-4#1)(2010-1#1)
of soaking##3##2##(2006-7#1)(2008-10#1)(2008-5#1)
of soap##2##2##(2008-1#1)(2011-1#1)
of social and economic##3##4##(1997-3#1)(2009-7#1)(2011-1#1)
of social and motivational##2##4##(2012-1#2)
of social and##17##3##(1991-1#1)(1997-3#1)(2005-7#1)(2007-1#1)(2008-11#1)(2008-2#2)(2008-4#1)(2009-7#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#2)(2013-1#1)
of social anxiety disorder##4##4##(2011-2#4)
of social anxiety symptoms##2##4##(2004-11#1)(2008-2#1)
of social anxiety##14##3##(2004-11#3)(2004-3#1)(2008-2#6)(2011-2#4)
of social audit##2##3##(2012-3#2)
of social audits##2##3##(2012-3#2)
of social behavior##4##3##(2008-11#1)(2008-8#1)(2009-4#1)(2010-3#1)
of social capital##4##3##(2010-2#2)(2010-5#1)(2012-12#1)
of social change on health##2##5##(2008-1#2)
of social class on clinical reasons for tooth##2##8##(2008-9#2)
of social class##3##3##(1997-3#1)(2008-9#2)
of social cognition and##3##4##(2008-11#1)(2012-1#1)(2013-1#1)
of social cognition##5##3##(2008-11#3)(2012-1#1)(2013-1#1)
of social cognitive##2##3##(2006-4#1)(2013-1#1)
of social cohesion##3##3##(2008-7#1)(2010-4#1)(2012-1#1)
of social contact##3##3##(1997-1#1)(2008-11#1)(2008-5#1)
of social determinants##2##3##(2011-1#1)(2013-1#1)
of social dominance##4##3##(1997-6#1)(2008-11#1)(2008-8#1)(2010-1#1)
of social evolution##4##3##(2008-8#1)(2012-3#3)
of social factors##2##3##(2008-2#1)(2009-7#1)
of social functioning##3##3##(1996-1#2)(2007-10#1)
of social influence and##2##4##(2008-5#1)(2012-2#1)
of social influence##5##3##(2008-5#3)(2010-2#1)(2012-2#1)
of social interaction##7##3##(1996-11#1)(2004-11#1)(2008-11#1)(2008-4#1)(2011-2#2)(2012-2#1)
of social interactions##8##3##(2008-12#1)(2008-8#2)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
of social justice##2##3##(2006-7#1)(2008-2#1)
of social marketing##2##3##(1997-3#1)(2007-10#1)
of social media in##3##4##(2013-1#3)
of social media##6##3##(2012-2#1)(2013-1#5)
of social medicine]##3##3##(1996-11#2)(1997-3#1)
of social network##5##3##(2008-5#1)(2010-1#1)(2012-12#1)(2012-2#2)
of social networking##2##3##(2012-2#2)
of social norms##2##3##(2008-2#1)(2013-1#1)
of social perception##2##3##(2008-11#2)
of social phobia##14##3##(2005-9#2)(2006-6#3)(2007-7#1)(2008-4#5)(2010-2#3)
of social rank##2##3##(1993-9#1)(2008-11#1)
of social recognition##2##3##(1993-2#2)
of social relationships in##2##4##(2008-5#2)
of social relationships##5##3##(2008-5#3)(2011-2#2)
of social research##2##3##(1994-3#1)(1997-1#1)
of social science research##2##4##(1995-2#1)(2008-12#1)
of social scientists##2##3##(1994-3#1)(1994-6#1)
of social security##2##3##(1995-5#1)(2007-7#1)
of social selection##2##3##(2008-8#1)(2012-3#1)
of social services##4##3##(1995-3#1)(2011-1#1)(2011-2#1)(2012-1#1)
of social spending##3##3##(2008-9#1)(2013-1#2)
of social support and##3##4##(1992-3#1)(2009-7#2)
of social support from##4##4##(2006-3#1)(2009-7#3)
of social support##27##3##(1991-1#1)(1992-1#1)(1992-2#1)(1992-3#4)(1996-3#1)(2005-10#1)(2006-3#2)(2007-1#1)(2007-2#1)(2007-4#1)(2008-12#1)(2009-10#1)(2009-5#2)(2009-7#6)(2009-9#2)(2010-10#1)
of social ties##2##3##(2011-2#1)(2013-1#1)
of social work practice##2##4##(2007-9#1)(2010-2#1)
of social work##5##3##(2007-9#2)(2009-12#1)(2010-10#1)(2010-2#1)
of social workers and##2##4##(2007-9#1)(2010-2#1)
of social workers in##2##4##(2007-9#1)(2010-2#1)
of social workers##5##3##(2007-9#3)(2010-2#2)
of social##299##2##(1991-1#2)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#4)(1992-8#1)(1993-10#1)(1993-2#3)(1993-3#2)(1993-6#1)(1993-9#1)(1994-2#2)(1994-3#3)(1994-6#1)(1995-2#1)(1995-3#2)(1995-5#2)(1996-1#6)(1996-11#4)(1996-12#1)(1996-3#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#5)(1997-6#2)(2004-11#4)(2004-12#1)(2004-3#2)(2005-10#1)(2005-7#1)(2005-9#2)(2006-3#2)(2006-4#1)(2006-6#3)(2006-7#3)(2006-9#1)(2007-1#2)(2007-10#4)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#2)(2007-7#5)(2007-8#1)(2007-9#5)(2008-1#3)(2008-11#16)(2008-12#7)(2008-2#12)(2008-4#7)(2008-5#14)(2008-6#4)(2008-7#2)(2008-8#7)(2008-9#6)(2009-10#4)(2009-12#1)(2009-4#4)(2009-5#3)(2009-6#1)(2009-7#9)(2009-8#1)(2009-9#3)(2010-1#3)(2010-10#2)(2010-2#11)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#6)(2011-2#17)(2012-1#5)(2012-11#1)(2012-12#4)(2012-2#11)(2012-3#11)(2013-1#19)(2013-7#1)
of sociality in##2##3##(2008-8#2)
of sociality##7##2##(2008-8#5)(2013-1#2)
of socially relevant##2##3##(1993-2#1)(2007-8#1)
of socially##5##2##(1993-2#1)(2007-8#1)(2009-6#1)(2009-7#1)(2012-2#1)
of societal appearance##2##3##(2007-12#2)
of societal standards of beauty##2##5##(2007-12#2)
of societal standards##4##3##(2007-12#4)
of societal##13##2##(2004-12#1)(2006-4#1)(2006-9#1)(2007-12#7)(2007-2#1)(2009-6#1)(2011-2#1)
of societies##2##2##(2008-7#1)(2012-1#1)
of society and##5##3##(1992-12#1)(1995-5#1)(2010-4#1)(2013-1#1)(2013-8#1)
of society in##2##3##(2008-7#1)(2008-8#1)
of society to##3##3##(1991-3#1)(1992-4#1)(2008-8#1)
of society##32##2##(1990-12#2)(1990-8#1)(1991-3#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-4#1)(1994-4#1)(1995-5#2)(2007-7#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-4#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
of socio-demographic##2##2##(1992-4#1)(2013-1#1)
of socio-economic and behavioural factors on childhood malnutrition in Yemen##2##10##(2010-6#2)
of socio-economic and##3##3##(2007-7#1)(2010-6#2)
of socio-economic development##3##3##(2007-12#2)(2012-1#1)
of socio-economic status##2##3##(2006-1#1)(2010-11#1)
of socio-economic##9##2##(2006-1#1)(2007-12#2)(2007-7#1)(2010-11#1)(2010-6#2)(2011-1#1)(2012-1#1)
of sociobiology##2##2##(2010-4#2)
of sociocultural##6##2##(2006-7#2)(2007-12#4)
of sociodemographic##3##2##(1997-4#1)(2007-6#1)(2011-2#1)
of socioeconomic change##3##3##(1991-12#1)(2008-12#2)
of socioeconomic status and##2##4##(2006-10#1)(2010-2#1)
of socioeconomic status##3##3##(2006-10#1)(2009-10#1)(2010-2#1)
of socioeconomic##15##2##(1991-12#1)(1994-2#1)(2005-10#1)(2006-10#2)(2007-9#1)(2008-12#2)(2009-10#1)(2010-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
of sociology##2##2##(2008-12#1)(2010-7#1)
of sodium (Na)##2##3##(1995-8#1)(2004-4#1)
of sodium acetate##4##3##(2005-12#1)(2006-10#1)(2008-10#1)(2013-7#1)
of sodium alginate##3##3##(2004-8#1)(2010-9#1)(2011-2#1)
of sodium and potassium ions##2##5##(2007-1#1)(2008-10#1)
of sodium and potassium##5##4##(2007-1#1)(2008-10#4)
of sodium and water retention in cirrhosis##2##7##(1997-7#2)
of sodium and water##3##4##(1997-7#2)(2013-8#1)
of sodium and##10##3##(1997-7#2)(2007-1#1)(2008-10#4)(2010-12#1)(2010-8#1)(2013-8#1)
of sodium ascorbate##2##3##(1997-4#2)
of sodium atoms##2##3##(1995-11#1)(2007-11#1)
of sodium azide##3##3##(1991-8#1)(1994-12#1)(2008-10#1)
of sodium borohydride##2##3##(1995-11#1)(2010-4#1)
of sodium bromate in##2##4##(2008-9#2)
of sodium bromate##3##3##(2008-9#3)
of sodium butyrate##3##3##(1992-3#1)(2008-11#1)(2013-7#1)
of sodium carboxymethyl cellulose##3##4##(2008-5#3)
of sodium channel##8##3##(1994-11#1)(1995-3#1)(1996-12#2)(2008-7#2)(2009-8#1)(2012-12#1)
of sodium channels in##2##4##(1995-8#2)
of sodium channels##3##3##(1995-3#1)(1995-8#2)
of sodium chloride in##2##4##(2008-10#1)(2011-2#1)
of sodium chloride to the##2##5##(1990-8#1)(2008-10#1)
of sodium chloride##20##3##(1990-8#1)(1994-5#1)(1996-3#1)(1997-6#1)(2005-11#3)(2008-10#5)(2008-12#2)(2008-4#1)(2008-5#1)(2010-4#3)(2011-2#1)
of sodium citrate##2##3##(1997-4#1)(2011-2#1)
of sodium dodecanoate##2##3##(2005-11#2)
of sodium dodecyl sulfate (SDS)##12##5##(1990-11#1)(1994-11#1)(1994-9#1)(1995-5#1)(1996-5#1)(2005-11#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#1)
of sodium dodecyl sulfate and##4##5##(1993-7#1)(1995-5#1)(1996-12#1)(2008-10#1)
of sodium dodecyl sulfate##20##4##(1990-11#1)(1990-5#1)(1991-2#1)(1991-9#1)(1993-7#1)(1994-11#1)(1994-9#1)(1995-5#2)(1996-12#1)(1996-5#1)(2005-11#3)(2007-8#1)(2008-10#3)(2008-2#1)(2008-4#1)
of sodium dodecyl sulphate (SDS) and##2##6##(2008-10#2)
of sodium dodecyl sulphate##4##4##(1993-9#1)(2008-10#3)
of sodium dodecyl##25##3##(1990-11#1)(1990-5#1)(1991-2#1)(1991-9#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-5#2)(1996-12#1)(1996-5#1)(2005-11#4)(2007-8#1)(2008-10#6)(2008-2#1)(2008-4#1)
of sodium dodecylsulfate (SDS)##3##4##(2005-11#1)(2008-10#2)
of sodium dodecylsulfate##4##3##(2005-11#1)(2008-10#3)
of sodium fluoride##5##3##(1990-2#1)(1995-12#1)(2008-12#1)(2010-3#1)(2013-1#1)
of sodium hydroxide##7##3##(1991-4#1)(2005-12#1)(2008-10#3)(2008-5#1)(2008-6#1)
of sodium hypochlorite and hydrogen peroxide##2##6##(1991-2#1)(2007-8#1)
of sodium hypochlorite and##3##4##(1991-2#1)(2007-8#1)(2008-10#1)
of sodium hypochlorite solution##2##4##(2008-5#2)
of sodium hypochlorite##6##3##(1991-2#1)(2007-8#1)(2008-10#1)(2008-5#2)(2009-2#1)
of sodium impurities##3##3##(2008-10#2)(2008-3#1)
of sodium in##6##3##(1995-4#1)(1997-1#1)(2008-10#4)
of sodium ion##5##3##(1992-3#1)(2008-10#4)
of sodium ions##4##3##(1991-8#2)(1992-3#2)
of sodium lactate##3##3##(2007-3#1)(2008-4#1)(2009-2#1)
of sodium lauryl##2##3##(2008-10#1)(2008-5#1)
of sodium metabisulfite in##2##4##(2008-10#2)
of sodium nitrite##3##3##(1990-5#2)(2008-10#1)
of sodium nitroprusside##5##3##(1993-9#1)(1994-2#1)(2007-11#1)(2007-8#1)(2013-7#1)
of sodium or##2##3##(1990-5#1)(2008-10#1)
of sodium restriction##2##3##(1995-9#1)(1996-12#1)
of sodium selenite##4##3##(1995-1#1)(1996-2#1)(2008-7#1)(2011-1#1)
of sodium sulfate##2##3##(2008-10#1)(2008-9#1)
of sodium thiosulfate##2##3##(2007-8#1)(2008-10#1)
of sodium valproate##3##3##(2006-4#3)
of sodium##269##2##(1990-11#2)(1990-2#2)(1990-5#4)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-7#1)(1991-8#4)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#4)(1992-5#2)(1992-8#1)(1993-4#2)(1993-7#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#2)(1995-3#2)(1995-4#1)(1995-5#2)(1995-8#3)(1995-9#1)(1996-12#5)(1996-2#2)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-4#4)(1997-6#1)(1997-7#4)(2004-4#1)(2004-8#1)(2005-11#12)(2005-12#3)(2005-4#1)(2005-8#1)(2006-10#1)(2006-4#3)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#74)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#11)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#5)(2009-12#1)(2009-2#3)(2009-8#1)(2010-12#1)(2010-3#3)(2010-4#7)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-3#1)(2013-1#5)(2013-7#3)(2013-8#1)
of sodium-caseinate-stabilized emulsions##2##3##(2005-11#2)
of sodium-dependent phosphate##3##3##(1991-9#1)(1994-3#2)
of sodium-dependent##6##2##(1991-9#2)(1993-9#1)(1994-3#3)
of sodium-depleted rats##2##3##(1994-10#1)(1997-4#1)
of sodium-selective electrodes##2##3##(2008-10#2)
of sodium/solute symporters##2##3##(1994-6#2)
of soft contact##2##3##(2005-11#1)(2011-1#1)
of soft lithography##3##3##(2007-5#1)(2008-11#1)(2008-7#1)
of soft parts##2##3##(2008-5#1)(2008-6#1)
of soft tissue and non-thrust joint manipulation##2##7##(2008-12#2)
of soft tissue and##4##4##(2007-8#1)(2008-12#2)(2008-6#1)
of soft tissue for##3##4##(2007-12#1)(2008-12#1)(2008-6#1)
of soft tissue in##2##4##(2008-3#1)(2009-4#1)
of soft tissue or##2##4##(2009-3#1)(2009-9#1)
of soft tissue sarcoma (STS)##2##5##(2008-6#2)
of soft tissue sarcoma in##2##5##(2008-6#1)(2008-7#1)
of soft tissue sarcoma##10##4##(2008-6#7)(2008-7#1)(2010-3#1)(2012-12#1)
of soft tissue sarcomas##8##4##(2006-6#1)(2008-6#6)(2013-7#1)
of soft tissue tumours##3##4##(2008-6#1)(2008-7#1)(2012-2#1)
of soft tissue##62##3##(1990-12#1)(1992-1#1)(1992-2#1)(1994-10#1)(1996-11#1)(1996-5#1)(2004-9#1)(2006-6#2)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#2)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#18)(2008-7#3)(2009-3#2)(2009-4#2)(2009-9#2)(2010-3#2)(2011-12#2)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#2)
of soft tissues in##2##4##(2007-5#1)(2008-2#1)
of soft tissues to##2##4##(2004-9#1)(2007-7#1)
of soft tissues##11##3##(2004-9#1)(2007-5#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-7#1)(2010-4#1)(2010-9#1)(2012-2#1)(2013-7#1)
of soft x-ray lasers##2##4##(1990-3#2)
of soft x-ray##3##3##(1990-3#3)
of soft##107##2##(1990-12#1)(1990-3#3)(1992-1#1)(1992-10#1)(1992-2#1)(1994-10#1)(1996-11#1)(1996-5#1)(2004-9#2)(2005-11#2)(2006-6#2)(2007-11#2)(2007-12#3)(2007-4#1)(2007-5#4)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-12#5)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#19)(2008-7#4)(2008-9#2)(2009-3#2)(2009-4#2)(2009-7#2)(2009-9#4)(2010-3#4)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#2)(2013-7#4)
of soft-tissue defects in##2##4##(2008-9#1)(2009-9#1)
of soft-tissue sarcomas##2##3##(2008-6#2)
of soft-tissue##8##2##(2008-6#3)(2008-9#2)(2009-9#1)(2012-12#1)(2013-1#1)
of soft-water acclimation##2##3##(2008-10#2)
of soft-x-ray##3##2##(2007-12#1)(2008-3#2)
of software development##3##3##(2011-2#1)(2013-1#2)
of software for##2##3##(1992-9#1)(2008-10#1)
of software##14##2##(1992-2#1)(1992-9#1)(2006-5#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
of soil CO2##2##3##(2011-12#2)
of soil ROC##2##3##(2013-8#2)
of soil and plant##2##4##(1990-9#1)(2008-11#1)
of soil and sediment##3##4##(2008-10#3)
of soil and vegetation##2##4##(2008-12#1)(2008-9#1)
of soil and##18##3##(1990-9#1)(2004-2#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-9#1)(2013-1#1)(2013-8#1)
of soil arthropod community##3##4##(2013-8#3)
of soil arthropod##4##3##(2013-8#4)
of soil bacteria##3##3##(2012-12#1)(2012-3#1)(2013-8#1)
of soil characteristics##2##3##(2008-10#1)(2010-12#1)
of soil chemical##2##3##(2006-5#1)(2008-10#1)
of soil contamination##3##3##(1996-3#1)(2004-4#1)(2008-4#1)
of soil fertility##3##3##(2006-4#1)(2008-11#1)(2010-7#1)
of soil in##4##3##(2008-10#4)
of soil macro-organisms##2##3##(2011-12#1)(2011-2#1)
of soil microbial##3##3##(2006-12#1)(2008-10#2)
of soil moisture and##2##4##(2008-10#1)(2008-9#1)
of soil moisture content##3##4##(2013-8#3)
of soil moisture##6##3##(2008-10#1)(2008-9#1)(2013-8#4)
of soil nutrients##2##3##(2008-5#1)(2013-8#1)
of soil of##3##3##(2008-10#2)(2008-7#1)
of soil organic carbon to total##2##6##(2013-8#2)
of soil organic carbon##4##4##(2013-8#4)
of soil organic matter##4##4##(2008-10#2)(2013-8#2)
of soil organic matters##2##4##(2005-4#1)(2008-12#1)
of soil organic phosphorus##3##4##(2008-10#3)
of soil organic##13##3##(2005-4#1)(2008-10#5)(2008-12#1)(2013-8#6)
of soil properties##2##3##(2008-10#1)(2012-2#1)
of soil samples##7##3##(2006-10#1)(2008-10#2)(2008-11#2)(2008-5#1)(2011-12#1)
of soil to##3##3##(2004-2#1)(2008-10#2)
of soil total nitrogen##2##4##(2013-8#2)
of soil was##2##3##(2008-10#1)(2011-1#1)
of soil were##3##3##(2008-10#3)
of soil with##5##3##(2008-10#4)(2008-12#1)
of soil##188##2##(1990-9#1)(1993-8#1)(1996-3#1)(2004-2#2)(2004-4#1)(2005-4#2)(2006-10#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#2)(2007-10#1)(2007-7#1)(2008-10#89)(2008-11#11)(2008-12#8)(2008-4#2)(2008-5#3)(2008-7#1)(2008-9#2)(2009-3#1)(2010-12#2)(2010-3#1)(2010-7#1)(2011-1#1)(2011-12#9)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)(2012-8#1)(2013-1#1)(2013-7#2)(2013-8#30)
of soil)##12##2##(2008-10#12)
of soil-transmitted##3##2##(2007-7#1)(2008-7#1)(2011-12#1)
of soilborne pathogens##7##3##(2008-10#7)
of soilborne plant pathogens##5##4##(2008-10#5)
of soilborne plant##6##3##(2008-10#6)
of soilborne##22##2##(2008-10#22)
of soils and sediments##2##4##(2008-10#2)
of soils and##5##3##(2007-3#1)(2008-10#4)
of soils by##2##3##(2008-10#1)(2008-12#1)
of soils in##2##3##(2008-10#2)
of soils on the man made mounds in the Harran Plain##2##11##(2008-12#2)
of soils with##3##3##(2008-10#2)(2011-1#1)
of soils##32##2##(2004-2#1)(2004-4#1)(2006-12#3)(2007-3#1)(2008-10#18)(2008-12#5)(2008-6#1)(2011-1#1)(2011-12#1)
of sol-gel and self-assembly process##2##5##(2008-10#2)
of sol-gel and##3##3##(2007-8#1)(2008-10#2)
of sol-gel##7##2##(2007-8#1)(2008-10#5)(2010-7#1)
of solanaceous##2##2##(2008-10#1)(2008-6#1)
of solar UV radiation##2##4##(1992-6#1)(2008-10#1)
of solar UV##5##3##(1992-6#1)(2008-10#1)(2008-5#2)(2010-9#1)
of solar energy##2##3##(2008-8#1)(2008-9#1)
of solar radiation and##2##4##(2008-2#1)(2010-1#1)
of solar radiation on##4##4##(2006-3#2)(2010-1#2)
of solar radiation##12##3##(2006-3#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2010-1#3)(2011-2#1)
of solar##42##2##(1990-8#1)(1991-5#1)(1992-6#2)(1995-10#1)(2006-12#1)(2006-3#2)(2007-3#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#9)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-1#3)(2010-12#1)(2010-7#2)(2010-9#3)(2011-2#2)
of soldiers##2##2##(2007-8#1)(2012-2#1)
of sole##2##2##(2008-10#1)(2011-2#1)
of solenoid##2##2##(2008-10#2)
of soleus##3##2##(1993-12#1)(1993-7#1)(2010-12#1)
of solid and liquid##2##4##(2008-2#1)(2010-2#1)
of solid and##5##3##(2005-7#1)(2007-8#1)(2008-2#1)(2010-12#1)(2010-2#1)
of solid or##2##3##(1992-3#1)(2010-4#1)
of solid organ##2##3##(2007-11#2)
of solid organs##2##3##(2007-12#2)
of solid phase extraction##2##4##(2008-10#2)
of solid phase##10##3##(1990-4#1)(1992-8#1)(1993-3#1)(1996-12#1)(2008-10#5)(2011-12#1)
of solid phases##2##3##(2004-9#1)(2013-1#1)
of solid samples##3##3##(2008-10#3)
of solid sorbents for##2##4##(2007-8#1)(2008-10#1)
of solid state##4##3##(1996-2#1)(2005-11#1)(2005-4#1)(2008-10#1)
of solid substrate##2##3##(1997-2#1)(2008-7#1)
of solid tumors and##5##4##(2008-1#1)(2008-7#1)(2009-3#1)(2011-2#1)(2013-8#1)
of solid tumors by##2##4##(2011-2#1)(2012-12#1)
of solid tumors including##2##4##(2011-1#1)(2013-1#1)
of solid tumors##21##3##(2005-6#1)(2006-11#1)(2006-5#1)(2006-6#1)(2006-9#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#3)(2009-3#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-1#1)(2013-8#1)
of solid tumours##5##3##(1992-6#1)(2007-7#1)(2008-11#1)(2008-8#1)(2009-4#1)
of solid waste##2##3##(2008-12#2)
of solid wastes##2##3##(1997-4#1)(2008-10#1)
of solid##113##2##(1990-12#1)(1990-4#1)(1991-5#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-8#2)(1994-8#1)(1995-4#1)(1996-12#1)(1996-2#1)(1997-2#3)(1997-4#1)(2004-9#1)(2005-11#3)(2005-4#1)(2005-6#1)(2005-7#2)(2006-10#1)(2006-11#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#6)(2007-12#2)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#24)(2008-11#3)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#4)(2008-7#7)(2008-8#2)(2009-3#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#4)
of solid-phase extraction (SPE)##2##4##(2008-10#2)
of solid-phase extraction##8##3##(1992-7#1)(2008-10#7)
of solid-phase microextraction##3##3##(2008-10#3)
of solid-phase##14##2##(1990-4#1)(1992-7#1)(2008-10#10)(2008-2#1)(2008-4#1)
of solid-state NMR##4##3##(1991-11#1)(2010-4#1)(2011-1#1)(2012-2#1)
of solid-state##8##2##(1991-11#1)(2007-12#1)(2008-10#1)(2008-9#1)(2010-4#2)(2011-1#1)(2012-2#1)
of solidarity##2##2##(1997-8#2)
of solids by##3##3##(2005-11#1)(2008-10#1)(2008-5#1)
of solids##13##2##(1994-12#1)(2005-11#3)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)
of solitary fibrous##2##3##(2007-8#1)(2011-1#1)
of solitary wasps and bees##2##5##(2008-6#2)
of solitary waves in##3##4##(2007-12#2)(2008-1#1)
of solitary waves##4##3##(2007-12#2)(2008-1#2)
of solitary##28##2##(1991-3#2)(1992-12#1)(2005-1#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-6#5)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#3)(2012-3#1)(2013-1#1)
of soliton collisions##2##3##(2007-11#1)(2007-12#1)
of soliton energy##2##3##(2008-1#2)
of soliton##16##2##(2007-11#4)(2007-12#9)(2008-1#3)
of soliton-induced waveguides##3##3##(2007-12#3)
of solitons in##3##3##(2007-11#1)(2007-12#2)
of solitons##12##2##(2007-11#2)(2007-12#10)
of solubility##9##2##(1991-12#1)(1991-2#1)(2008-10#4)(2008-11#1)(2010-3#1)(2012-2#1)
of solubilization##4##2##(2005-11#2)(2008-5#1)(2010-2#1)
of solubilized##5##2##(1990-11#1)(1992-3#1)(2008-11#1)(2013-1#2)
of solubilizing##2##2##(1992-7#1)(2008-12#1)
of soluble CD95##3##3##(1997-7#3)
of soluble P-glycoprotein in##2##4##(1994-8#2)
of soluble P-glycoprotein##4##3##(1994-8#4)
of soluble and exchangeable##2##4##(2011-2#2)
of soluble and insoluble##2##4##(1996-1#1)(2011-2#1)
of soluble and membrane-bound##2##4##(2008-4#2)
of soluble and##10##3##(1990-11#1)(1996-1#1)(2007-11#1)(2008-10#1)(2008-4#3)(2011-2#3)
of soluble factors in##2##4##(1996-11#1)(2008-9#1)
of soluble factors##5##3##(1996-11#1)(2005-10#1)(2008-5#1)(2008-9#1)(2012-12#1)
of soluble fulvic##2##3##(2008-10#2)
of soluble guanylate cyclase##3##4##(1993-6#1)(2007-9#1)(2008-4#1)
of soluble guanylyl cyclase##3##4##(1996-6#3)
of soluble methane monooxygenase##2##4##(1995-10#1)(2009-3#1)
of soluble or membrane-bound##3##4##(2008-4#3)
of soluble or##5##3##(1990-4#1)(1995-2#1)(2008-4#3)
of soluble phenolics##2##3##(2004-4#2)
of soluble phosphates in##2##4##(2008-10#2)
of soluble protein A##2##4##(1990-12#1)(1994-12#1)
of soluble protein##4##3##(1990-12#1)(1994-12#1)(1995-3#1)(1995-8#1)
of soluble proteins from##2##4##(2008-4#2)
of soluble proteins##8##3##(1997-4#1)(2007-8#1)(2008-11#1)(2008-4#4)(2008-6#1)
of soluble##124##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-9#1)(1991-12#1)(1992-11#1)(1992-4#1)(1992-6#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#2)(1994-8#5)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-8#2)(1996-1#1)(1996-11#1)(1996-2#1)(1996-6#3)(1996-9#1)(1997-3#2)(1997-4#1)(1997-7#4)(2004-11#1)(2004-12#1)(2004-4#2)(2005-10#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-6#1)(2007-10#2)(2007-11#2)(2007-8#2)(2007-9#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#14)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#2)(2009-3#2)(2009-6#2)(2009-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-8#1)
of solute diffusion##3##3##(1993-11#2)(2008-6#1)
of solute is##2##3##(2008-10#1)(2008-3#1)
of solute was##2##3##(1991-4#1)(2009-5#1)
of solute##16##2##(1991-4#1)(1993-11#2)(2005-12#1)(2006-10#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#1)(2012-2#2)
of solute-solvent##2##2##(2008-10#1)(2010-2#1)
of solutes##13##2##(1993-11#1)(1995-5#1)(1996-5#1)(1996-8#1)(2008-10#2)(2008-7#3)(2010-2#1)(2011-2#1)(2012-2#2)
of solution acidity##2##3##(2008-10#2)
of solution and##2##3##(1992-8#1)(2005-4#1)
of solution conditions##3##3##(1991-4#1)(2005-11#1)(2010-4#1)
of solution in##2##3##(1995-3#1)(2008-3#1)
of solution pH on the##2##5##(2008-10#1)(2008-5#1)
of solution pH##9##3##(1995-2#1)(2007-8#1)(2008-10#5)(2008-5#2)
of solution to##2##3##(2008-2#1)(2009-6#1)
of solution##52##2##(1990-10#1)(1991-4#2)(1991-7#1)(1992-8#1)(1993-12#1)(1993-4#1)(1994-2#1)(1995-2#1)(1995-3#1)(1995-6#1)(2004-9#1)(2005-11#2)(2005-4#2)(2006-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#20)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2009-6#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-8#1)
of solution-phase##2##2##(2006-12#1)(2007-8#1)
of solution-synthesized CdS nanowires##2##4##(2009-2#2)
of solutions and the##2##4##(2008-10#2)
of solutions and##3##3##(2008-10#3)
of solutions containing##2##3##(2008-10#2)
of solutions is##2##3##(1997-5#1)(2008-2#1)
of solutions of##6##3##(1990-7#1)(1997-7#1)(2005-11#1)(2008-10#2)(2010-2#1)
of solutions with##3##3##(2008-10#3)
of solutions##33##2##(1990-11#1)(1990-7#1)(1994-2#1)(1997-5#1)(1997-7#1)(2005-11#1)(2007-10#1)(2007-12#1)(2008-10#15)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2010-2#1)(2011-12#1)(2013-8#1)
of solvated biomolecules##2##3##(1992-6#1)(2006-10#1)
of solvated##4##2##(1992-6#1)(2006-10#2)(2012-2#1)
of solvation in##3##3##(1990-8#1)(2008-5#2)
of solvation of##2##3##(2006-10#1)(2008-10#1)
of solvation##12##2##(1990-8#2)(2006-10#1)(2008-10#3)(2008-4#1)(2008-5#2)(2009-9#1)(2010-7#1)(2011-1#1)
of solved##2##2##(2007-8#2)
of solvent and##5##3##(2006-10#1)(2008-10#4)
of solvent composition##5##3##(1995-4#1)(2008-10#3)(2009-3#1)
of solvent effects##2##3##(1991-8#1)(2008-10#1)
of solvent on the##2##4##(2008-10#2)
of solvent perturbation on##2##4##(2006-10#2)
of solvent##58##2##(1990-2#1)(1990-5#1)(1991-7#1)(1991-8#1)(1992-2#2)(1992-4#1)(1993-11#1)(1993-2#1)(1994-9#1)(1995-4#1)(1996-8#1)(1997-1#2)(2005-11#1)(2006-10#5)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#21)(2008-5#1)(2008-7#2)(2009-3#2)(2009-9#1)(2010-9#1)(2011-1#2)(2012-12#1)(2013-1#2)
of solvents##22##2##(1991-10#1)(1991-8#1)(1995-2#1)(1995-4#1)(1997-1#1)(1997-4#1)(2006-10#2)(2007-11#2)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2010-10#1)(2010-5#1)(2011-2#1)
of solving the##3##3##(2007-7#1)(2007-9#1)(2008-10#1)
of solving##4##2##(2007-7#1)(2007-9#1)(2008-10#2)
of somal appositions##2##3##(1994-10#2)
of somal##3##2##(1994-10#3)
of somatic alterations##2##3##(2008-9#2)
of somatic and##2##3##(1996-8#1)(2006-9#1)
of somatic cell nuclear transfer##2##5##(2012-2#1)(2013-1#1)
of somatic cell##3##3##(2008-7#1)(2012-2#1)(2013-1#1)
of somatic cells##5##3##(2006-5#1)(2008-5#1)(2008-9#1)(2010-7#1)(2012-12#1)
of somatic gene##2##3##(1994-5#1)(2007-4#1)
of somatic mutations##3##3##(1995-12#1)(2007-4#1)(2008-4#1)
of somatic##33##2##(1991-4#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-9#1)(1996-2#1)(1996-8#1)(2005-6#1)(2006-5#1)(2006-9#1)(2007-12#2)(2007-4#2)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-4#1)(2009-8#1)(2010-2#1)(2010-7#1)(2012-12#1)(2012-2#3)(2013-1#1)
of somatization disorder##2##3##(2006-8#2)
of somatization##5##2##(1991-4#3)(2006-8#2)
of somatoform disorders##2##3##(1997-8#1)(2011-12#1)
of somatoform##3##2##(1997-8#1)(2011-12#2)
of somatosensory evoked potentials##2##4##(1991-1#1)(2006-10#1)
of somatosensory##11##2##(1991-1#1)(1993-2#1)(1995-12#1)(1997-5#2)(2006-10#2)(2007-8#2)(2008-5#1)(2010-7#1)
of somatostatin analogues##2##3##(2006-1#2)
of somatostatin gene##2##3##(1995-8#1)(1996-10#1)
of somatostatin in##4##3##(1994-8#1)(1995-9#1)(1997-2#2)
of somatostatin receptor##2##3##(1997-8#1)(2011-2#1)
of somatostatin receptors##6##3##(1995-12#1)(1997-2#2)(2006-12#1)(2012-12#1)(2012-3#1)
of somatostatin##32##2##(1991-5#1)(1992-6#3)(1992-9#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-8#1)(1995-9#2)(1996-10#1)(1996-5#1)(1997-2#4)(1997-4#4)(1997-8#2)(2006-1#2)(2006-10#1)(2006-12#1)(2008-1#1)(2008-4#1)(2011-2#1)(2012-12#1)(2012-3#1)
of somatostatinergic##2##2##(1995-2#1)(1996-5#1)
of somatotropes##3##2##(1992-6#2)(1994-9#1)
of somatropin##3##2##(2007-11#3)
of some 3##2##3##(2008-5#1)(2013-1#1)
of some 5-substituted##2##3##(2007-11#2)
of some B vitamins##2##4##(1995-6#2)
of some DNA##2##3##(2008-8#1)(2013-1#1)
of some Nigerian##2##3##(2008-4#1)(2010-12#1)
of some PAHs##2##3##(2004-4#1)(2008-10#1)
of some POPs##2##3##(2008-7#2)
of some active principles##2##4##(2005-8#1)(2008-10#1)
of some active##4##3##(2005-8#1)(2008-10#2)(2008-3#1)
of some amino acids##3##4##(1996-2#1)(2008-10#2)
of some amino##4##3##(1996-2#1)(1997-2#1)(2008-10#2)
of some analytical##2##3##(2008-10#2)
of some anions##3##3##(2008-10#3)
of some antioxidant enzymes##2##4##(2009-12#1)(2012-2#1)
of some aromatic amines##5##4##(1990-8#1)(2007-11#2)(2008-10#2)
of some aromatic##9##3##(1990-8#1)(2007-11#2)(2008-10#4)(2008-5#2)
of some aspects of the##4##5##(1995-12#1)(2008-10#2)(2008-7#1)
of some aspects of##7##4##(1995-12#1)(2006-6#1)(2008-10#2)(2008-12#1)(2008-7#1)(2012-1#1)
of some bacterial##2##3##(2010-4#1)(2010-7#1)
of some bands##2##3##(1992-8#1)(2005-4#1)
of some basic##4##3##(1996-5#1)(2005-12#1)(2008-1#1)(2008-2#1)
of some biological##3##3##(2008-10#3)
of some biologically##3##3##(2007-11#1)(2008-12#1)(2013-8#1)
of some blood##2##3##(1992-9#1)(2008-10#1)
of some cancers##4##3##(1992-7#1)(2005-10#1)(2009-4#1)(2013-1#1)
of some cardiovascular##2##3##(1996-5#1)(2007-9#1)
of some cases of##2##4##(2006-10#1)(2008-4#1)
of some catechol derivatives##2##4##(2008-10#2)
of some cell##3##3##(1991-5#1)(1997-6#1)(2008-8#1)
of some cells##3##3##(1993-11#1)(1997-2#1)(2007-5#1)
of some chronic##2##3##(1996-1#1)(2007-8#1)
of some clinical##4##3##(2006-2#1)(2008-10#1)(2008-5#1)(2010-12#1)
of some commercial##3##3##(1997-1#1)(2007-5#1)(2010-8#1)
of some commercially available##2##4##(1993-12#1)(2011-12#1)
of some common##4##3##(1993-11#1)(1993-6#1)(2007-12#1)(2012-2#1)
of some commonly used##2##4##(1992-2#1)(2011-1#1)
of some commonly##3##3##(1992-2#1)(2008-4#1)(2011-1#1)
of some components##2##3##(1994-3#1)(1996-12#1)
of some compounds##2##3##(2007-6#1)(2008-10#1)
of some derivatives of##2##4##(2007-10#1)(2008-10#1)
of some diseases##3##3##(1993-2#1)(1997-7#1)(2008-11#1)
of some drugs##2##3##(1995-7#1)(2008-10#1)
of some elements##2##3##(2008-10#2)
of some enzymes involved in##2##5##(1990-8#1)(1991-4#1)
of some enzymes##5##3##(1990-8#1)(1991-4#1)(1993-1#1)(2006-8#1)(2007-9#1)
of some epidemiological##2##3##(2007-7#1)(2008-10#1)
of some essential##2##3##(2006-9#1)(2010-11#1)
of some experimental##3##3##(2008-10#2)(2010-12#1)
of some extracellular matrix##2##4##(2006-2#1)(2010-11#1)
of some factors##2##3##(2008-10#1)(2008-4#1)
of some form of##2##4##(2007-3#1)(2008-10#1)
of some forms of##2##4##(1991-12#1)(2006-7#1)
of some functional##2##3##(2008-10#1)(2008-5#1)
of some genes##6##3##(1995-6#1)(2007-12#1)(2009-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
of some genetic and##2##4##(1995-6#1)(1996-8#1)
of some genetic##3##3##(1995-6#1)(1996-8#1)(2006-10#1)
of some groups of##3##4##(2007-12#1)(2010-4#2)
of some heavy metals##2##4##(2008-10#1)(2008-4#1)
of some heavy##3##3##(2008-10#2)(2008-4#1)
of some higher plants##2##4##(2007-1#1)(2008-8#1)
of some immunological parameters##2##4##(1991-5#1)(2007-11#1)
of some immunological##3##3##(1990-8#1)(1991-5#1)(2007-11#1)
of some important factors##2##4##(2008-10#1)(2012-11#1)
of some important##8##3##(1992-7#1)(1994-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-3#1)(2012-11#1)(2012-2#1)
of some increase##2##3##(1990-6#1)(2008-3#1)
of some individuals to##2##4##(2008-11#1)(2012-2#1)
of some individuals##3##3##(1991-8#1)(2008-11#1)(2012-2#1)
of some instrumental factors##2##4##(2008-10#2)
of some instrumental##3##3##(2008-10#3)
of some ions##3##3##(2008-10#3)
of some isolates##3##3##(2008-10#2)(2012-12#1)
of some lesions##2##3##(2007-3#1)(2010-12#1)
of some markers in##2##4##(2007-7#1)(2009-2#1)
of some markers##3##3##(1990-4#1)(2007-7#1)(2009-2#1)
of some matrix##3##3##(2006-9#1)(2008-10#2)
of some mechanisms##2##3##(1993-3#1)(2008-7#1)
of some metal ions and anions were studied##2##8##(2008-10#2)
of some metal ions and##3##5##(2008-10#3)
of some metal ions##6##4##(2008-10#6)
of some metal-4-(2-pyridylazo) resorcinol##2##4##(2008-10#2)
of some metals##4##3##(2008-10#4)
of some myocytes##2##3##(2010-12#2)
of some neurons##2##3##(1994-10#1)(1996-9#1)
of some new##17##3##(2007-11#8)(2007-9#1)(2008-10#2)(2008-3#1)(2009-6#1)(2011-1#1)(2012-11#3)
of some novel##9##3##(1996-5#1)(2006-9#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-5#1)(2012-2#1)
of some nutrients##2##3##(1991-11#1)(2006-4#1)
of some of our##2##4##(1994-6#1)(2004-2#1)
of some of the compounds##3##5##(1993-11#1)(1994-8#1)(2008-10#1)
of some of the key##2##5##(2010-6#1)(2012-2#1)
of some of the main##2##5##(2008-4#1)(2008-7#1)
of some of the major##3##5##(1997-2#1)(2006-10#1)(2007-10#1)
of some of the more common##2##6##(2008-9#1)(2012-2#1)
of some of the more##5##5##(1995-9#1)(2006-1#1)(2007-7#1)(2008-9#1)(2012-2#1)
of some of the most common##2##6##(2005-8#1)(2008-11#1)
of some of the most##5##5##(2005-8#1)(2006-2#1)(2007-5#1)(2008-11#1)(2011-2#1)
of some of the recent##2##5##(2007-8#1)(2008-7#1)
of some of the##92##4##(1990-4#1)(1990-7#1)(1991-12#1)(1992-12#1)(1993-1#1)(1993-11#2)(1993-2#2)(1993-4#1)(1994-8#1)(1995-10#1)(1995-4#1)(1995-9#1)(1996-2#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#6)(2008-7#4)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#2)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-7#1)(2013-1#1)
of some of their##2##4##(2006-5#1)(2008-5#1)
of some of them##3##4##(2008-12#1)(2008-2#1)(2008-4#1)
of some of these##16##4##(1990-7#1)(1993-4#1)(1994-12#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-11#1)(2013-8#1)
of some of##117##3##(1990-4#1)(1990-7#2)(1991-12#2)(1992-12#1)(1993-1#1)(1993-11#2)(1993-2#2)(1993-4#2)(1994-12#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-2#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2004-12#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#5)(2008-11#3)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#7)(2008-5#2)(2008-7#6)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#2)(2009-9#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-7#1)(2013-1#1)(2013-8#1)
of some or all##2##4##(1996-5#1)(2011-1#1)
of some organic and biological molecules##2##6##(2008-10#2)
of some organic##6##3##(1990-9#1)(2008-10#5)
of some other##5##3##(2006-10#1)(2006-12#1)(2006-3#1)(2008-4#1)(2009-6#1)
of some parameters##4##3##(1997-1#1)(1997-8#1)(2008-10#1)(2012-1#1)
of some patients with##2##4##(2006-10#1)(2006-7#1)
of some patients##5##3##(1994-2#1)(2006-10#1)(2006-7#1)(2008-12#1)(2012-3#1)
of some performance criteria##2##4##(2008-10#1)(2008-3#1)
of some pharmaceutical formulations##2##4##(2008-10#1)(2011-1#1)
of some pharmaceutical##5##3##(2007-2#2)(2008-10#2)(2011-1#1)
of some physical##2##3##(2006-10#1)(2008-2#1)
of some physiological##2##3##(2008-12#2)
of some plants##3##3##(2008-10#2)(2013-1#1)
of some pollutants##2##3##(2004-4#1)(2008-10#1)
of some properties##2##3##(1990-6#1)(2008-2#1)
of some protein##2##3##(1996-8#1)(2007-6#1)
of some proteins##4##3##(1993-11#1)(2007-6#1)(2009-9#1)(2013-1#1)
of some psychiatric disorders##2##4##(1995-11#1)(2008-4#1)
of some putative##2##3##(1993-7#1)(1996-9#1)
of some recently synthesized##2##4##(2008-10#2)
of some relevant##2##3##(1997-1#1)(2006-2#1)
of some representative##3##3##(2007-11#1)(2008-3#2)
of some risk factors##2##4##(2007-11#1)(2008-1#1)
of some samples##2##3##(2008-10#2)
of some selected##4##3##(2006-8#1)(2007-11#1)(2007-9#1)(2012-2#1)
of some sex##2##3##(1997-5#1)(2012-2#1)
of some species of the##2##5##(2007-12#1)(2012-2#1)
of some species of##3##4##(2007-12#1)(2008-12#1)(2012-2#1)
of some species##4##3##(2007-12#1)(2008-12#1)(2008-5#1)(2012-2#1)
of some specific##4##3##(2008-2#1)(2008-4#1)(2010-12#1)(2012-2#1)
of some standard##3##3##(2008-10#1)(2008-2#2)
of some statins##2##3##(2008-10#1)(2011-1#1)
of some strains##3##3##(1994-11#1)(2008-10#1)(2008-9#1)
of some structural##2##3##(2006-10#1)(2010-7#1)
of some trace elements##3##4##(2008-10#2)(2010-12#1)
of some transition metals##2##4##(2008-10#2)
of some transition##3##3##(2008-10#3)
of some trivalent metal##2##4##(2008-10#2)
of some tumor##2##3##(2007-11#1)(2008-8#1)
of some types of##4##4##(2007-11#1)(2007-2#1)(2008-1#1)(2011-2#1)
of some variables##2##3##(2008-10#1)(2008-8#1)
of some well##2##3##(2008-10#1)(2009-5#1)
of some well-known##2##3##(1993-3#1)(2008-2#1)
of some##904##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#4)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#5)(1990-9#2)(1991-11#2)(1991-12#7)(1991-2#4)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#3)(1992-8#1)(1992-9#5)(1993-1#2)(1993-11#7)(1993-12#2)(1993-2#5)(1993-3#3)(1993-4#2)(1993-6#3)(1993-7#2)(1993-8#2)(1994-10#3)(1994-11#4)(1994-12#2)(1994-2#3)(1994-3#3)(1994-6#3)(1994-8#3)(1994-9#4)(1995-1#6)(1995-10#2)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#6)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#1)(1996-10#3)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#5)(1996-4#2)(1996-5#9)(1996-6#3)(1996-8#7)(1996-9#4)(1997-1#6)(1997-2#6)(1997-3#4)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#6)(1997-8#4)(1997-9#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-4#2)(2004-9#1)(2005-10#2)(2005-11#6)(2005-12#1)(2005-4#3)(2005-6#1)(2005-7#5)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#20)(2006-11#2)(2006-12#5)(2006-2#6)(2006-3#1)(2006-4#3)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#6)(2006-9#5)(2007-1#4)(2007-10#4)(2007-11#40)(2007-12#12)(2007-2#6)(2007-3#4)(2007-4#2)(2007-5#4)(2007-6#4)(2007-7#4)(2007-8#7)(2007-9#5)(2008-1#11)(2008-10#177)(2008-11#13)(2008-12#14)(2008-2#14)(2008-3#20)(2008-4#19)(2008-5#34)(2008-6#4)(2008-7#20)(2008-8#16)(2008-9#8)(2009-1#2)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#4)(2009-9#2)(2010-10#1)(2010-11#4)(2010-12#15)(2010-2#1)(2010-4#3)(2010-6#2)(2010-7#3)(2010-8#5)(2011-1#9)(2011-12#1)(2011-2#13)(2012-1#6)(2012-11#4)(2012-12#9)(2012-2#16)(2012-3#5)(2012-7#1)(2013-1#14)(2013-7#8)(2013-8#7)
of sometimes##2##2##(2007-9#1)(2008-10#1)
of somites##4##2##(1994-12#3)(1996-5#1)
of song sparrows (Melospiza melodia)##3##5##(2008-8#1)(2008-9#2)
of song##6##2##(2008-8#3)(2008-9#3)
of songbirds##2##2##(1990-4#1)(2010-2#1)
of sonicated##7##2##(1990-2#1)(1993-3#1)(1994-11#2)(1996-1#1)(2008-11#1)(2013-1#1)
of sonication##3##2##(2008-10#3)
of sonography in##2##3##(1991-3#1)(2013-1#1)
of sonography##4##2##(1991-3#1)(1997-8#1)(2012-2#1)(2013-1#1)
of sonoluminescence##3##2##(1994-2#1)(1995-7#1)(2008-2#1)
of soot in##2##3##(2008-3#2)
of soot volume fraction##4##4##(2008-2#3)(2008-3#1)
of soot##20##2##(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#7)(2008-3#9)(2011-2#1)
of sophisticated##7##2##(1990-12#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-8#1)(2010-7#1)(2013-1#1)
of sophistication##3##2##(1996-2#1)(2006-10#1)(2010-12#1)
of sorbent and##2##3##(2008-10#2)
of sorbent##10##2##(1996-8#1)(2008-10#8)(2008-5#1)
of sorbic##2##2##(2011-2#2)
of sorbinil on##3##3##(1994-8#3)
of sorbitan acrylate##3##3##(2008-5#3)
of sorbitan##4##2##(2008-5#4)
of sorbitol##4##2##(2008-6#2)(2008-8#1)(2012-7#1)
of sorghum anthracnose##3##3##(2008-10#3)
of sorghum##10##2##(2008-10#7)(2008-9#3)
of sorption of##5##3##(2007-8#1)(2008-10#4)
of sorption##18##2##(2005-11#1)(2007-8#2)(2008-10#13)(2010-4#2)
of sorts##3##2##(1996-6#1)(2004-12#1)(2010-2#1)
of sound speed##2##3##(2008-3#2)
of sound##24##2##(1992-11#1)(1992-2#1)(1992-3#1)(1994-12#1)(1994-3#1)(1995-5#1)(1996-6#1)(2008-11#1)(2008-2#4)(2008-3#7)(2008-5#1)(2008-9#1)(2010-8#1)(2011-1#1)(2013-8#1)
of sounds by##2##3##(1997-7#1)(2008-11#1)
of sounds##9##2##(1997-7#2)(2007-9#1)(2008-11#1)(2009-4#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
of sour orange##4##3##(2008-10#4)
of source##15##2##(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2011-2#1)
of source-sink dynamics##2##3##(2008-8#2)
of sources and##2##3##(1992-6#1)(2008-11#1)
of sources in##2##3##(1990-6#1)(2010-10#1)
of sources of indoor##2##4##(1992-4#1)(2008-10#1)
of sources of##6##3##(1992-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2012-11#1)
of sources##31##2##(1990-6#1)(1992-4#1)(1992-6#2)(1993-12#1)(1993-2#1)(1994-5#1)(1995-1#1)(1995-5#1)(1997-3#1)(1997-4#1)(2006-5#1)(2006-9#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-3#1)
of south##5##2##(1996-8#1)(2006-2#1)(2009-7#1)(2012-3#1)(2013-7#1)
of southeastern##2##2##(2008-10#1)(2008-5#1)
of southern##21##2##(1991-7#1)(1996-4#1)(2006-10#1)(2006-4#1)(2007-5#1)(2008-10#5)(2008-8#1)(2008-9#1)(2010-1#1)(2010-8#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
of southwestern##2##2##(2008-10#1)(2011-1#1)
of sowing date##5##3##(2008-10#4)(2013-8#1)
of sowing distances on edible pod yields and yield components of three vegetable cowpea cultivars (Vigna unguiculata L##2##18##(2008-12#2)
of sowing##9##2##(2008-10#6)(2008-12#2)(2013-8#1)
of sows that##2##3##(1992-12#2)
of sows##6##2##(1992-12#4)(2008-8#1)(2010-2#1)
of soy sauce##2##3##(1996-2#1)(2008-10#1)
of soy##6##2##(1996-2#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-1#1)
of soybean (Glycine max (L##3##5##(2012-11#3)
of soybean (Glycine max L##3##5##(1997-6#1)(2008-12#1)(2012-2#1)
of soybean (Glycine max##7##4##(1997-6#1)(2008-12#1)(2012-11#4)(2012-2#1)
of soybean (Glycine max)##5##4##(1991-12#1)(2008-10#3)(2012-2#1)
of soybean (Glycine##12##3##(1991-12#1)(1997-6#1)(2008-10#3)(2008-12#1)(2012-11#4)(2012-2#2)
of soybean and palm oils##2##5##(2013-1#2)
of soybean and##3##3##(2008-10#1)(2013-1#2)
of soybean fungal diseases in##2##5##(2008-10#2)
of soybean lipoxygenase##2##3##(1992-7#1)(2008-6#1)
of soybean mosaic virus##3##4##(2008-10#2)(2008-8#1)
of soybean oil ethanolysis##2##4##(2008-10#2)
of soybean oil with##2##4##(2004-8#1)(2008-5#1)
of soybean oil##8##3##(2004-8#3)(2008-10#2)(2008-5#2)(2012-11#1)
of soybean rust and##2##4##(2008-10#2)
of soybean rust##10##3##(2008-10#10)
of soybean sclerotinia stem rot##2##5##(2008-10#2)
of soybean seed##4##3##(2006-12#2)(2012-11#2)
of soybean seedlings##4##3##(1993-8#1)(2008-10#2)(2008-8#1)
of soybean##87##2##(1990-11#1)(1991-10#1)(1991-12#1)(1992-7#1)(1993-8#1)(1996-12#1)(1997-6#2)(2004-8#3)(2005-10#1)(2006-12#2)(2008-10#41)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-3#1)(2012-11#18)(2012-2#2)(2013-1#2)
of soybeans##6##2##(2008-10#5)(2011-2#1)
of space and time##2##4##(2007-11#1)(2009-9#1)
of space and##6##3##(2007-11#1)(2008-2#3)(2009-6#1)(2009-9#1)
of space curves##2##3##(2008-2#2)
of space exposure on##2##4##(2008-2#2)
of space in##4##3##(2007-11#1)(2009-10#1)(2012-2#1)(2013-8#1)
of space##39##2##(1990-4#1)(1992-5#1)(1994-9#1)(1995-12#3)(1996-4#1)(2006-3#1)(2006-6#1)(2007-10#1)(2007-11#3)(2008-10#2)(2008-2#8)(2008-3#2)(2008-4#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-2#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#1)
of space-occupying##3##2##(1991-3#1)(2009-3#1)(2013-7#1)
of space-time coupling##3##3##(2007-11#2)(2008-3#1)
of space-time duality##2##3##(2007-12#1)(2008-2#1)
of space-time##8##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#3)(2008-6#1)
of spaceborne##3##2##(2008-3#3)
of spaced##2##2##(2008-6#1)(2009-11#1)
of spaceflight##2##2##(1991-2#1)(2009-7#1)
of spacer##3##2##(2004-12#1)(2008-10#1)(2009-4#1)
of spacing##4##2##(1990-2#1)(1995-2#1)(2008-1#1)(2009-2#1)
of sparfloxacin induced TEN##2##4##(2007-7#2)
of sparfloxacin##4##2##(2007-7#2)(2008-11#1)(2010-5#1)
of sparkling wines##3##3##(2008-10#3)
of sparkling##4##2##(2008-10#4)
of sparse##3##2##(2008-10#1)(2008-2#1)(2008-7#1)
of sparsity##2##2##(1995-5#1)(2008-3#1)
of sparsomycin##3##2##(1992-6#1)(1993-4#1)(2006-12#1)
of spasm##3##2##(1995-3#2)(2007-8#1)
of spasmodic##4##2##(1990-10#1)(1991-8#1)(1996-2#2)
of spastic##5##2##(1992-8#2)(1995-6#1)(2007-7#1)(2009-11#1)
of spasticity and##3##3##(1997-5#1)(2006-12#1)(2007-7#1)
of spasticity with botulinum##2##4##(1997-5#1)(2007-7#1)
of spasticity##11##2##(1997-5#2)(2006-12#3)(2007-7#5)(2012-1#1)
of spatial abilities##2##3##(1993-2#1)(2008-11#1)
of spatial aggregation and##2##4##(2008-10#1)(2008-8#1)
of spatial aggregation##5##3##(2007-6#1)(2008-10#2)(2008-8#2)
of spatial analysis##2##3##(2008-8#2)
of spatial and temporal features of##2##6##(2009-11#1)(2009-3#1)
of spatial and temporal##7##4##(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-11#1)(2009-3#1)(2011-11#1)
of spatial and##8##3##(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-11#1)(2009-3#1)(2011-11#1)
of spatial association##2##3##(2008-10#2)
of spatial autocorrelation##2##3##(2008-10#1)(2011-1#1)
of spatial coherence and##2##4##(2007-11#2)
of spatial coherence##10##3##(2007-11#4)(2007-12#3)(2008-3#3)
of spatial correlation##2##3##(2008-10#2)
of spatial data##2##3##(1997-6#1)(2008-10#1)
of spatial delayed alternation##2##4##(1991-2#1)(1994-8#1)
of spatial filtering##2##3##(2007-12#1)(2008-2#1)
of spatial frequencies##4##3##(1996-12#1)(2008-2#3)
of spatial frequency##3##3##(1996-12#1)(2008-2#1)(2008-3#1)
of spatial heterogeneity in the##2##5##(1991-12#1)(2008-10#1)
of spatial heterogeneity##4##3##(1991-12#1)(2008-10#2)(2008-8#1)
of spatial hole burning##4##4##(2007-11#2)(2008-3#2)
of spatial information##3##3##(1995-12#1)(2008-1#1)(2008-2#1)
of spatial learning##5##3##(1991-7#1)(1993-11#1)(1997-5#2)(2012-2#1)
of spatial light modulators (SLM's)##2##5##(2007-12#1)(2008-2#1)
of spatial light modulators##5##4##(2007-12#2)(2008-2#3)
of spatial location##2##3##(1995-12#1)(2008-10#1)
of spatial memory in##2##4##(1993-2#1)(1993-5#1)
of spatial memory##13##3##(1993-12#2)(1993-2#2)(1993-5#3)(1994-11#1)(1994-8#3)(2008-11#1)(2008-4#1)
of spatial mode##2##3##(2007-12#2)
of spatial organization##2##3##(1991-2#1)(1995-6#1)
of spatial pattern##2##3##(2007-9#1)(2008-10#1)
of spatial patterns##3##3##(2008-10#1)(2008-8#2)
of spatial proximity##2##3##(2008-7#2)
of spatial resolution##4##3##(1995-11#1)(2008-7#1)(2008-8#1)(2013-8#1)
of spatial scales##2##3##(2007-11#1)(2008-10#1)
of spatial solitary waves##2##4##(2007-12#1)(2008-1#1)
of spatial soliton pairs##2##4##(2007-12#2)
of spatial solitons in##5##4##(2007-11#1)(2007-12#4)
of spatial solitons##7##3##(2007-11#2)(2007-12#5)
of spatial variability##2##3##(2008-10#1)(2009-11#1)
of spatial working memory##3##4##(1992-11#1)(1994-5#1)(1994-8#1)
of spatial##171##2##(1991-11#1)(1991-12#1)(1991-2#4)(1991-7#1)(1992-11#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#3)(1993-5#4)(1994-11#1)(1994-5#1)(1994-8#5)(1995-11#1)(1995-12#2)(1995-4#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-5#2)(1997-6#2)(1997-8#1)(2006-4#1)(2007-11#11)(2007-12#23)(2007-5#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#23)(2008-11#4)(2008-2#10)(2008-3#11)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#10)(2008-9#1)(2009-11#2)(2009-2#1)(2009-3#1)(2009-9#2)(2010-12#2)(2010-4#1)(2011-1#1)(2011-11#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#5)
of spatial-temporal##2##2##(2007-12#1)(2008-2#1)
of spatially correlated extinctions##2##4##(2008-8#2)
of spatially referenced##3##3##(2008-10#3)
of spatially resolved##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
of spatially##23##2##(1991-3#1)(1995-11#1)(1996-9#1)(2007-10#1)(2007-11#1)(2007-12#4)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#3)(2010-10#1)(2011-2#1)(2013-8#1)
of spatiotemporal##6##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2013-7#1)
of spawning##5##2##(2010-8#5)
of spawnings##2##2##(2010-8#2)
of speaker##3##2##(2009-10#1)(2010-12#1)(2013-8#1)
of speakers##3##2##(2004-12#1)(2005-9#1)(2006-7#1)
of spear grass##2##3##(2006-8#2)
of special importance in##2##4##(2008-10#1)(2013-8#1)
of special interest for##6##4##(2007-11#1)(2008-10#1)(2011-2#3)(2013-8#1)
of special interest groups##2##4##(1996-3#1)(2008-5#1)
of special interest##20##3##(1990-9#1)(1991-11#1)(1996-3#1)(1996-6#1)(2006-12#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#8)(2013-8#1)
of special##58##2##(1990-6#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-6#2)(1991-8#1)(1992-7#1)(1994-3#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-8#2)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#9)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
of specialised cells##2##3##(1993-11#2)
of specialised##3##2##(1993-11#2)(2007-11#1)
of specialist services##2##3##(1993-12#1)(1993-8#1)
of specialist##14##2##(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1996-1#1)(2007-11#1)(2008-11#2)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
of specialistic##2##2##(2007-11#1)(2009-2#1)
of specialists in##2##3##(1996-5#1)(2011-1#1)
of specialists##10##2##(1990-10#1)(1991-2#1)(1996-5#1)(2005-11#1)(2006-7#1)(2007-11#2)(2007-8#2)(2011-1#1)
of specialization and##4##3##(1990-10#1)(2008-8#3)
of specialization in##2##3##(1993-12#1)(1993-2#1)
of specialization that##2##3##(2008-9#1)(2011-12#1)
of specialization##18##2##(1990-10#1)(1992-11#1)(1993-12#1)(1993-2#1)(1993-5#2)(2008-10#1)(2008-8#7)(2008-9#2)(2011-12#1)(2013-1#1)
of specialized cells##2##3##(2006-7#1)(2009-4#1)
of specialized equipment##2##3##(2010-4#1)(2013-8#1)
of specialized metabolites##2##3##(2011-2#2)
of specialized services##4##3##(1993-2#2)(1996-1#1)(2008-7#1)
of specialized training##2##3##(1994-12#1)(1996-11#1)
of specialized##39##2##(1990-6#1)(1991-2#1)(1991-3#1)(1993-2#3)(1994-12#1)(1994-2#1)(1995-1#1)(1996-1#1)(1996-11#1)(1996-2#1)(2005-8#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-10#1)(2008-11#2)(2008-2#2)(2008-5#1)(2008-7#2)(2008-9#3)(2009-4#1)(2009-6#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-11#2)(2012-2#1)(2012-3#1)(2013-8#1)
of specially##4##2##(1993-3#1)(1996-4#1)(1997-8#1)(2006-3#1)
of specialties##4##2##(1993-6#1)(2007-4#1)(2007-9#1)(2013-1#1)
of specialty and##2##3##(1993-6#2)
of specialty##11##2##(1991-2#1)(1991-6#3)(1993-6#2)(1995-12#1)(1996-3#1)(2007-12#1)(2007-4#1)(2009-9#1)
of speciation##21##2##(1996-6#1)(1996-8#1)(2006-5#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-8#6)(2008-9#1)(2010-3#1)(2010-8#1)(2013-1#3)
of species affected##2##3##(2007-6#1)(2012-2#1)
of species and##5##3##(1993-2#1)(2006-2#1)(2008-11#1)(2008-5#1)(2008-8#1)
of species at##2##3##(1997-5#1)(2008-10#1)
of species composition##3##3##(2012-2#1)(2013-7#1)(2013-8#1)
of species differences##3##3##(1994-9#1)(2005-8#1)(2012-2#1)
of species diversity##3##3##(2008-8#1)(2008-9#1)(2012-3#1)
of species from the##2##4##(2008-8#1)(2012-3#1)
of species from##7##3##(1995-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
of species has been##2##4##(2008-8#1)(2012-2#1)
of species has##3##3##(2008-10#1)(2008-8#1)(2012-2#1)
of species in a##3##4##(1991-8#1)(2008-8#2)
of species in the##3##4##(1995-2#1)(2007-12#2)
of species in##15##3##(1991-8#1)(1994-3#1)(1995-2#1)(2007-12#2)(2007-9#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#4)
of species is##3##3##(2006-8#1)(2008-8#1)(2013-1#1)
of species of##9##3##(1993-2#1)(1994-12#1)(2008-10#2)(2008-5#1)(2010-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
of species on##2##3##(2008-10#1)(2008-8#1)
of species relationships##2##3##(2008-6#1)(2013-1#1)
of species richness##2##3##(1994-3#1)(2008-5#1)
of species specificity##4##3##(1991-3#1)(2008-1#1)(2008-12#1)(2008-7#1)
of species that are##4##4##(2007-9#1)(2008-6#1)(2008-9#1)(2010-3#1)
of species that##8##3##(1991-6#1)(2007-3#1)(2007-9#1)(2008-6#1)(2008-9#1)(2009-4#1)(2010-3#1)(2010-6#1)
of species to##3##3##(2004-4#1)(2008-5#1)(2009-8#1)
of species with##5##3##(2008-10#1)(2008-9#1)(2010-3#1)(2010-8#1)(2011-1#1)
of species within a##2##4##(2008-8#1)(2010-2#1)
of species within##3##3##(2008-8#1)(2010-10#1)(2010-2#1)
of species##174##2##(1991-3#1)(1991-6#1)(1991-8#3)(1993-2#3)(1993-3#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-4#2)(1997-5#1)(1997-7#1)(2004-4#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-2#2)(2006-8#1)(2007-12#2)(2007-2#1)(2007-3#3)(2007-5#4)(2007-6#1)(2007-9#2)(2008-1#1)(2008-10#22)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#14)(2008-6#2)(2008-7#1)(2008-8#16)(2008-9#12)(2009-4#1)(2009-5#2)(2009-8#2)(2010-10#2)(2010-2#2)(2010-3#2)(2010-4#3)(2010-6#6)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#4)(2013-7#6)(2013-8#3)
of species-specific##4##2##(1997-5#1)(2008-10#2)(2009-5#1)
of species-tree##2##2##(2010-6#2)
of specific B##2##3##(1992-7#1)(2008-4#1)
of specific BCR-ABL##2##3##(1996-2#2)
of specific DNA##4##3##(1990-6#1)(1991-4#1)(2008-5#1)(2009-2#1)
of specific IgE in##2##4##(1990-12#2)
of specific IgE##4##3##(1990-12#2)(1992-8#1)(2008-10#1)
of specific IgG##3##3##(1992-8#2)(2012-12#1)
of specific activity##2##3##(1994-9#1)(1995-3#1)
of specific alleles##2##3##(1992-1#1)(2008-9#1)
of specific and##3##3##(2006-8#1)(2008-4#1)(2010-4#1)
of specific antibodies against##3##4##(2008-4#1)(2008-7#1)(2011-1#1)
of specific antibodies##7##3##(1992-8#1)(1997-6#1)(2008-4#2)(2008-7#1)(2011-1#1)(2013-7#1)
of specific antibody##4##3##(1992-8#2)(1995-6#1)(2008-10#1)
of specific antigens##2##3##(1990-4#1)(2006-6#1)
of specific antiviral##2##3##(2010-7#1)(2011-1#1)
of specific aspects of##2##4##(1991-3#1)(2008-8#1)
of specific assays##2##3##(2007-11#1)(2010-3#1)
of specific binding sites for##6##5##(1990-11#1)(1990-3#2)(1990-5#1)(1990-8#1)(1992-7#1)
of specific binding sites##8##4##(1990-11#1)(1990-3#2)(1990-5#1)(1990-8#1)(1991-4#1)(1992-12#1)(1992-7#1)
of specific binding##12##3##(1990-11#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-8#1)(1991-4#1)(1992-12#1)(1992-7#1)(1997-2#1)(2008-1#1)(2012-12#1)
of specific biological##4##3##(2008-1#1)(2008-7#1)(2010-12#1)(2010-5#1)
of specific brain regions##2##4##(1997-5#2)
of specific brain##3##3##(1997-5#2)(2009-7#1)
of specific cell surface##2##4##(1992-8#1)(2005-7#1)
of specific cell types##4##4##(1996-6#1)(1997-4#1)(2008-4#2)
of specific cell##8##3##(1992-8#1)(1996-6#1)(1997-4#1)(2005-7#1)(2007-8#1)(2008-11#1)(2008-4#2)
of specific cells##2##3##(2008-2#1)(2008-7#1)
of specific cellular##4##3##(1992-9#1)(2004-11#1)(2007-11#1)(2010-12#1)
of specific changes in##2##4##(1994-6#1)(1996-1#1)
of specific changes##3##3##(1994-6#1)(1996-1#1)(2008-11#1)
of specific chemical##2##3##(2006-8#1)(2010-12#1)
of specific combinations of##2##4##(1994-9#1)(2008-10#1)
of specific complications##2##3##(2007-12#1)(2013-1#1)
of specific components of the##2##5##(2008-4#1)(2009-10#1)
of specific compounds##5##3##(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2010-2#1)
of specific cytokine##2##3##(1992-11#1)(2012-2#1)
of specific developmental##2##3##(2004-10#1)(2008-9#1)
of specific diseases##4##3##(2008-9#1)(2010-8#1)(2012-2#1)(2013-1#1)
of specific drug##2##3##(2007-11#1)(2011-3#1)
of specific elements##3##3##(1995-4#1)(1996-5#1)(2006-4#1)
of specific factors##2##3##(2008-11#1)(2008-9#1)
of specific gene expression##2##4##(1996-11#1)(1997-4#1)
of specific gene products##2##4##(1991-4#1)(1995-11#1)
of specific gene##9##3##(1991-4#1)(1995-11#2)(1996-11#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-8#1)(2012-2#1)
of specific genes is##2##4##(1991-5#1)(2007-10#1)
of specific genes##17##3##(1991-12#1)(1991-5#1)(1993-2#1)(1994-3#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-4#3)(2008-7#2)(2009-5#1)(2009-8#1)(2010-11#1)(2012-12#1)
of specific genetic##3##3##(1996-5#1)(1997-4#1)(2008-7#1)
of specific glycosyltransferases##2##3##(1994-11#1)(2010-12#1)
of specific growth##3##3##(2008-11#2)(2008-9#1)
of specific immune##2##3##(1996-12#1)(2011-2#1)
of specific infectious##2##3##(2007-2#1)(2008-1#1)
of specific inhibitors##3##3##(1995-2#1)(1996-5#1)(2008-10#1)
of specific interaction##2##3##(1990-5#1)(2008-10#1)
of specific interactions between the##2##5##(1992-12#1)(2008-3#1)
of specific interactions between##3##4##(1992-12#1)(2008-3#1)(2013-1#1)
of specific interest##2##3##(2008-11#1)(2009-4#1)
of specific intervention##3##3##(2006-10#1)(2007-9#1)(2011-2#1)
of specific interventions##3##3##(1995-6#1)(2006-7#1)(2007-9#1)
of specific intracellular##3##3##(2006-2#1)(2009-2#1)(2010-9#1)
of specific ion##2##3##(1991-11#1)(2007-12#1)
of specific issues##2##3##(2007-8#1)(2012-3#1)
of specific mRNAs##2##3##(2007-8#1)(2012-12#1)
of specific markers for##3##4##(2008-9#2)(2012-11#1)
of specific molecular##2##3##(2008-11#1)(2008-4#1)
of specific molecules within##2##4##(2008-1#1)(2012-1#1)
of specific molecules##3##3##(2008-1#1)(2008-3#1)(2012-1#1)
of specific monoclonal##2##3##(2008-8#1)(2012-3#1)
of specific mutations##2##3##(2008-10#1)(2008-4#1)
of specific myofascial##2##3##(2007-11#1)(2009-1#1)
of specific neural systems##2##4##(1996-6#1)(2008-4#1)
of specific neuronal##3##3##(1996-3#1)(2010-12#1)(2010-9#1)
of specific neurons##2##3##(1994-5#1)(2007-12#1)
of specific nuclear##2##3##(1995-2#1)(2012-2#1)
of specific nutrients##4##3##(1991-11#1)(2006-2#1)(2007-12#1)(2012-1#1)
of specific operative##2##3##(2006-10#1)(2009-5#1)
of specific parameters##2##3##(1990-3#1)(1991-5#1)
of specific pathogen-free##2##3##(1997-6#1)(2008-5#1)
of specific peptide##3##3##(1993-11#1)(1995-3#1)(2008-4#1)
of specific primers and##2##4##(2008-10#2)
of specific primers##6##3##(2005-11#1)(2008-10#3)(2013-8#2)
of specific problems##4##3##(1994-2#1)(2006-1#1)(2006-10#1)(2008-7#1)
of specific procedures##2##3##(1995-8#1)(2006-10#1)
of specific protein##5##3##(1991-9#1)(1994-12#1)(1996-10#1)(2008-4#2)
of specific proteins in##2##4##(1993-11#1)(2010-11#1)
of specific proteins##14##3##(1992-4#1)(1993-11#1)(1997-6#1)(2006-10#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2010-11#2)
of specific receptors##2##3##(2007-11#1)(2008-4#1)
of specific regions##2##3##(1992-6#1)(2008-4#1)
of specific residues##3##3##(1990-8#1)(1995-3#1)(1997-7#1)
of specific risk factors##2##4##(2006-10#1)(2008-1#1)
of specific sensory##3##3##(1996-3#1)(2007-12#1)(2012-1#1)
of specific sites##2##3##(1994-12#1)(2010-8#1)
of specific substrates##3##3##(2008-1#1)(2008-2#1)(2012-12#1)
of specific surface##2##3##(2005-11#1)(2005-12#1)
of specific symptoms##2##3##(2007-11#1)(2012-1#1)
of specific therapeutic##2##3##(1990-4#1)(2006-10#1)
of specific therapy##2##3##(2007-11#1)(2008-4#1)
of specific transcription##3##3##(1993-3#1)(1995-2#1)(1996-8#1)
of specific transcripts##2##3##(1991-7#1)(1996-2#1)
of specific transport##3##3##(1995-8#1)(2006-10#2)
of specific treatment##3##3##(1997-2#1)(2007-5#1)(2008-9#1)
of specific treatments##2##3##(1995-12#1)(2008-9#1)
of specific types of##2##4##(2007-8#1)(2009-8#1)
of specific##597##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#5)(1990-4#2)(1990-5#6)(1990-6#2)(1990-7#3)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#4)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#5)(1991-5#5)(1991-6#2)(1991-7#2)(1991-9#1)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#3)(1992-8#9)(1992-9#2)(1993-11#3)(1993-12#3)(1993-2#3)(1993-3#3)(1993-4#1)(1993-5#1)(1993-8#2)(1993-9#1)(1994-1#2)(1994-10#1)(1994-11#4)(1994-12#3)(1994-2#2)(1994-3#4)(1994-5#2)(1994-6#5)(1994-8#1)(1994-9#5)(1995-1#1)(1995-11#6)(1995-12#1)(1995-2#6)(1995-3#5)(1995-4#1)(1995-5#1)(1995-6#5)(1995-7#1)(1995-8#2)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#4)(1996-5#6)(1996-6#2)(1996-7#1)(1996-8#2)(1997-1#3)(1997-2#4)(1997-3#2)(1997-4#6)(1997-5#2)(1997-6#4)(1997-7#2)(2004-10#1)(2004-11#3)(2004-12#2)(2004-2#1)(2004-3#1)(2004-4#2)(2005-11#3)(2005-12#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#18)(2006-12#4)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#4)(2007-10#3)(2007-11#11)(2007-12#14)(2007-2#5)(2007-3#3)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#14)(2007-9#3)(2008-1#13)(2008-10#30)(2008-11#16)(2008-12#1)(2008-2#11)(2008-3#10)(2008-4#33)(2008-5#5)(2008-6#4)(2008-7#18)(2008-8#7)(2008-9#13)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#4)(2009-7#4)(2009-8#4)(2009-9#2)(2010-10#1)(2010-11#4)(2010-12#7)(2010-2#5)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#8)(2011-3#1)(2012-1#6)(2012-11#3)(2012-12#11)(2012-2#11)(2012-3#4)(2012-7#1)(2013-1#7)(2013-7#5)(2013-8#5)
of specific-pathogen-free (SPF)##2##3##(2013-8#2)
of specific-pathogen-free chickens##2##3##(1997-6#1)(2008-5#1)
of specific-pathogen-free##4##2##(1997-6#1)(2008-5#1)(2013-8#2)
of specifically bound##2##3##(1992-9#1)(2008-10#1)
of specifically##12##2##(1991-5#1)(1992-9#1)(1994-3#1)(1995-11#1)(1995-12#1)(2008-10#2)(2008-4#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-2#1)
of specification##2##2##(2008-8#1)(2011-2#1)
of specifications for##2##3##(2008-1#1)(2008-3#1)
of specificity and##3##3##(1992-6#1)(2008-10#1)(2008-5#1)
of specificity for##2##3##(1991-6#1)(1992-6#1)
of specificity in##2##3##(2007-3#1)(2008-10#1)
of specificity##21##2##(1990-1#1)(1991-6#1)(1992-6#2)(1994-11#1)(1994-6#2)(1995-10#1)(1996-3#1)(2005-8#1)(2007-3#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-6#1)(2013-1#1)(2013-8#1)
of specified##3##2##(1995-2#1)(2006-12#1)(2008-10#1)
of specimen##5##2##(1993-12#2)(2004-2#1)(2008-4#1)(2009-7#1)
of specimens and##2##3##(2005-12#1)(2008-11#1)
of specimens from##3##3##(2008-4#1)(2008-5#1)(2011-2#1)
of specimens of##4##3##(1995-8#1)(2007-11#1)(2008-10#1)(2010-1#1)
of specimens using##2##3##(2008-12#1)(2012-2#1)
of specimens were##2##3##(1996-12#1)(2013-7#1)
of specimens##27##2##(1990-6#1)(1991-12#1)(1995-8#1)(1996-12#2)(2004-11#1)(2005-12#1)(2007-1#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
of speckle patterns##4##3##(2008-2#2)(2008-3#2)
of speckle##22##2##(2006-5#1)(2007-12#2)(2008-2#13)(2008-3#4)(2010-2#1)(2013-1#1)
of speckled##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
of speckles##3##2##(2008-2#2)(2008-3#1)
of spectra for##2##3##(1997-2#1)(2008-3#1)
of spectra is##2##3##(2008-10#2)
of spectra##19##2##(1997-2#1)(2006-5#1)(2007-12#3)(2008-10#7)(2008-2#2)(2008-3#2)(2008-6#1)(2008-8#1)(2011-1#1)
of spectral and##3##3##(2007-1#1)(2008-3#1)(2010-3#1)
of spectral data##9##3##(1990-11#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#1)
of spectral extinction##2##3##(2008-3#2)
of spectral hole burning##2##4##(2007-11#1)(2007-12#1)
of spectral image##2##3##(2007-12#2)
of spectral interference##2##3##(2007-12#1)(2008-3#1)
of spectral interferences##4##3##(2006-12#1)(2008-10#2)(2011-1#1)
of spectral lines##2##3##(2008-3#1)(2013-8#1)
of spectral phase interferometry for direct electric-field reconstruction##3##8##(2007-12#3)
of spectral##73##2##(1990-11#1)(1993-6#1)(1996-5#1)(2006-10#1)(2006-12#1)(2007-1#3)(2007-11#7)(2007-12#13)(2007-5#1)(2007-8#1)(2008-10#13)(2008-11#2)(2008-2#5)(2008-3#13)(2008-5#2)(2008-6#1)(2008-7#1)(2010-3#1)(2011-1#1)(2012-12#1)(2013-8#3)
of spectral-domain OCT##4##3##(2011-7#4)
of spectrally decomposed##2##3##(2007-12#2)
of spectrally distinct##3##3##(2007-12#1)(2008-2#1)(2008-9#1)
of spectrally resolved##3##3##(2007-12#1)(2008-2#2)
of spectrally##11##2##(1996-7#1)(2007-12#5)(2008-2#4)(2008-9#1)
of spectrin##4##2##(1990-3#1)(1991-4#2)(1993-11#1)
of spectrograms##2##2##(2007-11#1)(2009-9#1)
of spectrophotometric data##3##3##(2008-10#3)
of spectrophotometric method##2##3##(2008-10#2)
of spectrophotometric##7##2##(2008-10#5)(2008-3#1)(2011-1#1)
of spectroscopic data##3##3##(2006-12#1)(2007-11#1)(2008-10#1)
of spectroscopic methods##2##3##(2007-1#1)(2009-2#1)
of spectroscopic techniques##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
of spectroscopic##20##2##(1991-8#1)(1992-9#1)(1994-3#1)(1994-8#1)(2006-12#1)(2007-1#1)(2007-11#2)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2009-2#1)(2013-1#1)
of spectroscopy##4##2##(1997-6#1)(2005-4#1)(2012-1#2)
of spectrum##3##2##(2008-3#1)(2013-8#2)
of speculation##4##2##(1996-12#1)(1997-8#1)(2008-4#1)(2013-1#1)
of speech and language##3##4##(1995-1#1)(2007-8#1)(2011-1#1)
of speech and music##2##4##(2008-9#1)(2012-1#1)
of speech and##8##3##(1995-1#1)(2007-8#1)(2008-9#1)(2011-1#2)(2012-1#2)(2012-2#1)
of speech in##4##3##(2008-11#1)(2011-1#3)
of speech perception##3##3##(2008-11#1)(2008-9#1)(2009-2#1)
of speech recognition##2##3##(2007-12#1)(2008-9#1)
of speech was##2##3##(2007-3#1)(2011-1#1)
of speech##52##2##(1990-3#1)(1990-5#1)(1991-11#1)(1995-1#1)(2006-12#1)(2006-2#1)(2007-10#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-4#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2011-1#12)(2012-1#3)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)
of speech-recognition technology##2##3##(2007-12#2)
of speed and##2##3##(1991-12#1)(2008-10#1)
of speed##11##2##(1991-12#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-4#2)(2011-1#1)(2012-1#1)
of spelling##2##2##(2009-2#1)(2009-7#1)
of spending##5##2##(1991-2#2)(2010-11#2)(2010-2#1)
of spent cell culture medium##2##5##(1994-5#2)
of spent##4##2##(1994-5#2)(2008-10#1)(2008-11#1)
of sperm and##2##3##(2012-12#1)(2012-2#1)
of sperm cells##4##3##(2006-10#1)(2008-12#3)
of sperm competition in##2##4##(2008-8#1)(2009-6#1)
of sperm competition##5##3##(2008-8#1)(2009-6#2)(2013-1#2)
of sperm from##2##3##(1995-11#1)(2007-12#1)
of sperm motility were##2##4##(2006-5#1)(2008-7#1)
of sperm motility##5##3##(1992-7#1)(1993-9#2)(2006-5#1)(2008-7#1)
of sperm movement##2##3##(2008-12#1)(2008-5#1)
of sperm storage##3##3##(2007-12#3)
of sperm transfer##2##3##(1995-2#1)(2007-12#1)
of sperm whale myoglobin##5##4##(1993-3#2)(1993-6#2)(1994-5#1)
of sperm whale##6##3##(1993-3#2)(1993-6#2)(1994-5#2)
of sperm with##2##3##(1992-8#2)
of sperm##71##2##(1990-10#1)(1990-11#1)(1990-9#1)(1991-8#1)(1992-7#4)(1992-8#3)(1993-3#2)(1993-6#2)(1993-9#2)(1994-5#2)(1995-11#1)(1995-2#1)(1996-9#1)(1997-4#1)(2006-10#1)(2006-5#6)(2007-12#5)(2007-9#2)(2008-12#5)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-6#2)(2011-1#3)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#5)(2013-1#3)(2013-8#1)
of sperm-oocyte##2##2##(2006-5#1)(2012-2#1)
of spermatic cord torsion##3##4##(2006-10#2)(2008-10#1)
of spermatic##5##2##(2006-10#3)(2008-10#1)(2008-5#1)
of spermatid##2##2##(1991-9#1)(2012-2#1)
of spermatids##6##2##(1992-7#2)(2008-7#2)(2012-12#2)
of spermatocytes##4##2##(2006-5#1)(2009-10#1)(2012-2#1)(2013-1#1)
of spermatodesms##4##2##(2008-7#4)
of spermatogenesis and##6##3##(2006-5#1)(2007-9#1)(2008-4#1)(2008-8#1)(2011-1#1)(2012-2#1)
of spermatogenesis are##2##3##(2009-10#1)(2012-2#1)
of spermatogenesis by##2##3##(2008-4#1)(2010-11#1)
of spermatogenesis in reptiles##2##4##(2012-2#2)
of spermatogenesis in the##2##4##(1996-8#1)(2012-2#1)
of spermatogenesis in##5##3##(1996-8#1)(2012-2#4)
of spermatogenesis##41##2##(1992-12#1)(1992-5#1)(1996-8#1)(2006-5#2)(2007-12#1)(2007-3#1)(2007-9#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-10#4)(2010-11#1)(2010-5#1)(2011-1#1)(2012-12#2)(2012-2#16)(2013-8#2)
of spermatogenic cells##3##3##(1990-11#1)(2008-5#1)(2012-2#1)
of spermatogenic##5##2##(1990-11#1)(2008-5#1)(2012-2#3)
of spermatozoa in##2##3##(1994-5#1)(2006-5#1)
of spermatozoa of the rove beetle Aleochara##2##7##(2007-12#1)(2008-7#1)
of spermatozoa of the##3##4##(2007-12#1)(2008-7#2)
of spermatozoa of##5##3##(2007-12#2)(2008-7#3)
of spermatozoa##28##2##(1991-6#1)(1994-2#1)(1994-5#1)(2006-5#6)(2007-12#2)(2008-6#1)(2008-7#7)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
of spermiation##3##2##(2012-2#3)
of spermidine and spermine##2##4##(2008-8#1)(2009-8#1)
of spermidine##6##2##(1990-10#1)(1991-10#1)(1991-4#1)(2006-10#1)(2008-8#1)(2009-8#1)
of spermidine/spermine N1-acetyltransferase##3##3##(1991-9#1)(1992-10#1)(1994-12#1)
of spermine and##2##3##(1990-7#1)(1991-4#1)
of spermine##8##2##(1990-10#1)(1990-7#1)(1991-4#1)(1992-11#2)(1994-8#1)(1996-2#1)(2008-8#1)
of spermiogenesis##8##2##(1990-11#1)(2007-12#3)(2008-7#3)(2012-2#1)
of sphenoid##3##2##(1990-9#1)(2007-6#2)
of spheres deposited on a##2##5##(2008-3#2)
of spheres with##2##3##(2008-2#2)
of spheres##20##2##(2006-2#1)(2007-12#1)(2008-2#7)(2008-3#11)
of spherical aberration caused by##2##5##(2008-2#1)(2008-3#1)
of spherical aberration is##2##4##(2007-12#2)
of spherical aberration on##4##4##(2008-2#1)(2008-3#2)(2009-4#1)
of spherical aberration##10##3##(2007-12#3)(2008-2#2)(2008-3#4)(2009-4#1)
of spherical aberrations##2##3##(2008-2#1)(2008-3#1)
of spherical and##6##3##(1990-3#1)(1991-9#1)(2007-12#1)(2008-2#2)(2008-3#1)
of spherical holographic gratings recorded by use of a##2##9##(2008-2#2)
of spherical microcavities##2##3##(2007-12#2)
of spherical monodisperse magnetite particles##2##5##(1992-12#2)
of spherical particles##7##3##(2005-11#3)(2007-12#1)(2008-2#2)(2008-7#1)
of spherical silica particles##2##4##(2005-11#2)
of spherical##58##2##(1990-2#1)(1990-3#1)(1991-9#1)(1992-12#2)(1993-12#1)(1995-2#1)(1996-1#1)(2005-11#7)(2006-10#1)(2006-12#1)(2006-5#1)(2007-12#10)(2008-10#3)(2008-11#1)(2008-2#11)(2008-3#13)(2008-7#1)(2009-4#1)
of spheroidal##2##2##(2008-2#1)(2008-7#1)
of sphincter##3##2##(1996-9#1)(2006-2#1)(2011-2#1)
of sphinganine##3##2##(1992-11#2)(2008-10#1)
of sphingoid##3##2##(1996-3#2)(2008-5#1)
of sphingolipid##2##2##(1991-4#1)(1995-1#1)
of sphingolipids##4##2##(1992-11#1)(1996-3#1)(1997-7#1)(2008-5#1)
of sphingomyelin##6##2##(1992-6#1)(1994-12#1)(1997-7#3)(2007-12#1)
of sphingomyelinase in##2##3##(1992-6#2)
of sphingomyelinase##6##2##(1992-6#2)(1996-5#2)(2008-8#1)(2009-9#1)
of sphingosine kinase##3##3##(2006-12#1)(2009-9#2)
of sphingosine##10##2##(1990-10#2)(1992-6#1)(1994-3#2)(1995-2#1)(2006-12#2)(2009-9#2)
of spices##3##2##(2008-11#1)(2011-2#2)
of spider toxins##2##3##(2006-12#2)
of spider##9##2##(2006-12#4)(2007-12#1)(2007-6#1)(2008-7#1)(2012-2#1)(2012-3#1)
of spike##12##2##(1990-7#2)(1993-12#1)(1997-6#1)(2008-1#1)(2008-10#4)(2008-11#2)(2012-1#1)
of spike-wave discharges##2##3##(1993-7#2)
of spike-wave##3##2##(1990-5#1)(1993-7#2)
of spiked samples and##3##4##(2008-10#3)
of spiked samples ranged from##2##5##(2007-8#1)(2008-10#1)
of spiked samples were found##2##5##(2008-10#2)
of spiked samples were##4##4##(2008-10#4)
of spiked samples##12##3##(1997-3#1)(2007-8#1)(2008-10#9)(2008-7#1)
of spiked tap##2##3##(2008-10#2)
of spiked water samples##5##4##(2007-8#1)(2008-10#4)
of spiked##31##2##(1992-8#2)(1997-2#1)(1997-3#1)(2006-12#1)(2007-8#3)(2008-10#21)(2008-7#1)(2011-1#1)
of spikelet##2##2##(2008-12#1)(2008-9#1)
of spikes in##2##3##(1990-4#1)(1994-10#1)
of spikes##12##2##(1990-4#1)(1991-6#1)(1994-10#1)(1994-3#1)(1996-12#1)(2004-11#2)(2008-10#2)(2008-11#1)(2009-8#2)
of spiking neurons##2##3##(2008-11#1)(2008-2#1)
of spiking##6##2##(2008-11#2)(2008-2#2)(2009-8#1)(2011-2#1)
of spilled##2##2##(2008-10#1)(2012-2#1)
of spin finishes##2##3##(2010-8#2)
of spin systems and sequential##2##5##(1995-5#1)(2008-8#1)
of spin##15##2##(1994-5#1)(1995-5#1)(1996-2#1)(1997-4#1)(2006-7#1)(2007-11#2)(2008-1#1)(2008-8#1)(2009-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2012-2#1)
of spin-flip##2##2##(2008-1#1)(2012-2#1)
of spin-labeled##6##2##(1992-3#1)(1993-3#1)(1994-5#2)(1997-7#1)(2006-10#1)
of spinach carbonic anhydrase##2##4##(1994-11#2)
of spinach chloroplasts##2##3##(1995-2#1)(2005-10#1)
of spinach thioredoxins f and m and of##2##8##(1995-6#2)
of spinach##23##2##(1990-5#1)(1991-8#1)(1992-12#2)(1993-6#1)(1994-11#4)(1994-12#1)(1994-9#1)(1995-2#1)(1995-6#3)(2005-10#1)(2008-10#3)(2008-9#4)
of spinal 5-HT1A receptors##3##4##(1997-7#3)
of spinal and##3##3##(1996-3#1)(2006-10#1)(2007-11#1)
of spinal anesthesia in##4##4##(2006-10#1)(2007-7#1)(2012-3#2)
of spinal anesthesia##8##3##(2006-10#1)(2007-7#2)(2012-3#5)
of spinal arteriovenous malformations##2##4##(2008-7#2)
of spinal arteriovenous##3##3##(2006-6#1)(2008-7#2)
of spinal bone##2##3##(2005-3#1)(2007-11#1)
of spinal canal endoscopy##2##4##(2006-8#2)
of spinal canal##5##3##(2006-8#2)(2007-11#1)(2007-8#2)
of spinal cord compression and##2##5##(1990-6#1)(2007-11#1)
of spinal cord compression caused by##2##6##(1991-9#1)(1993-11#1)
of spinal cord compression##13##4##(1990-6#1)(1991-9#1)(1992-12#1)(1993-11#1)(2006-2#1)(2007-11#5)(2008-10#1)(2008-7#2)
of spinal cord glioma##2##4##(1995-9#1)(2007-2#1)
of spinal cord injured##2##4##(1996-9#1)(2011-2#1)
of spinal cord injury##9##4##(1991-12#1)(1996-11#1)(2005-11#1)(2006-7#1)(2007-11#1)(2007-7#1)(2009-4#1)(2010-2#2)
of spinal cord stimulation##8##4##(1991-2#1)(1997-2#2)(2006-8#4)(2013-1#1)
of spinal cord was##2##4##(2008-5#2)
of spinal cord##56##3##(1990-6#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-11#1)(1994-10#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-9#2)(1997-2#2)(1997-6#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#4)(2007-11#8)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-4#1)(2010-2#2)(2011-2#1)(2013-1#2)
of spinal curvature##3##3##(2007-8#3)
of spinal deformations##2##3##(2007-8#1)(2012-2#1)
of spinal deformity##2##3##(2006-8#1)(2007-8#1)
of spinal development##2##3##(2006-11#1)(2007-4#1)
of spinal disorders##3##3##(2007-1#1)(2007-7#1)(2008-8#1)
of spinal endoscopic adhesiolysis##2##4##(2006-8#2)
of spinal epidural hematoma##2##4##(2007-3#1)(2008-7#1)
of spinal fusion and##2##4##(2007-7#1)(2012-3#1)
of spinal fusion##9##3##(2005-2#3)(2007-7#2)(2008-8#2)(2009-3#1)(2012-3#1)
of spinal injuries##2##3##(2007-11#1)(2009-4#1)
of spinal injury##4##3##(2007-11#2)(2011-2#2)
of spinal instability##3##3##(2007-11#2)(2008-11#1)
of spinal intramedullary##2##3##(2012-2#2)
of spinal metastases##8##3##(1994-10#1)(2006-2#3)(2007-11#3)(2008-7#1)
of spinal metastatic##3##3##(2006-2#1)(2007-11#2)
of spinal mu##2##3##(1994-10#1)(1995-7#1)
of spinal nerve roots##2##4##(2006-12#1)(2013-1#1)
of spinal nerve##3##3##(2006-12#2)(2013-1#1)
of spinal nociceptive##2##3##(1990-2#1)(1991-5#1)
of spinal orthoses##2##3##(2007-8#2)
of spinal pain##3##3##(2006-7#1)(2006-8#1)(2009-5#1)
of spinal reflex##2##3##(1996-1#1)(2005-8#1)
of spinal stability##3##3##(2006-2#1)(2010-12#1)(2013-7#1)
of spinal trauma##2##3##(2007-11#2)
of spinal tuberculosis##5##3##(2007-11#1)(2010-12#4)
of spinal##203##2##(1990-2#1)(1990-6#2)(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-11#1)(1994-10#3)(1994-6#1)(1995-12#1)(1995-5#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#1)(1996-3#1)(1996-9#2)(1997-2#2)(1997-6#1)(1997-7#3)(1997-8#2)(2005-11#1)(2005-2#3)(2005-3#1)(2005-8#2)(2006-10#7)(2006-11#1)(2006-12#2)(2006-2#6)(2006-6#3)(2006-7#2)(2006-8#12)(2007-1#2)(2007-11#31)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#8)(2007-8#13)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#8)(2008-8#4)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#1)(2010-12#5)(2010-2#2)(2011-2#4)(2012-2#5)(2012-3#7)(2013-1#4)(2013-7#1)(2013-8#2)
of spindle cell##3##3##(1990-12#1)(1991-8#1)(2008-6#1)
of spindle cells and##2##4##(2012-12#1)(2012-2#1)
of spindle cells##4##3##(1996-9#1)(2007-7#1)(2012-12#1)(2012-2#1)
of spindle##10##2##(1990-12#1)(1991-8#1)(1996-9#1)(1997-6#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-6#1)(2012-12#1)(2012-2#1)
of spindle-shaped##2##2##(1990-5#1)(2008-5#1)
of spindles##3##2##(1992-9#3)
of spine and##3##3##(2006-10#1)(2007-11#1)(2007-8#1)
of spine curve##4##3##(2007-8#4)
of spine deformation in##2##4##(2007-8#2)
of spine deformation##3##3##(2007-8#3)
of spine##29##2##(1990-12#1)(1994-10#1)(1995-6#1)(2006-10#1)(2007-11#5)(2007-7#1)(2007-8#14)(2008-1#1)(2009-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
of spines##8##2##(1995-7#2)(1995-8#2)(2008-11#3)(2013-7#1)
of spinfilter rotation velocity##2##4##(2008-11#2)
of spinning##2##2##(2007-11#1)(2007-9#1)
of spinocerebellar ataxias##3##3##(2008-6#3)
of spinocerebellar##5##2##(2005-8#1)(2006-11#1)(2008-6#3)
of spiral computed##2##3##(1995-2#1)(2008-7#1)
of spiral##7##2##(1995-2#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-7#1)(2012-3#1)
of spirit##3##2##(2007-8#1)(2009-5#1)(2013-1#1)
of spirits##2##2##(1993-9#1)(2008-10#1)
of spiritual##6##2##(2006-4#1)(2008-4#1)(2010-11#1)(2010-2#3)
of spirituality and religiosity##2##4##(2008-4#2)
of spirituality and##4##3##(2008-4#2)(2010-11#1)(2013-1#1)
of spirituality in nursing##3##4##(2008-4#3)
of spirituality in##6##3##(2008-12#2)(2008-4#4)
of spirituality on health##2##4##(2006-3#1)(2008-4#1)
of spirituality##24##2##(2006-3#1)(2008-11#1)(2008-12#3)(2008-4#11)(2010-11#2)(2012-12#1)(2013-1#5)
of spiro##2##2##(2007-11#2)
of spiro[imidazolidine-4##2##2##(1992-5#2)
of spirometric##2##2##(1990-9#1)(2010-8#1)
of spirometry in##3##3##(2006-5#2)(2008-1#1)
of spirometry##8##2##(2006-5#6)(2008-1#1)(2009-6#1)
of spironolactone##6##2##(2005-7#1)(2008-10#3)(2012-12#2)
of spiroplasma##2##2##(2008-10#2)
of spiroplasmas##3##2##(2008-10#3)
of splanchnic##2##2##(1996-3#1)(2006-12#1)
of splash##2##2##(2008-10#2)
of splashed rain##4##3##(2008-10#4)
of spleen cells##8##3##(1991-12#1)(1995-9#1)(1996-12#1)(2006-8#1)(2007-2#1)(2008-11#1)(2008-4#1)(2008-7#1)
of spleen in##2##3##(1992-2#1)(2008-10#1)
of spleen lymphocytes in##2##4##(1990-9#2)
of spleen lymphocytes##4##3##(1990-9#4)
of spleen##26##2##(1990-12#1)(1990-9#4)(1991-12#1)(1992-2#1)(1995-11#1)(1995-9#1)(1996-12#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#3)(2010-12#1)(2012-2#1)
of splenectomy##4##2##(1992-10#1)(2012-12#1)(2012-2#1)(2012-3#1)
of splenic abscess##2##3##(1991-5#1)(2006-2#1)
of splenic injury##2##3##(2007-4#2)
of splenic lymphoid tissue##2##4##(2008-7#1)(2010-12#1)
of splenic macrophages to##2##4##(1995-10#1)(2006-8#1)
of splenic rupture##4##3##(1992-2#1)(2007-4#1)(2011-12#1)(2011-2#1)
of splenic tissue##2##3##(1992-10#1)(2010-12#1)
of splenic##34##2##(1991-10#1)(1991-5#1)(1992-10#1)(1992-2#2)(1993-12#1)(1995-10#1)(1997-3#1)(1997-8#1)(2006-2#2)(2006-8#1)(2007-2#1)(2007-4#3)(2008-10#1)(2008-11#4)(2008-4#1)(2008-7#3)(2010-12#3)(2011-1#1)(2011-12#1)(2011-2#2)(2012-3#2)
of splenocyte##2##2##(2008-10#1)(2008-4#1)
of splenocytes from##3##3##(1991-12#1)(1995-2#1)(2012-1#1)
of splenocytes was##2##3##(1995-12#1)(1995-2#1)
of splenocytes##16##2##(1991-1#1)(1991-12#3)(1991-8#1)(1993-12#1)(1995-12#1)(1995-2#2)(2007-2#1)(2008-10#4)(2010-12#1)(2012-1#1)
of splenomegaly##6##2##(2007-12#1)(2007-3#2)(2007-4#1)(2011-2#1)(2012-2#1)
of spliceosomal##2##2##(1990-11#1)(1995-8#1)
of spliceosomes##2##2##(1991-6#1)(2013-8#1)
of splicing##14##2##(1991-2#2)(1991-5#1)(1991-6#2)(1992-5#1)(1993-8#1)(1997-4#2)(2007-12#1)(2008-8#2)(2010-12#2)
of spline wavelet least square##2##5##(2008-10#2)
of spline wavelet##3##3##(2008-10#3)
of split rice spikelet##2##4##(2008-8#2)
of split##9##2##(1990-5#1)(1994-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#2)(2012-3#1)
of spoilage##4##2##(1997-4#1)(2008-10#3)
of spoken language##2##3##(2006-2#1)(2008-9#1)
of spoken word##2##3##(2008-11#1)(2008-9#1)
of spoken##4##2##(2006-2#1)(2008-11#1)(2008-9#2)
of spondylarthritis]##2##2##(1990-6#2)
of spondyloarthritis##2##2##(2010-12#1)(2012-12#1)
of spondylodesis##2##2##(2007-11#1)(2007-7#1)
of spondylodiscitis##2##2##(1996-8#1)(2006-10#1)
of spondylolisthesis##5##2##(2007-11#3)(2007-6#1)(2007-7#1)
of spondylolysis##4##2##(1996-6#2)(2007-7#1)(2009-3#1)
of sponges##5##2##(2004-9#4)(2011-2#1)
of spontaneous Brillouin##2##3##(2007-11#1)(2008-3#1)
of spontaneous P-cell activity##2##4##(1995-7#2)
of spontaneous P-cell##3##3##(1995-7#3)
of spontaneous PC##2##3##(2008-7#2)
of spontaneous activity##8##3##(1992-7#1)(1995-6#1)(1995-7#1)(1996-9#1)(2008-11#1)(2013-1#1)(2013-8#2)
of spontaneous and induced##2##4##(1994-3#1)(2008-7#1)
of spontaneous and##6##3##(1990-3#1)(1991-11#1)(1994-3#1)(2007-12#1)(2008-11#1)(2008-7#1)
of spontaneous atherosclerosis##2##3##(2008-1#1)(2009-10#1)
of spontaneous bacterial peritonitis and##2##5##(2006-8#1)(2011-2#1)
of spontaneous bacterial peritonitis##3##4##(2006-8#1)(2009-8#1)(2011-2#1)
of spontaneous bacterial##4##3##(2006-8#2)(2009-8#1)(2011-2#1)
of spontaneous bleeding##2##3##(2009-9#2)
of spontaneous circulation##6##3##(1990-12#1)(1993-8#1)(2006-10#1)(2007-3#3)
of spontaneous cleavage##2##3##(1993-3#2)
of spontaneous emission from##2##4##(2007-11#2)
of spontaneous emission in##2##4##(2007-11#1)(2008-3#1)
of spontaneous emission rates##3##4##(2007-11#3)
of spontaneous emission##10##3##(1993-5#1)(2007-11#7)(2008-3#2)
of spontaneous hypertensive##2##3##(1996-3#1)(2011-1#1)
of spontaneous intraventricular haemorrhage##3##4##(2008-7#3)
of spontaneous oscillations##2##3##(1992-12#1)(1997-1#1)
of spontaneous pneumothorax##8##3##(2006-10#1)(2007-8#4)(2008-7#3)
of spontaneous regression##2##3##(2006-8#1)(2012-2#1)
of spontaneous remission##2##3##(2008-10#1)(2010-2#1)
of spontaneous renal artery dissection with##2##6##(1992-7#2)
of spontaneous revertants in##2##4##(1995-6#2)
of spontaneous rupture of the##3##5##(1990-2#1)(2007-8#1)(2011-12#1)
of spontaneous speech##2##3##(2008-10#1)(2008-4#1)
of spontaneous splenic rupture##3##4##(1992-2#2)(1993-9#1)
of spontaneous##173##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-2#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-2#2)(1992-7#3)(1993-10#1)(1993-12#2)(1993-3#3)(1993-5#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#3)(1994-5#1)(1995-11#1)(1995-6#4)(1995-7#4)(1995-8#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-11#9)(2007-12#5)(2007-3#4)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#12)(2009-10#1)(2009-12#1)(2009-8#1)(2009-9#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2011-1#3)(2011-12#2)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#3)
of spontaneously hypertensive rats (SHR)##2##5##(1991-2#1)(1997-5#1)
of spontaneously hypertensive rats##5##4##(1991-2#2)(1997-5#1)(2010-12#1)(2012-1#1)
of spontaneously hypertensive##8##3##(1991-2#2)(1992-3#1)(1996-5#1)(1997-5#1)(2010-12#1)(2012-1#2)
of spontaneously##17##2##(1991-2#2)(1992-3#1)(1992-7#1)(1994-12#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-5#1)(2007-12#1)(2010-12#1)(2010-3#2)(2012-1#2)(2012-12#1)
of sporadic PD##3##3##(2008-11#2)(2008-7#1)
of sporadic colorectal cancer##3##4##(1990-5#1)(1992-3#1)(2010-12#1)
of sporadic forms of##2##4##(1993-10#1)(2008-7#1)
of sporadic##21##2##(1990-5#2)(1991-5#1)(1992-3#1)(1993-10#1)(1994-7#1)(1996-3#1)(2004-2#1)(2007-12#2)(2007-4#1)(2008-11#2)(2008-4#1)(2008-7#2)(2009-12#1)(2010-12#1)(2011-2#1)(2012-11#1)(2013-1#1)
of sporamin in the foam##2##5##(2008-6#2)
of sporamin##3##2##(2008-6#3)
of sporangia and zoospores in##2##5##(2008-10#2)
of sporangia and zoospores of##2##5##(2008-10#2)
of sporangia and zoospores##6##4##(2008-10#6)
of sporangia of##3##3##(2008-10#3)
of sporangia produced##3##3##(2008-10#3)
of sporangia##23##2##(2007-7#1)(2008-10#22)
of sporangiophores##2##2##(2008-10#2)
of spore deposition of##2##4##(2008-10#2)
of spore deposition##6##3##(2008-10#6)
of spore dispersal##2##3##(2008-10#2)
of spore germination and outgrowth##2##5##(2011-2#2)
of spore germination in##2##4##(1994-5#2)
of spore germination##7##3##(1994-5#3)(2011-2#3)(2013-1#1)
of spore##27##2##(1993-6#1)(1994-5#4)(2008-10#17)(2011-2#4)(2013-1#1)
of spore-forming bacteria##3##3##(2011-2#3)
of spores from a##2##4##(2008-10#2)
of spores from##5##3##(2007-5#1)(2008-10#4)
of spores in water##2##4##(2008-10#2)
of spores in##3##3##(1997-4#1)(2008-10#2)
of spores of Bacillus cereus##2##5##(2011-2#2)
of spores of##6##3##(2006-8#1)(2008-10#2)(2008-5#1)(2011-2#2)
of spores##43##2##(1993-6#1)(1997-4#1)(2006-8#1)(2007-5#1)(2008-10#24)(2008-4#1)(2008-5#2)(2008-8#1)(2009-8#1)(2010-10#2)(2010-2#1)(2010-5#1)(2011-2#6)
of sport research##3##3##(2013-7#3)
of sport##12##2##(1993-3#1)(2008-10#1)(2008-6#1)(2009-5#1)(2009-9#3)(2012-2#1)(2013-7#4)
of sporting##2##2##(2013-1#2)
of sports and##5##3##(1997-3#1)(2008-10#1)(2009-7#1)(2013-1#2)
of sports medicine##2##3##(1994-7#1)(1995-8#1)
of sports nutrition##2##3##(2008-5#2)
of sports##17##2##(1993-3#1)(1994-7#1)(1995-8#2)(1995-9#1)(1996-6#1)(1997-3#1)(2007-6#1)(2008-10#1)(2008-5#2)(2009-7#1)(2010-11#1)(2012-6#1)(2013-1#3)
of sports-related injuries##4##3##(1995-8#2)(2013-1#2)
of sporulating lesions##3##3##(2008-10#3)
of sporulating##7##2##(2008-10#6)(2008-8#1)
of sporulation by light##2##4##(2008-10#2)
of sporulation##17##2##(1990-11#1)(1990-12#1)(1995-6#2)(1995-9#1)(2005-11#1)(2008-10#9)(2011-2#2)
of spot arrays##2##3##(2008-3#2)
of spot blotch##2##3##(2008-10#2)
of spot##8##2##(2006-4#1)(2006-5#1)(2008-10#3)(2008-3#2)(2008-5#1)
of spots##7##2##(2007-12#1)(2008-3#1)(2008-9#1)(2010-12#1)(2010-2#2)(2012-2#1)
of spotted fever##2##3##(1991-8#1)(2009-2#1)
of spotted##3##2##(1991-8#1)(2006-12#1)(2009-2#1)
of spousal influence##2##3##(2007-12#2)
of spousal##3##2##(2007-12#2)(2012-11#1)
of spouse##3##2##(1991-10#1)(2006-9#1)(2008-1#1)
of spouses##2##2##(1993-4#1)(2011-2#1)
of spray and point inoculation##2##5##(2008-10#2)
of spray##6##2##(2008-10#4)(2008-3#1)(2010-12#1)
of spread and##4##3##(1991-12#1)(2008-7#1)(2008-8#2)
of spread in##2##3##(1996-10#1)(1996-5#1)
of spread of the##4##4##(2005-12#1)(2008-10#2)(2011-2#1)
of spread of##14##3##(1991-6#1)(2005-12#1)(2007-2#1)(2008-1#1)(2008-10#5)(2008-8#1)(2009-2#1)(2011-1#2)(2011-2#1)
of spread was##2##3##(2008-10#1)(2009-2#1)
of spread##39##2##(1991-12#1)(1991-6#1)(1996-10#1)(1996-5#1)(2005-12#1)(2005-4#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#15)(2008-7#1)(2008-8#5)(2009-2#2)(2011-1#2)(2011-12#1)(2011-2#2)(2013-8#2)
of spreading depression##4##3##(1990-2#1)(1993-7#1)(1996-5#2)
of spreading##17##2##(1990-12#1)(1990-2#2)(1991-8#1)(1993-7#1)(1996-5#2)(2004-12#1)(2005-11#4)(2006-10#1)(2008-10#1)(2009-10#1)(2009-6#1)(2012-2#1)
of spring##6##2##(1996-12#1)(2006-6#1)(2008-10#2)(2008-12#1)(2013-1#1)
of sprouts##2##2##(1997-5#1)(2008-11#1)
of spruce##9##2##(2005-10#1)(2008-10#2)(2008-5#4)(2013-1#2)
of spun and unspun fibers##2##5##(2007-12#2)
of spun fibers##3##3##(2007-11#3)
of spun##5##2##(2007-11#3)(2007-12#2)
of sputter-deposited##2##2##(2008-2#2)
of sputtered##3##2##(2008-2#2)(2008-7#1)
of sputum from##3##3##(1997-1#1)(2007-11#1)(2012-2#1)
of sputum##13##2##(1991-11#1)(1991-12#1)(1997-1#1)(2007-11#1)(2007-8#2)(2008-3#1)(2009-1#1)(2010-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
of squalene synthase##3##3##(1994-9#1)(1995-2#1)(2005-7#1)
of squalene##8##2##(1992-5#1)(1994-3#1)(1994-9#1)(1995-2#1)(2005-7#1)(2008-10#1)(2008-5#1)(2010-5#1)
of squamous and adenosquamous##2##4##(1996-9#2)
of squamous cell carcinoma and##3##5##(1993-8#1)(2008-12#1)(2012-3#1)
of squamous cell carcinoma of the##2##6##(2010-9#1)(2012-2#1)
of squamous cell carcinoma of##3##5##(2010-9#1)(2011-12#1)(2012-2#1)
of squamous cell carcinoma with sarcomatous stroma##2##7##(2008-5#2)
of squamous cell carcinoma##22##4##(1991-6#1)(1993-8#1)(1993-9#1)(2006-12#1)(2007-8#2)(2008-12#1)(2008-5#2)(2008-9#1)(2009-5#1)(2010-8#1)(2010-9#1)(2011-12#2)(2011-2#3)(2012-2#1)(2012-3#2)(2013-8#1)
of squamous cell carcinomas##5##4##(1990-10#1)(1997-3#1)(2005-11#2)(2011-2#1)
of squamous cell lung##2##4##(1997-7#1)(2012-2#1)
of squamous cell papilloma of the##2##6##(2008-9#2)
of squamous cell papilloma##5##4##(2008-9#5)
of squamous cell##38##3##(1990-10#1)(1991-6#1)(1993-8#1)(1993-9#1)(1997-3#1)(1997-7#1)(2005-11#2)(2006-12#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-5#2)(2008-9#8)(2009-5#1)(2010-8#1)(2010-9#1)(2011-12#3)(2011-2#4)(2012-2#2)(2012-3#2)(2013-8#1)
of squamous intraepithelial lesions##3##4##(2006-10#2)(2012-1#1)
of squamous##46##2##(1990-10#1)(1991-2#1)(1991-6#1)(1993-8#1)(1993-9#1)(1996-9#2)(1997-3#1)(1997-7#1)(2005-11#2)(2006-10#3)(2006-12#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-5#2)(2008-9#8)(2009-5#1)(2010-8#1)(2010-9#1)(2011-12#3)(2011-2#5)(2012-1#1)(2012-2#2)(2012-3#2)(2013-8#1)
of squamous-cell carcinoma##4##3##(1992-10#1)(1993-9#2)(2007-11#1)
of squamous-cell##5##2##(1992-10#1)(1992-9#1)(1993-9#2)(2007-11#1)
of square wave voltammetry##3##4##(2008-10#3)
of square wave##4##3##(2008-10#4)
of square##10##2##(2007-12#1)(2007-8#1)(2008-10#5)(2008-2#2)(2009-2#1)
of square-law##2##2##(2007-11#1)(2008-2#1)
of squares##8##2##(1994-5#1)(1995-12#1)(1996-1#1)(2008-10#2)(2008-7#1)(2010-2#1)(2013-1#1)
of squeezing and##2##3##(2007-12#1)(2009-6#1)
of squeezing##3##2##(2007-12#2)(2009-6#1)
of squid##2##2##(1994-3#1)(1997-4#1)
of src##6##2##(1992-5#2)(1992-9#1)(1994-3#1)(1994-8#1)(1996-2#1)
of src-related protein##2##3##(1992-11#2)
of src-related##3##2##(1992-11#2)(1994-12#1)
of srebf1a##2##2##(2012-2#2)
of ssDNA##5##2##(1991-5#2)(1996-7#1)(2008-10#1)(2012-2#1)
of stabilisation##3##2##(1991-2#1)(2007-8#1)(2008-10#1)
of stability and##4##3##(2007-2#1)(2008-10#1)(2008-8#1)(2009-10#1)
of stability constants for##3##4##(2008-10#3)
of stability constants of##7##4##(2008-10#7)
of stability constants##16##3##(2008-10#16)
of stability in##2##3##(1996-6#1)(2008-5#1)
of stability of a##2##4##(1992-12#1)(2008-11#1)
of stability of the##3##4##(1993-8#1)(2007-8#1)(2008-11#1)
of stability of##6##3##(1992-12#1)(1993-8#1)(2007-8#1)(2008-10#1)(2008-11#2)
of stability to##2##3##(1992-9#1)(2008-6#1)
of stability was##2##3##(2005-11#1)(2008-2#1)
of stability##51##2##(1991-4#2)(1992-12#1)(1992-9#1)(1993-8#1)(1995-8#1)(1996-6#1)(1996-7#1)(2005-11#1)(2005-4#1)(2006-2#1)(2006-3#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#22)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#2)(2009-10#1)(2011-1#1)(2013-7#1)
of stabilization and##3##3##(1990-8#1)(2007-8#2)
of stabilization of the##2##4##(2008-3#1)(2008-5#1)
of stabilization of##3##3##(2007-11#1)(2008-3#1)(2008-5#1)
of stabilization##15##2##(1990-8#1)(1994-11#1)(1995-10#1)(1995-4#1)(1995-5#1)(2005-11#1)(2007-11#2)(2007-7#1)(2007-8#3)(2008-3#1)(2008-5#1)(2008-9#1)
of stabilized##5##2##(1997-4#1)(2008-10#2)(2008-2#1)(2010-4#1)
of stabilizing agents##2##3##(2006-9#2)
of stabilizing and destabilizing##2##4##(1995-5#1)(1997-7#1)
of stabilizing selection##3##3##(2008-8#2)(2008-9#1)
of stabilizing##12##2##(1995-5#1)(1997-7#1)(2006-9#2)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2012-3#1)
of stable and unstable##3##4##(2007-1#1)(2007-8#1)(2008-2#1)
of stable and##10##3##(1991-3#1)(1994-8#1)(2007-1#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)
of stable carbon##2##3##(2006-5#2)
of stable cell lines##3##4##(2008-1#1)(2008-11#1)(2008-2#1)
of stable cell##4##3##(1994-5#1)(2008-1#1)(2008-11#1)(2008-2#1)
of stable disease##7##3##(2006-11#1)(2006-12#1)(2008-6#5)
of stable glycosylated##2##3##(1991-2#2)
of stable isotope##3##3##(2008-6#1)(2010-8#1)(2012-12#1)
of stable transfectants##3##3##(2008-11#1)(2008-2#1)(2008-4#1)
of stable##112##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-2#2)(1991-3#1)(1992-7#1)(1992-9#1)(1993-12#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-11#1)(1997-4#1)(1997-6#2)(2004-1#1)(2005-11#2)(2006-10#3)(2006-11#1)(2006-12#2)(2006-4#1)(2006-5#2)(2007-1#1)(2007-11#5)(2007-12#5)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#7)(2008-11#7)(2008-2#6)(2008-3#3)(2008-4#5)(2008-5#2)(2008-6#7)(2008-7#1)(2008-9#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)
of stably transfected##2##3##(2008-11#1)(2008-2#1)
of stably##4##2##(2008-11#2)(2008-2#1)(2008-8#1)
of stachyose in Chinese artichoke##3##5##(2008-10#3)
of stachyose in##4##3##(2008-10#4)
of stachyose##5##2##(2008-10#5)
of stacked##6##2##(1994-9#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)
of stacking##7##2##(1991-11#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-3#1)(2008-4#1)
of staff and##3##3##(1993-2#1)(2005-5#1)(2008-11#1)
of staff development##3##3##(1994-1#2)(2008-9#1)
of staff in##4##3##(1994-7#1)(2011-2#3)
of staff members##3##3##(2005-5#1)(2007-2#1)(2007-4#1)
of staff to##2##3##(1991-11#1)(2008-12#1)
of staff who##4##3##(2008-11#3)(2013-8#1)
of staff##48##2##(1991-11#1)(1991-12#3)(1992-12#1)(1993-12#1)(1993-2#1)(1994-1#2)(1994-2#1)(1994-7#1)(1995-1#2)(1997-2#1)(2005-12#1)(2005-5#3)(2005-7#1)(2007-11#2)(2007-2#2)(2007-4#1)(2007-5#1)(2008-1#1)(2008-11#5)(2008-12#2)(2008-9#1)(2009-7#1)(2010-10#1)(2011-12#2)(2011-2#6)(2012-11#1)(2013-7#1)(2013-8#2)
of staffing and##2##3##(1996-11#1)(2012-3#1)
of stage I##6##3##(1990-2#1)(1995-10#1)(2007-8#3)(2013-7#1)
of stage IA##3##3##(2007-8#2)(2008-1#1)
of stage II and##2##4##(1994-7#1)(2007-4#1)
of stage II##10##3##(1991-7#1)(1993-11#1)(1994-12#1)(1994-7#1)(2006-6#1)(2007-4#1)(2009-10#2)(2012-1#1)(2012-12#1)
of stage III##3##3##(1994-8#1)(2007-11#1)(2012-1#1)
of stage IV##3##3##(1990-6#1)(2006-7#1)(2011-12#1)
of stage and##2##3##(2011-2#2)
of stage at diagnosis##2##4##(1990-12#1)(2012-3#1)
of stage##41##2##(1990-12#1)(1990-2#1)(1990-6#2)(1991-7#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-7#1)(1994-8#1)(1995-10#1)(1996-3#1)(2004-1#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-4#1)(2007-8#5)(2008-1#1)(2008-4#1)(2008-8#3)(2009-10#2)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-3#2)(2013-7#1)
of staged##3##2##(1997-3#2)(2009-2#1)
of stages##3##2##(1995-1#1)(1996-5#1)(2009-2#1)
of staghorn calculi##2##3##(1990-12#1)(2007-7#1)
of staging##3##2##(2007-8#1)(2008-8#1)(2013-1#1)
of stained##5##2##(1990-10#1)(1993-12#1)(1994-5#1)(2008-9#1)(2010-2#1)
of staining for##2##3##(1991-3#1)(1992-12#1)
of staining was##2##3##(1990-5#1)(1992-8#1)
of staining with##2##3##(1994-2#2)
of staining##15##2##(1990-5#1)(1990-8#1)(1991-3#1)(1992-12#1)(1992-8#1)(1994-2#2)(1994-3#1)(1995-12#1)(1997-6#1)(2006-2#1)(2007-12#1)(2008-5#1)(2008-7#1)(2012-7#1)
of stains##3##2##(2005-11#1)(2006-2#1)(2008-5#1)
of stakeholder management##2##3##(1993-3#1)(2008-1#1)
of stakeholder##5##2##(1993-3#1)(1995-1#1)(2004-10#1)(2008-1#1)(2013-1#1)
of stakeholders in##3##3##(2008-5#2)(2013-1#1)
of stakeholders##12##2##(1995-3#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
of stalk##4##2##(1993-6#1)(2008-8#2)(2011-12#1)
of stalled transcription complexes##2##4##(1996-8#1)(1997-5#1)
of stallion semen##2##3##(2006-5#2)
of stallion##3##2##(2006-5#3)
of stallions##2##2##(2006-5#2)
of stamen##2##2##(2008-8#1)(2009-8#1)
of staminate##2##2##(2012-3#2)
of stance balance performance##2##4##(1994-1#2)
of stance##3##2##(1994-1#2)(2012-1#1)
of stand##2##2##(2008-10#1)(2013-8#1)
of stand-alone body image treatments##2##5##(2007-12#2)
of stand-alone body image##3##4##(2007-12#3)
of stand-alone##4##2##(2007-12#4)
of stand-by therapy##2##3##(1993-8#2)
of standard addition##2##3##(2008-10#2)
of standard additions##8##3##(2007-8#1)(2008-10#7)
of standard and##7##3##(1991-5#1)(1995-5#1)(2008-2#2)(2010-10#1)(2011-2#1)(2012-12#1)
of standard curves##3##3##(1993-11#1)(1996-6#1)(2008-5#1)
of standard data##4##3##(2013-1#4)
of standard drink##2##3##(2009-7#2)
of standard fiber##3##3##(2007-12#2)(2008-3#1)
of standard in vitro##2##4##(2008-4#1)(2008-5#1)
of standard language##2##3##(2007-4#1)(2010-9#1)
of standard methods##2##3##(1997-6#2)
of standard optical##3##3##(2007-11#1)(2007-12#1)(2007-8#1)
of standard precautions##2##3##(2012-1#2)
of standard proteins##2##3##(1996-8#1)(2008-10#1)
of standard reference materials and##2##5##(2007-8#1)(2008-10#1)
of standard reference materials##8##4##(2007-8#1)(2008-10#7)
of standard reference##9##3##(2007-8#1)(2008-10#8)
of standard samples##2##3##(2008-10#2)
of standard single-mode##2##3##(2007-12#2)
of standard solutions##4##3##(2008-10#3)(2012-11#1)
of standard therapy##2##3##(1995-2#1)(2007-11#1)
of standard##165##2##(1991-5#1)(1991-8#1)(1993-11#1)(1993-8#1)(1994-5#1)(1994-6#4)(1995-2#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-6#2)(1996-8#1)(1997-1#1)(1997-6#2)(2005-1#1)(2005-11#1)(2005-8#2)(2006-10#1)(2006-5#2)(2006-6#3)(2007-1#3)(2007-11#5)(2007-12#11)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#3)(2008-10#39)(2008-11#2)(2008-2#7)(2008-3#6)(2008-4#4)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#3)(2010-10#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
of standardised##3##2##(2008-11#1)(2008-12#1)(2008-3#1)
of standardization in##2##3##(1990-12#1)(2008-9#1)
of standardization##13##2##(1990-12#1)(1992-5#1)(1992-9#1)(1996-12#1)(2008-10#2)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
of standardized extract##2##3##(2013-1#2)
of standardized##30##2##(1991-11#2)(1992-11#1)(1994-5#1)(1996-1#1)(2004-12#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#4)
of standardizing##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2010-9#1)
of standards and##5##3##(1994-12#1)(2008-10#1)(2008-11#1)(2012-12#1)(2012-3#1)
of standards for##6##3##(1996-9#1)(2007-4#1)(2008-3#1)(2008-9#1)(2009-9#1)(2010-4#1)
of standards in##2##3##(2009-2#1)(2013-1#1)
of standards that##2##3##(1994-3#1)(2004-12#1)
of standards##35##2##(1994-12#2)(1994-3#1)(1995-2#1)(1996-9#2)(1997-7#1)(2004-12#3)(2004-3#1)(2007-4#2)(2007-8#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
of standards)##2##2##(1991-5#1)(2008-10#1)
of standing estrus##2##3##(2006-5#1)(2013-1#1)
of standing##8##2##(2006-5#1)(2007-10#1)(2007-12#1)(2008-2#1)(2010-8#1)(2012-1#1)(2013-1#2)
of staphylococcal nuclease##9##3##(1991-7#2)(1992-6#2)(1994-9#2)(1995-4#2)(1997-2#1)
of staphylococcal protein A##3##4##(1990-12#1)(1992-7#1)(1994-12#1)
of staphylococcal##14##2##(1990-12#1)(1991-7#3)(1992-6#2)(1992-7#1)(1994-12#1)(1994-9#2)(1995-4#2)(1997-2#1)(2012-12#1)
of staphylococcus aureus in##2##4##(2010-12#1)(2010-8#1)
of staple foods with FA##2##5##(2012-12#2)
of staple##3##2##(1991-12#1)(2012-12#2)
of staplers from##2##3##(1990-4#1)(2010-8#1)
of starch and##2##3##(2004-8#1)(2008-5#1)
of starch in##3##3##(2006-12#1)(2008-10#2)
of starch with##2##3##(1991-7#1)(2008-10#1)
of starch##22##2##(1991-7#1)(1997-4#1)(2004-8#1)(2006-12#4)(2008-10#5)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-4#1)
of starch-based##2##2##(2005-11#1)(2010-4#1)
of starchy foods##2##3##(1991-5#1)(2012-1#1)
of starfish coelomocytes##2##3##(1991-10#2)
of starfish##3##2##(1991-10#2)(2008-4#1)
of staring##2##2##(2008-3#2)
of stars##4##2##(1996-5#1)(2007-9#2)(2008-3#1)
of starting material##3##3##(2007-10#1)(2008-1#2)
of starting the##2##3##(2007-7#1)(2010-8#1)
of starting treatment##3##3##(1991-9#1)(2007-7#1)(2007-8#1)
of starting##19##2##(1991-4#1)(1991-8#1)(1991-9#1)(1992-2#1)(1993-8#1)(1997-2#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#3)(2010-8#1)
of startle##7##2##(1991-1#1)(1996-5#1)(2008-11#2)(2008-4#3)
of starvation and##2##3##(1995-6#1)(2008-4#1)
of starvation the##3##3##(2013-1#3)
of starvation##16##2##(1991-2#1)(1995-6#1)(1996-8#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-9#1)(2013-1#7)
of stat##2##2##(1993-1#1)(1996-5#1)
of state 3##3##3##(1994-12#2)(2005-11#1)
of state and federal##2##4##(1995-2#1)(1997-3#1)
of state and##6##3##(1995-2#1)(1996-3#1)(1997-3#1)(2005-11#1)(2011-1#1)(2012-3#1)
of state anxiety##4##3##(1990-8#3)(2010-6#1)
of state hospital##2##3##(1991-4#1)(1996-9#1)
of state of##2##3##(1994-10#1)(2007-12#1)
of state space##2##3##(2008-11#1)(2008-2#1)
of state variables and##3##4##(2008-11#2)(2008-2#1)
of state variables##4##3##(2008-11#2)(2008-2#1)(2009-12#1)
of state##55##2##(1990-12#1)(1990-8#3)(1991-4#1)(1993-1#1)(1993-4#1)(1994-10#1)(1994-12#3)(1994-2#3)(1995-12#1)(1995-2#2)(1996-12#1)(1996-3#2)(1996-5#1)(1996-9#2)(1997-1#1)(1997-3#2)(1997-8#3)(2005-11#2)(2007-10#2)(2007-12#1)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-2#2)(2010-6#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-2#1)(2012-3#1)
of state-dependent##2##2##(2008-8#2)
of state-of-the-art##4##2##(2007-5#1)(2008-2#1)(2008-9#1)(2012-2#1)
of statements##3##2##(1996-11#1)(2007-8#1)(2012-12#1)
of states in##4##3##(1995-3#1)(1997-3#1)(2009-11#1)(2011-2#1)
of states that##3##3##(1997-2#1)(2008-12#1)(2010-12#1)
of states##18##2##(1990-10#1)(1991-6#1)(1991-9#1)(1995-3#1)(1997-1#1)(1997-2#1)(1997-3#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-11#4)(2010-12#1)(2011-2#1)
of static and dynamic##5##4##(1990-6#1)(1994-3#1)(2007-11#1)(2007-7#1)(2008-3#1)
of static and##9##3##(1990-6#1)(1994-3#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-2#1)(2008-3#2)(2009-1#1)
of static extraction and 5##2##5##(2008-10#2)
of static venous##2##3##(2007-7#2)
of static##37##2##(1990-10#1)(1990-6#1)(1991-9#1)(1993-8#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1996-9#1)(1997-7#1)(2005-4#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-7#3)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-1#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-1#1)
of statin therapy##4##3##(2008-3#1)(2008-7#1)(2009-11#1)(2013-8#1)
of statin treatment##2##3##(2007-8#1)(2009-5#1)
of statin##8##2##(2007-8#1)(2008-3#1)(2008-7#1)(2009-11#3)(2009-5#1)(2013-8#1)
of statins and##3##3##(2008-12#1)(2009-6#1)(2012-2#1)
of statins in##5##3##(2009-11#1)(2012-1#1)(2013-1#3)
of statins##25##2##(1997-2#1)(2005-7#1)(2006-10#2)(2006-5#1)(2007-1#1)(2008-1#1)(2008-12#1)(2009-11#1)(2009-6#3)(2010-10#3)(2010-2#1)(2012-1#1)(2012-2#1)(2013-1#7)
of station 3##2##3##(2007-8#2)
of station##3##2##(2006-5#1)(2007-8#2)
of stationary phase in##2##4##(2007-12#1)(2008-10#1)
of stationary phase##7##3##(2007-12#1)(2008-10#4)(2008-11#1)(2012-12#1)
of stationary##12##2##(2007-12#2)(2008-10#4)(2008-11#2)(2008-2#1)(2009-8#1)(2012-1#1)(2012-12#1)
of statistical analysis of the##2##5##(1990-3#1)(2008-9#1)
of statistical analysis##7##3##(1990-3#1)(1997-8#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-9#1)(2011-2#1)
of statistical and##3##3##(1993-12#1)(2007-12#1)(2008-3#1)
of statistical data##2##3##(1995-1#1)(2008-10#1)
of statistical geometry##2##3##(1997-6#2)
of statistical methods for##3##4##(1996-8#1)(1997-4#1)(2012-3#1)
of statistical methods##8##3##(1995-12#1)(1996-8#1)(1997-1#1)(1997-4#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-3#1)
of statistical models for##2##4##(2008-4#1)(2010-1#1)
of statistical power##3##3##(1996-12#1)(2006-10#1)(2010-12#1)
of statistical process control##3##4##(1995-2#1)(2008-10#1)(2008-3#1)
of statistical significance##4##3##(1991-2#1)(2005-10#1)(2007-4#1)(2009-7#1)
of statistical tests for##2##4##(1997-3#1)(2009-4#1)
of statistical tests##3##3##(1997-3#2)(2009-4#1)
of statistical tools##2##3##(1993-3#1)(2008-10#1)
of statistical##72##2##(1990-3#1)(1991-12#1)(1991-2#1)(1992-2#1)(1993-12#1)(1993-3#1)(1993-4#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-12#2)(1996-8#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-4#1)(2009-7#2)(2010-1#1)(2010-12#2)(2010-2#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
of statistically significant##3##3##(1990-8#1)(2006-12#1)(2008-7#1)
of statistically##6##2##(1990-8#1)(1994-12#1)(2006-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
of statistics in##3##3##(1996-3#1)(2008-10#1)(2013-8#1)
of statistics##13##2##(1992-2#1)(1996-3#1)(2005-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-4#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
of status asthmaticus##2##3##(2007-2#2)
of status##11##2##(2006-4#1)(2007-2#2)(2008-12#3)(2008-8#1)(2009-3#1)(2009-4#1)(2009-8#1)(2012-12#1)
of statutory##3##2##(1996-3#1)(1996-8#1)(2008-11#1)
of staurosporine##5##2##(1992-3#1)(1994-2#1)(1995-12#2)(1995-3#1)
of stavudine##3##2##(2008-5#1)(2008-7#1)(2010-7#1)
of stay (LOS)##17##3##(1990-8#1)(1991-12#1)(1993-12#3)(1994-12#1)(1994-3#1)(1995-3#1)(1997-1#1)(2004-1#1)(2006-1#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-3#1)(2011-2#1)
of stay among the##2##4##(1992-2#1)(2012-3#1)
of stay among##3##3##(1992-2#1)(2011-2#1)(2012-3#1)
of stay and##15##3##(1990-12#1)(1993-3#1)(1995-12#2)(1995-3#1)(1996-3#1)(2006-1#1)(2006-4#1)(2007-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
of stay are##2##3##(1996-1#1)(2006-10#1)
of stay by##2##3##(1992-3#1)(1995-3#1)
of stay decreased##2##3##(1993-1#1)(2007-8#1)
of stay in hospital##5##4##(1990-6#1)(1992-5#1)(1996-1#1)(2011-2#1)(2013-1#1)
of stay in the##7##4##(1996-2#1)(2006-10#2)(2007-5#1)(2009-8#1)(2010-2#1)(2012-2#1)
of stay in##16##3##(1990-6#1)(1992-5#1)(1996-1#1)(1996-2#1)(2006-10#3)(2007-12#1)(2007-5#1)(2008-3#2)(2009-8#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
of stay of##6##3##(1991-1#1)(1992-12#1)(2006-10#1)(2008-8#1)(2012-12#1)(2013-1#1)
of stay to##2##3##(2010-8#1)(2012-2#1)
of stay was also##2##4##(2006-10#1)(2006-12#1)
of stay was##9##3##(1992-12#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-3#1)(2011-2#1)(2012-2#1)
of stay were##2##3##(1994-3#1)(1996-3#1)
of stay which##2##3##(1994-12#1)(2012-2#1)
of stay##152##2##(1990-12#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-3#1)(1992-1#2)(1992-12#4)(1992-2#2)(1992-3#4)(1992-5#1)(1993-1#3)(1993-12#8)(1993-2#2)(1993-3#2)(1994-12#3)(1994-3#5)(1995-1#2)(1995-12#3)(1995-3#5)(1996-1#2)(1996-2#1)(1996-3#2)(1997-1#3)(1997-2#1)(2004-1#1)(2006-1#2)(2006-10#8)(2006-12#2)(2006-4#1)(2006-8#1)(2007-10#4)(2007-11#1)(2007-12#3)(2007-5#2)(2007-8#7)(2007-9#3)(2008-11#1)(2008-3#5)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-2#2)(2010-8#2)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#13)(2012-3#4)(2013-1#10)(2013-8#2)
of steady state##7##3##(1993-12#1)(1996-3#1)(2008-10#2)(2008-6#1)(2008-7#2)
of steady states##2##3##(1996-8#1)(2007-9#1)
of steady##10##2##(1993-12#1)(1996-3#1)(1996-8#1)(2006-10#1)(2007-9#1)(2008-10#2)(2008-6#1)(2008-7#2)
of steady-state##14##2##(1990-12#1)(1990-7#1)(1991-7#1)(1993-11#1)(1993-4#1)(1994-5#1)(1995-6#1)(1996-9#1)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#1)(2012-12#1)
of stealth liposomes##5##3##(1991-9#5)
of stealth##6##2##(1991-9#6)
of steam##2##2##(2006-6#1)(2009-10#1)
of steam-exploded poplar biomass##2##4##(2008-6#2)
of stearic acid monolayer##2##4##(2005-11#2)
of stearic acid##5##3##(1991-3#1)(1996-4#1)(2005-11#3)
of steatosis##4##2##(2006-10#1)(2007-8#1)(2012-2#1)(2013-1#1)
of steel##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2013-1#1)
of steep##3##2##(2007-12#1)(2007-9#1)(2008-10#1)
of steering##3##2##(2006-6#1)(2007-12#1)(2008-3#1)
of steering-wheel##2##2##(1994-6#1)(2007-4#1)
of steers##2##2##(2012-2#2)
of stellar scintillation##3##3##(2008-2#1)(2008-3#2)
of stellar##5##2##(1996-5#1)(2008-2#1)(2008-3#3)
of stellate ganglion##2##3##(1995-12#1)(2006-12#1)
of stellate##4##2##(1994-10#1)(1995-12#1)(2006-12#1)(2008-11#1)
of stem and progenitor cells in##2##6##(2010-12#1)(2012-2#1)
of stem and progenitor cells##5##5##(2006-6#1)(2009-4#1)(2010-12#1)(2012-12#1)(2012-2#1)
of stem and progenitor##6##4##(1995-12#1)(2006-6#1)(2009-4#1)(2010-12#1)(2012-12#1)(2012-2#1)
of stem and##9##3##(1995-12#1)(2006-6#1)(2008-10#3)(2009-4#1)(2010-12#1)(2012-12#1)(2012-2#1)
of stem canker##3##3##(2008-10#3)
of stem cell based therapy and tissue engineering in the regeneration of the##2##13##(2008-5#2)
of stem cell derived hepatocytes##2##5##(2008-1#2)
of stem cell fate##3##4##(2008-11#1)(2009-3#1)(2010-11#1)
of stem cell research##3##4##(2010-11#1)(2012-12#2)
of stem cell therapy##3##4##(2012-1#1)(2013-1#2)
of stem cell transplantation##4##4##(2005-8#1)(2008-10#1)(2010-12#1)(2010-8#1)
of stem cell##38##3##(1995-1#1)(2005-11#1)(2005-8#1)(2007-10#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#4)(2008-5#3)(2008-6#2)(2009-12#1)(2009-3#3)(2010-11#2)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
of stem cell-based##4##3##(2012-12#4)
of stem cells and##5##4##(2008-11#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-11#1)
of stem cells are##2##4##(2008-11#1)(2010-6#1)
of stem cells for##4##4##(2006-10#1)(2008-11#2)(2012-12#1)
of stem cells from##4##4##(2008-11#1)(2008-8#1)(2008-9#1)(2012-1#1)
of stem cells in##7##4##(1990-12#1)(2007-8#1)(2008-1#1)(2008-5#1)(2012-12#2)(2012-2#1)
of stem cells into##2##4##(2008-11#2)
of stem cells to the##2##5##(2008-10#1)(2008-11#1)
of stem cells to##3##4##(2008-10#1)(2008-11#1)(2012-12#1)
of stem cells will be##2##5##(2008-11#1)(2010-12#1)
of stem cells with##2##4##(2008-1#1)(2008-11#1)
of stem cells##72##3##(1990-12#1)(1995-12#3)(2005-11#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-8#3)(2008-1#6)(2008-10#2)(2008-11#15)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-6#4)(2011-1#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#7)(2012-2#3)(2013-7#1)(2013-8#1)
of stem diameter##2##3##(2008-10#2)
of stem infection##2##3##(2008-10#2)
of stem rot##2##3##(2008-10#2)
of stem rust resistance in##3##5##(2008-10#3)
of stem rust resistance##4##4##(2008-10#4)
of stem rust##8##3##(2008-10#8)
of stem tissue##3##3##(2008-10#3)
of stem##156##2##(1990-12#1)(1995-1#1)(1995-12#4)(2005-11#2)(2005-8#1)(2006-10#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-8#4)(2008-1#10)(2008-10#33)(2008-11#19)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#3)(2009-4#1)(2009-6#2)(2009-8#1)(2010-11#3)(2010-12#5)(2010-3#1)(2010-5#1)(2010-6#5)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#4)(2012-11#1)(2012-12#14)(2012-2#6)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
of stem-cell##2##2##(2007-3#1)(2009-4#1)
of stem-like tumor cells##2##4##(2012-12#2)
of stem-like##3##2##(2012-12#2)(2013-8#1)
of stems and leaves##2##4##(2008-12#1)(2008-5#1)
of stems and##3##3##(1990-7#1)(2008-12#1)(2008-5#1)
of stems with##7##3##(2008-10#7)
of stems##15##2##(1990-7#1)(2008-10#8)(2008-11#1)(2008-12#3)(2008-5#1)(2013-1#1)
of stenophagy in spiders##2##4##(2012-3#2)
of stenophagy were##2##3##(2012-3#2)
of stenophagy##4##2##(2012-3#4)
of stenoses##2##2##(2007-7#1)(2008-7#1)
of stenosing##2##2##(1990-7#1)(2008-9#1)
of stenosis and##4##3##(2007-5#1)(2007-9#1)(2008-5#1)(2008-7#1)
of stenosis in the##2##4##(2008-5#1)(2011-2#1)
of stenosis in##5##3##(2007-10#2)(2008-3#1)(2008-5#1)(2011-2#1)
of stenosis of##3##3##(1990-11#1)(1992-10#1)(2009-3#1)
of stenosis##30##2##(1990-11#1)(1990-7#1)(1992-10#1)(1993-8#1)(2006-11#1)(2007-10#3)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-3#1)(2008-5#3)(2008-7#4)(2008-8#1)(2009-2#1)(2009-3#1)(2011-2#2)(2012-2#1)(2013-1#1)
of stenotic coronary##2##3##(2006-7#1)(2008-5#1)
of stenotic##7##2##(1993-10#1)(2006-2#2)(2006-7#1)(2008-12#1)(2008-5#1)(2008-7#1)
of stent implantation##3##3##(1996-8#1)(2008-11#1)(2010-5#1)
of stent placement##2##3##(2006-11#1)(2010-10#1)
of stent thrombosis and thromboembolism##2##5##(2010-12#2)
of stent thrombosis##3##3##(2010-12#2)(2010-5#1)
of stent wires##2##3##(2010-12#2)
of stent##20##2##(1990-8#1)(1994-11#1)(1996-8#1)(2006-11#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-7#1)(2010-10#2)(2010-12#5)(2010-5#4)(2011-2#1)
of stents and##2##3##(1993-10#1)(2006-10#1)
of stents##10##2##(1993-10#2)(1994-11#1)(1994-9#1)(2006-10#2)(2006-7#1)(2006-8#1)(2008-5#1)(2013-7#1)
of step##6##2##(1996-1#1)(2008-7#1)(2010-7#1)(2011-2#2)(2012-2#1)
of steps and##3##3##(1993-4#1)(2008-6#1)(2010-3#1)
of steps of##2##3##(2006-10#1)(2008-3#1)
of steps that##2##3##(2008-11#1)(2012-3#1)
of steps##23##2##(1991-2#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-4#1)(1995-10#1)(2006-10#1)(2007-10#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2010-3#2)(2012-3#1)(2013-1#1)
of stepwise graded##2##3##(2008-3#2)
of stepwise##8##2##(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2009-11#1)(2010-4#1)
of stereo##2##2##(2008-2#1)(2008-9#1)
of stereochemically##2##2##(1995-3#1)(1996-7#1)
of stereochemistry##2##2##(1995-7#1)(2009-5#1)
of stereodefined PS-oligos##2##3##(2008-4#2)
of stereoisomers##5##2##(1996-6#1)(2010-2#4)
of stereolithographic##2##2##(2010-9#1)(2013-1#1)
of stereopsis##3##2##(1994-8#1)(2008-9#1)(2009-3#1)
of stereoregular poly(methyl methacrylate)##2##4##(2007-12#2)
of stereoselectivity##3##2##(1990-6#1)(1991-12#2)
of stereospecific##2##2##(1995-3#1)(1995-8#1)
of stereotactic##6##2##(2007-12#2)(2007-4#1)(2008-7#2)(2012-1#1)
of stereotype##2##2##(2008-5#2)
of stereotyped##4##2##(1993-4#1)(1996-10#1)(2007-12#1)(2012-2#1)
of stereotypic and##2##3##(2009-4#1)(2011-12#1)
of stereotypic##3##2##(2009-4#2)(2011-12#1)
of stereotypy##3##2##(1995-3#1)(2008-11#2)
of steric and electronic##2##4##(1993-4#1)(2010-6#1)
of steric##9##2##(1991-1#1)(1993-4#1)(1996-8#1)(2007-11#2)(2008-10#2)(2010-6#1)(2012-2#1)
of sterically stabilized liposomes##3##4##(2006-10#1)(2008-5#2)
of sterically##6##2##(1996-5#1)(2006-10#1)(2008-5#2)(2010-5#1)(2010-7#1)
of sterile##27##2##(2004-4#1)(2007-10#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#2)(2013-1#4)
of sterilisation##2##2##(1995-7#1)(2004-10#1)
of sterility##6##2##(1995-8#1)(2008-10#1)(2008-11#2)(2013-8#2)
of sterilization##10##2##(1991-3#3)(1992-12#1)(1995-1#2)(1996-3#1)(2007-4#1)(2009-11#1)(2011-1#1)
of sterilizations##2##2##(2007-3#1)(2009-7#1)
of sternal wound dehiscence##2##4##(2007-8#2)
of sternal wound infection##3##4##(2012-2#3)
of sternal wound##6##3##(2007-8#3)(2012-2#3)
of sternal##8##2##(2007-8#4)(2012-2#4)
of sternum##3##2##(2007-8#3)
of steroid 5 alpha-reductase##5##4##(1990-11#2)(1994-11#1)(1995-9#1)(1996-4#1)
of steroid action##4##3##(1990-10#1)(2005-8#1)(2008-4#1)(2008-5#1)
of steroid administration##2##3##(2007-8#1)(2009-3#1)
of steroid hormone action##2##4##(1996-4#1)(2008-4#1)
of steroid hormone##6##3##(1992-9#1)(1993-11#1)(1996-4#2)(2007-4#1)(2008-4#1)
of steroid hormones in##2##4##(2011-1#2)
of steroid hormones on##2##4##(1994-9#1)(2012-3#1)
of steroid hormones##7##3##(1992-7#1)(1993-2#1)(1994-9#1)(2008-6#1)(2011-1#2)(2012-3#1)
of steroid in##2##3##(1993-11#1)(2007-7#1)
of steroid receptor##3##3##(1992-11#1)(1993-2#1)(1997-1#1)
of steroid receptors##4##3##(1992-9#1)(2008-4#1)(2008-7#1)(2012-12#1)
of steroid therapy##3##3##(2006-8#1)(2008-3#1)(2008-5#1)
of steroid treatment##2##3##(1992-12#1)(2006-10#1)
of steroid##64##2##(1990-10#1)(1990-11#2)(1990-2#1)(1990-9#2)(1991-12#1)(1991-7#1)(1992-11#1)(1992-12#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#3)(1993-2#2)(1994-11#1)(1994-9#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-4#5)(1996-6#1)(1997-1#1)(1997-3#1)(2005-8#3)(2006-10#3)(2006-12#2)(2006-8#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2009-3#1)(2009-4#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)
of steroid-linked##2##2##(2005-8#2)
of steroid-resistant##3##2##(2005-8#1)(2007-7#1)(2007-8#1)
of steroidal##7##2##(1991-12#1)(1996-5#1)(2006-10#1)(2007-1#1)(2007-11#2)(2007-8#1)
of steroidogenesis by##2##3##(1990-2#1)(1991-7#1)
of steroidogenesis in the##2##4##(1990-3#1)(1996-8#1)
of steroidogenesis in##4##3##(1990-3#1)(1996-2#2)(1996-8#1)
of steroidogenesis##14##2##(1990-2#1)(1990-3#1)(1991-10#2)(1991-3#1)(1991-7#1)(1991-9#1)(1996-2#2)(1996-8#2)(2012-2#2)(2013-1#1)
of steroids and##6##3##(2006-4#1)(2006-8#1)(2006-9#1)(2007-7#1)(2008-6#1)(2012-2#1)
of steroids are##3##3##(2006-12#1)(2007-10#1)(2010-6#1)
of steroids for##3##3##(2005-8#1)(2006-9#2)
of steroids in##3##3##(1996-3#1)(2006-10#1)(2006-8#1)
of steroids on##2##3##(2008-7#1)(2012-2#1)
of steroids to##2##3##(2007-8#1)(2012-2#1)
of steroids##51##2##(1990-11#1)(1990-2#1)(1992-3#1)(1993-11#1)(1995-12#2)(1996-3#1)(1996-5#1)(2005-8#1)(2006-10#6)(2006-12#1)(2006-4#1)(2006-8#3)(2006-9#4)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-6#1)(2010-8#1)(2012-2#5)(2013-1#1)(2013-8#1)
of sterol biosynthesis in##2##4##(1991-5#1)(1996-5#1)
of sterol biosynthesis##3##3##(1991-5#1)(1995-4#1)(1996-5#1)
of sterol synthesis##4##3##(1990-7#1)(1992-3#1)(1993-6#1)(1994-5#1)
of sterol##13##2##(1990-12#1)(1990-7#1)(1991-5#2)(1992-3#2)(1993-6#1)(1994-5#1)(1995-4#1)(1996-12#1)(1996-5#1)(2007-11#2)
of sterols##11##2##(1990-11#1)(1992-3#1)(1996-5#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-5#1)(2009-4#1)(2009-7#1)(2010-2#1)
of stethoscope##2##2##(1996-12#1)(2009-6#1)
of stethoscopes used by medical students in Nigeria##2##8##(2009-6#2)
of stethoscopes##3##2##(1996-12#1)(2009-6#2)
of stevia##3##2##(2010-2#1)(2013-1#2)
of stewardship in health policy##2##5##(2012-2#2)
of stewardship in health##3##4##(2012-2#3)
of stewardship##5##2##(2007-9#1)(2012-2#4)
of sticky##2##2##(2008-8#1)(2011-12#1)
of stiff##2##2##(2005-11#1)(2007-4#1)
of stiffness after##2##3##(2006-3#1)(2008-8#1)
of stiffness and##2##3##(2008-8#1)(2009-7#1)
of stiffness of the##2##4##(2005-10#1)(2009-10#1)
of stiffness##9##2##(2005-10#1)(2006-3#1)(2007-8#1)(2008-8#2)(2009-10#1)(2009-7#1)(2011-1#1)(2012-1#1)
of stifle##2##2##(2012-3#2)
of stigma and discrimination##2##4##(2010-8#1)(2012-12#1)
of stigma and##3##3##(2010-8#1)(2012-12#1)(2013-1#1)
of stigma##17##2##(2006-9#2)(2007-7#4)(2008-4#1)(2008-6#1)(2009-5#2)(2010-8#2)(2011-1#2)(2012-1#1)(2012-12#1)(2013-1#1)
of stigmasterol##2##2##(1990-2#1)(2008-12#1)
of stigmata of##2##3##(1994-11#1)(2007-8#1)
of stigmata##3##2##(1994-11#1)(2007-8#1)(2008-10#1)
of stigmatization##4##2##(2006-9#1)(2008-2#1)(2012-12#2)
of stigmatizing##2##2##(2007-12#1)(2008-9#1)
of still water##2##3##(2010-12#1)(2011-1#1)
of still##5##2##(1994-10#1)(2008-5#1)(2010-12#1)(2011-1#1)(2012-12#1)
of stillbirth and death during the##2##6##(1993-1#1)(1995-6#1)
of stillbirth and death##3##4##(1993-1#2)(1995-6#1)
of stillbirth##5##2##(1993-1#2)(1995-6#1)(2007-10#2)
of stimulant medication##2##3##(1995-1#1)(2011-2#1)
of stimulant##4##2##(1993-3#1)(1995-1#1)(2010-11#1)(2011-2#1)
of stimulants##4##2##(2008-10#2)(2008-3#1)(2011-2#1)
of stimulated Brillouin scattering in optical fiber##2##7##(2007-11#1)(2007-12#1)
of stimulated Brillouin scattering##4##4##(2007-11#3)(2007-12#1)
of stimulated Raman scattering (SRS) at##2##6##(2008-2#1)(2008-3#1)
of stimulated Raman scattering and##2##5##(2007-12#1)(2008-2#1)
of stimulated Raman scattering##7##4##(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)
of stimulated emission##2##3##(2007-11#2)
of stimulated scattering##2##3##(2008-3#2)
of stimulated##28##2##(1990-11#1)(1990-2#1)(1991-7#1)(1992-6#1)(1992-8#1)(1993-11#1)(1995-12#1)(1997-6#1)(2007-11#7)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#3)(2009-8#1)(2011-2#1)(2012-12#1)
of stimulating##15##2##(1990-9#1)(1991-7#1)(1993-3#1)(1993-4#1)(1995-3#1)(1995-9#1)(1997-2#1)(2005-6#1)(2006-10#3)(2008-11#1)(2008-4#1)(2009-10#1)(2011-2#1)
of stimulation and##3##3##(1991-2#1)(1992-8#1)(2006-12#1)
of stimulation of the##4##4##(1990-8#1)(1995-3#1)(1996-5#1)(2006-6#1)
of stimulation of##15##3##(1990-8#1)(1991-10#1)(1992-6#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-5#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-11#1)(2008-2#1)(2008-7#1)(2012-2#1)
of stimulation rate##2##3##(2008-9#2)
of stimulation was##5##3##(1990-2#1)(1994-8#1)(2007-8#1)(2008-7#1)(2011-1#1)
of stimulation##66##2##(1990-11#2)(1990-2#2)(1990-4#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#3)(1993-6#1)(1994-2#1)(1994-8#1)(1995-10#2)(1995-2#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-3#2)(2006-6#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#5)(2008-9#6)(2010-10#1)(2010-7#1)(2011-1#3)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
of stimulation-induced##3##2##(1994-3#1)(1994-6#2)
of stimulator##2##2##(2012-3#2)
of stimulatory##4##2##(1993-9#1)(1995-6#1)(1996-2#1)(2008-11#1)
of stimuli and##3##3##(1993-12#1)(2008-9#1)(2012-2#1)
of stimuli for##2##3##(1992-9#1)(1993-12#1)
of stimuli to##2##3##(1997-7#1)(2009-2#1)
of stimuli##30##2##(1990-2#1)(1992-11#1)(1992-9#1)(1993-12#3)(1993-3#1)(1997-7#1)(2006-3#1)(2008-2#1)(2008-4#3)(2008-6#1)(2008-9#3)(2009-2#2)(2009-8#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-8#2)
of stimulus delivery##2##3##(1995-12#1)(2008-4#1)
of stimulus duration##2##3##(2008-9#2)
of stimulus intensities##2##3##(1997-5#1)(2011-2#1)
of stimulus##19##2##(1990-10#2)(1992-7#1)(1993-12#1)(1993-7#1)(1994-10#1)(1994-6#1)(1995-12#1)(1997-5#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#2)(2011-2#2)(2012-1#1)(2012-2#1)
of stimulus--reward##2##2##(1993-6#2)
of stimulus-frequency##2##2##(2009-5#2)
of stimulus-induced##3##2##(1996-5#1)(1997-5#1)(2008-4#1)
of stimulus-specific##2##2##(1995-11#1)(2013-8#1)
of stirred##2##2##(2008-10#1)(2008-11#1)
of stirring##5##2##(2006-2#1)(2007-10#1)(2008-10#3)
of stochastic effects##2##3##(1996-6#1)(2008-8#1)
of stochastic learning##2##3##(2008-2#2)
of stochastic variability##2##3##(1991-6#2)
of stochastic##22##2##(1991-6#3)(1992-6#1)(1992-9#1)(1996-6#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#3)(2008-7#4)(2008-8#3)(2009-8#1)(2011-1#1)(2011-2#1)
of stochasticity##2##2##(2008-9#1)(2013-8#1)
of stock##6##2##(2005-7#1)(2005-9#1)(2006-5#1)(2008-4#1)(2011-2#1)(2013-8#1)
of stocking rate on##3##4##(1996-12#2)(2008-5#1)
of stocking rate##4##3##(1996-12#3)(2008-5#1)
of stoichiometric amounts of##5##4##(1990-11#1)(1991-5#1)(1994-9#1)(1996-2#1)(2005-12#1)
of stoichiometric##11##2##(1990-11#1)(1991-5#1)(1994-9#1)(1995-8#1)(1996-2#1)(2005-12#1)(2007-12#2)(2008-10#1)(2008-11#1)(2010-6#1)
of stoichiometry and##3##3##(1994-5#1)(2008-10#2)
of stolon regression##2##3##(2009-8#2)
of stolon##3##2##(2009-8#3)
of stomach and##4##3##(2006-2#1)(2011-12#1)(2011-2#1)(2013-1#1)
of stomach cancer in##4##4##(1992-12#1)(2011-2#1)(2012-12#2)
of stomach cancer##10##3##(1990-9#1)(1991-6#1)(1992-11#1)(1992-12#1)(1995-6#1)(2011-2#1)(2012-12#4)
of stomach##29##2##(1990-9#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-9#1)(1995-6#1)(1996-12#1)(1996-7#1)(1997-7#1)(2006-2#1)(2007-2#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-2#1)(2010-12#1)(2011-12#1)(2011-2#2)(2012-12#4)(2012-2#1)(2013-1#1)(2013-7#1)
of stomachs##2##2##(1995-11#1)(2008-12#1)
of stomata##3##2##(2008-10#2)(2013-7#1)
of stomatopods##2##2##(2007-12#2)
of stone formers##3##3##(1991-12#1)(1995-7#1)(2006-9#1)
of stone##11##2##(1991-12#1)(1995-7#1)(2006-9#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-5#1)(2009-6#1)(2012-12#1)
of stones##5##2##(1991-12#1)(2006-6#1)(2006-9#1)(2011-2#2)
of stool##6##2##(1991-3#1)(1991-8#1)(1996-1#1)(2008-6#1)(2010-2#1)(2011-2#1)
of stop##2##2##(1994-12#1)(1996-7#1)
of stopping##3##2##(2007-7#1)(2008-11#1)(2011-1#1)
of stops##3##2##(1993-2#2)(2008-2#1)
of storage and##3##3##(2007-12#1)(2008-11#1)(2009-8#1)
of storage at 4 degrees C##4##6##(1994-12#1)(2008-10#3)
of storage at##9##3##(1994-12#1)(2006-5#1)(2008-10#6)(2008-12#1)
of storage in##6##3##(2008-10#3)(2008-5#1)(2009-7#1)(2010-8#1)
of storage of##2##3##(1990-1#1)(2009-2#1)
of storage space##3##3##(1994-3#2)(1996-1#1)
of storage tanks##2##3##(2009-10#1)(2011-1#1)
of storage time and##4##4##(1997-8#1)(2008-10#2)(2010-4#1)
of storage time##5##3##(1997-8#1)(2007-12#1)(2008-10#2)(2010-4#1)
of storage##72##2##(1990-1#1)(1992-12#1)(1992-3#1)(1994-12#1)(1994-3#2)(1995-7#3)(1996-1#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-5#3)(2007-12#2)(2007-3#2)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-4#8)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#2)
of store-operated##2##2##(1996-9#1)(2008-8#1)
of stored potato tubers##2##4##(2008-10#2)
of stored##20##2##(1990-11#1)(1991-12#1)(1992-10#1)(1993-2#1)(1995-12#1)(1996-2#1)(1997-6#1)(2005-11#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#1)(2010-4#1)(2011-1#1)(2011-2#1)
of stories##4##2##(1992-3#1)(2007-2#1)(2008-11#1)(2012-2#1)
of storing##6##2##(1990-11#1)(1991-11#1)(1996-12#1)(1996-7#1)(2008-3#2)
of storm damage##2##3##(2011-2#2)
of storm##3##2##(2010-2#1)(2011-2#2)
of story##2##2##(2007-2#1)(2008-12#1)
of storytelling##5##2##(1992-3#1)(2008-11#3)(2008-12#1)
of strabismus##4##2##(1992-2#1)(1992-7#1)(2008-12#1)(2010-9#1)
of straight##4##2##(1992-8#1)(2008-2#2)(2013-1#1)
of straightforward##2##2##(2008-12#1)(2008-7#1)
of strain 1505##2##3##(2008-10#2)
of strain 50##2##3##(2008-5#2)
of strain 70T01##2##3##(2008-10#2)
of strain A506##4##3##(2008-10#4)
of strain F11(T)##2##3##(2012-2#2)
of strain Q8r1-96##2##3##(2008-10#2)
of strain is##2##3##(2008-2#1)(2008-3#1)
of strain of##2##3##(2008-2#1)(2010-12#1)
of strain##62##2##(1991-4#1)(1992-12#1)(1995-12#1)(1996-12#1)(1996-4#1)(2007-12#1)(2008-10#32)(2008-11#1)(2008-2#2)(2008-3#7)(2008-5#3)(2008-7#1)(2009-7#1)(2010-10#1)(2010-12#1)(2011-12#2)(2012-2#3)(2012-3#2)
of strain-specific##4##2##(1996-12#1)(2008-10#1)(2008-12#1)(2013-8#1)
of strained##2##2##(2006-8#1)(2007-12#1)
of strains agglutinated##2##3##(2008-5#2)
of strains carrying##3##3##(1991-7#1)(1995-8#1)(1996-9#1)
of strains from##3##3##(2006-3#1)(2007-8#1)(2008-10#1)
of strains in##2##3##(1991-8#1)(2008-10#1)
of strains into##3##3##(2008-10#3)
of strains of##9##3##(1996-4#1)(1997-4#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-10#4)
of strains producing##2##3##(1997-7#1)(2008-5#1)
of strains that##3##3##(1992-12#1)(2008-10#1)(2010-4#1)
of strains were Gram##2##4##(2012-2#2)
of strains were##5##3##(1990-6#1)(2008-10#2)(2012-2#2)
of strains with##4##3##(2007-12#1)(2008-10#2)(2008-7#1)
of strains##70##2##(1990-6#1)(1991-1#1)(1991-7#1)(1991-8#1)(1992-12#1)(1993-9#1)(1995-4#1)(1995-8#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-3#2)(2006-5#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#25)(2008-12#1)(2008-5#5)(2008-7#1)(2008-9#3)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
of strains)##2##2##(2008-10#2)
of strand##9##2##(1990-7#1)(1994-9#1)(1995-12#2)(1996-6#1)(1996-8#1)(1997-2#1)(2006-10#1)(2007-3#1)
of strangers##2##2##(2007-8#1)(2009-6#1)
of strangles##3##2##(1993-8#1)(2013-8#2)
of strangulated##2##2##(1990-10#1)(2009-8#1)
of strategic planning##5##3##(1993-1#1)(1995-1#1)(1997-1#1)(2005-11#1)(2007-7#1)
of strategic##15##2##(1991-8#1)(1993-1#1)(1994-2#1)(1995-1#1)(1996-1#1)(1997-1#1)(1997-3#2)(2005-11#1)(2007-7#1)(2008-12#1)(2008-4#1)(2009-9#1)(2010-2#1)(2012-12#1)
of strategies and##2##3##(2005-7#1)(2012-12#1)
of strategies are##2##3##(2007-7#1)(2008-4#1)
of strategies for##14##3##(1994-3#1)(1994-6#1)(1995-6#1)(1996-5#1)(2007-11#1)(2007-2#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)(2013-1#4)
of strategies in##2##3##(2007-8#1)(2008-8#1)
of strategies that##3##3##(2010-11#1)(2010-6#1)(2013-8#1)
of strategies to minimize##2##4##(1996-9#1)(2006-10#1)
of strategies to reduce##2##4##(2012-3#1)(2013-1#1)
of strategies to##13##3##(1996-9#1)(2006-10#1)(2006-11#1)(2007-12#2)(2008-11#3)(2009-4#1)(2012-3#2)(2013-1#2)
of strategies##48##2##(1993-12#1)(1994-3#1)(1994-6#1)(1995-6#1)(1996-5#1)(1996-9#1)(1997-2#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-11#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#6)(2013-8#1)
of strategy for##2##3##(2006-10#1)(2013-1#1)
of strategy##3##2##(2006-10#1)(2007-8#1)(2013-1#1)
of stratification##2##2##(2008-7#1)(2011-2#1)
of stratified##4##2##(2008-2#2)(2009-4#1)(2012-2#1)
of stratospheric aerosol##2##3##(2008-2#1)(2008-3#1)
of stratospheric aerosols##3##3##(2008-2#3)
of stratospheric trace-gas species##2##4##(2008-3#2)
of stratospheric##14##2##(1991-5#1)(2008-2#5)(2008-3#8)
of stratum corneum##20##3##(1991-9#1)(1996-5#2)(2005-11#1)(2006-9#1)(2007-7#1)(2008-5#14)
of stratum##21##2##(1991-9#1)(1994-5#1)(1996-5#2)(2005-11#1)(2006-9#1)(2007-7#1)(2008-5#14)
of strawberry and##2##3##(2008-10#2)
of strawberry leaf blight##2##4##(2008-10#2)
of strawberry leaflets##2##3##(2008-10#2)
of strawberry leaves##3##3##(2008-10#3)
of strawberry plants##2##3##(2008-10#2)
of strawberry production##2##3##(2008-10#2)
of strawberry##25##2##(2008-10#25)
of stray light and##2##4##(2006-12#1)(2008-3#1)
of stray light##4##3##(2006-12#1)(2008-3#3)
of stray##6##2##(2006-12#1)(2008-3#3)(2011-1#2)
of stream##2##2##(2006-2#1)(2009-8#1)
of streaming##2##2##(2005-11#2)
of streams##2##2##(2008-10#1)(2009-8#1)
of street##4##2##(1997-6#1)(2007-7#1)(2008-10#1)(2008-11#1)
of strength training on##2##4##(2006-10#1)(2006-3#1)
of strength training##4##3##(2006-10#1)(2006-3#1)(2006-9#1)(2013-8#1)
of strength##12##2##(1997-5#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-4#1)(2009-6#1)(2013-8#1)
of strengthening##7##2##(1991-12#1)(2008-9#1)(2012-12#1)(2012-3#4)
of streptavidin in##2##3##(1990-2#1)(2008-10#1)
of streptavidin##15##2##(1990-2#1)(1990-4#2)(1991-4#2)(1997-2#1)(2008-10#4)(2008-7#1)(2008-9#1)(2009-12#3)
of streptavidin-bound##2##2##(1995-11#2)
of streptococcal##5##2##(1990-11#1)(1994-11#1)(2006-10#1)(2008-4#1)(2011-2#1)
of streptokinase and##2##3##(2008-8#1)(2012-2#1)
of streptokinase from##2##3##(2012-2#2)
of streptokinase##16##2##(1993-12#1)(1994-12#1)(1994-6#1)(1995-6#2)(1997-4#1)(2008-8#1)(2010-12#1)(2012-2#8)
of streptomycin sulfate##4##3##(2008-10#4)
of streptomycin##5##2##(2008-10#4)(2013-1#1)
of streptozotocin (STZ)-induced##2##3##(1991-12#1)(2008-10#1)
of streptozotocin##13##2##(1991-12#1)(1994-8#1)(1995-10#2)(2007-9#1)(2008-10#2)(2009-11#1)(2010-12#3)(2011-3#1)(2012-2#1)
of streptozotocin-induced diabetic rats##3##4##(1993-11#1)(2011-3#2)
of streptozotocin-induced diabetic##5##3##(1993-11#1)(2004-11#1)(2011-3#3)
of stress among##2##3##(2012-2#2)
of stress and burnout##4##4##(2006-3#1)(2007-10#1)(2010-7#1)(2012-2#1)
of stress and##17##3##(1992-2#1)(1994-10#1)(1995-12#2)(1996-4#1)(1996-5#1)(2006-3#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-7#1)(2009-9#1)(2010-7#1)(2012-1#1)(2012-2#2)
of stress are##2##3##(2008-11#1)(2008-5#1)
of stress in the##2##4##(2008-11#1)(2008-7#1)
of stress in##10##3##(2008-11#1)(2008-5#1)(2008-7#2)(2009-2#1)(2009-4#1)(2009-6#1)(2012-1#1)(2013-1#1)(2013-8#1)
of stress on distress##2##4##(2012-3#2)
of stress on the##5##4##(1995-12#1)(1997-4#1)(2007-11#1)(2008-7#2)
of stress on##17##3##(1994-2#1)(1995-12#2)(1997-4#1)(2006-12#1)(2007-11#1)(2008-6#1)(2008-7#5)(2012-3#4)(2013-1#1)
of stress proteins in##3##4##(1992-5#1)(1993-6#1)(2008-7#1)
of stress proteins##5##3##(1992-5#1)(1993-6#1)(1996-1#1)(2008-11#1)(2008-7#1)
of stress resistance##2##3##(2006-12#1)(2011-2#1)
of stress response genes##2##4##(2012-2#1)(2013-8#1)
of stress response##6##3##(1995-12#1)(2006-10#1)(2011-2#2)(2012-2#1)(2013-8#1)
of stress responses##3##3##(1994-11#1)(2008-7#1)(2012-2#1)
of stress that##3##3##(1996-4#1)(2009-3#1)(2012-3#1)
of stress ulcer##2##3##(2008-9#1)(2012-3#1)
of stress urinary incontinence in##2##5##(2008-10#1)(2013-1#1)
of stress urinary incontinence##12##4##(1994-5#1)(2006-10#2)(2006-7#1)(2006-9#5)(2008-10#1)(2008-3#1)(2013-1#1)
of stress was##2##3##(2007-3#1)(2012-2#1)
of stress were##2##3##(1994-12#1)(2013-8#1)
of stress##180##2##(1991-11#2)(1991-12#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-5#1)(1995-12#14)(1995-3#1)(1995-5#1)(1996-1#2)(1996-10#1)(1996-4#2)(1996-5#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-6#1)(2006-10#3)(2006-12#3)(2006-3#2)(2006-7#1)(2006-9#5)(2007-10#5)(2007-11#4)(2007-12#1)(2007-2#4)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#16)(2008-8#1)(2008-9#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#3)(2009-7#4)(2009-8#2)(2009-9#1)(2010-2#2)(2010-4#3)(2010-7#1)(2011-1#1)(2011-2#8)(2012-1#5)(2012-12#2)(2012-2#9)(2012-3#6)(2013-1#3)(2013-7#2)(2013-8#5)
of stress)##2##2##(2012-1#1)(2013-1#1)
of stress-activated##2##2##(1996-5#1)(2005-8#1)
of stress-induced##5##2##(1994-11#1)(1994-8#1)(1996-9#1)(2007-11#1)(2008-11#1)
of stress-limiting systems##5##3##(2012-3#5)
of stress-response##2##2##(1996-10#1)(2010-12#1)
of stressed##2##2##(2008-10#1)(2008-5#1)
of stressful life events##4##4##(2007-6#2)(2011-2#2)
of stressful##5##2##(1992-1#1)(2007-6#2)(2011-2#2)
of stressogenic substances##3##3##(1991-11#3)
of stressor effects##2##3##(2008-11#2)
of stressors and##2##3##(1990-5#1)(2009-8#1)
of stressors##7##2##(1990-5#1)(1995-12#1)(2007-10#1)(2007-11#1)(2009-6#1)(2009-8#1)(2012-2#1)
of stretch##2##2##(1990-8#1)(1996-3#1)
of stretched##2##2##(1992-9#1)(2008-3#1)
of stretching##3##2##(1993-11#1)(2008-6#2)
of striatal and##2##3##(1991-6#1)(1992-10#1)
of striatal cells##2##3##(1993-12#1)(1996-1#1)
of striatal dopamine receptors##2##4##(1994-5#1)(1995-2#1)
of striatal dopamine##6##3##(1991-3#1)(1994-5#1)(1995-2#2)(2008-11#1)(2008-7#1)
of striatal neurons to##2##4##(1991-3#1)(1992-9#1)
of striatal neurons##4##3##(1990-5#1)(1991-3#2)(1992-9#1)
of striatal##35##2##(1990-5#1)(1990-7#3)(1991-3#3)(1991-5#1)(1991-6#2)(1992-10#1)(1992-9#1)(1993-12#3)(1994-5#1)(1995-10#1)(1995-12#3)(1995-2#2)(1995-5#1)(1996-1#2)(1996-2#1)(1997-2#1)(1997-5#1)(1997-8#2)(2006-8#1)(2008-11#2)(2008-5#1)(2008-7#1)
of striate##2##2##(1995-8#1)(2008-8#1)
of striated muscle##3##3##(1993-4#1)(1994-9#1)(1996-5#1)
of striated##5##2##(1993-4#1)(1994-9#1)(1996-5#1)(2009-9#2)
of strict BP control##2##4##(2007-10#2)
of strict##8##2##(2006-2#1)(2006-8#1)(2007-10#2)(2007-7#2)(2008-12#1)(2008-7#1)
of strictures##4##2##(2006-6#1)(2007-5#1)(2013-1#1)(2013-8#1)
of stride##2##2##(2008-7#1)(2012-1#1)
of stridor##4##2##(1991-11#1)(1996-1#1)(2011-2#1)(2013-8#1)
of striga##3##2##(2008-10#3)
of strike##2##2##(1990-11#1)(2012-3#1)
of string##4##2##(2006-10#1)(2008-7#1)(2013-1#2)
of strings##2##2##(2006-10#1)(2008-5#1)
of strip##3##2##(2008-10#2)(2012-3#1)
of stripe rust##2##3##(2008-10#2)
of stripping potentiometry##2##3##(2008-10#2)
of stripping##6##2##(2008-10#6)
of stroke and brain##2##4##(2008-2#1)(2008-3#1)
of stroke and death##2##4##(1991-11#1)(2007-10#1)
of stroke and other##2##4##(2006-10#1)(2008-8#1)
of stroke and the need##2##5##(2007-9#1)(2010-10#1)
of stroke and the##3##4##(2007-9#1)(2010-10#1)(2011-1#1)
of stroke and##22##3##(1990-3#1)(1991-11#1)(1993-12#1)(2005-10#1)(2006-10#2)(2007-10#2)(2007-4#1)(2007-8#3)(2007-9#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2010-10#1)(2011-1#1)(2012-1#1)
of stroke are##4##3##(2007-10#1)(2007-9#1)(2008-8#2)
of stroke by##3##3##(2007-10#2)(2008-8#1)
of stroke caused by##2##4##(2007-10#2)
of stroke for##2##3##(2007-10#1)(2008-9#1)
of stroke in Japan##2##4##(2008-8#2)
of stroke in patients with##4##5##(2007-8#1)(2008-1#1)(2008-5#1)(2008-8#1)
of stroke in patients##5##4##(2007-10#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-8#1)
of stroke in the young##3##5##(2007-9#2)(2008-8#1)
of stroke in the##9##4##(2007-8#2)(2007-9#3)(2008-8#2)(2009-7#1)(2010-12#1)
of stroke in##32##3##(1995-5#1)(2007-10#1)(2007-8#5)(2007-9#5)(2008-1#1)(2008-5#1)(2008-7#2)(2008-8#12)(2009-7#1)(2010-12#1)(2011-1#1)(2013-8#1)
of stroke is##7##3##(2007-10#1)(2007-8#1)(2007-9#2)(2008-5#1)(2008-8#1)(2008-9#1)
of stroke management##3##3##(2006-10#2)(2008-8#1)
of stroke onset##6##3##(2006-7#1)(2007-10#4)(2008-8#1)
of stroke or##7##3##(1991-11#1)(2007-10#2)(2007-7#1)(2007-9#1)(2011-1#1)(2011-2#1)
of stroke patients in a##2##5##(1990-2#1)(1995-5#1)
of stroke patients in##3##4##(1990-2#1)(1995-5#1)(2007-9#1)
of stroke patients is##3##4##(2007-10#1)(2007-9#1)(2008-8#1)
of stroke patients to##2##4##(2007-9#1)(2012-1#1)
of stroke patients##17##3##(1990-2#1)(1995-5#1)(2007-10#4)(2007-9#8)(2008-8#1)(2012-1#2)
of stroke presentation##2##3##(2007-9#1)(2010-11#1)
of stroke risk factors##8##4##(2007-10#1)(2007-9#6)(2008-2#1)
of stroke risk##11##3##(2007-10#2)(2007-9#6)(2008-2#1)(2013-1#2)
of stroke survivors continue to##2##5##(2007-10#1)(2012-1#1)
of stroke survivors##5##3##(2007-10#2)(2012-1#3)
of stroke symptoms and##2##4##(2007-10#1)(2010-10#1)
of stroke symptoms##7##3##(2007-10#2)(2007-9#3)(2010-10#2)
of stroke that##2##3##(2007-9#1)(2008-8#1)
of stroke was##3##3##(2007-10#1)(2007-9#1)(2013-8#1)
of stroke##302##2##(1990-10#1)(1990-2#1)(1990-3#1)(1991-11#4)(1992-4#1)(1993-12#2)(1994-2#1)(1995-5#7)(1995-9#1)(1996-11#2)(1996-2#1)(1996-8#1)(1996-9#1)(2005-10#2)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-10#78)(2007-11#3)(2007-4#1)(2007-7#1)(2007-8#10)(2007-9#55)(2008-1#4)(2008-2#4)(2008-3#3)(2008-5#4)(2008-7#3)(2008-8#52)(2008-9#2)(2009-11#1)(2009-7#1)(2009-9#1)(2010-10#3)(2010-11#4)(2010-12#2)(2010-8#1)(2011-1#5)(2011-2#2)(2012-1#7)(2012-12#3)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#4)
of stroke-related##2##2##(2007-10#1)(2007-7#1)
of strokes##6##2##(1990-12#1)(2007-10#1)(2007-8#1)(2008-7#1)(2008-8#1)(2010-9#1)
of stroma in##2##3##(1995-12#1)(2008-4#1)
of stromal and##2##3##(2009-6#1)(2012-1#1)
of stromal cell##2##3##(1994-9#1)(1995-12#1)
of stromal cells in##2##4##(1992-6#1)(1995-12#1)
of stromal cells##7##3##(1992-6#1)(1994-9#2)(1995-12#2)(2010-3#1)(2011-1#1)
of stromal fibroblasts##2##3##(2011-1#2)
of stromal tissue##2##3##(1996-4#2)
of stromal##21##2##(1992-6#1)(1993-9#1)(1994-7#1)(1994-9#4)(1995-12#3)(1996-4#2)(2008-11#1)(2009-6#1)(2010-3#1)(2011-1#3)(2012-1#2)(2013-8#1)
of strong and##3##3##(1993-4#1)(1995-3#1)(2008-7#1)
of strong earthquakes##2##3##(1996-4#2)
of strong ligands##2##3##(1990-8#2)
of strong##64##2##(1990-5#1)(1990-8#2)(1991-7#1)(1992-1#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-4#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-3#1)(1996-4#2)(1996-6#2)(2005-11#1)(2006-10#3)(2006-4#1)(2006-6#1)(2007-11#4)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#5)(2008-5#2)(2008-7#2)(2008-9#3)(2009-11#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-1#1)
of stronger##5##2##(1995-5#2)(2008-3#1)(2008-9#1)(2013-7#1)
of strongly polar##2##3##(2012-12#2)
of strongly reducing species of V##2##6##(2008-10#2)
of strongly scattering media##4##4##(2007-12#2)(2008-2#2)
of strongly##21##2##(1995-10#1)(1995-2#1)(2006-10#2)(2007-11#1)(2007-12#6)(2008-10#4)(2008-2#2)(2008-3#1)(2011-1#1)(2012-12#2)
of strontium 89 (Metastron)##2##4##(2007-11#2)
of strontium 89##3##3##(2007-11#3)
of strontium ion##3##3##(2008-10#3)
of strontium or lanthanum##3##4##(2008-10#3)
of strontium oxide##2##3##(2004-9#2)
of strontium##15##2##(2004-9#2)(2007-11#3)(2008-10#10)
of structural analogues of##2##4##(1992-6#1)(1996-12#1)
of structural analysis##2##3##(2006-7#1)(2010-11#1)
of structural and functional imaging##2##5##(2008-11#1)(2010-12#1)
of structural and functional##5##4##(2008-11#1)(2009-10#1)(2010-12#1)(2011-1#1)(2012-12#1)
of structural and##12##3##(1990-12#1)(1991-6#1)(2008-10#2)(2008-11#1)(2009-10#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
of structural changes in##2##4##(1997-4#1)(2012-12#1)
of structural changes##6##3##(1994-11#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-12#1)
of structural components##2##3##(2009-2#1)(2010-8#1)
of structural damage##2##3##(1990-7#1)(2013-8#1)
of structural differences##2##3##(1995-8#1)(1997-8#1)
of structural elements##2##3##(1992-9#1)(2010-12#1)
of structural equation modeling##2##4##(2009-8#1)(2012-3#1)
of structural equation##4##3##(2009-7#1)(2009-8#1)(2012-2#1)(2012-3#1)
of structural features of##2##4##(2006-10#1)(2008-10#1)
of structural features##4##3##(1996-8#1)(2006-10#1)(2008-10#2)
of structural genes##4##3##(1990-1#1)(1990-5#1)(2008-11#1)(2008-9#1)
of structural information about the##2##5##(2008-7#1)(2008-8#1)
of structural information##6##3##(1997-1#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-6#1)(2012-2#1)
of structural models##2##3##(2009-4#1)(2010-4#1)
of structural robustness##2##3##(2006-10#2)
of structural similarity##3##3##(1990-4#1)(1992-6#1)(1993-6#1)
of structural woody habitat##2##4##(2010-8#2)
of structural##121##2##(1990-1#1)(1990-12#1)(1990-4#3)(1990-5#3)(1990-7#1)(1991-3#1)(1991-6#1)(1992-6#2)(1992-9#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-3#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2005-11#2)(2005-8#1)(2006-10#3)(2006-12#2)(2006-4#1)(2006-5#1)(2006-7#4)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#3)(2007-9#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#4)(2008-7#5)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-6#1)(2010-8#3)(2011-1#2)(2011-3#3)(2012-12#3)(2012-2#4)(2012-3#2)(2012-9#1)(2013-1#2)(2013-7#2)(2013-8#1)
of structurally and functionally##4##4##(1991-2#1)(1991-4#1)(2007-12#1)(2008-11#1)
of structurally related##9##3##(1992-11#1)(1994-3#1)(1994-5#1)(1997-7#1)(2005-8#1)(2006-12#1)(2008-4#1)(2011-2#1)(2013-7#1)
of structurally similar##2##3##(2007-1#1)(2008-10#1)
of structurally##27##2##(1990-4#1)(1991-2#1)(1991-4#1)(1992-11#1)(1992-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1997-7#1)(2005-8#1)(2006-12#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-7#1)(2013-8#1)
of structure and function in##2##5##(1992-11#1)(1997-4#1)
of structure and function##5##4##(1992-11#1)(1997-4#2)(2008-8#1)(2011-1#1)
of structure and##12##3##(1992-11#1)(1992-3#1)(1997-4#2)(2007-11#1)(2007-12#3)(2008-8#1)(2011-1#1)(2012-2#1)(2012-3#1)
of structure are##2##3##(1996-11#1)(2007-12#1)
of structure elucidation of##2##4##(2008-12#1)(2011-2#1)
of structure formation##2##3##(2005-11#1)(2008-4#1)
of structure in the##2##4##(1995-4#1)(2006-8#1)
of structure to function for##2##5##(1993-6#1)(1996-2#1)
of structure to##3##3##(1993-6#1)(1996-2#1)(2008-5#1)
of structure##41##2##(1992-11#1)(1992-3#1)(1993-6#1)(1995-4#1)(1995-5#1)(1996-11#2)(1996-2#1)(1997-4#2)(2005-11#2)(2006-8#1)(2007-11#2)(2007-12#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
of structure-activity relationship##2##3##(1997-2#1)(2012-2#1)
of structure-function relationships##4##3##(1990-5#1)(1990-6#1)(1991-5#1)(2007-6#1)
of structure-function##5##2##(1990-5#1)(1990-6#1)(1991-5#1)(2007-6#1)(2011-1#1)
of structure-selective ligand binding##2##4##(2008-4#2)
of structured student tutorial support##2##5##(2008-11#2)
of structured##22##2##(1995-4#1)(2006-10#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-3#3)(2008-7#1)(2009-10#1)(2009-11#1)(2010-3#1)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#1)
of structures and##7##3##(2007-12#1)(2008-12#2)(2008-4#1)(2010-5#1)(2011-7#1)(2013-1#1)
of structures for##2##3##(2007-11#1)(2008-4#1)
of structures in the##3##4##(1995-3#1)(1997-5#1)(2006-12#1)
of structures in##4##3##(1995-3#1)(1995-5#1)(1997-5#1)(2006-12#1)
of structures of##4##3##(2008-1#1)(2008-10#1)(2008-3#1)(2009-4#1)
of structures with##4##3##(1994-5#1)(1996-3#1)(2008-3#1)(2013-1#1)
of structures##37##2##(1994-12#1)(1994-5#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-3#1)(1997-5#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#5)(2008-4#2)(2008-8#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-5#1)(2011-7#1)(2012-12#1)(2013-1#2)
of struma ovarii##2##3##(1994-6#1)(2009-5#1)
of struvite##3##2##(2010-2#2)(2011-2#1)
of strychnine##3##2##(1990-7#1)(1997-3#1)(2007-8#1)
of student and##2##3##(2005-12#1)(2005-7#1)
of student nurses##7##3##(2008-11#5)(2010-3#1)(2013-8#1)
of student outcomes##2##3##(2007-12#2)
of student##31##2##(1995-3#2)(2005-12#1)(2005-7#1)(2006-5#1)(2007-12#2)(2007-3#1)(2008-11#11)(2008-12#3)(2010-3#1)(2010-8#1)(2010-9#1)(2012-1#1)(2012-11#2)(2012-12#1)(2013-1#1)(2013-8#1)
of students and##5##3##(1997-5#1)(2008-11#1)(2008-12#1)(2012-2#1)(2012-3#1)
of students are##2##3##(2006-6#1)(2008-11#1)
of students had##2##3##(1991-9#1)(2008-11#1)
of students in##7##3##(1991-2#1)(2008-1#1)(2008-12#1)(2011-2#1)(2012-2#1)(2013-7#2)
of students of##2##3##(2004-12#1)(2007-3#1)
of students presenting##2##3##(1992-1#1)(2011-1#1)
of students reported##2##3##(2006-10#1)(2012-3#1)
of students to##3##3##(1990-10#1)(2008-11#2)
of students undertaking##2##3##(2008-11#2)
of students was##3##3##(1992-2#1)(1997-5#1)(2013-1#1)
of students were##4##3##(2005-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
of students who had##2##4##(2008-11#1)(2013-1#1)
of students who##4##3##(2004-12#1)(2008-11#2)(2013-1#1)
of students with##3##3##(2006-7#1)(2008-12#1)(2012-2#1)
of students##81##2##(1990-10#1)(1991-2#2)(1991-9#1)(1992-1#1)(1992-2#1)(1994-2#1)(1996-2#1)(1997-2#1)(1997-5#3)(2004-12#2)(2005-10#3)(2006-10#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-3#1)(2008-1#3)(2008-11#19)(2008-12#7)(2008-7#1)(2009-4#1)(2010-12#1)(2010-9#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#4)(2012-3#4)(2013-1#8)(2013-7#3)(2013-8#1)
of students' clinical##2##3##(2008-12#2)
of students' competence##2##3##(1993-1#1)(2008-12#1)
of students'##17##2##(1993-1#1)(2006-12#1)(2006-2#2)(2007-10#1)(2008-10#1)(2008-11#2)(2008-12#6)(2008-2#1)(2012-3#1)(2013-7#1)
of studied subjects##2##3##(1997-1#1)(2013-1#1)
of studied##9##2##(1997-1#1)(2006-6#1)(2007-8#1)(2008-10#2)(2008-7#2)(2010-12#1)(2013-1#1)
of studies and their##3##4##(2006-10#1)(2013-1#2)
of studies and##8##3##(2006-10#2)(2008-6#1)(2009-5#1)(2010-5#1)(2012-3#1)(2013-1#2)
of studies are##3##3##(1997-1#1)(2009-8#1)(2012-2#1)
of studies comparing##3##3##(2006-2#1)(2008-10#1)(2013-1#1)
of studies examining##2##3##(2008-4#1)(2008-7#1)
of studies have been conducted##2##5##(2008-10#1)(2012-3#1)
of studies have been##6##4##(1995-5#1)(2006-1#1)(2006-8#1)(2008-10#1)(2008-4#1)(2012-3#1)
of studies have focused on##2##5##(2008-3#1)(2009-10#1)
of studies have reported##2##4##(2008-9#1)(2013-8#1)
of studies have shown that##4##5##(2008-11#1)(2008-3#1)(2012-12#1)(2012-2#1)
of studies have shown##5##4##(1992-2#1)(2008-11#1)(2008-3#1)(2012-12#1)(2012-2#1)
of studies have##28##3##(1991-11#1)(1992-2#1)(1995-11#1)(1995-3#1)(1995-5#1)(2004-1#1)(2006-1#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-9#1)(2009-10#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-8#1)
of studies in##8##3##(1995-1#1)(1995-5#1)(1996-7#1)(2004-4#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-11#1)
of studies of the##7##4##(1997-2#1)(1997-4#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-7#1)(2011-2#1)
of studies of##22##3##(1990-12#1)(1990-8#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-7#1)
of studies on the##9##4##(1993-5#1)(2005-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-4#1)(2010-8#1)(2011-2#1)(2011-3#1)
of studies on##21##3##(1992-3#1)(1993-5#1)(1997-5#1)(2004-9#1)(2005-7#1)(2006-6#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-5#2)(2008-8#1)(2009-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-3#1)
of studies reporting##3##3##(2006-10#1)(2008-7#1)(2013-1#1)
of studies support the##2##4##(1996-5#1)(2011-2#1)
of studies that have##3##4##(2004-11#1)(2008-2#1)(2012-2#1)
of studies that##10##3##(2004-11#1)(2006-10#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
of studies using##2##3##(2009-2#1)(2009-9#1)
of studies was##2##3##(1995-2#1)(2013-1#1)
of studies were##4##3##(1995-2#1)(2004-12#1)(2006-4#1)(2013-1#1)
of studies which##4##3##(1990-8#1)(1997-1#1)(2005-10#1)(2008-11#1)
of studies with##5##3##(1993-9#1)(1995-2#1)(2007-11#1)(2007-3#1)(2010-12#1)
of studies##221##2##(1990-12#1)(1990-8#2)(1991-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-9#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#3)(2004-1#2)(2004-11#1)(2004-12#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-7#2)(2006-1#2)(2006-10#9)(2006-12#1)(2006-2#3)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#2)(2007-10#2)(2007-11#5)(2007-12#1)(2007-2#1)(2007-3#4)(2007-4#4)(2007-7#2)(2007-8#3)(2008-1#3)(2008-10#8)(2008-11#8)(2008-12#4)(2008-2#3)(2008-3#6)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#2)(2009-10#5)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-4#1)(2010-5#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#7)(2012-3#4)(2013-1#10)(2013-7#2)(2013-8#3)
of study and##4##3##(2008-11#1)(2009-10#1)(2013-1#1)(2013-8#1)
of study are##2##3##(1993-6#1)(2008-2#1)
of study area##2##3##(2008-12#1)(2013-8#1)
of study design and##2##4##(2006-2#1)(2012-2#1)
of study design##3##3##(1990-12#1)(2006-2#1)(2012-2#1)
of study duration##2##3##(2008-5#2)
of study for##4##3##(2006-9#1)(2007-2#1)(2008-11#1)(2012-1#1)
of study in##4##3##(2006-6#1)(2008-12#1)(2010-10#1)(2012-3#1)
of study is in##2##4##(1990-6#1)(2012-2#1)
of study is to##2##4##(2012-3#2)
of study is##5##3##(1990-6#1)(2012-2#1)(2012-3#2)(2013-7#1)
of study of##4##3##(1997-2#1)(2008-6#1)(2013-1#2)
of study on##5##3##(1994-5#1)(2008-11#1)(2008-8#1)(2009-4#1)(2010-10#1)
of study patients##3##3##(1993-12#1)(2004-3#1)(2010-12#1)
of study protocols##2##3##(2007-1#1)(2008-6#1)
of study results##3##3##(1993-12#1)(1996-7#1)(2011-2#1)
of study since##2##3##(2008-10#1)(2012-12#1)
of study subjects##5##3##(1990-4#1)(2008-12#1)(2010-12#1)(2013-1#2)
of study that##3##3##(1997-7#1)(2007-10#1)(2008-12#1)
of study was 14##2##4##(2007-2#1)(2013-1#1)
of study was to##4##4##(2007-9#1)(2008-1#1)(2012-2#1)(2013-8#1)
of study was##12##3##(1995-9#1)(2006-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of study would##2##3##(1993-2#1)(2006-1#1)
of study##145##2##(1990-12#2)(1990-4#1)(1990-6#1)(1990-8#1)(1991-6#1)(1992-11#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-5#1)(1995-9#2)(1996-1#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-7#2)(2004-1#2)(2004-3#1)(2005-12#2)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#3)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#3)(2008-11#7)(2008-12#7)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-4#3)(2009-6#2)(2009-7#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-6#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#6)(2012-3#7)(2013-1#9)(2013-7#1)(2013-8#5)
of study-specific##2##2##(1995-12#1)(2008-10#1)
of studying the##14##3##(1993-6#1)(1995-12#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-8#1)(2013-1#1)
of studying##38##2##(1990-3#1)(1990-4#1)(1990-5#1)(1992-9#1)(1993-4#1)(1993-6#1)(1995-12#1)(1997-2#1)(1997-5#1)(2006-11#1)(2006-12#1)(2007-11#2)(2007-12#3)(2007-6#2)(2007-9#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-5#2)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#2)
of stunning##5##2##(2008-3#1)(2010-4#3)(2011-1#1)
of stunting and##3##3##(2008-1#1)(2008-10#1)(2010-6#1)
of stunting##6##2##(2008-1#1)(2008-10#1)(2010-6#2)(2011-1#1)(2013-7#1)
of stuttering##8##2##(2008-2#3)(2008-8#1)(2012-12#4)
of stylalgia##3##2##(2013-8#3)
of stylet##2##2##(2008-10#2)
of stylohyoid ligament##2##3##(2012-2#2)
of styloid process##2##3##(2012-2#1)(2013-8#1)
of styrene and##4##3##(2008-10#2)(2008-11#1)(2010-2#1)
of styrene in##2##3##(1997-8#1)(2008-10#1)
of styrene to##2##3##(1997-8#1)(2008-5#1)
of styrene##20##2##(1997-8#4)(2005-11#2)(2005-8#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2010-2#4)(2010-5#1)
of sub##2##2##(2007-8#1)(2008-10#1)
of sub-10-fs pulses##4##3##(2007-11#1)(2007-12#3)
of sub-10-fs##7##2##(2007-11#1)(2007-12#6)
of sub-6-fs##2##2##(2007-12#2)
of sub-Saharan Africa##2##3##(2008-3#1)(2012-12#1)
of sub-cellular compartments##2##3##(2010-2#2)
of sub-cellular localization##2##3##(2010-2#2)
of sub-cellular##8##2##(2006-8#1)(2009-8#1)(2010-12#1)(2010-2#5)
of sub-chronic##2##2##(1996-12#2)
of sub-populations##2##2##(1990-8#1)(2008-8#1)
of subacromial space##2##3##(2007-11#2)
of subacromial##3##2##(2007-11#3)
of subacute and##2##3##(2006-10#1)(2012-1#1)
of subacute osteomyelitis##2##3##(1993-10#2)
of subacute##14##2##(1991-11#1)(1991-9#1)(1993-10#2)(1995-12#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#2)(2007-8#1)(2010-9#1)(2012-1#1)
of subaortic##2##2##(2013-1#2)
of subarachnoid haemorrhage##5##3##(1995-9#1)(2005-11#1)(2006-4#1)(2008-7#2)
of subarachnoid hemorrhage and mortality##2##5##(2007-10#2)
of subarachnoid hemorrhage##10##3##(1995-5#1)(2007-10#5)(2007-7#1)(2007-9#1)(2008-2#1)(2012-1#1)
of subarachnoid##15##2##(1995-5#1)(1995-9#1)(2005-11#1)(2006-4#1)(2007-10#5)(2007-7#1)(2007-9#1)(2008-2#1)(2008-7#2)(2012-1#1)
of subcapital growth plate##2##4##(2007-11#2)
of subcellular fractions##2##3##(1990-12#1)(1995-9#1)
of subcellular localization##5##3##(1997-5#1)(2007-12#2)(2012-12#2)
of subcellular##15##2##(1990-12#1)(1993-9#1)(1995-6#1)(1995-9#1)(1997-5#1)(2006-2#1)(2007-12#2)(2008-11#1)(2008-4#1)(2009-6#1)(2011-1#1)(2012-12#3)
of subchondral bone##4##3##(2005-7#1)(2007-11#1)(2007-4#1)(2007-7#1)
of subchronic##2##2##(1996-10#1)(2008-6#1)
of subclavian##3##2##(2007-7#3)
of subclinical atherosclerosis##6##3##(2008-11#3)(2008-3#1)(2013-1#2)
of subclinical cryptosporidiosis##2##3##(1996-12#2)
of subclinical disease##2##3##(2006-11#1)(2009-12#1)
of subclinical rejection##2##3##(1995-2#1)(2007-8#1)
of subclinical##23##2##(1990-11#1)(1991-2#1)(1994-10#1)(1995-2#1)(1996-12#2)(2005-7#1)(2006-11#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-8#2)(2009-12#1)(2010-4#1)(2010-8#1)(2012-1#1)(2013-1#2)
of subcortical##6##2##(1992-8#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#2)
of subcutaneous and mesenteric##2##4##(2006-4#2)
of subcutaneous fat##9##3##(1996-3#1)(2008-1#1)(2011-1#1)(2012-12#1)(2012-2#5)
of subcutaneous lipomatous soft-tissue##2##4##(2012-2#2)
of subcutaneous tissue##4##3##(1990-8#1)(1997-3#1)(2004-9#1)(2010-6#1)
of subcutaneous##33##2##(1990-8#1)(1991-10#1)(1991-5#1)(1991-6#3)(1996-3#1)(1997-3#1)(1997-8#1)(2004-12#1)(2004-9#1)(2006-4#2)(2007-7#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-6#1)(2009-12#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#8)(2012-3#1)(2013-1#1)
of subcutaneously##2##2##(1992-7#1)(2010-2#1)
of subduction##2##2##(1993-4#1)(1995-6#1)
of subdural##5##2##(1996-11#1)(2006-8#3)(2008-5#1)
of subendocardial##3##2##(1991-3#1)(2009-4#2)
of suberin##3##2##(1995-3#2)(2008-10#1)
of subfamily##3##2##(1993-6#2)(2006-8#1)
of subfragment-1##2##2##(1990-12#1)(1991-2#1)
of subgenus Leishmania (Viannia) DNA##2##5##(2013-1#2)
of subglottic laryngitis##3##3##(2007-9#3)
of subglottic##5##2##(2007-9#3)(2011-2#1)(2012-2#1)
of subgraphs##2##2##(2010-10#2)
of subgroup##10##2##(1994-11#1)(2007-6#1)(2008-10#4)(2008-12#1)(2008-9#1)(2012-3#1)(2013-7#1)
of subgroups##2##2##(1996-2#1)(2008-5#1)
of subject##3##2##(1993-11#1)(2008-10#1)(2009-7#1)
of subject-specific##2##2##(2008-6#1)(2013-1#1)
of subjective and objective measures##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
of subjective and objective##4##4##(1992-9#1)(2007-12#1)(2008-2#1)(2008-3#1)
of subjective health##2##3##(2011-2#1)(2013-1#1)
of subjective symptoms##4##3##(1991-4#1)(2007-11#3)
of subjective##28##2##(1991-4#1)(1992-2#1)(1992-9#1)(1994-4#1)(1994-7#1)(1996-6#1)(2006-7#1)(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-11#1)(2013-1#2)(2013-7#1)
of subjectively##2##2##(2008-7#1)(2013-1#1)
of subjectivity##2##2##(2007-1#1)(2008-11#1)
of subjects aged##2##3##(2008-3#1)(2012-1#1)
of subjects and##8##3##(1991-6#1)(2004-11#2)(2006-8#2)(2010-12#1)(2011-2#1)(2013-8#1)
of subjects at##4##3##(1997-7#1)(2008-10#1)(2008-4#1)(2010-5#1)
of subjects for##3##3##(2012-3#3)
of subjects from a##2##4##(2008-12#1)(2012-11#1)
of subjects from##5##3##(1997-2#1)(2008-12#1)(2011-2#1)(2012-11#1)(2012-3#1)
of subjects had##5##3##(1992-6#1)(2006-2#1)(2006-4#1)(2007-12#1)(2010-1#1)
of subjects in the##3##4##(2007-2#1)(2012-12#2)
of subjects in##7##3##(1995-5#1)(1995-9#1)(2007-2#1)(2009-7#1)(2009-8#1)(2012-12#2)
of subjects on the##2##4##(1991-6#1)(2008-7#1)
of subjects on##5##3##(1991-2#1)(1991-6#1)(1994-6#1)(2008-7#1)(2011-2#1)
of subjects reporting##2##3##(2006-10#1)(2008-12#1)
of subjects to##2##3##(2006-6#1)(2007-10#1)
of subjects under##2##3##(1994-8#1)(2011-2#1)
of subjects was##4##3##(2008-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
of subjects were##5##3##(2008-11#1)(2008-4#1)(2008-7#2)(2010-1#1)
of subjects who reported##2##4##(2006-2#1)(2008-11#1)
of subjects who##7##3##(1992-6#1)(1995-12#1)(2006-11#1)(2006-2#2)(2008-11#1)(2013-8#1)
of subjects with bipolar##2##4##(1995-11#2)
of subjects with high##2##4##(1997-1#1)(2009-1#1)
of subjects with hypercholesterolemia##2##4##(2008-7#1)(2008-8#1)
of subjects with low##2##4##(1997-1#1)(2013-8#1)
of subjects with the##2##4##(2008-3#1)(2009-9#1)
of subjects with##36##3##(1991-11#1)(1995-11#2)(1996-1#1)(1997-1#2)(2006-10#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#4)(2008-8#1)(2009-1#1)(2009-9#1)(2010-8#1)(2011-2#2)(2012-11#1)(2012-2#4)(2012-3#2)(2013-8#1)
of subjects##170##2##(1990-10#1)(1990-3#1)(1990-9#2)(1991-11#1)(1991-2#3)(1991-6#2)(1992-11#1)(1992-6#2)(1993-4#1)(1993-5#1)(1993-7#2)(1994-11#1)(1994-12#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-5#1)(1995-9#3)(1996-1#2)(1996-2#1)(1996-5#2)(1996-7#2)(1996-9#1)(1997-1#3)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-11#2)(2005-11#1)(2006-10#5)(2006-11#1)(2006-2#5)(2006-4#1)(2006-6#3)(2006-8#4)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#2)(2008-1#1)(2008-10#6)(2008-11#6)(2008-12#4)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#1)(2009-1#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#4)(2011-1#3)(2011-2#10)(2012-1#3)(2012-11#2)(2012-12#2)(2012-2#7)(2012-3#7)(2013-1#4)(2013-8#4)
of sublethal##4##2##(2006-8#1)(2007-11#1)(2008-4#1)(2011-1#1)
of sublimation##2##2##(2008-5#2)
of submarine##2##2##(2010-2#2)
of submaximal##2##2##(1991-8#1)(2013-8#1)
of submerged##4##2##(2008-2#1)(2008-7#2)(2009-12#1)
of submicrometer##3##2##(2007-11#1)(2007-12#1)(2008-1#1)
of submicron##4##2##(2008-10#1)(2008-11#1)(2008-5#2)
of submillimeter##3##2##(2008-2#3)
of submitochondrial particles##3##3##(1990-8#1)(1995-6#1)(1997-1#1)
of submitochondrial##4##2##(1990-8#1)(1993-3#1)(1995-6#1)(1997-1#1)
of submucosal hematoma of the esophagus##2##6##(2011-2#2)
of submucosal##9##2##(1990-10#1)(1990-5#1)(1991-9#1)(2005-8#1)(2008-12#1)(2008-5#1)(2011-2#2)(2012-1#1)
of suboptimal##6##2##(1997-4#1)(2004-12#1)(2004-9#1)(2008-4#1)(2008-8#1)(2012-2#1)
of subordinate rats##2##3##(1992-1#1)(1997-5#1)
of subordinate##5##2##(1992-1#2)(1997-5#1)(2008-8#1)(2013-8#1)
of subpicosecond electrical pulses by optical rectification##2##7##(2007-12#2)
of subpicosecond electrical pulses##3##4##(2007-11#1)(2007-12#2)
of subpicosecond pulses##2##3##(2007-11#1)(2007-12#1)
of subpicosecond##10##2##(2007-11#3)(2007-12#5)(2008-2#1)(2009-4#1)
of subpopulation##2##2##(2008-10#1)(2008-12#1)
of subpopulations of##2##3##(2008-5#1)(2008-6#1)
of subpopulations##6##2##(1997-4#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-9#1)
of subsequent complications##2##3##(2008-7#1)(2012-12#1)
of subsequent##65##2##(1990-2#1)(1990-7#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-8#1)(1995-9#2)(1996-1#2)(1997-1#1)(1997-8#1)(2004-1#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-3#2)(2013-1#2)
of subsequently##2##2##(1996-6#1)(2010-3#1)
of subsets of##4##3##(1997-4#1)(1997-8#1)(2008-11#1)(2008-3#1)
of subsets##6##2##(1997-4#1)(1997-8#1)(2008-11#1)(2008-3#1)(2008-9#2)
of subsidy##2##2##(1990-12#1)(2008-12#1)
of subspecies of##2##3##(2006-8#1)(2008-9#1)
of subspecies##3##2##(2006-8#1)(2008-9#1)(2011-1#1)
of substance P (SP) and##2##5##(1992-3#1)(1992-9#1)
of substance P (SP)##4##4##(1990-11#1)(1991-8#1)(1992-3#1)(1992-9#1)
of substance P carbamate in##2##5##(1993-8#2)
of substance P on striatal##2##5##(1990-2#1)(1994-8#1)
of substance P was##2##4##(1990-2#1)(1992-3#1)
of substance P##30##3##(1990-11#1)(1990-2#2)(1991-10#1)(1991-4#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-3#4)(1992-8#1)(1992-9#1)(1993-11#1)(1993-8#3)(1994-6#1)(1994-8#5)(1995-9#1)(1996-12#1)(1997-5#1)(2006-2#1)(2008-7#1)
of substance P-immunoreactive##2##3##(1991-9#2)
of substance abuse on##2##4##(2007-11#1)(2009-9#1)
of substance abuse treatment##2##4##(2005-9#1)(2010-11#1)
of substance abuse##11##3##(2005-9#2)(2006-9#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-6#1)(2009-5#1)(2009-9#1)(2010-11#1)(2013-8#1)
of substance abusers##3##3##(1991-1#1)(1994-2#1)(2011-1#1)
of substance dependence##2##3##(1991-1#1)(2011-1#1)
of substance use##12##3##(1994-2#1)(2005-6#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-7#4)(2010-10#1)(2010-8#1)(2013-1#1)
of substance##72##2##(1990-11#1)(1990-2#2)(1991-1#2)(1991-10#1)(1991-4#2)(1991-8#1)(1991-9#3)(1992-10#1)(1992-3#4)(1992-8#1)(1992-9#1)(1993-11#1)(1993-8#3)(1994-2#3)(1994-6#1)(1994-8#5)(1995-9#1)(1996-12#1)(1997-5#1)(1997-7#1)(2005-6#1)(2005-9#2)(2006-2#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-3#2)(2008-5#1)(2008-6#4)(2008-7#2)(2009-5#1)(2009-7#4)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#3)(2010-4#1)(2010-8#1)(2011-1#2)(2012-11#1)(2012-12#2)(2013-1#1)(2013-8#1)
of substance-dependent patients##5##3##(2011-1#5)
of substance-dependent##6##2##(2008-3#1)(2011-1#5)
of substances for##2##3##(2007-8#1)(2010-8#1)
of substances from##2##3##(1990-2#1)(2007-12#1)
of substances in a##2##4##(2008-11#1)(2013-8#1)
of substances in##6##3##(2005-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-11#1)(2013-8#1)
of substances that##3##3##(2007-8#1)(2008-10#1)(2008-3#1)
of substances##45##2##(1990-2#1)(1990-3#1)(1990-6#2)(1991-6#2)(1991-8#1)(1993-12#1)(1995-3#1)(1996-3#1)(1997-8#1)(2005-1#1)(2005-11#1)(2005-4#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-10#3)(2008-11#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-5#1)(2010-8#1)(2010-9#3)(2012-3#1)(2013-8#2)
of substantia innominata##2##3##(1991-5#2)
of substantia nigra##6##3##(1990-5#2)(1991-3#1)(1993-4#1)(1995-12#1)(1996-10#1)
of substantia##9##2##(1990-5#2)(1991-3#1)(1991-5#2)(1992-8#1)(1993-4#1)(1995-12#1)(1996-10#1)
of substantial and##2##3##(2006-10#1)(2008-3#1)
of substantial##15##2##(1991-1#1)(1991-12#1)(1992-11#1)(1993-2#1)(1994-10#1)(1995-2#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
of substantially##3##2##(1994-3#1)(1995-3#1)(2008-3#1)
of substantive##2##2##(1995-8#1)(2009-4#1)
of substituent##2##2##(1991-4#1)(2012-3#1)
of substituents at##3##3##(1992-6#1)(1994-9#1)(2009-10#1)
of substituents on the##2##4##(1994-9#1)(2009-10#1)
of substituents##9##2##(1991-5#1)(1992-6#1)(1993-4#1)(1994-9#2)(1995-11#1)(2006-12#1)(2009-10#2)
of substituted norbornadienes##2##3##(2009-9#2)
of substituted phenols##2##3##(1990-9#1)(2007-11#1)
of substituted##26##2##(1990-9#1)(1992-2#1)(1996-2#1)(1997-2#1)(2007-10#3)(2007-11#7)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-3#2)(2009-9#2)(2010-2#1)
of substituting##3##2##(1990-12#1)(1990-5#1)(2008-10#1)
of substitution of the##2##4##(1997-7#1)(2010-4#1)
of substitution of##8##3##(1994-4#1)(1997-7#1)(2007-8#2)(2008-8#1)(2010-4#1)(2011-2#2)
of substitution##29##2##(1991-7#1)(1991-9#1)(1992-3#2)(1992-6#1)(1993-3#1)(1994-4#1)(1995-11#1)(1997-7#1)(2005-11#1)(2005-7#1)(2007-11#1)(2007-8#2)(2008-10#4)(2008-4#3)(2008-5#2)(2008-8#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#1)
of substitutions##2##2##(1990-3#1)(2008-10#1)
of substitutive##2##2##(2008-3#1)(2013-1#1)
of substrata##2##2##(2006-3#1)(2007-7#1)
of substrate affinity##2##3##(1996-7#1)(1997-7#1)
of substrate and ligand##2##4##(1992-9#2)
of substrate and##9##3##(1991-3#1)(1992-9#2)(1993-8#1)(1994-8#1)(2008-10#1)(2008-3#1)(2009-11#1)(2010-3#1)
of substrate converted##2##3##(2008-6#1)(2008-7#1)
of substrate dissolution##2##3##(2008-7#2)
of substrate in##2##3##(1995-2#1)(2008-7#1)
of substrate inhibition##3##3##(1990-5#1)(1996-7#1)(1997-2#1)
of substrate proteins##3##3##(2009-6#1)(2009-7#1)(2012-11#1)
of substrate solution with or without inhibitor##2##7##(2008-4#2)
of substrate specificity##3##3##(1992-7#1)(2007-11#1)(2011-2#1)
of substrate to##4##3##(1990-2#1)(1993-2#1)(1994-9#1)(1996-7#1)
of substrate##87##2##(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-7#1)(1992-11#2)(1992-3#2)(1992-7#1)(1992-9#3)(1993-2#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-10#2)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-7#3)(1997-1#2)(1997-2#1)(1997-7#1)(2006-11#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#11)(2008-8#1)(2009-11#2)(2009-6#1)(2009-7#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)
of substrate/product##3##2##(1995-5#3)
of substrates across##2##3##(1993-11#1)(2008-11#1)
of substrates and inhibitors##2##4##(1994-8#2)
of substrates and##9##3##(1992-6#1)(1993-9#1)(1994-12#1)(1994-8#2)(2005-8#1)(2008-3#1)(2008-4#1)(2009-8#1)
of substrates by##2##3##(1990-2#1)(1991-7#1)
of substrates for##2##3##(1992-8#1)(2008-5#1)
of substrates on##2##3##(1990-3#1)(1992-11#1)
of substrates to##2##3##(1991-11#1)(1992-7#1)
of substrates##49##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1991-11#1)(1991-7#2)(1992-11#2)(1992-6#2)(1992-7#1)(1992-8#3)(1993-11#1)(1993-2#1)(1993-3#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#5)(1995-11#1)(1995-8#1)(1996-5#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-8#1)(2010-4#1)
of subsurface structure##2##3##(2007-12#2)
of subsurface##5##2##(2007-12#2)(2008-1#1)(2008-2#1)(2011-1#1)
of subsystems##2##2##(2008-10#1)(2008-11#1)
of subtalar joint##2##3##(2012-2#2)
of subtalar##5##2##(2008-12#1)(2008-8#1)(2010-7#1)(2012-2#2)
of subtelomeric DNA##2##3##(1991-7#1)(1997-6#1)
of subtelomeric##3##2##(1991-7#1)(1997-6#2)
of subterranean##2##2##(2006-12#1)(2011-2#1)
of subtherapeutic##2##2##(2007-11#1)(2010-10#1)
of subthreshold##2##2##(1994-2#1)(2008-11#1)
of subtilisin Carlsberg by##2##4##(1994-8#2)
of subtilisin Carlsberg##6##3##(1994-8#3)(1995-7#1)(1997-4#1)(2008-7#1)
of subtilisin and##2##3##(1992-4#1)(1995-11#1)
of subtilisin##21##2##(1991-4#1)(1992-11#2)(1992-4#1)(1994-8#3)(1995-11#5)(1995-3#1)(1995-5#1)(1995-7#1)(1997-4#2)(2008-7#3)(2008-8#1)
of subtle##11##2##(1992-8#1)(1994-3#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-7#1)(2012-1#2)(2012-2#1)(2013-1#1)
of subtotal removal##3##3##(2007-1#1)(2008-7#1)(2012-1#1)
of subtotal##4##2##(1991-5#1)(2007-1#1)(2008-7#1)(2012-1#1)
of subtraction##3##2##(2008-2#3)
of subtropical rocky shores##2##4##(2010-8#2)
of subtype C##2##3##(1994-12#2)
of subtype##9##2##(1994-12#6)(2006-10#1)(2008-5#1)(2013-8#1)
of subtype-specific##2##2##(1994-2#1)(2008-4#1)
of subtypes of neuronal##2##4##(1994-2#1)(1995-11#1)
of subtypes of##3##3##(1994-2#1)(1995-11#1)(2007-6#1)
of subtypes##4##2##(1994-2#1)(1995-11#1)(2007-6#1)(2010-9#1)
of subungual##2##2##(2007-7#2)
of subunit 8 is##2##4##(1992-11#2)
of subunit 9##2##3##(1992-11#2)
of subunit VIa of##2##4##(1994-12#1)(1997-3#1)
of subunit VIa##3##3##(1994-12#1)(1997-3#2)
of subunit a##3##3##(2008-4#3)
of subunit assembly##3##3##(1990-8#1)(1997-2#2)
of subunit association##2##3##(1994-11#1)(1995-8#1)
of subunit b##4##3##(1990-5#3)(1997-3#1)
of subunit structure##2##3##(1990-11#1)(2008-3#1)
of subunit##41##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#6)(1990-8#1)(1991-3#4)(1992-11#4)(1993-11#1)(1994-11#2)(1994-12#2)(1994-6#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-7#1)(1997-2#3)(1997-3#3)(2006-8#1)(2008-1#1)(2008-3#1)(2008-4#4)
of subunit-specific##2##2##(1994-12#1)(2008-8#1)
of subunit-subunit##2##2##(1990-8#1)(1995-8#1)
of subunits a and##2##4##(1997-3#1)(2008-4#1)
of subunits as##2##3##(1991-10#1)(1992-8#1)
of subunits b##2##3##(1994-9#2)
of subunits in the##2##4##(1990-8#1)(1992-8#1)
of subunits of the##3##4##(1990-5#1)(2005-8#1)(2006-9#1)
of subunits of##6##3##(1990-3#1)(1990-5#1)(1992-6#1)(2005-8#1)(2006-9#1)(2011-2#1)
of subunits##27##2##(1990-12#1)(1990-3#2)(1990-5#1)(1990-8#1)(1991-10#1)(1991-3#1)(1991-7#1)(1992-6#1)(1992-8#3)(1993-11#1)(1994-3#1)(1994-6#1)(1994-9#3)(1995-4#1)(1997-3#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-8#1)(2006-9#1)(2008-4#1)(2011-2#1)
of subwavelength diffractive##4##3##(2007-12#2)(2008-3#2)
of subwavelength gratings##2##3##(2008-2#1)(2008-3#1)
of subwavelength##16##2##(2007-11#1)(2007-12#5)(2008-2#3)(2008-3#7)
of success and##5##3##(1993-11#1)(2008-2#1)(2008-3#1)(2011-12#1)(2013-8#1)
of success for##2##3##(2008-4#1)(2013-1#1)
of success in the##3##4##(2006-2#1)(2007-2#1)(2008-1#1)
of success in##9##3##(2006-2#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-8#1)(2009-12#1)(2010-5#1)(2012-3#2)
of success of##8##3##(1991-8#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-7#1)(2009-4#1)(2012-2#1)(2013-7#1)
of success or##2##3##(1996-3#1)(2007-4#1)
of success that##4##3##(1993-3#2)(2007-4#1)(2011-1#1)
of success was##3##3##(1991-2#1)(1994-3#1)(2013-1#1)
of success with##4##3##(1991-12#1)(2006-9#1)(2008-5#1)(2010-8#1)
of success##77##2##(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-7#1)(1996-3#2)(2005-11#1)(2005-8#3)(2006-10#5)(2006-12#4)(2006-2#2)(2006-8#1)(2006-9#4)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#3)(2007-7#1)(2008-1#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-11#1)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
of successes and##2##3##(1994-12#1)(1994-3#1)
of successes##3##2##(1994-12#1)(1994-3#1)(2012-3#1)
of successful clinical trials##2##4##(2007-10#1)(2010-10#1)
of successful demands was##2##4##(2007-2#2)
of successful endoscopic##2##3##(2008-7#1)(2012-12#1)
of successful gene therapy##2##4##(2008-4#1)(2010-12#1)
of successful management##2##3##(2009-11#1)(2012-12#1)
of successful service redeployment##2##4##(1993-1#2)
of successful transmission##2##3##(2008-10#1)(2013-8#1)
of successful treatment of##3##4##(1991-4#1)(2007-2#1)(2008-10#1)
of successful treatment##4##3##(1991-4#1)(2007-2#1)(2008-10#1)(2010-3#1)
of successful##76##2##(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1993-1#2)(1993-12#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(2005-9#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#3)(2007-4#3)(2007-7#2)(2007-8#1)(2008-10#6)(2008-11#2)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#2)(2012-12#5)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
of successfully##9##2##(1991-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-7#1)(2011-2#1)(2013-1#1)
of successive approximation##2##3##(2008-10#1)(2008-2#1)
of successive##14##2##(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)(2013-1#1)
of succinate##2##2##(1990-8#1)(1997-7#1)
of succinic acid in biotechnological processes##2##6##(2008-10#2)
of succinic acid in##3##4##(2008-10#3)
of succinic acid##11##3##(1990-8#1)(2006-12#2)(2008-10#3)(2008-6#2)(2013-1#3)
of succinic semialdehyde##2##3##(1997-2#2)
of succinic##15##2##(1990-8#1)(1995-11#1)(1997-2#2)(2006-12#2)(2008-10#4)(2008-6#2)(2013-1#3)
of succinylcholine##3##2##(1990-11#2)(2006-10#1)
of such a beam##2##4##(2007-12#1)(2008-2#1)
of such a change in##3##5##(1994-3#1)(2006-12#1)(2008-7#1)
of such a change##4##4##(1994-3#1)(2006-12#1)(2008-12#1)(2008-7#1)
of such a complex##3##4##(2006-12#1)(2006-8#1)(2009-5#1)
of such a critical##2##4##(2008-8#2)
of such a database##2##4##(1994-6#1)(2008-10#1)
of such a device##4##4##(2006-6#1)(2007-12#1)(2008-2#1)(2009-3#1)
of such a disease##2##4##(1994-3#1)(2012-2#1)
of such a generalized##2##4##(2008-2#1)(2008-6#1)
of such a lesion##4##4##(2008-1#1)(2008-4#1)(2008-7#1)(2010-7#1)
of such a method##4##4##(1992-4#1)(2008-10#2)(2008-5#1)
of such a model##2##4##(2006-10#1)(2008-11#1)
of such a new##3##4##(1990-12#1)(1990-3#1)(2011-2#1)
of such a program##3##4##(1990-12#1)(1992-12#1)(1992-3#1)
of such a sensor##3##4##(2007-12#1)(2008-10#1)(2010-2#1)
of such a strategy##2##4##(1993-1#1)(1994-9#1)
of such a system in##2##5##(2004-9#2)
of such a system##8##4##(1992-2#1)(1994-1#1)(2004-9#2)(2008-2#2)(2008-3#2)
of such a team##2##4##(1996-7#1)(2007-6#1)
of such a technique##2##4##(1992-12#1)(2008-7#1)
of such a##151##3##(1990-10#1)(1990-12#3)(1990-3#1)(1990-4#1)(1990-8#1)(1991-11#1)(1991-2#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-12#2)(1996-4#1)(1996-7#1)(1997-6#1)(1997-8#1)(2004-12#1)(2004-9#2)(2005-10#1)(2005-11#2)(2006-10#2)(2006-12#4)(2006-2#1)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#6)(2007-6#2)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#5)(2008-12#4)(2008-2#11)(2008-3#11)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#5)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)
of such activities##3##3##(1991-12#1)(2008-11#1)(2010-5#1)
of such alterations##3##3##(1993-2#1)(2008-12#1)(2011-2#1)
of such an approach is##2##5##(1992-8#1)(1994-2#1)
of such an approach##8##4##(1992-8#1)(1994-2#1)(1996-11#1)(2007-8#1)(2008-3#1)(2008-7#1)(2010-8#1)(2012-12#1)
of such an assessment##2##4##(2008-11#2)
of such an association##2##4##(2008-10#1)(2012-2#1)
of such an event##2##4##(1997-5#1)(2008-11#1)
of such an experience##2##4##(2008-2#1)(2008-7#1)
of such an interferometer##2##4##(2008-2#2)
of such an##47##3##(1990-6#1)(1991-6#1)(1992-1#1)(1992-8#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-5#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#5)(2008-2#5)(2008-3#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-3#1)(2010-1#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
of such analyses##2##3##(2008-10#1)(2008-7#1)
of such antibodies is##2##4##(2008-10#1)(2013-1#1)
of such antibodies##4##3##(1992-7#1)(2008-10#1)(2008-4#1)(2013-1#1)
of such background signals##2##4##(2008-3#2)
of such background##3##3##(1994-12#1)(2008-3#2)
of such carriers##2##3##(2010-1#1)(2010-7#1)
of such cases is##2##4##(2005-11#1)(2013-1#1)
of such cases will##2##4##(2007-7#1)(2011-2#1)
of such cases##22##3##(1992-11#1)(2004-10#1)(2005-11#1)(2005-7#1)(2005-9#1)(2007-3#1)(2007-7#1)(2008-11#2)(2008-12#1)(2009-4#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#4)(2013-8#1)
of such cells##4##3##(1992-5#1)(2008-11#1)(2012-12#2)
of such changes##3##3##(2006-6#1)(2008-10#1)(2011-1#1)
of such characteristic##2##3##(1996-4#1)(2011-2#1)
of such children##2##3##(2007-12#1)(2012-12#1)
of such clones##2##3##(1994-3#1)(2008-9#1)
of such complaints##2##3##(1992-6#1)(1993-5#1)
of such complex##4##3##(2007-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
of such complexes##2##3##(1990-5#1)(2008-5#1)
of such complications##5##3##(1995-9#1)(2009-4#1)(2011-2#2)(2013-7#1)
of such compounds##6##3##(1990-1#1)(1991-12#1)(1993-12#1)(2005-7#1)(2007-1#1)(2008-1#1)
of such conditions##3##3##(1990-12#1)(2005-11#1)(2009-3#1)
of such data##12##3##(1991-12#2)(1992-1#1)(1993-9#1)(2004-4#1)(2008-3#1)(2008-8#1)(2010-11#1)(2010-7#1)(2011-3#1)(2012-2#1)(2013-1#1)
of such deaths in##2##4##(1996-11#1)(1997-8#1)
of such defects is##2##4##(2006-9#1)(2008-4#1)
of such defects##3##3##(2006-9#1)(2008-4#1)(2012-12#1)
of such devices in##2##4##(2006-10#1)(2007-12#1)
of such devices is##2##4##(2009-11#1)(2010-5#1)
of such devices with##2##4##(2008-3#1)(2012-2#1)
of such devices##12##3##(1997-1#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-12#2)(2008-3#2)(2008-7#1)(2009-11#1)(2010-5#1)(2012-2#1)
of such differences##2##3##(1993-12#1)(2007-6#1)
of such disasters##2##3##(1991-2#1)(1993-1#1)
of such disease##3##3##(1993-9#1)(1995-9#1)(2008-10#1)
of such diseases##2##3##(1993-9#1)(2013-8#1)
of such disorders##3##3##(1997-3#1)(2005-6#1)(2011-12#1)
of such diversity##3##3##(2007-12#1)(2008-10#1)(2010-2#1)
of such drugs##5##3##(1997-5#1)(2008-3#1)(2008-9#1)(2010-12#1)(2012-2#1)
of such effects in##3##4##(1995-5#1)(1996-8#1)(2011-1#1)
of such effects##6##3##(1995-5#1)(1996-6#1)(1996-8#1)(2007-11#1)(2008-9#1)(2011-1#1)
of such efforts##2##3##(1993-2#1)(1994-12#1)
of such elements##2##3##(2008-10#1)(2008-3#1)
of such events##3##3##(2007-10#1)(2009-10#1)(2010-5#1)
of such experiments##2##3##(2008-1#1)(2008-7#1)
of such factors as##2##4##(2008-11#1)(2008-8#1)
of such factors##5##3##(1991-5#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-8#1)
of such filters##2##3##(2007-12#1)(2008-2#1)
of such findings##2##3##(1992-12#1)(1995-11#1)
of such flow##2##3##(1992-8#1)(1996-12#1)
of such food##2##3##(2008-1#1)(2008-10#1)
of such forms##2##3##(2006-8#1)(2008-10#1)
of such formulations##2##3##(2004-9#1)(2010-12#1)
of such genes is##2##4##(2008-10#1)(2008-4#1)
of such genes##5##3##(1993-10#1)(1993-9#1)(1994-8#1)(2008-10#1)(2008-4#1)
of such growth##2##3##(1996-5#1)(2008-11#1)
of such high##3##3##(2005-5#1)(2006-7#1)(2008-3#1)
of such infections##6##3##(2007-12#1)(2007-9#1)(2008-2#1)(2009-2#1)(2011-1#1)(2013-8#1)
of such information##3##3##(2007-12#1)(2008-11#1)(2008-8#1)
of such initiatives##2##3##(2008-7#1)(2011-2#1)
of such injuries##4##3##(1990-2#1)(1990-9#1)(1993-3#1)(2007-11#1)
of such interactions##5##3##(1992-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-10#1)
of such intervention##2##3##(1994-8#1)(2007-10#1)
of such interventions##3##3##(2005-11#1)(2007-1#1)(2010-12#1)
of such isolates##2##3##(2008-10#1)(2011-2#1)
of such lasers##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-9#1)
of such lesions is##2##4##(2008-11#1)(2012-3#1)
of such lesions##6##3##(2006-9#1)(2007-8#1)(2008-11#1)(2008-9#1)(2012-3#1)(2013-1#1)
of such local##2##3##(1996-6#1)(2013-8#1)
of such materials##4##3##(2006-6#1)(2008-10#1)(2010-10#1)(2010-2#1)
of such measurements##2##3##(2005-11#1)(2008-3#1)
of such measures##2##3##(2008-3#1)(2009-6#1)
of such medical devices##2##4##(2008-11#1)(2013-1#1)
of such methods##4##3##(1992-6#1)(1993-9#1)(2006-10#1)(2008-11#1)
of such models is##2##4##(2008-9#1)(2011-1#1)
of such models##4##3##(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#1)
of such modifications##2##3##(2008-10#1)(2013-8#1)
of such molecules##2##3##(1991-9#1)(2008-4#1)
of such mutations##3##3##(2006-10#1)(2009-5#1)(2011-1#1)
of such neuronal##2##3##(1997-7#1)(2008-4#1)
of such new##3##3##(2008-10#2)(2012-2#1)
of such ontologies would##2##4##(2009-5#2)
of such ontologies##3##3##(2008-7#1)(2009-5#2)
of such particles is##2##4##(2005-11#1)(2010-7#1)
of such particles##4##3##(1992-6#1)(2005-11#2)(2010-7#1)
of such pathogenic##3##3##(2010-4#1)(2013-1#2)
of such patients in##3##4##(2007-12#1)(2012-2#2)
of such patients were##2##4##(1991-3#2)
of such patients with##2##4##(2008-7#1)(2011-2#1)
of such patients##26##3##(1990-2#1)(1991-11#1)(1991-3#2)(1992-2#1)(1993-9#1)(1995-11#1)(1995-2#1)(1997-8#1)(2005-8#1)(2006-12#1)(2007-12#1)(2007-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)
of such procedures##2##3##(1997-6#1)(2007-1#1)
of such products##2##3##(2007-11#1)(2008-5#1)
of such programs##6##3##(1991-1#1)(1992-1#1)(1995-3#1)(2007-2#1)(2012-12#2)
of such projections##2##3##(2007-11#1)(2008-2#1)
of such properties##3##3##(1992-2#1)(2007-6#1)(2009-2#1)
of such proteins in##2##4##(2006-5#1)(2007-11#1)
of such proteins##4##3##(1993-3#1)(1993-9#1)(2006-5#1)(2007-11#1)
of such rapid##2##3##(2011-1#1)(2012-2#1)
of such rational##2##3##(1993-11#1)(2008-11#1)
of such roles##2##3##(2008-12#1)(2010-7#1)
of such secondary##2##3##(1995-4#1)(2008-10#1)
of such sensors##2##3##(2008-10#2)
of such sequences##2##3##(1997-4#2)
of such services##2##3##(2010-11#1)(2012-2#1)
of such small##2##3##(1991-5#1)(2009-2#1)
of such solutions##3##3##(1993-4#1)(2005-11#1)(2008-10#1)
of such species##2##3##(2008-10#1)(2008-5#1)
of such spectra is##2##4##(2008-2#2)
of such studies is##2##4##(2008-10#1)(2010-12#1)
of such studies##17##3##(1991-5#1)(1993-6#1)(1994-12#1)(1994-6#1)(2005-10#1)(2005-7#1)(2006-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#2)(2012-1#1)(2013-1#2)
of such symptoms##2##3##(1995-8#1)(2006-7#1)
of such system##2##3##(2008-5#1)(2013-8#1)
of such systems is##3##4##(2006-6#1)(2008-3#1)(2013-8#1)
of such systems requires##2##4##(2007-12#1)(2009-8#1)
of such systems##16##3##(1996-1#1)(1997-6#2)(2006-10#1)(2006-6#3)(2007-12#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-8#1)(2012-12#1)(2013-7#1)(2013-8#1)
of such techniques##7##3##(1992-6#1)(1994-9#1)(1997-6#1)(2006-10#1)(2008-10#2)(2008-8#1)
of such technologies##3##3##(2008-2#1)(2008-5#1)(2012-2#1)
of such technology##2##3##(2008-12#1)(2009-6#1)
of such testing##2##3##(1996-12#1)(2012-12#1)
of such therapy in the##2##5##(2006-3#1)(2007-11#1)
of such therapy##3##3##(2006-3#1)(2007-10#1)(2007-11#1)
of such tools##4##3##(1993-12#1)(2013-1#3)
of such training##2##3##(2007-2#1)(2012-3#1)
of such traits##2##3##(2007-12#1)(2008-8#1)
of such treatment##3##3##(1991-8#1)(2009-2#1)(2011-2#1)
of such treatments##3##3##(2004-9#1)(2010-12#1)(2012-12#1)
of such trials##3##3##(1994-9#1)(2010-3#1)(2013-7#1)
of such unusual##2##3##(2006-12#1)(2012-2#1)
of such variables##2##3##(2009-12#1)(2013-8#1)
of such variance##2##3##(1994-3#1)(2007-8#1)
of such variation##3##3##(2008-5#1)(2008-7#1)(2009-4#1)
of such##1019##2##(1990-1#1)(1990-10#1)(1990-11#3)(1990-12#8)(1990-2#5)(1990-3#3)(1990-4#2)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#4)(1991-12#9)(1991-2#2)(1991-3#4)(1991-5#5)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#5)(1992-11#1)(1992-12#5)(1992-2#3)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#3)(1992-9#3)(1993-1#2)(1993-10#2)(1993-11#4)(1993-12#5)(1993-2#3)(1993-3#3)(1993-4#1)(1993-5#3)(1993-6#3)(1993-7#2)(1993-9#9)(1994-1#2)(1994-11#2)(1994-12#8)(1994-2#4)(1994-3#5)(1994-5#1)(1994-6#2)(1994-8#4)(1994-9#5)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#5)(1995-3#3)(1995-4#2)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#2)(1995-9#2)(1996-1#3)(1996-11#8)(1996-12#6)(1996-3#2)(1996-4#6)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#10)(1997-5#3)(1997-6#7)(1997-7#3)(1997-8#4)(2004-10#1)(2004-11#2)(2004-12#2)(2004-4#1)(2004-9#5)(2005-10#3)(2005-11#16)(2005-12#1)(2005-5#1)(2005-6#1)(2005-7#3)(2005-8#6)(2005-9#2)(2006-10#9)(2006-11#1)(2006-12#10)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#10)(2006-7#5)(2006-8#3)(2006-9#3)(2007-1#4)(2007-10#7)(2007-11#17)(2007-12#33)(2007-2#3)(2007-3#6)(2007-4#1)(2007-5#1)(2007-6#5)(2007-7#4)(2007-8#12)(2007-9#3)(2008-1#11)(2008-10#59)(2008-11#37)(2008-12#13)(2008-2#38)(2008-3#45)(2008-4#15)(2008-5#19)(2008-6#8)(2008-7#27)(2008-8#21)(2008-9#15)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#6)(2009-3#5)(2009-4#4)(2009-5#10)(2009-6#4)(2009-7#1)(2009-8#3)(2009-9#2)(2010-1#4)(2010-10#2)(2010-11#5)(2010-12#10)(2010-2#8)(2010-3#9)(2010-4#3)(2010-5#8)(2010-6#2)(2010-7#8)(2010-8#1)(2011-1#17)(2011-12#3)(2011-2#25)(2011-3#2)(2012-1#3)(2012-11#2)(2012-12#18)(2012-2#26)(2012-3#10)(2013-1#43)(2013-7#3)(2013-8#15)
of suckling lambs according to the rearing system##2##8##(2010-4#2)
of suckling##6##2##(1993-2#1)(2006-10#1)(2010-4#2)(2012-2#2)
of sucrase-isomaltase gene##2##3##(1990-12#2)
of sucrase-isomaltase##5##2##(1990-12#4)(1992-11#1)
of sucrose and##4##3##(1990-8#1)(2006-9#1)(2007-3#1)(2008-10#1)
of sucrose esters##3##3##(2005-12#3)
of sucrose in##6##3##(1992-3#1)(2008-10#4)(2011-2#1)
of sucrose monostearate##2##3##(1994-12#2)
of sucrose or##2##3##(1994-8#1)(2008-10#1)
of sucrose was not##2##4##(2008-5#1)(2009-6#1)
of sucrose##50##2##(1990-8#1)(1991-5#1)(1992-1#3)(1992-3#1)(1992-9#1)(1993-6#2)(1994-12#2)(1994-8#2)(1995-1#1)(1995-3#1)(1996-4#1)(2004-9#1)(2005-11#2)(2005-12#3)(2006-9#1)(2007-11#1)(2007-3#1)(2008-10#14)(2008-5#2)(2009-6#4)(2009-8#1)(2010-12#1)(2011-2#2)(2012-1#1)
of suction##5##2##(1991-3#1)(2007-8#3)(2012-2#1)
of sudden and##3##3##(1990-8#1)(2006-4#1)(2010-11#1)
of sudden cardiac death in##3##5##(2009-10#1)(2010-11#1)(2012-3#1)
of sudden cardiac death##14##4##(2006-7#1)(2006-9#2)(2007-8#1)(2008-10#1)(2008-4#1)(2009-10#1)(2009-5#1)(2010-11#1)(2011-2#3)(2012-3#1)(2013-8#1)
of sudden cardiac##16##3##(2006-7#1)(2006-9#2)(2007-8#1)(2008-10#1)(2008-4#1)(2009-10#1)(2009-5#1)(2010-1#1)(2010-11#1)(2011-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
of sudden death and##2##4##(1997-1#1)(2006-9#1)
of sudden death in##4##4##(1992-11#1)(1993-8#1)(2008-12#1)(2009-4#1)
of sudden death out-of-hospital in##2##5##(2006-10#2)
of sudden death syndrome##3##4##(2008-10#3)
of sudden death##27##3##(1991-5#1)(1992-11#1)(1993-8#1)(1997-1#1)(1997-2#1)(2005-8#1)(2006-10#3)(2006-9#4)(2008-10#5)(2008-12#1)(2009-4#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-8#1)
of sudden infant death syndrome (SIDS)##2##6##(1991-11#1)(1994-4#1)
of sudden infant death syndrome##6##5##(1991-11#2)(1991-9#1)(1994-4#1)(1996-4#1)(2007-12#1)
of sudden infant death##10##4##(1991-11#2)(1991-9#2)(1992-4#2)(1994-4#1)(1996-4#1)(1996-9#1)(2007-12#1)
of sudden infant##12##3##(1991-11#2)(1991-9#2)(1992-4#2)(1994-4#1)(1996-4#1)(1996-9#1)(2005-6#1)(2005-7#1)(2007-12#1)
of sudden onset##3##3##(1992-12#1)(1993-8#1)(2007-10#1)
of sudden##78##2##(1990-8#1)(1991-11#3)(1991-5#2)(1991-9#2)(1992-11#2)(1992-12#1)(1992-4#2)(1993-8#2)(1994-4#1)(1996-1#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-2#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#5)(2006-4#1)(2006-7#1)(2006-9#7)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-12#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-4#2)(2009-5#1)(2010-1#1)(2010-11#3)(2010-12#2)(2011-1#2)(2011-2#4)(2012-2#2)(2012-3#1)(2013-7#3)(2013-8#3)
of sufentanil##3##2##(1991-1#1)(1993-4#2)
of sufferers##2##2##(2006-4#1)(2010-12#1)
of suffering from##2##3##(2012-1#1)(2012-3#1)
of suffering the##2##3##(2009-10#1)(2011-2#1)
of suffering##12##2##(1991-8#1)(1996-3#1)(2005-10#1)(2005-7#1)(2008-5#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)
of sufficient blood##2##3##(2005-8#1)(2007-9#1)
of sufficient magnitude to##2##4##(1996-8#1)(2008-5#1)
of sufficient quality to##2##4##(2008-10#1)(2010-9#1)
of sufficient quality##4##3##(2008-10#1)(2008-3#2)(2010-9#1)
of sufficient##38##2##(1991-2#1)(1992-12#1)(1993-5#1)(1994-3#3)(1995-1#1)(1995-2#1)(1995-5#1)(1996-8#1)(1997-6#1)(2005-8#2)(2006-3#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-9#1)(2012-2#1)(2013-1#1)
of sufficiently##3##2##(1992-3#1)(2005-11#1)(2008-5#1)
of sugar beet (Beta##2##4##(1991-5#1)(2012-3#1)
of sugar beet##18##3##(1991-5#1)(2006-12#2)(2006-8#1)(2008-10#6)(2008-12#5)(2008-5#2)(2012-3#1)
of sugar cane##2##3##(2008-5#2)
of sugar in the##3##4##(2008-10#1)(2008-9#1)(2009-8#1)
of sugar in##5##3##(1993-9#1)(2008-10#1)(2008-9#1)(2009-8#1)(2012-1#1)
of sugar transport##2##3##(1991-12#1)(2008-10#1)
of sugar utilization##2##3##(2008-6#2)
of sugar##51##2##(1991-12#1)(1991-5#1)(1993-11#2)(1993-7#1)(1993-9#3)(1995-1#1)(1995-11#1)(1997-2#1)(2006-10#1)(2006-12#2)(2006-8#1)(2008-10#9)(2008-12#6)(2008-4#2)(2008-5#4)(2008-6#3)(2008-8#2)(2008-9#1)(2009-8#2)(2012-1#1)(2012-11#2)(2012-2#2)(2012-3#2)
of sugar-sweetened beverages##3##3##(2011-2#2)(2012-1#1)
of sugarbeet cyst nematodes##2##4##(2009-3#2)
of sugarcane (Saccharum##2##3##(2008-10#2)
of sugarcane##16##2##(2008-10#12)(2008-5#1)(2011-2#1)(2013-1#2)
of sugars and##5##3##(1992-8#1)(2008-10#3)(2008-6#1)
of sugars in##3##3##(2004-11#2)(2010-4#1)
of sugars or##2##3##(1990-6#1)(2008-7#1)
of sugars##27##2##(1990-6#1)(1992-8#1)(1995-11#2)(1997-8#1)(2004-11#2)(2006-9#1)(2008-10#4)(2008-12#1)(2008-5#5)(2008-6#3)(2008-7#1)(2009-10#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
of suggested##3##2##(1995-1#1)(2008-12#1)(2013-1#1)
of suggestions##2##2##(2008-12#1)(2010-2#1)
of suicidal behavior##3##3##(2009-9#1)(2013-1#2)
of suicidal ideation and##2##4##(2008-10#1)(2013-1#1)
of suicidal ideation##4##3##(1992-1#1)(2008-10#1)(2010-6#1)(2013-1#1)
of suicidal##19##2##(1990-10#1)(1992-1#2)(1992-5#1)(2005-6#1)(2008-10#1)(2008-6#1)(2009-9#1)(2010-6#3)(2010-7#1)(2011-2#2)(2012-1#1)(2013-1#3)(2013-7#1)
of suicide and##2##3##(2010-12#1)(2011-2#1)
of suicide attempts##4##3##(1990-12#1)(2006-7#2)(2012-1#1)
of suicide by##3##3##(2009-2#1)(2011-2#2)
of suicide gene therapy##2##4##(2007-3#2)
of suicide in Abitibi-Temiscamingue##2##4##(1996-1#2)
of suicide in older##2##4##(2009-5#2)
of suicide in##10##3##(1996-1#2)(2008-2#1)(2009-10#1)(2009-5#3)(2010-6#1)(2011-2#1)(2012-12#1)
of suicide is##2##3##(2005-9#1)(2010-6#1)
of suicide notes##2##3##(1991-10#2)
of suicide of men in Québec##2##6##(2008-2#2)
of suicide prevention centers##2##4##(1991-12#2)
of suicide substrates##2##3##(1990-8#1)(2008-5#1)
of suicide##66##2##(1990-12#1)(1990-8#1)(1991-10#2)(1991-12#3)(1992-8#2)(1993-7#5)(1994-8#2)(1996-1#2)(2005-9#3)(2006-10#1)(2006-7#2)(2007-3#2)(2008-2#3)(2008-5#1)(2008-7#2)(2008-8#2)(2009-10#2)(2009-2#1)(2009-4#1)(2009-5#5)(2009-7#3)(2010-12#1)(2010-4#1)(2010-6#2)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
of suicides##6##2##(1991-12#1)(1993-7#1)(2005-9#1)(2011-2#3)
of suitability##2##2##(1992-4#1)(2007-2#1)
of suitable##41##2##(1990-6#1)(1990-9#1)(1992-5#1)(1992-8#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-9#1)(1996-3#1)(2004-9#1)(2005-12#1)(2005-7#1)(2005-9#1)(2006-11#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2009-11#1)(2009-3#1)(2009-4#1)(2011-3#1)(2012-12#2)(2013-1#2)
of suitably protected##3##3##(1992-12#1)(1996-4#1)(2008-4#1)
of suitably sized##2##3##(2008-2#1)(2008-3#1)
of suitably##9##2##(1992-12#1)(1996-4#1)(2005-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-6#1)(2010-7#1)(2013-1#1)
of sulbactam##2##2##(2012-2#2)
of sulci##2##2##(2010-12#2)
of sulfaguanidine##3##2##(2008-10#3)
of sulfasalazine##2##2##(1990-6#1)(1992-11#1)
of sulfate aerosols##2##3##(2008-3#2)
of sulfate and##4##3##(2006-8#1)(2008-10#2)(2008-6#1)
of sulfate ion##5##3##(2005-11#1)(2008-10#4)
of sulfate ions##3##3##(1991-7#1)(2005-11#1)(2008-10#1)
of sulfate reduction##2##3##(2006-3#1)(2012-2#1)
of sulfate was##2##3##(2008-6#2)
of sulfate##29##2##(1990-4#1)(1991-7#1)(1992-10#1)(1993-2#1)(1993-3#3)(1995-4#2)(2005-11#2)(2006-3#1)(2006-8#1)(2008-10#8)(2008-3#2)(2008-6#3)(2009-8#2)(2012-2#1)
of sulfated glycosaminoglycans##4##3##(1993-12#3)(1995-2#1)
of sulfated octadecyl##2##3##(1996-2#2)
of sulfated##11##2##(1991-12#1)(1991-3#2)(1992-12#1)(1993-12#3)(1995-2#1)(1995-4#1)(1996-2#2)
of sulfathiazole in##2##3##(2008-10#2)
of sulfatide and GM3 ganglioside##2##5##(1995-1#2)
of sulfatide and##3##3##(1991-9#1)(1995-1#2)
of sulfation of##4##3##(1990-3#2)(1993-6#1)(1997-8#1)
of sulfation##6##2##(1990-3#2)(1993-6#1)(1994-3#1)(1995-4#1)(1997-8#1)
of sulfhydryl groups in the##2##5##(1991-5#2)
of sulfhydryl groups in##3##4##(1991-5#2)(1993-6#1)
of sulfhydryl groups##5##3##(1991-5#2)(1992-5#1)(1992-8#1)(1993-6#1)
of sulfhydryl##10##2##(1991-5#2)(1992-5#2)(1992-8#1)(1993-4#1)(1993-6#1)(1995-6#1)(1996-2#1)(2010-2#1)
of sulfide in##8##3##(2007-8#2)(2008-10#6)
of sulfide silver staining##3##4##(1994-6#3)
of sulfide##29##2##(1994-6#3)(2007-8#4)(2008-10#21)(2008-11#1)
of sulfides##5##2##(2005-12#2)(2008-10#1)(2008-6#1)(2009-8#1)
of sulfisoxazole was##2##3##(2008-12#2)
of sulfisoxazole##5##2##(2008-12#5)
of sulfite in a##2##4##(2007-8#1)(2008-10#1)
of sulfite in##10##3##(2007-8#5)(2008-10#5)
of sulfite ion##2##3##(2008-10#2)
of sulfite ions##2##3##(2008-10#2)
of sulfite is##3##3##(2007-8#2)(2008-10#1)
of sulfite reductase##2##3##(1990-5#1)(1993-8#1)
of sulfite##32##2##(1990-3#1)(1990-5#1)(1993-8#2)(1995-5#1)(2007-8#9)(2008-10#18)
of sulfites##2##2##(1995-5#2)
of sulfobromophthalein##5##2##(1990-3#3)(1992-3#1)(1993-7#1)
of sulfoglycolipid synthesis##2##3##(1993-9#2)
of sulfoglycolipid##3##2##(1993-9#3)
of sulfonamide##5##2##(2008-10#2)(2009-3#2)(2009-8#1)
of sulfonamides and quinolones on##2##5##(2008-10#2)
of sulfonamides on##2##3##(1991-5#1)(2008-10#1)
of sulfonamides##12##2##(1991-5#2)(2008-10#9)(2013-1#1)
of sulfonate##2##2##(2007-11#1)(2008-10#1)
of sulfonylurea##3##2##(1992-3#1)(1994-8#1)(2008-10#1)
of sulfonylureas##3##2##(1991-12#1)(1992-3#1)(2008-3#1)
of sulforhodamine-GM1##2##2##(1996-3#2)
of sulfosalicylic acid##2##3##(2008-10#2)
of sulfur and##3##3##(2006-4#1)(2008-10#1)(2008-9#1)
of sulfur dioxide and nitrogen dioxide by##2##7##(2005-4#2)
of sulfur dioxide in##3##4##(2008-10#3)
of sulfur dioxide##6##3##(2005-4#2)(2008-10#4)
of sulfur in##3##3##(1994-7#1)(2008-10#2)
of sulfur##28##2##(1994-7#1)(1996-2#1)(1997-7#2)(2005-11#1)(2005-4#2)(2006-4#1)(2007-10#1)(2008-10#16)(2008-5#1)(2008-9#1)(2011-2#1)
of sulfuric acid##7##3##(2008-10#5)(2008-2#1)(2010-6#1)
of sulfuric##9##2##(2005-11#1)(2008-10#6)(2008-2#1)(2010-6#1)
of sulindac and##2##3##(1992-3#1)(2009-12#1)
of sulphamethoxazole##2##2##(2008-10#2)
of sulphanilic acid##2##3##(2007-8#1)(2008-10#1)
of sulphate conjugated##2##3##(1997-7#2)
of sulphate##9##2##(1997-7#2)(2008-10#7)
of sulphated##2##2##(1993-6#1)(1994-8#1)
of sulphide at##2##3##(2008-10#2)
of sulphide##8##2##(2008-10#8)
of sulphite##2##2##(2008-10#2)
of sulphur compounds##2##3##(2008-10#2)
of sulphur dioxide##2##3##(2008-10#2)
of sulphur in##5##3##(2008-10#5)
of sulphur mustard##2##3##(2006-7#2)
of sulphur spa therapy with##2##5##(2008-4#2)
of sulphur##20##2##(1995-7#1)(2005-11#1)(2006-12#1)(2006-7#2)(2008-10#11)(2008-11#1)(2008-4#3)
of sulphur-containing##3##2##(2006-8#1)(2008-10#2)
of sulphuric acid##4##3##(2008-10#4)
of sulphuric##6##2##(2004-4#1)(2008-10#5)
of sulphydryl compounds##2##3##(1992-8#2)
of sulphydryl##4##2##(1992-8#2)(1993-4#1)(2008-10#1)
of sulpiride in##2##3##(1997-3#2)
of sulpiride##6##2##(1990-7#1)(1996-1#2)(1997-3#3)
of sum##3##2##(2007-12#1)(2007-6#1)(2008-7#1)
of sumatriptan##8##2##(1992-5#1)(1994-3#3)(1997-3#1)(2005-7#1)(2007-9#1)(2012-3#1)
of summary##2##2##(1993-12#1)(1994-9#1)
of summation##3##2##(2008-10#3)
of summative##2##2##(1996-11#1)(2006-12#1)
of summed##2##2##(1994-8#1)(2005-12#1)
of summer##8##2##(1992-10#1)(2006-10#1)(2006-12#1)(2008-10#3)(2012-2#1)(2013-1#1)
of sun care products##3##4##(2008-5#3)
of sun exposure in##2##4##(2011-2#2)
of sun exposure##5##3##(1995-4#1)(2007-1#1)(2011-2#3)
of sun protection factors##3##4##(2008-5#3)
of sun reactive skin##2##4##(1991-6#1)(2008-5#1)
of sun##16##2##(1991-6#1)(1995-4#1)(2007-1#2)(2008-2#1)(2008-3#1)(2008-5#7)(2011-2#3)
of sunburn cells in##2##4##(2008-5#2)
of sunburn##4##2##(1992-6#1)(1996-6#1)(2008-5#2)
of sunflower (Helianthus##2##3##(2008-10#2)
of sunflower oil##2##3##(2008-2#1)(2010-4#1)
of sunflower##13##2##(2006-12#1)(2008-10#10)(2008-2#1)(2010-4#1)
of sunitinib##2##2##(2008-6#1)(2009-11#1)
of sunlight intensity##2##3##(2008-6#1)(2008-8#1)
of sunlight is##2##3##(2008-10#1)(2011-2#1)
of sunlight##16##2##(2007-7#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#1)(2011-2#6)(2013-8#1)
of sunscreen films##2##3##(2008-5#1)(2012-12#1)
of sunscreen formulations is##2##4##(2008-5#2)
of sunscreen formulations##3##3##(2008-5#2)(2012-12#1)
of sunscreen lotions##2##3##(2008-5#2)
of sunscreen products##3##3##(2008-5#3)
of sunscreen##25##2##(2006-10#1)(2006-12#1)(2007-1#2)(2008-10#1)(2008-3#1)(2008-5#14)(2008-7#2)(2008-8#1)(2012-12#2)
of sunscreening agents##2##3##(2008-5#2)
of sunscreens is##2##3##(2008-5#2)
of sunscreens##13##2##(1991-6#2)(2008-3#1)(2008-5#10)
of sunset yellow##2##3##(2008-10#2)
of superabsorbent polymer##3##3##(2008-12#3)
of superabsorbent##4##2##(2008-11#1)(2008-12#3)
of superantigen##2##2##(2007-7#2)
of superantigens##2##2##(2006-10#1)(2007-7#1)
of supercoiled##4##2##(1994-5#1)(1995-11#1)(1997-4#2)
of superconducting##2##2##(2008-7#1)(2012-2#1)
of supercontinuum generation in##2##4##(2007-11#1)(2007-12#1)
of supercontinuum##4##2##(2007-11#2)(2007-12#2)
of supercooled##2##2##(1995-3#1)(2008-2#1)
of supercritical CO(2)##2##3##(2008-10#2)
of supercritical carbon dioxide##3##4##(2008-10#1)(2010-4#2)
of supercritical fluid extraction##2##4##(2008-10#1)(2012-3#1)
of supercritical fluid##3##3##(2008-10#2)(2012-3#1)
of supercritical##10##2##(2008-10#6)(2010-4#2)(2012-2#1)(2012-3#1)
of superficial and##3##3##(2005-11#1)(2008-7#1)(2010-7#1)
of superficial bladder cancer##3##4##(1993-11#1)(2007-10#1)(2007-2#1)
of superficial bladder##6##3##(1993-11#1)(1993-9#2)(2007-10#1)(2007-2#1)(2008-1#1)
of superficial involvement of the PU##2##6##(2007-7#2)
of superficial lesions##2##3##(2008-7#1)(2011-1#1)
of superficial mycosis##3##3##(2008-5#2)(2011-2#1)
of superficial##41##2##(1993-11#1)(1993-12#1)(1993-9#2)(2004-10#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-10#3)(2007-2#1)(2007-4#1)(2007-7#3)(2008-1#1)(2008-5#6)(2008-6#1)(2008-7#3)(2008-9#1)(2009-9#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)
of superheated water##2##3##(2008-10#2)
of superimposed##5##2##(1995-3#1)(2006-10#1)(2008-3#2)(2009-3#1)
of superior and inferior##2##4##(1996-3#1)(2008-8#1)
of superior mesenteric artery##3##4##(2005-10#1)(2009-6#1)(2013-1#1)
of superior vena cava syndrome##2##5##(2010-8#1)(2013-1#1)
of superior vena cava##7##4##(2007-8#4)(2010-8#1)(2013-1#2)
of superior vena##8##3##(2007-8#4)(2010-8#1)(2011-2#1)(2013-1#2)
of superior##30##2##(1991-5#1)(1993-12#1)(1993-9#1)(1994-3#1)(1996-3#1)(1997-3#1)(2005-10#1)(2005-11#1)(2005-7#1)(2007-8#5)(2008-1#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#4)(2013-8#1)
of superior-posterior radiograms##2##3##(2007-8#2)
of supernatant##6##2##(1997-4#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-2#1)(2013-1#1)
of supernatants from##2##3##(1991-1#2)
of supernatants##4##2##(1991-1#2)(2013-1#2)
of supernumerary chromosomes##2##3##(2008-5#1)(2010-3#1)
of supernumerary##7##2##(1990-5#2)(2008-3#2)(2008-5#1)(2010-3#1)(2013-1#1)
of superoxide (O(2)##2##3##(2008-10#2)
of superoxide and##3##3##(1994-12#1)(2007-10#1)(2012-1#1)
of superoxide anion and hydrogen peroxide##2##6##(1994-8#1)(2008-10#1)
of superoxide anion and##3##4##(1991-12#1)(1994-8#1)(2008-10#1)
of superoxide anion radicals##2##4##(1990-12#1)(1994-2#1)
of superoxide anion##22##3##(1990-12#1)(1991-12#1)(1991-4#2)(1992-6#2)(1993-6#3)(1994-2#1)(1994-3#1)(1994-8#1)(1995-6#1)(1997-8#1)(2005-8#1)(2006-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-8#1)(2012-2#1)
of superoxide dismutase (250 U/ml)##2##5##(1997-5#2)
of superoxide dismutase (SOD) and catalase##2##6##(1994-6#1)(1997-2#1)
of superoxide dismutase (SOD) and##3##5##(1994-6#1)(1997-2#1)(2012-2#1)
of superoxide dismutase (SOD)##21##4##(1990-4#1)(1992-4#1)(1992-9#1)(1994-3#1)(1994-6#1)(1997-2#1)(1997-4#1)(1997-8#2)(2006-5#1)(2007-8#1)(2007-9#1)(2008-10#2)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)
of superoxide dismutase activity##2##4##(1997-6#1)(2008-5#1)
of superoxide dismutase and catalase##3##5##(1992-11#1)(1994-6#2)
of superoxide dismutase and##6##4##(1990-7#1)(1992-11#1)(1994-6#2)(2008-8#2)
of superoxide dismutase in##4##4##(1991-1#1)(1991-7#1)(2008-10#1)(2010-4#1)
of superoxide dismutase iso-enzyme##2##4##(1995-9#2)
of superoxide dismutase##58##3##(1990-3#2)(1990-4#1)(1990-7#1)(1991-1#2)(1991-12#1)(1991-7#1)(1992-11#3)(1992-4#2)(1992-9#1)(1994-3#1)(1994-6#4)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#2)(1997-2#1)(1997-4#1)(1997-5#3)(1997-6#2)(1997-8#2)(2006-12#1)(2006-5#1)(2006-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-5#1)(2008-8#3)(2010-3#1)(2010-4#3)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
of superoxide generation##3##3##(1992-11#1)(1993-6#1)(1994-11#1)
of superoxide radical##6##3##(1994-11#1)(1995-7#1)(1997-2#1)(2005-8#1)(2007-8#1)(2010-5#1)
of superoxide radicals##7##3##(1991-12#1)(1995-3#1)(1995-6#1)(1996-10#1)(2005-8#2)(2008-4#1)
of superoxide##114##2##(1990-12#1)(1990-3#2)(1990-4#1)(1990-7#1)(1991-1#2)(1991-12#3)(1991-4#2)(1991-7#1)(1992-11#4)(1992-4#2)(1992-5#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-6#4)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#4)(1994-8#1)(1995-2#1)(1995-3#2)(1995-6#3)(1995-7#1)(1995-9#2)(1996-1#1)(1996-10#1)(1997-2#2)(1997-4#1)(1997-5#4)(1997-6#2)(1997-8#4)(2005-8#4)(2006-12#2)(2006-5#2)(2006-7#1)(2007-10#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#7)(2008-4#3)(2008-5#2)(2008-8#3)(2009-8#1)(2009-9#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#3)(2013-1#1)
of superparamagnetic iron oxide##2##4##(2012-2#2)
of superparamagnetic##4##2##(2010-9#1)(2012-2#2)(2013-1#1)
of superresolution##3##2##(2008-2#2)(2008-3#1)
of superresolving##2##2##(2007-12#1)(2008-3#1)
of supersaturated n-butanol vapor on##2##5##(2005-11#2)
of supersaturated##3##2##(2005-11#3)
of supervised##5##2##(2008-10#1)(2009-7#2)(2013-1#2)
of supervision##5##2##(1991-9#1)(1992-11#1)(1992-6#1)(1995-3#1)(2009-4#1)
of supervisory##2##2##(2012-3#1)(2013-1#1)
of supplemental oxygen##3##3##(2010-2#3)
of supplemental vitamin E##2##4##(1992-9#2)
of supplemental##9##2##(1992-9#2)(2007-10#1)(2007-3#1)(2007-7#1)(2010-2#3)(2012-2#1)
of supplementary##6##2##(1992-9#1)(1993-3#2)(2007-3#1)(2008-7#1)(2012-2#1)
of supplementation of##4##3##(2007-8#1)(2008-11#1)(2008-7#1)(2013-7#1)
of supplementation with##2##3##(2008-10#1)(2008-5#1)
of supplementation##11##2##(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#4)(2008-7#1)(2011-1#1)(2013-7#1)
of supplements and##2##3##(2008-11#1)(2009-5#1)
of supplements##3##2##(2008-11#1)(2009-5#1)(2013-7#1)
of supplies and##2##3##(1991-12#1)(2007-12#1)
of supply##3##2##(1996-3#1)(2007-11#1)(2012-12#1)
of support and##4##3##(1994-7#1)(1995-6#1)(2007-8#1)(2013-1#1)
of support during##3##3##(1993-3#1)(2007-2#1)(2013-1#1)
of support for##5##3##(1993-1#2)(2008-1#1)(2008-11#1)(2013-1#1)
of support in##2##3##(2009-7#1)(2010-1#1)
of support services##3##3##(1993-1#2)(2004-12#1)
of support to##3##3##(1995-1#1)(1997-2#1)(2009-9#1)
of support##56##2##(1991-2#1)(1992-3#1)(1993-1#4)(1993-3#1)(1994-1#2)(1994-3#2)(1994-7#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-3#1)(1997-2#1)(2004-12#1)(2006-10#2)(2007-1#2)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#4)(2008-4#1)(2008-9#1)(2009-5#1)(2009-7#3)(2009-9#1)(2010-1#2)(2010-10#3)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#3)
of supported##4##2##(1994-11#1)(2008-4#1)(2010-9#2)
of supporting electrolyte##3##3##(2008-10#3)
of supporting the##2##3##(2008-7#1)(2009-5#1)
of supporting##30##2##(1991-4#1)(1993-4#1)(1994-5#1)(1996-10#1)(1996-3#1)(1996-5#1)(2006-11#1)(2006-2#1)(2007-12#2)(2007-2#1)(2008-10#5)(2008-12#1)(2008-3#2)(2008-7#1)(2009-5#1)(2010-8#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)
of supportive cancer therapy##3##4##(2008-7#3)
of supportive cancer##4##3##(2008-7#4)
of supportive care in##3##4##(2007-5#1)(2008-7#2)
of supportive care##11##3##(1991-8#1)(2005-8#1)(2007-5#2)(2008-7#4)(2011-2#2)(2012-11#1)
of supportive therapy##2##3##(2008-7#1)(2011-2#1)
of supportive##27##2##(1991-8#1)(1993-1#1)(1993-12#1)(2005-8#1)(2007-11#1)(2007-4#1)(2007-5#2)(2008-7#10)(2009-1#1)(2010-10#1)(2011-2#4)(2012-11#1)(2012-12#1)(2013-8#1)
of suppressed##2##2##(1991-9#1)(2008-7#1)
of suppressing the##7##3##(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2013-1#1)
of suppressing##13##2##(1997-2#1)(2005-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-8#1)(2012-2#1)(2013-1#1)
of suppression of the##4##4##(1992-5#1)(2008-2#1)(2008-7#1)(2011-12#1)
of suppression of##16##3##(1991-4#1)(1992-5#1)(1993-9#1)(1995-1#1)(2006-9#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2011-12#1)(2013-7#1)
of suppression was##2##3##(2008-10#1)(2009-11#1)
of suppression##31##2##(1991-4#1)(1992-5#1)(1993-9#1)(1994-8#1)(1995-1#1)(2006-10#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#2)(2009-11#2)(2009-3#1)(2011-12#1)(2012-12#2)(2012-3#1)(2013-7#1)
of suppressive##2##2##(2008-10#1)(2008-8#1)
of suppressiveness##5##2##(2008-10#5)
of suppressor T cell##2##4##(1991-12#1)(2007-11#1)
of suppressor T##3##3##(1990-5#1)(1991-12#1)(2007-11#1)
of suppressor##4##2##(1990-5#1)(1991-12#1)(1993-11#1)(2007-11#1)
of supracondylar humerus fractures in children##2##6##(2009-3#1)(2013-1#1)
of supracondylar humerus fractures in##3##5##(2009-3#1)(2013-1#2)
of supracondylar##5##2##(2009-3#1)(2010-11#1)(2013-1#2)(2013-8#1)
of supramolecular##4##2##(1993-12#1)(1994-2#1)(2010-12#2)
of supratentorial##3##2##(2008-7#1)(2012-12#2)
of suprathreshold##3##2##(2008-9#2)(2011-2#1)
of supraventricular arrhythmia##2##3##(2005-7#1)(2007-8#1)
of supraventricular arrhythmias##2##3##(1995-6#2)
of supraventricular tachycardia##5##3##(1995-6#1)(2006-8#1)(2006-9#1)(2008-7#1)(2012-3#1)
of supraventricular##12##2##(1995-6#4)(2005-7#1)(2006-8#2)(2006-9#1)(2007-8#1)(2008-7#1)(2012-1#1)(2012-3#1)
of suramin on p34cdc2 kinase##2##5##(1994-9#2)
of suramin on##3##3##(1990-5#1)(1994-9#2)
of suramin were##2##3##(1993-11#2)
of suramin##8##2##(1990-5#1)(1993-11#2)(1994-9#5)
of surface acoustic waves##4##4##(2007-11#1)(2008-10#1)(2008-3#2)
of surface acoustic##6##3##(1995-10#1)(2007-11#2)(2008-10#1)(2008-3#2)
of surface active##2##3##(2008-10#2)
of surface and cytoplasmic##2##4##(1990-12#1)(2008-9#1)
of surface and##9##3##(1990-12#3)(1996-12#1)(2006-12#1)(2007-5#1)(2008-10#1)(2008-9#2)
of surface charge##5##3##(1994-5#1)(1997-2#1)(2008-4#1)(2008-8#1)(2013-1#1)
of surface charges##6##3##(1994-8#1)(2005-11#4)(2007-9#1)
of surface chemistry##2##3##(2005-11#2)
of surface composition##4##3##(1993-3#1)(2005-11#1)(2006-12#1)(2008-5#1)
of surface coverage##2##3##(2007-5#1)(2008-10#1)
of surface defects on thin metallic wires##2##7##(2008-3#2)
of surface defects##3##3##(1990-7#1)(2008-3#2)
of surface enhanced Raman##2##4##(2005-4#1)(2013-8#1)
of surface enhanced##3##3##(2005-4#1)(2006-9#1)(2013-8#1)
of surface expression of##2##4##(1994-6#1)(2008-4#1)
of surface features##2##3##(2006-5#1)(2007-11#1)
of surface immunoglobulin##2##3##(1991-6#1)(1992-9#1)
of surface layers##3##3##(2004-9#3)
of surface lipids##2##3##(2008-4#1)(2010-3#1)
of surface markers##3##3##(2008-4#2)(2008-9#1)
of surface plasmon resonance (SPR)##4##5##(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)
of surface plasmon resonance##7##4##(1992-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#1)
of surface plasmon##9##3##(1992-11#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)
of surface potential##3##3##(1992-6#1)(2008-10#2)
of surface potentials##2##3##(1991-3#2)
of surface pressure##3##3##(2008-10#1)(2009-7#2)
of surface profiles##2##3##(2007-12#1)(2008-2#1)
of surface proteins##2##3##(1995-8#1)(1996-5#1)
of surface receptors##2##3##(2005-7#1)(2008-4#1)
of surface reliefs##2##3##(2008-3#2)
of surface roughness and##4##4##(2008-2#4)
of surface roughness##9##3##(2008-2#5)(2008-3#2)(2009-7#1)(2012-2#1)
of surface scattering from##2##4##(2008-2#1)(2008-3#1)
of surface silanol##2##3##(2005-11#1)(2008-10#1)
of surface structure##2##3##(2006-7#1)(2012-1#1)
of surface tension and##4##4##(2005-11#2)(2008-2#1)(2013-8#1)
of surface tension##13##3##(1994-5#1)(2005-11#6)(2008-2#1)(2008-3#1)(2008-5#1)(2012-11#2)(2013-8#1)
of surface water##6##3##(2008-10#2)(2008-11#1)(2008-8#3)
of surface waves##3##3##(2008-2#2)(2008-3#1)
of surface##232##2##(1990-12#4)(1990-5#2)(1990-7#1)(1991-3#3)(1991-6#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-5#4)(1994-6#1)(1994-8#1)(1995-10#1)(1995-5#2)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#2)(1997-2#2)(1997-4#1)(1997-6#1)(2004-9#5)(2005-11#27)(2005-12#1)(2005-4#1)(2005-7#1)(2006-10#2)(2006-12#4)(2006-2#1)(2006-3#2)(2006-5#1)(2006-7#2)(2006-9#1)(2007-11#6)(2007-12#6)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#23)(2008-11#3)(2008-2#20)(2008-3#19)(2008-4#11)(2008-5#7)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#6)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#3)(2009-8#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-11#2)(2012-2#4)(2013-1#4)(2013-7#1)(2013-8#4)
of surface-active agents##2##3##(2005-11#2)
of surface-active##5##2##(2005-11#2)(2007-8#1)(2008-10#2)
of surface-bound molecules##2##3##(2008-2#2)
of surface-bound##6##2##(1996-10#1)(2006-2#1)(2007-11#1)(2008-2#2)(2008-3#1)
of surface-enhanced Raman scattering##4##4##(2006-12#1)(2008-10#1)(2013-8#2)
of surface-enhanced Raman spectroscopy (SERS)##2##5##(2008-10#1)(2012-1#1)
of surface-enhanced Raman spectroscopy##3##4##(2008-10#1)(2012-1#1)(2013-8#1)
of surface-enhanced Raman##7##3##(2006-12#1)(2008-10#2)(2012-1#1)(2013-8#3)
of surface-enhanced##9##2##(2006-12#1)(2007-11#1)(2008-10#2)(2012-1#1)(2013-8#4)
of surface-esterified##2##2##(2005-11#2)
of surface-grafted##2##2##(2010-4#2)
of surface-harmonic generation##2##3##(2005-4#2)
of surface-patterned nanostructures##2##3##(2008-10#2)
of surface-plasmon polaritons##2##3##(2008-3#2)
of surface-plasmon##4##2##(2008-3#4)
of surface-relief##2##2##(2008-3#2)
of surfaces and##3##3##(2007-12#1)(2008-7#1)(2009-5#1)
of surfaces from##2##3##(2008-3#2)
of surfaces in##4##3##(2005-11#1)(2008-2#1)(2008-3#2)
of surfaces is##2##3##(2008-10#1)(2008-3#1)
of surfaces with##4##3##(2007-12#1)(2008-3#1)(2008-4#1)(2010-12#1)
of surfaces##32##2##(1996-11#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#3)(2008-3#12)(2008-4#1)(2008-7#3)(2009-5#1)(2010-12#1)(2010-4#1)(2011-11#1)(2013-7#1)
of surfactant concentration##3##3##(2005-11#1)(2008-10#2)
of surfactant concentrations##2##3##(1990-3#1)(1996-5#1)
of surfactant in##2##3##(1992-5#1)(2008-10#1)
of surfactant is##2##3##(1992-5#1)(2005-11#1)
of surfactant lipids##3##3##(1994-12#1)(1996-5#1)(2007-11#1)
of surfactant may be##3##4##(2006-5#2)(2010-3#1)
of surfactant micelles##3##3##(1990-10#1)(2008-10#2)
of surfactant molecules##2##3##(2005-11#2)
of surfactant preparations##2##3##(2007-11#2)
of surfactant therapy##3##3##(2006-7#1)(2006-8#1)(2007-11#1)
of surfactant##65##2##(1990-10#1)(1990-11#2)(1990-3#1)(1992-11#1)(1992-5#5)(1993-7#1)(1994-12#1)(1994-5#4)(1996-1#1)(1996-5#2)(1996-6#1)(2005-11#14)(2006-5#2)(2006-7#2)(2006-8#1)(2007-11#4)(2008-10#14)(2008-5#2)(2008-6#2)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#1)
of surfactants added##2##3##(2005-11#1)(2008-5#1)
of surfactants and##2##3##(2008-10#1)(2008-6#1)
of surfactants as##2##3##(1992-11#1)(2008-5#1)
of surfactants at##2##3##(2005-11#1)(2012-1#1)
of surfactants in the##2##4##(2005-11#1)(2008-10#1)
of surfactants in##4##3##(2005-11#1)(2008-10#2)(2008-5#1)
of surfactants##42##2##(1992-11#2)(2005-11#8)(2007-11#1)(2008-10#11)(2008-3#1)(2008-5#13)(2008-6#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
of surgeon's##2##2##(2006-6#1)(2007-8#1)
of surgeonfish##3##2##(2008-5#3)
of surgeons and##3##3##(1992-3#1)(2008-10#1)(2011-2#1)
of surgeons in##2##3##(2006-6#1)(2008-1#1)
of surgeons##19##2##(1991-5#1)(1992-3#1)(1993-8#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-6#4)(2007-9#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-2#1)(2010-11#1)(2010-8#1)(2011-2#1)
of surgeries and##2##3##(2006-12#1)(2013-7#1)
of surgeries##5##2##(2006-12#1)(2007-7#1)(2011-1#1)(2011-2#1)(2013-7#1)
of surgery and chemotherapy##3##4##(2004-1#1)(2012-1#1)(2013-1#1)
of surgery and the##3##4##(2007-12#1)(2007-7#1)(2007-8#1)
of surgery and##26##3##(1992-3#1)(1993-1#1)(1993-6#1)(2004-1#1)(2006-10#3)(2006-12#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#2)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
of surgery are##4##3##(2006-10#1)(2006-6#1)(2013-1#2)
of surgery as##2##3##(2004-1#1)(2007-11#1)
of surgery for pancreatic cancer##2##5##(1990-9#1)(2008-3#1)
of surgery for##14##3##(1990-9#1)(1991-3#1)(1994-12#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-3#1)(2009-10#2)(2009-4#1)(2009-5#1)(2010-7#1)(2012-11#1)(2012-3#1)
of surgery has##2##3##(2006-6#1)(2007-12#1)
of surgery in the treatment of##5##6##(2005-12#2)(2006-2#1)(2007-11#2)
of surgery in the##8##4##(2005-12#2)(2006-10#1)(2006-2#1)(2007-11#2)(2007-8#1)(2011-2#1)
of surgery in##14##3##(1991-6#1)(1994-11#1)(2005-12#2)(2006-10#1)(2006-2#1)(2007-1#1)(2007-11#2)(2007-8#2)(2008-6#1)(2010-8#1)(2011-2#1)
of surgery is##6##3##(1991-7#1)(2007-11#1)(2008-7#1)(2010-3#1)(2011-2#2)
of surgery may##2##3##(2004-1#1)(2006-3#1)
of surgery of##2##3##(1990-6#1)(2007-11#1)
of surgery on##3##3##(1996-4#1)(2008-7#1)(2012-3#1)
of surgery or##3##3##(1994-12#1)(2004-10#1)(2009-3#1)
of surgery was##7##3##(1992-11#1)(2005-10#1)(2007-7#3)(2008-7#1)(2013-8#1)
of surgery were##2##3##(1993-12#1)(2011-2#1)
of surgery##199##2##(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#3)(1991-1#2)(1991-12#1)(1991-3#3)(1991-4#2)(1991-6#1)(1991-7#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#2)(1995-1#1)(1996-4#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-7#1)(2004-1#3)(2004-10#2)(2004-2#1)(2005-10#1)(2005-12#2)(2006-10#13)(2006-12#1)(2006-2#2)(2006-3#1)(2006-6#3)(2006-8#4)(2006-9#1)(2007-1#1)(2007-11#13)(2007-12#5)(2007-2#4)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#9)(2007-8#10)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#1)(2009-10#2)(2009-3#1)(2009-4#1)(2009-5#5)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#4)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#10)(2013-1#11)(2013-8#2)
of surgical and adjuvant##2##4##(2008-6#1)(2010-12#1)
of surgical and medical##4##4##(2007-5#1)(2008-9#1)(2009-2#1)(2010-3#1)
of surgical and nonsurgical treatment##2##5##(2006-7#1)(2011-1#1)
of surgical and percutaneous transaxillary approaches##2##6##(2007-7#2)
of surgical and##20##3##(1990-12#1)(1993-5#1)(2006-10#1)(2006-7#2)(2006-8#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-6#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-3#1)(2011-1#1)(2013-1#1)(2013-8#1)
of surgical approach and##2##4##(2006-6#1)(2008-5#1)
of surgical approach##6##3##(1992-6#1)(2006-6#1)(2008-5#1)(2011-2#1)(2011-3#1)(2013-1#1)
of surgical approaches to the cervical spine##2##7##(2007-11#2)
of surgical approaches to##4##4##(2007-11#2)(2008-7#1)(2010-8#1)
of surgical approaches##7##3##(1991-3#1)(2007-11#2)(2007-12#1)(2008-7#1)(2010-8#1)(2012-2#1)
of surgical care##7##3##(1991-5#1)(2006-10#1)(2007-8#1)(2008-4#1)(2010-8#1)(2013-1#2)
of surgical closure##2##3##(2012-1#2)
of surgical complications##6##3##(1993-3#1)(2006-9#1)(2007-8#1)(2008-9#1)(2011-1#1)(2013-8#1)
of surgical correction of##2##4##(2006-7#1)(2007-7#1)
of surgical correction##5##3##(2006-7#1)(2007-7#2)(2011-2#2)
of surgical excision##5##3##(1991-6#1)(2007-12#1)(2007-2#1)(2008-9#1)(2013-1#1)
of surgical infection##2##3##(1990-6#1)(2011-2#1)
of surgical infections in##2##4##(1990-2#1)(1992-6#1)
of surgical instruments##6##3##(2007-5#1)(2007-7#1)(2009-12#1)(2009-2#1)(2009-4#1)(2012-3#1)
of surgical intervention and##3##4##(2006-7#1)(2008-7#1)(2012-2#1)
of surgical intervention are##2##4##(1990-8#1)(2007-12#1)
of surgical intervention##11##3##(1990-8#1)(2006-5#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-7#1)(2009-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
of surgical jaundice in##2##4##(2013-8#2)
of surgical magnification##4##3##(2006-2#4)
of surgical management of##3##4##(2007-12#1)(2008-10#1)(2011-1#1)
of surgical management##6##3##(2005-12#1)(2006-6#1)(2007-12#1)(2008-10#1)(2011-1#2)
of surgical margin##3##3##(2008-6#2)(2013-8#1)
of surgical margins##5##3##(1995-4#3)(2008-9#1)(2013-1#1)
of surgical operations##3##3##(2006-6#1)(2008-4#1)(2011-2#1)
of surgical patients##5##3##(2005-12#1)(2006-10#2)(2010-12#1)(2010-8#1)
of surgical practice##2##3##(2007-2#1)(2008-4#1)
of surgical procedure##6##3##(1992-3#1)(1993-5#1)(2007-11#1)(2012-2#2)(2013-1#1)
of surgical procedures in##3##4##(2006-6#1)(2008-7#1)(2012-3#1)
of surgical procedures##25##3##(1991-6#1)(1992-6#1)(2006-10#2)(2006-12#1)(2006-6#2)(2007-11#1)(2007-5#2)(2007-8#2)(2008-7#2)(2008-8#2)(2010-12#1)(2010-2#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#4)
of surgical removal##2##3##(2008-5#1)(2008-7#1)
of surgical repair##2##3##(2007-8#1)(2008-10#1)
of surgical resection##10##3##(1990-9#1)(1994-4#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-7#2)(2010-3#1)(2011-1#1)(2013-8#1)
of surgical site infection##2##4##(2010-12#1)(2012-3#1)
of surgical site infections in##3##5##(2008-10#2)(2009-3#1)
of surgical site infections##10##4##(2006-6#2)(2008-10#2)(2009-3#1)(2010-2#1)(2012-11#2)(2012-3#1)(2013-1#1)
of surgical site##14##3##(2006-6#2)(2008-10#2)(2009-3#1)(2010-12#1)(2010-2#1)(2012-11#2)(2012-3#3)(2013-1#2)
of surgical specimens##2##3##(1996-10#1)(1996-6#1)
of surgical sponge##2##3##(2007-8#1)(2012-3#1)
of surgical stress on##2##4##(2009-6#2)
of surgical stress##6##3##(1992-5#1)(1996-8#1)(2007-11#1)(2007-9#1)(2009-6#2)
of surgical technique##5##3##(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2009-8#1)
of surgical techniques##5##3##(1994-5#1)(2008-5#1)(2009-10#1)(2009-5#1)(2010-8#1)
of surgical therapy##6##3##(1990-5#1)(1992-4#1)(2006-10#1)(2006-2#2)(2011-3#1)
of surgical treatment for##6##4##(2006-7#1)(2007-7#1)(2008-7#1)(2008-8#1)(2012-11#1)(2013-7#1)
of surgical treatment in##4##4##(1991-5#1)(2007-11#1)(2007-7#1)(2013-1#1)
of surgical treatment is to##3##5##(1991-8#1)(1993-3#1)(2007-7#1)
of surgical treatment is##7##4##(1990-4#1)(1991-8#1)(1993-3#1)(2007-11#1)(2007-7#2)(2011-2#1)
of surgical treatment of metastatic bone tumors##2##7##(2007-11#2)
of surgical treatment of the##2##5##(2006-10#1)(2007-11#1)
of surgical treatment of##20##4##(1990-5#1)(1992-3#1)(1997-2#1)(2006-10#1)(2006-6#1)(2007-11#6)(2007-7#1)(2007-8#1)(2008-8#1)(2009-2#2)(2012-1#2)(2013-1#1)(2013-7#1)
of surgical treatment was##4##4##(1994-12#1)(2007-7#1)(2007-8#1)(2008-8#1)
of surgical treatment##62##3##(1990-4#2)(1990-5#1)(1990-9#2)(1991-5#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-8#1)(1997-2#1)(2006-10#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#10)(2007-7#8)(2007-8#6)(2008-10#1)(2008-7#2)(2008-8#3)(2009-2#2)(2009-3#1)(2009-5#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#1)(2013-1#2)(2013-7#2)
of surgical##347##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#3)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#2)(1991-8#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#4)(1993-3#3)(1993-5#2)(1994-10#1)(1994-12#2)(1994-4#1)(1994-5#3)(1995-3#3)(1995-4#3)(1995-8#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#2)(2004-1#1)(2005-12#2)(2005-8#1)(2006-1#1)(2006-10#11)(2006-12#2)(2006-2#6)(2006-4#1)(2006-5#1)(2006-6#16)(2006-7#6)(2006-8#2)(2006-9#2)(2007-10#1)(2007-11#17)(2007-12#7)(2007-2#3)(2007-5#6)(2007-7#16)(2007-8#17)(2007-9#2)(2008-1#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#5)(2008-7#9)(2008-8#7)(2008-9#5)(2009-10#1)(2009-12#2)(2009-2#4)(2009-3#2)(2009-4#4)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#4)(2010-2#5)(2010-3#3)(2010-6#1)(2010-8#6)(2010-9#1)(2011-1#6)(2011-2#12)(2011-3#2)(2011-7#1)(2012-1#5)(2012-11#6)(2012-12#4)(2012-2#6)(2012-3#11)(2013-1#21)(2013-7#3)(2013-8#8)
of surgically managed##3##3##(2007-4#2)(2013-8#1)
of surgically treated##3##3##(2006-12#1)(2008-7#1)(2011-2#1)
of surgically##12##2##(1996-1#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-4#2)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#2)
of surprise and##2##3##(1990-11#2)
of surrogate measures##3##3##(2006-5#3)
of surrogate##10##2##(1991-7#1)(2006-10#1)(2006-5#3)(2007-1#2)(2008-11#1)(2008-5#1)(2008-7#1)
of surrogates##2##2##(1995-5#1)(2008-10#1)
of surrounding normal##2##3##(2006-6#1)(2009-2#1)
of surrounding structures##3##3##(2007-11#2)(2008-10#1)
of surrounding##12##2##(2006-2#1)(2006-6#1)(2007-11#2)(2008-10#2)(2008-5#1)(2009-2#1)(2009-6#1)(2011-12#1)(2011-2#1)(2012-3#1)
of surveillance and##7##3##(1997-2#1)(2005-5#1)(2007-12#1)(2008-7#1)(2009-12#1)(2009-8#1)(2011-12#1)
of surveillance systems##2##3##(1997-3#1)(2006-10#1)
of surveillance##18##2##(1993-2#1)(1997-2#1)(1997-3#2)(2005-5#1)(2005-8#1)(2006-1#1)(2006-10#2)(2007-12#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-8#1)(2011-12#2)(2011-2#1)(2013-8#1)
of survey data collected##2##4##(2007-12#1)(2013-1#1)
of survey data##3##3##(1997-3#1)(2007-12#1)(2013-1#1)
of survey##9##2##(1993-2#1)(1997-3#1)(1997-8#1)(2007-12#1)(2009-4#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
of surveyed##3##2##(1996-9#1)(2007-3#1)(2008-3#1)
of surveys##3##2##(1991-3#1)(1993-1#1)(1993-6#1)
of survival after##2##3##(2005-9#1)(2007-11#1)
of survival and the##3##4##(2007-8#1)(2010-5#1)(2013-1#1)
of survival and##12##3##(1994-6#1)(1996-2#1)(1996-3#1)(2005-8#1)(2007-11#1)(2007-3#1)(2007-8#1)(2010-5#1)(2010-8#1)(2013-1#1)(2013-7#2)
of survival by##4##3##(1995-4#1)(1996-12#1)(2004-10#1)(2007-8#1)
of survival curves##4##3##(1992-2#1)(1995-1#1)(1995-3#1)(1995-8#1)
of survival during##2##3##(2008-6#1)(2009-10#1)
of survival in##9##3##(1994-12#1)(1996-3#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-12#1)(2011-1#1)(2013-1#2)
of survival is##2##3##(1994-2#1)(2006-10#1)
of survival of##7##3##(1993-2#1)(2007-9#1)(2008-3#1)(2008-5#1)(2009-5#1)(2012-2#1)(2013-1#1)
of survival rate##2##3##(1995-9#1)(2007-11#1)
of survival rates##2##3##(2008-4#1)(2011-2#1)
of survival time##3##3##(1991-2#1)(2009-10#1)(2012-3#1)
of survival times for##2##4##(2007-9#1)(2013-8#1)
of survival was##7##3##(1990-10#1)(1991-6#1)(1993-2#1)(2007-8#1)(2008-5#1)(2008-7#1)(2013-1#1)
of survival were##2##3##(2007-9#1)(2012-2#1)
of survival with##2##3##(2008-6#1)(2011-12#1)
of survival##134##2##(1990-10#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-2#4)(1993-1#1)(1993-11#1)(1993-2#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#2)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-8#3)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-6#1)(1997-3#1)(2004-10#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-2#1)(2006-4#1)(2006-8#2)(2007-10#2)(2007-11#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#7)(2007-9#3)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2009-10#4)(2009-3#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-12#2)(2011-2#4)(2011-3#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#6)(2013-7#3)(2013-8#1)
of survivin and##3##3##(2008-4#1)(2010-12#1)(2011-2#1)
of survivin in##5##3##(2007-7#1)(2008-4#1)(2009-3#1)(2010-1#1)(2011-2#1)
of survivin##12##2##(2007-7#1)(2008-4#2)(2009-3#3)(2010-1#1)(2010-12#1)(2011-2#4)
of surviving##20##2##(1991-11#1)(1991-9#1)(1994-5#1)(1995-1#1)(1995-7#1)(2006-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#4)(2010-4#1)(2010-8#1)(2011-2#1)(2012-3#1)
of survivors of##7##3##(1990-5#1)(2005-10#2)(2008-11#3)(2010-7#1)
of survivors with##2##3##(1990-11#1)(2008-7#1)
of survivors##16##2##(1990-11#1)(1990-5#1)(1991-4#1)(2004-10#1)(2005-10#2)(2007-9#1)(2008-11#3)(2008-5#2)(2008-7#1)(2010-3#1)(2010-7#1)(2011-3#1)
of susceptibility genes has##2##4##(2008-10#1)(2008-7#1)
of susceptibility of##2##3##(1991-7#1)(2008-10#1)
of susceptibility testing and##2##4##(2008-8#1)(2008-9#1)
of susceptibility testing##3##3##(2008-8#1)(2008-9#1)(2009-5#1)
of susceptibility to##12##3##(1992-2#1)(1994-8#1)(1995-2#1)(1997-4#1)(2008-10#2)(2008-5#1)(2009-5#2)(2012-2#1)(2012-3#2)
of susceptibility were##2##3##(2008-10#1)(2012-2#1)
of susceptibility##35##2##(1991-7#1)(1992-2#1)(1994-8#1)(1995-2#1)(1997-4#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#8)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#3)(2011-2#3)(2012-2#3)(2012-3#2)
of susceptible and resistant cultivars##2##5##(2008-10#2)
of susceptible and resistant##5##4##(2008-10#5)
of susceptible and##8##3##(2008-10#7)(2011-2#1)
of susceptible animals##2##3##(2007-6#1)(2011-2#1)
of susceptible cells##2##3##(1991-12#1)(1996-10#1)
of susceptible crops##5##3##(2008-10#5)
of susceptible cultivars##2##3##(2008-10#2)
of susceptible host tissue##3##4##(2008-10#3)
of susceptible host##4##3##(2008-10#4)
of susceptible patients##2##3##(2006-2#1)(2008-8#1)
of susceptible plants##2##3##(2008-10#2)
of susceptible potato cv##2##4##(2008-10#2)
of susceptible potato##3##3##(2008-10#3)
of susceptible strains##2##3##(1991-4#1)(1994-5#1)
of susceptible tissue##2##3##(2008-10#2)
of susceptible##59##2##(1991-12#1)(1991-4#1)(1992-11#1)(1993-10#2)(1994-3#1)(1994-5#1)(1996-10#1)(1996-12#1)(1996-5#1)(1997-1#1)(2006-2#1)(2007-2#2)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#36)(2008-5#1)(2008-8#1)(2009-10#1)(2011-2#3)
of suspect##3##2##(1994-7#1)(2008-10#1)(2008-11#1)
of suspected MDR-TB##2##3##(2013-1#2)
of suspected acute##4##3##(1990-3#1)(1995-11#2)(2010-8#1)
of suspected breast cancer local recurrences##2##6##(1990-6#2)
of suspected drug##2##3##(2013-7#2)
of suspected##50##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#3)(1992-11#1)(1992-3#1)(1993-5#1)(1993-8#1)(1995-10#1)(1995-11#2)(1996-2#1)(1996-6#1)(2005-7#1)(2006-10#3)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#5)(2009-3#1)(2009-4#1)(2010-10#1)(2010-8#1)(2011-1#2)(2011-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#2)
of suspended matter##2##3##(2008-10#1)(2008-5#1)
of suspended particles and##2##4##(2008-2#2)
of suspended particulate##2##3##(2008-2#1)(2008-3#1)
of suspended sediment##2##3##(1992-6#1)(1997-4#1)
of suspended solids##3##3##(2008-10#1)(2008-5#1)(2010-5#1)
of suspended##17##2##(1992-6#1)(1997-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#2)(2008-5#2)(2008-7#2)(2010-5#1)
of suspending##2##2##(2005-11#2)
of suspension cells##3##3##(2008-11#3)
of suspension cultures##2##3##(1996-10#1)(2008-11#1)
of suspension##12##2##(1996-10#1)(2008-10#1)(2008-11#5)(2008-7#1)(2008-8#2)(2009-8#1)(2011-12#1)
of suspension-cultured##2##2##(1992-11#1)(1994-11#1)
of suspensions of##4##3##(1994-12#1)(2005-11#1)(2005-3#1)(2008-3#1)
of suspensions##6##2##(1994-12#1)(2005-11#2)(2005-3#1)(2008-3#2)
of suspicion and##7##3##(2005-10#1)(2008-1#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
of suspicion is needed to##2##5##(2011-2#1)(2012-2#1)
of suspicion is needed##4##4##(2006-4#1)(2009-6#1)(2011-2#1)(2012-2#1)
of suspicion is required to##5##5##(1995-10#1)(2007-7#1)(2008-1#1)(2010-1#1)(2012-12#1)
of suspicion is required##7##4##(1995-10#1)(2006-4#1)(2007-7#1)(2008-1#1)(2010-1#1)(2012-12#1)(2013-8#1)
of suspicion is##19##3##(1993-6#1)(1995-10#1)(2006-4#2)(2007-7#3)(2008-1#1)(2009-3#2)(2009-4#1)(2009-6#1)(2010-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
of suspicion of##4##3##(1992-5#1)(2007-6#1)(2007-8#1)(2010-7#1)
of suspicion on the part of the##2##7##(2010-5#1)(2012-12#1)
of suspicion on##3##3##(2010-5#1)(2012-12#1)(2012-2#1)
of suspicion should be##2##4##(2011-2#1)(2012-2#1)
of suspicion##65##2##(1992-5#1)(1993-2#1)(1993-5#1)(1993-6#1)(1995-10#1)(2005-10#3)(2005-12#1)(2005-2#1)(2006-10#2)(2006-11#1)(2006-4#3)(2007-12#1)(2007-6#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-3#3)(2009-4#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#3)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-8#5)
of suspicious##4##2##(1990-6#1)(2008-10#1)(2009-3#1)(2013-8#1)
of sustainability and##2##3##(2012-3#1)(2013-7#1)
of sustainability##5##2##(1997-7#2)(2012-3#1)(2013-7#1)(2013-8#1)
of sustainable##6##2##(2006-5#1)(2008-10#1)(2008-4#1)(2009-3#1)(2012-1#1)(2013-8#1)
of sustained and controlled release parenterals##2##6##(2008-5#2)
of sustained and transient##2##4##(2008-9#2)
of sustained and##5##3##(2008-4#1)(2008-5#2)(2008-9#2)
of sustained attention and##2##4##(2005-10#1)(2008-2#1)
of sustained hyperglycemia##2##3##(2008-1#1)(2012-4#1)
of sustained oscillations##2##3##(1996-6#1)(2007-9#1)
of sustained release##2##3##(2008-11#1)(2012-2#1)
of sustained##35##2##(1990-3#1)(1991-1#1)(1991-12#1)(1992-8#2)(1994-5#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-9#1)(2005-10#1)(2005-7#1)(2006-3#1)(2006-8#1)(2006-9#2)(2007-11#3)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-9#2)(2010-4#1)(2012-2#2)(2012-4#1)(2013-1#1)
of sustained-release##2##2##(2007-8#1)(2011-1#1)
of sustaining##9##2##(1993-5#1)(2007-1#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)
of suture##4##2##(1993-9#1)(1995-1#1)(2007-12#1)(2011-2#1)
of sutured##2##2##(1993-11#1)(2013-1#1)
of sutureless##2##2##(2007-8#2)
of suxamethonium##2##2##(1996-8#1)(2012-2#1)
of swainsonine##3##2##(2008-11#3)
of swallowing exercises##2##3##(2013-8#2)
of swallowing in##2##3##(2007-10#1)(2013-1#1)
of swallowing##11##2##(1993-12#2)(2007-10#3)(2007-3#1)(2012-2#1)(2013-1#1)(2013-8#3)
of swallows and martins##2##4##(2008-8#2)
of swarm size on##3##4##(2013-8#3)
of swarm size##4##3##(2013-8#4)
of swarm##6##2##(1993-8#1)(2007-9#1)(2013-8#4)
of swarming in##2##3##(2009-6#2)
of sweat gland##3##3##(1991-6#1)(2007-11#1)(2008-5#1)
of sweat glands##3##3##(1991-11#1)(1991-6#1)(2008-5#1)
of sweat##9##2##(1991-11#1)(1991-6#2)(1992-3#1)(2007-11#1)(2008-10#1)(2008-5#3)
of sweating##2##2##(2008-5#1)(2013-7#1)
of sweet cherry##4##3##(2008-10#4)
of sweet orange##4##3##(2008-10#4)
of sweet pepper##4##3##(2008-10#1)(2011-2#3)
of sweet potato feathery mottle potyvirus##2##6##(2008-10#2)
of sweet potato##4##3##(2008-10#4)
of sweet##22##2##(1996-1#1)(2008-10#16)(2008-2#1)(2008-5#1)(2011-2#3)
of swelling and##2##3##(2006-1#1)(2008-10#1)
of swelling in##2##3##(2005-8#1)(2012-12#1)
of swelling of the##3##4##(2009-5#1)(2012-12#1)(2013-1#1)
of swelling##9##2##(2005-8#1)(2006-1#1)(2006-9#1)(2008-10#1)(2008-5#1)(2009-5#1)(2012-12#2)(2013-1#1)
of swimmers##2##2##(1996-8#1)(2009-1#1)
of swimming behavior##2##3##(2008-4#1)(2008-5#1)
of swimming in##2##3##(1990-11#1)(2012-2#1)
of swimming##7##2##(1990-11#1)(1991-2#1)(2008-11#1)(2008-4#1)(2008-5#1)(2012-2#1)(2013-8#1)
of swine flu##3##3##(2011-1#3)
of swine origin##2##3##(2012-1#1)(2013-1#1)
of swine pepsin##3##3##(1996-5#3)
of swine vesicular disease virus##2##5##(2005-11#2)
of swine vesicular disease##4##4##(2005-11#3)(2011-2#1)
of swine##17##2##(1992-5#1)(1996-5#3)(1997-6#1)(2005-11#3)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)
of switching junctions##2##3##(2007-12#2)
of switching##4##2##(1997-1#1)(2007-12#2)(2008-1#1)
of swollen##4##2##(1997-6#1)(2012-12#2)(2012-2#1)
of syllable##2##2##(2008-9#1)(2013-8#1)
of symbiosis##2##2##(2008-11#1)(2012-8#1)
of symbiotic##9##2##(2006-3#2)(2007-12#3)(2008-11#1)(2009-8#1)(2012-11#1)(2013-1#1)
of symbolic##3##2##(2006-10#1)(2008-2#1)(2009-4#1)
of symmetric##8##2##(1993-8#1)(2006-10#1)(2007-11#3)(2008-11#1)(2008-3#1)(2008-8#1)
of symmetrical##8##2##(1995-3#1)(1996-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
of symmetry and##3##3##(2008-5#1)(2008-6#1)(2012-1#1)
of symmetry in##2##3##(1990-2#1)(1990-8#1)
of symmetry##23##2##(1990-2#1)(1990-8#2)(1991-4#1)(1996-2#1)(1996-5#1)(2006-12#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2012-1#1)(2012-11#2)
of symmetry-related##3##2##(1992-9#2)(1996-2#1)
of sympathetic activity##2##3##(1992-7#1)(2005-10#1)
of sympathetic and##2##3##(1990-7#1)(2012-2#1)
of sympathetic nerve activity##4##4##(2005-10#3)(2008-7#1)
of sympathetic nervous system##2##4##(2005-10#2)
of sympathetic nervous##3##3##(2005-10#3)
of sympathetic neurotransmission##2##3##(1996-12#1)(2008-2#1)
of sympathetic outflow in heart failure##2##6##(2005-10#2)
of sympathetic outflow with##2##4##(2005-10#2)
of sympathetic outflow##6##3##(2005-10#5)(2008-1#1)
of sympathetic##30##2##(1990-7#1)(1991-1#1)(1991-6#1)(1992-7#1)(1995-12#1)(1995-7#1)(1996-12#2)(1997-5#1)(2005-10#14)(2008-1#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2012-2#1)
of sympathetically maintained pain##5##4##(2006-12#5)
of sympathomimetic drug##2##3##(1997-8#2)
of sympathomimetic##3##2##(1997-8#2)(2007-10#1)
of sympathovagal##2##2##(2011-1#1)(2012-2#1)
of sympathy##5##2##(2008-10#2)(2012-2#3)
of sympatric species##2##3##(2008-9#2)
of sympatric##8##2##(1991-11#2)(2008-10#3)(2008-9#2)(2010-8#1)
of sympatry##3##2##(2008-10#2)(2011-12#1)
of symptom burden##2##3##(2008-7#2)
of symptom development##2##3##(2008-10#2)
of symptom expression and##2##4##(2008-10#2)
of symptom expression##3##3##(2008-10#3)
of symptom onset##5##3##(2007-10#1)(2007-9#3)(2008-9#1)
of symptom recurrence##2##3##(2006-8#1)(2010-6#1)
of symptom severity##8##3##(1996-12#1)(1996-2#1)(2008-10#5)(2011-2#1)
of symptom##41##2##(1996-12#1)(1996-2#1)(2004-3#1)(2005-10#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-8#2)(2007-9#3)(2008-10#13)(2008-3#3)(2008-7#5)(2008-9#2)(2009-9#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-2#1)
of symptomatic Meckel's diverticulum is##2##5##(1991-4#2)
of symptomatic and##3##3##(1993-8#1)(2006-11#1)(2008-7#1)
of symptomatic carotid##2##3##(2008-8#2)
of symptomatic disease##2##3##(2006-11#1)(2007-2#1)
of symptomatic illness##2##3##(2007-2#1)(2011-2#1)
of symptomatic patients with##3##4##(2005-9#1)(2006-9#1)(2007-5#1)
of symptomatic patients##5##3##(2005-9#1)(2006-10#1)(2006-9#1)(2007-5#1)(2011-2#1)
of symptomatic plants##3##3##(2008-10#3)
of symptomatic relapses##2##3##(2006-2#2)
of symptomatic thoraco-abdominal aneurysm##2##4##(2012-12#2)
of symptomatic trees##3##3##(2008-10#3)
of symptomatic##77##2##(1990-1#1)(1990-6#1)(1991-4#2)(1992-2#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1995-12#1)(1995-4#2)(1996-3#1)(2005-9#1)(2006-10#1)(2006-11#2)(2006-2#2)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-2#4)(2007-3#1)(2007-5#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#1)(2009-10#1)(2009-6#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#5)(2012-12#6)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)
of symptomatology in##2##3##(1991-5#1)(1996-9#1)
of symptomatology##10##2##(1990-9#1)(1991-5#1)(1992-2#1)(1994-6#1)(1996-5#1)(1996-9#2)(2008-10#1)(2011-1#1)(2012-12#1)
of symptomless##3##2##(2008-10#3)
of symptoms (P##2##3##(2008-6#1)(2012-2#1)
of symptoms after##4##3##(1992-8#1)(2007-2#1)(2007-8#1)(2012-2#1)
of symptoms and the##4##4##(2006-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
of symptoms and##42##3##(1991-2#1)(1991-3#1)(1991-6#1)(1992-4#2)(1992-5#1)(1992-9#1)(1996-1#1)(2004-3#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#3)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-2#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#6)(2012-2#1)(2013-1#1)(2013-7#1)
of symptoms and/or##2##3##(2006-5#1)(2007-11#1)
of symptoms associated with##2##4##(2006-8#1)(2008-11#1)
of symptoms before##4##3##(1991-8#1)(1997-4#1)(2006-10#1)(2012-2#1)
of symptoms by##2##3##(2008-5#1)(2008-7#1)
of symptoms during##3##3##(1990-6#1)(1995-4#1)(2006-10#1)
of symptoms from##3##3##(1990-7#1)(1995-6#1)(2011-2#1)
of symptoms has been##2##4##(1992-4#1)(2006-9#1)
of symptoms in patients with##2##5##(2006-8#1)(2010-5#1)
of symptoms in patients##3##4##(2006-8#1)(2007-8#1)(2010-5#1)
of symptoms in the##3##4##(2008-10#1)(2010-12#1)(2012-12#1)
of symptoms in##20##3##(1990-2#1)(1997-6#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#2)(2010-5#1)(2011-12#1)(2011-2#3)(2011-8#1)(2012-12#2)
of symptoms induced by##2##4##(2008-10#2)
of symptoms induced##3##3##(2008-10#3)
of symptoms is##3##3##(2006-12#1)(2007-11#1)(2009-9#1)
of symptoms may##2##3##(2006-12#2)
of symptoms of##9##3##(2005-11#1)(2006-10#3)(2007-11#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
of symptoms on##3##3##(2008-10#3)
of symptoms or##2##3##(1991-8#1)(2006-8#1)
of symptoms prior to##2##4##(1990-6#1)(2005-10#1)
of symptoms than##2##3##(2007-8#1)(2008-9#1)
of symptoms to##5##3##(1990-4#1)(2007-11#1)(2008-3#1)(2008-6#1)(2013-1#1)
of symptoms was 5##2##4##(2007-2#1)(2007-7#1)
of symptoms was observed##2##4##(2007-11#1)(2007-8#1)
of symptoms was##18##3##(1990-10#1)(1995-8#1)(1997-6#1)(1997-8#1)(2006-8#1)(2007-11#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#3)(2012-12#1)(2013-1#1)
of symptoms were##2##3##(2007-1#1)(2012-12#1)
of symptoms with##3##3##(2006-10#1)(2010-1#1)(2010-7#1)
of symptoms##283##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#2)(1990-6#4)(1990-7#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#2)(1991-8#4)(1992-11#1)(1992-4#3)(1992-5#1)(1992-8#3)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-5#1)(1993-9#2)(1995-4#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(2004-11#1)(2004-3#1)(2004-7#1)(2005-10#3)(2005-11#2)(2006-10#11)(2006-11#1)(2006-12#4)(2006-2#2)(2006-4#3)(2006-5#1)(2006-6#1)(2006-8#6)(2006-9#3)(2007-1#1)(2007-10#4)(2007-11#11)(2007-12#2)(2007-2#5)(2007-3#1)(2007-6#2)(2007-7#1)(2007-8#11)(2007-9#7)(2008-1#1)(2008-10#20)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#5)(2008-6#9)(2008-7#14)(2008-9#2)(2009-10#2)(2009-2#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#4)(2010-1#1)(2010-10#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#14)(2011-8#1)(2012-1#1)(2012-12#16)(2012-2#7)(2013-1#11)(2013-7#2)(2013-8#1)
of symptoms]##2##2##(1990-5#1)(2013-8#1)
of synaesthesia##7##2##(2008-9#4)(2012-1#3)
of synaesthetic##2##2##(2008-9#2)
of synapse##3##2##(1997-5#1)(2009-11#1)(2009-8#1)
of synapses in##2##3##(1996-6#2)
of synapses##18##2##(1991-11#2)(1991-6#1)(1992-12#1)(1992-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-9#1)(1996-2#1)(1996-6#2)(1996-9#1)(2008-4#1)(2012-12#2)(2012-2#1)(2012-3#1)
of synapsin I to actin##2##5##(1993-8#2)
of synapsin I to##3##4##(1993-8#3)
of synapsin I##5##3##(1993-8#3)(2007-10#2)
of synapsin IIa##2##3##(2007-10#2)
of synapsin##9##2##(1993-8#3)(1994-9#1)(2007-10#5)
of synapsins##3##2##(2007-10#3)
of synaptic activity##5##3##(1992-9#1)(1996-12#1)(2007-12#1)(2009-3#1)(2013-8#1)
of synaptic connections##5##3##(1996-1#1)(1996-9#1)(1997-2#1)(2007-10#1)(2008-11#1)
of synaptic efficacy##2##3##(1994-8#1)(2008-7#1)
of synaptic homeostasis##4##3##(2009-9#4)
of synaptic inhibition##3##3##(1991-10#1)(1997-5#1)(2008-4#1)
of synaptic membrane##2##3##(1990-2#2)
of synaptic membranes##6##3##(1990-2#3)(1994-2#1)(1995-12#2)
of synaptic plasticity in this##2##5##(1995-12#1)(2008-4#1)
of synaptic plasticity in##3##4##(1995-12#1)(2008-4#2)
of synaptic plasticity##13##3##(1990-9#1)(1993-12#1)(1995-12#2)(1997-5#1)(2007-8#1)(2008-4#3)(2009-8#2)(2009-9#1)(2012-2#1)
of synaptic strength##3##3##(1995-2#1)(2008-11#1)(2008-7#1)
of synaptic structure##2##3##(1997-7#1)(2007-11#1)
of synaptic transmission and plasticity##2##5##(2009-8#2)
of synaptic transmission and##4##4##(2008-7#1)(2009-6#1)(2009-8#2)
of synaptic transmission in the hippocampus##3##6##(1990-7#1)(1993-12#1)(1993-2#1)
of synaptic transmission in the##5##5##(1990-7#1)(1993-12#1)(1993-2#1)(1995-12#1)(2008-5#1)
of synaptic transmission in##6##4##(1990-7#1)(1993-12#1)(1993-2#1)(1995-12#1)(1995-2#1)(2008-5#1)
of synaptic transmission induced by##3##5##(1990-7#1)(1995-12#1)(1995-3#1)
of synaptic transmission##31##3##(1990-7#2)(1993-12#1)(1993-2#1)(1994-2#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#2)(1996-1#1)(1996-2#1)(1996-5#2)(1997-7#1)(2008-11#1)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#1)(2009-6#1)(2009-8#2)(2009-9#1)
of synaptic vesicle##3##3##(2008-4#2)(2013-8#1)
of synaptic vesicles in nerve terminals##2##6##(1990-12#1)(1997-7#1)
of synaptic vesicles in##3##4##(1990-12#1)(1991-5#1)(1997-7#1)
of synaptic vesicles##18##3##(1990-12#2)(1990-4#3)(1991-5#2)(1992-6#1)(1993-12#1)(1993-6#1)(1994-9#1)(1996-9#2)(1997-7#2)(2008-1#1)(2008-8#1)(2013-1#1)
of synaptic##126##2##(1990-12#3)(1990-2#5)(1990-3#1)(1990-4#3)(1990-7#2)(1990-9#2)(1991-10#1)(1991-5#2)(1992-12#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-2#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#7)(1995-2#2)(1995-3#2)(1995-5#2)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#3)(1996-9#3)(1997-2#1)(1997-3#1)(1997-5#3)(1997-7#5)(2007-10#2)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#2)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#10)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2009-3#1)(2009-6#1)(2009-8#5)(2009-9#7)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
of synaptophysin##4##2##(1996-3#1)(1996-5#1)(2012-3#1)(2013-1#1)
of synaptosomes and of synaptic##2##5##(1990-2#2)
of synaptosomes with##3##3##(1995-11#2)(1995-3#1)
of synaptosomes##7##2##(1990-2#3)(1995-11#2)(1995-3#1)(1995-9#1)
of synchronised##2##2##(2008-11#2)
of synchronization in##3##3##(1994-5#1)(2007-12#1)(2012-2#1)
of synchronization of a##2##4##(2010-2#1)(2013-7#1)
of synchronization##9##2##(1994-5#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-11#1)(2010-2#1)(2012-1#1)(2012-2#1)(2013-7#1)
of synchronized##5##2##(1993-10#1)(1994-5#1)(1994-9#1)(2012-2#1)(2013-1#1)
of synchronous and##3##3##(1992-8#1)(2005-4#1)(2008-10#1)
of synchronous fluorescence spectroscopy##2##4##(2008-10#2)
of synchronous luminescence##2##3##(2008-10#2)
of synchronous##21##2##(1991-6#1)(1992-8#1)(1993-5#1)(1993-8#1)(1994-12#1)(1996-2#1)(1997-2#1)(2005-4#1)(2007-12#1)(2008-10#7)(2008-3#1)(2008-6#1)(2009-1#1)(2013-1#1)(2013-8#1)
of synchronously##3##2##(1995-11#1)(2007-11#2)
of synchrony##4##2##(2008-11#3)(2013-8#1)
of synchrotron radiation in##3##4##(2006-5#1)(2008-10#1)(2008-3#1)
of synchrotron radiation##14##3##(2006-4#1)(2006-5#10)(2008-10#2)(2008-3#1)
of synchrotron##15##2##(2006-4#1)(2006-5#10)(2008-10#2)(2008-3#1)(2012-2#1)
of syncope##12##2##(1990-8#2)(2006-12#1)(2006-9#2)(2008-3#1)(2009-4#1)(2010-12#2)(2011-2#3)
of syncytial##2##2##(2006-12#1)(2008-9#1)
of syncytiotrophoblast in resorption villi of placentas##2##7##(2011-1#2)
of syncytiotrophoblast in resorption villi of##5##6##(2011-1#5)
of syncytiotrophoblast in resorption villi##6##5##(2011-1#6)
of syncytiotrophoblast##8##2##(2009-2#1)(2011-1#7)
of syndicate learning##3##3##(2012-1#3)
of syndicate##4##2##(2012-1#4)
of syndrome##4##2##(1990-6#1)(1994-7#1)(2008-10#1)(2008-12#1)
of syndromes##8##2##(1990-3#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-7#2)(2008-7#1)(2013-8#1)
of syndromic management##2##3##(2011-12#1)(2011-2#1)
of syneresis##3##2##(2012-11#3)
of synergetics##3##2##(2008-1#3)
of synergism##3##2##(1996-1#1)(2013-1#2)
of synergistic movement patterns of the upper extremity following stroke##2##10##(2012-1#2)
of synergistic movement patterns##3##4##(2012-1#3)
of synergistic##6##2##(2004-4#1)(2008-11#1)(2008-3#1)(2012-1#3)
of synergy##5##2##(1993-9#1)(1994-11#1)(2008-10#2)(2008-11#1)
of syngeneic##6##2##(1990-12#1)(1991-12#1)(1991-5#1)(1996-11#1)(2008-4#1)(2013-1#1)
of synonymous and nonsynonymous##2##4##(1990-4#1)(2012-3#1)
of synonymous##3##2##(1990-4#2)(2012-3#1)
of synovectomy of the knee##2##5##(2007-7#2)
of synovectomy##3##2##(2007-11#1)(2007-7#2)
of synovial bursae##2##3##(2007-11#2)
of synovial chondromatosis##2##3##(2007-7#1)(2008-6#1)
of synovial fluid##7##3##(1990-6#2)(2006-10#3)(2008-10#1)(2010-10#1)
of synovial membrane##2##3##(2013-1#2)
of synovial sarcoma##6##3##(2008-6#3)(2009-3#1)(2012-1#1)(2013-1#1)
of synovial tissue##2##3##(1991-5#1)(2013-1#1)
of synovial##28##2##(1990-6#2)(1991-10#1)(1991-5#1)(1992-3#2)(2005-7#1)(2006-10#4)(2007-11#2)(2007-7#2)(2008-10#1)(2008-6#5)(2009-3#1)(2010-10#1)(2012-1#1)(2013-1#4)
of synoviocytes in rats of##2##5##(2006-4#2)
of synoviocytes##4##2##(2006-4#4)
of synovium in##2##3##(2006-10#1)(2007-7#1)
of synovium##3##2##(2006-10#1)(2007-7#1)(2010-4#1)
of syntactic and##2##3##(2007-3#1)(2008-7#1)
of syntactic##4##2##(2007-3#1)(2008-2#1)(2008-4#1)(2008-7#1)
of syntax##3##2##(2006-3#1)(2008-2#1)(2008-4#1)
of synthesis and##5##3##(1990-8#1)(1991-6#1)(1994-3#1)(1994-8#1)(2009-4#1)
of synthesis conditions and##2##4##(2008-1#1)(2010-4#1)
of synthesis for##2##3##(2004-11#1)(2008-5#1)
of synthesis in the##2##4##(1995-8#1)(2008-1#1)
of synthesis of##7##3##(1990-11#1)(1992-6#1)(1993-12#1)(1994-8#1)(2007-12#1)(2008-5#1)(2009-8#1)
of synthesis##30##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-8#1)(2004-11#2)(2004-9#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-5#2)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-4#1)
of synthesizing##9##2##(1992-8#1)(1997-2#1)(1997-8#1)(2007-1#1)(2007-12#1)(2008-3#1)(2008-6#1)(2009-12#1)(2011-2#1)
of synthetic and natural##2##4##(2008-10#1)(2010-10#1)
of synthetic and##6##3##(2005-11#1)(2008-10#3)(2010-10#1)(2011-2#1)
of synthetic biology##6##3##(2009-5#3)(2011-1#1)(2012-2#1)(2013-7#1)
of synthetic chemicals##2##3##(2008-11#1)(2012-2#1)
of synthetic fragments of##2##4##(1991-5#2)
of synthetic grafts##3##3##(2007-7#2)(2009-4#1)
of synthetic mixtures of##2##4##(2008-10#2)
of synthetic mixtures##4##3##(2008-10#4)
of synthetic molecules##2##3##(2006-10#1)(2008-9#1)
of synthetic peptide##5##3##(1990-10#1)(1991-3#1)(1991-6#1)(1992-8#1)(1997-3#1)
of synthetic peptides and##3##4##(1994-9#1)(2008-4#2)
of synthetic peptides corresponding to the##3##6##(1990-7#1)(1992-12#1)(2006-10#1)
of synthetic peptides derived from##3##5##(1992-8#1)(1994-3#1)(2008-4#1)
of synthetic peptides in##2##4##(1992-6#1)(2008-4#1)
of synthetic peptides to##2##4##(2008-2#1)(2008-4#1)
of synthetic peptides##31##3##(1990-3#1)(1990-6#1)(1990-7#2)(1991-7#1)(1992-12#2)(1992-6#1)(1992-8#1)(1993-9#1)(1994-3#1)(1994-9#3)(1995-3#1)(2005-7#1)(2006-10#1)(2008-10#1)(2008-2#3)(2008-4#9)(2012-1#1)
of synthetic playing surfaces##2##4##(2013-1#2)
of synthetic polymers##2##3##(2009-12#1)(2011-1#1)
of synthetic rat##3##3##(1990-3#1)(1994-6#1)(1994-8#1)
of synthetic samples##2##3##(2008-10#2)
of synthetic##180##2##(1990-10#2)(1990-12#2)(1990-2#1)(1990-3#2)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-2#2)(1991-3#2)(1991-5#3)(1991-6#1)(1991-7#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-6#2)(1992-8#2)(1993-6#1)(1993-7#1)(1993-9#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#1)(2004-9#1)(2005-10#2)(2005-11#1)(2005-4#1)(2005-7#4)(2005-8#1)(2006-10#4)(2006-12#2)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#2)(2008-10#26)(2008-11#2)(2008-2#10)(2008-3#4)(2008-4#14)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#3)(2010-10#1)(2010-12#1)(2010-4#3)(2010-7#3)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#5)(2013-8#1)
of syphilis and##3##3##(1993-3#1)(2011-2#1)(2012-3#1)
of syphilis in the##3##4##(2007-7#1)(2009-9#2)
of syphilis in##9##3##(1993-3#1)(2007-7#2)(2009-2#1)(2009-8#2)(2009-9#2)(2011-1#1)
of syphilis##33##2##(1993-3#3)(1995-2#1)(1997-5#1)(2007-12#1)(2007-2#1)(2007-7#4)(2007-9#1)(2008-10#1)(2009-10#1)(2009-2#1)(2009-8#7)(2009-9#3)(2010-7#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)
of syringaldazine##2##2##(2008-10#2)
of syringe exchange programs in##2##5##(2008-11#1)(2012-11#1)
of syringe##3##2##(2008-10#1)(2008-11#1)(2012-11#1)
of syringomycin##2##2##(2006-3#1)(2008-10#1)
of syringomyelia##5##2##(2006-5#3)(2007-8#1)(2011-2#1)
of syringosubarachnoid##2##2##(2006-5#2)
of syrinx##6##2##(2006-5#5)(2008-8#1)
of system is##3##3##(2007-11#1)(2008-2#1)(2013-8#1)
of system parameters##3##3##(2007-12#2)(2008-3#1)
of system variables##3##3##(1990-7#1)(2008-10#1)(2008-2#1)
of system##32##2##(1990-7#1)(1992-1#1)(1992-12#1)(1992-6#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#1)(2008-9#2)(2009-6#1)(2010-8#2)(2012-3#2)(2013-1#5)(2013-8#2)
of systematic error##3##3##(2008-10#1)(2008-3#1)(2012-12#1)
of systematic errors in##2##4##(2007-11#1)(2008-3#1)
of systematic errors##5##3##(1996-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
of systematic patient education##2##4##(1993-12#2)
of systematic reviews##2##3##(2011-2#1)(2012-2#1)
of systematic screening##2##3##(1991-3#1)(2013-1#1)
of systematic##43##2##(1990-6#1)(1990-8#1)(1991-12#1)(1991-3#1)(1993-12#2)(1993-2#1)(1994-6#1)(1996-3#1)(1996-5#1)(1997-8#1)(2005-10#1)(2006-1#1)(2007-11#3)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#6)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
of systemic acquired resistance##5##4##(1992-11#1)(2007-11#1)(2008-10#3)
of systemic acquired##7##3##(1992-11#1)(2007-11#1)(2008-10#4)(2008-5#1)
of systemic adjuvant therapy##2##4##(1993-11#1)(2004-1#1)
of systemic adverse##2##3##(2007-11#2)
of systemic amyloidosis##4##3##(1990-3#1)(1993-11#1)(2009-8#1)(2011-2#1)
of systemic and local##3##4##(1992-9#1)(1995-7#2)
of systemic and##5##3##(1992-9#1)(1995-7#2)(2006-10#1)(2007-8#1)
of systemic autoimmune diseases##3##4##(2008-10#1)(2010-4#1)(2012-3#1)
of systemic autoimmune##4##3##(2008-10#1)(2008-5#1)(2010-4#1)(2012-3#1)
of systemic chemotherapy##2##3##(2006-8#1)(2011-1#1)
of systemic disease##7##3##(2005-5#1)(2006-8#1)(2008-10#2)(2008-6#1)(2009-8#1)(2012-1#1)
of systemic diseases##3##3##(2006-10#1)(2009-2#1)(2011-2#1)
of systemic ethanol on##2##4##(1992-3#2)
of systemic fungal infections##3##4##(1997-2#1)(2005-8#1)(2007-7#1)
of systemic hypertension in##2##4##(2006-2#1)(2009-4#1)
of systemic hypertension##5##3##(1992-4#2)(2006-2#2)(2009-4#1)
of systemic illness##2##3##(2007-7#1)(2010-9#1)
of systemic infection##4##3##(1992-3#1)(1993-12#1)(2008-10#1)(2008-11#1)
of systemic infections##3##3##(1995-5#1)(2008-10#1)(2008-7#1)
of systemic inflammation##5##3##(2005-10#1)(2007-9#1)(2010-10#1)(2013-1#2)
of systemic inflammatory reaction##2##4##(2007-12#2)
of systemic inflammatory##4##3##(2006-10#1)(2007-12#2)(2010-5#1)
of systemic involvement##2##3##(2005-11#1)(2013-1#1)
of systemic lupus erythematosus (SLE)##8##5##(1992-11#1)(2006-10#3)(2008-1#2)(2011-2#2)
of systemic lupus erythematosus##23##4##(1992-11#1)(1994-2#2)(2006-10#6)(2007-11#1)(2007-7#1)(2008-1#2)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#2)
of systemic lupus##24##3##(1992-11#1)(1994-2#2)(2006-10#6)(2007-11#1)(2007-7#1)(2008-1#2)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
of systemic mastocytosis##3##3##(2011-12#1)(2011-2#1)(2013-8#1)
of systemic or##2##3##(2007-3#1)(2008-3#1)
of systemic resistance##10##3##(2007-12#1)(2008-10#9)
of systemic sclerosis and##2##4##(2006-10#1)(2007-7#1)
of systemic sclerosis##8##3##(1991-12#1)(2006-10#3)(2007-7#3)(2008-8#1)
of systemic therapy##6##3##(2006-10#1)(2007-3#1)(2008-5#1)(2009-12#1)(2010-11#2)
of systemic toxicity##2##3##(2005-10#1)(2012-2#1)
of systemic treatment##2##3##(1996-1#1)(2013-1#1)
of systemic vascular##2##3##(2009-5#2)
of systemic vasculitides##2##3##(2010-4#1)(2012-1#1)
of systemic vasculitis##2##3##(2006-10#1)(2008-3#1)
of systemic##204##2##(1990-3#2)(1990-7#1)(1991-12#1)(1991-2#2)(1992-11#2)(1992-3#3)(1992-4#2)(1992-5#1)(1992-9#1)(1993-11#2)(1993-12#1)(1994-10#1)(1994-2#4)(1994-3#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-7#4)(1996-1#1)(1996-2#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(2004-1#1)(2005-10#4)(2005-11#1)(2005-5#1)(2005-8#3)(2006-10#15)(2006-2#4)(2006-8#2)(2006-9#1)(2007-11#8)(2007-12#6)(2007-2#1)(2007-3#2)(2007-7#6)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#24)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#3)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#4)(2010-10#1)(2010-11#3)(2010-4#3)(2010-5#2)(2010-6#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#1)
of systemically administered##4##3##(1993-12#1)(1995-7#1)(1996-12#1)(2007-11#1)
of systemically##6##2##(1993-12#1)(1995-7#1)(1996-12#1)(2005-9#1)(2007-11#1)(2008-10#1)
of systems and forms of payment##2##6##(1994-3#2)
of systems biology approaches##2##4##(2010-9#1)(2012-2#1)
of systems biology##6##3##(2006-10#2)(2009-8#1)(2010-9#1)(2012-2#1)(2012-3#1)
of systems containing##3##3##(2005-11#1)(2006-10#1)(2007-12#1)
of systems for##3##3##(1995-7#1)(2007-11#1)(2008-7#1)
of systems of plane##2##4##(2008-2#2)
of systems of##4##3##(2008-2#2)(2010-12#1)(2013-1#1)
of systems that##2##3##(1994-8#1)(1996-12#1)
of systems with##6##3##(2008-10#2)(2008-3#3)(2008-7#1)
of systems##56##2##(1990-12#1)(1991-2#1)(1992-12#1)(1994-3#2)(1994-8#1)(1995-3#1)(1995-7#1)(1996-12#2)(2005-11#1)(2005-8#1)(2006-10#7)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#4)(2008-7#5)(2009-10#2)(2009-8#1)(2010-12#1)(2010-7#1)(2010-9#2)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)
of systolic HF##3##3##(2010-12#3)
of systolic and diastolic blood pressure##2##6##(1990-12#1)(2008-1#1)
of systolic and diastolic heart failure##2##6##(2010-5#2)
of systolic and diastolic##5##4##(1990-12#1)(2008-1#1)(2010-5#2)(2012-12#1)
of systolic and##6##3##(1990-12#1)(1990-8#1)(2008-1#1)(2010-5#2)(2012-12#1)
of systolic blood pressure##4##4##(1991-10#1)(2006-4#1)(2007-8#1)(2013-7#1)
of systolic blood##5##3##(1991-10#1)(2006-4#1)(2007-8#1)(2010-11#1)(2013-7#1)
of systolic hypertension##4##3##(1993-12#1)(2008-1#1)(2008-4#1)(2011-1#1)
of systolic##27##2##(1990-12#1)(1990-8#1)(1991-10#1)(1991-12#1)(1993-12#1)(2006-4#1)(2006-6#1)(2007-8#2)(2008-1#3)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-5#2)(2011-1#2)(2012-12#1)(2013-7#1)
of t(R)##2##2##(2008-10#1)(2012-3#1)
of t-AML##3##2##(2007-12#1)(2013-7#2)
of t-PA and##2##3##(1990-11#2)
of t-PA antigen##2##3##(2007-9#2)
of t-PA for plasminogen by##2##5##(1995-3#2)
of t-PA for plasminogen##3##4##(1995-3#3)
of t-PA for##6##3##(1990-5#2)(1995-3#3)(2007-9#1)
of t-PA is##2##3##(1995-3#1)(2007-10#1)
of t-PA##33##2##(1990-11#9)(1990-5#4)(1992-2#2)(1995-3#4)(1997-2#2)(2007-10#3)(2007-9#6)(2008-11#3)
of t-PA/PAI-1 complexes by monocytes##2##5##(1995-8#2)
of t-PA/PAI-1 complexes##3##3##(1995-8#3)
of t-RNA##2##2##(2008-11#1)(2008-8#1)
of tBRD-1##3##2##(2012-12#3)
of tNOX##3##2##(2008-7#1)(2009-9#2)
of tPA in the##2##4##(2008-8#1)(2010-3#1)
of tPA##8##2##(1990-11#3)(2008-11#2)(2008-8#2)(2010-3#1)
of tRNA and##2##3##(1990-2#1)(2012-2#1)
of tRNA genes and##2##4##(2008-9#2)
of tRNA genes##5##3##(1995-1#1)(1995-8#2)(2008-9#2)
of tRNA##22##2##(1990-10#1)(1990-2#1)(1991-10#2)(1992-6#3)(1994-12#2)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#2)(1997-5#1)(2006-12#1)(2008-4#2)(2008-8#1)(2008-9#2)(2012-2#1)
of tRNA(Gly)1##2##2##(1997-7#2)
of tRNA(Leu)##2##2##(2008-4#1)(2008-8#1)
of tRNA(Lys3)##2##2##(1996-11#1)(1997-1#1)
of tRNA(Phe)##3##2##(1990-8#1)(1991-11#1)(1992-2#1)
of tRNA(fMet)##2##2##(1995-6#2)
of tRNA(m5U54)-methyltransferase##2##2##(1995-2#2)
of tRNA2(fMet)##3##2##(1993-11#3)
of tRNAs was##3##3##(1990-8#1)(2012-12#2)
of tRNAs##10##2##(1990-8#3)(1991-10#1)(1994-8#1)(1997-2#1)(1997-5#1)(2010-11#1)(2012-12#2)
of table##3##2##(2006-1#1)(2006-4#1)(2007-2#1)
of tablet##8##2##(2006-1#1)(2010-5#7)
of tablets##10##2##(2007-8#1)(2008-10#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2012-12#1)
of tachycardia##4##2##(1991-5#1)(2006-8#2)(2008-1#1)
of tachykinin NK1 and NK2 receptor antagonists##2##7##(1997-4#2)
of tachykinin NK1##3##3##(1993-11#1)(1997-4#2)
of tachykinin NK2 receptors##2##4##(1993-3#2)
of tachykinin NK2##3##3##(1993-3#2)(1996-12#1)
of tachykinin receptors##2##3##(2008-8#2)
of tachykinin##8##2##(1993-11#1)(1993-3#2)(1996-12#1)(1997-4#2)(2008-8#2)
of tachykinins##4##2##(1990-11#1)(1991-5#1)(1993-12#1)(1997-4#1)
of tackling##3##2##(2005-11#1)(2007-9#1)(2008-7#1)
of tacrine##6##2##(1993-11#4)(2011-3#1)(2012-3#1)
of tacrolimus and##3##3##(2006-10#1)(2007-11#1)(2011-2#1)
of tacrolimus in##3##3##(2007-11#1)(2008-10#1)(2012-2#1)
of tacrolimus##16##2##(2005-7#1)(2006-10#2)(2006-8#1)(2007-11#5)(2008-10#1)(2011-2#1)(2012-2#4)(2013-8#1)
of tactic##2##2##(2006-10#1)(2007-7#1)
of tactics of##2##3##(2008-6#1)(2011-1#1)
of tactile##7##2##(1994-6#1)(1996-1#1)(2006-6#1)(2007-5#1)(2008-5#1)(2009-8#2)
of tadalafil in pharmaceutical preparation##2##5##(2008-10#2)
of tadalafil in pharmaceutical##3##4##(2008-10#3)
of tadalafil in##4##3##(2008-10#3)(2008-11#1)
of tadalafil##5##2##(2008-10#4)(2008-11#1)
of tadpoles##4##2##(1991-5#3)(1995-12#1)
of tag##3##2##(2008-6#1)(2010-8#1)(2011-12#1)
of tagged##4##2##(2007-3#1)(2010-8#2)(2012-3#1)
of tagging##2##2##(2006-12#1)(2010-8#1)
of tagitinin C in##2##4##(2008-10#2)
of tagitinin C##3##3##(2008-10#3)
of tags were##2##3##(2006-12#1)(2010-8#1)
of tags##5##2##(2006-12#1)(2008-2#1)(2008-7#1)(2010-8#2)
of tai chi##2##3##(2008-10#2)
of tail markings##3##3##(2008-9#3)
of tail##15##2##(1992-8#1)(1993-1#1)(1993-3#1)(1994-4#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#4)
of tailored##3##2##(2008-8#1)(2013-1#2)
of tailoring##3##2##(1993-12#1)(2008-10#1)(2013-8#1)
of take-all epidemics on winter wheat yield formation##2##8##(2008-10#2)
of take-all epidemics##3##3##(2008-10#3)
of take-all in##2##3##(2008-10#2)
of take-all on##3##3##(2008-10#3)
of take-all##13##2##(2008-10#13)
of taking into consideration the##2##5##(1995-9#1)(2006-8#1)
of taking into##4##3##(1995-9#1)(2005-12#1)(2006-8#1)(2008-12#1)
of taking the##3##3##(1991-2#1)(2010-3#1)(2010-4#1)
of taking##24##2##(1990-8#1)(1991-2#1)(1992-10#1)(1995-9#1)(2005-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-8#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
of talar##2##2##(1991-10#1)(2011-2#1)
of talin and G-actin##2##4##(1990-9#1)(1991-7#1)
of talin and##4##3##(1990-9#2)(1991-7#2)
of talin##9##2##(1990-9#3)(1991-7#2)(2006-10#3)(2009-7#1)
of talk##2##2##(2008-9#1)(2010-2#1)
of tall fescue (Festuca arundinacea)##2##5##(1994-3#1)(2006-12#1)
of tall fescue##8##3##(1994-3#3)(2006-12#1)(2008-10#3)(2008-2#1)
of tall##10##2##(1994-3#4)(2006-12#1)(2007-5#1)(2008-10#3)(2008-2#1)
of tamoxifen (TAM)##2##3##(1993-7#1)(1994-7#1)
of tamoxifen and its##2##4##(2007-11#2)
of tamoxifen and##7##3##(1990-8#1)(1993-4#1)(1996-4#1)(1996-9#1)(2007-11#3)
of tamoxifen as##2##3##(1995-9#1)(2008-10#1)
of tamoxifen for##2##3##(2008-5#2)
of tamoxifen in##4##3##(1990-8#1)(1993-7#1)(2008-10#1)(2008-7#1)
of tamoxifen on serum cholesterol##2##5##(1993-12#2)
of tamoxifen on serum##3##4##(1993-12#2)(2004-1#1)
of tamoxifen on##6##3##(1993-11#1)(1993-12#4)(2004-1#1)
of tamoxifen resistance##2##3##(2008-7#2)
of tamoxifen##37##2##(1990-4#1)(1990-8#3)(1991-10#1)(1993-10#2)(1993-11#1)(1993-12#4)(1993-4#1)(1993-7#2)(1994-7#1)(1995-9#1)(1996-4#1)(1996-9#2)(1997-7#1)(2004-1#1)(2007-11#4)(2008-10#4)(2008-5#3)(2008-7#4)
of tamoxifen-induced##2##2##(1994-8#1)(1997-3#1)
of tan spot and##3##4##(2008-10#3)
of tan spot caused by##2##5##(2008-10#2)
of tan spot of wheat##4##5##(2008-10#4)
of tan spot##16##3##(2008-10#16)
of tan##17##2##(2007-10#1)(2008-10#16)
of tandem repeats in##2##4##(1990-12#1)(2009-3#1)
of tandem repeats##9##3##(1990-12#1)(1991-7#1)(1992-5#1)(1995-12#1)(2004-10#1)(2008-3#2)(2008-4#1)(2009-3#1)
of tandem##23##2##(1990-12#1)(1991-2#1)(1991-7#1)(1992-11#1)(1992-5#1)(1993-12#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-5#1)(2004-10#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#2)(2009-3#1)(2009-5#1)(2012-1#1)(2013-8#1)
of tandemly##2##2##(1990-5#1)(1991-8#1)
of tangential##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
of tankships on the marine environment##2##6##(2008-11#2)
of tannic acid solution on##2##5##(2004-9#2)
of tannic acid##8##3##(1996-1#1)(2004-9#2)(2008-10#4)(2008-5#1)
of tannin##3##2##(2007-1#1)(2007-10#1)(2008-10#1)
of tanning##2##2##(2007-10#1)(2007-3#1)
of tanshinones##3##2##(2008-10#3)
of tantalum##5##2##(2008-10#2)(2008-2#2)(2008-3#1)
of tanycytes##2##2##(1997-5#1)(2012-1#1)
of tanycytic ependymoma##3##3##(2007-12#3)
of tap and mineral##2##4##(2008-10#2)
of tap water##2##3##(2008-10#2)
of tap##5##2##(2006-2#1)(2008-10#4)
of tape##8##2##(1991-12#1)(2004-9#1)(2008-10#1)(2012-2#5)
of tapered##4##2##(2007-12#2)(2008-3#2)
of taperin##2##2##(2012-12#2)
of tapwater##2##2##(2008-10#2)
of tarabine PFS and adriblastina##3##5##(2008-10#3)
of tardive dyskinesia##2##3##(1997-8#1)(2010-6#1)
of tardive##3##2##(1997-8#1)(2008-7#1)(2010-6#1)
of target DNA##6##3##(1991-8#1)(1991-9#1)(2008-10#3)(2013-1#1)
of target analytes##3##3##(2008-10#2)(2008-8#1)
of target and##4##3##(1990-12#1)(1995-9#1)(2008-10#1)(2010-5#1)
of target antigens##2##3##(1996-4#1)(2006-2#1)
of target attainment##2##3##(2011-2#2)
of target cells following##2##4##(1990-5#1)(2008-4#1)
of target cells to##3##4##(1992-1#1)(2008-4#2)
of target cells##23##3##(1990-5#1)(1991-12#1)(1992-1#1)(1993-2#1)(1994-2#1)(1995-3#1)(2006-10#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-2#1)
of target detection##2##3##(2008-1#1)(2008-2#1)
of target eccentricity##2##3##(2008-1#2)
of target gene##3##3##(2008-11#1)(2008-4#1)(2008-5#1)
of target genes in##2##4##(2009-8#2)
of target genes##17##3##(1991-2#1)(1993-2#1)(1996-4#1)(1997-4#2)(2005-11#1)(2008-1#1)(2008-5#1)(2009-3#1)(2009-4#1)(2009-8#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
of target mRNA##4##3##(1996-12#1)(2008-4#3)
of target mRNAs##3##3##(2010-11#1)(2011-2#1)(2013-1#1)
of target molecules##2##3##(2008-10#1)(2009-4#1)
of target motion##4##3##(1996-1#4)
of target nucleic acids##3##4##(2007-8#2)(2008-10#1)
of target protein##2##3##(2006-11#1)(2008-7#1)
of target proteins##3##3##(2008-11#1)(2008-4#2)
of target receptor##2##3##(2008-8#2)
of target tissues and##2##4##(2008-3#1)(2009-4#1)
of target tissues##5##3##(1994-11#1)(1997-7#1)(2008-3#1)(2009-4#1)(2010-8#1)
of target words##2##3##(2007-4#2)
of target##147##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-1#1)(1993-2#2)(1993-7#1)(1994-11#1)(1994-2#2)(1995-12#1)(1995-3#1)(1995-9#1)(1996-1#4)(1996-12#1)(1996-3#2)(1996-4#2)(1997-4#2)(1997-7#1)(2004-4#1)(2005-11#2)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2007-12#2)(2007-4#2)(2007-8#4)(2008-1#4)(2008-10#15)(2008-11#5)(2008-2#6)(2008-3#3)(2008-4#9)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-8#4)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#3)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
of target-cell##2##2##(1993-9#1)(2008-4#1)
of targeted agents##2##3##(2012-1#1)(2012-2#1)
of targeted genes##2##3##(2008-7#1)(2012-3#1)
of targeted molecular##2##3##(2009-4#1)(2010-5#1)
of targeted therapies in##2##4##(2009-11#1)(2011-2#1)
of targeted therapies##5##3##(2008-8#1)(2009-11#1)(2011-2#1)(2012-1#1)(2012-12#1)
of targeted therapy for##2##4##(2010-12#1)(2013-8#1)
of targeted therapy in##3##4##(2009-8#2)(2011-3#1)
of targeted therapy##7##3##(2008-3#1)(2009-8#2)(2010-12#2)(2011-3#1)(2013-8#1)
of targeted##49##2##(1997-7#1)(2005-9#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-8#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-2#3)(2011-3#3)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
of targeting the##3##3##(2008-1#2)(2008-7#1)
of targeting these##3##3##(2010-1#1)(2011-1#1)(2011-2#1)
of targeting##19##2##(1992-5#1)(1992-7#1)(1995-12#1)(1997-6#1)(2005-6#1)(2005-8#1)(2008-1#2)(2008-11#1)(2008-7#2)(2009-10#1)(2009-3#1)(2010-1#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
of targets and##3##3##(2006-5#1)(2008-11#1)(2013-1#1)
of targets for##4##3##(2006-12#1)(2008-4#1)(2008-5#1)(2009-11#1)
of targets in addition to##2##5##(2009-12#1)(2010-12#1)
of targets in##4##3##(2008-10#1)(2009-12#1)(2009-8#1)(2010-12#1)
of targets##26##2##(1994-8#1)(1997-7#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
of tartaric acid released##3##4##(2008-5#3)
of tartaric acid##10##3##(2005-11#1)(2008-10#3)(2008-5#6)
of tartaric##12##2##(2005-11#1)(2008-10#5)(2008-5#6)
of tartrate##2##2##(2008-10#1)(2008-6#1)
of tartrazine##2##2##(2008-10#2)
of task##17##2##(1991-1#1)(1994-8#1)(1995-12#1)(2006-4#1)(2006-6#1)(2007-4#1)(2007-8#1)(2008-11#2)(2008-6#1)(2008-8#1)(2011-12#1)(2011-2#1)(2012-3#2)(2013-1#2)
of task-irrelevant##3##2##(2008-11#1)(2009-1#1)(2012-2#1)
of tasks##6##2##(1996-2#1)(2008-11#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-3#1)
of taste are##2##3##(1991-3#1)(2008-9#1)
of taste in##2##3##(2008-7#1)(2008-9#1)
of taste##16##2##(1990-9#1)(1991-1#1)(1991-3#1)(1993-9#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#4)(2012-12#1)(2012-3#1)(2013-1#1)
of tattooing##3##2##(2007-12#2)(2008-8#1)
of tattoos##2##2##(1991-11#1)(1992-10#1)
of tau at##2##3##(2003-11#1)(2008-3#1)
of tau in##3##3##(1995-11#1)(2007-9#2)
of tau protein and Alzheimer paired helical filaments##2##8##(1994-9#2)
of tau protein##8##3##(1994-9#2)(1995-11#1)(1995-12#1)(1995-8#1)(2008-3#1)(2011-2#2)
of tau with##5##3##(1993-6#2)(1995-10#1)(1995-12#1)(1997-1#1)
of tau##41##2##(1992-3#2)(1993-6#2)(1994-9#3)(1995-10#5)(1995-11#4)(1995-12#4)(1995-2#2)(1995-3#1)(1995-8#1)(1996-3#2)(1996-7#1)(1996-8#2)(1997-1#1)(2003-11#2)(2007-9#2)(2008-3#4)(2011-2#3)
of taurine against##2##3##(2012-12#2)
of taurine and##3##3##(1995-1#1)(2008-7#1)(2009-10#1)
of taurine in##5##3##(1992-9#1)(2007-1#1)(2008-10#3)
of taurine##27##2##(1990-4#1)(1992-1#2)(1992-9#1)(1994-12#1)(1995-1#3)(1996-12#1)(2007-1#2)(2008-10#7)(2008-5#1)(2008-7#1)(2009-10#4)(2012-12#3)
of taurocholate##2##2##(1994-11#1)(1994-12#1)
of tax##2##2##(1993-2#1)(2008-9#1)
of tax-exemption##2##2##(1993-1#1)(1995-2#1)
of taxa have##2##3##(2010-6#1)(2012-12#1)
of taxa##12##2##(2006-5#1)(2007-3#1)(2008-8#1)(2010-3#2)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)
of taxane therapy##2##3##(2008-9#2)
of taxane##3##2##(2008-4#1)(2008-9#2)
of taxanes##4##2##(2007-5#1)(2009-8#1)(2010-12#1)(2011-2#1)
of taxine B and isotaxine B in the##2##8##(2010-9#2)
of taxines##2##2##(2010-9#2)
of taxol and##3##3##(1994-11#1)(1994-9#1)(2006-12#1)
of taxol on##2##3##(1994-9#1)(1996-4#1)
of taxol with##2##3##(1994-11#1)(2008-5#1)
of taxol##12##2##(1992-8#1)(1993-11#1)(1994-11#4)(1994-9#2)(1995-3#1)(1996-4#1)(2006-12#1)(2008-5#1)
of taxon##3##2##(2007-12#1)(2010-6#1)(2012-2#1)
of taxonomic##4##2##(2008-5#2)(2008-8#1)(2008-9#1)
of te##2##2##(2008-11#2)
of tea leaves##2##3##(1993-9#2)
of tea##11##2##(1993-9#5)(1997-8#1)(2008-10#2)(2008-11#1)(2012-12#1)(2013-7#1)
of teacher##3##2##(2008-12#2)(2009-7#1)
of teachers##7##2##(2005-12#1)(2006-7#2)(2008-10#2)(2008-12#1)(2011-2#1)
of teachers' practices##2##3##(2008-12#2)
of teachers'##5##2##(2007-12#1)(2008-12#2)(2009-7#1)(2012-1#1)
of teaching and assessing##2##4##(2008-11#2)
of teaching and learning##5##4##(1996-1#1)(2005-12#2)(2008-12#1)(2012-1#1)
of teaching and##9##3##(1996-1#1)(2005-12#2)(2008-11#2)(2008-12#1)(2010-7#1)(2012-1#1)(2013-1#1)
of teaching hospitals##3##3##(1992-12#1)(1997-1#1)(2008-11#1)
of teaching##40##2##(1992-12#2)(1992-2#1)(1993-12#2)(1993-3#1)(1994-12#1)(1995-1#1)(1996-1#1)(1997-1#1)(2005-12#2)(2006-5#2)(2007-5#1)(2007-9#1)(2008-11#3)(2008-12#3)(2008-7#1)(2009-2#2)(2009-9#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#4)(2013-1#2)(2013-8#2)
of team##6##2##(1993-12#1)(1994-12#1)(1996-3#1)(2011-1#3)
of teams##2##2##(2008-2#1)(2011-2#1)
of teamwork##2##2##(1996-1#1)(2013-1#1)
of tear film dynamics##2##4##(2006-11#2)
of tear##7##2##(2006-11#4)(2010-4#1)(2011-7#1)(2013-8#1)
of tears##2##2##(2006-11#1)(2007-1#1)
of teas##2##2##(2008-11#2)
of tebuconazole##4##2##(2008-10#4)
of technical and##3##3##(1991-1#1)(2008-3#2)
of technical difficulties##2##3##(2007-8#1)(2011-1#1)
of technical experts##2##3##(1996-1#1)(2008-1#1)
of technical grade##2##3##(2008-10#2)
of technical knowledge##2##3##(1990-12#1)(2008-11#1)
of technical objects##2##3##(2008-3#2)
of technical oils in supercritical##2##5##(2008-10#2)
of technical skills##2##3##(1995-10#1)(2012-2#1)
of technical surfaces##2##3##(2008-2#1)(2008-3#1)
of technical tasks##2##3##(2010-2#2)
of technical##47##2##(1990-12#2)(1991-1#1)(1991-12#1)(1992-1#3)(1993-8#2)(1995-10#1)(1996-1#1)(1997-3#1)(2005-11#1)(2006-5#1)(2006-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#5)(2008-5#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-2#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)
of technique and##4##3##(2008-1#1)(2008-5#1)(2011-2#1)(2012-12#1)
of technique##14##2##(1991-4#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2009-3#1)(2011-2#2)(2012-12#3)(2012-2#1)
of techniques and##6##3##(1991-10#1)(1994-11#1)(2006-8#1)(2007-7#1)(2008-10#1)(2009-10#1)
of techniques based on##2##4##(2008-1#1)(2008-8#1)
of techniques for the##3##4##(2007-8#1)(2008-5#1)(2011-2#1)
of techniques for##7##3##(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-9#1)(2011-2#1)
of techniques have been##2##4##(2007-11#1)(2010-7#1)
of techniques including##2##3##(1990-2#1)(2008-6#1)
of techniques such as##2##4##(2010-7#1)(2012-2#1)
of techniques that allow##2##4##(2009-12#1)(2010-11#1)
of techniques that are##2##4##(1992-12#1)(2006-10#1)
of techniques that##7##3##(1992-12#1)(1994-1#1)(2006-10#1)(2008-9#2)(2009-12#1)(2010-11#1)
of techniques to study##2##4##(2009-4#1)(2010-9#1)
of techniques to##4##3##(1991-3#1)(1995-5#1)(2009-4#1)(2010-9#1)
of techniques used to##2##4##(2006-7#1)(2011-2#1)
of techniques used##3##3##(2006-7#1)(2007-11#1)(2011-2#1)
of techniques##58##2##(1990-2#1)(1990-9#2)(1991-10#1)(1991-3#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-1#1)(1994-11#1)(1995-5#1)(1996-5#1)(1997-1#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-7#3)(2010-9#1)(2011-2#3)(2012-2#2)
of technological advances##2##3##(2011-1#1)(2013-8#1)
of technological and##3##3##(2006-10#1)(2008-2#1)(2010-12#1)
of technological breakthroughs##3##3##(2007-5#1)(2008-9#1)(2013-8#1)
of technological##15##2##(1991-5#1)(1992-3#1)(2006-10#1)(2007-12#1)(2007-5#1)(2008-1#3)(2008-2#1)(2008-9#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#2)
of technologies and##3##3##(2005-9#1)(2012-12#1)(2012-3#1)
of technologies to##2##3##(1995-5#1)(2007-4#1)
of technologies##12##2##(1995-5#1)(2005-9#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-4#1)(2010-4#1)(2010-7#1)(2012-12#1)(2012-3#2)
of technologists in##2##3##(1990-12#1)(1992-1#1)
of technologists##6##2##(1990-12#1)(1992-1#2)(1992-3#1)(1994-9#1)(2007-4#1)
of technology and##3##3##(1993-2#1)(2008-7#1)(2013-1#1)
of technology for##4##3##(1995-12#1)(2005-11#1)(2007-11#1)(2010-12#1)
of technology has##3##3##(2006-10#1)(2008-12#1)(2009-8#1)
of technology in health care and##2##6##(1990-12#1)(2008-1#1)
of technology in health care##3##5##(1990-12#1)(2008-1#1)(2008-10#1)
of technology in health##4##4##(1990-12#1)(2008-1#1)(2008-10#1)(2012-12#1)
of technology in##11##3##(1990-12#3)(2006-6#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-8#1)(2012-12#1)(2013-1#1)
of technology that##2##3##(1992-1#1)(2004-9#1)
of technology to##3##3##(2004-10#1)(2008-11#1)(2013-1#1)
of technology##55##2##(1990-12#3)(1991-11#1)(1992-1#1)(1992-12#1)(1993-2#1)(1993-5#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-3#1)(1997-3#1)(2004-10#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-10#4)(2007-11#1)(2007-12#2)(2008-1#3)(2008-10#3)(2008-11#4)(2008-12#4)(2008-5#1)(2008-7#3)(2008-8#1)(2009-8#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#6)
of teenage pregnancy##2##3##(2008-3#1)(2013-1#1)
of teeth and##2##3##(2005-11#1)(2010-3#1)
of teeth restored by use of##2##6##(2013-8#2)
of teeth##29##2##(1991-2#1)(1991-6#1)(2005-11#2)(2006-2#2)(2006-3#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-7#3)(2010-3#1)(2010-8#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#2)
of tegafur##4##2##(1994-7#1)(1997-3#3)
of tegaserod maleate##3##3##(2010-2#3)
of tegaserod##5##2##(2008-3#2)(2010-2#3)
of teicoplanin##4##2##(2008-10#4)
of telecommunication technology##2##3##(2005-10#1)(2006-4#1)
of telecommunication##4##2##(2005-10#1)(2006-4#1)(2007-11#1)(2008-3#1)
of telecommunications##2##2##(1995-2#1)(2005-10#1)
of telehealth and##2##3##(2010-5#1)(2013-8#1)
of telehealth##4##2##(2010-5#2)(2010-9#1)(2013-8#1)
of telemedicine and##3##3##(1996-11#1)(2008-5#1)(2012-2#1)
of telemedicine in##2##3##(2005-10#1)(2013-1#1)
of telemedicine##14##2##(1996-11#2)(1996-3#4)(2005-10#1)(2006-10#1)(2007-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
of teleocidin##2##2##(1993-7#2)
of teleological explanation##2##3##(2012-2#2)
of teleological##3##2##(2012-2#3)
of teleost fish##3##3##(1991-10#1)(1995-12#1)(2012-11#1)
of teleost##7##2##(1991-10#1)(1995-12#1)(1997-2#1)(1997-9#1)(2008-7#1)(2010-8#1)(2012-11#1)
of teleosts##5##2##(1991-5#1)(1995-2#1)(2007-3#1)(2010-2#1)(2010-5#1)
of telephone calls##2##3##(2004-7#1)(2007-11#1)
of telephone consultations##2##3##(2004-7#2)
of telephone##6##2##(1993-5#1)(2004-7#3)(2007-11#1)(2008-11#1)
of teleradiology##3##2##(2007-11#3)
of telescope mirrors##2##3##(2008-3#2)
of telescope##4##2##(2008-3#4)
of television##2##2##(2010-11#1)(2011-2#1)
of teliospore germination##2##3##(2008-10#2)
of teliospores##4##2##(2008-10#4)
of tellurite-based erbium-doped fiber##3##4##(2007-12#3)
of tellurium in##4##3##(2008-10#4)
of tellurium(IV)##3##2##(2008-10#3)
of telomerase activity and telomere##2##5##(2008-11#2)
of telomerase activity and##3##4##(2007-12#1)(2008-11#2)
of telomerase activity in##2##4##(2008-11#1)(2008-6#1)
of telomerase activity##6##3##(2007-12#1)(2008-11#3)(2008-6#1)(2008-8#1)
of telomerase and##2##3##(2008-11#2)
of telomerase##19##2##(2004-8#1)(2005-8#1)(2007-11#3)(2007-12#1)(2008-11#6)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#2)(2011-1#1)
of telomere biology##2##3##(2008-11#1)(2012-3#1)
of telomere length and telomerase activity##2##6##(2008-4#2)
of telomere length##4##3##(2008-4#2)(2008-9#2)
of telomere maintenance##2##3##(2010-12#1)(2011-1#1)
of telomere repeat##2##3##(1990-8#1)(2008-1#1)
of telomere repeats##3##3##(2008-11#1)(2011-1#2)
of telomere##24##2##(1990-8#1)(2008-1#1)(2008-11#2)(2008-4#2)(2008-9#3)(2009-5#1)(2010-12#1)(2010-2#2)(2010-3#3)(2011-1#3)(2012-2#1)(2012-3#3)(2013-1#1)
of telomeres and telomerase##3##4##(2006-10#1)(2008-1#1)(2008-8#1)
of telomeres and##7##3##(2006-10#1)(2008-1#1)(2008-11#2)(2008-8#1)(2011-2#1)(2012-3#1)
of telomeres##15##2##(1990-8#1)(2006-10#1)(2008-1#1)(2008-11#5)(2008-4#1)(2008-8#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-3#1)
of telomeric DNA in##2##4##(1990-5#1)(1995-6#1)
of telomeric DNA##6##3##(1990-5#4)(1993-9#1)(1995-6#1)
of telomeric repeat##2##3##(1990-8#1)(2013-8#1)
of telomeric##14##2##(1990-5#5)(1990-8#1)(1993-9#1)(1995-6#1)(2008-4#1)(2009-5#1)(2010-2#3)(2013-8#1)
of temafloxacin##9##2##(1991-12#9)
of temperament##3##2##(1995-12#1)(2008-6#1)(2009-8#1)
of temperate##5##2##(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)
of temperature (5 to##2##4##(2008-10#2)
of temperature and duration of##3##5##(2008-10#3)
of temperature and humidity on##2##5##(2011-2#2)
of temperature and humidity##3##4##(2011-2#3)
of temperature and leaf wetness duration on##2##7##(2008-10#2)
of temperature and moisture##3##4##(2008-10#2)(2008-2#1)
of temperature and pH##3##4##(2006-8#1)(2008-10#1)(2008-5#1)
of temperature and pain##2##4##(2008-7#2)
of temperature and pressure on##2##5##(2005-12#1)(2008-6#1)
of temperature and pressure##5##4##(2005-12#1)(2008-3#3)(2008-6#1)
of temperature and strain##2##4##(2007-11#2)
of temperature and viscosity##2##4##(2005-11#2)
of temperature and wetness##2##4##(2008-10#2)
of temperature and##62##3##(1990-3#1)(1992-5#1)(1992-8#1)(1994-7#1)(1996-12#1)(1997-2#1)(2005-11#6)(2005-12#1)(2006-8#1)(2007-11#3)(2007-12#3)(2007-6#1)(2008-10#15)(2008-2#3)(2008-3#8)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-10#1)(2010-8#2)(2011-2#3)(2012-4#1)
of temperature at##3##3##(1990-3#1)(2005-12#1)(2008-3#1)
of temperature by##2##3##(2008-10#1)(2008-2#1)
of temperature change##2##3##(2010-6#1)(2012-12#1)
of temperature changes##2##3##(2007-12#1)(2008-3#1)
of temperature for##3##3##(1997-7#1)(2005-11#1)(2012-2#1)
of temperature in the range##3##5##(1997-2#1)(1997-8#1)(2008-10#1)
of temperature in the##4##4##(1991-11#1)(1997-2#1)(1997-8#1)(2008-10#1)
of temperature in##6##3##(1991-11#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#1)(2013-7#1)
of temperature is##2##3##(2008-2#1)(2008-9#1)
of temperature measurement with multiband##2##5##(2008-3#2)
of temperature measurements##2##3##(2008-3#2)
of temperature on the##14##4##(1990-11#1)(1990-8#1)(1991-11#1)(1991-5#1)(1992-5#1)(2008-10#4)(2008-3#2)(2008-5#1)(2011-2#1)(2013-8#1)
of temperature on##39##3##(1990-11#2)(1990-8#1)(1991-11#1)(1991-5#2)(1991-6#1)(1992-5#1)(1993-5#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-8#2)(2011-2#1)(2013-8#1)
of temperature resolution of##2##4##(2008-3#2)
of temperature sensitive##2##3##(2008-10#1)(2011-2#1)
of temperature tuning##2##3##(2007-12#2)
of temperature was##4##3##(1996-2#1)(2008-10#1)(2008-6#1)(2010-4#1)
of temperature##228##2##(1990-10#1)(1990-11#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-8#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#2)(1991-7#1)(1992-5#2)(1992-8#1)(1992-9#2)(1993-3#1)(1993-5#1)(1994-11#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-7#1)(1997-2#2)(1997-4#2)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#11)(2005-12#4)(2006-1#2)(2006-10#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#11)(2007-5#1)(2007-6#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#55)(2008-11#6)(2008-2#11)(2008-3#22)(2008-5#10)(2008-6#3)(2008-7#4)(2008-9#3)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-4#2)(2010-6#2)(2010-8#5)(2011-2#5)(2012-12#2)(2012-2#1)(2012-4#1)(2013-1#1)(2013-7#2)(2013-8#4)
of temperature)##2##2##(2008-7#2)
of temperature-dependent sex determination##2##4##(1995-11#2)
of temperature-dependent##5##2##(1995-11#2)(2006-5#2)(2008-10#1)
of temperature-measurement##2##2##(2008-2#2)
of temperature-sensitive##5##2##(1990-5#1)(1997-3#1)(2005-11#1)(2008-10#1)(2008-4#1)
of temperatures &gt##3##3##(1995-6#1)(2008-10#2)
of temperatures and##4##3##(1991-4#1)(2008-10#2)(2008-3#1)
of temperatures between##4##3##(1992-2#1)(2005-11#1)(2008-10#1)(2008-2#1)
of temperatures in the##2##4##(1994-7#1)(1995-11#1)
of temperatures of##2##3##(2008-10#1)(2008-8#1)
of temperatures##30##2##(1990-3#1)(1991-4#1)(1992-2#1)(1994-7#1)(1995-11#1)(1995-6#1)(2005-11#1)(2006-12#1)(2007-6#1)(2008-10#8)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-3#1)(2012-8#1)
of tempered##2##2##(2008-10#1)(2008-3#1)
of template responses##3##3##(1991-2#3)
of template##15##2##(1990-11#1)(1991-2#3)(1995-1#1)(2005-11#3)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-9#1)(2011-1#1)
of templates##2##2##(2008-2#2)
of temporal and spatial##7##4##(2007-11#1)(2007-5#1)(2008-1#1)(2008-3#1)(2008-8#1)(2009-11#1)(2011-2#1)
of temporal and##9##3##(2007-11#2)(2007-5#1)(2008-1#1)(2008-3#1)(2008-8#2)(2009-11#1)(2011-2#1)
of temporal bone fracture##2##4##(2009-10#2)
of temporal bone##7##3##(2008-9#2)(2009-10#2)(2011-2#3)
of temporal broadening##2##3##(2008-3#2)
of temporal cortex##2##3##(1993-6#1)(1996-7#1)
of temporal lobe epilepsy##5##4##(2004-11#1)(2005-9#1)(2008-1#1)(2008-3#1)(2008-4#1)
of temporal lobe##9##3##(1990-7#1)(1995-12#1)(1996-7#1)(2004-11#1)(2005-9#1)(2008-1#1)(2008-3#1)(2008-4#1)(2011-1#1)
of temporal optical##3##3##(2007-12#1)(2008-2#2)
of temporal overlap##2##3##(1997-5#1)(2009-8#1)
of temporal patterns of##2##4##(1993-12#1)(2008-9#1)
of temporal phase##2##3##(2007-12#1)(2008-3#1)
of temporal prediction##2##3##(2009-7#1)(2013-8#1)
of temporal processing##2##3##(2006-2#1)(2009-7#1)
of temporal variables##2##3##(2008-5#1)(2013-8#1)
of temporal##73##2##(1990-7#1)(1992-11#1)(1993-12#1)(1993-6#1)(1995-12#1)(1996-7#2)(1997-3#1)(1997-5#1)(1997-8#1)(2004-11#2)(2005-10#1)(2005-9#1)(2006-10#2)(2006-2#1)(2007-11#3)(2007-12#3)(2007-5#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#6)(2008-4#4)(2008-5#2)(2008-8#2)(2008-9#6)(2009-10#3)(2009-11#1)(2009-7#2)(2009-8#1)(2011-1#3)(2011-2#4)(2012-2#1)(2013-8#2)
of temporally restricted##4##3##(2007-12#3)(2008-2#1)
of temporally##9##2##(2007-12#4)(2008-10#1)(2008-2#2)(2009-10#1)(2009-9#1)
of temporarily##2##2##(1995-6#1)(2012-3#1)
of temporary##8##2##(1993-12#1)(1993-5#1)(1993-8#1)(2008-1#1)(2008-9#1)(2010-10#1)(2011-2#1)(2013-1#1)
of temporomandibular disorders##2##3##(2007-12#1)(2008-10#1)
of temporomandibular joint (TMJ)##2##4##(2007-12#2)
of temporomandibular joint surgery##2##4##(2007-12#2)
of temporomandibular joint##10##3##(1995-10#1)(2007-12#5)(2007-6#1)(2009-4#1)(2011-1#1)(2012-2#1)
of temporomandibular##15##2##(1995-10#1)(2007-12#6)(2007-6#1)(2007-7#1)(2008-10#1)(2009-4#1)(2011-1#1)(2012-2#1)(2013-1#2)
of temsirolimus##3##2##(2010-11#1)(2010-12#2)
of ten cases##4##3##(2010-7#2)(2012-2#1)(2013-8#1)
of ten healthy##2##3##(1996-3#1)(1997-2#1)
of ten lambs##2##3##(1996-12#2)
of ten lots##2##3##(2006-11#2)
of ten natural p-terphenyl derivatives##2##5##(2006-12#2)
of ten new##2##3##(2008-6#1)(2011-1#1)
of ten normal##2##3##(1990-11#1)(2008-10#1)
of ten patients with##2##4##(2007-5#1)(2011-1#1)
of ten patients##4##3##(1994-2#1)(2007-5#1)(2008-6#1)(2011-1#1)
of ten years##5##3##(1990-4#1)(1992-11#1)(1996-9#1)(2006-4#1)(2008-3#1)
of ten##108##2##(1990-10#1)(1990-11#1)(1990-4#1)(1991-2#4)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#3)(1992-11#2)(1992-3#1)(1992-7#1)(1993-12#1)(1994-11#1)(1994-2#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-11#3)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#3)(2007-1#1)(2007-11#1)(2007-12#1)(2007-5#2)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-5#1)(2009-7#1)(2009-8#1)(2010-7#2)(2011-1#6)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#2)
of tendon##10##2##(1997-5#1)(2004-9#1)(2006-3#2)(2008-11#1)(2008-12#2)(2010-4#1)(2013-1#2)
of tendons##6##2##(2008-7#2)(2008-9#1)(2009-4#1)(2009-9#1)(2013-1#1)
of tenofovir##2##2##(2010-12#2)
of tens of micrometers##3##4##(2006-12#1)(2008-10#1)(2008-2#1)
of tens of##14##3##(2006-12#1)(2007-12#6)(2008-10#2)(2008-2#1)(2008-3#3)(2013-1#1)
of tense##2##2##(2011-12#1)(2012-1#1)
of tensile##6##2##(2004-9#1)(2007-4#1)(2008-5#1)(2012-2#1)(2013-1#2)
of tension pneumocephalus##2##3##(2006-12#1)(2008-7#1)
of tension##14##2##(1990-5#1)(1991-4#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-4#1)(1997-2#2)(2006-12#1)(2007-4#1)(2008-7#1)(2009-3#1)(2010-9#1)(2011-1#1)
of tensor##2##2##(1995-12#1)(2008-2#1)
of terahertz (THz) pulses##2##4##(2007-11#1)(2007-12#1)
of terahertz (THz)##6##3##(2007-11#2)(2007-12#4)
of terahertz electromagnetic##2##3##(2007-12#1)(2012-2#1)
of terahertz imaging##3##3##(2008-3#1)(2012-12#2)
of terahertz pulse##2##3##(2007-12#1)(2010-5#1)
of terahertz pulses in##2##4##(2007-12#1)(2008-2#1)
of terahertz pulses##7##3##(2007-12#5)(2008-2#2)
of terahertz radiation##5##3##(2007-11#2)(2007-12#2)(2008-3#1)
of terahertz##30##2##(2007-11#4)(2007-12#17)(2008-2#2)(2008-3#2)(2010-5#1)(2012-12#2)(2012-2#1)(2013-8#1)
of teratogenicity##2##2##(1993-12#1)(1993-3#1)
of terazosin##3##2##(2008-10#3)
of terbinafine against##2##3##(2008-3#1)(2008-5#1)
of terbinafine##9##2##(2008-10#4)(2008-3#1)(2008-5#4)
of terbium##6##2##(1995-5#1)(2008-10#3)(2008-2#2)
of terbium(III)##3##2##(2007-8#1)(2008-10#1)(2008-4#1)
of terbutaline##4##2##(1995-3#1)(2004-1#1)(2008-10#2)
of terfenadine##3##2##(1992-8#3)
of terlipressin in##2##3##(2008-12#2)
of terlipressin##7##2##(1995-9#2)(2008-12#4)(2013-8#1)
of term infants##2##3##(2006-8#1)(2007-11#1)
of term##7##2##(1993-7#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-12#1)(2011-1#1)
of terminal arbor size##2##4##(2008-4#2)
of terminal cisternae##2##3##(1991-7#2)
of terminal complementarity##2##3##(1994-8#2)
of terminal differentiation##5##3##(1990-11#1)(1990-5#1)(1991-5#1)(1993-6#1)(2009-3#1)
of terminal keratinocyte differentiation##2##4##(2005-11#1)(2010-12#1)
of terminal respiration##4##3##(1996-6#4)
of terminal ureter##2##3##(2009-5#1)(2013-1#1)
of terminal values##2##3##(2011-1#2)
of terminal##43##2##(1990-11#1)(1990-5#1)(1991-5#1)(1991-7#2)(1993-12#1)(1993-6#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-10#1)(1995-11#1)(1996-5#1)(1996-6#4)(1997-2#1)(1997-5#1)(2005-11#1)(2006-5#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-6#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#1)
of terminally differentiated##2##3##(1995-2#1)(2009-10#1)
of terminally ill patients##2##4##(1990-10#1)(2007-11#1)
of terminally ill##4##3##(1990-10#1)(1994-12#1)(2007-11#1)(2012-12#1)
of terminally##7##2##(1990-10#1)(1994-12#1)(1995-2#1)(2007-11#1)(2008-7#1)(2009-10#1)(2012-12#1)
of terminating##2##2##(1996-6#1)(2007-12#1)
of termination of translation##2##4##(2008-11#2)
of termination##7##2##(1995-11#1)(1996-8#1)(2007-4#1)(2008-11#3)(2009-12#1)
of terminology and##4##3##(1995-1#1)(2006-12#1)(2008-4#1)(2012-2#1)
of terminology##10##2##(1990-3#1)(1991-12#1)(1995-1#1)(2005-9#1)(2006-12#1)(2006-8#1)(2008-4#1)(2012-2#1)(2013-1#2)
of termite##4##2##(2007-6#1)(2011-2#3)
of terms and analytic methods##2##5##(1996-2#2)
of terms and##7##3##(1991-10#1)(1996-2#2)(2006-10#1)(2006-3#1)(2008-4#1)(2008-7#1)
of terms such as &quot##2##5##(2008-1#1)(2013-1#1)
of terms##25##2##(1991-10#1)(1992-9#1)(1993-12#1)(1995-3#1)(1996-2#3)(2006-10#2)(2006-3#1)(2008-1#1)(2008-2#2)(2008-4#1)(2008-7#4)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
of ternary and multicomponent complexes##2##5##(2008-10#2)
of ternary complex##3##3##(1994-6#1)(1995-10#1)(2008-10#1)
of ternary complexes##3##3##(2008-10#3)
of ternary mixtures of##3##4##(2008-10#3)
of ternary mixtures##7##3##(2008-10#6)(2013-8#1)
of ternary##20##2##(1994-6#1)(1995-10#1)(2004-9#1)(2007-8#1)(2008-10#14)(2009-2#1)(2013-8#1)
of ternatins##2##2##(2006-12#2)
of terpene trilactones##2##3##(2008-10#1)(2011-12#1)
of terpene##3##2##(2008-10#1)(2008-6#1)(2011-12#1)
of terpenes in water##2##4##(2008-10#2)
of terpenes in##3##3##(2008-10#2)(2010-12#1)
of terpenes##6##2##(2008-10#4)(2010-12#1)(2011-2#1)
of terpenoid##4##2##(1990-11#1)(1994-8#1)(2008-10#1)(2012-2#1)
of terpenoids##2##2##(2006-12#1)(2008-10#1)
of terrestrial ecosystems##2##3##(2006-5#1)(2008-6#1)
of terrestrial impact##2##3##(1997-5#2)
of terrestrial##13##2##(1991-6#1)(1997-5#2)(2006-5#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-5#1)(2010-6#1)(2012-3#1)
of territory##4##2##(2007-8#1)(2008-8#3)
of terrorism##6##2##(2007-9#2)(2008-4#1)(2008-7#2)(2008-8#1)
of terrorist##2##2##(2008-7#1)(2008-9#1)
of tert-butyl chloride##2##3##(2011-1#2)
of tert-butyl##8##2##(1992-11#2)(2007-11#1)(2008-12#2)(2009-8#1)(2011-1#2)
of tertiary alkyl##2##3##(2009-10#1)(2011-1#1)
of tertiary care##2##3##(2005-8#1)(2011-2#1)
of tertiary or##2##3##(2008-4#2)
of tertiary structure##5##3##(1991-4#1)(1994-10#1)(1995-3#1)(1997-4#1)(2008-4#1)
of tertiary##13##2##(1991-4#1)(1994-10#1)(1994-8#1)(1995-11#1)(1995-3#1)(1997-4#1)(2005-8#1)(2008-4#3)(2009-10#1)(2011-1#1)(2011-2#1)
of test animals##2##3##(2005-8#1)(2007-8#1)
of test methods for##2##4##(1990-11#1)(2008-10#1)
of test peptide##2##3##(2008-4#2)
of test peptides##2##3##(1991-10#1)(2008-4#1)
of test refusal##3##3##(2005-10#3)
of test results##9##3##(1993-6#2)(1993-9#1)(1995-12#1)(2005-10#1)(2007-2#1)(2007-7#2)(2008-11#1)
of test samples##3##3##(1990-4#1)(2008-10#1)(2008-2#1)
of test sensitivity##2##3##(1997-6#1)(2011-2#1)
of test solution##2##3##(2008-10#1)(2012-2#1)
of test solutions##3##3##(2008-10#3)
of test subjects##2##3##(1997-5#1)(2008-5#1)
of test takers##2##3##(2009-12#2)
of test##68##2##(1990-11#1)(1990-4#1)(1991-10#1)(1992-9#1)(1993-6#2)(1993-9#1)(1995-12#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-10#4)(2005-11#1)(2005-8#1)(2006-10#1)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-2#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
of testable hypotheses##3##3##(2005-10#1)(2008-7#1)(2009-6#1)
of testable##4##2##(2005-10#1)(2008-7#1)(2008-8#1)(2009-6#1)
of tested compounds##4##3##(1993-4#1)(2008-10#2)(2008-5#1)
of tested solutions##2##3##(2009-6#2)
of tested##14##2##(1993-4#1)(2006-6#2)(2007-11#1)(2008-10#4)(2008-12#1)(2008-5#1)(2009-6#2)(2009-8#1)(2013-1#1)
of tester strains##2##3##(1995-4#1)(2008-10#1)
of testes and##4##3##(2007-12#1)(2008-3#1)(2008-5#1)(2008-6#1)
of testes in the##2##4##(2008-10#1)(2008-4#1)
of testes##11##2##(1993-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2011-2#1)(2013-7#1)
of testicles##4##2##(2012-12#2)(2013-1#2)
of testicular cancer##9##3##(1994-7#2)(2006-7#1)(2007-5#1)(2008-7#1)(2009-5#1)(2012-2#3)
of testicular descent##2##3##(2006-9#1)(2008-10#1)
of testicular function##2##3##(2011-2#2)
of testicular neoplasms##3##3##(2007-5#3)
of testicular torsion##3##3##(2008-10#3)
of testicular tubules##2##3##(1990-9#1)(2010-5#1)
of testicular tumors##2##3##(1990-9#1)(1992-5#1)
of testicular tumours##3##3##(1996-8#1)(2011-2#2)
of testicular##44##2##(1990-5#1)(1990-9#3)(1991-4#1)(1992-3#1)(1992-5#1)(1994-2#1)(1994-7#2)(1995-11#1)(1995-5#1)(1996-8#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-5#5)(2007-7#1)(2008-10#6)(2008-12#1)(2008-7#1)(2009-5#1)(2010-4#1)(2010-5#1)(2011-2#4)(2012-2#3)(2012-3#2)(2013-1#2)
of testing and##3##3##(2007-12#1)(2008-10#1)(2009-11#1)
of testing for##4##3##(2008-4#2)(2009-11#1)(2012-3#1)
of testing in##2##3##(2008-10#1)(2012-2#1)
of testing is##2##3##(1995-9#1)(2009-12#1)
of testing results##2##3##(1995-9#1)(2005-5#1)
of testing the##5##3##(1990-3#1)(1995-8#1)(2008-10#1)(2008-12#1)(2009-9#1)
of testing##56##2##(1990-3#1)(1991-1#1)(1992-2#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1995-5#1)(1995-8#1)(1995-9#3)(1997-2#1)(2005-10#2)(2005-5#1)(2005-7#1)(2006-11#1)(2006-12#1)(2007-12#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#4)(2008-5#1)(2008-9#2)(2009-11#2)(2009-12#1)(2009-9#1)(2010-2#1)(2012-2#3)(2012-3#2)(2013-1#1)
of testis development##2##3##(1995-11#2)
of testis##18##2##(1990-11#1)(1991-2#4)(1994-11#1)(1995-11#3)(1995-2#1)(1996-7#1)(2006-10#1)(2008-10#1)(2009-4#1)(2009-7#1)(2010-11#1)(2012-2#1)(2013-8#1)
of testosterone (T)##3##3##(1991-5#1)(1996-2#1)(2008-3#1)
of testosterone and##6##3##(1990-12#1)(1993-2#1)(1993-8#1)(1995-4#1)(2006-9#1)(2012-2#1)
of testosterone concentrations##2##3##(2012-12#1)(2013-8#1)
of testosterone in aqueous##2##4##(2008-10#2)
of testosterone in the##3##4##(1993-2#1)(1995-2#1)(2012-2#1)
of testosterone in##8##3##(1993-1#1)(1993-2#1)(1995-2#1)(2008-10#2)(2008-5#1)(2012-2#1)(2012-3#1)
of testosterone on##3##3##(1996-5#2)(2008-9#1)
of testosterone or##2##3##(2010-8#1)(2012-2#1)
of testosterone replacement##2##3##(1994-2#1)(2012-12#1)
of testosterone secretion by rat Leydig cells##2##7##(1994-12#2)
of testosterone to##3##3##(1993-8#1)(1996-9#1)(2008-2#1)
of testosterone with##2##3##(2008-10#1)(2012-12#1)
of testosterone##71##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#3)(1991-5#2)(1992-12#2)(1993-1#4)(1993-2#2)(1993-8#3)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-2#4)(1995-4#1)(1995-5#1)(1996-2#1)(1996-5#2)(1996-9#2)(2006-9#3)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#2)(2010-12#1)(2010-8#2)(2012-12#3)(2012-2#4)(2012-3#1)(2013-8#1)
of tests and##7##3##(1990-9#1)(1994-3#1)(1994-5#1)(2007-7#1)(2008-10#1)(2008-4#1)(2013-1#1)
of tests based on##2##4##(2008-7#1)(2012-3#1)
of tests for##2##3##(1995-4#1)(2012-2#1)
of tests in##2##3##(1990-11#1)(1996-1#1)
of tests is##2##3##(1994-5#1)(2008-10#1)
of tests on##3##3##(1996-12#1)(2008-10#1)(2009-4#1)
of tests run##2##3##(2007-8#1)(2008-3#1)
of tests that##2##3##(1997-3#1)(2006-11#1)
of tests to##4##3##(2005-8#1)(2007-7#1)(2008-10#1)(2008-11#1)
of tests used for##2##4##(2008-7#1)(2008-9#1)
of tests used##3##3##(2008-7#1)(2008-9#1)(2009-3#1)
of tests were##3##3##(2006-10#1)(2008-10#1)(2008-5#1)
of tests with##2##3##(1993-9#1)(2007-4#1)
of tests##65##2##(1990-11#1)(1990-3#2)(1990-8#1)(1990-9#3)(1993-9#1)(1994-3#1)(1994-5#2)(1995-10#1)(1995-4#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-3#1)(2005-8#1)(2006-10#2)(2006-11#3)(2006-2#1)(2007-4#3)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#4)(2009-3#1)(2009-4#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
of tetanic##2##2##(1997-5#1)(2012-7#1)
of tetanus toxin##11##3##(1990-3#1)(1991-10#3)(1994-9#2)(1995-12#1)(1995-2#1)(2008-10#3)
of tetanus toxoid##2##3##(1994-2#1)(2007-8#1)
of tetanus##17##2##(1990-3#1)(1991-10#3)(1992-5#1)(1994-2#1)(1994-9#2)(1995-12#1)(1995-2#1)(2006-4#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-7#1)
of tetanus-induced##2##2##(1992-12#1)(2008-7#1)
of tetany##3##2##(1991-12#1)(2005-1#2)
of tethered cord syndrome##2##4##(2008-7#1)(2009-3#1)
of tethered phosphoramidites##2##3##(2008-4#2)
of tethered##6##2##(2008-11#1)(2008-4#2)(2008-7#1)(2009-3#1)(2010-4#1)
of tetrabromoindate(III)##2##2##(2008-10#2)
of tetrabutylammonium bromide##4##3##(2008-10#4)
of tetrabutylammonium##7##2##(2008-10#7)
of tetracalcium phosphate##2##3##(2004-9#1)(2009-9#1)
of tetracarboxylate-18-crown-6##2##2##(2008-10#2)
of tetrachloroethylene (PCE)##2##3##(1996-11#1)(2012-12#1)
of tetracycline (TC)##2##3##(2008-10#2)
of tetracycline and##2##3##(2008-1#1)(2008-10#1)
of tetracycline antibiotics##4##3##(1997-8#1)(2008-10#3)
of tetracycline##19##2##(1991-6#1)(1994-3#1)(1997-7#1)(1997-8#2)(2005-10#3)(2008-1#1)(2008-10#9)(2008-11#1)
of tetracyclines and##2##3##(1997-8#1)(2012-12#1)
of tetracyclines in##3##3##(2008-10#3)
of tetracyclines was##2##3##(2004-9#1)(2008-10#1)
of tetracyclines##14##2##(1997-6#2)(1997-8#3)(2004-9#2)(2008-10#6)(2012-12#1)
of tetradecyldimethylbenzylammonium chloride##2##3##(2005-11#2)
of tetraethyl orthosilicate (TEOS) and##2##5##(2008-10#1)(2010-3#1)
of tetraethyl orthosilicate (TEOS) in##2##5##(2005-11#2)
of tetraethyl orthosilicate (TEOS)##4##4##(2005-11#2)(2008-10#1)(2010-3#1)
of tetraethyl##5##2##(2005-11#2)(2008-10#1)(2010-3#1)(2012-11#1)
of tetraethylorthosilicate##3##2##(2005-11#2)(2008-10#1)
of tetragonal##2##2##(2008-10#1)(2008-3#1)
of tetrahydrobiopterin (BH4)##3##3##(1992-12#1)(1993-8#1)(1997-5#1)
of tetrahydrobiopterin##14##2##(1991-3#2)(1992-1#1)(1992-12#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-1#1)(1995-5#2)(1995-8#1)(1996-9#2)(1997-5#1)
of tetrahydrocannabinol##2##2##(2008-7#1)(2010-4#1)
of tetrahydrofuran##6##2##(2006-3#1)(2007-11#1)(2008-10#3)(2008-5#1)
of tetrahydroisoquinoline##4##2##(2007-11#2)(2011-3#2)
of tetrakis rare-earth chromophores in rare-earth-doped##2##6##(2008-2#2)
of tetrakis##3##2##(2008-10#1)(2008-2#2)
of tetralogy of Fallot##4##4##(2007-8#2)(2009-10#1)(2009-9#1)
of tetralogy##5##2##(1993-10#1)(2007-8#2)(2009-10#1)(2009-9#1)
of tetramer##2##2##(1990-8#1)(1997-1#1)
of tetrameric##2##2##(1991-7#1)(1994-8#1)
of tetramerization##3##2##(1991-2#1)(1993-8#2)
of tetramers of##2##3##(1994-8#1)(2008-11#1)
of tetramers##7##2##(1990-10#1)(1994-8#1)(1997-2#3)(2008-11#1)(2010-8#1)
of tetramethylpyrazine on##3##3##(1991-6#2)(2012-12#1)
of tetramethylpyrazine##6##2##(1991-6#4)(2011-1#1)(2012-12#1)
of tetrandrine##5##2##(1997-5#5)
of tetranectin##3##2##(1992-8#1)(1997-7#2)
of tetranorDHLA##2##2##(1994-2#2)
of tetraphenylporphyrin##4##2##(2008-10#2)(2010-7#2)
of tetrapod##3##2##(1994-7#1)(2008-8#1)(2013-1#1)
of tetrapods##5##2##(1991-5#3)(1994-7#1)(2009-6#1)
of tetrathiafulvalene##2##2##(1996-5#1)(2006-12#1)
of tetrodotoxin##6##2##(1991-5#1)(1993-3#1)(1995-12#1)(1996-12#1)(2012-12#1)(2013-7#1)
of text messaging as a##4##5##(2013-1#4)
of text##15##2##(2008-1#2)(2008-11#1)(2008-7#1)(2010-12#2)(2013-1#8)(2013-7#1)
of textile##2##2##(2008-5#1)(2009-10#1)
of texting##4##2##(2013-1#4)
of texts##2##2##(2009-4#1)(2010-8#1)
of textual##3##2##(2005-12#1)(2013-1#2)
of texture at##2##3##(2013-8#2)
of texture features##2##3##(2008-10#1)(2008-2#1)
of texture##15##2##(1995-8#1)(2006-11#1)(2006-5#1)(2008-10#1)(2008-2#6)(2008-5#2)(2008-6#1)(2013-8#2)
of textured##2##2##(2008-2#1)(2008-3#1)
of textures##2##2##(1992-7#1)(2011-12#1)
of th##2##2##(2008-11#1)(2013-8#1)
of thalamic oscillations##2##3##(2008-2#2)
of thalamic##7##2##(1996-12#1)(1997-7#1)(2008-2#5)
of thalamus##2##2##(1995-11#1)(1996-10#1)
of thalassaemia##2##2##(2011-12#1)(2013-8#1)
of thalassemia and##2##3##(2008-10#1)(2008-3#1)
of thalassemia##7##2##(1993-8#1)(2006-10#1)(2008-10#2)(2008-3#1)(2011-2#1)(2012-2#1)
of thaliblastine##2##2##(1992-2#2)
of thalidomide have##2##3##(2007-10#1)(2007-11#1)
of thalidomide in##12##3##(1991-11#1)(1991-6#1)(2006-10#1)(2006-8#1)(2007-11#2)(2008-3#1)(2008-5#5)
of thalidomide##22##2##(1991-11#1)(1991-6#1)(2006-10#1)(2006-8#2)(2007-10#1)(2007-11#5)(2008-3#1)(2008-5#10)
of thallium in##5##3##(1991-12#1)(1994-5#2)(2008-10#2)
of thallium##15##2##(1991-12#3)(1994-5#3)(1995-2#1)(2008-10#8)
of thallium(I)##5##2##(2008-10#5)
of thallium(III) salts##2##3##(2007-11#2)
of thallium-201##2##2##(1995-4#1)(2007-12#1)
of thapsigargin##6##2##(1991-6#1)(1992-11#1)(1992-5#1)(1995-3#1)(1997-5#1)(2008-4#1)
of that approach##3##3##(1997-2#1)(2008-10#1)(2008-4#1)
of that care##2##3##(1991-3#1)(1994-2#1)
of that class##2##3##(1992-8#1)(2007-12#1)
of that condition##2##3##(1997-1#1)(2008-1#1)
of that disease##2##3##(2006-5#1)(2007-11#1)
of that fact##2##3##(2008-10#1)(2008-12#1)
of that for##6##3##(1990-3#2)(1990-9#1)(1994-2#1)(2008-6#1)(2013-1#1)
of that found in##2##4##(1991-3#1)(2011-2#1)
of that found##3##3##(1991-3#1)(1993-4#1)(2011-2#1)
of that from the##2##4##(1995-7#1)(2008-11#1)
of that gene##2##3##(2007-10#1)(2007-3#1)
of that group##3##3##(1994-4#1)(2005-7#1)(2007-4#1)
of that in the control##2##5##(1994-12#1)(2008-9#1)
of that in the##4##4##(1990-11#1)(1994-12#1)(2008-3#1)(2008-9#1)
of that in##16##3##(1990-11#1)(1990-4#1)(1994-12#1)(1994-2#1)(1994-7#1)(1996-9#1)(1997-4#1)(1997-7#2)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#2)(2012-3#1)
of that measured##2##3##(1990-5#1)(2008-5#1)
of that observed in##5##4##(1996-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-8#1)
of that observed with##3##4##(1991-11#1)(1993-12#1)(1993-6#1)
of that observed##9##3##(1991-11#1)(1993-12#1)(1993-6#1)(1996-12#1)(1997-9#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-8#1)
of that obtained with the wild-type enzyme##2##7##(1990-12#2)
of that obtained##6##3##(1990-12#2)(1993-6#1)(2008-10#2)(2008-11#1)
of that of a##2##4##(1997-3#1)(2008-2#1)
of that of cells##2##4##(1991-1#1)(1992-6#1)
of that of insulin##2##4##(2008-9#2)
of that of the control##2##5##(1997-2#2)
of that of the controls##2##5##(1994-2#2)
of that of the wild-type##3##5##(1992-6#1)(1995-3#1)(1996-7#1)
of that of the##11##4##(1992-6#1)(1993-6#1)(1994-2#2)(1995-3#1)(1996-7#1)(1997-2#2)(2008-2#1)(2008-7#1)(2008-8#1)
of that of##40##3##(1990-11#1)(1990-12#1)(1991-1#2)(1992-12#1)(1992-6#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-5#1)(1996-7#1)(1997-2#3)(1997-3#1)(1997-6#1)(2005-11#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#3)(2010-11#1)
of that part of the##3##5##(2006-3#1)(2008-3#1)(2011-2#1)
of that particular##2##3##(2008-4#1)(2009-3#1)
of that period##2##3##(2008-12#2)
of that predicted##2##3##(1996-2#1)(2007-12#1)
of that process##3##3##(1994-2#1)(2007-12#1)(2008-3#1)
of that protein##2##3##(2008-1#1)(2008-5#1)
of that region##3##3##(1994-8#1)(2008-5#1)(2009-5#1)
of that seen##3##3##(1991-10#1)(1995-10#1)(1995-5#1)
of that site##2##3##(1995-2#1)(1996-5#1)
of that value##4##3##(1995-5#1)(2008-10#3)
of that with##2##3##(1992-3#1)(2011-2#1)
of that year##3##3##(1990-2#1)(1991-2#1)(1997-3#1)
of that##274##2##(1990-11#2)(1990-12#4)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#4)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-6#2)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#5)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#6)(1994-3#1)(1994-4#1)(1994-6#2)(1994-7#1)(1994-8#3)(1994-9#2)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#2)(1995-4#2)(1995-5#2)(1995-7#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-9#1)(2005-10#1)(2005-11#2)(2005-5#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#4)(2007-12#7)(2007-3#4)(2007-4#1)(2007-9#2)(2008-1#2)(2008-10#18)(2008-11#5)(2008-12#6)(2008-2#8)(2008-3#11)(2008-4#5)(2008-5#6)(2008-6#6)(2008-7#3)(2008-8#7)(2008-9#7)(2009-3#2)(2009-4#1)(2009-5#1)(2010-1#1)(2010-11#2)(2010-4#3)(2010-5#1)(2010-8#1)(2011-2#7)(2012-2#5)(2012-3#4)(2013-1#5)(2013-7#2)
of thaxtomin##2##2##(2008-10#2)
of the &lt##3##3##(2008-10#1)(2008-3#1)(2009-7#1)
of the &quot##135##3##(1990-12#1)(1990-5#2)(1990-6#1)(1991-12#2)(1991-4#4)(1991-9#1)(1992-1#1)(1992-7#1)(1993-10#3)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-2#1)(1994-8#1)(1995-2#2)(1995-5#3)(1995-6#2)(1995-9#1)(1996-10#1)(1996-11#1)(1996-4#3)(1996-9#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(2004-7#1)(2005-10#1)(2005-11#3)(2005-6#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-9#2)(2007-10#2)(2007-11#4)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#4)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-2#5)(2012-2#1)(2013-1#8)(2013-7#1)(2013-8#2)
of the '90s##3##3##(1990-4#1)(1994-3#2)
of the 'König' reaction##6##4##(1993-8#6)
of the 'natural##2##3##(1994-12#1)(2010-2#1)
of the (-)-cis-anti-[BP]dG##5##3##(1996-7#5)
of the (1)H NMR##4##4##(2006-10#1)(2010-5#1)(2012-12#2)
of the (1)H##5##3##(1997-7#1)(2006-10#1)(2010-5#1)(2012-12#2)
of the (23)Na frequency##2##4##(1997-7#2)
of the (Na##2##3##(1990-11#1)(1997-8#1)
of the -NO2 group in##2##5##(2007-11#2)
of the 0##11##3##(1990-4#1)(2005-4#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-9#1)
of the 1 375 and 1 638 cm(-1)##2##8##(2013-8#2)
of the 1##47##3##(1990-2#1)(1991-10#1)(1991-8#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#1)(1996-2#3)(1996-5#3)(1997-1#2)(1997-2#1)(1997-6#1)(1997-8#1)(2005-11#2)(2006-12#1)(2007-1#1)(2007-12#2)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-3#1)(2012-2#1)(2013-1#1)(2013-8#2)
of the 1--hydrogen perfluorocarbon octane##2##5##(2013-1#2)
of the 1-deoxy-1-phosphatidylethanolamino-lactitol-type##2##3##(1994-3#2)
of the 1-year##3##3##(1991-8#1)(2012-12#2)
of the 10 NH2-terminal amino acids##2##6##(1997-2#2)
of the 10 patients##2##4##(2006-5#1)(2007-7#1)
of the 10 subjects##2##4##(1996-5#1)(2012-1#1)
of the 10##34##3##(1990-12#1)(1991-10#1)(1993-7#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#2)(2005-9#1)(2006-5#2)(2007-1#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#2)(2008-5#2)(2008-7#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-12#1)
of the 10-week##2##3##(1996-1#1)(1996-11#1)
of the 100 cases##2##4##(1996-11#1)(2007-9#1)
of the 100##8##3##(1994-11#1)(1995-4#1)(1996-11#1)(2006-8#1)(2007-9#2)(2008-9#1)(2013-8#1)
of the 1000 Genomes Project##3##5##(2012-3#3)
of the 1000 Genomes##4##4##(2012-3#4)
of the 103##3##3##(1992-4#1)(2007-7#1)(2007-9#1)
of the 105##2##3##(2008-10#1)(2013-8#1)
of the 1064-nm##2##3##(2007-12#2)
of the 10th Asian##2##4##(2008-4#1)(2011-1#1)
of the 10th##6##3##(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2011-1#1)(2011-2#1)
of the 11 kDa delta-zein gene in##2##7##(2006-12#2)
of the 11 kDa delta-zein gene##3##6##(2006-12#3)
of the 11 kDa delta-zein##4##5##(2006-12#4)
of the 11 patients##5##4##(1990-2#1)(1990-9#1)(1996-9#1)(1997-7#1)(2008-10#1)
of the 11##24##3##(1990-2#1)(1990-9#1)(1992-11#1)(1993-9#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-7#1)(2006-12#4)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#2)(2010-4#1)(2012-12#1)
of the 110##3##3##(1994-9#1)(2003-11#1)(2009-7#1)
of the 116##2##3##(2006-8#1)(2008-10#1)
of the 117##2##3##(1996-9#1)(2008-10#1)
of the 118##2##3##(1996-1#1)(2012-2#1)
of the 12 cases##2##4##(2007-7#2)
of the 12 patients##2##4##(1997-7#1)(1997-8#1)
of the 12 rice chromosomes##2##5##(1997-4#1)(2008-9#1)
of the 12##30##3##(1990-2#1)(1991-10#1)(1991-4#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-6#1)(1997-4#1)(1997-7#1)(1997-8#2)(2004-11#1)(2005-10#1)(2007-2#2)(2007-3#1)(2007-7#2)(2008-10#4)(2008-2#1)(2008-5#3)(2008-9#1)(2009-10#1)(2010-12#1)(2013-1#1)
of the 12-item General Health Questionnaire##2##6##(2012-1#2)
of the 125##2##3##(2008-1#1)(2008-2#1)
of the 126 a##2##4##(1990-12#1)(1991-8#1)
of the 12th##2##3##(2006-9#1)(2008-10#1)
of the 13 patients##5##4##(1992-5#1)(2004-11#1)(2007-2#1)(2008-5#1)(2008-7#1)
of the 13##17##3##(1991-12#1)(1992-5#1)(1992-6#1)(1993-10#1)(1994-2#1)(1995-2#1)(1996-12#1)(1996-7#1)(2004-11#1)(2007-2#1)(2007-8#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)
of the 13-14 year olds##2##5##(2007-2#2)
of the 13-14##3##3##(2007-2#3)
of the 130##2##3##(1993-2#1)(2012-2#1)
of the 135##2##3##(2008-10#1)(2012-12#1)
of the 13C NMR##2##4##(1992-12#1)(1993-11#1)
of the 13C##3##3##(1991-7#1)(1992-12#1)(1993-11#1)
of the 13C-NMR##2##3##(1990-3#2)
of the 13th##2##3##(1996-5#1)(2008-11#1)
of the 14 cases showed base substitution##2##7##(2007-12#2)
of the 14 cases##3##4##(1990-11#1)(2007-12#2)
of the 14 patients with##3##5##(1990-8#1)(1991-4#1)(1996-4#1)
of the 14 patients##7##4##(1990-8#1)(1991-4#1)(1996-11#1)(1996-4#1)(2006-7#1)(2007-2#1)(2007-3#1)
of the 14##27##3##(1990-11#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-6#2)(1991-8#1)(1992-11#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-6#1)(2006-4#2)(2006-7#1)(2007-12#2)(2007-2#1)(2007-3#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
of the 140##2##3##(1991-2#1)(2006-10#1)
of the 15##15##3##(1991-3#1)(1992-1#1)(1993-3#1)(1995-2#1)(1995-3#1)(1997-2#1)(2007-8#2)(2008-10#2)(2008-7#1)(2008-9#2)(2010-8#1)(2012-3#1)
of the 15- and##2##4##(1990-12#1)(1994-3#1)
of the 15-##3##3##(1990-12#1)(1994-3#2)
of the 15-kDa##2##3##(1991-2#1)(1997-7#1)
of the 150 kDa##2##4##(1990-5#1)(1997-2#1)
of the 15N##2##3##(1994-11#1)(1997-7#1)
of the 16 S##2##4##(1994-12#1)(1997-1#1)
of the 16 participating##2##4##(2008-11#1)(2013-1#1)
of the 16 patients##3##4##(1995-2#1)(2006-8#1)(2008-10#1)
of the 16##22##3##(1992-7#1)(1994-12#2)(1995-10#1)(1995-2#1)(1996-10#1)(1996-3#1)(1997-1#1)(1997-3#1)(2006-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2009-6#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
of the 160##3##3##(1996-7#1)(2008-10#2)
of the 164##2##3##(2007-7#1)(2008-3#1)
of the 168##2##3##(1990-9#1)(2008-5#1)
of the 16S rDNA gene##2##5##(2008-12#2)
of the 16S rDNA of##2##5##(1997-3#1)(2005-11#1)
of the 16S rDNA##4##4##(1997-3#1)(2005-11#1)(2008-12#2)
of the 16S rRNA gene##3##5##(2008-10#2)(2009-6#1)
of the 16S rRNA##7##4##(2006-8#2)(2008-10#4)(2009-6#1)
of the 16S##14##3##(1993-4#1)(1997-3#1)(2005-11#1)(2006-8#2)(2007-12#1)(2008-10#5)(2008-12#2)(2009-6#1)
of the 16S-23S rDNA##2##4##(2008-10#2)
of the 16S-23S##3##3##(2008-10#3)
of the 16th century]##2##4##(2008-11#2)
of the 16th##4##3##(2008-11#2)(2011-1#1)(2011-2#1)
of the 17 compounds##2##4##(2008-10#1)(2008-11#1)
of the 17 patients##3##4##(1991-3#1)(1991-4#1)(2008-1#1)
of the 17##18##3##(1990-2#1)(1991-3#1)(1991-4#2)(2007-4#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-5#1)(2010-7#1)(2010-9#1)
of the 171##2##3##(1993-2#2)
of the 175R protein##2##4##(1993-2#2)
of the 17th century##2##4##(2008-10#2)
of the 17th##7##3##(2008-10#3)(2008-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
of the 18##17##3##(1991-2#1)(1992-3#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-3#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-5#1)(2009-8#1)(2012-3#1)
of the 18-kDa##3##3##(1992-3#1)(1995-12#1)(1997-7#1)
of the 18S rRNA##3##4##(1997-2#1)(1997-6#1)(2006-11#1)
of the 18S##5##3##(1997-2#1)(1997-6#1)(2006-11#1)(2007-3#1)(2008-10#1)
of the 18th century##3##4##(1993-11#1)(1994-3#1)(2012-2#1)
of the 18th century]##5##4##(2008-8#5)
of the 18th##13##3##(1993-11#2)(1994-3#1)(2008-1#1)(2008-7#1)(2008-8#6)(2011-2#1)(2012-2#1)
of the 19 patients##4##4##(1992-10#1)(1995-6#1)(2006-12#1)(2006-2#1)
of the 19##12##3##(1991-2#1)(1992-10#1)(1992-2#1)(1995-6#1)(2006-12#1)(2006-2#1)(2007-10#1)(2008-10#2)(2008-3#1)(2010-11#1)(2010-2#1)
of the 19(th) century##2##4##(2008-12#1)(2012-12#1)
of the 1918##3##3##(2011-1#3)
of the 1960s##4##3##(1990-12#1)(1992-4#1)(1997-2#1)(1997-3#1)
of the 1970s and 1980s##2##5##(1990-12#1)(2008-1#1)
of the 1970s##7##3##(1990-12#1)(1991-2#1)(1992-5#1)(2007-8#1)(2008-1#1)(2009-2#1)(2012-12#1)
of the 1980s##12##3##(1991-3#1)(1992-2#1)(1993-2#1)(1993-3#1)(1994-11#1)(1997-3#1)(2007-11#1)(2009-1#1)(2010-12#1)(2011-2#3)
of the 1988##3##3##(1992-1#1)(1995-6#1)(2006-9#1)
of the 1990##4##3##(1992-3#1)(1993-1#1)(2005-10#1)(2009-7#1)
of the 1990s##13##3##(1990-12#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-3#1)(1997-3#1)(1997-6#1)(2006-10#2)(2008-10#1)(2008-8#1)(2009-2#1)
of the 1991##3##3##(1996-1#1)(1997-4#1)(2009-3#1)
of the 1992##4##3##(1994-3#1)(1996-3#1)(1996-4#1)(2006-2#1)
of the 1993##2##3##(1994-1#1)(1994-3#1)
of the 1996##2##3##(2007-7#1)(2008-2#1)
of the 1997##6##3##(1997-4#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-3#1)
of the 1998##6##3##(2004-4#1)(2008-1#1)(2008-10#1)(2008-2#1)(2011-2#1)(2012-12#1)
of the 1999##2##3##(2006-9#2)
of the 19th century and##3##5##(2005-11#1)(2009-7#1)(2011-2#1)
of the 19th century##12##4##(1991-6#1)(1994-5#1)(2005-11#1)(2006-9#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-2#1)(2009-4#1)(2009-7#2)(2011-2#1)
of the 19th century]##2##4##(2009-10#1)(2009-4#1)
of the 19th##17##3##(1991-6#1)(1994-5#1)(2005-11#1)(2006-9#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-4#2)(2009-7#2)(2010-9#1)(2011-2#2)
of the 1D##2##3##(1995-7#1)(2012-1#1)
of the 1H NMR resonances##2##5##(1991-4#1)(1994-10#1)
of the 1H NMR##3##4##(1991-4#1)(1994-10#1)(1994-5#1)
of the 1H##5##3##(1991-4#1)(1994-10#1)(1994-3#1)(1994-5#1)(2009-7#1)
of the 1st and##2##4##(1990-10#2)
of the 1st##7##3##(1990-10#3)(2008-10#2)(2008-4#1)(2008-6#1)
of the 2 lead ECG##2##5##(2009-3#2)
of the 2 lead##3##4##(2009-3#3)
of the 2 microns plasmid##2##5##(1990-4#1)(1993-9#1)
of the 2##48##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-9#2)(1994-5#2)(1995-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-12#2)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-3#4)(2009-8#1)(2010-8#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#1)
of the 2'##3##3##(1991-4#2)(1995-8#1)
of the 2- and##2##4##(1997-4#1)(2008-4#1)
of the 2-##3##3##(1995-3#1)(1997-4#1)(2008-4#1)
of the 2-D##2##3##(2008-3#1)(2008-4#1)
of the 2-amino-6-chloro-4-cyclopropyl-7-fluoro-5-methoxy-pyrido[1##2##3##(2010-2#2)
of the 20 kDa myosin light chain##3##7##(1990-11#1)(1990-9#1)(1991-3#1)
of the 20 patients##3##4##(2008-6#3)
of the 20##23##3##(1990-11#1)(1990-9#1)(1991-3#1)(1993-11#1)(1994-10#2)(1994-12#1)(1996-5#1)(1996-8#1)(2006-10#2)(2006-8#1)(2008-10#3)(2008-5#1)(2008-6#3)(2011-2#3)(2012-1#1)
of the 200##2##3##(1990-3#1)(2008-1#1)
of the 2000##4##3##(2006-11#1)(2007-9#1)(2008-10#1)(2012-3#1)
of the 2002##3##3##(2006-2#1)(2008-10#1)(2011-2#1)
of the 2003##4##3##(2006-9#1)(2007-4#2)(2008-9#1)
of the 2004 Intersociety Conference##2##5##(2007-4#2)
of the 2004##6##3##(2007-12#1)(2007-4#2)(2008-10#1)(2008-4#1)(2011-2#1)
of the 2005##2##3##(2008-4#1)(2011-2#1)
of the 2006##3##3##(2008-6#2)(2011-2#1)
of the 2007##3##3##(2008-12#1)(2010-8#1)(2012-1#1)
of the 2008##3##3##(2010-8#1)(2012-1#1)(2012-2#1)
of the 2008-2009##3##3##(2010-3#3)
of the 2009##7##3##(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-8#1)
of the 2010##5##3##(2011-2#3)(2013-1#2)
of the 2011##2##3##(2011-6#1)(2013-1#1)
of the 20S proteasome##3##4##(2008-4#2)(2008-5#1)
of the 20S##6##3##(1995-12#1)(1996-9#1)(2008-4#2)(2008-5#2)
of the 20th century##32##4##(1994-12#1)(2004-3#2)(2006-10#5)(2006-8#1)(2007-11#1)(2007-5#1)(2007-8#2)(2008-1#3)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2009-7#4)(2010-1#1)(2010-10#1)(2010-9#1)(2011-2#2)(2011-7#1)(2013-8#1)
of the 20th##34##3##(1994-12#1)(1997-2#1)(2004-3#2)(2006-10#5)(2006-8#1)(2007-11#1)(2007-5#1)(2007-8#2)(2008-1#3)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2009-7#4)(2010-1#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-7#1)(2013-8#1)
of the 21 patients##2##4##(2006-8#1)(2007-11#1)
of the 21##10##3##(1991-12#1)(1993-3#1)(1995-8#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
of the 21(st) century##2##4##(2008-11#1)(2012-12#1)
of the 21st Century##3##4##(2007-10#1)(2007-2#1)(2009-4#1)
of the 21st century##14##4##(1994-2#1)(2005-1#1)(2006-10#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2011-1#1)(2012-12#1)
of the 21st##19##3##(1994-2#1)(2005-1#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2009-4#1)(2010-12#1)(2011-1#2)(2012-12#1)
of the 22 kDa protein##3##5##(1994-12#3)
of the 22 patients with##3##5##(2006-5#1)(2007-7#1)(2008-7#1)
of the 22 patients##7##4##(1997-8#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-7#1)
of the 22##18##3##(1992-2#1)(1994-12#4)(1997-8#2)(2004-2#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-7#3)(2007-8#1)(2008-3#2)(2008-7#1)
of the 225##2##3##(1992-8#1)(2005-8#1)
of the 22q11##3##3##(1997-3#2)(2012-12#1)
of the 23 patients##2##4##(1992-6#1)(1992-8#1)
of the 23##11##3##(1991-10#1)(1991-9#1)(1992-6#1)(1992-8#1)(1994-12#1)(2006-11#1)(2007-2#1)(2008-7#1)(2008-8#1)(2011-12#1)(2013-8#1)
of the 23-kDa##2##3##(1990-5#1)(1996-4#1)
of the 23S ribosomal##2##4##(1995-8#2)
of the 23S##4##3##(1992-3#1)(1995-8#2)(2005-7#1)
of the 23rd##2##3##(2006-3#1)(2012-2#1)
of the 24 cases##2##4##(1991-9#1)(2008-6#1)
of the 24 discussed case scenarios are presented in this article##2##11##(2012-12#2)
of the 24 h##3##4##(1990-12#1)(1995-6#1)(2008-3#1)
of the 24 patients with##2##5##(2007-10#1)(2008-6#1)
of the 24 patients##3##4##(1993-8#1)(2007-10#1)(2008-6#1)
of the 24##32##3##(1990-12#1)(1991-10#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-2#1)(1993-2#1)(1993-8#1)(1994-3#1)(1995-11#1)(1995-6#1)(1996-2#1)(1996-9#1)(1997-6#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#2)(2008-8#1)(2011-1#1)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#1)
of the 24- and##2##4##(1991-2#2)
of the 24-hydroxylase##2##3##(1994-11#2)
of the 24-kDa oleosin##2##4##(2009-10#2)
of the 240##3##3##(1990-5#1)(2008-1#1)(2008-3#1)
of the 25##13##3##(1991-2#1)(1992-12#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-6#2)(2008-8#1)(2009-5#1)(2010-1#1)
of the 252-day reproductive period##3##5##(1997-4#3)
of the 26##7##3##(1993-12#1)(1996-11#1)(2009-4#1)(2011-2#2)(2013-1#1)(2013-8#1)
of the 26S proteasome##3##4##(1996-11#2)(2009-8#1)
of the 26S##4##3##(1996-11#2)(1997-7#1)(2009-8#1)
of the 27##5##3##(1990-12#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-5#1)
of the 271##2##3##(1996-6#1)(2004-10#1)
of the 28##6##3##(1996-10#1)(1996-7#1)(2006-10#1)(2008-3#1)(2008-6#1)(2008-7#1)
of the 287 were related to##2##6##(2013-1#2)
of the 2874 mesh cases##4##5##(2013-1#4)
of the 28S rRNA##3##4##(1992-12#1)(2008-5#1)(2010-4#1)
of the 28S##5##3##(1992-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-4#1)
of the 29##11##3##(1991-11#1)(1991-12#1)(1993-5#1)(1994-3#1)(1995-6#1)(1997-7#1)(2005-11#1)(2008-10#1)(2009-2#1)(2009-7#1)(2010-5#1)
of the 296##2##3##(2008-10#2)
of the 2D##3##3##(2008-10#1)(2011-1#1)(2012-1#1)
of the 2Fe-2S*##2##3##(1991-7#2)
of the 2R4F##2##3##(2007-8#2)
of the 2nd and 3rd##2##5##(2010-3#2)
of the 2nd##5##3##(1994-8#1)(2006-3#1)(2008-10#1)(2010-3#2)
of the 3 strains tested##2##5##(2007-11#2)
of the 3##46##3##(1990-11#2)(1991-1#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-5#1)(1992-7#1)(1993-8#2)(1995-3#1)(1995-4#1)(1995-9#1)(1996-2#2)(1997-4#1)(1997-8#1)(2004-3#2)(2005-10#1)(2005-7#1)(2005-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#2)(2011-2#2)(2013-1#2)(2013-7#1)
of the 3' end of the##2##6##(1990-8#1)(1997-4#1)
of the 3' end of##4##5##(1990-8#1)(1993-11#1)(1994-12#1)(1997-4#1)
of the 3' end##7##4##(1990-8#1)(1993-11#1)(1994-12#1)(1997-4#2)(2005-11#1)(2007-12#1)
of the 3' noncoding region##3##5##(1990-12#1)(1992-11#1)(1992-5#1)
of the 3' terminal##2##4##(1991-9#1)(2008-10#1)
of the 3' untranslated region##2##5##(1991-10#1)(1997-4#1)
of the 3' untranslated##4##4##(1991-10#1)(1991-2#1)(1997-4#1)(1997-8#1)
of the 3'##28##3##(1990-12#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1996-12#1)(1996-7#1)(1996-8#2)(1997-3#1)(1997-4#3)(1997-7#1)(1997-8#1)(2005-11#1)(2007-12#1)(2008-10#4)
of the 3'-hydroxyl##2##3##(1996-6#1)(1997-2#1)
of the 3'-terminal region of##2##5##(1997-2#1)(2008-10#1)
of the 3'-terminal##4##3##(1994-9#1)(1997-2#1)(2008-10#2)
of the 3'-untranslated region##3##4##(1990-5#1)(1994-9#1)(1995-3#1)
of the 3'-untranslated##4##3##(1990-5#2)(1994-9#1)(1995-3#1)
of the 3-4 hydrophobic repeat to the stability of the two-stranded alpha-helical coiled-coil##2##13##(1992-6#2)
of the 3-D cross-correlation function##2##5##(2008-2#2)
of the 3-D reference object##2##5##(2008-2#2)
of the 3-D##10##3##(1992-12#1)(2008-2#5)(2008-3#2)(2008-8#1)(2011-2#1)
of the 3-h##2##3##(2006-5#1)(2008-10#1)
of the 3-phosphoglycerate##2##3##(1991-9#2)
of the 3-thia##2##3##(1995-3#1)(2007-8#1)
of the 30 patients##2##4##(1993-2#1)(1997-6#1)
of the 30 strains##2##4##(2007-7#1)(2008-5#1)
of the 30##20##3##(1990-8#1)(1993-2#1)(1995-1#1)(1995-4#1)(1995-6#1)(1996-11#1)(1997-6#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#2)(2012-3#1)
of the 30-kDa##2##3##(1993-3#1)(1994-11#1)
of the 30S##3##3##(1993-11#1)(2009-9#2)
of the 31 kDa protein##2##5##(1990-2#2)
of the 31##6##3##(1990-2#3)(1990-9#1)(2006-8#1)(2007-5#1)
of the 32 patients##5##4##(1993-9#1)(1994-3#1)(1996-2#1)(2006-12#1)(2008-4#1)
of the 32##10##3##(1993-9#1)(1994-3#1)(1995-10#1)(1996-2#1)(2006-12#1)(2008-12#1)(2008-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
of the 32-##2##3##(1995-6#1)(2008-10#1)
of the 32P-postlabeling##2##3##(1992-1#1)(1993-2#1)
of the 33 kDa##3##4##(1994-12#3)
of the 33##10##3##(1990-3#1)(1994-12#3)(1994-2#1)(1996-12#1)(1997-5#1)(2008-9#1)(2011-2#2)
of the 34 kDa##5##4##(1997-6#1)(2009-7#4)
of the 34##10##3##(1993-3#1)(1994-12#1)(1996-3#1)(1997-6#1)(2008-7#1)(2009-7#4)(2012-11#1)
of the 35 children##2##4##(1993-1#1)(1996-3#1)
of the 35 patients##2##4##(1995-4#1)(2007-11#1)
of the 35##7##3##(1990-12#1)(1993-1#1)(1995-4#1)(1996-3#1)(2007-11#2)(2013-1#1)
of the 35-kDa##2##3##(1991-2#2)
of the 355 nm##2##4##(2009-7#1)(2012-2#1)
of the 35th Annual##2##4##(2008-7#1)(2010-3#1)
of the 36 patients with##2##5##(1991-8#1)(2007-8#1)
of the 36 patients##4##4##(1990-11#1)(1991-8#1)(1997-5#1)(2007-8#1)
of the 36##7##3##(1990-11#1)(1990-2#1)(1991-2#1)(1991-8#1)(1997-5#1)(2007-3#1)(2007-8#1)
of the 36-kDa##2##3##(1992-11#1)(1994-9#1)
of the 37 degrees C-grown##2##5##(2008-5#2)
of the 37##8##3##(1990-8#1)(1991-5#1)(1993-3#1)(2008-5#2)(2009-5#1)(2009-7#1)(2010-8#1)
of the 370-bp##2##3##(1992-4#1)(1993-11#1)
of the 38##7##3##(1990-4#1)(1990-9#1)(1995-9#1)(1996-3#1)(2006-2#1)(2008-12#1)(2011-2#1)
of the 39 patients##2##4##(1990-6#1)(2007-8#1)
of the 39##6##3##(1990-6#1)(1991-9#1)(1995-10#1)(1996-11#1)(2007-8#2)
of the 39K##2##3##(1995-1#2)
of the 3D object##2##4##(2008-3#2)
of the 3D reference object##2##5##(2008-3#2)
of the 3D##10##3##(1996-7#1)(2008-11#1)(2008-2#1)(2008-3#5)(2010-9#1)(2012-2#1)
of the 3d##2##3##(1990-9#1)(2008-5#1)
of the 3rd International##2##4##(2011-1#1)(2012-11#1)
of the 3rd##10##3##(1991-9#1)(1992-10#1)(1992-7#1)(1994-2#1)(1995-11#1)(2006-10#1)(2007-12#1)(2008-12#1)(2011-1#1)(2012-11#1)
of the 3th cervical vertebra##2##5##(2008-9#2)
of the 4 patients were##2##5##(1991-2#1)(2007-8#1)
of the 4 patients##3##4##(1991-2#1)(2007-8#1)(2011-1#1)
of the 4 types of##2##5##(2011-1#1)(2012-12#1)
of the 4##32##3##(1990-12#1)(1990-7#2)(1990-8#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-2#2)(1993-3#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-2#1)(1996-8#1)(2005-11#1)(2006-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-11#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
of the 40 kDa##2##4##(1994-2#1)(2006-10#1)
of the 40 patients##3##4##(2007-8#1)(2008-4#1)(2008-9#1)
of the 40##10##3##(1994-2#1)(1995-2#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-8#2)(2008-4#1)(2008-5#1)(2008-9#1)
of the 40-kDa##2##3##(1990-3#1)(2006-8#1)
of the 400##5##3##(1990-3#1)(1996-2#1)(1997-3#1)(2011-2#1)(2012-12#1)
of the 402##2##3##(1992-12#1)(1993-10#1)
of the 41##2##3##(1996-10#1)(2007-8#1)
of the 42##2##3##(1994-7#1)(2013-8#1)
of the 43 kDa##2##4##(1991-12#1)(2009-7#1)
of the 43##5##3##(1991-11#1)(1991-12#1)(1996-3#1)(2009-7#1)(2011-2#1)
of the 44##2##3##(2007-7#1)(2013-1#1)
of the 45 items##2##4##(2009-4#1)(2011-1#1)
of the 45##12##3##(1993-11#1)(1994-12#1)(1994-9#1)(1995-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2011-1#1)
of the 45-kDa protein##2##4##(1991-8#1)(1994-11#1)
of the 45-kDa##3##3##(1991-8#1)(1994-11#1)(1996-4#1)
of the 46 patients##3##4##(1992-3#2)(1997-3#1)
of the 46##6##3##(1990-11#1)(1991-3#1)(1991-6#1)(1992-3#2)(1997-3#1)
of the 47##2##3##(1997-8#1)(2007-7#1)
of the 48##2##3##(2005-8#1)(2008-5#1)
of the 484##2##3##(1991-12#2)
of the 49##4##3##(1994-3#1)(1997-1#1)(2008-1#1)(2008-6#1)
of the 4th instar##2##4##(1991-5#2)
of the 4th##5##3##(1991-5#2)(2008-12#1)(2011-12#1)(2011-2#1)
of the 5 cases##2##4##(1991-8#1)(1991-9#1)
of the 5 patients had##2##5##(2007-10#1)(2007-11#1)
of the 5 patients##3##4##(2007-10#1)(2007-11#1)(2011-2#1)
of the 5##25##3##(1990-5#1)(1991-8#1)(1991-9#1)(1993-7#1)(1994-6#1)(1995-10#1)(1995-9#1)(1996-6#1)(2004-11#1)(2007-10#2)(2007-11#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
of the 5' end of the gene##2##7##(1991-11#1)(1996-2#1)
of the 5' end of the##7##6##(1991-11#1)(1992-9#1)(1996-2#1)(1997-4#1)(2008-10#3)
of the 5' end of##8##5##(1991-11#1)(1992-9#1)(1993-3#1)(1996-2#1)(1997-4#1)(2008-10#3)
of the 5' end##9##4##(1990-5#1)(1991-11#1)(1992-9#1)(1993-3#1)(1996-2#1)(1997-4#1)(2008-10#3)
of the 5' exon##2##4##(1991-2#1)(1991-9#1)
of the 5' flanking region of Ha-ras##3##7##(1997-7#3)
of the 5' flanking region of##4##6##(1997-7#4)
of the 5' flanking region##7##5##(1993-2#1)(1997-2#1)(1997-7#4)(2008-7#1)
of the 5' flanking##8##4##(1993-2#1)(1993-4#1)(1997-2#1)(1997-7#4)(2008-7#1)
of the 5' non-coding region##2##5##(1994-2#1)(2012-12#1)
of the 5' region of the##2##6##(1995-2#1)(2008-8#1)
of the 5' untranslated region and##2##6##(1992-3#1)(1995-10#1)
of the 5' untranslated region of##2##6##(1991-9#1)(2012-2#1)
of the 5' untranslated region##6##5##(1991-9#1)(1992-11#1)(1992-3#1)(1995-10#1)(2008-10#1)(2012-2#1)
of the 5' untranslated##7##4##(1991-9#1)(1992-11#1)(1992-3#1)(1994-12#1)(1995-10#1)(2008-10#1)(2012-2#1)
of the 5' upstream region##2##5##(1992-12#1)(1997-2#1)
of the 5'##48##3##(1990-5#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-7#1)(1991-9#2)(1992-11#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1994-12#3)(1994-2#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-2#2)(1997-4#1)(1997-7#4)(2006-12#1)(2008-10#6)(2008-4#2)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)
of the 5'- and##3##4##(1990-11#1)(1990-4#1)(2008-10#1)
of the 5'-UTR##5##3##(1996-5#5)
of the 5'-flanking region of the##4##6##(1993-8#2)(1994-9#1)(1997-7#1)
of the 5'-flanking region of##6##5##(1993-8#2)(1994-12#1)(1994-9#1)(1997-7#1)(1997-8#1)
of the 5'-flanking region were##3##5##(1991-11#2)(1993-2#1)
of the 5'-flanking region with##2##5##(1993-11#1)(1994-11#1)
of the 5'-flanking region##14##4##(1990-12#1)(1991-11#2)(1993-11#1)(1993-2#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-9#1)(1997-7#2)(1997-8#1)(2010-5#1)
of the 5'-flanking regulatory sequences##2##5##(1992-5#2)
of the 5'-flanking sequence of the##2##6##(1990-8#1)(1997-7#1)
of the 5'-flanking sequence##4##4##(1990-8#1)(1992-5#1)(1995-6#1)(1997-7#1)
of the 5'-flanking##23##3##(1990-12#1)(1990-8#1)(1991-11#3)(1992-5#3)(1993-11#1)(1993-2#1)(1993-7#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-9#1)(1995-6#1)(1997-7#3)(1997-8#1)(2010-5#1)
of the 5'-nucleotidase##2##3##(1995-1#1)(2008-4#1)
of the 5'-untranslated region (UTR)##2##5##(1990-12#1)(1996-5#1)
of the 5'-untranslated region##4##4##(1990-12#1)(1991-4#1)(1993-4#1)(1996-5#1)
of the 5'-untranslated##5##3##(1990-12#1)(1991-4#1)(1993-2#1)(1993-4#1)(1996-5#1)
of the 5-HT##4##3##(1994-2#1)(1996-12#1)(2005-9#1)(2008-8#1)
of the 5-HT(7) receptor##2##4##(2012-12#2)
of the 5-HT1A agonist##2##4##(1994-12#1)(1995-12#1)
of the 5-HT1A receptor##5##4##(1993-3#1)(1994-2#1)(1995-12#1)(1997-1#1)(1997-5#1)
of the 5-HT1A##8##3##(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-12#2)(1997-1#1)(1997-5#1)
of the 5-HT2 receptor##2##4##(1991-12#1)(1993-9#1)
of the 5-HT2##3##3##(1991-12#1)(1993-9#1)(1994-12#1)
of the 5-HT2A receptor##3##4##(1995-9#2)(1997-5#1)
of the 5-HT2A##4##3##(1995-9#2)(1997-5#2)
of the 5-HT2C receptor##2##4##(1996-12#2)
of the 5-HT3 receptor##2##4##(1993-3#1)(2008-7#1)
of the 5-HT3##4##3##(1992-3#1)(1993-3#1)(1996-8#1)(2008-7#1)
of the 5-LO##3##3##(1993-7#1)(1994-12#2)
of the 5-amino##2##3##(1993-1#2)
of the 5-year##2##3##(1997-7#1)(2011-2#1)
of the 50 kDa##2##4##(1994-5#2)
of the 50 patients were##2##5##(1992-2#1)(2006-7#1)
of the 50 patients##7##4##(1992-2#2)(1993-2#2)(1996-8#1)(2006-7#1)(2008-4#1)
of the 50##14##3##(1992-2#2)(1993-2#2)(1994-5#2)(1996-8#1)(1997-2#1)(2006-7#1)(2007-7#1)(2008-10#2)(2008-4#1)(2012-2#1)
of the 50%##4##3##(2008-4#1)(2009-8#1)(2012-2#2)
of the 50(th) percentile##3##4##(2006-11#1)(2007-1#1)(2007-4#1)
of the 500##3##3##(2008-9#1)(2010-5#2)
of the 50K SNPs##2##4##(2012-1#2)
of the 51##4##3##(1996-12#1)(2008-12#1)(2008-5#1)(2012-11#1)
of the 51Cr##2##3##(1995-6#2)
of the 52##5##3##(1995-2#1)(2008-10#2)(2012-12#2)
of the 54##4##3##(2006-8#1)(2007-9#1)(2008-10#2)
of the 55 kDa##2##4##(1994-2#2)
of the 55##8##3##(1992-4#1)(1994-2#2)(1996-12#1)(2006-10#1)(2006-8#2)(2008-2#1)
of the 56##3##3##(1990-3#1)(1991-3#1)(2010-9#1)
of the 57##4##3##(1990-8#1)(1994-10#1)(2008-10#1)(2009-10#1)
of the 58##3##3##(1996-3#1)(2008-10#1)(2008-5#1)
of the 58K##2##3##(1997-3#1)(2008-8#1)
of the 5HT3 antagonist ondansetron##2##5##(1991-1#1)(2008-6#1)
of the 5th International##3##4##(2007-12#1)(2008-5#1)(2009-6#1)
of the 5th##12##3##(1993-4#1)(2006-11#1)(2007-12#1)(2008-5#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#2)(2013-7#1)
of the 6 carcinoma cell lines##2##6##(1991-10#2)
of the 6 patients with##2##5##(1994-7#1)(2010-8#1)
of the 6 patients##3##4##(1994-7#1)(2008-1#1)(2010-8#1)
of the 6 studies##2##4##(2007-8#2)
of the 6##17##3##(1991-10#2)(1992-7#1)(1994-7#1)(1996-6#2)(2006-11#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-8#1)(2011-1#1)(2013-1#1)
of the 6-7 year olds and##2##6##(2007-2#2)
of the 6-month##3##3##(2008-6#2)(2013-1#1)
of the 60##4##3##(1990-11#1)(1990-12#1)(2005-1#1)(2013-8#1)
of the 61 patients##2##4##(2008-8#1)(2011-2#1)
of the 61##4##3##(1993-9#1)(2008-8#1)(2009-10#1)(2011-2#1)
of the 62##2##3##(1991-4#1)(1996-12#1)
of the 63 patients with##2##5##(1992-11#1)(2008-1#1)
of the 63 patients##4##4##(1992-11#1)(2005-10#1)(2007-1#1)(2008-1#1)
of the 64##4##3##(1992-11#1)(1996-9#1)(2007-7#1)(2008-9#1)
of the 66 patients##2##4##(2008-4#1)(2013-1#1)
of the 66##5##3##(1993-12#1)(1994-12#1)(1994-9#1)(2008-4#1)(2013-1#1)
of the 67 K protein##3##5##(1995-12#3)
of the 67##6##3##(1991-5#2)(1995-12#3)(2013-8#1)
of the 67-kDa native cucumisin##2##5##(1994-12#2)
of the 68##3##3##(1991-4#1)(2006-8#1)(2007-5#1)
of the 69##5##3##(1990-11#1)(1990-8#1)(2008-10#1)(2013-1#2)
of the 695##3##3##(1992-12#1)(1992-9#1)(1995-10#1)
of the 697##2##3##(2012-3#2)
of the 6th International##5##4##(2007-10#1)(2007-2#1)(2009-10#1)(2011-2#2)
of the 6th##11##3##(1993-12#1)(1997-2#1)(2007-10#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#2)
of the 7 patients in whom the treatment failed##2##9##(2013-1#2)
of the 7 patients##8##4##(1990-3#1)(1991-5#1)(2007-8#2)(2010-2#2)(2013-1#2)
of the 7##23##3##(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-3#1)(1991-5#1)(1995-4#1)(2004-3#1)(2005-11#1)(2006-10#1)(2007-8#3)(2008-10#1)(2008-5#1)(2010-2#2)(2012-12#2)(2013-1#3)
of the 7- and##2##4##(1997-4#2)
of the 70##5##3##(1992-1#1)(1992-12#1)(1994-9#1)(2004-1#1)(2007-1#1)
of the 72##2##3##(1991-10#1)(1996-7#1)
of the 73##2##3##(1993-3#1)(1996-8#1)
of the 735##2##3##(1990-4#1)(1992-2#1)
of the 75##3##3##(1990-3#1)(1992-12#1)(2012-12#1)
of the 75-kDa subunit##2##4##(1991-2#2)
of the 75-kDa##4##3##(1990-12#1)(1991-2#2)(1993-3#1)
of the 75th##3##3##(1997-3#1)(2007-11#1)(2010-12#1)
of the 76##2##3##(1994-11#1)(2011-2#1)
of the 79##4##3##(1994-9#1)(1996-8#1)(1997-2#1)(2007-12#1)
of the 793/B serotype##3##4##(2008-5#3)
of the 7alpha-hydroxylase gene##3##4##(1997-1#3)
of the 7th Annual##3##4##(2005-7#1)(2009-9#1)(2010-12#1)
of the 7th##6##3##(2005-7#1)(2008-6#1)(2009-9#1)(2010-12#1)(2011-1#1)(2013-8#1)
of the 8 patients##2##4##(2007-8#1)(2008-5#1)
of the 8##8##3##(1990-2#1)(1991-3#1)(1992-3#1)(1994-12#1)(1996-5#1)(2007-8#1)(2008-5#1)(2011-2#1)
of the 80##3##3##(1991-5#2)(1996-4#1)
of the 810-nm##3##3##(2007-12#1)(2008-1#1)(2008-2#1)
of the 83 kDa peptide##2##5##(1990-11#2)
of the 84##4##3##(1993-2#1)(1996-10#1)(2006-10#1)(2012-3#1)
of the 87##2##3##(2010-2#1)(2012-2#1)
of the 88##2##3##(1990-3#1)(2007-8#1)
of the 8th##7##3##(1994-8#1)(2008-10#1)(2008-4#2)(2008-5#1)(2009-12#1)(2011-2#1)
of the 9 species##3##4##(2008-12#3)
of the 9##7##3##(1991-5#1)(2008-12#3)(2008-3#1)(2011-2#2)
of the 90 degrees##2##4##(2007-1#1)(2007-11#1)
of the 90##6##3##(1990-12#1)(1996-11#1)(2007-1#1)(2007-11#1)(2008-10#2)
of the 90K##2##3##(1997-2#2)
of the 92##2##3##(1991-12#1)(2008-7#1)
of the 94##2##3##(2007-7#1)(2013-7#1)
of the 95% confidence interval##3##5##(1997-1#2)(2008-10#1)
of the 95%##4##3##(1997-1#2)(2008-10#2)
of the 95-kDa protein##2##4##(1991-7#2)
of the 95-kDa##4##3##(1991-7#2)(1994-9#1)(1996-12#1)
of the 96##3##3##(1994-9#1)(1997-4#1)(2006-4#1)
of the 98##2##3##(2007-3#1)(2007-8#1)
of the 99##2##3##(1991-9#1)(2007-8#1)
of the 9th##5##3##(1991-9#1)(1992-3#1)(1996-4#1)(2008-8#1)(2009-2#1)
of the A and B##4##5##(1990-3#1)(1993-6#1)(1996-11#1)(2009-3#1)
of the A and##5##4##(1990-3#1)(1993-6#1)(1996-11#1)(2008-3#1)(2009-3#1)
of the A beta peptide##2##5##(1996-6#1)(1996-8#1)
of the A beta##4##4##(1995-3#1)(1996-6#2)(1996-8#1)
of the A chain##2##4##(1991-10#1)(1997-4#1)
of the A subunit##3##4##(1992-6#1)(1995-2#1)(1995-6#1)
of the A##38##3##(1990-12#1)(1990-3#3)(1990-4#1)(1991-10#1)(1991-7#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-12#2)(1994-9#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-11#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-4#1)(1997-8#1)(2006-11#3)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2009-3#2)(2012-3#1)
of the A(549)/DDP cells##2##4##(2008-9#2)
of the A(section)E((R))##2##3##(2008-9#2)
of the A* state##2##4##(2009-6#2)
of the A-form##2##3##(1992-8#1)(1994-6#1)
of the A-ring##4##3##(1996-9#4)
of the A/B##2##3##(1991-4#1)(1994-12#1)
of the A1 pulley##2##4##(2008-9#1)(2009-5#1)
of the A1##5##3##(1990-5#1)(1991-9#2)(2008-9#1)(2009-5#1)
of the A2 and A4##2##5##(2008-9#2)
of the A2 segment##3##4##(1996-3#3)
of the A2##10##3##(1991-5#1)(1991-6#1)(1996-3#3)(2008-10#2)(2008-12#1)(2008-9#2)
of the A4##3##3##(1990-7#1)(1996-2#1)(1996-7#1)
of the A6 mAb##2##4##(1994-5#2)
of the AA or TT clusters in the bent DNA fragment##2##11##(1990-5#2)
of the AA##7##3##(1990-12#1)(1990-5#2)(2009-4#1)(2011-2#3)
of the AAC##2##3##(2008-10#2)
of the AB##2##3##(1990-2#1)(2012-1#1)
of the ABC transporter##3##4##(1994-12#1)(1997-1#1)(2011-2#1)
of the ABC##6##3##(1994-12#1)(1997-1#1)(2008-7#1)(2010-12#1)(2011-2#2)
of the ABCD##2##3##(2008-3#1)(2009-10#1)
of the ABL##5##3##(1997-6#2)(2008-2#3)
of the ABO##2##3##(1992-9#1)(2009-5#1)
of the ABRZ##2##3##(2013-7#1)(2013-8#1)
of the AC##5##3##(1991-11#1)(1993-7#2)(2005-11#1)(2006-10#1)
of the ACAT##2##3##(1995-3#1)(1996-5#1)
of the ACC##2##3##(2009-1#1)(2009-5#1)
of the ACCx##2##3##(1996-9#2)
of the ACE D/I##2##4##(2010-6#2)
of the ACE gene##3##4##(1991-12#1)(2007-11#1)(2010-6#1)
of the ACE inhibitor##2##4##(1993-9#1)(2007-11#1)
of the ACE##8##3##(1990-2#1)(1991-12#1)(1993-9#1)(2007-11#2)(2010-6#3)
of the ACF##2##3##(2007-8#2)
of the ACL##6##3##(1996-11#1)(2007-4#1)(2007-5#1)(2009-9#1)(2013-1#2)
of the ACP##2##3##(1995-6#1)(2005-9#1)
of the ACR task force on##3##6##(2007-4#3)
of the ACR##7##3##(2007-4#7)
of the ACS##3##3##(2005-8#1)(2008-5#2)
of the ACTH##2##3##(1994-2#1)(2011-1#1)
of the ACh##3##3##(1997-1#1)(2008-5#1)(2009-12#1)
of the AChE##3##3##(1992-9#1)(1995-3#1)(2008-10#1)
of the AChR##2##3##(1997-5#1)(2012-2#1)
of the ACs studied##2##4##(2005-11#2)
of the AD##4##3##(1994-2#1)(1997-7#1)(2007-8#1)(2007-9#1)
of the ADA##4##3##(1995-6#1)(1996-1#1)(1997-5#1)(2007-5#1)
of the ADH1##2##3##(1990-5#2)
of the ADP/ATP carrier##2##4##(1994-8#1)(2005-8#1)
of the ADR##2##3##(2008-10#1)(2011-2#1)
of the ADRs##3##3##(2011-2#2)(2013-8#1)
of the AE##2##3##(2008-10#1)(2010-12#1)
of the AE1 specific##3##4##(1991-8#3)
of the AE1##4##3##(1991-8#4)
of the AF##2##3##(2008-5#2)
of the AF4Q initiative##2##4##(2013-1#2)
of the AFC##4##3##(2011-2#4)
of the AFLP markers##2##4##(2008-10#2)
of the AFLP##5##3##(2008-10#5)
of the AGL2 gene family##2##5##(1997-2#1)(1997-8#1)
of the AGT##3##3##(1993-11#1)(1995-5#2)
of the AGabaA a(3) ion##2##5##(2012-12#2)
of the AHL##2##3##(2007-11#2)
of the AHRA Statistical Resource Committee salary survey##2##8##(1991-12#1)(1991-3#1)
of the AHRA's##3##3##(1990-12#1)(1992-12#1)(1993-2#1)
of the AIDS epidemic##11##4##(1990-12#2)(1990-3#1)(1993-3#1)(1994-9#1)(1995-1#1)(1996-1#1)(1996-5#1)(2004-9#1)(2007-7#1)(2008-5#1)
of the AIDS virus##3##4##(1990-5#1)(1992-12#1)(1992-9#1)
of the AIDS##21##3##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1992-12#1)(1992-9#2)(1993-3#1)(1994-7#1)(1994-9#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-5#1)(2004-9#1)(2007-7#3)(2008-5#1)(2010-10#1)
of the AL##2##3##(1992-12#2)
of the ALD##2##3##(1994-12#1)(1995-2#1)
of the ALDH-3 gene##2##4##(1991-10#2)
of the ALK##2##3##(2008-9#1)(2011-2#1)
of the ALP gene##2##4##(1991-5#2)
of the ALP##4##3##(1990-12#1)(1991-5#3)
of the ALT##2##3##(2008-1#2)
of the AM##5##3##(1992-2#1)(1994-2#1)(2006-3#1)(2008-7#1)(2009-8#1)
of the AML##3##3##(2008-10#2)(2008-6#1)
of the AMPA receptor##2##4##(1993-12#1)(1994-2#1)
of the AMPs##2##3##(1996-10#2)
of the ANCOVA with equal##3##5##(2012-1#3)
of the ANCOVA with##4##4##(2012-1#4)
of the ANCOVA##5##3##(1993-1#1)(2012-1#4)
of the ANP##2##3##(1990-11#2)
of the AO system##2##4##(2008-3#1)(2010-5#1)
of the AO##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2010-5#1)
of the AOA##2##3##(2009-10#1)(2012-12#1)
of the AP site##3##4##(1995-2#1)(2007-8#1)(2008-10#1)
of the AP##7##3##(1992-7#1)(1994-8#1)(1995-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2010-4#1)
of the APC##3##3##(1995-1#1)(2006-2#1)(2008-8#1)
of the APOE gene##2##4##(2012-12#2)
of the APP gene##3##4##(1992-1#1)(1995-6#1)(1996-6#1)
of the APP##5##3##(1992-1#1)(1992-9#1)(1995-6#1)(1996-6#2)
of the APS##2##3##(2006-10#1)(2006-5#1)
of the AR##11##3##(1990-8#1)(1994-2#1)(1995-3#2)(1996-5#4)(2008-2#1)(2008-8#1)(2011-2#1)
of the AS##2##3##(2008-5#1)(2009-4#1)
of the ASA##2##3##(1997-6#2)
of the ASD is##2##4##(2008-2#1)(2008-3#1)
of the ASD##4##3##(2007-8#1)(2008-2#1)(2008-3#1)(2013-1#1)
of the ASMF##2##3##(2008-3#2)
of the AT1 receptor subtype##3##5##(1993-3#1)(1994-8#1)(1994-9#1)
of the AT1 receptor##7##4##(1992-7#1)(1993-3#1)(1994-8#2)(1994-9#1)(1995-10#1)(2005-7#1)
of the ATA monomers and##2##5##(1992-5#2)
of the ATA##3##3##(1992-5#3)
of the ATG##4##3##(1993-3#1)(1994-10#1)(1994-12#1)(2007-9#1)
of the ATP and##2##4##(1993-8#1)(1994-6#1)
of the ATP binding##4##4##(1990-3#1)(1993-3#1)(1994-11#1)(1994-9#1)
of the ATP hydrolysis##2##4##(1997-4#2)
of the ATP synthase##4##4##(1997-7#1)(2005-8#2)(2008-4#1)
of the ATP##18##3##(1990-3#1)(1992-1#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-6#1)(1994-9#1)(1997-4#3)(1997-7#1)(2005-8#2)(2008-4#1)(2010-12#1)
of the ATP-binding##4##3##(1991-6#1)(1997-4#1)(2006-10#1)(2008-11#1)
of the ATP-citrate lyase mRNA##2##5##(1992-11#2)
of the ATP-dependent##4##3##(1992-11#1)(1995-8#2)(1997-4#1)
of the ATP-sensitive K+##3##4##(1994-11#1)(1994-3#1)(1996-2#1)
of the ATP7B gene##2##4##(2007-12#1)(2008-9#1)
of the ATPase activity##2##4##(1997-1#1)(1997-2#1)
of the ATPase and##2##4##(1995-3#1)(2010-7#1)
of the ATPase complex##2##4##(1995-3#2)
of the ATPase cycle##2##4##(1997-4#2)
of the ATPase##16##3##(1990-2#1)(1992-6#2)(1994-3#1)(1995-3#5)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#1)(2010-7#1)(2012-3#1)
of the AVM by##2##4##(2008-7#2)
of the AVM##5##3##(2008-7#5)
of the AVR##2##3##(2007-8#1)(2008-10#1)
of the AWI 31##2##4##(1997-2#2)
of the Abelson##2##3##(1991-6#1)(2009-7#1)
of the Abl##3##3##(1994-10#1)(1995-2#2)
of the Ac##2##3##(2012-3#2)
of the Academy of##3##4##(2008-8#1)(2009-7#1)(2012-2#1)
of the Acceptability E-scale##2##4##(2010-10#2)
of the Achatina##2##3##(1991-5#2)
of the Achilles tendon##4##4##(1995-8#1)(2006-11#1)(2009-10#1)(2012-1#1)
of the Achilles##5##3##(1995-8#1)(2006-11#1)(2009-10#1)(2011-2#1)(2012-1#1)
of the Act##6##3##(1991-10#1)(1993-3#2)(1993-4#1)(1997-8#1)(2012-3#1)
of the Active##2##3##(2008-12#1)(2013-8#1)
of the Acute##2##3##(2007-9#1)(2008-10#1)
of the Ad12 E1a gene##2##5##(1991-12#2)
of the Adair constants##2##4##(1990-8#2)
of the Addenbrooke's Cognitive##2##4##(2013-1#2)
of the Ade2 protein##2##4##(1997-6#2)
of the Adh gene##2##4##(1997-8#2)
of the Advanced##2##3##(2008-2#1)(2008-3#1)
of the Advisory Committee##3##4##(1990-12#1)(2004-12#2)
of the African American##2##4##(2010-8#2)
of the African##11##3##(1991-7#1)(1992-8#1)(1994-2#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-8#2)
of the AfsR##2##3##(1990-10#2)
of the Ag-specific##2##3##(1990-5#2)
of the Age of Enlightenment##3##5##(2008-12#3)
of the Agency for##3##4##(1993-12#1)(2006-12#1)(2011-2#1)
of the Agrobacterium##3##3##(1991-7#1)(2006-12#1)(2006-3#1)
of the Ah receptor##3##4##(1992-12#1)(1993-3#1)(1994-8#1)
of the Ah##4##3##(1992-12#1)(1993-12#1)(1993-3#1)(1994-8#1)
of the Ailanthus##2##3##(2013-8#2)
of the Airy##2##3##(2007-11#2)
of the Al##6##3##(1996-8#2)(2005-11#2)(2008-10#2)
of the Alberta##2##3##(1996-1#1)(2006-10#1)
of the Algarve##2##3##(2012-2#2)
of the Alu##3##3##(1991-5#1)(1995-2#1)(1997-2#1)
of the Alzheimer amyloid protein precursor (APP)##2##7##(1992-8#1)(1994-11#1)
of the Alzheimer amyloid##4##4##(1992-8#1)(1992-9#1)(1993-8#1)(1994-11#1)
of the Alzheimer##15##3##(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#3)(1993-8#1)(1994-11#2)(1994-5#3)(1995-11#1)(1996-11#1)(2008-7#1)
of the Alzheimer's beta-amyloid##2##4##(1991-11#1)(2010-4#1)
of the Alzheimer's disease amyloid##2##5##(1990-5#1)(1992-12#1)
of the Alzheimer's disease##3##4##(1990-5#1)(1992-12#1)(1995-10#1)
of the Alzheimer's##8##3##(1990-5#2)(1991-11#1)(1992-12#1)(1992-7#1)(1995-10#1)(2008-6#1)(2010-4#1)
of the Amazon forest##2##4##(2007-2#1)(2010-7#1)
of the Amazon##7##3##(1991-11#1)(1994-7#1)(2007-2#1)(2007-9#1)(2010-7#2)(2013-1#1)
of the American Academy of Neurology##2##6##(2006-12#1)(2011-1#1)
of the American Academy of##5##5##(2006-12#1)(2006-9#1)(2007-11#1)(2007-7#1)(2011-1#1)
of the American Association for##2##5##(2005-6#1)(2008-9#1)
of the American Association##3##4##(2005-6#1)(2006-12#1)(2008-9#1)
of the American Astronomical Society's##2##5##(2007-8#1)(2007-9#1)
of the American Astronomical##3##4##(1995-6#1)(2007-8#1)(2007-9#1)
of the American College of Physicians##3##6##(1993-12#2)(2010-8#1)
of the American College of Rheumatology##2##6##(2005-8#1)(2007-8#1)
of the American College of##11##5##(1993-12#2)(1996-2#1)(2005-8#2)(2007-10#1)(2007-4#1)(2007-8#1)(2008-6#1)(2010-8#1)(2011-2#1)
of the American Heart Association##6##5##(1996-6#1)(2008-3#1)(2008-4#1)(2009-5#1)(2012-12#1)(2012-3#1)
of the American Journal of##2##5##(2005-8#1)(2011-2#1)
of the American Medical Association##10##5##(1991-8#2)(2006-10#8)
of the American Psychological Association##2##5##(1994-12#1)(2006-2#1)
of the American Society for Biochemistry and Molecular Biology##2##9##(1996-4#1)(1997-7#1)
of the American Society for##4##5##(1996-4#1)(1997-7#1)(2005-7#1)(2011-2#1)
of the American Society of Clinical Oncology##4##7##(2008-7#3)(2009-8#1)
of the American Society of Clinical##5##6##(2007-1#1)(2008-7#3)(2009-8#1)
of the American Society of Hematology##3##6##(2005-9#1)(2008-7#2)
of the American Society of##13##5##(2005-9#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-5#1)(2008-7#5)(2008-8#1)(2009-8#1)(2011-2#1)
of the American Society##17##4##(1996-4#1)(1997-7#1)(2005-7#1)(2005-9#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-5#1)(2008-7#5)(2008-8#1)(2009-8#1)(2011-2#2)
of the American Urological Association##2##5##(2006-9#2)
of the American cockroach##3##4##(1997-8#3)
of the American##95##3##(1990-12#1)(1991-8#2)(1993-12#4)(1994-12#1)(1995-1#1)(1995-6#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-6#1)(1997-7#1)(1997-8#4)(2005-11#1)(2005-6#1)(2005-7#1)(2005-8#4)(2005-9#1)(2006-10#9)(2006-12#2)(2006-2#1)(2006-9#4)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#6)(2008-8#2)(2008-9#3)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#1)
of the Americans with Disabilities Act##5##6##(1992-12#1)(1993-3#1)(1994-2#1)(1995-6#1)(1996-11#1)
of the Americans##7##3##(1992-12#1)(1993-3#1)(1993-7#1)(1994-2#1)(1995-1#1)(1995-6#1)(1996-11#1)
of the Americas##2##3##(2011-2#1)(2013-1#1)
of the Amide I band##2##5##(1990-3#2)
of the Amplitype PM system##2##5##(1996-7#2)
of the Amplitype PM##3##4##(1996-7#3)
of the An##4##3##(1995-8#2)(2004-11#1)(2007-12#1)
of the Anabaena##2##3##(1994-9#2)
of the Anatomical Society of Great Britain and Ireland was held at the Royal##2##14##(2006-11#2)
of the Anatomical Society of Great Britain and Ireland was held at the##3##13##(2006-11#3)
of the Anatomical Society of Great Britain and Ireland was held at##5##12##(2006-11#5)
of the Anatomical Society of Great Britain and Ireland##11##9##(2006-11#11)
of the Andean##4##3##(1997-6#1)(2008-5#1)(2011-2#1)(2013-7#1)
of the Anderson##2##3##(1993-3#1)(2010-5#1)
of the Andes##4##3##(2008-10#1)(2008-5#2)(2008-8#1)
of the Antarctic##6##3##(1991-5#1)(1995-3#1)(2012-12#2)(2013-8#2)
of the Antarctica##2##3##(1993-9#1)(2008-10#1)
of the Anterior##2##3##(2008-12#1)(2013-1#1)
of the Antiviral##2##3##(2008-10#1)(2008-5#1)
of the Apc gene##3##4##(1995-1#2)(2012-2#1)
of the Aplysia##2##3##(1997-2#1)(2008-6#1)
of the Apple##2##3##(2008-10#2)
of the Arab##2##3##(2008-1#1)(2013-1#1)
of the Arabian Peninsula##2##4##(2008-1#1)(2012-12#1)
of the Arabidopsis genome##2##4##(2006-12#1)(2008-7#1)
of the Arabidopsis thaliana##3##4##(1997-6#1)(1997-8#1)(2008-10#1)
of the Arabidopsis##14##3##(1994-3#1)(1995-2#2)(1997-6#1)(1997-8#1)(2006-12#3)(2008-10#2)(2008-7#1)(2009-8#2)(2012-3#1)
of the Arctic Ocean##3##4##(1991-11#2)(1994-7#1)
of the Arctic##7##3##(1991-11#2)(1991-5#1)(1994-7#3)(2010-8#1)
of the Arg-Gly-Asp##2##3##(1990-6#1)(1993-11#1)
of the Arina##2##3##(2008-10#2)
of the Armed##2##3##(1995-6#1)(2011-1#1)
of the Arp2/3 complex##3##4##(2009-8#1)(2012-2#2)
of the ArsA protein##2##4##(1994-5#2)
of the Asian corn borer##2##5##(2006-4#2)
of the Asian##11##3##(2005-8#1)(2006-12#1)(2006-4#2)(2006-9#1)(2008-10#1)(2009-11#1)(2009-8#1)(2010-8#1)(2013-1#1)(2013-8#1)
of the Aspergillus nidulans##2##4##(1991-7#1)(2008-10#1)
of the Aspergillus##5##3##(1991-7#1)(1993-3#1)(1994-8#1)(2008-10#2)
of the Assessment##2##3##(1997-2#1)(2007-12#1)
of the Association for the Care of Children's Health##2##9##(1992-3#1)(1994-3#1)
of the Association for the##3##5##(1992-3#1)(1994-3#1)(2008-8#1)
of the Association for##4##4##(1992-3#1)(1994-3#2)(2008-8#1)
of the Association of Marine Laboratories of the Caribbean##2##9##(2007-8#1)(2011-2#1)
of the Association of Medical##2##5##(2007-12#1)(2008-12#1)
of the Association of Psychologists in Academic Health Centers##2##9##(2008-12#2)
of the Association of##13##4##(1991-3#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-12#3)(2009-11#1)(2009-2#1)(2010-3#1)(2011-2#1)(2012-12#1)
of the Association##19##3##(1991-3#1)(1992-3#1)(1994-3#2)(2005-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#3)(2008-8#1)(2009-11#1)(2009-2#1)(2010-3#1)(2011-2#1)(2011-4#1)(2012-12#1)
of the Atlantic##5##3##(1991-8#1)(1994-2#1)(2007-3#1)(2007-9#1)(2010-12#1)
of the Au##2##3##(2008-10#1)(2008-2#1)
of the Australasian##2##3##(2007-2#1)(2008-7#1)
of the Australian and New Zealand##2##6##(2009-4#1)(2011-2#1)
of the Australian population##2##4##(2007-12#1)(2011-2#1)
of the Australian##13##3##(1994-12#1)(1994-2#1)(2005-7#1)(2007-12#3)(2007-2#2)(2008-5#1)(2009-4#1)(2011-2#2)(2012-12#1)
of the Austrian Pharmacopoeia##3##4##(2012-12#3)
of the Authors##2##3##(1992-10#1)(1992-6#1)
of the Autism##2##3##(2012-11#1)(2012-12#1)
of the Autographa californica##2##4##(1993-12#1)(1997-3#1)
of the Autonomous University of##2##5##(2012-12#1)(2012-3#1)
of the Autonomous##5##3##(1995-9#1)(1996-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
of the Avahan HIV prevention##2##5##(2012-3#2)
of the Avahan program##2##4##(2012-3#2)
of the Avahan##5##3##(2012-3#5)
of the B antigen##2##4##(1996-3#2)
of the B cell antigen receptor##2##6##(1994-9#1)(2008-4#1)
of the B cell##5##4##(1991-12#1)(1994-12#1)(1994-9#1)(1995-2#1)(2008-4#1)
of the B chromosome number##2##5##(2008-12#2)
of the B chromosomes##2##4##(2008-12#1)(2008-5#1)
of the B fragment##2##4##(1990-3#2)
of the B ring##2##4##(1993-6#1)(2007-11#1)
of the B subunit##2##4##(1995-3#1)(1996-5#1)
of the B##54##3##(1990-11#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#2)(1991-12#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#1)(1996-3#3)(1996-5#1)(1997-2#3)(1997-4#1)(1997-8#1)(2006-5#1)(2006-8#3)(2007-11#1)(2008-10#3)(2008-12#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2009-3#1)(2010-12#1)(2011-2#3)(2012-3#1)
of the B1 domain##2##4##(1994-11#2)
of the B1##4##3##(1994-11#2)(1994-5#1)(1994-9#1)
of the B2 subunit##2##4##(1991-12#1)(1995-3#1)
of the B800-850 complex##2##4##(1993-3#1)(2007-12#1)
of the B800/850##2##3##(1996-7#2)
of the BA##4##3##(2007-9#3)(2009-5#1)
of the BAC##2##3##(2008-4#1)(2008-7#1)
of the BAL##2##3##(1994-6#1)(2010-12#1)
of the BBA##4##3##(2008-11#4)
of the BBB##7##3##(1993-12#1)(2007-11#2)(2008-1#1)(2008-7#2)(2008-8#1)
of the BBWV-K##2##3##(2008-10#2)
of the BC##3##3##(1993-3#1)(2009-4#1)(2009-9#1)
of the BCR-ABL##2##3##(2007-12#1)(2012-12#1)
of the BI##2##3##(1994-9#1)(2007-10#1)
of the BK channel in##2##5##(2008-8#1)(2009-2#1)
of the BK channel##3##4##(2008-8#1)(2009-2#2)
of the BK##4##3##(1990-12#1)(2008-8#1)(2009-2#2)
of the BLAST##2##3##(2008-4#2)
of the BLCG##2##3##(1993-11#2)
of the BM##2##3##(1991-8#1)(2009-5#1)
of the BMI##4##3##(2007-8#2)(2008-12#1)(2009-2#1)
of the BN##3##3##(2008-10#1)(2009-5#1)(2010-10#1)
of the BP##3##3##(1996-5#1)(2008-11#1)(2008-3#1)
of the BPI##2##3##(2008-7#2)
of the BPV##2##3##(1991-7#2)
of the BPs##3##3##(2008-7#3)
of the BR##3##3##(1991-12#1)(2007-12#1)(2009-4#1)
of the BSA##2##3##(1993-2#1)(2007-2#1)
of the BTB##5##3##(2009-10#3)(2012-2#2)
of the BZD##2##3##(1991-12#2)
of the BaP##3##3##(2006-3#3)
of the Bacillus cereus group##2##5##(2011-2#2)
of the Bacillus stearothermophilus##3##4##(1996-8#2)(1997-5#1)
of the Bacillus subtilis##7##4##(1991-9#1)(1993-12#1)(1993-6#1)(1995-12#1)(1996-8#2)(1997-7#1)
of the Bacillus##16##3##(1990-7#1)(1991-9#1)(1993-12#1)(1993-6#1)(1995-12#1)(1996-8#4)(1997-5#1)(1997-7#1)(2008-10#2)(2008-3#1)(2011-2#2)
of the Bacterium##2##3##(2008-10#2)
of the Bacteroides fragilis##3##4##(1990-9#1)(2006-8#2)
of the Bacteroides##4##3##(1990-9#1)(1997-2#1)(2006-8#2)
of the Bahian##2##3##(2009-10#2)
of the Baja California peninsula##2##5##(2007-3#1)(2010-8#1)
of the Baja California##3##4##(2007-3#1)(2010-8#2)
of the Balkan##2##3##(2011-1#2)
of the Baltic Sea##4##4##(2008-11#2)(2008-5#1)(2010-8#1)
of the Bam##2##3##(2008-8#2)
of the Bantu##2##3##(1991-11#1)(2008-12#1)
of the Bardet-Biedl syndrome##2##4##(2013-8#2)
of the Barley##2##3##(2008-10#2)
of the Basic Protocol for##2##5##(2008-4#2)
of the Basque Country##2##4##(2008-10#1)(2012-11#1)
of the Basque##4##3##(2008-10#2)(2012-11#2)
of the Bayesian##3##3##(1994-9#1)(1995-6#1)(2008-2#1)
of the Bcl-2 family of##2##5##(2008-11#1)(2009-12#1)
of the Bcl-2 family##6##4##(1996-10#1)(2008-11#2)(2009-12#1)(2011-2#2)
of the Bcl-2 gene##2##4##(1995-12#1)(2010-9#1)
of the Bcl-2##9##3##(1995-12#1)(1996-10#1)(2008-11#3)(2009-12#1)(2010-9#1)(2011-2#2)
of the Bean##2##3##(2008-10#2)
of the Berlin Deinstitutionalisation##2##4##(2007-1#2)
of the Berlin##3##3##(1994-6#1)(2007-1#2)
of the Bible##2##3##(2007-10#1)(2009-3#1)
of the Big##2##3##(1996-4#1)(2010-12#1)
of the BioRID II and the RID2 are##2##8##(2006-11#2)
of the BioRID II and##3##5##(2006-11#3)
of the BioRID##4##3##(2006-11#3)(2013-8#1)
of the Biocontrol Agent Pseudomonas##2##5##(2008-10#2)
of the Biocontrol##5##3##(2008-10#5)
of the Biological Control##2##4##(2008-10#2)
of the Black Sea##2##4##(2007-9#1)(2010-8#1)
of the Blue Cross and Blue Shield##2##7##(1994-12#1)(2008-4#1)
of the Blue##3##3##(1994-12#1)(1997-6#1)(2008-4#1)
of the BmNPV##2##3##(1997-3#2)
of the BoNT/E##3##3##(1992-2#3)
of the Board of Health##2##5##(1993-3#1)(1993-8#1)
of the Board of##4##4##(1993-3#1)(1993-8#1)(2008-10#1)(2008-8#1)
of the Board##7##3##(1993-3#3)(1993-8#1)(2007-12#1)(2008-10#1)(2008-8#1)
of the Bogota##5##3##(2012-12#4)(2013-1#1)
of the Bohr effect in##2##5##(1990-8#1)(1994-9#1)
of the Bohr effect of##3##5##(1990-8#2)(1994-8#1)
of the Bohr effect##5##4##(1990-8#3)(1994-8#1)(1994-9#1)
of the Bolton anterior ratio##2##5##(2010-2#2)
of the Bolton overall ratio##2##5##(2010-2#2)
of the Bolton##5##3##(2010-2#5)
of the Boltzmann##3##3##(2007-12#2)(2008-2#1)
of the Boston EMS STEMI Triage Plan and Treatment Registry##2##10##(2008-3#2)
of the Boston##3##3##(2008-3#3)
of the Bradford Hill criteria for causality##2##7##(2013-8#2)
of the Bragg grating##4##4##(2007-11#2)(2008-2#2)
of the Bragg wavelength##4##4##(2007-11#1)(2007-12#2)(2008-1#1)
of the Bragg##12##3##(2006-5#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-2#4)(2008-3#1)
of the Brassaia strains##2##4##(2008-10#2)
of the Brassica##2##3##(2008-7#1)(2012-3#1)
of the Brazilian Medical Association##2##5##(2011-2#2)
of the Brazilian version of the##2##6##(2011-2#1)(2013-8#1)
of the Brazilian##15##3##(1991-12#1)(1991-9#1)(2006-5#1)(2008-10#1)(2008-9#1)(2009-10#1)(2011-2#5)(2012-12#1)(2013-8#3)
of the Breast and##2##4##(1996-6#1)(1997-1#1)
of the Breast##14##3##(1994-12#1)(1994-7#2)(1995-4#2)(1996-3#1)(1996-6#5)(1997-1#1)(1997-7#1)(2013-8#1)
of the Bright/ARID##2##3##(2009-7#2)
of the Brillouin backscattered light##2##5##(2008-3#2)
of the Brillouin##4##3##(2007-12#2)(2008-3#2)
of the Brillouin-loss spectrum of single-mode fibers##2##7##(2007-12#2)
of the Brillouin-loss##3##3##(2007-12#2)(2008-3#1)
of the British##16##3##(1992-1#1)(1997-8#1)(2005-7#1)(2005-8#1)(2005-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
of the Brugada syndrome##3##4##(2008-12#3)
of the Bs##3##3##(2008-12#1)(2008-5#1)(2010-3#1)
of the Bulletin##2##3##(2007-8#1)(2013-1#1)
of the Button##2##3##(2008-5#2)
of the C##36##3##(1990-5#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-6#1)(1992-9#1)(1994-12#3)(1994-6#1)(1995-11#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-4#1)(2007-11#2)(2007-12#5)(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-3#1)(2010-6#1)(2012-11#1)(2012-3#1)(2013-1#1)
of the C(1)-N(15)##2##3##(2008-3#2)
of the C-1##3##3##(1995-3#1)(1997-7#1)(2006-9#1)
of the C-2##3##3##(1994-8#2)(1996-7#1)
of the C-4 methyl##2##4##(1996-5#1)(2007-12#1)
of the C-9 and C-9a substituents##2##6##(1995-5#2)
of the C-H##2##3##(1992-6#1)(2010-4#1)
of the C-PR##3##3##(1991-6#3)
of the C-terminal amino##2##4##(1991-7#1)(1994-2#1)
of the C-terminal cytoplasmic##2##4##(1996-2#1)(1996-8#1)
of the C-terminal domain of the##2##6##(2009-7#1)(2011-1#1)
of the C-terminal domain of##5##5##(1995-2#1)(1996-7#1)(2009-7#1)(2011-1#2)
of the C-terminal domain##10##4##(1992-7#2)(1995-2#2)(1996-7#2)(1997-5#1)(2009-7#1)(2011-1#2)
of the C-terminal half##2##4##(1990-11#1)(2006-12#1)
of the C-terminal region of the##3##6##(1992-6#1)(1993-7#1)(2008-4#1)
of the C-terminal region of##5##5##(1991-10#1)(1992-6#1)(1993-7#1)(1993-8#1)(2008-4#1)
of the C-terminal sequence##3##4##(1990-7#1)(1997-4#1)(2008-4#1)
of the C-terminal##46##3##(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-6#1)(1992-7#3)(1992-8#2)(1992-9#1)(1993-7#1)(1993-8#1)(1994-2#1)(1994-8#1)(1994-9#2)(1995-2#3)(1995-6#1)(1996-2#1)(1996-7#3)(1996-8#1)(1997-4#1)(1997-5#1)(2006-12#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#2)(2009-7#2)(2011-1#3)
of the C-terminus of##2##4##(1993-3#1)(2012-2#1)
of the C-terminus##7##3##(1990-7#1)(1991-7#1)(1993-3#1)(1996-7#1)(1997-3#1)(2011-2#1)(2012-2#1)
of the C-type lectin##2##4##(1997-7#1)(2012-1#1)
of the C-type lectins##2##4##(2012-3#1)(2013-7#1)
of the C-type##4##3##(1997-7#1)(2012-1#1)(2012-3#1)(2013-7#1)
of the C/EBP family of transcription factors##2##7##(1995-3#1)(1996-5#1)
of the C1 screw##2##4##(2012-12#2)
of the C1##4##3##(1990-9#1)(2007-1#1)(2012-12#2)
of the C1-2##2##3##(2006-7#1)(2012-3#1)
of the C103S mutant of the N-terminal domain of DsbD from Neisseria##2##12##(2009-7#2)
of the C16TAB##4##3##(2005-11#4)
of the C2 content##2##4##(2007-12#2)
of the C2##7##3##(1992-4#1)(1993-11#1)(1994-12#1)(2007-11#1)(2007-12#2)(2012-3#1)
of the C3 substrate##3##4##(1992-12#3)
of the C3##4##3##(1992-12#4)
of the C3H/HeJ##2##3##(1991-12#1)(1996-11#1)
of the C4##2##3##(1992-12#1)(1995-2#1)
of the C4A4##2##3##(1990-5#2)
of the C5##2##3##(2005-5#1)(2008-9#1)
of the C6##4##3##(1994-9#1)(2005-5#2)(2007-11#1)
of the CA cases were##2##5##(2011-1#2)
of the CA##6##3##(1994-2#1)(2006-10#1)(2008-5#1)(2011-1#3)
of the CA-MRSA##2##3##(2012-12#2)
of the CA1 region of##2##5##(1995-12#1)(1997-5#1)
of the CA1 region##4##4##(1991-8#1)(1995-12#1)(1997-5#1)(1997-7#1)
of the CA1##9##3##(1990-2#2)(1991-8#1)(1994-10#1)(1994-5#1)(1995-12#1)(1997-5#1)(1997-7#1)(1997-8#1)
of the CA3##2##3##(1990-5#1)(2008-11#1)
of the CAG repeats in the##2##6##(1992-1#1)(1997-5#1)
of the CAG##3##3##(1992-1#1)(1996-5#1)(1997-5#1)
of the CALUX (DX##2##4##(2008-10#2)
of the CALUX bioassay for##2##5##(2008-10#2)
of the CALUX##7##3##(2008-10#7)
of the CAM##8##3##(2008-1#1)(2008-10#1)(2009-5#1)(2013-1#5)
of the CARS##2##3##(2007-11#1)(2008-2#1)
of the CArG##3##3##(1993-8#2)(1995-3#1)
of the CB##2##3##(1993-12#1)(1993-2#1)
of the CBS##3##3##(1993-8#3)
of the CBT##2##3##(2011-1#2)
of the CC##7##3##(2007-5#1)(2008-10#1)(2008-7#1)(2010-12#3)(2013-1#1)
of the CCA##2##3##(1992-2#1)(2008-4#1)
of the CCAAT transcription##2##4##(1993-2#2)
of the CCAAT##3##3##(1993-2#2)(1994-9#1)
of the CCD camera##3##4##(2006-4#1)(2008-2#1)(2008-3#1)
of the CCD##15##3##(2006-4#1)(2007-11#1)(2007-12#1)(2008-2#6)(2008-3#3)(2008-5#2)(2011-1#1)
of the CCK-B receptor##2##4##(1992-2#1)(1992-3#1)
of the CCK-B##3##3##(1992-2#1)(1992-3#1)(1996-2#1)
of the CCKA##2##3##(1993-6#1)(1995-12#1)
of the CCOP and##2##4##(1992-12#2)
of the CCOP##4##3##(1992-12#4)
of the CCP##3##3##(2005-9#2)(2006-5#1)
of the CD _ 2##2##5##(2008-5#2)
of the CD spectra##2##4##(1990-5#1)(1996-1#1)
of the CD##15##3##(1990-5#1)(1994-11#2)(1994-5#1)(1994-8#1)(1995-4#3)(1996-1#1)(2004-7#1)(2008-10#3)(2008-5#2)
of the CD4 Ag##2##4##(1993-3#2)
of the CD4 cell count##2##5##(2007-7#1)(2009-8#1)
of the CD4##8##3##(1993-11#1)(1993-3#3)(1993-9#1)(2007-7#1)(2009-8#1)(2013-8#1)
of the CD95##2##3##(1997-7#2)
of the CDC##4##3##(1995-2#1)(1996-1#1)(2008-8#1)(2012-12#1)
of the CDS##2##3##(2008-3#2)
of the CE##8##3##(1996-5#1)(1997-2#1)(2007-3#2)(2008-1#1)(2008-10#1)(2008-5#2)
of the CEA##4##3##(1990-10#1)(1990-5#1)(1992-11#1)(1994-5#1)
of the CEDO##2##3##(1993-9#2)
of the CFH and Worland strains##2##6##(2008-10#2)
of the CFH##4##3##(2008-10#4)
of the CGA molecule##2##4##(1992-9#2)
of the CH##3##3##(2008-10#1)(2008-2#1)(2008-6#1)
of the CH(2) symmetric##2##4##(2008-10#2)
of the CH(2)##7##3##(1997-2#1)(2008-10#5)(2008-5#1)
of the CHOD##2##3##(1990-10#1)(1990-12#1)
of the CII##2##3##(1991-4#1)(1996-12#1)
of the CIP##2##3##(2008-10#2)
of the CL reaction##2##4##(2008-10#2)
of the CL##6##3##(1996-6#1)(2008-10#5)
of the CM##4##3##(1993-9#1)(2008-10#2)(2011-2#1)
of the CMF##2##3##(2012-12#2)
of the CMRD##2##3##(2008-2#2)
of the CMS##2##3##(1996-7#2)
of the CN##3##3##(2005-4#1)(2008-10#1)(2012-2#1)
of the CNS to##2##4##(1995-5#1)(2008-5#1)
of the CNS##34##3##(1990-3#1)(1991-12#1)(1991-2#1)(1991-3#1)(1994-9#1)(1995-12#3)(1995-5#1)(2005-7#1)(2006-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-11#2)(2008-12#2)(2008-5#4)(2008-7#6)(2009-9#1)(2010-12#2)(2011-2#1)(2013-1#2)
of the CNT##2##3##(2010-7#1)(2013-8#1)
of the CNTs##5##3##(2006-12#1)(2010-7#2)(2011-2#2)
of the CO 2 laser##2##5##(1991-3#1)(1992-3#1)
of the CO 2##3##4##(1991-3#1)(1992-3#2)
of the CO##13##3##(1991-3#1)(1991-7#1)(1992-12#1)(1992-3#2)(1992-6#1)(1994-11#1)(1996-2#1)(2006-12#1)(2007-11#1)(2008-2#2)(2008-8#1)
of the CO(2)##5##3##(2008-10#1)(2008-2#3)(2012-3#1)
of the CO-bound##2##3##(1992-12#2)
of the CO-diffusion capacity##2##4##(1992-6#2)
of the CO-stretching mode##3##4##(1992-12#3)
of the CO2 laser##2##4##(1992-10#1)(2013-8#1)
of the CO2##3##3##(1990-8#1)(1992-10#1)(2013-8#1)
of the COL1A1##2##3##(1994-2#1)(2008-9#1)
of the CONNJUR##2##3##(2012-1#2)
of the COOH-terminal domain of the##2##6##(1992-3#1)(1995-6#1)
of the COOH-terminal##7##3##(1990-2#1)(1992-3#1)(1994-12#2)(1994-9#1)(1995-3#1)(1995-6#1)
of the COP in##3##4##(1994-1#2)(2007-4#1)
of the COP procedure##2##4##(2012-12#2)
of the COP##8##3##(1994-1#2)(2007-4#2)(2008-2#1)(2009-7#1)(2012-12#2)
of the COPII##2##3##(1997-6#1)(2012-2#1)
of the COX-2##2##3##(2006-10#1)(2009-1#1)
of the COXI##2##3##(1993-2#1)(1995-6#1)
of the CP gene##7##4##(1997-6#1)(2008-10#6)
of the CP genes##3##4##(2008-10#3)
of the CP##20##3##(1997-6#2)(1997-8#1)(2005-11#1)(2008-10#15)(2008-7#1)
of the CPAx##2##3##(2012-12#2)
of the CPC##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
of the CPM##4##3##(2007-11#1)(2007-2#1)(2008-11#1)(2008-2#1)
of the CPMG##2##3##(2011-1#1)(2011-2#1)
of the CPS##2##3##(1990-7#1)(2007-7#1)
of the CPTQ##3##3##(2008-12#3)
of the CPU##2##3##(2008-3#2)
of the CR##3##3##(1993-6#1)(2009-8#1)(2010-8#1)
of the CRF##2##3##(2008-4#2)
of the CRP##4##3##(1995-8#1)(1997-6#1)(2006-7#1)(2010-12#1)
of the CS##2##3##(1995-12#1)(1996-7#1)
of the CSF##3##3##(2006-12#1)(2008-12#1)(2008-3#1)
of the CSF-1##2##3##(1991-6#1)(1993-4#1)
of the CSL molecules##2##4##(1990-2#2)
of the CT and MRI##2##5##(2007-11#2)
of the CT##9##3##(1991-12#1)(2007-11#3)(2007-7#1)(2008-4#1)(2008-7#1)(2012-2#1)(2013-8#1)
of the CTAB/water system##2##4##(2005-11#2)
of the CTL##2##3##(2008-8#2)
of the CTLL-2##2##3##(2008-4#2)
of the CTV##4##3##(2008-10#3)(2008-2#1)
of the CV##3##3##(1993-12#1)(2005-7#1)(2008-10#1)
of the CVC##3##3##(2007-7#3)
of the CVG##2##3##(1996-3#2)
of the CYP11B1 and##2##4##(1994-2#2)
of the CYP11B1##3##3##(1994-2#3)
of the CYP1A##2##3##(1992-12#2)
of the CYP1A1 gene##4##4##(1992-12#1)(1994-6#2)(1997-2#1)
of the CYP1A1##7##3##(1992-12#1)(1994-6#2)(1994-8#1)(1997-2#1)(2006-12#1)(2011-1#1)
of the CYP2A6##2##3##(2007-8#1)(2008-8#1)
of the CYP2E1##3##3##(1990-11#1)(1995-3#1)(2008-8#1)
of the CYP3A##3##3##(1994-5#1)(2011-2#2)
of the Ca##2##3##(2008-10#1)(2011-1#1)
of the Ca(2+)##5##3##(2006-10#1)(2008-11#1)(2008-4#2)(2012-2#1)
of the Ca(2+)-ATPase of sarcoplasmic reticulum##2##6##(1991-9#1)(1994-10#1)
of the Ca(2+)-ATPase of##4##4##(1991-9#1)(1993-8#1)(1994-10#2)
of the Ca(2+)-ATPase##8##3##(1991-9#3)(1992-6#2)(1993-8#1)(1994-10#2)
of the Ca(2+)-dependent##3##3##(1994-3#1)(1994-6#1)(2008-8#1)
of the Ca(2+)-independent##2##3##(1995-8#2)
of the Ca-ATPase##5##3##(1991-2#4)(1991-7#1)
of the Ca2(+)-ATPase##3##3##(1990-3#3)
of the Ca2+ channel blocker nifedipine##2##6##(1990-10#1)(1995-12#1)
of the Ca2+ channel##5##4##(1990-10#1)(1994-3#2)(1994-9#1)(1995-12#1)
of the Ca2+ pump##3##4##(1994-5#1)(1994-9#2)
of the Ca2+##19##3##(1990-10#1)(1990-12#1)(1990-2#1)(1991-5#1)(1991-8#1)(1992-1#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-9#3)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#1)(2009-3#1)
of the Ca2+/calmodulin-dependent##3##3##(1993-12#2)(1996-8#1)
of the CaG-channel##3##3##(1990-2#3)
of the CaM-BP68##2##3##(1994-5#2)
of the Caenorhabditis elegans##2##4##(1993-12#1)(1995-6#1)
of the California##6##3##(1996-3#1)(2007-9#1)(2008-10#2)(2010-8#2)
of the Canada Basin##2##4##(1994-7#2)
of the Canadian Association of##2##5##(2007-3#1)(2008-11#1)
of the Canadian C-Spine Rule##2##5##(2007-7#2)
of the Canadian Health##2##4##(2008-12#1)(2009-4#1)
of the Canadian##29##3##(1991-11#1)(1991-3#1)(1993-9#1)(1994-2#1)(1995-1#1)(1995-12#1)(2005-11#1)(2006-4#1)(2007-12#5)(2007-3#1)(2007-5#1)(2007-7#2)(2008-10#3)(2008-11#2)(2008-12#2)(2008-4#1)(2009-4#1)(2009-5#1)(2010-11#1)(2013-1#1)
of the Candida albicans##2##4##(1990-5#1)(1997-6#1)
of the Candida##5##3##(1990-5#1)(1991-9#1)(1996-11#1)(1997-6#1)(2005-8#1)
of the Cardiac##2##3##(2005-12#1)(2010-8#1)
of the Cardiovascular##2##3##(2007-12#1)(2013-7#1)
of the Care##2##3##(1995-3#1)(2010-7#1)
of the Caribbean##11##3##(2007-12#2)(2007-5#4)(2007-8#1)(2008-10#1)(2011-2#2)(2012-1#1)
of the Cartesian##3##3##(2007-9#2)(2008-3#1)
of the Catania##2##3##(1996-6#1)(2007-1#1)
of the Catholic University of Chile##2##6##(2013-1#2)
of the Catholic##5##3##(1990-6#1)(1994-1#1)(2011-2#1)(2013-1#2)
of the Catphan##3##3##(2012-1#3)
of the Catterall##2##3##(2007-7#2)
of the Cd and Pb##2##5##(2008-10#2)
of the Ce##2##3##(2007-12#1)(2013-8#1)
of the Center for##3##4##(1997-2#1)(2008-12#1)(2008-2#1)
of the Center of##2##4##(1994-1#1)(2007-8#1)
of the Center##5##3##(1994-1#1)(1997-2#1)(2007-8#1)(2008-12#1)(2008-2#1)
of the Centers for Disease Control and Prevention##3##8##(1996-1#1)(2007-12#1)(2008-10#1)
of the Centers for Disease Control and Prevention's##2##8##(1997-2#1)(2008-11#1)
of the Centers for Disease Control and##5##7##(1996-1#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)
of the Central##5##3##(1990-4#1)(1996-5#1)(2006-10#1)(2007-5#1)(2008-5#1)
of the Centre hospitalier Robert-Giffard##2##5##(2008-2#2)
of the Centre hospitalier##3##4##(2008-2#3)
of the Centre##4##3##(2008-2#4)
of the Centro##2##3##(1993-3#1)(2011-2#1)
of the Cervical##3##3##(2008-12#2)(2008-8#1)
of the Child and##2##4##(2010-1#1)(2011-1#1)
of the Child##8##3##(1992-7#1)(2008-9#2)(2010-1#1)(2011-1#4)
of the Childhood##2##3##(1995-3#1)(1995-6#1)
of the Children's##5##3##(1994-3#1)(1996-7#1)(2008-11#1)(2008-6#1)(2012-12#1)
of the Chinese Version of the Mood Disorder Questionnaire##2##9##(2011-1#2)
of the Chinese elderly##2##4##(2008-7#2)
of the Chinese hamster##2##4##(1994-12#1)(1997-7#1)
of the Chinese herbal##2##4##(2006-4#1)(2007-6#1)
of the Chinese yew##3##4##(2007-1#3)
of the Chinese##20##3##(1990-8#1)(1994-12#1)(1995-6#1)(1997-7#1)(2006-4#1)(2006-7#1)(2007-1#3)(2007-6#1)(2008-4#1)(2008-7#2)(2008-8#1)(2011-1#2)(2013-8#4)
of the Chiropractic and Osteopathic College of##2##7##(2007-11#2)
of the Chlamydia##4##3##(1991-4#1)(1991-9#1)(2008-5#1)(2008-9#1)
of the Christchurch##2##3##(2012-2#2)
of the Chrysiridia croesus moth##2##5##(2008-2#2)
of the Citrus##2##3##(2008-10#2)
of the City##2##3##(1991-12#1)(2011-2#1)
of the Cl-##2##3##(1990-2#1)(1994-5#1)
of the Clarion CII##2##4##(2008-9#2)
of the Clarion##4##3##(2008-9#4)
of the Clearinghouse##5##3##(1994-1#3)(1996-3#2)
of the Clinic##2##3##(2008-9#1)(2010-9#1)
of the Clinical##8##3##(1992-12#1)(1992-2#1)(1993-12#1)(1994-2#1)(2008-12#1)(2010-12#1)(2010-9#1)(2012-12#1)
of the Clostridium##5##3##(1991-7#1)(1995-2#1)(1997-4#1)(2006-5#1)(2008-5#1)
of the Co##2##3##(1992-2#1)(2012-11#1)
of the Co(2+)##3##3##(2008-3#3)
of the Co(II)##2##3##(1992-9#1)(2008-10#1)
of the Cobb angle##2##4##(2007-8#2)
of the Cochran approximation##2##4##(1994-8#2)
of the Cochran##3##3##(1992-9#1)(1994-8#2)
of the Cochrane##3##3##(2006-2#1)(2007-10#1)(2009-9#1)
of the Codex Alimentarius Commission##2##5##(2011-2#1)(2012-12#1)
of the Codex Alimentarius##3##4##(2011-2#1)(2012-12#2)
of the Cognitive##2##3##(1991-1#1)(2008-12#1)
of the College of American Pathologists##2##6##(1993-9#1)(1996-2#1)
of the College of##5##4##(1993-12#1)(1993-9#1)(1996-2#1)(2007-3#1)(2011-2#1)
of the College##7##3##(1993-12#1)(1993-9#1)(1996-2#1)(2007-11#1)(2007-2#1)(2007-3#1)(2011-2#1)
of the Colombian##2##3##(2007-5#1)(2012-12#1)
of the Colorado potato beetle##2##5##(2008-10#2)
of the Colorado##3##3##(2008-10#3)
of the Committee on##3##4##(1991-1#1)(1996-2#1)(2007-11#1)
of the Common##5##3##(1996-5#1)(2006-8#1)(2008-10#1)(2008-5#1)(2013-8#1)
of the Communist##2##3##(2011-2#1)(2012-2#1)
of the Comprehensive##3##3##(1996-12#1)(2011-2#1)(2012-3#1)
of the Computerized##3##3##(2010-8#1)(2013-1#2)
of the Continuous Performance Test##2##5##(1996-3#2)
of the Copenhagen Psychosocial Questionnaire##5##5##(2011-1#5)
of the Copenhagen##6##3##(2007-10#1)(2011-1#5)
of the Corn##2##3##(2008-10#1)(2013-7#1)
of the Council of##2##4##(2005-11#1)(2006-10#1)
of the Council##5##3##(1991-8#1)(1995-6#1)(2005-11#1)(2006-10#2)
of the Court of##2##4##(1993-5#1)(2011-12#1)
of the Cp##2##3##(1991-7#1)(1996-2#1)
of the CpG island##3##4##(1991-5#1)(1997-4#2)
of the CpG##5##3##(1990-5#1)(1991-5#1)(1995-2#1)(1997-4#2)
of the CpIr(CO)(PR(3)) complexes##2##4##(1996-2#2)
of the Cr##8##3##(2007-11#2)(2008-10#1)(2008-2#4)(2008-3#1)
of the Cr(4+)##2##3##(2008-3#2)
of the Cr(VI)##3##3##(2008-10#3)
of the Cr2 gene##2##4##(2008-10#2)
of the Cricket##2##3##(2005-12#1)(2008-5#1)
of the Croatian National Institute of Public Health##2##8##(2010-9#1)(2011-2#1)
of the Croatian##4##3##(2008-10#1)(2010-9#2)(2011-2#1)
of the Csfm##2##3##(1990-5#2)
of the Cu##3##3##(1993-11#1)(2007-11#1)(2012-1#1)
of the Cu(II) complex##3##4##(2008-10#1)(2008-3#2)
of the Cu(II)##5##3##(1996-8#1)(2007-8#1)(2008-10#1)(2008-3#2)
of the Cu/Zn SOD##2##4##(1996-10#2)
of the Cys residues##2##4##(1991-2#1)(1993-3#1)
of the Cys##3##3##(1990-12#1)(1991-2#1)(1993-3#1)
of the CysB protein##2##4##(1990-3#2)
of the Czech##3##3##(1990-9#1)(2005-1#1)(2012-12#1)
of the D and##2##4##(1995-3#1)(2008-10#1)
of the D##17##3##(1990-4#1)(1991-5#1)(1992-1#1)(1993-2#2)(1993-4#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-8#1)(2006-8#1)(2007-12#2)(2008-10#2)(2008-2#1)(2013-1#1)
of the D(1)##2##3##(2007-11#2)
of the D(2)##2##3##(2007-11#1)(2008-2#1)
of the D-E region##2##4##(1994-8#2)
of the D-loop region##2##4##(2009-5#2)
of the D-loop##4##3##(2008-5#1)(2008-8#1)(2009-5#2)
of the D1 dopamine receptor##2##5##(1995-11#2)
of the D1 protein##3##4##(1994-8#2)(1994-9#1)
of the D1##9##3##(1990-10#1)(1993-2#1)(1994-8#2)(1994-9#2)(1995-11#2)(2006-9#1)
of the D2 receptor##2##4##(1990-12#1)(1991-5#1)
of the D2##3##3##(1990-12#1)(1990-5#1)(1991-5#1)
of the D222A##2##3##(1992-6#2)
of the D4##2##3##(1990-5#1)(1996-11#1)
of the DA D-2 receptor agonist##2##6##(1990-2#2)
of the DA neuron##2##4##(1990-7#2)
of the DA transporter##2##4##(1996-1#2)
of the DA##14##3##(1990-2#4)(1990-7#2)(1994-12#1)(1996-1#2)(1996-10#1)(1996-12#1)(1997-5#1)(2005-8#1)(2008-1#1)
of the DAT##5##3##(1992-3#1)(1995-11#2)(1996-12#1)(1996-8#1)
of the DCC##2##3##(1992-10#1)(2007-12#1)
of the DCP-1##2##3##(2008-3#2)
of the DCT##2##3##(2008-2#2)
of the DDR##2##3##(2011-2#2)
of the DFB##2##3##(2008-3#2)
of the DFT##4##3##(2007-11#1)(2010-5#1)(2012-12#2)
of the DG##3##3##(1991-12#1)(2009-8#1)(2012-12#1)
of the DH##2##3##(2008-10#1)(2008-8#1)
of the DHFR##5##3##(1994-12#1)(1994-2#2)(1995-2#1)(1996-5#1)
of the DIAL technique##2##4##(2008-2#1)(2008-3#1)
of the DIAL##5##3##(2008-2#4)(2008-3#1)
of the DIC is##2##4##(2010-2#2)
of the DIC##3##3##(2010-2#2)(2011-1#1)
of the DLPE/POPC mixtures##4##4##(1994-3#4)
of the DM soliton##2##4##(2007-12#2)
of the DM##3##3##(2004-9#1)(2007-12#2)
of the DMN##3##3##(2012-1#2)(2013-8#1)
of the DMPC/sphingosine##2##3##(1994-3#2)
of the DMS task##2##4##(1991-3#1)(1993-2#1)
of the DNA and##2##4##(1991-2#1)(1996-4#1)
of the DNA binding domain of##3##6##(1990-11#1)(1992-7#1)(1995-2#1)
of the DNA binding domain##4##5##(1990-11#1)(1992-7#2)(1995-2#1)
of the DNA binding site for##2##6##(1991-5#1)(1992-8#1)
of the DNA binding site##3##5##(1991-5#1)(1992-8#1)(1995-10#1)
of the DNA binding##9##4##(1990-11#1)(1991-5#1)(1992-7#2)(1992-8#1)(1995-10#1)(1995-2#1)(1995-8#1)(1996-3#1)
of the DNA chain##2##4##(2006-10#1)(2012-2#1)
of the DNA double helix##2##5##(1990-2#1)(2008-10#1)
of the DNA double##3##4##(1990-2#1)(1996-2#1)(2008-10#1)
of the DNA extraction##2##4##(2012-3#2)
of the DNA fragment##3##4##(1996-11#1)(2008-4#2)
of the DNA fragments##4##4##(1995-3#1)(2008-10#2)(2008-4#1)
of the DNA helix##2##4##(1995-1#1)(1996-2#1)
of the DNA hybridization##2##4##(2008-10#2)
of the DNA ligase##2##4##(1990-6#1)(1997-7#1)
of the DNA markers##2##4##(1994-3#1)(1996-10#1)
of the DNA molecule##2##4##(1990-5#1)(2008-11#1)
of the DNA molecules##2##4##(1995-8#1)(2008-2#1)
of the DNA polymerase##6##4##(1990-12#1)(1991-7#1)(1992-3#1)(1994-9#1)(1997-6#1)(2009-8#1)
of the DNA repair##3##4##(1995-2#1)(2007-10#1)(2009-5#1)
of the DNA sequence of##2##5##(1995-3#1)(1997-7#1)
of the DNA sequence##5##4##(1994-8#1)(1995-3#1)(1997-7#1)(2007-9#1)(2008-8#1)
of the DNA sequences##3##4##(1993-6#1)(2007-12#1)(2008-10#1)
of the DNA strands##3##4##(1993-3#1)(2008-5#1)(2009-5#1)
of the DNA template##2##4##(1996-11#1)(2008-5#1)
of the DNA##118##3##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#2)(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-3#2)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#3)(1995-10#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-8#5)(1996-10#1)(1996-11#2)(1996-2#2)(1996-3#1)(1996-4#2)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#3)(2005-8#1)(2006-10#5)(2006-8#2)(2007-10#2)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#5)(2008-5#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-5#2)(2009-8#1)(2010-12#1)(2012-2#4)(2012-3#2)(2013-1#1)
of the DNA-binding domain of the##3##6##(1990-11#1)(1991-4#1)(1995-2#1)
of the DNA-binding domain of##5##5##(1990-11#2)(1991-4#1)(1995-2#1)(1995-8#1)
of the DNA-binding domain##7##4##(1990-11#3)(1991-4#1)(1993-3#1)(1995-2#1)(1995-8#1)
of the DNA-binding##8##3##(1990-11#3)(1991-4#1)(1993-3#1)(1995-2#1)(1995-8#1)(2008-2#1)
of the DNA-dependent##2##3##(1993-3#1)(1997-4#1)
of the DNA-protein##2##3##(2008-10#1)(2008-4#1)
of the DNA/protein##2##3##(1994-9#1)(1995-3#1)
of the DNB and##2##4##(1993-3#2)
of the DNB##3##3##(1993-3#3)
of the DNLL responded to tone bursts with##2##8##(1996-9#2)
of the DNLL##3##3##(1996-9#3)
of the DNR##5##3##(1992-12#1)(1996-1#4)
of the DNase##2##3##(1990-7#1)(1991-9#1)
of the DOE##2##3##(2007-12#1)(2008-3#1)
of the DPD signal##3##4##(2008-2#3)
of the DPH probe##2##4##(1990-2#1)(2008-9#1)
of the DPH2##4##3##(1993-9#4)
of the DPM##2##3##(2008-5#2)
of the DPPC##3##3##(1993-3#1)(1995-10#1)(2005-11#1)
of the DR##3##3##(1996-12#1)(2008-7#2)
of the DRG##2##3##(1992-2#1)(1994-12#1)
of the DRR206 promoter##2##4##(2008-10#2)
of the DRUJ##4##3##(2006-3#1)(2008-9#2)(2012-2#1)
of the DRUVS##2##3##(2005-4#2)
of the DSES##2##3##(2009-11#2)
of the DSM and ICD##2##5##(2006-4#2)
of the DTH response##2##4##(1991-12#1)(2008-4#1)
of the DVS##2##3##(2005-5#2)
of the Danish##6##3##(1990-12#1)(1992-5#1)(1992-8#1)(1993-8#1)(1995-5#1)(2013-7#1)
of the Danish-speaking##3##3##(1992-8#3)
of the Darcy number##3##4##(2005-11#3)
of the Data##2##3##(1990-12#1)(2012-3#1)
of the Debye approximation##2##4##(2007-12#2)
of the Deer Branch of the##2##6##(2005-7#2)
of the Delphi technique##2##4##(2007-12#1)(2013-1#1)
of the Delphi##4##3##(2007-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
of the Dengue fever vector Aedes aegypti (Diptera##2##8##(2008-5#2)
of the Department of Forensic Medicine##2##6##(2009-4#2)
of the Department of Health and Human Services##2##8##(1990-12#1)(2006-8#1)
of the Department of Health and Human##3##7##(1990-12#1)(1997-3#1)(2006-8#1)
of the Department of Health##6##5##(1990-12#1)(1991-2#1)(1992-1#1)(1997-3#1)(2006-8#1)(2011-2#1)
of the Department of Pathology at##2##6##(2006-10#1)(2009-5#1)
of the Department of##36##4##(1990-10#1)(1990-12#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1997-3#1)(1997-5#1)(2005-5#1)(2006-10#1)(2006-8#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2009-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
of the Department##40##3##(1990-10#1)(1990-12#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2005-5#1)(2006-10#1)(2006-8#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#2)(2009-5#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
of the Diagnostic and Statistical Manual of Mental Disorders##4##9##(2007-7#1)(2011-1#1)(2011-2#2)
of the Diagnostic##5##3##(2007-7#1)(2008-11#1)(2011-1#1)(2011-2#2)
of the Disease IncidencePrognostic or Predictive FactorsCurrent Therapy##2##8##(2009-4#2)
of the Disease IncidencePrognostic or Predictive FactorsCurrent##3##7##(2009-4#3)
of the Disease##10##3##(2009-4#10)
of the Diskus has##2##4##(1996-2#2)
of the Dominican Republic##2##4##(2008-10#1)(2008-5#1)
of the Doppler shift##3##4##(2007-12#2)(2008-3#1)
of the Doppler##9##3##(2006-10#1)(2007-12#4)(2008-3#4)
of the Drosophila 26S protease##2##5##(1997-7#2)
of the Drosophila melanogaster##7##4##(1991-12#1)(1993-2#1)(1993-4#1)(1993-6#2)(1994-12#1)(2012-12#1)
of the Drosophila suppressor of forked##2##6##(1995-6#2)
of the Drosophila visual system##2##5##(2007-12#1)(2008-9#1)
of the Drosophila##45##3##(1990-6#2)(1991-11#1)(1991-12#3)(1992-4#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#2)(1994-12#3)(1994-3#1)(1994-8#3)(1995-6#4)(1997-1#3)(1997-3#1)(1997-7#4)(1997-8#1)(2007-12#2)(2007-3#1)(2008-9#5)(2009-3#1)(2012-12#3)(2012-3#1)
of the Drug##3##3##(1991-3#1)(2013-1#1)(2013-7#1)
of the Duchenne muscular dystrophy gene##2##6##(1990-7#1)(1993-10#1)
of the Duchenne##3##3##(1990-7#1)(1993-10#1)(1993-4#1)
of the Duffy gene##2##4##(1996-6#2)
of the Duffy##5##3##(1993-4#3)(1996-6#2)
of the Dutch Society of##2##5##(1996-9#1)(2006-12#1)
of the Dutch Society##3##4##(1996-9#2)(2006-12#1)
of the Dutch##11##3##(1992-10#1)(1994-5#1)(1996-9#2)(1997-8#1)(2006-10#1)(2006-12#1)(2009-2#2)(2009-8#1)(2013-8#1)
of the E##33##3##(1990-11#2)(1990-3#2)(1990-5#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-9#2)(1993-12#1)(1993-3#1)(1994-2#2)(1994-7#1)(1994-9#1)(1995-11#1)(1995-4#1)(1995-8#1)(1996-7#1)(1997-2#3)(1997-7#3)(2007-11#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-3#1)
of the E1 alpha##2##4##(1990-10#2)
of the E1 beta subunit in##2##6##(1990-10#1)(1994-8#1)
of the E1 beta##3##4##(1990-10#1)(1994-8#1)(1995-1#1)
of the E1##9##3##(1990-10#3)(1990-7#1)(1991-8#2)(1994-5#1)(1994-8#1)(1995-1#1)
of the E1A##2##3##(1994-3#2)
of the E2##3##3##(1991-1#2)(2008-10#1)
of the E2F##4##3##(1995-2#2)(2012-12#2)
of the EBF2##2##3##(2009-8#2)
of the EBV##6##3##(1990-5#1)(1995-2#1)(1997-3#1)(2008-5#2)(2008-8#1)
of the ECG##6##3##(1991-3#1)(1991-5#1)(1992-3#1)(1992-6#1)(1993-8#1)(2008-4#1)
of the ECM##4##3##(2008-11#1)(2009-12#1)(2009-8#2)
of the ED##4##3##(1997-8#1)(2007-5#1)(2008-3#1)(2009-6#1)
of the EDNRB##2##3##(1994-12#1)(1996-4#1)
of the EDTA##4##3##(2008-10#3)(2008-11#1)
of the EEG##4##3##(1992-8#1)(1996-3#1)(2009-8#1)(2010-8#1)
of the EF-1 alpha##3##4##(1992-11#2)(1994-9#1)
of the EF-hand##3##3##(1991-12#1)(1992-11#1)(1995-6#1)
of the EGF receptor##6##4##(1993-8#2)(1993-9#1)(1997-6#2)(2006-10#1)
of the EGF##7##3##(1993-8#2)(1993-9#1)(1997-6#2)(2006-10#1)(2007-12#1)
of the EGF-R##3##3##(1992-9#1)(1995-1#2)
of the EGFR by##2##4##(1996-5#2)
of the EGFR gene##2##4##(1993-3#1)(2008-4#1)
of the EGFR##10##3##(1993-3#1)(1996-5#3)(2008-4#2)(2008-5#1)(2010-12#1)(2011-2#1)(2013-8#1)
of the EHR incentive program##2##5##(2013-1#2)
of the EHR##3##3##(2010-8#1)(2013-1#2)
of the EIA##2##3##(1995-2#1)(1996-1#1)
of the ELBW children##2##4##(2006-7#2)
of the ELISA and##2##4##(1992-7#1)(1997-3#1)
of the ELISA assay##2##4##(1995-2#1)(2008-7#1)
of the ELISA##13##3##(1990-12#1)(1990-2#1)(1992-7#1)(1995-2#1)(1997-3#2)(1997-7#2)(2005-8#1)(2005-9#1)(2008-4#1)(2008-7#1)(2011-2#1)
of the ELISAs##2##3##(2005-12#1)(2005-9#1)
of the EM##2##3##(2008-2#2)
of the EMG##3##3##(2005-1#1)(2008-9#1)(2013-1#1)
of the ENS##2##3##(2008-8#2)
of the ENTO##2##3##(1994-3#2)
of the EO##4##3##(2008-2#2)(2013-1#2)
of the EOF##2##3##(2007-8#1)(2008-10#1)
of the EORTC##2##3##(1992-10#1)(2008-6#1)
of the EOs##2##3##(2012-12#2)
of the EP##3##3##(1994-12#1)(2008-10#1)(2013-8#1)
of the EPO##4##3##(2007-8#1)(2008-11#2)(2008-5#1)
of the EPR signal##2##4##(1996-7#1)(1997-7#1)
of the EPR spectra##2##4##(1992-9#1)(1993-11#1)
of the EPR##6##3##(1992-9#1)(1993-11#1)(1994-12#1)(1996-7#1)(1997-7#1)(2010-4#1)
of the EPSP##9##3##(1991-8#1)(1992-8#2)(1993-12#1)(1993-2#4)(1996-6#1)
of the EQ-5D and##2##4##(2008-6#1)(2009-11#1)
of the EQ-5D##5##3##(2008-6#3)(2009-11#2)
of the ER and##2##4##(1996-2#1)(2011-2#1)
of the ER gene##2##4##(1996-11#1)(1997-4#1)
of the ER in##2##4##(1997-2#1)(2008-11#1)
of the ER retention##2##4##(2008-8#2)
of the ER##23##3##(1990-6#1)(1990-7#1)(1993-6#1)(1993-8#1)(1996-11#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#2)(2008-11#3)(2008-8#2)(2009-8#2)(2011-2#2)(2012-2#1)
of the ER-ICA assay##2##4##(1992-10#2)
of the ERBB2##2##3##(1994-6#1)(1995-8#1)
of the ERF domain##2##4##(2006-9#2)
of the ERF##4##3##(2006-9#3)(2009-8#1)
of the ERG##2##3##(2009-12#2)
of the ERK and##2##4##(2008-3#1)(2008-4#1)
of the ERK cascade##2##4##(1996-5#1)(2009-8#1)
of the ERK pathway##2##4##(2008-4#1)(2010-10#1)
of the ERK##6##3##(1996-5#1)(2008-3#1)(2008-4#2)(2009-8#1)(2010-10#1)
of the ESPU##2##3##(2008-10#2)
of the ESRF##6##3##(2006-4#3)(2006-5#3)
of the EST##2##3##(2006-12#1)(2008-7#1)
of the ET-1##2##3##(1992-3#1)(1995-11#1)
of the ETA receptor##4##4##(1992-9#3)(1994-8#1)
of the ETAAS instrument##2##4##(2008-10#2)
of the EU##7##3##(2005-5#1)(2006-2#1)(2008-10#3)(2010-5#1)(2011-2#1)
of the EXAFS##4##3##(1994-8#1)(1995-8#1)(2005-4#2)
of the Early Archean Apex##2##5##(1993-4#2)
of the Early##7##3##(1993-4#2)(2008-10#3)(2008-5#2)
of the Earth##11##3##(1994-6#1)(1997-5#1)(2008-12#1)(2008-2#1)(2008-3#7)
of the Earth's surface##3##4##(2008-2#3)
of the Earth's##7##3##(1992-1#1)(2008-2#3)(2008-3#3)
of the East##6##3##(1993-4#1)(2007-11#1)(2007-6#1)(2009-7#1)(2010-1#1)(2010-8#1)
of the Eastern##3##3##(2005-8#1)(2008-5#1)(2008-6#1)
of the Eating Disorder##2##4##(2006-7#2)
of the Eating##3##3##(2006-7#2)(2009-2#1)
of the Ebro river basin##2##5##(2008-10#2)
of the EcoRV##2##3##(1995-8#2)
of the Ecuadorian A2##2##4##(2008-10#2)
of the Ecuadorian##3##3##(2008-10#2)(2008-8#1)
of the Edge Hill##2##4##(2009-10#2)
of the Edinburgh Royal Maternity Hospital##2##6##(2008-7#2)
of the Edinger-Westphal nucleus in the rat##2##7##(1993-12#2)
of the Edinger-Westphal nucleus##4##4##(1993-12#4)
of the Editorial Board##2##4##(2005-7#2)
of the EfSTE12 gene##2##4##(2010-10#2)
of the Effect##2##3##(2008-10#1)(2008-6#1)
of the Effects of##3##4##(2008-10#3)
of the Egyptian##4##3##(2007-1#1)(2008-10#2)(2009-5#1)
of the Ehrlich##2##3##(1990-5#1)(2012-3#1)
of the Eighth Annual##2##4##(1991-1#1)(2010-3#1)
of the Eighth##5##3##(1991-1#1)(1996-11#1)(2008-9#1)(2010-3#1)(2010-6#1)
of the El##4##3##(1992-5#1)(1994-2#1)(2006-7#1)(2008-5#1)
of the Elderly##2##3##(1990-10#1)(2012-12#1)
of the Electronic Health Record##3##5##(2008-11#1)(2013-1#2)
of the Endo-Periscope##2##3##(2006-6#2)
of the English language##2##4##(2009-5#1)(2012-3#1)
of the English##5##3##(2008-11#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
of the Enterobacteriaceae##4##3##(1997-2#1)(2008-4#1)(2011-1#2)
of the Ephemeroptera##2##3##(2007-12#2)
of the EpiAir##3##3##(2010-9#3)
of the Epstein-Barr virus##3##4##(1991-7#1)(2006-12#1)(2011-2#1)
of the Er##2##3##(2008-7#1)(2013-1#1)
of the Erwinia##2##3##(1992-5#1)(2010-11#1)
of the Escherichia coli K-12##12##5##(1990-3#1)(1990-7#1)(1994-9#1)(1996-12#4)(1996-6#3)(1997-4#2)
of the Escherichia coli and##2##5##(1991-5#1)(1997-1#1)
of the Escherichia coli chromosome##4##5##(1990-7#2)(1994-12#1)(1995-2#1)
of the Escherichia coli rnpB##2##5##(1997-2#2)
of the Escherichia coli##53##4##(1990-11#1)(1990-3#1)(1990-7#4)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#2)(1992-3#1)(1992-9#1)(1993-11#1)(1993-5#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-2#4)(1995-4#1)(1995-6#1)(1995-8#1)(1996-12#4)(1996-4#1)(1996-6#3)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-4#3)(2008-4#1)(2013-1#1)
of the Ethics Committee##2##4##(2006-2#1)(2012-2#1)
of the Ethics##3##3##(2006-2#2)(2012-2#1)
of the Eu##2##3##(2006-9#1)(2008-11#1)
of the Eu(3+) ions##2##4##(2007-12#1)(2008-3#1)
of the Eu(III) bound to the FA##2##7##(2008-10#2)
of the Eu(III)##5##3##(2008-10#5)
of the Euclidean##2##3##(2008-3#1)(2011-2#1)
of the Eurasian##2##3##(2010-3#1)(2010-8#1)
of the EuroFIR NoE project##2##5##(2012-12#2)
of the European Association of##3##5##(2006-9#2)(2009-4#1)
of the European Association##4##4##(1996-3#1)(2006-9#2)(2009-4#1)
of the European Community##4##4##(1995-7#1)(2006-10#2)(2007-1#1)
of the European Medicines Agency##2##5##(2008-7#1)(2012-12#1)
of the European Medicines##3##4##(2008-7#1)(2012-12#1)(2013-7#1)
of the European Parliament and of the Council##2##8##(2005-11#1)(2006-10#1)
of the European Pharmacopoeia##3##4##(2007-8#1)(2008-10#1)(2012-12#1)
of the European Society of Cardiology##2##6##(2010-12#1)(2013-8#1)
of the European Society of Radiology##2##6##(2012-2#2)
of the European Society of##11##5##(1992-10#1)(1993-12#1)(2008-6#1)(2008-7#3)(2010-12#1)(2011-2#1)(2012-2#2)(2013-8#1)
of the European Space Agency##2##5##(2007-9#1)(2008-3#1)
of the European Synchrotron Radiation Facility##3##6##(2006-4#1)(2006-5#2)
of the European Union##5##4##(1996-11#1)(1997-6#1)(2005-11#2)(2008-10#1)
of the European part of Russia##2##6##(2009-8#1)(2011-2#1)
of the European part of##3##5##(1994-9#1)(2009-8#1)(2011-2#1)
of the European##75##3##(1990-2#1)(1991-7#2)(1992-10#1)(1993-12#1)(1994-9#1)(1995-4#1)(1995-7#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-6#3)(2005-11#3)(2005-8#1)(2006-10#4)(2006-4#1)(2006-5#2)(2006-6#1)(2006-9#2)(2007-1#3)(2007-10#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#3)
of the Eustachian tube##2##4##(1995-4#2)
of the Ewing##2##3##(2008-6#2)
of the Executive##2##3##(1996-9#1)(2008-9#1)
of the F plasmid##2##4##(1990-11#2)
of the F protein##3##4##(2007-6#1)(2008-5#2)
of the F##11##3##(1990-11#2)(1991-7#1)(1992-7#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-5#2)(2011-2#1)
of the F(1) generation were##3##5##(2008-10#3)
of the F(1)##8##3##(2008-10#8)
of the F(2)##2##3##(2008-10#2)
of the F(3)##3##3##(2008-10#3)
of the F-actin##3##3##(1993-8#1)(2008-10#1)(2010-7#1)
of the F0##2##3##(1992-11#1)(1995-3#1)
of the F0F1##2##3##(1991-9#1)(1992-11#1)
of the F1##6##3##(1990-7#1)(1991-5#1)(1995-3#1)(2005-8#1)(2011-2#1)(2013-8#1)
of the F1F0-ATP synthase##2##4##(1997-7#2)
of the F1F0-ATPase##2##3##(1994-9#2)
of the F2##2##3##(1994-8#1)(2007-6#1)
of the F3##2##3##(2008-12#2)
of the FA was##2##4##(2007-3#2)
of the FA##6##3##(1995-1#1)(2007-3#2)(2008-10#2)(2008-8#1)
of the FAB classification##2##4##(1991-2#1)(1992-10#1)
of the FAB##3##3##(1991-2#1)(1992-10#1)(2013-8#1)
of the FABP##3##3##(1993-2#1)(1994-9#2)
of the FAD##2##3##(1990-7#1)(1992-1#1)
of the FAS##2##3##(2009-8#1)(2009-9#1)
of the FB/SM mixtures##2##4##(2005-11#2)
of the FBG##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
of the FBN1 gene##6##4##(1996-3#3)(2012-2#3)
of the FCU##2##3##(2013-7#2)
of the FDA##3##3##(2013-1#2)(2013-8#1)
of the FDTD##4##3##(2008-3#4)
of the FES##2##3##(2008-2#2)
of the FFQ(CA)##2##3##(2010-12#2)
of the FG##3##3##(2008-9#2)(2012-2#1)
of the FGF family##3##4##(1993-6#1)(1994-11#1)(2008-1#1)
of the FGF##7##3##(1993-6#2)(1994-11#1)(2008-1#1)(2012-12#1)(2012-3#2)
of the FHL tendon##2##4##(2009-10#2)
of the FHL##3##3##(2009-10#2)(2012-3#1)
of the FI##3##3##(2008-10#3)
of the FIA system##3##4##(2008-10#3)
of the FIA##4##3##(1995-3#1)(2008-10#3)
of the FKNMS##2##3##(2007-5#2)
of the FLAG peptides##2##4##(1997-3#2)
of the FLC##3##3##(2008-2#3)
of the FMLP receptor molecule##2##5##(1994-3#2)
of the FMOC##2##3##(2008-10#2)
of the FMR1 gene##2##4##(2009-5#2)
of the FNR protein##2##4##(1992-3#2)
of the FNR##3##3##(1992-3#3)
of the FRET##2##3##(2007-9#1)(2008-4#1)
of the FRT##2##3##(2007-12#1)(2008-3#1)
of the FSH##2##3##(1993-12#1)(1995-11#1)
of the FSWs##2##3##(2010-8#1)(2012-3#1)
of the FTIR##2##3##(1991-10#1)(2008-10#1)
of the FTND##2##3##(2008-8#1)(2013-1#1)
of the Fab##4##3##(1993-6#1)(1995-5#3)
of the Fabry-Perot cavity##4##4##(2007-12#1)(2008-3#2)(2013-8#1)
of the Fabry-Perot##10##3##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#4)(2013-8#1)
of the Face##3##3##(2007-12#1)(2009-4#1)(2010-1#1)
of the Faculty of Dentistry at the Hebrew University##2##9##(2011-2#2)
of the Faculty of Medicine of the University of##2##9##(1994-2#1)(2009-7#1)
of the Faculty of Medicine##4##5##(1994-2#1)(2009-7#1)(2010-8#1)(2011-2#1)
of the Faculty of##7##4##(1994-2#1)(2006-10#1)(2009-7#1)(2010-8#1)(2011-2#3)
of the Faculty##8##3##(1994-2#1)(2006-10#1)(2007-2#1)(2009-7#1)(2010-8#1)(2011-2#3)
of the Family Health##2##4##(2008-9#1)(2012-12#1)
of the Family Violence Option##2##5##(2008-2#2)
of the Family##11##3##(1997-5#1)(1997-6#1)(2006-4#1)(2006-8#1)(2008-10#1)(2008-2#2)(2008-9#2)(2010-8#1)(2012-12#1)
of the Fantastic questionnaire##2##4##(2012-12#2)
of the Fas/FasL##2##3##(2009-9#1)(2010-3#1)
of the Fc gamma RIIA-H/R 131##2##6##(1996-11#2)
of the Fc##4##3##(1990-12#1)(1996-11#2)(2007-11#1)
of the Fd##2##3##(1993-6#2)
of the Fe##5##3##(1991-10#1)(2006-5#1)(2007-12#1)(2009-11#1)(2010-5#1)
of the Fe(3+)##2##3##(2008-10#1)(2008-9#1)
of the Fe(III)##2##3##(1993-3#1)(1997-7#1)
of the Fe-Fe distance##2##4##(1995-6#1)(2009-11#1)
of the Federal##8##3##(1991-3#1)(1993-1#1)(1994-2#1)(1995-1#1)(1997-2#1)(2008-6#1)(2012-3#1)(2013-8#1)
of the Fermi level##2##4##(1991-6#1)(2008-10#1)
of the Fermi##3##3##(1991-6#1)(2008-10#2)
of the Fiji##2##3##(2008-1#2)
of the Final##2##3##(2006-8#1)(2009-4#1)
of the Finnish##2##3##(1996-3#1)(2007-7#1)
of the First##6##3##(1994-7#1)(1996-2#2)(2010-6#1)(2011-2#1)(2013-1#1)
of the Flavobacterium##2##3##(1993-11#1)(1997-1#1)
of the Flex-PLI##2##3##(2006-11#2)
of the Florida##3##3##(1991-8#1)(1992-5#1)(2008-10#1)
of the Food and Drug Administration##2##6##(1997-5#1)(2008-8#1)
of the Food##8##3##(1997-5#1)(2007-1#1)(2008-10#2)(2008-8#1)(2009-2#1)(2012-1#1)(2012-2#1)
of the Form 90##3##4##(2008-6#3)
of the Fourier spectrum##2##4##(2008-2#1)(2008-3#1)
of the Fourier transform of the##2##6##(1992-9#1)(2007-12#1)
of the Fourier transform of##4##5##(1992-9#1)(2007-12#2)(2008-3#1)
of the Fourier transform##6##4##(1992-9#1)(2007-12#2)(2008-2#1)(2008-3#2)
of the Fourier##10##3##(1992-9#1)(2007-12#2)(2008-2#3)(2008-3#4)
of the Fourier-transform##2##3##(1993-6#1)(2007-12#1)
of the Fragile X##2##4##(2009-5#2)
of the Framingham##2##3##(1993-3#1)(1996-9#1)
of the Frankfurt plane##3##4##(2013-8#3)
of the Free##2##3##(1993-7#1)(2012-12#1)
of the French##13##3##(1990-8#1)(2005-5#1)(2007-2#1)(2007-3#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2010-9#2)(2011-3#1)(2012-2#1)(2012-3#1)
of the Fresnel number##2##4##(2008-2#1)(2008-3#1)
of the Fresnel##6##3##(2008-2#3)(2008-3#3)
of the FucT-VI gene##2##4##(1992-8#2)
of the Functional Assessment of Cancer##2##6##(2009-11#1)(2011-2#1)
of the Functional Movement Screen##2##5##(2011-2#2)
of the Functional##5##3##(2007-7#1)(2009-11#1)(2011-2#3)
of the Fungus##2##3##(2008-10#2)
of the Fur##2##3##(1994-5#1)(1996-4#1)
of the Fusarium graminearum##3##4##(2008-10#2)(2010-10#1)
of the Fusarium oxysporum##2##4##(2008-10#2)
of the Fusarium##7##3##(1995-2#1)(2008-10#4)(2009-3#1)(2010-10#1)
of the Future Search##2##4##(1996-3#2)
of the Fv##2##3##(1990-10#1)(1993-8#1)
of the G domain##2##4##(1990-12#2)
of the G protein##2##4##(1995-7#1)(1997-2#1)
of the G protein-coupled receptor##3##5##(1993-8#1)(1994-12#1)(1996-2#1)
of the G##12##3##(1990-12#2)(1993-1#1)(1993-8#1)(1994-12#1)(1995-7#1)(1996-2#1)(1997-2#2)(2008-11#1)(2008-5#1)(2009-4#1)
of the G- and H-helix##2##5##(1993-6#2)
of the G- and##4##4##(1993-6#4)
of the G-CSFR##6##3##(1994-11#6)
of the G-protein coupled##2##4##(1991-9#1)(1994-5#1)
of the G-protein##5##3##(1991-9#1)(1994-5#2)(1996-2#1)(2008-7#1)
of the G-protein-coupled##3##3##(1995-11#1)(1996-10#1)(2008-4#1)
of the G1 phase of##2##5##(1996-5#1)(1996-7#1)
of the G1 phase##4##4##(1996-5#1)(1996-7#1)(2007-8#1)(2008-11#1)
of the G1##6##3##(1996-10#1)(1996-5#1)(1996-7#1)(1997-7#1)(2007-8#1)(2008-11#1)
of the G1-phase##3##3##(2007-9#2)(2012-3#1)
of the G190E##2##3##(1996-7#2)
of the G6PD gene##2##4##(1991-10#1)(1991-6#1)
of the GA##6##3##(1993-12#3)(1995-1#1)(2008-2#2)
of the GABA system##2##4##(1995-11#1)(1995-5#1)
of the GABA##10##3##(1991-2#1)(1992-3#1)(1994-2#1)(1995-11#1)(1995-5#1)(1995-7#1)(1996-12#1)(1996-9#1)(1997-5#1)(2013-1#1)
of the GABA(A) receptor##3##4##(1990-7#1)(1997-5#2)
of the GABAA receptor complex##2##5##(1995-11#1)(1997-3#1)
of the GABAA receptor##6##4##(1990-10#1)(1992-8#2)(1995-11#1)(1996-10#1)(1997-3#1)
of the GABAB##2##3##(1993-12#2)
of the GABAergic##2##3##(1991-1#1)(1993-12#1)
of the GAG##4##3##(1990-12#3)(2013-8#1)
of the GAL##2##3##(1995-2#1)(1997-3#1)
of the GAL4##3##3##(1991-4#2)(1995-4#1)
of the GAP-43##3##3##(1994-2#2)(2008-7#1)
of the GAP1##2##3##(1990-5#2)
of the GAPDH##3##3##(1991-9#1)(1995-6#1)(2008-4#1)
of the GAW17 data##2##4##(2012-3#2)
of the GB virus##2##4##(2008-10#2)
of the GB##3##3##(2006-3#1)(2008-10#2)
of the GBC##2##3##(2010-12#2)
of the GC##6##3##(1993-3#1)(1993-5#1)(2008-10#3)(2008-7#1)
of the GCAP##3##3##(1996-7#3)
of the GCM##2##3##(1996-1#1)(1997-4#1)
of the GCN5 gene##2##4##(1997-3#2)
of the GDI##2##3##(1997-4#1)(2013-1#1)
of the GDP##2##3##(1993-3#1)(1996-2#1)
of the GFAP##2##3##(1997-2#1)(2011-2#1)
of the GFP##2##3##(2004-4#1)(2008-10#1)
of the GGT##2##3##(1992-9#2)
of the GH receptor##4##4##(1995-3#2)(2006-9#1)(2008-4#1)
of the GH##5##3##(1995-3#2)(2006-9#1)(2007-7#1)(2008-4#1)
of the GHQ-12##2##3##(2012-1#2)
of the GHR##2##3##(2008-4#2)
of the GI tract##4##4##(2007-5#1)(2008-12#2)(2012-1#1)
of the GI##5##3##(2007-12#1)(2007-5#1)(2008-12#2)(2012-1#1)
of the GLUT4 gene##2##4##(1995-1#2)
of the GLUT4##3##3##(1994-11#1)(1995-1#2)
of the GM##2##3##(2011-2#2)
of the GM1##2##3##(1994-8#1)(2011-1#1)
of the GM1-galactosidase##2##3##(1992-7#2)
of the GM3 was##2##4##(1990-5#2)
of the GM3##3##3##(1990-5#2)(1991-2#1)
of the GN##2##3##(1991-10#1)(2007-7#1)
of the GNP##2##3##(1991-3#1)(2013-1#1)
of the GP##4##3##(1990-6#1)(1990-7#1)(1991-9#1)(2007-12#1)
of the GP's##2##3##(1997-4#2)
of the GPi##4##3##(1996-8#3)(2012-1#1)
of the GPs##4##3##(2006-2#1)(2007-2#2)(2013-8#1)
of the GR and c-jun genes##2##6##(1996-7#2)
of the GR and##3##4##(1994-11#1)(1996-7#2)
of the GR in##2##4##(1994-11#2)
of the GR strain##2##4##(2012-3#2)
of the GR##12##3##(1994-11#5)(1996-5#1)(1996-7#2)(2008-4#1)(2010-10#1)(2012-3#2)
of the GRIN profile##3##4##(2010-4#3)
of the GRIN##4##3##(2010-4#4)
of the GRP##2##3##(1995-8#1)(1997-7#1)
of the GST##5##3##(1990-2#1)(1993-11#1)(1994-2#1)(2009-11#2)
of the GTP##2##3##(1990-7#1)(1996-5#1)
of the GTP-binding proteins##3##4##(1991-12#1)(1992-11#1)(1993-9#1)
of the GTP-binding##7##3##(1990-3#1)(1990-7#1)(1991-11#1)(1991-12#1)(1992-11#1)(1993-9#1)(2008-4#1)
of the GTPase##3##3##(1992-11#1)(1992-8#1)(1997-7#1)
of the GTS1 gene##3##4##(1997-6#3)
of the GUS gene##3##4##(1997-2#2)(2006-12#1)
of the GUS##5##3##(1997-2#2)(2006-12#2)(2012-2#1)
of the GaAs##4##3##(2007-12#1)(2008-2#3)
of the GaHV-2##2##3##(2013-8#2)
of the Gaussian beam##2##4##(2008-3#2)
of the Gaussian field##2##4##(2008-3#2)
of the Gaussian mirror spot size##2##6##(2008-2#2)
of the Gaussian##11##3##(2008-10#1)(2008-2#5)(2008-3#5)
of the Gene Ontology project##2##5##(2008-9#2)
of the Gene Ontology##6##4##(2008-7#4)(2008-9#2)
of the General Health Questionnaire (GHQ 20)##2##7##(2008-1#2)
of the General Health Questionnaire##3##5##(2008-1#2)(2008-3#1)
of the General##7##3##(1992-5#1)(1996-7#1)(2008-1#2)(2008-3#1)(2010-12#1)(2012-2#1)
of the Genetic Analysis Workshop 17 data##4##7##(2012-3#4)
of the Genetic Analysis Workshop 17##9##6##(2012-3#9)
of the Genetic##10##3##(2008-10#1)(2012-3#9)
of the Genome##2##3##(2008-10#1)(2008-4#1)
of the Genomic##41##3##(2011-2#41)
of the Genus##4##3##(2008-10#3)(2010-2#1)
of the Georgia##3##3##(1996-12#2)(2010-12#1)
of the Geriatric Depression Scale (GDS)##3##6##(2006-10#2)(2007-9#1)
of the German Health##2##4##(2009-7#1)(2012-2#1)
of the German Society of##5##5##(1993-4#1)(1997-4#1)(2005-11#1)(2007-9#1)(2012-2#1)
of the German##17##3##(1993-4#1)(1997-4#1)(1997-8#1)(2005-11#4)(2005-7#1)(2007-11#1)(2007-9#1)(2008-8#1)(2009-7#2)(2012-2#3)(2013-8#1)
of the Gi##2##3##(1990-3#1)(2008-4#1)
of the Gibbs##3##3##(1993-6#1)(1997-2#1)(2006-10#1)
of the Global##7##3##(1995-10#1)(2006-10#1)(2008-2#1)(2008-4#1)(2009-6#1)(2010-5#1)(2011-1#1)
of the Glu##2##3##(1992-3#1)(1994-9#1)
of the Glu-50--&gt##2##3##(1995-6#2)
of the GluR delta 2##3##5##(1996-4#3)
of the GnRH##2##3##(1995-11#1)(1996-8#1)
of the Golden##2##3##(1991-6#1)(1992-10#1)
of the Golgi apparatus##5##4##(1991-1#1)(1993-12#1)(2007-9#3)
of the Golgi complex in##2##5##(1990-12#1)(1994-9#1)
of the Golgi complex##7##4##(1990-12#3)(1994-9#1)(2008-7#3)
of the Golgi##16##3##(1990-12#3)(1991-1#1)(1992-12#1)(1993-12#2)(1994-9#1)(2007-9#3)(2008-11#1)(2008-7#3)(2012-2#1)
of the Gompertz##2##3##(1993-12#1)(2008-1#1)
of the Gouy##2##3##(2007-11#1)(2007-12#1)
of the Gouy-Chapman theory##2##4##(1990-11#1)(1991-9#1)
of the Government##3##3##(1995-3#2)(2008-5#1)
of the Gr##2##3##(1990-5#2)
of the Gram-negative##2##3##(2006-5#1)(2007-7#1)
of the Great##6##3##(2008-10#1)(2009-7#1)(2013-1#2)(2013-8#2)
of the Greater##3##3##(1993-9#1)(2008-3#2)
of the Green's function##2##4##(2008-3#2)
of the Greenlandic-speaking##3##3##(1992-8#3)
of the GroEL##3##3##(1994-5#1)(1994-9#1)(1996-4#1)
of the Group Environment Questionnaire##2##5##(2013-7#2)
of the Group##4##3##(1997-7#1)(2008-11#1)(2013-7#2)
of the Gulf of California##4##5##(2007-5#3)(2008-5#1)
of the Gulf of Tehuantepec##2##5##(2008-5#2)
of the Gulf of##10##4##(2007-5#7)(2008-5#3)
of the Gulf##12##3##(1997-4#1)(2007-5#7)(2008-5#3)(2012-2#1)
of the Gurrieri syndrome##2##4##(1996-3#2)
of the Gus##2##3##(1993-8#2)
of the H##13##3##(1990-9#1)(1992-11#2)(1993-2#1)(1994-11#1)(1996-10#1)(1996-11#1)(1997-6#1)(2008-10#4)(2008-11#1)
of the H(+)-ATPase from Saccharomyces cerevisiae##2##6##(1990-12#1)(1994-9#1)
of the H(+)-ATPase##7##3##(1990-12#1)(1990-3#2)(1992-11#1)(1992-6#1)(1994-9#1)(2006-8#1)
of the H(2)O##2##3##(2008-2#1)(2008-3#1)
of the H-2Kk##3##3##(1991-8#3)
of the H-NHase gene##4##4##(1996-4#4)
of the H-Wave(R) device##3##4##(2010-1#3)
of the H-point standard##2##4##(2008-10#2)
of the H-point##3##3##(2008-10#3)
of the H1 and##3##4##(1992-9#2)(1996-6#1)
of the H1##5##3##(1992-11#1)(1992-9#2)(1993-6#1)(1996-6#1)
of the H2##2##3##(1991-9#1)(1992-9#1)
of the H2(80) Se##2##4##(2005-4#2)
of the H2A##3##3##(1994-9#2)(2009-5#1)
of the H2O##3##3##(1990-7#1)(1991-4#1)(2005-11#1)
of the H2O2 detoxifying enzymes##2##5##(1997-7#2)
of the H2O2##3##3##(1990-1#1)(1997-7#2)
of the H3##2##3##(1992-3#1)(1996-6#1)
of the HA##10##3##(1992-9#1)(2004-9#2)(2008-10#2)(2008-5#3)(2010-8#1)(2011-2#1)
of the HA-PEO hydrogel##2##4##(2008-5#2)
of the HA1 gene were##2##5##(1994-8#2)
of the HA1 gene##3##4##(1994-8#3)
of the HA1##4##3##(1994-8#3)(1997-6#1)
of the HACEK group##2##4##(2007-12#1)(2007-7#1)
of the HAs##2##3##(2008-10#1)(2008-5#1)
of the HBV genome##2##4##(1993-12#1)(1997-4#1)
of the HBV##4##3##(1993-12#1)(1997-4#2)(2007-12#1)
of the HBX protein##3##4##(2008-8#3)
of the HCV##4##3##(1996-2#1)(2006-10#1)(2008-8#1)(2013-1#1)
of the HD##5##3##(1995-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2010-8#1)
of the HDAC inhibitor##3##4##(2007-11#1)(2012-12#2)
of the HDC##2##3##(1997-1#2)
of the HDE gene##3##4##(1991-8#3)
of the HDL##2##3##(2008-3#1)(2008-4#1)
of the HDL(3)##2##3##(1996-5#2)
of the HER2##3##3##(1993-1#1)(1995-2#1)(2009-9#1)
of the HERG##2##3##(1996-2#1)(2008-8#1)
of the HGF gene##3##4##(1990-11#2)(1991-6#1)
of the HII phase and##2##5##(1990-12#2)
of the HII##3##3##(1990-12#2)(2012-3#1)
of the HIPAA privacy rule##2##5##(2005-8#1)(2007-12#1)
of the HIPAA privacy##3##4##(2005-8#1)(2006-8#1)(2007-12#1)
of the HIS3##2##3##(1997-4#2)
of the HIV epidemic in the##2##6##(1995-1#1)(2012-3#1)
of the HIV epidemic in##4##5##(1990-12#1)(1995-1#1)(2012-12#1)(2012-3#1)
of the HIV epidemic##12##4##(1990-12#1)(1992-9#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-11#1)(2006-10#1)(2007-7#1)(2010-5#2)(2012-12#1)(2012-3#1)
of the HIV infected##2##4##(1993-12#1)(1993-8#1)
of the HIV##31##3##(1990-12#2)(1991-5#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-11#1)(1997-5#1)(1997-6#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-4#2)(2010-5#2)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)
of the HIV-1 envelope##3##4##(1994-8#1)(1997-4#2)
of the HIV-1 long terminal repeat (LTR)##2##7##(1991-5#1)(1994-8#1)
of the HIV-1 long terminal repeat##3##6##(1991-5#2)(1994-8#1)
of the HIV-1 replication cycle##4##5##(1996-1#1)(2011-3#3)
of the HIV-1##19##3##(1991-3#1)(1991-5#2)(1993-12#1)(1994-8#2)(1994-9#1)(1995-8#1)(1996-1#1)(1997-4#3)(1997-6#1)(2008-11#1)(2008-2#1)(2011-3#3)(2013-1#1)
of the HIV-2##2##3##(1996-4#2)
of the HIV-positive##3##3##(1993-8#1)(1996-5#1)(2010-8#1)
of the HIV/AIDS##3##3##(1994-2#1)(1996-11#1)(2007-7#1)
of the HM##2##3##(2008-10#1)(2008-2#1)
of the HMG box##3##4##(1993-2#1)(1996-7#1)(2008-8#1)
of the HMG##4##3##(1993-2#2)(1996-7#1)(2008-8#1)
of the HMG2 gene##3##4##(1995-2#3)
of the HMO##4##3##(1991-1#2)(1993-3#1)(1994-12#1)
of the HN##2##3##(2007-6#1)(2008-11#1)
of the HO-1##2##3##(1995-2#1)(2010-12#1)
of the HOOK##2##3##(2008-8#2)
of the HPA axis in##3##5##(1995-12#3)
of the HPA axis##15##4##(1994-2#2)(1995-12#8)(2006-10#1)(2007-11#2)(2008-4#1)(2011-2#1)
of the HPA##17##3##(1994-11#1)(1994-2#2)(1995-12#9)(2006-10#1)(2007-11#2)(2008-4#1)(2011-2#1)
of the HPAA##2##3##(1994-11#2)
of the HPE##2##3##(1996-12#2)
of the HPI##2##3##(1996-2#2)
of the HPLC assay##2##4##(1997-3#2)
of the HPLC method was##2##5##(1996-6#1)(2008-10#1)
of the HPLC method##4##4##(1996-6#1)(2008-10#2)(2008-6#1)
of the HPLC##7##3##(1996-6#1)(1996-8#1)(1997-3#2)(2008-10#2)(2008-6#1)
of the HPSAM##2##3##(2008-10#2)
of the HPSP##2##3##(2012-3#2)
of the HR##2##3##(2008-11#1)(2013-8#1)
of the HRP-rotating biosensor##2##4##(2008-10#2)
of the HSA##3##3##(1996-1#2)(2008-10#1)
of the HSC niche##2##4##(2008-9#2)
of the HSP##4##3##(1993-4#1)(1994-11#1)(2012-3#2)
of the HSP70 family##2##4##(1994-6#1)(2006-8#1)
of the HSP70##5##3##(1994-6#1)(1996-2#1)(2006-8#1)(2008-10#1)(2012-3#1)
of the Haemophilus influenzae##4##4##(1996-10#1)(2007-2#1)(2008-11#1)(2008-7#1)
of the Hall technique##3##4##(2013-1#3)
of the Hall##4##3##(1993-3#1)(2013-1#3)
of the Hamilton##2##3##(1996-2#1)(1997-3#1)
of the Hartmann test##2##4##(2008-3#2)
of the Hartmann##3##3##(2008-2#1)(2008-3#2)
of the Hartmanngram##2##3##(2008-3#2)
of the Harvard##3##3##(1990-11#1)(2010-5#1)(2013-1#1)
of the Haversian canals##2##4##(1995-6#1)(2013-1#1)
of the HbE mutation##2##4##(1990-7#2)
of the HeLa##2##3##(1997-4#1)(2008-11#1)
of the HeNe##2##3##(2007-12#2)
of the Health Care Financing Administration##2##6##(1991-1#1)(1997-2#1)
of the Health Care Financing##9##5##(1991-1#1)(1992-2#1)(1994-12#1)(1996-1#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#1)
of the Health Care Quality Improvement##2##6##(1991-1#1)(1993-2#1)
of the Health Care Quality##3##5##(1991-1#1)(1993-2#1)(1996-2#1)
of the Health Care##14##4##(1991-1#2)(1992-2#1)(1993-2#1)(1994-1#1)(1994-12#1)(1996-1#1)(1996-2#3)(1996-3#2)(1997-2#1)(1997-3#1)
of the Health Centers##2##4##(2008-9#2)
of the Health Level##3##4##(2013-1#3)
of the Health Plan Employer Data##2##6##(1996-3#1)(1997-2#1)
of the Health Plan##3##4##(1995-1#1)(1996-3#1)(1997-2#1)
of the Health and##2##4##(2004-12#1)(2011-2#1)
of the Health##31##3##(1990-8#1)(1991-1#2)(1992-2#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#1)(1996-1#1)(1996-2#3)(1996-3#3)(1997-2#2)(1997-3#1)(2004-12#1)(2006-2#1)(2007-10#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-9#2)(2011-2#1)(2013-1#3)
of the Healthcare Information Management Department##2##6##(2007-12#2)
of the Healthcare##3##3##(2007-12#2)(2008-9#1)
of the Heat##2##3##(2008-3#1)(2008-5#1)
of the Helmholtz equation##2##4##(2007-12#1)(2008-3#1)
of the Hematology and Oncology##2##5##(2008-9#2)
of the Hematology and##3##4##(2008-9#3)
of the Hg##3##3##(2007-11#1)(2008-10#2)
of the HiRIS##2##3##(2008-10#2)
of the Hibiscus rosa-sinensys##2##4##(2008-10#2)
of the High##3##3##(1993-4#1)(2012-12#2)
of the Hip##2##3##(2007-11#1)(2012-12#1)
of the History of Medicine##2##5##(1994-2#1)(1995-12#1)
of the Holy##4##3##(1993-12#1)(2013-8#3)
of the Hospital##3##3##(2010-12#1)(2013-8#2)
of the Hox gene##2##4##(2007-12#1)(2008-1#1)
of the Hox##5##3##(2007-12#2)(2008-1#1)(2010-12#1)(2011-12#1)
of the Hsp70##3##3##(1991-9#1)(1995-4#1)(2009-5#1)
of the Ht1 gene##3##4##(2008-10#3)
of the Ht1##4##3##(2008-10#4)
of the Hubble Space Telescope##4##5##(2008-2#3)(2008-3#1)
of the Hubble##6##3##(2006-7#2)(2008-2#3)(2008-3#1)
of the Human Genome Project##3##5##(1990-6#1)(2007-3#1)(2008-4#1)
of the Human Genome##5##4##(1990-6#1)(1994-9#1)(2007-3#1)(2008-4#2)
of the Human##14##3##(1990-6#1)(1994-9#1)(2005-8#1)(2006-11#3)(2007-3#1)(2007-4#1)(2008-11#1)(2008-4#3)(2009-10#1)(2010-2#1)
of the Hungarian##3##3##(1993-1#1)(1997-6#1)(2005-8#1)
of the Hv145SV##2##3##(2008-10#2)
of the Hybrid III and##2##5##(2006-11#1)(2007-4#1)
of the Hybrid III is##2##5##(2006-11#2)
of the Hybrid III##8##4##(2006-11#5)(2007-4#3)
of the Hydrogen##2##3##(1991-8#1)(2008-10#1)
of the Hydrolight##4##3##(2008-2#1)(2008-3#3)
of the I (ATP)##2##4##(2008-4#2)
of the I##8##3##(1996-8#2)(2006-5#1)(2008-4#2)(2012-11#2)(2013-1#1)
of the I'-form of deoxyMb##2##5##(1994-11#2)
of the I'-form##3##3##(1994-11#3)
of the IA##2##3##(1992-8#1)(2012-2#1)
of the IA-1##3##3##(1997-7#3)
of the IABP##2##3##(2010-8#2)
of the IAC##3##3##(2008-10#3)
of the IAM##2##3##(1996-6#2)
of the IAP##2##3##(1990-5#1)(2007-8#1)
of the IAR##2##3##(2012-2#2)
of the IC##3##3##(1990-7#1)(2008-10#2)
of the ICA##6##3##(1997-3#1)(2005-5#1)(2005-9#1)(2007-9#1)(2012-3#1)(2013-1#1)
of the ICD##2##3##(1994-3#1)(2006-12#1)
of the ICE##2##3##(1995-8#1)(1996-5#1)
of the ICU environment##2##4##(1992-2#2)
of the ICU##7##3##(1992-2#4)(1995-12#1)(1996-9#1)(2013-8#1)
of the IFN##2##3##(1994-9#1)(2008-11#1)
of the IGF-I receptor##2##4##(1990-9#1)(1991-5#1)
of the IGF-I##4##3##(1990-9#1)(1991-5#1)(1995-10#1)(2008-11#1)
of the IGF-II gene##3##4##(1992-9#2)(1994-9#1)
of the IGF-II##4##3##(1992-9#2)(1994-9#1)(2008-6#1)
of the IIA##3##3##(1992-2#1)(1995-1#2)
of the IKVAV peptide##3##4##(1995-5#3)
of the IKVAV##4##3##(1995-5#4)
of the IL-1##3##3##(1990-9#1)(1993-11#1)(1996-12#1)
of the IL-11 gene##4##4##(1994-12#4)
of the IL-11 mRNA##4##4##(1994-12#4)
of the IL-11##9##3##(1994-12#9)
of the IL-13##2##3##(2007-2#1)(2012-2#1)
of the IL-2 receptor##2##4##(1995-8#1)(2004-12#1)
of the IL-2##4##3##(1994-11#1)(1995-8#1)(1996-5#1)(2004-12#1)
of the IL-6 receptor##3##4##(1990-5#1)(1992-6#1)(1994-2#1)
of the IL-6##10##3##(1990-5#2)(1992-6#2)(1994-2#1)(1995-2#1)(1996-2#2)(1996-5#1)(2009-6#1)
of the IL-8##2##3##(1993-6#1)(1996-5#1)
of the ILR1-like family##2##4##(2008-7#2)
of the ILS##2##3##(2008-10#1)(2008-3#1)
of the IN subtype##2##4##(2008-2#2)
of the INM##2##3##(2011-2#2)
of the IOP##2##3##(2008-3#1)(2013-8#1)
of the IOR##2##3##(1997-4#1)(2008-2#1)
of the IP3 receptor##2##4##(1995-3#2)
of the IP3##3##3##(1991-2#1)(1995-3#2)
of the IP3-sensitive Ca2+ store##2##5##(1993-8#2)
of the IP3-sensitive Ca2+##3##4##(1991-10#1)(1993-8#2)
of the IPT##2##3##(2007-8#2)
of the IPr(Me) ligand##2##4##(2010-5#2)
of the IR absorption##2##4##(2005-4#1)(2007-11#1)
of the IR##10##3##(1993-5#1)(1994-11#1)(2005-4#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)
of the IRMA##2##3##(2009-11#2)
of the ISE##2##3##(2008-10#2)
of the ISEs##4##3##(2008-10#4)
of the ISFET##2##3##(2008-10#2)
of the ISO gene##2##4##(1990-11#2)
of the ISO##4##3##(1990-11#2)(2007-1#1)(2008-2#1)
of the ITFDE##2##3##(1993-12#2)
of the ITS and##3##4##(1997-5#1)(2008-10#1)(2010-3#1)
of the ITS region##6##4##(2008-10#4)(2009-2#1)(2010-3#1)
of the ITS##14##3##(1997-5#1)(2008-10#10)(2009-2#1)(2010-3#2)
of the IVC##8##3##(2007-8#2)(2008-7#1)(2011-2#3)(2013-1#2)
of the IVD##2##3##(2005-8#1)(2012-2#1)
of the IVF patients had##2##5##(1990-2#2)
of the IVF##3##3##(1990-2#2)(1995-7#1)
of the IX nerve##2##4##(1991-9#2)
of the Icelandic Heart Association##3##5##(2006-8#3)
of the Icelandic Heart##4##4##(2006-8#4)
of the Icelandic population##4##4##(2006-10#2)(2006-8#2)
of the Icelandic##12##3##(2006-10#5)(2006-8#7)
of the Id##2##3##(1994-12#1)(1994-3#1)
of the IgA##3##3##(1994-8#1)(2007-11#1)(2008-10#1)
of the IgE##2##3##(2004-12#1)(2010-5#1)
of the IgG##10##3##(1990-12#2)(1992-7#1)(1992-8#1)(1994-11#1)(1994-3#1)(1994-9#1)(2007-10#1)(2008-1#1)(2008-11#1)
of the IgG-binding##2##3##(1994-11#1)(1996-12#1)
of the Ih##2##3##(1995-7#1)(1997-4#1)
of the IleRS##2##3##(1994-9#2)
of the Ilizarov apparatus##2##4##(2007-11#2)
of the Ilizarov method in the treatment of##2##8##(2007-8#2)
of the Ilizarov method##3##4##(2007-8#2)(2008-8#1)
of the Ilizarov##6##3##(2007-11#2)(2007-8#2)(2008-4#1)(2008-8#1)
of the Impact of##4##4##(2008-1#1)(2008-10#1)(2010-2#1)(2010-8#1)
of the Implementation of##2##4##(2008-10#1)(2008-12#1)
of the Implementation##3##3##(1996-1#1)(2008-10#1)(2008-12#1)
of the InSb detectors##2##4##(2008-2#1)(2008-3#1)
of the InSb##3##3##(2008-2#2)(2008-3#1)
of the IncP##2##3##(1990-4#1)(1990-9#1)
of the Indian Ocean##2##4##(2006-7#2)
of the Indian##14##3##(1992-12#1)(1994-8#1)(1997-8#1)(2006-12#1)(2006-2#1)(2006-7#2)(2008-10#2)(2008-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
of the Indiana##2##3##(2004-11#1)(2008-6#1)
of the Infant##2##3##(2008-6#1)(2010-5#1)
of the Information##2##3##(1991-9#1)(2011-2#1)
of the Initiative##2##3##(1995-3#1)(1996-12#1)
of the Ins(1##6##3##(1990-11#1)(1990-7#1)(1991-2#1)(1991-3#1)(1994-12#1)(1994-5#1)
of the Institut##2##3##(1992-9#1)(2008-11#1)
of the Institute for##2##4##(2008-5#1)(2013-7#1)
of the Institute of##6##4##(1990-2#1)(1996-4#1)(2006-5#2)(2007-11#1)(2012-2#1)
of the Institute##11##3##(1990-2#1)(1991-11#1)(1996-4#1)(2006-5#2)(2007-11#1)(2008-10#1)(2008-5#1)(2010-1#1)(2012-2#1)(2013-7#1)
of the Instituto##3##3##(1997-2#1)(2013-1#1)(2013-7#1)
of the Intensive Care##2##4##(2011-2#1)(2013-8#1)
of the Interaction Between##3##4##(2008-10#2)(2008-5#1)
of the Internal##3##3##(2008-10#2)(2013-8#1)
of the International Association for##2##5##(2006-8#2)
of the International Classification of##3##5##(1994-3#1)(1997-8#1)(2012-12#1)
of the International Organization for Standardization##2##6##(2005-5#1)(2011-2#1)
of the International Physical Activity Questionnaire##3##6##(2011-1#2)(2012-3#1)
of the International Society for##7##5##(2007-12#1)(2007-7#1)(2008-12#1)(2008-5#2)(2009-11#1)(2011-2#1)
of the International Society of##6##5##(1996-6#1)(2005-8#2)(2008-5#1)(2010-11#1)(2011-2#1)
of the International Society on Thrombosis and Haemostasis##2##8##(1993-6#1)(1996-2#1)
of the International Society##15##4##(1993-6#1)(1996-2#1)(1996-6#1)(2005-8#2)(2007-12#1)(2007-7#1)(2008-12#1)(2008-5#3)(2009-11#1)(2010-11#1)(2011-2#2)
of the International Standards##2##4##(2007-11#2)
of the International Task Force for Disease Eradication##2##8##(1993-12#2)
of the International##57##3##(1990-11#2)(1991-12#1)(1991-5#1)(1993-12#2)(1993-6#1)(1994-3#1)(1996-2#1)(1996-6#1)(1997-8#1)(2005-5#1)(2005-8#2)(2006-2#2)(2006-8#2)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-11#1)(2009-4#1)(2010-10#1)(2010-11#1)(2011-1#4)(2011-12#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
of the Internet and##2##4##(1994-3#1)(2008-11#1)
of the Internet##10##3##(1994-12#1)(1994-3#1)(1996-2#1)(2004-10#1)(2006-6#3)(2008-11#1)(2008-6#1)(2009-5#1)
of the Inverness Blood Grouping System##2##6##(1994-6#2)
of the Iowa##3##3##(1997-1#1)(2008-10#1)(2009-2#1)
of the Iranian version of##2##5##(2012-11#2)
of the Island##2##3##(2008-1#1)(2011-2#1)
of the Israeli##2##3##(2008-10#1)(2013-1#1)
of the Istituto##2##3##(1991-12#1)(2010-4#1)
of the Italian Association of##3##5##(1990-8#1)(1991-6#1)(2012-2#1)
of the Italian NEO-PI-R##2##4##(2008-11#2)
of the Italian Society of Cancerology##2##6##(1990-8#1)(1991-6#1)
of the Italian Society of##4##5##(1990-8#1)(1991-6#1)(2007-1#1)(2011-2#1)
of the Italian Society##5##4##(1990-8#1)(1991-6#1)(2007-1#1)(2011-2#2)
of the Italian version of the##2##6##(2011-2#1)(2013-8#1)
of the Italian##28##3##(1990-3#1)(1990-8#2)(1991-6#2)(1991-8#1)(1992-9#1)(1993-11#1)(2007-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-6#2)(2008-7#3)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-8#1)
of the JCV##2##3##(1997-1#2)
of the JDs##2##3##(1993-8#2)
of the JNK pathway##4##4##(2008-1#4)
of the JNK##5##3##(1995-6#1)(2008-1#4)
of the JPR##2##3##(2007-12#2)
of the Jackson Hole Group##3##5##(1993-12#1)(1994-1#2)
of the Jacobian matrix##2##4##(2008-3#1)(2008-9#1)
of the Japanese Society of Internal Medicine##2##7##(2009-12#1)(2012-11#1)
of the Japanese Society of##6##5##(1994-12#1)(2009-12#2)(2010-1#1)(2012-11#2)
of the Japanese beetle##2##4##(2007-12#2)
of the Japanese##25##3##(1994-12#1)(1995-2#1)(1995-4#1)(2005-3#1)(2007-12#2)(2008-1#1)(2008-5#1)(2008-6#2)(2009-12#3)(2010-1#3)(2011-1#2)(2011-3#1)(2012-1#3)(2012-11#2)(2013-7#1)
of the Jebsen-Taylor##2##3##(2007-10#1)(2011-1#1)
of the Joint Commission##2##4##(1993-2#1)(1996-2#1)
of the Joint National##2##4##(1996-9#2)
of the Joint##6##3##(1993-2#2)(1996-2#1)(1996-9#2)(2008-8#1)
of the Jones##3##3##(2008-2#2)(2008-3#1)
of the Journal of the##2##5##(2007-11#1)(2008-3#1)
of the Journal of##12##4##(2007-11#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-4#1)(2009-10#1)(2009-8#2)(2011-2#2)
of the Journal##18##3##(1994-3#1)(1997-1#1)(2006-11#1)(2007-11#1)(2007-2#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-8#2)(2011-2#2)(2011-4#1)
of the K##5##3##(1994-11#2)(1997-2#1)(1997-7#2)
of the K(+) channel##2##4##(2006-10#1)(2008-4#1)
of the K+ channel##2##4##(1991-1#1)(1997-7#1)
of the K+##5##3##(1990-12#1)(1991-1#1)(1991-11#1)(1997-4#1)(1997-7#1)
of the KDR##4##3##(1992-9#1)(1994-11#3)
of the KMSKS##3##3##(1994-9#3)
of the KP theory##2##4##(2009-9#2)
of the KP##3##3##(2009-6#1)(2009-9#2)
of the KRAS##2##3##(2011-2#1)(2012-12#1)
of the Kalman filter##2##4##(2008-2#1)(2008-3#1)
of the Kazal##2##3##(1994-5#1)(1996-6#1)
of the Keck##3##3##(2008-3#3)
of the Keggin complex##2##4##(2005-11#1)(2010-5#1)
of the Keggin##5##3##(2005-11#4)(2010-5#1)
of the Ki##2##3##(1992-8#1)(1997-1#1)
of the Ki-67##3##3##(2004-9#2)(2013-8#1)
of the Kidney##3##3##(2006-9#1)(2007-2#1)(2008-4#1)
of the Kingdom of##2##4##(2007-7#1)(2008-10#1)
of the Kingdom##5##3##(2007-3#2)(2007-7#1)(2008-1#1)(2008-10#1)
of the Kirchhoff##3##3##(2007-11#1)(2008-3#2)
of the Kjeldahl method##2##4##(2008-10#2)
of the Km##2##3##(1990-11#1)(2008-5#1)
of the Knee##4##3##(2010-12#1)(2013-1#3)
of the Korean##3##3##(2008-10#1)(2009-3#1)(2010-12#1)
of the Kromoscopic##2##3##(2008-3#2)
of the Ku##2##3##(1995-1#2)
of the Kubelka-Munk##2##3##(2008-10#1)(2008-3#1)
of the Kumba Health District##3##5##(2007-2#1)(2007-7#2)
of the Kunitz-type##2##3##(1991-11#1)(1992-7#1)
of the Kv1##2##3##(1996-2#1)(1996-5#1)
of the L##9##3##(1992-1#1)(1992-8#1)(1993-7#1)(1995-5#1)(2008-10#4)(2011-2#1)
of the L-5##2##3##(2006-8#2)
of the L-A dsRNA virus##3##5##(1997-3#3)
of the L-A##4##3##(1997-3#4)
of the L-L##2##3##(1993-8#1)(2007-8#1)
of the L-arginine##2##3##(1997-7#1)(2005-1#1)
of the L-arginine-nitric oxide pathway##2##5##(1993-3#1)(1995-12#1)
of the L-type calcium channel##2##5##(1993-7#1)(1995-3#1)
of the L-type calcium##3##4##(1993-7#1)(1995-3#1)(2004-11#1)
of the L-type##5##3##(1990-8#1)(1993-7#1)(1995-3#2)(2004-11#1)
of the L1 and##2##4##(2008-5#1)(2011-2#1)
of the L1##5##3##(1991-11#1)(1996-11#1)(1997-2#1)(2008-5#1)(2011-2#1)
of the L15 gene##2##4##(1992-2#1)(1994-5#1)
of the L2##2##3##(2008-3#1)(2011-2#1)
of the L3##2##3##(1991-11#1)(1992-8#1)
of the L4##4##3##(1995-9#1)(2006-8#1)(2008-7#1)(2011-2#1)
of the L5##2##3##(2007-11#2)
of the LA and##2##4##(2005-8#1)(2008-2#1)
of the LA##3##3##(2005-8#2)(2008-2#1)
of the LAD##2##3##(2006-6#1)(2013-1#1)
of the LATEBLIGHT Model##3##4##(2008-10#3)
of the LC##2##3##(1993-2#1)(2008-2#1)
of the LCAL##2##3##(2008-2#2)
of the LCAT gene##2##4##(1991-7#2)
of the LCD##2##3##(2008-2#1)(2010-9#1)
of the LD##4##3##(1992-3#1)(2007-11#1)(2008-3#1)(2010-4#1)
of the LDL receptor##7##4##(1990-7#4)(1993-10#1)(1995-6#1)(2008-6#1)
of the LDL##15##3##(1990-7#4)(1991-6#2)(1993-10#1)(1993-6#1)(1994-3#2)(1995-5#1)(1995-6#1)(1996-5#1)(1996-6#1)(2008-6#1)
of the LE model##4##4##(2008-10#4)
of the LEAP##2##3##(1996-3#2)
of the LEC##2##3##(1990-11#1)(1993-12#1)
of the LED##3##3##(2008-3#2)(2012-12#1)
of the LES##2##3##(2011-2#1)(2013-8#1)
of the LG##2##3##(2008-10#2)
of the LH receptor##2##4##(1995-10#2)
of the LH##6##3##(1994-6#1)(1995-10#2)(1995-2#1)(2009-10#2)
of the LH/hCG receptor##2##4##(1990-10#1)(1995-8#1)
of the LHR##2##3##(1996-5#2)
of the LIBS##2##3##(2006-12#1)(2008-2#1)
of the LIDT of##2##4##(2008-3#2)
of the LIF calibration##2##4##(2008-2#2)
of the LII##2##3##(2008-3#2)
of the LIMA##2##3##(2007-8#2)
of the LIN-12/Notch##2##3##(2007-12#2)
of the LIP proteins##2##4##(1990-12#1)(1991-8#1)
of the LIPWP##2##3##(2006-4#2)
of the LITA graft were##2##5##(2007-8#2)
of the LITA graft##3##4##(2007-8#3)
of the LOV##2##3##(2008-10#1)(2011-12#1)
of the LP##2##3##(2006-8#1)(2008-6#1)
of the LP(11) mode##4##4##(2007-11#1)(2007-12#3)
of the LPIA##4##3##(2008-3#4)
of the LPL gene##3##4##(1993-3#2)(1994-11#1)
of the LPL##4##3##(1993-3#2)(1994-11#2)
of the LPP##2##3##(1992-1#1)(2008-5#1)
of the LPS-induced##2##3##(1993-4#1)(2008-8#1)
of the LTR##3##3##(1991-5#2)(1994-8#1)
of the LV##2##3##(2009-4#1)(2012-2#1)
of the La##2##3##(1995-1#1)(2008-5#1)
of the Laboratory##2##3##(2005-12#1)(2011-1#1)
of the Lac repressor##2##4##(1996-8#2)
of the LamB protein##2##4##(1994-5#2)
of the Lambda##2##3##(1994-2#1)(2008-10#1)
of the Lang-Kobayashi##2##3##(2007-11#1)(2007-12#1)
of the Langmuir isotherm##2##4##(1991-7#1)(2008-10#1)
of the Langmuir##4##3##(1991-7#1)(1994-5#1)(2008-10#2)
of the Langmuir-Blodgett##2##3##(2005-11#1)(2007-12#1)
of the Laplace##2##3##(2008-2#1)(2012-1#1)
of the Latex beads##3##4##(2008-6#3)
of the Latin##3##3##(2007-10#1)(2010-10#1)(2012-2#1)
of the Laue##2##3##(2006-4#1)(2006-5#1)
of the Leaves##2##3##(2008-8#1)(2011-2#1)
of the Lebanese##2##3##(2008-9#2)
of the Leishmania genus##2##4##(2013-1#2)
of the Leishmania##5##3##(1994-9#1)(2005-8#1)(2008-8#1)(2013-1#2)
of the Leydig##2##3##(1990-6#1)(2009-10#1)
of the LiF##2##3##(2008-3#2)
of the LifeSite##2##3##(2007-7#2)
of the Listening to Mothers II##2##6##(2008-9#2)
of the Literature##18##3##(1997-3#1)(2005-5#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
of the Liver##3##3##(2009-3#1)(2009-8#2)
of the LnDOTP(5)(-)##2##3##(1997-7#2)
of the Local Sanitary##2##4##(1994-6#2)
of the Local##4##3##(1994-6#2)(2007-1#1)(2008-10#1)
of the London##2##3##(2008-11#1)(2012-2#1)
of the Lower##2##3##(2008-4#1)(2013-8#1)
of the Lublin##2##3##(2007-11#1)(2007-7#1)
of the Lung##5##3##(2007-10#1)(2008-5#1)(2010-8#2)(2013-1#1)
of the Lys residues##3##4##(1991-8#2)(1995-6#1)
of the Lys##4##3##(1990-8#1)(1991-8#2)(1995-6#1)
of the M RNA##2##4##(2008-10#2)
of the M##24##3##(1993-12#1)(1994-11#2)(1994-12#1)(1995-5#1)(1997-3#2)(1997-4#2)(1997-6#1)(2006-6#1)(2007-2#1)(2008-10#3)(2008-3#3)(2008-5#2)(2008-7#1)(2009-3#1)(2009-6#1)(2010-8#1)
of the M(2)##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
of the M-D##2##3##(2008-2#2)
of the M1##2##3##(1992-10#1)(2013-8#1)
of the M2 proteins##2##4##(2011-1#2)
of the M2##5##3##(1990-2#1)(2007-12#1)(2008-2#1)(2011-1#2)
of the M2(D)##2##3##(2008-8#2)
of the M3##3##3##(1994-3#1)(2007-10#1)(2013-1#1)
of the MA and##3##4##(2008-10#2)(2008-3#1)
of the MAC##3##3##(2008-4#2)(2012-3#1)
of the MADS##2##3##(1997-8#2)
of the MADS-box genes##2##4##(2012-2#2)
of the MAFF##2##3##(2005-5#2)
of the MAP kinase family##3##5##(1996-3#1)(1996-4#1)(2008-4#1)
of the MAP kinase##7##4##(1995-2#1)(1995-8#1)(1996-3#2)(1996-4#1)(1997-6#1)(2008-4#1)
of the MAP##11##3##(1995-2#1)(1995-6#1)(1995-8#1)(1996-3#2)(1996-4#1)(1996-5#1)(1997-4#1)(1997-6#1)(2006-7#1)(2008-4#1)
of the MAPK cascade##3##4##(1995-1#1)(1995-2#1)(2009-8#1)
of the MAPK signaling cascades##4##5##(2008-1#2)(2008-2#2)
of the MAPK##11##3##(1995-1#1)(1995-2#1)(2008-1#2)(2008-2#2)(2009-8#3)(2013-8#2)
of the MARCKS family##2##4##(1996-5#2)
of the MAb##2##3##(1992-12#1)(1997-2#1)
of the MC##5##3##(1997-8#1)(2007-11#2)(2007-3#1)(2012-2#1)
of the MCA was##2##4##(2007-10#2)
of the MCA##8##3##(2006-11#1)(2007-10#4)(2007-9#1)(2008-12#2)
of the MCF-7##3##3##(1994-12#1)(2008-11#1)(2008-5#1)
of the MCMC##2##3##(2009-12#1)(2012-7#1)
of the MCP's##2##3##(2008-3#2)
of the MDC peptide##4##4##(1997-4#4)
of the MDCK and the dog##2##6##(1995-11#2)
of the MDCK##3##3##(1995-11#2)(2008-11#1)
of the MDM##2##3##(2008-3#1)(2008-9#1)
of the MDM2 gene##2##4##(1994-12#2)
of the MDM2##3##3##(1994-12#3)
of the MDR1 and##2##4##(2007-10#2)
of the MDR1 gene##3##4##(1994-3#1)(2008-11#2)
of the MDR1##7##3##(1994-3#1)(1994-5#1)(2007-10#3)(2008-11#2)
of the MDV genome##2##4##(2007-6#1)(2013-8#1)
of the MED-EL##2##3##(2008-9#2)
of the MELAS and##2##4##(1991-4#1)(2006-11#1)
of the MET##2##3##(2009-4#1)(2012-1#1)
of the MFS##3##3##(1994-1#2)(2011-1#1)
of the MGMT##2##3##(1992-3#2)
of the MHC class I##2##5##(2008-4#2)
of the MHC class##3##4##(1992-4#1)(2008-4#2)
of the MHC##10##3##(1992-4#1)(1995-5#1)(1995-8#1)(1997-6#1)(1997-9#1)(2007-11#1)(2008-4#4)
of the MI##2##3##(1991-4#1)(2008-5#1)
of the MIB1##2##3##(1997-7#2)
of the MIC##2##3##(2012-2#2)
of the MIQ-RS##2##3##(2008-10#2)
of the MIS##2##3##(1993-12#1)(1995-11#1)
of the MLL##3##3##(1996-10#1)(2011-3#2)
of the MLR##3##3##(1991-11#2)(1991-3#1)
of the MM##2##3##(1991-8#1)(2009-8#1)
of the MMA##3##3##(2005-9#1)(2008-12#2)
of the MMDM##2##3##(2008-3#2)
of the MMPs##2##3##(1997-2#1)(2011-2#1)
of the MMRPE##2##3##(2013-1#2)
of the MONICA##2##3##(2006-10#1)(2006-8#1)
of the MP##3##3##(1991-9#1)(2008-9#2)
of the MR##5##3##(2007-11#1)(2008-10#1)(2010-12#1)(2011-1#1)(2011-2#1)
of the MRC##2##3##(2006-7#1)(2012-3#1)
of the MRI##4##3##(2007-11#1)(2008-2#1)(2011-2#1)(2012-12#1)
of the MRP encoded protein P190##2##6##(2008-11#2)
of the MRP##4##3##(2008-11#3)(2008-3#1)
of the MRP/GS-X pump##2##4##(2008-11#2)
of the MRSA##2##3##(2009-3#1)(2011-2#1)
of the MS was##2##4##(2008-3#2)
of the MS##13##3##(2008-10#2)(2008-3#9)(2009-3#1)(2012-3#1)
of the MSP-2 gene##2##4##(2006-4#2)
of the MT gene##2##4##(1997-2#2)
of the MT isoforms##3##4##(2008-10#3)
of the MT##7##3##(1997-2#2)(2008-10#5)
of the MTAS-treated microsomes##2##4##(1991-9#2)
of the MTC test##3##4##(2008-7#3)
of the MTHFR gene is##2##5##(1996-6#1)(2007-10#1)
of the MTX##4##3##(1996-11#3)(2008-11#1)
of the MUC1##2##3##(1991-7#1)(1992-5#1)
of the MVB group##2##4##(2007-7#2)
of the MYC##2##3##(2009-2#1)(2011-2#1)
of the Maillard reaction##2##4##(1991-5#1)(1994-6#1)
of the Malassezia spp##2##4##(2008-5#1)(2011-2#1)
of the Male##2##3##(1996-3#1)(2007-12#1)
of the Man alpha 1----2Man alpha glycosidic linkage##2##8##(1990-2#2)
of the Man##3##3##(1990-1#1)(1990-2#2)
of the Management##3##3##(1993-12#1)(2011-2#2)
of the Marek's disease##2##4##(2013-8#2)
of the Markov chain##2##4##(2008-7#1)(2010-2#1)
of the Markov model##2##4##(2008-6#1)(2008-8#1)
of the Markov##5##3##(2007-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-2#1)
of the Maslach Burnout Inventory##2##5##(2008-10#1)(2008-11#1)
of the Massachusetts serotype##2##4##(2008-5#2)
of the Massachusetts##22##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-12#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-7#1)(2008-5#2)
of the McGill##3##3##(2008-6#1)(2009-12#1)(2011-2#1)
of the MeOH##2##3##(2006-12#1)(2008-11#1)
of the Mechanism##2##3##(2008-4#1)(2008-6#1)
of the Meckel's diverticulum##3##4##(2012-2#3)
of the Medicaid##4##3##(1991-3#1)(1994-2#1)(1996-1#1)(1997-2#1)
of the Medical Research Council's##2##5##(1996-3#1)(2008-7#1)
of the Medical University in##2##5##(2007-11#1)(2007-8#1)
of the Medical University of##3##5##(2006-11#1)(2008-7#1)(2009-4#1)
of the Medical University##5##4##(2006-11#1)(2007-11#1)(2007-8#1)(2008-7#1)(2009-4#1)
of the Medical##20##3##(1996-1#1)(1996-3#1)(2006-11#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-7#2)(2008-9#1)(2009-4#1)(2013-1#4)(2013-8#2)
of the Medicare and Medicaid##3##5##(1991-12#2)(1996-3#1)
of the Medicare fee schedule (MFS)##2##6##(1994-1#1)(1996-1#1)
of the Medicare fee schedule##4##5##(1993-3#1)(1994-1#2)(1996-1#1)
of the Medicare hospice benefit##2##5##(1991-3#1)(1994-12#1)
of the Medicare payment system##2##5##(1992-12#1)(2007-4#1)
of the Medicare payment##3##4##(1992-12#1)(2007-4#2)
of the Medicare population##2##4##(1993-12#1)(1995-12#1)
of the Medicare program##3##4##(1991-1#1)(1995-2#1)(2007-4#1)
of the Medicare prospective payment system##3##6##(1991-3#1)(1992-1#1)(1993-12#1)
of the Medicare##32##3##(1990-12#2)(1991-1#1)(1991-12#2)(1991-3#2)(1992-1#1)(1992-12#2)(1993-12#2)(1993-3#2)(1994-1#3)(1994-12#3)(1994-3#1)(1995-12#2)(1995-2#2)(1996-1#1)(1996-3#1)(2007-2#1)(2007-4#3)(2008-6#1)
of the Mediterranean diet##2##4##(2010-12#1)(2012-12#1)
of the Mediterranean seagrass Posidonia oceanica to##2##7##(2013-1#2)
of the Mediterranean##10##3##(1996-11#1)(2007-6#1)(2008-10#2)(2010-1#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
of the Medtronic##2##3##(2006-7#1)(2006-8#1)
of the Member##2##3##(2008-10#1)(2011-2#1)
of the Memphis Business Group on Health##2##7##(1994-12#2)
of the Mental##2##3##(1991-6#1)(2010-12#1)
of the Metabolic Syndrome##2##4##(2008-3#1)(2013-1#1)
of the Metropolitan##2##3##(2008-5#1)(2013-1#1)
of the Mexican Society of##2##5##(2008-10#2)
of the Mexican##14##3##(1991-9#1)(1993-6#1)(2007-5#3)(2008-10#3)(2008-5#3)(2011-1#2)(2011-2#1)
of the Mg2+##2##3##(1990-5#1)(1992-3#1)
of the Mi##2##3##(1995-11#2)
of the Michaelis constant##2##4##(1990-5#1)(2007-6#1)
of the Michaelis##3##3##(1990-5#1)(1994-8#1)(2007-6#1)
of the Michelson interferometer##4##4##(2008-2#4)
of the Michelson##6##3##(2008-2#4)(2008-3#2)
of the Michigan##2##3##(2005-12#1)(2012-2#1)
of the Mid Staffordshire##2##4##(2013-8#2)
of the Middle Ages##2##4##(2007-10#1)(2008-10#1)
of the Middle East##3##4##(2006-12#1)(2007-2#1)(2009-2#1)
of the Middle##6##3##(2006-12#1)(2007-10#1)(2007-2#1)(2008-10#1)(2009-2#1)(2013-1#1)
of the Milky Way##2##4##(1997-5#1)(2007-9#1)
of the Millennium Development Goals (MDGs)##2##6##(2008-8#1)(2010-12#1)
of the Millennium Development Goals##3##5##(2008-8#1)(2010-12#1)(2010-5#1)
of the Mini-Mental##2##3##(2007-3#1)(2008-7#1)
of the Ministry of Health (MOH)##2##6##(1991-6#1)(2011-2#1)
of the Ministry of Health##6##5##(1991-6#1)(2006-4#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
of the Ministry of##10##4##(1991-3#1)(1991-6#1)(2005-12#1)(2005-5#1)(2006-4#1)(2008-10#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
of the Ministry##11##3##(1991-3#1)(1991-6#1)(1995-4#1)(2005-12#1)(2005-5#1)(2006-4#1)(2008-10#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
of the Minnesota##2##3##(1990-2#1)(2008-9#1)
of the Mississippi##2##3##(2007-10#1)(2008-10#1)
of the Mn##3##3##(1994-12#1)(1996-7#1)(2007-8#1)
of the Mn(II)##2##3##(1996-7#2)
of the Monte Carlo technique##2##5##(2008-2#1)(2008-3#1)
of the Monte Carlo##4##4##(2008-2#3)(2008-3#1)
of the Montreal Protocol##3##4##(1992-3#1)(1992-4#1)(1996-1#1)
of the Mood Disorder Questionnaire##3##5##(2011-1#2)(2011-2#1)
of the Mos##2##3##(1994-8#2)
of the Mount##2##3##(1991-12#1)(2005-10#1)
of the Mueller matrix for##2##5##(2007-11#1)(2009-5#1)
of the Mueller matrix##10##4##(2007-11#2)(2008-2#3)(2008-3#3)(2009-5#2)
of the Mueller##11##3##(2007-11#2)(2008-2#4)(2008-3#3)(2009-5#2)
of the Multidimensional 10 Commandments Questionnaire (M10CQ)##2##7##(2008-12#2)
of the Multidimensional##4##3##(2006-1#1)(2008-12#2)(2012-2#1)
of the Multinational##2##3##(2008-7#2)
of the Municipal Forest##2##4##(2008-5#2)
of the Municipal##5##3##(1993-1#1)(1997-5#1)(2007-8#1)(2008-5#2)
of the Mycobacterium##4##3##(1992-12#1)(2008-7#1)(2008-8#1)(2011-1#1)
of the N gene##2##4##(2008-10#2)
of the N terminus##3##4##(1990-10#1)(1995-6#1)(2008-10#1)
of the N##13##3##(1990-10#1)(1994-5#1)(1995-6#1)(1997-7#2)(2008-10#5)(2008-4#1)(2008-5#2)
of the N- and C-terminal##2##5##(1990-10#1)(1992-6#1)
of the N- and##3##4##(1990-10#1)(1992-6#1)(1994-11#1)
of the N-CAM gene##2##4##(1994-3#2)
of the N-glycan##2##3##(2008-11#1)(2008-4#1)
of the N-glycosylation##2##3##(1993-9#1)(2006-12#1)
of the N-linked oligosaccharides##2##4##(1993-11#1)(1997-4#1)
of the N-linked##6##3##(1993-11#1)(1993-8#1)(1996-7#1)(1997-4#1)(2008-11#1)(2008-7#1)
of the N-methyl group##2##4##(1996-8#2)
of the N-methyl-D-aspartate (NMDA) receptor antagonist##2##6##(1990-4#1)(1992-8#1)
of the N-methyl-D-aspartate (NMDA) receptor##5##5##(1990-4#1)(1992-1#1)(1992-8#2)(1997-2#1)
of the N-methyl-D-aspartate (NMDA)##9##4##(1990-4#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-8#2)(1997-2#2)(1997-8#1)
of the N-methyl-D-aspartate receptor subunit##2##5##(1995-3#1)(1997-2#1)
of the N-methyl-D-aspartate receptor##5##4##(1994-8#1)(1995-3#1)(1996-8#1)(1997-2#1)(1997-4#1)
of the N-methyl-D-aspartate##16##3##(1990-4#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-8#2)(1994-8#1)(1995-12#1)(1995-3#1)(1996-8#1)(1997-2#3)(1997-4#1)(1997-8#1)
of the N-myc oncogene##2##4##(1996-12#2)
of the N-myc protein##3##4##(1996-2#3)
of the N-myc##6##3##(1996-12#2)(1996-2#3)(1997-7#1)
of the N-myristoylation##2##3##(1997-6#2)
of the N-protecting group##2##4##(2007-11#2)
of the N-terminal blocking group##2##5##(1996-7#2)
of the N-terminal domain of##6##5##(2006-6#1)(2008-9#1)(2009-7#3)(2011-1#1)
of the N-terminal domain##11##4##(1992-9#2)(1993-3#1)(1995-3#1)(2006-6#1)(2008-4#1)(2008-9#1)(2009-7#3)(2011-1#1)
of the N-terminal extracellular domain of##2##6##(1992-9#1)(1995-12#1)
of the N-terminal methionine##2##4##(1994-11#2)
of the N-terminal portion##2##4##(1990-7#1)(1994-6#1)
of the N-terminal region of##2##5##(1994-11#1)(2009-7#1)
of the N-terminal region##4##4##(1992-1#1)(1994-11#1)(1996-3#1)(2009-7#1)
of the N-terminal sequence##2##4##(1990-12#1)(1991-7#1)
of the N-terminal##68##3##(1990-12#1)(1990-7#4)(1991-1#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-7#2)(1992-1#1)(1992-2#1)(1992-5#1)(1992-8#2)(1992-9#3)(1993-3#2)(1994-11#4)(1994-12#3)(1994-3#2)(1994-6#1)(1995-1#2)(1995-12#1)(1995-3#2)(1995-5#2)(1995-8#1)(1996-11#2)(1996-3#1)(1996-7#2)(1997-2#2)(1997-6#2)(1997-8#2)(2005-7#1)(2006-6#2)(2008-10#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#6)(2011-1#1)(2011-2#1)
of the N-terminus of the##2##5##(1990-2#2)
of the N-terminus of##5##4##(1990-2#2)(1991-9#1)(1996-7#1)(1997-9#1)
of the N-terminus##9##3##(1990-2#2)(1990-7#1)(1991-8#1)(1991-9#1)(1992-8#1)(1993-11#1)(1996-7#1)(1997-9#1)
of the N2 adsorption##2##4##(2005-11#2)
of the N2##3##3##(2005-11#2)(2008-11#1)
of the NAC##3##3##(1996-5#2)(2011-1#1)
of the NAD radical##2##4##(1990-2#2)
of the NADH##8##3##(1993-11#1)(1994-11#1)(1994-12#2)(1995-3#2)(2008-11#1)(2010-5#1)
of the NADPH oxidase in##2##5##(1990-2#1)(1990-5#1)
of the NADPH oxidase##7##4##(1990-2#1)(1990-5#1)(1992-7#1)(1995-4#1)(1996-2#2)(2012-12#1)
of the NADPH-dependent##2##3##(1990-11#1)(1997-2#1)
of the NAc##3##3##(2008-7#3)
of the NB##2##3##(1991-9#1)(2008-3#1)
of the NBM##2##3##(1992-8#1)(1993-3#1)
of the NC strip##2##4##(2008-10#2)
of the NC##5##3##(1996-7#2)(2006-12#1)(2008-10#2)
of the NCI##2##3##(2005-10#1)(2008-7#1)
of the NCM##2##3##(2006-1#1)(2010-3#1)
of the ND6 mRNA##2##4##(1994-10#2)
of the NDs##2##3##(2009-2#2)
of the NEO##2##3##(1997-4#1)(2008-11#1)
of the NF-kappa B##5##4##(1995-1#2)(1995-3#2)(1995-8#1)
of the NF1 gene##3##4##(1994-2#2)(1996-12#1)
of the NGF##2##3##(1992-8#1)(1993-11#1)
of the NH2##2##3##(1994-9#2)
of the NH2-terminal##6##3##(1990-6#2)(1994-8#1)(1996-5#1)(1996-8#1)(1997-1#1)
of the NH2-terminus##2##3##(1997-7#1)(2008-8#1)
of the NHC##2##3##(2010-5#1)(2013-8#1)
of the NHS##7##3##(1993-10#1)(2005-9#1)(2008-4#1)(2008-7#1)(2013-1#1)(2013-8#2)
of the NILs##6##3##(2008-10#6)
of the NIMH##5##3##(1997-5#5)
of the NIRS##2##3##(2007-9#1)(2008-10#1)
of the NIST##2##3##(2008-10#1)(2008-3#1)
of the NK-1##2##3##(1995-5#1)(2008-7#1)
of the NK1 receptor##2##4##(1992-10#1)(1997-4#1)
of the NK1##5##3##(1992-10#4)(1997-4#1)
of the NMDA R1##2##4##(1994-9#1)(1996-3#1)
of the NMDA receptor in the##2##6##(1994-8#1)(2010-12#1)
of the NMDA receptor##30##4##(1990-2#2)(1991-6#2)(1991-9#2)(1992-3#1)(1992-6#3)(1993-12#2)(1994-6#1)(1994-8#4)(1995-12#1)(1995-5#1)(1996-1#3)(1996-2#3)(1996-8#1)(1997-2#1)(2008-7#1)(2008-8#1)(2010-12#1)
of the NMDA receptors##3##4##(1993-11#1)(2008-3#1)(2012-12#1)
of the NMDA##41##3##(1990-2#2)(1991-11#1)(1991-6#2)(1991-9#3)(1992-3#1)(1992-6#3)(1993-11#1)(1993-12#2)(1993-4#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-1#3)(1996-12#1)(1996-2#3)(1996-3#1)(1996-8#1)(1997-2#1)(1997-8#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-12#1)
of the NMDA/R1 receptor subunit##2##5##(1995-12#2)
of the NMDAR1##2##3##(1995-3#1)(1996-1#1)
of the NMR data##2##4##(1992-11#1)(1995-1#1)
of the NMR properties##2##4##(1994-5#1)(1995-1#1)
of the NMR##8##3##(1992-11#1)(1994-5#1)(1995-1#2)(1995-3#1)(2006-11#1)(2008-10#1)(2009-9#1)
of the NNB##2##3##(2012-11#2)
of the NO##10##3##(1993-12#1)(1993-6#1)(1994-8#1)(1995-5#2)(1997-6#2)(2006-8#1)(2008-2#1)(2011-2#1)
of the NOESY spectra##2##4##(1991-11#1)(1996-7#1)
of the NOM##2##3##(1992-5#1)(2008-3#1)
of the NOS##4##3##(1993-6#1)(1995-6#1)(2008-10#2)
of the NOS-3##2##3##(2007-10#2)
of the NOS-positive##2##3##(1992-8#1)(1997-6#1)
of the NOS2 gene##2##4##(1996-2#2)
of the NPC##11##3##(1993-6#3)(2011-2#8)
of the NPP##2##3##(2008-4#2)
of the NPY gene##3##4##(1992-12#3)
of the NPY##4##3##(1991-2#1)(1992-12#3)
of the NR1 subunits##2##4##(1996-3#1)(2008-3#1)
of the NR1##3##3##(1996-3#1)(2008-3#1)(2010-12#1)
of the NR2 subunit##2##4##(1996-8#2)
of the NS##2##3##(2007-7#1)(2010-7#1)
of the NS3##2##3##(2008-10#1)(2012-2#1)
of the NS5B##2##3##(2012-2#1)(2013-1#1)
of the NSAIDs##3##3##(2005-8#1)(2007-12#1)(2008-3#1)
of the NSAIDs?]##3##3##(2007-12#2)(2008-3#1)
of the NTP##2##3##(2007-2#1)(2009-3#1)
of the NTPDase##2##3##(2008-4#2)
of the NTRC receiver domain##2##5##(1995-1#2)
of the NTRC##3##3##(1995-1#3)
of the NTS##7##3##(1992-3#1)(1992-9#2)(1997-5#4)
of the NW##3##3##(2009-2#3)
of the NZVA##2##3##(2005-7#2)
of the Na channel##3##4##(1991-9#1)(1994-8#2)
of the Na##15##3##(1990-3#1)(1991-9#1)(1992-11#4)(1992-9#1)(1994-8#4)(1994-9#4)
of the Na(+)##2##3##(2006-10#1)(2008-10#1)
of the Na(+)-H+ antiport systems##2##5##(1992-5#2)
of the Na(+)-H+##4##3##(1992-5#3)(1992-7#1)
of the Na(+)/Ca(2+)##2##3##(2008-8#2)
of the Na+ binding site##2##5##(1997-1#1)(1997-7#1)
of the Na+##8##3##(1992-12#1)(1994-12#1)(1995-12#1)(1996-1#1)(1997-1#1)(1997-7#1)(1997-8#1)(2006-9#1)
of the Na+/H(+)-antiporter by dimethylamiloride or##2##6##(1990-3#1)(1991-5#1)
of the Na+/H(+)-antiporter##6##3##(1990-3#3)(1991-5#3)
of the Na+/H+ antiporter##4##4##(1990-2#2)(1990-7#1)(1995-6#1)
of the Na+/H+ exchanger in human platelets##2##7##(1991-4#1)(1991-9#1)
of the Na+/H+ exchanger##8##4##(1991-4#1)(1991-9#2)(1992-4#1)(1997-7#3)(2005-8#1)
of the Na+/H+##14##3##(1990-2#2)(1990-7#1)(1991-3#1)(1991-4#1)(1991-9#2)(1992-4#1)(1994-3#1)(1995-6#1)(1997-7#3)(2005-8#1)
of the Na+/K(+)-ATPase##7##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1991-2#1)(1994-12#1)
of the Na-ASP-2 vaccine##2##4##(2006-10#2)
of the NaPi-2##2##3##(1994-9#2)
of the Nafion/MV##2##3##(2008-10#2)
of the Nagasaki atomic bombing##2##5##(2004-11#2)
of the Naples##2##3##(1993-5#2)
of the Nation##3##3##(1990-12#1)(1996-2#1)(2008-11#1)
of the Nation's output##2##4##(1990-12#1)(1992-12#1)
of the Nation's##6##3##(1990-12#1)(1992-12#1)(1992-3#1)(1993-3#1)(1995-3#1)(2008-6#1)
of the National Association##2##4##(1992-3#1)(2009-4#1)
of the National Cancer Institute##4##5##(1991-3#1)(1993-6#1)(2008-10#1)(2012-3#1)
of the National Health Service (NHS)##2##6##(2011-2#1)(2013-1#1)
of the National Health Service##3##5##(2008-12#1)(2011-2#1)(2013-1#1)
of the National Health##6##4##(1997-3#1)(2007-7#1)(2008-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
of the National Heart##2##4##(1996-6#1)(2007-10#1)
of the National Institute of Neurological Disorders and Stroke (NINDS)##2##10##(2007-10#1)(2007-9#1)
of the National Institute of Neurological Disorders and Stroke##3##9##(2007-10#1)(2007-9#1)(2011-2#1)
of the National Institute of Obstetrics and Gynecology on the##2##10##(1991-3#2)
of the National Institute of##9##5##(1991-3#2)(2006-9#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-7#1)(2009-9#1)(2011-2#1)
of the National Institutes of##2##5##(1994-2#1)(2008-7#1)
of the National Library of Medicine##3##6##(1992-2#1)(1995-1#1)(2010-4#1)
of the National Library of Medicine's##2##6##(1993-3#1)(2012-2#1)
of the National Library of##5##5##(1992-2#1)(1993-3#1)(1995-1#1)(2010-4#1)(2012-2#1)
of the National Longitudinal Study of Adolescent Health##2##8##(2009-10#1)(2010-10#1)
of the National Nutrition##2##4##(1995-1#1)(2008-4#1)
of the National Plan##2##4##(2007-7#1)(2013-1#1)
of the National Practitioner Data Bank##3##6##(1990-12#2)(2007-3#1)
of the National Science##2##4##(1997-6#1)(2007-9#1)
of the National Survey of##2##5##(2008-2#1)(2009-5#1)
of the National##87##3##(1990-12#3)(1991-12#1)(1991-3#3)(1992-2#1)(1992-3#1)(1993-3#2)(1993-6#1)(1994-2#1)(1995-1#2)(1995-11#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-3#2)(1997-6#4)(1997-7#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-10#4)(2007-11#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-9#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#2)(2008-7#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#7)(2013-7#1)
of the Navier-Stokes##2##3##(1992-1#1)(2008-3#1)
of the Nd##7##3##(1994-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)
of the Nd(3+)##2##3##(2007-11#1)(2008-3#1)
of the Neisseria meningitidis##2##4##(1997-5#1)(2008-12#1)
of the Neotropical##2##3##(2007-3#1)(2008-5#1)
of the Nervous System##2##4##(2008-2#1)(2009-5#1)
of the Netherlands##10##3##(1991-8#2)(1992-2#2)(1993-5#1)(1993-8#2)(1996-3#1)(2008-10#1)(2010-8#1)
of the Network of##2##4##(1991-3#1)(2011-12#1)
of the Network##3##3##(1991-3#1)(2008-3#1)(2011-12#1)
of the Neurospora crassa##2##4##(1990-11#1)(1995-8#1)
of the Neurospora##4##3##(1990-11#1)(1995-8#1)(2011-1#2)
of the New World Sciurus##2##5##(2008-5#2)
of the New World##3##4##(2008-5#2)(2011-2#1)
of the New York State##2##5##(1992-8#1)(1996-2#1)
of the New York##7##4##(1990-3#1)(1991-12#1)(1992-8#1)(1994-12#1)(1996-2#1)(2008-8#1)(2011-2#1)
of the New Zealand Intensive Medicines Monitoring Programme##2##8##(2008-11#1)(2008-8#1)
of the New Zealand Veterinary Journal##4##6##(2005-7#4)
of the New Zealand Veterinary##5##5##(2005-7#5)
of the New Zealand cot death study##2##7##(1991-2#2)
of the New Zealand##11##4##(1991-2#2)(1997-4#1)(2005-7#6)(2008-11#1)(2008-8#1)
of the New##24##3##(1990-3#1)(1991-12#1)(1991-2#2)(1992-8#1)(1994-1#1)(1994-12#1)(1996-2#1)(1997-4#1)(2005-7#6)(2006-12#2)(2008-11#1)(2008-5#2)(2008-8#2)(2011-2#2)
of the Ni##2##3##(1994-11#1)(2008-10#1)
of the NiFe##2##3##(1992-12#2)
of the Nordic##2##3##(2008-10#1)(2011-4#1)
of the North American Spine Society##2##6##(2006-12#1)(2007-10#1)
of the North American Symptomatic Carotid Endarterectomy Trial##2##8##(2006-11#1)(2008-7#1)
of the North American##14##4##(1994-3#1)(1995-2#1)(1996-5#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#1)(2010-3#1)(2011-2#1)(2013-7#1)
of the North##17##3##(1994-3#1)(1995-2#1)(1996-5#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#1)(2010-3#1)(2011-2#2)(2012-12#1)(2013-7#1)
of the Northern##11##3##(1996-12#1)(1996-3#1)(2008-1#5)(2008-10#1)(2011-1#1)(2013-8#2)
of the Norwegian Medical Association##2##5##(1990-6#1)(1997-6#1)
of the Norwegian population##3##4##(1990-6#2)(1992-11#1)
of the Norwegian##15##3##(1990-5#2)(1990-6#3)(1992-11#1)(1993-8#1)(1994-6#1)(1995-4#1)(1996-1#1)(1996-6#1)(1996-9#1)(1997-6#1)(2010-6#1)(2011-2#1)
of the Nur77 family##2##4##(1994-12#2)
of the Nursing##2##3##(2008-11#1)(2009-4#1)
of the O##6##3##(1994-11#1)(1996-7#1)(1997-4#1)(2008-10#1)(2010-7#1)(2013-1#1)
of the O-H##2##3##(2008-3#1)(2009-10#1)
of the O-acetyl##2##3##(1996-10#2)
of the O-polysaccharide##2##3##(1992-12#1)(1996-10#1)
of the O-specific polysaccharide##2##4##(1990-3#1)(1995-4#1)
of the O-specific##3##3##(1990-3#1)(1995-4#1)(1996-2#1)
of the O2##2##3##(2007-8#1)(2008-10#1)
of the OAc##2##3##(1991-9#2)
of the OB-fold##2##3##(2010-10#2)
of the OCT imaging depth at##2##6##(2011-1#2)
of the OCT##7##3##(2007-12#2)(2008-3#1)(2011-1#3)(2011-7#1)
of the ODT##2##3##(2007-9#1)(2008-5#1)
of the OECD##2##3##(2011-1#2)
of the OH group of##2##5##(1991-6#1)(1993-11#1)
of the OH group##3##4##(1991-6#1)(1993-11#1)(2006-12#1)
of the OH stretching##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
of the OH##9##3##(1991-6#1)(1993-11#1)(2006-12#2)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
of the OIE##5##3##(2005-5#5)
of the OM##2##3##(1992-7#1)(2013-1#1)
of the OPD##2##3##(2008-2#1)(2008-3#1)
of the OPO##11##3##(2007-12#7)(2008-1#1)(2008-2#1)(2008-3#2)
of the OPV##2##3##(1994-9#2)
of the OR##2##3##(2006-6#1)(2007-5#1)
of the ORA##2##3##(2008-2#2)
of the ORF##5##3##(1990-4#1)(1995-2#1)(1997-4#1)(2008-7#1)(2008-8#1)
of the ORFs##9##3##(1991-7#1)(1993-12#1)(1994-12#2)(1997-3#2)(1997-4#2)(2008-5#1)
of the OSC##2##3##(2008-5#1)(2008-6#1)
of the OSCE##2##3##(2006-10#1)(2008-11#1)
of the OSEs##2##3##(1991-10#2)
of the Obesity Prevention##2##4##(2008-1#1)(2012-1#1)
of the Oct-2 POU domain##2##5##(1992-6#2)
of the Oct-2##3##3##(1992-6#2)(1994-12#1)
of the Office##2##3##(2007-6#1)(2008-2#1)
of the Old World##4##4##(1990-11#1)(2008-5#2)(2008-8#1)
of the Old##5##3##(1990-11#1)(1994-3#1)(2008-5#2)(2008-8#1)
of the Omnibus##2##3##(1991-1#1)(1997-3#1)
of the Onchocerciasis Control Programme in West Africa##2##8##(1990-6#2)
of the Onchocerciasis Control Programme##3##5##(1990-6#2)(2006-10#1)
of the Ontario##3##3##(1994-8#1)(2010-12#1)(2011-2#1)
of the Onychophora##4##3##(2007-12#2)(2008-5#2)
of the Optical Properties##2##4##(2008-2#1)(2008-3#1)
of the Optical##7##3##(2008-2#3)(2008-3#4)
of the Oral##2##3##(2007-8#1)(2011-2#1)
of the Order##2##3##(2008-3#1)(2010-1#1)
of the Organization for Economic Cooperation and Development##2##8##(1993-2#1)(1994-1#1)
of the Organization##3##3##(1993-2#1)(1994-1#1)(1996-11#1)
of the Orinoco Oil Belt##2##5##(2008-10#2)
of the Orthopedics and Traumatology##2##5##(2007-7#1)(2007-8#1)
of the Oryza##2##3##(2007-3#1)(2008-10#1)
of the Ox IgG1 Fab##2##5##(1993-6#2)
of the Ox IgG3##2##4##(1993-6#2)
of the Ox##4##3##(1993-6#4)
of the P##25##3##(1990-12#1)(1990-9#1)(1993-9#1)(1996-10#1)(1996-11#1)(1996-7#1)(2006-11#1)(2006-3#1)(2006-8#1)(2008-10#8)(2009-2#1)(2010-12#1)(2010-2#1)(2011-1#2)(2012-1#1)(2013-1#1)(2013-8#1)
of the P-glycoprotein##6##3##(1992-12#1)(1995-11#1)(1995-6#1)(2008-11#3)
of the P-type##2##3##(1990-12#1)(1993-11#1)
of the P1##4##3##(1991-4#1)(1993-12#1)(2007-12#1)(2011-1#1)
of the P2##5##3##(1990-11#1)(1990-8#1)(1995-2#1)(1995-8#2)
of the P2Y##2##3##(1995-11#1)(2008-4#1)
of the P2Y(1) receptor##3##4##(2008-4#3)
of the P4##4##3##(1993-5#1)(2010-9#3)
of the P450##3##3##(1990-12#1)(2009-9#2)
of the P6##3##3##(1996-10#3)
of the PA method##2##4##(2012-2#2)
of the PA##3##3##(1990-11#1)(2012-2#2)
of the PAC##2##3##(1995-5#1)(2008-10#1)
of the PACE##3##3##(1992-1#1)(2008-7#2)
of the PAG##2##3##(1994-6#2)
of the PAH##3##3##(1996-3#1)(2008-10#1)(2010-10#1)
of the PAHs##2##3##(2008-10#2)
of the PAI##2##3##(2008-10#2)
of the PANAS##2##3##(2013-8#2)
of the PANI film##2##4##(2008-10#2)
of the PAP##2##3##(2008-11#2)
of the PB films##2##4##(2008-10#2)
of the PB layer##3##4##(2008-10#3)
of the PB##9##3##(1997-2#1)(2005-11#2)(2008-10#6)
of the PBMCs##2##3##(1997-2#2)
of the PBS##2##3##(2008-11#1)(2008-2#1)
of the PC membrane##2##4##(2006-10#2)
of the PC##4##3##(1993-8#1)(2006-10#2)(2007-12#1)
of the PCNA promoter##2##4##(1994-8#2)
of the PCNA##3##3##(1994-8#2)(1995-6#1)
of the PCOS and##2##4##(2010-4#1)(2011-1#1)
of the PCOS##4##3##(2010-4#1)(2011-1#3)
of the PCR product##3##4##(1994-12#1)(1994-2#1)(2008-10#1)
of the PCR products##7##4##(1990-11#1)(1992-9#1)(1995-2#1)(2004-11#1)(2008-10#3)
of the PCR##20##3##(1990-11#1)(1992-9#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-2#1)(1997-6#1)(2004-11#1)(2005-11#2)(2006-10#1)(2007-8#1)(2008-10#4)(2008-5#2)(2012-3#1)
of the PD catheter##2##4##(2011-2#2)
of the PD##5##3##(2004-9#1)(2008-7#2)(2011-2#2)
of the PDA##5##3##(2008-10#1)(2008-12#2)(2012-12#2)
of the PDC##2##3##(2007-7#2)
of the PDE##3##3##(1990-2#1)(1991-12#1)(2008-3#1)
of the PDFE##2##3##(2008-2#2)
of the PDGF##3##3##(1990-3#1)(1992-9#1)(1994-6#1)
of the PDGF-betaR##2##3##(1997-7#2)
of the PDH##2##3##(1994-11#1)(2010-2#1)
of the PDMS##2##3##(2009-2#1)(2010-4#1)
of the PDO##2##3##(2008-10#1)(2008-5#1)
of the PDT group##2##4##(2008-5#2)
of the PDT##4##3##(2008-5#4)
of the PE absorption coefficient##2##5##(2008-3#2)
of the PE##3##3##(1991-1#1)(2008-3#2)
of the PEEK##2##3##(2004-9#2)
of the PEG hydrogel group compared with 66##2##8##(2012-3#2)
of the PEG##8##3##(1994-9#2)(2005-11#1)(2008-11#1)(2008-3#1)(2008-4#1)(2012-3#2)
of the PEPCK gene##3##4##(1993-3#1)(1995-6#1)(1996-2#1)
of the PFs##2##3##(1991-11#2)
of the PG##3##3##(1990-2#2)(2007-8#1)
of the PGNG##2##3##(2007-9#2)
of the PGs##3##3##(1990-2#2)(2012-2#1)
of the PH neurons##2##4##(1993-2#2)
of the PH##6##3##(1993-2#3)(1994-8#1)(1995-1#1)(2013-8#1)
of the PHOX2B gene##2##4##(2007-6#2)
of the PI##3##3##(1990-10#1)(1992-6#1)(2008-8#1)
of the PI3K-Akt pathway##2##4##(2013-7#2)
of the PICOC##2##3##(2008-2#2)
of the PISHG##2##3##(2008-3#2)
of the PITSLRE beta 1 protein kinase##3##7##(1994-3#3)
of the PKA inhibitor##3##4##(1993-6#1)(1996-9#1)(2011-12#1)
of the PKA##4##3##(1993-6#1)(1996-8#1)(1996-9#1)(2011-12#1)
of the PKC activator##2##4##(1994-2#1)(1996-11#1)
of the PKC##12##3##(1990-12#1)(1990-6#2)(1992-7#1)(1992-9#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-5#1)(1996-11#1)(1996-5#1)(1996-8#1)
of the PKCepsilon##2##3##(1996-5#2)
of the PL8 mutant##2##4##(1995-1#2)
of the PL8##3##3##(1995-1#3)
of the PLS##2##3##(2007-11#1)(2008-5#1)
of the PMA##2##3##(1993-6#1)(2005-11#1)
of the PMD##2##3##(2007-11#1)(2007-12#1)
of the PMHS##2##3##(2006-11#2)
of the POA neurons##2##4##(2008-8#2)
of the POU##2##3##(1997-7#2)
of the PP##4##3##(1990-8#1)(1993-7#1)(1995-2#1)(2007-12#1)
of the PP-fold##3##3##(1993-3#3)
of the PP1##2##3##(1993-7#1)(1997-6#1)
of the PPAR##3##3##(1992-8#1)(1994-2#1)(2008-1#1)
of the PPAR-α##2##3##(2013-7#2)
of the PPLN##2##3##(2007-12#2)
of the PPS##2##3##(2008-2#2)
of the PPTg##3##3##(1994-10#1)(1994-2#2)
of the PQ(35) transition##2##4##(2008-3#2)
of the PR and##2##4##(2008-10#1)(2010-1#1)
of the PR##4##3##(1993-11#1)(1996-5#1)(2008-10#1)(2010-1#1)
of the PRN##2##3##(2006-4#1)(2007-3#1)
of the PS##6##3##(1993-2#2)(2006-10#1)(2008-1#1)(2008-10#1)(2010-4#1)
of the PS-1##3##3##(1995-12#1)(1997-1#1)(1997-5#1)
of the PS/PDI##2##3##(2008-3#2)
of the PSA##2##3##(2006-9#1)(2009-6#1)
of the PSC##2##3##(1997-2#2)
of the PSD##4##3##(2008-2#2)(2008-4#2)
of the PSF##4##3##(2008-2#1)(2008-3#3)
of the PSR##2##3##(2008-3#2)
of the PT##3##3##(2006-3#2)(2013-1#1)
of the PTH structure##2##4##(2007-8#2)
of the PTH##3##3##(2007-8#2)(2008-8#1)
of the PTS strain under aerobic conditions##2##7##(2008-7#2)
of the PTS##4##3##(1995-1#2)(2008-7#2)
of the PTT##2##3##(1994-4#2)
of the PUF##3##3##(1995-1#2)(2008-11#1)
of the PVMVA##2##3##(2012-12#2)
of the PVN##3##3##(1994-12#1)(1994-8#1)(1995-12#1)
of the PVP##4##3##(2006-2#1)(2008-10#1)(2010-4#2)
of the PVY 1-2 HC##2##5##(2008-10#2)
of the PVY##3##3##(2008-10#3)
of the PYK1 mRNA##2##4##(1990-4#2)
of the PYK1##3##3##(1990-4#3)
of the Pacific Ocean##2##4##(1990-4#1)(2008-9#1)
of the Pacific coast of##4##5##(2007-3#1)(2007-5#2)(2012-12#1)
of the Pacific salmon##3##4##(1990-12#1)(1995-11#2)
of the Pacific##22##3##(1990-12#1)(1990-4#1)(1995-11#2)(1995-8#1)(2007-3#3)(2007-5#3)(2008-1#5)(2008-10#1)(2008-9#1)(2010-9#1)(2012-12#1)(2013-7#2)
of the Paediatric Standard Treatment Book##2##6##(2008-4#2)
of the Paediatric##3##3##(2008-4#2)(2009-5#1)
of the Palau##2##3##(2005-11#1)(2008-1#1)
of the Pap smear##4##4##(1991-6#1)(1992-3#2)(2011-2#1)
of the Pap##5##3##(1991-6#2)(1992-3#2)(2011-2#1)
of the Papanicolaou##2##3##(2006-10#1)(2008-11#1)
of the Paramecium aurelia##4##4##(2008-12#4)
of the Patient Safety Authority##2##5##(2007-4#2)
of the Patient##3##3##(2007-4#2)(2012-1#1)
of the Pediatric##5##3##(2008-1#1)(2008-9#1)(2010-3#1)(2013-1#2)
of the Pennes-equation##2##3##(2007-11#2)
of the People's Republic of China in##2##7##(2007-7#1)(2008-7#1)
of the Perception of##2##4##(2009-12#1)(2011-2#1)
of the Perfluorooctane##2##3##(2013-1#2)
of the Performance of##2##4##(2006-11#1)(2008-11#1)
of the Performance##3##3##(2006-11#1)(2007-12#1)(2008-11#1)
of the Persian##2##3##(2008-12#1)(2012-1#1)
of the Peruvian Amazon##2##4##(2011-2#2)
of the Peruvian species##2##4##(2009-2#2)
of the Peruvian##7##3##(2009-2#2)(2011-2#3)(2013-8#2)
of the Petrous##2##3##(2011-2#2)
of the Pharmaceutical##3##3##(2008-10#1)(2008-11#1)(2010-12#1)
of the Phase Metrics DFHT IV##2##6##(2008-3#2)
of the Phe##2##3##(1990-9#1)(1996-8#1)
of the Philadelphia##3##3##(1996-11#1)(2009-3#1)(2012-12#1)
of the Philippine##2##3##(2008-10#2)
of the Physician's Recognition Award of the American Medical Association##7##10##(2006-10#7)
of the Physician's##8##3##(1994-3#1)(2006-10#7)
of the Phytophthora genus-specific##2##4##(2008-10#2)
of the Phytophthora sp-h isolates##2##5##(2008-10#2)
of the Phytophthora##6##3##(2008-10#5)(2008-11#1)
of the Pierre Auger##3##4##(2008-2#1)(2008-3#2)
of the Pinewood Nematode##2##4##(2008-10#2)
of the Pit-1##2##3##(1995-3#1)(1996-11#1)
of the Plant Ontology Consortium##4##5##(2008-7#4)
of the Plant-Parasitic Nematode##2##4##(2008-10#2)
of the Plasmodium yoelii##2##4##(1994-12#1)(2008-3#1)
of the Plasmodium##5##3##(1990-9#1)(1994-12#1)(2008-3#1)(2012-12#2)
of the Pleistocene##3##3##(2008-8#1)(2008-9#1)(2010-8#1)
of the Plum##3##3##(2007-9#1)(2008-10#1)(2011-2#1)
of the Pluronic##2##3##(2005-11#2)
of the Pm-AMP1##2##3##(2008-10#2)
of the Polish Society of Internal##2##6##(2008-7#2)
of the Polish Society of Pediatric Oncology and Hematology]##3##9##(2008-9#3)
of the Polish Society of##7##5##(2007-8#1)(2008-7#2)(2008-9#3)(2009-5#1)
of the Polish##14##3##(2007-8#2)(2008-12#1)(2008-7#2)(2008-9#3)(2009-2#1)(2009-5#1)(2011-2#1)(2012-2#2)(2013-8#1)
of the Polyscias strains##2##4##(2008-10#2)
of the Population of##2##4##(2006-3#1)(2008-10#1)
of the Population##3##3##(1996-3#1)(2006-3#1)(2008-10#1)
of the Port Moresby General Hospital##2##6##(2006-2#2)
of the Portuguese##2##3##(2009-7#1)(2012-12#1)
of the Positive and Negative##2##5##(1996-5#1)(2013-8#1)
of the Posterior##2##3##(2008-12#1)(2013-1#1)
of the Postharvest##2##3##(2008-10#2)
of the President of the##2##5##(1992-3#1)(2008-7#1)
of the Primary##3##3##(1996-2#1)(2008-10#2)
of the Program##2##3##(2007-3#1)(2008-7#1)
of the Protein##2##3##(2011-1#1)(2011-2#1)
of the Proximal##2##3##(2007-11#1)(2012-12#1)
of the Prussian Blue##2##4##(2008-10#2)
of the Pseudomonas##3##3##(1996-9#1)(2008-10#1)(2013-7#1)
of the Pt-incorporated##2##3##(2010-4#2)
of the Public Health (Control of Disease) Act 1984##2##9##(2011-2#2)
of the Public Health##4##4##(1996-2#1)(2011-2#2)(2012-12#1)
of the Pyr(x)PC species decreased with increasing sn-2 acyl-chain length##2##10##(1991-11#2)
of the Pythium##2##3##(2008-10#2)
of the Pyy##2##3##(1994-12#2)
of the Q biotype##2##4##(2011-2#2)
of the Q##7##3##(1992-3#1)(2007-12#1)(2008-3#2)(2010-5#1)(2011-2#2)
of the Q-switched##2##3##(2007-12#1)(2008-3#1)
of the Q3 and Hybrid III 3-year-old##2##7##(2007-4#2)
of the Q3 and Hybrid III##3##6##(2007-4#3)
of the Q3##4##3##(2007-4#4)
of the QCM with LB##2##5##(2008-10#2)
of the QCM##4##3##(2008-10#4)
of the QD##2##3##(2008-7#2)
of the QIAamp DNA Investigator Kit and##2##7##(2010-9#2)
of the QIs##2##3##(1996-2#2)
of the QRS duration##2##4##(2008-10#1)(2010-1#1)
of the QRS##3##3##(1995-6#1)(2008-10#1)(2010-1#1)
of the QT interval##4##4##(2007-2#2)(2011-2#2)
of the QT##5##3##(2005-7#1)(2007-2#2)(2011-2#2)
of the QTL##5##3##(2006-12#1)(2008-10#3)(2012-3#1)
of the Qinghai-Tibet Plateau##2##4##(2008-9#2)
of the Quality Assurance##2##4##(1997-2#1)(2008-11#1)
of the Questionnaire##2##3##(2009-10#1)(2012-3#1)
of the Quick Vue test##2##5##(2007-1#2)
of the Quick Vue##3##4##(2007-1#3)
of the Quick##4##3##(2006-3#1)(2007-1#3)
of the QuickVue##2##3##(2011-2#2)
of the R##10##3##(1990-8#1)(1991-4#1)(1992-3#1)(1993-6#1)(1995-8#1)(1996-8#1)(2007-11#1)(2008-10#2)(2010-10#1)
of the R&amp##3##3##(2008-5#2)(2008-8#1)
of the R-D-LSI##2##3##(2012-2#2)
of the R2 protein##2##4##(1995-10#2)
of the RA##3##3##(1995-10#1)(2007-4#1)(2007-8#1)
of the RAAS##2##3##(2005-7#1)(2007-1#1)
of the RACE##2##3##(2008-3#1)(2009-7#1)
of the RAND##2##3##(2008-10#2)
of the RAP1 gene##2##4##(1996-7#2)
of the RAPD##2##3##(2008-10#1)(2008-5#1)
of the RAS##6##3##(1993-12#1)(2005-7#1)(2005-8#1)(2009-10#2)(2012-3#1)
of the RB##3##3##(1993-8#1)(1996-12#1)(2008-10#1)
of the RBC##3##3##(1992-11#1)(1995-2#1)(2013-1#1)
of the RBRVS##2##3##(2006-10#1)(2007-4#1)
of the RCA##2##3##(1992-3#2)
of the RDC1 gene##2##4##(1992-3#2)
of the RE##4##3##(1993-3#1)(1993-4#1)(2007-8#1)(2010-2#1)
of the RFLP##2##3##(2008-10#1)(2008-5#1)
of the RGD sequence##3##4##(1995-6#3)
of the RGD##6##3##(1995-6#3)(1996-5#1)(1997-2#1)(2008-7#1)
of the RGD-BBN##2##3##(2010-6#2)
of the RI##2##3##(2008-10#2)
of the RIA was##2##4##(1990-11#1)(1991-8#1)
of the RIA##3##3##(1990-11#1)(1991-8#1)(1994-10#1)
of the RID2a##2##3##(2007-4#2)
of the RIFLE classification##2##4##(2007-8#2)
of the RN as##2##4##(2008-1#1)(2008-12#1)
of the RN##4##3##(2008-1#1)(2008-12#3)
of the RNA 4##2##4##(2008-10#2)
of the RNA bacteriophage##2##4##(1990-11#1)(1997-4#1)
of the RNA molecule##2##4##(2008-4#1)(2008-7#1)
of the RNA polymerase II##3##5##(1995-2#1)(2008-10#1)(2010-11#1)
of the RNA polymerase##7##4##(1995-2#1)(1995-6#2)(1996-5#1)(1997-2#1)(2008-10#1)(2010-11#1)
of the RNA secondary##2##4##(1991-9#1)(2008-4#1)
of the RNA##35##3##(1990-11#1)(1991-9#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-11#1)(2008-10#6)(2008-2#1)(2008-4#5)(2008-7#1)(2009-7#1)(2010-11#1)(2010-6#1)(2011-1#1)
of the RNAP##2##3##(1997-5#2)
of the RNAi##2##3##(2008-1#1)(2009-8#1)
of the RNAs##2##3##(1996-2#1)(2008-10#1)
of the RNAstructure##2##3##(2008-4#2)
of the RNFL##3##3##(2007-11#1)(2009-4#2)
of the RNN##2##3##(2008-2#1)(2010-8#1)
of the RNase H domain##2##5##(1995-3#2)
of the RNase##3##3##(1990-11#1)(1995-3#2)
of the ROM-check##2##3##(1992-2#2)
of the RP25##2##3##(2008-5#2)
of the RPA##2##3##(2007-8#2)
of the RPE melanin##2##4##(1992-2#2)
of the RPE##4##3##(1992-2#2)(2008-3#2)
of the RPRP##2##3##(2007-6#2)
of the RPT technique##2##4##(2008-3#2)
of the RR##3##3##(1994-11#2)(2013-8#1)
of the RRS##2##3##(2007-8#1)(2008-10#1)
of the RS##2##3##(1991-9#2)
of the RTCs##6##3##(2009-4#6)
of the RTP emission##2##4##(2008-10#2)
of the RTP##4##3##(2008-10#4)
of the Radiology##3##3##(1990-10#1)(1992-1#1)(2008-6#1)
of the Radon##2##3##(2008-2#2)
of the Radon-Wigner display for one-dimensional##2##6##(2007-12#1)(2008-2#1)
of the Radon-Wigner display for##3##5##(2007-12#2)(2008-2#1)
of the Raji##2##3##(1993-9#1)(2008-5#1)
of the Raman bands##3##4##(2007-11#1)(2007-12#1)(2008-4#1)
of the Raman cross##2##4##(2008-1#1)(2008-3#1)
of the Raman effect##2##4##(2007-12#1)(2008-10#1)
of the Raman gain##3##4##(2007-11#1)(2007-12#1)(2008-1#1)
of the Raman scattering coefficient##2##5##(2008-2#1)(2008-3#1)
of the Raman scattering##3##4##(2008-2#1)(2008-3#1)(2011-1#1)
of the Raman spectra of the##2##6##(2006-7#1)(2010-8#1)
of the Raman spectra##4##4##(2005-4#1)(2006-7#1)(2008-1#1)(2010-8#1)
of the Raman spectrum##2##4##(2007-11#1)(2008-2#1)
of the Raman##32##3##(1991-5#1)(1996-2#1)(2005-4#1)(2006-7#1)(2007-11#4)(2007-12#4)(2008-1#3)(2008-10#3)(2008-2#2)(2008-3#6)(2008-4#1)(2010-8#1)(2011-1#2)(2013-8#2)
of the Raman-scattering coefficient##2##4##(2008-2#1)(2008-3#1)
of the Raman-scattering coefficients##2##4##(2008-2#2)
of the Raman-scattering##4##3##(2008-2#3)(2008-3#1)
of the Rapid##2##3##(1997-6#1)(2007-6#1)
of the Ras superfamily##5##4##(1994-5#1)(1995-2#2)(1995-8#1)(1996-5#1)
of the Ras##9##3##(1993-6#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#2)(1995-8#1)(1996-5#1)(2008-5#1)
of the Ras-related##2##3##(1991-11#1)(1997-4#1)
of the Rates of##3##4##(2011-1#1)(2013-1#2)
of the Rayleigh##4##3##(2008-2#1)(2008-3#3)
of the RecQ##2##3##(2008-8#1)(2012-2#1)
of the Red Cross##2##4##(1991-11#1)(2008-10#1)
of the Red##3##3##(1991-11#1)(2008-10#1)(2009-2#1)
of the Regional Training Centres (RTCs) is##2##7##(2009-4#2)
of the Regional Training Centres (RTCs)##3##6##(2009-4#3)
of the Regional Training Centres##5##5##(2009-4#5)
of the Regional##7##3##(2008-10#2)(2009-4#5)
of the Registered Professional Nurse##2##5##(2007-10#2)
of the Regulatory##2##3##(2006-3#1)(2012-12#1)
of the Relationship between##2##4##(2010-3#1)(2013-1#1)
of the Relationship##3##3##(2008-10#1)(2010-3#1)(2013-1#1)
of the Rep gene##2##4##(2008-10#2)
of the Rep##4##3##(2008-10#4)
of the Republic of Korea and Japan##2##7##(2005-5#2)
of the Republic of Korea##3##5##(2005-5#3)
of the Republic of##8##4##(2005-5#3)(2005-9#1)(2008-1#2)(2008-10#1)(2011-2#1)
of the Republic##11##3##(2005-5#3)(2005-9#1)(2008-1#3)(2008-10#1)(2009-4#2)(2011-2#1)
of the Research##6##3##(1992-2#1)(1997-8#1)(2007-9#1)(2008-1#1)(2011-2#1)(2012-12#1)
of the Resilience Scale##2##4##(2011-1#2)
of the Reveal##2##3##(2006-10#2)
of the Review##3##3##(1997-2#1)(1997-3#2)
of the Revista de##2##4##(2007-3#1)(2010-12#1)
of the Revista##3##3##(2007-3#2)(2010-12#1)
of the Rex-1 gene##3##4##(1994-9#3)
of the Rh##3##3##(1992-12#1)(1994-12#1)(2008-2#1)
of the Rho family of small GTPases##2##7##(1997-7#1)(2009-8#1)
of the Rho family##4##4##(1995-6#1)(1996-5#1)(1997-7#1)(2009-8#1)
of the Rhodopseudomonas viridis##2##4##(1991-3#1)(1993-8#1)
of the Rio##2##3##(2006-7#1)(2008-5#1)
of the River##3##3##(2004-4#1)(2008-10#1)(2010-8#1)
of the Road Map##2##4##(2011-1#2)
of the Road##3##3##(2005-9#1)(2011-1#2)
of the Robert Wood Johnson##2##5##(1996-12#1)(2007-10#1)
of the Robert##3##3##(1996-12#1)(2007-10#1)(2011-2#1)
of the Robertsonian##2##3##(1996-12#1)(2010-3#1)
of the Role of##3##4##(2008-10#3)
of the Ronchi##2##3##(2008-3#2)
of the Root##2##3##(2008-10#1)(2009-4#1)
of the Royal College of Pathologists##2##6##(1994-12#1)(2012-11#1)
of the Royal College of Physicians of London##3##8##(1990-9#1)(1996-8#2)
of the Royal College of##5##5##(1990-9#1)(1994-12#1)(1996-8#2)(2012-11#1)
of the Royal College##6##4##(1990-9#1)(1994-12#1)(1996-8#2)(2008-11#1)(2012-11#1)
of the Royal Society of London##2##6##(2006-10#1)(2007-9#1)
of the Royal##15##3##(1990-9#1)(1992-1#1)(1992-3#1)(1994-12#1)(1996-8#2)(2005-8#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-8#2)(2010-12#1)(2012-11#1)
of the Russian##5##3##(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
of the RyR##2##3##(1995-3#2)
of the RyR1s##4##3##(2008-9#4)
of the Rydberg##2##3##(1992-9#1)(2005-4#1)
of the S RNA##2##4##(2008-10#2)
of the S phase##2##4##(1994-8#1)(2008-9#1)
of the S##21##3##(1990-10#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-5#1)(1993-1#1)(1993-2#1)(1994-3#1)(1994-8#1)(1997-5#1)(1997-7#1)(2004-11#1)(2008-10#4)(2008-3#1)(2008-8#1)(2008-9#1)(2010-8#1)
of the S(2) state##2##4##(2006-4#2)
of the S(2)##3##3##(2006-4#3)
of the S-100##2##3##(1991-6#1)(1994-6#1)
of the S-phase fraction##2##4##(1993-1#1)(1993-11#1)
of the S-type##2##3##(1993-5#1)(1995-8#1)
of the S1 x##2##4##(1997-4#2)
of the S1##7##3##(1997-1#1)(1997-3#2)(1997-4#2)(2007-11#1)(2008-5#1)
of the SA##2##3##(1997-5#1)(2011-10#1)
of the SAA gene##3##4##(1993-6#1)(1995-3#2)
of the SAA promoter##2##4##(1995-3#2)
of the SAA##5##3##(1993-6#1)(1995-3#4)
of the SAM##8##3##(2006-12#1)(2008-10#5)(2008-4#1)(2009-3#1)
of the SAMs##2##3##(2005-11#1)(2007-9#1)
of the SAO stroke subtype##2##5##(2007-10#2)
of the SAR##3##3##(2008-8#2)(2009-8#1)
of the SBD##3##3##(1993-5#1)(1996-6#1)(2006-12#1)
of the SC##9##3##(1993-9#1)(2008-2#1)(2008-5#7)
of the SCAR##2##3##(2008-10#1)(2012-12#1)
of the SCN##5##3##(1993-12#1)(1993-9#2)(1994-2#1)(1996-1#1)
of the SD##2##3##(1990-7#1)(2013-1#1)
of the SDS##2##3##(1992-11#1)(2008-10#1)
of the SEA##2##3##(1993-6#2)
of the SEM##2##3##(2008-5#1)(2013-1#1)
of the SERS##2##3##(2008-10#1)(2010-4#1)
of the SF-36##5##3##(1994-3#2)(2008-8#1)(2011-1#1)(2012-12#1)
of the SGB##3##3##(2008-11#3)
of the SGLT1##2##3##(1991-12#2)
of the SH field##2##4##(2007-12#2)
of the SHR##4##3##(1993-2#3)(1994-8#1)
of the SI##5##3##(1991-5#1)(1994-10#1)(2006-10#1)(2007-12#1)(2008-10#1)
of the SIA system##3##4##(2008-10#3)
of the SIJ capsule##2##4##(2006-8#2)
of the SIJ##3##3##(2006-12#1)(2006-8#2)
of the SIJs##2##3##(2006-12#2)
of the SIL##2##3##(2007-12#1)(2008-3#1)
of the SIP##2##3##(2008-3#2)
of the SL##4##3##(1992-12#2)(2007-9#2)
of the SLE patients##2##4##(1994-3#1)(2006-10#1)
of the SM##3##3##(1996-2#1)(2005-11#1)(2007-12#1)
of the SMB system##2##4##(1997-3#2)
of the SMF##2##3##(2007-11#1)(2008-10#1)
of the SNARE complex##3##4##(2009-12#3)
of the SNARE##4##3##(2009-12#4)
of the SNB##3##3##(1994-5#1)(1995-5#1)(2011-2#1)
of the SNF##2##3##(1990-12#1)(1994-12#1)
of the SNOMED CT##4##4##(2013-1#4)
of the SNP##2##3##(2012-11#1)(2012-5#1)
of the SNPs##3##3##(2012-1#2)(2012-3#1)
of the SOA##2##3##(2007-12#2)
of the SOD##3##3##(1990-11#1)(1995-2#2)
of the SOHO##3##3##(2008-2#1)(2008-3#2)
of the SOL project##2##4##(2008-7#2)
of the SOM##3##3##(1992-1#1)(1995-2#1)(2008-2#1)
of the SON##2##3##(1993-12#1)(1996-8#1)
of the SOS##3##3##(1994-9#2)(1995-2#1)
of the SP##3##3##(1990-11#1)(1995-2#1)(1997-4#1)
of the SPE##2##3##(1997-2#1)(2011-2#1)
of the SPR##5##3##(2008-10#4)(2008-3#1)
of the SR##5##3##(1990-11#1)(1991-5#1)(1992-4#2)(2008-10#1)
of the SS##5##3##(1993-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-11#1)
of the SSCT##4##3##(2008-9#4)
of the ST segment##4##4##(1990-3#2)(1993-11#1)(2008-7#1)
of the ST##8##3##(1990-3#2)(1993-11#1)(2008-10#4)(2008-7#1)
of the STARD##2##3##(2008-12#2)
of the STN##3##3##(1997-7#2)(2008-11#1)
of the STP##2##3##(1991-9#2)
of the STR##4##3##(1994-12#1)(1996-7#1)(2008-12#1)(2009-4#1)
of the SV40 early##2##4##(1990-11#1)(1993-12#1)
of the SV40 late genes##2##5##(1990-11#2)
of the SV40 late##3##4##(1990-11#2)(1997-2#1)
of the SV40##9##3##(1990-11#4)(1990-8#1)(1993-12#1)(1996-10#1)(1997-2#1)(2008-2#1)
of the SVC##3##3##(2007-8#2)(2008-1#1)
of the SVM##4##3##(2007-8#1)(2008-2#2)(2011-1#1)
of the SVZ##3##3##(2008-7#2)(2012-2#1)
of the Saccharomyces cerevisiae##16##4##(1990-5#1)(1991-11#1)(1992-11#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-4#1)(1995-8#1)(1996-7#2)(1997-3#1)(1997-8#1)(2007-2#1)
of the Saccharomyces##17##3##(1990-5#1)(1991-11#1)(1992-11#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-4#1)(1995-8#1)(1996-7#2)(1997-3#1)(1997-8#1)(2007-2#1)(2012-3#1)
of the Safety##2##3##(2008-11#1)(2012-2#1)
of the Sagnac interferometer##3##4##(2007-11#1)(2008-1#1)(2008-2#1)
of the Sagnac##6##3##(2007-11#2)(2008-1#1)(2008-2#3)
of the SalI##2##3##(1991-9#1)(1994-12#1)
of the Salmonella typhimurium##4##4##(1991-12#1)(1996-6#1)(1997-4#1)(2011-1#1)
of the Salmonella##6##3##(1991-12#1)(1996-2#1)(1996-6#1)(1997-4#1)(2011-1#1)(2012-2#1)
of the San Francisco##2##4##(1996-12#1)(2007-9#1)
of the San##3##3##(1996-12#1)(1996-4#1)(2007-9#1)
of the Sarajevo##2##3##(2005-10#2)
of the Scandinavian##2##3##(1997-6#1)(2010-3#1)
of the Scarlet Pimpernel##2##4##(2008-10#2)
of the Schaffer##3##3##(1991-3#1)(1991-6#1)(1995-12#1)
of the Schiff base ligands##2##5##(2008-10#1)(2008-5#1)
of the Schiff base with##2##5##(1995-5#1)(2008-10#1)
of the Schiff base##11##4##(1994-5#2)(1995-10#1)(1995-11#1)(1995-5#3)(2008-10#2)(2008-5#2)
of the Schizosaccharomyces pombe##3##4##(1993-11#1)(1993-3#1)(1994-12#1)
of the Schlieren effect##2##4##(2008-10#2)
of the School of Medicine in##3##6##(1994-6#1)(2008-1#2)
of the School of Medicine##7##5##(1992-1#1)(1994-6#1)(2008-1#3)(2008-4#1)(2012-3#1)
of the School of##8##4##(1992-1#1)(1994-6#1)(2008-1#3)(2008-10#1)(2008-4#1)(2012-3#1)
of the Schwann##2##3##(1990-7#1)(2007-10#1)
of the Scientific##2##3##(2008-7#1)(2010-7#1)
of the Se-enriched##2##3##(2008-10#1)(2010-11#1)
of the Sea Urchin##2##4##(2008-5#2)
of the Sea##4##3##(2007-9#1)(2008-2#1)(2008-5#2)
of the Sea-viewing Wide Field-of-view Sensor (SeaWiFS)##2##7##(2008-3#2)
of the Sea-viewing Wide##3##4##(2008-3#3)
of the SeaWiFS bands##2##4##(2008-3#2)
of the SeaWiFS##7##3##(2008-2#1)(2008-3#6)
of the Second Annual##2##4##(2008-6#1)(2011-2#1)
of the Second##8##3##(1997-7#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#3)(2011-2#1)
of the Seed##2##3##(2008-10#1)(2012-2#1)
of the Self-Help Clearinghouse##2##4##(1994-1#2)
of the Semliki Forest clade##2##5##(2008-7#2)
of the Serbian##4##3##(2008-1#4)
of the Sertoli cells##2##4##(2009-10#1)(2013-1#1)
of the Sertoli##3##3##(1992-5#1)(2009-10#1)(2013-1#1)
of the Serum##2##3##(1994-6#1)(2013-8#1)
of the Sexual Function Questionnaire##3##5##(2012-3#3)
of the Short##3##3##(2007-10#1)(2011-1#2)
of the Shoulder##3##3##(2007-1#1)(2012-12#2)
of the Si##2##3##(2005-11#1)(2007-12#1)
of the Sialis-type##2##3##(2008-12#2)
of the Sickness Impact Profile##2##5##(2006-10#1)(2007-10#1)
of the Sika Deer (Cervus##2##5##(2008-5#2)
of the Silesian##2##3##(2007-11#1)(2008-9#1)
of the Sisters of##2##4##(2013-8#2)
of the Slp gene##3##4##(1995-2#3)
of the Slp##4##3##(1995-2#4)
of the Sm##2##3##(1993-2#1)(2008-10#1)
of the Small##2##3##(2008-6#1)(2013-1#1)
of the Sn##2##3##(2004-9#1)(2008-2#1)
of the Social Insurance##2##4##(2007-7#1)(2009-4#1)
of the Social Security number##2##5##(1993-9#2)
of the Social Security##3##4##(1993-9#2)(2012-12#1)
of the Social##6##3##(1993-9#2)(2007-7#1)(2009-4#1)(2012-12#2)
of the Society for Neuroscience##2##5##(2005-7#1)(2012-1#1)
of the Society for##4##4##(2005-7#1)(2008-7#1)(2011-1#1)(2012-1#1)
of the Society of##5##4##(2006-11#1)(2006-9#1)(2007-9#1)(2008-10#1)(2010-3#1)
of the Society##13##3##(2005-7#1)(2006-11#2)(2006-9#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-7#2)(2010-3#1)(2011-1#1)(2012-1#1)
of the Sociocultural Attitudes Towards Appearance Questionnaire-3##2##7##(2007-12#2)
of the Sociocultural Attitudes Towards Appearance##3##6##(2007-12#2)(2010-9#1)
of the Solanaceae##2##3##(1993-12#1)(2005-10#1)
of the Solar##3##3##(1996-5#1)(2008-2#1)(2008-3#1)
of the Sonoran Desert##2##4##(2008-10#2)
of the Soret band and##2##5##(1991-7#2)
of the Soret band##4##4##(1991-7#2)(1992-12#1)(1995-2#1)
of the Soret##5##3##(1991-7#2)(1992-12#1)(1995-2#1)(2009-2#1)
of the Sorin##2##3##(2007-8#2)
of the South African##2##4##(2007-12#1)(2009-10#1)
of the South American##2##4##(2010-3#1)(2011-2#1)
of the South Pacific##2##4##(2008-1#2)
of the South##9##3##(2007-12#1)(2007-6#1)(2008-1#2)(2009-10#1)(2010-3#1)(2011-2#2)(2012-3#1)
of the Southeast##3##3##(1993-6#1)(2008-10#1)(2008-4#1)
of the Southern##5##3##(1990-8#1)(2008-9#1)(2009-5#1)(2013-7#2)
of the Soviet Union and##2##5##(1992-5#1)(2008-12#1)
of the Soviet Union##3##4##(1992-5#1)(2008-12#2)
of the Soybean##2##3##(2008-10#2)
of the Spanish##10##3##(1990-8#1)(1993-5#1)(1995-2#1)(2008-10#3)(2008-6#1)(2010-12#1)(2010-9#1)(2011-1#1)
of the Spatial##3##3##(2008-10#1)(2010-11#1)(2011-2#1)
of the Species##2##3##(2008-10#1)(2010-8#1)
of the Spectralon##3##3##(2008-2#3)
of the SrTiO(3)##2##3##(2008-3#2)
of the Src##4##3##(1994-3#1)(1995-3#1)(1995-6#1)(2011-2#1)
of the St##2##3##(1996-3#1)(2007-9#1)
of the Staphylococcus aureus##4##4##(1993-11#1)(1996-12#1)(1996-6#1)(2007-7#1)
of the Staphylococcus##5##3##(1991-7#1)(1993-11#1)(1996-12#1)(1996-6#1)(2007-7#1)
of the State Food and Veterinary Service##2##7##(2005-5#2)
of the State Food and##3##5##(2005-5#2)(2012-3#1)
of the State of##6##4##(1991-8#2)(1997-3#1)(2010-10#1)(2011-2#2)
of the State##17##3##(1991-8#2)(1993-3#2)(1995-12#1)(1997-3#1)(2005-5#2)(2007-11#1)(2008-9#1)(2009-10#1)(2010-10#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
of the States have##2##4##(1994-3#2)
of the States##4##3##(1994-3#2)(1995-1#1)(1997-2#1)
of the Stern layer##2##4##(2005-11#2)
of the Stokes vector##2##4##(2008-2#1)(2008-3#1)
of the Stokes##10##3##(2007-12#4)(2008-2#5)(2008-3#1)
of the Strehl##2##3##(2008-3#2)
of the Strengths and Difficulties Questionnaire##3##6##(2008-10#2)(2012-2#1)
of the Streptococcus pneumoniae##4##4##(1990-1#1)(1990-9#1)(1991-9#1)(2011-2#1)
of the Streptococcus##8##3##(1990-1#1)(1990-9#1)(1991-9#1)(1994-8#1)(1996-10#1)(2011-1#1)(2011-2#2)
of the Streptomyces coelicolor chromosome##2##5##(1994-12#2)
of the Streptomyces coelicolor##3##4##(1994-12#2)(1995-8#1)
of the Streptomyces##6##3##(1990-9#2)(1994-12#3)(1995-8#1)
of the Stroke Belt Consortium##2##5##(2007-9#2)
of the Stroke##3##3##(2007-9#2)(2012-12#1)
of the Strong##2##3##(1996-9#1)(2012-3#1)
of the Stroop Test##3##4##(1997-2#1)(2006-4#2)
of the Stroop task##2##4##(2007-1#1)(2013-1#1)
of the Stroop##7##3##(1995-1#1)(1997-2#1)(2006-4#2)(2007-1#1)(2007-8#1)(2013-1#1)
of the Structure##2##3##(1996-2#2)
of the Study##2##3##(2009-9#1)(2012-2#1)
of the Sun##3##3##(1996-5#1)(2008-3#2)
of the Swansea Muscularity Attitudes Questionnaire (SMAQ)##2##7##(2007-12#2)
of the Swedish##3##3##(2006-10#1)(2009-6#1)(2013-1#1)
of the Swine##2##3##(2006-7#1)(2013-8#1)
of the Swiss Canton of Vaud##3##6##(1990-4#1)(1993-9#2)
of the Swiss Federal Office of Statistics##2##7##(1991-11#2)
of the Swiss##13##3##(1990-12#1)(1990-4#1)(1991-11#3)(1991-2#1)(1993-9#2)(1996-12#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-7#1)
of the Sylvian fissure##2##4##(1996-7#1)(2006-12#1)
of the Syphilis Study at Tuskegee##2##6##(2013-1#2)
of the Syrian hamster##2##4##(1990-7#1)(1996-8#1)
of the T cell clones##3##5##(1994-2#2)(2008-11#1)
of the T cell##7##4##(1994-12#1)(1994-2#2)(1995-2#2)(1996-7#1)(2008-11#1)
of the T cells##2##4##(1991-12#1)(2009-9#1)
of the T state##2##4##(1991-5#1)(1993-9#1)
of the T##28##3##(1990-6#1)(1990-7#2)(1991-12#1)(1991-3#1)(1991-5#1)(1992-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#2)(1995-11#1)(1995-2#2)(1996-7#1)(2006-10#2)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-9#1)(2011-2#2)(2012-12#1)(2013-8#1)
of the T(in) channel##4##4##(2008-4#4)
of the T(in)##6##3##(1995-2#1)(2008-4#5)
of the T-DNA##4##3##(1990-11#1)(2006-12#1)(2008-10#2)
of the T-cell receptor##2##4##(1990-5#1)(1994-3#1)
of the T-cell##4##3##(1990-5#1)(1994-12#1)(1994-3#1)(1997-6#1)
of the T-matrix##3##3##(2008-3#3)
of the T-quaternary structure##2##4##(1992-3#2)
of the T3##2##3##(1995-8#1)(2008-10#1)
of the T4 DNA polymerase holoenzyme##4##6##(1990-5#1)(1994-9#3)
of the T4 DNA##5##4##(1990-4#1)(1990-5#1)(1994-9#3)
of the T4##9##3##(1990-4#1)(1990-5#2)(1994-12#1)(1994-9#3)(1995-8#1)(1997-3#1)
of the T7 RNA polymerase##5##5##(1990-11#1)(1990-4#1)(1993-11#1)(1996-11#1)(2008-8#1)
of the T7 genome##3##4##(1992-2#3)
of the T7##8##3##(1990-11#1)(1990-4#1)(1992-2#3)(1993-11#1)(1996-11#1)(2008-8#1)
of the TA* photoproduct##2##4##(1995-1#2)
of the TA*##3##3##(1995-1#3)
of the TAP-1 complex##2##4##(1994-12#2)
of the TATA box##3##4##(1993-12#1)(1995-8#2)
of the TATA-binding polypeptide (TBP)##2##5##(1995-8#1)(1996-5#1)
of the TATA-binding protein##3##4##(1993-8#1)(1995-8#2)
of the TATA-binding##5##3##(1993-8#1)(1995-8#3)(1996-5#1)
of the TCR##5##3##(1990-3#1)(1991-12#1)(1997-7#1)(2008-4#1)(2012-1#1)
of the TDT##2##3##(2008-4#1)(2008-9#1)
of the TDX system##3##4##(1993-8#3)
of the TEMPO+ behind-the-ear speech processor##2##6##(2008-9#2)
of the TEMPO+##3##3##(2008-9#3)
of the TF reflex produced by##3##6##(1990-7#2)(1991-5#1)
of the TF reflex##8##4##(1990-7#5)(1991-5#3)
of the TF##11##3##(1990-7#5)(1991-5#3)(1993-3#1)(1995-8#2)
of the TFIIIA gene##2##4##(1991-3#1)(1992-11#1)
of the TGF beta##2##4##(1992-4#1)(1992-8#1)
of the TGF-beta family##2##4##(2005-8#1)(2008-9#1)
of the TGF-beta type##3##4##(1995-2#1)(2009-4#2)
of the TGF-beta##11##3##(1990-9#2)(1991-4#1)(1995-2#3)(2005-8#1)(2008-9#1)(2009-4#2)(2013-1#1)
of the TGF-beta1/SMAD signaling pathway in##2##6##(2011-2#2)
of the TGF-beta1/SMAD signaling pathway##4##5##(2011-2#4)
of the TGF-beta1/SMAD##5##3##(2011-2#5)
of the TH gene##5##4##(1997-2#4)(1997-5#1)
of the TH##8##3##(1991-12#1)(1993-8#1)(1997-2#4)(1997-5#1)(2011-2#1)
of the THG microscope##2##4##(2008-3#2)
of the THOR-alpha##3##3##(2006-11#3)
of the THP-1##2##3##(1993-4#1)(1993-6#1)
of the THz##6##3##(2007-12#4)(2008-3#1)(2011-1#1)
of the TK promoter##2##4##(1992-11#1)(1992-12#1)
of the TLC##3##3##(1997-3#1)(2005-11#1)(2007-1#1)
of the TLR4##3##3##(2008-10#1)(2010-2#1)(2013-8#1)
of the TM##8##3##(1994-3#2)(2009-7#5)(2011-2#1)
of the TMJ##4##3##(2007-12#2)(2011-2#1)(2012-3#1)
of the TNF receptor##3##4##(1997-6#2)(2007-8#1)
of the TNF##5##3##(1997-6#2)(2007-8#1)(2008-8#1)(2009-3#1)
of the TNF-beta gene##2##4##(1997-7#2)
of the TNF-beta##3##3##(1997-7#3)
of the TNM classification##2##4##(1993-11#1)(2013-7#1)
of the TOF##2##3##(2007-8#1)(2008-10#1)
of the TP53##2##3##(2008-7#1)(2009-8#1)
of the TPA response element was##2##6##(1991-7#2)
of the TPA response element##4##5##(1991-2#1)(1991-7#3)
of the TPMT##2##3##(1996-3#1)(2008-8#1)
of the TQM process##2##4##(1993-3#1)(1994-1#1)
of the TRP gene##3##4##(1992-4#3)
of the TS gene##2##4##(1994-5#1)(2006-12#1)
of the TS##3##3##(1994-5#1)(2006-12#1)(2008-2#1)
of the TSH receptor##8##4##(1990-12#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#2)(1996-5#1)
of the TSH##11##3##(1990-12#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#2)(1993-8#1)(1996-5#1)(2006-10#1)
of the TSHR##3##3##(1991-8#2)(1994-3#1)
of the TSI##4##3##(2012-3#4)
of the TSP14 gene##2##4##(2006-12#2)
of the TSPO##2##3##(2012-2#2)
of the TSPO-targeted probe##2##4##(2012-2#2)
of the TSS##3##3##(2009-4#1)(2011-1#1)(2013-8#1)
of the TTF-1 binding##2##4##(1997-2#2)
of the TTRF##2##3##(2005-12#2)
of the TUNEL##3##3##(1995-12#1)(2008-11#1)(2010-1#1)
of the TYLCV##3##3##(2008-10#3)
of the Tapajos##2##3##(2013-7#2)
of the Tapajós##2##3##(2013-7#2)
of the Taq##2##3##(1991-6#1)(2007-8#1)
of the Task##2##3##(2007-6#1)(2009-4#1)
of the Tat##2##3##(1997-1#1)(2008-4#1)
of the Technical University##2##4##(1993-8#1)(2008-11#1)
of the Technical##3##3##(1993-8#1)(2008-11#1)(2008-12#1)
of the Teen Outreach program##2##5##(2007-1#2)
of the Tempisque##2##3##(2007-3#1)(2008-5#1)
of the Ten##2##3##(2006-2#1)(2010-5#1)
of the Test##2##3##(2005-10#1)(2006-11#1)
of the Tetrahymena large##2##4##(1991-2#1)(1995-1#1)
of the Tetrahymena ribozyme##3##4##(1991-11#2)(1992-7#1)
of the Tetrahymena##9##3##(1990-7#2)(1991-11#2)(1991-2#2)(1992-7#1)(1993-1#1)(1995-1#1)
of the Th1##2##3##(1996-10#1)(2006-10#1)
of the ThinPrep##3##3##(2007-6#2)(2013-8#1)
of the Third##7##3##(2006-9#1)(2008-3#1)(2008-7#2)(2011-2#3)
of the Thirteenth Amendment##2##4##(2011-2#2)
of the Ti plasmid##3##4##(1990-11#1)(1992-5#1)(2008-10#1)
of the Ti##11##3##(1990-11#1)(1992-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#1)(2009-7#2)
of the Ti-peroxy##2##3##(2005-11#2)
of the TiO(2) film##2##4##(2007-12#1)(2008-10#1)
of the TiO(2)##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
of the TiO2##3##3##(2007-12#3)
of the Tiam1 promoter##2##4##(2012-12#2)
of the Time Course##2##4##(2009-12#1)(2010-11#1)
of the Toll##2##3##(1991-5#1)(1994-2#1)
of the Tongan##2##3##(2008-1#2)
of the Torpedo nicotinic acetylcholine receptor##2##6##(1994-5#1)(1995-1#1)
of the Torpedo##4##3##(1991-7#1)(1993-3#1)(1994-5#1)(1995-1#1)
of the Toyota##2##3##(2012-2#1)(2013-8#1)
of the Trachelomonas##2##3##(2012-2#2)
of the Training##2##3##(1996-6#1)(2013-7#1)
of the Translocator Protein##2##4##(2012-2#2)
of the Trinidad##2##3##(2008-8#1)(2008-9#1)
of the Tripartite##2##3##(2007-12#2)
of the Triton X-100##2##4##(1990-11#1)(1993-6#1)
of the Trp fluorescence##2##4##(1991-7#1)(2008-4#1)
of the Trp residues##2##4##(1997-8#2)
of the Trp##7##3##(1991-12#1)(1991-7#1)(1997-8#3)(2008-4#1)(2008-5#1)
of the Ts cell##2##4##(1990-5#2)
of the Ts##3##3##(1990-5#3)
of the Turo group##2##4##(2008-10#2)
of the Tutotest##3##3##(2008-10#3)
of the TxtA##2##3##(2008-10#2)
of the Ty1##2##3##(1995-9#2)
of the Type III##2##4##(2012-12#1)(2013-1#1)
of the Type##4##3##(1992-9#1)(2006-8#1)(2012-12#1)(2013-1#1)
of the Tyr##3##3##(1990-9#3)
of the U##39##3##(1990-11#1)(1990-4#2)(1991-10#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#1)(2006-12#1)(2006-7#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-12#1)(2009-12#1)(2009-4#5)(2009-5#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#3)
of the U-G units##2##4##(1997-3#2)
of the U1##2##3##(1995-6#1)(1996-11#1)
of the U2##2##3##(1993-8#1)(1995-6#1)
of the UCLA##2##3##(2010-7#1)(2011-1#1)
of the UCS##2##3##(1995-12#1)(1996-6#1)
of the UGT1A##3##3##(1993-12#3)
of the UGT1D##3##3##(1993-12#3)
of the UK National##2##4##(2008-2#1)(2009-4#1)
of the UK##14##3##(1991-3#1)(1997-8#1)(2004-1#1)(2004-2#1)(2005-8#1)(2007-2#1)(2007-5#1)(2008-11#2)(2008-12#2)(2008-2#1)(2009-4#1)(2011-2#1)
of the UL5/52 proteins##2##4##(1996-8#2)
of the UL5/52##3##3##(1996-8#3)
of the URA3 gene##2##4##(1991-7#2)
of the URA3 promoter##2##4##(1991-7#2)
of the URA3##6##3##(1991-7#5)(2008-10#1)
of the URA5 gene##2##4##(1995-4#2)
of the US Congress##2##4##(1994-8#1)(2008-1#1)
of the US adult##2##4##(2006-12#1)(2013-1#1)
of the US population##3##4##(2008-9#1)(2010-12#1)(2010-2#1)
of the US##23##3##(1990-9#1)(1994-11#1)(1994-8#1)(1995-6#1)(1997-2#2)(2006-12#1)(2007-4#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-2#2)(2012-12#2)(2013-1#2)(2013-8#1)
of the US-1 genotype##2##4##(2008-10#2)
of the US-1##3##3##(2008-10#3)
of the US-7 and##2##4##(2008-10#2)
of the US-7##3##3##(2008-10#3)
of the US-8 genotype##2##4##(2008-10#2)
of the US-8##6##3##(2008-10#6)
of the USA##6##3##(1996-11#1)(2006-10#1)(2007-3#1)(2008-4#1)(2008-9#1)(2010-4#1)
of the USP##2##3##(2008-10#2)
of the USPHS Syphilis Study at Tuskegee##2##7##(2013-1#2)
of the UV light##3##4##(2006-10#1)(2008-3#1)(2009-12#1)
of the UV spectra##3##4##(1992-2#1)(2005-11#1)(2008-10#1)
of the UV##17##3##(1992-2#1)(1997-3#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#3)(2009-12#1)(2011-2#1)
of the UV-induced##2##3##(2007-11#1)(2008-3#1)
of the UVA##2##3##(1994-3#1)(2008-5#1)
of the UVA/UVB ratio##2##4##(2008-5#2)
of the Unified##2##3##(2008-7#1)(2012-3#1)
of the Unit##2##3##(2007-11#1)(2012-3#1)
of the United Kingdom##4##4##(1991-10#1)(2006-5#1)(2008-11#1)(2011-2#1)
of the United Kingdom's##3##4##(1995-3#1)(2008-11#1)(2008-5#1)
of the United Nations##5##4##(1992-4#1)(1995-9#1)(2008-5#1)(2008-9#1)(2012-12#1)
of the United States (U##2##5##(2008-12#1)(2009-12#1)
of the United States Department of Agriculture's##2##7##(2008-3#2)
of the United States and Canada##3##6##(2008-10#3)
of the United States and the##2##6##(1990-3#1)(2008-10#1)
of the United States and##8##5##(1990-3#1)(2007-12#1)(2008-1#1)(2008-10#5)
of the United States in##2##5##(1993-2#1)(2008-10#1)
of the United States is##2##5##(1991-5#1)(2009-4#1)
of the United States##68##4##(1990-3#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-2#1)(1995-1#1)(1996-12#1)(1997-5#1)(2006-10#1)(2007-1#1)(2007-12#3)(2007-2#2)(2008-1#2)(2008-10#20)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#3)(2008-9#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-8#1)(2010-9#2)(2011-2#4)(2012-3#1)(2013-8#1)
of the United##82##3##(1990-3#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-2#1)(1995-1#1)(1995-3#1)(1995-9#1)(1996-12#1)(1997-5#1)(2006-10#2)(2006-5#1)(2007-1#1)(2007-12#3)(2007-2#2)(2007-8#1)(2008-1#2)(2008-10#20)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#3)(2008-5#2)(2008-9#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-8#1)(2010-9#2)(2011-2#5)(2012-12#1)(2012-3#1)(2013-8#1)
of the Universidad##3##3##(2010-12#1)(2011-2#2)
of the University Hospital in##2##5##(1992-12#1)(2006-8#1)
of the University Hospital of the##2##6##(2011-2#2)
of the University Hospital of##4##5##(1991-3#1)(1996-11#1)(2011-2#2)
of the University Hospital##7##4##(1991-3#1)(1992-12#1)(1996-11#1)(2006-8#1)(2011-2#3)
of the University of California##3##5##(2007-9#2)(2008-10#1)
of the University of Ibadan##2##5##(2007-3#1)(2013-7#1)
of the University of Pennsylvania##3##5##(2007-9#2)(2008-2#1)
of the University of São Paulo##2##6##(2008-10#1)(2011-2#1)
of the University of Western Ontario Pediatric Audiological Monitoring Protocol (UWO##2##11##(2011-12#2)
of the University of##48##4##(1990-10#1)(1990-9#1)(1991-12#1)(1992-10#1)(1992-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-12#1)(1997-6#1)(2006-11#2)(2006-6#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#6)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
of the University##58##3##(1990-10#1)(1990-9#1)(1991-12#1)(1991-3#1)(1992-10#1)(1992-12#2)(1994-1#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-11#1)(1996-12#1)(1997-6#1)(2005-7#1)(2006-11#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#6)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
of the Upper Galilee##2##4##(2011-2#2)
of the Upper##5##3##(2006-4#2)(2010-9#1)(2011-2#2)
of the Urinary Bladder##2##4##(2008-10#1)(2008-12#1)
of the Use of##2##4##(2008-3#1)(2012-12#1)
of the V##5##3##(1993-7#1)(2008-10#2)(2009-8#1)(2012-11#1)
of the V-ATPase##5##3##(1993-11#2)(1995-6#2)(1996-5#1)
of the V2 receptor mRNA##2##5##(1994-12#2)
of the V2##3##3##(1994-12#2)(1996-11#1)
of the V3 region##2##4##(1990-12#1)(1994-9#1)
of the V3##3##3##(1990-12#1)(1994-9#2)
of the VAS##2##3##(2008-1#2)
of the VCE##2##3##(2007-5#2)
of the VDR gene##3##4##(1994-11#1)(2008-4#1)(2013-1#1)
of the VDR##4##3##(1992-6#1)(1994-11#1)(2008-4#1)(2013-1#1)
of the VEGF##2##3##(1992-3#1)(2006-9#1)
of the VEP##2##3##(1991-4#1)(1995-12#1)
of the VIP##2##3##(1990-5#1)(1993-9#1)
of the VIaL polypeptide##2##4##(1994-12#2)
of the VLH##2##3##(1995-5#2)
of the VLO##3##3##(1994-3#3)
of the VNO##3##3##(1993-2#3)
of the VNR##2##3##(1991-12#2)
of the VO(2)##2##3##(2007-11#2)
of the VR##2##3##(1992-6#2)
of the VSF##2##3##(2008-3#2)
of the VTA##4##3##(1993-6#1)(1994-12#3)
of the Valsalva maneuver##2##4##(2006-4#1)(2008-7#1)
of the Vater's ampulla##2##4##(1990-6#1)(2006-2#1)
of the Veillonella species##2##4##(2006-8#2)
of the Veillonella##3##3##(2006-8#3)
of the Veneto##2##3##(1992-7#1)(2012-12#1)
of the Venezuelan##3##3##(2008-5#3)
of the Veterinary Services##2##4##(2005-5#2)
of the Veterinary##3##3##(2005-5#3)
of the Vibrio alginolyticus sucrose uptake-encoding region##2##7##(1990-10#2)
of the Vmax##6##3##(1990-11#1)(1992-1#2)(1994-6#1)(1996-5#1)(1996-6#1)
of the W/O/W multiple emulsions##2##5##(2005-11#1)(2008-5#1)
of the W54S##2##3##(1997-2#2)
of the WCST##2##3##(1995-1#1)(1996-8#1)
of the WDF##2##3##(2008-2#2)
of the WHO##9##3##(1990-12#1)(1990-6#1)(1997-5#1)(2006-6#1)(2006-9#1)(2007-7#1)(2009-12#1)(2012-1#1)(2013-8#1)
of the WNN model##2##4##(2008-10#2)
of the WPA##3##3##(2006-9#3)
of the WSMV##3##3##(2008-10#3)
of the WT##3##3##(1995-5#1)(2008-4#1)(2012-12#1)
of the WWTP##3##3##(2007-8#1)(2008-10#2)
of the Water Framework Directive##3##5##(2008-10#3)
of the Water##4##3##(2008-10#3)(2011-2#1)
of the Wechsler##2##3##(1997-8#1)(2010-2#1)
of the Wei-Lin-Weissfeld##2##3##(1997-4#2)
of the Weibull##3##3##(2004-2#1)(2008-10#1)(2010-4#1)
of the West Indies##8##4##(2011-2#8)
of the West##11##3##(2007-3#1)(2011-2#9)(2013-1#1)
of the Western##9##3##(1993-11#1)(1997-2#1)(2006-9#1)(2007-2#1)(2008-10#1)(2008-4#1)(2009-7#1)(2010-3#1)(2011-2#1)
of the Wiberg angle##2##4##(2007-7#1)(2007-8#1)
of the Wigner transform of##2##5##(2007-12#2)
of the Wigner##3##3##(2007-11#1)(2007-12#2)
of the Wilcoxon##2##3##(1996-3#1)(2008-7#1)
of the Wilson##2##3##(1993-11#1)(2008-5#1)
of the Wnt##4##3##(1994-9#2)(1995-8#1)(2008-10#1)
of the World Federation of Neurosurgical Societies##2##7##(2008-2#1)(2011-2#1)
of the World Health Organization (WHO) has##2##7##(2008-1#1)(2008-8#1)
of the World Health Organization (WHO)##4##6##(1994-3#1)(2008-1#1)(2008-8#1)(2008-9#1)
of the World Health Organization##15##5##(1990-11#1)(1991-12#1)(1994-3#1)(1997-8#1)(2006-10#2)(2007-3#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-1#1)(2013-1#1)
of the World Health##18##4##(1990-11#1)(1991-12#1)(1994-3#1)(1997-8#1)(2006-10#2)(2007-2#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
of the World Organisation for Animal Health##2##7##(2011-2#2)
of the World Trade Center##2##5##(2008-8#2)
of the World Trade Organization (WTO)##2##6##(2005-5#2)
of the World Trade##4##4##(2005-5#2)(2008-8#2)
of the World Wide Web##4##5##(1996-9#2)(1997-5#1)(2006-5#1)
of the World##42##3##(1990-11#1)(1991-12#1)(1994-3#1)(1996-9#2)(1997-5#1)(1997-8#2)(2005-5#2)(2006-10#2)(2006-5#2)(2006-7#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-8#4)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of the WorldSID prototype##2##4##(2007-4#2)
of the WorldSID##5##3##(2007-1#1)(2007-4#4)
of the Wölter mirror##2##4##(2008-2#2)
of the X and Y##2##5##(1994-1#1)(2008-7#1)
of the X chromosome##4##4##(1994-8#1)(1995-11#1)(2008-12#1)(2012-1#1)
of the X##15##3##(1993-6#1)(1994-1#1)(1994-8#1)(1995-11#3)(2006-10#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#1)(2012-1#1)(2012-2#1)
of the X-chromosome##4##3##(1994-11#1)(1997-5#3)
of the X-linked##2##3##(2008-4#1)(2008-9#1)
of the X-ray beam##3##4##(1995-2#1)(2006-5#1)(2008-10#1)
of the X-ray##16##3##(1991-2#1)(1991-7#1)(1994-8#1)(1995-2#1)(1995-8#1)(2006-5#3)(2006-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2012-12#1)(2013-8#3)
of the XE-2100##2##3##(2008-10#2)
of the XIII Congress##2##4##(1994-2#1)(1994-9#1)
of the XIIIth##2##3##(2008-5#2)
of the XR data##2##4##(2006-5#2)
of the XR##4##3##(1995-8#1)(2006-5#3)
of the XVII##2##3##(1996-3#1)(2008-11#1)
of the XX##4##3##(2008-2#2)(2008-9#1)(2011-1#1)
of the Xanthomonas avr/pth##3##4##(2008-10#3)
of the Xanthomonas##4##3##(2008-10#4)
of the Xenopus laevis##7##4##(1993-12#1)(1993-6#2)(1994-12#2)(1995-8#1)(1997-6#1)
of the Xenopus vitellogenin A2 gene##2##6##(1992-6#2)
of the Xenopus##16##3##(1992-6#2)(1993-12#1)(1993-6#4)(1994-12#2)(1995-8#1)(1996-5#1)(1996-7#2)(1997-6#1)(1997-7#1)(2008-5#1)
of the Y chromosome##8##4##(1990-11#2)(1993-9#1)(1995-11#3)(1996-12#1)(2012-3#1)
of the Y##12##3##(1990-11#2)(1993-9#1)(1995-11#4)(1996-12#1)(1996-7#1)(2008-2#1)(2012-3#1)(2013-8#1)
of the Y(1) and Y(5)##2##5##(2005-6#2)
of the Y(1)##3##3##(2005-6#3)
of the YAC##2##3##(1996-10#1)(1996-12#1)
of the Yanomámi##3##3##(1991-12#3)
of the Yb##5##3##(2008-2#1)(2008-3#4)
of the Yb(3+)##2##3##(2007-12#2)
of the Yellow##2##3##(2008-2#1)(2012-12#1)
of the Z##3##3##(1994-11#2)(2008-3#1)
of the Z-scan technique as a method to##2##8##(2007-12#2)
of the Z-scan technique##3##4##(2007-11#1)(2007-12#2)
of the ZIP##3##3##(2013-1#2)(2013-8#1)
of the Zernike##4##3##(2007-12#1)(2008-1#1)(2008-3#2)
of the Zeus##2##3##(2007-8#1)(2011-2#1)
of the Zn##3##3##(2008-10#2)(2012-12#1)
of the ZnO was##2##4##(2006-12#1)(2009-8#1)
of the ZnO##3##3##(2006-12#1)(2009-8#1)(2010-4#1)
of the Zone##2##3##(2008-3#1)(2008-7#1)
of the [(MGD)2-Fe(2+)-NO] complex##2##4##(1994-5#2)
of the [1##2##3##(1992-3#1)(1995-1#1)
of the [2Fe-2S] cluster of the##2##6##(1992-3#1)(1997-3#1)
of the [2Fe-2S]##4##3##(1991-4#1)(1992-3#2)(1997-3#1)
of the [4Fe-4S] cluster##3##4##(1995-8#2)(1996-7#1)
of the [Eu(Tc)(HP)] complex##2##4##(2007-11#2)
of the a##4##3##(1996-4#1)(2008-1#1)(2008-3#1)(2009-4#1)
of the aa sequence##3##4##(1990-5#1)(1993-2#1)(1997-1#1)
of the aa##6##3##(1990-5#1)(1991-9#1)(1993-12#1)(1993-2#1)(1997-1#1)(2005-8#1)
of the abbey##3##3##(1994-3#3)
of the abbot##2##3##(1994-3#2)
of the abdomen and pelvis##3##5##(2007-4#1)(2009-8#1)(2012-2#1)
of the abdomen and##7##4##(2007-4#1)(2008-4#1)(2009-10#1)(2009-2#2)(2009-8#1)(2012-2#1)
of the abdomen is##3##4##(2006-11#1)(2006-6#1)(2008-7#1)
of the abdomen revealed##3##4##(1997-3#1)(2006-4#1)(2008-6#1)
of the abdomen showed a##2##5##(2010-9#1)(2013-8#1)
of the abdomen showed##5##4##(2008-9#1)(2010-9#1)(2011-2#1)(2013-8#2)
of the abdomen were##3##4##(2007-4#1)(2010-9#1)(2011-2#1)
of the abdomen##36##3##(1990-10#1)(1990-6#1)(1991-2#1)(1991-9#1)(1993-8#1)(1997-3#1)(2006-1#1)(2006-11#2)(2006-4#1)(2006-6#1)(2007-2#1)(2007-4#3)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-2#2)(2009-8#1)(2010-9#2)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
of the abdominal aorta in##2##5##(1991-9#2)
of the abdominal aorta##8##4##(1991-9#3)(1992-4#1)(1993-11#1)(1997-8#1)(2006-10#1)(2008-5#1)
of the abdominal aorta]##2##4##(1990-6#1)(1993-10#1)
of the abdominal cavity##3##4##(2009-2#3)
of the abdominal muscles##2##4##(1993-10#1)(2008-10#1)
of the abdominal wall is##2##5##(1990-5#1)(1991-9#1)
of the abdominal wall##10##4##(1990-10#1)(1990-5#1)(1991-12#1)(1991-9#1)(1996-3#1)(2008-10#2)(2011-2#2)(2012-12#1)
of the abdominal##48##3##(1990-10#1)(1990-4#1)(1990-5#2)(1990-6#1)(1991-12#1)(1991-9#4)(1992-3#1)(1992-4#1)(1993-10#2)(1993-11#1)(1993-12#1)(1993-6#1)(1996-3#1)(1997-8#1)(2006-10#1)(2007-12#2)(2007-4#2)(2007-8#2)(2008-10#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#4)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#2)
of the abducens nerve##6##4##(2006-12#4)(2012-3#2)
of the abducens##7##3##(1991-3#1)(2006-12#4)(2012-3#2)
of the abductor digiti minimi muscle##2##6##(2008-12#2)
of the aberrant##3##3##(2007-8#1)(2012-2#2)
of the aberrations present##2##4##(2008-2#1)(2008-3#1)
of the abilities##2##3##(2010-2#2)
of the ability of the##5##5##(1995-10#1)(1997-7#1)(2008-3#1)(2008-5#1)(2010-10#1)
of the ability of these##2##5##(2007-12#1)(2008-10#1)
of the ability of##19##4##(1994-8#1)(1995-10#1)(1997-7#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-8#1)(2008-9#2)(2010-10#1)(2012-3#1)
of the ability to##13##4##(1991-10#1)(1995-2#1)(1996-7#1)(2007-10#1)(2007-12#1)(2008-12#1)(2008-8#1)(2009-8#3)(2010-12#1)(2012-3#1)(2013-7#1)
of the ability##33##3##(1991-10#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#1)(1996-7#1)(1997-7#1)(2007-10#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-8#2)(2008-9#2)(2009-8#3)(2010-10#1)(2010-12#1)(2012-3#2)(2013-7#1)
of the abiotic##3##3##(2008-10#1)(2008-8#1)(2013-7#1)
of the ablated##2##3##(2008-10#1)(2008-3#1)
of the ablation process##2##4##(2007-12#1)(2008-3#1)
of the ablation##4##3##(2007-12#1)(2007-8#1)(2008-3#1)(2011-2#1)
of the abnormal##6##3##(1990-11#1)(1990-5#1)(1992-3#1)(2007-10#1)(2008-7#2)
of the abnormalities##8##3##(1992-5#1)(1997-8#1)(2006-4#1)(2006-5#1)(2007-8#1)(2011-12#1)(2011-2#1)(2013-1#1)
of the abnormality##4##3##(2008-4#1)(2011-2#3)
of the abortion##2##3##(2007-3#1)(2011-1#1)
of the above mentioned parameters##2##5##(1990-9#1)(2008-10#1)
of the above mentioned##11##4##(1990-9#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#5)(2011-2#2)
of the above parameters##7##4##(1994-4#1)(1994-5#1)(1996-5#1)(2006-9#1)(2008-8#1)(2013-1#2)
of the above species##4##4##(2008-10#2)(2008-4#2)
of the above three##2##4##(2008-10#1)(2008-5#1)
of the above two##3##4##(1992-4#1)(1995-11#1)(2008-4#1)
of the above##88##3##(1990-12#1)(1990-4#2)(1990-9#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-9#1)(1993-12#1)(1994-4#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1996-1#1)(1996-3#1)(1996-5#2)(1997-3#1)(2004-11#1)(2004-2#1)(2004-9#2)(2005-7#1)(2006-12#1)(2006-5#1)(2006-6#3)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#1)(2008-2#1)(2008-4#4)(2008-5#3)(2008-7#1)(2008-8#2)(2009-4#1)(2009-5#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-2#1)(2013-1#5)(2013-8#2)
of the above-mentioned##7##3##(1997-7#1)(2005-11#1)(2006-6#1)(2007-12#1)(2008-4#1)(2008-8#2)
of the abscess and##3##4##(1993-1#1)(1993-9#1)(2013-8#1)
of the abscess##6##3##(1993-1#1)(1993-9#1)(2008-9#1)(2010-12#2)(2013-8#1)
of the absence of a##2##5##(1995-3#1)(2009-4#1)
of the absence of##18##4##(1990-11#1)(1991-2#1)(1992-1#1)(1992-4#1)(1995-3#1)(1996-3#1)(1997-8#1)(2006-4#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)
of the absence##19##3##(1990-11#1)(1991-2#1)(1992-1#1)(1992-4#1)(1995-3#1)(1996-3#1)(1997-8#1)(2006-4#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#1)
of the absolute configuration##2##4##(2006-12#2)
of the absolute number##2##4##(2010-1#1)(2013-7#1)
of the absolute value of the##2##6##(2008-3#2)
of the absolute##24##3##(1997-2#2)(1997-5#1)(2005-10#1)(2006-10#1)(2006-12#2)(2007-5#1)(2008-10#1)(2008-2#4)(2008-3#7)(2009-3#1)(2010-1#1)(2010-6#1)(2013-7#1)
of the absorbance and##2##4##(1992-8#1)(2008-10#1)
of the absorbance maximum##2##4##(1991-12#1)(2008-10#1)
of the absorbance of the##3##5##(2008-10#3)
of the absorbance of##5##4##(2008-10#5)
of the absorbance##18##3##(1991-12#1)(1992-8#1)(1997-1#1)(2006-10#1)(2008-10#12)(2008-6#1)(2008-8#1)
of the absorbed##2##3##(1996-8#1)(2007-12#1)
of the absorber##2##3##(2007-12#1)(2012-2#1)
of the absorbing medium##2##4##(2008-3#2)
of the absorbing##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
of the absorption and the reduced scattering coefficients##3##8##(2007-12#1)(2008-3#2)
of the absorption and##8##4##(1992-8#1)(1994-11#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
of the absorption band##3##4##(2007-11#1)(2008-2#1)(2010-7#1)
of the absorption bands##3##4##(1991-7#1)(2006-12#1)(2008-10#1)
of the absorption coefficient and##2##5##(2008-2#2)
of the absorption coefficient is##2##5##(2008-3#2)
of the absorption coefficient of##4##5##(2008-2#2)(2008-3#2)
of the absorption coefficient was##2##5##(2007-12#1)(2008-3#1)
of the absorption coefficient##19##4##(2007-11#1)(2007-12#5)(2008-2#5)(2008-3#8)
of the absorption line##2##4##(2008-2#1)(2008-3#1)
of the absorption of the##4##5##(1993-11#1)(2007-11#1)(2008-2#1)(2008-3#1)
of the absorption of##6##4##(1993-11#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
of the absorption spectra##2##4##(2008-10#1)(2008-2#1)
of the absorption spectrum##2##4##(1991-9#1)(2008-3#1)
of the absorption##63##3##(1991-7#1)(1991-9#1)(1992-8#1)(1993-11#1)(1994-11#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-12#1)(2007-11#6)(2007-12#8)(2008-10#4)(2008-11#1)(2008-2#12)(2008-3#19)(2008-6#1)(2009-9#1)(2010-7#1)(2013-1#1)
of the absorptive##2##3##(2007-11#1)(2007-12#1)
of the abstracts##2##3##(2008-5#1)(2013-1#1)
of the abundance of##2##4##(1997-6#1)(2008-3#1)
of the abundant##7##3##(1990-5#1)(1994-9#1)(2006-12#2)(2007-5#1)(2008-10#1)(2012-2#1)
of the abuse##2##3##(2006-4#1)(2010-7#1)
of the abusers##2##3##(1993-5#2)
of the ac##3##3##(2006-12#1)(2007-12#1)(2008-3#1)
of the academic##7##3##(1994-12#1)(1997-1#1)(1997-2#1)(2008-11#2)(2009-4#1)(2012-3#1)
of the accelerated##2##3##(1997-7#1)(2008-5#1)
of the acceleration##2##3##(2012-12#2)
of the acceptable##4##3##(2006-4#2)(2008-10#1)(2013-8#1)
of the acceptor sites##2##4##(1994-9#1)(1996-11#1)
of the acceptor##13##3##(1991-7#1)(1994-9#1)(1995-6#1)(1996-11#1)(1996-5#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#3)(2013-8#1)
of the acceptors were##2##4##(2008-10#1)(2010-5#1)
of the acceptors##3##3##(2005-7#1)(2008-10#1)(2010-5#1)
of the access##3##3##(1990-11#1)(2008-1#1)(2011-2#1)
of the accessibility of the##2##5##(1990-3#1)(2008-1#1)
of the accessible##5##3##(1992-6#1)(1997-6#1)(2006-12#1)(2008-11#1)(2010-5#1)
of the accessions were##2##4##(2008-10#2)
of the accessions##3##3##(2008-10#3)
of the accessory glands##3##4##(2007-12#1)(2008-7#2)
of the accessory olfactory bulb##2##5##(1992-8#1)(1997-7#1)
of the accessory olfactory##3##4##(1992-8#1)(1994-10#1)(1997-7#1)
of the accessory##15##3##(1990-3#2)(1992-8#1)(1994-10#1)(1995-11#1)(1997-7#1)(2007-12#2)(2008-10#1)(2008-7#3)(2010-11#1)(2012-2#1)(2013-1#1)
of the accident##4##3##(2008-4#2)(2009-10#1)(2012-2#1)
of the accidents##4##3##(2005-12#2)(2008-11#1)(2013-8#1)
of the accompanying##4##3##(2007-11#1)(2007-8#1)(2008-7#1)(2012-2#1)
of the accumulated##5##3##(1990-8#1)(1992-3#1)(1996-9#1)(2007-12#1)(2008-1#1)
of the accumulating##4##3##(1993-5#1)(1994-5#1)(2008-7#1)(2012-3#1)
of the accumulation of##5##4##(1991-3#1)(1996-6#1)(2005-8#1)(2008-10#1)(2008-8#1)
of the accumulation##7##3##(1991-3#1)(1996-6#1)(2005-8#1)(2008-10#2)(2008-8#1)(2013-1#1)
of the accuracy of the##5##5##(2008-10#2)(2008-3#3)
of the accuracy of##13##4##(2006-5#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-8#1)(2012-3#1)
of the accuracy##16##3##(2006-5#1)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#4)(2008-4#1)(2008-6#1)(2008-8#1)(2012-3#1)
of the acetabular component##5##4##(2007-7#1)(2008-11#1)(2008-3#1)(2009-3#2)
of the acetabular roof##2##4##(2007-8#2)
of the acetabular##9##3##(2007-7#2)(2007-8#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-3#2)
of the acetabulum in##2##4##(2007-7#1)(2009-3#1)
of the acetabulum##19##3##(1995-9#1)(2006-11#1)(2007-7#5)(2008-5#2)(2008-8#1)(2009-3#3)(2009-4#2)(2013-1#2)(2013-8#2)
of the acetabulum]##2##3##(1993-8#1)(1995-9#1)
of the acetamido group##2##4##(1993-6#2)
of the acetate##3##3##(1997-2#1)(2008-10#1)(2008-6#1)
of the acetone powder##2##4##(2008-5#2)
of the acetone##4##3##(2008-11#2)(2008-5#2)
of the acetyl##3##3##(1991-10#1)(1991-9#1)(1997-2#1)
of the acetylated##2##3##(1995-8#1)(2008-6#1)
of the acetylcholine receptor##3##4##(1991-3#1)(1993-3#1)(1994-5#1)
of the acetylcholine transporter-vesamicol receptor##2##5##(1992-6#2)
of the acetylcholine##11##3##(1990-7#2)(1991-3#1)(1992-3#1)(1992-6#3)(1993-3#1)(1994-5#1)(1995-11#1)(2008-10#1)
of the achaete-scute##5##3##(1990-5#1)(1990-8#3)(2009-5#1)
of the achievement##3##3##(2007-11#1)(2012-2#2)
of the achievements##3##3##(2008-12#1)(2010-8#1)(2013-7#1)
of the achromatic##4##3##(2008-2#2)(2008-3#2)
of the acid and the##2##5##(2008-10#1)(2008-5#1)
of the acid and##6##4##(1990-7#1)(1996-9#1)(1997-7#1)(2005-4#1)(2008-10#1)(2008-5#1)
of the acid solid solution##2##5##(2008-5#2)
of the acid##25##3##(1990-7#1)(1996-9#1)(1997-7#1)(2004-9#1)(2005-4#1)(2007-11#2)(2008-10#9)(2008-12#1)(2008-5#6)(2008-7#1)(2012-1#1)
of the acid-base##4##3##(2006-6#1)(2008-10#3)
of the acid-labile##3##3##(1990-11#2)(2006-12#1)
of the acidic##10##3##(1990-7#1)(1991-9#1)(1993-11#1)(1994-5#1)(1995-4#1)(1996-2#1)(2006-6#1)(2008-10#2)(2008-5#1)
of the acidity##4##3##(2008-10#4)
of the acids##3##3##(2008-10#2)(2012-1#1)
of the acinar cells##2##4##(1992-8#1)(1995-11#1)
of the acne##2##3##(2010-5#1)(2012-12#1)
of the acorn barnacle Megabalanus rosa##4##6##(1990-5#4)
of the acoustic field##3##4##(2008-2#3)
of the acoustic startle response##2##5##(1991-1#2)
of the acoustic##10##3##(1991-1#2)(2006-12#1)(2007-1#1)(2008-2#3)(2008-3#1)(2009-3#1)(2009-5#1)
of the acquired immunodeficiency syndrome (AIDS)##2##6##(1990-6#1)(1995-8#1)
of the acquired immunodeficiency syndrome##4##5##(1990-6#1)(1995-8#1)(2005-10#1)(2008-1#1)
of the acquired##10##3##(1990-6#1)(1994-8#1)(1995-8#1)(2005-10#1)(2008-1#1)(2008-10#1)(2010-3#1)(2012-1#1)(2013-1#2)
of the acquisition##2##3##(2007-8#1)(2008-4#1)
of the acridine##2##3##(2008-3#2)
of the acrosomal process##2##4##(1995-10#2)
of the acrosomal##3##3##(1995-10#2)(2007-12#1)
of the acrosome and##3##4##(2008-7#3)
of the acrosome reaction##3##4##(2008-8#3)
of the acrosome##9##3##(1994-2#1)(2008-7#3)(2008-8#3)(2012-12#2)
of the acrylic##3##3##(2005-11#1)(2008-2#1)(2008-5#1)
of the act##2##3##(1994-1#1)(2009-10#1)
of the actin cytoskeleton and##3##5##(1997-4#1)(1997-6#1)(2008-5#1)
of the actin cytoskeleton in##3##5##(2008-10#1)(2008-11#1)(2009-10#1)
of the actin cytoskeleton is##2##5##(1997-4#1)(2012-12#1)
of the actin cytoskeleton##16##4##(1991-5#1)(1997-4#2)(1997-6#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2011-1#1)(2011-12#1)(2012-12#1)
of the actin gene##2##4##(1991-8#1)(2008-10#1)
of the actin##30##3##(1991-2#1)(1991-5#1)(1991-8#1)(1992-3#1)(1993-12#2)(1995-3#1)(1997-4#3)(1997-6#1)(1997-7#1)(2008-10#2)(2008-11#6)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-7#1)(2009-8#1)(2011-1#1)(2011-12#1)(2012-12#1)
of the actin-binding protein##2##4##(1994-8#1)(2011-1#1)
of the action of a##2##5##(1991-10#1)(2007-11#1)
of the action of##13##4##(1990-5#1)(1991-10#1)(1992-6#1)(1993-3#1)(1995-6#1)(1996-4#1)(1997-2#1)(2006-3#1)(2007-11#2)(2008-10#1)(2008-7#1)(2012-3#1)
of the action potential##7##4##(1990-7#2)(1991-5#2)(1992-8#1)(1996-2#1)(2009-5#1)
of the action##25##3##(1990-5#1)(1990-7#2)(1991-10#1)(1991-11#1)(1991-5#2)(1992-6#1)(1992-8#1)(1993-3#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-4#1)(1997-2#1)(2006-3#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-7#1)(2009-2#1)(2009-5#1)(2012-12#1)(2012-3#1)
of the actions of##8##4##(1990-5#1)(1991-4#1)(1991-5#1)(1993-11#1)(1994-10#1)(1996-10#1)(2008-4#2)
of the actions##14##3##(1990-5#1)(1991-4#1)(1991-5#1)(1993-11#1)(1994-10#1)(1996-10#1)(2004-12#1)(2007-6#3)(2007-8#1)(2008-4#2)(2011-2#1)
of the activated and##2##4##(1992-12#1)(1997-1#1)
of the activated receptor##4##4##(1991-4#1)(1996-2#1)(1997-7#1)(2012-3#1)
of the activated##24##3##(1990-2#2)(1991-11#1)(1991-3#1)(1991-4#1)(1992-12#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-6#1)(1997-7#2)(2005-11#4)(2008-10#2)(2008-4#1)(2012-3#1)
of the activating light##2##4##(2005-7#2)
of the activating##5##3##(1992-7#1)(1995-2#1)(2005-7#2)(2008-3#1)
of the activation motif##2##4##(1997-3#2)
of the activation of the##3##5##(1990-2#1)(2008-6#1)(2009-2#1)
of the activation of##12##4##(1990-2#1)(1991-2#1)(1992-9#2)(1993-11#1)(1994-6#1)(1996-2#1)(2008-10#1)(2008-6#1)(2009-2#1)(2009-6#1)(2009-8#1)
of the activation parameters##2##4##(1996-2#1)(2008-10#1)
of the activation##25##3##(1990-2#1)(1991-2#2)(1992-9#2)(1993-11#1)(1994-6#1)(1994-9#1)(1996-2#2)(1997-2#1)(1997-3#2)(2006-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-2#1)(2009-6#1)(2009-8#1)
of the activator protein-1##2##4##(1996-3#1)(2008-5#1)
of the activator##6##3##(1992-9#1)(1994-9#1)(1996-3#1)(1997-4#1)(2008-5#2)
of the activators##3##3##(1993-12#1)(1993-3#1)(2008-10#1)
of the active beta##2##4##(1991-9#1)(2006-5#1)
of the active components of##2##5##(2008-10#1)(2013-1#1)
of the active components##3##4##(1996-2#1)(2008-10#1)(2013-1#1)
of the active compounds##4##4##(1991-3#1)(1994-9#1)(2008-10#1)(2012-2#1)
of the active decameric form of wild-type##2##7##(1994-11#2)
of the active enzyme##2##4##(1995-3#1)(1995-5#1)
of the active form##2##4##(1991-6#1)(1995-2#1)
of the active ingredient##5##4##(2008-5#3)(2011-2#2)
of the active ingredients##4##4##(2008-5#1)(2009-6#1)(2010-2#1)(2010-9#1)
of the active material##2##4##(2008-3#1)(2008-5#1)
of the active mutants##2##4##(1992-9#1)(1993-3#1)
of the active principle##2##4##(2008-10#2)
of the active scar##2##4##(2007-11#1)(2009-6#1)
of the active site cysteine##2##5##(1995-2#1)(1995-5#1)
of the active site in the##2##6##(1992-6#1)(1994-8#1)
of the active site in##3##5##(1990-7#1)(1992-6#1)(1994-8#1)
of the active site iron##2##5##(1993-6#2)
of the active site of the enzyme##3##7##(1994-8#1)(2008-4#1)(2009-9#1)
of the active site of the##5##6##(1994-11#1)(1994-8#1)(2007-6#1)(2008-4#1)(2009-9#1)
of the active site of##10##5##(1990-2#1)(1991-5#1)(1991-8#1)(1992-11#1)(1994-11#2)(1994-8#1)(2007-6#1)(2008-4#1)(2009-9#1)
of the active site residues##2##5##(1997-4#1)(2007-6#1)
of the active site serine residue##2##6##(1992-6#2)
of the active site serine##4##5##(1991-4#1)(1992-6#2)(1994-8#1)
of the active site##58##4##(1990-2#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-2#2)(1991-4#3)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#2)(1992-6#5)(1993-6#2)(1994-11#3)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#6)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-11#1)(1997-1#1)(1997-2#1)(1997-4#2)(2007-6#2)(2008-4#3)(2009-9#1)(2010-11#1)(2010-12#1)(2013-8#2)
of the active sites##3##4##(1990-8#1)(1992-8#1)(2008-10#1)
of the active##147##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-4#3)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#2)(1992-6#8)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#5)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#7)(1994-9#2)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#3)(1996-11#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#1)(2005-8#1)(2006-10#2)(2006-5#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#5)(2008-5#8)(2008-8#2)(2009-6#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#2)
of the active-site##7##3##(1991-2#1)(1993-3#1)(1994-5#1)(1995-2#1)(1995-6#2)(2009-9#1)
of the activin##2##3##(1992-6#1)(1994-9#1)
of the activities and##2##4##(2008-4#1)(2008-5#1)
of the activities of the enzyme complexes of the electron transport chain##2##12##(1996-9#2)
of the activities of the##6##5##(1995-5#1)(1996-9#2)(2008-7#1)(2012-12#1)(2013-1#1)
of the activities of##13##4##(1990-8#1)(1991-8#1)(1994-1#1)(1995-3#1)(1995-5#1)(1996-9#2)(2008-5#2)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#1)
of the activities##25##3##(1990-8#1)(1991-8#1)(1993-3#1)(1994-1#1)(1994-11#1)(1995-3#1)(1995-5#1)(1996-9#2)(2004-4#1)(2006-2#1)(2006-8#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#2)(2009-7#1)(2012-12#1)(2013-1#1)
of the activity and##2##4##(1995-1#1)(2013-7#1)
of the activity coefficients of the##3##6##(1991-5#1)(2008-10#2)
of the activity coefficients of##5##5##(1990-8#1)(1991-5#1)(2006-10#1)(2008-10#2)
of the activity coefficients##7##4##(1990-8#1)(1991-5#1)(2006-10#1)(2008-10#4)
of the activity in##3##4##(1990-10#1)(2012-1#1)(2013-1#1)
of the activity is##2##4##(1995-6#1)(2013-1#1)
of the activity observed##2##4##(1990-9#1)(1997-8#1)
of the activity of the##10##5##(1990-11#1)(1990-2#1)(1990-5#1)(1990-9#1)(1992-6#1)(1995-12#1)(1995-2#1)(1996-9#1)(2008-10#2)
of the activity of this##2##5##(1991-10#1)(1991-6#1)
of the activity of##43##4##(1990-11#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-10#1)(1991-6#1)(1991-9#1)(1992-5#1)(1992-6#1)(1993-11#2)(1993-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(2006-12#1)(2007-12#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#2)(2012-3#2)(2013-1#1)
of the activity was##4##4##(1990-2#1)(1992-2#1)(1992-8#1)(1995-11#1)
of the activity with##2##4##(1990-11#1)(1995-3#1)
of the activity##84##3##(1990-10#1)(1990-11#3)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#3)(1990-7#2)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-11#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#10)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#2)(2012-1#1)(2012-3#2)(2013-1#3)(2013-7#1)
of the actomyosin##4##3##(1990-12#1)(1990-4#1)(1991-10#1)(1994-3#1)
of the actual number of##2##5##(2008-8#1)(2012-3#1)
of the actual surface##2##4##(2005-11#1)(2008-3#1)
of the actual##30##3##(1990-12#1)(1991-12#1)(1993-9#1)(1995-11#1)(1995-8#1)(1996-7#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-7#1)(2012-3#3)
of the actuator##5##3##(2008-2#1)(2008-3#1)(2010-2#1)(2010-4#1)(2012-1#1)
of the actuators##3##3##(2008-2#1)(2010-2#2)
of the aculeus##2##3##(2008-6#2)
of the acupuncture##2##3##(2011-1#2)
of the acute coronary##2##4##(2008-10#1)(2010-12#1)
of the acute effects of##3##5##(1990-5#1)(1992-3#1)(2007-11#1)
of the acute injury##2##4##(1997-2#1)(2006-10#1)
of the acute myocardial infarction##2##5##(1997-3#1)(2008-10#1)
of the acute phase response##3##5##(1995-2#1)(1996-2#2)
of the acute phase##6##4##(1991-7#1)(1993-12#1)(1995-2#1)(1996-2#2)(1996-9#1)
of the acute##31##3##(1990-5#1)(1991-7#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-6#1)(1995-2#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(2005-8#1)(2006-10#2)(2007-10#2)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-5#1)
of the acute-phase##3##3##(1994-10#1)(1994-3#1)(1995-11#1)
of the acutely compensated state##2##5##(1991-2#2)
of the acutely lethal##3##4##(1995-2#1)(1997-3#2)
of the acutely##7##3##(1991-2#2)(1995-2#1)(1996-9#1)(1997-3#2)(2007-12#1)
of the acyl chain##2##4##(1993-11#1)(1993-3#1)
of the acyl chains##4##4##(1991-2#1)(1992-1#1)(1992-9#2)
of the acyl##9##3##(1990-8#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-9#2)(1993-11#1)(1993-3#1)(2008-10#1)
of the acyl-CoA##2##3##(1994-6#1)(1995-5#1)
of the ad4bp gene##3##4##(1995-3#3)
of the ada##4##3##(1991-9#3)(1997-1#1)
of the adamantyl cation##2##4##(2006-12#2)
of the adaptation##3##3##(1991-5#1)(2007-5#1)(2008-11#1)
of the adaptive controller##2##4##(1997-2#1)(2010-2#1)
of the adaptive effect##2##4##(1992-10#2)
of the adaptive immune response##4##5##(2007-11#1)(2008-10#1)(2010-2#1)(2012-12#1)
of the adaptive immune##5##4##(2007-11#1)(2008-10#1)(2010-2#1)(2012-12#1)(2013-8#1)
of the adaptive response##3##4##(1997-1#3)
of the adaptive##24##3##(1992-10#2)(1993-12#1)(1997-1#3)(1997-2#1)(2005-12#1)(2007-11#1)(2008-10#1)(2008-2#5)(2008-8#1)(2009-8#1)(2010-2#2)(2010-4#1)(2011-1#2)(2012-12#1)(2013-8#1)
of the added amount##2##4##(2004-9#1)(2008-10#1)
of the added inulin was##2##5##(2011-1#2)
of the added##20##3##(1990-5#1)(1990-8#1)(1991-5#1)(1991-7#1)(1994-3#1)(1994-5#1)(1995-1#1)(1997-3#1)(2004-9#1)(2006-12#1)(2006-3#1)(2007-9#1)(2008-10#3)(2009-4#1)(2011-1#2)(2011-2#2)
of the addition of fenofibrate to##2##6##(1991-3#1)(2008-7#1)
of the addition of the##2##5##(1995-1#1)(1997-1#1)
of the addition of##15##4##(1991-3#1)(1993-12#1)(1995-1#1)(1997-1#1)(2006-3#1)(2007-8#1)(2008-10#3)(2008-6#1)(2008-7#1)(2010-11#1)(2010-4#1)(2010-5#1)(2013-8#1)
of the addition##16##3##(1991-3#1)(1993-12#1)(1995-1#1)(1997-1#1)(2006-10#1)(2006-3#1)(2007-8#1)(2008-10#3)(2008-6#1)(2008-7#1)(2010-11#1)(2010-4#1)(2010-5#1)(2013-8#1)
of the additional##9##3##(1992-5#1)(1993-5#1)(2005-10#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-9#1)(2012-1#1)
of the additive##7##3##(2007-8#1)(2008-2#2)(2008-6#1)(2011-12#1)(2012-3#1)(2013-7#1)
of the adduct profiles##2##4##(2008-5#2)
of the adduct##10##3##(1992-7#1)(1994-5#1)(1995-1#2)(1995-2#1)(1996-7#1)(2007-11#1)(2008-10#1)(2008-5#2)
of the adductor pollicis##3##4##(1996-9#2)(2008-9#1)
of the adductor##4##3##(1996-9#2)(2008-9#1)(2013-7#1)
of the adducts##4##3##(1992-7#1)(1993-11#1)(1997-7#1)(2008-10#1)
of the adenine residue##2##4##(1994-12#1)(2008-3#1)
of the adenine##5##3##(1992-6#1)(1994-12#1)(1995-3#1)(1995-8#1)(2008-3#1)
of the adenocarcinoma##3##3##(1995-9#1)(2006-10#1)(2013-8#1)
of the adenoma##3##3##(1990-11#1)(1996-11#1)(2010-2#1)
of the adenomas##2##3##(1990-11#1)(2013-8#1)
of the adenomatous##3##3##(2008-1#1)(2008-10#1)(2010-5#1)
of the adenosine moiety of##2##5##(1991-4#1)(1993-11#1)
of the adenosine##11##3##(1990-12#1)(1991-4#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-9#1)(1995-8#1)(1997-5#1)(2008-4#2)(2011-1#1)
of the adenovirus E1A##2##4##(1994-3#1)(2008-11#1)
of the adenovirus##6##3##(1990-7#1)(1991-12#1)(1993-2#1)(1994-3#1)(1997-2#1)(2008-11#1)
of the adenylate cyclase##3##4##(1993-7#1)(1996-11#1)(1996-2#1)
of the adenylate##5##3##(1992-3#1)(1993-7#1)(1994-5#1)(1996-11#1)(1996-2#1)
of the adenylyl cyclase##3##4##(1994-12#2)(1994-5#1)
of the adequacy of##4##4##(1995-1#1)(1996-3#2)(2011-1#1)
of the adequate##2##3##(2009-2#1)(2013-8#1)
of the adherent cells##3##4##(1992-8#1)(2008-11#2)
of the adherent##6##3##(1992-8#1)(1995-12#1)(2006-8#1)(2008-10#1)(2008-11#2)
of the adhesion##8##3##(1992-1#1)(1995-8#1)(2005-11#1)(2006-6#1)(2008-10#1)(2008-5#1)(2010-4#1)(2013-8#1)
of the adhesive##9##3##(2008-3#2)(2008-5#2)(2008-9#1)(2010-4#3)(2013-8#1)
of the adipocyte##4##3##(1992-12#1)(1997-1#1)(2008-3#1)(2008-5#1)
of the adiponectin gene##3##4##(2007-8#1)(2011-1#2)
of the adipose##4##3##(1992-9#1)(1994-12#1)(2008-5#2)
of the adjacency effects on##2##5##(2008-3#2)
of the adjacent gene##2##4##(1990-3#1)(1993-5#1)
of the adjacent##16##3##(1990-3#1)(1991-9#1)(1993-5#1)(1994-9#1)(1995-12#2)(1995-3#1)(1997-2#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)(2012-1#1)
of the adjustment of the##3##5##(2005-11#1)(2006-5#1)(2008-2#1)
of the adjuvant##3##3##(1996-10#1)(2008-6#1)(2009-9#1)
of the administered dose##4##4##(1990-5#1)(1995-3#2)(2008-5#1)
of the administered radioactivity was recovered##2##6##(1990-3#1)(1991-12#1)
of the administered radioactivity##3##4##(1990-3#2)(1991-12#1)
of the administered##12##3##(1990-3#3)(1990-5#1)(1991-12#1)(1991-2#1)(1995-3#2)(1996-3#1)(1997-8#1)(2008-5#1)(2010-12#1)
of the administration of##8##4##(1990-12#1)(1995-12#1)(1996-2#1)(2005-1#1)(2007-11#1)(2010-3#1)(2011-2#1)(2012-2#1)
of the administration##10##3##(1990-12#1)(1994-10#1)(1995-12#1)(1996-2#1)(2005-1#1)(2006-8#1)(2007-11#1)(2010-3#1)(2011-2#1)(2012-2#1)
of the administrative data##2##4##(1992-3#1)(1997-2#1)
of the administrative##4##3##(1992-3#1)(1997-2#1)(2005-5#1)(2013-8#1)
of the admissions were##2##4##(1990-10#1)(2007-7#1)
of the admissions##5##3##(1990-10#1)(1990-5#1)(1991-1#1)(1996-2#1)(2007-7#1)
of the admixtures##2##3##(2008-10#2)
of the adolescent##10##3##(1993-3#1)(1994-2#1)(2004-12#1)(2006-9#1)(2007-2#2)(2008-11#1)(2008-7#1)(2010-9#1)(2011-1#1)
of the adolescents in##2##4##(2008-9#1)(2012-12#1)
of the adolescents##8##3##(1990-2#1)(1990-5#1)(2007-3#1)(2008-9#2)(2009-4#1)(2010-11#1)(2012-12#1)
of the adrenal cortex##10##4##(1990-11#1)(1990-5#2)(1995-12#1)(1997-5#2)(2006-10#1)(2008-4#2)(2011-1#1)
of the adrenal gland and##2##5##(2008-4#1)(2011-2#1)
of the adrenal gland in the##3##6##(1990-5#2)(1996-10#1)
of the adrenal gland##11##4##(1990-5#2)(1991-6#1)(1992-3#1)(1996-10#1)(2008-12#1)(2008-4#1)(2011-2#2)(2013-1#2)
of the adrenal glands##4##4##(1995-12#1)(1997-8#1)(2009-2#1)(2011-2#1)
of the adrenal medulla##2##4##(1995-12#1)(1996-12#1)
of the adrenal##33##3##(1990-11#1)(1990-5#4)(1991-10#1)(1991-6#1)(1991-7#1)(1992-3#1)(1994-2#1)(1995-12#4)(1996-10#1)(1996-12#1)(1996-5#1)(1997-5#2)(1997-8#1)(2005-8#1)(2006-10#1)(2008-12#1)(2008-4#3)(2009-2#1)(2011-1#1)(2011-2#3)(2013-1#2)
of the adrenals##5##3##(1990-3#3)(1994-5#1)(2010-12#1)
of the adrenergic nervous system##2##5##(2005-10#2)
of the adrenergic##3##3##(1993-5#1)(2005-10#2)
of the adrenocorticotropic hormone##2##4##(1993-5#1)(1993-7#1)
of the adrenogenital syndrome##3##4##(2009-2#3)
of the adsorbed protein##2##4##(2005-11#2)
of the adsorbed species##2##4##(2008-10#2)
of the adsorbed##15##3##(2005-11#2)(2007-8#1)(2008-10#9)(2008-5#1)(2010-2#1)(2011-2#1)
of the adsorbent particles##2##4##(1996-8#2)
of the adsorbent##9##3##(1996-8#2)(2005-11#2)(2007-10#1)(2008-10#4)
of the adsorbents##2##3##(1996-8#1)(2005-11#1)
of the adsorption isotherms##2##4##(2005-11#2)
of the adsorption of the##3##5##(1996-1#1)(2005-11#2)
of the adsorption of##9##4##(1996-1#1)(2005-11#6)(2008-10#2)
of the adsorption process##3##4##(2005-11#2)(2008-10#1)
of the adsorption##28##3##(1996-1#1)(1996-4#1)(1997-2#1)(2005-11#15)(2008-10#7)(2008-2#1)(2010-4#1)(2013-8#1)
of the adult Chiari malformation##3##5##(2006-5#3)
of the adult brain##3##4##(1996-12#1)(2008-7#1)(2010-8#1)
of the adult head##2##4##(2008-3#2)
of the adult human##2##4##(1990-2#1)(1991-6#1)
of the adult immune system##2##5##(2008-1#1)(2008-5#1)
of the adult mouse##3##4##(1994-2#1)(1995-2#1)(2010-11#1)
of the adult population had diabetes##2##6##(2013-8#2)
of the adult population in##2##5##(2008-11#1)(2013-8#1)
of the adult population was##2##5##(2013-1#1)(2013-8#1)
of the adult population##16##4##(1992-10#1)(1996-6#1)(1997-2#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-8#2)(2009-7#1)(2013-1#2)(2013-7#1)(2013-8#4)
of the adult rat##9##4##(1992-1#1)(1993-9#1)(1994-2#1)(1995-12#1)(1995-5#1)(1996-3#1)(1996-6#1)(2008-11#1)(2012-2#1)
of the adult##90##3##(1990-2#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-11#1)(1993-2#1)(1993-9#1)(1994-10#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-6#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-5#2)(1996-6#2)(1997-2#1)(1997-4#1)(2004-10#1)(2006-10#2)(2006-5#3)(2007-12#5)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#4)(2008-8#4)(2009-10#1)(2009-2#1)(2009-7#1)(2010-11#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#4)
of the adults are overweight or obese and##2##8##(2013-8#2)
of the adults##12##3##(1993-2#1)(2008-12#1)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-8#4)
of the advanced##2##3##(2006-10#1)(2008-3#1)
of the advancement##2##3##(2010-11#1)(2010-8#1)
of the advances in##4##4##(2005-10#1)(2006-8#1)(2009-2#1)(2013-1#1)
of the advances##8##3##(2005-10#1)(2006-10#1)(2006-8#1)(2008-11#1)(2009-2#1)(2010-11#1)(2010-8#1)(2013-1#1)
of the advantage of##2##4##(1997-4#1)(2008-11#1)
of the advantages and##4##4##(1990-10#1)(1990-12#1)(2007-10#1)(2011-1#1)
of the advantages of the##3##5##(2005-9#1)(2007-12#1)(2008-2#1)
of the advantages of##9##4##(1991-2#1)(2005-9#1)(2006-7#2)(2007-12#1)(2008-2#1)(2008-8#1)(2009-4#1)(2010-12#1)
of the advantages##15##3##(1990-10#1)(1990-12#1)(1991-2#1)(1993-2#1)(2005-9#1)(2006-7#2)(2007-10#1)(2007-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#1)(2011-1#1)
of the adventitia##3##3##(1991-8#1)(1997-8#2)
of the adventitious root was##3##5##(2008-12#3)
of the adverse effects of##4##5##(1995-5#1)(1996-9#1)(2008-10#1)(2012-12#1)
of the adverse effects##5##4##(1995-5#1)(1996-9#1)(2007-11#1)(2008-10#1)(2012-12#1)
of the adverse events##2##4##(2008-11#1)(2013-8#1)
of the adverse##16##3##(1991-12#1)(1992-2#1)(1995-5#1)(1996-9#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
of the aerial parts of##4##5##(2007-1#4)
of the aerial parts##5##4##(2007-1#4)(2008-11#1)
of the aerial##6##3##(2005-11#1)(2007-1#4)(2008-11#1)
of the aerobic##2##3##(2007-10#1)(2008-7#1)
of the aerodynamic##2##3##(1992-3#1)(2008-11#1)
of the aerosol extinction coefficient##2##5##(2008-2#1)(2008-3#1)
of the aerosol optical depth##2##5##(2008-2#2)
of the aerosol optical thickness##2##5##(2008-2#1)(2008-3#1)
of the aerosol optical##4##4##(2008-2#3)(2008-3#1)
of the aerosol refractive index##3##5##(2008-2#1)(2008-3#2)
of the aerosol##27##3##(1992-3#2)(1994-12#1)(1995-3#1)(2008-10#3)(2008-2#10)(2008-3#10)
of the aetiologic##2##3##(1996-7#1)(2008-5#1)
of the aetiological##3##3##(1996-12#1)(1997-7#1)(2010-1#1)
of the aetiology and##3##4##(1997-1#1)(2006-10#1)(2008-12#1)
of the aetiology of##5##4##(2006-10#1)(2006-3#1)(2008-10#1)(2009-4#1)(2010-1#1)
of the aetiology##9##3##(1997-1#1)(2006-10#2)(2006-3#1)(2008-10#1)(2008-12#1)(2009-4#2)(2010-1#1)
of the affect##2##3##(1993-6#1)(2010-3#1)
of the affected areas##3##4##(1995-2#1)(2011-2#2)
of the affected bone##2##4##(2007-11#1)(2009-3#1)
of the affected children##2##4##(1990-11#1)(1993-12#1)
of the affected hip##2##4##(1990-2#1)(2007-7#1)
of the affected individuals##2##4##(1997-4#1)(2010-8#1)
of the affected limb##3##4##(2007-7#1)(2009-3#2)
of the affected patients##3##4##(1996-12#1)(2008-10#1)(2009-4#1)
of the affected side##2##4##(2007-7#1)(2009-5#1)
of the affected site##2##4##(2011-2#1)(2012-1#1)
of the affected teeth##2##4##(2007-2#1)(2013-1#1)
of the affected tissue##3##4##(1997-8#1)(2007-7#2)
of the affected##62##3##(1990-11#1)(1990-2#1)(1991-3#1)(1991-7#2)(1992-1#1)(1992-10#1)(1992-5#2)(1993-12#1)(1994-5#1)(1995-2#1)(1996-12#2)(1996-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-7#1)(2006-11#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#6)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-6#1)(2009-3#3)(2009-4#2)(2009-5#2)(2010-10#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)
of the affection##2##3##(1993-5#1)(2007-8#1)
of the afferent##3##3##(1997-3#1)(2006-10#1)(2009-2#1)
of the affinity of the##2##5##(1996-11#1)(1997-4#1)
of the affinity of##5##4##(1990-12#1)(1995-3#1)(1996-11#1)(1996-12#1)(1997-4#1)
of the affinity##16##3##(1990-12#1)(1992-1#1)(1992-6#1)(1993-1#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-11#1)(1996-12#1)(1997-4#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-7#1)
of the aforementioned##8##3##(1996-11#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-11#1)(2010-9#1)(2013-1#1)
of the afterhyperpolarization##2##3##(1996-8#1)(2009-2#1)
of the agarose##2##3##(2008-4#1)(2008-8#1)
of the age groups##2##4##(1996-5#1)(2008-7#1)
of the age of a##2##5##(1996-7#1)(2008-10#1)
of the age of the patient##2##6##(1990-11#1)(2008-5#1)
of the age of the##4##5##(1990-11#1)(1992-10#1)(1996-5#1)(2008-5#1)
of the age of##7##4##(1990-11#1)(1992-10#1)(1996-5#1)(1996-7#1)(2007-1#1)(2008-10#1)(2008-5#1)
of the age##18##3##(1990-11#1)(1992-10#1)(1996-5#2)(1996-7#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-11#1)(2012-2#1)(2012-3#1)(2013-1#3)
of the aged rat##2##4##(1994-2#1)(1995-7#1)
of the aged##14##3##(1990-2#1)(1991-11#2)(1993-11#1)(1993-3#1)(1994-2#1)(1994-5#1)(1995-7#1)(1995-8#1)(1996-2#2)(1997-6#1)(2008-5#1)(2008-7#1)
of the ageing##4##3##(1992-11#1)(1995-3#1)(2008-11#1)(2011-1#1)
of the agency's##2##3##(1995-6#1)(2007-2#1)
of the agent in##2##4##(1995-2#1)(2007-11#1)
of the agent##9##3##(1991-12#1)(1995-2#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
of the agents and##2##4##(2007-4#1)(2008-8#1)
of the agents are##2##4##(1991-2#1)(2008-1#1)
of the agents##15##3##(1990-6#1)(1991-2#1)(1994-6#1)(2005-11#1)(2006-5#1)(2006-9#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-12#1)
of the ages##2##3##(1993-2#1)(2008-7#1)
of the agglomerated##2##3##(2005-11#1)(2008-10#1)
of the aggrecan gene##2##4##(1992-1#2)
of the aggrecan##4##3##(1992-1#4)
of the aggregate##4##3##(2006-10#2)(2006-12#1)(2008-10#1)
of the aggregated##4##3##(2008-10#1)(2008-3#1)(2009-10#1)(2012-11#1)
of the aggregates are##2##4##(2005-11#1)(2008-4#1)
of the aggregates##8##3##(1990-12#1)(1992-2#1)(2005-11#3)(2008-10#1)(2008-4#1)(2010-8#1)
of the aggregation##7##3##(1990-4#1)(1995-5#1)(1995-8#1)(2005-11#1)(2006-2#1)(2008-6#1)(2010-7#1)
of the aggressive##2##3##(2008-10#2)
of the aging face##2##4##(2007-7#1)(2010-11#1)
of the aging process##5##4##(1993-11#1)(1996-3#1)(1996-6#1)(2008-10#1)(2010-2#1)
of the aging##18##3##(1991-12#1)(1993-11#1)(1994-6#2)(1996-3#1)(1996-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#2)(2010-11#4)(2010-2#1)(2013-7#1)
of the agonist##11##3##(1990-7#2)(1992-5#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-12#1)(1996-5#1)(1996-9#1)(1997-1#1)(2008-4#1)
of the agonists##3##3##(1995-11#2)(1995-12#1)
of the agr##2##3##(1995-8#2)
of the agreement##2##3##(1997-2#1)(2005-8#1)
of the air##9##3##(1991-11#1)(2006-6#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-3#1)
of the airborne##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
of the airway circulation##3##4##(1996-1#1)(1997-1#2)
of the airway##15##3##(1992-11#1)(1992-2#1)(1996-1#2)(1997-1#2)(2005-11#3)(2006-10#1)(2007-12#3)(2009-9#1)(2010-7#1)
of the airways##10##3##(1994-11#1)(1996-2#1)(1996-7#2)(1997-2#1)(2005-11#2)(2006-10#1)(2009-1#1)(2009-4#1)
of the albumin-fixed membrane was##2##5##(2008-5#2)
of the alcohol##18##3##(1990-4#1)(1991-2#1)(1992-7#1)(1993-12#1)(1994-11#1)(1994-5#1)(1994-6#1)(1996-10#1)(1996-6#1)(1996-9#1)(1997-8#1)(2005-11#1)(2008-10#4)(2008-5#1)(2011-1#1)
of the alcoholic group##2##4##(2007-9#1)(2008-10#1)
of the alcoholic##5##3##(2007-11#1)(2007-9#1)(2008-10#2)(2011-2#1)
of the alcohols with##2##4##(1996-5#1)(2008-10#1)
of the alcohols##5##3##(1990-4#2)(1992-6#1)(1996-5#1)(2008-10#1)
of the aldehyde dehydrogenase##2##4##(1994-12#1)(1995-2#1)
of the aldehyde substrate##2##4##(1995-7#1)(1997-2#1)
of the aldehyde##6##3##(1994-12#1)(1995-2#1)(1995-7#1)(1996-7#2)(1997-2#1)
of the aldolase##2##3##(1992-1#1)(1994-12#1)
of the aldosterone##2##3##(1990-5#1)(2007-8#1)
of the alert and action lines##2##6##(1992-5#2)
of the alert##3##3##(1992-5#2)(1995-12#1)
of the algae##4##3##(2008-10#3)(2008-5#1)
of the alginate##2##3##(2008-11#1)(2008-7#1)
of the alginic##2##3##(1990-10#1)(1992-3#1)
of the algorithm and##4##4##(2008-1#1)(2008-2#1)(2008-3#2)
of the algorithm is demonstrated##2##5##(2007-12#1)(2007-7#1)
of the algorithm is##8##4##(2007-12#1)(2007-7#1)(2008-2#2)(2008-3#3)(2008-6#1)
of the algorithm to##2##4##(2008-2#2)
of the algorithm yields##2##4##(2008-2#2)
of the algorithm##44##3##(1997-2#1)(1997-3#1)(2006-10#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-2#16)(2008-3#13)(2008-6#3)(2008-7#1)(2009-9#1)(2010-2#1)(2010-8#1)(2012-2#1)
of the algorithms and##2##4##(2007-11#1)(2008-3#1)
of the algorithms##8##3##(2007-11#1)(2008-2#4)(2008-3#3)
of the alien##2##3##(2008-10#1)(2008-5#1)
of the alignment##6##3##(1994-8#1)(1995-8#1)(2007-12#1)(2008-3#1)(2008-4#1)(2012-3#1)
of the alimentary canal##2##4##(1991-4#1)(2008-7#1)
of the alimentary tract##3##4##(1992-12#1)(1993-1#1)(2008-5#1)
of the alimentary##6##3##(1991-4#1)(1992-12#1)(1993-1#1)(2008-5#1)(2008-7#1)(2013-7#1)
of the aliphatic##4##3##(1994-8#1)(1995-3#1)(1996-5#1)(2010-4#1)
of the alkali metals##2##4##(2008-10#1)(2010-5#1)
of the alkali##4##3##(1992-8#1)(2008-10#2)(2010-5#1)
of the alkaline##7##3##(1990-10#1)(1992-3#1)(1993-11#1)(1994-8#1)(1997-4#2)(2008-5#1)
of the alkaloid##2##3##(2006-12#1)(2007-1#1)
of the alkanediyl##2##3##(2005-11#2)
of the alkyl chain of##2##5##(1996-11#1)(2005-11#1)
of the alkyl chain##6##4##(1996-11#2)(2005-11#3)(2008-5#1)
of the alkyl chains of the##2##6##(2005-11#1)(2008-5#1)
of the alkyl group##2##4##(1990-3#1)(2005-11#1)
of the alkyl groups##2##4##(1994-12#1)(1997-2#1)
of the alkyl##16##3##(1990-3#1)(1994-12#1)(1996-11#2)(1996-2#1)(1997-2#1)(2005-11#6)(2007-11#1)(2008-10#1)(2008-5#2)
of the all##3##3##(1993-10#1)(2007-8#1)(2008-5#1)
of the allele##2##3##(1993-3#1)(2012-2#1)
of the alleles##3##3##(1991-1#1)(1994-8#1)(2007-2#1)
of the allelic diversity##2##4##(2006-4#1)(2008-10#1)
of the allelic##3##3##(2006-4#1)(2008-10#1)(2008-8#1)
of the alliance between##2##4##(2006-5#1)(2009-2#1)
of the alligator##3##3##(2007-9#2)(2008-7#1)
of the allocation of##3##4##(1991-6#1)(2008-7#1)(2012-2#1)
of the allograft##5##3##(2006-8#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-6#1)
of the allometric##2##3##(2008-5#1)(2010-8#1)
of the allosteric inhibitor##2##4##(1995-2#1)(2008-4#1)
of the allosteric interaction of semi-rigid verapamil analogues with##2##9##(1995-11#2)
of the allosteric##11##3##(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1994-8#1)(1995-11#2)(1995-2#1)(1996-10#1)(2008-4#1)(2012-1#1)
of the alloy##3##3##(2009-7#2)(2010-4#1)
of the almond##2##3##(2008-10#1)(2008-11#1)
of the almost##3##3##(2006-12#1)(2006-8#1)(2008-1#1)
of the alpha 1 (I)##3##5##(1991-5#2)(1994-2#1)
of the alpha 1 subunit##5##5##(1994-2#1)(1994-5#1)(1994-6#1)(1995-2#1)(1996-2#1)
of the alpha 1##12##4##(1991-5#2)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#1)(1995-2#2)(1995-3#1)(1996-2#1)
of the alpha 3 beta 3##2##6##(1990-9#1)(1992-11#1)
of the alpha 3##3##4##(1990-9#1)(1991-7#1)(1992-11#1)
of the alpha 4 beta 2##2##6##(1995-11#2)
of the alpha and beta subunits##2##6##(1992-11#1)(1996-2#1)
of the alpha and beta##3##5##(1990-9#1)(1992-11#1)(1996-2#1)
of the alpha anomers##2##4##(1997-2#2)
of the alpha subunit of the##2##6##(1995-1#1)(1997-6#1)
of the alpha subunit of transducin##2##6##(1990-2#1)(1990-7#1)
of the alpha subunit of##13##5##(1990-2#3)(1990-7#1)(1992-2#1)(1995-1#2)(1995-2#1)(1996-5#2)(1997-6#2)(2012-2#1)
of the alpha subunit##19##4##(1990-2#3)(1990-7#2)(1992-2#1)(1995-1#2)(1995-2#1)(1995-8#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-4#1)(1997-6#2)(2008-11#1)(2012-2#1)
of the alpha subunits##4##4##(1990-7#1)(1992-11#1)(1995-8#1)(1997-5#1)
of the alpha##80##3##(1990-12#1)(1990-2#4)(1990-7#6)(1990-9#3)(1991-1#1)(1991-3#1)(1991-5#4)(1991-7#1)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#1)(1993-2#1)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#1)(1995-1#2)(1995-11#2)(1995-2#3)(1995-3#4)(1995-8#2)(1996-10#1)(1996-2#2)(1996-5#2)(1996-8#2)(1997-1#2)(1997-2#3)(1997-4#2)(1997-5#1)(1997-6#2)(1997-8#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-9#1)(2008-11#1)(2012-2#1)
of the alpha- and beta-globin##2##5##(1991-5#1)(1994-8#1)
of the alpha- and##4##4##(1990-10#1)(1991-5#1)(1994-8#1)(1996-6#1)
of the alpha-##5##3##(1990-10#1)(1991-5#1)(1993-3#1)(1994-8#1)(1996-6#1)
of the alpha-1##2##3##(1993-12#1)(1995-5#1)
of the alpha-2##3##3##(1993-12#1)(1997-5#2)
of the alpha-MSH##2##3##(1993-5#2)
of the alpha-amino group of##2##5##(1992-6#1)(1994-9#1)
of the alpha-amino##3##3##(1992-6#1)(1992-8#1)(1994-9#1)
of the alpha-amylase##2##3##(1990-7#1)(1997-3#1)
of the alpha-chain of##2##4##(1990-5#1)(1995-6#1)
of the alpha-chain##3##3##(1990-5#1)(1992-5#1)(1995-6#1)
of the alpha-crystallin B chain##2##5##(1992-9#2)
of the alpha-factor##2##3##(1995-1#1)(1997-2#1)
of the alpha-helical##3##3##(1994-3#1)(1995-6#1)(1995-8#1)
of the alpha-helices##6##3##(1993-3#1)(1994-11#1)(1994-9#1)(1995-8#1)(2008-10#2)
of the alpha-helix##3##3##(1991-2#1)(1993-3#1)(1995-5#1)
of the alpha-hydroxy##2##3##(1992-1#1)(2008-5#1)
of the alpha-keto##2##3##(1991-1#1)(2008-3#1)
of the alpha-myosin heavy chain##2##5##(1991-9#2)
of the alpha-proton of##2##4##(1992-6#1)(1993-8#1)
of the alpha-subunit of the##7##5##(1990-11#1)(1991-3#1)(1991-7#2)(1992-11#1)(1992-8#1)(1995-3#1)
of the alpha-subunit of##8##4##(1990-11#1)(1991-3#1)(1991-6#1)(1991-7#2)(1992-11#1)(1992-8#1)(1995-3#1)
of the alpha-subunit##13##3##(1990-11#3)(1991-3#3)(1991-6#1)(1991-7#2)(1992-11#1)(1992-8#1)(1995-3#1)(1995-6#1)
of the alpha-subunits##2##3##(1995-6#2)
of the alpha-tocopherol##2##3##(2005-8#1)(2007-8#1)
of the alpha1##2##3##(1997-5#1)(2008-7#1)
of the alpha2AAR##2##3##(1996-5#2)
of the alphabet##2##3##(2008-3#1)(2013-8#1)
of the already##3##3##(2007-12#1)(2008-2#1)(2013-1#1)
of the alteration of the##2##5##(1992-11#1)(1996-3#1)
of the alterations in##2##4##(1996-10#1)(2008-7#1)
of the alterations##6##3##(1992-12#1)(1992-5#1)(1996-10#1)(1996-3#1)(2008-1#1)(2008-7#1)
of the altered enzyme##2##4##(1992-1#2)
of the altered mineral metabolism##2##5##(2009-1#2)
of the altered##17##3##(1990-3#1)(1991-4#1)(1992-1#2)(1994-11#1)(1994-2#1)(1997-5#1)(1997-8#1)(2007-5#1)(2008-4#1)(2009-1#2)(2010-3#1)(2013-1#3)(2013-8#1)
of the alternate##4##3##(1995-1#1)(1995-6#1)(2008-10#1)(2013-1#1)
of the alternating##5##3##(1990-10#1)(1997-3#1)(2008-3#1)(2009-6#1)(2012-2#1)
of the alternative oxidase##2##4##(1993-8#1)(2008-9#1)
of the alternative pathway of the complement system##2##8##(1995-9#1)(1997-1#1)
of the alternative pathway of the complement##3##7##(1995-9#1)(1997-1#2)
of the alternative pathway##4##4##(1995-9#1)(1997-1#2)(2005-8#1)
of the alternative procedure##3##4##(1997-6#1)(2008-10#1)(2008-11#1)
of the alternative##19##3##(1992-6#1)(1993-5#1)(1993-8#1)(1995-1#1)(1995-9#1)(1996-12#1)(1997-1#2)(1997-6#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-5#1)(2012-2#1)
of the alternatively spliced##2##4##(2007-11#1)(2008-7#1)
of the alumina particles##2##4##(2005-11#2)
of the alumina##3##3##(2005-11#3)
of the aluminum recovered##2##4##(1992-4#2)
of the aluminum##4##3##(1992-4#2)(2007-8#1)(2008-10#1)
of the alveolar bone and##2##5##(2005-3#1)(2011-1#1)
of the alveolar bone##4##4##(2005-3#2)(2011-1#1)(2012-11#1)
of the alveolar cleft##2##4##(2009-8#1)(2012-12#1)
of the alveolar epithelium##2##4##(1995-8#2)
of the alveolar##14##3##(1991-1#1)(1992-12#1)(1995-8#2)(1996-8#1)(2005-3#2)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)
of the alveoli##2##3##(2005-11#1)(2006-10#1)
of the ambient##6##3##(1995-3#1)(2004-4#2)(2005-11#1)(2006-4#1)(2008-2#1)
of the ambiguity function##2##4##(2007-11#1)(2008-3#1)
of the ambiguity##4##3##(2006-3#1)(2007-11#1)(2008-3#1)(2010-11#1)
of the ambulance##3##3##(1991-9#1)(2011-1#1)(2013-1#1)
of the american##12##3##(2006-9#1)(2008-10#8)(2008-3#1)(2008-8#1)(2011-2#1)
of the amide I band##3##5##(1991-9#1)(1997-7#1)(2010-5#1)
of the amide I##4##4##(1991-9#2)(1997-7#1)(2010-5#1)
of the amide##10##3##(1991-9#2)(1997-7#1)(2007-6#2)(2008-10#1)(2008-11#1)(2008-12#1)(2010-5#1)(2012-12#1)
of the amine group##2##4##(2008-10#2)
of the amine groups##2##4##(2008-10#2)
of the amine##9##3##(1990-5#2)(2008-10#7)
of the amines##3##3##(1996-5#1)(2006-10#1)(2010-8#1)
of the amino acid (aa)##4##5##(1990-9#1)(1993-11#1)(1993-12#1)(1993-5#1)
of the amino acid at position##2##6##(1994-8#1)(1995-7#1)
of the amino acid composition##3##5##(1990-7#1)(1997-2#1)(2008-10#1)
of the amino acid residues##2##5##(1993-3#1)(2009-8#1)
of the amino acid sequence of the##5##7##(1990-5#1)(1991-2#1)(1992-12#1)(1993-8#1)(2008-10#1)
of the amino acid sequence of##10##6##(1990-5#1)(1991-2#1)(1992-11#1)(1992-12#2)(1993-12#1)(1993-6#1)(1993-8#1)(1996-7#1)(2008-10#1)
of the amino acid sequence##17##5##(1990-5#1)(1991-2#1)(1992-11#1)(1992-12#3)(1992-4#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-7#2)(2007-11#1)(2008-10#1)
of the amino acid sequences of the##3##7##(1991-12#1)(1993-3#1)(2006-5#1)
of the amino acid sequences of##8##6##(1990-7#1)(1991-12#2)(1991-2#1)(1992-11#1)(1993-3#1)(1993-5#1)(2006-5#1)
of the amino acid sequences##9##5##(1990-7#1)(1991-12#2)(1991-2#1)(1992-11#1)(1993-3#1)(1993-5#1)(2006-5#1)(2010-5#1)
of the amino acid side chain##2##6##(1991-8#1)(1997-3#1)
of the amino acid side##3##5##(1991-8#1)(1997-3#1)(2012-3#1)
of the amino acid substitutions##2##5##(1990-8#1)(1997-9#1)
of the amino acid##65##4##(1990-3#2)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#3)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-5#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-8#2)(1994-9#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-7#3)(1997-2#2)(1997-3#1)(1997-6#1)(1997-9#1)(2005-11#1)(2006-12#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#2)(2008-10#4)(2008-11#2)(2008-5#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-3#1)
of the amino acids and##2##5##(1992-8#1)(2008-10#1)
of the amino acids in##2##5##(1992-8#1)(2012-2#1)
of the amino acids was##2##5##(2007-8#1)(2008-5#1)
of the amino acids##25##4##(1992-8#2)(1993-11#1)(1994-12#1)(1994-9#1)(1995-5#1)(2005-11#1)(2006-10#8)(2007-8#2)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#1)
of the amino and##3##4##(1992-6#1)(2006-10#1)(2006-12#1)
of the amino group##4##4##(1991-7#1)(1992-3#1)(2006-10#1)(2008-10#1)
of the amino groups##2##4##(2006-10#2)
of the amino terminus##3##4##(1995-3#1)(1996-8#1)(2008-11#1)
of the amino##104##3##(1990-3#2)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#3)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#2)(1993-11#2)(1993-12#2)(1993-3#2)(1993-5#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#2)(1994-9#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-5#1)(1996-7#4)(1996-8#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-9#1)(2005-11#2)(2006-10#12)(2006-12#3)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-8#2)(2008-10#7)(2008-11#5)(2008-5#2)(2008-7#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
of the amino- and carboxyl-terminal##3##5##(1992-6#1)(1995-8#1)(1996-5#1)
of the amino-terminal region of##2##5##(1994-9#1)(1995-5#1)
of the amino-terminal##14##3##(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-9#1)(1992-7#1)(1994-2#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-7#1)(2007-11#1)
of the ammonia##3##3##(2005-11#1)(2008-11#1)(2011-1#1)
of the amniotic membrane##2##4##(2007-1#1)(2008-10#1)
of the amniotic##5##3##(1992-2#1)(2005-11#1)(2007-1#1)(2008-10#1)(2008-9#1)
of the amoA##2##3##(2007-12#2)
of the amorphous content of##2##5##(2008-10#2)
of the amorphous content##3##4##(2007-11#1)(2008-10#2)
of the amorphous##6##3##(2005-11#1)(2007-11#1)(2008-10#3)(2010-8#1)
of the amount of time##2##5##(1996-3#1)(2008-12#1)
of the amount of##38##4##(1990-10#1)(1991-4#1)(1991-9#1)(1992-12#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-11#1)(1996-3#1)(1997-4#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-4#1)(2009-8#1)(2012-11#1)(2013-8#1)
of the amount##44##3##(1990-10#1)(1990-3#1)(1991-4#1)(1991-9#1)(1992-12#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-11#1)(1996-3#1)(1996-8#1)(1997-4#1)(2005-11#1)(2005-4#1)(2006-10#2)(2006-2#2)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-9#1)(2009-4#1)(2009-8#1)(2012-11#1)(2013-8#1)
of the amounts of the##2##5##(2008-10#1)(2008-12#1)
of the amounts of##6##4##(1991-10#1)(2007-11#1)(2008-10#3)(2008-12#1)
of the amperometric response##2##4##(2008-10#2)
of the amperometric##4##3##(2008-10#4)
of the amphibian##2##3##(1990-12#1)(1997-3#1)
of the amphipathic##5##3##(1990-2#2)(1990-5#1)(1993-9#1)(1995-5#1)
of the amphiphiles##4##3##(2005-11#3)(2012-2#1)
of the amphiphilic##6##3##(1990-5#1)(1994-11#1)(1994-5#1)(2005-4#1)(2008-5#1)(2010-4#1)
of the amplicon##2##3##(1996-6#1)(2007-1#1)
of the amplicons##2##3##(2008-10#2)
of the amplification##5##3##(2006-8#2)(2007-1#1)(2008-10#1)(2008-4#1)
of the amplified DNA##5##4##(1990-12#1)(1991-5#1)(1997-6#1)(2008-5#1)(2011-2#1)
of the amplified fragments##3##4##(1992-8#1)(2008-10#1)(2012-2#1)
of the amplified gene##2##4##(2008-11#2)
of the amplified products##4##4##(1996-2#1)(2008-10#2)(2008-4#1)
of the amplified pulse spectrum##2##5##(2007-12#2)
of the amplified pulse##3##4##(2007-12#2)(2008-3#1)
of the amplified signal##3##4##(2007-11#2)(2008-2#1)
of the amplified spontaneous emission##3##5##(2007-12#2)(2008-2#1)
of the amplified##32##3##(1990-12#1)(1991-1#1)(1991-5#1)(1992-11#1)(1992-8#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-6#1)(2007-11#2)(2007-12#4)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
of the amplifier gain##2##4##(2007-11#1)(2008-3#1)
of the amplifier##9##3##(2007-11#1)(2007-12#6)(2008-1#1)(2008-3#1)
of the amplitude and##2##4##(2007-11#1)(2007-12#1)
of the amplitude of the##4##5##(1997-4#1)(2007-12#1)(2007-8#1)(2008-2#1)
of the amplitude of##5##4##(1994-2#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-2#1)
of the amplitude##12##3##(1991-8#1)(1994-2#1)(1997-4#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-2#2)(2008-3#1)
of the amplitudes of the##2##5##(1992-8#1)(1996-7#1)
of the amplitudes of##3##4##(1992-8#1)(1996-7#1)(2007-11#1)
of the amputation##2##3##(2009-12#1)(2011-2#1)
of the amygdala after##2##4##(1995-11#1)(1995-12#1)
of the amygdala and the##2##5##(1995-6#1)(2008-7#1)
of the amygdala and##4##4##(1995-6#1)(1997-5#1)(2008-4#1)(2008-7#1)
of the amygdala central nucleus##3##5##(2009-2#3)
of the amygdala in the acquisition##2##6##(1994-12#1)(2008-11#1)
of the amygdala in the##3##5##(1994-12#1)(1996-6#1)(2008-11#1)
of the amygdala in##6##4##(1993-12#1)(1994-12#1)(1996-6#1)(2007-5#1)(2008-11#1)(2008-6#1)
of the amygdala was##2##4##(1995-11#1)(1996-9#1)
of the amygdala##53##3##(1991-1#2)(1991-10#2)(1991-11#1)(1991-5#1)(1992-7#1)(1993-12#9)(1993-6#3)(1994-11#1)(1994-12#1)(1994-2#2)(1994-8#1)(1995-11#8)(1995-12#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-9#2)(1997-5#1)(1997-8#1)(2007-10#2)(2007-5#1)(2008-11#3)(2008-4#1)(2008-6#1)(2008-7#1)(2009-2#3)
of the amyloid beta protein (A beta)##2##7##(1995-3#1)(1996-6#1)
of the amyloid beta protein##3##5##(1995-3#1)(1996-6#1)(2004-11#1)
of the amyloid beta##4##4##(1992-8#1)(1995-3#1)(1996-6#1)(2004-11#1)
of the amyloid beta-protein##3##4##(1991-1#1)(1991-11#1)(1991-2#1)
of the amyloid precursor protein (APP)##2##6##(1993-11#1)(1994-2#1)
of the amyloid precursor protein##6##5##(1992-1#1)(1992-12#1)(1993-11#2)(1994-2#1)(1996-5#1)
of the amyloid precursor##7##4##(1992-1#1)(1992-12#1)(1992-3#1)(1993-11#2)(1994-2#1)(1996-5#1)
of the amyloid##25##3##(1990-9#2)(1991-1#2)(1991-11#2)(1991-2#1)(1992-1#1)(1992-12#2)(1992-3#3)(1992-8#1)(1993-11#2)(1993-3#1)(1994-2#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-5#1)(1996-6#1)(2004-11#1)(2008-5#1)
of the amyloid-β##2##3##(2010-8#1)(2012-12#1)
of the anaerobic##9##3##(1994-11#1)(2005-1#3)(2006-8#2)(2008-1#1)(2008-9#1)(2010-12#1)
of the anaesthesia##2##3##(2007-9#1)(2012-2#1)
of the anaesthetic##4##3##(1990-4#1)(1991-6#1)(2006-10#1)(2013-1#1)
of the anaesthetized rat##2##4##(1992-3#1)(1993-11#1)
of the anaesthetized##3##3##(1992-3#1)(1993-11#1)(1995-11#1)
of the anal canal and##2##5##(2011-2#2)
of the anal canal##14##4##(1994-4#1)(2007-4#1)(2010-5#4)(2011-2#7)(2013-1#1)
of the anal sphincter##4##4##(1992-10#1)(2011-2#3)
of the anal##22##3##(1990-6#1)(1992-10#1)(1994-4#1)(2007-4#1)(2010-5#6)(2011-2#10)(2013-1#2)
of the analgesic effects of##3##5##(1992-11#1)(1997-5#1)(2010-1#1)
of the analgesic##9##3##(1990-2#1)(1990-6#1)(1992-11#1)(1997-5#1)(2006-10#1)(2006-12#2)(2010-1#1)(2011-2#1)
of the analog##8##3##(1991-5#1)(1992-6#1)(1995-1#1)(1995-5#1)(1997-6#1)(2008-2#3)
of the analogs##5##3##(1994-5#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-2#1)
of the analogues##3##3##(1992-6#1)(2012-2#1)(2013-8#1)
of the analysed samples##2##4##(2008-10#1)(2013-8#1)
of the analysed##4##3##(2008-10#2)(2010-8#1)(2013-8#1)
of the analyser##2##3##(2008-10#2)
of the analyses are##2##4##(2006-10#1)(2008-10#1)
of the analyses##9##3##(1995-5#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)
of the analysis have been##2##5##(1996-12#1)(2010-5#1)
of the analysis is##2##4##(2008-2#1)(2008-9#1)
of the analysis of the##3##5##(1993-12#1)(2008-10#2)
of the analysis of##15##4##(1990-8#1)(1993-12#1)(2007-4#1)(2007-7#1)(2008-10#6)(2008-2#1)(2008-7#1)(2010-5#1)(2012-2#1)(2013-1#1)
of the analysis to##2##4##(2008-9#1)(2009-11#1)
of the analysis was##2##4##(1995-6#1)(2008-10#1)
of the analysis##56##3##(1990-6#1)(1990-8#1)(1993-12#1)(1994-9#1)(1995-12#1)(1995-4#1)(1995-6#1)(1996-11#1)(1996-12#2)(2007-4#1)(2007-6#1)(2007-7#1)(2008-10#15)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#4)(2009-11#1)(2010-3#1)(2010-5#3)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)
of the analyte and##4##4##(2006-12#1)(2008-10#3)
of the analyte by##3##4##(2008-10#2)(2009-8#1)
of the analyte concentration##2##4##(2007-8#1)(2008-10#1)
of the analyte extracted into the organic##2##7##(2007-8#1)(2008-10#1)
of the analyte from the##2##5##(2008-10#2)
of the analyte from##3##4##(1996-5#1)(2008-10#2)
of the analyte in the##7##5##(2008-10#5)(2010-5#1)(2011-1#1)
of the analyte in##9##4##(2008-10#7)(2010-5#1)(2011-1#1)
of the analyte on the##2##5##(1996-8#1)(2008-10#1)
of the analyte or##2##4##(2008-10#1)(2008-5#1)
of the analyte pulse##2##4##(2008-10#2)
of the analyte solution##4##4##(2008-10#4)
of the analyte was##3##4##(2008-10#3)
of the analyte with##3##4##(2008-10#3)
of the analyte##73##3##(1996-5#1)(1996-8#1)(2006-12#1)(2007-8#3)(2008-10#58)(2008-5#1)(2008-7#1)(2009-8#1)(2010-5#1)(2011-1#2)(2012-12#1)(2013-8#2)
of the analytes can be##2##5##(2008-10#2)
of the analytes from##3##4##(2008-10#3)
of the analytes in##5##4##(2007-8#1)(2008-10#4)
of the analytes on the##3##5##(2008-10#2)(2008-3#1)
of the analytes on##6##4##(2008-10#5)(2008-3#1)
of the analytes retained on##2##5##(2008-10#2)
of the analytes retained##3##4##(2008-10#3)
of the analytes was##3##4##(2005-12#1)(2008-10#2)
of the analytes were investigated##2##5##(2008-10#2)
of the analytes were##6##4##(2008-10#6)
of the analytes with the##2##5##(2008-10#2)
of the analytes with##3##4##(2007-8#1)(2008-10#2)
of the analytes##59##3##(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#1)(2005-12#1)(2007-8#3)(2008-1#1)(2008-10#47)(2008-3#3)
of the analytical characteristics##2##4##(2008-10#2)
of the analytical community##2##4##(2007-5#1)(2008-10#1)
of the analytical method##2##4##(1997-3#1)(2008-10#1)
of the analytical performances##2##4##(2008-10#2)
of the analytical procedure##5##4##(2008-10#5)
of the analytical properties##2##4##(2008-10#2)
of the analytical results##2##4##(2008-10#2)
of the analytical signal##2##4##(2008-10#2)
of the analytical signals##2##4##(2008-10#2)
of the analytical solution##2##4##(2007-11#1)(2008-3#1)
of the analytical system##3##4##(2006-2#1)(2008-10#2)
of the analytical##47##3##(1996-8#1)(1997-3#1)(2005-11#1)(2005-4#1)(2006-2#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-10#34)(2008-3#2)(2010-11#1)(2010-12#1)
of the analyzed##9##3##(2007-11#1)(2008-10#3)(2008-3#1)(2008-7#2)(2011-2#1)(2012-2#1)
of the analyzer##2##3##(2008-10#2)
of the anamorphic##2##3##(1996-9#1)(2008-3#1)
of the anastomosis was##2##4##(2005-9#1)(2007-8#1)
of the anastomosis##13##3##(1990-6#1)(1991-3#1)(1993-2#2)(2005-9#1)(2006-6#2)(2007-8#3)(2008-10#1)(2008-12#1)(2008-5#1)
of the anatase TiO2 particles##2##5##(2005-11#2)
of the anatase nanoparticles##2##4##(2005-11#2)
of the anatase##4##3##(2005-11#4)
of the anatomic##3##3##(1990-9#1)(2006-12#1)(2013-8#1)
of the anatomical##15##3##(1990-6#1)(1995-2#1)(2006-11#6)(2008-10#1)(2009-10#1)(2010-8#1)(2011-2#3)(2013-8#1)
of the anatomy and##3##4##(2007-8#1)(2008-8#1)(2010-6#1)
of the anatomy##6##3##(2006-6#1)(2007-12#1)(2007-8#1)(2008-8#1)(2010-6#1)(2013-1#1)
of the ancestral##8##3##(1991-6#1)(1995-8#1)(1996-10#1)(1997-4#1)(2008-8#3)(2013-1#1)
of the ancient##2##3##(1991-2#1)(2008-1#1)
of the androgen receptor (AR)##4##5##(1996-11#1)(1997-7#1)(2011-2#1)(2012-12#1)
of the androgen receptor and##2##5##(1996-5#1)(2006-10#1)
of the androgen receptor##15##4##(1990-8#1)(1991-3#1)(1995-11#1)(1995-3#2)(1996-11#1)(1996-5#1)(1997-7#1)(2006-10#4)(2009-4#1)(2011-2#1)(2012-12#1)
of the androgenic##2##3##(1991-9#1)(2010-3#1)
of the androgens##2##3##(1990-9#1)(1992-5#1)
of the anemia##2##3##(1992-2#1)(2006-10#1)
of the anesthetic##6##3##(1990-12#1)(1990-2#2)(2007-7#1)(2008-3#1)(2009-8#1)
of the anesthetized##2##3##(1993-2#1)(2008-8#1)
of the aneurysm and##3##4##(1991-6#1)(2007-8#1)(2013-8#1)
of the aneurysm was##2##4##(2006-10#1)(2012-2#1)
of the aneurysm##19##3##(1991-6#1)(1997-3#1)(2005-9#1)(2006-10#1)(2006-11#1)(2007-8#3)(2008-11#1)(2008-7#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
of the aneurysmal sac##2##4##(1997-3#2)
of the aneurysmal##4##3##(1997-3#2)(2007-6#1)(2012-2#1)
of the angiogenic##4##3##(2006-9#1)(2008-1#1)(2013-1#2)
of the angiographic##2##3##(2006-10#1)(2008-7#1)
of the angioplasty##2##3##(2007-7#1)(2008-4#1)
of the angiotensin I-converting enzyme##2##5##(1992-11#1)(1996-4#1)
of the angiotensin II receptor##3##5##(1994-8#1)(1997-7#1)(2005-7#1)
of the angiotensin II##5##4##(1994-8#1)(1995-10#1)(1997-7#1)(2005-7#1)(2008-8#1)
of the angiotensin converting enzyme##2##5##(1990-1#1)(1990-12#1)
of the angiotensin receptors##3##4##(1991-9#1)(1994-2#2)
of the angiotensin##14##3##(1990-1#1)(1990-12#1)(1991-9#1)(1992-11#1)(1992-5#1)(1994-2#2)(1994-8#1)(1995-10#1)(1996-4#1)(1997-7#1)(2005-7#2)(2008-8#1)
of the angiotensin-converting enzyme (ACE) inhibitor##2##6##(1990-2#1)(2008-7#1)
of the angiotensin-converting enzyme##5##4##(1990-2#1)(2006-6#2)(2008-12#1)(2008-7#1)
of the angle between##2##4##(2007-12#1)(2008-3#1)
of the angle of incidence with##2##6##(2008-2#1)(2008-3#1)
of the angle of incidence##7##5##(2008-2#4)(2008-3#3)
of the angle of the##2##5##(2007-12#1)(2013-7#1)
of the angle of##13##4##(2007-12#2)(2008-2#5)(2008-3#4)(2013-7#2)
of the angle##21##3##(2007-12#3)(2007-8#1)(2008-2#5)(2008-3#9)(2010-7#1)(2013-7#2)
of the angular distribution##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
of the angular response##2##4##(2008-2#1)(2008-3#1)
of the angular variation of##2##5##(2008-3#2)
of the angular##18##3##(1995-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#5)(2008-3#8)
of the aniline##2##3##(1991-4#1)(2008-10#1)
of the animal as##2##4##(1993-2#1)(1996-2#1)
of the animal in##2##4##(2005-10#1)(2008-4#1)
of the animal industry##2##4##(2005-5#2)
of the animal kingdom##2##4##(1990-12#1)(2007-12#1)
of the animal models##5##4##(2007-11#2)(2008-7#1)(2010-4#1)(2010-6#1)
of the animal to##2##4##(1992-10#1)(2008-4#1)
of the animal##47##3##(1990-12#1)(1990-2#1)(1990-4#2)(1992-10#1)(1992-12#1)(1993-12#1)(1993-2#1)(1994-10#3)(1995-12#2)(1995-8#1)(1996-2#1)(1996-6#1)(2005-10#1)(2005-5#3)(2006-2#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-11#1)(2008-4#5)(2008-5#2)(2008-7#1)(2009-8#1)(2010-11#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#1)(2013-7#1)
of the animal's##3##3##(1995-12#1)(1995-8#1)(2008-11#1)
of the animals treated with##2##5##(2011-2#1)(2013-8#1)
of the animals was##5##4##(1991-2#1)(1993-4#1)(2008-2#1)(2008-5#2)
of the animals with##2##4##(1991-11#2)
of the animals##50##3##(1990-10#1)(1991-10#1)(1991-11#2)(1991-2#1)(1992-11#1)(1992-7#1)(1993-4#1)(1993-5#1)(1993-7#1)(1993-9#2)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-11#1)(2004-4#3)(2006-10#1)(2006-12#1)(2006-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#5)(2009-3#1)(2010-4#1)(2011-2#3)(2012-1#1)(2013-8#2)
of the anion and##2##4##(1994-5#1)(2007-12#1)
of the anion exchanger##2##4##(2008-10#2)
of the anion##6##3##(1994-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2010-5#1)
of the anionic form of##2##5##(1995-6#1)(2008-10#1)
of the anionic subsite##2##4##(1995-11#2)
of the anionic##13##3##(1990-3#1)(1990-5#1)(1991-4#1)(1995-11#2)(1995-6#1)(2005-11#1)(2007-8#1)(2008-10#4)(2012-12#1)
of the anions in##3##4##(2008-10#2)(2010-5#1)
of the anions of##2##4##(1990-5#1)(2005-11#1)
of the anions##8##3##(1990-5#1)(1995-5#1)(2005-11#1)(2008-10#3)(2010-4#1)(2010-5#1)
of the anisotropic##7##3##(1997-8#1)(2006-12#1)(2007-12#1)(2008-2#1)(2008-3#3)
of the anisotropy##3##3##(1997-8#2)(2008-2#1)
of the ankle and foot##3##5##(2006-1#3)
of the ankle and the##2##5##(2006-4#1)(2008-4#1)
of the ankle and##8##4##(1995-8#1)(2006-1#3)(2006-4#2)(2008-4#2)
of the ankle did not##2##5##(1991-10#1)(2007-11#1)
of the ankle joint in##2##5##(1993-3#1)(2007-1#1)
of the ankle joint##12##4##(1991-10#2)(1993-3#1)(2007-1#2)(2008-12#1)(2009-7#2)(2010-3#2)(2010-5#1)(2012-2#1)
of the ankle using##2##4##(2008-8#1)(2012-2#1)
of the ankle##43##3##(1991-10#3)(1992-2#1)(1993-11#1)(1993-3#2)(1995-12#1)(1995-8#1)(2006-1#3)(2006-10#1)(2006-4#3)(2007-1#3)(2007-11#1)(2007-7#1)(2008-12#2)(2008-4#2)(2008-8#2)(2009-5#1)(2009-7#2)(2010-3#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#6)(2012-3#1)(2013-1#1)
of the ankle-brachial##2##3##(1990-10#1)(2005-10#1)
of the ankle/foot complex##3##4##(2006-12#3)
of the ankle/foot##6##3##(2006-12#6)
of the annelid##2##3##(1990-5#1)(1996-10#1)
of the annexin VI gene##2##5##(1994-3#2)
of the annexin family of##2##5##(1993-9#1)(1995-8#1)
of the annexin family##3##4##(1993-8#1)(1993-9#1)(1995-8#1)
of the annexin##10##3##(1993-4#1)(1993-8#1)(1993-9#1)(1994-3#2)(1995-11#2)(1995-8#1)(1997-6#1)(2008-11#1)
of the annual budget##2##4##(1992-3#1)(2007-9#1)
of the annual##15##3##(1992-2#2)(1992-3#1)(1994-2#1)(2005-7#2)(2007-5#1)(2007-9#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-5#1)(2013-8#2)
of the annular##3##3##(2007-12#1)(2008-10#1)(2008-4#1)
of the annulus##5##3##(1996-6#3)(2006-7#1)(2007-1#1)
of the anogenital##2##3##(1994-1#1)(2010-12#1)
of the anomalies##3##3##(2008-5#1)(2010-1#1)(2012-3#1)
of the anomalous##7##3##(2007-11#1)(2007-8#2)(2008-2#2)(2008-3#1)(2008-7#1)
of the anomaly zone##2##4##(2010-6#2)
of the anomaly##3##3##(2009-9#1)(2010-6#2)
of the anorectal##4##3##(1991-12#1)(2006-11#1)(2007-11#2)
of the answers##5##3##(1990-5#1)(1994-1#1)(1996-9#1)(2012-2#1)(2013-1#1)
of the ant##4##3##(2007-12#2)(2008-5#1)(2008-8#1)
of the antagonist in##2##4##(2008-10#2)
of the antagonist##15##3##(1993-2#1)(1995-11#1)(1995-6#1)(1996-2#1)(1997-6#1)(1997-7#1)(2008-10#8)(2008-4#1)
of the antagonistic##5##3##(2007-12#1)(2008-10#2)(2008-4#1)(2010-3#1)
of the antagonists##6##3##(1990-11#2)(1995-11#1)(1996-6#1)(2007-7#1)(2008-8#1)
of the antecedent##2##3##(2007-3#1)(2008-2#1)
of the antecedents and consequences of##2##6##(2007-7#1)(2008-11#1)
of the antecedents##3##3##(1996-3#1)(2007-7#1)(2008-11#1)
of the antenatal##2##3##(2007-7#1)(2008-1#1)
of the antenna of the grasshopper Schistocerca gregaria##2##8##(2007-12#2)
of the antenna of##3##4##(1994-5#1)(2007-12#2)
of the antenna##12##3##(1991-7#1)(1994-5#1)(1995-6#1)(2007-12#9)
of the antennal glands##2##4##(2007-12#2)
of the antennal lobe##4##4##(1997-6#2)(2007-12#2)
of the antennal##9##3##(1997-6#2)(2007-12#6)(2008-7#1)
of the anterior abdominal wall##3##5##(1991-1#2)(2012-12#1)
of the anterior abdominal##4##4##(1991-1#2)(2006-10#1)(2012-12#1)
of the anterior approach##3##4##(2006-8#1)(2007-11#1)(2008-8#1)
of the anterior cerebral artery##4##5##(1994-4#1)(1997-3#1)(2006-11#1)(2008-7#1)
of the anterior cerebral##5##4##(1994-4#1)(1997-3#1)(2006-11#1)(2008-7#2)
of the anterior cingulate##3##4##(1994-3#1)(2008-4#2)
of the anterior cruciate ligament and##2##6##(2007-8#1)(2008-4#1)
of the anterior cruciate ligament##12##5##(1996-11#1)(2006-6#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-4#1)(2009-1#1)(2013-1#2)
of the anterior foot##2##4##(2008-6#2)
of the anterior horn##3##4##(1990-9#1)(1995-6#1)(2008-7#1)
of the anterior hypothalamus##2##4##(1991-8#1)(2008-9#1)
of the anterior lobe##2##4##(1991-5#1)(1992-9#1)
of the anterior pituitary##3##4##(1995-10#1)(1996-11#1)(2008-1#1)
of the anterior portion of##2##5##(2006-12#1)(2008-4#1)
of the anterior segment##2##4##(2010-9#1)(2011-7#1)
of the anterior skull base##2##5##(2005-5#1)(2006-12#1)
of the anterior spinal canal##2##5##(2006-8#2)
of the anterior spinal##3##4##(2006-8#2)(2007-7#1)
of the anterior teeth##2##4##(2004-3#1)(2013-7#1)
of the anterior tibial artery##4##5##(2008-12#1)(2008-8#2)(2009-3#1)
of the anterior vertebral##2##4##(2006-2#1)(2006-7#1)
of the anterior wall of the frontal sinus##2##8##(2006-12#2)
of the anterior wall of the##3##6##(2006-12#2)(2007-8#1)
of the anterior##118##3##(1990-10#1)(1990-9#2)(1991-1#2)(1991-11#2)(1991-5#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-3#1)(1994-4#1)(1994-8#1)(1995-10#1)(1995-6#1)(1996-11#2)(1997-3#1)(2004-3#2)(2005-5#2)(2005-9#2)(2006-10#2)(2006-11#2)(2006-12#7)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#4)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#7)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#5)(2008-5#1)(2008-6#5)(2008-7#5)(2008-8#4)(2008-9#1)(2009-1#1)(2009-2#2)(2009-3#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#3)(2011-7#1)(2012-12#1)(2013-1#3)(2013-7#3)
of the anterograde tracer##2##4##(1993-12#1)(1996-9#1)
of the anteromedial##2##3##(1992-10#1)(2006-12#1)
of the anteroventral third ventricle##2##5##(1992-7#2)
of the anthraquinones##2##3##(2008-10#2)
of the anthropogenic##2##3##(2007-9#1)(2008-11#1)
of the anti##2##3##(1990-8#1)(1997-8#1)
of the anti-FLAG mAbs##2##4##(1997-3#2)
of the anti-HIV agent 2'##2##5##(1990-10#1)(1991-3#1)
of the anti-Stokes##2##3##(2007-11#1)(2008-3#1)
of the anti-apoptotic proteins Bcl-2##2##5##(2012-12#2)
of the anti-apoptotic##4##3##(2010-1#1)(2010-12#1)(2012-12#2)
of the anti-histamine antibody with histamine##2##6##(2007-8#2)
of the anti-histamine antibody##3##4##(2007-8#3)
of the anti-inflammatory drug##3##4##(2008-10#2)(2009-11#1)
of the anti-inflammatory##6##3##(1990-5#1)(1993-4#2)(2008-10#2)(2009-11#1)
of the anti-oncogenic##2##3##(1997-7#2)
of the anti-predatory behavior of the hare##2##7##(2007-9#2)
of the anti-tumor##3##3##(1995-5#1)(1996-6#1)(2008-11#1)
of the antiarrhythmic##2##3##(1990-5#1)(1994-3#1)
of the antibacterial##5##3##(1990-6#1)(2006-12#2)(2008-3#1)(2009-1#1)
of the antibiotic 2##2##4##(2008-10#2)
of the antibiotic##21##3##(1990-2#1)(1991-2#1)(1992-12#2)(1994-6#1)(1996-3#1)(1997-2#2)(2005-8#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-9#1)(2010-12#1)(2010-5#1)(2011-1#1)(2013-8#2)
of the antibiotics##6##3##(1991-1#1)(2006-10#2)(2008-10#1)(2013-8#2)
of the antibodies against HBc##2##5##(2008-4#2)
of the antibodies and##4##4##(1997-5#1)(2008-10#1)(2008-4#1)(2008-7#1)
of the antibodies recognized##3##4##(1994-9#1)(1995-3#2)
of the antibodies to##2##4##(1992-11#1)(1995-10#1)
of the antibodies was##3##4##(1994-11#1)(2008-1#1)(2008-10#1)
of the antibodies##24##3##(1992-11#1)(1992-4#1)(1994-11#1)(1994-9#2)(1995-10#1)(1995-3#2)(1997-3#1)(1997-5#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-4#3)(2008-7#1)(2009-2#1)
of the antibody after##2##4##(1990-4#1)(2012-12#1)
of the antibody and##2##4##(1997-4#1)(2008-10#1)
of the antibody in##4##4##(1993-7#1)(2008-7#3)
of the antibody is##2##4##(1994-8#1)(2008-7#1)
of the antibody on##2##4##(1990-2#1)(1997-2#1)
of the antibody response##5##4##(2008-10#4)(2008-4#1)
of the antibody were##3##4##(1991-5#1)(2005-8#1)(2008-8#1)
of the antibody##41##3##(1990-10#1)(1990-2#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-5#1)(1993-7#1)(1994-11#1)(1994-8#2)(1995-4#1)(1995-5#1)(1995-6#1)(1996-11#1)(1997-2#2)(1997-4#1)(1997-5#1)(2005-8#1)(2007-11#2)(2007-8#1)(2008-10#6)(2008-11#2)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#2)(2012-12#1)
of the anticancer drug##3##4##(1996-5#1)(2005-11#1)(2008-10#1)
of the anticancer##7##3##(1996-5#1)(2005-11#1)(2007-1#1)(2007-5#1)(2008-10#1)(2008-11#1)(2009-8#1)
of the anticipated##2##3##(2008-10#1)(2008-3#1)
of the anticipatory##2##3##(2012-1#2)
of the anticlotting##2##3##(1995-8#2)
of the anticoagulant effect##2##4##(2008-10#2)
of the anticoagulant##4##3##(2006-10#1)(2008-10#3)
of the anticodon##4##3##(1991-4#1)(1992-7#1)(1992-9#1)(2008-4#1)
of the anticonvulsant drug milacemide##2##5##(1994-8#1)(1995-7#1)
of the anticonvulsant milacemide##2##4##(1994-8#1)(1995-7#1)
of the anticonvulsant##4##3##(1994-8#2)(1995-7#2)
of the antidepressant effect##2##4##(1993-2#1)(2008-6#1)
of the antidepressant fluoxetine##2##4##(2008-10#2)
of the antidepressant##6##3##(1993-2#1)(2004-3#1)(2008-10#3)(2008-6#1)
of the antidepressants##2##3##(2008-9#1)(2013-8#1)
of the antiemetic##3##3##(1991-11#1)(2006-10#1)(2008-7#1)
of the antiepileptic##5##3##(1991-3#1)(1993-11#1)(1996-8#1)(2008-6#1)(2013-1#1)
of the antiferromagnetic##2##3##(2008-5#1)(2012-2#1)
of the antifouling biocides##2##4##(2008-11#2)
of the antifouling##3##3##(2008-10#1)(2008-11#2)
of the antifungal##5##3##(1996-7#1)(2008-10#3)(2013-1#1)
of the antigen by##3##4##(1990-12#2)(1994-2#1)
of the antigen from##3##4##(1995-11#2)(2008-5#1)
of the antigen is##2##4##(1990-12#1)(2008-8#1)
of the antigen##21##3##(1990-12#5)(1991-12#3)(1992-9#1)(1994-11#2)(1994-2#1)(1995-11#2)(1997-7#1)(2007-2#2)(2008-11#2)(2008-5#1)(2008-8#1)
of the antigen-antibody complex##2##4##(2008-10#1)(2008-4#1)
of the antigen-antibody##4##3##(2008-10#3)(2008-4#1)
of the antigen-binding##2##3##(1995-5#1)(2007-11#1)
of the antigenic##5##3##(1990-12#1)(1994-3#1)(2007-8#1)(2007-9#1)(2008-4#1)
of the antigens##3##3##(1990-12#2)(1995-5#1)
of the antiherpetic##2##3##(1995-6#1)(2006-12#1)
of the antihypertensive drug##2##4##(1995-10#1)(2008-10#1)
of the antihypertensive##4##3##(1990-8#1)(1992-8#1)(1995-10#1)(2008-10#1)
of the antimalarial drug##2##4##(1994-8#1)(1995-3#1)
of the antimalarial##4##3##(1993-2#1)(1994-8#1)(1995-3#1)(2006-12#1)
of the antimicrobial activity of the##2##6##(2007-11#1)(2008-11#1)
of the antimicrobial activity##4##4##(2007-11#1)(2008-11#1)(2009-6#1)(2011-1#1)
of the antimicrobial agents##2##4##(2006-8#1)(2008-5#1)
of the antimicrobial susceptibility##2##4##(2007-8#2)
of the antimicrobial##15##3##(1991-8#1)(2006-8#2)(2007-11#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
of the antimony##3##3##(2004-4#1)(2008-10#2)
of the antioxidant activity of##4##5##(2008-10#3)(2008-4#1)
of the antioxidant capacity of##3##5##(2008-10#3)
of the antioxidant defense system##2##5##(2010-12#1)(2011-1#1)
of the antioxidant system##2##4##(1990-4#1)(2010-5#1)
of the antioxidant##27##3##(1990-4#1)(1994-6#1)(1995-1#1)(1996-12#1)(1997-3#1)(2006-10#1)(2007-11#1)(2008-10#8)(2008-2#2)(2008-4#1)(2009-4#3)(2010-12#1)(2010-5#1)(2011-1#1)(2013-1#1)(2013-8#2)
of the antioxidants##8##3##(1992-9#1)(1993-2#1)(1997-8#2)(2008-10#2)(2008-5#2)
of the antioxidative##2##3##(2008-3#1)(2011-2#1)
of the antipsychotic##3##3##(1997-7#1)(2008-6#1)(2008-8#1)
of the antiretroviral##3##3##(1990-6#1)(1991-7#1)(1992-6#1)
of the antisense##3##3##(1991-9#1)(1995-12#1)(2008-11#1)
of the antisera##4##3##(1991-8#1)(2007-12#1)(2008-5#1)(2010-6#1)
of the antithrombotic##2##3##(2006-6#1)(2007-11#1)
of the antitumor activity of##3##5##(1996-10#1)(2006-6#1)(2008-1#1)
of the antitumor agent##3##4##(1995-2#1)(1995-3#1)(2013-1#1)
of the antitumor immune response##2##5##(1991-12#1)(2013-1#1)
of the antitumor##9##3##(1991-12#1)(1995-2#1)(1995-3#1)(1996-10#1)(2006-6#1)(2008-1#1)(2008-4#1)(2013-1#2)
of the antitussive##2##3##(1991-2#1)(1993-3#1)
of the antiviral##6##3##(1990-10#1)(1994-11#2)(1994-3#1)(1994-6#1)(2008-3#1)
of the ants##2##3##(2006-12#1)(2011-1#1)
of the aorta and its branches##4##6##(1997-8#1)(2006-10#1)(2008-6#2)
of the aorta and##11##4##(1991-11#1)(1997-8#1)(2006-10#1)(2007-8#3)(2008-3#1)(2008-6#2)(2009-8#1)(2012-1#1)
of the aorta in##4##4##(2006-4#1)(2008-4#1)(2009-2#1)(2013-1#1)
of the aorta##43##3##(1990-2#1)(1991-11#2)(1991-9#1)(1993-5#1)(1996-11#1)(1997-8#2)(2006-10#2)(2006-4#1)(2006-8#1)(2007-11#2)(2007-2#2)(2007-3#2)(2007-4#1)(2007-8#10)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2009-2#1)(2009-7#1)(2009-8#2)(2010-4#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-3#1)
of the aortic arch and##2##5##(2008-8#1)(2013-1#1)
of the aortic arch in##2##5##(2007-8#2)
of the aortic arch##11##4##(2007-8#3)(2008-8#4)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
of the aortic root##2##4##(2007-8#1)(2009-4#1)
of the aortic valve##10##4##(1993-5#1)(1997-5#1)(2006-4#1)(2007-8#3)(2008-1#1)(2009-5#1)(2010-9#1)(2012-2#1)
of the aortic wall##4##4##(2007-8#1)(2009-5#2)(2009-7#1)
of the aortic##38##3##(1991-9#1)(1993-5#1)(1997-5#1)(1997-6#1)(2006-10#1)(2006-4#1)(2007-8#11)(2007-9#1)(2008-1#1)(2008-8#4)(2009-4#1)(2009-5#5)(2009-7#1)(2010-7#1)(2010-8#1)(2010-9#3)(2012-2#2)(2013-1#1)
of the aperture##8##3##(2007-11#1)(2007-12#1)(2008-2#5)(2008-3#1)
of the apertures##3##3##(2008-2#2)(2008-3#1)
of the apex##4##3##(2007-11#1)(2007-8#2)(2008-10#1)
of the aphid Schizaphis graminum##2##5##(1996-12#1)(2008-10#1)
of the aphid##10##3##(1996-12#3)(2007-12#1)(2008-10#5)(2011-2#1)
of the aphids##2##3##(2004-2#1)(2011-2#1)
of the apical cell membrane##2##5##(2007-12#2)
of the apical cell##3##4##(2007-12#2)(2009-8#1)
of the apical ectoplasmic specialization (apical ES)##2##7##(2012-2#2)
of the apical ectoplasmic##3##4##(2012-2#3)
of the apical##18##3##(1990-11#1)(1996-3#1)(1997-4#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-9#1)(2009-8#1)(2012-2#4)(2013-1#5)
of the apo B gene##2##5##(1997-8#2)
of the apo B##3##4##(1994-3#1)(1997-8#2)
of the apo##7##3##(1991-12#1)(1993-6#1)(1994-3#1)(1995-10#2)(1997-8#2)
of the apo-E##2##3##(2008-10#2)
of the apoB##2##3##(1990-7#1)(2010-12#1)
of the apoE##2##3##(1995-1#1)(1995-6#1)
of the apoenzyme##3##3##(1990-11#1)(1994-8#1)(1997-7#1)
of the apolipoprotein B gene##3##5##(1995-2#1)(1997-8#1)(2007-2#1)
of the apolipoprotein E##4##4##(1995-5#1)(1996-5#1)(2008-4#1)(2008-8#1)
of the apolipoprotein##10##3##(1993-6#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-8#1)(2005-7#1)(2007-2#1)(2008-4#1)(2008-8#1)(2012-11#1)
of the apolipoproteins##3##3##(1991-2#1)(1993-9#1)(2008-5#1)
of the apoprotein##2##3##(1990-2#1)(1993-8#1)
of the apoptosis##3##3##(1996-8#1)(2008-10#1)(2008-11#1)
of the apoptotic##7##3##(1995-12#1)(1995-2#1)(2008-8#2)(2009-3#1)(2010-1#1)(2010-12#1)
of the apparatus##10##3##(1997-6#1)(2006-5#1)(2007-8#1)(2008-3#5)(2008-4#1)(2012-1#1)
of the apparent catalytic##2##4##(1996-7#1)(2008-10#1)
of the apparent diffusion coefficient##4##5##(2005-11#1)(2008-10#1)(2008-11#1)(2010-12#1)
of the apparent##27##3##(1990-11#1)(1990-4#1)(1990-7#1)(1991-9#1)(1992-9#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-4#1)(1997-6#1)(2005-11#2)(2006-5#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2009-9#1)(2010-12#1)(2013-8#1)
of the appearance of##6##4##(1991-12#1)(1993-2#1)(1994-11#1)(1996-1#1)(1997-6#1)(2011-2#1)
of the appendicular##5##3##(1991-11#1)(2007-11#1)(2007-12#1)(2010-3#1)(2011-2#1)
of the appendix and##3##4##(1997-8#1)(2008-2#1)(2008-9#1)
of the appendix##9##3##(1990-10#1)(1993-12#2)(1997-8#1)(2004-10#1)(2008-12#1)(2008-2#2)(2008-9#1)
of the apple snail##2##4##(2008-11#2)
of the apple##6##3##(2008-10#4)(2008-11#2)
of the applicability of##4##4##(1993-6#1)(2007-3#1)(2008-2#1)(2010-11#1)
of the applicable##2##3##(1992-12#1)(2008-11#1)
of the applicants##4##3##(1992-5#1)(1995-5#1)(1997-3#1)(2010-12#1)
of the application and##3##4##(1996-12#1)(2013-1#2)
of the application of the##8##5##(1990-9#1)(1992-9#1)(1993-10#1)(1995-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-9#1)
of the application of these##2##5##(2008-10#1)(2012-2#1)
of the application of this##3##5##(2007-11#1)(2008-10#1)(2008-2#1)
of the application of##37##4##(1990-9#1)(1991-8#1)(1992-7#1)(1992-9#1)(1993-10#1)(1995-5#1)(1995-9#1)(1996-9#1)(2004-11#1)(2006-7#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-2#2)(2010-1#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#1)
of the application##46##3##(1990-9#1)(1991-8#1)(1992-7#1)(1992-9#1)(1993-10#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-9#1)(2004-11#1)(2006-7#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-2#2)(2009-6#1)(2010-1#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#1)(2013-1#4)
of the applications of##4##4##(2007-11#1)(2008-3#1)(2008-4#1)(2008-9#1)
of the applications##8##3##(2007-11#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2013-7#1)
of the applied current##3##4##(2008-10#3)
of the applied electric field##3##5##(2005-11#3)
of the applied treatment##2##4##(2008-10#2)
of the applied voltage##3##4##(2008-2#1)(2013-8#2)
of the applied##25##3##(1995-3#2)(2005-11#4)(2006-12#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-2#1)(2008-6#1)(2008-7#1)(2013-8#2)
of the appressoria##2##3##(2008-10#2)
of the approach and##4##4##(1995-2#1)(1996-1#1)(1996-2#1)(2006-5#1)
of the approach is##2##4##(1996-5#1)(2008-10#1)
of the approach of the##2##5##(1994-9#1)(2011-2#1)
of the approach of##4##4##(1994-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
of the approach to##4##4##(1992-8#1)(2008-11#1)(2008-4#1)(2011-2#1)
of the approach was##2##4##(2007-8#1)(2008-5#1)
of the approach with##2##4##(1996-8#1)(2008-10#1)
of the approach##37##3##(1990-12#1)(1992-8#1)(1994-9#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-8#1)(2006-5#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-11#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#2)(2013-1#1)
of the approaches are##2##4##(2008-4#1)(2012-1#1)
of the approaches##9##3##(2004-2#1)(2006-3#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-4#1)(2012-1#1)(2013-1#2)
of the appropriate type of##2##5##(2007-11#1)(2007-7#1)
of the appropriate##42##3##(1990-8#1)(1991-3#1)(1991-9#1)(1993-12#1)(1994-3#1)(1996-11#1)(1996-5#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#5)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#3)
of the appropriateness of##2##4##(2008-11#1)(2010-6#1)
of the approval##2##3##(1991-3#1)(2010-4#1)
of the approved##2##3##(2008-8#1)(2011-1#1)
of the approximate##6##3##(1994-9#1)(2008-2#2)(2008-3#1)(2009-2#1)(2012-1#1)
of the approximately##6##3##(1990-3#1)(1990-8#1)(1991-4#1)(2006-10#1)(2008-7#1)(2009-7#1)
of the approximation##6##3##(1996-3#1)(2007-12#1)(2008-3#1)(2009-9#1)(2012-1#1)(2013-1#1)
of the aptamers##4##3##(2007-11#1)(2011-1#2)(2013-1#1)
of the aquatic HS##2##4##(2008-10#2)
of the aquatic environment##3##4##(2004-4#1)(2008-10#1)(2008-11#1)
of the aquatic##9##3##(2004-4#1)(2007-7#2)(2008-10#3)(2008-11#1)(2010-6#1)(2010-8#1)
of the aqueous extract of Phyllantus amarus Schumach and Thonn##2##10##(2008-4#2)
of the aqueous extract of the leaves and stem of the plant##2##12##(2008-4#2)
of the aqueous extract of the##3##6##(2008-4#2)(2010-2#1)
of the aqueous extract of##7##5##(2008-4#4)(2008-5#1)(2010-2#1)(2011-1#1)
of the aqueous extract##9##4##(2008-11#1)(2008-4#5)(2008-5#1)(2010-2#1)(2011-1#1)
of the aqueous glucose##2##4##(2008-2#2)
of the aqueous leaf extract of##2##6##(2013-7#2)
of the aqueous leaf extract##3##5##(2010-4#1)(2013-7#2)
of the aqueous leaves extracts of##2##6##(2008-12#2)
of the aqueous leaves extracts##3##5##(2008-12#3)
of the aqueous phase##7##4##(2006-12#1)(2008-10#6)
of the aqueous##38##3##(1994-12#1)(1994-2#1)(1994-3#1)(1996-4#1)(2006-12#1)(2007-11#1)(2008-10#11)(2008-11#1)(2008-12#3)(2008-2#2)(2008-4#5)(2008-5#2)(2009-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2011-1#1)(2013-7#2)
of the aquo-met and cyano-met derivatives of the loggerhead sea turtle (Caretta caretta) myoglobin##2##14##(1995-3#2)
of the arachidonic##2##3##(1990-7#1)(1991-4#1)
of the arachnoid##2##3##(2006-12#1)(2008-7#1)
of the arc of##2##4##(2008-5#1)(2008-8#1)
of the arc##3##3##(2008-11#1)(2008-5#1)(2008-8#1)
of the arch##3##3##(2007-11#1)(2007-7#1)(2011-1#1)
of the architecture of the##3##5##(1993-5#1)(1994-2#1)(2008-5#1)
of the architecture of##5##4##(1993-5#1)(1994-2#1)(2007-12#1)(2008-5#1)(2009-2#1)
of the architecture##7##3##(1993-5#1)(1994-2#1)(2007-12#2)(2008-5#1)(2009-2#1)(2009-5#1)
of the archival##2##3##(1996-2#1)(2009-9#1)
of the arcjet plume##2##4##(2008-3#2)
of the arcjet##4##3##(2008-2#2)(2008-3#2)
of the arcuate nucleus##2##4##(1993-5#1)(2010-10#1)
of the arcuate##6##3##(1993-2#1)(1993-5#1)(2006-12#3)(2010-10#1)
of the area of the##3##5##(1997-3#1)(2006-6#1)(2008-2#1)
of the area of##7##4##(1995-8#1)(1997-3#1)(2006-6#1)(2007-11#2)(2008-2#1)(2008-4#1)
of the area under the ROC curve##3##7##(2008-10#1)(2012-1#2)
of the area under the receiver operating##2##7##(2010-2#1)(2012-3#1)
of the area under the##8##5##(1990-7#1)(2008-1#1)(2008-10#2)(2010-2#1)(2012-1#2)(2012-3#1)
of the area##34##3##(1990-7#1)(1991-1#1)(1991-8#1)(1992-6#2)(1994-10#1)(1994-6#1)(1995-8#1)(1996-8#1)(1997-3#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-1#3)(2008-10#5)(2008-2#1)(2008-4#1)(2008-5#2)(2010-2#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-7#1)
of the areas of##5##4##(1990-12#1)(1991-2#1)(2007-8#2)(2010-9#1)
of the areas##12##3##(1990-12#1)(1991-2#1)(1996-4#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-8#2)(2008-12#1)(2008-7#1)(2010-9#1)(2011-1#1)
of the arginase activity##2##4##(1992-5#1)(1994-9#1)
of the arginine##2##3##(1992-4#1)(1997-4#1)
of the argument##2##3##(2006-7#1)(2012-1#1)
of the arguments##2##3##(2009-4#1)(2011-2#1)
of the arm##13##3##(1992-10#1)(1994-5#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-1#3)
of the armadillo##2##3##(1991-11#1)(1995-2#1)
of the armyworm##2##3##(1992-1#1)(1992-6#1)
of the aromatase inhibitor##2##4##(1996-8#1)(2004-1#1)
of the aromatase##4##3##(1991-5#1)(1993-8#1)(1996-8#1)(2004-1#1)
of the aromatic amino acid##3##5##(1991-10#1)(1997-8#1)(2006-12#1)
of the aromatic ring##4##4##(1996-8#1)(1997-8#1)(2007-8#1)(2010-4#1)
of the aromatic rings of##3##5##(1994-9#1)(2008-5#1)(2010-5#1)
of the aromatic##18##3##(1991-10#1)(1992-12#1)(1994-9#1)(1995-1#1)(1995-10#1)(1996-5#1)(1996-8#1)(1997-8#2)(2005-11#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-5#2)(2010-4#1)(2010-5#1)
of the arrangement of##2##4##(1992-3#1)(2008-7#1)
of the arrangement##4##3##(1992-3#1)(1996-3#1)(2008-3#1)(2008-7#1)
of the array is##2##4##(2007-12#1)(2008-2#1)
of the array of##4##4##(1990-8#1)(1991-3#1)(2011-12#1)(2011-2#1)
of the array##17##3##(1990-8#1)(1991-3#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-3#1)
of the arrested cells##2##4##(1991-2#1)(1992-3#1)
of the arsenic in these##2##5##(2008-10#1)(2008-4#1)
of the arsenic species was performed by##2##7##(2008-10#2)
of the arsenic species##3##4##(2008-10#3)
of the arsenic##7##3##(1996-7#1)(2008-10#5)(2008-4#1)
of the art and future##2##5##(2007-5#1)(2008-11#1)
of the art and##9##4##(1993-3#1)(1994-6#1)(2006-8#2)(2007-5#1)(2008-11#1)(2010-11#1)(2012-12#1)(2013-1#1)
of the art in##14##4##(2004-2#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-8#1)(2010-9#2)
of the art of##9##4##(1991-4#1)(1993-3#1)(2007-8#1)(2008-3#1)(2008-5#1)(2009-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
of the art on##2##4##(2007-5#1)(2010-12#1)
of the art##78##3##(1991-12#1)(1991-4#1)(1991-9#1)(1993-3#3)(1994-6#2)(1994-8#1)(1995-2#1)(1995-5#2)(2004-2#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-6#2)(2006-8#3)(2006-9#1)(2007-12#2)(2007-5#3)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#4)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-12#2)(2009-4#2)(2009-5#1)(2010-11#1)(2010-12#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
of the arterial baroreflex during the BJR##2##7##(2010-11#2)
of the arterial baroreflex during the##3##6##(2010-11#3)
of the arterial blood##2##4##(1990-4#1)(1996-3#1)
of the arterial wall##5##4##(2007-8#1)(2008-3#1)(2009-1#1)(2009-4#1)(2011-2#1)
of the arterial##26##3##(1990-4#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#2)(1993-1#1)(1995-4#1)(1995-8#1)(1996-3#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-3#2)(2008-7#2)(2009-1#1)(2009-4#1)(2010-11#3)(2011-2#1)
of the arterialized##2##3##(2006-6#2)
of the arteries##3##3##(1991-3#1)(2007-8#1)(2008-7#1)
of the arteriovenous##2##3##(1993-6#1)(2011-3#1)
of the artery responsible for the##2##6##(1993-10#1)(2008-10#1)
of the artery##15##3##(1991-7#1)(1992-3#1)(1993-10#1)(1995-12#1)(1996-8#1)(1997-2#1)(2005-1#1)(2007-7#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)
of the arthritis##3##3##(2006-10#2)(2009-5#1)
of the arthropod nervous system##2##5##(2007-12#2)
of the arthropod##8##3##(2007-12#5)(2007-5#1)(2008-6#2)
of the article is##3##4##(1990-12#1)(1993-3#1)(2009-5#1)
of the article##23##3##(1990-12#3)(1993-3#1)(1993-6#1)(1995-3#1)(1997-3#1)(2005-6#1)(2007-10#1)(2007-2#1)(2009-4#3)(2009-5#1)(2010-11#2)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#1)
of the articles in this special##2##6##(1994-3#1)(1997-1#1)
of the articles published in this##2##6##(1997-3#1)(2008-10#1)
of the articles##7##3##(1992-6#1)(1994-3#1)(1997-1#1)(1997-3#1)(2008-10#1)(2009-4#1)(2012-2#1)
of the articular cartilage##5##4##(1997-6#1)(2007-11#1)(2007-8#2)(2008-8#1)
of the articular surface##4##4##(2006-3#1)(2007-11#1)(2010-12#1)(2012-2#1)
of the articular surfaces##2##4##(2007-11#2)
of the articular##15##3##(1994-12#1)(1997-6#1)(2006-3#1)(2007-11#6)(2007-8#2)(2008-12#1)(2008-8#1)(2010-12#1)(2012-2#1)
of the articulating surface##2##4##(2012-2#1)(2012-3#1)
of the artifact##2##3##(2008-2#1)(2008-3#1)
of the artificial##10##3##(1991-7#1)(1991-9#1)(1994-2#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-1#1)
of the aryl hydrocarbon receptor (AHR)##2##6##(1995-5#1)(2008-7#1)
of the aryl hydrocarbon receptor##3##5##(1995-5#1)(2008-7#2)
of the aryl hydrocarbon##4##4##(1995-11#1)(1995-5#1)(2008-7#2)
of the as-prepared##2##3##(2010-4#1)(2013-7#1)
of the ascending aorta after##2##5##(1997-5#1)(2007-8#1)
of the ascending aorta was##3##5##(1997-5#1)(2007-8#2)
of the ascending aorta with a##2##6##(1990-6#1)(2007-8#1)
of the ascending aorta with##4##5##(1990-6#1)(2007-8#3)
of the ascending aorta##29##4##(1990-6#1)(1993-10#1)(1997-5#4)(1997-8#1)(2007-8#18)(2008-11#1)(2010-8#1)(2011-2#1)(2012-2#1)
of the ascending aorta]##2##4##(1992-4#1)(1993-5#1)
of the ascending##33##3##(1990-6#1)(1992-4#1)(1993-10#1)(1993-5#1)(1997-5#4)(1997-8#1)(2007-11#1)(2007-8#18)(2008-11#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-2#1)
of the ascidian Ecteinascidia turbinata##2##5##(2008-5#2)
of the ascidian##4##3##(1993-6#1)(2008-5#2)(2008-6#1)
of the ascites##2##3##(2005-9#1)(2011-2#1)
of the ascospore##3##3##(2008-10#3)
of the ash##2##3##(1996-8#1)(2008-10#1)
of the asparagine##2##3##(1993-3#1)(1994-3#1)
of the asparagus##2##3##(2008-10#2)
of the aspartate##4##3##(1992-8#3)(1992-9#1)
of the aspartic##3##3##(1990-12#1)(1990-3#1)(2008-4#1)
of the aspect##2##3##(2007-11#1)(2008-2#1)
of the assay and the##2##5##(1993-1#1)(2008-4#1)
of the assay and##4##4##(1993-1#1)(2007-9#1)(2008-10#1)(2008-4#1)
of the assay are##4##4##(1994-9#1)(1995-3#1)(2008-10#1)(2008-9#1)
of the assay extends from##2##5##(2008-11#2)
of the assay for##2##4##(1994-10#1)(2013-1#1)
of the assay is##7##4##(1990-11#1)(1992-9#1)(1993-2#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-9#1)
of the assay of##3##4##(1991-5#1)(1993-11#1)(2008-10#1)
of the assay was determined##2##5##(1992-7#1)(2008-10#1)
of the assay was##12##4##(1992-6#1)(1992-7#2)(1995-1#2)(1996-1#1)(1996-9#1)(1997-8#1)(2008-10#3)(2010-4#1)
of the assay were satisfactory##2##5##(1991-5#1)(2007-8#1)
of the assay were##6##4##(1991-5#1)(1996-3#1)(1997-3#1)(2007-11#1)(2007-8#1)(2013-8#1)
of the assay##73##3##(1990-11#1)(1990-12#1)(1991-10#1)(1991-5#3)(1992-6#1)(1992-7#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-2#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-3#1)(1996-1#2)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#2)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#16)(2008-11#3)(2008-4#3)(2008-9#3)(2010-11#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of the assays##5##3##(1997-3#2)(2008-10#3)
of the assemblage##3##3##(2006-12#1)(2007-11#1)(2008-9#1)
of the assembled##4##3##(1991-11#1)(1996-6#1)(2008-10#1)(2008-8#1)
of the assembly##4##3##(1990-5#1)(1993-12#1)(1995-6#1)(2009-2#1)
of the assessment and##4##4##(1992-12#1)(2007-7#1)(2009-5#1)(2012-2#1)
of the assessment of the##4##5##(1996-12#1)(2007-1#1)(2008-10#1)(2008-3#1)
of the assessment of##9##4##(1996-11#1)(1996-12#1)(2006-10#2)(2007-1#1)(2008-10#1)(2008-11#1)(2008-3#2)
of the assessment##19##3##(1992-12#1)(1996-11#1)(1996-12#1)(2006-10#2)(2007-1#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-8#1)(2009-5#1)(2012-1#1)(2012-2#2)(2013-1#1)
of the assigned##4##3##(2008-10#1)(2010-12#1)(2010-5#1)(2013-1#1)
of the assistants##2##3##(1992-1#1)(2013-1#1)
of the associated##22##3##(1991-12#1)(1994-7#1)(1997-3#1)(2005-4#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2012-2#2)(2012-3#1)(2013-1#2)
of the association and##2##4##(1991-8#1)(2010-2#1)
of the association between the##3##5##(1994-12#1)(2008-10#1)(2009-11#1)
of the association between##23##4##(1991-8#1)(1994-12#1)(2005-10#1)(2006-9#1)(2007-6#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-1#1)(2010-3#1)(2010-6#1)(2010-9#1)(2013-1#3)(2013-7#1)
of the association is##2##4##(2010-9#1)(2011-2#1)
of the association of nonpolar spheres##2##6##(2005-11#2)
of the association of##14##4##(1991-4#1)(1993-6#1)(1996-5#1)(2005-11#2)(2005-4#1)(2006-10#1)(2006-2#1)(2006-9#1)(2008-7#1)(2009-7#1)(2012-2#1)(2013-1#2)
of the association##51##3##(1990-10#1)(1991-4#1)(1991-8#2)(1993-2#1)(1993-6#1)(1994-12#1)(1996-5#1)(1997-4#1)(2005-10#1)(2005-11#2)(2005-4#1)(2006-10#1)(2006-2#2)(2006-9#2)(2007-10#1)(2007-6#1)(2008-10#6)(2008-12#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#3)(2010-1#1)(2010-2#2)(2010-3#1)(2010-6#1)(2010-9#2)(2011-2#1)(2012-2#1)(2013-1#5)(2013-7#1)
of the associations##3##3##(1995-2#1)(2008-5#1)(2009-7#1)
of the assumed##3##3##(2008-10#1)(2009-3#1)(2011-2#1)
of the assumption of##2##4##(2012-1#2)
of the assumption##3##3##(2008-3#1)(2012-1#2)
of the assumptions##7##3##(1994-11#1)(1994-9#1)(2007-11#1)(2008-3#2)(2008-9#1)(2012-2#1)
of the asthma##4##3##(2006-5#1)(2008-12#2)(2009-6#1)
of the asthmatic##4##3##(2007-6#1)(2007-8#1)(2012-12#2)
of the astrocyte##3##3##(1990-7#1)(1996-2#1)(2008-11#1)
of the astroglial##2##3##(1996-10#1)(2012-1#1)
of the asymmetric##4##3##(1995-2#1)(2007-11#1)(2007-6#1)(2010-7#1)
of the asymmetry##4##3##(2007-11#1)(2008-2#2)(2008-5#1)
of the asymptomatic period##3##4##(1997-3#3)
of the asymptomatic##6##3##(1996-9#1)(1997-3#3)(2008-3#2)
of the asymptotic technique##2##4##(2008-3#2)
of the asymptotic##4##3##(1996-3#1)(2008-3#3)
of the asynchronous##2##3##(1994-9#1)(1996-8#1)
of the at-risk group##2##4##(2007-9#2)
of the atheromatous plaque and##3##5##(2008-5#1)(2009-5#2)
of the atheromatous plaque##4##4##(2008-5#2)(2009-5#2)
of the atherosclerosis##2##3##(2008-10#1)(2012-3#1)
of the atherosclerotic disease##2##4##(1991-6#1)(1997-3#1)
of the atherosclerotic plaque##5##4##(2005-10#1)(2007-10#1)(2008-7#1)(2010-9#1)(2011-2#1)
of the atherosclerotic process##4##4##(1991-11#1)(1997-3#1)(2008-10#1)(2013-8#1)
of the atherosclerotic##12##3##(1991-11#1)(1991-6#1)(1997-3#2)(1997-7#1)(2005-10#1)(2007-10#1)(2008-10#1)(2008-7#1)(2010-9#1)(2011-2#1)(2013-8#1)
of the athlete##2##3##(2006-3#1)(2010-12#1)
of the athletes##2##3##(1995-6#1)(1995-9#1)
of the athletic##2##3##(2008-7#1)(2009-5#1)
of the atlanto-axial joint##2##4##(2008-4#2)
of the atlas##5##3##(1997-4#1)(2013-1#4)
of the atmosphere and##2##4##(2008-2#2)
of the atmosphere with##3##4##(2008-2#1)(2008-3#2)
of the atmosphere##27##3##(2007-9#2)(2008-2#14)(2008-3#10)(2012-3#1)
of the atmospheric aerosol##2##4##(2008-2#2)
of the atmospheric coherence length##2##5##(2008-2#2)
of the atmospheric##20##3##(1996-1#1)(2008-10#1)(2008-2#10)(2008-3#7)(2013-8#1)
of the atom##3##3##(1996-3#1)(2007-11#1)(2007-9#1)
of the atomic##12##3##(1990-6#1)(2004-11#1)(2006-10#2)(2007-5#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2010-7#1)
of the atoms in##2##4##(1991-5#1)(2007-12#1)
of the atoms that##2##4##(1991-12#1)(2007-9#1)
of the atoms##6##3##(1991-12#1)(1991-5#1)(1994-11#1)(2007-12#1)(2007-9#1)(2010-12#1)
of the atria##2##3##(2007-8#1)(2009-5#1)
of the atrial septal##2##4##(2008-11#2)
of the atrial##6##3##(1990-9#1)(2006-4#1)(2007-8#2)(2008-11#2)
of the attached##2##3##(2010-5#1)(2011-2#1)
of the attachment##3##3##(2005-10#2)(2008-10#1)
of the attempts##2##3##(1994-2#1)(2008-11#1)
of the attendees##2##3##(2007-4#1)(2008-10#1)
of the attention is##2##4##(2008-10#1)(2011-2#1)
of the attention##5##3##(1997-3#1)(2007-9#1)(2008-10#1)(2011-2#1)(2013-8#1)
of the attentional##3##3##(1993-11#1)(2005-10#1)(2013-8#1)
of the attenuated##3##3##(2008-7#1)(2008-9#1)(2012-2#1)
of the attenuation##2##3##(2007-11#1)(2008-2#1)
of the attitudes of staff in##2##6##(2011-2#2)
of the attitudes##3##3##(1997-3#1)(2011-2#2)
of the attractive##2##3##(2005-11#1)(2008-3#1)
of the attributes##2##3##(1995-1#1)(2006-6#1)
of the atypical antipsychotic##2##4##(2008-3#1)(2011-1#1)
of the atypical##7##3##(1997-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#1)(2011-1#1)(2013-7#1)
of the audit tool##2##4##(2008-11#2)
of the audit##6##3##(1993-1#2)(1995-5#1)(2007-11#1)(2008-11#2)
of the auditory cortex##6##4##(1991-3#1)(1993-9#1)(2010-12#1)(2010-7#3)
of the auditory nerve##2##4##(2008-8#1)(2008-9#1)
of the auditory pathway##2##4##(2008-9#1)(2012-2#1)
of the auditory##22##3##(1990-3#1)(1991-1#1)(1991-3#2)(1992-11#1)(1992-7#1)(1993-9#1)(1995-5#1)(1996-9#1)(2006-10#1)(2008-4#1)(2008-8#2)(2008-9#3)(2010-12#1)(2010-5#1)(2010-7#3)(2012-2#1)
of the auricle##2##3##(2012-3#1)(2013-1#1)
of the authentic##6##3##(1990-12#1)(1990-2#2)(1995-1#1)(1995-2#1)(2008-10#1)
of the author in##2##4##(1992-8#1)(2008-12#1)
of the author##7##3##(1990-12#1)(1992-8#1)(1994-6#1)(2008-12#2)(2008-8#1)(2012-2#1)
of the author's own##2##4##(2007-11#2)
of the author's##9##3##(1992-12#1)(1994-12#1)(2006-8#1)(2007-11#2)(2007-2#1)(2008-2#1)(2008-7#1)(2009-10#1)
of the authorities##2##3##(1991-6#1)(2008-3#1)
of the authors of##2##4##(2009-2#1)(2012-3#1)
of the authors that##2##4##(2006-3#1)(2008-8#1)
of the authors was##2##4##(2007-11#1)(2007-12#1)
of the authors##23##3##(1991-9#1)(1994-2#1)(1995-6#1)(1996-6#1)(1997-3#1)(2005-10#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
of the authors'##10##3##(1993-3#1)(1993-9#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-5#1)(2011-1#1)
of the autistic##3##3##(2006-2#1)(2008-11#1)(2009-9#1)
of the autocorrelation function of##2##5##(2008-2#2)
of the autocorrelation function##6##4##(2007-12#1)(2007-8#1)(2008-2#2)(2008-3#1)(2008-8#1)
of the autocorrelation##9##3##(2007-12#1)(2007-8#1)(2008-2#3)(2008-3#2)(2008-8#1)(2013-1#1)
of the autofluorescence##6##3##(2007-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2011-2#1)
of the autogenous##2##3##(1996-2#1)(2007-12#1)
of the autoimmune##2##3##(1991-5#1)(2013-8#1)
of the autologous##4##3##(1991-12#1)(1992-1#1)(2008-11#1)(2012-12#1)
of the automated system##2##4##(2008-10#2)
of the automated##10##3##(1993-12#1)(2006-12#1)(2007-7#1)(2008-10#7)
of the automatic##4##3##(2008-10#2)(2008-3#1)(2009-11#1)
of the automation##3##3##(1990-3#1)(2008-10#2)
of the autonomic nervous system (ANS)##6##6##(2008-10#1)(2009-11#1)(2009-7#1)(2011-1#2)(2013-8#1)
of the autonomic nervous system##17##5##(1991-7#1)(1995-12#1)(1996-12#5)(2007-10#1)(2008-10#1)(2009-11#1)(2009-7#1)(2010-2#1)(2011-1#2)(2013-1#2)(2013-8#1)
of the autonomic nervous##19##4##(1991-7#1)(1995-12#1)(1996-12#5)(2006-10#1)(2007-10#1)(2008-10#1)(2009-11#1)(2009-7#1)(2010-2#1)(2010-5#1)(2011-1#2)(2013-1#2)(2013-8#1)
of the autonomic##25##3##(1991-7#1)(1995-12#1)(1996-12#5)(2005-1#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-4#1)(2009-11#1)(2009-2#1)(2009-7#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2013-1#2)(2013-8#3)
of the autophagy##2##3##(2013-1#2)
of the autoreactive T##2##4##(1991-12#1)(2007-5#1)
of the autosampler in the##2##5##(2008-10#2)
of the autosomal recessive##2##4##(1996-6#1)(2008-7#1)
of the autosomes and##2##4##(2008-12#1)(2008-7#1)
of the autumnal##4##3##(2008-11#1)(2008-8#2)(2010-8#1)
of the auxiliary##4##3##(1995-3#1)(2007-12#1)(2008-3#1)(2008-8#1)
of the auxin##2##3##(2009-6#1)(2009-8#1)
of the availability of##4##4##(2006-10#1)(2008-10#1)(2009-10#1)(2011-1#1)
of the availability##5##3##(1993-8#1)(2006-10#1)(2008-10#1)(2009-10#1)(2011-1#1)
of the available data##7##4##(1991-12#1)(1994-6#1)(1995-5#1)(1996-1#1)(1997-4#1)(2008-2#1)(2010-8#1)
of the available evidence##3##4##(1992-2#1)(1993-12#1)(2008-11#1)
of the available information on the##2##6##(2005-10#1)(2013-8#1)
of the available information##4##4##(1991-9#1)(2005-10#1)(2007-11#1)(2013-8#1)
of the available literature indicates that##2##6##(2007-11#1)(2012-12#1)
of the available literature##9##4##(1993-5#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-8#1)(2009-4#1)(2009-5#1)(2012-12#1)
of the available techniques##2##4##(1991-2#1)(2013-7#1)
of the available treatment##2##4##(1996-2#1)(2006-12#1)
of the available treatments##2##4##(2008-7#1)(2011-2#1)
of the available##58##3##(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-2#1)(1993-12#1)(1993-5#1)(1994-6#1)(1995-10#1)(1995-5#1)(1996-1#2)(1996-2#1)(1996-4#1)(1997-4#1)(2005-10#1)(2005-12#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
of the average number of##2##5##(2012-12#1)(2012-3#1)
of the average of the##2##5##(2008-2#1)(2008-3#1)
of the average values of##2##5##(2012-3#1)(2013-8#1)
of the average values##3##4##(2008-10#1)(2012-3#1)(2013-8#1)
of the average##40##3##(1991-9#1)(1992-6#1)(1993-9#1)(1994-11#1)(1995-8#1)(1996-11#3)(1996-2#1)(1996-7#1)(1997-7#1)(2005-11#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
of the avian##4##3##(1993-8#1)(1995-2#1)(2006-7#1)(2009-2#1)
of the avoidance##3##3##(1994-6#1)(1996-10#1)(2007-6#1)
of the axial ligand##2##4##(1996-2#1)(1997-7#1)
of the axial##16##3##(1991-2#1)(1995-11#1)(1995-8#1)(1996-2#1)(1997-7#3)(2006-12#1)(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#1)(2010-5#1)
of the axilla##8##3##(1996-12#1)(2008-12#1)(2008-5#6)
of the axillary artery##5##4##(2007-8#1)(2008-7#2)(2011-12#2)
of the axillary lymph nodes##2##5##(1992-4#1)(1993-8#1)
of the axillary microflora##2##4##(2008-5#2)
of the axillary nodes##2##4##(2008-10#2)
of the axillary region##2##4##(2008-7#1)(2010-12#1)
of the axillary##21##3##(1990-10#1)(1992-4#1)(1993-8#1)(1995-10#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-5#4)(2008-7#3)(2010-12#1)(2011-12#2)(2013-1#1)(2013-8#1)
of the axis of the##2##5##(2007-12#1)(2007-7#1)
of the axis##3##3##(2007-12#1)(2007-7#1)(2008-3#1)
of the axon distal to the##2##6##(1991-10#1)(2007-11#1)
of the axon to##2##4##(1996-12#1)(2012-2#1)
of the axon##11##3##(1991-10#1)(1991-9#1)(1994-11#2)(1994-5#1)(1995-11#1)(1996-12#1)(2007-11#1)(2012-2#2)(2013-7#1)
of the axonal##2##3##(1995-2#1)(2008-6#1)
of the axoneme##2##3##(1991-2#2)
of the axons##4##3##(1990-4#1)(1995-3#2)(2009-7#1)
of the azimuthal##2##3##(2007-12#1)(2008-10#1)
of the azobenzene##4##3##(2007-12#1)(2008-10#3)
of the b##5##3##(1994-10#1)(1994-8#1)(1996-4#1)(2008-10#1)(2008-7#1)
of the babies##3##3##(1994-3#1)(2006-8#1)(2007-7#1)
of the baboon and##2##4##(1993-6#1)(2008-9#1)
of the baboon##5##3##(1993-5#1)(1993-6#1)(1994-12#2)(2008-9#1)
of the baby##10##3##(1993-5#1)(1994-3#1)(2006-2#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-6#1)(2011-2#1)(2012-3#1)
of the back and##3##4##(1992-9#1)(1997-3#1)(2006-8#1)
of the back##13##3##(1992-9#1)(1996-9#1)(1997-3#1)(2005-10#1)(2006-11#1)(2006-8#1)(2007-7#1)(2008-5#1)(2008-6#2)(2011-1#1)(2012-2#1)(2013-1#1)
of the back-scattering of##2##4##(2006-7#2)
of the backbone amide##2##4##(1995-2#1)(1997-7#1)
of the backbone and##2##4##(1995-5#1)(2008-4#1)
of the backbone##12##3##(1990-7#1)(1992-9#1)(1994-11#1)(1995-2#1)(1995-5#1)(1996-7#1)(1997-7#1)(2006-12#1)(2008-4#1)(2009-2#1)(2009-7#1)(2012-3#1)
of the background and##2##4##(2007-12#1)(2008-10#1)
of the background medium##2##4##(2008-2#2)
of the background signals##3##4##(2008-3#3)
of the background##19##3##(1990-9#1)(1994-2#1)(2005-11#1)(2005-4#1)(2007-12#3)(2008-10#4)(2008-2#3)(2008-3#4)(2008-5#1)
of the backscatter##3##3##(2008-2#2)(2008-3#1)
of the backscattered beam##2##4##(2008-2#2)
of the backscattered intensity in##2##5##(2008-3#2)
of the backscattered intensity##4##4##(2007-12#1)(2008-3#3)
of the backscattered laser pulse##2##5##(2008-3#2)
of the backscattered light##5##4##(2008-2#2)(2008-3#3)
of the backscattered##14##3##(2007-12#2)(2008-2#4)(2008-3#8)
of the backscattering coefficient##2##4##(2008-2#1)(2008-3#1)
of the backscattering##6##3##(2007-12#1)(2008-2#3)(2008-3#2)
of the baclofen##2##3##(2008-10#1)(2011-2#1)
of the bacteria or##2##4##(2006-6#1)(2008-5#1)
of the bacteria to##6##4##(1990-2#1)(1993-11#1)(1995-2#1)(2008-11#1)(2008-8#1)(2011-2#1)
of the bacteria with##2##4##(1995-2#1)(1997-2#1)
of the bacteria##30##3##(1990-2#1)(1991-11#1)(1992-10#1)(1993-11#1)(1993-2#1)(1995-2#2)(1996-12#3)(1996-2#1)(1997-2#1)(1997-4#3)(2006-10#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#3)(2008-8#1)(2011-12#2)(2011-2#1)(2012-2#1)
of the bacterial cell##3##4##(2008-10#1)(2008-11#1)(2008-4#1)
of the bacterial cells##4##4##(2005-12#1)(2006-8#1)(2008-4#1)(2011-1#1)
of the bacterial chloramphenicol acetyltransferase##2##5##(1993-3#1)(1993-8#1)
of the bacterial chloramphenicol##3##4##(1991-1#1)(1993-3#1)(1993-8#1)
of the bacterial community##2##4##(2008-10#1)(2010-6#1)
of the bacterial enzyme##2##4##(1996-7#1)(1997-6#1)
of the bacterial enzymes##2##4##(2008-4#1)(2008-5#1)
of the bacterial populations##2##4##(2008-10#2)
of the bacterial spot pathogen##2##5##(2008-10#2)
of the bacterial strains##2##4##(2008-10#1)(2013-8#1)
of the bacterial transposon##2##4##(1995-8#2)
of the bacterial##58##3##(1990-3#1)(1991-1#1)(1991-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#3)(1994-5#1)(1994-6#1)(1995-2#1)(1995-8#3)(1996-7#1)(1997-6#1)(2005-12#1)(2005-9#1)(2006-11#1)(2006-2#1)(2006-8#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-6#2)(2011-1#2)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of the bacterially expressed##2##4##(1994-11#1)(1994-5#1)
of the bacterially##3##3##(1994-11#1)(1994-5#1)(2006-10#1)
of the bacteriophage T4##2##4##(1990-5#1)(1992-5#1)
of the bacteriophage T7##4##4##(1990-4#1)(1991-5#1)(1992-12#2)
of the bacteriophage##11##3##(1990-4#1)(1990-5#1)(1991-5#1)(1991-6#2)(1992-12#2)(1992-5#1)(1995-4#1)(1997-7#1)(2008-8#1)
of the bacterium in##2##4##(2012-12#1)(2013-1#1)
of the bacterium##20##3##(1990-12#1)(1995-10#1)(1996-12#1)(1997-4#1)(1997-6#1)(2006-10#3)(2008-1#1)(2008-10#5)(2008-7#2)(2008-8#1)(2009-8#1)(2012-12#1)(2013-1#1)
of the baculovirus expression system##2##5##(2008-2#2)
of the baculovirus##6##3##(1997-3#3)(2008-2#3)
of the bags##3##3##(2008-10#2)(2012-1#1)
of the baker's##2##3##(1995-11#1)(2007-10#1)
of the balance between##2##4##(1992-12#1)(2007-4#1)
of the balance##4##3##(1992-12#1)(1994-8#1)(2006-10#1)(2007-4#1)
of the balanced##3##3##(2008-2#2)(2010-7#1)
of the ball lens##3##4##(2011-1#3)
of the ball##6##3##(2009-7#2)(2011-1#3)(2011-2#1)
of the balloon##3##3##(1997-6#1)(2008-5#1)(2008-7#1)
of the ban##2##3##(1995-6#1)(1996-6#1)
of the band gap##2##4##(2008-10#1)(2009-2#1)
of the band##11##3##(1991-6#1)(1991-9#1)(1994-11#1)(1994-5#1)(2005-4#1)(2007-8#2)(2008-10#1)(2008-3#1)(2009-2#1)(2010-4#1)
of the bands at##2##4##(1994-6#1)(2007-8#1)
of the bands in##2##4##(2008-10#1)(2008-9#1)
of the bands##9##3##(1993-11#1)(1994-6#1)(1995-3#1)(2005-4#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#1)
of the bandwidth##5##3##(2008-10#1)(2008-2#1)(2008-3#3)
of the bar gene##3##4##(2006-12#2)(2007-12#1)
of the bar##6##3##(2006-12#3)(2007-12#1)(2008-2#2)
of the bare##3##3##(2008-10#3)
of the barium##2##3##(2008-10#2)
of the bark##3##3##(2006-12#2)(2008-10#1)
of the barley##6##3##(2008-10#5)(2008-9#1)
of the barndoor skate##2##4##(2009-4#2)
of the barrel and##2##4##(1994-3#2)
of the barrel##4##3##(1993-7#1)(1994-11#1)(1994-3#2)
of the barrier function in a reconstituted human epidermis##2##9##(2008-5#2)
of the barrier function##5##4##(2006-10#1)(2007-7#1)(2008-5#3)
of the barrier##14##3##(2006-10#2)(2007-4#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#4)(2008-7#1)(2011-1#1)(2013-8#1)
of the barriers to the##2##5##(2008-8#1)(2012-2#1)
of the barriers to##5##4##(1993-12#1)(1997-2#1)(2008-8#1)(2011-12#1)(2012-2#1)
of the barriers##7##3##(1993-12#1)(1994-1#1)(1997-2#1)(2008-11#1)(2008-8#1)(2011-12#1)(2012-2#1)
of the basal activity##2##4##(1990-7#1)(1992-6#1)
of the basal cell##2##4##(2007-12#2)
of the basal ganglia and##2##5##(1995-5#1)(2006-3#1)
of the basal ganglia##14##4##(1995-3#1)(1995-5#1)(1995-9#1)(1996-12#2)(1997-3#1)(2006-3#1)(2008-11#4)(2010-2#1)(2012-2#1)(2013-8#1)
of the basal medium##2##4##(2008-11#2)
of the basal nuclear complex##2##5##(1996-12#2)
of the basal septum##2##4##(1992-9#2)
of the basal transcription machinery##3##5##(1992-2#1)(1995-8#1)(2006-11#1)
of the basal transcription##4##4##(1992-2#1)(1995-8#1)(1997-6#1)(2006-11#1)
of the basal##58##3##(1990-10#3)(1990-3#1)(1990-7#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-9#3)(1993-4#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#2)(1995-9#1)(1996-12#4)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2007-12#4)(2008-10#1)(2008-11#9)(2008-5#2)(2008-9#1)(2010-2#1)(2010-4#1)(2012-2#1)(2013-8#1)
of the base N##2##4##(1992-9#2)
of the base and##2##4##(2008-10#1)(2012-2#1)
of the base of the thumb##4##6##(2006-10#1)(2006-3#1)(2009-5#2)
of the base of the tongue##2##6##(2012-3#2)
of the base of the##9##5##(2006-10#1)(2006-3#1)(2006-4#1)(2008-12#1)(2008-7#1)(2009-5#2)(2012-3#2)
of the base of tongue that required reconstructive surgery##4##9##(2013-1#4)
of the base of tongue##9##5##(2012-3#1)(2013-1#8)
of the base of##21##4##(1994-1#1)(2006-10#1)(2006-3#2)(2006-4#1)(2008-12#1)(2008-7#1)(2009-5#2)(2012-2#1)(2012-3#3)(2013-1#8)
of the base pair##2##4##(1993-3#2)
of the base pairs##2##4##(1992-6#1)(2006-10#1)
of the base##48##3##(1991-12#1)(1991-5#1)(1991-9#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-3#2)(1994-1#1)(1994-9#1)(1997-2#1)(1997-8#1)(2005-12#1)(2006-10#2)(2006-3#3)(2006-4#1)(2007-7#2)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#2)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#8)
of the baseline values##2##4##(2007-9#1)(2008-7#1)
of the baseline##14##3##(1990-11#1)(1991-12#1)(1991-9#2)(1993-6#1)(1997-6#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-5#1)(2013-1#2)
of the basement membrane##5##4##(1991-7#1)(1992-7#1)(2004-1#1)(2008-1#1)(2009-3#1)
of the bases##8##3##(1994-9#1)(1995-1#2)(2006-12#1)(2008-4#1)(2008-6#1)(2009-7#2)
of the basic analytes##2##4##(2013-8#2)
of the basic concepts##2##4##(1994-3#1)(2007-12#1)
of the basic features of##2##5##(1994-8#1)(1995-7#1)
of the basic mechanisms of##2##5##(2006-10#2)
of the basic mechanisms##5##4##(2006-10#2)(2010-10#1)(2013-1#2)
of the basic motif##2##4##(1995-5#2)
of the basic principles##2##4##(2007-12#1)(2008-8#1)
of the basic protocol##2##4##(2008-4#1)(2012-12#1)
of the basic protocols##2##4##(2008-4#2)
of the basic##65##3##(1990-12#1)(1990-2#1)(1990-7#1)(1993-11#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-7#1)(1995-9#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-3#2)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-4#1)(2007-5#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#7)(2008-6#1)(2008-8#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-1#2)(2012-12#1)(2013-1#3)(2013-8#2)
of the basilar artery##11##4##(1996-2#2)(1997-6#1)(2005-9#1)(2006-5#1)(2007-10#1)(2007-9#2)(2011-2#1)(2013-8#2)
of the basilar membrane##2##4##(2008-9#1)(2012-2#1)
of the basilar##15##3##(1996-2#3)(1997-6#1)(2005-9#1)(2006-5#1)(2007-10#2)(2007-9#2)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#2)
of the basin##4##3##(1992-6#1)(1997-5#1)(2007-5#1)(2008-11#1)
of the basis functions##2##4##(2008-2#1)(2008-6#1)
of the basis of##2##4##(1991-11#1)(2012-1#1)
of the basis##7##3##(1991-11#1)(2008-10#1)(2008-2#2)(2008-6#2)(2012-1#1)
of the basolateral amygdala##6##4##(1990-5#1)(1993-6#2)(1995-12#1)(1997-6#1)(2008-7#1)
of the basolateral##7##3##(1990-5#2)(1993-6#2)(1995-12#1)(1997-6#1)(2008-7#1)
of the batch##6##3##(2008-10#1)(2008-6#1)(2008-7#2)(2010-8#1)(2011-2#1)
of the bath##2##3##(1992-11#1)(1994-3#1)
of the bathorhodopsin##3##3##(1991-7#3)
of the battered##3##3##(1995-5#3)
of the bc1 complex##5##4##(1992-11#1)(1994-10#1)(1997-3#3)
of the bcl-2 family##3##4##(1996-10#1)(1996-3#1)(1996-4#1)
of the bcl-2 product##2##4##(1994-10#2)
of the bcl-2##11##3##(1993-3#1)(1994-10#3)(1996-10#1)(1996-3#1)(1996-4#1)(2007-1#1)(2008-11#3)
of the beach##3##3##(2007-5#2)(2010-2#1)
of the bead##3##3##(2008-10#1)(2008-7#1)(2010-12#1)
of the beads task##2##4##(2012-1#2)
of the beads##4##3##(2008-10#1)(2008-11#1)(2012-1#2)
of the beam and##2##4##(2008-2#2)
of the beam at##2##4##(2006-5#1)(2008-3#1)
of the beam attenuation coefficient##4##5##(2008-2#1)(2008-3#3)
of the beam attenuation##5##4##(2008-2#1)(2008-3#4)
of the beam former##2##4##(2008-3#2)
of the beam in##2##4##(2007-12#1)(2008-3#1)
of the beam profile##3##4##(2008-2#2)(2008-3#1)
of the beam splitter##6##4##(2007-12#1)(2008-2#3)(2008-3#2)
of the beam that##2##4##(2007-12#1)(2008-3#1)
of the beam##62##3##(2006-4#1)(2006-5#3)(2006-8#1)(2007-11#4)(2007-12#8)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#17)(2008-3#25)
of the beam's##3##3##(2006-12#1)(2007-11#1)(2007-12#1)
of the beam-splitting cube##2##4##(2008-3#2)
of the beamline##2##3##(2006-5#2)
of the beams##9##3##(2006-4#1)(2007-12#1)(2008-2#5)(2008-3#2)
of the bean##4##3##(2008-10#2)(2008-8#1)(2009-8#1)
of the beat frequency##3##4##(2007-11#1)(2008-3#2)
of the beat##8##3##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#2)
of the beating heart##3##4##(2007-4#1)(2010-2#2)
of the beating##4##3##(2007-4#1)(2010-2#2)(2010-9#1)
of the bed##3##3##(1997-8#1)(2008-11#1)(2010-10#1)
of the beds##2##3##(1990-10#2)
of the bee##2##3##(1996-5#1)(2006-12#1)
of the beginning of##2##4##(1993-12#1)(2008-10#1)
of the beginning##4##3##(1993-12#1)(2006-10#1)(2008-10#1)(2011-2#1)
of the behavior of##10##4##(1994-8#1)(1995-10#1)(1996-11#1)(2006-10#1)(2008-10#2)(2008-9#1)(2009-5#1)(2010-9#1)(2011-2#1)
of the behavior##13##3##(1993-2#1)(1994-8#1)(1995-10#1)(1996-11#1)(2006-10#1)(2006-8#1)(2008-10#3)(2008-9#1)(2009-5#1)(2010-9#1)(2011-2#1)
of the behavioral and##2##4##(1995-12#1)(2005-8#1)
of the behavioral deficits##2##4##(1992-11#1)(2011-2#1)
of the behavioral##12##3##(1991-6#1)(1992-11#1)(1993-3#1)(1994-2#1)(1995-12#2)(2005-8#1)(2006-1#1)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#1)
of the behaviors##3##3##(1993-2#1)(2006-11#1)(2008-10#1)
of the behaviour of##3##4##(2007-9#1)(2008-10#1)(2010-12#1)
of the behaviour##5##3##(1993-12#1)(2007-9#1)(2008-10#2)(2010-12#1)
of the behavioural##4##3##(1991-4#1)(1992-11#1)(1993-2#1)(2006-9#1)
of the bellow knee arteries##2##5##(2008-8#2)
of the belt##3##3##(2006-11#2)(2007-4#1)
of the benchmark##3##3##(2012-12#2)(2012-2#1)
of the benchmarking##2##3##(1995-12#1)(2008-11#1)
of the bend##3##3##(1996-2#1)(2007-12#1)(2008-3#1)
of the bending energy of the membrane##2##7##(2006-10#2)
of the bending energy##3##4##(2006-10#2)(2008-7#1)
of the bending##5##3##(2006-10#2)(2008-3#1)(2008-7#1)(2013-8#1)
of the beneficial effects of##2##5##(2008-7#1)(2012-2#1)
of the beneficial##5##3##(2007-11#1)(2008-7#1)(2011-1#1)(2012-2#2)
of the beneficiaries##2##3##(1991-3#1)(1994-3#1)
of the benefit of##3##4##(1995-11#1)(2008-5#1)(2010-7#1)
of the benefit##11##3##(1993-11#1)(1994-2#1)(1995-11#1)(1995-3#1)(1995-9#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-7#1)(2012-2#1)
of the benefit-risk ratio##2##4##(2007-11#2)
of the benefits and costs##2##5##(1995-3#1)(2009-4#1)
of the benefits and##4##4##(1995-3#1)(1997-3#1)(2009-4#1)(2010-5#1)
of the benefits of early##2##5##(1997-1#1)(2007-7#1)
of the benefits of these##3##5##(1996-3#1)(2008-2#1)(2009-4#1)
of the benefits of##12##4##(1990-11#1)(1993-1#1)(1996-3#1)(1997-1#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-2#1)(2007-7#1)(2008-2#1)(2009-4#1)(2009-9#1)
of the benefits##19##3##(1990-11#1)(1993-1#1)(1995-3#1)(1996-3#1)(1997-1#1)(1997-3#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-6#1)(2009-4#2)(2009-9#1)(2010-5#1)(2012-12#1)
of the benign##6##3##(1997-3#1)(2007-12#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-2#1)
of the bent##7##3##(1990-5#1)(1993-8#1)(2006-4#1)(2008-3#4)
of the benthic##2##3##(2007-5#1)(2008-5#1)
of the bentonite##2##3##(2008-10#2)
of the benzene ring##2##4##(1996-1#1)(2004-7#1)
of the benzene##4##3##(1996-1#1)(2004-7#1)(2008-10#1)(2008-3#1)
of the benzodiazepine receptor antagonist##2##5##(1990-2#1)(1994-2#1)
of the benzodiazepine receptor##3##4##(1990-2#1)(1991-1#1)(1994-2#1)
of the benzodiazepine##12##3##(1990-2#1)(1990-3#1)(1991-1#1)(1991-3#1)(1993-12#1)(1994-2#2)(1995-11#2)(1995-7#1)(1996-11#1)(2008-10#1)
of the benzopyranic-4-one##2##3##(1997-8#2)
of the benzoyl carbanion##2##4##(2007-11#2)
of the benzoyl##4##3##(1990-9#1)(2007-11#2)(2010-8#1)
of the benzylic substituent##2##4##(1995-3#2)
of the best available##3##4##(2008-1#1)(2011-2#1)(2013-1#1)
of the best characterized##5##4##(1995-8#1)(1997-4#1)(2008-10#1)(2008-11#1)(2013-1#1)
of the best known##2##4##(1996-3#1)(2005-10#1)
of the best possible##3##4##(1995-1#1)(2006-10#1)(2012-3#1)
of the best ways to##2##5##(2007-10#1)(2010-4#1)
of the best##59##3##(1990-12#1)(1991-6#1)(1993-10#1)(1993-12#1)(1993-8#2)(1994-6#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-2#1)(2005-10#1)(2005-7#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#2)(2008-7#2)(2009-12#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
of the beta 1##3##4##(1991-2#1)(1994-3#1)(1995-6#1)
of the beta 1-adrenergic receptor##2##5##(1995-5#2)
of the beta 2##3##4##(1994-5#1)(1996-8#1)(2008-11#1)
of the beta 2AR##3##4##(1992-3#1)(1995-11#2)
of the beta chain of a##2##6##(1995-3#2)
of the beta chain of##3##5##(1995-3#2)(2008-7#1)
of the beta chain##6##4##(1990-12#1)(1993-8#1)(1995-3#3)(2008-7#1)
of the beta subunit of the##2##6##(1991-3#2)
of the beta subunit of##5##5##(1991-3#2)(1994-11#1)(1994-8#1)(1995-2#1)
of the beta subunit was found##2##6##(1992-11#1)(1992-9#1)
of the beta subunit##17##4##(1991-3#2)(1992-11#2)(1992-2#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-8#4)(1996-8#1)
of the beta toxin##3##4##(2006-5#3)
of the beta##63##3##(1990-11#1)(1990-12#1)(1991-1#1)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-7#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-7#1)(1992-9#3)(1993-5#1)(1993-6#3)(1993-8#2)(1994-11#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#1)(1995-10#2)(1995-11#4)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#2)(1995-8#4)(1996-5#1)(1996-8#2)(2006-5#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
of the beta(2a)##3##3##(2008-8#3)
of the beta-1##2##3##(1991-12#2)
of the beta-adrenergic##2##3##(1995-3#1)(2008-9#1)
of the beta-amyloid precursor protein##6##5##(1990-3#2)(1991-10#2)(1992-12#1)(1996-2#1)
of the beta-amyloid precursor##7##4##(1990-3#2)(1991-10#2)(1992-12#1)(1996-2#2)
of the beta-binomial distribution##5##4##(2008-10#5)
of the beta-binomial##10##3##(2008-10#9)(2010-3#1)
of the beta-cell##2##3##(1997-4#1)(2013-1#1)
of the beta-chain of bovine hemoglobin##3##6##(1992-11#1)(1995-3#2)
of the beta-chain##6##3##(1992-11#2)(1992-5#1)(1993-8#1)(1995-3#2)
of the beta-elimination##2##3##(2007-8#1)(2009-8#1)
of the beta-globin##3##3##(1994-12#1)(1997-4#2)
of the beta-lactamase##2##3##(1992-6#1)(1997-4#1)
of the beta-protein##4##3##(1991-1#2)(1992-12#2)
of the beta-sheet##4##3##(1992-6#1)(1995-1#2)(1995-11#1)
of the beta-subunit of the##2##5##(1991-8#1)(1995-3#1)
of the beta-subunit of##6##4##(1991-8#1)(1993-8#1)(1994-8#1)(1995-3#1)(1996-12#1)(1997-4#1)
of the beta-subunit##8##3##(1991-8#1)(1992-9#1)(1993-8#1)(1994-8#1)(1995-3#1)(1996-12#1)(1996-8#1)(1997-4#1)
of the beta-transducin##2##3##(1995-8#2)
of the beta-tubulin gene##4##4##(2008-10#2)(2008-4#2)
of the beta-tubulin##9##3##(1994-3#1)(2008-10#3)(2008-4#4)(2010-3#1)
of the beta2##2##3##(1995-9#1)(1996-5#1)
of the better##4##3##(1993-12#1)(2008-10#1)(2012-2#1)(2013-7#1)
of the beverage##2##3##(2006-10#2)
of the bias voltage##2##4##(2007-12#1)(2008-2#1)
of the bias##8##3##(1994-8#1)(1996-12#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-2#2)(2013-8#1)
of the bicell##2##3##(2008-2#2)
of the biceps brachii tendon##2##5##(2007-2#1)(2013-7#1)
of the biceps tendon##4##4##(2006-3#1)(2007-2#1)(2013-7#2)
of the biceps##9##3##(2006-3#1)(2007-11#1)(2007-2#2)(2013-7#5)
of the bicycle##2##3##(1991-2#1)(1991-9#1)
of the bicyclic##3##3##(1991-8#1)(1996-5#1)(2007-11#1)
of the bidirectional hydrogenase##2##4##(1996-9#2)
of the bidirectional##4##3##(1994-10#1)(1996-9#2)(2008-2#1)
of the bifurcation developed##2##4##(2007-9#2)
of the bifurcation##6##3##(2007-9#6)
of the big toe##3##4##(2008-12#1)(2010-9#2)
of the big##7##3##(1990-9#1)(1995-1#1)(2006-10#1)(2008-12#1)(2010-4#1)(2010-9#2)
of the biggest##7##3##(1991-2#2)(1992-9#1)(2008-3#1)(2008-7#1)(2010-11#1)(2012-2#1)
of the bilateral common carotid arteries##2##6##(2007-10#1)(2008-7#1)
of the bilateral##9##3##(1997-6#1)(2006-8#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-7#1)(2011-3#1)(2012-12#1)
of the bilaterian##2##3##(2010-4#2)
of the bilayer##22##3##(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1991-2#2)(1991-5#1)(1992-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-11#1)(1996-7#1)(2006-10#2)(2008-10#3)
of the bilayer-stabilizing peptides##2##4##(1991-2#2)
of the bilayers and##2##4##(2006-10#1)(2008-10#1)
of the bilayers##4##3##(1992-11#1)(2006-10#1)(2008-10#1)(2008-8#1)
of the bile acids##2##4##(1995-8#1)(1997-3#1)
of the bile alcohols##2##4##(1991-3#1)(1996-6#1)
of the bile duct##4##4##(2008-5#1)(2008-6#1)(2013-1#2)
of the bile ducts##2##4##(2006-2#1)(2006-6#1)
of the bile##16##3##(1991-3#3)(1995-1#1)(1995-8#1)(1996-6#1)(1997-3#1)(2005-11#1)(2006-2#1)(2006-6#1)(2008-11#2)(2008-5#1)(2008-6#1)(2013-1#2)
of the biliary tract are##2##5##(1990-6#1)(2009-7#1)
of the biliary tract in geriatric##2##6##(1992-9#2)
of the biliary tract with##2##5##(1991-5#1)(2006-2#1)
of the biliary tract##20##4##(1990-5#1)(1990-6#2)(1990-8#1)(1991-5#1)(1992-9#5)(2006-2#3)(2008-4#4)(2009-7#3)
of the biliary tree##5##4##(2006-10#2)(2012-12#2)(2013-1#1)
of the biliary##31##3##(1990-5#1)(1990-6#2)(1990-8#1)(1991-5#1)(1991-6#1)(1992-9#5)(2006-10#2)(2006-2#4)(2008-3#1)(2008-4#4)(2009-7#3)(2010-12#2)(2012-12#2)(2013-1#1)(2013-8#1)
of the bilirubin##3##3##(1990-1#2)(1993-12#1)
of the bill##2##3##(1991-10#1)(1992-1#1)
of the bimolecular complex##3##4##(1992-2#1)(1995-11#1)(1996-8#1)
of the binary and ternary complexes##3##6##(1997-1#1)(2008-10#2)
of the binary and ternary##4##5##(1997-1#1)(2008-10#2)(2010-2#1)
of the binary complex##3##4##(1992-12#1)(1993-11#1)(1995-5#1)
of the binary power law##3##5##(2008-10#3)
of the binary##14##3##(1992-12#1)(1993-11#1)(1995-5#1)(1997-1#1)(2006-8#1)(2008-10#8)(2010-2#1)
of the binding by##2##4##(1991-7#1)(1996-6#1)
of the binding characteristics of##2##5##(1991-9#1)(1994-5#1)
of the binding characteristics##3##4##(1991-9#1)(1994-5#1)(1995-9#1)
of the binding data showed##2##5##(1993-1#1)(1995-9#1)
of the binding data##3##4##(1991-5#1)(1993-1#1)(1995-9#1)
of the binding is##2##4##(1990-12#1)(2006-10#1)
of the binding of ligands by##3##6##(1996-11#3)
of the binding of the##3##5##(1995-2#1)(1997-2#1)(2008-6#1)
of the binding of these##2##5##(1994-8#1)(1997-1#1)
of the binding of##28##4##(1990-12#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-7#1)(1992-11#1)(1992-6#1)(1994-8#2)(1995-2#1)(1995-6#1)(1995-7#2)(1996-10#1)(1996-11#3)(1996-12#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#2)(2006-10#1)(2008-11#1)(2008-6#1)(2008-7#1)
of the binding pocket##3##4##(1991-8#1)(2008-4#1)(2011-1#1)
of the binding process##3##4##(1994-8#1)(1994-9#1)(2007-8#1)
of the binding protein##2##4##(1990-11#1)(1994-2#1)
of the binding reaction##3##4##(1995-8#1)(2008-10#1)(2008-4#1)
of the binding site and##2##5##(1995-1#1)(1997-4#1)
of the binding site for##2##5##(1990-7#1)(2010-10#1)
of the binding site##10##4##(1990-7#1)(1992-6#1)(1992-9#1)(1994-12#1)(1995-1#2)(1995-3#1)(1997-4#1)(2010-10#1)(2012-2#1)
of the binding sites##6##4##(1993-3#1)(1994-5#1)(1997-1#1)(1997-2#1)(2008-10#2)
of the binding to##2##4##(1996-7#1)(2008-3#1)
of the binding##97##3##(1990-11#1)(1990-12#2)(1990-5#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-5#2)(1991-7#2)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-6#2)(1992-9#1)(1993-1#1)(1993-3#1)(1994-12#1)(1994-2#2)(1994-5#3)(1994-8#3)(1994-9#1)(1995-1#2)(1995-2#2)(1995-3#2)(1995-6#1)(1995-7#2)(1995-8#1)(1995-9#2)(1996-10#1)(1996-11#6)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#2)(1996-7#2)(1997-1#2)(1997-2#7)(1997-4#2)(1997-7#1)(2005-11#1)(2006-1#1)(2006-10#2)(2007-8#2)(2008-10#6)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-2#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-2#1)
of the binge##2##3##(2006-12#1)(2006-7#1)
of the binomial distribution##2##4##(2008-10#2)
of the binormal##2##3##(1996-7#1)(1997-3#1)
of the binuclear##2##3##(1992-9#2)
of the bioactive glass##3##4##(2008-5#1)(2009-7#2)
of the bioactive##8##3##(1995-7#1)(1996-9#1)(2007-8#1)(2008-5#1)(2009-7#2)(2011-1#1)(2012-2#1)
of the bioassay##4##3##(1991-9#2)(2008-10#1)(2008-5#1)
of the bioavailability of##4##4##(1993-12#1)(1996-4#1)(2008-10#1)(2012-1#1)
of the biocatalyst##4##3##(1991-5#1)(2008-6#1)(2008-7#1)(2011-2#1)
of the biochemical and##4##4##(1994-11#1)(1994-8#1)(1995-2#1)(2012-2#1)
of the biochemical##21##3##(1993-11#1)(1993-9#1)(1994-11#2)(1994-3#1)(1994-8#1)(1995-2#2)(1995-3#1)(1997-1#1)(1997-2#1)(2006-10#2)(2006-7#1)(2008-5#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-4#1)(2011-1#1)(2012-2#1)
of the biochemistry and##2##4##(2010-4#1)(2012-2#1)
of the biochemistry of##2##4##(1995-12#1)(2008-8#1)
of the biochemistry##5##3##(1995-12#1)(1997-8#1)(2008-8#1)(2010-4#1)(2012-2#1)
of the biocompatibility of##2##4##(2009-11#1)(2012-2#1)
of the biocontrol agent##2##4##(2008-10#2)
of the biocontrol agents##2##4##(2008-10#2)
of the biocontrol fungus Trichoderma harzianum ThzID1##2##7##(2008-10#2)
of the biocontrol isolates##2##4##(2008-10#2)
of the biocontrol##10##3##(2008-10#10)
of the biodegradable##2##3##(2004-12#1)(2009-12#1)
of the bioelectrical##2##3##(2011-1#2)
of the bioelectrode is##3##4##(2007-8#1)(2008-10#2)
of the bioelectrode##4##3##(2007-8#1)(2008-10#3)
of the biofidelity tests##2##4##(2006-11#2)
of the biofidelity##3##3##(2006-11#3)
of the biofilm##7##3##(2008-7#3)(2009-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
of the biological activities of the GPIs##2##7##(2013-8#2)
of the biological activities of##4##5##(1996-7#1)(1997-7#1)(2013-8#2)
of the biological activities##6##4##(1992-6#1)(1995-3#1)(1996-7#1)(1997-7#1)(2013-8#2)
of the biological activity of##4##5##(1990-9#1)(1992-8#1)(1997-7#1)(2008-1#1)
of the biological activity##8##4##(1990-7#1)(1990-9#1)(1992-8#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-8#1)(2009-3#1)
of the biological and##2##4##(2008-4#1)(2008-5#1)
of the biological basis of##2##5##(2008-10#1)(2013-1#1)
of the biological clock is##2##5##(2008-1#2)
of the biological clock##3##4##(1994-5#1)(2008-1#2)
of the biological control agent##2##5##(2008-10#2)
of the biological control##3##4##(2008-10#3)
of the biological function of##2##5##(1991-2#1)(2008-7#1)
of the biological function##3##4##(1991-2#1)(2008-4#1)(2008-7#1)
of the biological functions of##3##5##(1991-5#1)(1993-11#1)(2009-11#1)
of the biological materials##2##4##(2008-10#1)(2009-5#1)
of the biological processes##2##4##(2007-9#1)(2008-1#1)
of the biological properties##2##4##(1993-9#1)(2007-11#1)
of the biological responses to##2##5##(1996-8#1)(2013-8#1)
of the biological role of##3##5##(1993-6#1)(2004-12#1)(2008-4#1)
of the biological roles of##3##5##(1991-4#1)(2012-2#2)
of the biological sample##2##4##(2007-11#1)(2008-10#1)
of the biological variability##2##4##(1992-10#1)(2008-10#1)
of the biological##81##3##(1990-7#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-6#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-6#1)(1997-7#2)(2004-12#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#10)(2008-11#2)(2008-2#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2009-11#1)(2009-3#2)(2009-5#1)(2009-6#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#3)
of the biologically active##2##4##(1993-3#1)(2006-12#1)
of the biologically##3##3##(1993-3#1)(2006-12#1)(2008-4#1)
of the biology and##5##4##(2006-10#1)(2008-10#1)(2012-3#1)(2013-1#2)
of the biology of the##6##5##(1994-8#1)(2008-10#1)(2008-3#1)(2008-7#2)(2010-12#1)
of the biology of##20##4##(1993-12#1)(1994-8#1)(1997-3#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
of the biology##27##3##(1993-12#1)(1994-11#1)(1994-8#1)(1997-3#1)(2006-10#3)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#1)(2010-12#1)(2011-2#1)(2012-3#2)(2013-1#3)
of the bioluminescence##2##3##(2008-10#1)(2011-1#1)
of the biomarker##2##3##(2008-11#1)(2010-8#1)
of the biomass dry weight##2##5##(2008-7#2)
of the biomass##7##3##(1996-2#1)(2008-5#1)(2008-7#3)(2008-8#2)
of the biomechanical##3##3##(2006-7#1)(2008-8#1)(2009-7#1)
of the biomedical##3##3##(2008-12#1)(2013-1#2)
of the biometric##2##3##(2006-10#1)(2011-1#1)
of the biomolecules##5##3##(2008-10#1)(2008-9#1)(2010-4#1)(2010-7#1)(2013-8#1)
of the biophysical##2##3##(1994-5#1)(2008-5#1)
of the biopolymer and##2##4##(1997-8#1)(2005-11#1)
of the biopolymer##3##3##(1997-8#1)(2005-11#1)(2008-11#1)
of the biopsies obtained for##2##5##(2008-1#2)
of the biopsies##8##3##(1992-10#1)(1994-1#1)(1994-6#1)(2007-12#1)(2008-1#3)(2008-11#1)
of the biopsy specimen##3##4##(2007-10#1)(2007-8#1)(2010-12#1)
of the biopsy##9##3##(1990-1#1)(1991-2#2)(1992-1#1)(2004-1#1)(2007-10#1)(2007-7#1)(2007-8#1)(2010-12#1)
of the bioreactor##6##3##(2005-11#1)(2007-8#1)(2008-11#1)(2008-7#2)(2009-4#1)
of the biosensing##2##3##(2007-8#1)(2008-10#1)
of the biosensor for##2##4##(2008-10#2)
of the biosensor in the##3##5##(2008-10#3)
of the biosensor was##2##4##(2008-10#2)
of the biosensor##27##3##(2007-8#2)(2008-10#24)(2008-4#1)
of the biosensors was evaluated##2##5##(2008-10#2)
of the biosensors was##3##4##(2007-8#1)(2008-10#2)
of the biosensors##8##3##(2007-8#2)(2008-10#6)
of the biosynthesis of these##2##5##(1994-11#1)(1994-8#1)
of the biosynthesis of##10##4##(1993-9#1)(1994-11#1)(1994-8#1)(1994-9#1)(1997-5#1)(2006-12#3)(2012-2#1)(2013-8#1)
of the biosynthesis##11##3##(1992-11#1)(1993-9#1)(1994-11#1)(1994-8#1)(1994-9#1)(1997-5#1)(2006-12#3)(2012-2#1)(2013-8#1)
of the biosynthetic##5##3##(1993-11#1)(1993-5#2)(2007-11#1)(2007-5#1)
of the biotic##2##3##(2008-7#1)(2009-3#1)
of the biotin transport##3##4##(1992-6#3)
of the biotin##5##3##(1992-6#3)(1994-8#2)
of the biotinylated target protein##2##5##(1990-12#2)
of the biotinylated##5##3##(1990-12#2)(1992-6#1)(1996-11#1)(1996-5#1)
of the biotransformation of##2##4##(1992-2#1)(1996-5#1)
of the bipartite##2##3##(2008-10#2)
of the biphasic##3##3##(1995-3#1)(1997-3#1)(2005-11#1)
of the bipolar##2##3##(1991-9#1)(2005-7#1)
of the bird##4##3##(2005-9#3)(2008-5#1)
of the birds##3##3##(1997-3#1)(2008-5#2)
of the birefringence of the##2##5##(2007-12#1)(2008-2#1)
of the birefringence of##6##4##(2007-12#1)(2008-2#1)(2008-3#3)(2009-11#1)
of the birefringence that##2##4##(2008-3#2)
of the birefringence##14##3##(1990-7#1)(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#7)(2009-11#1)
of the birefringent##3##3##(2008-2#1)(2008-3#2)
of the birth of##4##4##(1990-12#1)(1991-6#1)(1992-11#1)(2006-6#1)
of the birth plan##2##4##(2008-6#2)
of the birth##10##3##(1990-12#1)(1991-6#1)(1992-11#1)(1992-6#1)(2006-6#1)(2007-2#1)(2008-4#1)(2008-6#2)(2008-7#1)
of the bismuth film electrode##2##5##(2007-8#1)(2008-10#1)
of the bismuth##3##3##(2007-8#1)(2008-10#1)(2010-8#1)
of the bisphenol##2##3##(2008-10#1)(2013-1#1)
of the bisphosphonates##4##3##(1992-11#3)(2007-11#1)
of the bithorax complex of Drosophila##2##6##(1995-8#2)
of the bitstream##2##3##(2008-2#2)
of the bivalve##2##3##(1991-4#1)(1994-11#1)
of the bivariate##2##3##(1995-6#1)(1997-4#1)
of the black##7##3##(2007-11#1)(2007-5#1)(2008-3#1)(2008-7#2)(2009-4#1)(2012-2#1)
of the bladder and##7##4##(1991-1#1)(1997-7#2)(2006-10#1)(2007-12#1)(2008-10#1)(2011-2#1)
of the bladder in a child##2##6##(2008-10#2)
of the bladder in a##3##5##(2006-9#1)(2008-10#2)
of the bladder in##8##4##(1995-9#1)(2006-9#1)(2007-10#2)(2008-10#2)(2008-4#1)(2011-2#1)
of the bladder is a rare##2##6##(1992-12#1)(2010-12#1)
of the bladder##64##3##(1991-1#1)(1991-11#1)(1991-6#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#2)(1993-2#1)(1994-2#1)(1994-3#2)(1995-9#1)(1996-12#1)(1997-4#1)(1997-7#2)(2006-10#3)(2006-6#3)(2006-8#1)(2006-9#6)(2007-10#3)(2007-12#1)(2007-9#1)(2008-10#14)(2008-4#1)(2010-12#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#4)
of the blank signal##4##4##(2008-10#4)
of the blank signal)##2##4##(2008-10#2)
of the blank##19##3##(2007-8#1)(2008-10#17)(2013-7#1)
of the blank) and##2##4##(2008-10#2)
of the blank)##4##3##(2008-10#4)
of the blastocyst##2##3##(1992-1#1)(1994-9#1)
of the bleeding vessels##2##4##(2006-6#1)(2010-9#1)
of the bleeding##8##3##(1990-11#1)(2006-6#2)(2007-10#1)(2008-8#2)(2010-9#1)(2013-1#1)
of the blend##2##3##(2009-8#1)(2010-1#1)
of the blends##3##3##(2005-11#2)(2011-1#1)
of the blind##3##3##(1991-9#1)(2007-2#1)(2008-7#1)
of the block of##2##4##(1994-2#1)(2008-8#1)
of the block##9##3##(1994-2#1)(1995-3#1)(2006-10#2)(2008-10#1)(2008-3#1)(2008-8#1)(2012-1#2)
of the blocking##4##3##(1990-12#1)(1992-7#1)(1996-12#1)(2007-8#1)
of the blocks##2##3##(2008-11#1)(2008-2#1)
of the blood cells##2##4##(1990-3#1)(2007-9#1)
of the blood coagulation##2##4##(1993-11#1)(1993-3#1)
of the blood donation##2##4##(2005-10#1)(2013-8#1)
of the blood flow##5##4##(2006-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)
of the blood glucose##3##4##(1992-9#1)(1996-7#1)(2011-3#1)
of the blood in##3##4##(1992-3#1)(2006-7#1)(2008-4#1)
of the blood meal source on the##2##7##(2004-11#2)
of the blood meal source##3##5##(2004-11#3)
of the blood pressure lowering effect of##2##7##(1991-9#1)(2010-2#1)
of the blood pressure##12##4##(1990-4#1)(1991-9#1)(1992-2#1)(1992-4#1)(1997-5#1)(2005-10#1)(2008-5#1)(2008-7#2)(2010-2#1)(2011-1#1)(2013-8#1)
of the blood retinal barrier##2##5##(2008-1#1)(2011-2#1)
of the blood samples##2##4##(1990-12#1)(1997-7#1)
of the blood supply##3##4##(1996-9#1)(2007-11#1)(2007-7#1)
of the blood to##2##4##(1991-3#1)(2010-2#1)
of the blood vessel##4##4##(1996-3#1)(1997-7#1)(2007-5#1)(2008-3#1)
of the blood vessels##2##4##(1991-3#1)(2013-1#1)
of the blood##73##3##(1990-11#1)(1990-12#2)(1990-3#2)(1990-4#1)(1990-6#1)(1990-7#1)(1991-3#3)(1991-9#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-3#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-5#1)(1997-7#2)(2004-11#3)(2005-10#2)(2005-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#3)(2008-7#2)(2008-9#1)(2010-11#1)(2010-2#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
of the blood-brain barrier (BBB)##3##5##(1990-5#1)(1996-5#1)(2008-7#1)
of the blood-brain barrier in the##2##6##(1994-5#1)(1995-12#1)
of the blood-brain barrier in##3##5##(1990-5#1)(1994-5#1)(1995-12#1)
of the blood-brain barrier##16##4##(1990-5#2)(1992-3#2)(1994-5#1)(1995-12#3)(1996-12#2)(1996-5#1)(2008-7#2)(2008-8#1)(2013-1#2)
of the blood-clotting##2##3##(1995-1#1)(2008-8#1)
of the blood-gas barrier##3##4##(2006-10#3)
of the blood-nerve##2##3##(1993-7#2)
of the bloodstream##2##3##(1992-4#1)(2007-12#1)
of the bloom##2##3##(2008-8#2)
of the blue color##3##4##(2008-10#3)
of the blue complex##2##4##(2008-10#2)
of the blue crab##5##4##(1994-11#1)(2007-12#2)(2007-5#2)
of the blue##21##3##(1992-11#1)(1994-11#1)(1997-6#1)(2007-12#7)(2007-5#2)(2007-8#1)(2008-10#6)(2008-5#2)
of the blunt##2##3##(2007-12#1)(2007-3#1)
of the board##3##3##(1995-12#1)(1995-6#1)(2007-9#1)
of the board's role##2##4##(1995-12#1)(2008-11#1)
of the body and its##2##5##(2011-2#1)(2012-12#1)
of the body and##10##4##(1992-5#1)(2006-11#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-12#1)
of the body are the##2##5##(2010-4#1)(2011-2#1)
of the body as a whole##2##6##(2007-11#1)(2007-8#1)
of the body as##3##4##(2007-11#1)(2007-8#2)
of the body by##2##4##(1992-9#1)(2013-1#1)
of the body image##3##4##(2007-12#2)(2011-1#1)
of the body in##2##4##(2006-8#1)(2008-9#1)
of the body mass index (BMI)##2##6##(2011-1#1)(2011-11#1)
of the body mass index##4##5##(1993-11#1)(2011-1#2)(2011-11#1)
of the body of talus##2##5##(2010-3#1)(2010-5#1)
of the body of the##5##5##(2007-2#1)(2007-7#1)(2009-7#1)(2010-12#1)(2011-12#1)
of the body of##11##4##(1991-2#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-5#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-12#1)
of the body plan##3##4##(1995-8#2)(2007-12#1)
of the body to##7##4##(1995-12#1)(2007-1#1)(2007-7#1)(2008-1#1)(2008-5#1)(2012-12#1)(2012-3#1)
of the body weight##3##4##(2005-10#1)(2010-4#1)(2013-1#1)
of the body were##3##4##(1992-3#1)(2007-8#1)(2008-5#1)
of the body with##2##4##(1992-6#1)(2013-1#1)
of the body##133##3##(1990-9#1)(1991-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-3#1)(1994-5#2)(1995-12#3)(1995-8#2)(1996-9#1)(1997-8#1)(2005-10#2)(2006-10#2)(2006-11#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#5)(2007-12#8)(2007-2#3)(2007-4#1)(2007-6#1)(2007-7#5)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#9)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#3)(2009-7#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-11#1)(2011-12#1)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#8)
of the body's defence##2##4##(1990-10#1)(1997-6#1)
of the body's defense##2##4##(1992-11#1)(2012-12#1)
of the body's##8##3##(1990-10#1)(1990-12#1)(1992-11#1)(1997-6#1)(2008-5#1)(2009-8#1)(2010-12#1)(2012-12#1)
of the body]##2##3##(1996-9#1)(2008-8#1)
of the bolometer##2##3##(2008-2#1)(2008-3#1)
of the bolometers##2##3##(2008-3#2)
of the bolus##3##3##(1995-12#1)(2008-10#1)(2009-8#1)
of the bond##2##3##(1994-11#1)(2010-6#1)
of the bonded##3##3##(1992-6#1)(2008-2#1)(2013-8#1)
of the bonding##7##3##(2007-9#3)(2008-10#1)(2008-7#1)(2010-12#1)(2010-6#1)
of the bone and the##2##5##(2008-10#1)(2009-3#1)
of the bone and##9##4##(2005-3#1)(2005-7#1)(2007-11#1)(2008-10#1)(2009-3#1)(2009-6#1)(2010-6#2)(2013-8#1)
of the bone grafts##2##4##(2007-11#2)
of the bone in##3##4##(2007-8#1)(2010-3#1)(2012-2#1)
of the bone is##3##4##(1991-11#1)(2008-6#1)(2011-2#1)
of the bone loss##3##4##(2008-12#1)(2008-5#1)(2009-3#1)
of the bone marrow microenvironment##3##5##(2008-3#1)(2009-3#1)(2011-1#1)
of the bone marrow##14##4##(2004-2#1)(2006-10#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2009-2#1)(2009-3#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-12#1)
of the bone scan##2##4##(2007-11#1)(2010-12#1)
of the bone tissue##6##4##(1995-6#2)(2007-11#1)(2007-7#2)(2008-8#1)
of the bone union##4##4##(2007-11#1)(2007-8#3)
of the bone##82##3##(1990-9#1)(1991-11#3)(1991-12#1)(1993-11#1)(1995-6#3)(2004-2#1)(2005-3#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-10#1)(2007-11#9)(2007-12#3)(2007-7#5)(2007-8#5)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-2#2)(2009-3#4)(2009-4#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#2)
of the bones##6##3##(1992-11#1)(1993-12#1)(2007-11#1)(2007-2#1)(2011-2#1)(2013-8#1)
of the bony defect##2##4##(2005-9#1)(2007-12#1)
of the bony##8##3##(2005-9#1)(2006-1#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-5#1)(2009-4#1)(2012-2#1)
of the book##3##3##(2008-1#2)(2008-4#1)
of the bootstrap##2##3##(2008-10#1)(2009-3#1)
of the border##2##3##(1990-11#1)(1997-3#1)
of the borderline##2##3##(1990-2#1)(1992-1#1)
of the boronic acid group##2##5##(2008-10#2)
of the boronic acid##3##4##(1996-7#1)(2008-10#2)
of the botanical##2##3##(2006-12#1)(2008-10#1)
of the both##3##3##(2007-6#1)(2008-10#1)(2013-1#1)
of the bottom layer##2##4##(2008-2#1)(2012-3#1)
of the bottom##10##3##(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2011-2#1)(2012-3#1)
of the bound TNP-ATP was fully chased##2##7##(1990-7#2)
of the bound inhibitor##2##4##(1993-11#1)(2012-2#1)
of the bound peptide##2##4##(1995-11#1)(1995-3#1)
of the bound##39##3##(1990-10#1)(1990-12#3)(1990-7#5)(1991-5#1)(1992-12#1)(1992-6#2)(1992-7#1)(1992-9#2)(1993-11#1)(1993-3#1)(1994-5#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-7#1)(1997-4#2)(2005-7#2)(2006-10#1)(2006-12#2)(2007-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-2#1)
of the boundaries between##2##4##(2006-3#1)(2008-11#1)
of the boundaries##4##3##(1996-4#1)(1996-8#1)(2006-3#1)(2008-11#1)
of the boundary between##3##4##(2013-1#1)(2013-7#1)(2013-8#1)
of the boundary##8##3##(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
of the bovine aorta##2##4##(1992-12#2)
of the bovine gene##2##4##(1991-2#2)
of the bovine mammary gland##2##5##(2011-2#1)(2012-1#1)
of the bovine##44##3##(1990-7#3)(1991-10#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#6)(1992-9#1)(1993-4#1)(1993-5#2)(1993-9#2)(1994-12#2)(1994-2#1)(1994-8#2)(1995-11#2)(1996-10#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-7#2)(2005-8#1)(2008-4#1)(2008-6#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)
of the bowel wall##4##4##(1992-5#1)(2008-8#1)(2012-2#2)
of the bowel##12##3##(1992-4#1)(1992-5#2)(1993-9#1)(1994-9#1)(2006-10#1)(2006-4#2)(2008-3#1)(2008-8#1)(2012-2#2)
of the bowels##2##3##(1996-6#1)(2009-10#1)
of the boy##3##3##(1995-5#2)(2012-2#1)
of the boys and##4##4##(1991-8#1)(1991-9#3)
of the boys##6##3##(1991-8#1)(1991-9#3)(1993-10#1)(2006-7#1)
of the brachial plexus##6##4##(2005-8#1)(2006-10#1)(2006-3#1)(2006-4#1)(2009-3#2)
of the brachial##9##3##(2005-8#1)(2006-10#1)(2006-3#1)(2006-4#1)(2009-1#3)(2009-3#2)
of the brain and in##2##5##(1990-5#1)(1992-3#1)
of the brain and its##2##5##(2010-11#1)(2012-2#1)
of the brain and spinal cord##3##6##(1995-3#1)(2008-7#1)(2010-8#1)
of the brain and the##3##5##(1995-4#1)(2010-8#1)(2012-3#1)
of the brain and##33##4##(1990-11#1)(1990-5#1)(1990-6#1)(1992-3#1)(1992-4#1)(1994-6#1)(1995-3#1)(1995-4#1)(1997-1#1)(1997-7#1)(2004-11#1)(2006-11#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-8#3)(2011-1#2)(2012-1#2)(2012-2#1)(2012-3#1)
of the brain are##6##4##(1993-7#1)(1995-5#1)(1997-6#1)(2008-11#1)(2008-3#1)(2010-12#1)
of the brain as##4##4##(2008-2#1)(2009-12#1)(2009-6#1)(2010-7#1)
of the brain cortex in##2##5##(1991-5#1)(2012-1#1)
of the brain cortex##4##4##(1991-5#1)(2006-6#1)(2010-12#1)(2012-1#1)
of the brain death##2##4##(1995-6#1)(2007-11#1)
of the brain during##3##4##(1995-2#1)(2007-8#1)(2011-1#1)
of the brain following##2##4##(1995-12#1)(1996-12#1)
of the brain for##3##4##(2008-1#2)(2012-1#1)
of the brain had##2##4##(1991-6#1)(2008-7#1)
of the brain has##2##4##(2007-12#1)(2008-11#1)
of the brain in##7##4##(2007-12#1)(2008-11#1)(2008-4#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-1#1)
of the brain is##5##4##(1991-11#1)(1994-2#1)(1995-11#1)(2007-12#1)(2008-11#1)
of the brain it is possible to##2##7##(1990-3#1)(1992-10#1)
of the brain may##2##4##(1992-3#1)(2011-1#1)
of the brain of the##5##5##(1990-4#1)(1991-7#1)(1996-10#1)(1997-6#1)(2007-12#1)
of the brain of##10##4##(1990-4#1)(1991-7#1)(1996-10#1)(1996-5#1)(1997-6#1)(2007-12#2)(2008-4#1)(2008-7#1)(2009-2#1)
of the brain parenchyma##3##4##(1996-2#1)(2007-11#1)(2007-9#1)
of the brain regions examined##2##5##(1994-2#1)(1996-3#1)
of the brain regions##3##4##(1992-9#1)(1994-2#1)(1996-3#1)
of the brain responsible for##2##5##(2008-4#1)(2010-2#1)
of the brain revealed a##2##5##(2006-10#1)(2008-12#1)
of the brain revealed##4##4##(2006-10#1)(2008-12#1)(2009-3#1)(2012-12#1)
of the brain reward##2##4##(2007-8#1)(2008-7#1)
of the brain slice##3##4##(2008-11#3)
of the brain stem##5##4##(1995-12#1)(2006-1#1)(2008-7#2)(2009-3#1)
of the brain that##7##4##(1995-1#1)(1996-12#1)(2006-10#1)(2006-3#1)(2007-12#1)(2008-4#1)(2009-5#1)
of the brain tissue##3##4##(1996-5#1)(2012-1#1)(2013-8#1)
of the brain to##4##4##(1991-1#1)(2007-1#1)(2007-4#1)(2009-9#1)
of the brain was##5##4##(1992-11#1)(1996-3#1)(1997-2#1)(2007-9#1)(2010-1#1)
of the brain were observed##2##5##(2008-8#1)(2008-9#1)
of the brain were##4##4##(1992-8#1)(2007-1#1)(2008-8#1)(2008-9#1)
of the brain where##2##4##(2007-11#1)(2008-6#1)
of the brain with##3##4##(2006-11#1)(2011-1#1)(2013-8#1)
of the brain##288##3##(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-3#1)(1993-7#2)(1993-9#1)(1994-10#3)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#2)(1995-12#4)(1995-2#3)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#1)(1996-10#3)(1996-12#4)(1996-2#1)(1996-3#4)(1996-5#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#4)(1997-6#3)(1997-7#1)(2004-11#1)(2006-1#1)(2006-10#3)(2006-11#7)(2006-12#1)(2006-2#2)(2006-3#1)(2006-6#2)(2006-8#1)(2007-1#7)(2007-10#4)(2007-11#6)(2007-12#15)(2007-4#2)(2007-8#3)(2007-9#3)(2008-1#6)(2008-10#1)(2008-11#8)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#12)(2008-5#2)(2008-6#4)(2008-7#14)(2008-8#4)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#4)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#2)(2010-11#2)(2010-12#5)(2010-2#2)(2010-7#1)(2010-8#3)(2011-1#11)(2011-2#3)(2012-1#10)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
of the brain's##5##3##(2007-8#1)(2008-11#1)(2008-4#1)(2009-8#1)(2011-1#1)
of the brain-gut axis##2##4##(2009-10#2)
of the brain-specific##3##3##(1991-1#1)(1992-8#1)(1995-12#1)
of the brain]##2##3##(1992-10#1)(1992-3#1)
of the brains of##7##4##(1995-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2011-2#1)
of the brains##9##3##(1995-5#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-11#1)(2011-2#1)(2013-1#1)
of the brainstem were##2##4##(1993-12#1)(2011-2#1)
of the brainstem##15##3##(1990-7#1)(1991-11#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-2#1)(2005-10#1)(2006-12#1)(2008-4#1)(2009-2#1)(2011-2#1)(2012-3#2)
of the branch##3##3##(2008-3#2)(2008-9#1)
of the branched chain##2##4##(1990-10#1)(1996-5#1)
of the branched##4##3##(1990-10#1)(1996-5#1)(1997-1#1)(1997-2#1)
of the branched-chain alpha-ketoacid dehydrogenase##2##5##(1990-10#1)(1991-1#1)
of the branched-chain##4##3##(1990-10#1)(1991-1#1)(1991-2#1)(2008-6#1)
of the branches of the##2##5##(1997-3#1)(2009-3#1)
of the branches of##3##4##(1997-3#1)(2009-3#1)(2011-1#1)
of the branches##5##3##(1997-3#1)(2008-2#1)(2008-7#1)(2009-3#1)(2011-1#1)
of the branchial heart complex of Sepia officinalis L##2##9##(2008-7#2)
of the branchial heart##4##4##(2008-7#4)
of the branchial podocytes##2##4##(2008-7#2)
of the branchial##7##3##(1995-6#1)(2008-7#6)
of the branching##2##3##(2007-12#1)(2012-2#1)
of the breakdown of the##2##5##(2006-10#1)(2006-3#1)
of the breakdown of##4##4##(1995-4#1)(2006-10#1)(2006-3#1)(2010-3#1)
of the breakdown##6##3##(1994-2#1)(1995-4#1)(1996-4#1)(2006-10#1)(2006-3#1)(2010-3#1)
of the breaking of##2##4##(1996-5#1)(2008-3#1)
of the breakpoints##3##3##(1995-1#1)(2008-5#1)(2013-1#1)
of the breaks##2##3##(2008-3#1)(2008-9#1)
of the breakup of##2##4##(2007-12#1)(2008-7#1)
of the breakup##3##3##(2007-12#2)(2008-7#1)
of the breast -##3##4##(2007-4#1)(2007-6#1)(2012-3#1)
of the breast and prostate##2##5##(2006-2#1)(2008-11#1)
of the breast and##8##4##(1994-12#1)(1994-2#1)(2006-2#1)(2007-11#1)(2008-11#1)(2008-7#1)(2010-7#1)(2013-8#1)
of the breast cancer##4##4##(1993-8#1)(1994-12#1)(1996-4#1)(2008-3#1)
of the breast coexisting with##2##5##(1994-7#1)(1995-4#1)
of the breast in the##2##5##(2007-8#1)(2012-2#1)
of the breast in##5##4##(1990-11#1)(1994-12#1)(2007-8#1)(2012-2#2)
of the breast is a##4##5##(1995-4#1)(2005-12#1)(2007-6#1)(2008-1#1)
of the breast is##10##4##(1990-12#1)(1992-2#1)(1995-4#1)(1996-6#1)(2005-12#1)(2007-6#1)(2008-1#1)(2009-6#1)(2009-9#2)
of the breast tumor##2##4##(2007-5#1)(2008-10#1)
of the breast using##2##4##(1995-4#1)(2004-2#1)
of the breast was performed##2##5##(1990-4#1)(1991-4#1)
of the breast was##3##4##(1990-4#2)(1991-4#1)
of the breast were##3##4##(1992-5#1)(2004-2#1)(2007-6#1)
of the breast with an##3##5##(1993-8#1)(2011-2#1)(2013-8#1)
of the breast with##7##4##(1993-8#1)(1994-6#1)(1996-6#2)(2011-2#1)(2012-3#1)(2013-8#1)
of the breast##115##3##(1990-11#1)(1990-12#2)(1990-4#4)(1990-6#1)(1991-4#3)(1991-8#1)(1992-1#1)(1992-10#1)(1992-2#3)(1992-5#1)(1992-8#1)(1993-12#2)(1993-5#2)(1993-6#1)(1993-8#3)(1994-12#4)(1994-2#1)(1994-6#2)(1994-7#5)(1994-8#1)(1995-4#5)(1995-9#1)(1996-3#1)(1996-4#1)(1996-6#7)(1997-3#1)(1997-8#2)(2004-1#1)(2004-2#4)(2005-12#1)(2006-1#2)(2006-2#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-5#3)(2007-6#4)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#1)(2009-1#1)(2009-2#1)(2009-6#3)(2009-9#2)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#4)(2012-3#3)(2013-7#1)(2013-8#6)
of the breast]##2##3##(1992-9#1)(1993-10#1)
of the breastfeeding##2##3##(2006-9#1)(2007-9#1)
of the breasts##2##3##(1995-4#1)(2004-2#1)
of the breeding colony##2##4##(1995-6#1)(2008-5#1)
of the breeding##8##3##(1992-12#1)(1995-6#1)(2005-7#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)
of the bridging ligand##2##4##(1997-7#2)
of the bridging##6##3##(1997-7#4)(2008-10#1)(2011-2#1)
of the brief##2##3##(2008-11#1)(2009-5#1)
of the bright##4##3##(2007-12#1)(2008-1#1)(2008-3#2)
of the brightness##2##3##(1995-6#1)(2008-2#1)
of the brine shrimp Artemia##2##5##(1994-8#1)(2008-9#1)
of the broad host range##2##5##(2008-5#1)(2011-12#1)
of the broad spectrum##2##4##(1992-3#1)(2006-1#1)
of the broad##11##3##(1992-3#1)(1994-3#1)(1997-3#1)(2006-1#1)(2006-10#1)(2008-5#2)(2008-8#1)(2009-4#1)(2011-12#1)(2012-3#1)
of the broader##4##3##(2008-11#1)(2008-3#1)(2008-5#1)(2009-5#1)
of the broiler isolates##2##4##(1997-3#2)
of the broiler##3##3##(1997-3#2)(2008-10#1)
of the broilers##2##3##(1997-3#1)(2008-5#1)
of the bromate##2##3##(2008-10#1)(2010-5#1)
of the bronchi and##3##4##(1993-2#1)(2006-6#1)(2010-8#1)
of the bronchi##4##3##(1993-2#1)(2006-6#1)(2010-8#1)(2012-12#1)
of the bronchi) and the non-striated muscles (artery##2##8##(2009-10#2)
of the bronchial tree##3##4##(1994-9#1)(2005-11#1)(2008-4#1)
of the bronchial vasculature##2##4##(1997-1#2)
of the bronchial##19##3##(1990-9#1)(1991-12#3)(1991-9#1)(1994-9#1)(1995-12#1)(1997-1#4)(2005-11#1)(2006-6#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-4#1)(2009-4#1)
of the bronchiolar stem##2##4##(2013-1#2)
of the bronchoscopic##2##3##(2007-8#1)(2010-8#1)
of the brood##2##3##(2008-12#1)(2008-9#1)
of the brown##5##3##(2008-10#2)(2008-12#2)(2013-1#1)
of the brush border##2##4##(1990-11#1)(1991-8#1)
of the brush##4##3##(1990-11#1)(1991-8#1)(2009-5#1)(2010-4#1)
of the bubble##5##3##(2008-11#5)
of the bubbles##3##3##(2005-11#1)(2009-11#2)
of the buccal mucosa##6##4##(1992-9#1)(1994-4#1)(1995-9#1)(2012-2#1)(2013-1#2)
of the buccal##10##3##(1991-7#1)(1992-9#1)(1994-4#1)(1995-9#1)(2008-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
of the bud##2##3##(2007-2#1)(2011-2#1)
of the budding yeast Saccharomyces cerevisiae##3##6##(1990-5#1)(1992-7#1)(1997-7#1)
of the budding yeast##5##4##(1990-5#1)(1992-7#1)(1997-6#1)(1997-7#1)(2008-9#1)
of the budding##7##3##(1990-5#1)(1992-7#1)(1996-6#1)(1997-6#1)(1997-7#1)(2007-9#1)(2008-9#1)
of the buffer solution##2##4##(2008-10#2)
of the buffer solutions##2##4##(1990-8#1)(2008-10#1)
of the buffer##16##3##(1990-8#1)(1991-5#1)(1992-4#1)(2007-12#1)(2008-10#10)(2008-3#1)(2008-8#1)
of the buffy coat##3##4##(1996-1#2)(2007-8#1)
of the building##4##3##(1992-2#2)(2010-7#1)(2012-2#1)
of the bulb##2##3##(1992-8#1)(2007-12#1)
of the bulbocavernosus##5##3##(1992-7#2)(1994-5#1)(1995-5#1)(1996-9#1)
of the bulbospinal neurons projecting to the phrenic motoneuron pool##2##10##(1990-7#2)
of the bulk aqueous medium##2##5##(1991-7#2)
of the bulk material##4##4##(2005-11#1)(2008-2#1)(2010-4#1)(2012-2#1)
of the bulk of the##2##5##(2008-3#1)(2010-8#1)
of the bulk of##5##4##(1990-5#1)(2008-10#1)(2008-3#1)(2010-8#2)
of the bulk solvent##2##4##(2008-10#2)
of the bulk##30##3##(1990-5#1)(1991-7#2)(1992-6#2)(2005-11#2)(2006-6#1)(2007-12#3)(2008-10#8)(2008-2#1)(2008-3#1)(2008-6#2)(2009-2#1)(2010-4#2)(2010-8#2)(2011-1#1)(2012-2#1)
of the bullfrog Rana catesbeiana##2##5##(1992-3#1)(1993-5#1)
of the burden of disease##2##5##(2012-12#2)
of the burden of stroke in##3##6##(2008-8#3)
of the burden of stroke##4##5##(2008-8#4)
of the burden of##11##4##(2006-10#1)(2008-8#4)(2010-12#1)(2012-12#5)
of the burden##12##3##(2006-10#1)(2008-8#4)(2010-12#1)(2011-2#1)(2012-12#5)
of the buried##3##3##(1990-12#1)(1991-4#1)(1997-2#1)
of the burn wound##2##4##(1994-5#1)(2005-10#1)
of the burned patient##2##4##(1994-5#1)(2006-10#1)
of the burned##5##3##(1991-3#1)(1994-5#1)(2006-10#1)(2006-4#1)(2011-2#1)
of the burnout syndrome##4##4##(2011-2#3)(2013-1#1)
of the burnout##5##3##(2011-2#4)(2013-1#1)
of the bursa of Fabricius##2##5##(2008-5#2)
of the c##4##3##(2007-12#1)(2008-3#2)(2010-8#1)
of the c-F0 genes##2##4##(1995-3#2)
of the c-F0 subunit##2##4##(1995-3#2)
of the c-F0##4##3##(1995-3#4)
of the c-Ki-ras gene##2##4##(1992-8#2)
of the c-Ki-ras##3##3##(1992-8#3)
of the c-Met##2##3##(1991-9#1)(2011-2#1)
of the c-Myc##2##3##(1996-12#1)(2008-8#1)
of the c-abl##2##3##(1991-6#1)(1995-8#1)
of the c-erbB-2##2##3##(1994-11#1)(1995-1#1)
of the c-fos promoter##5##4##(1994-11#2)(1994-9#2)(1995-6#1)
of the c-fos proto-oncogene in##2##5##(1991-11#1)(1996-9#1)
of the c-fos##12##3##(1991-11#1)(1992-9#1)(1993-6#1)(1994-10#1)(1994-11#2)(1994-9#2)(1995-6#1)(1996-9#2)(2008-5#1)
of the c-kit gene##3##4##(1995-10#3)
of the c-kit##5##3##(1995-10#3)(1997-5#2)
of the c-met gene##3##4##(1992-11#3)
of the c-met##4##3##(1992-11#3)(1995-8#1)
of the c-myb##4##3##(1992-12#1)(1995-3#3)
of the c-myc gene in##2##5##(1991-7#1)(1993-2#1)
of the c-myc gene##12##4##(1991-7#1)(1992-7#2)(1992-8#2)(1992-9#2)(1993-12#1)(1993-2#2)(1996-5#2)
of the c-myc protein##2##4##(1992-12#1)(1992-2#1)
of the c-myc##20##3##(1991-4#4)(1991-7#1)(1992-12#1)(1992-2#1)(1992-7#2)(1992-8#2)(1992-9#2)(1993-12#1)(1993-2#2)(1994-8#1)(1996-5#2)(2008-11#1)
of the c-type##2##3##(1995-4#1)(2011-1#1)
of the cAMP signal##3##4##(1992-6#2)(1993-7#1)
of the cAMP##9##3##(1992-3#1)(1992-6#2)(1993-7#2)(1994-8#1)(1995-3#1)(1996-5#1)(2008-11#1)
of the cAMP-dependent protein kinase##6##5##(1992-6#1)(1993-6#2)(1994-9#1)(1995-3#1)(1997-8#1)
of the cDNA and##4##4##(1991-9#1)(1994-5#2)(1996-4#1)
of the cDNA clone##2##4##(1991-4#1)(1991-5#1)
of the cDNA clones##7##4##(1992-4#1)(1993-6#1)(1994-6#1)(1996-10#1)(1996-2#1)(1997-4#1)(2006-12#1)
of the cDNA comprises##2##4##(1993-2#1)(1996-7#1)
of the cDNA encoding bovine##2##5##(1993-2#1)(1997-2#1)
of the cDNA encoding##8##4##(1991-12#1)(1991-6#1)(1993-2#1)(1993-3#1)(1996-7#1)(1997-1#1)(1997-2#2)
of the cDNA for the human##2##6##(1991-1#1)(1996-12#1)
of the cDNA for the##3##5##(1991-1#1)(1995-8#1)(1996-12#1)
of the cDNA for##5##4##(1991-1#1)(1991-9#1)(1995-2#1)(1995-8#1)(1996-12#1)
of the cDNA in##5##4##(1990-12#1)(1992-12#1)(1994-10#1)(1994-8#1)(1997-8#1)
of the cDNA into##2##4##(1991-2#1)(2008-10#1)
of the cDNA sequence##6##4##(1990-8#1)(1991-11#1)(1992-10#1)(1994-8#1)(1996-12#1)(2008-4#1)
of the cDNA was##2##4##(1991-1#1)(1994-8#1)
of the cDNA##74##3##(1990-12#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-4#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-2#2)(1993-3#2)(1993-4#4)(1993-6#1)(1994-10#1)(1994-12#1)(1994-5#4)(1994-6#1)(1994-8#5)(1995-2#1)(1995-8#2)(1996-10#1)(1996-12#3)(1996-2#1)(1996-4#2)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#4)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#2)(2010-5#1)
of the cDNAs##5##3##(1991-5#1)(1994-11#1)(1995-8#2)(1997-7#1)
of the cI repressor##2##4##(1997-1#2)
of the cPLA2##3##3##(1993-11#3)
of the caa3-type oxidase##2##4##(1994-2#2)
of the cabbage looper moth##2##5##(1990-8#2)
of the cabbage##3##3##(1990-8#2)(2008-8#1)
of the cabin##2##3##(1996-12#1)(2007-2#1)
of the cabinet##2##3##(2006-7#2)
of the cacao##2##3##(2008-10#2)
of the cadaver##3##3##(2006-11#2)(2007-1#1)
of the cadherin##6##3##(1991-11#4)(1994-9#1)(1997-2#1)
of the cadmium##5##3##(1990-3#1)(2006-12#1)(2008-10#3)
of the caecilian##2##3##(2010-6#2)
of the caecum##3##3##(2008-5#1)(2011-2#1)(2012-2#1)
of the caesarean section##2##4##(2007-2#2)
of the cage##2##3##(1995-12#1)(2006-8#1)
of the cages##2##3##(2006-8#1)(2009-3#1)
of the calcaneus##6##3##(2007-11#2)(2007-9#2)(2008-8#1)(2010-11#1)
of the calcific##3##3##(2009-9#1)(2012-12#2)
of the calcification##2##3##(2004-9#2)
of the calcified##3##3##(1993-5#1)(2009-7#1)(2013-8#1)
of the calcineurin##3##3##(1995-6#2)(2007-11#1)
of the calcitonin gene##3##4##(1990-12#2)(1990-2#1)
of the calcitonin##4##3##(1990-12#2)(1990-2#1)(1990-3#1)
of the calcitonin/alpha-CGRP##2##3##(1992-6#2)
of the calcium antagonist##3##4##(1990-11#1)(1993-7#1)(2006-1#1)
of the calcium channel blocker##3##5##(1991-6#1)(1996-5#1)(2007-9#1)
of the calcium channel##4##4##(1991-6#1)(1993-12#1)(1996-5#1)(2007-9#1)
of the calcium pump##4##4##(1992-12#2)(1993-3#2)
of the calcium##24##3##(1990-10#1)(1990-11#1)(1990-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-12#2)(1993-12#1)(1993-3#2)(1993-7#1)(1995-11#2)(1995-3#1)(1996-5#1)(2006-1#1)(2006-10#1)(2007-9#1)(2008-10#2)
of the calcium-binding##5##3##(1991-5#1)(1992-8#1)(1994-2#1)(1994-5#1)(2011-1#1)
of the calcium-independent##2##3##(1990-5#1)(1994-9#1)
of the calcium-phosphate##2##3##(2012-2#1)(2013-8#1)
of the calcium-transporting##2##3##(1990-5#1)(2007-12#1)
of the calculated and the##2##5##(2008-2#1)(2008-3#1)
of the calculated phase##2##4##(2008-3#2)
of the calculated##13##3##(1990-12#1)(1990-5#1)(2007-11#1)(2008-2#2)(2008-3#5)(2008-5#1)(2012-12#1)(2013-1#1)
of the calculation of##3##4##(1992-12#1)(2005-11#1)(2013-7#1)
of the calculation##4##3##(1992-12#1)(2005-11#1)(2008-2#1)(2013-7#1)
of the calculations##2##3##(2008-3#1)(2008-8#1)
of the calf and##2##4##(1991-6#1)(2007-11#1)
of the calf uterine androgen receptor##2##6##(1990-11#2)
of the calf##8##3##(1990-11#2)(1991-6#1)(2007-11#1)(2008-10#1)(2009-3#2)(2011-2#1)
of the calibration curve is##2##5##(2008-10#2)
of the calibration curve of##2##5##(2005-12#1)(2008-10#1)
of the calibration curve was##4##5##(1996-8#1)(2008-10#3)
of the calibration curve##14##4##(1996-8#1)(2005-12#1)(2008-10#11)(2008-2#1)
of the calibration curves##8##4##(2008-10#5)(2008-2#1)(2008-3#1)(2009-8#1)
of the calibration graph is##5##5##(2008-10#5)
of the calibration graph##7##4##(2008-10#7)
of the calibration graphs##4##4##(1992-1#1)(2007-8#1)(2008-10#2)
of the calibration matrix##2##4##(2008-10#2)
of the calibration model##2##4##(2007-12#1)(2008-10#1)
of the calibration models##3##4##(2007-11#1)(2008-10#2)
of the calibration of the##2##5##(1996-12#1)(2008-3#1)
of the calibration of##4##4##(1996-12#1)(2008-3#1)(2013-1#2)
of the calibration set and##2##5##(2007-11#1)(2008-10#1)
of the calibration set##3##4##(2007-11#1)(2008-10#1)(2010-12#1)
of the calibration##64##3##(1992-1#1)(1995-9#1)(1996-12#1)(1996-8#1)(2005-12#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#44)(2008-2#4)(2008-3#3)(2009-8#1)(2010-12#1)(2013-1#2)
of the calibrator##4##3##(1995-2#1)(2008-10#3)
of the callus##2##3##(2008-10#1)(2008-9#1)
of the calmodulin binding domain of the plasma membrane Ca2+##2##10##(1994-9#2)
of the calmodulin binding domain of the plasma membrane##3##9##(1992-3#1)(1994-9#2)
of the calmodulin binding domain of##4##6##(1992-12#1)(1992-3#1)(1994-9#2)
of the calmodulin##7##3##(1990-12#1)(1992-12#1)(1992-3#1)(1992-6#1)(1994-9#2)(1995-3#1)
of the calorimetric transitions##3##4##(1991-2#3)
of the calpain##2##3##(1990-6#1)(2010-11#1)
of the calvarium##2##3##(2008-4#1)(2008-7#1)
of the calves##3##3##(1992-10#1)(1997-5#1)(2010-2#1)
of the calyx##3##3##(2008-10#1)(2008-11#2)
of the camera is##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
of the camera##6##3##(2007-11#1)(2008-2#2)(2008-3#1)(2008-6#2)
of the campaign was##2##4##(2008-12#2)
of the campaign##6##3##(1992-2#1)(1995-1#1)(1996-8#1)(2008-12#2)(2008-9#1)
of the canal##3##3##(2007-12#1)(2008-11#1)(2008-5#1)
of the canalicular##2##3##(1994-12#2)
of the canary##2##3##(1996-7#2)
of the cancer cell##2##4##(1994-8#1)(2007-6#1)
of the cancer cells##4##4##(1994-8#1)(1996-9#1)(2008-6#1)(2011-2#1)
of the cancer patient##3##4##(2006-10#2)(2009-10#1)
of the cancer##34##3##(1990-8#1)(1994-8#2)(1996-6#4)(1996-9#1)(2005-8#1)(2006-10#3)(2006-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-12#5)(2011-1#1)(2011-2#3)(2012-3#1)
of the candidate genes##4##4##(2008-11#1)(2008-8#1)(2011-2#1)(2012-3#1)
of the candidate##19##3##(1991-10#1)(1993-9#1)(1994-3#1)(1996-1#1)(1997-4#1)(2006-12#1)(2007-11#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-8#1)(2009-10#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-3#1)
of the canine##5##3##(1990-11#1)(1992-3#1)(1996-12#1)(2006-10#1)(2008-11#1)
of the cannabinoid##4##3##(1991-4#1)(1996-1#1)(2008-7#2)
of the canonical##4##3##(1992-1#1)(1992-6#1)(1996-7#1)(2008-4#1)
of the canopy##5##3##(2008-10#3)(2008-12#1)(2008-9#1)
of the cantilever##2##3##(2008-3#1)(2012-2#1)
of the cap site##2##4##(1991-6#1)(1995-6#1)
of the cap structure##5##4##(1997-2#2)(2008-10#2)(2008-9#1)
of the cap##8##3##(1991-6#1)(1995-6#1)(1997-2#2)(2005-10#1)(2008-10#2)(2008-9#1)
of the capabilities of##2##4##(2008-10#1)(2011-1#1)
of the capability##3##3##(2006-8#1)(2007-11#1)(2009-7#1)
of the capacity of a##2##5##(2010-10#1)(2010-4#1)
of the capacity of##5##4##(1997-1#1)(2008-4#1)(2010-10#1)(2010-4#1)(2013-8#1)
of the capacity##7##3##(1996-5#1)(1997-1#1)(2008-4#1)(2010-10#1)(2010-4#2)(2013-8#1)
of the capillaries and##2##4##(2005-11#1)(2007-12#1)
of the capillaries##3##3##(2005-11#1)(2006-10#1)(2007-12#1)
of the capillary endothelium##2##4##(2006-10#2)
of the capillary wave##2##4##(2008-2#1)(2008-3#1)
of the capillary##28##3##(1994-9#4)(1995-1#1)(1996-5#1)(1997-3#1)(2005-11#1)(2006-10#2)(2007-8#8)(2008-10#5)(2008-2#1)(2008-3#2)(2011-1#1)(2012-3#1)
of the capital##3##3##(2007-1#1)(2007-8#1)(2010-5#1)
of the capsid is##3##4##(1994-9#2)(2008-10#1)
of the capsid protein##3##4##(1997-6#1)(2007-6#1)(2008-10#1)
of the capsid##10##3##(1991-5#1)(1992-8#1)(1994-9#3)(1997-6#1)(2007-6#1)(2008-10#3)
of the capsular##2##3##(1991-12#1)(2011-1#1)
of the capsule##4##3##(1990-11#1)(1993-10#1)(2006-8#1)(2013-7#1)
of the capsules##3##3##(1994-2#1)(2008-10#1)(2008-5#1)
of the captopril group##2##4##(1992-5#1)(1993-9#1)
of the capture##3##3##(1990-12#1)(2007-9#1)(2012-2#1)
of the carbachol##2##3##(1990-10#1)(1990-7#1)
of the carbohydrate moiety of##2##5##(1991-7#1)(1992-7#1)
of the carbohydrate moiety##6##4##(1990-11#2)(1990-7#1)(1991-7#1)(1992-7#1)(1995-4#1)
of the carbohydrate recognition domain##2##5##(1990-6#1)(2011-1#1)
of the carbohydrate##15##3##(1990-11#2)(1990-4#1)(1990-6#1)(1990-7#1)(1991-7#1)(1992-7#1)(1993-7#1)(1995-4#1)(1996-6#1)(1996-9#1)(2004-11#1)(2008-8#1)(2011-1#1)(2013-8#1)
of the carbohydrate-binding##2##3##(1990-7#1)(1996-5#1)
of the carbohydrates in the##2##5##(2008-3#1)(2008-5#1)
of the carbohydrates##4##3##(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)
of the carbon content of##2##5##(2008-10#1)(2008-3#1)
of the carbon source##3##4##(1995-9#1)(2008-6#2)
of the carbon##19##3##(1992-12#1)(1995-6#1)(1995-9#1)(2006-8#2)(2006-9#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-6#2)(2009-2#1)(2011-2#2)(2013-8#1)
of the carbonyl##5##3##(1995-5#1)(1996-5#1)(1996-6#1)(2007-11#1)(2008-10#1)
of the carboxy terminal##2##4##(1995-3#1)(1995-4#1)
of the carboxy##6##3##(1993-8#2)(1995-3#1)(1995-4#1)(1997-8#1)(2006-12#1)
of the carboxy-terminal##5##3##(1994-6#1)(1995-6#1)(1996-4#2)(2008-11#1)
of the carboxyl group##2##4##(1993-11#1)(1993-3#1)
of the carboxyl groups##2##4##(1992-3#1)(2005-4#1)
of the carboxyl terminus##3##4##(1992-3#1)(1995-10#1)(1995-2#1)
of the carboxyl##10##3##(1990-7#1)(1992-3#2)(1993-11#1)(1993-3#1)(1995-10#1)(1995-2#1)(1997-7#1)(2005-4#1)(2008-5#1)
of the carboxyl-terminal##5##3##(1992-2#1)(1994-3#1)(1995-2#1)(1995-3#1)(1997-7#1)
of the carboxylate group##2##4##(1997-7#1)(2005-11#1)
of the carboxylate groups##2##4##(1994-9#1)(2008-5#1)
of the carboxylate##9##3##(1994-8#2)(1994-9#1)(1995-1#1)(1997-3#1)(1997-7#1)(2005-11#2)(2008-5#1)
of the carboxylic acid##5##4##(1995-5#2)(1996-7#1)(2005-11#1)(2008-10#1)
of the carboxylic##11##3##(1991-1#1)(1991-9#1)(1992-4#1)(1995-5#2)(1996-7#1)(2005-11#2)(2008-10#3)
of the carcases##2##3##(1997-5#2)
of the carcass##2##3##(2008-6#1)(2010-4#1)
of the carcinoembryonic antigen (CEA)##2##5##(1993-8#1)(1994-12#1)
of the carcinoembryonic antigen##3##4##(1993-8#1)(1994-12#2)
of the carcinogen benzo[a]pyrene##2##4##(1992-4#2)
of the carcinogen##4##3##(1990-11#1)(1992-4#2)(1995-2#1)
of the carcinogenic##7##3##(1990-5#2)(1991-10#1)(1992-5#1)(1993-7#1)(2008-10#1)(2009-5#1)
of the carcinoma cells##2##4##(1991-10#1)(1994-6#1)
of the carcinoma##5##3##(1991-10#2)(1994-6#1)(2005-11#1)(2012-12#1)
of the carcinomas##2##3##(1990-11#1)(1995-9#1)
of the cardia and##2##4##(1990-4#1)(1992-4#1)
of the cardia##5##3##(1990-4#3)(1992-4#2)
of the cardiac alpha 1 subunit##2##6##(1994-6#2)
of the cardiac and##2##4##(2007-12#1)(2007-7#1)
of the cardiac glycoside##2##4##(1992-11#1)(1994-9#1)
of the cardiac muscle##2##4##(1992-3#1)(2005-1#1)
of the cardiac rhythm##4##4##(2011-1#4)
of the cardiac sarcoplasmic reticulum##3##5##(1993-3#2)(1994-8#1)
of the cardiac sympathetic##3##4##(2005-10#2)(2006-1#1)
of the cardiac##39##3##(1992-11#1)(1992-12#1)(1992-3#1)(1993-3#2)(1994-6#2)(1994-8#1)(1994-9#1)(1996-6#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-1#2)(2005-10#2)(2006-1#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-2#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#4)(2012-12#1)(2012-3#1)
of the cardinal##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
of the cardioplegia##2##3##(2007-8#1)(2009-4#1)
of the cardiopulmonary##3##3##(1991-8#1)(2007-9#1)(2009-4#1)
of the cardiorespiratory##4##3##(1993-2#1)(2006-10#1)(2013-1#2)
of the cardiovascular response to##2##5##(1991-8#1)(1995-12#1)
of the cardiovascular risk##3##4##(1995-10#1)(2008-3#2)
of the cardiovascular system and##2##5##(1993-5#1)(1995-10#1)
of the cardiovascular system in##2##5##(1990-6#1)(2013-8#1)
of the cardiovascular system##20##4##(1990-6#3)(1991-4#1)(1991-8#1)(1992-3#1)(1993-5#1)(1995-10#1)(1997-4#1)(2005-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-10#1)(2009-3#1)(2009-9#2)(2010-5#1)(2013-8#1)
of the cardiovascular##36##3##(1990-12#1)(1990-6#3)(1990-9#2)(1991-4#1)(1991-8#2)(1992-3#1)(1993-4#1)(1993-5#1)(1995-10#2)(1995-12#1)(1996-5#1)(1997-1#1)(1997-4#1)(2005-12#1)(2007-12#2)(2008-1#2)(2008-10#2)(2008-3#3)(2008-5#1)(2009-10#1)(2009-3#1)(2009-9#2)(2010-5#1)(2013-1#1)(2013-8#1)
of the care of chronically##2##5##(2008-12#2)
of the care of##6##4##(1993-12#1)(2008-12#3)(2011-2#1)(2012-12#1)
of the care plan##3##4##(1993-3#1)(2013-1#2)
of the care##22##3##(1993-12#1)(1993-3#1)(1997-1#1)(2006-6#1)(2007-10#1)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)
of the career##2##3##(2007-4#1)(2009-4#1)
of the caregiver##2##3##(1992-2#1)(2011-2#1)
of the caregiving##3##3##(1992-3#1)(2008-6#1)(2008-7#1)
of the carotenoid##3##3##(1997-1#2)(2011-2#1)
of the carotenoids##3##3##(1992-9#1)(2010-2#2)
of the carotid arteries and##3##5##(1990-2#1)(1994-5#1)(2007-10#1)
of the carotid arteries##10##4##(1990-2#1)(1991-3#1)(1994-5#1)(2006-12#1)(2007-10#1)(2008-7#4)(2011-2#1)
of the carotid artery and the##3##6##(2007-10#1)(2010-12#1)(2011-2#1)
of the carotid artery and##4##5##(1997-5#1)(2007-10#1)(2010-12#1)(2011-2#1)
of the carotid artery##14##4##(1993-3#1)(1997-5#1)(2007-10#1)(2007-7#2)(2008-2#1)(2008-7#1)(2009-7#2)(2010-11#1)(2010-12#2)(2011-2#2)
of the carotid bifurcation##2##4##(1991-5#1)(2006-11#1)
of the carotid plaque##2##4##(2008-8#2)
of the carotid##35##3##(1990-2#1)(1990-7#1)(1991-3#1)(1991-5#1)(1992-6#1)(1993-3#1)(1994-5#1)(1997-5#1)(2005-5#1)(2006-11#1)(2006-12#1)(2007-10#2)(2007-7#2)(2007-9#2)(2008-2#1)(2008-7#6)(2008-8#2)(2009-7#2)(2010-11#1)(2010-12#2)(2010-6#1)(2011-2#3)
of the carp##2##3##(2008-5#2)
of the carpal tunnel##3##4##(2006-3#1)(2008-9#1)(2010-9#1)
of the carpal##6##3##(2006-3#2)(2008-9#2)(2010-9#1)(2013-1#1)
of the carpophores##2##3##(1997-2#1)(2008-11#1)
of the carpus##5##3##(1993-3#1)(2006-3#1)(2006-4#1)(2007-11#1)(2008-9#1)
of the carrier concentration##2##4##(2008-10#1)(2008-3#1)
of the carrier density##2##4##(2007-11#1)(2008-2#1)
of the carrier ligands##2##4##(2010-11#1)(2013-1#1)
of the carrier solution##4##4##(2008-10#4)
of the carrier##31##3##(1990-11#2)(1991-5#2)(1992-3#1)(1994-12#2)(1995-6#1)(1996-11#1)(2006-12#1)(2006-9#1)(2007-11#2)(2007-12#2)(2008-10#6)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#2)(2009-2#1)(2010-11#1)(2013-1#1)
of the carrier-envelope phase of##2##5##(2007-11#2)
of the carrier-envelope phase##3##4##(2007-11#2)(2007-12#1)
of the carrier-envelope##5##3##(2007-11#4)(2007-12#1)
of the carriers##4##3##(1992-8#1)(2005-11#1)(2007-12#1)(2008-11#1)
of the cartilage and##2##4##(2007-11#2)
of the cartilage##12##3##(1990-3#1)(1991-7#1)(2005-12#1)(2006-11#1)(2007-11#4)(2007-7#1)(2008-3#1)(2009-1#1)(2009-2#1)
of the cartilaginous##5##3##(1990-6#1)(2005-12#1)(2007-11#1)(2010-8#1)(2013-7#1)
of the cascade##6##3##(1992-2#1)(1994-6#1)(2005-8#1)(2006-12#1)(2008-3#1)(2009-10#1)
of the cascaded nonlinearity##2##4##(2007-12#2)
of the cascaded##4##3##(2007-12#4)
of the case and##2##4##(2010-12#1)(2010-5#1)
of the case are##3##4##(1990-9#1)(2006-2#1)(2008-7#1)
of the case law##4##4##(1993-1#1)(1993-12#1)(1994-3#1)(2005-12#1)
of the case##37##3##(1990-9#1)(1991-2#1)(1992-10#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-3#1)(1996-1#1)(1996-3#1)(1996-9#1)(2005-12#1)(2006-1#2)(2006-2#3)(2007-12#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
of the casein##2##3##(1990-8#1)(1994-8#1)
of the cases and##12##4##(1992-2#1)(1993-2#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
of the cases are##3##4##(1995-12#1)(2007-8#1)(2008-1#1)
of the cases by##2##4##(1990-9#1)(2008-5#1)
of the cases described in the literature##3##7##(1992-12#1)(2013-1#2)
of the cases had##3##4##(2006-4#1)(2007-2#1)(2011-12#1)
of the cases have been##3##5##(1992-9#1)(1995-6#1)(2007-7#1)
of the cases have##6##4##(1992-9#1)(1995-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)
of the cases in the##2##5##(1995-10#2)
of the cases in##3##4##(1995-10#2)(2008-10#1)
of the cases it was##2##5##(1991-12#1)(1991-8#1)
of the cases no##2##4##(1993-5#1)(2008-8#1)
of the cases of##10##4##(1995-8#1)(2006-10#1)(2006-8#1)(2007-3#1)(2007-7#3)(2008-7#1)(2009-4#1)(2011-2#1)
of the cases received##2##4##(1991-9#1)(2012-3#1)
of the cases showed##2##4##(2007-12#1)(2007-7#1)
of the cases studied##3##4##(1993-2#1)(2007-11#1)(2012-3#1)
of the cases the##4##4##(1991-2#1)(1991-9#1)(2006-7#1)(2013-1#1)
of the cases was##3##4##(1991-8#1)(2007-2#1)(2008-10#1)
of the cases we##2##4##(1990-8#1)(2008-8#1)
of the cases were reported##2##5##(1995-12#1)(1997-8#1)
of the cases were##12##4##(1991-4#1)(1993-2#1)(1995-12#1)(1996-9#1)(1997-8#1)(2007-2#1)(2007-7#3)(2011-1#1)(2011-2#1)(2013-8#1)
of the cases with##3##4##(1993-8#1)(1996-6#1)(2011-1#1)
of the cases##241##3##(1990-10#4)(1990-12#4)(1990-2#2)(1990-3#2)(1990-4#2)(1990-6#1)(1990-8#1)(1990-9#3)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#3)(1991-9#3)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#1)(1992-5#2)(1992-6#2)(1992-8#3)(1992-9#1)(1993-10#1)(1993-2#3)(1993-5#4)(1993-8#1)(1994-1#1)(1995-10#2)(1995-11#1)(1995-12#2)(1995-4#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-3#2)(1996-5#1)(1996-6#4)(1996-9#2)(1997-6#1)(1997-8#2)(2005-10#1)(2005-12#1)(2005-5#2)(2006-10#3)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#6)(2007-3#5)(2007-7#18)(2007-8#7)(2008-1#5)(2008-10#8)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#9)(2008-7#2)(2008-8#6)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#6)(2011-12#1)(2011-2#8)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#9)
of the cases)##3##3##(1992-2#2)(2008-9#1)
of the casiragua insulin##2##4##(1992-8#2)
of the cat gene##3##4##(1990-9#2)(1993-6#1)
of the cat##17##3##(1990-7#3)(1990-9#2)(1991-2#1)(1991-6#1)(1991-8#1)(1993-12#3)(1993-3#1)(1993-6#1)(1994-12#1)(1996-6#1)(2007-9#1)(2008-8#1)
of the catabolic##3##3##(1990-1#1)(1994-12#1)(2012-1#1)
of the catalyst##9##3##(2005-11#1)(2006-9#1)(2007-11#2)(2008-10#4)(2010-4#1)
of the catalysts##4##3##(2005-4#2)(2007-11#1)(2008-10#1)
of the catalytic activity of the enzyme##2##7##(1991-5#1)(2008-10#1)
of the catalytic activity of the##3##6##(1991-5#1)(2008-10#2)
of the catalytic activity of##4##5##(1990-11#1)(1991-5#1)(2008-10#2)
of the catalytic activity##6##4##(1990-11#1)(1991-5#2)(1992-3#1)(2008-10#2)
of the catalytic base##2##4##(1995-10#2)
of the catalytic center##4##4##(1993-8#1)(1995-6#2)(2009-2#1)
of the catalytic core##2##4##(1996-8#1)(2006-12#1)
of the catalytic domain of Cex##2##6##(1992-11#2)
of the catalytic domain of##4##5##(1992-11#2)(1997-2#1)(2006-8#1)
of the catalytic domain##7##4##(1990-5#2)(1992-11#2)(1995-8#1)(1997-2#1)(2006-8#1)
of the catalytic hydrogen signal##2##5##(2008-10#2)
of the catalytic mechanism##2##4##(1993-11#1)(2013-8#1)
of the catalytic process##2##4##(2010-12#1)(2012-3#1)
of the catalytic protein##2##4##(1994-9#2)
of the catalytic reaction##4##4##(1990-12#1)(2008-10#3)
of the catalytic sector##3##4##(1994-9#3)
of the catalytic serine##2##4##(1993-8#1)(1994-8#1)
of the catalytic site##3##4##(1991-6#1)(1995-5#1)(1997-7#1)
of the catalytic subunit of protein##3##6##(1992-12#1)(1994-9#1)(1995-8#1)
of the catalytic subunit of the##3##6##(1994-9#1)(1995-11#1)(1997-6#1)
of the catalytic subunit of##9##5##(1992-12#1)(1993-3#1)(1993-7#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-8#1)(1997-6#1)
of the catalytic subunit##14##4##(1992-12#1)(1992-8#1)(1993-3#1)(1993-6#2)(1993-7#1)(1994-9#2)(1995-11#1)(1995-2#3)(1995-8#1)(1997-6#1)
of the catalytic triad##3##4##(1992-3#1)(1994-12#1)(1995-3#1)
of the catalytic##85##3##(1990-11#1)(1990-12#1)(1990-5#2)(1990-8#1)(1991-2#1)(1991-5#3)(1991-6#1)(1991-7#1)(1992-11#2)(1992-12#1)(1992-3#4)(1992-6#1)(1992-8#1)(1993-11#3)(1993-3#1)(1993-6#4)(1993-7#1)(1993-8#2)(1994-12#1)(1994-8#1)(1994-9#8)(1995-10#2)(1995-11#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#2)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#2)(2006-12#1)(2006-8#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-5#1)(2009-2#2)(2010-12#2)(2010-2#1)(2012-3#1)(2013-8#1)
of the catalytically essential##2##4##(1990-12#1)(1995-5#1)
of the catalytically##3##3##(1990-12#1)(1994-11#1)(1995-5#1)
of the cataract##3##3##(1991-4#1)(2010-8#2)
of the catechol##4##3##(2008-10#3)(2009-9#1)
of the catechol-O-methyltransferase inhibitor##2##4##(1992-2#2)
of the catecholamine##3##3##(1993-3#1)(1995-12#1)(1996-6#1)
of the catecholamines##3##3##(1990-8#1)(1992-7#1)(1997-2#1)
of the categories##4##3##(1997-8#1)(2004-12#1)(2010-2#1)(2012-1#1)
of the category &quot##2##4##(1995-6#1)(2009-10#1)
of the category##3##3##(1990-11#1)(1995-6#1)(2009-10#1)
of the catfish##4##3##(1997-4#1)(2008-5#1)(2008-7#2)
of the cathepsin D gene##2##5##(1991-1#1)(2009-4#1)
of the cathepsin##5##3##(1991-1#1)(1992-9#1)(1995-2#1)(1995-6#1)(2009-4#1)
of the cathepsins##2##3##(1995-6#1)(2008-4#1)
of the catheter and##2##4##(1993-5#1)(2011-2#1)
of the catheter fragment##3##4##(2007-7#3)
of the catheter is##2##4##(2007-7#1)(2011-2#1)
of the catheter tip in the##2##6##(2007-7#2)
of the catheter tip##7##4##(2006-7#1)(2007-7#6)
of the catheter was##4##4##(1992-3#1)(2007-7#2)(2011-2#1)
of the catheter##35##3##(1992-3#1)(1993-5#1)(1996-3#1)(1997-3#1)(2006-10#2)(2006-7#2)(2007-12#1)(2007-7#15)(2008-5#1)(2008-7#1)(2009-9#1)(2010-8#3)(2011-2#5)
of the catheters##4##3##(1997-3#1)(2007-7#2)(2008-10#1)
of the cation channel##2##4##(2008-8#2)
of the cation##7##3##(1992-3#1)(1996-2#2)(2008-10#1)(2008-8#3)
of the cationic probe##4##4##(1992-6#4)
of the cationic surfactant##2##4##(2008-10#1)(2008-8#1)
of the cationic trypsinogen gene)##2##5##(2006-10#2)
of the cationic##17##3##(1992-11#1)(1992-6#4)(1996-5#1)(2006-10#3)(2007-11#1)(2007-8#1)(2008-10#3)(2008-5#2)(2008-8#1)
of the cations and##2##4##(2005-11#1)(2008-10#1)
of the cations into the##2##5##(2008-10#1)(2008-5#1)
of the cations##11##3##(2005-11#1)(2006-10#2)(2008-10#6)(2008-5#2)
of the cats had##2##4##(2007-2#1)(2012-3#1)
of the cats were##3##4##(1996-9#1)(2012-3#1)(2013-8#1)
of the cats##10##3##(1990-9#1)(1996-9#2)(2007-2#2)(2008-8#1)(2012-3#3)(2013-8#1)
of the cattle##3##3##(2010-4#1)(2012-3#1)(2013-8#1)
of the caudal neurosecretory system##2##5##(2008-5#1)(2008-7#1)
of the caudal neurosecretory##3##4##(2008-5#2)(2008-7#1)
of the caudal nucleus##2##4##(1990-9#1)(1997-5#1)
of the caudal part of##2##5##(1990-7#1)(2007-8#1)
of the caudal##18##3##(1990-5#1)(1990-7#1)(1990-9#1)(1992-8#1)(1993-2#1)(1993-7#1)(1996-1#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-7#1)(2009-2#1)(2012-3#1)
of the caudate nucleus##4##4##(1991-9#1)(1996-8#1)(2007-8#1)(2008-11#1)
of the caudate##5##3##(1991-9#1)(1996-8#1)(2007-8#1)(2008-11#1)(2008-6#1)
of the caudate-putamen##5##3##(1990-5#1)(1993-2#1)(1995-12#2)(2008-7#1)
of the causal SNPs##2##4##(2012-3#2)
of the causal agent##3##4##(2008-10#3)
of the causal organism##2##4##(2008-10#2)
of the causal##20##3##(1991-5#1)(2008-10#9)(2008-6#2)(2010-12#1)(2010-5#1)(2011-1#2)(2012-3#4)
of the causative agent##3##4##(1994-5#1)(2008-8#1)(2011-2#1)
of the causative organism is##2##5##(1993-7#1)(1997-3#1)
of the causative organism##3##4##(1990-2#1)(1993-7#1)(1997-3#1)
of the causative##12##3##(1990-2#1)(1991-6#1)(1992-10#1)(1993-7#1)(1994-12#1)(1994-5#1)(1997-3#1)(2005-10#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-8#1)
of the cause and##3##4##(1991-11#1)(2005-4#1)(2011-2#1)
of the cause of##5##4##(1990-9#1)(1991-7#1)(2006-10#1)(2007-9#1)(2010-12#1)
of the cause##14##3##(1990-9#1)(1991-11#2)(1991-7#1)(1996-2#1)(2005-4#1)(2006-10#1)(2007-9#1)(2008-2#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#2)
of the causes for this##2##5##(2009-4#1)(2010-12#1)
of the causes for##3##4##(2009-4#1)(2010-12#1)(2012-12#1)
of the causes of low##3##5##(2010-12#1)(2010-8#1)(2012-1#1)
of the causes of##24##4##(1990-10#1)(1990-8#1)(1994-6#1)(1994-7#1)(1995-5#1)(1996-2#1)(1996-6#1)(1997-1#1)(2005-1#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-3#2)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
of the causes##31##3##(1990-10#1)(1990-8#1)(1991-6#1)(1994-6#1)(1994-7#1)(1995-5#1)(1996-2#2)(1996-6#1)(1997-1#1)(2005-1#1)(2006-6#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-3#2)(2009-4#1)(2010-12#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
of the caustic##2##3##(2008-2#2)
of the cavernous sinus##3##4##(1990-12#1)(1993-9#1)(2006-12#1)
of the cavernous##4##3##(1990-12#1)(1993-9#1)(2006-12#2)
of the cavity and the##2##5##(2008-10#1)(2008-2#1)
of the cavity design##3##4##(2007-12#1)(2008-3#2)
of the cavity in##2##4##(1996-5#1)(2008-3#1)
of the cavity is##4##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
of the cavity length and##2##5##(2007-11#1)(2007-12#1)
of the cavity length##4##4##(2007-11#2)(2007-12#1)(2008-1#1)
of the cavity##39##3##(1991-2#1)(1996-5#1)(2007-11#4)(2007-12#9)(2008-1#1)(2008-10#1)(2008-2#6)(2008-3#14)(2008-7#1)(2009-9#1)
of the cavo-tricuspid isthmus##2##4##(2007-8#2)
of the cecum and##2##4##(1992-10#1)(2007-12#1)
of the cecum##6##3##(1992-10#1)(2006-1#1)(2007-12#1)(2008-11#1)(2008-12#2)
of the celiac tripod##2##4##(1992-10#2)
of the celiac##4##3##(1990-10#1)(1992-10#2)(2005-10#1)
of the cell adhesion##2##4##(1990-11#1)(1997-4#1)
of the cell and##8##4##(2005-8#1)(2007-12#1)(2007-2#1)(2008-2#1)(2008-6#2)(2008-9#1)(2013-1#1)
of the cell bodies##2##4##(1991-5#1)(1992-9#1)
of the cell body##2##4##(2007-5#1)(2008-7#1)
of the cell culture medium##2##5##(2008-11#1)(2010-4#1)
of the cell culture##6##4##(1996-2#1)(2008-11#1)(2009-11#1)(2010-4#1)(2012-1#1)(2012-2#1)
of the cell cycle and##10##5##(1990-8#1)(1993-11#1)(1994-3#1)(1994-5#1)(1996-2#1)(2004-11#1)(2008-11#1)(2008-3#1)(2008-4#1)(2012-12#1)
of the cell cycle but##2##5##(2004-9#1)(2007-11#1)
of the cell cycle by##3##5##(1994-3#1)(1995-8#1)(1997-1#1)
of the cell cycle following##2##5##(1994-3#1)(1996-5#1)
of the cell cycle in##8##5##(1992-4#1)(1994-6#1)(1996-5#1)(2007-1#1)(2008-11#1)(2008-4#2)(2008-9#1)
of the cell cycle is##2##5##(2007-9#1)(2008-1#1)
of the cell cycle was##2##5##(2008-10#1)(2008-11#1)
of the cell cycle were##3##5##(1993-12#1)(2008-7#1)(2011-1#1)
of the cell cycle##93##4##(1990-8#1)(1991-10#1)(1991-5#2)(1991-9#1)(1992-11#1)(1992-4#2)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-3#5)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-5#1)(1995-8#4)(1996-10#1)(1996-2#2)(1996-4#2)(1996-5#3)(1996-6#1)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-11#2)(2004-9#1)(2007-1#1)(2007-11#2)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#11)(2008-3#1)(2008-4#6)(2008-5#1)(2008-7#2)(2008-9#3)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#3)(2011-1#1)(2012-12#3)(2012-2#1)(2013-1#1)
of the cell diameter##2##4##(1990-4#1)(2005-11#1)
of the cell division cycle##3##5##(1995-3#2)(2005-8#1)
of the cell division##4##4##(1990-7#1)(1995-3#2)(2005-8#1)
of the cell dry weight##2##5##(1996-6#1)(2008-5#1)
of the cell growth##2##4##(1992-9#1)(2008-11#1)
of the cell into##2##4##(2008-11#1)(2012-2#1)
of the cell is##4##4##(1993-8#1)(2008-1#1)(2008-2#1)(2009-10#1)
of the cell line to##2##5##(2008-11#2)
of the cell line##9##4##(1990-5#1)(1992-1#1)(2008-11#7)
of the cell lines are##2##5##(1994-12#1)(2008-11#1)
of the cell lines in the##2##6##(1993-12#1)(1997-1#1)
of the cell lines##15##4##(1992-8#1)(1993-11#1)(1993-12#1)(1993-7#1)(1994-12#1)(1995-8#1)(1997-1#1)(2008-11#4)(2008-6#1)(2008-8#1)(2010-12#1)(2013-8#1)
of the cell lysate##2##4##(1997-4#1)(2008-10#1)
of the cell membrane and##2##5##(2006-12#1)(2009-2#1)
of the cell membrane preparation##2##5##(1995-7#2)
of the cell membrane##24##4##(1990-3#2)(1991-5#2)(1992-5#1)(1995-3#1)(1995-7#2)(1997-1#1)(1997-3#1)(1997-6#1)(2006-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-11#1)(2009-2#1)(2009-7#1)(2009-9#1)(2011-1#2)(2012-2#1)
of the cell population##8##4##(1990-5#1)(1991-4#1)(1994-3#1)(1996-7#1)(2008-11#2)(2008-7#1)(2013-1#1)
of the cell proliferation##5##4##(1997-2#3)(2008-4#1)(2008-5#1)
of the cell size##4##4##(1995-9#3)(2008-7#1)
of the cell surface##9##4##(1993-12#1)(1993-6#1)(1994-12#1)(1995-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2009-9#2)
of the cell suspension##3##4##(2006-3#1)(2008-11#2)
of the cell that##2##4##(2008-4#1)(2008-5#1)
of the cell to##2##4##(1993-3#1)(2008-4#1)
of the cell type in##2##5##(1997-6#1)(2008-2#1)
of the cell type##3##4##(1997-3#1)(1997-6#1)(2008-2#1)
of the cell volume##2##4##(2008-11#1)(2008-7#1)
of the cell wall##12##4##(1990-5#1)(2007-2#2)(2008-10#4)(2008-5#1)(2010-4#1)(2012-1#1)(2012-2#2)
of the cell##339##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#3)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-4#1)(1991-5#6)(1991-6#1)(1991-9#4)(1992-1#2)(1992-11#1)(1992-4#2)(1992-5#3)(1992-6#1)(1992-8#1)(1992-9#3)(1993-11#4)(1993-12#3)(1993-3#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-12#4)(1994-3#6)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#6)(1995-9#4)(1996-10#1)(1996-2#3)(1996-4#2)(1996-5#3)(1996-6#2)(1996-7#1)(1997-1#4)(1997-2#3)(1997-3#2)(1997-4#4)(1997-6#4)(1997-7#1)(1997-8#2)(2004-11#2)(2004-9#1)(2005-10#1)(2005-11#4)(2005-12#4)(2005-8#3)(2006-10#2)(2006-12#1)(2006-3#1)(2006-8#2)(2007-1#1)(2007-11#3)(2007-12#4)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-9#3)(2008-1#4)(2008-10#14)(2008-11#44)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#15)(2008-5#7)(2008-6#4)(2008-7#14)(2008-8#4)(2008-9#7)(2009-10#4)(2009-11#2)(2009-2#2)(2009-5#1)(2009-7#1)(2009-8#5)(2009-9#4)(2010-10#1)(2010-12#2)(2010-4#7)(2010-9#1)(2011-1#6)(2011-2#1)(2012-1#3)(2012-12#5)(2012-2#9)(2012-3#2)(2013-1#3)(2013-8#1)
of the cell's##2##3##(2008-2#1)(2009-8#1)
of the cell)##2##3##(1990-5#1)(2006-10#1)
of the cell-associated##5##3##(1992-5#1)(1992-9#1)(1993-6#1)(1994-12#1)(1997-3#1)
of the cell-free##2##3##(1990-3#1)(2011-2#1)
of the cells after##2##4##(2008-5#1)(2008-6#1)
of the cells and was##3##5##(2008-10#1)(2008-11#2)
of the cells and##13##4##(1990-8#1)(1995-12#1)(1995-8#1)(1996-9#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-5#1)
of the cells at##5##4##(1996-9#1)(2008-11#4)
of the cells by##4##4##(1992-5#1)(1993-4#1)(1996-1#1)(2008-11#1)
of the cells co-cultured with the##2##6##(2009-7#2)
of the cells from##2##4##(1990-8#1)(1996-5#1)
of the cells grown at##2##5##(2005-12#1)(2008-5#1)
of the cells grown##3##4##(2005-12#1)(2008-11#1)(2008-5#1)
of the cells had##2##4##(1994-8#1)(1997-4#1)
of the cells in the culture##2##6##(2008-11#2)
of the cells in the##7##5##(1994-9#1)(1997-1#1)(1997-2#1)(2007-11#1)(2007-9#1)(2008-11#2)
of the cells in vitro##2##5##(1990-9#1)(2008-11#1)
of the cells in##19##4##(1990-9#1)(1991-1#1)(1993-7#1)(1994-9#1)(1995-9#1)(1996-2#3)(1997-1#1)(1997-2#1)(2007-11#1)(2007-9#2)(2008-11#5)(2012-12#1)
of the cells into the##2##5##(2008-1#1)(2008-4#1)
of the cells into##3##4##(2008-1#1)(2008-10#1)(2008-4#1)
of the cells is##3##4##(1995-2#1)(2007-12#1)(2008-8#1)
of the cells of the##2##5##(2004-11#1)(2008-4#1)
of the cells responded to##2##5##(1991-10#1)(1994-3#1)
of the cells tested##2##4##(1992-3#1)(1992-8#1)
of the cells that##2##4##(1992-6#1)(2008-11#1)
of the cells through##3##4##(1990-11#1)(1993-11#1)(2004-11#1)
of the cells to UV##2##5##(1991-3#1)(1993-8#1)
of the cells to a##3##5##(1990-5#1)(1995-3#1)(2008-11#1)
of the cells to be##2##5##(1994-9#1)(2008-4#1)
of the cells to the##4##5##(1990-8#1)(1992-11#1)(1992-3#1)(2004-9#1)
of the cells to##21##4##(1990-10#1)(1990-5#1)(1990-8#1)(1991-3#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-4#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-3#2)(1995-7#1)(1996-2#1)(2004-9#1)(2008-11#2)(2008-4#1)(2012-12#1)
of the cells was measured by##2##6##(1990-8#1)(2013-7#1)
of the cells was##16##4##(1990-8#1)(1991-12#1)(1992-3#1)(1993-7#1)(1995-2#1)(1995-3#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-5#1)(2010-12#1)(2013-1#1)(2013-7#1)
of the cells were##10##4##(1991-2#1)(1991-5#1)(1991-9#1)(1994-6#1)(1994-8#1)(2004-9#1)(2007-3#1)(2007-5#1)(2008-11#1)(2008-6#1)
of the cells with##30##4##(1990-11#1)(1990-2#1)(1990-7#1)(1991-2#1)(1991-7#1)(1992-1#1)(1992-2#1)(1993-2#1)(1993-9#2)(1994-11#2)(1994-12#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-5#3)(1996-6#1)(1997-1#5)(1997-4#1)(1997-7#1)(2008-11#1)(2008-4#1)
of the cells##261##3##(1990-10#1)(1990-11#2)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#4)(1992-5#1)(1992-6#4)(1992-8#4)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#3)(1993-6#2)(1993-7#2)(1993-8#2)(1993-9#6)(1994-10#2)(1994-11#5)(1994-12#4)(1994-2#1)(1994-3#4)(1994-6#2)(1994-8#3)(1994-9#5)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#4)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#2)(1996-2#6)(1996-5#4)(1996-6#1)(1996-9#2)(1997-1#7)(1997-2#2)(1997-4#2)(1997-7#4)(2004-11#3)(2004-12#1)(2004-9#3)(2005-12#1)(2006-10#1)(2006-6#1)(2006-7#2)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#8)(2008-11#38)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#7)(2008-6#3)(2008-7#3)(2008-8#4)(2009-3#2)(2009-6#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-3#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
of the cells'##2##3##(2012-2#1)(2013-8#1)
of the cellular DNA##3##4##(1993-4#1)(1994-8#1)(2008-4#1)
of the cellular and molecular##3##5##(1991-3#1)(2006-11#1)(2007-11#1)
of the cellular and##4##4##(1991-10#1)(1991-3#1)(2006-11#1)(2007-11#1)
of the cellular antioxidant##2##4##(1990-4#1)(1992-3#1)
of the cellular fatty##2##4##(2011-1#2)
of the cellular immune response##2##5##(1995-1#1)(2009-12#1)
of the cellular machinery##2##4##(2007-8#1)(2008-7#1)
of the cellular mechanisms##2##4##(1993-2#1)(2006-10#1)
of the cellular microenvironment##2##4##(2008-11#2)
of the cellular morphology##2##4##(1994-3#1)(2008-11#1)
of the cellular prion protein##2##5##(1995-11#1)(1995-12#1)
of the cellular response to##2##5##(2008-1#1)(2011-2#1)
of the cellular response##3##4##(2008-1#1)(2010-2#1)(2011-2#1)
of the cellular slime mold##2##5##(1995-3#1)(1995-6#1)
of the cellular systems##2##4##(1995-6#1)(1996-6#1)
of the cellular##73##3##(1990-2#1)(1990-4#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-2#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-5#1)(1996-6#3)(1997-3#1)(2004-12#1)(2005-11#1)(2006-10#3)(2006-11#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#6)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-12#2)(2010-11#1)(2010-2#1)(2011-1#3)(2011-2#2)(2012-12#2)(2013-1#2)
of the cellulase-encoding##3##3##(1990-4#1)(1991-9#2)
of the cellulose##6##3##(2006-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2013-8#1)
of the cellulosome of##2##4##(1991-2#1)(1995-2#1)
of the cellulosome##5##3##(1991-2#1)(1995-2#2)(2006-8#2)
of the cement##5##3##(2004-9#2)(2008-5#2)(2013-1#1)
of the censoring##3##3##(2008-10#1)(2010-8#1)(2012-3#1)
of the center of##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
of the center##11##3##(2007-11#2)(2008-10#2)(2008-2#4)(2008-3#1)(2008-8#1)(2012-11#1)
of the centers##3##3##(1990-10#2)(2008-3#1)
of the central and peripheral nervous system##4##7##(2008-7#2)(2008-8#1)(2013-7#1)
of the central and peripheral nervous systems##2##7##(2008-11#1)(2008-4#1)
of the central and peripheral nervous##6##6##(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2013-7#1)
of the central and peripheral##7##5##(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-6#1)(2013-7#1)
of the central and##8##4##(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-6#1)(2013-7#1)
of the central beta-noradrenergic##2##4##(1997-2#2)
of the central carbon metabolism##2##5##(2007-6#2)
of the central cell##4##4##(2008-11#1)(2008-9#3)
of the central glycine##2##4##(2008-8#2)
of the central metabolism##2##4##(2008-7#2)
of the central nervous system (CNS) are##2##7##(2007-11#1)(2008-7#1)
of the central nervous system (CNS) can##2##7##(1997-4#1)(2007-11#1)
of the central nervous system (CNS) is##2##7##(2006-12#1)(2013-1#1)
of the central nervous system (CNS)##16##6##(1991-2#1)(1992-12#1)(1995-5#1)(1996-12#1)(1997-4#1)(2006-12#1)(2007-11#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
of the central nervous system and##10##6##(1991-11#1)(1997-5#1)(2006-12#1)(2007-6#1)(2008-2#1)(2008-9#1)(2011-2#1)(2012-2#2)(2013-7#1)
of the central nervous system by##3##6##(2008-7#1)(2011-2#1)(2012-12#1)
of the central nervous system in##3##6##(2005-10#1)(2006-10#1)(2007-10#1)
of the central nervous system including##2##6##(2006-10#1)(2007-8#1)
of the central nervous system is##2##6##(1990-8#1)(1997-5#1)
of the central nervous system of##2##6##(1990-5#1)(1995-6#1)
of the central nervous system which##2##6##(1995-4#1)(1995-6#1)
of the central nervous system##118##5##(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#3)(1991-11#1)(1991-12#2)(1991-2#2)(1991-5#1)(1992-12#1)(1992-7#1)(1993-1#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#2)(1996-12#2)(1996-2#1)(1996-4#2)(1996-6#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-5#2)(2005-10#2)(2005-8#1)(2006-1#1)(2006-10#7)(2006-11#1)(2006-12#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#7)(2007-12#3)(2007-6#1)(2007-8#3)(2008-11#2)(2008-2#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#9)(2008-9#2)(2009-2#2)(2009-5#1)(2009-7#2)(2009-8#1)(2010-12#4)(2010-2#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
of the central nervous##120##4##(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#3)(1991-11#1)(1991-12#2)(1991-2#2)(1991-5#1)(1992-12#1)(1992-7#1)(1993-1#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#2)(1996-12#2)(1996-2#1)(1996-4#2)(1996-6#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-5#2)(2005-10#2)(2005-8#1)(2006-1#1)(2006-10#7)(2006-11#1)(2006-12#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#7)(2007-12#3)(2007-6#1)(2007-8#3)(2008-11#2)(2008-2#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#9)(2008-9#2)(2009-2#2)(2009-5#1)(2009-7#2)(2009-8#1)(2010-12#4)(2010-2#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
of the central nucleus of the amygdala##4##7##(1993-12#3)(1994-11#1)
of the central nucleus of the##5##6##(1993-12#3)(1994-11#1)(2012-3#1)
of the central nucleus##7##4##(1993-12#3)(1994-11#1)(1995-5#1)(2009-2#1)(2012-3#1)
of the central part of the##2##6##(1994-3#2)
of the central thermoregulatory##2##4##(1996-8#1)(2007-10#1)
of the central venous catheter##2##5##(2007-7#1)(2012-12#1)
of the central venous##3##4##(2007-7#2)(2012-12#1)
of the central##211##3##(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#3)(1991-11#1)(1991-12#2)(1991-2#3)(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-1#1)(1993-12#5)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-3#1)(1995-4#2)(1995-5#4)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-4#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#2)(1997-8#1)(2005-10#2)(2005-11#2)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#7)(2006-11#2)(2006-12#3)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#4)(2007-6#3)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#3)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#15)(2008-8#6)(2008-9#5)(2009-2#3)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-12#4)(2010-2#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#4)(2013-7#3)(2013-8#2)
of the centre##3##3##(1993-9#1)(1995-5#1)(1996-4#1)
of the centres##2##3##(1996-12#1)(2012-12#1)
of the centrifugal projection##2##4##(1994-2#2)
of the centrifugal##4##3##(1994-2#2)(1995-11#2)
of the centrofacial region##3##4##(2011-1#3)
of the centroid##3##3##(2007-12#1)(2008-3#1)(2009-9#1)
of the centromere of##2##4##(2008-5#1)(2012-3#1)
of the centrosome protein##2##4##(2008-9#2)
of the centrosome##6##3##(1991-5#2)(2008-8#2)(2008-9#2)
of the century in the##2##5##(1997-6#1)(2013-1#1)
of the century of##2##4##(1990-10#1)(1991-11#1)
of the century##23##3##(1990-10#2)(1990-3#1)(1991-11#1)(1992-2#1)(1993-11#1)(1994-5#1)(1994-9#1)(1996-3#1)(1997-3#1)(1997-6#1)(2006-10#3)(2006-6#1)(2007-4#1)(2008-10#1)(2008-5#2)(2009-10#1)(2010-8#1)(2013-1#1)(2013-7#1)
of the cephalic vein and the##2##6##(2007-7#2)
of the cephalic##3##3##(2007-7#2)(2008-5#1)
of the ceramic##4##3##(2006-2#1)(2007-11#1)(2007-8#1)(2008-5#1)
of the ceramide moiety##3##4##(1990-7#1)(1993-11#1)(1997-8#1)
of the ceramide##5##3##(1990-7#1)(1993-11#1)(1994-5#1)(1997-8#1)(2008-5#1)
of the cerebellar cortex##4##4##(1991-1#1)(1991-11#1)(1991-3#1)(1994-2#1)
of the cerebellar interpositus nucleus##2##5##(1990-4#2)
of the cerebellar##15##3##(1990-4#2)(1991-1#1)(1991-11#1)(1991-3#2)(1994-2#1)(1997-3#1)(2006-9#1)(2007-10#1)(2008-11#1)(2010-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
of the cerebellopontine angle##3##4##(2006-11#1)(2006-12#1)(2011-2#1)
of the cerebellum were##2##4##(1996-4#1)(2011-1#1)
of the cerebellum##25##3##(1990-7#1)(1991-1#1)(1991-11#1)(1991-6#1)(1992-6#1)(1992-8#1)(1993-8#1)(1995-6#1)(1996-4#1)(1996-5#3)(1996-7#2)(1997-8#1)(2006-4#1)(2007-1#1)(2007-8#2)(2008-6#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#1)
of the cerebral aqueduct##2##4##(1997-1#1)(2012-3#1)
of the cerebral cortex and##3##5##(1991-9#1)(1996-9#1)(2012-2#1)
of the cerebral cortex in##2##5##(1995-11#1)(2007-1#1)
of the cerebral cortex##11##4##(1991-3#1)(1991-9#1)(1992-8#1)(1994-10#1)(1995-11#2)(1996-9#1)(2007-1#1)(2008-11#1)(2011-2#1)(2012-2#1)
of the cerebral glucose##2##4##(1992-1#1)(1994-5#1)
of the cerebral vessels##2##4##(2006-10#1)(2006-11#1)
of the cerebral##35##3##(1991-3#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-8#1)(1994-10#1)(1994-2#1)(1994-5#1)(1995-11#2)(1996-12#1)(1996-9#3)(1997-1#1)(1997-5#1)(2006-10#2)(2006-11#2)(2006-6#1)(2007-1#1)(2007-10#4)(2008-11#1)(2008-7#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#2)
of the cerebrospinal fluid##6##4##(1990-10#1)(1995-5#1)(2006-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
of the cerebrospinal##7##3##(1990-10#1)(1995-5#1)(2006-12#1)(2006-9#1)(2008-7#1)(2011-2#1)(2012-2#1)
of the cerebrovascular##2##3##(1992-2#1)(2012-3#1)
of the cerebrum##5##3##(1995-10#1)(1997-8#1)(2008-9#3)
of the certified athletic trainer##2##5##(2006-3#2)
of the certified reference##3##4##(2008-10#3)
of the certified values##2##4##(2008-10#2)
of the certified##12##3##(2006-3#2)(2008-10#8)(2008-12#2)
of the cervical and##4##4##(2007-11#1)(2009-8#1)(2011-12#1)(2013-1#1)
of the cervical cancer##4##4##(2007-8#1)(2011-3#1)(2012-3#1)(2013-7#1)
of the cervical esophagus##4##4##(2013-1#4)
of the cervical facet##2##4##(2007-1#2)
of the cervical lymph nodes##2##5##(2008-2#1)(2010-7#1)
of the cervical spinal cord##3##5##(1991-5#1)(1992-7#1)(1995-3#1)
of the cervical spinal##5##4##(1991-5#1)(1992-7#1)(1995-3#1)(2013-8#2)
of the cervical spine are##4##5##(1990-12#1)(1997-4#1)(2008-9#1)(2011-2#1)
of the cervical spine in##3##5##(2008-4#1)(2009-3#1)(2011-2#1)
of the cervical spine is##4##5##(2006-11#1)(2006-8#1)(2007-11#1)(2011-2#1)
of the cervical spine or##2##5##(2007-6#1)(2008-4#1)
of the cervical spine revealed##2##5##(2009-3#2)
of the cervical spine was##2##5##(2007-1#1)(2007-11#1)
of the cervical spine##50##4##(1990-12#2)(1991-6#1)(1997-4#1)(2006-10#1)(2006-11#4)(2006-8#2)(2007-1#1)(2007-11#10)(2007-4#3)(2007-6#2)(2007-7#1)(2007-8#2)(2008-4#4)(2008-9#1)(2009-3#4)(2010-12#3)(2011-2#4)(2012-12#2)(2013-1#2)
of the cervical##88##3##(1990-12#3)(1990-6#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-7#1)(1992-9#1)(1993-3#1)(1995-3#1)(1997-4#1)(2006-10#3)(2006-11#4)(2006-8#2)(2007-1#3)(2007-11#11)(2007-4#4)(2007-6#3)(2007-7#1)(2007-8#4)(2008-2#1)(2008-4#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#4)(2009-8#1)(2010-12#3)(2010-7#1)(2011-12#3)(2011-2#6)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#2)
of the cervix and##2##4##(1996-2#1)(2013-7#1)
of the cervix in##10##4##(1991-3#1)(1994-5#2)(1996-6#1)(2006-10#5)(2009-5#1)
of the cervix is a rare##2##6##(2006-10#2)
of the cervix is##3##4##(2006-10#3)
of the cervix presenting##2##4##(2004-10#1)(2006-10#1)
of the cervix was##3##4##(1992-12#1)(1992-2#1)(1996-12#1)
of the cervix with##3##4##(1992-2#1)(2006-10#1)(2009-5#1)
of the cervix##52##3##(1990-12#2)(1990-8#3)(1991-3#1)(1992-12#1)(1992-2#3)(1993-10#1)(1994-1#1)(1994-3#2)(1994-5#2)(1995-5#1)(1996-12#1)(1996-2#1)(1996-6#1)(2004-10#5)(2006-10#17)(2007-12#1)(2008-11#1)(2008-7#1)(2009-5#3)(2011-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
of the cervix]##2##3##(2005-1#1)(2012-3#1)
of the cesium##2##3##(2007-12#1)(2008-3#1)
of the cestode##2##3##(2010-8#1)(2011-2#1)
of the chain is##2##4##(1994-3#2)
of the chain length##2##4##(2005-11#1)(2007-9#1)
of the chain of survival##2##5##(2006-10#1)(2010-8#1)
of the chain of##4##4##(1994-2#1)(2006-10#1)(2008-12#1)(2010-8#1)
of the chain##18##3##(1990-2#1)(1991-5#1)(1991-7#1)(1994-2#1)(1994-3#3)(1995-11#1)(1996-2#1)(2005-11#2)(2006-10#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-8#1)
of the chain-length##2##3##(1990-11#1)(1990-7#1)
of the chains and##2##4##(2010-2#1)(2010-4#1)
of the chains##8##3##(1991-2#2)(2005-11#2)(2010-2#1)(2010-4#1)(2013-1#2)
of the chalcogenide##2##3##(2007-11#1)(2008-10#1)
of the challenge is##3##4##(2006-10#1)(2013-1#2)
of the challenge##5##3##(2006-10#1)(2008-10#1)(2013-1#3)
of the challenges and##6##4##(1996-2#1)(2005-10#1)(2007-12#1)(2008-1#1)(2010-5#1)(2010-6#1)
of the challenges facing##2##4##(2008-1#1)(2008-7#1)
of the challenges of##5##4##(2006-5#1)(2008-11#1)(2008-4#1)(2010-8#1)(2011-1#1)
of the challenges##21##3##(1993-2#1)(1996-2#1)(1996-4#1)(2005-10#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
of the chamber##2##3##(2008-11#1)(2008-7#1)
of the change in the##3##5##(1990-5#1)(1997-2#1)(2008-2#1)
of the change in##11##4##(1990-12#1)(1990-5#1)(1994-5#1)(1997-2#1)(2008-10#3)(2008-2#1)(2009-2#1)(2012-12#1)(2013-1#1)
of the change of##3##4##(2008-10#2)(2008-8#1)
of the change##23##3##(1990-12#1)(1990-5#1)(1991-3#1)(1993-3#1)(1994-5#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-4#1)(1997-2#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-8#1)(2009-2#1)(2012-12#1)(2013-1#1)
of the changed behavior of##2##5##(1996-2#1)(2005-11#1)
of the changed##4##3##(1996-2#1)(2005-11#1)(2005-8#1)(2007-11#1)
of the changes in the##4##5##(2007-8#1)(2008-10#1)(2010-12#1)(2013-7#1)
of the changes in##19##4##(1990-6#1)(1991-5#1)(1994-1#1)(1994-12#1)(1996-8#1)(1996-9#1)(2005-10#1)(2005-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-9#2)(2013-7#1)(2013-8#1)
of the changes of##3##4##(2008-5#1)(2008-8#1)(2012-2#1)
of the changes that occur##2##5##(1991-12#1)(2005-7#1)
of the changes##40##3##(1990-6#1)(1991-12#1)(1991-5#1)(1992-8#1)(1994-1#2)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-9#1)(2005-10#1)(2005-7#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-9#2)(2012-2#2)(2013-7#1)(2013-8#1)
of the changing##10##3##(1992-4#1)(1995-11#2)(1996-3#1)(2006-4#1)(2007-10#1)(2007-11#2)(2008-10#1)(2008-7#1)
of the channel complex##2##4##(1995-8#2)
of the channel protein##2##4##(1994-9#1)(1997-4#1)
of the channel to##2##4##(1995-3#1)(2008-8#1)
of the channel walls##2##4##(2006-12#1)(2010-12#1)
of the channel##35##3##(1991-3#1)(1991-9#1)(1992-11#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-5#1)(1994-9#2)(1995-3#1)(1995-8#2)(1996-2#2)(1997-2#2)(1997-4#1)(2005-11#2)(2006-10#2)(2006-12#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-8#3)(2009-11#1)(2010-12#1)(2012-2#1)
of the channeled spectrum##2##4##(2007-12#1)(2008-2#1)
of the channels and##2##4##(1991-12#1)(2008-10#1)
of the channels##10##3##(1991-12#1)(1992-7#1)(1995-12#1)(1995-2#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-8#1)
of the chaotic##2##3##(2007-11#1)(2010-1#1)
of the chaotropic##2##3##(1990-5#1)(1994-8#1)
of the chaperonin##2##3##(1994-5#1)(1994-9#1)
of the character##2##3##(2008-10#1)(2013-7#1)
of the characteristic clinical##2##4##(2005-11#1)(2011-2#1)
of the characteristic features of##2##5##(2008-5#1)(2010-7#1)
of the characteristic features##4##4##(2008-11#1)(2008-5#1)(2010-12#1)(2010-7#1)
of the characteristic##27##3##(1992-7#1)(1994-8#1)(2005-11#2)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2009-12#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-8#1)
of the characteristics of the##8##5##(1993-12#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-8#1)(2011-2#1)
of the characteristics of##19##4##(1990-11#1)(1990-5#1)(1992-1#1)(1992-2#1)(1993-12#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-3#1)
of the characteristics that##3##4##(2007-8#1)(2008-10#1)(2008-6#1)
of the characteristics##23##3##(1990-11#1)(1990-5#1)(1992-1#1)(1992-2#1)(1993-12#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-6#2)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-3#1)
of the characterization of recombinant##2##5##(1995-6#1)(2008-4#1)
of the characterization of##4##4##(1994-2#1)(1995-6#1)(2008-11#1)(2008-4#1)
of the characterization##7##3##(1994-2#1)(1995-6#1)(2005-8#1)(2008-11#1)(2008-3#2)(2008-4#1)
of the characters##2##3##(1997-1#1)(2008-11#1)
of the charge distribution##2##4##(1993-3#1)(1997-6#1)
of the charge is##2##4##(2007-11#2)
of the charge of##2##4##(1994-9#1)(2008-5#1)
of the charge transfer##2##4##(2008-10#1)(2010-5#1)
of the charge##16##3##(1992-3#1)(1992-9#1)(1993-3#2)(1994-9#1)(1995-5#1)(1997-6#1)(2007-11#2)(2008-10#3)(2008-5#1)(2008-7#1)(2009-12#1)(2010-5#1)
of the charged##6##3##(1990-8#1)(1993-5#1)(1994-9#1)(2006-10#2)(2007-8#1)
of the charges##2##3##(1992-8#1)(1993-5#1)
of the checkpoint genes tested##2##5##(1997-6#2)
of the checkpoint##3##3##(1997-6#3)
of the cheek##4##3##(2008-4#2)(2008-5#1)(2010-11#1)
of the chelate is 1##3##5##(2008-10#3)
of the chelate##7##3##(1995-8#1)(2008-10#6)
of the chelating agent##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
of the chelating resin##2##4##(2008-10#2)
of the chelating##9##3##(2008-10#6)(2008-3#2)(2008-5#1)
of the chelator##2##3##(1992-12#1)(2008-10#1)
of the chelators##3##3##(1994-10#1)(1996-4#1)(2008-5#1)
of the chemical alternatives##2##4##(2008-10#2)
of the chemical composition of##4##5##(2006-12#1)(2008-11#1)(2008-2#1)(2008-3#1)
of the chemical composition##6##4##(2006-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-4#1)
of the chemical environment of##2##5##(2008-10#2)
of the chemical properties of##2##5##(1992-6#1)(2007-9#1)
of the chemical reaction##2##4##(2006-12#1)(2008-10#1)
of the chemical shift##4##4##(1990-7#1)(1995-3#1)(2006-1#1)(2008-10#1)
of the chemical shifts of##2##5##(1991-7#1)(1991-8#1)
of the chemical shifts##3##4##(1991-7#1)(1991-8#1)(1992-4#1)
of the chemical species##3##4##(2008-10#2)(2008-3#1)
of the chemical structure of the##2##6##(1991-2#1)(2005-4#1)
of the chemical structure##4##4##(1990-4#1)(1991-2#1)(1995-11#1)(2005-4#1)
of the chemical##71##3##(1990-12#1)(1990-4#1)(1990-7#1)(1991-2#1)(1991-7#2)(1991-8#1)(1992-3#1)(1992-4#1)(1992-6#2)(1993-12#2)(1995-11#2)(1995-3#1)(1996-7#1)(1996-9#1)(1997-3#1)(2005-4#1)(2006-1#1)(2006-12#2)(2006-3#1)(2007-11#2)(2007-9#1)(2008-10#21)(2008-11#4)(2008-2#2)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-5#1)(2010-4#1)(2010-5#1)(2010-7#1)(2012-3#1)(2013-8#1)
of the chemically modified##3##4##(1990-12#1)(2008-10#2)
of the chemicals##6##3##(1995-6#2)(1996-12#1)(2008-10#1)(2008-5#1)(2011-1#1)
of the chemiluminescence##6##3##(1991-5#1)(2007-8#1)(2008-10#4)
of the chemistry##3##3##(1996-8#1)(2008-3#1)(2009-2#1)
of the chemoattractant##3##3##(1994-6#1)(1997-3#2)
of the chemokine receptors##3##4##(2005-7#1)(2008-8#2)
of the chemokine##11##3##(1994-3#1)(1994-9#1)(2005-7#2)(2008-11#1)(2008-8#2)(2009-12#1)(2011-2#2)(2013-1#1)
of the chemometric##3##3##(2008-10#2)(2008-3#1)
of the chemostat culture##2##4##(2008-6#1)(2008-7#1)
of the chemotactic##3##3##(1993-11#1)(1994-9#1)(2006-10#1)
of the chemotaxis##2##3##(1991-2#1)(1994-8#1)
of the chemotherapeutic##3##3##(1992-10#1)(2008-7#1)(2010-8#1)
of the chemotherapy##7##3##(1990-9#1)(1991-3#1)(1992-1#1)(2005-11#1)(2006-6#1)(2008-7#2)
of the chest and abdomen##2##5##(2006-11#1)(2007-6#1)
of the chest and##7##4##(2006-11#1)(2007-11#1)(2007-6#1)(2007-8#2)(2012-2#2)
of the chest demonstrated##2##4##(2007-8#1)(2008-1#1)
of the chest revealed a##2##5##(1991-9#1)(2008-7#1)
of the chest revealed##5##4##(1991-9#1)(2007-8#2)(2008-7#1)(2012-12#1)
of the chest wall and##2##5##(2007-8#1)(2012-2#1)
of the chest wall is##2##5##(2007-8#2)
of the chest wall##21##4##(1992-10#1)(2007-8#7)(2008-5#1)(2008-6#4)(2012-2#8)
of the chest##47##3##(1991-9#1)(1992-10#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-5#1)(2007-6#2)(2007-8#12)(2008-1#1)(2008-3#1)(2008-5#1)(2008-6#5)(2008-7#1)(2009-2#1)(2010-12#2)(2010-2#1)(2010-8#1)(2012-12#2)(2012-2#10)(2013-7#1)
of the chestnut blight fungus##3##5##(2008-10#3)
of the chi##2##3##(1992-6#1)(2007-11#1)
of the chick embryo##4##4##(1991-3#1)(2003-11#1)(2008-1#1)(2008-11#1)
of the chick spinal##2##4##(1995-11#1)(1997-8#1)
of the chick##11##3##(1990-5#2)(1991-3#1)(1994-2#1)(1995-11#1)(1996-5#1)(1997-6#1)(1997-8#1)(2003-11#1)(2008-1#1)(2008-11#1)
of the chicken Z chromosome##2##5##(2008-5#2)
of the chicken alpha-globin gene domain##3##6##(1991-5#1)(1991-8#2)
of the chicken beta##2##4##(1991-5#2)
of the chicken c-kit##2##4##(1993-6#2)
of the chicken embryo##4##4##(1992-3#1)(2007-6#1)(2008-11#1)(2008-12#1)
of the chicken genome##3##4##(2008-8#3)
of the chicken##44##3##(1990-4#1)(1991-5#4)(1991-6#2)(1991-8#2)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#4)(1993-8#1)(1993-9#1)(1994-8#1)(1996-10#1)(1996-4#2)(1997-6#1)(1997-7#1)(1997-9#1)(2005-9#1)(2007-12#2)(2007-6#1)(2008-11#1)(2008-12#1)(2008-5#7)(2008-8#3)(2013-8#1)
of the chickens and##2##4##(2008-5#1)(2013-8#1)
of the chickens##6##3##(2008-5#5)(2013-8#1)
of the chickpea cultivar##3##4##(2008-10#3)
of the chicks##2##3##(2008-12#1)(2008-6#1)
of the chief##3##3##(1990-12#1)(2007-7#1)(2008-9#1)
of the child and the##3##5##(2006-10#1)(2011-1#1)(2013-1#1)
of the child and##8##4##(1995-5#1)(2006-10#1)(2006-7#1)(2007-2#1)(2008-11#1)(2010-11#1)(2011-1#1)(2013-1#1)
of the child with##6##4##(1990-10#1)(2005-9#1)(2006-2#1)(2008-11#2)(2013-8#1)
of the child##65##3##(1990-10#1)(1990-3#1)(1991-10#1)(1991-7#2)(1992-12#1)(1992-9#2)(1993-12#2)(1994-12#1)(1994-6#1)(1995-5#7)(1996-2#1)(1996-5#1)(1997-2#1)(2004-12#1)(2005-11#2)(2005-8#3)(2005-9#1)(2006-10#2)(2006-11#2)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-9#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
of the child's body##2##4##(1992-1#1)(2009-4#1)
of the child's##13##3##(1992-1#2)(2005-10#1)(2006-4#1)(2007-2#1)(2007-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-6#1)(2011-12#1)(2011-2#1)
of the childbearing woman##2##4##(2013-1#2)
of the childbearing##5##3##(2013-1#2)(2013-8#3)
of the childhood##2##3##(2012-2#1)(2013-1#1)
of the children and their##2##5##(1991-2#1)(2007-12#1)
of the children and##4##4##(1991-2#1)(2007-12#1)(2008-11#1)(2012-12#1)
of the children are##3##4##(1990-6#1)(2006-10#1)(2008-9#1)
of the children by##2##4##(1995-5#1)(2010-12#1)
of the children had##8##4##(1991-12#1)(1993-1#1)(1997-4#1)(2006-10#2)(2006-2#1)(2012-12#1)(2012-2#1)
of the children of##2##4##(2007-3#1)(2013-8#1)
of the children were diagnosed with##2##6##(2006-10#1)(2006-3#1)
of the children were##17##4##(1990-12#2)(1993-6#1)(1995-6#1)(1996-1#1)(1997-5#1)(2006-10#3)(2006-3#1)(2007-7#2)(2008-10#1)(2008-2#1)(2012-12#2)(2013-8#1)
of the children who##3##4##(2006-10#1)(2010-4#1)(2012-2#1)
of the children with severe##2##5##(2008-2#1)(2008-4#1)
of the children with##16##4##(1995-5#1)(1996-1#2)(2006-10#1)(2007-11#1)(2007-7#1)(2008-11#2)(2008-2#1)(2008-4#2)(2010-8#2)(2011-1#2)(2012-2#1)
of the children##95##3##(1990-12#5)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#2)(1992-2#1)(1993-1#1)(1993-5#2)(1993-6#1)(1993-8#1)(1994-12#1)(1995-5#3)(1995-6#1)(1996-1#3)(1996-3#1)(1996-9#1)(1997-4#2)(1997-5#1)(1997-6#1)(2004-12#1)(2005-8#1)(2006-10#11)(2006-2#1)(2006-3#2)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-7#5)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#2)(2008-8#1)(2008-9#5)(2009-2#1)(2010-12#1)(2010-4#1)(2010-8#3)(2010-9#1)(2011-1#2)(2012-12#5)(2012-2#3)(2013-1#1)(2013-8#2)
of the children's##7##3##(1993-6#1)(1995-12#1)(1995-6#2)(1996-12#1)(2006-3#1)(2008-3#1)
of the chimaera##2##3##(1994-6#1)(1995-12#1)
of the chimeric protein##2##4##(1991-5#1)(1994-9#1)
of the chimeric##8##3##(1991-5#1)(1994-12#1)(1994-9#1)(1995-10#1)(1995-8#1)(1996-11#1)(1997-2#1)(2007-12#1)
of the chimpanzee##2##3##(1997-4#1)(1997-6#1)
of the chin##2##3##(2007-3#1)(2009-1#1)
of the chip##5##3##(2008-2#4)(2010-1#1)
of the chiral##8##3##(1995-2#1)(1997-2#1)(2007-11#2)(2008-10#3)(2009-5#1)
of the chirp##3##3##(2008-1#1)(2008-2#2)
of the chitinase##2##3##(2008-10#1)(2010-10#1)
of the chitosan derivative##2##4##(2007-8#2)
of the chitosan##3##3##(2007-2#1)(2007-8#2)
of the chloramphenicol acetyltransferase##2##4##(1991-2#1)(1996-5#1)
of the chloramphenicol##4##3##(1991-2#1)(1995-10#1)(1996-5#1)(2008-11#1)
of the chloride conductance in##2##5##(1995-11#2)
of the chloride ion##2##4##(2008-10#2)
of the chloride##7##3##(1995-11#2)(1997-7#1)(2008-10#3)(2008-8#1)
of the chlorophyllides##2##3##(2007-1#2)
of the chloroplast genome##2##4##(1997-2#1)(2008-12#1)
of the chloroplast signal recognition particle##2##6##(2009-7#2)
of the chloroplast##7##3##(1990-7#1)(1997-2#2)(2008-12#1)(2009-10#1)(2009-7#2)
of the choice of##3##4##(1991-3#1)(2006-11#1)(2008-8#1)
of the choice##7##3##(1991-10#1)(1991-3#1)(1991-4#1)(2006-11#1)(2007-6#1)(2008-10#1)(2008-8#1)
of the cholecystokinin##4##3##(1992-3#1)(1992-9#1)(1996-12#1)(1997-2#1)
of the choledochus##4##3##(1990-6#1)(1991-5#1)(2006-8#1)(2008-5#1)
of the cholestatic##2##3##(2005-10#1)(2010-2#1)
of the cholesteric##2##3##(2007-11#1)(2007-12#1)
of the cholesterol content##2##4##(2008-10#1)(2008-6#1)
of the cholesterol precursor##2##4##(1997-1#2)
of the cholesterol##9##3##(1993-3#1)(1994-8#1)(1997-1#2)(2005-11#1)(2006-2#1)(2008-10#2)(2008-6#1)
of the choline##2##3##(1990-3#1)(1996-6#1)
of the cholinergic##7##3##(1990-7#1)(1992-8#1)(1994-8#1)(1996-6#1)(1997-5#1)(1997-6#1)(2008-8#1)
of the cholinesterase inhibitors##2##4##(1993-11#1)(2005-6#1)
of the cholinesterase##4##3##(1991-1#1)(1992-4#1)(1993-11#1)(2005-6#1)
of the chondral##2##3##(2007-11#1)(2011-2#1)
of the chorion##3##3##(2007-12#1)(2008-12#2)
of the choroid plexus##6##4##(1996-12#1)(1996-3#2)(1996-5#1)(1997-5#1)(1997-8#1)
of the choroid##9##3##(1996-12#1)(1996-3#2)(1996-5#1)(1997-3#1)(1997-5#1)(1997-8#1)(2013-1#2)
of the chosen##5##3##(2006-2#1)(2007-2#1)(2008-7#1)(2008-8#1)(2010-8#1)
of the chromatic##3##3##(2007-12#1)(2008-3#2)
of the chromaticity##3##3##(2008-2#3)
of the chromatin structure##2##4##(1992-3#1)(1997-2#1)
of the chromatin##5##3##(1992-3#1)(1995-11#1)(1997-2#1)(1997-6#1)(2012-1#1)
of the chromatogram##2##3##(1991-5#1)(1996-9#1)
of the chromatographic conditions##2##4##(1992-2#1)(2013-7#1)
of the chromatographic##10##3##(1991-3#1)(1992-2#1)(1996-6#1)(2008-10#5)(2008-5#1)(2013-7#1)
of the chromatography##2##3##(1993-2#1)(2008-10#1)
of the chromium##6##3##(1995-6#1)(2008-10#4)(2008-2#1)
of the chromophore in##2##4##(2008-10#1)(2008-8#1)
of the chromophore##13##3##(1990-7#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-10#1)(1996-5#1)(1997-4#1)(1997-8#1)(2005-11#1)(2008-10#2)(2008-8#1)(2009-9#1)
of the chromophores##3##3##(1994-9#1)(1996-5#1)(2009-9#1)
of the chromosomal RAP1 gene##2##5##(1996-7#2)
of the chromosomal##10##3##(1993-9#1)(1994-9#1)(1996-7#2)(2006-10#1)(2008-10#1)(2008-12#1)(2008-6#1)(2010-3#1)(2012-3#1)
of the chromosome and##2##4##(2007-6#1)(2011-3#1)
of the chromosome number##2##4##(1990-8#1)(2013-1#1)
of the chromosome##31##3##(1990-5#1)(1990-8#2)(1990-9#1)(1991-7#2)(1992-11#1)(1994-12#1)(1994-5#1)(1995-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#3)(1997-5#1)(1997-8#1)(2006-5#1)(2007-11#1)(2007-6#1)(2008-10#2)(2008-12#1)(2008-9#1)(2009-10#1)(2010-8#1)(2010-9#1)(2011-3#1)(2013-1#1)(2013-8#1)
of the chromosomes##7##3##(1997-3#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-3#1)
of the chronic disease##2##4##(1997-2#1)(2010-5#1)
of the chronic inflammatory##3##4##(2008-5#1)(2008-6#1)(2012-1#1)
of the chronic pain##2##4##(1996-1#1)(2011-1#1)
of the chronic##27##3##(1990-8#1)(1992-10#1)(1995-2#2)(1996-1#1)(1996-10#2)(1997-2#1)(1997-3#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-1#1)(2013-8#1)
of the chronically ill##2##4##(1994-6#1)(1997-1#1)
of the chronically##7##3##(1992-1#1)(1993-11#2)(1994-6#1)(1997-1#1)(1997-6#1)(2008-3#1)
of the churna##3##3##(2013-8#3)
of the cibarial armature##3##4##(2004-11#1)(2008-5#2)
of the cibarial##4##3##(2004-11#1)(2008-5#3)
of the cicatricial wall##2##4##(2012-1#2)
of the cichlid##2##3##(2008-7#1)(2010-8#1)
of the ciliary##4##3##(1992-8#1)(1995-12#1)(1997-1#1)(2011-2#1)
of the ciliates##2##3##(2008-4#2)
of the cilium##2##3##(2008-7#1)(2013-1#1)
of the ciprofloxacin##2##3##(2006-8#1)(2008-10#1)
of the circadian clock##2##4##(2006-1#1)(2009-8#1)
of the circadian pacemaker##2##4##(1997-5#1)(2008-5#1)
of the circadian rhythm of##3##5##(1992-3#1)(1994-2#2)
of the circadian rhythm##5##4##(1992-3#1)(1993-6#1)(1994-2#3)
of the circadian system that##2##5##(1995-9#1)(2008-8#1)
of the circadian system##3##4##(1995-9#1)(2006-1#1)(2008-8#1)
of the circadian##20##3##(1992-3#1)(1993-12#2)(1993-5#1)(1993-6#1)(1994-2#3)(1995-7#1)(1995-9#1)(1996-3#1)(1997-1#1)(1997-5#1)(2006-1#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)
of the circle of Willis##2##5##(1993-12#1)(2008-7#1)
of the circle of least confusion##3##6##(2008-2#2)(2008-3#1)
of the circle of##5##4##(1993-12#1)(2008-2#2)(2008-3#1)(2008-7#1)
of the circle##7##3##(1993-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#1)
of the circuit and##2##4##(2008-11#1)(2010-9#1)
of the circuit##8##3##(1990-4#1)(2008-11#2)(2008-2#2)(2008-3#1)(2010-11#1)(2010-9#1)
of the circular dichroism##2##4##(1991-9#1)(2005-4#1)
of the circular muscle of the##3##6##(1991-10#2)(1996-12#1)
of the circular muscle of##4##5##(1991-10#2)(1996-12#2)
of the circular muscle##6##4##(1991-10#2)(1993-11#1)(1996-12#3)
of the circular##15##3##(1991-10#2)(1991-9#1)(1993-11#1)(1996-12#4)(2005-4#1)(2006-6#1)(2007-8#1)(2008-3#2)(2008-6#2)
of the circularly##3##3##(1991-11#1)(2007-12#1)(2008-2#1)
of the circulating##6##3##(1991-10#2)(1993-12#1)(2006-6#1)(2007-9#1)(2010-10#1)
of the circulation of the##2##5##(1992-7#1)(2007-10#1)
of the circulation##9##3##(1990-4#1)(1991-4#1)(1992-7#1)(1997-7#1)(2005-1#1)(2005-10#1)(2006-10#1)(2007-10#1)(2008-3#1)
of the circulatory system in##2##5##(2007-12#1)(2008-7#1)
of the circulatory system##4##4##(2007-12#1)(2008-7#2)(2013-8#1)
of the circulatory##5##3##(2007-12#1)(2008-10#1)(2008-7#2)(2013-8#1)
of the circumference of the##2##5##(2008-6#1)(2013-1#1)
of the circumflex##2##3##(2007-8#2)
of the cis isomer##3##4##(1993-2#1)(2007-12#1)(2008-5#1)
of the cis##8##3##(1993-2#1)(1995-1#1)(2007-12#2)(2008-5#1)(2008-9#1)(2010-2#2)
of the cited##2##3##(2008-10#2)
of the cities##4##3##(2007-2#1)(2008-10#1)(2008-11#1)(2013-1#1)
of the citrate synthase##2##4##(1996-9#1)(2011-1#1)
of the citrate##4##3##(1992-9#1)(1996-9#1)(2011-1#1)(2012-5#1)
of the city as well as##2##6##(2008-1#1)(2008-10#1)
of the city of Catania##2##5##(2007-10#1)(2008-7#1)
of the city of Rio de Janeiro##3##7##(1994-3#2)(2009-7#1)
of the city of##16##4##(1991-7#1)(1993-6#1)(1994-3#2)(1996-5#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-7#1)(2013-1#1)
of the city##26##3##(1990-11#1)(1991-7#1)(1993-6#1)(1994-3#3)(1996-5#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2009-6#1)(2009-7#1)(2013-1#2)
of the civil war##2##4##(1997-6#1)(2005-9#1)
of the civilized##2##3##(2008-12#1)(2008-3#1)
of the cladding##7##3##(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#1)
of the clade##2##3##(2008-8#1)(2012-12#1)
of the clamping##2##3##(2008-10#1)(2011-2#1)
of the clams##2##3##(2007-10#1)(2008-5#1)
of the class I##6##4##(1990-11#1)(1991-2#1)(1991-5#1)(1995-1#1)(1995-12#1)(2008-4#1)
of the class II##3##4##(1991-9#1)(1992-7#1)(1995-3#1)
of the class of##6##4##(1994-5#1)(1995-1#1)(2008-8#1)(2008-9#1)(2009-4#1)(2012-1#1)
of the class##28##3##(1990-11#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-6#1)(1992-7#1)(1994-5#1)(1995-1#2)(1995-12#1)(1995-3#1)(1997-7#1)(2006-8#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#2)(2012-1#1)(2013-8#1)
of the classes##2##3##(2008-3#1)(2008-4#1)
of the classic##14##3##(1991-8#1)(1994-5#1)(2006-3#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2010-12#1)(2010-7#1)(2011-1#1)
of the classical##30##3##(1991-12#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-5#1)(1995-12#1)(1996-11#1)(1996-3#1)(1997-2#2)(2005-11#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-2#2)(2012-3#1)
of the classically##2##3##(2008-2#1)(2012-11#1)
of the classification of##2##4##(2005-8#1)(2008-4#1)
of the classification##11##3##(1991-12#1)(1991-9#1)(2005-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-4#1)(2010-6#1)(2013-1#2)
of the clavicle is a rare##2##6##(2007-8#1)(2009-6#1)
of the clavicle##8##3##(2006-4#1)(2007-8#3)(2009-3#1)(2009-6#2)(2012-3#1)
of the claw##3##3##(2011-1#1)(2011-2#2)
of the clay##3##3##(2005-11#1)(2008-10#1)(2008-5#1)
of the cleavage products##2##4##(1996-5#1)(1996-7#1)
of the cleavage##8##3##(1990-2#1)(1992-11#1)(1995-6#2)(1996-5#1)(1996-7#1)(2005-9#2)
of the cleaved DNA##2##4##(1997-4#1)(1997-7#1)
of the cleaved##7##3##(1991-9#1)(1994-8#1)(1995-1#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-4#1)
of the cleft##4##3##(1996-7#1)(2007-12#2)(2012-12#1)
of the client##2##3##(2008-2#1)(2009-6#1)
of the clientele##5##3##(1991-12#1)(1994-3#1)(2008-2#3)
of the clients##2##3##(1993-1#1)(2007-7#1)
of the clinic##5##3##(2006-2#1)(2006-3#1)(2007-7#1)(2010-5#2)
of the clinical and pathological##3##5##(1991-12#1)(1995-3#1)(2011-2#1)
of the clinical and radiological##5##5##(1997-3#1)(2005-8#1)(2006-7#1)(2008-6#1)(2012-12#1)
of the clinical and##15##4##(1991-12#1)(1995-3#1)(1997-3#1)(2005-8#1)(2006-7#1)(2007-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
of the clinical assessment##2##4##(1991-4#1)(2007-3#1)
of the clinical care##2##4##(1997-2#1)(2006-10#1)
of the clinical condition##2##4##(1990-8#1)(2006-7#1)
of the clinical course of##2##5##(2007-11#1)(2011-12#1)
of the clinical course##5##4##(1997-3#1)(1997-6#1)(2006-11#1)(2007-11#1)(2011-12#1)
of the clinical curriculum##3##4##(1992-6#3)
of the clinical diagnosis##2##4##(1993-2#1)(2008-3#1)
of the clinical efficacy##2##4##(1990-3#1)(2007-7#1)
of the clinical experience##4##4##(2005-10#1)(2007-11#2)(2008-11#1)
of the clinical features and##3##5##(2007-3#2)(2011-1#1)
of the clinical features of##3##5##(2008-4#1)(2008-5#1)(2012-12#1)
of the clinical features##9##4##(2007-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
of the clinical history##3##4##(1992-5#1)(2007-10#1)(2012-12#1)
of the clinical implications of##2##5##(2008-10#1)(2011-1#1)
of the clinical importance of##3##5##(1994-11#1)(1997-8#1)(2005-8#1)
of the clinical management##2##4##(2007-12#1)(2008-11#1)
of the clinical manifestations of##2##5##(1995-12#1)(1996-3#1)
of the clinical manifestations##3##4##(1995-12#1)(1996-3#1)(2008-7#1)
of the clinical phenotype and the##2##6##(2007-7#1)(2011-2#1)
of the clinical phenotype##4##4##(2007-7#1)(2010-12#1)(2011-1#1)(2011-2#1)
of the clinical picture and##2##5##(2007-10#1)(2007-11#1)
of the clinical picture##11##4##(1990-3#1)(1993-8#1)(1997-6#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-4#1)(2008-6#1)(2010-2#1)
of the clinical population##2##4##(1997-8#2)
of the clinical presentation##4##4##(2007-7#1)(2009-4#1)(2009-8#1)(2012-3#1)
of the clinical records##2##4##(1992-9#1)(1993-11#1)
of the clinical spectrum of##2##5##(1996-12#1)(2006-8#1)
of the clinical state of the patient##2##7##(1995-12#1)(2006-5#1)
of the clinical studies##4##4##(2006-10#1)(2007-11#1)(2007-8#1)(2010-5#1)
of the clinical symptoms##3##4##(2007-11#1)(2012-12#1)(2012-2#1)
of the clinical team##2##4##(2008-1#1)(2008-11#1)
of the clinical trial##4##4##(1992-9#1)(2007-4#1)(2008-7#1)(2013-8#1)
of the clinical trials##5##4##(1996-8#1)(1997-5#1)(2008-1#1)(2008-5#2)
of the clinical use of##2##5##(1990-3#1)(2008-2#1)
of the clinical##184##3##(1990-10#1)(1990-12#1)(1990-3#3)(1990-8#1)(1991-12#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-6#3)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1995-12#3)(1995-3#2)(1996-12#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-5#2)(1997-6#4)(1997-8#3)(2004-1#1)(2004-9#1)(2005-10#1)(2005-8#2)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-5#2)(2006-7#3)(2006-8#2)(2007-1#2)(2007-10#7)(2007-11#14)(2007-12#2)(2007-3#3)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#4)(2008-1#3)(2008-10#3)(2008-11#6)(2008-2#2)(2008-3#1)(2008-4#6)(2008-5#7)(2008-6#6)(2008-7#5)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-12#3)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#7)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#4)
of the clinically important##2##4##(2005-7#1)(2008-5#1)
of the clinically significant##3##4##(2008-8#1)(2009-2#1)(2011-2#1)
of the clinically##8##3##(1997-2#1)(2005-7#1)(2007-11#1)(2008-5#2)(2008-8#1)(2009-2#1)(2011-2#1)
of the clinician##4##3##(2006-2#1)(2007-4#1)(2007-9#1)(2012-1#1)
of the clinician-trainer program##2##4##(2008-11#2)
of the clinicians##2##3##(2006-8#1)(2013-8#1)
of the clivus##5##3##(2006-12#1)(2006-6#2)(2013-8#2)
of the clonal##7##3##(1994-11#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-9#1)
of the clone##11##3##(1990-10#1)(1990-11#3)(1990-2#1)(1991-2#1)(1992-12#1)(1994-12#1)(1994-8#1)(1996-7#1)(1997-2#1)
of the cloned DNA##3##4##(1991-1#1)(1991-9#1)(1997-4#1)
of the cloned fragment##2##4##(1994-12#1)(1996-7#1)
of the cloned fragments##2##4##(2008-10#2)
of the cloned gene product was##2##6##(1994-3#2)
of the cloned gene product##4##5##(1990-3#1)(1994-3#3)
of the cloned gene##6##4##(1990-3#1)(1991-9#1)(1994-3#3)(1995-6#1)
of the cloned genes##2##4##(1990-2#1)(1990-4#1)
of the cloned human##3##4##(1991-12#1)(1993-11#1)(1996-5#1)
of the cloned receptor##3##4##(1990-8#1)(1992-11#1)(1992-3#1)
of the cloned receptors##3##4##(1993-3#1)(1994-9#1)(1995-10#1)
of the cloned sequences##2##4##(1992-2#1)(2006-8#1)
of the cloned##59##3##(1990-1#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#3)(1991-3#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-2#2)(1992-3#2)(1993-11#3)(1993-3#1)(1994-12#1)(1994-3#3)(1994-9#4)(1995-10#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-4#3)(1997-6#1)(1997-8#1)(2006-12#1)(2006-8#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)
of the clones in##2##4##(1993-3#1)(1995-10#1)
of the clones was##4##4##(1996-10#1)(1997-8#1)(2007-1#1)(2008-11#1)
of the clones##23##3##(1991-6#1)(1992-2#1)(1992-8#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-9#1)(1995-10#1)(1995-3#1)(1996-10#2)(1997-2#2)(1997-4#1)(1997-8#2)(2006-8#1)(2007-1#2)(2007-3#1)(2008-11#1)(2008-9#2)
of the close##6##3##(1990-11#1)(1991-6#1)(2007-5#1)(2008-11#1)(2008-3#1)(2013-1#1)
of the closed and the open##2##6##(1997-1#2)
of the closed##8##3##(1992-3#1)(1996-11#1)(1997-1#2)(2008-7#2)(2011-12#1)(2012-12#1)
of the closely##2##3##(1994-5#1)(1996-2#1)
of the closure##2##3##(1993-3#1)(2013-7#1)
of the cloud##10##3##(1992-3#1)(2008-10#1)(2008-2#5)(2008-3#3)
of the cluster##10##3##(1990-5#1)(1993-4#1)(1996-6#1)(2005-11#2)(2007-1#1)(2007-10#1)(2007-12#1)(2008-1#1)(2013-1#1)
of the clustering##4##3##(2008-10#2)(2013-1#2)
of the clusters##10##3##(1995-6#1)(1997-5#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-7#1)(2011-1#1)
of the coadsorption of benzyl alcohol and phenyl ethanol with the cationic surfactant##2##13##(2005-11#2)
of the coagulation cascade##2##4##(1995-8#1)(2004-11#1)
of the coagulation system##4##4##(1990-11#1)(1991-8#1)(1996-6#1)(2006-10#1)
of the coagulation##8##3##(1990-11#2)(1991-8#1)(1995-8#1)(1996-6#1)(2004-11#1)(2006-10#1)(2012-12#1)
of the coalition##3##3##(2009-10#1)(2009-11#1)(2009-4#1)
of the coarctation##2##3##(2007-8#2)
of the coast##2##3##(1996-7#1)(2007-5#1)
of the coastal##5##3##(2007-10#1)(2008-5#1)(2008-8#1)(2010-4#1)(2010-8#1)
of the coat protein (CP) and##2##6##(2008-10#2)
of the coat protein (CP) gene was##2##7##(2008-10#1)(2008-8#1)
of the coat protein (CP) gene##3##6##(2008-10#2)(2008-8#1)
of the coat protein (CP)##6##5##(2008-10#5)(2008-8#1)
of the coat protein gene##4##5##(1997-2#1)(1997-4#1)(2008-10#2)
of the coat protein##19##4##(1991-5#3)(1992-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(2008-10#10)(2008-8#1)
of the coat##22##3##(1991-5#3)(1992-9#1)(1997-1#1)(1997-2#2)(1997-4#3)(2008-10#11)(2008-8#1)
of the coated vesicle V-ATPase##2##5##(1995-6#2)
of the coated vesicle##3##4##(1992-11#1)(1995-6#2)
of the coated##10##3##(1992-11#1)(1995-6#2)(2004-9#1)(2007-12#1)(2008-10#3)(2010-1#1)(2010-5#1)
of the coating##13##3##(2004-12#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-5#1)(2009-6#1)(2009-7#1)(2010-4#2)(2010-5#1)(2013-1#1)
of the coatings##5##3##(2004-9#1)(2007-12#1)(2008-3#2)(2010-4#1)
of the cobalt complex##2##4##(2008-10#2)
of the cobalt##3##3##(2008-10#2)(2010-7#1)
of the cocaine##4##3##(1996-1#1)(1996-10#2)(1997-5#1)
of the coccyx##3##3##(1992-11#2)(2009-5#1)
of the cochlea and the cochlear implant##2##7##(2012-2#2)
of the cochlea and the##3##5##(2012-2#3)
of the cochlea and##4##4##(2008-9#1)(2012-2#3)
of the cochlea##8##3##(1991-1#1)(1996-3#1)(2008-9#2)(2012-2#4)
of the cochlear implant##2##4##(2008-9#1)(2012-2#1)
of the cochlear nucleus##2##4##(1992-9#1)(1995-12#1)
of the cochlear##6##3##(1992-9#1)(1995-12#1)(1996-3#1)(2008-9#1)(2012-2#2)
of the cockroach##3##3##(1990-4#1)(2007-12#1)(2011-12#1)
of the cod##2##3##(1995-6#1)(2012-12#1)
of the code##3##3##(2008-2#1)(2008-3#1)(2012-12#1)
of the coding and##3##4##(1990-11#1)(1994-2#1)(2012-2#1)
of the coding region for##2##5##(1990-7#2)
of the coding region of the chicken##2##7##(1993-6#2)
of the coding region of the##7##6##(1992-11#1)(1993-6#2)(1996-1#1)(2006-12#1)(2007-1#1)(2008-4#1)
of the coding region of##12##5##(1992-11#1)(1992-7#1)(1993-2#1)(1993-6#2)(1995-12#1)(1996-1#1)(1996-6#1)(2006-12#1)(2007-1#1)(2008-4#1)(2008-8#1)
of the coding region##20##4##(1990-7#2)(1991-10#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-7#1)(1993-2#1)(1993-6#3)(1995-12#1)(1996-1#1)(1996-6#1)(1997-8#1)(2006-12#1)(2007-1#1)(2008-4#1)(2008-8#1)
of the coding regions##3##4##(1991-9#1)(1993-11#1)(2008-10#1)
of the coding sequence of##2##5##(1992-8#1)(1994-5#1)
of the coding sequence##5##4##(1990-10#1)(1990-4#1)(1991-5#1)(1992-8#1)(1994-5#1)
of the coding sequences##6##4##(1992-3#1)(1995-8#1)(1996-10#1)(1996-2#2)(1997-4#1)
of the coding##44##3##(1990-10#1)(1990-11#1)(1990-4#1)(1990-7#2)(1991-10#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-6#3)(1994-2#1)(1994-5#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#2)(1996-6#1)(1997-4#1)(1997-8#1)(2006-12#1)(2007-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2012-2#1)(2013-8#1)
of the codon##6##3##(1991-11#1)(1992-11#1)(1993-7#1)(1994-8#1)(1997-8#1)(2005-8#1)
of the coefficient of##2##4##(2005-11#1)(2008-10#1)
of the coefficient##3##3##(2005-11#1)(2008-10#1)(2008-6#1)
of the coefficients of the##2##5##(1997-6#1)(2008-6#1)
of the coefficients of##3##4##(1997-6#1)(2008-2#1)(2008-6#1)
of the coefficients##6##3##(1997-6#1)(2006-4#1)(2008-2#2)(2008-3#1)(2008-6#1)
of the coelomic##2##3##(2008-5#1)(2011-2#1)
of the coenzyme and##2##4##(1991-2#1)(1996-8#1)
of the coenzyme##10##3##(1991-11#1)(1991-2#2)(1992-6#3)(1996-8#2)(2008-10#1)(2013-8#1)
of the coevolution##2##3##(2008-8#2)
of the coexistence of##4##4##(2007-11#1)(2007-12#1)(2008-1#1)(2013-8#1)
of the cofactor##14##3##(1990-4#1)(1990-7#3)(1992-11#2)(1992-6#1)(1993-6#1)(1994-5#3)(1996-7#2)(1997-7#1)
of the cofactors##2##3##(1992-11#1)(1994-8#1)
of the cognate##8##3##(1990-3#1)(1991-4#1)(1995-1#1)(1995-8#1)(1996-5#1)(2007-11#1)(2008-9#2)
of the cognitive and##3##4##(2007-8#1)(2008-9#1)(2011-12#1)
of the cognitive deficits observed##2##5##(1993-12#1)(1995-11#1)
of the cognitive deficits##3##4##(1993-12#1)(1995-11#1)(2008-11#1)
of the cognitive map##2##4##(2008-11#2)
of the cognitive##20##3##(1991-6#1)(1993-12#1)(1994-5#1)(1995-11#1)(2006-3#1)(2007-7#1)(2007-8#1)(2008-11#3)(2008-2#2)(2008-4#2)(2008-9#1)(2009-10#1)(2009-4#2)(2011-12#2)
of the coherence##4##3##(2008-2#1)(2008-3#3)
of the coherent and##2##4##(2008-10#1)(2008-3#1)
of the coherent beam##3##4##(2008-1#2)(2008-2#1)
of the coherent##11##3##(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#2)
of the cohort had##2##4##(2006-8#1)(2010-4#1)
of the cohort was##3##4##(2006-8#1)(2007-9#1)(2013-1#1)
of the cohort were##3##4##(1993-12#1)(2012-12#2)
of the cohort##15##3##(1990-10#1)(1993-12#1)(1994-2#1)(1994-4#1)(1995-8#1)(2006-8#2)(2006-9#1)(2007-9#1)(2009-8#1)(2010-4#2)(2012-12#2)(2013-1#1)
of the coiled##3##3##(1992-9#1)(2008-2#1)(2011-2#1)
of the coiled-coil##3##3##(1992-9#1)(1993-3#1)(1995-6#1)
of the coils##3##3##(1995-11#1)(2008-4#1)(2013-7#1)
of the coin##3##3##(2008-4#2)(2010-12#1)
of the coincidence##2##3##(1996-6#1)(2006-7#1)
of the cold##4##3##(2007-12#1)(2008-11#1)(2011-2#1)(2012-3#1)
of the colicin E1 channel peptide##2##6##(1995-5#2)
of the coliphage##2##3##(1993-3#1)(1996-8#1)
of the collaborative##3##3##(2007-5#1)(2008-10#1)(2013-1#1)
of the collagen and##2##4##(2007-8#1)(2012-3#1)
of the collagen##13##3##(1991-5#1)(1992-6#2)(2004-2#1)(2007-8#1)(2008-7#1)(2009-7#1)(2010-8#2)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
of the collapse of the##3##5##(2007-7#1)(2007-8#1)(2008-12#1)
of the collapse of##5##4##(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-12#1)
of the collapse##6##3##(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-12#1)
of the collar##2##3##(2005-10#2)
of the collateral##4##3##(1991-2#1)(1992-9#1)(1997-3#1)(2006-2#1)
of the collected data##3##4##(2005-11#1)(2008-10#1)(2008-11#1)
of the collected samples##2##4##(2008-10#1)(2009-6#1)
of the collected##9##3##(1991-2#1)(2005-11#1)(2007-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-6#1)
of the collectin##2##3##(2005-11#1)(2011-1#1)
of the collecting##5##3##(1996-3#1)(2007-9#1)(2008-2#1)(2008-6#1)(2011-2#1)
of the collection##9##3##(2004-11#1)(2008-10#1)(2008-2#2)(2010-1#1)(2010-2#1)(2011-2#1)(2012-12#2)
of the collective##3##3##(1995-3#1)(2007-8#1)(2008-2#1)
of the collector##2##3##(2008-10#2)
of the collisional##2##3##(2007-12#1)(2008-2#1)
of the colloid of bentonite in##2##6##(2005-4#2)
of the colloidal##5##3##(2005-11#3)(2006-5#1)(2008-5#1)
of the colon and rectum##5##5##(1993-10#1)(2006-2#1)(2011-2#2)(2013-1#1)
of the colon and##8##4##(1990-2#1)(1993-10#1)(1993-5#1)(2006-2#2)(2011-2#2)(2013-1#1)
of the colon are##2##4##(2008-6#1)(2010-2#1)
of the colon in##3##4##(1991-6#1)(2006-8#2)
of the colon is an##2##5##(1991-5#1)(1993-10#1)
of the colon is##5##4##(1990-9#1)(1991-5#1)(1993-10#1)(1993-8#1)(2010-12#1)
of the colon or##2##4##(1997-8#1)(2006-2#1)
of the colon was##3##4##(2007-5#1)(2008-11#1)(2009-2#1)
of the colon with a##2##5##(1990-3#1)(2007-5#1)
of the colon with##3##4##(1990-3#1)(2007-5#1)(2008-11#1)
of the colon##58##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#1)(1990-9#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-8#1)(1992-9#2)(1993-10#2)(1993-5#1)(1993-8#2)(1993-9#1)(1994-2#2)(1995-9#1)(1996-2#1)(1997-5#1)(1997-8#1)(2006-2#3)(2006-8#3)(2007-5#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-6#1)(2009-1#1)(2009-12#1)(2009-2#2)(2010-12#1)(2010-2#1)(2010-5#2)(2010-6#1)(2011-2#4)(2013-1#1)(2013-8#2)
of the colonial##2##3##(1995-9#1)(2008-7#1)
of the colonic##7##3##(1991-10#1)(1995-8#1)(1995-9#1)(2006-8#1)(2009-1#1)(2010-8#1)(2011-2#1)
of the colonies##5##3##(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#2)
of the colonization process##2##4##(2008-10#1)(2008-8#1)
of the colonization##3##3##(2008-10#1)(2008-8#2)
of the colonoscope##2##3##(2007-5#2)
of the colony##6##3##(2008-10#3)(2008-4#1)(2008-6#1)(2009-5#1)
of the color and shape of alphanumeric characters##2##8##(1997-1#2)
of the color and##3##4##(1997-1#2)(2008-5#1)
of the color centers##2##4##(2007-12#1)(2008-3#1)
of the color of the##2##5##(2008-10#2)
of the color##13##3##(1997-1#3)(2007-12#1)(2008-10#4)(2008-3#3)(2008-5#1)(2011-1#1)
of the colorectal carcinoma##3##4##(1990-8#1)(1992-8#1)(2006-6#1)
of the colorectal##7##3##(1990-4#1)(1990-8#2)(1992-8#1)(2006-6#1)(2008-5#2)
of the colored##4##3##(2007-3#1)(2008-10#2)(2008-4#1)
of the colour##3##3##(1992-11#1)(2008-10#2)
of the coloured complex##2##4##(2008-10#2)
of the coloured##7##3##(2008-10#6)(2010-2#1)
of the colposcopy directed##2##4##(2008-11#2)
of the column##11##3##(1990-9#1)(1996-8#1)(2004-12#1)(2005-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)
of the columnar##2##3##(2007-3#1)(2008-2#1)
of the columns has been##2##5##(2005-12#1)(2008-10#1)
of the columns were##2##4##(1991-3#1)(2008-10#1)
of the columns##7##3##(1991-3#1)(2005-12#1)(2007-8#1)(2008-10#4)
of the comb spectrum##2##4##(2007-12#2)
of the comb##4##3##(2007-12#4)
of the combination of BG +##2##6##(1994-11#2)
of the combination of##20##4##(1994-11#2)(1997-7#1)(2004-1#1)(2004-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-4#1)(2012-2#2)(2013-8#3)
of the combination vaccine##2##4##(1995-5#1)(2007-11#1)
of the combination##31##3##(1992-10#1)(1994-11#2)(1995-5#2)(1995-6#2)(1997-7#1)(2004-1#1)(2004-12#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-4#3)(2012-1#1)(2012-2#2)(2013-8#3)
of the combined effect of##2##5##(2008-3#1)(2008-5#1)
of the combined effect##3##4##(2007-9#1)(2008-3#1)(2008-5#1)
of the combined effects##2##4##(1997-7#1)(2008-3#1)
of the combined method of##2##5##(2008-10#1)(2013-1#1)
of the combined probe##2##4##(2008-3#2)
of the combined treatment##2##4##(2004-12#1)(2006-6#1)
of the combined use of##3##5##(1997-7#1)(2007-8#1)(2008-7#1)
of the combined##33##3##(1991-9#1)(1992-9#1)(1993-6#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-7#2)(1997-8#1)(2004-12#1)(2006-10#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#5)(2008-5#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-4#1)(2013-1#1)(2013-8#1)
of the combining site##3##4##(1990-10#2)(1996-5#1)
of the combustion products##2##4##(1996-12#2)
of the combustion##4##3##(1996-12#2)(2007-8#1)(2008-11#1)
of the comet assay##3##4##(1997-4#3)
of the comet##4##3##(1997-4#3)(1997-5#1)
of the comfort##2##3##(2009-8#1)(2013-7#1)
of the coming##2##3##(1993-7#1)(2008-7#1)
of the commercial##17##3##(1994-8#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-6#1)(2007-12#1)(2007-2#2)(2008-10#2)(2008-11#1)(2008-9#1)(2009-3#1)(2010-4#1)(2012-1#1)(2012-3#1)(2013-8#1)
of the commercially available##3##4##(2007-1#1)(2008-10#2)
of the commercially##4##3##(2005-7#1)(2007-1#1)(2008-10#2)
of the common bean (Phaseolus vulgaris)##2##6##(2008-10#2)
of the common bean##4##4##(2008-10#4)
of the common bile duct##9##5##(1990-5#2)(1990-6#1)(1990-9#1)(1996-11#1)(2007-5#1)(2008-6#1)(2009-9#1)(2012-1#1)
of the common carotid arteries##2##5##(2007-10#2)
of the common carotid artery##6##5##(2008-7#2)(2009-12#1)(2010-12#1)(2012-11#1)(2013-8#1)
of the common carotid##8##4##(2007-10#2)(2008-7#2)(2009-12#1)(2010-12#1)(2012-11#1)(2013-8#1)
of the common frog (Rana temporaria)##2##6##(1996-11#2)
of the common hepatic artery##2##5##(2008-3#1)(2012-12#1)
of the common hepatic duct##2##5##(2008-3#1)(2009-2#1)
of the common hepatic##4##4##(2008-3#2)(2009-2#1)(2012-12#1)
of the common marmoset (Callithrix jacchus)##2##6##(1991-9#2)
of the common marmoset##4##4##(1991-9#2)(1995-5#2)
of the common methods##2##4##(2007-8#1)(2008-4#1)
of the common mutations##2##4##(2008-3#2)
of the common problems encountered##2##5##(2007-7#1)(2008-7#1)
of the common problems##3##4##(2005-8#1)(2007-7#1)(2008-7#1)
of the common region##2##4##(2008-10#2)
of the common##99##3##(1990-5#2)(1990-6#1)(1990-9#1)(1991-12#1)(1991-8#1)(1991-9#2)(1994-2#1)(1994-3#1)(1995-5#2)(1995-6#1)(1996-11#3)(1996-12#1)(1996-3#3)(1996-5#4)(1997-6#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-4#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#2)(2007-7#2)(2007-8#2)(2008-10#14)(2008-11#2)(2008-12#2)(2008-3#5)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
of the commonest##10##3##(2006-4#1)(2007-6#1)(2007-7#2)(2008-5#1)(2008-7#1)(2009-6#1)(2011-1#2)(2012-3#1)
of the commonly used##7##4##(2006-4#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-4#1)(2009-9#1)(2010-11#1)
of the commonly##15##3##(2006-4#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-9#1)(2010-11#1)(2012-12#1)(2013-1#2)
of the communication##13##3##(2007-11#1)(2008-11#1)(2008-3#3)(2008-6#1)(2010-3#3)(2012-3#2)(2013-1#2)
of the communications##3##3##(2008-8#1)(2008-9#2)
of the community and the##2##5##(1995-3#1)(2007-12#1)
of the community and##4##4##(1995-2#1)(1995-3#1)(2007-12#1)(2009-5#1)
of the community health##4##4##(1996-2#1)(1997-2#2)(2006-2#1)
of the community##36##3##(1990-12#1)(1991-1#1)(1992-1#1)(1993-1#1)(1993-2#1)(1995-2#2)(1995-3#1)(1996-2#2)(1996-3#1)(1997-2#2)(1997-8#1)(2006-11#2)(2006-2#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-8#2)(2009-5#1)(2009-6#1)(2011-2#1)(2012-1#1)(2013-1#3)
of the company's##3##3##(1990-2#1)(1992-3#1)(2005-8#1)
of the compared##2##3##(1992-1#1)(2013-8#1)
of the comparison show##2##4##(2008-2#2)
of the comparison##8##3##(1996-3#1)(2006-3#1)(2006-8#1)(2008-10#1)(2008-2#3)(2010-2#1)
of the compartment##2##3##(2007-11#1)(2008-1#1)
of the compensated##2##3##(1991-2#1)(2008-2#1)
of the compensation##2##3##(1990-7#1)(2012-1#1)
of the compensatory##2##3##(1995-8#1)(2008-1#1)
of the competence##3##3##(1992-3#1)(2008-4#1)(2010-9#1)
of the competing##3##3##(1993-3#1)(2006-5#1)(2008-5#1)
of the competition between##2##4##(2010-4#1)(2010-5#1)
of the competition##7##3##(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-5#1)
of the competitive inhibitor##3##4##(1991-7#1)(1992-8#1)(2008-10#1)
of the competitive interaction##2##4##(2008-10#2)
of the competitive##10##3##(1991-7#2)(1992-8#1)(1996-9#1)(1997-5#1)(2008-10#5)
of the complement (C) system##2##5##(1996-6#1)(2008-4#1)
of the complement system and##2##5##(2008-1#1)(2008-10#1)
of the complement system##13##4##(1991-2#1)(1995-9#1)(1997-1#1)(2007-1#2)(2007-7#1)(2008-1#1)(2008-10#1)(2010-4#2)(2012-1#2)(2012-3#1)
of the complement##31##3##(1991-2#1)(1992-12#1)(1993-11#1)(1994-6#1)(1995-9#1)(1996-5#1)(1996-6#1)(1997-1#2)(2005-8#2)(2007-1#2)(2007-11#2)(2007-7#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#3)(2010-4#2)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#1)
of the complementarity##2##3##(1997-4#1)(2009-7#1)
of the complementary DNA##2##4##(1990-12#1)(1992-4#1)
of the complementary strand##2##4##(1996-9#1)(2008-4#1)
of the complementary strands##3##4##(1994-11#2)(2006-12#1)
of the complementary target##2##4##(2008-10#2)
of the complementary##18##3##(1990-12#2)(1992-4#1)(1993-2#1)(1994-11#2)(1994-8#2)(1996-9#1)(2005-11#1)(2006-12#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)
of the complemented##2##3##(1991-5#1)(2010-12#1)
of the complete ITS##2##4##(2008-10#2)
of the complete coding region##2##5##(1992-11#1)(1994-2#1)
of the complete gene##2##4##(1993-8#1)(1994-2#1)
of the complete human genome sequence##2##6##(2008-10#1)(2008-8#1)
of the complete system##3##4##(2007-5#1)(2008-3#2)
of the complete##48##3##(1990-4#1)(1990-8#2)(1991-11#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-2#2)(1994-6#1)(1995-2#1)(1995-8#2)(1996-12#1)(1996-8#1)(1997-7#1)(2006-2#1)(2007-1#1)(2007-2#1)(2007-5#2)(2008-10#9)(2008-11#1)(2008-3#4)(2008-6#2)(2008-8#1)(2009-5#1)(2010-11#1)(2011-1#1)(2013-8#2)
of the completed##3##3##(1992-3#2)(2012-12#1)
of the completely##4##3##(1991-2#1)(2005-11#1)(2006-10#1)(2008-7#1)
of the completion of##2##4##(1995-10#1)(2013-1#1)
of the complex amplitude of the##2##6##(2007-11#1)(2007-12#1)
of the complex amplitude##5##4##(2007-11#2)(2007-12#3)
of the complex and##5##4##(1991-3#1)(2006-2#1)(2010-2#1)(2010-6#1)(2011-2#1)
of the complex are##5##4##(1995-2#1)(2008-10#3)(2009-10#1)
of the complex at -0##2##5##(2007-8#1)(2008-10#1)
of the complex between##5##4##(1992-3#1)(1994-11#1)(1994-9#1)(1997-1#1)(2006-12#1)
of the complex biological##2##4##(2008-4#1)(2008-9#1)
of the complex cellular##2##4##(1995-6#1)(2013-1#1)
of the complex during the##2##5##(1992-8#1)(2010-5#1)
of the complex formation##3##4##(1997-2#1)(2008-10#2)
of the complex formed by the##2##6##(1992-3#1)(2009-8#1)
of the complex formed##4##4##(1992-3#1)(1994-5#1)(2008-10#1)(2009-8#1)
of the complex genetic##2##4##(2009-10#1)(2012-1#1)
of the complex has been##2##5##(2008-10#2)
of the complex hydrogels##2##4##(2013-7#2)
of the complex impedance##2##4##(2008-10#1)(2008-7#1)
of the complex in##4##4##(1991-4#1)(2008-10#2)(2008-5#1)
of the complex index of refraction and##3##7##(2008-2#2)(2008-3#1)
of the complex index of refraction##6##6##(2008-2#5)(2008-3#1)
of the complex interaction of##2##5##(2006-1#1)(2009-8#1)
of the complex interactions between##2##5##(2006-10#1)(2008-7#1)
of the complex is 1##2##5##(2008-10#2)
of the complex is##15##4##(1990-8#1)(1991-8#1)(1993-3#1)(2005-4#2)(2007-12#1)(2008-10#8)(2008-5#1)
of the complex molecular##2##4##(2007-12#1)(2012-1#1)
of the complex nature of##2##5##(2006-10#1)(2006-12#1)
of the complex network##2##4##(2007-12#1)(2012-2#1)
of the complex of the##2##5##(1991-2#1)(2008-10#1)
of the complex of##9##4##(1990-3#1)(1991-2#1)(1993-8#2)(1996-7#1)(1996-8#1)(1997-1#1)(2008-10#1)(2008-11#1)
of the complex on##2##4##(1992-12#1)(1995-1#1)
of the complex refractive index of##2##6##(2008-2#1)(2008-3#1)
of the complex refractive index##8##5##(2008-2#2)(2008-3#6)
of the complex refractive##9##4##(2007-11#1)(2008-2#2)(2008-3#6)
of the complex species##3##4##(2008-10#3)
of the complex to##3##4##(1993-11#1)(2007-12#1)(2008-5#1)
of the complex was##11##4##(1990-5#2)(1994-11#1)(1996-11#1)(2007-12#1)(2008-10#5)(2008-5#1)
of the complex were determined##2##5##(1995-2#1)(1996-2#1)
of the complex were##3##4##(1991-4#1)(1995-2#1)(1996-2#1)
of the complex with the##2##5##(1997-4#1)(2011-1#1)
of the complex with##7##4##(1992-2#1)(1993-3#1)(1997-4#1)(2008-10#2)(2009-2#1)(2011-1#1)
of the complex##236##3##(1990-12#1)(1990-3#1)(1990-4#3)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#1)(1991-2#2)(1991-3#4)(1991-4#2)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#1)(1993-11#1)(1993-3#3)(1993-8#3)(1993-9#1)(1994-11#4)(1994-2#2)(1994-3#1)(1994-5#2)(1994-9#2)(1995-1#2)(1995-2#4)(1995-4#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#1)(1997-4#2)(1997-7#1)(2005-11#2)(2005-12#1)(2005-4#3)(2006-1#1)(2006-10#6)(2006-12#2)(2006-2#1)(2006-3#1)(2006-6#1)(2007-11#4)(2007-12#11)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#53)(2008-11#2)(2008-2#12)(2008-3#10)(2008-4#6)(2008-5#8)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#3)(2009-2#2)(2009-6#1)(2009-8#3)(2010-12#1)(2010-2#2)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#3)(2013-8#2)
of the complexation reaction##2##4##(2008-10#2)
of the complexation##6##3##(2006-11#1)(2008-10#5)
of the complexed##5##3##(1996-6#1)(2007-9#1)(2008-10#2)(2008-5#1)
of the complexes and##5##4##(1990-12#1)(1992-9#1)(2006-10#2)(2008-10#1)
of the complexes at##2##4##(1993-11#1)(2008-10#1)
of the complexes formed##4##4##(1991-11#1)(1996-2#1)(2008-10#1)(2008-3#1)
of the complexes is discussed##2##5##(1996-2#1)(2008-5#1)
of the complexes is##4##4##(1996-2#1)(2008-10#1)(2008-5#2)
of the complexes of the##2##5##(1996-9#1)(2008-3#1)
of the complexes of##9##4##(1996-8#1)(1996-9#1)(2005-11#1)(2007-11#1)(2008-10#4)(2008-3#1)
of the complexes was##6##4##(1993-4#1)(1994-8#2)(2007-11#1)(2008-10#1)(2010-12#1)
of the complexes were##2##4##(1994-5#1)(2006-10#1)
of the complexes with##2##4##(1991-2#1)(2008-5#1)
of the complexes##71##3##(1990-12#1)(1990-2#2)(1991-11#1)(1991-2#3)(1991-4#1)(1992-9#2)(1993-11#1)(1993-4#1)(1993-9#2)(1994-5#2)(1994-8#2)(1995-8#1)(1996-2#3)(1996-7#1)(1996-8#1)(1996-9#1)(2005-11#1)(2006-10#4)(2007-11#4)(2008-10#18)(2008-3#4)(2008-5#9)(2008-6#1)(2009-2#1)(2010-12#1)(2010-5#1)(2010-7#1)(2012-12#1)
of the complexing agent was##2##5##(2008-10#2)
of the complexing agent##5##4##(2008-10#5)
of the complexing##6##3##(1997-8#1)(2008-10#5)
of the complexities of##2##4##(2005-8#1)(2008-5#1)
of the complexities##3##3##(2005-8#1)(2008-4#1)(2008-5#1)
of the complexity associated with##2##5##(2007-4#1)(2008-8#1)
of the complexity of the##11##5##(1995-5#1)(1997-3#2)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-12#1)
of the complexity of##17##4##(1995-5#1)(1996-3#1)(1996-4#1)(1997-3#2)(2006-10#1)(2006-4#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2010-12#1)(2012-12#1)
of the complexity##19##3##(1995-5#1)(1996-3#1)(1996-4#1)(1997-3#2)(2006-10#1)(2006-4#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-12#1)
of the complicated##5##3##(2006-8#1)(2007-5#1)(2008-3#1)(2012-3#1)(2013-8#1)
of the complication##2##3##(1990-9#1)(2006-8#1)
of the complications and##2##4##(1997-3#1)(2008-6#1)
of the complications can be##2##5##(1992-5#1)(2007-11#1)
of the complications involved##2##4##(1996-12#1)(2006-2#1)
of the complications of the##2##5##(2006-2#1)(2007-11#1)
of the complications of##12##4##(2005-11#1)(2006-10#3)(2006-2#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-4#1)(2009-7#1)(2011-2#1)
of the complications##24##3##(1990-6#1)(1992-5#1)(1994-6#1)(1996-12#1)(1997-3#1)(2005-11#1)(2006-10#3)(2006-2#2)(2006-8#1)(2007-11#2)(2007-7#2)(2008-1#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-1#1)(2010-2#1)(2011-2#1)
of the component materials##2##4##(2008-3#2)
of the component of the##2##5##(2008-10#1)(2008-2#1)
of the component proteins##3##4##(1992-12#1)(1992-9#1)(2008-7#1)
of the component##20##3##(1991-12#1)(1992-12#1)(1992-9#1)(1993-5#1)(2006-10#1)(2008-10#4)(2008-2#1)(2008-3#5)(2008-7#1)(2010-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
of the components and##3##4##(2008-10#2)(2008-3#1)
of the components in##3##4##(2008-10#2)(2011-1#1)
of the components is##3##4##(1992-9#1)(1994-11#1)(2008-10#1)
of the components of the##13##5##(1991-12#1)(1991-2#1)(1991-4#1)(1996-12#1)(2007-12#2)(2007-3#1)(2008-10#4)(2008-3#1)(2009-10#1)
of the components of##21##4##(1991-12#1)(1991-2#1)(1991-4#1)(1993-1#1)(1995-5#1)(1996-12#1)(1996-2#1)(2006-12#1)(2007-12#2)(2007-3#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#1)
of the components was##2##4##(1993-6#1)(2008-10#1)
of the components##51##3##(1990-7#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-11#1)(1995-5#2)(1996-12#1)(1996-2#2)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#1)(2008-10#15)(2008-11#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-4#1)(2010-2#1)(2011-1#1)(2012-12#1)
of the composite cements##3##4##(2008-5#3)
of the composite film##2##4##(2008-3#1)(2010-4#1)
of the composite materials##2##4##(2008-10#1)(2009-7#1)
of the composite##23##3##(1994-3#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-3#2)(2008-5#7)(2009-2#1)(2009-6#1)(2009-7#3)(2010-4#1)
of the composites were##2##4##(2005-11#1)(2008-5#1)
of the composites##5##3##(2005-11#1)(2008-3#1)(2008-5#2)(2010-4#1)
of the composition of sialoliths##2##5##(2008-10#2)
of the composition of the##10##5##(1994-12#1)(2006-8#1)(2007-8#1)(2008-10#5)(2008-5#1)(2012-11#1)
of the composition of##20##4##(1994-12#1)(2006-8#1)(2007-8#1)(2008-10#10)(2008-2#2)(2008-5#1)(2009-11#1)(2009-7#1)(2012-11#1)(2013-8#1)
of the composition##24##3##(1990-5#1)(1994-12#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#12)(2008-2#2)(2008-5#1)(2009-11#1)(2009-7#1)(2012-11#1)(2013-8#1)
of the compositional##2##3##(1994-12#1)(2011-1#1)
of the compositions##3##3##(1991-4#1)(2008-10#1)(2008-5#1)
of the compost mix##2##4##(2008-10#2)
of the compost water extract##2##5##(2008-10#2)
of the compost##7##3##(2008-10#6)(2008-12#1)
of the compound action potential##2##5##(1990-2#1)(1992-3#1)
of the compound in##6##4##(1996-6#1)(2005-7#1)(2005-9#1)(2007-11#1)(2008-10#2)
of the compound on##2##4##(2008-4#1)(2008-5#1)
of the compound that##2##4##(1990-5#1)(2008-2#1)
of the compound to##2##4##(2008-10#2)
of the compound was##4##4##(2005-8#1)(2006-12#2)(2009-6#1)
of the compound##48##3##(1990-2#1)(1990-5#1)(1992-3#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-4#1)(1993-6#1)(1994-6#2)(1995-11#1)(1995-3#1)(1996-6#2)(1996-7#1)(2005-6#1)(2005-7#1)(2005-8#5)(2005-9#1)(2006-12#2)(2007-11#2)(2007-12#1)(2008-10#8)(2008-2#1)(2008-4#1)(2008-5#2)(2009-10#1)(2009-6#1)(2011-2#1)(2011-3#1)(2012-12#1)
of the compounds and the##3##5##(1996-6#1)(2007-1#1)(2012-12#1)
of the compounds and##4##4##(1996-6#1)(2007-1#1)(2008-10#1)(2012-12#1)
of the compounds are##3##4##(2008-10#1)(2008-5#1)(2009-8#1)
of the compounds at##4##4##(1996-10#1)(2007-3#1)(2008-10#1)(2011-3#1)
of the compounds could##2##4##(2008-10#1)(2010-12#1)
of the compounds from##2##4##(1993-2#1)(2008-10#1)
of the compounds in##3##4##(1996-6#1)(2008-10#1)(2010-12#1)
of the compounds is##2##4##(1996-2#1)(2008-10#1)
of the compounds most frequently##2##5##(2008-10#2)
of the compounds on##2##4##(1995-12#1)(2008-10#1)
of the compounds present##3##4##(2007-11#1)(2008-10#2)
of the compounds responsible for##2##5##(2008-10#1)(2012-11#1)
of the compounds studied##4##4##(1994-11#2)(1994-8#1)(2007-8#1)
of the compounds tested##5##4##(1990-7#1)(1992-11#1)(1993-11#1)(1993-6#1)(2008-3#1)
of the compounds to##2##4##(1992-8#1)(1996-8#1)
of the compounds using##2##4##(1997-3#1)(2008-10#1)
of the compounds was determined##2##5##(2008-10#1)(2008-5#1)
of the compounds was##9##4##(1993-11#1)(1995-2#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#2)
of the compounds were determined by##2##6##(2008-5#2)
of the compounds were determined##3##5##(2007-8#1)(2008-5#2)
of the compounds were found##2##5##(1995-3#1)(2005-9#1)
of the compounds were##11##4##(1993-2#1)(1995-3#1)(1996-8#1)(2005-9#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-5#2)(2012-11#1)
of the compounds##100##3##(1990-7#1)(1991-3#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#3)(1993-2#2)(1993-4#2)(1993-6#1)(1994-11#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-2#1)(1996-5#2)(1996-6#2)(1996-8#4)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(2004-12#1)(2005-11#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-2#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#24)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#8)(2009-3#1)(2009-8#1)(2010-12#4)(2010-5#1)(2011-3#1)(2012-11#2)(2012-12#1)
of the comprehension##2##3##(1997-3#1)(2013-7#1)
of the comprehensive##2##3##(2007-12#1)(2009-2#1)
of the compressed pulses##2##4##(2007-12#1)(2008-2#1)
of the compressed##5##3##(2007-12#1)(2008-1#1)(2008-2#3)
of the compression##7##3##(1996-1#1)(2007-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2013-8#1)
of the compressive##2##3##(2008-1#1)(2009-7#1)
of the computation##2##3##(2008-3#1)(2012-3#1)
of the computational##4##3##(1992-9#1)(2005-4#1)(2008-3#1)(2008-7#1)
of the computed##5##3##(2007-11#1)(2008-2#1)(2008-3#1)(2009-9#1)(2010-5#1)
of the computer program##2##4##(2008-10#1)(2008-7#1)
of the computer technology##2##4##(2006-11#1)(2010-8#1)
of the computer##12##3##(1991-9#1)(1992-12#1)(1993-9#1)(2006-11#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-7#1)(2010-5#2)(2010-8#1)(2013-8#1)
of the concentrate was##2##4##(2008-10#1)(2012-2#1)
of the concentrated##4##3##(2008-10#4)
of the concentration and##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
of the concentration dependence of the##2##6##(1994-8#1)(1995-6#1)
of the concentration dependence of##3##5##(1994-8#1)(1995-4#1)(1995-6#1)
of the concentration of free##2##5##(2005-11#1)(2008-1#1)
of the concentration of the##3##5##(1996-5#1)(2008-10#1)(2010-4#1)
of the concentration of##45##4##(1990-11#1)(1991-1#1)(1992-8#1)(1994-12#1)(1994-9#1)(1996-5#2)(1996-8#1)(1997-3#1)(1997-4#1)(2004-12#1)(2005-11#2)(2007-12#1)(2008-1#1)(2008-10#20)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2010-3#1)(2010-4#1)(2013-8#1)
of the concentration range##2##4##(2008-10#2)
of the concentration##62##3##(1990-11#1)(1991-1#1)(1991-7#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-4#1)(1995-6#1)(1996-5#2)(1996-8#1)(1997-3#1)(1997-4#1)(2004-12#1)(2005-11#2)(2006-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#25)(2008-11#2)(2008-2#1)(2008-3#7)(2008-4#1)(2009-2#1)(2010-3#1)(2010-4#1)(2013-8#1)
of the concentration-dependent##2##3##(1995-4#1)(2008-2#1)
of the concentration-response curve##3##4##(1990-12#1)(1996-12#2)
of the concentration-response##4##3##(1990-12#1)(1996-12#2)(2008-10#1)
of the concentrations of the##4##5##(1996-11#2)(1996-5#1)(1997-8#1)
of the concentrations of##12##4##(1994-11#1)(1996-11#2)(1996-5#1)(1997-1#1)(1997-6#1)(1997-8#1)(2006-10#1)(2008-10#2)(2009-7#1)(2010-12#1)
of the concentrations##15##3##(1994-11#1)(1996-11#2)(1996-5#1)(1997-1#1)(1997-6#1)(1997-8#1)(2006-10#1)(2008-10#4)(2009-7#1)(2010-12#1)(2013-7#1)
of the concentrator##3##3##(2007-8#1)(2008-3#2)
of the concept and##4##4##(1993-2#1)(2008-7#1)(2009-5#1)(2011-2#1)
of the concept in##2##4##(2008-3#1)(2012-12#1)
of the concept of &quot##2##5##(2009-10#1)(2012-2#1)
of the concept of continuity of care##2##7##(1993-1#1)(2008-2#1)
of the concept of the##2##5##(2005-11#1)(2008-12#1)
of the concept of##35##4##(1993-1#1)(1993-12#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-3#2)(2005-11#1)(2006-10#2)(2006-12#1)(2007-11#1)(2008-1#2)(2008-12#2)(2008-2#5)(2008-3#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-6#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
of the concept##54##3##(1990-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-3#2)(2005-11#1)(2006-10#3)(2006-12#1)(2006-4#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-12#2)(2008-2#5)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#2)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
of the concepts of##2##4##(2007-12#1)(2007-5#1)
of the concepts##5##3##(2006-8#1)(2007-12#1)(2007-5#1)(2008-9#1)(2010-9#1)
of the conceptual##2##3##(1997-6#1)(2011-1#1)
of the concerns##3##3##(1994-2#1)(2006-10#1)(2006-5#1)
of the conclusions were##2##4##(1993-6#1)(2013-7#1)
of the conclusions##9##3##(1993-6#1)(1993-9#1)(1995-11#1)(1996-12#1)(2007-8#1)(2008-10#1)(2010-6#1)(2012-12#1)(2013-7#1)
of the concomitant##2##3##(2008-10#1)(2011-2#1)
of the concrements##2##3##(1992-5#1)(2008-10#1)
of the concurrent##3##3##(1992-5#1)(1992-8#1)(1994-11#1)
of the condensation products##2##4##(2007-11#1)(2010-12#1)
of the condensation##3##3##(2007-11#1)(2008-10#1)(2010-12#1)
of the condensed tannin##2##4##(2008-10#2)
of the condensed##4##3##(1990-2#1)(2005-11#1)(2008-10#2)
of the condenser##2##3##(2008-3#1)(2010-6#1)
of the condition and##3##4##(1992-4#1)(1992-5#1)(2012-2#1)
of the condition of##2##4##(1992-4#1)(2007-9#1)
of the condition##47##3##(1990-3#1)(1990-9#1)(1991-2#1)(1991-4#1)(1992-4#2)(1992-5#1)(1993-1#2)(1994-4#1)(1996-3#1)(2004-10#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-4#1)(2006-6#1)(2006-7#2)(2007-11#1)(2007-3#1)(2007-6#2)(2007-7#3)(2007-9#1)(2008-10#1)(2008-11#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
of the conditional##5##3##(1992-2#1)(1993-6#1)(1996-4#1)(2008-10#2)
of the conditioned##4##3##(1990-2#2)(1993-5#1)(1993-9#1)
of the conditions for##3##4##(2007-3#1)(2008-10#2)
of the conditions in##2##4##(2008-9#1)(2009-4#1)
of the conditions of##2##4##(2008-10#1)(2013-1#1)
of the conditions##13##3##(2007-2#1)(2007-3#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-4#1)(2010-3#1)(2013-1#1)
of the condom##4##3##(1992-2#1)(2007-7#3)
of the conducting airways##2##4##(1991-12#1)(2013-1#1)
of the conducting##4##3##(1991-12#1)(2008-10#1)(2013-1#2)
of the conduction electrons##2##4##(2007-12#1)(2008-7#1)
of the conduction##3##3##(1992-1#1)(2007-12#1)(2008-7#1)
of the conduit from##2##4##(2007-8#1)(2007-9#1)
of the condylar process of the mandible##2##7##(2007-7#2)
of the condylar process##6##4##(2007-7#5)(2012-12#1)
of the condylar##8##3##(2007-7#5)(2012-12#3)
of the cone ERG##3##4##(2006-8#3)
of the cone##6##3##(1991-1#1)(1992-3#1)(2006-8#4)
of the conference were##2##4##(2005-7#1)(2010-4#1)
of the conference##16##3##(1993-12#1)(1994-3#1)(2005-7#2)(2005-8#2)(2007-7#1)(2008-12#2)(2008-3#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-2#1)
of the confidence interval for the##2##6##(1996-1#2)
of the confidence interval for##3##5##(1996-1#2)(2008-10#1)
of the confidence interval##4##4##(1996-1#2)(1997-6#1)(2008-10#1)
of the configuration of the##3##5##(2006-12#1)(2008-11#1)(2008-2#1)
of the configuration space##3##4##(2008-4#2)(2012-2#1)
of the configuration##13##3##(1996-2#1)(2005-4#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#2)(2010-7#1)(2012-2#1)
of the confined-reference coherence-encoding method for##2##6##(2008-2#2)
of the confinement##2##3##(1991-3#2)
of the confining##2##3##(1991-3#1)(2011-1#1)
of the conflict##5##3##(2004-7#1)(2008-2#1)(2010-5#1)(2011-1#1)(2012-12#1)
of the conflicting##4##3##(1995-1#1)(2006-2#1)(2007-5#1)(2008-9#1)
of the conflicts##3##3##(2008-8#1)(2008-9#1)(2013-1#1)
of the confocal##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
of the conformation and##2##4##(1992-12#1)(1995-3#1)
of the conformation of##4##4##(1992-8#1)(1995-1#2)(2011-2#1)
of the conformation##10##3##(1992-12#1)(1992-5#1)(1992-8#1)(1992-9#1)(1995-1#2)(1995-3#1)(1995-8#1)(2005-4#1)(2011-2#1)
of the conformational change of##2##5##(1993-3#1)(2005-4#1)
of the conformational change##3##4##(1993-3#1)(2005-4#1)(2009-5#1)
of the conformational changes##2##4##(1992-6#1)(2008-4#1)
of the conformational diseases##2##4##(2006-9#2)
of the conformational##13##3##(1991-9#1)(1992-6#1)(1993-11#1)(1993-3#1)(1995-1#1)(1996-8#1)(1997-6#1)(2005-4#1)(2006-9#2)(2008-4#1)(2009-5#1)(2010-7#1)
of the conformationally##2##3##(1990-12#1)(1992-1#1)
of the conformations of the##3##5##(1993-3#1)(1993-4#1)(1994-11#1)
of the conformations of##5##4##(1991-4#1)(1993-3#1)(1993-4#1)(1994-11#1)(2008-8#1)
of the confounding factors##2##4##(2008-7#1)(2011-1#1)
of the confusion##4##3##(2006-1#1)(2006-10#1)(2011-1#1)(2013-1#1)
of the congenital##3##3##(2005-11#1)(2006-3#1)(2007-11#1)
of the congress##2##3##(2005-8#1)(2007-9#1)
of the congruence##2##3##(2007-8#1)(2010-12#1)
of the conical##5##3##(2006-4#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-2#1)
of the conically sculpted##2##4##(1995-2#2)
of the conidia##4##3##(2008-10#4)
of the conjugate beam##2##4##(2007-12#1)(2008-2#1)
of the conjugate was##2##4##(1996-1#1)(2008-10#1)
of the conjugate##12##3##(1993-11#1)(1993-3#1)(1994-11#1)(1996-1#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-4#1)(2013-8#1)
of the conjugated##4##3##(1991-5#1)(1992-3#1)(1995-1#1)(2008-10#1)
of the conjugates were##2##4##(1997-8#1)(2012-12#1)
of the conjugates##6##3##(1991-3#1)(1992-11#1)(1993-3#1)(1997-8#1)(2008-10#1)(2012-12#1)
of the conjunctiva##11##3##(1990-5#2)(2006-11#2)(2007-8#1)(2008-11#1)(2009-8#4)(2011-1#1)
of the connected##2##3##(2007-11#1)(2010-8#1)
of the connecting peptide##3##4##(2008-9#3)
of the connection domain##2##4##(1997-1#2)
of the connection##3##3##(1997-1#2)(2012-2#1)
of the connections between##2##4##(2006-5#1)(2008-11#1)
of the connections##3##3##(1996-9#1)(2006-5#1)(2008-11#1)
of the connective tissue##10##4##(2007-7#1)(2007-8#1)(2008-5#1)(2009-2#2)(2012-1#1)(2012-2#1)(2013-1#3)
of the connective##11##3##(1990-2#1)(2007-7#1)(2007-8#1)(2008-5#1)(2009-2#2)(2012-1#1)(2012-2#1)(2013-1#3)
of the connectivity index##2##4##(2007-11#2)
of the connectivity##4##3##(2007-11#2)(2008-2#2)
of the conscious##4##3##(1993-4#1)(1995-1#1)(1996-9#1)(1997-8#1)
of the consensus sequence##4##4##(1992-4#1)(1993-8#1)(1994-12#1)(1995-7#1)
of the consensus values##2##4##(2008-10#2)
of the consensus##17##3##(1992-4#1)(1992-6#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-7#1)(2007-4#1)(2008-10#5)(2011-2#1)
of the consequences of such##2##5##(1996-12#1)(2011-2#1)
of the consequences of the##2##5##(2007-6#1)(2008-11#1)
of the consequences of##12##4##(1993-10#1)(1995-12#1)(1996-12#1)(2007-6#1)(2007-9#1)(2008-11#1)(2008-2#2)(2009-7#1)(2011-2#2)(2012-3#1)
of the consequences##13##3##(1990-4#1)(1993-10#1)(1995-12#1)(1996-12#1)(2007-6#1)(2007-9#1)(2008-11#1)(2008-2#2)(2009-7#1)(2011-2#2)(2012-3#1)
of the conservation of##2##4##(1995-3#1)(2008-12#1)
of the conservative##3##3##(1997-8#1)(2007-11#1)(2008-8#1)
of the conserved motifs of the##2##6##(2008-10#1)(2011-1#1)
of the conserved residues##2##4##(1993-6#1)(1994-8#1)
of the conserved##21##3##(1990-12#1)(1990-5#1)(1991-4#1)(1993-6#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-2#2)(1997-7#2)(2008-10#1)(2008-2#1)(2008-6#1)(2009-3#1)(2009-5#1)(2011-1#1)
of the considerable##3##3##(2004-2#1)(2006-5#1)(2006-8#1)
of the considered##3##3##(1994-3#1)(2008-10#2)
of the constant region##2##4##(1991-4#1)(1992-7#1)
of the constant##6##3##(1991-4#1)(1992-7#1)(1994-9#1)(1997-6#1)(2006-4#1)(2008-3#1)
of the constituent components##2##4##(2007-8#1)(2012-2#1)
of the constituent layers##2##4##(2008-10#1)(2012-2#1)
of the constituent##11##3##(1990-7#1)(1992-9#1)(1996-5#1)(1997-7#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2012-2#3)
of the constituents and##2##4##(2010-2#1)(2011-3#1)
of the constituents of the flower of Trollius ledibouri Reichb##2##10##(2007-8#2)
of the constituents of the##3##5##(2007-8#2)(2008-10#1)
of the constituents of##6##4##(1993-7#1)(2007-8#2)(2008-10#1)(2008-5#1)(2010-3#1)
of the constituents##17##3##(1993-7#1)(2006-12#1)(2007-1#1)(2007-8#6)(2008-10#1)(2008-11#1)(2008-5#1)(2009-7#2)(2010-2#1)(2010-3#1)(2011-3#1)
of the constitution##2##3##(2009-7#1)(2011-2#1)
of the constitutional##2##3##(1996-9#1)(2011-2#1)
of the constitutive expression##2##4##(1995-5#1)(2009-3#1)
of the constitutive law parameters##2##5##(1996-4#2)
of the constitutive##12##3##(1990-10#1)(1995-11#1)(1995-5#1)(1996-4#3)(2005-11#1)(2006-11#1)(2008-1#1)(2009-3#1)(2012-1#1)(2013-1#1)
of the constitutively expressed##2##4##(1995-3#1)(2009-8#1)
of the constraining##2##3##(2008-8#1)(2012-1#1)
of the constraints##3##3##(2007-10#1)(2008-9#1)(2012-12#1)
of the construct of##2##4##(2012-12#1)(2013-1#1)
of the construct##7##3##(1992-12#2)(2004-3#1)(2007-12#1)(2008-10#1)(2012-12#1)(2013-1#1)
of the construction and##2##4##(1990-8#1)(2009-10#1)
of the construction of##3##4##(1993-3#1)(2008-10#1)(2008-3#1)
of the construction##7##3##(1990-8#1)(1993-3#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#1)
of the constructs##5##3##(1993-3#1)(1995-10#1)(2008-8#2)(2011-2#1)
of the consultant##2##3##(1996-2#1)(2012-3#1)
of the consultation##4##3##(1992-3#1)(1994-4#1)(2008-10#1)(2011-2#1)
of the consultations##2##3##(1994-6#1)(1997-6#1)
of the consumer##7##3##(1994-2#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)
of the consumers##2##3##(2008-8#1)(2010-8#1)
of the consumption of##6##4##(2005-10#1)(2008-10#1)(2008-4#1)(2012-12#1)(2012-2#2)
of the consumption##7##3##(2005-10#1)(2008-10#1)(2008-4#1)(2012-12#1)(2012-2#2)(2013-1#1)
of the contact angle##6##4##(2005-11#3)(2008-5#1)(2009-11#1)(2013-1#1)
of the contact area##2##4##(1990-10#1)(2013-1#1)
of the contact surface##2##4##(2008-10#2)
of the contact system##3##4##(1990-11#2)(1995-5#1)
of the contact##23##3##(1990-10#1)(1990-11#2)(1993-1#1)(1993-9#1)(1994-12#1)(1995-2#1)(1995-5#1)(2005-11#3)(2007-6#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)(2013-1#3)
of the contacts##2##3##(1993-9#1)(2008-7#1)
of the containers##2##3##(1993-10#1)(2007-5#1)
of the contaminant's##2##3##(2008-3#2)
of the contaminants##2##3##(2004-4#1)(2008-10#1)
of the contaminating bacterial##2##4##(1991-8#1)(2005-10#1)
of the contaminating##3##3##(1991-8#1)(1997-3#1)(2005-10#1)
of the contamination##3##3##(1996-12#1)(2006-8#1)(2008-10#1)
of the contemporary literature##2##4##(2007-12#1)(2011-2#1)
of the contemporary##11##3##(1990-11#1)(1996-1#1)(2006-6#1)(2007-12#2)(2008-7#1)(2011-1#1)(2011-2#3)(2012-2#1)
of the content of aminopyrine in##2##6##(2005-4#2)
of the content of these##2##5##(2008-7#1)(2009-10#1)
of the content of##13##4##(1991-6#1)(2005-10#1)(2005-4#2)(2008-10#2)(2008-2#2)(2008-7#1)(2009-10#1)(2010-12#1)(2011-3#1)(2012-2#1)
of the content##19##3##(1991-6#1)(2005-10#1)(2005-4#2)(2008-10#2)(2008-2#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-3#1)(2012-2#1)(2013-1#4)(2013-8#1)
of the contents of the##3##5##(2006-12#1)(2008-9#1)(2011-7#1)
of the contents of##7##4##(2006-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-7#1)(2011-7#1)(2012-12#1)
of the context in which##2##5##(2008-2#1)(2009-6#1)
of the context##3##3##(2008-2#1)(2008-7#1)(2009-6#1)
of the contigs##2##3##(1995-6#1)(2008-7#1)
of the continent##4##3##(1994-3#1)(2008-10#1)(2008-12#1)(2008-8#1)
of the continental##2##3##(1995-6#1)(2007-5#1)
of the continuation of##2##4##(2008-4#1)(2011-2#1)
of the continued##2##3##(1992-6#1)(1996-2#1)
of the continuing##2##3##(1994-12#1)(2007-11#1)
of the continuous wavelet transform##2##5##(2007-12#1)(2008-2#1)
of the continuous##17##3##(1993-3#1)(1996-12#1)(2005-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2012-11#1)(2013-1#1)(2013-7#1)
of the continuously##2##3##(2008-10#1)(2013-1#1)
of the continuum##6##3##(1994-12#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
of the contour points is##2##5##(2008-2#2)
of the contour##6##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2012-12#1)
of the contract##5##3##(1993-12#1)(1994-2#1)(1996-12#1)(2007-4#2)
of the contracted##2##3##(2006-10#1)(2013-1#1)
of the contractile activity of##2##5##(1992-2#1)(2006-6#1)
of the contractile##10##3##(1990-5#2)(1991-5#1)(1991-9#1)(1992-2#1)(1993-11#1)(1996-12#1)(2006-6#1)(2009-3#1)(2010-2#1)
of the contraction##3##3##(2006-10#2)(2013-8#1)
of the contractions##4##3##(1992-1#1)(2006-7#2)(2008-3#1)
of the contralateral side##2##4##(2008-8#2)
of the contralateral##27##3##(1990-12#1)(1990-4#1)(1990-9#1)(1991-5#2)(1991-9#1)(1993-12#1)(1993-3#2)(1994-2#1)(1995-11#3)(1996-1#1)(1996-12#1)(1996-3#1)(1997-3#1)(2004-10#1)(2006-11#1)(2006-7#1)(2007-10#1)(2008-2#1)(2008-8#2)(2008-9#1)(2010-12#1)(2012-1#1)
of the contrast material##2##4##(2008-7#2)
of the contrast of##2##4##(2007-12#1)(2008-3#1)
of the contrast##15##3##(1992-7#1)(2006-4#1)(2007-12#1)(2008-3#3)(2008-6#2)(2008-7#5)(2011-1#1)(2011-2#1)
of the contribution from##3##4##(1992-5#1)(2008-3#2)
of the contribution of the##6##5##(1991-4#1)(1994-11#1)(2006-11#1)(2008-12#1)(2008-3#1)(2009-3#1)
of the contribution of##19##4##(1991-4#1)(1992-5#1)(1993-1#1)(1994-11#1)(1995-5#1)(2006-11#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2009-3#1)(2009-4#1)(2010-8#1)(2011-1#2)(2013-7#1)
of the contribution##25##3##(1991-12#1)(1991-4#2)(1992-5#2)(1993-1#1)(1994-11#1)(1995-5#1)(2006-11#1)(2006-7#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#1)(2009-3#1)(2009-4#1)(2010-8#1)(2011-1#2)(2013-7#1)
of the contributions of##3##4##(1992-11#1)(2008-10#1)(2008-4#1)
of the contributions##7##3##(1992-11#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2012-1#1)
of the control and##4##4##(2005-11#1)(2007-11#1)(2008-5#1)(2008-7#1)
of the control by##2##4##(1996-12#1)(1997-2#1)
of the control coefficients##3##4##(1990-7#2)(2008-2#1)
of the control diet##2##4##(1993-12#1)(2012-2#1)
of the control group (P &lt##2##6##(1994-3#1)(2012-3#1)
of the control group was##3##5##(1996-11#1)(2007-10#1)(2008-8#1)
of the control group with##2##5##(2007-2#1)(2011-1#1)
of the control group##37##4##(1990-9#1)(1993-12#1)(1994-3#1)(1994-5#1)(1995-11#1)(1996-11#2)(1996-7#1)(1997-2#2)(1997-6#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-4#2)(2008-8#1)(2008-9#4)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
of the control groups in both studies##2##7##(2008-9#2)
of the control groups##13##4##(2008-5#2)(2008-8#1)(2008-9#10)
of the control knees and##2##5##(2008-8#2)
of the control level##6##4##(1992-1#1)(1992-5#2)(1994-12#2)(2013-8#1)
of the control of the##3##5##(1994-12#1)(2006-11#1)(2010-8#1)
of the control of##9##4##(1994-12#1)(1994-5#1)(2004-12#1)(2006-11#1)(2007-8#2)(2008-7#1)(2010-8#1)(2011-1#1)
of the control rats##4##4##(1991-5#1)(1993-11#1)(1995-12#1)(1997-2#1)
of the control subjects##2##4##(2008-1#2)
of the control value##8##4##(1990-11#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-6#1)(1992-6#1)(1992-8#1)(1997-8#1)
of the control values##2##4##(1995-11#1)(1996-5#1)
of the control voltage##2##4##(2007-12#2)
of the control##162##3##(1990-11#2)(1990-12#2)(1990-3#1)(1990-5#1)(1990-7#4)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-5#2)(1992-6#1)(1992-8#3)(1993-11#2)(1993-12#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#2)(1995-12#1)(1996-1#1)(1996-11#2)(1996-12#3)(1996-5#1)(1996-7#1)(1997-2#6)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#5)(2008-8#6)(2008-9#16)(2010-2#2)(2010-3#1)(2010-8#1)(2011-1#2)(2011-12#3)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#5)
of the control's##2##3##(1990-1#1)(2004-9#1)
of the controller##3##3##(2008-10#1)(2008-5#1)(2012-1#1)
of the controlling##2##3##(2007-11#1)(2008-10#1)
of the controls and EAMG were##2##6##(1992-8#2)
of the controls and##4##4##(1992-8#2)(1994-2#1)(2008-5#1)
of the controls for##3##4##(2008-10#1)(2008-9#1)(2011-2#1)
of the controls##37##3##(1990-2#2)(1990-5#1)(1992-8#3)(1992-9#1)(1994-2#2)(1996-11#1)(1996-12#1)(1997-8#1)(2005-1#1)(2006-1#1)(2006-10#2)(2007-7#1)(2007-9#2)(2008-10#2)(2008-5#1)(2008-8#4)(2008-9#6)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
of the controversies##2##3##(2008-8#1)(2012-2#1)
of the controversy##4##3##(1993-6#1)(1993-9#1)(2006-10#1)(2007-4#1)
of the conus medullaris##2##4##(1990-6#1)(2008-7#1)
of the conus##3##3##(1990-6#1)(2008-7#1)(2012-2#1)
of the convective##2##3##(2008-3#2)
of the conventional method##5##4##(1990-8#1)(2007-6#1)(2008-12#2)(2008-8#1)
of the conventional##51##3##(1990-8#2)(1991-6#1)(1992-12#1)(1994-8#1)(1995-1#1)(1996-6#1)(2005-10#1)(2005-9#1)(2007-12#5)(2007-5#1)(2007-6#2)(2008-1#1)(2008-10#6)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#3)(2008-8#2)(2009-3#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
of the convergence##2##3##(2008-3#1)(2009-3#1)
of the convergent neurones but##2##5##(1991-8#2)
of the convergent##3##3##(1991-8#2)(2004-10#1)
of the conversion of##9##4##(1995-3#1)(2005-12#2)(2008-10#1)(2008-8#2)(2010-5#1)(2012-11#2)
of the conversion##11##3##(1995-3#1)(2005-12#2)(2006-4#1)(2008-10#1)(2008-2#1)(2008-8#2)(2010-5#1)(2012-11#2)
of the converters##3##3##(2007-2#3)
of the convex##4##3##(2007-8#1)(2008-2#2)(2008-6#1)
of the convolution##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
of the cooperation##2##3##(1990-4#1)(2008-2#1)
of the cooperative##4##3##(1991-7#1)(2007-12#1)(2010-12#1)(2013-1#1)
of the cooperativity##2##3##(1990-5#1)(1997-7#1)
of the coordinate##2##3##(2008-10#1)(2010-7#1)
of the coordinated##4##3##(1994-5#1)(2008-3#1)(2009-8#2)
of the coordinating##2##3##(1996-8#1)(1997-7#1)
of the coordination complex##3##4##(1992-9#1)(2008-10#1)(2010-12#1)
of the coordination sphere of the##2##6##(1996-7#1)(2010-5#1)
of the coordination##9##3##(1992-9#1)(1996-7#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)(2010-5#1)(2011-1#1)
of the copolymer##5##3##(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)
of the copolymers##3##3##(2005-11#1)(2008-10#1)(2011-2#1)
of the copper ions##2##4##(1990-7#1)(2008-9#1)
of the copper oxide##2##4##(2008-10#2)
of the copper oxides##2##4##(2006-7#2)
of the copper##11##3##(1990-7#1)(1992-2#1)(1994-9#2)(2006-7#2)(2008-10#4)(2008-9#1)
of the copper(II)##2##3##(2008-10#2)
of the coracoid##4##3##(2013-1#4)
of the coral colonies##2##4##(2008-5#1)(2011-2#1)
of the coral##6##3##(2007-3#1)(2007-5#3)(2008-5#1)(2011-2#1)
of the coralyne-poly(dA) interaction##2##4##(2010-5#2)
of the cord##7##3##(2006-8#1)(2008-3#1)(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#2)
of the core and the##2##5##(2008-3#2)
of the core functionalities##2##4##(2007-12#2)
of the core histones##2##4##(1991-2#1)(1992-9#1)
of the core material##3##4##(2007-11#1)(2009-8#2)
of the core protein##2##4##(1992-11#1)(1992-5#1)
of the core region##2##4##(1991-2#1)(1996-2#1)
of the core##44##3##(1990-4#1)(1991-2#2)(1991-9#1)(1992-11#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-5#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-2#2)(1996-4#3)(1997-3#1)(2006-12#1)(2007-11#2)(2007-12#5)(2007-4#1)(2007-9#1)(2008-10#1)(2008-12#2)(2008-3#2)(2008-7#1)(2009-8#3)(2010-1#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
of the core-histone genes##2##4##(1990-5#2)
of the core-shell##2##3##(2005-11#1)(2009-9#1)
of the cores##2##3##(2007-11#1)(2007-12#1)
of the corn##4##3##(1990-7#1)(1995-2#1)(2008-6#1)(2008-8#1)
of the cornea and the##3##5##(2007-12#2)(2007-9#1)
of the cornea and##6##4##(2006-11#1)(2007-12#2)(2007-9#1)(2008-2#1)(2011-2#1)
of the cornea by##2##4##(2007-12#1)(2008-11#1)
of the cornea in##2##4##(2007-9#1)(2013-1#1)
of the cornea##30##3##(2005-11#1)(2006-11#3)(2006-7#3)(2007-12#4)(2007-2#1)(2007-9#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#2)(2009-7#1)(2011-2#1)(2011-7#1)(2013-1#2)(2013-7#1)
of the corneal epithelium##2##4##(2005-11#1)(2008-4#1)
of the corneal##6##3##(1993-12#1)(2005-11#1)(2008-3#1)(2008-4#1)(2009-7#1)(2011-2#1)
of the corneocyte##3##3##(2008-5#3)
of the coronal##2##3##(2007-2#1)(2012-12#1)
of the coronary arteries and##2##5##(2005-10#1)(2008-3#1)
of the coronary arteries in##2##5##(2012-3#2)
of the coronary arteries##12##4##(2005-10#2)(2007-8#1)(2008-10#1)(2008-3#1)(2009-12#1)(2009-5#1)(2011-2#1)(2012-3#4)
of the coronary artery##3##4##(2006-6#1)(2008-12#1)(2013-2#1)
of the coronary sinus##3##4##(2007-8#1)(2009-3#1)(2012-2#1)
of the coronary syndromes]##2##4##(2008-10#2)
of the coronary##32##3##(1990-6#1)(1993-11#1)(1994-11#1)(1995-3#1)(1997-6#1)(2005-10#2)(2006-6#1)(2007-8#4)(2008-10#4)(2008-12#1)(2008-3#2)(2008-5#2)(2009-12#1)(2009-3#1)(2009-5#1)(2011-2#2)(2012-2#1)(2012-3#4)(2013-2#1)
of the corpora cavernosa and##2##5##(2008-10#2)
of the corpora cavernosa##4##4##(2008-10#3)(2011-2#1)
of the corpus callosum (CC)##3##5##(1992-9#1)(2008-7#1)(2010-12#1)
of the corpus callosum is##2##5##(1996-5#1)(2008-7#1)
of the corpus callosum##21##4##(1992-9#1)(1993-7#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-3#1)(2006-5#1)(2007-10#2)(2008-6#1)(2008-7#2)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-7#1)
of the corpus spongiosum##3##4##(2009-5#1)(2013-1#2)
of the corpus vertebrae##2##4##(2007-11#2)
of the corpus##30##3##(1992-9#1)(1993-7#2)(1995-11#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-3#1)(2006-5#2)(2007-10#2)(2007-11#3)(2008-6#1)(2008-7#2)(2009-5#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#2)(2013-7#1)
of the correct diagnosis##2##4##(1993-5#1)(2006-11#1)
of the correct##13##3##(1993-4#1)(1993-5#1)(2006-11#1)(2006-2#1)(2006-6#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2011-2#1)(2012-3#1)
of the correction##5##3##(2008-2#3)(2009-4#1)(2013-8#1)
of the correlation between the##5##5##(1995-6#1)(2008-10#1)(2008-2#2)(2008-6#1)
of the correlation between##9##4##(1992-4#1)(1994-2#1)(1995-6#1)(1995-9#1)(2008-10#2)(2008-2#2)(2008-6#1)
of the correlation coefficients##2##4##(2008-10#2)
of the correlation function##4##4##(2008-3#4)
of the correlation of##3##4##(1995-2#1)(2008-1#1)(2010-7#1)
of the correlation time of##3##5##(2008-10#2)(2008-3#1)
of the correlation time##4##4##(2008-10#2)(2008-3#2)
of the correlation##29##3##(1991-2#1)(1992-4#1)(1994-2#1)(1995-2#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-12#1)(2008-1#1)(2008-10#6)(2008-2#4)(2008-3#8)(2008-6#1)(2010-7#1)
of the correlations##4##3##(1997-3#1)(2008-6#1)(2009-11#1)(2013-8#1)
of the correlator and##2##4##(2008-3#2)
of the correlator##6##3##(2007-12#1)(2008-2#1)(2008-3#4)
of the correlogram##2##3##(1996-4#1)(2008-3#1)
of the correspondence##2##3##(2008-12#1)(2011-1#1)
of the corresponding cDNA##2##4##(1995-6#1)(1996-5#1)
of the corresponding gene in##3##5##(1997-2#1)(2010-12#1)(2011-1#1)
of the corresponding gene##10##4##(1990-11#1)(1993-11#1)(1993-2#1)(1995-8#1)(1997-2#2)(1997-6#1)(2010-12#1)(2011-1#1)(2013-1#1)
of the corresponding genes##11##4##(1993-6#1)(1994-12#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-4#1)(1997-6#1)(2006-12#1)(2008-10#1)(2009-8#1)(2013-1#1)
of the corresponding mRNA##2##4##(1996-7#1)(2011-2#1)
of the corresponding part of the##2##6##(1993-6#1)(2009-10#1)
of the corresponding part##3##4##(1993-6#1)(2005-10#1)(2009-10#1)
of the corresponding polypeptide##2##4##(1995-6#1)(1996-3#1)
of the corresponding protein##2##4##(1994-5#1)(2008-8#1)
of the corresponding proteins##4##4##(1997-3#1)(2008-10#1)(2009-8#1)(2011-2#1)
of the corresponding residues##2##4##(1990-10#1)(1996-9#1)
of the corresponding sense##2##4##(1993-5#1)(2008-7#1)
of the corresponding##159##3##(1990-10#1)(1990-11#2)(1990-3#2)(1990-4#2)(1990-5#3)(1990-9#1)(1991-12#1)(1991-2#2)(1991-6#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#3)(1993-2#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#3)(1995-4#1)(1995-6#3)(1995-8#5)(1996-10#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#3)(1996-9#1)(1997-2#4)(1997-3#2)(1997-6#2)(1997-7#1)(1997-8#1)(2005-10#1)(2005-4#1)(2006-12#4)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#15)(2007-5#1)(2008-10#19)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#3)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-12#1)(2010-2#1)(2010-5#2)(2010-6#1)(2011-1#2)(2011-2#2)(2012-11#1)(2013-1#2)
of the corrosion##2##3##(2007-11#1)(2007-12#1)
of the corrugated##2##3##(2008-3#2)
of the cortex and##3##4##(1992-12#1)(1993-2#1)(1997-8#1)
of the cortex##23##3##(1990-12#1)(1990-7#1)(1990-9#1)(1992-12#1)(1992-8#1)(1993-2#1)(1993-7#1)(1995-6#1)(1996-12#1)(1996-9#2)(1997-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-7#3)(2011-12#1)
of the cortical regions##3##4##(1994-12#2)(1996-5#1)
of the cortical##20##3##(1994-12#2)(1994-3#2)(1996-10#1)(1996-5#1)(1996-6#1)(1997-8#1)(2004-9#1)(2006-5#1)(2007-12#2)(2008-11#2)(2008-5#1)(2008-7#1)(2010-7#3)(2012-2#1)
of the corticotropin-releasing factor##2##4##(1995-1#1)(1997-5#1)
of the corticotropin-releasing##3##3##(1995-1#1)(1995-12#1)(1997-5#1)
of the cortistatin##3##3##(2009-11#3)
of the cos##2##3##(1990-11#1)(1996-2#1)
of the cosmetic##5##3##(2007-12#1)(2008-5#2)(2010-8#2)
of the cosolvent##3##3##(1990-2#2)(2008-7#1)
of the cost function##2##4##(2008-2#2)
of the cost of##8##4##(1995-2#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
of the cost##15##3##(1990-12#1)(1995-1#1)(1995-2#1)(2008-11#1)(2008-2#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#2)(2012-2#1)(2013-1#1)
of the costs and##5##4##(1993-12#1)(2004-1#1)(2008-10#1)(2010-8#1)(2010-9#1)
of the costs of##7##4##(1995-2#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-2#1)(2012-1#1)
of the costs##12##3##(1993-12#1)(1995-2#1)(1997-8#1)(2004-1#1)(2007-8#1)(2008-10#2)(2008-7#1)(2009-2#1)(2010-8#1)(2010-9#1)(2012-1#1)
of the cotton##6##3##(2006-11#1)(2009-3#1)(2010-3#1)(2011-1#1)(2011-12#1)(2013-8#1)
of the cotyledons##2##3##(1990-10#1)(2008-10#1)
of the couch in psychoanalysis##2##5##(2011-2#2)
of the couch##3##3##(2011-2#3)
of the cough##2##3##(1993-11#1)(1994-10#1)
of the counter ion##2##4##(2008-10#2)
of the counterion##5##3##(1994-9#1)(2005-11#4)
of the counterpart##3##3##(1993-8#1)(1994-11#1)(2008-9#1)
of the countries included##2##4##(1990-4#1)(2012-11#1)
of the countries##7##3##(1990-12#1)(1990-4#1)(2007-11#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-11#1)
of the country to##2##4##(1996-12#1)(2012-3#1)
of the country were##2##4##(2008-12#1)(2012-12#1)
of the country with##2##4##(2007-9#1)(2013-1#1)
of the country##49##3##(1991-5#2)(1993-12#1)(1994-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-6#1)(2004-4#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#2)(2010-12#1)(2010-9#2)(2011-1#1)(2011-11#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#2)
of the country's##4##3##(2006-4#1)(2006-7#1)(2007-5#1)(2008-11#1)
of the country]##2##3##(2009-5#1)(2013-1#1)
of the counts##2##3##(1990-2#1)(1996-3#1)
of the couple##3##3##(1993-2#1)(1996-9#1)(2007-7#1)
of the coupled system##2##4##(2007-12#1)(2008-10#1)
of the coupled##11##3##(1993-3#1)(1996-1#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-12#1)
of the coupled-dipole approximation##2##4##(2008-1#2)
of the coupler##7##3##(2007-12#2)(2008-2#3)(2008-3#2)
of the couples##4##3##(1996-9#2)(2012-11#1)(2013-8#1)
of the coupling between##3##4##(1991-1#1)(1991-7#1)(2008-3#1)
of the coupling efficiency##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
of the coupling products##2##4##(2008-10#1)(2009-11#1)
of the coupling##19##3##(1991-1#1)(1991-7#1)(1995-11#1)(2005-10#1)(2007-12#5)(2008-10#1)(2008-2#4)(2008-3#3)(2008-4#1)(2009-11#1)
of the course and##2##4##(1995-5#1)(2008-11#1)
of the course is to present colposcopic cases that are unusual or instructive in terms of appearance##8##17##(2006-10#8)
of the course of pregnancy and labor##2##7##(2012-3#2)
of the course of the##2##5##(1994-5#1)(2007-12#1)
of the course of##12##4##(1992-5#1)(1994-5#1)(2005-10#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-1#1)(2011-2#1)(2012-3#2)
of the course##40##3##(1991-7#1)(1992-5#1)(1994-5#1)(1995-5#1)(2005-10#1)(2006-10#8)(2006-8#1)(2007-10#1)(2007-12#2)(2007-2#3)(2007-7#1)(2008-1#1)(2008-11#8)(2008-12#2)(2008-5#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-8#2)
of the courses##2##3##(2007-8#1)(2013-1#1)
of the courts##4##3##(1992-12#1)(1992-3#1)(2005-8#1)(2005-9#1)
of the covalent##2##3##(2010-12#1)(2013-1#1)
of the covalently attached##5##4##(1991-7#1)(1995-1#1)(1995-6#1)(1996-7#2)
of the covalently immobilized##2##4##(1995-5#1)(2010-4#1)
of the covalently##10##3##(1990-10#1)(1991-7#1)(1995-1#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-7#2)(1997-6#1)(2010-4#1)
of the covariance matrix of the##2##6##(1992-6#1)(2008-2#1)
of the covariance matrix##3##4##(1992-6#1)(1997-3#1)(2008-2#1)
of the covariance##6##3##(1992-6#1)(1994-6#1)(1997-3#2)(2008-2#1)(2008-3#1)
of the covariates##8##3##(1994-2#1)(1995-6#1)(1996-7#1)(1997-4#1)(1997-6#1)(2008-8#1)(2010-8#1)(2011-1#1)
of the cover glass##3##4##(2008-1#2)(2008-11#1)
of the cover##5##3##(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)
of the coverage##3##3##(1993-9#1)(2008-10#1)(2008-11#1)
of the cows##3##3##(1990-6#2)(1991-3#1)
of the cox I and II##2##6##(2008-10#2)
of the coxa pedis##2##4##(2010-11#2)
of the coxa##4##3##(2007-12#1)(2008-5#1)(2010-11#2)
of the crab##3##3##(2008-5#1)(2008-6#1)(2013-7#1)
of the crabs Callinectes arcuatus and C##2##7##(2008-5#2)
of the crack##3##3##(2005-10#1)(2009-7#1)(2010-4#1)
of the cranial##10##3##(1997-3#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-12#3)(2010-12#1)
of the cranio-cervical function##2##4##(2007-11#2)
of the cranio-cervical##3##3##(2007-11#3)
of the craniocervical##2##3##(2006-5#1)(2012-12#1)
of the craniofacial region##3##4##(1996-6#1)(2007-12#1)(2008-9#1)
of the craniofacial skeleton##4##4##(2010-6#4)
of the craniofacial##9##3##(1996-6#1)(2007-12#1)(2008-6#1)(2008-9#1)(2010-6#4)(2012-12#1)
of the craniospinal axis##2##4##(1994-4#1)(2006-12#1)
of the craniosynostoses##2##3##(2007-12#2)
of the cranium##9##3##(1995-10#1)(1996-9#2)(2007-11#1)(2008-7#2)(2009-6#1)(2010-6#1)(2013-8#1)
of the crashes##2##3##(1991-2#1)(2012-12#1)
of the cream##3##3##(2006-10#1)(2008-5#2)
of the creams##2##3##(2008-5#2)
of the creatine transporter##3##4##(2008-5#3)
of the creatine##4##3##(1994-8#1)(2008-5#3)
of the creatinine##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
of the creation of the##3##5##(2009-4#1)(2009-5#1)(2012-2#1)
of the creation of##6##4##(2006-10#1)(2008-10#1)(2008-11#1)(2009-4#1)(2009-5#1)(2012-2#1)
of the creation##7##3##(2006-10#1)(2006-4#1)(2008-10#1)(2008-11#1)(2009-4#1)(2009-5#1)(2012-2#1)
of the creative##2##3##(1994-3#1)(1995-1#1)
of the creep##2##3##(2006-7#1)(2009-4#1)
of the cricopharyngeal muscle##3##4##(1997-2#1)(2011-1#2)
of the cricopharyngeal##4##3##(1997-2#1)(2011-1#3)
of the crisis and##2##4##(1996-8#1)(2006-4#1)
of the crisis##4##3##(1993-12#1)(1996-8#1)(2006-4#1)(2013-1#1)
of the cristae##4##3##(2005-8#4)
of the criteria of the##2##5##(2006-8#1)(2008-3#1)
of the criteria##9##3##(1997-8#1)(2006-10#1)(2006-11#1)(2006-8#1)(2008-2#3)(2008-3#1)(2010-11#1)
of the criterion##4##3##(2006-11#1)(2008-10#1)(2010-2#1)(2011-2#1)
of the critical points##2##4##(2007-12#1)(2013-1#1)
of the critical steps##3##4##(2008-8#1)(2008-9#1)(2009-4#1)
of the critical##27##3##(1990-3#1)(1992-12#1)(1993-8#1)(1994-3#1)(1995-12#1)(2004-12#1)(2005-11#1)(2007-12#1)(2007-2#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
of the critically ill patient##3##5##(2006-10#1)(2007-9#1)(2009-4#1)
of the critically ill##4##4##(2006-10#1)(2007-9#1)(2009-4#1)(2011-2#1)
of the crop plant##2##4##(2004-2#1)(2006-12#1)
of the crop##10##3##(2004-2#1)(2006-12#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-8#1)(2011-12#1)
of the cropping##2##3##(2008-10#2)
of the cross section##2##4##(2007-12#1)(2008-3#1)
of the cross##8##3##(1990-5#1)(1996-9#1)(2007-12#1)(2008-10#3)(2008-3#2)
of the cross-bridge##2##3##(1995-3#1)(2009-6#1)
of the cross-linked##2##3##(1995-6#1)(2010-4#1)
of the cross-linking reaction##2##4##(1992-3#1)(1994-5#1)
of the cross-linking##3##3##(1992-3#1)(1994-5#1)(2008-5#1)
of the cross-section##2##3##(1992-7#1)(1993-9#1)
of the cross-validation##3##3##(1992-2#1)(2010-3#1)(2011-3#1)
of the crossed gratings##2##4##(2008-2#2)
of the crown##6##3##(2007-1#1)(2008-10#3)(2011-1#1)(2013-1#1)
of the crude extract of##2##5##(2008-12#1)(2011-1#1)
of the crude extract##3##4##(2008-10#1)(2008-12#1)(2011-1#1)
of the crude##15##3##(1990-2#1)(1990-7#1)(1995-12#1)(1996-5#1)(2006-3#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#1)(2011-1#1)(2013-1#1)
of the crust##2##3##(1996-4#1)(1997-5#1)
of the crustacean##2##3##(1990-2#1)(2007-12#1)
of the cryopreservation##3##3##(1996-8#2)(2007-7#1)
of the crypt##2##3##(2008-8#1)(2011-2#1)
of the crypts##4##3##(1995-8#1)(2008-5#1)(2009-12#1)(2011-2#1)
of the crystal has been##3##5##(2006-5#2)(2013-1#1)
of the crystal is##2##4##(2007-12#1)(2008-3#1)
of the crystal structure of the##2##6##(1990-7#1)(1994-3#1)
of the crystal structure of this##2##6##(1991-2#1)(1995-1#1)
of the crystal structure of##5##5##(1990-7#1)(1991-2#1)(1994-3#1)(1995-1#1)(2012-2#1)
of the crystal structure##6##4##(1990-7#1)(1991-2#1)(1994-3#1)(1995-1#1)(2008-4#1)(2012-2#1)
of the crystal temperature##4##4##(2007-11#1)(2007-12#3)
of the crystal##46##3##(1990-7#1)(1991-2#1)(1991-5#1)(1992-8#1)(1994-3#1)(1995-1#1)(1996-7#1)(2006-4#3)(2006-5#3)(2007-11#5)(2007-12#8)(2008-2#11)(2008-3#6)(2008-4#1)(2012-2#1)(2013-1#1)
of the crystalline enzyme##2##4##(1992-1#1)(1993-8#1)
of the crystalline##11##3##(1992-1#1)(1993-8#1)(1996-2#1)(1996-5#1)(2005-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
of the crystallites##2##3##(2005-11#1)(2006-12#1)
of the crystallization##4##3##(2006-12#1)(2008-3#1)(2009-5#1)(2010-4#1)
of the crystallized##2##3##(1993-6#1)(2009-11#1)
of the crystallographic##2##3##(1997-5#1)(2011-2#1)
of the crystals##5##3##(1991-4#1)(2006-10#1)(2007-12#2)(2008-3#1)
of the cube##4##3##(2008-2#1)(2008-3#3)
of the cuff##3##3##(2006-10#1)(2006-6#1)(2009-9#1)
of the cultivars##7##3##(2008-10#7)
of the cultivated##2##3##(2008-10#1)(2008-12#1)
of the cultivation of##3##4##(2008-11#3)
of the cultivation##4##3##(2008-11#3)(2008-6#1)
of the culturable##2##3##(2008-10#2)
of the cultural##5##3##(2007-10#1)(2008-1#1)(2008-10#2)(2012-3#1)
of the culture and##2##4##(2008-11#1)(2008-7#1)
of the culture in the##2##5##(2008-7#1)(2013-7#1)
of the culture medium##9##4##(1990-9#1)(1993-9#1)(1994-12#1)(1995-3#1)(1995-6#1)(2008-11#1)(2008-5#2)(2013-1#1)
of the culture under no CO(2) supply was##2##8##(2008-11#2)
of the culture under##4##4##(2008-11#4)
of the culture was##2##4##(1991-1#1)(2008-7#1)
of the culture##42##3##(1990-4#1)(1990-9#1)(1991-1#3)(1991-12#1)(1992-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-3#1)(1995-6#1)(2004-11#1)(2006-12#1)(2008-11#12)(2008-4#1)(2008-5#3)(2008-7#5)(2008-8#1)(2009-10#1)(2010-12#1)(2013-1#2)(2013-7#1)
of the cultured bovine lens##2##5##(2008-5#2)
of the cultured##6##3##(2008-11#2)(2008-4#1)(2008-5#3)
of the cultures with##2##4##(1992-8#1)(1995-12#1)
of the cultures##26##3##(1991-5#1)(1992-11#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-10#7)(1995-12#1)(1995-4#1)(1995-7#1)(1996-11#1)(1996-5#1)(2007-11#1)(2008-10#2)(2008-11#6)
of the cumulative effect of##2##5##(2008-10#1)(2012-3#1)
of the cumulative##5##3##(2007-7#1)(2008-10#2)(2008-7#1)(2012-3#1)
of the current and##2##4##(2006-10#1)(2008-11#1)
of the current article##2##4##(2008-9#1)(2013-8#1)
of the current clinical##2##4##(2008-3#1)(2010-10#1)
of the current debate##3##4##(1993-12#1)(2006-10#1)(2008-11#1)
of the current epidemic of##2##5##(2007-11#1)(2008-3#1)
of the current evidence##2##4##(2008-11#1)(2010-12#1)
of the current health care##3##5##(1993-12#1)(1997-3#1)(2008-8#1)
of the current health##4##4##(1993-12#1)(1997-3#1)(2007-6#1)(2008-8#1)
of the current investigation##2##4##(2011-2#1)(2012-2#1)
of the current knowledge on the##2##6##(2009-4#1)(2011-7#1)
of the current knowledge on##3##5##(2008-11#1)(2009-4#1)(2011-7#1)
of the current knowledge##4##4##(2008-11#1)(2008-3#1)(2009-4#1)(2011-7#1)
of the current literature and##2##5##(2008-6#1)(2011-2#1)
of the current literature in##2##5##(2006-10#1)(2013-7#1)
of the current literature##19##4##(1997-8#1)(2005-11#1)(2006-10#1)(2007-4#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-11#1)(2012-12#1)(2013-7#2)
of the current management strategies##2##5##(2006-6#1)(2013-8#1)
of the current management##3##4##(2006-6#1)(2008-1#1)(2013-8#1)
of the current methods##4##4##(1993-6#1)(1997-7#1)(2008-10#1)(2008-11#1)
of the current paper##2##4##(1997-3#1)(2010-10#1)
of the current research in##2##5##(2009-5#1)(2010-12#1)
of the current research##5##4##(2008-7#1)(2009-5#1)(2010-12#1)(2012-12#1)(2012-2#1)
of the current situation##2##4##(2008-1#1)(2008-4#1)
of the current state of research##2##6##(2009-4#1)(2012-2#1)
of the current state of the art##2##7##(2008-1#1)(2008-10#1)
of the current state of##9##5##(2007-4#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-4#2)(2009-5#1)(2011-2#1)(2012-2#1)
of the current status of the##2##6##(2009-11#1)(2010-2#1)
of the current status of##6##5##(1996-8#1)(2006-12#1)(2008-1#1)(2008-4#1)(2009-11#1)(2010-2#1)
of the current status##7##4##(1996-8#1)(2006-12#1)(2008-1#1)(2008-4#1)(2009-11#1)(2010-11#1)(2010-2#1)
of the current study and##2##5##(2007-11#1)(2007-12#1)
of the current study is to##2##6##(2007-9#1)(2011-2#1)
of the current study is##3##5##(2007-8#1)(2007-9#1)(2011-2#1)
of the current study was to##16##6##(2006-10#1)(2007-1#1)(2007-12#3)(2007-4#1)(2007-8#1)(2009-2#2)(2009-5#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
of the current study were to##2##6##(2007-1#1)(2012-3#1)
of the current study were##3##5##(2007-1#2)(2012-3#1)
of the current study##27##4##(2006-10#1)(2007-1#3)(2007-11#1)(2007-12#4)(2007-4#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#1)(2009-2#2)(2009-5#1)(2010-2#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
of the current system##3##4##(2006-12#1)(2006-8#2)
of the current treatment##2##4##(2007-11#1)(2008-5#1)
of the current understanding of the##2##6##(2009-12#1)(2012-12#1)
of the current understanding of##3##5##(1995-12#1)(2009-12#1)(2012-12#1)
of the current version of the##2##6##(2007-4#1)(2008-5#1)
of the current##226##3##(1990-12#1)(1990-3#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#3)(1993-2#2)(1993-6#1)(1994-1#1)(1994-3#2)(1995-12#2)(1995-4#2)(1995-5#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-8#1)(1996-9#2)(1997-3#2)(1997-7#1)(1997-8#1)(2004-12#1)(2004-7#1)(2005-11#1)(2005-7#1)(2006-10#8)(2006-11#1)(2006-12#4)(2006-2#1)(2006-6#2)(2006-7#1)(2006-8#5)(2007-1#3)(2007-11#6)(2007-12#10)(2007-3#1)(2007-4#6)(2007-5#2)(2007-6#2)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#12)(2008-11#8)(2008-2#4)(2008-3#8)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#1)(2009-11#2)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#6)(2009-5#4)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#11)(2011-7#1)(2012-11#2)(2012-12#4)(2012-2#5)(2012-3#6)(2013-1#7)(2013-7#4)(2013-8#3)
of the currently available##8##4##(1993-9#1)(1997-3#1)(2006-6#1)(2007-11#1)(2008-11#1)(2008-8#1)(2012-3#1)(2013-1#1)
of the currently existing##2##4##(1996-12#1)(2009-5#1)
of the currently used##2##4##(2009-5#1)(2013-8#1)
of the currently##25##3##(1993-6#1)(1993-9#1)(1996-12#2)(1997-3#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-11#1)(2008-8#1)(2009-5#2)(2010-4#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
of the currents##2##3##(1997-5#1)(2007-8#1)
of the curriculum##11##3##(1990-5#1)(1994-1#2)(1994-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-4#1)(2011-2#1)(2012-12#1)
of the curvature of##2##4##(2007-11#1)(2008-9#1)
of the curvature##8##3##(2007-11#2)(2007-7#1)(2007-8#1)(2008-3#1)(2008-9#1)(2012-2#2)
of the curve##14##3##(1993-1#1)(1997-1#1)(2005-11#1)(2007-11#3)(2008-10#2)(2008-2#1)(2008-7#2)(2010-3#1)(2011-2#2)
of the curved##2##3##(2006-12#1)(2008-3#1)
of the curves for##3##4##(2008-10#1)(2008-7#2)
of the curves in the reperfusion period) (IPC##2##8##(2007-8#2)
of the curves##13##3##(1994-3#2)(2007-8#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)
of the cut##3##3##(1994-12#1)(2008-7#1)(2009-12#1)
of the cutaneous##9##3##(1990-4#1)(1990-9#1)(1991-2#1)(1992-11#1)(1992-6#1)(2008-5#3)(2009-1#1)
of the cuticle of##2##4##(2007-12#1)(2008-10#1)
of the cuticle##12##3##(1993-12#1)(2007-12#4)(2007-5#1)(2008-10#5)(2008-5#1)
of the cuticular apparatus##3##4##(2007-12#3)
of the cuticular hydrocarbons##2##4##(2008-9#2)
of the cuticular intima##2##4##(2007-12#2)
of the cuticular##10##3##(2007-12#7)(2008-5#1)(2008-9#2)
of the cutoff##2##3##(1992-6#2)
of the cuts##4##3##(1996-5#1)(2007-5#1)(2008-3#2)
of the cuvette##2##3##(2005-8#1)(2009-8#1)
of the cw##6##3##(2007-12#2)(2008-2#2)(2008-3#2)
of the cyanide##2##3##(1993-8#1)(2008-10#1)
of the cyanobacterium Anabaena##2##4##(1991-8#1)(1995-1#1)
of the cyanobacterium Synechocystis sp##3##5##(1994-8#1)(2009-10#2)
of the cyanobacterium##8##3##(1991-11#1)(1991-8#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-12#1)(2009-10#2)
of the cyclase##2##3##(1996-11#1)(2008-7#1)
of the cycle##12##3##(1990-12#1)(1991-11#1)(1991-12#1)(1992-4#1)(1992-7#2)(1994-9#2)(1996-11#1)(1996-4#1)(2007-9#1)(2008-10#1)
of the cycles##3##3##(1994-7#2)(2012-2#1)
of the cyclic AMP##4##4##(1990-12#1)(1993-6#1)(1994-10#1)(1997-2#1)
of the cyclic##11##3##(1990-12#1)(1990-3#1)(1992-6#1)(1993-6#1)(1994-10#1)(1996-12#1)(1997-2#1)(2007-8#1)(2008-10#2)(2008-4#1)
of the cyclin##3##3##(1997-4#1)(1997-8#1)(2012-3#1)
of the cyclin-dependent kinase inhibitor##2##5##(2008-11#2)
of the cyclin-dependent kinase##4##4##(1994-8#1)(2008-11#2)(2010-12#1)
of the cyclin-dependent##6##3##(1994-12#1)(1994-8#1)(1997-6#1)(2008-11#2)(2010-12#1)
of the cyclo-oxygenase##2##3##(1995-11#1)(1995-6#1)
of the cyclodextrin##5##3##(1996-2#2)(2006-12#1)(2008-10#2)
of the cyclomaltoheptaose##2##3##(1991-12#2)
of the cyclooxygenase##4##3##(1994-5#2)(2006-10#1)(2008-4#1)
of the cyclosporin##2##3##(1991-11#1)(1993-11#1)
of the cylinder##13##3##(1995-4#1)(1995-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)(2009-2#2)(2010-8#1)
of the cylinder's##3##3##(2008-2#1)(2008-3#2)
of the cylinders##3##3##(2005-11#2)(2012-2#1)
of the cylindrical##6##3##(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
of the cysB gene##2##4##(1990-3#2)
of the cyst and##5##4##(1991-8#1)(2008-10#1)(2008-5#1)(2012-1#1)(2012-12#1)
of the cyst is##2##4##(2011-2#1)(2012-1#1)
of the cyst was##5##4##(1997-8#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-7#1)
of the cyst##33##3##(1990-6#1)(1991-8#3)(1997-8#1)(2006-10#1)(2006-5#4)(2007-1#2)(2007-7#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-12#2)(2012-2#1)
of the cystatin##2##3##(1991-3#1)(1993-3#1)
of the cysteine proteinase##3##4##(1992-3#1)(1993-5#1)(1997-6#1)
of the cysteine residues##4##4##(1992-5#1)(1993-4#1)(1993-6#1)(1993-9#1)
of the cysteine##14##3##(1991-1#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-3#1)(1995-11#1)(1997-6#2)(2006-12#1)(2007-6#1)
of the cysteinyl##2##3##(1991-5#1)(2005-8#1)
of the cystic duct##5##4##(1992-9#3)(2008-12#2)
of the cystic fibrosis conductance regulator##2##6##(1990-8#1)(2006-10#1)
of the cystic fibrosis transmembrane conductance regulator##2##7##(1995-11#1)(1997-6#1)
of the cystic fibrosis##5##4##(1990-8#1)(1995-11#1)(1997-6#1)(2006-10#1)(2007-6#1)
of the cystic##17##3##(1990-8#1)(1992-9#3)(1993-5#1)(1993-9#1)(1995-11#1)(1997-6#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-12#2)(2008-5#2)(2009-3#1)
of the cysts##9##3##(1995-12#1)(1996-12#1)(2007-6#1)(2007-9#1)(2008-5#2)(2011-2#1)(2012-2#1)(2012-3#1)
of the cyt bc1##2##4##(1992-3#2)
of the cyt##3##3##(1992-3#3)
of the cytobrush##2##3##(1992-1#2)
of the cytochrome P450 superfamily##2##5##(1995-5#1)(2008-4#1)
of the cytochrome P450##7##4##(1991-10#1)(1994-2#2)(1995-5#1)(1996-3#1)(2008-4#1)(2012-2#1)
of the cytochrome b##3##4##(1995-11#1)(2008-10#1)(2009-9#1)
of the cytochrome b6-f complex##3##5##(1991-3#3)
of the cytochrome c##2##4##(1995-2#1)(1997-3#1)
of the cytochrome oxidase##3##4##(1995-6#2)(2008-11#1)
of the cytochrome with##2##4##(1994-5#1)(1994-8#1)
of the cytochrome##40##3##(1990-2#1)(1990-4#1)(1991-10#1)(1991-3#3)(1992-3#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-5#5)(1994-8#3)(1995-11#1)(1995-2#1)(1995-5#3)(1995-6#4)(1996-3#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-9#2)(2012-2#1)
of the cytochromes##3##3##(1991-4#1)(1994-8#1)(2006-8#1)
of the cytokine receptor domain of the##2##7##(1996-11#2)
of the cytokine receptor superfamily##5##5##(1994-11#1)(1994-5#1)(1996-10#1)(1996-2#2)
of the cytokine receptor##7##4##(1994-11#1)(1994-5#1)(1996-10#1)(1996-11#2)(1996-2#2)
of the cytokine##16##3##(1991-10#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-12#1)(1996-10#1)(1996-11#2)(1996-2#3)(2006-10#1)(2007-11#3)(2008-6#1)
of the cytokines on##2##4##(1990-2#1)(1994-6#1)
of the cytokines##5##3##(1990-2#1)(1992-8#1)(1994-6#2)(2008-11#1)
of the cytological##5##3##(1991-6#1)(2007-9#1)(2008-10#1)(2008-11#1)(2009-7#1)
of the cytomegalovirus##3##3##(1995-12#1)(2007-12#1)(2008-11#1)
of the cytopathic effect of##2##5##(1991-3#1)(1992-5#1)
of the cytopathic##3##3##(1991-3#1)(1992-5#2)
of the cytoplasm of##2##4##(1991-11#1)(1995-1#1)
of the cytoplasm##6##3##(1991-11#1)(1995-1#1)(2008-10#1)(2008-7#1)(2011-1#1)(2012-7#1)
of the cytoplasmic domain of the##2##6##(1994-5#1)(1997-6#1)
of the cytoplasmic domain##5##4##(1994-5#1)(1995-8#1)(1996-8#1)(1997-6#2)
of the cytoplasmic matrix##2##4##(1997-4#1)(2007-9#1)
of the cytoplasmic membrane##3##4##(1990-8#2)(1994-3#1)
of the cytoplasmic##21##3##(1990-12#1)(1990-4#1)(1990-8#2)(1994-3#2)(1994-5#1)(1994-6#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-6#3)(1997-7#1)(2007-9#1)(2008-2#1)
of the cytoskeletal structure##2##4##(1994-11#1)(2008-11#1)
of the cytoskeletal##4##3##(1994-11#1)(1997-2#1)(2004-12#1)(2008-11#1)
of the cytoskeleton##8##3##(1992-6#1)(1996-4#1)(1997-7#1)(2006-10#1)(2008-1#1)(2008-10#1)(2009-8#1)(2011-2#1)
of the cytosol fraction##2##4##(1990-11#1)(2008-10#1)
of the cytosol of##2##4##(1992-3#1)(2010-12#1)
of the cytosol##12##3##(1990-11#1)(1990-5#2)(1992-3#1)(1995-11#1)(1996-5#1)(2008-1#2)(2008-10#1)(2009-10#1)(2009-8#1)(2010-12#1)
of the cytosolic PKC##2##4##(1997-6#2)
of the cytosolic enzyme##4##4##(1990-5#1)(1991-4#1)(1992-11#1)(1997-2#1)
of the cytosolic fraction##3##4##(1991-1#2)(1991-7#1)
of the cytosolic##20##3##(1990-2#1)(1990-5#1)(1990-7#1)(1991-1#2)(1991-3#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-11#1)(1994-11#2)(1994-2#1)(1995-9#1)(1996-8#1)(1997-2#1)(1997-6#2)(2005-8#1)(2009-12#1)
of the cytostatic genes##2##4##(2008-7#2)
of the cytostatic##4##3##(2006-6#1)(2008-7#3)
of the cytotoxic activity of##3##5##(1990-12#2)(2008-3#1)
of the cytotoxic##10##3##(1990-12#2)(1990-4#1)(1990-8#1)(1993-1#1)(1995-8#1)(1997-5#1)(2008-11#1)(2008-3#1)(2010-12#1)
of the d(G3T4G3)*d(G3A4G3)##2##3##(1995-3#2)
of the dLGN##2##3##(1992-10#1)(1995-11#1)
of the daily dose##2##4##(1992-10#1)(2011-2#1)
of the daily##16##3##(1990-11#1)(1991-2#1)(1992-10#1)(1992-2#1)(1996-12#1)(1996-3#2)(2008-1#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-1#1)(2013-8#3)
of the dairy##2##3##(2006-10#1)(2011-2#1)
of the damage and##2##4##(2007-8#1)(2011-1#1)
of the damage was##2##4##(1997-4#1)(2008-5#1)
of the damage##14##3##(1991-9#1)(1992-9#2)(1997-4#1)(2005-7#1)(2007-8#1)(2008-1#2)(2008-2#2)(2008-5#2)(2009-10#1)(2011-1#1)
of the damaged##6##3##(1990-11#1)(2007-11#2)(2007-7#1)(2008-2#1)(2009-3#1)
of the damages##2##3##(1995-6#1)(2009-8#1)
of the damped##2##3##(2008-10#1)(2009-10#1)
of the damping##2##3##(1991-12#1)(2006-10#1)
of the danger of##3##4##(2005-11#1)(2006-10#1)(2006-2#1)
of the dansyl derivative of##2##5##(1996-5#1)(1997-3#1)
of the dansyl derivative##4##4##(1996-5#2)(1997-3#1)(2008-10#1)
of the dansyl##9##3##(1990-2#1)(1991-7#1)(1994-5#2)(1996-5#2)(1997-3#1)(2008-10#2)
of the dark decay##2##4##(2007-11#1)(2007-12#1)
of the dark soliton##2##4##(2007-12#1)(2008-1#1)
of the dark##15##3##(1992-8#1)(1994-2#1)(1997-4#1)(2006-12#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#1)(2008-3#2)(2008-8#1)
of the data acquisition##2##4##(2008-7#1)(2013-7#1)
of the data and the##3##5##(2007-1#1)(2008-8#1)(2013-8#1)
of the data and##12##4##(1995-11#1)(1995-4#1)(1996-12#1)(2007-1#1)(2007-2#1)(2008-3#2)(2008-8#1)(2009-5#1)(2011-3#1)(2012-3#1)(2013-8#1)
of the data are##3##4##(1995-12#1)(1996-5#1)(2007-12#1)
of the data available##2##4##(1994-6#1)(2013-8#1)
of the data for a##2##5##(1992-4#1)(2012-3#1)
of the data for##4##4##(1992-4#1)(2008-3#1)(2008-9#1)(2012-3#1)
of the data from the##3##5##(2008-10#3)
of the data from these##2##5##(2008-7#1)(2009-11#1)
of the data from##8##4##(2008-10#3)(2008-3#3)(2008-7#1)(2009-11#1)
of the data have been##2##5##(1994-6#1)(2008-10#1)
of the data in##7##4##(1995-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)
of the data indicated that##2##5##(2004-12#1)(2008-10#1)
of the data indicated##3##4##(2004-12#1)(2008-10#2)
of the data is##8##4##(1990-3#1)(1994-5#1)(1997-4#1)(2007-10#1)(2008-3#1)(2008-6#1)(2009-9#1)(2012-1#1)
of the data obtained from##3##5##(1990-11#1)(2008-10#1)(2010-8#1)
of the data obtained##7##4##(1990-11#1)(1990-3#1)(1991-2#1)(1993-6#1)(2005-11#1)(2008-10#1)(2010-8#1)
of the data of##4##4##(1997-8#1)(2008-10#1)(2008-2#1)(2012-3#1)
of the data on##3##4##(2007-7#1)(2008-11#1)(2008-3#1)
of the data or##2##4##(1990-8#1)(2007-12#1)
of the data paper##2##4##(2012-3#2)
of the data presented##2##4##(2008-10#1)(2008-5#1)
of the data revealed that the##2##6##(2008-10#1)(2011-1#1)
of the data revealed that##5##5##(1990-6#1)(2007-12#1)(2008-10#1)(2011-1#1)(2011-12#1)
of the data set##5##4##(1997-6#1)(2007-1#1)(2007-8#1)(2008-10#2)
of the data sets at the##2##6##(2008-10#2)
of the data sets using##2##5##(2008-10#2)
of the data sets##6##4##(2008-10#5)(2012-11#1)
of the data showed that##2##5##(2007-2#1)(2010-4#1)
of the data showed##4##4##(1993-3#1)(2007-2#1)(2010-4#1)(2012-3#1)
of the data that##2##4##(1995-6#1)(2008-9#1)
of the data to the##2##5##(1997-6#1)(2008-10#1)
of the data to##9##4##(1997-6#1)(1997-8#1)(2005-11#1)(2008-10#3)(2008-11#1)(2010-2#1)(2010-8#1)
of the data was undertaken##2##5##(2008-11#1)(2009-7#1)
of the data was##5##4##(1995-8#1)(2007-10#1)(2008-10#1)(2008-11#1)(2009-7#1)
of the data were##2##4##(2008-10#1)(2012-1#1)
of the data with##3##4##(2008-10#1)(2009-5#1)(2009-6#1)
of the data##211##3##(1990-11#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#3)(1991-12#1)(1991-2#2)(1992-3#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#2)(1995-11#1)(1995-12#1)(1995-4#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-12#2)(1996-5#1)(1996-8#1)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2004-12#1)(2004-9#1)(2005-11#2)(2005-4#1)(2005-8#1)(2006-11#2)(2006-12#1)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#3)(2007-12#5)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#33)(2008-11#5)(2008-12#1)(2008-2#12)(2008-3#15)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#8)(2008-8#4)(2008-9#5)(2009-11#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-4#2)(2010-8#3)(2011-1#2)(2011-12#2)(2011-2#1)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#6)(2013-1#3)(2013-7#1)(2013-8#4)
of the data-acquisition##2##3##(2007-12#1)(2008-10#1)
of the database to##2##4##(2008-4#1)(2013-1#1)
of the database##15##3##(1990-3#1)(1991-3#1)(1992-12#1)(1994-1#1)(1994-12#1)(1997-3#1)(2008-4#2)(2008-7#2)(2008-8#1)(2010-5#2)(2013-1#1)(2013-8#1)
of the dataset##2##3##(2008-10#1)(2008-7#1)
of the daughter cells##2##4##(1997-6#1)(2009-2#1)
of the daughter##3##3##(1997-6#1)(2009-10#1)(2009-2#1)
of the day to##2##4##(2008-5#1)(2012-3#1)
of the day##21##3##(1991-2#1)(1991-9#1)(1992-1#2)(1992-3#1)(1994-6#2)(1995-1#1)(2007-3#1)(2008-10#2)(2008-5#3)(2009-7#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
of the days##3##3##(2008-11#1)(2008-3#1)(2008-9#1)
of the de novo##2##4##(1997-3#1)(2008-4#1)
of the de##4##3##(1997-3#1)(2008-10#2)(2008-4#1)
of the dead##7##3##(1991-11#1)(2008-2#3)(2008-3#1)(2008-5#1)(2011-2#1)
of the deaf##2##3##(2011-2#2)
of the death machinery##2##4##(2008-8#1)(2009-3#1)
of the death of##4##4##(2007-11#2)(2009-3#1)(2013-1#1)
of the death##9##3##(1991-12#1)(2007-11#2)(2007-8#1)(2008-3#1)(2008-8#1)(2009-3#2)(2013-1#1)
of the deaths were##2##4##(1993-8#1)(2012-3#1)
of the deaths##8##3##(1993-8#1)(1995-3#1)(2006-2#1)(2007-7#1)(2008-4#1)(2009-4#1)(2012-12#1)(2012-3#1)
of the debate over##2##4##(1996-5#1)(2008-8#1)
of the debate##8##3##(1996-5#1)(1996-8#1)(1997-1#1)(2006-10#1)(2006-11#2)(2007-10#1)(2008-8#1)
of the debris##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)
of the decade##5##3##(1990-12#1)(1990-5#1)(1994-2#1)(1994-9#1)(2007-8#1)
of the decapeptide##3##3##(1992-12#1)(1996-4#1)(2008-4#1)
of the decapping##2##3##(1995-12#2)
of the decay##6##3##(2005-11#1)(2007-11#1)(2008-2#2)(2008-3#2)
of the decaying tissue##2##4##(2008-10#2)
of the deceased and##2##4##(1995-6#1)(2007-11#1)
of the deceased##7##3##(1995-6#2)(2005-7#1)(2006-2#1)(2007-11#1)(2011-2#1)(2013-1#1)
of the deciduous first molars##2##5##(2012-12#2)
of the deciduous##5##3##(2008-5#1)(2011-1#1)(2012-12#2)(2013-1#1)
of the decision##3##3##(2008-10#2)(2012-2#1)
of the decision-making##2##3##(2011-2#1)(2012-2#1)
of the decisions##2##3##(1993-5#1)(2010-9#1)
of the decline##5##3##(2005-1#1)(2008-11#1)(2008-5#1)(2010-3#1)(2011-2#1)
of the decoding##2##3##(1991-6#1)(1994-12#1)
of the decomposition of##4##4##(1992-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
of the decomposition##5##3##(1992-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
of the decrease in the##3##5##(1995-12#1)(2008-10#2)
of the decrease in##12##4##(1990-5#1)(1991-3#1)(1991-6#1)(1992-9#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-10#1)(2006-6#1)(2008-10#2)(2009-7#1)
of the decrease of##2##4##(2005-11#1)(2013-1#1)
of the decrease##15##3##(1990-5#1)(1991-3#1)(1991-6#1)(1992-9#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-10#1)(2005-11#1)(2006-6#1)(2008-10#2)(2009-7#1)(2013-1#1)
of the decreased##5##3##(1994-5#1)(1995-3#1)(1997-1#1)(2008-10#1)(2008-8#1)
of the decreasing##2##3##(2008-10#1)(2012-3#1)
of the decrypting phase mask##2##5##(2008-3#2)
of the deduced amino acid (aa) sequence##3##7##(1994-12#1)(1997-1#1)(1997-2#1)
of the deduced amino acid (aa) sequences##2##7##(1991-6#1)(1995-2#1)
of the deduced amino acid (aa)##5##6##(1991-6#1)(1994-12#1)(1995-2#1)(1997-1#1)(1997-2#1)
of the deduced amino acid sequence of##3##7##(1991-7#1)(1994-8#1)(2006-8#1)
of the deduced amino acid sequence##10##6##(1991-7#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-8#1)(1997-2#1)(1997-5#1)(2005-11#1)(2006-8#1)(2008-8#1)
of the deduced amino acid sequences of the##4##8##(1992-12#1)(1995-3#1)(2008-10#2)
of the deduced amino acid sequences of##5##7##(1992-12#1)(1993-2#1)(1995-3#1)(2008-10#2)
of the deduced amino acid sequences##7##6##(1992-12#1)(1993-2#1)(1995-3#1)(2008-10#3)(2008-9#1)
of the deduced amino acid##22##5##(1991-6#1)(1991-7#1)(1992-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#2)(1994-8#1)(1995-2#1)(1995-3#1)(1997-1#1)(1997-2#2)(1997-5#1)(2005-11#1)(2006-8#1)(2008-10#3)(2008-8#1)(2008-9#1)
of the deduced amino-acid sequence##3##5##(1994-12#1)(1996-10#1)(1996-9#1)
of the deduced protein##2##4##(1991-9#1)(1996-4#1)
of the deduced##40##3##(1991-6#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#4)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-5#1)(2005-11#1)(2006-8#1)(2008-10#5)(2008-3#1)(2008-8#1)(2008-9#1)
of the deep infections of the neck]##2##7##(2008-8#1)(2008-9#1)
of the deep sea##2##4##(2007-9#1)(2008-5#1)
of the deep##17##3##(1990-2#1)(1991-11#1)(1994-10#1)(1997-6#1)(2006-12#1)(2007-9#1)(2008-5#1)(2008-8#2)(2008-9#5)(2011-1#1)(2013-1#1)(2013-7#1)
of the default mode network##2##5##(2012-1#1)(2013-8#1)
of the defect and##4##4##(2007-11#1)(2008-5#1)(2009-5#1)(2010-7#1)
of the defect##25##3##(1991-2#1)(1997-3#1)(2007-11#7)(2007-12#3)(2007-8#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#2)(2012-2#1)
of the defective##3##3##(1995-9#1)(2006-11#1)(2008-11#1)
of the defects was##2##4##(2006-8#1)(2007-8#1)
of the defects##5##3##(1990-5#1)(2006-8#1)(2007-11#2)(2007-8#1)
of the defense##8##3##(1992-12#1)(1994-6#1)(1995-6#1)(2008-10#1)(2008-9#3)(2009-8#1)
of the defensive##2##3##(2007-12#2)
of the deficiency in##2##4##(1993-12#1)(2008-9#1)
of the deficiency##5##3##(1993-12#1)(1993-2#1)(2008-8#1)(2008-9#1)(2011-2#1)
of the deficient LEU2d gene##2##5##(1991-8#2)
of the deficit##4##3##(1990-3#1)(1992-9#1)(1995-1#1)(2008-8#1)
of the deficits##2##3##(1992-9#1)(2012-1#1)
of the defined##3##3##(1993-2#1)(2008-10#1)(2008-11#1)
of the defining##4##3##(1997-6#1)(2010-8#1)(2013-1#2)
of the definite##2##3##(2006-2#1)(2012-2#1)
of the definition and##2##4##(2008-10#1)(2008-2#1)
of the definition of the##2##5##(2006-5#1)(2008-10#1)
of the definition of##4##4##(2006-10#1)(2006-5#1)(2008-10#1)(2008-7#1)
of the definition##7##3##(2006-10#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#1)
of the definitions##2##3##(1991-2#1)(1993-2#1)
of the definitive##2##3##(2007-12#1)(2010-3#1)
of the deformable mirror##6##4##(2007-11#1)(2008-2#2)(2008-3#1)(2010-5#2)
of the deformable##7##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2010-5#2)
of the deformation##11##3##(1996-1#2)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)(2009-6#1)(2009-7#1)
of the deformed##2##3##(2005-11#1)(2008-5#1)
of the deforming##2##3##(2005-11#1)(2008-3#1)
of the deformity was achieved##2##5##(2005-2#1)(2006-8#1)
of the deformity was##3##4##(2005-2#1)(2006-8#1)(2007-8#1)
of the deformity##12##3##(2005-2#1)(2006-3#1)(2006-8#1)(2007-12#1)(2007-7#3)(2007-8#2)(2008-4#1)(2008-8#1)(2009-3#1)
of the degeneration##2##3##(1992-12#1)(1994-8#1)
of the degenerative##2##3##(2007-11#1)(2011-2#1)
of the degradable##2##3##(1990-3#1)(2010-2#1)
of the degradation of##2##4##(1991-7#1)(2008-10#1)
of the degradation products of##3##5##(1996-5#1)(2008-10#2)
of the degradation products##9##4##(1996-5#1)(2004-12#1)(2006-8#1)(2008-10#6)
of the degradation##17##3##(1990-4#1)(1991-7#1)(1996-5#1)(2004-12#1)(2005-12#1)(2006-11#1)(2006-12#1)(2006-8#1)(2008-10#8)(2008-11#1)
of the degree of##51##4##(1990-11#1)(1990-12#1)(1990-2#1)(1991-5#1)(1992-1#1)(1992-11#1)(1993-12#1)(1993-2#1)(1994-10#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-8#1)(1996-9#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-11#3)(2007-12#4)(2007-5#2)(2008-10#3)(2008-11#2)(2008-3#4)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-6#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
of the degree to which##3##5##(2008-2#1)(2008-4#1)(2008-7#1)
of the degree##55##3##(1990-11#1)(1990-12#1)(1990-2#1)(1991-5#1)(1992-1#1)(1992-11#1)(1993-12#1)(1993-2#1)(1994-10#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-8#1)(1996-9#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-11#3)(2007-12#4)(2007-5#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-6#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
of the delay between##3##4##(1991-2#1)(2008-12#1)(2008-3#1)
of the delay in##3##4##(1991-9#1)(2007-2#1)(2010-3#1)
of the delay of##3##4##(1993-7#1)(2008-10#1)(2012-12#1)
of the delay##15##3##(1990-11#1)(1991-2#1)(1991-9#1)(1993-7#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-11#1)(2010-3#1)(2012-12#1)(2012-3#1)(2013-8#1)
of the delayed##3##3##(1992-6#1)(1995-5#1)(2009-5#1)
of the deleted##5##3##(1990-10#1)(1990-12#1)(1991-7#1)(1997-3#1)(2008-10#1)
of the deleterious##2##3##(2008-3#1)(2008-5#1)
of the deletion##7##3##(1990-7#1)(1990-9#1)(1994-11#1)(1994-9#1)(1996-12#1)(2008-7#1)(2013-8#1)
of the deletions##3##3##(1991-8#1)(1992-6#1)(1996-8#1)
of the delivered##5##3##(1997-8#1)(2008-11#1)(2008-3#1)(2013-1#1)(2013-7#1)
of the delivery of##3##4##(2005-8#1)(2006-10#1)(2006-2#1)
of the delivery system##4##4##(1995-1#1)(2009-5#1)(2012-2#1)(2012-6#1)
of the delivery##7##3##(1995-1#1)(2005-8#1)(2006-10#1)(2006-2#1)(2009-5#1)(2012-2#1)(2012-6#1)
of the delta opioid receptor##2##5##(1997-2#1)(1997-7#1)
of the delta##7##3##(1993-8#1)(1994-8#1)(1995-12#1)(1995-3#1)(1997-2#1)(1997-7#2)
of the deltoid muscle##2##4##(2007-12#1)(2013-8#1)
of the deltoid##4##3##(2007-12#1)(2010-4#1)(2013-8#2)
of the demand for##4##4##(1995-6#1)(1996-3#1)(2010-5#1)(2011-2#1)
of the demand##5##3##(1994-1#1)(1995-6#1)(1996-3#1)(2010-5#1)(2011-2#1)
of the demands##3##3##(1992-3#1)(2008-11#1)(2011-2#1)
of the dementia syndrome##2##4##(1994-11#1)(2008-3#1)
of the dementia##4##3##(1994-11#1)(1996-11#1)(2008-3#1)(2008-7#1)
of the demodulation##2##3##(2008-2#1)(2008-3#1)
of the demographic##8##3##(1992-5#2)(1995-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)
of the demonstrated##2##3##(2008-11#1)(2008-7#1)
of the denaturant##3##3##(1990-10#1)(1992-8#1)(1992-9#1)
of the denaturation##3##3##(1993-9#1)(1996-11#1)(2008-10#1)
of the denatured state##3##4##(1992-6#1)(1994-9#2)
of the denatured##6##3##(1990-5#1)(1992-6#1)(1994-9#2)(1996-9#1)(2009-9#1)
of the dendrimer##3##3##(2007-12#1)(2008-1#1)(2008-7#1)
of the dendrites##3##3##(1995-11#1)(2007-12#2)
of the dendritic region##2##4##(2007-12#2)
of the dendritic tree##2##4##(1994-2#2)
of the dendritic##10##3##(1994-2#4)(1995-7#1)(1997-7#1)(2005-10#1)(2007-12#2)(2013-1#1)
of the dengue##2##3##(2009-7#1)(2012-2#1)
of the dense tubular pump was##2##6##(1992-6#2)
of the dense tubular pump##3##5##(1992-6#3)
of the dense tubular##4##4##(1992-6#4)
of the dense##5##3##(1992-6#4)(2008-2#1)
of the density of##14##4##(1991-6#1)(1993-3#1)(1995-12#1)(1995-7#1)(1996-2#1)(1996-3#1)(2004-11#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-8#2)
of the density##24##3##(1991-6#1)(1993-3#1)(1995-12#1)(1995-7#1)(1996-2#1)(1996-3#1)(1997-4#1)(2004-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-8#2)(2008-9#1)(2013-8#1)
of the density-dependent##2##3##(2008-7#1)(2008-9#1)
of the dental arch##2##4##(2008-11#1)(2012-12#1)
of the dental arches##2##4##(1991-1#1)(2012-12#1)
of the dental hygiene profession and##2##6##(2006-2#2)
of the dental hygiene profession##3##5##(2006-2#3)
of the dental hygiene##4##4##(2006-2#4)
of the dental##24##3##(1990-2#1)(1991-1#1)(1991-4#1)(1991-9#1)(1993-2#1)(2006-2#4)(2006-7#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2011-12#1)(2012-11#1)(2012-12#2)(2013-1#2)(2013-8#3)
of the dentate gyrus and##4##5##(1992-7#1)(1992-8#1)(1994-8#1)(1995-7#1)
of the dentate gyrus##20##4##(1990-7#2)(1991-9#2)(1992-7#4)(1992-8#1)(1993-12#1)(1994-8#1)(1995-12#3)(1995-7#3)(1997-7#1)(1997-8#1)(2008-9#1)
of the dentate##23##3##(1990-5#1)(1990-7#2)(1991-7#1)(1991-9#2)(1992-7#4)(1992-8#1)(1993-12#1)(1994-8#1)(1995-12#3)(1995-7#4)(1997-7#1)(1997-8#1)(2008-9#1)
of the dentist##4##3##(1990-10#1)(1996-3#1)(2011-1#1)(2011-12#1)
of the dentists##2##3##(2006-7#1)(2008-1#1)
of the dentition##4##3##(1990-11#1)(2008-7#1)(2012-11#1)(2012-3#1)
of the denture##4##3##(2007-9#1)(2012-2#1)(2013-1#2)
of the deoxy##2##3##(1994-11#1)(1994-9#1)
of the department of##4##4##(1990-10#1)(2006-2#1)(2008-10#1)(2013-8#1)
of the department##12##3##(1990-10#1)(1993-1#1)(1993-8#1)(1996-1#1)(2006-2#1)(2006-8#1)(2007-4#1)(2008-10#1)(2008-12#3)(2013-8#1)
of the departmental portfolio##2##4##(2008-12#2)
of the departmental##4##3##(2008-12#2)(2008-6#2)
of the departments and municipalities##2##5##(2012-12#2)
of the departments of##4##4##(1997-3#1)(2006-10#1)(2012-12#2)
of the departments##10##3##(1990-9#1)(1993-10#2)(1997-3#1)(2006-10#1)(2006-8#1)(2012-12#4)
of the dependence of the##6##5##(1990-3#1)(1994-7#1)(2007-11#2)(2007-12#1)(2008-2#1)
of the dependence of##14##4##(1990-12#1)(1990-3#1)(1994-7#1)(2006-11#1)(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#2)
of the dependence on##3##4##(2007-11#1)(2008-3#2)
of the dependence##18##3##(1990-12#1)(1990-3#1)(1994-7#1)(2006-10#1)(2006-11#1)(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#4)(2008-7#1)(2008-9#2)
of the dependencies##2##3##(1996-5#1)(2008-3#1)
of the dependent##3##3##(2008-12#2)(2011-1#1)
of the dephosphorylation##2##3##(1993-12#1)(1994-12#1)
of the depleted##2##3##(1990-6#1)(2008-10#1)
of the depolarization##5##3##(1992-6#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)
of the deposit##2##3##(2008-10#1)(2010-4#1)
of the deposited##5##3##(1996-12#1)(2007-12#1)(2008-10#1)(2008-3#2)
of the depositing##2##3##(1996-9#1)(2010-4#1)
of the deposition of##3##4##(2005-11#2)(2008-10#1)
of the deposition##9##3##(1992-6#1)(1994-12#1)(2005-11#2)(2007-8#1)(2008-10#2)(2008-2#2)
of the depressed##2##3##(1996-5#1)(2008-7#1)
of the depressive##4##3##(1991-10#1)(1991-11#1)(2008-8#1)(2013-8#1)
of the deprived##4##3##(1994-3#2)(1995-11#1)(1995-5#1)
of the deprotonated##2##3##(1994-12#1)(2008-5#1)
of the depth of##4##4##(2006-10#1)(2007-12#1)(2008-3#1)(2011-2#1)
of the depth##8##3##(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#4)(2011-2#1)
of the derivation##3##3##(2008-2#1)(2013-1#2)
of the derivative of the##2##5##(2008-10#1)(2008-2#1)
of the derivative##9##3##(1996-9#1)(2005-4#1)(2008-10#3)(2008-2#1)(2008-3#2)(2010-7#1)
of the derivatives were##2##4##(2008-11#1)(2013-8#1)
of the derivatives##15##3##(1990-5#1)(1992-1#1)(1993-2#1)(2008-10#5)(2008-11#3)(2008-6#1)(2008-7#1)(2011-2#1)(2013-8#1)
of the derivatization##2##3##(2008-10#1)(2012-12#1)
of the derivatized##4##3##(1992-9#1)(2008-10#2)(2008-7#1)
of the derived##11##3##(1992-12#1)(1995-2#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-7#2)(2010-8#1)
of the dermal##4##3##(1992-12#1)(1994-7#1)(2011-2#1)(2012-3#1)
of the dermis and##2##4##(2008-5#1)(2008-9#1)
of the dermis##12##3##(2006-12#1)(2008-5#5)(2008-9#5)(2012-12#1)
of the descending aorta and##2##5##(2007-8#1)(2012-2#1)
of the descending aorta##5##4##(1992-8#1)(2007-8#3)(2012-2#1)
of the descending colon##2##4##(1993-9#1)(2006-4#1)
of the descending thoracic aorta##3##5##(2007-8#1)(2010-8#2)
of the descending thoracic##5##4##(2007-8#2)(2008-10#1)(2010-8#2)
of the descending##13##3##(1990-4#1)(1992-8#1)(1993-9#1)(2006-4#1)(2007-8#5)(2008-10#1)(2010-8#2)(2012-2#1)
of the described changes are discussed##2##6##(1991-5#1)(2005-1#1)
of the described system##2##4##(2008-10#1)(2008-8#1)
of the described##13##3##(1990-9#2)(1991-5#1)(2005-1#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)(2010-1#1)(2012-2#1)(2013-8#1)
of the desert##2##3##(2008-2#1)(2011-12#1)
of the design and##3##4##(2006-4#1)(2008-3#1)(2012-3#1)
of the design are##2##4##(2008-2#1)(2012-2#1)
of the design of##5##4##(1994-4#1)(2008-2#1)(2008-3#1)(2012-11#2)
of the design##29##3##(1994-4#1)(1995-2#1)(1995-8#1)(2005-8#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-2#5)(2008-3#9)(2010-10#1)(2011-2#1)(2012-11#2)(2012-2#1)(2012-3#2)(2013-7#1)
of the designated##2##3##(2007-12#1)(2009-2#1)
of the designed##9##3##(1991-9#1)(1995-1#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2011-2#1)
of the designs##5##3##(1994-9#1)(1997-2#1)(2008-2#1)(2008-3#1)(2009-7#1)
of the desire for##3##4##(2008-7#1)(2009-4#2)
of the desire##4##3##(2006-9#1)(2008-7#1)(2009-4#2)
of the desired image##4##4##(2008-2#1)(2008-3#3)
of the desired product##2##4##(1997-3#1)(2008-10#1)
of the desired products##2##4##(2008-4#1)(2009-12#1)
of the desired##24##3##(1992-6#1)(1996-12#1)(1997-2#1)(1997-3#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#4)(2008-3#4)(2008-4#2)(2008-7#1)(2009-10#1)(2009-12#1)(2009-7#1)(2012-2#1)
of the desmosome##4##3##(1990-12#1)(1997-2#1)(2008-3#1)(2012-2#1)
of the desquamation process##2##4##(2008-5#2)
of the desquamation##3##3##(2008-5#3)
of the destroyed##2##3##(2005-7#1)(2007-8#1)
of the detail##2##3##(2008-2#2)
of the detailed##6##3##(1995-5#1)(1997-5#1)(2007-12#1)(2007-6#1)(2008-7#1)(2012-1#1)
of the details of the##2##5##(2008-8#1)(2010-9#1)
of the details##3##3##(2007-4#1)(2008-8#1)(2010-9#1)
of the detected##13##3##(1994-1#1)(1995-4#1)(2007-12#1)(2008-10#3)(2008-2#4)(2008-3#3)
of the detection limit of##3##5##(2008-10#3)
of the detection limit##4##4##(2008-10#4)
of the detection limits##2##4##(2008-10#2)
of the detection method##2##4##(1997-4#1)(2008-2#1)
of the detection of##4##4##(1996-3#1)(2007-11#1)(2008-10#1)(2008-2#1)
of the detection sensitivity##2##4##(2007-9#2)
of the detection##23##3##(1995-6#1)(1996-3#1)(1997-4#1)(2007-11#1)(2007-9#2)(2008-10#9)(2008-2#6)(2008-3#1)(2008-9#1)
of the detector is##2##4##(2008-2#1)(2008-3#1)
of the detector##24##3##(2006-4#1)(2007-12#3)(2008-10#3)(2008-2#8)(2008-3#6)(2008-9#1)(2009-5#1)(2010-12#1)
of the detectors##4##3##(2008-2#3)(2008-3#1)
of the detergent##8##3##(1990-2#1)(1990-5#1)(1990-9#1)(1992-6#1)(1994-12#1)(1994-9#1)(1997-4#1)(2010-12#1)
of the detergents##2##3##(1994-12#2)
of the determinants of##3##4##(1992-2#1)(1995-4#1)(2008-8#1)
of the determinants##5##3##(1992-2#1)(1994-10#1)(1995-4#1)(2008-10#1)(2008-8#1)
of the determination is##2##4##(2008-10#2)
of the determination of##20##4##(1992-5#1)(1996-12#1)(2005-4#2)(2006-4#1)(2008-10#13)(2008-3#1)(2012-12#1)
of the determination was 1##3##5##(2008-10#3)
of the determination was##9##4##(2008-10#9)
of the determination##37##3##(1992-5#1)(1996-12#1)(2005-11#1)(2005-4#3)(2006-4#1)(2008-10#27)(2008-3#1)(2008-5#1)(2012-12#1)
of the determinations were##3##4##(2006-8#1)(2008-10#2)
of the determinations##6##3##(2006-8#1)(2008-10#5)
of the determined##6##3##(1996-8#1)(1997-2#1)(2008-10#1)(2008-3#2)(2008-8#1)
of the deterministic##5##3##(1991-12#2)(2007-9#1)(2008-9#1)(2010-9#1)
of the detuning##2##3##(2007-11#1)(2007-12#1)
of the deuterium##2##3##(1990-7#1)(2008-9#1)
of the deutocerebrum##4##3##(2007-12#4)
of the developed formulation##2##4##(2012-2#2)
of the developed method and##2##5##(2008-10#1)(2008-3#1)
of the developed method for##4##5##(2008-10#4)
of the developed method is##2##5##(2008-10#2)
of the developed method was##8##5##(2007-8#1)(2008-10#6)(2009-2#1)
of the developed method##30##4##(2007-8#1)(2008-10#27)(2008-3#1)(2009-2#1)
of the developed model##3##4##(2007-11#1)(2008-3#1)(2009-3#1)
of the developed procedure##5##4##(2008-10#5)
of the developed system##4##4##(2006-2#1)(2008-10#1)(2008-3#1)(2010-8#1)
of the developed technique##2##4##(2008-10#2)
of the developed##71##3##(1996-2#1)(2006-2#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#49)(2008-3#4)(2008-7#1)(2009-2#1)(2009-3#2)(2010-8#2)(2011-1#1)(2012-2#2)(2012-6#1)(2013-1#2)
of the developing limb##2##4##(2003-11#1)(2009-3#1)
of the developing organism##2##4##(1996-8#1)(2008-9#1)
of the developing rat##3##4##(1993-11#1)(1996-4#1)(1997-2#1)
of the developing world##6##4##(2005-8#1)(2006-10#1)(2007-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
of the developing##42##3##(1992-7#1)(1993-11#1)(1994-2#1)(1995-11#1)(1995-8#1)(1996-10#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#2)(2003-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#5)(2007-4#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#2)
of the development and use of##2##6##(1996-5#1)(2008-10#1)
of the development and##8##4##(1996-5#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#1)(2013-8#1)
of the development of a new##4##6##(1991-10#1)(1995-3#1)(1997-4#1)(2008-5#1)
of the development of a##10##5##(1990-12#1)(1991-10#1)(1992-1#1)(1995-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-11#1)
of the development of the##12##5##(1990-11#1)(1990-6#1)(1995-11#1)(1996-12#1)(2006-4#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-7#1)(2009-2#1)(2009-9#1)(2010-5#1)
of the development of this##2##5##(1994-6#1)(2007-8#1)
of the development of visual##2##5##(1991-12#1)(1992-7#1)
of the development of##78##4##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-3#2)(1991-6#1)(1992-1#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-6#2)(1995-11#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(2004-12#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-4#2)(2007-1#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#4)(2009-7#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#2)
of the development##92##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-3#2)(1991-6#1)(1992-1#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-6#2)(1995-11#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(2004-12#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#2)(2007-1#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-5#2)(2007-8#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#3)(2009-11#1)(2009-2#4)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#1)
of the developmental toxicity of##2##5##(1993-12#1)(1995-2#1)
of the developmental##16##3##(1992-11#1)(1993-12#2)(1995-2#1)(1995-9#1)(1996-9#1)(1997-2#1)(2007-7#1)(2007-8#1)(2008-7#1)(2008-8#2)(2009-12#1)(2012-12#2)(2012-2#1)
of the developments in##4##4##(2006-2#1)(2008-10#1)(2008-12#1)(2012-2#1)
of the developments##6##3##(2005-7#1)(2006-2#1)(2006-4#1)(2008-10#1)(2008-12#1)(2012-2#1)
of the deviance##2##3##(1994-9#1)(1996-3#1)
of the deviation##3##3##(1991-2#1)(2008-12#1)(2008-3#1)
of the device and##5##4##(2008-2#1)(2008-3#1)(2008-9#1)(2010-7#1)(2012-3#1)
of the device are##4##4##(2008-2#3)(2008-3#1)
of the device as a##3##5##(2006-6#1)(2007-12#1)(2008-2#1)
of the device as##5##4##(2006-6#1)(2007-12#1)(2008-2#2)(2008-3#1)
of the device for##3##4##(2006-2#1)(2008-3#1)(2008-5#1)
of the device in the##3##5##(2007-12#1)(2008-11#1)(2008-2#1)
of the device in##7##4##(1992-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-6#1)
of the device is##9##4##(2006-6#1)(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#2)
of the device to the##2##5##(2007-8#1)(2008-11#1)
of the device to##6##4##(1994-3#1)(2007-11#1)(2007-8#1)(2008-11#2)(2008-3#1)
of the device was##3##4##(2007-11#1)(2008-10#1)(2008-11#1)
of the device were##2##4##(2007-8#1)(2008-3#1)
of the device##98##3##(1992-10#2)(1994-3#1)(1996-6#1)(2006-2#2)(2006-6#7)(2007-11#9)(2007-12#7)(2007-7#2)(2007-8#5)(2008-10#3)(2008-11#9)(2008-2#16)(2008-3#13)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#3)(2009-10#1)(2009-7#1)(2010-6#2)(2010-7#3)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)
of the devices##8##3##(1993-12#1)(2007-11#1)(2008-11#1)(2008-3#2)(2008-9#1)(2010-12#1)(2010-6#1)
of the diabetes##5##3##(1993-11#1)(2008-1#1)(2008-3#1)(2008-6#2)
of the diabetic men##2##4##(2008-7#1)(2011-2#1)
of the diabetic##12##3##(1990-3#1)(1994-3#1)(1995-10#1)(2007-1#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-7#1)(2011-11#1)(2011-2#3)
of the diacylglycerol##2##3##(1991-1#1)(1991-9#1)
of the diagnoses were##3##4##(2007-12#2)(2012-12#1)
of the diagnoses##5##3##(1997-8#2)(2007-12#2)(2012-12#1)
of the diagnosis and treatment of##3##6##(2007-11#1)(2009-2#1)(2012-2#1)
of the diagnosis and treatment##4##5##(2007-11#1)(2007-6#1)(2009-2#1)(2012-2#1)
of the diagnosis and##12##4##(1993-10#1)(1993-9#1)(1997-3#1)(2007-11#1)(2007-6#2)(2008-9#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
of the diagnosis of##11##4##(1990-8#1)(1997-3#1)(2006-8#1)(2007-11#1)(2007-5#1)(2010-6#1)(2011-12#2)(2012-12#1)(2013-8#2)
of the diagnosis##45##3##(1990-8#1)(1991-12#2)(1992-6#1)(1993-10#1)(1993-9#1)(1996-4#1)(1996-9#1)(1997-3#2)(2005-12#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-5#3)(2007-6#2)(2007-8#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-6#1)(2011-12#2)(2011-2#7)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#3)
of the diagnostic accuracy of##2##5##(2008-1#1)(2009-11#1)
of the diagnostic and##2##4##(1990-12#1)(1997-2#1)
of the diagnostic approach##2##4##(1992-9#1)(2010-4#1)
of the diagnostic criteria##3##4##(2008-7#1)(2011-2#2)
of the diagnostic process and##2##5##(1990-9#1)(2008-10#1)
of the diagnostic process##4##4##(1990-10#1)(1990-9#1)(2006-12#1)(2008-10#1)
of the diagnostic##35##3##(1990-10#1)(1990-12#1)(1990-9#1)(1992-12#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-5#1)(1994-1#2)(1995-11#1)(1996-3#1)(1997-2#1)(1997-8#1)(2006-12#1)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-7#1)(2009-11#1)(2010-4#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
of the diagonal band of Broca##3##6##(1993-4#1)(1994-3#1)(1997-8#1)
of the diagonal band of##4##5##(1993-4#1)(1994-3#2)(1997-8#1)
of the diagonal band##5##4##(1990-7#1)(1993-4#1)(1994-3#2)(1997-8#1)
of the diagonal##6##3##(1990-7#1)(1993-4#1)(1994-3#2)(1997-8#1)(2007-8#1)
of the dialysate##4##3##(1995-7#1)(2007-9#1)(2008-1#1)(2008-10#1)
of the dialysis system##2##4##(2004-8#1)(2008-1#1)
of the dialysis##12##3##(1996-12#1)(2004-8#1)(2006-8#1)(2007-7#3)(2007-8#2)(2008-1#3)(2008-5#1)
of the dialytic##2##3##(2007-7#2)
of the diameter of the##4##5##(1993-12#1)(2008-2#1)(2008-3#1)(2009-2#1)
of the diameter of##7##4##(1993-12#1)(2005-1#1)(2008-2#1)(2008-3#1)(2009-2#1)(2011-2#1)(2013-8#1)
of the diameter##8##3##(1993-12#1)(2005-1#1)(2008-2#1)(2008-3#1)(2009-2#1)(2011-1#1)(2011-2#1)(2013-8#1)
of the diamond##2##3##(2008-10#1)(2008-2#1)
of the diamondback moth##3##4##(2007-6#2)(2010-4#1)
of the diaphragm are##2##4##(2007-8#2)
of the diaphragm is##5##4##(2007-3#1)(2007-8#1)(2010-5#2)(2012-1#1)
of the diaphragm of##2##4##(1994-4#1)(2009-6#1)
of the diaphragm was repaired##2##5##(2007-8#1)(2012-1#1)
of the diaphragm was##3##4##(1994-4#1)(2007-8#1)(2012-1#1)
of the diaphragm##31##3##(1991-3#1)(1994-4#3)(1997-8#1)(2005-11#1)(2007-3#1)(2007-8#11)(2009-6#1)(2009-8#1)(2010-2#1)(2010-5#2)(2011-2#1)(2012-1#5)(2012-12#1)(2013-1#1)
of the diaphragmatic incision##2##4##(2007-8#2)
of the diaphragmatic##3##3##(1993-10#1)(2007-8#2)
of the diaphysis##3##3##(2009-2#1)(2009-7#2)
of the diastereomers##2##3##(1996-2#1)(2005-12#1)
of the diastolic##5##3##(1996-6#2)(2006-6#1)(2008-8#1)(2011-1#1)
of the diatom Odontella sinensis##2##5##(1993-3#2)
of the diatom##3##3##(1993-3#2)(2010-11#1)
of the diazonium##2##3##(2008-10#2)
of the diblock copolymer##2##4##(2005-11#1)(2009-2#1)
of the diblock##3##3##(2005-11#1)(2008-10#1)(2009-2#1)
of the dielectric constant##3##4##(2005-11#1)(2007-12#1)(2008-7#1)
of the dielectric permittivity of##2##5##(2005-11#2)
of the dielectric permittivity##3##4##(2005-11#2)(2007-11#1)
of the dielectric properties##2##4##(2006-10#2)
of the dielectric response##2##4##(1995-2#1)(2008-2#1)
of the dielectric susceptibility##2##4##(2007-12#2)
of the dielectric##17##3##(1993-5#1)(1995-2#1)(1997-2#1)(2005-11#3)(2006-10#2)(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#1)(2008-7#1)
of the dielectrophoretic force##2##4##(2006-2#2)
of the diencephalon##3##3##(1994-2#1)(1994-9#1)(2009-2#1)
of the diet of##4##4##(1997-3#1)(2007-3#1)(2008-1#1)(2008-5#1)
of the diet was##2##4##(1990-6#1)(2007-3#1)
of the diet with##2##4##(2008-7#1)(2009-5#1)
of the diet##21##3##(1990-6#1)(1990-8#1)(1991-11#2)(1994-6#1)(1997-3#1)(2007-3#3)(2007-5#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#3)(2009-5#1)(2010-4#1)(2013-7#1)
of the dietary##4##3##(1991-11#1)(1995-9#1)(1996-11#1)(2007-2#1)
of the dietitian##3##3##(1993-12#1)(1993-3#1)(1994-2#1)
of the diets##3##3##(1991-11#1)(1991-12#1)(1993-11#1)
of the diferric##2##3##(1997-7#2)
of the difference between the##3##5##(2007-4#1)(2008-5#1)(2008-7#1)
of the difference between##8##4##(2007-4#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-2#1)(2012-3#1)
of the difference in the##4##5##(1993-4#1)(2007-12#1)(2008-1#1)(2011-12#1)
of the difference in##9##4##(1990-11#1)(1993-4#1)(1994-11#1)(1995-11#1)(2005-11#1)(2007-1#1)(2007-12#1)(2008-1#1)(2011-12#1)
of the difference##26##3##(1990-11#1)(1992-11#1)(1993-4#1)(1994-11#1)(1994-4#1)(1995-11#1)(2005-11#1)(2007-1#1)(2007-12#2)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)(2011-12#1)(2012-3#1)
of the differences between##7##4##(1992-2#1)(1994-8#1)(1996-12#1)(1997-6#1)(2007-4#1)(2008-10#1)(2010-3#1)
of the differences in their##2##5##(1996-5#1)(2008-10#1)
of the differences in##15##4##(1992-12#1)(1993-10#1)(1994-10#1)(1996-5#1)(2006-4#1)(2007-2#1)(2008-10#2)(2008-2#2)(2008-3#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-8#1)
of the differences##28##3##(1990-12#1)(1992-12#1)(1992-2#1)(1993-10#1)(1994-10#1)(1994-8#1)(1996-12#1)(1996-5#1)(1997-6#1)(2006-10#1)(2006-4#1)(2007-2#1)(2007-4#1)(2008-10#3)(2008-2#2)(2008-3#3)(2008-5#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
of the different approaches##3##4##(2007-12#1)(2008-10#2)
of the different assays##2##4##(1996-12#1)(2011-1#1)
of the different available##2##4##(2007-11#1)(2009-1#1)
of the different cell##4##4##(1993-7#1)(2008-1#1)(2010-7#1)(2011-1#1)
of the different classes##4##4##(2008-10#1)(2012-12#3)
of the different clinical##3##4##(1991-9#1)(2008-1#1)(2008-8#1)
of the different elements of##2##5##(2008-2#1)(2013-7#1)
of the different forms of##2##5##(2006-7#1)(2010-3#1)
of the different forms##5##4##(1990-12#1)(1992-12#1)(1996-7#1)(2006-7#1)(2010-3#1)
of the different fragments##2##4##(1992-7#1)(1997-1#1)
of the different humic##2##4##(2008-10#2)
of the different imaging techniques##2##5##(2011-2#1)(2012-2#1)
of the different mechanisms##3##4##(1993-3#1)(2006-12#1)(2008-8#1)
of the different members of the##2##6##(1990-5#1)(2005-7#1)
of the different methods##4##4##(2006-2#1)(2006-6#1)(2008-10#1)(2008-2#1)
of the different protein##2##4##(1994-12#1)(2008-10#1)
of the different species of##2##5##(1994-6#1)(2010-10#1)
of the different species##7##4##(1993-11#1)(1994-6#1)(2008-10#2)(2008-5#1)(2010-10#1)(2010-12#1)
of the different structural##3##4##(1995-6#1)(2005-7#1)(2008-10#1)
of the different systems##3##4##(1991-2#1)(2006-6#1)(2007-9#1)
of the different techniques##3##4##(1991-12#1)(2006-10#1)(2008-10#1)
of the different treatment##3##4##(2006-10#1)(2008-7#1)(2011-2#1)
of the different types of##10##5##(1991-10#1)(1991-11#1)(1992-11#1)(1993-11#1)(1996-11#1)(2006-10#1)(2008-10#1)(2010-9#1)(2012-2#1)(2013-1#1)
of the different##225##3##(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#2)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-11#3)(1993-2#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#3)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-7#2)(1996-8#1)(1997-1#3)(1997-2#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-9#1)(2005-11#2)(2005-4#1)(2005-7#3)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#3)(2006-2#2)(2006-5#1)(2006-6#2)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#8)(2008-10#35)(2008-11#6)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#5)(2009-1#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-1#2)(2012-12#4)(2012-2#4)(2012-9#1)(2013-1#5)(2013-7#1)(2013-8#2)
of the differential absorption lidar##2##5##(2008-2#1)(2008-3#1)
of the differential diagnosis of##3##5##(2006-10#1)(2011-1#1)(2012-2#1)
of the differential diagnosis##5##4##(1990-5#1)(2006-10#1)(2007-10#1)(2011-1#1)(2012-2#1)
of the differential group delay (DGD)##2##6##(2007-12#2)
of the differential group delay and##2##6##(2007-11#1)(2007-12#1)
of the differential group delay##5##5##(2007-11#1)(2007-12#4)
of the differential pulse##3##4##(2008-10#3)
of the differential scattering cross section##2##6##(2008-2#1)(2008-3#1)
of the differential##34##3##(1990-5#1)(1993-4#1)(1996-12#1)(1996-4#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#6)(2008-10#7)(2008-2#3)(2008-3#5)(2008-7#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-2#1)
of the differentially expressed proteins##2##5##(2011-3#2)
of the differentially expressed##3##4##(1996-2#1)(2011-3#2)
of the differentially##4##3##(1996-2#1)(2008-7#1)(2011-3#2)
of the differentiated state##4##4##(1994-9#1)(1996-1#1)(1996-3#1)(2008-9#1)
of the differentiated##9##3##(1991-1#1)(1992-1#1)(1994-9#1)(1995-3#1)(1996-1#1)(1996-3#1)(1997-2#1)(2007-11#1)(2008-9#1)
of the differentiation of##3##4##(1991-10#1)(2008-11#1)(2012-2#1)
of the differentiation process##6##4##(1992-3#1)(1994-2#1)(2008-3#3)(2010-6#1)
of the differentiation##17##3##(1991-10#1)(1992-3#1)(1992-8#2)(1993-2#1)(1994-2#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#1)(2010-6#1)(2012-2#1)
of the difficult and##2##4##(1990-12#1)(2009-9#1)
of the difficult##5##3##(1990-12#1)(2006-10#2)(2006-4#1)(2009-9#1)
of the difficulties in##2##4##(1990-10#1)(1995-12#1)
of the difficulties of##5##4##(1990-9#1)(2007-2#1)(2008-2#1)(2013-1#2)
of the difficulties##15##3##(1990-10#2)(1990-9#1)(1995-12#1)(2005-11#1)(2006-10#1)(2007-2#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)(2013-1#3)
of the difficulty in##7##4##(1990-12#1)(2007-9#1)(2008-11#1)(2008-3#1)(2010-3#1)(2013-1#2)
of the difficulty involved in##2##5##(2009-3#1)(2012-2#1)
of the difficulty of##6##4##(1992-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-1#1)(2012-12#1)
of the difficulty##16##3##(1990-12#1)(1992-12#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2009-3#1)(2010-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
of the diffracted light##4##4##(2007-11#1)(2008-2#2)(2008-3#1)
of the diffracted##12##3##(2007-11#1)(2007-12#4)(2008-2#3)(2008-3#4)
of the diffraction efficiency of the##2##6##(2008-2#1)(2008-3#1)
of the diffraction efficiency of##3##5##(2008-2#2)(2008-3#1)
of the diffraction efficiency with##2##5##(2008-2#2)
of the diffraction efficiency##11##4##(2007-12#2)(2008-2#7)(2008-3#2)
of the diffraction limit##2##4##(2008-3#1)(2009-5#1)
of the diffraction orders##3##4##(2008-2#2)(2008-3#1)
of the diffraction pattern##6##4##(2005-11#1)(2007-11#1)(2008-2#2)(2008-3#2)
of the diffraction##38##3##(1992-4#1)(1992-9#1)(2005-11#1)(2007-11#2)(2007-12#5)(2008-2#14)(2008-3#13)(2009-5#1)
of the diffraction-limited spot##2##4##(2008-3#2)
of the diffractive optical##2##4##(2008-2#1)(2008-3#1)
of the diffractive##7##3##(2007-11#2)(2008-2#3)(2008-3#2)
of the diffuse attenuation coefficient##2##5##(2008-3#2)
of the diffuse backscattering##2##4##(2008-3#2)
of the diffuse reflectivity of##2##5##(2008-3#2)
of the diffuse##11##3##(2005-11#1)(2007-12#1)(2008-3#8)(2012-12#1)
of the diffuse-sunlight##2##3##(2008-3#2)
of the diffuser as##2##4##(2008-2#2)
of the diffuser##5##3##(2007-11#1)(2008-2#4)
of the diffusion abnormality at 48 hours##2##7##(2007-10#2)
of the diffusion abnormality##3##4##(2007-10#3)
of the diffusion approximation in##2##5##(2008-2#1)(2008-3#1)
of the diffusion approximation##8##4##(2007-12#1)(2008-2#4)(2008-3#3)
of the diffusion coefficient of##2##5##(2005-11#1)(2008-3#1)
of the diffusion coefficient##5##4##(2005-11#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)
of the diffusion equation for##2##5##(2008-2#2)
of the diffusion equation##9##4##(2007-11#2)(2007-12#1)(2008-2#5)(2008-3#1)
of the diffusion##31##3##(1990-12#1)(2005-11#2)(2005-12#1)(2007-10#3)(2007-11#2)(2007-12#3)(2007-8#1)(2008-2#11)(2008-3#5)(2008-5#1)(2008-7#1)
of the digastric##2##3##(1990-9#1)(2010-11#1)
of the digest##2##3##(1996-8#1)(1997-2#1)
of the digestion##5##3##(1992-7#1)(2008-10#3)(2008-5#1)
of the digestive system##4##4##(2006-8#2)(2008-5#1)(2009-10#1)
of the digestive tract of 4 authoctonous species of fishes##2##10##(2007-11#2)
of the digestive tract of##3##5##(2007-11#2)(2008-5#1)
of the digestive tract was##2##5##(1990-6#1)(2010-12#1)
of the digestive tract##20##4##(1990-6#1)(1990-8#2)(1991-6#1)(1991-9#1)(1993-10#1)(1993-8#1)(2006-2#1)(2007-11#2)(2008-4#1)(2008-5#1)(2009-2#1)(2010-12#4)(2011-2#3)
of the digestive##29##3##(1990-6#1)(1990-8#2)(1991-4#1)(1991-6#1)(1991-9#1)(1993-10#1)(1993-8#1)(2006-2#1)(2006-8#2)(2007-11#2)(2007-12#1)(2008-4#1)(2008-5#2)(2009-10#1)(2009-2#1)(2010-12#5)(2010-8#1)(2011-2#3)(2013-1#1)
of the digital##11##3##(2004-9#2)(2006-3#1)(2007-7#1)(2008-10#1)(2008-2#3)(2008-7#1)(2008-9#2)
of the dihydropyridine##4##3##(1990-7#1)(1991-1#1)(1993-4#1)(1996-3#1)
of the diiron clusters##2##4##(1995-10#2)
of the diiron##3##3##(1991-8#1)(1995-10#2)
of the dilated##3##3##(1991-3#1)(2006-2#1)(2008-10#1)
of the dimensional##3##3##(2007-12#1)(2008-4#1)(2012-2#1)
of the dimensionless##3##3##(2005-11#2)(2009-6#1)
of the dimensions##3##3##(1991-12#1)(2004-10#1)(2009-2#1)
of the dimer is##2##4##(1991-4#1)(2008-10#1)
of the dimer##15##3##(1991-4#1)(1991-7#1)(1992-1#1)(1995-5#1)(1996-11#1)(1996-8#1)(1997-7#1)(2006-12#3)(2008-10#2)(2008-7#1)(2008-8#2)
of the dimeric structure##2##4##(1990-5#1)(1991-4#1)
of the dimeric##8##3##(1990-5#1)(1991-4#1)(1995-5#1)(1995-8#1)(1996-8#1)(2008-10#1)(2010-2#2)
of the dimerization equilibrium##2##4##(2008-10#2)
of the dimerization##3##3##(2008-10#3)
of the dimers was##2##4##(2009-9#2)
of the dimers##6##3##(1997-1#1)(2005-11#1)(2005-4#1)(2006-4#1)(2009-9#2)
of the dimorphic##2##3##(2008-5#1)(2013-7#1)
of the dinuclear iron centers##2##5##(1995-10#2)
of the dinuclear iron##3##4##(1995-10#2)(1997-4#1)
of the dinuclear##7##3##(1995-10#2)(1995-11#1)(1996-2#2)(1997-4#1)(2007-11#1)
of the dinucleotide##4##3##(1993-3#1)(1996-7#1)(1997-6#1)(2008-4#1)
of the diode laser##2##4##(2007-12#1)(2008-10#1)
of the diode##8##3##(2007-12#3)(2008-10#1)(2008-3#4)
of the diode-laser sensor##2##4##(2008-2#1)(2008-3#1)
of the diodes##3##3##(2008-2#1)(2008-3#2)
of the diol##2##3##(1991-5#1)(2008-7#1)
of the dioptric##2##3##(1992-7#1)(2007-12#1)
of the dioxin-responsive##2##3##(1992-8#1)(2006-12#1)
of the dioxygen##3##3##(1990-10#1)(1997-4#1)(2010-5#1)
of the dipeptide##2##3##(1990-9#1)(2006-7#1)
of the diploid##2##3##(1991-8#1)(2008-11#1)
of the dipolar##2##3##(1991-3#1)(1994-5#1)
of the dipole particles##2##4##(1992-12#2)
of the dipole##8##3##(1992-12#2)(1992-6#1)(2007-11#2)(2007-12#1)(2008-3#1)(2010-8#1)
of the direct and##2##4##(1990-8#1)(1992-1#1)
of the direct##20##3##(1990-8#1)(1991-3#2)(1991-6#1)(1992-1#1)(1992-9#1)(1994-2#1)(2007-12#1)(2008-10#7)(2008-2#2)(2008-3#1)(2009-2#1)(2012-2#1)
of the direct-binary-search algorithm for hologram synthesis##2##7##(2008-3#2)
of the direction of the##2##5##(2008-3#1)(2008-5#1)
of the direction of##8##4##(1996-1#1)(1997-3#1)(1997-8#1)(2008-3#3)(2008-5#1)(2008-8#1)
of the direction##12##3##(1992-2#1)(1993-12#1)(1996-1#1)(1997-3#1)(1997-8#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#1)
of the directly##2##3##(2007-8#1)(2008-10#1)
of the director##2##3##(2008-3#2)
of the disability##4##3##(2006-8#1)(2007-11#1)(2008-9#1)(2011-2#1)
of the disabled##3##3##(1995-2#1)(1995-5#1)(2005-11#1)
of the disaccharide##2##3##(1992-6#1)(1995-11#1)
of the disadvantages of##2##4##(2006-5#1)(2007-2#1)
of the disadvantages##4##3##(2006-5#1)(2007-2#1)(2008-3#1)(2012-12#1)
of the disaster##4##3##(1991-2#1)(2008-2#1)(2008-8#1)(2013-1#1)
of the disc##13##3##(1994-11#1)(1996-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-8#2)(2009-4#4)(2010-12#1)(2011-2#1)
of the discharge needs##2##4##(2007-10#2)
of the discharge##4##3##(2007-10#2)(2007-12#1)(2008-3#1)
of the discharges##2##3##(1990-5#1)(1992-2#1)
of the discipline##3##3##(2008-5#1)(2009-2#1)(2010-7#1)
of the disciplines of##2##4##(2008-10#1)(2008-4#1)
of the disciplines##4##3##(1991-2#1)(2008-10#1)(2008-4#1)(2012-2#1)
of the discolored region##2##4##(1995-11#2)
of the discolored##3##3##(1995-11#3)
of the discomfort##3##3##(1996-9#1)(2008-12#1)(2008-4#1)
of the discontinuous##2##3##(1996-5#1)(2008-3#1)
of the discount##2##3##(1997-1#1)(2006-8#1)
of the discovered##2##3##(2008-1#1)(2008-9#1)
of the discovery and##3##4##(1996-3#1)(1997-1#1)(2008-6#1)
of the discovery of##4##4##(2009-10#1)(2009-12#1)(2009-2#2)
of the discovery##9##3##(1995-12#1)(1996-3#1)(1997-1#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-12#1)(2009-2#2)
of the discrepancies##5##3##(1992-2#1)(1994-9#1)(2008-4#1)(2008-7#1)(2008-9#1)
of the discrepancy between##3##4##(1990-8#1)(2007-1#1)(2008-8#1)
of the discrepancy##6##3##(1990-8#1)(2007-1#1)(2008-2#1)(2008-8#1)(2010-9#1)(2012-2#1)
of the discrete##2##3##(2006-5#1)(2008-3#1)
of the discriminant##2##3##(2007-9#1)(2008-10#1)
of the discrimination##2##3##(1992-7#1)(2011-1#1)
of the discriminations##2##3##(1993-12#2)
of the discriminator base##2##4##(1992-9#2)
of the discussion##6##3##(1995-11#1)(2006-10#2)(2008-10#1)(2008-11#1)(2008-9#1)
of the discussions##3##3##(1993-9#1)(2008-3#1)(2011-2#1)
of the disease after##2##4##(2007-2#1)(2007-8#1)
of the disease among##2##4##(1993-2#1)(2011-2#1)
of the disease and a##2##5##(2007-7#1)(2008-8#1)
of the disease and its treatment##2##6##(1991-2#1)(2009-1#1)
of the disease and its##7##5##(1991-2#1)(1995-4#1)(2008-1#1)(2008-2#1)(2008-5#1)(2009-1#1)(2012-12#1)
of the disease and the lack of##2##7##(2005-8#1)(2007-10#1)
of the disease and the treatment##2##6##(2007-12#1)(2013-7#1)
of the disease and the##20##5##(1991-6#1)(2004-3#1)(2005-8#1)(2006-4#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-8#1)(2010-12#1)(2010-9#1)(2012-12#2)(2013-7#1)
of the disease and##80##4##(1990-3#1)(1990-9#1)(1991-2#1)(1991-6#1)(1992-11#1)(1993-1#1)(1993-8#1)(1994-6#1)(1995-4#1)(1995-6#1)(1995-9#1)(1997-8#1)(2004-3#1)(2004-9#1)(2005-11#2)(2005-8#2)(2006-1#1)(2006-10#1)(2006-11#1)(2006-2#2)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#3)(2009-1#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-12#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-1#2)(2012-12#4)(2013-1#2)(2013-7#1)(2013-8#1)
of the disease and/or##2##4##(1991-9#1)(2012-2#1)
of the disease are not##2##5##(2008-9#1)(2013-1#1)
of the disease are the##2##5##(1990-9#1)(2008-9#1)
of the disease are##19##4##(1990-9#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1993-6#1)(1994-11#1)(2005-7#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-11#1)(2012-3#1)(2013-1#1)
of the disease as well as##2##6##(2008-3#1)(2008-8#1)
of the disease as##8##4##(1992-11#1)(1993-11#1)(1997-2#1)(2008-11#3)(2008-3#1)(2008-8#1)
of the disease at##5##4##(1995-8#1)(2007-2#1)(2008-6#1)(2010-9#1)(2011-1#1)
of the disease both##2##4##(2007-7#1)(2008-7#1)
of the disease but##4##4##(1993-1#1)(2008-10#1)(2008-7#1)(2013-1#1)
of the disease by##4##4##(1993-11#1)(2008-3#1)(2008-4#2)
of the disease can be##4##5##(2005-7#1)(2007-7#1)(2008-9#1)(2010-6#1)
of the disease can##7##4##(2005-7#1)(2007-7#1)(2008-10#1)(2008-4#2)(2008-9#1)(2010-6#1)
of the disease caused##2##4##(2009-5#1)(2011-2#1)
of the disease cycle##3##4##(2008-10#3)
of the disease during##2##4##(1992-9#1)(2006-6#1)
of the disease for##2##4##(2006-6#1)(2010-11#1)
of the disease from##5##4##(2006-2#1)(2008-10#2)(2008-8#1)(2010-4#1)
of the disease gene##3##4##(1993-1#1)(1995-5#1)(1997-8#1)
of the disease has been##5##5##(1995-6#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-4#1)
of the disease has changed##2##5##(2007-12#1)(2013-8#1)
of the disease has##12##4##(1991-9#1)(1995-6#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-12#1)(2013-8#1)
of the disease have##2##4##(1995-1#1)(2008-1#1)
of the disease in 2##2##5##(1991-8#1)(1992-6#1)
of the disease in Iceland##2##5##(2006-10#1)(2006-8#1)
of the disease in a##3##5##(2006-10#1)(2007-7#1)(2008-10#1)
of the disease in our##2##5##(1993-5#1)(1995-4#1)
of the disease in patients with##2##6##(2008-10#1)(2010-12#1)
of the disease in the##9##5##(1990-9#1)(1994-9#1)(1996-7#1)(2007-2#2)(2008-10#2)(2008-8#1)(2010-10#1)
of the disease in this##2##5##(1990-11#1)(2008-10#1)
of the disease in##45##4##(1990-11#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-8#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-5#1)(1994-9#1)(1995-2#1)(1995-4#1)(1996-12#1)(1996-7#1)(1997-6#1)(2006-10#2)(2006-8#1)(2007-12#2)(2007-2#3)(2007-6#1)(2007-7#2)(2008-10#10)(2008-8#1)(2009-3#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-3#1)
of the disease increased##2##4##(2008-6#1)(2013-8#1)
of the disease is discussed##3##5##(2004-11#1)(2012-12#1)(2013-8#1)
of the disease is highly variable##2##6##(2007-8#1)(2008-7#1)
of the disease is necessary##2##5##(2005-11#1)(2008-2#1)
of the disease is still##2##5##(2012-2#2)
of the disease is unknown##3##5##(1991-11#1)(2010-5#1)(2012-2#1)
of the disease is##40##4##(1991-11#1)(1991-2#1)(1991-8#1)(1992-10#1)(1992-5#1)(1992-8#1)(1996-6#1)(2004-11#1)(2005-1#1)(2005-11#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-2#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-8#2)
of the disease itself##3##4##(1990-6#1)(2005-11#1)(2008-10#1)
of the disease may be##3##5##(2005-11#1)(2009-10#1)(2011-2#1)
of the disease may##5##4##(2005-11#1)(2008-7#1)(2009-10#1)(2009-2#1)(2011-2#1)
of the disease of##4##4##(1997-8#1)(2006-9#1)(2007-12#1)(2008-8#1)
of the disease on##3##4##(1990-3#1)(2012-1#1)(2012-3#1)
of the disease or##4##4##(1994-12#1)(2010-5#1)(2010-6#1)(2012-2#1)
of the disease over##2##4##(1994-11#1)(2013-7#1)
of the disease process and##3##5##(2008-3#1)(2010-8#1)(2013-8#1)
of the disease process##13##4##(1995-5#1)(1996-8#1)(2006-10#4)(2008-10#1)(2008-3#1)(2008-9#1)(2010-3#1)(2010-8#1)(2012-3#1)(2013-8#1)
of the disease progress curve##3##5##(2008-10#3)
of the disease regardless##2##4##(1990-11#1)(2008-10#1)
of the disease should##2##4##(2008-10#1)(2013-1#1)
of the disease shows##2##4##(1993-2#1)(2006-10#1)
of the disease stage##2##4##(2010-12#1)(2011-2#1)
of the disease status of##2##5##(1992-3#1)(2008-10#1)
of the disease through##7##4##(2005-7#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#2)(2012-12#1)
of the disease to the##2##5##(1993-7#1)(2011-2#1)
of the disease to##5##4##(1993-7#1)(2008-10#1)(2009-3#2)(2011-2#1)
of the disease varies##2##4##(2006-1#1)(2007-11#1)
of the disease was also##2##5##(2006-12#1)(2007-8#1)
of the disease was##22##4##(1990-9#2)(1991-8#1)(1992-8#1)(1994-6#1)(1997-5#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#2)(2008-10#3)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)
of the disease were studied##3##5##(1991-5#1)(2008-5#1)(2008-7#1)
of the disease were##8##4##(1990-10#1)(1991-5#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)
of the disease will##2##4##(2006-2#1)(2013-8#1)
of the disease with##7##4##(1990-2#1)(1996-1#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-7#1)(2011-2#1)
of the disease##858##3##(1990-10#3)(1990-11#4)(1990-2#3)(1990-3#3)(1990-4#2)(1990-5#2)(1990-6#7)(1990-8#2)(1990-9#6)(1991-10#1)(1991-11#3)(1991-12#6)(1991-2#3)(1991-3#1)(1991-4#4)(1991-5#4)(1991-6#5)(1991-7#1)(1991-8#6)(1991-9#8)(1992-10#4)(1992-11#4)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#4)(1992-8#5)(1992-9#2)(1993-1#4)(1993-10#1)(1993-11#11)(1993-12#2)(1993-2#4)(1993-3#2)(1993-5#1)(1993-6#3)(1993-7#2)(1993-8#5)(1993-9#5)(1994-11#3)(1994-12#1)(1994-3#2)(1994-5#2)(1994-6#9)(1994-8#1)(1994-9#4)(1995-1#2)(1995-11#1)(1995-2#3)(1995-4#4)(1995-5#2)(1995-6#3)(1995-8#1)(1995-9#2)(1996-1#3)(1996-11#2)(1996-12#4)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-2#2)(1997-3#6)(1997-5#1)(1997-6#4)(1997-8#6)(2004-11#1)(2004-3#1)(2004-9#1)(2005-1#2)(2005-10#1)(2005-11#9)(2005-12#1)(2005-5#1)(2005-7#6)(2005-8#7)(2006-1#2)(2006-10#26)(2006-11#3)(2006-12#4)(2006-2#10)(2006-4#5)(2006-6#14)(2006-7#1)(2006-8#7)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#34)(2007-12#14)(2007-2#11)(2007-3#5)(2007-4#1)(2007-5#5)(2007-6#5)(2007-7#26)(2007-8#19)(2007-9#2)(2008-1#17)(2008-10#71)(2008-11#12)(2008-12#3)(2008-2#3)(2008-3#9)(2008-4#16)(2008-5#12)(2008-6#10)(2008-7#28)(2008-8#13)(2008-9#10)(2009-1#2)(2009-10#4)(2009-11#2)(2009-2#6)(2009-3#5)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#4)(2010-1#2)(2010-10#4)(2010-11#3)(2010-12#19)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#4)(2010-8#6)(2010-9#4)(2011-1#9)(2011-12#2)(2011-2#38)(2011-3#1)(2012-1#9)(2012-11#1)(2012-12#13)(2012-2#11)(2012-3#10)(2013-1#20)(2013-7#4)(2013-8#17)
of the disease-causing strain##2##4##(1993-9#2)
of the diseased##8##3##(1994-11#1)(1996-12#1)(2007-11#1)(2008-10#2)(2011-2#1)(2012-2#1)(2012-3#1)
of the diseases of the##2##5##(1992-10#1)(1997-1#1)
of the diseases##20##3##(1992-10#1)(1993-11#1)(1997-1#1)(2005-10#1)(2005-7#1)(2006-10#1)(2008-1#1)(2008-10#6)(2008-3#2)(2008-5#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)
of the dish##4##3##(2011-2#4)
of the dishes##2##3##(1995-8#1)(2008-11#1)
of the disk##12##3##(1995-11#1)(2007-8#1)(2008-2#3)(2008-3#6)(2009-3#1)
of the disks##2##3##(2008-10#1)(2008-2#1)
of the dislocated##3##3##(2008-4#1)(2009-4#1)(2011-2#1)
of the dislocation##2##3##(2008-2#2)
of the disorder and the##2##5##(2007-11#1)(2008-7#1)
of the disorder and##5##4##(2007-11#1)(2008-2#1)(2008-7#2)(2008-9#1)
of the disorder are##2##4##(2012-12#1)(2013-7#1)
of the disorder in##2##4##(1997-8#1)(2008-1#1)
of the disorder is##2##4##(2006-8#1)(2007-11#1)
of the disorder to##2##4##(1996-3#1)(2006-3#1)
of the disorder##64##3##(1990-10#1)(1993-9#1)(1994-11#4)(1995-5#1)(1996-12#3)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-3#1)(2005-8#1)(2006-10#4)(2006-3#1)(2006-8#1)(2006-9#3)(2007-1#1)(2007-11#4)(2008-1#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-6#2)(2008-7#4)(2008-9#1)(2009-4#1)(2010-1#1)(2010-11#1)(2010-3#1)(2011-1#2)(2011-12#2)(2011-2#3)(2012-12#2)(2013-7#2)(2013-8#1)
of the disordered##2##3##(1990-2#1)(2006-3#1)
of the disorders that##2##4##(2006-4#1)(2008-3#1)
of the disorders##8##3##(1996-12#1)(1997-5#1)(2006-3#1)(2006-4#1)(2008-1#1)(2008-3#1)(2013-1#1)(2013-7#1)
of the disparity##4##3##(1990-8#1)(2008-2#1)(2008-3#1)(2010-9#1)
of the dispersal##3##3##(2008-10#2)(2009-2#1)
of the dispersed##2##3##(2007-12#1)(2008-10#1)
of the dispersing detergent##3##4##(1991-7#3)
of the dispersion in the##2##5##(1997-5#1)(2007-12#1)
of the dispersion of##2##4##(2007-11#1)(2007-12#1)
of the dispersion##14##3##(1997-5#1)(2005-11#1)(2007-11#1)(2007-12#8)(2008-2#3)
of the dispersions##2##3##(2007-12#1)(2013-1#1)
of the dispersive##2##3##(2007-11#1)(2007-12#1)
of the displaced##4##3##(1991-9#1)(2011-12#1)(2012-12#2)
of the displacement of##2##4##(2010-7#1)(2013-1#1)
of the displacement##6##3##(2007-7#1)(2008-3#1)(2008-7#1)(2009-7#1)(2010-7#1)(2013-1#1)
of the displacements of##2##4##(2007-12#1)(2008-2#1)
of the displacements##3##3##(2007-12#1)(2008-2#2)
of the display##5##3##(1992-7#1)(2008-3#3)(2013-8#1)
of the dissected##4##3##(2006-4#1)(2007-8#1)(2008-11#1)(2008-2#1)
of the dissection##4##3##(1993-10#1)(2007-8#2)(2010-10#1)
of the dissociation and##2##4##(1996-8#1)(2008-10#1)
of the dissociation constants of the##2##6##(1993-8#1)(1996-5#1)
of the dissociation constants of##3##5##(1993-8#1)(1996-5#1)(2008-10#1)
of the dissociation constants##7##4##(1991-5#1)(1992-3#1)(1993-8#1)(1994-9#1)(1996-5#1)(2005-11#1)(2008-10#1)
of the dissociation##14##3##(1990-7#1)(1991-5#1)(1992-3#1)(1993-8#1)(1994-9#1)(1996-10#1)(1996-5#1)(1996-8#1)(2005-11#3)(2008-10#3)
of the dissolution##5##3##(2005-11#2)(2010-12#1)(2010-3#1)(2010-5#1)
of the dissolved organic carbon##2##5##(2008-10#2)
of the dissolved oxygen##2##4##(1994-2#1)(2008-10#1)
of the dissolved##8##3##(1994-2#1)(2008-10#7)
of the distal end of the##3##6##(1993-11#1)(1997-6#1)(2007-8#1)
of the distal esophagus##4##4##(2006-10#1)(2009-3#1)(2013-1#2)
of the distal femoral##3##4##(1993-8#1)(2007-7#1)(2013-1#1)
of the distal femur##5##4##(1993-8#1)(2008-6#1)(2011-12#1)(2011-2#1)(2013-1#1)
of the distal interphalangeal joint##2##5##(2006-3#2)
of the distal lung in##2##5##(1991-12#1)(2005-8#1)
of the distal phalanx##2##4##(1992-3#1)(2006-3#1)
of the distal radioulnar joint##2##5##(2006-4#1)(2012-2#1)
of the distal radius and##3##5##(2006-3#2)(2012-2#1)
of the distal radius is##2##5##(2006-3#1)(2009-3#1)
of the distal radius##23##4##(2006-3#8)(2006-4#2)(2008-9#6)(2009-3#3)(2012-2#3)(2013-1#1)
of the distal rectum##2##4##(2011-2#1)(2012-1#1)
of the distal tibia##4##4##(1993-11#1)(2007-8#2)(2011-2#1)
of the distal ulna##3##4##(2006-6#1)(2009-3#2)
of the distal##101##3##(1990-8#1)(1991-12#1)(1992-3#1)(1993-11#2)(1993-6#1)(1993-8#2)(1996-11#1)(1996-9#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-11#1)(2005-8#1)(2006-10#1)(2006-3#11)(2006-4#3)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#6)(2007-8#8)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#10)(2009-3#6)(2010-11#1)(2010-12#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#6)(2013-1#6)(2013-8#1)
of the distance between the##4##5##(1993-3#1)(2007-11#1)(2008-2#1)(2008-3#1)
of the distance between##5##4##(1993-3#1)(1995-8#1)(2007-11#1)(2008-2#1)(2008-3#1)
of the distance from##2##4##(2008-10#1)(2008-3#1)
of the distance##13##3##(1991-11#1)(1993-3#1)(1995-8#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-7#1)
of the distances##3##3##(2007-3#1)(2008-10#1)(2008-2#1)
of the distinct##4##3##(1997-1#1)(1997-7#1)(2010-9#1)(2012-1#1)
of the distinction between##3##4##(2008-12#1)(2013-1#1)(2013-8#1)
of the distinctions between##2##4##(2008-11#1)(2008-12#1)
of the distinctive##4##3##(2005-12#1)(2008-10#1)(2010-3#1)(2013-8#1)
of the distraction##2##3##(2008-4#1)(2011-2#1)
of the distributed##2##3##(2007-12#1)(2007-3#1)
of the distribution and##6##4##(1995-11#1)(1997-8#1)(2006-4#1)(2008-10#1)(2008-2#1)(2008-4#1)
of the distribution function##2##4##(2008-2#1)(2008-3#1)
of the distribution of the##6##5##(1995-12#1)(1995-6#1)(1996-1#1)(2008-10#1)(2008-2#1)(2012-12#1)
of the distribution of##38##4##(1991-2#1)(1992-2#1)(1992-6#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-11#1)(2007-5#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-8#5)(2008-9#2)(2009-5#1)(2010-10#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
of the distribution ratio##2##4##(2008-10#2)
of the distribution##59##3##(1991-2#1)(1992-2#1)(1992-6#1)(1995-11#2)(1995-12#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-4#1)(2007-5#1)(2008-10#12)(2008-11#1)(2008-2#5)(2008-3#4)(2008-4#1)(2008-6#1)(2008-8#5)(2008-9#2)(2009-5#1)(2010-10#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)
of the distributions##5##3##(1990-7#1)(1996-3#1)(1996-7#1)(2008-10#1)(2008-2#1)
of the district##5##3##(1993-3#1)(1996-1#1)(1997-6#1)(2009-6#2)
of the districts in each province##2##6##(2011-12#2)
of the disturbance##4##3##(2005-11#1)(2008-3#1)(2008-9#1)(2011-12#1)
of the disturbed##2##3##(1997-4#1)(2012-1#1)
of the disturbing##3##3##(2008-3#3)
of the disulfide bond on the##2##6##(1993-3#1)(1995-8#1)
of the disulfide bond##9##4##(1991-1#3)(1993-3#2)(1993-4#1)(1994-5#1)(1995-8#1)(1997-4#1)
of the disulfide bonds##4##4##(1990-5#1)(1991-2#2)(1993-8#1)
of the disulfide##16##3##(1990-5#1)(1991-1#3)(1991-2#2)(1993-3#2)(1993-4#1)(1993-8#1)(1994-5#2)(1995-6#1)(1995-8#1)(1997-4#1)(2006-4#1)
of the disulphide##2##3##(2008-10#2)
of the dither modulation##2##4##(2007-12#2)
of the diuretic amiloride##2##4##(2008-10#1)(2008-4#1)
of the diuretic##3##3##(2007-1#1)(2008-10#1)(2008-4#1)
of the diurnal rhythm##2##4##(1993-1#1)(2007-11#1)
of the diurnal##3##3##(1990-8#1)(1993-1#1)(2007-11#1)
of the divalent##3##3##(1994-5#1)(1996-7#1)(2008-10#1)
of the divergence of##2##4##(2008-3#1)(2010-3#1)
of the divergent##2##3##(1995-11#1)(1996-11#1)
of the diverse##7##3##(1991-9#1)(2005-11#1)(2008-1#2)(2008-3#1)(2008-4#1)(2008-7#1)
of the diversification##2##3##(1991-1#1)(2011-2#1)
of the diversity of##6##4##(1990-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
of the diversity##10##3##(1990-12#1)(1997-3#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-8#1)(2012-3#1)(2013-1#1)
of the diverticulum##4##3##(1991-6#1)(1992-1#1)(2012-2#2)
of the division of##2##4##(2005-8#1)(2008-8#1)
of the division##3##3##(1995-8#1)(2005-8#1)(2008-8#1)
of the dnaA region of the##2##6##(1996-12#2)
of the doctor##6##3##(1992-11#1)(1997-6#1)(2004-3#1)(2008-4#1)(2008-5#1)(2010-12#1)
of the doctor's##4##3##(1992-3#1)(1992-4#1)(1993-7#1)(2013-1#1)
of the doctor-patient relationship in##2##5##(2011-2#2)
of the doctor-patient relationship##3##4##(2008-3#1)(2011-2#2)
of the doctor-patient##5##3##(1997-6#2)(2008-3#1)(2011-2#2)
of the doctors##7##3##(1991-6#1)(1992-2#1)(1993-5#1)(1995-6#1)(1996-12#1)(1996-8#1)(2008-5#1)
of the document##4##3##(2007-9#1)(2011-1#1)(2011-2#1)(2013-7#1)
of the documented##3##3##(1992-11#1)(2007-2#1)(2008-11#1)
of the does##2##3##(1993-7#1)(2006-5#1)
of the dog##7##3##(1991-3#1)(1995-11#1)(1996-12#1)(1997-5#1)(2004-12#1)(2008-8#2)
of the dogs##8##3##(1990-11#1)(1991-6#1)(1992-5#2)(2004-9#1)(2007-8#1)(2012-3#2)
of the dolichyl moiety##2##4##(1994-8#2)
of the domain II##3##4##(1995-1#3)
of the domain##15##3##(1991-8#1)(1991-9#1)(1994-12#1)(1994-9#1)(1995-1#4)(1996-10#1)(1996-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-2#1)
of the domain-inverted##2##3##(2007-12#1)(2008-2#1)
of the domains##8##3##(1991-7#1)(1994-5#1)(1994-8#1)(1996-11#1)(2007-12#1)(2008-11#1)(2011-1#1)(2012-3#1)
of the dome##2##3##(2008-5#1)(2010-5#1)
of the domestic##5##3##(1997-2#1)(2007-12#1)(2008-12#1)(2008-5#1)(2008-8#1)
of the dominant consequent matrix##2##5##(2008-2#2)
of the dominant##19##3##(1990-11#1)(1992-9#1)(1995-6#1)(1997-2#1)(2006-4#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#2)(2008-8#1)(2010-3#1)(2010-5#1)(2012-3#1)(2013-1#1)
of the dominating##2##3##(1996-8#1)(2008-2#1)
of the donation##3##3##(2011-2#1)(2012-11#1)(2013-8#1)
of the donor lipid##2##4##(1994-11#2)
of the donor site##4##4##(2006-3#1)(2009-9#1)(2011-12#1)(2011-2#1)
of the donor##25##3##(1990-4#1)(1991-12#1)(1991-7#1)(1993-12#1)(1994-11#2)(1994-6#1)(1994-9#1)(2005-11#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#1)(2009-9#1)(2010-10#1)(2011-12#1)(2011-2#6)(2013-8#1)
of the donor's##2##3##(1994-9#1)(2011-2#1)
of the donors##10##3##(1990-5#3)(1992-5#1)(1994-9#1)(1997-1#1)(2008-7#1)(2011-2#1)(2013-8#2)
of the dopamine D2 receptor##3##5##(1993-11#1)(1995-3#2)
of the dopamine D3 receptor##2##5##(1995-2#1)(1996-12#1)
of the dopamine agonist##2##4##(1992-9#1)(2008-7#1)
of the dopamine receptor##2##4##(1990-5#1)(1995-3#1)
of the dopamine transporter##3##4##(1996-4#2)(2009-4#1)
of the dopamine uptake system##2##5##(1995-11#2)
of the dopamine##25##3##(1990-10#1)(1990-5#1)(1992-9#1)(1993-11#1)(1994-2#1)(1994-5#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#3)(1996-12#1)(1996-4#3)(1996-5#1)(1997-7#1)(2007-2#1)(2008-7#2)(2009-4#1)(2013-1#1)
of the dopaminergic and##2##4##(1991-5#1)(2008-12#1)
of the dopaminergic antagonist##2##4##(1993-5#1)(1995-5#1)
of the dopaminergic system in##3##5##(1996-12#1)(2008-11#2)
of the dopaminergic system##5##4##(1994-5#1)(1996-12#1)(2008-11#3)
of the dopaminergic##15##3##(1991-5#1)(1992-10#1)(1992-8#1)(1993-5#1)(1994-5#1)(1995-5#1)(1995-7#1)(1996-12#1)(2008-11#4)(2008-12#1)(2009-2#1)(2009-6#1)
of the doped##2##3##(2007-11#1)(2009-2#1)
of the dorsal and ventral##3##5##(1996-11#1)(1996-12#1)(2009-2#1)
of the dorsal and##5##4##(1991-12#1)(1994-2#1)(1996-11#1)(1996-12#1)(2009-2#1)
of the dorsal hippocampus##3##4##(1991-5#1)(1992-8#1)(1995-12#1)
of the dorsal horn in##2##5##(1991-5#1)(1997-3#1)
of the dorsal horn of the##2##6##(1990-4#1)(1995-12#1)
of the dorsal horn##13##4##(1990-4#1)(1990-7#2)(1991-5#1)(1993-12#1)(1995-12#2)(1995-3#1)(1996-12#1)(1997-3#3)(2008-9#1)
of the dorsal nucleus of the lateral lemniscus##2##8##(1997-3#2)
of the dorsal nucleus of##3##5##(1991-7#1)(1997-3#2)
of the dorsal prestriate cortex##2##5##(1993-9#2)
of the dorsal rami##2##4##(2006-7#1)(2006-8#1)
of the dorsal root ganglion##2##5##(2006-8#1)(2011-2#1)
of the dorsal root##4##4##(1990-4#1)(1996-5#1)(2006-8#1)(2011-2#1)
of the dorsal##66##3##(1990-4#2)(1990-7#2)(1991-12#1)(1991-3#2)(1991-5#3)(1991-7#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-5#1)(1993-7#1)(1993-9#2)(1994-2#1)(1994-9#1)(1995-12#4)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#2)(1997-1#1)(1997-3#5)(1997-7#2)(2006-3#2)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#3)(2007-12#2)(2007-5#1)(2007-8#1)(2008-11#1)(2008-5#4)(2008-9#1)(2009-2#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
of the dorsalis pedis artery##2##5##(2010-7#2)
of the dorsolateral##5##3##(1991-5#1)(1994-2#1)(2006-9#1)(2007-12#2)
of the dorsomedial and dorsolateral caudate-putamen##2##6##(1994-2#2)
of the dorsomedial##4##3##(1994-2#4)
of the dorsoventral axis in the##2##6##(1991-5#1)(2010-4#1)
of the dosage##3##3##(2005-10#1)(2007-12#1)(2008-11#1)
of the dose at##3##4##(1994-11#1)(2010-9#2)
of the dose was recovered in the caval##2##8##(1991-7#2)
of the dose was##3##4##(1990-3#1)(1991-7#2)
of the dose##26##3##(1990-3#4)(1991-7#2)(1992-10#2)(1992-4#1)(1993-1#1)(1993-4#1)(1994-11#2)(1994-3#1)(1994-6#1)(1995-3#1)(1996-2#1)(1996-6#1)(1997-8#1)(2006-12#1)(2008-3#2)(2008-7#2)(2010-9#2)
of the dose-response curve for the##2##6##(1990-7#1)(1997-4#1)
of the dose-response curve##5##4##(1990-7#1)(1994-11#1)(1997-1#1)(1997-4#1)(2007-9#1)
of the dose-response curves for##2##5##(1990-8#1)(1994-12#1)
of the dose-response curves##5##4##(1990-8#1)(1992-3#1)(1994-12#1)(1995-10#1)(2008-7#1)
of the dose-response##13##3##(1990-7#1)(1990-8#1)(1992-3#1)(1994-11#1)(1994-12#1)(1995-10#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-4#1)(2007-9#1)(2008-7#2)
of the double bond##3##4##(1992-11#1)(1992-6#1)(2005-8#1)
of the double helix##2##4##(1997-6#1)(2008-7#1)
of the double mutant is##2##5##(2007-11#1)(2009-8#1)
of the double mutant##5##4##(1991-4#1)(1993-3#1)(1995-11#1)(2007-11#1)(2009-8#1)
of the double##23##3##(1990-4#1)(1990-5#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-6#1)(1993-3#1)(1995-11#1)(1995-8#1)(1997-6#1)(2005-11#2)(2005-8#1)(2007-11#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-4#1)(2011-1#1)
of the double-edge technique for##2##5##(2008-2#1)(2008-3#1)
of the double-edge technique##4##4##(2008-2#3)(2008-3#1)
of the double-edge##7##3##(2008-2#5)(2008-3#2)
of the double-strand breaks induced by##2##6##(1993-3#2)
of the double-stranded DNA##2##4##(2010-5#2)
of the double-stranded##4##3##(1996-5#1)(2008-10#1)(2010-5#2)
of the doubled##2##3##(2007-11#1)(2008-10#1)
of the doublet##3##3##(1994-11#1)(2005-11#1)(2008-3#1)
of the doubling##3##3##(1995-7#1)(2008-1#1)(2008-3#1)
of the doubly ligated species##2##5##(1990-8#2)
of the doubly ligated##3##4##(1990-8#2)(1997-2#1)
of the doubly scattered##2##4##(2008-2#1)(2008-3#1)
of the doubly##11##3##(1990-8#2)(1991-3#1)(1994-10#1)(1997-2#1)(2006-12#1)(2007-11#1)(2008-2#2)(2008-3#1)(2013-8#1)
of the doula##2##3##(2007-2#1)(2008-6#1)
of the downregulated##3##3##(2008-7#1)(2012-12#2)
of the downstream flanking region of the##2##7##(1991-9#2)
of the downstream##10##3##(1991-9#2)(1992-9#1)(1995-2#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-9#1)(2010-5#1)(2012-2#1)
of the draft##5##3##(2007-1#1)(2008-9#2)(2010-3#1)(2012-12#1)
of the drain##2##3##(2011-2#2)
of the drainage##2##3##(1991-3#1)(2011-1#1)
of the draining lymph nodes##2##5##(1997-2#1)(2008-10#1)
of the draining##3##3##(1997-2#1)(2006-6#1)(2008-10#1)
of the drawbacks of##2##4##(2008-7#1)(2012-1#1)
of the drawn##3##3##(2008-3#1)(2009-10#2)
of the dream##4##3##(1993-6#1)(2008-2#2)(2013-8#1)
of the dried##2##3##(2008-10#1)(2010-4#1)
of the drink##2##3##(2004-11#2)
of the driving##4##3##(2007-11#1)(2007-12#2)(2012-12#1)
of the drop base and##2##5##(2005-11#2)
of the drop base##6##4##(2005-11#6)
of the drop##15##3##(2005-11#14)(2008-2#1)
of the droplet and##2##4##(2008-10#1)(2010-4#1)
of the droplet##12##3##(1994-9#1)(2005-11#3)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2010-4#1)(2012-2#1)
of the droplets were##2##4##(2005-11#1)(2008-10#1)
of the droplets##4##3##(1996-3#1)(2005-11#2)(2008-10#1)
of the dropping mercury electrode##2##5##(2008-10#2)
of the drops##4##3##(2005-11#1)(2008-10#1)(2009-5#1)(2013-7#1)
of the drug activity##2##4##(2007-9#1)(2008-5#1)
of the drug and the##2##5##(1990-12#1)(2008-10#1)
of the drug and##6##4##(1990-12#2)(1992-1#1)(1993-6#1)(2008-10#1)(2012-12#1)
of the drug approval##2##4##(1991-3#1)(2012-11#1)
of the drug are##3##4##(2006-10#1)(2007-11#1)(2008-10#1)
of the drug at##3##4##(1991-10#1)(2008-10#2)
of the drug binding##2##4##(1991-2#1)(2008-10#1)
of the drug but##2##4##(2006-11#1)(2007-11#1)
of the drug by##3##4##(2007-11#1)(2008-7#1)(2010-8#1)
of the drug discovery##2##4##(2008-10#1)(2008-7#1)
of the drug for the##2##5##(2009-10#1)(2010-2#1)
of the drug from the##2##5##(1990-11#1)(2009-11#1)
of the drug from##4##4##(1990-11#1)(2008-10#1)(2009-11#1)(2010-12#1)
of the drug in human serum##2##6##(2008-10#2)
of the drug in human##3##5##(2008-10#3)
of the drug in plasma##2##5##(2007-11#1)(2008-8#1)
of the drug in the##4##5##(1990-11#1)(2007-9#1)(2008-10#1)(2010-11#1)
of the drug in this##2##5##(1990-5#1)(1992-9#1)
of the drug in##25##4##(1990-11#1)(1990-2#1)(1990-5#1)(1992-9#1)(1993-2#1)(2007-11#1)(2007-9#1)(2008-10#13)(2008-8#1)(2009-10#1)(2010-11#1)(2010-12#1)(2013-7#1)
of the drug is##9##4##(1994-12#1)(1996-1#1)(1996-12#1)(2005-8#1)(2007-11#2)(2007-9#1)(2010-8#1)(2012-12#1)
of the drug itself##2##4##(1992-7#1)(1996-2#1)
of the drug molecule##3##4##(2008-10#2)(2008-7#1)
of the drug on##9##4##(1994-8#1)(1996-3#1)(1997-2#1)(2005-8#1)(2007-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-1#1)
of the drug substance##3##4##(1992-2#2)(2008-10#1)
of the drug to##4##4##(1990-3#1)(2008-10#1)(2008-11#1)(2008-3#1)
of the drug treatment##4##4##(1990-3#1)(1993-7#1)(2008-5#1)(2011-2#1)
of the drug treatments##2##4##(1995-12#1)(1997-5#1)
of the drug was##7##4##(1990-6#1)(1991-6#1)(1996-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2010-5#1)
of the drug were observed at##2##6##(2008-10#1)(2008-11#1)
of the drug were observed##3##5##(1990-9#1)(2008-10#1)(2008-11#1)
of the drug were##7##4##(1990-10#1)(1990-9#1)(1997-2#1)(2004-12#1)(2006-10#1)(2008-10#1)(2008-11#1)
of the drug with##5##4##(1995-1#1)(2008-10#2)(2010-12#1)(2012-12#1)
of the drug##207##3##(1990-10#1)(1990-11#4)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#3)(1990-6#3)(1990-9#1)(1991-10#2)(1991-2#1)(1991-3#4)(1991-6#1)(1992-1#1)(1992-11#2)(1992-2#3)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-6#1)(1995-7#1)(1995-9#2)(1996-1#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-7#2)(1997-2#4)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-12#2)(2005-10#1)(2005-12#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-4#1)(2006-6#3)(2007-11#12)(2007-12#1)(2007-6#1)(2007-9#8)(2008-1#1)(2008-10#38)(2008-11#5)(2008-3#2)(2008-5#8)(2008-6#1)(2008-7#4)(2008-8#4)(2009-10#2)(2009-11#2)(2009-2#1)(2009-7#1)(2010-11#1)(2010-12#7)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#4)(2012-3#1)(2013-7#1)
of the drug)##2##3##(1990-10#1)(2013-1#1)
of the drug-loaded##2##3##(2008-5#1)(2013-7#1)
of the drug-treated L5178Y lymphoma line##2##6##(1992-9#2)
of the drug-treated##3##3##(1990-10#1)(1992-9#2)
of the drugs and##3##4##(1992-12#1)(2006-12#1)(2009-7#1)
of the drugs being##2##4##(1996-1#1)(2008-3#1)
of the drugs currently used##2##5##(1991-12#1)(2008-8#1)
of the drugs for##2##4##(2008-10#1)(2012-12#1)
of the drugs have been##2##5##(2007-11#1)(2010-11#1)
of the drugs have##3##4##(2007-11#1)(2010-11#1)(2013-1#1)
of the drugs in urine##3##5##(1996-5#1)(2008-10#2)
of the drugs in##13##4##(1990-8#1)(1996-5#2)(2008-1#1)(2008-10#7)(2008-8#1)(2010-12#1)
of the drugs on the##3##5##(1995-6#1)(1997-5#1)(2008-11#1)
of the drugs on##6##4##(1995-6#1)(1996-10#1)(1997-5#1)(2008-10#2)(2008-11#1)
of the drugs studied##2##4##(2008-10#2)
of the drugs used##6##4##(1994-11#1)(2006-10#1)(2007-7#1)(2007-9#1)(2010-12#1)(2011-1#1)
of the drugs was##2##4##(2007-8#1)(2008-7#1)
of the drugs were obtained##2##5##(1994-3#1)(2007-7#1)
of the drugs##85##3##(1990-8#2)(1991-11#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-11#1)(1994-11#1)(1994-3#1)(1995-1#2)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-5#3)(1997-1#1)(1997-4#2)(1997-5#1)(2005-8#3)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#4)(2007-2#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#21)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#3)(2009-7#1)(2010-11#1)(2010-12#3)(2010-2#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
of the dry air storage##2##5##(2013-8#2)
of the dry chemistry##2##4##(1992-12#2)
of the dry season##7##4##(2005-8#1)(2007-2#1)(2007-3#2)(2007-8#1)(2008-5#2)
of the dry##16##3##(1992-12#2)(2004-11#1)(2005-8#1)(2007-2#1)(2007-3#2)(2007-5#1)(2007-8#1)(2008-5#4)(2013-7#1)(2013-8#2)
of the drying process##2##4##(2008-2#1)(2008-7#1)
of the drying##5##3##(1996-2#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)
of the dsRNA##4##3##(1991-4#1)(2008-10#3)
of the dsRNAs##2##3##(2008-10#2)
of the dual##7##3##(1994-11#1)(1996-5#1)(2008-11#1)(2008-3#1)(2011-2#1)(2013-1#2)
of the dual-isotope protocol was##2##5##(2005-1#2)
of the dually##2##3##(1995-3#1)(2007-8#1)
of the duck##2##3##(2005-9#2)
of the duct##4##3##(1991-9#1)(2007-12#1)(2008-3#1)(2011-2#1)
of the duct-mucosa pancreaticojejunostomy##3##4##(2008-10#3)
of the ductus##3##3##(1994-9#1)(2007-9#1)(2009-9#1)
of the dummies##5##3##(2006-11#3)(2007-4#2)
of the dummy was##2##4##(2007-1#1)(2007-4#1)
of the dummy##8##3##(2006-11#4)(2007-1#1)(2007-4#3)
of the dummy's##2##3##(2007-4#2)
of the duodenal##3##3##(1990-7#1)(2008-5#1)(2012-12#1)
of the duodenum are##2##4##(1990-10#1)(2006-2#1)
of the duodenum in##2##4##(2009-6#1)(2012-1#1)
of the duodenum##21##3##(1990-10#3)(1996-11#1)(1997-3#1)(1997-5#1)(2006-2#3)(2008-12#1)(2008-5#3)(2008-8#1)(2009-6#1)(2011-2#1)(2012-1#3)(2012-12#1)(2013-1#1)
of the duplex##15##3##(1990-5#1)(1993-3#1)(1994-11#2)(1994-8#1)(1995-1#2)(1995-3#2)(1995-5#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-5#1)(2012-3#1)
of the dura mater##3##4##(2006-8#1)(2007-12#1)(2009-8#1)
of the dura##7##3##(1997-6#1)(2006-8#1)(2007-12#1)(2008-7#1)(2009-8#2)(2011-2#1)
of the durability of resistance##4##5##(2008-10#4)
of the dural##4##3##(2007-9#1)(2008-7#1)(2011-2#1)(2012-3#1)
of the duration of the##3##5##(1991-9#1)(2008-10#1)(2010-8#1)
of the duration of##11##4##(1990-3#1)(1991-9#1)(1995-3#1)(1996-4#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2011-3#1)
of the dust samples##2##4##(2010-5#2)
of the duty cycle##2##4##(2007-12#1)(2008-3#1)
of the duty##3##3##(2007-12#1)(2008-3#1)(2008-5#1)
of the dwellings##2##3##(1995-6#2)
of the dyad##2##3##(2007-1#1)(2011-2#1)
of the dye and##2##4##(2008-1#1)(2008-2#1)
of the dye are at##2##5##(2008-10#2)
of the dye molecules in##2##5##(2005-11#1)(2007-11#1)
of the dye molecules##5##4##(1991-5#1)(2005-11#1)(2007-11#1)(2007-8#1)(2010-4#1)
of the dye were##3##4##(2008-10#2)(2008-3#1)
of the dye##43##3##(1991-5#2)(1992-1#1)(1992-6#1)(1993-11#1)(1994-12#2)(1996-1#1)(2005-11#3)(2006-10#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-1#3)(2008-10#15)(2008-2#3)(2008-3#2)(2008-9#2)(2010-4#3)
of the dyes to##2##4##(1996-1#1)(2008-10#1)
of the dyes##10##3##(1990-6#1)(1996-1#1)(1997-1#2)(2008-10#3)(2008-3#2)(2008-5#1)
of the dying process##2##4##(1990-10#1)(2004-3#1)
of the dying##8##3##(1990-10#1)(1991-12#1)(1991-2#1)(1997-6#1)(2004-3#1)(2007-12#1)(2010-10#1)(2010-8#1)
of the dynactin complex##2##4##(1995-2#2)
of the dynamic range of the##2##6##(2007-11#1)(2013-8#1)
of the dynamic range##5##4##(2007-11#1)(2007-12#1)(2008-3#2)(2013-8#1)
of the dynamic structure##2##4##(1993-3#1)(2007-12#1)
of the dynamic surface tension data##2##6##(2005-11#1)(2008-10#1)
of the dynamic##30##3##(1991-2#1)(1993-3#1)(1995-1#1)(1996-4#1)(1996-8#1)(1997-5#1)(2005-11#1)(2006-11#1)(2007-11#2)(2007-12#4)(2008-10#1)(2008-3#4)(2008-4#1)(2008-9#2)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-1#2)(2013-8#1)
of the dynamical##2##3##(1990-5#1)(2006-10#1)
of the dynamics of the##9##5##(1994-3#1)(1997-2#1)(2005-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)
of the dynamics of##23##4##(1993-5#1)(1994-12#1)(1994-3#1)(1995-9#1)(1997-2#1)(1997-3#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#3)(2008-9#1)(2010-3#1)
of the dynamics##29##3##(1993-5#1)(1994-12#1)(1994-3#1)(1995-9#1)(1996-11#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#3)(2008-9#2)(2010-3#1)(2010-4#1)
of the dysfunction##2##3##(2006-5#1)(2013-1#1)
of the dysplastic hip##3##4##(2007-11#1)(2007-8#2)
of the dystonias##2##3##(2006-8#2)
of the dystrophin gene##4##4##(1992-1#1)(1994-7#1)(1997-3#2)
of the dystrophin##6##3##(1992-1#1)(1993-2#1)(1994-7#1)(1996-6#1)(1997-3#2)
of the e##2##3##(1994-3#1)(1995-12#1)
of the e-spun SF##2##4##(2008-5#2)
of the each##3##3##(2005-10#1)(2007-2#1)(2008-10#1)
of the ear with##2##4##(2012-12#1)(2013-7#1)
of the ear##9##3##(1995-9#1)(2008-1#1)(2008-7#1)(2010-8#3)(2012-12#1)(2013-7#2)
of the earlier##8##3##(1997-4#1)(2005-7#1)(2008-10#1)(2009-5#1)(2012-1#1)(2013-1#3)
of the earliest##16##3##(1991-11#2)(1992-5#1)(1995-6#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-2#1)
of the early and##2##4##(2006-12#1)(2009-8#1)
of the early component##2##4##(1991-11#1)(1991-4#1)
of the early embryonic##2##4##(2007-12#1)(2008-11#1)
of the early events##2##4##(1992-4#1)(2012-2#1)
of the early manipulations##2##4##(1996-4#2)
of the early phase##2##4##(1995-1#1)(1995-11#1)
of the early phases##2##4##(1991-8#1)(2008-11#1)
of the early research##2##4##(2007-1#1)(2012-12#1)
of the early stage of##2##5##(1990-6#1)(1990-8#1)
of the early stage##3##4##(1990-6#1)(1990-8#1)(1994-7#1)
of the early stages of biofilm formation##2##7##(2008-9#1)(2013-8#1)
of the early stages of##4##5##(2008-4#1)(2008-9#1)(2011-1#1)(2013-8#1)
of the early steps in##2##5##(2009-8#1)(2011-1#1)
of the early steps##3##4##(1993-9#1)(2009-8#1)(2011-1#1)
of the early studies##2##4##(2008-11#1)(2008-2#1)
of the early##79##3##(1990-6#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-7#1)(1995-1#1)(1995-11#2)(1995-6#1)(1996-2#1)(1996-4#2)(2005-11#1)(2006-11#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-4#1)(2008-1#3)(2008-10#1)(2008-11#5)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-11#2)(2009-12#1)(2009-8#3)(2010-1#1)(2010-12#1)(2011-1#2)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
of the ears##3##3##(1991-3#1)(2008-8#1)(2010-6#1)
of the earth##2##3##(2008-10#1)(2008-5#1)
of the earth's##2##3##(1990-5#1)(1996-4#1)
of the earthquake##7##3##(1996-4#3)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
of the earthworm##5##3##(1997-6#2)(2004-4#1)(2008-5#1)(2008-9#1)
of the ease of##7##4##(2005-11#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#2)(2012-2#1)
of the ease##8##3##(2005-11#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2012-2#1)
of the east##2##3##(2007-5#1)(2008-10#1)
of the eating disorders##2##4##(1993-7#1)(2006-8#1)
of the eating##5##3##(1993-12#1)(1993-7#1)(2006-7#1)(2006-8#1)(2012-3#1)
of the ecchymosis and##2##4##(2012-12#2)
of the eccrine##2##3##(2007-7#1)(2010-6#1)
of the echinoderms##4##3##(2007-5#4)
of the echo##2##3##(2007-11#1)(2011-2#1)
of the ecological approach##3##4##(2011-1#2)(2013-7#1)
of the ecological##10##3##(2005-11#1)(2007-10#1)(2007-3#1)(2008-11#1)(2008-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-7#1)
of the ecology of##8##4##(2008-10#4)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)
of the ecology##10##3##(2008-10#4)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#2)(2009-5#1)
of the economic and##2##4##(2011-2#1)(2013-8#1)
of the economic costs##2##4##(2008-11#1)(2008-3#1)
of the economic downturn##2##4##(2012-3#2)
of the economic##13##3##(1993-12#1)(1995-11#1)(2006-6#1)(2008-11#1)(2008-12#2)(2008-3#1)(2009-10#1)(2011-2#2)(2012-3#2)(2013-8#1)
of the economically important##2##4##(2008-10#1)(2008-7#1)
of the economically##4##3##(2008-10#1)(2008-7#1)(2010-3#1)(2013-8#1)
of the economy##4##3##(2007-4#1)(2007-7#1)(2008-11#1)(2008-6#1)
of the ecosystem and##2##4##(1995-11#1)(2012-1#1)
of the ecosystem##8##3##(1995-11#1)(2007-3#1)(2008-5#1)(2008-8#1)(2009-4#1)(2012-1#1)(2013-8#2)
of the ecto-nucleoside triphosphate diphosphohydrolase##2##5##(2008-4#2)
of the ectoderm##2##3##(1990-5#1)(1991-5#1)
of the ectopic##4##3##(2009-5#1)(2011-2#2)(2012-2#1)
of the edentulous##2##3##(2007-12#1)(2012-2#1)
of the edge enhancement of##2##5##(2008-2#1)(2008-3#1)
of the edge image motion##2##5##(2008-3#2)
of the edge image##3##4##(2008-3#3)
of the edge##13##3##(1994-9#1)(2007-11#1)(2008-1#1)(2008-2#4)(2008-3#6)
of the edges##3##3##(2008-2#1)(2013-1#2)
of the edible##4##3##(1991-8#1)(1995-2#1)(2008-10#1)(2013-7#1)
of the editing protein##2##4##(1994-8#2)
of the editing##3##3##(1994-8#2)(2006-12#1)
of the editorials##2##3##(2011-1#2)
of the education and training programme on##2##7##(2008-12#2)
of the education##7##3##(1996-1#1)(2006-10#1)(2008-12#3)(2010-9#1)(2011-2#1)
of the educational environment##2##4##(2009-7#1)(2012-1#1)
of the educational##9##3##(1992-1#1)(1993-8#1)(2008-11#2)(2009-7#1)(2010-9#1)(2011-1#1)(2012-1#1)(2013-7#1)
of the eel##6##3##(1990-7#2)(1991-10#2)(2008-5#2)
of the efe gene##4##4##(2008-10#4)
of the efe##5##3##(2008-10#5)
of the effect of a##5##5##(1990-5#1)(1995-8#1)(2008-10#1)(2008-3#1)(2011-2#1)
of the effect of an##3##5##(2005-12#1)(2008-3#1)(2009-6#1)
of the effect of electrode##2##5##(2006-2#1)(2008-10#1)
of the effect of image##2##5##(2008-2#1)(2009-4#1)
of the effect of the##10##5##(1992-2#1)(1993-3#1)(1995-4#1)(1996-12#1)(2006-10#1)(2006-12#1)(2008-2#2)(2008-8#1)(2011-2#1)
of the effect of these##2##5##(1997-1#1)(2008-11#1)
of the effect of##130##4##(1990-11#1)(1990-3#1)(1990-5#2)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-12#2)(1993-3#3)(1994-10#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-4#2)(1995-8#2)(1996-12#1)(1996-2#1)(1996-7#1)(1997-1#2)(1997-4#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-2#2)(2006-6#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-7#2)(2007-9#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-2#6)(2008-3#7)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#4)(2011-3#2)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#2)
of the effect on##2##4##(2008-3#1)(2008-5#1)
of the effect that##5##4##(2008-3#1)(2013-1#4)
of the effect##155##3##(1990-11#1)(1990-3#1)(1990-5#2)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-2#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#3)(1994-10#1)(1994-6#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-4#2)(1995-5#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-7#1)(1997-1#2)(1997-4#1)(1997-5#1)(1997-8#2)(2005-10#1)(2005-11#2)(2005-12#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-2#2)(2006-6#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#18)(2008-11#2)(2008-12#2)(2008-2#6)(2008-3#12)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#4)(2011-3#2)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#2)
of the effective refractive index##2##5##(2007-12#1)(2008-3#1)
of the effective size of a##2##6##(2007-12#1)(2008-8#1)
of the effective telescope area##2##5##(2008-2#2)
of the effective##36##3##(1991-10#1)(1991-2#1)(1993-11#1)(1997-2#1)(1997-8#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#6)(2007-4#1)(2008-10#1)(2008-2#10)(2008-3#4)(2008-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
of the effectiveness and##2##4##(1997-1#1)(2013-1#1)
of the effectiveness of a##8##5##(1994-12#1)(1995-3#1)(2008-2#1)(2008-7#4)(2012-3#1)
of the effectiveness of different##2##5##(2011-2#1)(2013-1#1)
of the effectiveness of marriage and relationship education##2##8##(2012-2#2)
of the effectiveness of palliative radiotherapy##2##6##(2007-6#2)
of the effectiveness of the##5##5##(2005-6#1)(2006-10#1)(2007-6#1)(2007-9#1)(2010-10#1)
of the effectiveness of##44##4##(1990-2#1)(1990-6#1)(1991-12#1)(1994-12#1)(1995-3#1)(1996-1#1)(2005-10#1)(2005-6#1)(2006-10#3)(2006-8#3)(2007-11#2)(2007-6#3)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#4)(2008-8#1)(2010-10#1)(2010-6#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)
of the effectiveness##48##3##(1990-2#1)(1990-6#1)(1991-12#1)(1994-12#1)(1995-3#1)(1996-1#1)(1997-1#1)(2005-10#1)(2005-6#1)(2006-10#3)(2006-8#3)(2007-11#2)(2007-6#3)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#4)(2008-8#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)
of the effector##7##3##(1991-12#1)(1991-9#1)(1992-6#1)(1993-3#1)(1994-9#1)(2007-2#1)(2008-10#1)
of the effects of CR on##2##6##(1994-5#1)(2008-11#1)
of the effects of a##7##5##(1992-8#1)(1997-8#1)(2008-2#1)(2008-3#2)(2008-6#1)(2012-12#1)
of the effects of age##2##5##(1994-9#1)(2008-10#1)
of the effects of an##2##5##(2006-10#1)(2011-1#1)
of the effects of nutritional##2##5##(2006-2#1)(2010-6#1)
of the effects of spectral##2##5##(2007-11#1)(2008-3#1)
of the effects of steroid##2##5##(1991-7#1)(1994-9#1)
of the effects of the##12##5##(1994-6#1)(1994-8#1)(1995-12#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2011-2#1)
of the effects of these##2##5##(2009-12#2)
of the effects of this##3##5##(2008-3#2)(2013-7#1)
of the effects of two##2##5##(1994-5#1)(2007-11#1)
of the effects of various##3##5##(1991-7#1)(2008-3#1)(2008-5#1)
of the effects of##177##4##(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1991-1#3)(1991-12#1)(1991-2#1)(1991-5#2)(1991-7#2)(1991-8#2)(1992-1#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#2)(1993-8#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-4#2)(1994-5#3)(1994-6#2)(1994-8#1)(1994-9#2)(1995-12#3)(1995-5#2)(1995-7#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-5#1)(1997-8#2)(2005-10#1)(2005-11#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-10#4)(2007-11#6)(2007-12#3)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#15)(2008-11#4)(2008-2#5)(2008-3#13)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#3)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-11#1)(2012-12#6)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#2)
of the effects on##3##4##(2008-3#1)(2008-5#1)(2011-2#1)
of the effects that##3##4##(1996-7#1)(2006-1#1)(2008-10#1)
of the effects##197##3##(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1991-1#3)(1991-12#2)(1991-2#1)(1991-5#2)(1991-7#2)(1991-8#3)(1992-1#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#2)(1993-8#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-4#2)(1994-5#3)(1994-6#3)(1994-8#1)(1994-9#2)(1995-12#3)(1995-2#1)(1995-5#2)(1995-7#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#2)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-10#4)(2007-11#6)(2007-12#4)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#18)(2008-11#4)(2008-2#5)(2008-3#14)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#3)(2009-7#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-11#1)(2012-12#6)(2012-2#4)(2012-3#3)(2013-1#2)(2013-7#2)
of the efferent##2##3##(2006-6#1)(2008-4#1)
of the efficacy and safety of##2##6##(2007-7#1)(2012-12#1)
of the efficacy and tolerance of##2##6##(1992-2#1)(2008-5#1)
of the efficacy and##10##4##(1990-12#2)(1992-2#1)(1994-8#1)(2007-7#1)(2008-4#1)(2008-5#1)(2011-1#2)(2012-12#1)
of the efficacy of a##2##5##(1995-2#1)(2010-4#1)
of the efficacy of injectable##2##5##(1993-8#1)(2005-7#1)
of the efficacy of the##4##5##(1991-12#1)(1997-3#1)(2011-1#1)(2013-7#1)
of the efficacy of##27##4##(1991-12#1)(1991-2#1)(1993-2#1)(1993-8#1)(1994-2#1)(1994-6#1)(1995-2#1)(1997-3#1)(2005-7#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#5)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-7#2)
of the efficacy##42##3##(1990-12#2)(1991-12#1)(1991-2#2)(1992-2#1)(1993-2#1)(1993-8#1)(1994-2#1)(1994-6#2)(1994-8#1)(1995-2#1)(1997-3#1)(1997-4#1)(2005-7#1)(2006-10#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#6)(2010-4#1)(2011-1#3)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#2)
of the efficiency and##4##4##(1997-1#1)(2006-6#1)(2006-8#1)(2013-1#1)
of the efficiency of the##4##5##(2006-11#1)(2007-11#1)(2008-2#1)(2011-1#1)
of the efficiency of treatment##2##5##(2008-4#1)(2011-2#1)
of the efficiency of##15##4##(1990-10#1)(1992-7#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-8#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#1)
of the efficiency##23##3##(1990-10#1)(1992-7#1)(1997-1#1)(2006-11#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-8#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
of the effluent##5##3##(1996-8#1)(2007-12#1)(2008-1#1)(2008-10#2)
of the efflux##3##3##(1991-1#1)(1994-12#1)(2005-8#1)
of the efforts##4##3##(1997-1#1)(2007-2#1)(2007-8#1)(2012-3#1)
of the egg##13##3##(1991-5#1)(1993-6#1)(1994-2#1)(1994-5#1)(2007-11#1)(2008-11#1)(2008-12#3)(2008-4#2)(2008-8#1)(2010-8#1)
of the eggs of##2##4##(2008-10#1)(2008-5#1)
of the eggs##9##3##(1995-2#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-5#2)(2008-9#1)(2010-8#1)
of the egl1 gene##2##4##(2008-10#2)
of the eigenvalue##2##3##(2008-3#2)
of the eight known##2##4##(1991-5#1)(2009-5#1)
of the eight patients##4##4##(1994-9#1)(2007-8#2)(2011-2#1)
of the eight##39##3##(1990-12#1)(1991-5#1)(1991-7#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-12#1)(1997-3#1)(2005-12#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-4#1)(2007-8#3)(2008-10#7)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-5#1)(2010-12#1)(2010-2#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
of the ejaculate##2##3##(1991-11#1)(2006-5#1)
of the ejaculatory duct##2##4##(2008-7#2)
of the ejaculatory ducts##3##4##(1997-8#3)
of the ejaculatory##5##3##(1997-8#3)(2008-7#2)
of the ejection##2##3##(2006-6#1)(2008-2#1)
of the elaborated device##2##4##(2006-6#2)
of the elaborated##3##3##(2004-9#1)(2006-6#2)
of the elastic modulus##2##4##(2009-7#2)
of the elastic##13##3##(1992-7#1)(2006-9#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#2)(2009-5#2)(2009-7#2)
of the elbow joint##6##4##(2007-11#3)(2012-1#3)
of the elbow##19##3##(1992-5#1)(1992-9#1)(1993-11#1)(1996-6#1)(2006-3#1)(2007-11#3)(2007-2#1)(2007-7#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-11#1)(2012-1#3)(2013-8#2)
of the elderly and##6##4##(1994-6#4)(2012-12#1)(2013-1#1)
of the elderly in##5##4##(1993-10#1)(1993-3#1)(1995-5#1)(2007-11#1)(2009-5#1)
of the elderly patient##2##4##(1994-4#1)(2006-10#1)
of the elderly population of the##2##6##(2008-7#2)
of the elderly population##8##4##(2008-7#4)(2010-10#1)(2011-2#1)(2011-7#1)(2012-2#1)
of the elderly##56##3##(1990-3#2)(1991-3#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-10#2)(1993-12#1)(1993-3#1)(1993-5#2)(1994-1#1)(1994-4#2)(1994-6#4)(1995-10#1)(1995-3#1)(1995-5#1)(1996-1#1)(1997-5#1)(2004-11#1)(2005-9#1)(2006-10#3)(2006-2#1)(2006-7#2)(2006-8#1)(2007-10#2)(2007-11#1)(2008-12#1)(2008-7#5)(2008-9#1)(2009-12#1)(2009-5#1)(2010-10#1)(2011-1#1)(2011-12#1)(2011-2#2)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
of the electric and magnetic##2##5##(1991-1#1)(1992-6#1)
of the electric field of##2##5##(2007-12#2)
of the electric field strength##2##5##(2008-10#1)(2008-3#1)
of the electric field##20##4##(1990-12#1)(1990-7#1)(1991-1#1)(1996-12#1)(2007-11#1)(2007-12#6)(2008-10#1)(2008-2#3)(2008-3#5)
of the electric##26##3##(1990-12#1)(1990-7#1)(1991-1#2)(1992-6#1)(1996-12#1)(1997-8#1)(2005-1#1)(2005-11#1)(2007-11#2)(2007-12#6)(2008-10#1)(2008-2#3)(2008-3#5)
of the electrical double layer##2##5##(2005-11#2)
of the electrical double-layer##2##4##(2005-11#2)
of the electrical resistance##2##4##(1996-5#1)(2010-2#1)
of the electrical##19##3##(1993-2#1)(1994-8#1)(1995-3#1)(1996-5#1)(2005-11#6)(2008-10#1)(2008-2#1)(2008-4#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-2#1)(2011-1#1)(2012-12#1)
of the electrically evoked##2##4##(1995-12#2)
of the electrically##6##3##(1990-5#2)(1995-12#2)(2008-3#2)
of the electro-optic##2##3##(2007-12#1)(2008-2#1)
of the electroactive##5##3##(2007-8#1)(2008-10#4)
of the electrocardiogram##3##3##(1991-5#1)(1996-4#1)(2008-10#1)
of the electrochemical behavior of##2##5##(2008-10#2)
of the electrochemical oxidation of iodide##2##6##(2007-8#2)
of the electrochemical##15##3##(1996-1#1)(2005-11#1)(2007-8#4)(2008-10#7)(2010-4#1)(2013-7#1)
of the electrochemically accumulated ahODN-Cu(I) complex##2##6##(2008-10#2)
of the electrochemically accumulated##3##4##(2008-10#3)
of the electrochemically##5##3##(2008-10#5)
of the electrochromic##2##3##(1996-4#1)(2010-7#1)
of the electrode and##5##4##(2008-10#3)(2008-9#1)(2010-10#1)
of the electrode array##5##4##(2008-10#1)(2008-9#3)(2010-2#1)
of the electrode by##2##4##(2008-10#2)
of the electrode can be##2##5##(2008-10#2)
of the electrode can##3##4##(2008-10#3)
of the electrode could be##2##5##(2008-10#1)(2008-7#1)
of the electrode double##2##4##(2008-10#2)
of the electrode in##2##4##(1992-8#1)(2008-10#1)
of the electrode is##5##4##(2007-8#1)(2008-10#4)
of the electrode prepared##2##4##(2008-10#2)
of the electrode reaction##2##4##(2007-8#1)(2008-10#1)
of the electrode response##3##4##(2008-10#3)
of the electrode surface##4##4##(2008-10#4)
of the electrode was 3##2##5##(2008-10#2)
of the electrode was about##2##5##(2008-10#2)
of the electrode was discussed##2##5##(2008-10#2)
of the electrode was##14##4##(2008-10#14)
of the electrode were##2##4##(2008-10#2)
of the electrode##94##3##(1992-8#1)(2006-12#1)(2006-3#2)(2007-10#1)(2007-8#3)(2008-10#72)(2008-2#1)(2008-7#2)(2008-9#8)(2010-10#1)(2010-2#2)
of the electrodes and##3##4##(2008-10#2)(2010-2#1)
of the electrodes is##2##4##(2010-7#1)(2011-1#1)
of the electrodes was##3##4##(2008-10#3)
of the electrodes##29##3##(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#21)(2008-2#1)(2009-10#1)(2010-2#1)(2010-7#1)(2011-1#1)
of the electroencephalogram##3##3##(2006-10#1)(2008-5#1)(2009-8#1)
of the electrolyte and##2##4##(2006-10#1)(2008-10#1)
of the electrolyte##9##3##(2005-11#1)(2005-4#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-10#4)
of the electrolytes##3##3##(2005-11#1)(2006-10#1)(2008-10#1)
of the electrolytic##2##3##(2008-10#2)
of the electromagnetic field in##2##5##(2007-12#1)(2008-3#1)
of the electromagnetic field scattered by##2##6##(2008-2#1)(2008-3#1)
of the electromagnetic field##7##4##(2007-12#3)(2008-2#1)(2008-3#3)
of the electromagnetic fields##2##4##(2008-2#2)
of the electromagnetic spectrum##3##4##(2008-2#2)(2012-12#1)
of the electromagnetic##18##3##(2007-11#1)(2007-12#5)(2007-8#1)(2008-2#6)(2008-3#4)(2012-12#1)
of the electron density##4##4##(1995-1#1)(1997-2#1)(2006-5#1)(2007-12#1)
of the electron transfer##4##4##(1991-12#1)(1996-8#1)(1997-7#1)(2011-1#1)
of the electron transport chain##7##5##(1996-8#1)(1996-9#2)(2005-8#1)(2008-10#1)(2011-1#1)(2013-8#1)
of the electron##29##3##(1990-2#1)(1990-8#1)(1991-10#1)(1991-12#1)(1992-3#1)(1992-9#1)(1994-7#1)(1995-1#1)(1996-8#2)(1996-9#2)(1997-2#1)(1997-7#1)(2005-8#2)(2006-4#1)(2006-5#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#2)(2009-11#1)(2011-1#3)(2013-8#1)
of the electron-density profile in a discharge-ablated capillary waveguide##2##9##(2007-12#2)
of the electron-phonon coupling factor##2##5##(2008-3#2)
of the electron-phonon coupling##3##4##(1990-4#1)(2008-3#2)
of the electron-transfer##2##3##(1990-5#1)(1994-8#1)
of the electronic coupling##2##4##(1997-1#1)(2008-10#1)
of the electronic health##3##4##(1994-2#1)(2013-1#2)
of the electronic medical record##2##5##(1993-12#1)(2008-8#1)
of the electronic properties of the##2##6##(1996-2#1)(2006-12#1)
of the electronic properties of##3##5##(1996-2#1)(2006-12#1)(2008-7#1)
of the electronic properties##4##4##(1996-2#1)(2006-12#1)(2008-10#1)(2008-7#1)
of the electronic structure of##2##5##(2007-9#1)(2010-7#1)
of the electronic structure##3##4##(2006-10#1)(2007-9#1)(2010-7#1)
of the electronic##26##3##(1990-2#1)(1992-2#1)(1993-12#1)(1994-2#1)(1995-1#1)(1996-2#1)(1997-1#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-9#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-12#1)(2010-7#1)(2012-2#1)(2013-1#2)
of the electronics##2##3##(2008-3#1)(2008-5#1)
of the electrons##3##3##(2008-3#1)(2008-7#2)
of the electrons'##2##3##(2007-11#2)
of the electroosmotic flow (EOF)##2##5##(2007-8#1)(2008-10#1)
of the electrophoretic##5##3##(1991-4#1)(1992-6#1)(1997-2#1)(1997-8#1)(2005-11#1)
of the electrophysiological##2##3##(1990-9#1)(1991-6#1)
of the electropolymerization##2##3##(2008-10#2)
of the electroretinogram##2##3##(2012-1#1)(2012-12#1)
of the electrostatic interactions##3##4##(1994-8#1)(2005-11#1)(2006-10#1)
of the electrostatic##11##3##(1993-3#1)(1994-8#1)(1996-11#1)(1996-4#1)(1996-8#2)(2005-11#1)(2006-10#1)(2008-4#1)(2009-5#1)(2010-2#1)
of the electrostrictive##4##3##(2007-12#4)
of the element are##2##4##(1992-5#1)(1995-8#1)
of the element is##3##4##(1994-6#1)(2008-10#1)(2008-3#1)
of the element##18##3##(1990-3#1)(1992-5#1)(1994-6#2)(1995-8#2)(1996-10#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#3)(2009-6#1)(2012-2#1)
of the elemental composition of##2##5##(2007-9#1)(2008-10#1)
of the elemental##6##3##(1992-9#1)(1993-6#1)(2006-5#1)(2007-9#1)(2008-10#1)(2013-7#1)
of the elements and the##3##5##(1991-11#1)(2008-10#1)(2013-1#1)
of the elements and##4##4##(1991-11#1)(2008-10#2)(2013-1#1)
of the elements in the##2##5##(2008-10#2)
of the elements in##4##4##(2006-10#1)(2008-10#3)
of the elements of##5##4##(1996-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-5#1)
of the elements that##2##4##(2006-12#1)(2008-10#1)
of the elements was##2##4##(2008-10#2)
of the elements were##4##4##(2008-10#4)
of the elements##42##3##(1991-11#1)(1991-5#1)(1992-6#3)(1996-11#1)(1996-9#1)(2006-10#1)(2006-12#1)(2007-5#1)(2007-8#1)(2008-10#24)(2008-12#1)(2008-2#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#2)
of the elevated##10##3##(1992-7#1)(1993-7#1)(1994-3#1)(1996-3#1)(1997-1#1)(1997-5#1)(1997-7#1)(2008-1#1)(2008-4#1)(2011-2#1)
of the elevation of##2##4##(2008-11#1)(2010-11#1)
of the elevation##3##3##(2008-11#1)(2008-3#1)(2010-11#1)
of the eleven##4##3##(1992-11#1)(1992-3#1)(1994-6#1)(2008-10#1)
of the elicitation phase of##2##5##(2005-11#2)
of the elimination##3##3##(1994-2#1)(2011-2#1)(2012-12#1)
of the elite##3##3##(2006-12#1)(2007-11#1)(2011-2#1)
of the ellipsometric##5##3##(2007-12#1)(2008-2#3)(2008-3#1)
of the elliptical##3##3##(2007-11#2)(2008-3#1)
of the elongated##2##3##(1997-6#1)(2007-12#1)
of the eluates##2##3##(2008-10#2)
of the eluent##8##3##(1993-2#1)(1996-6#1)(2008-10#5)(2008-7#1)
of the eluted metals##2##4##(2008-10#2)
of the elution##2##3##(1990-5#1)(1992-6#1)
of the embedded##2##3##(1994-8#1)(2008-10#1)
of the emboli##2##3##(2007-9#1)(2009-8#1)
of the embolization##2##3##(2007-3#1)(2008-7#1)
of the embryo sac##2##4##(2007-4#1)(2008-4#1)
of the embryo##27##3##(1992-12#1)(1993-12#1)(1994-9#1)(1996-8#1)(2006-11#1)(2006-7#2)(2007-10#4)(2007-12#5)(2007-4#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2012-1#1)(2012-11#1)(2012-12#2)(2013-1#1)
of the embryonal##2##3##(1990-8#1)(1994-3#1)
of the embryonic brain##6##4##(2007-12#5)(2007-3#1)
of the embryonic hindgut##2##4##(2008-10#2)
of the embryonic##20##3##(1994-8#2)(1995-1#1)(1996-5#1)(2007-12#7)(2007-3#1)(2008-10#3)(2008-11#2)(2008-5#1)(2012-12#2)
of the embryos##8##3##(1990-6#2)(1994-2#1)(2006-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-7#1)
of the emergence of modern##2##5##(1996-4#1)(2009-2#1)
of the emergence of##7##4##(1996-4#1)(2005-8#1)(2006-11#1)(2008-11#1)(2008-4#1)(2009-2#1)(2009-5#1)
of the emergence##8##3##(1996-4#1)(2005-8#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-2#1)(2009-5#1)
of the emergency ambulance##2##4##(2006-10#2)
of the emergency care##2##4##(1991-5#2)
of the emergency department##3##4##(2008-3#2)(2010-12#1)
of the emergency service##2##4##(1991-11#1)(1994-5#1)
of the emergency##15##3##(1991-11#1)(1991-5#2)(1994-5#1)(2006-10#2)(2007-5#1)(2008-3#2)(2008-8#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-1#1)(2013-1#1)
of the emergent##3##3##(1991-3#1)(2010-1#1)(2011-2#1)
of the emerging trends in the##2##6##(1997-2#1)(2008-12#1)
of the emerging##16##3##(1997-2#1)(1997-5#1)(2006-7#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-4#1)(2010-12#1)(2011-1#2)(2012-2#1)
of the emission from##2##4##(2008-1#1)(2008-3#1)
of the emission intensity##2##4##(1995-2#1)(2008-10#1)
of the emission of a##2##5##(2007-11#1)(2008-1#1)
of the emission of the##2##5##(2007-12#1)(2008-10#1)
of the emission of##6##4##(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)
of the emission spectrum##6##4##(1991-8#1)(1996-12#1)(1997-1#1)(2006-10#1)(2008-2#1)(2008-3#1)
of the emission wavelength##2##4##(2008-10#1)(2008-2#1)
of the emission##27##3##(1990-5#1)(1991-8#1)(1995-2#1)(1996-12#1)(1997-1#2)(2006-10#1)(2007-11#3)(2007-12#2)(2008-1#4)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#2)
of the emitted radiation##2##4##(2008-2#2)
of the emitted##8##3##(2004-12#1)(2006-5#1)(2008-10#1)(2008-2#3)(2008-3#2)
of the emitter##2##3##(2007-12#1)(2010-8#1)
of the emitting##2##3##(1995-6#1)(2012-2#1)
of the emotional##4##3##(1997-1#1)(2007-1#1)(2008-4#1)(2012-12#1)
of the empire##2##3##(2007-5#1)(2008-8#1)
of the empirical evidence##2##4##(2008-2#1)(2010-12#1)
of the empirical literature on##2##5##(2007-12#1)(2008-10#1)
of the empirical literature##3##4##(2007-12#2)(2008-10#1)
of the empirical##11##3##(1995-11#1)(1996-1#1)(1997-2#1)(2007-12#2)(2008-10#1)(2008-2#2)(2010-12#1)(2010-2#1)(2010-3#1)
of the employed##2##3##(1995-8#1)(2008-2#1)
of the employees in the##2##5##(1996-9#1)(2010-4#1)
of the employees##4##3##(1996-9#1)(2007-7#1)(2010-4#1)(2011-2#1)
of the empty##2##3##(1990-5#1)(2006-12#1)
of the emulsion##7##3##(1991-2#1)(1997-8#1)(2005-11#1)(2008-10#1)(2008-5#3)
of the emulsions##4##3##(2008-10#1)(2008-5#2)(2008-8#1)
of the enamel##6##3##(1993-11#1)(2008-7#1)(2012-2#1)(2013-1#2)(2013-8#1)
of the enantiomer##2##3##(2008-6#1)(2013-1#1)
of the enantiomeric composition of samples##2##6##(1992-1#1)(2008-10#1)
of the enantiomeric composition of##3##5##(1992-1#1)(2008-10#2)
of the enantiomeric##7##3##(1992-1#1)(1993-2#1)(1995-6#1)(2008-10#3)(2009-12#1)
of the enantiomers of##7##4##(1992-1#1)(1992-2#1)(1993-2#1)(1997-3#2)(2008-10#1)(2008-11#1)
of the enantiomers##11##3##(1992-1#1)(1992-2#1)(1993-2#1)(1995-2#1)(1997-3#2)(2008-10#4)(2008-11#1)
of the encapsulated##5##3##(2008-10#1)(2008-5#2)(2010-1#2)
of the enclosure or##2##4##(1996-12#1)(2013-8#1)
of the enclosure##3##3##(1996-12#1)(2008-9#1)(2013-8#1)
of the encoded protein##3##4##(1990-12#1)(1991-8#1)(2008-9#1)
of the encoded proteins##3##4##(1992-6#1)(1994-12#1)(2008-7#1)
of the encoded##11##3##(1990-12#1)(1991-8#1)(1992-3#1)(1992-6#1)(1994-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2012-12#1)
of the encoding##4##3##(2007-7#1)(2008-3#3)
of the encounters##3##3##(1991-6#3)
of the encrypted image##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
of the encrypted##4##3##(2006-10#1)(2007-11#1)(2008-2#1)(2008-3#1)
of the end of the##5##5##(1990-10#1)(2008-4#1)(2008-7#2)(2012-7#1)
of the end of##9##4##(1990-10#1)(1992-9#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2011-1#1)(2012-7#1)
of the end point##2##4##(2008-10#2)
of the end users##2##4##(1992-12#1)(2009-9#1)
of the end##16##3##(1990-10#1)(1992-12#1)(1992-9#1)(2006-2#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#2)(2009-2#1)(2009-9#1)(2011-1#1)(2012-7#1)
of the endangered##3##3##(1996-12#1)(2009-5#1)(2010-8#1)
of the endemic diet with##2##5##(1994-3#2)
of the endemic##7##3##(1994-3#2)(1996-11#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-12#1)
of the endocannabinoid system##2##4##(2008-9#2)
of the endocrine##9##3##(1991-7#1)(1996-6#1)(2006-12#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-11#2)
of the endogeneous##2##3##(1990-11#1)(1992-5#1)
of the endogenous antioxidant##4##4##(2012-1#2)(2012-12#1)(2013-8#1)
of the endogenous gene##2##4##(1991-9#1)(1997-4#1)
of the endogenous opioid system##3##5##(1996-12#1)(2009-7#1)(2012-1#1)
of the endogenous promoter##2##4##(1997-8#1)(2006-11#1)
of the endogenous##46##3##(1991-9#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-4#1)(1994-10#1)(1994-6#1)(1994-9#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-12#1)(1996-4#1)(1996-5#4)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-3#1)(2013-8#1)
of the endoglucanase##3##3##(1991-7#1)(2006-8#1)(2008-6#1)
of the endometrial##2##3##(1992-6#1)(1996-2#1)
of the endometrium and##2##4##(1991-9#1)(2012-3#1)
of the endometrium is##2##4##(2011-2#1)(2012-3#1)
of the endometrium##22##3##(1991-9#1)(1992-3#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-9#4)(1995-3#1)(1996-2#2)(2006-5#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)
of the endonuclease activity of##2##5##(1990-7#1)(1996-8#1)
of the endonuclease##4##3##(1990-7#1)(1992-12#1)(1995-2#1)(1996-8#1)
of the endoplasmic reticulum (ER)##6##5##(1994-11#1)(1995-3#1)(1997-1#1)(2008-4#1)(2009-10#1)(2013-1#1)
of the endoplasmic reticulum##16##4##(1992-6#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-1#1)(2006-10#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-10#1)(2012-2#1)(2013-1#1)
of the endoplasmic##17##3##(1992-6#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-1#2)(2006-10#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-10#1)(2012-2#1)(2013-1#1)
of the endoprostheses##2##3##(2007-11#1)(2008-2#1)
of the endoprosthesis##3##3##(1992-1#1)(2007-7#1)(2007-8#1)
of the endoscope##4##3##(2006-12#1)(2006-5#1)(2008-5#1)(2012-12#1)
of the endoscopic##10##3##(1992-1#1)(1993-12#1)(2006-10#1)(2006-5#2)(2006-6#1)(2007-5#1)(2007-7#1)(2011-12#2)
of the endoscopy##2##3##(1992-11#1)(2006-10#1)
of the endosperm##2##3##(1994-3#1)(2006-12#1)
of the endosymbiont of the aphid##2##6##(1996-12#2)
of the endosymbiont##4##3##(1993-12#1)(1996-12#3)
of the endothelial cell##4##4##(1990-9#1)(1991-2#1)(1993-8#1)(2008-1#1)
of the endothelial nitric oxide synthase gene##2##7##(2007-10#1)(2008-7#1)
of the endothelial##9##3##(1990-9#1)(1991-2#1)(1992-9#1)(1993-8#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)
of the endothelin receptor##2##4##(1991-7#1)(2011-2#1)
of the endothelin##6##3##(1990-2#2)(1990-6#1)(1991-7#1)(1993-6#1)(2011-2#1)
of the endothelin-B##2##3##(1994-12#1)(1996-4#1)
of the endothelium and##3##4##(1995-2#1)(2008-10#1)(2010-12#1)
of the endothelium##11##3##(1990-12#1)(1992-11#1)(1992-12#1)(1995-2#1)(1996-9#1)(1997-5#2)(2007-8#1)(2008-10#1)(2010-12#1)(2012-12#1)
of the endovascular##3##3##(1996-9#1)(2008-7#1)(2008-8#1)
of the ends of##3##4##(1994-6#1)(2008-10#1)(2008-4#1)
of the energetic material##2##4##(2008-3#1)(2010-4#1)
of the energetic parameters##2##4##(1992-1#2)
of the energetic##7##3##(1992-1#2)(1995-10#1)(2005-8#1)(2008-3#2)(2010-4#1)
of the energy from##3##4##(2008-3#3)
of the energy in the##2##5##(2007-11#1)(2008-1#1)
of the energy of the##2##5##(2007-12#1)(2008-2#1)
of the energy of##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
of the energy supply##2##4##(1994-2#1)(2012-1#1)
of the energy##31##3##(1992-12#1)(1992-3#1)(1993-5#1)(1994-11#1)(1994-2#1)(1995-10#1)(1995-4#1)(1997-6#1)(2004-12#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#8)(2008-7#1)(2008-9#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
of the engine##5##3##(2007-10#4)(2008-2#1)
of the engineered ear##2##4##(2013-8#2)
of the engineered##4##3##(1994-11#1)(2008-1#1)(2013-8#2)
of the engrailed protein##2##4##(2007-12#2)
of the engrailed##3##3##(1990-8#1)(2007-12#2)
of the enhanced##13##3##(1995-11#1)(1995-6#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2010-4#1)
of the enhancement effect##2##4##(2005-4#1)(2008-10#1)
of the enhancement is##2##4##(2007-12#1)(2008-8#1)
of the enhancement of##2##4##(2008-2#1)(2008-3#1)
of the enhancement##9##3##(1997-8#1)(2005-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-2#1)
of the enhancer##6##3##(1990-11#1)(1991-11#1)(1994-9#1)(1995-8#1)(1996-4#1)(2005-11#1)
of the enhancers##2##3##(1991-5#2)
of the enhancing##2##3##(2006-11#1)(2008-8#1)
of the enlarged segment##2##4##(2013-7#2)
of the enlarged##3##3##(2007-2#1)(2013-7#2)
of the enormous##3##3##(2007-12#1)(2008-9#1)(2010-4#1)
of the enriched##2##3##(1994-2#1)(2008-10#1)
of the enrichment##4##3##(2006-3#1)(2008-10#3)
of the enteric nervous system##2##5##(2006-10#1)(2008-7#1)
of the enteric##6##3##(2006-10#2)(2006-2#1)(2008-7#2)(2012-2#1)
of the enterprise##2##3##(1996-3#1)(2007-4#1)
of the enthalpy and##2##4##(1990-8#1)(2006-10#1)
of the enthalpy change##2##4##(2006-10#1)(2008-10#1)
of the enthalpy of##2##4##(1993-3#1)(2005-11#1)
of the enthalpy##8##3##(1990-8#1)(1993-3#1)(2005-11#1)(2006-10#4)(2008-10#1)
of the entire ITS region##2##5##(2008-10#2)
of the entire beam##2##4##(2007-11#1)(2008-3#1)
of the entire body##2##4##(1990-5#1)(2011-1#1)
of the entire chromosome##2##4##(1991-2#1)(2008-5#1)
of the entire coding sequence##2##5##(1996-10#1)(2011-2#1)
of the entire coding##4##4##(1994-12#1)(1996-10#1)(1996-2#1)(2011-2#1)
of the entire colon and##2##5##(2006-2#1)(2009-10#1)
of the entire genome and##3##5##(1996-6#2)(2011-2#1)
of the entire genome of an##2##6##(2005-11#1)(2008-10#1)
of the entire genome of##4##5##(1996-11#1)(1996-6#1)(2005-11#1)(2008-10#1)
of the entire genome##9##4##(1996-11#1)(1996-6#3)(1996-8#1)(2005-11#1)(2006-10#1)(2008-10#1)(2011-2#1)
of the entire group##2##4##(2008-1#1)(2008-10#1)
of the entire posterior##2##4##(2007-8#2)
of the entire sequence##3##4##(1993-8#1)(1995-9#1)(2013-8#1)
of the entire set of##2##5##(1991-4#1)(2008-7#1)
of the entire##119##3##(1990-5#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-10#3)(1996-11#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#4)(1996-8#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-11#1)(2004-8#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-10#5)(2006-2#2)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#5)(2007-3#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#4)(2013-7#1)(2013-8#1)
of the entorhinal cortex##12##4##(1994-3#1)(1994-8#1)(1995-10#1)(1997-3#1)(2004-11#2)(2008-11#4)(2011-2#2)
of the entorhinal##15##3##(1991-1#2)(1994-3#1)(1994-8#1)(1995-10#1)(1997-3#1)(1997-7#1)(2004-11#2)(2008-11#4)(2011-2#2)
of the entrapment##2##3##(1993-12#1)(2008-8#1)
of the entrapped cells##2##4##(2008-11#1)(2008-5#1)
of the entrapped##5##3##(1990-2#2)(2004-9#1)(2008-11#1)(2008-5#1)
of the entries##3##3##(2008-2#1)(2013-1#2)
of the entropy of##2##4##(1995-6#1)(2006-10#1)
of the entropy##3##3##(1995-6#1)(2006-10#1)(2009-8#1)
of the entry inhibitors##2##4##(2011-2#2)
of the entry##5##3##(1992-4#1)(1994-4#1)(2007-8#1)(2011-2#2)
of the env gene##2##4##(2007-6#2)
of the envelope glycoprotein gp41##2##5##(1993-3#2)
of the envelope glycoprotein##4##4##(1993-3#3)(1995-5#1)
of the envelope##8##3##(1992-2#1)(1993-3#3)(1995-5#1)(1996-1#1)(2007-12#1)(2009-7#1)
of the environment and##2##4##(2008-3#1)(2008-9#1)
of the environment being##2##4##(2008-10#1)(2008-2#1)
of the environment of##3##4##(1992-12#1)(1992-6#1)(1995-5#1)
of the environment on the##2##5##(2006-8#1)(2007-8#1)
of the environment on##3##4##(2006-8#1)(2007-8#1)(2008-10#1)
of the environment to##2##4##(2008-10#1)(2013-8#1)
of the environment##43##3##(1992-10#1)(1992-12#1)(1992-6#1)(1993-12#1)(1994-3#2)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2010-2#1)(2010-5#1)(2012-1#1)(2012-2#1)(2013-8#1)
of the environmental conditions##2##4##(2007-8#1)(2008-5#1)
of the environmental problems##2##4##(1992-3#1)(2008-1#1)
of the environmental##23##3##(1990-12#1)(1992-3#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-5#4)(2008-8#2)(2008-9#1)(2010-5#1)(2012-11#2)
of the enzymatic activities##3##4##(1990-3#1)(1993-12#1)(2008-4#1)
of the enzymatic activity of the##3##6##(1990-2#1)(1991-9#1)(1995-8#1)
of the enzymatic activity of##6##5##(1990-2#1)(1990-5#1)(1991-9#1)(1995-8#1)(2008-10#1)(2008-11#1)
of the enzymatic activity##12##4##(1990-2#1)(1990-4#1)(1990-5#1)(1991-5#1)(1991-9#1)(1992-11#1)(1995-5#1)(1995-8#1)(2006-8#1)(2008-10#2)(2008-11#1)
of the enzymatic hydrolysis of##2##5##(2008-10#1)(2008-6#1)
of the enzymatic hydrolysis##4##4##(2008-10#3)(2008-6#1)
of the enzymatic reaction##6##4##(1990-8#1)(1994-8#1)(2008-10#4)
of the enzymatic##35##3##(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-12#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-5#1)(2006-8#1)(2007-6#1)(2008-10#11)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#3)
of the enzymatically##2##3##(1994-6#1)(2008-10#1)
of the enzyme [Schirmer##2##4##(1995-2#1)(1995-5#1)
of the enzyme activities##2##4##(2004-11#1)(2008-10#1)
of the enzyme activity and##3##5##(1991-12#1)(1992-8#1)(1997-6#1)
of the enzyme activity by##3##5##(1990-5#2)(1992-11#1)
of the enzyme activity expressed##3##5##(1992-6#1)(1993-9#1)(2008-8#1)
of the enzyme activity was##3##5##(2008-10#3)
of the enzyme activity were##2##5##(1990-9#1)(2005-11#1)
of the enzyme activity##23##4##(1990-3#1)(1990-5#2)(1990-9#1)(1991-12#1)(1991-2#1)(1992-11#2)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-9#1)(1996-7#1)(1997-6#1)(2005-11#1)(2006-8#1)(2008-10#5)(2008-8#1)
of the enzyme and the##3##5##(1996-8#1)(2008-10#2)
of the enzyme and##15##4##(1990-7#1)(1990-9#1)(1991-1#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-8#1)(1995-1#1)(1996-5#1)(1996-8#1)(2008-10#4)(2008-6#1)
of the enzyme are##3##4##(1991-6#1)(1995-12#1)(2008-7#1)
of the enzyme as##2##4##(1992-4#1)(2008-9#1)
of the enzyme at low##2##5##(1991-5#1)(1993-8#1)
of the enzyme at##4##4##(1991-5#1)(1993-8#1)(1994-6#1)(2008-10#1)
of the enzyme by##21##4##(1990-2#2)(1990-7#3)(1990-8#1)(1991-1#2)(1991-9#1)(1992-2#1)(1992-4#1)(1993-11#2)(1993-9#2)(1994-11#1)(1994-12#1)(1996-2#1)(1997-8#1)(2008-7#1)(2009-7#1)
of the enzyme complex##5##4##(1991-1#1)(1994-12#1)(1996-2#2)(2010-12#1)
of the enzyme electrode##3##4##(2008-10#3)
of the enzyme encoded##2##4##(1995-8#1)(1996-7#1)
of the enzyme for its##2##5##(1990-7#1)(1994-11#1)
of the enzyme for the##3##5##(1991-3#1)(1991-7#1)(1996-7#1)
of the enzyme for##18##4##(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#2)(1991-2#2)(1991-3#1)(1991-7#1)(1992-11#1)(1992-6#1)(1993-3#2)(1994-11#1)(1996-2#1)(1996-7#1)(2005-11#1)
of the enzyme from the##2##5##(1991-2#1)(2008-11#1)
of the enzyme from##8##4##(1991-2#1)(1991-5#1)(1995-8#1)(1996-7#1)(1997-2#1)(2008-11#1)(2008-4#1)(2008-6#1)
of the enzyme gave##2##4##(1996-5#1)(2008-8#1)
of the enzyme glucose oxidase##2##5##(2008-10#2)
of the enzyme had##2##4##(1992-6#1)(1995-8#1)
of the enzyme has been##3##5##(1994-8#1)(2008-10#1)(2008-7#1)
of the enzyme has##6##4##(1990-12#1)(1994-8#1)(1995-5#1)(1996-6#1)(2008-10#1)(2008-7#1)
of the enzyme have##2##4##(1990-12#1)(1996-8#1)
of the enzyme heme oxygenase##2##5##(1994-5#1)(1995-2#1)
of the enzyme in a##3##5##(1990-11#1)(1990-4#1)(2008-10#1)
of the enzyme in human##2##5##(1990-10#1)(1992-4#1)
of the enzyme in the##7##5##(1990-10#1)(1990-5#1)(1992-2#1)(1992-9#1)(2008-10#3)
of the enzyme in##27##4##(1990-10#3)(1990-11#2)(1990-4#1)(1990-5#2)(1990-8#1)(1991-12#1)(1991-2#2)(1992-2#1)(1992-4#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-11#1)(1996-2#2)(1997-4#1)(2008-10#4)
of the enzyme increased##2##4##(1990-5#1)(1990-7#1)
of the enzyme involved in##2##5##(1994-8#1)(1997-4#1)
of the enzyme is compared##2##5##(1990-12#1)(1994-9#1)
of the enzyme is##15##4##(1990-12#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-8#1)(1992-9#2)(1993-8#1)(1994-9#1)(1995-10#1)(1995-5#1)(1995-7#1)(1996-7#1)
of the enzyme may##2##4##(1993-11#1)(1995-3#1)
of the enzyme molecule##2##4##(1991-5#1)(1993-8#1)
of the enzyme on##4##4##(1990-7#1)(1991-5#1)(1995-6#1)(2008-10#1)
of the enzyme preparation##2##4##(1990-2#1)(1992-2#1)
of the enzyme protein##2##4##(1994-2#1)(1996-7#1)
of the enzyme reaction product##2##5##(1997-2#1)(2008-10#1)
of the enzyme reaction##8##4##(1990-5#1)(1995-1#1)(1997-2#1)(1997-6#1)(2007-8#1)(2008-10#3)
of the enzyme reactor##2##4##(2008-10#1)(2008-6#1)
of the enzyme responsible for the##3##6##(1990-8#1)(1991-8#1)(1994-3#1)
of the enzyme shows##2##4##(1990-9#1)(1991-5#1)
of the enzyme that##5##4##(1990-5#2)(1992-6#1)(1993-9#1)(1995-10#1)
of the enzyme to the##4##5##(1990-2#1)(1992-12#1)(1993-6#1)(1995-8#1)
of the enzyme to##12##4##(1990-2#2)(1990-3#1)(1991-1#1)(1992-12#1)(1993-6#1)(1995-6#3)(1995-8#1)(1997-2#1)(2008-10#1)
of the enzyme tyrosinase##2##4##(1992-3#1)(2008-5#1)
of the enzyme upon##2##4##(1990-5#1)(1996-8#1)
of the enzyme was also##2##5##(1990-2#1)(1992-12#1)
of the enzyme was found to be##2##7##(1992-12#1)(1997-4#1)
of the enzyme was##23##4##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-8#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-8#1)(2008-6#1)
of the enzyme we##2##4##(1990-12#1)(1997-1#1)
of the enzyme were##10##4##(1990-12#2)(1990-5#1)(1991-2#1)(1991-5#1)(1992-12#1)(1996-5#1)(1996-7#1)(2006-10#1)(2006-8#1)
of the enzyme which##3##4##(1992-9#1)(1994-11#1)(2008-11#1)
of the enzyme with a##2##5##(1992-5#1)(1993-6#1)
of the enzyme with respect to the##2##7##(1991-2#1)(1993-8#1)
of the enzyme with##16##4##(1990-2#2)(1990-7#1)(1991-2#2)(1991-5#1)(1992-5#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-6#2)(1997-6#1)(2008-10#1)
of the enzyme##540##3##(1990-10#9)(1990-11#4)(1990-12#10)(1990-2#13)(1990-3#2)(1990-4#3)(1990-5#18)(1990-7#14)(1990-8#10)(1990-9#5)(1991-1#6)(1991-10#2)(1991-11#2)(1991-12#6)(1991-2#13)(1991-3#3)(1991-4#1)(1991-5#16)(1991-6#1)(1991-7#3)(1991-8#5)(1991-9#4)(1992-1#3)(1992-11#7)(1992-12#12)(1992-2#5)(1992-3#6)(1992-4#5)(1992-5#3)(1992-6#8)(1992-7#1)(1992-8#6)(1992-9#5)(1993-11#8)(1993-3#9)(1993-4#1)(1993-6#6)(1993-8#4)(1993-9#6)(1994-11#8)(1994-12#6)(1994-2#3)(1994-3#4)(1994-5#4)(1994-6#8)(1994-8#11)(1994-9#9)(1995-1#4)(1995-10#2)(1995-11#3)(1995-12#2)(1995-2#5)(1995-3#4)(1995-5#4)(1995-6#9)(1995-7#1)(1995-8#5)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#8)(1996-3#1)(1996-5#4)(1996-6#2)(1996-7#16)(1996-8#10)(1996-9#3)(1997-1#10)(1997-2#10)(1997-4#8)(1997-6#7)(1997-7#4)(1997-8#1)(2004-11#1)(2005-11#3)(2006-10#3)(2006-5#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#3)(2007-6#1)(2007-8#4)(2008-10#41)(2008-11#4)(2008-4#5)(2008-5#5)(2008-6#5)(2008-7#6)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#3)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#2)(2013-8#2)
of the enzyme's active site##3##5##(1992-12#1)(2009-12#2)
of the enzyme's##8##3##(1992-12#1)(1992-9#1)(1994-8#1)(1995-6#1)(2008-5#1)(2008-8#1)(2009-12#2)
of the enzyme(s)##2##3##(1990-7#1)(1994-8#1)
of the enzyme)##2##3##(1993-11#1)(2009-12#1)
of the enzyme-bound##2##3##(1991-4#1)(1992-6#1)
of the enzyme-catalyzed reaction##5##4##(2007-8#1)(2008-10#4)
of the enzyme-catalyzed##6##3##(2007-8#1)(2008-10#4)(2010-4#1)
of the enzyme-inhibitor adduct##2##4##(1992-6#2)
of the enzyme-inhibitor complex##2##4##(1993-11#1)(1997-6#1)
of the enzyme-inhibitor##5##3##(1991-2#1)(1992-6#2)(1993-11#1)(1997-6#1)
of the enzyme-substrate complex##3##4##(1990-8#1)(2007-6#1)(2008-5#1)
of the enzymes involved in##4##5##(1994-9#1)(2007-10#1)(2011-1#1)(2013-1#1)
of the enzymes that##2##4##(2008-4#1)(2010-2#1)
of the enzymes##33##3##(1990-11#1)(1990-3#1)(1990-5#1)(1991-5#4)(1992-11#1)(1992-9#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-10#1)(1996-12#1)(1996-8#1)(1997-6#3)(1997-8#1)(2004-11#1)(2005-8#1)(2006-10#1)(2007-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-2#1)(2011-1#1)(2011-12#1)(2013-1#1)
of the eosinophil##2##3##(1992-6#1)(2012-2#1)
of the epidemic growth rate to##2##6##(2008-10#2)
of the epidemic in##4##4##(1990-12#1)(1995-6#1)(2007-12#1)(2011-1#1)
of the epidemic##35##3##(1990-12#2)(1990-6#1)(1993-3#1)(1995-6#1)(1996-5#1)(2007-12#1)(2007-7#2)(2007-9#2)(2008-1#2)(2008-10#20)(2011-1#1)(2012-3#1)
of the epidemics##3##3##(2008-10#3)
of the epidemiological##5##3##(2005-10#3)(2013-1#2)
of the epidemiologist on the health care management team##2##9##(1994-3#2)
of the epidemiologist##3##3##(1994-3#3)
of the epidemiology and##4##4##(2005-11#1)(2007-11#1)(2008-10#1)(2008-4#1)
of the epidemiology of##10##4##(2006-10#1)(2006-8#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-8#1)(2009-10#1)(2010-9#1)(2013-1#1)
of the epidemiology##22##3##(2005-11#1)(2006-10#3)(2006-8#1)(2006-9#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-4#2)(2008-8#1)(2009-10#1)(2010-6#1)(2010-9#1)(2011-12#1)(2012-12#1)(2013-1#1)
of the epidermal cell##2##4##(1991-1#1)(2008-7#1)
of the epidermal growth factor (EGF) receptor##2##7##(1990-5#1)(1997-2#1)
of the epidermal growth factor (EGF)##3##6##(1990-5#1)(1997-2#1)(2011-2#1)
of the epidermal growth factor receptor (EGFR)##2##7##(2008-7#1)(2010-12#1)
of the epidermal growth factor receptor family##3##7##(1995-3#1)(2013-1#2)
of the epidermal growth factor receptor##12##6##(1991-11#1)(1993-4#1)(1993-8#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-5#1)(2008-7#1)(2010-12#1)(2012-12#1)(2013-1#2)
of the epidermal growth factor##16##5##(1990-5#1)(1991-11#1)(1993-4#1)(1993-8#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-2#1)(2008-7#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
of the epidermal growth##17##4##(1990-5#1)(1991-11#1)(1993-4#1)(1993-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-2#1)(2008-7#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
of the epidermal##21##3##(1990-5#1)(1991-1#1)(1991-11#1)(1993-4#1)(1993-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-2#1)(2006-12#1)(2008-5#1)(2008-7#2)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
of the epidermis and##3##4##(2008-5#1)(2008-9#2)
of the epidermis##32##3##(1993-5#1)(1994-5#1)(1996-2#1)(1996-6#2)(2006-9#1)(2007-12#6)(2007-2#1)(2008-10#3)(2008-4#2)(2008-5#6)(2008-9#5)(2009-8#1)(2010-12#1)(2010-6#1)
of the epididymal##3##3##(1997-1#2)(1997-8#1)
of the epididymis and##2##4##(2006-7#1)(2008-9#1)
of the epididymis##6##3##(1992-3#1)(2006-7#1)(2008-9#2)(2011-1#2)
of the epidural##4##3##(1993-4#1)(2006-10#1)(2006-12#2)
of the epigenetic##3##3##(2008-8#1)(2009-3#1)(2012-2#1)
of the epilepsy##3##3##(1997-8#1)(2008-8#1)(2010-8#1)
of the epileptic##3##3##(1995-9#1)(2008-11#1)(2009-8#1)
of the epileptogenic##2##3##(1992-8#1)(2009-8#1)
of the epiphysis##4##3##(1990-2#1)(2007-11#1)(2008-1#1)(2008-8#1)
of the epistatic interactions##2##4##(2008-4#2)
of the epithelial barrier##2##4##(2006-10#2)
of the epithelial cell##2##4##(1992-3#1)(1992-5#1)
of the epithelial cells##5##4##(1990-12#1)(1996-11#1)(2007-12#2)(2013-1#1)
of the epithelial cycle##4##4##(2009-10#2)(2012-2#2)
of the epithelial##21##3##(1990-12#1)(1991-11#1)(1992-3#1)(1992-5#1)(1996-11#1)(2005-11#1)(2006-10#2)(2007-12#3)(2008-8#1)(2009-10#2)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#1)
of the epithelium in##2##4##(1994-3#1)(2010-12#1)
of the epithelium##13##3##(1991-5#1)(1992-6#1)(1994-3#1)(1994-5#1)(1997-1#1)(2006-10#2)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#2)(2013-1#1)
of the epitope##6##3##(1991-3#1)(1995-4#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-11#1)
of the epitopes##4##3##(1993-6#1)(1995-8#1)(2006-6#1)(2008-10#1)
of the epothilones##2##3##(2011-12#2)
of the epoxidation of##3##4##(1990-12#1)(1992-5#1)(2007-11#1)
of the epoxidation##4##3##(1990-12#1)(1992-5#1)(1996-5#1)(2007-11#1)
of the epoxide hydrolase##2##4##(1994-9#1)(1995-8#1)
of the epoxide##4##3##(1994-9#2)(1995-1#1)(1995-8#1)
of the epoxy##5##3##(2007-11#1)(2008-10#1)(2008-3#1)(2010-4#2)
of the epsilon##7##3##(1991-1#2)(1995-1#1)(1996-1#1)(1997-1#1)(2009-7#2)
of the epsp##2##3##(1991-6#2)
of the equal##2##3##(1997-5#1)(2005-11#1)
of the equation of transfer##2##5##(2008-2#2)
of the equation of##3##4##(2008-2#3)
of the equation was##2##4##(2008-10#1)(2012-2#1)
of the equation##8##3##(2008-10#1)(2008-2#4)(2008-3#2)(2012-2#1)
of the equations##5##3##(1990-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
of the equatorial##5##3##(1992-7#1)(1996-2#1)(1997-7#2)(2008-3#1)
of the equilibrium between##3##4##(1991-4#1)(1997-4#1)(2005-1#1)
of the equilibrium constant##2##4##(1997-2#1)(2008-10#1)
of the equilibrium distribution of the##2##6##(2008-10#2)
of the equilibrium unfolding##2##4##(1990-7#1)(1994-8#1)
of the equilibrium##22##3##(1990-7#1)(1991-4#1)(1992-10#1)(1994-11#1)(1994-8#1)(1995-4#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-1#1)(2005-11#3)(2006-4#1)(2008-10#6)(2008-9#2)
of the equine genome##3##4##(2008-8#3)
of the equine##6##3##(1994-5#1)(1996-10#1)(2005-7#1)(2008-8#3)
of the equipment and##2##4##(2007-5#1)(2008-4#1)
of the equipment##9##3##(2006-8#1)(2007-5#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-1#1)(2012-3#1)
of the equivalence point##2##4##(2008-10#2)
of the equivalent##5##3##(1995-12#1)(1995-2#1)(2007-11#1)(2008-3#1)(2012-3#1)
of the eradication##2##3##(2006-6#1)(2008-10#1)
of the erbium-doped fiber##2##4##(2008-2#1)(2008-3#1)
of the error filter##2##4##(2008-2#2)
of the error of##2##4##(2008-3#2)
of the error##19##3##(1995-3#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-2#9)(2008-3#3)(2012-2#2)
of the error-reduction##2##3##(2007-11#1)(2008-3#1)
of the errors in##2##4##(2008-2#1)(2008-3#1)
of the errors of##4##4##(2008-10#1)(2008-2#1)(2008-3#2)
of the errors##13##3##(1992-6#2)(2006-8#1)(2008-10#1)(2008-12#1)(2008-2#4)(2008-3#4)
of the erythrocyte membrane##5##4##(1991-7#1)(1993-4#1)(1996-1#2)(2008-11#1)
of the erythrocyte sedimentation rate##2##5##(1997-6#1)(2007-7#1)
of the erythrocyte##12##3##(1990-11#1)(1990-2#1)(1991-7#1)(1991-8#1)(1992-7#1)(1993-4#1)(1994-9#1)(1996-1#2)(1997-6#1)(2007-7#1)(2008-11#1)
of the erythrocytes in##2##4##(1996-1#1)(2008-2#1)
of the erythrocytes##3##3##(1996-1#1)(1997-6#1)(2008-2#1)
of the erythroid##2##3##(1991-5#1)(1994-8#1)
of the eschar showed##2##4##(2013-8#2)
of the eschar##4##3##(2013-8#4)
of the esophageal##9##3##(1990-4#1)(1992-11#1)(2006-10#1)(2006-2#1)(2007-8#3)(2013-8#2)
of the esophagus and stomach##2##5##(2006-8#1)(2011-2#1)
of the esophagus and the##2##5##(2006-10#1)(2009-3#1)
of the esophagus and##10##4##(1990-6#1)(1994-4#1)(2005-1#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-7#1)(2009-3#1)(2011-2#1)
of the esophagus in##2##4##(2008-5#1)(2011-2#1)
of the esophagus is a rare##2##6##(2007-6#1)(2011-2#1)
of the esophagus is##5##4##(1993-11#1)(2007-6#1)(2007-8#1)(2009-3#1)(2011-2#1)
of the esophagus with##2##4##(2008-12#1)(2013-8#1)
of the esophagus##64##3##(1990-6#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-8#2)(1994-4#2)(1995-3#2)(1995-5#1)(1996-9#2)(2005-1#1)(2006-10#7)(2006-2#1)(2006-8#1)(2007-2#2)(2007-6#3)(2007-7#1)(2007-8#3)(2008-12#1)(2008-5#5)(2009-2#1)(2009-3#3)(2009-7#2)(2010-12#4)(2011-2#7)(2013-7#2)(2013-8#5)
of the esophagus]##4##3##(1990-5#1)(1992-9#1)(1993-5#1)(1996-3#1)
of the essential amino acid##3##5##(1994-3#1)(2008-3#1)(2008-5#1)
of the essential amino##4##4##(1994-3#1)(2008-3#1)(2008-5#1)(2012-2#1)
of the essential cofactor##2##4##(1995-8#2)
of the essential components##2##4##(1994-3#1)(1994-8#1)
of the essential elements of##2##5##(2006-10#1)(2007-11#1)
of the essential elements##6##4##(2006-10#1)(2007-11#3)(2008-2#1)(2009-6#1)
of the essential oil of the fruits##2##7##(2008-11#1)(2008-12#1)
of the essential oil of the leaves##2##7##(2008-11#1)(2010-12#1)
of the essential oil of the##4##6##(2008-11#2)(2008-12#1)(2010-12#1)
of the essential oil of##7##5##(2007-1#2)(2008-11#3)(2008-12#1)(2010-12#1)
of the essential oil were##2##5##(2007-1#1)(2012-3#1)
of the essential oil##16##4##(2007-1#3)(2007-11#1)(2007-8#1)(2008-11#3)(2008-12#2)(2010-12#1)(2012-12#1)(2012-3#2)(2013-1#2)
of the essential oils and##2##5##(2008-10#1)(2010-4#1)
of the essential oils from##2##5##(2007-1#1)(2008-12#1)
of the essential oils obtained##2##5##(2007-11#1)(2008-11#1)
of the essential oils of Ocimum##2##6##(2007-1#1)(2008-5#1)
of the essential oils of##3##5##(2007-1#1)(2008-11#1)(2008-5#1)
of the essential oils##11##4##(2007-1#3)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2010-4#1)(2012-12#1)
of the essential role of##3##5##(1995-12#1)(2008-1#1)(2013-8#1)
of the essential##54##3##(1994-3#2)(1994-8#1)(1995-12#1)(1995-8#2)(1997-3#2)(1997-6#1)(2005-7#1)(2006-10#1)(2007-1#6)(2007-11#5)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#4)(2008-2#1)(2008-3#1)(2008-5#2)(2009-6#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
of the established##11##3##(1997-7#1)(2005-10#1)(2005-7#1)(2005-9#1)(2006-12#1)(2006-6#1)(2007-4#1)(2008-10#1)(2008-5#1)(2010-10#1)(2010-5#1)
of the establishment of##4##4##(1997-7#1)(2007-9#1)(2008-1#1)(2009-10#1)
of the establishment##5##3##(1997-7#1)(2005-8#1)(2007-9#1)(2008-1#1)(2009-10#1)
of the establishments##3##3##(1996-1#2)(2008-12#1)
of the ester##3##3##(1991-2#2)(2007-11#1)
of the esterase S gene##2##5##(1995-2#2)
of the esterase S##3##4##(1995-2#3)
of the esterase##4##3##(1995-2#3)(2008-11#1)
of the estimate of the##2##5##(2007-12#1)(2008-10#1)
of the estimate of##3##4##(1994-2#1)(2007-12#1)(2008-10#1)
of the estimated value##2##4##(2008-10#2)
of the estimated##25##3##(1990-11#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-6#1)(2004-11#2)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-7#1)(2010-8#2)(2012-1#1)(2012-12#1)
of the estimates##8##3##(1997-3#1)(2007-8#1)(2008-8#2)(2010-3#2)(2010-6#1)(2012-12#1)
of the estimation##5##3##(1997-3#1)(2008-2#1)(2008-3#2)(2010-2#1)
of the estimator is##2##4##(2006-5#1)(2008-2#1)
of the estimator##4##3##(2006-5#1)(2008-2#1)(2010-3#1)(2012-1#1)
of the estrogen receptor (ER)##2##5##(1996-11#1)(2007-5#1)
of the estrogen receptor##9##4##(1990-5#1)(1990-7#1)(1991-8#1)(1994-12#1)(1996-11#1)(1996-8#2)(2007-10#1)(2007-5#1)
of the estrogen##15##3##(1990-5#1)(1990-7#1)(1991-2#1)(1991-8#1)(1994-12#2)(1996-11#1)(1996-5#1)(1996-8#2)(2007-10#1)(2007-5#1)(2008-10#1)(2008-5#1)(2013-1#1)
of the estrogens##2##3##(1996-5#1)(2008-4#1)
of the estrous cycle##7##4##(1992-3#2)(1992-9#1)(1993-11#2)(2006-5#1)(2007-2#1)
of the estrous##8##3##(1992-3#2)(1992-9#2)(1993-11#2)(2006-5#1)(2007-2#1)
of the etalon is##2##4##(2008-3#2)
of the etalon##9##3##(2008-2#4)(2008-3#5)
of the etched##2##3##(2008-10#2)
of the etching##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
of the ethanol extract of leaves of##2##7##(2010-12#1)(2011-3#1)
of the ethanol extract of##3##5##(2010-12#1)(2011-3#1)(2013-7#1)
of the ethanol extract##4##4##(2010-12#1)(2011-3#1)(2013-1#1)(2013-7#1)
of the ethanol##10##3##(1993-11#1)(2005-11#1)(2008-10#3)(2008-5#1)(2010-12#1)(2011-3#1)(2013-1#1)(2013-7#1)
of the ethanol-associated##2##3##(1996-4#2)
of the ethanolic extract of##2##5##(2007-1#1)(2008-10#1)
of the ethanolic extract##3##4##(2007-1#2)(2008-10#1)
of the ethanolic##4##3##(2007-1#2)(2008-10#1)(2011-2#1)
of the ether##4##3##(1994-8#1)(1995-3#1)(1997-4#1)(2008-8#1)
of the ethical issues##2##4##(2008-9#1)(2013-8#1)
of the ethical##7##3##(1994-3#1)(2005-7#1)(2006-11#1)(2007-7#1)(2008-11#1)(2008-9#1)(2013-8#1)
of the ethics##4##3##(1993-1#1)(2007-3#1)(2008-7#1)(2013-8#1)
of the ethnic groups##2##4##(2008-9#1)(2011-2#1)
of the ethnic##3##3##(2008-1#1)(2008-9#1)(2011-2#1)
of the ethoxyresorufin O-deethylation##2##4##(1990-4#2)
of the ethyl##4##3##(2007-11#2)(2008-10#1)(2010-2#1)
of the ethylene##3##3##(2007-12#1)(2008-10#1)(2009-8#1)
of the etiologic agent##2##4##(2012-3#2)
of the etiologic##5##3##(1991-8#1)(2008-4#1)(2008-7#1)(2012-3#2)
of the etiology of the##2##5##(2007-12#1)(2013-1#1)
of the etiology of##13##4##(1995-6#1)(1997-2#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2013-1#3)(2013-8#1)
of the etiology##16##3##(1995-6#1)(1997-2#1)(2005-11#1)(2006-10#2)(2006-6#2)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2011-12#1)(2013-1#3)(2013-8#1)
of the etiopathogenesis of##2##4##(1990-6#1)(1991-2#1)
of the ets##2##3##(1994-10#1)(1994-8#1)
of the eukaryotic cell##3##4##(1993-9#1)(2008-7#1)(2008-9#1)
of the eukaryotic nucleus##2##4##(2008-8#2)
of the eukaryotic##18##3##(1990-11#1)(1991-2#2)(1993-6#1)(1993-9#1)(1994-12#1)(1996-5#2)(1996-7#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#2)(2011-1#1)
of the eutherian orders##2##4##(1993-6#2)
of the eutherian##3##3##(1993-6#3)
of the evacuation##2##3##(1991-2#1)(1996-12#1)
of the evaluated##7##3##(1990-9#1)(2007-10#1)(2007-7#1)(2008-3#1)(2012-12#1)(2013-1#2)
of the evaluation of##7##4##(1996-5#1)(2004-11#1)(2005-5#1)(2008-8#1)(2008-9#1)(2010-9#1)(2012-2#1)
of the evaluation##20##3##(1996-5#1)(2004-11#1)(2005-5#2)(2006-11#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
of the evaluations##2##3##(2006-10#1)(2009-6#1)
of the evanescent field##3##4##(2007-12#2)(2008-2#1)
of the evanescent##4##3##(2007-12#2)(2008-10#1)(2008-2#1)
of the evaporation##2##3##(1995-3#1)(2013-8#1)
of the event##11##3##(2005-8#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-8#1)(2010-2#1)(2010-8#2)(2011-1#1)
of the event-related##3##3##(1996-1#1)(2008-11#2)
of the events and##2##4##(2009-10#1)(2013-1#1)
of the events that occur during##2##6##(1997-5#1)(2008-4#1)
of the events that##3##4##(1997-5#1)(2008-1#1)(2008-4#1)
of the events##12##3##(1995-4#2)(1995-8#1)(1996-11#1)(1997-5#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-10#1)(2009-2#1)(2009-7#1)(2013-1#1)
of the ever##2##3##(1996-5#1)(2008-1#1)
of the everyday##2##3##(1995-6#1)(2009-11#1)
of the evidence and##3##4##(2006-10#1)(2008-8#1)(2009-4#1)
of the evidence for the##3##5##(2006-8#1)(2011-12#1)(2012-12#1)
of the evidence for##6##4##(2006-8#1)(2007-8#1)(2008-10#1)(2011-12#1)(2012-12#2)
of the evidence from##2##4##(2005-10#1)(2009-7#1)
of the evidence in the##3##5##(2007-6#1)(2008-6#2)
of the evidence in##4##4##(2007-6#1)(2008-6#2)(2013-1#1)
of the evidence is##3##4##(1992-5#1)(2008-7#1)(2008-8#1)
of the evidence suggests##2##4##(2008-9#1)(2010-12#1)
of the evidence to support this##2##6##(2008-6#1)(2008-8#1)
of the evidence to support##3##5##(2008-11#1)(2008-6#1)(2008-8#1)
of the evidence##50##3##(1992-5#1)(1993-12#1)(1996-12#1)(1996-6#1)(2005-10#3)(2006-10#2)(2006-8#3)(2007-11#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-6#3)(2008-7#1)(2008-8#5)(2008-9#1)(2009-11#1)(2009-4#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-11#1)(2012-12#4)(2013-1#2)(2013-7#1)(2013-8#2)
of the evidence-based medicine##2##4##(2006-6#1)(2013-8#1)
of the evidence-based##5##3##(2006-6#1)(2008-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
of the evoked response##2##4##(1992-7#1)(1993-2#1)
of the evoked##4##3##(1992-7#1)(1993-2#1)(1995-12#1)(2008-9#1)
of the evolution and##2##4##(2008-7#1)(2009-5#1)
of the evolution of a##2##5##(2008-10#1)(2010-12#1)
of the evolution of genes in##2##6##(2013-1#2)
of the evolution of the##10##5##(1990-3#1)(2006-5#1)(2007-12#4)(2008-2#1)(2008-3#2)(2010-8#1)
of the evolution of##38##4##(1990-12#1)(1990-3#1)(1991-1#1)(1991-4#1)(1992-7#1)(1994-5#1)(2006-5#1)(2007-11#1)(2007-12#6)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2013-1#2)
of the evolution##42##3##(1990-12#1)(1990-3#1)(1991-1#1)(1991-4#1)(1992-7#1)(1994-5#1)(2005-11#1)(2006-5#1)(2007-11#1)(2007-12#6)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2013-1#2)
of the evolutionary history of##2##5##(1996-3#1)(1997-4#1)
of the evolutionary##12##3##(1990-12#1)(1991-6#1)(1996-3#1)(1997-4#1)(2006-3#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#2)(2010-4#1)(2010-7#1)
of the evolved##4##3##(1997-4#1)(2008-10#2)(2011-1#1)
of the evolving##4##3##(2006-1#1)(2006-10#1)(2008-2#1)(2011-2#1)
of the ex##2##3##(1996-6#1)(2006-8#1)
of the exacerbation as compared to the##2##7##(2008-11#2)
of the exact##15##3##(1990-4#1)(1993-11#1)(1996-3#2)(2007-10#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#4)(2012-12#1)(2013-1#1)
of the examination##11##3##(1990-3#2)(1990-4#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-7#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-8#1)
of the examinations##4##3##(1990-4#1)(1993-5#1)(1995-5#1)(1996-9#1)
of the examined patients##2##4##(2007-7#1)(2008-4#1)
of the examined##15##3##(1991-2#1)(1993-5#1)(2005-10#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-4#1)(2010-12#1)(2010-4#1)(2012-12#1)(2013-1#1)
of the example##2##3##(2008-3#1)(2011-1#1)
of the examples##3##3##(1991-12#1)(2007-11#1)(2011-12#1)
of the excellent##3##3##(2007-11#1)(2008-10#1)(2008-5#1)
of the excess##11##3##(1995-10#1)(1996-7#2)(2005-11#1)(2006-10#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-2#1)
of the exchange##8##3##(1990-8#1)(1992-4#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#2)
of the exchanger##2##3##(2008-10#2)
of the excised intein and##2##5##(1995-8#2)
of the excised intervening sequence##2##5##(1995-8#2)
of the excised specimen##2##4##(2009-5#1)(2011-1#1)
of the excised tumor##2##4##(1990-12#1)(2012-12#1)
of the excised##15##3##(1990-12#1)(1991-5#1)(1995-4#1)(1995-8#4)(2005-12#1)(2007-8#1)(2008-11#1)(2009-5#1)(2010-12#1)(2011-1#1)(2012-12#2)
of the excision##3##3##(1995-9#1)(2008-5#1)(2008-7#1)
of the excitation and##2##4##(1990-3#1)(2008-2#1)
of the excitation beam##6##4##(2007-11#3)(2008-3#3)
of the excitation laser##4##4##(2005-11#1)(2006-12#1)(2008-3#2)
of the excitation light##4##4##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
of the excitation##25##3##(1990-3#1)(1997-1#1)(2005-11#1)(2006-12#1)(2007-11#3)(2007-12#4)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#8)
of the excitatory amino acid##5##5##(1991-5#1)(1994-2#1)(1996-3#1)(2008-7#2)
of the excitatory amino acids##2##5##(1990-11#1)(1990-7#1)
of the excitatory amino##7##4##(1990-11#1)(1990-7#1)(1991-5#1)(1994-2#1)(1996-3#1)(2008-7#2)
of the excitatory##14##3##(1990-11#1)(1990-7#1)(1991-5#1)(1991-6#1)(1994-2#1)(1995-12#1)(1996-1#1)(1996-3#1)(1996-7#1)(1997-2#1)(2005-10#1)(2007-1#1)(2008-7#2)
of the excited state energy##2##5##(2009-12#2)
of the excited state##5##4##(1990-3#1)(1997-4#1)(2007-12#1)(2009-12#2)
of the excited states##3##4##(2006-12#1)(2006-5#1)(2008-10#1)
of the excited transitions##2##4##(2008-3#2)
of the excited##16##3##(1990-3#1)(1992-12#1)(1997-4#1)(2006-12#1)(2006-5#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#4)(2009-11#1)(2009-12#2)
of the excited-state absorption##2##4##(2008-3#2)
of the exciting light##2##4##(2007-12#1)(2008-2#1)
of the exciting##6##3##(2006-10#1)(2007-12#2)(2008-2#1)(2008-3#2)
of the excitotoxic##2##3##(2009-10#1)(2011-2#1)
of the excretory##2##3##(2007-12#1)(2008-5#1)
of the executive##3##3##(2007-8#1)(2012-1#1)(2013-8#1)
of the exercise##9##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-7#1)(2013-1#1)(2013-8#2)
of the exercises##4##3##(2007-11#3)(2013-8#1)
of the exhausted##2##3##(1994-6#1)(2008-2#1)
of the exhaustive##2##3##(1991-1#1)(2008-2#1)
of the existence and uniqueness of##2##6##(2008-11#1)(2009-10#1)
of the existence and##3##4##(2007-12#1)(2008-11#1)(2009-10#1)
of the existence of a##3##5##(1990-8#1)(2008-10#1)(2013-8#1)
of the existence of the##5##5##(1990-5#1)(1994-12#1)(2005-8#1)(2008-3#1)(2010-5#1)
of the existence of##29##4##(1990-5#1)(1990-8#1)(1994-12#1)(1995-12#1)(1995-8#1)(1996-11#1)(1997-8#1)(2005-12#1)(2005-8#1)(2006-6#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-5#1)(2010-6#1)(2010-8#1)(2013-1#1)(2013-8#4)
of the existence##33##3##(1990-5#1)(1990-8#1)(1993-2#1)(1994-12#1)(1995-12#1)(1995-8#1)(1996-11#1)(1997-8#1)(2005-12#1)(2005-8#1)(2006-6#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#2)(2010-5#1)(2010-6#1)(2010-8#1)(2013-1#1)(2013-8#4)
of the existing literature on##2##5##(1993-12#1)(2010-2#1)
of the existing literature##5##4##(1993-12#1)(1994-7#1)(2007-2#1)(2008-2#1)(2010-2#1)
of the existing methods for##3##5##(2008-5#1)(2008-7#1)(2013-1#1)
of the existing##43##3##(1992-11#1)(1992-2#1)(1992-3#1)(1993-12#1)(1994-7#1)(1994-9#1)(1995-1#1)(1996-2#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-11#2)(2007-2#1)(2007-4#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-7#1)(2010-10#2)(2010-12#2)(2010-2#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
of the exit site##3##4##(2007-12#1)(2007-7#2)
of the exit##4##3##(2007-12#1)(2007-7#2)(2008-3#1)
of the exocrine##2##3##(2006-10#1)(2007-10#1)
of the exocytotic##3##3##(1996-9#1)(2007-9#1)(2012-2#1)
of the exogenous##7##3##(1990-10#1)(1992-7#1)(1993-12#1)(1994-12#1)(2008-11#1)(2008-8#1)(2010-10#1)
of the exon 8##2##4##(1993-8#2)
of the exon##7##3##(1991-5#1)(1992-8#1)(1993-8#3)(1995-6#1)(1997-8#1)
of the exons and##2##4##(1991-5#1)(1993-3#1)
of the exons##6##3##(1991-5#1)(1992-3#1)(1993-3#1)(1994-3#1)(1995-1#1)(1997-2#1)
of the exopolysaccharide##2##3##(1991-9#1)(2009-8#1)
of the exoskeleton##4##3##(2012-1#4)
of the expanded##5##3##(1991-12#1)(2008-10#1)(2010-9#1)(2012-1#1)(2012-12#1)
of the expanding##2##3##(2006-10#1)(2008-10#1)
of the expansion of the##2##5##(2006-5#1)(2008-10#1)
of the expansion##6##3##(2006-5#1)(2008-10#1)(2008-2#3)(2008-3#1)
of the expected genetic##2##4##(2008-10#1)(2010-5#1)
of the expected length were##2##5##(1992-6#1)(2008-5#1)
of the expected size##2##4##(2006-12#1)(2008-10#1)
of the expected##31##3##(1990-12#2)(1990-6#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-1#1)(1995-1#1)(1995-12#1)(1996-11#1)(2006-12#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-5#2)(2010-5#2)(2011-1#1)(2011-2#1)
of the expensive##2##3##(2008-10#1)(2011-1#1)
of the experience of the##2##5##(2004-11#1)(2012-3#1)
of the experience of##7##4##(1995-1#1)(2004-10#1)(2004-11#1)(2007-2#1)(2008-2#1)(2011-1#1)(2012-3#1)
of the experience##13##3##(1995-1#1)(1995-2#1)(2004-10#1)(2004-11#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-2#3)(2011-1#1)(2012-3#1)
of the experiences of##5##4##(1992-2#1)(2008-11#1)(2008-9#1)(2009-5#1)(2013-1#1)
of the experiences##6##3##(1992-2#1)(2008-11#1)(2008-9#1)(2009-5#1)(2010-1#1)(2013-1#1)
of the experiment and##3##4##(2008-10#1)(2008-7#1)(2012-1#1)
of the experiment are##2##4##(2008-2#2)
of the experiment was to develop##2##6##(2009-9#1)(2010-9#1)
of the experiment was to##4##5##(1993-9#1)(2008-4#1)(2009-9#1)(2010-9#1)
of the experiment was##5##4##(1993-9#1)(2008-12#1)(2008-4#1)(2009-9#1)(2010-9#1)
of the experiment##68##3##(1991-12#1)(1991-9#1)(1992-2#1)(1992-9#2)(1993-9#1)(1995-7#1)(1996-6#3)(1997-3#1)(1997-4#3)(1997-6#1)(2004-11#2)(2004-4#1)(2007-11#3)(2007-12#1)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#3)(2008-7#6)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#2)(2009-9#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#4)(2011-2#1)(2012-1#3)(2012-12#1)(2013-1#1)(2013-7#2)(2013-8#1)
of the experimental and calculated##2##5##(2008-3#2)
of the experimental and theoretical##2##5##(2008-2#1)(2008-3#1)
of the experimental and##7##4##(2008-2#2)(2008-3#3)(2011-1#2)
of the experimental animals##2##4##(1994-8#1)(2007-1#1)
of the experimental conditions for##2##5##(1992-6#1)(2008-10#1)
of the experimental conditions##11##4##(1992-6#1)(1995-4#1)(1996-8#1)(2008-10#7)(2008-3#1)
of the experimental data##11##4##(1995-6#1)(2005-11#1)(2006-2#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)
of the experimental design##2##4##(2008-10#1)(2011-1#1)
of the experimental group##2##4##(1992-7#1)(1993-12#1)
of the experimental groups##2##4##(2007-3#1)(2008-12#1)
of the experimental parameters##4##4##(2008-10#2)(2008-2#1)(2013-8#1)
of the experimental results##9##4##(2007-12#3)(2008-2#2)(2008-5#1)(2008-7#1)(2011-1#1)(2011-12#1)
of the experimental setup##4##4##(2007-1#1)(2007-11#1)(2008-3#1)(2010-10#1)
of the experimental variables##2##4##(2008-10#2)
of the experimental##97##3##(1991-7#1)(1992-1#1)(1992-6#1)(1992-7#1)(1993-12#1)(1994-8#1)(1995-4#1)(1995-6#2)(1996-8#1)(1997-7#1)(2005-11#1)(2006-2#1)(2006-5#1)(2007-1#4)(2007-11#3)(2007-12#5)(2007-3#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#23)(2008-12#1)(2008-2#10)(2008-3#14)(2008-5#2)(2008-7#2)(2009-12#1)(2010-10#1)(2010-2#1)(2011-1#4)(2011-12#1)(2011-2#2)(2012-2#1)(2013-8#1)
of the experimentally measured##2##4##(2008-10#1)(2008-2#1)
of the experimentally##5##3##(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-3#1)
of the experiments showed that the##2##6##(2007-12#1)(2008-3#1)
of the experiments##20##3##(1991-9#2)(1995-3#1)(1995-8#1)(1996-8#2)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#3)(2011-12#1)
of the expert##4##3##(2008-10#2)(2008-4#1)(2010-8#1)
of the experts##2##3##(1990-3#1)(2011-2#1)
of the experts'##2##3##(1992-9#1)(2013-1#1)
of the explanatory variables##3##4##(1995-2#1)(2010-8#2)
of the explanatory##5##3##(1995-2#1)(1995-6#1)(2005-10#1)(2010-8#2)
of the explicit##2##3##(2008-8#1)(2011-2#1)
of the explored##2##3##(1993-2#1)(2009-9#1)
of the explosion##2##3##(2008-2#1)(2009-4#1)
of the exponent##2##3##(2005-11#1)(2008-2#1)
of the exponential phase of##2##5##(1991-9#1)(2008-11#1)
of the exponential phase##4##4##(1991-9#1)(2008-11#3)
of the exponential##9##3##(1991-9#1)(1996-1#1)(2005-11#1)(2006-7#1)(2008-10#1)(2008-11#3)(2008-2#1)
of the exposed workers##2##4##(2008-10#1)(2010-9#1)
of the exposed##11##3##(1992-4#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2009-1#1)(2010-9#1)(2011-2#2)(2013-1#2)
of the exposure to##3##4##(1991-10#1)(1994-6#1)(2008-7#1)
of the exposure##17##3##(1991-10#1)(1991-12#1)(1993-3#1)(1993-4#1)(1994-6#1)(2006-12#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-7#4)(2008-8#1)(2009-11#1)
of the expressed enzyme##3##4##(1991-3#1)(1991-5#1)(1993-8#1)
of the expressed protein was##2##5##(1990-6#1)(1995-1#1)
of the expressed protein##7##4##(1990-11#1)(1990-6#1)(1995-1#1)(1995-11#1)(2008-11#1)(2008-2#1)(2008-4#1)
of the expressed proteins##2##4##(1994-8#1)(1995-11#1)
of the expressed##21##3##(1990-11#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-5#2)(1992-9#1)(1993-8#1)(1994-8#1)(1995-1#1)(1995-11#2)(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#4)
of the expression cassette##3##4##(1997-4#2)(2008-8#1)
of the expression level##3##4##(2005-11#2)(2008-1#1)
of the expression of a##3##5##(1993-6#1)(1994-5#1)(1995-12#1)
of the expression of lamins A and C is##2##9##(1992-12#2)
of the expression of the gene##2##6##(1994-2#1)(2012-3#1)
of the expression of the##12##5##(1990-7#1)(1991-3#1)(1992-8#1)(1992-9#1)(1994-2#1)(1995-12#1)(1997-4#2)(2006-10#1)(2008-11#1)(2008-4#1)(2012-3#1)
of the expression of these genes##3##6##(1991-9#1)(1994-3#1)(1995-12#1)
of the expression of these##4##5##(1991-9#1)(1994-3#1)(1995-12#1)(2012-1#1)
of the expression of##66##4##(1990-12#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-5#1)(1992-8#2)(1992-9#2)(1993-3#1)(1993-6#3)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-12#3)(1995-8#2)(1996-1#1)(1996-11#1)(1997-1#1)(1997-4#2)(2006-10#1)(2006-5#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-4#1)(2010-12#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
of the expression plasmids##2##4##(2008-9#2)
of the expression vector##3##4##(1997-8#2)(2008-4#1)
of the expression##89##3##(1990-12#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-5#1)(1992-8#2)(1992-9#2)(1993-3#1)(1993-6#3)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-12#3)(1995-8#2)(1996-1#1)(1996-11#1)(1996-8#1)(1997-1#1)(1997-4#4)(1997-5#1)(1997-8#2)(2004-3#2)(2005-11#2)(2006-10#1)(2006-5#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-3#2)(2008-4#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#1)(2009-4#1)(2010-12#2)(2010-3#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
of the expressions##3##3##(1995-6#1)(2008-11#1)(2011-2#1)
of the extant##2##3##(2006-10#1)(2011-1#1)
of the extended boundary condition method##3##6##(2008-3#3)
of the extended##17##3##(1990-10#1)(1993-12#1)(1993-6#1)(1994-11#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-9#1)(2008-3#3)(2008-4#1)(2008-5#1)(2009-5#1)(2011-1#1)(2012-3#1)(2013-8#1)
of the extension##2##3##(1997-2#1)(2011-1#1)
of the extensive##3##3##(1991-2#1)(2010-12#1)(2013-8#1)
of the extensor carpi ulnaris##3##5##(2006-4#1)(2007-4#2)
of the extensor carpi##5##4##(2006-3#1)(2006-4#1)(2007-4#3)
of the extensor tendons##3##4##(2007-8#2)(2012-2#1)
of the extensor##14##3##(1993-11#1)(1997-2#1)(2006-3#3)(2006-4#1)(2007-4#3)(2007-8#2)(2009-4#1)(2011-2#1)(2012-2#1)
of the extent and##4##4##(2005-9#1)(2008-11#1)(2009-2#1)(2011-2#1)
of the extent of the##3##5##(1994-9#1)(1995-10#1)(2010-6#1)
of the extent of##27##4##(1990-8#1)(1991-12#1)(1991-4#1)(1992-12#1)(1993-11#1)(1993-2#1)(1994-9#1)(1995-10#2)(1995-7#1)(1995-9#1)(1997-4#1)(1997-7#1)(2005-11#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#3)(2010-6#1)
of the extent to which##5##5##(1994-12#1)(1995-1#1)(1997-8#1)(2010-2#1)(2010-9#1)
of the extent##37##3##(1990-8#1)(1991-12#1)(1991-4#1)(1992-12#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-7#1)(1995-9#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-9#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#2)(2008-7#3)(2009-2#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-2#1)
of the external Schiff base intermediate in the##2##8##(1996-7#2)
of the external and internal##2##5##(2007-8#1)(2012-12#1)
of the external auditory canal##2##5##(2006-12#1)(2008-9#1)
of the external auditory##3##4##(1994-2#1)(2006-12#1)(2008-9#1)
of the external buffer##2##4##(1990-11#2)
of the external carotid artery##8##5##(1997-3#2)(1997-6#4)(2006-11#1)(2007-12#1)
of the external carotid##10##4##(1996-9#1)(1997-3#2)(1997-6#4)(2006-11#1)(2007-12#1)(2013-1#1)
of the external cavity##2##4##(2007-12#1)(2008-2#1)
of the external ear canal##2##5##(2010-7#2)
of the external ear##4##4##(2010-7#2)(2012-12#2)
of the external genitalia##2##4##(2007-7#1)(2008-1#1)
of the external iliac##2##4##(2011-2#2)
of the external medium##4##4##(2008-3#2)(2008-5#1)(2011-12#1)
of the external mirror##2##4##(2008-3#2)
of the external##58##3##(1990-11#3)(1990-3#1)(1990-7#1)(1994-2#1)(1995-5#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-3#2)(1997-6#4)(2005-11#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#5)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-10#2)(2010-7#2)(2011-12#1)(2011-2#2)(2012-12#4)(2013-1#2)
of the extinction coefficient##2##4##(1990-8#1)(2007-11#1)
of the extinction spectrum##2##4##(2008-3#1)(2009-12#1)
of the extinction##7##3##(1990-8#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-12#1)
of the extra##2##3##(2007-8#1)(2008-10#1)
of the extracellular Ca2+##2##4##(1993-2#2)
of the extracellular domain of the##6##6##(1990-12#1)(1990-8#1)(1991-8#1)(1993-3#1)(1995-3#1)(2008-8#1)
of the extracellular domain of##13##5##(1990-12#1)(1990-8#1)(1991-8#1)(1992-12#1)(1992-7#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-5#1)(1997-7#1)(2008-8#1)
of the extracellular domain##15##4##(1990-12#1)(1990-8#1)(1991-8#1)(1992-12#1)(1992-7#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-7#1)(2008-11#1)(2008-8#1)
of the extracellular domains##2##4##(1990-12#1)(1995-11#1)
of the extracellular environment##2##4##(2008-7#2)
of the extracellular matrix and##2##5##(1996-8#1)(2007-11#1)
of the extracellular matrix as##2##5##(1995-12#1)(2012-2#1)
of the extracellular matrix##22##4##(1990-5#1)(1990-7#1)(1991-3#1)(1991-8#1)(1993-9#1)(1994-5#1)(1995-12#1)(1995-3#1)(1996-5#1)(1996-8#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-9#2)(2009-5#1)(2009-8#1)(2010-10#1)(2012-2#2)(2013-8#1)
of the extracellular polysaccharide##2##4##(1991-9#1)(1995-11#1)
of the extracellular potassium concentration##2##5##(1995-11#1)(2009-8#1)
of the extracellular protease##2##4##(2008-10#2)
of the extracellular##71##3##(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-7#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#2)(1993-9#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#4)(1995-12#1)(1995-2#1)(1995-3#3)(1996-5#3)(1996-8#1)(1997-3#2)(1997-5#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#1)(2009-8#3)(2010-10#2)(2012-1#2)(2012-12#1)(2012-2#2)(2013-8#1)
of the extracranial##7##3##(1992-5#1)(2006-8#1)(2008-7#4)(2013-8#1)
of the extract and##8##4##(1995-6#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)
of the extract in##3##4##(2008-10#1)(2008-5#1)(2010-2#1)
of the extract of##2##4##(1994-11#1)(1996-10#1)
of the extract on##3##4##(2007-1#2)(2010-12#1)
of the extract significantly##2##4##(2009-6#1)(2010-12#1)
of the extract was##3##4##(1996-11#1)(2008-4#1)(2010-2#1)
of the extract were##2##4##(2008-10#1)(2010-12#1)
of the extract with##2##4##(2007-8#1)(2008-10#1)
of the extract##41##3##(1992-3#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-4#1)(1997-1#1)(2007-1#3)(2007-8#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#2)(2009-5#2)(2009-6#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-5#1)(2011-2#1)(2013-8#1)
of the extractant##3##3##(2008-10#3)
of the extracted complexes##3##4##(2008-10#3)
of the extracted species is##2##5##(2008-10#2)
of the extracted species##6##4##(2008-10#6)
of the extracted##24##3##(1990-7#1)(1995-3#1)(1996-4#1)(1997-4#1)(2005-10#1)(2008-10#14)(2008-7#1)(2008-8#1)(2010-4#1)(2012-1#2)
of the extracting solvent##2##4##(2008-10#2)
of the extracting##5##3##(2007-8#1)(2008-10#4)
of the extraction and desorption##3##5##(2007-8#1)(2008-10#2)
of the extraction and##5##4##(2007-8#1)(2008-10#3)(2012-1#1)
of the extraction method and##2##5##(2008-10#1)(2008-5#1)
of the extraction method##3##4##(1993-1#1)(2008-10#1)(2008-5#1)
of the extraction of##3##4##(2008-10#3)
of the extraction procedures##2##4##(2008-10#2)
of the extraction process##4##4##(2008-10#4)
of the extraction vessel##2##4##(2008-10#2)
of the extraction##39##3##(1993-1#1)(2005-4#2)(2007-8#1)(2008-10#33)(2008-5#1)(2012-1#1)
of the extracts of##4##4##(2008-10#1)(2008-4#1)(2008-5#1)(2009-5#1)
of the extracts on##2##4##(1992-5#1)(2010-3#1)
of the extracts were##4##4##(1996-5#1)(2008-10#2)(2009-5#1)
of the extracts with##2##4##(1991-8#1)(2008-10#1)
of the extracts##24##3##(1990-8#1)(1991-8#1)(1992-4#1)(1992-5#1)(1992-8#1)(1996-5#1)(1997-1#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#1)(2009-5#2)(2010-2#1)(2010-3#2)(2012-1#1)(2013-1#1)
of the extrahepatic bile duct##3##5##(2010-12#3)
of the extrahepatic bile##4##4##(2007-5#1)(2010-12#3)
of the extrahepatic##6##3##(2006-2#1)(2007-5#1)(2009-2#1)(2010-12#3)
of the extraocular muscles##2##4##(1997-3#1)(2011-1#1)
of the extraordinary##2##3##(2008-2#2)
of the extrapyramidal system##2##4##(2008-7#2)
of the extrapyramidal##3##3##(2008-7#2)(2008-9#1)
of the extreme##10##3##(1994-3#1)(1995-5#1)(1997-4#1)(2006-12#1)(2006-6#1)(2008-6#1)(2009-2#1)(2011-1#2)(2011-12#1)
of the extremely high##2##4##(2008-3#1)(2009-3#1)
of the extremely thermophilic##2##4##(1990-5#1)(1994-2#1)
of the extremely##8##3##(1990-5#1)(1994-2#1)(2008-10#1)(2008-3#2)(2009-3#1)(2011-2#1)(2011-3#1)
of the extremities and##3##4##(2008-6#1)(2012-1#1)(2013-1#1)
of the extremities or##2##4##(2008-3#1)(2008-6#1)
of the extremities##25##3##(1990-12#1)(1992-6#4)(2006-10#1)(2007-4#1)(2007-8#2)(2008-3#1)(2008-6#5)(2008-9#1)(2009-2#1)(2009-4#1)(2010-3#2)(2011-2#1)(2012-1#2)(2013-1#2)
of the extremity and superficial trunk##3##6##(1993-9#1)(2008-6#2)
of the extremity##10##3##(1992-6#2)(1993-9#1)(2008-6#3)(2010-3#4)
of the extrinsic##4##3##(1995-8#1)(2005-12#1)(2008-3#1)(2009-9#1)
of the eye and##7##4##(1992-2#1)(1995-3#1)(1995-5#1)(2005-8#1)(2006-11#1)(2007-12#1)(2008-4#1)
of the eye field##2##4##(2007-12#2)
of the eye in##2##4##(2008-5#1)(2009-2#1)
of the eye is##3##4##(2007-12#2)(2008-11#1)
of the eye that##2##4##(2007-1#1)(2012-12#1)
of the eye were##2##4##(2006-11#1)(2007-11#1)
of the eyeball##3##3##(2008-6#1)(2009-2#1)(2012-3#1)
of the eyes and##2##4##(1996-12#1)(2007-10#1)
of the eyes##9##3##(1990-10#1)(1996-12#1)(2007-1#2)(2007-10#1)(2007-12#1)(2009-4#1)(2012-12#1)(2013-8#1)
of the eyespot##5##3##(2008-10#1)(2009-10#1)(2012-2#1)(2012-3#2)
of the eyestalk##2##3##(1996-5#1)(2008-5#1)
of the f10##2##3##(1993-3#2)
of the fEPSP##2##3##(1996-8#1)(2009-5#1)
of the fabA gene##2##4##(1991-12#1)(1992-8#1)
of the fabella##2##3##(2011-2#2)
of the fabricated##14##3##(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#4)(2008-3#1)(2008-4#1)(2009-11#1)(2013-1#1)
of the fabrication process##3##4##(2008-2#1)(2008-3#1)(2013-7#1)
of the face and neck##7##5##(1996-11#1)(2007-8#1)(2009-6#2)(2010-12#1)(2010-6#1)(2011-1#1)
of the face and##15##4##(1991-9#1)(1995-11#1)(1996-11#1)(2005-5#1)(2007-8#1)(2007-9#1)(2008-5#1)(2009-4#2)(2009-6#2)(2010-1#1)(2010-12#1)(2010-6#1)(2011-1#1)
of the face in##2##4##(2009-4#1)(2012-12#1)
of the face is##5##4##(2007-8#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-11#1)
of the face was##3##4##(2009-4#1)(2011-2#1)(2012-3#1)
of the face with##2##4##(2010-1#1)(2012-3#1)
of the face##69##3##(1991-3#1)(1991-9#1)(1995-11#1)(1995-6#1)(1996-11#1)(2005-11#2)(2005-5#1)(2006-12#2)(2007-12#4)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#3)(2008-1#1)(2008-2#1)(2008-5#6)(2009-4#6)(2009-6#3)(2009-8#1)(2009-9#2)(2010-1#6)(2010-11#2)(2010-12#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#6)(2012-2#1)(2012-3#4)(2013-1#1)(2013-7#1)
of the faces##2##3##(1992-5#1)(2009-4#1)
of the facet joint##4##4##(1996-9#1)(2010-12#1)(2011-2#2)
of the facet joints##3##4##(1996-9#2)(2009-3#1)
of the facet##7##3##(1996-9#3)(2009-3#1)(2010-12#1)(2011-2#2)
of the facets##2##3##(2008-2#1)(2008-3#1)
of the facial bone and##2##5##(2007-4#1)(2008-6#1)
of the facial nerve by##2##5##(2006-12#1)(2008-12#1)
of the facial nerve in##3##5##(2006-11#2)(2008-12#1)
of the facial nerve##15##4##(1993-10#1)(2006-11#3)(2006-12#4)(2008-12#2)(2008-9#2)(2010-12#1)(2011-2#1)(2012-3#1)
of the facial skeleton##4##4##(2006-7#1)(2007-12#3)
of the facial skin##3##4##(2008-5#3)
of the facial##36##3##(1993-10#1)(1996-5#1)(1997-8#1)(2005-5#1)(2006-11#3)(2006-12#4)(2006-2#1)(2006-7#1)(2007-12#4)(2007-3#1)(2007-4#1)(2008-12#2)(2008-5#3)(2008-6#2)(2008-9#2)(2009-9#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#1)
of the facilities##4##3##(1995-2#1)(2007-5#1)(2007-9#1)(2008-8#1)
of the facility##5##3##(1992-12#1)(1992-2#1)(1994-3#1)(2008-2#1)(2008-5#1)
of the fact that it##2##5##(1992-12#1)(1997-8#1)
of the fact that the##12##5##(1991-4#1)(1992-12#1)(1996-2#1)(2004-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-5#1)(2010-7#1)(2013-1#1)
of the fact that they##3##5##(1994-2#1)(2006-8#1)(2008-11#1)
of the fact that##50##4##(1991-10#1)(1991-2#1)(1991-4#2)(1992-12#2)(1993-5#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-5#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#5)(2008-2#1)(2008-4#3)(2008-5#3)(2008-9#1)(2009-8#1)(2010-5#1)(2010-7#1)(2011-1#2)(2012-2#1)(2013-1#1)
of the factor IX gene##2##5##(1990-11#2)
of the factor VIII gene##3##5##(1992-10#1)(2008-12#1)(2012-2#1)
of the factor is##2##4##(1990-11#1)(1993-6#1)
of the factor##14##3##(1990-11#5)(1992-10#1)(1993-6#2)(1994-11#1)(1995-10#1)(1996-3#1)(2008-12#1)(2008-6#1)(2012-2#1)
of the factor(s)##3##3##(1992-12#2)(2006-9#1)
of the factories in##2##4##(1994-6#1)(2008-8#1)
of the factors affecting the##2##5##(2008-7#1)(2013-8#1)
of the factors contributing to##3##5##(1991-1#1)(2007-3#1)(2012-3#1)
of the factors driving the##2##5##(1991-3#1)(2008-8#1)
of the factors responsible for##5##5##(1992-12#1)(1995-12#1)(1997-4#1)(2008-12#1)(2013-8#1)
of the factors that can##2##5##(2012-10#1)(2013-1#1)
of the factors that influence the##4##6##(1995-2#1)(2008-1#1)(2008-10#2)
of the factors that influence##5##5##(1995-2#1)(2008-1#1)(2008-10#2)(2012-1#1)
of the factors that##17##4##(1995-2#1)(1997-1#1)(1997-2#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#1)(2009-8#1)(2012-1#1)(2012-10#1)(2013-1#4)
of the factors which##3##4##(1990-12#1)(1992-6#1)(2008-7#1)
of the factors##55##3##(1990-12#1)(1991-1#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-9#1)(1994-6#1)(1995-12#1)(1995-2#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#2)(2009-8#1)(2010-1#1)(2012-1#3)(2012-10#1)(2012-12#3)(2012-3#1)(2013-1#4)(2013-8#2)
of the faculty##4##3##(1992-1#1)(1993-2#1)(2007-4#1)(2009-10#1)
of the faecal occult blood##2##5##(1993-8#2)
of the faecal samples##2##4##(2008-5#2)
of the faecal##4##3##(1993-8#2)(2008-5#2)
of the failed##2##3##(1995-2#1)(2006-10#1)
of the failing heart##4##4##(1994-3#1)(2005-7#1)(2008-10#1)(2011-2#1)
of the failing##5##3##(1994-3#1)(2005-7#1)(2008-10#1)(2011-2#2)
of the failure of##3##4##(1997-3#1)(2006-10#1)(2008-8#1)
of the failure##7##3##(1997-3#1)(2006-10#1)(2006-6#1)(2008-11#1)(2008-8#1)(2009-3#1)(2012-12#1)
of the fall##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
of the fallopian tube##5##4##(1992-1#2)(1992-12#1)(1993-2#1)(2009-6#1)
of the falls##2##3##(1994-6#1)(2005-9#1)
of the false##2##3##(2007-8#1)(2012-3#1)
of the familial##3##3##(1997-5#1)(2008-7#1)(2010-4#1)
of the familiar##3##3##(1995-12#1)(2008-3#1)(2010-2#1)
of the families of##2##4##(2007-6#1)(2007-7#1)
of the families##12##3##(1991-11#1)(1996-5#2)(1997-2#1)(2006-4#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-4#1)(2011-1#1)(2012-3#1)(2013-8#1)
of the family Araceae##2##4##(2008-10#2)
of the family Brachyspiraceae##3##4##(2011-2#3)
of the family Bunyaviridae##3##4##(2008-10#2)(2010-2#1)
of the family Enterobacteriaceae##4##4##(2008-10#2)(2008-11#1)(2008-4#1)
of the family Geodermatophilaceae##2##4##(2011-2#2)
of the family Luteoviridae##2##4##(2008-10#2)
of the family Potyviridae and##2##5##(2008-10#2)
of the family Potyviridae##9##4##(2008-10#9)
of the family Solanaceae##2##4##(1996-10#1)(2010-2#1)
of the family Synergistaceae##2##4##(2011-2#2)
of the family and##3##4##(1997-2#1)(1997-8#1)(2013-1#1)
of the family are##3##4##(1997-4#1)(1997-6#1)(2011-1#1)
of the family environment##2##4##(2008-7#1)(2012-3#1)
of the family history##2##4##(2007-2#1)(2008-5#1)
of the family in##3##4##(1991-2#1)(1992-1#1)(2008-8#1)
of the family members##6##4##(1990-10#1)(1997-3#1)(2006-9#1)(2007-7#1)(2008-11#1)(2012-2#1)
of the family of##12##4##(1990-10#1)(1990-8#1)(1992-12#1)(1993-11#1)(1995-1#2)(1995-3#1)(1995-8#1)(1996-12#1)(1997-4#1)(2004-2#1)(2006-12#1)
of the family physician in##2##5##(1995-11#1)(1995-9#1)
of the family physician##3##4##(1995-11#1)(1995-9#1)(1997-4#1)
of the family##152##3##(1990-10#2)(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-6#1)(1994-8#1)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#3)(1995-9#1)(1996-10#1)(1996-12#1)(1996-2#1)(1997-2#2)(1997-3#1)(1997-4#5)(1997-6#1)(1997-8#2)(2004-2#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-8#1)(2006-9#1)(2007-2#1)(2007-3#3)(2007-6#1)(2007-7#2)(2008-10#27)(2008-11#3)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-2#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#31)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
of the family-B##2##3##(1996-6#2)
of the famous##3##3##(1991-6#1)(1994-3#1)(2009-7#1)
of the far field of##2##5##(2008-2#2)
of the far field##4##4##(2007-12#1)(2008-2#3)
of the far##5##3##(1992-1#1)(2007-12#1)(2008-2#3)
of the far-field intensity##2##4##(2007-12#1)(2008-3#1)
of the far-field##9##3##(2007-12#3)(2008-2#3)(2008-3#3)
of the farm##2##3##(1990-9#1)(2007-7#1)
of the farmers##2##3##(1993-8#1)(2011-1#1)
of the farms##3##3##(1992-10#1)(1996-12#1)(2008-4#1)
of the fascia##2##3##(2009-6#1)(2009-9#1)
of the fast Fourier transform##2##5##(2008-2#1)(2008-3#1)
of the fast##11##3##(1990-10#1)(1991-12#1)(1994-12#1)(1996-5#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2010-12#1)
of the fast-EPSP##4##3##(1997-5#4)
of the faster##2##3##(1995-3#1)(1996-2#1)
of the fasting##2##3##(2006-6#1)(2013-7#1)
of the fat content in bakery##4##6##(2008-10#4)
of the fat pads##2##4##(2008-11#2)
of the fat##10##3##(1995-4#1)(1997-3#1)(2008-10#4)(2008-11#2)(2012-2#1)(2013-1#1)
of the fatal outcome##2##4##(2007-3#1)(2011-2#1)
of the fatal##5##3##(2007-12#1)(2007-3#1)(2007-8#1)(2010-12#1)(2011-2#1)
of the fate of##3##4##(2005-8#1)(2008-4#1)(2009-12#1)
of the father##3##3##(2006-12#1)(2012-12#1)(2012-3#1)
of the fathers in Group##2##5##(2010-3#2)
of the fathers of the##2##5##(1994-6#1)(2012-2#1)
of the fathers##4##3##(1994-6#1)(2010-3#2)(2012-2#1)
of the fatigue##2##3##(2013-8#2)
of the fattening diet on the##2##6##(2010-4#2)
of the fatty acid amide hydrolase##2##6##(2010-12#1)(2012-2#1)
of the fatty acid reductase##2##5##(1993-2#2)
of the fatty acid##10##4##(1990-11#2)(1992-11#1)(1993-2#2)(2005-11#1)(2008-5#1)(2010-12#1)(2010-4#1)(2012-2#1)
of the fatty acids##4##4##(1992-11#1)(2008-10#1)(2010-9#1)(2011-1#1)
of the fatty acyl##2##4##(1995-1#1)(1996-5#1)
of the fatty##17##3##(1990-11#2)(1992-11#2)(1993-2#3)(1995-1#1)(1996-5#1)(2005-11#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2012-2#1)
of the fault zone##2##4##(1996-4#2)
of the fault##7##3##(1991-3#1)(1996-4#5)(2007-9#1)
of the favourable##2##3##(1991-9#1)(1993-4#1)
of the fears and##2##4##(1995-2#1)(2007-10#1)
of the feasibility of##6##4##(1994-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)
of the feasibility##7##3##(1994-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-4#1)(2011-2#1)
of the feather##3##3##(2008-5#2)(2013-8#1)
of the features of the##4##5##(2007-11#1)(2008-2#2)(2012-11#1)
of the features of##9##4##(2004-9#1)(2007-11#1)(2008-2#3)(2008-8#1)(2010-6#1)(2012-11#1)(2012-2#1)
of the features which##2##4##(1996-3#1)(2008-2#1)
of the features##21##3##(1994-1#1)(1996-3#1)(2004-9#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#4)(2008-3#2)(2008-8#1)(2009-12#1)(2010-1#1)(2010-12#1)(2010-6#1)(2012-11#1)(2012-2#2)(2013-8#1)
of the fecal##4##3##(2006-8#1)(2008-10#1)(2012-1#1)(2012-3#1)
of the federal government##2##4##(1991-12#1)(2009-4#1)
of the federal##7##3##(1991-12#1)(1993-1#1)(2006-3#1)(2006-8#1)(2007-12#1)(2009-4#1)(2010-11#1)
of the fee schedule##2##4##(1992-1#1)(1994-1#1)
of the fee##3##3##(1992-1#1)(1993-3#1)(1994-1#1)
of the feed##7##3##(1997-3#1)(2004-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-4#1)
of the feedback##8##3##(1994-12#1)(1996-4#1)(2007-11#2)(2008-2#1)(2008-3#1)(2008-8#2)
of the feeder##2##3##(1993-9#1)(2008-10#1)
of the feeding apparatus##4##4##(2010-8#4)
of the feeding artery##2##4##(2007-9#1)(2008-7#1)
of the feeding##9##3##(2007-9#1)(2008-7#3)(2008-9#1)(2010-8#4)
of the feeds##2##3##(2008-10#2)
of the feet in##2##4##(2012-11#1)(2012-3#1)
of the feet##16##3##(1994-12#1)(1996-3#1)(1996-9#1)(1997-8#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-9#1)(2010-12#1)(2010-9#1)(2012-11#1)(2012-3#1)(2013-1#3)(2013-8#1)
of the female and male##2##5##(2006-5#1)(2007-3#1)
of the female and##3##4##(2006-5#1)(2007-12#1)(2007-3#1)
of the female body##3##4##(1991-6#1)(2007-3#1)(2009-4#1)
of the female condom##3##4##(1997-7#3)
of the female genital tract##2##5##(2006-10#1)(2012-2#1)
of the female genital##3##4##(2006-10#1)(2012-2#1)(2012-3#1)
of the female reproductive system##2##5##(2007-12#1)(2007-7#1)
of the female reproductive##3##4##(2007-12#1)(2007-7#1)(2009-12#1)
of the female##53##3##(1990-11#1)(1991-2#1)(1991-6#2)(1992-12#1)(1992-3#1)(1992-4#2)(1992-6#1)(1994-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1997-3#2)(1997-7#3)(2004-2#1)(2006-10#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-12#4)(2007-3#2)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-12#1)(2009-2#2)(2009-4#2)(2009-9#1)(2010-5#2)(2011-2#1)(2012-2#1)(2012-3#1)
of the females were##2##4##(2007-12#1)(2008-4#1)
of the females##15##3##(1992-6#1)(1993-11#1)(1994-2#1)(1995-3#1)(1997-4#2)(2007-12#1)(2007-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2012-2#1)(2013-8#2)
of the femoral artery##5##4##(1993-10#1)(1996-11#1)(2007-7#2)(2008-3#1)
of the femoral bone##8##4##(2007-11#1)(2007-7#1)(2009-2#6)
of the femoral cortex##2##4##(1995-6#1)(2007-7#1)
of the femoral diaphysis##2##4##(2009-7#1)(2013-1#1)
of the femoral head and##6##5##(2007-7#5)(2009-3#1)
of the femoral head by the acetabulum##3##7##(2007-7#2)(2011-12#1)
of the femoral head by the##5##6##(1993-5#1)(2007-7#2)(2007-8#1)(2011-12#1)
of the femoral head during pregnancy##2##6##(2009-3#2)
of the femoral head in the##2##6##(2007-7#1)(2009-3#1)
of the femoral head in##6##5##(2007-6#1)(2007-7#1)(2008-12#1)(2008-3#1)(2009-10#1)(2009-3#1)
of the femoral head is a##2##6##(2009-3#2)
of the femoral head occurring##2##5##(2007-8#1)(2009-3#1)
of the femoral head##47##4##(1991-10#2)(1992-6#1)(1993-5#1)(2006-10#1)(2007-6#1)(2007-7#19)(2007-8#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#2)(2009-10#1)(2009-3#10)(2009-4#1)(2011-12#1)
of the femoral neck fractures##3##5##(2006-6#3)
of the femoral neck in##2##5##(2006-10#1)(2009-3#1)
of the femoral neck##19##4##(2006-10#2)(2006-11#1)(2006-6#3)(2007-11#1)(2007-3#1)(2007-8#4)(2009-3#3)(2009-4#2)(2013-1#2)
of the femoral nerve##5##4##(1992-12#1)(1993-12#1)(1994-2#1)(2007-7#1)(2009-3#1)
of the femoral shaft##3##4##(2007-7#3)
of the femoral tunnel##2##4##(2013-1#1)(2013-7#1)
of the femoral vein is##2##5##(2007-7#2)
of the femoral vein was##3##5##(2007-7#3)
of the femoral vein##9##4##(2006-10#1)(2007-7#6)(2013-1#2)
of the femoral##116##3##(1991-10#2)(1992-12#1)(1992-3#1)(1992-6#1)(1993-10#1)(1993-12#1)(1993-5#1)(1994-2#1)(1995-6#1)(1996-11#1)(2005-1#1)(2005-7#1)(2006-10#4)(2006-11#1)(2006-6#3)(2007-11#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#36)(2007-8#8)(2008-10#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-8#2)(2009-10#1)(2009-2#7)(2009-3#14)(2009-4#4)(2009-7#1)(2011-12#2)(2013-1#8)(2013-7#1)
of the femoropatellar joint##3##4##(2007-11#2)(2012-3#1)
of the femtosecond##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2009-4#1)
of the femur and the##2##5##(2006-11#1)(2010-12#1)
of the femur and##5##4##(2006-11#1)(2007-11#1)(2008-7#1)(2010-12#1)(2013-1#1)
of the femur in##3##4##(2007-11#1)(2007-3#1)(2007-5#1)
of the femur is##2##4##(2007-11#1)(2007-7#1)
of the femur relative to the##2##6##(2006-11#2)
of the femur was##2##4##(2006-11#1)(2007-4#1)
of the femur##58##3##(1990-2#1)(1991-11#1)(1992-2#1)(2005-9#1)(2006-11#9)(2006-6#2)(2007-11#11)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#5)(2007-8#5)(2008-4#1)(2008-7#4)(2008-8#1)(2009-3#2)(2009-4#1)(2010-12#1)(2011-12#1)(2011-2#2)(2013-1#3)
of the fenestrated##2##3##(2010-12#1)(2013-8#1)
of the fermentation product##2##4##(1994-9#1)(2012-2#1)
of the fermentation##7##3##(1994-9#1)(2006-8#1)(2007-6#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-2#1)
of the ferret##2##3##(1991-11#2)
of the ferric enterobactin receptor##2##5##(1995-10#1)(1997-4#1)
of the ferric##6##3##(1992-12#1)(1995-10#1)(1997-4#1)(2008-10#1)(2008-5#1)(2011-2#1)
of the ferritin##3##3##(1990-5#1)(1996-7#1)(2008-1#1)
of the ferromagnetic##2##3##(1997-7#1)(2008-5#1)
of the fertile##2##3##(2008-3#1)(2013-1#1)
of the fertility##2##3##(2009-10#1)(2009-12#1)
of the fertilization##2##3##(1994-11#1)(2005-10#1)
of the fetal hydantoin syndrome##2##5##(1990-5#2)
of the fetal rat##2##4##(1994-5#1)(1995-12#1)
of the fetal stomach##2##4##(1994-4#2)
of the fetal##17##3##(1990-5#2)(1992-6#1)(1994-4#2)(1994-5#2)(1995-12#1)(2006-10#1)(2007-7#1)(2008-12#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)
of the fetus and the##2##5##(2007-11#1)(2012-3#1)
of the fetus and##3##4##(2007-11#1)(2010-11#1)(2012-3#1)
of the fetus##19##3##(1993-12#1)(1994-5#1)(1994-7#2)(2006-9#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-5#1)(2008-2#1)(2009-9#2)(2010-11#2)(2011-2#2)(2012-2#1)(2012-3#1)
of the fetuses##4##3##(1991-3#1)(2008-11#1)(2008-12#1)(2012-3#1)
of the few studies that##2##5##(2008-11#1)(2010-2#1)
of the few studies##3##4##(1990-8#1)(2008-11#1)(2010-2#1)
of the few##21##3##(1990-3#1)(1990-7#1)(1990-8#1)(1993-11#1)(1993-12#1)(1994-5#1)(1994-6#1)(1995-10#1)(1997-7#1)(2007-11#2)(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2009-6#1)(2009-9#1)(2010-2#1)(2013-7#1)
of the fiber Bragg##2##4##(2007-11#2)
of the fiber and the##4##5##(2007-11#1)(2008-10#1)(2008-3#2)
of the fiber can be##2##5##(2007-11#2)
of the fiber continuum##2##4##(2012-11#2)
of the fiber core is##2##5##(2007-11#2)
of the fiber core##9##4##(2007-11#2)(2007-12#6)(2008-3#1)
of the fiber gratings##2##4##(2007-12#2)
of the fiber is##2##4##(2008-3#2)
of the fiber laser##5##4##(2007-11#1)(2007-12#2)(2008-3#2)
of the fiber to##3##4##(2007-8#1)(2008-2#2)
of the fiber was##6##4##(1992-1#1)(1997-8#1)(2007-12#1)(2008-10#2)(2010-1#1)
of the fiber##95##3##(1992-1#3)(1994-10#1)(1997-8#1)(2007-11#19)(2007-12#36)(2007-8#1)(2008-10#7)(2008-2#5)(2008-3#18)(2008-6#1)(2010-1#1)(2012-11#2)
of the fiber's##4##3##(2007-11#2)(2008-3#2)
of the fiber-optic##5##3##(2008-10#2)(2008-2#1)(2008-3#2)
of the fibers are##2##4##(2008-10#1)(2008-3#1)
of the fibers##18##3##(1991-11#1)(1991-12#1)(1992-7#1)(1994-8#1)(1995-11#1)(1996-11#1)(2005-11#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2010-1#2)(2012-3#1)
of the fibre##4##3##(2008-10#1)(2008-5#1)(2009-7#1)(2011-2#1)
of the fibres##2##3##(1997-4#1)(2008-5#1)
of the fibrillar material##2##4##(1994-5#2)
of the fibrillar##3##3##(1994-5#2)(2010-4#1)
of the fibrils##2##3##(1993-11#1)(2008-5#1)
of the fibrin structure##2##4##(2009-4#1)(2011-2#1)
of the fibrin##6##3##(1990-11#1)(1991-7#1)(1995-3#1)(2009-4#1)(2011-1#1)(2011-2#1)
of the fibroblast growth factor (FGF)##4##6##(1991-5#1)(1993-6#1)(1994-3#1)(2010-5#1)
of the fibroblast growth factor##5##5##(1991-5#1)(1993-6#1)(1994-3#1)(1995-10#1)(2010-5#1)
of the fibroblast growth factor-2##2##5##(1997-4#2)
of the fibroblast growth##8##4##(1991-5#1)(1993-6#1)(1994-3#1)(1995-10#1)(1997-4#3)(2010-5#1)
of the fibroblast##10##3##(1991-3#1)(1991-5#1)(1993-6#1)(1994-3#1)(1995-10#1)(1997-4#3)(2008-11#1)(2010-5#1)
of the fibroblasts##2##3##(1996-11#1)(2006-9#1)
of the fibronectin##2##3##(1990-7#1)(1993-12#1)
of the fibrous##6##3##(2007-9#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
of the fibula##4##3##(2007-2#1)(2010-12#1)(2011-2#2)
of the field EPSP##4##4##(1991-12#1)(1992-7#1)(1996-5#1)(1997-5#1)
of the field and##5##4##(1994-2#1)(2005-7#1)(2008-10#1)(2009-12#1)(2013-1#1)
of the field can be##3##5##(2007-11#1)(2008-3#1)(2008-7#1)
of the field can##4##4##(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#1)
of the field excitatory postsynaptic potential##2##6##(1991-8#1)(1995-3#1)
of the field excitatory postsynaptic##3##5##(1991-8#1)(1995-12#1)(1995-3#1)
of the field experiment##3##4##(2008-10#3)
of the field in the##2##5##(2008-3#1)(2010-8#1)
of the field is##3##4##(2007-1#1)(2007-12#1)(2008-12#1)
of the field isolates##2##4##(2008-10#2)
of the field of view is##2##6##(2007-11#1)(2008-5#1)
of the field of view##5##5##(2007-11#1)(2008-3#2)(2008-5#2)
of the field of##18##4##(1991-6#1)(1991-9#1)(1992-1#1)(2005-8#1)(2006-5#1)(2007-11#2)(2007-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2010-11#1)(2010-12#1)(2012-1#1)
of the field that##2##4##(2008-2#2)
of the field##82##3##(1991-12#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-7#1)(1994-10#1)(1994-2#1)(1994-3#2)(1995-12#2)(1995-3#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-5#1)(1997-7#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-5#2)(2007-1#1)(2007-11#3)(2007-12#10)(2008-10#9)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#2)(2008-5#3)(2008-7#3)(2008-9#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-1#1)(2013-1#2)
of the fields in##3##4##(2008-10#2)(2008-3#1)
of the fields of##2##4##(2008-3#1)(2010-7#1)
of the fields##12##3##(1992-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-3#2)(2008-7#1)(2010-7#1)
of the fifteen beta-agonists##2##4##(2011-1#2)
of the fifth##11##3##(1994-9#1)(1995-2#1)(1997-4#1)(1997-8#1)(2006-10#1)(2008-10#2)(2009-4#1)(2010-4#1)(2012-12#2)
of the fight against##2##4##(2009-10#1)(2011-2#1)
of the fight##3##3##(2008-7#1)(2009-10#1)(2011-2#1)
of the figures of merit##2##5##(2007-8#1)(2008-10#1)
of the filamentous fungus##2##4##(1994-9#1)(1995-6#1)
of the filamentous##5##3##(1994-9#1)(1995-6#1)(1997-4#1)(2008-10#1)(2008-8#1)
of the file##2##3##(1994-1#1)(2006-6#1)
of the filling##2##3##(2007-7#1)(2008-3#1)
of the film is##4##4##(2008-10#3)(2008-2#1)
of the film thickness##5##4##(2004-12#1)(2006-5#1)(2008-10#3)
of the film##46##3##(1991-9#1)(1992-5#1)(2004-12#1)(2005-11#1)(2006-5#1)(2007-11#1)(2007-12#3)(2008-10#19)(2008-11#1)(2008-2#7)(2008-3#4)(2008-5#1)(2008-7#1)(2009-2#1)(2010-7#1)(2013-1#2)
of the films and##5##4##(2005-11#1)(2008-10#2)(2008-2#2)
of the films is##3##4##(2008-10#1)(2009-11#2)
of the films was##5##4##(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)
of the films were##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
of the films##35##3##(2005-11#2)(2007-11#2)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#5)(2008-3#5)(2008-5#3)(2009-11#3)(2009-2#1)(2010-4#1)
of the filter is##4##4##(2007-12#2)(2008-2#2)
of the filter paper##3##4##(2008-10#1)(2008-5#1)(2011-1#1)
of the filter##34##3##(2007-11#1)(2007-12#4)(2008-10#2)(2008-2#19)(2008-3#6)(2008-5#1)(2011-1#1)
of the filtering##3##3##(2007-11#1)(2007-12#1)(2008-1#1)
of the filters##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
of the filtrate##2##3##(1994-5#1)(2008-7#1)
of the filtration##2##3##(1995-10#1)(2012-1#1)
of the fimbria/fornix##2##3##(1992-11#1)(1997-7#1)
of the final diagnosis##2##4##(2007-3#1)(2012-3#1)
of the final material##2##4##(1994-12#1)(2010-7#1)
of the final product##10##4##(1994-12#1)(1996-8#1)(2005-11#2)(2008-5#1)(2008-7#1)(2010-4#1)(2012-12#1)(2012-2#2)
of the final products##2##4##(2008-4#1)(2011-2#1)
of the final protein##2##4##(2008-1#1)(2008-5#1)
of the final##57##3##(1990-2#1)(1991-2#1)(1992-3#1)(1994-12#3)(1995-3#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-8#1)(2004-9#2)(2005-11#3)(2006-4#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
of the financial##5##3##(1990-12#1)(1992-2#1)(2007-11#1)(2007-4#1)(2008-8#1)
of the finding##3##3##(1991-4#1)(2010-12#1)(2013-1#1)
of the findings and##2##4##(2012-1#1)(2012-3#1)
of the findings are discussed##5##5##(2007-12#2)(2012-1#1)(2012-2#1)(2013-7#1)
of the findings for##8##4##(1993-11#1)(1994-2#1)(1997-1#1)(2006-7#1)(2007-12#1)(2009-12#1)(2009-5#1)(2009-9#1)
of the findings of##3##4##(1990-8#1)(2006-12#1)(2006-7#1)
of the findings on##2##4##(2008-11#1)(2008-12#1)
of the findings was##2##4##(1991-6#1)(1993-6#1)
of the findings with##2##4##(1994-1#1)(1994-3#1)
of the findings##47##3##(1990-11#1)(1990-8#1)(1991-6#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-3#1)(1997-1#1)(1997-5#1)(2005-8#2)(2006-12#1)(2006-7#3)(2006-9#1)(2007-12#7)(2007-4#1)(2008-1#2)(2008-11#1)(2008-12#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-9#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-7#1)(2013-8#1)
of the fine##8##3##(2005-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-9#2)(2009-5#1)(2012-1#1)
of the finger##8##3##(2006-3#3)(2008-9#3)(2009-2#1)(2009-5#1)
of the fingernails##2##3##(2006-12#2)
of the fingerprints##2##3##(2006-3#1)(2008-2#1)
of the fingers and toes##3##5##(2006-10#2)(2012-2#1)
of the fingers and##5##4##(2006-10#2)(2006-4#1)(2012-1#1)(2012-2#1)
of the fingers##12##3##(1993-11#1)(2006-10#3)(2006-4#1)(2008-1#1)(2009-3#1)(2009-5#1)(2012-1#1)(2012-2#2)(2013-7#1)
of the finished##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
of the finite size of the##4##6##(2008-2#3)(2008-3#1)
of the finite##8##3##(2007-4#1)(2008-2#5)(2008-3#2)
of the finite-difference##4##3##(2006-10#1)(2007-11#3)
of the fire ant Solenopsis saevissima##2##6##(2007-12#2)
of the fire##8##3##(1996-12#5)(2007-12#2)(2013-8#1)
of the firing rate##2##4##(1993-6#1)(2005-8#1)
of the firing##4##3##(1991-8#1)(1993-6#1)(2005-8#1)(2008-7#1)
of the firm##2##3##(1993-3#1)(1997-1#1)
of the first (ED50##2##4##(1995-12#2)
of the first 10##2##4##(1990-3#1)(1994-2#1)
of the first 12##2##4##(1990-2#1)(1990-7#1)
of the first 3##3##4##(1997-1#1)(2005-11#1)(2011-2#1)
of the first 35##2##4##(1994-9#1)(1996-6#1)
of the first Stokes##2##4##(2007-12#2)
of the first and last##2##5##(1996-7#1)(2008-10#1)
of the first and second##10##5##(1990-8#1)(1991-3#1)(1995-3#1)(1996-3#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-7#1)(2011-2#1)
of the first and the second##2##6##(2008-10#1)(2010-1#1)
of the first and##14##4##(1990-8#1)(1991-3#1)(1995-3#1)(1996-3#1)(1996-7#1)(2008-10#4)(2008-5#1)(2008-8#1)(2009-7#1)(2010-1#1)(2011-2#1)
of the first author##4##4##(2007-12#1)(2007-8#1)(2013-1#2)
of the first base##2##4##(1992-11#1)(2008-10#1)
of the first carpometacarpal##2##4##(2006-3#1)(2008-9#1)
of the first case and is a##2##7##(2007-10#2)
of the first case of##2##5##(2005-12#1)(2010-4#1)
of the first case##5##4##(2005-12#1)(2007-10#2)(2010-4#1)(2013-1#1)
of the first decade##2##4##(2012-12#1)(2013-8#1)
of the first dorsal##2##4##(2007-11#1)(2008-9#1)
of the first dose##3##4##(1991-12#1)(2007-11#1)(2008-5#1)
of the first effective##2##4##(2005-7#1)(2008-1#1)
of the first episode##2##4##(2006-6#1)(2009-4#1)
of the first ever##3##4##(2008-8#1)(2012-12#2)
of the first exon##3##4##(1991-6#1)(1992-1#1)(1995-3#1)
of the first extracellular loop##2##5##(1994-9#1)(1996-5#1)
of the first extracellular##3##4##(1990-6#1)(1994-9#1)(1996-5#1)
of the first five##5##4##(1990-3#1)(1991-10#1)(1993-3#1)(1993-5#1)(2007-12#1)
of the first group##2##4##(1990-10#1)(1994-6#1)
of the first hospital##2##4##(1992-12#1)(2008-9#1)
of the first international classifications of mental health and developmental disorders of infancy and early##2##15##(2013-8#2)
of the first jerk##2##4##(2008-4#2)
of the first kind##4##4##(2008-10#1)(2008-2#2)(2008-3#1)
of the first large##2##4##(2007-10#1)(2008-8#1)
of the first layer##5##4##(2008-12#1)(2008-2#4)
of the first line##5##4##(2007-8#1)(2008-2#1)(2013-1#2)(2013-8#1)
of the first metacarpal##3##4##(2006-4#1)(2008-9#2)
of the first metatarsal##5##4##(2008-12#4)(2013-7#1)
of the first metatarsophalangeal joint##2##5##(2008-12#1)(2010-5#1)
of the first method##2##4##(2008-3#1)(2008-8#1)
of the first optical##2##4##(2006-4#1)(2007-12#1)
of the first or##2##4##(1990-8#1)(2008-7#1)
of the first part of##2##5##(2010-12#1)(2013-8#1)
of the first permanent##2##4##(2013-1#2)
of the first phase##3##4##(1994-11#1)(1995-12#1)(2008-9#1)
of the first round of##2##5##(1995-12#1)(2007-11#1)
of the first semester in##2##5##(2008-10#1)(2012-3#1)
of the first semester##4##4##(2007-10#1)(2008-10#1)(2012-3#2)
of the first six##2##4##(1991-10#1)(2007-8#1)
of the first stage of##4##5##(1994-6#2)(2008-10#1)(2011-2#1)
of the first stage##7##4##(1994-6#2)(1997-2#2)(2008-10#1)(2011-2#1)(2013-8#1)
of the first step##2##4##(1996-1#1)(2009-8#1)
of the first stimulus##2##4##(1993-2#1)(2008-11#1)
of the first survey of##2##5##(1997-8#1)(2007-3#1)
of the first symptomatic fruit##2##5##(2008-10#2)
of the first three##8##4##(1990-5#1)(1992-4#1)(1995-11#1)(2007-8#1)(2008-3#2)(2010-5#1)(2012-1#1)
of the first to##3##4##(1996-3#1)(2008-11#1)(2012-3#1)
of the first trigeminal branch##2##5##(1992-2#1)(2010-12#1)
of the first trimester##2##4##(1993-10#1)(2012-1#1)
of the first two amino acids##2##6##(1991-10#2)
of the first two##23##4##(1990-10#1)(1990-4#1)(1991-10#3)(1991-4#1)(1997-3#1)(1997-4#1)(2006-10#2)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-8#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#2)
of the first type##2##4##(1997-4#1)(2008-2#1)
of the first year of##5##5##(1991-2#1)(1992-7#1)(1995-1#1)(2008-12#1)(2012-2#1)
of the first year##15##4##(1991-2#1)(1991-6#1)(1992-7#1)(1993-7#1)(1995-1#1)(1996-12#1)(2005-10#4)(2007-9#1)(2008-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
of the first##411##3##(1990-10#3)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#1)(1990-8#3)(1991-10#6)(1991-12#4)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#2)(1993-7#1)(1993-9#1)(1994-11#2)(1994-12#5)(1994-2#1)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#5)(1995-1#1)(1995-11#1)(1995-12#5)(1995-2#4)(1995-3#4)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#3)(1996-3#6)(1996-4#2)(1996-5#4)(1996-6#1)(1996-7#3)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-1#1)(2004-10#2)(2005-10#4)(2005-11#1)(2005-12#1)(2005-7#2)(2006-10#4)(2006-12#2)(2006-3#1)(2006-4#3)(2006-6#3)(2006-8#1)(2006-9#1)(2007-10#5)(2007-11#5)(2007-12#7)(2007-2#1)(2007-3#6)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#5)(2007-8#4)(2007-9#3)(2008-1#4)(2008-10#23)(2008-11#4)(2008-12#11)(2008-2#15)(2008-3#14)(2008-4#8)(2008-5#8)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#10)(2009-10#3)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#2)(2009-7#4)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-12#5)(2010-3#1)(2010-4#3)(2010-5#2)(2010-7#1)(2010-8#3)(2011-1#5)(2011-12#2)(2011-2#12)(2011-8#1)(2012-1#4)(2012-12#8)(2012-2#7)(2012-3#5)(2013-1#12)(2013-7#2)(2013-8#7)
of the first- and the second-order##2##6##(2008-2#1)(2008-3#1)
of the first-derivative##2##3##(2008-10#2)
of the first-line##3##3##(1997-2#1)(2007-11#1)(2010-10#1)
of the first-order diffraction##2##4##(1996-4#1)(2008-3#1)
of the first-order##13##3##(1991-4#1)(1995-5#1)(1996-4#1)(2007-12#2)(2008-2#5)(2008-3#3)
of the first-round##2##3##(1997-4#1)(2008-10#1)
of the fish community##2##4##(2011-2#1)(2013-7#1)
of the fish##19##3##(1992-8#1)(1997-4#1)(2007-3#2)(2007-5#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#4)(2008-7#1)(2009-4#1)(2009-6#2)(2011-2#1)(2012-2#1)(2013-7#1)
of the fishery##3##3##(2007-5#2)(2013-8#1)
of the fishes##3##3##(2007-3#1)(2008-7#1)(2008-8#1)
of the fission yeast Schizosaccharomyces pombe##3##6##(1990-2#2)(1992-7#1)
of the fission##4##3##(1990-2#2)(1992-7#1)(2008-10#1)
of the fistula was##4##4##(1996-9#1)(1997-3#1)(2006-6#1)(2007-7#1)
of the fistula##16##3##(1993-5#1)(1995-11#1)(1996-12#1)(1996-9#2)(1997-3#2)(2006-6#2)(2007-7#2)(2008-5#1)(2011-3#1)(2012-12#1)(2013-1#2)
of the fistulas were##2##4##(1993-2#1)(2007-7#1)
of the fistulas##5##3##(1993-2#1)(1995-11#1)(2006-12#1)(2007-7#1)(2008-7#1)
of the fistulous tract##3##4##(1990-4#2)(2008-4#1)
of the fit and##2##4##(2008-6#1)(2013-8#1)
of the fit parameters##2##4##(2008-3#2)
of the fit##7##3##(1995-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2013-8#1)
of the fitness##4##3##(2008-10#1)(2008-9#2)(2013-1#1)
of the fitted##2##3##(1997-3#1)(2012-3#1)
of the fitting##3##3##(2008-2#3)
of the five Cys residues##2##5##(1994-11#1)(2008-8#1)
of the five Taiwan##3##4##(2008-10#3)
of the five isolates##2##4##(2008-10#2)
of the five known##2##4##(1995-3#1)(1996-12#1)
of the five patients##2##4##(2006-3#1)(2008-6#1)
of the five##70##3##(1990-10#1)(1990-12#1)(1990-2#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-8#1)(1995-11#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-12#1)(2006-3#1)(2006-7#1)(2007-1#2)(2007-2#2)(2008-10#16)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-12#1)(2010-2#2)(2010-3#1)(2011-2#2)(2013-1#1)(2013-7#1)
of the fixation of##2##4##(2007-11#1)(2010-12#1)
of the fixation##4##3##(2007-11#2)(2008-10#1)(2010-12#1)
of the fixed polarizer##2##4##(2008-3#2)
of the fixed##6##3##(1995-9#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-7#1)
of the fixing##2##3##(2007-11#1)(2008-3#1)
of the flagella##2##3##(2007-12#1)(2008-10#1)
of the flagellar master operon##2##5##(1997-4#2)
of the flagellar##3##3##(1997-4#2)(2007-5#1)
of the flagellum##3##3##(2008-7#3)
of the flame##6##3##(1990-11#1)(2006-12#1)(2008-10#4)
of the flanking##5##3##(1993-5#1)(1995-8#1)(2008-10#1)(2008-9#1)(2012-2#1)
of the flap are##2##4##(2007-5#1)(2008-4#1)
of the flap##9##3##(1991-5#2)(1995-1#1)(2007-12#1)(2007-5#1)(2008-4#2)(2008-6#1)(2008-9#1)
of the flaps and##2##4##(1990-6#1)(2008-4#1)
of the flaps##3##3##(1990-6#1)(2008-4#1)(2009-5#1)
of the flat##2##3##(1993-4#1)(2007-6#1)
of the flat-field##2##3##(2008-3#2)
of the flathead mullet Mugil cephalus##2##6##(2010-8#2)
of the flavin##7##3##(1990-4#2)(1992-1#2)(1994-8#1)(1995-10#1)(1995-5#1)
of the flavonoid pathway##3##4##(2008-10#2)(2009-10#1)
of the flavonoid##5##3##(2007-1#1)(2008-10#3)(2009-10#1)
of the flavonoids##2##3##(2007-11#1)(2008-11#1)
of the fleece##2##3##(1997-5#2)
of the flesh##2##3##(2008-12#1)(2009-10#1)
of the flexibility of the##2##5##(1994-11#1)(2008-10#1)
of the flexibility##4##3##(1994-11#1)(1997-8#1)(2007-4#1)(2008-10#1)
of the flexible##4##3##(1991-9#1)(2007-8#1)(2011-2#1)(2012-1#1)
of the flexion synergy##3##4##(2012-1#3)
of the flexion##5##3##(1997-2#1)(2012-1#3)(2013-8#1)
of the flexor carpi ulnaris##2##5##(2007-4#1)(2009-5#1)
of the flexor digitorum superficialis##3##5##(2008-9#2)(2012-2#1)
of the flexor tendons##2##4##(1993-1#1)(2006-10#1)
of the flexor##15##3##(1993-1#1)(1996-12#2)(2006-10#1)(2007-4#1)(2007-7#3)(2007-8#1)(2008-9#3)(2009-5#1)(2010-7#1)(2012-2#1)
of the flies##4##3##(2007-12#2)(2007-2#1)(2008-9#1)
of the flight##7##3##(2007-12#2)(2008-2#2)(2008-3#2)(2012-12#1)
of the floor of the##3##5##(1996-6#1)(2005-11#1)(2006-5#1)
of the flora##4##3##(1991-11#1)(2006-10#1)(2006-8#1)(2013-7#1)
of the floral##2##3##(2006-9#1)(2009-8#1)
of the floristic##3##3##(2008-8#1)(2012-2#1)(2013-7#1)
of the flotation##2##3##(2008-10#2)
of the flour beetle##2##4##(1991-8#1)(2008-9#1)
of the flow cell##8##4##(2008-10#5)(2008-3#1)(2008-9#2)
of the flow channel##2##4##(2008-3#1)(2013-1#1)
of the flow cytometric##2##4##(1990-12#1)(2008-9#1)
of the flow injection##5##4##(2008-10#5)
of the flow of information##2##5##(2006-10#1)(2010-2#1)
of the flow of##3##4##(2006-10#1)(2008-5#1)(2010-2#1)
of the flow rates##2##4##(2008-10#2)
of the flow system##4##4##(2008-10#4)
of the flow velocity##2##4##(2008-3#2)
of the flow##54##3##(1990-12#1)(1992-8#1)(1997-5#1)(2005-10#2)(2005-11#2)(2006-10#1)(2007-11#2)(2008-10#20)(2008-11#1)(2008-2#5)(2008-3#6)(2008-5#3)(2008-6#1)(2008-9#5)(2010-2#1)(2013-1#1)(2013-8#1)
of the flow-injection##2##3##(2008-10#2)
of the flower of T##2##5##(2007-8#2)
of the flower of##4##4##(2007-8#4)
of the flower##8##3##(2006-12#1)(2007-8#4)(2009-12#2)(2009-8#1)
of the flowering##2##3##(1996-10#1)(2006-12#1)
of the flowers of P##2##5##(2012-3#2)
of the flowers of##5##4##(2007-1#2)(2012-3#3)
of the flowers##7##3##(2007-1#2)(2008-12#1)(2008-5#1)(2012-3#3)
of the flowing##3##3##(2008-10#2)(2011-2#1)
of the fluctuation method##2##4##(2010-9#2)
of the fluctuations in the##2##5##(2008-2#2)
of the fluctuations in##3##4##(2008-2#2)(2008-9#1)
of the fluctuations##5##3##(1996-4#1)(2008-2#2)(2008-3#1)(2008-9#1)
of the fluid##12##3##(1990-8#1)(1991-8#1)(1996-8#1)(2005-11#4)(2006-11#1)(2006-8#1)(2007-9#2)(2008-3#1)
of the fluorescein##2##3##(1993-3#1)(2008-10#1)
of the fluorescence at##2##4##(2007-12#1)(2008-3#1)
of the fluorescence change##2##4##(1994-11#1)(1995-6#1)
of the fluorescence changes##3##4##(1994-11#1)(1994-5#1)(1996-12#1)
of the fluorescence decay##3##4##(1990-7#1)(1991-4#1)(1996-11#1)
of the fluorescence emission of##2##5##(1990-2#1)(1992-2#1)
of the fluorescence emission##8##4##(1990-2#1)(1992-2#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
of the fluorescence intensity of the##3##6##(1990-12#1)(2008-10#2)
of the fluorescence intensity of##5##5##(1990-12#1)(2008-10#4)
of the fluorescence intensity##9##4##(1990-12#1)(2008-10#5)(2008-3#2)(2008-4#1)
of the fluorescence lifetime##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
of the fluorescence of the##2##5##(2008-10#2)
of the fluorescence of##6##4##(1990-5#1)(2008-10#4)(2008-3#1)
of the fluorescence quantum yield##2##5##(2008-3#2)
of the fluorescence resonance energy##2##5##(2008-10#1)(2008-9#1)
of the fluorescence signal##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
of the fluorescence signals##2##4##(2008-10#1)(2008-2#1)
of the fluorescence spectra##2##4##(1997-4#1)(2005-4#1)
of the fluorescence spectrum##2##4##(1991-9#1)(2008-10#1)
of the fluorescence yield##2##4##(2008-2#2)
of the fluorescence##76##3##(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#2)(1991-2#1)(1991-4#1)(1991-9#1)(1992-2#1)(1994-11#2)(1994-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-4#1)(1997-8#1)(2005-4#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#20)(2008-11#1)(2008-2#8)(2008-3#15)(2008-4#2)(2008-7#2)(2008-9#1)
of the fluorescent dye##5##4##(1991-11#1)(1992-6#1)(1996-1#2)(2013-1#1)
of the fluorescent light##2##4##(2007-12#1)(2008-3#1)
of the fluorescent phospholipid##2##4##(1993-11#1)(1994-5#1)
of the fluorescent probe##4##4##(1990-5#1)(1990-7#1)(1992-6#1)(2008-10#1)
of the fluorescent pseudomonad community##2##5##(2008-10#2)
of the fluorescent pseudomonad##3##4##(2008-10#3)
of the fluorescent signal##2##4##(2008-11#1)(2008-2#1)
of the fluorescent##39##3##(1990-5#3)(1990-7#1)(1991-11#1)(1992-6#3)(1993-11#1)(1994-5#1)(1996-1#3)(1996-9#1)(1997-2#1)(1997-4#1)(2006-10#2)(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-9#1)(2009-7#1)(2010-12#1)(2013-1#1)
of the fluorescing##2##3##(1995-2#1)(2008-10#1)
of the fluoride##3##3##(1990-9#1)(2008-10#2)
of the fluorinated##4##3##(2005-11#1)(2009-9#1)(2010-4#2)
of the fluorine atoms##2##4##(1992-3#1)(2008-5#1)
of the fluorine##4##3##(1990-12#1)(1992-3#1)(1997-4#1)(2008-5#1)
of the fluorophore##6##3##(1996-9#1)(1997-1#2)(1997-2#1)(1997-8#1)(2008-2#1)
of the fluorophores##3##3##(2008-1#1)(2008-10#1)(2008-3#1)
of the fluoroquinolone##2##3##(1991-12#2)
of the fluoroquinolones##2##3##(2008-10#1)(2013-8#1)
of the flux##2##3##(1993-3#1)(2008-10#1)
of the fly ash##4##4##(2008-10#4)
of the fly##11##3##(1995-8#2)(1996-11#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-8#1)(2012-12#1)
of the foam##5##3##(2005-11#1)(2006-6#1)(2007-8#1)(2008-5#1)(2012-2#1)
of the focal plane##2##4##(2008-3#2)
of the focal point##5##4##(2006-5#1)(2007-12#2)(2008-3#2)
of the focal spot##4##4##(2007-12#2)(2008-3#1)(2011-1#1)
of the focal##21##3##(1994-9#1)(2006-5#1)(2007-12#6)(2008-2#2)(2008-3#6)(2008-8#2)(2010-12#1)(2011-1#1)(2011-2#1)
of the foci##2##3##(2007-11#1)(2008-5#1)
of the focus on##2##4##(1993-11#1)(2010-8#1)
of the focus##14##3##(1990-9#1)(1991-12#2)(1993-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2010-8#1)(2012-1#1)(2012-3#2)
of the focused##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
of the focusing lens##3##4##(2008-2#1)(2008-3#2)
of the focusing##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
of the foetal##3##3##(1995-8#1)(2008-4#1)(2008-7#1)
of the foetus after##2##4##(1992-4#1)(1996-11#1)
of the foetus as##2##4##(1991-9#1)(2012-3#1)
of the foetus##16##3##(1991-9#2)(1992-4#3)(1993-1#1)(1993-6#1)(1994-2#1)(1996-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-2#3)(2012-3#1)
of the folate complex##2##4##(1991-2#1)(1995-2#1)
of the folate##4##3##(1991-2#1)(1993-12#1)(1994-6#1)(1995-2#1)
of the fold##2##3##(2009-9#2)
of the folded##8##3##(1990-5#1)(1991-4#1)(1991-6#1)(1991-8#1)(2008-2#1)(2009-7#1)(2009-9#1)(2013-1#1)
of the folding pathway of##3##5##(1993-6#1)(1997-2#2)
of the folding##10##3##(1991-7#1)(1992-3#2)(1993-3#1)(1993-6#1)(1995-5#1)(1996-5#1)(1997-2#3)
of the follicle cells##3##4##(2008-6#3)
of the follicle##10##3##(1990-6#2)(1990-8#1)(1992-4#1)(2008-12#1)(2008-5#1)(2008-6#3)(2011-2#1)
of the follicular##4##3##(2006-5#1)(2008-12#2)(2012-3#1)
of the follistatin molecule##2##4##(1991-8#2)
of the follow-up period##6##4##(2008-3#1)(2008-7#3)(2013-1#1)(2013-8#1)
of the follow-up##17##3##(1990-8#1)(1992-6#1)(1992-8#1)(1993-10#1)(1995-6#1)(2007-3#1)(2007-6#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#2)(2011-2#1)(2013-1#1)(2013-8#1)
of the following categories##2##4##(1995-2#1)(2008-2#1)
of the following clinical##2##4##(1997-1#1)(2010-2#1)
of the following diseases##3##4##(1994-3#1)(2009-5#1)(2011-1#1)
of the following four##4##4##(1991-2#1)(1992-2#1)(2008-10#1)(2008-9#1)
of the following methods##2##4##(1995-12#1)(2007-11#1)
of the following parameters##3##4##(2008-10#1)(2008-7#1)(2008-8#1)
of the following study##2##4##(2008-7#1)(2011-1#1)
of the following three##2##4##(1994-2#1)(1996-4#1)
of the following##104##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#3)(1993-1#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#1)(1996-10#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(2004-10#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-2#2)(2007-5#3)(2007-7#1)(2008-1#1)(2008-10#14)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)
of the food and##2##4##(1991-11#1)(2005-10#1)
of the food canal of nematodes that##2##7##(2008-10#2)
of the food canal of##3##5##(2008-10#3)
of the food chain##2##4##(2008-9#2)
of the food supply##4##4##(1990-6#1)(2006-4#1)(2007-12#2)
of the food web##5##4##(2007-9#1)(2008-8#1)(2008-9#3)
of the food##29##3##(1990-6#1)(1991-11#1)(1992-3#1)(2005-10#1)(2006-4#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-9#1)(2008-10#4)(2008-7#2)(2008-8#1)(2008-9#5)(2009-11#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-7#1)
of the foods##2##3##(2006-10#1)(2013-1#1)
of the foot and ankle##7##5##(2007-4#1)(2008-12#2)(2011-2#2)(2012-2#1)(2012-3#1)
of the foot and##10##4##(2006-11#1)(2007-4#1)(2008-12#2)(2010-3#1)(2011-2#2)(2012-2#2)(2012-3#1)
of the foot are rare##2##5##(2008-12#1)(2009-10#1)
of the foot are##3##4##(2008-12#1)(2009-10#1)(2012-12#1)
of the foot in##2##4##(2007-11#1)(2010-3#1)
of the foot is##4##4##(2006-11#1)(2006-8#1)(2010-3#1)(2010-5#1)
of the foot protein##4##4##(1992-3#4)
of the foot with##2##4##(2008-12#1)(2010-3#1)
of the foot##47##3##(1992-3#5)(2006-11#2)(2006-8#1)(2007-11#1)(2007-4#1)(2007-8#2)(2008-12#6)(2008-4#3)(2008-6#1)(2008-7#1)(2009-10#2)(2009-3#2)(2010-3#5)(2010-5#2)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#4)
of the foraging##2##3##(2008-8#1)(2008-9#1)
of the foramen magnum##3##4##(1996-9#2)(2010-2#1)
of the foramen##5##3##(1996-9#2)(2006-8#1)(2010-2#1)(2012-12#1)
of the forbidden##2##3##(2007-11#1)(2007-12#1)
of the force##9##3##(1991-7#1)(1994-8#1)(2005-11#1)(2007-11#3)(2007-5#1)(2009-7#1)(2010-3#1)
of the forces##6##3##(2007-5#2)(2008-3#1)(2008-8#1)(2008-9#1)(2012-1#1)
of the fore##2##3##(2006-11#1)(2007-12#1)
of the forearm##17##3##(1994-4#1)(1996-1#1)(1996-7#1)(2006-11#4)(2006-3#1)(2006-8#1)(2008-10#1)(2008-5#2)(2008-9#1)(2009-3#3)(2009-9#1)
of the forearms##2##3##(2008-10#1)(2008-5#1)
of the forebrain##7##3##(1993-8#1)(1994-9#1)(1995-12#1)(1997-1#1)(1997-6#2)(2008-11#1)
of the forecast##3##3##(1996-4#1)(2008-10#1)(2008-8#1)
of the forefoot##2##3##(1994-11#1)(2009-3#1)
of the foregut##2##3##(2007-7#1)(2007-8#1)
of the forehead##4##3##(1992-2#1)(1994-4#1)(1997-3#1)(2006-12#1)
of the foreign gene##3##4##(1990-3#2)(1994-12#1)
of the foreign##12##3##(1990-3#2)(1994-12#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-8#1)(2012-12#3)
of the forelimbs##4##3##(1993-3#1)(1996-6#1)(2005-7#1)(2012-3#1)
of the foreskin##2##3##(2006-7#1)(2008-10#1)
of the forest ecosystem was##2##5##(2013-8#2)
of the forest ecosystem##5##4##(2008-9#1)(2013-8#4)
of the forest##11##3##(1992-1#1)(2008-5#3)(2008-6#1)(2008-9#1)(2013-8#5)
of the forestomach in 100 mg/kg females##2##7##(2008-9#2)
of the forestomach in##4##4##(2008-9#4)
of the forestomach##6##3##(2008-9#6)
of the form of##3##4##(1992-3#1)(2008-2#1)(2013-1#1)
of the form##11##3##(1990-2#1)(1990-7#1)(1992-3#1)(1993-5#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2013-1#1)
of the forma specialis##2##4##(2008-10#2)
of the formal potential of##2##5##(1997-1#1)(2008-10#1)
of the formal potential##4##4##(1997-1#1)(2008-10#3)
of the formal##6##3##(1997-1#1)(2008-10#3)(2010-8#1)(2013-1#1)
of the formalin test and the##3##6##(2006-12#3)
of the formalin test##8##4##(1995-12#1)(2006-12#7)
of the formalin##9##3##(1995-12#1)(2006-12#7)(2011-1#1)
of the formate##2##3##(1991-7#1)(1992-6#1)
of the formation and##6##4##(1996-7#1)(2006-9#1)(2007-12#1)(2008-10#3)
of the formation of a##5##5##(1993-11#2)(1994-3#1)(2008-10#1)(2008-9#1)
of the formation of the##5##5##(1991-5#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-5#1)
of the formation of these##2##5##(1991-5#1)(2009-2#1)
of the formation of weak complexes##2##6##(2008-10#1)(2011-1#1)
of the formation of##36##4##(1991-11#1)(1991-5#2)(1992-2#1)(1992-3#1)(1992-5#2)(1993-11#2)(1994-11#1)(1994-3#1)(1995-11#1)(1995-12#1)(1997-1#1)(2005-11#1)(2007-11#1)(2007-12#3)(2007-3#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-5#1)
of the formation##44##3##(1991-11#1)(1991-5#2)(1992-2#1)(1992-3#1)(1992-5#2)(1993-11#2)(1994-11#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-7#1)(1997-1#1)(2005-11#1)(2006-9#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-8#1)(2008-10#10)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-5#1)
of the formed complex##2##4##(1991-2#1)(2008-10#1)
of the formed complexes##2##4##(2008-10#2)
of the formed##19##3##(1991-2#1)(1991-7#1)(1994-3#1)(1995-6#1)(2008-10#14)(2011-2#1)
of the former Soviet Union##2##5##(1995-3#1)(2006-10#1)
of the former Soviet##3##4##(1995-3#1)(2005-10#1)(2006-10#1)
of the former and##3##4##(2006-10#1)(2006-9#1)(2008-7#1)
of the former was##3##4##(1990-4#1)(2004-9#1)(2006-4#1)
of the former were##2##4##(2008-6#1)(2008-8#1)
of the former##50##3##(1990-4#1)(1990-7#1)(1990-8#1)(1991-1#1)(1992-12#1)(1992-4#1)(1992-8#1)(1994-1#1)(1994-3#2)(1994-5#1)(1995-1#1)(1995-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#2)(2006-10#4)(2006-12#1)(2006-4#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-9#1)(2011-2#2)(2013-1#1)(2013-7#1)
of the forms of##3##4##(1990-8#1)(2008-6#1)(2012-3#1)
of the forms##7##3##(1990-8#1)(1991-6#1)(1992-8#1)(1992-9#1)(2008-6#1)(2011-1#1)(2012-3#1)
of the formula##5##3##(1993-10#1)(1994-3#1)(2008-2#1)(2008-5#2)
of the formulation##7##3##(2008-10#2)(2008-5#4)(2011-3#1)
of the formulations##6##3##(2004-12#1)(2008-5#2)(2010-5#1)(2012-12#1)(2013-7#1)
of the forum##2##3##(2007-2#1)(2013-7#1)
of the forward and##2##4##(1992-4#1)(2007-12#1)
of the forward problem##2##4##(1997-6#1)(2007-12#1)
of the forward##9##3##(1991-12#1)(1991-9#1)(1992-4#1)(1997-6#1)(2007-12#2)(2008-3#1)(2009-1#1)(2013-1#1)
of the foundation##3##3##(2007-2#1)(2008-5#1)(2011-2#1)
of the foundations of##2##4##(2007-2#1)(2012-12#1)
of the founder##3##3##(1991-9#1)(1995-11#1)(1996-12#1)
of the founders of##2##4##(2007-6#1)(2009-2#1)
of the founding of##2##4##(1996-12#1)(2005-9#1)
of the founding##6##3##(1996-12#1)(1996-6#1)(2005-9#1)(2008-10#1)(2008-3#1)(2008-8#1)
of the four adenosine##2##4##(2008-4#1)(2010-5#1)
of the four cysteines##3##4##(1991-7#1)(1993-3#1)(1995-2#1)
of the four dimensions of##2##5##(2011-2#1)(2012-2#1)
of the four domains##2##4##(1992-4#2)
of the four groups##9##4##(1991-8#2)(1992-11#1)(2006-7#1)(2007-2#1)(2008-7#2)(2011-1#1)(2011-2#1)
of the four main##2##4##(1992-2#1)(2006-5#1)
of the four major##2##4##(1994-9#1)(2009-3#1)
of the four mammalian##2##4##(1997-7#1)(2008-7#1)
of the four methods##2##4##(2007-8#1)(2012-3#1)
of the four positions##2##4##(1997-4#1)(2008-8#1)
of the four proteins were##2##5##(1993-4#2)
of the four proteins##3##4##(1992-9#1)(1993-4#2)
of the four species##2##4##(1997-3#1)(2007-12#1)
of the four##159##3##(1990-2#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#3)(1991-10#1)(1991-2#2)(1991-3#1)(1991-7#2)(1991-8#2)(1992-11#2)(1992-2#1)(1992-3#2)(1992-4#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-4#2)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#2)(2004-4#1)(2005-11#1)(2006-11#1)(2006-5#1)(2006-7#1)(2006-8#3)(2007-11#1)(2007-12#3)(2007-2#2)(2007-5#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#31)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#8)(2008-7#4)(2008-8#2)(2008-9#2)(2009-11#1)(2009-3#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
of the four-helix bundle##3##4##(1994-6#1)(1995-8#1)(1997-4#1)
of the four-pass##2##3##(2008-2#2)
of the fourteen##2##3##(2008-4#1)(2009-11#1)
of the fourth and fifth##3##5##(1997-3#2)(2008-10#1)
of the fourth and##4##4##(1997-3#2)(2008-10#1)(2012-9#1)
of the fourth harmonic of a##2##6##(2007-12#1)(2008-3#1)
of the fourth ventricle##7##4##(1991-11#1)(1996-5#1)(2007-2#1)(2010-11#1)(2011-2#1)(2013-1#2)
of the fourth##27##3##(1991-11#1)(1991-12#1)(1991-2#1)(1992-12#2)(1992-2#1)(1994-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-3#2)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-9#1)(2013-1#2)
of the fraction of##5##4##(1997-7#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-9#1)
of the fraction##7##3##(1990-7#1)(1997-2#1)(1997-7#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-9#1)
of the fractional Fourier transform to##2##6##(2008-2#2)
of the fractional Fourier transform##4##5##(2008-2#3)(2008-3#1)
of the fractional quantum Hall##2##5##(1993-5#1)(1995-11#1)
of the fractional##13##3##(1993-5#1)(1995-11#1)(1997-1#1)(1997-4#1)(2008-2#5)(2008-3#4)
of the fractionated##3##3##(1990-4#1)(1991-7#1)(1997-2#1)
of the fractions##5##3##(1990-8#1)(1991-9#1)(1992-7#1)(2008-11#2)
of the fracture and##4##4##(2007-8#1)(2010-3#1)(2013-1#2)
of the fracture site##2##4##(2011-2#1)(2012-12#1)
of the fracture##21##3##(1993-8#1)(2006-11#1)(2006-8#1)(2007-11#2)(2007-8#4)(2008-9#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-3#1)(2011-2#3)(2012-12#1)(2013-1#3)
of the fractured##7##3##(2005-11#1)(2006-3#1)(2007-11#1)(2010-10#1)(2013-1#2)(2013-8#1)
of the fractures##9##3##(1992-3#1)(2007-11#2)(2007-8#2)(2008-9#1)(2010-3#1)(2013-1#1)(2013-8#1)
of the fragile X##2##4##(1991-5#1)(2006-12#1)
of the fragment##10##3##(1991-4#1)(1995-2#1)(1995-6#1)(1996-4#1)(1997-2#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)
of the fragments and##2##4##(2010-12#1)(2013-7#1)
of the fragments could##2##4##(1995-11#1)(2008-9#1)
of the fragments##14##3##(1990-11#1)(1992-3#1)(1992-6#1)(1994-10#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-8#1)(2005-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-12#1)(2013-7#1)
of the fragrance##8##3##(2006-12#1)(2008-5#7)
of the frail elderly##3##4##(1991-12#1)(1993-1#2)
of the framework##7##3##(1996-1#1)(2006-10#1)(2009-1#1)(2012-2#1)(2013-1#3)
of the free amino##3##4##(1990-11#1)(1990-5#1)(2007-11#1)
of the free and##3##4##(2008-10#2)(2008-6#1)
of the free carriers in metallic##2##6##(2008-3#2)
of the free carriers##3##4##(2008-3#3)
of the free energies of##2##5##(1990-8#2)
of the free energy of##5##5##(1991-7#1)(1994-9#1)(1995-10#1)(1995-11#1)(2005-11#1)
of the free energy##10##4##(1991-7#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-5#1)(1996-12#1)(2005-11#1)(2012-2#1)
of the free ligand##3##4##(1994-11#2)(2008-10#1)
of the free market##2##4##(2007-4#1)(2008-7#1)
of the free peptide##2##4##(1995-3#1)(2007-11#1)
of the free radical scavenger##2##5##(1995-12#1)(2007-9#1)
of the free radical theory of aging##2##7##(2009-12#1)(2009-5#1)
of the free radical##5##4##(1995-12#1)(2007-11#1)(2007-9#1)(2009-12#1)(2009-5#1)
of the free radicals##2##4##(1996-5#1)(2007-9#1)
of the free spectral range of the##2##7##(2007-11#1)(2008-2#1)
of the free wall of##2##5##(2008-10#1)(2008-7#1)
of the free wall##3##4##(2008-10#1)(2008-7#1)(2010-10#1)
of the free##69##3##(1990-11#1)(1990-3#1)(1990-5#2)(1990-8#2)(1991-5#2)(1991-7#1)(1991-9#1)(1994-11#3)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-12#2)(1996-4#1)(1996-5#1)(1996-8#1)(2005-11#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-4#1)(2007-8#1)(2007-9#2)(2008-10#11)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2009-12#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-6#1)(2012-2#1)
of the free-electron laser##2##4##(2006-5#1)(2007-12#1)
of the free-living##4##3##(2006-3#2)(2007-12#1)(2008-7#1)
of the free-running##4##3##(2007-2#1)(2008-2#1)(2008-3#2)
of the free-space diffraction efficiency##2##5##(2007-12#1)(2008-3#1)
of the free-space##5##3##(2007-12#3)(2008-3#2)
of the freeze-dried powder##2##4##(2007-1#1)(2011-2#1)
of the frequency and##5##4##(1991-6#1)(1996-7#1)(2006-10#1)(2007-2#1)(2011-2#1)
of the frequency comb is##2##5##(2007-12#2)
of the frequency distribution##2##4##(2004-9#1)(2008-6#1)
of the frequency of##9##4##(1991-9#1)(1994-2#1)(1996-11#1)(1997-1#1)(2006-6#1)(2008-10#1)(2008-3#1)(2010-8#1)(2011-2#1)
of the frequency response of##2##5##(2008-1#1)(2008-3#1)
of the frequency response##3##4##(2008-1#2)(2008-3#1)
of the frequency shift##5##4##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#2)
of the frequency##39##3##(1991-6#1)(1991-9#1)(1994-2#1)(1996-11#1)(1996-7#2)(1997-1#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#4)(2007-2#1)(2008-1#4)(2008-10#4)(2008-2#1)(2008-3#7)(2008-6#1)(2010-8#1)(2011-2#2)
of the frequently##2##3##(2007-3#1)(2011-1#1)
of the fresh water##2##4##(2008-10#1)(2008-7#1)
of the fresh##7##3##(2007-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-4#1)
of the freshly##2##3##(1992-8#1)(1997-1#1)
of the freshwater bryozoan Cristatella mucedo##2##6##(2011-2#2)
of the freshwater##10##3##(1996-3#1)(2005-12#1)(2008-12#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#3)
of the fringe patterns##3##4##(2008-2#1)(2008-3#2)
of the fringe spacing##2##4##(2008-3#2)
of the fringe visibility##2##4##(2008-3#2)
of the fringe##16##3##(2007-12#1)(2008-2#6)(2008-3#9)
of the fringes of##3##4##(2008-2#3)
of the fringes##4##3##(2008-2#3)(2008-3#1)
of the frog Rana##4##4##(1993-5#1)(1997-3#2)(2008-7#1)
of the frog##14##3##(1992-11#2)(1992-3#1)(1993-3#1)(1993-5#2)(1994-10#2)(1995-8#1)(1996-7#1)(1997-3#2)(1997-5#1)(2008-7#1)
of the front and##2##4##(2008-3#1)(2012-3#1)
of the front##4##3##(2008-3#2)(2012-12#1)(2012-3#1)
of the frontal and##2##4##(1996-3#1)(2008-9#1)
of the frontal bone##4##4##(2007-12#1)(2007-4#1)(2009-3#1)(2012-8#1)
of the frontal cortex##5##4##(1990-10#1)(1991-12#1)(1991-5#2)(2008-11#1)
of the frontal eye field##2##5##(1993-2#2)
of the frontal lobe and##2##5##(2007-8#1)(2008-9#1)
of the frontal lobe##6##4##(1995-1#1)(1997-2#1)(2007-8#1)(2008-9#3)
of the frontal##26##3##(1990-10#1)(1991-1#1)(1991-12#1)(1991-5#2)(1992-8#1)(1993-2#2)(1995-1#1)(1996-3#1)(1997-2#1)(2006-12#3)(2007-12#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-9#4)(2009-3#1)(2010-8#1)(2012-8#1)
of the frontoparietal cortex##4##4##(1997-7#2)(1997-8#2)
of the fruit (fresh fruit##2##5##(2010-2#2)
of the fruit fly Drosophila##2##5##(1992-3#1)(2007-12#1)
of the fruit fly##6##4##(1992-3#1)(2007-12#1)(2008-7#2)(2008-9#2)
of the fruit##18##3##(1992-3#1)(2007-1#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#2)(2008-9#3)(2009-6#1)(2010-2#2)
of the fruits and##2##4##(2008-11#1)(2010-2#1)
of the fruits##9##3##(2008-11#5)(2008-12#1)(2010-2#3)
of the fucoidan extracts on##2##5##(2008-11#2)
of the fuel##2##3##(2006-4#1)(2008-3#1)
of the full length cDNA##2##5##(1992-11#1)(1997-7#1)
of the full length##3##4##(1991-5#1)(1992-11#1)(1997-7#1)
of the full system##4##4##(2006-10#1)(2007-11#1)(2007-12#2)
of the full width at half-maximum##2##6##(2008-2#1)(2008-3#1)
of the full##28##3##(1991-1#1)(1991-5#1)(1991-6#1)(1992-11#2)(1995-12#1)(1996-12#1)(1997-7#1)(2005-12#1)(2006-10#1)(2007-11#2)(2007-12#4)(2008-10#2)(2008-2#3)(2008-3#2)(2008-4#1)(2010-5#1)(2012-1#1)(2012-2#1)(2013-1#1)
of the full-length cDNA was##2##5##(1990-2#1)(1997-7#1)
of the full-length cDNA##4##4##(1990-2#1)(1995-3#1)(1997-7#2)
of the full-length construct##2##4##(1992-6#1)(1995-5#1)
of the full-length##16##3##(1990-2#1)(1991-5#1)(1992-6#1)(1994-8#2)(1994-9#1)(1995-3#1)(1995-5#1)(1996-10#2)(1996-4#1)(1997-1#1)(1997-7#2)(2008-10#1)(2008-8#1)
of the fully##8##3##(1990-10#1)(1993-2#1)(1994-9#1)(1997-1#1)(2007-9#1)(2010-3#1)(2011-2#2)
of the fume##4##3##(2008-10#4)
of the function and##3##4##(2008-6#1)(2008-7#1)(2008-8#1)
of the function of the##4##5##(1996-8#1)(2008-7#1)(2009-8#1)(2009-9#1)
of the function of##24##4##(1991-11#2)(1993-11#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-8#1)(1996-11#1)(1996-8#1)(1997-6#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-8#2)(2008-7#2)(2008-8#1)(2009-8#1)(2009-9#1)(2011-1#1)(2013-1#1)(2013-8#2)
of the function##31##3##(1991-11#2)(1993-11#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-8#1)(1996-11#1)(1996-8#1)(1997-6#2)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-8#1)(2009-9#1)(2011-1#1)(2013-1#1)(2013-8#2)
of the functional anatomy of the##2##6##(2012-3#1)(2013-1#1)
of the functional anatomy##3##4##(2012-2#1)(2012-3#1)(2013-1#1)
of the functional and##4##4##(1994-11#1)(2007-12#1)(2008-7#1)(2010-2#1)
of the functional domains##4##4##(1990-7#1)(1993-12#1)(1995-8#1)(1997-6#1)
of the functional enzyme##2##4##(1992-2#1)(1996-7#1)
of the functional form##2##4##(2008-7#1)(2012-2#1)
of the functional groups in the##2##6##(2005-11#1)(2006-12#1)
of the functional groups##3##4##(2005-11#1)(2006-12#1)(2008-10#1)
of the functional imaging##2##4##(2006-3#1)(2007-11#1)
of the functional nature of##2##5##(1992-5#1)(2008-4#1)
of the functional properties of the##2##6##(2008-6#1)(2013-8#1)
of the functional state of##3##5##(1995-4#1)(2008-4#1)(2013-1#1)
of the functional status of the##4##6##(1992-4#1)(1995-2#1)(1997-8#1)(2008-9#1)
of the functional##81##3##(1990-7#1)(1991-12#1)(1991-3#1)(1992-11#2)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#2)(1993-12#1)(1993-2#2)(1993-8#1)(1994-11#1)(1995-2#2)(1995-4#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-7#2)(1997-1#1)(1997-6#1)(1997-8#1)(2004-4#1)(2005-1#1)(2005-11#2)(2006-12#3)(2006-3#1)(2006-6#2)(2007-11#2)(2007-12#5)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-4#5)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-2#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#1)
of the functionality##3##3##(2008-4#1)(2009-2#1)(2013-8#1)
of the functionally##5##3##(1990-7#1)(2006-3#1)(2007-12#1)(2009-10#1)(2011-1#1)
of the functions and##3##4##(1995-2#1)(2006-10#1)(2009-5#1)
of the functions of##7##4##(2004-3#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-6#1)(2012-2#1)(2013-8#1)
of the functions##14##3##(1995-2#1)(1996-1#1)(1997-2#1)(2004-3#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-6#1)(2009-5#1)(2009-9#1)(2012-2#1)(2013-8#1)
of the fundamental and##4##4##(2007-12#2)(2008-2#1)(2013-8#1)
of the fundamental equilibrium constants##2##5##(2008-10#2)
of the fundamental field##2##4##(2007-12#2)
of the fundamental frequency##3##4##(1997-5#1)(2007-12#1)(2008-2#1)
of the fundamental mode in##2##5##(2007-12#1)(2008-2#1)
of the fundamental mode##6##4##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)
of the fundamental principles of##2##5##(2008-4#1)(2008-5#1)
of the fundamental pulse##2##4##(2007-12#1)(2008-2#1)
of the fundamental radiation##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
of the fundamental wave##2##4##(2007-12#2)
of the fundamental##47##3##(1992-1#1)(1992-3#1)(1993-3#1)(1995-8#1)(1996-8#1)(1997-5#1)(2005-11#1)(2006-4#1)(2007-1#1)(2007-11#6)(2007-12#14)(2008-10#3)(2008-2#6)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2010-7#1)(2012-3#1)(2013-8#1)
of the fundus##2##3##(2006-5#1)(2010-6#1)
of the fungal cell wall##2##5##(2008-10#1)(2009-8#1)
of the fungal community isolated from##2##6##(2008-10#2)
of the fungal community##3##4##(2008-10#3)
of the fungal isolates##2##4##(2007-7#1)(2008-10#1)
of the fungal pathogen##3##4##(2008-10#3)
of the fungal##28##3##(1997-4#1)(2007-11#1)(2007-7#1)(2008-10#20)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)
of the fungi##15##3##(2006-12#1)(2007-3#1)(2007-7#1)(2008-10#8)(2008-5#1)(2008-8#1)(2009-8#1)(2013-1#1)
of the fungicide applications##2##4##(2008-10#2)
of the fungicide cymoxanil in##2##5##(1991-5#2)
of the fungicide##12##3##(1991-5#2)(2006-5#2)(2008-10#8)
of the fungicides##4##3##(2008-10#3)(2008-5#1)
of the fungus Leptolegnia chapmanii (Oomycetes##2##6##(2008-5#2)
of the fungus and##2##4##(2008-10#2)
of the fungus in the##3##5##(2008-10#3)
of the fungus in##7##4##(2008-10#7)
of the fungus is##2##4##(2005-11#1)(2008-10#1)
of the fungus to##4##4##(2008-10#3)(2008-5#1)
of the fungus was##4##4##(2008-10#3)(2008-5#1)
of the fungus were##2##4##(2008-10#2)
of the fungus##64##3##(1990-9#1)(1991-5#1)(1991-8#1)(1994-11#1)(1995-8#1)(2004-8#1)(2005-11#1)(2006-9#1)(2008-1#1)(2008-10#47)(2008-5#5)(2009-2#1)(2009-8#1)(2011-1#1)
of the funnel warts##3##4##(2007-12#3)
of the funnel##4##3##(1990-5#1)(2007-12#3)
of the furazolidone metabolite##2##4##(1997-3#2)
of the further##2##3##(1990-10#1)(2007-11#1)
of the fusant ZJF-71##2##4##(2005-11#2)
of the fused##5##3##(2006-9#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)
of the fushi tarazu gene##2##5##(1992-4#1)(1993-9#1)
of the fusiform rust##2##4##(2008-10#2)
of the fusion pore##2##4##(2008-8#2)
of the fusion protein gene##2##5##(2008-5#2)
of the fusion protein was##3##5##(1994-8#1)(1996-5#1)(2008-6#1)
of the fusion protein##16##4##(1991-3#1)(1993-3#1)(1994-3#2)(1994-8#1)(1995-3#1)(1996-5#1)(1996-7#1)(1997-4#1)(2005-9#1)(2008-1#1)(2008-4#1)(2008-5#2)(2008-6#1)(2012-2#1)
of the fusion proteins##6##4##(1993-5#1)(1994-3#1)(1997-7#1)(2006-12#1)(2008-6#1)(2008-7#1)
of the fusion##34##3##(1991-3#1)(1991-4#1)(1993-3#2)(1993-5#1)(1994-3#3)(1994-8#1)(1995-3#1)(1996-5#1)(1996-7#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-9#1)(2006-12#1)(2006-9#1)(2007-6#1)(2008-1#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2011-2#1)(2012-2#3)(2013-1#1)
of the future for##2##4##(1992-1#1)(2007-7#1)
of the future is##2##4##(1992-11#1)(1995-12#1)
of the future number of##2##5##(1990-11#1)(1991-2#1)
of the future will##2##4##(1992-12#1)(1994-12#1)
of the future##44##3##(1990-10#1)(1990-11#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-12#1)(1993-2#3)(1993-6#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#2)(1995-2#2)(1996-12#1)(1996-5#1)(2006-10#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#1)(2009-12#1)(2009-7#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#1)
of the future?##3##3##(1993-12#1)(2007-1#1)(2012-2#1)
of the fuzzy relation equation##2##5##(2008-8#2)
of the fuzzy##4##3##(2008-2#2)(2008-8#2)
of the g = 2##2##5##(1990-3#2)
of the g##4##3##(1990-3#2)(1994-3#1)(2008-2#1)
of the gRNA##2##3##(2006-12#1)(2008-10#1)
of the gag##2##3##(1991-10#1)(2006-2#1)
of the gain and##2##4##(2007-12#1)(2008-3#1)
of the gain medium##3##4##(2008-2#1)(2008-3#2)
of the gain profile##2##4##(2007-12#1)(2008-2#1)
of the gain##20##3##(2007-11#3)(2007-12#6)(2008-1#2)(2008-2#5)(2008-3#4)
of the gain-scheduling##2##3##(2008-10#2)
of the gains##2##3##(1995-6#1)(2008-2#1)
of the gait performance##2##4##(2012-12#1)(2013-1#1)
of the gait##5##3##(2007-10#1)(2012-1#1)(2012-12#1)(2013-1#2)
of the galactose binding##2##4##(1993-7#1)(1994-6#1)
of the galactose##7##3##(1991-6#1)(1991-9#2)(1993-7#1)(1994-6#1)(1995-3#1)(2006-10#1)
of the galanin-induced hyperpolarization##2##4##(1990-7#2)
of the gall bladder##3##4##(1992-6#1)(2006-9#1)(2008-8#1)
of the gallbladder in a##3##5##(1990-6#1)(1991-12#1)(2007-2#1)
of the gallbladder is##2##4##(1991-6#1)(2011-2#1)
of the gallbladder wall##2##4##(1991-8#1)(2010-5#1)
of the gallbladder##33##3##(1990-6#2)(1991-12#4)(1991-4#1)(1991-6#2)(1991-8#2)(1992-6#3)(1992-9#1)(2006-10#1)(2006-2#2)(2007-2#2)(2008-3#1)(2008-4#1)(2009-3#4)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-3#1)
of the gallbladder]##2##3##(1991-6#1)(1993-10#1)
of the game is##2##4##(2008-2#2)
of the gamma 2 subunit##4##5##(1992-11#1)(1994-12#2)(1995-12#1)
of the gamma 2##5##4##(1992-11#1)(1994-12#2)(1995-12#1)(1995-5#1)
of the gamma and##2##4##(1994-10#1)(1994-9#1)
of the gamma chain gene##2##5##(1995-3#2)
of the gamma chain##4##4##(1990-12#1)(1995-3#3)
of the gamma subunit in##2##5##(1992-11#1)(1994-8#1)
of the gamma subunit##5##4##(1992-11#3)(1994-8#1)(1994-9#1)
of the gamma##23##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-9#1)(1992-11#4)(1992-6#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-3#3)(1995-5#1)(2008-1#1)
of the gamma-glutamyl transpeptidase gene##2##5##(1991-5#2)
of the gamma-subunit##4##3##(1991-7#1)(1995-3#3)
of the ganglia##3##3##(1991-5#1)(1996-5#1)(2008-7#1)
of the ganglion##2##3##(1991-10#1)(2008-5#1)
of the ganglion's##2##3##(1995-11#1)(2006-3#1)
of the ganglioside##4##3##(1990-8#1)(1991-5#1)(1994-3#2)
of the gap between the##3##5##(2011-1#1)(2012-1#2)
of the gap##10##3##(1993-12#1)(1996-1#1)(2007-11#1)(2008-3#3)(2011-1#1)(2012-1#3)
of the gaps in the##2##5##(2006-10#1)(2010-2#1)
of the gaps in##3##4##(2006-10#1)(2010-2#1)(2012-12#1)
of the gaps##5##3##(1997-1#1)(2006-10#1)(2010-2#1)(2012-12#2)
of the gas in the##3##5##(2008-10#2)(2008-2#1)
of the gas##14##3##(1990-11#1)(1997-1#1)(2007-12#3)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#2)(2009-9#1)(2012-2#1)
of the gas-phase##2##3##(2006-12#1)(2010-7#1)
of the gaseous##4##3##(1997-1#1)(2007-12#1)(2008-10#2)
of the gasoline##2##3##(2006-10#1)(2007-8#1)
of the gastric content##2##4##(2007-11#2)
of the gastric mucosa##3##4##(1993-12#1)(1997-1#1)(2005-1#1)
of the gastric transplant##2##4##(2010-12#1)(2012-1#1)
of the gastric wall##2##4##(2006-6#1)(2009-8#1)
of the gastric##29##3##(1990-9#2)(1992-8#1)(1993-12#1)(1993-8#1)(1994-3#1)(1997-1#3)(1997-4#2)(1997-6#1)(2005-1#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-9#1)(2009-3#1)(2009-8#1)(2010-12#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#4)
of the gastrin##2##3##(1992-3#1)(1992-8#1)
of the gastro-intestinal tract##3##4##(1991-4#1)(2006-2#1)(2008-9#1)
of the gastro-intestinal##4##3##(1991-10#1)(1991-4#1)(2006-2#1)(2008-9#1)
of the gastrocnemius##2##3##(1995-2#1)(2012-2#1)
of the gastroduodenal##2##3##(1990-10#1)(2006-10#1)
of the gastrointestinal (GI) tract##3##5##(2012-1#2)(2012-12#1)
of the gastrointestinal and##2##4##(1993-7#1)(2008-5#1)
of the gastrointestinal mucosa##2##4##(1996-3#1)(2012-1#1)
of the gastrointestinal tract and the##2##6##(1996-8#1)(2008-7#1)
of the gastrointestinal tract and##3##5##(1996-8#1)(2008-7#1)(2011-2#1)
of the gastrointestinal tract in##3##5##(1991-10#1)(2012-1#1)(2013-7#1)
of the gastrointestinal tract is a##2##6##(2006-6#1)(2009-1#1)
of the gastrointestinal tract is##7##5##(1990-11#1)(2006-2#1)(2006-6#1)(2008-7#1)(2009-1#1)(2009-2#1)(2011-2#1)
of the gastrointestinal tract##52##4##(1990-10#1)(1990-11#1)(1990-8#1)(1991-10#1)(1991-6#1)(1992-2#1)(1993-10#2)(1995-6#1)(1996-8#1)(2006-10#2)(2006-2#3)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-6#2)(2008-7#4)(2008-8#1)(2009-1#1)(2009-2#1)(2009-8#1)(2010-12#2)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#3)
of the gastrointestinal##71##3##(1990-10#1)(1990-11#1)(1990-8#1)(1991-10#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-10#2)(1993-7#1)(1995-11#1)(1995-6#2)(1996-3#1)(1996-8#1)(1997-8#1)(2006-10#3)(2006-2#3)(2006-6#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#2)(2009-1#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-12#2)(2011-2#5)(2012-1#6)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#3)
of the gate##5##3##(1995-1#1)(2008-7#2)(2009-11#1)(2012-2#1)
of the gating##2##3##(1994-3#1)(2008-2#1)
of the gaze shift##2##4##(2008-11#2)
of the gcs gene##2##4##(1997-7#2)
of the gel network##2##4##(2008-5#2)
of the gel phase##2##4##(1994-8#1)(2005-11#1)
of the gel phases of##2##5##(1990-3#1)(1993-8#1)
of the gel##30##3##(1990-11#1)(1990-3#1)(1990-5#1)(1992-12#1)(1993-8#1)(1994-8#3)(1996-9#1)(1997-5#1)(2005-11#4)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)
of the gels##2##3##(1990-3#1)(2008-10#1)
of the gender and##2##4##(2006-11#1)(2009-4#1)
of the gender##4##3##(1991-6#1)(2006-11#1)(2009-4#1)(2011-2#1)
of the gene and the##4##5##(1990-5#1)(1993-2#1)(1996-8#1)(2008-7#1)
of the gene and##9##4##(1990-5#1)(1991-2#1)(1993-2#1)(1994-11#1)(1995-8#1)(1996-2#1)(1996-8#1)(1996-9#1)(2008-7#1)
of the gene are##3##4##(1993-2#1)(1995-1#1)(1997-2#1)
of the gene as##2##4##(1990-12#1)(1997-2#1)
of the gene by##2##4##(1991-3#1)(2007-9#1)
of the gene cluster##3##4##(1993-9#1)(1995-2#1)(1996-4#1)
of the gene coding for the##3##6##(1992-3#1)(1993-8#1)(1997-2#1)
of the gene coding for##7##5##(1990-9#1)(1992-2#1)(1992-3#1)(1993-8#1)(1994-2#1)(1996-8#1)(1997-2#1)
of the gene encoding a##5##5##(1990-1#1)(1993-11#1)(1994-12#1)(1994-8#1)(1996-7#1)
of the gene encoding for the##2##6##(1992-9#1)(1997-6#1)
of the gene encoding human##6##5##(1991-6#2)(1992-2#1)(1993-5#1)(1993-7#1)(1997-7#1)
of the gene encoding potato UDP-glucose pyrophosphorylase##2##7##(1997-2#2)
of the gene encoding the##23##5##(1990-10#1)(1990-8#1)(1991-9#2)(1993-2#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-12#3)(1995-4#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-5#1)(2008-9#1)(2009-4#1)(2012-3#1)
of the gene encoding##67##4##(1990-1#2)(1990-10#4)(1990-5#1)(1990-8#1)(1991-12#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-12#2)(1992-2#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-2#4)(1993-3#2)(1993-4#1)(1993-5#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-12#6)(1994-8#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#3)(1996-12#1)(1996-3#1)(1996-7#2)(1996-8#1)(1997-2#2)(1997-3#2)(1997-6#1)(1997-7#2)(2007-11#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-10#1)(2012-3#1)
of the gene expression##5##4##(1991-5#1)(1993-8#1)(1997-6#1)(2009-9#1)(2013-1#1)
of the gene for nerve growth factor (NGF)##2##8##(1993-7#2)
of the gene for the##3##5##(1990-4#1)(1992-11#1)(1994-9#1)
of the gene for##17##4##(1990-4#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1992-11#1)(1993-7#2)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1996-11#1)(1996-7#1)(1997-4#1)(1997-7#1)(2010-4#1)
of the gene from##2##4##(1994-2#1)(1994-3#1)
of the gene in the##2##5##(1991-1#1)(1993-2#1)
of the gene in##9##4##(1991-1#1)(1991-9#1)(1993-2#1)(1993-3#1)(1993-9#1)(1995-3#2)(1997-1#1)(2008-10#1)
of the gene is##10##4##(1991-12#2)(1992-9#1)(1993-11#1)(1993-4#1)(1993-5#1)(1993-8#1)(1995-2#1)(1996-2#1)(1996-5#1)
of the gene of interest##3##5##(1991-12#1)(2008-9#2)
of the gene of##5##4##(1990-10#1)(1990-12#1)(1991-12#1)(2008-9#2)
of the gene or the##2##5##(1990-11#1)(2008-4#1)
of the gene or##4##4##(1990-11#1)(1996-2#1)(2008-10#1)(2008-4#1)
of the gene product##5##4##(1991-8#1)(1995-3#1)(1996-7#1)(1997-7#1)(2006-5#1)
of the gene products##3##4##(1991-7#1)(1994-12#1)(1997-4#1)
of the gene that encodes the##3##6##(1995-8#1)(2013-1#2)
of the gene therapy##2##4##(2008-5#1)(2013-8#1)
of the gene to##3##4##(1990-8#1)(1993-2#1)(1995-3#1)
of the gene was determined##2##5##(1991-11#1)(1997-8#1)
of the gene was##11##4##(1991-1#1)(1991-11#1)(1993-9#1)(1997-2#1)(1997-8#1)(2006-12#1)(2006-8#1)(2008-5#2)(2008-8#2)
of the gene were##3##4##(1990-11#1)(1990-9#1)(1997-4#1)
of the gene##304##3##(1990-1#2)(1990-10#6)(1990-11#4)(1990-12#3)(1990-4#4)(1990-5#4)(1990-8#4)(1990-9#3)(1991-1#4)(1991-10#2)(1991-11#4)(1991-12#9)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#3)(1991-7#3)(1991-8#3)(1991-9#4)(1992-11#3)(1992-12#2)(1992-2#3)(1992-3#2)(1992-8#2)(1992-9#2)(1993-1#1)(1993-10#2)(1993-11#5)(1993-12#2)(1993-2#9)(1993-3#7)(1993-4#4)(1993-5#3)(1993-6#2)(1993-7#3)(1993-8#9)(1993-9#7)(1994-11#2)(1994-12#10)(1994-2#4)(1994-3#2)(1994-5#1)(1994-8#3)(1994-9#2)(1995-1#2)(1995-11#1)(1995-2#4)(1995-3#5)(1995-4#3)(1995-5#1)(1995-6#4)(1995-8#6)(1996-10#3)(1996-11#2)(1996-12#1)(1996-2#4)(1996-3#3)(1996-4#2)(1996-5#2)(1996-7#5)(1996-8#3)(1996-9#1)(1997-1#3)(1997-2#12)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#5)(1997-7#5)(1997-8#1)(2005-12#1)(2005-6#2)(2006-12#1)(2006-5#3)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#7)(2008-4#4)(2008-5#5)(2008-7#7)(2008-8#3)(2008-9#6)(2009-10#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-4#2)(2010-5#1)(2012-3#1)(2013-1#4)(2013-8#2)
of the genera Sphaerochaeta##2##4##(2013-8#2)
of the genera##9##3##(1997-4#1)(2008-10#2)(2008-5#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-8#2)
of the general amino acid##2##5##(1990-5#1)(1996-5#1)
of the general form##2##4##(2008-7#1)(2010-9#1)
of the general formula##5##4##(1994-9#1)(1996-2#1)(2007-8#1)(2008-5#1)(2008-6#1)
of the general health##2##4##(2008-10#1)(2013-1#1)
of the general hospital##3##4##(1990-12#1)(2006-9#1)(2011-2#1)
of the general population and##2##5##(2007-5#1)(2009-1#1)
of the general population in##2##5##(2006-11#1)(2008-9#1)
of the general population of the##3##6##(1991-2#1)(1993-9#2)
of the general population##36##4##(1991-2#3)(1993-1#1)(1993-9#2)(1995-9#1)(1997-3#2)(2006-10#6)(2006-11#1)(2006-5#1)(2006-8#2)(2007-5#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-1#1)(2010-11#1)(2010-12#2)(2010-6#1)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of the general practitioner##2##4##(1993-11#1)(1995-11#1)
of the general practitioners##6##4##(1991-5#1)(1993-2#3)(1997-4#2)
of the general public##4##4##(2008-7#1)(2009-2#1)(2012-2#1)(2013-8#1)
of the general##88##3##(1990-12#1)(1990-5#1)(1990-6#1)(1991-2#3)(1991-5#1)(1992-4#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-2#4)(1993-9#3)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-9#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(2006-10#6)(2006-11#1)(2006-3#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#3)(2009-1#1)(2009-2#1)(2010-11#1)(2010-12#3)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
of the generality of##2##4##(1993-2#1)(2007-2#1)
of the generalized estimating equation##2##5##(1993-9#1)(1995-9#1)
of the generalized susceptibility##2##4##(1991-9#1)(1994-10#1)
of the generalized t and##2##5##(1992-2#2)
of the generalized##18##3##(1990-3#1)(1991-9#1)(1992-2#2)(1993-9#1)(1994-10#1)(1995-9#1)(2005-11#1)(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#2)(2012-2#1)(2013-7#1)
of the generally observed##2##4##(2013-7#2)
of the generated blue##2##4##(2007-12#2)
of the generated data##2##4##(2008-10#1)(2008-7#1)
of the generated##20##3##(1990-7#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-8#1)(2004-9#1)(2007-11#1)(2007-12#4)(2008-10#4)(2008-2#1)(2008-7#1)(2011-1#1)(2013-1#2)
of the generation of##3##4##(1990-3#1)(1994-3#1)(1996-10#1)
of the generation##6##3##(1990-3#1)(1994-3#1)(1996-10#1)(2007-12#1)(2008-4#1)(2013-1#1)
of the generative##3##3##(2007-12#1)(2009-12#1)(2010-4#1)
of the generic group Anaphothrips##2##5##(2008-5#2)
of the generic##6##3##(2007-10#1)(2008-5#2)(2009-5#1)(2011-2#1)(2013-7#1)
of the genes and##2##4##(1997-1#1)(2008-8#1)
of the genes are involved in##2##6##(2008-10#1)(2009-8#1)
of the genes are##4##4##(1991-2#1)(1993-6#1)(2008-10#1)(2009-8#1)
of the genes coding for the##2##6##(1995-2#2)
of the genes coding for##4##5##(1991-2#1)(1991-6#1)(1995-2#2)
of the genes coding##5##4##(1990-6#1)(1991-2#1)(1991-6#1)(1995-2#2)
of the genes encoding the##6##5##(1990-7#1)(1991-6#1)(1992-9#1)(1996-2#1)(2008-7#1)(2009-10#1)
of the genes encoding##16##4##(1990-7#1)(1991-6#1)(1992-9#1)(1993-12#1)(1993-3#2)(1995-3#1)(1996-2#1)(1997-1#1)(1997-7#1)(2006-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-7#1)
of the genes for both##2##5##(1990-2#1)(1997-8#1)
of the genes for the##2##5##(1996-5#1)(2010-11#1)
of the genes for##10##4##(1990-2#1)(1992-3#1)(1993-2#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-10#1)(2010-11#1)
of the genes have##2##4##(1996-2#1)(2008-9#1)
of the genes identified##2##4##(2008-9#1)(2010-9#1)
of the genes in##6##4##(1990-5#1)(1992-3#1)(1994-8#1)(2008-10#2)(2009-8#1)
of the genes involved in the##2##6##(1990-5#1)(2008-9#1)
of the genes involved in##7##5##(1990-5#1)(1991-2#1)(2007-12#1)(2008-10#1)(2008-9#2)(2012-2#1)
of the genes involved##8##4##(1990-5#1)(1991-2#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#2)(2012-2#1)
of the genes of the achaete-scute complex##2##7##(1990-5#1)(1990-8#1)
of the genes of the##3##5##(1990-5#2)(1990-8#1)
of the genes of##5##4##(1990-5#2)(1990-8#1)(1993-4#1)(2013-1#1)
of the genes required for##2##5##(1995-2#1)(2005-8#1)
of the genes that##3##4##(1993-6#1)(1997-2#1)(2012-3#1)
of the genes was##2##4##(1992-3#1)(1994-9#1)
of the genes were##3##4##(2008-10#2)(2009-10#1)
of the genes##111##3##(1990-11#1)(1990-2#1)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#3)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-3#3)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#1)(1993-6#2)(1994-8#2)(1994-9#1)(1995-10#1)(1995-2#3)(1995-3#1)(1996-10#1)(1996-2#2)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-6#2)(1997-7#3)(1997-8#4)(2005-8#1)(2006-10#1)(2006-11#1)(2006-4#1)(2007-12#1)(2008-10#8)(2008-11#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#6)(2009-10#3)(2009-6#1)(2009-8#3)(2010-11#1)(2010-12#1)(2010-7#3)(2010-9#1)(2011-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
of the genetic and##3##4##(2008-10#1)(2009-12#1)(2012-11#1)
of the genetic architecture of##2##5##(2008-8#1)(2013-8#1)
of the genetic architectures of##2##5##(2008-11#1)(2008-8#1)
of the genetic basis for##2##5##(2008-4#1)(2012-3#1)
of the genetic basis of brain##2##6##(2008-4#1)(2012-3#1)
of the genetic basis of the##2##6##(2008-10#1)(2012-12#1)
of the genetic basis of##10##5##(2006-10#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
of the genetic basis##12##4##(2006-10#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-11#1)(2012-12#1)(2012-2#1)(2012-3#2)
of the genetic code##4##4##(1994-5#1)(1997-6#1)(2006-12#1)(2008-1#1)
of the genetic connectedness measures among##2##6##(2012-1#2)
of the genetic dissection of complex##2##6##(1994-9#2)
of the genetic distance##2##4##(1997-5#1)(2008-10#1)
of the genetic diversity##5##4##(1995-2#1)(2008-10#3)(2010-7#1)
of the genetic effect##3##4##(1994-2#1)(2012-3#2)
of the genetic factors##3##4##(2006-10#1)(2010-10#1)(2011-1#1)
of the genetic map##2##4##(2008-10#1)(2012-3#1)
of the genetic polymorphism##2##4##(1996-3#1)(2010-2#1)
of the genetic structure of##5##5##(2006-10#1)(2008-10#2)(2008-8#1)(2011-2#1)
of the genetic structure##6##4##(2006-10#1)(2008-10#3)(2008-8#1)(2011-2#1)
of the genetic variance##2##4##(2008-10#1)(2008-5#1)
of the genetic variation for##2##5##(2008-10#2)
of the genetic variation##5##4##(2008-10#4)(2012-11#1)
of the genetic##92##3##(1994-2#2)(1994-5#1)(1994-9#2)(1995-2#1)(1996-3#1)(1996-5#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#5)(2006-12#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#19)(2008-11#2)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#1)(2009-12#2)(2009-6#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#1)(2013-8#1)
of the genetically##3##3##(2008-10#2)(2013-7#1)
of the genetics of##4##4##(2008-1#1)(2008-10#1)(2008-8#1)(2009-9#1)
of the genetics##9##3##(2005-9#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#2)(2009-3#1)(2009-9#1)
of the geniculate ganglion##2##4##(2006-12#1)(2011-2#1)
of the geniculate##3##3##(2006-12#1)(2011-2#2)
of the genital tract##5##4##(1994-3#1)(2006-5#1)(2008-7#1)(2012-2#1)(2013-8#1)
of the genital##11##3##(1994-3#1)(2006-5#1)(2007-12#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
of the genitalia##4##3##(1997-3#1)(2008-10#2)(2013-7#1)
of the genitourinary##2##3##(1990-6#1)(2007-12#1)
of the genome and##4##4##(2008-10#1)(2008-5#1)(2010-2#1)(2012-3#1)
of the genome by##4##4##(1993-11#1)(1995-6#1)(2012-2#1)(2012-3#1)
of the genome contains##2##4##(1996-2#1)(2008-10#1)
of the genome in##2##4##(1991-8#1)(2008-7#1)
of the genome of the##6##5##(1995-12#1)(1995-8#1)(1996-6#2)(1997-3#1)(2008-10#1)
of the genome of##16##4##(1992-6#1)(1995-12#1)(1995-8#2)(1996-6#2)(1997-1#2)(1997-3#2)(2008-10#4)(2010-8#1)(2013-8#1)
of the genome project##2##4##(2007-12#1)(2008-12#1)
of the genome sequence##2##4##(2006-10#1)(2012-11#1)
of the genome that##3##4##(2008-4#1)(2008-8#1)(2010-3#1)
of the genome to##2##4##(1995-4#1)(2008-11#1)
of the genome was##3##4##(1996-6#1)(2008-10#2)
of the genome were also##2##5##(1996-7#1)(2008-10#1)
of the genome were##3##4##(1992-9#1)(1996-7#1)(2008-10#1)
of the genome##94##3##(1991-8#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-4#1)(1995-6#1)(1995-8#3)(1996-2#1)(1996-6#7)(1996-7#1)(1997-1#3)(1997-3#2)(2005-8#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#17)(2008-11#4)(2008-12#1)(2008-4#3)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#2)(2009-3#1)(2010-2#1)(2010-3#2)(2010-8#1)(2011-12#1)(2011-2#4)(2012-11#3)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#1)(2013-8#1)
of the genomes of##9##4##(1997-6#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)
of the genomes##10##3##(1997-6#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)
of the genomic DNA##6##4##(1991-7#1)(1991-8#1)(1991-9#1)(1994-8#1)(1995-8#1)(2008-8#1)
of the genomic and##2##4##(1992-3#1)(2006-10#1)
of the genomic clone##2##4##(1991-4#1)(2006-12#1)
of the genomic regions##3##4##(1996-12#1)(2008-10#1)(2009-10#1)
of the genomic sequence##4##4##(1992-3#1)(1993-3#1)(2008-1#1)(2008-7#1)
of the genomic structure##2##4##(1993-12#1)(1994-8#1)
of the genomic##36##3##(1990-8#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-3#2)(1992-4#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-8#2)(1995-1#2)(1995-8#1)(1996-12#1)(2006-10#1)(2006-12#1)(2006-4#1)(2008-1#1)(2008-10#6)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#2)(2010-4#1)(2013-8#1)
of the genotoxic##2##3##(1995-5#1)(1997-4#1)
of the genotoxicity##2##3##(1992-6#1)(2013-1#1)
of the genotype##3##3##(2008-10#1)(2012-3#1)(2013-8#1)
of the genotypes in##2##4##(2008-7#1)(2011-2#1)
of the genotypes##8##3##(2008-10#6)(2008-7#1)(2011-2#1)
of the genotyping primers##2##4##(2008-9#2)
of the genuine##2##3##(1990-12#1)(2010-11#1)
of the genus Alphavirus##5##4##(2008-7#5)
of the genus Aminobacterium##2##4##(2011-2#2)
of the genus Aminomonas##2##4##(2011-2#2)
of the genus Arcanobacterium##2##4##(2011-2#2)
of the genus Arcobacter##2##4##(2011-2#2)
of the genus Astyanax##2##4##(2010-8#2)
of the genus Cellulomonas##3##4##(2011-2#3)
of the genus Closterovirus##2##4##(2008-10#2)
of the genus Ferrimonas##2##4##(2011-2#2)
of the genus Haloterrigena##2##4##(2011-2#2)
of the genus Hypolobocera##2##4##(2008-5#2)
of the genus Intrasporangium##2##4##(2011-2#2)
of the genus Meiothermus and only the third genome sequence to be published from a member of the family Thermaceae##2##20##(2011-2#2)
of the genus Meiothermus##3##4##(2011-2#3)
of the genus Methanoplanus are##2##5##(2011-2#2)
of the genus Methanoplanus##3##4##(2011-2#3)
of the genus Microsomacanthus Lopez-Neyra##2##5##(2011-2#2)
of the genus Microsomacanthus##4##4##(2011-2#4)
of the genus Nocardiopsis##2##4##(2011-2#2)
of the genus Olsenella##2##4##(2011-2#2)
of the genus Phenylobacterium##2##4##(2005-11#2)
of the genus Potyvirus##6##4##(2008-10#6)
of the genus Puntius Hamilton 1822 harvested from 15##2##9##(2008-12#2)
of the genus Puntius Hamilton 1822##4##6##(2008-12#4)
of the genus Sinularia##3##4##(2010-2#3)
of the genus Sulfurimonas##2##4##(2011-2#2)
of the genus Sulfurospirillum##2##4##(2011-2#2)
of the genus Thermobispora##2##4##(2011-2#2)
of the genus Thermosediminibacter##2##4##(2011-2#2)
of the genus Tobamovirus##3##4##(2008-10#3)
of the genus Tospovirus##2##4##(2008-10#2)
of the genus Trichovirus##4##4##(2008-10#4)
of the genus Tymovirus##2##4##(2008-10#2)
of the genus##190##3##(1996-3#2)(1996-8#1)(1997-2#1)(1997-4#3)(2005-11#2)(2006-8#3)(2007-12#3)(2007-2#2)(2007-3#5)(2007-7#1)(2008-1#1)(2008-10#43)(2008-11#1)(2008-12#4)(2008-4#4)(2008-5#14)(2008-6#6)(2008-7#7)(2008-9#1)(2009-5#3)(2010-1#1)(2010-2#3)(2010-3#2)(2010-4#1)(2010-8#4)(2011-1#1)(2011-2#63)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#2)
of the geographic area##2##4##(1991-3#1)(2011-2#1)
of the geographic##7##3##(1991-3#2)(1993-9#1)(2008-10#2)(2011-2#2)
of the geographical##3##3##(2008-4#1)(2008-8#1)(2013-7#1)
of the geometric mean##2##4##(2011-2#2)
of the geometric##9##3##(1990-12#1)(2008-2#2)(2008-3#3)(2011-2#2)(2013-7#1)
of the geometrical##5##3##(1995-8#1)(1997-4#1)(2007-11#1)(2008-2#1)(2008-3#1)
of the geometrical-optics approximation##2##4##(2008-2#1)(2008-3#1)
of the geometrical-optics##3##3##(2008-2#1)(2008-3#2)
of the geometry and##3##4##(2006-5#1)(2010-4#2)
of the geometry of a##2##5##(2008-2#2)
of the geometry of the##4##5##(1995-11#1)(1996-7#1)(2008-10#1)(2008-2#1)
of the geometry of##8##4##(1995-11#1)(1996-7#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#1)
of the geometry##13##3##(1995-11#1)(1996-7#1)(2005-10#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-2#4)(2008-3#1)(2010-4#2)
of the gerbil cochlear nucleus##2##5##(1995-12#2)
of the gerbil##6##3##(1990-7#1)(1992-11#1)(1995-12#2)(1995-5#1)(1997-7#1)
of the gerbils##2##3##(1994-5#2)
of the geriatric##4##3##(1993-5#1)(2005-10#1)(2010-1#1)(2011-2#1)
of the germ line##2##4##(2007-12#1)(2009-3#1)
of the germ tubes##2##4##(2008-7#2)
of the germ##10##3##(1994-3#1)(2007-12#1)(2008-10#1)(2008-7#3)(2009-10#1)(2009-3#1)(2010-3#1)(2010-4#1)
of the germinal vesicle##2##4##(2007-12#1)(2008-7#1)
of the germinal##3##3##(1992-11#1)(2007-12#1)(2008-7#1)
of the germline##5##3##(1991-11#1)(1992-10#1)(2007-10#1)(2010-5#1)(2012-3#1)
of the gestational##3##3##(2007-4#1)(2008-12#1)(2009-1#1)
of the ghost##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
of the giant##7##3##(1991-2#1)(1995-11#1)(1997-6#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-2#1)
of the gills##3##3##(2006-8#1)(2008-5#1)(2008-7#1)
of the ginbuna##2##3##(2008-5#2)
of the gingiva##3##3##(2009-8#1)(2012-3#1)(2013-7#1)
of the gingival##6##3##(2004-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
of the girls##7##3##(1991-8#1)(1991-9#1)(1993-10#1)(2006-4#2)(2007-3#1)(2013-1#1)
of the girls)##2##3##(1991-9#2)
of the given shape##2##4##(2008-2#2)
of the given##7##3##(2007-8#1)(2008-10#1)(2008-2#2)(2008-5#1)(2010-12#1)(2013-1#1)
of the gizzard##5##3##(1991-5#1)(2008-5#4)
of the gland and##2##4##(2007-12#2)
of the gland opening##3##4##(2007-12#3)
of the gland##16##3##(1992-5#1)(2006-6#2)(2006-9#1)(2007-12#7)(2007-7#1)(2008-7#1)(2009-12#1)(2011-1#1)(2011-2#1)
of the glands##4##3##(2006-6#2)(2007-12#2)
of the glandular epithelium##2##4##(2007-9#1)(2012-12#1)
of the glandular##5##3##(2005-10#1)(2007-12#1)(2007-9#1)(2012-12#2)
of the glans penis##3##4##(2007-7#2)(2007-8#1)
of the glass are##2##4##(2008-2#1)(2008-3#1)
of the glass electrode##3##4##(2008-10#3)
of the glass to##2##4##(2008-10#1)(2010-4#1)
of the glass transition##2##4##(1995-3#1)(2004-9#1)
of the glass##33##3##(1995-3#1)(2004-9#2)(2006-7#1)(2007-12#6)(2008-1#1)(2008-10#11)(2008-2#3)(2008-3#4)(2010-2#1)(2010-4#2)(2010-8#1)
of the glassy carbon electrode##3##5##(1995-6#1)(2008-10#2)
of the glassy##5##3##(1995-3#1)(1995-6#1)(2008-10#2)(2008-7#1)
of the glassy-winged sharpshooter##2##4##(2007-12#1)(2011-12#1)
of the glaucoma##2##3##(2010-2#1)(2013-8#1)
of the glenohumeral joint##4##4##(2006-11#1)(2007-10#1)(2007-4#1)(2007-7#1)
of the glenoid##2##3##(2007-11#1)(2010-11#1)
of the glial##7##3##(1990-7#1)(1993-11#1)(1997-2#1)(2007-12#1)(2008-2#1)(2008-7#1)(2009-8#1)
of the glioblastoma##2##3##(1990-9#1)(2011-2#1)
of the glioma##2##3##(2007-10#2)
of the global and##2##4##(2008-11#1)(2008-2#1)
of the global pathway##2##4##(2007-12#2)
of the global shape##2##4##(1997-1#1)(2008-4#1)
of the global##36##3##(1990-12#1)(1991-9#1)(1993-10#1)(1994-12#1)(1996-5#1)(1997-1#1)(1997-3#1)(2006-10#3)(2007-12#2)(2007-5#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
of the globe##2##3##(2005-11#1)(2007-8#1)
of the globular##6##3##(1990-7#1)(1991-1#1)(1991-5#1)(1995-12#1)(2005-11#1)(2009-7#1)
of the globule##2##3##(1990-7#1)(2006-10#1)
of the globus pallidus##3##4##(1994-2#1)(2008-11#1)(2012-2#1)
of the glomerular basement membrane##5##5##(1992-7#1)(2007-7#1)(2007-8#1)(2008-1#1)(2012-2#1)
of the glomerular filtration rate##3##5##(2007-7#1)(2011-2#1)(2012-12#1)
of the glomerular##14##3##(1992-5#1)(1992-7#1)(1996-6#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-1#1)(2009-2#1)(2011-2#1)(2012-12#2)(2012-2#1)
of the glomerulonephritis##2##3##(1993-2#2)
of the glomerulus##3##3##(2007-7#1)(2007-8#2)
of the glossopharyngeal##2##3##(1995-6#2)
of the gloves##4##3##(1995-6#2)(2012-2#2)
of the glucagon receptor##2##4##(1995-11#2)
of the glucagon##4##3##(1990-3#1)(1995-11#2)(2011-2#1)
of the glucocorticoid receptor (GR)##2##5##(1994-11#1)(1996-5#1)
of the glucocorticoid receptor##12##4##(1990-12#1)(1991-12#1)(1993-12#1)(1993-8#1)(1994-11#3)(1996-12#3)(1996-5#1)(2008-7#1)
of the glucocorticoid##14##3##(1990-12#1)(1991-12#1)(1993-12#1)(1993-4#1)(1993-8#1)(1994-11#3)(1996-12#3)(1996-5#1)(2007-11#1)(2008-7#1)
of the glucose biosensor##2##4##(2008-10#1)(2010-5#1)
of the glucose concentration##2##4##(1994-5#1)(2008-10#1)
of the glucose oxidase##2##4##(2007-6#1)(2008-10#1)
of the glucose sensing##2##4##(2008-11#2)
of the glucose transporter##3##4##(1990-2#1)(1993-6#1)(1995-10#1)
of the glucose##17##3##(1990-2#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-10#1)(1996-11#1)(2007-6#1)(2008-10#4)(2008-11#2)(2008-7#1)(2010-5#1)
of the glutamate dehydrogenase##2##4##(2008-11#1)(2008-8#1)
of the glutamate receptor##2##4##(1996-4#1)(1997-4#1)
of the glutamate transporter##3##4##(1993-3#1)(1995-11#1)(1997-7#1)
of the glutamate##16##3##(1990-2#1)(1990-7#1)(1993-2#1)(1993-3#1)(1994-6#1)(1995-11#1)(1996-1#2)(1996-4#1)(1997-4#1)(1997-5#1)(1997-7#1)(2008-11#1)(2008-7#2)(2008-8#1)
of the glutamatergic system##3##4##(1993-2#1)(1996-3#1)(2008-1#1)
of the glutamatergic##4##3##(1993-2#1)(1995-11#1)(1996-3#1)(2008-1#1)
of the glutaminase##3##3##(1991-7#3)
of the glutamine repeat##2##4##(1994-11#2)
of the glutamine synthetase##2##4##(2008-10#1)(2008-2#1)
of the glutamine##5##3##(1994-11#2)(1997-1#1)(2008-10#1)(2008-2#1)
of the glutathione peroxidase##2##4##(1994-9#1)(2013-1#1)
of the glutathione##6##3##(1991-9#1)(1992-9#1)(1993-3#1)(1994-9#2)(2013-1#1)
of the gluteal region##2##4##(1992-2#1)(2010-8#1)
of the gluteal##3##3##(1992-2#1)(2010-8#1)(2013-7#1)
of the gluteus medius##2##4##(2006-10#1)(2013-7#1)
of the glutinous##2##3##(2008-10#2)
of the glycan##3##3##(1990-4#1)(1990-7#1)(1991-12#1)
of the glycans##2##3##(1990-5#1)(1994-9#1)
of the glyceraldehyde-3-phosphate dehydrogenase gene##2##5##(1995-6#1)(2008-10#1)
of the glycerol##5##3##(1990-2#1)(1990-3#1)(1996-5#1)(1997-3#1)(2011-2#1)
of the glycine cleavage system##4##5##(1991-4#2)(1992-10#1)(1996-5#1)
of the glycine cleavage##5##4##(1991-4#2)(1992-10#1)(1996-5#1)(1997-1#1)
of the glycine receptor##4##4##(1990-7#1)(1992-11#3)
of the glycine site##2##4##(1996-12#1)(1997-2#1)
of the glycine##14##3##(1990-12#1)(1990-7#1)(1991-4#2)(1992-10#1)(1992-11#3)(1994-3#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)
of the glycine-rich##4##3##(1994-8#1)(1997-7#2)(2008-10#1)
of the glycol##2##3##(1995-2#1)(2007-11#1)
of the glycolipids##3##3##(1993-9#1)(2005-11#2)
of the glycolytic enzymes##2##4##(1994-8#1)(1997-2#1)
of the glycolytic##6##3##(1990-7#1)(1991-2#1)(1993-3#1)(1994-8#1)(1994-9#1)(1997-2#1)
of the glycolytic-glycogenolytic##2##3##(1994-3#2)
of the glycopeptide##2##3##(1990-5#1)(2009-12#1)
of the glycoprotein is##2##4##(1992-2#1)(1994-8#1)
of the glycoprotein##12##3##(1991-7#1)(1992-2#1)(1992-7#1)(1993-12#1)(1993-6#1)(1994-8#1)(1996-3#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-4#1)(2008-7#1)
of the glycoproteins##2##3##(2008-7#1)(2010-12#1)
of the glycosaminoglycan##3##3##(1995-12#1)(1997-2#1)(2011-12#1)
of the glycoside##2##3##(1992-11#1)(2007-5#1)
of the glycosidic bond##4##4##(1995-1#1)(1996-4#2)(2008-10#1)
of the glycosidic##7##3##(1993-3#1)(1995-1#1)(1996-4#2)(2008-10#1)(2009-12#1)(2010-5#1)
of the glycosyl##2##3##(1990-12#1)(1994-10#1)
of the glycosylated##2##3##(1990-7#1)(1996-9#1)
of the glycosylation##3##3##(1992-6#1)(2008-7#1)(2010-11#1)
of the glycosylphosphatidylinositol##2##3##(1995-3#1)(2008-4#1)
of the glycyl radical##2##4##(1995-2#2)
of the goal##2##3##(1994-7#1)(2010-2#1)
of the goals of the##2##5##(2008-10#1)(2009-5#1)
of the goals of##10##4##(1994-2#1)(1994-3#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-9#2)(2009-5#1)(2013-1#2)
of the goals##12##3##(1993-6#1)(1994-2#1)(1994-3#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-9#2)(2009-5#1)(2012-3#1)(2013-1#2)
of the goats##3##3##(1993-1#1)(1997-8#1)(2010-2#1)
of the gold##9##3##(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-7#1)(2012-12#1)
of the goldfish##4##3##(1995-7#1)(2008-5#2)(2008-6#1)
of the gonad##2##3##(1991-5#1)(2007-12#1)
of the gonadal steroid environment##2##5##(2008-11#2)
of the gonadal steroid##3##4##(2008-11#3)
of the gonadal##5##3##(1995-11#1)(2008-11#3)(2008-6#1)
of the good##7##3##(1992-10#1)(1996-1#1)(2007-11#1)(2009-10#1)(2012-10#1)(2012-11#2)
of the governing##2##3##(1995-6#1)(2007-12#1)
of the government to##3##4##(1994-7#1)(1995-3#1)(2011-2#1)
of the government##8##3##(1994-7#2)(1995-3#1)(2005-5#1)(2007-12#1)(2007-7#1)(2011-1#1)(2011-2#1)
of the government's##3##3##(1990-12#1)(1996-1#1)(2007-9#1)
of the gradient of the##2##5##(2008-1#1)(2013-8#1)
of the gradient##12##3##(2005-12#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#1)(2013-8#1)
of the graft and##4##4##(2007-8#2)(2008-11#1)(2013-1#1)
of the graft to##2##4##(2006-6#1)(2007-7#1)
of the graft##27##3##(1991-11#1)(1996-2#2)(1996-3#1)(2004-9#1)(2005-11#1)(2006-6#1)(2007-11#3)(2007-5#2)(2007-7#3)(2007-8#3)(2008-1#1)(2008-11#1)(2008-12#1)(2009-9#1)(2011-3#1)(2013-1#4)
of the grafted polymer##2##4##(2008-10#1)(2009-10#1)
of the grafted##6##3##(2008-10#2)(2009-10#1)(2010-4#2)(2010-7#1)
of the grafting##2##3##(2004-9#1)(2008-10#1)
of the grafts with##2##4##(2008-11#1)(2010-4#1)
of the grafts##7##3##(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-4#1)
of the grain##2##3##(1991-12#1)(2013-8#1)
of the grains##3##3##(2007-5#1)(2008-12#1)(2008-2#1)
of the gram-negative##2##3##(2006-8#1)(2008-8#1)
of the gramicidin channel##2##4##(1995-10#2)
of the gramicidin##4##3##(1995-10#2)(1996-7#2)
of the grammatical##2##3##(1991-2#1)(2008-4#1)
of the grant##6##3##(1992-12#1)(1995-6#2)(1996-2#1)(2007-4#1)(2007-8#1)
of the granular##4##3##(1996-6#2)(2007-9#1)(2008-1#1)
of the granule cell layer##2##5##(1990-5#1)(2009-8#1)
of the granule cell##5##4##(1990-5#1)(1991-6#1)(1994-8#1)(1995-7#1)(2009-8#1)
of the granule cells##2##4##(1995-11#1)(2009-8#1)
of the granule##8##3##(1990-5#1)(1991-1#1)(1991-6#1)(1994-8#1)(1995-11#1)(1995-7#1)(2009-8#2)
of the granules were##2##4##(2008-10#2)
of the granules##5##3##(2008-10#2)(2008-5#2)(2010-11#1)
of the granulocyte##2##3##(1994-11#1)(1996-2#1)
of the granulosa##2##3##(1996-11#1)(2008-12#1)
of the grapes##3##3##(2008-10#3)
of the grapevine##2##3##(2008-10#1)(2010-9#1)
of the graph##4##3##(2012-2#1)(2013-1#3)
of the graphite##6##3##(2008-10#6)
of the grass##3##3##(1994-3#1)(2005-7#1)(2008-7#1)
of the grasshopper Schistocerca gregaria##7##5##(2007-12#7)
of the grasshopper##11##3##(2007-12#8)(2008-5#1)(2008-9#1)(2013-7#1)
of the grating amplitude##2##4##(2008-3#2)
of the grating and##3##4##(2008-2#1)(2008-3#2)
of the grating aperture##2##4##(2008-3#2)
of the grating diffraction efficiency##2##5##(2008-2#1)(2008-3#1)
of the grating is##4##4##(2007-12#1)(2008-3#3)
of the grating pair##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
of the grating with##2##4##(2007-11#2)
of the grating##72##3##(2006-4#1)(2007-11#5)(2007-12#11)(2008-1#1)(2008-2#16)(2008-3#38)
of the gratings##13##3##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#7)
of the gravity waves##2##4##(2008-3#2)
of the gravity##4##3##(2008-10#1)(2008-3#2)(2009-8#1)
of the gray##2##3##(1997-5#1)(2008-10#1)
of the grazing season##2##4##(1991-8#1)(1996-12#1)
of the great arteries##9##4##(1996-12#1)(2006-8#1)(2007-8#1)(2008-4#1)(2009-10#2)(2009-4#1)(2010-6#1)(2012-1#1)
of the great toe##5##4##(1992-3#1)(2008-5#1)(2010-5#2)(2010-9#1)
of the great vessels##4##4##(1990-11#1)(1996-11#1)(2007-8#1)(2012-2#1)
of the great##35##3##(1990-11#1)(1991-11#1)(1992-3#1)(1992-4#1)(1996-11#1)(1996-12#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-10#2)(2009-4#1)(2009-5#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
of the greater omentum##2##4##(2006-10#1)(2012-1#1)
of the greater prairie chicken##2##5##(2008-9#2)
of the greater trochanter##2##4##(2007-11#1)(2007-7#1)
of the greater##16##3##(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2012-1#1)
of the greatest challenges##3##4##(2007-11#1)(2008-4#1)(2008-8#1)
of the greatest##16##3##(1996-1#1)(2004-2#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-8#1)(2010-9#1)(2011-2#1)(2012-11#1)
of the green alga Chlamydomonas reinhardtii##4##6##(1992-12#1)(1994-12#1)(2009-10#1)(2012-3#1)
of the green alga Chlamydomonas##5##5##(1992-12#1)(1994-12#1)(2006-3#1)(2009-10#1)(2012-3#1)
of the green alga##7##4##(1992-11#1)(1992-12#1)(1994-12#1)(2006-3#1)(2009-10#1)(2010-4#1)(2012-3#1)
of the green fluorescent protein (GFP)##2##6##(2005-8#1)(2009-6#1)
of the green fluorescent protein##3##5##(2005-8#1)(2009-6#1)(2009-9#1)
of the green toad##2##4##(2008-12#2)
of the green##23##3##(1991-9#1)(1992-11#1)(1992-12#1)(1992-8#1)(1994-12#1)(1997-7#1)(2005-8#1)(2006-12#1)(2006-3#1)(2007-12#3)(2008-11#1)(2008-12#2)(2008-5#1)(2009-10#1)(2009-6#3)(2009-9#1)(2010-4#1)(2012-3#1)
of the greenhouse effect##3##4##(1991-6#2)(1992-3#1)
of the greenhouse##5##3##(1991-6#2)(1992-3#2)(2008-10#1)
of the grey##3##3##(2008-9#1)(2009-9#1)(2010-8#1)
of the grid##3##3##(2008-1#1)(2009-11#1)(2010-5#1)
of the groE##2##3##(1996-12#1)(2008-10#1)
of the groin##2##3##(2007-3#2)
of the groove##8##3##(1995-1#1)(2008-2#4)(2008-3#2)(2008-8#1)
of the grooves##5##3##(1995-8#3)(2007-12#1)(2008-3#1)
of the gross motor function measure##2##6##(2006-10#2)
of the gross national product##2##5##(1993-1#1)(2008-3#1)
of the gross##8##3##(1993-1#1)(2006-10#2)(2006-4#1)(2008-3#2)(2008-4#1)(2013-8#1)
of the ground reaction##2##4##(2012-1#2)
of the ground squirrel##3##4##(1990-5#1)(2008-8#2)
of the ground state##6##4##(1994-10#1)(1994-9#2)(2008-3#1)(2010-2#2)
of the ground##15##3##(1990-5#1)(1994-10#1)(1994-9#2)(2008-3#3)(2008-8#2)(2010-2#2)(2012-1#3)(2012-2#1)
of the ground-based##2##3##(2008-2#1)(2008-3#1)
of the ground-dwelling ant fauna##2##5##(2007-3#2)
of the ground-state##3##3##(2006-5#1)(2007-12#1)(2008-2#1)
of the group II chaperonin from the##2##7##(1997-7#2)
of the group II chaperonin##3##5##(1997-7#3)
of the group II##4##4##(1997-2#1)(1997-7#3)
of the group and##4##4##(1996-6#1)(2008-10#1)(2008-11#1)(2008-9#1)
of the group in##3##4##(2008-11#1)(2008-9#1)(2012-1#1)
of the group of##6##4##(1991-10#1)(1996-1#1)(2008-10#1)(2008-7#1)(2011-2#2)
of the group##54##3##(1991-10#1)(1991-11#1)(1991-12#1)(1992-6#1)(1993-1#1)(1993-8#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-6#1)(1997-2#1)(1997-7#3)(2004-11#1)(2006-10#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-2#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2011-1#2)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#1)
of the group's##3##3##(1993-9#1)(1996-3#1)(2008-5#1)
of the group-velocity##2##3##(2007-11#2)
of the groups##19##3##(1990-8#1)(1992-3#1)(1993-7#1)(1994-11#1)(1995-6#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-7#2)(2008-10#2)(2008-11#2)(2008-5#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-7#1)
of the growing cells##2##4##(1991-2#1)(1995-11#1)
of the growing season##7##4##(2004-4#1)(2008-10#4)(2009-2#1)(2012-5#1)
of the growing##23##3##(1991-2#1)(1993-1#1)(1993-3#1)(1994-12#1)(1995-11#1)(2004-4#1)(2007-1#1)(2008-10#6)(2008-7#2)(2009-10#1)(2009-12#1)(2009-2#2)(2010-2#1)(2012-1#1)(2012-5#1)(2013-1#1)
of the grown##2##3##(2013-1#2)
of the growth and##5##4##(2006-3#1)(2006-8#1)(2007-3#1)(2008-4#1)(2013-8#1)
of the growth associated protein##2##5##(1991-9#1)(1997-5#1)
of the growth cone##4##4##(1994-11#1)(1995-11#1)(1996-3#2)
of the growth control##2##4##(2008-10#2)
of the growth factor##9##4##(1991-7#1)(1994-10#1)(1994-12#1)(1997-1#1)(1997-7#2)(2008-1#1)(2008-8#1)(2009-8#1)
of the growth hormone (GH)##2##5##(1995-3#1)(2011-2#1)
of the growth hormone receptor gene##2##6##(2006-9#1)(2008-1#1)
of the growth hormone receptor##3##5##(2006-9#1)(2008-1#1)(2008-4#1)
of the growth hormone##6##4##(1995-3#1)(2006-9#1)(2007-7#1)(2008-1#1)(2008-4#1)(2011-2#1)
of the growth in##2##4##(2008-10#1)(2009-10#1)
of the growth kinetics##2##4##(2008-11#1)(2008-7#1)
of the growth medium with##2##5##(1994-12#1)(1996-6#1)
of the growth medium##6##4##(1991-11#2)(1994-12#2)(1996-6#1)(2008-11#1)
of the growth of human##2##5##(1991-8#1)(2008-8#1)
of the growth of the##2##5##(2005-11#1)(2013-1#1)
of the growth of##15##4##(1991-8#2)(1993-3#1)(1993-6#1)(1994-3#1)(1994-8#1)(1997-2#1)(2005-11#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#1)(2013-1#1)
of the growth phase##3##4##(2008-11#3)
of the growth plate##6##4##(2007-11#2)(2007-8#3)(2012-1#1)
of the growth rate##6##4##(2006-8#1)(2008-11#3)(2008-7#1)(2009-6#1)
of the growth substrate##2##4##(2008-7#2)
of the growth zone##2##4##(2009-8#2)
of the growth##107##3##(1990-4#1)(1991-11#2)(1991-7#1)(1991-8#2)(1991-9#1)(1993-3#2)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#2)(1995-11#2)(1995-2#1)(1995-3#2)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#2)(2005-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-8#2)(2006-9#1)(2007-11#4)(2007-3#2)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#6)(2008-11#10)(2008-2#3)(2008-3#1)(2008-4#4)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#2)(2009-6#1)(2009-8#5)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
of the growth-associated protein##2##4##(1996-9#1)(2008-7#1)
of the gsa-1 gene##2##4##(1997-7#2)
of the guanine base##2##4##(1994-9#1)(2008-10#1)
of the guanine##6##3##(1991-5#1)(1992-11#1)(1992-3#1)(1994-9#1)(2008-10#2)
of the guanine-nucleotide-binding pocket##2##4##(1990-12#2)
of the guanosine##3##3##(1992-7#1)(2006-11#1)(2008-1#1)
of the guest molecules##3##4##(2006-12#1)(2008-10#1)(2008-2#1)
of the guest##8##3##(1997-7#1)(2006-12#2)(2008-10#4)(2008-2#1)
of the guests##2##3##(2008-10#1)(2010-4#1)
of the guide##3##3##(1996-2#1)(1996-9#1)(2008-3#1)
of the guided light##3##4##(2007-12#1)(2008-10#2)
of the guided mode##2##4##(2007-12#1)(2008-10#1)
of the guided modes##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
of the guided##12##3##(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)
of the guideline##5##3##(1995-6#1)(2008-10#2)(2010-8#1)(2013-1#1)
of the guidelines for the##2##5##(2008-7#1)(2012-12#1)
of the guidelines was##2##4##(2008-9#1)(2010-11#1)
of the guidelines##20##3##(1990-12#1)(1990-6#2)(1994-2#2)(2006-10#1)(2006-2#1)(2007-12#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-11#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
of the guiding##5##3##(1995-3#1)(2007-11#1)(2007-12#2)(2008-2#1)
of the guinea pig extraocular muscles##3##6##(1997-3#3)
of the guinea pig##12##4##(1991-5#1)(1991-7#1)(1992-8#1)(1994-3#1)(1995-12#2)(1996-3#2)(1996-6#1)(1997-3#3)
of the guinea-pig colon##2##4##(1997-1#1)(1997-4#1)
of the guinea-pig proximal colon##3##5##(1993-11#2)(1997-4#1)
of the guinea-pig##14##3##(1990-5#1)(1991-2#1)(1992-8#1)(1993-11#2)(1994-5#1)(1994-6#1)(1996-3#1)(1997-1#1)(1997-4#2)(1997-7#2)(2004-12#1)
of the gulf toadfish Opsanus beta##2##6##(2010-8#2)
of the gulf##6##3##(2007-5#4)(2010-8#2)
of the gum##2##3##(2008-5#1)(2011-2#1)
of the gusA gene was##2##5##(2006-12#2)
of the gusA##3##3##(2006-12#3)
of the gustatory##2##3##(1992-11#2)
of the gut and##3##4##(1991-10#1)(2008-5#1)(2012-1#1)
of the gut with##2##4##(2006-2#1)(2007-12#1)
of the gut##28##3##(1991-10#1)(1992-8#1)(1993-1#1)(1993-5#1)(1993-6#2)(1993-8#1)(1995-6#1)(1996-5#1)(2006-10#2)(2006-2#1)(2007-12#1)(2008-4#2)(2008-5#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#6)(2012-1#1)(2013-7#1)
of the gyro##2##3##(2007-12#1)(2008-1#1)
of the h-lamp-2##2##3##(1994-11#2)
of the hDRS##2##3##(1994-12#2)
of the hFSH receptor##2##4##(1991-8#2)
of the hIL-6##2##3##(2008-11#2)
of the hP2Y(1) receptor##3##4##(2008-4#3)
of the hTERT mRNA and##2##5##(2008-11#2)
of the hTERT##4##3##(2008-11#4)
of the habitat for##2##4##(2008-10#1)(2008-8#1)
of the habitat##7##3##(2007-8#1)(2007-9#1)(2008-10#2)(2008-5#1)(2008-8#2)
of the habitats##3##3##(2007-10#1)(2007-3#1)(2013-7#1)
of the haemagglutinin##3##3##(1997-6#2)(2008-5#1)
of the haemagglutinin-neuraminidase (HN)##2##4##(2007-6#2)
of the haematoma and##2##4##(2008-7#2)
of the haematoma##4##3##(1997-3#1)(2008-7#3)
of the haemodynamic##3##3##(1990-6#1)(2006-12#1)(2011-2#1)
of the haemoglobin##5##3##(1991-9#1)(1994-6#1)(1997-6#1)(2007-11#2)
of the hair and##2##4##(2008-5#2)
of the hair cells##2##4##(1993-9#1)(1995-8#1)
of the hair follicle##2##4##(2008-5#1)(2012-2#1)
of the hair##22##3##(1990-6#1)(1993-9#1)(1995-8#1)(2008-5#17)(2010-4#1)(2012-2#1)
of the hairpin ribozyme##2##4##(1996-7#2)
of the hairpin##5##3##(1991-7#1)(1996-7#2)(2006-10#1)(2008-10#1)
of the hairy##3##3##(1990-9#1)(2007-1#1)(2008-7#1)
of the half##4##3##(1991-10#1)(1993-5#1)(2008-10#1)(2008-11#1)
of the half-life##2##3##(1990-10#1)(2006-12#1)
of the halftone##2##3##(2008-2#1)(2008-3#1)
of the halide##2##3##(2006-9#1)(2011-1#1)
of the hallmarks of cancer##3##5##(2007-10#1)(2011-2#1)(2012-2#1)
of the hallmarks of##9##4##(1994-6#1)(1995-8#1)(2007-10#1)(2007-6#1)(2008-10#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
of the hallux##3##3##(2007-7#1)(2009-10#1)(2012-2#1)
of the halo##2##3##(2008-2#1)(2008-3#1)
of the halobacterial##2##3##(1992-2#1)(2006-8#1)
of the halogenated##2##3##(1992-9#1)(1997-1#1)
of the hamster##4##3##(1995-12#1)(1995-5#1)(1996-8#1)(2008-9#1)
of the hamstring##2##3##(2007-11#1)(2009-5#1)
of the hand and fingers##2##5##(2010-9#1)(2011-2#1)
of the hand and wrist##2##5##(2006-4#1)(2012-2#1)
of the hand and##14##4##(1990-10#1)(2006-10#1)(2006-4#2)(2007-11#2)(2008-2#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
of the hand as##2##4##(2007-5#1)(2007-8#1)
of the hand can be##2##5##(2007-11#1)(2008-9#1)
of the hand in##2##4##(2008-6#1)(2012-1#1)
of the hand is##2##4##(2007-8#1)(2008-9#1)
of the hand or##3##4##(2008-6#3)
of the hand##63##3##(1990-10#1)(1990-4#2)(1991-9#1)(1993-3#1)(1996-1#2)(1996-9#1)(1997-8#1)(2006-10#4)(2006-3#1)(2006-4#4)(2006-6#1)(2007-11#5)(2007-5#1)(2007-7#2)(2007-8#3)(2008-11#1)(2008-2#2)(2008-6#8)(2008-7#2)(2008-9#7)(2009-3#2)(2009-9#1)(2010-1#1)(2010-9#1)(2011-2#2)(2012-1#3)(2012-2#2)(2013-1#1)
of the hands and feet##6##5##(2007-7#1)(2008-4#1)(2008-7#1)(2011-12#1)(2012-12#1)(2013-1#1)
of the hands and##7##4##(2007-7#1)(2008-4#1)(2008-7#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
of the hands in##2##4##(1994-11#1)(1997-3#1)
of the hands##20##3##(1993-11#1)(1994-11#1)(1997-3#1)(2005-11#1)(2006-10#4)(2007-7#2)(2007-8#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-3#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
of the hapten##3##3##(1994-8#1)(1997-3#1)(2008-4#1)
of the haptic device##2##4##(2012-1#2)
of the haptic##3##3##(2012-1#3)
of the hard palate##3##4##(1991-11#2)(2013-1#1)
of the hard##7##3##(1991-11#3)(2008-10#1)(2008-5#1)(2009-2#1)(2013-1#1)
of the hardness of##2##4##(2008-3#1)(2013-8#1)
of the hardware##2##3##(2008-2#1)(2008-9#1)
of the hare##4##3##(2007-9#4)
of the harmonic##2##3##(2007-11#1)(2007-12#1)
of the harmonics in##2##4##(2008-3#2)
of the harmonics##3##3##(2008-1#1)(2008-3#2)
of the harvested##2##3##(1994-5#1)(2006-4#1)
of the hazards of##5##4##(1991-5#1)(1996-2#1)(2008-11#2)(2010-3#1)
of the head and neck are##4##6##(1993-8#1)(1995-8#1)(2006-12#1)(2010-11#1)
of the head and neck region is##3##7##(2008-6#2)(2013-8#1)
of the head and neck region##6##6##(2008-6#4)(2012-12#1)(2013-8#1)
of the head and neck##37##5##(1990-6#2)(1991-10#1)(1992-10#1)(1992-4#2)(1993-4#1)(1993-8#1)(1993-9#1)(1995-8#1)(2005-7#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-6#2)(2007-7#1)(2008-3#1)(2008-6#5)(2010-11#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#4)
of the head and##48##4##(1990-6#2)(1991-10#1)(1992-10#1)(1992-4#2)(1993-4#1)(1993-8#1)(1993-9#1)(1995-8#1)(2005-7#1)(2006-12#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-4#2)(2007-6#2)(2007-7#2)(2008-2#1)(2008-3#1)(2008-6#5)(2008-8#2)(2009-3#1)(2009-4#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#5)
of the head by##3##4##(1990-5#1)(1993-12#1)(2010-12#1)
of the head during##3##4##(2007-4#1)(2012-11#1)(2013-8#1)
of the head groups##2##4##(2005-11#2)
of the head of the pancreas##4##6##(1990-9#1)(1991-9#1)(2008-8#2)
of the head of the##10##5##(1990-2#1)(1990-9#1)(1991-11#1)(1991-9#1)(1994-6#1)(1995-6#1)(1995-8#1)(2008-8#2)(2010-10#1)
of the head of##12##4##(1990-2#1)(1990-9#1)(1991-11#1)(1991-9#1)(1994-6#1)(1995-6#1)(1995-8#1)(2007-12#1)(2008-3#1)(2008-8#2)(2010-10#1)
of the head##108##3##(1990-2#1)(1990-5#1)(1990-6#2)(1990-9#2)(1991-10#1)(1991-11#2)(1991-9#1)(1992-10#1)(1992-4#2)(1993-12#4)(1993-4#1)(1993-8#1)(1993-9#1)(1994-6#2)(1994-8#1)(1995-6#1)(1995-8#3)(1996-9#1)(1997-3#1)(2004-11#1)(2005-11#3)(2005-7#1)(2006-11#1)(2006-12#1)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#1)(2007-12#7)(2007-3#1)(2007-4#10)(2007-5#1)(2007-6#2)(2007-7#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#6)(2008-7#1)(2008-8#5)(2009-3#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#7)
of the head-neck##3##3##(2007-1#2)(2011-2#1)
of the headache was##2##4##(2004-12#1)(2012-2#1)
of the headache##5##3##(2004-12#2)(2012-2#2)(2013-7#1)
of the headgroup##2##3##(1991-7#1)(1994-11#1)
of the headspace##2##3##(2008-10#1)(2011-2#1)
of the healing process##3##4##(2007-11#1)(2008-5#1)(2011-2#1)
of the healing##6##3##(1994-3#3)(2007-11#1)(2008-5#1)(2011-2#1)
of the health and##5##4##(1992-3#1)(1997-4#1)(2008-2#1)(2010-9#1)(2013-8#1)
of the health care delivery system##5##6##(1993-12#1)(1995-2#1)(1995-3#1)(2007-4#1)(2009-4#1)
of the health care in##2##5##(1994-11#1)(1997-8#1)
of the health care industry##5##5##(1990-12#1)(1991-1#1)(1991-12#1)(1993-12#1)(2005-7#1)
of the health care organization##2##5##(1994-12#1)(2010-8#1)
of the health care system in##3##6##(1992-12#1)(1992-2#1)(2005-10#1)
of the health care system##14##5##(1990-12#2)(1992-12#1)(1992-2#1)(1993-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-2#1)(1996-3#1)(2005-10#2)(2007-3#1)(2012-2#1)
of the health care systems##2##5##(2007-9#1)(2013-8#1)
of the health care team##3##5##(1995-3#2)(2008-11#1)
of the health care##50##4##(1990-12#3)(1991-1#1)(1991-12#1)(1992-12#1)(1992-2#1)(1993-12#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-3#4)(1995-9#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-8#2)(2005-10#2)(2005-7#2)(2006-2#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
of the health consequences##3##4##(2006-10#1)(2008-7#1)(2009-2#1)
of the health effects of##2##5##(2008-4#1)(2010-9#1)
of the health effects##3##4##(2008-4#1)(2010-9#2)
of the health sector##4##4##(1992-1#1)(2008-7#1)(2011-2#1)(2013-8#1)
of the health services##8##4##(1990-11#1)(1990-8#1)(1992-11#1)(1994-3#1)(1994-4#1)(1997-3#1)(2008-1#1)(2008-12#1)
of the health status of##2##5##(1990-6#1)(1995-12#1)
of the health system in##2##5##(1996-12#1)(2010-8#1)
of the health system##14##4##(1994-12#1)(1996-12#1)(1996-3#1)(1997-3#1)(2007-5#1)(2008-1#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)
of the health##121##3##(1990-11#1)(1990-12#3)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#3)(1994-3#4)(1994-4#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#3)(1996-3#3)(1997-3#2)(1997-4#1)(1997-8#3)(2005-10#2)(2005-7#2)(2006-10#1)(2006-2#2)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-1#6)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#4)(2009-2#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#2)(2010-9#3)(2011-1#4)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#4)
of the healthcare industry##2##4##(2011-2#1)(2013-8#1)
of the healthcare system##4##4##(1995-10#1)(2009-4#1)(2013-8#2)
of the healthcare##16##3##(1992-11#1)(1995-10#1)(2005-7#1)(2006-1#1)(2006-12#1)(2006-8#1)(2007-5#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-8#1)(2011-2#1)(2013-8#3)
of the healthy controls##2##4##(1996-7#1)(2008-9#1)
of the healthy##20##3##(1994-3#1)(1995-12#1)(1996-7#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#1)(2011-1#1)(2011-11#1)(2012-1#1)(2012-3#2)
of the hearing##4##3##(2007-9#1)(2008-9#3)
of the heart and blood vessels##2##6##(1997-8#1)(2011-1#1)
of the heart and lung##2##5##(2007-8#1)(2008-4#1)
of the heart and##13##4##(1991-6#1)(1996-2#1)(1997-8#1)(2006-10#1)(2007-8#5)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)
of the heart are##2##4##(1993-12#1)(2007-12#1)
of the heart during coronary##2##5##(2007-8#2)
of the heart during##3##4##(2007-8#2)(2010-8#1)
of the heart in##5##4##(1993-12#1)(2007-11#1)(2007-8#1)(2008-4#1)(2010-12#1)
of the heart is##7##4##(1990-3#1)(1996-6#1)(2007-7#1)(2008-4#1)(2008-7#1)(2010-5#1)(2011-2#1)
of the heart muscle##9##4##(1995-12#1)(2005-1#4)(2007-9#1)(2008-4#2)(2009-4#1)
of the heart through##2##4##(2008-8#1)(2010-8#1)
of the heart to##2##4##(1994-11#1)(2009-4#1)
of the heart was##2##4##(1993-12#1)(2009-11#1)
of the heart with##2##4##(2008-7#1)(2009-1#1)
of the heart##111##3##(1990-3#1)(1991-11#2)(1991-6#2)(1992-8#2)(1993-12#3)(1993-2#1)(1993-6#1)(1994-11#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-6#2)(1997-1#1)(1997-8#1)(2004-11#1)(2005-1#4)(2005-7#1)(2006-10#2)(2006-6#2)(2006-7#1)(2006-9#2)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#3)(2007-8#15)(2007-9#3)(2008-10#1)(2008-3#1)(2008-4#9)(2008-5#3)(2008-7#4)(2008-8#2)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-4#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#4)(2010-7#1)(2010-8#5)(2011-1#3)(2011-2#4)(2012-1#2)(2012-12#1)(2013-1#1)
of the heart-type##2##3##(1997-6#2)
of the heartbeat##2##3##(1997-4#1)(2008-4#1)
of the heat capacity##2##4##(1993-6#1)(2006-10#1)
of the heat shock protein 70##3##6##(1995-11#1)(1996-2#1)(2008-10#1)
of the heat shock protein family##3##6##(1994-11#1)(2007-11#1)(2008-7#1)
of the heat shock protein##7##5##(1994-11#1)(1995-11#1)(1996-2#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-7#1)
of the heat shock proteins##2##5##(2006-10#1)(2012-3#1)
of the heat shock response##2##5##(1994-11#1)(2008-7#1)
of the heat shock##15##4##(1992-12#1)(1994-11#2)(1994-8#2)(1995-11#1)(1995-2#1)(1996-2#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-7#2)(2012-3#1)
of the heat##25##3##(1992-12#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-8#2)(1995-11#1)(1995-2#1)(1996-2#1)(1996-7#1)(1997-6#1)(2005-11#2)(2006-10#2)(2006-12#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-7#2)(2010-3#1)(2012-3#1)
of the heat-treated##3##3##(2008-10#1)(2010-4#2)
of the heated##2##3##(2007-12#1)(2008-2#1)
of the heating##4##3##(1996-12#1)(2008-10#1)(2008-2#2)
of the heavy chain and##2##5##(1993-6#1)(1995-1#1)
of the heavy chain of##3##5##(1990-5#1)(1994-3#1)(1995-2#1)
of the heavy chain##13##4##(1990-5#1)(1991-5#3)(1993-6#2)(1994-3#1)(1995-1#1)(1995-2#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-9#1)
of the heavy chains##3##4##(1990-6#3)
of the heavy fraction of SR (HSR)##2##7##(1992-3#1)(1994-3#1)
of the heavy metal##3##4##(1997-4#1)(2008-10#2)
of the heavy metals##4##4##(1995-3#1)(2007-8#2)(2008-12#1)
of the heavy##30##3##(1990-5#1)(1990-6#3)(1991-5#3)(1992-3#1)(1992-6#1)(1993-6#2)(1994-3#2)(1994-5#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-4#1)(1997-9#1)(2007-8#2)(2008-10#4)(2008-12#1)(2008-2#1)
of the height of the##2##5##(2007-11#1)(2008-2#1)
of the height##5##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
of the helical##8##3##(1993-11#3)(1995-6#2)(2008-10#1)(2008-4#2)
of the helicase##3##3##(1994-12#1)(1995-3#1)(1997-7#1)
of the helix axis##4##4##(1990-2#1)(1992-4#2)(1995-1#1)
of the helix to##2##4##(1995-6#1)(2006-12#1)
of the helix##21##3##(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1992-4#2)(1992-6#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-5#3)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-7#1)(1997-7#1)(2006-12#1)(2008-10#1)
of the helix&lt##2##3##(1997-7#2)
of the helminth parasites of vertebrates in Costa Rica##2##9##(2007-3#2)
of the helminth parasites of vertebrates in Costa##3##8##(2007-3#3)
of the helminth##4##3##(2007-3#3)(2011-1#1)
of the helper virus##2##4##(2008-10#2)
of the helper##4##3##(1994-12#1)(2008-10#3)
of the hemagglutinin##2##3##(1994-8#1)(2011-1#1)
of the hematoma was##2##4##(2008-7#1)(2012-12#1)
of the hematoma##3##3##(2008-7#2)(2012-12#1)
of the hematopoietic stem cell niche##3##6##(2008-9#1)(2012-3#2)
of the hematopoietic##9##3##(1996-11#1)(2008-7#2)(2008-9#1)(2010-12#1)(2012-12#1)(2012-3#2)(2013-8#1)
of the heme group##3##4##(1990-2#1)(1994-11#1)(1994-5#1)
of the heme in the##2##5##(1993-6#1)(1994-5#1)
of the heme in##4##4##(1991-4#1)(1993-6#2)(1994-5#1)
of the heme iron by the##2##6##(1994-8#1)(1995-10#1)
of the heme iron##3##4##(1991-8#1)(1994-8#1)(1995-10#1)
of the heme##25##3##(1990-2#1)(1990-7#1)(1990-8#1)(1991-4#2)(1991-7#1)(1991-8#1)(1992-12#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#3)(1994-8#2)(1995-10#1)(1995-3#1)(1995-5#1)(1997-4#1)(1997-7#1)(2008-3#1)(2008-5#1)
of the hemes##4##3##(1990-8#1)(1991-3#1)(1992-3#1)(1994-3#1)
of the hemiacetal##2##3##(2009-2#2)
of the hemicelluloses##3##3##(2008-5#3)
of the hemodialysis##3##3##(2007-7#3)
of the hemodynamic##3##3##(1992-3#1)(2008-11#1)(2013-8#1)
of the hemodynamics in a##2##5##(2008-5#1)(2010-3#1)
of the hemoglobin molecule##2##4##(1990-8#1)(2006-8#1)
of the hemoglobin##4##3##(1990-8#2)(2006-8#1)(2010-4#1)
of the hemopoietic stem cell##2##5##(2008-4#1)(2011-1#1)
of the hemopoietic##3##3##(2007-4#1)(2008-4#1)(2011-1#1)
of the hemorrhagic##2##3##(2008-7#1)(2010-6#1)
of the hemostasis##2##3##(2008-10#1)(2011-1#1)
of the hemostatic##2##3##(2005-11#1)(2006-10#1)
of the heparin##2##3##(1995-2#1)(1997-2#1)
of the hepatic arterial wall##2##5##(2006-6#2)
of the hepatic arterial##3##4##(1990-3#1)(2006-6#2)
of the hepatic##24##3##(1990-2#1)(1990-3#1)(1990-5#1)(1993-12#3)(1993-2#1)(1993-9#1)(1994-3#2)(1994-6#1)(1995-12#1)(2006-6#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-9#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)
of the hepatitis B virus surface##2##6##(1997-6#1)(2011-2#1)
of the hepatitis B virus##5##5##(1993-6#1)(1997-6#2)(2009-7#1)(2011-2#1)
of the hepatitis B##7##4##(1993-6#1)(1995-2#1)(1997-6#2)(2008-4#1)(2009-7#1)(2011-2#1)
of the hepatitis C viral genome##2##6##(1994-11#1)(1994-2#1)
of the hepatitis C virus (HCV)##2##6##(1994-8#1)(2006-2#1)
of the hepatitis C virus##5##5##(1994-8#1)(1995-1#1)(2006-2#1)(2008-10#1)(2013-8#1)
of the hepatitis C##7##4##(1994-11#1)(1994-2#1)(1994-8#1)(1995-1#1)(2006-2#1)(2008-10#1)(2013-8#1)
of the hepatitis E virus##2##5##(1997-4#2)
of the hepatitis##18##3##(1993-6#1)(1994-11#2)(1994-2#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-4#1)(1997-4#2)(1997-6#2)(2006-2#1)(2008-10#1)(2008-4#1)(2009-7#1)(2011-2#1)(2013-8#1)
of the hepato-billiary##2##3##(2008-10#1)(2008-9#1)
of the hepatocellular##2##3##(1992-3#1)(2010-2#1)
of the hepatocyte growth##2##4##(1993-8#1)(1996-5#1)
of the hepatocyte##10##3##(1991-10#1)(1993-8#1)(1996-11#1)(1996-5#1)(1997-1#1)(2004-11#1)(2008-11#2)(2008-9#2)
of the hepatocytes##8##3##(1990-7#1)(1991-6#1)(1993-3#1)(1994-11#1)(1995-3#1)(2008-11#1)(2009-2#2)
of the hepatoma cells##2##4##(1993-7#1)(2008-11#1)
of the hepatoma##3##3##(1993-7#1)(2008-11#2)
of the heptamer repeat##2##4##(1992-5#2)
of the herbal granules##2##4##(2010-5#2)
of the herbal##7##3##(2008-2#1)(2008-6#1)(2010-12#1)(2010-5#2)(2011-2#1)(2013-1#1)
of the herbicide desmetryne##2##4##(2008-10#2)
of the herbicide mixture##3##4##(2006-5#3)
of the herbicide##18##3##(1993-3#1)(1997-2#1)(1997-8#1)(2006-5#3)(2008-10#10)(2008-2#1)(2010-1#1)
of the herbicides from##2##4##(2008-10#1)(2008-11#1)
of the herbicides##3##3##(2007-8#1)(2008-10#1)(2008-11#1)
of the herbs##2##3##(2008-10#1)(2013-1#1)
of the herds##3##3##(1992-5#2)(1994-4#1)
of the heritability##2##3##(2008-8#1)(2012-3#1)
of the hernia##2##3##(1993-9#1)(2009-8#1)
of the herpes simplex virus type 1##2##7##(1994-3#1)(1995-3#1)
of the herpes simplex virus##3##5##(1994-3#1)(1995-3#1)(1996-8#1)
of the herpes simplex##4##4##(1994-3#1)(1995-3#2)(1996-8#1)
of the herpes##6##3##(1994-3#1)(1995-3#2)(1996-8#1)(2009-2#1)(2009-7#1)
of the herpesvirus##2##3##(2006-10#1)(2008-5#1)
of the heteroatom in the pi-electron system is beneficial for the description of##2##13##(2007-11#2)
of the heteroatom##4##3##(2007-11#3)(2010-5#1)
of the heterocyclic ring##2##4##(2007-11#1)(2012-2#1)
of the heterocyclic##6##3##(1992-2#1)(2007-11#2)(2008-4#1)(2010-5#1)(2012-2#1)
of the heterodimeric##3##3##(1993-11#1)(1993-8#1)(2011-2#1)
of the heterodyne##3##3##(2007-12#1)(2008-2#2)
of the heterogeneity of the##3##5##(2006-10#1)(2008-12#1)(2011-2#1)
of the heterogeneity of##5##4##(2006-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-12#1)
of the heterogeneity##8##3##(1992-7#1)(1994-5#1)(2006-10#1)(2008-11#1)(2008-12#1)(2011-2#2)(2012-12#1)
of the heterogeneous nature of the##3##6##(2007-11#1)(2008-11#1)(2009-5#1)
of the heterogeneous##7##3##(1995-6#1)(2007-11#1)(2008-11#1)(2008-4#1)(2009-12#1)(2009-5#1)(2011-2#1)
of the heterogenous##2##3##(1992-2#1)(2008-10#1)
of the heterologous protein##2##4##(1993-3#1)(1994-11#1)
of the heterologous##9##3##(1990-10#1)(1993-3#1)(1994-11#1)(1996-7#2)(2008-10#1)(2008-11#1)(2008-5#2)
of the heterosexual transmission##2##4##(1991-2#1)(2006-10#1)
of the heterotrimeric G##2##4##(1996-5#1)(2008-7#1)
of the heterotrophic##2##3##(2008-5#2)
of the heterozygous##2##3##(1996-6#1)(2010-6#1)
of the hexagonal column##3##4##(2008-3#3)
of the hexagonal##7##3##(1990-2#1)(1991-11#1)(1995-6#1)(2004-9#1)(2008-3#3)
of the hexamer motif##2##4##(1997-2#2)
of the hexamer##6##3##(1992-3#1)(1995-11#1)(1995-8#1)(1997-2#3)
of the hexameric##3##3##(1995-11#1)(1995-3#1)(1997-7#1)
of the hexapeptide##4##3##(1991-9#1)(1992-8#1)(2008-5#2)
of the hexon##2##3##(1994-9#2)
of the hexose transporter##2##4##(1996-12#1)(2010-2#1)
of the hexose##3##3##(1993-3#1)(1996-12#1)(2010-2#1)
of the hidden##4##3##(1996-12#1)(2008-2#1)(2008-6#1)(2008-7#1)
of the hierarchical##3##3##(1992-5#1)(2004-3#1)(2008-11#1)
of the hierarchy##4##3##(2008-11#1)(2008-2#1)(2013-1#2)
of the high affinity##6##4##(1990-3#1)(1990-5#1)(1991-11#1)(1991-5#1)(1994-11#1)(2008-11#1)
of the high and low##2##5##(1997-3#1)(2008-10#1)
of the high incidence of##5##5##(1993-3#1)(2006-10#1)(2006-2#1)(2006-6#1)(2009-9#1)
of the high level of##2##5##(2008-7#1)(2009-3#1)
of the high levels of##2##5##(2006-10#1)(2007-1#1)
of the high molecular weight##3##5##(1992-3#1)(2008-10#1)(2008-5#1)
of the high percentage of##2##5##(1991-7#1)(2006-10#1)
of the high prevalence of##6##5##(1991-5#1)(1992-11#1)(2006-10#1)(2007-12#1)(2007-7#1)(2009-3#1)
of the high prevalence##7##4##(1991-5#1)(1992-11#1)(1996-2#1)(2006-10#1)(2007-12#1)(2007-7#1)(2009-3#1)
of the high rate of##2##5##(1993-8#1)(2007-8#1)
of the high risk of##4##5##(2005-10#1)(2007-1#1)(2010-12#1)(2012-1#1)
of the high risk##6##4##(1993-6#1)(2005-10#1)(2007-1#1)(2010-12#1)(2011-1#1)(2012-1#1)
of the high specificity##2##4##(2012-2#1)(2012-3#1)
of the high##102##3##(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-8#2)(1991-1#1)(1991-11#1)(1991-4#1)(1991-5#2)(1991-7#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-3#2)(1997-7#1)(2005-10#1)(2006-10#5)(2006-12#2)(2006-2#2)(2006-6#1)(2007-1#2)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-9#3)(2009-3#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#3)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
of the high-affinity agonist binding state##2##6##(1993-2#2)
of the high-affinity##14##3##(1990-3#1)(1991-10#1)(1991-2#1)(1992-6#1)(1993-2#2)(1994-11#1)(1995-2#1)(1995-7#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(2009-7#1)
of the high-energy##2##3##(1990-11#1)(2008-3#1)
of the high-potential##2##3##(1995-6#1)(1996-4#1)
of the high-resolution monitors##2##4##(2004-9#2)
of the high-resolution##6##3##(2004-9#3)(2008-2#1)(2008-3#2)
of the high-risk##2##3##(2007-8#1)(2011-2#1)
of the high-spin##3##3##(1991-2#1)(2008-10#1)(2009-3#1)
of the higher harmonics##2##4##(1996-11#1)(2008-10#1)
of the higher##19##3##(1992-1#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-8#1)(1995-11#1)(1996-11#1)(1997-8#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
of the highest risk##2##4##(1993-11#1)(2008-10#1)
of the highest##36##3##(1990-9#1)(1993-11#1)(1994-12#1)(1994-2#1)(1996-2#1)(1996-3#1)(1996-8#1)(2005-12#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-5#2)(2008-8#1)(2010-10#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#1)
of the highest-order##2##3##(2007-11#2)
of the highlights of the##2##5##(2005-7#1)(2009-3#1)
of the highlights of##3##4##(2005-7#1)(2007-11#1)(2009-3#1)
of the highlights##4##3##(2005-7#1)(2005-8#1)(2007-11#1)(2009-3#1)
of the highly conserved##5##4##(1990-12#1)(1992-6#1)(1994-11#1)(1994-9#1)(2008-8#1)
of the highly reactive##2##4##(2006-5#1)(2008-11#1)
of the highly selective##2##4##(1993-11#1)(1997-2#1)
of the highly specific##2##4##(1996-9#1)(2007-11#1)
of the highly##35##3##(1990-12#1)(1990-5#1)(1991-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-1#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-7#1)(1996-9#1)(1997-2#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-12#1)(2009-3#1)(2011-1#1)(2012-3#1)(2013-8#1)
of the hind leg##2##4##(2007-12#2)
of the hind legs##2##4##(2004-11#1)(2007-12#1)
of the hind##4##3##(2004-11#1)(2007-12#3)
of the hindbrain##3##3##(1991-3#1)(2006-5#1)(2008-3#1)
of the hindered##2##3##(2005-11#1)(2008-8#1)
of the hindfoot##2##3##(2009-3#1)(2010-4#1)
of the hindgut##3##3##(1997-8#1)(2005-12#1)(2007-12#1)
of the hindlimb##7##3##(1993-11#1)(1994-2#5)(2006-4#1)
of the hindpaw##3##3##(1990-4#1)(1996-1#1)(2009-12#1)
of the hip (DDH)##4##4##(2007-11#1)(2007-8#2)(2013-8#1)
of the hip -##2##4##(2007-11#2)
of the hip and knee##2##5##(1995-5#1)(2008-5#1)
of the hip and the##3##5##(2007-8#1)(2012-2#1)(2013-1#1)
of the hip and##6##4##(1995-5#1)(2007-11#1)(2007-8#1)(2008-5#1)(2012-2#1)(2013-1#1)
of the hip in the##2##5##(2006-11#1)(2007-11#1)
of the hip in##8##4##(2006-11#2)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#2)(2009-3#1)
of the hip is still##2##5##(2007-11#1)(2007-8#1)
of the hip is##7##4##(2006-10#1)(2006-11#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-4#1)(2009-3#1)
of the hip joint after##2##5##(2007-7#2)
of the hip joint and##3##5##(1991-10#1)(1997-6#1)(2007-11#1)
of the hip joint in##4##5##(2007-11#2)(2007-8#2)
of the hip joint is##4##5##(1997-6#1)(2007-7#2)(2010-4#1)
of the hip joint##32##4##(1991-10#1)(1992-12#1)(1997-6#2)(2006-11#1)(2006-6#1)(2007-11#7)(2007-7#6)(2007-8#7)(2008-6#1)(2008-8#1)(2009-5#1)(2010-2#1)(2010-4#1)(2013-7#1)
of the hip joints##2##4##(2007-11#1)(2008-6#1)
of the hip using##2##4##(2007-8#2)
of the hip with##2##4##(2007-11#1)(2013-8#1)
of the hip##123##3##(1991-10#1)(1991-11#1)(1992-12#1)(1992-2#1)(1993-11#6)(1995-5#1)(1997-6#2)(2006-10#2)(2006-11#5)(2006-6#1)(2006-9#1)(2007-11#25)(2007-6#1)(2007-7#19)(2007-8#25)(2008-4#2)(2008-5#1)(2008-6#2)(2008-8#2)(2009-3#3)(2009-5#1)(2009-7#1)(2010-2#4)(2010-4#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#4)(2013-8#3)
of the hippocampal formation and##2##5##(1996-6#1)(2008-3#1)
of the hippocampal formation of##2##5##(1993-4#1)(1996-6#1)
of the hippocampal formation##10##4##(1992-7#2)(1993-4#1)(1993-5#1)(1996-6#3)(1996-7#1)(2005-10#1)(2008-3#1)
of the hippocampal lesioned##2##4##(1990-11#2)
of the hippocampal region##3##4##(1992-11#1)(1994-3#2)
of the hippocampal slice##2##4##(1990-2#1)(1994-2#1)
of the hippocampal##25##3##(1990-11#2)(1990-2#1)(1992-11#1)(1992-7#2)(1992-8#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-2#2)(1994-3#2)(1995-3#1)(1996-6#3)(1996-7#1)(1996-9#1)(2005-10#1)(2008-11#2)(2008-3#1)(2013-8#1)
of the hippocampus CA1##5##4##(1997-7#5)
of the hippocampus after##2##4##(1994-12#1)(1997-3#1)
of the hippocampus and in the##2##6##(1995-5#1)(1997-2#1)
of the hippocampus and the##3##5##(1994-3#1)(1995-12#1)(2010-12#1)
of the hippocampus and##13##4##(1991-5#1)(1992-11#1)(1994-11#1)(1994-3#2)(1994-8#1)(1995-12#1)(1995-5#1)(1997-2#1)(2004-11#1)(2007-10#1)(2008-11#1)(2010-12#1)
of the hippocampus in##8##4##(1993-2#2)(1993-6#1)(1994-2#1)(1994-5#1)(1994-6#1)(1996-12#1)(2009-2#1)
of the hippocampus induced by##2##5##(1993-6#1)(1995-12#1)
of the hippocampus of the reeler##2##6##(1994-10#2)
of the hippocampus to##2##4##(1994-11#1)(2007-10#1)
of the hippocampus##79##3##(1990-11#1)(1990-4#1)(1991-11#1)(1991-5#1)(1992-11#2)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#2)(1993-2#3)(1993-6#5)(1994-10#3)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#3)(1994-6#3)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#3)(1995-8#1)(1996-1#1)(1996-12#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#5)(2004-11#2)(2007-10#3)(2007-8#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#3)(2009-5#1)(2010-12#1)
of the hips treated with Frejka pillow and##2##8##(2007-8#2)
of the hips##11##3##(1990-2#1)(1990-5#1)(2007-11#2)(2007-7#4)(2007-8#2)(2013-8#1)
of the histamine H1##2##4##(1992-11#1)(1992-3#1)
of the histamine H3 receptor ligands thioperamide and (R)-alpha-methylhistamine on##2##10##(1992-5#2)
of the histamine H3 receptor##3##5##(1992-5#2)(1993-11#1)
of the histamine##6##3##(1992-11#1)(1992-3#1)(1992-5#2)(1993-11#1)(1994-5#1)
of the histidine residue##2##4##(1992-7#2)
of the histidine residues##3##4##(1991-4#1)(1991-8#1)(1996-9#1)
of the histidine##7##3##(1990-5#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-7#2)(1996-9#1)
of the histograms##2##3##(2008-10#1)(2008-2#1)
of the histological##8##3##(1991-5#1)(1991-9#1)(1992-8#1)(1995-2#1)(2006-2#1)(2006-6#1)(2009-2#1)(2011-7#1)
of the histology##3##3##(2005-12#1)(2008-3#1)(2009-1#1)
of the histone H3##2##4##(1992-2#1)(1992-8#1)
of the histone##10##3##(1991-5#1)(1992-2#1)(1992-8#1)(1994-9#1)(1995-3#1)(1996-4#1)(1996-8#1)(1997-1#1)(2009-5#1)(2010-3#1)
of the histopathological##2##3##(2010-8#1)(2011-12#1)
of the historical development of##2##5##(2008-6#1)(2013-1#1)
of the historical##10##3##(1995-1#1)(1997-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
of the history and physical##2##5##(2007-7#1)(2010-1#1)
of the history and##3##4##(2007-7#1)(2008-5#1)(2010-1#1)
of the history of medicine##2##5##(1993-11#1)(2007-5#1)
of the history of##20##4##(1990-5#1)(1993-11#1)(1994-12#1)(1995-8#1)(1996-12#1)(1997-1#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-6#1)(2013-8#1)
of the history##27##3##(1990-5#1)(1993-11#1)(1994-12#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-2#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-10#1)(2010-1#1)(2010-12#1)(2010-6#1)(2010-7#1)(2013-8#1)
of the hitherto##6##3##(1990-11#1)(1993-3#1)(1995-8#1)(1997-4#1)(2008-10#1)(2010-5#1)
of the hole##6##3##(1993-4#1)(1995-6#1)(2007-11#1)(2007-12#3)
of the holes##2##3##(2007-11#1)(2007-12#1)
of the hollow##9##3##(1994-2#1)(2005-11#1)(2006-5#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#2)
of the hollow-beam geometry##2##4##(2008-2#2)
of the holo##2##3##(1994-2#1)(1995-10#1)
of the holoenzyme##10##3##(1990-8#2)(1991-2#1)(1992-11#1)(1993-6#1)(1995-10#1)(1997-7#3)(2008-11#1)
of the hologram##13##3##(2007-12#1)(2008-2#7)(2008-3#5)
of the holograms##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
of the holographic aerial image-recording technique##2##6##(2008-3#2)
of the holographic gratings##3##4##(2008-2#2)(2008-3#1)
of the holographic information##2##4##(2008-2#2)
of the holographic##13##3##(2007-11#1)(2007-12#1)(2008-2#5)(2008-3#6)
of the home in##2##4##(2007-12#2)
of the home##12##3##(1992-9#1)(1995-12#1)(1995-3#1)(2005-10#2)(2007-12#4)(2007-8#1)(2007-9#1)(2011-2#1)
of the homeobox-containing##4##3##(1992-3#1)(1994-11#2)(1995-8#1)
of the homeodomain##5##3##(1992-4#1)(1993-5#1)(1995-1#1)(1995-5#1)(1996-8#1)
of the homeopathic##3##3##(2008-10#3)
of the homeostasis##2##3##(1995-12#1)(2011-1#1)
of the homeostatic##3##3##(2008-4#1)(2008-7#2)
of the homes##2##3##(1993-9#1)(1997-3#1)
of the homogenate##2##3##(1991-1#1)(1991-2#1)
of the homogeneity of##2##4##(2006-12#1)(2008-10#1)
of the homogeneous##2##3##(2007-9#1)(2008-1#1)
of the homologous##13##3##(1990-2#1)(1991-9#1)(1992-7#1)(1992-8#1)(1993-9#1)(1994-12#1)(1995-1#1)(1995-5#1)(1996-10#1)(1996-5#1)(2006-11#1)(2008-5#1)(2011-2#1)
of the homologs##5##3##(1994-9#1)(1996-5#1)(2008-10#2)(2011-2#1)
of the homozygous##3##3##(1991-6#1)(1996-12#1)(2008-10#1)
of the honey bee##4##4##(1997-6#2)(2008-6#1)(2013-1#1)
of the honey stomach##3##4##(2006-12#3)
of the honey##8##3##(1997-6#2)(2006-12#3)(2008-10#1)(2008-6#1)(2013-1#1)
of the hood##3##3##(2006-11#3)
of the horizontal##11##3##(1990-5#1)(1992-10#3)(1994-3#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-5#1)(2013-7#1)
of the hormesis##2##3##(2008-7#1)(2013-8#1)
of the hormetic##4##3##(2008-7#4)
of the hormonal##3##3##(2007-8#1)(2009-2#1)(2012-1#1)
of the hormone binding##3##4##(1990-7#2)(1995-2#1)
of the hormone effect##2##4##(1992-6#1)(1995-12#1)
of the hormone in##2##4##(1990-2#1)(2010-5#1)
of the hormone on##2##4##(1994-8#1)(1996-10#1)
of the hormone to##2##4##(1990-3#1)(1994-6#1)
of the hormone##27##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#2)(1991-10#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-6#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-10#1)(2006-10#1)(2008-1#1)(2008-3#2)(2010-2#1)(2010-5#1)(2011-1#1)(2013-8#1)
of the hormones##8##3##(1994-8#1)(1995-11#1)(1995-12#1)(2008-1#3)(2009-8#1)(2012-2#1)
of the horse##3##3##(1997-4#2)(2008-8#1)
of the hospital and##3##4##(1993-2#1)(2006-8#1)(2008-8#1)
of the hospital employees##2##4##(1992-5#1)(2008-8#1)
of the hospital stay##2##4##(2010-8#1)(2012-2#1)
of the hospital were##3##4##(2006-8#1)(2007-12#1)(2008-12#1)
of the hospital##63##3##(1990-12#2)(1990-8#1)(1991-1#2)(1991-3#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-5#2)(1993-2#2)(1993-5#1)(1994-12#2)(1994-2#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(2004-9#1)(2005-7#1)(2006-8#2)(2007-12#5)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-7#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
of the hospital's##6##3##(1995-3#1)(1996-12#1)(1996-2#1)(2007-1#1)(2008-3#1)(2010-4#1)
of the hospitalized##2##3##(1991-4#1)(2012-2#1)
of the hospitals had##2##4##(1990-4#1)(2007-7#1)
of the hospitals in##2##4##(2011-1#1)(2012-3#1)
of the hospitals##15##3##(1990-4#1)(1994-2#1)(1996-1#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-2#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#3)
of the host and##3##4##(2007-12#1)(2008-10#1)(2013-1#1)
of the host by a##2##5##(2008-10#1)(2012-2#1)
of the host by##3##4##(2008-10#2)(2012-2#1)
of the host cell is##2##5##(2008-11#1)(2013-1#1)
of the host cell wall##2##5##(2008-10#2)
of the host cell##6##4##(2008-10#3)(2008-11#2)(2013-1#1)
of the host defense system##2##5##(1992-10#1)(2013-1#1)
of the host defense##3##4##(1992-10#1)(2008-10#1)(2013-1#1)
of the host gene##2##4##(2008-10#1)(2013-1#1)
of the host immune system##3##5##(2005-7#1)(2006-10#1)(2007-11#1)
of the host inflammatory response##2##5##(2011-1#1)(2012-12#1)
of the host material##2##4##(2007-12#1)(2008-2#1)
of the host organism##3##4##(1996-3#1)(2006-2#1)(2008-1#1)
of the host plant by##2##5##(2008-10#2)
of the host plant##7##4##(2007-12#1)(2008-10#4)(2009-8#2)
of the host population##5##4##(1994-2#1)(2008-10#2)(2008-9#1)(2011-2#1)
of the host response to##2##5##(1991-12#1)(1995-2#1)
of the host response##3##4##(1991-12#1)(1995-2#1)(2006-10#1)
of the host species##4##4##(2008-10#2)(2008-8#2)
of the host tissue##2##4##(2008-10#2)
of the host tissues##2##4##(2008-10#2)
of the host was##2##4##(2006-7#1)(2008-10#1)
of the host##124##3##(1990-1#1)(1990-11#1)(1990-9#1)(1991-12#1)(1992-10#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-2#2)(1996-12#1)(1996-3#2)(1996-8#1)(1997-6#2)(2005-7#1)(2006-10#4)(2006-2#2)(2006-4#1)(2006-7#1)(2007-11#1)(2007-12#8)(2007-7#1)(2008-1#1)(2008-10#40)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#9)(2008-9#1)(2009-5#1)(2009-8#6)(2010-1#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#2)
of the host's immune system##2##5##(2006-10#1)(2007-11#1)
of the host's##3##3##(2006-10#1)(2007-11#1)(2012-12#1)
of the hosts##5##3##(2007-3#1)(2008-5#3)(2011-2#1)
of the hot##4##3##(1991-2#1)(2007-3#1)(2009-5#1)(2011-2#1)
of the hottest##2##3##(2005-8#1)(2009-5#1)
of the hour##3##3##(2010-7#1)(2012-1#1)(2012-3#1)
of the house##5##3##(1993-9#1)(1994-3#1)(1995-6#1)(2009-5#1)(2010-5#1)
of the household##4##3##(1994-6#1)(1995-7#1)(2007-2#1)(2009-11#1)
of the households##2##3##(2007-2#1)(2009-9#1)
of the housekeeping##2##3##(1997-4#1)(2007-10#1)
of the houses##3##3##(1993-9#1)(2007-10#1)(2012-2#1)
of the hsp70 and##2##4##(1994-8#1)(1996-5#1)
of the hsp70##11##3##(1991-12#1)(1993-3#1)(1994-11#1)(1994-8#3)(1995-2#1)(1995-6#2)(1995-7#1)(1996-5#1)
of the hsp83##2##3##(1993-5#2)
of the huge##2##3##(2005-10#1)(2006-4#1)
of the human 1##2##4##(1990-12#1)(1993-3#1)
of the human A(3) receptor##2##5##(2008-4#2)
of the human AT2R##2##4##(1994-9#2)
of the human Ah receptor##2##5##(1994-8#2)
of the human BMP-4 gene is##2##6##(1996-2#2)
of the human CD38 gene##2##5##(1997-2#2)
of the human CPT1B gene##2##5##(1997-5#2)
of the human ER gene##2##5##(1993-6#2)
of the human GABAA receptor##3##5##(1994-12#1)(1995-11#2)
of the human IGF-II gene##3##5##(1990-11#2)(1992-8#1)
of the human MC1##2##4##(1997-6#2)
of the human MDR1 gene product##2##6##(1995-10#1)(2008-11#1)
of the human MDR1##5##4##(1993-9#3)(1995-10#1)(2008-11#1)
of the human MUC1##2##4##(1992-5#2)
of the human NGF##2##4##(1990-8#2)
of the human PRLR##2##4##(1995-10#2)
of the human T cell##2##5##(1996-5#1)(2008-4#1)
of the human T##3##4##(1996-5#1)(2008-4#1)(2011-1#1)
of the human TSH receptor in##2##6##(1990-9#1)(1993-3#1)
of the human X##3##4##(1995-11#1)(1997-4#1)(2008-7#1)
of the human abdomen##2##4##(2007-4#2)
of the human alpha##2##4##(1992-11#1)(1995-11#1)
of the human and mouse##7##5##(1990-11#1)(1992-11#2)(1992-4#1)(1992-8#1)(1997-7#1)(2008-4#1)
of the human and simian immunodeficiency viruses##2##7##(1997-6#1)(2007-3#1)
of the human and##14##4##(1990-11#1)(1992-11#3)(1992-4#1)(1992-8#1)(1993-6#1)(1995-11#1)(1997-6#1)(1997-7#1)(2007-3#1)(2008-4#1)(2008-8#1)(2010-5#1)
of the human androgen receptor##2##5##(1995-3#1)(2008-4#1)
of the human annexin VI gene##2##6##(1994-3#2)
of the human annexin##3##4##(1994-3#3)
of the human apoA-II promoter##2##5##(1997-7#2)
of the human apolipoprotein B gene has been##2##8##(1990-8#1)(2007-2#1)
of the human apolipoprotein B gene##3##6##(1990-8#2)(2007-2#1)
of the human arm##2##4##(2012-1#2)
of the human being##2##4##(2011-1#1)(2013-1#1)
of the human beta-like globin##3##5##(2008-8#3)
of the human blood##2##4##(2007-11#1)(2007-7#1)
of the human body and##2##5##(2012-3#2)
of the human body##16##4##(1990-2#1)(1994-3#1)(1997-8#1)(2004-8#1)(2005-11#1)(2007-4#2)(2007-8#2)(2008-1#1)(2008-7#1)(2008-8#1)(2009-3#1)(2012-3#2)(2013-1#1)
of the human bone morphogenetic protein-4##2##6##(1996-2#2)
of the human bone##3##4##(1996-2#2)(2008-11#1)
of the human brain and##2##5##(1992-11#1)(2012-12#1)
of the human brain##10##4##(1991-2#1)(1991-5#1)(1992-11#1)(1992-3#1)(1994-2#1)(2005-9#1)(2006-11#1)(2006-3#1)(2009-12#1)(2012-12#1)
of the human breast##3##4##(1991-8#1)(1993-9#1)(2008-3#1)
of the human c-erbA alpha gene##2##6##(1993-3#2)
of the human c-fos##3##4##(1991-12#2)(1994-6#1)
of the human c-myc gene##4##5##(1992-7#1)(1992-8#3)
of the human c-myc##5##4##(1992-7#1)(1992-8#3)(1997-7#1)
of the human cDNA encoding##2##5##(1996-4#1)(1996-5#1)
of the human cDNA##3##4##(1996-4#1)(1996-5#1)(1997-6#1)
of the human cardiac alpha-myosin heavy chain gene##2##8##(1991-9#2)
of the human cell line AGE1##2##6##(2012-3#2)
of the human cell##4##4##(1990-11#1)(1994-6#1)(2012-3#2)
of the human central nervous system##3##6##(1991-7#1)(2007-11#1)(2011-2#1)
of the human cerebrum##7##4##(2008-9#7)
of the human chromosome##2##4##(1996-8#1)(1997-8#1)
of the human ciliary neurotrophic factor##2##6##(1995-12#1)(1997-1#1)
of the human colon tumor cell lines##2##7##(1992-2#2)
of the human colon##3##4##(1992-2#2)(1992-8#1)
of the human cornea##5##4##(2007-9#3)(2008-2#1)(2013-8#1)
of the human coronary arteries##3##5##(2005-10#3)
of the human cytochrome##2##4##(1994-6#1)(1994-8#1)
of the human dopamine##2##4##(1991-12#1)(1993-3#1)
of the human elastin##2##4##(1994-8#2)
of the human endogenous retrovirus-like sequence##2##6##(1996-12#2)
of the human endogenous##3##4##(1996-12#2)(2007-6#1)
of the human endometrium##2##4##(1994-9#2)
of the human enzyme##4##4##(1990-3#1)(1993-9#1)(1995-11#1)(1995-3#1)
of the human epidermal growth factor receptor##2##7##(2008-7#1)(2011-2#1)
of the human erythrocyte L-isoaspartyl/D-aspartyl##2##5##(1991-2#2)
of the human erythrocyte##8##4##(1990-11#2)(1991-2#2)(1994-5#1)(2006-10#1)(2007-9#1)(2008-11#1)
of the human estrogen receptor gene##2##6##(1992-3#2)
of the human eye##7##4##(2006-11#1)(2007-11#1)(2007-12#2)(2008-3#2)(2011-7#1)
of the human factor##2##4##(1990-5#1)(2008-12#1)
of the human fast skeletal troponin T (TNNT3) gene##2##9##(2008-7#2)
of the human femur##2##4##(1995-6#1)(2007-1#1)
of the human form##2##4##(1997-2#1)(1997-8#1)
of the human gastrointestinal tract##3##5##(2006-10#1)(2008-4#1)(2010-10#1)
of the human gene##6##4##(1990-7#1)(1991-2#1)(1991-6#1)(1991-7#1)(1993-5#1)(1997-7#1)
of the human genome is##2##5##(2008-8#2)
of the human genome project##4##5##(1993-9#1)(2006-10#1)(2006-5#1)(2008-11#1)
of the human genome##21##4##(1993-9#1)(1995-6#1)(1996-4#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-4#3)(2008-7#3)(2008-8#5)
of the human glucocorticoid receptor##3##5##(1990-11#1)(1995-10#1)(1995-2#1)
of the human growth hormone##2##5##(1995-3#1)(1997-1#1)
of the human growth##3##4##(1995-3#1)(1997-1#1)(2008-11#1)
of the human head##3##4##(2006-11#2)(2008-3#1)
of the human heart##2##4##(1993-12#1)(1996-2#1)
of the human immune system##4##5##(1997-3#1)(2008-4#2)(2011-2#1)
of the human immune##5##4##(1997-3#1)(2006-10#1)(2008-4#2)(2011-2#1)
of the human immunodeficiency virus (HIV)##6##6##(1991-5#1)(1991-9#1)(1993-12#1)(1994-3#1)(1996-1#1)(2012-2#1)
of the human immunodeficiency virus type 1 (HIV-1)##2##8##(1992-8#1)(1995-8#1)
of the human immunodeficiency virus type 1##3##7##(1991-10#1)(1992-8#1)(1995-8#1)
of the human immunodeficiency virus##16##5##(1990-11#1)(1991-10#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-1#1)(1997-4#1)(1997-7#1)(2007-7#1)(2012-2#1)
of the human immunodeficiency##17##4##(1990-11#1)(1991-10#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-1#1)(1997-4#2)(1997-7#1)(2007-7#1)(2012-2#1)
of the human immunoglobulin##3##4##(1996-11#1)(2008-4#2)
of the human insulin receptor##2##5##(1991-1#1)(1993-4#1)
of the human insulin##4##4##(1991-1#1)(1993-4#1)(1997-8#1)(2008-11#1)
of the human insulin-like growth factor II (IGF-II) gene##2##9##(1990-11#1)(1991-9#1)
of the human left ventricle##2##5##(2013-1#2)
of the human lung##3##4##(1991-5#1)(1992-12#1)(2008-11#1)
of the human lysosomal##2##4##(1993-8#1)(1994-9#1)
of the human melanocortin##2##4##(1996-10#1)(1997-6#1)
of the human mitochondrial acetoacetyl-CoA##2##5##(1991-12#2)
of the human mitochondrial##3##4##(1991-12#2)(1995-11#1)
of the human muscle glycogen phosphorylase gene##2##7##(1991-11#2)
of the human neurotropic virus##2##5##(1997-1#2)
of the human neutrophil elastase##2##5##(1991-12#2)
of the human neutrophil##4##4##(1991-12#2)(1993-11#1)(2005-9#1)
of the human papillomavirus (HPV)##2##5##(1996-7#1)(1997-4#1)
of the human papillomavirus##4##4##(1996-4#1)(1996-7#1)(1997-4#1)(2013-7#1)
of the human pelvis##2##4##(2007-4#1)(2013-1#1)
of the human placental##3##4##(1990-7#1)(2008-11#1)(2008-4#1)
of the human platelet##3##4##(1992-8#1)(2006-6#2)
of the human population##3##4##(2006-7#1)(2008-5#1)(2012-3#1)
of the human proliferating cell##2##5##(1991-10#1)(1997-4#1)
of the human promyelocytic##6##4##(1991-11#1)(1991-12#1)(1992-1#1)(1992-8#1)(1994-6#1)(1996-2#1)
of the human protein##4##4##(1990-6#1)(1991-2#1)(1997-6#1)(2009-5#1)
of the human psoas major muscle##2##6##(2011-2#2)
of the human respiratory##2##4##(1997-1#1)(2008-1#1)
of the human retina##2##4##(2007-11#2)
of the human retinal nerve fiber layer (RNFL)##2##8##(2007-11#1)(2009-4#1)
of the human retinal nerve fiber layer##3##7##(2007-11#2)(2009-4#1)
of the human retinal##6##4##(1994-11#2)(2007-11#2)(2007-12#1)(2009-4#1)
of the human rho##2##4##(1995-7#2)
of the human serum##2##4##(1993-3#1)(2010-1#1)
of the human shoulder##5##4##(2007-1#1)(2007-4#4)
of the human skin##2##4##(2008-5#1)(2009-11#1)
of the human stromelysin-1 promoter##2##5##(1996-5#2)
of the human stromelysin-1##3##4##(1996-5#3)
of the human subiculum##2##4##(2010-12#2)
of the human thyroid##2##4##(1991-2#1)(1992-1#1)
of the human thyrotropin (TSH) receptor##2##6##(1991-5#1)(1991-9#1)
of the human thyrotropin##3##4##(1991-5#1)(1991-9#1)(1995-12#1)
of the human transferrin receptor##2##5##(1991-6#1)(1992-2#1)
of the human transferrin##4##4##(1991-6#1)(1992-2#1)(1994-9#2)
of the human type I insulin-like growth factor receptor##2##9##(1991-7#2)
of the human type##4##4##(1991-7#2)(1994-11#1)(1997-2#1)
of the human vacuolar H(+)-ATPase##2##5##(1993-11#1)(1995-3#1)
of the human visual system##2##5##(2008-2#2)
of the human visual##4##4##(1997-7#1)(2008-2#2)(2009-10#1)
of the human##709##3##(1990-10#1)(1990-11#11)(1990-12#4)(1990-2#1)(1990-3#4)(1990-4#2)(1990-5#3)(1990-6#2)(1990-7#3)(1990-8#4)(1990-9#1)(1991-1#2)(1991-10#6)(1991-11#5)(1991-12#13)(1991-2#7)(1991-3#3)(1991-4#2)(1991-5#5)(1991-6#4)(1991-7#6)(1991-8#2)(1991-9#9)(1992-1#4)(1992-10#1)(1992-11#9)(1992-12#7)(1992-2#6)(1992-3#4)(1992-4#2)(1992-5#7)(1992-6#1)(1992-7#2)(1992-8#13)(1992-9#3)(1993-11#5)(1993-12#10)(1993-2#4)(1993-3#6)(1993-4#4)(1993-5#4)(1993-6#4)(1993-7#2)(1993-8#1)(1993-9#7)(1994-11#6)(1994-12#15)(1994-2#7)(1994-3#9)(1994-5#10)(1994-6#4)(1994-8#15)(1994-9#14)(1995-1#3)(1995-10#8)(1995-11#8)(1995-12#4)(1995-2#3)(1995-3#10)(1995-5#2)(1995-6#4)(1995-7#3)(1995-8#4)(1995-9#1)(1996-1#1)(1996-10#10)(1996-11#5)(1996-12#5)(1996-2#7)(1996-4#6)(1996-5#10)(1996-6#1)(1996-7#1)(1996-8#5)(1997-1#5)(1997-2#11)(1997-3#1)(1997-4#12)(1997-5#7)(1997-6#8)(1997-7#16)(1997-8#4)(1997-9#1)(2004-11#1)(2004-8#1)(2005-10#3)(2005-11#1)(2005-7#1)(2005-8#2)(2005-9#2)(2006-10#5)(2006-11#9)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#3)(2006-7#1)(2006-9#2)(2007-1#6)(2007-10#2)(2007-11#10)(2007-12#7)(2007-2#2)(2007-3#2)(2007-4#19)(2007-6#2)(2007-7#3)(2007-8#3)(2007-9#4)(2008-1#2)(2008-10#1)(2008-11#12)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#20)(2008-5#7)(2008-7#10)(2008-8#13)(2008-9#8)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#3)(2009-5#2)(2009-8#1)(2010-1#2)(2010-10#2)(2010-12#6)(2010-5#1)(2011-1#6)(2011-2#11)(2011-7#1)(2012-1#8)(2012-12#1)(2012-2#8)(2012-3#6)(2013-1#8)(2013-7#1)(2013-8#2)
of the humeral bone##5##4##(2007-11#3)(2009-2#2)
of the humeral head##5##4##(2008-7#1)(2008-8#2)(2009-3#1)(2010-12#1)
of the humeral##15##3##(2007-11#3)(2007-7#1)(2007-8#1)(2008-7#1)(2008-8#2)(2009-2#3)(2009-3#1)(2010-12#1)(2012-1#1)(2012-3#1)
of the humerii##2##3##(2013-8#2)
of the humerus and##4##4##(1992-1#1)(2012-3#1)(2013-8#2)
of the humerus were##2##4##(2013-8#2)
of the humerus##22##3##(1992-1#1)(1995-6#2)(2006-3#1)(2007-11#1)(2007-2#1)(2007-8#4)(2008-7#2)(2012-3#2)(2013-1#1)(2013-8#7)
of the humoral immune##4##4##(1990-5#1)(1996-9#1)(2007-11#1)(2008-4#1)
of the humoral response##2##4##(1991-12#1)(2008-10#1)
of the humoral##9##3##(1990-5#1)(1991-12#1)(1996-9#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-4#1)(2011-1#2)
of the hump##4##3##(1990-11#1)(2007-7#3)
of the hunchback (hb) gene##2##5##(1991-11#1)(1996-8#1)
of the hyaline##4##3##(1990-2#1)(1996-12#1)(2007-11#1)(2010-4#1)
of the hybrid method##3##4##(2008-3#3)
of the hybrid phage##2##4##(1990-9#2)
of the hybrid##25##3##(1990-9#2)(1991-6#1)(1994-11#1)(1994-8#1)(1995-10#1)(2005-11#1)(2006-10#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#1)(2008-9#2)(2009-2#1)(2010-4#1)(2010-7#2)(2013-1#2)
of the hybridisation##2##3##(1994-6#1)(1996-12#1)
of the hybridization##4##3##(1997-6#1)(2007-8#1)(2008-10#2)
of the hybridoma cells##3##4##(1995-2#1)(2008-11#2)
of the hybridoma##4##3##(1995-2#2)(2008-11#2)
of the hybridomas##2##3##(1992-8#1)(2008-11#1)
of the hybrids##5##3##(2008-10#1)(2008-11#1)(2008-9#1)(2010-4#1)(2010-7#1)
of the hydatid##2##3##(1991-8#1)(2010-12#1)
of the hydrated##3##3##(1996-2#1)(2005-11#1)(2008-10#1)
of the hydration process in 3CaO##2##6##(2008-10#2)
of the hydration process##3##4##(2008-10#3)
of the hydration##8##3##(2006-10#2)(2006-6#1)(2008-10#3)(2008-5#1)(2008-7#1)
of the hydride##2##3##(1994-11#1)(2008-10#1)
of the hydrocarbon chain##5##4##(1990-7#1)(1992-8#1)(2005-11#1)(2008-10#1)(2013-7#1)
of the hydrocarbon chains##2##4##(1992-9#1)(1993-11#1)
of the hydrocarbon##8##3##(1990-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1995-1#1)(2005-11#1)(2008-10#1)(2013-7#1)
of the hydrocarbons##4##3##(1992-3#1)(1992-7#1)(2008-10#2)
of the hydrocephalus##3##3##(2005-10#1)(2006-12#1)(2006-5#1)
of the hydrodynamic##3##3##(2005-11#1)(2008-10#1)(2008-2#1)
of the hydrogel##7##3##(2005-11#1)(2008-5#4)(2010-2#1)(2013-1#1)
of the hydrogels##2##3##(2005-11#1)(2013-7#1)
of the hydrogen 1S-2S transition##2##5##(1990-7#1)(1992-9#1)
of the hydrogen bond##3##4##(1991-7#1)(1992-3#1)(2008-10#1)
of the hydrogen bonding##2##4##(2005-11#1)(2009-2#1)
of the hydrogen coma##2##4##(1991-8#2)
of the hydrogen feed##2##4##(2010-5#2)
of the hydrogen##18##3##(1990-7#1)(1991-7#1)(1991-8#2)(1992-3#1)(1992-6#1)(1992-9#2)(1993-2#1)(1993-8#1)(1996-7#1)(2005-11#1)(2007-8#1)(2008-10#2)(2009-2#1)(2010-5#2)
of the hydrolysates by##2##4##(2008-6#1)(2008-7#1)
of the hydrolysates##5##3##(1990-7#1)(2005-11#1)(2008-6#1)(2008-7#2)
of the hydrolysis of wheat starch##2##6##(2008-7#2)
of the hydrolysis of##11##4##(1990-5#1)(1992-8#1)(1993-8#2)(1994-8#1)(1994-9#1)(1996-5#1)(2005-11#2)(2008-7#2)
of the hydrolysis products##3##4##(1994-11#1)(1997-2#1)(2010-3#1)
of the hydrolysis##18##3##(1990-5#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-8#1)(1994-9#1)(1996-5#1)(1997-2#1)(2005-11#2)(2008-10#2)(2008-7#2)(2010-3#1)
of the hydrolytic##5##3##(1991-3#1)(1995-1#1)(1995-2#1)(1996-6#1)(2008-10#1)
of the hydropathy##3##3##(1990-5#2)(1990-8#1)
of the hydroperoxo##2##3##(1996-2#2)
of the hydrophilic##8##3##(1990-11#1)(1990-2#1)(1995-11#1)(2005-11#3)(2006-10#1)(2008-10#1)
of the hydrophobic and##2##4##(2004-8#1)(2007-11#1)
of the hydrophobic binding##2##4##(1995-5#1)(2008-5#1)
of the hydrophobic core of the##2##6##(1994-12#1)(1995-1#1)
of the hydrophobic core##5##4##(1991-6#1)(1994-12#1)(1995-1#2)(1996-11#1)
of the hydrophobic effect##2##4##(1991-4#1)(2007-12#1)
of the hydrophobic fluorocarbon##2##4##(2005-11#2)
of the hydrophobic interactions##2##4##(1992-6#1)(2006-10#1)
of the hydrophobic tails##2##4##(2005-11#1)(2008-10#1)
of the hydrophobic##34##3##(1991-4#1)(1991-6#1)(1992-6#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-3#1)(1995-5#1)(1996-11#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-8#1)(2005-11#5)(2006-10#4)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-2#1)(2010-4#1)
of the hydrophobicity of the##2##5##(1990-3#1)(1995-6#1)
of the hydrophobicity of##3##4##(1990-3#1)(1995-2#1)(1995-6#1)
of the hydroxamate group##2##4##(1995-10#1)(2012-2#1)
of the hydroxide residue with##3##5##(2008-10#3)
of the hydroxide##5##3##(1990-5#1)(1990-8#1)(2008-10#3)
of the hydroxo##2##3##(2005-11#1)(2010-5#1)
of the hydroxy##2##3##(2007-11#1)(2008-5#1)
of the hydroxyl group in##2##5##(1991-2#1)(1991-3#1)
of the hydroxyl group##4##4##(1991-2#2)(1991-3#1)(1993-11#1)
of the hydroxyl groups##2##4##(2007-11#1)(2007-9#1)
of the hydroxyl radical##4##4##(1991-9#1)(1992-3#1)(1997-8#1)(2008-10#1)
of the hydroxyl##13##3##(1991-2#2)(1991-3#1)(1991-9#1)(1992-3#1)(1993-11#1)(1997-8#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-5#1)(2008-8#1)
of the hyperfine##2##3##(1994-8#1)(2007-11#1)
of the hyperparasite##3##3##(2008-10#1)(2008-9#2)
of the hypersensitive response (HR)##3##5##(2008-10#3)
of the hypersensitive response##4##4##(2008-10#4)
of the hyperstriatum##2##3##(1992-9#2)
of the hypertension##3##3##(1992-4#1)(2008-10#1)(2008-4#1)
of the hypertensive##9##3##(1990-12#1)(1991-10#1)(1992-4#1)(1992-8#1)(1996-9#1)(2007-1#1)(2010-12#1)(2013-8#2)
of the hypervariable##2##3##(1990-7#1)(1995-2#1)
of the hyphae##2##3##(2008-10#1)(2008-7#1)
of the hyphal##2##3##(2008-7#1)(2009-8#1)
of the hypodermis##2##3##(2008-10#1)(2008-5#1)
of the hypoglossal nerve##3##4##(1993-12#1)(1997-3#2)
of the hypophysis##5##3##(1992-12#1)(2009-2#3)(2009-8#1)
of the hypothalamic paraventricular nucleus (PVN)##2##6##(1994-12#1)(1994-8#1)
of the hypothalamic paraventricular nucleus##7##5##(1991-3#1)(1993-12#1)(1993-2#2)(1994-12#1)(1994-8#2)
of the hypothalamic paraventricular##8##4##(1991-3#1)(1993-12#2)(1993-2#2)(1994-12#1)(1994-8#2)
of the hypothalamic##14##3##(1991-3#1)(1991-8#1)(1991-9#1)(1993-12#2)(1993-2#2)(1994-10#1)(1994-12#1)(1994-8#2)(1995-12#1)(2007-6#1)(2011-2#1)
of the hypothalamic-pituitary##2##3##(1993-3#1)(2010-2#1)
of the hypothalamic-pituitary-adrenal (HPA) axis##6##5##(2007-11#2)(2008-4#1)(2011-2#1)(2013-1#2)
of the hypothalamic-pituitary-adrenal (HPA)##7##4##(1996-4#1)(2007-11#2)(2008-4#1)(2011-2#1)(2013-1#2)
of the hypothalamic-pituitary-adrenal axis and##2##5##(2008-4#1)(2013-8#1)
of the hypothalamic-pituitary-adrenal axis in##2##5##(1994-11#1)(2008-5#1)
of the hypothalamic-pituitary-adrenal axis##12##4##(1994-11#2)(1995-12#3)(1997-2#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-8#1)(2012-12#1)(2013-8#1)
of the hypothalamic-pituitary-adrenal##19##3##(1994-11#2)(1995-12#3)(1996-4#1)(1997-2#1)(2007-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
of the hypothalamic-pituitary-gonadal axis##2##4##(2006-1#1)(2009-6#1)
of the hypothalamic-pituitary-thyroid axis on##2##5##(2008-1#2)
of the hypothalamo-pituitary-adrenal axis##2##4##(1994-2#1)(1995-12#1)
of the hypothalamo-pituitary-adrenal##3##3##(1994-2#2)(1995-12#1)
of the hypothalamus and##3##4##(1990-4#1)(1996-12#1)(2010-12#1)
of the hypothalamus##34##3##(1990-4#1)(1991-4#1)(1991-8#1)(1992-8#1)(1993-12#3)(1993-5#1)(1993-7#1)(1994-2#6)(1994-5#1)(1995-1#1)(1995-12#5)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1997-5#1)(1997-8#2)(2006-1#1)(2008-7#1)(2010-12#1)(2010-9#1)
of the hypothalamus-pituitary-adrenal axis##2##4##(2007-7#1)(2011-2#1)
of the hypotheses##4##3##(2004-7#1)(2007-5#1)(2008-9#2)
of the hypothesis that##10##4##(1991-11#1)(1993-4#1)(1993-7#1)(1995-11#1)(1995-2#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-2#1)
of the hypothesis##20##3##(1991-11#1)(1993-4#1)(1993-7#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-5#1)(1997-8#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-4#1)(2011-12#1)(2013-1#1)
of the hypothetical##4##3##(2006-11#1)(2007-3#1)(2008-8#1)(2012-1#1)
of the hypovirulent isolate##2##4##(2008-10#2)
of the hypovirulent##3##3##(2008-10#3)
of the hypoxia-induced##2##3##(2011-2#1)(2013-1#1)
of the i##4##3##(1992-1#1)(1992-8#1)(1996-2#1)(1996-6#1)
of the iNOS gene##2##4##(1996-2#1)(1997-7#1)
of the ice crystals##2##4##(2008-2#1)(2008-3#1)
of the ice##8##3##(2007-7#1)(2007-9#2)(2008-10#1)(2008-2#2)(2008-3#2)
of the icosahedral##3##3##(1991-6#1)(1994-9#1)(2008-4#1)
of the idea##3##3##(2007-4#1)(2008-2#1)(2010-12#1)
of the ideal##5##3##(1990-4#1)(2008-1#1)(2008-11#1)(2008-2#1)(2011-2#1)
of the ideas of##2##4##(2012-1#1)(2012-2#1)
of the ideas##4##3##(2008-11#1)(2012-1#1)(2012-2#2)
of the identical##2##3##(2006-12#2)
of the identification of##3##4##(2008-10#1)(2010-11#1)(2010-9#1)
of the identified allelochemicals##2##4##(2004-2#2)
of the identified neurons##2##4##(1997-5#2)
of the identified variants##2##4##(2012-3#2)
of the identified##24##3##(1991-8#1)(1993-6#1)(1994-3#1)(1995-11#1)(1996-6#1)(1997-5#2)(2004-2#2)(2006-10#1)(2008-10#3)(2008-7#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)
of the identity of the##3##5##(1992-7#1)(1995-7#1)(1997-3#1)
of the identity of##6##4##(1990-12#1)(1992-7#1)(1995-7#1)(1997-3#1)(2008-10#1)(2011-2#1)
of the identity##7##3##(1990-12#1)(1992-7#1)(1995-7#1)(1997-3#1)(2004-12#1)(2008-10#1)(2011-2#1)
of the idiopathic##3##3##(2005-8#1)(2007-8#2)
of the idler light was##2##5##(2007-12#2)
of the idler##7##3##(2007-11#1)(2007-12#5)(2008-3#1)
of the ileal##2##3##(1991-5#1)(1993-11#1)
of the ileocecal valve##2##4##(1994-5#1)(2010-12#1)
of the ileostomy##2##3##(2009-5#2)
of the ileum with##2##4##(1993-3#1)(1996-3#1)
of the ileum##12##3##(1993-1#1)(1993-3#1)(1996-11#1)(1996-3#1)(2006-12#1)(2007-4#2)(2008-4#1)(2009-5#1)(2011-2#1)(2013-1#1)(2013-7#1)
of the iliac arteries##3##4##(2005-10#3)
of the iliac##5##3##(1991-11#1)(2005-10#3)(2008-12#1)
of the iliopsoas muscle##2##4##(1990-6#1)(2007-8#1)
of the iliotibial band##5##4##(2007-7#5)
of the ill##2##3##(1990-10#1)(2011-7#1)
of the illness and##5##4##(1992-11#1)(1992-12#1)(2008-4#1)(2008-7#1)(2011-1#1)
of the illness may##2##4##(2007-11#1)(2008-11#1)
of the illness##32##3##(1990-9#1)(1991-12#1)(1992-11#1)(1992-12#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(2006-10#1)(2006-6#2)(2006-9#1)(2007-11#2)(2008-11#2)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)
of the illuminated##4##3##(2007-8#1)(2008-3#3)
of the illuminating beam##4##4##(2008-2#3)(2008-3#1)
of the illuminating##8##3##(2008-1#1)(2008-2#4)(2008-3#3)
of the illumination source##3##4##(2007-11#2)(2008-3#1)
of the illumination##11##3##(2007-11#2)(2008-2#2)(2008-3#7)
of the image and##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
of the image data from##2##5##(2008-2#1)(2008-3#1)
of the image data##4##4##(1997-8#1)(2008-2#1)(2008-3#1)(2009-3#1)
of the image is##2##4##(1995-11#1)(2008-1#1)
of the image of the##2##5##(2008-2#1)(2010-8#1)
of the image of##3##4##(2008-2#2)(2010-8#1)
of the image plane##2##4##(2008-3#1)(2011-1#1)
of the image with##2##4##(2008-2#1)(2008-3#1)
of the image##56##3##(1992-9#1)(1995-11#1)(1995-6#1)(1997-8#1)(2006-5#1)(2007-11#3)(2007-12#4)(2008-1#2)(2008-10#2)(2008-2#23)(2008-3#10)(2008-4#1)(2009-3#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2013-8#1)
of the imager##2##3##(2008-3#1)(2010-12#1)
of the images formed by##2##5##(2008-2#1)(2008-3#1)
of the images##14##3##(1995-11#1)(2007-11#1)(2008-2#6)(2008-3#3)(2009-7#1)(2012-2#1)(2013-8#1)
of the imaginary##3##3##(2007-12#1)(2008-3#2)
of the imaging system##4##4##(2007-12#2)(2008-2#1)(2008-3#1)
of the imaging##14##3##(1991-12#1)(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#6)(2008-7#1)
of the imidazobenzodiazepine##2##3##(1990-10#1)(1995-7#1)
of the imidazole##3##3##(2008-10#2)(2010-2#1)
of the imine##3##3##(1991-3#1)(2006-12#1)(2010-2#1)
of the imino##2##3##(1991-8#1)(2008-3#1)
of the immature brain to##2##5##(1996-3#1)(1996-5#1)
of the immature stages of C##2##6##(2007-6#2)
of the immature stages of the##2##6##(2007-10#1)(2012-12#1)
of the immature stages of##5##5##(2007-10#1)(2007-6#2)(2008-5#1)(2012-12#1)
of the immature##12##3##(1994-3#1)(1996-3#2)(1996-5#1)(2007-10#1)(2007-6#2)(2007-7#1)(2008-5#1)(2008-7#1)(2009-2#1)(2012-12#1)
of the immediate early gene c-fos##3##6##(1993-12#1)(1996-7#2)
of the immediate early gene##6##5##(1991-3#1)(1993-12#1)(1993-2#1)(1996-10#1)(1996-7#2)
of the immediate early##8##4##(1991-3#1)(1993-12#1)(1993-2#1)(1993-8#1)(1995-12#1)(1996-10#1)(1996-7#2)
of the immediate postoperative##2##4##(1990-3#1)(2007-12#1)
of the immediate##19##3##(1990-3#1)(1991-3#1)(1991-9#1)(1993-12#1)(1993-2#1)(1993-8#1)(1995-12#1)(1995-7#1)(1996-10#1)(1996-7#2)(2005-10#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-4#1)
of the immediate-early##2##3##(1997-3#1)(1997-5#1)
of the immense##2##3##(2005-8#1)(2006-10#1)
of the immersion##3##3##(2007-12#2)(2008-11#1)
of the immigrants##3##3##(1992-5#1)(1993-9#1)(1995-5#1)
of the immobilization and##2##4##(2007-11#1)(2008-10#1)
of the immobilization substrate##2##4##(2007-9#2)
of the immobilization##6##3##(2007-11#1)(2007-8#1)(2007-9#2)(2008-10#2)
of the immobilized enzymes##2##4##(2008-10#2)
of the immobilized##28##3##(1990-12#1)(1991-11#1)(1993-11#2)(1996-8#1)(2004-8#1)(2005-8#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#14)(2008-12#1)(2008-7#3)
of the immortalized##3##3##(1995-5#2)(2008-11#1)
of the immune response and##2##5##(2008-10#1)(2008-5#1)
of the immune response by##2##5##(2007-11#1)(2010-12#1)
of the immune response in vivo##2##6##(1995-2#1)(2007-11#1)
of the immune response in##6##5##(1991-12#1)(1995-2#1)(2007-11#1)(2008-11#1)(2010-12#1)(2012-1#1)
of the immune response to##2##5##(2008-11#1)(2008-8#1)
of the immune response##32##4##(1991-12#3)(1991-9#1)(1993-12#1)(1994-3#1)(1995-2#1)(1995-5#1)(2007-1#1)(2007-11#6)(2007-9#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#2)(2008-8#1)(2009-5#1)(2009-9#1)(2010-12#3)(2012-1#1)(2013-1#2)
of the immune system and the##2##6##(1995-12#1)(2010-4#1)
of the immune system and##8##5##(1990-9#1)(1991-6#1)(1995-12#1)(1996-11#1)(2008-10#1)(2008-4#1)(2010-4#1)(2012-3#1)
of the immune system are##2##5##(2008-10#1)(2010-10#1)
of the immune system for##2##5##(1993-3#1)(2008-10#1)
of the immune system in the##2##6##(2008-10#1)(2012-1#1)
of the immune system in##8##5##(2008-10#1)(2010-12#1)(2011-2#1)(2012-1#3)(2012-3#1)(2013-1#1)
of the immune system is##2##5##(2007-9#1)(2008-4#1)
of the immune system to##2##5##(2009-12#1)(2013-7#1)
of the immune system##89##4##(1990-9#1)(1991-1#1)(1991-10#1)(1991-6#1)(1992-2#1)(1993-11#1)(1993-3#1)(1995-12#2)(1995-3#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-4#1)(2004-12#1)(2005-11#1)(2006-10#8)(2006-6#1)(2006-7#2)(2007-11#5)(2007-2#2)(2007-3#2)(2007-5#1)(2007-6#1)(2007-9#2)(2008-1#1)(2008-10#9)(2008-4#10)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-10#1)(2010-12#3)(2010-4#1)(2010-5#1)(2011-2#2)(2012-1#6)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#1)
of the immune##136##3##(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-5#2)(1997-4#1)(2004-12#1)(2005-10#1)(2005-11#1)(2006-10#10)(2006-6#2)(2006-7#2)(2007-1#1)(2007-11#12)(2007-2#3)(2007-3#2)(2007-5#1)(2007-6#1)(2007-9#3)(2008-1#1)(2008-10#10)(2008-11#3)(2008-4#12)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#6)(2010-4#2)(2010-5#1)(2011-2#2)(2012-1#7)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#1)
of the immunization##5##3##(1995-5#1)(2008-4#2)(2008-9#1)(2013-1#1)
of the immunoaffinity column##2##4##(1992-2#1)(2008-11#1)
of the immunoaffinity-purified##2##3##(1990-7#1)(1997-4#1)
of the immunoassay##3##3##(2008-10#3)
of the immunochemical reaction##2##4##(1994-3#1)(2008-10#1)
of the immunogenicity of##4##4##(1995-5#1)(2006-12#1)(2008-10#1)(2008-8#1)
of the immunoglobulin heavy chain##2##5##(1990-5#1)(2008-11#1)
of the immunoglobulin superfamily##5##4##(1995-3#1)(1997-7#1)(2008-7#1)(2009-6#1)(2009-8#1)
of the immunoglobulin##15##3##(1990-5#2)(1991-9#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-7#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)
of the immunological agglutination##3##4##(1990-12#3)
of the immunological reaction##2##4##(2004-9#1)(2008-10#1)
of the immunological synapse##2##4##(2008-4#2)
of the immunological##13##3##(1990-12#3)(1997-7#1)(2004-9#1)(2005-7#1)(2006-4#1)(2008-10#2)(2008-4#2)(2008-9#1)(2012-1#1)
of the immunology of##3##4##(1992-12#1)(2006-10#1)(2007-7#1)
of the immunology##4##3##(1992-12#1)(2006-10#1)(2007-7#1)(2008-1#1)
of the immunomodulating##2##3##(1991-11#1)(2006-10#1)
of the immunophenotype##3##3##(1991-2#1)(2006-6#2)
of the immunoprecipitated##5##3##(1992-9#1)(1994-3#1)(2008-1#1)(2008-2#2)
of the immunoprecipitates##2##3##(1992-4#1)(1992-9#1)
of the immunoreaction was##2##4##(1990-7#1)(1994-2#1)
of the immunoreaction##4##3##(1990-7#1)(1991-4#1)(1994-2#1)(2008-10#1)
of the immunoreactive##4##3##(1990-7#1)(1994-9#1)(1995-5#1)(1997-5#1)
of the immunoreactivity of##2##4##(1990-12#1)(2013-8#1)
of the immunosensing device##2##4##(2008-10#2)
of the immunosensor##7##3##(2007-8#1)(2008-10#5)(2008-7#1)
of the immunostained##2##3##(1993-12#1)(1995-11#1)
of the immunosuppressant 15-deoxyspergualin##2##4##(1993-11#1)(1993-8#1)
of the immunosuppressive##8##3##(1990-8#1)(1993-11#1)(1995-1#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-8#1)(2011-2#1)
of the immunotoxin##2##3##(1993-7#1)(2010-12#1)
of the impact and##3##4##(2006-10#1)(2011-2#1)(2012-3#1)
of the impact flux##2##4##(1997-5#2)
of the impact of a##3##5##(1995-6#1)(2007-3#1)(2009-3#1)
of the impact of disease##2##5##(2007-7#1)(2012-2#1)
of the impact of management##3##5##(2006-4#1)(2012-11#2)
of the impact of the##6##5##(1991-2#1)(1995-6#1)(1996-1#1)(2008-10#1)(2008-12#1)(2009-2#1)
of the impact of these##2##5##(2007-11#1)(2007-5#1)
of the impact of##52##4##(1991-2#1)(1993-6#1)(1994-2#1)(1995-12#1)(1995-6#2)(1996-1#1)(1996-7#1)(1997-5#1)(2005-11#1)(2006-10#1)(2006-4#2)(2006-5#1)(2006-7#1)(2007-10#2)(2007-11#2)(2007-3#2)(2007-5#1)(2007-7#3)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-7#2)(2013-8#1)
of the impact that##2##4##(2008-10#1)(2008-3#1)
of the impact##66##3##(1991-2#1)(1992-3#1)(1993-6#1)(1994-2#1)(1995-12#1)(1995-6#2)(1996-1#1)(1996-7#1)(1997-5#3)(2005-11#1)(2006-10#2)(2006-11#2)(2006-4#2)(2006-5#1)(2006-7#1)(2007-10#2)(2007-11#2)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-11#2)(2012-12#3)(2012-2#2)(2012-3#3)(2013-7#2)(2013-8#1)
of the impacted##2##3##(2007-12#1)(2013-1#1)
of the impacts of##3##4##(1992-3#1)(1993-1#1)(2008-1#1)
of the impaired arm##2##4##(2012-1#2)
of the impairment##3##3##(1995-1#1)(1995-12#1)(2009-10#1)
of the impedance##4##3##(2008-10#2)(2008-3#1)(2010-12#1)
of the impending##2##3##(1992-3#1)(2012-3#1)
of the implant and the##2##5##(2007-7#1)(2007-8#1)
of the implant and##3##4##(2007-7#1)(2007-8#1)(2011-12#1)
of the implant is##2##4##(1996-2#1)(2012-12#1)
of the implant##26##3##(1990-3#1)(1996-2#1)(2004-1#1)(2004-9#2)(2005-11#1)(2007-11#2)(2007-7#2)(2007-8#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#2)(2009-3#1)(2011-12#1)(2011-2#1)(2012-12#2)
of the implanted##10##3##(1995-11#1)(1997-4#2)(2004-9#1)(2007-7#1)(2007-8#1)(2008-9#2)(2010-10#1)(2012-2#1)
of the implants##5##3##(2008-6#1)(2008-7#1)(2012-2#1)(2013-1#2)
of the implementation and##3##4##(2007-12#1)(2008-2#1)(2011-2#1)
of the implementation of a##3##5##(2008-9#1)(2012-2#1)(2013-1#1)
of the implementation of an##3##5##(2008-2#1)(2008-7#1)(2011-2#1)
of the implementation of the##4##5##(1991-1#1)(2008-2#1)(2011-2#1)(2013-1#1)
of the implementation of##20##4##(1991-1#1)(1993-3#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#4)
of the implementation##27##3##(1991-1#1)(1993-3#1)(1994-3#1)(1997-2#1)(2006-10#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#4)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#3)(2012-2#1)(2013-1#6)
of the implemented##4##3##(2007-9#1)(2011-3#1)(2012-12#2)
of the implications of the##3##5##(2006-8#1)(2010-8#1)(2013-1#1)
of the implications of these##2##5##(1996-2#1)(2007-4#1)
of the implications of##7##4##(1994-2#1)(1996-2#1)(2006-8#1)(2007-4#1)(2008-7#1)(2010-8#1)(2013-1#1)
of the implications##10##3##(1991-11#1)(1994-2#1)(1996-2#1)(2006-8#1)(2007-4#1)(2008-11#1)(2008-7#1)(2010-8#1)(2012-11#1)(2013-1#1)
of the implicit##2##3##(2006-8#1)(2008-7#1)
of the import##6##3##(1990-5#1)(1990-9#1)(1991-7#1)(1995-6#1)(2006-12#2)
of the importance of early##2##5##(2007-12#1)(2008-11#1)
of the importance of the##6##5##(2006-10#1)(2007-12#2)(2007-3#1)(2007-8#1)(2010-12#1)
of the importance of this##3##5##(1990-5#1)(2008-10#2)
of the importance of##47##4##(1990-2#1)(1990-5#1)(1991-12#1)(1992-11#1)(1995-1#1)(1996-8#1)(1997-3#1)(2006-10#4)(2007-10#1)(2007-12#5)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#1)(2009-11#1)(2009-7#2)(2010-10#1)(2010-12#2)(2010-5#1)(2010-6#1)(2011-2#2)(2012-1#2)(2012-3#1)(2013-8#1)
of the importance##49##3##(1990-2#1)(1990-5#1)(1991-12#1)(1992-11#1)(1995-1#1)(1996-8#1)(1997-3#1)(2006-10#4)(2007-10#1)(2007-12#5)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#4)(2008-3#1)(2008-5#2)(2009-11#1)(2009-7#2)(2010-10#1)(2010-12#2)(2010-5#1)(2010-6#1)(2011-2#2)(2012-1#2)(2012-3#1)(2013-8#1)
of the important changes##2##4##(1996-3#1)(2007-7#1)
of the important events in##2##5##(1991-11#1)(1994-8#1)
of the important factors##5##4##(2007-12#1)(2007-9#1)(2008-8#1)(2008-9#1)(2009-2#1)
of the important means##2##4##(1995-5#1)(2005-3#1)
of the important role of##3##5##(2006-10#1)(2008-1#1)(2009-4#1)
of the important##65##3##(1990-12#1)(1991-11#1)(1992-12#1)(1992-3#2)(1993-3#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-5#2)(1996-3#1)(1997-1#1)(1997-7#1)(2005-10#1)(2005-3#1)(2006-10#4)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#2)(2009-4#2)(2009-7#1)(2009-8#1)(2010-3#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#3)
of the imported##2##3##(2008-10#2)
of the imprinted polymer##3##4##(2008-10#3)
of the imprinted##6##3##(1992-8#1)(2008-10#5)
of the improved##8##3##(1993-8#1)(2008-2#3)(2008-3#2)(2010-12#1)(2010-3#1)
of the improvement in the##2##5##(2009-6#1)(2013-1#1)
of the improvement##5##3##(1996-2#1)(2008-10#1)(2008-3#1)(2009-6#1)(2013-1#1)
of the impulse##3##3##(1990-8#1)(1991-5#1)(2008-3#1)
of the impulses##2##3##(1996-12#2)
of the impurities##4##3##(2008-10#2)(2010-2#2)
of the impurity##3##3##(2007-11#1)(2008-10#2)
of the in situ##4##4##(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)
of the in vitro activity##3##5##(1990-10#1)(2006-8#1)(2008-3#1)
of the in vitro synthesized pma+##2##6##(1990-11#2)
of the in vitro synthesized##4##5##(1990-11#2)(1996-5#1)(2009-6#1)
of the in vitro##31##4##(1990-10#1)(1990-11#2)(1991-3#1)(1991-7#1)(1993-3#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-7#3)(1996-5#1)(1997-3#1)(1997-4#2)(2004-12#1)(2006-8#1)(2007-11#1)(2007-6#1)(2008-11#2)(2008-3#1)(2008-5#4)(2008-7#1)(2009-6#1)(2009-9#1)(2010-5#1)
of the in vivo##15##4##(1992-8#1)(1994-3#1)(1995-12#1)(1995-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(2004-12#1)(2005-6#1)(2008-1#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-5#1)
of the in##52##3##(1990-10#1)(1990-11#2)(1991-3#1)(1991-7#1)(1992-8#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-7#3)(1996-5#1)(1997-2#1)(1997-3#2)(1997-4#3)(2004-12#2)(2005-6#1)(2006-8#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#8)(2008-7#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-5#1)
of the in-phase and the##2##5##(2006-12#1)(2008-3#1)
of the in-plane##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
of the inability of##2##4##(2009-4#1)(2011-2#1)
of the inactivated enzyme##3##4##(1991-5#1)(1992-7#1)(2008-8#1)
of the inactivation of##4##4##(1990-7#1)(1993-11#1)(1995-5#1)(1996-5#1)
of the inactivation##8##3##(1990-7#1)(1990-8#1)(1991-5#1)(1993-11#1)(1995-5#1)(1996-5#1)(2008-5#1)(2008-7#1)
of the inactive isomer##2##4##(1993-12#1)(1993-6#1)
of the inactive##9##3##(1990-3#1)(1992-12#1)(1992-4#1)(1993-12#1)(1993-6#1)(1994-12#1)(1995-12#1)(1996-5#1)(2013-1#1)
of the inadequate##3##3##(1992-12#1)(2006-12#1)(2008-10#1)
of the inbred lines##2##4##(2008-10#1)(2008-5#1)
of the inbred##3##3##(1995-8#1)(2008-10#1)(2008-5#1)
of the incarcerated##2##3##(2011-2#1)(2012-1#1)
of the incidence of##20##4##(1990-3#1)(1995-8#1)(1996-2#1)(1996-4#1)(1997-5#1)(2006-10#2)(2008-10#6)(2008-6#1)(2008-7#1)(2009-6#1)(2009-8#1)(2011-2#2)(2012-2#1)
of the incidence##31##3##(1990-3#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-5#1)(2006-10#2)(2007-12#1)(2008-10#7)(2008-2#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#5)(2012-2#1)
of the incident aberration##2##4##(2008-2#2)
of the incident beam##12##4##(2007-11#2)(2007-12#5)(2008-1#1)(2008-2#1)(2008-3#3)
of the incident beams##2##4##(2008-3#2)
of the incident field##5##4##(2007-11#1)(2007-12#3)(2008-2#1)
of the incident laser beam##4##5##(2007-12#1)(2008-3#3)
of the incident light##14##4##(2007-11#1)(2007-12#2)(2008-1#3)(2008-2#4)(2008-3#4)
of the incident radiation##2##4##(2008-2#1)(2008-3#1)
of the incident wave##2##4##(2008-2#1)(2008-3#1)
of the incident##58##3##(1996-12#1)(2007-11#5)(2007-12#15)(2008-1#4)(2008-11#1)(2008-2#12)(2008-3#19)(2012-12#1)
of the incinerated##2##3##(1995-6#2)
of the incision##2##3##(2009-8#1)(2013-1#1)
of the incisor##2##3##(1991-4#1)(1996-3#1)
of the included studies##3##4##(2012-2#2)(2013-8#1)
of the included##5##3##(2006-12#1)(2008-10#1)(2012-2#2)(2013-8#1)
of the inclusion complex##5##4##(2008-10#5)
of the inclusion complexes##2##4##(2008-10#2)
of the inclusion of##6##4##(1995-1#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-4#1)(2011-1#1)
of the inclusion##20##3##(1995-1#1)(2007-11#1)(2008-10#14)(2008-3#2)(2010-4#1)(2011-1#1)
of the inclusions##4##3##(1996-5#1)(2008-10#2)(2008-2#1)
of the incoherent beam##4##4##(2007-12#1)(2008-1#2)(2008-2#1)
of the incoherent##6##3##(2007-12#1)(2008-1#3)(2008-2#1)(2008-3#1)
of the incoming wave##2##4##(2007-11#1)(2008-3#1)
of the incoming##9##3##(2007-11#2)(2008-1#3)(2008-2#2)(2008-3#2)
of the incorporated##2##3##(1993-11#1)(1997-1#1)
of the incorporation of##6##4##(1992-8#1)(1994-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2011-2#1)
of the incorrect##2##3##(1994-11#1)(2008-12#1)
of the increase in the##4##5##(1995-11#1)(1995-12#1)(1997-1#1)(1997-3#1)
of the increase in##28##4##(1990-2#1)(1990-7#1)(1991-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-1#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-8#2)(2005-10#1)(2005-11#1)(2008-10#3)(2008-11#1)(2009-4#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-1#1)
of the increase of##4##4##(1990-10#1)(2005-11#1)(2008-10#1)(2008-9#1)
of the increase was##2##4##(1992-5#1)(2008-10#1)
of the increase##37##3##(1990-10#1)(1990-2#1)(1990-7#1)(1991-12#1)(1992-5#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#1)(1996-1#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-8#2)(2005-10#1)(2005-11#2)(2008-10#6)(2008-11#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-1#1)
of the increased use of##2##5##(1995-2#1)(2012-2#1)
of the increased##28##3##(1990-12#1)(1990-2#1)(1990-6#1)(1992-1#1)(1992-6#1)(1993-2#1)(1993-5#1)(1994-11#1)(1994-2#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-7#1)(2005-5#1)(2006-10#2)(2006-6#1)(2006-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#2)
of the increases##3##3##(1990-11#1)(1991-2#1)(2008-9#1)
of the increasing number of##4##5##(1993-11#1)(2008-8#1)(2011-2#1)(2012-1#1)
of the increasing prevalence of##2##5##(2010-5#1)(2012-3#1)
of the increasing prevalence##3##4##(2006-2#1)(2010-5#1)(2012-3#1)
of the increasing##17##3##(1990-11#1)(1990-4#1)(1993-11#2)(2006-12#1)(2006-2#1)(2007-4#1)(2008-10#2)(2008-8#1)(2008-9#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-3#1)
of the increment##5##3##(1993-7#2)(1994-3#1)(2010-10#1)(2012-2#1)
of the incubation period##3##4##(1992-6#1)(2008-10#1)(2008-11#1)
of the incubation time##2##4##(1990-12#1)(1990-2#1)
of the incubation##12##3##(1990-12#1)(1990-2#1)(1991-2#1)(1992-6#2)(1995-2#1)(1995-6#1)(2006-4#1)(2008-10#2)(2008-11#1)(2011-2#1)
of the incubator##2##3##(2007-10#2)
of the independent variable##2##4##(2008-11#2)
of the independent##8##3##(1992-2#1)(1993-8#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-11#3)
of the index change is##2##5##(2007-12#2)
of the index of refraction of water##2##7##(2008-2#2)
of the index of refraction of##5##6##(2008-2#5)
of the index of refraction##16##5##(1991-9#1)(2007-12#1)(2008-2#10)(2008-3#3)(2008-7#1)
of the index of##18##4##(1991-9#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-2#10)(2008-3#3)(2008-7#1)
of the index##38##3##(1990-10#2)(1991-9#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-5#1)(2007-11#1)(2007-12#4)(2007-2#1)(2008-10#1)(2008-2#11)(2008-3#6)(2008-7#2)(2011-2#5)
of the indications for both##2##5##(2005-8#1)(2010-11#1)
of the indications for##3##4##(2005-8#1)(2010-11#1)(2012-2#1)
of the indications##6##3##(1990-9#1)(2005-8#1)(2007-8#1)(2009-4#1)(2010-11#1)(2012-2#1)
of the indicator##10##3##(1990-12#1)(1990-2#1)(2008-10#4)(2008-9#2)(2011-2#1)(2012-3#1)
of the indicators##4##3##(1996-2#1)(2005-10#1)(2008-10#1)(2010-5#1)
of the indices of refraction of##2##6##(2008-2#2)
of the indices of##4##4##(2008-11#1)(2008-2#2)(2013-8#1)
of the indices##8##3##(2006-6#1)(2007-11#2)(2008-11#1)(2008-2#3)(2013-8#1)
of the indigenous##3##3##(2006-10#1)(2008-10#2)
of the indirect##6##3##(1995-2#1)(2005-10#1)(2007-7#1)(2008-10#1)(2008-8#1)(2011-2#1)
of the individual and##2##4##(1993-12#1)(2008-10#1)
of the individual beams##2##4##(2007-12#2)
of the individual cells##3##4##(1992-8#1)(2008-11#1)(2009-4#1)
of the individual child##4##4##(2006-10#1)(2008-12#1)(2010-8#2)
of the individual component##2##4##(2006-8#1)(2009-11#1)
of the individual components of the##4##6##(1994-2#1)(2008-10#1)(2009-2#1)(2011-12#1)
of the individual components of##7##5##(1994-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-2#1)(2011-12#1)
of the individual components##11##4##(1994-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#3)(2009-12#1)(2009-2#1)(2011-12#1)
of the individual emitters##2##4##(2007-11#1)(2008-3#1)
of the individual in##2##4##(2007-7#1)(2010-12#1)
of the individual patient and##2##5##(1996-8#1)(2013-8#1)
of the individual patient##4##4##(1992-2#1)(1996-8#1)(2013-1#1)(2013-8#1)
of the individual proteins##3##4##(1991-10#1)(1994-6#1)(1995-8#1)
of the individual responses##2##4##(1993-6#1)(2008-4#1)
of the individual species##3##4##(2008-10#2)(2010-2#1)
of the individual tryptophans were##2##5##(1994-11#2)
of the individual##162##3##(1990-11#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-4#1)(1995-5#2)(1995-7#1)(1995-8#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-9#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-4#2)(2006-5#2)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-12#5)(2007-7#3)(2007-8#2)(2008-10#17)(2008-11#5)(2008-12#3)(2008-2#4)(2008-3#7)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#3)(2009-2#2)(2009-4#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#3)(2013-1#6)(2013-8#4)
of the individual's##4##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-8#1)
of the individuals in an##2##5##(2007-4#1)(2008-5#1)
of the individuals to##2##4##(2008-5#1)(2012-1#1)
of the individuals##19##3##(1997-2#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-4#3)(2008-10#1)(2008-11#1)(2008-5#3)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
of the indole##4##3##(1994-9#1)(1995-10#2)(1996-3#1)
of the indoleamine##2##3##(1992-7#1)(2008-11#1)
of the induced absorption##2##4##(2007-12#1)(2008-3#1)
of the induced##25##3##(1990-7#1)(1991-10#1)(1991-12#1)(1991-7#1)(1992-9#1)(1993-6#1)(1996-10#1)(1997-4#1)(2005-11#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#4)(2008-5#1)(2009-10#1)(2012-2#1)(2012-3#1)
of the inducer##4##3##(1990-11#1)(1991-9#1)(1992-11#1)(1994-12#1)
of the inducible isoform##3##4##(1995-11#2)(2005-7#1)
of the inducible macromolecules##2##4##(1991-10#2)
of the inducible##14##3##(1991-10#2)(1991-12#1)(1993-12#1)(1993-6#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-6#1)(1996-6#1)(1997-3#1)(2005-7#1)(2013-1#1)
of the induction of labor##2##5##(1994-6#1)(2008-11#1)
of the induction of##14##4##(1992-7#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1996-10#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2011-2#2)
of the induction period##2##4##(2007-8#1)(2008-10#1)
of the induction##22##3##(1990-6#1)(1991-10#2)(1991-12#1)(1992-4#1)(1992-7#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1996-10#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2011-2#2)
of the industrial production of##2##5##(2008-6#1)(2012-2#1)
of the industrial##7##3##(1992-5#1)(2006-7#1)(2008-11#1)(2008-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
of the industry##9##3##(1990-5#1)(1992-3#1)(1996-3#1)(2005-5#1)(2008-10#1)(2008-11#3)(2008-5#1)
of the inevitable##2##3##(2006-7#1)(2008-3#1)
of the infant##12##3##(1992-11#1)(1996-5#1)(2005-11#1)(2005-6#1)(2006-11#1)(2007-10#1)(2008-12#1)(2009-12#1)(2010-9#1)(2011-1#2)(2011-12#1)
of the infant's##4##3##(1993-3#1)(2006-10#1)(2009-11#1)(2012-2#1)
of the infants were##3##4##(1991-11#1)(1994-6#1)(2007-2#1)
of the infants##17##3##(1991-11#1)(1991-9#1)(1992-6#1)(1994-6#2)(2006-3#2)(2007-2#1)(2007-7#1)(2008-10#1)(2009-9#1)(2011-1#4)(2012-2#2)
of the infants'##3##3##(1992-2#1)(2007-8#1)(2008-10#1)
of the infarct##3##3##(1993-8#1)(2007-9#1)(2012-2#1)
of the infarct-related artery##2##4##(2008-3#1)(2008-6#1)
of the infarcted area##2##4##(1997-8#1)(2008-4#1)
of the infarcted##5##3##(1993-8#1)(1997-8#1)(2006-10#1)(2008-4#1)(2012-12#1)
of the infarction##2##3##(1997-5#1)(2008-10#1)
of the infected subjects##2##4##(2007-4#2)
of the infected##19##3##(1990-6#1)(1990-9#1)(1991-12#1)(1996-4#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-4#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-12#1)(2011-2#1)(2013-1#1)
of the infecting##2##3##(1992-2#1)(2005-8#1)
of the infection and the##2##5##(2006-10#1)(2008-5#1)
of the infection and##5##4##(2006-10#1)(2006-2#1)(2008-10#1)(2008-5#1)(2010-12#1)
of the infection by##2##4##(2006-10#1)(2008-9#1)
of the infection in##5##4##(1990-9#1)(1993-8#1)(2008-1#1)(2008-7#1)(2008-9#1)
of the infection of##2##4##(2008-10#1)(2008-5#1)
of the infection process##5##4##(1992-12#1)(2008-10#3)(2009-12#1)
of the infection with##2##4##(2007-12#1)(2012-12#1)
of the infection##66##3##(1990-6#1)(1990-9#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-6#1)(1993-8#1)(1994-5#2)(1997-3#2)(1997-7#1)(2005-10#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-2#2)(2006-8#2)(2007-12#4)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#3)(2009-12#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-12#1)
of the infections##4##3##(1994-6#1)(2007-10#1)(2007-2#1)(2012-12#1)
of the infectious agent##3##4##(1994-3#1)(1995-5#1)(1996-3#1)
of the infectious complications##2##4##(2008-7#1)(2008-9#1)
of the infectious diseases##2##4##(2008-10#1)(2009-2#1)
of the infectious##17##3##(1994-3#1)(1995-5#1)(1996-1#2)(1996-3#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-2#2)(2010-6#1)(2011-12#1)(2011-2#1)(2012-3#1)
of the infective##2##3##(1997-3#1)(2007-12#1)
of the infectivity of##2##4##(2007-10#1)(2008-9#1)
of the infectivity##3##3##(2007-10#1)(2008-5#1)(2008-9#1)
of the inferior alveolar##2##4##(1991-1#1)(2007-12#1)
of the inferior competitor##2##4##(2008-8#2)
of the inferior olive##2##4##(1990-9#1)(1993-12#1)
of the inferior vena cava and##6##6##(2008-11#6)
of the inferior vena cava in##2##6##(2010-10#1)(2013-1#1)
of the inferior vena cava##16##5##(2007-8#3)(2008-11#8)(2008-4#1)(2008-7#1)(2010-10#1)(2013-1#2)
of the inferior vena##17##4##(2007-8#3)(2008-11#8)(2008-4#1)(2008-7#1)(2009-5#1)(2010-10#1)(2013-1#2)
of the inferior##31##3##(1990-9#1)(1991-1#1)(1993-12#1)(1993-2#1)(1995-12#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-8#3)(2008-11#8)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-10#1)(2010-3#1)(2013-1#2)(2013-8#1)
of the inferred##4##3##(1994-9#1)(2008-3#1)(2013-1#2)
of the infestation##2##3##(2008-10#1)(2010-3#1)
of the infiltrative##2##3##(1993-4#1)(2008-1#1)
of the infirmary##2##3##(2008-10#2)
of the inflamed##3##3##(1990-6#1)(1993-8#1)(2013-7#1)
of the inflammation##5##3##(1995-7#1)(2007-12#1)(2007-9#1)(2008-11#1)(2013-8#1)
of the inflammatory process##9##4##(1992-6#1)(1993-1#1)(1995-2#1)(2005-10#1)(2005-8#1)(2009-12#1)(2009-5#1)(2010-12#1)(2012-1#1)
of the inflammatory reaction##4##4##(1995-12#1)(2006-10#1)(2008-5#1)(2013-8#1)
of the inflammatory response to cardiopulmonary bypass##2##7##(2006-10#1)(2007-9#1)
of the inflammatory response to##4##5##(2005-10#1)(2006-10#1)(2007-9#1)(2012-1#1)
of the inflammatory response##16##4##(1991-8#1)(1993-12#1)(1994-12#1)(1995-1#1)(1995-11#1)(1996-5#1)(2005-10#2)(2006-10#2)(2006-3#1)(2007-9#1)(2010-4#2)(2010-8#1)(2012-1#1)
of the inflammatory##52##3##(1990-5#1)(1991-8#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-8#1)(2005-10#5)(2005-8#1)(2006-10#3)(2006-2#1)(2006-3#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-12#2)(2009-5#1)(2010-12#4)(2010-3#1)(2010-4#3)(2010-8#1)(2011-1#1)(2012-1#2)(2012-12#1)(2013-7#1)(2013-8#2)
of the inflorescence##2##3##(2008-10#2)
of the influence function##2##4##(2007-12#2)
of the influence of age##2##5##(2008-8#1)(2010-10#1)
of the influence of the##4##5##(2008-2#1)(2008-3#1)(2009-9#1)(2011-1#1)
of the influence of##30##4##(1990-11#1)(1990-7#1)(1992-9#1)(1993-1#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2011-1#3)(2011-2#1)(2013-1#1)
of the influence##32##3##(1990-11#1)(1990-7#1)(1992-9#1)(1993-1#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2011-1#3)(2011-2#1)(2013-1#1)
of the influent##2##3##(2008-10#1)(2010-5#1)
of the influenza A virus transmembrane proteins and genome in##2##10##(2013-1#2)
of the influenza A##4##4##(2007-12#1)(2010-4#1)(2013-1#2)
of the influenza virus##5##4##(1997-6#1)(2007-6#1)(2010-4#1)(2012-12#2)
of the influenza##12##3##(1997-6#1)(2007-12#1)(2007-6#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#3)
of the influx##2##3##(1992-8#1)(2012-12#1)
of the information and##2##4##(1997-3#1)(2007-4#1)
of the information available##3##4##(2008-4#1)(2009-4#1)(2011-2#1)
of the information content##2##4##(1997-4#1)(2010-6#1)
of the information gathered##3##4##(2006-8#1)(2008-3#1)(2008-4#1)
of the information obtained##3##4##(2007-1#1)(2010-3#1)(2012-11#1)
of the information on the##2##5##(2008-2#1)(2010-1#1)
of the information on##4##4##(2004-10#1)(2006-1#1)(2008-2#1)(2010-1#1)
of the information storage##2##4##(2007-8#1)(2008-3#1)
of the information that##2##4##(2007-11#1)(2008-6#1)
of the information was##2##4##(2004-10#1)(2012-12#1)
of the information##47##3##(1992-1#1)(1993-3#1)(1995-2#1)(1996-3#2)(1996-5#1)(1997-3#2)(1997-4#1)(1997-5#1)(2004-10#2)(2005-7#1)(2006-1#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2009-4#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
of the infrabuccal##2##3##(2007-12#2)
of the infraorbital##2##3##(1995-5#1)(2008-5#1)
of the infrared detection efficiency of##2##6##(2007-11#2)
of the infrared spectrum##2##4##(1991-5#1)(2007-8#1)
of the infrared##8##3##(1991-5#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-3#2)(2013-8#1)
of the infrastructure##3##3##(1996-12#1)(1997-1#1)(2007-4#1)
of the infratemporal fossa##2##4##(2005-9#1)(2011-2#1)
of the infused##2##3##(1993-6#1)(2007-1#1)
of the infusion were##2##4##(2010-12#2)
of the infusion##12##3##(1990-10#1)(1990-12#1)(1993-7#1)(1997-1#1)(1997-3#1)(2008-7#2)(2010-12#5)
of the ingested##5##3##(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#2)
of the ingroup and outgroup##2##5##(2009-11#2)
of the inguinal##3##3##(2007-2#1)(2009-9#1)(2011-1#1)
of the inhabitants##2##3##(1991-6#1)(2013-8#1)
of the inhaled##7##3##(1990-8#2)(1992-3#1)(2007-11#1)(2007-9#1)(2010-6#1)(2013-1#1)
of the inherent optical properties of##2##6##(2008-3#2)
of the inherent optical properties##3##5##(2008-3#3)
of the inherent##10##3##(1994-5#1)(2006-9#1)(2008-11#1)(2008-12#1)(2008-3#4)(2008-7#1)(2010-2#1)
of the inherently##2##3##(2008-3#1)(2009-12#1)
of the inheritance of##3##4##(1996-6#1)(2006-12#1)(2008-8#1)
of the inheritance##4##3##(1996-6#1)(2006-12#1)(2008-8#1)(2012-12#1)
of the inherited##2##3##(1997-7#1)(2008-7#1)
of the inhibited##3##3##(1990-2#1)(2005-11#1)(2008-10#1)
of the inhibition kinetics##2##4##(1993-4#1)(1994-6#1)
of the inhibition of##12##4##(1990-5#1)(1992-6#1)(1995-1#1)(1995-11#1)(1995-7#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(2008-10#1)(2008-8#1)(2013-7#1)
of the inhibition period and##3##5##(1991-12#3)
of the inhibition period##4##4##(1991-12#4)
of the inhibition##34##3##(1990-2#1)(1990-5#1)(1991-12#4)(1992-11#1)(1992-6#3)(1992-9#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-7#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-7#1)(2008-10#4)(2008-8#2)(2013-7#1)
of the inhibitor of##3##4##(1995-9#1)(1997-5#1)(2013-1#1)
of the inhibitor to##4##4##(1994-3#1)(2008-4#1)(2008-6#1)(2012-2#1)
of the inhibitor was##3##4##(1996-12#1)(1997-8#2)
of the inhibitor##46##3##(1990-11#1)(1990-2#1)(1990-3#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-1#2)(1995-2#1)(1995-5#1)(1995-9#1)(1996-12#1)(1997-5#1)(1997-7#1)(1997-8#6)(2006-12#1)(2007-7#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2012-2#1)(2013-1#2)
of the inhibitors used##2##4##(1995-5#1)(1996-5#1)
of the inhibitors##22##3##(1990-7#1)(1991-10#1)(1991-2#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-8#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-5#2)(1996-6#1)(1996-8#2)(1997-8#1)(2005-7#1)(2009-9#1)
of the inhibitory G-protein##2##4##(1995-3#1)(2005-10#1)
of the inhibitory action##2##4##(1992-4#1)(1993-11#1)
of the inhibitory activity##4##4##(1997-8#1)(2008-2#2)(2008-5#1)
of the inhibitory effect of##3##5##(1993-12#1)(1996-5#1)(1997-5#1)
of the inhibitory effect##6##4##(1992-12#1)(1993-12#1)(1996-5#2)(1997-5#1)(2008-10#1)
of the inhibitory effects of##3##5##(1990-10#1)(1991-8#1)(2008-4#1)
of the inhibitory effects on##2##5##(1991-2#1)(1995-12#1)
of the inhibitory effects##5##4##(1990-10#1)(1991-2#1)(1991-8#1)(1995-12#1)(2008-4#1)
of the inhibitory##42##3##(1990-10#1)(1990-2#4)(1990-4#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#2)(1996-2#2)(1996-5#2)(1997-1#1)(1997-5#1)(1997-8#1)(2005-10#1)(2006-1#1)(2006-11#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2012-12#1)
of the inhomogeneity##2##3##(1996-4#1)(2008-7#1)
of the initial activity after##2##5##(2008-10#1)(2012-11#1)
of the initial activity##4##4##(1990-2#1)(2006-10#1)(2008-10#1)(2012-11#1)
of the initial and terminal##2##5##(1993-11#1)(2007-3#1)
of the initial and##3##4##(1993-11#1)(2007-3#1)(2008-10#1)
of the initial asymmetric##4##4##(2012-12#4)
of the initial concentration##3##4##(1996-6#1)(2008-10#2)
of the initial enzyme##2##4##(1990-6#1)(2011-1#1)
of the initial inoculum##2##4##(2008-10#2)
of the initial slope##4##4##(1991-8#3)(2008-3#1)
of the initial##128##3##(1990-10#1)(1990-12#3)(1990-2#4)(1990-5#3)(1990-6#1)(1990-7#3)(1991-11#1)(1991-12#1)(1991-3#1)(1991-8#3)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-7#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-5#2)(1997-7#1)(2004-11#2)(2005-11#2)(2005-8#1)(2006-10#3)(2006-2#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-8#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#2)(2009-8#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
of the initially##6##3##(1990-11#1)(2004-9#1)(2005-11#1)(2008-2#2)(2010-12#1)
of the initiating##2##3##(1995-3#1)(2007-9#1)
of the initiation codon##2##4##(1992-11#1)(1995-3#1)
of the initiation of##3##4##(1997-8#1)(2008-5#1)(2011-2#1)
of the initiation##7##3##(1990-3#1)(1992-11#1)(1995-3#1)(1997-8#1)(2008-5#1)(2011-2#1)(2012-12#1)
of the initiative##5##3##(1994-12#1)(1995-2#1)(2008-11#1)(2008-5#1)(2012-2#1)
of the initiator##9##3##(1990-8#1)(1991-12#1)(1991-3#1)(1993-11#1)(1995-2#1)(1995-6#1)(2005-11#1)(2012-12#2)
of the injected dose##3##4##(1990-3#1)(1993-11#1)(2013-1#1)
of the injected sample##2##4##(2008-10#2)
of the injected##14##3##(1990-3#1)(1991-12#1)(1991-9#1)(1993-11#1)(1993-2#1)(1993-6#1)(1995-12#2)(2006-10#1)(2008-10#3)(2008-7#1)(2013-1#1)
of the injection site##2##4##(1993-2#1)(1995-5#1)
of the injection##14##3##(1991-6#1)(1993-2#1)(1993-3#1)(1994-9#1)(1995-5#1)(1997-5#2)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)
of the injured extremity##2##4##(2007-11#2)
of the injured knee##2##4##(2008-1#1)(2008-4#1)
of the injured were##2##4##(1992-6#1)(2007-2#1)
of the injured##24##3##(1990-6#1)(1991-10#2)(1991-3#1)(1991-9#1)(1992-6#1)(1992-9#1)(1995-6#1)(1995-8#1)(1996-1#1)(1997-3#2)(2006-10#2)(2007-11#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-10#1)(2012-7#1)
of the injuries were##2##4##(1990-6#1)(1991-2#1)
of the injuries##8##3##(1990-6#1)(1991-2#1)(1993-5#1)(1995-8#1)(1997-3#1)(2006-11#1)(2008-9#1)(2009-4#1)
of the injury and##3##4##(2007-11#1)(2011-12#1)(2012-12#1)
of the injury##25##3##(1993-11#1)(1994-5#1)(1996-5#1)(2005-7#1)(2006-11#1)(2007-11#2)(2007-4#3)(2007-8#1)(2007-9#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-12#3)(2012-12#1)(2012-2#1)(2013-8#1)
of the innate and adaptive immune##2##6##(2006-10#1)(2008-4#1)
of the innate and##3##4##(2006-10#1)(2008-4#1)(2013-8#1)
of the innate immune response##3##5##(2008-1#1)(2008-3#1)(2010-12#1)
of the innate immune system##14##5##(2005-10#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of the innate immune##17##4##(2005-10#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#1)(2010-12#3)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of the innate##24##3##(2005-10#1)(2006-10#3)(2008-1#2)(2008-10#1)(2008-3#2)(2008-4#2)(2010-12#3)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
of the inner and outer##3##5##(1994-12#1)(2007-5#1)(2007-7#1)
of the inner arms##2##4##(1991-2#2)
of the inner core##3##4##(1995-3#2)(2008-8#1)
of the inner ear##5##4##(1993-9#1)(1994-9#1)(1995-5#1)(2008-4#1)(2008-9#1)
of the inner membrane##3##4##(1992-11#1)(1995-6#1)(2013-8#1)
of the inner mitochondrial membrane##5##5##(1992-11#1)(1993-6#1)(1997-1#2)(2005-8#1)
of the inner mitochondrial##6##4##(1990-3#1)(1992-11#1)(1993-6#1)(1997-1#2)(2005-8#1)
of the inner nuclear layer##2##5##(1990-5#1)(1994-3#1)
of the inner nuclear##3##4##(1990-5#1)(1994-3#1)(2011-2#1)
of the inner##50##3##(1990-12#2)(1990-3#1)(1990-5#1)(1991-2#2)(1991-5#1)(1992-11#2)(1992-6#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-3#3)(1995-5#1)(1995-6#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(2005-1#1)(2005-11#3)(2005-8#1)(2007-5#2)(2007-7#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-5#1)(2010-4#1)(2011-2#1)(2013-8#1)
of the innominate artery##2##4##(2007-8#2)
of the innovative##2##3##(1997-3#1)(2008-5#1)
of the inoculated stalk pieces##2##5##(2008-10#2)
of the inoculated##13##3##(2004-11#2)(2008-10#7)(2008-5#3)(2012-3#1)
of the inoculum##5##3##(1991-11#1)(2008-10#3)(2008-5#1)
of the inorganic##8##3##(1991-7#1)(1994-6#1)(2005-11#2)(2008-10#1)(2009-2#2)(2010-5#1)
of the inositol 1##2##4##(1993-12#1)(2007-9#1)
of the inositol trisphosphate##3##4##(1991-2#1)(1992-8#1)(1993-6#1)
of the inositol##10##3##(1990-7#2)(1991-2#2)(1992-8#1)(1993-12#1)(1993-6#2)(2007-9#1)(2010-9#1)
of the inpatient##4##3##(1992-3#1)(1992-9#1)(1993-12#1)(2010-12#1)
of the input and output surfaces##2##6##(2008-2#2)
of the input and the reference##2##6##(2007-12#1)(2008-3#1)
of the input and##6##4##(1991-6#1)(2007-12#1)(2008-2#2)(2008-3#2)
of the input beam##3##4##(2007-12#1)(2008-3#2)
of the input data##3##4##(1992-3#1)(2008-2#1)(2010-8#1)
of the input image##2##4##(2008-2#2)
of the input intensity##2##4##(2007-12#1)(2008-1#1)
of the input light##4##4##(2008-2#2)(2008-3#2)
of the input parameters##3##4##(2008-10#1)(2008-2#2)
of the input pulse##2##4##(2007-12#2)
of the input pulses##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
of the input scene##2##4##(2008-2#2)
of the input spatial##2##4##(2007-12#1)(2008-2#1)
of the input spike trains##2##5##(2008-11#2)
of the input##61##3##(1991-6#1)(1992-3#1)(1992-6#1)(1993-12#1)(1997-8#1)(2007-11#4)(2007-12#17)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#16)(2008-3#11)(2008-4#1)(2009-4#1)(2010-8#1)(2012-2#1)
of the input-output characteristics of##2##5##(1991-6#1)(2007-12#1)
of the input-output##3##3##(1991-6#1)(2007-12#1)(2008-2#1)
of the inputs##4##3##(1992-2#1)(2007-11#1)(2008-3#2)
of the insane##3##3##(2007-5#1)(2012-2#2)
of the insanity defense##5##4##(2011-1#5)
of the insanity##6##3##(2010-9#1)(2011-1#5)
of the insect brain##2##4##(2007-12#2)
of the insect##17##3##(1991-10#1)(1994-12#1)(1994-8#1)(1997-8#2)(2007-12#6)(2008-10#1)(2008-11#2)(2008-3#1)(2010-10#1)(2012-2#1)
of the insecticide##4##3##(1997-2#2)(2005-8#1)(2008-11#1)
of the insects##2##3##(2006-12#1)(2008-9#1)
of the insert##10##3##(1990-11#1)(1991-12#1)(1991-5#1)(1996-10#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)
of the inserted gene(s)##2##4##(1997-8#2)
of the inserted genes##2##4##(1997-8#2)
of the inserted##10##3##(1991-12#1)(1993-6#1)(1994-12#1)(1997-8#4)(2006-10#1)(2007-8#1)(2008-10#1)
of the insertion of##3##4##(1997-2#1)(2008-12#1)(2013-1#1)
of the insertion##11##3##(1990-11#1)(1993-3#1)(1997-2#1)(2005-11#1)(2007-5#1)(2008-12#1)(2008-3#1)(2009-7#3)(2013-1#1)
of the inserts##2##3##(2008-10#1)(2008-5#1)
of the insights##2##3##(2008-9#1)(2009-5#1)
of the insoluble##2##3##(1990-5#1)(1994-12#1)
of the instability##4##3##(2006-10#1)(2007-11#1)(2011-7#1)(2012-3#1)
of the instantaneous##5##3##(1990-11#1)(1996-6#1)(2007-12#1)(2008-2#1)(2010-8#1)
of the institute##2##3##(2007-11#1)(2011-2#1)
of the institution##7##3##(1994-1#1)(1994-12#1)(2008-9#1)(2009-7#1)(2012-11#1)(2012-12#1)(2012-2#1)
of the institution's##3##3##(1991-3#1)(1996-2#1)(1996-3#1)
of the institutional##2##3##(1994-12#1)(2007-1#1)
of the institutions##2##3##(2010-1#1)(2012-12#1)
of the instruction##3##3##(1996-1#1)(2007-3#1)(2009-11#1)
of the instrument can##2##4##(2006-5#1)(2008-3#1)
of the instrument for##3##4##(2008-2#1)(2008-3#1)(2008-9#1)
of the instrument in##3##4##(2006-10#1)(2008-1#1)(2008-2#1)
of the instrument is##4##4##(2007-11#1)(2008-10#1)(2008-3#2)
of the instrument tip##3##4##(2006-6#3)
of the instrument to##3##4##(2008-2#2)(2011-1#1)
of the instrument was##3##4##(2007-8#1)(2008-11#1)(2011-1#1)
of the instrument we##2##4##(2007-12#1)(2008-3#1)
of the instrument were##2##4##(2008-11#1)(2013-8#1)
of the instrument##65##3##(1991-2#1)(1993-3#1)(1993-5#1)(1994-11#1)(1997-1#1)(2006-10#1)(2006-4#1)(2006-5#2)(2006-6#6)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#6)(2008-11#2)(2008-2#8)(2008-3#19)(2008-9#1)(2009-12#1)(2011-1#2)(2012-2#1)(2013-8#3)
of the instrument's performance##2##4##(2007-11#1)(2008-3#1)
of the instrument's##4##3##(2007-11#1)(2008-10#1)(2008-3#2)
of the instrumental##7##3##(1991-3#1)(2006-5#1)(2008-10#3)(2008-3#2)
of the instrumentation and##2##4##(2006-5#1)(2007-7#1)
of the instrumentation##4##3##(2006-5#1)(2007-7#1)(2008-10#1)(2009-4#1)
of the instruments##11##3##(2006-6#1)(2008-10#1)(2008-3#3)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#2)
of the instruments'##2##3##(2005-4#1)(2008-2#1)
of the insufflation gas##2##4##(1992-12#1)(2006-6#1)
of the insular cortex##2##4##(1991-5#1)(1995-11#1)
of the insulin B chain##3##5##(1992-3#1)(1992-8#2)
of the insulin gene##3##4##(1994-8#1)(2008-4#1)(2010-11#1)
of the insulin on##2##4##(2011-2#2)
of the insulin receptor and##2##5##(1994-12#1)(1997-6#1)
of the insulin receptor gene##2##5##(1994-12#1)(2012-12#1)
of the insulin receptor in##2##5##(1994-12#1)(1995-3#1)
of the insulin receptor is##3##5##(1990-11#1)(1992-8#1)(1994-12#1)
of the insulin receptor kinase##2##5##(1991-12#2)
of the insulin receptor tyrosine kinase##3##6##(1990-4#2)(1991-5#1)
of the insulin receptor##29##4##(1990-11#2)(1990-4#2)(1990-7#1)(1991-12#5)(1991-5#1)(1992-12#1)(1992-8#1)(1993-8#1)(1994-12#9)(1995-3#1)(1996-5#1)(1997-6#1)(2008-4#1)(2011-12#1)(2012-12#1)
of the insulin##54##3##(1990-11#2)(1990-4#2)(1990-5#1)(1990-7#1)(1991-12#5)(1991-2#1)(1991-5#2)(1992-12#1)(1992-3#2)(1992-6#2)(1992-7#1)(1992-8#3)(1993-8#1)(1994-12#9)(1994-8#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-6#1)(2007-11#1)(2008-1#2)(2008-4#2)(2009-8#1)(2010-11#4)(2011-12#2)(2011-2#3)(2012-12#1)
of the insulin-like growth factor##3##5##(1992-4#1)(1995-6#1)(1996-11#1)
of the insulin-sensitive##2##3##(1990-7#1)(1990-8#1)
of the insurance##2##3##(1997-5#1)(2008-7#1)
of the intact and##2##4##(1996-12#1)(2010-4#1)
of the intact cells##2##4##(1992-4#1)(1993-9#1)
of the intact heart##2##4##(1997-4#2)
of the intact jejunum##2##4##(2008-10#2)
of the intact modified base pair##2##6##(1995-1#2)
of the intact molecule##2##4##(1992-5#1)(1992-6#1)
of the intact peptide##2##4##(1990-11#1)(1994-10#1)
of the intact protein##2##4##(1991-7#1)(2008-12#1)
of the intact##39##3##(1990-11#1)(1990-12#1)(1990-2#1)(1991-12#1)(1991-3#3)(1991-7#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#1)(1995-1#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-4#2)(2006-3#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-9#1)(2010-4#1)(2013-8#1)
of the intake of##4##4##(2005-10#1)(2007-8#1)(2008-2#1)(2013-7#1)
of the intake##5##3##(2005-10#1)(2007-8#1)(2008-12#1)(2008-2#1)(2013-7#1)
of the integer and fractional quantum Hall effects##2##8##(1990-7#2)
of the integral##8##3##(1991-9#3)(1997-6#1)(2006-12#1)(2008-2#2)(2012-1#1)
of the integrase##2##3##(1992-6#1)(1997-3#1)
of the integrate-and-fire type##2##4##(2008-11#2)
of the integrated system##2##4##(2006-8#1)(2011-1#1)
of the integrated##14##3##(1993-5#1)(1996-6#1)(1997-2#1)(2006-4#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-8#2)
of the integration method and##2##5##(2008-3#2)
of the integration method##3##4##(2008-3#3)
of the integration of##8##4##(2005-9#1)(2006-10#1)(2008-10#1)(2008-4#1)(2009-12#1)(2010-2#1)(2012-3#1)(2013-1#1)
of the integration##16##3##(2005-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#5)(2008-4#1)(2009-12#1)(2010-2#2)(2012-3#1)(2013-1#1)
of the integrin##7##3##(1992-12#1)(1994-6#1)(1994-9#2)(2005-7#1)(2006-6#1)(2008-1#1)
of the integrity of the##6##5##(2006-12#1)(2006-6#1)(2008-10#1)(2011-2#1)(2012-11#1)(2012-3#1)
of the integrity of##7##4##(2006-12#1)(2006-6#1)(2008-10#1)(2010-2#1)(2011-2#1)(2012-11#1)(2012-3#1)
of the intellectual##4##3##(1993-12#1)(2011-2#2)(2012-2#1)
of the intelligentsia in##2##4##(2008-12#2)
of the intended##4##3##(2007-11#1)(2009-8#1)(2012-12#2)
of the intensities of the##2##5##(1992-7#1)(2008-8#1)
of the intensities of##3##4##(1992-7#1)(1994-7#1)(2008-8#1)
of the intensity and the phase of the##2##8##(2007-11#1)(2007-12#1)
of the intensity and##4##4##(2007-11#1)(2007-12#2)(2008-2#1)
of the intensity distribution##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
of the intensity noise##2##4##(2007-12#1)(2008-3#1)
of the intensity of the##6##5##(1991-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)
of the intensity of##18##4##(1991-4#1)(1992-1#1)(1997-2#1)(2005-11#1)(2006-4#1)(2007-11#2)(2007-12#2)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2012-2#1)
of the intensity profile of the##3##6##(2008-2#2)(2008-3#1)
of the intensity profile##4##4##(2008-2#3)(2008-3#1)
of the intensity##50##3##(1991-4#1)(1992-1#1)(1997-2#1)(2005-11#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-11#7)(2007-12#8)(2008-10#6)(2008-2#12)(2008-3#8)(2008-4#1)(2012-2#1)
of the intensive care##2##4##(2007-11#1)(2007-8#1)
of the intensive##4##3##(2005-1#1)(2007-11#1)(2007-8#1)(2013-8#1)
of the inter atrial septum##2##5##(2012-3#2)
of the inter-relationships##2##3##(1997-8#1)(2010-2#1)
of the interacting waves##4##4##(2007-11#2)(2007-12#2)
of the interacting##12##3##(2005-11#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-11#2)(2008-2#1)(2008-4#1)(2009-12#1)(2012-12#1)
of the interaction and##2##4##(2008-3#1)(2008-4#1)
of the interaction between the##10##5##(1994-12#1)(1995-2#1)(1997-6#1)(2006-10#2)(2007-4#1)(2008-10#1)(2008-7#1)(2009-7#1)(2010-8#1)
of the interaction between##40##4##(1992-12#1)(1992-3#1)(1992-4#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#1)(1997-6#2)(2005-11#2)(2006-10#5)(2007-10#1)(2007-4#1)(2008-10#7)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-7#1)(2010-5#2)(2010-8#1)(2011-1#2)(2012-12#1)(2013-1#2)
of the interaction can be##2##5##(1994-3#1)(1997-7#1)
of the interaction free energy##2##5##(2006-10#2)
of the interaction is##2##4##(2008-10#1)(2010-9#1)
of the interaction of the##7##5##(1994-10#1)(1994-5#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-2#1)(2008-3#1)
of the interaction of these##2##5##(1990-10#1)(1997-2#1)
of the interaction of##28##4##(1990-10#1)(1990-5#1)(1992-2#1)(1993-11#1)(1994-10#1)(1994-11#1)(1994-5#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-2#1)(2004-9#1)(2005-4#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-8#1)(2013-7#1)
of the interaction was##2##4##(1997-4#1)(2007-10#1)
of the interaction with##3##4##(1992-3#1)(1996-5#1)(2008-5#1)
of the interaction##105##3##(1990-10#1)(1990-5#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1993-11#1)(1993-12#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#2)(2004-9#1)(2005-11#4)(2005-4#1)(2006-10#9)(2006-12#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#20)(2008-2#5)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#3)(2012-12#1)(2013-1#2)(2013-7#1)
of the interactions between the##3##5##(1994-9#1)(1995-1#1)(2008-10#1)
of the interactions between##17##4##(1992-3#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-1#1)(1996-5#1)(2006-10#2)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-11#1)(2010-4#1)(2011-1#1)
of the interactions of the##2##5##(1990-8#1)(2008-4#1)
of the interactions of##7##4##(1990-8#1)(1991-9#1)(1993-9#2)(1997-2#1)(2008-4#1)(2012-3#1)
of the interactions that##2##4##(2006-10#1)(2011-2#1)
of the interactions##35##3##(1990-8#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-9#3)(1994-11#1)(1994-8#1)(1994-9#1)(1995-1#1)(1996-5#1)(1997-2#1)(2005-11#1)(2006-10#3)(2006-6#1)(2008-10#3)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
of the interatrial##2##3##(2009-2#1)(2009-5#1)
of the interbody space##2##4##(2006-8#1)(2007-8#1)
of the intercalated##2##3##(1996-7#1)(2010-4#1)
of the intercellular##5##3##(1993-8#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-7#1)
of the intercept##3##3##(2008-10#3)
of the interconnect##2##3##(2008-3#2)
of the interconnections##3##3##(2004-9#2)(2009-12#1)
of the intercultural##2##3##(2008-2#2)
of the interdependence between##2##4##(2009-8#2)
of the interesting##2##3##(2008-10#1)(2009-9#1)
of the interface and##2##4##(1996-7#1)(2010-5#1)
of the interface between##2##4##(2007-12#1)(2008-10#1)
of the interface is##2##4##(2007-12#1)(2008-3#1)
of the interface of##2##4##(2008-10#1)(2008-8#1)
of the interface##22##3##(1992-12#1)(1992-7#1)(1995-11#1)(1995-8#1)(1996-7#1)(2005-11#4)(2007-12#3)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-8#1)(2010-5#2)(2013-8#1)
of the interfaces and##2##4##(2007-12#1)(2008-3#1)
of the interfaces##6##3##(2007-12#1)(2008-3#4)(2008-7#1)
of the interfacial tension##2##4##(2005-11#1)(2008-3#1)
of the interfacial##10##3##(1994-9#1)(2005-11#3)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-3#1)
of the interference blots##2##4##(2008-2#2)
of the interference fringe##2##4##(2007-11#1)(2008-2#1)
of the interference fringes##5##4##(2008-2#1)(2008-3#4)
of the interference of the##2##5##(2007-12#1)(2013-8#1)
of the interference of##5##4##(2007-12#2)(2008-10#1)(2008-2#1)(2013-8#1)
of the interference pattern##6##4##(2007-11#1)(2007-12#2)(2008-3#3)
of the interference signal##4##4##(2007-11#1)(2008-2#1)(2008-3#2)
of the interference##36##3##(1995-4#1)(1996-7#1)(2007-11#5)(2007-12#6)(2008-10#2)(2008-2#8)(2008-3#11)(2008-5#1)(2013-8#1)
of the interferences##2##3##(2008-10#2)
of the interfering cations##2##4##(2008-10#2)
of the interfering##4##3##(2007-8#1)(2008-10#3)
of the interferogram##7##3##(2006-12#1)(2008-2#4)(2008-3#2)
of the interferograms##4##3##(2008-2#3)(2008-3#1)
of the interferometer and##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
of the interferometer are##2##4##(2007-11#1)(2008-2#1)
of the interferometer for##2##4##(2007-11#1)(2008-2#1)
of the interferometer in##2##4##(2007-11#1)(2007-12#1)
of the interferometer is##7##4##(2007-12#1)(2008-2#1)(2008-3#5)
of the interferometer phase##2##4##(2007-12#2)
of the interferometer was##2##4##(2008-2#2)
of the interferometer with##2##4##(2007-11#1)(2008-3#1)
of the interferometer##38##3##(2007-11#6)(2007-12#7)(2008-1#2)(2008-2#11)(2008-3#12)
of the interferometric signal##2##4##(2008-3#2)
of the interferometric##5##3##(2007-11#2)(2008-3#3)
of the interferon-gamma receptor##2##4##(1995-3#1)(1996-5#1)
of the intergenic region##2##4##(2008-10#2)
of the intergenic spacer (IGS)##2##5##(2008-10#2)
of the intergenic spacer##3##4##(2008-10#3)
of the intergenic##5##3##(2008-10#5)
of the interhyoid muscle##4##4##(2011-2#4)
of the interhyoid##5##3##(2011-2#5)
of the interictal##2##3##(1995-12#2)
of the interior of##3##4##(1994-11#1)(2007-11#2)
of the interior residues##2##4##(1995-11#2)
of the interior##9##3##(1992-3#1)(1994-11#1)(1995-11#2)(1997-6#1)(2007-11#2)(2008-3#1)(2008-9#1)
of the interlaboratory study were##2##5##(2008-10#1)(2008-5#1)
of the interleukin 2##2##4##(1994-3#1)(1995-8#1)
of the interleukin 6 signal transducer gp130##3##7##(1996-5#3)
of the interleukin##7##3##(1994-3#1)(1995-3#1)(1995-8#2)(1996-5#3)
of the interleukin-1##3##3##(1994-2#1)(1997-5#1)(2013-1#1)
of the interleukin-2 receptor##4##4##(1990-5#1)(1991-9#1)(1997-5#1)(2007-11#1)
of the interleukin-6##3##3##(1994-5#1)(1995-3#2)
of the intermediate and##2##4##(2008-8#1)(2012-1#1)
of the intermediate filament and nuclear matrix networks##2##8##(1991-8#2)
of the intermediate filament##4##4##(1991-3#1)(1991-8#2)(2012-2#1)
of the intermediate results##2##4##(2008-3#2)
of the intermediate state##3##4##(1994-8#1)(1995-5#1)(1997-4#1)
of the intermediate##33##3##(1991-3#1)(1991-4#1)(1991-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-5#1)(1997-4#1)(2006-4#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-7#1)(2009-8#2)(2010-10#1)(2012-1#1)(2012-2#1)(2013-1#1)
of the intermediates of energy metabolism in##2##7##(1992-4#2)
of the intermediates of##3##4##(1992-4#2)(1997-4#1)
of the intermediates to the##2##5##(1991-7#1)(1997-4#1)
of the intermediates##13##3##(1990-8#2)(1991-7#1)(1992-4#2)(1994-12#1)(1994-8#2)(1995-3#1)(1997-4#3)(2005-7#1)
of the intermediolateral##2##3##(1993-12#1)(1995-12#1)
of the intermembrane##3##3##(1990-4#1)(1994-12#1)(2006-10#1)
of the intermittent##2##3##(2007-12#1)(2012-2#1)
of the internal Globus Pallidus (GPi)##2##6##(1996-8#2)
of the internal aldimine##2##4##(1992-6#1)(1996-8#1)
of the internal and##3##4##(1994-9#1)(2008-1#2)
of the internal auditory canal##2##5##(2006-12#1)(2008-7#1)
of the internal auditory##3##4##(2006-11#1)(2006-12#1)(2008-7#1)
of the internal carotid artery (ICA)##6##6##(2005-5#1)(2006-12#2)(2007-10#1)(2007-9#2)
of the internal carotid artery in##3##6##(2006-12#1)(2007-10#1)(2008-7#1)
of the internal carotid artery is##2##6##(2006-4#1)(2012-3#1)
of the internal carotid artery was##2##6##(2006-1#1)(2007-10#1)
of the internal carotid artery##28##5##(2005-5#1)(2006-1#2)(2006-11#1)(2006-12#5)(2006-4#3)(2007-10#3)(2007-9#3)(2008-7#5)(2009-2#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
of the internal carotid##30##4##(2005-10#2)(2005-5#1)(2006-1#2)(2006-11#1)(2006-12#5)(2006-4#3)(2007-10#3)(2007-9#3)(2008-7#5)(2009-2#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
of the internal consistency##2##4##(2010-2#1)(2012-12#1)
of the internal field##3##4##(2008-2#2)(2008-3#1)
of the internal jugular vein##6##5##(1992-12#2)(2007-7#3)(2008-9#1)
of the internal jugular##9##4##(1992-12#2)(2007-7#3)(2008-9#1)(2012-3#3)
of the internal mammary##2##4##(1990-4#1)(2007-8#1)
of the internal organs##2##4##(2006-11#1)(2012-3#1)
of the internal scattering and##2##5##(2007-12#1)(2008-3#1)
of the internal standard##5##4##(1993-2#1)(1996-6#1)(1997-8#1)(2008-10#1)(2008-9#1)
of the internal structure of##2##5##(2008-2#2)
of the internal transcribed spacer (ITS) region of the ribosomal##2##10##(2008-10#1)(2008-5#1)
of the internal transcribed spacer (ITS) region of the##3##9##(2008-10#2)(2008-5#1)
of the internal transcribed spacer (ITS) region of##6##8##(2008-10#5)(2008-5#1)
of the internal transcribed spacer (ITS) region##8##7##(2008-10#7)(2008-5#1)
of the internal transcribed spacer (ITS) regions of##2##8##(2008-10#2)
of the internal transcribed spacer (ITS) regions##3##7##(2008-10#3)
of the internal transcribed spacer (ITS)##13##6##(2008-10#11)(2008-5#1)(2010-10#1)
of the internal transcribed spacer 1##3##6##(2008-10#3)
of the internal transcribed spacer of the##2##7##(2008-10#2)
of the internal transcribed spacer region##4##6##(2008-10#4)
of the internal transcribed spacer regions of##2##7##(2008-10#2)
of the internal transcribed spacer regions##3##6##(2008-10#3)
of the internal transcribed spacer##27##5##(2008-10#25)(2008-5#1)(2010-10#1)
of the internal transcribed##28##4##(2008-10#25)(2008-5#1)(2009-2#1)(2010-10#1)
of the internal##143##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-6#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-9#1)(1995-8#1)(1996-3#1)(1996-6#1)(1996-8#3)(1996-9#1)(1997-8#1)(2005-10#2)(2005-12#1)(2005-5#1)(2006-1#2)(2006-10#2)(2006-11#3)(2006-12#7)(2006-4#3)(2006-5#2)(2007-10#3)(2007-12#4)(2007-7#3)(2007-8#1)(2007-9#4)(2008-1#3)(2008-10#31)(2008-11#1)(2008-2#5)(2008-3#2)(2008-5#1)(2008-7#6)(2008-9#3)(2009-10#1)(2009-2#4)(2009-7#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#1)
of the internalization of##2##4##(2007-12#2)
of the international literature##2##4##(1991-9#1)(2008-10#1)
of the international##13##3##(1990-10#1)(1991-9#2)(1993-1#1)(1997-7#1)(2006-9#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#1)(2012-2#1)
of the internet##7##3##(2006-2#1)(2007-7#2)(2008-12#2)(2012-3#2)
of the interparticle##2##3##(2005-11#1)(2009-11#1)
of the interpersonal##2##3##(1991-3#1)(2009-7#1)
of the interphalangeal joints##2##4##(1993-11#1)(2006-10#1)
of the interphalangeal##3##3##(1993-11#1)(2006-10#1)(2007-7#1)
of the interphase##3##3##(1991-9#1)(2008-3#1)(2010-4#1)
of the interplay between the##2##5##(2006-10#1)(2007-7#1)
of the interplay between##7##4##(2006-10#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)
of the interpretation of##2##4##(1994-2#1)(1997-8#1)
of the interpretation##3##3##(1994-2#1)(1995-11#1)(1997-8#1)
of the interrelations##2##3##(1993-12#1)(1993-6#1)
of the interrelationship##3##3##(1994-3#1)(2008-10#1)(2011-2#1)
of the interrelationships of##2##4##(2008-4#1)(2008-7#1)
of the interrelationships##5##3##(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)
of the intersection##2##3##(2006-5#1)(2008-7#1)
of the interspecific##2##3##(2008-10#1)(2008-8#1)
of the interstitial cells##2##4##(1997-6#1)(2008-5#1)
of the interstitial##4##3##(1997-6#1)(2005-8#1)(2008-5#1)(2011-1#1)
of the intervening sequence##5##4##(1991-2#2)(1994-9#1)(1995-3#1)(2008-11#1)
of the intervening##7##3##(1991-2#2)(1993-3#2)(1994-9#1)(1995-3#1)(2008-11#1)
of the intervention a##2##4##(2007-7#1)(2012-2#1)
of the intervention and##3##4##(2008-1#1)(2008-8#1)(2011-2#1)
of the intervention are##2##4##(1995-12#1)(2013-1#1)
of the intervention in##2##4##(2007-7#1)(2011-2#1)
of the intervention on##4##4##(1996-1#1)(2006-12#1)(2010-2#2)
of the intervention was##4##4##(2007-7#1)(2008-2#1)(2008-8#1)(2011-12#1)
of the intervention##41##3##(1992-11#1)(1993-1#1)(1995-1#1)(1995-12#1)(1996-1#1)(1997-2#1)(1997-4#1)(2006-12#2)(2006-2#1)(2007-3#1)(2007-7#4)(2007-9#1)(2008-1#2)(2008-12#1)(2008-2#2)(2008-4#2)(2008-6#1)(2008-8#3)(2010-10#2)(2010-2#3)(2010-3#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
of the interventions were##2##4##(2012-2#2)
of the interventions##9##3##(1995-3#1)(1996-2#1)(2007-7#1)(2009-11#1)(2009-6#1)(2012-2#3)(2013-1#1)
of the interventricular septum##2##4##(1990-6#1)(2008-7#1)
of the intervertebral disc##14##4##(1992-1#1)(2007-11#8)(2007-7#1)(2007-8#3)(2012-2#1)
of the intervertebral foramen##4##4##(2006-8#3)(2007-7#1)
of the intervertebral##21##3##(1992-1#1)(2006-8#3)(2007-11#10)(2007-7#2)(2007-8#3)(2010-9#1)(2012-2#1)
of the interview transcripts##5##4##(1993-3#1)(2009-5#1)(2013-1#3)
of the interview##11##3##(1990-6#1)(1993-3#1)(1996-1#1)(1997-1#1)(2007-7#1)(2009-5#1)(2010-8#1)(2011-1#1)(2013-1#3)
of the interviewed##2##3##(2008-8#1)(2013-1#1)
of the interviewees##3##3##(2007-2#1)(2008-12#1)(2011-2#1)
of the interviews was##3##4##(2007-12#1)(2013-1#2)
of the interviews##5##3##(2007-12#1)(2007-2#1)(2011-2#1)(2013-1#2)
of the intestinal anastomoses sutures##2##5##(2011-2#2)
of the intestinal barrier##2##4##(2008-3#1)(2008-4#1)
of the intestinal epithelial cell##2##5##(2006-10#1)(2011-1#1)
of the intestinal epithelium##2##4##(2008-4#1)(2012-1#1)
of the intestinal homogenate##2##4##(1992-8#2)
of the intestinal immune system##2##5##(2008-5#1)(2009-12#1)
of the intestinal microbiota##3##4##(2010-5#1)(2010-9#2)
of the intestinal mucosa##5##4##(1996-2#1)(1996-3#1)(2006-10#1)(2008-7#1)(2012-1#1)
of the intestinal tract##3##4##(1993-2#1)(1996-2#1)(2011-2#1)
of the intestinal wall##2##4##(2008-3#1)(2010-12#1)
of the intestinal##35##3##(1992-12#2)(1992-6#1)(1992-8#2)(1993-2#1)(1994-9#1)(1996-2#2)(1996-3#1)(2006-10#3)(2008-10#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2009-12#1)(2009-2#2)(2010-12#1)(2010-5#1)(2010-9#2)(2011-1#2)(2011-11#1)(2011-2#3)(2012-1#2)
of the intestine and##4##4##(1990-2#2)(1996-11#1)(2008-5#1)
of the intestine in patients with##2##6##(2007-11#1)(2008-5#1)
of the intestine in##4##4##(2007-11#1)(2008-3#2)(2008-5#1)
of the intestine##21##3##(1990-2#2)(1992-11#1)(1993-9#3)(1996-11#2)(2005-3#1)(2006-4#1)(2006-8#1)(2007-11#2)(2008-3#2)(2008-4#2)(2008-5#3)(2013-7#1)
of the intestines##4##3##(1992-11#1)(2006-10#1)(2008-10#1)(2008-8#1)
of the intimal hyperplasia in##2##5##(2006-6#2)
of the intimal##3##3##(2006-6#2)(2007-8#1)
of the intonational phrase preceding and following the pause##2##9##(2008-4#2)
of the intoxication##2##3##(1995-9#1)(2005-7#1)
of the intra-thoracic##2##3##(2012-2#2)
of the intracavity laser##2##4##(2007-11#1)(2007-12#1)
of the intracavity##9##3##(2007-11#1)(2007-12#3)(2008-10#1)(2008-3#4)
of the intracellular Ca2+ concentration##4##5##(1990-4#1)(1992-8#1)(1994-6#1)(1997-7#1)
of the intracellular domain##2##4##(1992-11#1)(1993-8#1)
of the intracellular domains##2##4##(1997-6#2)
of the intracellular sodium##2##4##(1992-7#1)(1994-3#1)
of the intracellular##37##3##(1990-2#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-5#2)(1991-7#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-3#2)(1994-6#2)(1994-8#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-6#2)(1997-7#1)(2007-12#1)(2008-11#2)(2008-4#2)(2008-7#2)(2009-4#1)(2010-12#1)(2012-11#1)
of the intracranial##7##3##(1990-9#1)(2006-11#2)(2006-12#1)(2007-9#1)(2008-7#1)(2011-2#1)
of the intrahepatic biliary tree##2##5##(2006-10#1)(2006-2#1)
of the intrahepatic##4##3##(2004-11#1)(2006-10#1)(2006-2#1)(2012-12#1)
of the intraindividual##3##3##(1990-9#1)(2013-1#2)
of the intramedullary##2##3##(2007-7#1)(2013-8#1)
of the intramembrane##2##3##(1994-12#1)(1997-1#1)
of the intramolecular##4##3##(2006-12#1)(2008-5#1)(2010-12#1)(2010-2#1)
of the intramural##2##3##(2008-10#1)(2008-8#1)
of the intramuscular connective tissue##2##5##(2010-2#1)(2013-1#1)
of the intramuscular fat##2##4##(2010-4#2)
of the intramuscular##4##3##(2010-2#1)(2010-4#2)(2013-1#1)
of the intranasal##2##3##(2007-11#1)(2008-10#1)
of the intraocular lens##2##4##(2007-3#1)(2011-2#1)
of the intraocular##3##3##(2007-3#1)(2011-2#2)
of the intraoperative##3##3##(2010-12#2)(2013-7#1)
of the intrathoracic##5##3##(1993-5#2)(2005-11#1)(2007-8#2)
of the intrauterine##3##3##(1994-3#1)(1994-4#1)(1994-9#1)
of the intraventricular##2##3##(1997-7#1)(2006-5#1)
of the intravesical##3##3##(2006-9#1)(2008-10#2)
of the intricate##3##3##(1993-5#1)(2008-10#1)(2010-8#1)
of the intrinsic and extrinsic##2##5##(1990-11#1)(2009-12#1)
of the intrinsic fluorescence##3##4##(1990-7#1)(1991-7#1)(2008-8#1)
of the intrinsic function##2##4##(2008-3#2)
of the intrinsic noise##2##4##(2007-9#1)(2008-3#1)
of the intrinsic##29##3##(1990-11#2)(1990-5#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-8#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-6#1)(2006-10#2)(2007-11#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#4)(2008-8#1)(2009-12#1)
of the introduced plasmid##2##4##(1994-9#1)(2008-8#1)
of the introduced##9##3##(1994-9#1)(2005-8#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-8#1)
of the introducing##2##3##(1997-6#1)(2007-9#1)
of the introduction of a##3##5##(1997-3#1)(2008-11#2)
of the introduction of new##4##5##(1995-5#1)(2006-12#1)(2007-12#1)(2008-10#1)
of the introduction of the##2##5##(2008-11#1)(2011-1#1)
of the introduction of##18##4##(1995-5#1)(1997-3#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-7#2)(2010-3#1)(2010-7#1)(2011-1#1)(2012-12#2)
of the introduction##19##3##(1995-5#1)(1997-3#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-7#2)(2010-3#1)(2010-7#1)(2011-1#1)(2012-12#2)
of the intron##9##3##(1990-2#1)(1991-5#1)(1991-6#2)(1992-10#1)(1993-12#1)(1994-12#1)(1995-8#2)
of the intron-exon##2##3##(1991-4#1)(1994-3#1)
of the introns##7##3##(1991-12#1)(1993-11#1)(1993-3#1)(1995-6#1)(1996-4#1)(1997-6#1)(1997-8#1)
of the inulinase##2##3##(2008-6#1)(2011-1#1)
of the invading##2##3##(2008-10#2)
of the invariant##2##3##(1995-8#1)(2006-12#1)
of the invasion of##2##4##(1991-12#1)(2007-8#1)
of the invasion process##2##4##(1994-9#1)(2008-10#1)
of the invasion##5##3##(1991-12#1)(1994-9#1)(2007-8#1)(2008-10#1)(2013-1#1)
of the invasive##4##3##(2005-11#1)(2008-5#1)(2010-12#1)(2013-7#1)
of the invasiveness##2##3##(1993-4#1)(2006-10#1)
of the inverse problem##4##4##(2008-2#3)(2013-1#1)
of the inverse##11##3##(1991-12#1)(2008-2#5)(2008-3#2)(2010-1#2)(2013-1#1)
of the inversion algorithm##2##4##(2008-3#2)
of the inversion##5##3##(2008-3#4)(2013-1#1)
of the inverted##9##3##(1990-10#1)(1990-2#1)(1992-4#2)(1995-8#1)(2008-2#1)(2008-3#2)(2008-5#1)
of the investigated compounds in##2##5##(2008-10#2)
of the investigated compounds##6##4##(1996-3#1)(2007-1#1)(2007-11#1)(2008-10#3)
of the investigated drugs##4##4##(2008-10#3)(2008-11#1)
of the investigated species##3##4##(2007-12#2)(2008-4#1)
of the investigated surfactants##2##4##(2005-11#2)
of the investigated##38##3##(1990-11#1)(1990-3#1)(1990-9#1)(1994-6#1)(1995-11#1)(1995-3#1)(1996-3#1)(2005-11#2)(2007-1#1)(2007-11#2)(2007-12#2)(2008-10#14)(2008-11#1)(2008-3#3)(2008-4#1)(2009-2#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
of the investigation are##2##4##(1991-9#1)(2008-3#1)
of the investigation of##4##4##(1991-5#1)(2008-10#1)(2008-11#1)(2008-4#1)
of the investigation was to evaluate##2##6##(1990-6#1)(2005-1#1)
of the investigation was to study##4##6##(2008-7#2)(2009-2#1)(2010-9#1)
of the investigation was to##9##5##(1990-6#1)(1991-11#1)(2005-1#1)(2007-11#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-9#1)
of the investigation was##13##4##(1990-6#1)(1991-11#1)(1991-12#1)(1992-8#1)(2005-1#1)(2007-11#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-9#2)(2011-1#1)
of the investigation##30##3##(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-8#1)(1993-3#1)(2004-1#1)(2005-1#1)(2005-11#1)(2006-8#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-2#1)(2010-9#2)(2011-1#1)(2012-2#1)(2013-8#1)
of the investigations was##2##4##(2005-10#1)(2009-4#1)
of the investigations##5##3##(1991-8#1)(2005-10#1)(2009-4#1)(2009-5#1)(2013-1#1)
of the investigators##2##3##(1993-10#1)(1996-8#1)
of the invited##2##3##(1995-12#1)(2008-7#1)
of the involuntary##2##3##(2006-9#1)(2008-7#1)
of the involved hip##2##4##(2007-8#1)(2008-12#1)
of the involved wrist##2##4##(2006-3#1)(2008-9#1)
of the involved##19##3##(1992-12#1)(1993-6#1)(1996-12#1)(1996-3#1)(2005-9#1)(2006-12#1)(2006-3#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2012-2#2)
of the involvement of##17##4##(1991-11#1)(1991-5#1)(1991-7#1)(1991-9#1)(1995-11#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-7#2)(2011-1#1)(2012-1#1)(2012-12#1)
of the inward##2##3##(1992-11#1)(1997-2#1)
of the inwardly rectifying K+##2##5##(1994-3#1)(1995-12#1)
of the iodate##2##3##(2008-10#2)
of the iodide##2##3##(1996-2#1)(2008-10#1)
of the iodine content of##2##5##(2006-4#1)(2007-2#1)
of the iodine##5##3##(2005-4#1)(2006-4#3)(2007-2#1)
of the ion associate##3##4##(2008-10#3)
of the ion association##4##4##(2008-10#4)
of the ion exchange##2##4##(1996-9#1)(1997-7#1)
of the ion exchanger##4##4##(2008-10#4)
of the ion pair##2##4##(2008-10#2)
of the ion transport##2##4##(1997-1#2)
of the ion##27##3##(1990-12#1)(1994-2#1)(1996-9#1)(1997-1#2)(1997-7#1)(2006-2#1)(2006-6#1)(2008-10#17)(2008-7#1)(2013-8#1)
of the ion-pair formed between##2##5##(2008-10#2)
of the ion-pair##5##3##(2005-4#1)(2008-10#4)
of the ionic fraction of heavy metals##2##7##(2008-10#2)
of the ionic strength##6##4##(1993-6#1)(1997-2#1)(2005-11#1)(2008-10#3)
of the ionic##19##3##(1993-6#1)(1997-2#1)(2005-11#2)(2008-10#11)(2008-4#1)(2008-9#1)(2009-3#1)(2010-7#1)
of the ionization##4##3##(2006-10#1)(2008-10#1)(2008-3#2)
of the ionized##2##3##(1993-2#1)(2008-2#1)
of the ionotropic##2##3##(1993-11#1)(1995-7#1)
of the ions##5##3##(1993-2#1)(1995-8#1)(2005-11#1)(2007-12#1)(2012-11#1)
of the ipsilateral##17##3##(1990-2#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-8#1)(1993-3#1)(1995-11#2)(1995-12#1)(1996-12#1)(1997-7#2)(2008-12#1)(2008-6#1)(2009-3#1)(2010-12#1)
of the iris and##2##4##(1993-1#1)(1997-3#1)
of the iron atom##2##4##(1991-7#1)(1993-6#1)
of the iron chalcogenide glass##2##5##(2008-10#2)
of the iron chelator##2##4##(1995-6#1)(2011-2#1)
of the iron site##3##4##(1997-7#3)
of the iron##21##3##(1990-1#1)(1991-5#2)(1991-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-12#1)(1995-10#1)(1995-11#1)(1995-6#1)(1996-7#1)(1997-7#3)(2007-7#1)(2008-10#3)(2011-2#1)
of the iron(III)##2##3##(1997-7#1)(2008-10#1)
of the irradiance##5##3##(2008-2#1)(2008-3#3)(2011-1#1)
of the irradiances##2##3##(2008-2#2)
of the irradiated LDH##2##4##(2011-2#2)
of the irradiated samples##2##4##(2007-12#1)(2013-7#1)
of the irradiated##12##3##(1992-6#1)(1993-2#1)(2005-11#1)(2007-12#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#2)(2013-7#1)
of the irradiation##2##3##(2007-11#1)(2008-8#1)
of the irregular##2##3##(2007-9#1)(2008-9#1)
of the irrigation methods##2##4##(2008-10#2)
of the irrigation##5##3##(2008-10#5)
of the irritable bowel##2##4##(1990-8#1)(2006-8#1)
of the irritable##3##3##(1990-8#1)(2006-8#1)(2009-2#1)
of the irritant##2##3##(2008-5#1)(2013-1#1)
of the irritation##2##3##(1994-6#1)(2008-5#1)
of the ischaemic##2##3##(1996-1#1)(2008-10#1)
of the ischemic myocardium##2##4##(1990-4#1)(2008-10#1)
of the ischemic##10##3##(1990-4#1)(1996-3#1)(2006-11#1)(2006-4#1)(2007-10#1)(2007-9#1)(2008-10#2)(2008-2#1)(2009-10#1)
of the island##7##3##(1993-7#1)(1994-6#1)(2007-5#1)(2008-1#1)(2008-4#1)(2010-2#1)(2011-1#1)
of the islet##6##3##(1992-6#1)(1995-8#1)(2007-5#2)(2010-11#2)
of the islets##4##3##(1995-2#1)(1997-4#1)(2010-11#2)
of the isoamylase##2##3##(1990-11#2)
of the isochromatic dye ion-pairs##2##5##(2005-4#2)
of the isochromatic##3##3##(2005-4#2)(2008-2#1)
of the isocoumarin ring##2##4##(1991-3#2)
of the isoelectric point##3##4##(1990-12#1)(2005-11#1)(2008-7#1)
of the isoenzyme##2##3##(1991-11#1)(1993-1#1)
of the isoflavones##2##3##(1996-3#1)(2010-1#1)
of the isoform##2##3##(1993-4#1)(1996-12#1)
of the isoforms##3##3##(1994-9#2)(1996-12#1)
of the isogenic wild type strain##2##6##(1993-11#1)(2008-10#1)
of the isoglobo-series gangliosides##2##4##(1996-4#2)
of the isolate##8##3##(2007-12#1)(2008-10#5)(2008-5#1)(2008-7#1)
of the isolated clones##3##4##(1993-6#1)(1995-2#1)(1996-10#1)
of the isolated compounds##4##4##(2006-12#1)(2007-1#1)(2008-11#1)(2013-1#1)
of the isolated enzyme##3##4##(1990-7#1)(1992-3#1)(1993-11#1)
of the isolated mature##2##4##(2008-11#2)
of the isolated peptide and##2##5##(1991-8#1)(1993-8#1)
of the isolated peptide##3##4##(1990-7#1)(1991-8#1)(1993-8#1)
of the isolated peptides##2##4##(1990-5#1)(1996-5#1)
of the isolated protein##2##4##(1993-11#1)(1994-12#1)
of the isolated proteins and##2##5##(1992-3#1)(1994-5#1)
of the isolated proteins##3##4##(1992-3#1)(1993-6#1)(1994-5#1)
of the isolated strains##2##4##(1991-3#1)(1992-10#1)
of the isolated##79##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#2)(1991-3#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-3#4)(1992-5#1)(1992-9#1)(1993-11#4)(1993-3#3)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-7#2)(1995-8#1)(1996-10#2)(1996-12#5)(1996-2#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-8#1)(2006-12#2)(2006-8#1)(2007-1#2)(2007-4#3)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#5)(2008-2#1)(2008-5#2)(2009-10#1)(2009-2#1)(2010-12#1)(2010-4#1)(2012-11#1)(2013-1#1)
of the isolates and##2##4##(2008-12#2)
of the isolates belonged to##2##5##(2008-10#2)
of the isolates from##6##4##(1992-2#1)(1997-4#1)(2007-7#1)(2008-5#2)(2013-1#1)
of the isolates in the##2##5##(2008-10#1)(2008-5#1)
of the isolates in##4##4##(2008-10#3)(2008-5#1)
of the isolates was##2##4##(2006-8#1)(2007-8#1)
of the isolates were found##2##5##(2006-5#1)(2007-7#1)
of the isolates were identified as##2##6##(2006-8#1)(2008-10#1)
of the isolates were resistant##3##5##(2008-10#1)(2008-7#1)(2011-2#1)
of the isolates were sensitive to##2##6##(2007-7#1)(2008-10#1)
of the isolates were##18##4##(1991-8#1)(2006-5#1)(2006-8#1)(2007-7#2)(2008-10#8)(2008-5#1)(2008-7#2)(2011-2#2)
of the isolates##76##3##(1991-8#1)(1992-2#1)(1993-10#1)(1996-12#1)(1997-3#1)(1997-4#1)(2005-8#1)(2006-3#1)(2006-5#1)(2006-8#2)(2007-7#5)(2007-8#1)(2008-10#34)(2008-11#1)(2008-12#3)(2008-5#6)(2008-7#3)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#5)(2012-3#1)(2013-1#1)(2013-8#2)
of the isolation of##2##4##(1990-7#1)(2008-5#1)
of the isolation##4##3##(1990-7#1)(1997-2#1)(2008-10#1)(2008-5#1)
of the isomeric##3##3##(1990-10#1)(1991-3#1)(1996-5#1)
of the isomers of##2##4##(1990-10#1)(2008-10#1)
of the isomers##7##3##(1990-10#1)(1990-5#1)(2006-12#1)(2007-8#1)(2008-10#2)(2013-7#1)
of the isoprenoid metabolism##2##4##(1990-12#1)(2012-2#1)
of the isoprenoid##3##3##(1990-12#1)(2007-8#1)(2012-2#1)
of the isotope##4##3##(1995-10#1)(2008-10#1)(2008-4#1)(2008-9#1)
of the isotopic##2##3##(1997-2#1)(2008-10#1)
of the isotropic##3##3##(1991-5#1)(1996-2#1)(2005-11#1)
of the isozyme##3##3##(1990-12#1)(1991-12#1)(2008-10#1)
of the issue of##3##4##(2006-12#1)(2008-11#1)(2009-6#1)
of the issue##10##3##(1991-11#1)(2006-12#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-6#2)(2012-2#1)(2013-1#1)
of the issues involved in##4##5##(1991-12#2)(1993-2#1)(1993-9#1)
of the issues involved##6##4##(1991-12#2)(1993-2#1)(1993-9#1)(2005-5#1)(2008-9#1)
of the issues raised##2##4##(2006-9#1)(2008-10#1)
of the issues surrounding##2##4##(2008-10#1)(2013-8#1)
of the issues that##7##4##(1991-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)
of the issues##34##3##(1991-12#2)(1991-3#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-9#1)(2005-11#1)(2005-5#1)(2006-11#1)(2006-9#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
of the items##8##3##(1990-11#1)(1990-4#1)(1994-2#1)(2006-3#1)(2008-11#1)(2012-2#1)(2013-1#2)
of the iterative##6##3##(1996-8#1)(2007-12#2)(2008-10#1)(2008-3#2)
of the iturin lipopeptides##2##4##(1994-2#2)
of the jaw##18##3##(1991-1#1)(1996-8#2)(1997-3#1)(2005-7#1)(2008-1#4)(2008-7#2)(2010-12#1)(2010-9#1)(2011-2#2)(2012-12#2)(2013-8#1)
of the jaws are##2##4##(2007-12#1)(2008-5#1)
of the jaws##16##3##(2007-12#3)(2008-1#2)(2008-5#2)(2011-1#2)(2012-12#3)(2013-1#3)(2013-7#1)
of the jejunal mucosa##2##4##(1991-11#1)(1996-11#1)
of the jejunum and##2##4##(1996-11#1)(2012-2#1)
of the jejunum##15##3##(1990-5#1)(1990-9#1)(1992-5#1)(1995-3#2)(1996-11#1)(1997-5#1)(2008-10#1)(2008-8#1)(2010-12#1)(2010-5#1)(2011-12#2)(2012-2#1)(2013-8#1)
of the jelly##3##3##(1992-8#1)(2008-8#2)
of the job##4##3##(1991-2#1)(1992-1#1)(1994-6#1)(2008-2#1)
of the joint and##2##4##(2005-7#1)(2007-11#1)
of the joint can be##3##5##(2006-3#1)(2013-1#2)
of the joint is##3##4##(2006-3#1)(2007-8#1)(2011-1#1)
of the joint transform power##2##5##(2008-2#1)(2008-3#1)
of the joint transform##5##4##(2008-2#3)(2008-3#2)
of the joint was##2##4##(2006-3#1)(2007-11#1)
of the joint##57##3##(1992-11#2)(1993-3#1)(2005-12#1)(2005-7#3)(2006-10#1)(2006-12#1)(2006-3#5)(2007-11#9)(2007-12#1)(2007-5#1)(2007-7#2)(2007-8#7)(2008-2#4)(2008-3#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#2)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#3)
of the joints were##2##4##(2007-11#1)(2009-7#1)
of the joints##10##3##(1990-6#1)(1990-7#1)(2006-4#1)(2007-11#3)(2007-7#2)(2009-2#1)(2009-7#1)
of the journal &quot##3##4##(2008-7#3)
of the journal Atención Primaria##2##5##(1996-2#1)(1996-4#1)
of the journal and##2##4##(2007-11#2)
of the journal to##2##4##(2007-11#1)(2012-2#1)
of the journal##21##3##(1990-12#1)(1991-2#1)(1992-2#1)(1996-2#1)(1996-4#1)(2005-7#1)(2005-9#1)(2007-11#3)(2007-2#1)(2008-1#1)(2008-10#1)(2008-7#3)(2011-1#1)(2012-2#1)(2013-1#3)
of the journey##2##3##(2009-7#1)(2010-2#1)
of the judge in##2##4##(2007-10#2)
of the judge##4##3##(2007-10#2)(2009-8#2)
of the judicial##2##3##(1996-12#1)(2007-10#1)
of the jugular vein##2##4##(2007-7#1)(2012-3#1)
of the jump##3##3##(2005-11#1)(2008-9#1)(2009-4#1)
of the junction##5##3##(1993-9#1)(1994-12#1)(1996-8#1)(2007-12#1)(2008-7#1)
of the junctions##2##3##(1996-9#1)(2008-4#1)
of the juvenile##4##3##(1996-5#1)(1996-8#1)(2010-8#1)(2012-11#1)
of the kainate response##2##4##(1997-1#2)
of the kappa##3##3##(1991-1#1)(1995-6#1)(1997-2#1)
of the karyosome capsule##2##4##(2007-12#2)
of the karyosome in##2##4##(2007-12#1)(2008-7#1)
of the karyosome##6##3##(2007-12#3)(2008-7#3)
of the keratin##5##3##(1991-12#1)(1995-8#1)(2005-7#1)(2008-5#1)(2009-10#1)
of the keratinocytes##2##3##(1993-11#1)(1995-11#1)
of the kernel##3##3##(2008-1#1)(2008-2#2)
of the kerosene##2##3##(2007-10#1)(2008-11#1)
of the key components of##2##5##(2008-5#1)(2008-7#1)
of the key enzyme##2##4##(1994-6#1)(2008-10#1)
of the key enzymes of##3##5##(1994-12#1)(1995-4#1)(1997-2#1)
of the key enzymes##8##4##(1992-1#1)(1994-12#1)(1994-3#1)(1995-4#1)(1996-10#1)(1997-2#1)(2008-9#2)
of the key factors in##2##5##(1990-2#1)(1993-9#1)
of the key factors##5##4##(1990-2#1)(1993-9#1)(2008-3#1)(2013-1#2)
of the key features##2##4##(2007-11#1)(2008-8#1)
of the key issues##3##4##(2008-12#1)(2008-5#1)(2010-2#1)
of the key steps##2##4##(1992-1#1)(2007-12#1)
of the key##88##3##(1990-2#1)(1992-1#2)(1992-12#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-4#1)(1996-1#1)(1996-10#1)(1996-5#1)(1997-2#1)(1997-4#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#1)(2012-12#6)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
of the kidney and liver##2##5##(2007-8#1)(2008-12#1)
of the kidney and##6##4##(1997-7#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-12#1)
of the kidney in##3##4##(1996-8#1)(2008-10#2)
of the kidney is a rare##2##6##(2006-8#1)(2010-12#1)
of the kidney is a##3##5##(2006-8#1)(2010-12#1)(2012-12#1)
of the kidney is##5##4##(1990-6#1)(2006-8#1)(2008-10#1)(2010-12#1)(2012-12#1)
of the kidney parenchyma##2##4##(2011-1#2)
of the kidney was##2##4##(1996-7#1)(2011-2#1)
of the kidney with##2##4##(2006-7#1)(2013-1#1)
of the kidney##56##3##(1990-6#3)(1992-1#1)(1992-8#2)(1994-5#1)(1995-9#1)(1996-7#1)(1996-8#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2006-7#3)(2006-8#1)(2006-9#1)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2009-2#1)(2009-3#1)(2010-1#1)(2010-12#4)(2011-1#3)(2011-2#2)(2012-11#2)(2012-12#1)(2013-1#3)
of the kidneys and##2##4##(1991-6#1)(2007-7#1)
of the kidneys in##4##4##(2006-6#1)(2006-9#1)(2008-4#2)
of the kidneys##21##3##(1990-3#1)(1991-6#1)(1992-12#2)(1993-3#1)(2006-6#1)(2006-9#1)(2007-2#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-4#7)(2009-10#1)(2012-1#1)
of the killed##2##3##(1990-12#1)(2005-11#1)
of the killer##2##3##(2007-7#1)(2009-4#1)
of the kinase and##2##4##(1995-2#1)(2008-5#1)
of the kinase was##3##4##(1990-4#1)(1990-5#1)(1997-6#1)
of the kinase##23##3##(1990-11#2)(1990-12#1)(1990-4#2)(1990-5#1)(1990-8#1)(1991-10#1)(1991-6#1)(1992-12#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-3#1)(1995-2#4)(1995-6#1)(1997-6#1)(2005-11#1)(2008-5#1)(2013-8#1)
of the kinases##4##3##(1993-11#1)(1994-12#1)(2007-12#1)(2009-8#1)
of the kind of##5##4##(1990-5#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-10#1)
of the kind##9##3##(1990-5#1)(1990-9#1)(1991-3#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-10#1)
of the kindling-like state##2##4##(1997-2#2)
of the kinds of##2##4##(2006-2#1)(2008-11#1)
of the kinesin##2##3##(1995-3#1)(1997-4#1)
of the kinetic behavior of##2##5##(1995-1#1)(2004-9#1)
of the kinetic constants##2##4##(1991-3#1)(2008-10#1)
of the kinetic data##4##4##(1991-8#1)(1995-5#1)(2008-10#1)(2008-3#1)
of the kinetic method##2##4##(2008-10#1)(2013-1#1)
of the kinetic model##2##4##(2007-9#1)(2010-5#1)
of the kinetic parameters##6##4##(1990-5#1)(1992-3#1)(1995-10#1)(1995-12#1)(2006-10#1)(2009-11#1)
of the kinetic##31##3##(1990-5#2)(1991-3#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-7#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-7#1)(1997-7#1)(2004-9#1)(2005-11#1)(2006-10#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-6#1)(2009-10#1)(2009-11#1)(2010-5#1)(2013-1#1)
of the kinetics of biomolecular interactions##2##6##(2008-4#2)
of the kinetics of cytokine##2##5##(1992-8#1)(1994-9#1)
of the kinetics of the##2##5##(2008-10#1)(2010-5#1)
of the kinetics of##20##4##(1990-7#1)(1990-8#1)(1991-7#1)(1992-8#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-3#1)(1997-1#2)(1997-7#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-4#2)(2010-5#2)(2011-1#1)
of the kinetics##22##3##(1990-7#1)(1990-8#1)(1991-7#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-3#1)(1997-1#2)(1997-7#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-4#2)(2010-5#3)(2011-1#1)
of the kinoform##4##3##(2008-2#4)
of the kissing##2##3##(1997-5#2)
of the kit##6##3##(1991-9#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-7#1)(2009-8#1)
of the knee after##3##4##(2007-11#1)(2007-8#1)(2008-11#1)
of the knee and hip##3##5##(2007-8#3)
of the knee and##6##4##(1996-11#1)(2007-11#1)(2007-8#4)
of the knee are##3##4##(2007-8#1)(2009-4#1)(2012-2#1)
of the knee during the##2##5##(2012-1#2)
of the knee during##4##4##(2012-1#3)(2013-7#1)
of the knee in the treatment of##2##7##(2007-7#1)(2008-8#1)
of the knee in the##3##5##(2007-7#2)(2008-8#1)
of the knee in##7##4##(2006-11#1)(2007-7#2)(2008-8#1)(2009-3#1)(2012-3#1)(2013-1#1)
of the knee is a##3##5##(2007-5#1)(2010-12#1)(2013-1#1)
of the knee is not##2##5##(2007-4#1)(2007-8#1)
of the knee is##6##4##(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2010-12#1)(2013-1#1)
of the knee joint in children and young adolescents##2##9##(2007-8#2)
of the knee joint in##5##5##(1993-8#1)(2007-11#1)(2007-7#1)(2007-8#2)
of the knee joint is##3##5##(2007-11#2)(2007-7#1)
of the knee joint was##2##5##(2007-4#1)(2007-8#1)
of the knee joint were##2##5##(2007-4#1)(2007-7#1)
of the knee joint##32##4##(1993-8#1)(1997-8#1)(2006-6#2)(2007-11#8)(2007-4#2)(2007-7#5)(2007-8#10)(2009-3#1)(2009-4#1)(2013-1#1)
of the knee joints##3##4##(2007-11#1)(2011-2#2)
of the knee performed##3##4##(2007-11#1)(2007-7#1)(2012-2#1)
of the knee was##2##4##(2007-11#1)(2007-8#1)
of the knee were##2##4##(2006-10#2)
of the knee with##3##4##(2006-10#1)(2008-12#1)(2013-1#1)
of the knee##155##3##(1990-11#1)(1992-3#1)(1993-3#1)(1993-8#1)(1996-11#2)(1996-3#3)(1997-1#1)(1997-8#1)(2006-10#8)(2006-11#4)(2006-5#1)(2006-6#2)(2007-1#3)(2007-11#22)(2007-4#6)(2007-5#2)(2007-7#20)(2007-8#25)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-3#2)(2009-4#2)(2009-5#2)(2010-12#4)(2010-3#1)(2010-4#1)(2011-2#5)(2012-1#3)(2012-2#7)(2012-3#1)(2013-1#12)(2013-7#1)
of the knees##5##3##(1991-12#1)(2006-10#1)(2008-7#1)(2008-8#1)(2013-1#1)
of the knowledge and##3##4##(1991-1#1)(2008-2#1)(2012-12#1)
of the knowledge##13##3##(1991-1#1)(1994-2#1)(2007-5#1)(2008-2#1)(2008-7#3)(2011-1#1)(2012-12#1)(2012-3#3)(2013-8#1)
of the known impurities##3##4##(2010-12#2)(2013-7#1)
of the known##40##3##(1990-10#1)(1990-3#1)(1990-6#1)(1992-12#1)(1992-3#1)(1993-2#1)(1993-6#3)(1995-2#2)(1996-10#1)(1996-4#1)(1996-6#1)(1997-6#1)(2005-10#1)(2006-12#2)(2006-4#1)(2007-1#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-2#1)(2010-12#2)(2010-2#1)(2011-2#2)(2012-2#1)(2013-7#1)
of the lab's##2##3##(2007-9#2)
of the label##5##3##(1991-4#1)(1991-5#1)(1992-1#1)(1996-3#1)(2008-11#1)
of the labeled cells##2##4##(1994-6#1)(1994-9#1)
of the labeled protein##2##4##(1991-7#2)
of the labeled##15##3##(1990-12#1)(1991-7#2)(1991-9#1)(1992-11#1)(1992-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-11#1)(2008-10#1)(2008-2#1)
of the labelled claim##2##4##(1996-2#2)
of the labelled##8##3##(1992-6#1)(1994-2#1)(1995-11#1)(1996-2#2)(2007-9#1)(2008-10#2)
of the labial gland##2##4##(2007-12#2)
of the labium##2##3##(2007-12#2)
of the labor market##3##4##(2006-4#1)(2010-2#1)(2011-2#1)
of the labor##4##3##(2006-4#1)(2008-9#1)(2010-2#1)(2011-2#1)
of the laboratories##3##3##(2007-7#1)(2008-10#2)
of the laboratory##17##3##(1990-8#1)(1992-11#1)(1994-2#1)(1997-3#1)(2005-5#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-4#1)(2013-7#1)(2013-8#1)
of the labrum is##2##4##(2007-12#2)
of the labrum##6##3##(2007-12#5)(2013-7#1)
of the labyrinthine segment of the facial nerve##2##8##(2006-11#2)
of the labyrinthine segment##3##4##(2006-11#3)
of the lac promoter##5##4##(1990-10#1)(1992-3#1)(1995-2#1)(1996-10#1)(2008-10#1)
of the lac##10##3##(1990-10#1)(1990-5#2)(1990-9#1)(1991-12#1)(1991-8#1)(1992-3#1)(1995-2#1)(1996-10#1)(2008-10#1)
of the lacZ alpha fragment##2##5##(1997-4#2)
of the lacZ gene in##3##5##(1991-7#1)(1995-12#1)(1997-1#1)
of the lacZ gene##6##4##(1990-5#1)(1991-7#2)(1995-12#2)(1997-1#1)
of the lacZ##12##3##(1990-5#1)(1991-7#2)(1995-12#2)(1997-1#1)(1997-4#2)(1997-6#2)(1997-7#1)(2009-12#1)
of the laccase##2##3##(2005-12#1)(2008-10#1)
of the lack of effect##4##5##(1993-2#1)(2012-2#1)(2013-1#2)
of the lack of##27##4##(1990-2#1)(1990-6#1)(1990-9#1)(1992-9#1)(1993-2#1)(1993-8#1)(1995-6#1)(1997-6#1)(1997-7#1)(2005-8#1)(2007-10#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#2)(2009-9#1)(2012-2#3)(2013-1#2)(2013-8#1)
of the lacquer films##2##4##(2008-10#2)
of the lacrimal and salivary glands##3##6##(2006-11#1)(2011-1#2)
of the lacrimal gland##4##4##(2007-1#4)
of the lacrimal##10##3##(1995-9#1)(2006-11#2)(2007-1#4)(2011-1#2)(2011-2#1)
of the lactate##3##3##(1990-8#1)(1994-9#1)(2008-10#1)
of the lactone and carboxylate forms of camptothecin##2##8##(1997-3#2)
of the lactone and carboxylate forms of##4##7##(1997-3#4)
of the lactone ring##2##4##(2005-8#1)(2007-11#1)
of the lactone##8##3##(1994-3#1)(1997-3#5)(2005-8#1)(2007-11#1)
of the lactose##3##3##(1991-12#1)(1993-11#1)(1996-7#1)
of the ladder##3##3##(2006-10#2)(2011-1#1)
of the lag period##3##4##(1990-11#1)(2008-10#2)
of the lag phase##3##4##(1990-11#1)(2011-2#2)
of the lag time between##2##5##(2008-10#2)
of the lag time##3##4##(1997-7#1)(2008-10#2)
of the lag##10##3##(1990-11#2)(1997-7#1)(2008-10#4)(2008-5#1)(2011-2#2)
of the lagoon##3##3##(2012-2#1)(2013-7#2)
of the lake##6##3##(1992-4#1)(1996-6#2)(2007-7#1)(2007-9#1)(2010-8#1)
of the lambda##6##3##(1990-3#1)(1991-6#3)(1995-2#1)(1997-5#1)
of the lamellar##3##3##(1991-4#1)(2008-2#1)(2008-5#1)
of the lamin A##2##4##(1992-12#1)(2012-12#1)
of the lamina terminalis##3##4##(1991-8#2)(2008-4#1)
of the lamina##6##3##(1990-7#1)(1991-8#2)(1997-3#1)(2008-4#1)(2013-7#1)
of the laminar##3##3##(1991-8#1)(1997-2#1)(1997-7#1)
of the laminaria tent##3##4##(1990-12#3)
of the laminin fragments##2##4##(1997-1#2)
of the laminin##6##3##(1991-2#2)(1995-5#1)(1997-1#2)(2013-8#1)
of the lamprey##4##3##(1993-3#1)(1997-3#3)
of the land##3##3##(2007-8#1)(2008-1#1)(2013-8#1)
of the landmark##3##3##(1992-9#1)(2008-2#1)(2008-9#1)
of the language##4##3##(1996-2#1)(1996-7#1)(2007-3#1)(2010-2#1)
of the lanthanide##5##3##(1990-11#1)(1994-8#1)(2008-10#1)(2008-3#1)(2008-4#1)
of the lanthanides##3##3##(2007-8#1)(2008-10#2)
of the laparoscopic approach##3##4##(2006-6#2)(2008-3#1)
of the laparoscopic##10##3##(2006-10#1)(2006-5#1)(2006-6#3)(2007-9#1)(2008-3#1)(2008-5#1)(2013-1#2)
of the laparoscopy setup##2##4##(2006-6#2)
of the laparoscopy##4##3##(2006-6#2)(2011-1#2)
of the lapped##2##3##(2008-2#2)
of the large and##2##4##(1997-6#1)(2011-2#1)
of the large bowel are##2##5##(1993-9#1)(2006-6#1)
of the large bowel##10##4##(1990-5#1)(1993-8#1)(1993-9#4)(2006-6#2)(2007-5#1)(2008-10#1)
of the large colon##2##4##(1992-10#1)(2005-7#1)
of the large extracellular domain##2##5##(1994-3#1)(1996-5#1)
of the large intestine is##2##5##(1990-10#1)(1991-6#1)
of the large intestine##11##4##(1990-10#1)(1990-11#1)(1991-3#1)(1991-6#1)(1993-9#2)(2006-2#2)(2006-8#1)(2007-8#1)(2011-2#1)
of the large number of patients##2##6##(2008-1#1)(2009-11#1)
of the large number of##6##5##(2007-12#1)(2008-1#1)(2008-2#1)(2008-6#1)(2009-11#1)(2012-1#1)
of the large size of the##2##6##(1993-2#1)(2005-9#1)
of the large size##3##4##(1993-2#1)(1993-8#1)(2005-9#1)
of the large subunit of##3##5##(1991-9#1)(1992-8#1)(1995-8#1)
of the large subunit##10##4##(1990-10#1)(1991-9#1)(1992-8#3)(1995-8#1)(2005-7#1)(2006-8#1)(2008-10#1)(2010-4#1)
of the large##98##3##(1990-10#2)(1990-11#1)(1990-3#2)(1990-5#1)(1990-9#1)(1991-10#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-5#1)(1992-6#1)(1992-8#3)(1993-2#1)(1993-6#1)(1993-8#3)(1993-9#6)(1994-3#1)(1995-12#1)(1995-8#1)(1996-10#1)(1996-5#1)(1997-6#1)(1997-8#1)(2005-7#2)(2005-9#1)(2006-11#1)(2006-12#1)(2006-2#2)(2006-6#2)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
of the larger protein##2##4##(1996-11#1)(1997-2#1)
of the larger##22##3##(1990-11#2)(1990-12#1)(1991-1#1)(1991-10#1)(1991-4#1)(1991-7#1)(1993-12#1)(1994-1#1)(1996-10#1)(1996-11#1)(1997-2#1)(1997-4#1)(1997-5#1)(2005-11#2)(2006-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-12#1)(2011-2#1)
of the largest follicle##3##4##(2006-5#1)(2008-12#1)(2008-3#1)
of the largest subunit of##2##5##(1992-5#1)(1993-11#1)
of the largest##35##3##(1991-2#1)(1992-5#1)(1993-11#1)(1993-12#1)(1994-10#1)(1995-6#1)(1995-8#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-4#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-4#1)(2010-5#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
of the larva##4##3##(2008-5#4)
of the larvae##10##3##(1997-8#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#2)(2010-8#2)(2011-2#1)(2012-2#1)
of the larval body wall##2##5##(1995-5#2)
of the larval##16##3##(1991-8#1)(1995-5#2)(2004-11#1)(2007-11#3)(2007-12#3)(2007-3#2)(2007-5#1)(2008-10#1)(2008-7#2)
of the laryngeal mask airway##5##5##(2006-10#3)(2006-2#1)(2007-7#1)
of the laryngeal##8##3##(2005-7#1)(2006-10#3)(2006-2#1)(2007-7#1)(2008-5#2)
of the larynx and##4##4##(1993-8#1)(2008-5#2)(2011-1#1)
of the larynx##25##3##(1991-4#1)(1992-2#2)(1993-6#3)(1993-8#2)(2007-9#1)(2008-11#1)(2008-5#3)(2009-10#3)(2009-2#1)(2011-1#2)(2011-2#3)(2012-2#2)(2013-8#1)
of the laser and the##2##5##(2007-12#1)(2008-3#1)
of the laser and##6##4##(2007-11#1)(2007-12#2)(2008-3#3)
of the laser as##2##4##(1991-1#1)(2008-3#1)
of the laser beam and##2##5##(2008-3#2)
of the laser beam intensity##2##5##(2007-12#1)(2008-2#1)
of the laser beam##24##4##(1993-3#1)(2007-11#2)(2007-12#5)(2008-10#1)(2008-2#5)(2008-3#10)
of the laser cavity##3##4##(2007-12#2)(2008-3#1)
of the laser current##2##4##(2008-3#2)
of the laser diode##5##4##(2007-12#1)(2008-2#1)(2008-3#3)
of the laser frequency and##2##5##(2007-12#1)(2008-1#1)
of the laser frequency##4##4##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
of the laser has been##2##5##(2008-3#2)
of the laser in the##2##5##(2008-3#2)
of the laser in##4##4##(2007-12#1)(2008-3#2)(2012-3#1)
of the laser intensity##2##4##(2007-12#2)
of the laser is demonstrated##2##5##(2007-11#1)(2007-12#1)
of the laser is##7##4##(2007-11#2)(2007-12#4)(2008-3#1)
of the laser light##2##4##(2007-11#1)(2008-2#1)
of the laser output##2##4##(2007-12#2)
of the laser performance##3##4##(2008-2#1)(2008-3#2)
of the laser power##4##4##(1992-12#1)(2008-2#1)(2008-3#2)
of the laser pulse##4##4##(2007-12#2)(2008-1#1)(2008-3#1)
of the laser radiation were##2##5##(2008-2#1)(2008-3#1)
of the laser radiation##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
of the laser resonator##2##4##(2007-12#1)(2008-2#1)
of the laser source##5##4##(2008-2#2)(2008-3#1)(2008-9#1)(2009-5#1)
of the laser system##2##4##(2008-2#2)
of the laser temporal pulse##2##5##(2008-10#2)
of the laser was##3##4##(2007-12#1)(2008-3#1)(2012-3#1)
of the laser with the##2##5##(2007-11#1)(2008-10#1)
of the laser with##4##4##(2007-11#1)(2007-12#2)(2008-10#1)
of the laser##151##3##(1991-1#1)(1991-3#1)(1991-4#2)(1992-12#1)(1993-3#2)(2006-12#1)(2007-11#12)(2007-12#44)(2008-1#2)(2008-10#6)(2008-2#33)(2008-3#42)(2008-9#1)(2009-5#1)(2012-3#2)
of the laser's output power##2##5##(2007-12#1)(2008-3#1)
of the laser's output##3##4##(2007-12#1)(2008-3#2)
of the laser's##9##3##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#3)
of the laser-active##2##3##(2007-12#2)
of the laser-diode##2##3##(2007-12#1)(2008-3#1)
of the laser-induced fluorescence##2##4##(2008-3#2)
of the laser-induced##5##3##(2006-12#1)(2007-12#1)(2008-3#3)
of the laserlike##2##3##(2007-12#1)(2008-3#1)
of the lasers##3##3##(2007-11#1)(2008-3#2)
of the lasing field##2##4##(2007-12#1)(2008-2#1)
of the lasing inside the##2##5##(2007-12#1)(2008-2#1)
of the lasing##7##3##(2007-12#3)(2008-2#4)
of the last 30 years##2##5##(2008-5#1)(2013-1#1)
of the last century##4##4##(2006-10#1)(2007-8#1)(2008-7#1)(2013-7#1)
of the last four phases of the strategy##2##8##(1996-1#1)(1996-2#1)
of the last instar larva and pupa of Cryptophlebia cortesi Clarke##2##11##(2008-6#2)
of the last ten years##2##5##(1992-12#1)(2012-3#1)
of the last three##2##4##(1997-2#1)(2008-7#1)
of the last two decades##4##5##(2007-11#1)(2007-12#1)(2008-5#1)(2010-10#1)
of the last two##5##4##(2007-11#1)(2007-12#1)(2008-5#1)(2010-10#1)(2013-7#1)
of the last##62##3##(1990-10#1)(1991-11#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-2#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-5#2)(2004-11#1)(2005-7#1)(2006-10#2)(2006-2#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-9#1)(2009-12#1)(2010-10#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
of the late afterhyperpolarization##2##4##(1992-8#2)
of the late blight pathogen Phytophthora infestans##2##7##(2008-10#2)
of the late blight pathogen##4##5##(2008-10#4)
of the late phase##3##4##(1990-4#1)(1995-11#1)(1995-12#1)
of the late##23##3##(1990-4#1)(1991-11#1)(1991-4#1)(1992-8#2)(1994-2#1)(1995-11#1)(1995-12#1)(1996-8#1)(2004-1#1)(2006-11#1)(2006-6#1)(2006-9#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2011-2#2)
of the latency##2##3##(2008-10#1)(2008-4#1)
of the latent##9##3##(1992-12#1)(1992-2#2)(1995-3#1)(2008-10#1)(2009-10#1)(2009-4#1)(2010-11#1)(2013-8#1)
of the later##8##3##(1991-4#1)(1992-5#1)(1994-8#1)(2005-12#1)(2006-8#1)(2007-1#1)(2008-7#1)(2009-12#1)
of the lateral and medial##2##5##(1996-7#1)(2007-7#1)
of the lateral and third ventricles##2##6##(1996-3#1)(2006-5#1)
of the lateral and##5##4##(1995-5#1)(1996-3#1)(1996-7#1)(2006-5#1)(2007-7#1)
of the lateral chain##2##4##(2006-10#1)(2008-10#1)
of the lateral condyle and##2##5##(2012-3#2)
of the lateral geniculate body##3##5##(2007-3#3)
of the lateral geniculate nucleus##2##5##(1992-9#1)(1993-12#1)
of the lateral geniculate##5##4##(1992-9#1)(1993-12#1)(2007-3#3)
of the lateral hypothalamus in##4##5##(2009-10#1)(2012-1#3)
of the lateral hypothalamus##7##4##(1992-10#1)(1994-2#1)(1996-2#1)(2009-10#1)(2012-1#3)
of the lateral line##4##4##(1995-8#2)(2012-12#2)
of the lateral meniscus##2##4##(1996-11#1)(2011-2#1)
of the lateral nucleus are##2##5##(1995-5#2)
of the lateral nucleus of the amygdala##3##7##(1993-6#2)(1996-6#1)
of the lateral nucleus##5##4##(1993-6#2)(1995-5#2)(1996-6#1)
of the lateral olfactory tract##2##5##(1995-5#1)(1997-6#1)
of the lateral process of the##2##6##(2006-11#1)(2006-12#1)
of the lateral projection##2##4##(1996-9#2)
of the lateral pterygoid##2##4##(2010-2#2)
of the lateral recess##2##4##(2008-7#1)(2011-2#1)
of the lateral ventricle##9##4##(1996-3#1)(1996-7#1)(2006-5#1)(2008-11#2)(2008-7#2)(2010-12#1)(2012-2#1)
of the lateral ventricles##3##4##(1991-8#1)(1996-5#2)
of the lateral##105##3##(1990-10#1)(1991-12#1)(1991-8#1)(1992-10#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-5#1)(1993-6#2)(1994-2#1)(1994-7#1)(1995-10#1)(1995-5#4)(1995-8#2)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#2)(1996-7#2)(1996-9#8)(1997-3#6)(1997-6#2)(1997-7#1)(1997-8#3)(2006-10#3)(2006-11#1)(2006-12#2)(2006-3#1)(2006-5#3)(2007-1#1)(2007-12#1)(2007-3#3)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#5)(2008-8#1)(2009-10#1)(2009-11#1)(2009-3#1)(2010-11#1)(2010-12#2)(2010-2#2)(2011-2#3)(2012-1#4)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
of the latest##9##3##(1992-9#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-10#1)(2012-1#1)
of the latex films##2##4##(2008-10#2)
of the latex##8##3##(1990-7#1)(2008-10#4)(2008-5#1)(2010-4#2)
of the latexes##2##3##(2004-9#1)(2008-10#1)
of the latissimus dorsi##2##4##(1990-9#1)(2013-1#1)
of the latter and##2##4##(2008-8#1)(2009-8#1)
of the latter are##2##4##(1996-9#1)(2012-1#1)
of the latter by##2##4##(2008-11#1)(2011-1#1)
of the latter compound##2##4##(1990-8#1)(1993-4#1)
of the latter in##4##4##(1991-11#1)(1991-7#1)(2006-10#1)(2008-10#1)
of the latter is##3##4##(1993-3#1)(2008-5#1)(2012-1#1)
of the latter on##2##4##(1997-2#1)(2007-11#1)
of the latter one##2##4##(1995-5#1)(2008-8#1)
of the latter species##2##4##(2008-10#1)(2011-2#1)
of the latter studies##2##4##(1990-7#1)(2007-4#1)
of the latter to##3##4##(1993-11#1)(1997-4#1)(2008-2#1)
of the latter two##2##4##(1990-7#1)(2008-10#1)
of the latter type of##3##5##(1996-7#1)(2007-12#1)(2010-5#1)
of the latter type##5##4##(1996-7#1)(2007-12#2)(2008-5#1)(2010-5#1)
of the latter were##3##4##(1996-11#1)(2008-1#1)(2008-7#1)
of the latter with##2##4##(1992-3#1)(2008-6#1)
of the latter##104##3##(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-9#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-8#1)(1996-11#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-2#3)(1997-4#1)(1997-7#1)(2006-10#3)(2006-4#1)(2006-8#1)(2007-11#2)(2007-12#4)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#1)(2008-2#5)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#2)(2013-7#1)
of the lattice and##2##4##(1992-4#1)(2007-12#1)
of the lattice that##2##4##(2007-11#1)(2013-8#1)
of the lattice##10##3##(1992-4#1)(1993-8#1)(2007-11#1)(2007-12#1)(2008-2#3)(2013-8#3)
of the law and##4##4##(1993-2#1)(1994-1#1)(1997-8#1)(2008-3#1)
of the law##16##3##(1991-1#1)(1993-2#1)(1993-6#1)(1994-1#1)(1995-5#1)(1995-9#2)(1996-3#1)(1997-8#1)(2005-8#1)(2006-5#1)(2007-10#2)(2008-3#1)(2008-8#1)(2010-9#1)
of the laws of##2##4##(1992-7#1)(2008-3#1)
of the layer##12##3##(1991-5#1)(1994-6#1)(1996-2#1)(2005-11#2)(2007-12#1)(2008-2#2)(2008-3#2)(2010-4#1)(2013-1#1)
of the layered##2##3##(1997-7#1)(2005-11#1)
of the layers##7##3##(1990-5#1)(2007-11#1)(2007-12#2)(2008-3#3)
of the layout area##2##4##(2008-6#2)
of the lead complex##2##4##(2008-10#2)
of the lead##12##3##(1997-1#1)(2006-8#1)(2008-10#5)(2008-11#1)(2008-3#2)(2011-2#1)(2013-8#1)
of the leader##2##3##(1992-8#1)(2008-11#1)
of the leading causes of##17##5##(2005-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-3#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-8#1)
of the leading##34##3##(1994-2#1)(1996-3#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#4)(2008-11#1)(2008-2#3)(2008-3#1)(2008-7#1)(2010-10#1)(2010-7#2)(2010-8#1)(2011-2#4)(2012-12#4)(2013-8#2)
of the leaf blade##2##4##(2007-3#1)(2008-5#1)
of the leaf extract##2##4##(2010-3#1)(2012-11#1)
of the leaf rust resistance##2##5##(2008-10#2)
of the leaf rust##3##4##(2008-10#3)
of the leaf##16##3##(2007-3#2)(2008-10#9)(2008-5#2)(2009-8#1)(2010-3#1)(2012-11#1)
of the leaf-cutting ant##2##4##(2008-6#1)(2008-8#1)
of the leaf-drop symptom##2##4##(2008-10#2)
of the leafhopper##3##3##(2007-12#1)(2008-10#1)(2011-2#1)
of the leaflets##2##3##(2007-8#1)(2013-1#1)
of the leak##2##3##(1994-8#1)(2010-5#1)
of the learning curve for##2##5##(2006-6#1)(2011-2#1)
of the learning curve##3##4##(2006-6#1)(2010-3#1)(2011-2#1)
of the learning process##2##4##(2010-8#1)(2013-1#1)
of the learning##15##3##(1994-2#1)(2006-6#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#1)(2009-9#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
of the least squares##3##4##(1995-4#2)(2008-6#1)
of the least##12##3##(1991-8#1)(1992-2#1)(1995-4#2)(2005-3#1)(2008-10#3)(2008-6#1)(2012-12#1)(2013-1#2)
of the least-squares##4##3##(2008-2#2)(2008-3#1)(2012-3#1)
of the leaves of##5##4##(1992-2#1)(2007-1#1)(2008-10#1)(2010-2#1)(2010-3#1)
of the leaves##15##3##(1992-2#1)(2007-1#1)(2008-10#3)(2008-11#2)(2008-4#2)(2010-12#2)(2010-2#1)(2010-3#3)
of the leaving group at##2##5##(1993-8#1)(1995-5#1)
of the leaving group##9##4##(1991-7#3)(1993-8#4)(1995-5#1)(2008-5#1)
of the leaving##10##3##(1991-7#3)(1993-8#4)(1995-11#1)(1995-5#1)(2008-5#1)
of the lecithin##2##3##(1992-1#1)(2008-5#1)
of the lectin and##2##4##(1997-8#1)(2008-10#1)
of the lectin from##2##4##(1990-2#1)(1996-5#1)
of the lectin##14##3##(1990-2#1)(1990-5#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-5#1)(1997-8#1)(2008-10#2)(2008-11#1)(2010-2#1)
of the lectins##4##3##(1990-7#1)(1995-11#3)
of the lecture classes##2##4##(2013-8#2)
of the lecture##3##3##(2013-8#3)
of the lecturer in##2##4##(2008-11#2)
of the lecturer practitioner##6##4##(2008-11#4)(2008-12#2)
of the lecturer##9##3##(2008-11#7)(2008-12#2)
of the leech##7##3##(1991-3#2)(1991-5#2)(1996-12#2)(1997-6#1)
of the left adrenal gland##2##5##(1997-3#1)(2011-2#1)
of the left and right##10##5##(1991-2#1)(1995-8#2)(2005-9#1)(2007-8#1)(2008-10#1)(2009-10#1)(2010-2#2)(2011-2#1)
of the left and##11##4##(1991-2#1)(1994-2#1)(1995-8#2)(2005-9#1)(2007-8#1)(2008-10#1)(2009-10#1)(2010-2#2)(2011-2#1)
of the left anterior descending artery and the##2##8##(2007-8#1)(2010-9#1)
of the left anterior descending coronary artery##2##7##(2008-7#1)(2013-1#1)
of the left anterior descending##6##5##(2007-8#3)(2008-7#1)(2010-9#1)(2013-1#1)
of the left anterior##10##4##(1991-2#1)(2006-9#1)(2007-8#4)(2008-7#2)(2010-9#1)(2013-1#1)
of the left arm##3##4##(1995-6#1)(2007-12#1)(2009-3#1)
of the left atrial appendage##3##5##(2007-8#2)(2010-12#1)
of the left atrial##5##4##(2007-8#2)(2008-11#1)(2010-12#1)(2010-9#1)
of the left atrium##7##4##(1993-5#1)(2007-8#2)(2008-7#1)(2012-2#1)(2013-1#2)
of the left branch##2##4##(2008-10#1)(2010-3#1)
of the left breast##4##4##(1996-6#2)(2011-2#1)(2012-3#1)
of the left cardiac sympathetic nerve##2##6##(2008-9#2)
of the left cardiac##3##4##(2007-8#1)(2008-9#2)
of the left cerebral##2##4##(1991-11#1)(2011-1#1)
of the left cervical##2##4##(1991-3#1)(2013-8#1)
of the left circumflex artery##2##5##(2007-8#2)
of the left circumflex coronary artery##2##6##(2007-5#1)(2008-12#1)
of the left circumflex##4##4##(2007-5#1)(2007-8#2)(2008-12#1)
of the left colon##2##4##(1990-4#1)(2006-10#1)
of the left coronary artery##9##5##(1990-3#1)(1991-9#1)(2007-8#1)(2008-4#3)(2010-12#2)(2012-1#1)
of the left coronary##12##4##(1990-3#1)(1991-9#1)(2006-4#1)(2007-8#3)(2008-4#3)(2010-12#2)(2012-1#1)
of the left elbow##4##4##(1992-11#1)(2007-11#1)(2008-4#1)(2012-3#1)
of the left eye##4##4##(1993-12#1)(2007-12#1)(2011-2#1)(2013-8#1)
of the left foot##5##4##(2008-12#2)(2009-3#2)(2010-3#1)
of the left hand##4##4##(1990-12#1)(2007-7#1)(2012-12#1)(2012-2#1)
of the left hemisphere##4##4##(1996-2#1)(2009-2#1)(2009-4#1)(2010-2#1)
of the left hepatic##3##4##(2008-3#1)(2012-2#2)
of the left hip##2##4##(2007-8#1)(2010-9#1)
of the left internal carotid artery##2##6##(2008-7#1)(2010-3#1)
of the left internal mammary artery##5##6##(2005-12#1)(2007-8#4)
of the left internal spermatic vein##3##6##(2008-7#3)
of the left internal thoracic##2##5##(2007-8#1)(2007-9#1)
of the left internal##12##4##(2005-12#1)(2007-8#5)(2007-9#1)(2008-7#4)(2010-3#1)
of the left kidney and##5##5##(2011-2#1)(2013-1#4)
of the left kidney##13##4##(2005-10#1)(2006-4#1)(2006-7#2)(2007-7#1)(2008-1#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#4)
of the left lateral wall of##2##6##(1993-12#1)(2011-2#1)
of the left lateral##3##4##(1993-12#1)(2008-7#1)(2011-2#1)
of the left lower extremity##2##5##(2007-10#1)(2008-8#1)
of the left lower lobe##5##5##(1991-3#1)(2007-8#2)(2008-5#1)(2009-8#1)
of the left lower##8##4##(1991-3#1)(1991-9#1)(2007-10#1)(2007-8#2)(2008-5#1)(2008-8#1)(2009-8#1)
of the left lung##4##4##(1991-9#1)(2007-8#1)(2008-4#2)
of the left main bronchus##2##5##(2007-8#1)(2008-6#1)
of the left main coronary artery without##2##7##(2007-8#1)(2011-1#1)
of the left main coronary artery##3##6##(2007-8#1)(2010-9#1)(2011-1#1)
of the left main##5##4##(2007-8#2)(2008-6#1)(2010-9#1)(2011-1#1)
of the left masseter muscle##2##5##(2008-10#1)(2008-4#1)
of the left maxillary sinus##2##5##(1991-12#1)(2008-2#1)
of the left middle cerebral artery##3##6##(1990-2#1)(2008-7#1)(2013-8#1)
of the left optic##2##4##(1996-2#1)(2009-8#1)
of the left renal artery was##2##6##(2007-5#1)(2012-2#1)
of the left renal artery##5##5##(1990-2#1)(1992-7#1)(2007-5#1)(2008-1#1)(2012-2#1)
of the left superior##3##4##(1996-2#1)(2007-8#1)(2011-2#1)
of the left testis##5##4##(2006-10#2)(2006-2#1)(2008-6#1)(2011-2#1)
of the left thalamus##2##4##(2006-1#1)(2008-7#1)
of the left thigh##5##4##(2007-7#1)(2008-6#2)(2010-8#1)(2013-8#1)
of the left upper##3##4##(2008-6#1)(2011-1#1)(2012-2#1)
of the left ureter##2##4##(1996-3#1)(2008-9#1)
of the left ventricle and##4##5##(2009-10#1)(2011-1#1)(2012-1#1)(2013-8#1)
of the left ventricle in##2##5##(1993-12#1)(2008-10#1)
of the left ventricle is##2##5##(1993-10#1)(2006-6#1)
of the left ventricle of##2##5##(2007-7#1)(2010-3#1)
of the left ventricle##36##4##(1992-9#2)(1993-10#1)(1993-12#1)(1997-8#1)(2006-6#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-4#1)(2008-7#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-3#2)(2010-5#1)(2011-1#2)(2012-1#3)(2012-12#1)(2013-1#6)(2013-8#1)
of the left ventricular outflow tract##3##6##(1992-9#1)(2008-4#1)(2011-1#1)
of the left ventricular##11##4##(1990-9#1)(1992-2#1)(1992-9#1)(1993-10#1)(2006-6#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-10#1)(2010-8#1)(2011-1#1)
of the left##295##3##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#3)(1990-4#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-6#1)(1991-9#3)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-9#3)(1993-10#2)(1993-12#4)(1993-3#1)(1993-5#2)(1993-9#2)(1994-12#1)(1994-2#1)(1995-12#1)(1995-6#1)(1995-8#2)(1996-2#3)(1996-3#1)(1996-6#2)(1996-9#2)(1997-3#2)(1997-8#3)(2004-11#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-9#1)(2006-1#1)(2006-10#7)(2006-11#1)(2006-2#2)(2006-4#2)(2006-6#4)(2006-7#2)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-4#1)(2007-5#2)(2007-7#6)(2007-8#35)(2007-9#5)(2008-1#3)(2008-10#7)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#9)(2008-5#5)(2008-6#6)(2008-7#12)(2008-8#1)(2008-9#4)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#5)(2009-4#2)(2009-6#1)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#5)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#4)(2011-1#8)(2011-2#10)(2012-1#4)(2012-12#7)(2012-2#6)(2012-3#2)(2013-1#15)(2013-7#3)(2013-8#7)
of the left-ventricular myocardium##2##4##(2010-12#1)(2012-1#1)
of the left-ventricular##3##3##(2010-12#1)(2012-1#2)
of the leg and##2##4##(2007-4#1)(2012-1#1)
of the leg at##2##4##(2007-8#1)(2008-5#1)
of the leg in##2##4##(2007-7#1)(2008-12#1)
of the leg##22##3##(1990-12#2)(1996-4#1)(2006-10#1)(2006-11#1)(2007-12#2)(2007-4#3)(2007-5#1)(2007-7#1)(2007-8#3)(2008-12#1)(2008-5#1)(2009-3#1)(2009-5#1)(2010-12#1)(2011-1#1)(2012-1#1)
of the legal and##2##4##(1992-3#1)(1993-3#1)
of the legal system##5##4##(1995-1#2)(1996-3#1)(2006-8#1)(2012-2#1)
of the legal##13##3##(1991-12#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-1#1)(1995-1#2)(1996-3#1)(2006-8#1)(2007-7#1)(2008-11#1)(2012-2#2)
of the legislation that##2##4##(2007-1#1)(2007-2#1)
of the legislation##4##3##(1997-3#1)(2007-1#1)(2007-2#1)(2012-12#1)
of the legs##9##3##(1990-6#1)(1991-1#1)(1991-6#1)(1992-4#1)(2007-12#1)(2007-2#1)(2008-5#2)(2013-8#1)
of the legumes##2##3##(2011-12#1)(2012-11#1)
of the length of the##14##5##(1991-9#1)(1992-1#1)(1992-8#1)(1992-9#1)(1996-8#1)(1996-9#1)(2005-11#1)(2005-4#1)(2007-10#1)(2007-12#3)(2008-3#1)(2009-10#1)
of the length of##18##4##(1991-9#1)(1992-1#1)(1992-8#1)(1992-9#1)(1996-8#1)(1996-9#1)(1997-4#1)(2005-11#1)(2005-4#1)(2006-8#1)(2007-10#2)(2007-12#3)(2008-3#1)(2009-10#1)(2012-2#1)
of the length##23##3##(1991-9#1)(1992-1#1)(1992-8#1)(1992-9#1)(1996-8#1)(1996-9#1)(1997-4#1)(2005-11#1)(2005-4#1)(2006-12#1)(2006-8#1)(2007-10#2)(2007-12#5)(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#1)(2012-2#1)
of the lengthening process##2##4##(2007-11#1)(2007-8#1)
of the lengthening##6##3##(2007-11#2)(2007-8#2)(2009-2#1)(2011-12#1)
of the lens and##2##4##(2006-8#1)(2008-2#1)
of the lens is##2##4##(2008-2#1)(2008-3#1)
of the lens##17##3##(2006-8#1)(2007-12#4)(2008-2#3)(2008-3#4)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
of the lenses##4##3##(2008-2#3)(2008-3#1)
of the lenslet##3##3##(2007-12#1)(2008-3#2)
of the lepidopteran##2##3##(2007-3#1)(2008-11#1)
of the leprosy##2##3##(1995-9#1)(2008-3#1)
of the leptin receptor##2##4##(2011-2#2)
of the lesion and the##3##5##(2007-9#1)(2008-6#1)(2008-7#1)
of the lesion and##17##4##(1990-3#1)(1993-9#1)(1995-11#1)(1997-6#1)(2005-12#1)(2006-10#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-6#3)(2008-7#2)(2008-8#1)(2009-1#1)(2012-12#1)
of the lesion by##3##4##(2006-10#1)(2008-8#1)(2010-12#1)
of the lesion confirmed##3##4##(2006-7#1)(2007-12#1)(2010-6#1)
of the lesion is##5##4##(1990-3#1)(2004-1#1)(2006-2#1)(2007-8#1)(2012-2#1)
of the lesion on##4##4##(1996-3#1)(2007-10#1)(2012-12#1)(2012-2#1)
of the lesion revealed##2##4##(1993-3#1)(2010-6#1)
of the lesion was##11##4##(1991-11#1)(1995-10#1)(2007-11#1)(2007-6#1)(2007-7#3)(2011-1#1)(2011-2#2)(2013-8#1)
of the lesion were##3##4##(1996-3#1)(2008-5#1)(2012-3#1)
of the lesion with preservation of##2##6##(2007-12#1)(2008-6#1)
of the lesion with##3##4##(2007-12#1)(2008-5#1)(2008-6#1)
of the lesion##116##3##(1990-12#1)(1990-3#3)(1991-1#1)(1991-11#1)(1991-3#1)(1991-9#1)(1992-10#2)(1993-10#1)(1993-3#1)(1993-9#1)(1994-6#1)(1995-10#1)(1995-11#3)(1995-12#1)(1996-3#3)(1997-1#1)(1997-6#1)(1997-8#1)(2003-11#1)(2004-1#1)(2005-10#1)(2005-12#2)(2006-10#4)(2006-2#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#4)(2007-2#1)(2007-6#2)(2007-7#7)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-5#6)(2008-6#5)(2008-7#4)(2008-8#2)(2008-9#1)(2009-1#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-5#1)(2010-6#5)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#5)
of the lesioned hemisphere in##2##5##(1995-12#1)(2008-11#1)
of the lesioned##4##3##(1995-12#2)(1997-6#1)(2008-11#1)
of the lesions and the##2##5##(2007-8#1)(2007-9#1)
of the lesions and##5##4##(2006-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-8#1)
of the lesions are##4##4##(2006-10#1)(2006-7#1)(2008-8#1)(2011-1#1)
of the lesions at##2##4##(2007-8#1)(2013-1#1)
of the lesions in##4##4##(2007-8#1)(2008-11#1)(2008-7#1)(2013-8#1)
of the lesions showed##2##4##(1993-7#1)(2007-7#1)
of the lesions was##4##4##(1992-11#1)(1995-4#1)(2008-5#1)(2013-1#1)
of the lesions were##6##4##(1995-4#1)(2006-4#1)(2007-2#2)(2007-7#1)(2007-8#1)
of the lesions##65##3##(1990-10#1)(1991-11#1)(1991-2#2)(1991-6#1)(1992-11#1)(1992-8#1)(1993-5#1)(1993-7#2)(1993-8#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-4#2)(1996-1#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-8#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-2#2)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2009-10#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
of the less##9##3##(1990-5#1)(1993-6#1)(1996-5#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-7#1)(2008-4#1)(2008-6#1)
of the lesser##3##3##(1996-12#1)(2008-4#1)(2012-2#1)
of the lessons learned##3##4##(1995-12#1)(2007-11#1)(2009-10#1)
of the lessons that##2##4##(1996-12#1)(2010-12#1)
of the lessons##6##3##(1995-12#1)(1996-12#1)(2007-11#1)(2008-12#1)(2009-10#1)(2010-12#1)
of the lethal##2##3##(1991-10#1)(1991-8#1)
of the leukemia##2##3##(2010-9#1)(2012-3#1)
of the leukocyte##2##3##(1991-12#1)(1995-1#1)
of the leukotriene##3##3##(1993-6#1)(1995-8#1)(2010-5#1)
of the levator ani muscle can##2##6##(1994-4#2)
of the levator ani muscle##5##5##(1994-4#5)
of the levator##6##3##(1994-4#5)(2009-8#1)
of the level in##2##4##(2006-12#1)(2010-5#1)
of the level obtained##2##4##(1990-9#1)(2008-11#1)
of the level of consciousness##2##5##(2007-2#1)(2013-8#1)
of the level of##32##4##(1991-11#1)(1993-11#1)(1993-5#1)(1994-10#1)(1995-8#1)(1997-3#1)(2004-12#1)(2004-4#1)(2007-11#1)(2007-2#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#1)(2009-2#1)(2009-3#1)(2009-6#1)(2011-1#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#2)
of the level##40##3##(1990-9#1)(1991-11#1)(1993-11#2)(1993-5#1)(1994-10#1)(1995-8#1)(1997-2#1)(1997-3#1)(2004-12#1)(2004-4#1)(2006-12#1)(2007-11#1)(2007-2#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#3)(2008-5#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#2)
of the levels managed with##2##5##(2008-11#2)
of the levels of the##3##5##(1990-5#1)(1996-2#1)(2008-10#1)
of the levels of##25##4##(1990-5#1)(1990-6#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-7#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-7#1)(1996-2#1)(1996-9#1)(2006-11#1)(2006-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
of the levels##31##3##(1990-5#1)(1990-6#1)(1991-6#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-7#1)(1994-6#2)(1994-8#1)(1995-2#1)(1995-7#1)(1996-2#1)(1996-9#1)(2006-11#1)(2006-2#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
of the lexical##3##3##(1991-2#1)(2008-7#1)(2009-7#1)
of the liberated##2##3##(1990-3#1)(2008-10#1)
of the libraries##2##3##(1991-3#1)(1997-3#1)
of the library with##2##4##(1996-7#1)(2008-5#1)
of the library##4##3##(1996-7#1)(1997-7#1)(2008-4#1)(2008-5#1)
of the lichen##3##3##(2008-11#2)(2008-5#1)
of the lid##2##3##(1992-8#1)(2006-11#1)
of the lidar ratio##3##4##(2008-2#3)
of the lidar return##2##4##(2008-2#1)(2008-3#1)
of the lidar signal##3##4##(2008-2#2)(2008-3#1)
of the lidar##18##3##(2008-2#9)(2008-3#9)
of the life cycle of##4##5##(1997-7#1)(2008-10#1)(2008-4#1)(2012-2#1)
of the life cycle##12##4##(1995-2#1)(1997-7#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-4#3)(2012-2#1)
of the life of##3##4##(1996-11#1)(2008-7#1)(2012-3#1)
of the life##27##3##(1990-3#1)(1992-12#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-11#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-4#3)(2008-7#4)(2009-10#1)(2009-6#1)(2010-10#1)(2012-2#2)(2012-3#1)
of the life-history##2##3##(2010-8#1)(2013-1#1)
of the lifespan of the##2##5##(1996-11#1)(2004-1#1)
of the lifestyle##2##3##(1990-9#1)(2009-9#1)
of the lifetime of##2##4##(1992-5#1)(2008-10#1)
of the lifetime##4##3##(1992-12#1)(1992-5#1)(2008-10#1)(2008-2#1)
of the ligament##4##3##(2005-7#1)(2006-3#1)(2008-6#1)(2009-7#1)
of the ligament-to-bone attachment##2##4##(2009-7#2)
of the ligament-to-bone##3##3##(2009-7#3)
of the ligaments##4##3##(2007-7#1)(2008-6#1)(2009-7#1)(2010-7#1)
of the ligamentum##2##3##(1996-3#1)(2007-4#1)
of the ligand and##6##4##(1995-1#1)(1995-5#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-5#1)
of the ligand as##2##4##(2008-10#2)
of the ligand binding site##2##5##(1991-2#1)(1993-3#1)
of the ligand binding##5##4##(1991-2#1)(1993-3#1)(1995-3#1)(1996-6#1)(2008-8#1)
of the ligand concentration##2##4##(1992-8#1)(2008-10#1)
of the ligand for##2##4##(1990-5#1)(1992-3#1)
of the ligand is##4##4##(1995-11#1)(1996-6#1)(2008-10#1)(2010-2#1)
of the ligand or macromolecule##2##5##(1997-2#2)
of the ligand to##3##4##(1990-12#1)(1994-9#1)(2010-5#1)
of the ligand were##3##4##(1995-3#1)(1997-1#1)(2008-10#1)
of the ligand##52##3##(1990-10#1)(1990-12#1)(1990-5#2)(1990-8#1)(1991-2#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-12#1)(1996-2#1)(1996-6#2)(1997-1#2)(1997-2#4)(1997-7#2)(2007-11#1)(2007-3#1)(2008-10#10)(2008-4#2)(2008-5#3)(2008-8#1)(2009-12#1)(2010-2#1)(2010-5#2)
of the ligand-binding domain of the##2##6##(1991-12#2)
of the ligand-binding domain##4##4##(1991-12#2)(2008-8#2)
of the ligand-binding##5##3##(1991-12#2)(2008-4#1)(2008-8#2)
of the ligand-receptor##2##3##(1994-9#1)(2011-1#1)
of the ligands and the##2##5##(2008-10#1)(2008-5#1)
of the ligands and##4##4##(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)
of the ligands to##2##4##(1993-11#1)(2008-4#1)
of the ligands were##4##4##(1990-10#1)(1996-8#1)(2008-10#1)(2008-5#1)
of the ligands with##2##4##(2008-5#2)
of the ligands##22##3##(1990-10#1)(1990-8#1)(1993-11#1)(1996-8#1)(1997-4#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-3#3)(2008-4#1)(2008-5#5)(2009-7#1)(2013-1#1)
of the light absorption##2##4##(2008-3#2)
of the light beam is##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
of the light beam##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
of the light chain##7##4##(1990-11#1)(1990-2#1)(1990-6#1)(1992-7#1)(1993-11#1)(1994-11#2)
of the light emitted##2##4##(1991-7#1)(2008-2#1)
of the light field##5##4##(2007-12#2)(2008-2#1)(2008-3#2)
of the light in##2##4##(2007-12#2)
of the light incident upon the##2##6##(2008-2#2)
of the light incident##3##4##(2008-2#2)(2008-3#1)
of the light intensity##3##4##(2006-2#1)(2007-12#1)(2008-2#1)
of the light propagation##2##4##(2007-11#1)(2008-2#1)
of the light reflected##3##4##(2008-3#3)
of the light scattered by##2##5##(2007-11#1)(2007-12#1)
of the light source and the##2##6##(2007-12#2)
of the light source and##4##5##(2007-11#1)(2007-12#2)(2008-2#1)
of the light source are##2##5##(2008-3#2)
of the light source is##2##5##(2007-12#1)(2008-2#1)
of the light source##27##4##(2007-11#2)(2007-12#5)(2008-2#7)(2008-3#12)(2008-5#1)
of the light that is##2##5##(2007-12#1)(2008-3#1)
of the light used##3##4##(2007-12#1)(2008-1#1)(2009-5#1)
of the light##109##3##(1990-11#1)(1990-2#1)(1990-6#2)(1991-7#1)(1992-4#1)(1992-7#1)(1993-11#1)(1994-11#3)(1994-2#1)(1994-3#1)(1995-1#1)(1997-6#2)(2006-2#1)(2007-11#5)(2007-12#19)(2007-3#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#24)(2008-3#26)(2008-4#2)(2008-5#3)(2008-9#1)(2009-5#1)(2010-8#1)(2011-1#1)(2012-2#1)
of the light-curing##2##3##(2008-12#1)(2008-5#1)
of the light-dark cycle##2##4##(1992-3#1)(2007-9#1)
of the light-dark##3##3##(1992-3#2)(2007-9#1)
of the light-harvesting efficiency in##2##5##(2010-4#2)
of the light-harvesting##6##3##(1994-5#1)(1995-6#1)(2008-4#1)(2010-4#2)(2012-6#1)
of the light-scattering##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
of the light/dark cycle##2##4##(1993-9#1)(1994-6#1)
of the light/dark##3##3##(1993-3#1)(1993-9#1)(1994-6#1)
of the lignan##2##3##(1990-9#1)(2009-10#1)
of the likelihood maximization approach is##2##6##(2008-2#2)
of the likelihood of##4##4##(1993-11#1)(2008-10#1)(2008-4#1)(2012-12#1)
of the likelihood ratio##5##4##(1996-12#1)(2008-10#3)(2008-3#1)
of the likelihood##15##3##(1993-11#1)(1994-8#1)(1996-12#1)(1997-3#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2012-12#1)
of the likely##5##3##(1996-1#1)(2006-3#1)(2010-12#1)(2010-4#1)(2012-12#1)
of the limb and##2##4##(1995-8#1)(2007-11#1)
of the limb axis##2##4##(2007-8#2)
of the limb bud##6##4##(1992-8#1)(1993-12#1)(1995-8#1)(2003-11#1)(2006-11#2)
of the limb is##2##4##(1992-9#1)(2007-8#1)
of the limb##23##3##(1990-11#1)(1990-6#1)(1990-8#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-3#1)(1995-8#2)(2003-11#1)(2006-11#2)(2006-4#1)(2007-11#1)(2007-7#1)(2007-8#4)(2008-7#1)(2011-1#1)(2011-3#1)(2012-3#1)
of the limbal##2##3##(2005-11#1)(2009-8#1)
of the limbic system##4##4##(1992-12#3)(1992-8#1)
of the limbic##5##3##(1991-11#1)(1992-12#3)(1992-8#1)
of the limbs##8##3##(1996-6#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#2)(2010-6#1)
of the limit of##2##4##(2008-10#1)(2010-8#1)
of the limit##4##3##(2007-12#1)(2007-8#1)(2008-10#1)(2010-8#1)
of the limitation of##2##4##(2006-10#1)(2011-2#1)
of the limitations and##5##4##(1993-11#1)(2005-10#1)(2008-10#2)(2008-7#1)
of the limitations of the##8##5##(1991-2#1)(1992-3#1)(1992-4#1)(2007-2#1)(2007-6#1)(2008-11#1)(2008-5#1)(2012-11#1)
of the limitations of##13##4##(1990-5#1)(1991-2#1)(1992-3#1)(1992-4#1)(2006-2#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-6#1)(2012-11#1)
of the limitations##22##3##(1990-5#1)(1991-2#1)(1992-3#1)(1992-4#1)(1993-11#1)(2005-10#1)(2006-12#1)(2006-2#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-6#1)(2012-11#1)(2013-1#2)
of the limited number of##2##5##(2008-10#1)(2008-8#1)
of the limited##12##3##(1992-12#1)(1995-2#1)(1996-11#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-3#1)(2009-7#1)(2011-2#1)
of the limiting##4##3##(1994-12#1)(2005-11#2)(2008-5#1)
of the limits of##5##4##(1996-9#1)(2006-10#1)(2007-10#1)(2008-2#1)(2012-3#1)
of the line and##2##4##(1997-2#1)(2007-12#1)
of the line shape##2##4##(2008-2#2)
of the line that##2##4##(1997-4#1)(2008-3#1)
of the line##17##3##(1990-10#1)(1993-5#1)(1995-8#2)(1997-2#1)(1997-4#1)(2007-12#2)(2007-9#1)(2008-2#3)(2008-3#5)
of the line-of-sight##2##3##(2007-11#1)(2008-3#1)
of the line-shape##2##3##(1992-3#1)(2008-3#1)
of the lineages##5##3##(1991-9#1)(2008-10#2)(2008-9#1)(2009-2#1)
of the linear and nonlinear##2##5##(2005-11#1)(2008-2#1)
of the linear and##3##4##(1996-9#1)(2005-11#1)(2008-2#1)
of the linear polarization of the##2##6##(2008-2#2)
of the linear polarization of##3##5##(2008-2#3)
of the linear polarization##4##4##(2008-2#4)
of the linear quadratic##2##4##(1994-4#1)(2007-11#1)
of the linear regression##3##4##(1990-11#1)(2008-3#1)(2010-5#1)
of the linear##50##3##(1990-11#1)(1990-8#1)(1992-6#1)(1994-12#2)(1994-2#1)(1994-4#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-6#1)(1996-6#1)(1996-8#2)(1996-9#1)(2005-11#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-6#1)(2008-10#7)(2008-2#7)(2008-3#8)(2008-8#1)(2010-2#2)(2010-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
of the linear-no threshold theory##2##5##(2008-7#2)
of the linearity of the##2##5##(2007-12#1)(2008-10#1)
of the linearity##3##3##(2005-11#1)(2007-12#1)(2008-10#1)
of the linearized problem##2##4##(1993-7#2)
of the linearly polarized##2##4##(2007-12#1)(2008-2#1)
of the linearly##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2009-7#1)
of the lined seahorse##3##4##(2010-8#1)(2012-12#2)
of the lines##9##3##(1992-3#1)(1993-11#1)(1993-7#1)(2008-10#3)(2008-2#1)(2008-8#1)(2011-1#1)
of the linewidth of##2##4##(2008-2#2)
of the linewidth##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
of the linguistic##3##3##(2007-9#1)(2010-2#1)(2010-5#1)
of the link between##5##4##(2007-1#1)(2009-12#1)(2009-4#1)(2009-9#1)(2012-12#1)
of the link##7##3##(2007-1#1)(2007-11#1)(2008-10#1)(2009-12#1)(2009-4#1)(2009-9#1)(2012-12#1)
of the linkage and##2##4##(1997-4#1)(2009-4#1)
of the linkage system##2##4##(1990-8#2)
of the linkage##8##3##(1990-2#1)(1990-8#2)(1993-12#1)(1994-11#1)(1995-8#1)(1997-4#1)(2009-4#1)
of the linker region of##2##5##(1995-10#2)
of the linker region##3##4##(1995-10#2)(1995-8#1)
of the linker##10##3##(1993-5#1)(1995-10#2)(1995-8#2)(1996-7#1)(1997-1#1)(2006-12#1)(2009-6#1)(2010-5#1)
of the linking##2##3##(2008-3#1)(2008-4#1)
of the links between##2##4##(1995-9#1)(2009-10#1)
of the links##3##3##(1995-9#1)(2008-4#1)(2009-10#1)
of the lion##3##3##(2007-2#3)
of the lip and##2##4##(2007-2#1)(2010-3#1)
of the lip##6##3##(2006-10#1)(2006-8#1)(2007-2#1)(2007-6#1)(2010-3#1)(2012-12#1)
of the lipase##6##3##(1994-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(2005-11#1)(2009-8#1)
of the lipid A precursor##2##5##(1992-5#2)
of the lipid A##3##4##(1992-5#2)(1994-12#1)
of the lipid bilayer##11##4##(1990-11#1)(1991-5#1)(1992-1#1)(1992-9#1)(1994-2#1)(1994-5#1)(1997-1#3)(2006-10#1)(2008-9#1)
of the lipid chains##2##4##(1996-1#1)(2008-10#1)
of the lipid layer##2##4##(1992-6#1)(2008-8#1)
of the lipid membrane##2##4##(1994-5#1)(2005-11#1)
of the lipid metabolism##3##4##(1990-2#1)(1997-7#1)(2010-3#1)
of the lipid molecules##2##4##(1990-2#1)(1993-4#1)
of the lipid peroxidation##2##4##(1994-11#1)(2006-6#1)
of the lipid##73##3##(1990-11#2)(1990-2#4)(1990-3#1)(1990-4#1)(1990-7#1)(1991-2#1)(1991-5#3)(1991-9#1)(1992-1#1)(1992-5#2)(1992-6#2)(1992-9#3)(1993-3#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#3)(1995-10#1)(1995-5#2)(1995-8#1)(1996-1#2)(1996-2#1)(1996-6#1)(1997-1#3)(1997-7#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#3)(2010-12#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#1)
of the lipid-protein##2##3##(1992-11#1)(1993-9#1)
of the lipid-stimulated##2##3##(1992-9#2)
of the lipids at##3##4##(1994-3#1)(1996-5#1)(2008-10#1)
of the lipids##11##3##(1990-2#1)(1991-5#1)(1992-9#1)(1994-11#1)(1994-3#1)(1996-5#2)(2008-10#1)(2008-9#1)(2012-12#1)(2013-1#1)
of the lipopeptide##3##3##(1990-3#1)(1991-12#1)(1997-2#1)
of the lipophilic surfactant##2##4##(2008-5#2)
of the lipophilic##12##3##(1990-11#1)(1993-11#1)(1996-1#1)(1996-8#1)(2006-12#1)(2008-10#3)(2008-5#3)(2012-12#1)
of the lipopolysaccharide##3##3##(1991-7#1)(1992-12#1)(2011-2#1)
of the lipoprotein lipase gene##2##5##(1992-9#1)(1993-3#1)
of the lipoprotein##6##3##(1992-12#1)(1992-3#1)(1992-9#1)(1993-3#1)(2005-8#1)(2008-5#1)
of the lipoproteins##2##3##(1991-2#1)(1992-5#1)
of the liposomal membrane##2##4##(1990-2#1)(1994-2#1)
of the liposomal##5##3##(1990-2#1)(1994-2#2)(1996-1#1)(2007-11#1)
of the liposome##6##3##(1990-11#2)(1992-6#1)(1994-12#1)(1994-5#1)(1995-5#1)
of the liposomes##5##3##(1991-5#1)(1994-11#1)(1994-12#2)(1994-3#1)
of the lipoxygenase##2##3##(1990-7#1)(2008-4#1)
of the liquid crystal##7##4##(1993-7#1)(1996-1#1)(2007-11#1)(2007-12#2)(2008-2#2)
of the liquid crystalline##6##4##(1992-9#1)(2005-11#3)(2007-12#1)(2008-7#1)
of the liquid sample##2##4##(2007-12#1)(2008-10#1)
of the liquid##40##3##(1992-5#2)(1992-9#1)(1993-7#1)(1995-3#1)(1996-1#1)(1996-8#1)(2005-11#9)(2007-11#1)(2007-12#4)(2008-10#4)(2008-2#3)(2008-3#3)(2008-6#1)(2008-7#1)(2010-4#5)(2010-8#1)(2011-1#1)
of the liquid-crystal##5##3##(2007-11#3)(2008-2#1)(2008-3#1)
of the liquids##3##3##(1990-3#1)(2005-11#2)
of the list##2##3##(1997-3#1)(2008-4#1)
of the listed##2##3##(1997-3#1)(2008-5#1)
of the literature and a##5##5##(2006-5#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-4#1)
of the literature and the authors'##2##6##(1990-10#1)(1992-8#1)
of the literature and the##4##5##(1990-10#1)(1992-8#1)(1994-8#1)(2007-8#1)
of the literature and##36##4##(1990-10#1)(1990-3#1)(1991-1#1)(1991-3#1)(1991-4#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-8#1)(1995-3#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-8#4)(2008-10#2)(2008-4#2)(2008-9#3)(2009-4#1)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
of the literature as##3##4##(1996-12#1)(2008-1#1)(2009-7#1)
of the literature concerning##5##4##(1996-3#1)(2008-2#1)(2008-8#1)(2010-9#1)(2011-2#1)
of the literature for##2##4##(2011-2#1)(2013-1#1)
of the literature found##5##4##(2007-3#1)(2008-10#2)(2008-11#1)(2010-2#1)
of the literature from##4##4##(2008-10#2)(2008-7#1)(2008-9#1)
of the literature in##4##4##(2006-10#1)(2008-10#1)(2008-11#1)(2012-12#1)
of the literature indicates##4##4##(1990-6#1)(1993-1#1)(2006-10#1)(2007-8#1)
of the literature is based on##2##6##(1995-9#1)(2008-11#1)
of the literature is##17##4##(1990-3#1)(1991-3#1)(1995-9#1)(1996-9#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#1)
of the literature of the##2##5##(2006-10#1)(2008-6#1)
of the literature of##7##4##(1996-8#1)(2006-10#1)(2006-12#1)(2008-6#1)(2008-9#1)(2012-3#2)
of the literature on the effects of##2##7##(1993-11#1)(2010-2#1)
of the literature on the subject##2##6##(1990-5#1)(2007-6#1)
of the literature on the##14##5##(1990-5#1)(1991-9#1)(1992-1#1)(1993-11#1)(1996-12#1)(1996-3#1)(2007-6#1)(2008-11#1)(2008-9#1)(2009-6#1)(2010-2#1)(2013-1#2)(2013-8#1)
of the literature on this subject##3##6##(1991-10#1)(2006-2#1)(2008-5#1)
of the literature on this##9##5##(1991-10#1)(1992-10#1)(1993-6#1)(2006-2#1)(2007-7#1)(2008-12#1)(2008-5#1)(2010-8#1)(2013-1#1)
of the literature on##46##4##(1990-5#1)(1991-10#1)(1991-9#1)(1992-1#1)(1992-10#1)(1993-11#1)(1993-6#1)(1996-12#1)(1996-3#2)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#2)(2013-1#3)(2013-8#1)
of the literature pertaining to##4##5##(1993-1#1)(2007-11#1)(2007-6#2)
of the literature pertaining##5##4##(1993-1#1)(2007-11#1)(2007-6#2)(2008-8#1)
of the literature related to##2##5##(2008-12#1)(2009-1#1)
of the literature revealed that##3##5##(1992-12#1)(2004-12#1)(2009-7#1)
of the literature revealed##8##4##(1992-12#1)(1995-1#1)(2004-12#1)(2006-10#1)(2006-11#1)(2008-12#1)(2008-3#1)(2009-7#1)
of the literature reveals##2##4##(2006-10#1)(2007-2#1)
of the literature showed##5##4##(1992-11#1)(1992-5#1)(2008-7#1)(2011-2#2)
of the literature shows that##6##5##(2005-10#1)(2008-10#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-3#1)
of the literature shows##8##4##(1990-6#1)(2005-10#1)(2006-10#1)(2008-10#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-3#1)
of the literature the##2##4##(2005-2#1)(2008-5#1)
of the literature to##3##4##(2006-10#1)(2011-2#1)(2013-7#1)
of the literature was##8##4##(1995-5#1)(2006-2#1)(2007-6#1)(2008-7#1)(2009-5#1)(2012-12#2)(2012-2#1)
of the literature we##2##4##(1991-4#1)(2008-6#1)
of the literature##511##3##(1990-10#2)(1990-12#2)(1990-3#3)(1990-5#1)(1990-6#4)(1991-1#1)(1991-10#2)(1991-12#2)(1991-3#2)(1991-4#2)(1991-6#2)(1991-9#1)(1992-1#2)(1992-10#2)(1992-11#1)(1992-12#4)(1992-2#1)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#2)(1995-1#2)(1995-11#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-12#3)(1996-3#4)(1996-6#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-5#1)(1997-6#2)(2004-12#1)(2005-10#3)(2005-11#2)(2005-12#3)(2005-2#1)(2005-7#1)(2005-8#1)(2005-9#4)(2006-1#1)(2006-10#18)(2006-11#1)(2006-12#16)(2006-2#5)(2006-5#2)(2006-6#2)(2006-7#3)(2006-8#4)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#8)(2007-12#8)(2007-2#15)(2007-3#9)(2007-4#6)(2007-5#4)(2007-6#10)(2007-7#9)(2007-8#9)(2007-9#1)(2008-1#7)(2008-10#21)(2008-11#14)(2008-12#11)(2008-2#6)(2008-3#3)(2008-4#7)(2008-5#6)(2008-6#8)(2008-7#10)(2008-8#7)(2008-9#12)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#6)(2009-4#6)(2009-5#2)(2009-6#5)(2009-7#2)(2009-8#3)(2009-9#1)(2010-10#2)(2010-12#8)(2010-2#3)(2010-3#5)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#5)(2010-9#2)(2011-1#5)(2011-2#23)(2011-3#1)(2012-1#3)(2012-12#14)(2012-2#16)(2012-3#7)(2013-1#32)(2013-7#3)(2013-8#7)
of the literature]##34##3##(1990-10#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-9#1)(1992-11#1)(1992-5#1)(1992-9#1)(1993-10#1)(1993-5#2)(1993-6#1)(1993-9#1)(1996-9#1)(1997-2#1)(1997-3#1)(2008-10#5)(2008-12#1)(2008-8#1)(2008-9#4)(2009-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
of the literatures in##2##4##(1996-6#1)(2011-2#1)
of the literatures##4##3##(1996-6#1)(2009-5#1)(2009-8#1)(2011-2#1)
of the lithium##4##3##(1997-7#1)(2008-10#3)
of the live##3##3##(1995-5#1)(2004-12#1)(2011-12#1)
of the lived experience##2##4##(2008-11#2)
of the liver and##14##4##(1990-3#1)(1993-1#1)(1995-11#1)(1997-3#1)(2006-10#1)(2006-6#1)(2008-4#1)(2008-5#1)(2009-8#2)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)
of the liver are##3##4##(1990-11#1)(1992-10#1)(2005-12#1)
of the liver has been##2##5##(1993-10#1)(2006-10#1)
of the liver in a##2##5##(1992-2#1)(2010-11#1)
of the liver in##9##4##(1990-11#1)(1991-12#1)(1992-10#1)(1992-2#1)(1993-10#1)(1994-3#1)(2008-5#1)(2008-7#1)(2010-11#1)
of the liver is a##2##5##(1990-10#1)(1992-1#1)
of the liver is##6##4##(1990-10#1)(1992-1#1)(2009-8#1)(2010-12#1)(2010-9#1)(2013-8#1)
of the liver may be##2##5##(2009-2#1)(2009-3#1)
of the liver that##2##4##(2005-12#1)(2009-8#1)
of the liver to##6##4##(1995-6#1)(1995-8#1)(1997-6#1)(2008-5#1)(2012-1#1)(2012-2#1)
of the liver using the##2##5##(1990-5#1)(2012-1#1)
of the liver using##3##4##(1990-5#1)(2009-12#1)(2012-1#1)
of the liver was##7##4##(1991-2#1)(1993-6#1)(1997-2#1)(2005-12#1)(2006-6#1)(2011-1#1)(2012-1#1)
of the liver with##4##4##(2007-8#1)(2009-1#1)(2010-12#1)(2013-1#1)
of the liver##159##3##(1990-10#3)(1990-11#4)(1990-2#1)(1990-3#2)(1990-5#2)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#3)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#2)(1994-3#1)(1994-5#1)(1995-11#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-12#5)(2006-10#7)(2006-2#1)(2006-6#2)(2007-11#2)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#3)(2008-10#4)(2008-11#1)(2008-3#5)(2008-4#4)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-7#1)(2009-8#6)(2009-9#1)(2010-11#1)(2010-12#8)(2010-5#3)(2010-9#3)(2011-1#2)(2011-2#4)(2012-1#6)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
of the liver-specific vitellogenin gene##2##5##(1994-12#2)
of the liver-specific##4##3##(1994-12#2)(1997-1#2)
of the liver/bone/kidney isoenzyme##2##4##(1993-11#2)
of the liver/bone/kidney##3##3##(1993-11#3)
of the liver]##6##3##(1991-3#1)(1993-5#1)(1993-8#1)(1997-7#1)(2009-2#2)
of the livers##2##3##(1995-3#1)(2008-8#1)
of the liverwort Marchantia polymorpha##3##5##(1996-7#1)(1997-2#2)
of the lives of##2##4##(2008-7#1)(2011-2#1)
of the livestock##2##3##(2008-5#1)(2011-1#1)
of the living##13##3##(1996-5#1)(1997-5#1)(2006-7#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-9#1)(2009-2#1)(2009-7#1)(2011-1#1)(2011-2#2)
of the lizard Anolis carolinensis##2##5##(2011-2#2)
of the lizard Mabuya carinata##2##5##(2007-9#2)
of the lizard##5##3##(2006-1#1)(2007-9#2)(2011-2#2)
of the load##7##3##(2007-1#1)(2007-4#3)(2008-5#2)(2010-12#1)
of the loaded resin##2##4##(2008-10#2)
of the loading##6##3##(2006-11#3)(2008-6#1)(2009-7#1)(2009-9#1)
of the lobes##2##3##(2007-12#2)
of the lobster##2##3##(1993-9#1)(1994-11#1)
of the local DIC##3##4##(2011-1#3)
of the local and regional##2##5##(1992-4#1)(1997-3#1)
of the local and##3##4##(1992-4#1)(1997-3#1)(2008-12#1)
of the local anesthetic##4##4##(1993-1#1)(1996-8#2)(1997-5#1)
of the local birefringence##2##4##(2007-12#2)
of the local environment##3##4##(2006-12#1)(2008-8#1)(2012-7#1)
of the local health##2##4##(2007-3#1)(2008-7#1)
of the local helical parameters##2##5##(1992-12#2)
of the local intensity##2##4##(2008-3#1)(2008-7#1)
of the local linear##2##4##(2008-2#1)(2008-3#1)
of the local nanomechanical motion of##2##6##(2007-2#2)
of the local shape##2##4##(1997-1#1)(2008-2#1)
of the local structure##3##4##(1992-6#1)(2005-11#1)(2008-4#1)
of the local##77##3##(1990-12#1)(1990-4#1)(1990-8#1)(1991-3#1)(1991-9#1)(1992-12#2)(1992-4#1)(1992-6#1)(1993-1#1)(1993-5#1)(1994-3#1)(1994-6#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-3#2)(1997-5#2)(2004-11#1)(2005-11#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#4)(2007-2#2)(2007-3#2)(2007-4#1)(2007-9#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#6)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-9#1)(2010-12#1)(2011-1#5)(2011-2#1)(2012-2#1)(2012-7#1)(2013-7#1)(2013-8#1)
of the localization and##2##4##(2008-1#1)(2012-2#1)
of the localization of##3##4##(1991-11#1)(2007-11#1)(2008-3#1)
of the localization##7##3##(1991-11#1)(2007-11#1)(2008-1#1)(2008-3#2)(2012-1#1)(2012-2#1)
of the locally##2##3##(2008-2#1)(2012-3#1)
of the location and extent of##2##6##(2008-2#1)(2012-2#1)
of the location and##3##4##(2008-2#1)(2008-3#1)(2012-2#1)
of the location of the##11##5##(1991-4#1)(1991-6#1)(1994-1#1)(2006-6#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-7#1)(2010-9#1)
of the location of##15##4##(1991-4#1)(1991-6#1)(1994-1#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-9#1)(2012-12#1)
of the location##19##3##(1991-4#1)(1991-6#2)(1994-1#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-9#1)(2012-12#1)(2012-2#1)
of the locations and##2##4##(1995-2#1)(2010-11#1)
of the locations##4##3##(1995-2#1)(2008-2#1)(2010-11#1)(2011-12#1)
of the loci##6##3##(1994-8#1)(1995-11#1)(1996-10#1)(2008-5#1)(2012-11#1)(2012-3#1)
of the locking ring##2##4##(2009-3#2)
of the locomotor apparatus##2##4##(2007-11#2)
of the locomotor system##5##4##(1990-6#1)(1995-4#1)(2007-11#2)(2007-8#1)
of the locomotor##10##3##(1990-6#1)(1993-12#1)(1994-11#1)(1995-4#1)(2007-11#5)(2007-8#1)
of the locoregional hyperthermic area##2##5##(1996-3#2)
of the locus coeruleus (LC)##2##5##(1992-9#1)(1995-12#1)
of the locus coeruleus##4##4##(1992-9#1)(1995-12#1)(2008-7#2)
of the locus encoding the##2##5##(1990-9#1)(1995-2#1)
of the locus##11##3##(1990-9#1)(1992-1#1)(1992-9#1)(1993-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(2008-5#1)(2008-7#2)(2010-8#1)
of the locust##4##3##(1990-2#1)(2007-12#3)
of the log##5##3##(1993-11#1)(1993-3#1)(2007-4#1)(2008-10#1)(2008-3#1)
of the log-normal##3##3##(2005-11#2)(2008-10#1)
of the logarithm of the##2##5##(1997-4#1)(2008-10#1)
of the logarithm of##3##4##(1997-4#1)(2008-10#2)
of the logarithmic transformed##2##4##(2004-12#2)
of the logarithmic##4##3##(2004-12#2)(2005-11#1)(2008-10#1)
of the logistic##2##3##(1992-2#1)(2011-2#1)
of the long and##2##4##(1997-6#1)(2006-6#1)
of the long arm of chromosome##3##6##(1996-6#1)(2008-9#1)(2012-12#1)
of the long arm of the##2##6##(2008-10#1)(2012-1#1)
of the long arm of##10##5##(1990-7#1)(1996-6#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-3#1)(2012-1#1)(2012-12#1)
of the long arm##11##4##(1990-7#1)(1996-6#1)(1997-8#1)(2008-10#3)(2008-12#1)(2008-9#1)(2010-3#1)(2012-1#1)(2012-12#1)
of the long arms of##2##5##(2008-5#1)(2008-7#1)
of the long arms##3##4##(2008-5#2)(2008-7#1)
of the long bones##5##4##(1992-3#1)(2007-11#1)(2008-12#1)(2008-4#1)(2010-6#1)
of the long head of the biceps##2##7##(2007-11#1)(2013-7#1)
of the long head of##3##5##(2007-11#1)(2007-8#1)(2013-7#1)
of the long terminal repeat (LTR)##2##6##(1991-3#1)(1992-2#1)
of the long terminal repeat of##2##6##(1991-12#1)(1996-5#1)
of the long terminal repeat##5##5##(1991-12#1)(1991-3#1)(1992-2#1)(1993-5#1)(1996-5#1)
of the long##53##3##(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-3#1)(1993-5#1)(1994-3#1)(1994-8#1)(1994-9#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-6#2)(1997-8#1)(2006-11#1)(2006-6#2)(2006-9#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#2)(2010-3#2)(2010-6#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
of the long-lived component##2##4##(1991-12#2)
of the long-period grating##2##4##(2007-12#2)
of the long-term effects of##2##5##(2010-3#1)(2013-1#1)
of the long-term##21##3##(1990-6#1)(1991-12#1)(1994-5#1)(1995-3#1)(1996-10#1)(1997-5#1)(2004-10#1)(2005-10#1)(2006-4#1)(2006-9#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2010-3#1)(2011-2#1)(2013-1#2)
of the long-time##3##3##(1992-6#1)(2006-1#1)(2008-3#1)
of the longer A beta 42 in##2##7##(1996-5#2)
of the longer##7##3##(1993-12#1)(1996-5#2)(1997-4#1)(2008-10#1)(2008-3#1)(2009-9#1)
of the longer-chain##2##3##(1991-9#1)(2009-3#1)
of the longest reported##2##4##(2008-7#2)
of the longest##13##3##(1991-2#1)(1993-12#1)(1994-10#1)(1995-1#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-7#3)(2008-8#1)(2011-2#1)(2012-3#1)
of the longitudinal##11##3##(1991-10#1)(2006-11#1)(2006-4#1)(2007-11#1)(2008-3#1)(2008-7#2)(2009-12#1)(2009-3#1)(2010-2#1)(2011-1#1)
of the loop##17##3##(1992-1#1)(1994-8#1)(1995-1#3)(1995-2#1)(1995-6#1)(1995-8#1)(1996-7#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#1)
of the loops##3##3##(1995-3#1)(1995-6#1)(1996-8#1)
of the loss of the##2##5##(2009-8#1)(2012-2#1)
of the loss of##16##4##(1991-7#1)(1992-2#1)(1993-11#1)(1993-7#1)(1994-7#1)(1997-7#2)(2006-3#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-1#1)(2012-12#1)(2012-2#1)
of the loss##19##3##(1991-7#1)(1992-2#1)(1993-11#1)(1993-7#1)(1994-7#1)(1997-7#2)(2006-3#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-1#1)(2012-12#1)(2012-2#1)
of the losses##3##3##(2007-11#1)(2008-1#1)(2008-2#1)
of the lost activity##2##4##(1994-8#1)(1995-6#1)
of the low affinity##6##4##(1990-2#1)(1990-3#1)(1990-5#1)(1994-11#2)(2008-7#1)
of the low contrast##2##4##(2012-1#2)
of the low density lipoprotein (LDL)##4##6##(1992-5#1)(1995-8#3)
of the low density lipoprotein##5##5##(1992-5#1)(1994-9#1)(1995-8#3)
of the low level of##2##5##(2008-10#1)(2008-7#1)
of the low level##3##4##(1996-2#1)(2008-10#1)(2008-7#1)
of the low molecular##2##4##(1995-3#1)(1996-8#1)
of the low##57##3##(1990-10#1)(1990-2#1)(1990-3#2)(1990-5#2)(1991-2#1)(1991-7#1)(1992-12#1)(1992-5#1)(1994-11#2)(1994-9#1)(1995-3#1)(1995-8#3)(1996-2#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(2005-11#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#1)(2008-6#1)(2008-7#5)(2010-8#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-8#2)
of the low-affinity##4##3##(1990-3#1)(1991-2#1)(1994-5#1)(2007-9#1)
of the low-molecular-weight##3##3##(1992-11#1)(1996-4#1)(2005-11#1)
of the low-temperature##2##3##(1991-7#1)(2011-2#1)
of the lower and upper##2##5##(2012-2#1)(2013-1#1)
of the lower back##2##4##(2007-7#1)(2008-5#1)
of the lower cervical##2##4##(2007-8#1)(2008-12#1)
of the lower dose of##2##5##(1991-6#1)(1995-11#1)
of the lower dose##3##4##(1991-6#1)(1995-11#1)(2008-10#1)
of the lower esophageal sphincter##2##5##(1992-6#1)(2013-8#1)
of the lower extremities and##2##5##(2008-4#1)(2011-12#1)
of the lower extremities##22##4##(1991-7#1)(1991-9#1)(1993-7#1)(1995-8#1)(1997-3#1)(1997-8#1)(2006-4#1)(2007-11#2)(2007-3#1)(2007-8#3)(2008-10#1)(2008-4#1)(2008-7#1)(2009-2#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-7#1)
of the lower extremity arteries##2##5##(2005-10#2)
of the lower extremity##13##4##(2005-10#2)(2006-7#1)(2007-4#1)(2007-7#1)(2008-6#1)(2009-2#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-12#1)
of the lower eyelid##6##4##(2008-5#2)(2008-8#1)(2010-12#3)
of the lower face##2##4##(2007-12#2)
of the lower female genital tract##2##6##(1994-1#1)(1996-12#1)
of the lower female##3##4##(1994-1#1)(1996-12#2)
of the lower genital tract##3##5##(1991-2#2)(1994-1#1)
of the lower jaw##2##4##(2007-5#1)(2008-5#1)
of the lower leg and foot##2##6##(1997-8#1)(2006-11#1)
of the lower leg with##2##5##(2012-12#2)
of the lower leg##17##4##(1990-11#2)(1994-6#1)(1997-8#2)(2006-11#2)(2007-11#1)(2007-4#1)(2007-8#5)(2009-3#1)(2012-12#2)
of the lower limb during##2##5##(2011-2#1)(2012-1#1)
of the lower limb##13##4##(1990-6#1)(1995-2#1)(2007-4#4)(2007-5#1)(2007-8#1)(2008-6#1)(2010-4#1)(2011-2#1)(2012-1#2)
of the lower limbs and##2##5##(1991-11#1)(2012-2#1)
of the lower limbs in##2##5##(2006-4#1)(2012-1#1)
of the lower limbs is##3##5##(1990-3#1)(1997-3#1)(2008-8#1)
of the lower limbs##28##4##(1990-10#1)(1990-11#2)(1990-3#2)(1990-6#1)(1991-11#1)(1991-4#2)(1991-6#2)(1993-5#1)(1995-9#1)(1997-3#2)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#2)(2009-3#1)(2012-1#2)(2012-2#1)
of the lower limbs]##2##4##(1990-6#1)(1991-6#1)
of the lower lip##4##4##(1991-8#2)(2007-9#1)(2013-1#1)
of the lower lumbar vertebrae##2##5##(1992-1#1)(2007-11#1)
of the lower rectum##2##4##(1990-9#1)(2009-5#1)
of the lower respiratory tract##4##5##(1991-6#1)(1993-5#1)(1996-9#1)(2013-1#1)
of the lower third of the ear##2##7##(2013-7#2)
of the lower urinary tract##3##5##(2006-6#1)(2007-11#1)(2008-8#1)
of the lower##177##3##(1990-10#1)(1990-11#4)(1990-3#2)(1990-6#4)(1990-9#1)(1991-11#1)(1991-2#2)(1991-4#2)(1991-6#6)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-5#2)(1993-7#1)(1994-1#2)(1994-5#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-8#3)(2005-1#1)(2005-10#2)(2006-10#1)(2006-11#2)(2006-12#2)(2006-4#2)(2006-6#2)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#3)(2007-3#1)(2007-4#6)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#14)(2007-9#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#1)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#4)(2012-12#3)(2012-2#3)(2013-1#4)(2013-7#3)(2013-8#1)
of the lowest##14##3##(1991-6#1)(1995-6#1)(1997-7#1)(2006-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-6#1)(2010-12#1)(2010-2#2)(2010-5#1)(2012-2#1)
of the luciferase gene##4##4##(1992-4#1)(1994-9#1)(1996-4#1)(2008-11#1)
of the luciferase reporter gene##2##5##(1992-9#1)(1994-8#1)
of the luciferase##8##3##(1992-12#1)(1992-4#1)(1992-9#1)(1994-8#1)(1994-9#1)(1996-4#1)(1997-2#1)(2008-11#1)
of the lucigenin##2##3##(2008-10#2)
of the lumbar spinal##2##4##(1994-2#1)(2008-7#1)
of the lumbar spine and##2##5##(1991-11#1)(2007-11#1)
of the lumbar spine in the##3##6##(2007-7#1)(2012-1#2)
of the lumbar spine were##2##5##(2007-11#1)(2007-8#1)
of the lumbar spine##26##4##(1991-11#2)(1992-1#1)(2006-12#1)(2006-8#6)(2007-11#4)(2007-7#1)(2007-8#2)(2008-12#1)(2009-2#1)(2011-2#3)(2012-1#2)(2012-2#1)(2012-3#1)
of the lumbar sympathetic trunk##3##5##(2006-7#3)
of the lumbar##38##3##(1991-11#2)(1992-1#1)(1994-2#1)(1996-6#1)(2006-12#1)(2006-2#1)(2006-7#3)(2006-8#7)(2007-11#5)(2007-7#2)(2007-8#2)(2008-12#1)(2008-7#1)(2009-2#2)(2011-2#4)(2012-1#2)(2012-2#1)(2012-3#1)
of the lumbo-sacral spine##4##4##(2007-11#3)(2007-8#1)
of the lumbosacral spine##4##4##(2006-10#1)(2006-8#1)(2007-1#1)(2008-7#1)
of the lumbosacral##7##3##(1992-11#1)(1996-12#1)(2006-10#1)(2006-8#2)(2007-1#1)(2008-7#1)
of the lumen of the##2##5##(2008-10#1)(2008-2#1)
of the lumen of##3##4##(2008-10#1)(2008-2#1)(2010-4#1)
of the lumen##8##3##(1992-5#1)(1996-3#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)(2010-4#1)
of the luminal surfaces##2##4##(1995-11#1)(2010-2#1)
of the luminal##6##3##(1990-6#1)(1992-9#1)(1995-11#1)(2006-10#2)(2010-2#1)
of the luminance##2##3##(2008-2#1)(2008-3#1)
of the luminescence##3##3##(2005-11#2)(2008-10#1)
of the luminescent##2##3##(2008-10#1)(2008-2#1)
of the luminous##2##3##(2008-2#1)(2008-3#1)
of the lump##2##3##(1991-12#1)(2005-12#1)
of the lunar##5##3##(1992-1#1)(2008-2#1)(2011-1#2)(2013-8#1)
of the lung and##7##4##(1990-12#1)(1994-2#1)(1996-3#1)(1997-1#1)(2008-12#1)(2009-10#1)(2010-9#1)
of the lung are##3##4##(1990-8#1)(2005-11#1)(2007-8#1)
of the lung as##2##4##(1991-2#1)(2012-12#1)
of the lung by##2##4##(1994-12#1)(2005-7#1)
of the lung can be##2##5##(1992-12#1)(2013-7#1)
of the lung can##3##4##(1992-12#1)(1996-4#1)(2013-7#1)
of the lung disease##4##4##(1994-6#2)(2005-11#1)(2006-10#1)
of the lung function##2##4##(2007-2#1)(2009-1#1)
of the lung in##5##4##(1991-12#1)(2005-11#1)(2007-4#1)(2008-2#1)(2010-7#1)
of the lung is##4##4##(1991-2#1)(1997-4#1)(2007-8#1)(2008-7#1)
of the lung or##3##4##(1991-12#1)(2005-11#1)(2006-8#1)
of the lung parenchyma##3##4##(1994-6#1)(2007-7#1)(2012-12#1)
of the lung tissue##2##4##(1991-12#1)(1996-3#1)
of the lung with##3##4##(1991-11#1)(1997-4#1)(2005-11#1)
of the lung##119##3##(1990-11#1)(1990-12#2)(1990-3#1)(1990-8#2)(1991-11#1)(1991-12#4)(1991-2#3)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-4#1)(1993-10#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#3)(1994-7#1)(1995-9#1)(1996-11#1)(1996-3#2)(1996-4#1)(1997-1#3)(1997-2#2)(1997-4#2)(2005-11#6)(2005-7#1)(2005-8#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#11)(2007-9#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#3)(2008-6#4)(2008-7#5)(2008-8#1)(2009-1#1)(2009-10#1)(2009-5#1)(2010-10#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#4)(2013-1#7)(2013-7#1)(2013-8#1)
of the lung]##3##3##(1994-3#1)(1997-5#1)(2008-1#1)
of the lungfish##2##3##(1993-5#1)(1995-5#1)
of the lungs and##6##4##(1996-3#1)(2005-11#1)(2007-12#1)(2010-12#1)(2011-2#1)(2012-1#1)
of the lungs by##2##4##(1991-9#1)(2005-7#1)
of the lungs was##2##4##(2007-12#1)(2012-12#1)
of the lungs##29##3##(1991-5#1)(1991-9#2)(1992-5#1)(1996-3#1)(1997-1#2)(2005-1#1)(2005-11#1)(2005-7#1)(2006-5#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#2)(2010-12#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)
of the lupane##2##3##(1991-10#1)(2008-11#1)
of the luteal phase##5##4##(1990-8#1)(1994-9#1)(2006-5#3)
of the luteal##6##3##(1990-8#1)(1992-9#1)(1994-9#1)(2006-5#3)
of the luteinizing hormone##2##4##(1990-9#1)(1995-3#1)
of the lux operon from Photobacterium leiognathi##2##7##(1993-2#2)
of the luxA and luxB genes of Xenorhabdus luminescens##2##9##(1990-7#2)
of the lyc gene##3##4##(1991-7#3)
of the lymph node##4##4##(1990-5#1)(1990-6#1)(1991-12#1)(1996-9#1)
of the lymph nodes##5##4##(1990-12#1)(1996-3#1)(2005-1#1)(2007-5#1)(2009-2#1)
of the lymph##10##3##(1990-12#1)(1990-5#1)(1990-6#1)(1991-12#1)(1996-3#1)(1996-9#2)(2005-1#1)(2007-5#1)(2009-2#1)
of the lymphatic system##2##4##(2005-11#1)(2008-4#1)
of the lymphatic##5##3##(1990-3#1)(1992-9#1)(2005-11#1)(2008-4#1)(2013-1#1)
of the lymphocyte##5##3##(1990-8#1)(1991-11#1)(1993-11#1)(1997-3#1)(2007-12#1)
of the lymphocytes##3##3##(1992-12#1)(1992-4#1)(2007-11#1)
of the lymphoid tissue##2##4##(1992-12#1)(2008-5#1)
of the lymphoid##10##3##(1992-12#2)(1992-3#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#1)
of the lymphoma##4##3##(1991-5#1)(2005-9#1)(2008-7#1)(2010-10#1)
of the lyn gene##2##4##(1996-4#2)
of the lysine##4##3##(1994-10#1)(2006-12#1)(2008-5#2)
of the lysis gene##3##4##(1997-1#3)
of the lysis##4##3##(1990-11#1)(1997-1#3)
of the lysosomal enzyme##3##4##(1990-5#1)(1994-3#1)(1997-7#1)
of the lysosomal enzymes##4##4##(1991-12#1)(1991-5#1)(1993-1#1)(2012-3#1)
of the lysosomal system##4##4##(1992-12#1)(2008-5#1)(2008-7#2)
of the lysosomal##21##3##(1990-2#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-12#1)(1993-1#1)(1993-8#1)(1993-9#1)(1994-3#3)(1994-5#1)(1994-8#1)(1995-10#1)(1997-7#1)(2008-5#1)(2008-7#2)(2012-3#1)
of the lytic##3##3##(1990-1#1)(1993-11#2)
of the m##2##3##(2005-1#1)(2013-8#1)
of the mAb##3##3##(1997-6#1)(2008-11#2)
of the mAbs##2##3##(1997-6#1)(1997-7#1)
of the mPFC##3##3##(1991-1#1)(2009-2#2)
of the mRNA and the##2##5##(1990-3#1)(1995-2#1)
of the mRNA and##4##4##(1990-3#1)(1993-4#1)(1994-5#1)(1995-2#1)
of the mRNA as##2##4##(1990-10#1)(1993-11#1)
of the mRNA coding for##3##5##(1991-2#1)(1992-1#1)(1993-3#1)
of the mRNA encoding##4##4##(1993-6#1)(1994-12#1)(1995-8#1)(2008-9#1)
of the mRNA for the high affinity receptor for monomeric IgG (Fc gamma R-I##2##14##(1990-7#2)
of the mRNA for the##5##5##(1990-7#3)(1991-4#1)(1996-12#1)
of the mRNA for##10##4##(1990-7#3)(1991-12#1)(1991-4#2)(1992-12#1)(1992-6#1)(1996-12#1)(2008-11#1)
of the mRNA has##2##4##(1993-2#1)(1993-8#1)
of the mRNA in the##3##5##(1990-11#1)(1992-6#1)(2008-9#1)
of the mRNA of##3##4##(1991-12#1)(1992-2#1)(1995-7#1)
of the mRNA was also##3##5##(1992-9#1)(1996-2#2)
of the mRNA was##5##4##(1992-9#2)(1996-2#2)(1996-7#1)
of the mRNA##61##3##(1990-10#1)(1990-11#1)(1990-3#2)(1990-7#3)(1991-12#2)(1991-2#1)(1991-4#2)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#4)(1993-6#2)(1993-7#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-5#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-7#2)(1996-9#1)(1997-2#2)(1997-6#1)(2006-11#2)(2008-11#1)(2008-2#1)(2008-9#3)(2013-1#1)
of the mRNAs and##2##4##(1991-2#1)(1995-7#1)
of the mRNAs by##2##4##(1991-2#1)(1995-1#1)
of the mRNAs##9##3##(1990-3#2)(1991-2#2)(1991-3#1)(1991-7#1)(1992-6#1)(1995-1#1)(1995-7#1)
of the mTOR signaling network##2##5##(2009-12#2)
of the mTOR##3##3##(2009-12#2)(2013-8#1)
of the macaque monkey##3##4##(1995-11#2)(1997-2#1)
of the macrocycle##3##3##(1991-12#1)(2008-10#1)(2009-10#1)
of the macrocyclic##7##3##(1992-6#1)(1996-2#2)(2006-12#1)(2008-10#1)(2008-5#2)
of the macrolide##2##3##(1990-12#1)(1990-5#1)
of the macromolecular##3##3##(1994-12#1)(2008-4#1)(2008-7#1)
of the macromolecule##2##3##(1990-8#1)(1997-2#1)
of the macronuclear DNA##2##4##(1994-12#2)
of the macrophage##11##3##(1990-5#1)(1991-5#1)(1991-8#2)(1992-7#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-5#1)(1997-5#1)
of the macrophages##2##3##(1992-12#1)(1995-5#1)
of the macrophyte##2##3##(2007-3#1)(2013-7#1)
of the macroscopic##3##3##(2007-5#1)(2008-11#1)(2008-8#1)
of the macula##3##3##(2005-1#1)(2008-4#1)(2011-2#1)
of the macular##2##3##(2011-2#1)(2012-12#1)
of the mad##3##3##(2007-5#1)(2008-7#2)
of the magnesium##2##3##(2007-8#1)(2010-4#1)
of the magnet of a cochlear implant receiver stimulator package following minor head trauma##2##14##(2008-9#2)
of the magnet##4##3##(2008-10#1)(2008-9#2)(2010-4#1)
of the magnetic beads##3##4##(2008-10#3)
of the magnetic field was##2##5##(2008-2#1)(2009-5#1)
of the magnetic field##12##4##(1994-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#1)(2012-1#3)
of the magnetic##27##3##(1990-3#1)(1990-9#1)(1991-7#1)(1993-5#1)(1994-2#1)(1995-11#1)(1997-7#3)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-8#1)(2009-11#1)(2009-5#1)(2010-2#1)(2012-1#3)(2012-2#1)
of the magnetization##6##3##(1997-7#1)(2005-11#1)(2006-4#1)(2008-10#1)(2008-2#1)(2009-6#1)
of the magnitude of the##10##5##(1994-12#1)(1994-2#1)(1995-2#2)(1996-1#1)(2007-12#1)(2007-5#1)(2008-2#1)(2008-3#1)(2011-2#1)
of the magnitude of##14##4##(1992-6#1)(1993-1#1)(1994-12#1)(1994-2#1)(1995-2#2)(1996-1#1)(1997-2#1)(2005-10#1)(2007-12#1)(2007-5#1)(2008-2#1)(2008-3#1)(2011-2#1)
of the magnitude##18##3##(1992-6#1)(1993-1#1)(1994-12#1)(1994-2#1)(1995-2#2)(1996-1#1)(1997-2#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)(2011-2#1)
of the magnitudes of##2##4##(2008-10#1)(2008-3#1)
of the magnocellular##2##3##(1996-2#1)(1997-6#1)
of the main advantages of##2##5##(2007-11#1)(2008-3#1)
of the main arteries of the##2##6##(2008-7#1)(2012-3#1)
of the main arteries##3##4##(2008-7#2)(2012-3#1)
of the main chain and##3##5##(2008-9#2)(2009-7#1)
of the main chain##4##4##(2006-12#1)(2008-9#2)(2009-7#1)
of the main characteristics of##2##5##(1991-9#1)(2006-5#1)
of the main components of the##3##6##(2004-12#1)(2009-5#1)(2010-12#1)
of the main components of##4##5##(1992-12#1)(2004-12#1)(2009-5#1)(2010-12#1)
of the main concepts##2##4##(2012-12#1)(2013-1#1)
of the main constituents of##2##5##(2008-11#2)
of the main constituents##3##4##(2008-11#3)
of the main factors influencing the##2##6##(1991-10#1)(2008-10#1)
of the main factors##6##4##(1991-10#1)(1992-1#1)(1994-12#1)(2008-10#1)(2010-12#1)(2011-1#1)
of the main functions##2##4##(2007-11#1)(2008-4#1)
of the main goals of##2##5##(2009-10#1)(2009-6#1)
of the main molecule##2##4##(2007-8#1)(2008-5#1)
of the main objectives in##2##5##(2008-11#1)(2011-2#1)
of the main objectives of the##2##6##(2006-10#1)(2011-2#1)
of the main objectives##4##4##(2006-10#1)(2008-11#1)(2011-2#2)
of the main photoproducts##2##4##(1992-8#1)(2011-1#1)
of the main problems in the##3##6##(2009-2#2)(2011-2#1)
of the main problems in##4##5##(2008-11#1)(2009-2#2)(2011-2#1)
of the main problems##6##4##(1996-10#1)(2008-11#1)(2008-5#1)(2009-2#2)(2011-2#1)
of the main reasons why##2##5##(2008-10#1)(2009-11#1)
of the main reasons##5##4##(1992-9#1)(2008-10#1)(2009-11#1)(2011-2#1)(2013-8#1)
of the main structural elements##2##5##(1997-4#2)
of the main techniques##2##4##(2007-7#1)(2008-11#1)
of the main##192##3##(1990-12#1)(1990-5#1)(1990-8#2)(1990-9#2)(1991-10#1)(1991-6#3)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-10#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2003-11#1)(2004-11#1)(2004-12#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-5#2)(2006-6#3)(2006-8#1)(2007-1#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-3#2)(2007-5#3)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#18)(2008-11#10)(2008-2#4)(2008-3#7)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#1)(2009-2#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-7#1)(2010-8#2)(2011-1#8)(2011-2#9)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#5)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#3)
of the maintenance of##2##4##(1995-10#1)(1995-12#1)
of the maintenance trial##2##4##(2012-2#2)
of the maintenance##5##3##(1995-10#1)(1995-12#1)(2012-2#2)(2013-8#1)
of the maize##5##3##(2006-12#1)(2008-7#2)(2009-10#1)(2011-2#1)
of the major NORs##2##4##(1993-12#2)
of the major alkaloids##2##4##(2007-1#1)(2012-3#1)
of the major axis##2##4##(2008-1#1)(2008-2#1)
of the major barriers to##2##5##(2004-10#1)(2008-11#1)
of the major capsid protein gene##2##6##(2007-2#1)(2009-5#1)
of the major challenges in##3##5##(2006-5#1)(2008-4#1)(2011-2#1)
of the major challenges##7##4##(1990-1#1)(1995-4#1)(2006-5#1)(2008-4#1)(2008-7#1)(2009-7#1)(2011-2#1)
of the major classes of##2##5##(2008-11#1)(2009-3#1)
of the major clinical##2##4##(2005-7#1)(2008-7#1)
of the major complications##8##4##(2006-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#2)
of the major component##3##4##(1992-3#1)(2006-12#1)(2008-10#1)
of the major components##2##4##(2008-10#1)(2008-5#1)
of the major concerns for##2##5##(2006-5#1)(2011-1#1)
of the major concerns##3##4##(2006-5#1)(2008-10#1)(2011-1#1)
of the major conformation##2##4##(1996-7#2)
of the major degradation##2##4##(1992-1#1)(2008-10#1)
of the major elements##2##4##(2005-4#1)(2008-10#1)
of the major exoglucanase##2##4##(1997-1#2)
of the major factors##6##4##(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2012-2#1)
of the major findings##2##4##(2006-10#1)(2011-1#1)
of the major form of##2##5##(1993-5#1)(2008-4#1)
of the major form##3##4##(1990-5#1)(1993-5#1)(2008-4#1)
of the major forms##2##4##(1992-2#1)(2004-4#1)
of the major groups##2##4##(2006-11#1)(2008-10#1)
of the major histocompatibility complex (MHC)##4##6##(1990-12#1)(1990-5#1)(2007-11#1)(2008-1#1)
of the major histocompatibility complex##6##5##(1990-12#1)(1990-5#1)(2006-10#2)(2007-11#1)(2008-1#1)
of the major histocompatibility##9##4##(1990-12#1)(1990-5#1)(1991-7#1)(2006-10#2)(2007-11#1)(2008-1#1)(2008-11#1)(2008-4#1)
of the major human##2##4##(1994-3#1)(2006-10#1)
of the major issues##3##4##(1995-1#1)(2008-6#1)(2010-9#1)
of the major limitations##2##4##(2008-8#1)(2011-2#1)
of the major mechanisms##2##4##(2008-4#1)(2012-2#1)
of the major mediators of##2##5##(1996-5#1)(2007-11#1)
of the major obstacles##5##4##(1996-5#1)(2007-6#1)(2008-12#1)(2008-4#1)(2008-5#1)
of the major parameters of##2##5##(2007-10#1)(2008-2#1)
of the major problems in##2##5##(2010-8#1)(2012-12#1)
of the major problems##4##4##(1997-2#1)(2008-12#1)(2010-8#1)(2012-12#1)
of the major promoter##4##4##(1995-10#4)
of the major protein##2##4##(1995-7#1)(2008-4#1)
of the major structural protein##2##5##(1991-10#1)(2005-11#1)
of the major tools##2##4##(2009-6#1)(2011-12#1)
of the major vessels##2##4##(2007-7#1)(2013-1#1)
of the major##286##3##(1990-1#1)(1990-10#2)(1990-12#2)(1990-3#1)(1990-5#2)(1990-7#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-11#2)(1992-2#2)(1992-3#2)(1992-5#1)(1992-8#2)(1993-11#2)(1993-12#2)(1993-4#1)(1993-5#2)(1993-6#1)(1994-10#2)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#4)(1995-12#2)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#4)(1995-7#1)(1995-8#2)(1996-3#1)(1996-5#2)(1996-7#2)(1996-8#2)(1997-1#3)(1997-2#3)(1997-5#1)(1997-6#1)(1997-8#2)(2004-10#1)(2004-12#1)(2004-4#1)(2005-11#1)(2005-4#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#9)(2006-11#2)(2006-12#1)(2006-2#2)(2006-5#3)(2006-6#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-2#2)(2007-3#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#24)(2008-11#9)(2008-12#5)(2008-2#5)(2008-3#4)(2008-4#13)(2008-5#10)(2008-6#3)(2008-7#6)(2008-8#7)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#9)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#8)(2013-7#2)(2013-8#3)
of the majority of cases##2##5##(1991-3#1)(2010-3#1)
of the majority of the##3##5##(2008-5#1)(2011-2#1)(2012-2#1)
of the majority of##18##4##(1991-11#1)(1991-3#1)(1991-7#1)(1991-9#1)(1997-2#1)(2007-12#1)(2008-4#2)(2008-5#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
of the malaria##8##3##(1994-5#1)(2006-10#2)(2008-2#1)(2012-12#4)
of the male accessory glands##2##5##(2007-12#1)(2008-7#1)
of the male accessory##3##4##(1991-5#1)(2007-12#1)(2008-7#1)
of the male and female##3##5##(1992-3#1)(2007-4#1)(2008-5#1)
of the male genital tract##2##5##(2012-1#1)(2012-2#1)
of the male genital##3##4##(2008-7#1)(2012-1#1)(2012-2#1)
of the male ideal##2##4##(2006-7#1)(2007-12#1)
of the male rat##4##4##(1991-11#2)(1991-2#2)
of the male rats##2##4##(1990-11#1)(1994-2#1)
of the male reproductive##4##4##(2006-10#1)(2007-12#1)(2007-9#1)(2012-2#1)
of the male urogenital##2##4##(1994-11#1)(2013-1#1)
of the male##58##3##(1990-11#1)(1990-8#1)(1991-11#2)(1991-2#2)(1991-5#1)(1992-2#2)(1992-3#3)(1992-6#2)(1992-8#2)(1993-6#2)(1994-11#1)(1994-2#1)(1994-5#1)(1996-1#1)(1996-3#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-12#7)(2007-3#2)(2007-4#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2009-2#1)(2010-2#1)(2010-8#2)(2012-1#1)(2012-2#3)(2013-1#1)(2013-8#1)
of the males were##2##4##(1995-3#1)(2007-12#1)
of the males##8##3##(1993-11#1)(1994-2#1)(1995-3#1)(2007-12#1)(2008-4#1)(2008-5#1)(2012-12#2)
of the malformation##4##3##(1990-8#1)(1990-9#2)(2008-9#1)
of the malignancy of the##2##5##(1990-10#1)(1992-9#1)
of the malignancy##3##3##(1990-10#1)(1990-8#1)(1992-9#1)
of the malignant cells##2##4##(2007-11#1)(2009-8#1)
of the malignant polyp##2##4##(2009-12#2)
of the malignant tumour##2##4##(2008-9#1)(2012-3#1)
of the malignant##14##3##(1990-5#1)(1990-6#1)(1996-6#1)(2005-1#1)(2005-7#1)(2007-11#1)(2007-3#1)(2008-9#1)(2009-12#2)(2009-8#1)(2010-12#1)(2011-3#1)(2012-3#1)
of the maltose binding protein##2##5##(1993-6#2)
of the mammalian and##2##4##(1991-2#1)(2006-12#1)
of the mammalian brain##3##4##(1995-6#1)(2008-11#2)
of the mammalian host##2##4##(2008-9#1)(2011-2#1)
of the mammalian inner ear##2##5##(1996-3#1)(2009-9#1)
of the mammalian pyruvate##2##4##(1991-2#1)(1996-5#1)
of the mammalian testis##2##4##(2012-2#2)
of the mammalian##56##3##(1990-2#1)(1990-7#2)(1991-10#1)(1991-2#3)(1991-6#2)(1992-1#1)(1992-7#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-9#2)(1995-2#2)(1995-3#1)(1995-6#2)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-12#1)(2008-11#4)(2008-4#1)(2008-8#2)(2008-9#2)(2009-2#2)(2009-9#1)(2010-7#1)(2011-2#2)(2012-2#2)(2013-1#3)(2013-8#1)
of the mammary gland##6##4##(1993-2#1)(1994-3#1)(2009-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
of the mammary glands were##3##5##(2012-1#1)(2012-12#2)
of the mammary glands##9##4##(2012-1#1)(2012-12#8)
of the mammary##18##3##(1993-2#1)(1994-3#1)(2007-8#1)(2009-12#2)(2011-2#1)(2012-1#2)(2012-12#8)(2012-2#1)(2013-1#1)
of the managed care system##4##5##(2006-10#4)
of the managed care##5##4##(1991-3#1)(2006-10#4)
of the managed##6##3##(1991-3#1)(1994-3#1)(2006-10#4)
of the management of##21##4##(1991-4#1)(1993-5#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-11#2)(2010-10#1)(2010-5#1)(2010-7#2)(2012-3#2)(2013-1#3)
of the management##28##3##(1991-4#1)(1992-12#1)(1993-1#1)(1993-5#1)(1997-1#1)(2006-10#2)(2006-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-11#2)(2010-10#1)(2010-5#1)(2010-7#2)(2012-3#2)(2013-1#3)
of the managerial functions##2##4##(1994-3#2)
of the managerial##3##3##(1994-3#2)(2008-1#1)
of the mandible and##3##4##(2007-12#1)(2007-6#1)(2012-2#1)
of the mandible in##3##4##(1996-8#1)(2007-6#1)(2007-7#1)
of the mandible##21##3##(1996-8#1)(1997-3#1)(2007-12#2)(2007-6#2)(2007-7#4)(2008-7#1)(2010-2#1)(2011-1#3)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
of the mandibular condyle##4##4##(1991-3#1)(1993-1#1)(2007-12#1)(2011-12#1)
of the mandibular ramus##3##4##(2007-7#1)(2010-2#2)
of the mandibular##14##3##(1991-3#1)(1993-1#1)(2004-9#1)(2007-12#3)(2007-7#1)(2010-2#4)(2011-12#1)(2012-12#1)(2012-2#1)
of the manganese##2##3##(2008-10#1)(2010-5#1)
of the mangrove forest##2##4##(2008-5#2)
of the mangrove##4##3##(2008-5#2)(2008-7#2)
of the manifestations of##2##4##(1992-12#1)(2007-6#1)
of the manifold##3##3##(2006-10#1)(2008-10#2)
of the manner in which##3##5##(1995-3#1)(2006-6#1)(2012-3#1)
of the mannitol permease##4##4##(1991-10#4)
of the manual methods##2##4##(1991-3#1)(2008-10#1)
of the manual##10##3##(1991-3#1)(1996-3#1)(2007-3#1)(2008-10#3)(2008-7#1)(2010-10#1)(2012-12#1)(2012-2#1)
of the manufacturers##3##3##(2004-9#1)(2006-10#1)(2008-10#1)
of the manufacturing process##3##4##(1995-5#1)(2008-3#1)(2008-5#1)
of the manufacturing##5##3##(1995-5#2)(2008-10#1)(2008-3#1)(2008-5#1)
of the many advantages of##2##5##(2007-11#1)(2008-4#1)
of the many##47##3##(1990-2#1)(1991-12#1)(1991-7#1)(1992-2#2)(1993-5#1)(1994-12#1)(1995-11#1)(1996-3#1)(2006-10#5)(2006-12#2)(2006-4#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-2#2)(2007-6#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-2#1)
of the map##2##3##(2007-12#1)(2012-11#1)
of the mapping##3##3##(2008-5#2)(2008-9#1)
of the mappings##2##3##(2008-2#1)(2008-7#1)
of the maps##2##3##(1991-3#1)(2008-3#1)
of the marginal periodontium##2##4##(2009-8#1)(2011-1#1)
of the marginal##12##3##(1993-6#1)(1995-9#1)(1997-3#1)(2008-2#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-12#2)
of the marine clam##2##4##(1994-8#1)(2007-3#1)
of the marine mollusc Aplysia##2##5##(1994-8#1)(1997-6#1)
of the marine ornamental##2##4##(2007-5#2)
of the marine##22##3##(1991-10#1)(1994-3#1)(1994-8#3)(1996-2#1)(1997-6#1)(2007-3#2)(2007-5#3)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#2)(2010-10#1)(2010-8#1)(2012-12#1)(2013-1#1)
of the mark##3##3##(2008-1#1)(2008-2#2)
of the marked strain##2##4##(2008-10#2)
of the marked##6##3##(1991-2#1)(1994-8#1)(2008-10#3)(2008-5#1)
of the marker genes##2##4##(2008-10#1)(2008-8#1)
of the marker##10##3##(1991-8#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-8#1)(2010-2#1)(2012-3#1)
of the markers in##3##4##(2008-10#1)(2008-5#2)
of the markers of##3##4##(1997-7#1)(2010-4#1)(2013-8#1)
of the markers##11##3##(1995-10#1)(1997-7#1)(2006-9#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-9#1)(2010-4#1)(2013-8#1)
of the market##10##3##(1991-12#1)(1993-2#2)(1993-5#1)(1994-3#2)(1995-1#1)(1997-5#1)(2008-10#1)(2010-5#1)
of the marketing##2##3##(1993-12#1)(2008-12#1)
of the marketplace##2##3##(1995-1#1)(2007-4#1)
of the marks##4##3##(1996-3#1)(2006-8#1)(2008-11#1)(2008-2#1)
of the martensitic phase##2##4##(2006-6#1)(2008-2#1)
of the martian##3##3##(1995-3#1)(2007-9#2)
of the masculine##2##3##(2008-11#1)(2013-1#1)
of the mask##3##3##(2007-12#1)(2008-3#1)(2010-7#1)
of the masking effect##2##4##(2008-10#1)(2008-5#1)
of the masking##5##3##(2007-12#1)(2008-10#3)(2008-5#1)
of the mass and##6##4##(2005-5#1)(2007-8#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-2#1)
of the mass media##2##4##(1994-3#1)(2006-7#1)
of the mass of the##2##5##(2004-9#1)(2008-10#1)
of the mass of##6##4##(1992-2#1)(2004-9#2)(2008-10#1)(2008-4#1)(2012-2#1)
of the mass revealed##2##4##(2010-5#1)(2013-8#1)
of the mass spectrum##2##4##(1990-12#1)(2008-6#1)
of the mass was done##2##5##(2012-12#1)(2013-8#1)
of the mass was##5##4##(2007-8#1)(2009-3#1)(2012-12#1)(2013-8#2)
of the mass##53##3##(1990-12#1)(1991-10#1)(1991-5#1)(1992-2#1)(1994-3#1)(1995-5#1)(2004-9#2)(2005-12#1)(2005-5#2)(2006-10#1)(2006-12#1)(2006-4#1)(2006-7#1)(2007-2#2)(2007-8#3)(2008-10#5)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#3)(2009-3#1)(2009-4#1)(2009-9#2)(2010-11#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#3)
of the masses##3##3##(1990-3#1)(2008-10#1)(2009-7#1)
of the masseter muscle at##2##5##(2010-12#1)(2012-2#1)
of the masseter muscle in##3##5##(2010-6#1)(2013-1#2)
of the masseter muscle##7##4##(1996-2#1)(2010-12#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#2)
of the mastectomy##2##3##(2004-1#2)
of the master##4##3##(1992-4#1)(1996-7#1)(2008-11#1)(2008-3#1)
of the masticatory##3##3##(1990-9#1)(2010-9#1)(2012-1#1)
of the mastoid process##4##4##(2008-7#3)(2008-9#1)
of the mastoid##10##3##(2007-2#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)
of the matched cord##2##4##(2010-11#2)
of the matched##3##3##(2008-3#1)(2010-11#2)
of the mate recognition system##3##5##(2008-8#1)(2008-9#2)
of the material and##3##4##(2004-9#1)(2007-11#1)(2010-9#1)
of the material for##2##4##(2008-10#1)(2008-7#1)
of the material is##2##4##(2007-12#2)
of the material properties of the##2##6##(2005-10#1)(2007-11#1)
of the material resulting from##3##5##(1996-8#1)(2008-3#2)
of the material was##2##4##(2008-10#1)(2008-2#1)
of the material##56##3##(1991-8#1)(1992-12#1)(1993-8#1)(1995-2#1)(1995-8#1)(1996-8#1)(2004-9#2)(2005-10#1)(2006-4#1)(2006-6#2)(2006-7#1)(2007-11#7)(2007-12#6)(2007-4#1)(2007-8#1)(2008-10#5)(2008-2#6)(2008-3#6)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2010-11#1)(2010-9#1)(2012-3#1)(2013-1#2)(2013-8#1)
of the materials and##2##4##(2008-2#1)(2011-2#1)
of the materials was##2##4##(2008-5#1)(2009-3#1)
of the materials##20##3##(1990-9#1)(1996-12#1)(1996-2#2)(2004-9#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-3#2)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of the maternal allele##3##4##(1994-9#1)(2010-12#2)
of the maternal circadian system##2##5##(1994-6#2)
of the maternal organism##2##4##(1996-11#1)(2011-2#1)
of the maternal##22##3##(1994-11#1)(1994-3#1)(1994-6#4)(1994-9#1)(1995-8#1)(1996-11#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-12#2)(2010-8#1)(2011-2#2)(2013-1#1)
of the mathematical##4##3##(1996-12#1)(2007-11#1)(2008-10#1)(2009-8#1)
of the mathematics##2##3##(2005-11#1)(2006-5#1)
of the mating system##3##4##(2008-10#1)(2013-1#2)
of the mating##6##3##(1996-2#1)(2008-10#3)(2013-1#2)
of the matrices##7##3##(1996-5#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-2#2)
of the matrix and##2##4##(2005-8#1)(2008-5#1)
of the matrix domain##2##4##(2012-12#2)
of the matrix is##2##4##(2008-10#2)
of the matrix metalloproteinase family##2##5##(1994-11#1)(1994-5#1)
of the matrix metalloproteinase##4##4##(1994-11#1)(1994-5#1)(2012-12#2)
of the matrix##55##3##(1990-11#1)(1990-8#1)(1990-9#1)(1992-1#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#2)(2005-11#1)(2005-8#1)(2006-1#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2008-10#16)(2008-2#2)(2008-3#1)(2008-5#2)(2008-8#5)(2009-12#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#2)
of the mats##2##3##(1990-11#1)(2011-2#1)
of the matter##5##3##(1994-3#2)(2007-9#1)(2008-10#1)(2010-7#1)
of the maturation##2##3##(2008-10#1)(2008-12#1)
of the mature 16S##2##4##(1993-9#2)
of the mature enzyme##3##4##(1991-7#1)(1991-8#1)(1994-12#1)
of the mature protein isolated from##2##6##(1991-9#1)(1992-12#1)
of the mature protein was##2##5##(1991-7#1)(1992-1#1)
of the mature protein##14##4##(1990-12#1)(1990-8#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#4)(1994-12#1)
of the mature sperm##2##4##(1996-8#1)(2007-12#1)
of the mature##44##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-5#1)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#3)(1992-3#4)(1993-2#1)(1993-9#2)(1994-12#3)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-8#1)(1997-6#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-4#1)(2012-12#2)(2012-2#1)
of the maturing##3##3##(1995-5#1)(2006-10#1)(2006-11#1)
of the maxi-K channel that##2##5##(1995-8#2)
of the maxi-K channel##3##4##(1995-8#3)
of the maxilla and mandible##2##5##(1991-1#1)(2007-12#1)
of the maxilla##8##3##(1991-1#1)(2007-12#1)(2008-6#1)(2009-5#1)(2012-12#1)(2012-2#1)(2013-1#2)
of the maxillary central##3##4##(2008-5#1)(2009-8#2)
of the maxillary sinus##11##4##(1991-12#1)(1993-1#1)(2007-7#1)(2008-2#1)(2008-3#1)(2011-1#1)(2011-7#1)(2012-12#3)(2013-7#1)
of the maxillary stylets##2##4##(2007-12#2)
of the maxillary##20##3##(1991-12#1)(1993-1#1)(2007-12#2)(2007-7#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-7#1)(2009-8#2)(2010-2#1)(2011-1#1)(2011-7#1)(2012-12#3)(2012-2#1)(2013-7#1)
of the maximal carbachol response with an EC50 value of##2##10##(1990-11#2)
of the maximal power##2##4##(2008-3#1)(2011-2#1)
of the maximal response##2##4##(1992-4#1)(1996-12#1)
of the maximal##22##3##(1990-11#2)(1990-12#2)(1990-4#1)(1990-7#1)(1991-5#1)(1992-4#1)(1992-6#1)(1994-11#1)(1994-6#1)(1996-12#1)(1997-1#1)(1997-7#1)(2005-1#2)(2005-8#1)(2008-3#2)(2008-5#1)(2008-7#1)(2011-2#1)
of the maximum likelihood estimate##2##5##(2008-2#2)
of the maximum likelihood##3##4##(2008-10#1)(2008-2#2)
of the maximum of the##2##5##(1991-2#1)(1995-5#1)
of the maximum possible##2##4##(2008-10#2)
of the maximum theoretical##2##4##(1990-7#1)(2008-5#1)
of the maximum##54##3##(1990-10#3)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-5#1)(1995-8#1)(1997-2#1)(1997-7#1)(2005-11#2)(2006-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-2#9)(2008-3#3)(2008-5#2)(2008-6#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)
of the maximum-likelihood##4##3##(1994-5#1)(2007-12#1)(2008-2#2)
of the maze##2##3##(1993-5#1)(2008-11#1)
of the meals##3##3##(2008-3#1)(2013-7#2)
of the mean daily##2##4##(2004-3#1)(2008-7#1)
of the mean intensity of##2##5##(2008-2#2)
of the mean measurements##3##4##(1993-1#3)
of the mean number of##2##5##(2007-12#1)(2008-10#1)
of the mean square##2##4##(2008-3#1)(2012-2#1)
of the mean value##3##4##(2008-10#2)(2012-12#1)
of the mean velocity##3##4##(1993-12#2)(1996-9#1)
of the mean##53##3##(1991-12#1)(1993-1#3)(1993-12#2)(1994-12#1)(1994-2#1)(1994-3#1)(1996-10#1)(1996-9#2)(2004-3#1)(2005-1#1)(2006-10#1)(2006-11#1)(2007-11#2)(2007-12#3)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#6)(2008-5#3)(2008-7#2)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
of the meaning of##5##4##(1993-1#1)(2008-11#1)(2008-6#1)(2010-2#1)(2013-8#1)
of the means by which##2##5##(1997-2#1)(2007-5#1)
of the means of##2##4##(2007-2#1)(2008-7#1)
of the means##5##3##(1997-2#1)(2007-2#1)(2007-5#1)(2008-7#1)(2010-4#1)
of the measurand and##2##4##(2008-3#2)
of the measure##5##3##(1990-2#1)(1996-3#1)(2006-9#1)(2008-1#1)(2008-11#1)
of the measured cross-correlation coefficient##2##5##(2007-12#2)
of the measured data##3##4##(2008-11#1)(2008-3#2)
of the measured radiance##2##4##(2008-2#2)
of the measured shape##2##4##(2008-6#2)
of the measured##57##3##(1992-8#1)(1994-11#1)(1994-3#1)(1995-6#1)(1997-7#1)(2005-11#3)(2007-11#1)(2007-12#7)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#14)(2008-3#13)(2008-4#1)(2008-6#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-4#1)(2013-1#1)
of the measurement and##4##4##(2008-10#2)(2008-3#2)
of the measurement error##2##4##(2008-3#2)
of the measurement of a##2##5##(2008-10#1)(2008-3#1)
of the measurement of##6##4##(1996-4#1)(2006-12#1)(2008-10#1)(2008-3#3)
of the measurement results##2##4##(2008-3#1)(2009-11#1)
of the measurement system##2##4##(2008-10#1)(2008-3#1)
of the measurement##36##3##(1996-4#1)(1997-6#1)(2006-12#1)(2007-11#2)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#18)(2009-11#1)(2009-3#1)
of the measurements at##2##4##(2008-10#1)(2008-3#1)
of the measurements is##2##4##(2007-12#1)(2008-3#1)
of the measurements made##3##4##(1996-1#1)(2008-10#2)
of the measurements was##2##4##(2008-10#2)
of the measurements##21##3##(1994-11#1)(1995-2#1)(1996-1#1)(2005-10#1)(2006-10#1)(2007-12#1)(2008-10#8)(2008-3#6)(2013-7#1)
of the measures are discussed##2##5##(1990-2#1)(2007-12#1)
of the measures##7##3##(1990-2#1)(2007-12#2)(2008-10#1)(2008-6#1)(2010-9#1)(2011-2#1)
of the measuring##4##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
of the meat##8##3##(2008-10#1)(2010-4#6)(2013-1#1)
of the mecA gene##3##4##(2008-10#2)(2011-2#1)
of the mechanical and thermal##2##5##(2007-9#1)(2012-1#1)
of the mechanical and##6##4##(2006-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2012-1#1)(2012-2#1)
of the mechanical properties of##5##5##(2007-5#1)(2008-3#1)(2009-8#2)(2013-8#1)
of the mechanical properties##8##4##(2004-9#1)(2007-5#1)(2008-3#1)(2008-5#1)(2009-8#2)(2012-2#1)(2013-8#1)
of the mechanical stimulus##2##4##(1990-8#1)(2006-2#1)
of the mechanical##36##3##(1990-8#2)(1993-12#1)(1993-9#1)(1995-9#1)(2004-9#1)(2005-11#1)(2006-11#2)(2006-12#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-2#2)(2008-3#2)(2008-5#2)(2009-8#2)(2010-2#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-2#2)(2013-8#2)
of the mechanism and##3##4##(2008-10#2)(2010-12#1)
of the mechanism for##2##4##(1995-5#1)(2008-8#1)
of the mechanism governing##2##4##(1990-8#1)(2008-7#1)
of the mechanism of action of##7##6##(1990-7#1)(1991-11#1)(1991-5#1)(2006-10#1)(2008-11#1)(2010-12#1)(2010-6#1)
of the mechanism of action##8##5##(1990-7#1)(1991-11#1)(1991-5#1)(2006-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2010-6#1)
of the mechanism of activation of##2##6##(1991-1#1)(1993-6#1)
of the mechanism of the##4##5##(1992-3#1)(1993-3#1)(2008-10#1)(2008-11#1)
of the mechanism of##45##4##(1990-7#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-5#1)(1992-3#1)(1993-3#1)(1993-6#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-7#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-9#1)(1997-4#1)(2004-11#1)(2005-12#1)(2006-10#1)(2006-11#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#2)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-3#1)
of the mechanism that##2##4##(2008-11#1)(2008-3#1)
of the mechanism underlying##2##4##(1996-12#1)(2009-4#1)
of the mechanism which##2##4##(1993-9#1)(1996-8#1)
of the mechanism##64##3##(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-5#1)(1992-3#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-5#1)(1995-7#1)(1996-11#1)(1996-12#2)(1996-4#1)(1996-8#1)(1996-9#1)(1997-4#1)(2004-11#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-4#1)(2009-8#1)(2010-12#2)(2010-5#1)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-8#1)
of the mechanisms accounting for the##2##6##(2006-10#1)(2009-1#1)
of the mechanisms and##3##4##(1997-7#1)(2008-10#1)(2012-12#1)
of the mechanisms by which##5##5##(1993-9#1)(1995-6#1)(2006-10#1)(2008-1#1)(2013-1#1)
of the mechanisms involved in the##4##6##(1997-3#1)(2006-10#1)(2007-5#1)(2010-12#1)
of the mechanisms involved in##11##5##(1994-7#1)(1996-11#1)(1996-7#1)(1997-3#1)(2004-11#1)(2006-10#1)(2007-5#1)(2008-1#1)(2008-4#1)(2009-2#1)(2010-12#1)
of the mechanisms involved##14##4##(1990-1#1)(1994-7#1)(1995-2#1)(1996-11#1)(1996-7#1)(1997-3#1)(2004-11#1)(2006-10#1)(2007-5#1)(2008-1#1)(2008-4#1)(2009-2#1)(2010-10#1)(2010-12#1)
of the mechanisms leading to##3##5##(1992-9#1)(1996-5#1)(2012-1#1)
of the mechanisms of interaction between##2##6##(2005-11#1)(2008-12#1)
of the mechanisms of##32##4##(1992-3#1)(1993-4#1)(1994-11#1)(1995-11#1)(1995-5#1)(1996-6#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-4#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#1)(2011-2#3)
of the mechanisms regulating the##2##5##(1997-4#1)(2010-3#1)
of the mechanisms responsible for##4##5##(1997-6#1)(2007-11#1)(2008-10#1)(2008-11#1)
of the mechanisms that##11##4##(1997-4#1)(2005-11#1)(2006-10#1)(2006-6#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
of the mechanisms underlying the##11##5##(1993-8#1)(1995-12#1)(2006-10#2)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
of the mechanisms underlying##14##4##(1993-8#1)(1995-12#1)(1997-8#1)(2006-10#2)(2007-3#1)(2008-1#2)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
of the mechanisms##104##3##(1990-1#1)(1990-12#1)(1992-3#1)(1992-9#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-11#3)(2005-7#1)(2006-10#9)(2006-6#1)(2006-9#1)(2007-11#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-8#3)(2008-1#4)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#6)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-8#2)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#2)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#2)
of the medaka##3##3##(2008-5#3)
of the medfly##2##3##(1996-11#1)(2007-12#1)
of the media and##3##4##(1991-2#1)(2006-5#1)(2008-3#1)
of the media as well as##2##6##(2008-3#1)(2009-5#1)
of the media used##2##4##(2008-1#1)(2008-12#1)
of the media##20##3##(1991-2#1)(1993-12#1)(1995-1#1)(1996-11#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2009-5#1)(2013-1#1)
of the medial and##2##4##(1994-8#1)(2008-8#1)
of the medial epicondyle of the humerus##2##7##(1995-6#2)
of the medial epicondyle##3##4##(1995-6#2)(2012-3#1)
of the medial femoral condyle##4##5##(2007-11#2)(2008-3#1)(2011-2#1)
of the medial frontal##2##4##(1992-8#1)(1994-5#1)
of the medial head of the##2##6##(2006-3#1)(2007-11#1)
of the medial malleolus##2##4##(2007-1#1)(2010-12#1)
of the medial meniscus##2##4##(1990-9#1)(1996-11#1)
of the medial nucleus##4##4##(1993-7#1)(1995-5#1)(1997-6#2)
of the medial perforant path##2##5##(1992-9#1)(1993-12#1)
of the medial prefrontal cortex##7##5##(1994-8#1)(1996-10#4)(1996-2#1)(1997-2#1)
of the medial prefrontal##8##4##(1991-2#1)(1994-8#1)(1996-10#4)(1996-2#1)(1997-2#1)
of the medial##60##3##(1990-6#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-3#1)(1992-8#1)(1992-9#1)(1993-12#3)(1993-7#1)(1993-9#1)(1994-5#2)(1994-8#2)(1995-10#1)(1995-11#1)(1995-5#1)(1995-6#2)(1996-10#4)(1996-11#3)(1996-12#1)(1996-2#3)(1996-4#1)(1996-9#1)(1997-2#1)(1997-6#2)(2006-3#1)(2006-7#1)(2007-1#1)(2007-11#3)(2007-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
of the median domain##2##4##(2007-12#2)
of the median nerve is##2##5##(2008-9#2)
of the median nerve##10##4##(1992-6#1)(2006-3#2)(2008-9#6)(2011-2#1)
of the median##22##3##(1990-9#1)(1992-6#1)(1994-9#1)(1996-12#2)(1997-8#1)(2006-3#2)(2007-12#2)(2007-7#1)(2008-9#6)(2009-8#1)(2010-2#2)(2011-2#1)(2012-2#1)
of the mediastinal##4##3##(1992-8#1)(2008-9#1)(2012-3#1)(2013-7#1)
of the mediastinum in##2##4##(2004-1#1)(2007-8#1)
of the mediastinum is##2##4##(1991-8#2)
of the mediastinum##12##3##(1990-8#2)(1991-8#2)(2004-1#1)(2006-11#1)(2007-8#2)(2008-6#1)(2009-5#1)(2010-12#1)(2011-2#1)
of the mediating##2##3##(2009-7#1)(2013-8#1)
of the mediators##2##3##(2008-10#1)(2009-7#1)
of the medical and##5##4##(1997-3#1)(2007-11#1)(2007-7#1)(2007-9#1)(2010-11#1)
of the medical care##2##4##(1991-6#1)(1996-12#1)
of the medical curriculum##4##4##(2007-2#2)(2010-12#1)(2011-12#1)
of the medical literature##7##4##(1992-12#1)(2007-5#3)(2008-12#1)(2009-10#1)(2012-3#1)
of the medical profession and the##2##6##(2008-7#1)(2009-10#1)
of the medical profession##8##4##(1991-11#1)(1995-11#1)(1996-11#1)(2007-4#1)(2008-7#1)(2009-10#1)(2009-5#1)(2013-1#1)
of the medical record##2##4##(2004-12#1)(2007-12#1)
of the medical records of##2##5##(2008-6#1)(2011-2#1)
of the medical records##6##4##(1991-1#1)(1994-3#1)(1994-8#1)(2008-6#1)(2008-9#1)(2011-2#1)
of the medical staff##5##4##(1992-2#1)(1994-2#2)(1997-1#1)(2012-2#1)
of the medical students##3##4##(1993-3#1)(2006-10#1)(2012-2#1)
of the medical treatment of##3##5##(2007-11#1)(2011-2#2)
of the medical##95##3##(1990-12#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#2)(1992-12#1)(1992-2#1)(1993-10#1)(1993-3#1)(1993-7#1)(1994-2#3)(1994-3#2)(1994-8#1)(1995-11#3)(1995-5#1)(1996-11#1)(1996-12#4)(1996-2#1)(1997-1#1)(1997-3#1)(1997-4#1)(2004-12#1)(2005-12#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-2#5)(2007-4#1)(2007-5#5)(2007-7#1)(2007-9#1)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#3)(2009-5#1)(2009-7#2)(2009-8#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-12#1)(2011-2#8)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
of the medication##12##3##(1992-12#1)(1994-4#1)(1997-2#1)(2006-8#1)(2006-9#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-5#1)(2010-8#1)
of the medicinal properties of##2##5##(2008-3#1)(2011-2#1)
of the medicinal##4##3##(2006-10#1)(2008-10#1)(2008-3#1)(2011-2#1)
of the medicine##2##3##(1996-11#1)(2010-8#1)
of the medium and the##4##5##(1994-8#1)(2007-12#1)(2008-10#2)
of the medium and##8##4##(1994-8#1)(1996-4#1)(2006-2#1)(2007-12#2)(2008-10#2)(2008-11#1)
of the medium by##2##4##(1990-3#1)(1991-3#1)
of the medium is##4##4##(1991-5#1)(1994-6#1)(2007-12#1)(2008-2#1)
of the medium lethal dose##2##5##(2004-9#2)
of the medium perfusion rate##2##5##(2008-11#2)
of the medium that##2##4##(2008-11#1)(2008-3#1)
of the medium tumors##2##4##(2006-12#2)
of the medium was increased##3##5##(2008-3#1)(2008-7#1)(2010-2#1)
of the medium with##3##4##(1992-5#1)(2006-11#1)(2008-6#1)
of the medium##71##3##(1990-3#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-5#1)(1992-6#1)(1993-12#1)(1994-6#1)(1994-8#1)(1996-4#1)(1997-2#1)(2004-9#2)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#2)(2007-10#1)(2007-11#1)(2007-12#5)(2008-10#7)(2008-11#7)(2008-2#7)(2008-3#12)(2008-5#2)(2008-6#2)(2008-7#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#1)
of the medulla oblongata##3##4##(1996-1#1)(1996-9#1)(1997-2#1)
of the medulla##9##3##(1991-11#1)(1991-8#2)(1993-12#1)(1996-1#1)(1996-9#1)(1997-2#1)(2008-5#2)
of the medullary cavity##3##4##(2010-3#1)(2013-1#2)
of the medullary##8##3##(1992-8#1)(1995-5#1)(1995-7#1)(1996-9#1)(2007-7#1)(2010-3#1)(2013-1#2)
of the meeting was the##3##5##(2005-8#2)(2008-5#1)
of the meeting was to present##3##6##(2005-7#1)(2005-8#1)(2008-5#1)
of the meeting was to##5##5##(1994-9#1)(2005-7#1)(2005-8#1)(2007-11#1)(2008-5#1)
of the meeting was##14##4##(1994-9#1)(2005-7#1)(2005-8#7)(2007-11#2)(2008-5#3)
of the meeting##29##3##(1994-9#1)(2005-7#1)(2005-8#12)(2005-9#2)(2006-7#1)(2007-11#2)(2007-4#1)(2008-11#1)(2008-5#5)(2008-7#1)(2010-11#2)
of the meiotic##2##3##(2006-10#1)(2008-7#1)
of the melanocortin receptors##2##4##(1995-12#2)
of the melanocortin##4##3##(1990-5#1)(1995-12#2)(2008-9#1)
of the melanoma##2##3##(2008-5#1)(2008-9#1)
of the melanotrope cells##3##4##(1993-5#3)
of the melatonin biosynthesis##2##4##(1994-5#2)
of the melatonin receptor##2##4##(1994-9#1)(1995-3#1)
of the melatonin##4##3##(1994-5#2)(1994-9#1)(1995-3#1)
of the melting##3##3##(1995-6#1)(1997-7#1)(2006-10#1)
of the members of the##7##5##(1993-12#1)(1994-7#1)(1996-3#1)(1997-6#1)(2005-7#1)(2007-7#1)(2008-10#1)
of the members of##12##4##(1993-12#1)(1994-7#1)(1994-8#1)(1996-3#1)(1997-6#1)(2005-11#1)(2005-7#1)(2007-7#1)(2008-10#2)(2008-9#1)(2013-8#1)
of the members##14##3##(1993-12#1)(1994-7#1)(1994-8#1)(1995-4#1)(1996-3#1)(1997-6#1)(2005-11#1)(2005-7#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-9#1)(2013-8#1)
of the membrane anchor##2##4##(1994-8#2)
of the membrane and##10##4##(1991-11#1)(1992-3#1)(1994-11#1)(1994-2#2)(2008-10#2)(2008-4#1)(2008-9#1)(2013-7#1)
of the membrane are##2##4##(1995-6#1)(2006-10#1)
of the membrane bilayer##4##4##(1991-11#1)(1994-11#1)(1994-2#1)(1997-4#1)
of the membrane can##2##4##(2008-10#1)(2008-2#1)
of the membrane could be##2##5##(2005-12#1)(2006-10#1)
of the membrane disks modified by 5 mg of the##2##10##(2008-10#2)
of the membrane disks modified by##4##6##(2008-10#4)
of the membrane disks modified##5##5##(2008-10#5)
of the membrane due to the##2##6##(2006-10#2)
of the membrane due to##3##5##(2006-10#2)(2008-10#1)
of the membrane fluidity##2##4##(1991-9#1)(2008-9#1)
of the membrane fraction##3##4##(1991-7#2)(1992-6#1)
of the membrane in a##2##5##(1991-2#1)(2012-2#1)
of the membrane in##6##4##(1990-11#1)(1991-2#1)(2009-11#1)(2009-9#1)(2011-1#1)(2012-2#1)
of the membrane is##2##4##(1992-1#1)(2007-2#1)
of the membrane material##2##4##(2005-11#1)(2009-5#1)
of the membrane matrix##2##4##(1990-4#1)(2012-2#1)
of the membrane of##3##4##(1996-2#1)(2007-5#1)(2008-7#1)
of the membrane potential in##3##5##(1993-12#2)(2009-2#1)
of the membrane potential##9##4##(1990-12#1)(1992-3#1)(1992-6#1)(1993-12#3)(1994-10#1)(2009-2#2)
of the membrane proteins of##2##5##(1993-4#1)(2008-7#1)
of the membrane proteins##5##4##(1993-4#1)(1993-8#1)(1994-8#1)(2008-4#1)(2008-7#1)
of the membrane receptor##2##4##(1992-12#1)(1996-11#1)
of the membrane skeleton##3##4##(1990-3#1)(1993-3#1)(1993-4#1)
of the membrane surface##5##4##(1991-4#1)(2006-10#4)
of the membrane was##6##4##(1993-3#1)(2005-11#1)(2008-10#2)(2008-5#1)(2011-2#1)
of the membrane##182##3##(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#1)(1990-3#4)(1990-4#2)(1990-5#2)(1990-7#2)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-7#2)(1991-9#2)(1992-1#2)(1992-11#2)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#5)(1993-12#3)(1993-3#5)(1993-4#2)(1993-8#2)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#6)(1994-5#1)(1994-8#5)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#4)(1996-1#4)(1996-10#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#5)(1997-4#2)(1997-6#1)(1997-7#3)(2004-9#1)(2005-11#3)(2005-12#1)(2006-10#11)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#24)(2008-2#2)(2008-4#6)(2008-5#6)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2009-2#2)(2009-5#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#3)(2013-1#1)(2013-7#1)
of the membrane-associated##3##3##(1992-11#1)(1992-3#1)(1995-8#1)
of the membrane-bound##10##3##(1990-10#1)(1990-11#1)(1990-5#2)(1990-7#1)(1991-2#1)(1991-5#1)(1994-9#1)(1995-6#1)(1997-7#1)
of the membranes and##2##4##(1997-1#1)(2005-11#1)
of the membranes was##2##4##(1990-11#1)(2009-7#1)
of the membranes were##3##4##(1997-1#1)(2008-5#1)(2011-2#1)
of the membranes with##5##4##(1991-4#1)(1992-7#1)(1993-3#1)(1995-11#1)(1995-7#1)
of the membranes##24##3##(1990-11#1)(1991-10#1)(1991-4#1)(1992-2#2)(1992-5#1)(1992-7#1)(1993-3#1)(1993-5#1)(1995-11#1)(1995-7#1)(1996-8#1)(1997-1#2)(2004-10#1)(2005-11#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-7#1)(2011-2#1)
of the membranous##3##3##(1991-4#1)(2007-8#1)(2010-8#1)
of the memory##3##3##(2008-11#1)(2008-3#1)(2010-8#1)
of the men and##4##4##(1994-11#1)(2013-1#1)(2013-8#2)
of the men##12##3##(1991-12#2)(1994-11#1)(1995-12#1)(2008-4#1)(2009-5#2)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#2)
of the meniscus##5##3##(2006-10#1)(2007-12#1)(2008-3#2)(2010-4#1)
of the menopause##2##3##(1993-11#1)(2011-2#1)
of the menstrual cycle on the reproducibility of anorectal##2##9##(1994-4#2)
of the menstrual cycle##10##4##(1990-4#1)(1994-4#2)(1994-7#1)(1994-9#1)(2006-10#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
of the mental health##4##4##(1992-1#1)(2004-12#1)(2006-1#1)(2008-2#1)
of the mental##7##3##(1992-1#1)(2004-12#1)(2006-1#1)(2008-2#1)(2012-3#2)(2013-1#1)
of the mentally ill and##2##5##(2008-2#1)(2008-7#1)
of the mentally ill in##3##5##(2008-2#1)(2008-4#1)(2008-8#1)
of the mentally ill##12##4##(1992-3#1)(1995-2#1)(1996-1#1)(1997-2#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-9#1)(2011-2#1)
of the mentally retarded##2##4##(1992-5#2)
of the mentally##16##3##(1991-3#1)(1992-3#1)(1992-5#2)(1995-2#1)(1996-1#1)(1997-2#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-1#1)
of the mentioned##4##3##(1991-3#1)(2008-2#1)(2010-6#1)(2011-2#1)
of the meq gene from##2##5##(2013-8#2)
of the meq gene##3##4##(2013-8#3)
of the meq##4##3##(2013-8#4)
of the mercury film##2##4##(2008-10#2)
of the mercury##8##3##(1990-2#1)(1993-9#1)(2007-12#1)(2008-10#4)(2008-6#1)
of the merits of##3##4##(1993-2#1)(2007-2#1)(2008-11#1)
of the mesencephalic locomotor region##2##5##(1994-2#1)(1997-2#1)
of the mesencephalon and##3##4##(1990-8#2)(2008-7#1)
of the mesenchymal##2##3##(1990-5#1)(2008-11#1)
of the mesenchyme##3##3##(2008-5#1)(2009-5#1)(2012-12#1)
of the mesenteric##2##3##(1992-5#1)(2009-2#1)
of the mesenteron##2##3##(2008-7#2)
of the mesentery##6##3##(1990-5#1)(1991-4#3)(2006-4#1)(2012-2#1)
of the mesodermal##3##3##(2007-12#1)(2012-12#2)
of the mesolimbic##2##3##(1992-10#1)(1994-10#1)
of the mesopharynx##3##3##(2008-5#3)
of the mesopontine complex##2##4##(1996-12#2)
of the mesostructure##2##3##(2006-12#2)
of the message##6##3##(1993-3#1)(2006-10#1)(2007-12#2)(2008-2#1)(2010-8#1)
of the messenger RNA##3##4##(1992-8#1)(1996-12#1)(2007-11#1)
of the messenger##5##3##(1992-8#1)(1993-3#1)(1996-12#1)(2007-11#1)(2011-12#1)
of the meta cleavage pathway##2##5##(2006-3#2)
of the meta-analysis##4##3##(1996-6#1)(2007-7#1)(2007-9#1)(2008-2#1)
of the metabolic inhibitor tissue homogenate##2##6##(2010-8#2)
of the metabolic inhibitor##3##4##(1991-6#1)(2010-8#2)
of the metabolic syndrome (MS)##2##5##(2008-3#2)
of the metabolic syndrome and its##2##6##(2008-3#1)(2008-7#1)
of the metabolic syndrome and##4##5##(2008-1#1)(2008-3#2)(2008-7#1)
of the metabolic syndrome are##4##5##(2008-11#1)(2008-3#3)
of the metabolic syndrome as##2##5##(2008-1#2)
of the metabolic syndrome in a clinical##2##7##(2008-3#2)
of the metabolic syndrome in a##3##6##(2008-3#3)
of the metabolic syndrome in##10##5##(2008-10#1)(2008-3#6)(2008-5#1)(2011-2#1)(2013-8#1)
of the metabolic syndrome is##2##5##(2008-1#1)(2008-3#1)
of the metabolic syndrome that##2##5##(2008-1#1)(2008-6#1)
of the metabolic syndrome to##2##5##(2008-3#2)
of the metabolic syndrome was##3##5##(2008-3#2)(2010-4#1)
of the metabolic syndrome##84##4##(1990-2#1)(2005-10#2)(2006-6#1)(2008-1#10)(2008-10#1)(2008-11#1)(2008-3#52)(2008-5#2)(2008-6#2)(2008-7#3)(2009-10#1)(2010-4#4)(2010-5#1)(2011-2#2)(2013-8#1)
of the metabolic##120##3##(1990-2#3)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-4#1)(1992-5#1)(1994-2#1)(1995-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-9#1)(2004-11#1)(2005-10#3)(2006-10#1)(2006-6#1)(2006-8#1)(2007-5#1)(2007-6#1)(2008-1#10)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#55)(2008-5#2)(2008-6#4)(2008-7#4)(2008-8#1)(2009-10#1)(2009-5#1)(2010-4#4)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#3)(2012-12#1)(2013-7#1)(2013-8#1)
of the metabolism and##2##4##(1997-8#1)(2008-7#1)
of the metabolism of##8##4##(1992-11#1)(1993-6#1)(1993-9#1)(1995-1#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-7#1)
of the metabolism##14##3##(1992-11#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-1#1)(1997-8#1)(2005-10#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-8#1)
of the metabolite##4##3##(1990-6#1)(1995-12#1)(1996-8#1)(1997-2#1)
of the metabolites of##2##4##(1997-8#1)(2006-2#1)
of the metabolites was##2##4##(1992-2#1)(1997-8#1)
of the metabolites were##4##4##(1996-7#1)(2008-10#1)(2008-11#1)(2013-7#1)
of the metabolites##20##3##(1990-7#1)(1992-2#1)(1992-7#3)(1993-2#1)(1996-12#1)(1996-7#1)(1997-8#2)(2006-2#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2011-2#1)(2011-3#2)(2013-7#1)
of the metabolome##3##3##(2008-9#1)(2009-3#1)(2010-11#1)
of the metabotropic glutamate receptor subtype##2##6##(1997-5#2)
of the metabotropic##5##3##(1993-11#2)(1997-5#2)(2008-4#1)
of the metacarpophalangeal joint of the##3##6##(1990-10#1)(2006-3#1)(2008-9#1)
of the metacarpophalangeal joint##6##4##(1990-10#1)(2006-10#1)(2006-3#2)(2007-11#1)(2008-9#1)
of the metacarpophalangeal##8##3##(1990-10#1)(1992-5#1)(2006-10#2)(2006-3#2)(2007-11#1)(2008-9#1)
of the metal cations##4##4##(1997-4#1)(2005-11#1)(2008-10#1)(2010-7#1)
of the metal center##2##4##(1996-2#1)(2010-5#1)
of the metal chelate##2##4##(1991-8#1)(2008-10#1)
of the metal cluster##3##4##(1994-5#3)
of the metal complex##2##4##(2008-10#1)(2008-3#1)
of the metal complexes##4##4##(2006-3#1)(2008-10#1)(2008-4#1)(2010-5#1)
of the metal in##2##4##(1996-3#1)(2008-10#1)
of the metal ion on##2##5##(2008-10#1)(2008-5#1)
of the metal ion to##3##5##(1997-4#1)(2008-10#2)
of the metal ion##11##4##(1991-4#1)(1991-7#1)(1992-11#1)(1997-2#1)(1997-4#1)(2006-2#1)(2008-10#4)(2008-5#1)
of the metal ions in##2##5##(2008-10#2)
of the metal ions##20##4##(1990-4#1)(2005-11#1)(2008-10#16)(2010-11#1)(2013-8#1)
of the metal species##2##4##(2008-10#2)
of the metal to the##2##5##(1991-8#1)(2008-10#1)
of the metal##91##3##(1990-4#1)(1991-12#1)(1991-4#2)(1991-7#1)(1991-8#2)(1992-11#1)(1992-7#1)(1993-6#1)(1994-5#5)(1994-6#1)(1994-8#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-7#1)(2005-11#3)(2006-2#1)(2006-3#1)(2007-12#1)(2008-10#43)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#2)(2009-9#1)(2010-11#2)(2010-12#1)(2010-5#2)(2010-7#1)(2012-12#1)(2013-8#1)
of the metallic##6##3##(1990-7#1)(2008-10#3)(2011-1#1)(2012-12#1)
of the metalloporphyrins##2##3##(2010-6#2)
of the metalloproteinase##2##3##(1994-8#1)(2010-1#1)
of the metals and##2##4##(2008-10#1)(2010-11#1)
of the metals in##2##4##(2008-10#1)(2013-8#1)
of the metals##17##3##(1992-6#1)(1997-7#1)(2006-1#1)(2008-10#8)(2008-12#1)(2008-6#1)(2010-11#1)(2010-12#1)(2013-1#1)(2013-8#1)
of the metastases##5##3##(1993-10#1)(1997-6#1)(2005-10#1)(2007-11#1)(2010-11#1)
of the metastasis in##2##4##(1997-6#1)(2007-11#1)
of the metastasis##5##3##(1991-6#1)(1997-6#2)(2007-11#1)(2009-10#1)
of the metastatic##8##3##(1991-4#1)(1991-6#1)(1993-12#1)(1995-1#1)(1996-6#1)(1997-7#1)(2009-3#2)
of the meteorite##2##3##(1995-3#1)(2007-8#1)
of the methane##4##3##(1997-4#1)(2008-1#1)(2008-2#2)
of the methanol##6##3##(1990-5#1)(1996-8#1)(1997-7#1)(2008-7#1)(2010-12#1)(2011-2#1)
of the methanolic##5##3##(1997-2#1)(2008-10#1)(2008-12#1)(2009-5#1)(2013-1#1)
of the methionine##4##3##(1994-9#1)(1995-5#1)(2004-10#1)(2013-8#1)
of the method allow##2##4##(2008-4#1)(2009-10#1)
of the method allows for##2##5##(1997-2#1)(2008-5#1)
of the method allows##3##4##(1992-6#1)(1997-2#1)(2008-5#1)
of the method and its##2##5##(2008-10#2)
of the method and the##2##5##(2008-2#1)(2008-7#1)
of the method and##11##4##(1990-10#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-7#1)
of the method are all satisfactory##2##6##(2008-10#2)
of the method are discussed##4##5##(1992-2#1)(1996-7#1)(2007-12#1)(2008-2#1)
of the method are less than##3##6##(2008-10#3)
of the method are presented##4##5##(2008-10#1)(2008-2#2)(2008-3#1)
of the method are##31##4##(1990-10#1)(1990-11#1)(1992-2#1)(1993-2#1)(1994-9#1)(1995-12#1)(1996-7#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#8)(2008-2#6)(2008-3#4)(2008-9#1)
of the method as##4##4##(1992-8#1)(2007-3#1)(2008-10#2)
of the method by##6##4##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
of the method can be##3##5##(1991-5#1)(2008-10#2)
of the method developed##2##4##(2008-10#1)(2008-5#1)
of the method for determining##2##5##(2007-6#1)(2007-8#1)
of the method for routine##2##5##(2007-10#1)(2008-10#1)
of the method for the determination of##2##7##(2008-10#2)
of the method for the##5##5##(2008-10#5)
of the method for##26##4##(1991-7#1)(1993-2#1)(2007-10#1)(2007-6#1)(2007-8#2)(2008-10#17)(2008-2#2)(2008-3#1)
of the method has been##9##5##(1992-8#1)(2008-10#8)
of the method have been##3##5##(2008-10#2)(2008-4#1)
of the method in the##2##5##(1991-5#1)(2008-8#1)
of the method in##10##4##(1991-5#1)(1994-12#1)(2008-10#3)(2008-3#1)(2008-8#1)(2012-1#1)(2012-2#1)(2013-8#1)
of the method is 0##9##5##(2005-4#1)(2008-10#8)
of the method is demonstrated by##4##6##(2008-10#2)(2008-2#1)(2008-3#1)
of the method is demonstrated##5##5##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
of the method is discussed##2##5##(2008-3#2)
of the method is evaluated##2##5##(2008-10#2)
of the method is poor##2##5##(1997-6#1)(2008-10#1)
of the method is tested##2##5##(2007-12#1)(2008-2#1)
of the method is that the##4##6##(2007-12#1)(2008-10#1)(2008-2#1)(2011-12#1)
of the method is that##7##5##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2011-12#1)
of the method is the use of##2##7##(2007-11#1)(2008-10#1)
of the method is the##3##5##(1994-11#1)(2007-11#1)(2008-10#1)
of the method is to##2##5##(2008-10#1)(2009-10#1)
of the method is##68##4##(1990-8#1)(1990-9#1)(1993-10#1)(1994-11#1)(1996-5#1)(1997-2#2)(1997-3#1)(1997-6#1)(2005-4#2)(2007-11#1)(2007-12#6)(2008-1#1)(2008-10#28)(2008-11#1)(2008-2#8)(2008-3#8)(2009-10#2)(2011-1#1)(2011-12#1)
of the method of##11##4##(1990-9#1)(1993-8#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2011-1#1)(2011-12#1)(2012-3#1)
of the method on##2##4##(1990-12#1)(2012-3#1)
of the method proposed by##2##5##(2008-3#2)
of the method proposed##3##4##(2008-10#1)(2008-3#2)
of the method shows##2##4##(2008-10#1)(2008-6#1)
of the method to a##3##5##(2008-2#2)(2010-2#1)
of the method to both##2##5##(1997-2#1)(2008-3#1)
of the method to real samples##3##6##(2008-10#3)
of the method to real##4##5##(2008-10#4)
of the method to the analysis of##4##7##(2008-10#3)(2008-3#1)
of the method to the determination of##2##7##(2008-10#2)
of the method to the study of the##2##8##(2008-10#1)(2008-3#1)
of the method to the##12##5##(2006-3#1)(2008-10#7)(2008-2#2)(2008-3#2)
of the method to##35##4##(1990-12#1)(1994-4#1)(1996-3#1)(1997-2#1)(1997-6#1)(2006-3#1)(2008-10#16)(2008-2#5)(2008-3#5)(2009-7#1)(2010-10#1)(2010-2#1)
of the method used##2##4##(1996-2#1)(2008-4#1)
of the method using##2##4##(2008-10#1)(2010-7#1)
of the method varied from##2##5##(1990-6#1)(2008-10#1)
of the method varied##3##4##(1990-6#1)(2008-10#2)
of the method was 0##6##5##(1995-6#1)(2005-4#2)(2008-10#3)
of the method was 12##2##5##(2008-10#2)
of the method was assessed##2##5##(1992-3#1)(2012-11#1)
of the method was carried out##2##6##(2007-11#1)(2008-10#1)
of the method was checked by##2##6##(2008-10#2)
of the method was checked##4##5##(1996-11#1)(2008-10#3)
of the method was confirmed by##4##6##(1991-7#1)(2007-8#1)(2008-10#2)
of the method was demonstrated by the##4##7##(2008-10#4)
of the method was demonstrated by##8##6##(1996-6#1)(2008-10#7)
of the method was demonstrated for##2##6##(2008-10#1)(2008-5#1)
of the method was demonstrated##11##5##(1994-9#1)(1996-6#1)(2008-10#8)(2008-5#1)
of the method was determined##2##5##(2007-8#1)(2008-10#1)
of the method was established by##2##6##(1990-8#1)(2008-10#1)
of the method was estimated##4##5##(2008-10#4)
of the method was evaluated##3##5##(2008-10#3)
of the method was found##2##5##(2008-10#2)
of the method was good##2##5##(2007-11#1)(2012-12#1)
of the method was tested by##2##6##(2008-10#2)
of the method was tested on##2##6##(2007-8#1)(2008-10#1)
of the method was tested##8##5##(2007-8#1)(2008-10#6)(2010-4#1)
of the method was##86##4##(1990-8#1)(1991-7#1)(1992-3#1)(1993-2#1)(1994-9#1)(1995-11#1)(1995-6#1)(1996-11#1)(1996-6#1)(1996-8#1)(2005-3#1)(2005-4#2)(2007-11#3)(2007-12#1)(2007-6#1)(2007-8#3)(2008-10#55)(2008-5#2)(2009-2#2)(2010-12#2)(2010-4#1)(2011-1#1)(2012-11#1)(2012-12#1)
of the method were 0##2##5##(2010-4#1)(2012-12#1)
of the method were established##2##5##(1996-6#1)(2008-10#1)
of the method were##16##4##(1990-8#1)(1996-6#2)(1997-3#1)(2005-4#1)(2008-10#5)(2008-3#1)(2008-5#2)(2010-4#1)(2011-1#1)(2012-12#1)
of the method##481##3##(1990-10#2)(1990-11#1)(1990-12#2)(1990-3#1)(1990-6#1)(1990-8#3)(1990-9#2)(1991-5#3)(1991-7#2)(1991-9#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-10#1)(1993-2#4)(1993-8#1)(1994-11#1)(1994-12#1)(1994-4#1)(1994-6#1)(1994-7#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#3)(1996-7#1)(1996-8#2)(1997-2#5)(1997-3#3)(1997-6#2)(1997-7#1)(1997-8#1)(2005-3#1)(2005-4#5)(2006-10#2)(2006-3#1)(2007-10#1)(2007-11#8)(2007-12#12)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#2)(2007-8#12)(2008-1#1)(2008-10#227)(2008-11#5)(2008-12#4)(2008-2#32)(2008-3#36)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#4)(2009-12#1)(2009-2#2)(2009-7#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#2)(2010-9#2)(2011-1#7)(2011-12#2)(2011-2#1)(2012-1#4)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-8#1)
of the methodologic shortcomings of##2##5##(2007-10#1)(2008-6#1)
of the methodological problems##2##4##(1993-2#1)(1993-7#1)
of the methodological##4##3##(1991-12#1)(1993-2#1)(1993-7#1)(2013-1#1)
of the methodologies##3##3##(2008-7#1)(2012-12#1)(2013-7#1)
of the methodology are##2##4##(2008-10#1)(2008-2#1)
of the methodology to the##4##5##(2008-10#1)(2009-10#1)(2012-12#2)
of the methodology##19##3##(1994-6#1)(1996-12#1)(2006-12#1)(2007-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-12#2)(2013-1#2)
of the methods and##2##4##(2008-10#1)(2008-4#1)
of the methods are##2##4##(1995-2#1)(2008-10#1)
of the methods available for##2##5##(2008-4#1)(2011-2#1)
of the methods for##3##4##(2008-4#1)(2012-1#1)(2013-8#1)
of the methods in##3##4##(1993-4#1)(2008-10#2)
of the methods of##6##4##(1990-6#1)(2005-9#1)(2006-10#1)(2007-11#1)(2009-2#1)(2012-2#1)
of the methods to##2##4##(2008-10#2)
of the methods used by##2##5##(1990-1#1)(2005-7#1)
of the methods used to##2##5##(2008-4#1)(2011-1#1)
of the methods used##6##4##(1990-1#1)(2005-7#1)(2007-7#1)(2008-11#1)(2008-4#1)(2011-1#1)
of the methods was confirmed by##2##6##(1991-5#1)(2008-10#1)
of the methods was##8##4##(1991-5#1)(2008-10#6)(2008-7#1)
of the methods were##4##4##(2008-10#4)
of the methods##76##3##(1990-1#1)(1990-6#2)(1991-5#1)(1992-12#1)(1993-4#1)(1995-2#1)(1996-7#1)(1997-6#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#2)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#23)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-2#1)(2009-9#2)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
of the methotrexate##2##3##(1991-2#1)(1994-9#1)
of the methoxy##2##3##(1991-4#1)(1993-6#1)
of the methyl groups##2##4##(2007-12#1)(2011-1#1)
of the methyl##7##3##(1991-5#1)(1994-9#1)(1996-4#2)(2007-12#1)(2008-10#1)(2011-1#1)
of the methylated HA##2##4##(2008-10#2)
of the methylated##4##3##(1992-7#1)(1997-2#1)(2008-10#2)
of the methylene group of##2##5##(1997-1#1)(2005-12#1)
of the methylene group##4##4##(1997-1#2)(2005-12#1)(2008-5#1)
of the metric##3##3##(1997-8#1)(2009-10#1)(2011-2#1)
of the mevalonate##2##3##(1994-3#1)(2012-2#1)
of the mice developed##3##4##(1991-8#1)(1995-12#1)(2013-1#1)
of the mice injected with the##2##6##(1995-8#2)
of the mice were##2##4##(1995-9#1)(2005-10#1)
of the mice##21##3##(1991-8#1)(1993-5#1)(1993-9#1)(1995-12#1)(1995-8#2)(1995-9#2)(1996-10#1)(1997-4#3)(2005-10#1)(2006-8#2)(2008-7#2)(2012-12#1)(2012-2#2)(2013-1#1)
of the micellar system##4##4##(1990-5#4)
of the micellar##8##3##(1990-5#4)(1993-11#1)(2005-11#1)(2008-10#1)(2008-8#1)
of the micelle##3##3##(1992-8#1)(2005-11#2)
of the micelles##2##3##(2005-11#2)
of the micro##2##3##(1997-3#1)(2011-1#1)
of the micro-organisms##3##3##(2006-8#1)(2010-4#1)(2013-8#1)
of the microarray##2##3##(2006-5#1)(2008-5#1)
of the microbe##4##3##(2007-1#1)(2008-10#1)(2008-5#1)(2011-2#1)
of the microbial biomass##2##4##(2008-6#2)
of the microbial cell##3##4##(2008-11#1)(2008-4#1)(2008-6#1)
of the microbial community##3##4##(2004-4#1)(2008-10#1)(2013-8#1)
of the microbial complex##2##4##(2008-10#2)
of the microbial##21##3##(1992-8#1)(2004-4#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-6#3)(2008-7#1)(2011-1#1)(2013-8#1)
of the microbiota of the##2##5##(2011-12#1)(2011-2#1)
of the microbiota##7##3##(2008-5#1)(2010-12#1)(2011-12#1)(2011-2#2)(2012-1#2)
of the microchannel##2##3##(2007-10#1)(2008-10#1)
of the microchannels##3##3##(2007-5#1)(2008-10#1)(2008-11#1)
of the microchip##2##3##(2007-11#1)(2008-10#1)
of the microcirculation##5##3##(1990-8#1)(1991-2#1)(2010-7#2)(2010-9#1)
of the microenvironment in##3##4##(2009-10#2)(2009-3#1)
of the microenvironment of##2##4##(2009-3#1)(2009-4#1)
of the microenvironment##6##3##(2009-10#2)(2009-3#3)(2009-4#1)
of the microflora##3##3##(2006-10#1)(2008-10#1)(2008-5#1)
of the microfluidic device##2##4##(2008-10#1)(2008-11#1)
of the microfluidic##6##3##(2008-10#3)(2008-11#2)(2010-6#1)
of the microgels##2##3##(2005-11#1)(2008-10#1)
of the microlens##5##3##(2008-10#1)(2008-2#2)(2008-3#2)
of the microlenses##3##3##(2007-12#1)(2008-3#2)
of the microneedle was##2##4##(2011-1#2)
of the microneedle##3##3##(2011-1#3)
of the microorganism##6##3##(1993-3#2)(2008-10#1)(2008-4#1)(2010-12#1)(2011-1#1)
of the microorganisms##6##3##(1994-2#1)(2006-10#1)(2008-10#2)(2008-11#1)(2012-2#1)
of the microparticle enzyme immunoassay##2##5##(1996-4#1)(2008-4#1)
of the microplot trials was##2##5##(2008-10#2)
of the micropump##3##3##(2007-2#3)
of the micropylar##2##3##(2007-12#1)(2009-12#1)
of the microscope are##2##4##(2007-11#1)(2008-3#1)
of the microscope objective##2##4##(2007-12#2)
of the microscope##13##3##(2006-12#1)(2007-11#1)(2007-12#3)(2007-2#1)(2008-3#4)(2009-12#1)(2009-7#1)(2010-1#1)
of the microscopic##6##3##(1992-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
of the microscopists##2##3##(2011-2#2)
of the microsensor##2##3##(2008-10#2)
of the microsomal fraction##2##4##(1993-3#1)(1997-4#1)
of the microsomal##9##3##(1990-11#1)(1991-1#1)(1991-9#1)(1992-6#1)(1993-3#1)(1994-5#1)(1995-3#1)(1997-4#1)(2011-2#1)
of the microsomes##3##3##(1990-6#1)(1991-10#1)(1997-7#1)
of the microspheres##2##3##(2008-2#1)(2008-7#1)
of the microstructure of the##2##5##(1991-3#1)(2009-7#1)
of the microstructure##6##3##(1991-3#1)(2007-11#1)(2007-12#1)(2008-3#1)(2009-7#2)
of the microtubular system in##2##5##(1994-8#2)
of the microtubular system##3##4##(1994-8#3)
of the microtubular##4##3##(1991-9#1)(1994-8#3)
of the microtubule##2##3##(1995-1#1)(2009-10#1)
of the microtubule-associated##2##3##(1995-3#1)(1997-6#1)
of the microtubules##2##3##(1992-5#1)(2008-7#1)
of the microvasculature##2##3##(1991-9#1)(2009-10#1)
of the microvilli##2##3##(2008-7#2)
of the microwave##4##3##(1994-10#1)(2008-10#1)(2008-2#1)(2013-8#1)
of the mid##2##3##(2007-4#1)(2009-7#1)
of the mid-shaft##3##3##(2007-1#2)(2011-2#1)
of the midbrain##6##3##(1992-7#1)(1994-9#1)(1995-12#1)(1997-2#1)(1997-5#1)(2009-10#1)
of the middle and##2##4##(2006-12#1)(2008-9#1)
of the middle cerebral artery (MCA)##3##6##(1996-1#1)(2006-11#1)(2008-12#1)
of the middle cerebral artery with##2##6##(2007-9#1)(2008-7#1)
of the middle cerebral artery##25##5##(1991-6#1)(1996-1#1)(1997-8#1)(2006-11#1)(2006-5#1)(2007-10#6)(2007-9#4)(2008-12#2)(2008-4#1)(2008-7#5)(2010-12#1)(2011-1#1)
of the middle ear##8##4##(1991-3#1)(1993-12#1)(1995-4#2)(1995-5#1)(2007-2#1)(2007-9#1)(2010-2#1)
of the middle fossa##2##4##(2006-12#1)(2011-2#1)
of the middle meningeal artery##2##5##(2008-12#2)
of the middle phalanx##3##4##(2006-3#3)
of the middle turbinate in##2##5##(2008-5#2)
of the middle##56##3##(1991-3#1)(1991-6#1)(1993-11#1)(1993-12#1)(1994-8#2)(1995-4#2)(1995-5#1)(1996-1#1)(1997-8#1)(2006-11#1)(2006-12#2)(2006-3#3)(2006-5#1)(2007-10#6)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2007-9#5)(2008-10#1)(2008-12#5)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#6)(2008-9#1)(2009-3#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
of the midface##4##3##(1996-6#1)(2010-11#2)(2012-12#1)
of the midget##3##3##(2008-5#3)
of the midgut epithelium##2##4##(2007-12#1)(2008-7#1)
of the midgut##11##3##(1996-3#1)(1997-3#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-7#2)(2011-1#2)
of the midline##2##3##(2009-1#1)(2011-1#1)
of the migraine attack##2##4##(2008-9#2)
of the migraine##4##3##(1994-11#1)(2007-10#1)(2008-9#2)
of the migrant##3##3##(2008-2#1)(2008-3#1)(2013-8#1)
of the migration time and peak area##2##7##(2008-10#2)
of the migration time and##3##5##(2008-10#3)
of the migration time##5##4##(1997-8#1)(2008-10#4)
of the migration##7##3##(1996-5#1)(1997-8#1)(2008-10#4)(2012-2#1)
of the military##3##3##(1993-3#1)(2008-3#1)(2011-2#1)
of the milk replacers##2##4##(2010-2#2)
of the milk samples##2##4##(2008-10#2)
of the milk##13##3##(1991-8#1)(1992-10#1)(1997-2#1)(2007-7#1)(2008-10#4)(2010-2#2)(2012-1#1)(2012-2#2)
of the millennium##3##3##(2006-10#2)(2008-4#1)
of the mind and##2##4##(2006-3#1)(2012-2#1)
of the mind##8##3##(2006-3#1)(2006-9#1)(2008-5#3)(2009-10#1)(2012-2#2)
of the mineral oil##2##4##(2004-4#2)
of the mineral##14##3##(1991-6#1)(1993-11#1)(2004-4#2)(2005-11#4)(2006-6#1)(2007-5#1)(2008-10#2)(2008-5#1)(2013-8#1)
of the mineralogical##2##3##(2008-10#2)
of the mini-Tn10kan##2##3##(1991-7#2)
of the minimAl homeodomain##2##4##(1994-8#2)
of the minimal##5##3##(1991-11#1)(1991-6#1)(1992-2#1)(1994-9#1)(1995-2#1)
of the minimum number of##2##5##(2008-3#2)
of the minimum##11##3##(1993-1#1)(1996-3#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-4#1)
of the minor NORs##2##4##(1993-12#2)
of the minor groove##2##4##(1990-5#1)(1993-3#1)
of the minor salivary##2##4##(1991-9#1)(2008-4#1)
of the minor species##3##4##(1992-8#2)(2008-10#1)
of the minor##18##3##(1990-5#1)(1991-6#1)(1991-9#1)(1992-8#2)(1993-12#2)(1993-3#1)(1995-4#1)(1995-6#1)(1997-7#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-12#1)
of the minority##2##3##(2006-10#1)(2008-2#1)
of the minus strand##2##4##(1990-10#1)(1990-11#1)
of the minus##3##3##(1990-10#1)(1990-11#1)(1995-3#1)
of the mirror is##2##4##(2007-11#1)(2007-12#1)
of the mirror##12##3##(2007-11#1)(2007-12#3)(2008-1#1)(2008-11#1)(2008-2#4)(2008-3#2)
of the mirrors##9##3##(2006-5#2)(2007-12#1)(2008-2#2)(2008-3#4)
of the misalignment##2##3##(2008-2#2)
of the mismatch##3##3##(1997-1#1)(2008-2#1)(2009-2#1)
of the missing at random assumption##2##6##(1995-6#2)
of the missing##7##3##(1992-5#1)(1995-6#3)(1997-2#1)(2010-5#1)(2012-3#1)
of the mites##2##3##(1997-5#1)(2006-10#1)
of the mitochondria in##5##4##(1994-11#1)(2006-9#1)(2008-10#1)(2009-11#1)(2012-2#1)
of the mitochondria to##2##4##(1997-7#1)(2007-10#1)
of the mitochondria##16##3##(1994-11#1)(1997-7#1)(2005-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-11#2)(2009-2#2)(2012-2#1)
of the mitochondrial 12S rRNA gene##2##6##(2008-6#1)(2009-5#1)
of the mitochondrial ATP synthase##2##5##(2005-8#2)
of the mitochondrial ATP##3##4##(1991-10#1)(2005-8#2)
of the mitochondrial DNA control region##3##6##(1996-6#1)(2009-2#1)(2010-8#1)
of the mitochondrial DNA##9##4##(1994-11#4)(1996-6#1)(2009-2#1)(2009-5#1)(2010-8#1)(2012-2#1)
of the mitochondrial citrate##2##4##(1992-2#1)(1997-8#1)
of the mitochondrial cytochrome b gene##6##6##(1995-11#2)(2008-5#1)(2010-8#3)
of the mitochondrial cytochrome oxidase##2##5##(2008-10#1)(2011-2#1)
of the mitochondrial cytochrome##9##4##(1992-11#1)(1995-11#2)(2008-10#1)(2008-5#1)(2010-8#3)(2011-2#1)
of the mitochondrial derivatives##3##4##(2007-12#3)
of the mitochondrial gene for##2##5##(2008-2#1)(2008-6#1)
of the mitochondrial gene products##2##5##(1990-8#2)
of the mitochondrial gene##5##4##(1990-8#2)(1993-2#1)(2008-2#1)(2008-6#1)
of the mitochondrial genome in##2##5##(1995-12#1)(2007-11#1)
of the mitochondrial genome##7##4##(1993-4#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-7#1)(2005-8#1)(2007-11#1)
of the mitochondrial inner membrane##2##5##(1994-8#2)
of the mitochondrial matrix##2##4##(1991-10#1)(1994-8#1)
of the mitochondrial membrane potential##2##5##(2008-9#1)(2011-1#1)
of the mitochondrial membrane##5##4##(1992-1#1)(2005-8#1)(2008-1#1)(2008-9#1)(2011-1#1)
of the mitochondrial outer membrane##2##5##(1997-2#1)(2012-2#1)
of the mitochondrial permeability transition##3##5##(2006-10#1)(2008-1#1)(2010-3#1)
of the mitochondrial respiratory chain##5##5##(1996-5#1)(1997-1#1)(1997-6#1)(2007-11#1)(2011-2#1)
of the mitochondrial respiratory##7##4##(1994-8#1)(1996-5#1)(1997-1#1)(1997-6#1)(2004-12#1)(2007-11#1)(2011-2#1)
of the mitochondrial transmembrane potential##2##5##(1997-6#1)(2008-1#1)
of the mitochondrial##103##3##(1990-5#1)(1990-8#3)(1991-10#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1993-2#2)(1993-4#1)(1994-11#5)(1994-12#2)(1994-6#2)(1994-8#5)(1995-11#5)(1995-12#1)(1995-3#2)(1995-6#1)(1995-7#1)(1995-9#1)(1996-10#1)(1996-5#1)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#3)(1997-3#2)(1997-6#2)(1997-8#1)(2004-12#1)(2005-8#10)(2006-10#1)(2007-11#2)(2007-12#3)(2008-1#4)(2008-10#2)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#2)(2010-3#1)(2010-8#4)(2011-1#3)(2011-2#3)(2012-2#4)(2012-3#1)(2013-8#1)
of the mitochondrially##2##3##(1994-3#1)(1995-6#1)
of the mitochondrion##2##3##(2005-8#1)(2007-5#1)
of the mitogen activated protein kinase##2##6##(2012-2#1)(2013-7#1)
of the mitogen##3##3##(1991-2#1)(2012-2#1)(2013-7#1)
of the mitogen-activated protein kinase##6##5##(1995-2#1)(1995-3#1)(1996-5#3)(2008-11#1)
of the mitogen-activated protein##7##4##(1995-2#1)(1995-3#1)(1996-5#3)(2008-11#1)(2010-10#1)
of the mitogen-activated##8##3##(1995-2#1)(1995-3#1)(1996-5#3)(2008-11#1)(2008-7#1)(2010-10#1)
of the mitogenic##4##3##(1990-12#1)(1990-3#1)(1997-1#1)(2008-2#1)
of the mitosene##2##3##(1992-3#2)
of the mitotic chromosomes and##2##5##(2008-1#2)
of the mitotic spindle##3##4##(2007-12#1)(2008-8#1)(2008-9#1)
of the mitotic##7##3##(1996-4#1)(2007-12#1)(2008-1#2)(2008-5#1)(2008-8#1)(2008-9#1)
of the mitral valve##17##4##(1990-6#1)(1994-3#1)(2007-8#3)(2007-9#1)(2009-10#1)(2010-12#2)(2012-12#1)(2013-1#6)(2013-8#1)
of the mitral valves##2##4##(1997-1#1)(2007-8#1)
of the mitral##23##3##(1990-3#1)(1990-6#1)(1992-3#1)(1994-3#1)(1997-1#1)(2007-8#4)(2007-9#1)(2008-10#1)(2009-10#1)(2010-12#2)(2011-1#1)(2012-12#1)(2013-1#6)(2013-8#1)
of the mitral-aortic intervalvular fibrosa##2##5##(2007-8#2)
of the mixed culture was##2##5##(2008-7#2)
of the mixed culture##4##4##(2006-3#1)(2008-6#1)(2008-7#2)
of the mixed films##5##4##(2005-11#5)
of the mixed type##2##4##(1995-4#1)(2011-1#1)
of the mixed##37##3##(1990-11#1)(1990-7#2)(1991-5#1)(1992-9#2)(1995-4#1)(1996-11#1)(1996-12#1)(2005-11#7)(2005-4#1)(2006-3#1)(2007-11#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#3)(2011-1#1)(2012-12#1)(2013-1#1)
of the mixing time##2##4##(1992-3#1)(2007-10#1)
of the mixing##7##3##(1992-3#1)(1992-6#1)(1995-10#1)(2007-10#1)(2008-2#3)
of the mixture in##2##4##(1997-8#1)(2008-10#1)
of the mixture of##2##4##(2008-10#1)(2008-6#1)
of the mixture##27##3##(1990-12#1)(1994-9#1)(1997-7#1)(1997-8#1)(2004-9#1)(2008-10#13)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2011-1#1)(2013-8#1)
of the mixtures in##2##4##(2008-10#2)
of the mixtures were##2##4##(1993-8#1)(2008-10#1)
of the mixtures##9##3##(1992-5#1)(1993-8#1)(2004-9#1)(2008-10#6)
of the mobile phase composition##2##5##(1996-5#1)(2008-10#1)
of the mobile phase was##3##5##(1997-3#1)(2008-10#2)
of the mobile phase##24##4##(1990-11#1)(1990-8#1)(1991-3#1)(1991-5#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#3)(2007-8#1)(2008-10#12)(2011-1#1)
of the mobile phases##2##4##(1997-3#1)(2008-10#1)
of the mobile##30##3##(1990-11#1)(1990-8#1)(1991-3#1)(1991-5#1)(1994-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#4)(2007-8#1)(2008-10#15)(2011-1#1)(2012-12#1)
of the mobilization##3##3##(1990-3#1)(1997-4#1)(2011-2#1)
of the modal birefringence of##2##5##(2008-3#2)
of the modal field##2##4##(2007-12#2)
of the modal fields##2##4##(2007-12#1)(2008-3#1)
of the modal##12##3##(2007-12#4)(2008-2#1)(2008-3#7)
of the modality##3##3##(2008-7#1)(2012-1#1)(2013-1#1)
of the mode cleaner##2##4##(2008-2#2)
of the mode field##2##4##(2008-2#1)(2008-3#1)
of the mode of action of##2##6##(1990-5#1)(1997-6#1)
of the mode of##6##4##(1990-5#1)(1997-6#1)(2004-12#1)(2006-10#1)(2008-2#1)(2013-1#1)
of the mode##14##3##(1990-5#1)(1997-6#1)(2004-12#1)(2006-10#1)(2007-12#3)(2008-2#4)(2008-3#1)(2012-11#1)(2013-1#1)
of the mode-locked##2##3##(2007-11#1)(2008-3#1)
of the model and##7##4##(1995-7#1)(2007-6#1)(2008-10#2)(2010-2#1)(2010-5#1)(2010-8#1)
of the model are discussed##2##5##(1996-1#1)(2008-2#1)
of the model are##8##4##(1996-1#1)(1997-8#1)(2005-7#1)(2008-10#2)(2008-2#2)(2012-1#1)
of the model at##2##4##(2008-11#1)(2008-3#1)
of the model compounds##2##4##(1990-12#1)(2008-10#1)
of the model developed##3##4##(1992-3#1)(1996-11#1)(2008-2#1)
of the model for the##5##5##(1993-4#1)(2008-2#3)(2013-1#1)
of the model for##10##4##(1992-1#1)(1993-4#1)(1994-5#1)(2006-3#1)(2008-2#3)(2008-3#1)(2008-6#1)(2013-1#1)
of the model has##2##4##(2006-11#1)(2008-3#1)
of the model in##5##4##(1991-9#1)(1994-3#1)(2007-11#1)(2008-11#1)(2008-7#1)
of the model is evaluated##2##5##(2008-11#1)(2008-7#1)
of the model is that##2##5##(1997-8#1)(2008-2#1)
of the model is the##2##5##(2007-4#1)(2007-9#1)
of the model is##13##4##(1997-8#2)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)
of the model of the##3##5##(1992-9#1)(2007-12#1)(2012-1#1)
of the model of##6##4##(1992-9#1)(2007-12#1)(2008-2#3)(2012-1#1)
of the model parameters##10##4##(1991-12#1)(1993-9#1)(1994-11#1)(1995-8#1)(1996-1#1)(2008-2#2)(2008-7#1)(2008-8#1)(2011-2#1)
of the model plant##2##4##(2008-10#1)(2011-1#1)
of the model showed that##2##5##(1991-2#1)(2008-10#1)
of the model showed##3##4##(1991-2#1)(1992-9#1)(2008-10#1)
of the model that##2##4##(2006-10#1)(2008-3#1)
of the model to##7##4##(1993-6#1)(2006-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)
of the model used##2##4##(1997-1#1)(2010-6#1)
of the model using##4##4##(2007-4#1)(2008-10#1)(2008-7#1)(2008-9#1)
of the model was##8##4##(1991-2#1)(1995-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-2#1)
of the model were##4##4##(1991-9#1)(1993-9#1)(1997-2#1)(2012-1#1)
of the model##200##3##(1990-12#2)(1990-4#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-9#2)(1992-1#2)(1992-3#3)(1992-9#2)(1993-1#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#4)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#4)(2005-11#1)(2005-7#1)(2006-10#1)(2006-11#3)(2006-3#1)(2007-1#2)(2007-10#4)(2007-11#2)(2007-12#4)(2007-4#3)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#21)(2008-11#10)(2008-2#18)(2008-3#12)(2008-5#3)(2008-6#4)(2008-7#12)(2008-8#6)(2008-9#7)(2009-10#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#2)(2012-1#3)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
of the model's##2##3##(1995-2#1)(2008-1#1)
of the model)##2##3##(1996-6#1)(2008-10#1)
of the modeled##2##3##(2008-3#1)(2013-1#1)
of the modeless laser##3##4##(2008-2#3)
of the modeling##4##3##(2008-11#1)(2008-3#2)(2008-7#1)
of the models in##2##4##(2008-11#1)(2008-8#1)
of the models to##2##4##(2008-10#1)(2008-2#1)
of the models##22##3##(1992-9#1)(1995-1#1)(1995-4#1)(1996-12#1)(1996-5#1)(2005-12#1)(2006-3#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-5#1)(2008-8#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#1)(2011-1#1)(2013-8#1)
of the moderate##2##3##(1992-3#1)(2008-4#1)
of the modern##15##3##(1991-5#1)(1992-2#1)(1993-2#1)(1997-4#1)(2007-4#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-9#1)(2009-11#1)(2010-6#1)(2011-2#1)
of the modes of##2##4##(2006-4#1)(2009-12#1)
of the modes##6##3##(2006-4#1)(2007-12#2)(2008-2#2)(2009-12#1)
of the modification of##2##4##(1991-9#1)(2007-10#1)
of the modification##4##3##(1991-9#1)(1993-6#1)(2007-10#1)(2008-4#1)
of the modifications##2##3##(2007-12#1)(2012-12#1)
of the modified Einthoven triangle##2##5##(2010-8#2)
of the modified and unmodified##2##5##(1993-11#1)(2008-10#1)
of the modified cytochrome c##2##5##(1995-2#2)
of the modified cytochrome##3##4##(1995-2#3)
of the modified electrode was##2##5##(2008-10#2)
of the modified electrode were##2##5##(2008-10#2)
of the modified electrode##8##4##(1995-6#1)(2008-10#7)
of the modified electrodes##3##4##(2007-8#1)(2008-10#2)
of the modified enzyme##4##4##(1990-7#1)(1992-5#1)(2008-10#2)
of the modified guanine##2##4##(1995-10#2)
of the modified maze procedure##2##5##(2007-8#2)
of the modified protein##2##4##(1993-11#1)(1995-2#1)
of the modified silica gel##2##5##(2008-10#2)
of the modified silica##3##4##(2008-10#3)
of the modified surface##3##4##(2005-11#1)(2008-10#2)
of the modified t test##2##5##(2008-4#2)
of the modified technique##2##4##(2007-12#1)(2007-8#1)
of the modified triangular interferometer##2##5##(2008-3#2)
of the modified##94##3##(1990-2#1)(1990-4#1)(1990-7#3)(1990-9#1)(1991-5#1)(1992-5#1)(1993-11#3)(1993-9#1)(1994-8#1)(1995-1#1)(1995-10#2)(1995-2#5)(1995-4#1)(1995-5#2)(1995-6#1)(1996-10#1)(1996-4#1)(1996-7#4)(1997-2#1)(2005-11#2)(2006-5#1)(2007-12#2)(2007-8#4)(2008-10#25)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2010-2#2)(2010-3#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-1#2)(2012-12#2)
of the modifier##6##3##(2007-8#1)(2008-10#5)
of the modifiers##2##3##(2008-10#2)
of the modulated##2##3##(2004-9#1)(2008-2#1)
of the modulation of the##2##5##(1990-4#1)(1992-11#1)
of the modulation of##4##4##(1990-4#1)(1992-11#1)(2008-4#2)
of the modulation transfer function of##2##6##(2008-2#2)
of the modulation transfer function##3##5##(2008-2#3)
of the modulation##14##3##(1990-4#1)(1992-11#1)(1996-12#2)(2007-12#1)(2008-2#3)(2008-3#3)(2008-4#2)(2009-5#1)
of the modulational##2##3##(2007-12#1)(2008-1#1)
of the modulator##2##3##(2007-11#1)(2007-12#1)
of the modulators##2##3##(1996-6#2)
of the modulatory##3##3##(1995-11#1)(2007-11#1)(2008-2#1)
of the module##3##3##(1996-7#1)(2008-11#1)(2009-7#1)
of the modulus##4##3##(1996-2#1)(2008-2#1)(2009-7#2)
of the moiré fringes##6##4##(2008-2#1)(2008-3#5)
of the moiré##8##3##(2008-2#1)(2008-3#7)
of the moist##4##3##(2007-3#2)(2008-10#2)
of the moisture##2##3##(2008-10#2)
of the molar concentration##2##4##(2005-11#1)(2008-4#1)
of the molar##7##3##(1997-6#1)(2005-11#1)(2008-10#1)(2008-3#1)(2008-4#2)(2011-2#1)
of the molds##2##3##(2008-3#1)(2011-2#1)
of the molecular M form##2##5##(2005-8#2)
of the molecular and cellular##2##5##(2008-7#2)
of the molecular and##4##4##(2008-11#1)(2008-7#2)(2010-5#1)
of the molecular basis of##13##5##(1994-9#1)(1995-1#1)(1995-11#2)(1996-11#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-8#1)(2011-2#2)
of the molecular biology of##4##5##(1997-7#1)(2005-8#1)(2010-12#1)(2012-2#1)
of the molecular biology##5##4##(1997-7#1)(2005-8#1)(2010-12#1)(2012-2#1)(2012-3#1)
of the molecular bridge##2##4##(2008-10#1)(2010-12#1)
of the molecular determinants##2##4##(1993-3#1)(2005-7#1)
of the molecular environment##2##4##(1990-2#1)(2008-2#1)
of the molecular events involved in##2##6##(2008-10#1)(2008-7#1)
of the molecular events##5##4##(2008-10#1)(2008-7#3)(2010-12#1)
of the molecular forms of##2##5##(1993-8#1)(2008-4#1)
of the molecular genetic##2##4##(2008-8#1)(2009-9#1)
of the molecular genetics of##3##5##(1993-10#1)(2006-10#2)
of the molecular genetics##5##4##(1993-10#1)(2006-10#2)(2007-7#1)(2009-3#1)
of the molecular interactions of##2##5##(2006-10#1)(2010-7#1)
of the molecular interactions##3##4##(1991-2#1)(2006-10#1)(2010-7#1)
of the molecular layer of the##2##6##(1991-9#1)(2010-12#1)
of the molecular layer##5##4##(1991-9#1)(1994-11#1)(1994-2#1)(1994-8#1)(2010-12#1)
of the molecular mass##2##4##(2008-10#1)(2008-4#1)
of the molecular masses of##5##5##(1990-12#1)(1993-8#1)(1996-5#1)(2008-3#2)
of the molecular masses##6##4##(1990-12#1)(1993-8#1)(1994-12#1)(1996-5#1)(2008-3#2)
of the molecular mechanism of the##3##6##(1994-8#1)(1996-4#1)(2011-1#1)
of the molecular mechanism of##5##5##(1994-11#1)(1994-8#1)(1995-1#1)(1996-4#1)(2011-1#1)
of the molecular mechanisms and##2##5##(1994-11#1)(2012-12#1)
of the molecular mechanisms by##2##5##(2010-9#1)(2011-3#1)
of the molecular mechanisms involved in##2##6##(1997-6#1)(2008-4#1)
of the molecular mechanisms of##6##5##(2006-10#1)(2006-5#1)(2008-11#1)(2008-6#1)(2009-3#1)(2013-1#1)
of the molecular mechanisms that##3##5##(2006-12#1)(2007-12#1)(2010-5#1)
of the molecular mechanisms underlying##2##5##(2008-1#1)(2012-12#1)
of the molecular mechanisms##19##4##(1991-11#1)(1992-4#1)(1994-11#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-3#1)(2010-5#1)(2010-9#1)(2011-3#1)(2012-12#2)(2013-1#1)
of the molecular pathways##3##4##(1991-11#1)(2008-10#1)(2010-9#1)
of the molecular##152##3##(1990-11#1)(1990-12#2)(1990-2#2)(1990-7#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-9#1)(1992-4#1)(1993-10#2)(1993-12#1)(1993-3#1)(1993-8#2)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#1)(1995-5#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#1)(1996-8#2)(1997-2#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-11#1)(2005-7#1)(2005-8#4)(2006-10#5)(2006-12#4)(2006-5#1)(2006-8#2)(2006-9#1)(2007-11#5)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#3)(2009-3#3)(2009-7#3)(2009-9#1)(2010-1#2)(2010-12#4)(2010-4#1)(2010-5#4)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#5)(2011-3#1)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
of the molecule and##4##4##(1992-4#1)(2005-11#1)(2009-12#1)(2012-2#1)
of the molecule has been##2##5##(1995-1#1)(2008-11#1)
of the molecule have##2##4##(1991-11#1)(1993-8#1)
of the molecule in the##2##5##(1993-12#1)(1997-2#1)
of the molecule in##3##4##(1993-12#1)(1997-2#1)(2008-11#1)
of the molecule is##4##4##(1990-5#1)(1990-6#1)(1992-5#1)(1997-6#1)
of the molecule on##2##4##(1996-6#1)(2008-10#1)
of the molecule was##2##4##(1991-2#1)(1997-8#1)
of the molecule were##3##4##(1991-2#1)(1996-9#1)(2013-1#1)
of the molecule##104##3##(1990-11#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#5)(1991-3#1)(1991-4#1)(1991-5#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#2)(1993-8#2)(1994-11#5)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#4)(1995-1#1)(1995-11#1)(1995-3#3)(1995-8#1)(1996-2#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#2)(1997-2#3)(1997-5#1)(1997-6#1)(1997-8#1)(1997-9#1)(2005-11#1)(2006-10#2)(2007-11#2)(2008-10#5)(2008-11#4)(2008-4#3)(2008-5#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-6#1)(2012-2#1)(2013-1#1)
of the molecules and##2##4##(1992-9#1)(2009-9#1)
of the molecules are##3##4##(1997-7#1)(2009-5#1)(2012-2#1)
of the molecules in the##2##5##(1991-2#1)(1992-9#1)
of the molecules in##3##4##(1991-2#1)(1992-9#1)(2008-8#1)
of the molecules that##3##4##(1991-3#1)(2008-8#1)(2013-8#1)
of the molecules##35##3##(1991-2#2)(1991-3#1)(1991-5#1)(1992-8#1)(1992-9#3)(1994-8#1)(1995-5#1)(1995-6#1)(1996-8#2)(1997-7#2)(2005-11#3)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-4#1)(2008-8#2)(2009-5#2)(2009-9#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-8#1)
of the molt-inhibiting hormone##2##4##(2007-12#1)(2008-6#1)
of the molybdenum blue##2##4##(2008-10#2)
of the molybdenum##8##3##(1991-3#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-10#4)
of the moment##4##3##(1996-4#1)(2005-8#1)(2007-10#1)(2012-2#1)
of the moments##2##3##(2008-2#1)(2008-3#1)
of the momentum##2##3##(1994-2#1)(2007-8#1)
of the monarchy##2##3##(2008-7#1)(2009-2#1)
of the monitored##3##3##(2007-12#1)(2008-10#1)(2009-3#1)
of the monitoring program##2##4##(1997-4#1)(2008-10#1)
of the monitoring##5##3##(1997-2#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-3#1)
of the monitors##3##3##(2004-9#2)(2008-10#1)
of the monkey##4##3##(1991-4#1)(1993-2#1)(2007-9#1)(2009-5#1)
of the monoadduct##2##3##(2008-5#2)
of the monoamine neurotransmitters in the##2##6##(2008-10#2)
of the monoamine oxidase##2##4##(1996-5#1)(2008-7#1)
of the monoamine pathways##2##4##(2010-2#2)
of the monoamine##8##3##(1993-12#1)(1994-8#1)(1996-5#1)(2008-10#2)(2008-7#1)(2010-2#2)
of the monochromator##2##3##(2006-4#1)(2006-5#1)
of the monoclonal antibodies##3##4##(1991-10#1)(1991-2#1)(1995-2#1)
of the monoclonal antibody##8##4##(1990-9#1)(1991-5#1)(1996-5#1)(1997-3#1)(2008-11#1)(2008-4#1)(2010-12#1)(2011-1#1)
of the monoclonal##13##3##(1990-9#1)(1991-10#1)(1991-2#1)(1991-5#1)(1995-2#1)(1996-5#1)(1997-3#1)(2006-2#1)(2008-11#2)(2008-4#1)(2010-12#1)(2011-1#1)
of the monocyte##3##3##(1993-9#1)(1994-9#1)(1995-4#1)
of the monofunctional##2##3##(1992-6#1)(1993-12#1)
of the monolayer in the##2##5##(2008-10#2)
of the monolayer##12##3##(1991-9#1)(1992-12#1)(1994-3#1)(2005-11#2)(2007-9#1)(2008-10#4)(2008-11#2)
of the monolithic##6##3##(2005-12#1)(2006-7#1)(2008-10#1)(2008-3#2)(2013-8#1)
of the monomer 13##2##4##(1992-12#2)
of the monomer and##3##4##(2008-10#2)(2012-1#1)
of the monomer##17##3##(1990-2#1)(1992-12#4)(1992-4#1)(1994-8#1)(2005-11#2)(2006-12#1)(2008-10#4)(2008-3#1)(2008-8#1)(2012-1#1)
of the monomeric##10##3##(1990-5#1)(1991-4#1)(1991-5#1)(1991-7#1)(1994-11#1)(1997-4#1)(1997-6#1)(2008-10#3)
of the monomers##7##3##(1994-8#2)(2008-10#1)(2008-8#1)(2010-12#1)(2010-4#2)
of the mononuclear phagocyte##2##4##(2006-10#1)(2008-4#1)
of the mononuclear##6##3##(1990-12#1)(1995-11#1)(2006-10#1)(2008-4#2)(2013-8#1)
of the month##12##3##(2004-12#2)(2006-2#1)(2006-8#1)(2007-5#1)(2008-3#2)(2010-5#1)(2011-2#4)
of the months##2##3##(2008-5#1)(2013-7#1)
of the mood##2##3##(2007-11#1)(2010-12#1)
of the moon##2##3##(2008-2#1)(2008-3#1)
of the morbidity and##2##4##(2007-2#1)(2009-3#1)
of the more advanced##2##4##(2008-1#1)(2008-11#1)
of the more common##12##4##(1996-9#1)(2006-10#1)(2008-1#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-9#2)(2009-9#1)(2010-7#1)(2012-2#1)
of the more commonly used##4##5##(2007-7#1)(2008-4#3)
of the more important##3##4##(1995-9#1)(1996-10#1)(2008-9#1)
of the more novel##2##4##(1996-10#1)(2009-5#1)
of the more prominent##2##4##(2007-5#1)(2008-4#1)
of the more recent##4##4##(1990-4#1)(2005-10#1)(2008-1#1)(2009-6#1)
of the more recently##2##4##(2005-11#1)(2006-10#1)
of the more significant##2##4##(1994-10#1)(2011-1#1)
of the more than##4##4##(1993-12#1)(2004-5#1)(2007-12#1)(2012-1#1)
of the more##81##3##(1990-12#1)(1990-4#1)(1991-7#2)(1992-11#2)(1992-6#1)(1993-12#1)(1994-10#1)(1994-12#1)(1994-5#1)(1995-10#1)(1995-3#1)(1995-9#1)(1996-10#2)(1996-3#1)(1996-9#1)(1997-2#1)(1997-6#1)(2004-11#1)(2004-5#1)(2005-10#1)(2005-11#2)(2005-9#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#2)(2008-1#3)(2008-10#3)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#5)(2008-8#2)(2008-9#3)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-4#2)(2010-7#1)(2010-8#2)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)
of the morphogenesis##2##3##(2009-2#1)(2010-12#1)
of the morphologic##3##3##(1992-11#1)(1992-9#1)(2007-2#1)
of the morphological and##2##4##(2007-11#1)(2008-2#1)
of the morphological characters##2##4##(1995-6#1)(1995-8#1)
of the morphological##11##3##(1995-6#1)(1995-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
of the morphology and function of##2##6##(2008-11#1)(2011-1#1)
of the morphology and##4##4##(1997-1#1)(2008-11#1)(2008-5#1)(2011-1#1)
of the morphology of the##4##5##(2007-12#1)(2007-8#2)(2013-7#1)
of the morphology of##5##4##(2007-12#1)(2007-8#3)(2013-7#1)
of the morphology##9##3##(1997-1#1)(2007-12#1)(2007-8#3)(2008-11#1)(2008-5#1)(2011-1#1)(2013-7#1)
of the mortality rate##2##4##(2008-9#2)
of the mortality##7##3##(1997-7#1)(2004-11#1)(2007-10#1)(2008-9#3)(2010-7#1)
of the morula##3##3##(1995-1#2)(2008-9#1)
of the mosquito AChE##2##4##(1990-5#2)
of the mosquito Aedes##2##4##(1995-1#1)(2011-2#1)
of the mosquito acetylcholinesterase##2##4##(1990-5#2)
of the mosquito##11##3##(1990-5#4)(1995-1#1)(2005-12#1)(2006-10#1)(2008-1#1)(2008-2#1)(2011-2#2)
of the moss Physcomitrella patens##3##5##(2010-2#3)
of the moss##4##3##(2008-10#1)(2010-2#3)
of the most abundant##13##4##(1993-12#1)(1995-3#1)(2005-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
of the most accurate##3##4##(2007-12#1)(2008-10#1)(2009-4#1)
of the most active compounds##2##5##(1995-3#1)(2008-5#1)
of the most active##10##4##(1991-6#1)(1995-3#1)(1996-4#1)(1997-4#1)(2005-11#1)(2007-5#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)
of the most appropriate##9##4##(2004-2#1)(2005-10#1)(2007-9#1)(2008-10#2)(2009-5#1)(2011-2#1)(2012-12#2)
of the most challenging##9##4##(1991-12#1)(2007-11#1)(2008-3#1)(2008-7#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)
of the most clinically##3##4##(2006-2#1)(2007-9#1)(2008-8#1)
of the most common causes of##8##6##(1991-4#1)(2006-10#2)(2007-7#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-8#1)
of the most common complaints##3##5##(2011-1#1)(2011-2#1)(2012-2#1)
of the most common sites of##2##6##(2013-1#1)(2013-8#1)
of the most common sites##3##5##(2013-1#2)(2013-8#1)
of the most common##147##4##(1990-8#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-3#2)(1996-12#1)(1996-6#1)(1997-2#1)(1997-7#1)(1997-8#2)(2004-11#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#8)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#2)(2006-9#2)(2007-11#3)(2007-12#2)(2007-2#4)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#7)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-5#3)(2009-8#1)(2010-12#3)(2010-2#3)(2010-4#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#8)(2011-3#1)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#10)(2013-7#3)(2013-8#4)
of the most commonly seen lower reproductive tract infections among women aged 25 - 54 years in Beijing##2##18##(2011-1#2)
of the most commonly used##12##5##(1994-6#1)(2006-10#1)(2008-11#1)(2008-4#3)(2008-8#1)(2008-9#2)(2010-4#1)(2010-6#1)(2012-2#1)
of the most commonly##24##4##(1994-6#1)(2005-10#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-7#1)(2008-11#1)(2008-4#3)(2008-8#2)(2008-9#2)(2009-5#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#1)
of the most conserved##4##4##(1990-9#1)(1991-9#1)(1995-11#1)(1996-5#1)
of the most controversial##2##4##(2007-4#1)(2009-7#1)
of the most densely populated##2##5##(2008-2#1)(2013-1#1)
of the most destructive plant##2##5##(2009-2#1)(2011-1#1)
of the most destructive##6##4##(2008-10#3)(2009-2#1)(2011-1#1)(2012-11#1)
of the most difficult problems in##2##6##(2007-11#1)(2007-7#1)
of the most difficult##14##4##(1995-1#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-7#1)(2009-3#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
of the most distal##5##4##(1992-11#1)(2011-2#4)
of the most distinctive##2##4##(1991-9#1)(2008-12#1)
of the most effective methods##3##5##(2006-10#1)(2007-11#1)(2011-1#1)
of the most effective##14##4##(1994-7#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-8#1)(2008-10#1)(2009-11#1)(2009-3#1)(2009-6#1)(2011-1#2)(2011-12#1)(2013-8#1)
of the most efficient##5##4##(1991-3#1)(1993-11#1)(2008-11#1)(2010-4#1)(2011-2#1)
of the most exciting fields of##2##6##(2007-12#1)(2011-2#1)
of the most exciting##8##4##(2006-10#2)(2006-6#1)(2007-12#1)(2007-5#1)(2008-9#1)(2010-7#1)(2011-2#1)
of the most extensive##2##4##(1994-1#1)(1997-4#1)
of the most extensively studied##2##5##(2009-3#1)(2012-3#1)
of the most extensively##4##4##(1995-5#1)(2009-3#1)(2009-4#1)(2012-3#1)
of the most flexible##2##4##(1997-2#1)(1997-3#1)
of the most frequent and##2##5##(2011-2#2)
of the most frequent side-effects##2##5##(2006-2#2)
of the most frequent##32##4##(1992-8#1)(1993-2#1)(1993-9#1)(2006-2#3)(2006-6#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-2#1)(2009-9#1)(2010-12#4)(2010-5#1)(2011-2#3)(2012-12#1)(2013-1#6)(2013-7#1)
of the most frequently encountered##2##5##(1997-3#1)(2011-3#1)
of the most frequently performed##3##5##(2007-8#1)(2010-9#1)(2013-1#1)
of the most frequently used##6##5##(1994-6#1)(2006-9#1)(2008-4#1)(2010-1#1)(2010-6#1)(2012-12#1)
of the most frequently##16##4##(1994-6#1)(1997-3#1)(2004-5#1)(2005-7#1)(2006-6#1)(2006-9#1)(2007-8#1)(2008-4#1)(2008-7#1)(2010-1#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-3#1)(2012-12#1)(2013-1#1)
of the most fundamental##5##4##(2008-2#1)(2009-6#1)(2010-12#1)(2012-12#1)(2012-2#1)
of the most general##2##4##(2008-3#1)(2010-12#1)
of the most hazardous##2##4##(2006-12#1)(2010-7#1)
of the most highly##2##4##(1990-3#1)(1995-3#1)
of the most important and##6##5##(2007-11#1)(2008-10#1)(2008-4#1)(2010-10#1)(2010-12#1)(2010-7#1)
of the most important aspects of##4##6##(1992-2#1)(2008-7#1)(2013-1#2)
of the most important characteristics##2##5##(1992-9#1)(2013-8#1)
of the most important factors that##2##6##(2008-3#2)
of the most important factors##7##5##(2007-2#1)(2007-7#1)(2008-3#2)(2008-7#1)(2012-2#1)(2013-1#1)
of the most important functions##3##5##(1997-7#1)(2008-10#1)(2008-11#1)
of the most important gluconeogenic##2##5##(1994-8#2)
of the most important issues in##2##6##(2008-7#1)(2008-9#1)
of the most important issues##3##5##(1995-1#1)(2008-7#1)(2008-9#1)
of the most important pathogens of##2##6##(2008-10#1)(2010-10#1)
of the most important pathogens##3##5##(2005-11#1)(2008-10#1)(2010-10#1)
of the most important sources of##2##6##(2008-8#1)(2012-12#1)
of the most important##161##4##(1990-12#2)(1990-3#1)(1990-5#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-4#1)(1994-5#1)(1994-8#2)(1995-1#2)(1995-4#1)(1995-7#1)(1995-9#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-1#1)(2005-11#2)(2005-8#2)(2006-1#1)(2006-10#3)(2006-12#2)(2006-6#1)(2006-7#1)(2007-11#5)(2007-12#1)(2007-2#4)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#16)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#5)(2009-11#1)(2009-8#2)(2010-10#2)(2010-12#2)(2010-4#1)(2010-5#2)(2010-7#3)(2010-9#2)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#10)(2012-1#1)(2012-11#3)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#2)
of the most informative##2##4##(2008-12#1)(2008-9#1)
of the most interesting and##3##5##(2006-10#1)(2007-5#1)(2008-8#1)
of the most interesting##10##4##(2006-10#1)(2007-12#1)(2007-5#1)(2008-2#2)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#1)(2013-1#1)
of the most intriguing##3##4##(1992-2#1)(2008-5#1)(2011-2#1)
of the most likely##3##4##(1990-9#1)(1996-2#1)(2008-10#1)
of the most modern##2##4##(1992-9#1)(2008-9#1)
of the most often##3##4##(2008-10#2)(2009-8#1)
of the most popular##12##4##(1997-2#1)(2005-9#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-8#1)(2011-1#1)(2013-7#1)
of the most potent##13##4##(1992-9#1)(1994-12#1)(1995-5#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-3#1)(2009-6#1)(2010-4#1)(2010-8#1)(2012-12#2)
of the most pressing##3##4##(2009-4#1)(2010-4#1)(2012-2#1)
of the most prevalent and##2##5##(2008-8#1)(2009-5#1)
of the most prevalent diseases##3##5##(2008-10#1)(2012-3#1)(2013-1#1)
of the most prevalent##15##4##(1991-9#1)(2004-11#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-5#2)(2010-3#1)(2012-3#1)(2013-1#1)
of the most primitive##6##4##(1994-11#1)(1996-7#1)(2007-8#1)(2008-8#1)(2008-9#1)(2009-12#1)
of the most probable##2##4##(2007-7#1)(2012-3#1)
of the most prominent##7##4##(1995-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2012-2#1)
of the most promising##11##4##(2006-5#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-6#1)(2011-1#1)(2013-7#1)
of the most recent and##2##5##(2006-10#1)(2010-11#1)
of the most recent developments in##2##6##(2005-8#1)(2008-10#1)
of the most recent literature##4##5##(1991-2#1)(1991-4#1)(2006-10#1)(2008-8#1)
of the most recent studies##2##5##(1995-6#1)(2012-1#1)
of the most recent##24##4##(1991-2#1)(1991-4#2)(1992-8#1)(1995-6#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-5#1)(2006-6#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#1)(2009-2#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-1#1)
of the most recently##2##4##(2008-11#1)(2011-2#1)
of the most relevant##6##4##(1997-3#1)(2008-1#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
of the most reliable##4##4##(1993-5#1)(2008-10#1)(2011-2#1)(2012-12#1)
of the most remarkable##3##4##(1994-3#1)(2008-2#1)(2008-8#1)
of the most representative##3##4##(2007-5#1)(2008-5#1)(2010-1#1)
of the most robust##2##4##(1997-7#1)(2008-10#1)
of the most salient##2##4##(1994-1#1)(2008-10#1)
of the most serious and##2##5##(1990-4#1)(2007-7#1)
of the most serious##7##4##(1990-4#1)(1991-3#1)(2007-7#1)(2008-10#1)(2008-8#1)(2012-11#1)(2012-12#1)
of the most severe##2##4##(1996-3#1)(2012-2#1)
of the most significant##13##4##(1993-12#1)(2006-10#1)(2007-11#1)(2008-1#2)(2008-7#1)(2008-8#1)(2009-7#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#2)
of the most studied##5##4##(2005-8#1)(2006-2#1)(2006-8#1)(2011-2#1)(2012-12#1)
of the most successful approaches##2##5##(2009-2#1)(2009-3#1)
of the most successful##4##4##(2009-2#1)(2009-3#1)(2011-1#1)(2012-2#1)
of the most suitable##5##4##(1992-10#1)(1992-2#1)(2007-8#1)(2008-10#2)
of the most used##4##4##(1993-11#1)(2008-10#1)(2011-12#1)(2013-7#1)
of the most useful##5##4##(1996-6#1)(2007-11#1)(2009-3#1)(2009-5#1)(2011-2#1)
of the most valuable##4##4##(1992-9#1)(1994-5#1)(2013-1#2)
of the most widely distributed##3##5##(2008-10#3)
of the most widely used##12##5##(2005-11#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
of the most widely##23##4##(2005-11#1)(2006-10#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#2)(2008-5#3)(2008-8#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
of the most##879##3##(1990-12#3)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#3)(1991-12#3)(1991-2#2)(1991-3#2)(1991-4#3)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#5)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#4)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-1#3)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#3)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#6)(1995-4#1)(1995-5#4)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#3)(1997-1#1)(1997-2#4)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#6)(1997-8#3)(2004-11#2)(2004-2#1)(2004-5#1)(2005-1#1)(2005-10#3)(2005-11#6)(2005-12#1)(2005-7#4)(2005-8#8)(2005-9#1)(2006-1#1)(2006-10#24)(2006-11#1)(2006-12#6)(2006-2#6)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#8)(2006-7#1)(2006-8#5)(2006-9#3)(2007-11#20)(2007-12#10)(2007-2#10)(2007-3#3)(2007-4#3)(2007-5#4)(2007-6#2)(2007-7#13)(2007-8#12)(2007-9#4)(2008-1#17)(2008-10#73)(2008-11#13)(2008-12#10)(2008-2#11)(2008-3#8)(2008-4#20)(2008-5#20)(2008-6#7)(2008-7#26)(2008-8#19)(2008-9#20)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#5)(2009-3#7)(2009-4#3)(2009-5#9)(2009-6#4)(2009-7#5)(2009-8#6)(2009-9#3)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#18)(2010-2#5)(2010-3#1)(2010-4#9)(2010-5#4)(2010-6#4)(2010-7#8)(2010-8#5)(2010-9#6)(2011-1#18)(2011-10#2)(2011-12#4)(2011-2#48)(2011-3#4)(2012-1#4)(2012-11#9)(2012-12#25)(2012-2#27)(2012-3#10)(2013-1#39)(2013-7#10)(2013-8#8)
of the moth##4##3##(2007-12#3)(2007-3#1)
of the mother and baby##2##5##(2006-10#1)(2009-9#1)
of the mother and her##2##5##(2007-2#1)(2010-10#1)
of the mother and##5##4##(1997-8#1)(2006-10#1)(2007-2#1)(2009-9#1)(2010-10#1)
of the mother cell##2##4##(1995-2#1)(2008-7#1)
of the mother for the##2##5##(1993-10#1)(1993-2#1)
of the mother for##3##4##(1993-10#1)(1993-2#1)(2006-10#1)
of the mother##29##3##(1990-6#1)(1991-9#1)(1992-12#1)(1993-10#1)(1993-2#2)(1993-6#1)(1995-2#1)(1995-6#1)(1997-3#1)(1997-8#1)(2006-10#2)(2007-2#1)(2007-6#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#2)(2012-2#1)
of the mother's##3##3##(1990-1#1)(1996-9#1)(2006-9#1)
of the mother-child relationship##2##4##(2008-2#1)(2011-1#1)
of the mothers used##2##4##(1990-10#1)(2007-7#1)
of the mothers were##2##4##(2007-12#1)(2008-10#1)
of the mothers##25##3##(1990-10#1)(1990-12#1)(1990-6#1)(1991-1#1)(1991-11#1)(1993-12#1)(1993-6#1)(2007-12#1)(2007-7#2)(2007-9#2)(2008-1#1)(2008-10#3)(2008-2#1)(2009-10#1)(2010-9#1)(2011-1#4)(2012-1#1)(2012-2#1)
of the motifs##3##3##(2008-4#1)(2008-8#1)(2008-9#1)
of the motion of the##2##5##(1991-7#1)(2006-11#1)
of the motion of##5##4##(1991-7#1)(2005-11#1)(2006-11#1)(2007-11#2)
of the motion segment##2##4##(2007-7#2)
of the motion##12##3##(1991-7#1)(1996-12#1)(2005-11#1)(2006-11#1)(2007-11#2)(2007-2#1)(2007-7#2)(2008-2#1)(2009-4#1)(2012-2#1)
of the motivational##5##3##(1994-6#1)(1996-5#1)(2005-12#1)(2008-9#1)(2010-10#1)
of the motor and##2##4##(2006-3#1)(2012-1#1)
of the motor cortex##6##4##(1991-1#1)(1993-9#3)(2008-9#1)(2010-7#1)
of the motor effects##2##4##(1992-6#1)(1996-12#1)
of the motor evoked potential##2##5##(2008-7#2)
of the motor system##2##4##(2007-11#2)
of the motor##32##3##(1990-2#1)(1991-1#1)(1992-6#1)(1993-12#1)(1993-9#4)(1994-10#1)(1994-2#1)(1995-12#2)(1995-3#1)(1996-10#1)(1996-12#2)(2006-10#2)(2006-12#2)(2006-3#1)(2007-11#2)(2008-4#1)(2008-7#3)(2008-9#1)(2010-1#1)(2010-7#1)(2012-1#2)
of the mouse DBH mRNA##2##5##(1992-11#2)
of the mouse DNA polymerase alpha-primase complex##2##7##(1990-7#2)
of the mouse and human##3##5##(1993-3#1)(1993-6#1)(1997-7#1)
of the mouse and##6##4##(1991-2#1)(1993-3#1)(1993-6#1)(1994-8#1)(1997-7#1)(2008-11#1)
of the mouse embryo##3##4##(1991-12#1)(1995-1#1)(2008-10#1)
of the mouse gene##2##4##(1994-8#1)(1996-2#1)
of the mouse genome sequence##2##5##(2008-8#2)
of the mouse genome##4##4##(2008-8#4)
of the mouse homolog##2##4##(1995-8#1)(2010-2#1)
of the mouse lactoferrin gene##3##5##(1992-12#3)
of the mouse mammary##3##4##(1992-8#2)(2009-12#1)
of the mouse ornithine decarboxylase##2##5##(1991-12#1)(1991-2#1)
of the mouse oxytocin receptor##2##5##(1996-11#2)
of the mouse peripherin gene##4##5##(1996-3#4)
of the mouse serotonin transporter##2##5##(1995-11#1)(1996-12#1)
of the mouse skin##2##4##(1992-7#1)(1997-4#1)
of the mouse tail##3##4##(1993-9#2)(1994-5#1)
of the mouse vas deferens##3##5##(1992-3#1)(1996-11#2)
of the mouse##143##3##(1990-11#3)(1990-4#1)(1990-6#1)(1990-7#2)(1991-12#2)(1991-2#3)(1991-5#1)(1991-6#2)(1991-9#2)(1992-11#5)(1992-12#4)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#2)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#7)(1993-6#2)(1993-9#2)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#4)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#4)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#3)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#5)(1996-12#3)(1996-2#2)(1996-3#4)(1997-1#1)(1997-2#1)(1997-4#3)(1997-7#5)(1997-8#1)(2004-9#1)(2006-12#1)(2008-10#3)(2008-11#2)(2008-4#15)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#6)(2009-12#1)(2009-5#1)(2010-2#1)(2013-8#1)
of the mouth and##4##4##(1996-1#1)(2005-10#1)(2011-2#2)
of the mouth in##4##4##(2008-11#1)(2008-5#1)(2012-2#1)(2013-1#1)
of the mouth##35##3##(1990-12#1)(1990-8#1)(1995-11#1)(1996-1#1)(1997-4#1)(2005-10#2)(2005-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-11#1)(2008-5#4)(2008-8#2)(2009-4#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-2#2)(2013-1#2)
of the mouthparts of##2##4##(2007-12#2)
of the mouthparts##3##3##(2007-12#3)
of the movable mirror##2##4##(2008-2#1)(2008-3#1)
of the movement disorder##2##4##(2005-10#1)(2008-7#1)
of the movement of the##2##5##(1996-12#1)(2008-3#1)
of the movement of##3##4##(1996-12#1)(2006-10#1)(2008-3#1)
of the movement##13##3##(1996-1#1)(1996-12#1)(1996-3#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#2)
of the movements of##3##4##(2005-10#1)(2007-12#1)(2012-1#1)
of the movements##6##3##(1992-9#1)(2005-10#1)(2007-12#1)(2008-11#1)(2012-1#1)(2012-3#1)
of the moving##7##3##(2007-11#1)(2008-10#1)(2008-3#3)(2011-2#1)(2012-1#1)
of the mt##2##3##(1991-4#1)(1994-10#1)
of the mtDNA control region##2##5##(2008-12#1)(2008-3#1)
of the mtDNA##7##3##(1994-11#1)(1994-8#1)(1996-12#1)(1996-3#1)(1996-7#1)(2008-12#1)(2008-3#1)
of the mu receptor##2##4##(1995-6#2)
of the mu##6##3##(1991-9#1)(1995-6#2)(1996-8#1)(1997-4#1)(2012-1#1)
of the much larger##3##4##(1991-9#1)(2008-7#2)
of the much##5##3##(1991-9#1)(2006-1#1)(2008-2#1)(2008-7#2)
of the mucin##3##3##(1992-5#1)(1993-2#1)(2007-1#1)
of the mucosa that##2##4##(1990-9#1)(2013-8#1)
of the mucosa##18##3##(1990-9#1)(1993-7#1)(2005-11#1)(2006-10#3)(2007-12#1)(2008-3#2)(2008-5#2)(2009-2#1)(2010-12#1)(2012-1#1)(2013-1#2)(2013-8#2)
of the mucosal epithelium##2##4##(1997-2#1)(2006-10#1)
of the mucosal immune response##2##5##(2007-11#1)(2010-9#1)
of the mucosal immune system##6##5##(2005-11#1)(2006-10#2)(2009-2#3)
of the mucosal immune##9##4##(2005-11#1)(2006-10#3)(2007-11#1)(2009-2#3)(2010-9#1)
of the mucosal layer##2##4##(2006-10#1)(2009-2#1)
of the mucosal lining##2##4##(2008-11#1)(2008-7#1)
of the mucosal##19##3##(1994-6#1)(1997-2#1)(2005-11#1)(2006-10#6)(2007-11#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-2#4)(2010-9#1)
of the mucous membrane in##2##5##(2007-8#1)(2009-2#1)
of the mucous membrane##3##4##(2007-8#1)(2009-2#1)(2012-2#1)
of the mucous##4##3##(2006-10#1)(2007-8#1)(2009-2#1)(2012-2#1)
of the multicatalytic proteinase##2##4##(1990-2#2)
of the multichannel##4##3##(2005-4#1)(2008-2#2)(2008-3#1)
of the multicomponent##2##3##(2005-4#1)(2008-10#1)
of the multicopy##3##3##(1990-4#1)(1995-5#1)(1997-6#1)
of the multidimensional##5##3##(1995-3#1)(2006-1#1)(2007-12#1)(2008-2#1)(2010-7#1)
of the multidisciplinary care##3##4##(2010-11#1)(2013-1#2)
of the multidisciplinary team##3##4##(2012-2#2)(2013-8#1)
of the multidisciplinary##9##3##(2008-8#1)(2010-11#1)(2012-2#2)(2013-1#4)(2013-8#1)
of the multidrug resistance##2##4##(2008-11#2)
of the multidrug resistant##2##4##(2012-12#1)(2013-8#1)
of the multidrug##5##3##(2008-11#3)(2012-12#1)(2013-8#1)
of the multifaceted nature of##2##5##(2008-11#1)(2009-7#1)
of the multifaceted##3##3##(2006-10#1)(2008-11#1)(2009-7#1)
of the multifarious##3##3##(2008-12#1)(2013-1#2)
of the multifunctional##2##3##(1992-11#1)(2008-8#1)
of the multilayer coatings##2##4##(2008-2#1)(2008-3#1)
of the multilayer films##2##4##(2005-11#1)(2008-3#1)
of the multilayer grating##2##4##(2008-3#2)
of the multilayer##14##3##(2005-11#1)(2008-10#1)(2008-2#5)(2008-3#7)
of the multilayers##2##3##(2007-11#1)(2008-2#1)
of the multimeric##2##3##(1994-12#1)(2008-10#1)
of the multiple factors##2##4##(2006-10#1)(2009-8#1)
of the multiple mechanisms of##2##5##(2006-10#1)(2010-1#1)
of the multiple mechanisms##5##4##(2006-10#1)(2007-10#1)(2009-12#1)(2010-1#1)(2012-12#1)
of the multiple shoot culture##2##5##(2007-1#2)
of the multiple##43##3##(1990-5#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-9#1)(1993-6#1)(1995-2#2)(1995-8#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-10#3)(2007-1#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-10#2)(2008-3#2)(2008-4#2)(2008-7#1)(2008-9#2)(2009-12#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#3)
of the multiple-scattering parameters##2##4##(2008-3#2)
of the multiple-scattering##3##3##(2008-2#1)(2008-3#2)
of the multiplicity of##2##4##(2007-8#1)(2008-2#1)
of the multiprotein##2##3##(1992-6#1)(1995-8#1)
of the multiscale##2##3##(2008-2#2)
of the multisubunit##2##3##(1991-3#1)(2008-2#1)
of the multivalent selectin##2##4##(1997-4#2)
of the multivalent##3##3##(1997-4#2)(2010-12#1)
of the multivariate##4##3##(2008-10#3)(2008-2#1)
of the multiwavelength##2##3##(2007-12#1)(2008-3#1)
of the municipal health##2##4##(1992-11#1)(2012-12#1)
of the municipal##3##3##(1992-11#1)(1992-3#1)(2012-12#1)
of the municipalities##7##3##(1990-10#1)(1991-6#1)(1992-2#1)(1992-3#1)(1993-8#1)(2012-12#2)
of the municipality##7##3##(1992-3#1)(1993-8#1)(2007-2#1)(2012-12#3)(2012-3#1)
of the muramidase of the##2##5##(1990-9#2)
of the murine GPIIb gene##2##5##(1993-9#2)
of the murine LHR##2##4##(1996-5#2)
of the murine gene encoding##3##5##(1990-5#1)(1993-6#1)(1996-10#1)
of the murine##45##3##(1990-11#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-2#1)(1993-6#1)(1993-9#3)(1994-12#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-5#2)(1995-6#1)(1996-10#2)(1996-5#5)(1996-7#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#1)(2008-11#1)(2008-4#4)
of the muscarinic receptor##4##4##(1990-2#1)(1994-2#1)(1995-11#1)(1996-12#1)
of the muscarinic receptors in the##2##6##(1990-5#2)
of the muscarinic##11##3##(1990-2#1)(1990-5#2)(1992-7#1)(1993-12#1)(1994-2#3)(1995-11#1)(1995-3#1)(1996-12#1)
of the muscle and##2##4##(2007-1#1)(2008-5#1)
of the muscle membrane##2##4##(1997-6#1)(2009-10#1)
of the muscle##28##3##(1990-2#1)(1990-8#1)(1991-2#1)(1992-8#1)(1993-9#1)(1994-8#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-6#1)(2005-1#1)(2005-10#1)(2006-4#1)(2007-1#1)(2008-5#2)(2008-6#2)(2008-7#3)(2009-10#1)(2009-3#2)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
of the muscles and##2##4##(2007-12#1)(2009-3#1)
of the muscles in##2##4##(1990-4#1)(2007-8#1)
of the muscles of facial expression##2##6##(2007-12#2)
of the muscles of the##4##5##(1995-5#1)(2006-11#1)(2008-9#2)
of the muscles of##6##4##(1995-5#1)(2006-11#1)(2007-12#2)(2008-9#2)
of the muscles##24##3##(1990-4#1)(1991-1#1)(1995-5#1)(1995-9#1)(1996-9#1)(2006-11#2)(2007-11#1)(2007-12#3)(2007-7#2)(2007-8#3)(2008-12#1)(2008-9#2)(2009-3#1)(2010-4#2)(2011-2#1)(2012-1#1)
of the muscular ideal##2##4##(2007-12#2)
of the muscular##6##3##(2007-12#3)(2008-8#1)(2010-6#1)(2013-1#1)
of the musculature##2##3##(2006-12#1)(2011-2#1)
of the musculoskeletal system##7##4##(2007-11#1)(2007-7#1)(2007-8#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-9#1)
of the musculoskeletal##8##3##(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-9#1)
of the musculus rectus##2##4##(1990-10#2)
of the mushroom bodies##3##4##(2007-12#3)
of the mushroom##4##3##(2007-12#4)
of the mustache bat##2##4##(1996-9#2)
of the mutagenic##2##3##(1993-9#1)(2008-10#1)
of the mutant LPL##2##4##(1992-3#2)
of the mutant allele##2##4##(1994-2#1)(2006-10#1)
of the mutant alleles##3##4##(1991-10#1)(1991-7#1)(1997-3#1)
of the mutant by##2##4##(1995-11#1)(2008-9#1)
of the mutant cells##3##4##(1991-5#1)(1996-5#1)(2006-8#1)
of the mutant complexes were##2##5##(1997-3#1)(2013-1#1)
of the mutant enzyme##6##4##(1992-3#1)(1992-6#1)(1992-9#1)(1993-6#1)(1995-6#1)(1997-7#1)
of the mutant enzymes were##3##5##(1995-2#1)(1995-5#1)(1997-3#1)
of the mutant enzymes##7##4##(1994-11#1)(1995-11#1)(1995-2#1)(1995-5#1)(1997-3#1)(1997-6#1)(2013-8#1)
of the mutant in##2##4##(2007-12#1)(2008-10#1)
of the mutant is##3##4##(1995-1#2)(2008-8#1)
of the mutant mice##3##4##(1994-12#1)(1997-7#1)(2008-8#1)
of the mutant mouse##3##4##(1991-8#1)(1994-10#1)(2008-2#1)
of the mutant protein##4##4##(1991-12#1)(1994-9#1)(1995-1#1)(1996-2#1)
of the mutant proteins in##2##5##(1990-9#1)(2011-1#1)
of the mutant proteins were##2##5##(1991-2#1)(1996-2#1)
of the mutant proteins##6##4##(1990-9#1)(1991-2#1)(1993-11#1)(1995-5#1)(1996-2#1)(2011-1#1)
of the mutant strain##2##4##(1995-6#1)(2011-2#1)
of the mutant strains##3##4##(1990-5#1)(1991-7#1)(2008-7#1)
of the mutant to##2##4##(1994-11#1)(1995-5#1)
of the mutant was##2##4##(1990-12#1)(1994-9#1)
of the mutant##91##3##(1990-10#1)(1990-12#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#1)(1992-12#1)(1992-3#3)(1992-6#3)(1992-8#1)(1992-9#2)(1993-11#1)(1993-6#3)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-5#1)(1994-9#2)(1995-1#5)(1995-11#3)(1995-2#1)(1995-5#5)(1995-6#2)(1995-7#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#3)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#1)(2006-8#2)(2007-12#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#2)(2013-8#2)
of the mutants and##3##4##(1994-12#1)(1996-5#1)(2008-7#1)
of the mutants is##2##4##(1995-5#1)(2008-9#1)
of the mutants studied##2##4##(1995-6#1)(1996-7#1)
of the mutants##33##3##(1990-8#1)(1991-2#2)(1991-4#1)(1992-8#1)(1992-9#2)(1994-12#1)(1995-1#5)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-7#2)(2008-9#4)(2011-1#1)(2012-3#1)(2013-8#1)
of the mutated protein##2##4##(1991-9#1)(2008-11#1)
of the mutated##13##3##(1991-2#1)(1991-4#1)(1991-9#1)(1992-4#1)(1993-10#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-9#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-8#1)
of the mutation in##6##4##(1990-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1996-7#1)(2010-9#1)
of the mutation on##2##4##(1990-5#1)(1993-8#1)
of the mutation##26##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-6#1)(1991-7#1)(1991-9#1)(1993-10#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-4#1)(1995-5#1)(1996-7#1)(1997-3#2)(2006-12#1)(2006-8#2)(2010-9#1)(2011-1#1)
of the mutational##2##3##(2008-7#1)(2009-5#1)
of the mutationally altered##2##4##(1990-8#2)
of the mutations affected the##2##5##(1994-8#1)(2011-2#1)
of the mutations in the##2##5##(2012-12#1)(2013-1#1)
of the mutations in##3##4##(1991-10#1)(2012-12#1)(2013-1#1)
of the mutations on##3##4##(1991-10#1)(1992-9#1)(1995-6#1)
of the mutations##20##3##(1990-12#1)(1990-8#1)(1991-10#2)(1991-4#1)(1991-5#1)(1992-10#1)(1992-9#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1997-2#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
of the mutual##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-9#1)
of the mycelium##6##3##(1996-2#1)(2008-10#4)(2008-7#1)
of the mycoparasite##3##3##(2008-10#3)
of the mycorrhizosphere##2##3##(2008-10#2)
of the mycotoxin##3##3##(1990-12#1)(2008-10#2)
of the myelin##3##3##(1996-12#1)(2008-7#2)
of the myelination of the##2##5##(1996-5#2)
of the myenteric plexus##2##4##(1995-5#1)(1997-4#1)
of the myocardial##7##3##(1997-3#1)(1997-6#1)(2004-11#1)(2008-10#1)(2010-6#1)(2012-2#2)
of the myocardium and##2##4##(2005-1#1)(2008-7#1)
of the myocardium in##2##4##(2010-12#1)(2011-2#1)
of the myocardium##20##3##(1990-9#2)(1992-5#1)(1992-9#1)(2005-1#1)(2005-10#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-12#4)(2011-2#1)(2012-1#1)(2013-8#1)
of the myocytes##3##3##(1990-3#1)(1990-9#1)(1994-12#1)
of the myocytic calcium channel blocker diltiazem##2##7##(2008-7#2)
of the myofibroma##2##3##(2010-6#2)
of the myogenic##4##3##(1992-8#1)(1993-5#1)(1995-6#1)(2005-10#1)
of the myoma##2##3##(1993-12#1)(2006-6#1)
of the myometrium##3##3##(2008-8#1)(2010-12#2)
of the myosin head##4##4##(1994-11#2)(1995-3#1)(1997-4#1)
of the myosin heads##3##4##(1990-4#1)(1997-4#2)
of the myosin heavy chain##2##5##(1997-6#1)(2008-5#1)
of the myosin light chain##3##5##(1990-5#1)(1992-5#2)
of the myosin subfragment 1##3##5##(1991-10#1)(1992-4#1)(1994-8#1)
of the myosin##20##3##(1990-4#1)(1990-5#1)(1991-10#1)(1991-2#1)(1992-4#1)(1992-5#2)(1993-12#1)(1994-11#3)(1994-8#2)(1995-3#1)(1996-4#1)(1997-4#3)(1997-6#1)(2008-5#1)
of the myotonic dystrophy gene product##2##6##(1994-9#2)
of the myristoylated alanine-rich C kinase substrate##2##7##(1991-7#2)
of the myristoylated##3##3##(1990-12#1)(1991-7#2)
of the n##2##3##(1990-4#1)(1995-4#1)
of the n-NOS##2##3##(1993-6#2)
of the nAChR##2##3##(1997-5#2)
of the nail plate##4##4##(2006-12#3)(2008-5#1)
of the nail##16##3##(2005-11#1)(2006-12#4)(2006-3#1)(2007-8#1)(2008-4#1)(2008-5#5)(2008-9#1)(2010-5#1)(2013-1#1)
of the naked##2##3##(2008-8#1)(2012-3#1)
of the name##4##3##(2008-10#3)(2010-4#1)
of the nanocarrier binding##2##4##(2008-12#2)
of the nanoclusters##2##3##(2008-10#2)
of the nanocomposites##3##3##(2007-8#1)(2008-10#1)(2008-8#1)
of the nanocrystals##6##3##(2006-12#1)(2008-10#1)(2008-7#1)(2009-2#1)(2012-11#2)
of the nanoelectrodes##2##3##(2008-10#2)
of the nanofilter##2##3##(2008-10#2)
of the nanoparticles and##2##4##(2009-11#1)(2009-3#1)
of the nanoparticles##16##3##(2005-11#1)(2008-10#4)(2008-7#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2010-1#2)(2010-12#1)(2010-2#2)(2010-7#1)
of the nanosheets##2##3##(2008-10#2)
of the nanoshells##2##3##(2010-4#1)(2013-1#1)
of the nanostructure of##2##4##(2008-10#1)(2012-2#1)
of the nanostructure##3##3##(2008-10#1)(2010-4#1)(2012-2#1)
of the nanostructures##3##3##(2005-11#1)(2010-4#2)
of the nanosuspension##2##3##(2013-7#2)
of the nanotube##2##3##(2008-7#1)(2009-9#1)
of the nanotubes##6##3##(2006-12#2)(2008-7#1)(2009-9#2)(2010-7#1)
of the narcotic##2##3##(2006-10#1)(2008-4#1)
of the narrow##6##3##(1991-2#1)(1992-12#1)(2004-8#1)(2008-10#1)(2008-2#2)
of the narrow-band##3##3##(2007-12#1)(2008-2#1)(2008-6#1)
of the narrow-bandpass##2##3##(2008-3#2)
of the narrow-field##2##3##(1990-12#2)
of the narrowing##2##3##(2008-10#1)(2013-8#1)
of the nasal airway##2##4##(2005-11#1)(2008-11#1)
of the nasal cavity and paranasal sinuses##3##7##(1990-6#1)(1992-10#1)(1993-4#1)
of the nasal cavity and##5##5##(1990-6#1)(1992-10#2)(1993-4#1)(2007-9#1)
of the nasal cavity##14##4##(1990-6#1)(1992-10#2)(1993-2#1)(1993-4#2)(2007-7#1)(2007-9#1)(2012-2#5)(2013-8#1)
of the nasal mucosa##3##4##(1995-7#1)(1996-3#1)(1996-5#1)
of the nasal septum##6##4##(1990-6#1)(2009-1#1)(2012-12#4)
of the nasal##40##3##(1990-6#2)(1990-9#1)(1992-10#2)(1992-4#1)(1993-2#1)(1993-4#3)(1993-8#1)(1993-9#1)(1995-7#1)(1996-3#1)(1996-5#1)(1997-6#1)(2005-11#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-1#1)(2009-11#1)(2009-9#2)(2011-1#1)(2011-2#1)(2012-12#5)(2012-2#5)(2013-8#1)
of the nascent##9##3##(1990-12#2)(1993-3#1)(1993-8#1)(1994-9#1)(1995-2#1)(1995-4#1)(1996-8#1)(2007-12#1)
of the nasolabial fold##2##4##(2008-5#1)(2008-8#1)
of the nasolabial##3##3##(2005-11#1)(2008-5#1)(2008-8#1)
of the nasopharyngeal##2##3##(1995-10#1)(2008-10#1)
of the nasopharynx##4##3##(1993-12#1)(2009-5#2)(2010-12#1)
of the natal##2##3##(2008-8#1)(2013-8#1)
of the nation##9##3##(1990-12#2)(1991-11#1)(1991-8#1)(1994-3#1)(2006-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
of the nation's health##2##4##(1990-12#1)(1997-6#1)
of the nation's##9##3##(1990-12#2)(1994-12#1)(1995-6#1)(1997-6#1)(2007-5#1)(2007-8#1)(2008-11#1)(2012-2#1)
of the national average##2##4##(1992-12#1)(2008-10#1)
of the national economy##2##4##(1994-2#1)(2010-1#1)
of the national equations to##2##5##(2013-1#2)
of the national total)##3##4##(1996-11#3)
of the national##33##3##(1992-1#1)(1992-12#1)(1994-2#1)(1995-2#1)(1996-11#3)(1996-12#1)(1997-4#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-10#2)(2010-1#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#2)
of the native Muscovy##2##4##(2008-3#2)
of the native and reconstituted##2##5##(1992-8#1)(1993-8#1)
of the native and##6##4##(1990-7#1)(1991-4#1)(1992-8#1)(1993-8#1)(2008-1#1)(2008-4#1)
of the native enzyme and##2##5##(1992-11#1)(1993-11#1)
of the native enzyme by##2##5##(1990-11#1)(1992-2#1)
of the native enzyme##18##4##(1990-11#4)(1990-5#1)(1992-11#1)(1992-2#1)(1993-11#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1997-4#1)(1997-5#1)(1997-6#1)(2008-10#1)(2008-5#1)
of the native extracellular##3##4##(2008-5#1)(2012-11#2)
of the native human##2##4##(1990-12#1)(1992-8#1)
of the native protein##13##4##(1990-12#1)(1990-2#1)(1990-4#1)(1990-8#1)(1991-2#1)(1992-5#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-3#1)(2008-11#1)(2008-4#1)(2008-7#1)
of the native state##7##4##(1991-4#1)(1992-3#1)(1992-6#1)(1993-11#1)(1995-1#1)(2006-10#2)
of the native structure##4##4##(1992-6#1)(1995-1#1)(1995-4#1)(1997-4#1)
of the native##106##3##(1990-11#6)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#2)(1990-7#4)(1990-8#1)(1991-10#1)(1991-2#1)(1991-4#3)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#3)(1992-8#2)(1993-11#3)(1993-12#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-5#2)(1994-8#1)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-5#3)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#1)(2005-11#1)(2006-10#2)(2006-12#1)(2007-11#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#4)(2008-5#4)(2008-7#1)(2008-8#3)(2009-2#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#1)
of the natriuretic##3##3##(1991-3#1)(1992-11#2)
of the natural antioxidants##2##4##(2010-4#2)
of the natural background##2##4##(1994-9#1)(2008-10#1)
of the natural cofactor##2##4##(1993-6#1)(1995-10#1)
of the natural course and##2##5##(1997-3#1)(2011-2#1)
of the natural ecosystem##2##4##(2006-7#1)(2008-12#1)
of the natural gene##2##4##(1994-5#1)(2008-9#1)
of the natural heme##2##4##(1990-8#2)
of the natural history of the##2##6##(1996-6#1)(2008-7#1)
of the natural history of this##2##6##(1990-12#1)(2008-7#1)
of the natural history of##11##5##(1990-12#1)(1995-10#1)(1996-6#1)(1997-8#1)(2006-12#1)(2007-8#1)(2008-3#1)(2008-7#2)(2009-8#1)(2013-1#1)
of the natural history##15##4##(1990-12#1)(1995-10#1)(1996-6#1)(1996-9#1)(1997-8#1)(2004-11#1)(2006-12#1)(2007-8#1)(2008-3#1)(2008-7#2)(2009-8#1)(2010-12#2)(2013-1#1)
of the natural product##2##4##(2005-8#1)(2010-2#1)
of the natural products##3##4##(1996-2#1)(2009-10#1)(2010-2#1)
of the natural##91##3##(1990-12#1)(1990-3#1)(1990-4#2)(1990-7#1)(1990-8#2)(1991-12#1)(1991-3#1)(1992-3#1)(1992-5#1)(1993-2#1)(1993-6#2)(1993-9#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-5#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-8#2)(2004-11#2)(2004-4#1)(2005-11#1)(2005-8#1)(2006-12#4)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-5#2)(2007-8#1)(2008-10#9)(2008-12#3)(2008-3#1)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-12#2)(2010-2#2)(2010-4#2)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#2)
of the naturally occurring amino##3##5##(2008-10#1)(2008-2#1)(2008-5#1)
of the naturally occurring##11##4##(1992-1#1)(1992-3#1)(1997-8#1)(2005-9#1)(2006-1#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#1)(2010-5#1)
of the naturally##12##3##(1992-1#1)(1992-12#1)(1992-3#1)(1997-8#1)(2005-9#1)(2006-1#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#1)(2010-5#1)
of the nature and##9##4##(1992-11#1)(1993-1#1)(1993-3#1)(1994-1#1)(1997-4#1)(2007-2#1)(2008-10#1)(2008-12#1)(2010-5#1)
of the nature of the##25##5##(1990-10#1)(1990-12#1)(1990-3#2)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1994-6#1)(1995-10#1)(1996-2#1)(2005-11#1)(2006-3#1)(2007-12#1)(2008-10#6)(2008-2#1)(2009-4#1)(2010-5#1)(2012-2#1)
of the nature of this interaction##2##6##(1991-6#1)(1995-7#1)
of the nature of this##3##5##(1991-6#1)(1995-7#1)(1997-2#1)
of the nature of##44##4##(1990-10#1)(1990-12#1)(1990-3#2)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-2#2)(1994-11#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-7#1)(1996-2#1)(1997-1#1)(1997-2#1)(2005-11#1)(2006-11#1)(2006-3#1)(2007-12#1)(2007-6#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-11#1)(2012-2#1)
of the nature##54##3##(1990-10#1)(1990-12#1)(1990-3#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-2#2)(1993-3#1)(1994-1#1)(1994-11#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-7#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-11#1)(2006-3#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-5#2)(2011-1#1)(2012-11#1)(2012-2#1)
of the near field##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
of the near##4##3##(1994-12#1)(2007-11#1)(2007-12#1)(2008-3#1)
of the near-field optical##2##4##(2008-2#1)(2008-3#1)
of the near-field##5##3##(2007-12#2)(2008-2#2)(2008-3#1)
of the near-infrared##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
of the nearby##2##3##(2009-6#1)(2011-2#1)
of the nearly##4##3##(1995-8#1)(1996-1#1)(2004-2#1)(2008-2#1)
of the nebulizer##5##3##(1994-12#2)(1995-12#1)(1995-3#1)(1996-3#1)
of the nebulizers##2##3##(1995-3#2)
of the necessary##5##3##(1990-8#1)(1997-8#1)(2007-10#1)(2008-1#1)(2008-3#1)
of the necessity to##2##4##(2007-4#1)(2010-7#1)
of the neck and##9##4##(1994-2#1)(2006-3#1)(2006-8#2)(2007-8#1)(2008-4#1)(2010-11#1)(2010-12#1)(2011-2#1)
of the neck in##4##4##(2007-12#1)(2009-6#1)(2010-6#1)(2011-1#1)
of the neck of##2##4##(1991-11#1)(2006-6#1)
of the neck seal##4##4##(1994-4#4)
of the neck##64##3##(1990-3#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-2#1)(1992-10#1)(1994-2#1)(1994-4#4)(1995-8#2)(1996-4#2)(1997-3#1)(2005-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#2)(2007-1#4)(2007-11#1)(2007-12#2)(2007-3#2)(2007-7#3)(2007-8#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-6#1)(2010-11#4)(2010-12#1)(2010-6#1)(2010-9#2)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#5)(2012-2#1)
of the necrosis##2##3##(1993-10#1)(2008-10#1)
of the necrotic##7##3##(1991-8#1)(2008-10#1)(2008-4#1)(2009-1#1)(2010-2#1)(2011-2#2)
of the need and coverage of##3##6##(2012-11#3)
of the need for##23##4##(1992-12#1)(1993-12#1)(1994-3#2)(1996-1#1)(1996-7#1)(2004-10#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-4#1)(2009-5#1)(2010-6#1)(2011-2#1)(2013-1#1)
of the need to##11##4##(1992-1#1)(1995-1#1)(2005-5#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-11#1)(2009-8#1)(2011-2#1)(2013-1#2)
of the need##38##3##(1992-1#1)(1992-12#1)(1993-12#1)(1994-3#2)(1995-1#1)(1996-1#1)(1996-7#1)(2004-10#1)(2005-5#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-6#1)(2011-2#2)(2012-11#3)(2013-1#3)
of the needle in the##2##5##(2010-6#1)(2012-2#1)
of the needle in##3##4##(2010-6#1)(2012-2#2)
of the needle was##2##4##(2007-8#1)(2008-11#1)
of the needle##12##3##(1992-12#1)(2006-8#2)(2007-8#2)(2008-11#1)(2008-4#1)(2010-6#1)(2010-8#1)(2012-2#3)
of the needles##4##3##(2007-7#2)(2010-6#1)(2013-1#1)
of the needs of##2##4##(2005-11#1)(2008-11#1)
of the needs##4##3##(2005-11#1)(2008-11#1)(2008-3#1)(2010-12#1)
of the negative binomial distribution##2##5##(2008-10#2)
of the negative control##2##4##(2008-10#2)
of the negative symptoms##2##4##(1995-3#1)(1996-2#1)
of the negative##19##3##(1992-3#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-2#1)(1996-5#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-9#1)(2010-7#1)(2012-12#1)
of the negatively charged##5##4##(1990-2#1)(1991-8#2)(1994-2#1)(2011-1#1)
of the neighborhood##2##3##(2008-6#1)(2009-9#1)
of the neighboring##3##3##(1991-9#1)(2008-2#1)(2008-6#1)
of the neighbouring##4##3##(1991-10#1)(1993-6#1)(1996-4#1)(2010-12#1)
of the nematic##4##3##(2005-11#1)(2007-11#1)(2007-12#1)(2008-2#1)
of the nematode Caenorhabditis elegans##2##5##(1995-3#1)(1996-6#1)
of the nematode population##4##4##(2008-10#3)(2009-3#1)
of the nematode##18##3##(1992-9#1)(1995-3#1)(1996-6#1)(2007-12#2)(2008-10#9)(2008-8#1)(2009-3#2)(2010-12#1)
of the nematodes##5##3##(2008-10#4)(2008-8#1)
of the neo gene##2##4##(1993-5#1)(1996-4#1)
of the neo##3##3##(1993-5#1)(1996-4#1)(2008-11#1)
of the neocortex##8##3##(1990-5#1)(1991-3#1)(2008-1#1)(2008-11#3)(2010-12#1)(2010-7#1)
of the neoglycolipid##2##3##(1992-9#2)
of the neomycin resistance##2##4##(2008-11#2)
of the neonatal period##3##4##(1992-8#1)(2006-6#2)
of the neonatal rat##2##4##(1991-5#1)(1995-10#1)
of the neonatal screening examination##2##5##(2007-3#2)
of the neonatal##10##3##(1991-5#1)(1992-8#1)(1995-10#1)(1996-5#1)(1997-3#1)(2006-6#2)(2007-3#2)(2013-1#1)
of the neonate##6##3##(1992-5#1)(1996-12#1)(2006-10#2)(2012-12#1)(2012-3#1)
of the neonates##3##3##(2007-8#1)(2011-1#2)
of the neoplasm and##2##4##(2006-2#1)(2011-12#1)
of the neoplasm as##2##4##(1993-6#1)(2007-7#1)
of the neoplasm##11##3##(1990-10#1)(1990-3#1)(1991-2#1)(1993-6#1)(1997-8#1)(2006-2#1)(2007-7#1)(2011-12#1)(2011-2#2)(2012-2#1)
of the neoplasms##2##3##(1990-5#1)(2008-5#1)
of the neoplastic cells##3##4##(1992-2#1)(1997-1#1)(2008-6#1)
of the neoplastic##6##3##(1992-2#1)(1997-1#1)(2006-6#1)(2008-4#1)(2008-6#1)(2013-1#1)
of the neostriatal##2##3##(1993-3#2)
of the neostriatum##3##3##(1993-3#2)(1994-10#1)
of the neotropical##3##3##(2007-3#1)(2008-5#1)(2008-7#1)
of the nephrology##4##3##(2005-2#3)(2010-7#1)
of the nephrotic syndrome##3##4##(1996-6#1)(2007-7#2)
of the nephrotic##5##3##(1996-6#1)(2006-7#2)(2007-7#2)
of the nephrotoxicity of##2##4##(1990-3#1)(1990-4#1)
of the nerve injuries##2##4##(2007-10#2)
of the nerve root##5##4##(2006-11#1)(2006-8#2)(2007-1#2)
of the nerve##34##3##(1991-2#1)(1991-3#2)(1993-12#1)(1994-2#1)(1997-3#1)(2006-11#1)(2006-8#2)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#1)(2007-8#1)(2008-1#2)(2008-2#1)(2008-8#1)(2008-9#3)(2009-5#4)(2009-9#1)(2010-12#1)(2011-2#1)(2012-2#1)
of the nerves##4##3##(1990-10#1)(1990-8#1)(1992-1#1)(2006-11#1)
of the nervous and immune systems##2##6##(2007-11#1)(2013-1#1)
of the nervous system and##4##5##(2006-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
of the nervous system are a##2##6##(2008-1#1)(2010-12#1)
of the nervous system are##4##5##(2006-12#1)(2008-1#1)(2008-5#1)(2010-12#1)
of the nervous system is##2##5##(1993-12#1)(2007-8#1)
of the nervous system on experimentally induced urethral inflammation##2##9##(1990-7#2)
of the nervous system on##3##5##(1990-7#2)(1994-2#1)
of the nervous system##59##4##(1990-5#1)(1990-7#2)(1990-8#1)(1991-3#3)(1991-7#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-2#2)(1995-5#1)(1997-6#3)(1997-7#1)(2006-11#1)(2006-12#2)(2006-6#1)(2006-8#2)(2007-11#3)(2007-12#4)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#2)(2009-3#2)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#2)
of the nervous##66##3##(1990-5#1)(1990-7#2)(1990-8#1)(1991-3#3)(1991-7#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-10#2)(1994-11#1)(1994-2#2)(1995-5#1)(1996-2#1)(1996-5#1)(1997-6#3)(1997-7#1)(2006-11#1)(2006-12#2)(2006-6#2)(2006-8#2)(2007-11#4)(2007-12#4)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#2)(2009-3#2)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)
of the nest##2##3##(2005-7#1)(2007-3#1)
of the nested##2##3##(1993-12#1)(2008-10#1)
of the nests##2##3##(2004-4#1)(2007-5#1)
of the net charge of##2##5##(2008-4#1)(2010-1#1)
of the net##13##3##(1990-10#1)(1991-7#1)(1993-11#1)(1994-9#1)(1996-5#1)(2007-8#1)(2008-10#2)(2008-4#1)(2009-4#1)(2010-1#1)(2011-1#1)(2013-8#1)
of the network and##4##4##(1993-12#1)(2006-10#1)(2008-11#1)(2008-2#1)
of the network of##3##4##(1991-10#1)(1996-4#1)(2008-7#1)
of the network##22##3##(1991-10#1)(1993-12#1)(1994-8#1)(1996-4#2)(2005-11#1)(2006-10#3)(2006-4#1)(2006-7#1)(2008-11#1)(2008-2#3)(2008-7#1)(2009-10#2)(2009-4#1)(2010-10#1)(2011-12#1)(2011-2#1)
of the network's##4##3##(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#1)
of the networks that control##2##5##(2009-8#1)(2010-4#1)
of the networks##9##3##(2008-11#2)(2008-2#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-4#1)(2012-2#1)
of the neural circuits##2##4##(1992-10#1)(2008-11#1)
of the neural elements##2##4##(1994-8#1)(2006-7#1)
of the neural network##7##4##(2008-10#2)(2008-2#1)(2008-3#2)(2008-8#1)(2009-5#1)
of the neural precursor cells##2##5##(2008-11#2)
of the neural substrates##2##4##(1993-2#1)(2009-9#1)
of the neural tube##2##4##(1997-4#1)(2008-5#1)
of the neural##42##3##(1991-4#1)(1992-10#1)(1992-2#1)(1993-2#1)(1994-12#1)(1994-8#1)(1995-1#1)(1996-10#1)(1997-4#1)(2006-10#1)(2006-7#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#5)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#2)(2009-9#2)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-8#1)
of the neuraxis##3##3##(1992-4#1)(2008-10#1)(2008-7#1)
of the neurite##2##3##(1994-11#1)(1996-9#1)
of the neurites##5##3##(1990-3#1)(1996-3#1)(2008-11#3)
of the neuritic##3##3##(1990-5#1)(1991-1#2)
of the neuroanatomical##2##3##(1990-7#1)(2008-4#1)
of the neurobiological##5##3##(1993-12#1)(1995-1#1)(1996-1#1)(2009-4#1)(2010-3#1)
of the neurobiology of##3##4##(2008-11#1)(2008-4#1)(2009-10#1)
of the neurobiology##4##3##(2008-11#1)(2008-4#1)(2009-10#1)(2012-12#1)
of the neuroblastoma cell##2##4##(1996-10#1)(2012-12#1)
of the neuroblastoma##3##3##(1991-9#1)(1996-10#1)(2012-12#1)
of the neurochemical##4##3##(1994-2#1)(2008-6#1)(2008-7#1)(2013-1#1)
of the neuroendocrine##3##3##(1995-9#1)(2007-2#1)(2011-2#1)
of the neuroendocrine-immune##2##3##(1994-5#1)(1996-4#1)
of the neurofibromatosis 1 (NF1) gene##3##6##(1995-7#2)(1996-1#1)
of the neurofilament##2##3##(1991-8#1)(1995-12#1)
of the neurogenic##3##3##(1991-9#1)(2008-7#1)(2012-7#1)
of the neurohormonal##2##3##(2006-10#1)(2008-7#1)
of the neurohypophyseal##4##3##(1990-5#1)(1997-8#3)
of the neurokinin-1 receptor##2##4##(1994-9#1)(1997-8#1)
of the neurologic deficits##2##4##(2010-8#1)(2012-3#1)
of the neurologic##5##3##(2006-10#2)(2008-7#1)(2010-8#1)(2012-3#1)
of the neurological symptoms##3##4##(1991-6#1)(1994-3#1)(2007-10#1)
of the neurological##14##3##(1991-11#1)(1991-6#1)(1994-3#1)(1996-11#1)(1996-12#1)(1997-5#1)(1997-8#1)(2006-4#1)(2007-10#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-7#1)(2012-12#1)
of the neuromodulatory##2##3##(2007-12#1)(2009-10#1)
of the neuromuscular##6##3##(1996-1#1)(2008-8#1)(2009-12#1)(2012-2#2)(2013-1#1)
of the neuron and##2##4##(2008-2#1)(2008-3#1)
of the neuron is##2##4##(1993-12#1)(2008-2#1)
of the neuron##8##3##(1992-12#1)(1993-12#2)(1995-9#1)(2008-2#2)(2008-3#1)(2008-4#1)
of the neuronal cytoskeleton##4##4##(1991-9#1)(1996-5#1)(1997-2#1)(1997-6#1)
of the neuronal marker##2##4##(1993-4#1)(1996-3#1)
of the neuronal##32##3##(1990-5#1)(1991-9#1)(1992-3#1)(1993-12#2)(1993-4#1)(1993-9#1)(1994-10#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-6#2)(1996-3#2)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-8#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-6#1)(2009-10#1)(2009-4#1)(2009-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
of the neurones##4##3##(1993-9#1)(1995-12#1)(1996-1#1)(1997-3#1)
of the neurons and##4##4##(1994-10#1)(1994-2#1)(1996-12#1)(2008-5#1)
of the neurons in the##2##5##(1994-10#1)(2008-11#1)
of the neurons in##4##4##(1992-7#1)(1994-10#1)(1995-6#1)(2008-11#1)
of the neurons of the##2##5##(1996-8#1)(2009-2#1)
of the neurons were##2##4##(1992-8#1)(1996-9#1)
of the neurons##33##3##(1990-7#1)(1991-5#1)(1992-12#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-4#1)(1994-10#3)(1994-2#1)(1994-5#1)(1995-6#2)(1996-10#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-8#2)(2007-9#1)(2008-11#3)(2008-5#1)(2008-8#1)(2009-2#2)(2009-8#1)(2013-7#1)(2013-8#1)
of the neuropathic pain##2##4##(1993-4#1)(2008-4#1)
of the neuropeptide Y##2##4##(1992-9#1)(1997-5#1)
of the neuropeptide##7##3##(1991-9#1)(1992-8#1)(1992-9#1)(1993-3#1)(1996-11#1)(1997-5#1)(2013-7#1)
of the neuropeptides##4##3##(1990-11#2)(1994-10#1)(1995-5#1)
of the neuropil##3##3##(1996-9#1)(2007-10#1)(2007-12#1)
of the neuroprotective effect of##2##5##(2009-12#1)(2012-2#1)
of the neuroprotective##4##3##(1994-2#1)(2005-7#1)(2009-12#1)(2012-2#1)
of the neuropsychiatric##3##3##(1991-9#1)(2007-9#2)
of the neurosurgical##2##3##(1993-10#1)(2006-4#1)
of the neurotoxic##3##3##(1992-4#1)(1994-2#1)(1994-8#1)
of the neurotoxicity##3##3##(1990-5#1)(1993-1#1)(1996-10#1)
of the neurotoxin##6##3##(1990-5#1)(1993-12#1)(1994-11#3)(1996-3#1)
of the neurotransmitter##5##3##(1996-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-8#1)
of the neurotrophic##2##3##(1996-2#1)(2013-1#1)
of the neurotrophin family##6##4##(1991-5#1)(1994-8#1)(1996-3#4)
of the neurotrophin##10##3##(1991-5#1)(1994-2#1)(1994-8#1)(1996-1#1)(1996-3#4)(2006-8#1)(2012-12#1)
of the neurovascular unit##2##4##(2007-11#1)(2013-1#1)
of the neurovascular##4##3##(2006-10#1)(2007-11#1)(2008-3#1)(2013-1#1)
of the neutral lipids##2##4##(1996-4#2)
of the neutral##17##3##(1990-4#1)(1991-1#1)(1991-9#1)(1992-4#1)(1992-6#1)(1996-2#1)(1996-4#2)(2006-10#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#1)(2009-11#1)(2009-7#1)
of the neutrophil##14##3##(1990-11#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-8#2)(1995-3#1)(1997-8#1)(2004-11#1)(2008-10#1)(2012-1#2)(2012-3#1)
of the nevus##2##3##(1992-2#2)
of the new Abak(®) bottle##3##5##(2011-2#3)
of the new Abak(®)##4##4##(2011-2#4)
of the new Medicare##4##4##(1992-1#2)(2007-9#1)(2011-2#1)
of the new algorithm is##3##5##(2008-10#1)(2008-3#2)
of the new algorithm##4##4##(2008-1#1)(2008-10#1)(2008-3#2)
of the new anticancer##2##4##(1991-8#1)(1997-8#1)
of the new approach##6##4##(1995-2#1)(2008-10#1)(2008-2#3)(2008-3#1)
of the new compound was established##3##6##(2007-1#3)
of the new compound was##6##5##(1997-1#1)(2007-1#4)(2008-4#1)
of the new compounds showed##2##5##(2008-11#1)(2012-2#1)
of the new compounds were determined by##3##7##(2006-12#2)(2007-1#1)
of the new compounds were##8##5##(2006-12#2)(2007-1#3)(2008-8#1)(2012-11#1)(2013-1#1)
of the new compounds##13##4##(1992-3#1)(2006-12#2)(2007-1#3)(2007-11#1)(2008-11#1)(2008-8#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-1#1)
of the new concept##2##4##(2006-4#1)(2008-8#1)
of the new device##2##4##(2007-7#1)(2008-7#1)
of the new drug##2##4##(2006-2#1)(2007-11#1)
of the new host##2##4##(2008-8#2)
of the new law##2##4##(1992-6#1)(1996-5#1)
of the new method is##2##5##(2006-10#1)(2008-10#1)
of the new method##10##4##(1992-2#1)(1997-8#1)(2006-10#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#1)(2013-1#1)
of the new millennium##5##4##(1993-2#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-11#1)
of the new modified alumina sorbent for##2##7##(2008-10#2)
of the new possibilities##2##4##(1994-8#1)(2006-5#1)
of the new procedure##2##4##(2005-11#1)(2008-3#1)
of the new proposed##2##4##(2006-8#1)(2008-3#1)
of the new scheme##2##4##(1993-12#1)(2006-8#1)
of the new species##3##4##(2008-10#1)(2008-5#1)(2012-11#1)
of the new technique##3##4##(2007-1#1)(2008-2#1)(2008-3#1)
of the new technologies##2##4##(2006-10#1)(2008-11#1)
of the new technology##2##4##(2007-8#1)(2010-4#1)
of the new test##5##4##(1995-4#1)(1996-5#1)(2005-8#1)(2007-7#1)(2012-3#1)
of the new##285##3##(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#4)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-6#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-11#2)(1996-12#1)(1996-5#2)(1996-6#2)(1996-8#2)(1997-1#2)(1997-2#3)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#4)(2004-9#1)(2005-11#2)(2005-4#2)(2005-7#3)(2005-8#3)(2005-9#1)(2006-10#5)(2006-11#3)(2006-12#6)(2006-2#3)(2006-3#2)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#6)(2006-9#1)(2007-1#10)(2007-10#1)(2007-11#6)(2007-12#6)(2007-2#2)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#5)(2007-8#4)(2007-9#2)(2008-1#6)(2008-10#27)(2008-11#8)(2008-2#16)(2008-3#18)(2008-4#6)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#6)(2008-9#2)(2009-11#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#3)(2011-1#3)(2011-2#8)(2012-1#3)(2012-11#2)(2012-2#2)(2012-3#4)(2013-1#3)(2013-7#1)
of the newborn and##2##4##(1994-2#1)(2011-1#1)
of the newborn is##2##4##(2012-2#2)
of the newborn##27##3##(1990-5#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-12#1)(2005-11#1)(2007-1#1)(2007-11#2)(2007-2#2)(2008-8#1)(2009-9#1)(2011-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
of the newborns##4##3##(2007-11#1)(2008-4#1)(2011-1#2)
of the newer agents have##2##5##(1993-12#1)(2005-7#1)
of the newer agents##3##4##(1993-12#1)(2005-7#1)(2008-5#1)
of the newer biologic targeted##2##5##(2005-11#1)(2008-3#1)
of the newer##20##3##(1993-12#1)(1994-1#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#5)(2006-2#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-5#1)(2009-5#1)(2009-9#1)(2010-6#1)(2010-7#1)(2013-1#1)
of the newly defined##2##4##(1995-6#1)(2008-3#1)
of the newly described##2##4##(1993-6#1)(1994-3#1)
of the newly developed##5##4##(1994-10#1)(2008-10#2)(2008-3#1)(2010-11#1)
of the newly diagnosed##2##4##(2009-11#1)(2011-2#1)
of the newly emerging##3##4##(2008-5#1)(2008-7#1)(2010-11#1)
of the newly established##2##4##(2007-11#1)(2008-10#1)
of the newly formed##4##4##(2005-7#1)(2008-10#1)(2008-9#1)(2009-2#1)
of the newly identified##4##4##(1996-6#1)(1997-1#1)(1997-4#1)(2006-10#1)
of the newly proposed method##2##5##(2008-3#2)
of the newly proposed##3##4##(2008-3#3)
of the newly recognized##2##4##(1994-12#1)(2005-5#1)
of the newly synthesized compounds were##3##6##(2007-11#3)
of the newly synthesized compounds##5##5##(2007-11#3)(2007-9#1)(2008-5#1)
of the newly synthesized##12##4##(1992-6#2)(1996-4#1)(1996-7#1)(1997-5#1)(2005-10#1)(2007-11#3)(2007-9#1)(2008-10#1)(2008-5#1)
of the newly##47##3##(1992-6#2)(1993-6#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-5#1)(2005-10#1)(2005-5#1)(2005-7#1)(2006-10#1)(2007-11#5)(2007-2#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-3#5)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-11#2)(2011-2#1)
of the next century##2##4##(1995-4#1)(2008-9#1)
of the next generation of##5##5##(1991-6#1)(1996-11#1)(2008-2#1)(2009-4#1)(2010-2#1)
of the next generation##8##4##(1991-6#1)(1996-11#1)(2007-3#1)(2008-11#2)(2008-2#1)(2009-4#1)(2010-2#1)
of the next##20##3##(1991-6#1)(1992-1#1)(1993-3#1)(1995-2#1)(1995-4#1)(1996-11#1)(1997-6#1)(2006-10#1)(2007-3#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-5#2)(2008-9#1)(2009-4#1)(2010-2#1)
of the next-generation##3##3##(2008-10#1)(2008-3#1)(2011-1#1)
of the nickel##5##3##(1997-7#1)(2007-12#1)(2008-10#3)
of the nickel(II)##2##3##(1996-2#1)(2008-10#1)
of the nickel-deficient##2##3##(1990-2#2)
of the nicotinamide##4##3##(1991-3#1)(1994-11#1)(1997-4#2)
of the nicotinic acetylcholine receptor##4##5##(1991-7#1)(1995-1#1)(1997-5#1)(2012-2#1)
of the nicotinic##5##3##(1991-7#1)(1995-1#1)(1996-12#1)(1997-5#1)(2012-2#1)
of the nidus in##2##4##(1996-3#1)(2008-7#1)
of the nidus##11##3##(1991-2#1)(1996-3#1)(2008-7#7)(2008-9#1)(2010-9#1)
of the nifedipine##2##3##(1992-4#1)(2011-2#1)
of the night##4##3##(1992-3#1)(1995-12#1)(2004-11#2)
of the nigral##2##3##(1992-11#2)
of the nigrostriatal dopamine system##2##5##(1996-4#1)(1997-1#1)
of the nigrostriatal dopamine##3##4##(1994-10#1)(1996-4#1)(1997-1#1)
of the nigrostriatal dopaminergic##2##4##(1992-7#1)(1996-12#1)
of the nigrostriatal system is##2##5##(1993-5#1)(2012-1#1)
of the nigrostriatal system##3##4##(1993-5#1)(1994-8#1)(2012-1#1)
of the nigrostriatal##10##3##(1992-7#1)(1993-5#1)(1994-10#1)(1994-8#1)(1995-8#1)(1996-12#1)(1996-4#1)(1997-1#1)(2008-4#1)(2012-1#1)
of the nine##28##3##(1993-5#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-10#1)(2007-11#1)(2007-2#2)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2011-1#1)(2012-3#1)(2013-8#2)
of the nineteenth century and##2##5##(2010-1#1)(2010-7#1)
of the nineteenth century##15##4##(1991-12#1)(2008-2#1)(2009-10#1)(2009-2#1)(2009-7#1)(2010-1#2)(2010-7#2)(2011-2#2)(2012-2#2)(2013-1#2)
of the nineteenth##16##3##(1991-12#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-7#1)(2010-1#2)(2010-7#2)(2011-2#2)(2012-2#2)(2013-1#2)
of the nipple##8##3##(1996-6#3)(1997-5#1)(2004-2#1)(2010-9#1)(2011-2#1)(2013-1#1)
of the nitrate##4##3##(1991-9#1)(1993-6#1)(2008-10#1)(2008-3#1)
of the nitric oxide precursor##2##5##(1996-12#2)
of the nitric oxide##10##4##(1994-2#3)(1996-12#2)(2004-4#1)(2008-10#1)(2012-8#1)(2013-1#1)(2013-7#1)
of the nitric##12##3##(1993-3#1)(1994-2#3)(1996-12#2)(1996-9#1)(2004-4#1)(2008-10#1)(2012-8#1)(2013-1#1)(2013-7#1)
of the nitro groups##2##4##(1995-3#1)(2008-10#1)
of the nitro radical##2##4##(1995-6#1)(1997-8#1)
of the nitro##9##3##(1991-3#1)(1995-3#1)(1995-6#2)(1996-2#1)(1997-2#1)(1997-8#1)(2007-11#1)(2008-10#1)
of the nitrogen fixation##2##4##(2008-9#2)
of the nitrogen##12##3##(1993-6#2)(1994-9#1)(1995-11#1)(1996-2#1)(2008-3#1)(2008-4#1)(2008-9#3)(2011-2#1)(2013-8#1)
of the nitrogen-centered radical##3##4##(1993-11#3)
of the nitrosamino##2##3##(1996-5#2)
of the nm23##2##3##(1990-11#1)(1993-8#1)
of the noble scallop##2##4##(2013-8#2)
of the noble##4##3##(2008-10#1)(2012-1#1)(2013-8#2)
of the nociceptive##5##3##(1990-7#1)(1997-2#1)(2007-6#1)(2009-12#1)(2013-1#1)
of the nocturnal##2##3##(2008-3#1)(2008-5#1)
of the node##2##3##(2008-7#1)(2012-2#1)
of the nodule##5##3##(2006-6#1)(2008-1#1)(2008-7#1)(2012-2#1)(2012-3#1)
of the nodules##5##3##(2006-10#1)(2007-7#1)(2008-1#1)(2011-1#1)(2012-3#1)
of the noise in##3##4##(2008-1#1)(2008-2#1)(2008-3#1)
of the noise is##2##4##(2008-2#2)
of the noise##17##3##(2007-12#1)(2008-1#1)(2008-2#7)(2008-3#6)(2008-6#1)(2008-8#1)
of the noises##2##3##(2008-4#2)
of the noisy##2##3##(2008-2#1)(2013-7#1)
of the nominal##3##3##(1997-3#1)(2007-12#1)(2008-2#1)
of the non##7##3##(2006-9#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-9#1)
of the non-cholesterol##2##3##(1992-6#1)(2009-4#1)
of the non-coding##2##3##(1994-12#1)(2006-11#1)
of the non-ergot dopamine agonist##2##5##(2008-7#2)
of the non-homologous##2##3##(1993-7#1)(2013-8#1)
of the non-ionic surfactant##3##4##(1990-3#1)(2008-10#2)
of the non-linear Poisson-Boltzmann##2##4##(1997-2#1)(2006-10#1)
of the non-polar##3##3##(2006-10#2)(2010-2#1)
of the non-specific immunologically-mediated resistance##2##5##(2011-1#2)
of the non-specific lipid-transfer protein##2##5##(1994-12#2)
of the non-specific##9##3##(1991-10#1)(1991-11#2)(1992-7#1)(1994-12#2)(2008-10#1)(2011-1#2)
of the non-steroidal anti-inflammatory drugs##2##5##(1990-11#1)(2008-3#1)
of the non-transformed##2##3##(1991-9#1)(1992-8#1)
of the noncatalytic##4##3##(1990-9#1)(1992-12#1)(1992-6#1)(1993-11#1)
of the noncoding##2##3##(2007-10#1)(2008-11#1)
of the nondominant##2##3##(1996-3#1)(2007-7#1)
of the nonionic surfactant##3##4##(2005-9#1)(2008-10#1)(2011-2#1)
of the nonionic##4##3##(2005-11#1)(2005-9#1)(2008-10#1)(2011-2#1)
of the nonlinear Schrödinger equation##4##5##(2007-11#2)(2007-12#2)
of the nonlinear coefficient##3##4##(2007-11#2)(2007-12#1)
of the nonlinear iterative##2##4##(2008-2#1)(2008-3#1)
of the nonlinear morphological correlation##2##5##(2008-2#1)(2008-3#1)
of the nonlinear optical##3##4##(2007-11#1)(2007-12#2)
of the nonlinear phase shift##2##5##(2007-11#1)(2007-12#1)
of the nonlinear phase##3##4##(2007-11#2)(2007-12#1)
of the nonlinear refractive index of##2##6##(2007-12#1)(2008-3#1)
of the nonlinear refractive index##3##5##(2007-12#1)(2008-1#1)(2008-3#1)
of the nonlinear region##2##4##(2007-12#2)
of the nonlinear response of##2##5##(2008-2#2)
of the nonlinear##50##3##(2005-11#2)(2007-11#9)(2007-12#18)(2008-1#4)(2008-2#8)(2008-3#7)(2008-7#1)(2009-5#1)
of the nonlinearity##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
of the nonnative##2##3##(1995-5#1)(1995-8#1)
of the nonparametric##4##3##(2008-10#1)(2009-10#1)(2009-5#1)(2010-2#1)
of the nonplanar##2##3##(1995-4#1)(2008-2#1)
of the nonpolar##3##3##(1996-11#1)(2005-11#1)(2008-10#1)
of the nonporous##2##3##(2005-11#2)
of the nonprofit hospital##2##4##(1993-2#1)(1996-2#1)
of the nonprofit##3##3##(1993-2#1)(1994-2#1)(1996-2#1)
of the nonselective cation##2##4##(1992-7#1)(1995-7#1)
of the nonselective##3##3##(1992-7#1)(1995-7#1)(1996-8#1)
of the nonspecific##2##3##(1990-5#1)(1995-8#1)
of the nonsteroidal antiinflammatory drugs##2##5##(2006-10#1)(2008-10#1)
of the nonsteroidal##3##3##(2006-10#2)(2008-10#1)
of the nonstructural protein##2##4##(2008-10#1)(2009-7#1)
of the nonstructural##4##3##(2008-10#3)(2009-7#1)
of the nonuniform##2##3##(2007-4#1)(2008-2#1)
of the nootropics##2##3##(1993-12#2)
of the noradrenergic system##2##4##(2007-7#1)(2011-1#1)
of the noradrenergic##5##3##(1995-12#1)(2007-5#1)(2007-7#1)(2011-1#1)(2012-12#1)
of the normal anatomy##3##4##(2004-2#1)(2008-1#1)(2012-2#1)
of the normal and##2##4##(1994-2#1)(2009-7#1)
of the normal appendix##2##4##(1997-8#2)
of the normal boiling points of##2##6##(2007-11#2)
of the normal controls##5##4##(2008-10#3)(2008-7#2)
of the normal human skin##2##5##(2007-7#1)(2010-10#1)
of the normal human##6##4##(1995-8#1)(2007-7#1)(2007-9#1)(2010-10#1)(2010-12#1)(2013-7#1)
of the normal intestinal##2##4##(2005-9#1)(2006-2#1)
of the normal pancreas##3##4##(2010-12#2)(2011-12#1)
of the normal pituitary gland##2##5##(2006-9#1)(2007-1#1)
of the normal range and##3##5##(1995-10#1)(2013-1#2)
of the normal range##5##4##(1990-11#1)(1995-10#2)(2013-1#2)
of the normal rat##2##4##(2008-7#1)(2008-9#1)
of the normal subjects##4##4##(1994-12#1)(2007-7#1)(2009-8#2)
of the normal##106##3##(1990-11#1)(1990-4#3)(1990-9#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-1#2)(1995-10#2)(1995-2#2)(1995-5#1)(1995-8#2)(1996-8#1)(1997-4#1)(1997-7#1)(1997-8#2)(2004-2#1)(2005-9#1)(2006-10#2)(2006-2#1)(2006-9#2)(2007-1#1)(2007-11#5)(2007-12#1)(2007-2#2)(2007-6#2)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#3)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#1)(2011-12#2)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
of the normalized##10##3##(1991-9#1)(1993-2#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#3)(2011-2#1)
of the normally##3##3##(1990-3#1)(2008-9#1)(2013-8#1)
of the normativity of##2##4##(2012-11#1)(2012-2#1)
of the north##2##3##(2007-1#1)(2012-2#1)
of the north-western zone of the Bogota Savanna##2##8##(2012-12#2)
of the north-western zone of the Bogota##3##7##(2012-12#3)
of the northeastern##2##3##(1996-4#1)(2011-2#1)
of the northern##12##3##(1990-11#1)(2007-5#1)(2007-7#1)(2008-5#4)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)(2013-8#1)
of the nose and paranasal sinuses##3##6##(2008-3#2)(2010-7#1)
of the nose and##6##4##(1990-6#1)(1992-4#1)(2008-3#2)(2010-7#1)(2011-12#1)
of the nose##15##3##(1990-6#2)(1992-4#1)(1995-4#1)(2007-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-2#1)(2010-7#2)(2011-12#1)(2011-2#1)(2013-1#1)
of the nosology##2##3##(1993-11#1)(2011-1#1)
of the not-for-profit##2##3##(1990-12#1)(1994-5#1)
of the notion of##4##4##(2008-10#1)(2009-4#1)(2009-7#1)(2010-7#1)
of the notion that##3##4##(1991-5#1)(1995-10#1)(2007-3#1)
of the notion##7##3##(1991-5#1)(1995-10#1)(2007-3#1)(2008-10#1)(2009-4#1)(2009-7#1)(2010-7#1)
of the novel acrylates##2##4##(2008-3#2)
of the novel##53##3##(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-12#2)(1995-3#2)(1996-10#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-5#1)(2004-4#2)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#3)(2008-8#2)(2008-9#2)(2009-2#1)(2010-4#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)
of the novelty filter##2##4##(2008-2#2)
of the now##2##3##(1995-11#1)(1995-12#1)
of the noxious##4##3##(1991-8#1)(1993-2#1)(2006-6#1)(2008-11#1)
of the nsLTP preparation##2##4##(1991-3#2)
of the nt sequences of##2##5##(1991-8#1)(1995-8#1)
of the nt##4##3##(1991-6#1)(1991-8#1)(1993-6#1)(1995-8#1)
of the nu(3)##2##3##(2007-12#1)(2008-2#1)
of the nuclear encoded##2##4##(1993-3#1)(1997-2#1)
of the nuclear envelope##4##4##(1995-2#1)(2011-12#1)(2011-2#2)
of the nuclear factor kappa B##2##6##(1995-3#2)
of the nuclear factor##4##4##(1995-3#2)(1997-6#1)(2006-10#1)
of the nuclear factors##2##4##(1994-9#1)(1996-4#1)
of the nuclear hormone receptor superfamily##5##6##(1993-6#1)(1995-2#1)(1996-5#1)(2006-8#1)(2010-12#1)
of the nuclear hormone receptor##7##5##(1993-6#1)(1994-2#1)(1995-2#1)(1996-5#1)(2005-11#1)(2006-8#1)(2010-12#1)
of the nuclear lamina##2##4##(1992-12#1)(2008-8#1)
of the nuclear matrix##2##4##(1991-8#1)(1996-11#1)
of the nuclear membrane##2##4##(2008-9#1)(2011-2#1)
of the nuclear pore complex##2##5##(1993-6#1)(2009-8#1)
of the nuclear proteins##3##4##(1992-11#2)(2007-9#1)
of the nuclear receptor family##3##5##(1995-8#1)(2008-1#1)(2008-4#1)
of the nuclear receptor superfamily##3##5##(1994-12#1)(1995-11#1)(2008-3#1)
of the nuclear receptor##9##4##(1990-8#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)
of the nuclear ribosomal DNA##4##5##(2008-10#4)
of the nuclear ribosomal##9##4##(2008-10#9)
of the nuclear##80##3##(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-8#1)(1992-11#4)(1992-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#4)(1995-8#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-2#2)(1997-6#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-9#1)(2008-1#1)(2008-10#12)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-4#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#1)
of the nuclear-encoded##3##3##(1990-5#1)(1996-7#1)(2010-4#1)
of the nucleation##3##3##(1996-4#1)(2005-11#1)(2008-2#1)
of the nuclei##6##3##(1993-6#1)(1996-6#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-9#1)
of the nucleic acid##7##4##(1991-7#1)(1992-6#2)(1994-6#1)(2008-10#1)(2008-4#1)(2010-4#1)
of the nucleic acids##4##4##(1994-3#1)(2006-10#1)(2008-2#1)(2008-3#1)
of the nucleic##11##3##(1991-7#1)(1992-6#2)(1994-3#1)(1994-6#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-4#1)
of the nucleobase##2##3##(1996-5#1)(2008-4#1)
of the nucleocapsid protein##5##4##(1994-9#4)(1997-6#1)
of the nucleocapsid##6##3##(1994-9#4)(1997-6#1)(2008-10#1)
of the nucleolar##4##3##(1991-2#1)(1994-9#1)(2008-8#2)
of the nucleolus##2##3##(2008-7#1)(2013-1#1)
of the nucleon##2##3##(1992-8#1)(1992-9#1)
of the nucleophile##2##3##(1991-5#1)(2010-2#1)
of the nucleophilic##3##3##(1993-6#1)(1995-2#1)(2010-5#1)
of the nucleoprotein##2##3##(1995-11#1)(1996-5#1)
of the nucleoside##2##3##(1995-1#1)(1995-3#1)
of the nucleosides##3##3##(1990-7#1)(1996-5#1)(1997-2#1)
of the nucleosome##2##3##(1992-9#1)(2009-5#1)
of the nucleotide and amino acid sequences##2##7##(2006-5#1)(2011-1#1)
of the nucleotide and amino acid##3##6##(1990-7#1)(2006-5#1)(2011-1#1)
of the nucleotide and polypeptide binding domains##2##7##(1996-8#2)
of the nucleotide and##10##4##(1990-7#1)(1991-5#1)(1993-11#1)(1993-3#1)(1994-3#1)(1996-8#2)(2006-5#1)(2008-10#1)(2011-1#1)
of the nucleotide binding##2##4##(1991-11#1)(1991-4#1)
of the nucleotide excision repair##2##5##(1996-11#1)(1997-1#1)
of the nucleotide sequence of the##6##6##(1990-4#1)(1992-11#1)(1994-12#1)(1995-8#1)(1997-1#1)(2008-10#1)
of the nucleotide sequence of##11##5##(1990-11#1)(1990-2#1)(1990-4#1)(1992-11#1)(1993-2#1)(1994-12#1)(1995-6#1)(1995-8#1)(1997-1#1)(2008-10#2)
of the nucleotide sequence##14##4##(1990-11#1)(1990-2#1)(1990-4#1)(1992-11#1)(1993-2#1)(1994-12#2)(1995-6#2)(1995-8#1)(1997-1#1)(1997-2#1)(2008-10#2)
of the nucleotide sequences of##4##5##(1990-2#1)(1996-10#1)(2008-10#1)(2008-5#1)
of the nucleotide sequences##5##4##(1990-2#1)(1996-10#1)(2008-10#2)(2008-5#1)
of the nucleotide##42##3##(1990-11#1)(1990-2#2)(1990-4#1)(1990-7#1)(1991-11#1)(1991-4#2)(1991-5#1)(1992-10#1)(1992-11#2)(1993-11#2)(1993-2#1)(1993-3#1)(1994-12#2)(1994-3#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-8#2)(1997-1#2)(1997-2#1)(2006-5#2)(2008-10#5)(2008-4#1)(2008-5#3)(2011-1#1)
of the nucleotide-binding##2##3##(1995-6#1)(2008-11#1)
of the nucleotides##6##3##(1990-8#1)(1994-11#1)(1995-10#2)(2006-10#1)(2008-11#1)
of the nucleus accumbens and its##2##6##(1993-6#1)(2008-7#1)
of the nucleus accumbens and##4##5##(1993-6#2)(1994-2#1)(2008-7#1)
of the nucleus accumbens##13##4##(1993-6#6)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-3#1)(2008-7#1)
of the nucleus ambiguus##2##4##(1993-12#1)(1993-7#1)
of the nucleus and##2##4##(2008-7#1)(2011-2#1)
of the nucleus basalis magnocellularis (NBM)##2##6##(1995-12#1)(1996-9#1)
of the nucleus basalis magnocellularis##4##5##(1993-3#1)(1994-12#1)(1995-12#1)(1996-9#1)
of the nucleus basalis of Meynert##4##6##(1992-8#2)(2010-8#2)
of the nucleus basalis##9##4##(1992-10#1)(1992-8#2)(1993-3#1)(1994-12#1)(1995-12#1)(1996-9#1)(2010-8#2)
of the nucleus in##2##4##(2008-9#1)(2011-2#1)
of the nucleus magnocellularis##2##4##(1991-5#1)(1996-9#1)
of the nucleus of##2##4##(1992-8#1)(2011-2#1)
of the nucleus pulposus##5##4##(2007-1#1)(2007-11#1)(2007-8#3)
of the nucleus tractus solitarii (NTS)##2##6##(1993-2#1)(1997-5#1)
of the nucleus tractus solitarii##4##5##(1993-2#2)(1997-5#2)
of the nucleus tractus solitarius##3##5##(1994-10#1)(1997-5#2)
of the nucleus tractus##7##4##(1993-2#2)(1994-10#1)(1997-5#4)
of the nucleus##65##3##(1991-3#1)(1991-5#2)(1992-10#2)(1992-11#1)(1992-7#1)(1992-8#3)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#2)(1993-6#6)(1993-7#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-5#1)(1996-9#2)(1997-3#1)(1997-4#1)(1997-5#4)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-7#7)(2008-9#1)(2009-2#1)(2009-7#1)(2010-8#2)(2011-2#6)(2012-1#1)
of the null hypothesis##3##4##(1997-2#1)(2008-3#1)(2008-7#1)
of the null##8##3##(1997-2#1)(1997-6#1)(2008-3#3)(2008-7#1)(2008-8#1)(2010-2#1)
of the nulling##2##3##(2007-11#1)(2008-3#1)
of the number and##7##4##(1992-3#1)(1993-3#1)(1994-9#1)(2007-12#1)(2008-4#1)(2013-1#2)
of the number of bacteria##2##5##(2008-9#1)(2012-3#1)
of the number of cells##2##5##(2008-2#1)(2008-4#1)
of the number of infected##3##5##(1997-4#1)(2008-10#2)
of the number of ions##2##5##(2007-12#1)(2008-10#1)
of the number of particles##2##5##(1990-6#1)(1994-3#1)
of the number of residues##2##5##(1993-9#1)(2008-4#1)
of the number of sites##2##5##(1997-2#1)(2008-10#1)
of the number of trials required##2##6##(2007-9#1)(2008-11#1)
of the number of##112##4##(1990-11#2)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-6#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-4#1)(1997-7#2)(2005-11#3)(2005-12#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#2)(2007-12#5)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#12)(2008-11#3)(2008-12#2)(2008-2#8)(2008-3#5)(2008-4#2)(2008-5#5)(2008-7#2)(2008-8#3)(2008-9#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
of the number##128##3##(1990-11#2)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-6#1)(1992-3#1)(1993-3#2)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-6#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-4#1)(1997-7#2)(2005-11#3)(2005-12#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#2)(2007-12#6)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#12)(2008-11#3)(2008-12#2)(2008-2#8)(2008-3#6)(2008-4#3)(2008-5#7)(2008-7#2)(2008-8#3)(2008-9#1)(2009-4#1)(2009-5#2)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
of the numbers of##2##4##(2006-8#1)(2008-2#1)
of the numbers##4##3##(2006-8#1)(2007-5#1)(2008-2#1)(2008-7#1)
of the numerical aperture of##3##5##(2008-2#3)
of the numerical aperture##5##4##(2007-12#1)(2008-2#4)
of the numerical##16##3##(1995-2#1)(2005-11#1)(2006-6#1)(2007-12#2)(2008-10#1)(2008-2#6)(2008-9#1)(2009-4#1)(2012-3#2)
of the numerous##12##3##(1991-7#1)(1992-1#1)(1995-3#1)(2006-10#1)(2006-8#1)(2007-7#2)(2008-5#1)(2009-9#1)(2012-2#1)(2013-1#2)
of the nurse##20##3##(1991-11#2)(1996-2#1)(2005-11#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-6#2)(2011-1#2)(2011-2#5)(2012-3#1)
of the nurses##9##3##(1990-2#2)(1996-1#1)(2005-7#1)(2007-10#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)
of the nursing curriculum##3##4##(2008-12#2)(2010-3#1)
of the nursing home##4##4##(1992-2#1)(1992-3#1)(1994-7#1)(2008-11#1)
of the nursing profession##4##4##(1996-3#1)(2011-1#1)(2013-8#2)
of the nursing staff]##2##4##(1994-3#1)(1994-5#1)
of the nursing team##2##4##(2011-2#2)
of the nursing workforce##2##4##(2012-3#2)
of the nursing##26##3##(1992-2#1)(1992-3#1)(1993-3#1)(1994-3#2)(1994-5#1)(1994-7#1)(1996-3#1)(2005-7#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#2)(2010-3#1)(2011-1#1)(2011-2#3)(2012-3#3)(2013-8#3)
of the nutrient foramen##6##4##(2013-8#6)
of the nutrient##11##3##(2008-10#2)(2008-7#2)(2009-12#1)(2013-8#6)
of the nutritional status of##3##5##(2007-7#1)(2010-4#1)(2013-7#1)
of the nutritional status##5##4##(1991-12#1)(2006-6#1)(2007-7#1)(2010-4#1)(2013-7#1)
of the nutritional##10##3##(1991-12#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-7#1)(2008-10#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-7#1)
of the oak##2##3##(2008-5#1)(2012-6#1)
of the obese##6##3##(1996-12#1)(2006-8#1)(2008-10#1)(2011-1#1)(2013-1#2)
of the obesity epidemic##2##4##(2009-12#1)(2012-2#1)
of the obesity##4##3##(2009-12#1)(2011-2#1)(2012-2#2)
of the object and##2##4##(2008-2#2)
of the object beam##2##4##(2007-12#2)
of the object by##2##4##(2008-11#1)(2008-9#1)
of the object in the##2##5##(1995-2#1)(2008-2#1)
of the object in##4##4##(1995-2#1)(2008-11#2)(2008-2#1)
of the object is##4##4##(2007-12#1)(2008-3#2)(2008-4#1)
of the object motion##2##4##(2008-2#2)
of the object of study##2##5##(1991-6#1)(1993-3#1)
of the object of##3##4##(1991-6#1)(1993-3#2)
of the object spectrum##2##4##(2008-3#2)
of the object structure##2##4##(2008-2#1)(2012-1#1)
of the object to be##5##5##(1992-9#1)(2008-3#2)(2012-12#2)
of the object under##2##4##(2007-12#1)(2008-3#1)
of the object wave##3##4##(2008-2#1)(2008-3#2)
of the object with a##2##5##(2007-11#1)(2008-2#1)
of the object with##5##4##(2007-11#2)(2008-2#3)
of the object##73##3##(1991-6#1)(1992-2#1)(1992-9#1)(1993-3#2)(1993-6#1)(1993-7#1)(1995-2#1)(1996-2#1)(2007-11#3)(2007-12#7)(2008-1#1)(2008-11#4)(2008-2#19)(2008-3#18)(2008-4#3)(2008-7#1)(2008-9#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)
of the objective lens and##4##5##(2007-12#2)(2008-3#2)
of the objective lens##8##4##(2007-12#2)(2008-2#2)(2008-3#4)
of the objective##14##3##(1994-2#1)(2007-12#3)(2008-2#2)(2008-3#6)(2012-3#1)(2013-7#1)
of the objectives of the##2##5##(2008-7#1)(2010-3#1)
of the objectives of##3##4##(2008-7#1)(2010-3#1)(2011-2#1)
of the objectives##6##3##(1996-2#1)(2007-11#1)(2008-7#1)(2010-3#1)(2011-2#1)(2013-7#1)
of the objects in##3##4##(1992-11#1)(2008-3#1)(2009-12#1)
of the objects##10##3##(1992-11#1)(2007-11#1)(2008-2#2)(2008-3#5)(2009-12#1)
of the obligately anaerobic bacterium Bacteroides gingivalis##2##7##(1990-11#2)
of the obligatory##2##3##(1997-8#1)(2011-1#1)
of the obliquity##2##3##(1990-8#1)(2007-11#1)
of the observable##2##3##(2006-12#1)(2010-7#1)
of the observation of##4##4##(2007-11#1)(2008-11#1)(2008-3#2)
of the observation period##7##4##(1992-6#1)(1993-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-6#1)
of the observation##15##3##(1992-6#1)(1993-1#1)(1993-3#1)(2005-11#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2013-8#1)
of the observations##9##3##(1991-8#1)(1995-8#1)(1996-4#1)(2005-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)
of the observed HIV-positive population size##3##6##(2008-1#3)
of the observed changes##2##4##(1995-12#1)(2008-1#1)
of the observed covariates##2##4##(1994-8#1)(2011-1#1)
of the observed effects##4##4##(1996-11#1)(2008-11#1)(2008-3#1)(2008-8#1)
of the observed patterns of##2##5##(2008-8#2)
of the observed patterns##4##4##(2008-8#4)
of the observed phenomena##2##4##(1992-1#1)(2008-3#1)
of the observed variation##2##4##(1995-3#1)(2013-7#1)
of the observed##76##3##(1991-4#1)(1991-5#1)(1992-1#1)(1992-6#2)(1993-12#2)(1993-5#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-8#3)(1996-11#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-6#1)(2004-4#1)(2004-9#1)(2006-10#1)(2006-5#1)(2007-11#2)(2007-12#2)(2007-5#1)(2008-1#7)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#8)(2008-5#1)(2008-7#3)(2008-8#7)(2009-9#2)(2010-1#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#2)(2013-7#1)
of the observer##4##3##(2008-2#1)(2008-5#1)(2009-11#1)(2010-5#1)
of the obstacles##5##3##(1990-9#1)(1993-2#1)(1995-3#1)(2007-4#1)(2007-5#1)
of the obstructed##3##3##(1990-4#1)(2006-10#1)(2007-10#1)
of the obstruction##2##3##(2007-12#1)(2011-2#1)
of the obstructive##5##3##(2006-8#1)(2007-12#1)(2011-2#1)(2013-1#2)
of the obtained compounds##2##4##(2007-10#1)(2007-11#1)
of the obtained results##6##4##(2006-4#1)(2007-10#1)(2007-8#1)(2008-10#3)
of the obtained##28##3##(1992-8#1)(1996-10#2)(1996-8#1)(1997-7#1)(2005-11#1)(2006-4#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#6)(2008-4#1)(2008-5#1)(2009-11#1)(2009-2#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-12#1)
of the obturator and femoral nerves##2##6##(2006-12#1)(2006-7#1)
of the occipital##6##3##(1990-8#1)(1995-8#1)(2006-7#2)(2008-7#2)
of the occluded##4##3##(1997-8#1)(2007-8#1)(2008-12#1)(2009-4#1)
of the occlusal##3##3##(2004-3#1)(2007-9#1)(2011-12#1)
of the occlusion and the##2##5##(1996-6#1)(2010-9#1)
of the occlusion##8##3##(1991-4#1)(1995-11#1)(1996-6#1)(2007-10#1)(2007-9#1)(2008-11#1)(2010-9#1)(2011-1#1)
of the occupational##3##3##(1996-3#1)(2007-7#1)(2008-11#1)
of the occurrence of a##2##5##(2007-8#1)(2012-2#1)
of the occurrence of infection##2##5##(2007-11#1)(2008-10#1)
of the occurrence of the##2##5##(1993-9#1)(2005-8#1)
of the occurrence of##22##4##(1992-1#1)(1993-9#1)(1995-6#1)(1995-7#1)(1996-3#2)(2003-11#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
of the occurrence##26##3##(1991-4#1)(1992-1#1)(1993-9#1)(1995-6#1)(1995-7#1)(1996-3#2)(2003-11#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
of the ocean and##2##4##(2008-2#1)(2008-3#1)
of the ocean color##2##4##(2008-2#1)(2008-3#1)
of the ocean##10##3##(2008-2#6)(2008-3#4)
of the octamer##3##3##(1992-12#1)(1992-8#1)(1996-5#1)
of the ocular surface##4##4##(2006-11#1)(2007-1#3)
of the ocular##9##3##(1992-2#2)(2006-11#1)(2007-1#3)(2007-2#1)(2007-3#1)(2011-1#1)
of the oculomotor nerve##4##4##(2006-12#4)
of the oculomotor##6##3##(1995-1#1)(1997-8#1)(2006-12#4)
of the odds ratio##2##4##(1993-9#1)(2012-3#1)
of the odds##3##3##(1993-9#1)(2010-12#1)(2012-3#1)
of the odontogenic keratocyst##5##4##(2007-12#5)
of the odontoid process##2##4##(2011-2#2)
of the odor##2##3##(2008-10#1)(2008-4#1)
of the oesophageal wall##2##4##(2005-1#2)
of the oesophageal##4##3##(1993-3#1)(1994-2#1)(2005-1#2)
of the oesophagus and stomach in chinchilla (Chinchilla##2##8##(2013-8#2)
of the oesophagus and stomach##3##5##(1993-10#1)(2013-8#2)
of the oesophagus and##4##4##(1990-6#1)(1993-10#1)(2013-8#2)
of the oesophagus##20##3##(1990-12#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-8#2)(1993-10#1)(1993-12#1)(1993-6#1)(2005-1#1)(2006-6#1)(2007-8#2)(2008-1#3)(2008-11#1)(2013-1#1)(2013-8#2)
of the oestrogen receptor##2##4##(1990-11#1)(1995-9#1)
of the of##3##3##(2008-10#1)(2012-2#1)(2012-3#1)
of the off-rate##2##3##(1992-9#1)(1995-11#1)
of the offending drug##4##4##(1993-6#1)(2008-7#2)(2008-8#1)
of the offending##7##3##(1993-6#1)(1994-6#1)(2007-8#1)(2008-7#2)(2008-8#1)(2010-5#1)
of the office##3##3##(1990-10#1)(1992-4#1)(2006-10#1)
of the official##3##3##(1993-5#1)(1997-6#1)(2008-10#1)
of the offspring##12##3##(1990-9#1)(1996-12#1)(1997-4#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2013-1#3)(2013-8#1)
of the often##3##3##(1993-5#1)(2007-11#1)(2007-4#1)
of the oh8Gua residue##2##4##(1997-1#2)
of the oh8Gua##3##3##(1997-1#3)
of the oil##16##3##(1992-7#1)(2006-12#1)(2007-1#2)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#3)(2011-1#1)(2011-2#1)(2012-12#1)
of the oils were##2##4##(2007-1#2)
of the oils##9##3##(2006-12#1)(2006-9#2)(2007-1#2)(2007-11#1)(2008-10#1)(2008-12#1)(2012-12#1)
of the old cells##3##4##(1992-3#3)
of the old##16##3##(1992-3#3)(1993-1#1)(1994-3#1)(1995-6#1)(1996-1#1)(2007-11#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-2#1)(2011-1#1)(2011-2#1)
of the older patients##2##4##(1992-9#1)(1997-1#1)
of the older person##5##4##(2010-10#4)(2011-1#1)
of the older##17##3##(1992-9#2)(1995-5#1)(1997-1#1)(2006-7#1)(2007-11#1)(2008-6#1)(2009-5#1)(2009-9#1)(2010-10#4)(2011-1#2)(2013-1#2)
of the oldest age group##2##5##(1992-8#1)(2012-3#1)
of the oldest known##3##4##(1990-3#1)(2007-7#1)(2008-1#1)
of the oldest##22##3##(1990-3#1)(1992-2#1)(1992-8#1)(1994-11#1)(1994-6#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-7#1)(2008-1#1)(2008-10#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
of the olecranon##2##3##(2007-2#1)(2011-2#1)
of the oleosin##2##3##(2009-10#2)
of the olfactory bulb was##2##5##(1992-8#2)
of the olfactory bulb##12##4##(1990-7#1)(1992-8#2)(1993-6#1)(1994-10#1)(1995-11#1)(2006-6#1)(2009-12#5)
of the olfactory bulbs##2##4##(1995-5#2)
of the olfactory groove##2##4##(2006-12#2)
of the olfactory nerve##3##4##(1995-12#2)(1996-7#1)
of the olfactory organ##2##4##(2007-12#2)
of the olfactory system##4##4##(2007-12#2)(2008-6#1)(2008-7#1)
of the olfactory##30##3##(1990-7#1)(1992-8#2)(1993-6#1)(1994-10#1)(1995-11#1)(1995-12#2)(1995-5#2)(1996-7#1)(2006-12#2)(2006-6#1)(2007-12#6)(2008-11#1)(2008-6#1)(2008-7#1)(2009-12#6)(2012-2#1)
of the oligomer##6##3##(1990-11#2)(1993-3#1)(1994-5#1)(2006-10#1)(2011-2#1)
of the oligomeric structure of##2##5##(1991-5#1)(1997-8#1)
of the oligomeric structure##3##4##(1991-5#1)(1997-8#1)(2008-4#1)
of the oligomeric##8##3##(1991-10#1)(1991-5#1)(1991-7#1)(1992-11#1)(1995-10#1)(1995-2#1)(1997-8#1)(2008-4#1)
of the oligomers##2##3##(1995-11#1)(1997-2#1)
of the oligonucleotide##14##3##(1990-2#1)(1993-11#1)(1994-8#1)(1995-1#1)(1996-12#1)(1997-1#1)(2008-10#3)(2008-4#4)(2012-3#1)
of the oligosaccharide chain##2##4##(1994-3#1)(1995-5#1)
of the oligosaccharide##12##3##(1990-12#1)(1990-9#1)(1992-12#1)(1993-11#2)(1994-3#1)(1994-9#1)(1995-11#1)(1995-5#2)(1996-10#1)(2008-7#1)
of the oligosaccharides of##2##4##(1990-12#1)(1997-7#1)
of the oligosaccharides##10##3##(1990-12#1)(1990-9#1)(1991-12#1)(1992-10#1)(1993-11#1)(1997-4#1)(1997-7#1)(2005-7#1)(2008-10#1)(2008-11#1)
of the ombudsman##2##3##(1990-12#1)(1996-2#1)
of the omentum##2##3##(2005-12#1)(2006-10#1)
of the ompH gene##3##4##(1990-11#1)(1990-3#2)
of the on##2##3##(2008-3#1)(2008-4#1)
of the on-axis##2##3##(2008-2#1)(2008-3#1)
of the on-line##4##3##(2008-10#4)
of the oncogenic##4##3##(1991-12#1)(2006-10#1)(2008-5#1)(2008-7#1)
of the oncological##2##3##(2006-6#1)(2008-10#1)
of the oncology##6##3##(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#2)
of the one##5##3##(1995-4#1)(1996-3#1)(1997-2#1)(2006-11#1)(2007-11#1)
of the one-dimensional##6##3##(1990-4#1)(1991-12#1)(1993-5#1)(2007-12#1)(2008-1#1)(2008-3#1)
of the one-electron##2##3##(1990-2#1)(1997-8#1)
of the one-way##2##3##(1996-10#1)(2007-11#1)
of the ongoing##12##3##(1991-1#1)(1991-6#1)(1993-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(2005-8#1)(2006-10#1)(2008-11#1)(2008-8#1)(2009-4#1)(2009-6#1)
of the online course##2##4##(2007-7#1)(2012-12#1)
of the only##8##3##(1993-6#1)(1994-9#1)(1995-12#1)(1996-11#1)(1997-2#1)(2008-10#1)(2008-2#1)(2011-2#1)
of the onset of jaundice##2##5##(1993-7#2)
of the onset of symptoms##3##5##(2007-9#1)(2008-7#1)(2008-9#1)
of the onset of the##2##5##(1995-6#1)(2008-3#1)
of the onset of##23##4##(1993-7#2)(1995-11#1)(1995-6#1)(2005-8#2)(2006-12#1)(2007-11#1)(2007-8#1)(2007-9#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#2)(2012-12#1)
of the onset##24##3##(1993-7#2)(1995-11#1)(1995-6#1)(2005-8#2)(2006-12#1)(2007-11#1)(2007-8#1)(2007-9#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#2)(2012-12#1)
of the ontology##3##3##(2008-7#3)
of the onychophoran##3##3##(2007-12#3)
of the oocyte nucleus##2##4##(2007-12#2)
of the oocyte##11##3##(2007-12#4)(2008-12#1)(2008-4#1)(2008-7#1)(2012-12#3)(2013-1#1)
of the oocytes##3##3##(2006-5#2)(2008-9#1)
of the open reading frame of##2##6##(1992-6#2)
of the open reading frame##11##5##(1992-12#1)(1992-6#2)(1992-8#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-8#1)(1997-2#1)(1997-5#1)
of the open reading frames##4##5##(1996-3#2)(2011-1#2)
of the open reading##16##4##(1992-12#1)(1992-6#2)(1992-8#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-8#1)(1996-3#2)(1997-2#1)(1997-5#1)(2011-1#3)
of the open##25##3##(1992-12#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-5#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-1#3)(2012-12#1)(2013-8#1)
of the opening##4##3##(1993-8#1)(2006-8#1)(2008-10#1)(2008-8#1)
of the operated group##2##4##(2008-5#2)
of the operated joint##3##4##(2007-7#1)(2007-8#2)
of the operated patients##2##4##(2011-2#1)(2013-1#1)
of the operated##14##3##(2006-6#1)(2006-8#1)(2007-11#2)(2007-7#2)(2007-8#2)(2008-3#1)(2008-5#3)(2011-2#1)(2013-1#1)
of the operating parameters##2##4##(2005-12#1)(2008-10#1)
of the operating room environment##2##5##(1991-1#1)(2008-8#1)
of the operating room##5##4##(1991-1#2)(1996-1#1)(2006-10#1)(2008-8#1)
of the operating team##2##4##(2006-6#1)(2007-11#1)
of the operating##16##3##(1990-4#1)(1991-1#2)(1996-1#1)(2005-12#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2013-1#1)
of the operation and##2##4##(2006-12#1)(2006-8#1)
of the operation is##3##4##(1991-3#1)(1991-5#1)(2007-11#1)
of the operation of##2##4##(1995-6#1)(2008-10#1)
of the operation was##4##4##(1996-2#1)(1996-3#1)(2006-8#1)(2008-5#1)
of the operation##37##3##(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-2#1)(1993-5#1)(1993-9#1)(1995-6#1)(1996-2#2)(1996-3#1)(2006-10#1)(2006-12#2)(2006-5#2)(2006-6#2)(2006-8#3)(2007-10#1)(2007-11#3)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-5#1)(2009-10#1)(2011-1#1)(2012-2#2)
of the operational##2##3##(1996-3#1)(2006-2#1)
of the operations##4##3##(1993-6#1)(2006-8#1)(2008-2#1)(2010-2#1)
of the operative site##2##4##(2011-11#2)
of the operative technique##2##4##(2008-4#1)(2013-8#1)
of the operative treatment of##3##5##(1992-8#1)(2007-11#1)(2007-8#1)
of the operative treatment##4##4##(1992-8#1)(2007-11#1)(2007-7#1)(2007-8#1)
of the operative##17##3##(1992-2#1)(1992-8#1)(2006-4#1)(2007-1#2)(2007-11#1)(2007-7#3)(2007-8#1)(2008-10#2)(2008-4#1)(2010-8#1)(2011-11#2)(2013-8#1)
of the operator##11##3##(1990-4#3)(1991-6#1)(1992-6#1)(2006-6#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-2#1)(2012-10#1)
of the operators##2##3##(2007-12#1)(2008-2#1)
of the operon##2##3##(1990-4#1)(1994-6#1)
of the ophthalmic nurse##2##4##(1991-7#1)(2007-5#1)
of the ophthalmic##4##3##(1991-7#1)(1992-8#1)(1993-12#1)(2007-5#1)
of the opiate##2##3##(1991-1#1)(2010-9#1)
of the opinion that the##3##5##(2007-9#1)(2008-1#1)(2008-7#1)
of the opinion that##6##4##(1990-4#1)(2004-10#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-7#1)
of the opinions of##2##4##(2008-12#2)
of the opioid##6##3##(1992-12#1)(1994-10#1)(1996-10#1)(1996-12#3)
of the opioids##2##3##(1993-5#1)(2007-12#1)
of the opium##2##3##(2008-10#1)(2008-3#1)
of the opportunities##2##3##(1993-3#1)(2008-1#1)
of the opportunity to##3##4##(2008-4#1)(2008-7#1)(2008-8#1)
of the opportunity##4##3##(2007-9#1)(2008-4#1)(2008-7#1)(2008-8#1)
of the opposite sex##4##4##(1995-12#1)(2007-12#1)(2008-9#1)(2010-2#1)
of the opposite##10##3##(1995-12#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-9#1)(2009-10#1)(2010-2#1)(2011-1#1)(2013-8#1)
of the opposition to##2##4##(2009-2#1)(2012-2#1)
of the opposition##3##3##(1995-1#1)(2009-2#1)(2012-2#1)
of the optic disc and retinal nerve fiber layer##3##9##(2007-6#3)
of the optic lobe##2##4##(2007-12#1)(2008-5#1)
of the optic nerve head##5##5##(2007-6#1)(2008-5#4)
of the optic nerve sheath##3##5##(2009-8#3)
of the optic nerve##17##4##(1991-3#1)(2005-5#1)(2006-12#2)(2007-6#1)(2008-5#5)(2008-7#1)(2009-8#3)(2010-5#1)(2011-2#2)
of the optic tract##3##4##(1992-7#1)(1992-9#1)(2008-7#1)
of the optic##33##3##(1991-3#1)(1992-7#1)(1992-9#1)(1995-5#1)(1997-8#1)(2005-11#1)(2005-5#1)(2006-12#2)(2007-12#3)(2007-6#4)(2008-2#1)(2008-3#2)(2008-5#6)(2008-7#2)(2009-8#3)(2010-5#1)(2011-2#2)
of the optical absorption##2##4##(1992-9#1)(2008-3#1)
of the optical amplifier##2##4##(2007-12#2)
of the optical axis with respect to the plane of incidence##2##11##(2008-3#2)
of the optical axis##6##4##(2007-11#1)(2008-2#1)(2008-3#4)
of the optical beam##2##4##(2007-12#1)(2008-2#1)
of the optical carrier##3##4##(2007-12#2)(2008-2#1)
of the optical coefficients##2##4##(2008-2#2)
of the optical constants##9##4##(2008-2#5)(2008-3#4)
of the optical depth##2##4##(2008-2#1)(2008-3#1)
of the optical elements##2##4##(2006-5#1)(2008-3#1)
of the optical excitation##2##4##(2007-11#1)(2007-12#1)
of the optical fiber##4##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
of the optical field##5##4##(2007-11#3)(2008-3#2)
of the optical fluctuation##2##4##(2008-3#2)
of the optical frequencies of##2##5##(2007-12#2)
of the optical frequency in a##2##6##(2007-11#1)(2008-2#1)
of the optical frequency##6##4##(2007-11#1)(2007-12#3)(2008-2#2)
of the optical functions of uniaxial##2##6##(2008-1#2)
of the optical functions##3##4##(2007-12#1)(2008-1#2)
of the optical near field##2##5##(2007-11#2)
of the optical nonlinearities##2##4##(2007-12#1)(2011-1#1)
of the optical parameters of##2##5##(2007-12#1)(2008-2#1)
of the optical parameters##5##4##(2007-12#1)(2008-2#1)(2008-3#3)
of the optical path difference##2##5##(2007-12#1)(2013-8#1)
of the optical path##5##4##(2007-12#3)(2013-8#2)
of the optical performance##2##4##(2007-12#1)(2008-3#1)
of the optical phase##3##4##(2007-12#3)
of the optical power##4##4##(2007-12#1)(2008-2#3)
of the optical properties and shape of nanoparticles##2##8##(2009-2#2)
of the optical properties of the##4##6##(2006-7#1)(2008-2#2)(2008-3#1)
of the optical properties of##13##5##(2006-7#1)(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#5)
of the optical properties##16##4##(2006-7#1)(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#6)(2009-2#2)
of the optical response##2##4##(1995-2#1)(2008-7#1)
of the optical signal##6##4##(2007-11#1)(2007-12#3)(2008-1#1)(2008-3#1)
of the optical spectrum##4##4##(1990-3#1)(2007-11#1)(2008-3#1)(2011-2#1)
of the optical system for##3##5##(2008-2#2)(2008-3#1)
of the optical system##14##4##(2007-12#1)(2008-2#6)(2008-3#7)
of the optical##197##3##(1990-3#2)(1991-7#1)(1992-3#1)(1992-9#1)(1995-2#1)(1997-6#1)(2005-11#1)(2006-5#1)(2006-7#1)(2007-11#17)(2007-12#41)(2007-8#1)(2008-1#4)(2008-10#4)(2008-2#42)(2008-3#65)(2008-7#1)(2009-2#3)(2010-2#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-8#3)
of the optically##6##3##(1994-3#1)(2005-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
of the optics##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
of the optimal method##2##4##(2006-5#1)(2007-11#1)
of the optimal##27##3##(1990-8#1)(1995-11#1)(1996-3#1)(1997-3#1)(2004-12#1)(2005-1#1)(2006-5#2)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-2#3)(2008-3#3)(2008-8#1)(2009-10#1)(2010-8#1)(2011-2#1)
of the optimality##2##3##(2006-5#1)(2008-2#1)
of the optimisation##2##3##(2008-10#2)
of the optimised BCR SEP##2##5##(2008-10#2)
of the optimised##3##3##(2007-8#1)(2008-10#2)
of the optimization of##3##4##(1997-1#1)(2007-12#1)(2008-10#1)
of the optimization problem##2##4##(2008-3#1)(2009-3#1)
of the optimization##10##3##(1997-1#1)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#1)(2009-3#1)
of the optimized concentrators##2##4##(2008-3#2)
of the optimized method##2##4##(2008-10#1)(2013-7#1)
of the optimized procedure##2##4##(2008-10#2)
of the optimized##14##3##(1993-8#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#1)(2010-12#1)(2012-12#1)(2013-1#1)(2013-7#1)
of the optimum##27##3##(1990-7#2)(1994-12#1)(1996-8#1)(2005-4#1)(2007-10#1)(2007-11#3)(2007-12#2)(2008-10#3)(2008-2#4)(2008-3#5)(2008-4#1)(2008-9#1)(2012-2#1)(2013-8#1)
of the options##6##3##(2007-4#1)(2008-10#1)(2008-4#2)(2009-5#1)(2012-2#1)
of the optode membrane##3##4##(2008-10#3)
of the optode##5##3##(2008-10#5)
of the oral and maxillofacial region##3##6##(2007-12#1)(2008-7#1)(2012-12#1)
of the oral and maxillofacial surgeon##3##6##(2007-12#3)
of the oral and maxillofacial surgery##3##6##(2007-12#2)(2008-7#1)
of the oral and maxillofacial##9##5##(2007-12#6)(2008-7#2)(2012-12#1)
of the oral and##10##4##(2007-12#6)(2008-7#2)(2012-12#1)(2013-1#1)
of the oral cavity and pharynx##3##6##(1995-5#1)(2013-1#2)
of the oral cavity is##4##5##(2005-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
of the oral cavity or##2##5##(1991-6#1)(2007-12#1)
of the oral cavity##26##4##(1990-1#1)(1990-3#1)(1991-10#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-8#1)(1995-5#1)(1995-9#1)(2005-11#1)(2007-12#3)(2007-7#1)(2008-4#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
of the oral cavity]##2##4##(1990-10#1)(2007-9#1)
of the oral dyskinesia##2##4##(1991-8#2)
of the oral mucosa##8##4##(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#1)(2007-7#1)(2010-12#1)(2010-4#1)(2013-8#1)
of the oral##71##3##(1990-1#1)(1990-10#1)(1990-3#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#2)(1992-8#3)(1993-7#1)(1995-5#2)(1995-9#1)(2005-11#2)(2006-2#1)(2006-8#1)(2007-10#1)(2007-12#9)(2007-4#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#2)(2010-5#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#3)
of the orbit and frontal sinus##2##6##(2011-2#2)
of the orbit##11##3##(1996-6#1)(2008-10#1)(2008-6#2)(2008-9#1)(2009-9#1)(2010-12#1)(2011-2#3)(2012-3#1)
of the orbitofrontal##2##3##(2009-10#1)(2012-12#1)
of the orbits##2##3##(2011-2#2)
of the orchard##6##3##(2008-10#6)
of the orchards##2##3##(2008-10#2)
of the orchid##3##3##(2007-3#1)(2012-2#1)(2013-8#1)
of the order Acipenseriformes##2##4##(2008-8#2)
of the order in the##3##5##(2008-10#2)(2008-5#1)
of the order of 0##7##5##(1990-4#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-9#1)
of the order of 1##10##5##(2007-12#3)(2008-2#3)(2008-3#3)(2010-9#1)
of the order of 1%##2##5##(2007-12#1)(2008-2#1)
of the order of 10##7##5##(1995-11#1)(2006-2#1)(2007-12#1)(2008-2#1)(2008-3#2)(2010-9#1)
of the order of 10(-3)##2##5##(2008-2#2)
of the order of 100 m##2##6##(1996-4#2)
of the order of 100##9##5##(1996-4#2)(2006-5#2)(2007-11#1)(2007-12#1)(2008-2#2)(2008-7#1)
of the order of 2-3##2##5##(2008-2#1)(2008-3#1)
of the order of 5 microm##2##6##(2006-4#1)(2008-3#1)
of the order of 5##4##5##(2006-4#1)(2007-12#1)(2008-2#1)(2008-3#1)
of the order of 50##2##5##(2007-11#1)(2007-12#1)
of the order of 70##2##5##(1994-3#1)(2007-12#1)
of the order of a few##5##6##(2007-12#1)(2008-2#1)(2008-3#3)
of the order of hundreds of##2##6##(2008-1#1)(2008-10#1)
of the order of less than##2##6##(2008-10#1)(2008-3#1)
of the order of magnitude of##2##6##(2008-3#2)
of the order of several##5##5##(1997-6#1)(2008-2#2)(2008-3#2)
of the order of tens of##4##6##(2007-12#2)(2008-10#1)(2008-3#1)
of the order of the wavelength##3##6##(2007-12#2)(2008-2#1)
of the order of the##8##5##(1990-4#1)(1991-3#1)(1996-3#1)(2007-11#1)(2007-12#3)(2008-2#1)
of the order of##136##4##(1990-12#2)(1990-3#1)(1990-4#2)(1991-2#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-3#1)(1994-3#1)(1994-6#1)(1995-11#1)(1996-3#1)(1996-4#2)(1996-7#1)(1997-6#1)(2005-11#1)(2006-2#1)(2006-4#1)(2006-5#2)(2007-11#7)(2007-12#29)(2008-1#1)(2008-10#9)(2008-2#25)(2008-3#36)(2008-7#1)(2009-4#1)(2010-9#3)(2012-2#1)
of the order##153##3##(1990-12#3)(1990-3#1)(1990-4#2)(1991-2#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-3#1)(1994-3#1)(1994-6#1)(1995-11#1)(1996-3#1)(1996-4#2)(1996-7#1)(1997-6#1)(2005-11#1)(2006-2#1)(2006-4#1)(2006-5#2)(2007-11#7)(2007-12#31)(2008-1#1)(2008-10#12)(2008-2#27)(2008-3#36)(2008-5#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-4#1)(2010-5#1)(2010-9#3)(2011-2#2)(2012-2#1)(2013-1#2)
of the ordered##3##3##(1990-5#1)(1992-11#1)(2005-11#1)
of the ordinary##5##3##(1993-3#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-7#1)
of the organ##11##3##(1990-11#1)(1994-6#1)(1996-9#1)(2006-10#1)(2007-9#1)(2008-5#2)(2009-2#1)(2010-12#1)(2011-2#1)(2012-12#1)
of the organelle##2##3##(2008-10#1)(2011-2#1)
of the organelles and##2##4##(1991-1#1)(2009-8#1)
of the organelles##3##3##(1991-1#1)(2008-7#1)(2009-8#1)
of the organic carbon##2##4##(2008-10#2)
of the organic crystal DAST##2##5##(2007-12#2)
of the organic crystal N-(4-nitrophenyl)-L-prolinol##2##5##(2007-12#2)
of the organic crystal##4##4##(2007-12#4)
of the organic matter##2##4##(1993-9#1)(2008-11#1)
of the organic phase electrolyte##3##5##(2010-5#3)
of the organic phase##7##4##(1996-8#1)(2008-10#3)(2010-5#3)
of the organic solvent##4##4##(1996-5#1)(1997-1#1)(2008-10#2)
of the organic##44##3##(1990-7#1)(1993-9#1)(1995-6#1)(1996-5#2)(1996-8#1)(1997-1#1)(2005-11#2)(2007-11#1)(2007-12#6)(2007-9#1)(2008-10#17)(2008-11#1)(2008-5#2)(2008-8#1)(2010-4#1)(2010-5#3)(2013-8#2)
of the organisation##4##3##(2005-5#1)(2008-11#1)(2008-7#2)
of the organism and##6##4##(1994-5#1)(1996-9#1)(2008-4#1)(2008-5#1)(2011-2#1)(2013-8#1)
of the organism in##3##4##(1996-11#1)(1997-1#1)(2009-5#1)
of the organism is##2##4##(1996-9#1)(2005-8#1)
of the organism to##2##4##(1990-8#1)(1997-6#1)
of the organism with##2##4##(2008-10#1)(2012-1#1)
of the organism##57##3##(1990-8#1)(1991-6#1)(1991-9#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-9#4)(1997-1#1)(1997-6#1)(2005-1#1)(2005-7#1)(2005-8#1)(2006-7#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-2#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#2)(2011-2#7)(2012-1#1)(2012-3#1)(2013-8#2)
of the organisms##13##3##(1991-10#1)(1996-9#1)(2004-4#1)(2007-3#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-5#2)(2011-1#2)(2012-1#1)(2013-8#1)
of the organization and##4##4##(1993-12#1)(1994-11#1)(2010-9#1)(2012-2#1)
of the organization of the##3##5##(1995-5#2)(2008-1#1)
of the organization of##7##4##(1992-5#1)(1993-6#1)(1995-11#1)(1995-5#2)(2008-1#1)(2012-1#1)
of the organization through the##2##5##(1993-12#1)(1995-12#1)
of the organization##27##3##(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-6#1)(1994-1#1)(1994-11#1)(1994-2#3)(1995-11#1)(1995-12#1)(1995-5#2)(1996-3#1)(1997-2#1)(2006-10#1)(2007-1#2)(2007-2#1)(2007-4#2)(2008-1#1)(2010-9#1)(2012-1#1)(2012-2#1)
of the organization's##2##3##(1993-1#1)(2007-4#1)
of the organizational##3##3##(1992-12#1)(2008-11#1)(2013-1#1)
of the organizations##2##3##(1994-12#1)(2013-1#1)
of the organotin compounds##2##4##(2008-10#1)(2008-3#1)
of the organotin##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
of the organs of##2##4##(2004-2#1)(2007-8#1)
of the organs##9##3##(1990-4#1)(1991-5#1)(2004-11#2)(2004-2#1)(2006-2#1)(2007-8#1)(2010-5#1)(2013-8#1)
of the oriental##2##3##(2008-6#1)(2011-2#1)
of the orientation of the##9##5##(1995-4#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)
of the orientation of##10##4##(1995-4#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)
of the orientation##18##3##(1990-11#1)(1990-3#1)(1994-3#1)(1995-4#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-8#1)(2009-5#1)(2010-2#1)
of the orienting reflex##2##4##(1992-4#1)(2013-8#1)
of the origin and##5##4##(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)
of the origin of replication##2##5##(1990-11#1)(1995-1#1)
of the origin of the##6##5##(2004-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)
of the origin of these##2##5##(1995-1#1)(2006-9#1)
of the origin of##23##4##(1990-11#1)(1995-1#2)(1995-2#1)(1997-3#1)(1997-4#1)(2004-3#1)(2006-7#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2011-2#1)(2012-12#3)
of the origin##30##3##(1990-11#2)(1995-1#2)(1995-2#1)(1997-1#1)(1997-3#1)(1997-4#1)(2004-3#1)(2006-7#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2011-2#2)(2012-12#3)
of the original amount##2##4##(1990-6#1)(1992-11#1)
of the original data can be achieved##2##7##(2008-3#2)
of the original data##4##4##(2008-10#2)(2008-3#2)
of the original hybrid linear analysis (HLA) method##2##8##(2008-10#2)
of the original image##2##4##(2008-2#2)
of the original level##2##4##(1992-1#1)(1996-7#1)
of the original object##3##4##(2008-3#2)(2009-4#1)
of the original observations##2##4##(1995-2#1)(2012-1#1)
of the original signal##2##4##(2007-11#1)(2008-3#1)
of the original system##3##4##(2008-3#2)(2008-8#1)
of the original tumor##2##4##(1990-2#1)(2011-2#1)
of the original version##2##4##(2007-8#1)(2012-12#1)
of the original##123##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-5#1)(1992-1#2)(1992-11#2)(1992-8#1)(1993-12#2)(1993-8#1)(1994-2#2)(1994-3#1)(1994-8#2)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-11#5)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-2#7)(2008-3#13)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#1)(2008-8#6)(2008-9#2)(2009-1#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#3)(2013-1#1)
of the originally##2##3##(1990-8#1)(1994-12#1)
of the origins of##4##4##(1990-7#1)(2006-3#1)(2009-2#1)(2009-9#1)
of the ornithine decarboxylase##2##4##(1991-3#1)(1994-6#1)
of the ornithine##3##3##(1991-3#1)(1994-6#1)(2008-7#1)
of the orofacial##2##3##(1996-8#1)(2009-11#1)
of the oropharyngeal##4##3##(1995-6#1)(2011-1#1)(2013-1#2)
of the oropharynx##7##3##(2006-10#1)(2006-6#1)(2008-7#1)(2009-10#2)(2010-7#2)
of the orthodontic##2##3##(2013-8#2)
of the orthogonal##3##3##(2008-10#1)(2008-2#1)(2011-1#1)
of the orthopaedic##2##3##(2004-9#1)(2012-12#1)
of the orthopedic surgeon##2##4##(2007-11#1)(2012-12#1)
of the orthopedic##4##3##(2006-10#1)(2007-11#1)(2012-12#2)
of the orthorhombic crystal form##2##5##(1993-8#1)(2008-8#1)
of the os pubis##2##4##(2006-10#2)
of the os##4##3##(2006-10#2)(2008-6#2)
of the oscillation period##2##4##(2008-10#1)(2010-10#1)
of the oscillation##4##3##(1996-7#1)(2005-11#1)(2008-10#1)(2010-10#1)
of the oscillations is equal to the##2##7##(2008-3#2)
of the oscillations##11##3##(1996-11#1)(1996-5#2)(1997-1#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-2#1)(2008-3#3)
of the oscillator##3##3##(1990-8#1)(2007-12#1)(2008-3#1)
of the osseous##4##3##(2007-11#1)(2010-5#1)(2011-2#1)(2013-7#1)
of the ossified cochlea##2##4##(2008-9#2)
of the osteoporosis##2##3##(2005-3#2)
of the osteoporotic##2##3##(2006-8#1)(2008-8#1)
of the osteotomy is##2##4##(2006-3#2)
of the osteotomy##7##3##(2006-3#4)(2007-7#3)
of the other cell lines##2##5##(2008-11#1)(2011-12#1)
of the other cell##3##4##(1993-7#1)(2008-11#1)(2011-12#1)
of the other components of##2##5##(2010-7#1)(2012-3#1)
of the other components##3##4##(2008-10#1)(2010-7#1)(2012-3#1)
of the other compounds##4##4##(1994-2#2)(1994-8#1)(2013-7#1)
of the other enzymes##2##4##(1994-6#1)(2011-12#1)
of the other five##2##4##(2008-9#1)(2012-1#1)
of the other genes##2##4##(1990-7#1)(2009-10#1)
of the other genotypes##2##4##(2008-10#1)(2010-4#1)
of the other groups##5##4##(2004-2#1)(2006-5#1)(2008-8#1)(2011-1#1)(2013-8#1)
of the other hospitals##2##4##(1992-2#2)
of the other isoforms##2##4##(1994-9#1)(1997-4#1)
of the other methods##2##4##(2012-3#2)
of the other mutants##2##4##(1991-2#1)(2008-10#1)
of the other one##2##4##(1995-3#1)(2008-10#1)
of the other parameters##3##4##(2008-3#1)(2009-8#2)
of the other peptides##2##4##(1991-5#1)(1992-12#1)
of the other species##3##4##(2006-8#1)(2008-10#1)(2010-3#1)
of the other strains##2##4##(2006-5#1)(2008-10#1)
of the other three##2##4##(2008-10#1)(2009-10#1)
of the other two groups##3##5##(1997-5#1)(2008-10#2)
of the other two##13##4##(1990-3#1)(1991-6#1)(1992-3#1)(1993-11#1)(1993-6#1)(1994-3#1)(1996-4#1)(1997-5#1)(2008-10#3)(2008-2#1)(2012-1#1)
of the other variables##6##4##(1991-7#1)(2006-10#1)(2008-10#1)(2008-2#2)(2009-4#1)
of the other##193##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#2)(1991-9#3)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#4)(1993-3#1)(1993-4#1)(1993-6#2)(1993-7#2)(1993-9#3)(1994-1#1)(1994-2#2)(1994-3#2)(1994-6#2)(1994-8#5)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-6#1)(1996-10#2)(1996-12#1)(1996-4#3)(1996-5#2)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#1)(2004-1#1)(2004-10#1)(2004-2#1)(2005-11#1)(2006-10#2)(2006-12#2)(2006-5#2)(2006-8#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#25)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#6)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#2)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#1)(2013-7#1)(2013-8#1)
of the others##5##3##(1990-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-5#1)
of the otolith##2##3##(2008-7#2)
of the ouabain-sensitive##2##3##(1992-11#1)(2008-8#1)
of the out-of-plane fringes##2##4##(2008-2#2)
of the outbreak and##3##4##(2011-3#1)(2013-1#1)(2013-8#1)
of the outbreak##11##3##(2006-8#1)(2007-3#1)(2008-6#1)(2008-8#3)(2011-3#1)(2013-1#1)(2013-8#3)
of the outcome of the##2##5##(2009-2#1)(2010-12#1)
of the outcome of##9##4##(1990-9#1)(2005-11#1)(2007-7#1)(2007-8#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-12#1)
of the outcome##17##3##(1990-9#1)(1994-3#1)(1996-5#1)(1997-7#1)(2005-11#2)(2007-11#1)(2007-7#1)(2007-8#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-12#1)
of the outcomes##5##3##(1994-3#1)(1996-2#1)(2008-4#1)(2009-10#1)(2009-6#1)
of the outer hair cell##2##5##(1997-7#2)
of the outer hair##3##4##(1993-9#1)(1997-7#2)
of the outer layer##5##4##(1992-6#1)(2008-10#1)(2008-3#2)(2008-7#1)
of the outer leaflet##2##4##(1990-11#1)(1995-6#1)
of the outer membrane in##2##5##(1997-8#1)(2008-5#1)
of the outer membrane of Pseudomonas aeruginosa##2##7##(1992-7#1)(1996-9#1)
of the outer membrane##8##4##(1992-7#1)(1994-12#1)(1996-9#1)(1997-2#1)(1997-8#2)(2006-8#1)(2008-5#1)
of the outer membrane)##2##4##(1997-8#2)
of the outer mitochondrial##2##4##(1994-8#1)(2005-8#1)
of the outer segment##2##4##(1990-6#1)(2008-7#1)
of the outer##43##3##(1990-11#1)(1990-6#1)(1991-7#1)(1992-12#2)(1992-6#1)(1992-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-6#1)(1996-11#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-7#2)(1997-8#4)(2005-8#1)(2006-11#1)(2006-8#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#5)(2010-1#1)(2011-2#1)(2012-2#2)
of the outflow##2##3##(1992-9#1)(2007-8#1)
of the outgoing##2##3##(2007-12#1)(2008-2#1)
of the outlet##2##3##(2006-8#1)(2007-8#1)
of the output beam was##2##5##(2007-12#1)(2011-1#1)
of the output beam##4##4##(2007-12#3)(2011-1#1)
of the output from##2##4##(2007-12#2)
of the output of a mode-locked##3##6##(2007-11#3)
of the output of a##7##5##(2007-11#4)(2007-12#2)(2008-7#1)
of the output of an##2##5##(2007-12#1)(2008-1#1)
of the output of##12##4##(2007-11#4)(2007-12#5)(2008-1#1)(2008-2#1)(2008-7#1)
of the output power##4##4##(2008-2#1)(2008-3#3)
of the output pulse peak power and##2##7##(2008-3#2)
of the output pulses##2##4##(2007-12#2)
of the output radiation##2##4##(2007-11#2)
of the output signal##4##4##(2007-11#2)(2008-10#2)
of the output##61##3##(1991-6#1)(1993-6#1)(1996-11#1)(2007-11#11)(2007-12#18)(2008-1#2)(2008-10#2)(2008-2#8)(2008-3#11)(2008-4#1)(2008-7#1)(2010-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
of the outputs of##2##4##(1992-6#1)(2008-10#1)
of the outreach##2##3##(1995-1#1)(2007-9#1)
of the outstanding##3##3##(1994-6#1)(1995-3#1)(2011-2#1)
of the outward##3##3##(1994-2#1)(1997-2#1)(2008-3#1)
of the oval##2##3##(2008-9#1)(2009-4#1)
of the ovarian follicles##2##4##(2008-12#2)
of the ovarian surface##2##4##(2011-2#2)
of the ovarian##18##3##(1991-4#1)(1991-9#1)(1992-3#2)(1996-1#2)(2004-10#1)(2007-12#1)(2008-12#2)(2008-4#1)(2008-6#1)(2011-2#3)(2012-12#1)(2012-3#2)
of the ovaries##3##3##(2008-4#1)(2012-1#1)(2012-12#1)
of the ovary and the stomach##2##6##(2008-4#2)
of the ovary and##5##4##(1993-2#1)(2007-4#1)(2008-4#2)(2012-1#1)
of the ovary are##2##4##(1991-5#1)(2010-12#1)
of the ovary as##2##4##(1990-3#1)(1997-8#1)
of the ovary in the##2##5##(2008-10#1)(2010-12#1)
of the ovary in##5##4##(2007-12#1)(2008-10#1)(2008-12#1)(2010-12#1)(2013-8#1)
of the ovary is a##3##5##(2012-2#1)(2013-1#2)
of the ovary is##7##4##(1991-5#1)(1996-2#1)(2008-9#1)(2012-2#1)(2013-1#2)(2013-8#1)
of the ovary on##2##4##(1994-6#2)
of the ovary with##2##4##(1993-1#1)(2004-10#1)
of the ovary##60##3##(1990-2#1)(1990-3#1)(1991-5#3)(1991-9#1)(1992-3#1)(1993-1#2)(1993-10#1)(1993-2#1)(1993-9#4)(1994-6#3)(1995-11#1)(1995-12#1)(1996-2#2)(1997-8#1)(2004-10#2)(2006-5#1)(2007-12#2)(2007-4#4)(2007-8#2)(2008-10#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-9#3)(2009-7#1)(2010-12#3)(2011-1#1)(2012-1#2)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#5)
of the ovary]##2##3##(1991-9#1)(1992-10#1)
of the overall costs##2##4##(2007-11#2)
of the overall fluorescence)##2##4##(1991-5#2)
of the overall group##2##4##(1996-4#1)(2010-6#1)
of the overall management of##2##5##(2007-6#1)(2010-3#1)
of the overall management##3##4##(2007-6#1)(2008-9#1)(2010-3#1)
of the overall method##2##4##(2008-10#2)
of the overall treatment##2##4##(1995-4#1)(2007-12#1)
of the overall##64##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#1)(1990-7#1)(1991-5#3)(1991-8#1)(1992-2#1)(1992-9#1)(1994-8#1)(1995-4#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-4#1)(1996-8#1)(1997-1#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2010-1#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2013-1#2)
of the overexpressed##6##3##(1994-12#1)(1994-5#2)(1996-5#1)(1997-6#1)(2009-8#1)
of the overlap of##2##4##(2008-10#1)(2008-3#1)
of the overlap##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
of the overlapping ORFs 3 and 4##2##7##(2008-10#2)
of the overlapping##13##3##(1992-11#1)(1996-12#1)(1996-8#1)(1997-1#1)(2008-10#6)(2008-3#1)(2009-6#1)(2011-2#1)
of the overlay##2##3##(2007-11#1)(2008-3#1)
of the overlying##3##3##(1993-6#1)(2007-12#1)(2008-11#1)
of the overweight##2##3##(2008-10#2)
of the oviduct##2##3##(1990-8#1)(2008-7#1)
of the ovine##3##3##(1990-12#1)(1991-12#1)(2008-8#1)
of the ovipositor##2##3##(2007-12#2)
of the oxalate##2##3##(1995-7#1)(2008-10#1)
of the oxidant##8##3##(1995-8#1)(2008-10#7)
of the oxidase##7##3##(1991-2#1)(1991-6#2)(1993-8#1)(1994-12#1)(1994-8#1)(2008-10#1)
of the oxidation of##6##4##(1992-8#1)(1993-9#1)(1995-7#1)(2008-10#3)
of the oxidation product of##3##5##(2005-7#1)(2008-10#2)
of the oxidation reaction of##2##5##(2008-10#2)
of the oxidation reaction##3##4##(2008-10#3)
of the oxidation state of##2##5##(2008-10#2)
of the oxidation state##3##4##(2007-11#1)(2008-10#2)
of the oxidation##24##3##(1992-8#1)(1993-9#1)(1995-7#1)(1997-7#1)(2005-7#1)(2006-3#1)(2007-11#1)(2008-10#14)(2008-5#1)(2010-5#1)(2012-3#1)
of the oxidative stress##3##4##(1997-5#1)(2009-4#2)
of the oxidative##8##3##(1994-5#1)(1997-5#1)(1997-7#1)(2008-10#2)(2009-4#2)(2011-1#1)
of the oxide##3##3##(2005-11#1)(2008-10#1)(2008-5#1)
of the oxides##4##3##(1996-5#1)(2005-11#1)(2007-8#1)(2012-2#1)
of the oxidizable##2##3##(2008-10#1)(2008-6#1)
of the oxidized and reduced##3##5##(1997-4#1)(2009-7#2)
of the oxidized form of the##2##6##(1991-4#1)(1993-6#1)
of the oxidized protein##2##4##(1991-7#1)(1997-1#1)
of the oxidized##18##3##(1990-10#1)(1990-5#1)(1991-4#2)(1991-7#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-8#1)(1997-1#1)(1997-4#1)(2008-10#3)(2008-11#1)(2009-7#2)
of the oxidizing##3##3##(1992-3#1)(2008-10#2)
of the oxygen Fick method##2##5##(2008-2#2)
of the oxygen atoms of the##2##6##(1995-5#1)(2012-2#1)
of the oxygen atoms##4##4##(1995-5#1)(1997-7#1)(2010-12#1)(2012-2#1)
of the oxygen binding##3##4##(1994-9#2)(1997-1#1)
of the oxygen partial pressure##2##5##(2005-11#1)(2013-8#1)
of the oxygen##22##3##(1992-8#1)(1993-6#1)(1994-12#1)(1994-8#1)(1994-9#2)(1995-5#1)(1997-1#1)(1997-7#1)(2005-11#1)(2006-3#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#1)(2010-12#1)(2012-2#1)(2013-8#3)
of the oxygen-binding##2##3##(1990-8#2)
of the oxygen-evolving complex##5##4##(1993-6#1)(1994-12#2)(1996-10#1)(2009-2#1)
of the oxygen-evolving##7##3##(1993-6#1)(1994-12#3)(1996-10#1)(1997-4#1)(2009-2#1)
of the oxygenated species##2##4##(1992-8#2)
of the oxygenated##4##3##(1992-8#2)(1993-8#1)(1994-6#1)
of the ozone layer##2##4##(1991-6#1)(2010-12#1)
of the ozone profile##2##4##(2008-2#1)(2008-3#1)
of the ozone##9##3##(1991-6#1)(2008-11#1)(2008-2#1)(2008-3#4)(2010-12#1)(2011-1#1)
of the p##4##3##(1997-4#1)(1997-8#1)(2007-11#1)(2013-1#1)
of the p15##2##3##(1997-1#2)
of the p16##3##3##(2006-10#3)
of the p53 gene##9##4##(1991-11#2)(1993-11#1)(2005-12#2)(2007-11#1)(2008-10#1)(2008-6#1)(2008-7#1)
of the p53 protein##4##4##(1990-8#1)(1992-3#1)(2008-5#1)(2013-7#1)
of the p53 tumor suppressor gene in##2##7##(1993-9#2)
of the p53 tumor suppressor gene##3##6##(1993-9#2)(1994-8#1)
of the p53 tumor suppressor##4##5##(1993-9#2)(1994-5#1)(1994-8#1)
of the p53 tumour suppressor gene##2##6##(1994-2#1)(2008-6#1)
of the p53 tumour suppressor##3##5##(1994-2#1)(2003-11#1)(2008-6#1)
of the p53##31##3##(1990-8#3)(1991-11#2)(1992-3#1)(1993-11#1)(1993-9#2)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#1)(1995-5#1)(1997-7#1)(2003-11#1)(2005-12#2)(2006-10#1)(2007-11#2)(2008-10#1)(2008-5#1)(2008-6#2)(2008-7#1)(2010-3#2)(2012-12#1)(2013-7#1)
of the p53-mediated##2##3##(1993-8#1)(1994-3#1)
of the p60##2##3##(1996-5#1)(1997-6#1)
of the p68##2##3##(1990-2#2)
of the p75 neurotrophin receptor##2##5##(2005-8#1)(2010-8#1)
of the pH and##4##4##(2005-11#1)(2006-10#1)(2008-10#2)
of the pH on the##3##5##(2005-11#1)(2008-10#1)(2010-4#1)
of the pH on##4##4##(2005-11#1)(2008-10#1)(2010-4#1)(2013-8#1)
of the pH##27##3##(1990-11#1)(1990-5#1)(1993-12#1)(1994-8#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-6#2)(2005-11#3)(2006-10#2)(2006-6#1)(2008-10#10)(2010-4#1)(2013-8#1)
of the pH-dependent##3##3##(1992-4#1)(1995-2#1)(1997-3#1)
of the pH-shifted##2##3##(1990-12#2)
of the pK(a)##3##3##(2008-10#3)
of the pO(2)##2##3##(2006-7#1)(2008-11#1)
of the pS2 gene##2##4##(1990-2#2)
of the pS2##3##3##(1990-2#3)
of the pacemaker##2##3##(1994-2#1)(1997-1#1)
of the package insert##2##4##(2006-10#2)
of the package##4##3##(2006-10#3)(2012-2#1)
of the packet##2##3##(2008-3#2)
of the packing##2##3##(1990-3#1)(1996-8#1)
of the paediatric airway##4##4##(2005-11#1)(2006-10#2)(2013-1#1)
of the paediatric patient##3##4##(2006-10#2)(2012-2#1)
of the paediatric##14##3##(2005-11#3)(2006-10#6)(2008-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
of the pain and##3##4##(1995-12#1)(2008-12#1)(2012-2#1)
of the pain is##2##4##(2007-7#1)(2008-7#1)
of the pain syndrome##3##4##(2006-6#1)(2007-11#1)(2008-6#1)
of the pain was##2##4##(1996-3#1)(2008-6#1)
of the pain##29##3##(1991-11#1)(1992-2#2)(1995-12#1)(1996-3#1)(2004-10#1)(2004-12#1)(2005-10#1)(2006-11#2)(2006-12#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#2)(2009-9#1)(2012-2#1)(2013-1#1)
of the painful shoulder is##2##5##(2006-12#1)(2007-11#1)
of the painful shoulder##3##4##(2006-12#2)(2007-11#1)
of the painful##9##3##(2006-10#1)(2006-12#5)(2007-11#1)(2010-7#2)
of the pair##2##3##(1995-2#1)(2008-7#1)
of the paired t-test##2##4##(2008-10#2)
of the paired##4##3##(2007-12#1)(2007-2#1)(2008-10#2)
of the palatal##2##3##(2009-8#1)(2012-2#1)
of the palate##10##3##(1990-1#1)(1991-1#2)(1991-2#1)(1996-8#1)(2006-2#1)(2009-1#1)(2011-2#2)(2012-2#1)
of the palladium##2##3##(2008-10#2)
of the palliative##2##3##(2007-8#1)(2008-7#1)
of the pallidum##2##3##(1991-5#1)(2009-2#1)
of the palm##5##3##(2008-6#4)(2012-12#1)
of the palmar##3##3##(2008-9#1)(2011-2#2)
of the palpebral##3##3##(1991-5#1)(2007-3#1)(2011-1#1)
of the pancreas and the##2##5##(1990-3#1)(2008-10#1)
of the pancreas and##10##4##(1990-3#1)(1990-6#1)(1991-3#1)(1993-5#1)(1994-8#1)(2006-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-12#1)
of the pancreas are##4##4##(2006-10#1)(2006-6#1)(2008-1#1)(2013-1#1)
of the pancreas as##2##4##(2008-7#1)(2013-1#1)
of the pancreas in##7##4##(1992-5#1)(2006-10#1)(2007-4#1)(2008-3#1)(2008-7#1)(2008-8#1)(2013-1#1)
of the pancreas is a##3##5##(2006-10#1)(2006-8#1)(2013-1#1)
of the pancreas is##11##4##(1990-3#1)(1991-3#1)(1991-9#1)(1992-6#1)(2006-10#3)(2006-8#1)(2012-2#1)(2013-1#2)
of the pancreas of##2##4##(1997-8#1)(2008-12#1)
of the pancreas or##2##4##(1993-5#1)(2006-4#1)
of the pancreas to##2##4##(2010-10#1)(2010-12#1)
of the pancreas was diagnosed##2##5##(2007-10#1)(2013-1#1)
of the pancreas was##3##4##(2007-10#1)(2008-8#1)(2013-1#1)
of the pancreas were##2##4##(1990-9#1)(2008-3#1)
of the pancreas with##5##4##(1990-3#1)(1991-9#1)(2005-10#1)(2008-3#2)
of the pancreas##122##3##(1990-3#6)(1990-6#1)(1990-9#7)(1991-3#2)(1991-5#1)(1991-9#2)(1992-5#2)(1992-6#2)(1992-9#1)(1993-10#1)(1993-5#5)(1994-3#2)(1994-8#1)(1995-10#1)(1997-5#1)(1997-8#1)(2005-10#4)(2006-10#9)(2006-2#1)(2006-4#2)(2006-6#9)(2006-8#1)(2007-10#2)(2007-12#1)(2007-3#1)(2007-4#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#7)(2008-7#6)(2008-8#3)(2009-2#1)(2010-10#1)(2010-11#1)(2010-12#9)(2012-2#4)(2012-3#2)(2013-1#14)
of the pancreatic duct##4##4##(2006-6#2)(2008-10#2)
of the pancreatic head and##2##5##(1990-9#1)(2008-10#1)
of the pancreatic head##4##4##(1990-9#1)(2008-10#2)(2008-6#1)
of the pancreatic islet##2##4##(1997-4#1)(2010-10#1)
of the pancreatic secretion##2##4##(2008-10#1)(2012-1#1)
of the pancreatic##25##3##(1990-9#1)(1991-3#1)(1992-11#1)(1997-4#1)(2006-6#3)(2007-5#1)(2008-10#5)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-7#2)(2010-10#1)(2010-12#1)(2012-1#1)(2012-3#1)(2013-8#1)
of the pancreaticoduodenal artery##2##4##(1990-10#1)(1991-6#1)
of the pancreaticoduodenal##3##3##(1990-10#1)(1991-6#1)(2008-7#1)
of the pandemic##3##3##(2008-10#1)(2011-2#2)
of the panel##3##3##(1997-6#1)(2008-5#1)(2011-2#1)
of the panels##2##3##(2008-2#2)
of the pap##2##3##(1997-4#1)(2006-10#1)
of the paper is the##2##5##(1996-1#1)(2007-6#1)
of the paper is to present the##3##7##(2007-11#1)(2011-2#1)(2013-1#1)
of the paper is to##9##5##(1996-9#1)(2006-5#1)(2006-6#1)(2007-11#1)(2008-1#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
of the paper is##13##4##(1996-1#1)(1996-9#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-12#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
of the paper was to present##2##6##(2007-7#1)(2007-8#1)
of the paper was to##3##5##(2007-7#1)(2007-8#1)(2008-10#1)
of the paper was##5##4##(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2011-2#1)
of the paper##38##3##(1991-2#1)(1992-9#1)(1996-1#1)(1996-9#1)(1997-8#1)(2005-6#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#4)(2008-4#1)(2008-5#2)(2009-4#1)(2009-6#2)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#1)
of the papers are##3##4##(2007-8#1)(2008-2#1)(2011-2#1)
of the papers##11##3##(1993-12#1)(1994-6#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-7#1)(2008-8#1)(2011-2#2)(2012-3#1)
of the papilla##3##3##(2006-6#2)(2008-5#1)
of the papillae##2##3##(2008-5#1)(2011-2#1)
of the papillary##3##3##(1990-9#1)(2006-1#1)(2008-5#1)
of the parabens##2##3##(2008-10#1)(2008-5#1)
of the parabolic##2##3##(2008-2#1)(2008-3#1)
of the paracellular##3##3##(1994-6#2)(1995-1#1)
of the paradigm##5##3##(1991-1#1)(1995-5#1)(2013-1#2)(2013-8#1)
of the parahippocampal region##2##4##(1993-5#2)
of the parallel##8##3##(1991-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2011-2#1)
of the parallel-slab division-of-amplitude photopolarimeter##2##5##(2008-3#2)
of the parallels##2##3##(1991-2#1)(2007-12#1)
of the paramagnetic##2##3##(1997-4#1)(2011-2#1)
of the parameter and##3##4##(2008-11#1)(2009-5#1)(2010-2#1)
of the parameter estimates##2##4##(2008-10#1)(2010-2#1)
of the parameter space##2##4##(1993-9#1)(2008-11#1)
of the parameter values##2##4##(2008-10#1)(2008-12#1)
of the parameter##14##3##(1993-4#1)(1993-9#2)(2006-10#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2009-5#1)(2010-2#2)
of the parameters affecting the##2##5##(2008-10#2)
of the parameters in the##4##5##(1992-6#1)(1995-9#1)(2008-7#1)(2010-8#1)
of the parameters in##5##4##(1992-6#1)(1995-9#1)(2007-12#1)(2008-7#1)(2010-8#1)
of the parameters of interest##2##5##(1993-9#1)(2008-3#1)
of the parameters of the model##2##6##(1997-2#1)(2008-3#1)
of the parameters of the##7##5##(1995-4#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)
of the parameters of##14##4##(1993-9#1)(1995-4#1)(1997-2#1)(2005-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-2#1)(2011-2#1)(2012-1#1)
of the parameters on the##2##5##(1997-2#1)(2008-10#1)
of the parameters that affect the##2##6##(2008-10#1)(2008-11#1)
of the parameters that affect##3##5##(1992-3#1)(2008-10#1)(2008-11#1)
of the parameters that characterize the##2##6##(2008-2#1)(2008-3#1)
of the parameters that##10##4##(1992-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-7#1)(2013-1#1)
of the parameters used##2##4##(2007-4#1)(2010-6#1)
of the parameters##58##3##(1990-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-9#1)(1995-4#1)(1995-9#1)(1996-4#1)(1997-2#4)(2004-12#1)(2005-1#1)(2005-11#2)(2006-8#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#7)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-7#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#1)(2013-8#1)
of the parametric and nonparametric##3##5##(2009-10#2)(2010-7#1)
of the parametric##6##3##(2007-11#1)(2007-12#1)(2008-3#1)(2009-10#2)(2010-7#1)
of the paranasal sinuses##3##4##(1991-6#1)(2008-11#1)(2011-2#1)
of the parasite in the##3##5##(2007-10#1)(2007-3#1)(2008-8#1)
of the parasite to##2##4##(2008-9#1)(2012-12#1)
of the parasite were##2##4##(2006-10#1)(2008-5#1)
of the parasite##42##3##(1991-2#1)(1992-7#2)(1992-9#1)(1993-6#1)(1994-5#1)(1995-8#1)(1996-8#1)(1997-6#1)(2006-10#3)(2007-10#1)(2007-3#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-8#2)(2008-9#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#4)(2012-2#1)(2013-1#2)(2013-8#1)
of the parasite's##2##3##(1990-12#1)(1994-8#1)
of the parasites##8##3##(1996-12#1)(1997-4#1)(2007-7#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)
of the parasitic protozoa##2##4##(1990-7#1)(1997-7#1)
of the parasitic wasp Diachasmimorpha longicaudata (Hymenoptera##2##7##(2007-12#2)
of the parasitic wasp##3##4##(1990-11#1)(2007-12#2)
of the parasitic##12##3##(1990-11#1)(1990-6#1)(1990-7#2)(1995-1#1)(1997-4#1)(1997-7#1)(2007-12#2)(2008-8#1)(2009-8#1)(2012-2#1)
of the parasitoid##5##3##(2007-12#4)(2008-8#1)
of the parathyroid glands##3##4##(1990-6#1)(1990-9#1)(1996-12#1)
of the parathyroid##8##3##(1990-6#2)(1990-9#1)(1996-12#1)(1996-5#1)(2007-3#2)(2008-5#1)
of the paraventricular and##2##4##(1990-11#1)(1997-8#1)
of the paraventricular nucleus (PVN)##3##5##(1995-12#1)(1996-12#1)(2005-10#1)
of the paraventricular nucleus can##2##5##(1993-2#1)(1996-9#1)
of the paraventricular nucleus of the hypothalamus (PVN)##2##8##(1996-4#1)(1997-8#1)
of the paraventricular nucleus##15##4##(1993-2#3)(1994-9#1)(1995-12#2)(1995-7#1)(1996-12#1)(1996-4#1)(1996-9#4)(1997-8#1)(2005-10#1)
of the paraventricular##17##3##(1990-11#1)(1993-2#3)(1994-9#1)(1995-12#2)(1995-7#1)(1996-12#1)(1996-4#1)(1996-9#4)(1997-8#2)(2005-10#1)
of the paraxial##3##3##(2007-12#1)(2008-2#2)
of the parenchyma##2##3##(1990-3#1)(2008-10#1)
of the parent and##2##4##(2008-10#2)
of the parent compound##3##4##(1995-6#1)(1996-10#1)(2008-11#1)
of the parent compounds##3##4##(1994-3#1)(1995-7#1)(2009-12#1)
of the parent drug and the##2##6##(2008-10#1)(2011-3#1)
of the parent drug##5##4##(2008-10#3)(2008-8#1)(2011-3#1)
of the parent ion##2##4##(2008-10#2)
of the parent virus##2##4##(1990-11#1)(1994-8#1)
of the parent##44##3##(1990-11#1)(1990-5#1)(1990-6#1)(1991-4#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-8#2)(1995-6#1)(1995-7#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-5#1)(1997-7#1)(2004-4#1)(2007-1#1)(2007-11#2)(2007-8#2)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-3#1)(2012-3#1)
of the parent-child relationship##2##4##(1995-5#1)(1996-9#1)
of the parental enzyme##2##4##(1995-3#2)
of the parental lines##2##4##(2008-10#1)(2008-5#1)
of the parental species##3##4##(2013-1#3)
of the parental strain##2##4##(2008-10#1)(2008-5#1)
of the parental##33##3##(1990-8#1)(1991-1#1)(1991-12#1)(1991-9#1)(1993-1#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-11#1)(2005-11#1)(2007-11#1)(2008-10#4)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
of the parents and##2##4##(2008-10#1)(2009-4#1)
of the parents in##2##4##(2007-7#1)(2008-5#1)
of the parents is a##2##5##(1990-6#1)(2013-1#1)
of the parents##14##3##(1990-6#1)(1995-5#1)(2007-7#1)(2008-10#4)(2008-5#1)(2008-7#1)(2009-11#1)(2009-4#2)(2013-1#1)(2013-7#1)
of the parents'##2##3##(1994-3#1)(2008-2#1)
of the paretic leg##2##4##(2012-1#2)
of the paretic##4##3##(2007-11#1)(2012-1#3)
of the parietal and##2##4##(1995-6#1)(2012-1#1)
of the parietal cell##4##4##(1997-1#3)(2006-10#1)
of the parietal##10##3##(1992-3#1)(1995-6#1)(1997-1#3)(1997-6#1)(2006-10#1)(2007-9#1)(2010-10#1)(2012-1#1)
of the parotid gland is##2##5##(1996-5#1)(2007-5#1)
of the parotid gland##17##4##(1991-6#2)(1996-5#1)(1996-6#1)(2007-10#1)(2007-5#3)(2009-3#1)(2010-12#3)(2010-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
of the parotid##21##3##(1991-6#2)(1992-11#1)(1993-10#1)(1996-5#1)(1996-6#1)(2007-10#1)(2007-5#3)(2009-10#1)(2009-3#1)(2010-12#3)(2010-2#1)(2012-2#2)(2013-1#1)(2013-8#2)
of the pars##3##3##(1992-9#2)(1993-2#1)
of the part of##2##4##(2005-10#1)(2007-8#1)
of the part##3##3##(1996-12#1)(2005-10#1)(2007-8#1)
of the partial least##2##4##(2008-10#2)
of the partial least-squares algorithm##2##5##(2008-10#2)
of the partial resistance##2##4##(2008-10#2)
of the partial##16##3##(1991-1#1)(1992-3#1)(1993-12#1)(1997-6#1)(1997-7#1)(2006-7#1)(2007-12#1)(2008-10#7)(2009-9#1)(2011-2#1)
of the partially ligated##2##4##(1990-8#1)(1997-2#1)
of the partially##12##3##(1990-8#1)(1991-3#1)(1993-3#1)(1993-8#1)(1994-9#1)(1995-9#1)(1996-3#1)(1997-2#2)(2007-7#1)(2008-10#1)(2008-2#1)
of the participants and##2##4##(2008-8#1)(2008-9#1)
of the participants believed##2##4##(2006-8#1)(2008-8#1)
of the participants had##3##4##(1994-12#1)(2007-7#1)(2008-10#1)
of the participants in##2##4##(2006-8#1)(2010-1#1)
of the participants reported##3##4##(2009-6#1)(2010-7#1)(2011-1#1)
of the participants showed##2##4##(2008-12#1)(2008-3#1)
of the participants were##5##4##(2006-8#1)(2007-7#1)(2011-1#1)(2013-1#2)
of the participants with##3##4##(2006-3#1)(2013-1#1)(2013-8#1)
of the participants##48##3##(1991-3#1)(1992-12#1)(1993-6#1)(1994-12#1)(1995-1#1)(2006-10#1)(2006-3#1)(2006-8#4)(2007-11#1)(2007-2#2)(2007-7#4)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-8#3)(2008-9#1)(2009-3#1)(2009-6#2)(2010-1#1)(2010-11#1)(2010-7#1)(2011-1#3)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#1)
of the participants'##4##3##(2007-12#1)(2008-11#1)(2013-1#2)
of the participating##10##3##(1992-5#1)(1994-3#1)(1996-9#1)(2005-11#1)(2008-11#1)(2008-12#2)(2008-4#1)(2012-3#1)(2013-1#1)
of the particle core##2##4##(2006-12#2)
of the particle in##2##4##(2005-11#1)(2007-11#1)
of the particle radius##3##4##(2005-11#3)
of the particle shape##2##4##(2007-12#1)(2008-3#1)
of the particle size distribution##3##5##(2008-3#3)
of the particle size##8##4##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-8#1)
of the particle##44##3##(1991-5#1)(1994-11#1)(1994-3#1)(2005-11#9)(2006-12#2)(2006-2#1)(2007-11#5)(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#13)(2008-7#1)(2008-8#1)(2009-5#1)(2010-4#1)
of the particles and their##2##5##(2005-11#1)(2012-11#1)
of the particles and##3##4##(2005-11#1)(2008-3#1)(2012-11#1)
of the particles are##3##4##(2005-11#2)(2006-5#1)
of the particles in the##2##5##(2008-10#1)(2008-2#1)
of the particles in##3##4##(2008-10#2)(2008-2#1)
of the particles was in the range##2##7##(2004-9#1)(2008-10#1)
of the particles was##3##4##(2004-9#1)(2005-11#1)(2008-10#1)
of the particles with##2##4##(1992-6#1)(2008-3#1)
of the particles##48##3##(1990-12#1)(1992-6#1)(1992-8#1)(1993-4#1)(1993-8#1)(1996-11#1)(2004-9#2)(2005-11#12)(2006-12#2)(2006-2#1)(2006-5#2)(2008-10#7)(2008-2#4)(2008-3#5)(2008-5#2)(2010-7#1)(2012-11#2)(2013-1#2)
of the particular##13##3##(1991-8#1)(1993-6#1)(1994-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
of the particulate phase##2##4##(2009-11#2)
of the particulate##9##3##(1992-3#1)(2007-8#1)(2008-2#1)(2008-3#4)(2009-11#2)
of the partition coefficient of##2##5##(2008-10#2)
of the partition coefficient##5##4##(2004-12#1)(2006-10#1)(2008-10#3)
of the partition##9##3##(1990-4#1)(1994-5#1)(1995-8#1)(2004-12#1)(2006-10#1)(2008-10#4)
of the partner##7##3##(1992-7#1)(1992-9#2)(2006-9#1)(2007-7#1)(2007-8#1)(2010-5#1)
of the partners were HIV##2##5##(2007-12#2)
of the partners were##3##4##(2007-12#3)
of the partners##5##3##(2007-12#4)(2007-4#1)
of the partnership##3##3##(1997-2#2)(2010-5#1)
of the partogram and##2##4##(1992-5#2)
of the parts##3##3##(1997-8#1)(2009-10#1)(2011-12#1)
of the passage of##3##4##(1996-11#1)(2008-10#1)(2011-2#1)
of the passenger##3##3##(1991-10#1)(1996-10#1)(1996-12#1)
of the passive##5##3##(1993-12#1)(1997-2#1)(2007-11#1)(2008-10#1)(2012-1#1)
of the past century##2##4##(2007-8#1)(2008-10#1)
of the past year##2##4##(2006-10#1)(2007-12#1)
of the past##27##3##(1991-9#1)(1992-5#1)(1993-12#2)(1993-3#1)(1996-2#1)(1996-6#1)(1997-7#1)(2006-10#2)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-7#1)(2009-10#1)(2010-3#1)(2011-2#2)(2012-3#2)(2013-8#1)
of the pasture##4##3##(2008-5#2)(2010-2#2)
of the patch clamp technique##2##5##(1993-3#1)(1994-11#1)
of the patch##11##3##(1990-2#1)(1990-3#1)(1993-12#1)(1993-3#1)(1994-11#1)(2007-8#1)(2007-9#1)(2008-5#2)(2008-8#1)(2008-9#1)
of the patch-clamp technique##5##4##(1990-10#1)(1992-11#1)(1993-3#1)(1995-2#1)(2007-12#1)
of the patches##2##3##(2004-12#1)(2008-5#1)
of the patella and##2##4##(2007-7#2)
of the patella##17##3##(2006-11#2)(2007-11#2)(2007-7#3)(2007-8#6)(2009-3#1)(2013-1#3)
of the patellar tendon##6##4##(2008-1#1)(2009-4#1)(2009-9#1)(2013-1#3)
of the patellar##7##3##(1997-8#1)(2008-1#1)(2009-4#1)(2009-9#1)(2013-1#3)
of the patello-femoral joint##2##4##(2006-11#1)(2007-7#1)
of the patello-femoral##3##3##(2006-11#1)(2007-1#1)(2007-7#1)
of the patellofemoral joint##3##4##(2007-7#2)(2007-8#1)
of the patent system##3##4##(2009-11#1)(2010-7#2)
of the patent##8##3##(1997-8#1)(2005-6#1)(2008-1#1)(2009-11#2)(2009-5#1)(2010-7#2)
of the paternal##3##3##(1994-9#1)(1997-3#1)(2010-12#1)
of the path length##2##4##(2008-3#2)
of the path##6##3##(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2009-7#1)
of the path-averaged##2##3##(2007-12#2)
of the pathogen after##2##4##(2008-10#2)
of the pathogen and the##7##5##(2007-12#1)(2008-10#6)
of the pathogen and##12##4##(2007-12#1)(2008-10#10)(2008-9#1)
of the pathogen at the##2##5##(2008-10#2)
of the pathogen between##2##4##(2008-10#2)
of the pathogen by##2##4##(2008-10#2)
of the pathogen collected##3##4##(2008-10#3)
of the pathogen did not##2##5##(2008-10#2)
of the pathogen from##2##4##(2007-12#1)(2008-10#1)
of the pathogen has##2##4##(2008-10#2)
of the pathogen in the##5##5##(2008-10#4)(2008-5#1)
of the pathogen in##14##4##(2008-10#12)(2008-5#2)
of the pathogen into##3##4##(2008-10#3)
of the pathogen on the##2##5##(2008-10#2)
of the pathogen on##5##4##(2008-10#5)
of the pathogen population##5##4##(2008-10#4)(2008-2#1)
of the pathogen through the##2##5##(2008-1#1)(2008-10#1)
of the pathogen through##3##4##(2008-1#1)(2008-10#2)
of the pathogen to##5##4##(2008-10#3)(2009-2#1)(2011-1#1)
of the pathogen was##7##4##(2008-10#7)
of the pathogen were##6##4##(2008-10#6)
of the pathogen##157##3##(2007-12#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#139)(2008-2#1)(2008-5#2)(2008-9#3)(2009-2#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)
of the pathogen's##2##3##(2008-10#2)
of the pathogenesis and development of##2##6##(2008-9#1)(2012-1#1)
of the pathogenesis and##7##4##(1996-12#1)(2005-7#1)(2006-8#1)(2008-9#1)(2009-2#1)(2012-1#1)(2012-2#1)
of the pathogenesis of atherosclerosis##2##5##(2008-1#1)(2008-3#1)
of the pathogenesis of these##3##5##(2006-12#1)(2007-10#1)(2007-7#1)
of the pathogenesis of##37##4##(1990-9#1)(1992-12#1)(1993-8#1)(1994-3#1)(1995-12#1)(1997-1#1)(1997-5#1)(2004-11#1)(2005-8#3)(2006-10#4)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-5#1)(2010-9#1)(2013-1#2)(2013-8#1)
of the pathogenesis##46##3##(1990-9#1)(1992-12#1)(1993-8#1)(1994-3#1)(1995-12#1)(1996-12#1)(1997-1#1)(1997-5#1)(2004-11#1)(2005-7#1)(2005-8#3)(2006-10#4)(2006-12#1)(2006-2#2)(2006-8#2)(2007-10#1)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-2#1)(2010-5#1)(2010-9#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
of the pathogenesis-related protein##2##4##(1997-2#1)(2008-10#1)
of the pathogenesis-related##3##3##(1997-2#1)(2008-10#2)
of the pathogenetic##2##3##(2005-7#1)(2010-12#1)
of the pathogenic##11##3##(1991-12#1)(1991-9#1)(1993-9#1)(2006-10#1)(2008-10#4)(2009-10#1)(2012-12#1)(2012-3#1)
of the pathogenicity of##3##4##(2008-5#2)(2013-7#1)
of the pathogenicity##5##3##(2008-10#1)(2008-12#1)(2008-5#2)(2013-7#1)
of the pathogens##12##3##(1993-2#1)(2006-8#1)(2007-12#1)(2008-10#7)(2008-7#1)(2013-1#1)
of the pathologic##2##3##(1992-8#1)(2005-7#1)
of the pathological changes##2##4##(2007-11#1)(2008-4#1)
of the pathological lesions##2##4##(1990-3#1)(2008-5#1)
of the pathological material##2##4##(2006-4#1)(2010-7#1)
of the pathological process##5##4##(2006-7#1)(2008-4#1)(2012-1#1)(2012-12#1)(2013-1#1)
of the pathological##27##3##(1990-3#1)(1991-9#1)(1995-3#1)(1995-8#1)(2005-8#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-11#2)(2007-2#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-8#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
of the pathologies##2##3##(2008-6#1)(2011-2#1)
of the pathology of the##2##5##(2007-8#1)(2007-9#1)
of the pathology of##3##4##(2007-8#1)(2007-9#1)(2008-10#1)
of the pathology##17##3##(1990-10#1)(1990-4#1)(1992-10#1)(1992-12#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-1#1)(2013-1#4)
of the pathophysiological##9##3##(2005-8#2)(2006-11#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-4#1)(2011-2#1)(2013-8#1)
of the pathophysiology and##4##4##(1993-5#1)(1994-6#1)(2006-10#1)(2008-8#1)
of the pathophysiology of asthma##2##5##(2005-11#1)(2011-12#1)
of the pathophysiology of##17##4##(1996-2#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-9#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2013-8#1)
of the pathophysiology##28##3##(1993-5#1)(1994-6#1)(1994-9#1)(1996-2#1)(1997-1#1)(2005-10#2)(2005-11#1)(2005-8#2)(2006-10#4)(2006-9#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
of the pathway that##2##4##(1995-7#1)(2009-8#1)
of the pathway##21##3##(1990-1#1)(1990-7#1)(1993-3#1)(1995-7#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-9#2)(2013-8#1)
of the pathways involved##3##4##(1996-10#1)(2011-1#1)(2011-2#1)
of the pathways regulating##2##4##(2005-10#1)(2009-8#1)
of the pathways##10##3##(1993-7#1)(1996-10#1)(1996-2#1)(2005-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#1)
of the patient and his##2##5##(1991-6#1)(1996-3#1)
of the patient and of##2##5##(1990-9#1)(2007-5#1)
of the patient and the##8##5##(1990-10#1)(1995-9#1)(2004-2#1)(2006-10#2)(2010-3#1)(2011-2#1)(2012-3#1)
of the patient and to improve##2##6##(2006-2#1)(2013-8#1)
of the patient and to##4##5##(2006-2#1)(2008-10#1)(2013-1#1)(2013-8#1)
of the patient and##30##4##(1990-10#1)(1990-6#1)(1990-9#1)(1991-6#1)(1994-12#1)(1995-9#1)(1996-3#1)(2004-2#1)(2006-10#3)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-8#1)(2009-11#1)(2010-3#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
of the patient are##3##4##(2006-10#1)(2008-8#1)(2009-3#1)
of the patient as##2##4##(2010-12#1)(2011-2#1)
of the patient before##2##4##(1997-4#1)(2013-8#1)
of the patient can##2##4##(2006-12#1)(2010-2#1)
of the patient care process##2##5##(1995-3#2)
of the patient care##3##4##(1995-12#1)(1995-3#2)
of the patient experience##2##4##(2009-8#1)(2012-3#1)
of the patient for##4##4##(1990-2#1)(1992-3#1)(2007-12#1)(2007-8#1)
of the patient from the##2##5##(2007-11#1)(2011-12#1)
of the patient in the##5##5##(2007-10#1)(2009-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
of the patient in##7##4##(2007-10#1)(2008-11#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
of the patient is##14##4##(1990-3#1)(1991-11#2)(1991-12#1)(1995-2#1)(2006-1#1)(2006-9#1)(2008-1#1)(2010-3#1)(2011-1#1)(2011-12#2)(2012-1#1)(2012-3#1)
of the patient on##4##4##(2006-10#1)(2007-12#1)(2008-3#1)(2011-2#1)
of the patient or##3##4##(1991-2#1)(2008-2#1)(2008-8#1)
of the patient population##7##4##(1995-1#1)(1997-8#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-6#1)(2010-12#1)
of the patient should##2##4##(2007-12#1)(2010-5#1)
of the patient taking##2##4##(2006-10#1)(2007-12#1)
of the patient to##3##4##(1992-3#1)(2007-11#1)(2011-1#1)
of the patient undergoing##2##4##(2009-2#1)(2011-1#1)
of the patient was##7##4##(1990-5#1)(1991-5#1)(2006-4#1)(2007-8#1)(2008-1#1)(2008-9#1)(2009-6#1)
of the patient were##2##4##(1994-11#1)(2012-12#1)
of the patient with a##2##5##(2006-10#2)
of the patient with chronic##2##5##(2008-3#1)(2008-9#1)
of the patient with##19##4##(1993-10#1)(1996-2#1)(1997-4#1)(2006-10#5)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-9#1)(2009-5#1)(2009-7#1)
of the patient##290##3##(1990-1#1)(1990-10#2)(1990-11#2)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-9#2)(1991-11#4)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-9#2)(1992-10#2)(1992-12#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#3)(1994-12#3)(1994-7#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#3)(1995-9#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-8#1)(2004-10#1)(2004-2#4)(2005-12#2)(2005-3#2)(2005-5#1)(2005-9#1)(2006-1#1)(2006-10#18)(2006-12#3)(2006-2#2)(2006-3#2)(2006-4#3)(2006-5#2)(2006-6#1)(2006-8#3)(2006-9#2)(2007-10#1)(2007-11#13)(2007-12#9)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#8)(2007-9#1)(2008-1#5)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#3)(2009-2#3)(2009-3#1)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#3)(2010-5#1)(2010-6#2)(2010-9#1)(2011-1#3)(2011-12#5)(2011-2#9)(2011-3#2)(2012-1#7)(2012-12#5)(2012-2#4)(2012-3#8)(2013-1#9)(2013-7#3)(2013-8#5)
of the patient's care##2##4##(2006-12#1)(2010-10#1)
of the patient's clinical##3##4##(2006-12#1)(2007-10#1)(2013-1#1)
of the patient's condition##2##4##(2013-8#2)
of the patient's history##3##4##(1990-6#1)(2006-2#1)(2008-8#1)
of the patient's life##2##4##(2011-12#1)(2013-1#1)
of the patient's medical##3##4##(2006-8#2)(2012-12#1)
of the patient's physical##2##4##(1992-12#1)(2007-11#1)
of the patient's symptoms##3##4##(1991-9#1)(2008-3#1)(2012-2#1)
of the patient's##72##3##(1990-1#1)(1990-11#2)(1990-3#1)(1990-6#1)(1991-6#2)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1995-2#1)(1996-12#1)(1996-9#1)(1997-4#1)(2004-10#1)(2006-10#5)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#4)(2007-11#3)(2007-12#1)(2007-5#1)(2007-6#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#4)(2013-1#4)(2013-8#2)
of the patients after surgical treatment of bone metastases##2##9##(2007-11#2)
of the patients after##5##4##(2006-10#1)(2006-8#1)(2007-11#2)(2007-9#1)
of the patients also##2##4##(1992-6#1)(2007-7#1)
of the patients and the##3##5##(2007-7#1)(2010-7#1)(2013-1#1)
of the patients and their##2##5##(2006-8#1)(2008-11#1)
of the patients and##23##4##(1990-2#1)(1990-4#1)(1990-8#1)(1991-3#1)(1992-2#1)(1993-9#1)(1994-11#1)(1997-6#1)(2005-1#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
of the patients are##8##4##(1990-12#1)(1991-12#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-7#1)(2010-3#1)
of the patients at##4##4##(2006-8#1)(2007-7#2)(2007-8#1)
of the patients because##2##4##(1996-3#1)(2008-10#1)
of the patients before##2##4##(1990-4#1)(1993-12#1)
of the patients being##3##4##(1990-10#1)(2008-5#1)(2012-2#1)
of the patients by the##2##5##(2007-9#1)(2012-3#1)
of the patients could not##2##5##(2007-2#1)(2007-7#1)
of the patients could##3##4##(1990-9#1)(2007-2#1)(2007-7#1)
of the patients developed##3##4##(2006-6#1)(2007-7#1)(2008-1#1)
of the patients developing##2##4##(1994-3#1)(2010-11#1)
of the patients died##4##4##(1996-6#1)(2007-8#1)(2008-11#1)(2011-3#1)
of the patients do not##3##5##(1996-9#1)(2006-10#1)(2008-8#1)
of the patients evaluated##2##4##(1990-8#1)(2011-2#1)
of the patients exhibited##2##4##(1991-8#1)(2013-8#1)
of the patients experienced##5##4##(1990-8#1)(2006-8#2)(2007-11#1)(2012-2#1)
of the patients for##3##4##(1993-6#1)(2006-10#1)(2006-8#1)
of the patients from the##2##5##(1993-10#1)(2007-10#1)
of the patients had a history of##2##7##(2009-10#1)(2010-6#1)
of the patients had a##12##5##(1991-6#1)(1992-1#1)(1993-2#2)(2004-4#1)(2006-12#2)(2006-8#1)(2008-1#1)(2009-10#1)(2010-6#1)(2013-1#1)
of the patients had an##2##5##(2007-8#1)(2011-11#1)
of the patients had been##3##5##(1990-4#1)(1994-5#1)(2011-1#1)
of the patients had complaints of##2##6##(2006-8#2)
of the patients had no##2##5##(2005-10#1)(2008-11#1)
of the patients had not##2##5##(1992-9#1)(1994-2#1)
of the patients had received##2##5##(1990-2#1)(1992-5#1)
of the patients had##68##4##(1990-12#1)(1990-2#1)(1990-4#1)(1990-8#1)(1991-2#2)(1991-6#1)(1992-1#1)(1992-5#1)(1992-9#2)(1993-12#1)(1993-2#2)(1994-11#1)(1994-2#1)(1994-5#1)(1995-9#1)(1996-6#1)(1997-8#1)(2004-4#1)(2005-10#1)(2006-10#2)(2006-12#2)(2006-7#1)(2006-8#5)(2007-12#3)(2007-2#1)(2007-3#2)(2007-7#2)(2007-8#3)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2010-6#1)(2011-1#3)(2011-11#1)(2012-12#1)(2013-1#7)(2013-8#1)
of the patients has been##3##5##(2006-8#1)(2007-11#1)(2007-2#1)
of the patients has##5##4##(2005-11#1)(2006-8#2)(2007-11#1)(2007-2#1)
of the patients have##8##4##(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2010-3#1)(2011-1#1)(2012-12#1)(2013-8#1)
of the patients having##2##4##(2007-7#1)(2008-1#1)
of the patients in the##12##5##(1990-5#1)(1990-8#1)(1994-3#1)(1995-9#1)(1997-5#2)(2006-10#1)(2006-8#2)(2007-11#2)(2007-8#1)
of the patients in this##2##5##(2006-8#1)(2011-2#1)
of the patients in##22##4##(1990-5#1)(1990-8#1)(1994-3#1)(1995-9#1)(1997-5#2)(2006-10#1)(2006-12#1)(2006-8#3)(2007-11#2)(2007-2#1)(2007-8#1)(2007-9#2)(2008-6#1)(2010-4#1)(2011-1#1)(2011-2#2)
of the patients is an##2##5##(1990-10#1)(2011-2#1)
of the patients is##5##4##(1990-10#1)(1992-2#1)(1993-10#1)(1997-7#1)(2011-2#1)
of the patients must be##2##5##(1997-8#1)(2012-3#1)
of the patients no##2##4##(1994-11#1)(2008-12#1)
of the patients on##3##4##(1997-1#2)(2006-1#1)
of the patients or##3##4##(1994-6#1)(1996-8#1)(2009-2#1)
of the patients presented with##4##5##(1991-8#1)(1997-3#1)(2007-3#1)(2013-8#1)
of the patients received##2##4##(2004-1#1)(2006-10#1)
of the patients receiving##3##4##(2008-1#1)(2008-5#1)(2013-1#1)
of the patients referred##2##4##(2007-8#1)(2008-1#1)
of the patients relapsed##2##4##(2007-11#1)(2007-7#1)
of the patients reported side effects##2##6##(1991-3#1)(1993-2#1)
of the patients reported##7##4##(1991-3#1)(1992-5#2)(1993-2#1)(1997-2#1)(2006-10#1)(2006-11#1)
of the patients required##2##4##(1991-8#1)(2006-10#1)
of the patients responded##2##4##(2006-8#1)(2011-2#1)
of the patients showed##8##4##(1991-6#1)(1992-4#1)(1996-7#1)(2007-11#2)(2007-7#1)(2010-10#1)(2013-1#1)
of the patients studied##3##4##(1993-7#1)(2007-11#1)(2008-7#1)
of the patients suffered from##4##5##(1993-3#1)(1993-9#1)(1997-8#1)(2005-5#1)
of the patients suffered##6##4##(1993-3#1)(1993-9#1)(1997-8#1)(2005-5#1)(2011-1#1)(2013-1#1)
of the patients suffering from##3##5##(2007-9#1)(2008-7#1)(2012-12#1)
of the patients suffering##4##4##(2006-8#1)(2007-9#1)(2008-7#1)(2012-12#1)
of the patients surveyed##2##4##(1992-5#1)(2006-10#1)
of the patients tested##2##4##(2005-7#1)(2009-3#1)
of the patients that##2##4##(1995-11#1)(2008-8#1)
of the patients the##2##4##(1990-6#1)(1992-5#1)
of the patients thought##2##4##(1990-2#1)(2006-8#1)
of the patients to##3##4##(1995-11#1)(2006-12#1)(2008-10#1)
of the patients treated with the##2##6##(1990-6#1)(2008-11#1)
of the patients treated with##3##5##(1990-6#1)(2006-10#1)(2008-11#1)
of the patients treated##6##4##(1990-6#1)(1996-8#1)(2006-10#1)(2007-12#1)(2008-11#1)(2011-1#1)
of the patients underwent##2##4##(1990-9#1)(1991-8#1)
of the patients was##41##4##(1990-12#1)(1990-4#1)(1991-8#1)(1992-8#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-4#1)(1995-4#1)(1996-1#1)(1997-8#1)(2007-3#2)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-6#1)(2011-1#2)(2011-11#1)(2011-2#1)(2011-3#1)(2012-2#3)(2012-3#1)(2013-7#1)
of the patients were above##2##5##(2008-3#1)(2013-1#1)
of the patients were admitted##2##5##(1996-9#1)(2007-9#1)
of the patients were between##2##5##(2004-10#1)(2007-6#1)
of the patients were classified as##2##6##(1993-2#1)(2013-1#1)
of the patients were discharged##2##5##(1990-8#1)(2007-8#1)
of the patients were in the##3##6##(2007-11#1)(2007-12#1)(2007-3#1)
of the patients were in##5##5##(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-7#1)
of the patients were male##2##5##(2007-8#1)(2013-1#1)
of the patients were on##2##5##(2008-1#1)(2012-5#1)
of the patients were over##2##5##(1990-10#1)(2008-1#1)
of the patients were satisfied with##2##6##(1990-4#1)(2008-9#1)
of the patients were taking##2##5##(2005-6#1)(2007-8#1)
of the patients were treated##2##5##(1990-10#1)(1997-6#1)
of the patients were using##2##5##(1992-10#1)(2006-7#1)
of the patients were##73##4##(1990-10#2)(1990-4#3)(1990-6#1)(1990-8#2)(1990-9#1)(1991-2#1)(1992-10#1)(1992-4#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-5#1)(1994-5#1)(1995-4#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-6#2)(2004-10#1)(2004-12#1)(2005-10#1)(2005-6#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#4)(2007-8#6)(2007-9#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-3#2)(2012-5#1)(2013-1#4)(2013-8#1)
of the patients who died##2##5##(2008-2#1)(2012-3#1)
of the patients who had##2##5##(1995-9#1)(1997-3#1)
of the patients who scored##2##5##(2008-1#2)
of the patients who##19##4##(1990-12#1)(1992-6#1)(1995-9#1)(1996-11#1)(1996-12#1)(1997-3#1)(2005-8#1)(2006-12#1)(2007-1#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2012-2#1)(2012-3#1)
of the patients will##2##4##(1996-12#1)(2011-2#1)
of the patients with Lbs##2##5##(2008-7#2)
of the patients with PKU of##2##6##(1990-12#2)
of the patients with a##4##5##(1990-10#1)(2006-8#2)(2008-11#1)
of the patients with alcoholic cirrhosis##2##6##(1990-4#2)
of the patients with alcoholic##3##5##(1990-4#3)
of the patients with an##2##5##(1992-5#1)(1993-2#1)
of the patients with cancer of the pancreas##3##8##(2008-7#3)
of the patients with cancer of the##4##7##(2008-7#4)
of the patients with cancer##5##5##(2008-7#4)(2011-2#1)
of the patients with chronic##3##5##(2006-7#1)(2006-8#2)
of the patients with fatty liver and in##2##8##(1990-4#2)
of the patients with partial##2##5##(1992-4#1)(2008-9#1)
of the patients with##85##4##(1990-10#1)(1990-12#2)(1990-2#1)(1990-4#5)(1990-6#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-4#2)(1992-5#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-9#1)(1994-5#1)(1995-4#1)(1995-5#1)(1996-9#1)(1997-2#1)(1997-6#1)(2004-1#1)(2004-8#1)(2005-1#1)(2005-10#1)(2006-3#1)(2006-6#1)(2006-7#2)(2006-8#6)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#3)(2007-8#3)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#1)(2010-12#2)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#3)
of the patients without##4##4##(1991-6#1)(2007-8#1)(2008-7#2)
of the patients would##3##4##(1997-6#1)(2008-5#1)(2010-3#1)
of the patients##791##3##(1990-10#11)(1990-11#1)(1990-12#9)(1990-2#4)(1990-3#1)(1990-4#14)(1990-5#2)(1990-6#7)(1990-7#1)(1990-8#8)(1990-9#7)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#5)(1991-3#6)(1991-4#1)(1991-5#2)(1991-6#4)(1991-7#1)(1991-8#5)(1991-9#2)(1992-1#2)(1992-10#2)(1992-11#2)(1992-2#3)(1992-3#3)(1992-4#5)(1992-5#8)(1992-6#4)(1992-8#1)(1992-9#2)(1993-1#3)(1993-10#4)(1993-12#4)(1993-2#6)(1993-3#3)(1993-4#1)(1993-5#5)(1993-6#1)(1993-7#1)(1993-9#4)(1994-11#3)(1994-2#2)(1994-3#3)(1994-4#1)(1994-5#3)(1994-6#2)(1994-9#4)(1995-11#3)(1995-12#1)(1995-2#1)(1995-4#3)(1995-5#3)(1995-9#5)(1996-1#2)(1996-11#2)(1996-12#5)(1996-2#1)(1996-3#1)(1996-4#3)(1996-6#3)(1996-7#2)(1996-8#2)(1996-9#5)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#3)(1997-6#5)(1997-7#1)(1997-8#6)(2004-1#4)(2004-10#1)(2004-12#2)(2004-4#1)(2004-8#1)(2005-1#2)(2005-10#6)(2005-11#1)(2005-12#1)(2005-5#1)(2005-6#1)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#24)(2006-11#2)(2006-12#9)(2006-2#2)(2006-3#1)(2006-4#3)(2006-6#8)(2006-7#6)(2006-8#38)(2007-1#1)(2007-10#8)(2007-11#24)(2007-12#10)(2007-2#7)(2007-3#8)(2007-4#1)(2007-6#2)(2007-7#45)(2007-8#28)(2007-9#14)(2008-1#31)(2008-10#12)(2008-11#11)(2008-12#2)(2008-2#1)(2008-3#7)(2008-4#3)(2008-5#9)(2008-6#5)(2008-7#21)(2008-8#15)(2008-9#9)(2009-10#2)(2009-2#4)(2009-3#3)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#3)(2010-4#2)(2010-6#3)(2010-7#3)(2010-8#3)(2011-1#16)(2011-11#2)(2011-12#1)(2011-2#33)(2011-3#3)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#10)(2012-3#9)(2012-5#1)(2013-1#24)(2013-7#1)(2013-8#14)
of the patients'##11##3##(1990-10#1)(1990-2#1)(1995-9#1)(2005-7#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-5#2)(2011-2#1)(2012-11#1)
of the patients) and##2##4##(1991-4#1)(2007-7#1)
of the patients)##5##3##(1991-4#1)(2005-10#1)(2006-10#1)(2007-7#2)
of the pattern and##2##4##(2008-3#1)(2008-8#1)
of the pattern of##11##4##(1990-12#1)(1992-12#1)(1992-6#1)(1992-9#1)(1996-12#1)(1996-9#2)(2003-11#1)(2007-9#1)(2008-3#1)(2008-6#1)
of the pattern##18##3##(1990-12#1)(1992-12#1)(1992-6#1)(1992-9#1)(1996-12#1)(1996-9#2)(2003-11#1)(2007-9#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#1)(2009-8#1)(2011-2#2)
of the patterns of##4##4##(1994-3#1)(1996-9#1)(2008-2#1)(2008-7#1)
of the patterns##12##3##(1991-5#1)(1994-3#1)(1996-9#1)(2006-10#1)(2006-12#2)(2008-10#1)(2008-2#2)(2008-7#1)(2008-8#1)(2011-12#1)
of the paucity of##2##4##(2007-11#1)(2008-3#1)
of the pea##3##3##(2008-10#2)(2009-8#1)
of the peak areas##3##4##(2006-12#1)(2008-4#1)(2013-1#1)
of the peak corresponds to##2##5##(2008-10#2)
of the peak current##5##4##(2008-10#5)
of the peak height##3##4##(2006-12#1)(2008-10#2)
of the peak intensity##3##4##(2008-3#3)
of the peak of the##2##5##(1990-3#1)(2008-6#1)
of the peak position##2##4##(2008-10#1)(2008-2#1)
of the peak##36##3##(1990-3#1)(1992-6#1)(1996-9#1)(2006-10#1)(2006-12#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#13)(2008-11#1)(2008-2#4)(2008-3#4)(2008-4#2)(2008-6#1)(2013-1#1)
of the peak)##2##3##(2008-2#1)(2008-3#1)
of the peaks are##4##4##(2007-12#1)(2008-10#2)(2008-3#1)
of the peaks of the##2##5##(2007-11#1)(2008-10#1)
of the peaks##12##3##(1996-8#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-3#1)
of the pecten##2##3##(2008-5#2)
of the pectin##2##3##(1990-4#1)(1995-4#1)
of the pectins##2##3##(2008-10#2)
of the pectoral fins##3##4##(2008-5#2)(2009-7#1)
of the pectoral##4##3##(1994-7#1)(2008-5#2)(2009-7#1)
of the pectoralis major##2##4##(2009-1#1)(2012-2#1)
of the pectoralis##3##3##(2009-1#1)(2010-9#1)(2012-2#1)
of the peculiar##3##3##(1995-4#1)(2006-10#1)(2008-5#1)
of the pediatric##14##3##(1992-3#1)(2006-10#1)(2006-8#1)(2007-1#2)(2007-12#2)(2007-4#1)(2008-4#1)(2010-7#1)(2011-2#1)(2012-12#3)
of the pedicle##5##3##(2007-1#2)(2007-5#1)(2008-4#1)(2008-7#1)
of the pedigrees##2##3##(2008-1#2)
of the pedunculopontine nucleus##2##4##(1994-3#1)(2012-2#1)
of the pedunculopontine tegmental nucleus##5##5##(1991-11#1)(1994-10#1)(1994-2#2)(1994-3#1)
of the pedunculopontine tegmentum (PPT)##2##5##(1992-1#2)
of the pedunculopontine##9##3##(1991-11#1)(1992-1#2)(1994-10#1)(1994-2#2)(1994-3#2)(2012-2#1)
of the peer-review##3##3##(2005-7#2)(2012-12#1)
of the peg##2##3##(2007-12#1)(2010-11#1)
of the pelvic floor##6##4##(1990-4#2)(1992-3#2)(2007-4#1)(2012-1#1)
of the pelvic girdle##2##4##(2008-6#1)(2008-7#1)
of the pelvic organs##2##4##(1994-3#1)(2007-4#1)
of the pelvic ring##3##4##(2006-11#1)(2008-6#2)
of the pelvic##28##3##(1990-4#2)(1990-5#2)(1990-6#1)(1992-12#1)(1992-3#3)(1993-8#1)(1994-3#1)(1994-4#2)(2005-7#2)(2006-11#1)(2007-4#2)(2007-5#1)(2007-7#2)(2008-5#1)(2008-6#3)(2008-7#1)(2010-8#1)(2012-1#1)
of the pelvis with##2##4##(1992-12#1)(2007-7#1)
of the pelvis##29##3##(1991-12#1)(1992-12#2)(2006-11#2)(2006-6#1)(2007-11#1)(2007-7#3)(2008-12#1)(2008-6#3)(2008-8#1)(2010-3#1)(2010-9#1)(2011-2#10)(2012-1#1)(2013-1#1)
of the pendant##2##3##(2006-12#1)(2010-5#1)
of the penetration and##2##4##(2006-10#1)(2012-3#1)
of the penetration of##2##4##(2008-2#1)(2011-1#1)
of the penetration##6##3##(1991-12#1)(1997-1#1)(2006-10#1)(2008-2#1)(2011-1#1)(2012-3#1)
of the penicillin##4##3##(1995-3#1)(1996-2#1)(2008-10#1)(2011-1#1)
of the penile##4##3##(1992-8#1)(2006-9#1)(2008-10#1)(2013-8#1)
of the penis and##2##4##(2005-7#1)(2008-10#1)
of the penis in a##3##5##(2006-5#1)(2008-10#2)
of the penis is##4##4##(1990-12#1)(2008-10#1)(2011-1#2)
of the penis##33##3##(1990-12#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-8#1)(2005-7#1)(2006-5#6)(2007-3#1)(2007-7#2)(2008-10#4)(2008-6#1)(2009-5#5)(2011-1#2)(2012-12#1)(2013-1#2)(2013-8#1)
of the penis]##2##3##(2008-10#2)
of the pentose phosphate pathway in##2##6##(1994-3#1)(2009-5#1)
of the pentose phosphate pathway##4##5##(1994-3#1)(1994-6#1)(2009-5#1)(2010-12#1)
of the pentose##5##3##(1994-3#1)(1994-6#1)(2009-5#1)(2010-12#1)(2012-1#1)
of the pentose-phosphate pathway##2##4##(1990-3#2)
of the penultimate##3##3##(2007-8#1)(2008-10#1)(2013-8#1)
of the people are##2##4##(2007-6#1)(2010-12#1)
of the people of##2##4##(1997-4#1)(2010-8#1)
of the people##27##3##(1990-12#1)(1994-11#1)(1994-8#1)(1996-11#1)(1997-4#1)(2007-1#1)(2007-3#1)(2007-5#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-7#1)(2009-12#1)(2010-12#2)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#2)
of the pepper##2##3##(2008-1#1)(2008-10#1)
of the peptide Ile88-Lys121 was##2##5##(1992-11#2)
of the peptide and##7##4##(1990-12#1)(1990-2#1)(1990-3#1)(1993-8#1)(2006-12#1)(2010-10#1)(2011-1#1)
of the peptide as##2##4##(1991-2#1)(1993-2#1)
of the peptide at##2##4##(1991-5#1)(1992-9#1)
of the peptide backbone##5##4##(1992-6#1)(1994-11#1)(1995-10#1)(1997-7#1)(2008-4#1)
of the peptide bond##2##4##(1992-6#1)(1993-11#1)
of the peptide in the##5##5##(1992-6#2)(1992-9#1)(1994-11#1)(2008-6#1)
of the peptide in##8##4##(1991-10#1)(1992-6#2)(1992-9#1)(1994-11#1)(1997-4#1)(2008-6#1)(2010-4#1)
of the peptide is##3##4##(1990-2#1)(1994-11#1)(2008-8#1)
of the peptide material and polystyrene##2##6##(2005-11#2)
of the peptide may be##2##5##(1993-3#1)(2006-10#1)
of the peptide sequence##4##4##(1991-9#1)(1993-6#1)(1995-1#1)(2008-10#1)
of the peptide substrate##3##4##(1993-11#1)(1994-12#1)(2012-3#1)
of the peptide that##3##4##(1994-12#1)(1995-6#1)(1996-12#1)
of the peptide to##3##4##(1990-3#1)(1991-7#1)(1991-9#1)
of the peptide was##4##4##(1991-5#1)(1991-7#1)(1993-8#1)(1996-9#1)
of the peptide were##3##4##(1994-5#1)(1995-5#1)(2006-12#1)
of the peptide##141##3##(1990-10#1)(1990-12#1)(1990-2#4)(1990-3#3)(1990-5#1)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#2)(1991-7#5)(1991-8#1)(1991-9#5)(1992-1#1)(1992-11#3)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#6)(1992-7#2)(1992-8#1)(1992-9#3)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#5)(1993-6#3)(1993-8#2)(1994-11#4)(1994-12#2)(1994-2#2)(1994-5#2)(1994-6#2)(1994-9#2)(1995-1#2)(1995-10#2)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#3)(1995-8#1)(1996-10#1)(1996-12#4)(1996-7#2)(1996-8#3)(1996-9#3)(1997-4#5)(1997-7#1)(2005-11#2)(2006-10#1)(2006-12#4)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-4#1)(2011-1#2)(2012-3#1)
of the peptides and of the##2##6##(1993-9#2)
of the peptides by##2##4##(1994-8#1)(1995-1#1)
of the peptides that##2##4##(2006-10#1)(2008-4#1)
of the peptides to##3##4##(1992-3#1)(1997-4#1)(2011-2#1)
of the peptides was##3##4##(1993-4#1)(1993-9#1)(1994-8#1)
of the peptides were##4##4##(1992-9#1)(1993-9#1)(1995-11#1)(2012-1#1)
of the peptides##50##3##(1990-10#1)(1990-11#2)(1990-2#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-11#2)(1992-3#1)(1992-4#3)(1992-7#1)(1992-9#2)(1993-3#2)(1993-4#1)(1993-9#4)(1994-11#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-5#1)(1995-6#2)(1996-4#1)(1997-2#1)(1997-4#1)(2005-12#1)(2006-10#1)(2008-10#1)(2008-4#2)(2008-6#1)(2009-10#1)(2011-2#2)(2012-1#1)
of the peptone##3##3##(2008-7#3)
of the per cent volume of the##2##7##(2012-12#2)
of the per##3##3##(1992-4#1)(2012-12#2)
of the perceived##8##3##(1990-8#1)(1991-1#1)(1994-1#1)(1996-2#1)(2006-12#1)(2007-12#1)(2008-6#1)(2009-7#1)
of the percent of##2##4##(2008-12#1)(2012-2#1)
of the percent##3##3##(2008-12#1)(2008-3#1)(2012-2#1)
of the percentage of diseased##2##5##(2008-10#2)
of the percentage of the##2##5##(2008-10#1)(2008-4#1)
of the percentage of##12##4##(1991-5#1)(1991-9#1)(2008-10#7)(2008-3#1)(2008-4#1)(2011-1#1)
of the percentage##13##3##(1991-5#1)(1991-9#1)(2008-10#7)(2008-3#1)(2008-4#1)(2010-1#1)(2011-1#1)
of the perception of##4##4##(1995-5#1)(1997-8#1)(2006-2#1)(2009-12#1)
of the perception##5##3##(1991-4#1)(1995-5#1)(1997-8#1)(2006-2#1)(2009-12#1)
of the perceptions##2##3##(2007-2#1)(2013-1#1)
of the perceptual##3##3##(2007-5#1)(2010-5#1)(2013-8#1)
of the perchlorate##4##3##(2005-4#1)(2007-8#1)(2008-10#2)
of the percolation##2##3##(2005-11#1)(2008-2#1)
of the perfect##2##3##(1994-5#1)(2007-12#1)
of the perforant path##6##4##(1990-7#1)(1992-7#1)(1992-9#2)(1996-7#1)(1997-5#1)
of the perforant##7##3##(1990-5#1)(1990-7#1)(1992-7#1)(1992-9#2)(1996-7#1)(1997-5#1)
of the perforation##2##3##(2008-2#1)(2013-8#1)
of the performance of a##4##5##(2006-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
of the performance of an##2##5##(2008-2#1)(2008-5#1)
of the performance of the##8##5##(2008-2#1)(2008-3#2)(2008-5#2)(2008-9#1)(2009-8#1)(2011-1#1)
of the performance of this##3##5##(1996-7#1)(2006-5#1)(2008-11#1)
of the performance of##30##4##(1995-12#2)(1996-7#1)(2006-1#1)(2006-11#1)(2006-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#4)(2008-5#4)(2008-9#1)(2009-8#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-8#1)
of the performance##34##3##(1995-12#2)(1996-12#1)(1996-7#1)(2006-1#1)(2006-11#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#5)(2008-3#4)(2008-5#4)(2008-9#1)(2009-8#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-8#1)
of the performances of##2##4##(1991-3#1)(2008-3#1)
of the performed operation##2##4##(2007-11#1)(2008-10#1)
of the performed##3##3##(2007-11#1)(2008-10#1)(2008-8#1)
of the performing##2##3##(2008-4#1)(2012-2#1)
of the perfusate##4##3##(1991-9#2)(1992-3#1)(2005-12#1)
of the perfusion chamber to##2##5##(2008-11#2)
of the perfusion chamber##3##4##(2008-11#3)
of the perfusion of the##2##5##(1990-4#1)(2008-10#1)
of the perfusion of##4##4##(1990-4#1)(2005-11#1)(2008-10#1)(2008-4#1)
of the perfusion rate##2##4##(2008-11#2)
of the perfusion system##2##4##(2008-11#1)(2012-2#1)
of the perfusion##18##3##(1990-2#2)(1990-4#1)(1990-7#1)(1991-9#1)(1993-11#1)(2005-11#1)(2007-9#1)(2008-10#1)(2008-11#7)(2008-4#1)(2012-2#1)
of the peri-implant soft tissue unit##2##6##(2012-11#2)
of the peri-implant soft tissue##3##5##(2012-11#3)
of the peri-implant soft##4##4##(2012-11#3)(2013-1#1)
of the peri-implant##7##3##(2012-11#4)(2013-1#3)
of the periacetabular osteotomy##2##4##(2007-7#1)(2007-8#1)
of the periamygdaloid cortex##2##4##(1996-6#2)
of the periapical lesion##2##4##(2009-8#1)(2013-1#1)
of the periaqueductal gray##2##4##(1993-12#1)(1995-6#1)
of the periaqueductal##5##3##(1991-5#1)(1993-12#1)(1994-6#2)(1995-6#1)
of the pericardium##6##3##(1992-2#1)(2004-9#1)(2007-4#2)(2007-8#1)(2008-11#1)
of the periglomerular##2##3##(2010-12#2)
of the perikaryon##3##3##(2008-7#3)
of the perimeter##2##3##(1996-3#1)(2007-6#1)
of the perinatal##5##3##(1991-6#1)(2006-6#1)(2007-10#1)(2010-6#1)(2012-2#1)
of the perinuclear##4##3##(2007-5#1)(2008-7#3)
of the period and##3##4##(1996-3#1)(2008-7#1)(2011-2#1)
of the period of##5##4##(1990-3#1)(1990-8#1)(1994-8#1)(2006-6#1)(2008-7#1)
of the period##17##3##(1990-3#1)(1990-8#1)(1994-8#1)(1996-3#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-3#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-9#1)(2011-2#1)(2012-11#1)(2012-12#1)
of the periodic##9##3##(1991-12#1)(2007-12#3)(2007-9#1)(2008-2#2)(2008-3#1)(2012-2#1)
of the periodontal tissues##2##4##(1991-9#1)(2006-2#1)
of the periodontal##10##3##(1990-11#1)(1991-9#1)(1995-11#1)(2006-2#1)(2006-5#1)(2011-1#1)(2012-3#3)(2013-1#1)
of the periods##2##3##(1992-1#1)(1995-12#1)
of the perioperative care##2##4##(2012-2#2)
of the perioperative##6##3##(2006-10#3)(2010-9#1)(2012-2#2)
of the perioral##2##3##(1991-11#1)(2008-5#1)
of the periosteum##3##3##(2007-11#1)(2009-2#1)(2012-12#1)
of the peripheral and##2##4##(1990-4#1)(1994-8#1)
of the peripheral benzodiazepine receptor##2##5##(1995-12#1)(2008-8#1)
of the peripheral blood##5##4##(1996-10#1)(2006-10#1)(2008-3#1)(2010-5#1)(2012-1#1)
of the peripheral nerve##3##4##(1991-9#1)(1993-4#1)(2009-10#1)
of the peripheral nervous system##9##5##(1994-11#1)(1995-12#1)(1996-2#1)(1996-3#1)(2007-10#1)(2007-7#2)(2012-12#1)(2013-1#1)
of the peripheral or##2##4##(1990-8#1)(2008-9#1)
of the peripheral vasculature##2##4##(2005-10#1)(2008-7#1)
of the peripheral##46##3##(1990-1#1)(1990-4#1)(1990-8#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-4#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-5#2)(1996-10#1)(1996-2#1)(1996-3#2)(1997-1#1)(2005-10#1)(2006-10#3)(2006-2#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-7#2)(2007-9#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#3)(2013-1#1)
of the periplasmic##3##3##(1990-9#1)(1993-6#1)(1996-11#1)
of the periradicular##4##3##(2008-7#1)(2012-2#1)(2013-1#2)
of the perirenal##2##3##(2007-8#1)(2010-4#1)
of the perisomatic space##3##4##(1994-2#3)
of the peritoneal cavity##4##4##(1990-4#2)(2008-1#1)(2011-11#1)
of the peritoneal##8##3##(1990-4#2)(1994-9#1)(2008-1#1)(2008-5#1)(2011-11#1)(2011-2#2)
of the peritoneum##2##3##(2006-6#1)(2011-2#1)
of the peritrophic membrane##3##4##(2007-12#1)(2008-7#2)
of the peritumoral brain##3##4##(2007-12#3)
of the permanent##10##3##(1992-2#1)(2005-9#1)(2006-12#1)(2007-12#1)(2008-5#4)(2009-7#1)(2013-1#1)
of the permanganates##2##3##(2008-10#2)
of the permeability of##2##4##(2005-11#1)(2012-2#1)
of the permeability##3##3##(2005-11#1)(2005-8#1)(2012-2#1)
of the permeant##2##3##(1991-5#1)(2008-5#1)
of the permease##3##3##(1991-10#1)(1993-11#1)(1995-1#1)
of the permittivity##3##3##(2005-11#2)(2008-3#1)
of the peroneal##2##3##(2009-9#1)(2012-3#1)
of the peroneus longus##2##4##(1997-8#1)(2009-3#1)
of the peroxidase##3##3##(1995-10#1)(2006-8#1)(2008-10#1)
of the peroxidase-oxidase reaction##3##4##(1992-7#1)(2006-10#2)
of the peroxidation##2##3##(1990-11#1)(1990-8#1)
of the peroxide##2##3##(2008-10#1)(2008-8#1)
of the peroxisomal bifunctional enzyme##2##5##(1992-5#1)(1995-2#1)
of the peroxisomal##6##3##(1992-4#1)(1992-5#1)(1995-2#1)(1995-3#2)(1997-7#1)
of the peroxisome proliferator activated receptor##2##6##(1992-8#2)
of the peroxisome proliferator-activated receptor##2##5##(2008-1#1)(2008-4#1)
of the peroxisome##6##3##(1992-8#2)(2008-1#1)(2008-4#1)(2009-8#2)
of the peroxyl radical##2##4##(1990-5#2)
of the persimmon bark borer##2##5##(2008-10#2)
of the persimmon##3##3##(2008-10#3)
of the persistence of##2##4##(1997-4#1)(2009-4#1)
of the persistence##3##3##(1997-4#1)(2009-10#1)(2009-4#1)
of the persistent##7##3##(1994-10#1)(2005-7#1)(2005-8#1)(2007-8#1)(2008-11#1)(2008-8#1)(2010-4#1)
of the persisting##2##3##(2004-4#1)(2010-12#1)
of the person and##2##4##(1994-1#1)(2006-6#1)
of the person##16##3##(1991-6#1)(1992-12#1)(1993-2#1)(1994-1#1)(1994-2#1)(1997-2#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-2#1)(2008-10#1)(2008-8#1)(2009-4#1)(2010-6#1)(2013-1#1)(2013-8#1)
of the person's##2##3##(1990-3#1)(2010-8#1)
of the personal##7##3##(1992-10#1)(2004-12#1)(2007-4#1)(2008-11#1)(2008-5#1)(2009-1#1)(2009-7#1)
of the personnel##9##3##(1992-11#1)(1993-5#1)(1995-2#1)(2007-6#2)(2009-2#3)(2010-9#1)
of the persons who were##2##5##(1994-11#1)(1996-1#1)
of the persons who##4##4##(1993-5#1)(1994-11#1)(1996-1#1)(2013-1#1)
of the persons##8##3##(1991-9#1)(1993-5#1)(1994-11#1)(1995-8#1)(1996-1#1)(2007-11#1)(2008-7#1)(2013-1#1)
of the pertinent literature##2##4##(2007-7#1)(2012-2#1)
of the pertinent##6##3##(1996-6#1)(2007-12#1)(2007-7#1)(2008-3#1)(2010-12#1)(2012-2#1)
of the perturbation of##3##4##(1997-6#1)(2006-6#1)(2008-10#1)
of the perturbation##10##3##(1997-6#1)(2005-11#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-3#5)
of the pest population##2##4##(2004-11#1)(2013-8#1)
of the pest##7##3##(2004-11#1)(2008-10#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-8#2)
of the pesticide carbaryl##2##4##(2007-8#2)
of the pesticide##18##3##(1991-3#1)(2007-8#3)(2008-10#10)(2008-7#2)(2011-1#1)(2013-1#1)
of the pesticides in##2##4##(1990-9#1)(2008-10#1)
of the pesticides##12##3##(1990-9#1)(1994-3#1)(2007-5#3)(2008-10#3)(2008-11#2)(2012-12#1)(2013-8#1)
of the pet##2##3##(2008-8#1)(2011-2#1)
of the petH##2##3##(1992-3#2)
of the petrous##5##3##(2006-12#1)(2008-7#1)(2009-10#1)(2011-2#2)
of the phage 434 repressor##2##5##(1990-5#1)(2008-8#1)
of the phage display##2##4##(1994-9#1)(2008-10#1)
of the phage genome##2##4##(1990-8#1)(2007-12#1)
of the phage lambda##2##4##(1991-6#1)(1995-8#1)
of the phage##19##3##(1990-1#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-6#1)(1994-12#1)(1994-9#2)(1995-8#1)(1997-1#1)(2007-12#1)(2008-10#3)(2008-8#1)(2011-12#2)(2013-1#1)
of the phages##3##3##(2012-2#1)(2013-1#2)
of the phagocytic##3##3##(1993-4#1)(1994-6#1)(2008-1#1)
of the phalanges##2##3##(1994-6#1)(1997-3#1)
of the phantom##5##3##(2008-3#2)(2011-1#1)(2011-2#1)(2012-1#1)
of the pharmaceutical industry##3##4##(1991-3#1)(2008-11#1)(2008-7#1)
of the pharmaceutical##6##3##(1991-3#2)(2008-11#2)(2008-7#1)(2010-12#1)
of the pharmacists##2##3##(2011-1#2)
of the pharmacodynamic##3##3##(2005-8#1)(2008-3#1)(2008-5#1)
of the pharmacokinetic##5##3##(1991-12#1)(1991-2#1)(1996-8#1)(2007-12#1)(2008-10#1)
of the pharmacokinetics of antiretroviral##2##5##(2006-10#1)(2007-8#1)
of the pharmacokinetics of##5##4##(1991-9#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-10#1)
of the pharmacokinetics##6##3##(1991-9#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-3#1)
of the pharmacological properties##2##4##(1990-3#1)(2006-12#1)
of the pharmacological##11##3##(1990-2#1)(1990-3#2)(1990-5#1)(1993-7#1)(1994-3#2)(2006-12#1)(2008-1#1)(2008-10#2)
of the pharmacology##2##3##(2005-8#1)(2007-8#1)
of the pharmacophore##2##3##(1996-9#1)(2012-3#1)
of the pharmacy##5##3##(2011-1#5)
of the pharynx##7##3##(1997-7#1)(2007-12#1)(2007-6#1)(2008-5#1)(2009-1#1)(2009-10#1)(2011-2#1)
of the phase I study##2##5##(2008-5#2)
of the phase I##3##4##(1995-12#1)(2008-5#2)
of the phase II##3##4##(2005-8#1)(2007-7#1)(2008-5#1)
of the phase and amplitude##2##5##(2006-5#1)(2008-2#1)
of the phase and the amplitude of##2##7##(2008-2#2)
of the phase and the##3##5##(2008-2#3)
of the phase and##7##4##(2006-5#1)(2007-12#1)(2008-2#4)(2008-3#1)
of the phase change on reflection##2##6##(2008-2#2)
of the phase change##4##4##(2008-2#2)(2008-3#2)
of the phase difference between the##2##6##(2008-3#2)
of the phase difference between##5##5##(2007-12#2)(2008-3#3)
of the phase difference##6##4##(2007-12#2)(2008-3#4)
of the phase distribution##2##4##(2008-3#2)
of the phase distributions##2##4##(2008-2#1)(2008-3#1)
of the phase function on##2##5##(2007-12#2)
of the phase function##7##4##(2007-12#2)(2008-2#2)(2008-3#3)
of the phase gradient##2##4##(2008-3#2)
of the phase is##3##4##(2007-12#1)(2008-1#1)(2008-2#1)
of the phase map##3##4##(2008-2#1)(2008-3#2)
of the phase modulation of##2##5##(2008-2#1)(2008-3#1)
of the phase modulation##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
of the phase of the##8##5##(2007-11#2)(2007-12#3)(2008-3#3)
of the phase of##11##4##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#5)
of the phase response of##2##5##(2007-12#1)(2008-2#1)
of the phase shift on##2##5##(2008-2#2)
of the phase shift##4##4##(2008-2#3)(2008-3#1)
of the phase transition##7##4##(1991-4#1)(1994-11#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-11#2)
of the phase variation##2##4##(2008-3#2)
of the phase##121##3##(1990-4#1)(1991-4#1)(1994-11#1)(1995-12#1)(2005-11#1)(2005-8#1)(2006-5#1)(2007-11#11)(2007-12#20)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#28)(2008-3#41)(2008-5#3)(2008-7#1)(2008-8#1)(2012-2#2)
of the phase-matching condition##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
of the phase-matching##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
of the phases of##2##4##(2008-2#1)(2008-3#1)
of the phases##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
of the phenol##2##3##(2006-8#1)(2008-10#1)
of the phenolate##2##3##(1990-5#1)(1996-2#1)
of the phenolic##11##3##(1990-5#1)(1992-9#1)(1993-2#1)(1995-3#2)(2006-12#1)(2007-11#1)(2008-10#3)(2008-5#1)
of the phenolics and##2##4##(2008-10#1)(2012-11#1)
of the phenomena of##2##4##(2008-5#1)(2010-10#1)
of the phenomena##8##3##(1997-8#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-1#1)
of the phenomenon of##2##4##(2008-2#1)(2008-3#1)
of the phenomenon##15##3##(1991-6#1)(1994-6#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-8#1)(2011-12#1)
of the phenotype##5##3##(1993-2#1)(2006-8#1)(2011-12#1)(2012-2#1)(2012-3#1)
of the phenotypes of##2##4##(1991-9#1)(2011-2#1)
of the phenotypes##6##3##(1991-9#1)(1997-8#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
of the phenotypic variance##10##4##(2008-10#8)(2012-3#2)
of the phenotypic variation for resistance##2##6##(2008-10#2)
of the phenotypic variation for the 5-day reading##2##8##(2008-10#2)
of the phenotypic variation for##6##5##(2008-10#6)
of the phenotypic variation in##2##5##(2008-10#2)
of the phenotypic variation##15##4##(2008-10#14)(2009-2#1)
of the phenotypic##31##3##(2008-10#25)(2008-8#1)(2009-2#1)(2012-1#1)(2012-3#3)
of the phenoxyl##2##3##(2006-10#1)(2008-8#1)
of the phenyl ring of##2##5##(1995-5#1)(2006-12#1)
of the phenyl ring##6##4##(1994-12#1)(1995-11#1)(1995-5#1)(2006-12#1)(2010-5#1)(2013-1#1)
of the phenyl rings##2##4##(1994-9#1)(1997-7#1)
of the phenyl##10##3##(1994-12#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-8#1)(1997-7#1)(2006-12#1)(2008-3#1)(2010-5#1)(2013-1#1)
of the phenylanthranilic##2##3##(1993-4#2)
of the pheromone signal-transduction pathway##2##5##(1997-4#2)
of the pheromone##7##3##(1991-12#1)(1992-11#1)(1995-1#1)(1997-4#2)(2008-10#1)(2008-6#1)
of the phi 29##2##4##(1990-3#1)(1990-9#1)
of the phi##4##3##(1990-3#1)(1990-9#1)(2008-11#1)(2008-3#1)
of the philosophical and##2##4##(2008-7#2)
of the philosophical##6##3##(2006-11#1)(2006-9#1)(2008-4#1)(2008-7#2)(2012-12#1)
of the philosophy##3##3##(2006-3#1)(2007-11#1)(2012-2#1)
of the phlegmon##2##3##(2005-10#1)(2013-1#1)
of the phloem##3##3##(2008-10#2)(2008-11#1)
of the phoAIV##2##3##(1990-11#2)
of the phonological loop in##2##5##(2008-4#2)
of the phonological##4##3##(2008-2#1)(2008-4#2)(2010-2#1)
of the phorbol ester##2##4##(1993-7#1)(1994-12#1)
of the phosphatase 2A catalytic subunit##3##6##(1992-9#3)
of the phosphatase##8##3##(1990-3#1)(1992-12#2)(1992-9#3)(1995-2#2)
of the phosphate##13##3##(1990-8#3)(1992-1#4)(1994-11#1)(1996-7#2)(2008-10#3)
of the phosphatidylinositol##5##3##(1992-6#1)(1994-11#1)(1994-6#1)(2008-5#1)(2012-12#1)
of the phosphine##2##3##(1996-2#1)(2010-5#1)
of the phosphodiester##5##3##(1991-7#2)(1992-8#1)(1993-8#1)(1996-4#1)
of the phosphodiesterase##5##3##(1991-10#1)(1991-8#1)(1992-12#1)(2008-3#1)(2012-2#1)
of the phosphoenolpyruvate##4##3##(1990-10#1)(1991-12#1)(1991-6#1)(1995-1#1)
of the phosphoenzyme##4##3##(1994-8#1)(1996-9#3)
of the phosphoenzymes##2##3##(1990-11#2)
of the phosphoinositide##4##3##(1990-3#1)(1991-6#1)(2006-9#1)(2008-8#1)
of the phosphoinositides##2##3##(1991-11#2)
of the phosphointermediate of##2##4##(1990-11#1)(1995-6#1)
of the phospholipid##20##3##(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-7#1)(1992-10#1)(1993-9#1)(1994-2#2)(1994-3#1)(1995-8#1)(1997-3#1)(2006-10#1)(2008-4#1)(2011-2#1)(2012-12#1)
of the phospholipids##9##3##(1990-3#1)(1991-9#1)(1993-8#1)(1994-3#1)(1994-9#2)(1997-1#1)(2008-10#1)(2008-5#1)
of the phosphomolybdenum blue##2##4##(2008-10#2)
of the phosphonate group##2##4##(2008-10#1)(2008-3#1)
of the phosphonate##5##3##(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)
of the phosphopeptide is##2##4##(1990-11#2)
of the phosphopeptide##3##3##(1990-11#3)
of the phosphopeptides##2##3##(1994-6#1)(2013-8#1)
of the phosphoproteins##2##3##(1992-10#1)(1995-11#1)
of the phosphoramidites##2##3##(2008-4#2)
of the phosphorescence emission##4##4##(2007-8#1)(2008-10#3)
of the phosphorescence##5##3##(1992-12#1)(2007-8#1)(2008-10#3)
of the phosphorus##5##3##(1991-7#1)(1997-7#2)(2007-11#1)(2008-11#1)
of the phosphorylase##2##3##(1991-11#1)(1995-3#1)
of the phosphorylated form of##2##5##(1997-1#1)(2010-2#1)
of the phosphorylated form##3##4##(1997-1#1)(2008-5#1)(2010-2#1)
of the phosphorylated residues##2##4##(1992-6#1)(1994-11#1)
of the phosphorylated##12##3##(1990-2#1)(1990-7#1)(1990-8#1)(1992-12#1)(1992-6#1)(1994-11#1)(1997-1#1)(1997-2#1)(2007-8#1)(2008-5#1)(2008-8#1)(2010-2#1)
of the phosphorylating##2##3##(1991-12#2)
of the phosphorylation of##6##4##(1991-1#1)(1992-5#1)(1994-12#1)(1995-12#1)(2009-3#1)(2012-3#1)
of the phosphorylation reaction##3##4##(1990-11#1)(1994-3#1)(1996-11#1)
of the phosphorylation site##2##4##(1992-5#1)(1996-8#1)
of the phosphorylation##15##3##(1990-11#1)(1990-12#1)(1991-1#1)(1991-6#1)(1992-5#2)(1994-12#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-8#1)(1996-9#1)(2009-3#1)(2012-3#1)
of the phosphotyrosine##2##3##(1994-2#1)(1996-5#1)
of the photoacoustic signal##3##4##(2008-3#3)
of the photoacoustic##4##3##(2008-3#3)(2011-7#1)
of the photoactive##3##3##(1992-8#3)
of the photoaffinity##2##3##(1991-4#1)(1996-8#1)
of the photobleached##2##3##(2008-1#1)(2008-2#1)
of the photobleaching##2##3##(2008-2#1)(2008-9#1)
of the photocatalytic##2##3##(1994-3#1)(2008-10#1)
of the photochemical##4##3##(1992-2#1)(2006-12#1)(2008-3#2)
of the photoconductive##2##3##(2007-12#1)(2008-2#1)
of the photocurrent##3##3##(2008-2#2)(2008-3#1)
of the photocycle##4##3##(1990-2#1)(1994-11#1)(1995-5#1)(1997-3#1)
of the photodetector and##2##4##(2008-2#2)
of the photodetector##5##3##(2008-10#1)(2008-2#3)(2008-3#1)
of the photodiode##3##3##(2008-2#1)(2008-3#2)
of the photodynamic##5##3##(2005-7#2)(2008-2#1)(2009-4#1)(2011-2#1)
of the photoinactivation##2##3##(1996-7#2)
of the photolabeled##2##3##(1996-8#2)
of the photomultiplier tube##2##4##(2008-3#2)
of the photomultiplier##3##3##(2008-3#3)
of the photon statistics##2##4##(1993-8#1)(2007-12#1)
of the photon transport equation##2##5##(2007-11#1)(2008-2#1)
of the photon##12##3##(1992-11#1)(1993-8#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#5)(2012-2#1)
of the photon-echo##2##3##(2007-12#1)(2008-2#1)
of the photon-number##2##3##(2007-11#1)(2007-12#1)
of the photonic crystal##2##4##(2007-12#1)(2008-7#1)
of the photonic switch##2##4##(2008-3#2)
of the photonic##9##3##(2007-12#3)(2008-2#1)(2008-3#4)(2008-7#1)
of the photophysical##2##3##(1995-1#1)(2008-5#1)
of the photoproducts##2##3##(1992-8#1)(2008-10#1)
of the photoreaction##2##3##(1991-7#1)(2008-3#1)
of the photoreceptive system##2##4##(2008-5#2)
of the photoreceptor##2##3##(1995-8#1)(2009-10#1)
of the photoreceptors##2##3##(2007-12#1)(2007-5#1)
of the photorefractive##8##3##(2007-11#1)(2007-12#3)(2008-1#2)(2008-2#1)(2008-3#1)
of the photosensitivity##3##3##(1993-12#1)(2007-12#2)
of the photosensitizer##5##3##(2008-2#4)(2008-3#1)
of the photosensitizers##3##3##(1993-11#1)(2008-11#1)(2008-5#1)
of the photosynthetic apparatus##4##4##(1991-3#1)(2008-10#2)(2012-6#1)
of the photosynthetic##8##3##(1990-7#1)(1991-3#1)(1994-5#1)(1994-8#1)(2008-10#2)(2009-2#1)(2012-6#1)
of the phycobilisomes##2##3##(1992-3#2)
of the phyllosilicate##2##3##(2008-6#2)
of the phylogenetic affinities of##2##5##(1991-6#1)(1993-6#1)
of the phylogenetic tree##2##4##(1996-5#1)(2007-1#1)
of the phylogenetic##8##3##(1991-6#1)(1993-6#1)(1996-5#1)(2007-1#1)(2007-12#1)(2008-1#2)(2010-6#1)
of the phylum Spirochaetes##2##4##(2013-8#2)
of the phylum##6##3##(2006-10#1)(2007-12#1)(2011-2#1)(2013-8#3)
of the physical and chemical environment##2##6##(2008-10#1)(2008-8#1)
of the physical and chemical##4##5##(1992-8#1)(2008-10#2)(2008-8#1)
of the physical and##6##4##(1992-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-12#1)
of the physical environment##2##4##(1992-4#2)
of the physical map##2##4##(1997-2#1)(2012-3#1)
of the physical parameters and##2##5##(2007-11#1)(2007-4#1)
of the physical properties of the##3##6##(1996-8#1)(2008-5#2)
of the physical properties of##4##5##(1996-8#1)(2008-5#3)
of the physical properties##6##4##(1996-8#1)(2007-8#1)(2008-3#1)(2008-5#3)
of the physical state of##2##5##(1992-9#1)(2008-4#1)
of the physical##51##3##(1990-9#1)(1992-2#1)(1992-4#2)(1992-8#1)(1992-9#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-2#1)(2006-1#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-4#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)
of the physical-chemical##2##3##(1992-3#1)(2008-5#1)
of the physically##2##3##(2008-3#1)(2013-1#1)
of the physician in##3##4##(1993-2#1)(1995-2#1)(1996-1#1)
of the physician is##3##4##(1993-5#1)(1996-2#1)(2012-12#1)
of the physician##14##3##(1991-4#1)(1991-6#1)(1993-2#2)(1993-5#1)(1995-2#1)(1996-1#1)(1996-2#2)(2007-2#1)(2007-4#1)(2008-8#1)(2010-11#1)(2012-12#1)
of the physician's##2##3##(2008-4#1)(2013-1#1)
of the physician-patient relationship and##2##5##(2009-7#1)(2011-2#1)
of the physician-patient relationship##3##4##(2008-4#1)(2009-7#1)(2011-2#1)
of the physicians had##2##4##(1997-6#1)(2008-8#1)
of the physicians in Saudi Arabia towards##2##7##(2007-7#1)(2008-1#1)
of the physicians in##4##4##(1993-5#1)(2007-7#2)(2008-1#1)
of the physicians##20##3##(1992-3#1)(1992-6#1)(1993-10#1)(1993-11#1)(1993-5#1)(1995-5#1)(1997-3#2)(1997-6#1)(2006-10#1)(2007-3#2)(2007-7#3)(2008-1#2)(2008-8#1)(2013-1#2)
of the physicians'##3##3##(1995-2#2)(1996-1#1)
of the physicochemical properties of the##2##6##(2008-5#2)
of the physicochemical##8##3##(1997-4#1)(2008-10#1)(2008-11#2)(2008-5#2)(2009-4#1)(2010-4#1)
of the physiologic##3##3##(1996-4#1)(2008-5#1)(2010-6#1)
of the physiological and##4##4##(1997-3#1)(2008-7#1)(2009-10#1)(2009-12#1)
of the physiological effects##2##4##(2008-4#1)(2013-1#1)
of the physiological functions of##2##5##(1990-3#1)(2006-6#1)
of the physiological processes##2##4##(1996-2#1)(2006-10#1)
of the physiological responses##2##4##(1993-3#1)(1997-8#1)
of the physiological##36##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-7#1)(1993-3#1)(1995-10#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-10#1)(2010-2#1)(2012-2#2)(2013-1#2)
of the physiologically relevant##2##4##(1997-1#1)(2011-1#1)
of the physiology of##4##4##(2006-10#1)(2007-11#1)(2009-3#1)(2012-12#1)
of the physiology##8##3##(2006-10#3)(2007-11#1)(2009-3#1)(2010-3#1)(2012-12#1)(2013-1#1)
of the physiopathology##2##3##(2008-10#1)(2008-7#1)
of the physiotherapist##2##3##(1992-12#1)(2008-9#1)
of the phytase expressed by P##2##6##(2008-4#2)
of the phytohormone##2##3##(1991-11#1)(2008-10#1)
of the phytopathogenic bacterium##2##4##(1990-4#1)(2008-10#1)
of the phytopathogenic##3##3##(1990-4#1)(1997-4#1)(2008-10#1)
of the pial artery##4##4##(1992-8#4)
of the picture##4##3##(1993-12#1)(1993-3#1)(2006-8#1)(2008-7#1)
of the piezoelectric quartz crystal##2##5##(2008-10#2)
of the piezoelectric##7##3##(1992-5#1)(2007-10#1)(2008-10#4)(2009-5#1)
of the pig PGI##2##4##(1990-11#2)
of the pig genome##2##4##(2008-7#1)(2008-8#1)
of the pig##7##3##(1990-11#3)(1991-12#1)(1994-9#1)(2008-7#1)(2008-8#1)
of the pigeon##2##3##(2006-5#1)(2008-5#1)
of the pigment##5##3##(1991-12#1)(1992-12#1)(1992-8#1)(2007-11#1)(2010-4#1)
of the pigmented##2##3##(2007-3#1)(2008-10#1)
of the pigments##5##3##(1997-6#1)(2008-10#4)
of the pigs##3##3##(2010-4#2)(2011-1#1)
of the pilosebaceous unit##3##4##(2008-5#1)(2010-3#1)(2010-7#1)
of the pilot study##5##4##(2007-10#1)(2010-3#2)(2010-7#1)(2012-3#1)
of the pilot##10##3##(1993-1#1)(2007-10#1)(2007-5#1)(2008-4#1)(2010-3#2)(2010-7#1)(2010-9#1)(2012-3#2)
of the pine##2##3##(2007-8#1)(2011-10#1)
of the pineal gland##6##4##(1994-2#1)(1994-5#5)
of the pineal hormone melatonin##2##5##(1990-2#2)
of the pineal organ##2##4##(1994-5#2)
of the pineal##19##3##(1990-2#2)(1990-5#1)(1994-2#1)(1994-5#9)(1995-1#1)(1995-12#1)(2008-5#1)(2010-4#1)(2012-2#1)(2013-7#1)
of the pink##3##3##(2008-10#1)(2008-5#1)(2010-10#1)
of the pioneer##2##3##(2007-1#1)(2007-3#1)
of the pioneering##2##3##(2007-8#1)(2008-4#1)
of the pioneers##4##3##(1993-6#1)(2008-5#1)(2012-2#2)
of the piperazine ring##2##4##(2008-5#1)(2013-7#1)
of the piperazine##3##3##(2006-12#1)(2008-5#1)(2013-7#1)
of the piperidine##2##3##(1995-3#2)
of the piston##2##3##(2008-10#1)(2008-2#1)
of the pitfalls##3##3##(1993-2#1)(2008-8#1)(2008-9#1)
of the pituitaries##2##3##(1990-3#1)(1995-11#1)
of the pituitary and##2##4##(1990-2#1)(1993-5#1)
of the pituitary gland##15##4##(1990-10#2)(1991-5#1)(1995-10#1)(1996-11#1)(1996-2#1)(2006-6#1)(2006-9#2)(2009-2#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
of the pituitary##30##3##(1990-10#2)(1990-2#2)(1990-7#1)(1991-5#1)(1993-5#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-5#1)(1996-11#1)(1996-2#1)(1997-3#1)(2006-6#1)(2006-9#2)(2008-5#1)(2008-7#1)(2009-2#1)(2011-2#2)(2012-1#2)(2012-3#1)(2013-1#1)
of the pituitary-adrenal axis##2##4##(1995-12#1)(2006-8#1)
of the pivot##2##3##(2008-2#1)(2008-3#1)
of the pivotal##2##3##(2008-7#2)
of the pixel##4##3##(2006-5#1)(2007-11#1)(2008-3#1)(2010-12#1)
of the pixelated##2##3##(2008-3#2)
of the place of##2##4##(1994-6#1)(2010-4#1)
of the placebo group##3##4##(1992-5#1)(2007-5#1)(2008-6#1)
of the placebo##7##3##(1990-10#1)(1992-5#1)(2005-8#1)(2007-5#1)(2008-5#1)(2008-6#1)(2013-8#1)
of the placement of##2##4##(2007-12#1)(2010-2#1)
of the placement##3##3##(2007-12#1)(2008-12#1)(2010-2#1)
of the placenta##13##3##(1992-10#1)(1992-4#1)(1992-8#1)(1994-6#2)(1995-12#1)(1996-7#1)(2008-9#1)(2009-9#2)(2012-12#1)(2013-1#1)(2013-7#1)
of the places##3##3##(2009-6#1)(2009-7#1)(2011-12#1)
of the plaintiffs##2##3##(1996-5#1)(1996-6#1)
of the plan##5##3##(1992-12#1)(2007-5#1)(2008-2#2)(2012-3#1)
of the planar##2##3##(2008-10#2)
of the planarian##3##3##(2008-5#3)
of the plane of the##2##5##(1996-2#1)(2008-3#1)
of the plane of##7##4##(1996-2#1)(2007-12#1)(2008-1#1)(2008-3#3)(2009-8#1)
of the plane##8##3##(1996-2#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-3#3)(2009-8#1)
of the planet##3##3##(1992-10#1)(2006-7#1)(2007-9#1)
of the planet's##2##3##(2007-9#1)(2010-4#1)
of the planetary##2##3##(1992-1#1)(2008-2#1)
of the planktonic##3##3##(2008-3#2)(2012-2#1)
of the planned surgical##2##4##(2006-6#1)(2012-3#1)
of the planned##6##3##(1996-7#1)(2006-6#1)(2007-7#1)(2010-7#1)(2011-2#1)(2012-3#1)
of the planning process##2##4##(1996-1#1)(2008-1#1)
of the planning##7##3##(1996-1#1)(2006-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-11#1)
of the plant against##2##4##(2008-4#1)(2009-8#1)
of the plant and##4##4##(2008-10#2)(2008-8#1)(2009-10#1)
of the plant body##2##4##(1991-11#1)(2012-1#1)
of the plant has##2##4##(2006-9#1)(2011-2#1)
of the plant in##2##4##(2010-5#1)(2012-2#1)
of the plant is##2##4##(2008-10#1)(2008-12#1)
of the plant material##2##4##(2004-2#1)(2008-11#1)
of the plant pathogen##2##4##(2008-10#1)(2011-1#1)
of the plant species##2##4##(2008-10#1)(2008-8#1)
of the plant was##3##4##(2005-11#1)(2008-4#1)(2013-7#1)
of the plant##81##3##(1990-5#1)(1991-11#1)(1991-7#1)(1992-1#1)(1994-3#2)(1994-8#1)(1996-2#1)(2004-2#1)(2005-11#2)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#22)(2008-11#1)(2008-12#3)(2008-2#1)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-6#3)(2009-8#6)(2010-10#1)(2010-4#1)(2010-5#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2013-7#1)
of the plant-pathogenic##3##3##(2008-10#3)
of the plantar fascia##2##4##(2006-10#1)(2011-12#1)
of the plants to##2##4##(2008-10#1)(2009-8#1)
of the plants with##2##4##(2007-1#1)(2008-10#1)
of the plants##19##3##(1995-2#1)(2007-1#2)(2008-10#11)(2008-12#1)(2008-8#1)(2009-8#2)(2012-2#1)
of the plaques##2##3##(2008-5#2)
of the plasma apolipoproteins##4##4##(1993-9#4)
of the plasma membrane Ca2+ pump##3##6##(1992-11#1)(1992-3#1)(1994-9#1)
of the plasma membrane Ca2+##4##5##(1992-11#1)(1992-3#1)(1994-9#2)
of the plasma membrane and##4##5##(1991-5#1)(2008-10#1)(2008-4#1)(2010-3#1)
of the plasma membrane by##2##5##(1992-9#1)(2009-8#1)
of the plasma membrane calcium pump##2##6##(1992-11#1)(1992-3#1)
of the plasma membrane in the##2##6##(1994-3#1)(2008-7#1)
of the plasma membrane in##4##5##(1990-11#1)(1992-12#1)(1994-3#1)(2008-7#1)
of the plasma membrane of##3##5##(1990-12#1)(2008-11#1)(2008-7#1)
of the plasma membrane potential##2##5##(2008-4#1)(2010-12#1)
of the plasma membrane##56##4##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#3)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#2)(1994-11#1)(1994-12#2)(1994-3#2)(1994-6#1)(1994-9#2)(1995-2#2)(1995-4#1)(1995-6#1)(1995-9#1)(1996-1#1)(1997-1#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-4#2)(2008-7#2)(2009-12#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-9#1)
of the plasma membranes##3##4##(1997-6#2)(2008-4#1)
of the plasma with##2##4##(1994-8#1)(1997-8#1)
of the plasma##90##3##(1990-11#4)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#3)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#2)(1993-9#5)(1994-11#1)(1994-12#2)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-2#2)(1995-4#1)(1995-6#1)(1995-9#1)(1996-1#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#3)(2008-10#4)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2009-12#1)(2009-8#3)(2009-9#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-9#1)(2011-12#1)
of the plasmalemma##7##3##(1991-11#1)(1997-4#2)(2007-12#1)(2008-10#2)(2008-7#1)
of the plasmid DNA##2##4##(1990-11#1)(1995-2#1)
of the plasmid in##2##4##(1991-7#1)(1995-8#1)
of the plasmid into the host##2##6##(2007-11#2)
of the plasmid##23##3##(1990-11#1)(1990-8#1)(1991-7#2)(1991-8#1)(1992-8#2)(1994-2#1)(1995-2#1)(1995-8#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#2)(2008-10#2)(2011-2#1)(2013-1#1)
of the plasmid-encoded##3##3##(1991-10#1)(1994-12#1)(1996-2#1)
of the plasmids##6##3##(1990-3#1)(1990-5#1)(1991-7#2)(1991-9#1)(1994-12#1)
of the plasminogen activator inhibitor-1##3##5##(1996-5#1)(2007-9#2)
of the plasminogen activator system##2##5##(1995-5#1)(2005-7#1)
of the plasminogen activator##5##4##(1995-5#1)(1996-5#1)(2005-7#1)(2007-9#2)
of the plasminogen##7##3##(1995-5#1)(1995-6#1)(1996-5#1)(2005-7#1)(2007-9#2)(2008-5#1)
of the plastic surgery##2##4##(1993-9#1)(2010-8#1)
of the plastic##9##3##(1991-3#1)(1993-9#1)(2007-12#1)(2008-11#1)(2008-3#2)(2010-8#1)(2011-2#1)(2012-2#1)
of the plasticizer admixtures##2##4##(2008-10#2)
of the plasticizer##4##3##(2008-10#4)
of the plasticizers##2##3##(2008-10#2)
of the plastid##4##3##(1995-10#1)(1997-6#1)(2011-2#1)(2013-1#1)
of the plate##11##3##(1993-8#1)(2006-12#1)(2006-3#2)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)
of the plateau##3##3##(1994-6#1)(2008-9#1)(2013-1#1)
of the platelet fibrinogen receptor##2##5##(1997-7#1)(2006-6#1)
of the platelet##12##3##(1991-9#1)(1992-11#1)(1992-6#3)(1994-12#1)(1995-2#1)(1996-7#1)(1997-7#1)(2006-6#1)(2006-9#1)(2008-5#1)
of the platelet-derived growth factor##4##5##(1990-3#1)(1996-5#1)(1996-8#1)(1997-7#1)
of the platform##5##3##(2008-10#2)(2008-7#1)(2009-9#1)(2011-1#1)
of the platinum group elements##3##5##(2008-10#2)(2008-11#1)
of the platinum##8##3##(1994-6#1)(2008-10#4)(2008-11#1)(2008-5#2)
of the play##3##3##(2008-2#1)(2008-9#1)(2010-2#1)
of the players##2##3##(1991-12#1)(2008-9#1)
of the pleura##16##3##(1990-12#1)(1991-12#1)(2007-5#2)(2007-8#4)(2008-6#2)(2010-3#1)(2010-8#1)(2011-1#2)(2012-2#2)
of the pleural air##2##4##(2007-7#1)(2008-7#1)
of the pleural cavity##2##4##(1995-6#1)(2007-8#1)
of the pleural effusion##2##4##(1990-10#1)(2013-8#1)
of the pleural space)##3##4##(2007-7#2)(2010-10#1)
of the pleural##12##3##(1990-10#1)(1995-6#1)(1996-12#1)(2007-7#3)(2007-8#1)(2008-7#1)(2010-10#1)(2012-12#1)(2012-2#1)(2013-8#1)
of the plot of##2##4##(2008-10#1)(2008-3#1)
of the plot##5##3##(2008-10#4)(2008-3#1)
of the plots##3##3##(2008-10#2)(2008-3#1)
of the plume##3##3##(2008-2#1)(2008-3#2)
of the pneumonia##2##3##(2008-5#1)(2013-1#1)
of the point of##2##4##(2007-7#1)(2013-7#1)
of the point##16##3##(1990-12#1)(2006-4#4)(2007-7#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#4)(2010-12#1)(2013-7#1)
of the pointing system##3##4##(2008-2#1)(2008-3#2)
of the pointing##6##3##(1992-10#2)(2008-2#1)(2008-3#3)
of the points##6##3##(1997-8#1)(2007-11#2)(2008-3#1)(2008-6#1)(2009-2#1)
of the pol##6##3##(1990-9#1)(1993-3#1)(1994-8#1)(1995-2#1)(1997-8#1)(2006-12#1)
of the polA gene##2##4##(1990-5#1)(1996-10#1)
of the polar head##2##4##(1990-5#1)(2005-11#1)
of the polar headgroup of##3##5##(1990-11#1)(1994-8#1)(2008-10#1)
of the polar headgroup##4##4##(1990-11#1)(1991-7#1)(1994-8#1)(2008-10#1)
of the polar lipids##2##4##(1996-11#1)(2011-2#1)
of the polar##18##3##(1990-11#1)(1990-5#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-6#2)(1994-8#1)(1996-11#1)(2005-11#2)(2005-12#1)(2007-11#1)(2008-10#2)(2008-3#1)(2011-2#1)(2012-12#1)
of the polarimeter##2##3##(2007-12#1)(2008-2#1)
of the polarizability##2##3##(1994-7#1)(1997-6#1)
of the polarization ellipse##4##4##(2007-12#3)(2008-2#1)
of the polarization mode##2##4##(2007-11#1)(2007-12#1)
of the polarization of the##5##5##(1995-6#1)(2005-11#1)(2007-11#1)(2008-2#1)(2008-3#1)
of the polarization of##7##4##(1990-3#1)(1995-6#1)(2005-11#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-9#1)
of the polarization state of a##3##6##(2007-11#2)(2008-3#1)
of the polarization state of light##2##6##(2007-12#1)(2008-3#1)
of the polarization state of the##2##6##(2008-3#2)
of the polarization state of##9##5##(2007-11#3)(2007-12#2)(2008-3#4)
of the polarization state##12##4##(2007-11#3)(2007-12#4)(2008-2#1)(2008-3#4)
of the polarization states of##2##5##(2007-12#1)(2013-7#1)
of the polarization states##3##4##(2007-12#2)(2013-7#1)
of the polarization##51##3##(1990-3#1)(1995-6#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#6)(2007-12#16)(2007-8#1)(2008-1#1)(2008-2#8)(2008-3#12)(2008-9#1)(2013-7#1)
of the polarization-mode dispersion##2##4##(2007-12#2)
of the polarization-mode##3##3##(2007-12#3)
of the polarized##3##3##(2006-10#1)(2008-2#1)(2010-8#1)
of the polarizer##6##3##(2007-12#1)(2008-2#1)(2008-3#4)
of the polarizing##3##3##(2008-2#1)(2008-3#2)
of the polarographic##2##3##(2008-10#2)
of the pole##3##3##(2011-2#3)
of the police##2##3##(1997-8#1)(2005-9#1)
of the policies##2##3##(1993-3#1)(2010-6#1)
of the policy##4##3##(1996-12#1)(1997-4#1)(2008-6#1)(2011-2#1)
of the polio##3##3##(2007-10#1)(2008-4#1)(2012-12#1)
of the political##6##3##(1995-2#1)(1996-12#1)(2006-2#1)(2008-2#1)(2009-4#1)(2011-2#1)
of the pollen tube##3##4##(2008-11#1)(2009-8#2)
of the pollen##7##3##(2007-3#1)(2008-10#1)(2008-11#1)(2009-8#2)(2012-7#2)
of the pollutants##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
of the polluted##2##3##(2006-10#1)(2006-12#1)
of the poly(A)##2##3##(1994-11#1)(1997-2#1)
of the poly(ADP-ribose)##2##3##(1992-6#1)(1993-12#1)
of the poly(P)- and ATP-dependent##2##5##(1996-7#2)
of the poly(SMA) hydrogel was##2##5##(2008-5#2)
of the poly(sodium 4-styrenesulfonate) coatings##2##5##(2008-10#2)
of the poly(sodium##3##3##(2008-10#3)
of the polyadenylation##2##3##(1994-11#1)(2010-4#1)
of the polyalcohol##2##3##(1991-12#2)
of the polyamine site of##2##5##(1996-2#2)
of the polyamine site##3##4##(1990-2#1)(1996-2#2)
of the polyamine##5##3##(1990-2#1)(1990-7#1)(1991-4#1)(1996-2#2)
of the polyamines##2##3##(1991-8#1)(1996-10#1)
of the polyanion##2##3##(1996-4#1)(1997-1#1)
of the polyanions##3##3##(1997-1#2)(2008-10#1)
of the polycrystalline##2##3##(1996-2#1)(2008-2#1)
of the polycystic ovary syndrome##4##5##(2008-3#1)(2008-4#3)
of the polyethylene glycol##2##4##(2008-3#1)(2011-2#1)
of the polyethylene##4##3##(2008-3#1)(2008-8#2)(2011-2#1)
of the polygenic inheritance of##2##5##(2008-10#2)
of the polymer and the##2##5##(1995-6#1)(2005-11#1)
of the polymer and##5##4##(1995-11#1)(1995-6#1)(2005-11#2)(2008-10#1)
of the polymer backbone##2##4##(2005-11#1)(2007-12#1)
of the polymer brushes##4##4##(2005-11#3)(2009-10#1)
of the polymer can##2##4##(1995-6#1)(2004-9#1)
of the polymer concentration##2##4##(2009-10#1)(2010-4#1)
of the polymer film##2##4##(2006-12#1)(2008-10#1)
of the polymer layer##2##4##(2005-11#1)(2010-5#1)
of the polymer matrix##3##4##(2008-3#1)(2008-7#1)(2010-4#1)
of the polymer on the##2##5##(1994-9#1)(2008-10#1)
of the polymer to##2##4##(2006-12#1)(2011-2#1)
of the polymer was##2##4##(2007-11#1)(2009-3#1)
of the polymer with##2##4##(2009-3#1)(2010-1#1)
of the polymer##74##3##(1991-7#2)(1994-2#1)(1994-9#4)(1995-11#1)(1995-2#1)(1995-6#2)(1996-2#1)(1996-6#1)(2004-9#2)(2005-11#14)(2005-7#1)(2006-10#2)(2006-12#2)(2006-2#1)(2007-11#1)(2007-12#3)(2008-10#9)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-10#3)(2009-3#2)(2009-5#1)(2010-1#1)(2010-4#8)(2010-5#3)(2011-2#1)(2013-1#1)
of the polymer-lipid##2##3##(2006-10#2)
of the polymerase chain reaction (PCR)##6##6##(1990-3#1)(1993-5#1)(1994-12#1)(2008-10#1)(2008-4#2)
of the polymerase chain reaction in##2##6##(1993-12#1)(1995-9#1)
of the polymerase chain reaction##15##5##(1990-3#2)(1990-7#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-5#1)(1994-12#1)(1995-9#1)(1996-10#1)(2006-10#1)(2008-10#1)(2008-4#2)(2013-8#1)
of the polymerase chain##16##4##(1990-3#2)(1990-7#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-5#1)(1994-12#1)(1995-9#1)(1996-10#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-4#2)(2013-8#1)
of the polymerase##23##3##(1990-3#2)(1990-7#1)(1992-12#1)(1992-6#1)(1993-12#2)(1993-5#1)(1994-12#2)(1994-9#1)(1995-9#1)(1996-10#1)(1997-3#1)(1997-4#1)(1997-5#1)(2006-10#1)(2008-10#1)(2008-4#2)(2011-1#1)(2012-12#1)(2013-8#1)
of the polymeric matrix##2##4##(2008-10#2)
of the polymeric##17##3##(1990-8#1)(1991-3#1)(1991-7#1)(1996-8#2)(1997-6#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#5)(2008-5#1)(2011-1#1)
of the polymerization##3##3##(1992-9#1)(2007-11#1)(2008-10#1)
of the polymers##14##3##(1990-8#1)(1994-11#1)(1994-9#1)(1996-11#1)(2008-10#2)(2008-3#1)(2010-12#1)(2010-4#2)(2010-5#2)(2013-1#2)
of the polymorphic##10##3##(1994-9#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-4#3)(2010-12#1)(2012-12#2)
of the polymorphism of##2##4##(2008-10#1)(2012-12#1)
of the polymorphisms##4##3##(2006-10#1)(2008-7#1)(2010-2#1)(2012-2#1)
of the polynomial##3##3##(2008-10#1)(2008-3#1)(2008-6#1)
of the polynucleotides##2##3##(1995-5#1)(2006-10#1)
of the polypeptide chain and##2##5##(1997-6#2)
of the polypeptide chain##10##4##(1991-4#3)(1992-8#1)(1992-9#1)(1994-12#1)(1994-2#1)(1997-6#2)(2008-8#1)
of the polypeptide to##2##4##(1990-5#1)(1993-8#1)
of the polypeptide##21##3##(1990-4#1)(1990-5#1)(1991-1#2)(1991-4#3)(1992-6#1)(1992-8#1)(1992-9#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1997-6#2)(2006-10#1)(2008-8#1)(2010-7#1)
of the polyps##3##3##(2008-11#1)(2008-5#1)(2010-12#1)
of the polypyrrole##2##3##(2008-10#2)
of the polysaccharide##5##3##(1990-3#1)(1991-12#1)(1991-7#2)(1993-6#1)
of the polyunsaturated fatty acid##2##5##(1995-11#1)(1996-10#1)
of the polyunsaturated fatty##3##4##(1995-11#1)(1996-10#1)(2008-7#1)
of the polyunsaturated##4##3##(1991-4#1)(1995-11#1)(1996-10#1)(2008-7#1)
of the polyurethane##4##3##(2007-7#1)(2008-10#1)(2009-7#1)(2013-8#1)
of the pooled##3##3##(2008-12#1)(2008-4#2)
of the pools##2##3##(1995-6#1)(1997-8#1)
of the poor##15##3##(1996-1#2)(1996-2#1)(1996-3#1)(1997-6#1)(2004-1#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-5#1)
of the poorest##4##3##(2008-7#1)(2012-12#1)(2012-2#1)(2012-3#1)
of the poplar##2##3##(2006-11#1)(2008-10#1)
of the popliteal artery##5##4##(1990-10#3)(1991-3#1)(2007-8#1)
of the popliteal##9##3##(1990-10#4)(1991-3#2)(2007-8#1)(2008-10#1)(2010-12#1)
of the populace##3##3##(2007-2#3)
of the popular##8##3##(1992-8#1)(1995-3#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-11#1)(2009-7#1)(2013-8#1)
of the population and are##2##5##(2008-1#1)(2010-12#1)
of the population and the##2##5##(2007-11#1)(2013-1#1)
of the population and were identified by##2##7##(1993-2#2)
of the population and##16##4##(1990-7#1)(1992-1#1)(1992-5#1)(1993-2#2)(1996-3#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-1#2)(2008-3#1)(2010-12#1)(2011-12#1)(2012-11#1)(2013-1#1)
of the population as a whole##3##6##(1992-4#1)(1993-11#1)(2012-12#1)
of the population as##4##4##(1992-4#1)(1993-11#1)(2006-10#1)(2012-12#1)
of the population at##2##4##(1993-11#1)(1997-6#1)
of the population being##2##4##(2008-7#1)(2008-9#1)
of the population by##6##4##(1991-3#1)(2008-1#1)(2008-11#1)(2010-8#1)(2012-2#1)(2013-8#1)
of the population densities##2##4##(2008-10#2)
of the population density##2##4##(2008-10#2)
of the population dynamics of##2##5##(2008-10#1)(2008-9#1)
of the population has##6##4##(1992-3#1)(1997-5#1)(1997-8#1)(2006-10#2)(2008-7#1)
of the population in the##6##5##(1993-8#1)(2008-10#1)(2008-5#1)(2008-6#2)(2012-12#1)
of the population in##9##4##(1993-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2012-12#1)
of the population inversion##2##4##(2007-12#1)(2008-2#1)
of the population is at risk##2##6##(2006-2#1)(2012-12#1)
of the population is##9##4##(1994-6#1)(1994-9#1)(2006-2#1)(2008-2#1)(2010-1#1)(2010-7#1)(2011-1#1)(2012-12#2)
of the population of a##2##5##(1995-9#1)(2007-2#1)
of the population of the##3##5##(1997-5#1)(2008-3#1)(2012-3#1)
of the population of##14##4##(1992-5#1)(1994-1#1)(1995-9#1)(1997-5#1)(2004-4#1)(2007-2#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-3#1)
of the population presented##2##4##(2013-8#2)
of the population spike in##2##5##(1991-12#2)
of the population spike##5##4##(1990-7#1)(1991-12#3)(1995-12#1)
of the population studied##2##4##(2007-10#1)(2009-5#1)
of the population that##5##4##(1995-12#1)(1995-2#1)(2008-10#1)(2008-4#1)(2009-4#1)
of the population to##4##4##(1997-2#1)(2006-2#1)(2008-9#1)(2011-2#1)
of the population was##4##4##(2007-12#1)(2008-10#1)(2008-5#1)(2011-1#1)
of the population were##3##4##(2012-12#3)
of the population who##2##4##(1996-8#1)(2008-7#1)
of the population with##2##4##(1990-9#1)(2010-12#1)
of the population##252##3##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-9#2)(1991-12#3)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#2)(1994-4#1)(1994-6#2)(1994-9#1)(1995-12#3)(1995-2#2)(1995-4#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-8#2)(1997-1#4)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#2)(2004-3#1)(2004-4#1)(2005-10#1)(2005-7#1)(2006-10#5)(2006-11#1)(2006-2#2)(2006-4#2)(2006-8#3)(2006-9#1)(2007-10#3)(2007-11#3)(2007-12#2)(2007-2#4)(2007-3#1)(2007-5#1)(2007-7#2)(2007-9#1)(2008-1#5)(2008-10#25)(2008-11#4)(2008-12#1)(2008-2#7)(2008-3#6)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#12)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#8)(2012-1#1)(2012-11#1)(2012-12#13)(2012-2#4)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#14)
of the population)##4##3##(2006-10#1)(2006-7#2)(2008-10#1)
of the population-based studies##2##4##(2007-12#1)(2008-6#1)
of the populations in##2##4##(2008-10#2)
of the populations of##5##4##(1993-6#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-8#1)
of the populations were##2##4##(2008-10#1)(2008-5#1)
of the populations##30##3##(1992-2#1)(1993-6#1)(1994-7#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-2#1)(2004-4#1)(2006-4#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2012-1#1)
of the porcine and##2##4##(1992-11#1)(2007-1#1)
of the porcine##12##3##(1991-6#1)(1992-11#1)(1992-8#1)(1996-12#1)(1997-8#1)(2004-11#2)(2006-11#1)(2007-1#1)(2008-5#1)(2012-2#2)
of the pore is##2##4##(1995-8#1)(2006-10#1)
of the pore size distribution##2##5##(2005-11#2)
of the pore##13##3##(1995-8#1)(1997-4#1)(1997-6#1)(2005-11#3)(2006-10#1)(2008-4#1)(2008-8#2)(2009-2#1)(2009-3#1)(2011-2#1)
of the pores##5##3##(2004-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-4#1)
of the pork##2##3##(2008-7#1)(2010-4#1)
of the porous##12##3##(1990-8#1)(1991-8#1)(2005-11#2)(2008-3#2)(2008-5#3)(2010-8#1)(2012-12#2)
of the porphyrin ring##2##4##(1996-2#2)
of the porphyrin rings##2##4##(2010-7#2)
of the porphyrin##14##3##(1991-5#1)(1992-8#1)(1996-2#3)(1997-6#1)(2008-10#4)(2010-6#2)(2010-7#2)
of the porphyrins in##2##4##(1992-9#1)(2006-12#1)
of the porphyrins##4##3##(1992-9#2)(2006-12#1)(2008-10#1)
of the port##2##3##(2007-7#1)(2007-8#1)
of the portable##2##3##(2006-6#1)(2013-8#1)
of the portal blood##2##4##(1993-3#1)(1997-7#1)
of the portal vein##6##4##(1995-2#1)(2005-12#2)(2009-11#1)(2009-9#1)(2012-2#1)
of the portal##9##3##(1993-3#1)(1995-2#1)(1997-7#1)(2005-12#2)(2007-5#1)(2009-11#1)(2009-9#1)(2012-2#1)
of the portions of##2##4##(1993-3#1)(2009-6#1)
of the position of the##6##5##(1993-6#1)(1996-6#1)(2005-7#1)(2007-12#1)(2008-2#2)
of the position of##9##4##(1991-6#1)(1993-6#1)(1994-8#1)(1996-6#1)(2005-7#1)(2007-12#1)(2008-2#2)(2013-7#1)
of the position##15##3##(1991-6#1)(1993-10#1)(1993-6#1)(1994-8#1)(1996-6#1)(2005-6#1)(2005-7#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-2#3)(2012-1#1)(2013-7#1)
of the positioning of the##2##5##(2008-9#2)
of the positions in##2##4##(1997-2#2)
of the positions##4##3##(1994-8#1)(1997-2#2)(2008-3#1)
of the positive cases##2##4##(2007-7#1)(2008-10#1)
of the positive charge of##2##5##(1994-10#1)(1994-3#1)
of the positive results##2##4##(2011-1#1)(2011-2#1)
of the positive##27##3##(1990-3#1)(1992-2#1)(1992-5#1)(1993-8#1)(1994-10#1)(1994-3#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-7#1)(2005-11#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#2)(2009-12#1)(2009-4#1)(2011-1#1)(2011-2#1)(2011-3#1)
of the positively charged##6##4##(1990-1#1)(1990-5#1)(1994-3#1)(1997-3#1)(1997-8#1)(2008-10#1)
of the possibilities of##4##4##(1993-5#1)(2007-7#1)(2011-1#1)(2012-1#1)
of the possibilities##6##3##(1990-12#1)(1993-5#1)(2007-7#1)(2011-1#1)(2012-1#1)(2012-2#1)
of the possibility of##10##4##(1996-3#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-12#1)(2008-7#1)(2009-2#1)(2010-9#1)(2011-2#1)(2013-1#1)
of the possibility##16##3##(1996-3#1)(2007-12#1)(2007-3#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-9#1)(2011-2#2)(2013-1#2)
of the possible association##2##4##(2011-2#2)
of the possible complications##3##4##(1994-3#1)(2010-10#1)(2012-12#1)
of the possible mechanisms of##2##5##(1996-1#1)(2006-2#1)
of the possible mechanisms##3##4##(1996-1#1)(2006-2#1)(2008-9#1)
of the possible role of##4##5##(1992-2#1)(1995-9#2)(2011-3#1)
of the possible##59##3##(1990-2#1)(1990-9#1)(1991-11#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-7#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-3#1)(1995-11#1)(1995-5#1)(1995-9#2)(1996-1#1)(1996-3#1)(1996-7#2)(1996-9#3)(1997-7#1)(2004-9#1)(2005-11#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
of the post##2##3##(1996-8#1)(2007-8#1)
of the post-lead-time survival##2##4##(1995-12#2)
of the post-operative##2##3##(1990-9#1)(2008-5#1)
of the post-reproductive period##2##4##(1997-4#2)
of the post-spike##2##3##(1990-12#1)(1992-8#1)
of the post-translational modifications of##2##5##(1997-6#1)(2008-12#1)
of the post-translational##4##3##(1997-6#1)(2008-12#2)(2008-9#1)
of the posterior and##3##4##(2011-7#1)(2013-7#2)
of the posterior canal wall##2##5##(2008-9#2)
of the posterior capsule##2##4##(2009-8#1)(2011-2#1)
of the posterior cerebral artery (PCA)##2##6##(2007-9#2)
of the posterior circulation##2##4##(2006-12#1)(2008-7#1)
of the posterior cruciate ligament##2##5##(2007-1#1)(2007-7#1)
of the posterior distribution##2##4##(1995-6#1)(1996-8#1)
of the posterior fossa##6##4##(2006-5#4)(2006-9#1)(2008-7#1)
of the posterior lobe##2##4##(1997-8#1)(2012-3#1)
of the posterior longitudinal ligament##2##5##(2007-8#1)(2008-12#1)
of the posterior maxilla##2##4##(2007-12#2)
of the posterior part of the##2##6##(2007-12#1)(2008-2#1)
of the posterior pituitary##3##4##(1997-8#1)(2007-10#1)(2008-4#1)
of the posterior portion of##2##5##(1997-3#1)(2008-4#1)
of the posterior tibial tendon##2##5##(1990-9#2)
of the posterior tibial##3##4##(1990-9#2)(1991-4#1)
of the posterior##83##3##(1990-9#2)(1991-11#1)(1991-2#1)(1991-4#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-7#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-8#3)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#5)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#4)(2010-12#1)(2011-1#1)(2011-2#3)(2011-7#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#3)(2013-8#1)
of the posterolateral corner##2##4##(2011-2#1)(2012-2#1)
of the posterolateral##5##3##(2009-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
of the posterosuperior labrum##2##4##(2007-10#2)
of the posterosuperior##3##3##(2007-10#2)(2007-9#1)
of the postings##2##3##(2008-2#2)
of the postmortem##2##3##(1996-6#1)(2011-1#1)
of the postnatal development of##2##5##(1993-12#1)(2011-2#1)
of the postnatal##5##3##(1993-12#1)(1997-5#1)(2009-4#1)(2009-8#1)(2011-2#1)
of the postoperative period##2##4##(1991-5#1)(2009-2#1)
of the postoperative##5##3##(1991-5#1)(2004-12#1)(2008-6#1)(2009-2#1)(2011-2#1)
of the postprandial##2##3##(1996-9#1)(2007-5#1)
of the postsynaptic density (PSD)##2##5##(2008-11#1)(2008-4#1)
of the postsynaptic density##3##4##(2008-11#1)(2008-4#1)(2012-3#1)
of the postsynaptic neuron##2##4##(1997-7#1)(2009-8#1)
of the postsynaptic##11##3##(1990-11#1)(1993-11#1)(1994-10#1)(1996-12#1)(1997-2#2)(1997-7#1)(2008-11#1)(2008-4#1)(2009-8#1)(2012-3#1)
of the postulated##4##3##(1990-7#1)(1995-5#1)(2008-11#1)(2008-5#1)
of the potassium channel##2##4##(1997-7#1)(2007-12#1)
of the potassium##10##3##(1991-10#1)(1991-3#1)(1993-11#1)(1995-8#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-5#1)
of the potato carboxypeptidase A protein inhibitor##2##7##(1991-4#2)
of the potato carboxypeptidase A##3##5##(1991-4#3)
of the potato##14##3##(1991-4#3)(1994-12#1)(2006-12#1)(2008-10#9)
of the potent##17##3##(1991-3#1)(1991-5#1)(1992-10#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-9#2)(1995-6#1)(1996-11#1)(1996-6#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-12#1)(2009-10#1)(2010-4#1)
of the potential advantages##2##4##(2008-7#1)(2010-2#1)
of the potential benefits##2##4##(1994-3#1)(2008-11#1)
of the potential buffer##2##4##(2008-10#2)
of the potential clinical##2##4##(2006-10#1)(2011-1#1)
of the potential for##15##4##(1991-4#1)(1996-12#1)(2005-7#3)(2006-10#1)(2006-12#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2011-2#1)(2013-7#1)
of the potential genes##2##4##(1997-6#1)(1997-8#1)
of the potential hazards##2##4##(2005-8#1)(2008-11#1)
of the potential impact of the##2##6##(2007-12#1)(2012-12#1)
of the potential impact of##4##5##(1994-6#1)(2007-12#1)(2008-8#1)(2012-12#1)
of the potential mechanisms##2##4##(2011-12#1)(2013-8#1)
of the potential of##7##4##(1996-3#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-3#1)(2010-5#1)
of the potential risks of##2##5##(2008-9#1)(2013-1#1)
of the potential risks##3##4##(2007-12#1)(2008-9#1)(2013-1#1)
of the potential therapeutic##2##4##(1996-1#1)(2005-8#1)
of the potential use of##3##5##(2005-7#2)(2008-5#1)
of the potential##109##3##(1991-4#2)(1991-7#1)(1992-1#1)(1993-7#1)(1994-11#1)(1994-3#2)(1994-6#2)(1994-8#1)(1995-1#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-3#4)(1996-5#1)(1997-1#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-7#6)(2005-8#2)(2006-10#10)(2006-12#2)(2006-3#1)(2006-5#1)(2007-12#3)(2007-2#1)(2007-4#2)(2007-9#1)(2008-10#16)(2008-11#3)(2008-3#1)(2008-5#4)(2008-7#3)(2008-8#5)(2008-9#4)(2009-4#2)(2009-5#1)(2009-7#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
of the potentially##6##3##(1993-10#1)(2007-12#1)(2008-10#1)(2008-4#1)(2012-12#1)(2013-1#1)
of the potentials##2##3##(2010-2#1)(2013-1#1)
of the potentiometric titration##2##4##(2008-10#2)
of the potentiometric##4##3##(2008-10#3)(2008-5#1)
of the powder pharmaceutical samples of sulfaguanidine##2##7##(2008-10#2)
of the powder##9##3##(2005-11#1)(2006-4#1)(2008-10#3)(2008-5#2)(2010-5#1)(2011-2#1)
of the powdered##2##3##(2005-11#1)(2009-8#1)
of the powders##2##3##(2004-9#2)
of the power noise##2##4##(2007-12#2)
of the power of##2##4##(2007-12#1)(2009-5#1)
of the power spectra##2##4##(2008-3#2)
of the power spectral##2##4##(2008-3#1)(2010-8#1)
of the power spectrum of the##2##6##(2008-2#1)(2008-3#1)
of the power spectrum##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
of the power##21##3##(1996-11#1)(2007-12#5)(2008-10#1)(2008-2#4)(2008-3#7)(2009-5#1)(2010-11#1)(2010-8#1)
of the powered orthosis##2##4##(2012-1#2)
of the powered##3##3##(2006-2#1)(2012-1#2)
of the practical aspects##2##4##(1993-12#1)(2012-2#1)
of the practical##9##3##(1992-3#1)(1993-12#1)(1995-3#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-2#2)(2013-1#1)
of the practically##2##3##(1995-2#1)(2010-12#1)
of the practice of##9##4##(2004-12#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-8#1)(2006-9#1)(2008-2#1)(2012-11#1)
of the practice##22##3##(1994-12#1)(1994-3#1)(1995-1#1)(1995-5#1)(2004-12#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-8#2)(2006-9#1)(2007-4#1)(2008-10#1)(2008-11#3)(2008-2#1)(2010-1#1)(2012-11#1)(2012-2#1)(2013-1#1)
of the practices##3##3##(1993-3#2)(2009-2#1)
of the practitioner##2##3##(1990-10#1)(1997-7#1)
of the practitioners##3##3##(2008-1#2)(2008-9#1)
of the prawns##2##3##(2008-8#1)(2011-12#1)
of the pre##2##3##(2011-1#1)(2011-3#1)
of the pre- and##3##4##(1991-1#1)(2008-2#1)(2010-8#1)
of the pre-clinical##2##3##(2009-7#1)(2013-1#1)
of the pre-existing##3##3##(1992-4#1)(2008-7#1)(2009-12#1)
of the pre-treatment##2##3##(1995-5#1)(2008-10#1)
of the preS2 region of the hepatitis B virus##2##9##(1997-6#2)
of the preS2 region##3##4##(1993-8#1)(1997-6#2)
of the precautionary##2##3##(2012-3#1)(2013-8#1)
of the precautions##2##3##(1994-7#1)(1995-7#1)
of the preceding##8##3##(1993-5#1)(1994-9#1)(1996-5#2)(1996-6#1)(2007-3#1)(2008-10#1)(2012-1#1)
of the precious##2##3##(2007-8#1)(2008-10#1)
of the precipitate##7##3##(1990-10#1)(2008-10#4)(2008-5#1)(2013-8#1)
of the precipitated##4##3##(2005-11#1)(2008-7#1)(2013-1#2)
of the precipitates##3##3##(2007-11#1)(2008-10#1)(2008-5#1)
of the precipitation in the same##2##6##(2013-8#2)
of the precise##6##3##(1994-10#1)(1997-3#1)(2006-12#1)(2008-10#1)(2012-2#1)(2012-3#1)
of the precision of the##2##5##(2008-10#1)(2008-3#1)
of the precision of##3##4##(2008-10#1)(2008-3#1)(2010-9#1)
of the precision##4##3##(2008-10#2)(2008-3#1)(2010-9#1)
of the preclinical##3##3##(2007-11#1)(2008-1#1)(2012-1#1)
of the precursor and##2##4##(1990-12#1)(2008-6#1)
of the precursor of the##2##5##(1992-3#1)(1997-1#1)
of the precursor of##10##4##(1990-8#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-11#1)(1994-6#1)(1997-1#1)
of the precursor protein##3##4##(1991-5#1)(1995-2#1)(1996-2#1)
of the precursor to##2##4##(1990-9#1)(1997-1#1)
of the precursor##32##3##(1990-12#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-7#2)(1992-12#1)(1992-3#1)(1992-6#2)(1993-3#2)(1994-11#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-1#2)(2008-6#1)(2009-10#1)(2010-4#1)(2013-1#1)(2013-7#1)
of the predator##6##3##(2007-3#1)(2007-9#1)(2008-8#2)(2008-9#1)(2010-8#1)
of the predicted amino acid sequence##3##6##(1991-2#1)(1995-8#1)(2008-10#1)
of the predicted amino acid##4##5##(1991-2#1)(1993-5#1)(1995-8#1)(2008-10#1)
of the predicted and the measured##2##6##(2007-12#1)(2008-3#1)
of the predicted polypeptide##2##4##(1990-5#1)(1995-6#1)
of the predicted protein products##2##5##(1993-12#1)(1997-4#1)
of the predicted protein##4##4##(1993-12#1)(1993-6#1)(1997-4#1)(1997-6#1)
of the predicted##44##3##(1990-1#1)(1990-5#2)(1991-2#1)(1991-4#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-8#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-12#2)(2008-10#5)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#1)(2011-3#1)(2013-1#1)(2013-8#2)
of the prediction##8##3##(1995-6#1)(2007-9#1)(2008-11#2)(2008-2#1)(2010-4#1)(2012-2#2)
of the predictions of##3##4##(1992-3#1)(2007-9#1)(2008-10#1)
of the predictions##8##3##(1992-3#1)(1996-1#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-8#1)
of the predictive validity of##2##5##(2008-4#1)(2008-8#1)
of the predictive##6##3##(1995-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2013-1#2)
of the predictor##3##3##(1993-6#1)(2008-6#1)(2010-12#1)
of the predictors of##4##4##(2008-11#1)(2009-11#1)(2010-12#1)(2011-2#1)
of the predictors##9##3##(1990-12#1)(1994-6#1)(1995-12#1)(2007-3#1)(2008-11#2)(2009-11#1)(2010-12#1)(2011-2#1)
of the predominant##8##3##(2004-2#1)(2006-8#1)(2008-10#2)(2008-12#1)(2010-2#1)(2013-1#1)(2013-8#1)
of the preference of##2##4##(1996-5#1)(2008-4#1)
of the preferential##5##3##(1993-12#1)(1993-7#1)(1996-12#1)(1997-2#1)(2008-10#1)
of the prefrontal cortex in##3##5##(1993-5#1)(1995-11#1)(1996-10#1)
of the prefrontal cortex##9##4##(1993-5#1)(1995-11#2)(1996-10#2)(2008-11#1)(2010-12#1)(2011-2#1)(2012-1#1)
of the prefrontal##10##3##(1993-5#1)(1994-8#1)(1995-11#2)(1996-10#2)(2008-11#1)(2010-12#1)(2011-2#1)(2012-1#1)
of the pregnancies##5##3##(1992-12#1)(1992-6#1)(1995-6#1)(2008-11#1)(2008-8#1)
of the pregnancy##5##3##(1990-6#1)(1996-9#1)(2005-10#1)(2007-11#1)(2007-3#1)
of the pregnant woman##2##4##(2009-10#1)(2009-5#1)
of the pregnant women##4##4##(1990-2#1)(1997-3#1)(1997-4#1)(2011-1#1)
of the pregnant##17##3##(1990-2#1)(1997-3#1)(1997-4#1)(2005-7#1)(2006-10#1)(2007-2#2)(2007-4#1)(2007-8#1)(2008-7#1)(2008-8#4)(2009-10#1)(2009-5#1)(2011-1#1)
of the prekallikrein heavy chain##2##5##(1996-5#2)
of the preliminary##6##3##(1991-2#1)(2006-4#1)(2006-6#1)(2008-7#1)(2012-1#1)(2013-1#1)
of the premature##7##3##(2007-10#2)(2007-7#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
of the premium##2##3##(1997-2#1)(2010-2#1)
of the prenatal##3##3##(1996-10#1)(2007-11#1)(2008-4#1)
of the preoperative##13##3##(1990-4#1)(1994-2#1)(1997-8#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-8#1)(2008-5#1)(2008-8#1)(2010-7#1)(2010-9#3)
of the preoptic area and##2##5##(1990-4#1)(1997-5#1)
of the preoptic area##3##4##(1990-4#1)(1997-5#1)(2008-9#1)
of the preoptic##5##3##(1990-4#2)(1995-5#1)(1997-5#1)(2008-9#1)
of the prepairing mechanism##2##4##(2008-10#2)
of the preparation of the##2##5##(2007-8#1)(2008-10#1)
of the preparation of##5##4##(2007-8#1)(2008-10#2)(2008-4#1)(2010-4#1)
of the preparation procedure##2##4##(1990-2#1)(2008-10#1)
of the preparation was##2##4##(1990-2#1)(1991-11#1)
of the preparation##17##3##(1990-11#1)(1990-2#2)(1991-11#1)(1992-5#1)(1993-3#1)(1996-1#1)(1996-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-4#1)(2009-4#1)(2010-4#1)
of the preparations of##2##4##(1996-7#1)(2011-2#1)
of the preparations##10##3##(1991-11#1)(1996-5#1)(1996-7#1)(2004-12#1)(2008-10#1)(2008-5#3)(2009-4#1)(2011-2#1)
of the prepared##9##3##(2005-12#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#2)(2013-8#1)
of the preproacrosin##2##3##(1990-5#2)
of the preprohormone##2##3##(2008-4#2)
of the preprotein##3##3##(1995-6#1)(1996-5#1)(1997-7#1)
of the prepuce##2##3##(2006-7#1)(2009-5#1)
of the preregistration##2##3##(1995-6#2)
of the preschool##3##3##(2006-4#1)(2010-7#1)(2011-12#1)
of the preschoolers##2##3##(2006-4#1)(2013-7#1)
of the prescribed dose##3##4##(2008-3#1)(2009-11#1)(2010-9#1)
of the prescribed##4##3##(2008-3#2)(2009-11#1)(2010-9#1)
of the prescription##2##3##(1995-11#1)(2008-11#1)
of the prescriptions contained##2##4##(2010-12#2)
of the prescriptions##7##3##(1990-4#1)(2007-2#2)(2010-12#3)(2012-12#1)
of the presence and##3##4##(2008-10#2)(2010-8#1)
of the presence of a##10##5##(1991-2#1)(1991-4#1)(1993-9#1)(1994-11#1)(2005-11#1)(2007-12#3)(2007-7#2)
of the presence of an##6##5##(1991-11#1)(1991-4#1)(1992-6#1)(1993-8#1)(1995-12#1)(2006-10#1)
of the presence of large##2##5##(2006-10#1)(2008-2#1)
of the presence of the##11##5##(1995-8#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2010-3#1)
of the presence of two##2##5##(1997-2#1)(2013-8#1)
of the presence of##100##4##(1990-3#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#2)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#5)(2006-8#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#4)(2007-8#1)(2008-10#17)(2008-11#3)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#5)(2008-7#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
of the presence or absence of the##2##7##(1995-9#1)(2010-9#1)
of the presence or absence of##13##6##(1990-5#1)(1992-9#1)(1993-12#1)(1993-3#1)(1995-9#1)(1996-11#1)(1996-8#1)(2007-10#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-9#1)
of the presence##118##3##(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#2)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-8#2)(1993-9#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-8#2)(1997-2#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#5)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#4)(2007-8#1)(2008-10#22)(2008-11#3)(2008-2#5)(2008-3#3)(2008-4#2)(2008-5#5)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
of the presenilin##2##3##(1996-2#2)
of the present article is to##2##6##(2008-11#1)(2012-2#1)
of the present article##3##4##(2007-12#1)(2008-11#1)(2012-2#1)
of the present case##3##4##(1997-7#1)(2007-7#1)(2008-7#1)
of the present cell##2##4##(2006-5#2)
of the present data##3##4##(1990-2#1)(1991-6#1)(2007-7#1)
of the present experiment was to##2##6##(1992-7#1)(2008-8#1)
of the present experiment##4##4##(1992-7#1)(1995-5#1)(2008-12#1)(2008-8#1)
of the present experiments##3##4##(1992-11#1)(1992-8#1)(1997-4#1)
of the present investigation was to develop##2##7##(1997-8#1)(2011-2#1)
of the present investigation was to##8##6##(1997-8#1)(2008-2#1)(2008-4#2)(2010-1#1)(2010-12#1)(2011-2#1)(2013-7#1)
of the present investigation was##9##5##(1992-3#1)(1997-8#1)(2008-2#1)(2008-4#2)(2010-1#1)(2010-12#1)(2011-2#1)(2013-7#1)
of the present investigation##16##4##(1990-11#1)(1992-3#1)(1994-10#1)(1995-3#1)(1997-8#1)(2008-2#1)(2008-4#2)(2010-1#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
of the present investigations##2##4##(2008-6#1)(2008-7#1)
of the present method for##2##5##(1996-5#1)(2008-10#1)
of the present method##9##4##(1993-8#1)(1994-2#1)(1996-11#1)(1996-5#1)(2008-10#5)
of the present paper is to review the##2##8##(2006-8#1)(2007-6#1)
of the present paper is to##6##6##(2006-6#1)(2006-8#1)(2007-12#1)(2007-6#1)(2008-12#1)(2009-6#1)
of the present paper was to##3##6##(1991-9#1)(2006-10#1)(2008-4#1)
of the present paper was##4##5##(1990-5#1)(1991-9#1)(2006-10#1)(2008-4#1)
of the present paper##13##4##(1990-5#1)(1991-9#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-6#1)(2008-12#1)(2008-4#2)(2008-7#1)(2009-6#1)(2012-3#1)
of the present procedure##2##4##(2008-10#2)
of the present report is to##3##6##(2008-8#1)(2008-9#1)(2011-1#1)
of the present report##5##4##(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-7#1)
of the present research##3##4##(2008-12#1)(2013-7#1)(2013-8#1)
of the present results with##3##5##(1991-5#1)(2005-11#1)(2008-2#1)
of the present results##10##4##(1991-2#1)(1991-5#1)(1995-12#1)(1995-7#1)(1996-8#1)(2005-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#1)
of the present review is to evaluate the##2##8##(2008-10#1)(2009-7#1)
of the present review is to##8##6##(2007-9#1)(2008-1#1)(2008-10#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-9#1)(2011-2#1)
of the present review was to##3##6##(2008-11#1)(2008-12#1)(2008-5#1)
of the present review##14##4##(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)
of the present situation##2##4##(1991-3#1)(1991-6#1)
of the present species##2##4##(2008-5#1)(2011-2#1)
of the present state of##3##5##(2006-10#1)(2008-11#1)(2009-2#1)
of the present state##4##4##(2005-7#1)(2006-10#1)(2008-11#1)(2009-2#1)
of the present study indicate that##5##6##(2006-5#1)(2008-10#1)(2008-12#1)(2010-2#1)(2011-12#1)
of the present study is to assess the##4##8##(2006-2#1)(2007-2#1)(2008-11#1)(2012-3#1)
of the present study is to assess##6##7##(2006-10#1)(2006-2#1)(2007-2#1)(2008-11#1)(2011-2#1)(2012-3#1)
of the present study is to evaluate##2##7##(2007-7#1)(2008-8#1)
of the present study is to examine##2##7##(2008-11#1)(2013-8#1)
of the present study is to investigate the##3##8##(2008-10#1)(2008-4#1)(2008-5#1)
of the present study is to investigate##4##7##(2007-10#1)(2008-10#1)(2008-4#1)(2008-5#1)
of the present study is to##32##6##(1993-9#1)(1996-3#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#2)(2007-9#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
of the present study is##34##5##(1993-9#1)(1996-3#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#3)(2007-9#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2011-2#2)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#2)(2013-7#1)(2013-8#1)
of the present study may##2##5##(2010-9#1)(2013-1#1)
of the present study provide##2##5##(2008-10#1)(2008-5#1)
of the present study suggest that##10##6##(1991-4#1)(1995-10#1)(1996-7#1)(2006-8#2)(2007-12#1)(2008-2#1)(2008-5#1)(2011-2#1)(2012-5#1)
of the present study suggest##11##5##(1991-4#1)(1995-10#1)(1996-1#1)(1996-7#1)(2006-8#2)(2007-12#1)(2008-2#1)(2008-5#1)(2011-2#1)(2012-5#1)
of the present study was the##6##6##(2007-2#1)(2008-2#1)(2008-5#1)(2010-5#1)(2012-12#1)(2012-2#1)
of the present study was to analyze the##4##8##(1995-8#1)(2007-8#2)(2008-7#1)
of the present study was to analyze##9##7##(1995-8#1)(2004-2#1)(2006-4#1)(2007-8#3)(2008-7#1)(2011-2#1)(2012-2#1)
of the present study was to assess the##8##8##(1993-5#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-7#1)(2009-2#1)
of the present study was to assess##10##7##(1993-5#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-7#1)(2008-8#1)(2009-2#1)(2012-2#1)
of the present study was to clarify the##2##8##(2007-10#1)(2012-2#1)
of the present study was to clarify##3##7##(2007-10#1)(2012-2#1)(2013-8#1)
of the present study was to compare the##2##8##(1997-5#1)(2007-9#1)
of the present study was to compare##5##7##(1993-12#1)(1997-5#1)(2007-2#1)(2007-9#1)(2008-12#1)
of the present study was to determine if##5##8##(1993-7#1)(1996-5#1)(2008-10#1)(2009-10#1)(2011-1#1)
of the present study was to determine the effect of##2##10##(1995-7#1)(2008-5#1)
of the present study was to determine the##13##8##(1993-7#1)(1995-7#1)(2005-12#1)(2006-10#1)(2006-4#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-2#1)
of the present study was to determine whether##4##8##(1995-12#1)(2006-7#1)(2006-8#1)(2008-12#1)
of the present study was to determine##24##7##(1993-7#2)(1995-12#1)(1995-7#1)(1996-5#1)(2005-12#1)(2006-10#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-10#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-10#1)(2011-1#2)(2011-2#3)(2012-2#1)
of the present study was to develop a##4##8##(2006-5#1)(2008-10#1)(2012-12#1)(2013-7#1)
of the present study was to develop##6##7##(2006-5#1)(2008-10#1)(2008-11#1)(2009-4#1)(2012-12#1)(2013-7#1)
of the present study was to establish##4##7##(1990-10#1)(2007-11#1)(2010-5#1)(2012-3#1)
of the present study was to evaluate the effectiveness of##3##10##(2006-6#1)(2007-7#1)(2013-1#1)
of the present study was to evaluate the efficacy of##2##10##(2007-7#1)(2013-7#1)
of the present study was to evaluate the##17##8##(2006-5#1)(2006-6#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-5#2)(2010-3#1)(2010-8#1)(2011-1#1)(2013-1#4)(2013-7#1)(2013-8#1)
of the present study was to evaluate whether##2##8##(1992-2#1)(2008-7#1)
of the present study was to evaluate##23##7##(1992-2#1)(1993-6#1)(1996-3#1)(2004-12#1)(2006-5#1)(2006-6#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-5#2)(2008-7#1)(2010-3#1)(2010-8#1)(2011-1#1)(2013-1#4)(2013-7#1)(2013-8#1)
of the present study was to examine the effect of##2##10##(2008-7#1)(2010-6#1)
of the present study was to examine the effects of##4##10##(2007-9#1)(2008-6#1)(2013-1#1)(2013-8#1)
of the present study was to examine the##14##8##(1992-2#1)(2006-4#1)(2007-11#1)(2007-9#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-6#1)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
of the present study was to examine whether##3##8##(1991-10#1)(1994-10#1)(2013-1#1)
of the present study was to examine##22##7##(1991-10#1)(1992-2#1)(1994-10#1)(1994-5#1)(1996-12#1)(2006-4#1)(2007-11#1)(2007-9#1)(2008-6#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-6#1)(2011-2#3)(2013-1#2)(2013-7#1)(2013-8#2)
of the present study was to explore the##2##8##(2006-8#1)(2010-12#1)
of the present study was to explore##4##7##(1997-7#1)(2006-8#1)(2006-9#1)(2010-12#1)
of the present study was to identify the##3##8##(1994-5#1)(2011-2#2)
of the present study was to identify##4##7##(1994-5#1)(2011-2#3)
of the present study was to investigate the effect of##7##10##(1996-7#1)(2007-10#1)(2008-12#1)(2008-3#1)(2009-6#1)(2010-2#2)
of the present study was to investigate the influence of##2##10##(1995-12#1)(2009-6#1)
of the present study was to investigate the relationship between##2##10##(2013-8#2)
of the present study was to investigate the##21##8##(1990-9#1)(1995-12#1)(1996-7#1)(1997-2#1)(2007-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-1#1)(2009-6#2)(2010-2#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#3)
of the present study was to investigate whether##4##8##(2008-11#1)(2011-2#1)(2012-1#1)(2012-12#1)
of the present study was to investigate##33##7##(1990-9#1)(1995-12#1)(1996-7#1)(1997-2#1)(2006-6#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-1#2)(2009-6#2)(2010-10#1)(2010-2#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#2)(2013-8#3)
of the present study was to monitor##2##7##(1994-12#1)(2010-5#1)
of the present study was to test the hypothesis that##2##10##(1990-8#1)(2009-6#1)
of the present study was to test the##3##8##(1990-8#1)(2009-2#1)(2009-6#1)
of the present study was to test##5##7##(1990-8#1)(1995-11#1)(1995-3#1)(2009-2#1)(2009-6#1)
of the present study was to##191##6##(1990-10#1)(1990-8#1)(1990-9#1)(1991-10#1)(1992-12#1)(1992-2#2)(1993-1#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-7#2)(1994-10#1)(1994-12#1)(1994-2#2)(1994-5#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-2#1)(2004-9#1)(2005-12#1)(2006-10#1)(2006-4#3)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#5)(2007-11#3)(2007-2#1)(2007-7#2)(2007-8#6)(2007-9#5)(2008-10#9)(2008-11#2)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#5)(2008-8#1)(2009-1#2)(2009-10#1)(2009-2#3)(2009-4#1)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-12#2)(2010-2#3)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#14)(2012-1#2)(2012-12#4)(2012-2#8)(2012-3#1)(2013-1#10)(2013-7#4)(2013-8#9)
of the present study was##200##5##(1990-10#1)(1990-8#1)(1990-9#1)(1991-10#1)(1992-12#1)(1992-2#2)(1993-1#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-7#2)(1994-10#1)(1994-12#1)(1994-2#2)(1994-5#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-2#1)(2004-9#1)(2005-12#1)(2006-10#2)(2006-4#3)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#5)(2007-11#3)(2007-12#1)(2007-2#2)(2007-7#2)(2007-8#6)(2007-9#5)(2008-10#9)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#10)(2008-6#1)(2008-7#5)(2008-8#1)(2009-1#2)(2009-10#1)(2009-2#3)(2009-4#1)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-12#2)(2010-2#3)(2010-3#1)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#15)(2012-1#2)(2012-12#5)(2012-2#9)(2012-3#1)(2013-1#10)(2013-7#4)(2013-8#9)
of the present study were to investigate##3##7##(2006-8#1)(2007-10#1)(2010-8#1)
of the present study were to##10##6##(1990-10#1)(1996-3#1)(1996-4#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#1)(2010-2#1)(2010-8#1)(2012-2#1)
of the present study were##13##5##(1990-10#1)(1996-3#1)(1996-4#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-2#1)(2010-8#1)(2012-2#1)
of the present study##302##4##(1990-10#2)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-2#2)(1993-1#1)(1993-12#1)(1993-5#1)(1993-6#2)(1993-7#2)(1993-9#1)(1994-10#2)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#1)(1996-7#3)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-2#1)(2004-9#1)(2005-12#1)(2006-10#5)(2006-2#1)(2006-4#3)(2006-5#3)(2006-6#3)(2006-7#2)(2006-8#6)(2006-9#1)(2007-10#7)(2007-11#3)(2007-12#3)(2007-2#3)(2007-7#5)(2007-8#6)(2007-9#6)(2008-1#1)(2008-10#17)(2008-11#4)(2008-12#6)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#17)(2008-6#2)(2008-7#7)(2008-8#3)(2009-1#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#3)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-12#2)(2010-2#5)(2010-3#1)(2010-5#4)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#3)(2011-2#19)(2011-7#1)(2012-1#2)(2012-12#7)(2012-2#13)(2012-3#3)(2012-5#2)(2013-1#14)(2013-7#5)(2013-8#11)
of the present system##3##4##(1994-1#1)(2007-7#1)(2008-2#1)
of the present work is to describe##2##7##(2005-1#1)(2008-1#1)
of the present work is to##8##6##(1995-6#1)(1997-2#1)(2005-1#1)(2008-1#1)(2008-6#1)(2008-8#1)(2009-12#1)(2011-2#1)
of the present work is##10##5##(1995-6#1)(1997-2#1)(2005-1#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-8#1)(2009-12#1)(2011-2#1)
of the present work was to evaluate the##3##8##(1993-11#1)(2008-5#1)(2012-2#1)
of the present work was to investigate##3##7##(1990-12#1)(1992-12#1)(2010-7#1)
of the present work was to##15##6##(1990-12#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-9#1)(1996-5#1)(2008-10#1)(2008-5#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#2)
of the present work##29##4##(1990-12#1)(1992-12#1)(1992-4#1)(1993-11#1)(1993-12#1)(1994-9#1)(1995-6#1)(1996-5#1)(1997-2#1)(2005-1#1)(2005-10#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
of the present##475##3##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#2)(1990-8#1)(1990-9#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-9#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#3)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-7#2)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#3)(1996-4#1)(1996-5#3)(1996-7#3)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#3)(1997-8#3)(2004-12#1)(2004-2#1)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#8)(2006-2#1)(2006-4#3)(2006-5#5)(2006-6#4)(2006-7#2)(2006-8#7)(2006-9#1)(2007-10#7)(2007-11#4)(2007-12#6)(2007-2#3)(2007-4#1)(2007-6#1)(2007-7#9)(2007-8#6)(2007-9#7)(2008-1#3)(2008-10#32)(2008-11#10)(2008-12#10)(2008-2#7)(2008-3#5)(2008-4#7)(2008-5#22)(2008-6#4)(2008-7#11)(2008-8#8)(2008-9#2)(2009-1#3)(2009-10#4)(2009-11#1)(2009-12#3)(2009-2#4)(2009-4#2)(2009-5#1)(2009-6#5)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#3)(2010-2#5)(2010-3#2)(2010-4#1)(2010-5#5)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#7)(2011-12#3)(2011-2#25)(2011-7#1)(2012-1#2)(2012-11#1)(2012-12#7)(2012-2#15)(2012-3#7)(2012-5#2)(2013-1#18)(2013-7#9)(2013-8#16)
of the present-day##3##3##(2008-10#1)(2008-3#2)
of the presentation of this##2##5##(2007-4#1)(2012-3#1)
of the presentation of##3##4##(2007-4#1)(2012-2#1)(2012-3#1)
of the presentation##7##3##(2006-2#1)(2007-4#1)(2008-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
of the presentations of##2##4##(2006-10#1)(2008-10#1)
of the presentations were##2##4##(2008-1#1)(2008-5#1)
of the presentations##11##3##(2005-7#1)(2005-8#2)(2006-10#1)(2006-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-5#2)
of the presented method##2##4##(2008-2#1)(2008-3#1)
of the presented model##2##4##(2008-10#1)(2008-8#1)
of the presented procedure##2##4##(1991-5#1)(2008-10#1)
of the presented scheme##2##4##(1996-7#1)(2008-2#1)
of the presented##15##3##(1991-5#1)(1996-7#1)(2006-2#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-8#1)(2013-1#2)
of the presenting problem##2##4##(2006-8#1)(2012-2#1)
of the presenting symptoms##2##4##(1990-6#1)(1991-11#1)
of the presenting##4##3##(1990-6#1)(1991-11#1)(2006-8#1)(2012-2#1)
of the presequence of the##2##5##(1991-9#1)(1994-11#1)
of the presequence##4##3##(1991-9#1)(1992-6#2)(1994-11#1)
of the press##3##3##(1990-12#1)(1996-2#1)(2009-10#1)
of the pressor response to##2##5##(1992-7#1)(2012-1#1)
of the pressor response##4##4##(1992-7#2)(1993-4#1)(2012-1#1)
of the pressor##6##3##(1991-5#1)(1992-7#2)(1993-4#1)(1995-11#1)(2012-1#1)
of the pressure and##2##4##(2008-10#1)(2009-6#1)
of the pressure##13##3##(2005-11#1)(2006-12#1)(2006-4#1)(2007-6#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2009-6#1)(2009-9#1)
of the presumed##4##3##(1994-12#1)(1995-6#1)(2008-6#1)(2011-2#1)
of the presumptive##2##3##(1995-8#1)(2006-5#1)
of the presynaptic dopamine##2##4##(1996-1#1)(2008-11#1)
of the presynaptic neuron##2##4##(1997-7#2)
of the presynaptic##10##3##(1992-5#1)(1992-8#1)(1995-12#1)(1996-1#1)(1997-7#2)(2007-12#1)(2008-11#2)(2008-3#1)
of the pretreated##3##3##(1991-12#1)(2004-8#1)(2013-1#1)
of the prevailing##3##3##(2007-7#1)(2008-5#1)(2008-8#1)
of the prevalence in##2##4##(1994-6#1)(2012-2#1)
of the prevalence of obesity in##2##6##(2006-2#1)(2007-11#1)
of the prevalence of##21##4##(1994-6#1)(1994-9#1)(1996-1#1)(2004-11#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-3#1)(2009-5#1)(2010-1#1)(2010-2#1)(2011-2#1)(2012-11#1)(2013-7#1)
of the prevalence##26##3##(1994-6#2)(1994-9#1)(1996-1#1)(1996-12#1)(1996-7#1)(2004-11#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-3#1)(2008-4#1)(2009-5#1)(2010-1#1)(2010-2#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-7#1)
of the prevalent##3##3##(2007-11#2)(2008-10#1)
of the prevention of##6##4##(1990-2#1)(2006-12#1)(2006-6#1)(2007-4#1)(2011-12#1)(2012-2#1)
of the prevention##7##3##(1990-2#1)(1993-12#1)(2006-12#1)(2006-6#1)(2007-4#1)(2011-12#1)(2012-2#1)
of the preventive effect of##2##5##(2008-5#1)(2009-8#1)
of the preventive##6##3##(1993-9#1)(1996-2#1)(2006-8#1)(2008-5#1)(2009-8#1)(2012-12#1)
of the previous research##2##4##(2007-12#1)(2011-1#1)
of the previous study on##2##5##(1990-2#1)(2004-9#1)
of the previous study##4##4##(1990-2#1)(1994-3#1)(2004-9#1)(2011-12#1)
of the previous work##2##4##(2009-7#1)(2012-2#1)
of the previous year's##2##4##(2008-10#2)
of the previous##30##3##(1990-2#2)(1990-5#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-6#1)(1994-2#1)(1994-3#1)(2004-9#1)(2005-7#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-5#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-2#2)
of the previously described##10##4##(1990-4#1)(1991-11#1)(1992-9#1)(1994-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2012-2#1)(2013-7#1)
of the previously isolated##2##4##(1990-12#1)(1993-9#1)
of the previously published##3##4##(1993-8#1)(2006-10#1)(2010-2#1)
of the previously reported##12##4##(1990-1#1)(1991-2#1)(1993-8#1)(1995-8#1)(1996-12#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-7#1)(2011-1#1)(2012-12#2)
of the previously##45##3##(1990-1#1)(1990-11#1)(1990-12#1)(1990-4#1)(1991-11#1)(1991-2#2)(1991-9#2)(1992-9#1)(1993-12#1)(1993-4#1)(1993-8#2)(1993-9#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-7#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
of the prey by##2##4##(2007-12#1)(2008-8#1)
of the prey##8##3##(2007-12#1)(2007-3#1)(2008-12#1)(2008-8#2)(2008-9#2)(2010-8#1)
of the prg isolates were##2##5##(2008-10#2)
of the primary afferent##2##4##(1995-12#1)(2006-12#1)
of the primary amine##3##4##(2007-8#1)(2008-10#2)
of the primary and metastatic##2##5##(1992-6#2)
of the primary and recurrent##2##5##(1991-6#2)
of the primary and secondary##5##5##(1991-4#1)(1992-6#2)(2006-9#1)(2009-3#1)
of the primary and##12##4##(1991-4#1)(1991-6#2)(1992-6#4)(1992-9#1)(2006-9#1)(2008-8#1)(2009-3#1)(2010-12#1)
of the primary auditory cortex##2##5##(1991-3#1)(2008-11#1)
of the primary beam##2##4##(2007-2#1)(2008-2#1)
of the primary breast##2##4##(1995-10#1)(2011-3#1)
of the primary care physician in the##2##7##(1994-10#1)(1995-2#1)
of the primary care physician##3##5##(1994-10#1)(1995-2#1)(2008-8#1)
of the primary care##5##4##(1994-10#1)(1994-8#1)(1995-2#1)(2008-8#1)(2012-12#1)
of the primary coating##2##4##(2007-11#2)
of the primary electron donor is##2##6##(2008-8#2)
of the primary electron donor##4##5##(1992-6#1)(1993-11#1)(2008-8#2)
of the primary electron##5##4##(1992-6#1)(1993-11#1)(1995-11#1)(2008-8#2)
of the primary factors##3##4##(1996-7#1)(2008-10#1)(2008-5#1)
of the primary health care##2##5##(2008-1#2)
of the primary inoculum##2##4##(2008-10#2)
of the primary lesion##5##4##(1991-5#1)(1992-2#1)(2007-12#1)(2007-7#1)(2008-10#1)
of the primary motor##3##4##(1995-11#1)(1997-8#1)(2008-9#1)
of the primary olfactory##2##4##(2007-12#2)
of the primary outcomes##3##4##(2008-7#1)(2010-1#1)(2013-8#1)
of the primary patients and in##2##6##(2008-4#2)
of the primary patients##3##4##(1995-2#1)(2008-4#2)
of the primary prevention##2##4##(2006-7#1)(2008-3#1)
of the primary quinone##2##4##(1992-6#1)(1994-10#1)
of the primary radical pair##3##5##(1991-7#2)(1996-7#1)
of the primary site##3##4##(1990-7#1)(1993-4#1)(2012-12#1)
of the primary somatosensory##2##4##(1995-12#1)(1996-1#1)
of the primary structure of the##2##6##(1994-9#1)(2008-10#1)
of the primary structure of##4##5##(1994-12#1)(1994-9#1)(1995-4#1)(2008-10#1)
of the primary structure##7##4##(1992-2#2)(1994-12#2)(1994-9#1)(1995-4#1)(2008-10#1)
of the primary structures of##2##5##(1992-1#1)(1993-12#1)
of the primary structures##3##4##(1992-1#1)(1993-12#1)(1993-3#1)
of the primary subtests of##2##5##(2006-10#2)
of the primary transcript##2##4##(1991-6#1)(1993-6#1)
of the primary tumor and##3##5##(2008-10#1)(2010-12#1)(2010-3#1)
of the primary tumor to##2##5##(1990-6#1)(2012-2#1)
of the primary tumor was##4##5##(1992-6#1)(1995-10#1)(2007-6#1)(2008-6#1)
of the primary tumor##28##4##(1990-6#1)(1991-3#1)(1992-6#2)(1992-8#1)(1995-10#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-6#2)(2009-3#1)(2009-5#1)(2010-12#2)(2010-3#3)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
of the primary tumour in##2##5##(2006-10#1)(2013-7#1)
of the primary tumour##11##4##(1990-1#1)(1991-6#1)(2004-2#1)(2006-10#3)(2008-1#1)(2008-6#1)(2009-2#1)(2011-3#1)(2013-7#1)
of the primary##220##3##(1990-1#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-1#3)(1991-12#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#6)(1991-7#4)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#3)(1992-6#8)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-10#2)(1994-11#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#3)(1995-11#2)(1995-12#3)(1995-2#2)(1995-4#1)(1995-6#1)(1996-1#1)(1996-5#6)(1996-7#2)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-2#1)(2006-10#7)(2006-12#1)(2006-2#3)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#8)(2007-12#3)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#14)(2008-11#4)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#6)(2008-6#4)(2008-7#2)(2008-8#8)(2008-9#2)(2009-10#2)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-3#3)(2011-1#2)(2011-12#1)(2011-2#4)(2011-3#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#2)
of the primate##9##3##(1992-2#1)(1995-11#1)(1995-5#3)(1997-4#1)(2007-2#1)(2008-1#1)(2012-2#1)
of the prime and its##2##5##(2008-4#2)
of the primer##6##3##(1990-5#1)(1993-3#2)(1994-12#1)(2008-4#1)(2010-4#1)
of the primers tested with##2##5##(2008-5#2)
of the primers tested##3##4##(2008-10#1)(2008-5#2)
of the primers##8##3##(1995-12#1)(2008-10#4)(2008-5#3)
of the priming activity of the##2##6##(1990-3#2)
of the priming##3##3##(1990-3#2)(2008-4#1)
of the primitive##2##3##(2006-8#1)(2007-5#1)
of the principal areas##2##4##(2005-8#1)(2009-10#1)
of the principal axis##3##4##(1997-4#1)(2007-12#1)(2008-3#1)
of the principal causes of##2##5##(2007-9#1)(2012-2#1)
of the principal state of polarization##2##6##(2007-12#2)
of the principal##29##3##(1991-9#1)(1992-3#1)(1993-11#1)(1995-1#1)(1995-4#1)(1997-4#1)(1997-7#1)(2005-8#1)(2006-11#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#4)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-7#1)(2009-10#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)
of the principle of the##2##5##(2008-12#1)(2008-4#1)
of the principle of##5##4##(1992-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)
of the principle##14##3##(1992-1#1)(1996-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-8#1)(2009-3#1)(2013-8#1)
of the principles and##4##4##(1993-12#1)(1995-3#1)(1997-3#1)(2005-8#1)
of the principles of##10##4##(1997-3#1)(2006-12#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#2)
of the principles##18##3##(1993-12#1)(1995-1#1)(1995-3#1)(1997-3#2)(2005-8#1)(2006-12#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#2)(2010-8#1)(2012-12#1)
of the prion protein##4##4##(1993-2#1)(2006-10#3)
of the prion##6##3##(1992-7#2)(1993-2#1)(2006-10#3)
of the prior##4##3##(1993-4#1)(1995-6#1)(2008-2#1)(2008-3#1)
of the priority##2##3##(1996-12#1)(2008-4#1)
of the prism##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
of the prismatic##3##3##(2007-12#1)(2008-2#1)(2013-1#1)
of the privacy##2##3##(2007-12#1)(2012-12#1)
of the private sector in##2##5##(2012-3#1)(2013-7#1)
of the private sector##5##4##(2006-10#1)(2007-7#1)(2008-9#1)(2012-3#1)(2013-7#1)
of the private##8##3##(2006-10#1)(2007-7#1)(2008-6#1)(2008-9#1)(2009-4#1)(2010-1#1)(2012-3#1)(2013-7#1)
of the pro-apoptotic##3##3##(2009-12#1)(2012-12#2)
of the pro-inflammatory chemokines##2##4##(2008-11#2)
of the pro-inflammatory##4##3##(2008-10#2)(2008-11#2)
of the pro-opiomelanocortin##2##3##(1991-9#1)(2006-12#1)
of the proC gene encoding delta 1-pyrroline-5-carboxylate reductase##2##8##(1994-2#2)
of the proU operon##2##4##(1994-12#2)
of the proU##3##3##(1994-12#3)
of the proacrosin##2##3##(1992-4#2)
of the probability density##2##4##(2007-9#1)(2008-2#1)
of the probability of developing the disease in the##2##9##(1992-9#2)
of the probability of##9##4##(1992-9#2)(1993-1#1)(1995-8#1)(1997-3#1)(2008-2#1)(2009-10#1)(2009-12#1)(2012-3#1)
of the probability##14##3##(1992-9#2)(1993-1#1)(1994-7#1)(1995-8#2)(1997-3#1)(2007-9#1)(2008-2#2)(2009-10#1)(2009-12#1)(2009-4#1)(2012-3#1)
of the probable##3##3##(1993-10#1)(2006-2#1)(2013-8#1)
of the proband were##2##4##(1991-12#1)(1993-3#1)
of the proband##3##3##(1991-12#2)(1993-3#1)
of the probands##3##3##(1990-9#1)(1994-2#1)(1995-11#1)
of the probe and##2##4##(2006-10#1)(2012-1#1)
of the probe array##4##4##(2007-12#2)(2008-3#2)
of the probe beam##5##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
of the probe is##2##4##(2008-2#1)(2010-5#1)
of the probe light##2##4##(2007-12#1)(2008-3#1)
of the probe pulse##4##4##(2007-11#1)(2007-12#3)
of the probe to the##3##5##(1992-6#2)(2008-4#1)
of the probe to##4##4##(1992-6#3)(2008-4#1)
of the probe##55##3##(1990-11#1)(1990-5#1)(1991-7#1)(1992-6#5)(1993-3#1)(1994-3#1)(1995-11#1)(1997-1#1)(1997-3#3)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#11)(2008-1#1)(2008-10#6)(2008-2#3)(2008-3#11)(2008-4#1)(2008-5#1)(2010-5#1)(2012-1#1)
of the probed##2##3##(2011-1#2)
of the probes##10##3##(1990-4#1)(1990-5#1)(2008-10#3)(2008-2#2)(2008-4#1)(2010-5#2)
of the probiotic Bacillus subtilis on the growth##2##8##(2007-3#2)
of the probiotic##11##3##(2007-3#5)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)
of the problem and##3##4##(2008-10#1)(2008-8#1)(2012-12#1)
of the problem in the##2##5##(2008-10#1)(2011-2#1)
of the problem in##8##4##(1993-11#1)(2004-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2008-10#1)(2009-4#1)(2011-2#1)
of the problem is##9##4##(2005-11#1)(2006-8#1)(2007-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#3)
of the problem of##11##4##(1990-10#1)(1993-11#1)(1996-6#1)(1996-9#1)(1997-7#1)(2006-10#1)(2007-2#1)(2007-3#1)(2007-6#1)(2008-7#1)(2012-12#1)
of the problem under##2##4##(2008-3#1)(2013-8#1)
of the problem]##2##3##(1991-6#1)(2013-1#1)
of the problems and##2##4##(1993-8#1)(2012-1#1)
of the problems associated with##6##5##(1992-3#1)(2005-5#1)(2006-5#1)(2007-8#1)(2011-1#1)(2011-2#1)
of the problems encountered##4##4##(1990-9#1)(1993-9#1)(2005-7#1)(2009-6#1)
of the problems faced by##2##5##(2008-11#1)(2008-6#1)
of the problems in##2##4##(1994-2#1)(2008-10#1)
of the problems of##8##4##(1991-3#1)(1994-8#1)(2007-6#1)(2008-11#1)(2008-7#1)(2009-5#1)(2010-4#1)(2011-2#1)
of the problems that##5##4##(1990-12#1)(1993-3#1)(1995-11#1)(2008-1#1)(2011-2#1)
of the problems with##2##4##(2010-12#1)(2010-8#1)
of the problems##46##3##(1990-12#1)(1990-9#1)(1991-3#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-8#1)(1994-9#1)(1995-11#1)(1996-2#1)(1996-3#1)(2005-10#1)(2005-5#1)(2005-7#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#2)(2008-7#1)(2009-5#2)(2009-6#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)
of the proboscis##2##3##(1994-8#1)(2007-12#1)
of the procarcinogen benzo[a]pyrene##2##4##(1995-5#2)
of the procedure and the##2##5##(2006-8#1)(2007-7#1)
of the procedure and##10##4##(1993-5#1)(1995-12#1)(2005-11#1)(2006-10#1)(2006-8#2)(2007-7#1)(2007-8#2)(2008-11#1)
of the procedure are##3##4##(2006-8#2)(2008-3#1)
of the procedure developed by##2##5##(1994-12#1)(2008-9#1)
of the procedure for##4##4##(2008-10#2)(2010-12#1)(2012-12#1)
of the procedure in##4##4##(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#1)
of the procedure is illustrated##4##5##(2008-10#3)(2010-5#1)
of the procedure is##11##4##(1996-12#1)(2006-10#1)(2007-3#1)(2008-10#4)(2008-3#3)(2010-5#1)
of the procedure or##2##4##(2006-8#1)(2007-7#1)
of the procedure to##4##4##(2005-11#1)(2007-8#1)(2008-10#1)(2008-3#1)
of the procedure was confirmed by##2##6##(1993-12#1)(2008-10#1)
of the procedure was##11##4##(1990-7#1)(1993-12#1)(2008-10#7)(2012-12#2)
of the procedure were##3##4##(2008-10#3)
of the procedure##125##3##(1990-11#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-12#1)(1992-3#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-12#3)(1995-8#1)(1996-12#4)(1997-3#1)(2004-10#2)(2005-11#3)(2006-1#1)(2006-10#8)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#6)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#6)(2007-8#6)(2008-10#24)(2008-11#2)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-5#2)(2011-1#2)(2011-2#5)(2012-12#3)(2012-2#1)(2013-1#1)
of the procedures in##3##4##(2006-8#1)(2007-11#1)(2007-8#1)
of the procedures used##2##4##(2006-10#1)(2008-1#1)
of the procedures##21##3##(1990-2#1)(1993-10#1)(1996-11#1)(1996-6#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#3)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-4#1)(2011-2#1)(2012-12#1)
of the process and its##2##5##(1991-1#1)(2008-1#1)
of the process and##7##4##(1991-1#1)(2005-11#1)(2005-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2012-2#1)
of the process by##3##4##(2006-11#1)(2008-11#1)(2008-5#1)
of the process has been##2##5##(1995-1#1)(2008-6#1)
of the process in##2##4##(2007-12#1)(2008-10#1)
of the process is##3##4##(1992-2#1)(2008-10#1)(2008-4#1)
of the process of bone##2##5##(2007-11#1)(2007-8#1)
of the process of hologram formation##2##6##(2008-2#2)
of the process of the##2##5##(1994-7#1)(2008-12#1)
of the process of##23##4##(1992-6#1)(1994-7#1)(2005-11#1)(2006-6#1)(2007-11#1)(2007-4#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#1)(2010-2#1)(2012-1#1)(2012-3#1)
of the process to##2##4##(2007-2#1)(2008-5#1)
of the process was##2##4##(2008-10#1)(2008-5#1)
of the process##102##3##(1990-11#1)(1990-6#1)(1991-1#1)(1991-9#1)(1992-2#2)(1992-6#1)(1993-12#1)(1994-12#1)(1994-7#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-8#1)(2005-10#1)(2005-11#5)(2005-7#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-11#2)(2007-12#4)(2007-2#2)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#13)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#5)(2009-3#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)
of the processed##5##3##(2007-11#1)(2008-10#1)(2008-6#1)(2012-1#1)(2013-1#1)
of the processes and mechanisms##2##5##(1992-6#1)(2008-7#1)
of the processes involved in##2##5##(1996-12#1)(2009-2#1)
of the processes involved##6##4##(1990-3#1)(1996-12#1)(1997-5#1)(2006-11#1)(2008-9#1)(2009-2#1)
of the processes of the##2##5##(2008-7#1)(2010-9#1)
of the processes of##7##4##(2007-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-9#1)(2012-3#1)
of the processes that##2##4##(2006-12#1)(2010-9#1)
of the processes underlying the##2##5##(1995-4#1)(2006-10#1)
of the processes##28##3##(1990-3#1)(1992-6#1)(1995-4#1)(1996-12#1)(1997-5#1)(2005-11#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2010-9#2)(2012-3#1)(2013-8#1)
of the processing and##2##4##(2006-12#1)(2013-8#1)
of the processing of##4##4##(1990-5#1)(1990-8#1)(1993-6#1)(1995-5#1)
of the processing##10##3##(1990-2#1)(1990-5#1)(1990-8#1)(1991-2#1)(1993-5#1)(1993-6#1)(1995-5#1)(2006-12#1)(2008-11#1)(2013-8#1)
of the prodomain##4##3##(1995-11#4)
of the prodrug##2##3##(1994-11#1)(1994-5#1)
of the prodrugs##2##3##(1995-3#1)(2009-4#1)
of the produced water##3##4##(2008-7#1)(2013-1#2)
of the produced##17##3##(1995-8#1)(1996-7#1)(1997-4#1)(2006-12#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
of the producer##3##3##(2008-11#3)
of the producing##2##3##(1992-9#1)(1994-2#1)
of the product and##2##4##(1995-5#1)(2008-5#1)
of the product in##2##4##(1991-7#1)(2008-7#1)
of the product of the##6##5##(1991-11#1)(2008-10#2)(2008-2#1)(2008-3#2)
of the product of##9##4##(1991-11#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-6#1)
of the product was##2##4##(2007-3#1)(2008-6#1)
of the product##68##3##(1990-10#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-7#1)(1993-4#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-5#1)(1996-2#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-3#2)(2007-6#1)(2008-10#15)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#7)(2008-6#3)(2008-7#2)(2009-10#1)(2009-11#1)(2009-9#1)(2010-10#1)(2010-4#2)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
of the production of the##2##5##(1992-9#1)(2010-4#1)
of the production of##12##4##(1990-2#1)(1991-9#1)(1992-9#1)(1994-2#1)(1995-12#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-4#1)
of the production process##4##4##(2008-11#1)(2012-2#2)(2013-8#1)
of the production##22##3##(1990-2#1)(1991-9#1)(1992-9#1)(1994-2#1)(1994-5#1)(1995-12#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2010-2#1)(2010-4#1)(2012-2#3)(2013-8#1)
of the productivity##2##3##(2008-11#2)
of the products formed##2##4##(1993-4#1)(2008-10#1)
of the products in##2##4##(2010-6#1)(2013-8#1)
of the products obtained##2##4##(2007-1#1)(2010-12#1)
of the products of the##4##5##(1992-12#1)(2006-5#1)(2007-8#1)(2013-7#1)
of the products of##14##4##(1990-7#2)(1992-12#1)(1994-8#1)(1995-1#1)(1995-3#1)(1996-12#2)(1996-8#1)(2006-2#1)(2006-5#1)(2007-8#1)(2008-10#1)(2013-7#1)
of the products were##2##4##(1990-4#1)(2007-11#1)
of the products##51##3##(1990-4#1)(1990-5#2)(1990-7#2)(1991-3#1)(1991-4#1)(1991-8#1)(1992-12#1)(1993-4#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#2)(1996-5#1)(1996-8#1)(2005-11#2)(2006-2#1)(2006-5#1)(2007-1#1)(2007-11#3)(2007-8#3)(2008-10#5)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#1)(2010-12#1)(2010-4#1)(2010-6#1)(2013-7#1)(2013-8#1)
of the profession and the##2##5##(2011-2#1)(2013-8#1)
of the profession and##3##4##(2008-12#1)(2011-2#1)(2013-8#1)
of the profession as##2##4##(1991-2#1)(2008-11#1)
of the profession to##3##4##(2007-8#1)(2012-3#2)
of the profession##27##3##(1991-2#2)(1993-1#2)(1993-2#1)(1995-1#2)(1996-1#1)(2006-2#2)(2007-4#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#2)(2009-4#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-3#4)(2013-8#1)
of the professional staff##2##4##(1991-12#1)(2008-8#1)
of the professional##13##3##(1991-12#1)(1991-3#1)(1992-3#1)(1993-3#1)(1996-3#1)(2007-2#1)(2008-10#2)(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
of the professionals##2##3##(2012-12#1)(2013-1#1)
of the professionals'##3##3##(2008-5#1)(2011-2#1)(2013-1#1)
of the professions##4##3##(1990-12#2)(2007-11#1)(2009-10#1)
of the profile of the##2##5##(2007-12#1)(2007-7#1)
of the profile of##5##4##(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)
of the profile##12##3##(1996-1#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#2)(2010-3#1)(2010-5#1)(2011-2#1)
of the profiles##3##3##(1997-3#1)(2006-5#1)(2011-2#1)
of the progenitor##2##3##(1994-5#1)(2008-8#1)
of the progenitors of##2##4##(1995-2#1)(2008-5#1)
of the progeny of##2##4##(2008-10#1)(2012-2#1)
of the progeny##4##3##(2008-10#2)(2009-6#1)(2012-2#1)
of the prognosis for##2##4##(2008-7#1)(2012-2#1)
of the prognosis of##3##4##(1990-9#1)(1993-5#1)(2010-12#1)
of the prognosis##9##3##(1990-9#1)(1993-5#1)(1996-11#1)(1997-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-2#1)
of the prognostic##3##3##(1990-6#1)(1990-9#1)(1995-9#1)
of the program and##2##4##(1993-1#1)(2008-1#1)
of the program in the##2##5##(1995-1#1)(2007-4#1)
of the program is to improve##2##6##(1993-12#1)(2008-4#1)
of the program is to##5##5##(1993-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2012-3#1)
of the program is##6##4##(1993-12#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2012-3#1)
of the program statement##2##4##(1996-2#2)
of the program to##3##4##(1991-2#1)(2008-3#1)(2008-7#1)
of the program was to##2##5##(1992-1#1)(1993-12#1)
of the program##51##3##(1990-12#1)(1991-12#3)(1991-2#2)(1992-1#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-3#1)(1996-2#2)(1996-3#1)(1997-1#1)(2006-3#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#2)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-7#1)(2010-9#1)(2012-12#1)(2012-3#2)(2013-1#5)
of the program's##3##3##(1996-1#1)(2008-6#1)(2010-3#1)
of the programme is##2##4##(2008-11#1)(2008-12#1)
of the programme##16##3##(1991-4#1)(2006-2#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2010-1#1)(2011-2#2)(2012-12#1)(2012-3#2)
of the programming##2##3##(2007-12#1)(2008-9#1)
of the programs##11##3##(1990-10#2)(1990-12#1)(1992-1#1)(1996-1#1)(1997-2#1)(2008-6#1)(2008-9#2)(2011-2#1)(2013-1#1)
of the progress of##4##4##(2007-8#1)(2008-10#1)(2009-4#1)(2013-8#1)
of the progress##10##3##(1992-8#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-4#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
of the progression of##4##4##(2004-11#1)(2008-1#1)(2008-7#1)(2011-2#1)
of the progressive##5##3##(1990-8#1)(1992-12#1)(2007-3#2)(2012-2#1)
of the prohormone##2##3##(1992-12#1)(2008-4#1)
of the proinflammatory cytokine##2##4##(2007-12#1)(2010-12#1)
of the proinflammatory##3##3##(2007-12#1)(2008-7#1)(2010-12#1)
of the proinsulin##2##3##(1996-7#1)(2008-11#1)
of the project are to##2##5##(1996-1#1)(2008-6#1)
of the project are##3##4##(1993-3#1)(1996-1#1)(2008-6#1)
of the project is to##2##5##(1996-2#1)(2011-9#1)
of the project was to##2##5##(1996-7#1)(1997-4#1)
of the project##34##3##(1992-3#1)(1993-3#3)(1995-2#2)(1995-3#2)(1996-1#1)(1996-2#1)(1996-7#1)(1997-4#1)(2005-12#2)(2006-5#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-5#1)(2010-9#1)(2011-2#2)(2011-9#2)(2012-2#2)
of the projected grating##2##4##(2008-2#1)(2008-3#1)
of the projected##7##3##(2008-1#1)(2008-2#1)(2008-3#2)(2008-6#1)(2010-11#1)(2011-1#1)
of the projectile##2##3##(2009-10#2)
of the projection system##2##4##(2008-2#1)(2008-3#1)
of the projection##7##3##(1992-10#1)(2008-2#2)(2008-3#4)
of the projections##3##3##(1991-1#1)(2006-10#1)(2009-2#1)
of the projector##2##3##(2008-3#2)
of the projects##4##3##(1994-1#1)(1997-2#1)(2009-4#1)(2012-3#1)
of the prokaryotic##3##3##(2008-10#1)(2011-1#2)
of the prolactin gene##2##4##(1995-3#2)
of the prolactin##4##3##(1992-7#1)(1995-3#2)(2008-4#1)
of the prolapse##3##3##(2007-8#1)(2013-1#2)
of the proliferating##3##3##(1995-2#1)(2008-5#1)(2009-9#1)
of the proliferation of##4##4##(1992-2#1)(2008-11#1)(2008-6#1)(2008-8#1)
of the proliferation##6##3##(1992-2#1)(2007-4#1)(2008-11#1)(2008-6#1)(2008-8#1)(2011-2#1)
of the proliferation-associated##2##3##(1993-11#1)(1994-7#1)
of the proliferative lymphocytes##2##4##(2008-9#2)
of the proliferative##13##3##(1991-5#1)(1992-3#1)(1992-8#1)(1995-6#1)(1997-3#1)(2006-9#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-2#1)(2011-2#2)
of the proline##4##3##(1991-5#1)(1994-12#2)(2008-5#1)
of the prolonged##5##3##(2007-2#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-3#1)
of the prominent##6##3##(1991-8#1)(2006-8#1)(2007-6#1)(2008-5#1)(2008-6#1)(2010-7#1)
of the promising##3##3##(2008-1#1)(2008-3#1)(2009-10#1)
of the promoter activity##2##4##(1992-9#1)(1994-8#1)
of the promoter and##4##4##(1990-11#1)(1991-12#1)(1993-12#1)(2006-10#1)
of the promoter for##2##4##(1995-2#1)(1995-6#1)
of the promoter in##3##4##(1995-6#1)(1997-4#2)
of the promoter of the human##2##6##(1997-2#2)
of the promoter of the##3##5##(1997-2#2)(2008-11#1)
of the promoter region of the##3##6##(1990-5#1)(1990-9#1)(1993-3#1)
of the promoter region of##7##5##(1990-5#1)(1990-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1997-7#1)(2007-8#1)
of the promoter region##14##4##(1990-5#1)(1990-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-1#2)(1996-5#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-8#1)(2011-1#1)
of the promoter regions##2##4##(1997-2#1)(2012-3#1)
of the promoter##55##3##(1990-11#1)(1990-5#2)(1990-9#1)(1991-12#1)(1991-9#1)(1992-11#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-3#3)(1993-6#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#3)(1995-2#2)(1995-3#3)(1995-6#2)(1996-5#1)(1996-7#1)(1997-2#4)(1997-4#4)(1997-6#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-8#2)(2008-9#1)(2011-1#2)(2012-3#1)
of the promoters##2##3##(1994-11#1)(1994-12#1)
of the prongs##2##3##(2008-7#2)
of the propagating light##2##4##(2008-2#1)(2008-3#1)
of the propagating photons##2##4##(2008-3#2)
of the propagating pulse##2##4##(2007-11#1)(2007-12#1)
of the propagating##8##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#4)
of the propagation of##4##4##(1991-11#1)(2007-11#1)(2007-12#1)(2008-3#1)
of the propagation properties of the LP(11) mode##2##8##(2007-12#2)
of the propagation##16##3##(1991-11#1)(1991-12#3)(2007-11#2)(2007-12#6)(2008-2#2)(2008-3#2)
of the propeptide##4##3##(1991-9#1)(1994-11#1)(1994-9#1)(1995-3#1)
of the proper##12##3##(1991-12#1)(2006-6#1)(2007-11#2)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
of the properly##2##3##(1994-11#1)(2012-3#1)
of the properties of the##4##5##(1993-12#1)(2009-3#1)(2012-2#1)(2013-1#1)
of the properties of these##2##5##(1991-11#1)(2008-11#1)
of the properties of##24##4##(1990-12#1)(1991-11#1)(1993-12#1)(1994-11#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-4#1)(1997-2#1)(2006-4#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-12#1)(2009-3#1)(2010-4#1)(2012-2#1)(2013-1#1)
of the properties##28##3##(1990-11#1)(1990-12#1)(1991-11#1)(1993-12#1)(1993-8#1)(1994-11#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-4#1)(1997-2#1)(2006-4#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2008-7#1)(2009-12#1)(2009-3#1)(2010-4#1)(2012-2#1)(2013-1#1)
of the prophylaxis##2##3##(1996-4#1)(2008-8#1)
of the proportion of genetic cases in late-onset diseases##2##9##(1995-6#2)
of the proportion of##12##4##(1992-12#1)(1993-6#2)(1995-6#2)(1996-3#1)(1997-7#1)(2006-2#1)(2008-10#3)(2010-4#1)
of the proportions of##2##4##(1990-12#1)(1992-9#1)
of the proportions##4##3##(1990-12#1)(1992-9#1)(1997-3#1)(1997-6#1)
of the proposal##3##3##(1992-2#3)
of the proposed algorithm is##2##5##(2008-2#1)(2008-3#1)
of the proposed algorithm##6##4##(2007-12#1)(2008-2#2)(2008-3#1)(2009-12#1)(2010-2#1)
of the proposed approach and##2##5##(2007-11#1)(2008-10#1)
of the proposed approach are##2##5##(2008-2#2)
of the proposed approach is##3##5##(2008-2#3)
of the proposed approach##15##4##(2007-11#1)(2008-10#1)(2008-2#7)(2008-3#1)(2008-5#1)(2011-1#2)(2012-1#1)(2012-12#1)
of the proposed approaches##4##4##(2008-2#2)(2013-1#2)
of the proposed architecture##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
of the proposed diet##2##4##(2008-3#2)
of the proposed estimator##2##4##(2008-2#1)(2012-3#1)
of the proposed estimators##4##4##(2010-11#1)(2010-2#3)
of the proposed framework##4##4##(2005-10#1)(2006-10#1)(2012-2#2)
of the proposed managed care##2##5##(1994-2#2)
of the proposed mechanism##2##4##(2008-10#1)(2010-5#1)
of the proposed method and the##2##6##(2008-10#1)(2008-6#1)
of the proposed method and##4##5##(2008-10#2)(2008-6#2)
of the proposed method are##7##5##(2006-10#1)(2008-10#3)(2008-2#1)(2008-3#2)
of the proposed method for determining##2##6##(2008-10#2)
of the proposed method for the##2##6##(2008-10#2)
of the proposed method for##10##5##(2008-10#10)
of the proposed method in##3##5##(2008-10#1)(2010-4#1)(2010-8#1)
of the proposed method is evaluated by##2##7##(2008-2#1)(2008-3#1)
of the proposed method is##18##5##(2008-10#13)(2008-2#2)(2008-3#2)(2010-7#1)
of the proposed method was checked with##2##7##(2008-10#1)(2008-3#1)
of the proposed method was checked##5##6##(2008-10#4)(2008-3#1)
of the proposed method was evaluated by analyzing##2##8##(2008-10#2)
of the proposed method was evaluated by##4##7##(2008-10#4)
of the proposed method was##19##5##(2008-10#18)(2008-3#1)
of the proposed method##100##4##(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#65)(2008-2#6)(2008-3#12)(2008-6#2)(2010-2#2)(2010-4#1)(2010-7#1)(2010-8#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-7#1)
of the proposed methodology has been##2##6##(2008-10#2)
of the proposed methodology in##2##5##(2008-10#1)(2012-1#1)
of the proposed methodology was##2##5##(2008-10#2)
of the proposed methodology##9##4##(2005-5#1)(2007-8#1)(2008-10#5)(2008-2#1)(2012-1#1)
of the proposed methods is##2##5##(2008-2#1)(2008-6#1)
of the proposed methods was assessed##2##6##(2008-10#1)(2010-4#1)
of the proposed methods##9##4##(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-11#1)(2010-4#1)
of the proposed model##6##4##(1995-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-8#1)(2013-1#1)
of the proposed models##4##4##(2008-10#1)(2008-2#1)(2008-7#1)(2009-8#1)
of the proposed numerical##2##4##(2008-2#1)(2011-1#1)
of the proposed procedure for##2##5##(2008-10#2)
of the proposed procedure is##2##5##(2008-10#2)
of the proposed procedure##13##4##(2007-10#2)(2008-10#9)(2008-3#1)(2009-9#1)
of the proposed scheme is##2##5##(1995-2#1)(2008-2#1)
of the proposed scheme##6##4##(1995-2#1)(2008-2#2)(2008-3#2)(2010-6#1)
of the proposed sensor##4##4##(2008-10#4)
of the proposed strategy##2##4##(2007-8#1)(2012-3#1)
of the proposed system is##4##5##(2008-10#1)(2008-2#1)(2008-3#2)
of the proposed system was##4##5##(2008-10#3)(2008-2#1)
of the proposed system##15##4##(2007-11#1)(2008-10#6)(2008-2#3)(2008-3#5)
of the proposed technique is##3##5##(1997-3#1)(2008-2#1)(2008-3#1)
of the proposed technique was##3##5##(2008-10#3)
of the proposed technique##15##4##(1997-3#1)(2007-11#1)(2008-10#5)(2008-2#4)(2008-3#4)
of the proposed treatment##3##4##(1997-8#3)
of the proposed##324##3##(1990-11#1)(1990-6#1)(1990-9#3)(1991-1#1)(1991-9#2)(1992-3#2)(1992-9#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#2)(1995-2#2)(1995-6#1)(1996-1#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-8#3)(2005-10#1)(2005-11#1)(2005-4#1)(2005-5#1)(2006-10#2)(2006-12#1)(2007-10#2)(2007-11#7)(2007-12#6)(2007-8#4)(2007-9#1)(2008-10#125)(2008-2#47)(2008-3#36)(2008-5#1)(2008-6#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#3)(2009-3#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#7)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#3)(2012-1#5)(2012-12#2)(2012-2#4)(2012-3#7)(2013-1#5)(2013-7#1)
of the proprioceptive system##2##4##(2011-1#2)
of the prosecution##2##3##(2008-12#1)(2012-1#1)
of the prosequence##2##3##(1990-10#1)(1995-6#1)
of the prospective payment system##6##5##(1990-12#2)(1991-1#1)(1991-2#2)(1992-12#1)
of the prospective payment##7##4##(1990-12#2)(1991-1#2)(1991-2#2)(1992-12#1)
of the prospective##10##3##(1990-12#2)(1991-1#2)(1991-2#2)(1992-12#1)(2006-10#1)(2007-11#1)(2012-12#1)
of the prostate and##3##4##(1995-11#1)(2006-9#1)(2013-1#1)
of the prostate gland##3##4##(2007-2#1)(2008-12#1)(2008-7#1)
of the prostate in##2##4##(1995-4#1)(2012-3#1)
of the prostate is##2##4##(2007-11#1)(2008-11#1)
of the prostate was##2##4##(1995-8#1)(2007-6#1)
of the prostate were##2##4##(1995-3#1)(2009-8#1)
of the prostate##48##3##(1990-9#1)(1991-8#2)(1991-9#3)(1992-10#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-3#1)(1995-4#3)(1995-8#3)(1996-4#1)(2006-1#1)(2006-12#1)(2006-8#1)(2006-9#4)(2007-11#1)(2007-2#1)(2007-3#3)(2007-6#1)(2007-9#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
of the prostatic##4##3##(1994-7#1)(2006-9#1)(2010-2#1)(2011-12#1)
of the prosthesis##17##3##(1990-10#1)(1990-2#1)(1997-6#1)(2007-7#3)(2007-8#2)(2008-11#1)(2008-6#1)(2009-1#1)(2009-3#2)(2011-2#1)(2011-7#1)(2012-2#1)(2013-1#1)
of the prosthetic group##3##4##(1992-10#1)(1995-8#1)(2013-1#1)
of the prosthetic##6##3##(1992-10#1)(1995-8#1)(1995-9#1)(2007-12#1)(2012-1#1)(2013-1#1)
of the protease domain##2##4##(1994-12#1)(1995-6#1)
of the protease##19##3##(1990-10#1)(1991-10#1)(1991-9#1)(1992-1#1)(1992-4#3)(1992-6#1)(1992-7#1)(1993-12#1)(1994-12#3)(1995-6#1)(1995-9#1)(2008-10#1)(2008-4#1)(2010-4#1)(2013-1#1)
of the proteasome##4##3##(1996-2#3)(2008-4#1)
of the protecting groups##3##4##(1994-9#1)(1996-4#1)(1997-2#1)
of the protecting##4##3##(1994-9#1)(1996-4#1)(1996-9#1)(1997-2#1)
of the protection afforded by##2##5##(2004-12#1)(2008-5#1)
of the protection against##3##4##(1990-2#1)(2008-10#1)(2008-11#1)
of the protection of##2##4##(1995-5#1)(2009-5#1)
of the protection##9##3##(1990-2#1)(1995-5#1)(2004-12#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-5#1)
of the protective effect of##2##5##(1995-12#1)(2011-1#1)
of the protective effect##3##4##(1990-5#1)(1995-12#1)(2011-1#1)
of the protective##12##3##(1990-5#1)(1995-12#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-12#1)(2011-1#1)(2012-12#1)
of the protein affected##2##4##(1996-2#1)(2011-12#1)
of the protein and lipid##4##5##(1993-11#1)(1995-1#1)(2008-5#1)(2008-9#1)
of the protein and not##2##5##(1994-11#1)(1994-8#1)
of the protein and the##4##5##(1997-2#1)(2005-11#1)(2006-8#1)(2009-3#1)
of the protein and##22##4##(1990-7#2)(1991-6#1)(1992-12#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-8#1)(1996-3#1)(1997-2#2)(1997-7#1)(1997-8#1)(2005-11#1)(2006-8#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-3#1)
of the protein appeared to be##2##6##(1992-7#1)(1996-11#1)
of the protein are##7##4##(1991-5#1)(1992-9#1)(1994-8#1)(1995-6#1)(1997-1#1)(1997-7#1)(2009-7#1)
of the protein around##2##4##(1995-10#1)(1997-6#1)
of the protein as determined by##2##6##(1990-5#1)(1993-3#1)
of the protein as determined##3##5##(1990-5#1)(1993-3#1)(1994-11#1)
of the protein as##5##4##(1990-5#1)(1993-3#1)(1994-11#1)(1995-1#1)(2008-8#1)
of the protein backbone##2##4##(1997-1#1)(2008-7#1)
of the protein bands##2##4##(1994-9#1)(2010-3#1)
of the protein binding site##3##5##(1992-11#1)(2010-2#2)
of the protein by##5##4##(1990-12#1)(1991-9#1)(1993-12#1)(1996-3#1)(1997-2#1)
of the protein complex##4##4##(1997-7#1)(2005-10#1)(2008-5#1)(2011-2#1)
of the protein components##2##4##(2008-7#1)(2013-8#1)
of the protein composition##2##4##(1995-7#1)(2010-11#1)
of the protein containing the##2##5##(1991-7#1)(1995-6#1)
of the protein core##2##4##(1995-1#1)(1997-8#1)
of the protein could be##2##5##(1991-8#1)(2008-5#1)
of the protein encoded by the##2##6##(1990-12#1)(1994-6#1)
of the protein encoded by##3##5##(1990-12#1)(1993-6#1)(1994-6#1)
of the protein environment##2##4##(1991-7#1)(1995-1#1)
of the protein folding##2##4##(1991-2#1)(1994-12#1)
of the protein for##3##4##(1991-4#1)(1997-2#1)(1997-4#1)
of the protein fraction##2##4##(1994-11#1)(2011-2#1)
of the protein from the nucleus to the cytoplasm##2##9##(1992-3#1)(1993-9#1)
of the protein from the##3##5##(1992-3#1)(1993-9#1)(2009-12#1)
of the protein from##7##4##(1992-3#1)(1993-9#1)(1994-9#2)(2008-4#1)(2009-12#1)(2010-7#1)
of the protein has been##2##5##(1991-2#1)(1997-7#1)
of the protein has##3##4##(1991-2#1)(1997-7#1)(2009-3#1)
of the protein in the##13##5##(1991-2#1)(1991-3#1)(1992-12#1)(1995-3#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-11#1)(2009-10#1)(2010-2#1)(2011-2#1)
of the protein in##23##4##(1991-2#2)(1991-3#1)(1991-7#1)(1992-12#1)(1992-3#1)(1995-3#4)(1995-5#1)(1996-10#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-7#1)(2005-11#1)(2008-10#1)(2009-10#1)(2010-2#1)(2011-2#1)
of the protein into##3##4##(2007-11#1)(2009-12#1)(2009-3#1)
of the protein is highly##2##5##(1993-12#1)(1996-7#1)
of the protein is not##4##5##(1990-4#1)(1990-6#1)(1991-4#1)(1992-6#1)
of the protein is##23##4##(1990-4#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-2#2)(1991-4#1)(1992-3#2)(1992-6#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-8#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#2)(1997-6#1)
of the protein itself##2##4##(1995-12#1)(1997-2#1)
of the protein kinase C (PKC)##4##6##(1990-5#1)(1992-9#1)(1996-1#1)(1996-11#1)
of the protein kinase C activator##2##6##(1990-10#1)(1992-12#1)
of the protein kinase C##8##5##(1990-10#1)(1990-12#1)(1990-5#1)(1992-12#1)(1992-9#1)(1993-9#1)(1996-1#1)(1996-11#1)
of the protein kinase inhibitor##3##5##(1994-3#1)(1995-3#1)(1997-2#1)
of the protein kinase##18##4##(1990-10#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-8#1)(1992-12#2)(1992-9#1)(1993-6#1)(1993-9#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-9#1)(1997-2#1)(2013-8#1)
of the protein multilayer##2##4##(2008-2#2)
of the protein of interest##5##5##(1992-5#1)(1993-12#1)(2008-4#2)(2008-9#1)
of the protein of##6##4##(1992-5#1)(1992-9#1)(1993-12#1)(2008-4#2)(2008-9#1)
of the protein on the##2##5##(1992-12#1)(2008-11#1)
of the protein on##3##4##(1992-12#1)(2008-11#1)(2008-4#1)
of the protein product##2##4##(1997-4#1)(2008-9#1)
of the protein rather than##2##5##(1995-1#1)(2005-12#1)
of the protein sequence##5##4##(1992-8#1)(1992-9#1)(2008-2#1)(2008-4#2)
of the protein structure is##2##5##(2008-4#1)(2008-7#1)
of the protein structure##6##4##(1993-3#1)(1996-8#1)(1997-6#1)(2008-4#1)(2008-7#1)(2009-9#1)
of the protein substrate##3##4##(1992-11#1)(1995-2#1)(2006-10#1)
of the protein synthesis##3##4##(1994-12#1)(1996-9#1)(1997-2#1)
of the protein that are##2##5##(1993-12#1)(1993-3#1)
of the protein that##4##4##(1993-12#1)(1993-3#1)(1996-7#1)(2008-4#1)
of the protein to the##3##5##(1990-5#1)(1992-3#1)(2006-12#1)
of the protein to##13##4##(1990-5#1)(1991-7#1)(1992-3#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1996-5#1)(1997-7#1)(2006-12#1)(2008-4#1)(2008-9#1)(2012-1#1)
of the protein using##3##4##(1991-7#1)(1991-8#1)(2008-4#1)
of the protein was deduced##2##5##(1991-9#1)(1993-9#1)
of the protein was evaluated##2##5##(1997-2#1)(2010-1#1)
of the protein was not##3##5##(1990-2#1)(1993-3#1)(2009-10#1)
of the protein was##17##4##(1990-12#1)(1990-2#2)(1990-3#1)(1991-1#1)(1991-2#1)(1991-9#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-3#1)(1997-2#2)(1997-7#1)(2007-8#1)(2009-10#1)(2010-1#1)
of the protein were##4##4##(1991-7#1)(1993-2#1)(1994-9#1)(2009-11#1)
of the protein which##3##4##(1990-4#1)(1991-2#1)(1991-7#1)
of the protein with##6##4##(1991-7#1)(1993-12#1)(1994-8#1)(1995-10#1)(1995-11#1)(2011-12#1)
of the protein##487##3##(1990-10#3)(1990-11#1)(1990-12#12)(1990-2#5)(1990-3#2)(1990-4#5)(1990-5#5)(1990-6#3)(1990-7#4)(1990-8#2)(1990-9#3)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#13)(1991-3#2)(1991-4#3)(1991-5#4)(1991-6#5)(1991-7#11)(1991-8#3)(1991-9#2)(1992-11#2)(1992-12#7)(1992-3#6)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#2)(1992-8#3)(1992-9#11)(1993-11#7)(1993-12#5)(1993-2#4)(1993-3#4)(1993-6#5)(1993-8#2)(1993-9#6)(1994-11#8)(1994-12#6)(1994-2#3)(1994-3#3)(1994-5#8)(1994-6#3)(1994-8#10)(1994-9#8)(1995-1#10)(1995-10#3)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#9)(1995-5#2)(1995-6#5)(1995-7#1)(1995-8#3)(1996-1#1)(1996-10#4)(1996-11#2)(1996-2#5)(1996-3#4)(1996-4#1)(1996-5#7)(1996-7#4)(1996-8#8)(1996-9#4)(1997-1#4)(1997-2#13)(1997-3#3)(1997-4#5)(1997-5#2)(1997-6#5)(1997-7#13)(1997-8#2)(2004-2#1)(2005-10#3)(2005-11#3)(2005-12#1)(2006-10#3)(2006-12#3)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#13)(2008-11#6)(2008-12#1)(2008-2#8)(2008-3#1)(2008-4#28)(2008-5#3)(2008-7#13)(2008-8#4)(2008-9#9)(2009-10#2)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#5)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#3)(2010-3#1)(2010-7#1)(2011-1#3)(2011-12#3)(2011-2#3)(2012-1#1)(2012-12#2)(2013-8#2)
of the protein's##2##3##(1991-2#1)(2008-8#1)
of the protein(s)##2##3##(1992-12#1)(1997-4#1)
of the protein-DNA complex##2##4##(1991-11#1)(1995-5#1)
of the protein-bound retinal##2##4##(1991-7#1)(1995-1#1)
of the protein-bound##4##3##(1990-3#2)(1991-7#1)(1995-1#1)
of the protein-coding##3##3##(1990-4#1)(1997-2#1)(2011-2#1)
of the protein-dependent##2##3##(1995-6#1)(2012-3#1)
of the protein-free medium##2##4##(1996-2#2)
of the protein-solvent##2##3##(1990-10#1)(2006-10#1)
of the proteinase inhibitors##2##4##(1996-2#2)
of the proteinase##12##3##(1990-2#1)(1991-3#1)(1991-8#1)(1992-6#2)(1992-9#1)(1994-9#2)(1996-2#2)(1997-8#1)(2008-11#1)
of the proteins and##3##4##(1991-9#1)(1992-12#1)(2009-5#1)
of the proteins are##4##4##(1993-11#1)(1995-10#1)(1997-2#1)(2008-10#1)
of the proteins in the##7##5##(1990-12#1)(1990-9#1)(1995-6#1)(1997-1#1)(2007-9#1)(2008-10#1)(2008-6#1)
of the proteins in##9##4##(1990-12#1)(1990-9#1)(1995-6#1)(1997-1#1)(1997-6#1)(2007-9#1)(2008-10#1)(2008-6#1)(2013-8#1)
of the proteins involved##2##4##(2006-10#1)(2008-4#1)
of the proteins is##3##4##(1993-6#1)(1997-3#1)(2008-10#1)
of the proteins of the##2##5##(2008-5#1)(2011-2#1)
of the proteins of##3##4##(2008-5#1)(2008-7#1)(2011-2#1)
of the proteins was##2##4##(1995-6#1)(2013-8#1)
of the proteins##71##3##(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#1)(1990-9#3)(1991-2#2)(1991-4#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-6#2)(1994-8#1)(1994-9#2)(1995-10#2)(1995-6#3)(1995-7#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-1#2)(2006-10#2)(2007-9#1)(2008-1#1)(2008-10#8)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#2)(2013-1#2)(2013-8#2)
of the proteoglycan##3##3##(1992-6#2)(1997-2#1)
of the proteolytic activity##3##4##(1992-9#1)(2008-6#1)(2010-12#1)
of the proteolytic##10##3##(1991-10#1)(1992-9#1)(1994-11#1)(1997-4#1)(2007-12#1)(2008-6#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)
of the proteome##7##3##(2005-10#1)(2007-12#2)(2008-4#1)(2008-7#1)(2009-6#1)(2010-6#1)
of the prothrombin##2##3##(1990-11#1)(1990-12#1)
of the prothrombinase complex##4##4##(1994-8#4)
of the proto-oncogene##8##3##(1991-11#1)(1992-5#1)(1992-9#1)(1994-12#1)(1994-6#1)(1997-7#1)(2008-4#1)(2011-2#1)
of the protocerebrum##3##3##(2007-12#3)
of the protocol for##2##4##(1997-2#1)(2010-2#1)
of the protocol to##2##4##(2012-3#1)(2013-8#1)
of the protocol will##2##4##(2008-8#1)(2008-9#1)
of the protocol##14##3##(1991-6#1)(1997-2#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-2#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-8#1)
of the protocols for##2##4##(1995-5#1)(2007-9#1)
of the protocols##14##3##(1995-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-2#1)(2013-1#1)
of the proton from##2##4##(1992-6#1)(1994-8#1)
of the proton gradient##2##4##(1990-2#1)(1996-8#1)
of the proton pump##4##4##(2006-10#2)(2008-11#1)(2008-8#1)
of the proton##14##3##(1990-12#1)(1990-2#1)(1991-3#1)(1992-6#1)(1994-8#1)(1996-8#1)(1997-4#1)(2006-10#2)(2006-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-12#1)
of the proton-motive force##2##4##(1996-9#2)
of the proton-translocating##2##3##(1990-2#1)(1997-7#1)
of the protonated##5##3##(1995-6#1)(2006-3#2)(2008-10#2)
of the protonation##3##3##(2008-10#2)(2009-9#1)
of the protons of##2##4##(1993-6#1)(2009-3#1)
of the protons##3##3##(1993-6#1)(2006-10#1)(2009-3#1)
of the protoporphyrin##2##3##(1993-6#1)(1994-5#1)
of the prototype system##2##4##(2006-6#1)(2008-5#1)
of the prototype##11##3##(1992-7#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)
of the prototypic##3##3##(1990-7#1)(1997-1#1)(2008-10#1)
of the protozoan parasite Trypanosoma##2##5##(1995-3#1)(1996-4#1)
of the protozoan parasite##3##4##(1993-5#1)(1995-3#1)(1996-4#1)
of the protozoan##5##3##(1992-8#1)(1993-5#1)(1995-3#1)(1996-4#1)(2007-9#1)
of the provenance##2##3##(2006-12#1)(2008-10#1)
of the provided##2##3##(2006-2#1)(2008-10#1)
of the provider##3##3##(2006-10#1)(2010-10#1)(2010-3#1)
of the provider's##2##3##(2008-11#1)(2013-8#1)
of the province of##2##4##(2008-10#1)(2009-7#1)
of the province##10##3##(1992-10#2)(2007-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-7#1)(2010-11#1)(2010-12#1)(2013-1#1)
of the provirus##2##3##(1994-3#1)(2008-5#1)
of the provision of##4##4##(1995-3#1)(2004-7#1)(2008-10#1)(2012-2#1)
of the provisions##3##3##(1991-3#1)(1992-3#1)(1993-1#1)
of the provoking agent##2##4##(2006-6#2)
of the provoking##3##3##(1993-6#1)(2006-6#2)
of the proximal and##2##4##(2008-11#1)(2012-12#1)
of the proximal epiphysis##3##4##(2007-11#3)
of the proximal femur after treatment##2##6##(2007-11#1)(2007-7#1)
of the proximal femur after##3##5##(2007-11#1)(2007-7#2)
of the proximal femur on##2##5##(2007-11#1)(2007-7#1)
of the proximal femur##29##4##(2007-11#7)(2007-5#2)(2007-7#13)(2008-6#1)(2009-3#3)(2011-2#1)(2013-1#2)
of the proximal fibula##3##4##(2008-1#2)(2009-1#1)
of the proximal histidine##2##4##(1991-7#1)(1994-5#1)
of the proximal humerus fractures##2##5##(2007-8#2)
of the proximal humerus##7##4##(2007-8#2)(2008-6#3)(2009-3#1)(2010-7#1)
of the proximal interphalangeal joint##3##5##(2006-3#2)(2006-4#1)
of the proximal interphalangeal##6##4##(2006-10#1)(2006-3#2)(2006-4#1)(2008-9#1)(2011-2#1)
of the proximal jejunum##2##4##(2006-8#1)(2008-10#1)
of the proximal nail fold##2##5##(2008-5#2)
of the proximal part of the##2##6##(2007-5#1)(2013-8#1)
of the proximal part of##3##5##(2007-5#1)(2012-2#1)(2013-8#1)
of the proximal phalanx##3##4##(2008-12#1)(2010-3#2)
of the proximal portion of the##2##6##(1993-8#1)(1996-3#1)
of the proximal promoter region##2##5##(1992-5#1)(1993-4#1)
of the proximal promoter##3##4##(1992-5#1)(1993-4#1)(1995-10#1)
of the proximal tibia##4##4##(2008-6#1)(2008-8#1)(2009-3#1)(2009-9#1)
of the proximal tibial physis##2##5##(2012-12#2)
of the proximal tubule##3##4##(1990-11#1)(1993-3#1)(2008-11#1)
of the proximal##105##3##(1990-11#1)(1990-12#1)(1990-8#1)(1991-7#1)(1992-5#1)(1992-9#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-5#2)(1995-10#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-7#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-3#4)(2006-4#1)(2006-8#1)(2007-11#12)(2007-12#3)(2007-3#1)(2007-5#3)(2007-7#13)(2007-8#5)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#2)(2008-5#2)(2008-6#5)(2008-8#1)(2008-9#1)(2009-1#1)(2009-3#5)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-7#1)(2011-2#2)(2012-12#3)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#2)
of the proximate##2##3##(2008-8#1)(2010-2#1)
of the proximity of this##2##5##(1996-3#1)(2007-12#1)
of the proximity of##3##4##(1996-3#1)(2007-12#1)(2009-3#1)
of the proximity##4##3##(1996-3#1)(2007-12#2)(2009-3#1)
of the proxy##2##3##(2011-1#2)
of the psbE##3##3##(1994-12#3)
of the pseudoaneurysm##3##3##(2007-8#1)(2010-12#1)(2012-2#1)
of the pseudoautosomal##2##3##(1990-11#1)(1995-11#1)
of the pseudocysts##2##3##(1991-8#1)(2013-1#1)
of the pseudoknot##2##3##(1990-7#1)(1996-8#1)
of the psoas##2##3##(1991-3#1)(1996-6#1)
of the psychiatric family nurse practitioner##2##6##(2004-3#2)
of the psychiatric##13##3##(1992-3#1)(1993-2#1)(1993-6#1)(2004-3#2)(2008-4#1)(2008-9#1)(2009-10#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#1)
of the psychiatrist##2##3##(1995-4#1)(2012-12#1)
of the psychological##8##3##(1990-10#1)(1996-9#1)(2006-8#1)(2008-2#1)(2008-5#1)(2009-10#1)(2011-12#1)(2012-5#1)
of the psychology of##2##4##(2006-7#1)(2008-12#1)
of the psychology##3##3##(2006-7#1)(2008-12#1)(2013-1#1)
of the psychometric##3##3##(2010-7#1)(2011-1#1)(2012-2#1)
of the psychopathology##2##3##(2008-1#1)(2009-7#1)
of the psychosocial##2##3##(2007-12#1)(2012-12#1)
of the pterothorax of##2##4##(2007-12#2)
of the pubic symphysis##4##4##(1997-7#3)(2007-2#1)
of the public and health professionals##2##6##(2008-5#2)
of the public and private sectors##2##6##(1996-2#1)(2005-5#1)
of the public and private##4##5##(1996-2#1)(2005-5#1)(2008-9#1)(2011-2#1)
of the public and##14##4##(1995-5#1)(1996-12#1)(1996-2#2)(2004-9#1)(2005-5#1)(2006-10#1)(2006-11#1)(2008-5#2)(2008-9#1)(2011-2#1)(2012-3#1)(2013-7#1)
of the public health system##2##5##(1997-2#1)(2006-5#1)
of the public health##11##4##(1992-4#1)(1995-12#1)(1997-2#1)(2006-10#1)(2006-2#1)(2006-5#1)(2008-1#1)(2008-10#1)(2011-1#2)(2012-12#1)
of the public to##4##4##(1991-3#2)(1993-8#1)(2008-5#1)
of the public##51##3##(1991-3#3)(1992-4#1)(1993-8#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-9#1)(1997-2#1)(1997-8#2)(2004-9#1)(2005-5#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-4#1)(2010-2#1)(2010-6#1)(2011-1#2)(2011-2#3)(2011-7#1)(2012-12#1)(2012-3#2)(2013-7#1)
of the public's##2##3##(1991-3#1)(2013-7#1)
of the publication of##2##4##(1994-10#1)(2013-1#1)
of the publication##5##3##(1994-10#1)(2009-4#1)(2012-1#1)(2012-2#1)(2013-1#1)
of the publications##2##3##(2008-1#1)(2010-8#1)
of the published literature on##2##5##(2006-10#1)(2009-9#1)
of the published literature was combined with a consensus process around the interpretation of the evidence in the context of conventional practice to develop an evidence-based practice guideline##2##28##(2008-6#2)
of the published literature##6##4##(2006-10#1)(2008-4#1)(2008-6#3)(2009-9#1)
of the published reports##2##4##(2006-10#1)(2011-1#1)
of the published##16##3##(1990-7#1)(1992-3#1)(1994-12#1)(1996-11#1)(2006-10#2)(2007-12#1)(2008-3#1)(2008-4#1)(2008-6#3)(2009-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
of the pullets and local chickens##2##6##(2008-5#2)
of the pulmonary arteries##9##4##(2005-11#1)(2008-10#1)(2008-4#2)(2008-7#3)(2013-1#2)
of the pulmonary artery in##3##5##(2010-10#1)(2013-7#2)
of the pulmonary artery is a##2##6##(2007-8#2)
of the pulmonary artery##16##4##(2006-10#1)(2007-8#3)(2008-11#1)(2010-10#3)(2012-2#1)(2013-1#1)(2013-7#6)
of the pulmonary valve##4##4##(2007-8#2)(2008-4#1)(2009-9#1)
of the pulmonary vascular##5##4##(1991-2#1)(1991-8#1)(2006-10#1)(2008-10#1)(2010-6#1)
of the pulmonary vasculature and##2##5##(2010-10#1)(2013-1#1)
of the pulmonary vasculature##5##4##(2010-10#1)(2010-5#1)(2013-1#3)
of the pulmonary vein##2##4##(2007-8#2)
of the pulmonary##57##3##(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1997-3#1)(2005-11#2)(2006-10#2)(2006-6#1)(2007-11#2)(2007-8#9)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#3)(2009-9#1)(2010-10#5)(2010-12#2)(2010-5#1)(2010-6#1)(2012-1#1)(2012-2#1)(2013-1#6)(2013-7#6)(2013-8#1)
of the pulp chamber##4##4##(1994-5#3)(2013-8#1)
of the pulp##7##3##(1994-5#3)(2006-8#1)(2008-5#1)(2011-2#1)(2013-8#1)
of the pulse energy##4##4##(2007-12#3)(2008-1#1)
of the pulse in the##2##5##(2006-5#1)(2007-12#1)
of the pulse in##3##4##(2006-5#1)(2007-12#2)
of the pulse is##2##4##(2007-12#1)(2008-2#1)
of the pulse shape##2##4##(2007-12#2)
of the pulse train##6##4##(2006-5#1)(2007-11#2)(2007-12#2)(2008-1#1)
of the pulse width##3##4##(2008-1#1)(2008-3#2)
of the pulse##50##3##(1990-8#1)(1993-1#1)(2006-5#2)(2007-11#11)(2007-12#24)(2008-1#3)(2008-2#1)(2008-3#6)(2008-4#1)
of the pulse-pair##2##3##(2008-2#2)
of the pulsed##3##3##(1991-3#1)(2008-3#2)
of the pulses in the##2##5##(2007-11#1)(2007-12#1)
of the pulses##9##3##(2007-11#1)(2007-12#6)(2008-2#1)(2008-5#1)
of the pump and the##2##5##(2007-12#1)(2008-3#1)
of the pump and##3##4##(2007-12#1)(2008-3#2)
of the pump beam was##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
of the pump beam##7##4##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)
of the pump laser##5##4##(2007-11#2)(2007-12#2)(2008-2#1)
of the pump light##3##4##(2007-12#1)(2008-1#1)(2008-2#1)
of the pump pulse##6##4##(2007-11#2)(2007-12#3)(2008-1#1)
of the pump source##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
of the pump##47##3##(1992-1#1)(1994-9#1)(2006-7#1)(2007-11#7)(2007-12#18)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#6)(2008-3#8)(2008-5#1)
of the pump's##2##3##(2007-12#1)(2008-10#1)
of the pumped##3##3##(1996-1#1)(2008-3#2)
of the pumping##4##3##(1990-3#1)(2007-12#2)(2008-3#1)
of the pupal##4##3##(2007-12#4)
of the pupil function##3##4##(2008-2#3)
of the pupil##7##3##(2007-12#1)(2008-2#3)(2008-3#1)(2008-7#2)
of the pupillary##2##3##(1992-7#1)(2008-7#1)
of the pupils##2##3##(2008-2#1)(2012-12#1)
of the pups##2##3##(1993-2#1)(1996-4#1)
of the pure analyte##2##4##(2008-10#2)
of the pure component spectra##2##5##(2007-12#2)
of the pure component##3##4##(2007-12#3)
of the pure phospholipid##4##4##(1990-2#1)(2006-10#3)
of the pure##35##3##(1990-12#1)(1990-2#1)(1990-4#1)(1990-9#1)(1995-4#1)(1996-2#1)(1997-5#1)(2005-11#4)(2006-10#4)(2006-5#1)(2007-12#4)(2007-6#1)(2008-10#7)(2008-12#2)(2008-5#1)(2009-3#1)(2010-10#2)(2010-4#1)
of the purification of##2##4##(1996-2#1)(2008-4#1)
of the purification##6##3##(1990-9#1)(1992-6#1)(1994-8#1)(1996-2#1)(2008-1#1)(2008-4#1)
of the purified enzyme was##5##5##(1990-11#1)(1990-2#1)(1991-8#1)(1997-6#1)(2008-5#1)
of the purified enzyme##16##4##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1991-8#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1995-1#1)(1996-7#2)(1997-4#1)(1997-6#1)(2006-3#1)(2008-5#1)
of the purified epimerase##2##4##(1994-9#2)
of the purified isozymes##2##4##(1990-7#1)(1991-8#1)
of the purified protein was##2##5##(1990-12#1)(2008-10#1)
of the purified protein##9##4##(1990-12#1)(1991-7#1)(1992-12#1)(1992-3#2)(1992-8#1)(1994-12#1)(2008-10#1)(2008-2#1)
of the purified recombinant human##2##5##(1990-6#1)(2008-8#1)
of the purified recombinant##4##4##(1990-12#1)(1990-6#1)(2006-12#1)(2008-8#1)
of the purified##86##3##(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#3)(1991-1#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#2)(1991-8#2)(1991-9#1)(1992-11#2)(1992-12#3)(1992-3#2)(1992-8#3)(1992-9#2)(1993-11#1)(1993-5#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-3#1)(1996-5#1)(1996-7#2)(1997-2#2)(1997-4#1)(1997-6#2)(2005-11#1)(2006-12#1)(2006-3#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-4#3)(2008-5#1)(2008-8#3)(2012-2#1)(2013-1#1)
of the purine base##2##4##(2008-10#1)(2008-5#1)
of the purine ring##2##4##(2006-12#1)(2010-2#1)
of the purine##10##3##(1992-9#1)(1995-3#1)(1996-8#1)(2006-12#2)(2008-10#2)(2008-5#1)(2010-2#2)
of the purines and pyrimidines##3##5##(1990-8#1)(1991-10#2)
of the purines##4##3##(1990-8#1)(1991-10#2)(2008-4#1)
of the purity of##2##4##(1992-11#1)(2008-10#1)
of the purple color##2##4##(2008-10#2)
of the purple membrane##2##4##(1994-11#1)(1995-6#1)
of the purple##8##3##(1991-8#1)(1994-11#1)(1995-6#1)(2007-3#1)(2008-10#3)(2010-2#1)
of the purpose and##2##4##(1995-1#1)(1995-12#1)
of the purpose##3##3##(1995-1#1)(1995-12#1)(2008-9#1)
of the putative C-terminal##2##4##(1990-2#1)(1990-7#1)
of the putative Crp/Fnr family##2##5##(2006-9#2)
of the putative active site##3##5##(1991-12#1)(1997-3#1)(1997-7#1)
of the putative promoter##2##4##(1992-10#1)(2009-10#1)
of the putative tetrahedral intermediate##2##5##(1990-2#1)(1992-5#1)
of the putative##71##3##(1990-2#3)(1990-6#1)(1990-7#3)(1991-12#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-5#1)(1992-6#4)(1992-7#2)(1993-11#1)(1993-12#3)(1993-2#2)(1993-6#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-10#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-7#2)(2006-9#2)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-11#1)(2009-9#1)(2012-11#1)(2012-12#2)(2013-1#1)
of the putatively##2##3##(1990-7#1)(2008-10#1)
of the pyloric##3##3##(1993-12#1)(2005-12#1)(2010-12#1)
of the pyramid##3##3##(2013-1#3)
of the pyramidal##4##3##(1990-4#1)(1996-5#1)(2006-7#1)(2010-12#1)
of the pyrazole##2##3##(1996-12#1)(2008-10#1)
of the pyridine ring##2##4##(1993-4#1)(2009-11#1)
of the pyridine##6##3##(1992-1#1)(1993-4#1)(1993-8#1)(1995-11#1)(2006-4#1)(2009-11#1)
of the pyridinic ring##2##4##(1991-2#1)(1994-8#1)
of the pyrimidine ring##5##4##(1991-4#1)(1993-9#1)(1996-6#3)
of the pyrimidine##9##3##(1990-7#1)(1991-4#1)(1993-9#1)(1995-3#1)(1996-6#4)(2007-11#1)
of the pyrolysis##2##3##(2008-10#1)(2008-3#1)
of the pyrrolidine##3##3##(2006-12#1)(2007-11#1)(2007-8#1)
of the pyruvate dehydrogenase multienzyme complex of Bacillus stearothermophilus##2##9##(1990-7#2)
of the pyruvate dehydrogenase##5##4##(1990-7#3)(2005-8#1)(2010-2#1)
of the pyruvate##11##3##(1990-7#3)(1990-8#1)(1992-8#1)(1993-8#2)(1996-5#1)(2005-8#1)(2008-10#1)(2010-2#1)
of the quadrat##3##3##(2008-10#3)
of the quadratic##4##3##(2007-12#2)(2008-2#2)
of the quadrature##2##3##(2008-2#1)(2011-1#1)
of the quadriceps femoris##2##4##(2007-7#1)(2012-1#1)
of the quadriceps muscle and##2##5##(2009-9#1)(2012-3#1)
of the quadriceps muscle of the thigh##3##7##(2007-11#2)(2012-1#1)
of the quadriceps muscle##6##4##(2007-11#2)(2008-4#1)(2009-9#1)(2012-1#1)(2012-3#1)
of the quadriceps##12##3##(2007-11#2)(2007-7#1)(2007-8#2)(2008-3#1)(2008-4#1)(2009-9#1)(2012-1#2)(2012-3#1)(2013-1#1)
of the quail##2##3##(1990-4#1)(1993-6#1)
of the qualitative##6##3##(1990-8#1)(1997-3#1)(2007-9#1)(2008-12#1)(2012-3#1)(2013-1#1)
of the quality and##3##4##(1991-1#1)(2008-7#1)(2009-7#1)
of the quality control##2##4##(2005-7#1)(2008-10#1)
of the quality factor##4##4##(2007-12#3)(2010-4#1)
of the quality of a##2##5##(2008-10#1)(2008-7#1)
of the quality of care##4##5##(1993-3#1)(1995-2#1)(2009-4#1)(2010-12#1)
of the quality of drinking water in##2##7##(2011-2#1)(2013-8#1)
of the quality of life in##3##6##(1992-6#1)(1997-4#1)(2011-1#1)
of the quality of life of the##3##7##(1994-4#1)(2007-11#1)(2008-5#1)
of the quality of life##7##5##(1992-6#1)(1994-4#1)(1997-4#1)(2007-11#1)(2008-5#1)(2009-4#1)(2011-1#1)
of the quality of prenatal##2##5##(1993-3#1)(1996-6#1)
of the quality of the##6##5##(1993-1#1)(1994-3#1)(2006-5#1)(2007-12#1)(2008-11#1)(2012-2#1)
of the quality of##41##4##(1992-2#1)(1992-6#1)(1993-1#1)(1993-3#2)(1993-5#1)(1994-11#1)(1994-3#1)(1994-4#1)(1995-2#1)(1996-1#1)(1996-6#1)(1997-1#1)(1997-4#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2010-1#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
of the quality##59##3##(1991-1#1)(1991-2#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-3#2)(1993-5#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-4#1)(1995-2#1)(1996-1#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#2)(2009-7#1)(2010-1#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-8#2)
of the quantification of##2##4##(1995-6#1)(2008-10#1)
of the quantification##4##3##(1995-6#1)(2008-10#1)(2010-8#1)(2013-1#1)
of the quantitative trait##2##4##(2008-10#1)(2012-3#1)
of the quantitative##14##3##(1990-9#1)(1991-8#1)(1992-11#1)(1992-3#1)(1996-12#1)(1996-7#1)(2006-12#1)(2008-10#2)(2008-5#1)(2009-10#1)(2010-11#1)(2012-3#2)
of the quantities of##2##4##(2008-10#2)
of the quantity of##6##4##(1992-3#1)(1993-12#1)(1995-5#1)(2008-10#2)(2008-4#1)
of the quantity##7##3##(1992-3#1)(1993-12#1)(1995-5#1)(2008-10#2)(2008-4#1)(2010-9#1)
of the quantum dots by##3##5##(1995-3#1)(2007-11#1)(2008-7#1)
of the quantum dots##6##4##(1995-3#1)(2007-11#2)(2008-7#3)
of the quantum noise##2##4##(2007-12#2)
of the quantum##14##3##(1995-3#1)(2005-11#2)(2007-11#3)(2007-12#3)(2007-9#1)(2008-2#1)(2008-7#3)
of the quantum-sized ZnO##2##4##(2009-8#2)
of the quaternary structure##2##4##(1990-9#1)(2008-4#1)
of the quaternary##6##3##(1990-9#1)(1995-11#1)(1995-8#1)(1997-2#1)(2007-8#1)(2008-4#1)
of the quenching effect##3##4##(2007-12#1)(2008-10#2)
of the quenching##10##3##(1991-5#1)(1996-1#1)(1997-7#1)(2007-12#2)(2008-10#4)(2008-2#1)
of the query##2##3##(2008-2#1)(2008-4#1)
of the questionnaire was##2##4##(2006-8#1)(2007-3#1)
of the questionnaire##12##3##(1996-3#1)(2004-10#2)(2006-8#1)(2007-2#1)(2007-3#1)(2008-11#1)(2010-4#1)(2012-1#1)(2012-2#2)(2013-1#1)
of the questionnaires##2##3##(1994-2#1)(2009-12#1)
of the questions correctly##2##4##(2007-9#2)
of the questions##16##3##(1990-2#1)(1996-1#1)(2004-12#1)(2005-10#1)(2006-5#1)(2007-9#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-5#1)(2012-1#1)(2013-1#3)
of the quick##3##3##(2007-1#1)(2008-5#1)(2012-2#1)
of the quinoline##2##3##(1993-9#1)(2008-7#1)
of the quinolones##2##3##(2005-8#1)(2008-5#1)
of the quinone##5##3##(1990-7#1)(1994-3#1)(1995-5#1)(1997-1#1)(2006-8#1)
of the rCCSP##2##3##(1997-2#2)
of the rDNA##10##3##(1996-5#1)(2008-10#8)(2008-5#1)
of the rOAT##2##3##(1993-3#2)
of the rPRL##2##3##(1994-8#2)
of the rRNA##4##3##(1996-8#1)(2008-10#1)(2010-4#2)
of the rVLM##2##3##(1997-6#2)
of the rab##3##3##(1992-8#2)(1993-8#1)
of the rab3##2##3##(1993-3#1)(1995-8#1)
of the rabbit skeletal muscle ryanodine##2##6##(1994-9#1)(2008-9#1)
of the rabbit##24##3##(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-11#1)(1993-12#2)(1993-8#1)(1994-10#1)(1994-12#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-10#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-4#2)(2008-9#1)
of the rabbit's##2##3##(1990-10#1)(2008-5#1)
of the rabies##2##3##(1991-12#2)
of the race##3##3##(2004-3#1)(2008-10#1)(2009-7#1)
of the racemic##2##3##(1990-3#1)(2008-5#1)
of the radial artery to##3##5##(2007-8#2)(2011-2#1)
of the radial artery##13##4##(1990-4#2)(1990-8#2)(2007-7#1)(2007-8#4)(2008-7#1)(2011-2#2)(2013-1#1)
of the radial breathing##2##4##(2008-10#2)
of the radial head##2##4##(2007-11#1)(2008-4#1)
of the radial nerve##6##4##(2006-3#2)(2007-8#1)(2008-7#2)(2012-2#1)
of the radial##39##3##(1990-4#2)(1990-8#2)(1991-12#1)(1995-6#1)(2006-12#1)(2006-3#4)(2006-5#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#7)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#3)(2011-2#5)(2012-2#2)(2013-1#1)
of the radiance##5##3##(2008-2#2)(2008-3#2)(2008-6#1)
of the radiation dose##2##4##(2008-2#1)(2008-5#1)
of the radiation oncologist##2##4##(2009-11#1)(2011-2#1)
of the radiation##34##3##(2006-4#2)(2006-8#1)(2007-11#1)(2007-12#4)(2007-4#1)(2008-10#2)(2008-2#6)(2008-3#4)(2008-5#1)(2008-7#4)(2009-11#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#2)
of the radiative transfer equation##5##5##(2007-12#1)(2008-2#3)(2008-3#1)
of the radiative transfer##8##4##(2007-12#1)(2008-2#4)(2008-3#3)
of the radiative##14##3##(2007-11#1)(2007-12#2)(2008-2#7)(2008-3#4)
of the radical pair state##2##5##(1991-7#2)
of the radical to##3##4##(1995-2#2)(2008-10#1)
of the radical##13##3##(1991-7#2)(1995-2#2)(1996-2#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-5#1)(2011-1#1)
of the radicals are##2##4##(2007-3#1)(2008-10#1)
of the radicals##7##3##(1997-8#3)(2007-11#1)(2007-3#1)(2008-10#2)
of the radii of both the drop base and the wetted##2##11##(2005-11#2)
of the radii of##3##4##(2005-11#2)(2008-2#1)
of the radii##4##3##(1996-12#1)(2005-11#2)(2008-2#1)
of the radioactive##4##3##(1990-2#1)(1991-3#1)(1992-3#1)(1994-5#1)
of the radioactivity in the##2##5##(1997-3#1)(2008-4#1)
of the radioactivity was##2##4##(1991-7#1)(1994-3#1)
of the radioactivity##6##3##(1990-3#1)(1991-1#1)(1991-7#1)(1994-3#1)(1997-3#1)(2008-4#1)
of the radiographic##3##3##(1993-1#1)(2006-10#1)(2008-7#1)
of the radioisotope##2##3##(1990-11#1)(1992-2#1)
of the radiolabeled##10##3##(1990-8#1)(1990-9#1)(1991-2#1)(1992-12#1)(1993-7#1)(1994-5#2)(1994-8#1)(1995-8#1)(1996-8#1)
of the radiolabelled##7##3##(1990-1#1)(1990-2#1)(1992-6#1)(1994-12#2)(1994-6#1)(2007-12#1)
of the radioligand was##2##4##(1990-5#1)(1996-3#1)
of the radioligand##3##3##(1990-5#1)(1991-12#1)(1996-3#1)
of the radiologic##3##3##(1992-1#1)(2006-6#1)(2007-4#1)
of the radiological##7##3##(2007-8#1)(2007-9#1)(2009-9#1)(2011-2#2)(2012-2#1)(2012-3#1)
of the radiologist assistant##4##4##(2007-4#4)
of the radiologist##7##3##(2007-4#7)
of the radiology department##4##4##(1995-2#1)(1996-1#1)(2012-2#2)
of the radiology##7##3##(1995-2#1)(1995-3#1)(1996-1#1)(2007-4#2)(2012-2#2)
of the radionuclide##4##3##(2007-5#1)(2007-8#1)(2008-7#2)
of the radionuclides##2##3##(1994-6#1)(2008-10#1)
of the radioprotective##2##3##(1994-5#1)(2008-5#1)
of the radiotherapy##2##3##(2008-10#1)(2008-2#1)
of the radius and the##3##5##(1995-6#2)(2008-3#1)
of the radius##12##3##(1991-11#1)(1991-4#1)(1995-6#3)(2006-10#1)(2006-3#1)(2006-5#1)(2008-3#1)(2009-3#1)(2012-2#2)
of the rain##2##3##(2008-10#1)(2008-5#1)
of the rainbow trout egg envelope##2##6##(1994-5#2)
of the rainbow trout##6##4##(1992-12#1)(1994-5#2)(1995-7#1)(2008-10#1)(2008-5#1)
of the rainbow##8##3##(1992-12#1)(1994-5#2)(1995-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)
of the rainy season to##2##5##(2007-2#1)(2013-7#1)
of the rainy season##6##4##(2006-2#1)(2007-2#1)(2007-3#2)(2013-7#2)
of the random birefringence##2##4##(2007-12#2)
of the random##11##3##(1991-6#1)(1993-12#1)(1995-2#1)(2006-10#2)(2007-11#1)(2007-12#2)(2008-2#2)(2010-6#1)
of the randomized trials##2##4##(1995-11#1)(2010-7#1)
of the randomized##5##3##(1991-5#1)(1995-11#1)(2005-11#1)(2008-10#1)(2010-7#1)
of the range of hip movement##2##6##(2007-7#2)
of the range of motion of##2##6##(2007-8#2)
of the range of movement##2##5##(2007-7#2)
of the range of validity of##2##6##(2008-3#2)
of the range of##16##4##(1992-1#1)(2007-7#4)(2007-8#2)(2008-3#2)(2008-8#5)(2008-9#1)(2011-1#1)
of the range##25##3##(1992-1#1)(2007-1#1)(2007-12#1)(2007-7#4)(2007-8#2)(2008-10#2)(2008-2#1)(2008-3#3)(2008-8#5)(2008-9#1)(2010-9#1)(2011-1#1)(2013-1#2)
of the rapeseed oil was converted at##2##7##(2008-6#2)
of the rapid growth##2##4##(2007-11#1)(2010-7#1)
of the rapid phase##2##4##(1994-8#1)(2007-12#1)
of the rapid test##3##4##(2007-11#1)(2007-12#1)(2012-2#1)
of the rapid##25##3##(1990-11#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#2)(2007-12#4)(2007-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-7#1)(2012-2#1)
of the rapidity##2##3##(1997-4#1)(2007-7#1)
of the rapidly exchangeable sites##2##5##(1995-6#2)
of the rapidly growing##4##4##(1992-3#1)(2011-2#1)(2013-1#2)
of the rapidly##9##3##(1992-3#1)(1993-4#1)(1995-6#2)(2007-2#1)(2008-12#1)(2011-2#1)(2013-1#2)
of the rare earth elements##2##5##(2008-10#2)
of the rare earth##5##4##(2005-4#1)(2006-4#1)(2008-10#3)
of the rare earths##5##4##(1992-11#1)(2008-10#4)
of the rare##31##3##(1992-11#1)(1994-11#1)(1994-3#1)(1997-5#1)(2005-10#1)(2005-4#1)(2006-4#1)(2007-8#1)(2008-10#9)(2008-3#1)(2009-3#1)(2009-4#1)(2010-10#2)(2010-4#1)(2010-5#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
of the rare-earth metal atoms##2##5##(2010-5#2)
of the rare-earth##3##3##(2007-11#1)(2010-5#2)
of the ras superfamily##3##4##(1992-8#1)(1993-6#1)(1994-6#1)
of the ras##5##3##(1991-2#1)(1992-8#2)(1993-6#1)(1994-6#1)
of the ras-related rap2 protein##2##5##(1991-9#1)(1992-11#1)
of the rat AT1##2##4##(1992-3#1)(1992-5#1)
of the rat FS##2##4##(1990-11#2)
of the rat IGF-I gene##2##5##(1991-4#1)(1995-10#1)
of the rat adrenal##4##4##(1990-5#1)(1995-10#2)(1996-5#1)
of the rat aldolase B gene##2##6##(1991-4#2)
of the rat aldolase B##3##5##(1990-12#1)(1991-4#2)
of the rat and human##3##5##(1991-10#1)(1993-3#1)(1995-2#1)
of the rat and monkey##2##5##(1991-4#1)(1996-9#1)
of the rat and##9##4##(1991-10#1)(1991-2#1)(1991-4#1)(1993-3#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-9#1)(1997-5#1)
of the rat anterior##2##4##(1992-3#1)(2009-2#1)
of the rat at the##2##5##(1993-12#1)(2008-8#1)
of the rat at##3##4##(1993-12#1)(1994-2#1)(2008-8#1)
of the rat bladder##3##4##(1990-5#3)
of the rat brain##19##4##(1991-2#1)(1991-3#2)(1991-4#1)(1992-10#1)(1993-8#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-3#1)(1995-7#1)(1996-11#1)(1996-5#1)(1997-5#1)(1997-8#1)(2005-8#1)(2007-1#1)(2008-10#1)
of the rat by##4##4##(1992-6#1)(1992-9#1)(1996-9#1)(2010-2#1)
of the rat class I alcohol dehydrogenase##2##7##(1993-3#2)
of the rat for##3##4##(1995-5#1)(1997-2#1)(2008-11#1)
of the rat gene encoding##2##5##(1993-3#1)(1993-8#1)
of the rat gene##5##4##(1991-7#1)(1992-12#1)(1993-3#1)(1993-8#1)(1994-11#1)
of the rat growth hormone (rGH)##2##6##(1990-8#1)(1996-8#1)
of the rat growth hormone##3##5##(1990-8#1)(1996-8#2)
of the rat hippocampal slice##2##5##(1990-4#1)(1991-9#1)
of the rat hippocampus##5##4##(1990-7#1)(1994-2#1)(1995-5#1)(1995-7#1)(1997-5#1)
of the rat hypothalamus##3##4##(1993-12#1)(1996-9#2)
of the rat in order to##3##6##(1990-2#1)(1992-8#1)(2008-7#1)
of the rat in vitro##2##5##(1991-3#1)(1995-12#1)
of the rat in##7##4##(1990-2#1)(1991-3#1)(1991-8#1)(1992-8#1)(1995-12#1)(1996-3#1)(2008-7#1)
of the rat insulin-like growth factor binding##2##7##(1992-6#1)(1993-3#1)
of the rat insulin-like growth##3##5##(1992-6#1)(1993-3#1)(1995-10#1)
of the rat is##2##4##(1992-3#1)(1994-8#1)
of the rat kidney##3##4##(1992-6#1)(1995-1#1)(1995-12#1)
of the rat liver##5##4##(1990-5#1)(1991-3#1)(1991-5#1)(1994-3#1)(2008-10#1)
of the rat neuronal cell##4##5##(1993-6#1)(2008-11#3)
of the rat olfactory bulb##3##5##(1990-2#1)(1990-7#1)(1993-7#1)
of the rat pituitary##2##4##(1991-9#1)(1992-2#1)
of the rat renal##2##4##(1990-2#1)(1991-2#1)
of the rat spinal cord##5##5##(1991-9#1)(1993-12#1)(1994-2#1)(1995-12#1)(1995-3#1)
of the rat spinal##6##4##(1991-9#1)(1993-12#1)(1994-2#2)(1995-12#1)(1995-3#1)
of the rat stomach##2##4##(1997-4#2)
of the rat striatum##2##4##(1994-2#1)(1996-3#1)
of the rat testis##2##4##(1992-3#1)(2013-1#1)
of the rat trachea##2##4##(2008-9#2)
of the rat type 1##2##5##(1992-7#1)(1997-8#1)
of the rat tyrosine##2##4##(1991-11#1)(1997-6#1)
of the rat using##4##4##(1990-5#1)(1994-5#2)(1996-9#1)
of the rat vibrissal##2##4##(2011-2#2)
of the rat was##2##4##(1992-10#1)(1995-5#1)
of the rat were investigated using##2##6##(1992-8#1)(1995-12#1)
of the rat were studied##2##5##(1990-10#1)(1990-4#1)
of the rat were##6##4##(1990-10#1)(1990-4#1)(1990-9#1)(1992-8#1)(1993-2#1)(1995-12#1)
of the rat with##2##4##(1991-2#1)(1993-4#1)
of the rat##357##3##(1990-10#5)(1990-11#3)(1990-12#2)(1990-2#5)(1990-4#3)(1990-5#12)(1990-6#1)(1990-7#4)(1990-8#3)(1990-9#2)(1991-1#2)(1991-10#3)(1991-11#4)(1991-12#2)(1991-2#6)(1991-3#5)(1991-4#6)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#4)(1991-9#6)(1992-10#3)(1992-11#3)(1992-12#4)(1992-2#4)(1992-3#10)(1992-5#4)(1992-6#4)(1992-7#1)(1992-8#4)(1992-9#4)(1993-11#2)(1993-12#9)(1993-2#4)(1993-3#11)(1993-4#6)(1993-6#3)(1993-7#2)(1993-8#6)(1993-9#1)(1994-10#5)(1994-11#5)(1994-12#7)(1994-2#10)(1994-3#3)(1994-4#1)(1994-5#7)(1994-6#1)(1994-8#5)(1994-9#2)(1995-1#3)(1995-10#5)(1995-11#2)(1995-12#9)(1995-2#2)(1995-3#7)(1995-5#6)(1995-6#2)(1995-7#4)(1995-8#1)(1996-1#4)(1996-10#1)(1996-11#3)(1996-12#2)(1996-2#2)(1996-3#3)(1996-5#6)(1996-8#4)(1996-9#7)(1997-2#3)(1997-3#1)(1997-4#4)(1997-5#6)(1997-6#2)(1997-7#6)(1997-8#6)(2005-8#1)(2007-1#1)(2007-12#1)(2007-3#3)(2007-9#1)(2008-10#2)(2008-11#8)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-2#1)(2009-5#1)(2009-8#1)(2010-2#1)(2011-2#4)(2013-1#3)(2013-8#1)
of the rat's behaviour##2##4##(1993-9#2)
of the rat's##3##3##(1991-2#1)(1993-9#2)
of the rate at which##2##5##(1990-12#1)(2008-8#1)
of the rate constant##3##4##(1996-1#1)(1996-12#1)(2008-10#1)
of the rate constants for##2##5##(1994-9#1)(1995-10#1)
of the rate constants##3##4##(1992-11#1)(1994-9#1)(1995-10#1)
of the rate limiting enzymes##2##5##(1993-12#1)(1996-12#1)
of the rate limiting##3##4##(1993-12#1)(1994-6#1)(1996-12#1)
of the rate of growth##2##5##(2005-10#1)(2013-7#1)
of the rate of release of##2##6##(1991-2#1)(1992-3#1)
of the rate of##41##4##(1990-12#1)(1990-3#2)(1990-4#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#3)(1992-1#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#2)(1993-12#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-6#1)(1996-4#1)(1996-7#1)(2004-2#1)(2005-10#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-7#3)(2009-5#2)(2012-12#1)(2013-7#1)
of the rate##63##3##(1990-12#2)(1990-3#3)(1990-4#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-8#3)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#2)(1992-9#1)(1993-11#2)(1993-12#2)(1993-8#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-4#1)(1996-7#1)(2004-2#1)(2005-10#1)(2005-11#1)(2006-11#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-5#2)(2012-12#1)(2013-7#1)
of the rate-limiting enzyme##2##4##(2007-11#1)(2012-2#1)
of the rate-limiting##3##3##(1990-2#1)(2007-11#1)(2012-2#1)
of the rates of##5##4##(1990-11#1)(1991-5#1)(1991-7#1)(1995-6#1)(2006-8#1)
of the ratio between the##2##5##(2008-10#1)(2008-11#1)
of the ratio between##4##4##(2008-10#1)(2008-11#1)(2008-2#1)(2012-3#1)
of the ratio of the##6##5##(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)
of the ratio of##13##4##(1991-7#1)(1994-12#1)(1996-12#1)(1997-3#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#2)(2011-1#1)(2012-2#1)
of the ratio spectra##5##4##(2008-10#5)
of the ratio##34##3##(1990-11#1)(1991-7#1)(1992-12#1)(1992-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1996-12#1)(1997-3#1)(2007-12#2)(2008-10#9)(2008-11#1)(2008-2#5)(2008-3#3)(2011-1#1)(2012-2#1)(2012-3#1)
of the rationale for##4##4##(1996-9#1)(1997-3#1)(2006-8#1)(2007-10#1)
of the rationale##5##3##(1996-9#1)(1997-3#1)(2006-8#1)(2007-10#1)(2007-11#1)
of the ratios##2##3##(1995-10#1)(2008-10#1)
of the rats given##2##4##(1993-9#1)(2008-6#1)
of the rats in##2##4##(1990-10#1)(1993-4#1)
of the rats with##2##4##(1997-2#1)(2008-10#1)
of the rats##20##3##(1990-10#1)(1993-4#2)(1993-8#1)(1993-9#1)(1995-3#2)(1996-11#1)(1996-3#1)(1997-2#1)(1997-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2010-12#1)(2013-1#2)
of the raw material##2##4##(2008-10#1)(2008-5#1)
of the raw materials used##2##5##(2008-10#1)(2012-3#1)
of the raw materials##3##4##(2008-10#2)(2012-3#1)
of the raw##9##3##(1996-12#1)(2008-10#4)(2008-5#2)(2010-4#1)(2012-3#1)
of the ray optics model##3##5##(2008-3#3)
of the rays##6##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)
of the rbcS##3##3##(1993-12#2)(1994-8#1)
of the rds1 gene##2##4##(1995-8#2)
of the reach##3##3##(1994-3#1)(1996-3#1)(2008-11#1)
of the reaching##3##3##(1992-9#1)(2008-4#1)(2008-6#1)
of the reactant##3##3##(2005-11#1)(2013-8#2)
of the reactants##5##3##(1994-9#1)(1997-1#1)(2005-11#1)(2010-12#1)(2013-8#1)
of the reacted##2##3##(1992-9#1)(2008-10#1)
of the reaction and the##2##5##(1990-2#1)(2007-5#1)
of the reaction and##3##4##(1990-2#1)(2007-5#1)(2010-7#1)
of the reaction at##2##4##(1994-6#1)(2006-12#1)
of the reaction between##9##4##(1997-3#1)(2006-12#1)(2007-11#1)(2008-10#6)
of the reaction by##5##4##(1995-11#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-9#1)
of the reaction center##4##4##(1992-3#2)(1993-8#1)(1997-7#1)
of the reaction conditions##2##4##(1996-2#1)(1997-2#1)
of the reaction is##8##4##(1994-12#1)(1995-3#1)(1996-5#1)(1996-6#1)(2008-10#3)(2009-10#1)
of the reaction medium##2##4##(2008-10#2)
of the reaction mixture##5##4##(1992-9#1)(1994-5#1)(1996-8#1)(2008-10#1)(2008-4#1)
of the reaction of##10##4##(1990-2#1)(1994-8#1)(1995-3#1)(2007-8#1)(2008-10#6)
of the reaction on##2##4##(1995-9#1)(2007-7#1)
of the reaction product##2##4##(1997-8#1)(2008-10#1)
of the reaction products##9##4##(1990-7#2)(1991-8#1)(1996-12#1)(2007-10#1)(2008-10#1)(2008-4#1)(2009-8#1)(2010-12#1)
of the reaction rates##2##4##(2008-10#1)(2008-5#1)
of the reaction system##2##4##(2008-10#1)(2011-1#1)
of the reaction was identified as##2##6##(1990-1#1)(1994-11#1)
of the reaction was studied##2##5##(1995-10#1)(2008-10#1)
of the reaction was##9##4##(1990-1#1)(1994-11#1)(1994-12#1)(1995-10#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-8#1)(2013-8#1)
of the reaction were##3##4##(1995-11#1)(1997-2#1)(2008-10#1)
of the reaction with##4##4##(1994-9#1)(2005-11#1)(2008-10#2)
of the reaction##150##3##(1990-1#1)(1990-2#3)(1990-3#1)(1990-5#1)(1990-7#2)(1991-5#1)(1991-8#1)(1992-11#1)(1992-3#2)(1992-6#1)(1992-9#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#3)(1997-8#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-12#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#44)(2008-2#1)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-8#3)
of the reactions are##2##4##(2007-8#1)(2008-10#1)
of the reactions of##4##4##(1990-10#2)(1995-10#1)(2008-5#1)
of the reactions##13##3##(1990-10#2)(1991-4#1)(1995-10#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-5#1)(2013-8#2)
of the reactivated##2##3##(1997-4#1)(2008-9#1)
of the reactivation##3##3##(1995-6#1)(1995-8#1)(2008-7#1)
of the reactive oxygen species (ROS)##2##6##(2008-10#1)(2013-1#1)
of the reactive oxygen species##3##5##(2008-10#1)(2011-2#1)(2013-1#1)
of the reactive site peptide bond##2##6##(1991-8#2)
of the reactive site##3##4##(1991-8#2)(1995-1#1)
of the reactive##8##3##(1991-8#2)(1995-1#1)(2008-10#2)(2009-8#1)(2011-2#1)(2013-1#1)
of the reactivity of monoclonal##3##5##(1994-3#2)(2008-10#1)
of the reactivity of##6##4##(1992-7#1)(1994-3#2)(2007-11#1)(2008-10#1)(2008-9#1)
of the reactor##6##3##(1991-5#1)(2007-10#1)(2008-10#2)(2008-11#2)
of the reading frame##2##4##(1992-9#1)(1997-4#1)
of the reading##6##3##(1992-9#1)(1997-4#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)
of the readout signal##2##4##(2008-3#2)
of the readout##6##3##(2008-2#2)(2008-3#4)
of the reagent and##4##4##(2007-8#1)(2008-10#3)
of the reagent solution in##2##5##(2008-10#2)
of the reagent##23##3##(1991-4#1)(1991-7#2)(1993-11#1)(1994-11#1)(2007-10#1)(2007-8#2)(2008-10#14)(2008-4#1)
of the reagents##9##3##(2007-11#1)(2008-10#5)(2008-4#1)(2010-3#1)(2013-1#1)
of the real and the imaginary parts of the##2##9##(2007-12#1)(2008-2#1)
of the real and the imaginary parts of##4##8##(2007-11#1)(2007-12#2)(2008-2#1)
of the real and##5##4##(1997-7#1)(2007-11#1)(2007-12#2)(2008-2#1)
of the real##24##3##(1991-4#1)(1992-12#1)(1997-7#1)(2005-9#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#3)(2008-10#5)(2008-2#5)(2008-3#2)(2010-11#1)(2013-8#1)
of the real-time##8##3##(2007-7#1)(2008-11#1)(2008-2#3)(2008-4#1)(2011-1#1)(2013-8#1)
of the reality##2##3##(2008-11#1)(2012-3#1)
of the realized##3##3##(2008-1#1)(2008-10#1)(2009-10#1)
of the realm##2##3##(2007-9#1)(2008-8#1)
of the reappearance of##2##4##(1993-10#1)(2006-10#1)
of the rear##2##3##(2006-10#1)(2013-1#1)
of the rearing##4##3##(1990-3#1)(1991-2#1)(2007-12#1)(2008-5#1)
of the reason for##2##4##(2007-2#1)(2010-2#1)
of the reason##3##3##(1991-9#1)(2007-2#1)(2010-2#1)
of the reasons behind##2##4##(2008-12#1)(2010-12#1)
of the reasons for the##6##5##(1996-2#1)(2004-12#1)(2006-10#1)(2008-8#1)(2013-1#2)
of the reasons for this##3##5##(2007-7#1)(2008-10#1)(2011-2#1)
of the reasons for##13##4##(1993-5#1)(1996-2#1)(1997-3#1)(2004-12#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
of the reasons why##5##4##(1990-12#1)(1993-11#1)(2009-11#1)(2009-6#1)(2012-2#1)
of the reasons##26##3##(1990-12#1)(1991-9#1)(1993-11#1)(1993-5#1)(1994-3#1)(1996-2#1)(1996-9#1)(1997-3#1)(2004-12#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-11#2)(2009-6#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#2)
of the recA gene##3##4##(1990-9#3)
of the received##5##3##(2007-11#1)(2008-2#2)(2008-3#2)
of the receiver##8##3##(1995-1#1)(2007-11#1)(2008-2#4)(2008-3#2)
of the receiver-stimulator##2##3##(2008-9#2)
of the recent advances in the##2##6##(2008-5#1)(2013-1#1)
of the recent advances in##4##5##(2005-8#1)(2008-5#1)(2012-3#1)(2013-1#1)
of the recent advances##5##4##(2005-8#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#1)
of the recent developments in the##2##6##(2008-10#1)(2008-4#1)
of the recent developments in##4##5##(1993-6#1)(2008-10#1)(2008-4#1)(2011-1#1)
of the recent developments##5##4##(1993-6#1)(2008-10#1)(2008-4#1)(2010-5#1)(2011-1#1)
of the recent improvements##2##4##(2008-2#1)(2012-8#1)
of the recent literature concerning##2##5##(2006-10#1)(2011-2#1)
of the recent literature reveals the potential of##2##8##(2006-10#2)
of the recent literature reveals the potential##3##7##(2006-10#3)
of the recent literature reveals##4##5##(2006-10#4)
of the recent literature##16##4##(1990-6#1)(1991-12#1)(2006-10#7)(2007-4#1)(2007-7#1)(2008-12#1)(2009-9#1)(2011-2#2)(2013-1#1)
of the recent past and measures taken##2##7##(1991-3#2)
of the recent progress##2##4##(2006-10#1)(2010-11#1)
of the recent research in this##2##6##(2006-10#1)(2008-10#1)
of the recent results of##2##5##(2008-4#1)(2008-5#1)
of the recent work##2##4##(1997-8#1)(2007-9#1)
of the recent##72##3##(1990-6#1)(1990-8#1)(1991-12#1)(1991-3#2)(1991-4#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1996-12#1)(1996-4#1)(1997-8#1)(2005-7#3)(2005-8#3)(2006-10#13)(2007-2#1)(2007-4#2)(2007-5#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2009-9#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-3#1)(2012-8#1)(2013-1#2)(2013-8#1)
of the recently described##4##4##(1995-5#1)(2008-10#1)(2008-4#1)(2008-6#1)
of the recently developed##5##4##(2006-4#1)(2007-12#1)(2008-2#2)(2008-3#1)
of the recently proposed##3##4##(1992-12#1)(2008-10#1)(2008-7#1)
of the recently published##2##4##(1992-4#1)(2008-12#1)
of the recently reported##2##4##(1991-9#1)(1997-4#1)
of the recently##27##3##(1991-2#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-7#1)(1994-5#1)(1995-10#1)(1995-3#1)(1995-5#1)(1997-4#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2011-2#1)
of the receptive field##2##4##(1992-9#1)(1995-11#1)
of the receptive##4##3##(1992-9#1)(1994-9#1)(1995-11#1)(2008-8#1)
of the receptor and##10##4##(1991-9#1)(1994-12#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-5#1)(2007-12#1)(2008-4#2)(2011-2#1)
of the receptor as a##2##5##(1992-9#1)(2009-6#1)
of the receptor as##4##4##(1992-9#1)(1995-3#1)(1997-1#1)(2009-6#1)
of the receptor binding domain##2##5##(1991-10#1)(1996-5#1)
of the receptor binding##5##4##(1990-11#1)(1991-10#1)(1992-8#1)(1994-12#1)(1996-5#1)
of the receptor by##3##4##(1990-7#1)(1991-4#1)(1995-8#1)
of the receptor cDNA##2##4##(1992-11#1)(1995-12#1)
of the receptor for##6##4##(1990-5#1)(1991-3#1)(1992-12#1)(1993-5#1)(1994-5#1)(1995-3#1)
of the receptor gene##2##4##(1991-5#1)(1992-9#1)
of the receptor in##2##4##(1990-11#1)(1996-5#1)
of the receptor is##4##4##(1990-11#1)(1995-2#1)(1995-6#1)(2010-8#1)
of the receptor occurs##2##4##(1991-4#1)(1992-9#1)
of the receptor protein##6##4##(1991-4#1)(1992-12#1)(1993-3#1)(1993-6#1)(1995-10#1)(2006-12#1)
of the receptor superfamily##2##4##(1996-5#1)(2006-10#1)
of the receptor to the##3##5##(1993-4#1)(1994-11#1)(1996-5#1)
of the receptor to##11##4##(1990-9#1)(1993-4#1)(1994-11#1)(1995-3#1)(1996-11#1)(1996-5#2)(1996-8#1)(2008-10#1)(2008-4#2)
of the receptor tyrosine kinase##4##5##(1996-11#1)(1996-6#2)(2013-1#1)
of the receptor was##3##4##(1990-2#1)(1992-8#1)(1995-10#1)
of the receptor were##2##4##(1990-8#1)(1992-12#1)
of the receptor which##2##4##(1992-12#1)(1993-9#1)
of the receptor with##3##4##(1991-4#1)(1995-10#2)
of the receptor##145##3##(1990-11#3)(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#4)(1991-5#2)(1991-9#1)(1992-11#1)(1992-12#6)(1992-3#1)(1992-4#1)(1992-8#2)(1992-9#4)(1993-12#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-9#3)(1994-11#1)(1994-12#5)(1994-2#1)(1994-3#1)(1994-5#3)(1994-8#2)(1994-9#1)(1995-10#7)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#6)(1995-5#1)(1995-6#2)(1995-8#3)(1996-10#1)(1996-11#3)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#11)(1996-6#2)(1996-8#4)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-6#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#5)(2008-5#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#3)
of the receptor-associated##2##3##(1994-2#1)(1997-6#1)
of the receptor-binding surface##2##4##(1991-7#2)
of the receptor-binding##5##3##(1991-7#2)(1992-11#2)(1992-9#1)
of the receptors for##5##4##(1992-4#1)(1993-8#1)(1993-9#1)(1995-8#1)(2008-10#1)
of the receptors in##3##4##(1994-3#1)(1995-1#1)(1995-10#1)
of the receptors of##2##4##(1993-2#1)(2009-8#1)
of the receptors were##2##4##(1995-10#1)(2008-4#1)
of the receptors##25##3##(1990-2#1)(1991-2#1)(1992-4#2)(1993-2#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-3#1)(1995-8#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-4#3)(2009-6#1)(2009-8#2)
of the recipient and##2##4##(1995-12#1)(2008-10#1)
of the recipient##9##3##(1995-12#1)(1997-2#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-9#1)(2011-2#1)
of the reciprocal##3##3##(1990-11#1)(1997-7#1)(2008-5#1)
of the reciprocity theorem##2##4##(2008-3#2)
of the recognition of##4##4##(1992-2#1)(1995-8#1)(2007-8#1)(2008-11#1)
of the recognition process##2##4##(1995-8#1)(2013-1#1)
of the recognition sequence of##2##5##(1994-12#1)(1995-8#1)
of the recognition sequence##3##4##(1994-12#1)(1995-3#1)(1995-8#1)
of the recognition##10##3##(1992-2#1)(1994-12#1)(1995-3#1)(1995-6#1)(1995-8#3)(2007-8#1)(2008-11#1)(2013-1#1)
of the recognized##4##3##(1990-12#1)(1991-12#1)(1997-5#1)(2008-10#1)
of the recombinant E##2##4##(2008-7#1)(2011-1#1)
of the recombinant clotting factor concentrates##2##6##(2007-11#2)
of the recombinant enzyme##2##4##(1992-12#1)(1994-3#1)
of the recombinant human alpha A- and beta-interferons##2##8##(1990-2#2)
of the recombinant human##9##4##(1990-2#2)(1990-5#2)(1990-8#1)(1993-1#1)(1994-5#3)
of the recombinant plasmids##2##4##(1990-1#1)(2005-11#1)
of the recombinant protein was##2##5##(2008-11#1)(2008-8#1)
of the recombinant protein##13##4##(1990-5#1)(1990-7#1)(1995-8#1)(1996-11#1)(1996-5#1)(1997-7#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)
of the recombinant proteins##2##4##(1994-5#1)(2011-2#1)
of the recombinant strain##2##4##(1994-2#2)
of the recombinant##70##3##(1990-1#1)(1990-11#1)(1990-2#2)(1990-5#3)(1990-7#2)(1990-8#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-6#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#4)(1994-9#1)(1995-1#1)(1995-2#1)(1995-8#2)(1996-11#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#2)(2007-11#3)(2008-10#3)(2008-11#7)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
of the recombinants##3##3##(1990-6#1)(1995-2#1)(1997-4#1)
of the recombinase activating gene 1##2##6##(1994-11#2)
of the recombination##4##3##(2008-10#1)(2008-4#1)(2010-2#1)(2013-8#1)
of the recommendations##4##3##(2006-9#1)(2007-4#1)(2011-1#1)(2013-1#1)
of the recommended feed intake##2##5##(2005-9#2)
of the recommended##14##3##(2005-8#1)(2005-9#3)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-1#1)(2010-2#1)(2010-4#1)(2011-2#1)(2013-1#2)
of the reconstituted InsP(3) receptor##2##5##(2008-8#2)
of the reconstituted##10##3##(1990-11#1)(1990-12#1)(1990-5#1)(1991-9#1)(1994-12#1)(1995-2#1)(1997-7#1)(2008-4#1)(2008-8#2)
of the reconstructed image is##2##5##(2007-11#1)(2008-3#1)
of the reconstructed image##7##4##(2007-11#3)(2008-2#2)(2008-3#2)
of the reconstructed images##7##4##(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-10#1)
of the reconstructed##27##3##(2006-4#1)(2006-5#1)(2007-11#4)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#7)(2008-5#1)(2008-7#1)(2008-9#2)(2009-1#1)(2009-10#1)
of the reconstruction procedure##2##4##(2008-2#1)(2008-3#1)
of the reconstruction##10##3##(2005-11#1)(2007-12#1)(2008-2#4)(2008-3#2)(2008-7#1)(2011-2#1)
of the reconstructive##5##3##(2007-12#4)(2011-2#1)
of the record of##2##4##(1990-8#1)(1997-3#1)
of the record##3##3##(1990-8#1)(1997-3#1)(2008-4#1)
of the recorded bit data is##2##6##(2007-12#1)(2008-3#1)
of the recorded cells##2##4##(1993-12#1)(1996-1#1)
of the recorded mirror##2##4##(2007-12#1)(2008-1#1)
of the recorded##20##3##(1990-8#1)(1992-1#1)(1993-12#1)(1994-9#1)(1996-1#1)(1997-5#1)(2007-12#3)(2008-1#2)(2008-10#3)(2008-2#2)(2008-3#2)(2008-4#1)(2012-12#1)
of the recording and the reconstruction##2##6##(2007-12#2)
of the recording and##3##4##(2007-12#2)(2008-2#1)
of the recording beam##2##4##(2007-12#1)(2008-3#1)
of the recording material##2##4##(2007-12#1)(2008-2#1)
of the recording medium##3##4##(2007-12#3)
of the recording of##3##4##(1995-12#2)(1996-4#1)
of the recording parameters##2##4##(2008-2#1)(2008-3#1)
of the recording process##3##4##(2008-1#1)(2008-3#2)
of the recording##23##3##(1991-12#1)(1991-3#1)(1995-12#2)(1996-4#1)(2007-12#8)(2008-1#1)(2008-2#3)(2008-3#6)
of the records of##3##4##(1995-9#1)(2005-6#1)(2008-7#1)
of the records##6##3##(1992-8#1)(1995-9#1)(1997-2#1)(2005-6#1)(2008-7#1)(2008-9#1)
of the recovered##7##3##(1993-8#1)(1995-6#1)(2008-10#3)(2010-4#1)(2011-1#1)
of the recoverin##3##3##(1992-11#2)(1995-6#1)
of the recovery of##3##4##(1995-6#1)(2007-7#1)(2008-12#1)
of the recovery##12##3##(1990-5#1)(1991-2#1)(1995-6#1)(2005-11#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2012-3#1)(2013-1#1)
of the recruitment##6##3##(1993-8#1)(1994-2#1)(2007-3#1)(2010-3#1)(2012-12#1)(2012-2#1)
of the rectal cancer]##2##4##(2008-8#2)
of the rectal stump##2##4##(1990-4#1)(2008-8#1)
of the rectal wall##2##4##(1990-9#1)(2006-6#1)
of the rectal##10##3##(1990-4#1)(1990-9#1)(1995-6#1)(2006-6#1)(2008-8#4)(2010-12#1)(2013-8#1)
of the rectified##3##3##(2007-11#3)
of the rectosigmoid##2##3##(2008-10#1)(2010-2#1)
of the rectum and##7##4##(1992-3#1)(1992-5#1)(2007-8#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)
of the rectum##30##3##(1990-10#1)(1990-4#2)(1991-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-8#3)(1994-4#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-5#1)(2007-8#1)(2008-3#1)(2008-8#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#3)(2013-7#1)(2013-8#2)
of the rectum]##3##3##(1991-12#1)(1993-5#1)(2007-8#1)
of the rectus femoris##3##4##(2008-12#1)(2008-6#1)(2011-2#1)
of the rectus##6##3##(1993-10#1)(2008-12#1)(2008-6#1)(2009-6#1)(2011-2#1)(2012-12#1)
of the recurrence of##2##4##(2006-10#1)(2008-3#1)
of the recurrent nerve##2##4##(1990-4#1)(1991-11#1)
of the recurrent##9##3##(1990-4#1)(1991-11#1)(1991-6#1)(1997-4#1)(2007-8#1)(2008-2#1)(2008-9#2)(2010-9#1)
of the recurring themes##2##4##(2008-5#1)(2010-7#1)
of the recurring##4##3##(1997-4#1)(2007-8#1)(2008-5#1)(2010-7#1)
of the red blood cell##3##5##(1997-1#1)(1997-6#1)(2011-2#1)
of the red blood##5##4##(1997-1#1)(1997-6#1)(2006-6#1)(2011-2#1)(2012-2#1)
of the red cell membrane##4##5##(1990-5#1)(1996-1#1)(1997-6#1)(2008-11#1)
of the red cell##5##4##(1990-5#1)(1994-5#1)(1996-1#1)(1997-6#1)(2008-11#1)
of the red##25##3##(1990-5#1)(1990-7#1)(1992-11#1)(1992-8#1)(1994-5#1)(1995-11#1)(1996-1#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#2)(2005-6#1)(2006-12#2)(2006-6#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-3#3)(2011-2#1)(2012-2#1)
of the reddish##2##3##(2004-2#1)(2008-10#1)
of the redox state of##2##5##(1991-2#1)(2008-10#1)
of the redox##15##3##(1991-2#1)(1992-8#1)(1994-11#1)(1994-8#1)(1996-2#1)(1996-6#1)(1997-6#2)(2008-10#6)(2009-8#1)
of the reduced and oxidized##2##5##(1993-3#1)(2009-7#1)
of the reduced form##2##4##(1994-5#1)(2006-12#1)
of the reduced scattering##2##4##(2008-2#2)
of the reduced##25##3##(1990-2#1)(1991-1#1)(1992-10#1)(1992-3#1)(1992-6#2)(1993-3#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-2#1)(1996-2#1)(1996-7#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-2#2)(2009-7#1)(2010-5#1)(2011-2#1)
of the reduced/denatured RNase A##2##5##(2011-1#2)
of the reducing end groups##2##5##(1992-12#1)(2005-11#1)
of the reducing end##4##4##(1992-12#1)(1995-11#1)(2005-11#1)(2011-1#1)
of the reducing##8##3##(1990-2#1)(1992-12#1)(1995-11#1)(1996-10#1)(2005-11#1)(2008-10#1)(2008-5#1)(2011-1#1)
of the reductase was##4##4##(1991-2#1)(1996-3#2)(2008-11#1)
of the reductase##6##3##(1991-2#3)(1996-3#2)(2008-11#1)
of the reduction in the##2##5##(1991-4#1)(2008-2#1)
of the reduction in##5##4##(1991-4#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)
of the reduction of the##2##5##(1994-8#1)(1996-6#1)
of the reduction of##9##4##(1994-8#1)(1996-6#1)(1997-1#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-3#1)
of the reduction potential of##2##5##(1991-8#1)(2005-11#1)
of the reduction potential##4##4##(1991-8#1)(1992-7#1)(1994-8#1)(2005-11#1)
of the reduction potentials##2##4##(1991-8#1)(2007-11#1)
of the reduction product##2##4##(2008-10#2)
of the reduction site##3##4##(1991-3#1)(1994-9#2)
of the reduction##33##3##(1991-3#1)(1991-4#1)(1991-8#2)(1992-7#1)(1994-8#2)(1994-9#2)(1995-3#1)(1996-6#1)(1997-1#1)(2005-10#1)(2005-11#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)
of the reductive half-reaction of xanthine oxidase##2##7##(1994-8#2)
of the reductive half-reaction##4##4##(1994-8#4)
of the reductive##10##3##(1994-8#4)(1995-2#1)(2006-8#1)(2008-1#1)(2008-10#1)(2009-10#1)(2012-2#1)
of the reef##2##3##(2007-3#1)(2011-2#1)
of the reef-building##3##3##(1992-6#2)(2007-3#1)
of the reeler mouse##4##4##(1994-10#4)
of the reeler##6##3##(1994-10#6)
of the reference beam and##2##5##(2008-3#2)
of the reference beam is##2##5##(2007-12#1)(2008-3#1)
of the reference beam##9##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#6)
of the reference field##2##4##(2007-11#1)(2008-3#1)
of the reference formulation##3##4##(1993-6#1)(1995-4#2)
of the reference image##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
of the reference material##2##4##(2005-11#1)(2008-10#1)
of the reference strains##2##4##(2008-5#1)(2011-1#1)
of the reference surface##2##4##(2008-3#2)
of the reference wave##2##4##(2008-3#2)
of the reference##56##3##(1993-6#1)(1995-1#1)(1995-3#1)(1995-4#2)(2005-11#1)(2006-4#1)(2006-7#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#7)(2008-2#9)(2008-3#17)(2008-5#3)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)
of the referral letters##2##4##(2007-3#2)
of the referral##4##3##(2007-2#1)(2007-3#2)(2007-7#1)
of the reflectance of##2##4##(2008-2#1)(2008-3#1)
of the reflectance##7##3##(2008-2#3)(2008-3#4)
of the reflectances of the##2##5##(2008-2#1)(2008-3#1)
of the reflectances##3##3##(2008-2#1)(2008-3#2)
of the reflected beam##5##4##(2007-12#1)(2008-2#2)(2008-3#2)
of the reflected fringe system##2##5##(2008-3#2)
of the reflected light##6##4##(2007-12#1)(2008-2#3)(2008-3#2)
of the reflected##21##3##(2007-12#4)(2008-1#1)(2008-2#7)(2008-3#8)(2009-1#1)
of the reflection coefficient##3##4##(2008-2#2)(2008-3#1)
of the reflection of an uncoated##2##6##(2008-2#2)
of the reflection of##3##4##(2008-2#2)(2008-3#1)
of the reflection##17##3##(2007-11#2)(2007-12#2)(2008-2#8)(2008-3#4)(2013-1#1)
of the reflective##2##3##(2008-3#1)(2012-12#1)
of the reflectivity of##2##4##(2007-11#1)(2008-2#1)
of the reflectivity##8##3##(2007-11#1)(2008-2#4)(2008-3#3)
of the reflector##2##3##(2007-12#1)(2008-2#1)
of the reflectors##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
of the reflex##3##3##(1991-5#1)(1992-8#1)(1993-12#1)
of the reflexes##2##3##(1992-12#1)(2010-11#1)
of the reform of##3##4##(2006-8#1)(2008-2#2)
of the reform##6##3##(2006-8#1)(2007-5#1)(2008-2#3)(2011-7#1)
of the reforms##4##3##(1996-3#1)(1997-5#1)(2007-12#1)(2012-1#1)
of the refraction##3##3##(2007-11#1)(2008-2#1)(2009-6#1)
of the refractive index and the##4##6##(2008-3#4)
of the refractive index and##7##5##(2007-11#1)(2008-3#6)
of the refractive index as##2##5##(2007-12#1)(2008-2#1)
of the refractive index for##2##5##(2008-1#1)(2008-2#1)
of the refractive index is##5##5##(2007-11#1)(2008-1#1)(2008-3#3)
of the refractive index of a##3##6##(2008-2#1)(2008-3#2)
of the refractive index of the##3##6##(2008-2#2)(2008-3#1)
of the refractive index of##13##5##(2007-11#1)(2008-2#5)(2008-3#6)(2011-12#1)
of the refractive index with##2##5##(2007-12#1)(2008-3#1)
of the refractive index##52##4##(2007-11#3)(2007-12#7)(2008-1#2)(2008-2#16)(2008-3#23)(2011-12#1)
of the refractive indices of the##2##6##(2008-2#1)(2008-3#1)
of the refractive indices of##7##5##(2008-2#2)(2008-3#5)
of the refractive indices##9##4##(2007-12#1)(2008-2#3)(2008-3#5)
of the refractive##63##3##(2007-11#3)(2007-12#8)(2008-1#2)(2008-2#20)(2008-3#28)(2011-12#1)(2012-12#1)
of the refractive-index change##3##4##(2007-12#1)(2008-3#2)
of the refractive-index difference between the##2##6##(2008-2#2)
of the refractive-index profile from##2##5##(2008-2#2)
of the refractive-index profile##5##4##(2008-2#5)
of the refractive-index structure##2##4##(2007-12#1)(2008-2#1)
of the refractive-index##19##3##(2007-12#3)(2008-2#8)(2008-3#8)
of the refractory ward and 'rumpus room'##2##7##(2008-7#2)
of the refractory##3##3##(2008-10#1)(2008-7#2)
of the regenerated bone##2##4##(2007-8#1)(2012-12#1)
of the regenerated gratings##2##4##(2013-8#2)
of the regenerated##4##3##(2007-8#1)(2012-12#1)(2013-8#2)
of the regenerating##3##3##(1990-2#1)(2008-1#1)(2008-4#1)
of the regeneration##3##3##(1992-6#1)(1994-2#1)(2008-10#1)
of the regenerative##2##3##(1993-3#1)(2009-10#1)
of the regimen##3##3##(1992-1#1)(2007-11#1)(2008-3#1)
of the region between the##2##5##(1993-6#1)(1995-1#1)
of the region downstream from##2##5##(1990-5#1)(1993-12#1)
of the region downstream##3##4##(1990-5#1)(1991-7#1)(1993-12#1)
of the region of the##3##5##(1991-7#1)(1995-6#1)(2007-8#1)
of the region of##6##4##(1991-7#1)(1995-6#1)(1997-4#1)(2007-8#1)(2008-3#1)(2010-6#1)
of the region was##2##4##(2008-3#1)(2008-8#1)
of the region##42##3##(1990-5#1)(1991-7#2)(1993-12#1)(1993-6#2)(1995-1#1)(1995-2#1)(1995-6#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-8#2)(2007-3#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-6#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#2)
of the region's##3##3##(2007-2#1)(2008-2#1)(2008-7#1)
of the regional lymph nodes##2##5##(2006-6#1)(2009-1#1)
of the regional##11##3##(1996-9#1)(1997-6#1)(2006-6#1)(2007-12#1)(2009-1#1)(2010-7#1)(2011-2#4)(2013-7#1)
of the regions involved in##2##5##(1991-2#1)(1996-8#1)
of the regions##10##3##(1991-2#1)(1995-1#1)(1995-10#1)(1995-2#1)(1996-8#1)(1997-8#1)(2006-10#1)(2008-10#2)(2008-2#1)
of the registration of##2##4##(1994-2#1)(2009-2#1)
of the registration##6##3##(1994-2#1)(2007-5#1)(2008-11#1)(2008-2#1)(2009-2#1)(2011-2#1)
of the registry##2##3##(2006-12#1)(2008-8#1)
of the regression analysis between observed and estimated SSR##2##9##(2008-10#2)
of the regression coefficients##3##4##(2008-10#2)(2008-12#1)
of the regression equation##2##4##(1993-9#1)(2005-12#1)
of the regression line##4##4##(1993-7#1)(2006-7#1)(2008-10#2)
of the regression model##2##4##(2008-10#1)(2008-3#1)
of the regression models##2##4##(1990-2#1)(2010-11#1)
of the regression##23##3##(1990-2#1)(1993-7#1)(1993-9#1)(1995-6#1)(2005-12#1)(2006-7#1)(2007-12#1)(2008-10#9)(2008-12#1)(2008-3#3)(2008-6#1)(2010-11#1)(2010-2#1)
of the regular##5##3##(1993-1#1)(1993-10#1)(1994-12#1)(2007-12#1)(2008-10#1)
of the regularization parameter##2##4##(2008-10#1)(2008-3#1)
of the regularized##2##3##(2008-3#1)(2008-6#1)
of the regulated CFCs##2##4##(1992-3#2)
of the regulated##6##3##(1992-3#2)(1994-2#1)(1997-2#1)(2008-4#2)
of the regulation of energy homeostasis##2##6##(2008-1#1)(2008-10#1)
of the regulation of the##4##5##(1991-4#1)(1995-12#1)(1995-2#1)(2008-11#1)
of the regulation of##15##4##(1990-3#1)(1991-4#1)(1991-9#1)(1993-3#1)(1995-12#1)(1995-2#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-6#1)(2008-8#1)
of the regulations##6##3##(1993-12#1)(1993-3#1)(1995-6#1)(2006-8#2)(2007-4#1)
of the regulator##4##3##(1990-7#2)(1995-2#2)
of the regulatory domain##4##4##(1990-12#2)(1990-7#1)(1996-11#1)
of the regulatory functions of##2##5##(1990-11#1)(2010-11#1)
of the regulatory mechanism for the##2##6##(1995-2#1)(2010-11#1)
of the regulatory protein##2##4##(1990-7#1)(1997-2#1)
of the regulatory proteins of##2##5##(1993-8#1)(1995-9#1)
of the regulatory site##2##4##(1990-4#1)(1992-12#1)
of the regulatory subunit (RII)##2##5##(1994-9#1)(1995-11#1)
of the regulatory subunit##4##4##(1990-8#1)(1994-9#1)(1995-11#1)(1997-1#1)
of the regulatory systems that##2##5##(1996-12#1)(2006-10#1)
of the regulatory##39##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-4#1)(1990-7#2)(1990-8#1)(1991-2#1)(1991-7#1)(1992-12#2)(1993-5#1)(1993-8#2)(1993-9#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-9#1)(1996-11#2)(1996-12#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-11#2)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
of the rehabilitation period##2##4##(2008-6#2)
of the rehabilitation process##2##4##(2007-11#1)(2010-10#1)
of the rehabilitation programme##3##4##(1990-4#1)(2006-8#1)(2013-1#1)
of the rehabilitation##15##3##(1990-4#1)(1993-12#1)(1995-5#1)(2006-8#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-6#2)(2008-9#1)(2010-10#1)(2012-2#1)(2013-1#2)
of the relapse##3##3##(1996-11#1)(2006-7#1)(2007-1#1)
of the related##19##3##(1990-4#2)(1991-2#1)(1992-8#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-5#1)(2005-11#2)(2007-12#1)(2008-12#1)(2008-9#2)(2009-12#1)(2011-12#1)(2013-8#1)
of the relation between the##2##5##(1993-6#1)(1997-5#1)
of the relation between##10##4##(1993-11#1)(1993-6#1)(1997-5#2)(2008-3#1)(2008-7#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)
of the relation of##5##4##(1990-7#1)(1996-2#1)(1996-6#1)(2012-12#1)(2013-7#1)
of the relation##18##3##(1990-7#1)(1993-11#1)(1993-6#1)(1996-2#1)(1996-6#1)(1997-5#3)(2007-12#1)(2008-3#1)(2008-7#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2012-12#1)(2013-7#1)
of the relational##2##3##(1990-3#1)(1996-2#1)
of the relations between##2##4##(2007-10#1)(2010-8#1)
of the relations##4##3##(2007-10#1)(2010-2#2)(2010-8#1)
of the relationship among##2##4##(2006-7#1)(2008-3#1)
of the relationship between body image##2##6##(2006-7#1)(2012-2#1)
of the relationship between oral##2##5##(2008-11#1)(2008-4#1)
of the relationship between sleep##2##5##(2006-10#1)(2013-1#1)
of the relationship between structure and function in the brain##2##10##(2009-5#2)
of the relationship between structure and##4##6##(2009-5#2)(2010-4#1)(2012-2#1)
of the relationship between the##14##5##(1992-6#1)(1992-8#1)(1994-5#1)(1995-10#1)(1996-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-2#1)(2010-2#1)(2011-1#1)(2012-2#1)(2012-5#1)
of the relationship between##79##4##(1990-8#1)(1992-1#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#2)(1995-10#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-9#1)(1997-8#1)(2006-10#1)(2006-5#1)(2006-7#2)(2006-9#2)(2007-12#2)(2007-2#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-10#1)(2012-1#3)(2012-12#1)(2012-2#4)(2012-3#2)(2012-5#1)(2013-1#1)(2013-7#1)
of the relationship of melancholia and the mother##2##8##(2008-12#2)
of the relationship of the##2##5##(1990-8#1)(2009-11#1)
of the relationship of##9##4##(1990-5#1)(1990-8#1)(2008-10#1)(2008-12#2)(2008-5#1)(2009-11#1)(2010-10#1)(2011-12#1)
of the relationship##101##3##(1990-5#1)(1990-8#2)(1992-1#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-10#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1995-10#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-9#1)(1997-8#2)(2006-10#2)(2006-4#1)(2006-5#1)(2006-7#3)(2006-9#2)(2007-1#2)(2007-12#2)(2007-2#1)(2008-10#7)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-10#1)(2011-12#1)(2012-1#3)(2012-12#1)(2012-2#4)(2012-3#3)(2012-5#1)(2013-1#1)(2013-7#1)
of the relationships between##14##4##(1991-6#1)(1993-1#1)(1995-11#1)(1995-6#1)(1996-2#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#2)(2010-8#1)
of the relationships of##2##4##(2006-3#1)(2007-9#1)
of the relationships##20##3##(1991-6#1)(1992-12#1)(1993-1#1)(1993-12#1)(1995-11#1)(1995-6#1)(1996-2#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#2)(2010-8#1)
of the relative abundance of##2##5##(1994-11#1)(2008-8#1)
of the relative contribution##2##4##(1991-2#1)(2008-2#1)
of the relative contributions of##2##5##(1992-2#1)(2008-10#1)
of the relative distribution of##2##5##(2008-2#1)(2010-12#1)
of the relative fluorescence##2##4##(2005-4#1)(2008-10#1)
of the relative frequencies##2##4##(2006-6#1)(2008-8#1)
of the relative importance of the##3##6##(1992-2#1)(2008-2#1)(2008-9#1)
of the relative importance of##4##5##(1992-2#1)(2008-2#1)(2008-8#1)(2008-9#1)
of the relative importance##5##4##(1992-2#1)(2007-3#1)(2008-2#1)(2008-8#1)(2008-9#1)
of the relative phase between##2##5##(2008-1#1)(2008-3#1)
of the relative phase##3##4##(2008-1#1)(2008-3#2)
of the relative potency##2##4##(1996-9#1)(2008-10#1)
of the relative risk##2##4##(1996-1#1)(2013-7#1)
of the relative##70##3##(1990-10#1)(1990-5#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#3)(1993-8#1)(1994-11#1)(1995-1#1)(1996-1#1)(1996-9#1)(2004-2#1)(2005-4#1)(2006-6#1)(2007-11#3)(2007-12#3)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#11)(2008-3#6)(2008-5#1)(2008-8#3)(2008-9#1)(2010-12#1)(2010-2#1)(2012-2#1)(2013-7#2)(2013-8#1)
of the relatively high##4##4##(1994-1#1)(1997-8#1)(2005-7#1)(2006-12#1)
of the relatively large##2##4##(2007-1#1)(2008-10#1)
of the relatively##15##3##(1992-3#1)(1994-1#1)(1996-8#1)(1997-8#1)(2005-7#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#1)
of the relatives##2##3##(1990-5#1)(2011-1#1)
of the relaxation oscillation##2##4##(2007-12#2)
of the relaxation time##2##4##(1997-7#1)(2008-3#1)
of the relaxation times of##2##5##(1991-7#1)(2012-7#1)
of the relaxation##12##3##(1991-7#1)(1993-3#1)(1994-8#2)(1996-12#1)(1997-7#1)(2007-12#3)(2008-2#1)(2008-3#1)(2012-7#1)
of the relay##3##3##(2008-2#1)(2008-3#2)
of the release of##12##4##(1990-12#1)(1990-2#1)(1991-4#1)(1992-3#1)(1992-6#1)(1993-4#1)(1994-9#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-12#1)
of the release tests##2##4##(2007-8#1)(2008-10#1)
of the release##24##3##(1990-12#1)(1990-2#2)(1990-7#1)(1991-3#1)(1991-4#1)(1992-3#1)(1992-6#1)(1993-4#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-9#1)(2006-10#1)(2006-8#1)(2007-8#2)(2008-10#4)(2008-12#1)(2008-8#1)(2010-12#1)
of the released species##2##4##(1992-7#2)
of the released##9##3##(1991-3#1)(1992-7#3)(1993-6#1)(1994-8#1)(1996-8#1)(2004-1#1)(2009-4#1)
of the relevance of##6##4##(1992-10#1)(2004-12#1)(2007-9#1)(2008-2#1)(2008-4#1)(2008-9#1)
of the relevant literature##9##4##(2005-8#1)(2006-10#1)(2007-12#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
of the relevant##34##3##(1990-8#1)(1992-1#1)(1993-2#1)(1994-6#1)(1997-7#1)(2005-8#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#1)(2009-2#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
of the reliability of##4##4##(1994-3#1)(2008-10#1)(2008-3#1)(2013-1#1)
of the reliability##5##3##(1993-11#1)(1994-3#1)(2008-10#1)(2008-3#1)(2013-1#1)
of the religious##2##3##(1994-3#1)(1996-12#1)
of the relocation##3##3##(1990-2#1)(2007-5#1)(2013-7#1)
of the remainder of the##2##5##(2008-10#1)(2011-12#1)
of the remainder##4##3##(1992-3#1)(2008-10#1)(2009-10#1)(2011-12#1)
of the remaining colon##2##4##(2007-7#2)
of the remaining nidus##2##4##(2008-7#2)
of the remaining patients##3##4##(1992-11#1)(2013-1#2)
of the remaining##69##3##(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-11#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-4#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#4)(2009-8#1)(2009-9#2)(2010-12#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#2)
of the remarkable##7##3##(1992-1#1)(1993-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-3#1)(2010-10#1)
of the remnant##2##3##(1991-10#1)(2013-1#1)
of the remodeling process##2##4##(2010-11#1)(2011-2#1)
of the remodeling##4##3##(2007-11#1)(2009-4#1)(2010-11#1)(2011-2#1)
of the removal of##2##4##(2011-2#1)(2012-12#1)
of the removal##3##3##(2006-10#1)(2011-2#1)(2012-12#1)
of the renal arteries##2##4##(1993-10#1)(2008-7#1)
of the renal artery##2##4##(1992-5#1)(1993-3#1)
of the renal cell##2##4##(1992-8#1)(2010-12#1)
of the renal parenchyma##2##4##(1993-2#1)(2011-2#1)
of the renal pelvis##3##4##(1994-4#1)(2008-1#1)(2011-2#1)
of the renal sodium channel##2##5##(1997-3#2)
of the renal tubular##2##4##(2008-8#1)(2013-1#1)
of the renal##53##3##(1990-11#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-2#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#2)(1993-10#1)(1993-2#1)(1993-3#1)(1994-4#1)(1996-6#1)(1997-3#2)(2007-7#2)(2008-1#7)(2008-6#1)(2008-7#3)(2008-8#3)(2010-12#1)(2010-4#1)(2011-2#4)(2011-3#1)(2012-11#1)(2012-12#1)(2013-1#4)(2013-8#2)
of the renin angiotensin system##3##5##(2005-7#1)(2006-10#1)(2012-3#1)
of the renin##5##3##(1991-5#1)(1995-9#1)(2005-7#1)(2006-10#1)(2012-3#1)
of the renin-angiotensin system (RAS) and##2##6##(1995-10#1)(2009-10#1)
of the renin-angiotensin system (RAS)##3##5##(1995-10#1)(2005-7#1)(2009-10#1)
of the renin-angiotensin system and##2##5##(1993-12#1)(2008-4#1)
of the renin-angiotensin system by##2##5##(2008-11#1)(2009-10#1)
of the renin-angiotensin system##14##4##(1991-5#1)(1993-12#1)(1994-9#1)(1995-10#1)(1995-9#1)(2005-10#1)(2005-7#1)(2006-8#1)(2007-9#1)(2008-11#1)(2008-4#1)(2009-10#2)(2011-1#1)
of the renin-angiotensin##15##3##(1991-5#1)(1993-12#1)(1994-9#1)(1995-10#1)(1995-9#1)(2005-10#1)(2005-7#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-10#2)(2011-1#1)
of the renin-angiotensin-aldosterone system (RAAS)##2##5##(2005-7#1)(2007-1#1)
of the renin-angiotensin-aldosterone system##9##4##(1996-6#1)(2005-10#1)(2005-7#1)(2006-11#1)(2007-1#1)(2007-8#2)(2011-2#1)(2013-8#1)
of the renin-angiotensin-aldosterone##10##3##(1996-6#1)(2005-10#1)(2005-7#1)(2006-11#1)(2007-1#1)(2007-8#2)(2011-2#1)(2013-1#1)(2013-8#1)
of the reorganization##2##3##(1990-2#1)(2008-2#1)
of the rep gene##2##4##(2008-10#2)
of the repair process##2##4##(1997-2#1)(2011-2#1)
of the repair##9##3##(1992-5#1)(1992-6#1)(1997-2#1)(2006-12#1)(2008-8#2)(2008-9#1)(2010-7#1)(2011-2#1)
of the repeat donors##2##4##(2012-2#2)
of the repeat##5##3##(2008-4#1)(2009-5#1)(2012-2#3)
of the repeatability of measurements##2##5##(1996-3#1)(2008-10#1)
of the repeated##2##3##(1993-5#1)(1994-11#1)
of the repeats##2##3##(1996-10#1)(2008-3#1)
of the repertoire##2##3##(1995-2#1)(1997-6#1)
of the repetitive##5##3##(1990-11#1)(1991-3#1)(1992-12#1)(1993-11#1)(2011-2#1)
of the replacement##3##3##(1991-2#1)(2008-10#1)(2008-9#1)
of the replicase##2##3##(2008-10#1)(2008-9#1)
of the replication fork##4##4##(1992-3#1)(1994-9#2)(1996-8#1)
of the replication of##4##4##(2006-10#1)(2008-4#1)(2011-3#1)(2013-1#1)
of the replication origin##2##4##(1991-5#1)(1994-12#1)
of the replication##17##3##(1990-11#1)(1990-9#1)(1991-5#1)(1991-8#1)(1992-3#1)(1993-9#1)(1994-12#1)(1994-9#3)(1996-8#1)(2006-10#1)(2008-2#1)(2008-4#1)(2010-3#1)(2011-3#1)(2013-1#1)
of the report and##2##4##(2009-2#1)(2011-12#1)
of the report is##2##4##(2008-1#1)(2011-2#1)
of the report##8##3##(1992-2#1)(2006-12#1)(2008-1#1)(2008-11#1)(2009-2#1)(2011-12#1)(2011-2#1)(2012-2#1)
of the reportable condition volume##4##5##(2013-1#4)
of the reported cases of##2##5##(1994-9#1)(1995-3#1)
of the reported cases##9##4##(1994-6#1)(1994-9#1)(1995-3#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-5#1)(2009-3#1)(2011-1#1)
of the reported findings##2##4##(2007-7#1)(2009-8#1)
of the reported sequence##2##4##(1994-12#1)(2008-12#1)
of the reported##26##3##(1990-8#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-3#2)(1996-6#1)(1997-1#1)(2006-10#1)(2007-1#1)(2007-12#2)(2007-6#1)(2007-7#3)(2008-1#2)(2008-10#1)(2008-12#1)(2008-5#1)(2009-3#1)(2009-8#1)(2011-1#1)(2011-2#2)
of the reporter gene##13##4##(1992-8#1)(1993-6#1)(1994-2#1)(1994-3#2)(1995-8#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-9#1)(2011-1#1)
of the reporter##19##3##(1991-7#1)(1992-12#1)(1992-8#1)(1993-6#1)(1994-2#1)(1994-3#2)(1995-8#1)(1997-1#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#4)(2008-9#1)(2011-1#1)(2011-12#1)
of the reporting forms##2##4##(2012-12#2)
of the reporting##5##3##(1994-2#1)(2007-2#1)(2012-12#3)
of the reports##6##3##(2006-10#1)(2007-2#1)(2008-11#2)(2010-2#1)(2013-7#1)
of the representation of the trigeminal nerve in##2##8##(1995-11#2)
of the representation of##4##4##(1995-11#2)(2009-10#1)(2011-1#1)
of the representation##7##3##(1995-11#2)(2009-10#1)(2011-1#1)(2012-3#1)(2013-1#2)
of the repressor##4##3##(1992-4#1)(1994-9#1)(1996-11#1)(1997-1#1)
of the reproducibility##3##3##(1994-3#1)(2008-10#1)(2012-1#1)
of the reproduction##2##3##(2009-9#2)
of the reproductive cycle##4##4##(1990-12#1)(2007-9#3)
of the reproductive period##2##4##(2012-11#1)(2013-1#1)
of the reproductive system##3##4##(2006-10#2)(2008-6#1)
of the reproductive tract##4##4##(1991-12#1)(1993-2#1)(1994-9#1)(2007-12#1)
of the reproductive##21##3##(1990-12#1)(1991-12#1)(1993-2#1)(1994-9#1)(1995-11#1)(1997-4#1)(2006-10#2)(2007-1#1)(2007-12#1)(2007-9#3)(2008-12#1)(2008-6#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
of the request for##2##4##(2008-11#1)(2009-6#1)
of the required plastic deformation##2##5##(2008-7#2)
of the required##13##3##(1994-12#1)(1995-6#1)(1996-12#1)(2006-5#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-5#1)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#1)
of the requirement for##2##4##(2006-10#1)(2009-5#1)
of the requirements for##4##4##(2008-2#1)(2008-8#1)(2010-12#1)(2013-1#1)
of the requirements of the##2##5##(2008-7#1)(2013-7#1)
of the requirements of##4##4##(1993-3#1)(1996-1#1)(2008-7#1)(2013-7#1)
of the requirements##11##3##(1993-11#1)(1993-3#1)(1996-1#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-7#1)
of the requisite##3##3##(1991-3#1)(1991-7#1)(2012-2#1)
of the rescue##2##3##(1990-9#1)(2010-7#1)
of the research and development of##2##6##(2013-1#1)(2013-8#1)
of the research and development##4##5##(2008-11#1)(2008-5#1)(2013-1#1)(2013-8#1)
of the research and##7##4##(1992-8#1)(1996-2#1)(2008-11#1)(2008-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
of the research data##4##4##(2008-10#3)(2008-11#1)
of the research has##2##4##(2008-10#1)(2008-5#1)
of the research into##2##4##(1997-7#1)(2009-8#1)
of the research on##3##4##(1990-10#1)(2009-7#1)(2013-1#1)
of the research process##3##4##(1992-5#1)(2009-4#1)(2011-1#1)
of the research project##3##4##(2006-8#1)(2007-11#1)(2013-8#1)
of the research was to##6##5##(2006-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)
of the research was##7##4##(2006-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2011-2#1)
of the research were##2##4##(2008-10#2)
of the research##77##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-5#1)(1992-6#1)(1992-8#1)(1994-12#1)(1994-7#1)(1995-1#1)(1996-2#1)(1997-1#1)(1997-7#1)(1997-8#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-8#2)(2007-1#1)(2007-11#3)(2007-5#1)(2007-9#3)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-4#3)(2009-7#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#3)
of the researcher##4##3##(1994-3#1)(2004-11#1)(2008-7#1)(2013-8#1)
of the researcher's##2##3##(1997-1#1)(2008-4#1)
of the researchers##3##3##(2009-5#1)(2010-9#1)(2011-2#1)
of the resected mass##2##4##(2012-2#2)
of the resected specimen showed##2##5##(2008-10#1)(2011-2#1)
of the resected specimen##6##4##(1992-6#1)(1996-6#1)(2007-4#1)(2008-10#1)(2011-2#1)(2013-7#1)
of the resected##15##3##(1992-6#1)(1996-6#1)(1997-3#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-7#1)(2013-8#1)
of the reservoir##5##3##(2005-11#1)(2007-12#2)(2008-10#1)(2008-3#1)
of the residence time of##2##5##(2007-9#1)(2008-2#1)
of the residence time##6##4##(2007-9#5)(2008-2#1)
of the residence##7##3##(2007-9#5)(2008-2#1)(2012-12#1)
of the resident##5##3##(2006-6#1)(2008-10#1)(2008-4#1)(2010-8#2)
of the residual yolk sac had no effect on serum total lipids##2##12##(2008-12#2)
of the residual yolk sac##6##5##(2008-12#6)
of the residual##28##3##(1990-9#1)(1991-2#1)(1992-8#1)(1993-11#1)(1997-2#1)(2004-9#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#6)(2008-2#3)(2008-3#1)(2009-3#1)(2010-12#2)(2010-7#1)(2012-1#1)(2012-2#1)(2013-8#1)
of the residuals##5##3##(1995-9#1)(2008-10#3)(2011-2#1)
of the residue##10##3##(1994-8#1)(1995-3#1)(2004-2#1)(2007-10#1)(2008-10#3)(2008-7#1)(2010-4#1)(2013-8#1)
of the residues in the##2##5##(1994-5#1)(1996-11#1)
of the residues##11##3##(1994-5#1)(1994-8#1)(1994-9#2)(1996-11#1)(1996-7#2)(1997-2#1)(1997-7#1)(2011-2#1)(2013-8#1)
of the resin and the##2##5##(2008-10#1)(2010-4#1)
of the resin for the##2##5##(2008-10#2)
of the resin for##5##4##(2008-10#5)
of the resin material##2##4##(2008-10#2)
of the resin matrix##2##4##(2011-2#1)(2013-8#1)
of the resin##24##3##(1990-12#1)(2005-11#1)(2008-10#17)(2008-8#1)(2010-4#1)(2011-2#2)(2013-8#1)
of the resin-phase##2##3##(2008-10#2)
of the resins##4##3##(2008-10#2)(2008-2#1)(2008-5#1)
of the resist##4##3##(2007-12#4)
of the resistance gene##5##4##(2008-10#3)(2008-5#1)(2012-11#1)
of the resistance genes##3##4##(2008-10#3)
of the resistance of##3##4##(2008-10#2)(2008-11#1)
of the resistance to##4##4##(1995-4#1)(2007-10#1)(2008-10#1)(2011-2#1)
of the resistance##30##3##(1995-4#1)(2005-11#1)(2005-8#1)(2007-10#1)(2007-8#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2009-1#1)(2011-2#1)(2012-11#1)(2012-3#1)
of the resistant genotype##2##4##(2008-10#2)
of the resistant lines##2##4##(2008-10#2)
of the resistant##16##3##(1995-8#1)(2007-7#1)(2008-10#12)(2008-11#1)(2011-2#1)
of the resolution##6##3##(1997-2#1)(2005-4#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-5#1)
of the resolved##3##3##(1995-3#1)(2007-12#1)(2008-2#1)
of the resonance wavelength##2##4##(2007-11#1)(2007-12#1)
of the resonance##12##3##(1990-8#1)(1993-8#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2010-1#1)(2010-4#1)
of the resonances##3##3##(1991-2#1)(2007-12#2)
of the resonant##10##3##(1995-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)
of the resonator##15##3##(2007-11#2)(2007-12#3)(2008-2#3)(2008-3#6)(2010-4#1)
of the resource##3##3##(1995-3#1)(2008-8#1)(2010-4#1)
of the resources available##3##4##(2008-4#2)(2012-11#1)
of the resources##11##3##(1990-12#1)(1994-3#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-11#1)
of the respective enzymes##2##4##(1991-12#1)(2011-2#1)
of the respective gene##3##4##(1994-8#1)(2008-8#1)(2010-12#1)
of the respective host##2##4##(2008-10#1)(2013-7#1)
of the respective##53##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#2)(1991-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-8#2)(1995-2#1)(1995-3#1)(1995-5#3)(1996-2#1)(1996-3#2)(1996-5#1)(1997-2#2)(1997-4#1)(2004-2#1)(2004-9#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-7#1)
of the respiration##3##3##(1994-11#1)(2007-8#1)(2011-1#1)
of the respiratory and##3##4##(1992-8#1)(2005-11#1)(2010-12#1)
of the respiratory burst##3##4##(1993-6#1)(1994-3#1)(1994-6#1)
of the respiratory chain enzymes##2##5##(1996-3#2)
of the respiratory chain##15##4##(1994-11#1)(1994-8#1)(1995-11#2)(1995-6#1)(1996-3#4)(1996-5#1)(2005-8#2)(2006-8#1)(2008-7#1)(2011-2#1)
of the respiratory epithelial##2##4##(2008-2#1)(2012-12#1)
of the respiratory rhythm generator##2##5##(1992-8#2)
of the respiratory rhythm##3##4##(1992-8#2)(1995-12#1)
of the respiratory system##12##4##(1990-9#3)(1992-2#1)(1994-4#1)(1996-3#1)(2008-5#2)(2010-7#1)(2010-9#1)(2011-1#1)(2013-7#1)
of the respiratory tract are##2##5##(1994-12#1)(2007-8#1)
of the respiratory tract##9##4##(1992-3#1)(1994-12#2)(1995-7#1)(2005-11#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-10#1)
of the respiratory tract]##2##4##(1994-3#1)(1995-8#1)
of the respiratory##73##3##(1990-10#1)(1990-9#3)(1991-3#1)(1991-6#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-8#3)(1993-6#1)(1994-11#1)(1994-12#3)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-3#5)(1996-5#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#2)(2005-8#2)(2005-9#1)(2006-10#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-2#2)(2008-5#2)(2008-7#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-7#1)
of the respondents felt that##2##5##(1996-1#1)(2011-2#1)
of the respondents felt##3##4##(1995-12#1)(1996-1#1)(2011-2#1)
of the respondents had had##2##5##(2007-3#1)(2011-2#1)
of the respondents had##9##4##(1996-9#1)(2004-10#1)(2006-8#1)(2007-3#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
of the respondents indicated that##2##5##(1996-3#1)(2006-8#1)
of the respondents reported##6##4##(2008-1#1)(2008-2#3)(2009-7#1)(2012-1#1)
of the respondents to##2##4##(2008-11#1)(2010-8#1)
of the respondents were aware that##2##6##(2004-10#2)
of the respondents were##9##4##(2004-10#2)(2006-12#1)(2007-3#1)(2007-6#1)(2008-2#1)(2008-9#1)(2012-12#1)(2013-1#1)
of the respondents##64##3##(1991-6#2)(1992-5#1)(1993-1#1)(1994-1#1)(1995-12#2)(1996-1#2)(1996-2#1)(1996-3#1)(1996-9#1)(2004-10#3)(2006-12#2)(2006-8#4)(2007-10#1)(2007-12#2)(2007-3#3)(2007-6#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-12#3)(2008-2#10)(2008-4#1)(2008-9#2)(2009-7#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#3)(2013-1#2)(2013-8#2)
of the responders and##2##4##(2011-2#1)(2012-12#1)
of the responders##6##3##(1990-2#1)(1997-8#2)(2006-2#1)(2011-2#1)(2012-12#1)
of the response and##2##4##(1990-5#1)(2008-2#1)
of the response at the##2##5##(1992-12#1)(2008-10#1)
of the response in##4##4##(1994-8#1)(1997-3#1)(2005-7#1)(2008-3#1)
of the response is##3##4##(1993-3#1)(2008-8#1)(2011-1#1)
of the response of M##2##5##(2008-10#2)
of the response of the##3##5##(1994-11#1)(2008-10#2)
of the response of##15##4##(1994-11#1)(1994-3#1)(1997-8#1)(2006-12#1)(2008-10#8)(2008-11#1)(2009-10#1)(2013-7#1)
of the response rate##2##4##(1996-10#1)(1997-8#1)
of the response reached##2##4##(1990-7#1)(2008-4#1)
of the response to 1 mM histamine)##2##7##(1995-3#2)
of the response to the##3##5##(1992-7#1)(2007-2#1)(2010-5#1)
of the response to##19##4##(1990-11#1)(1991-1#1)(1991-12#1)(1991-6#1)(1992-7#2)(1992-8#1)(1993-11#1)(1995-11#1)(1995-3#2)(2006-5#1)(2007-2#1)(2008-1#1)(2008-4#1)(2008-8#1)(2009-8#1)(2010-3#1)(2010-5#1)
of the response##86##3##(1990-11#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-6#2)(1991-7#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#3)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-8#2)(1995-11#1)(1995-3#2)(1995-4#1)(1996-10#1)(1997-2#1)(1997-3#1)(1997-8#2)(2005-7#1)(2006-12#1)(2006-5#1)(2007-2#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
of the responses of the##2##5##(1997-2#1)(2008-10#1)
of the responses of##4##4##(1991-2#1)(1997-2#1)(2008-10#1)(2009-8#1)
of the responses to##2##4##(1996-1#1)(2008-11#1)
of the responses##19##3##(1991-2#1)(1991-3#1)(1992-11#1)(1996-1#2)(1997-2#1)(2005-7#1)(2006-10#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-8#1)(2009-8#1)(2010-11#1)(2011-2#2)
of the responsible genes##2##4##(1997-7#1)(2007-10#1)
of the responsible##8##3##(1995-11#1)(1995-5#1)(1997-2#1)(1997-7#1)(2006-10#1)(2006-7#1)(2007-10#1)(2008-8#1)
of the responsive##2##3##(1995-11#1)(2009-8#1)
of the responsivity##2##3##(2008-2#1)(2008-3#1)
of the rest of the##4##5##(1991-4#1)(1993-2#1)(2005-11#1)(2007-11#1)
of the rest of##5##4##(1991-4#1)(1993-2#1)(2005-11#1)(2007-11#1)(2012-2#1)
of the rest##7##3##(1991-4#1)(1993-2#1)(1997-7#1)(2005-11#1)(2007-11#1)(2011-2#1)(2012-2#1)
of the resting##13##3##(1990-10#2)(1990-6#1)(1992-6#1)(1993-12#1)(1994-3#1)(1997-7#2)(2006-4#1)(2008-5#1)(2011-2#2)(2013-8#1)
of the restorations##2##3##(2010-2#1)(2011-2#1)
of the restored##3##3##(1991-5#1)(2007-12#1)(2008-3#1)
of the restraint##2##3##(2006-11#1)(2007-4#1)
of the restricted##2##3##(1993-12#1)(2012-12#1)
of the restriction endonuclease##3##4##(1993-12#1)(1994-8#1)(2005-11#1)
of the restriction sites##2##4##(1990-9#1)(1991-9#1)
of the restriction##10##3##(1990-9#1)(1991-12#1)(1991-9#1)(1993-12#1)(1994-8#1)(1997-4#1)(2005-11#1)(2006-8#1)(2007-2#1)(2008-5#1)
of the result of##4##4##(1993-8#1)(1997-6#2)(2006-5#1)
of the result##9##3##(1992-10#1)(1992-4#1)(1993-8#1)(1997-6#2)(2006-5#1)(2007-11#1)(2007-8#1)(2009-6#1)
of the resultant xerogels##2##4##(2005-11#2)
of the resultant##19##3##(1991-10#1)(1994-5#1)(2005-11#3)(2005-2#1)(2007-12#2)(2007-3#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
of the resulting complex##2##4##(1994-3#1)(2008-10#1)
of the resulting fragments##3##4##(1992-3#1)(1993-6#1)(2006-10#1)
of the resulting modified##2##4##(2008-10#2)
of the resulting##93##3##(1990-3#2)(1991-4#1)(1991-7#2)(1992-12#1)(1992-3#1)(1992-6#2)(1993-6#1)(1993-8#1)(1994-11#2)(1994-3#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#5)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#23)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#3)(2008-5#4)(2008-9#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-4#4)(2010-6#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
of the results and##6##4##(1996-5#1)(2006-10#1)(2006-4#1)(2007-12#1)(2008-4#1)(2011-2#1)
of the results are discussed in##2##6##(2008-2#1)(2008-5#1)
of the results are discussed##3##5##(2008-2#1)(2008-5#2)
of the results are##8##4##(2008-2#3)(2008-5#2)(2009-9#1)(2013-1#2)
of the results based on the##2##6##(2006-10#1)(2008-3#1)
of the results between##2##4##(1990-12#1)(2013-1#1)
of the results collected during##2##5##(1991-12#1)(2013-1#1)
of the results derived by##2##5##(2007-10#1)(2008-3#1)
of the results for the##3##5##(1995-1#1)(2007-11#1)(2011-2#1)
of the results for##12##4##(1993-12#1)(1995-1#2)(2007-11#3)(2008-10#3)(2008-6#1)(2009-7#1)(2011-2#1)
of the results from##2##4##(2006-2#1)(2011-2#1)
of the results in##5##4##(1994-12#1)(2005-10#1)(2008-4#1)(2009-9#1)(2012-12#1)
of the results is##6##4##(1991-12#1)(2006-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-7#1)
of the results obtained by the##2##6##(2008-10#2)
of the results obtained by##5##5##(1992-8#1)(2007-11#1)(2008-10#3)
of the results obtained for##4##5##(2007-11#1)(2008-10#3)
of the results obtained is##2##5##(2006-6#1)(2008-5#1)
of the results obtained with##3##5##(1992-6#1)(2007-11#1)(2008-5#1)
of the results obtained##23##4##(1990-6#1)(1990-7#1)(1991-3#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-8#1)(1996-3#1)(2006-6#1)(2007-11#4)(2008-10#6)(2008-2#2)(2008-5#2)
of the results of clinical##2##5##(2008-7#1)(2012-12#1)
of the results of studies##3##5##(1994-5#1)(1997-4#1)(2011-2#1)
of the results of the study##2##6##(2007-3#1)(2008-6#1)
of the results of the treatment of##2##7##(1991-9#1)(2011-2#1)
of the results of the##17##5##(1991-3#1)(1991-9#1)(1992-11#1)(1993-1#1)(1994-2#1)(1996-4#1)(1997-8#1)(2005-11#2)(2006-10#1)(2007-3#1)(2007-7#1)(2008-4#1)(2008-6#1)(2008-7#1)(2011-12#1)(2011-2#1)
of the results of this##2##5##(1993-1#1)(1996-12#1)
of the results of##50##4##(1990-9#1)(1991-3#1)(1991-9#2)(1992-11#1)(1993-1#2)(1994-2#1)(1994-5#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-4#1)(1997-4#1)(1997-8#1)(2005-11#2)(2005-4#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-5#1)(2011-12#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#1)(2013-1#1)
of the results on the##3##5##(2008-10#1)(2008-4#2)
of the results on##4##4##(2008-10#1)(2008-2#1)(2008-4#2)
of the results presented##2##4##(2008-9#1)(2009-5#1)
of the results reported##3##4##(1994-3#1)(2008-3#1)(2013-1#1)
of the results revealed that##2##5##(2007-4#1)(2008-10#1)
of the results suggested that##2##5##(1995-5#1)(2007-7#1)
of the results the##2##4##(1991-9#1)(2011-2#1)
of the results to##4##4##(1994-2#1)(2007-9#1)(2008-3#1)(2008-4#1)
of the results was done by##2##6##(2008-10#1)(2013-8#1)
of the results was##7##4##(1990-12#2)(2007-12#1)(2008-10#3)(2013-8#1)
of the results were##3##4##(2008-10#2)(2008-5#1)
of the results with##6##4##(2007-12#1)(2008-10#3)(2008-2#1)(2011-2#1)
of the results##209##3##(1990-1#1)(1990-10#1)(1990-12#3)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-12#3)(1991-3#2)(1991-9#4)(1992-11#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-12#1)(1993-8#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1995-1#2)(1995-12#1)(1995-5#2)(1995-8#1)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#2)(2005-4#2)(2005-9#1)(2006-10#6)(2006-2#1)(2006-4#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#8)(2007-12#4)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#31)(2008-11#2)(2008-2#10)(2008-3#8)(2008-4#7)(2008-5#9)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-5#3)(2009-7#1)(2009-9#2)(2010-11#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#14)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#2)(2013-1#8)(2013-8#2)
of the ret proto-oncogene##3##4##(1991-9#1)(1994-12#2)
of the retained##3##3##(1991-3#1)(2008-10#1)(2009-12#1)
of the retardance##3##3##(2008-2#1)(2008-3#2)
of the retarder##3##3##(2008-2#2)(2008-3#1)
of the retention indices of the hydrocarbons on##2##8##(2008-10#2)
of the retention mechanism##2##4##(2008-10#1)(2013-8#1)
of the retention of##2##4##(1997-8#1)(2008-10#1)
of the retention system##2##4##(1990-6#2)
of the retention##15##3##(1990-6#2)(1996-11#1)(1996-5#1)(1997-8#1)(2008-10#7)(2012-12#1)(2013-8#2)
of the reticular formation##3##4##(1991-3#1)(1994-3#1)(1997-6#1)
of the reticular lamina##3##4##(1995-5#3)
of the reticular##6##3##(1991-3#1)(1994-3#1)(1995-5#3)(1997-6#1)
of the reticuloendothelial system##3##4##(1992-6#1)(2006-10#1)(2008-3#1)
of the reticuloendothelial##4##3##(1992-6#1)(1997-7#1)(2006-10#1)(2008-3#1)
of the reticulum##4##3##(1993-1#4)
of the retina and##4##4##(1995-11#1)(2006-1#1)(2006-6#1)(2011-2#1)
of the retina with##2##4##(1997-3#1)(2012-1#1)
of the retina##29##3##(1990-7#1)(1991-2#1)(1995-1#3)(1995-11#1)(1996-2#1)(1997-3#1)(2006-1#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-3#2)(2007-6#1)(2007-9#1)(2008-8#4)(2009-2#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-1#1)
of the retinal chromophore##4##4##(1995-1#1)(1997-3#1)(2007-12#1)(2008-7#1)
of the retinal##25##3##(1990-7#1)(1991-12#1)(1991-7#2)(1992-11#1)(1995-1#3)(1995-10#1)(1995-5#1)(1997-3#1)(2007-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-2#2)(2009-8#1)(2010-10#1)(2011-1#1)(2011-7#1)
of the retinoblastoma gene product##3##5##(1992-8#1)(1995-2#1)(1997-7#1)
of the retinoblastoma gene##4##4##(1992-8#1)(1995-2#1)(1997-7#1)(2010-3#1)
of the retinoblastoma protein##3##4##(1993-9#1)(1996-4#1)(1997-1#1)
of the retinoblastoma susceptibility gene##2##5##(1996-11#1)(1996-2#1)
of the retinoblastoma##9##3##(1992-8#1)(1993-9#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-7#1)(2010-3#1)
of the retinoic acid receptor alpha##2##6##(1990-9#1)(1991-11#1)
of the retinoic acid##3##4##(1990-9#1)(1991-11#1)(1995-11#1)
of the retinoid##2##3##(1995-10#1)(2012-2#1)
of the retrieval##13##3##(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#7)(2013-8#1)
of the retrieved aerosol##2##4##(2008-2#1)(2008-3#1)
of the retrieved aerosol-extinction##2##4##(2008-3#2)
of the retrieved profiles##2##4##(2008-3#2)
of the retrieved##19##3##(2005-11#1)(2007-12#1)(2008-2#4)(2008-3#10)(2008-8#2)(2010-9#1)
of the retrograde tracer##4##4##(1990-11#1)(1992-12#1)(1995-6#1)(2010-10#1)
of the retrograde##7##3##(1990-11#1)(1992-12#1)(1995-6#1)(2007-8#2)(2009-2#1)(2010-10#1)
of the retromer##2##3##(2012-12#2)
of the retroperitoneal##4##3##(1992-8#1)(2006-6#1)(2008-6#1)(2012-3#1)
of the retroperitoneum##6##3##(1992-12#1)(2008-6#2)(2009-7#1)(2010-12#1)(2013-1#1)
of the retrospective##3##3##(2006-10#1)(2006-2#1)(2008-11#1)
of the return##3##3##(2008-2#2)(2008-9#1)
of the revenue##3##3##(1992-1#1)(1992-12#1)(2007-5#1)
of the reverse transcriptase##3##4##(1991-12#1)(1997-1#1)(2007-11#1)
of the reverse##7##3##(1991-12#1)(1991-7#1)(1994-9#1)(1996-10#1)(1997-1#1)(2007-11#1)(2008-7#1)
of the reversibly##3##3##(1997-1#1)(2008-10#1)(2010-4#1)
of the review and##2##4##(1992-1#1)(2012-1#1)
of the review is to##3##5##(2007-12#1)(2008-11#1)(2013-8#1)
of the review is##5##4##(1992-1#1)(2007-12#1)(2008-11#1)(2010-12#1)(2013-8#1)
of the review##18##3##(1992-1#3)(1994-3#1)(1994-8#1)(1996-7#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#3)(2008-6#1)(2009-10#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-8#1)
of the revised##8##3##(1992-1#1)(1997-1#1)(2007-12#1)(2007-2#1)(2007-5#1)(2009-7#1)(2009-9#1)(2010-5#1)
of the revision of##2##4##(1992-9#1)(2012-2#1)
of the revision##3##3##(1992-9#1)(2008-8#1)(2012-2#1)
of the reward##3##3##(1993-6#1)(2010-10#1)(2013-8#1)
of the rf##3##3##(2007-12#2)(2008-3#1)
of the rhamnose##2##3##(1995-1#2)
of the rhesus##2##3##(1996-5#1)(2013-8#1)
of the rheumatoid hand##3##4##(2006-4#1)(2007-11#2)
of the rheumatoid process##2##4##(2007-7#2)
of the rheumatoid##7##3##(1990-6#1)(2006-4#1)(2007-11#2)(2007-7#2)(2007-8#1)
of the rhizobacterium##2##3##(2006-3#1)(2007-8#1)
of the rho##3##3##(1993-6#1)(1994-11#1)(1995-7#1)
of the rho/rac proteins##3##4##(1990-2#3)
of the rho2 mRNA in the##2##6##(2008-4#2)
of the rhythm to##2##4##(1994-2#1)(2008-5#1)
of the rhythm##4##3##(1994-2#1)(2008-5#2)(2008-6#1)
of the rib##7##3##(2007-8#2)(2009-3#1)(2010-2#2)(2013-1#2)
of the ribbon-like structures##2##4##(1992-6#2)
of the ribbon-like##3##3##(1992-6#2)(2008-10#1)
of the ribonuclease##2##3##(1992-12#1)(1992-9#1)
of the ribonucleoprotein particles##2##4##(1995-2#1)(1995-3#1)
of the ribonucleoprotein##4##3##(1995-2#1)(1995-3#1)(2012-12#2)
of the ribonucleotide reductase##2##4##(1994-8#1)(2013-8#1)
of the ribose moiety##3##4##(1992-9#1)(1994-9#1)(1995-8#1)
of the ribose##6##3##(1992-9#1)(1994-9#1)(1995-8#1)(1996-5#1)(2008-4#2)
of the ribosomal DNA (rDNA)##2##5##(2008-10#2)
of the ribosomal DNA##7##4##(2007-2#1)(2007-3#1)(2008-10#5)
of the ribosomal RNA##2##4##(2008-10#1)(2008-5#1)
of the ribosomal genes##2##4##(2008-10#2)
of the ribosomal protein##3##4##(1996-11#1)(1997-2#1)(2012-12#1)
of the ribosomal proteins and##2##5##(2005-10#1)(2006-12#1)
of the ribosomal proteins##3##4##(1997-4#1)(2005-10#1)(2006-12#1)
of the ribosomal##19##3##(1996-11#1)(1997-2#1)(1997-4#1)(2005-10#1)(2006-12#1)(2007-2#1)(2007-3#1)(2008-10#10)(2008-5#1)(2012-12#1)
of the ribosome as##2##4##(1990-2#1)(2006-12#1)
of the ribosome##16##3##(1990-2#1)(1995-3#1)(1997-2#1)(2005-10#2)(2005-7#1)(2006-12#4)(2007-12#2)(2008-11#1)(2008-7#1)(2009-9#1)(2010-12#1)
of the ribozyme in##2##4##(1993-9#1)(2008-9#1)
of the ribozyme##9##3##(1993-9#3)(1994-11#2)(1994-9#1)(1995-6#1)(2006-11#1)(2008-9#1)
of the ribs##2##3##(1991-11#1)(2006-7#1)
of the rice blast fungus##3##5##(2008-10#3)
of the rice genome##2##4##(2006-11#1)(2008-9#1)
of the rice##14##3##(2006-11#1)(2007-6#1)(2008-10#5)(2008-8#1)(2008-9#6)
of the richest##2##3##(2010-5#1)(2011-3#1)
of the right MCA##2##4##(2008-12#2)
of the right adrenal##2##4##(2007-10#1)(2012-12#1)
of the right and left hemispheres in 3##2##8##(2012-1#2)
of the right and left hemispheres in##3##7##(2012-1#3)
of the right and left##6##5##(1996-5#1)(2007-8#1)(2010-6#1)(2012-1#3)
of the right and##7##4##(1996-5#1)(2005-12#1)(2007-8#1)(2010-6#1)(2012-1#3)
of the right arm of##3##5##(1993-11#1)(1995-4#1)(1997-3#1)
of the right atrium and##3##5##(2007-8#3)
of the right atrium##5##4##(1997-6#1)(2007-8#4)
of the right breast##3##4##(1994-12#1)(1996-6#1)(2008-10#1)
of the right cheek##3##4##(2008-5#2)(2012-12#1)
of the right colon##2##4##(1990-4#2)
of the right coronary artery to the##2##7##(2007-8#1)(2010-7#1)
of the right coronary artery##7##5##(1990-3#1)(1994-11#1)(2007-8#3)(2009-8#1)(2010-7#1)
of the right coronary##8##4##(1990-3#1)(1994-11#1)(2007-8#4)(2009-8#1)(2010-7#1)
of the right eye showed##2##5##(2009-8#1)(2011-1#1)
of the right eye##7##4##(1994-2#1)(2007-3#1)(2009-8#1)(2011-1#2)(2012-2#1)(2013-7#1)
of the right foot##3##4##(2008-12#1)(2009-10#1)(2012-3#1)
of the right gastroepiploic artery##3##5##(2007-8#3)
of the right hand##3##4##(1990-11#1)(2007-7#1)(2013-7#1)
of the right hemidiaphragm##3##4##(2009-2#2)(2012-1#1)
of the right hemisphere are##2##5##(1990-3#2)
of the right hemisphere##10##4##(1990-3#4)(1993-9#1)(1996-2#3)(2005-10#1)(2009-2#1)
of the right hepatic##2##4##(1991-6#1)(2009-2#1)
of the right hip##4##4##(2006-10#1)(2007-8#2)(2009-2#1)
of the right inferior lobe##2##5##(1992-4#2)
of the right internal carotid artery and##2##7##(2006-4#1)(2009-2#1)
of the right internal carotid artery##4##6##(2006-2#1)(2006-4#2)(2009-2#1)
of the right internal##5##4##(2006-2#1)(2006-4#2)(2007-8#1)(2009-2#1)
of the right kidney##5##4##(1994-5#1)(2007-10#1)(2007-7#1)(2012-1#2)
of the right lobe of the##2##6##(1993-6#1)(2010-12#1)
of the right lobe##3##4##(1993-6#1)(2009-9#1)(2010-12#1)
of the right lower##2##4##(1992-11#1)(2008-6#1)
of the right lung##4##4##(2007-12#1)(2007-7#1)(2007-8#1)(2013-1#1)
of the right middle cerebral artery##3##6##(1996-3#1)(2008-7#2)
of the right middle##4##4##(1996-3#2)(2008-7#2)
of the right optic nerve##2##5##(1996-2#1)(2011-1#1)
of the right orbit##2##4##(2008-4#1)(2008-7#1)
of the right parotid##2##4##(1990-2#1)(2006-4#1)
of the right pulmonary artery##4##5##(1997-5#1)(2007-8#1)(2008-11#1)(2010-10#1)
of the right side##3##4##(2008-12#1)(2009-9#1)(2013-7#1)
of the right size##2##4##(1996-2#1)(2008-5#1)
of the right subclavian artery##2##5##(2007-8#2)
of the right superior##2##4##(2007-8#1)(2013-8#1)
of the right temporal##3##4##(2006-10#1)(2008-8#1)(2008-9#1)
of the right to##4##4##(1991-12#1)(1992-3#1)(2006-9#1)(2013-8#1)
of the right upper lobe##2##5##(2007-11#1)(2007-8#1)
of the right upper##3##4##(2005-1#1)(2007-11#1)(2007-8#1)
of the right ventricle in##3##5##(1997-1#1)(2008-11#1)(2009-10#1)
of the right ventricle##9##4##(1997-1#1)(2007-8#1)(2008-11#1)(2009-10#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
of the right ventricular outflow tract##2##6##(2007-8#1)(2013-2#1)
of the right ventricular##3##4##(2006-9#1)(2007-8#1)(2013-2#1)
of the right##204##3##(1990-11#2)(1990-2#1)(1990-3#5)(1990-4#2)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-6#2)(1992-11#1)(1992-2#2)(1992-3#1)(1992-4#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-4#1)(1995-6#1)(1995-7#1)(1996-2#5)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#2)(1997-5#1)(1997-6#1)(2005-1#1)(2005-10#1)(2005-12#1)(2006-10#5)(2006-2#1)(2006-4#4)(2006-6#2)(2006-9#3)(2007-10#3)(2007-11#1)(2007-12#2)(2007-3#1)(2007-6#1)(2007-7#6)(2007-8#26)(2008-10#2)(2008-11#3)(2008-12#8)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#3)(2009-2#9)(2009-3#1)(2009-4#1)(2009-8#2)(2009-9#4)(2010-10#3)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#5)(2011-2#3)(2012-1#7)(2012-12#4)(2012-2#4)(2012-3#3)(2013-1#2)(2013-2#1)(2013-7#3)(2013-8#3)
of the right-sided##2##3##(2006-10#1)(2011-2#1)
of the rigor##2##3##(1994-5#1)(1996-11#1)
of the ring laser##2##4##(2007-11#1)(2008-2#1)
of the ring##19##3##(1994-12#1)(1995-10#1)(2006-12#3)(2007-11#3)(2008-10#1)(2008-2#4)(2008-3#1)(2010-12#1)(2010-7#2)(2010-9#1)(2012-2#1)
of the ring-shaped##2##3##(2007-12#1)(2012-2#1)
of the rise in##3##4##(1992-4#1)(2008-2#1)(2009-4#1)
of the rise was##2##4##(1992-4#1)(2008-5#1)
of the rise##7##3##(1992-4#2)(2005-11#1)(2006-8#1)(2008-2#1)(2008-5#1)(2009-4#1)
of the risk analysis##2##4##(2005-5#1)(2008-10#1)
of the risk assessment##2##4##(2005-3#1)(2008-10#1)
of the risk factors for##9##5##(1993-12#1)(2006-8#1)(2007-11#1)(2008-10#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
of the risk factors##23##4##(1990-9#1)(1993-12#1)(1993-2#1)(1997-3#1)(2005-11#1)(2006-2#1)(2006-8#2)(2007-11#1)(2007-6#2)(2008-10#1)(2008-3#2)(2008-9#1)(2010-10#1)(2010-9#2)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
of the risk for##2##4##(1997-1#1)(2007-7#1)
of the risk in##2##4##(1992-3#1)(2011-2#1)
of the risk of malignant##2##5##(1993-10#1)(2013-1#1)
of the risk of##50##4##(1991-6#1)(1992-12#1)(1993-10#2)(1993-11#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-7#1)(1995-6#1)(1996-3#1)(2004-9#1)(2005-1#2)(2005-12#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#2)
of the risk##100##3##(1990-12#1)(1990-2#2)(1990-9#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-10#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-2#2)(1994-7#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-8#1)(2004-9#1)(2005-1#2)(2005-11#1)(2005-12#1)(2005-3#1)(2005-5#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#3)(2007-11#2)(2007-12#4)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-5#1)(2010-9#2)(2011-1#2)(2011-2#6)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
of the risks of##8##4##(2005-9#1)(2007-1#1)(2007-2#2)(2008-4#1)(2008-5#1)(2011-2#1)(2012-11#1)
of the risks##14##3##(2005-9#1)(2007-1#1)(2007-10#1)(2007-2#2)(2008-4#1)(2008-5#1)(2010-10#1)(2010-12#2)(2011-2#2)(2012-11#1)(2012-2#1)
of the river Chittar##3##4##(2008-5#3)
of the river##8##3##(2007-3#1)(2008-5#5)(2009-6#1)(2012-12#1)
of the rms##3##3##(2007-12#1)(2008-3#2)
of the road ahead##2##4##(1994-6#2)
of the road##4##3##(1994-6#2)(2010-11#1)(2011-1#1)
of the robot is##2##4##(2012-1#1)(2012-2#1)
of the robot##8##3##(2007-5#1)(2008-2#1)(2011-1#1)(2012-1#4)(2012-2#1)
of the robotic##2##3##(2011-1#1)(2012-1#1)
of the robust##3##3##(2007-11#1)(2008-10#2)
of the robustness of##2##4##(2006-12#1)(2009-3#1)
of the rock##3##3##(2007-5#1)(2008-10#2)
of the rod##6##3##(1990-11#1)(1990-7#3)(2007-7#1)(2008-2#1)
of the rodent micronucleus assay##3##5##(1997-2#3)
of the rodent##10##3##(1992-9#1)(1993-2#1)(1997-2#3)(2007-9#1)(2008-11#2)(2008-4#2)
of the rodenticides warfarin##2##4##(2008-10#2)
of the role and functions of##2##6##(2007-10#1)(2008-12#1)
of the role and##5##4##(1995-12#1)(2007-10#1)(2008-12#1)(2009-9#1)(2012-2#1)
of the role of H##2##5##(2006-10#1)(2006-2#1)
of the role of early##2##5##(2007-12#1)(2008-1#1)
of the role of oxygen free radicals in##3##8##(1991-9#1)(1992-12#1)(1994-2#1)
of the role of the##13##5##(1990-2#1)(1990-4#1)(1991-1#1)(1992-11#1)(1994-11#1)(1995-2#1)(1997-7#1)(2007-10#1)(2008-2#1)(2010-12#1)(2012-1#1)(2012-3#1)(2013-1#1)
of the role of these##4##5##(1991-8#1)(1994-10#1)(2004-11#1)(2013-8#1)
of the role of##124##4##(1990-11#1)(1990-2#2)(1990-4#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#3)(1992-12#2)(1992-2#1)(1993-12#2)(1993-3#3)(1993-6#1)(1994-10#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-5#1)(2005-7#2)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#4)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#2)(2009-12#1)(2009-3#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#1)(2012-1#2)(2012-2#6)(2012-3#3)(2013-1#3)(2013-8#5)
of the role played by##4##5##(1990-11#1)(2008-8#1)(2008-9#1)(2012-2#1)
of the role played##5##4##(1990-11#1)(2005-9#1)(2008-8#1)(2008-9#1)(2012-2#1)
of the role##147##3##(1990-11#2)(1990-2#2)(1990-4#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#2)(1992-2#1)(1993-12#2)(1993-3#3)(1993-6#1)(1994-10#1)(1994-11#1)(1994-2#1)(1995-12#2)(1995-2#2)(1996-10#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-5#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-8#2)(2007-10#2)(2007-11#5)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-1#2)(2009-12#1)(2009-3#1)(2009-6#2)(2009-7#1)(2009-9#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#1)(2012-1#2)(2012-2#8)(2012-3#3)(2013-1#3)(2013-8#5)
of the roles of##10##4##(1994-8#1)(2004-12#1)(2005-11#1)(2007-11#1)(2008-4#1)(2008-9#1)(2010-3#1)(2012-11#1)(2012-12#1)(2012-3#1)
of the roles##17##3##(1994-10#1)(1994-3#1)(1994-8#1)(2004-12#1)(2005-11#1)(2007-11#1)(2007-4#2)(2008-4#2)(2008-9#1)(2009-8#2)(2010-3#1)(2012-11#1)(2012-12#1)(2012-3#1)
of the romance##2##3##(2012-2#2)
of the roof of the##2##5##(2006-12#1)(2009-3#1)
of the root and##4##4##(2008-10#2)(2013-1#2)
of the root bark of##3##5##(2007-1#1)(2008-10#1)(2008-11#1)
of the root canal##6##4##(2005-10#1)(2012-2#1)(2013-1#4)
of the root cap##2##4##(2008-10#1)(2009-8#1)
of the root of##9##4##(1990-6#1)(1993-9#1)(2007-2#1)(2009-5#1)(2010-12#4)(2012-3#1)
of the root system##4##4##(2008-10#4)
of the root##44##3##(1990-6#1)(1993-9#1)(1995-12#1)(2005-10#1)(2006-10#1)(2006-4#1)(2007-1#2)(2007-2#1)(2008-10#15)(2008-11#1)(2009-5#1)(2009-6#2)(2009-8#2)(2010-12#4)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#1)
of the root-knot nematode Meloidogyne javanica##2##6##(2008-10#2)
of the root-knot nematode Meloidogyne##3##5##(2008-10#3)
of the root-knot nematode##4##4##(2008-10#4)
of the root-mean-square##2##3##(2007-12#1)(2008-10#1)
of the roots of##12##4##(2007-1#5)(2007-11#2)(2008-10#1)(2010-6#1)(2011-1#1)(2012-12#1)(2013-1#1)
of the roots##19##3##(1995-9#1)(2007-1#6)(2007-11#2)(2008-10#3)(2008-5#1)(2008-9#1)(2009-10#1)(2010-6#1)(2011-1#1)(2012-12#1)(2013-1#1)
of the rostral ventrolateral medulla##3##5##(1991-5#1)(1997-6#2)
of the rostral##12##3##(1991-5#1)(1993-12#2)(1995-7#2)(1996-3#1)(1997-5#1)(1997-6#2)(2007-2#1)(2008-7#1)(2011-1#1)
of the rosy bitterling##2##4##(2008-5#2)
of the rotating##3##3##(2005-11#1)(2008-10#1)(2008-9#1)
of the rotation of##2##4##(1993-2#1)(2008-3#1)
of the rotation##4##3##(1993-2#1)(2008-3#2)(2011-1#1)
of the rotational motion##2##4##(1990-2#1)(1994-3#1)
of the rotational##10##3##(1990-2#1)(1990-7#1)(1991-12#1)(1993-12#1)(1994-10#1)(1994-3#1)(2007-11#1)(2008-2#1)(2008-3#1)(2010-2#1)
of the rotator cuff##7##4##(1994-2#1)(2007-11#2)(2007-7#1)(2009-4#1)(2012-12#2)
of the rotator##8##3##(1990-3#1)(1994-2#1)(2007-11#2)(2007-7#1)(2009-4#1)(2012-12#2)
of the rotenone-sensitive##3##3##(1990-11#2)(1990-8#1)
of the rotifer##3##3##(2010-12#1)(2012-2#2)
of the rough endoplasmic reticulum##4##5##(1996-8#1)(2008-7#2)(2009-2#1)
of the rough endoplasmic##5##4##(1996-8#1)(2008-7#2)(2009-2#2)
of the rough##8##3##(1996-8#1)(2008-3#3)(2008-7#2)(2009-2#2)
of the roughly##2##3##(1990-8#1)(2007-9#1)
of the roughness##5##3##(2007-12#3)(2008-2#2)
of the round cells##2##4##(1993-4#1)(1996-5#1)
of the routine investigations##2##4##(2008-9#1)(2010-6#1)
of the routine##8##3##(1990-6#1)(1993-2#1)(1994-6#1)(1996-9#1)(2007-8#1)(2008-2#1)(2008-9#1)(2010-6#1)
of the rows##4##3##(2007-12#2)(2008-10#1)(2008-3#1)
of the royal##2##3##(2008-8#1)(2011-1#1)
of the rubredoxin-like##2##3##(1991-11#2)
of the rule##2##3##(2008-11#1)(2008-2#1)
of the rules##8##3##(1995-6#2)(2007-10#1)(2008-2#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
of the running##2##3##(2007-8#1)(2008-11#1)
of the rupture##4##3##(1995-5#1)(2007-7#1)(2009-9#1)(2011-3#1)
of the ruptured##4##3##(2006-4#1)(2007-5#1)(2008-5#1)(2009-5#1)
of the rural##6##3##(2008-12#1)(2008-6#1)(2011-1#2)(2011-11#1)(2013-1#1)
of the ruthenium binding##2##4##(2008-3#2)
of the ruthenium complex##2##4##(2005-11#1)(2010-12#1)
of the ruthenium##4##3##(2005-11#1)(2008-3#2)(2010-12#1)
of the ryanodine receptor##4##4##(1991-7#1)(1994-8#1)(1997-3#1)(2006-10#1)
of the ryanodine sensitive ion channel##2##6##(1994-8#2)
of the ryanodine##6##3##(1991-7#1)(1994-8#3)(1997-3#1)(2006-10#1)
of the rye##3##3##(1997-3#2)(2008-5#1)
of the sIL-6R##3##3##(1996-11#3)
of the sTNF-R2##2##3##(1993-3#2)
of the sTT/PSA ratio##3##4##(2012-12#3)
of the sac##4##3##(1995-11#2)(2007-12#1)(2008-6#1)
of the saccharide##3##3##(1991-7#1)(2008-10#1)(2012-12#1)
of the sacral##4##3##(1993-12#2)(2007-11#1)(2008-3#1)
of the sacroiliac joint##4##4##(2006-12#1)(2006-8#1)(2007-11#1)(2011-2#1)
of the sacroiliac joints##4##4##(1990-6#1)(2006-10#1)(2006-12#1)(2011-2#1)
of the sacroiliac##9##3##(1990-6#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-11#1)(2007-7#1)(2011-2#2)
of the sacrum##4##3##(1991-11#1)(1995-9#1)(2007-11#1)(2008-12#1)
of the safety and efficacy of##3##6##(1994-5#1)(2006-5#1)(2011-2#1)
of the safety and##4##4##(1994-5#1)(2006-5#1)(2010-4#1)(2011-2#1)
of the safety of the##2##5##(2008-5#1)(2008-7#1)
of the safety of##8##4##(1990-11#1)(1990-6#1)(1995-5#1)(2005-7#1)(2006-10#1)(2008-5#1)(2008-7#1)(2008-8#1)
of the safety##17##3##(1990-11#1)(1990-6#1)(1991-6#1)(1994-5#1)(1995-5#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-2#1)(2010-4#1)(2011-1#1)(2011-2#1)
of the sag##2##3##(2008-5#2)
of the sagitta##2##3##(2013-7#2)
of the sagittal##3##3##(2006-4#1)(2006-5#1)(2007-8#1)
of the said##2##3##(2008-10#2)
of the salient##2##3##(2007-8#2)
of the saline matrix##2##4##(2008-10#2)
of the saline##7##3##(1990-11#1)(1993-7#1)(2008-10#2)(2008-7#1)(2011-2#1)(2013-8#1)
of the saliva volume##2##4##(2007-9#2)
of the saliva##5##3##(1991-8#1)(2007-9#3)(2010-12#1)
of the salivary and the serum##2##6##(2013-8#2)
of the salivary glands##3##4##(2008-4#3)
of the salivary##13##3##(1992-5#2)(2007-9#2)(2008-4#3)(2009-3#2)(2010-2#1)(2011-2#1)(2013-8#2)
of the salt concentration and##2##5##(2005-11#1)(2012-12#1)
of the salt is##2##4##(1990-2#1)(2007-12#1)
of the salt samples##2##4##(2006-4#1)(2007-2#1)
of the salt##12##3##(1990-2#1)(1992-11#1)(1995-1#1)(1997-2#1)(2005-11#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-4#1)(2012-12#1)
of the salt-bridge##3##3##(2006-2#2)(2006-4#1)
of the salts##2##3##(1996-2#1)(2005-11#1)
of the salvage##2##3##(1996-10#1)(2007-11#1)
of the same Nd##4##4##(2007-12#1)(2008-1#1)(2008-2#2)
of the same acids##4##4##(1995-5#4)
of the same age and sex##2##6##(1990-11#1)(1991-11#1)
of the same age and##3##5##(1990-11#1)(1991-11#1)(2006-4#1)
of the same age group##6##5##(1990-2#1)(1992-4#1)(2008-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
of the same age##21##4##(1990-11#1)(1990-2#1)(1991-11#1)(1991-12#1)(1991-9#2)(1992-4#1)(1995-9#1)(1996-6#1)(1997-5#1)(2004-11#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-12#1)(2008-1#2)(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
of the same agent##2##4##(1994-5#1)(1997-8#1)
of the same analytes##2##4##(2008-10#1)(2008-3#1)
of the same area##4##4##(1996-7#1)(2008-2#1)(2008-5#1)(2011-1#1)
of the same bacterial##2##4##(2011-2#1)(2012-12#1)
of the same brand##2##4##(2008-10#1)(2013-1#1)
of the same cell##2##4##(1995-3#1)(2008-4#1)
of the same cells##3##4##(1990-8#1)(1991-8#1)(1996-5#1)
of the same chronological age##2##5##(1995-5#1)(2010-4#1)
of the same class##4##4##(1991-4#1)(2008-2#1)(2008-8#1)(2011-1#1)
of the same compound##3##4##(1990-4#1)(2007-1#1)(2007-8#1)
of the same compounds##3##4##(2008-10#2)(2008-4#1)
of the same construct##2##4##(2007-3#1)(2008-4#1)
of the same disease##3##4##(1991-9#1)(2005-8#1)(2006-1#1)
of the same dose of##2##5##(1996-1#1)(1996-10#1)
of the same doses of##2##5##(1996-6#1)(2008-10#1)
of the same drug##3##4##(1993-9#1)(2007-11#1)(2012-2#1)
of the same factors##2##4##(2007-12#1)(2008-11#1)
of the same family##12##4##(1994-11#1)(1995-5#1)(1997-4#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-4#1)(2010-3#1)(2012-12#1)
of the same four##3##4##(1997-5#1)(2007-9#1)(2011-2#1)
of the same fungal##2##4##(2011-12#1)(2013-7#1)
of the same gene##7##4##(1991-4#1)(1993-2#1)(1994-5#1)(1994-9#1)(1996-5#1)(1997-4#1)(2011-1#1)
of the same genetic##2##4##(2006-2#1)(2010-3#1)
of the same length##5##4##(1993-3#1)(1996-11#1)(2008-4#1)(2008-9#1)(2011-2#1)
of the same magnitude as##3##5##(1994-5#1)(1997-4#1)(2006-12#1)
of the same magnitude##6##4##(1993-2#1)(1994-5#1)(1997-4#1)(1997-5#1)(2006-12#1)(2008-10#1)
of the same material##8##4##(1990-12#1)(2005-11#1)(2006-5#1)(2006-7#1)(2007-11#1)(2008-3#1)(2010-4#1)(2013-8#1)
of the same membrane##2##4##(1993-3#1)(2012-4#1)
of the same mutant##3##4##(1992-12#2)(1993-11#1)
of the same or##4##4##(1996-10#1)(1996-9#1)(2008-10#1)(2008-8#1)
of the same order as##3##5##(1993-2#1)(1994-6#1)(2007-12#1)
of the same order of magnitude as the##4##8##(1992-6#1)(1993-3#1)(2005-11#1)(2007-11#1)
of the same order of magnitude as##6##7##(1991-2#1)(1992-6#1)(1993-3#1)(1994-11#1)(2005-11#1)(2007-11#1)
of the same order of magnitude##7##6##(1991-2#1)(1992-6#1)(1993-3#1)(1994-11#1)(2004-11#1)(2005-11#1)(2007-11#1)
of the same order##13##4##(1991-2#1)(1991-5#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-6#1)(2004-11#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-2#1)
of the same patients##2##4##(1991-4#1)(1996-8#1)
of the same plant species##2##5##(2007-1#1)(2013-8#1)
of the same plant##3##4##(2007-1#1)(2008-10#1)(2013-8#1)
of the same polymer##2##4##(1996-11#1)(2008-11#1)
of the same population##3##4##(1997-4#1)(2008-10#2)
of the same product##3##4##(2008-3#1)(2009-10#1)(2012-2#1)
of the same region##4##4##(1990-10#1)(2008-10#1)(2008-2#2)
of the same sample##2##4##(2008-10#2)
of the same scene##3##4##(2008-2#2)(2008-3#1)
of the same sex##4##4##(1994-5#1)(2008-7#1)(2008-9#2)
of the same size as##2##5##(2008-11#1)(2008-3#1)
of the same size##12##4##(1997-2#1)(1997-3#1)(2005-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-1#1)
of the same species##13##4##(1995-2#1)(1996-12#2)(2007-3#1)(2008-10#2)(2008-7#1)(2008-8#2)(2011-12#1)(2012-2#2)(2013-7#1)
of the same strain##2##4##(1992-10#1)(2008-5#1)
of the same system##2##4##(2008-10#1)(2012-2#1)
of the same tumor##2##4##(1991-6#1)(1992-9#1)
of the same type as##3##5##(1997-6#1)(2008-11#1)(2012-2#1)
of the same type of##3##5##(1997-4#1)(2008-12#2)
of the same type##10##4##(1992-6#1)(1995-12#1)(1997-4#2)(1997-6#1)(2008-11#1)(2008-12#2)(2008-9#1)(2012-2#1)
of the same variable##2##4##(1997-2#1)(2007-3#1)
of the same virus##2##4##(2008-10#1)(2010-4#1)
of the same##458##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#4)(1990-4#2)(1990-5#1)(1990-7#3)(1990-8#3)(1991-1#1)(1991-11#5)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#3)(1991-5#2)(1991-6#2)(1991-8#2)(1991-9#5)(1992-1#1)(1992-10#3)(1992-12#3)(1992-3#1)(1992-4#2)(1992-5#2)(1992-6#3)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#5)(1993-3#3)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#6)(1994-6#2)(1994-8#4)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#9)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#2)(1996-11#2)(1996-12#5)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#3)(1996-7#1)(1996-8#8)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#2)(1997-4#10)(1997-5#4)(1997-6#2)(1997-7#2)(1997-8#1)(2004-1#1)(2004-11#2)(2004-7#1)(2004-9#1)(2005-10#1)(2005-11#7)(2005-12#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#6)(2007-12#13)(2007-2#2)(2007-3#4)(2007-6#1)(2007-8#3)(2007-9#4)(2008-1#6)(2008-10#50)(2008-11#8)(2008-12#2)(2008-2#17)(2008-3#11)(2008-4#6)(2008-5#8)(2008-6#1)(2008-7#14)(2008-8#9)(2008-9#7)(2009-1#2)(2009-10#3)(2009-12#3)(2009-4#1)(2009-8#1)(2010-2#4)(2010-3#3)(2010-4#5)(2010-8#3)(2011-1#4)(2011-12#5)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#10)(2012-3#3)(2012-4#2)(2013-1#6)(2013-7#2)(2013-8#3)
of the sample and of the##2##6##(2008-10#1)(2008-3#1)
of the sample and of##3##5##(2008-10#2)(2008-3#1)
of the sample and##12##4##(1997-2#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-3#1)(2009-8#1)
of the sample for##2##4##(1997-5#1)(2006-7#1)
of the sample had##3##4##(1997-8#1)(2008-4#1)(2008-6#1)
of the sample in the##3##5##(2005-4#1)(2006-5#1)(2012-12#1)
of the sample in##10##4##(2005-4#1)(2006-5#1)(2008-10#5)(2008-5#1)(2008-9#1)(2012-12#1)
of the sample into the##2##5##(1990-12#1)(1992-1#1)
of the sample introduction##2##4##(2008-10#2)
of the sample is##6##4##(1995-12#1)(2008-10#3)(2008-3#2)
of the sample matrix##4##4##(1992-1#1)(2008-10#3)
of the sample medium##2##4##(2008-3#2)
of the sample plug##2##4##(2008-10#2)
of the sample population##2##4##(2007-2#1)(2007-7#1)
of the sample reported##3##4##(2008-1#1)(2008-4#2)
of the sample set##2##4##(2013-8#2)
of the sample size##2##4##(2007-11#1)(2009-9#1)
of the sample solution on##2##5##(2008-10#2)
of the sample solution was##2##5##(2008-10#2)
of the sample solution##11##4##(2008-10#11)
of the sample surface##2##4##(2008-2#1)(2008-3#1)
of the sample thickness##2##4##(2008-2#2)
of the sample to be tested##2##6##(2012-12#2)
of the sample to be##3##5##(2011-2#1)(2012-12#2)
of the sample to##7##4##(2008-10#3)(2008-3#1)(2011-2#1)(2012-12#2)
of the sample treated##2##4##(2008-9#1)(2013-1#1)
of the sample was##8##4##(2006-10#1)(2007-2#1)(2008-10#3)(2008-5#1)(2009-7#1)(2013-8#1)
of the sample were##5##4##(1992-5#1)(1995-5#1)(2007-2#1)(2008-12#1)(2011-2#1)
of the sample with##5##4##(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#2)
of the sample zone##2##4##(2008-10#2)
of the sample##221##3##(1990-12#2)(1990-4#1)(1991-2#2)(1991-8#3)(1992-1#3)(1992-2#1)(1992-5#1)(1993-1#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#2)(2005-4#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#2)(2006-5#1)(2006-7#2)(2007-11#5)(2007-12#12)(2007-2#3)(2007-7#1)(2007-8#4)(2008-1#6)(2008-10#87)(2008-12#1)(2008-2#12)(2008-3#16)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#5)(2012-12#3)(2013-1#6)(2013-8#5)
of the sample)##3##3##(2007-8#1)(2008-10#1)(2012-3#1)
of the sampled##7##3##(2008-10#2)(2008-2#1)(2008-5#2)(2011-12#1)(2013-7#1)
of the samples and##8##4##(2005-11#1)(2008-10#5)(2008-11#1)(2008-5#1)
of the samples are##3##4##(2008-10#3)
of the samples by##2##4##(2008-10#2)
of the samples collected in the##2##6##(2008-5#2)
of the samples collected##4##4##(2007-3#2)(2008-5#2)
of the samples did not##2##5##(2008-10#1)(2008-11#1)
of the samples from##5##4##(1995-11#1)(2008-12#3)(2010-4#1)
of the samples have##2##4##(2008-10#2)
of the samples in MeOH##2##5##(2008-10#2)
of the samples in##9##4##(1990-8#1)(2008-10#6)(2008-3#1)(2010-4#1)
of the samples is##2##4##(2008-10#2)
of the samples obtained##2##4##(2007-7#1)(2008-2#1)
of the samples of##2##4##(2008-10#2)
of the samples showed##2##4##(2007-5#1)(2008-6#1)
of the samples studied##4##4##(1992-6#1)(1996-12#1)(1997-3#1)(2008-10#1)
of the samples that##3##4##(2007-3#1)(2008-10#1)(2008-2#1)
of the samples under study were##2##6##(2005-11#2)
of the samples under##3##4##(2005-11#2)(2006-5#1)
of the samples was##5##4##(2005-4#1)(2008-10#3)(2012-12#1)
of the samples were##15##4##(1990-1#1)(1992-2#1)(2005-11#1)(2007-3#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2011-1#1)(2012-11#1)(2012-3#1)
of the samples with##7##4##(1995-1#1)(1995-6#1)(1996-6#1)(2008-10#4)
of the samples##150##3##(1990-1#1)(1990-12#1)(1990-8#1)(1992-2#1)(1992-6#1)(1994-6#3)(1995-1#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-3#1)(2005-11#6)(2005-4#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-3#4)(2007-5#1)(2007-7#2)(2008-10#59)(2008-11#5)(2008-12#6)(2008-2#3)(2008-3#2)(2008-5#7)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#4)(2009-5#1)(2010-11#1)(2010-2#1)(2010-4#3)(2010-8#1)(2011-1#4)(2011-2#2)(2011-3#1)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
of the sampling design##2##4##(2010-2#1)(2013-7#1)
of the sampling grid##3##4##(2008-10#3)
of the sampling points##2##4##(2008-3#2)
of the sampling##25##3##(2007-11#1)(2007-12#2)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#7)(2008-5#1)(2010-2#1)(2013-7#2)
of the samplings##2##3##(2008-10#1)(2008-6#1)
of the sandwich##2##3##(1991-10#1)(2008-2#1)
of the saphenous vein##3##4##(2007-8#3)
of the saphenous##6##3##(1992-3#1)(1995-11#1)(2007-8#4)
of the sarcoplasmic reticulum Ca(2+)-ATPase##3##5##(1992-6#1)(1994-10#1)(1994-12#1)
of the sarcoplasmic reticulum##15##4##(1990-11#1)(1990-2#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-3#1)(1992-6#1)(1994-10#1)(1994-12#1)(1994-5#1)(1996-9#2)(2008-5#1)(2010-12#2)
of the satellite##3##3##(2008-2#1)(2008-3#2)
of the saturable absorber##2##4##(2008-2#1)(2008-3#1)
of the saturable##3##3##(1996-12#1)(2008-2#1)(2008-3#1)
of the saturated fatty acids##2##5##(1994-9#1)(2008-11#1)
of the saturated##12##3##(1990-11#1)(1991-12#1)(1992-9#1)(1994-8#1)(1994-9#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-5#1)
of the saturation##7##3##(1991-9#1)(1994-12#1)(2005-11#1)(2008-2#2)(2008-3#1)(2010-7#1)
of the savings##3##3##(1990-12#1)(1990-4#1)(1992-2#1)
of the scaffold##4##3##(2008-1#1)(2009-7#2)(2012-1#1)
of the scaffolding##3##3##(2008-4#1)(2009-7#1)(2012-2#1)
of the scaffolds##6##3##(2008-5#2)(2009-7#3)(2010-9#1)
of the scalar diffraction##2##4##(2007-12#1)(2008-2#1)
of the scalar##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
of the scale and##3##4##(2008-2#1)(2008-9#1)(2011-2#1)
of the scale parameter##3##4##(1996-3#2)(2008-2#1)
of the scale##21##3##(1996-3#2)(2007-11#1)(2008-11#1)(2008-2#5)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#4)(2009-10#1)(2011-1#1)(2011-2#2)(2012-3#1)
of the scales##4##3##(1990-5#1)(2006-7#1)(2007-9#1)(2012-2#1)
of the scaling##4##3##(1996-12#1)(2006-2#1)(2007-12#1)(2013-8#1)
of the scalp in the##2##5##(2008-9#1)(2012-11#1)
of the scalp in##3##4##(2007-7#1)(2008-9#1)(2012-11#1)
of the scalp##16##3##(1996-7#1)(2007-11#2)(2007-7#5)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#2)(2010-5#1)(2012-11#1)
of the scan##4##3##(1990-5#1)(2008-10#2)(2009-2#1)
of the scandium-alizarin red S complex onto a carbon paste electrode##2##11##(2008-10#2)
of the scanning##6##3##(1991-2#2)(2007-12#1)(2008-2#2)(2008-3#1)
of the scans##2##3##(1996-7#1)(2008-7#1)
of the scaphoid and##2##4##(2006-3#1)(2008-9#1)
of the scaphoid bone##3##4##(2009-2#3)
of the scaphoid##11##3##(2006-3#4)(2008-9#4)(2009-2#3)
of the scapholunate##2##3##(2006-4#1)(2012-1#1)
of the scapula##3##3##(2006-11#2)(2013-7#1)
of the scapular##2##3##(2010-9#1)(2012-3#1)
of the scapulohumeral joint##2##4##(1992-11#1)(2007-2#1)
of the scar##6##3##(1996-4#1)(2009-6#1)(2012-1#2)(2013-8#2)
of the scarcity##2##3##(1995-8#1)(2008-4#1)
of the scattered and##2##4##(2007-12#1)(2008-3#1)
of the scattered field to the##2##6##(2007-12#1)(2008-3#1)
of the scattered field##4##4##(2007-11#2)(2007-12#1)(2008-3#1)
of the scattered fields##2##4##(2008-2#1)(2008-3#1)
of the scattered light and##3##5##(2006-12#1)(2007-12#1)(2008-2#1)
of the scattered light##18##4##(2006-12#1)(2006-2#1)(2007-12#2)(2008-2#6)(2008-3#8)
of the scattered wave is shown to##2##7##(2008-2#1)(2008-3#1)
of the scattered wave##6##4##(2008-2#1)(2008-3#5)
of the scattered##39##3##(2006-12#1)(2006-2#1)(2007-11#2)(2007-12#5)(2008-2#10)(2008-3#19)(2009-11#1)
of the scattered-light##2##3##(2008-2#2)
of the scatterers are##2##4##(2008-2#1)(2008-3#1)
of the scatterers##3##3##(2008-2#2)(2008-3#1)
of the scattering and##2##4##(2008-2#1)(2008-3#1)
of the scattering angle##3##4##(2008-2#1)(2008-3#2)
of the scattering coefficient in##2##5##(1997-6#1)(2008-3#1)
of the scattering coefficient##6##4##(1997-6#1)(2008-2#1)(2008-3#4)
of the scattering delay##3##4##(2008-2#3)
of the scattering layer##3##4##(2008-2#3)
of the scattering matrix##2##4##(2008-3#2)
of the scattering medium##4##4##(2008-2#1)(2008-3#3)
of the scattering object##2##4##(2007-12#1)(2008-2#1)
of the scattering of light from##2##6##(2007-12#1)(2008-9#1)
of the scattering of##3##4##(2007-12#2)(2008-9#1)
of the scattering phase function##4##5##(2008-2#2)(2008-3#1)(2008-6#1)
of the scattering phase##5##4##(2008-2#2)(2008-3#2)(2008-6#1)
of the scattering properties of##3##5##(2008-2#2)(2008-3#1)
of the scattering properties##4##4##(2007-11#1)(2008-2#2)(2008-3#1)
of the scattering##62##3##(1997-6#1)(2005-11#1)(2006-5#1)(2007-1#1)(2007-11#2)(2007-12#3)(2008-2#27)(2008-3#23)(2008-6#2)(2008-9#1)
of the scene##3##3##(2008-2#2)(2009-7#1)
of the scheme is##3##4##(2008-2#2)(2008-3#1)
of the scheme##5##3##(1991-12#1)(2008-2#2)(2008-3#1)(2013-8#1)
of the schizo-obsessive subtype##2##4##(2008-3#2)
of the schizophrenic##2##3##(1996-3#1)(2006-9#1)
of the scholarly##2##3##(1995-12#1)(2005-12#1)
of the school children##3##4##(2007-2#3)
of the school year##3##4##(2008-12#1)(2010-3#1)(2010-8#1)
of the school##13##3##(1990-5#1)(1990-6#1)(1991-12#1)(1993-1#1)(2007-2#3)(2007-7#1)(2008-12#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-8#1)
of the sciatic nerve in##2##5##(1993-12#1)(1996-8#1)
of the sciatic nerve##14##4##(1990-2#1)(1990-7#2)(1991-2#1)(1992-3#1)(1993-10#1)(1993-12#2)(1994-2#1)(1996-5#1)(1996-8#1)(2006-12#1)(2008-1#1)(2008-7#1)
of the sciatic##17##3##(1990-2#1)(1990-7#2)(1991-2#2)(1992-3#1)(1993-10#1)(1993-12#2)(1994-2#1)(1996-5#1)(1996-8#1)(1997-3#1)(2006-12#1)(2008-1#1)(2008-6#1)(2008-7#1)
of the science and##2##4##(2008-4#1)(2009-7#1)
of the science of##4##4##(1992-6#1)(2007-7#1)(2007-9#1)(2009-5#1)
of the science##14##3##(1992-3#1)(1992-6#1)(1997-1#1)(2005-7#1)(2006-5#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-4#1)(2009-5#2)(2009-7#1)(2010-9#1)(2012-3#1)
of the sciences##3##3##(2009-2#1)(2009-4#2)
of the scientific and##2##4##(2006-5#1)(2008-7#1)
of the scientific committee of the##3##6##(1996-6#1)(2005-8#1)(2008-10#1)
of the scientific literature##4##4##(1993-6#1)(2007-11#1)(2008-3#1)(2013-1#1)
of the scientific method##2##4##(1996-6#1)(2007-9#1)
of the scientific##17##3##(1993-6#1)(1996-6#2)(2005-8#1)(2006-5#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
of the scissile bond##4##4##(1991-2#3)(1991-6#1)
of the scoliosis##3##3##(2007-7#1)(2007-8#2)
of the scope of##6##4##(1991-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2008-1#1)(2009-6#1)
of the scope##8##3##(1991-12#1)(2006-2#1)(2006-4#2)(2006-5#1)(2008-1#1)(2008-5#1)(2009-6#1)
of the score and##3##4##(2006-10#1)(2008-10#1)(2012-3#1)
of the score##7##3##(1990-7#1)(1994-6#1)(2006-10#1)(2006-2#1)(2008-10#1)(2012-3#1)(2013-1#1)
of the scores##2##3##(2008-11#2)
of the scoring system##2##4##(2012-12#1)(2013-1#1)
of the scorpion Centruroides noxius Hoffmann##4##6##(1993-3#2)(1993-6#1)(2008-7#1)
of the scorpion##7##3##(1990-8#1)(1993-3#2)(1993-6#1)(2007-12#2)(2008-7#1)
of the screen##3##3##(2008-2#1)(2008-3#2)
of the screen-printed##2##3##(2007-8#1)(2008-10#1)
of the screening process##2##4##(2007-6#1)(2008-11#1)
of the screening tests##2##4##(2007-7#1)(2012-2#1)
of the screening##13##3##(1990-2#2)(1992-2#1)(1993-3#1)(1997-2#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2010-8#1)(2012-2#2)
of the screws##3##3##(1991-9#1)(2007-11#1)(2008-10#1)
of the script##2##3##(1994-3#2)
of the scrotum##4##3##(1990-9#1)(1993-10#1)(1995-11#1)(2007-11#1)
of the scute##2##3##(2008-7#2)
of the sea surface temperature##2##5##(2006-7#1)(2008-2#1)
of the sea surface##5##4##(2006-7#1)(2008-2#1)(2008-3#3)
of the sea urchin Centrostephanus coronatus##2##6##(2007-3#2)
of the sea urchin##6##4##(1990-10#1)(2007-3#2)(2007-5#2)(2008-5#1)
of the sea##16##3##(1990-10#1)(2006-7#1)(2007-12#1)(2007-3#2)(2007-5#2)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#2)
of the seagrass##2##3##(2011-2#2)
of the search for##2##4##(1992-11#1)(2012-2#1)
of the search##5##3##(1992-11#1)(2007-8#1)(2008-6#1)(2012-2#1)(2012-3#1)
of the season in##2##4##(2007-5#1)(2008-8#1)
of the season##11##3##(2007-5#2)(2008-10#6)(2008-8#3)
of the seasonal ascospore release occurred##2##6##(2008-10#2)
of the seasonal##4##3##(2008-10#2)(2011-1#1)(2013-8#1)
of the seawater eels##2##4##(2008-5#2)
of the seawater##3##3##(2008-3#1)(2008-5#2)
of the sebaceous gland and##2##5##(2008-5#1)(2010-3#1)
of the sebaceous gland##6##4##(2008-5#1)(2010-3#5)
of the sebaceous##7##3##(2008-5#1)(2010-3#6)
of the second amino##2##4##(1997-2#1)(1997-3#1)
of the second and third##6##5##(1993-12#1)(2006-10#1)(2008-3#1)(2008-5#2)(2013-1#1)
of the second and##11##4##(1993-12#1)(1996-1#1)(1997-1#1)(2006-10#1)(2008-3#1)(2008-5#2)(2009-3#1)(2013-1#3)
of the second grade##2##4##(2007-9#1)(2010-3#1)
of the second group##3##4##(1990-10#1)(1994-6#1)(2009-4#1)
of the second harmonic of##2##5##(2007-12#2)
of the second harmonic##8##4##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#1)(2013-1#1)
of the second lumbar vertebra##3##5##(2007-2#1)(2009-3#2)
of the second lumbar##4##4##(2007-2#2)(2009-3#2)
of the second messenger##3##4##(1993-6#1)(2010-11#1)(2013-7#1)
of the second messengers##3##4##(2006-10#1)(2007-11#1)(2010-2#1)
of the second metacarpal##2##4##(2009-3#1)(2011-2#1)
of the second method##2##4##(2008-3#1)(2008-8#1)
of the second molar##2##4##(2010-2#1)(2013-8#1)
of the second one##3##4##(1997-5#1)(2008-10#1)(2009-8#1)
of the second order##4##4##(1996-7#1)(2008-10#1)(2008-11#1)(2009-7#1)
of the second particle##2##4##(2008-3#2)
of the second substrate##2##4##(1992-3#1)(2008-11#1)
of the second week##4##4##(1997-2#1)(2006-10#1)(2008-7#1)(2008-8#1)
of the second##152##3##(1990-10#2)(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-3#2)(1992-8#2)(1992-9#2)(1993-12#3)(1993-3#1)(1993-4#1)(1993-6#2)(1993-7#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-10#1)(2006-10#3)(2006-12#3)(2006-3#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#9)(2007-2#2)(2007-8#1)(2007-9#1)(2008-10#11)(2008-11#3)(2008-2#5)(2008-3#7)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#5)(2009-10#1)(2009-3#4)(2009-4#1)(2009-6#2)(2009-7#4)(2009-8#2)(2010-11#1)(2010-2#2)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#6)(2013-7#1)(2013-8#2)
of the second-harmonic generation of a short pulse##3##8##(2008-2#3)
of the second-harmonic wave##2##4##(2007-12#2)
of the second-harmonic##10##3##(2007-11#2)(2007-12#3)(2008-2#4)(2008-3#1)
of the second-order advantage##2##4##(2008-10#2)
of the second-order nonlinear##4##4##(2007-11#1)(2007-12#3)
of the second-order##18##3##(1993-8#1)(2007-11#1)(2007-12#6)(2008-1#2)(2008-10#3)(2008-2#2)(2008-3#3)
of the secondary and tertiary##2##5##(1992-1#1)(1995-5#1)
of the secondary mirror##2##4##(2008-2#2)
of the secondary ones##2##4##(2008-4#2)
of the secondary spectrum##3##4##(2008-3#3)
of the secondary structure content##2##5##(1992-9#1)(2012-2#1)
of the secondary structure##8##4##(1992-4#1)(1992-9#1)(1993-3#1)(1994-12#1)(1995-11#1)(1997-1#1)(2008-4#1)(2012-2#1)
of the secondary##41##3##(1990-4#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-4#2)(1992-9#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-5#1)(1997-1#1)(1997-4#1)(2006-10#2)(2006-6#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#2)(2009-10#1)(2010-2#2)(2012-12#1)(2012-2#2)
of the secreted protein##3##4##(1991-2#1)(1997-4#1)(1997-7#1)
of the secreted##8##3##(1991-1#1)(1991-2#1)(1991-9#1)(1997-1#1)(1997-4#2)(1997-7#1)(2008-11#1)
of the secretion of##2##4##(1990-11#1)(2008-11#1)
of the secretion##4##3##(1990-11#1)(2006-6#1)(2007-12#1)(2008-11#1)
of the secretory pathway##2##4##(1990-3#1)(1997-6#1)
of the secretory##14##3##(1990-12#1)(1990-3#1)(1991-5#1)(1993-12#1)(1994-12#1)(1997-3#1)(1997-6#1)(2007-12#2)(2008-11#1)(2008-5#1)(2008-7#2)(2010-12#1)
of the sections##4##3##(2006-11#1)(2008-4#2)(2009-1#1)
of the sector##3##3##(1995-3#1)(2008-10#1)(2008-2#1)
of the security##8##3##(1993-12#1)(1994-12#1)(1994-2#1)(1995-2#1)(2006-8#1)(2009-2#1)(2010-7#1)(2010-8#1)
of the sedative##2##3##(2008-6#1)(2010-3#1)
of the sediment##5##3##(1992-3#1)(1996-12#1)(2006-6#1)(2007-5#1)(2008-10#1)
of the sedimentation##2##3##(2008-10#1)(2009-2#1)
of the sediments##2##3##(2007-5#1)(2007-8#1)
of the seed lots##2##4##(2008-10#2)
of the seed oils##2##4##(2008-11#2)
of the seed##19##3##(2006-12#1)(2007-12#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#2)(2008-5#1)(2008-9#1)(2009-10#1)(2009-5#1)(2011-12#1)(2013-8#1)
of the seedlings##7##3##(2004-4#1)(2008-10#2)(2008-5#1)(2009-8#1)(2011-10#1)(2011-12#1)
of the seeds##8##3##(2006-12#2)(2007-11#1)(2008-12#1)(2008-9#1)(2011-1#2)(2013-7#1)
of the segment polarity gene##4##5##(1991-11#1)(2007-12#3)
of the segment##14##3##(1991-11#1)(2007-12#4)(2007-8#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-5#2)(2009-8#1)
of the segmental##3##3##(1990-11#1)(1993-12#1)(2007-12#1)
of the segmentation##4##3##(1994-3#1)(2007-12#1)(2008-2#1)(2009-10#1)
of the segmented##3##3##(2005-11#1)(2007-11#1)(2008-3#1)
of the segments##3##3##(1995-8#1)(2008-5#1)(2008-9#1)
of the seismicity##3##3##(1996-4#3)
of the seizure##3##3##(2008-7#1)(2010-12#1)(2010-5#1)
of the selected compounds##3##4##(1993-3#1)(1994-9#1)(2008-10#1)
of the selected genes##2##4##(2008-5#1)(2008-7#1)
of the selected##36##3##(1993-3#1)(1994-8#1)(1994-9#1)(1995-7#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-6#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#3)
of the selection of##4##4##(1997-1#1)(2007-8#1)(2011-2#1)(2012-3#1)
of the selection process##2##4##(1997-1#1)(2008-6#1)
of the selection##14##3##(1997-1#3)(2006-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
of the selective serotonin reuptake inhibitors##4##6##(1996-12#3)(2005-6#1)
of the selective serotonin reuptake##5##5##(1996-12#3)(2005-6#1)(2012-3#1)
of the selective serotonin##6##4##(1996-12#3)(1996-8#1)(2005-6#1)(2012-3#1)
of the selective##29##3##(1990-12#1)(1990-7#1)(1991-11#1)(1992-2#1)(1993-4#1)(1994-2#1)(1994-5#1)(1994-6#2)(1995-12#2)(1996-10#1)(1996-12#4)(1996-8#1)(1997-8#1)(2005-6#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-4#2)(2009-4#1)(2009-9#1)(2012-3#1)
of the selectivity##4##3##(1996-8#1)(2005-11#1)(2008-10#1)(2008-8#1)
of the selenium##5##3##(2008-10#4)(2008-7#1)
of the selenoprotein##2##3##(2008-10#1)(2012-2#1)
of the self in##2##4##(2008-5#2)
of the self##15##3##(2005-7#1)(2006-6#2)(2006-9#1)(2008-11#2)(2008-2#1)(2008-5#4)(2011-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
of the self-assembled##4##3##(1997-4#1)(2008-10#2)(2010-4#1)
of the self-imaging##2##3##(2007-12#1)(2008-2#1)
of the self-murderers##2##3##(2013-1#2)
of the self-sampling procedure##2##4##(2006-10#2)
of the self-system##2##3##(2009-7#1)(2010-4#1)
of the sellar region##5##4##(2012-3#5)
of the semantic##4##3##(1991-2#1)(1996-7#1)(2009-9#1)(2010-5#1)
of the semi-arid Brazilian &quot##2##5##(2007-3#2)
of the semiconductor##6##3##(2007-12#3)(2008-10#2)(2008-3#1)
of the seminal vesicle##4##4##(2008-11#2)(2011-2#2)
of the seminal vesicles##2##4##(1997-8#1)(2012-12#1)
of the seminal##10##3##(1997-8#1)(2008-11#2)(2008-7#1)(2008-9#1)(2011-1#2)(2011-2#2)(2012-12#1)
of the seminiferous epithelial cycle##2##5##(2009-10#2)
of the seminiferous epithelium and##2##5##(2006-5#1)(2012-2#1)
of the seminiferous epithelium##9##4##(2006-5#1)(2009-10#5)(2012-2#2)(2013-8#1)
of the seminiferous tubules##2##4##(1993-7#1)(2008-7#1)
of the seminiferous##14##3##(1993-7#1)(2006-5#1)(2008-7#1)(2009-10#7)(2012-2#3)(2013-8#1)
of the senescent##3##3##(1990-9#1)(1996-9#1)(2013-7#1)
of the senior##4##3##(2006-11#1)(2007-8#1)(2008-8#1)(2011-2#1)
of the sense of smell and taste##2##7##(2007-9#2)
of the sense of##3##4##(2007-9#2)(2008-7#1)
of the sense##6##3##(1994-11#1)(2007-9#2)(2008-1#1)(2008-5#1)(2008-7#1)
of the sensilla##4##3##(2007-12#4)
of the sensillum##3##3##(2005-10#1)(2007-12#1)(2010-11#1)
of the sensing film##4##4##(2007-9#1)(2008-10#3)
of the sensing system##3##4##(2008-2#3)
of the sensing##19##3##(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-2#4)(2008-3#1)(2008-7#1)(2010-2#1)(2011-1#1)(2013-8#1)
of the sensitive strain##2##4##(2008-10#1)(2008-5#1)
of the sensitive##7##3##(1991-12#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-2#1)
of the sensitivity of a##2##5##(1995-6#1)(2008-7#1)
of the sensitivity of the system to##2##7##(2008-11#1)(2008-2#1)
of the sensitivity of the##8##5##(1993-8#1)(1995-10#1)(1995-12#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)
of the sensitivity of##16##4##(1992-6#1)(1993-8#1)(1995-10#1)(1995-12#1)(1995-6#1)(1996-9#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-7#2)
of the sensitivity to##3##4##(2008-3#3)
of the sensitivity##27##3##(1990-12#1)(1990-7#1)(1992-6#1)(1993-8#1)(1995-10#1)(1995-12#1)(1995-6#1)(1996-3#1)(1996-9#1)(1997-8#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#5)(2008-7#2)(2010-6#1)(2011-1#1)
of the sensitization##2##3##(1991-6#1)(2008-10#1)
of the sensitized film##2##4##(2008-10#2)
of the sensitized##3##3##(2008-10#3)
of the sensor are##3##4##(2008-2#1)(2008-3#2)
of the sensor for##3##4##(2008-10#3)
of the sensor has been##2##5##(2007-8#1)(2008-10#1)
of the sensor is 6##2##5##(2008-10#2)
of the sensor is about##2##5##(2008-10#2)
of the sensor is based on##2##6##(2008-10#1)(2008-3#1)
of the sensor is##14##4##(2007-12#1)(2007-8#1)(2008-10#8)(2008-2#1)(2008-3#3)
of the sensor response##5##4##(2008-10#3)(2008-3#1)(2010-5#1)
of the sensor to the##2##5##(2008-10#1)(2008-3#1)
of the sensor to##6##4##(2008-10#4)(2008-2#1)(2008-3#1)
of the sensor was evaluated##2##5##(2008-10#2)
of the sensor was##9##4##(2008-10#9)
of the sensor were##3##4##(2008-10#3)
of the sensor##92##3##(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#4)(2008-10#58)(2008-2#5)(2008-3#14)(2009-9#1)(2010-12#1)(2010-2#3)(2010-5#1)(2013-1#1)
of the sensorimotor cortex in##2##5##(1995-11#1)(1995-12#1)
of the sensorimotor cortex##3##4##(1995-11#1)(1995-12#1)(1996-2#1)
of the sensorimotor##4##3##(1995-11#1)(1995-12#1)(1996-2#1)(2007-10#1)
of the sensors##6##3##(2008-10#5)(2008-2#1)
of the sensory attributes##2##4##(2008-10#1)(2012-2#1)
of the sensory cell##2##4##(2007-12#1)(2008-7#1)
of the sensory hand cortical representation##2##6##(1997-8#2)
of the sensory hand##3##4##(1997-8#3)
of the sensory stimuli##2##4##(1990-10#1)(1993-2#1)
of the sensory##29##3##(1990-10#1)(1990-5#1)(1993-12#1)(1993-2#1)(1996-3#1)(1996-6#1)(1997-8#4)(2006-10#2)(2006-3#1)(2007-12#5)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2010-4#2)(2012-2#1)(2013-8#2)
of the sentinel node##2##4##(2005-12#1)(2008-10#1)
of the sentinel sheep##2##4##(1997-6#2)
of the sentinel##5##3##(1997-6#3)(2005-12#1)(2008-10#1)
of the separate##6##3##(1995-4#1)(1995-5#1)(1997-8#1)(2006-11#1)(2008-10#1)(2013-7#1)
of the separated analytes##2##4##(2008-10#2)
of the separated##5##3##(2007-12#1)(2008-10#3)(2010-5#1)
of the separation between the##2##5##(1996-5#1)(2007-11#1)
of the separation channel##2##4##(2008-10#2)
of the separation distance##2##4##(2005-11#2)
of the separation of##4##4##(2006-3#1)(2008-10#2)(2011-1#1)
of the separation was##2##4##(1996-5#1)(2008-10#1)
of the separation##25##3##(1990-8#1)(1995-3#1)(1996-5#4)(2005-11#2)(2005-12#1)(2006-2#1)(2006-3#1)(2007-11#1)(2008-10#10)(2010-5#1)(2011-1#1)(2012-1#1)
of the separations##2##3##(1990-9#1)(2008-10#1)
of the septohippocampal system##2##4##(1993-12#2)
of the septohippocampal##3##3##(1993-12#3)
of the septum##3##3##(1994-8#1)(1997-3#1)(2008-7#1)
of the sequelae of##2##4##(2006-9#1)(2007-11#1)
of the sequelae##5##3##(1990-10#1)(1997-2#1)(2006-9#1)(2007-11#2)
of the sequence context##2##4##(2008-4#1)(2010-1#1)
of the sequence of events##2##5##(2008-11#1)(2012-3#1)
of the sequence of the##2##5##(1993-6#1)(2008-10#1)
of the sequence of##10##4##(1991-2#1)(1993-2#1)(1993-6#1)(2005-11#2)(2008-10#1)(2008-11#2)(2009-10#1)(2012-3#1)
of the sequence revealed that##2##5##(1990-2#1)(1996-12#1)
of the sequence revealed##5##4##(1990-2#1)(1993-11#1)(1993-9#1)(1996-12#1)(1996-3#1)
of the sequence space##2##4##(1997-6#1)(2008-7#1)
of the sequence##58##3##(1990-12#1)(1990-2#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#3)(1992-2#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-9#2)(1994-12#3)(1994-6#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#2)(2005-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-1#1)(2011-2#1)(2012-2#1)(2012-3#2)
of the sequenced region##2##4##(1993-11#1)(1995-8#1)
of the sequenced##6##3##(1993-11#1)(1995-8#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-8#1)
of the sequences of the##4##5##(1991-2#1)(1991-7#1)(1992-7#1)(1995-11#1)
of the sequences of##8##4##(1991-2#1)(1991-7#2)(1992-7#1)(1993-12#1)(1995-11#1)(1997-8#1)(2010-4#1)
of the sequences were##2##4##(1991-8#1)(2006-8#1)
of the sequences with##2##4##(1997-4#1)(2008-10#1)
of the sequences##29##3##(1990-2#1)(1991-2#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-4#1)(2010-4#1)
of the sequencing##6##3##(1995-7#1)(1996-4#1)(2008-4#2)(2011-2#1)(2012-2#1)
of the sequential injection##2##4##(2008-10#2)
of the sequential##7##3##(1992-1#1)(1997-6#1)(1997-7#1)(2008-10#3)(2008-11#1)
of the sera from##2##4##(1992-3#1)(1994-3#1)
of the sera##4##3##(1992-3#1)(1994-3#1)(2005-9#1)(2008-10#1)
of the serial##4##3##(1991-12#1)(1991-6#1)(1995-12#1)(2008-11#1)
of the series of##4##4##(1994-8#1)(1996-2#1)(2008-5#1)(2011-2#1)
of the series##13##3##(1990-12#1)(1994-8#1)(1995-10#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-5#1)(2009-8#1)(2011-2#2)
of the serine protease subtilisin##2##5##(1991-4#1)(1997-4#1)
of the serine protease##4##4##(1991-4#1)(1994-12#1)(1996-8#1)(1997-4#1)
of the serine proteinase##2##4##(1992-7#1)(1993-3#1)
of the serine##16##3##(1990-5#1)(1990-7#2)(1991-4#1)(1991-6#1)(1992-7#1)(1993-3#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-4#1)(2009-10#1)
of the serine/threonine##2##3##(1994-12#1)(1994-6#1)
of the serious##8##3##(2007-11#1)(2007-8#1)(2008-11#1)(2009-6#2)(2010-7#1)(2012-12#1)(2013-8#1)
of the seriousness of the##2##5##(1990-3#1)(2011-2#1)
of the seriousness of##4##4##(1990-3#1)(1995-6#1)(2006-8#1)(2011-2#1)
of the serogroup Y##2##4##(2007-12#2)
of the serological##4##3##(1991-9#1)(1993-6#1)(1993-8#1)(2008-4#1)
of the seronegative##3##3##(1994-6#1)(1995-9#1)(2006-4#1)
of the seropositive##2##3##(1994-6#1)(2008-3#1)
of the serotonergic##3##3##(1994-10#1)(1994-6#1)(1996-4#1)
of the serotonin transporter##3##4##(1996-7#1)(2012-3#2)
of the serotonin##11##3##(1996-1#1)(1996-5#1)(1996-7#1)(2005-7#1)(2006-9#3)(2007-12#1)(2008-7#1)(2012-3#2)
of the serotype of##2##4##(1997-3#1)(2008-10#1)
of the serpin##2##3##(1995-8#1)(2006-9#1)
of the serum and##2##4##(2008-10#1)(2009-3#1)
of the serum concentration of##2##5##(1991-12#1)(1996-4#1)
of the serum ferritin##2##4##(2012-12#1)(2013-8#1)
of the serum samples##2##4##(1996-3#1)(2013-1#1)
of the serum triglyceride##2##4##(1991-12#2)
of the serum##37##3##(1991-12#3)(1991-3#1)(1991-4#1)(1992-4#1)(1994-9#1)(1996-3#1)(1996-4#1)(1997-5#1)(2006-4#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#2)(2010-10#1)(2010-6#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
of the service is##2##4##(1992-11#1)(2011-1#1)
of the service##21##3##(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-12#1)(1994-2#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-7#1)(2007-9#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)
of the services offered##2##4##(1994-12#1)(1995-1#1)
of the services provided##2##4##(1992-1#1)(1995-1#1)
of the services##11##3##(1992-1#1)(1994-12#1)(1995-1#2)(2005-5#2)(2006-8#1)(2007-7#1)(2008-4#1)(2011-7#1)(2013-1#1)
of the session##6##3##(1991-12#1)(2007-12#1)(2008-4#1)(2008-6#1)(2009-9#1)(2012-3#1)
of the sessions##4##3##(2005-8#1)(2007-7#1)(2011-12#2)
of the set of##6##4##(1994-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)
of the set##15##3##(1992-12#1)(1994-2#1)(1994-9#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2012-2#2)(2013-1#1)
of the sets and##2##4##(1997-6#2)
of the sets##4##3##(1993-8#1)(1997-6#2)(2007-3#1)
of the setting##3##3##(2004-9#2)(2008-3#1)
of the settlement##3##3##(1995-12#1)(1997-5#1)(2008-9#1)
of the setup is##2##4##(2007-11#1)(2007-12#1)
of the setup##6##3##(2007-11#2)(2007-12#1)(2008-3#2)(2010-12#1)
of the seven other##2##4##(1992-8#1)(2008-6#1)
of the seven remaining##2##4##(1997-3#1)(2010-10#1)
of the seven##37##3##(1990-11#1)(1990-5#1)(1991-2#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-2#1)(1994-3#2)(1995-3#1)(1996-6#1)(1997-1#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#9)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2009-2#1)(2010-10#1)(2012-12#1)(2012-3#1)
of the seventeenth century##2##4##(2008-8#1)(2009-7#1)
of the seventh##3##3##(2007-12#1)(2008-10#1)(2008-12#1)
of the seventies##2##3##(2007-5#2)
of the several##13##3##(1994-8#1)(1995-1#1)(1997-3#1)(2005-1#1)(2005-10#1)(2005-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-8#2)
of the severe acute respiratory syndrome (SARS)##2##7##(2008-5#1)(2008-7#1)
of the severe##6##3##(2006-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2013-1#1)
of the severity and##2##4##(2009-10#1)(2009-3#1)
of the severity of the lesion##2##6##(1993-10#1)(2007-2#1)
of the severity of the##5##5##(1993-10#1)(2007-11#1)(2007-2#1)(2007-8#2)
of the severity of##20##4##(1990-3#1)(1991-11#1)(1993-10#1)(1996-2#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#2)(2008-4#3)(2008-8#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#1)
of the severity##23##3##(1990-3#1)(1991-11#1)(1993-10#1)(1996-2#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#2)(2008-4#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)
of the sex pheromone##3##4##(2007-12#1)(2008-10#2)
of the sex##12##3##(1990-2#1)(1994-7#1)(1995-5#1)(2006-10#1)(2007-1#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)
of the sexes##8##3##(1990-12#1)(1991-6#1)(1997-7#1)(2008-7#1)(2008-9#4)
of the sexual##12##3##(1992-9#1)(1993-3#1)(1996-1#1)(1996-3#1)(2008-10#4)(2008-12#1)(2008-2#1)(2010-2#1)(2010-3#1)
of the sexually dimorphic##2##4##(1992-3#1)(1996-9#1)
of the sexually##5##3##(1992-3#1)(1995-5#1)(1996-9#1)(2007-7#1)(2012-12#1)
of the shaft##3##3##(2007-11#1)(2007-7#1)(2011-2#1)
of the sham##2##3##(2008-5#1)(2012-7#1)
of the sham-operated##3##3##(1990-7#1)(1993-3#1)(1997-6#1)
of the shampoo##4##3##(2008-10#1)(2008-5#3)
of the shape of a##2##5##(1994-5#1)(2007-9#1)
of the shape of the##4##5##(2006-12#1)(2007-9#1)(2008-2#1)(2008-3#1)
of the shape of##12##4##(1993-12#1)(1993-3#1)(1994-5#1)(2006-12#1)(2007-9#2)(2008-2#2)(2008-3#2)(2012-11#2)
of the shape##17##3##(1993-12#1)(1993-3#1)(1993-4#1)(1994-5#1)(1995-9#1)(2006-12#1)(2007-9#2)(2008-2#3)(2008-3#3)(2012-11#2)(2012-2#1)
of the shaped##2##3##(2007-12#1)(2008-3#1)
of the shared##2##3##(2005-10#1)(2008-10#1)
of the shark##3##3##(1990-4#1)(2007-5#2)
of the sharp##3##3##(1990-5#1)(1991-3#1)(2006-12#1)
of the shaver##4##3##(2007-5#4)
of the shear##6##3##(2005-11#1)(2006-11#2)(2007-1#2)(2008-3#1)
of the sheath protein##2##4##(1990-5#2)
of the sheath##8##3##(1990-5#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#3)
of the sheep##5##3##(1991-5#1)(1993-8#1)(1996-12#1)(2005-8#1)(2008-10#1)
of the sheet##3##3##(2007-8#1)(2007-9#1)(2008-3#1)
of the shell##2##3##(2008-3#1)(2012-2#1)
of the shield##2##3##(2008-10#1)(2008-2#1)
of the shift in the##2##5##(2007-11#1)(2011-2#1)
of the shift in##5##4##(1990-8#1)(2007-11#1)(2007-4#1)(2008-3#1)(2011-2#1)
of the shift##12##3##(1990-8#1)(1991-11#1)(1994-6#1)(2007-11#2)(2007-12#2)(2007-4#1)(2008-2#1)(2008-3#2)(2011-2#1)
of the shifts##4##3##(1992-2#1)(2007-12#1)(2008-2#1)(2012-3#1)
of the shock wave##2##4##(2008-11#1)(2008-2#1)
of the shock##3##3##(2008-11#1)(2008-2#1)(2010-12#1)
of the shoot##6##3##(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-6#1)(2012-1#1)
of the shoots##2##3##(2004-4#1)(2008-10#1)
of the shore crab##2##4##(1992-12#1)(1994-11#1)
of the short arm of chromosome##9##6##(1990-8#1)(1996-12#2)(1996-3#1)(2006-12#1)(2007-12#2)(2008-10#1)(2012-3#1)
of the short arm of the##2##6##(1990-11#1)(1995-11#1)
of the short arm of##12##5##(1990-11#1)(1990-8#1)(1995-11#1)(1996-12#2)(1996-3#1)(2006-12#1)(2006-8#1)(2007-12#2)(2008-10#1)(2012-3#1)
of the short posterior ciliary artery##2##6##(2009-8#2)
of the short time##2##4##(2006-6#1)(2012-12#1)
of the short##27##3##(1990-11#1)(1990-8#1)(1992-12#1)(1995-11#1)(1996-12#2)(1996-3#1)(2006-10#1)(2006-12#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#3)(2008-10#3)(2008-7#1)(2009-10#1)(2009-6#1)(2009-8#2)(2011-12#1)(2012-12#1)(2012-3#1)
of the short- and long-term##3##5##(1996-7#1)(2013-1#2)
of the short-lived radon##2##4##(1996-3#2)
of the short-term##2##3##(1990-9#1)(2008-10#1)
of the shortened##2##3##(2007-11#1)(2012-2#1)
of the shorter##4##3##(1992-5#1)(1997-6#1)(2005-11#1)(2006-12#1)
of the shoulder after##2##4##(2006-3#1)(2008-7#1)
of the shoulder and elbow##3##5##(2012-1#3)
of the shoulder and##5##4##(1990-12#1)(2008-7#1)(2012-1#3)
of the shoulder are##3##4##(1992-11#1)(2007-8#1)(2011-12#1)
of the shoulder girdle##5##4##(1994-7#1)(2006-9#1)(2007-4#1)(2012-1#1)(2012-2#1)
of the shoulder in lateral##2##5##(2007-4#2)
of the shoulder in side impact##2##6##(2007-4#2)
of the shoulder in##6##4##(1997-6#1)(2007-4#4)(2010-12#1)
of the shoulder is##3##4##(2007-11#1)(2007-4#1)(2008-8#1)
of the shoulder joint is##2##5##(1991-4#1)(2008-8#1)
of the shoulder joint##3##4##(1991-4#1)(2007-1#1)(2008-8#1)
of the shoulder##76##3##(1990-12#1)(1990-3#1)(1991-4#1)(1992-11#3)(1994-7#1)(1997-5#2)(1997-6#1)(2006-11#6)(2006-3#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#15)(2007-4#8)(2007-7#2)(2007-8#5)(2008-1#1)(2008-7#4)(2008-8#4)(2010-12#3)(2011-12#2)(2011-2#1)(2012-1#6)(2012-2#3)(2013-1#2)
of the shoulder]##2##3##(1997-6#1)(2010-9#1)
of the shrimp##4##3##(2008-5#2)(2011-12#2)
of the shunt pathway of mevalonate metabolism##2##7##(1991-1#2)
of the shunt##4##3##(1991-1#2)(1991-12#1)(1996-6#1)
of the siRNA##3##3##(2008-4#1)(2012-2#1)(2013-8#1)
of the sialic##2##3##(1993-11#1)(1995-1#1)
of the sibling vole##2##4##(2013-1#2)
of the siblings##2##3##(1995-12#1)(2011-1#1)
of the sick##4##3##(1992-4#2)(1993-9#1)(2007-9#1)
of the sickle cell##2##4##(2013-8#2)
of the side chain at##2##5##(1995-5#1)(2008-8#1)
of the side chain attached to the##2##7##(1995-7#1)(2005-3#1)
of the side chain of##3##5##(1992-1#1)(2007-11#1)(2008-10#1)
of the side chain##11##4##(1992-1#1)(1993-6#1)(1995-5#1)(1995-7#1)(2005-3#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-8#1)(2008-9#1)
of the side chains of##3##5##(1991-10#1)(1995-1#1)(1997-1#1)
of the side chains##9##4##(1991-10#1)(1991-2#1)(1993-11#2)(1993-12#1)(1995-1#1)(1996-8#1)(1997-1#1)(2008-10#1)
of the side effects##3##4##(1996-11#1)(2007-2#1)(2008-11#1)
of the side##26##3##(1990-10#1)(1991-10#1)(1991-2#1)(1992-1#1)(1993-11#2)(1993-12#1)(1993-6#1)(1995-1#1)(1995-5#1)(1995-7#1)(1996-11#1)(1996-8#1)(1997-1#1)(2005-3#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-11#2)(2008-8#1)(2008-9#1)(2009-12#1)
of the side-chain##2##3##(1991-10#1)(2012-3#1)
of the siderophore##2##3##(1996-10#1)(2011-2#1)
of the sigma##5##3##(1991-5#1)(1994-12#2)(1994-5#1)(1996-3#1)
of the sigmoid colon and##2##5##(1991-6#1)(2011-11#1)
of the sigmoid colon##12##4##(1991-4#2)(1991-6#1)(1993-10#1)(2006-2#1)(2008-4#1)(2010-12#1)(2010-5#1)(2011-11#2)(2011-2#1)(2012-1#1)
of the sigmoid notch##3##4##(2012-2#3)
of the sigmoid##17##3##(1991-4#2)(1991-6#1)(1993-10#1)(2006-2#1)(2007-8#1)(2008-11#1)(2008-4#1)(2010-12#1)(2010-5#1)(2011-11#2)(2011-2#1)(2012-1#1)(2012-2#3)
of the sign and##2##4##(1995-4#1)(2008-10#1)
of the sign##4##3##(1995-4#1)(1996-1#1)(2008-10#1)(2008-3#1)
of the signal and has an##2##6##(1991-11#1)(2008-3#1)
of the signal and idler##2##5##(2007-11#1)(2007-12#1)
of the signal and the idler##2##6##(2007-12#1)(2008-1#1)
of the signal and##8##4##(1991-11#1)(1997-7#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-3#1)
of the signal beam##3##4##(2007-12#1)(2008-1#1)(2008-3#1)
of the signal by##2##4##(2008-1#1)(2011-2#1)
of the signal field##2##4##(2007-12#1)(2008-3#1)
of the signal from##2##4##(2008-2#2)
of the signal intensity##3##4##(2008-10#1)(2008-3#1)(2010-8#1)
of the signal pathway##2##4##(1994-3#1)(2007-12#1)
of the signal peptide##6##4##(1992-11#2)(1992-12#1)(1993-12#1)(1997-4#1)(2008-6#1)
of the signal pulse relative to that of the pump##2##10##(2007-12#2)
of the signal pulse##4##4##(2007-12#4)
of the signal recognition##3##4##(1992-6#2)(1995-6#1)
of the signal sequence##8##4##(1990-1#1)(1991-6#2)(1992-2#1)(1993-9#1)(1995-1#1)(2008-11#2)
of the signal to##2##4##(2007-12#1)(2008-2#1)
of the signal transducers and activators of transcription##2##8##(1996-2#1)(2011-2#1)
of the signal transducing##2##4##(1993-6#1)(2009-4#1)
of the signal transduction pathway##2##5##(1996-10#1)(1997-2#1)
of the signal transduction##7##4##(1993-8#1)(1995-12#1)(1996-10#1)(1996-5#2)(1997-2#1)(2007-9#1)
of the signal was##2##4##(2008-10#1)(2008-3#1)
of the signal##100##3##(1990-1#1)(1990-5#1)(1991-11#2)(1991-12#2)(1991-6#2)(1991-8#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-6#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-2#2)(1996-5#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-11#2)(2007-12#16)(2007-9#1)(2008-1#5)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#12)(2008-3#12)(2008-6#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-8#2)(2011-2#2)
of the signal-to-noise ratio with respect to the##2##8##(2008-2#1)(2008-3#1)
of the signal-to-noise ratio##9##4##(2007-12#1)(2008-2#3)(2008-3#5)
of the signal-to-noise##10##3##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#5)
of the signalling##2##3##(2006-12#1)(2013-8#1)
of the signals##17##3##(1990-2#1)(1992-12#1)(1992-6#1)(1994-6#1)(1996-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#5)(2013-1#1)
of the significance of the##2##5##(2008-7#1)(2012-3#1)
of the significance of##13##4##(1990-2#1)(1990-5#1)(1991-12#1)(1991-9#1)(1992-11#1)(1997-1#1)(2005-9#1)(2006-4#1)(2006-8#1)(2007-12#1)(2008-7#1)(2012-3#1)(2013-1#1)
of the significance##16##3##(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-11#1)(1996-12#1)(1997-1#1)(2005-9#1)(2006-4#1)(2006-8#1)(2007-12#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)
of the significant##14##3##(1992-2#1)(1993-9#1)(1994-10#1)(1997-5#1)(2005-7#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2010-12#1)(2011-2#1)
of the significantly##2##3##(1995-6#1)(2008-8#1)
of the signs and symptoms of##3##6##(2007-2#1)(2007-7#1)(2009-3#1)
of the signs and symptoms##4##5##(2007-2#1)(2007-7#1)(2009-3#1)(2010-9#1)
of the signs of##2##4##(2007-12#1)(2008-5#1)
of the signs##8##3##(1996-9#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-4#1)(2008-5#1)(2009-3#1)(2010-9#1)
of the sika deer##2##4##(2008-5#2)
of the silane##2##3##(2004-9#1)(2005-11#1)
of the silencing##2##3##(2008-10#1)(2009-8#1)
of the silent##5##3##(1995-2#1)(2008-4#2)(2008-7#1)(2009-5#1)
of the silica gel##2##4##(2008-10#2)
of the silica##12##3##(2005-11#1)(2008-10#9)(2010-12#1)(2010-7#1)
of the silicate##2##3##(2005-11#1)(2008-10#1)
of the silicon##11##3##(2005-11#1)(2006-12#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-4#1)
of the silicone##2##3##(1992-2#1)(2007-8#1)
of the silk glands##2##4##(2007-12#2)
of the silk##3##3##(2007-12#3)
of the silkmoth Bombyx mori##4##5##(1996-6#2)(2008-6#1)(2013-8#1)
of the silkmoth##6##3##(1996-6#2)(2007-12#1)(2008-6#1)(2008-7#1)(2013-8#1)
of the silkworm Bombyx mori##2##5##(2008-5#1)(2008-9#1)
of the silkworm##10##3##(1990-12#1)(1992-11#1)(1993-12#1)(1995-11#2)(1997-4#1)(2008-11#1)(2008-5#2)(2008-9#1)
of the silver nanoparticles##3##4##(2005-11#3)
of the silver##14##3##(1996-2#1)(2005-11#3)(2005-4#1)(2007-12#1)(2008-10#2)(2008-3#4)(2008-5#1)(2013-8#1)
of the silyl##2##3##(2008-4#2)
of the simian immunodeficiency virus##3##5##(1992-6#1)(1995-8#1)(1997-3#1)
of the simian##6##3##(1992-6#1)(1993-3#1)(1993-4#1)(1995-8#1)(1997-3#1)(2008-9#1)
of the similar##2##3##(2007-8#1)(2008-1#1)
of the similarities##2##3##(1992-9#1)(2007-12#1)
of the similarity##3##3##(1997-1#1)(2008-2#2)
of the simple##14##3##(1990-11#1)(1990-5#1)(1991-9#1)(1992-1#1)(1992-9#1)(1994-3#1)(2005-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-12#1)
of the simpler##2##3##(1990-7#1)(2008-7#1)
of the simplest##7##3##(1995-2#1)(1995-3#1)(2008-10#2)(2008-2#1)(2008-8#1)(2009-8#1)
of the simplicity of##2##4##(2008-10#1)(2008-7#1)
of the simplified##2##3##(1991-2#1)(2008-10#1)
of the simulated and##2##4##(2005-11#1)(2007-12#1)
of the simulated##8##3##(1997-2#1)(2005-11#1)(2007-12#1)(2007-9#2)(2008-3#1)(2012-2#1)(2012-3#1)
of the simulation is##2##4##(2007-5#1)(2008-2#1)
of the simulation model##4##4##(2008-10#1)(2012-3#3)
of the simulation parameters##2##4##(2012-3#2)
of the simulation##16##3##(1993-9#1)(2006-5#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#3)(2010-2#1)(2010-8#1)(2012-3#5)
of the simulations##5##3##(2008-2#1)(2008-3#2)(2008-8#1)(2010-9#1)
of the simultaneous determination of##3##5##(1996-8#1)(2008-10#1)(2008-3#1)
of the simultaneous##10##3##(1992-4#1)(1995-6#1)(1996-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2009-5#1)(2009-7#1)
of the simultaneously##2##3##(1990-10#1)(2007-12#1)
of the single chain form##2##5##(1991-8#2)
of the single chain##4##4##(1991-8#3)(2008-8#1)
of the single intradermal comparative tuberculin test##2##7##(1997-8#2)
of the single mutant##2##4##(1995-6#1)(2007-11#1)
of the single nucleotide polymorphism##2##5##(2007-12#2)
of the single tryptophan##3##4##(1991-5#1)(1995-1#1)(1995-5#1)
of the single tryptophanyl residue##2##5##(1991-7#1)(1996-8#1)
of the single##45##3##(1990-6#1)(1990-7#1)(1991-5#1)(1991-7#1)(1991-8#3)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-5#1)(1997-8#2)(2006-2#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-5#2)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#1)
of the single-chain##3##3##(1990-12#1)(1991-7#1)(1991-8#1)
of the single-frequency##3##3##(2007-12#1)(2008-2#2)
of the single-scattering albedo##3##4##(2008-2#1)(2008-3#2)
of the single-scattering##5##3##(2008-2#2)(2008-3#3)
of the single-step##2##3##(1996-11#1)(2008-3#1)
of the singly##6##3##(1990-8#1)(1996-2#1)(1996-7#1)(2007-12#1)(2008-2#1)(2013-8#1)
of the singular##2##3##(2008-2#1)(2008-3#1)
of the sinus of Valsalva and of the ascending aorta##3##10##(1997-5#3)
of the sinus##9##3##(1996-9#1)(1997-5#3)(2006-12#1)(2007-12#1)(2007-8#1)(2008-5#1)(2012-8#1)
of the sinusoidal##4##3##(1991-12#1)(1995-2#1)(2008-3#2)
of the sisters-in-charge##2##3##(2010-3#2)
of the site of##14##4##(1991-11#1)(1994-5#2)(1996-5#1)(1997-7#1)(2005-9#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-9#1)(2012-2#1)(2013-7#1)
of the site##32##3##(1990-12#1)(1990-7#2)(1991-11#2)(1991-4#1)(1994-5#2)(1995-6#1)(1996-5#1)(1997-7#1)(2005-9#1)(2006-8#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-11#3)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
of the site-directed##2##3##(1995-10#1)(2008-8#1)
of the site-specific##3##3##(1995-1#1)(1996-4#1)(2008-8#1)
of the sites of##3##4##(1991-7#1)(1991-9#1)(1997-4#1)
of the sites to##2##4##(1994-9#1)(2013-1#1)
of the sites where##2##4##(2007-9#1)(2008-5#1)
of the sites##21##3##(1990-7#2)(1991-7#1)(1991-9#1)(1992-2#1)(1993-11#1)(1994-6#1)(1994-9#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-4#2)(2004-4#2)(2007-12#1)(2007-2#1)(2007-9#1)(2008-5#1)(2010-8#1)(2013-1#1)
of the sitting behavior of the##2##6##(2007-7#2)
of the situation in##2##4##(2009-8#1)(2013-1#1)
of the situation##10##3##(1990-3#1)(1993-1#1)(1993-3#1)(2008-7#1)(2009-8#1)(2010-5#1)(2010-7#1)(2012-12#1)(2013-1#2)
of the six patients##3##4##(1992-2#1)(1995-1#1)(2013-8#1)
of the six variables##2##4##(2008-10#2)
of the six##56##3##(1990-10#1)(1990-5#2)(1991-2#2)(1991-6#1)(1992-1#1)(1992-2#2)(1992-7#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-8#2)(1995-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(2004-9#1)(2006-9#1)(2007-2#1)(2007-5#2)(2007-9#1)(2008-10#9)(2008-12#1)(2008-5#2)(2008-6#2)(2008-8#3)(2009-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-3#1)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
of the sixteen##4##3##(1990-2#1)(1995-1#1)(2007-3#1)(2007-8#1)
of the sixth##3##3##(1997-7#1)(2008-8#1)(2011-2#1)
of the sixties##2##3##(1990-9#1)(2012-2#1)
of the size and morphology of##2##6##(2006-12#1)(2010-12#1)
of the size and shape of##2##6##(2005-11#1)(2006-11#1)
of the size and##7##4##(2005-11#1)(2006-11#1)(2006-12#1)(2008-2#1)(2008-8#1)(2010-12#1)(2013-1#1)
of the size distribution##4##4##(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)
of the size of the##12##5##(1990-2#1)(1991-6#1)(1993-3#1)(1997-2#1)(1997-8#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-10#1)(2012-11#1)
of the size of##17##4##(1990-2#1)(1991-6#1)(1993-3#1)(1993-8#1)(1997-2#1)(1997-8#1)(2007-12#1)(2007-5#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#1)(2010-2#1)(2012-11#1)
of the size##35##3##(1990-2#1)(1991-6#1)(1993-3#1)(1993-8#1)(1996-6#1)(1997-2#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-12#1)(2007-5#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#7)(2008-3#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2012-11#1)(2013-1#1)
of the skeletal muscle##10##4##(1991-6#1)(1992-3#1)(1993-8#1)(1994-2#1)(1994-4#1)(1997-1#1)(2004-4#1)(2006-10#1)(2008-2#1)(2008-7#1)
of the skeletal##14##3##(1991-6#1)(1992-3#1)(1993-8#1)(1994-2#1)(1994-4#1)(1997-1#1)(2004-4#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-7#1)(2010-8#1)
of the skeleton##5##3##(2006-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-3#1)
of the skill##3##3##(2007-12#1)(2008-11#2)
of the skin after##2##4##(2008-5#1)(2012-3#1)
of the skin and gastrointestinal##2##5##(1997-6#1)(2013-7#1)
of the skin and soft##2##5##(2006-10#1)(2008-8#1)
of the skin and##23##4##(1991-11#1)(1995-12#1)(1997-6#1)(2006-10#3)(2006-12#1)(2008-1#1)(2008-5#4)(2008-8#1)(2009-4#1)(2009-9#1)(2010-3#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-7#1)
of the skin at the site of application##3##8##(2008-9#3)
of the skin at the site of##5##7##(2008-9#5)
of the skin at##6##4##(2008-3#1)(2008-9#5)
of the skin barrier##3##4##(1994-8#1)(2008-5#1)(2010-3#1)
of the skin before and after##2##6##(2008-10#2)
of the skin by##3##4##(2008-5#1)(2009-6#1)(2013-1#1)
of the skin is##3##4##(1990-4#1)(2006-7#1)(2011-2#1)
of the skin lesions##5##4##(1990-3#2)(1991-4#1)(2007-11#1)(2011-2#1)
of the skin of##2##4##(1990-6#1)(1992-8#1)
of the skin or##3##4##(2007-7#1)(2008-10#1)(2008-5#1)
of the skin over##2##4##(2008-10#1)(2008-5#1)
of the skin prior to joint injection##2##7##(2009-5#2)
of the skin surface and##2##5##(2008-5#2)
of the skin surface were##2##5##(2007-2#1)(2008-5#1)
of the skin surface##8##4##(2007-2#1)(2008-5#7)
of the skin tissue##2##4##(1992-9#1)(2008-3#1)
of the skin to##4##4##(2006-7#1)(2008-5#3)
of the skin were##3##4##(2008-5#1)(2008-6#2)
of the skin which##3##4##(1990-5#1)(2007-8#1)(2008-9#1)
of the skin with##2##4##(2008-6#1)(2010-12#1)
of the skin##214##3##(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#2)(1990-9#1)(1991-11#2)(1991-12#1)(1991-4#1)(1991-5#2)(1991-8#3)(1991-9#1)(1992-10#1)(1992-2#1)(1992-8#2)(1992-9#1)(1993-3#1)(1993-5#1)(1994-10#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-8#1)(1996-12#1)(1996-6#3)(1997-3#1)(1997-6#2)(2005-11#3)(2006-10#3)(2006-12#1)(2006-7#2)(2006-8#3)(2007-11#5)(2007-2#2)(2007-4#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#5)(2008-4#1)(2008-5#65)(2008-6#5)(2008-7#1)(2008-8#1)(2008-9#10)(2009-4#1)(2009-5#2)(2009-6#4)(2009-9#1)(2010-12#3)(2010-3#5)(2010-6#1)(2010-7#1)(2010-9#3)(2011-12#1)(2011-2#10)(2012-1#1)(2012-12#6)(2012-2#4)(2012-3#4)(2013-1#2)(2013-7#2)(2013-8#2)
of the skin's##3##3##(2008-5#3)
of the skull are##2##4##(2006-12#1)(2007-6#1)
of the skull base and the##2##6##(2006-12#1)(2007-1#1)
of the skull base and##3##5##(2006-12#2)(2007-1#1)
of the skull base##11##4##(2006-12#4)(2006-6#3)(2007-1#1)(2008-7#2)(2011-2#1)
of the skull was##2##4##(1995-6#1)(2007-4#1)
of the skull##42##3##(1991-3#1)(1993-10#3)(1993-2#1)(1994-2#1)(1995-6#1)(1996-9#1)(1997-3#1)(2006-11#2)(2006-12#6)(2006-6#3)(2007-1#3)(2007-11#3)(2007-4#2)(2007-6#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-3#1)(2009-6#2)(2011-2#2)(2012-2#1)(2013-1#1)
of the sky radiance##2##4##(2008-2#1)(2008-3#1)
of the sky##9##3##(2007-12#1)(2007-8#1)(2007-9#2)(2008-2#4)(2008-3#1)
of the sl/sl rats##3##4##(1996-4#3)
of the slab is##3##4##(1995-6#2)(2008-3#1)
of the slab##6##3##(1995-6#3)(2008-3#3)
of the slave##2##3##(2007-12#1)(2008-8#1)
of the sleep##6##3##(1996-7#1)(2004-11#1)(2007-6#1)(2009-8#1)(2011-2#1)(2013-1#1)
of the sleep-wake cycle##2##4##(1994-2#2)
of the sleeve##2##3##(2008-11#2)
of the slider##3##3##(2007-3#1)(2008-2#2)
of the sliding velocity##2##4##(2005-11#1)(2006-10#1)
of the sliding##3##3##(2005-11#1)(2006-10#1)(2008-5#1)
of the slippage##2##3##(2007-7#2)
of the slit##3##3##(2006-4#1)(2008-2#2)
of the slope and##3##4##(1993-12#1)(1996-12#1)(2010-8#1)
of the slope of the##4##5##(2007-7#1)(2007-9#1)(2008-10#1)(2008-3#1)
of the slope##13##3##(1993-12#1)(1996-12#1)(2007-12#3)(2007-7#1)(2007-9#1)(2008-10#2)(2008-3#2)(2010-8#1)(2013-8#1)
of the slow reaction step##2##5##(1991-2#2)
of the slow##13##3##(1991-12#1)(1991-2#2)(1992-6#1)(1993-5#1)(1993-8#1)(1994-10#1)(1996-5#1)(1997-1#1)(2006-1#1)(2007-12#1)(2008-10#2)
of the slower##2##3##(1990-3#1)(1993-3#1)
of the slowest##4##3##(1990-7#1)(2007-9#1)(2008-3#1)(2013-8#1)
of the slowly varying envelope approximation##3##6##(2007-11#2)(2007-12#1)
of the slowly##4##3##(1995-11#1)(2007-11#2)(2007-12#1)
of the slurries##2##3##(2004-9#1)(2008-10#1)
of the small and large##2##5##(1994-11#1)(2008-7#1)
of the small and##5##4##(1994-11#1)(2006-12#2)(2008-10#1)(2008-7#1)
of the small bowel can##2##5##(1990-11#1)(2013-8#1)
of the small bowel in##2##5##(2006-8#1)(2011-2#1)
of the small bowel##19##4##(1990-11#2)(1991-9#1)(1992-5#2)(1993-10#2)(2006-2#1)(2006-8#1)(2007-5#1)(2008-6#1)(2009-1#1)(2009-4#1)(2010-12#2)(2011-2#3)(2013-8#1)
of the small intestinal mucosa##2##5##(1990-2#1)(2006-10#1)
of the small intestine and the##2##6##(2010-12#1)(2010-2#1)
of the small intestine and##5##5##(1995-3#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)
of the small intestine are##2##5##(2006-10#1)(2009-2#1)
of the small intestine in a##2##6##(1991-9#1)(2012-2#1)
of the small intestine in##4##5##(1990-11#1)(1991-9#1)(1992-11#1)(2012-2#1)
of the small intestine is##3##5##(1993-8#1)(2006-10#1)(2006-2#1)
of the small intestine was##2##5##(2011-12#1)(2012-12#1)
of the small intestine##51##4##(1990-11#1)(1990-5#1)(1991-10#1)(1991-5#2)(1991-9#1)(1992-11#1)(1992-5#1)(1992-6#3)(1993-1#1)(1993-10#1)(1993-8#1)(1995-12#1)(1995-3#2)(1996-11#2)(1996-2#1)(1997-3#1)(2005-10#1)(2006-10#9)(2006-2#3)(2007-5#1)(2007-8#1)(2008-3#1)(2009-2#5)(2010-11#1)(2010-12#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#1)
of the small intestine]##5##4##(1990-5#1)(1992-5#2)(2009-2#1)(2012-11#1)
of the small molecule##2##4##(2005-12#1)(2012-12#1)
of the small nuclear##2##4##(1995-6#1)(1996-4#1)
of the small number of##3##5##(1993-5#1)(1995-5#1)(1997-8#1)
of the small ribosomal subunit##4##5##(1994-12#1)(1997-4#1)(2006-12#1)(2009-11#1)
of the small sample size and##2##6##(2009-8#1)(2013-1#1)
of the small sample size##4##5##(2006-10#1)(2008-12#1)(2009-8#1)(2013-1#1)
of the small size VLDL##2##5##(1993-8#2)
of the small size of##3##5##(2008-10#1)(2009-3#1)(2012-12#1)
of the small size##5##4##(1993-8#2)(2008-10#1)(2009-3#1)(2012-12#1)
of the small subunit of##2##5##(1992-3#1)(2009-10#1)
of the small subunit##3##4##(1992-3#1)(2005-7#1)(2009-10#1)
of the small##150##3##(1990-10#1)(1990-11#3)(1990-2#1)(1990-5#2)(1990-7#1)(1991-10#1)(1991-3#1)(1991-5#3)(1991-8#1)(1991-9#2)(1992-11#2)(1992-3#1)(1992-5#5)(1992-6#3)(1992-9#1)(1993-1#1)(1993-10#3)(1993-5#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#3)(1995-5#2)(1995-6#1)(1996-10#1)(1996-11#2)(1996-2#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-8#2)(2005-10#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#11)(2006-11#1)(2006-12#4)(2006-2#4)(2006-8#1)(2007-11#1)(2007-12#2)(2007-5#2)(2007-8#1)(2008-10#3)(2008-12#1)(2008-3#5)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#1)(2009-1#2)(2009-10#1)(2009-11#1)(2009-2#6)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-6#1)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#4)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
of the small-angle##5##3##(2006-10#1)(2006-5#1)(2008-3#2)(2009-12#1)
of the smaller##9##3##(1990-11#1)(1991-3#1)(1994-11#1)(1994-12#1)(1997-2#1)(2005-11#1)(2006-10#1)(2010-4#1)(2012-2#1)
of the smallest and##2##4##(1992-7#1)(2011-2#1)
of the smallest##12##3##(1991-7#1)(1992-7#1)(1995-8#1)(1996-12#1)(2005-8#1)(2006-10#1)(2007-3#1)(2008-5#1)(2011-1#1)(2011-2#2)(2012-2#1)
of the smart##3##3##(2007-8#1)(2012-11#2)
of the smco7 mutant##2##4##(1997-4#2)
of the smokers##3##3##(1990-6#1)(1993-10#1)(1993-2#1)
of the smoking##8##3##(1994-4#1)(1996-3#1)(1997-7#1)(2005-9#1)(2012-12#1)(2013-1#3)
of the smooth muscle##7##4##(1994-9#1)(1995-12#1)(1997-1#1)(2007-11#1)(2007-8#1)(2008-5#1)(2011-2#1)
of the smooth##11##3##(1990-7#1)(1994-9#1)(1995-12#1)(1997-1#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-2#1)(2011-2#1)
of the snail##3##3##(2008-12#1)(2008-5#2)
of the snake##5##3##(1994-5#1)(1995-5#1)(1997-2#1)(2007-12#1)(2010-3#1)
of the so called##3##4##(1993-3#1)(2009-7#1)(2013-8#1)
of the so##4##3##(1993-3#1)(1997-2#1)(2009-7#1)(2013-8#1)
of the so-called &quot##2##4##(2008-11#1)(2012-1#1)
of the so-called##28##3##(1990-12#1)(1993-5#1)(1993-6#1)(1994-6#1)(1997-8#1)(2006-12#3)(2006-7#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-5#1)(2008-7#1)(2009-2#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)
of the social and##5##4##(1992-12#1)(1993-11#1)(2009-4#2)(2010-7#1)
of the social brain##2##4##(2007-12#2)
of the social determinants##2##4##(2008-2#1)(2013-1#1)
of the social network##2##4##(2010-10#1)(2012-3#1)
of the social##42##3##(1992-12#1)(1992-3#1)(1993-1#1)(1993-11#1)(1994-3#1)(1995-11#1)(1995-5#1)(1997-6#1)(2007-10#2)(2007-12#3)(2007-7#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-4#5)(2009-6#1)(2010-10#1)(2010-4#1)(2010-6#1)(2010-7#1)(2012-3#2)(2013-1#2)
of the society##11##3##(1993-9#1)(2005-8#1)(2005-9#1)(2006-10#1)(2008-10#1)(2008-9#1)(2011-1#2)(2012-1#1)(2012-2#2)
of the socio-economic##2##3##(2007-7#1)(2008-1#1)
of the sodium channel##5##4##(1991-9#1)(1992-3#1)(1992-9#1)(1995-9#2)
of the sodium pump##3##4##(1990-11#1)(1992-11#1)(2008-7#1)
of the sodium salt of a new##2##7##(2007-10#2)
of the sodium##18##3##(1990-11#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-9#2)(1995-9#2)(1996-2#1)(2007-10#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-8#1)
of the soft palate##7##4##(1991-3#1)(2006-6#1)(2008-3#1)(2009-8#1)(2012-12#3)
of the soft tissue##4##4##(2010-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
of the soft tissues and##2##5##(2009-4#1)(2013-1#1)
of the soft tissues in##3##5##(1994-10#1)(2010-3#1)(2012-2#1)
of the soft tissues##11##4##(1994-10#1)(1995-3#1)(2007-1#1)(2007-4#1)(2009-4#2)(2009-6#1)(2010-3#1)(2012-2#1)(2013-1#2)
of the soft##25##3##(1991-3#1)(1994-10#1)(1995-3#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-3#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2012-12#3)(2012-2#2)(2013-1#3)(2013-7#1)
of the software##7##3##(1995-6#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-1#2)
of the soil arthropod community##3##5##(2013-8#3)
of the soil microbial community##2##5##(2008-10#2)
of the soil microbial##4##4##(1990-9#1)(2006-12#1)(2008-10#2)
of the soil##20##3##(1990-9#1)(2004-4#1)(2006-12#1)(2008-10#9)(2008-11#1)(2008-2#1)(2010-10#1)(2011-12#1)(2011-2#1)(2013-8#3)
of the soils##3##3##(2004-2#1)(2008-10#2)
of the sol-gel transition##3##4##(2005-11#2)(2008-2#1)
of the sol-gel##8##3##(2005-11#2)(2008-10#3)(2008-2#1)(2010-1#1)(2010-4#1)
of the solar spectrum##2##4##(2008-2#1)(2008-3#1)
of the solar##12##3##(1990-8#1)(1992-9#1)(1996-5#2)(2007-9#1)(2008-2#3)(2008-3#4)
of the sole##2##3##(2008-4#1)(2009-10#1)
of the soleus and##2##4##(1993-7#1)(2013-8#1)
of the soleus##4##3##(1993-7#1)(1996-8#2)(2013-8#1)
of the solid and##2##4##(2005-11#1)(2008-10#1)
of the solid content of the porous material##2##8##(2008-3#2)
of the solid organs##2##4##(2006-11#1)(2007-4#1)
of the solid particles##2##4##(1990-12#1)(2008-10#1)
of the solid phase##4##4##(1990-12#1)(1993-9#1)(2005-11#1)(2008-10#1)
of the solid solution##2##4##(2007-11#1)(2008-10#1)
of the solid##30##3##(1990-12#2)(1991-11#1)(1993-9#1)(1995-3#1)(2005-11#4)(2006-11#1)(2006-6#1)(2007-11#1)(2007-4#1)(2007-6#1)(2008-1#2)(2008-10#9)(2008-2#1)(2008-3#3)(2008-5#1)
of the solid-phase##2##3##(2007-11#1)(2008-10#1)
of the solid-state##2##3##(1991-11#1)(2008-2#1)
of the solitary tract##15##4##(1991-11#4)(1992-8#2)(1992-9#1)(1993-12#2)(1993-2#1)(1994-10#1)(1995-5#1)(1996-5#1)(1997-8#1)(2013-1#1)
of the solitary##21##3##(1991-11#4)(1992-8#2)(1992-9#2)(1993-12#2)(1993-2#1)(1994-10#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-5#1)(1997-8#1)(2006-7#1)(2008-7#1)(2012-2#1)(2013-1#1)
of the soliton pulse##2##4##(2007-11#2)
of the soliton##7##3##(2007-11#2)(2007-12#5)
of the solitons##2##3##(2007-12#2)
of the solubilisate##2##3##(1990-7#2)
of the solubility of##3##4##(2006-10#1)(2008-10#1)(2008-5#1)
of the solubility product##2##4##(2008-10#1)(2010-4#1)
of the solubility##8##3##(2006-10#2)(2008-10#4)(2008-5#1)(2010-4#1)
of the solubilized##6##3##(1990-2#1)(1990-5#2)(1994-11#1)(1994-3#1)(1996-5#1)
of the soluble and membrane-bound##2##5##(1994-2#1)(2008-4#1)
of the soluble and##4##4##(1992-6#1)(1994-2#1)(1997-1#1)(2008-4#1)
of the soluble interleukin-6 receptor##2##5##(1996-11#2)
of the soluble protein##5##4##(1990-5#2)(1994-6#1)(1995-2#2)
of the soluble##33##3##(1990-2#3)(1990-5#2)(1991-1#1)(1992-12#3)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1994-2#2)(1994-6#2)(1995-2#2)(1995-5#1)(1996-11#2)(1996-2#1)(1996-8#1)(1997-1#1)(1997-4#1)(2006-10#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-9#1)
of the solute and the##2##5##(2008-10#2)
of the solute and##3##4##(2006-10#1)(2008-10#2)
of the solute in the##2##5##(2008-10#2)
of the solute in##3##4##(2006-10#1)(2008-10#2)
of the solute molecules##2##4##(2005-11#2)
of the solute##23##3##(1992-2#1)(1994-9#1)(2005-11#2)(2006-10#8)(2008-10#8)(2008-3#1)(2009-5#1)(2010-2#1)
of the solutes##11##3##(1992-1#1)(1996-5#1)(1997-8#2)(2005-12#1)(2008-10#3)(2012-12#3)
of the solution and##4##4##(2005-11#1)(2007-8#1)(2008-10#2)
of the solution can##2##4##(2008-2#1)(2010-5#1)
of the solution conformation of##2##5##(1992-1#1)(2005-7#1)
of the solution from the##2##5##(2008-10#2)
of the solution in##2##4##(1995-3#1)(2008-10#1)
of the solution structure of the (-)-cis-anti-[BP]dG##2##7##(1996-7#2)
of the solution structure of the##4##6##(1995-1#1)(1995-2#1)(1996-7#2)
of the solution that##2##4##(1995-1#1)(2009-6#1)
of the solution to##2##4##(2008-10#1)(2009-4#1)
of the solution was##5##4##(1990-8#1)(2005-4#1)(2008-10#2)(2013-1#1)
of the solution##71##3##(1990-11#1)(1990-2#1)(1990-5#2)(1990-8#1)(1991-2#2)(1992-1#1)(1995-1#2)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#2)(2004-9#1)(2005-11#6)(2005-12#1)(2005-4#2)(2005-7#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#24)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-5#1)(2012-1#1)(2013-1#1)
of the solutions is##2##4##(2008-10#1)(2008-3#1)
of the solutions to##2##4##(2007-10#1)(2013-8#1)
of the solutions were##2##4##(2008-10#1)(2012-12#1)
of the solutions##17##3##(1991-1#1)(1991-9#1)(1997-4#1)(2007-10#1)(2007-12#1)(2008-10#7)(2008-3#1)(2008-5#1)(2012-12#2)(2013-8#1)
of the solvation of##2##4##(1990-2#1)(2006-10#1)
of the solvation##9##3##(1990-2#1)(2005-11#2)(2006-10#2)(2008-5#1)(2010-7#1)(2011-3#1)(2013-1#1)
of the solvent and the##3##5##(1996-2#1)(2008-10#2)
of the solvent and##6##4##(1996-2#1)(1997-7#1)(1997-8#1)(2008-10#3)
of the solvent is##2##4##(1991-4#1)(2007-12#1)
of the solvent molecules##2##4##(2006-10#1)(2008-10#1)
of the solvent systems##2##4##(2008-10#2)
of the solvent to##2##4##(1997-1#1)(2008-10#1)
of the solvent##40##3##(1990-9#1)(1991-4#1)(1995-4#1)(1996-2#3)(1997-1#2)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#2)(2006-10#5)(2007-10#1)(2007-12#1)(2008-10#15)(2008-3#1)(2008-7#1)(2010-5#1)(2010-8#1)(2013-1#1)
of the solvents were##2##4##(2008-10#2)
of the solvents##3##3##(2008-10#3)
of the soma##2##3##(1996-3#1)(1996-9#1)
of the somatic gonad##3##4##(2007-12#1)(2012-12#2)
of the somatic value at 60 microns dendritic distance##2##9##(1997-7#2)
of the somatic##11##3##(1991-12#1)(1991-8#1)(1997-7#2)(2007-12#2)(2008-4#1)(2008-7#1)(2012-12#3)
of the somatosensory cortex##2##4##(1995-11#1)(2008-5#1)
of the somatosensory##3##3##(1994-3#1)(1995-11#1)(2008-5#1)
of the somatostatin analog octreotide##2##5##(1991-7#2)
of the somatostatin##7##3##(1991-7#2)(1995-8#2)(2006-12#2)(2010-11#1)
of the somitic mesoderm##2##4##(1994-12#1)(1997-4#1)
of the sorbed##3##3##(2005-11#1)(2008-10#2)
of the sorbent##6##3##(1996-8#1)(2008-10#5)
of the sorghum##2##3##(2008-10#2)
of the sorption of##3##4##(2007-8#1)(2008-10#2)
of the sorption##8##3##(2005-11#2)(2007-8#1)(2008-10#5)
of the sort##2##3##(2008-4#1)(2008-9#1)
of the soul##3##3##(2006-12#1)(2008-11#1)(2008-7#1)
of the soul&quot##2##3##(2011-1#1)(2012-2#1)
of the sound##5##3##(2008-2#2)(2008-3#1)(2009-5#1)(2013-8#1)
of the source and##4##4##(2008-10#1)(2008-2#2)(2008-3#1)
of the source is##2##4##(2008-3#2)
of the source population##2##4##(2008-10#2)
of the source spectrum##2##4##(2007-12#1)(2008-3#1)
of the source##33##3##(2006-10#1)(2006-4#1)(2006-5#1)(2007-11#4)(2007-12#2)(2008-10#7)(2008-11#1)(2008-2#5)(2008-3#9)(2011-1#1)(2012-2#1)
of the sources of##3##4##(2008-10#1)(2008-3#1)(2012-3#1)
of the sources##5##3##(1990-11#1)(2008-10#1)(2008-3#1)(2012-1#1)(2012-3#1)
of the southeastern United States##2##5##(1992-8#1)(2012-1#1)
of the southern Ryukyus##2##4##(2010-3#2)
of the southern red tabira bitterling Acheilognathus tabira jordani##2##9##(2010-8#2)
of the southern red##3##4##(2010-8#2)(2013-1#1)
of the southern##13##3##(1996-12#1)(1997-3#1)(1997-4#1)(2006-4#1)(2008-10#1)(2008-8#1)(2010-3#2)(2010-8#2)(2011-2#1)(2013-1#2)
of the soybean fields in##2##5##(2008-10#2)
of the soybean genome##4##4##(2012-11#4)
of the soybean##12##3##(1993-6#1)(1996-12#1)(2008-10#3)(2009-3#1)(2012-11#5)(2012-2#1)
of the spa##3##3##(1992-11#1)(1994-3#1)(2008-4#1)
of the space of##2##4##(2006-10#1)(2009-10#1)
of the space##7##3##(1991-1#1)(1994-11#1)(2006-10#1)(2007-9#1)(2008-2#1)(2008-3#1)(2009-10#1)
of the space-charge field##3##4##(2007-11#2)(2007-12#1)
of the space-charge##5##3##(2007-11#2)(2007-12#2)(2008-1#1)
of the spacer##12##3##(1994-12#1)(1995-6#1)(1995-8#1)(1997-1#1)(1997-3#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-5#1)
of the spatial VG##3##4##(2010-11#3)
of the spatial and temporal##5##5##(1992-9#1)(2007-12#2)(2008-11#1)(2008-3#1)
of the spatial and##7##4##(1992-9#1)(2007-12#3)(2008-11#1)(2008-2#1)(2008-3#1)
of the spatial coherence##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
of the spatial distribution of##6##5##(1990-7#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-3#1)
of the spatial light modulator##2##5##(2008-2#2)
of the spatial light##4##4##(2008-2#4)
of the spatial relationships among##2##5##(2007-5#1)(2008-9#1)
of the spatial resolution##3##4##(2006-12#1)(2008-2#1)(2011-1#1)
of the spatial##60##3##(1990-7#1)(1991-1#1)(1992-9#1)(1993-5#1)(2006-12#2)(2006-7#1)(2007-11#6)(2007-12#7)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#11)(2008-3#8)(2008-4#1)(2008-8#3)(2008-9#2)(2009-10#2)(2009-8#1)(2010-11#3)(2011-1#1)
of the spatially varying##2##4##(2008-3#1)(2013-1#1)
of the spatially##4##3##(2008-3#2)(2011-2#1)(2013-1#1)
of the spatiotemporal evolution of##2##5##(2007-12#1)(2008-11#1)
of the spatiotemporal##6##3##(1991-2#1)(2007-12#3)(2008-11#1)(2008-3#1)
of the special properties of##2##5##(2007-12#1)(2008-2#1)
of the special##9##3##(1993-3#1)(1994-9#1)(1996-3#1)(2007-12#2)(2008-2#1)(2008-4#1)(2008-8#1)(2010-12#1)
of the specialist##2##3##(1993-5#1)(2008-7#1)
of the specialized##4##3##(1992-6#1)(1995-6#1)(1996-11#1)(2008-1#1)
of the specialty of##2##4##(2006-10#1)(2007-12#1)
of the specialty##6##3##(2006-10#2)(2007-12#2)(2007-4#1)(2007-8#1)
of the speciation process##2##4##(2008-8#1)(2013-1#1)
of the species and the##4##5##(1996-11#1)(2007-9#1)(2008-5#1)(2009-2#1)
of the species and##8##4##(1994-9#1)(1996-11#1)(2007-9#1)(2008-5#1)(2009-2#2)(2012-2#1)(2012-3#1)
of the species are##4##4##(2007-3#1)(2008-11#1)(2008-8#1)(2010-8#1)
of the species examined##2##4##(1996-5#2)
of the species found##2##4##(2008-5#1)(2013-7#1)
of the species in the##4##5##(2007-9#1)(2008-10#2)(2008-5#1)
of the species in##6##4##(2007-9#1)(2008-10#3)(2008-5#1)(2012-5#1)
of the species is##3##4##(2008-5#1)(2013-7#2)
of the species of##2##4##(2008-10#1)(2013-7#1)
of the species studied##4##4##(1994-8#1)(2007-11#2)(2010-5#1)
of the species was##4##4##(2006-10#1)(2008-10#1)(2011-2#1)(2012-2#1)
of the species were##2##4##(2008-5#1)(2012-2#1)
of the species##90##3##(1990-8#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-5#2)(1997-4#1)(1997-6#1)(2006-10#2)(2006-4#1)(2007-11#2)(2007-12#1)(2007-3#4)(2007-9#2)(2008-10#23)(2008-11#1)(2008-12#1)(2008-5#9)(2008-6#1)(2008-8#5)(2009-2#2)(2009-3#1)(2009-8#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-1#2)(2012-2#6)(2012-3#2)(2012-5#1)(2013-7#5)(2013-8#1)
of the specific activity of the##2##6##(2008-10#1)(2008-4#1)
of the specific activity of##3##5##(1993-11#1)(2008-10#1)(2008-4#1)
of the specific binding##3##4##(1991-9#1)(1993-8#1)(1995-7#1)
of the specific cause##2##4##(2004-10#1)(2008-2#1)
of the specific conductivity##2##4##(2005-11#2)
of the specific energy##3##4##(1990-11#1)(2008-7#2)
of the specific genetic##2##4##(2008-7#1)(2012-11#1)
of the specific glucose##2##4##(1994-5#1)(2008-11#1)
of the specific mechanisms##2##4##(2006-10#1)(2010-8#1)
of the specific microbe##2##4##(2011-2#2)
of the specific nature of the##2##6##(1990-5#1)(2007-12#1)
of the specific roles of##2##5##(1993-8#1)(2008-4#1)
of the specific##81##3##(1990-11#1)(1990-5#1)(1990-6#1)(1991-2#2)(1991-9#1)(1992-1#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-7#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-6#2)(1997-7#1)(2004-10#1)(2004-11#1)(2005-11#5)(2006-10#2)(2006-12#2)(2006-8#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#4)(2009-10#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#2)(2013-1#1)
of the specifications and##3##4##(2008-4#1)(2013-1#2)
of the specificity of the##3##5##(1991-12#1)(1991-9#1)(2006-12#1)
of the specificity of##8##4##(1991-12#1)(1991-9#1)(1992-3#1)(1995-3#1)(1996-5#1)(2006-12#1)(2006-9#1)(2009-4#1)
of the specificity##12##3##(1990-11#1)(1991-12#1)(1991-9#1)(1992-3#1)(1995-3#2)(1996-5#1)(2005-12#1)(2006-12#1)(2006-9#1)(2009-4#1)(2011-2#1)
of the specified##3##3##(2008-10#1)(2008-4#2)
of the specimen##19##3##(1991-9#1)(1994-9#1)(2004-2#1)(2005-12#3)(2007-11#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-7#1)(2011-1#2)(2012-12#2)(2013-8#1)
of the specimens showed##2##4##(2007-8#1)(2012-2#1)
of the specimens was##2##4##(2004-9#1)(2013-8#1)
of the specimens were##5##4##(1990-7#1)(2009-3#1)(2013-7#2)(2013-8#1)
of the specimens##22##3##(1990-7#1)(1991-9#1)(1995-5#1)(2004-9#1)(2006-8#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-9#1)(2009-3#1)(2010-2#1)(2012-2#2)(2013-7#2)(2013-8#3)
of the speckle pattern is##2##5##(2007-12#1)(2008-3#1)
of the speckle pattern##3##4##(2007-12#1)(2008-3#1)(2013-1#1)
of the speckle signal##2##4##(2008-3#2)
of the speckle##14##3##(2007-11#1)(2007-12#3)(2008-3#9)(2013-1#1)
of the speckles##3##3##(2007-12#1)(2008-2#2)
of the spectra is##2##4##(2007-8#1)(2010-2#1)
of the spectra obtained##2##4##(2008-10#1)(2008-2#1)
of the spectra of the##2##5##(2008-3#1)(2008-8#1)
of the spectra of##5##4##(1992-8#1)(2008-10#1)(2008-3#2)(2008-8#1)
of the spectra##21##3##(1992-3#1)(1992-8#1)(1992-9#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#4)(2008-3#5)(2008-8#1)(2010-2#1)
of the spectral and##3##4##(1992-2#1)(2008-10#1)(2008-3#1)
of the spectral bands##2##4##(2008-10#1)(2010-11#1)
of the spectral bandwidth##4##4##(2008-2#1)(2008-3#3)
of the spectral calibration##2##4##(2008-3#2)
of the spectral characteristics##2##4##(2008-2#1)(2008-3#1)
of the spectral distribution of the##2##6##(2008-2#2)
of the spectral distribution##3##4##(2008-2#2)(2008-3#1)
of the spectral features##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
of the spectral information##2##4##(2008-3#2)
of the spectral phase##2##4##(2007-12#1)(2008-3#1)
of the spectral properties##2##4##(2008-2#1)(2012-12#1)
of the spectral reflectance##3##4##(2008-2#2)(2008-3#1)
of the spectral response of##3##5##(2008-2#2)(2008-3#1)
of the spectral response##5##4##(2008-2#3)(2008-3#2)
of the spectral##65##3##(1992-2#1)(1994-8#1)(1994-9#1)(2006-10#1)(2007-11#1)(2007-12#7)(2008-10#7)(2008-2#19)(2008-3#20)(2008-4#1)(2008-8#1)(2010-11#1)(2012-12#1)(2013-8#3)
of the spectrally resolved##2##4##(2007-12#1)(2008-3#1)
of the spectrally##3##3##(2007-12#2)(2008-3#1)
of the spectrin tetramer##2##4##(1993-4#2)
of the spectrometer with##2##4##(2008-10#1)(2008-3#1)
of the spectrometer##14##3##(2006-4#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-2#1)(2008-3#3)
of the spectrophotometer##3##3##(2007-3#1)(2008-10#1)(2008-3#1)
of the spectrophotometric##4##3##(2006-10#1)(2008-10#2)(2010-2#1)
of the spectroscopic##6##3##(2008-10#3)(2008-2#1)(2010-2#2)
of the spectrum and##2##4##(2007-12#1)(2008-3#1)
of the spectrum by##2##4##(2008-10#1)(2008-3#1)
of the spectrum is##3##4##(2007-11#1)(2007-12#1)(2008-10#1)
of the spectrum of the##3##5##(2007-12#1)(2008-3#1)(2009-6#1)
of the spectrum of##10##4##(1990-5#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)(2012-2#1)
of the spectrum##64##3##(1990-3#2)(1990-5#3)(1992-7#1)(1994-10#1)(1995-11#1)(1995-5#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#8)(2008-10#3)(2008-11#1)(2008-2#11)(2008-3#12)(2008-5#1)(2008-7#2)(2009-6#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-8#2)
of the specular peak perpendicular to the principal plane##2##9##(2008-3#2)
of the specular##3##3##(2006-7#1)(2008-3#2)
of the speech signal##2##4##(2008-2#1)(2010-2#1)
of the speech##5##3##(2008-2#2)(2008-9#2)(2010-2#1)
of the speed of sound##2##5##(2008-2#1)(2008-3#1)
of the speed of##5##4##(1993-12#1)(2007-9#1)(2008-2#2)(2008-3#1)
of the sperm##12##3##(1990-5#1)(1991-11#1)(1991-8#1)(1993-6#1)(1994-5#1)(1994-8#2)(2006-5#1)(2008-7#1)(2008-8#2)(2012-2#1)
of the spermatheca##2##3##(2007-12#1)(2008-6#1)
of the spermathecal##3##3##(2008-5#2)(2008-8#1)
of the spermatic cord##4##4##(2007-7#1)(2008-10#1)(2008-6#2)
of the spermatic##5##3##(2007-7#1)(2008-10#1)(2008-6#2)(2009-5#1)
of the spermatozoa with##2##4##(2008-8#1)(2011-1#1)
of the spermatozoa##8##3##(2007-12#1)(2008-7#2)(2008-8#2)(2011-1#3)
of the spermatozoon##3##3##(2006-5#1)(2008-7#1)(2008-8#1)
of the sphenoid sinus##3##4##(2008-7#2)(2012-3#1)
of the sphenoid##8##3##(2007-6#1)(2008-10#3)(2008-7#3)(2012-3#1)
of the sphenopalatine ganglion##2##4##(2006-7#2)
of the sphenopalatine##4##3##(2006-7#2)(2009-10#2)
of the sphere and##2##4##(2007-12#1)(2008-2#1)
of the sphere##5##3##(2007-12#1)(2008-2#3)(2008-3#1)
of the spheres##2##3##(2007-12#1)(2008-3#1)
of the spherical LCAL##2##4##(2008-2#2)
of the spherical##8##3##(1991-11#1)(1996-5#1)(2005-11#1)(2008-2#4)(2008-3#1)
of the spheroid##2##3##(1995-1#2)
of the spheroidal functions##2##4##(2008-2#2)
of the sphincter of Oddi##3##5##(2006-6#2)(2010-12#1)
of the sphingolipid##2##3##(1993-9#1)(1995-8#1)
of the spider Nephila clavipes##3##5##(2006-12#3)
of the spider##8##3##(1993-11#1)(1996-11#2)(2006-12#3)(2007-12#1)(2008-5#1)
of the spike AHP##2##4##(1992-3#2)
of the spike train##2##4##(1991-6#1)(2009-8#1)
of the spike##11##3##(1991-6#1)(1992-3#3)(1993-9#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-8#1)
of the spiked amount##2##4##(2008-10#2)
of the spiked mercury(II)##2##4##(2008-10#2)
of the spiked##16##3##(1992-8#1)(2007-1#1)(2008-10#14)
of the spin labels##2##4##(1993-8#1)(2010-9#1)
of the spin##9##3##(1992-3#1)(1993-3#1)(1993-8#1)(1995-10#1)(1995-11#1)(2006-10#1)(2008-2#1)(2009-5#1)(2010-9#1)
of the spin-dependent##2##3##(2006-4#2)
of the spinach##3##3##(2008-10#2)(2011-1#1)
of the spinal and##2##4##(1992-12#1)(1997-8#1)
of the spinal arteriovenous malformation (AVM)##2##6##(2008-7#1)(2013-1#1)
of the spinal canal and##3##5##(2007-7#1)(2007-8#1)(2008-1#1)
of the spinal canal in##2##5##(2007-8#1)(2009-4#1)
of the spinal canal##10##4##(1991-8#1)(1992-11#1)(2007-11#1)(2007-7#1)(2007-8#4)(2008-1#1)(2009-4#1)
of the spinal column##3##4##(1995-5#1)(2007-11#1)(2007-8#1)
of the spinal cord and the##2##6##(1992-12#1)(2008-7#1)
of the spinal cord and##5##5##(1992-12#1)(1996-11#1)(2007-11#1)(2008-7#1)(2009-3#1)
of the spinal cord in##3##5##(1996-9#1)(2008-7#1)(2013-8#1)
of the spinal cord of##5##5##(1991-6#1)(1992-9#1)(1996-11#1)(1996-6#1)(2006-11#1)
of the spinal cord were##2##5##(1995-7#1)(2006-5#1)
of the spinal cord##78##4##(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1991-3#2)(1991-6#2)(1992-10#2)(1992-12#1)(1992-9#2)(1994-9#3)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-7#5)(1996-11#2)(1996-12#1)(1996-6#1)(1996-9#3)(2006-10#1)(2006-11#2)(2006-12#2)(2006-2#1)(2006-5#3)(2006-8#4)(2007-1#2)(2007-10#3)(2007-11#4)(2007-2#2)(2008-5#2)(2008-7#7)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
of the spinal dorsal horn##2##5##(1997-2#2)
of the spinal gray matter##2##5##(1991-5#1)(1995-11#1)
of the spinal gray##3##4##(1991-5#2)(1995-11#1)
of the spinal muscular##2##4##(2007-11#1)(2012-3#1)
of the spinal nerve##2##4##(1993-11#1)(2011-2#1)
of the spinal nerves##2##4##(1994-2#1)(2008-7#1)
of the spinal trigeminal nucleus##2##5##(1996-9#1)(1997-1#1)
of the spinal##123##3##(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#2)(1991-3#2)(1991-5#2)(1991-6#2)(1991-8#1)(1992-10#3)(1992-11#1)(1992-12#2)(1992-9#2)(1993-11#1)(1994-2#1)(1994-9#3)(1995-11#3)(1995-12#1)(1995-3#1)(1995-5#2)(1995-7#5)(1996-11#3)(1996-12#1)(1996-5#1)(1996-6#1)(1996-9#4)(1997-1#1)(1997-2#2)(1997-8#1)(2006-10#2)(2006-11#3)(2006-12#2)(2006-2#1)(2006-5#3)(2006-8#5)(2007-1#2)(2007-10#3)(2007-11#7)(2007-2#2)(2007-7#2)(2007-8#6)(2008-1#1)(2008-5#2)(2008-7#10)(2008-9#1)(2009-3#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
of the spindle cell##2##4##(2008-10#1)(2011-2#1)
of the spindle##6##3##(1990-6#1)(2008-10#1)(2008-2#1)(2008-8#2)(2011-2#1)
of the spine and the##2##5##(2007-11#2)
of the spine and##14##4##(1991-11#1)(1994-8#1)(2006-9#1)(2007-11#4)(2007-6#1)(2008-1#1)(2008-8#1)(2009-5#1)(2010-1#1)(2011-2#1)(2012-2#1)
of the spine are##3##4##(2007-6#2)(2008-6#1)
of the spine in the##2##5##(2007-11#2)
of the spine in##5##4##(1990-12#1)(2007-11#3)(2011-2#1)
of the spine is a##2##5##(2005-2#1)(2011-2#1)
of the spine trauma##4##4##(2007-11#4)
of the spine was##2##4##(2006-7#1)(2010-12#1)
of the spine with##2##4##(1993-1#1)(2006-7#1)
of the spine##92##3##(1990-12#1)(1990-6#1)(1991-11#1)(1992-10#1)(1993-1#1)(1994-8#1)(1996-6#1)(2005-2#1)(2006-10#2)(2006-2#3)(2006-5#1)(2006-7#6)(2006-8#6)(2006-9#1)(2007-11#25)(2007-4#1)(2007-6#3)(2007-7#3)(2007-8#2)(2008-1#8)(2008-11#2)(2008-12#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-5#1)(2010-1#1)(2010-12#3)(2010-3#1)(2011-2#4)(2012-2#2)
of the spine]##3##3##(1992-10#1)(2008-1#1)(2008-6#1)
of the spinocerebellar projection##2##4##(1991-3#1)(1991-8#1)
of the spiral##3##3##(2007-12#2)(2008-8#1)
of the spleen and##6##4##(1990-3#1)(1992-10#1)(1995-3#1)(1997-3#1)(2005-10#1)(2012-3#1)
of the spleen##36##3##(1990-3#1)(1990-4#1)(1992-10#2)(1992-3#1)(1992-5#2)(1993-9#1)(1994-9#1)(1995-2#1)(1995-3#1)(1997-3#2)(2005-10#2)(2006-1#1)(2006-6#3)(2006-8#1)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#4)(2011-12#3)(2012-1#1)(2012-2#1)(2012-3#1)
of the spleen]##3##3##(1992-10#1)(2008-9#1)(2009-5#1)
of the splenic artery##7##4##(1990-10#1)(1993-10#3)(2006-6#1)(2008-7#1)(2011-2#1)
of the splenic##11##3##(1990-10#1)(1992-10#1)(1993-10#3)(1993-12#2)(2006-6#1)(2008-7#1)(2011-2#1)(2012-2#1)
of the splenocolic##2##3##(1990-3#2)
of the splice acceptor site##2##5##(1990-6#1)(1993-11#1)
of the splice##3##3##(1990-6#1)(1991-12#1)(1993-11#1)
of the spliceosome by##2##4##(2008-2#2)
of the spliceosome##4##3##(1995-6#2)(2008-2#2)
of the splint##4##3##(1991-6#1)(2007-11#1)(2009-3#2)
of the split fovea theory##2##5##(2008-4#2)
of the split##5##3##(1994-3#1)(2007-12#1)(2008-4#2)(2013-8#1)
of the split-step##3##3##(2008-3#3)
of the splitter##2##3##(2008-2#2)
of the spoIIID##2##3##(1995-2#2)
of the spontaneous Brillouin backscattered light##3##6##(2008-3#3)
of the spontaneous##18##3##(1990-3#1)(1991-10#1)(1991-5#1)(1992-3#1)(1992-8#1)(1995-1#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#4)(2008-6#1)(2008-8#1)
of the spontaneous-emission##2##3##(2007-11#1)(2008-1#1)
of the spontaneously hypertensive rat (SHR)##2##6##(1993-2#1)(1994-8#1)
of the spontaneously hypertensive rat##3##5##(1993-2#2)(1994-8#1)
of the spontaneously##6##3##(1991-6#1)(1992-9#2)(1993-2#2)(1994-8#1)
of the sporadic##2##3##(1990-11#1)(2008-7#1)
of the spore##3##3##(2008-10#3)
of the spores were##2##4##(2008-10#2)
of the spores##6##3##(2008-10#5)(2011-2#1)
of the sporocysts##2##3##(1996-12#2)
of the sporophyte##2##3##(2009-6#1)(2013-7#1)
of the spot size##2##4##(2008-10#1)(2008-2#1)
of the spot##5##3##(2006-5#1)(2007-12#1)(2008-10#2)(2008-2#1)
of the spots##3##3##(2006-5#1)(2008-10#1)(2008-3#1)
of the spray##2##3##(1996-3#1)(2008-3#1)
of the spread of##11##4##(1995-8#1)(1996-3#1)(2005-7#1)(2005-8#1)(2006-2#1)(2008-10#2)(2008-8#1)(2010-4#1)(2011-2#1)(2012-11#1)
of the spread##12##3##(1992-2#1)(1995-8#1)(1996-3#1)(2005-7#1)(2005-8#1)(2006-2#1)(2008-10#2)(2008-8#1)(2010-4#1)(2011-2#1)(2012-11#1)
of the spreading of##2##4##(2005-11#1)(2009-10#1)
of the spreading process##2##4##(2005-11#2)
of the spreading##7##3##(1996-5#1)(2005-11#4)(2008-5#1)(2009-10#1)
of the spring##3##3##(1994-3#1)(2008-10#1)(2012-1#1)
of the springs##2##3##(1994-3#1)(2009-7#1)
of the sputum##3##3##(1991-12#1)(2007-3#1)(2008-5#1)
of the squamocolumnar junction##2##4##(1991-2#1)(2006-10#1)
of the squamous##2##3##(1997-5#1)(2012-3#1)
of the square wave##3##4##(2008-10#3)
of the square##6##3##(1997-7#1)(2008-10#4)(2008-3#1)
of the squared##2##3##(2007-12#1)(2008-2#1)
of the squares of the##2##5##(2007-11#1)(2007-5#1)
of the squid##4##3##(1992-9#1)(1994-3#1)(1995-8#2)
of the squirrel monkey (Saimiri sciureus)##2##6##(1991-5#1)(1995-11#1)
of the squirrel##3##3##(1991-5#1)(1995-11#1)(2008-5#1)
of the src family of##3##5##(1991-11#1)(1991-5#1)(1992-9#1)
of the src family##4##4##(1990-12#1)(1991-11#1)(1991-5#1)(1992-9#1)
of the src##5##3##(1990-12#1)(1991-11#1)(1991-5#1)(1992-9#1)(1994-9#1)
of the src-family##2##3##(1990-7#1)(1993-3#1)
of the ssa##2##3##(2006-12#2)
of the stabilities of the##2##5##(1993-11#1)(2007-10#1)
of the stability constant##3##4##(2008-10#3)
of the stability constants for##2##5##(2008-10#2)
of the stability constants of##2##5##(2008-10#2)
of the stability constants##4##4##(2008-10#4)
of the stability of the##5##5##(1992-2#1)(1994-9#1)(2005-11#1)(2008-10#2)
of the stability of##14##4##(1992-2#1)(1994-3#1)(1994-9#1)(1996-4#1)(2005-11#1)(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2011-2#1)
of the stability##28##3##(1992-2#1)(1992-6#1)(1994-3#1)(1994-9#1)(1996-4#1)(2005-11#1)(2006-10#2)(2007-11#1)(2008-10#11)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2011-2#1)
of the stabilization##2##3##(1990-8#1)(1993-3#1)
of the stabilizing##4##3##(1992-6#1)(1997-4#1)(2007-7#1)(2008-5#1)
of the stable##16##3##(1990-3#1)(1991-11#1)(1991-6#2)(1992-7#3)(1995-2#1)(1995-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-12#1)(2012-2#1)
of the stacked##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
of the staff and##2##4##(1996-3#1)(2008-12#1)
of the staff in##2##4##(1996-2#1)(2006-6#1)
of the staff##10##3##(1994-7#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-8#1)(2006-6#1)(2008-11#1)(2008-12#1)(2013-1#1)
of the stage of##5##4##(1991-5#1)(1996-8#1)(2008-7#1)(2011-1#1)(2012-3#1)
of the stage##9##3##(1991-5#1)(1995-2#1)(1996-8#1)(2007-12#1)(2008-2#1)(2008-7#2)(2011-1#1)(2012-3#1)
of the stages##2##3##(2008-3#1)(2013-1#1)
of the staging##2##3##(1990-12#1)(2008-10#1)
of the stain##2##3##(2006-2#1)(2008-9#1)
of the stained##2##3##(2008-3#1)(2008-9#1)
of the staining##2##3##(2008-9#2)
of the stalk##3##3##(1997-3#2)(2008-10#1)
of the standard SVM##2##4##(2008-2#2)
of the standard additions method in flame atomic absorption spectrometry##2##10##(2008-10#2)
of the standard additions method##5##5##(2008-10#5)
of the standard algorithm##2##4##(2008-1#1)(2008-3#1)
of the standard curve was##3##5##(1992-2#1)(2008-10#2)
of the standard curve##5##4##(1992-2#1)(1995-1#1)(2008-10#2)(2010-11#1)
of the standard logrank##2##4##(1997-3#2)
of the standard weight for age##2##6##(2006-2#2)
of the standard##74##3##(1990-11#1)(1990-5#1)(1992-2#2)(1993-4#1)(1993-5#1)(1995-1#1)(1995-6#1)(1995-9#1)(1996-7#1)(1996-8#1)(1997-3#3)(2005-4#1)(2006-10#2)(2006-12#2)(2006-2#2)(2006-9#1)(2007-11#2)(2007-12#3)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-12#1)(2010-1#1)(2010-11#2)(2010-4#1)(2010-7#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
of the standardized##2##3##(2008-10#1)(2008-5#1)
of the standards for##2##4##(1996-3#1)(2007-4#1)
of the standards##6##3##(1994-3#1)(1996-3#1)(2006-5#1)(2007-4#1)(2008-10#1)(2013-1#1)
of the standing##5##3##(1990-6#1)(2004-2#1)(2007-11#1)(2007-12#1)(2008-10#1)
of the staphylokinase##3##3##(1993-12#1)(2012-2#2)
of the star##2##3##(1994-8#1)(2008-2#1)
of the starch granules##2##4##(2006-12#1)(2009-8#1)
of the starch##7##3##(1991-12#1)(2006-11#1)(2006-12#1)(2007-11#1)(2008-8#1)(2009-8#1)(2010-4#1)
of the start of##3##4##(1992-9#1)(2008-3#1)(2008-9#1)
of the start##6##3##(1992-9#1)(1996-10#1)(1997-5#1)(2005-11#1)(2008-3#1)(2008-9#1)
of the starting material##3##4##(1990-12#1)(1997-2#1)(2008-5#1)
of the starting materials##3##4##(2004-9#1)(2007-11#1)(2008-1#1)
of the starting##15##3##(1990-12#1)(1991-5#1)(1997-2#1)(1997-3#1)(2004-9#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-7#1)(2010-7#1)
of the startle response to##2##5##(2008-11#1)(2008-4#1)
of the startle response##3##4##(2008-11#1)(2008-4#2)
of the startle##5##3##(2008-11#2)(2008-4#3)
of the state in##2##4##(1991-11#1)(2012-2#1)
of the state near 577##3##5##(2008-2#3)
of the state of polarization##4##5##(2007-12#2)(2008-2#1)(2008-3#1)
of the state of the##6##5##(1990-8#1)(1991-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-7#1)
of the state of##19##4##(1990-8#1)(1991-11#1)(1991-2#1)(1992-5#1)(1993-2#1)(2006-10#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#1)
of the state##37##3##(1990-12#1)(1990-8#1)(1991-11#2)(1991-2#1)(1992-5#1)(1993-2#1)(1996-1#1)(2006-10#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-2#8)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
of the state's##5##3##(1991-8#1)(1992-8#1)(2007-9#1)(2012-12#1)(2012-3#1)
of the states of##3##4##(1991-12#1)(2008-2#1)(2008-3#1)
of the static contact angle##2##5##(2005-11#2)
of the static##7##3##(1993-9#1)(2005-11#2)(2008-2#1)(2008-6#1)(2010-5#1)(2013-8#1)
of the statins##2##3##(2006-5#2)
of the stationary phase and##4##5##(1996-8#1)(1997-3#1)(2008-10#1)(2008-7#1)
of the stationary phase##14##4##(1991-3#1)(1992-2#1)(1996-8#1)(1997-3#1)(2008-10#6)(2008-7#2)(2011-2#1)(2012-12#1)
of the stationary##16##3##(1991-3#1)(1992-2#1)(1996-8#1)(1997-3#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-7#2)(2011-2#1)(2012-12#1)
of the statistic##4##3##(1992-6#1)(2008-10#2)(2013-8#1)
of the statistical analysis##3##4##(2008-8#1)(2009-2#1)(2013-8#1)
of the statistical characteristics##2##4##(2008-2#1)(2010-3#1)
of the statistical properties of##2##5##(2007-11#1)(2008-2#1)
of the statistical##18##3##(1993-3#1)(1996-2#1)(1997-7#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-2#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2010-3#1)(2012-3#1)(2013-8#1)
of the statistically##2##3##(2007-12#1)(2008-8#1)
of the status of the##5##5##(1994-2#1)(1995-3#1)(2007-10#1)(2007-7#1)(2009-12#1)
of the status of##15##4##(1994-2#1)(1995-3#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)(2010-12#2)(2012-2#1)(2013-1#1)
of the status##18##3##(1992-6#1)(1994-2#1)(1995-3#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-7#1)(2010-12#2)(2012-2#1)(2013-1#2)
of the statute##2##3##(1993-1#1)(1993-2#1)
of the statutory##3##3##(1992-12#1)(1992-5#1)(2008-10#1)
of the stay##2##3##(1992-12#2)
of the steady state##6##4##(1994-3#2)(1996-5#1)(1997-6#1)(2007-10#1)(2008-7#1)
of the steady##8##3##(1994-3#3)(1996-5#1)(1997-6#1)(2006-12#1)(2007-10#1)(2008-7#1)
of the steady-state##13##3##(1990-8#1)(1991-9#1)(1992-5#1)(1993-6#1)(1994-8#1)(1997-1#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-3#2)(2008-7#1)
of the steering wheel##2##4##(2006-11#2)
of the steering##3##3##(1997-3#1)(2006-11#2)
of the stellate##3##3##(1995-5#1)(2008-11#1)(2009-2#1)
of the stem bark of##2##5##(2010-12#2)
of the stem bark##3##4##(2010-12#2)(2010-2#1)
of the stem cell niche##3##5##(2007-10#1)(2012-12#1)(2012-2#1)
of the stem cell population##2##5##(2008-11#1)(2008-4#1)
of the stem cell proteome##2##5##(2008-1#2)
of the stem cell##10##4##(1992-12#1)(1994-11#1)(2007-10#1)(2008-1#2)(2008-11#1)(2008-4#1)(2009-4#1)(2012-12#1)(2012-2#1)
of the stem cells##2##4##(2006-8#1)(2008-11#1)
of the stem to##2##4##(2008-10#2)
of the stem##30##3##(1990-4#1)(1992-12#1)(1992-3#2)(1994-11#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-4#1)(2008-5#1)(2009-4#2)(2009-6#2)(2010-12#2)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
of the stems##2##3##(2008-11#1)(2008-3#1)
of the stenoses##2##3##(2006-11#1)(2008-7#1)
of the stenosis and the##2##5##(1992-1#1)(2008-8#1)
of the stenosis##7##3##(1992-1#1)(2007-5#1)(2007-8#2)(2008-8#1)(2013-1#2)
of the stenotic segment was##2##5##(2008-3#1)(2008-5#1)
of the stenotic segment##3##4##(2008-3#1)(2008-5#2)
of the stenotic##4##3##(2006-7#1)(2008-3#1)(2008-5#2)
of the stent##8##3##(1994-11#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-12#2)(2013-1#1)
of the step-by-step##2##3##(2005-2#1)(2006-2#1)
of the stepping##2##3##(1995-5#1)(2013-1#1)
of the steps in the##3##5##(1992-8#1)(1996-1#1)(2008-1#1)
of the steps in##4##4##(1992-8#1)(1996-1#1)(2007-4#1)(2008-1#1)
of the steps involved##2##4##(2008-11#1)(2009-8#1)
of the steps taken##2##4##(2007-2#1)(2008-9#1)
of the steps##13##3##(1992-8#1)(1993-2#1)(1995-9#1)(1996-1#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-2#1)(2011-1#1)
of the stereo##2##3##(1991-1#1)(2008-2#1)
of the stereochemical##2##3##(1991-5#1)(1994-8#1)
of the stereochemistry##2##3##(1990-8#1)(1992-6#1)
of the stereoisomeric##3##3##(1990-6#1)(1996-7#1)(2008-5#1)
of the steric##3##3##(1991-5#1)(2010-5#1)(2013-7#1)
of the sternoclavicular joint##4##4##(2007-4#1)(2009-3#3)
of the sternocleidomastoid##4##3##(2006-12#1)(2007-1#3)
of the sternum (pectus##2##4##(2012-2#2)
of the sternum and##2##4##(2007-1#1)(2007-8#1)
of the sternum##8##3##(2007-1#1)(2007-8#4)(2008-4#1)(2012-2#2)
of the sternum?##2##3##(2007-8#2)
of the steroid and##2##4##(1995-8#1)(2010-2#1)
of the steroid binding##2##4##(1990-12#1)(1991-12#1)
of the steroid hormone receptor superfamily##3##6##(1992-2#1)(1995-2#1)(1995-6#1)
of the steroid hormone##4##4##(1992-2#1)(1994-5#1)(1995-2#1)(1995-6#1)
of the steroid nucleus##2##4##(1994-8#1)(2006-12#1)
of the steroid receptor##2##4##(1993-9#1)(1996-5#1)
of the steroid##24##3##(1990-11#2)(1990-12#1)(1991-12#1)(1992-2#1)(1993-9#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-5#1)(2006-12#1)(2006-4#1)(2008-10#1)(2008-11#3)(2008-4#1)(2010-2#1)
of the steroidogenic##3##3##(1995-3#1)(2006-9#1)(2010-10#1)
of the steroids tested##2##4##(1990-11#1)(1994-9#1)
of the steroids##3##3##(1990-11#1)(1994-9#1)(2006-8#1)
of the sterol##3##3##(1990-11#1)(1991-10#1)(1997-7#1)
of the sterols##2##3##(1997-2#2)
of the stethoscopes##2##3##(1996-12#1)(2009-6#1)
of the stick insect##2##4##(2007-12#2)
of the stifle but##2##4##(2005-7#2)
of the stifle##7##3##(2005-7#7)
of the stigma and##2##4##(2008-10#1)(2010-8#1)
of the stigma##4##3##(2007-12#1)(2008-10#2)(2010-8#1)
of the stimulant##3##3##(1992-3#1)(1993-3#1)(2008-7#1)
of the stimulated Raman gain##2##5##(2007-11#2)
of the stimulated Raman##3##4##(2006-12#1)(2007-11#2)
of the stimulated##9##3##(1990-5#1)(1991-8#1)(1992-9#1)(1997-4#1)(1997-6#1)(2006-12#1)(2007-11#2)(2008-2#1)
of the stimulated-emission cross section in an end-pumped solid-state laser##2##10##(2007-11#2)
of the stimulated-emission##3##3##(1992-9#1)(2007-11#2)
of the stimulating##3##3##(1990-7#1)(2008-9#2)
of the stimulation##10##3##(1994-9#1)(1996-12#1)(2006-9#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-3#1)(2012-1#1)(2012-3#1)
of the stimulatory G protein##2##5##(1994-6#2)
of the stimulatory effect##2##4##(1990-12#1)(1993-3#1)
of the stimulatory##6##3##(1990-12#1)(1992-7#1)(1993-3#1)(1994-2#1)(1994-6#2)
of the stimuli and##2##4##(2008-9#1)(2009-10#1)
of the stimuli##14##3##(1992-11#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-8#1)(2008-4#2)(2008-9#2)(2009-10#1)(2009-2#1)(2011-2#1)(2013-8#1)
of the stimulus##20##3##(1991-2#1)(1991-3#1)(1991-9#1)(1992-4#2)(1992-6#1)(1993-12#1)(1994-6#1)(1995-3#1)(1996-11#1)(1996-2#1)(1997-5#1)(1997-8#2)(2007-12#1)(2007-9#2)(2008-11#1)(2009-9#1)(2013-1#1)
of the stir bar##2##4##(2008-10#2)
of the stochastic circulatory models##2##5##(2007-9#2)
of the stock##3##3##(2007-5#2)(2008-5#1)
of the stoichiometric##3##3##(2008-10#2)(2008-5#1)
of the stoichiometry of the##2##5##(2006-10#1)(2008-10#1)
of the stoichiometry of##3##4##(1995-6#1)(2006-10#1)(2008-10#1)
of the stoma##4##3##(2006-5#4)
of the stomach and duodenum##5##5##(2006-10#5)
of the stomach and##8##4##(1991-9#1)(2006-10#5)(2008-7#2)
of the stomach contents##2##4##(1992-12#1)(2007-3#1)
of the stomach during##2##4##(1990-9#1)(2009-8#1)
of the stomach in the##2##5##(1994-4#1)(2008-7#1)
of the stomach in##6##4##(1993-10#1)(1993-9#1)(1994-4#1)(2006-10#1)(2008-7#1)(2009-2#1)
of the stomach represent a##2##5##(1995-11#1)(2006-10#1)
of the stomach with##7##4##(1991-8#1)(1992-6#1)(2007-3#1)(2007-8#1)(2008-1#1)(2012-1#1)(2012-12#1)
of the stomach##95##3##(1990-8#1)(1990-9#1)(1991-2#2)(1991-5#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-10#1)(1993-4#2)(1993-7#1)(1993-9#2)(1994-4#1)(1995-11#1)(1997-1#2)(2005-12#1)(2005-8#2)(2006-10#13)(2006-2#3)(2007-2#2)(2007-3#2)(2007-5#1)(2007-8#3)(2008-1#1)(2008-12#2)(2008-5#4)(2008-7#12)(2008-8#3)(2008-9#2)(2009-2#2)(2009-3#3)(2009-5#1)(2009-8#1)(2010-1#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
of the stomach]##6##3##(1990-6#1)(1991-11#1)(1992-3#2)(2009-2#1)(2012-11#1)
of the stone##2##3##(1993-10#1)(2011-2#1)
of the stones##4##3##(2006-9#1)(2009-6#1)(2011-2#1)(2013-7#1)
of the stool##2##3##(2010-4#1)(2011-2#1)
of the stop band##2##4##(2007-12#1)(2008-2#1)
of the stop##8##3##(1993-11#1)(1994-12#1)(1996-7#3)(2007-12#1)(2008-2#1)(2008-3#1)
of the storage ring##2##4##(2006-5#2)
of the storage##9##3##(1990-4#1)(2006-5#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-9#1)(2012-2#1)
of the stored##5##3##(2006-5#2)(2008-1#1)(2008-2#1)(2011-2#1)
of the story##5##3##(1993-12#1)(1997-3#1)(2007-4#1)(2007-8#1)(2013-8#1)
of the storytelling##2##3##(2007-8#1)(2008-12#1)
of the straight line##3##4##(2008-10#2)(2008-3#1)
of the straight##6##3##(1996-6#1)(2008-10#3)(2008-3#1)(2009-6#1)
of the strain##19##3##(1993-11#1)(1996-4#1)(1996-9#1)(2005-11#1)(2006-4#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#3)(2008-8#2)(2011-2#1)(2012-12#1)(2013-1#1)
of the strains are##2##4##(2008-10#1)(2008-7#1)
of the strains produced##2##4##(2008-10#2)
of the strains that##2##4##(2008-10#2)
of the strains were resistant to##2##6##(2006-8#1)(2008-12#1)
of the strains were##11##4##(2006-10#1)(2006-8#2)(2008-10#3)(2008-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
of the strains##53##3##(1991-3#1)(1996-12#1)(1997-4#1)(1997-5#1)(1997-9#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-8#4)(2007-12#1)(2007-6#1)(2007-7#2)(2008-10#19)(2008-11#1)(2008-12#1)(2008-5#5)(2008-7#2)(2009-6#1)(2010-4#2)(2010-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
of the strategic plan##3##4##(1992-3#3)
of the strategic##7##3##(1992-3#3)(1994-2#1)(1997-1#1)(2007-7#1)(2008-4#1)
of the strategies used##2##4##(2008-5#1)(2010-11#1)
of the strategies##8##3##(1991-12#1)(1992-1#1)(1997-7#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-5#1)(2010-11#1)
of the strategy##10##3##(1990-2#1)(1992-1#1)(1992-5#1)(1992-6#1)(1996-1#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-3#1)
of the stratified##3##3##(1995-8#1)(1996-8#1)(2010-7#1)
of the stratospheric aerosol layer##2##5##(2008-2#2)
of the stratospheric aerosol##3##4##(2008-2#3)
of the stratum corneum (SC)##3##5##(2008-10#1)(2008-5#2)
of the stratum corneum cell matrix postulates##2##7##(2008-5#2)
of the stratum corneum intercellular##2##5##(1991-9#1)(2008-5#1)
of the stratum corneum is##2##5##(2007-7#2)
of the stratum corneum lipids##4##5##(2008-5#4)
of the stratum corneum of##3##5##(2008-5#3)
of the stratum corneum##46##4##(1991-9#1)(2007-7#2)(2008-10#1)(2008-5#41)(2010-8#1)
of the stratum##51##3##(1990-7#1)(1991-9#1)(1995-3#1)(1997-1#2)(1997-5#1)(2007-7#2)(2008-10#1)(2008-5#41)(2010-8#1)
of the straw pretreated by CTSR with##2##7##(2013-1#2)
of the strawberry##2##3##(2008-10#2)
of the streak camera##2##4##(2007-12#1)(2008-1#1)
of the stream##3##3##(1995-3#1)(2008-1#1)(2009-8#1)
of the streams##5##3##(2004-4#2)(2008-10#3)
of the strength and##2##4##(2007-12#1)(2007-7#1)
of the strength of##6##4##(1994-4#1)(2005-10#1)(2007-8#1)(2008-7#1)(2008-8#1)(2010-4#1)
of the strength##9##3##(1994-4#1)(2005-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-7#1)(2008-8#1)(2010-4#1)(2013-1#1)
of the strengths and limitations of##3##6##(2005-10#1)(2006-10#1)(2008-7#1)
of the strengths and weaknesses of##2##6##(2008-4#1)(2012-1#1)
of the strengths and##5##4##(2005-10#1)(2006-10#1)(2008-4#1)(2008-7#1)(2012-1#1)
of the strengths of##3##4##(2006-10#1)(2006-8#1)(2013-1#1)
of the strengths##9##3##(1991-1#1)(2005-10#1)(2006-10#2)(2006-8#1)(2008-4#1)(2008-7#1)(2012-1#1)(2013-1#1)
of the streptavidin##4##3##(1991-4#2)(2008-7#1)(2009-12#1)
of the streptavidin-biotin system##2##4##(1991-10#1)(1991-4#1)
of the stress and##3##4##(1992-1#1)(1995-1#1)(2013-7#1)
of the stress axis##2##4##(1995-12#2)
of the stress reaction##2##4##(2008-5#2)
of the stress response##8##4##(1995-12#4)(2007-9#1)(2008-11#1)(2012-12#2)
of the stress system##4##4##(1995-12#2)(2012-3#2)
of the stress##42##3##(1992-1#4)(1993-2#1)(1994-2#1)(1995-1#1)(1995-12#8)(1996-4#1)(2004-9#1)(2007-11#1)(2007-9#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#1)(2009-10#1)(2009-7#1)(2010-11#1)(2012-12#4)(2012-3#3)(2013-7#2)
of the stress-induced##3##3##(1994-2#2)(2009-10#1)
of the stress-related##2##3##(2009-8#1)(2012-1#1)
of the stress-responsive##2##3##(1996-2#1)(2009-10#1)
of the stressful##2##3##(2008-11#1)(2012-3#1)
of the stressor##5##3##(2006-8#1)(2008-11#2)(2008-4#1)(2010-8#1)
of the stressosome##2##3##(2009-8#2)
of the stretch##2##3##(1993-9#1)(2008-8#1)
of the striatum and##3##4##(1997-2#1)(1997-3#2)
of the striatum##12##3##(1990-2#1)(1991-6#1)(1991-9#1)(1992-8#1)(1995-11#1)(1996-10#1)(1997-2#1)(1997-3#3)(1997-8#1)(2013-8#1)
of the striking##3##3##(1995-1#1)(2006-10#1)(2008-12#1)
of the stringent##3##3##(1994-5#1)(2007-12#1)(2008-10#1)
of the stripe##2##3##(1991-11#1)(2009-7#1)
of the stroke##8##3##(1995-5#1)(2007-10#3)(2007-9#2)(2010-12#1)(2011-1#1)
of the stromal##3##3##(1990-5#1)(2007-11#1)(2011-1#1)
of the stromata##2##3##(2008-10#1)(2011-1#1)
of the strong##18##3##(1991-4#1)(1992-8#1)(1993-3#1)(1995-10#1)(1995-8#1)(1996-7#1)(2006-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2011-1#1)(2011-12#1)(2012-1#1)(2013-1#1)(2013-7#1)
of the strongly##4##3##(1993-11#1)(2008-10#1)(2008-3#1)(2009-5#1)
of the structural and functional##3##5##(1994-8#1)(2008-6#1)(2008-8#1)
of the structural and##4##4##(1993-6#1)(1994-8#1)(2008-6#1)(2008-8#1)
of the structural basis##2##4##(1992-11#1)(2008-4#1)
of the structural gene##4##4##(1990-3#2)(1991-12#1)(1992-4#1)
of the structural##43##3##(1990-3#3)(1991-12#2)(1991-6#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-6#1)(1994-3#1)(1994-8#1)(1994-9#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-4#2)(2005-11#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#4)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#2)(2009-12#1)(2009-5#1)(2011-1#2)(2012-3#1)
of the structurally related##2##4##(1993-11#1)(2008-10#1)
of the structurally##7##3##(1993-11#1)(1993-2#1)(1995-1#1)(1995-3#1)(2008-10#1)(2009-7#1)(2010-4#1)
of the structure and function of the##3##7##(1994-9#1)(2005-10#1)(2012-2#1)
of the structure and function of##5##6##(1994-9#1)(2005-10#1)(2008-4#1)(2008-9#1)(2012-2#1)
of the structure and##15##4##(1991-5#1)(1992-12#2)(1994-9#1)(1997-6#1)(2003-11#1)(2005-10#1)(2006-4#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#1)(2012-2#1)(2013-1#1)
of the structure are##2##4##(2007-11#1)(2011-1#1)
of the structure is##5##4##(1996-2#1)(2007-11#1)(2007-12#1)(2008-3#1)(2010-2#1)
of the structure of a##4##5##(1992-9#1)(1995-11#1)(1995-8#1)(1997-3#1)
of the structure of the##20##5##(1990-12#1)(1991-5#1)(1992-12#1)(1992-9#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-4#1)(1997-1#1)(2005-1#1)(2007-3#1)(2008-6#1)(2010-4#1)(2010-8#1)(2012-11#1)(2013-1#1)
of the structure of##41##4##(1990-1#1)(1990-12#1)(1990-9#1)(1991-5#2)(1991-6#1)(1992-12#3)(1992-9#2)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-3#1)(2005-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-12#1)(2008-4#2)(2008-6#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-11#1)(2013-1#2)
of the structure##95##3##(1990-1#1)(1990-11#1)(1990-12#1)(1990-7#1)(1990-9#1)(1991-4#1)(1991-5#3)(1991-6#2)(1992-12#5)(1992-4#1)(1992-7#1)(1992-9#2)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-4#1)(1997-1#1)(1997-3#2)(1997-6#1)(2003-11#1)(2005-1#1)(2005-10#1)(2006-4#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#3)
of the structure-activity relationships##3##4##(1991-3#1)(2008-11#1)(2008-4#1)
of the structure-activity##4##3##(1991-3#1)(1994-11#1)(2008-11#1)(2008-4#1)
of the structured##2##3##(2008-11#1)(2008-7#1)
of the structures and##3##4##(1997-1#1)(2005-5#1)(2007-5#1)
of the structures of the##3##5##(2007-6#1)(2008-4#1)(2013-1#1)
of the structures of##6##4##(1992-8#1)(2006-12#1)(2007-6#1)(2008-4#1)(2008-9#1)(2013-1#1)
of the structures that##2##4##(2006-10#1)(2010-12#1)
of the structures##20##3##(1990-5#1)(1992-8#1)(1994-3#1)(1997-1#1)(2005-5#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-12#2)(2013-1#1)
of the struts##3##3##(2007-9#1)(2008-5#2)
of the student##6##3##(1995-4#1)(2008-11#3)(2008-12#1)(2011-2#1)
of the student's##2##3##(2009-7#1)(2011-2#1)
of the students and##4##4##(1994-6#1)(2008-11#1)(2013-8#2)
of the students had##5##4##(1992-5#1)(1992-6#1)(2008-11#1)(2013-1#1)(2013-8#1)
of the students reported##2##4##(1991-9#1)(2013-8#1)
of the students would##2##4##(1993-3#2)
of the students##40##3##(1991-9#1)(1992-5#1)(1992-6#4)(1993-3#4)(1994-6#2)(2005-7#1)(2007-10#1)(2007-12#1)(2008-11#3)(2008-7#1)(2009-5#1)(2011-1#3)(2011-2#3)(2012-1#3)(2012-2#1)(2013-1#2)(2013-8#8)
of the students' perceptions##2##4##(2009-7#1)(2012-3#1)
of the students'##4##3##(2007-12#1)(2008-11#1)(2009-7#1)(2012-3#1)
of the studied cases##3##4##(1993-2#1)(2008-11#1)(2011-2#1)
of the studied drug##2##4##(2008-10#2)
of the studied drugs##4##4##(2008-10#4)
of the studied dyes##2##4##(2008-10#2)
of the studied films##2##4##(2007-12#1)(2008-3#1)
of the studied patients##2##4##(1990-6#1)(2013-1#1)
of the studied population was##2##5##(2007-7#1)(2008-3#1)
of the studied proteins##2##4##(2008-4#1)(2013-8#1)
of the studied species##2##4##(2009-2#1)(2012-2#1)
of the studied##55##3##(1990-6#1)(1993-2#1)(1994-2#1)(1996-5#1)(1997-2#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#21)(2008-11#1)(2008-12#2)(2008-3#4)(2008-4#2)(2008-5#2)(2009-2#2)(2009-3#1)(2010-12#2)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
of the studies and##5##4##(1992-8#1)(1993-8#1)(1995-3#1)(2012-2#1)(2013-1#1)
of the studies are##3##4##(2006-2#1)(2008-12#1)(2011-2#1)
of the studies conducted##2##4##(1995-1#1)(2013-7#1)
of the studies have##3##4##(2007-1#1)(2008-3#1)(2012-3#1)
of the studies is##2##4##(2011-1#1)(2011-2#1)
of the studies of##3##4##(1995-2#1)(2006-10#1)(2007-12#1)
of the studies presented##3##4##(2008-12#1)(2008-3#1)(2011-2#1)
of the studies were##2##4##(2008-11#1)(2008-8#1)
of the studies##63##3##(1990-6#1)(1992-11#2)(1992-3#2)(1992-8#1)(1993-8#2)(1994-2#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-9#3)(1997-1#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-12#1)(2007-2#2)(2008-11#4)(2008-12#2)(2008-3#4)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2011-1#1)(2011-12#1)(2011-2#8)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
of the study and the##2##5##(2007-8#1)(2008-9#1)
of the study and##14##4##(1992-5#1)(1995-2#1)(2007-5#1)(2007-8#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-11#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
of the study are##4##4##(2007-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
of the study area##2##4##(2008-12#2)
of the study by##2##4##(2007-1#1)(2008-10#1)
of the study clearly indicate##2##5##(1994-6#1)(2008-11#1)
of the study clearly##3##4##(1994-6#1)(2006-1#1)(2008-11#1)
of the study described##2##4##(1991-2#1)(2012-1#1)
of the study duration##2##4##(2008-5#1)(2012-3#1)
of the study for##2##4##(2008-10#1)(2008-7#1)
of the study group##5##4##(2008-1#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
of the study in##7##4##(1990-9#1)(1995-1#1)(2006-6#1)(2008-5#1)(2010-11#1)(2010-9#1)(2011-2#1)
of the study included##3##4##(1992-2#1)(2006-10#1)(2010-12#1)
of the study indicate that the##2##6##(2008-12#1)(2010-2#1)
of the study indicate that##5##5##(1991-10#1)(1996-1#1)(2007-7#1)(2008-12#1)(2010-2#1)
of the study indicated that##2##5##(2007-10#1)(2008-1#1)
of the study is that##3##5##(2008-3#1)(2008-8#1)(2013-8#1)
of the study is to establish##2##6##(2007-10#1)(2013-1#1)
of the study is to evaluate the risk of##2##9##(2007-11#1)(2011-2#1)
of the study is to evaluate the##4##7##(2006-6#1)(2007-11#1)(2011-2#2)
of the study is to evaluate##5##6##(2006-11#1)(2006-6#1)(2007-11#1)(2011-2#2)
of the study is to examine##2##6##(2010-9#1)(2011-1#1)
of the study is to present##2##6##(1997-3#1)(2007-8#1)
of the study is to##24##5##(1993-3#1)(1997-3#1)(2006-11#1)(2006-6#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2010-1#1)(2010-9#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#2)(2012-3#3)(2013-1#3)
of the study is##34##4##(1993-3#1)(1997-3#1)(2006-11#1)(2006-6#2)(2007-10#1)(2007-11#3)(2007-8#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-2#1)(2010-1#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2011-3#2)(2012-12#2)(2012-3#3)(2013-1#3)(2013-8#1)
of the study of##9##4##(1991-5#1)(1995-4#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#2)(2010-2#1)(2011-1#1)
of the study participants##4##4##(2007-11#1)(2008-12#1)(2010-7#1)(2013-1#1)
of the study patients was##5##5##(2007-7#3)(2008-1#2)
of the study patients were##3##5##(2007-7#1)(2008-1#2)
of the study patients##14##4##(2007-7#4)(2008-1#9)(2013-1#1)
of the study period##8##4##(2006-8#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-3#2)
of the study population was##2##5##(2006-12#1)(2008-1#1)
of the study population were##2##5##(2008-5#1)(2011-2#1)
of the study population##9##4##(1993-12#1)(2006-12#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-3#1)(2011-2#1)
of the study results##2##4##(1992-12#1)(2007-8#1)
of the study revealed##2##4##(2007-2#1)(2007-7#1)
of the study sample##2##4##(2009-7#1)(2013-1#1)
of the study showed a##3##5##(1996-2#1)(2010-4#1)(2012-2#1)
of the study showed that there was a##2##8##(2007-10#1)(2011-1#1)
of the study showed that##10##5##(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
of the study showed##15##4##(1996-2#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
of the study subjects and the##2##6##(1990-8#1)(2011-2#1)
of the study subjects with##2##5##(1994-2#1)(2013-1#1)
of the study subjects##5##4##(1990-8#1)(1994-2#1)(2008-1#1)(2011-2#1)(2013-1#1)
of the study suggests##2##4##(2007-7#1)(2010-8#1)
of the study to##3##4##(2005-8#1)(2006-10#1)(2008-10#1)
of the study was the assessment of the##2##8##(2007-11#1)(2012-2#1)
of the study was the assessment of##3##7##(2007-11#2)(2012-2#1)
of the study was the##10##5##(1994-7#1)(2006-6#1)(2007-11#3)(2007-8#1)(2008-12#1)(2008-5#1)(2012-12#1)(2012-2#1)
of the study was to analyse the##4##7##(2008-5#1)(2011-1#1)(2011-12#1)(2013-1#1)
of the study was to analyse##6##6##(2008-5#1)(2011-1#2)(2011-12#1)(2012-3#1)(2013-1#1)
of the study was to analyze##5##6##(1997-8#1)(2007-8#2)(2008-12#1)(2012-3#1)
of the study was to asses the##2##7##(2007-9#1)(2008-7#1)
of the study was to assess the##12##7##(2005-1#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
of the study was to assess##17##6##(1990-8#1)(1995-6#1)(2005-1#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
of the study was to characterize##2##6##(2008-5#1)(2011-2#1)
of the study was to compare the efficacy of##2##9##(2011-12#1)(2013-1#1)
of the study was to compare the results obtained##2##9##(2007-7#1)(2013-1#1)
of the study was to compare the##10##7##(1994-3#1)(1997-8#1)(2007-7#1)(2008-3#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#3)
of the study was to compare##15##6##(1990-2#1)(1994-3#1)(1997-8#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-12#1)(2011-2#1)(2012-12#2)(2013-1#4)
of the study was to describe the##3##7##(2008-11#1)(2008-4#1)(2010-10#1)
of the study was to describe##5##6##(1996-9#1)(2008-11#1)(2008-4#1)(2010-10#1)(2013-1#1)
of the study was to determine if##3##7##(2009-2#1)(2010-4#1)(2012-12#1)
of the study was to determine the changes in##2##9##(2011-1#1)(2012-2#1)
of the study was to determine the##14##7##(2004-12#1)(2006-2#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-4#2)(2008-7#1)(2010-8#1)(2011-1#1)(2012-2#2)(2013-8#1)
of the study was to determine whether##2##7##(1990-8#1)(2008-5#1)
of the study was to determine##22##6##(1990-8#1)(1994-12#1)(2004-12#1)(2006-2#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
of the study was to establish##4##6##(2007-10#1)(2007-11#1)(2007-5#1)(2010-4#1)
of the study was to evaluate a##2##7##(2008-7#1)(2012-2#1)
of the study was to evaluate the##17##7##(1990-10#1)(1997-3#1)(2006-8#1)(2007-11#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#2)(2011-12#1)(2012-1#1)(2013-1#1)
of the study was to evaluate##34##6##(1990-10#1)(1996-9#1)(1997-3#1)(2006-6#1)(2006-7#2)(2006-8#2)(2007-11#2)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-10#2)(2010-11#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
of the study was to examine the##5##7##(2007-10#1)(2007-12#1)(2008-11#2)(2011-2#1)
of the study was to examine##8##6##(2005-10#1)(2007-10#1)(2007-12#1)(2008-11#2)(2009-5#1)(2011-2#1)(2013-7#1)
of the study was to explore##4##6##(1996-3#1)(2007-7#1)(2008-1#1)(2012-1#1)
of the study was to find out##3##7##(1990-2#1)(2006-8#1)(2007-8#1)
of the study was to identify the##6##7##(1996-12#1)(2007-8#1)(2008-6#1)(2009-7#1)(2010-1#1)(2011-2#1)
of the study was to identify##9##6##(1996-12#1)(2004-10#1)(2007-8#1)(2007-9#1)(2008-6#1)(2009-7#1)(2010-1#1)(2011-2#1)(2013-1#1)
of the study was to investigate the##10##7##(1991-10#1)(1994-6#1)(2007-2#1)(2007-8#1)(2008-5#1)(2009-6#1)(2010-1#1)(2010-12#2)(2010-3#1)
of the study was to investigate##16##6##(1991-10#1)(1994-6#1)(1995-1#1)(2005-10#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-5#2)(2008-9#1)(2009-6#1)(2010-1#1)(2010-12#2)(2010-3#1)
of the study was to verify##2##6##(2007-3#1)(2008-5#1)
of the study was to##186##5##(1990-10#1)(1990-2#2)(1990-8#2)(1991-10#1)(1991-12#1)(1991-5#1)(1992-3#1)(1993-1#1)(1993-2#2)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#3)(1997-3#1)(1997-8#3)(2004-10#2)(2004-12#1)(2005-1#1)(2005-10#2)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#5)(2007-1#2)(2007-10#4)(2007-11#4)(2007-12#2)(2007-2#3)(2007-3#1)(2007-5#1)(2007-7#7)(2007-8#11)(2007-9#4)(2008-1#2)(2008-11#5)(2008-12#4)(2008-3#1)(2008-4#5)(2008-5#8)(2008-6#2)(2008-7#6)(2008-9#3)(2009-2#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#6)(2011-12#4)(2011-2#8)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#11)(2013-7#1)(2013-8#4)
of the study was##210##4##(1990-10#1)(1990-2#2)(1990-8#2)(1991-10#1)(1991-12#1)(1991-5#1)(1992-3#1)(1993-1#1)(1993-2#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#3)(1997-3#1)(1997-8#3)(2004-10#2)(2004-12#1)(2005-1#1)(2005-10#2)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#2)(2006-7#4)(2006-8#5)(2007-1#2)(2007-10#4)(2007-11#9)(2007-12#2)(2007-2#4)(2007-3#1)(2007-5#1)(2007-7#7)(2007-8#12)(2007-9#4)(2008-1#2)(2008-11#5)(2008-12#5)(2008-3#2)(2008-4#5)(2008-5#9)(2008-6#2)(2008-7#7)(2008-9#3)(2009-2#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#8)(2011-12#4)(2011-2#11)(2012-1#2)(2012-12#5)(2012-2#6)(2012-3#3)(2013-1#11)(2013-7#1)(2013-8#4)
of the study were as follows##2##6##(1990-10#1)(2007-9#1)
of the study were to assess the##2##7##(1991-5#1)(2012-2#1)
of the study were to assess##3##6##(1991-5#1)(1994-6#1)(2012-2#1)
of the study were to determine##2##6##(2007-2#1)(2008-8#1)
of the study were to##10##5##(1991-5#1)(1994-6#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-8#1)(2012-2#2)(2012-3#1)(2013-8#1)
of the study were##27##4##(1990-10#2)(1991-1#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-9#1)(1994-6#1)(1995-9#1)(2007-10#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#2)(2010-1#1)(2011-1#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
of the study##610##3##(1990-10#3)(1990-2#3)(1990-5#1)(1990-8#3)(1990-9#3)(1991-1#1)(1991-10#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#4)(1991-7#1)(1991-8#1)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#3)(1993-1#4)(1993-12#2)(1993-2#2)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#3)(1994-7#2)(1995-1#2)(1995-10#1)(1995-2#4)(1995-3#2)(1995-4#1)(1995-6#1)(1995-9#1)(1996-1#4)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-9#3)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#4)(2004-10#3)(2004-12#1)(2004-3#2)(2005-1#1)(2005-10#3)(2005-5#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#6)(2006-11#2)(2006-12#2)(2006-2#3)(2006-5#3)(2006-6#7)(2006-7#4)(2006-8#11)(2007-1#3)(2007-10#15)(2007-11#14)(2007-12#5)(2007-2#10)(2007-3#8)(2007-4#3)(2007-5#2)(2007-7#24)(2007-8#19)(2007-9#7)(2008-1#19)(2008-10#21)(2008-11#14)(2008-12#12)(2008-2#1)(2008-3#5)(2008-4#9)(2008-5#23)(2008-6#6)(2008-7#22)(2008-8#4)(2008-9#32)(2009-11#1)(2009-2#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#2)(2010-1#5)(2010-10#3)(2010-11#3)(2010-12#3)(2010-2#3)(2010-3#4)(2010-4#4)(2010-7#1)(2010-8#5)(2010-9#3)(2011-1#19)(2011-12#4)(2011-2#30)(2011-3#2)(2012-1#5)(2012-12#11)(2012-2#16)(2012-3#12)(2013-1#24)(2013-7#1)(2013-8#11)
of the study's##3##3##(1995-1#1)(2007-12#1)(2012-3#1)
of the study)##3##3##(1993-7#1)(2006-10#1)(2013-1#1)
of the stump and##2##4##(1991-6#1)(2007-11#1)
of the stump##5##3##(1991-6#1)(2007-11#2)(2007-7#1)(2011-2#1)
of the style##4##3##(2008-10#1)(2009-12#3)
of the subarachnoid space##2##4##(2006-5#1)(2008-7#1)
of the subarachnoid##5##3##(2006-12#1)(2006-5#2)(2008-7#2)
of the subcellular localization of##3##5##(1993-9#1)(1995-7#1)(2007-12#1)
of the subcellular##4##3##(1993-9#1)(1995-7#1)(2007-12#1)(2008-4#1)
of the subchondral bone##4##4##(2007-11#3)(2008-5#1)
of the subchondral##5##3##(2007-11#3)(2008-5#1)(2011-2#1)
of the subclavian artery##4##4##(1993-3#1)(2007-11#1)(2008-7#2)
of the subclavian vein##2##4##(2007-7#2)
of the subclavian##7##3##(1993-3#1)(2007-11#1)(2007-7#2)(2008-7#3)
of the subcortical##2##3##(1991-11#1)(1992-7#1)
of the subcutaneous fat##2##4##(2007-6#1)(2010-11#1)
of the subcutaneous tissue##3##4##(2004-9#1)(2008-5#1)(2008-9#1)
of the subcutaneous##10##3##(1997-4#1)(2004-9#2)(2006-10#2)(2007-6#1)(2008-5#2)(2008-9#1)(2010-11#1)
of the subepithelial##3##3##(2009-8#1)(2011-12#1)(2013-1#1)
of the subesophageal ganglion##3##4##(2008-5#2)(2008-9#1)
of the subfamily##3##3##(2008-10#1)(2012-12#1)(2013-7#1)
of the subgroup##2##3##(1994-12#1)(2008-4#1)
of the subgroups##3##3##(1991-4#1)(2005-10#1)(2008-7#1)
of the subject and##3##4##(1995-12#1)(1997-6#1)(2008-9#1)
of the subject in##2##4##(2011-1#1)(2011-2#1)
of the subject matter##2##4##(1993-1#1)(2008-6#1)
of the subject of##2##4##(1991-1#1)(2011-1#1)
of the subject phrase##2##4##(2010-2#2)
of the subject were##2##4##(2006-11#1)(2013-1#1)
of the subject##32##3##(1991-1#1)(1991-2#1)(1992-3#1)(1993-1#1)(1993-2#1)(1995-12#1)(1995-3#1)(1997-6#1)(2006-11#3)(2006-4#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-2#2)(2010-5#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
of the subject's own##2##4##(1997-8#1)(2013-8#1)
of the subject's##7##3##(1990-12#1)(1994-2#1)(1997-8#1)(2008-11#1)(2009-11#1)(2011-2#1)(2013-8#1)
of the subjective##2##3##(1994-2#1)(2008-1#1)
of the subjects are##2##4##(2006-12#1)(2013-1#1)
of the subjects had##5##4##(2007-2#1)(2008-6#1)(2008-7#1)(2012-12#1)(2013-1#1)
of the subjects in##3##4##(2008-1#1)(2012-12#1)(2013-8#1)
of the subjects showed##2##4##(1990-3#1)(1997-7#1)
of the subjects was##3##4##(2007-7#1)(2008-4#2)
of the subjects were##8##4##(1991-2#1)(1995-11#1)(1996-5#1)(2007-2#1)(2008-12#1)(2008-9#1)(2011-2#1)(2013-1#1)
of the subjects with##3##4##(2007-4#2)(2008-5#1)
of the subjects##71##3##(1990-10#3)(1990-3#1)(1991-2#3)(1991-3#1)(1992-8#1)(1993-9#2)(1994-10#1)(1995-11#2)(1996-3#1)(1996-5#1)(1997-7#1)(2004-11#1)(2004-3#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-1#1)(2007-2#3)(2007-4#2)(2007-6#1)(2007-7#3)(2008-1#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-9#1)(2009-10#1)(2009-2#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#4)(2013-8#6)
of the subjects'##3##3##(2007-1#1)(2008-12#1)(2013-8#1)
of the submandibular gland##6##4##(1992-5#1)(2007-11#2)(2008-8#1)(2011-1#1)(2011-2#1)
of the submandibular##7##3##(1992-5#1)(2007-11#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
of the submental##4##3##(2010-11#2)(2013-1#2)
of the submitted##3##3##(1996-1#1)(2006-6#1)(2011-1#1)
of the submucosal layer##4##4##(2008-5#3)(2013-7#1)
of the submucosal##8##3##(1992-2#1)(1993-9#1)(2006-9#1)(2008-12#1)(2008-5#3)(2013-7#1)
of the subordinate##2##3##(1997-5#1)(2008-8#1)
of the subparafascicular parvocellular##2##4##(2010-10#2)
of the subscales##2##3##(2006-12#1)(2007-2#1)
of the subscapularis##2##3##(2012-12#2)
of the subsequent##13##3##(1990-11#1)(1993-11#1)(1995-1#1)(1995-12#1)(1995-2#1)(1997-2#1)(2008-10#2)(2008-4#2)(2008-6#2)(2012-3#1)
of the subsite##2##3##(1996-11#1)(1996-2#1)
of the substance abuse##2##4##(1995-1#1)(2007-10#1)
of the substance##9##3##(1990-6#1)(1991-11#1)(1991-8#1)(1995-1#1)(1996-1#1)(2005-10#1)(2007-10#1)(2008-4#1)(2008-5#1)
of the substances as##2##4##(1992-5#1)(1997-2#1)
of the substances##12##3##(1992-5#1)(1993-1#1)(1994-12#1)(1995-2#1)(1997-2#1)(2007-1#1)(2008-10#2)(2010-4#1)(2010-8#1)(2013-1#2)
of the substantia nigra pars compacta##3##6##(1995-8#1)(1996-12#2)
of the substantia nigra pars##4##5##(1995-8#1)(1996-12#2)(2008-12#1)
of the substantia nigra##12##4##(1990-5#3)(1992-9#2)(1995-8#1)(1996-12#4)(2008-12#1)(2012-1#1)
of the substantia##13##3##(1990-5#3)(1992-9#2)(1994-10#1)(1995-8#1)(1996-12#4)(2008-12#1)(2012-1#1)
of the substituent at##2##4##(1996-5#1)(1997-1#1)
of the substituent##8##3##(1992-3#1)(1994-9#1)(1996-5#1)(1997-1#1)(2005-11#1)(2007-11#1)(2008-10#1)(2010-5#1)
of the substituents##4##3##(1996-2#1)(1997-1#1)(1997-7#1)(2009-7#1)
of the substituted##3##3##(1993-11#1)(1996-10#1)(2009-3#1)
of the substitutions was##2##4##(1990-12#1)(2013-1#1)
of the substitutions##4##3##(1990-12#1)(1992-6#1)(1994-3#1)(2013-1#1)
of the substrate and the##3##5##(1992-5#1)(2013-7#1)(2013-8#1)
of the substrate and##9##4##(1992-5#1)(1995-3#1)(2007-10#1)(2008-10#1)(2008-11#2)(2010-4#1)(2013-7#1)(2013-8#1)
of the substrate between##2##4##(1990-5#2)
of the substrate in the##2##5##(2007-12#1)(2008-7#1)
of the substrate in##6##4##(1990-5#1)(1994-5#1)(2007-12#1)(2008-10#1)(2008-7#1)(2012-2#1)
of the substrate into##2##4##(1990-8#1)(1994-11#1)
of the substrate is##6##4##(1991-5#1)(1992-6#1)(1995-10#1)(2008-2#3)
of the substrate on##2##4##(2007-11#1)(2007-8#1)
of the substrate specificities##2##4##(1991-4#1)(1994-12#1)
of the substrate specificity of##5##5##(1992-9#1)(1994-9#1)(1995-1#1)(1995-3#1)(2008-7#1)
of the substrate specificity##7##4##(1990-5#1)(1992-9#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-7#1)(2008-7#1)
of the substrate to the##5##5##(1991-3#1)(1993-6#1)(1997-2#1)(2006-12#1)(2011-1#1)
of the substrate to##9##4##(1991-3#1)(1992-4#1)(1993-6#1)(1995-11#1)(1997-2#1)(2006-12#1)(2008-3#1)(2008-6#1)(2011-1#1)
of the substrate with##3##4##(1994-8#1)(1996-7#1)(2008-10#1)
of the substrate##117##3##(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#6)(1990-8#3)(1991-1#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-8#2)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#3)(1993-8#1)(1994-11#3)(1994-12#2)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-3#3)(1995-5#2)(1996-2#1)(1996-7#4)(1997-2#1)(1997-4#2)(2005-11#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-8#2)(2008-10#9)(2008-11#4)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#5)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
of the substrate's##2##3##(1996-2#1)(2008-3#1)
of the substrate-binding##3##3##(1995-3#1)(1996-4#1)(2008-6#1)
of the substrate/product##3##3##(1995-5#2)(2006-12#1)
of the substrates##15##3##(1990-12#1)(1990-7#2)(1991-3#1)(1993-6#1)(1994-5#3)(1996-6#1)(2008-10#3)(2008-11#1)(2008-3#1)(2010-4#1)
of the subsurface cisterna##2##4##(1997-7#2)
of the subsynovial connective tissue##2##5##(2008-9#2)
of the subtalar joint##2##4##(2010-3#1)(2011-2#1)
of the subtelomeric##2##3##(1997-6#1)(2009-10#1)
of the subthalamic nucleus (STN)##2##5##(1997-7#1)(2012-1#1)
of the subthalamic nucleus is##2##5##(2008-11#2)
of the subthalamic nucleus##7##4##(1997-7#1)(2008-11#3)(2008-2#1)(2012-1#1)(2012-2#1)
of the subthalamic##8##3##(1997-7#1)(2008-11#3)(2008-2#1)(2012-1#2)(2012-2#1)
of the subthalamo-pallidal complex in Parkinson's disease during deep brain stimulation##2##11##(2009-8#2)
of the subtropical##2##3##(2008-10#1)(2008-5#1)
of the subtypes of##2##4##(1993-8#1)(1997-2#1)
of the subunit##10##3##(1990-7#1)(1991-12#1)(1992-11#1)(1992-7#1)(1992-8#1)(1994-12#2)(1994-8#1)(1995-8#1)(2009-11#1)
of the subunits in##3##4##(1994-9#1)(1997-2#1)(2008-9#1)
of the subunits of##3##4##(1991-2#1)(2008-2#1)(2012-2#1)
of the subunits##12##3##(1991-2#1)(1992-3#2)(1994-9#1)(1995-5#1)(1997-2#1)(2006-10#1)(2008-2#1)(2008-5#1)(2008-9#2)(2012-2#1)
of the subwavelength##2##3##(2007-11#1)(2008-1#1)
of the succeeding##2##3##(1995-6#1)(1996-6#1)
of the success of these##2##5##(1990-12#1)(2008-11#1)
of the success of##5##4##(1990-12#1)(1994-9#1)(1996-5#1)(2007-4#1)(2008-11#1)
of the success##7##3##(1990-12#1)(1994-9#1)(1996-5#1)(2007-4#1)(2008-11#1)(2010-11#1)(2012-3#1)
of the successful use of##2##5##(1990-8#1)(2007-8#1)
of the successful##6##3##(1990-8#1)(2005-2#1)(2007-8#1)(2008-6#1)(2011-2#1)(2012-3#1)
of the succinate##2##3##(1990-11#1)(2006-9#1)
of the sucking pump of##2##5##(2007-12#2)
of the sucrose##2##3##(2008-10#2)
of the sudden infant death syndrome (SIDS)##2##7##(1991-11#1)(1992-11#1)
of the sudden##3##3##(1991-11#1)(1992-11#2)
of the sugar beet##2##4##(2008-10#1)(2008-12#1)
of the sugar chains contain##2##5##(1991-2#2)
of the sugar chains of##2##5##(1993-11#1)(2008-4#1)
of the sugar chains##4##4##(1991-2#2)(1993-11#1)(2008-4#1)
of the sugar moiety##3##4##(1992-6#1)(2008-3#1)(2008-4#1)
of the sugar##22##3##(1991-2#2)(1991-4#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-11#1)(1994-3#1)(1996-7#1)(2005-11#2)(2007-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2010-2#1)
of the sugarcane##3##3##(2007-12#2)(2008-5#1)
of the sugars##2##3##(2008-10#2)
of the suggested method##2##4##(2008-10#1)(2008-2#1)
of the suggested##6##3##(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-2#1)
of the suggestion##2##3##(1990-12#1)(2008-12#1)
of the suicidal##3##3##(2010-6#3)
of the suicide##4##3##(1996-1#1)(2005-6#1)(2007-10#1)(2007-12#1)
of the suicides##2##3##(1995-11#1)(2009-4#1)
of the sulci##2##3##(2008-9#1)(2010-12#1)
of the sulfate##5##3##(1992-12#1)(1993-2#1)(1996-5#1)(2008-10#2)
of the sulfhydryl groups of##3##5##(1990-12#1)(1993-4#1)(1994-9#1)
of the sulfhydryl groups##4##4##(1990-12#1)(1991-2#1)(1993-4#1)(1994-9#1)
of the sulfhydryl##6##3##(1990-12#1)(1991-2#1)(1992-12#1)(1993-4#1)(1994-9#1)(1995-6#1)
of the sulfotransferases##2##3##(1993-4#1)(1993-9#1)
of the sulfur##6##3##(1994-9#1)(1995-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2010-11#1)
of the sum of the##2##5##(1993-6#1)(1996-3#1)
of the sum of##4##4##(1993-6#1)(1996-3#1)(1997-8#1)(2008-3#1)
of the sum##6##3##(1993-6#1)(1996-3#1)(1997-8#1)(2006-8#2)(2008-3#1)
of the summed mortality in the##2##6##(2005-12#2)
of the summed mortality##3##4##(2005-12#3)
of the summed##4##3##(1991-12#1)(2005-12#3)
of the summer##2##3##(2008-3#1)(2009-8#1)
of the sun and##3##4##(1994-3#2)(2008-3#1)
of the sun##11##3##(1991-6#1)(1994-3#2)(1996-5#4)(2008-3#1)(2010-7#1)(2011-2#2)
of the sun's##3##3##(1996-5#3)
of the sunflower##2##3##(2011-12#2)
of the sunlight##2##3##(2008-5#1)(2011-2#1)
of the sunscreen agents in##2##5##(1996-6#2)
of the sunscreen##3##3##(1996-6#2)(2008-5#1)
of the super##3##3##(1991-12#1)(2007-12#1)(2008-10#1)
of the supercontinuum##3##3##(2007-11#3)
of the superfamily of##5##4##(1992-11#1)(1995-12#1)(2008-1#1)(2008-11#1)(2012-12#1)
of the superfamily##6##3##(1992-11#1)(1995-11#1)(1995-12#1)(2008-1#1)(2008-11#1)(2012-12#1)
of the superficial femoral##2##4##(2007-8#1)(2008-1#1)
of the superficial zone##3##4##(1991-10#1)(2007-11#2)
of the superficial##18##3##(1991-10#2)(1992-2#2)(1993-4#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-11#2)(2011-2#1)(2013-8#1)
of the superimposed##2##3##(2006-10#1)(2007-12#1)
of the superior and inferior vena cava##2##7##(1996-3#1)(2007-7#1)
of the superior and inferior##3##5##(1996-3#1)(2007-7#1)(2010-5#1)
of the superior and##4##4##(1995-6#1)(1996-3#1)(2007-7#1)(2010-5#1)
of the superior ankle joint##2##5##(2007-8#2)
of the superior cerebellar peduncle##3##5##(1991-8#2)(1992-11#1)
of the superior colliculus##6##4##(1991-11#1)(1991-3#1)(1991-5#2)(1993-3#1)(1994-2#1)
of the superior hypogastric plexus##2##5##(2006-11#2)
of the superior laryngeal nerve##2##5##(1993-12#1)(1996-5#1)
of the superior mesenteric artery##12##5##(1990-10#1)(1991-5#1)(1991-9#3)(1992-8#1)(2007-5#1)(2013-1#5)
of the superior mesenteric##14##4##(1990-10#2)(1991-5#1)(1991-9#3)(1992-8#2)(2007-5#1)(2013-1#5)
of the superior sagittal sinus##2##5##(1997-3#1)(2007-9#1)
of the superior temporal gyrus##2##5##(1996-7#1)(1997-8#1)
of the superior vena cava##2##5##(2007-8#1)(2008-12#1)
of the superior##49##3##(1990-10#2)(1991-11#1)(1991-3#1)(1991-5#3)(1991-6#1)(1991-8#2)(1991-9#3)(1992-11#1)(1992-8#2)(1993-12#1)(1993-3#1)(1993-9#1)(1994-2#1)(1995-6#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-8#1)(2006-11#2)(2006-12#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-12#1)(2009-3#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#1)(2013-1#5)
of the supernatant of##2##4##(2008-10#1)(2010-10#1)
of the supernatant##8##3##(1991-5#1)(1995-6#1)(1997-8#1)(2008-10#2)(2010-10#3)
of the superoxide anion##4##4##(1990-5#2)(1991-2#1)(2008-11#1)
of the superoxide##5##3##(1990-5#2)(1991-2#1)(2008-11#1)(2013-1#1)
of the superoxide-generating##2##3##(1994-3#1)(2010-12#1)
of the superposition##2##3##(1991-12#2)
of the superstrate##2##3##(2007-11#1)(2008-1#1)
of the supine##2##3##(2006-10#1)(2011-2#1)
of the supplements##2##3##(2008-3#1)(2011-1#1)
of the supplied##2##3##(2012-12#1)(2012-3#1)
of the supply of##2##4##(1991-2#1)(2008-12#1)
of the support##8##3##(1990-2#1)(2005-11#1)(2007-2#1)(2007-6#1)(2008-11#1)(2009-12#1)(2010-6#1)(2010-8#1)
of the supported bilayer##2##4##(1994-11#1)(2008-4#1)
of the supporting electrolyte##5##4##(2008-10#4)(2008-5#1)
of the supporting##12##3##(1994-12#1)(1995-11#1)(2006-2#1)(2006-6#1)(2008-10#6)(2008-5#1)(2013-1#1)
of the supposed##2##3##(1997-3#1)(2007-7#1)
of the suppression of##3##4##(1993-3#1)(2006-3#1)(2009-2#1)
of the suppressive effect##2##4##(2008-10#1)(2008-5#1)
of the suppressive##4##3##(1994-11#1)(2008-10#1)(2008-4#1)(2008-5#1)
of the suppressor##2##3##(1990-5#1)(1991-12#1)
of the suprachiasmatic nucleus##3##4##(1992-3#1)(1992-8#1)(1996-9#1)
of the supraglottic larynx##2##4##(2012-2#2)
of the supraglottic##3##3##(1996-1#1)(2012-2#2)
of the supramolecular organization##2##4##(1992-7#1)(2006-10#1)
of the supraspinatus tendon##2##4##(2008-7#2)
of the supraventricular##2##3##(1996-6#1)(2006-9#1)
of the surface active agent##3##5##(2004-12#3)
of the surface and##4##4##(2005-11#1)(2007-5#1)(2008-3#1)(2008-5#1)
of the surface area##2##4##(1994-3#1)(2006-10#1)
of the surface charge##3##4##(1990-3#2)(2010-2#1)
of the surface components##2##4##(1991-12#2)
of the surface epithelium##2##4##(1997-1#1)(2008-4#1)
of the surface flux##2##4##(2008-10#1)(2008-2#1)
of the surface glycoprotein##2##4##(1996-12#1)(2005-7#1)
of the surface is##5##4##(2007-12#1)(2008-10#1)(2008-2#2)(2008-5#1)
of the surface of HDL(3)##2##5##(1996-5#2)
of the surface of a##3##5##(2008-3#1)(2008-4#1)(2008-7#1)
of the surface of the##8##5##(1991-2#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)
of the surface of##21##4##(1991-2#1)(1991-7#1)(1993-7#1)(1996-11#1)(1996-5#2)(2006-10#3)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2013-8#1)
of the surface plasmons##2##4##(2007-12#2)
of the surface profile##3##4##(2005-10#1)(2008-2#1)(2008-5#1)
of the surface properties of##2##5##(1990-2#1)(2005-11#1)
of the surface roughness##2##4##(2007-12#1)(2008-2#1)
of the surface temperature##2##4##(2007-9#1)(2008-7#1)
of the surface tension##5##4##(2005-11#3)(2008-10#1)(2008-2#1)
of the surface velocity of debris flow##2##7##(2008-2#1)(2008-3#1)
of the surface was##2##4##(1990-2#1)(2005-11#1)
of the surface with##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
of the surface##159##3##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#3)(1990-7#1)(1991-12#2)(1991-2#1)(1991-7#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-7#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-6#1)(1996-11#1)(1996-12#1)(1996-5#4)(1996-8#1)(1997-1#1)(1997-8#1)(2004-12#3)(2004-9#1)(2005-10#1)(2005-11#19)(2005-4#1)(2005-7#1)(2006-10#5)(2006-5#1)(2007-11#2)(2007-12#8)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-2#14)(2008-3#21)(2008-4#6)(2008-5#6)(2008-7#4)(2009-3#1)(2009-7#2)(2009-8#1)(2010-2#1)(2010-4#3)(2010-8#2)(2011-2#1)(2012-2#1)(2013-8#1)
of the surfaces and##2##4##(2008-2#1)(2008-7#1)
of the surfaces of the##3##5##(2004-9#1)(2008-3#2)
of the surfaces of##4##4##(2004-9#1)(2008-3#2)(2010-8#1)
of the surfaces##12##3##(2004-9#1)(2005-11#2)(2007-5#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)(2010-8#1)
of the surfactant and##2##4##(2008-10#1)(2009-12#1)
of the surfactant in the##2##5##(1996-5#1)(2005-11#1)
of the surfactant protein SP-B##2##5##(1992-9#2)
of the surfactant##31##3##(1990-11#1)(1991-2#2)(1992-11#1)(1992-5#1)(1992-9#2)(1994-9#1)(1996-5#2)(1997-1#1)(1997-8#1)(2005-11#9)(2008-10#6)(2008-5#2)(2008-7#1)(2009-12#1)
of the surfactants and##3##4##(2008-10#2)(2012-2#1)
of the surfactants##13##3##(1996-5#2)(2005-11#3)(2007-11#1)(2008-10#3)(2008-5#3)(2012-2#1)
of the surgeon and##2##4##(2006-6#1)(2007-5#1)
of the surgeon to##3##4##(2006-6#1)(2010-8#2)
of the surgeon##16##3##(1991-8#1)(1996-12#1)(2006-3#1)(2006-6#3)(2007-11#1)(2007-5#3)(2008-10#1)(2009-5#1)(2010-5#1)(2010-8#2)(2011-1#1)
of the surgery and##2##4##(2006-7#1)(2008-7#1)
of the surgery in##2##4##(1990-9#1)(2008-10#1)
of the surgery##18##3##(1990-3#1)(1990-9#1)(1996-8#2)(2006-7#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-2#1)(2012-12#2)(2013-1#2)
of the surgical field##4##4##(1996-1#1)(2006-10#1)(2006-12#1)(2008-7#1)
of the surgical intervention##2##4##(2008-8#1)(2013-1#1)
of the surgical management##2##4##(1990-9#1)(2006-12#1)
of the surgical patient##3##4##(2007-12#1)(2009-2#1)(2011-12#1)
of the surgical procedure##12##4##(2005-9#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-8#3)(2011-12#1)(2013-1#1)
of the surgical procedures##3##4##(2007-11#1)(2007-7#1)(2012-12#1)
of the surgical site##2##4##(2008-10#1)(2009-6#1)
of the surgical specimen revealed##4##5##(1991-9#1)(1992-4#1)(2011-2#1)(2013-1#1)
of the surgical specimen##5##4##(1991-9#1)(1992-4#1)(2007-8#1)(2011-2#1)(2013-1#1)
of the surgical techniques##3##4##(1990-6#1)(1992-9#1)(2006-4#1)
of the surgical treatment of##8##5##(1990-3#1)(1990-9#2)(2006-3#1)(2007-11#1)(2008-8#1)(2008-9#1)(2009-2#1)
of the surgical treatment##12##4##(1990-3#1)(1990-9#2)(1992-9#1)(2006-3#1)(2007-11#2)(2008-8#1)(2008-9#1)(2009-2#2)(2012-12#1)
of the surgical##74##3##(1990-3#1)(1990-6#1)(1990-9#3)(1991-11#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-9#2)(1993-9#1)(1995-4#1)(1996-1#1)(2005-7#1)(2005-9#1)(2006-10#4)(2006-12#2)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#4)(2007-12#2)(2007-5#1)(2007-7#3)(2007-8#4)(2008-10#2)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-2#4)(2009-6#1)(2010-8#1)(2011-12#2)(2011-2#3)(2011-3#1)(2012-12#3)(2012-2#1)(2013-1#3)
of the surgically treated##3##4##(1992-9#1)(2006-11#1)(2008-9#1)
of the surgically##5##3##(1990-6#1)(1992-9#1)(2006-11#1)(2007-9#1)(2008-9#1)
of the surrounding environment##2##4##(1993-3#1)(2010-10#1)
of the surrounding fluid##2##4##(2007-11#1)(2011-1#1)
of the surrounding medium##3##4##(1991-7#1)(2008-2#1)(2008-3#1)
of the surrounding tissue##2##4##(2006-6#1)(2006-9#1)
of the surrounding##24##3##(1991-7#1)(1993-1#1)(1993-3#1)(1995-11#1)(1995-9#1)(2005-11#1)(2006-11#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-6#1)(2008-2#1)(2008-3#2)(2009-12#1)(2009-2#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#2)
of the surveillance##4##3##(1994-2#1)(1996-11#1)(2011-12#1)(2011-2#1)
of the survey and the##2##5##(2007-2#1)(2008-10#1)
of the survey are##2##4##(1990-10#1)(1994-1#1)
of the survey showed##3##4##(2006-2#1)(2008-10#1)(2008-12#1)
of the survey was##4##4##(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)
of the survey were##3##4##(1991-12#1)(1996-1#1)(2008-10#1)
of the survey##37##3##(1990-10#1)(1990-3#4)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1994-1#1)(1994-4#1)(1994-6#1)(1995-12#1)(1996-1#1)(2006-2#2)(2007-1#1)(2007-2#1)(2008-10#5)(2008-11#1)(2008-12#3)(2009-2#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#5)
of the surveyed##2##3##(2007-11#1)(2013-1#1)
of the survival curve##3##4##(1995-3#3)
of the survival function##3##4##(1996-1#1)(2008-10#1)(2008-3#1)
of the survival of the##2##5##(2008-1#1)(2013-1#1)
of the survival of##3##4##(1991-4#1)(2008-1#1)(2013-1#1)
of the survival##15##3##(1991-10#1)(1991-4#1)(1995-3#3)(1996-1#1)(2006-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-3#2)(2013-1#1)
of the surviving##4##3##(1991-9#1)(1993-11#1)(1997-4#1)(2008-9#1)
of the survivors##5##3##(1993-11#1)(1994-6#1)(1995-5#1)(2004-11#1)(2011-2#1)
of the susceptibility##7##3##(2006-8#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-12#1)(2009-6#1)(2011-1#1)
of the susceptible and resistant##2##5##(2008-10#2)
of the susceptible and##3##4##(2008-10#3)
of the susceptible potato##2##4##(2008-10#2)
of the susceptible##10##3##(2008-10#10)
of the suspended##6##3##(2007-11#1)(2008-2#2)(2008-3#2)(2009-7#1)
of the suspension##9##3##(2004-9#2)(2005-11#3)(2007-12#1)(2008-10#2)(2010-4#1)
of the suspensions##2##3##(2005-11#2)
of the sustained##3##3##(1993-12#1)(2007-12#1)(2008-12#1)
of the sustained-release##2##3##(1993-10#2)
of the suture##2##3##(2004-9#1)(2007-5#1)
of the swabs##2##3##(2006-8#1)(2011-2#1)
of the swelling##2##3##(1991-10#1)(2010-9#1)
of the swimming##2##3##(2008-10#1)(2008-4#1)
of the swine##3##3##(1992-12#1)(2008-7#1)(2010-4#1)
of the switch##3##3##(1995-5#1)(2008-3#1)(2011-2#1)
of the switching##3##3##(2007-11#1)(2008-1#1)(2008-7#1)
of the swollen##3##3##(2005-11#1)(2008-5#1)(2009-5#1)
of the symbiotic##4##3##(2006-3#3)(2007-12#1)
of the symbolic##2##3##(1993-2#1)(2011-3#1)
of the symmetric##4##3##(1991-5#1)(2007-12#1)(2008-10#2)
of the symmetry of the##2##5##(2007-11#1)(2008-2#1)
of the symmetry of##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
of the symmetry##5##3##(2007-11#2)(2008-2#1)(2008-3#1)(2012-1#1)
of the sympathetic and##2##4##(2007-8#1)(2008-10#1)
of the sympathetic nervous system##6##5##(1990-5#1)(1991-2#1)(1997-2#1)(2005-10#1)(2006-12#1)(2012-2#1)
of the sympathetic nervous##7##4##(1990-5#1)(1991-2#1)(1997-2#1)(2005-10#1)(2006-12#1)(2008-5#1)(2012-2#1)
of the sympathetic##17##3##(1990-5#1)(1991-2#2)(1994-10#1)(1995-12#1)(1995-3#1)(1996-3#1)(1997-2#1)(2005-10#2)(2006-12#1)(2007-1#1)(2007-8#2)(2008-10#1)(2008-5#1)(2012-2#1)
of the symphysis pubis##2##4##(1994-3#1)(2012-12#1)
of the symposium##3##3##(2008-10#1)(2008-5#1)(2011-12#1)
of the symptom##7##3##(1991-11#1)(1991-4#1)(2006-6#1)(2008-5#1)(2011-2#3)
of the symptomatic##4##3##(1990-12#1)(2007-12#1)(2007-8#1)(2013-1#1)
of the symptomatology##3##3##(1990-11#1)(1991-3#1)(1991-9#1)
of the symptoms and the##4##5##(1991-11#1)(1991-12#1)(2006-10#1)(2008-1#1)
of the symptoms and##7##4##(1991-11#1)(1991-12#1)(2006-10#1)(2008-1#1)(2008-7#1)(2010-3#1)(2011-2#1)
of the symptoms caused by the##2##6##(1991-3#1)(2008-10#1)
of the symptoms of##7##4##(2005-11#1)(2007-11#1)(2007-9#1)(2008-2#1)(2010-12#1)(2012-2#2)
of the symptoms##42##3##(1990-11#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-3#1)(1995-3#1)(1996-12#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2009-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
of the synapse##4##3##(1992-6#1)(2008-2#1)(2008-7#1)(2009-11#1)
of the synapses##4##3##(1995-12#1)(2008-2#2)(2008-7#1)
of the synapsins##2##3##(1994-8#2)
of the synaptic sites in##2##5##(1996-8#2)
of the synaptic vesicle##3##4##(1992-6#1)(2007-12#1)(2008-1#1)
of the synaptic##14##3##(1990-12#1)(1991-11#1)(1992-6#1)(1994-12#1)(1996-8#2)(2007-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#2)(2012-12#2)
of the synchronized##3##3##(2006-5#1)(2007-11#1)(2008-11#1)
of the synchrotron radiation##3##4##(2006-5#2)(2008-3#1)
of the synchrotron##4##3##(2006-5#2)(2008-3#1)(2008-4#1)
of the syncytial##2##3##(1995-8#1)(2009-2#1)
of the syndrome and in##2##5##(1996-12#1)(2008-1#1)
of the syndrome and##5##4##(1990-2#1)(1996-12#1)(2007-11#1)(2008-1#1)(2009-7#1)
of the syndrome in##4##4##(1992-2#1)(1995-8#1)(1996-3#1)(2008-9#1)
of the syndrome is##4##4##(2006-10#1)(2007-7#1)(2008-8#1)(2011-12#1)
of the syndrome of##3##4##(1993-7#1)(1995-5#1)(2011-1#1)
of the syndrome##47##3##(1990-12#1)(1990-2#3)(1991-12#1)(1992-2#1)(1993-5#1)(1993-7#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-3#2)(1996-8#1)(1997-1#2)(1997-3#1)(2006-10#5)(2006-2#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#4)(2008-8#1)(2008-9#1)(2009-11#2)(2009-4#1)(2009-7#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)
of the syndromic##2##3##(1996-12#1)(2007-7#1)
of the synergid##2##3##(2008-11#1)(2009-8#1)
of the synergistic##4##3##(1995-8#1)(2008-10#2)(2009-7#1)
of the synovial membrane and##2##5##(1996-6#1)(2009-3#1)
of the synovial membrane##5##4##(1992-4#1)(1996-6#1)(2007-11#1)(2009-3#1)(2010-12#1)
of the synovial##7##3##(1992-4#1)(1996-6#1)(2007-11#2)(2009-3#1)(2010-12#1)(2011-2#1)
of the syntactic##2##3##(2006-2#1)(2007-3#1)
of the synthesis are##2##4##(2008-3#1)(2009-11#1)
of the synthesis is##3##4##(1990-12#1)(2006-12#1)(2010-6#1)
of the synthesis matrix##2##4##(2007-12#2)
of the synthesis of a cytosolic thyroid hormone binding protein##2##10##(1992-11#2)
of the synthesis of the##4##5##(1991-10#1)(1992-3#1)(2007-11#1)(2012-1#1)
of the synthesis of##20##4##(1990-2#1)(1991-10#2)(1992-11#2)(1992-12#1)(1992-3#1)(1997-3#1)(1997-5#1)(1997-7#1)(2005-8#1)(2006-7#1)(2007-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#1)(2012-1#1)
of the synthesis##33##3##(1990-12#1)(1990-2#1)(1991-10#2)(1992-11#2)(1992-12#1)(1992-3#1)(1993-4#1)(1996-2#1)(1997-3#2)(1997-5#1)(1997-7#1)(2005-8#1)(2006-12#1)(2006-7#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2009-11#1)(2009-7#1)(2010-6#1)(2012-1#1)
of the synthesized compound##2##4##(2006-12#1)(2013-1#1)
of the synthesized compounds have##2##5##(2007-11#1)(2012-3#1)
of the synthesized compounds was##2##5##(2008-5#1)(2012-11#1)
of the synthesized compounds##9##4##(2007-11#4)(2008-5#1)(2012-11#2)(2012-2#1)(2012-3#1)
of the synthesized proteins##2##4##(1993-2#1)(2008-1#1)
of the synthesized##25##3##(1993-2#1)(1997-6#1)(2004-9#1)(2006-12#1)(2007-11#5)(2008-1#1)(2008-10#4)(2008-5#1)(2008-6#1)(2010-5#1)(2011-2#2)(2012-11#2)(2012-2#1)(2012-3#2)(2013-1#1)
of the synthetase##3##3##(1994-11#1)(1994-6#1)(1994-9#1)
of the synthetic glucocorticoid##2##4##(1991-5#1)(1995-8#1)
of the synthetic peptide corresponding to##2##6##(1991-7#1)(1994-12#1)
of the synthetic peptide with##2##5##(1990-7#1)(1996-8#1)
of the synthetic peptide##5##4##(1990-7#1)(1991-7#1)(1994-12#1)(1996-8#1)(2008-4#1)
of the synthetic peptides##2##4##(1992-8#1)(1997-8#1)
of the synthetic##36##3##(1990-7#1)(1991-5#1)(1991-7#2)(1992-6#1)(1992-8#1)(1993-7#1)(1994-12#1)(1995-8#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-8#1)(2005-11#3)(2006-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#1)(2009-3#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-3#1)
of the syrB gene##3##4##(2008-10#3)
of the syrinx##2##3##(2005-5#1)(2006-5#1)
of the system and its##2##5##(2005-11#1)(2006-6#1)
of the system and the##4##5##(1996-1#1)(2008-10#1)(2008-3#1)(2012-3#1)
of the system and to##4##5##(2008-10#1)(2008-2#2)(2008-3#1)
of the system and##25##4##(1991-2#1)(1994-12#1)(1996-1#1)(1996-3#1)(2005-11#1)(2006-6#1)(2007-12#3)(2007-6#1)(2008-10#4)(2008-2#4)(2008-3#3)(2010-12#1)(2012-3#1)(2013-1#2)
of the system are described##2##5##(2008-3#1)(2012-1#1)
of the system are##6##4##(2007-11#1)(2007-12#1)(2007-5#1)(2008-3#2)(2012-1#1)
of the system as a##2##5##(2008-10#1)(2012-2#1)
of the system as well as##3##6##(2007-11#1)(2008-10#1)(2010-4#1)
of the system as##6##4##(1991-2#1)(2007-11#1)(2008-10#2)(2010-4#1)(2012-2#1)
of the system at##2##4##(2006-10#1)(2008-10#1)
of the system by the##2##5##(2007-7#1)(2008-1#1)
of the system by##5##4##(1991-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)
of the system can be##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
of the system can##4##4##(2008-10#2)(2008-2#1)(2008-3#1)
of the system compared##2##4##(2008-3#1)(2008-9#1)
of the system for the##3##5##(2008-2#1)(2008-5#2)
of the system for##10##4##(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2012-2#1)
of the system from the##2##5##(2008-2#1)(2011-2#1)
of the system from##3##4##(2006-10#1)(2008-2#1)(2011-2#1)
of the system has been##2##5##(1992-9#1)(2008-2#1)
of the system have been##2##5##(2008-2#1)(2008-3#1)
of the system have##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
of the system in##4##4##(1990-2#1)(2008-10#1)(2008-2#1)(2008-5#1)
of the system include##4##4##(2006-1#1)(2007-12#2)(2007-8#1)
of the system is 1##2##5##(2008-2#2)
of the system is 3##2##5##(2008-3#2)
of the system is discussed##2##5##(2006-6#1)(2007-12#1)
of the system is set by the##2##7##(2008-3#2)
of the system is the##2##5##(2008-10#1)(2008-5#1)
of the system is##34##4##(2006-6#2)(2007-11#2)(2007-12#5)(2008-10#7)(2008-11#2)(2008-2#8)(2008-3#6)(2008-5#1)(2008-8#1)
of the system of##5##4##(1996-1#1)(1996-2#1)(2007-11#1)(2007-12#1)(2012-3#1)
of the system to##13##4##(1990-8#1)(1992-12#2)(1992-2#1)(1992-3#1)(1997-3#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-10#1)
of the system was ascertained by analyzing a set of##2##10##(2008-10#2)
of the system was##23##4##(1994-1#1)(1997-1#1)(2007-8#4)(2008-10#14)(2008-2#1)(2012-1#1)(2013-8#1)
of the system were optimized##3##5##(2008-10#3)
of the system were##10##4##(1992-12#1)(2006-8#1)(2007-12#1)(2008-10#6)(2008-12#1)
of the system will be discussed##2##6##(2008-10#1)(2008-2#1)
of the system will##4##4##(1992-3#1)(2006-6#1)(2008-10#1)(2008-2#1)
of the system with##6##4##(2006-10#1)(2008-10#2)(2008-2#1)(2008-3#2)
of the system without##2##4##(2008-10#2)
of the system##320##3##(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#4)(1991-9#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-5#2)(1992-6#1)(1992-9#1)(1993-1#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-6#1)(1995-11#1)(1996-1#2)(1996-2#2)(1996-3#2)(1996-4#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-11#8)(2006-1#1)(2006-10#8)(2006-3#1)(2006-5#1)(2006-6#4)(2006-8#1)(2006-9#1)(2007-11#7)(2007-12#22)(2007-5#2)(2007-6#2)(2007-7#4)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#65)(2008-11#7)(2008-12#2)(2008-2#38)(2008-3#36)(2008-4#2)(2008-5#6)(2008-6#4)(2008-7#1)(2008-8#3)(2008-9#6)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#6)(2012-11#1)(2012-2#3)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#2)
of the system's##6##3##(1991-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2013-1#1)
of the systematic error##2##4##(2007-12#1)(2008-10#1)
of the systematic errors##4##4##(1990-8#1)(2008-2#1)(2008-3#2)
of the systematic review##2##4##(2007-11#1)(2013-1#1)
of the systematic##11##3##(1990-8#1)(1992-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2013-1#1)
of the systemic inflammatory response##2##5##(2006-10#2)
of the systemic nature of##2##5##(2004-1#1)(2007-11#1)
of the systemic##14##3##(1993-1#1)(2004-1#1)(2006-10#2)(2007-11#2)(2008-10#2)(2008-3#1)(2009-2#1)(2010-11#1)(2010-2#1)(2012-1#1)(2013-8#1)
of the systems and##3##4##(2008-7#1)(2013-1#2)
of the systems to##2##4##(2008-10#1)(2008-2#1)
of the systems were##2##4##(2008-10#1)(2008-8#1)
of the systems with##2##4##(1994-3#1)(2005-11#1)
of the systems##25##3##(1991-1#1)(1991-2#1)(1994-3#1)(1996-1#1)(2005-11#3)(2006-10#1)(2006-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-4#1)(2012-11#1)(2012-12#1)(2013-1#2)
of the t##2##3##(1992-2#1)(1992-5#1)
of the t(2g) orbitals##2##4##(1997-7#2)
of the t(2g)##3##3##(1997-7#3)
of the t-PA gene##2##4##(1994-3#1)(1995-3#1)
of the tRNA##3##3##(1991-1#1)(1993-11#1)(1996-11#1)
of the tRNA[Ser]Sec##2##3##(1995-8#1)(1997-2#1)
of the table##2##3##(2007-8#1)(2008-10#1)
of the tables##4##3##(1991-11#1)(1996-1#2)(1996-5#1)
of the tablet##2##3##(2008-10#1)(2010-2#1)
of the tablets##2##3##(2008-10#2)
of the tachykinin NK2 receptor##2##5##(1993-3#1)(1996-12#1)
of the tachykinin##6##3##(1990-2#1)(1991-5#1)(1993-3#1)(1996-12#3)
of the tactile##3##3##(1997-2#1)(2008-5#2)
of the tadpoles##2##3##(2007-3#1)(2008-5#1)
of the tag##2##3##(1992-5#1)(1994-12#1)
of the tagged gene##2##4##(1997-8#2)
of the tagged##5##3##(1997-8#3)(2007-11#1)(2007-12#1)
of the tail domain of##2##5##(1990-11#1)(2009-7#1)
of the tail sheath protein##2##5##(1990-5#2)
of the tail sheath##4##4##(1990-5#4)
of the tail##17##3##(1990-11#1)(1990-4#1)(1990-5#4)(1992-9#1)(1993-5#1)(1993-9#1)(1995-12#1)(1995-8#1)(2007-12#1)(2008-5#1)(2008-7#1)(2009-7#1)(2011-12#2)
of the talar##3##3##(2006-3#1)(2008-12#1)(2009-1#1)
of the talks##2##3##(2008-7#2)
of the tall##2##3##(1994-3#1)(2009-5#1)
of the talus is##2##4##(2009-10#1)(2010-5#1)
of the talus##12##3##(2006-11#2)(2008-12#1)(2009-1#1)(2009-10#1)(2009-5#1)(2010-3#2)(2010-5#3)(2012-2#1)
of the tandem##4##3##(1991-10#1)(1992-11#2)(1995-1#1)
of the tapered##4##3##(2007-12#2)(2008-3#2)
of the target DNA##2##4##(1990-9#1)(1992-3#1)
of the target analyte##3##4##(2006-12#1)(2008-10#1)(2011-1#1)
of the target and the##2##5##(2008-1#1)(2008-7#1)
of the target and##3##4##(2008-1#1)(2008-3#1)(2008-7#1)
of the target area##2##4##(1994-8#1)(2008-10#1)
of the target cell##2##4##(2008-11#2)
of the target cells##2##4##(1990-12#1)(2008-4#1)
of the target compounds in##2##5##(2007-11#1)(2013-1#1)
of the target compounds##6##4##(2007-11#1)(2008-10#4)(2013-1#1)
of the target gene##5##4##(1995-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2011-12#1)
of the target molecule##3##4##(2008-6#1)(2009-10#1)(2010-12#1)
of the target object##3##4##(1997-8#1)(2008-3#1)(2008-4#1)
of the target organ to##2##5##(1994-11#1)(2013-1#1)
of the target organ##3##4##(1990-4#1)(1994-11#1)(2013-1#1)
of the target organs##2##4##(2009-2#1)(2012-1#1)
of the target population##5##4##(1997-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-1#1)
of the target protein##5##4##(2006-11#1)(2008-11#1)(2008-2#2)(2008-4#1)
of the target sequence##3##4##(1994-12#1)(2008-2#1)(2011-1#1)
of the target species##5##4##(1997-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
of the target tissue##3##4##(1991-10#1)(1996-3#1)(2009-7#1)
of the target volume##3##4##(1993-4#1)(2009-11#1)(2010-9#1)
of the target with respect to##2##6##(2008-4#2)
of the target with##3##4##(2007-12#1)(2008-4#2)
of the target##118##3##(1990-11#1)(1990-12#1)(1990-4#1)(1990-9#1)(1991-10#2)(1991-4#1)(1992-3#1)(1993-3#1)(1993-4#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-8#1)(1997-1#2)(1997-7#1)(1997-8#1)(2005-9#1)(2006-11#1)(2006-12#1)(2006-6#2)(2007-11#4)(2007-12#2)(2007-5#1)(2007-8#4)(2008-1#3)(2008-10#21)(2008-11#4)(2008-2#8)(2008-3#6)(2008-4#6)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#3)(2009-2#1)(2009-7#1)(2010-12#1)(2010-9#1)(2011-1#6)(2011-12#1)(2012-1#3)(2012-12#3)(2013-1#3)(2013-8#1)
of the target's##2##3##(2008-3#1)(2010-7#1)
of the targeted##10##3##(1995-6#1)(2008-1#1)(2008-10#2)(2008-12#1)(2009-7#1)(2010-12#1)(2012-2#2)(2013-7#1)
of the targeting vector##2##4##(1996-10#2)
of the targeting##3##3##(1993-9#1)(1996-10#2)
of the targets##7##3##(1991-5#1)(1994-9#1)(1995-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2011-2#1)
of the tartrate-resistant acid phosphatase##2##5##(1990-4#2)
of the task of##2##4##(2008-10#1)(2008-2#1)
of the task##30##3##(1991-1#1)(1991-2#2)(1991-3#1)(1992-7#1)(1994-1#1)(1994-3#1)(1995-1#2)(1995-12#2)(2006-6#1)(2007-6#2)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-8#2)
of the tasks##11##3##(1992-11#1)(1993-12#1)(2006-10#1)(2007-2#1)(2008-4#3)(2008-8#1)(2011-2#1)(2012-1#2)
of the taste system##2##4##(2007-12#1)(2010-2#1)
of the taste##6##3##(1992-11#1)(1994-5#1)(2007-12#1)(2008-10#1)(2010-2#1)(2012-1#1)
of the tau##6##3##(1992-9#1)(1994-12#1)(1995-2#1)(2007-9#1)(2008-9#1)(2013-1#1)
of the taxa##2##3##(2008-10#1)(2010-3#1)
of the teacher##2##3##(1992-9#1)(2008-9#1)
of the teachers##2##3##(1991-12#1)(2007-7#1)
of the teaching and learning##2##5##(2008-12#1)(2012-1#1)
of the teaching##7##3##(2007-4#1)(2007-6#1)(2008-12#2)(2010-6#1)(2010-8#1)(2012-1#1)
of the team and##2##4##(2006-8#1)(2009-6#1)
of the team to##2##4##(2007-8#1)(2010-11#1)
of the team##15##3##(1991-2#1)(1992-2#1)(1995-5#1)(1996-1#1)(1996-3#1)(1997-3#1)(2006-8#1)(2007-5#1)(2007-8#3)(2008-10#1)(2009-6#1)(2010-11#1)(2012-1#1)
of the teams##2##3##(2007-12#1)(2012-3#1)
of the tear film##2##4##(2006-11#1)(2007-1#1)
of the tear##4##3##(2006-11#1)(2007-1#1)(2009-4#1)(2013-8#1)
of the technical##8##3##(1990-4#1)(1997-8#1)(2006-5#1)(2007-2#1)(2008-7#1)(2010-9#1)(2012-12#1)(2013-1#1)
of the technician##2##3##(2007-10#1)(2012-1#1)
of the technique and##10##4##(1990-10#1)(2005-9#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-7#1)(2010-7#1)
of the technique are##11##4##(1990-4#1)(1992-7#1)(1995-11#1)(1996-5#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-1#1)
of the technique as##2##4##(2008-3#1)(2008-6#1)
of the technique by##7##4##(2007-12#3)(2008-1#1)(2008-3#2)(2011-2#1)
of the technique for##5##4##(2008-2#2)(2008-3#1)(2009-12#1)(2012-12#1)
of the technique in the##3##5##(2007-8#1)(2008-7#1)(2013-8#1)
of the technique in##7##4##(2006-10#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-7#1)(2010-1#1)(2013-8#1)
of the technique is demonstrated##3##5##(2008-2#1)(2008-3#1)(2008-6#1)
of the technique is discussed##2##5##(2007-12#1)(2008-3#1)
of the technique is that##2##5##(2008-2#1)(2008-3#1)
of the technique is##17##4##(1995-4#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#6)(2008-6#1)(2009-5#1)
of the technique of##7##4##(1990-7#1)(2006-12#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-9#1)
of the technique to the##2##5##(2008-3#1)(2011-12#1)
of the technique to##7##4##(2008-11#2)(2008-3#3)(2008-4#1)(2011-12#1)
of the technique used##2##4##(2008-2#1)(2012-2#1)
of the technique was##8##4##(1991-2#1)(1991-5#1)(1993-12#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-2#1)
of the technique were##2##4##(2008-5#1)(2008-7#1)
of the technique##126##3##(1990-10#1)(1990-12#1)(1990-4#1)(1990-7#1)(1991-2#1)(1991-5#1)(1992-7#1)(1993-10#1)(1993-12#1)(1993-5#1)(1995-11#1)(1995-4#1)(1996-5#1)(1997-2#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-12#3)(2006-4#2)(2007-11#3)(2007-12#11)(2007-7#1)(2007-8#4)(2008-1#3)(2008-10#11)(2008-11#2)(2008-12#2)(2008-2#14)(2008-3#23)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#3)(2008-9#1)(2009-1#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-7#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-8#1)
of the techniques and##3##4##(2008-11#1)(2008-4#1)(2009-4#1)
of the techniques are##2##4##(2008-10#1)(2008-7#1)
of the techniques of##3##4##(2006-5#1)(2012-12#1)(2012-2#1)
of the techniques that##2##4##(1995-5#1)(2008-9#1)
of the techniques used##3##4##(2007-7#1)(2008-7#1)(2009-10#1)
of the techniques##25##3##(1995-5#1)(1996-8#1)(2006-10#2)(2006-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
of the technologies##3##3##(2006-10#1)(2008-11#1)(2011-1#1)
of the technology is##2##4##(2008-11#1)(2012-11#1)
of the technology to##2##4##(2008-9#2)
of the technology##12##3##(1991-11#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#2)(2010-5#1)(2012-11#1)
of the tectum##3##3##(1993-9#1)(1995-11#1)(2006-5#1)
of the teeth and##3##4##(1995-6#1)(1995-9#1)(2013-8#1)
of the teeth in##2##4##(1997-5#1)(2013-1#1)
of the teeth##13##3##(1995-6#1)(1995-9#1)(1997-4#2)(1997-5#1)(2006-8#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
of the telencephalon##6##3##(1990-10#1)(1993-2#2)(1994-3#2)(1995-12#1)
of the teleomorph##2##3##(2008-10#2)
of the teleost##6##3##(1991-9#1)(1995-2#1)(2008-7#1)(2008-8#1)(2009-4#2)
of the telescope##8##3##(1991-2#1)(2007-7#1)(2008-2#2)(2008-3#4)
of the telotrophic meroistic##2##4##(2007-12#2)
of the temperature and pH##2##5##(2008-10#2)
of the temperature and##5##4##(2007-11#1)(2008-10#2)(2008-2#1)(2011-1#1)
of the temperature dependence of the##4##6##(1991-4#1)(2007-12#1)(2008-3#2)
of the temperature dependence of##6##5##(1991-4#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
of the temperature distribution##2##4##(2008-3#1)(2008-7#1)
of the temperature in##2##4##(1994-12#1)(2008-10#1)
of the temperature program##2##4##(2007-10#1)(2007-8#1)
of the temperature##38##3##(1991-4#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#2)(1997-2#1)(2005-11#1)(2006-3#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#5)(2008-2#4)(2008-3#6)(2008-5#2)(2008-7#1)(2009-4#1)(2010-4#1)(2011-1#1)
of the temperature-dependent##3##3##(2008-3#2)(2013-8#1)
of the temperature-sensitive##2##3##(1990-5#1)(1996-9#1)
of the template##11##3##(1991-2#1)(1991-7#2)(1994-8#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-12#2)
of the templated polymer##2##4##(2007-8#2)
of the temporal and##3##4##(2007-11#1)(2007-12#1)(2009-10#1)
of the temporal artery##2##4##(1994-9#1)(2006-10#1)
of the temporal bone are##2##5##(2006-12#1)(2011-2#1)
of the temporal bone##10##4##(2005-5#2)(2006-12#3)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#2)
of the temporal evolution of the##2##6##(2007-12#1)(2008-2#1)
of the temporal lobe##8##4##(1991-12#1)(1991-3#1)(1993-9#1)(1994-2#1)(1995-12#1)(2008-4#1)(2011-2#2)
of the temporal organization of##2##5##(1995-12#1)(2009-8#1)
of the temporal pole##2##4##(1993-9#2)
of the temporal profile of the##3##6##(2006-3#1)(2008-2#1)(2008-3#1)
of the temporal profile##4##4##(2006-3#1)(2008-2#2)(2008-3#1)
of the temporal profiles##2##4##(1994-3#1)(2007-11#1)
of the temporal response##2##4##(2007-12#1)(2008-3#1)
of the temporal##59##3##(1991-11#1)(1991-12#1)(1991-3#1)(1993-1#1)(1993-12#1)(1993-5#2)(1993-9#3)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#2)(1997-8#1)(2005-5#2)(2006-10#1)(2006-12#3)(2006-3#1)(2007-11#2)(2007-12#5)(2007-8#1)(2008-2#9)(2008-3#5)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-8#2)(2011-1#1)(2011-2#4)
of the temporalis muscle##2##4##(2007-12#1)(2008-8#1)
of the temporo-mandibular joint##3##4##(2011-2#3)
of the temporomandibular joint##6##4##(2007-12#1)(2007-6#1)(2011-12#1)(2012-2#1)(2013-1#2)
of the temporomandibular##8##3##(2007-12#1)(2007-6#1)(2007-7#2)(2011-12#1)(2012-2#1)(2013-1#2)
of the ten patients##2##4##(2006-7#1)(2008-7#1)
of the ten##15##3##(1990-2#1)(1990-4#1)(1992-8#1)(1995-12#1)(1996-2#1)(2005-8#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-12#1)(2008-5#1)(2008-7#1)(2010-3#1)(2012-12#1)(2013-7#1)
of the tendinous##2##3##(2007-8#1)(2012-12#1)
of the tendon##6##3##(2006-3#1)(2006-4#1)(2007-2#1)(2007-8#1)(2009-10#1)(2013-7#1)
of the tendons##2##3##(1993-1#1)(2012-1#1)
of the tennis serve##2##4##(2011-2#2)
of the tensile##2##3##(2007-4#1)(2009-7#1)
of the tension##2##3##(1991-12#1)(2012-2#1)
of the tensions##2##3##(2009-10#1)(2011-2#1)
of the tensor##2##3##(2007-11#1)(2008-5#1)
of the tentacles##3##3##(2010-8#3)
of the terahertz##2##3##(2007-11#1)(2008-2#1)
of the term &quot##3##4##(2006-9#2)(2008-9#1)
of the term##14##3##(1993-2#1)(2006-12#1)(2006-9#2)(2008-1#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#1)(2013-1#4)
of the terminal CN groups##2##5##(2008-10#2)
of the terminal branches##2##4##(2010-12#2)
of the terminal##35##3##(1990-11#1)(1990-9#2)(1991-5#2)(1992-1#1)(1993-11#1)(1993-4#1)(1994-2#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-10#2)(1996-12#1)(1997-1#1)(2005-11#1)(2007-10#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-12#2)(2010-5#1)(2011-2#2)(2012-11#1)
of the terminally##2##3##(1990-10#1)(2008-5#1)
of the termini##2##3##(1990-5#1)(2006-10#1)
of the termite##3##3##(2007-12#1)(2008-11#1)(2011-2#1)
of the terms##5##3##(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)
of the ternary complex was##2##5##(1996-5#1)(2008-10#1)
of the ternary complex##12##4##(1991-2#1)(1993-8#1)(1994-8#2)(1995-5#2)(1996-5#1)(1996-7#1)(2005-11#1)(2006-10#1)(2008-10#2)
of the ternary##17##3##(1991-2#1)(1993-8#1)(1994-8#2)(1995-5#2)(1996-5#1)(1996-7#1)(2005-11#1)(2006-10#1)(2008-10#5)(2008-2#1)(2009-11#1)
of the terpenoids##2##3##(1990-11#1)(2008-10#1)
of the terrestrial##5##3##(1990-5#1)(2007-12#1)(2008-3#1)(2008-6#1)(2008-7#1)
of the territory##4##3##(1990-7#1)(2007-2#1)(2008-8#2)
of the tertiary structure##2##4##(1991-5#1)(1992-9#1)
of the tertiary##7##3##(1991-5#1)(1992-9#1)(1994-3#1)(1994-8#1)(1996-6#1)(2008-10#1)(2009-6#1)
of the test are##2##4##(2008-2#1)(2012-3#1)
of the test is##3##4##(1990-4#1)(1997-3#1)(2008-10#1)
of the test of##3##4##(1997-5#1)(2006-10#1)(2012-12#1)
of the test results##3##4##(2006-11#1)(2008-5#1)(2013-1#1)
of the test sample##3##4##(2008-10#1)(2008-2#1)(2008-9#1)
of the test samples##5##4##(1996-8#1)(2006-5#1)(2008-10#2)(2008-4#1)
of the test set##2##4##(2010-12#1)(2010-2#1)
of the test specimen##2##4##(2008-10#2)
of the test substance##4##4##(2005-10#3)(2008-10#1)
of the test to##2##4##(1996-3#1)(1997-2#1)
of the test was##3##4##(1996-12#1)(2006-10#1)(2012-2#1)
of the test with the##2##5##(1993-6#1)(1996-3#1)
of the test with##3##4##(1992-9#1)(1993-6#1)(1996-3#1)
of the test##100##3##(1990-4#1)(1990-6#1)(1991-12#4)(1992-9#3)(1993-11#1)(1993-6#1)(1995-11#1)(1996-12#1)(1996-3#2)(1996-5#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(2004-4#1)(2004-9#1)(2005-10#3)(2005-8#1)(2006-10#2)(2006-11#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-12#3)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#5)(2008-7#2)(2008-9#1)(2009-12#1)(2010-12#2)(2010-2#2)(2010-4#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
of the test's##2##3##(2004-12#1)(2009-12#1)
of the tested compounds showed significant##2##6##(2007-11#1)(2011-2#1)
of the tested compounds##8##4##(1995-12#1)(1997-1#1)(2007-11#1)(2007-8#1)(2008-5#2)(2009-6#1)(2011-2#1)
of the tested samples##2##4##(1997-4#1)(2008-10#1)
of the tested solutions##2##4##(2008-10#1)(2011-1#1)
of the tested species##3##4##(1997-1#3)
of the tested substances##2##4##(2008-10#1)(2008-5#1)
of the tested##46##3##(1990-8#1)(1991-5#1)(1995-12#2)(1996-4#1)(1996-7#1)(1997-1#4)(1997-4#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#4)(2008-7#1)(2009-6#2)(2009-7#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
of the testes##5##3##(2006-5#1)(2006-7#1)(2008-7#2)(2012-1#1)
of the testicular##3##3##(1995-11#1)(2008-10#1)(2009-11#1)
of the testing##13##3##(1990-11#1)(1993-8#1)(1994-2#1)(1996-6#1)(2004-12#1)(2006-11#2)(2007-4#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#1)
of the testis and##3##4##(2008-10#1)(2008-7#1)(2010-12#1)
of the testis determining gene##2##5##(1994-11#1)(1995-11#1)
of the testis during breeding and nonbreeding phases of the reproductive cycle##2##12##(2007-9#2)
of the testis is a rare##3##6##(2007-8#1)(2011-2#1)(2012-2#1)
of the testis is a##4##5##(2007-8#1)(2011-2#1)(2012-2#2)
of the testis is##6##4##(2006-10#1)(2007-6#1)(2007-8#1)(2011-2#1)(2012-2#2)
of the testis with##2##4##(1997-3#1)(2007-6#1)
of the testis##33##3##(1990-11#1)(1991-6#1)(1992-6#1)(1994-10#1)(1994-11#1)(1994-4#1)(1995-11#1)(1995-3#1)(1997-3#1)(2005-8#1)(2006-10#3)(2007-3#1)(2007-5#1)(2007-6#3)(2007-8#1)(2007-9#2)(2008-10#2)(2008-7#1)(2008-9#1)(2010-12#2)(2011-2#1)(2012-2#4)(2013-7#1)
of the testis-determining##2##3##(1991-11#1)(1995-11#1)
of the tests and##3##4##(1995-4#1)(1997-2#1)(2013-1#1)
of the tests##20##3##(1990-3#1)(1995-4#2)(1997-2#2)(2006-6#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
of the tether##2##3##(1996-5#1)(2012-1#1)
of the tetra(tertiary phosphine)##2##4##(2008-5#2)
of the tetracycline##3##3##(1994-12#1)(2008-10#2)
of the tetrahedral##5##3##(1991-2#1)(1996-2#1)(2005-11#2)(2010-12#1)
of the tetrahydropyridine ring##2##4##(1992-11#1)(2007-11#1)
of the tetramer##2##3##(1992-8#1)(1996-11#1)
of the tetrameric##2##3##(1990-8#1)(1993-7#1)
of the tetrapeptide Pro-D-Phe-Pro-Gly in##2##5##(1991-5#2)
of the tetrapeptide##4##3##(1991-5#2)(1997-3#1)(2006-12#1)
of the tetrapyrrole##5##3##(1991-5#1)(1995-3#1)(1997-7#1)(2011-1#2)
of the tetrasaccharide##2##3##(1995-1#1)(1995-11#1)
of the text##5##3##(1995-11#1)(2008-1#1)(2008-10#2)(2010-8#1)
of the textile##3##3##(2005-10#1)(2008-1#1)(2010-8#1)
of the thalamus##12##3##(1992-10#1)(1992-2#1)(1992-3#1)(1995-11#1)(1995-5#1)(1996-1#1)(1996-7#1)(1997-5#1)(2007-1#1)(2008-11#1)(2012-12#1)(2012-3#1)
of the thalassaemia patients##2##4##(2013-8#2)
of the the##10##3##(1990-5#1)(1993-2#1)(1995-9#1)(1996-9#1)(2005-7#1)(2007-12#1)(2008-4#2)(2008-7#1)(2011-12#1)
of the theme##2##3##(2007-12#1)(2012-2#1)
of the then##2##3##(2011-1#1)(2012-12#1)
of the theoretical maximum##2##4##(2007-10#1)(2007-12#1)
of the theoretical value##2##4##(1994-3#1)(2008-3#1)
of the theoretical yield##2##4##(2004-8#1)(2008-6#1)
of the theoretical##25##3##(1990-6#1)(1991-12#1)(1993-3#1)(1993-6#1)(1994-3#1)(1996-11#1)(2004-8#1)(2006-10#1)(2007-10#1)(2007-12#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-5#1)(2011-2#1)
of the theory is##2##4##(1991-1#1)(2008-2#1)
of the theory of##4##4##(2008-3#2)(2008-8#1)(2012-3#1)
of the theory to the##2##5##(1991-6#1)(2007-8#1)
of the theory##26##3##(1990-3#1)(1991-1#1)(1991-6#1)(1992-6#1)(1995-8#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-8#3)(2009-2#2)(2009-3#1)(2009-5#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
of the theory-practice gap##2##4##(2008-11#2)
of the therapeutic protein##3##4##(1996-8#1)(2008-5#1)(2012-2#1)
of the therapeutic##28##3##(1990-12#2)(1992-2#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-5#1)(1996-8#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-5#2)(2009-9#1)(2010-12#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#2)(2013-1#1)
of the therapeutical##2##3##(1995-12#1)(2012-7#1)
of the therapist##3##3##(1991-2#1)(2009-6#2)
of the therapists##2##3##(1993-5#1)(2007-10#1)
of the therapy is##4##4##(1991-12#1)(1997-3#1)(2006-2#1)(2006-8#1)
of the therapy of##2##4##(2006-6#1)(2008-12#1)
of the therapy was##2##4##(2007-7#1)(2011-2#1)
of the therapy with##2##4##(2005-1#1)(2013-8#1)
of the therapy##27##3##(1991-12#1)(1991-2#1)(1992-12#1)(1993-4#1)(1994-2#1)(1997-3#1)(2005-1#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#2)
of the thermal characteristics of##3##5##(2007-8#1)(2008-2#1)(2008-3#1)
of the thermal lens was##2##5##(2008-2#2)
of the thermal lens##8##4##(2007-11#1)(2008-2#3)(2008-3#4)
of the thermal transition of##2##5##(1994-2#1)(1994-8#1)
of the thermal##35##3##(1990-3#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-10#1)(1996-6#1)(1996-7#1)(2006-4#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-10#1)(2008-2#5)(2008-3#9)(2008-8#2)(2011-1#1)(2011-2#2)(2012-6#1)
of the thermally induced##2##4##(2008-2#1)(2008-3#1)
of the thermally##4##3##(1997-4#1)(2008-10#1)(2008-2#1)(2008-3#1)
of the thermodynamic parameters##4##4##(1990-7#1)(1993-8#1)(1994-11#1)(1997-1#1)
of the thermodynamic stability##2##4##(2006-10#1)(2007-11#1)
of the thermodynamic##16##3##(1990-7#1)(1993-8#1)(1994-11#1)(1997-1#1)(1997-2#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-4#1)(2010-2#1)
of the thermodynamics##2##3##(1991-7#1)(1997-2#1)
of the thermophilic##3##3##(1994-12#2)(1997-7#1)
of the thermoregulatory system##2##4##(2006-10#2)
of the thermoregulatory##3##3##(1994-2#1)(2006-10#2)
of the these##2##3##(2007-3#1)(2008-10#1)
of the thesis##2##3##(2006-7#1)(2011-2#1)
of the theta##2##3##(2008-11#2)
of the thia FA##2##4##(2007-8#2)
of the thia##3##3##(1995-3#1)(2007-8#2)
of the thickness and##2##4##(2008-2#1)(2008-3#1)
of the thickness of the##5##5##(1991-5#1)(1994-3#1)(2005-11#1)(2007-12#1)(2007-8#1)
of the thickness of##6##4##(1991-5#1)(1994-3#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#1)
of the thickness##13##3##(1991-5#1)(1994-3#1)(2005-11#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#3)
of the thigh and##2##4##(2007-11#1)(2012-2#1)
of the thigh##16##3##(1991-3#2)(1991-6#1)(1997-3#1)(2007-11#5)(2008-12#1)(2008-6#3)(2012-1#1)(2012-2#1)(2013-1#1)
of the thighs##2##3##(2006-10#1)(2008-5#1)
of the thin filament##3##4##(1990-12#1)(2008-6#1)(2010-5#1)
of the thin filaments##2##4##(1991-5#1)(1997-4#1)
of the thin films##5##4##(2008-3#3)(2009-4#1)(2010-1#1)
of the thin ideal##2##4##(2007-12#2)
of the thin##16##3##(1990-12#1)(1991-5#1)(1997-4#1)(2007-12#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2009-4#1)(2010-1#1)(2010-5#1)(2011-1#1)
of the thiocyanate##2##3##(1995-11#1)(2008-10#1)
of the thiocyanato-complexes##2##3##(2008-10#2)
of the thiohydroximate ester##2##4##(2007-11#2)
of the thiol##4##3##(1995-6#1)(2008-10#2)(2008-11#1)
of the thiolase##3##3##(1991-12#1)(1992-7#2)
of the thioredoxin##3##3##(1991-4#1)(1992-2#1)(1996-2#1)
of the thiotemplate##2##3##(1994-2#2)
of the thiourea##2##3##(2005-4#1)(2007-9#1)
of the third and fourth##3##5##(1990-8#1)(2008-5#2)
of the third group##2##4##(1994-6#1)(2006-7#1)
of the third harmonic of##2##5##(2007-11#1)(2007-12#1)
of the third harmonic##4##4##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)
of the third intracellular loop##2##5##(1995-3#1)(1996-5#1)
of the third millennium##3##4##(2006-10#1)(2008-10#2)
of the third molar##2##4##(2013-8#2)
of the third molars##2##4##(2013-8#2)
of the third stage##2##4##(1990-3#1)(1992-1#1)
of the third strand##3##4##(1992-9#1)(1995-3#2)
of the third trimester##2##4##(1997-8#1)(2007-12#1)
of the third ventricle and##3##5##(1996-2#1)(1997-5#1)(1997-8#1)
of the third ventricle##13##4##(1991-8#1)(1996-2#1)(1997-5#1)(1997-8#2)(2006-5#3)(2008-7#5)
of the third##68##3##(1990-10#1)(1990-3#2)(1990-8#3)(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#2)(1992-7#1)(1992-9#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#3)(1994-9#1)(1995-3#4)(1995-4#1)(1995-8#1)(1996-2#1)(1996-5#2)(1997-5#1)(1997-8#3)(2006-10#1)(2006-5#3)(2006-7#2)(2006-8#1)(2007-11#2)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#5)(2008-8#1)(2013-1#2)(2013-8#4)
of the third-harmonic##2##3##(2007-11#1)(2007-12#1)
of the third-order nonlinear optical##2##5##(2007-11#1)(2007-12#1)
of the third-order nonlinearity of##2##5##(2007-12#2)
of the third-order##7##3##(2007-11#1)(2007-12#4)(2008-3#2)
of the thirteen bisquinolines had##2##5##(1992-6#2)
of the thirteen##6##3##(1992-6#2)(1992-7#1)(1994-2#1)(2006-4#1)(2007-4#1)
of the thirty##3##3##(1995-6#1)(2008-12#2)
of the thoracic and abdominal##2##5##(2011-2#1)(2012-2#1)
of the thoracic aorta##8##4##(1990-6#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2009-10#1)(2011-2#1)(2012-2#1)
of the thoracic cage##2##4##(2005-11#1)(2013-1#1)
of the thoracic cavity##3##4##(2004-2#1)(2007-2#1)(2013-1#1)
of the thoracic duct##3##4##(2008-4#1)(2011-2#1)(2012-3#1)
of the thoracic spine are##2##5##(1997-4#1)(2007-11#1)
of the thoracic spine##12##4##(1997-4#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-1#1)(2007-11#5)(2007-4#1)(2009-3#1)
of the thoracic vertebrae##2##4##(1993-3#1)(2011-2#1)
of the thoracic wall##2##4##(1992-6#1)(2012-2#1)
of the thoracic##48##3##(1990-12#1)(1990-3#1)(1990-6#1)(1991-5#1)(1992-6#1)(1993-10#1)(1993-3#1)(1995-12#1)(1997-4#1)(1997-8#2)(2004-2#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-7#2)(2007-1#1)(2007-11#5)(2007-12#1)(2007-2#2)(2007-4#1)(2007-8#3)(2008-10#1)(2008-12#1)(2008-4#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-8#1)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
of the thoraco-lumbar spine##4##4##(2007-11#1)(2007-7#3)
of the thoraco-lumbar##5##3##(2007-11#1)(2007-7#4)
of the thoracolumbar spine##6##4##(2006-8#4)(2008-7#1)(2012-12#1)
of the thoracolumbar##7##3##(2006-8#4)(2007-7#1)(2008-7#1)(2012-12#1)
of the thorax and##2##4##(2007-12#1)(2012-2#1)
of the thorax##18##3##(1991-11#1)(1991-12#1)(1991-3#1)(1993-10#1)(1993-3#1)(1997-8#1)(2006-11#2)(2007-12#2)(2007-8#2)(2008-4#1)(2008-8#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
of the thought processes##2##4##(2007-3#1)(2011-2#1)
of the thought##3##3##(2007-3#1)(2011-2#2)
of the thousands of##2##4##(2008-7#1)(2009-12#1)
of the threat (the##2##4##(2008-5#2)
of the threat##5##3##(2008-10#2)(2008-5#2)(2010-9#1)
of the three IGF-II promoters##2##5##(1994-9#2)
of the three analytes##2##4##(2008-10#1)(2010-5#1)
of the three arsenic species##2##5##(2008-10#2)
of the three basic##2##4##(1994-9#1)(2007-12#1)
of the three clonal lineages of##2##6##(2009-2#2)
of the three common mutations##2##5##(1995-1#1)(2007-12#1)
of the three components of##2##5##(1992-6#1)(2007-12#1)
of the three components##5##4##(1992-6#1)(2007-12#1)(2008-10#1)(2008-5#1)(2013-1#1)
of the three compounds was##2##5##(1993-2#1)(2008-10#1)
of the three compounds##5##4##(1992-11#1)(1993-2#1)(2008-10#1)(2011-2#1)(2012-12#1)
of the three conditions##3##4##(2006-7#1)(2008-11#1)(2012-1#1)
of the three different##2##4##(2008-10#1)(2008-7#1)
of the three dyes##2##4##(2008-10#2)
of the three families##3##4##(1991-6#1)(2008-7#1)(2008-8#1)
of the three genera##2##4##(1996-6#1)(2008-10#1)
of the three genes was##2##5##(1995-6#1)(2009-12#1)
of the three genes##3##4##(1995-6#1)(1996-5#1)(2009-12#1)
of the three groups##8##4##(2007-6#1)(2008-10#3)(2008-12#1)(2010-3#1)(2011-12#1)(2013-8#1)
of the three human##2##4##(1993-12#1)(1994-6#1)
of the three indices##3##4##(1995-8#1)(2007-6#1)(2008-5#1)
of the three isolates##2##4##(2008-10#2)
of the three known##2##4##(1993-4#1)(2005-11#1)
of the three ligands##2##4##(1997-4#1)(2008-10#1)
of the three loop##2##4##(1997-1#2)
of the three main##7##4##(1994-5#1)(2007-12#1)(2007-8#1)(2008-10#2)(2012-2#1)(2012-3#1)
of the three major classes of##2##6##(1995-11#1)(2008-4#1)
of the three major##9##4##(1992-7#1)(1995-11#1)(1997-3#1)(2006-8#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-4#1)(2012-2#1)
of the three markers##2##4##(1991-2#1)(1995-12#1)
of the three metals##2##4##(2008-10#2)
of the three methods used##2##5##(1993-5#1)(2008-10#1)
of the three methods##8##4##(1992-2#1)(1993-5#1)(1995-1#2)(2008-10#2)(2012-2#1)(2013-8#1)
of the three monomers##2##4##(1995-6#1)(2010-4#1)
of the three most##3##4##(1990-12#1)(2007-8#1)(2011-2#1)
of the three mouse##2##4##(1994-12#1)(1996-10#1)
of the three natriuretic peptides##2##5##(1991-3#2)
of the three patients##4##4##(1995-1#1)(2006-7#1)(2006-8#1)(2013-8#1)
of the three primary##2##4##(2008-2#2)
of the three proteins##2##4##(1994-8#2)
of the three resources##2##4##(2011-2#2)
of the three species##6##4##(2007-1#1)(2007-8#1)(2011-3#2)(2012-8#1)(2012-9#1)
of the three studied##2##4##(2005-11#1)(2008-10#1)
of the three studies##3##4##(1990-12#1)(2006-10#1)(2007-12#1)
of the three subunits##3##4##(1994-12#1)(1995-3#1)(2009-2#1)
of the three test emulsions##2##5##(2008-5#2)
of the three test##3##4##(2007-4#1)(2008-5#2)
of the three types of##5##5##(1995-11#1)(1997-4#1)(2008-10#1)(2009-7#2)
of the three types##7##4##(1992-1#1)(1995-11#1)(1996-11#1)(1997-4#1)(2008-10#1)(2009-7#2)
of the three##353##3##(1990-11#2)(1990-12#4)(1990-3#1)(1990-4#3)(1990-5#2)(1990-7#2)(1991-2#2)(1991-3#3)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-1#2)(1992-11#2)(1992-2#3)(1992-6#3)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-12#2)(1994-3#3)(1994-5#2)(1994-6#3)(1994-8#2)(1994-9#4)(1995-1#5)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#4)(1995-8#2)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#2)(1996-5#5)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#2)(2004-11#1)(2004-4#1)(2005-1#1)(2005-11#2)(2005-12#1)(2005-4#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-11#2)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#2)(2007-1#5)(2007-11#4)(2007-12#8)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#1)(2007-8#5)(2007-9#1)(2008-10#61)(2008-11#5)(2008-12#7)(2008-2#7)(2008-3#6)(2008-4#4)(2008-5#11)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#4)(2009-10#1)(2009-12#2)(2009-2#3)(2009-4#1)(2009-7#3)(2010-11#3)(2010-12#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-8#2)(2011-1#2)(2011-12#2)(2011-2#8)(2011-3#2)(2012-1#3)(2012-12#4)(2012-2#6)(2012-3#1)(2012-8#1)(2012-9#1)(2013-1#2)(2013-8#7)
of the three-dimensional structure##3##4##(1993-11#1)(1993-3#1)(1995-1#1)
of the three-dimensional##17##3##(1993-11#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-1#1)(2006-12#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#1)(2010-9#1)
of the three-spined stickleback Gasterosteus aculeatus from the##2##8##(2010-8#2)
of the three-spined stickleback Gasterosteus aculeatus in##2##7##(2010-8#2)
of the three-spined stickleback Gasterosteus aculeatus##4##6##(2010-8#4)
of the three-way##2##3##(2008-10#2)
of the threshold##6##3##(1990-11#1)(1996-11#1)(2006-4#1)(2008-2#2)(2008-7#1)
of the thrombin aptamer##2##4##(2009-3#2)
of the thrombin receptor##2##4##(1996-8#1)(1997-5#1)
of the thrombin##5##3##(1996-8#1)(1997-1#1)(1997-5#1)(2009-3#2)
of the thrombocyte##2##3##(1995-3#1)(2007-10#1)
of the thrombocytes number##2##4##(2007-9#2)
of the thrombolytic##2##3##(1990-12#1)(2007-9#1)
of the thrombotic##4##3##(1990-3#1)(2006-6#1)(2007-7#1)(2008-7#1)
of the thrombus was##3##4##(1990-8#1)(2013-1#2)
of the thrombus##5##3##(1990-8#1)(2007-8#1)(2007-9#1)(2013-1#2)
of the throughput##2##3##(2008-2#1)(2008-3#1)
of the thumb metacarpal##2##4##(2006-3#1)(2009-3#1)
of the thumb metacarpophalangeal##2##4##(2006-3#2)
of the thumb##22##3##(1990-8#1)(1996-9#1)(1997-1#2)(2006-10#2)(2006-3#9)(2008-9#4)(2009-3#1)(2009-5#2)
of the thylakoid membranes##2##4##(1990-5#1)(1997-4#1)
of the thylakoid##3##3##(1990-5#1)(1992-6#1)(1997-4#1)
of the thymic##3##3##(1991-8#1)(1997-4#1)(2013-7#1)
of the thymidine##3##3##(1993-11#1)(1993-12#1)(2008-4#1)
of the thymine##2##3##(1992-3#1)(2007-8#1)
of the thymus is##2##4##(1997-5#1)(2010-2#1)
of the thymus##14##3##(1991-12#1)(1992-12#2)(1997-5#1)(1997-7#2)(1997-9#1)(2008-10#1)(2008-5#1)(2008-9#2)(2010-2#1)(2013-1#2)
of the thyroid and parathyroid##3##5##(2006-6#2)(2013-1#1)
of the thyroid and##5##4##(2006-6#2)(2008-4#1)(2009-3#1)(2013-1#1)
of the thyroid gland in##2##5##(2008-7#1)(2012-1#1)
of the thyroid gland was##2##5##(2005-12#1)(2009-5#1)
of the thyroid gland##30##4##(1990-3#1)(1990-4#1)(1990-8#1)(1992-1#1)(1992-2#1)(1992-4#1)(1993-4#3)(1993-5#1)(1997-2#1)(2005-12#1)(2006-2#1)(2006-6#1)(2007-3#1)(2008-6#1)(2008-7#2)(2009-5#1)(2009-7#1)(2011-1#1)(2012-1#5)(2012-12#1)(2012-2#1)(2013-1#2)
of the thyroid hormone##2##4##(1991-7#1)(1994-11#1)
of the thyroid in a##3##5##(1992-2#2)(2011-2#1)
of the thyroid in##5##4##(1992-2#2)(2008-6#1)(2011-1#1)(2011-2#1)
of the thyroid is##2##4##(2008-7#1)(2012-1#1)
of the thyroid was##2##4##(1991-10#1)(2006-2#1)
of the thyroid##72##3##(1990-3#1)(1990-4#1)(1990-8#1)(1991-10#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-2#3)(1992-4#1)(1992-8#2)(1993-4#3)(1993-5#1)(1994-11#1)(1995-12#1)(1996-11#1)(1997-2#1)(2005-12#1)(2006-10#3)(2006-2#2)(2006-6#4)(2007-3#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-6#3)(2008-7#3)(2009-12#1)(2009-3#3)(2009-5#1)(2009-7#2)(2009-9#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-1#8)(2012-12#4)(2012-2#2)(2013-1#3)(2013-8#1)
of the thyroid]##3##3##(1992-10#1)(1992-5#1)(1996-6#1)
of the thyrotropin (TSH) receptor##2##5##(1991-7#1)(1992-12#1)
of the thyrotropin receptor##5##4##(1991-8#1)(1994-3#2)(1996-5#1)(2008-4#1)
of the thyrotropin##7##3##(1991-7#1)(1991-8#1)(1992-12#1)(1994-3#2)(1996-5#1)(2008-4#1)
of the tibia and##4##4##(2007-1#1)(2007-7#1)(2010-12#2)
of the tibia has been noted##2##6##(2007-4#1)(2008-6#1)
of the tibia##39##3##(1993-11#1)(2006-10#2)(2006-11#1)(2006-6#2)(2007-1#4)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-6#6)(2008-8#2)(2009-3#4)(2009-9#5)(2010-12#2)(2011-2#2)(2013-8#2)
of the tibial component##3##4##(1991-12#1)(2007-8#1)(2009-4#1)
of the tibial metaphysis##4##4##(2007-1#2)(2013-1#2)
of the tibial nerve##3##4##(2007-7#3)
of the tibial plateau##3##4##(2007-4#2)(2008-10#1)
of the tibial##23##3##(1990-6#1)(1991-12#1)(2007-1#2)(2007-11#1)(2007-4#2)(2007-5#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#2)(2011-2#1)(2013-1#3)
of the tick##7##3##(1994-3#1)(1994-6#1)(2008-10#1)(2008-12#1)(2010-1#1)(2010-2#1)(2013-8#1)
of the tick-borne pathogen##2##4##(2013-8#2)
of the tidal##2##3##(2007-9#1)(2010-8#1)
of the tight##3##3##(1993-11#1)(2005-10#1)(2006-7#1)
of the tightly##2##3##(1992-6#1)(2009-5#1)
of the tilt##2##3##(2008-2#2)
of the tilted##2##3##(2007-12#1)(2008-3#1)
of the time and##7##4##(1990-9#1)(1992-12#1)(2006-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2010-9#1)
of the time axis##2##4##(1995-9#1)(2008-8#1)
of the time constant##2##4##(2007-12#1)(2007-9#1)
of the time course of##2##5##(1995-12#1)(2008-10#1)
of the time course##5##4##(1995-12#2)(1996-7#1)(2008-10#1)(2010-7#1)
of the time in##2##4##(2008-9#1)(2009-2#1)
of the time interval##2##4##(2008-9#1)(2013-1#1)
of the time intervals between##2##5##(2007-12#1)(2011-1#1)
of the time necessary##2##4##(2008-10#2)
of the time of##6##4##(1992-8#1)(2006-12#1)(2006-5#2)(2008-10#2)
of the time points##2##4##(1991-11#1)(1995-11#1)
of the time spent##2##4##(1993-9#1)(2007-7#1)
of the time temperature superposition##2##5##(2008-5#2)
of the time the##3##4##(1992-2#1)(1992-8#1)(2006-3#1)
of the time to the##2##5##(1996-4#1)(2008-4#1)
of the time to##4##4##(1996-4#1)(2007-12#1)(2008-4#1)(2011-2#1)
of the time##105##3##(1990-2#1)(1990-9#1)(1991-11#1)(1991-3#1)(1992-12#2)(1992-2#2)(1992-8#2)(1993-7#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-6#1)(2004-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#3)(2006-9#1)(2007-12#7)(2007-4#2)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#12)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-2#3)(2009-7#1)(2009-8#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#4)
of the time-dependent##8##3##(1992-4#1)(1995-6#1)(2004-9#1)(2007-12#1)(2007-3#1)(2008-2#1)(2008-5#1)(2008-7#1)
of the time-resolved##3##3##(2005-11#1)(2008-2#2)
of the time-varying##2##3##(2008-1#1)(2008-3#1)
of the times##2##3##(2012-2#1)(2013-8#1)
of the timing for##2##4##(2007-8#1)(2008-2#1)
of the timing of##6##4##(1991-10#1)(2007-7#1)(2008-10#2)(2010-12#1)(2010-2#1)
of the timing##12##3##(1990-4#1)(1991-10#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-12#1)(2010-2#1)
of the tip by##3##4##(2006-12#1)(2007-7#1)(2008-10#1)
of the tip of the##3##5##(1991-3#1)(2008-5#1)(2010-8#1)
of the tip of##6##4##(1991-3#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-8#1)
of the tip with##2##4##(2007-12#1)(2008-2#1)
of the tip##16##3##(1991-3#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-12#2)(2007-7#4)(2008-10#2)(2008-2#2)(2008-5#1)(2010-8#1)
of the tip-sample##2##3##(2007-12#1)(2008-3#1)
of the tips##2##3##(2007-12#1)(2008-7#1)
of the tissue are##2##4##(2008-11#1)(2008-2#1)
of the tissue autofluorescence##2##4##(2008-3#1)(2011-1#1)
of the tissue by##2##4##(2008-3#1)(2012-2#1)
of the tissue distribution of##2##5##(1994-9#1)(2008-4#1)
of the tissue sample##3##4##(1996-12#1)(2007-12#1)(2010-12#1)
of the tissue to##3##4##(1990-5#1)(1993-12#1)(2008-3#1)
of the tissue##70##3##(1990-10#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-3#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-4#2)(2004-9#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-3#1)(2007-4#2)(2007-5#1)(2008-10#1)(2008-11#5)(2008-2#5)(2008-3#5)(2008-4#2)(2008-5#4)(2008-6#1)(2009-11#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
of the tissues was##2##4##(1994-5#1)(2008-9#1)
of the tissues##18##3##(1990-4#1)(1993-12#1)(1994-10#1)(1994-5#1)(1994-9#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-8#1)(2012-1#1)(2013-1#2)
of the tissular##2##3##(1992-12#1)(2008-10#1)
of the titanium##2##3##(2007-8#1)(2013-8#1)
of the title compound##6##4##(2004-7#1)(2007-11#2)(2008-10#1)(2008-11#1)(2013-1#1)
of the title compounds##9##4##(1994-3#1)(1997-4#1)(2006-10#1)(2007-11#2)(2008-3#1)(2008-5#1)(2009-7#1)(2012-3#1)
of the title##22##3##(1991-12#1)(1992-3#1)(1994-3#1)(1997-4#1)(2004-7#1)(2006-10#1)(2007-10#1)(2007-11#4)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#2)(2009-7#1)(2012-3#1)(2013-1#1)
of the titrant##12##3##(2008-10#12)
of the titratable##2##3##(2008-4#2)
of the titration and##2##4##(2008-10#2)
of the titration curve##2##4##(2008-10#2)
of the titration##11##3##(1991-8#1)(2008-10#9)(2009-3#1)
of the toad Bufo marinus##2##5##(1992-11#1)(1993-5#1)
of the toad##5##3##(1992-11#1)(1993-5#2)(2007-1#1)(2008-6#1)
of the tobacco epidemic##2##4##(2007-11#2)
of the tobacco pouch on the distal rectal stump##2##9##(1990-4#2)
of the tobacco##14##3##(1990-4#2)(1992-2#1)(1992-3#1)(1996-4#1)(2006-12#3)(2007-11#2)(2008-10#1)(2008-7#1)(2009-12#1)(2011-2#1)
of the toenail##2##3##(1990-9#1)(2007-5#1)
of the toes##2##3##(1997-1#1)(2010-6#1)
of the toll-like receptor##2##4##(2008-3#1)(2009-8#1)
of the toll-like##3##3##(2008-1#1)(2008-3#1)(2009-8#1)
of the tomato##4##3##(2006-12#1)(2008-10#1)(2008-7#1)(2008-9#1)
of the tomographic##2##3##(2008-2#2)
of the tongue in##3##4##(2007-3#1)(2011-12#1)(2013-7#1)
of the tongue with##2##4##(1997-4#1)(2008-10#1)
of the tongue##31##3##(1990-1#1)(1997-4#1)(2006-2#4)(2006-8#3)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-10#1)(2010-6#1)(2010-9#2)(2011-12#3)(2011-2#1)(2012-1#1)(2012-3#3)(2013-1#2)(2013-7#1)
of the tonoplast##3##3##(1996-5#1)(2008-10#1)(2008-11#1)
of the tonsil##2##3##(1993-12#1)(2007-4#1)
of the tool and##2##4##(2009-11#1)(2012-2#1)
of the tool##8##3##(2008-11#3)(2008-12#1)(2008-9#1)(2009-11#1)(2012-2#2)
of the toolkit is##2##4##(2009-12#1)(2013-1#1)
of the tools of##2##4##(2008-12#1)(2008-9#1)
of the tools##9##3##(1996-3#1)(1997-7#1)(2005-10#1)(2008-12#1)(2008-9#2)(2009-10#1)(2011-2#1)(2012-12#1)
of the tooth in the mouth##2##6##(2008-7#2)
of the tooth in##3##4##(2008-7#2)(2013-8#1)
of the tooth##17##3##(1991-2#1)(1996-2#1)(1997-4#2)(2005-11#1)(2008-5#2)(2008-7#4)(2009-4#1)(2010-6#1)(2012-2#1)(2013-1#2)(2013-8#1)
of the top of##2##4##(2008-3#2)
of the top##15##3##(1992-8#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-9#2)(2009-10#1)(2009-9#1)(2010-4#1)(2013-1#1)
of the topic##2##3##(2008-9#1)(2012-2#1)
of the topics addressed##2##4##(2008-4#1)(2008-5#1)
of the topics##3##3##(2008-11#1)(2008-4#1)(2008-5#1)
of the topography of##2##4##(1992-11#1)(2008-11#1)
of the topography##5##3##(1992-11#1)(2008-11#1)(2008-3#2)(2012-1#1)
of the topoisomerase##2##3##(1990-2#1)(1996-6#1)
of the topological##2##3##(2007-12#2)
of the torso##5##3##(2006-11#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-1#1)
of the tospoviruses##2##3##(2008-10#2)
of the total UV##2##4##(2004-4#1)(2008-5#1)
of the total activity##2##4##(1992-6#1)(1994-9#1)
of the total alpha##2##4##(1990-7#1)(1994-3#1)
of the total amount of##6##5##(1991-2#1)(1997-3#1)(2008-10#4)
of the total amount##7##4##(1991-2#1)(1996-5#1)(1997-3#1)(2008-10#4)
of the total area##2##4##(2008-2#1)(2012-1#1)
of the total bacterial##3##4##(2005-11#1)(2008-8#1)(2010-4#1)
of the total cell##2##4##(1994-8#1)(2012-1#1)
of the total cellular protein##3##5##(1990-3#1)(1991-1#1)(2008-9#1)
of the total cellular##6##4##(1990-3#2)(1991-1#1)(1995-11#1)(1996-8#1)(2008-9#1)
of the total concentration of##3##5##(1994-9#1)(2008-10#2)
of the total content##2##4##(2007-1#1)(2008-10#1)
of the total culture##2##4##(2008-11#2)
of the total disease that##2##5##(2008-10#2)
of the total dose##4##4##(2007-10#2)(2007-9#1)(2008-7#1)
of the total fatty acids##2##5##(2005-12#2)
of the total fatty##3##4##(2005-12#2)(2007-11#1)
of the total femur length)##2##5##(2009-7#2)
of the total femur##3##4##(2009-7#3)
of the total gene##2##4##(2008-10#1)(2010-1#1)
of the total genetic variability##2##5##(2008-10#1)(2012-1#1)
of the total genetic variation was distributed##2##7##(2008-10#2)
of the total genetic variation##4##5##(2008-10#4)
of the total genetic##7##4##(2008-10#6)(2012-1#1)
of the total glaucoma patients##2##5##(2013-8#2)
of the total health##2##4##(1992-11#1)(1997-2#1)
of the total internal##2##4##(2008-1#1)(2008-3#1)
of the total linkage region##3##5##(1995-3#3)
of the total lipids##2##4##(1997-3#1)(2010-11#1)
of the total membrane##2##4##(1990-2#1)(1993-3#1)
of the total nitrogen##2##4##(2013-1#1)(2013-8#1)
of the total nuclear##2##4##(1990-7#1)(1992-12#1)
of the total number of##14##5##(1991-4#1)(1995-3#1)(1997-3#1)(2005-10#1)(2005-9#2)(2007-10#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-4#1)(2011-2#1)(2013-8#1)
of the total number##15##4##(1991-4#1)(1994-10#1)(1995-3#1)(1997-3#1)(2005-10#1)(2005-9#2)(2007-10#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-4#1)(2011-2#1)(2013-8#1)
of the total of##7##4##(1991-8#1)(2008-4#1)(2008-5#1)(2009-2#2)(2010-1#1)(2013-1#1)
of the total opioid sites##2##5##(1991-5#2)
of the total opioid##3##4##(1991-5#3)
of the total organic##2##4##(2007-7#1)(2011-1#1)
of the total patients##2##4##(2007-7#1)(2011-2#1)
of the total phenotypic variance##2##5##(2008-10#1)(2012-3#1)
of the total phenotypic variation for resistance in##2##8##(2008-10#2)
of the total phenotypic variation##3##5##(2008-10#3)
of the total phenotypic##6##4##(2008-10#5)(2012-3#1)
of the total population of the##2##6##(2008-1#1)(2008-5#1)
of the total population##7##4##(2008-1#2)(2008-10#2)(2008-5#1)(2008-8#1)(2013-8#1)
of the total power##3##4##(2006-6#1)(2007-11#1)(2010-8#1)
of the total protein in##3##5##(2006-12#1)(2008-10#2)
of the total protein##9##4##(1990-11#1)(1995-2#1)(1996-2#1)(2006-12#1)(2008-10#2)(2008-6#3)
of the total proteins in the##2##6##(2008-8#2)
of the total proteins in##3##5##(2008-8#3)
of the total radioactivity##3##4##(1992-2#1)(1993-11#1)(1996-6#1)
of the total recording time##2##5##(1992-8#1)(2007-12#1)
of the total recovery was##2##5##(2008-10#1)(2008-5#1)
of the total sample##3##4##(2006-6#1)(2006-8#1)(2008-10#1)
of the total scattered##2##4##(2008-2#2)
of the total serum##2##4##(1993-2#1)(2011-1#1)
of the total soluble protein##3##5##(1993-12#1)(1994-5#1)(2008-9#1)
of the total structure##2##4##(1995-2#1)(2008-3#1)
of the total suspended##2##4##(2013-1#1)(2013-8#1)
of the total value of##2##5##(2007-5#1)(2008-10#1)
of the total variance and##3##5##(2008-10#2)(2008-5#1)
of the total variance in the##2##6##(2008-10#1)(2008-8#1)
of the total variance in##5##5##(2008-10#1)(2008-8#1)(2010-12#2)(2011-2#1)
of the total variance of##2##5##(1993-8#1)(2008-10#1)
of the total variance##20##4##(1993-8#1)(1997-5#1)(2007-10#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-8#1)(2010-12#2)(2010-2#1)(2011-2#1)
of the total variation of##2##5##(2010-12#2)
of the total variation##6##4##(2008-10#2)(2008-8#1)(2010-12#2)(2013-1#1)
of the total##400##3##(1990-1#1)(1990-10#2)(1990-11#1)(1990-2#2)(1990-3#5)(1990-4#1)(1990-5#1)(1990-7#3)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#6)(1992-6#3)(1992-8#2)(1992-9#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#3)(1993-8#2)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#4)(1995-1#1)(1995-11#2)(1995-2#3)(1995-3#5)(1995-9#1)(1996-1#1)(1996-10#2)(1996-2#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#2)(1997-2#1)(1997-3#4)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-10#1)(2005-11#3)(2005-12#2)(2005-9#2)(2006-10#1)(2006-12#2)(2006-4#2)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#5)(2007-1#1)(2007-10#4)(2007-11#6)(2007-12#4)(2007-2#2)(2007-3#7)(2007-4#2)(2007-5#4)(2007-6#1)(2007-7#9)(2007-8#5)(2007-9#2)(2008-1#4)(2008-10#71)(2008-11#8)(2008-12#3)(2008-2#8)(2008-3#8)(2008-4#1)(2008-5#10)(2008-6#4)(2008-7#7)(2008-8#10)(2008-9#3)(2009-11#1)(2009-2#2)(2009-7#3)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#7)(2010-2#3)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#6)(2011-10#1)(2011-12#1)(2011-2#11)(2012-1#3)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#8)(2013-7#4)(2013-8#11)
of the total)##12##3##(1991-12#1)(1994-6#1)(1997-3#1)(2006-12#1)(2006-2#1)(2007-10#1)(2008-10#4)(2008-8#1)(2013-8#1)
of the totally##2##3##(1990-3#1)(2011-1#1)
of the toxic effects of##3##5##(2006-12#1)(2008-1#1)(2010-4#1)
of the toxic effects##4##4##(2006-12#1)(2008-1#1)(2010-4#1)(2011-12#1)
of the toxic##19##3##(1995-3#1)(2005-10#1)(2006-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-5#2)(2008-7#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)
of the toxicities##2##3##(2009-3#1)(2009-7#1)
of the toxicity of this##2##5##(1996-7#1)(2010-12#1)
of the toxicity of##8##4##(1992-3#1)(1994-5#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-7#1)(2010-12#1)(2010-7#1)
of the toxicity##16##3##(1990-5#1)(1992-3#1)(1994-5#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-7#1)(2005-8#1)(2008-10#2)(2008-6#2)(2008-7#1)(2010-12#1)(2010-7#1)(2012-3#1)
of the toxicokinetics of aluminum##2##5##(1996-8#2)
of the toxin from##2##4##(1993-7#1)(2012-12#1)
of the toxin has##2##4##(1991-5#1)(2008-10#1)
of the toxin in the##2##5##(1990-2#1)(2008-8#1)
of the toxin in##4##4##(1990-2#1)(1990-5#1)(2008-10#1)(2008-8#1)
of the toxin is##2##4##(1991-5#1)(1994-2#1)
of the toxin##28##3##(1990-2#2)(1990-3#2)(1990-5#1)(1991-10#1)(1991-12#1)(1991-5#2)(1993-7#1)(1994-2#6)(1994-3#1)(1994-9#1)(1996-8#1)(1997-6#2)(2008-10#3)(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#1)
of the toxins produced##2##4##(1997-4#1)(2008-10#1)
of the toxins##6##3##(1990-5#1)(1992-8#1)(1993-12#1)(1994-3#1)(1997-4#1)(2008-10#1)
of the trace elements in##2##5##(2008-10#1)(2013-8#1)
of the trace elements##3##4##(2005-11#1)(2008-10#1)(2013-8#1)
of the trace metals##2##4##(2008-10#1)(2008-5#1)
of the trace##11##3##(2005-11#1)(2005-4#1)(2008-10#5)(2008-5#1)(2013-1#2)(2013-8#1)
of the tracer##6##3##(1990-12#1)(1990-5#1)(1995-12#1)(2008-2#1)(2010-12#1)(2010-2#1)
of the trachea and##4##4##(2007-8#1)(2008-5#1)(2009-9#1)(2010-12#1)
of the trachea##18##3##(1991-11#1)(1994-3#1)(1996-3#1)(1997-3#1)(2007-8#2)(2008-5#3)(2008-8#2)(2009-2#1)(2009-9#1)(2010-12#1)(2010-5#2)(2011-1#2)
of the tracheae##2##3##(2007-12#2)
of the tracheal walls##2##4##(2007-12#2)
of the tracheal wound##2##4##(2009-6#2)
of the tracheal##10##3##(1990-4#1)(1996-3#1)(1997-1#1)(2007-12#4)(2009-6#2)(2013-1#1)
of the tracheobronchial circulation in##2##5##(1996-1#1)(1997-1#1)
of the tracked##4##3##(2007-11#1)(2008-6#1)(2009-12#1)(2012-2#1)
of the tracking##3##3##(2008-2#2)(2008-3#1)
of the trade##5##3##(1990-7#1)(2006-1#1)(2007-5#1)(2007-8#1)(2010-11#1)
of the trade-off between##2##4##(2007-3#1)(2008-2#1)
of the trade-off##3##3##(2007-3#1)(2008-2#1)(2010-8#1)
of the traditional Chinese##2##4##(1992-2#1)(2010-2#1)
of the traditional methods##2##4##(2008-10#1)(2010-8#1)
of the traditional technique##2##4##(2006-7#1)(2013-1#1)
of the traditional##36##3##(1991-12#1)(1991-2#1)(1992-1#1)(1992-2#1)(1994-2#1)(1995-1#1)(1996-5#1)(1997-2#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#2)(2009-12#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#2)
of the trafficking##2##3##(2008-5#1)(2013-7#1)
of the train##2##3##(2006-5#1)(2008-2#1)
of the trained##5##3##(2007-6#1)(2008-12#1)(2008-2#1)(2013-1#1)(2013-7#1)
of the training period##2##4##(2005-1#1)(2010-12#1)
of the training program##3##4##(1991-2#1)(2007-4#1)(2008-1#1)
of the training##25##3##(1991-2#1)(1991-3#2)(1991-5#1)(1993-2#1)(1994-1#1)(1994-12#1)(1995-2#1)(2005-1#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#1)(2009-2#1)(2010-12#2)(2010-7#1)(2012-1#1)(2013-8#1)
of the trait##6##3##(2006-5#1)(2009-4#1)(2012-3#4)
of the traits##2##3##(1997-4#1)(2013-8#1)
of the trajectories of##2##4##(2011-1#1)(2013-7#1)
of the trajectories##3##3##(2006-10#1)(2011-1#1)(2013-7#1)
of the trans isomer##4##4##(1991-5#2)(2008-5#2)
of the trans##11##3##(1990-8#1)(1990-9#1)(1991-5#2)(1992-4#2)(2008-10#1)(2008-5#2)(2010-2#2)
of the transactivation##2##3##(1993-8#1)(1997-1#1)
of the transcatheter##3##3##(1997-8#1)(2010-8#1)(2013-1#1)
of the transcript of##2##4##(1991-5#1)(1997-2#1)
of the transcript##9##3##(1990-9#1)(1991-5#2)(1993-12#1)(1995-4#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-7#1)
of the transcription bubble##2##4##(1995-2#2)
of the transcription complex##2##4##(1990-4#1)(1996-7#1)
of the transcription cycle##2##4##(1990-8#2)
of the transcription factor Sp1##2##5##(1991-4#1)(1992-12#1)
of the transcription factor##26##4##(1991-11#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-8#2)(1993-12#2)(1993-9#1)(1994-11#1)(1994-8#2)(1996-5#3)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#2)
of the transcription factors##3##4##(1997-7#2)(2009-4#1)
of the transcription initiation site##2##5##(1990-12#1)(1997-4#1)
of the transcription initiation##3##4##(1990-12#1)(1992-5#1)(1997-4#1)
of the transcription of##2##4##(1991-12#1)(2008-1#1)
of the transcription start point (tsp)##3##6##(1993-2#1)(1993-3#1)(1994-12#1)
of the transcription start site##7##5##(1990-5#1)(1991-3#1)(1992-2#1)(1994-3#1)(1994-8#2)(1994-9#1)
of the transcription start##11##4##(1990-5#1)(1991-3#1)(1992-2#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-8#2)(1994-9#1)(1997-2#1)
of the transcription##57##3##(1990-12#1)(1990-4#1)(1990-5#2)(1990-8#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-8#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#4)(1994-9#2)(1995-2#2)(1996-5#3)(1996-7#1)(1997-2#1)(1997-4#1)(1997-7#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-4#1)(2009-6#1)(2010-12#2)(2011-1#1)(2012-12#1)(2012-3#2)
of the transcriptional activity##2##4##(1995-8#1)(1996-4#1)
of the transcriptional initiation##2##4##(1994-3#1)(2008-9#1)
of the transcriptional regulatory##2##4##(1990-8#1)(1992-3#1)
of the transcriptional status of##2##5##(1995-2#1)(2013-1#1)
of the transcriptional##18##3##(1990-11#1)(1990-8#1)(1991-5#1)(1992-3#1)(1994-3#2)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-4#1)(1996-7#2)(1997-6#1)(2008-6#1)(2008-9#2)(2013-1#1)
of the transcriptome##4##3##(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
of the transcripts and##2##4##(1997-2#1)(2009-10#1)
of the transcripts of the##5##5##(1990-8#1)(1993-11#1)(1995-3#2)(1997-2#1)
of the transcripts of##6##4##(1990-8#1)(1993-11#1)(1995-3#2)(1997-2#2)
of the transcripts##14##3##(1990-8#1)(1992-8#1)(1993-11#1)(1994-12#2)(1995-3#2)(1995-4#1)(1995-8#1)(1996-8#1)(1997-2#3)(2009-10#1)
of the transducer##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
of the transfectant##2##3##(1993-8#1)(1995-5#1)
of the transfectants##2##3##(1992-5#1)(1993-1#1)
of the transfected cells##6##4##(1992-9#1)(1993-6#1)(1994-8#3)(2008-11#1)
of the transfected##14##3##(1992-2#2)(1992-9#1)(1993-6#1)(1994-6#1)(1994-8#4)(1996-5#1)(1997-5#1)(2008-11#1)(2008-2#1)(2008-4#1)
of the transfecting##2##3##(1997-7#1)(2008-11#1)
of the transfer of the##2##5##(1993-11#1)(1994-12#1)
of the transfer of##7##4##(1993-11#1)(1994-12#2)(1996-5#1)(1997-4#1)(2008-10#2)
of the transfer##17##3##(1991-2#2)(1991-7#1)(1993-11#1)(1993-12#1)(1994-12#2)(1996-5#2)(1997-2#1)(1997-4#1)(2005-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-11#1)
of the transferase##2##3##(1991-10#1)(1995-5#1)
of the transferred gene##2##4##(1995-7#1)(2008-8#1)
of the transferred##4##3##(1990-7#1)(1995-7#1)(2008-8#1)(2012-11#1)
of the transferrin family of##2##5##(1994-3#1)(1996-5#1)
of the transferrin family##3##4##(1994-3#2)(1996-5#1)
of the transferrin##6##3##(1990-11#1)(1992-4#1)(1994-3#2)(1996-5#1)(1996-7#1)
of the transformants##8##3##(1990-5#1)(1990-8#1)(1996-7#1)(1997-8#1)(2008-10#2)(2008-8#1)(2012-2#1)
of the transformation frequency below the spontaneous##2##7##(2008-7#2)
of the transformation of##4##4##(1993-7#1)(1995-4#1)(2004-9#1)(2008-10#1)
of the transformation zone##6##4##(1994-12#1)(1994-2#2)(2006-10#2)(2011-2#1)
of the transformation##13##3##(1993-7#1)(1994-12#1)(1994-2#2)(1995-4#1)(1996-4#1)(2004-9#1)(2006-10#2)(2008-10#1)(2008-7#2)(2011-2#1)
of the transformations##5##3##(2004-4#1)(2008-10#1)(2008-11#2)(2008-12#1)
of the transformed cell##2##4##(1993-6#1)(2008-11#1)
of the transformed cells##5##4##(1991-2#2)(1992-9#1)(1993-7#1)(2008-11#1)
of the transformed phenotype##4##4##(1990-7#1)(1994-9#1)(1995-6#1)(1997-2#1)
of the transformed##18##3##(1990-7#2)(1991-2#2)(1992-9#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-9#1)(1995-2#1)(1995-6#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)
of the transforming growth factor beta##2##6##(1995-8#1)(2007-8#1)
of the transforming growth factor##5##5##(1995-8#1)(2007-8#1)(2008-11#1)(2011-2#1)(2012-12#1)
of the transforming growth factor-beta superfamily##2##6##(1992-4#1)(1993-12#1)
of the transforming growth factor-beta##5##5##(1992-4#1)(1993-12#1)(1994-8#1)(1995-11#1)(2007-12#1)
of the transforming growth##10##4##(1992-4#1)(1993-12#1)(1994-8#1)(1995-11#1)(1995-8#1)(2007-12#1)(2007-8#1)(2008-11#1)(2011-2#1)(2012-12#1)
of the transforming##13##3##(1991-6#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-8#1)(1995-11#1)(1995-8#1)(2007-12#1)(2007-8#1)(2008-11#1)(2011-2#1)(2012-12#1)
of the transfusion##3##3##(1996-9#1)(1997-5#1)(2010-11#1)
of the transgene in##3##4##(1995-12#1)(1995-2#1)(2008-10#1)
of the transgene##21##3##(1990-8#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(2006-12#1)(2008-10#8)(2008-8#2)(2009-8#2)(2012-12#1)(2012-3#1)
of the transgenes and##2##4##(1994-5#1)(2008-11#1)
of the transgenes in the##2##5##(2006-12#2)
of the transgenes##8##3##(1994-5#1)(2006-12#4)(2008-11#1)(2010-12#1)(2011-1#1)
of the transgenic lines##2##4##(2008-10#2)
of the transgenic mice and##2##5##(1995-8#2)
of the transgenic mice##4##4##(1994-2#1)(1995-8#2)(2007-10#1)
of the transgenic##8##3##(1994-2#1)(1994-3#1)(1995-2#1)(1995-8#2)(2007-10#1)(2008-10#2)
of the transient##9##3##(1993-9#1)(1996-5#1)(2005-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#3)
of the transit##4##3##(1990-2#1)(1992-12#1)(1992-3#1)(2007-11#1)
of the transition from##2##4##(2007-12#1)(2008-6#1)
of the transition protein 2 gene##2##6##(1993-11#2)
of the transition state and##2##5##(1996-11#1)(2008-4#1)
of the transition state for##2##5##(1996-11#2)
of the transition state of##2##5##(1995-10#1)(1996-11#1)
of the transition state##12##4##(1990-5#2)(1991-2#1)(1995-10#1)(1996-11#5)(2007-11#2)(2008-4#1)
of the transition to adulthood##2##5##(2009-7#1)(2011-2#1)
of the transition zone##3##4##(2009-2#2)(2013-7#1)
of the transition##44##3##(1990-4#1)(1990-5#2)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-9#1)(1993-11#2)(1993-6#1)(1994-8#1)(1995-1#3)(1995-10#1)(1996-11#5)(2006-12#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#2)(2008-10#4)(2008-3#3)(2008-4#1)(2008-6#1)(2009-2#2)(2009-7#1)(2011-2#1)(2013-7#1)
of the transitions are measured##2##5##(2006-12#1)(2008-2#1)
of the transitions##4##3##(1992-9#1)(2006-12#1)(2008-2#1)(2011-3#1)
of the translated##3##3##(1992-1#1)(1997-7#1)(2009-12#1)
of the translation apparatus##2##4##(2005-10#1)(2013-8#1)
of the translation initiation##4##4##(1992-11#1)(1997-2#1)(1997-6#1)(2013-7#1)
of the translation start site##4##5##(1997-2#2)(2008-11#1)(2008-9#1)
of the translation start##6##4##(1995-12#1)(1997-2#3)(2008-11#1)(2008-9#1)
of the translation##21##3##(1990-5#1)(1991-4#1)(1992-11#1)(1992-2#1)(1994-9#1)(1995-12#1)(1996-4#1)(1997-1#1)(1997-2#5)(1997-6#1)(2005-10#1)(2008-11#1)(2008-2#2)(2008-9#1)(2013-7#1)(2013-8#1)
of the translational start##4##4##(1990-11#1)(1990-3#1)(1997-7#1)(2008-4#1)
of the translational##9##3##(1990-11#1)(1990-3#1)(1990-5#1)(1994-8#1)(1997-7#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-3#1)
of the translocation##8##3##(1991-5#1)(1992-8#1)(1993-8#1)(1993-9#2)(2008-1#1)(2008-10#1)(2012-2#1)
of the transmembrane domain of the TSH receptor##2##8##(1992-12#2)
of the transmembrane domain##4##4##(1992-12#2)(1994-9#1)(1996-5#1)
of the transmembrane potential##2##4##(1994-12#1)(2007-3#1)
of the transmembrane##21##3##(1990-5#1)(1990-9#1)(1991-4#1)(1992-12#4)(1994-12#1)(1994-9#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-4#1)(1996-5#1)(1996-9#2)(2007-3#1)(2008-4#2)(2008-8#1)
of the transmission of##6##4##(1997-3#1)(2006-10#1)(2007-9#1)(2008-3#2)(2011-3#1)
of the transmission spectra of a##2##6##(2008-2#1)(2008-3#1)
of the transmission spectra of##3##5##(2008-2#1)(2008-3#2)
of the transmission spectra##4##4##(2008-1#1)(2008-2#1)(2008-3#2)
of the transmission spectrum of##2##5##(2007-12#1)(2008-2#1)
of the transmission spectrum##3##4##(2007-12#2)(2008-2#1)
of the transmission##34##3##(1997-3#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-11#3)(2007-12#6)(2007-9#1)(2008-1#2)(2008-10#2)(2008-2#3)(2008-3#10)(2009-11#1)(2011-3#1)(2012-11#1)
of the transmittance and the##2##5##(2008-3#2)
of the transmittance##6##3##(2008-2#3)(2008-3#3)
of the transmitted and##2##4##(2008-2#1)(2008-3#1)
of the transmitted beam##3##4##(2007-12#1)(2008-3#2)
of the transmitted fundamental##2##4##(2007-12#1)(2008-1#1)
of the transmitted light through the##2##6##(2008-2#1)(2008-3#1)
of the transmitted light##6##4##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)
of the transmitted##22##3##(2007-12#6)(2008-1#3)(2008-10#1)(2008-2#3)(2008-3#8)(2013-8#1)
of the transmitter##5##3##(2007-11#1)(2007-12#2)(2008-2#2)
of the transpapillary##2##3##(2007-5#1)(2013-1#1)
of the transparent##4##3##(2007-12#1)(2008-2#1)(2009-12#1)(2013-8#1)
of the transplant##6##3##(1995-2#2)(1997-8#1)(2008-1#2)(2013-1#1)
of the transplantation##4##3##(1995-9#1)(1996-9#1)(2008-11#1)(2008-5#1)
of the transplanted kidney##2##4##(2007-7#2)
of the transplanted##12##3##(1991-5#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-3#2)(2008-9#1)(2010-11#1)(2012-12#3)
of the transplants##2##3##(2007-2#1)(2008-8#1)
of the transport mean free path##3##6##(2007-12#2)(2008-3#1)
of the transport of##4##4##(1990-3#1)(2007-11#1)(2008-10#1)(2008-9#1)
of the transport system##3##4##(1990-3#1)(1997-1#1)(2008-10#1)
of the transport##22##3##(1990-3#2)(1991-5#2)(1992-6#1)(1992-7#1)(1995-5#2)(1995-8#1)(1996-11#1)(1997-1#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)
of the transporter##3##3##(1992-1#1)(1995-2#1)(1996-1#1)
of the transposable element##2##4##(1994-3#1)(2008-9#1)
of the transposed basilic vein fistula##2##6##(2007-7#2)
of the transposition##2##3##(1991-9#1)(1995-8#1)
of the transposon##3##3##(1997-2#2)(2008-10#1)
of the transthyretin gene##2##4##(1992-1#1)(1992-8#1)
of the transthyretin##3##3##(1991-3#1)(1992-1#1)(1992-8#1)
of the transverse carpal ligament##3##5##(2008-9#2)(2012-2#1)
of the transverse sinus##3##4##(2006-12#1)(2008-7#2)
of the transverse##26##3##(1991-2#1)(1991-9#1)(1993-3#1)(1993-9#1)(2006-12#1)(2007-11#2)(2007-12#4)(2008-2#1)(2008-3#2)(2008-7#2)(2008-9#2)(2009-3#1)(2009-6#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#2)
of the trap##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2009-8#1)
of the trapped##2##3##(1996-8#1)(2007-11#1)
of the trapping##4##3##(1992-9#1)(1996-4#1)(2008-10#1)(2008-2#1)
of the trauma patient##2##4##(2006-10#2)
of the trauma##7##3##(1993-11#1)(2006-10#2)(2006-11#1)(2007-10#1)(2007-9#1)(2011-1#1)
of the traumatic event##2##4##(2008-10#1)(2008-6#1)
of the traumatic lesions##2##4##(2007-11#1)(2007-7#1)
of the traumatic##9##3##(2007-11#1)(2007-7#2)(2008-10#1)(2008-6#1)(2008-7#1)(2012-1#2)(2012-12#1)
of the treated cells##2##4##(1990-9#1)(1992-6#1)
of the treated embryos##2##4##(2008-11#1)(2008-12#1)
of the treated group##2##4##(2007-8#1)(2009-8#1)
of the treated leg##3##4##(2007-11#1)(2007-8#1)(2012-11#1)
of the treated mice##3##4##(2006-8#1)(2008-4#1)(2008-8#1)
of the treated patients##2##4##(2007-7#1)(2013-8#1)
of the treated rats##2##4##(1996-10#1)(2009-4#1)
of the treated##44##3##(1990-9#1)(1992-6#1)(1994-12#1)(1994-5#2)(1996-10#1)(2005-11#1)(2006-11#2)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#4)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#4)(2008-8#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2012-1#2)(2012-11#1)(2012-12#1)(2013-8#2)
of the treating physician##4##4##(1992-8#1)(1993-12#1)(2011-1#2)
of the treating##6##3##(1992-8#1)(1993-12#1)(2006-5#1)(2010-2#1)(2011-1#2)
of the treatment and the##4##5##(1992-6#1)(2007-8#1)(2011-12#1)(2011-2#1)
of the treatment and##6##4##(1991-7#1)(1992-6#1)(2007-7#1)(2007-8#1)(2011-12#1)(2011-2#1)
of the treatment applied##2##4##(2007-7#2)
of the treatment effect##3##4##(1992-6#1)(1994-11#1)(1997-4#1)
of the treatment group##2##4##(2006-4#1)(2012-1#1)
of the treatment groups was##2##5##(1994-12#1)(1996-10#1)
of the treatment groups##5##4##(1991-2#1)(1994-12#3)(1996-10#1)
of the treatment in##2##4##(2007-8#1)(2013-1#1)
of the treatment is##5##4##(1994-4#1)(1996-12#1)(2007-12#1)(2008-10#1)(2011-1#1)
of the treatment methods applied##2##5##(2007-11#2)
of the treatment of acute##2##5##(2005-10#1)(2007-11#1)
of the treatment of iron-deficiency anemia]##2##6##(1996-10#1)(1996-4#1)
of the treatment of renal##2##5##(1992-5#1)(2008-10#1)
of the treatment of the##3##5##(1996-6#1)(2007-2#1)(2007-8#1)
of the treatment of##43##4##(1990-12#1)(1990-5#1)(1991-9#1)(1992-1#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-2#1)(1995-8#1)(1996-10#1)(1996-4#1)(1996-6#1)(1996-8#2)(1997-3#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-12#2)(2007-11#2)(2007-2#2)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#3)(2013-7#1)
of the treatment on##2##4##(2008-5#1)(2012-2#1)
of the treatment options##2##4##(2006-12#1)(2006-8#1)
of the treatment patients with##2##5##(1993-1#1)(2007-11#1)
of the treatment plan##2##4##(2011-2#1)(2012-2#1)
of the treatment process##2##4##(1992-5#1)(2008-7#1)
of the treatment protocol##2##4##(2007-8#1)(2013-8#1)
of the treatment regime##4##4##(2011-1#1)(2011-2#1)(2012-12#2)
of the treatment regimen##3##4##(1992-1#1)(2005-10#1)(2006-7#1)
of the treatment results of##2##5##(2007-11#1)(2008-7#1)
of the treatment results##3##4##(2007-11#1)(2008-7#1)(2011-2#1)
of the treatment to##3##4##(1991-12#1)(1994-2#1)(2013-8#1)
of the treatment was evaluated by##2##6##(2006-8#1)(2007-7#1)
of the treatment was##8##4##(1992-3#1)(1993-5#1)(1994-7#1)(2006-8#1)(2007-7#3)(2012-3#1)
of the treatment with##3##4##(1992-11#1)(2007-7#2)
of the treatment##200##3##(1990-10#3)(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-3#2)(1992-5#3)(1992-6#3)(1992-8#1)(1993-1#1)(1993-11#1)(1993-5#2)(1993-9#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-4#1)(1994-7#1)(1994-9#1)(1995-12#2)(1995-4#3)(1995-8#1)(1996-10#2)(1996-12#1)(1996-4#2)(1996-6#1)(1996-7#1)(1996-8#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(2005-10#3)(2005-7#1)(2006-10#3)(2006-12#3)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#3)(2007-11#11)(2007-12#2)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#10)(2007-8#7)(2008-1#6)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#1)(2009-11#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-2#1)(2011-1#6)(2011-12#2)(2011-2#8)(2012-1#2)(2012-12#6)(2012-2#2)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#4)
of the treatments##19##3##(1992-8#1)(1995-2#1)(1995-5#2)(1996-12#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-10#2)(2008-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-12#1)(2012-5#1)(2013-1#1)
of the tree Peltogyne purpurea##2##5##(2008-5#2)
of the tree canopy##2##4##(2008-10#2)
of the tree##14##3##(1995-3#1)(2006-11#1)(2007-3#1)(2008-10#3)(2008-5#3)(2008-6#1)(2008-7#1)(2010-3#1)(2010-6#2)
of the trees in a##2##5##(2008-10#2)
of the trees##3##3##(2008-10#2)(2008-5#1)
of the trehalose##2##3##(1991-9#2)
of the trematode##2##3##(2006-10#1)(2008-5#1)
of the trend##4##3##(1993-2#1)(1996-8#1)(2006-7#1)(2007-3#1)
of the trends in##2##4##(1996-9#1)(2008-10#1)
of the trends##3##3##(1993-2#1)(1996-9#1)(2008-10#1)
of the triad##2##3##(2009-4#1)(2010-1#1)
of the trial are##2##4##(1991-10#1)(1994-9#1)
of the trial was##2##4##(2004-1#1)(2009-4#1)
of the trial##34##3##(1991-10#1)(1991-3#3)(1993-1#1)(1993-5#1)(1994-6#2)(1994-9#1)(1997-2#1)(1997-6#1)(2004-1#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-5#1)(2008-10#4)(2008-3#2)(2008-5#1)(2008-8#3)(2009-11#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-3#1)
of the trials used##2##4##(2007-10#1)(2008-10#1)
of the trials##15##3##(1993-8#2)(1997-1#1)(1997-8#1)(2007-10#1)(2007-9#1)(2008-10#4)(2008-4#2)(2009-9#1)(2013-8#2)
of the triangle##3##3##(2008-6#1)(2010-12#1)(2011-2#1)
of the triangular##4##3##(1994-5#1)(2006-4#2)(2008-3#1)
of the triceps surae##2##4##(1991-5#1)(2007-11#1)
of the triceps##7##3##(1991-5#1)(2006-3#1)(2007-11#3)(2008-5#1)(2008-9#1)
of the tricuspid valve##3##4##(1997-2#1)(2007-8#1)(2012-12#1)
of the tricuspid##5##3##(1997-2#1)(2007-8#2)(2011-1#1)(2012-12#1)
of the tricyclic##3##3##(1996-5#2)(1997-2#1)
of the trifunctional protein##2##4##(1995-1#2)
of the trigeminal and sphenopalatine ganglions##2##6##(2006-11#2)
of the trigeminal complex##2##4##(1990-4#2)
of the trigeminal ganglion##3##4##(1997-3#1)(2006-7#1)(2008-7#1)
of the trigeminal nerve##16##4##(1990-12#1)(1991-8#2)(1992-8#1)(1995-11#2)(1996-5#2)(1997-8#1)(2006-11#1)(2007-3#1)(2011-2#4)(2013-7#1)
of the trigeminal sensory##2##4##(1990-4#1)(1995-7#1)
of the trigeminal##31##3##(1990-12#1)(1990-4#3)(1991-8#2)(1992-10#1)(1992-8#1)(1995-11#4)(1995-7#1)(1996-5#3)(1997-3#1)(1997-8#1)(2006-11#3)(2006-7#1)(2007-3#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#4)(2013-7#1)
of the trigger##3##3##(2006-6#1)(2008-9#1)(2011-1#1)
of the triggering##2##3##(1995-11#1)(2006-10#1)
of the trimer##5##3##(1994-9#1)(1996-7#2)(2006-3#1)(2008-8#1)
of the trimeric##4##3##(1991-12#1)(1994-9#1)(1996-7#1)(2006-9#1)
of the trimers##2##3##(2006-12#1)(2006-3#1)
of the tripartite##2##3##(1990-6#1)(2007-12#1)
of the tripeptide##2##3##(1992-5#1)(1992-6#1)
of the triple helix##3##4##(1992-2#1)(1997-4#1)(2008-4#1)
of the triple test in##2##5##(1990-10#1)(1996-12#1)
of the triple test##3##4##(1990-10#2)(1996-12#1)
of the triple##12##3##(1990-10#2)(1992-2#1)(1994-9#1)(1996-12#1)(1996-7#1)(1997-4#1)(1997-6#1)(2008-10#2)(2008-4#1)(2008-5#1)
of the triplet##5##3##(1995-1#1)(1997-7#1)(2006-11#2)(2010-4#1)
of the triplex##3##3##(1993-8#1)(1995-1#1)(1996-4#1)
of the triply##2##3##(1990-8#1)(2013-8#1)
of the trivalent##2##3##(1997-2#1)(2010-11#1)
of the trk family##2##4##(1996-3#2)
of the trocar##2##3##(2007-8#1)(2009-3#1)
of the tropharium##2##3##(2007-12#2)
of the trophic##4##3##(1997-1#1)(2007-3#1)(2008-5#2)
of the trophoblast##2##3##(1992-1#1)(1995-8#1)
of the tropical marine sponge Agelas oroides##2##7##(2007-1#2)
of the tropical##16##3##(2007-1#2)(2007-12#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-5#5)(2008-8#1)(2012-2#1)(2013-7#1)
of the troponin##3##3##(1990-12#1)(1991-12#1)(2008-3#1)
of the tropospheric##3##3##(2008-2#1)(2008-3#2)
of the true incidence of##2##5##(2006-8#1)(2007-2#1)
of the true lumen##2##4##(2007-8#1)(2012-2#1)
of the true value of##2##5##(1993-6#1)(2006-10#1)
of the true vocal fold##2##5##(2008-5#1)(2012-2#1)
of the true##34##3##(1990-6#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-9#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#5)(2008-5#2)(2008-7#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#3)
of the truncated##4##3##(1993-6#2)(1994-8#1)(1995-5#1)
of the trunk and##3##4##(2007-8#1)(2008-5#1)(2008-6#1)
of the trunk in##2##4##(2007-7#1)(2007-8#1)
of the trunk##12##3##(1995-8#2)(2007-7#2)(2007-8#3)(2008-5#1)(2008-6#3)(2010-12#1)
of the trypsin##2##3##(1990-11#1)(1991-9#1)
of the tryptic##3##3##(1990-3#1)(1997-2#1)(2008-10#1)
of the tryptophan residues are##2##5##(1990-8#1)(2006-10#1)
of the tryptophan residues to the##2##6##(1994-11#1)(2006-10#1)
of the tryptophan residues##9##4##(1990-8#1)(1991-7#1)(1994-11#1)(1994-9#1)(1997-8#2)(2006-10#2)(2008-10#1)
of the tryptophan##18##3##(1990-7#1)(1990-8#1)(1991-6#1)(1991-7#2)(1992-12#1)(1994-11#2)(1994-9#1)(1995-1#1)(1996-8#1)(1997-4#1)(1997-8#2)(2006-10#2)(2008-10#1)(2010-5#1)
of the tsp##3##3##(1991-8#1)(1995-8#1)(1996-8#1)
of the tsx gene##2##4##(1990-11#2)
of the tuatara##2##3##(2010-3#2)
of the tube and##4##4##(2005-4#1)(2006-6#1)(2008-7#1)(2010-5#1)
of the tube is##3##4##(1997-5#2)(2008-3#1)
of the tube stomach##3##4##(1993-2#3)
of the tube wall##2##4##(2005-11#2)
of the tube##17##3##(1993-2#3)(1994-9#1)(1997-5#2)(2005-11#2)(2005-4#1)(2006-6#1)(2008-3#2)(2008-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2013-1#1)
of the tuber##2##3##(2008-10#2)
of the tuberculin test##2##4##(1994-4#1)(2013-1#1)
of the tuberculin##4##3##(1991-5#1)(1994-4#1)(2012-12#1)(2013-1#1)
of the tuberculosis##4##3##(2007-8#1)(2010-12#1)(2010-4#1)(2013-8#1)
of the tuberomammillary##2##3##(1994-3#2)
of the tuberous sclerosis##2##4##(1993-12#1)(2008-7#1)
of the tubes with##2##4##(2008-7#1)(2011-1#1)
of the tubes##8##3##(1992-6#1)(1993-2#1)(2006-12#2)(2008-7#2)(2011-1#1)(2012-2#1)
of the tubular##4##3##(1994-9#1)(2006-10#1)(2008-2#1)(2009-1#1)
of the tubule##3##3##(1994-7#1)(2007-12#1)(2008-7#1)
of the tubulin##6##3##(1990-10#1)(1990-6#1)(1991-5#2)(1993-8#1)(1995-5#1)
of the tumor and chemotherapy##2##5##(2009-3#1)(2011-1#1)
of the tumor and its##2##5##(1990-9#1)(2005-9#1)
of the tumor and the##3##5##(1991-10#1)(1993-11#1)(2006-6#1)
of the tumor and##20##4##(1990-9#1)(1991-10#1)(1993-11#1)(1993-6#1)(2005-8#1)(2005-9#1)(2006-11#1)(2006-6#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-11#1)(2009-3#1)(2009-5#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-8#1)
of the tumor by##2##4##(2006-4#1)(2006-6#1)
of the tumor cells and##2##5##(1992-9#1)(1997-7#1)
of the tumor cells in##2##5##(1991-6#1)(1994-7#1)
of the tumor cells##11##4##(1991-6#1)(1992-7#1)(1992-9#2)(1994-7#1)(1995-10#1)(1996-3#1)(1997-7#1)(2007-12#1)(2008-5#1)(2008-8#1)
of the tumor from##2##4##(1990-10#1)(2006-12#1)
of the tumor in the##6##5##(1990-10#1)(1993-5#1)(2006-7#1)(2008-10#1)(2009-5#1)(2011-2#1)
of the tumor in##9##4##(1990-10#1)(1993-5#1)(2006-7#1)(2007-11#1)(2008-10#1)(2009-5#1)(2010-12#1)(2011-2#2)
of the tumor is##4##4##(2005-5#1)(2007-8#1)(2010-12#1)(2010-2#1)
of the tumor markers CA 15-3 and CASA##2##8##(2006-10#2)
of the tumor markers##3##4##(2006-10#2)(2010-1#1)
of the tumor mass##3##4##(1990-9#1)(2006-12#1)(2009-4#1)
of the tumor microenvironment##4##4##(2009-3#1)(2010-3#1)(2011-1#1)(2013-8#1)
of the tumor necrosis factor##4##5##(1995-1#1)(1996-5#3)
of the tumor necrosis##6##4##(1992-8#1)(1995-1#1)(1996-5#3)(2013-7#1)
of the tumor position##3##4##(2009-11#3)
of the tumor showed##3##4##(2007-10#1)(2008-11#1)(2012-12#1)
of the tumor suppressor protein##2##5##(2009-9#1)(2010-12#1)
of the tumor suppressor##5##4##(2007-8#1)(2008-7#1)(2009-9#1)(2010-12#1)(2013-1#1)
of the tumor to##2##4##(1995-5#1)(2012-3#1)
of the tumor vasculature##4##4##(1993-9#1)(1994-5#1)(2008-5#1)(2009-3#1)
of the tumor was achieved##2##5##(2008-8#1)(2011-2#1)
of the tumor was performed##4##5##(2006-8#1)(2006-9#1)(2010-9#1)(2013-1#1)
of the tumor was##17##4##(1992-10#1)(1994-7#1)(1996-4#1)(2005-10#1)(2006-12#2)(2006-2#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-7#2)(2008-8#1)(2010-6#1)(2010-9#1)(2011-2#1)(2013-1#1)
of the tumor were##3##4##(1991-8#1)(2008-2#1)(2008-5#1)
of the tumor with##5##4##(2007-11#2)(2007-6#1)(2009-3#1)(2013-1#1)
of the tumor##217##3##(1990-10#2)(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-10#1)(1991-12#3)(1991-4#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-7#1)(1992-8#1)(1992-9#7)(1993-11#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-5#2)(1994-6#1)(1994-7#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-4#1)(1995-5#1)(1995-7#1)(1996-10#1)(1996-3#2)(1996-4#2)(1996-5#3)(1997-1#1)(1997-7#1)(2005-10#1)(2005-5#1)(2005-8#1)(2005-9#1)(2006-10#6)(2006-11#1)(2006-12#8)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#4)(2006-7#2)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#8)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#9)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#3)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#4)(2009-1#1)(2009-11#3)(2009-2#3)(2009-3#7)(2009-4#1)(2009-5#6)(2009-9#1)(2010-1#1)(2010-12#8)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#4)(2011-1#4)(2011-2#8)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#6)(2013-7#2)(2013-8#5)
of the tumor's##4##3##(2006-12#1)(2006-6#1)(2008-6#1)(2011-1#1)
of the tumors was##4##4##(1995-5#2)(2007-8#1)(2009-7#1)
of the tumors were##3##4##(1992-4#1)(1993-7#1)(2006-8#1)
of the tumors##30##3##(1990-12#1)(1990-5#1)(1991-12#1)(1991-5#1)(1992-4#1)(1992-9#2)(1993-7#2)(1995-5#2)(2005-11#1)(2005-9#1)(2006-1#1)(2006-12#2)(2006-5#1)(2006-8#1)(2007-8#1)(2008-11#1)(2008-6#3)(2009-5#3)(2009-7#1)(2010-1#1)(2010-3#1)(2012-2#1)
of the tumour and##4##4##(1992-6#1)(1992-8#1)(2008-7#1)(2012-12#1)
of the tumour cells##3##4##(2008-5#1)(2008-6#2)
of the tumour following##2##4##(2008-6#2)
of the tumour in##2##4##(1991-5#1)(2007-11#1)
of the tumour is##3##4##(2008-7#1)(2011-1#1)(2013-8#1)
of the tumour suppressor gene##2##5##(1997-5#1)(2007-9#1)
of the tumour suppressor##3##4##(1991-11#1)(1997-5#1)(2007-9#1)
of the tumour to##3##4##(1990-2#1)(2008-1#1)(2008-9#1)
of the tumour was##4##4##(2008-7#3)(2012-12#1)
of the tumour##79##3##(1990-1#1)(1990-2#1)(1990-4#1)(1990-9#2)(1991-11#1)(1991-5#1)(1991-6#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-8#1)(1994-4#1)(1996-4#1)(1997-5#1)(1997-6#1)(2004-1#1)(2006-10#1)(2007-11#4)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#3)(2008-6#11)(2008-7#13)(2008-9#1)(2009-3#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#1)(2012-12#9)(2013-1#3)(2013-8#2)
of the tumours were##4##4##(1990-12#2)(2006-8#2)
of the tumours##15##3##(1990-12#2)(1990-5#1)(1993-5#1)(2006-10#1)(2006-8#6)(2008-10#1)(2008-6#2)(2013-1#1)
of the tungsten##2##3##(2008-10#2)
of the tunica##4##3##(1996-7#1)(2008-10#1)(2009-10#1)(2011-1#1)
of the tunicate##2##3##(1997-6#1)(2008-5#1)
of the tuning##4##3##(2007-11#1)(2008-2#2)(2012-3#1)
of the tunnel##6##3##(1991-12#1)(1994-11#2)(1997-1#1)(2005-12#1)(2007-12#1)
of the tunneling##4##3##(1995-2#1)(2007-12#2)(2008-3#1)
of the turbid##4##3##(2008-2#2)(2008-3#2)
of the turbulence##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
of the turbulent##2##3##(2007-12#1)(2008-3#1)
of the turning point##2##4##(1993-1#1)(1995-7#1)
of the turnover##3##3##(1990-12#1)(1990-3#1)(1996-3#1)
of the turtle##2##3##(1994-5#1)(2007-3#1)
of the twelve##4##3##(1993-12#1)(1994-9#1)(2008-8#1)(2011-3#1)
of the twentieth century##17##4##(2005-7#1)(2007-11#1)(2008-10#1)(2008-7#3)(2008-8#1)(2009-2#1)(2009-7#2)(2010-1#1)(2010-7#1)(2011-2#3)(2012-2#2)
of the twentieth##18##3##(2005-7#1)(2007-11#1)(2008-10#1)(2008-7#3)(2008-8#1)(2009-2#1)(2009-7#2)(2010-1#2)(2010-7#1)(2011-2#3)(2012-2#2)
of the twenty##2##3##(2007-1#1)(2008-1#1)
of the twenty-first century##5##4##(1994-2#1)(1997-1#1)(1997-3#1)(2006-7#1)(2008-12#1)
of the twin##2##3##(1996-12#1)(1997-5#1)
of the two acids##2##4##(1991-7#1)(2008-5#1)
of the two agents##3##4##(1992-1#1)(1997-1#1)(2008-8#1)
of the two alleles##2##4##(1995-1#1)(2006-2#1)
of the two amino groups##2##5##(2006-10#2)
of the two analytes##3##4##(2008-10#3)
of the two analytical methods##2##5##(2008-10#1)(2010-5#1)
of the two bacterial##2##4##(1994-3#1)(2006-5#1)
of the two basic##2##4##(2005-10#1)(2008-3#1)
of the two beams##2##4##(2007-12#1)(2008-3#1)
of the two binding sites##2##5##(1991-4#1)(1992-9#1)
of the two binding##3##4##(1991-4#1)(1992-9#1)(1995-8#1)
of the two cell lines##3##5##(2008-11#1)(2008-9#2)
of the two cell##4##4##(1990-11#1)(2008-11#1)(2008-9#2)
of the two classes of##3##5##(1991-6#1)(1997-8#1)(2008-2#1)
of the two complexes##2##4##(1992-6#1)(1996-2#1)
of the two components##8##4##(1991-7#1)(1995-3#1)(2005-11#2)(2007-12#2)(2008-2#1)(2008-6#1)
of the two compounds##2##4##(2008-10#2)
of the two conditions##2##4##(2007-10#1)(2011-2#1)
of the two constituents##2##4##(2008-10#2)
of the two corresponding##3##4##(1996-12#1)(2013-8#2)
of the two coupled##2##4##(2007-12#1)(2008-3#1)
of the two different##5##4##(1994-8#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-5#1)
of the two diseases##5##4##(2008-10#5)
of the two disorders##2##4##(2007-6#1)(2008-10#1)
of the two distribution##2##4##(2008-10#1)(2011-1#1)
of the two domains of##3##5##(1991-9#1)(1992-3#1)(1995-6#1)
of the two domains##5##4##(1991-9#1)(1992-3#1)(1995-6#1)(1996-7#1)(2008-4#1)
of the two drugs in##3##5##(1993-2#1)(2008-10#1)(2011-2#1)
of the two drugs on##2##5##(1997-4#1)(2011-1#1)
of the two drugs##13##4##(1990-9#1)(1992-3#1)(1993-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1997-4#1)(2008-10#1)(2008-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
of the two dyes##2##4##(2005-4#1)(2008-2#1)
of the two enzymes##9##4##(1992-4#1)(1994-3#2)(1995-10#1)(1995-5#1)(1995-7#2)(1996-9#1)(2008-10#1)
of the two epitopes##2##4##(1995-2#1)(2008-8#1)
of the two extreme##2##4##(2008-11#1)(2008-2#1)
of the two fatty##2##4##(1990-11#1)(1991-5#1)
of the two for##3##4##(1994-2#1)(2008-10#1)(2012-1#1)
of the two forms of##5##5##(1990-2#1)(1991-12#1)(1997-4#1)(2008-10#1)(2010-5#1)
of the two genes##12##4##(1990-8#1)(1991-2#2)(1991-9#1)(1993-3#1)(1993-6#1)(1995-8#1)(1996-11#1)(1996-3#1)(1997-7#2)(2008-9#1)
of the two groups was##2##5##(2007-8#1)(2011-2#1)
of the two groups were##3##5##(1996-5#1)(2007-7#1)(2008-6#1)
of the two groups##15##4##(1991-3#1)(1994-6#1)(1995-12#1)(1996-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
of the two human##2##4##(1991-12#1)(1992-12#1)
of the two hydrogenases##2##4##(1990-8#1)(1996-9#1)
of the two input##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
of the two is##3##4##(2010-7#1)(2011-2#2)
of the two isolated##2##4##(1990-12#1)(1994-12#1)
of the two isolates##2##4##(2008-10#2)
of the two key##2##4##(1994-9#1)(2012-2#1)
of the two kinds of macrocycle stationary phases##2##8##(2008-10#2)
of the two kinds of##3##5##(2008-10#2)(2008-8#1)
of the two known##2##4##(1991-12#1)(1992-3#1)
of the two lasers##4##4##(2007-12#1)(2008-3#2)(2011-1#1)
of the two layers##3##4##(2008-2#2)(2008-3#1)
of the two ligands##2##4##(1995-1#1)(1997-2#1)
of the two mRNAs##2##4##(1994-6#1)(1996-11#1)
of the two main components of##2##6##(1993-8#1)(2008-1#1)
of the two main##4##4##(1993-8#1)(2008-1#1)(2008-10#1)(2010-8#1)
of the two major metabolites of##2##6##(1990-12#1)(1990-6#1)
of the two major##15##4##(1990-12#1)(1990-3#1)(1990-6#1)(1991-3#1)(1992-6#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-5#1)(2008-10#1)(2008-2#2)(2008-8#1)(2009-6#1)(2011-2#1)
of the two materials##4##4##(2004-9#2)(2007-12#1)(2013-1#1)
of the two mating##2##4##(1992-12#1)(2008-10#1)
of the two metals##2##4##(2008-10#2)
of the two methods was##2##5##(1995-2#1)(2007-12#1)
of the two methods##8##4##(1995-2#1)(2007-12#1)(2007-8#2)(2008-10#3)(2012-2#1)
of the two models##3##4##(2008-10#1)(2008-2#1)(2009-8#1)
of the two most##6##4##(2006-3#2)(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
of the two mouse##2##4##(1993-6#1)(1996-10#1)
of the two new##3##4##(2006-12#1)(2007-1#1)(2008-11#1)
of the two oils##2##4##(1993-8#1)(2008-11#1)
of the two orthogonal##2##4##(2007-12#1)(2008-2#1)
of the two parameters##2##4##(2008-2#1)(2008-6#1)
of the two pathogens##2##4##(2008-10#1)(2010-4#1)
of the two patients##2##4##(1991-10#1)(2007-12#1)
of the two peptide fragments##2##5##(1991-7#1)(2006-12#1)
of the two peptides##6##4##(1990-10#1)(1992-11#1)(1994-11#1)(1995-11#1)(2006-12#1)(2008-10#1)
of the two phases##5##4##(1990-10#1)(2008-10#2)(2008-5#1)(2008-7#1)
of the two plant##2##4##(2007-1#1)(2008-10#1)
of the two preparations##2##4##(1992-8#1)(2004-12#1)
of the two procedures##4##4##(1995-1#1)(2005-5#1)(2008-10#2)
of the two processes##2##4##(1996-11#1)(2009-8#1)
of the two proteins was##2##5##(1990-12#1)(1994-11#1)
of the two proteins##9##4##(1990-11#2)(1990-12#1)(1990-7#1)(1991-12#1)(1991-2#1)(1994-11#1)(1996-4#1)(1997-1#1)
of the two receptor##3##4##(1990-8#1)(1991-12#1)(1996-12#1)
of the two regions##2##4##(1990-10#1)(2008-8#1)
of the two resistance##2##4##(2008-10#2)
of the two responses##3##4##(1995-4#1)(1997-4#1)(2008-10#1)
of the two second##2##4##(1991-6#1)(2008-10#1)
of the two series of##2##5##(1995-11#1)(2008-10#1)
of the two series##3##4##(1995-11#1)(2008-10#1)(2008-4#1)
of the two sets of##3##5##(1994-9#1)(1995-8#1)(2008-10#1)
of the two signals##2##4##(1996-1#1)(2008-2#1)
of the two sites##4##4##(1990-3#1)(1990-7#2)(1991-3#1)
of the two species is##2##5##(1991-7#1)(2008-10#1)
of the two species##20##4##(1990-10#1)(1991-7#1)(1993-2#1)(1994-3#1)(2007-6#1)(2008-10#4)(2008-5#2)(2008-8#1)(2008-9#1)(2010-8#3)(2011-12#1)(2011-2#2)(2012-5#1)
of the two sterols##3##4##(2006-10#3)
of the two strains##3##4##(1996-10#1)(2008-10#1)(2009-6#1)
of the two structures##3##4##(2008-10#1)(2010-6#1)(2012-2#1)
of the two study groups##2##5##(1991-11#1)(2010-4#1)
of the two substrates##4##4##(1994-5#2)(1997-2#1)(2008-7#1)
of the two subunits of##2##5##(1993-8#1)(2006-8#1)
of the two subunits##8##4##(1991-10#1)(1991-12#1)(1993-11#1)(1993-6#1)(1993-8#1)(2006-10#1)(2006-8#1)(2011-1#1)
of the two tasks##2##4##(1991-2#1)(1994-8#1)
of the two techniques##5##4##(2008-10#1)(2008-4#1)(2008-7#1)(2010-5#1)(2010-9#1)
of the two tests##2##4##(1991-6#1)(2012-12#1)
of the two tryptophan residues##2##5##(1992-6#1)(1993-11#1)
of the two types of##10##5##(1990-7#1)(1991-12#1)(1993-11#1)(1995-12#1)(1996-4#1)(2005-11#1)(2006-12#1)(2008-2#1)(2008-5#2)
of the two types##13##4##(1990-7#1)(1991-12#1)(1993-11#1)(1995-12#1)(1996-4#1)(2005-11#1)(2005-4#1)(2006-12#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-5#2)
of the two viruses##4##4##(2007-6#1)(2008-10#2)(2008-9#1)
of the two wave fronts##2##5##(2008-2#1)(2008-3#1)
of the two wavelengths##2##4##(2008-1#1)(2008-2#1)
of the two years##2##4##(2008-10#1)(2008-5#1)
of the two##757##3##(1990-1#1)(1990-10#6)(1990-11#5)(1990-12#8)(1990-2#5)(1990-3#2)(1990-4#1)(1990-5#4)(1990-6#2)(1990-7#7)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#5)(1991-12#10)(1991-2#4)(1991-3#6)(1991-4#2)(1991-5#1)(1991-6#7)(1991-7#5)(1991-8#4)(1991-9#5)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#1)(1992-3#9)(1992-4#1)(1992-5#1)(1992-6#8)(1992-8#3)(1992-9#3)(1993-11#5)(1993-12#2)(1993-2#3)(1993-3#5)(1993-6#5)(1993-8#5)(1994-1#1)(1994-10#2)(1994-11#6)(1994-12#4)(1994-2#3)(1994-3#5)(1994-5#4)(1994-6#4)(1994-8#11)(1994-9#6)(1995-1#7)(1995-10#3)(1995-11#3)(1995-12#4)(1995-2#4)(1995-3#4)(1995-4#1)(1995-5#3)(1995-6#3)(1995-7#3)(1995-8#5)(1995-9#1)(1996-1#2)(1996-10#3)(1996-11#6)(1996-12#3)(1996-2#5)(1996-3#3)(1996-4#5)(1996-5#6)(1996-7#1)(1996-8#2)(1996-9#4)(1997-1#4)(1997-2#6)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#5)(2004-10#2)(2004-11#1)(2004-12#1)(2004-2#1)(2004-9#4)(2005-10#1)(2005-11#7)(2005-12#1)(2005-4#3)(2005-5#2)(2006-10#7)(2006-11#1)(2006-12#9)(2006-2#1)(2006-3#4)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#5)(2007-10#1)(2007-11#6)(2007-12#18)(2007-6#4)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#7)(2008-10#99)(2008-11#11)(2008-12#4)(2008-2#36)(2008-3#35)(2008-4#9)(2008-5#15)(2008-6#7)(2008-7#8)(2008-8#15)(2008-9#12)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#4)(2010-12#1)(2010-3#1)(2010-4#3)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#10)(2011-12#4)(2011-2#13)(2012-1#3)(2012-12#3)(2012-2#11)(2012-3#1)(2012-5#2)(2012-6#1)(2013-1#9)(2013-7#1)(2013-8#7)
of the two-color##2##3##(2008-3#2)
of the two-component##3##3##(1996-12#2)(1997-4#1)
of the two-dimensional emissivity##2##4##(2008-3#2)
of the two-dimensional##23##3##(1990-4#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#5)(2008-3#8)(2010-1#1)(2010-12#2)
of the two-node model##2##4##(1992-3#2)
of the two-photon absorption coefficient##2##5##(2007-11#1)(2008-2#1)
of the two-photon excitation##2##4##(2008-2#1)(2008-3#1)
of the two-photon##7##3##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#2)
of the two-state##3##3##(1990-8#1)(1997-2#2)
of the two-step##2##3##(2007-12#1)(2008-10#1)
of the two-stranded alpha-helical coiled-coil##3##5##(1992-6#2)(1993-3#1)
of the two-winged Cloeodes##2##4##(2013-8#2)
of the two-year##2##3##(1995-5#1)(2007-3#1)
of the twofold##2##3##(1990-12#1)(2008-3#1)
of the tympanic##2##3##(2008-2#1)(2008-4#1)
of the type 1##6##4##(1992-2#1)(1992-3#1)(1992-7#1)(1994-12#1)(1996-4#1)(2008-3#1)
of the type A gamma-aminobutyric acid receptor##2##7##(1994-3#2)
of the type I IFN##2##5##(1996-11#1)(2012-2#1)
of the type I and##2##5##(1990-6#1)(1996-5#1)
of the type I##11##4##(1990-6#1)(1992-3#1)(1992-5#1)(1995-3#1)(1996-11#1)(1996-5#2)(2006-10#1)(2008-11#1)(2012-2#1)(2012-3#1)
of the type II enzyme##2##5##(1997-2#2)
of the type II##12##4##(1994-10#2)(1994-12#1)(1994-8#2)(1994-9#1)(1995-2#2)(1996-4#1)(1997-2#2)(2008-4#1)
of the type III##2##4##(2007-12#2)
of the type and##5##4##(2008-10#2)(2008-2#1)(2008-5#1)(2011-2#1)
of the type of fracture##2##5##(2007-8#1)(2011-2#1)
of the type of the##2##5##(1992-9#1)(1996-3#1)
of the type of##43##4##(1990-11#1)(1990-5#1)(1992-9#1)(1993-1#1)(1994-12#1)(1994-3#1)(1995-11#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-1#2)(1997-2#1)(2005-11#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-7#1)(2009-9#1)(2010-11#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
of the type##113##3##(1990-11#1)(1990-5#1)(1990-6#1)(1991-3#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-10#2)(1994-12#3)(1994-3#3)(1994-8#3)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#4)(1996-5#6)(1997-1#2)(1997-2#3)(1997-3#1)(1997-7#1)(2005-11#2)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#8)(2008-6#2)(2008-8#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-5#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
of the type-I##3##3##(1993-5#1)(2007-2#1)(2012-2#1)
of the types and##2##4##(2008-5#1)(2009-7#1)
of the types of##19##4##(1990-6#1)(1992-12#1)(1993-1#1)(1995-4#1)(1997-2#1)(2005-8#1)(2005-9#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-1#1)(2013-1#2)
of the types##23##3##(1990-6#1)(1992-12#1)(1993-1#1)(1995-4#1)(1997-2#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-4#1)(2012-1#1)(2013-1#2)
of the typical##25##3##(1991-7#1)(1992-2#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-3#1)(1997-8#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-4#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2010-2#1)(2011-1#1)(2012-2#1)
of the tyrosinase gene promoter##2##5##(1994-12#2)
of the tyrosinase gene##4##4##(1994-12#2)(1996-2#1)(1997-4#1)
of the tyrosinase##7##3##(1994-12#2)(1996-2#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-5#1)
of the tyrosine hydroxylase##3##4##(1996-10#1)(1997-2#1)(1997-5#1)
of the tyrosine kinase##7##4##(1991-12#1)(1991-5#1)(1991-6#1)(1993-4#1)(1996-5#1)(2008-6#2)
of the tyrosine##18##3##(1990-12#1)(1990-5#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1993-4#1)(1996-10#1)(1996-5#4)(1997-2#1)(1997-5#2)(2008-6#2)(2012-2#1)
of the tyrosyl radical and##2##5##(1993-11#1)(1995-10#1)
of the tyrosyl radical##6##4##(1991-7#1)(1993-11#2)(1995-10#1)(1997-7#2)
of the tyrosyl##8##3##(1991-7#3)(1993-11#2)(1995-10#1)(1997-7#2)
of the ubiquinone##2##3##(1990-7#1)(1997-3#1)
of the ubiquitin system##2##4##(2008-1#2)
of the ubiquitin##5##3##(2008-1#3)(2008-9#1)(2012-12#1)
of the ubiquitinated##2##3##(1994-8#2)
of the ubiquitous##4##3##(2007-12#1)(2008-10#1)(2008-4#1)(2011-2#1)
of the ulcer##5##3##(1990-12#1)(2007-11#1)(2007-7#1)(2008-5#1)(2013-8#1)
of the ulcerations##2##3##(2007-8#2)
of the ulcerative##2##3##(1994-2#1)(2012-11#1)
of the ulna in##3##4##(2007-11#1)(2011-2#2)
of the ulna##6##3##(2006-11#1)(2006-3#1)(2007-11#1)(2011-2#2)(2013-1#1)
of the ulnar collateral ligament##3##5##(2006-3#3)
of the ulnar nerve and##2##5##(1992-6#1)(2007-11#1)
of the ulnar nerve by##2##5##(1993-11#1)(2008-9#1)
of the ulnar nerve##11##4##(1992-6#1)(1993-11#1)(2007-11#2)(2008-12#1)(2008-4#1)(2008-9#5)
of the ulnar##23##3##(1992-6#1)(1993-11#1)(2006-3#4)(2007-11#5)(2007-6#1)(2008-12#1)(2008-4#1)(2008-9#8)(2009-2#1)
of the ultimate##5##3##(1995-5#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)
of the ultradian##2##3##(1996-3#1)(2005-8#1)
of the ultrafast##2##3##(2008-1#1)(2012-8#1)
of the ultrasonic separation##2##4##(2008-11#2)
of the ultrasonic##11##3##(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#3)(2008-2#1)(2010-8#1)
of the ultrasound##4##3##(1996-11#1)(2007-12#1)(2008-5#1)(2010-12#1)
of the ultrasound-modulated optical signal##2##5##(2008-2#2)
of the ultrastructure of##3##4##(1996-6#1)(2007-12#1)(2008-10#1)
of the ultraviolet##2##3##(1991-12#1)(2005-4#1)
of the umbilical artery##4##4##(1990-8#1)(1990-9#1)(1992-1#1)(1995-6#1)
of the umbilical cord##2##4##(2004-10#1)(2008-6#1)
of the umbilical##9##3##(1990-8#1)(1990-9#1)(1992-1#1)(1995-6#1)(2004-10#1)(2008-10#1)(2008-6#1)(2013-1#2)
of the unaffected##2##3##(2007-11#1)(2010-3#1)
of the unavailability of##2##4##(2008-7#1)(2010-7#1)
of the unavailability##3##3##(2008-7#1)(2010-7#1)(2010-8#1)
of the unbound##3##3##(1990-12#1)(1993-12#1)(1994-9#1)
of the unbudded period##2##4##(1992-3#2)
of the uncertainties in##2##4##(1995-6#1)(1996-12#1)
of the uncertainties##7##3##(1995-6#1)(1996-12#1)(2007-11#2)(2008-3#3)
of the uncertainty associated with the##2##6##(2008-10#2)
of the uncertainty##8##3##(1994-1#1)(1996-12#1)(2008-10#3)(2008-2#1)(2008-8#1)(2009-8#1)
of the uncharged##2##3##(2005-11#1)(2007-10#1)
of the uncoated##2##3##(2008-10#1)(2008-3#1)
of the uncommon##3##3##(2007-7#1)(2012-2#1)(2013-1#1)
of the uncomplexed##7##3##(1990-2#1)(1996-6#3)(2008-10#2)(2008-5#1)
of the unconscious##3##3##(2007-7#1)(2008-12#1)(2013-1#1)
of the undergraduate##4##3##(1991-6#1)(2010-2#1)(2012-1#1)(2013-1#1)
of the underlying cause of##2##5##(1991-12#1)(2010-10#1)
of the underlying cause##4##4##(1991-12#1)(1991-8#1)(2010-10#2)
of the underlying conditions##2##4##(1994-3#1)(2007-7#1)
of the underlying disease and##3##5##(2005-10#1)(2007-11#1)(2011-3#1)
of the underlying disease process##2##5##(1997-4#1)(2013-8#1)
of the underlying disease##10##4##(1997-4#1)(2005-10#1)(2006-10#1)(2007-11#2)(2011-2#1)(2011-3#1)(2012-2#1)(2013-7#1)(2013-8#1)
of the underlying malignancy##2##4##(2007-7#1)(2011-2#1)
of the underlying matrix##2##4##(2008-5#2)
of the underlying mechanisms##6##4##(2005-11#1)(2008-1#1)(2008-4#1)(2009-3#1)(2010-2#1)(2011-12#1)
of the underlying molecular##2##4##(2007-7#1)(2008-11#1)
of the underlying wave front##2##5##(2008-3#2)
of the underlying##91##3##(1991-12#1)(1991-8#1)(1992-11#1)(1994-3#1)(1995-1#1)(1995-12#2)(1996-1#2)(1996-12#1)(1996-7#2)(1996-8#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#1)(2010-2#2)(2010-9#1)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#5)
of the unemployed##3##3##(1992-2#1)(2010-2#1)(2013-1#1)
of the unfolding pathway of##2##5##(1994-8#1)(1995-3#1)
of the unfolding##10##3##(1990-5#2)(1992-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1997-4#1)(2007-12#1)(2008-4#1)
of the unicellular cyanobacterium Synechocystis sp##5##6##(1994-12#1)(1995-6#1)(1995-8#1)(1996-6#2)
of the unicellular cyanobacterium##6##4##(1994-12#1)(1995-6#1)(1995-8#1)(1996-6#3)
of the uniform##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
of the uniformity##2##3##(2008-12#1)(2008-3#1)
of the uniformly##2##3##(1992-9#1)(2012-2#1)
of the uninsured##4##3##(1990-12#1)(1992-2#1)(1993-2#1)(1994-2#1)
of the unique anatomic##2##4##(2007-9#1)(2010-8#1)
of the unique challenges##3##4##(2006-5#1)(2007-10#1)(2010-12#1)
of the unique features##2##4##(2007-12#1)(2008-11#1)
of the unique##32##3##(1990-3#1)(1991-1#1)(1991-8#1)(1993-12#1)(1995-1#1)(1996-1#1)(1996-7#1)(1996-8#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-12#3)(2007-9#1)(2008-11#2)(2008-12#1)(2008-2#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
of the uniqueness##2##3##(2005-8#1)(2006-12#1)
of the unirradiated normal tissue corridor##2##6##(2008-6#2)
of the unit cell##2##4##(1992-9#1)(1994-9#1)
of the unit is##4##4##(2008-11#1)(2008-4#3)
of the unit##18##3##(1992-1#1)(1992-9#1)(1994-9#1)(1995-12#1)(2006-10#1)(2007-10#2)(2008-11#1)(2008-4#6)(2008-7#2)(2010-8#1)(2013-1#1)
of the units##6##3##(1993-2#1)(1995-6#3)(2008-1#1)(2008-9#1)
of the universal##4##3##(2007-2#1)(2007-8#1)(2008-8#1)(2011-2#1)
of the universe##5##3##(1995-6#1)(1996-12#1)(2007-8#1)(2007-9#1)(2008-4#1)
of the university##4##3##(1990-12#1)(2008-9#1)(2011-1#1)(2013-8#1)
of the unknown parameters##3##4##(2008-10#1)(2008-2#2)
of the unknown##11##3##(1992-8#1)(2007-12#1)(2008-10#3)(2008-2#2)(2010-11#1)(2011-2#2)(2012-3#1)
of the unlabeled patterns##2##4##(2008-2#2)
of the unlabeled##5##3##(1993-4#1)(1995-10#1)(1995-3#1)(2008-2#2)
of the unliganded##3##3##(1990-8#1)(1994-8#1)(1995-5#1)
of the unlinked##3##3##(1991-7#1)(1995-1#1)(1995-8#1)
of the unnatural##2##3##(1991-8#1)(1994-6#1)
of the unphosphorylated myosin##2##4##(1990-7#2)
of the unphosphorylated##3##3##(1990-7#2)(2013-8#1)
of the unquantified##2##3##(2008-4#2)
of the unrelated##2##3##(1996-4#1)(2012-3#1)
of the unresolved##2##3##(2008-10#1)(2011-2#1)
of the unsaturated##3##3##(1990-11#1)(1991-12#1)(2011-1#1)
of the unstable##5##3##(1990-6#1)(2006-4#1)(2007-6#1)(2008-3#2)
of the unstirred layers##2##4##(1991-5#2)
of the unstirred##7##3##(1991-5#7)
of the untrained##2##3##(2013-1#1)(2013-8#1)
of the untreated group##2##4##(2006-8#1)(2012-2#1)
of the untreated##10##3##(1991-12#1)(1992-11#1)(2004-9#1)(2006-8#1)(2008-10#1)(2008-4#1)(2012-12#1)(2012-2#1)(2013-7#2)
of the unusual##16##3##(1990-8#1)(1992-7#1)(1992-9#1)(1994-3#1)(1996-10#1)(2006-2#1)(2006-7#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#2)(2008-7#1)(2009-5#1)(2010-4#1)(2013-8#1)
of the unwanted##3##3##(2006-10#1)(2008-2#2)
of the upcoming##4##3##(2008-11#2)(2008-3#1)(2010-12#1)
of the upper abdomen##3##4##(1990-3#1)(1990-8#1)(2008-4#1)
of the upper aerodigestive tract##6##5##(1993-5#1)(2008-1#1)(2008-5#2)(2009-5#1)(2012-12#1)
of the upper airway##3##4##(1990-6#1)(2005-11#1)(2007-12#1)
of the upper airways##5##4##(1991-6#1)(1996-6#1)(1997-4#1)(2008-8#1)(2008-9#1)
of the upper and lower##7##5##(1990-11#1)(1992-11#2)(1992-12#1)(2008-10#1)(2009-5#1)(2012-12#1)
of the upper and the lower##2##6##(1992-7#1)(2006-11#1)
of the upper and##9##4##(1990-11#1)(1992-11#2)(1992-12#1)(1992-7#1)(2006-11#1)(2008-10#1)(2009-5#1)(2012-12#1)
of the upper arm##2##4##(1991-1#1)(1996-9#1)
of the upper cervical cord##2##5##(1992-3#2)
of the upper cervical##4##4##(1990-4#1)(1992-3#2)(2007-1#1)
of the upper digestive tract##3##5##(1993-9#1)(1995-5#1)(2011-2#1)
of the upper digestive##4##4##(1991-5#1)(1993-9#1)(1995-5#1)(2011-2#1)
of the upper extremities##7##4##(1991-4#1)(1992-1#1)(1993-12#1)(1997-4#1)(2005-1#1)(2007-4#1)(2007-8#1)
of the upper extremity following##3##5##(2009-9#1)(2012-1#2)
of the upper extremity in##2##5##(2005-1#1)(2012-1#1)
of the upper extremity##19##4##(1990-11#1)(2005-1#1)(2006-3#2)(2007-11#2)(2008-12#1)(2008-9#2)(2009-9#1)(2010-2#1)(2010-8#1)(2011-2#3)(2012-1#3)(2012-2#1)
of the upper face##2##4##(1997-1#1)(2009-4#1)
of the upper gastrointestinal tract##5##5##(1993-5#1)(2005-7#1)(2006-10#1)(2007-3#1)(2007-8#1)
of the upper gastrointestinal##6##4##(1991-2#1)(1993-5#1)(2005-7#1)(2006-10#1)(2007-3#1)(2007-8#1)
of the upper grating##2##4##(2008-2#2)
of the upper jaw##4##4##(1991-1#2)(2013-1#1)(2013-7#1)
of the upper limb##5##4##(2007-11#1)(2007-8#1)(2009-1#2)(2012-1#1)
of the upper limbs##4##4##(2006-10#3)(2007-10#1)
of the upper limit##2##4##(1993-2#1)(2009-2#1)
of the upper lobe##2##4##(1991-9#1)(2008-4#1)
of the upper moieties##2##4##(2008-7#2)
of the upper respiratory tract##5##5##(1990-8#1)(1995-12#1)(2007-4#1)(2008-10#1)(2012-12#1)
of the upper trapezius##2##4##(2010-9#2)
of the upper urinary tract##4##5##(1992-3#1)(2006-10#1)(2011-2#1)(2013-1#1)
of the upper##145##3##(1990-11#2)(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#2)(1991-1#3)(1991-2#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#3)(1992-6#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-5#2)(1993-9#1)(1994-2#1)(1994-3#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-12#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#2)(2005-1#2)(2005-10#1)(2005-11#2)(2005-7#1)(2006-10#5)(2006-11#1)(2006-3#3)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#3)(2007-8#3)(2008-1#2)(2008-10#5)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#6)(2009-1#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-6#2)(2010-8#1)(2010-9#3)(2011-1#1)(2011-2#6)(2012-1#5)(2012-12#3)(2012-2#1)(2013-1#3)(2013-7#2)
of the upstream gene##2##4##(1993-9#1)(1997-2#1)
of the upstream region##2##4##(1991-9#1)(1993-4#1)
of the upstream sequences##2##4##(1990-8#1)(2008-9#1)
of the upstream##10##3##(1990-8#1)(1991-6#1)(1991-7#1)(1991-9#2)(1993-4#1)(1993-9#1)(1997-2#2)(2008-9#1)
of the uptake and##4##4##(1992-6#1)(2008-10#1)(2008-7#1)(2008-9#1)
of the uptake of##3##4##(1992-3#1)(1995-6#1)(2011-2#1)
of the uptake##11##3##(1992-3#1)(1992-4#1)(1992-6#1)(1995-1#1)(1995-2#1)(1995-6#1)(2008-10#2)(2008-7#1)(2008-9#1)(2011-2#1)
of the upwelling##3##3##(2008-2#1)(2008-3#2)
of the urachus##4##3##(2010-2#4)
of the uracil##2##3##(2008-5#1)(2010-2#1)
of the urban##3##3##(2008-10#1)(2008-6#1)(2013-1#1)
of the urea cycle##4##4##(1991-9#1)(1992-7#1)(1993-3#1)(2008-7#1)
of the urea##8##3##(1991-9#1)(1992-7#1)(1993-11#1)(1993-3#1)(1995-6#1)(2008-10#2)(2008-7#1)
of the urea-induced unfolding##2##4##(1990-7#1)(1994-8#1)
of the urease##2##3##(1991-12#1)(1996-2#1)
of the ureter in##2##4##(2008-9#1)(2013-7#1)
of the ureter is##3##4##(1990-12#1)(2006-7#1)(2009-5#1)
of the ureter##19##3##(1990-12#2)(1992-3#1)(1996-12#1)(1997-3#1)(1997-4#1)(2006-7#1)(2006-9#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-5#3)(2013-7#3)
of the ureters##2##3##(2006-6#1)(2008-3#1)
of the urethra and##3##4##(2008-10#2)(2012-2#1)
of the urethra##9##3##(1990-7#1)(1996-12#1)(1997-7#2)(2008-10#4)(2012-2#1)
of the urethra]##2##3##(1991-4#1)(2006-7#1)
of the urethral##8##3##(1990-4#2)(1990-7#1)(1992-1#1)(1996-11#1)(2006-10#1)(2013-1#2)
of the uridine##3##3##(1993-8#1)(1995-8#1)(2006-11#1)
of the urinary bladder and##3##5##(1992-8#1)(2011-2#1)(2013-7#1)
of the urinary bladder is a##2##6##(1991-4#1)(1992-4#1)
of the urinary bladder was##2##5##(1993-2#1)(2012-2#1)
of the urinary bladder##26##4##(1991-4#1)(1991-6#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-2#2)(1993-9#2)(1997-2#1)(2006-9#1)(2007-11#3)(2007-4#2)(2008-10#1)(2008-7#1)(2011-2#3)(2012-12#1)(2012-2#3)(2013-7#1)
of the urinary excretion##2##4##(1992-1#1)(1994-6#1)
of the urinary tract and##2##5##(1996-12#1)(2008-10#1)
of the urinary tract in##2##5##(1990-11#1)(2008-9#1)
of the urinary tract system##2##5##(2011-1#1)(2013-8#1)
of the urinary tract##18##4##(1990-11#2)(1996-12#1)(2006-10#1)(2006-6#1)(2007-5#2)(2007-7#1)(2008-10#2)(2008-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
of the urinary##59##3##(1990-11#2)(1991-4#1)(1991-6#1)(1992-1#2)(1992-12#2)(1992-3#1)(1992-4#1)(1992-8#1)(1993-2#2)(1993-8#1)(1993-9#3)(1994-4#1)(1994-6#1)(1995-12#1)(1996-12#1)(1997-2#1)(1997-7#1)(2006-10#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#3)(2007-4#2)(2007-5#2)(2007-7#1)(2008-10#4)(2008-7#1)(2008-9#1)(2009-3#1)(2010-2#1)(2011-1#2)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#5)(2013-1#1)(2013-7#1)(2013-8#1)
of the urine sample##3##4##(1996-12#1)(2008-10#2)
of the urine##10##3##(1993-11#1)(1995-3#1)(1996-12#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2010-12#2)
of the urogenital tract##6##4##(1995-5#1)(1997-2#1)(1997-5#1)(1997-6#1)(2007-11#1)(2008-5#1)
of the urogenital##8##3##(1995-5#1)(1997-2#1)(1997-5#1)(1997-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2008-5#1)
of the usage of##4##4##(1997-2#2)(2005-10#1)(2009-3#1)
of the usage##5##3##(1997-2#2)(2005-10#1)(2009-3#1)(2012-12#1)
of the use and##2##4##(2009-4#1)(2013-8#1)
of the use of a homologous promoter##2##7##(2006-11#2)
of the use of a##8##5##(2006-11#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-4#1)(2013-7#1)
of the use of different##3##5##(2008-10#3)
of the use of heteropoly anions##2##6##(2008-10#2)
of the use of oral##2##5##(2008-11#1)(2012-2#1)
of the use of the##10##5##(1991-5#1)(2006-7#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)
of the use of this##3##5##(1995-11#1)(2007-11#1)(2007-7#1)
of the use of##125##4##(1990-4#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-12#1)(1993-11#1)(1993-2#1)(1993-9#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#2)(1996-12#1)(1996-6#1)(1996-8#1)(1997-3#2)(1997-8#1)(2005-6#1)(2006-10#3)(2006-11#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#7)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#16)(2008-11#6)(2008-12#3)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-2#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#4)
of the use##127##3##(1990-4#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-12#1)(1993-11#1)(1993-2#1)(1993-9#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#2)(1996-12#1)(1996-6#1)(1996-8#1)(1997-3#2)(1997-8#1)(2005-6#1)(2006-10#3)(2006-11#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#7)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#16)(2008-11#6)(2008-12#3)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#5)
of the used##4##3##(2008-10#2)(2008-11#1)(2010-4#1)
of the useful##2##3##(2006-6#1)(2013-8#1)
of the usefulness of##5##4##(1997-6#1)(2006-4#1)(2007-11#1)(2007-7#1)(2010-9#1)
of the user##5##3##(1997-1#1)(2006-10#1)(2008-7#1)(2011-1#1)(2012-1#1)
of the user's##4##3##(2008-7#1)(2012-1#3)
of the users of##2##4##(1997-6#1)(2008-11#1)
of the users##9##3##(1991-1#1)(1993-10#2)(1995-2#1)(1997-6#2)(2008-11#1)(2012-2#1)(2013-1#1)
of the uses of##3##4##(2006-10#1)(2009-4#1)(2009-5#1)
of the usual abdominal##2##4##(1994-2#1)(1997-3#1)
of the usual##25##3##(1990-3#1)(1991-12#1)(1992-3#1)(1992-7#1)(1992-9#1)(1994-2#1)(1995-8#1)(1996-4#1)(1997-3#2)(1997-8#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-7#1)(2008-10#2)(2008-3#1)(2012-3#1)
of the uterine adnexa##2##4##(2007-12#2)
of the uterine artery##2##4##(1994-9#1)(2006-9#1)
of the uterine body##2##4##(2011-1#2)
of the uterine cervix is##2##5##(1993-8#1)(2006-10#1)
of the uterine cervix##22##4##(1990-4#1)(1990-6#1)(1992-3#1)(1993-8#2)(1993-9#1)(1994-4#1)(1994-7#2)(2006-10#3)(2007-12#1)(2007-7#1)(2008-11#1)(2008-4#1)(2009-11#2)(2009-5#1)(2011-2#2)(2012-2#1)
of the uterine corpus##2##4##(2012-2#2)
of the uterine##43##3##(1990-4#1)(1990-6#1)(1991-3#1)(1992-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-4#2)(1994-7#2)(1994-9#2)(1995-12#1)(1995-3#1)(1996-1#1)(1996-5#1)(2006-10#3)(2006-9#1)(2007-12#3)(2007-4#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-4#3)(2009-11#2)(2009-5#1)(2009-8#1)(2011-1#2)(2011-2#2)(2012-2#3)
of the uterus and##3##4##(2009-6#1)(2012-2#1)(2012-3#1)
of the uterus##24##3##(1990-10#1)(1992-12#1)(1992-8#1)(1994-9#2)(1995-11#1)(2006-6#2)(2007-3#1)(2007-9#2)(2008-1#1)(2008-4#2)(2008-6#1)(2008-8#1)(2009-4#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
of the uterus]##2##3##(1993-6#1)(2008-8#1)
of the utility of##5##4##(2008-10#1)(2008-5#1)(2008-9#2)(2012-3#1)
of the utility##6##3##(1993-1#1)(2008-10#1)(2008-5#1)(2008-9#2)(2012-3#1)
of the utilization of the##4##5##(1990-5#1)(1991-4#1)(1992-10#1)(2008-7#1)
of the utilization of##6##4##(1990-5#1)(1991-12#1)(1991-4#1)(1992-10#1)(1992-3#1)(2008-7#1)
of the utilization##7##3##(1990-5#1)(1991-12#1)(1991-4#1)(1992-10#1)(1992-3#1)(2006-5#1)(2008-7#1)
of the utmost importance##5##4##(1990-9#1)(2006-10#2)(2007-12#1)(2011-2#1)
of the vaccinated animals##2##4##(1995-9#2)
of the vaccinated##7##3##(1992-8#1)(1994-11#1)(1995-9#2)(2007-2#1)(2011-2#1)(2013-8#1)
of the vaccination##5##3##(1993-3#1)(2009-12#1)(2011-2#3)
of the vaccine against serogroup B##2##6##(1992-10#1)(2013-8#1)
of the vaccine and##5##4##(1990-2#1)(1992-10#1)(2007-11#1)(2008-11#1)(2013-1#1)
of the vaccine antigens##2##4##(1995-5#1)(2012-12#1)
of the vaccine in##3##4##(1990-9#1)(1992-10#1)(1995-5#1)
of the vaccine##27##3##(1990-2#1)(1990-9#1)(1992-10#3)(1995-5#2)(1996-12#1)(2007-11#5)(2008-11#2)(2008-4#1)(2010-10#1)(2010-12#3)(2011-2#2)(2012-12#1)(2013-1#3)(2013-8#1)
of the vaccines##3##3##(1995-5#1)(2010-4#1)(2013-8#1)
of the vaccinia virus##3##4##(1994-9#1)(2008-2#2)
of the vacuolar H(+)-ATPase##4##4##(1990-3#2)(1994-9#1)(1995-3#1)
of the vacuolar pyrophosphatase##2##4##(1991-2#1)(2008-11#1)
of the vacuolar type##2##4##(1994-6#1)(1994-8#1)
of the vacuolar##11##3##(1990-3#2)(1991-2#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-3#1)(1996-5#1)(2008-11#1)(2009-10#1)
of the vacuole##2##3##(2009-8#1)(2011-2#1)
of the vacuum disc##2##4##(2012-2#2)
of the vacuum##3##3##(2007-8#1)(2012-2#2)
of the vagal##2##3##(2010-2#2)
of the vagina and the##2##5##(2008-9#2)
of the vagina may##2##4##(1996-12#1)(2006-10#1)
of the vagina##16##3##(1990-2#1)(1992-12#1)(1994-1#1)(1994-7#1)(1995-11#1)(1996-12#3)(2006-10#2)(2006-12#1)(2007-8#1)(2008-9#3)(2013-1#1)
of the vaginal fluid at the time of insemination##3##9##(2006-5#3)
of the vaginal##12##3##(1991-12#1)(1991-3#1)(1991-4#1)(1992-12#1)(1996-9#1)(2006-5#3)(2006-8#1)(2008-10#1)(2008-9#1)(2010-2#1)
of the vagus nerve in##2##5##(1994-6#1)(2008-4#1)
of the vagus nerve##12##4##(1991-10#1)(1993-12#2)(1994-6#3)(1995-12#1)(1996-1#1)(1997-3#1)(2008-4#1)(2010-12#1)(2013-1#1)
of the vagus##16##3##(1991-10#1)(1993-12#5)(1994-2#1)(1994-6#3)(1995-12#1)(1996-1#1)(1997-3#1)(2008-4#1)(2010-12#1)(2013-1#1)
of the valence##3##3##(2005-11#1)(2007-5#1)(2008-10#1)
of the validated model##2##4##(2007-4#1)(2008-7#1)
of the validated##3##3##(2007-4#1)(2008-7#1)(2010-12#1)
of the validation of##2##4##(1997-2#1)(2008-10#1)
of the validation process##2##4##(2007-12#1)(2007-5#1)
of the validation##10##3##(1997-2#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#5)(2008-3#1)
of the validity of##5##4##(1991-2#1)(2007-11#2)(2007-12#1)(2007-3#1)
of the validity##6##3##(1991-2#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-3#1)
of the value at##2##4##(2005-1#1)(2008-10#1)
of the value for##3##4##(1994-2#1)(2008-10#1)(2009-12#1)
of the value of the##3##5##(1995-1#1)(2008-3#2)
of the value of##13##4##(1990-7#1)(1994-7#1)(1995-1#1)(1995-2#1)(1997-7#1)(2005-11#2)(2007-4#1)(2007-7#1)(2008-3#2)(2009-11#1)(2009-2#1)
of the value##24##3##(1990-7#1)(1991-2#1)(1992-9#1)(1994-10#1)(1994-2#1)(1994-7#1)(1995-1#1)(1995-2#1)(1997-7#1)(2005-1#1)(2005-11#2)(2007-4#1)(2007-7#1)(2008-10#2)(2008-3#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2011-1#1)(2012-2#1)
of the values measured##2##4##(1990-9#1)(1995-8#1)
of the values obtained##2##4##(1996-11#1)(2005-10#1)
of the values of the##5##5##(1995-5#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-5#1)
of the values of##6##4##(1994-12#1)(1995-5#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-5#1)
of the values were##2##4##(2006-4#1)(2007-10#1)
of the values##18##3##(1990-3#1)(1990-9#1)(1993-2#1)(1994-12#1)(1995-5#1)(1995-8#1)(1996-11#1)(2005-10#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)
of the valve apparatus##2##4##(2008-5#2)
of the valve##13##3##(1990-3#1)(2006-8#4)(2007-8#2)(2008-10#1)(2008-5#2)(2011-2#1)(2012-12#1)(2013-1#1)
of the valves##3##3##(1997-2#1)(2006-8#1)(2011-1#1)
of the van Cittert-Zernike theorem##3##5##(2007-12#2)(2008-2#1)
of the van der Waals##3##5##(1995-3#1)(2007-11#1)(2013-1#1)
of the van##7##3##(1995-3#1)(2005-12#1)(2007-11#1)(2007-12#2)(2008-2#1)(2013-1#1)
of the vapor##2##3##(2008-10#2)
of the vapour pressure of the##2##6##(2008-5#2)
of the variability between##2##4##(2008-10#2)
of the variability in protein rankings##2##6##(1995-3#2)
of the variability in##15##4##(1992-6#1)(1993-12#1)(1995-3#2)(1996-1#1)(2005-10#2)(2007-12#1)(2007-3#1)(2008-10#2)(2010-10#1)(2010-9#1)(2012-2#1)(2013-7#1)
of the variability was##2##4##(2008-10#1)(2008-7#1)
of the variability##27##3##(1992-5#1)(1992-6#1)(1993-12#1)(1995-3#2)(1996-1#1)(1996-9#1)(2005-10#2)(2007-12#1)(2007-3#1)(2008-10#10)(2008-6#1)(2008-7#1)(2010-10#1)(2010-9#1)(2012-2#1)(2013-7#1)
of the variable region##4##4##(1992-7#1)(2008-11#1)(2008-8#1)(2012-12#1)
of the variable regions##2##4##(1996-11#2)
of the variable##14##3##(1990-11#1)(1990-8#1)(1991-7#1)(1992-6#1)(1992-7#1)(1994-9#1)(1996-11#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-12#2)
of the variables affecting##2##4##(2008-10#2)
of the variables and##2##4##(2008-10#2)
of the variables investigated##2##4##(2007-7#1)(2011-2#1)
of the variables##24##3##(1991-12#1)(1993-5#1)(1994-3#1)(2004-9#1)(2007-7#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-5#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)
of the variance explained##3##4##(2010-9#1)(2011-1#2)
of the variance in exercise##2##5##(2007-10#2)
of the variance in gait speed##2##6##(2007-10#2)
of the variance in mobility##2##5##(2010-9#2)
of the variance in social function in the##2##8##(2013-1#2)
of the variance in the##10##5##(1995-3#1)(1995-7#1)(2007-10#2)(2008-10#1)(2008-4#1)(2008-9#1)(2009-12#1)(2010-9#1)(2012-3#1)
of the variance in##39##4##(1994-3#1)(1994-9#1)(1995-3#1)(1995-7#1)(1996-1#2)(2007-10#6)(2007-7#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-9#3)(2009-10#1)(2009-12#3)(2010-2#1)(2010-3#1)(2010-9#4)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
of the variance of the##5##5##(1993-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
of the variance of##7##4##(1993-12#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-5#1)
of the variance##72##3##(1993-12#2)(1993-2#1)(1994-3#1)(1994-9#1)(1995-3#1)(1995-7#1)(1996-1#2)(1997-2#1)(2006-10#1)(2007-10#6)(2007-11#1)(2007-7#1)(2007-9#2)(2008-10#9)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#3)(2009-10#1)(2009-12#3)(2009-5#1)(2009-9#1)(2010-10#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-9#5)(2011-1#6)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#3)(2013-1#4)(2013-8#1)
of the variant enzymes##2##4##(2011-2#2)
of the variant##9##3##(1990-8#1)(1992-12#1)(1994-2#1)(1995-8#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#2)
of the variants##3##3##(1992-2#1)(1997-1#1)(2012-12#1)
of the variation for resistance in##2##6##(2008-10#2)
of the variation for resistance##3##5##(2008-10#3)
of the variation in disease##2##5##(2008-10#2)
of the variation in population##2##5##(2008-8#1)(2012-3#1)
of the variation in##33##4##(1992-2#1)(1993-3#1)(1994-2#2)(1997-4#1)(1997-5#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-10#9)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#3)(2010-9#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)
of the variation of the##2##5##(2008-2#1)(2008-3#1)
of the variation of##6##4##(1996-1#1)(2006-6#2)(2008-2#1)(2008-3#1)(2010-9#1)
of the variation was##4##4##(1994-5#1)(2004-2#1)(2008-10#1)(2013-8#1)
of the variation##56##3##(1992-2#1)(1992-6#1)(1993-3#1)(1994-2#2)(1994-5#1)(1996-1#1)(1997-4#1)(1997-5#1)(2004-2#1)(2006-10#1)(2006-12#1)(2006-6#2)(2007-1#1)(2007-11#1)(2007-7#1)(2008-10#18)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#3)(2010-8#1)(2010-9#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
of the variations in the##4##5##(1993-2#1)(2008-2#1)(2013-8#2)
of the variations##6##3##(1993-2#1)(2005-10#1)(2008-2#1)(2011-1#1)(2013-8#2)
of the varicella##3##3##(2007-11#1)(2008-11#1)(2008-7#1)
of the varieties##2##3##(2008-12#1)(2013-8#1)
of the variety of##3##4##(1996-12#1)(2008-1#1)(2010-3#1)
of the variety##7##3##(1996-12#1)(2007-7#1)(2008-1#1)(2008-5#2)(2010-3#1)(2010-6#1)
of the various algorithms##2##4##(2008-2#1)(2008-3#1)
of the various complex##2##4##(2008-10#1)(2008-3#1)
of the various components##3##4##(2007-11#1)(2007-12#1)(2008-4#1)
of the various factors that##2##5##(1990-3#1)(2013-1#1)
of the various factors##4##4##(1990-3#1)(2006-5#1)(2012-12#1)(2013-1#1)
of the various forms of##4##5##(1991-4#1)(1992-11#1)(1994-11#1)(1996-12#1)
of the various forms##5##4##(1991-4#1)(1992-11#1)(1994-11#1)(1994-9#1)(1996-12#1)
of the various methods##4##4##(1992-9#1)(2007-9#1)(2008-2#1)(2009-7#1)
of the various models##2##4##(1990-12#1)(2008-11#1)
of the various options##2##4##(2005-10#1)(2008-10#1)
of the various protocols##2##4##(2008-9#1)(2013-8#1)
of the various species##2##4##(2008-10#1)(2010-12#1)
of the various treatment##2##4##(1997-3#1)(2006-9#1)
of the various treatments##2##4##(1992-8#1)(2006-12#1)
of the various types of##2##5##(1992-12#1)(2008-10#1)
of the various types##3##4##(1992-12#1)(2005-8#1)(2008-10#1)
of the various##158##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-12#3)(1996-2#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#2)(2005-10#2)(2005-2#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-9#2)(2007-1#1)(2007-11#4)(2007-12#9)(2007-3#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#3)(2008-3#8)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-11#1)(2009-7#2)(2010-11#1)(2010-12#2)(2010-3#1)(2011-1#2)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
of the vas deferens and##2##5##(1992-5#1)(1997-8#1)
of the vas deferens##10##4##(1990-12#1)(1992-5#1)(1994-8#1)(1996-12#1)(1997-8#1)(2007-9#1)(2008-10#4)
of the vas##11##3##(1990-12#1)(1992-5#1)(1994-8#2)(1996-12#1)(1997-8#1)(2007-9#1)(2008-10#4)
of the vasa nervorum##2##4##(1993-11#1)(1993-12#1)
of the vasa##3##3##(1993-11#1)(1993-12#1)(2010-9#1)
of the vascular access##3##4##(2007-11#1)(2007-7#2)
of the vascular complications##2##4##(1991-12#1)(1993-12#1)
of the vascular endothelial growth factor##3##6##(1992-3#1)(2008-6#1)(2012-3#1)
of the vascular endothelium##3##4##(1990-10#1)(1990-4#1)(2012-1#1)
of the vascular smooth muscle cells##2##6##(1995-11#1)(2009-1#1)
of the vascular supply##2##4##(1992-1#1)(2006-6#1)
of the vascular system##3##4##(1991-4#1)(2006-10#1)(2006-5#1)
of the vascular tree##3##4##(2005-11#1)(2008-1#1)(2012-2#1)
of the vascular wall##2##4##(1992-9#1)(2005-6#1)
of the vascular##42##3##(1990-10#1)(1990-4#1)(1991-12#1)(1991-4#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-12#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-10#1)(1996-11#1)(1997-1#1)(1997-6#1)(2005-1#1)(2005-11#1)(2005-6#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#1)(2009-1#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
of the vascularized##2##3##(2006-3#1)(2009-3#1)
of the vasculature##3##3##(1991-2#1)(1997-3#1)(2006-11#1)
of the vasculitis##2##3##(1997-4#1)(2006-10#1)
of the vasoactive##2##3##(1992-3#1)(1996-5#1)
of the vasoconstrictor##3##3##(1992-5#1)(1992-8#1)(2007-10#1)
of the vasopressin V1##2##4##(1995-12#2)
of the vasopressin##3##3##(1995-12#2)(1996-10#1)
of the vast##4##3##(1991-8#1)(1993-12#1)(2006-10#1)(2008-5#1)
of the vector from##2##4##(1991-9#1)(2008-11#1)
of the vector##24##3##(1990-11#1)(1991-7#4)(1991-9#1)(1992-8#1)(1995-1#1)(1997-1#1)(1997-4#2)(2004-11#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-11#1)(2008-2#3)(2008-4#1)(2008-6#1)(2010-1#1)(2011-2#1)
of the vectorial##2##3##(2007-11#1)(2008-3#1)
of the vectors##8##3##(1990-9#2)(1993-12#1)(1995-8#1)(2006-10#1)(2008-10#1)(2012-12#1)(2013-8#1)
of the vegetation##4##3##(2008-5#1)(2008-8#1)(2010-8#1)(2011-2#1)
of the vegetative##4##3##(2007-1#1)(2008-8#1)(2013-1#2)
of the vehicle control groups##8##5##(2008-9#8)
of the vehicle control##9##4##(2008-9#9)
of the vehicle controls##31##4##(2008-9#31)
of the vehicle##52##3##(1995-3#1)(1997-6#1)(2005-11#1)(2006-11#3)(2008-4#3)(2008-5#1)(2008-9#40)(2009-5#1)(2010-5#1)
of the vehicles on the##2##5##(2008-5#2)
of the vein of##2##4##(1996-6#1)(2006-12#1)
of the vein or##2##4##(2007-7#2)
of the vein##8##3##(1991-10#1)(1996-6#1)(2006-12#1)(2007-7#2)(2008-12#1)(2008-7#1)(2012-3#1)
of the velocity and the##2##5##(2007-12#1)(2008-3#1)
of the velocity##7##3##(2005-11#1)(2007-12#1)(2008-2#4)(2008-3#1)
of the vena cava##2##4##(1992-9#1)(2010-4#1)
of the vena##3##3##(1992-5#1)(1992-9#1)(2010-4#1)
of the venom of the spider Phoneutria nigriventer##2##8##(1996-11#2)
of the venom of##4##4##(1996-11#2)(2008-5#2)
of the venom##7##3##(1996-11#2)(2008-5#3)(2008-7#1)(2009-6#1)
of the venous system##4##4##(1990-6#1)(2008-12#1)(2008-6#1)(2011-2#1)
of the venous##12##3##(1990-11#1)(1990-6#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
of the ventilator##6##3##(1995-12#1)(1997-4#2)(2007-8#1)(2011-1#1)(2011-2#1)
of the ventilatory##2##3##(1994-6#1)(1995-7#1)
of the ventral and dorsal##2##5##(2007-12#1)(2007-5#1)
of the ventral nerve cord##3##5##(2007-12#3)
of the ventral tegmental area (VTA)##3##6##(1991-8#1)(1994-12#1)(2008-7#1)
of the ventral tegmental area##5##5##(1991-8#1)(1994-12#1)(1994-2#1)(1997-2#1)(2008-7#1)
of the ventral##33##3##(1991-8#1)(1992-9#1)(1993-12#2)(1993-5#1)(1993-6#2)(1993-9#2)(1994-12#1)(1994-2#1)(1995-11#1)(1995-5#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-12#1)(1997-2#1)(1997-7#1)(2006-7#1)(2007-12#4)(2007-5#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-9#1)(2013-8#1)
of the ventricles##3##3##(1992-11#1)(2007-8#1)(2008-6#1)
of the ventricular myocardium##2##4##(1996-9#1)(2005-1#1)
of the ventricular rate##2##4##(2010-12#1)(2012-3#1)
of the ventricular system##2##4##(2006-5#1)(2008-7#1)
of the ventricular##13##3##(1990-9#1)(1991-9#1)(1996-9#1)(2005-1#2)(2006-5#2)(2007-8#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-9#1)(2012-3#1)
of the ventriculi##2##3##(2008-5#2)
of the ventrolateral##2##3##(1994-3#1)(1997-6#1)
of the ventromedial##5##3##(1994-6#1)(1995-11#1)(1997-7#1)(2008-4#1)(2013-1#1)
of the verbal##2##3##(2007-12#1)(2008-10#1)
of the vermiform appendix##2##4##(2008-12#1)(2010-6#1)
of the vertebra##3##3##(1992-1#3)
of the vertebrae and##3##4##(2007-11#2)(2007-4#1)
of the vertebrae##11##3##(2006-8#2)(2007-11#6)(2007-4#1)(2007-8#1)(2008-11#1)
of the vertebral arteries##3##4##(1995-3#2)(2007-10#1)
of the vertebral artery##5##4##(1990-7#1)(1991-8#1)(1993-3#1)(2007-11#1)(2008-7#1)
of the vertebral bodies##6##4##(1995-9#1)(1996-12#1)(1997-3#1)(2007-11#1)(2007-8#1)(2012-1#1)
of the vertebral body and##2##5##(2007-11#1)(2007-8#1)
of the vertebral body##8##4##(2006-8#2)(2007-11#2)(2007-8#1)(2009-6#1)(2012-1#1)(2012-2#1)
of the vertebral canal##8##4##(1995-3#1)(2007-11#6)(2007-8#1)
of the vertebral column##5##4##(1990-10#1)(2007-11#1)(2008-7#1)(2009-2#1)(2011-2#1)
of the vertebral venous##2##4##(2011-2#2)
of the vertebral##42##3##(1990-10#1)(1990-7#1)(1991-8#2)(1993-3#1)(1995-3#3)(1995-9#1)(1996-12#1)(1997-3#1)(2006-8#2)(2007-10#1)(2007-11#11)(2007-7#1)(2007-8#3)(2008-7#3)(2009-2#1)(2009-4#1)(2009-6#1)(2011-2#3)(2012-1#2)(2012-2#2)
of the vertebrate retina##2##4##(1995-5#1)(2008-2#1)
of the vertebrate##14##3##(1990-2#1)(1992-8#1)(1995-5#1)(1996-3#1)(1997-7#2)(2007-3#1)(2008-2#1)(2008-9#1)(2010-8#1)(2010-9#1)(2012-12#2)(2013-1#1)
of the vertebrates##2##3##(1995-6#1)(2007-7#1)
of the vertebrobasilar system##3##4##(2007-9#3)
of the vertebrobasilar##5##3##(2007-10#1)(2007-9#3)(2008-2#1)
of the vertical cell##2##4##(2009-7#2)
of the vertical##13##3##(1992-10#1)(2008-1#1)(2008-2#2)(2008-3#3)(2008-5#1)(2009-7#3)(2009-8#1)(2010-12#1)
of the very complex##3##4##(1992-5#1)(2008-10#1)(2011-1#1)
of the very important##2##4##(2007-5#1)(2009-6#1)
of the very low##2##4##(1992-10#1)(2013-1#1)
of the very old##2##4##(1994-6#1)(2009-5#1)
of the very##23##3##(1992-10#1)(1992-5#1)(1992-6#1)(1994-6#1)(1997-4#1)(2005-1#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
of the vesamicol receptor##2##4##(1992-6#1)(1993-9#1)
of the vesicle##3##3##(1992-10#1)(1992-3#1)(1994-11#1)
of the vesicles in##2##4##(1990-2#1)(1995-11#1)
of the vesicles with##2##4##(1992-8#1)(1994-12#1)
of the vesicles##17##3##(1990-11#1)(1990-2#2)(1990-9#1)(1991-4#1)(1991-9#1)(1992-8#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-8#1)(1996-8#1)(1997-1#1)(2006-10#1)(2008-10#1)(2008-5#2)
of the vesicular monoamine##2##4##(1995-12#1)(2010-6#1)
of the vesicular##4##3##(1994-8#1)(1995-12#1)(2008-11#1)(2010-6#1)
of the vesiculated##2##3##(1991-9#2)
of the vessel and##2##4##(1993-8#1)(2011-1#1)
of the vessel wall##2##4##(2007-10#1)(2011-1#1)
of the vessel##20##3##(1991-8#1)(1993-8#1)(1993-9#1)(1994-11#1)(2007-10#1)(2007-5#2)(2007-7#3)(2008-3#1)(2008-5#2)(2009-10#1)(2010-4#1)(2011-1#3)(2011-2#1)(2012-2#1)
of the vessels##12##3##(1991-4#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-2#1)(2013-8#1)
of the vestibular##7##3##(1990-10#1)(1990-6#1)(1991-2#1)(1994-10#1)(1995-8#1)(1997-7#1)(2011-2#1)
of the vetispiradiene synthase##2##4##(1995-3#2)
of the viability of##3##4##(1993-9#1)(1997-2#1)(2006-10#1)
of the viability##8##3##(1992-2#1)(1993-9#1)(1997-2#1)(2006-10#1)(2006-5#2)(2008-5#1)(2012-12#1)
of the viable cell density##2##5##(2008-11#2)
of the viable cell##4##4##(2008-11#4)
of the vibration##3##3##(2008-2#2)(2008-3#1)
of the vibrational##5##3##(2007-11#1)(2008-2#1)(2011-2#1)(2013-7#1)(2013-8#1)
of the vibrissae##2##3##(1991-5#1)(2013-1#1)
of the vibrissal FSC##2##4##(2011-2#2)
of the victim was##2##4##(1995-3#1)(2011-2#1)
of the victim##4##3##(1995-3#1)(2011-1#1)(2011-2#1)(2012-1#1)
of the victims of##4##4##(1995-11#1)(2009-6#1)(2011-2#1)(2013-1#1)
of the victims were##2##4##(1996-5#1)(2007-2#1)
of the victims##15##3##(1991-2#1)(1993-3#1)(1993-5#1)(1995-11#1)(1996-11#1)(1996-5#1)(1996-6#1)(2007-2#1)(2008-2#1)(2009-6#3)(2011-1#1)(2011-2#1)(2013-1#1)
of the video##3##3##(1995-12#1)(2008-11#1)(2008-3#1)
of the viewing##2##3##(2008-3#2)
of the views of##2##4##(1996-9#1)(2012-2#1)
of the views##3##3##(1996-9#1)(2012-2#2)
of the villages##2##3##(2007-10#1)(2007-2#1)
of the villus##2##3##(1991-12#2)
of the vimentin##2##3##(1991-3#1)(2009-10#1)
of the violence##2##3##(2011-2#1)(2013-1#1)
of the violent patients##2##4##(1991-9#2)
of the violent##3##3##(1991-9#2)(2011-2#1)
of the viral DNA polymerase##2##5##(1990-7#1)(1997-3#1)
of the viral DNA##3##4##(1990-7#1)(1997-1#1)(1997-3#1)
of the viral RNA was##2##5##(1997-2#1)(2008-10#1)
of the viral RNA##6##4##(1990-9#1)(1997-2#1)(2008-10#3)(2008-9#1)
of the viral S RNA##2##5##(2008-10#2)
of the viral coat protein##2##5##(1993-5#1)(2008-10#1)
of the viral early##2##4##(1995-2#1)(1997-1#1)
of the viral fusion##2##4##(2008-1#1)(2009-8#1)
of the viral genome##14##4##(1991-6#1)(1995-8#2)(1997-2#1)(1997-6#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2011-2#1)
of the viral proteins##4##4##(1997-5#1)(2008-10#1)(2008-8#1)(2013-1#1)
of the viral##70##3##(1990-7#1)(1990-9#1)(1991-1#1)(1991-5#1)(1991-6#1)(1992-12#4)(1992-6#1)(1992-9#1)(1993-11#2)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-8#2)(1994-9#1)(1995-2#2)(1995-7#1)(1995-8#2)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-7#1)(2006-10#2)(2007-11#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#12)(2008-11#1)(2008-4#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#2)(2010-6#1)(2011-2#1)(2011-3#1)(2013-1#1)
of the virtual hand##3##4##(2008-11#3)
of the virulence factors of##2##5##(2008-10#1)(2008-9#1)
of the virulence markers in##2##5##(2013-8#2)
of the virulence##10##3##(2008-10#6)(2008-9#1)(2009-8#1)(2013-8#2)
of the virulent##6##3##(1994-12#1)(2008-10#4)(2013-8#1)
of the virus and is##2##5##(1994-8#1)(2011-1#1)
of the virus and##7##4##(1994-8#1)(1996-11#1)(2006-10#1)(2008-10#2)(2008-5#1)(2011-1#1)
of the virus as##2##4##(1990-2#1)(2008-11#1)
of the virus by##4##4##(1990-11#1)(2008-10#3)
of the virus did not##2##5##(1992-10#1)(2008-10#1)
of the virus for##2##4##(2008-10#1)(2008-4#1)
of the virus from##4##4##(1992-11#1)(2008-10#3)
of the virus genome##3##4##(1991-12#1)(2007-3#1)(2008-10#1)
of the virus in the##3##5##(2008-1#1)(2008-11#1)(2012-2#1)
of the virus in##19##4##(1991-8#1)(1995-8#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-1#2)(2012-2#1)(2013-8#2)
of the virus life cycle##2##5##(2008-10#1)(2013-1#1)
of the virus that##2##4##(2007-12#1)(2010-10#1)
of the virus through##2##4##(2007-11#1)(2008-10#1)
of the virus to the##2##5##(1992-5#1)(1994-9#1)
of the virus to##4##4##(1992-5#1)(1994-9#1)(2008-10#2)
of the virus was##4##4##(2008-10#2)(2010-12#1)(2012-3#1)
of the virus##137##3##(1990-11#1)(1990-2#2)(1991-12#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-7#1)(1994-10#2)(1994-8#3)(1994-9#4)(1995-8#2)(1996-11#1)(1997-4#1)(1997-6#1)(2005-12#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-2#4)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-3#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#42)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#6)(2008-8#3)(2008-9#3)(2009-11#1)(2010-1#1)(2010-10#1)(2010-12#2)(2011-1#4)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#4)
of the virus-associated##2##3##(1990-2#2)
of the viruses in##2##4##(2008-10#1)(2009-10#1)
of the viruses was##2##4##(2008-10#2)
of the viruses##14##3##(2007-10#1)(2008-10#5)(2008-5#3)(2009-10#1)(2009-6#1)(2010-4#1)(2011-2#2)
of the viscera##2##3##(1991-6#1)(1993-10#1)
of the visceral##5##3##(1991-8#3)(2007-12#1)(2011-2#1)
of the viscoelastic##2##3##(2005-11#1)(2007-12#1)
of the viscosity distribution##2##4##(2007-11#2)
of the viscosity##4##3##(2005-11#1)(2007-11#2)(2008-10#1)
of the visible##10##3##(1992-1#1)(1994-5#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#4)(2009-4#1)
of the visit##3##3##(1996-1#1)(2012-12#1)(2013-1#1)
of the visual cortex##4##4##(1995-11#1)(1997-6#1)(2011-2#2)
of the visual evoked potential (VEP)##2##6##(1992-7#1)(1995-12#1)
of the visual evoked potential in##2##6##(1995-12#1)(2013-8#1)
of the visual evoked potential##4##5##(1992-7#1)(1995-12#2)(2013-8#1)
of the visual field and##2##5##(1996-3#1)(2012-11#1)
of the visual field##5##4##(1993-7#1)(1994-2#1)(1996-3#1)(2012-11#1)(2012-3#1)
of the visual input in##4##5##(1991-2#4)
of the visual input##5##4##(1991-2#5)
of the visual span##4##4##(2008-1#4)
of the visual stimulus##4##4##(1992-11#2)(1993-2#1)(2009-10#1)
of the visual system##10##4##(1992-6#1)(1993-12#1)(1994-6#1)(1995-5#2)(1996-1#1)(2007-12#2)(2008-10#1)(2012-1#1)
of the visual world##2##4##(1993-9#1)(2012-3#1)
of the visual##60##3##(1990-10#1)(1990-2#1)(1991-2#6)(1992-11#2)(1992-6#1)(1992-7#1)(1993-12#2)(1993-2#2)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-5#2)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-6#1)(1997-8#1)(2005-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2008-1#5)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-10#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#2)(2013-8#2)
of the visualization##2##3##(2008-1#1)(2008-6#1)
of the visually##2##3##(2006-11#1)(2008-2#1)
of the vital##8##3##(1992-11#1)(1994-7#1)(1997-3#1)(2006-10#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
of the vitality##2##3##(1994-7#1)(2011-2#1)
of the vitamin D##8##4##(1990-4#1)(1991-1#1)(1994-9#1)(2007-11#1)(2008-1#1)(2008-4#1)(2013-1#2)
of the vitamin K cycle##2##5##(2009-11#2)
of the vitamin K##3##4##(2009-11#3)
of the vitamin K-dependent##4##4##(1994-11#2)(1995-8#1)(2009-11#1)
of the vitamin##25##3##(1990-4#1)(1991-1#1)(1991-12#1)(1992-9#2)(1993-11#1)(1994-11#2)(1994-6#1)(1994-9#2)(1995-8#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-4#1)(2009-11#4)(2013-1#3)
of the vitamins##2##3##(2006-10#1)(2008-5#1)
of the vitelline##3##3##(1993-6#2)(1994-5#1)
of the vitellogenin##3##3##(1995-8#2)(2008-6#1)
of the vitronectin gene##2##4##(1990-3#2)
of the vitronectin##4##3##(1990-3#3)(1994-6#1)
of the vocabulary##3##3##(2008-7#1)(2011-2#2)
of the vocal cord##2##4##(1991-4#1)(2008-2#1)
of the vocal cords##3##4##(1990-4#1)(2008-11#1)(2008-8#1)
of the vocal fold##2##4##(2009-10#1)(2012-2#1)
of the vocal##9##3##(1990-4#1)(1991-4#1)(1996-7#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-10#1)(2012-12#1)(2012-2#1)
of the voice##4##3##(1996-12#1)(2008-9#1)(2009-4#1)(2011-1#1)
of the volar forearm##4##4##(2008-5#4)
of the volar lip##2##4##(2006-3#1)(2008-9#1)
of the volar##8##3##(2006-3#2)(2008-5#4)(2008-9#2)
of the volatile compounds of##2##5##(2008-10#1)(2010-12#1)
of the volatile constituents from##2##5##(2006-12#1)(2007-1#1)
of the volatile fraction of##2##5##(2007-1#1)(2010-12#1)
of the volatile fraction##3##4##(2007-1#1)(2008-3#1)(2010-12#1)
of the volatile##17##3##(1990-9#1)(1996-1#1)(1997-8#1)(2006-12#1)(2006-8#1)(2007-1#2)(2007-12#1)(2008-10#3)(2008-3#2)(2008-5#1)(2009-8#1)(2010-12#2)
of the volatiles##2##3##(2007-1#1)(2008-10#1)
of the voltage##5##3##(1991-8#1)(1992-8#1)(2007-12#1)(2008-8#2)
of the voltage-dependent##2##3##(1992-7#1)(2004-11#1)
of the voltage-gated calcium channel##2##5##(1990-7#1)(2008-8#1)
of the voltage-gated sodium channel##2##5##(2010-12#1)(2010-2#1)
of the voltage-gated##7##3##(1990-7#1)(1994-10#1)(2008-8#3)(2010-12#1)(2010-2#1)
of the voltammetric##7##3##(2008-10#7)
of the volume of the##2##5##(1995-1#1)(2007-12#1)
of the volume of##4##4##(1995-1#1)(1997-8#1)(2007-12#1)(2010-12#1)
of the volume##16##3##(1995-1#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-12#6)(2008-2#2)(2008-3#2)(2009-2#1)(2010-12#1)
of the volumes of##2##4##(2008-10#1)(2013-8#1)
of the volumes##4##3##(2008-10#1)(2009-2#1)(2012-1#1)(2013-8#1)
of the volumetric##3##3##(2008-11#1)(2008-2#1)(2008-7#1)
of the voluntary##4##3##(1990-12#1)(2008-11#1)(2009-4#1)(2013-1#1)
of the volunteer##3##3##(1993-12#1)(1994-3#1)(2006-11#1)
of the volunteers were##2##4##(1996-5#1)(2011-1#1)
of the volunteers##4##3##(1996-5#1)(2008-5#2)(2011-1#1)
of the vomeronasal##3##3##(1993-2#2)(2008-6#1)
of the von Hippel-Lindau##2##4##(2008-6#1)(2009-11#1)
of the von##5##3##(2005-10#1)(2007-12#1)(2008-3#1)(2008-6#1)(2009-11#1)
of the vortex structure##2##4##(1995-7#1)(2007-12#1)
of the vortex##4##3##(1995-7#1)(2007-12#1)(2008-2#2)
of the vulnerable plaque##3##4##(2012-2#3)
of the vulnerable##4##3##(2008-8#1)(2012-2#3)
of the vulva with##2##4##(2004-10#1)(2005-11#1)
of the vulva##21##3##(1992-3#4)(1993-6#1)(1994-1#1)(2004-10#1)(2005-11#2)(2005-7#1)(2006-10#7)(2007-12#1)(2007-8#1)(2008-7#2)
of the w##2##3##(1991-5#2)
of the waist##2##3##(2007-12#1)(2008-2#1)
of the waiting time##2##4##(1991-11#1)(2008-5#1)
of the waiting##5##3##(1990-5#1)(1991-11#2)(2008-5#1)(2008-7#1)
of the waiver##3##3##(1992-2#2)(1997-2#1)
of the walking legs##3##4##(2007-12#3)
of the walking##4##3##(2007-12#4)
of the wall of the##4##5##(2006-4#1)(2007-8#1)(2008-7#1)(2009-2#1)
of the wall of##5##4##(1992-4#1)(2006-4#1)(2007-8#1)(2008-7#1)(2009-2#1)
of the wall velocity##2##4##(2009-6#2)
of the wall##16##3##(1992-4#1)(1997-3#1)(2006-4#1)(2007-1#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-1#1)(2009-2#1)(2009-6#4)(2012-2#1)
of the walls of the##2##5##(2007-12#1)(2011-1#1)
of the walls of##3##4##(2007-12#2)(2011-1#1)
of the walls##6##3##(2006-5#1)(2007-12#3)(2009-11#1)(2011-1#1)
of the war##2##3##(2008-10#1)(2008-6#1)
of the wards##7##3##(2010-3#5)(2013-1#2)
of the waste##4##3##(2008-10#3)(2008-2#1)
of the wastewater treatment##2##4##(2005-11#1)(2008-10#1)
of the water barrier function##2##5##(2008-5#2)
of the water column and##2##5##(2007-5#1)(2012-2#1)
of the water column##7##4##(2007-5#2)(2008-2#2)(2008-3#1)(2008-8#1)(2012-2#1)
of the water content of acetonitrile on the electrochemistry of##2##10##(2005-11#2)
of the water content##3##4##(2005-11#2)(2008-10#1)
of the water in##4##4##(1991-11#1)(2008-10#1)(2008-3#2)
of the water maze##2##4##(1994-3#1)(1996-12#1)
of the water molecules##3##4##(1995-10#1)(2005-11#1)(2008-10#1)
of the water oxidizing complex##2##5##(1997-7#2)
of the water quality##2##4##(2013-1#1)(2013-8#1)
of the water sample##3##4##(2008-10#3)
of the water samples##3##4##(2008-10#2)(2013-8#1)
of the water with##2##4##(1995-5#1)(2008-5#1)
of the water##71##3##(1990-7#1)(1990-9#1)(1991-11#2)(1991-5#2)(1993-2#1)(1994-3#1)(1995-10#2)(1995-3#1)(1995-5#1)(1996-12#1)(1997-6#1)(1997-7#2)(2005-10#1)(2005-11#5)(2007-5#3)(2007-7#1)(2008-10#11)(2008-11#3)(2008-2#3)(2008-3#5)(2008-5#9)(2008-8#2)(2009-6#1)(2010-4#2)(2010-8#1)(2012-12#1)(2012-2#2)(2012-5#1)(2013-1#1)(2013-8#3)
of the water-ethanol extract of##2##5##(2008-4#2)
of the water-insoluble##2##3##(2007-8#2)
of the water-leaving##2##3##(2008-2#1)(2008-3#1)
of the water-oxidizing complex##2##4##(1990-5#1)(1997-7#1)
of the water-soluble##2##3##(1990-11#1)(2008-10#1)
of the water-vapor mixing ratio##2##5##(2008-3#2)
of the water-vapor##3##3##(2008-3#3)
of the watershed##3##3##(2008-2#2)(2008-9#1)
of the wave front under##2##5##(2008-3#2)
of the wave front##12##4##(2007-12#1)(2008-2#5)(2008-3#6)
of the wave fronts##3##4##(2007-11#1)(2008-3#2)
of the wave number of the##2##6##(2007-12#1)(2008-2#1)
of the wave##23##3##(2005-11#1)(2007-11#1)(2007-12#2)(2008-2#7)(2008-3#11)(2009-1#1)
of the wave-front##7##3##(2007-11#2)(2008-2#2)(2008-3#3)
of the waveguide and##3##4##(2007-12#1)(2008-3#2)
of the waveguide can##2##4##(2007-12#1)(2008-3#1)
of the waveguide polymers##2##4##(2008-2#2)
of the waveguide was##2##4##(2007-11#1)(2008-2#1)
of the waveguide##26##3##(1992-3#1)(2007-11#2)(2007-12#9)(2008-1#1)(2008-10#1)(2008-2#6)(2008-3#6)
of the waveguides##7##3##(2007-12#2)(2008-2#4)(2008-3#1)
of the wavelength are##2##4##(2007-11#1)(2008-2#1)
of the wavelength dependence of beam divergence for##2##8##(2007-12#2)
of the wavelength dependence of the##2##6##(2007-11#1)(2008-2#1)
of the wavelength dependence of##4##5##(2007-11#1)(2007-12#2)(2008-2#1)
of the wavelength of the##7##5##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)
of the wavelength of##9##4##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#3)
of the wavelength range and##2##5##(2008-10#1)(2008-2#1)
of the wavelength range##4##4##(2008-10#1)(2008-2#2)(2008-3#1)
of the wavelength##35##3##(2007-11#5)(2007-12#7)(2008-10#2)(2008-2#14)(2008-3#7)
of the wavelengths##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
of the wavelet graph##2##4##(2008-2#2)
of the wavelet transform##3##4##(2007-12#1)(2008-2#2)
of the wavelet##10##3##(2007-12#1)(2008-2#8)(2008-3#1)
of the waves##2##3##(2008-10#1)(2008-3#1)
of the wax matrix##6##4##(2008-5#6)
of the wax##7##3##(2007-12#1)(2008-5#6)
of the way the##2##4##(2008-11#1)(2011-1#1)
of the way##7##3##(1990-11#1)(1992-12#1)(2008-11#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
of the ways in which##5##5##(1992-12#1)(2005-11#1)(2006-11#1)(2007-11#1)(2008-9#1)
of the ways##9##3##(1992-12#1)(1997-2#1)(2005-11#1)(2006-11#1)(2007-11#1)(2007-4#1)(2008-2#1)(2008-7#1)(2008-9#1)
of the weak##9##3##(1993-6#1)(1993-9#1)(1994-5#1)(2007-12#1)(2008-10#3)(2008-3#1)(2009-2#1)
of the weakest##2##3##(2008-5#1)(2012-3#1)
of the weakly##3##3##(1995-5#1)(2008-7#1)(2011-2#1)
of the weapon##5##3##(1995-11#1)(2007-12#1)(2008-10#1)(2013-7#2)
of the wear debris##2##4##(2004-9#2)
of the web##2##3##(2007-10#1)(2008-9#1)
of the weed##3##3##(2008-10#1)(2008-5#1)(2010-12#1)
of the week##5##3##(1996-1#1)(2005-10#1)(2005-9#1)(2006-12#1)(2011-1#1)
of the weight of##4##4##(1996-8#1)(2009-12#1)(2012-12#2)
of the weight##9##3##(1992-12#1)(1996-8#2)(2007-12#1)(2008-11#1)(2008-3#1)(2009-12#1)(2012-12#2)
of the welded##2##3##(2008-3#1)(2013-8#1)
of the welfare state?]##2##4##(1996-8#2)
of the welfare##3##3##(1996-8#3)
of the well known##3##4##(1991-2#1)(1992-3#1)(2008-11#1)
of the well##10##3##(1990-9#1)(1991-2#1)(1991-7#1)(1992-3#1)(2007-12#1)(2008-11#4)(2012-12#1)
of the well-known##21##3##(1994-6#2)(1997-7#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#4)(2008-6#1)(2009-12#1)(2010-12#3)
of the western world##3##4##(1990-2#1)(2008-2#2)
of the western##12##3##(1990-2#1)(1994-8#1)(2006-10#2)(2008-1#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-8#1)(2011-12#1)(2011-2#1)
of the wet##7##3##(1992-12#1)(2005-4#1)(2008-10#2)(2008-5#2)(2010-8#1)
of the wetland##3##3##(2007-5#3)
of the wetted and dewetted regions##2##6##(2005-11#2)
of the wetted region inside the porous layer##2##8##(2005-11#2)
of the wetted##5##3##(2005-11#5)
of the wetting##4##3##(2008-10#1)(2008-5#1)(2009-11#1)(2012-2#1)
of the wheat histone H3 gene##2##6##(1992-3#2)
of the wheat sown##2##4##(2013-8#2)
of the wheat varieties##3##4##(2013-8#3)
of the wheat##15##3##(1992-3#2)(2006-12#1)(2008-10#5)(2008-5#1)(2013-8#6)
of the wheelchair##2##3##(2007-7#2)
of the whispering-gallery modes##2##4##(2007-11#2)
of the white blood##2##4##(1992-4#1)(2008-1#1)
of the white matter##11##4##(1991-12#1)(1995-5#1)(1996-11#2)(1997-5#1)(2007-1#1)(2007-10#1)(2008-11#1)(2010-12#2)(2011-1#1)
of the white pine blister rust##2##6##(2008-10#2)
of the white pine##3##4##(2008-10#3)
of the white rot##2##4##(2005-12#1)(2009-9#1)
of the white##25##3##(1991-12#1)(1992-4#1)(1992-8#1)(1992-9#1)(1995-5#1)(1996-11#2)(1997-5#2)(2004-4#1)(2005-12#1)(2007-1#1)(2007-10#1)(2008-1#1)(2008-10#4)(2008-11#1)(2009-9#1)(2010-12#2)(2010-5#1)(2011-1#1)(2012-12#1)
of the white-rot##2##3##(1990-4#1)(1991-8#1)
of the whitefly Bemisia tabaci##2##5##(2008-10#1)(2011-2#1)
of the whitefly##3##3##(2008-10#2)(2011-2#1)
of the whole analytical procedure##2##5##(2008-10#2)
of the whole and##2##4##(2009-9#1)(2013-8#1)
of the whole body##3##4##(1992-3#1)(2008-10#1)(2008-7#1)
of the whole brain##2##4##(1991-6#1)(2010-12#1)
of the whole cell##2##4##(1997-6#1)(2006-12#1)
of the whole cortical##2##4##(1995-5#1)(2008-7#1)
of the whole genome##4##4##(2007-3#1)(2008-8#1)(2011-1#1)(2012-3#1)
of the whole group##4##4##(1990-6#1)(1993-12#1)(2006-6#2)
of the whole organism##4##4##(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)
of the whole population##2##4##(1992-5#1)(2010-12#1)
of the whole procedure##3##4##(2008-10#2)(2011-2#1)
of the whole system##4##4##(2007-8#1)(2008-2#2)(2008-3#1)
of the whole##108##3##(1990-12#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-3#2)(1995-3#1)(1995-5#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2004-4#1)(2005-1#1)(2005-11#1)(2006-12#1)(2006-6#2)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#2)(2008-10#15)(2008-11#1)(2008-2#4)(2008-3#4)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-9#2)(2010-10#1)(2010-12#5)(2010-8#3)(2011-1#5)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
of the whole-cell##4##3##(1993-7#1)(1994-2#1)(2008-5#1)(2011-3#1)
of the whole-genome##2##3##(2010-3#1)(2011-1#1)
of the wide excision group (chi(2)=##2##6##(2004-1#2)
of the wide range of##3##5##(1991-11#1)(2012-2#2)
of the wide spectrum of##2##5##(1990-6#1)(2007-11#1)
of the wide variety of##3##5##(2008-11#1)(2008-8#1)(2008-9#1)
of the wide##17##3##(1990-6#1)(1991-11#1)(1997-2#1)(2004-1#2)(2007-11#2)(2007-12#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#2)
of the widely used##10##4##(1994-1#1)(1995-2#1)(2005-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-9#1)
of the widely##14##3##(1994-1#1)(1995-2#1)(1997-8#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-6#1)(2008-9#1)(2012-12#1)
of the wider##2##3##(2012-2#1)(2013-7#1)
of the widespread use of##2##5##(2005-9#1)(2012-2#1)
of the widespread##9##3##(1990-7#1)(1992-2#1)(1993-3#1)(1996-3#1)(2005-9#1)(2008-10#2)(2010-8#1)(2012-2#1)
of the widest##2##3##(2006-5#1)(2008-4#1)
of the width of the##2##5##(2007-12#1)(2008-3#1)
of the wild type and##5##5##(2005-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)
of the wild type protein##2##5##(1992-8#1)(1996-8#1)
of the wild type strain##2##5##(2006-8#1)(2008-8#1)
of the wild type with##2##5##(1991-7#1)(1997-4#1)
of the wild type##42##4##(1990-5#2)(1990-7#1)(1991-2#3)(1991-4#1)(1991-7#2)(1991-8#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#3)(1993-6#1)(1993-8#1)(1995-1#2)(1995-5#1)(1995-7#1)(1995-8#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-4#3)(1997-8#1)(2005-11#1)(2006-8#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-8#3)(2010-10#1)(2013-8#1)
of the wild##48##3##(1990-5#2)(1990-7#1)(1991-2#3)(1991-4#1)(1991-7#2)(1991-8#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#3)(1993-6#1)(1993-8#1)(1995-1#2)(1995-5#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-4#3)(1997-8#1)(2005-11#1)(2006-8#1)(2008-10#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#4)(2010-10#1)(2013-8#1)
of the wild-type (wt)##2##4##(1990-3#1)(1990-5#1)
of the wild-type LCAT##2##4##(1993-3#1)(1993-8#1)
of the wild-type activity##2##4##(1990-3#1)(1996-11#1)
of the wild-type and Del 49 enzymes##2##7##(1995-2#2)
of the wild-type and##8##4##(1994-11#1)(1994-9#1)(1995-10#1)(1995-2#2)(1997-3#1)(1997-4#1)(2006-10#1)
of the wild-type bacteriorhodopsin##2##4##(1992-11#2)
of the wild-type enzyme by##2##5##(1991-12#1)(1995-1#1)
of the wild-type enzyme##22##4##(1990-10#2)(1990-8#3)(1991-12#1)(1992-3#3)(1992-6#2)(1992-9#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#1)(2008-4#1)
of the wild-type level of##2##5##(1995-2#2)
of the wild-type level##3##4##(1995-2#2)(1997-4#1)
of the wild-type protein##10##4##(1990-2#1)(1990-5#1)(1992-3#1)(1992-9#1)(1994-11#1)(1994-6#1)(1994-9#1)(1997-5#3)
of the wild-type strain on##2##5##(2008-10#2)
of the wild-type strain##6##4##(1997-4#1)(2008-10#4)(2008-6#1)
of the wild-type##102##3##(1990-10#2)(1990-2#1)(1990-3#2)(1990-5#2)(1990-8#4)(1991-10#1)(1991-12#2)(1991-2#1)(1991-8#2)(1992-11#2)(1992-3#4)(1992-4#2)(1992-6#2)(1992-9#2)(1993-11#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#3)(1994-5#4)(1994-6#1)(1994-9#3)(1995-1#2)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#6)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#4)(1996-11#2)(1996-7#3)(1997-2#3)(1997-3#1)(1997-4#4)(1997-5#3)(2006-10#2)(2006-12#3)(2006-9#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-6#3)(2009-10#1)
of the willingness to pay (WTP)##2##6##(2007-7#1)(2013-8#1)
of the window##2##3##(2008-2#1)(2008-3#1)
of the windows period##2##4##(2012-2#2)
of the windows##3##3##(2008-3#1)(2012-2#2)
of the wine##3##3##(2008-10#3)
of the wing base##2##4##(2007-12#2)
of the wing##7##3##(2007-12#6)(2009-5#1)
of the wings##6##3##(1990-9#1)(2008-3#2)(2009-12#1)(2013-8#2)
of the winter##4##3##(2008-10#1)(2008-7#1)(2008-8#1)(2010-8#1)
of the wire##3##3##(2007-8#1)(2010-10#1)(2012-1#1)
of the wireless##3##3##(2010-10#1)(2010-2#1)(2010-8#1)
of the wires##2##3##(2007-8#1)(2008-3#1)
of the withdrawal syndrome##3##4##(1991-12#3)
of the withdrawal##4##3##(1991-12#3)(2008-11#1)
of the wolf spider##3##4##(2007-12#1)(2009-6#2)
of the woman##3##3##(1993-9#1)(2007-7#2)
of the women did not##2##5##(1991-4#1)(1996-1#1)
of the women had##6##4##(1990-8#1)(1995-8#1)(2006-10#1)(2006-7#1)(2008-11#1)(2011-1#1)
of the women have##2##4##(2007-12#1)(2010-3#1)
of the women in the##2##5##(1992-1#1)(2006-8#1)
of the women in##5##4##(1992-1#1)(2006-4#1)(2006-8#1)(2008-11#1)(2009-11#1)
of the women of##2##4##(2009-4#1)(2013-8#1)
of the women on##3##4##(1992-2#3)
of the women received##3##4##(2006-7#1)(2010-8#1)(2011-1#1)
of the women were still##2##5##(2006-7#1)(2011-1#1)
of the women were##13##4##(1991-6#1)(1996-6#1)(2006-4#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-6#1)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-8#2)
of the women##71##3##(1990-12#1)(1990-8#2)(1991-4#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#3)(1992-3#1)(1993-9#1)(1994-11#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-6#2)(2006-10#4)(2006-4#2)(2006-7#3)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-3#2)(2007-6#1)(2007-7#1)(2008-11#3)(2008-5#1)(2008-7#1)(2009-11#1)(2009-4#2)(2009-7#1)(2010-3#3)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#6)(2013-1#2)(2013-8#4)
of the women's##5##3##(1994-3#2)(1995-8#1)(2012-12#2)
of the wood##10##3##(2005-10#1)(2007-1#1)(2008-10#1)(2008-3#2)(2009-8#1)(2011-2#1)(2013-8#3)
of the word##10##3##(1992-8#1)(1995-5#2)(2006-3#1)(2008-1#2)(2008-3#1)(2008-5#1)(2010-12#1)(2012-2#1)
of the words##2##3##(2007-5#1)(2008-4#1)
of the work environment in a##2##6##(2008-7#2)
of the work environment##5##4##(2006-6#1)(2008-7#3)(2011-1#1)
of the work is##2##4##(2007-11#1)(2010-8#1)
of the work of##5##4##(1992-11#1)(1996-1#1)(2007-10#1)(2008-8#1)(2009-7#1)
of the work reported here##2##5##(1991-5#1)(2008-5#1)
of the work was to##5##5##(2005-1#1)(2007-11#1)(2008-10#1)(2010-2#1)(2013-1#1)
of the work was##6##4##(2005-1#1)(2006-3#1)(2007-11#1)(2008-10#1)(2010-2#1)(2013-1#1)
of the work##43##3##(1990-4#1)(1991-5#1)(1992-11#1)(1994-6#1)(1995-2#1)(1996-1#1)(1997-4#1)(2005-1#1)(2005-5#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-10#2)(2007-11#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#2)(2009-7#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#3)
of the work-up##2##3##(1992-2#1)(2006-10#1)
of the worker##3##3##(2008-6#3)
of the workers##5##3##(1991-11#1)(1994-6#2)(1996-3#1)(2006-10#1)
of the workforce reported exposure to a coworker who approved of##2##11##(2012-12#2)
of the workforce reported exposure to a coworker who used or was impaired by##2##14##(2012-12#2)
of the workforce reported exposure to a coworker who##4##9##(2012-12#4)
of the workforce reported that they could easily##2##8##(2012-12#2)
of the workforce reported##6##4##(2012-12#6)
of the workforce##9##3##(2007-4#1)(2009-5#1)(2011-1#1)(2012-12#6)
of the working electrode and##2##5##(2008-10#2)
of the working electrode##6##4##(2008-10#5)(2010-4#1)
of the working##20##3##(1990-9#1)(1991-3#1)(1993-2#1)(1994-6#1)(2007-11#1)(2007-5#1)(2008-10#7)(2008-3#2)(2008-4#1)(2008-6#1)(2010-4#1)(2011-2#1)(2013-1#1)
of the workplace##5##3##(1997-2#1)(2007-7#1)(2008-9#2)(2011-1#1)
of the workshop on##2##4##(1992-1#1)(2008-10#1)
of the workshop was##2##4##(2008-10#1)(2013-8#1)
of the workshop##9##3##(1992-1#1)(1996-4#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-5#1)(2011-2#1)(2013-8#1)
of the workshops and##2##4##(2008-12#1)(2011-2#1)
of the workshops##4##3##(2008-12#3)(2011-2#1)
of the world and##5##4##(2005-11#1)(2010-10#1)(2010-5#1)(2011-11#1)(2012-2#1)
of the world are##3##4##(1991-11#1)(2007-9#1)(2008-6#1)
of the world as##2##4##(2011-1#1)(2011-2#1)
of the world in which##2##5##(2007-3#1)(2008-11#1)
of the world in##3##4##(2007-3#1)(2008-10#1)(2008-11#1)
of the world population##6##4##(2006-10#1)(2006-2#1)(2008-3#1)(2008-7#1)(2009-2#1)(2011-2#1)
of the world to##4##4##(1991-11#1)(2010-12#1)(2010-9#1)(2012-12#1)
of the world where##2##4##(2012-11#1)(2012-12#1)
of the world##144##3##(1990-2#1)(1991-11#2)(1991-6#1)(1992-5#1)(1992-9#1)(1993-10#1)(1994-1#2)(1995-4#1)(1996-11#1)(1997-4#2)(1997-6#1)(1997-8#2)(2004-11#1)(2005-11#3)(2005-7#4)(2005-8#1)(2006-10#5)(2006-2#3)(2006-9#1)(2007-10#1)(2007-12#2)(2007-2#4)(2007-3#3)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#19)(2008-11#7)(2008-12#6)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-9#1)(2009-10#2)(2009-2#2)(2009-6#3)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#5)(2011-11#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)
of the world's children##2##4##(1990-2#1)(2006-10#1)
of the world's most##5##4##(1994-3#1)(2005-8#1)(2008-10#1)(2012-2#1)(2013-8#1)
of the world's population##11##4##(2006-10#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-10#1)(2012-12#1)(2013-7#1)
of the world's smallest##2##4##(1996-12#1)(2006-5#1)
of the world's##32##3##(1990-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-3#2)(1995-9#1)(1996-12#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#4)(2006-5#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-7#1)(2013-8#1)
of the world)##2##3##(1990-6#1)(2013-1#1)
of the worldwide##3##3##(1993-12#1)(2009-9#1)(2010-11#1)
of the worm##2##3##(2007-12#1)(2007-6#1)
of the worst##3##3##(2007-11#1)(2008-1#1)(2011-2#1)
of the wound and##2##4##(2007-7#1)(2012-12#1)
of the wound healing process##2##5##(2006-11#1)(2011-1#1)
of the wound healing##3##4##(2006-11#1)(2007-12#1)(2011-1#1)
of the wound site##2##4##(2008-10#1)(2012-3#1)
of the wound##19##3##(1990-2#1)(1990-7#1)(1996-9#1)(2005-10#1)(2006-11#1)(2006-9#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-4#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
of the wound-healing process##2##4##(2008-7#1)(2012-12#1)
of the wounds and##2##4##(2007-8#1)(2010-3#1)
of the wounds##4##3##(2006-9#1)(2007-8#1)(2008-5#1)(2010-3#1)
of the wrist##16##3##(1996-3#2)(2006-3#4)(2006-4#1)(2008-7#1)(2008-9#4)(2009-5#1)(2011-2#2)(2012-3#1)
of the writing beams##2##4##(2007-11#1)(2007-12#1)
of the writing##7##3##(1991-1#1)(2007-11#1)(2007-12#2)(2008-3#2)(2010-10#1)
of the written##3##3##(2007-11#1)(2008-11#1)(2009-9#1)
of the wt##2##3##(1990-3#1)(1990-5#1)
of the x##2##3##(2007-12#1)(2008-2#1)
of the x-ray##8##3##(1990-2#1)(2008-2#1)(2008-3#4)(2010-1#1)(2012-1#1)
of the xylan content##2##4##(2008-5#2)
of the xylan##4##3##(2006-8#1)(2008-5#3)
of the xylem vessels##2##4##(2007-12#1)(2008-10#1)
of the xylem##3##3##(2007-12#1)(2008-10#2)
of the xylose##3##3##(2008-6#3)
of the year 2000##3##4##(2007-12#1)(2007-3#1)(2008-1#1)
of the year and##2##4##(2007-11#1)(2008-5#1)
of the year##44##3##(1990-12#1)(1991-11#1)(1991-12#1)(1992-12#1)(1997-3#1)(1997-4#1)(2005-7#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#3)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-3#4)(2008-5#7)(2009-12#1)(2009-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
of the years##3##3##(1997-1#1)(1997-3#1)(2004-11#1)
of the yeast Candida oleophila##2##5##(2008-10#2)
of the yeast Candida##3##4##(1991-8#1)(2008-10#2)
of the yeast HIS3 mRNA##2##5##(1997-4#2)
of the yeast MAT alpha 2##2##6##(1993-7#1)(1994-10#1)
of the yeast Saccharomyces cerevisiae##13##5##(1990-3#1)(1991-7#1)(1992-2#1)(1992-3#2)(1992-8#1)(1994-9#1)(1995-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(2007-12#1)
of the yeast cell##2##4##(1991-5#1)(1993-8#1)
of the yeast interactome##3##4##(2008-7#2)(2009-5#1)
of the yeast mitochondrial##2##4##(1995-6#1)(1996-9#1)
of the yeast mutants##2##4##(1995-2#1)(2011-1#1)
of the yeast to##2##4##(1992-11#1)(2008-5#1)
of the yeast transcription factor##2##5##(1992-2#1)(1996-2#1)
of the yeast transcriptional activator##2##5##(1996-3#1)(2006-12#1)
of the yeast was##2##4##(1990-10#1)(2008-5#1)
of the yeast##99##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#1)(1992-11#3)(1992-12#2)(1992-2#4)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-5#1)(1993-7#1)(1993-8#3)(1993-9#2)(1994-10#2)(1994-6#1)(1994-9#3)(1995-2#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-2#3)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#4)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#3)(2006-12#2)(2007-12#1)(2008-10#5)(2008-5#4)(2008-7#4)(2009-5#1)(2011-1#1)
of the yeasts##2##3##(2007-9#1)(2012-3#1)
of the yellowfin seabream Acanthopagrus latus##2##6##(2009-5#2)
of the yield components##2##4##(2008-10#1)(2008-12#1)
of the yield of##3##4##(1991-9#1)(1995-2#1)(2008-12#1)
of the yield##5##3##(1991-9#1)(1995-2#1)(2008-10#1)(2008-12#2)
of the young adult##2##4##(2010-7#1)(2011-12#1)
of the young and old##2##5##(1991-12#1)(2008-6#1)
of the young and##3##4##(1991-12#1)(2005-1#1)(2008-6#1)
of the young cells##2##4##(1992-3#2)
of the young patients who##2##5##(1992-6#1)(2007-7#1)
of the young people##3##4##(1995-8#2)(2009-2#1)
of the young##24##3##(1990-12#1)(1991-12#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#1)(1995-6#1)(1995-8#2)(2005-1#1)(2006-10#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#2)(2008-6#1)(2008-7#2)(2009-2#1)(2010-12#1)(2010-7#1)(2011-12#1)
of the younger and##3##4##(1992-9#3)
of the younger patients##4##4##(1994-6#4)
of the younger##9##3##(1990-5#1)(1992-9#3)(1994-6#4)(2009-10#1)
of the youngest##3##3##(2007-8#1)(2008-10#1)(2008-5#1)
of the zebrafish##3##3##(1997-2#1)(2007-9#1)(2008-8#1)
of the zero-dispersion wavelength##2##4##(2007-11#1)(2007-12#1)
of the zero-order##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
of the zeta##3##3##(1993-6#1)(1995-6#1)(2005-11#1)
of the zinc##16##3##(1990-8#3)(1991-5#1)(1994-2#1)(1996-5#1)(2005-4#1)(2008-10#5)(2009-12#1)(2009-4#1)(2010-10#1)(2012-2#1)
of the zinc-binding##2##3##(2008-1#1)(2013-7#1)
of the zona incerta##3##4##(1991-5#1)(2009-2#2)
of the zona##4##3##(1990-5#1)(1991-5#1)(2009-2#2)
of the zone of##3##4##(2008-10#1)(2008-9#1)(2010-12#1)
of the zone##5##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-12#1)
of the zygomatic##3##3##(2006-12#1)(2008-3#1)(2010-12#1)
of the zygote##2##3##(2005-8#1)(2012-1#1)
of the zymogen granule membrane##2##5##(1992-4#1)(2006-10#1)
of the zymogen##3##3##(1992-4#1)(2006-10#1)(2012-1#1)
of the##122013##2##(1990-1#54)(1990-10#347)(1990-11#541)(1990-12#615)(1990-2#495)(1990-3#447)(1990-4#356)(1990-5#653)(1990-6#297)(1990-7#496)(1990-8#449)(1990-9#361)(1991-1#250)(1991-10#260)(1991-11#367)(1991-12#587)(1991-2#586)(1991-3#427)(1991-4#333)(1991-5#549)(1991-6#379)(1991-7#430)(1991-8#393)(1991-9#567)(1992-1#321)(1992-10#187)(1992-11#428)(1992-12#583)(1992-2#408)(1992-3#630)(1992-4#231)(1992-5#315)(1992-6#593)(1992-7#254)(1992-8#516)(1992-9#539)(1993-1#175)(1993-10#140)(1993-11#496)(1993-12#635)(1993-2#424)(1993-3#602)(1993-4#194)(1993-5#282)(1993-6#506)(1993-7#155)(1993-8#402)(1993-9#440)(1994-1#96)(1994-10#181)(1994-11#551)(1994-12#757)(1994-2#580)(1994-3#702)(1994-4#80)(1994-5#473)(1994-6#426)(1994-7#91)(1994-8#667)(1994-9#706)(1995-1#513)(1995-10#264)(1995-11#533)(1995-12#523)(1995-2#591)(1995-3#679)(1995-4#178)(1995-5#549)(1995-6#612)(1995-7#146)(1995-8#578)(1995-9#161)(1996-1#325)(1996-10#229)(1996-11#366)(1996-12#602)(1996-2#597)(1996-3#480)(1996-4#322)(1996-5#706)(1996-6#385)(1996-7#413)(1996-8#447)(1996-9#380)(1997-1#517)(1997-2#780)(1997-3#587)(1997-4#698)(1997-5#368)(1997-6#558)(1997-7#653)(1997-8#581)(1997-9#23)(2003-11#13)(2004-1#35)(2004-10#53)(2004-11#116)(2004-12#91)(2004-2#58)(2004-3#36)(2004-4#70)(2004-5#2)(2004-7#12)(2004-8#14)(2004-9#142)(2005-1#88)(2005-10#294)(2005-11#1220)(2005-12#143)(2005-2#10)(2005-3#17)(2005-4#113)(2005-5#86)(2005-6#26)(2005-7#267)(2005-8#322)(2005-9#116)(2006-1#86)(2006-10#1804)(2006-11#453)(2006-12#899)(2006-2#346)(2006-3#266)(2006-4#338)(2006-5#401)(2006-6#500)(2006-7#283)(2006-8#674)(2006-9#250)(2007-1#402)(2007-10#551)(2007-11#2590)(2007-12#3645)(2007-2#510)(2007-3#457)(2007-4#432)(2007-5#463)(2007-6#283)(2007-7#1198)(2007-8#1754)(2007-9#661)(2008-1#1217)(2008-10#11414)(2008-11#2199)(2008-12#870)(2008-2#4028)(2008-3#4855)(2008-4#1818)(2008-5#2959)(2008-6#978)(2008-7#2403)(2008-8#1613)(2008-9#1539)(2009-1#82)(2009-10#461)(2009-11#215)(2009-12#277)(2009-2#518)(2009-3#419)(2009-4#470)(2009-5#442)(2009-6#287)(2009-7#433)(2009-8#491)(2009-9#303)(2010-1#175)(2010-10#241)(2010-11#262)(2010-12#943)(2010-2#512)(2010-3#317)(2010-4#536)(2010-5#442)(2010-6#207)(2010-7#285)(2010-8#526)(2010-9#311)(2011-1#1342)(2011-10#11)(2011-11#18)(2011-12#289)(2011-2#2833)(2011-3#94)(2011-4#5)(2011-6#1)(2011-7#27)(2011-8#1)(2011-9#2)(2012-1#785)(2012-10#4)(2012-11#222)(2012-12#1442)(2012-2#1632)(2012-3#1015)(2012-4#2)(2012-5#15)(2012-6#8)(2012-7#15)(2012-8#8)(2012-9#5)(2013-1#2255)(2013-2#2)(2013-3#1)(2013-7#542)(2013-8#1450)
of theanine##4##2##(2008-11#4)
of theca-interstitial##2##2##(2008-5#1)(2010-10#1)
of their C-terminal##2##3##(1993-8#1)(2010-7#1)
of their DNA##4##3##(2005-7#1)(2008-1#1)(2008-9#1)(2011-12#1)
of their ED##3##3##(2006-7#3)
of their HIV##3##3##(1996-5#1)(2012-2#1)(2012-3#1)
of their RNA##2##3##(2007-12#1)(2008-2#1)
of their abilities##2##3##(1991-8#1)(2008-2#1)
of their ability to inhibit the##2##6##(2006-10#1)(2008-10#1)
of their ability to inhibit##3##5##(2005-7#1)(2006-10#1)(2008-10#1)
of their ability to provide##2##5##(1997-8#1)(2008-6#1)
of their ability to##16##4##(1990-4#1)(1992-9#1)(1996-11#1)(1997-8#1)(2005-7#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-2#1)
of their accuracy##3##3##(2008-10#1)(2008-7#1)(2011-7#1)
of their action##4##3##(1996-12#1)(2005-1#1)(2007-7#1)(2009-8#1)
of their actions##3##3##(1993-5#1)(2008-11#1)(2013-7#1)
of their active##3##3##(2008-3#1)(2008-4#1)(2008-5#1)
of their activities##2##3##(1997-3#1)(1997-4#1)
of their activity##6##3##(1993-2#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-8#1)(2012-1#1)
of their actual##3##3##(2008-2#1)(2008-3#2)
of their adult##2##3##(2008-7#1)(2009-10#1)
of their afferent##2##3##(1990-5#1)(2007-12#1)
of their age##5##3##(2007-3#1)(2008-1#1)(2008-3#1)(2012-2#1)(2012-3#1)
of their amino acid##2##4##(1992-12#1)(2008-7#1)
of their amino##3##3##(1992-12#1)(2008-10#1)(2008-7#1)
of their apparent##2##3##(2005-8#1)(2008-1#1)
of their appearance##2##3##(1992-8#1)(2007-12#1)
of their applicability##2##3##(2008-1#2)
of their application in##2##4##(2006-7#1)(2008-10#1)
of their application##6##3##(2006-10#1)(2006-12#1)(2006-7#1)(2008-10#2)(2013-7#1)
of their association with the##2##5##(2008-9#1)(2009-4#1)
of their association##3##3##(2008-4#1)(2008-9#1)(2009-4#1)
of their average##2##3##(2006-12#1)(2010-3#1)
of their axons##2##3##(1997-6#1)(2007-12#1)
of their basic##2##3##(2006-12#1)(2008-3#1)
of their being##2##3##(1995-12#1)(1995-8#1)
of their beneficial effects##2##4##(2013-7#1)(2013-8#1)
of their benefit##2##3##(1992-3#1)(2007-11#1)
of their binding##4##3##(1991-2#1)(2008-10#1)(2008-4#1)(2012-3#1)
of their biological activities##2##4##(1995-8#1)(2011-1#1)
of their biological##5##3##(1995-8#1)(2008-4#1)(2008-7#1)(2009-3#1)(2011-1#1)
of their biology##2##3##(2009-5#1)(2009-8#1)
of their body weight##2##4##(2006-10#1)(2008-5#1)
of their body##6##3##(2006-10#1)(2007-12#2)(2007-3#1)(2008-5#1)(2009-4#1)
of their brain##2##3##(1993-11#1)(2008-5#1)
of their capability##2##3##(1991-4#1)(2006-10#1)
of their capacity to##2##4##(1991-8#1)(2008-2#1)
of their care##5##3##(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
of their career##2##3##(2012-12#1)(2012-2#1)
of their catalytic##3##3##(1993-12#1)(2010-12#1)(2010-5#1)
of their cell##2##3##(1993-6#1)(2008-11#1)
of their central##2##3##(1996-1#1)(2008-2#1)
of their chemical properties##3##4##(2008-10#2)(2008-11#1)
of their chemical##6##3##(1990-3#1)(2008-10#2)(2008-11#1)(2009-2#1)(2013-8#1)
of their child##4##3##(1993-12#1)(2005-7#1)(2008-2#1)(2008-9#1)
of their children##10##3##(1995-1#1)(1995-9#1)(2006-4#1)(2008-12#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#2)
of their children's##2##3##(2009-7#1)(2013-1#1)
of their choice##2##3##(2008-9#1)(2010-10#1)
of their clinical and##2##4##(2007-9#1)(2009-6#1)
of their clinical##15##3##(1996-2#1)(1997-6#1)(2005-8#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-7#1)(2008-9#1)(2009-5#1)(2009-6#1)(2012-3#1)
of their combination##2##3##(2008-10#1)(2009-6#1)
of their comments##2##3##(2008-11#1)(2008-2#1)
of their communities##2##3##(1995-2#1)(2011-2#1)
of their complex##4##3##(1991-12#1)(1995-2#1)(2008-3#1)(2008-5#1)
of their complexes with##4##4##(2007-8#1)(2008-10#3)
of their complexes##5##3##(2007-8#1)(2008-10#3)(2008-5#1)
of their components##4##3##(1993-2#1)(2008-10#2)(2008-3#1)
of their concerns##2##3##(1991-2#1)(2005-9#1)
of their condition##3##3##(2011-1#1)(2012-2#1)(2012-3#1)
of their conformational##2##3##(1994-6#1)(2008-3#1)
of their consumption##2##3##(1991-9#1)(2011-1#1)
of their content##2##3##(2007-11#1)(2007-5#1)
of their contents##4##3##(2008-12#1)(2008-7#1)(2012-1#1)(2012-3#1)
of their control rats##2##4##(2008-12#2)
of their correction with##3##4##(2008-4#1)(2011-2#1)(2012-1#1)
of their correlation##2##3##(2007-7#1)(2008-3#1)
of their corresponding mRNAs##2##4##(1992-8#1)(2009-8#1)
of their corresponding##4##3##(1990-2#1)(1992-8#1)(2009-10#1)(2009-8#1)
of their costs##2##3##(2005-10#1)(2007-4#1)
of their course##2##3##(2008-11#2)
of their current##2##3##(1996-1#1)(2008-4#1)
of their customers'##2##3##(1992-1#2)
of their daily##4##3##(1993-3#1)(2007-3#1)(2008-11#1)(2012-2#1)
of their death##2##3##(1995-6#1)(2012-1#1)
of their degradation##2##3##(1990-7#1)(2009-8#1)
of their degree of##3##4##(2008-4#1)(2008-9#1)(2013-1#1)
of their design##3##3##(2004-4#1)(2006-10#1)(2006-11#1)
of their detection##4##3##(2008-10#2)(2008-11#1)(2010-6#1)
of their development and##3##4##(1992-6#1)(2008-1#1)(2008-4#1)
of their development in##2##4##(2009-10#1)(2012-1#1)
of their development##9##3##(1992-6#1)(2006-10#1)(2007-1#1)(2008-1#1)(2008-4#1)(2009-10#1)(2009-8#1)(2010-12#1)(2012-1#1)
of their developmental##2##3##(1991-2#1)(1994-9#1)
of their diabetes##2##3##(1997-3#1)(2012-1#1)
of their diagnosis##2##3##(1997-8#1)(2010-8#1)
of their diagnostic and therapeutic##2##5##(2006-12#1)(2009-2#1)
of their diagnostic##3##3##(2006-12#1)(2009-2#1)(2012-1#1)
of their different##12##3##(1996-12#1)(1997-4#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-5#1)(2008-9#1)(2009-4#1)(2012-11#2)
of their disease##17##3##(1990-1#1)(1990-6#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-2#2)(2007-3#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-2#1)(2010-11#2)(2010-12#1)
of their disorder##2##3##(1995-1#1)(2010-2#1)
of their distal##2##3##(2011-12#1)(2012-3#1)
of their distinctive##2##3##(2008-8#1)(2010-7#1)
of their distribution##2##3##(1990-5#1)(2008-10#1)
of their driving##2##3##(2012-12#2)
of their early##3##3##(2006-8#1)(2010-12#1)(2013-8#1)
of their education##2##3##(2007-1#1)(2013-1#1)
of their effect on the##2##5##(2008-10#2)
of their effect on##7##4##(1993-12#1)(1994-2#1)(2008-10#2)(2008-8#1)(2008-9#1)(2010-2#1)
of their effect##9##3##(1993-12#1)(1994-2#1)(2008-10#2)(2008-8#1)(2008-9#2)(2010-2#1)(2012-1#1)
of their effectiveness##5##3##(1993-11#1)(1993-3#1)(1994-2#1)(2008-1#1)(2012-12#1)
of their effects on##6##4##(2006-10#1)(2006-12#1)(2008-10#1)(2008-8#2)(2009-4#1)
of their effects##13##3##(1990-2#1)(1992-5#1)(1994-8#1)(2006-10#2)(2006-12#1)(2008-1#1)(2008-10#2)(2008-8#2)(2009-4#1)(2011-12#1)
of their efficacy and##2##4##(1990-1#1)(2013-1#1)
of their efficacy##4##3##(1990-1#1)(2008-3#1)(2010-9#1)(2013-1#1)
of their efforts##6##3##(1991-8#1)(2006-11#1)(2008-1#1)(2008-10#1)(2010-10#1)(2011-1#1)
of their electrical##2##3##(2012-2#1)(2013-8#1)
of their elemental##2##3##(2008-10#1)(2008-5#1)
of their employment##2##3##(1995-1#1)(2007-12#1)
of their endogenous##2##3##(2008-4#1)(2009-7#1)
of their environments##2##3##(1991-8#1)(2008-9#1)
of their essential##3##3##(1996-5#1)(2008-8#1)(2012-12#1)
of their evolutionary history##2##4##(2010-5#1)(2010-6#1)
of their evolutionary##4##3##(2008-8#1)(2010-2#1)(2010-5#1)(2010-6#1)
of their existing##3##3##(1994-1#1)(2013-1#2)
of their experience and##2##4##(1993-10#1)(1994-2#1)
of their experience##8##3##(1991-8#1)(1993-10#2)(1994-2#1)(2008-2#1)(2009-5#1)(2011-2#1)(2013-8#1)
of their experiences##5##3##(2007-2#1)(2007-5#1)(2008-11#1)(2009-12#1)(2010-3#1)
of their expertise##3##3##(2007-4#2)(2008-1#1)
of their exposure to##2##4##(2004-9#1)(2006-5#1)
of their expression in##2##4##(2008-8#1)(2011-2#1)
of their expression##12##3##(1992-3#1)(1994-11#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-4#3)(2008-8#1)(2009-5#1)(2011-2#1)
of their families##3##3##(1992-1#1)(1992-12#1)(2008-7#1)
of their family were##2##4##(1990-4#1)(1993-3#1)
of their family##5##3##(1990-4#1)(1993-3#1)(1995-1#1)(2008-11#1)(2011-2#1)
of their findings##2##3##(2004-10#1)(2013-7#1)
of their first##5##3##(2004-3#1)(2006-12#1)(2008-7#1)(2010-3#1)(2012-2#1)
of their function as##2##4##(1992-9#1)(2006-10#1)
of their function##3##3##(1992-9#1)(2006-10#1)(2008-5#1)
of their functional##6##3##(1990-8#1)(1996-3#1)(2004-10#1)(2006-10#1)(2013-1#1)(2013-8#1)
of their functions##4##3##(2007-11#1)(2008-8#1)(2009-10#1)(2011-1#1)
of their general##2##3##(2007-12#1)(2008-5#1)
of their genetic##4##3##(1992-10#1)(2008-10#1)(2008-12#1)(2013-1#1)
of their genomes##2##3##(2007-1#1)(2008-10#1)
of their genomic DNA##2##4##(2008-10#1)(2008-7#1)
of their geographical location##2##4##(2009-5#1)(2009-6#1)
of their geographical##4##3##(2008-8#2)(2009-5#1)(2009-6#1)
of their great##2##3##(1991-9#1)(2008-3#1)
of their growth kinetics##2##4##(2008-11#2)
of their growth##5##3##(2005-8#1)(2008-11#2)(2008-7#1)(2012-2#1)
of their hands##2##3##(2007-2#1)(2010-4#1)
of their health care##4##4##(1994-1#1)(2008-10#1)(2013-1#2)
of their health##10##3##(1994-1#1)(2005-10#1)(2006-10#2)(2008-10#1)(2010-3#1)(2010-9#2)(2013-1#2)
of their healthcare##2##3##(2012-2#1)(2013-8#1)
of their high##18##3##(1995-10#1)(1995-6#1)(1996-6#1)(1997-8#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-7#2)(2008-9#1)(2010-12#2)(2010-9#1)
of their higher##2##3##(2010-12#1)(2013-8#1)
of their histologic##2##3##(1994-1#1)(2010-3#1)
of their history##2##3##(2005-11#1)(2009-2#1)
of their host##3##3##(2008-11#1)(2009-8#1)(2010-3#1)
of their hosts##5##3##(2007-9#1)(2008-8#1)(2012-2#2)(2013-1#1)
of their hydrolysis##2##3##(2008-10#1)(2008-4#1)
of their identification##3##3##(1992-6#1)(2006-10#1)(2008-11#1)
of their identity##2##3##(2008-10#1)(2008-11#1)
of their illness and##2##4##(1992-12#1)(2006-8#1)
of their illness##10##3##(1992-12#1)(1996-1#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-2#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
of their immediate environment##2##4##(1991-3#1)(2007-11#1)
of their impact on the##2##5##(2008-10#1)(2012-2#1)
of their impact on##4##4##(1992-12#1)(2007-2#1)(2008-10#1)(2012-2#1)
of their impact##5##3##(1992-12#1)(2007-2#1)(2008-10#1)(2011-2#1)(2012-2#1)
of their implications for##3##4##(1991-4#1)(1993-6#1)(2008-5#1)
of their importance##3##3##(1997-4#1)(2008-7#1)(2012-12#1)
of their in vitro##2##4##(1995-3#1)(2010-12#1)
of their in##4##3##(1995-3#1)(2008-8#1)(2009-12#1)(2010-12#1)
of their increased##2##3##(1993-12#1)(2006-8#1)
of their increasing##3##3##(1994-3#2)(2011-2#1)
of their indications##2##3##(1993-2#1)(2007-8#1)
of their individual##4##3##(1995-6#1)(1996-12#1)(2008-7#1)(2009-8#1)
of their infection##3##3##(2006-6#1)(2010-11#1)(2010-12#1)
of their inherent##3##3##(2006-8#1)(2008-3#1)(2010-3#1)
of their inhibition of##2##4##(1991-2#1)(1993-8#1)
of their inhibitory##2##3##(2006-9#1)(2012-2#1)
of their initial##6##3##(1994-2#1)(2005-11#1)(2008-6#1)(2009-11#1)(2010-8#1)(2011-11#1)
of their insolubility in##2##4##(2007-11#1)(2011-1#1)
of their institutions##2##3##(1994-1#1)(2010-1#1)
of their interaction with##5##4##(1992-9#1)(1994-2#1)(2008-12#1)(2010-12#1)(2011-2#1)
of their interaction##9##3##(1992-9#1)(1994-2#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)
of their interactions##5##3##(1994-3#1)(1996-12#1)(2006-10#1)(2006-5#1)(2008-10#1)
of their internal##2##3##(2007-12#1)(2007-8#1)
of their intervention##2##3##(2009-2#1)(2009-6#1)
of their involvement in##4##4##(1994-11#1)(1996-5#1)(2008-4#1)(2011-2#1)
of their involvement##5##3##(1994-11#1)(1995-3#1)(1996-5#1)(2008-4#1)(2011-2#1)
of their ionic##2##3##(1995-4#1)(2008-10#1)
of their job##4##3##(1993-6#1)(2004-4#1)(2006-2#1)(2010-9#1)
of their key##3##3##(2007-2#1)(2008-3#1)(2012-3#1)
of their knowledge and##2##4##(1993-2#1)(2011-3#1)
of their knowledge##5##3##(1993-2#1)(2007-3#1)(2008-11#1)(2011-3#1)(2013-8#1)
of their learning##3##3##(2008-11#1)(2012-3#1)(2013-1#1)
of their length##2##3##(2010-4#1)(2012-2#1)
of their life##8##3##(1994-4#1)(2006-10#1)(2007-11#1)(2008-7#2)(2010-8#1)(2011-1#1)(2013-7#1)
of their limitations##3##3##(2007-12#1)(2008-4#1)(2008-5#1)
of their limited##2##3##(1996-4#1)(2011-2#1)
of their lives##14##3##(1993-3#1)(1994-4#1)(1994-9#1)(1996-9#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-3#1)(2012-12#1)(2013-1#2)(2013-8#1)
of their local##4##3##(1996-3#1)(1997-3#1)(1997-4#1)(2008-7#1)
of their mRNAs##3##3##(1990-7#1)(1993-9#1)(1995-2#1)
of their main##4##3##(1994-2#1)(2006-2#1)(2008-10#2)
of their material##2##3##(2007-7#1)(2009-11#1)
of their maturation##2##3##(2013-1#1)(2013-8#1)
of their maximal##3##3##(1992-1#1)(2008-3#1)(2013-8#1)
of their mechanical##3##3##(2006-12#1)(2008-5#1)(2008-7#1)
of their mechanisms of action##3##5##(1995-5#1)(2012-3#1)(2013-1#1)
of their mechanisms##4##3##(1995-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
of their medical##2##3##(1991-1#1)(2008-4#1)
of their medication##3##3##(2008-11#1)(2008-3#1)(2011-1#1)
of their mental health##3##4##(2008-2#1)(2011-2#1)(2012-3#1)
of their mentally ill##2##4##(2008-2#2)
of their mitogenic##3##3##(1995-3#1)(1996-5#1)(2008-11#1)
of their mode of action##2##5##(2008-1#1)(2009-8#1)
of their molecular nature##2##4##(1992-8#1)(1996-2#1)
of their molecular##9##3##(1990-12#1)(1992-6#1)(1992-8#1)(1995-6#1)(1996-2#1)(2008-2#1)(2008-4#1)(2011-1#1)(2012-12#1)
of their more##4##3##(1994-5#1)(2013-1#3)
of their morphological##2##3##(2008-5#1)(2013-7#1)
of their mothers##2##3##(1992-2#1)(1993-1#1)
of their movements##2##3##(2008-5#1)(2012-1#1)
of their multiple##3##3##(1990-11#1)(2004-12#1)(2012-12#1)
of their native##2##3##(1990-8#1)(2008-4#1)
of their natural history##2##4##(2006-6#1)(2011-7#1)
of their necks in flexion and extension##2##7##(2006-11#2)
of their new##4##3##(1992-1#1)(2008-11#1)(2008-4#1)(2010-4#1)
of their newborn infants##2##4##(2006-7#2)
of their novel##2##3##(2008-5#1)(2008-7#1)
of their number##2##3##(2007-9#1)(2009-5#1)
of their nursing##3##3##(2007-3#1)(2008-12#1)(2013-1#1)
of their occupation##2##3##(2008-11#1)(2009-12#1)
of their occurrence and##3##4##(2008-10#1)(2012-2#1)(2013-8#1)
of their operation##2##3##(1996-2#1)(2007-12#1)
of their optical##2##3##(2010-4#1)(2011-2#1)
of their oral##2##3##(2008-9#1)(2012-1#1)
of their organizations##2##3##(1992-9#1)(1994-1#1)
of their origin##3##3##(1991-9#1)(1994-3#1)(1996-3#1)
of their original##3##3##(1990-11#2)(2007-12#1)
of their overall##4##3##(1991-2#1)(1993-2#1)(2011-1#1)(2012-4#1)
of their own experience##3##4##(1993-10#1)(2004-12#1)(2008-4#1)
of their own health##4##4##(1996-6#1)(2006-9#1)(2008-9#1)(2013-7#1)
of their own species##2##4##(2008-8#1)(2012-2#1)
of their own##47##3##(1990-6#1)(1991-10#1)(1991-8#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-10#2)(1993-12#1)(1993-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(2004-1#1)(2004-12#1)(2005-1#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-8#2)(2010-2#1)(2010-6#1)(2011-1#1)(2012-12#3)(2012-2#1)(2013-7#2)
of their paired##2##3##(2007-12#1)(2010-2#1)
of their parents##7##3##(1995-11#1)(1995-5#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-8#1)(2008-9#1)
of their parents'##2##3##(1990-5#1)(2007-8#1)
of their pathophysiology##2##3##(2006-10#1)(2010-12#1)
of their patient##2##3##(1994-12#1)(1994-2#1)
of their patients##12##3##(1990-9#1)(1992-1#1)(1992-12#2)(2007-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-4#1)(2011-2#1)(2013-8#1)
of their peers##6##3##(1997-1#1)(2008-10#1)(2009-7#1)(2009-8#1)(2012-2#1)(2013-1#1)
of their perceived##3##3##(1996-2#1)(2010-12#1)(2011-2#1)
of their performance in##2##4##(2005-11#1)(2008-11#1)
of their performance##7##3##(2005-11#1)(2006-6#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-9#1)
of their personal##4##3##(1990-5#1)(1996-1#1)(2007-7#1)(2009-4#1)
of their phenolic##2##3##(2007-11#1)(2008-10#1)
of their phenotype##2##3##(1995-1#1)(2008-9#1)
of their physical##7##3##(2007-2#1)(2008-12#1)(2008-5#4)(2011-1#1)
of their physico-chemical##2##3##(2008-10#1)(2008-5#1)
of their physiological##3##3##(1996-2#1)(2007-11#1)(2010-5#1)
of their plasma##2##3##(1992-7#1)(1996-8#1)
of their political##2##3##(1995-9#1)(2010-12#1)
of their poor##4##3##(2007-8#1)(2007-9#1)(2008-7#1)(2009-2#1)
of their positive##2##3##(2006-2#1)(2008-10#1)
of their possible##2##3##(1992-6#1)(1995-7#1)
of their potential##12##3##(1995-10#1)(1995-3#1)(2007-1#1)(2007-9#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-2#1)(2010-4#1)(2012-12#1)
of their practice##2##3##(2008-3#1)(2008-6#1)
of their practices##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)
of their pregnancy##2##3##(1990-6#1)(2009-2#1)
of their prescribing##2##3##(2007-2#1)(2008-11#1)
of their preventive##2##3##(2010-12#1)(2013-1#1)
of their primary##4##3##(1991-12#1)(1995-3#1)(2007-11#1)(2012-12#1)
of their production##7##3##(1994-9#1)(1995-5#1)(1996-2#1)(2008-10#1)(2008-4#1)(2012-2#1)(2013-1#1)
of their products##3##3##(2005-10#1)(2008-10#1)(2009-4#1)
of their profession##2##3##(1991-4#1)(2012-2#1)
of their professional##6##3##(1997-7#1)(2006-5#1)(2008-11#1)(2009-7#1)(2010-2#1)(2010-9#1)
of their proliferative##2##3##(2008-5#1)(2008-7#1)
of their properties##3##3##(2008-2#1)(2008-6#1)(2008-8#1)
of their proteins are enzymes##2##5##(1997-6#1)(1997-8#1)
of their proteins##3##3##(1994-8#1)(1997-6#1)(1997-8#1)
of their psychosis##2##3##(1996-8#2)
of their ratio##2##3##(2005-1#1)(2008-10#1)
of their receptors##2##3##(1994-8#1)(2009-8#1)
of their relationship##5##3##(2007-2#1)(2007-9#1)(2009-12#1)(2010-7#1)(2013-1#1)
of their relationships##2##3##(1997-2#1)(2007-2#1)
of their relative##5##3##(2007-12#1)(2008-10#1)(2008-4#1)(2009-10#1)(2011-1#1)
of their reproducibility##2##3##(2008-10#1)(2008-5#1)
of their reproductive##3##3##(1997-5#1)(2008-8#1)(2010-2#1)
of their research##3##3##(1990-9#1)(1996-1#1)(2006-8#1)
of their resistance##3##3##(1993-2#1)(2007-11#1)(2008-10#1)
of their respective##14##3##(1990-5#1)(1990-7#1)(1992-1#1)(1992-12#1)(1994-1#1)(1994-5#1)(1996-3#1)(1997-6#1)(2006-10#1)(2007-1#1)(2008-10#1)(2008-2#1)(2008-9#1)(2011-2#1)
of their response##2##3##(1992-11#1)(2011-1#1)
of their responses##3##3##(1996-7#1)(2007-11#1)(2008-12#1)
of their responsiveness to these##2##5##(1990-7#1)(1995-12#1)
of their results##5##3##(1993-10#1)(2007-8#1)(2009-4#1)(2010-3#1)(2011-1#1)
of their retention##3##3##(2008-10#3)
of their role in the##3##5##(2008-10#1)(2010-1#1)(2011-1#1)
of their role in##5##4##(1994-11#1)(2007-10#1)(2008-10#1)(2010-1#1)(2011-1#1)
of their role##9##3##(1993-6#1)(1994-11#1)(2007-10#1)(2008-10#1)(2008-11#1)(2010-1#1)(2010-11#1)(2011-1#2)
of their roles in##3##4##(1994-3#1)(2011-1#2)
of their roles##5##3##(1994-3#1)(2006-10#1)(2007-2#1)(2011-1#2)
of their safety##2##3##(1994-3#1)(2010-12#1)
of their science##3##3##(2005-7#1)(2008-2#1)(2009-12#1)
of their secretion##2##3##(1994-9#1)(2004-11#1)
of their sequences##3##3##(1993-3#1)(1995-6#1)(2008-7#1)
of their serum##2##3##(2006-12#1)(2007-10#1)
of their services##3##3##(1992-2#1)(1992-6#1)(2008-11#1)
of their sexual##2##3##(2009-5#1)(2011-2#1)
of their sexuality##2##3##(1990-5#1)(2007-3#1)
of their shape##2##3##(1993-11#1)(2008-2#1)
of their shorter##2##3##(2007-1#1)(2013-1#1)
of their significance##2##3##(1992-11#1)(2005-8#1)
of their similar##2##3##(1990-2#1)(1991-8#1)
of their size##3##3##(2007-3#1)(2008-5#1)(2009-2#1)
of their small size##3##4##(1993-8#1)(2006-12#1)(2011-1#1)
of their small##4##3##(1993-8#1)(2006-12#1)(2008-4#1)(2011-1#1)
of their smoking##2##3##(2010-2#1)(2011-2#1)
of their solutions##3##3##(1992-4#1)(2008-10#1)(2008-9#1)
of their spatial##3##3##(2008-8#1)(2009-8#1)(2010-10#1)
of their spectral##2##3##(2007-1#1)(2008-3#1)
of their speech##2##3##(2007-7#1)(2008-4#1)
of their spinal pathway during##2##5##(1996-5#2)
of their spinal pathway##3##4##(1996-5#3)
of their stability##3##3##(2004-9#1)(2008-10#1)(2012-3#1)
of their state##2##3##(1990-5#1)(2007-6#1)
of their structure##2##3##(1992-6#1)(1993-6#1)
of their students##5##3##(2005-10#2)(2008-11#1)(2008-12#1)(2010-3#1)
of their studies##3##3##(2006-12#1)(2008-7#1)(2011-1#1)
of their study##3##3##(1990-5#1)(2007-9#1)(2009-7#1)
of their suckling kids##2##4##(2012-2#2)
of their suitability##2##3##(2007-11#1)(2008-10#1)
of their surface##3##3##(1990-11#1)(1997-6#1)(2004-9#1)
of their surgery##3##3##(1995-1#1)(2007-9#1)(2012-3#1)
of their symptoms##7##3##(1990-12#1)(1990-8#1)(1992-3#1)(2007-8#1)(2008-4#1)(2009-9#1)(2012-2#1)
of their synthesis##2##3##(1997-7#1)(2007-11#1)
of their target##4##3##(1996-3#1)(1996-9#1)(2006-10#1)(2008-1#1)
of their targets##2##3##(2009-8#1)(2012-2#1)
of their three##2##3##(2008-9#1)(2010-2#1)
of their time in##2##4##(1994-2#1)(2008-11#1)
of their time on##2##4##(1994-2#1)(2011-1#1)
of their time##7##3##(1994-2#2)(2008-1#1)(2008-11#1)(2010-8#1)(2011-1#1)(2012-2#1)
of their tissue##2##3##(2007-1#1)(2011-2#1)
of their total FTEs as##2##5##(1996-3#2)
of their total##11##3##(1990-11#1)(1991-10#1)(1992-5#1)(1993-10#1)(1996-3#3)(1997-2#1)(1997-7#1)(2008-10#1)(2008-4#1)
of their traditional##2##3##(1990-12#1)(1996-1#1)
of their training##6##3##(1992-6#1)(2008-11#2)(2008-8#1)(2009-4#1)(2012-2#1)
of their treatments##2##3##(2006-7#1)(2008-5#1)
of their underlying##4##3##(2005-8#1)(2006-2#1)(2008-8#1)(2009-11#1)
of their understanding of##2##4##(2008-12#2)
of their understanding##3##3##(2008-12#2)(2009-12#1)
of their unique##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)
of their use in the##2##5##(1991-12#1)(2009-3#1)
of their use in##4##4##(1991-12#1)(2008-10#1)(2008-6#1)(2009-3#1)
of their use##19##3##(1990-2#1)(1991-11#1)(1991-12#2)(1992-3#1)(1993-1#1)(1994-4#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2013-7#2)(2013-8#1)
of their vascular##2##3##(2007-7#2)
of their weight##2##3##(1991-10#1)(2007-12#1)
of their work in##2##4##(2005-7#1)(2008-7#1)
of their work##15##3##(1991-12#1)(1992-2#1)(1994-12#1)(1995-6#1)(2004-10#1)(2005-11#1)(2005-7#1)(2007-2#1)(2008-12#1)(2008-4#1)(2008-7#2)(2012-2#1)(2012-3#1)(2013-8#1)
of their working##3##3##(1992-6#1)(1993-1#1)(2008-10#1)
of their##2089##2##(1990-1#2)(1990-10#1)(1990-11#8)(1990-12#5)(1990-2#4)(1990-3#2)(1990-4#2)(1990-5#11)(1990-6#4)(1990-7#5)(1990-8#4)(1990-9#4)(1991-1#4)(1991-10#4)(1991-11#4)(1991-12#10)(1991-2#8)(1991-3#4)(1991-4#7)(1991-5#1)(1991-6#3)(1991-7#3)(1991-8#10)(1991-9#5)(1992-1#11)(1992-10#4)(1992-11#4)(1992-12#11)(1992-2#6)(1992-3#10)(1992-4#2)(1992-5#4)(1992-6#13)(1992-7#2)(1992-8#3)(1992-9#7)(1993-1#5)(1993-10#6)(1993-11#4)(1993-12#10)(1993-2#11)(1993-3#7)(1993-5#3)(1993-6#5)(1993-7#2)(1993-8#5)(1993-9#6)(1994-1#6)(1994-11#5)(1994-12#6)(1994-2#10)(1994-3#10)(1994-4#4)(1994-5#5)(1994-6#5)(1994-7#2)(1994-8#5)(1994-9#11)(1995-1#14)(1995-10#3)(1995-11#6)(1995-12#6)(1995-2#7)(1995-3#11)(1995-4#3)(1995-5#5)(1995-6#10)(1995-7#1)(1995-8#7)(1995-9#3)(1996-1#12)(1996-10#1)(1996-11#2)(1996-12#10)(1996-2#8)(1996-3#18)(1996-4#2)(1996-5#11)(1996-6#4)(1996-7#2)(1996-8#7)(1996-9#5)(1997-1#6)(1997-2#7)(1997-3#8)(1997-4#8)(1997-5#1)(1997-6#7)(1997-7#5)(1997-8#9)(2004-1#1)(2004-10#3)(2004-11#3)(2004-12#2)(2004-2#1)(2004-3#1)(2004-4#3)(2004-9#4)(2005-1#3)(2005-10#10)(2005-11#10)(2005-4#2)(2005-5#3)(2005-6#1)(2005-7#9)(2005-8#8)(2005-9#2)(2006-10#40)(2006-11#8)(2006-12#22)(2006-2#5)(2006-3#1)(2006-4#5)(2006-5#13)(2006-6#5)(2006-7#13)(2006-8#9)(2006-9#5)(2007-1#13)(2007-10#13)(2007-11#30)(2007-12#42)(2007-2#22)(2007-3#17)(2007-4#8)(2007-5#4)(2007-6#4)(2007-7#17)(2007-8#21)(2007-9#19)(2008-1#28)(2008-10#126)(2008-11#69)(2008-12#23)(2008-2#41)(2008-3#42)(2008-4#50)(2008-5#57)(2008-6#18)(2008-7#44)(2008-8#45)(2008-9#38)(2009-1#1)(2009-10#8)(2009-11#5)(2009-12#12)(2009-2#14)(2009-3#3)(2009-4#14)(2009-5#14)(2009-6#6)(2009-7#10)(2009-8#22)(2009-9#9)(2010-1#5)(2010-10#5)(2010-11#5)(2010-12#29)(2010-2#19)(2010-3#18)(2010-4#14)(2010-5#9)(2010-6#6)(2010-7#6)(2010-8#15)(2010-9#8)(2011-1#38)(2011-11#1)(2011-12#4)(2011-2#45)(2011-3#1)(2011-7#2)(2012-1#17)(2012-11#3)(2012-12#30)(2012-2#44)(2012-3#27)(2012-4#2)(2012-5#1)(2013-1#55)(2013-7#15)(2013-8#30)
of them admitted to##2##4##(2008-7#1)(2012-3#1)
of them also##8##3##(1991-12#1)(1992-2#1)(1997-2#1)(2006-6#1)(2007-11#2)(2008-4#1)(2008-7#1)
of them and##7##3##(1992-11#1)(1994-8#1)(1997-4#1)(2007-11#1)(2008-8#1)(2009-8#1)(2013-8#1)
of them are associated with##3##5##(1995-7#1)(2007-8#1)(2013-7#1)
of them are in##2##4##(2008-10#1)(2011-2#1)
of them are known##2##4##(1997-6#1)(2007-1#1)
of them are new##2##4##(2007-1#1)(2008-5#1)
of them are not##3##4##(1990-6#1)(1996-4#1)(2007-3#1)
of them are present in##2##5##(2008-10#1)(2012-2#1)
of them are probably##2##4##(1994-8#1)(2008-9#1)
of them are##60##3##(1990-6#1)(1990-9#1)(1991-10#1)(1991-5#1)(1992-10#1)(1992-7#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-7#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-6#1)(2005-12#1)(2005-7#2)(2006-10#1)(2007-1#2)(2007-11#1)(2007-3#3)(2007-7#2)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#3)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
of them as##3##3##(2009-2#1)(2010-10#1)(2010-8#1)
of them became##2##3##(2008-8#1)(2012-1#1)
of them being##11##3##(1993-5#1)(1995-11#1)(1995-12#1)(1997-1#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-5#1)(2013-1#1)(2013-7#1)
of them by##3##3##(1990-10#1)(1992-1#1)(1994-3#1)
of them can be##6##4##(1990-12#1)(1992-6#1)(1996-3#1)(2006-6#1)(2008-9#1)(2013-8#1)
of them contained##4##3##(1993-8#1)(1995-12#1)(2008-10#2)
of them continued##3##3##(2006-8#1)(2007-7#2)
of them correlated##2##3##(2006-4#1)(2007-1#1)
of them could be##3##4##(1993-5#1)(2006-8#1)(2011-1#1)
of them could##7##3##(1993-5#1)(1995-8#1)(2006-8#1)(2007-11#1)(2011-1#1)(2012-11#1)(2013-1#1)
of them developed##4##3##(1994-4#1)(2007-7#1)(2007-8#1)(2008-7#1)
of them did not##2##4##(2007-7#1)(2008-10#1)
of them died##7##3##(1993-5#2)(1995-2#1)(1996-4#1)(2007-2#1)(2008-4#1)(2011-2#1)
of them during##2##3##(1993-1#1)(2006-10#1)
of them encode##3##3##(1993-2#1)(2008-4#2)
of them exhibit significant similarity to known proteins##2##8##(1996-8#1)(1997-7#1)
of them exhibited##2##3##(1992-1#1)(2007-6#1)
of them experienced##2##3##(1991-9#1)(2009-4#1)
of them from##4##3##(2007-3#1)(2011-2#2)(2013-1#1)
of them had a##7##4##(1990-3#1)(1991-11#1)(1991-2#1)(1991-4#1)(1997-6#1)(2008-7#1)(2011-2#1)
of them had no##3##4##(1996-2#1)(2007-8#1)(2011-2#1)
of them had not##2##4##(2008-9#1)(2013-1#1)
of them had some##2##4##(2007-7#1)(2012-12#1)
of them had##61##3##(1990-11#1)(1990-3#1)(1990-6#2)(1991-11#1)(1991-2#2)(1991-4#2)(1991-9#1)(1992-10#1)(1992-2#1)(1993-5#1)(1996-2#1)(1996-3#1)(1997-4#1)(1997-6#1)(2006-10#2)(2006-7#1)(2007-10#2)(2007-11#1)(2007-2#2)(2007-3#3)(2007-7#4)(2007-8#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2011-1#2)(2011-2#8)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
of them has been##2##4##(2011-2#2)
of them has##6##3##(2007-12#1)(2008-1#1)(2008-10#1)(2011-2#3)
of them have already##2##4##(2007-1#1)(2009-10#1)
of them have been##5##4##(1990-3#1)(1997-8#1)(2005-7#1)(2008-8#1)(2009-10#1)
of them have not been##2##5##(2006-6#1)(2013-1#1)
of them have the##3##4##(1990-6#1)(2007-7#1)(2008-9#1)
of them have##21##3##(1990-3#1)(1990-6#1)(1996-1#1)(1996-6#1)(1997-8#1)(2005-7#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-10#2)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
of them having##4##3##(2006-6#1)(2007-7#1)(2008-2#1)(2011-2#1)
of them iatrogenic##2##3##(2007-8#2)
of them in the course of the first##2##8##(1991-10#2)
of them in the##5##4##(1991-10#2)(1994-5#1)(1996-10#1)(2009-8#1)
of them in##14##3##(1991-10#2)(1991-4#1)(1993-6#1)(1994-5#1)(1996-10#1)(1996-3#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-2#1)(2009-8#1)
of them involving##2##3##(2008-10#1)(2009-1#1)
of them is##12##3##(1991-6#1)(1992-3#1)(1992-9#1)(1996-11#1)(2005-10#1)(2006-6#1)(2007-2#1)(2008-10#3)(2008-9#1)(2009-2#1)
of them may be##3##4##(1995-8#1)(2007-12#1)(2011-1#1)
of them may##6##3##(1995-8#1)(2007-12#1)(2008-7#1)(2010-9#1)(2011-1#1)(2013-1#1)
of them of the##2##4##(2009-5#1)(2011-2#1)
of them of##3##3##(2007-11#1)(2009-5#1)(2011-2#1)
of them on##3##3##(2008-11#1)(2010-2#1)(2011-2#1)
of them only##2##3##(2008-2#1)(2011-2#1)
of them present##2##3##(2005-11#1)(2011-2#1)
of them presented with##5##4##(1990-6#1)(1991-8#1)(2007-7#1)(2008-7#1)(2013-1#1)
of them presented##7##3##(1990-6#1)(1991-8#1)(2007-7#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)
of them received##3##3##(2008-10#1)(2008-8#2)
of them remain##3##3##(2007-12#1)(2009-8#1)(2011-2#1)
of them reported##3##3##(2007-10#1)(2011-2#1)(2013-8#1)
of them seems to##2##4##(1991-8#1)(2007-11#1)
of them show##2##3##(2005-11#1)(2007-11#1)
of them showed the##2##4##(2007-3#1)(2011-12#1)
of them showed##15##3##(1991-10#1)(1992-10#1)(1992-12#1)(1993-7#1)(1995-12#1)(1996-2#1)(2007-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2010-2#1)(2010-8#1)(2011-12#1)(2013-1#1)
of them showing##4##3##(1997-3#1)(2008-5#3)
of them suffer from##2##4##(1996-2#1)(2013-1#1)
of them suffered from##2##4##(1990-12#1)(2012-3#1)
of them suffered##3##3##(1990-12#1)(2006-8#1)(2012-3#1)
of them the##6##3##(1990-10#1)(1994-3#1)(2007-7#2)(2008-10#2)
of them there was##2##4##(1992-5#1)(2008-4#1)
of them to##4##3##(1990-12#1)(2007-4#1)(2008-2#1)(2010-8#1)
of them underwent##7##3##(1992-10#1)(1993-5#1)(2008-1#1)(2008-3#1)(2010-3#1)(2011-2#1)(2012-2#1)
of them use##3##3##(2008-11#1)(2013-1#2)
of them used##4##3##(1990-10#1)(2010-8#1)(2011-2#2)
of them was a##2##4##(1995-6#1)(2006-10#1)
of them was the##2##4##(1993-5#1)(2007-8#1)
of them was##21##3##(1991-10#1)(1991-3#1)(1993-5#1)(1993-8#1)(1994-6#1)(1995-3#1)(1995-6#1)(1996-10#1)(1997-4#1)(1997-5#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-6#1)(2008-9#1)(2009-2#1)(2010-4#1)(2012-12#1)(2012-3#1)
of them were also##4##4##(1997-2#1)(2006-8#1)(2008-5#1)(2012-11#1)
of them were carriers##2##4##(1993-9#1)(2008-9#1)
of them were classified##2##4##(2011-2#1)(2013-1#1)
of them were for##2##4##(1992-2#1)(2007-8#1)
of them were found##2##4##(2007-11#1)(2013-7#1)
of them were identified as##4##5##(1990-7#1)(2008-10#1)(2008-5#1)(2010-12#1)
of them were##99##3##(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-5#1)(1993-2#1)(1993-5#1)(1993-9#1)(1995-12#1)(1995-7#1)(1996-7#2)(1996-9#1)(1997-2#2)(1997-3#2)(1997-6#1)(2004-2#1)(2006-11#2)(2006-2#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-3#1)(2007-7#8)(2007-8#3)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#1)(2008-9#3)(2009-2#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-4#2)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#3)(2013-1#8)(2013-7#2)
of them will##4##3##(2006-8#1)(2009-3#1)(2012-2#1)(2013-1#1)
of them with##7##3##(1991-8#1)(2008-10#2)(2008-9#1)(2009-5#1)(2012-12#1)(2013-8#1)
of them##846##2##(1990-10#5)(1990-11#1)(1990-12#8)(1990-2#1)(1990-3#4)(1990-6#9)(1990-7#3)(1990-9#1)(1991-10#6)(1991-11#5)(1991-12#3)(1991-2#6)(1991-3#1)(1991-4#5)(1991-5#2)(1991-6#2)(1991-8#4)(1991-9#4)(1992-1#2)(1992-10#5)(1992-11#2)(1992-12#3)(1992-2#4)(1992-3#2)(1992-4#2)(1992-5#3)(1992-6#4)(1992-7#3)(1992-8#2)(1992-9#4)(1993-1#1)(1993-10#2)(1993-11#1)(1993-2#5)(1993-4#1)(1993-5#9)(1993-6#1)(1993-7#4)(1993-8#4)(1993-9#2)(1994-1#1)(1994-2#3)(1994-3#6)(1994-4#1)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#7)(1995-2#2)(1995-3#2)(1995-6#4)(1995-7#2)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#3)(1996-11#2)(1996-12#3)(1996-2#5)(1996-3#6)(1996-4#2)(1996-5#1)(1996-6#3)(1996-7#2)(1996-8#2)(1996-9#3)(1997-1#2)(1997-2#4)(1997-3#4)(1997-4#5)(1997-5#5)(1997-6#5)(1997-7#4)(1997-8#3)(1997-9#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-7#4)(2006-1#1)(2006-10#14)(2006-11#3)(2006-2#4)(2006-4#5)(2006-6#10)(2006-7#3)(2006-8#11)(2006-9#2)(2007-1#7)(2007-10#6)(2007-11#23)(2007-12#5)(2007-2#5)(2007-3#15)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#35)(2007-8#19)(2007-9#3)(2008-1#7)(2008-10#59)(2008-11#8)(2008-12#3)(2008-2#16)(2008-3#4)(2008-4#14)(2008-5#24)(2008-6#2)(2008-7#21)(2008-8#13)(2008-9#22)(2009-1#1)(2009-10#3)(2009-11#1)(2009-2#9)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#3)(2009-8#4)(2009-9#2)(2010-10#3)(2010-12#6)(2010-2#4)(2010-3#2)(2010-4#4)(2010-5#2)(2010-8#8)(2010-9#2)(2011-1#18)(2011-12#4)(2011-2#41)(2012-1#8)(2012-11#2)(2012-12#14)(2012-2#12)(2012-3#12)(2012-4#1)(2013-1#30)(2013-7#9)(2013-8#9)
of them)##5##2##(2008-10#1)(2008-4#1)(2008-6#1)(2009-9#1)(2011-12#1)
of themes identified##2##3##(2007-2#1)(2008-11#1)
of themes##5##2##(2005-7#1)(2006-9#1)(2007-2#1)(2008-11#1)(2010-10#1)
of themselves##8##2##(1995-3#1)(2006-7#1)(2007-11#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-11#1)(2012-2#1)
of theophylline and##3##3##(1990-8#1)(1992-3#2)
of theophylline from##4##3##(2004-12#2)(2006-1#2)
of theophylline in tea and drug formulation##2##7##(2008-10#2)
of theophylline in##3##3##(1997-8#1)(2008-10#2)
of theophylline on ion transport in##2##6##(2008-1#2)
of theophylline on##4##3##(1990-10#2)(2008-1#2)
of theophylline##26##2##(1990-10#2)(1990-8#1)(1991-12#1)(1991-2#2)(1992-2#1)(1992-3#3)(1997-8#3)(2004-12#3)(2006-1#3)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#3)
of theoretical analysis##2##3##(2007-12#1)(2008-2#1)
of theoretical and experimental##5##4##(1992-1#1)(2008-3#3)(2009-4#1)
of theoretical and##9##3##(1990-12#1)(1992-1#1)(1994-3#1)(2008-3#5)(2009-4#1)
of theoretical calculation##2##3##(2008-2#1)(2011-1#1)
of theoretical knowledge##3##3##(2008-1#1)(2008-11#2)
of theoretical maximum##2##3##(2008-6#2)
of theoretical models##5##3##(2007-7#1)(2008-11#1)(2009-5#1)(2009-7#1)(2013-8#1)
of theoretical predictions##2##3##(2008-2#1)(2008-3#1)
of theoretical studies##2##3##(2007-11#1)(2008-9#1)
of theoretical work##2##3##(2008-2#1)(2011-1#1)
of theoretical yield##2##3##(2008-6#2)
of theoretical##65##2##(1990-12#1)(1990-7#1)(1992-1#1)(1992-5#1)(1994-3#1)(1994-9#1)(1996-5#3)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#11)(2008-3#8)(2008-5#1)(2008-6#6)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-4#1)(2011-1#4)(2013-1#1)(2013-7#1)(2013-8#3)
of theoretically##2##2##(1997-6#1)(2012-11#1)
of theories and##3##3##(2006-6#1)(2007-9#1)(2013-8#1)
of theories##6##2##(2006-6#1)(2007-9#1)(2008-9#1)(2009-5#1)(2011-1#1)(2013-8#1)
of theory and##4##3##(1993-3#1)(2007-12#1)(2010-7#1)(2012-3#1)
of theory in practice##2##4##(2008-12#1)(2013-8#1)
of theory of mind in##2##5##(2006-2#1)(2012-1#1)
of theory of mind##6##4##(2006-2#3)(2008-12#1)(2012-1#2)
of theory to practice##3##4##(2008-11#3)
of theory to##4##3##(2008-11#3)(2011-2#1)
of theory##31##2##(1993-3#1)(1996-3#1)(2006-2#4)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#5)(2008-12#2)(2008-3#1)(2008-9#2)(2009-8#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
of therapeutic aPTT##2##3##(2006-9#2)
of therapeutic aerosols##2##3##(1995-3#1)(1996-2#1)
of therapeutic agents for##2##4##(2008-1#1)(2011-12#1)
of therapeutic agents##12##3##(2005-7#1)(2005-8#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-12#1)(2013-1#1)(2013-8#1)
of therapeutic and##2##3##(2005-10#1)(2007-7#1)
of therapeutic antibodies##5##3##(2008-11#3)(2010-11#2)
of therapeutic applications for##2##4##(1994-5#1)(2005-7#1)
of therapeutic applications##6##3##(1991-11#1)(1994-5#1)(1997-8#1)(2005-7#2)(2012-1#1)
of therapeutic approaches##2##3##(2008-5#1)(2008-9#1)
of therapeutic benefit in##2##4##(2008-10#1)(2008-3#1)
of therapeutic communication##2##3##(2008-11#2)
of therapeutic drug monitoring##2##4##(2008-6#1)(2009-4#1)
of therapeutic drug##3##3##(2008-6#1)(2009-4#1)(2012-2#1)
of therapeutic drugs##5##3##(1994-11#1)(2008-3#1)(2008-8#1)(2009-6#1)(2010-12#1)
of therapeutic effect of##3##4##(2006-7#1)(2008-12#1)(2008-7#1)
of therapeutic effects##2##3##(1997-2#1)(2012-3#1)
of therapeutic efficacy##6##3##(2005-10#2)(2008-11#1)(2009-12#1)(2009-8#1)(2010-4#1)
of therapeutic endoscopy##2##3##(2006-10#1)(2007-5#1)
of therapeutic failure##3##3##(1992-5#1)(2008-10#1)(2012-2#1)
of therapeutic genes##2##3##(2005-8#1)(2008-5#1)
of therapeutic hypothermia##2##3##(2008-8#1)(2010-12#1)
of therapeutic interest##2##3##(1995-3#1)(2006-6#1)
of therapeutic intervention##5##3##(1994-8#1)(1995-9#1)(2007-11#2)(2007-12#1)
of therapeutic interventions##5##3##(2006-7#1)(2006-8#1)(2008-11#1)(2010-2#1)(2013-7#1)
of therapeutic methods##2##3##(1990-6#1)(2013-1#1)
of therapeutic modalities##2##3##(1994-8#1)(2012-2#1)
of therapeutic options##5##3##(1995-5#1)(2007-11#1)(2008-3#1)(2009-9#1)(2011-1#1)
of therapeutic outcome##3##3##(1995-12#1)(1996-7#1)(2011-2#1)
of therapeutic procedures##2##3##(2007-1#1)(2007-8#1)
of therapeutic proteins##7##3##(2008-10#2)(2008-11#2)(2012-2#2)(2013-8#1)
of therapeutic response##4##3##(1993-9#1)(1997-1#1)(2006-6#1)(2009-11#1)
of therapeutic results##2##3##(2010-5#1)(2012-3#1)
of therapeutic strategies for##2##4##(2007-8#1)(2011-9#1)
of therapeutic strategies##8##3##(1990-6#1)(2006-2#2)(2007-8#1)(2008-4#1)(2008-5#1)(2010-4#1)(2011-9#1)
of therapeutic success##3##3##(2007-11#1)(2007-8#1)(2008-7#1)
of therapeutic targets##3##3##(2008-5#1)(2009-12#1)(2012-2#1)
of therapeutic use##2##3##(2005-10#2)
of therapeutic vaccines##2##3##(2007-12#1)(2008-4#1)
of therapeutic value in##3##4##(1991-4#1)(1991-9#1)(1993-11#1)
of therapeutic value##5##3##(1991-4#1)(1991-9#1)(1993-11#1)(1993-2#1)(2009-8#1)
of therapeutic##194##2##(1990-10#1)(1990-6#3)(1991-11#3)(1991-2#1)(1991-4#2)(1991-9#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#1)(1995-9#2)(1996-12#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-10#5)(2005-7#3)(2005-8#4)(2006-10#5)(2006-2#2)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#3)(2006-9#2)(2007-1#1)(2007-11#6)(2007-12#5)(2007-3#1)(2007-5#2)(2007-7#2)(2007-8#4)(2008-1#3)(2008-10#6)(2008-11#9)(2008-12#3)(2008-3#3)(2008-4#3)(2008-5#7)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#2)(2009-11#1)(2009-12#4)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#3)(2010-11#2)(2010-12#3)(2010-2#1)(2010-4#4)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#5)(2011-9#1)(2012-1#2)(2012-12#1)(2012-2#6)(2012-3#2)(2012-5#1)(2013-1#5)(2013-7#2)(2013-8#2)
of therapeutics##10##2##(1995-8#1)(2005-6#1)(2005-7#1)(2007-11#4)(2010-4#1)(2012-12#2)
of therapies for##2##3##(2004-11#1)(2005-11#1)
of therapies in##2##3##(2006-10#1)(2008-7#1)
of therapies that##3##3##(1995-6#1)(2007-8#1)(2012-1#1)
of therapies to##3##3##(1997-3#1)(2006-10#1)(2013-8#1)
of therapies##21##2##(1993-7#1)(1995-4#1)(1995-6#1)(1997-3#1)(2004-11#1)(2005-11#1)(2006-10#3)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-7#2)(2010-3#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
of therapists##2##2##(1993-5#1)(1995-12#1)
of therapists' supervision time##2##4##(1995-3#2)
of therapy and for##2##4##(1993-8#1)(2009-9#1)
of therapy and##23##3##(1991-2#1)(1993-8#1)(1994-5#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-4#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
of therapy are##6##3##(1993-9#1)(1994-7#1)(1997-4#1)(2004-1#1)(2011-2#1)(2012-3#1)
of therapy can be##2##4##(2008-3#1)(2011-1#1)
of therapy can##3##3##(1996-6#1)(2008-3#1)(2011-1#1)
of therapy depends on##2##4##(2006-1#1)(2007-11#1)
of therapy for both##2##4##(2007-12#1)(2008-11#1)
of therapy for patients with##2##5##(2006-5#1)(2007-10#1)
of therapy for##27##3##(1991-6#1)(1992-2#2)(2005-7#1)(2006-4#1)(2006-5#1)(2007-10#2)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2010-12#3)(2011-2#1)(2012-1#2)(2012-2#1)
of therapy has been##2##4##(1990-1#1)(1996-3#1)
of therapy has##4##3##(1990-1#1)(1996-3#1)(2006-2#1)(2007-10#1)
of therapy have##2##3##(2006-10#1)(2010-6#1)
of therapy in the##5##4##(1995-5#1)(2007-7#1)(2008-10#2)(2009-6#1)
of therapy in##17##3##(1991-12#1)(1991-4#1)(1995-5#1)(2006-10#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#2)(2009-6#1)(2009-9#1)(2010-12#1)(2010-6#1)(2013-1#1)
of therapy is to eliminate or##2##6##(2012-3#1)(2013-8#1)
of therapy is to##4##4##(2007-11#1)(2008-7#1)(2012-3#1)(2013-8#1)
of therapy is##9##3##(1990-10#1)(2006-10#1)(2007-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
of therapy may##2##3##(2010-2#1)(2010-6#1)
of therapy of##4##3##(1993-10#1)(2007-7#1)(2008-1#1)(2011-2#1)
of therapy on##3##3##(1996-2#1)(2008-3#1)(2013-8#1)
of therapy progress feedback##2##4##(2012-2#2)
of therapy progress##4##3##(2012-2#4)
of therapy received##2##3##(1995-2#1)(2011-2#1)
of therapy than##3##3##(2008-5#1)(2008-8#2)
of therapy to improve the##2##5##(1994-12#1)(2006-7#1)
of therapy to##6##3##(1991-12#1)(1994-12#1)(2006-10#1)(2006-7#1)(2009-4#1)(2010-2#1)
of therapy was##4##3##(2005-7#1)(2007-12#1)(2007-8#1)(2008-1#1)
of therapy were##6##3##(1991-12#1)(1992-10#1)(1996-1#1)(1997-1#1)(2007-7#1)(2013-1#1)
of therapy with##10##3##(1991-6#1)(1992-4#1)(1994-6#1)(1996-3#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-1#1)(2013-1#2)
of therapy##319##2##(1990-1#1)(1990-10#1)(1990-12#3)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#3)(1991-12#6)(1991-2#4)(1991-4#3)(1991-6#4)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-4#2)(1992-5#3)(1992-6#3)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#1)(1993-7#1)(1993-8#1)(1993-9#4)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#3)(1994-7#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#2)(1996-7#1)(1997-1#3)(1997-2#3)(1997-4#1)(2004-1#1)(2004-2#1)(2004-3#1)(2005-11#2)(2005-7#5)(2005-9#1)(2006-1#1)(2006-10#17)(2006-11#1)(2006-12#3)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#2)(2006-6#3)(2006-7#1)(2006-9#2)(2007-10#3)(2007-11#15)(2007-12#5)(2007-2#2)(2007-4#2)(2007-6#1)(2007-7#13)(2007-8#8)(2007-9#3)(2008-1#10)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#10)(2008-5#8)(2008-6#5)(2008-7#5)(2008-8#6)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#3)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#6)(2011-1#6)(2011-12#2)(2011-2#10)(2012-1#2)(2012-12#3)(2012-2#11)(2012-3#3)(2013-1#13)(2013-8#4)
of therapy-related##5##2##(2004-2#2)(2007-12#1)(2008-7#2)
of therapy]##3##2##(1992-5#1)(1993-10#1)(2012-3#1)
of thermal and##4##3##(1995-2#1)(2007-12#1)(2008-3#1)(2009-5#1)
of thermal annealing##4##3##(2008-2#4)
of thermal conductivity##2##3##(2008-3#2)
of thermal decomposition products##2##4##(2008-10#2)
of thermal decomposition##4##3##(2008-10#4)
of thermal denaturation##2##3##(1993-11#1)(1997-2#1)
of thermal diffusion##2##3##(1990-8#1)(2008-3#1)
of thermal effects in a diode-end-pumped##2##6##(2008-2#2)
of thermal effects##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
of thermal fluctuations##4##3##(1993-7#1)(2008-3#2)(2009-11#1)
of thermal hyperalgesia in a##2##5##(1995-12#1)(1996-5#1)
of thermal hyperalgesia induced by##3##5##(1995-12#2)(2008-7#1)
of thermal hyperalgesia##6##3##(1995-12#4)(1996-5#1)(2008-7#1)
of thermal inactivation##2##3##(2008-10#2)
of thermal infrared##2##3##(2007-11#1)(2008-3#1)
of thermal injury on##3##4##(2008-9#3)
of thermal injury##5##3##(1995-1#1)(2005-10#1)(2008-9#3)
of thermal ionization mass spectrometry##2##5##(1992-7#1)(2008-10#1)
of thermal lens spectrometry##3##4##(2008-10#3)
of thermal lensing and##2##4##(2007-11#1)(2007-12#1)
of thermal lensing##9##3##(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#4)
of thermal loading##2##3##(2008-2#2)
of thermal pain##2##3##(2009-3#1)(2011-1#1)
of thermal processing##2##3##(2004-9#1)(2011-2#1)
of thermal silica and##2##4##(2005-11#2)
of thermal silica##3##3##(2005-11#3)
of thermal stability##2##3##(2007-12#1)(2010-4#1)
of thermal treatment##2##3##(2007-11#1)(2008-10#1)
of thermal##115##2##(1990-2#2)(1990-8#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-7#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-7#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-5#1)(2004-9#1)(2005-10#2)(2005-11#4)(2006-10#2)(2007-11#5)(2007-12#9)(2008-10#19)(2008-2#13)(2008-3#17)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-3#2)(2009-5#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
of thermally evaporated germanium thin##2##5##(2008-2#2)
of thermally induced birefringence in##2##5##(2008-2#1)(2008-3#1)
of thermally induced birefringence##3##4##(2008-2#2)(2008-3#1)
of thermally induced##8##3##(1994-5#1)(2007-12#3)(2008-2#2)(2008-3#2)
of thermally##22##2##(1994-5#1)(2007-11#2)(2007-12#6)(2008-1#1)(2008-2#6)(2008-3#4)(2009-5#1)(2011-1#1)
of thermo-coagulated blood##2##3##(1996-12#2)
of thermo-inducible vectors##2##3##(2007-6#2)
of thermodynamic parameters##2##3##(2006-12#1)(2008-10#1)
of thermodynamic stability##2##3##(1990-8#1)(2010-5#1)
of thermodynamic##11##2##(1990-8#1)(1995-5#1)(1996-11#1)(2006-12#1)(2007-11#1)(2008-10#3)(2008-3#1)(2010-5#1)(2011-2#1)
of thermodynamics##5##2##(1993-12#1)(2007-9#1)(2008-3#1)(2008-5#2)
of thermoelectric##2##2##(1996-5#1)(2007-11#1)
of thermogenesis in##2##3##(1997-3#1)(2013-1#1)
of thermogenesis##3##2##(1997-3#1)(2013-1#2)
of thermographic##3##2##(1993-11#1)(2007-7#2)
of thermolysin##3##2##(1994-5#3)
of thermophilic##4##2##(1990-9#1)(1992-11#1)(2006-8#1)(2008-7#1)
of thermoregulation##3##2##(2007-10#1)(2009-8#1)(2011-2#1)
of thermosensitive##6##2##(1994-11#1)(2009-10#3)(2013-1#2)
of thermostability##2##2##(1993-4#1)(1996-12#1)
of thermostable##6##2##(1994-9#1)(1996-7#1)(1997-4#2)(2008-10#1)(2008-7#1)
of thermotolerance was##2##3##(1992-5#1)(1992-7#1)
of thermotolerance##4##2##(1992-5#1)(1992-7#2)(1995-8#1)
of these &quot##4##3##(1994-3#1)(2006-3#1)(2008-1#1)(2009-7#1)
of these (the##2##3##(1992-4#1)(2008-8#1)
of these 10##2##3##(2006-12#1)(2007-8#1)
of these 11##3##3##(1991-8#1)(2008-10#1)(2010-3#1)
of these 14##2##3##(1991-7#1)(1996-4#1)
of these 2##8##3##(1992-2#1)(1992-6#1)(1992-8#1)(1997-2#1)(2006-10#1)(2007-12#1)(2009-1#1)(2013-7#1)
of these 21##3##3##(1992-12#1)(2007-9#2)
of these 23##2##3##(1996-1#1)(2008-10#1)
of these 24##2##3##(2008-8#1)(2013-1#1)
of these 26 patients##2##4##(2005-5#1)(2013-1#1)
of these 27##2##3##(1997-7#1)(2007-7#1)
of these 3##3##3##(1990-6#1)(1991-3#1)(2006-5#1)
of these 38##2##3##(2007-10#1)(2013-8#1)
of these 4##4##3##(2007-12#1)(2008-5#1)(2009-12#1)(2012-2#1)
of these 6##4##3##(1991-9#1)(1993-8#1)(1994-3#1)(2007-10#1)
of these 7 patients were##2##5##(1996-11#1)(2007-9#1)
of these 7##3##3##(1996-11#1)(2007-12#1)(2007-9#1)
of these DNA##2##3##(1997-1#1)(2008-10#1)
of these ELISAs##2##3##(2013-8#2)
of these G-protein alpha-subunits##2##4##(1991-9#1)(1994-6#1)
of these M##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
of these MAbs##2##3##(1993-9#1)(2008-4#1)
of these ORFs were##2##4##(1997-4#1)(2008-10#1)
of these ORFs##6##3##(1991-9#1)(1995-9#1)(1997-3#2)(1997-4#1)(2008-10#1)
of these PCR##2##3##(1991-9#1)(2008-10#1)
of these PKC##2##3##(1990-9#1)(1991-9#1)
of these QTL##2##3##(2008-10#1)(2009-5#1)
of these RNA##2##3##(1990-7#1)(1997-4#1)
of these T cells##2##4##(1994-2#1)(2013-1#1)
of these a##2##3##(2008-11#1)(2013-8#1)
of these abnormalities has been##2##5##(1991-10#1)(2006-2#1)
of these abnormalities is##2##4##(2006-10#1)(2007-2#1)
of these abnormalities##8##3##(1991-10#1)(1993-8#1)(1995-2#1)(2006-10#1)(2006-2#1)(2007-2#1)(2007-7#1)(2008-4#1)
of these absorption##2##3##(2008-10#1)(2013-8#1)
of these accounts##2##3##(2005-7#1)(2008-8#1)
of these acids were##2##4##(2006-12#1)(2007-11#1)
of these acids##3##3##(2006-12#1)(2007-11#1)(2011-2#1)
of these actions##2##3##(2006-12#1)(2008-9#1)
of these activities are##2##4##(2006-10#1)(2012-12#1)
of these activities##16##3##(1990-6#1)(1991-1#1)(1991-5#1)(1991-9#1)(1994-11#1)(1995-10#1)(2004-3#1)(2006-10#1)(2007-5#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-3#1)(2012-1#1)(2012-12#1)
of these additives##2##3##(1991-2#1)(2012-3#1)
of these adrenal androgens##2##4##(2007-11#2)
of these advances##6##3##(2006-10#3)(2006-7#1)(2010-4#1)(2011-1#1)
of these advantages##2##3##(1994-3#1)(2012-2#1)
of these adverse effects##5##4##(1991-11#1)(2007-11#1)(2007-7#1)(2009-3#1)(2011-2#1)
of these adverse events##3##4##(1992-11#1)(2006-9#1)(2012-12#1)
of these adverse##9##3##(1991-11#1)(1992-11#1)(1996-7#1)(2006-9#1)(2007-11#1)(2007-7#1)(2009-3#1)(2011-2#1)(2012-12#1)
of these agents are##5##4##(2005-8#1)(2008-5#1)(2008-8#2)(2013-1#1)
of these agents for##2##4##(1990-2#1)(2009-3#1)
of these agents has##3##4##(2004-11#1)(2007-12#1)(2011-2#1)
of these agents have##3##4##(2006-10#1)(2007-11#1)(2008-8#1)
of these agents in patients##2##5##(2005-7#1)(2007-11#1)
of these agents in the treatment of##2##7##(2006-10#1)(2006-12#1)
of these agents in the##4##5##(2006-10#2)(2006-12#1)(2010-4#1)
of these agents in##13##4##(1993-6#1)(1995-11#1)(2005-6#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)
of these agents is##5##4##(2006-10#1)(2007-11#1)(2008-3#1)(2009-8#1)(2010-3#1)
of these agents on##8##4##(1990-2#1)(1993-3#1)(1995-10#1)(2007-10#1)(2007-2#1)(2008-8#1)(2012-1#1)(2012-2#1)
of these agents to##4##4##(1992-3#1)(1995-1#1)(1997-5#1)(2006-8#1)
of these agents was##2##4##(1996-9#1)(2005-7#1)
of these agents were##2##4##(1997-4#1)(2011-2#1)
of these agents with##2##4##(2007-11#1)(2007-7#1)
of these agents##95##3##(1990-2#2)(1991-5#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-5#3)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-5#1)(2004-11#1)(2005-6#1)(2005-7#2)(2005-8#2)(2006-10#10)(2006-12#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#3)(2008-5#4)(2008-7#4)(2008-8#4)(2008-9#1)(2009-1#1)(2009-3#2)(2009-8#2)(2010-3#1)(2010-4#1)(2011-2#2)(2012-1#3)(2012-2#1)(2013-1#1)(2013-7#1)
of these agonists##3##3##(1990-2#1)(1990-3#1)(1993-11#1)
of these aids has##2##4##(2012-1#2)
of these algorithms##3##3##(2008-2#2)(2008-3#1)
of these alleles##2##3##(2008-2#1)(2012-12#1)
of these also had##2##4##(1993-5#1)(1994-7#1)
of these also##6##3##(1992-12#1)(1993-5#1)(1994-7#1)(2006-10#1)(2008-6#1)(2012-12#1)
of these alterations in##2##4##(2008-11#1)(2008-2#1)
of these alterations on##2##4##(1990-2#1)(1996-2#1)
of these alterations##12##3##(1990-2#1)(1993-4#1)(1995-5#1)(1996-10#1)(1996-2#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-12#1)(2012-12#2)
of these alternative##3##3##(1997-5#1)(2008-8#1)(2012-1#1)
of these amino acid##2##4##(1995-5#1)(1996-7#1)
of these amino acids in##2##5##(1995-6#1)(2006-12#1)
of these amino acids##7##4##(1991-9#1)(1994-3#1)(1995-6#1)(2006-12#1)(2008-10#2)(2010-12#1)
of these amino##9##3##(1991-9#1)(1994-3#1)(1995-5#1)(1995-6#1)(1996-7#1)(2006-12#1)(2008-10#2)(2010-12#1)
of these analogs on##2##4##(1994-9#1)(1997-8#1)
of these analogs were##2##4##(1990-4#1)(2009-2#1)
of these analogs##7##3##(1990-4#1)(1993-6#1)(1994-11#1)(1994-9#1)(1996-8#1)(1997-8#1)(2009-2#1)
of these analogues##3##3##(1991-5#1)(1996-5#1)(2005-11#1)
of these analyses##8##3##(1990-11#1)(1994-1#1)(1995-5#1)(1996-1#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-2#1)
of these analytes##5##3##(1996-5#2)(2008-10#3)
of these and other##9##4##(1990-11#1)(1996-12#1)(2007-11#3)(2007-4#1)(2008-10#1)(2008-9#1)(2010-1#1)
of these and##18##3##(1990-11#1)(1990-5#1)(1993-6#1)(1995-11#1)(1995-7#1)(1996-12#1)(1996-2#1)(2007-11#3)(2007-4#1)(2007-5#1)(2008-10#2)(2008-9#1)(2009-4#1)(2010-1#2)
of these animals showed##2##4##(2004-11#1)(2008-12#1)
of these animals were##2##4##(1994-10#1)(2008-9#1)
of these animals##9##3##(1994-10#1)(1994-2#1)(1996-12#2)(1996-3#1)(2004-11#1)(2008-10#1)(2008-12#1)(2008-9#1)
of these anions##2##3##(1991-8#1)(2008-10#1)
of these annulenes##2##3##(1996-5#2)
of these antagonists was##2##4##(1997-2#2)
of these antagonists##5##3##(1990-2#1)(1991-7#1)(1993-3#1)(1997-2#2)
of these antibiotics in##2##4##(2006-8#1)(2008-10#1)
of these antibiotics##6##3##(2005-11#1)(2006-8#1)(2008-10#2)(2008-11#1)(2013-8#1)
of these antibodies had##2##4##(1991-5#1)(1991-9#1)
of these antibodies in##2##4##(1990-6#1)(1997-7#1)
of these antibodies##12##3##(1990-6#2)(1991-12#1)(1991-5#1)(1991-9#1)(1993-2#1)(1993-9#1)(1996-11#2)(1997-7#1)(2007-11#1)(2008-1#1)
of these antibody##2##3##(1991-12#1)(2009-11#1)
of these antigens##7##3##(1994-7#1)(1997-7#1)(2009-2#1)(2012-12#2)(2012-2#2)
of these antioxidants in##2##4##(1995-3#1)(2008-10#1)
of these antioxidants##5##3##(1995-3#1)(2006-10#1)(2008-10#2)(2009-12#1)
of these applications##4##3##(1997-7#1)(2008-1#1)(2008-2#1)(2008-7#1)
of these approaches and##4##4##(1993-2#1)(2009-12#1)(2013-1#2)
of these approaches are##3##4##(2006-12#1)(2006-9#1)(2008-1#1)
of these approaches have##2##4##(2004-1#1)(2012-2#1)
of these approaches##21##3##(1993-2#1)(1997-6#1)(2004-1#1)(2006-12#1)(2006-5#1)(2006-9#2)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-12#1)(2010-11#1)(2010-7#1)(2012-2#3)(2013-1#2)(2013-7#1)
of these are located in##2##5##(1995-10#1)(2007-8#1)
of these are located##3##4##(1995-1#1)(1995-10#1)(2007-8#1)
of these are not##2##4##(2006-12#1)(2013-1#1)
of these are##31##3##(1990-5#1)(1992-11#1)(1994-9#1)(1995-1#1)(1995-10#1)(1996-3#1)(1997-7#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-11#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
of these areas##14##3##(1991-3#1)(1992-3#1)(1993-2#1)(1994-8#1)(1997-2#2)(1997-3#1)(2006-6#1)(2006-8#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)
of these arteries##2##3##(1996-6#1)(2010-9#1)
of these as##3##3##(1994-12#1)(2013-1#2)
of these aspects##3##3##(2008-10#1)(2008-11#1)(2010-7#1)
of these assays are##3##4##(2008-10#1)(2008-12#1)(2008-9#1)
of these assays is##2##4##(2008-4#1)(2008-9#1)
of these assays was##2##4##(2008-8#1)(2012-1#1)
of these assays##17##3##(1996-4#1)(1997-3#1)(1997-7#1)(2005-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#2)(2011-1#1)(2012-1#1)
of these associations is##3##4##(2005-11#1)(2012-12#2)
of these associations##6##3##(1997-3#1)(2005-11#1)(2008-10#1)(2009-7#1)(2012-12#2)
of these assumptions##2##3##(2006-3#1)(2008-9#1)
of these attitudes##3##3##(1996-2#1)(2010-10#1)(2010-2#1)
of these authors##2##3##(2007-8#1)(2008-2#1)
of these autoimmune conditions##2##4##(2006-1#1)(2012-3#1)
of these autoimmune##3##3##(2004-11#1)(2006-1#1)(2012-3#1)
of these bacteria and##2##4##(2005-8#1)(2008-10#1)
of these bacteria in##2##4##(2008-10#1)(2013-1#1)
of these bacteria were##2##4##(1993-2#1)(2008-10#1)
of these bacteria##18##3##(1993-2#1)(2005-8#1)(2006-10#1)(2006-8#2)(2008-10#7)(2008-2#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
of these bacterial##2##3##(1997-8#1)(2009-5#1)
of these bands are##2##4##(1993-5#1)(1996-4#1)
of these bands##6##3##(1993-5#1)(1996-4#1)(2007-11#1)(2008-10#2)(2008-5#1)
of these bats##2##3##(2005-12#1)(2007-3#1)
of these beams##3##3##(2007-12#2)(2008-2#1)
of these behavioral tasks##2##4##(1992-10#1)(1997-2#1)
of these behavioral##3##3##(1991-5#1)(1992-10#1)(1997-2#1)
of these behaviors##5##3##(1993-6#1)(1997-7#1)(2008-4#3)
of these behaviours##2##3##(1991-2#1)(2008-11#1)
of these being##4##3##(1995-2#1)(2005-7#1)(2007-11#1)(2011-1#1)
of these benefits##2##3##(1991-8#1)(2010-1#1)
of these benzamides##2##3##(1990-5#1)(2008-10#1)
of these bile acids##2##4##(1991-3#1)(1996-7#1)
of these biochemical##2##3##(1992-6#1)(2007-9#1)
of these biological##6##3##(1991-3#1)(2005-8#1)(2006-9#1)(2008-4#1)(2010-2#1)(2012-11#1)
of these biologicals##2##3##(2007-11#1)(2008-11#1)
of these biomarkers##3##3##(2007-5#1)(2011-1#1)(2013-1#1)
of these biomolecules are##2##4##(2008-1#1)(2008-3#1)
of these biomolecules##3##3##(1994-6#1)(2008-1#1)(2008-3#1)
of these biosensors##2##3##(2008-10#2)
of these birds##2##3##(1993-9#1)(2007-2#1)
of these brain##2##3##(1991-2#1)(1994-2#1)
of these buffers##2##3##(1991-11#1)(2008-10#1)
of these cDNA clones##3##4##(1990-12#1)(1992-11#1)(1993-11#1)
of these cDNAs##5##3##(1991-7#1)(1993-12#2)(1993-8#1)(1994-12#1)
of these calibration curves##2##4##(2008-10#1)(2008-3#1)
of these campaigns##2##3##(2008-3#1)(2008-9#1)
of these can be##3##4##(1996-9#1)(2006-10#1)(2012-2#1)
of these can##4##3##(1996-9#1)(2006-10#1)(2008-7#1)(2012-2#1)
of these cancer##2##3##(1990-7#1)(2009-3#1)
of these cancers##2##3##(2008-11#1)(2013-1#1)
of these cardiac##2##3##(1991-11#1)(2007-8#1)
of these carriers##2##3##(2006-8#1)(2008-11#1)
of these cases are##5##4##(1991-8#1)(2008-8#1)(2010-1#1)(2013-1#2)
of these cases could##2##4##(1997-6#1)(2008-7#1)
of these cases had##2##4##(1992-8#1)(2008-7#1)
of these cases should##2##4##(2007-7#1)(2010-8#1)
of these cases the##4##4##(1992-2#1)(2006-11#1)(2008-3#1)(2012-3#1)
of these cases were##2##4##(1996-3#1)(2009-5#1)
of these cases##62##3##(1990-5#1)(1991-12#2)(1991-6#1)(1991-8#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-11#1)(1996-3#1)(1996-6#2)(1997-2#1)(1997-6#1)(2006-10#2)(2006-11#1)(2007-10#1)(2007-11#2)(2007-7#3)(2007-8#3)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)
of these catalysts##3##3##(2004-12#1)(2009-3#2)
of these categories and##2##4##(2008-11#1)(2008-12#1)
of these categories of##2##4##(1995-6#1)(2010-7#1)
of these categories##7##3##(1995-6#1)(2007-10#1)(2007-4#1)(2008-11#1)(2008-12#1)(2010-2#1)(2010-7#1)
of these catheters##2##3##(2007-7#1)(2008-1#1)
of these cell bioassay systems##2##5##(2008-10#2)
of these cell lines to##2##5##(1990-5#1)(1991-12#1)
of these cell lines with##2##5##(1993-12#1)(1995-6#1)
of these cell lines##12##4##(1990-5#1)(1991-12#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-9#1)(1995-6#1)(2008-11#2)(2008-4#1)
of these cell populations##2##4##(1991-3#1)(1991-5#1)
of these cell types##6##4##(1993-4#1)(1997-1#1)(2006-10#1)(2008-4#1)(2008-7#1)(2012-2#1)
of these cell##24##3##(1990-5#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-9#1)(1995-6#1)(1997-1#1)(1997-6#1)(2006-10#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-7#1)(2010-3#1)(2012-2#1)
of these cells against##2##4##(1994-9#1)(2008-5#1)
of these cells and the##2##5##(1996-12#1)(2012-1#1)
of these cells and##3##4##(1996-12#1)(2008-4#1)(2012-1#1)
of these cells are##4##4##(2007-12#1)(2008-4#1)(2008-9#1)(2009-3#1)
of these cells as##2##4##(1996-8#1)(2008-11#1)
of these cells during##2##4##(1991-8#1)(2008-4#1)
of these cells for##2##4##(2007-5#1)(2013-1#1)
of these cells in a##2##5##(2008-11#1)(2010-1#1)
of these cells in the##6##5##(1992-9#1)(1995-2#1)(1996-12#1)(2009-5#1)(2012-12#2)
of these cells in##15##4##(1991-9#1)(1992-9#1)(1993-9#1)(1995-2#1)(1996-12#1)(1996-4#1)(2008-11#1)(2009-5#1)(2010-1#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-8#1)
of these cells into the##2##5##(2010-12#1)(2012-1#1)
of these cells into##3##4##(1997-4#1)(2010-12#1)(2012-1#1)
of these cells is##3##4##(1992-12#1)(1994-9#1)(2011-2#1)
of these cells may##2##4##(1996-9#1)(2008-9#1)
of these cells received barosensory input##2##6##(1991-8#2)
of these cells to an##2##5##(1991-12#1)(2008-1#1)
of these cells to##13##4##(1990-8#1)(1991-12#1)(1996-2#1)(1996-7#1)(1996-8#2)(2007-11#1)(2008-1#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-9#1)(2012-3#1)
of these cells was##5##4##(1991-6#1)(1992-3#1)(1994-3#1)(1994-9#1)(2008-5#1)
of these cells were##5##4##(1992-6#1)(1993-3#1)(2008-5#1)(2008-8#1)(2008-9#1)
of these cells with##11##4##(1991-9#2)(1992-2#1)(1992-9#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-6#1)
of these cells##140##3##(1990-11#1)(1990-12#3)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-6#1)(1991-8#3)(1991-9#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-9#4)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#4)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-6#1)(2008-1#3)(2008-10#1)(2008-11#9)(2008-4#5)(2008-5#5)(2008-7#6)(2008-8#1)(2008-9#4)(2009-3#2)(2009-5#1)(2010-1#1)(2010-12#5)(2010-9#2)(2011-1#1)(2011-2#1)(2012-1#6)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
of these cellular factors##2##4##(1993-12#2)
of these cellular##5##3##(1992-12#1)(1993-12#2)(2009-9#1)(2012-12#1)
of these centers##2##3##(1992-8#1)(2008-1#1)
of these challenges##7##3##(2006-7#1)(2007-12#1)(2007-5#1)(2008-1#1)(2009-12#1)(2010-10#1)(2011-1#1)
of these changes are##3##4##(1996-5#1)(2007-10#1)(2011-2#1)
of these changes can##2##4##(1991-2#1)(2007-12#1)
of these changes for the##2##5##(2009-3#1)(2009-9#1)
of these changes have been##2##5##(1992-3#1)(2013-7#1)
of these changes in##2##4##(2007-8#1)(2008-2#1)
of these changes on##3##4##(1992-1#1)(1992-4#1)(2010-2#1)
of these changes to##2##4##(1991-10#1)(2008-10#1)
of these changes were##2##4##(2008-12#1)(2011-1#1)
of these changes##40##3##(1991-10#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1994-11#1)(1995-1#1)(1995-3#1)(1996-5#1)(2005-10#2)(2005-8#1)(2006-10#1)(2006-5#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-2#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-2#1)(2013-7#2)
of these channels##10##3##(1994-11#2)(1994-2#1)(1995-8#1)(2006-10#1)(2007-9#1)(2008-5#1)(2008-7#1)(2008-8#2)
of these characteristic##3##3##(2005-12#1)(2010-10#1)(2012-12#1)
of these characteristics##10##3##(1991-12#1)(1992-9#1)(2004-4#1)(2006-10#1)(2007-4#2)(2008-11#1)(2008-2#1)(2008-3#2)
of these chemicals in##3##4##(1993-3#1)(2008-10#1)(2009-6#1)
of these chemicals##13##3##(1993-3#1)(2006-12#1)(2007-10#1)(2008-10#6)(2008-11#1)(2008-2#1)(2009-6#1)(2012-2#1)
of these children have##3##4##(2008-9#1)(2010-12#1)(2010-3#1)
of these children were##3##4##(1990-12#1)(1996-1#1)(2012-12#1)
of these children##25##3##(1990-12#1)(1994-6#1)(1996-1#1)(2005-11#1)(2006-10#2)(2006-4#2)(2007-12#1)(2007-7#1)(2008-2#1)(2008-4#2)(2008-9#1)(2010-12#2)(2010-2#1)(2010-3#2)(2011-2#2)(2012-11#1)(2012-12#1)(2013-1#2)
of these chromosomes##4##3##(1996-12#1)(1997-5#1)(2007-2#1)(2008-7#1)
of these chronic##2##3##(2007-11#1)(2008-12#1)
of these classes of##3##4##(1997-2#1)(2006-11#1)(2007-10#1)
of these classes##5##3##(1996-6#1)(1997-2#1)(2005-8#1)(2006-11#1)(2007-10#1)
of these clinical##7##3##(1994-12#1)(2007-11#1)(2008-12#1)(2009-9#1)(2010-6#1)(2013-7#2)
of these clinics##2##3##(1992-1#1)(1992-2#1)
of these clones were##2##4##(1991-12#1)(2008-11#1)
of these clones##7##3##(1990-12#1)(1991-12#1)(1993-5#1)(1997-7#1)(1997-8#2)(2008-11#1)
of these clusters##5##3##(1995-2#1)(2007-11#1)(2007-12#1)(2008-5#1)(2010-4#1)
of these coated##2##3##(2008-10#1)(2012-11#1)
of these collections##2##3##(2008-10#1)(2008-7#1)
of these columns##2##3##(1991-3#1)(1996-8#1)
of these combinations and##2##4##(2009-11#1)(2009-12#1)
of these combinations##3##3##(2009-11#2)(2009-12#1)
of these communities##2##3##(2007-7#1)(2008-9#1)
of these companies##2##3##(1995-1#2)
of these complex##5##3##(2008-1#1)(2008-4#1)(2008-8#1)(2009-3#1)(2010-2#1)
of these complexes are##2##4##(2008-10#1)(2009-3#1)
of these complexes have been determined##2##6##(1992-9#1)(2010-5#1)
of these complexes in the##4##5##(1996-2#1)(2008-10#1)(2012-12#2)
of these complexes in##9##4##(1992-9#1)(1996-11#1)(1996-2#1)(2008-10#1)(2008-11#1)(2012-12#4)
of these complexes were##2##4##(1996-8#1)(2006-12#1)
of these complexes##35##3##(1992-5#1)(1992-9#2)(1993-8#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-6#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#3)(2009-3#1)(2010-5#2)(2010-7#1)(2012-12#4)
of these complications is##2##4##(2008-8#1)(2013-7#1)
of these complications##13##3##(1991-5#1)(1996-2#1)(2005-7#1)(2006-9#1)(2007-6#1)(2007-7#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2013-7#1)(2013-8#2)
of these components are##2##4##(2007-11#1)(2012-12#1)
of these components in##3##4##(1994-5#1)(1997-3#1)(2007-12#1)
of these components is##2##4##(1996-9#1)(2009-8#1)
of these components##25##3##(1994-5#1)(1996-9#1)(1997-3#1)(2005-11#2)(2005-5#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-12#2)
of these composites##3##3##(2008-8#1)(2010-4#1)(2011-2#1)
of these compounds against##3##4##(1992-9#1)(2008-10#1)(2008-5#1)
of these compounds and their##2##5##(2006-10#1)(2008-8#1)
of these compounds and##9##4##(1990-7#1)(1991-4#1)(2006-10#1)(2007-10#1)(2008-10#2)(2008-8#1)(2009-8#1)(2010-11#1)
of these compounds are##11##4##(1992-8#1)(1997-8#1)(2005-4#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#4)
of these compounds as##3##4##(2008-11#1)(2008-5#1)(2010-6#1)
of these compounds by##2##4##(1996-8#1)(2008-10#1)
of these compounds can be##2##5##(2008-10#1)(2012-2#1)
of these compounds did not##2##5##(1994-11#1)(2007-10#1)
of these compounds for the##2##5##(1995-12#1)(2008-11#1)
of these compounds for##5##4##(1993-4#1)(1995-12#2)(1997-2#1)(2008-11#1)
of these compounds has been##3##5##(1997-2#1)(2005-8#1)(2008-10#1)
of these compounds has##4##4##(1997-2#1)(2005-8#1)(2008-10#1)(2008-11#1)
of these compounds have been##3##5##(2006-9#1)(2007-11#1)(2011-1#1)
of these compounds have##7##4##(1995-3#1)(1997-2#1)(2006-9#1)(2007-11#1)(2008-1#1)(2010-12#1)(2011-1#1)
of these compounds in animal models##2##6##(2008-5#2)
of these compounds in natural##2##5##(2008-10#2)
of these compounds in the##5##5##(1990-5#1)(2008-10#1)(2008-5#1)(2010-5#1)(2011-2#1)
of these compounds in##30##4##(1990-11#1)(1990-12#1)(1990-5#1)(1992-5#1)(1992-7#1)(1993-11#1)(1994-2#1)(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#11)(2008-5#4)(2009-4#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#1)
of these compounds is##2##4##(1991-12#1)(2008-10#1)
of these compounds on the##3##5##(2008-1#1)(2008-10#2)
of these compounds on##7##4##(1990-11#1)(1993-12#1)(1997-1#1)(2007-11#1)(2008-1#1)(2008-10#2)
of these compounds showed##4##4##(1995-3#1)(2007-11#1)(2008-5#1)(2009-12#1)
of these compounds to the##2##5##(1996-8#1)(2008-10#1)
of these compounds to##3##4##(1993-11#1)(1996-8#1)(2008-10#1)
of these compounds was##14##4##(1991-2#1)(1993-11#1)(1995-12#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2012-2#1)
of these compounds were confirmed##2##5##(2006-12#1)(2009-10#1)
of these compounds were##17##4##(1990-11#1)(1990-8#1)(1992-5#1)(1993-12#1)(2006-12#2)(2007-1#1)(2007-11#3)(2008-10#2)(2008-11#1)(2009-10#1)(2009-5#1)(2011-2#2)
of these compounds with##8##4##(1991-5#1)(1992-11#1)(2008-10#1)(2009-7#1)(2009-9#1)(2010-2#1)(2011-1#1)(2012-3#1)
of these compounds##206##3##(1990-11#3)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#4)(1990-8#2)(1991-12#1)(1991-2#1)(1991-4#3)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-3#1)(1992-5#3)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#4)(1993-12#2)(1993-4#3)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-12#4)(1995-3#2)(1995-6#1)(1996-8#3)(1997-1#1)(1997-2#5)(1997-5#1)(1997-8#2)(2005-4#1)(2005-7#1)(2005-8#2)(2006-10#3)(2006-12#8)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#14)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#45)(2008-11#6)(2008-3#1)(2008-4#1)(2008-5#12)(2008-8#2)(2009-10#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#5)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)
of these computational models is##2##5##(2008-11#1)(2008-7#1)
of these concepts and##2##4##(2006-10#1)(2008-2#1)
of these concepts##8##3##(2006-10#1)(2006-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-5#1)(2010-12#1)
of these concerns##4##3##(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)
of these conditions and##5##4##(2006-8#1)(2007-12#1)(2007-2#1)(2008-4#1)(2012-2#1)
of these conditions are discussed##3##5##(2006-5#1)(2007-7#1)(2010-5#1)
of these conditions are##8##4##(1991-8#1)(2006-10#2)(2006-5#1)(2007-7#2)(2010-5#1)(2013-1#1)
of these conditions in##3##4##(2008-2#1)(2008-8#1)(2012-2#1)
of these conditions is##4##4##(1994-2#1)(2005-11#1)(2009-11#1)(2012-7#1)
of these conditions were##2##4##(2008-8#2)
of these conditions will##3##4##(2006-11#1)(2006-12#1)(2008-7#1)
of these conditions##56##3##(1990-7#1)(1991-8#1)(1993-6#1)(1994-2#1)(1994-9#1)(1996-12#1)(2005-11#2)(2006-10#3)(2006-11#2)(2006-12#2)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-2#3)(2007-7#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#2)(2009-11#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#2)(2011-12#1)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#2)(2013-8#1)
of these conjugates##3##3##(1996-1#1)(1997-8#1)(2008-4#1)
of these considerations##2##3##(1991-3#1)(2011-1#1)
of these constituents##2##3##(1995-6#1)(2007-8#1)
of these constructs##5##3##(1993-11#1)(2008-11#1)(2008-12#1)(2009-12#1)(2009-2#1)
of these control##3##3##(2008-10#2)(2013-8#1)
of these countries##10##3##(1994-12#1)(2005-7#1)(2005-8#1)(2008-4#1)(2009-10#1)(2010-7#1)(2012-12#2)(2012-2#1)(2013-8#1)
of these couplers##2##3##(2007-11#1)(2008-2#1)
of these criteria##14##3##(1992-6#1)(1993-8#1)(1995-2#1)(1997-8#1)(2006-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-2#1)(2010-5#1)(2013-1#2)
of these critical##3##3##(1995-2#1)(2006-6#1)(2011-1#1)
of these crystals##3##3##(1992-6#1)(2008-2#1)(2008-4#1)
of these currently##2##3##(2008-11#1)(2013-1#1)
of these cytokines and##2##4##(2008-8#1)(2008-9#1)
of these cytokines are##2##4##(2006-10#1)(2009-11#1)
of these cytokines in the##2##5##(2005-8#1)(2008-3#1)
of these cytokines in##4##4##(1994-11#1)(1994-6#1)(2005-8#1)(2008-3#1)
of these cytokines##14##3##(1990-2#1)(1994-11#1)(1994-6#1)(1995-2#1)(1997-4#1)(2005-8#1)(2006-10#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-11#1)
of these data are##2##4##(2008-4#1)(2009-4#1)
of these data for##2##4##(2006-5#1)(2008-2#1)
of these data indicates that##2##5##(2006-9#1)(2007-4#1)
of these data is##8##4##(1990-11#1)(1993-11#2)(1995-9#1)(2007-12#1)(2012-2#1)(2013-1#2)
of these data we##2##4##(1993-8#1)(1996-6#1)
of these data##48##3##(1990-11#1)(1991-5#1)(1992-11#1)(1992-12#1)(1993-11#2)(1993-7#1)(1993-8#1)(1994-8#1)(1995-1#1)(1995-9#1)(1996-2#1)(1996-6#1)(1997-1#1)(2004-12#1)(2005-11#2)(2006-10#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-2#3)(2008-3#4)(2008-4#3)(2008-6#1)(2008-7#1)(2009-12#1)(2009-4#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)
of these databases##3##3##(1997-1#1)(2008-6#1)(2009-3#1)
of these deaths##2##3##(2010-8#1)(2012-1#1)
of these defects and##2##4##(2005-11#1)(2010-12#1)
of these defects##5##3##(2005-11#2)(2010-12#1)(2010-9#1)(2011-2#1)
of these defenses##2##3##(1995-8#1)(2006-7#1)
of these deficits##4##3##(1992-11#1)(1995-1#1)(1996-8#1)(2007-11#1)
of these deformities##2##3##(2008-4#1)(2010-11#1)
of these deletants##2##3##(2008-8#2)
of these deliberations##2##3##(2007-12#1)(2008-11#1)
of these derivatives is##2##4##(1991-12#1)(1992-1#1)
of these derivatives were##2##4##(1990-12#1)(2008-5#1)
of these derivatives##9##3##(1990-12#1)(1991-12#1)(1992-1#1)(1992-9#1)(1994-11#1)(1997-2#1)(2006-12#1)(2008-5#1)(2012-3#1)
of these descriptors##2##3##(2008-10#2)
of these detectors##3##3##(2008-2#3)
of these developments and##3##4##(2006-10#1)(2007-2#1)(2011-1#1)
of these developments##11##3##(1991-2#1)(1993-1#1)(2005-5#1)(2006-10#1)(2006-9#1)(2007-2#1)(2007-4#1)(2007-5#1)(2008-10#1)(2010-12#1)(2011-1#1)
of these devices and##5##4##(2005-12#1)(2008-10#1)(2008-3#1)(2010-9#1)(2011-2#1)
of these devices are discussed##2##5##(2007-12#1)(2010-11#1)
of these devices are##3##4##(2007-11#1)(2007-12#1)(2010-11#1)
of these devices for##2##4##(2007-2#1)(2008-7#1)
of these devices is##4##4##(2006-6#1)(2007-12#1)(2008-5#1)(2010-8#1)
of these devices##24##3##(2005-12#1)(2006-6#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-11#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#2)
of these diabetic##2##3##(2008-1#1)(2008-10#1)
of these diagnostic procedures##2##4##(1990-12#1)(1996-4#1)
of these diagnostic##3##3##(1990-12#1)(1992-6#1)(1996-4#1)
of these dietary##2##3##(2008-11#1)(2008-5#1)
of these differences for the##3##5##(1995-8#1)(1996-2#1)(2007-1#1)
of these differences in##4##4##(1993-12#1)(2006-11#1)(2008-8#2)
of these differences was##2##4##(1993-11#1)(1995-2#1)
of these differences##22##3##(1990-5#1)(1991-12#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-7#1)(2006-11#1)(2007-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)
of these different##14##3##(1990-8#1)(1993-11#1)(1993-6#1)(1994-12#1)(1995-11#1)(1995-12#1)(1997-7#1)(2006-11#1)(2006-9#1)(2007-3#1)(2008-10#1)(2009-2#1)(2011-1#1)(2011-2#1)
of these difficult##2##3##(2007-8#1)(2008-7#1)
of these dinucleotides##2##3##(2008-4#2)
of these disciplines##2##3##(2010-3#1)(2010-9#1)
of these disease states##4##4##(2006-12#1)(2007-11#1)(2008-3#1)(2008-4#1)
of these disease##7##3##(2006-12#1)(2007-11#1)(2008-1#1)(2008-3#2)(2008-4#1)(2010-4#1)
of these disease-associated##2##3##(1997-8#1)(2011-1#1)
of these diseases and the##3##5##(1997-8#1)(2006-8#1)(2007-7#1)
of these diseases and##7##4##(1997-8#1)(2006-8#1)(2007-7#1)(2009-9#1)(2011-1#1)(2013-1#2)
of these diseases are##8##4##(1995-9#1)(2006-10#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2013-8#1)
of these diseases by##2##4##(1991-12#1)(2007-1#1)
of these diseases in##2##4##(2007-7#1)(2010-6#1)
of these diseases is the##2##5##(1994-5#1)(1996-5#1)
of these diseases is##4##4##(1994-5#1)(1996-5#1)(2009-4#1)(2013-1#1)
of these diseases##66##3##(1990-12#1)(1990-2#1)(1991-12#1)(1992-9#1)(1994-3#1)(1994-5#1)(1995-5#1)(1995-9#1)(1996-5#1)(1997-3#1)(1997-6#1)(1997-8#3)(2006-10#3)(2006-11#1)(2006-8#2)(2007-1#1)(2007-12#1)(2007-2#1)(2007-5#2)(2007-7#4)(2008-1#1)(2008-10#5)(2008-3#2)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#2)
of these disorders are##2##4##(1997-7#1)(2008-8#1)
of these disorders in##2##4##(2005-7#1)(2011-2#1)
of these disorders is still##3##5##(2008-7#1)(2013-7#2)
of these disorders is##4##4##(1995-5#1)(2008-7#1)(2013-7#2)
of these disorders##34##3##(1990-9#1)(1992-1#1)(1993-12#2)(1994-2#1)(1995-5#1)(1997-7#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-3#1)(2007-2#3)(2007-7#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#3)(2008-8#2)(2010-12#2)(2011-12#1)(2011-2#2)(2012-3#1)(2013-7#2)
of these diverse##4##3##(1991-1#1)(2006-1#1)(2007-11#1)(2008-10#1)
of these doctors##2##3##(1997-8#1)(2010-11#1)
of these domains##6##3##(1991-5#1)(1992-4#1)(1993-3#1)(1993-6#1)(1994-9#1)(2008-7#1)
of these doses##3##3##(1991-3#2)(2006-9#1)
of these drug delivery systems##2##5##(2008-5#1)(2013-1#1)
of these drug delivery##3##4##(2008-5#1)(2010-1#1)(2013-1#1)
of these drug effects##2##4##(2008-3#2)
of these drug##5##3##(2008-3#2)(2008-5#1)(2010-1#1)(2013-1#1)
of these drugs are##2##4##(2008-8#1)(2013-1#1)
of these drugs by the##2##5##(1995-3#1)(1996-6#1)
of these drugs has##2##4##(1991-8#1)(2006-12#1)
of these drugs have been##2##5##(1997-2#1)(2013-7#1)
of these drugs have##4##4##(1997-2#1)(2006-10#1)(2013-7#2)
of these drugs in the treatment of##4##7##(1996-3#1)(2005-7#1)(2007-11#2)
of these drugs in the##6##5##(1996-3#1)(2005-7#1)(2007-11#3)(2010-6#1)
of these drugs in##16##4##(1991-4#1)(1991-8#1)(1996-3#1)(2005-7#1)(2006-8#1)(2007-11#4)(2008-10#1)(2008-7#1)(2010-2#1)(2010-6#3)(2011-1#1)
of these drugs is not##2##5##(1990-5#1)(2010-11#1)
of these drugs is##7##4##(1990-5#1)(2008-1#1)(2010-11#2)(2010-4#1)(2010-5#1)(2011-2#1)
of these drugs may##3##4##(2008-10#1)(2008-8#1)(2009-4#1)
of these drugs on the##4##5##(1993-12#1)(1994-3#1)(2008-10#1)(2011-1#1)
of these drugs on##6##4##(1993-12#1)(1994-3#2)(2008-10#1)(2011-1#1)(2013-1#1)
of these drugs to##3##4##(1997-7#1)(2006-5#1)(2012-1#1)
of these drugs was##2##4##(1991-5#1)(1997-2#1)
of these drugs with##4##4##(1990-10#1)(1995-5#1)(2008-8#1)(2013-8#1)
of these drugs##105##3##(1990-10#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-12#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-3#2)(1994-4#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-7#1)(2005-7#1)(2006-10#2)(2006-12#2)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#9)(2007-8#3)(2008-1#2)(2008-10#11)(2008-11#3)(2008-2#1)(2008-3#3)(2008-7#2)(2008-8#6)(2009-4#1)(2009-7#1)(2010-11#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#3)(2011-1#3)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#3)(2013-8#1)
of these dyes##3##3##(2005-11#1)(2008-10#1)(2010-2#1)
of these early##4##3##(1990-8#1)(1994-6#1)(1994-8#1)(1996-5#1)
of these effector##2##3##(2008-4#1)(2008-8#1)
of these effectors##2##3##(1996-2#1)(2011-2#1)
of these effects and the##2##5##(1997-2#1)(2007-12#1)
of these effects and##6##4##(1997-2#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-3#1)(2008-5#1)
of these effects are##3##4##(1996-4#1)(2007-11#1)(2008-8#1)
of these effects may##2##4##(2005-10#1)(2005-12#1)
of these effects were##2##4##(1993-8#1)(1996-2#1)
of these effects##37##3##(1990-3#1)(1990-5#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-7#1)(1993-8#1)(1994-11#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1997-2#1)(2005-10#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)
of these efforts##5##3##(2005-7#1)(2006-10#1)(2006-7#1)(2008-4#1)(2013-1#1)
of these electrodes in##2##4##(2008-10#2)
of these electrodes to##2##4##(2008-10#2)
of these electrodes##7##3##(2008-10#7)
of these elements are##4##4##(1992-6#1)(1995-1#1)(2010-9#1)(2013-1#1)
of these elements from##2##4##(2008-10#2)
of these elements in the##4##5##(1990-5#1)(1991-11#1)(2008-10#1)(2012-2#1)
of these elements in##7##4##(1990-5#1)(1991-11#1)(1995-3#1)(2008-10#2)(2009-6#1)(2012-2#1)
of these elements was##3##4##(1996-10#1)(2005-4#1)(2008-10#1)
of these elements##32##3##(1990-5#1)(1990-9#1)(1991-11#1)(1991-7#1)(1992-6#1)(1993-6#1)(1995-1#1)(1995-3#1)(1996-10#1)(1996-4#1)(2004-4#1)(2005-4#1)(2007-11#1)(2008-10#10)(2008-3#1)(2008-7#1)(2009-6#1)(2010-9#1)(2012-2#2)(2012-3#1)(2013-1#2)
of these employees##2##3##(2007-7#1)(2011-2#1)
of these enigmatic##3##3##(2007-7#1)(2009-3#1)(2011-2#1)
of these entities##4##3##(1996-3#1)(2008-3#1)(2008-4#1)(2010-7#1)
of these enzymatic##2##3##(1995-1#1)(1995-3#1)
of these enzymes and##3##4##(2006-10#1)(2007-8#1)(2013-8#1)
of these enzymes by##4##4##(1990-1#1)(1992-4#1)(1992-8#1)(2005-8#1)
of these enzymes during##2##4##(2008-5#1)(2011-1#1)
of these enzymes has been##3##5##(2008-10#1)(2012-12#2)
of these enzymes in the metabolism of##2##7##(1992-12#1)(2008-8#1)
of these enzymes in the##3##5##(1992-12#1)(1995-11#1)(2008-8#1)
of these enzymes in##11##4##(1990-7#1)(1991-11#1)(1992-12#1)(1992-4#1)(1994-6#1)(1995-11#1)(1995-3#1)(2008-11#1)(2008-8#1)(2009-8#1)(2010-2#1)
of these enzymes were##5##4##(1990-12#1)(1994-12#1)(2008-10#1)(2008-4#1)(2009-8#1)
of these enzymes which##3##4##(1990-7#1)(1992-5#1)(1994-11#1)
of these enzymes##64##3##(1990-1#1)(1990-12#1)(1990-4#1)(1990-7#4)(1990-8#1)(1991-11#1)(1991-5#2)(1991-7#1)(1992-12#1)(1992-4#3)(1992-5#2)(1992-8#2)(1993-11#1)(1993-3#1)(1994-11#3)(1994-12#1)(1994-6#1)(1994-8#2)(1995-11#2)(1995-3#1)(1995-7#1)(1996-2#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-10#6)(2008-11#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-8#1)(2009-8#2)(2010-11#1)(2010-2#1)(2011-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
of these epidemics and##2##4##(2008-5#1)(2009-5#1)
of these epidemics##4##3##(2008-10#1)(2008-5#1)(2009-5#2)
of these episodes##3##3##(1990-11#1)(1991-9#1)(2008-1#1)
of these equations##5##3##(2005-11#1)(2006-6#1)(2007-3#1)(2008-10#1)(2008-3#1)
of these error##2##3##(2008-3#2)
of these errors##7##3##(1993-4#1)(2007-7#1)(2008-3#4)(2009-9#1)
of these essential##3##3##(2008-10#1)(2008-6#1)(2012-2#1)
of these esters##2##3##(1993-8#1)(1997-8#1)
of these evaluations##2##3##(2006-7#1)(2013-1#1)
of these events is##2##4##(1997-1#1)(2013-1#1)
of these events##12##3##(1991-12#1)(1992-11#1)(1997-1#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-9#2)(2009-3#1)(2009-4#1)(2013-1#1)
of these examples##4##3##(2005-8#1)(2008-12#1)(2008-3#1)(2010-2#1)
of these exons##2##3##(2008-4#1)(2008-7#1)
of these experimental##4##3##(2007-12#1)(2008-10#1)(2008-5#1)(2010-4#1)
of these experiments and##2##4##(1993-3#1)(2008-10#1)
of these experiments are##3##4##(1990-11#1)(1990-8#1)(2006-4#1)
of these experiments do not##2##5##(1992-11#1)(2008-10#1)
of these experiments was to##2##5##(1995-10#1)(1997-1#1)
of these experiments was##3##4##(1995-10#1)(1996-10#1)(1997-1#1)
of these experiments##23##3##(1990-11#1)(1990-7#1)(1990-8#1)(1992-11#1)(1992-3#1)(1993-3#1)(1994-3#1)(1995-10#1)(1995-6#1)(1996-10#1)(1997-1#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-3#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-6#1)(2013-1#1)
of these expressions##2##3##(2007-12#1)(2008-3#1)
of these extracts##3##3##(2008-5#1)(2010-12#1)(2013-1#1)
of these extremely##2##3##(2007-8#1)(2008-1#1)
of these factors and the##2##5##(2007-9#1)(2011-1#1)
of these factors and##8##4##(1996-5#1)(2006-10#1)(2007-9#1)(2008-2#1)(2008-3#1)(2009-9#1)(2011-1#1)(2012-2#1)
of these factors are##6##4##(1993-12#1)(2006-10#1)(2008-11#1)(2008-12#1)(2009-4#1)(2011-2#1)
of these factors as##2##4##(2006-8#1)(2008-4#1)
of these factors in##6##4##(1993-6#1)(2008-12#1)(2008-2#1)(2011-2#2)(2013-8#1)
of these factors is##3##4##(2006-10#1)(2008-10#1)(2009-10#1)
of these factors may contribute##2##5##(1993-2#1)(2010-2#1)
of these factors may##3##4##(1993-2#1)(2005-11#1)(2010-2#1)
of these factors on##5##4##(2008-10#3)(2008-3#1)(2009-3#1)
of these factors to##3##4##(1995-3#1)(1996-12#1)(2007-7#1)
of these factors will##3##4##(2010-8#1)(2011-1#1)(2012-12#1)
of these factors##73##3##(1990-12#1)(1991-10#2)(1991-11#1)(1991-5#2)(1991-8#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#2)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-4#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-8#1)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-6#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-2#2)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
of these facts##2##3##(2005-9#1)(2008-10#1)
of these families is##3##4##(1994-6#1)(2007-8#1)(2008-5#1)
of these families##11##3##(1994-6#3)(1997-9#1)(2006-6#1)(2007-2#2)(2007-8#2)(2008-5#1)(2008-9#1)
of these fatty acids##3##4##(2008-11#1)(2012-1#2)
of these features##7##3##(1991-12#1)(1994-6#1)(2007-12#1)(2008-11#1)(2008-3#1)(2013-1#2)
of these fibers##2##3##(2007-12#2)
of these fields##3##3##(1995-6#1)(2005-7#1)(2008-5#1)
of these films is##2##4##(1990-9#1)(2010-2#1)
of these films##8##3##(1990-9#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-2#2)(2010-2#1)
of these filters are##3##4##(2007-11#1)(2008-3#2)
of these filters##6##3##(2007-11#1)(2008-2#2)(2008-3#2)(2008-5#1)
of these findings and the##2##5##(2007-7#1)(2008-11#1)
of these findings and##3##4##(1993-9#1)(2007-7#1)(2008-11#1)
of these findings are discussed##15##5##(1991-2#1)(1993-1#1)(1994-2#1)(1996-9#1)(2004-2#1)(2006-3#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-4#1)(2009-7#1)(2010-12#1)(2010-9#1)(2012-1#1)(2013-1#1)
of these findings are##20##4##(1991-2#1)(1993-1#1)(1993-6#1)(1994-2#1)(1996-9#1)(2004-10#1)(2004-2#1)(2005-8#1)(2006-3#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-12#1)(2010-9#1)(2012-1#1)(2013-1#2)
of these findings for the##12##5##(1991-5#1)(1994-2#1)(1996-4#1)(2007-6#1)(2007-7#1)(2008-10#1)(2009-11#1)(2009-9#1)(2012-1#2)(2013-1#2)
of these findings for##30##4##(1991-5#1)(1992-3#1)(1993-8#1)(1994-2#1)(1995-1#1)(1996-4#1)(1996-5#1)(1996-8#1)(2004-11#1)(2004-12#1)(2007-12#1)(2007-6#2)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-11#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-9#2)(2012-1#2)(2012-2#1)(2013-1#2)
of these findings in##6##4##(1990-10#1)(1994-11#1)(1996-3#1)(2008-10#1)(2011-2#1)(2012-12#1)
of these findings is discussed##4##5##(1991-10#1)(2006-5#1)(2008-8#1)(2009-7#1)
of these findings is##5##4##(1991-10#1)(2006-5#1)(2007-12#1)(2008-8#1)(2009-7#1)
of these findings the##2##4##(1990-8#1)(2005-11#1)
of these findings to##6##4##(2007-10#1)(2007-12#1)(2008-10#2)(2009-12#1)(2010-6#1)
of these findings with##2##4##(1993-7#1)(2008-10#1)
of these findings##107##3##(1990-10#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-5#1)(1992-3#1)(1993-1#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(2004-10#1)(2004-11#1)(2004-12#1)(2004-2#1)(2005-11#2)(2005-8#2)(2006-10#2)(2006-11#1)(2006-3#1)(2006-5#1)(2006-7#2)(2007-10#1)(2007-12#4)(2007-4#1)(2007-6#3)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-11#2)(2009-12#1)(2009-4#2)(2009-5#1)(2009-7#3)(2009-9#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#6)(2012-12#2)(2012-2#1)(2013-1#5)(2013-8#2)
of these fish species##2##4##(2007-3#1)(2008-10#1)
of these fish were##2##4##(2008-5#1)(2010-8#1)
of these fish##5##3##(2007-3#1)(2008-10#1)(2008-5#1)(2010-8#2)
of these five patients##2##4##(1997-1#1)(2006-10#1)
of these five##15##3##(1992-11#1)(1993-6#1)(1993-8#1)(1995-3#2)(1997-1#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-6#2)(2012-1#1)(2012-2#1)(2013-1#1)
of these for##2##3##(1995-8#1)(2012-2#1)
of these formae speciales##2##4##(2008-10#2)
of these forms of##6##4##(1995-2#1)(1997-8#3)(2004-10#1)(2008-9#1)
of these forms##11##3##(1990-12#1)(1990-2#1)(1992-12#1)(1995-2#1)(1997-8#3)(2004-10#1)(2006-2#1)(2008-3#1)(2008-9#1)
of these four flavonoids##2##4##(2007-8#1)(2008-10#1)
of these four##17##3##(1990-8#1)(1992-12#1)(1993-10#1)(2005-10#1)(2007-4#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)(2013-7#1)
of these fractions##6##3##(1990-12#1)(1990-5#2)(1994-3#1)(1997-2#1)(2008-10#1)
of these fractures##5##3##(2006-3#1)(2008-6#1)(2013-1#3)
of these fragments##6##3##(1990-3#1)(1993-11#1)(1995-12#1)(1995-3#1)(1996-8#1)(2008-11#1)
of these functional##5##3##(1997-2#1)(2005-11#1)(2006-8#1)(2010-5#1)(2012-2#1)
of these functions are##2##4##(1996-5#1)(2013-1#1)
of these functions##13##3##(1990-3#1)(1991-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-5#1)(1996-7#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2013-1#1)
of these funds##2##3##(1996-1#2)
of these fungi##6##3##(2008-10#2)(2009-8#1)(2010-10#1)(2013-1#2)
of these gels##2##3##(2005-10#1)(2009-9#1)
of these gene products##3##4##(1990-9#1)(2006-10#1)(2012-12#1)
of these gene##7##3##(1990-9#1)(2006-10#1)(2008-4#1)(2008-6#1)(2012-12#3)
of these genes are##6##4##(1996-10#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
of these genes as##2##4##(1990-7#1)(1993-12#1)
of these genes has been##2##5##(1990-5#1)(2012-11#1)
of these genes has##4##4##(1990-5#1)(1991-9#2)(2012-11#1)
of these genes in the##3##5##(1996-6#1)(2008-10#1)(2008-4#1)
of these genes in##12##4##(1990-4#1)(1995-12#1)(1996-12#1)(1996-6#1)(2008-10#3)(2008-11#2)(2008-4#1)(2009-10#1)(2011-2#1)
of these genes is##6##4##(1990-8#2)(1993-6#1)(2008-9#1)(2012-2#1)(2013-8#1)
of these genes may##2##4##(1990-3#1)(2008-9#1)
of these genes play##2##4##(2006-8#1)(2008-7#1)
of these genes to##2##4##(2008-10#2)
of these genes were##7##4##(2008-10#3)(2008-7#1)(2008-8#1)(2009-8#1)(2013-8#1)
of these genes##105##3##(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#3)(1990-8#2)(1991-7#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-8#2)(1994-9#2)(1995-12#3)(1995-3#2)(1996-10#1)(1996-12#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-8#1)(2003-11#1)(2006-10#1)(2006-12#2)(2006-8#2)(2008-1#2)(2008-10#10)(2008-11#6)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#3)(2009-8#3)(2010-12#1)(2010-5#1)(2011-2#3)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#4)
of these genetic##3##3##(2007-2#1)(2010-4#1)(2013-1#1)
of these genomic##3##3##(1997-3#1)(2008-11#1)(2008-7#1)
of these glands##3##3##(2006-12#1)(2007-12#2)
of these glass##2##3##(2004-9#1)(2008-10#1)
of these glasses##2##3##(2007-12#1)(2008-2#1)
of these gradients##2##3##(2010-3#2)
of these gratings##5##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
of these groups is##2##4##(2008-10#2)
of these groups were##2##4##(2010-2#1)(2011-1#1)
of these groups##16##3##(1990-4#1)(1991-12#1)(1993-2#1)(1995-9#1)(2006-7#1)(2006-9#1)(2007-7#1)(2008-10#4)(2008-11#1)(2009-4#1)(2010-2#1)(2011-1#1)(2013-7#1)
of these growth factors##4##4##(1992-9#1)(2007-11#1)(2008-1#1)(2010-10#1)
of these growth##5##3##(1992-9#1)(2007-11#1)(2008-1#1)(2008-11#1)(2010-10#1)
of these guidelines##5##3##(2007-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-1#1)
of these had a##2##4##(1991-5#1)(1995-5#1)
of these had been##3##4##(1990-4#1)(2007-2#1)(2008-5#1)
of these had developed AIDS and##3##6##(1996-11#3)
of these had##24##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-10#1)(1993-5#1)(1994-2#1)(1994-6#1)(1995-5#1)(1995-9#1)(1996-11#4)(2006-11#1)(2007-2#2)(2008-5#1)(2008-6#1)(2012-12#1)(2013-1#1)
of these have a##2##4##(2006-12#1)(2008-7#1)
of these have been developed##2##5##(2008-2#1)(2008-9#1)
of these have been##7##4##(1994-9#1)(2006-8#1)(2007-1#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-8#1)
of these have##13##3##(1994-9#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-8#1)(2013-1#1)
of these health##3##3##(1996-12#1)(2008-4#2)
of these herbicides in##5##4##(2006-5#1)(2008-10#4)
of these herbicides##8##3##(1996-3#1)(2006-5#2)(2008-10#5)
of these heuristic algorithms##2##4##(2010-2#2)
of these hierarchies##2##3##(1997-4#1)(2004-3#1)
of these high##4##3##(1993-11#1)(1995-3#1)(1997-3#1)(2008-10#1)
of these highly##5##3##(2006-6#1)(2008-1#1)(2008-5#2)(2010-6#1)
of these histidines##2##3##(1992-4#1)(1994-10#1)
of these hormones##5##3##(1990-10#1)(1993-12#1)(1996-12#1)(2008-1#1)(2008-4#1)
of these hospitals##3##3##(1992-12#1)(1992-2#1)(2011-2#1)
of these host##2##3##(2006-5#1)(2007-7#1)
of these human##2##3##(1990-5#1)(1994-5#1)
of these hydrophobic##2##3##(1997-1#1)(2006-1#1)
of these hypotheses##5##3##(2005-10#1)(2007-11#1)(2008-6#1)(2008-9#2)
of these ideas##5##3##(1992-3#1)(2007-11#1)(2008-7#1)(2012-1#2)
of these images##3##3##(1997-6#1)(2009-10#1)(2009-4#1)
of these immunological##2##3##(2007-11#1)(2013-7#1)
of these implants##3##3##(2007-12#1)(2008-9#1)(2009-3#1)
of these important##6##3##(2006-10#3)(2008-11#1)(2009-7#1)(2011-1#1)
of these improvements##3##3##(1991-11#1)(1996-9#1)(2008-5#1)
of these in vitro##4##4##(1992-11#1)(1995-1#1)(2008-10#1)(2008-5#1)
of these in##12##3##(1992-11#1)(1993-12#1)(1994-8#1)(1995-1#1)(1995-4#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-3#1)(2012-2#1)(2013-1#1)
of these independent##2##3##(2005-10#1)(2007-6#1)
of these indicators##5##3##(1992-10#1)(1994-2#1)(2006-5#1)(2010-11#1)(2010-5#1)
of these indices##3##3##(2006-11#1)(2008-8#1)(2012-3#1)
of these individuals##14##3##(1991-11#1)(1994-11#1)(1995-3#2)(1997-8#1)(2005-8#1)(2008-11#3)(2008-7#1)(2008-8#1)(2009-7#1)(2010-11#2)
of these infants were##2##4##(1992-7#1)(2011-2#1)
of these infants will##2##4##(1992-3#1)(1992-7#1)
of these infants##6##3##(1992-3#2)(1992-7#2)(1996-8#1)(2011-2#1)
of these infected##2##3##(2007-11#1)(2007-8#1)
of these infections and the##2##5##(1990-8#1)(2011-2#1)
of these infections##22##3##(1990-8#1)(1994-3#1)(2005-7#1)(2005-9#1)(2006-10#3)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-7#1)(2010-4#1)(2010-6#1)(2011-2#3)(2012-11#2)
of these inflammatory##2##3##(2005-10#1)(2006-4#1)
of these information##2##3##(2009-2#1)(2009-5#1)
of these inhibitors was##2##4##(1991-2#1)(1992-6#1)
of these inhibitors with##2##4##(1992-6#1)(1995-11#1)
of these inhibitors##12##3##(1990-12#1)(1991-2#1)(1992-12#1)(1992-6#3)(1993-3#1)(1994-3#1)(1994-9#1)(1995-11#1)(1997-3#1)(2008-5#1)
of these inhibitory##2##3##(1996-9#1)(2008-10#1)
of these initial##6##3##(1994-4#1)(1995-11#1)(1997-2#1)(2008-10#1)(2008-11#1)(2013-1#1)
of these injuries and##2##4##(2010-9#1)(2011-2#1)
of these injuries can be##3##5##(1994-3#2)(2008-8#1)
of these injuries in##2##4##(1995-8#1)(2007-3#1)
of these injuries is##2##4##(1990-6#1)(2007-4#1)
of these injuries occur in##2##5##(2006-11#1)(2007-4#1)
of these injuries occur##3##4##(2006-11#1)(2007-4#1)(2008-9#1)
of these injuries##19##3##(1990-6#1)(1991-4#1)(1994-3#2)(1995-8#2)(2006-10#1)(2006-11#1)(2006-4#1)(2006-8#1)(2007-3#1)(2007-4#2)(2007-8#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-9#1)(2011-2#1)
of these innovative##3##3##(1991-12#1)(2008-10#1)(2008-3#1)
of these instruments##8##3##(1991-6#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)
of these interactions and##3##4##(1995-9#1)(2007-11#1)(2008-10#1)
of these interactions is##3##4##(1993-1#1)(2008-10#1)(2011-2#1)
of these interactions was##2##4##(2008-10#1)(2008-5#1)
of these interactions##20##3##(1990-6#1)(1992-11#1)(1992-12#1)(1993-1#1)(1993-9#1)(1995-9#1)(1997-1#1)(1997-6#1)(2007-1#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-5#1)(2009-7#1)(2011-2#1)(2012-2#1)
of these intermediates##2##3##(1992-1#1)(1997-4#1)
of these interventions in##2##4##(2008-10#1)(2008-2#1)
of these interventions on##3##4##(2006-10#1)(2013-1#2)
of these interventions##13##3##(2005-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#1)(2012-2#3)(2013-1#4)
of these introns##2##3##(1993-11#1)(1993-2#1)
of these investigations are##2##4##(2006-12#1)(2008-3#1)
of these investigations##7##3##(1993-12#1)(1995-5#1)(2006-12#1)(2007-9#1)(2008-3#1)(2010-9#1)(2012-12#1)
of these ions##12##3##(1996-7#1)(2008-10#11)
of these is that##2##4##(2005-11#1)(2008-2#1)
of these is##18##3##(1990-8#1)(1991-3#1)(1992-11#1)(1992-6#1)(1993-3#1)(1993-9#1)(1995-1#1)(1997-1#2)(2004-9#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-2#1)
of these islands##4##3##(1990-5#1)(2007-12#1)(2008-8#2)
of these isoforms has##2##4##(1996-3#1)(2008-10#1)
of these isoforms in##2##4##(1994-12#1)(1995-5#1)
of these isoforms##7##3##(1990-12#1)(1994-12#2)(1995-5#1)(1996-3#1)(2008-10#2)
of these isolates could##2##4##(2007-8#1)(2008-10#1)
of these isolates in##2##4##(2008-10#1)(2008-9#1)
of these isolates was##3##4##(2008-10#3)
of these isolates were determined##2##5##(2008-10#2)
of these isolates were##8##4##(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#1)(2010-4#1)(2013-8#1)
of these isolates##30##3##(1995-12#1)(2007-7#1)(2007-8#2)(2008-10#18)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
of these issues and##4##4##(2007-10#1)(2007-2#1)(2008-1#1)(2009-2#1)
of these issues is##3##4##(2006-9#1)(2007-12#1)(2011-1#1)
of these issues with##2##4##(1996-3#1)(2010-5#1)
of these issues##30##3##(1990-12#1)(1990-6#1)(1991-2#1)(1991-3#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-3#1)(2006-10#5)(2006-2#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-7#1)(2009-2#1)(2010-5#1)(2010-9#1)(2011-1#1)
of these items##3##3##(1996-3#1)(2008-7#2)
of these junctions##2##3##(1993-6#1)(2007-12#1)
of these key variables##2##4##(1991-2#2)
of these key##3##3##(1991-2#2)(2010-8#1)
of these kinases##2##3##(2008-9#1)(2012-12#1)
of these kinetic##3##3##(1990-2#1)(1994-11#1)(1995-8#1)
of these labeled##2##3##(1995-1#1)(1997-3#1)
of these large##3##3##(1992-2#1)(2011-1#1)(2012-3#1)
of these lasers##2##3##(2008-3#2)
of these last##2##3##(2008-10#1)(2008-3#1)
of these latter##4##3##(1996-10#1)(2008-10#1)(2008-7#2)
of these laws##2##3##(1994-12#1)(1996-11#1)
of these lesions and##3##4##(2006-10#1)(2006-2#1)(2010-7#1)
of these lesions are##3##4##(2005-12#1)(2006-5#1)(2007-6#1)
of these lesions has been##2##5##(2007-10#1)(2008-9#1)
of these lesions has##3##4##(2007-10#1)(2008-5#1)(2008-9#1)
of these lesions is##7##4##(1992-4#1)(2006-10#1)(2007-8#2)(2008-7#1)(2009-10#1)(2012-2#1)
of these lesions may##2##4##(2007-12#1)(2010-8#1)
of these lesions##51##3##(1992-2#1)(1992-4#1)(1994-6#1)(1995-2#1)(1996-9#1)(1997-1#4)(2005-12#2)(2005-5#1)(2006-10#3)(2006-2#3)(2006-5#2)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-6#2)(2007-8#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-7#2)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)
of these levels##2##3##(1997-2#1)(2009-8#1)
of these libraries##2##3##(1995-7#1)(2008-5#1)
of these ligands to##2##4##(1993-11#1)(1994-6#1)
of these ligands##6##3##(1990-7#1)(1993-11#1)(1994-11#1)(1994-6#1)(1994-9#1)(2008-3#1)
of these light##2##3##(1991-8#1)(1993-9#1)
of these limitations##4##3##(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)
of these lineages##4##3##(1993-3#1)(1996-3#1)(2008-10#2)
of these lines are##2##4##(1994-3#1)(2008-2#1)
of these lines##4##3##(1994-3#1)(2008-10#2)(2008-2#1)
of these lipids##7##3##(1990-4#1)(1991-7#1)(1992-8#1)(1993-8#1)(1994-3#1)(1996-5#1)(2008-10#1)
of these liposomes##2##3##(1990-2#1)(2008-5#1)
of these local##2##3##(2008-11#1)(2008-3#1)
of these loci on##2##4##(2008-10#1)(2008-5#1)
of these loci##7##3##(1991-6#1)(1992-7#1)(1996-4#1)(2008-10#1)(2008-5#1)(2009-10#1)(2013-8#1)
of these low##2##3##(1995-5#1)(2007-11#1)
of these mRNAs##8##3##(1992-12#1)(1994-6#1)(1994-8#1)(1995-8#1)(1996-12#1)(2004-11#1)(2008-10#1)(2008-7#1)
of these macromolecules##3##3##(1991-10#1)(2005-1#1)(2006-10#1)
of these major##3##3##(1994-12#1)(1995-12#1)(2008-7#1)
of these many##2##3##(1996-3#1)(2008-4#1)
of these markers for the##2##5##(2008-7#1)(2013-1#1)
of these markers have##2##4##(2010-11#1)(2012-2#1)
of these markers in the##2##5##(2006-9#1)(2012-1#1)
of these markers in##5##4##(1991-4#1)(1994-7#1)(2006-9#1)(2008-10#1)(2012-1#1)
of these markers##16##3##(1991-2#1)(1991-4#1)(1994-7#1)(1996-9#1)(2005-10#1)(2006-3#1)(2006-9#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2012-1#1)(2012-2#1)(2013-1#1)
of these materials in##3##4##(2007-11#1)(2008-3#1)(2010-12#1)
of these materials into##2##4##(2008-7#1)(2009-11#1)
of these materials is##2##4##(2008-11#1)(2009-7#1)
of these materials##33##3##(2004-9#2)(2006-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-12#3)(2010-7#2)(2010-8#1)(2011-2#1)(2012-11#3)(2012-2#1)(2012-3#1)(2013-7#1)
of these matrices##2##3##(2008-10#1)(2008-3#1)
of these may##4##3##(1997-1#1)(2006-10#1)(2006-12#1)(2009-5#1)
of these measurements for##2##4##(2008-2#2)
of these measurements##7##3##(2008-2#2)(2008-3#3)(2008-7#1)(2008-9#1)
of these measures to##2##4##(2008-8#1)(2009-10#1)
of these measures was##2##4##(1993-2#1)(2007-12#1)
of these measures with the##2##5##(1990-2#1)(2006-10#1)
of these measures##17##3##(1990-2#1)(1992-11#1)(1992-9#1)(1993-2#2)(1994-3#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-7#1)
of these mechanisms and##2##4##(1994-12#1)(2010-5#1)
of these mechanisms in##2##4##(2011-2#2)
of these mechanisms is##2##4##(1990-2#1)(2008-7#1)
of these mechanisms to##3##4##(2008-10#1)(2008-8#1)(2012-12#1)
of these mechanisms##27##3##(1990-2#1)(1993-12#1)(1993-9#1)(1994-12#1)(1997-4#1)(2006-10#3)(2007-8#1)(2008-1#2)(2008-10#3)(2008-7#1)(2008-8#2)(2009-11#1)(2009-12#1)(2010-11#1)(2010-5#1)(2011-2#4)(2012-1#1)(2012-12#1)
of these media##4##3##(1991-8#1)(1996-6#1)(2012-2#2)
of these mediators##4##3##(1995-10#1)(2006-10#1)(2010-5#1)(2012-12#1)
of these medications are##2##4##(2008-1#1)(2008-8#1)
of these medications##8##3##(2004-12#1)(2006-10#2)(2007-8#1)(2008-1#1)(2008-8#1)(2010-11#1)(2011-2#1)
of these medicinal plants##2##4##(2008-10#1)(2008-4#1)
of these membranes to##2##4##(1991-5#1)(2009-8#1)
of these membranes were##2##4##(1991-9#1)(2005-11#1)
of these membranes##9##3##(1991-11#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-7#1)(2005-11#2)(2008-5#1)(2009-8#1)
of these men##2##3##(2005-10#1)(2008-4#1)
of these mental##2##3##(2012-1#1)(2013-8#1)
of these metabolic##4##3##(1997-4#1)(2006-10#1)(2008-3#1)(2010-4#1)
of these metabolites are##2##4##(2007-11#1)(2010-11#1)
of these metabolites in##2##4##(1994-8#1)(2007-1#1)
of these metabolites##9##3##(1991-5#1)(1994-8#1)(1996-8#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-11#1)(2013-7#1)
of these metagenomes##2##3##(2011-2#1)(2012-2#1)
of these metal ions were##2##5##(2008-10#2)
of these metal ions##17##4##(1997-2#1)(2008-10#14)(2008-5#1)(2010-5#1)
of these metal##18##3##(1997-2#1)(2008-10#14)(2008-5#1)(2010-5#2)
of these metals in the##2##5##(2008-10#1)(2011-1#1)
of these metals in##6##4##(2008-10#4)(2011-1#2)
of these metals was##2##4##(2008-10#2)
of these metals were##2##4##(1997-4#1)(2008-10#1)
of these metals##19##3##(1997-4#1)(2005-4#1)(2006-12#1)(2007-8#1)(2008-10#10)(2008-12#1)(2008-5#1)(2009-6#1)(2011-1#2)
of these methodological##2##3##(1995-9#1)(2011-1#1)
of these methods are##7##4##(1992-1#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-3#1)
of these methods for testing##2##5##(2004-9#1)(2008-9#1)
of these methods for##7##4##(1992-3#1)(1992-6#2)(2004-9#1)(2008-2#1)(2008-9#1)(2010-2#1)
of these methods on##2##4##(2012-3#2)
of these methods to##9##4##(1990-6#1)(1994-9#1)(1996-8#1)(2006-10#1)(2006-2#1)(2006-7#1)(2008-10#1)(2008-8#1)(2009-4#1)
of these methods was##3##4##(1996-12#1)(2008-10#1)(2012-2#1)
of these methods with##4##4##(1992-1#1)(1994-5#1)(2008-2#1)(2010-3#1)
of these methods##61##3##(1990-3#1)(1990-6#1)(1992-1#2)(1992-3#1)(1992-6#3)(1994-5#1)(1994-9#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-6#1)(2004-9#1)(2005-11#1)(2006-10#3)(2006-2#1)(2006-7#1)(2008-10#9)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-2#3)(2012-2#2)(2012-3#4)
of these miRNAs##3##3##(2008-1#1)(2009-8#1)(2013-8#1)
of these mice##4##3##(1993-12#1)(1993-5#1)(1996-9#1)(1997-4#1)
of these microbes##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
of these microorganisms##2##3##(2007-11#1)(2008-10#1)
of these microspheres##2##3##(2009-2#1)(2010-12#1)
of these mixtures##3##3##(1993-8#1)(2004-2#1)(2008-10#1)
of these modalities are##2##4##(1995-5#1)(2008-8#1)
of these modalities##4##3##(1995-5#1)(1996-2#1)(2008-8#1)(2013-1#1)
of these models and##2##4##(2008-2#1)(2013-1#1)
of these models are##4##4##(1996-4#1)(2007-9#1)(2009-5#1)(2011-12#1)
of these models has##2##4##(2007-4#1)(2012-2#1)
of these models in##2##4##(2009-3#1)(2010-5#1)
of these models to##2##4##(2008-8#1)(2012-4#1)
of these models was##2##4##(2008-5#1)(2012-2#1)
of these models##32##3##(1992-2#1)(1993-11#1)(1994-3#1)(1994-8#1)(1995-4#1)(1996-10#1)(1996-4#1)(1997-3#1)(2007-4#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-3#1)(2009-5#1)(2010-5#1)(2010-9#1)(2011-12#1)(2012-2#2)(2012-4#1)(2013-1#1)
of these modes and##2##4##(1993-6#1)(2011-1#1)
of these modes##4##3##(1993-6#1)(1994-12#1)(2007-12#1)(2011-1#1)
of these modifications##6##3##(1990-4#1)(1991-12#1)(1992-3#1)(1997-6#1)(2007-8#1)(2009-5#1)
of these modified##10##3##(1991-4#1)(1996-7#1)(2004-9#1)(2005-11#2)(2008-10#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-3#1)
of these modulatory##2##3##(1995-3#1)(2009-12#1)
of these modules##2##3##(1995-12#1)(2008-3#1)
of these molecular##7##3##(1994-11#1)(2008-1#1)(2008-2#1)(2009-5#1)(2010-11#1)(2012-12#1)(2013-1#1)
of these molecules are##4##4##(1990-3#1)(1994-9#1)(2005-8#1)(2008-4#1)
of these molecules in the##2##5##(2007-5#1)(2007-8#1)
of these molecules in##6##4##(1991-2#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-5#1)(2010-10#1)
of these molecules with##2##4##(2008-10#1)(2009-10#1)
of these molecules##43##3##(1990-3#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-6#1)(1996-4#1)(1996-7#1)(2005-8#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#3)(2008-5#3)(2009-10#1)(2009-6#1)(2010-10#1)(2010-12#1)(2012-12#2)(2013-8#1)
of these monoclonal antibodies##3##4##(1990-3#1)(1992-1#1)(2007-11#1)
of these more##3##3##(2006-5#1)(2007-8#1)(2008-7#1)
of these mothers##3##3##(1991-11#1)(2007-7#1)(2008-2#1)
of these motifs##3##3##(1993-12#1)(1996-10#1)(2008-4#1)
of these multiple##2##3##(2010-7#1)(2013-1#1)
of these muscles##3##3##(2007-7#1)(2007-8#2)
of these mutant##2##3##(1993-3#1)(1996-5#1)
of these mutants to##2##4##(1995-2#1)(2012-11#1)
of these mutants was##2##4##(1994-12#1)(2010-8#1)
of these mutants were##3##4##(1993-11#1)(1995-2#1)(1995-8#1)
of these mutants##19##3##(1990-7#1)(1993-11#1)(1994-10#1)(1994-12#2)(1995-2#2)(1995-8#1)(1996-7#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-8#1)(2008-9#1)(2010-8#1)(2012-11#1)
of these mutational##2##3##(1994-8#1)(2008-5#1)
of these mutations is##2##4##(2008-7#1)(2009-5#1)
of these mutations on##5##4##(1996-7#1)(1997-2#1)(1997-5#1)(2008-11#2)
of these mutations was##2##4##(1991-5#1)(1997-8#1)
of these mutations were##2##4##(1992-11#1)(1993-3#1)
of these mutations##25##3##(1990-8#1)(1991-5#1)(1992-11#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-10#1)(1995-6#1)(1996-11#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2007-9#1)(2008-11#2)(2008-3#1)(2008-7#1)(2009-4#1)(2009-5#1)(2012-3#1)(2013-1#1)
of these nanocrystals##2##3##(2008-10#1)(2009-2#1)
of these nanoparticles##13##3##(2005-11#1)(2008-7#1)(2009-2#2)(2010-6#1)(2011-2#3)(2012-11#4)(2013-1#1)
of these natural##5##3##(1992-3#1)(1993-4#1)(2007-5#1)(2008-11#1)(2009-6#1)
of these neoplasms##4##3##(1990-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
of these nerves may##2##4##(2008-2#2)
of these nerves##5##3##(1992-8#1)(1995-8#1)(2008-2#2)(2011-2#1)
of these networks##5##3##(1991-6#1)(1996-3#1)(2007-12#1)(2008-2#1)(2008-7#1)
of these neuroendocrine##2##3##(1993-4#2)
of these neurological##2##3##(1995-12#1)(2007-7#1)
of these neurons in##2##4##(1991-3#1)(2008-4#1)
of these neurons to##3##4##(1991-3#1)(1992-7#1)(1995-7#1)
of these neurons was##2##4##(1993-12#1)(2009-2#1)
of these neurons were##2##4##(1993-12#1)(1996-3#1)
of these neurons##25##3##(1990-11#1)(1990-5#1)(1990-8#1)(1991-3#2)(1991-8#1)(1992-3#1)(1992-7#1)(1993-12#2)(1994-2#1)(1995-11#1)(1995-12#1)(1995-7#1)(1996-12#2)(1996-3#1)(1996-9#2)(2007-12#1)(2008-11#3)(2008-4#1)(2009-2#1)
of these neuropeptides##2##3##(1990-5#1)(1995-11#1)
of these neurotransmitters in the##2##5##(1992-12#1)(2008-7#1)
of these neurotransmitters##4##3##(1992-12#1)(1995-12#1)(2008-2#1)(2008-7#1)
of these neurotrophins##2##3##(1991-5#1)(1996-3#1)
of these new compounds##2##4##(1996-8#1)(2007-11#1)
of these new drugs##2##4##(2006-10#1)(2006-12#1)
of these new technologies##3##4##(2006-10#1)(2010-7#1)(2012-2#1)
of these new therapeutic##2##4##(1993-2#1)(2010-5#1)
of these new##38##3##(1990-12#1)(1992-7#1)(1993-2#1)(1994-3#2)(1994-8#1)(1996-8#1)(1997-1#1)(1997-4#1)(2006-10#4)(2006-12#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#3)(2008-6#1)(2009-12#1)(2010-12#2)(2010-2#1)(2010-5#3)(2010-7#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)
of these newer agents##3##4##(2004-3#1)(2007-12#1)(2009-3#1)
of these newer##4##3##(1992-2#1)(2004-3#1)(2007-12#1)(2009-3#1)
of these newly recognized##2##4##(2010-5#1)(2010-7#1)
of these newly##3##3##(2010-5#1)(2010-7#1)(2012-12#1)
of these nine##2##3##(1996-3#1)(2008-10#1)
of these noble##2##3##(2007-7#1)(2008-10#1)
of these nociceptors##2##3##(1991-3#1)(2006-7#1)
of these non motor symptoms##2##5##(2012-12#2)
of these non##4##3##(2007-8#1)(2008-1#1)(2012-12#2)
of these novel##17##3##(1994-5#1)(1997-8#1)(2006-12#1)(2008-10#3)(2008-4#1)(2008-7#2)(2009-3#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#2)
of these nuclear oncogenes##2##4##(1991-12#1)(1993-4#1)
of these nuclear##4##3##(1991-12#1)(1993-4#1)(1994-12#1)(2010-7#1)
of these nucleosides##5##3##(1991-8#1)(1992-3#2)(1996-8#1)(1997-5#1)
of these nutrients##2##3##(1993-9#1)(2008-11#1)
of these objects##2##3##(2007-11#1)(2008-3#1)
of these observations are##2##4##(1995-3#1)(2008-8#1)
of these observations for the##2##5##(1996-1#1)(2008-10#1)
of these observations for##5##4##(1994-6#1)(1996-1#1)(2008-10#1)(2009-9#1)(2010-9#1)
of these observations remains to be##2##6##(1990-2#1)(1992-4#1)
of these observations to##4##4##(1990-9#1)(1994-2#1)(2008-7#1)(2011-2#1)
of these observations##24##3##(1990-12#1)(1990-2#1)(1990-9#1)(1992-3#1)(1992-4#1)(1992-7#1)(1994-2#1)(1994-6#1)(1995-10#1)(1995-3#1)(1996-1#1)(1996-2#1)(2005-8#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-9#1)(2010-5#1)(2010-9#1)(2011-2#1)
of these occurred##2##3##(1995-7#1)(2009-8#1)
of these oils##3##3##(2007-1#1)(2007-7#1)(2008-10#1)
of these oligosaccharides##5##3##(1990-7#1)(1991-12#1)(1991-3#1)(2008-12#1)(2012-2#1)
of these operations##3##3##(2007-7#1)(2008-10#1)(2008-3#1)
of these opportunities##2##3##(1992-3#1)(2004-10#1)
of these optical##2##3##(1990-8#1)(2008-2#1)
of these options##7##3##(1997-7#1)(2004-1#1)(2005-11#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)
of these oral##2##3##(2006-8#1)(2009-8#1)
of these organelles##2##3##(1997-6#1)(2008-4#1)
of these organisms in the##3##5##(2007-12#1)(2011-2#2)
of these organisms in##4##4##(2007-12#2)(2011-2#2)
of these organisms is still##3##5##(2006-8#1)(2008-9#1)(2013-7#1)
of these organisms is##4##4##(2006-8#1)(2007-7#1)(2008-9#1)(2013-7#1)
of these organisms##15##3##(2006-10#1)(2006-8#1)(2007-12#2)(2007-7#2)(2008-11#1)(2008-9#3)(2011-2#3)(2012-2#1)(2013-7#1)
of these organizations##3##3##(1992-12#1)(1994-12#1)(1996-3#1)
of these organs##4##3##(1990-11#1)(1990-3#1)(2006-10#1)(2010-11#1)
of these other##3##3##(2007-4#1)(2011-2#1)(2012-3#1)
of these outbreaks##2##3##(1991-6#1)(2008-10#1)
of these outcomes##2##3##(2009-11#1)(2012-3#1)
of these oxides##2##3##(1996-5#1)(2008-10#1)
of these painful##2##3##(1992-5#1)(2008-7#1)
of these papers are tabulated##32##5##(2007-8#32)
of these papers##34##3##(2007-8#32)(2008-1#1)(2008-2#1)
of these parameters are##5##4##(2005-11#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-12#1)
of these parameters as##2##4##(2006-12#1)(2008-3#1)
of these parameters for##2##4##(1992-6#1)(2008-10#1)
of these parameters in##4##4##(1991-12#1)(1993-11#1)(2007-8#1)(2008-10#1)
of these parameters is##2##4##(2008-2#1)(2008-7#1)
of these parameters on the##3##5##(2008-10#1)(2010-4#1)(2011-2#1)
of these parameters on##5##4##(2008-10#3)(2010-4#1)(2011-2#1)
of these parameters##41##3##(1990-5#1)(1991-12#1)(1992-11#1)(1992-6#2)(1992-7#1)(1993-11#1)(1996-8#1)(1997-4#1)(2004-4#1)(2005-11#1)(2005-8#1)(2006-12#1)(2007-10#1)(2007-12#3)(2007-8#1)(2008-10#6)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#2)(2010-12#1)(2010-4#1)(2011-12#1)(2011-2#1)(2013-1#1)
of these parasites were##2##4##(2007-2#1)(2007-7#1)
of these parasites##6##3##(2007-12#1)(2007-2#1)(2007-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
of these participants##5##3##(2008-5#1)(2010-2#1)(2010-8#1)(2013-1#2)
of these particles in##2##4##(2006-12#1)(2013-7#1)
of these particles on##2##4##(2008-10#1)(2010-7#1)
of these particles##5##3##(2006-12#1)(2008-10#2)(2010-7#1)(2013-7#1)
of these pathogens are##2##4##(2008-10#2)
of these pathogens##13##3##(1995-5#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#7)(2012-3#1)
of these pathologies##4##3##(2006-2#1)(2008-1#1)(2011-1#1)(2012-2#1)
of these pathways are##2##4##(2006-10#1)(2007-11#1)
of these pathways is##2##4##(1995-12#1)(2012-3#1)
of these pathways##15##3##(1995-11#1)(1995-12#1)(1996-2#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-5#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
of these patients a##2##4##(2008-6#1)(2012-3#1)
of these patients also##3##4##(2006-6#1)(2007-2#1)(2008-7#1)
of these patients and##8##4##(1991-6#1)(2005-1#1)(2007-10#1)(2007-9#1)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#1)
of these patients are also##2##5##(2008-2#1)(2011-1#1)
of these patients are##10##4##(1990-9#1)(1997-8#1)(2006-10#1)(2007-3#1)(2008-2#1)(2008-4#1)(2008-8#2)(2011-1#1)(2013-1#1)
of these patients as compared##2##5##(2006-10#1)(2008-7#1)
of these patients as##3##4##(2006-10#1)(2008-7#1)(2012-3#1)
of these patients can be##2##5##(1997-3#1)(2007-3#1)
of these patients develop regional or distant metastases##2##8##(2008-10#1)(2008-8#1)
of these patients developed##2##4##(2006-10#1)(2012-2#1)
of these patients die##2##4##(2013-8#2)
of these patients had a##2##5##(2007-10#1)(2007-7#1)
of these patients had an##3##5##(1992-2#1)(2006-10#1)(2012-3#1)
of these patients had been##3##5##(1990-12#1)(2007-8#1)(2011-1#1)
of these patients had##16##4##(1990-12#1)(1991-4#1)(1992-2#1)(1995-2#1)(1997-5#1)(2006-10#1)(2006-8#1)(2007-10#2)(2007-7#1)(2007-8#2)(2008-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
of these patients has##5##4##(1991-12#1)(1993-10#1)(2007-7#1)(2007-9#1)(2008-7#1)
of these patients have been##2##5##(1994-3#1)(2011-1#1)
of these patients have##4##4##(1994-3#1)(2006-10#1)(2007-1#1)(2011-1#1)
of these patients in##3##4##(1992-5#1)(2006-1#1)(2013-1#1)
of these patients is##11##4##(1990-9#1)(2006-10#3)(2006-12#2)(2006-2#1)(2007-8#2)(2009-12#1)(2012-2#1)
of these patients lived##2##4##(1993-7#1)(2013-1#1)
of these patients may##3##4##(2008-1#1)(2008-3#1)(2011-1#1)
of these patients presented##2##4##(1990-5#1)(2013-7#1)
of these patients received##3##4##(1993-1#1)(2006-9#1)(2007-11#1)
of these patients required##4##4##(1992-2#1)(2007-7#1)(2008-6#1)(2012-2#1)
of these patients requires##3##4##(2005-8#2)(2007-9#1)
of these patients showed##2##4##(2008-1#1)(2010-9#1)
of these patients subsequently##2##4##(2007-2#1)(2008-9#1)
of these patients the##3##4##(2006-10#1)(2007-11#1)(2007-7#1)
of these patients to##4##4##(2007-8#1)(2008-3#1)(2010-6#1)(2011-2#1)
of these patients underwent##2##4##(2005-5#1)(2010-12#1)
of these patients was##8##4##(1991-3#1)(1993-8#1)(2006-9#1)(2007-7#2)(2008-7#1)(2012-2#1)(2012-3#1)
of these patients were reviewed##4##5##(2006-10#1)(2007-7#1)(2007-8#1)(2011-12#1)
of these patients were##24##4##(1990-4#1)(1990-8#1)(1991-2#1)(1993-8#1)(1994-2#1)(1994-9#1)(1996-9#1)(1997-7#1)(2004-1#1)(2004-10#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-7#1)(2008-9#2)(2011-12#1)(2013-1#2)
of these patients who had##2##5##(2004-1#1)(2006-1#1)
of these patients who##3##4##(2004-1#1)(2006-1#1)(2007-7#1)
of these patients will##5##4##(2006-10#1)(2007-10#1)(2007-8#1)(2010-11#1)(2012-1#1)
of these patients with##4##4##(2007-8#1)(2009-6#1)(2012-12#1)(2012-3#1)
of these patients##278##3##(1990-10#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-8#2)(1990-9#2)(1991-12#1)(1991-2#4)(1991-3#1)(1991-4#2)(1991-6#4)(1991-8#1)(1992-12#1)(1992-2#2)(1992-5#2)(1992-8#1)(1993-1#2)(1993-10#1)(1993-2#2)(1993-7#2)(1993-8#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-2#2)(1995-5#1)(1995-9#1)(1996-1#1)(1996-3#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#3)(2004-1#2)(2004-10#1)(2005-1#1)(2005-11#1)(2005-12#2)(2005-5#1)(2005-8#2)(2005-9#2)(2006-1#4)(2006-10#17)(2006-12#3)(2006-2#3)(2006-4#1)(2006-6#5)(2006-7#1)(2006-8#4)(2006-9#3)(2007-1#1)(2007-10#6)(2007-11#13)(2007-2#3)(2007-3#2)(2007-5#1)(2007-7#13)(2007-8#13)(2007-9#4)(2008-1#6)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#5)(2008-5#1)(2008-6#6)(2008-7#8)(2008-8#4)(2008-9#7)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#9)(2011-12#2)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#8)(2012-3#5)(2013-1#8)(2013-7#1)(2013-8#3)
of these patterns on the##2##5##(2008-2#1)(2008-3#1)
of these patterns on##3##4##(2008-2#1)(2008-3#1)(2009-4#1)
of these patterns##9##3##(1994-2#1)(2006-9#1)(2008-10#1)(2008-2#3)(2008-3#2)(2009-4#1)
of these peaks##6##3##(1990-5#2)(1996-9#1)(2008-10#1)(2008-9#1)(2009-6#1)
of these people##7##3##(2004-8#1)(2007-1#1)(2007-11#1)(2007-9#1)(2008-1#1)(2012-12#1)(2013-8#1)
of these peptide##2##3##(1996-11#1)(2008-7#1)
of these peptides have been##2##5##(1993-6#2)
of these peptides in##2##4##(1990-10#1)(2009-6#1)
of these peptides on the##2##5##(1996-5#1)(1997-7#1)
of these peptides on##4##4##(1996-12#2)(1996-5#1)(1997-7#1)
of these peptides to the##2##5##(1990-4#1)(1992-9#1)
of these peptides to##5##4##(1990-4#1)(1991-2#1)(1992-9#1)(1994-11#1)(2008-10#1)
of these peptides##36##3##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#2)(1990-4#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-9#2)(1992-11#1)(1992-9#1)(1993-3#1)(1993-6#2)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-12#2)(1996-5#2)(1996-8#1)(1997-3#1)(1997-7#1)(2006-1#1)(2006-10#1)(2008-10#1)(2009-6#1)(2011-2#1)
of these persons##6##3##(1991-11#1)(1993-9#2)(1994-2#1)(2012-2#2)
of these pesticides##6##3##(2007-3#1)(2007-8#1)(2008-10#4)
of these phages##2##3##(1994-12#2)
of these pharmacological##3##3##(1993-2#1)(2008-5#1)(2009-4#1)
of these phase##2##3##(2007-11#1)(2008-3#1)
of these phases##2##3##(2005-8#1)(2013-8#1)
of these phenomena##9##3##(1991-1#1)(1991-12#1)(1997-2#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-7#1)(2008-8#1)
of these phenotypes##3##3##(1994-11#1)(2008-8#1)(2013-1#1)
of these phosphatidylcholines##2##3##(1990-7#1)(1991-4#1)
of these plans##3##3##(2007-4#1)(2008-1#1)(2008-12#1)
of these plant##2##3##(2008-10#1)(2009-3#1)
of these plants##7##3##(2007-6#1)(2008-10#4)(2009-8#1)(2010-3#1)
of these plasmids##6##3##(1990-4#1)(1991-7#1)(1991-8#1)(1994-9#1)(2008-5#2)
of these points##2##3##(2007-5#1)(2008-3#1)
of these polarization##2##3##(2008-2#1)(2008-3#1)
of these policies##5##3##(1993-3#1)(1997-7#1)(2007-4#1)(2008-5#1)(2008-7#1)
of these pollutants in the environment##2##6##(2008-10#1)(2011-1#1)
of these pollutants in the##3##5##(2007-10#1)(2008-10#1)(2011-1#1)
of these pollutants##4##3##(2007-10#1)(2008-10#2)(2011-1#1)
of these polymer##2##3##(2007-12#1)(2008-10#1)
of these polymers##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
of these polymorphic##3##3##(1996-11#1)(2008-9#1)(2013-8#1)
of these polymorphisms##7##3##(2008-10#1)(2008-12#1)(2008-4#1)(2010-12#1)(2010-2#1)(2012-12#2)
of these polypeptides##2##3##(1992-4#1)(2008-11#1)
of these populations and##2##4##(2007-3#1)(2008-1#1)
of these populations are##3##4##(2006-2#1)(2008-10#1)(2008-8#1)
of these populations changed##2##4##(2008-10#2)
of these populations##15##3##(2006-2#1)(2007-3#1)(2008-1#1)(2008-10#6)(2008-4#1)(2008-8#1)(2009-10#1)(2012-3#2)(2012-7#1)
of these potential##3##3##(1992-3#1)(2007-8#1)(2008-1#1)
of these potentially##2##3##(1995-12#1)(2011-2#1)
of these precursors##2##3##(2008-12#1)(2013-1#1)
of these predictions##4##3##(2008-11#1)(2008-3#2)(2008-7#1)
of these pregnancies##3##3##(1991-4#1)(1992-1#1)(2006-8#1)
of these preliminary##4##3##(1995-2#1)(2006-4#1)(2008-3#1)(2011-2#1)
of these preparations##4##3##(1991-3#1)(1991-9#1)(2010-2#1)(2011-1#1)
of these presentations##4##3##(1994-7#1)(1997-7#1)(2006-11#1)(2008-1#1)
of these previous##2##3##(2008-8#1)(2009-3#1)
of these primers##2##3##(2008-10#2)
of these principles##4##3##(2006-10#1)(2006-3#1)(2007-11#1)(2008-4#1)
of these probes was##3##4##(1990-2#1)(1990-3#1)(2008-3#1)
of these probes##7##3##(1990-2#1)(1990-3#1)(1990-4#2)(2008-10#1)(2008-3#1)(2008-9#1)
of these problems are discussed in an interactive case presentation##3##10##(2006-12#2)(2008-1#1)
of these problems are##4##4##(1996-9#1)(2006-12#2)(2008-1#1)
of these problems in##2##4##(2007-8#1)(2008-8#1)
of these problems##24##3##(1990-6#1)(1993-5#1)(1994-12#1)(1995-9#1)(1996-1#1)(1996-9#1)(2004-2#1)(2005-8#1)(2006-12#2)(2006-3#2)(2007-10#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-3#1)(2012-12#1)
of these procedures are##2##4##(2006-7#1)(2008-10#1)
of these procedures##18##3##(1991-6#1)(1991-8#1)(1993-12#1)(1994-12#1)(2006-10#2)(2006-7#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-3#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-2#1)
of these processes are##4##4##(2006-3#1)(2008-10#2)(2008-8#1)
of these processes in##4##4##(1996-5#1)(2006-9#1)(2010-11#1)(2012-2#1)
of these processes is##4##4##(2007-8#1)(2008-10#1)(2011-2#1)(2012-2#1)
of these processes may##2##4##(2008-11#1)(2008-5#1)
of these processes##39##3##(1990-11#1)(1990-4#1)(1992-1#1)(1992-3#1)(1994-8#1)(1996-5#1)(1997-5#1)(2005-5#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-3#1)(2009-8#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
of these products is##3##4##(1993-11#1)(2008-10#2)
of these products to##2##4##(2008-10#1)(2008-6#1)
of these products##28##3##(1991-2#1)(1993-11#1)(1997-3#2)(2005-11#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-4#1)(2012-2#2)
of these profiles##5##3##(1993-3#1)(1996-8#1)(1997-8#1)(2008-10#1)(2008-3#1)
of these programs are##2##4##(1991-4#1)(2013-1#1)
of these programs##17##3##(1990-12#1)(1991-4#1)(1995-1#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-3#2)(2012-12#1)(2013-1#4)
of these projects##2##3##(2008-10#1)(2008-8#1)
of these promoters##3##3##(1995-2#1)(1997-4#1)(2006-12#1)
of these properties##12##3##(1991-12#1)(1994-8#1)(1996-6#1)(2007-6#1)(2007-9#1)(2008-5#1)(2008-7#2)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
of these prophylactic##2##3##(2007-11#1)(2009-3#1)
of these proteases##3##3##(1990-7#1)(1994-6#1)(2012-3#1)
of these protective##2##3##(1994-6#1)(2013-1#1)
of these protein kinases##2##4##(1993-11#1)(1994-12#1)
of these protein##6##3##(1990-5#1)(1993-11#1)(1994-12#1)(2008-10#1)(2008-11#1)(2009-6#1)
of these proteins and##2##4##(1991-2#1)(1992-12#1)
of these proteins are##3##4##(1993-2#1)(2008-7#1)(2009-8#1)
of these proteins by##3##4##(1994-9#1)(1995-3#1)(2007-12#1)
of these proteins during##2##4##(1993-5#1)(2012-12#1)
of these proteins have been##2##5##(1997-7#1)(2005-7#1)
of these proteins identified##2##4##(2008-10#1)(2013-1#1)
of these proteins in the##4##5##(1990-11#1)(2006-12#1)(2007-10#1)(2013-8#1)
of these proteins in##15##4##(1990-11#1)(1993-6#1)(1994-10#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-8#1)(2006-12#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-8#1)(2013-1#1)(2013-8#1)
of these proteins is##6##4##(1993-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#1)(2012-2#1)
of these proteins may##3##4##(1994-8#1)(2005-12#1)(2011-2#1)
of these proteins result in##2##5##(2007-11#1)(2013-1#1)
of these proteins showed##2##4##(1990-11#1)(1997-4#1)
of these proteins to##2##4##(1994-11#1)(1996-12#1)
of these proteins was##3##4##(1994-12#1)(1997-3#1)(2009-10#1)
of these proteins were##3##4##(1991-3#1)(1994-12#1)(1995-6#1)
of these proteins##96##3##(1990-1#1)(1990-10#1)(1990-11#3)(1990-3#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-1#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#2)(1993-8#1)(1994-10#2)(1994-11#1)(1994-12#2)(1994-3#2)(1994-8#2)(1994-9#5)(1995-1#1)(1995-10#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#2)(2005-12#1)(2005-7#1)(2006-12#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#2)(2009-10#2)(2009-5#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#5)(2013-8#2)
of these protocols##5##3##(1994-3#1)(2008-4#3)(2008-9#1)
of these proved to be##2##5##(1995-3#1)(2007-8#1)
of these providers##2##3##(1997-1#1)(1997-2#1)
of these publications##2##3##(2010-8#1)(2011-2#1)
of these pumps##4##3##(1990-8#1)(2011-2#3)
of these purified##2##3##(1990-7#1)(1994-6#1)
of these purposes##2##3##(1992-10#1)(2008-9#1)
of these putative##6##3##(1990-7#1)(1993-3#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-11#1)
of these questions##11##3##(1991-11#1)(1991-3#1)(1995-11#1)(1995-5#1)(2005-10#1)(2006-10#2)(2008-7#2)(2010-7#1)(2011-12#1)
of these rare##10##3##(1993-11#1)(2007-2#1)(2007-5#1)(2007-7#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
of these rates##2##3##(2007-8#1)(2008-7#1)
of these reactions are##2##4##(2008-5#1)(2010-8#1)
of these reactions is##2##4##(1994-9#1)(2008-7#1)
of these reactions##10##3##(1994-9#1)(1995-6#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2010-8#1)
of these reactive##2##3##(1990-2#1)(2008-3#1)
of these reagents##6##3##(1990-12#1)(1995-5#1)(2008-10#1)(2008-4#2)(2008-9#1)
of these recent##4##3##(1991-11#1)(2007-6#1)(2008-2#1)(2008-3#1)
of these receptor##2##3##(1996-2#1)(2006-10#1)
of these receptors and##2##4##(1993-2#1)(2008-5#1)
of these receptors are##2##4##(1993-2#1)(2012-1#1)
of these receptors by##2##4##(1993-6#1)(1997-4#1)
of these receptors in##5##4##(1994-8#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-11#1)
of these receptors on##2##4##(1992-9#1)(1996-12#1)
of these receptors##38##3##(1990-3#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#2)(1995-3#1)(1995-5#2)(1996-12#3)(1996-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-10#2)(2006-3#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2012-1#1)
of these recombinant##3##3##(1990-10#1)(2007-11#1)(2008-10#1)
of these recommendations##4##3##(1994-2#1)(2007-2#1)(2008-6#2)
of these reference##3##3##(2008-10#2)(2008-2#1)
of these regions are##2##4##(1993-6#1)(2008-3#1)
of these regions of##2##4##(1992-11#1)(1994-10#1)
of these regions##18##3##(1991-10#1)(1991-8#1)(1992-11#1)(1992-9#2)(1993-6#1)(1993-8#2)(1994-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#2)(2008-3#1)(2009-4#1)(2010-5#1)
of these regulatory##3##3##(1993-12#1)(2008-11#1)(2011-2#1)
of these relationships##8##3##(1993-12#2)(2008-10#1)(2008-8#1)(2009-8#2)(2010-12#1)(2010-2#1)
of these relatively##2##3##(1992-7#1)(2008-10#1)
of these repeat##2##3##(1995-11#1)(2008-7#1)
of these repeats are##2##4##(1993-9#2)
of these repeats##7##3##(1992-1#1)(1992-10#1)(1993-9#2)(2007-6#1)(2008-10#1)(2008-7#1)
of these reported##2##3##(2009-5#1)(2011-2#1)
of these reports##5##3##(2005-7#1)(2007-7#1)(2010-3#1)(2013-1#1)(2013-8#1)
of these requirements##2##3##(2008-3#1)(2009-1#1)
of these research##2##3##(2008-9#1)(2011-1#1)
of these researches##2##3##(1991-9#1)(2011-3#1)
of these residues in the##3##5##(1990-5#1)(1993-8#1)(1995-5#1)
of these residues to##2##4##(1993-4#1)(1997-2#1)
of these residues##17##3##(1990-5#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-4#2)(1993-4#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-5#1)(1997-2#2)(1997-3#1)(2012-12#1)
of these resonances##2##3##(2007-11#1)(2007-8#1)
of these resources##2##3##(2008-7#1)(2013-7#1)
of these responses##8##3##(1991-8#1)(1992-10#1)(1994-12#1)(1994-9#1)(2007-4#1)(2008-10#2)(2008-7#1)
of these results and the##2##5##(1990-9#1)(2008-10#1)
of these results and##5##4##(1990-9#1)(1992-6#1)(2008-10#1)(2008-3#1)(2009-8#1)
of these results are discussed##5##5##(1991-12#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-2#1)
of these results are##7##4##(1991-12#1)(1991-5#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)
of these results for the##4##5##(1994-1#1)(1996-2#1)(1997-1#1)(2008-10#1)
of these results for##13##4##(1990-6#1)(1991-5#1)(1994-1#1)(1994-2#1)(1995-4#1)(1996-2#1)(1997-1#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-8#1)
of these results in terms of##2##6##(2007-12#1)(2013-8#1)
of these results in##5##4##(2007-12#1)(2008-10#1)(2008-2#1)(2013-1#1)(2013-8#1)
of these results is that##2##5##(2005-11#1)(2006-9#1)
of these results is##8##4##(1993-8#1)(1995-2#1)(2005-11#1)(2006-9#1)(2007-12#1)(2008-3#1)(2010-3#1)(2011-2#1)
of these results to the##2##5##(2007-11#1)(2008-3#1)
of these results to##6##4##(1995-3#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-9#1)
of these results were##2##4##(1991-12#1)(2012-12#1)
of these results with##4##4##(1993-12#1)(1993-2#1)(1995-2#1)(2008-12#1)
of these results##93##3##(1990-12#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-12#2)(1991-5#2)(1991-7#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-3#2)(1995-4#2)(1995-5#1)(1995-6#1)(1996-10#1)(1996-2#1)(1997-1#1)(1997-2#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#1)(2011-2#4)(2012-12#2)(2013-1#2)(2013-8#1)
of these risk factors##9##4##(2005-10#1)(2005-11#1)(2008-1#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-6#1)(2011-1#1)
of these risk##10##3##(2005-10#1)(2005-11#1)(2008-1#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-6#1)(2011-1#1)(2012-2#1)
of these roles##3##3##(2008-12#1)(2010-5#1)(2011-1#1)
of these ruptures##3##3##(2006-3#1)(2007-7#2)
of these same##12##3##(1990-5#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-1#2)(1995-3#1)(1996-4#1)(1996-5#1)(2008-10#1)(2008-2#1)(2009-4#1)
of these samples in##2##4##(2008-10#1)(2010-12#1)
of these samples is##2##4##(2008-2#1)(2008-3#1)
of these samples was##3##4##(2008-10#2)(2011-1#1)
of these samples##18##3##(1994-8#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-4#2)(2011-1#1)(2013-1#1)
of these satellite##2##3##(2008-10#1)(2013-8#1)
of these screening tests##2##4##(2007-2#1)(2007-4#1)
of these seaweeds revealed##2##4##(2008-11#2)
of these secondary##6##3##(1991-10#1)(1991-5#1)(1997-3#1)(2006-10#1)(2007-11#1)(2008-5#1)
of these seedlings##2##3##(2007-3#1)(2008-10#1)
of these seizures##3##3##(1996-3#1)(2008-8#1)(2009-9#1)
of these sensitive##2##3##(2006-10#1)(2008-4#1)
of these sensors were##2##4##(2008-10#2)
of these sensors##7##3##(2008-10#5)(2008-7#1)(2010-4#1)
of these sensory##2##3##(1994-5#1)(2007-12#1)
of these sequence##2##3##(1994-11#1)(1995-3#1)
of these sequences in##2##4##(1990-12#1)(1994-12#1)
of these sequences to##3##4##(1991-1#1)(1991-12#1)(2008-10#1)
of these sequences with##2##4##(1990-11#1)(1993-6#1)
of these sequences##16##3##(1990-11#1)(1990-12#1)(1991-1#2)(1991-12#1)(1991-3#1)(1991-7#2)(1993-6#1)(1994-12#1)(1995-1#1)(1995-4#1)(2008-10#4)
of these sera##2##3##(1991-9#1)(1995-2#1)
of these services were##2##4##(1994-1#1)(2012-12#1)
of these services##15##3##(1994-1#3)(1995-2#1)(1997-8#1)(2005-5#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-2#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-3#1)
of these sets##2##3##(2008-3#1)(2010-9#1)
of these settings##2##3##(1991-1#1)(2009-2#1)
of these seven##3##3##(1991-12#1)(2005-9#1)(2006-9#1)
of these showed a##2##4##(1993-5#1)(2013-8#1)
of these side effects##3##4##(1991-6#1)(2004-3#1)(2007-7#1)
of these side##4##3##(1991-6#1)(1994-3#1)(2004-3#1)(2007-7#1)
of these signaling pathways##2##4##(2008-4#1)(2008-9#1)
of these signaling##4##3##(2008-4#1)(2008-9#1)(2009-4#1)(2009-9#1)
of these signals##7##3##(1991-7#1)(1994-9#1)(2008-10#1)(2008-4#1)(2009-3#1)(2012-1#1)(2012-3#1)
of these significant##2##3##(2008-3#1)(2010-4#1)
of these signs##4##3##(2006-12#2)(2007-7#1)(2008-1#1)
of these simulations##4##3##(1993-11#1)(2006-2#1)(2008-3#2)
of these single##2##3##(1993-7#1)(2008-10#1)
of these sites are##3##4##(1994-12#1)(1994-9#1)(1996-7#1)
of these sites for##2##4##(1990-7#1)(1996-3#1)
of these sites is##2##4##(1990-5#1)(1993-6#1)
of these sites to the##2##5##(1990-3#1)(1994-8#1)
of these sites was kinetically ordered##2##6##(1995-2#2)
of these sites was##3##4##(1995-2#2)(2007-2#1)
of these sites##31##3##(1990-3#1)(1990-5#1)(1990-7#1)(1992-6#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-2#3)(1995-8#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-8#2)(2007-2#1)(2012-2#2)(2013-7#1)
of these six##5##3##(1991-3#1)(1994-6#1)(1996-6#1)(1996-8#1)(2010-4#1)
of these small##4##3##(1992-11#1)(1996-8#1)(2007-8#1)(2008-2#1)
of these so-called##2##3##(2005-11#1)(2008-4#1)
of these solutions##3##3##(1997-4#1)(2008-12#1)(2008-2#1)
of these sources##6##3##(2008-1#1)(2008-10#1)(2008-4#1)(2009-2#1)(2010-9#1)(2012-2#1)
of these special##2##3##(2008-12#1)(2008-2#1)
of these species and##2##4##(2008-10#1)(2008-5#1)
of these species are##4##4##(2007-12#1)(2007-3#1)(2008-5#1)(2008-9#1)
of these species in the##3##5##(1997-5#1)(2008-10#1)(2008-5#1)
of these species in##5##4##(1997-5#1)(2008-10#2)(2008-5#1)(2010-8#1)
of these species is##4##4##(1997-2#1)(2008-10#1)(2008-5#1)(2008-9#1)
of these species##43##3##(1991-9#2)(1993-3#1)(1994-8#1)(1995-8#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-7#1)(2004-11#1)(2004-4#1)(2006-5#1)(2007-12#2)(2007-3#2)(2008-10#12)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#2)(2009-2#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#1)
of these specific##6##3##(1993-3#1)(1994-2#1)(1996-5#1)(2008-11#1)(2009-5#1)(2010-8#1)
of these specimens##3##3##(1997-1#1)(2007-2#1)(2012-2#1)
of these spectra##2##3##(2008-10#2)
of these spectral##2##3##(1995-5#1)(2008-3#1)
of these stable##2##3##(1994-10#1)(2013-8#1)
of these stages##2##3##(2008-10#1)(2013-8#1)
of these state##2##3##(1997-2#1)(2008-2#1)
of these states##3##3##(1991-6#1)(2006-11#1)(2012-2#1)
of these steps##4##3##(1992-6#1)(2008-1#1)(2008-9#1)(2011-2#1)
of these steroids into##2##4##(1990-2#1)(2012-3#1)
of these steroids##8##3##(1990-11#1)(1990-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(2008-9#1)(2012-3#1)
of these stimuli##2##3##(1991-7#1)(2008-10#1)
of these strains as##2##4##(1993-5#1)(2008-10#1)
of these strains was##5##4##(1993-3#1)(1996-9#1)(2008-10#2)(2008-4#1)
of these strains were##5##4##(1993-5#1)(2008-10#2)(2008-5#2)
of these strains##27##3##(1990-3#1)(1993-12#1)(1993-3#1)(1993-5#2)(1995-8#1)(1996-9#1)(2005-11#1)(2006-5#1)(2008-10#9)(2008-4#2)(2008-5#3)(2008-8#1)(2009-6#1)(2010-9#1)(2012-3#1)
of these strategies are##2##4##(1995-8#1)(2008-11#1)
of these strategies have been##2##5##(2006-10#1)(2007-8#1)
of these strategies##12##3##(1991-6#1)(1995-8#1)(1996-2#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-1#2)(2013-8#1)
of these strokes##2##3##(2007-10#2)
of these structural##2##3##(1992-8#1)(1995-6#1)
of these structures in##4##4##(1993-7#1)(2009-12#1)(2011-2#1)(2012-2#1)
of these structures to##3##4##(1991-11#1)(2007-12#2)
of these structures##26##3##(1990-12#1)(1991-1#1)(1991-11#2)(1991-2#1)(1992-11#1)(1993-7#2)(2006-11#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-2#2)(2011-2#2)(2012-2#1)(2013-8#1)
of these students##2##3##(2008-11#1)(2013-8#1)
of these studies and##4##4##(2005-7#1)(2006-10#1)(2008-10#1)(2008-11#1)
of these studies are##6##4##(1991-9#1)(1993-4#1)(2006-9#1)(2007-8#1)(2008-7#1)(2012-1#1)
of these studies has##2##4##(1993-7#1)(2008-3#1)
of these studies have been##2##5##(2008-5#1)(2008-7#1)
of these studies have##3##4##(2006-6#1)(2008-5#1)(2008-7#1)
of these studies in##3##4##(1995-3#1)(2006-12#1)(2010-12#1)
of these studies indicate that##3##5##(1991-9#1)(2006-12#1)(2008-4#1)
of these studies is##4##4##(2005-11#1)(2008-10#1)(2008-7#1)(2009-6#1)
of these studies was to compare the##2##7##(2008-3#2)
of these studies was to##4##5##(1995-1#1)(2008-10#1)(2008-3#2)
of these studies was##8##4##(1992-11#1)(1994-10#1)(1994-11#1)(1995-1#1)(2008-10#1)(2008-3#2)(2009-8#1)
of these studies were##2##4##(2008-5#1)(2009-11#1)
of these studies with##2##4##(1990-12#1)(2006-8#1)
of these studies##92##3##(1990-12#1)(1991-9#2)(1992-11#3)(1992-7#1)(1993-11#2)(1993-3#1)(1993-4#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-1#1)(1995-3#1)(1995-9#1)(1996-2#2)(1996-8#1)(1997-4#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#2)(2006-3#1)(2006-5#2)(2006-6#1)(2006-8#1)(2006-9#2)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-2#3)(2012-1#3)(2012-12#2)(2012-2#2)(2013-1#2)
of these subjects had##2##4##(1994-3#1)(2008-10#1)
of these subjects##8##3##(1991-10#1)(1994-3#1)(1995-5#1)(2006-10#1)(2008-10#1)(2008-5#1)(2012-2#2)
of these sublines##2##3##(2008-11#2)
of these subpopulations##3##3##(2008-11#1)(2008-4#2)
of these substances are##2##4##(1995-9#1)(2009-7#1)
of these substances for##2##4##(1990-4#1)(1996-3#1)
of these substances from##2##4##(1991-10#1)(2007-10#1)
of these substances have##2##4##(2007-11#1)(2008-7#1)
of these substances in##3##4##(1991-11#1)(2005-10#1)(2008-10#1)
of these substances##26##3##(1990-3#1)(1990-4#1)(1991-10#1)(1991-11#1)(1991-9#1)(1994-3#1)(1994-8#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-3#1)(2005-10#1)(2006-12#1)(2006-8#1)(2007-10#2)(2007-11#2)(2008-10#2)(2008-5#2)(2008-7#1)(2009-7#1)(2010-12#1)
of these substitutions on##4##4##(1994-8#1)(1995-2#1)(1995-8#1)(1997-3#1)
of these substitutions##5##3##(1990-8#1)(1994-8#1)(1995-2#1)(1995-8#1)(1997-3#1)
of these substrates##7##3##(1991-9#1)(1994-8#1)(1996-5#2)(1997-7#1)(2008-11#1)(2008-6#1)
of these subunits##3##3##(1993-11#1)(1993-6#1)(1995-12#1)
of these sunscreens##2##3##(2008-5#2)
of these suppressors##3##3##(1996-9#1)(1997-2#2)
of these surfaces##4##3##(2008-2#1)(2008-3#1)(2010-4#1)(2013-1#1)
of these surfactants##3##3##(1992-1#1)(2005-11#1)(2008-10#1)
of these surgical procedures##2##4##(2006-6#1)(2008-9#1)
of these symmetries##2##3##(2008-3#1)(2010-8#1)
of these symptoms and the##2##5##(2006-12#1)(2007-11#1)
of these symptoms and##3##4##(2006-12#2)(2007-11#1)
of these symptoms in##3##4##(2007-11#1)(2008-6#1)(2011-2#1)
of these symptoms##17##3##(1991-8#1)(1996-4#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-3#1)(2006-6#2)(2007-11#3)(2007-12#1)(2008-2#1)(2008-6#1)(2011-2#1)(2012-2#1)
of these syndromes is##2##4##(1995-12#1)(2010-7#1)
of these syndromes##9##3##(1995-12#1)(1996-11#1)(1996-6#1)(2007-6#1)(2008-10#1)(2009-12#2)(2010-7#1)(2012-2#1)
of these synthetic##3##3##(1993-8#1)(2008-5#1)(2008-6#1)
of these systems and##4##4##(2004-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
of these systems are compared##2##5##(2008-3#1)(2011-2#1)
of these systems are##5##4##(1991-6#1)(1994-12#1)(2005-7#1)(2008-3#1)(2011-2#1)
of these systems can##2##4##(1996-2#1)(2007-12#1)
of these systems in a##2##5##(2008-3#2)
of these systems in##4##4##(1994-1#1)(2008-3#2)(2008-8#1)
of these systems is##2##4##(2008-11#1)(2011-7#1)
of these systems should##2##4##(1997-6#1)(2008-10#1)
of these systems to##2##4##(1991-6#1)(2008-3#1)
of these systems##55##3##(1990-12#1)(1991-6#2)(1994-1#1)(1994-12#2)(1994-2#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-3#1)(1997-6#1)(2004-9#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-12#1)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#7)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-2#1)(2012-3#4)
of these targeted##3##3##(2010-10#1)(2010-2#1)(2013-1#1)
of these targets##3##3##(2008-1#1)(2008-7#1)(2009-12#1)
of these tasks##4##3##(2006-4#2)(2013-1#2)
of these teams##2##3##(2008-2#1)(2010-5#1)
of these techniques are discussed##2##5##(2006-12#1)(2008-3#1)
of these techniques are##5##4##(1991-3#1)(1991-9#1)(2006-12#1)(2008-3#1)(2010-6#1)
of these techniques for##3##4##(1991-10#1)(2008-8#1)(2013-1#1)
of these techniques has been##2##5##(2009-5#1)(2009-8#1)
of these techniques has##3##4##(2008-1#1)(2009-5#1)(2009-8#1)
of these techniques in the research##2##6##(2007-9#1)(2008-11#1)
of these techniques in the##5##5##(2005-8#1)(2007-9#1)(2008-11#2)(2012-2#1)
of these techniques in##10##4##(2005-8#1)(2006-10#3)(2007-12#1)(2007-9#1)(2008-11#2)(2012-2#1)(2012-3#1)
of these techniques is##7##4##(1994-11#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-11#1)(2012-2#1)
of these techniques to##6##4##(2006-7#1)(2007-12#1)(2008-3#2)(2008-8#1)(2010-9#1)
of these techniques##54##3##(1991-10#1)(1991-3#1)(1991-9#1)(1993-6#1)(1994-11#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-5#1)(2006-7#2)(2006-9#1)(2007-12#2)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-3#5)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-6#1)(2010-9#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
of these technologies##7##3##(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-1#1)(2010-7#1)
of these terms##4##3##(2008-2#1)(2008-7#1)(2013-1#2)
of these test##3##3##(2006-8#1)(2008-10#1)(2008-4#1)
of these tests and##2##4##(1993-1#1)(2012-2#1)
of these tests in the##2##5##(1996-9#1)(2006-10#1)
of these tests provided##2##4##(1997-2#1)(2008-10#1)
of these tests##26##3##(1993-1#1)(1995-2#1)(1996-9#1)(1997-2#1)(2005-9#1)(2006-10#2)(2006-11#2)(2006-2#1)(2006-8#2)(2007-11#1)(2007-4#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2010-3#1)(2011-2#3)(2012-2#1)
of these the##2##3##(1994-8#1)(2008-7#1)
of these theoretical##2##3##(2008-2#1)(2010-3#1)
of these theories##3##3##(2007-8#1)(2008-2#1)(2010-7#1)
of these therapeutic##4##3##(2006-2#1)(2008-5#1)(2008-8#1)(2009-7#1)
of these therapies##6##3##(1990-9#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-7#1)(2009-8#1)
of these there##2##3##(1990-10#1)(1996-8#1)
of these three clinical##2##4##(1996-8#1)(2007-7#1)
of these three compounds##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
of these three indexes##2##4##(2012-2#2)
of these three parameters##2##4##(2008-10#1)(2013-8#1)
of these three species##3##4##(2004-11#1)(2008-10#1)(2011-12#1)
of these three types of##2##5##(1995-11#1)(2008-7#1)
of these three##62##3##(1990-10#1)(1990-11#1)(1991-1#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-7#1)(1993-3#1)(1993-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#2)(1995-8#1)(1996-1#1)(1996-3#1)(1996-8#1)(1997-2#1)(2004-11#1)(2005-12#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-12#1)(2012-2#4)(2012-3#1)(2013-8#2)
of these tissues to##3##4##(1994-9#1)(2008-6#1)(2013-1#1)
of these tissues##9##3##(1990-11#1)(1990-4#1)(1991-10#1)(1993-7#1)(1994-9#1)(1995-8#1)(2008-6#1)(2009-7#1)(2013-1#1)
of these to##4##3##(2008-1#1)(2008-8#1)(2012-12#2)
of these tools is##2##4##(2008-10#1)(2011-2#1)
of these tools to##2##4##(2008-12#1)(2011-2#1)
of these tools##8##3##(1997-8#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#2)(2012-3#1)
of these toxic##2##3##(2007-10#1)(2007-11#1)
of these toxins##2##3##(2008-10#1)(2008-5#1)
of these trajectories##2##3##(2008-7#1)(2009-9#1)
of these transcription factors##3##4##(1993-12#1)(2008-9#1)(2012-3#1)
of these transcription##4##3##(1993-12#1)(2008-9#1)(2011-2#1)(2012-3#1)
of these transcripts with##2##4##(1990-8#1)(2008-4#1)
of these transcripts##4##3##(1990-8#1)(2008-10#1)(2008-4#1)(2008-8#1)
of these transgenic lines##2##4##(2006-12#1)(2008-10#1)
of these transgenic##4##3##(1997-7#1)(2006-12#1)(2008-10#2)
of these transiently expressed##2##4##(2008-9#1)(2012-2#1)
of these transitions##2##3##(2007-12#1)(2009-12#1)
of these transport##2##3##(1990-12#1)(2011-2#1)
of these transporters in##2##4##(2008-7#1)(2012-12#1)
of these transporters##6##3##(1991-9#1)(1992-8#1)(2008-7#3)(2012-12#1)
of these treatments##12##3##(1990-5#1)(2006-2#1)(2006-6#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-1#1)(2011-12#1)(2012-12#2)
of these trends##2##3##(1997-2#1)(2008-8#1)
of these trials were##2##4##(2009-9#1)(2012-12#1)
of these trials##12##3##(1991-12#1)(1995-2#1)(1996-11#1)(1997-4#1)(2005-11#1)(2007-4#1)(2007-9#1)(2008-11#1)(2009-3#1)(2009-9#1)(2010-6#1)(2012-12#1)
of these tumor##3##3##(1990-12#1)(1992-9#1)(2006-10#1)
of these tumors and should##2##5##(2007-12#1)(2013-8#1)
of these tumors and##6##4##(1992-5#1)(1993-6#1)(2006-12#1)(2007-12#2)(2013-8#1)
of these tumors are##3##4##(1996-10#1)(2005-5#1)(2006-12#1)
of these tumors has##2##4##(2006-12#1)(2013-1#1)
of these tumors is##2##4##(2007-6#1)(2010-12#1)
of these tumors##40##3##(1990-10#1)(1991-1#1)(1991-8#1)(1991-9#1)(1992-5#1)(1993-10#1)(1993-6#1)(1995-2#1)(1996-10#1)(1997-1#1)(2005-10#1)(2005-5#2)(2006-1#1)(2006-10#2)(2006-12#4)(2006-5#1)(2007-12#2)(2007-6#2)(2010-12#1)(2010-7#1)(2010-9#3)(2011-2#3)(2012-12#3)(2013-1#3)(2013-8#1)
of these tumour##2##3##(2005-12#1)(2012-2#1)
of these tumours is##2##4##(2009-2#1)(2012-12#1)
of these tumours##9##3##(1993-11#1)(1997-3#1)(2008-6#1)(2008-7#1)(2009-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
of these two agents##2##4##(2008-10#1)(2008-8#1)
of these two amino##2##4##(1990-11#1)(2008-10#1)
of these two approaches##4##4##(2007-10#1)(2008-10#1)(2008-2#1)(2008-4#1)
of these two cell types is##2##6##(1990-5#1)(2012-12#1)
of these two cell types##3##5##(1990-5#1)(1997-4#1)(2012-12#1)
of these two competing##2##4##(1991-3#1)(2005-11#1)
of these two complexes##2##4##(1997-7#1)(2008-5#1)
of these two components##3##4##(1994-12#1)(2008-3#1)(2012-12#1)
of these two compounds##3##4##(1991-9#1)(1996-6#1)(2008-5#1)
of these two conditions##4##4##(1992-11#1)(2007-4#1)(2007-8#1)(2010-4#1)
of these two different##2##4##(1996-7#1)(2006-10#1)
of these two diseases##3##4##(1991-10#1)(2006-10#1)(2008-10#1)
of these two disorders##3##4##(2009-7#1)(2012-2#1)(2012-3#1)
of these two distinct##3##4##(2005-8#1)(2006-2#1)(2008-7#1)
of these two drugs##4##4##(1991-9#1)(1993-8#1)(1995-12#1)(1996-1#1)
of these two effects##2##4##(1996-9#1)(2007-12#1)
of these two elements##2##4##(1994-6#1)(2005-10#1)
of these two enzymes##3##4##(1990-6#1)(1995-10#1)(2005-11#1)
of these two factors##4##4##(1992-12#1)(1992-5#1)(1993-4#1)(2008-10#1)
of these two forms##3##4##(1994-11#1)(1996-8#1)(2007-7#1)
of these two genera##3##4##(2008-10#3)
of these two genes are##2##5##(1990-9#1)(2008-4#1)
of these two genes was##2##5##(1991-9#1)(2008-1#1)
of these two genes##8##4##(1990-9#1)(1991-5#1)(1991-9#1)(1994-11#1)(1996-7#1)(2008-1#1)(2008-4#1)(2010-3#1)
of these two groups##2##4##(2007-9#1)(2008-7#1)
of these two herbicides##2##4##(2006-5#1)(2008-10#1)
of these two herbs on##2##5##(1992-2#2)
of these two hypotheses##2##4##(2008-2#1)(2009-8#1)
of these two isolates##2##4##(2008-10#2)
of these two kinds of##2##5##(1995-9#1)(2012-3#1)
of these two methods##3##4##(1995-9#1)(1996-5#1)(2009-3#1)
of these two molecules##3##4##(1993-11#1)(2010-10#1)(2011-1#1)
of these two parameters##4##4##(1992-6#1)(2005-11#1)(2007-2#1)(2008-7#1)
of these two patients##2##4##(2006-10#1)(2007-7#1)
of these two peptides##2##4##(1990-5#1)(1992-9#1)
of these two populations of##2##5##(1995-11#1)(2008-11#1)
of these two populations##3##4##(1995-11#1)(2008-11#1)(2009-9#1)
of these two procedures##2##4##(2009-12#2)
of these two processes##2##4##(2009-2#1)(2009-8#1)
of these two proteins in##4##5##(1992-12#1)(1994-3#1)(1994-5#1)(1996-1#1)
of these two proteins were##3##5##(2005-11#2)(2008-5#1)
of these two proteins##10##4##(1990-7#1)(1992-12#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-3#1)(1996-1#1)(2005-11#2)(2008-5#1)
of these two receptors##2##4##(1992-1#1)(2012-2#1)
of these two regions##2##4##(1997-6#1)(2008-10#1)
of these two residues##2##4##(1990-12#1)(1996-5#1)
of these two sets of##2##5##(1992-6#1)(1992-7#1)
of these two signals##2##4##(2008-3#2)
of these two species##8##4##(1995-8#2)(2006-11#1)(2006-5#1)(2007-1#1)(2008-10#1)(2008-5#1)(2012-11#1)
of these two techniques##3##4##(1992-2#1)(2007-12#1)(2011-1#1)
of these two treatments##2##4##(2007-11#1)(2013-1#1)
of these two types of##8##5##(1990-7#1)(1995-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-2#1)(2012-3#1)
of these two variables##2##4##(2007-2#1)(2013-8#1)
of these two viruses##2##4##(2007-6#1)(2008-10#1)
of these two##255##3##(1990-11#2)(1990-12#1)(1990-5#2)(1990-6#1)(1990-7#4)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-5#3)(1991-9#4)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#4)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#2)(1992-9#2)(1993-11#2)(1993-4#1)(1993-8#1)(1994-11#3)(1994-12#2)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-8#2)(1995-9#2)(1996-1#4)(1996-12#1)(1996-2#1)(1996-4#2)(1996-5#3)(1996-6#1)(1996-7#3)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-9#1)(2003-11#1)(2004-11#1)(2004-3#1)(2005-10#1)(2005-11#7)(2005-8#2)(2006-10#4)(2006-11#2)(2006-2#1)(2006-3#1)(2006-5#2)(2007-1#2)(2007-10#2)(2007-11#2)(2007-12#4)(2007-2#4)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#24)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#7)(2008-4#3)(2008-5#9)(2008-7#7)(2008-8#3)(2009-10#2)(2009-12#4)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#5)(2013-8#2)
of these type##2##3##(1991-3#1)(2008-10#1)
of these types of##7##4##(1991-1#1)(1991-11#1)(1993-2#1)(2007-9#1)(2008-7#1)(2010-5#1)(2013-8#1)
of these uncertainties##2##3##(2008-10#1)(2009-11#1)
of these unique##6##3##(1997-2#1)(2006-10#2)(2006-3#1)(2007-11#1)(2012-2#1)
of these units was##2##4##(1991-6#1)(1994-9#1)
of these units##5##3##(1991-6#2)(1994-9#1)(2008-10#1)(2013-1#1)
of these uses##2##3##(1991-5#1)(2007-2#1)
of these vaccines##2##3##(2008-3#1)(2011-2#1)
of these values was##2##4##(2007-1#1)(2008-3#1)
of these values with##2##4##(1995-8#1)(2008-3#1)
of these values##14##3##(1990-5#1)(1995-10#1)(1995-8#2)(2006-4#1)(2007-1#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#1)(2009-4#1)
of these variables in##5##4##(1991-6#1)(1994-8#1)(1996-12#1)(2006-6#1)(2007-2#1)
of these variables were##2##4##(1993-8#1)(2013-1#1)
of these variables##19##3##(1991-6#1)(1993-2#1)(1993-8#1)(1994-8#1)(1996-12#1)(1997-5#1)(2004-10#1)(2004-12#1)(2006-6#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#2)(2011-2#1)(2013-1#1)
of these variants##7##3##(1992-9#1)(1995-6#2)(1996-3#1)(2007-7#1)(2009-3#1)(2010-2#1)
of these variations are##2##4##(1997-2#1)(2007-10#1)
of these variations##7##3##(1993-1#1)(1997-2#1)(2007-10#1)(2008-7#1)(2008-9#1)(2010-9#1)(2013-1#1)
of these various##8##3##(1990-9#1)(1992-6#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-9#1)(2011-2#1)
of these vectors##7##3##(1990-3#1)(1991-7#1)(1993-12#1)(1993-2#1)(1994-5#1)(1996-10#1)(2007-6#1)
of these virulence##2##3##(2010-12#1)(2011-1#1)
of these viruses in the##2##5##(2006-10#1)(2008-10#1)
of these viruses##14##3##(1995-2#1)(1995-6#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-10#7)(2009-12#1)(2013-8#1)
of these was##8##3##(1990-12#1)(2004-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-12#2)(2013-8#1)
of these waves is##2##4##(2007-12#1)(2008-3#1)
of these waves##3##3##(1991-3#1)(2007-12#1)(2008-3#1)
of these were found to##2##5##(1997-2#1)(2007-9#1)
of these were from##2##4##(2008-5#1)(2013-7#1)
of these were further##2##4##(2008-10#1)(2008-7#1)
of these were treated##2##4##(1997-3#1)(1997-4#1)
of these were##48##3##(1990-5#2)(1991-2#1)(1991-4#1)(1991-8#1)(1992-4#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-3#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-10#1)(2005-11#1)(2005-9#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-12#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
of these will##4##3##(1992-2#1)(2007-11#1)(2008-11#1)(2009-1#1)
of these women had##2##4##(1990-12#1)(2011-2#1)
of these women##14##3##(1990-12#1)(1991-8#1)(1991-9#1)(1995-5#1)(1996-12#1)(1997-7#1)(2004-1#1)(2008-1#1)(2008-5#1)(2009-9#1)(2011-2#2)(2012-3#2)
of these works##3##3##(2007-2#1)(2010-11#1)(2013-7#1)
of these years##2##3##(2009-2#1)(2011-2#1)
of these yeasts##3##3##(1997-4#1)(2008-5#1)(2013-1#1)
of these young people##4##4##(2006-1#1)(2007-3#2)(2009-5#1)
of these##7728##2##(1990-1#3)(1990-10#16)(1990-11#29)(1990-12#49)(1990-2#25)(1990-3#26)(1990-4#18)(1990-5#39)(1990-6#14)(1990-7#34)(1990-8#29)(1990-9#18)(1991-1#17)(1991-10#18)(1991-11#22)(1991-12#47)(1991-2#36)(1991-3#32)(1991-4#16)(1991-5#36)(1991-6#26)(1991-7#20)(1991-8#26)(1991-9#42)(1992-1#23)(1992-10#9)(1992-11#28)(1992-12#31)(1992-2#20)(1992-3#31)(1992-4#16)(1992-5#17)(1992-6#37)(1992-7#20)(1992-8#22)(1992-9#30)(1993-1#12)(1993-10#4)(1993-11#42)(1993-12#43)(1993-2#27)(1993-3#28)(1993-4#18)(1993-5#14)(1993-6#32)(1993-7#13)(1993-8#32)(1993-9#27)(1994-1#8)(1994-10#12)(1994-11#39)(1994-12#46)(1994-2#34)(1994-3#39)(1994-4#3)(1994-5#18)(1994-6#35)(1994-7#5)(1994-8#43)(1994-9#46)(1995-1#32)(1995-10#14)(1995-11#30)(1995-12#35)(1995-2#49)(1995-3#51)(1995-4#5)(1995-5#33)(1995-6#29)(1995-7#6)(1995-8#33)(1995-9#17)(1996-1#20)(1996-10#16)(1996-11#23)(1996-12#33)(1996-2#29)(1996-3#33)(1996-4#25)(1996-5#43)(1996-6#22)(1996-7#18)(1996-8#32)(1996-9#27)(1997-1#33)(1997-2#47)(1997-3#36)(1997-4#39)(1997-5#16)(1997-6#20)(1997-7#36)(1997-8#38)(1997-9#2)(2003-11#2)(2004-1#5)(2004-10#6)(2004-11#9)(2004-12#8)(2004-2#6)(2004-3#7)(2004-4#4)(2004-8#1)(2004-9#8)(2005-1#2)(2005-10#24)(2005-11#65)(2005-12#17)(2005-4#7)(2005-5#9)(2005-6#1)(2005-7#23)(2005-8#32)(2005-9#11)(2006-1#11)(2006-10#177)(2006-11#26)(2006-12#86)(2006-2#25)(2006-3#17)(2006-4#14)(2006-5#29)(2006-6#23)(2006-7#25)(2006-8#37)(2006-9#33)(2007-1#18)(2007-10#49)(2007-11#152)(2007-12#128)(2007-2#50)(2007-3#22)(2007-4#31)(2007-5#22)(2007-6#29)(2007-7#79)(2007-8#120)(2007-9#39)(2008-1#95)(2008-10#684)(2008-11#166)(2008-12#48)(2008-2#148)(2008-3#183)(2008-4#156)(2008-5#178)(2008-6#60)(2008-7#186)(2008-8#122)(2008-9#109)(2009-1#5)(2009-10#41)(2009-11#18)(2009-12#34)(2009-2#27)(2009-3#38)(2009-4#28)(2009-5#35)(2009-6#14)(2009-7#20)(2009-8#42)(2009-9#33)(2010-1#14)(2010-10#17)(2010-11#35)(2010-12#58)(2010-2#46)(2010-3#29)(2010-4#36)(2010-5#37)(2010-6#17)(2010-7#29)(2010-8#28)(2010-9#30)(2011-1#82)(2011-10#1)(2011-12#18)(2011-2#159)(2011-3#6)(2011-7#1)(2012-1#50)(2012-11#23)(2012-12#110)(2012-2#138)(2012-3#64)(2012-4#1)(2012-7#3)(2013-1#167)(2013-7#35)(2013-8#71)
of theses##5##2##(1997-1#1)(2008-2#2)(2012-3#1)(2013-1#1)
of theta phase precession in##2##5##(2008-11#2)
of theta phase precession##3##4##(2008-11#3)
of theta##8##2##(1997-8#1)(2005-11#2)(2007-12#1)(2008-11#3)(2008-8#1)
of thetwo##2##2##(2008-2#2)
of thiabendazole##3##2##(2007-8#3)
of thiacetazone##2##2##(1992-2#1)(1995-5#1)
of thiamine and benfotiamine##2##4##(2012-4#2)
of thiamine and##5##3##(1995-1#2)(1997-5#1)(2012-4#2)
of thiamine nutrition##2##3##(1990-11#1)(1995-1#1)
of thiamine with##2##3##(2008-10#2)
of thiamine##30##2##(1990-11#2)(1990-9#1)(1991-5#1)(1995-1#6)(1996-9#1)(1997-5#3)(2006-4#1)(2008-1#3)(2008-10#10)(2012-4#2)
of thiazide##2##2##(1995-6#1)(1996-9#1)
of thiazides##3##2##(1993-8#2)(1995-6#1)
of thiazolidinediones##3##2##(2008-1#1)(2008-3#1)(2010-10#1)
of thick##14##2##(1997-2#1)(1997-3#1)(2004-2#1)(2007-12#1)(2008-10#3)(2008-2#4)(2008-3#2)(2010-4#1)
of thickened##2##2##(1997-2#1)(2010-12#1)
of thickening of the##2##4##(2007-11#1)(2008-7#1)
of thickness and##2##3##(2008-3#2)
of thickness##6##2##(2006-4#1)(2007-10#1)(2008-2#2)(2008-3#2)
of thickness-modulated designs are##2##4##(2008-2#1)(2008-3#1)
of thienorphine metabolism##2##3##(2011-3#2)
of thienorphine##9##2##(2011-3#9)
of thigh in##2##3##(2006-1#1)(2012-12#1)
of thigh##5##2##(2006-1#1)(2007-11#1)(2008-5#2)(2012-12#1)
of thigmotaxis##2##2##(1994-3#2)
of thin Al2O3 films##2##4##(2008-3#2)
of thin absorbing films##6##4##(2008-2#2)(2008-3#4)
of thin and##2##3##(2008-2#1)(2008-7#1)
of thin clouds##2##3##(2008-3#2)
of thin films and multilayer##2##5##(2008-2#1)(2008-3#1)
of thin films from##2##4##(2008-2#2)
of thin films of##3##4##(2007-8#1)(2008-2#1)(2008-3#1)
of thin films using##2##4##(2006-5#1)(2008-2#1)
of thin films##23##3##(2006-5#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-2#11)(2008-3#6)(2009-2#1)
of thin layer chromatography##2##4##(1997-3#1)(2005-10#1)
of thin layers##3##3##(2006-12#1)(2008-10#2)
of thin lines##2##3##(2008-2#2)
of thin liquid films##3##4##(2008-10#1)(2008-3#2)
of thin polymer films##2##4##(2006-5#2)
of thin sections##2##3##(2005-12#1)(2008-10#1)
of thin##87##2##(1992-2#1)(1997-2#1)(1997-3#1)(1997-7#2)(2004-2#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-12#2)(2006-5#3)(2007-11#2)(2007-12#7)(2007-3#1)(2007-8#2)(2008-1#2)(2008-10#11)(2008-11#1)(2008-2#19)(2008-3#22)(2008-7#1)(2009-2#1)(2009-4#1)(2009-7#2)(2010-11#1)
of thin-film materials##2##3##(2007-11#1)(2008-3#1)
of thin-film##14##2##(2006-12#1)(2006-5#1)(2007-11#2)(2008-10#2)(2008-2#2)(2008-3#6)
of things to come##2##4##(2008-7#1)(2009-5#1)
of things to##3##3##(1995-2#1)(2008-7#1)(2009-5#1)
of things##5##2##(1995-2#1)(2008-7#1)(2009-5#1)(2012-3#2)
of thinking about crisis##2##4##(2008-2#2)
of thinking about##7##3##(1992-1#1)(2006-5#1)(2008-2#2)(2008-6#1)(2010-5#1)(2013-8#1)
of thinking that##2##3##(2007-12#1)(2012-12#1)
of thinking##23##2##(1992-1#1)(1993-6#1)(1994-12#1)(1995-5#1)(2006-5#1)(2006-9#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
of thinness##3##2##(2007-12#3)
of thinning##3##2##(2008-3#2)(2009-2#1)
of thiobarbiturates##2##2##(2008-6#2)
of thiobarbituric acid reactive substances (TBARS)##6##6##(1995-3#2)(1997-8#1)(2004-12#1)(2011-2#1)(2013-8#1)
of thiobarbituric acid reactive substances in##2##6##(1992-3#1)(1992-8#1)
of thiobarbituric acid reactive substances##10##5##(1992-3#2)(1992-8#1)(1995-3#2)(1997-8#1)(2004-12#1)(2008-4#1)(2011-2#1)(2013-8#1)
of thiobarbituric acid reactive##11##4##(1992-3#2)(1992-8#1)(1995-3#2)(1997-8#1)(2004-12#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
of thiobarbituric acid##13##3##(1992-3#2)(1992-8#1)(1995-3#2)(1997-8#1)(2004-12#1)(2007-3#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
of thiobarbituric acid-reactive substances##5##4##(1991-7#1)(1994-3#1)(1995-12#3)
of thiobarbituric##18##2##(1991-7#1)(1992-3#2)(1992-8#1)(1994-3#1)(1995-12#3)(1995-3#2)(1997-8#1)(2004-12#1)(2007-3#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
of thiocyanate in##3##3##(2008-10#3)
of thiocyanate##14##2##(1992-9#1)(1995-11#1)(2006-8#1)(2008-10#11)
of thiocyanato-complexes##2##2##(2008-10#2)
of thiocytosine##2##2##(2008-10#2)
of thiodicarb by reversed-phase high performance liquid##2##7##(2005-3#2)
of thioethers##2##2##(1994-8#1)(2008-11#1)
of thiol compounds##2##3##(1992-8#1)(2008-10#1)
of thiol groups##4##3##(1991-9#1)(1992-3#1)(1993-3#1)(1994-9#1)
of thiol oxidation##2##3##(2008-5#2)
of thiol##18##2##(1991-9#3)(1992-11#1)(1992-3#1)(1992-8#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-5#1)(2008-10#4)(2008-3#1)(2008-5#2)(2010-11#1)
of thiol-containing##3##2##(1991-9#2)(2008-10#1)
of thiol-ene##2##2##(2008-7#1)(2010-12#1)
of thiolic proteins##2##3##(2008-10#2)
of thiols and ascorbate##2##4##(1997-8#2)
of thiols and##3##3##(1997-8#2)(2008-10#1)
of thiols at##2##3##(2008-10#2)
of thiols in##4##3##(1995-5#1)(1997-2#1)(2008-10#2)
of thiols##18##2##(1990-8#2)(1991-9#1)(1995-5#1)(1995-6#1)(1997-2#1)(1997-8#2)(2007-11#1)(2008-10#6)(2009-9#1)(2010-11#2)
of thiopental##3##2##(1990-12#1)(1996-10#1)(2012-12#1)
of thioperamide##5##2##(1992-5#1)(1993-3#4)
of thiophene##2##2##(2008-10#1)(2010-4#1)
of thiopurine drugs##3##3##(1994-11#1)(2008-8#2)
of thiopurine##5##2##(1994-11#1)(2008-8#3)(2013-1#1)
of thioredoxin fusion proteins##2##4##(2008-4#2)
of thioredoxin stability to##2##4##(1991-7#2)
of thioredoxin##9##2##(1991-7#3)(1993-11#1)(2008-4#3)(2009-10#2)
of thioredoxins##2##2##(2009-10#2)
of thiorphan##2##2##(1996-2#2)
of thiosulfate or##3##3##(1993-3#2)(2006-8#1)
of thiosulfate##8##2##(1993-3#2)(2006-5#1)(2006-8#2)(2008-10#3)
of thiotetronic##2##2##(2006-5#2)
of thiourea B13 analogues was##2##5##(2011-2#2)
of thiourea##11##2##(1995-12#1)(2005-4#2)(2007-11#1)(2008-10#5)(2011-2#2)
of thioxanthones##3##2##(2012-3#3)
of thiram##3##2##(2008-10#3)
of third and##2##3##(2006-5#1)(2008-7#1)
of third generation##3##3##(1995-9#1)(1996-11#1)(2007-7#1)
of third molar removal##2##4##(2007-12#2)
of third molar surgery##3##4##(2007-12#3)
of third molar##6##3##(2007-12#6)
of third molars is##2##4##(2007-12#2)
of third molars##4##3##(1993-1#1)(2007-12#3)
of third parties##2##3##(1992-3#1)(2006-8#1)
of third trimester##2##3##(1996-4#1)(2004-10#1)
of third ventricular##2##3##(2006-8#1)(2011-1#1)
of third ventriculostomy in##2##4##(2006-5#2)
of third##35##2##(1992-1#1)(1992-3#1)(1993-1#1)(1994-12#1)(1994-3#1)(1995-9#1)(1996-11#1)(1996-4#1)(1997-4#1)(2004-10#1)(2005-7#1)(2006-5#3)(2006-8#2)(2007-1#1)(2007-12#9)(2007-7#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-4#1)(2011-1#2)(2013-1#2)
of third-generation synchrotron##2##3##(2006-5#1)(2008-2#1)
of third-generation##3##2##(2006-5#2)(2008-2#1)
of third-harmonic generation (THG)##2##4##(2007-11#1)(2008-3#1)
of third-harmonic generation##4##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)
of third-harmonic##5##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#2)
of third-order##8##2##(2007-11#2)(2007-12#5)(2008-2#1)
of third-space fluid shift##2##4##(2005-8#2)
of thirteen##11##2##(1995-6#1)(1997-2#1)(2007-10#2)(2008-4#1)(2008-7#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
of thirty##6##2##(1994-2#1)(2006-8#1)(2007-10#1)(2007-5#1)(2008-5#1)(2011-1#1)
of this &quot##12##3##(1990-8#2)(1994-8#1)(1997-3#1)(2006-7#1)(2008-1#1)(2008-10#2)(2009-4#1)(2012-12#1)(2012-2#1)(2013-8#1)
of this 1##2##3##(1991-2#1)(2008-10#1)
of this 3-year##2##3##(2007-8#1)(2008-10#1)
of this AHRA membership survey reports on information relating to staff utilization in##2##13##(1994-1#1)(1994-2#1)
of this ATPase##3##3##(1991-9#1)(1996-11#1)(1996-9#1)
of this Ca2+##2##3##(1992-8#1)(1993-9#1)
of this DNA fragment##2##4##(1991-9#1)(2007-9#1)
of this DNA##9##3##(1990-5#1)(1991-7#1)(1991-9#1)(1994-11#1)(1997-4#1)(2007-9#1)(2008-4#2)(2008-5#1)
of this EDF system##2##4##(2008-2#2)
of this OPO##2##3##(2007-12#2)
of this Program##3##3##(2007-3#1)(2008-9#2)
of this RNA##4##3##(1990-5#1)(1991-9#1)(1992-8#1)(2008-10#1)
of this a##2##3##(2004-7#1)(2008-3#1)
of this aberration##2##3##(2008-10#1)(2008-6#1)
of this ability##2##3##(1990-11#1)(2008-5#1)
of this abnormality##3##3##(1994-2#1)(2007-9#1)(2010-8#1)
of this action##3##3##(1991-10#1)(1996-10#1)(2006-5#1)
of this activation##3##3##(1993-12#1)(1995-11#1)(2013-8#1)
of this active##2##3##(1991-7#1)(1992-1#1)
of this activity was##2##4##(1996-10#1)(1997-8#1)
of this activity##12##3##(1990-5#1)(1991-2#1)(1993-4#1)(1994-1#1)(1996-10#1)(1997-8#1)(2005-8#1)(2006-2#1)(2008-11#1)(2008-12#1)(2012-12#1)(2012-3#1)
of this actual##2##3##(1997-2#1)(2012-12#1)
of this adhesion##2##3##(1993-6#1)(2008-10#1)
of this adjunct therapy##2##4##(2009-7#2)
of this advanced##2##3##(1995-9#1)(2010-12#1)
of this adverse##3##3##(1995-5#1)(1996-4#1)(2007-8#1)
of this age##8##3##(1990-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-4#1)(2009-7#1)(2010-8#1)(2011-1#1)
of this agent in##4##4##(1990-6#1)(1995-12#1)(2007-10#1)(2009-9#1)
of this agent is##2##4##(1993-2#1)(2005-7#1)
of this agent on##2##4##(1994-12#1)(1994-3#1)
of this agent were evaluated##2##5##(2008-4#1)(2012-1#1)
of this agent##21##3##(1990-6#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-12#1)(2005-7#2)(2006-1#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#2)(2009-2#1)(2009-9#1)(2012-1#1)(2012-2#1)(2013-8#1)
of this aggressive##3##3##(2008-12#1)(2012-12#2)
of this algorithm##6##3##(2007-11#1)(2008-2#2)(2008-3#2)(2013-8#1)
of this allele##3##3##(2007-2#1)(2010-12#1)(2011-1#1)
of this alpha##2##3##(1990-12#1)(1995-11#1)
of this amino acid##5##4##(1992-6#3)(1995-8#1)(2008-3#1)
of this analysis indicate that the##2##6##(1994-3#1)(1997-5#1)
of this analysis is##3##4##(1994-11#1)(1995-12#1)(2008-12#1)
of this analysis to##3##4##(1992-3#1)(2008-10#1)(2008-2#1)
of this analysis were##3##4##(2007-5#1)(2007-7#1)(2008-11#1)
of this analysis##30##3##(1990-4#1)(1991-12#1)(1991-9#1)(1992-3#1)(1994-11#2)(1994-3#1)(1995-12#1)(1997-3#1)(1997-5#1)(2006-7#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-6#1)(2009-2#2)(2011-2#1)(2012-2#1)(2013-7#1)
of this analyte##2##3##(2008-10#2)
of this analytical##4##3##(1991-5#1)(2008-10#2)(2010-5#1)
of this anatomic##2##3##(2011-12#1)(2013-1#1)
of this and other studies##2##5##(1995-11#1)(2005-11#1)
of this and other##7##4##(1995-11#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
of this and similar##3##4##(2008-6#1)(2011-1#1)(2011-2#1)
of this and the##2##4##(1994-2#1)(2007-4#1)
of this and##13##3##(1994-2#1)(1995-11#1)(1996-7#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2011-1#1)(2011-2#1)
of this annual##4##3##(2005-8#2)(2010-11#1)(2010-2#1)
of this anomaly##2##3##(1991-9#1)(1993-9#1)
of this antibody##5##3##(1990-10#1)(1991-2#1)(1991-3#1)(1994-8#1)(2006-10#1)
of this antigen##3##3##(1992-4#1)(1995-5#1)(2007-2#1)
of this apparently##3##3##(1996-5#1)(1997-1#1)(2008-10#1)
of this appeal##2##3##(1991-1#1)(2013-8#1)
of this approach are discussed##2##5##(1993-2#1)(2006-6#1)
of this approach are##11##4##(1993-2#1)(2006-6#1)(2007-10#1)(2008-10#2)(2008-2#3)(2010-11#1)(2010-12#1)(2010-2#1)
of this approach for##5##4##(1994-5#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-8#1)
of this approach has##4##4##(2007-5#1)(2007-6#1)(2007-8#1)(2013-1#1)
of this approach in the##2##5##(2008-5#1)(2012-11#1)
of this approach in##5##4##(2006-6#1)(2006-9#1)(2008-5#1)(2010-5#1)(2012-11#1)
of this approach include##2##4##(1992-4#1)(2004-2#1)
of this approach is demonstrated##2##5##(2008-3#1)(2010-8#1)
of this approach is limited##2##5##(2008-3#1)(2012-3#1)
of this approach is that it##3##6##(2008-2#1)(2008-4#1)(2012-1#1)
of this approach is that the##3##6##(2008-4#1)(2008-9#1)(2012-1#1)
of this approach is that##8##5##(2008-2#1)(2008-4#2)(2008-9#1)(2009-2#1)(2010-7#1)(2012-1#2)
of this approach is to##3##5##(1997-2#1)(2010-2#1)(2012-3#1)
of this approach is##20##4##(1992-3#1)(1997-2#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-2#1)(2010-7#1)(2010-8#1)(2012-1#2)(2012-3#3)
of this approach that##2##4##(2008-5#1)(2012-12#1)
of this approach to##8##4##(1993-11#1)(1996-12#1)(2005-12#1)(2007-12#2)(2008-11#1)(2008-2#2)
of this approach was demonstrated##2##5##(1996-12#1)(2013-1#1)
of this approach was##7##4##(1996-12#1)(2008-10#4)(2009-8#1)(2013-1#1)
of this approach we##3##4##(2007-12#1)(2008-3#2)
of this approach##106##3##(1992-3#1)(1992-4#1)(1993-11#1)(1993-2#1)(1994-2#2)(1994-5#1)(1996-1#1)(1996-12#2)(1997-2#2)(1997-3#1)(1997-6#1)(2004-2#1)(2005-12#1)(2006-2#1)(2006-6#2)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#8)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#11)(2008-3#6)(2008-4#4)(2008-5#2)(2008-7#3)(2008-9#2)(2009-2#2)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#1)(2012-1#3)(2012-11#1)(2012-12#1)(2012-3#4)(2013-1#4)(2013-8#1)
of this approximately##2##3##(1997-6#1)(2010-5#1)
of this are discussed##3##4##(2008-10#1)(2008-5#1)(2008-7#1)
of this area##15##3##(1993-2#1)(1995-5#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-7#1)(2008-9#2)(2010-11#1)(2011-2#1)(2013-8#2)
of this arrangement##3##3##(1996-2#1)(2008-11#1)(2010-12#1)
of this arrhythmia##6##3##(1996-4#2)(2006-10#1)(2007-8#1)(2007-9#1)(2011-2#1)
of this article are to describe##3##6##(2012-12#2)(2013-1#1)
of this article are to provide##2##6##(2007-2#1)(2011-1#1)
of this article are to##6##5##(2006-9#1)(2007-2#1)(2011-1#1)(2012-12#2)(2013-1#1)
of this article examines##2##4##(1995-1#1)(2012-12#1)
of this article is to assess the##4##7##(1995-12#1)(2007-7#1)(2011-2#1)(2013-1#1)
of this article is to assess##5##6##(1995-12#1)(2007-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
of this article is to describe a##3##7##(2007-11#1)(2008-12#1)(2011-2#1)
of this article is to describe the process##2##8##(2009-9#1)(2012-1#1)
of this article is to describe the##11##7##(1994-1#1)(2006-10#2)(2007-11#1)(2008-12#1)(2008-5#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)
of this article is to describe##23##6##(1994-1#1)(1994-4#1)(2006-10#2)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-12#2)(2008-5#1)(2009-10#1)(2009-9#1)(2010-2#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)
of this article is to discuss the##3##7##(2006-9#1)(2007-7#1)(2008-7#1)
of this article is to discuss##6##6##(1995-1#1)(1996-2#1)(2006-9#2)(2007-7#1)(2008-7#1)
of this article is to emphasize##2##6##(1994-11#1)(2010-4#1)
of this article is to examine##2##6##(2005-10#1)(2008-1#1)
of this article is to explain##3##6##(2007-7#2)(2013-1#1)
of this article is to familiarize##3##6##(2007-12#1)(2011-2#1)(2012-3#1)
of this article is to highlight the##2##7##(2007-5#1)(2008-1#1)
of this article is to highlight##4##6##(2005-11#1)(2005-8#1)(2007-5#1)(2008-1#1)
of this article is to identify the##4##7##(2007-11#1)(2008-2#1)(2012-11#2)
of this article is to identify##5##6##(2005-10#1)(2007-11#1)(2008-2#1)(2012-11#2)
of this article is to present a##4##7##(1993-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
of this article is to present the##4##7##(2007-11#2)(2007-7#1)(2013-1#1)
of this article is to present##14##6##(1993-12#1)(1997-8#1)(2007-11#3)(2007-7#2)(2008-9#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#2)
of this article is to provide a##8##7##(1997-3#1)(2007-12#2)(2010-11#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
of this article is to provide an##3##7##(2010-12#1)(2012-2#1)(2013-1#1)
of this article is to provide##15##6##(1994-3#1)(1997-3#1)(2007-12#2)(2010-11#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
of this article is to report##2##6##(2008-11#1)(2013-1#1)
of this article is to review current##2##7##(2008-3#1)(2012-1#1)
of this article is to review the literature##3##8##(2006-10#1)(2009-5#1)(2013-1#1)
of this article is to review the##20##7##(1994-11#1)(1994-3#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#2)(2009-7#1)(2009-9#1)(2013-1#1)(2013-8#1)
of this article is to review##30##6##(1994-11#1)(1994-3#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2009-11#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-12#1)(2012-1#1)(2013-1#1)(2013-8#2)
of this article is to show the##2##7##(2009-4#1)(2009-9#1)
of this article is to show##3##6##(2007-5#1)(2009-4#1)(2009-9#1)
of this article is to##161##5##(1993-1#1)(1993-12#1)(1994-1#2)(1994-11#2)(1994-3#2)(1994-4#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-2#2)(1997-3#1)(1997-8#1)(2004-12#1)(2005-10#3)(2005-11#2)(2005-7#2)(2005-8#1)(2006-10#3)(2006-8#1)(2006-9#2)(2007-1#3)(2007-11#10)(2007-12#9)(2007-2#2)(2007-4#1)(2007-5#2)(2007-7#9)(2007-8#3)(2008-1#4)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-4#2)(2009-5#3)(2009-7#1)(2009-9#4)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#3)(2012-11#2)(2012-12#3)(2012-2#10)(2012-3#4)(2013-1#9)(2013-7#1)(2013-8#3)
of this article is##174##4##(1993-1#1)(1993-12#1)(1994-1#2)(1994-11#2)(1994-3#2)(1994-4#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-2#3)(1997-3#1)(1997-8#1)(2004-12#1)(2004-2#1)(2005-10#3)(2005-11#2)(2005-7#2)(2005-8#1)(2006-10#4)(2006-8#1)(2006-9#2)(2007-1#3)(2007-11#10)(2007-12#9)(2007-2#2)(2007-4#1)(2007-5#2)(2007-7#9)(2007-8#4)(2008-1#4)(2008-10#6)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-4#2)(2009-5#3)(2009-7#1)(2009-9#4)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#3)(2012-11#2)(2012-12#4)(2012-2#11)(2012-3#4)(2013-1#9)(2013-7#1)(2013-8#3)
of this article was to describe##3##6##(2009-4#1)(2010-10#1)(2010-3#1)
of this article was to review the##2##7##(2011-1#1)(2011-7#1)
of this article was to review##5##6##(1993-6#1)(2008-8#1)(2011-1#1)(2011-7#1)(2012-2#1)
of this article was to##17##5##(1993-6#1)(1997-8#1)(2006-7#1)(2007-7#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-10#2)(2010-11#1)(2010-3#1)(2011-1#2)(2011-2#1)(2011-7#1)(2012-2#2)
of this article was##19##4##(1993-12#1)(1993-6#1)(1997-8#1)(2006-7#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-10#2)(2010-11#1)(2010-3#1)(2011-1#2)(2011-2#1)(2011-7#1)(2012-2#2)
of this article will##3##4##(1996-1#1)(2005-7#1)(2008-5#1)
of this article##265##3##(1991-1#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-1#3)(1994-11#2)(1994-3#2)(1994-4#1)(1995-1#2)(1995-12#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#3)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#2)(2004-12#1)(2004-2#1)(2005-10#3)(2005-11#2)(2005-7#3)(2005-8#1)(2006-10#5)(2006-3#1)(2006-7#1)(2006-8#1)(2006-9#3)(2007-1#3)(2007-11#12)(2007-12#10)(2007-2#4)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#10)(2007-8#5)(2008-1#4)(2008-10#7)(2008-11#4)(2008-12#4)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#4)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#2)(2009-4#3)(2009-5#3)(2009-7#1)(2009-9#4)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#8)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#4)(2011-1#9)(2011-12#1)(2011-2#11)(2011-7#1)(2012-1#6)(2012-11#4)(2012-12#8)(2012-2#20)(2012-3#7)(2013-1#12)(2013-7#2)(2013-8#3)
of this assay are##2##4##(1991-9#1)(1997-4#1)
of this assay for##2##4##(1997-2#1)(2008-10#1)
of this assay is that##4##5##(1990-12#1)(2008-4#1)(2012-12#2)
of this assay is##5##4##(1990-12#1)(2008-10#1)(2008-4#1)(2012-12#2)
of this assay system##2##4##(1991-2#1)(1994-10#1)
of this assay##19##3##(1990-12#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-4#1)(1993-2#1)(1994-10#1)(1994-3#1)(1995-11#1)(1997-2#1)(1997-4#1)(2008-10#4)(2008-4#1)(2012-12#2)
of this assessment##2##3##(2008-11#1)(2011-3#1)
of this association##11##3##(1991-12#1)(1993-10#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-7#1)(2008-10#2)(2008-7#1)(2008-9#1)(2013-1#1)
of this assumption##3##3##(1990-10#1)(2008-3#1)(2012-2#1)
of this asymmetry##2##3##(1992-7#1)(1997-3#1)
of this audit##3##3##(2007-9#2)(2013-8#1)
of this bacterial##5##3##(1995-2#1)(2006-8#1)(2008-10#2)(2008-11#1)
of this bacterium in##2##4##(2013-1#1)(2013-8#1)
of this bacterium##6##3##(1993-8#1)(1995-6#1)(2007-1#1)(2008-9#1)(2013-1#1)(2013-8#1)
of this balance##2##3##(2007-11#1)(2007-2#1)
of this barrier##3##3##(1997-4#1)(2012-12#2)
of this basic##3##3##(1993-8#1)(1997-2#1)(2008-1#1)
of this behavior##7##3##(1991-9#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-11#1)(2013-1#1)
of this behavioral##2##3##(1991-3#1)(2006-9#1)
of this behaviour##2##3##(2007-9#1)(2008-11#1)
of this belief##2##3##(2006-2#1)(2013-1#1)
of this binding##5##3##(1990-1#1)(1990-5#1)(1991-3#1)(1995-11#1)(2008-8#1)
of this biological##4##3##(2008-10#1)(2008-8#1)(2009-4#1)(2012-2#1)
of this body##2##3##(2012-1#1)(2012-2#1)
of this bond##2##3##(1990-5#1)(1996-4#1)
of this bone##2##3##(1991-11#1)(1995-2#1)
of this brief review is to##2##6##(2006-10#1)(2008-7#1)
of this brief review##3##4##(2006-10#1)(2008-7#1)(2010-2#1)
of this brief##6##3##(2006-10#1)(2006-6#1)(2007-5#1)(2008-6#1)(2008-7#1)(2010-2#1)
of this burden##2##3##(2008-6#1)(2011-2#1)
of this cDNA##9##3##(1990-12#4)(1991-2#1)(1991-7#1)(1994-8#1)(2005-11#1)(2008-6#1)
of this campaign##3##3##(1995-3#1)(2006-2#1)(2007-2#1)
of this cancer and##2##4##(2009-4#1)(2011-2#1)
of this cancer##8##3##(1992-5#1)(2007-11#1)(2009-4#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-2#1)
of this capacity##4##3##(1993-11#1)(2007-3#1)(2010-12#1)(2013-8#1)
of this carcinoma##2##3##(1992-3#1)(2007-7#1)
of this case are##2##4##(2008-5#1)(2011-2#1)
of this case is that the patient##2##7##(2006-7#1)(2012-2#1)
of this case is that the##3##6##(2006-7#1)(2010-6#1)(2012-2#1)
of this case is that##4##5##(2006-7#1)(2008-1#1)(2010-6#1)(2012-2#1)
of this case is##5##4##(1992-10#1)(2006-7#1)(2008-1#1)(2010-6#1)(2012-2#1)
of this case report is to##2##6##(2008-8#1)(2010-9#1)
of this case report is##3##5##(2008-8#1)(2010-9#1)(2013-1#1)
of this case report##6##4##(2008-1#1)(2008-8#1)(2010-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
of this case study##6##4##(1991-1#1)(1992-3#1)(1993-1#1)(2006-8#1)(2010-5#1)(2012-12#1)
of this case##36##3##(1990-6#1)(1991-1#1)(1991-3#1)(1992-10#1)(1992-3#1)(1993-1#1)(2004-3#1)(2006-10#1)(2006-2#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-12#2)(2008-5#1)(2008-8#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-12#3)(2012-2#2)(2013-1#4)(2013-8#1)
of this category of##2##4##(1991-8#1)(2008-6#1)
of this cavity##2##3##(1994-3#1)(2008-3#1)
of this cell line##7##4##(1990-5#1)(1992-8#1)(1994-8#1)(1997-1#1)(1997-7#1)(2008-11#2)
of this cell##13##3##(1990-5#1)(1991-2#1)(1992-8#1)(1993-4#1)(1993-6#1)(1994-3#1)(1994-8#1)(1997-1#2)(1997-7#1)(2008-11#2)(2008-5#1)
of this century##6##3##(1995-9#1)(2006-10#2)(2007-2#1)(2007-8#1)(2008-11#1)
of this challenging##2##3##(2010-8#1)(2012-12#1)
of this change in##2##4##(2008-10#1)(2010-3#1)
of this change on##2##4##(2008-2#1)(2010-7#1)
of this change##9##3##(1995-3#1)(1997-8#1)(2004-10#1)(2008-10#1)(2008-2#1)(2009-6#1)(2010-3#1)(2010-7#1)(2013-7#1)
of this channel are##2##4##(1990-11#1)(1991-5#1)
of this channel##9##3##(1990-11#1)(1991-5#1)(1992-11#1)(1994-9#1)(1995-8#1)(1996-10#1)(2006-12#1)(2007-12#1)(2009-12#1)
of this chapter is to##2##5##(2008-9#1)(2010-4#1)
of this chapter##4##3##(2008-4#1)(2008-9#1)(2010-4#2)
of this chemical##3##3##(1993-2#1)(1996-9#1)(2008-11#1)
of this chimera##2##3##(1996-4#1)(1997-3#1)
of this chromosome##3##3##(1997-6#1)(2007-12#1)(2008-10#1)
of this chronic##3##3##(1992-2#1)(1993-8#1)(2004-12#1)
of this class of agents##2##5##(2006-10#1)(2006-12#1)
of this class of compounds##4##5##(1993-8#2)(1996-8#1)(2008-1#1)
of this class of drugs##2##5##(1993-2#1)(2011-2#1)
of this class of##22##4##(1990-7#2)(1991-12#1)(1991-6#1)(1992-5#1)(1993-2#1)(1993-8#2)(1994-12#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
of this class##27##3##(1990-7#2)(1991-12#1)(1991-6#1)(1992-5#1)(1993-2#2)(1993-8#2)(1994-12#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-1#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
of this classification##2##3##(1992-7#1)(2008-8#1)
of this clinical entity##2##4##(2004-1#1)(2006-6#1)
of this clinical##8##3##(1993-2#1)(1995-2#1)(2004-1#1)(2006-12#1)(2006-6#1)(2011-1#1)(2011-2#1)(2012-11#1)
of this clone in##2##4##(1993-6#1)(1994-8#1)
of this clone was##2##4##(1993-11#1)(1995-2#1)
of this clone##8##3##(1990-2#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-6#2)(1994-8#1)(1995-2#1)
of this cohort##4##3##(1991-7#1)(1994-12#1)(1994-5#1)(2007-8#1)
of this collaborative##2##3##(2008-11#1)(2008-12#1)
of this combination is##3##4##(1992-11#1)(2004-12#1)(2005-7#1)
of this combination##9##3##(1992-11#1)(1997-3#1)(1997-6#1)(2004-12#1)(2005-7#1)(2006-10#2)(2007-11#1)(2008-12#1)
of this combined##6##3##(1995-6#1)(1996-7#1)(2007-11#1)(2007-7#1)(2008-7#1)(2013-1#1)
of this commentary is to discuss##2##6##(2009-5#1)(2012-2#1)
of this commentary is to##3##5##(2009-5#1)(2012-1#1)(2012-2#1)
of this common and##2##4##(1991-8#1)(2012-12#1)
of this common##7##3##(1991-8#1)(2007-10#1)(2007-12#1)(2009-5#1)(2009-6#1)(2010-5#1)(2012-12#1)
of this commonly used##2##4##(1990-12#1)(2006-10#1)
of this comparative study##2##4##(1993-12#1)(1997-7#1)
of this comparison##2##3##(2008-3#1)(2012-12#1)
of this complex and##3##4##(2006-8#1)(2008-10#1)(2008-7#1)
of this complex could be##2##5##(1990-5#1)(1997-5#1)
of this complex disorder##3##4##(2006-10#1)(2008-7#2)
of this complex entity##2##4##(1996-12#1)(2010-6#1)
of this complex is##2##4##(2008-10#1)(2008-5#1)
of this complex to##3##4##(1992-12#1)(1994-11#1)(2006-12#1)
of this complex##38##3##(1990-5#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-7#1)(1994-11#1)(1994-8#1)(1995-6#3)(1996-12#1)(1997-5#1)(2006-10#2)(2006-12#2)(2006-7#1)(2006-8#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-7#5)(2009-8#1)(2009-9#1)(2010-6#1)(2011-1#1)(2012-12#1)(2013-8#1)
of this complexity##4##3##(2008-4#1)(2008-5#1)(2010-2#1)(2011-2#1)
of this complication and##3##4##(2012-3#1)(2013-1#2)
of this complication in##4##4##(2007-7#1)(2008-1#1)(2013-1#2)
of this complication is##3##4##(1991-3#1)(2007-11#1)(2013-1#1)
of this complication##26##3##(1990-6#1)(1991-3#1)(1993-6#1)(1995-9#1)(1997-3#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-4#1)(2012-3#1)(2013-1#5)
of this component was found##2##5##(1990-7#1)(1996-2#1)
of this component##3##3##(1990-7#1)(1996-2#1)(2009-9#1)
of this composite##2##3##(2006-11#1)(2007-12#1)
of this compound as a##2##5##(1991-2#1)(2009-6#1)
of this compound by##2##4##(1995-7#1)(2008-10#1)
of this compound for##2##4##(1990-4#1)(2005-7#1)
of this compound in human##2##5##(1993-2#1)(2008-10#1)
of this compound in##6##4##(1993-2#1)(1997-5#1)(2008-10#2)(2009-8#1)(2010-5#1)
of this compound may##3##4##(1996-8#1)(2005-3#1)(2006-12#1)
of this compound to##2##4##(1993-1#1)(2013-1#1)
of this compound##44##3##(1990-4#1)(1991-1#1)(1991-2#2)(1991-7#1)(1992-11#1)(1993-1#1)(1993-2#2)(1993-3#1)(1993-4#2)(1995-2#1)(1995-6#1)(1995-7#1)(1996-2#2)(1996-7#1)(1996-8#2)(1997-5#1)(1997-7#1)(2005-3#1)(2005-7#1)(2005-8#2)(2006-12#3)(2007-11#1)(2008-10#7)(2008-3#1)(2008-5#1)(2009-6#1)(2009-8#1)(2010-5#1)(2010-8#1)(2013-1#1)
of this concept is##3##4##(1992-12#1)(2007-12#1)(2008-2#1)
of this concept##9##3##(1992-12#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2011-1#1)(2012-11#1)(2012-2#1)
of this condition and##5##4##(2006-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#1)
of this condition in a##2##5##(2006-10#1)(2007-7#1)
of this condition in##6##4##(2006-10#1)(2006-4#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-6#1)
of this condition is essential##2##5##(2007-11#1)(2010-5#1)
of this condition is##10##4##(2007-11#1)(2007-7#1)(2007-8#1)(2009-11#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
of this condition remains unknown##2##5##(1995-9#1)(2009-3#1)
of this condition requires##2##4##(2008-7#1)(2009-7#1)
of this condition with##2##4##(2008-5#1)(2008-7#1)
of this condition##73##3##(1991-7#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(1994-6#1)(1995-8#1)(1995-9#1)(1997-1#1)(1997-6#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-11#3)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#3)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#6)(2013-8#3)
of this conference was##2##4##(2005-8#2)
of this conference##3##3##(2005-8#2)(2010-4#1)
of this configuration##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
of this congenital anomaly##2##4##(1996-9#1)(2008-9#1)
of this congress was##2##4##(2008-5#2)
of this consensus##2##3##(2009-10#1)(2009-6#1)
of this conserved##4##3##(1994-9#1)(1995-2#1)(1997-1#1)(2008-4#1)
of this constraint##2##3##(1997-2#1)(2006-3#1)
of this construct##4##3##(2007-12#2)(2010-6#1)(2012-1#1)
of this contribution##2##3##(2006-7#1)(2008-2#1)
of this controversy and the##2##5##(2007-4#1)(2008-1#1)
of this controversy##3##3##(2007-4#1)(2008-1#1)(2009-12#1)
of this correlation##2##3##(1992-6#1)(2008-3#1)
of this correlational##2##3##(2010-11#1)(2011-1#1)
of this crime##2##3##(2004-12#1)(2005-8#1)
of this critical##5##3##(1994-11#1)(2007-5#1)(2010-12#2)(2010-5#1)
of this cross##3##3##(1994-12#1)(2008-4#1)(2009-11#1)
of this cross-sectional study was to##3##6##(2007-2#1)(2010-2#1)(2012-12#1)
of this cross-sectional study##5##4##(2007-2#1)(2008-3#1)(2010-2#1)(2012-12#1)(2013-1#1)
of this cross-sectional##7##3##(2007-2#1)(2007-7#1)(2008-3#1)(2010-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
of this crystal##2##3##(1991-7#1)(2008-2#1)
of this current##2##3##(1991-9#1)(2006-8#1)
of this curve##2##3##(2008-10#1)(2009-1#1)
of this cytochrome##2##3##(1994-3#1)(2010-2#1)
of this cytokine##12##3##(1992-11#1)(1992-8#2)(1994-2#1)(1996-10#1)(1996-4#1)(1996-7#1)(2006-10#1)(2006-2#1)(2006-3#1)(2009-9#1)(2010-12#1)
of this data set##2##4##(2012-3#2)
of this data##11##3##(1997-4#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-3#1)(2011-1#1)(2012-3#2)(2013-1#3)
of this database##2##3##(1994-8#1)(2007-6#1)
of this debate##2##3##(1993-3#1)(2006-10#1)
of this debilitating##2##3##(2008-5#1)(2009-4#1)
of this decade##2##3##(1990-1#1)(1996-1#1)
of this decapeptide##2##3##(1992-11#1)(1995-8#1)
of this decline##4##3##(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#1)
of this decrease in##2##4##(2005-12#1)(2010-4#1)
of this decrease##3##3##(1997-2#1)(2005-12#1)(2010-4#1)
of this defect##3##3##(1995-9#1)(2007-9#1)(2008-1#1)
of this delivery##2##3##(2008-1#1)(2008-5#1)
of this dependence##5##3##(2007-11#1)(2008-2#2)(2008-3#1)(2009-8#1)
of this derivative##3##3##(1992-9#1)(1997-2#1)(2008-10#1)
of this design##6##3##(1994-2#1)(2006-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
of this detection##2##3##(2008-10#2)
of this detector##3##3##(2008-10#2)(2008-9#1)
of this detergent##2##3##(1992-6#1)(2012-2#1)
of this devastating##3##3##(2006-11#1)(2009-8#1)(2010-3#1)
of this development is##2##4##(1992-5#1)(2008-10#1)
of this development##6##3##(1992-5#1)(2006-11#1)(2006-4#1)(2008-10#1)(2008-12#1)(2012-1#1)
of this device for##2##4##(2008-10#1)(2008-3#1)
of this device in the##2##5##(2008-10#1)(2008-5#1)
of this device in##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
of this device##19##3##(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#4)(2008-3#4)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-1#1)
of this diagnosis##7##3##(2006-7#1)(2011-1#1)(2011-2#1)(2013-1#4)
of this diagnostic##5##3##(1990-6#1)(1990-9#1)(1993-10#2)(2011-1#1)
of this diet##3##3##(1995-3#1)(2007-5#1)(2013-1#1)
of this difference##7##3##(1991-8#1)(1992-11#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-2#1)(2009-12#1)
of this differential##3##3##(1992-10#1)(2008-3#1)(2012-8#1)
of this difficult##2##3##(2006-10#1)(2007-11#1)
of this disaster on the##2##5##(2008-2#2)
of this discipline##3##3##(2007-8#1)(2008-2#1)(2013-8#1)
of this discrepancy##4##3##(1991-10#1)(1995-11#1)(2005-11#1)(2012-2#1)
of this discussion##6##3##(1994-2#1)(2008-10#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-7#1)
of this disease among##2##4##(1992-2#1)(2008-5#1)
of this disease and the##3##5##(2006-10#1)(2007-2#1)(2010-5#1)
of this disease and##11##4##(1996-6#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-3#1)(2010-5#1)(2012-3#1)(2013-7#1)(2013-8#1)
of this disease are discussed##2##5##(1990-6#1)(2008-10#1)
of this disease are##8##4##(1990-6#1)(1992-6#1)(1993-8#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2012-1#1)
of this disease as##2##4##(1995-11#1)(2006-10#1)
of this disease by##2##4##(2006-10#1)(2011-2#1)
of this disease cluster##2##4##(2005-10#1)(2008-10#1)
of this disease has been##2##5##(2007-2#1)(2012-11#1)
of this disease has##6##4##(1996-6#1)(2007-2#1)(2010-11#1)(2010-5#1)(2010-6#1)(2012-11#1)
of this disease in the##4##5##(2006-10#1)(2007-3#1)(2007-8#1)(2008-10#1)
of this disease in##10##4##(1994-7#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-3#1)(2007-8#2)(2008-10#1)(2012-3#1)(2013-8#1)
of this disease is##13##4##(1994-4#1)(1994-6#1)(1996-6#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-8#1)(2007-11#1)(2008-7#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-8#1)
of this disease may##2##4##(1996-12#1)(2010-6#1)
of this disease on the##2##5##(2008-11#1)(2012-12#1)
of this disease process##3##4##(1995-9#1)(1996-9#2)
of this disease that##4##4##(1996-11#1)(2006-10#1)(2006-11#1)(2009-6#1)
of this disease was##4##4##(2005-8#1)(2008-10#2)(2010-12#1)
of this disease##182##3##(1990-12#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-2#2)(1993-4#1)(1993-6#1)(1993-8#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#2)(1994-7#1)(1995-1#1)(1995-11#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-6#4)(1996-9#2)(1997-2#1)(1997-7#1)(1997-8#3)(2004-11#1)(2004-12#1)(2005-10#2)(2005-11#2)(2005-8#5)(2006-10#10)(2006-11#2)(2006-2#2)(2006-4#1)(2006-8#2)(2006-9#1)(2007-11#4)(2007-2#2)(2007-3#3)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#4)(2008-1#4)(2008-10#19)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#4)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#3)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-5#3)(2010-6#3)(2010-8#1)(2011-1#3)(2011-2#6)(2011-7#1)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#5)
of this disorder has##2##4##(2007-6#1)(2011-1#1)
of this disorder in##4##4##(2007-7#1)(2010-12#2)(2011-2#1)
of this disorder is##6##4##(2007-11#1)(2008-3#1)(2008-8#1)(2009-9#1)(2011-2#1)(2012-1#1)
of this disorder##47##3##(1990-3#1)(1993-11#1)(1994-9#1)(1995-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(2004-10#1)(2006-12#1)(2006-4#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-6#1)(2007-7#2)(2007-9#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-9#3)(2010-12#3)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
of this distinction##2##3##(2008-11#2)
of this distribution##2##3##(2008-2#1)(2008-3#1)
of this document is to##4##5##(2008-3#1)(2008-7#1)(2009-6#1)(2012-3#1)
of this domain is##2##4##(1990-11#1)(1996-5#1)
of this domain revealed##2##4##(2011-1#1)(2013-1#1)
of this domain##10##3##(1990-11#1)(1991-10#1)(1991-3#1)(1992-3#1)(1995-6#1)(1995-8#1)(1996-5#1)(2008-3#1)(2011-1#1)(2013-1#1)
of this drug class##2##4##(1993-12#1)(2006-12#1)
of this drug in patients##2##5##(2008-1#1)(2008-10#1)
of this drug in##10##4##(1991-12#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#2)(2010-12#1)
of this drug is##4##4##(2006-10#1)(2008-5#1)(2010-2#1)(2012-12#1)
of this drug with##3##4##(2006-6#1)(2008-10#1)(2012-12#1)
of this drug##40##3##(1990-8#1)(1991-12#1)(1993-12#1)(1994-3#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-4#1)(1997-2#3)(2005-7#2)(2006-10#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#3)(2010-2#1)(2012-12#2)
of this dsRNA##4##3##(2008-10#4)
of this dummy##2##3##(2007-4#2)
of this effect at##2##4##(1990-3#1)(2008-7#1)
of this effect in##2##4##(1990-6#1)(2008-9#1)
of this effect is dependent on##2##6##(1997-2#1)(2008-5#1)
of this effect is##8##4##(1990-2#1)(1991-9#1)(1997-2#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-8#1)
of this effect was##4##4##(1990-10#1)(1990-3#1)(1995-10#1)(2008-10#1)
of this effect##42##3##(1990-10#1)(1990-2#1)(1990-3#2)(1990-6#1)(1990-7#1)(1990-8#2)(1991-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-3#1)(1995-10#1)(1995-8#2)(1997-2#2)(2005-11#1)(2007-11#2)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-12#1)(2010-5#1)(2012-1#1)
of this effort##2##3##(2008-1#1)(2010-12#1)
of this electrode was##3##4##(2008-10#3)
of this electrode##10##3##(2007-8#1)(2008-10#9)
of this element in the##2##5##(1990-8#1)(2008-10#1)
of this element in##5##4##(1990-8#1)(1994-6#1)(2008-10#3)
of this element is##4##4##(1996-3#1)(2008-1#1)(2008-10#2)
of this element##17##3##(1990-10#1)(1990-8#1)(1994-6#1)(1996-3#1)(2008-1#1)(2008-10#11)(2009-9#1)
of this elevation##2##3##(1997-1#1)(2008-10#1)
of this enantiomer##2##3##(1997-3#2)
of this enhancement##2##3##(1995-12#1)(2009-7#1)
of this enquiry##2##3##(1995-8#1)(2008-10#1)
of this entirely##2##3##(1993-2#1)(1995-3#1)
of this entity is##3##4##(2007-12#1)(2011-1#1)(2013-8#1)
of this entity to##2##4##(2007-2#1)(2011-12#1)
of this entity with##2##4##(2009-9#1)(2011-2#1)
of this entity##22##3##(1990-10#1)(1992-3#1)(1993-8#1)(1993-9#1)(1995-11#1)(1996-3#1)(2005-7#1)(2005-8#1)(2006-11#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-11#1)(2009-5#1)(2009-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-3#1)(2013-8#1)
of this environmental##2##3##(1993-7#1)(2008-10#1)
of this enzyme activity##4##4##(1994-2#1)(2008-6#2)(2008-8#1)
of this enzyme and##4##4##(1991-10#1)(1992-12#1)(2008-5#1)(2010-10#1)
of this enzyme as##2##4##(1994-3#1)(1997-4#1)
of this enzyme during##2##4##(2008-10#1)(2008-7#1)
of this enzyme has##2##4##(1993-8#1)(1994-11#1)
of this enzyme in the##2##5##(1994-6#1)(1997-4#1)
of this enzyme in##10##4##(1991-10#1)(1991-5#2)(1994-6#1)(1994-8#1)(1995-3#2)(1996-5#1)(1997-4#1)(2009-8#1)
of this enzyme is##3##4##(1992-10#1)(2008-1#1)(2008-4#1)
of this enzyme may be##2##5##(1997-2#1)(1997-4#1)
of this enzyme to##4##4##(1991-6#1)(1993-5#1)(1994-8#1)(2008-10#1)
of this enzyme was##9##4##(1990-12#1)(1990-5#1)(1991-11#1)(1991-2#2)(1992-6#1)(1994-6#1)(1995-4#1)(2004-11#1)
of this enzyme##93##3##(1990-12#4)(1990-5#3)(1991-1#1)(1991-10#2)(1991-11#1)(1991-2#2)(1991-5#6)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-11#2)(1992-12#1)(1992-2#2)(1992-6#1)(1992-7#2)(1993-5#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#5)(1994-9#2)(1995-1#3)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#1)(1995-8#4)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-7#2)(2004-11#2)(2006-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-2#2)
of this epidemic##3##3##(1994-7#1)(1997-3#1)(2009-4#1)
of this equation##3##3##(1994-9#1)(2007-12#1)(2008-8#1)
of this equilibrium##2##3##(2008-1#1)(2012-12#1)
of this essay is to##2##5##(2008-5#1)(2013-1#1)
of this essay##3##3##(2008-5#1)(2011-2#1)(2013-1#1)
of this evaluation include##2##4##(2008-2#2)
of this evaluation##7##3##(1992-12#1)(2005-7#2)(2006-12#1)(2008-2#2)(2012-3#1)
of this examination##3##3##(1994-2#1)(2007-5#1)(2013-8#1)
of this excess##2##3##(1991-12#1)(1992-8#1)
of this exchange##2##3##(1990-11#1)(1994-8#1)
of this exciting##3##3##(1991-3#1)(2011-1#1)(2013-1#1)
of this experience##5##3##(2005-11#1)(2008-11#2)(2008-6#1)(2008-9#1)
of this experiment is##2##4##(2008-3#2)
of this experiment was to investigate##2##6##(1994-2#1)(2012-12#1)
of this experiment was to##6##5##(1993-12#1)(1994-2#1)(1997-2#1)(2007-9#1)(2009-4#1)(2012-12#1)
of this experiment##14##3##(1993-12#2)(1994-2#1)(1997-2#1)(2006-5#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#2)(2009-4#1)(2010-10#1)(2012-12#1)
of this experimental##2##3##(1993-3#1)(2008-5#1)
of this exploratory##3##3##(2007-12#1)(2011-2#1)(2012-1#1)
of this extra##2##3##(1995-4#1)(2008-11#1)
of this extract##6##3##(2005-11#1)(2008-11#1)(2008-5#1)(2009-5#1)(2009-6#1)(2010-12#1)
of this fact##3##3##(2007-7#1)(2008-10#1)(2010-1#1)
of this factor and##2##4##(1994-12#1)(2008-3#1)
of this factor in the##3##5##(1990-2#2)(1994-8#1)
of this factor in##5##4##(1990-2#3)(1991-8#1)(1994-8#1)
of this factor##18##3##(1990-10#1)(1990-2#4)(1991-3#2)(1991-8#1)(1992-12#1)(1993-12#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-10#1)(2007-8#1)(2008-3#1)(2009-3#2)
of this family have been identified##2##6##(1994-3#1)(2006-10#1)
of this family have##3##4##(1994-3#1)(2006-10#1)(2011-2#1)
of this family include##2##4##(1990-8#1)(1994-3#1)
of this family of proteins##2##5##(2010-10#1)(2010-2#1)
of this family of##12##4##(1990-5#1)(1994-12#1)(1994-8#1)(1995-3#1)(1996-12#1)(2005-8#1)(2008-6#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-2#1)
of this family##51##3##(1990-12#2)(1990-5#1)(1990-8#1)(1991-11#1)(1991-2#1)(1992-2#1)(1993-11#1)(1993-6#1)(1994-10#1)(1994-12#3)(1994-3#2)(1994-8#2)(1994-9#1)(1995-3#2)(1996-12#1)(1996-2#1)(1996-5#2)(1997-4#1)(1997-7#1)(2005-8#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-3#1)
of this fascinating##3##3##(2006-10#1)(2006-9#1)(2012-1#1)
of this fast##2##3##(2005-9#1)(2012-12#1)
of this fastidious##3##3##(2006-5#1)(2008-9#1)(2013-1#1)
of this fatal##2##3##(1993-2#1)(2013-1#1)
of this fatty acid##2##4##(1991-1#1)(1993-8#1)
of this feature##5##3##(1996-5#1)(1996-9#1)(2007-12#1)(2008-6#1)(2010-5#1)
of this fiber##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
of this field are##2##4##(2007-5#1)(2008-2#1)
of this field##5##3##(2005-8#1)(2007-5#1)(2008-11#1)(2008-2#1)(2012-12#1)
of this film##2##3##(2008-1#1)(2008-10#1)
of this finding is##3##4##(1995-12#1)(2008-1#1)(2010-12#1)
of this finding##13##3##(1990-12#1)(1990-4#1)(1990-6#1)(1991-10#1)(1991-3#1)(1995-12#1)(2006-12#1)(2008-1#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-12#1)(2011-1#1)
of this flap##4##3##(2007-12#4)
of this food##3##3##(2006-10#1)(2008-12#1)(2012-1#1)
of this foreign##2##3##(1996-2#1)(2006-12#1)
of this form of therapy##2##5##(1991-12#2)
of this form of##15##4##(1990-2#1)(1990-5#1)(1991-12#2)(1994-6#1)(1997-1#1)(2004-11#1)(2006-2#1)(2006-9#1)(2007-7#1)(2008-10#1)(2009-2#1)(2012-2#2)(2013-7#1)
of this form##17##3##(1990-2#1)(1990-5#1)(1991-12#2)(1991-9#1)(1994-6#1)(1995-5#1)(1997-1#1)(2004-11#1)(2006-2#1)(2006-9#1)(2007-7#1)(2008-10#1)(2009-2#1)(2012-2#2)(2013-7#1)
of this formula##3##3##(2008-3#2)(2008-5#1)
of this fraction on##2##4##(1993-12#1)(2008-12#1)
of this fraction##3##3##(1992-1#1)(1993-12#1)(2008-12#1)
of this fragment##9##3##(1990-11#1)(1990-3#1)(1990-9#1)(1993-11#1)(1995-4#2)(2006-5#1)(2008-8#1)(2012-12#1)
of this framework##4##3##(1993-4#1)(1997-8#1)(2012-1#1)(2013-1#1)
of this frequent complication##2##4##(2007-7#1)(2008-3#1)
of this function##6##3##(1990-3#1)(1994-9#1)(1997-4#1)(2008-6#1)(2008-8#1)(2012-1#1)
of this functional group##3##4##(2008-10#2)(2008-4#1)
of this functional##6##3##(1993-2#1)(2008-10#2)(2008-4#1)(2008-7#1)(2012-2#1)
of this fundamental##2##3##(1995-5#1)(2012-2#1)
of this fungal##2##3##(2008-10#2)
of this fungus in##2##4##(2007-7#1)(2008-10#1)
of this fungus with##2##4##(2005-11#1)(2008-5#1)
of this fungus##12##3##(2005-11#1)(2007-7#1)(2008-10#9)(2008-5#1)
of this gas##2##3##(1990-5#1)(2005-12#1)
of this gene can##2##4##(1995-1#1)(2011-1#1)
of this gene contains a##2##5##(1990-6#1)(2008-11#1)
of this gene contains##3##4##(1990-6#1)(1993-12#1)(2008-11#1)
of this gene family##3##4##(1991-9#1)(2008-7#1)(2012-12#1)
of this gene in the##2##5##(1991-5#1)(2008-8#1)
of this gene in##13##4##(1991-1#1)(1991-5#1)(1991-7#1)(1992-4#1)(1994-5#1)(1997-7#2)(2006-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-1#1)(2012-2#1)
of this gene is##8##4##(1990-8#1)(1993-2#1)(1994-5#1)(1995-6#1)(1996-10#1)(1997-4#1)(2006-12#1)(2008-10#1)
of this gene may##2##4##(1990-8#1)(1993-8#1)
of this gene was##6##4##(1993-11#1)(1994-6#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-1#1)
of this gene with##3##4##(1993-6#1)(1997-3#1)(2008-10#1)
of this gene##79##3##(1990-11#3)(1990-12#1)(1990-5#1)(1990-6#2)(1990-8#2)(1991-1#1)(1991-11#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#1)(1994-12#1)(1994-5#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#2)(1996-1#1)(1996-10#1)(1996-3#1)(1997-1#2)(1997-3#1)(1997-4#2)(1997-7#3)(2006-12#1)(2006-5#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#1)(2011-1#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
of this genetic##5##3##(1992-9#1)(1996-12#1)(1997-8#1)(2010-4#1)(2013-1#1)
of this genomic##2##3##(2008-8#1)(2013-8#1)
of this genotype##5##3##(1994-3#1)(1996-11#1)(2008-10#2)(2012-2#1)
of this genus from##2##4##(2007-11#1)(2013-1#1)
of this genus with##2##4##(2008-1#1)(2008-10#1)
of this genus##10##3##(2007-11#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-9#2)(2013-1#1)(2013-7#1)
of this goal##2##3##(2008-11#1)(2010-3#1)
of this good##2##3##(2008-10#2)
of this grating##2##3##(2007-12#1)(2008-3#1)
of this group is##2##4##(1991-11#1)(2007-3#1)
of this group of patients##4##5##(1993-12#1)(1994-2#1)(2006-9#1)(2008-6#1)
of this group of##18##4##(1992-1#1)(1993-12#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-2#1)(1996-2#1)(2006-10#2)(2006-9#1)(2007-12#1)(2007-3#1)(2008-5#1)(2008-6#2)(2008-8#2)(2010-9#1)
of this group was##2##4##(1991-9#1)(2008-9#1)
of this group##45##3##(1990-12#1)(1990-3#1)(1991-11#1)(1991-9#1)(1992-1#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#1)(1996-12#1)(1996-2#2)(1997-8#1)(2006-10#2)(2006-5#2)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-8#1)(2008-10#1)(2008-12#3)(2008-2#1)(2008-5#1)(2008-6#2)(2008-8#3)(2008-9#2)(2009-2#1)(2010-9#1)(2013-8#1)
of this has##2##3##(2005-8#1)(2008-11#1)
of this heterogeneity##2##3##(1990-12#1)(2008-9#1)
of this heterogeneous##2##3##(2008-3#1)(2008-6#1)
of this high##2##3##(1997-7#1)(2008-9#1)
of this highly##8##3##(1991-1#1)(1992-1#1)(2006-10#1)(2006-6#1)(2008-4#1)(2008-9#1)(2009-4#1)(2011-2#1)
of this hormone to##2##4##(1995-10#1)(2005-10#1)
of this hormone##7##3##(1991-6#1)(1993-6#1)(1995-10#1)(1995-12#1)(2005-10#1)(2008-1#1)(2008-4#1)
of this host##2##3##(2004-11#1)(2008-10#1)
of this human##4##3##(1992-10#1)(1993-4#2)(1995-8#1)
of this hybrid##2##3##(1990-3#1)(1994-2#1)
of this hypothesis is##3##4##(1990-11#1)(2010-7#1)(2012-3#1)
of this hypothesis##16##3##(1990-11#2)(1991-9#1)(1994-11#1)(1995-11#1)(2005-8#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2010-7#1)(2012-3#1)
of this idea##3##3##(2006-10#1)(2009-6#1)(2012-2#1)
of this illness##5##3##(1990-9#1)(1993-3#1)(1993-5#1)(2008-6#1)(2010-12#1)
of this impactor and##2##4##(2007-4#2)
of this impairment##2##3##(1995-5#1)(2008-7#1)
of this important and##2##4##(2007-2#1)(2009-10#1)
of this important risk factor##2##5##(2006-2#1)(2008-1#1)
of this important##29##3##(1991-7#1)(1991-8#1)(1992-11#1)(1992-3#1)(1994-12#1)(1994-2#1)(1994-3#3)(1997-4#1)(2005-11#1)(2005-8#1)(2006-2#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#3)(2009-10#1)(2009-8#2)(2011-2#1)(2012-12#1)
of this improved##2##3##(1990-2#1)(2008-2#1)
of this in the##3##4##(2007-8#1)(2012-2#1)(2013-1#1)
of this in vitro study was to determine the##2##9##(2006-8#1)(2011-2#1)
of this in vitro study was to##3##7##(2006-8#1)(2008-5#1)(2011-2#1)
of this in vitro study##4##5##(2006-8#1)(2008-5#1)(2011-2#1)(2013-1#1)
of this in vitro##7##4##(1994-12#1)(1995-12#1)(2006-8#1)(2008-5#1)(2009-9#1)(2011-2#1)(2013-1#1)
of this in vivo study was to##3##7##(2007-8#1)(2008-5#1)(2012-12#1)
of this in vivo##4##4##(2007-8#1)(2008-10#1)(2008-5#1)(2012-12#1)
of this in##16##3##(1994-12#1)(1995-12#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-8#2)(2008-10#1)(2008-5#2)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
of this increase##3##3##(1990-8#1)(1991-3#1)(1991-8#1)
of this increased##5##3##(1994-11#1)(2005-10#1)(2007-12#1)(2008-10#1)(2008-3#1)
of this index##6##3##(1991-11#1)(1991-6#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)
of this infection##12##3##(1996-3#1)(2006-10#1)(2006-2#1)(2007-12#3)(2007-2#1)(2007-8#2)(2010-12#1)(2011-2#1)(2013-1#1)
of this infectious##2##3##(2011-1#1)(2013-1#1)
of this inflammatory##2##3##(2007-9#1)(2012-2#1)
of this information in##5##4##(1997-8#1)(2007-10#1)(2008-11#1)(2013-1#2)
of this information is##2##4##(2006-12#1)(2008-9#1)
of this information##14##3##(1997-4#1)(1997-8#2)(2006-12#1)(2007-10#1)(2008-11#3)(2008-4#1)(2008-9#1)(2009-8#1)(2013-1#3)
of this infrequent##3##3##(1992-6#1)(2009-7#1)(2012-3#1)
of this inhibition##2##3##(1994-3#1)(1995-8#1)
of this inhibitory##3##3##(1992-6#1)(1994-6#1)(1995-1#1)
of this initiative##7##3##(1991-12#1)(2007-9#1)(2008-2#1)(2008-4#1)(2008-5#1)(2012-2#1)(2013-8#1)
of this injury##4##3##(2006-2#1)(2009-3#1)(2012-12#1)(2013-1#1)
of this insect##5##3##(1991-2#1)(2008-6#1)(2008-7#1)(2011-12#2)
of this insert##3##3##(2008-8#1)(2010-10#2)
of this insoluble##2##3##(2007-7#1)(2008-5#1)
of this institution##3##3##(1991-9#1)(2008-8#2)
of this instrument for##2##4##(2008-3#1)(2013-8#1)
of this instrument in##2##4##(1990-4#1)(2012-2#1)
of this instrument##13##3##(1990-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#5)(2010-11#1)(2012-2#1)(2013-8#1)
of this integrated##3##3##(1990-12#1)(2008-10#1)(2008-2#1)
of this integrin##2##3##(2012-12#2)
of this intensive##2##3##(2004-3#1)(2007-11#1)
of this interaction in##4##4##(1996-10#1)(2008-9#1)(2012-1#1)(2012-2#1)
of this interaction is##2##4##(1994-6#1)(1995-3#1)
of this interaction were##2##4##(1994-8#1)(1996-8#1)
of this interaction##16##3##(1991-6#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-10#1)(1996-8#1)(2005-7#1)(2007-11#1)(2008-1#1)(2008-8#2)(2008-9#1)(2012-1#1)(2012-2#1)
of this interferometer##3##3##(2007-12#1)(2008-3#2)
of this intermediate##4##3##(1996-8#1)(2007-6#1)(2010-6#1)(2013-8#1)
of this international##2##3##(2008-4#1)(2011-2#1)
of this intervention is##2##4##(1990-9#1)(2008-3#1)
of this intervention on##2##4##(1995-1#1)(2008-3#1)
of this intervention##10##3##(1990-9#1)(1995-1#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-3#2)(2008-4#1)(2010-4#1)(2012-3#1)
of this inversion##2##3##(2008-3#2)
of this investigation was to evaluate the##2##7##(2004-12#1)(2005-5#1)
of this investigation was to examine the##2##7##(1990-4#1)(2009-3#1)
of this investigation was to study the##3##7##(1991-3#1)(1996-9#1)(2011-1#1)
of this investigation was to study##5##6##(1991-3#1)(1996-9#1)(2006-10#1)(2007-12#1)(2011-1#1)
of this investigation was to##17##5##(1990-4#1)(1991-12#1)(1991-3#1)(1994-2#1)(1995-11#1)(1996-5#1)(1996-9#1)(2004-12#1)(2005-5#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-3#1)(2011-1#1)(2013-8#1)
of this investigation was##18##4##(1990-4#1)(1991-12#1)(1991-3#1)(1994-2#1)(1995-11#1)(1996-5#1)(1996-9#1)(2004-12#1)(2005-5#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
of this investigation##28##3##(1990-4#1)(1990-6#1)(1991-12#1)(1991-3#1)(1994-2#1)(1995-11#1)(1996-3#1)(1996-5#1)(1996-9#1)(2004-12#1)(2005-5#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#1)
of this involvement##2##3##(2006-10#1)(2007-12#1)
of this ion##4##3##(1994-8#1)(1996-7#1)(2008-10#2)
of this is a##2##4##(1990-11#1)(2012-2#1)
of this is the##3##4##(2008-3#1)(2008-5#1)(2008-7#1)
of this is##14##3##(1990-11#1)(1992-6#1)(1993-10#1)(2006-6#2)(2008-3#1)(2008-5#2)(2008-7#3)(2009-8#1)(2011-2#1)(2012-2#1)
of this isoform##2##3##(1994-12#1)(2011-2#1)
of this issue of Science##2##5##(2007-9#2)
of this issue##12##3##(1996-1#1)(2006-7#1)(2007-9#4)(2008-11#1)(2008-8#1)(2009-7#1)(2010-9#1)(2011-2#2)
of this joint##3##3##(2006-10#1)(2007-12#1)(2007-7#1)
of this journal##7##3##(1992-2#1)(1992-3#1)(1995-9#1)(2005-7#1)(2008-10#1)(2008-7#1)(2013-1#1)
of this kinase##4##3##(1990-7#1)(1994-9#1)(1995-11#1)(1995-6#1)
of this kind are##2##4##(1995-5#1)(2009-8#1)
of this kind in##2##4##(2007-8#1)(2008-3#1)
of this kind of##22##4##(1990-6#1)(1991-9#1)(1992-8#1)(1993-3#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-8#2)(2007-9#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-2#1)(2011-1#1)(2011-2#1)
of this kind##42##3##(1990-6#1)(1991-2#1)(1991-9#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-5#1)(2005-11#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-8#3)(2007-9#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)
of this knowledge##7##3##(1991-2#1)(1993-10#1)(1995-5#1)(2008-4#1)(2010-5#1)(2011-2#2)
of this large##6##3##(1992-1#1)(2006-9#1)(2008-10#1)(2008-5#1)(2009-4#1)(2010-2#1)
of this laser is##2##4##(2008-2#1)(2008-3#1)
of this laser##9##3##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#4)(2008-3#1)
of this last##2##3##(1994-2#1)(1994-3#1)
of this latter group##3##4##(1992-5#2)(2007-8#1)
of this latter##4##3##(1992-5#2)(2007-8#1)(2010-5#1)
of this lectin##2##3##(1990-7#1)(1993-3#1)
of this lesion is##4##4##(1991-6#2)(2006-2#1)(2010-12#1)
of this lesion##20##3##(1990-9#1)(1991-6#2)(1994-8#1)(1996-3#1)(2006-2#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
of this library##3##3##(1990-11#1)(2008-4#1)(2013-1#1)
of this life-threatening##2##3##(2005-8#1)(2011-2#1)
of this ligand##3##3##(1991-5#1)(1992-9#1)(2008-5#1)
of this line##3##3##(1991-5#1)(2008-10#1)(2008-3#1)
of this lineage##5##3##(1995-12#1)(1995-2#1)(2008-10#2)(2008-4#1)
of this linear##2##3##(2007-12#1)(2008-2#1)
of this linkage##2##3##(1990-2#1)(2010-2#1)
of this lipase##2##3##(1995-5#1)(2006-8#1)
of this lipid##4##3##(1990-4#1)(1994-12#1)(2007-8#1)(2008-10#1)
of this liquid##3##3##(2005-11#1)(2008-10#1)(2008-7#1)
of this literature review will##2##5##(2008-5#1)(2009-5#1)
of this literature review##5##4##(2006-10#1)(2007-2#1)(2008-5#1)(2009-5#1)(2012-12#1)
of this literature##11##3##(1995-3#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-5#2)(2012-12#1)(2013-1#2)
of this local##2##3##(2010-11#1)(2012-2#1)
of this locus##6##3##(1991-7#1)(1996-10#1)(1997-3#1)(2008-10#1)(2008-5#2)
of this loop##4##3##(1991-7#1)(1992-11#1)(1995-2#1)(2012-3#1)
of this loss##3##3##(1990-8#1)(2007-12#1)(2007-3#1)
of this lymphoma##2##3##(2006-10#1)(2008-7#1)
of this mRNA##3##3##(1991-10#1)(1992-12#1)(1994-11#1)
of this magnitude##6##3##(1990-9#1)(1993-12#1)(1993-9#1)(2007-12#1)(2008-10#1)(2013-1#1)
of this major##3##3##(2006-2#1)(2008-10#1)(2008-11#1)
of this malformation##3##3##(2008-7#1)(2009-5#2)
of this malignancy##4##3##(2007-4#1)(2009-11#1)(2009-5#1)(2012-2#1)
of this manuscript is to review##2##6##(2009-3#1)(2010-3#1)
of this manuscript is to##3##5##(2009-3#1)(2010-3#1)(2011-2#1)
of this manuscript was to##2##5##(2008-5#1)(2013-1#1)
of this manuscript was##3##4##(2008-5#1)(2010-7#1)(2013-1#1)
of this manuscript##7##3##(2006-8#1)(2008-5#1)(2009-3#1)(2010-3#1)(2010-7#1)(2011-2#1)(2013-1#1)
of this marine##2##3##(2007-5#1)(2011-2#1)
of this marker##6##3##(1992-9#1)(2008-10#2)(2011-1#1)(2011-12#1)(2012-1#1)
of this material is##2##4##(1991-12#1)(2007-8#1)
of this material was##2##4##(1992-6#1)(2008-3#1)
of this material were##2##4##(2008-10#1)(2008-3#1)
of this material##19##3##(1990-9#1)(1991-12#1)(1992-6#1)(1995-12#1)(1996-12#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2010-8#1)
of this matrix in##2##4##(1993-4#1)(2008-10#1)
of this matrix##7##3##(1990-9#1)(1993-4#1)(2007-12#1)(2008-10#3)(2008-3#1)
of this matter##3##3##(2005-4#1)(2008-9#1)(2011-2#1)
of this measure of##2##4##(2008-2#1)(2010-6#1)
of this measure##4##3##(1997-7#1)(2007-12#1)(2008-2#1)(2010-6#1)
of this measurement##2##3##(2007-12#1)(2008-9#1)
of this mechanism and the role##2##6##(1994-8#1)(1995-11#1)
of this mechanism is##3##4##(2007-3#1)(2008-2#1)(2009-3#1)
of this mechanism##10##3##(1992-11#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-6#1)(1995-8#1)(2007-3#1)(2008-2#1)(2009-3#1)(2012-1#1)
of this meeting was##4##4##(2005-9#1)(2008-5#2)(2011-1#1)
of this meeting##12##3##(1997-8#1)(2005-8#2)(2005-9#1)(2008-2#1)(2008-5#5)(2009-4#1)(2011-1#1)
of this member of the##2##5##(2007-7#1)(2008-10#1)
of this membrane##5##3##(1990-11#1)(1990-8#1)(1991-1#1)(2008-10#2)
of this messenger##2##3##(1991-2#1)(2004-8#1)
of this metabolic##2##3##(2011-1#1)(2011-2#1)
of this metabolite##4##3##(1991-9#1)(1993-2#1)(2006-10#2)
of this metal##3##3##(2008-10#3)
of this method and##4##4##(1990-3#1)(2008-1#1)(2008-2#1)(2008-3#1)
of this method are that##2##5##(2008-10#1)(2008-3#1)
of this method are##13##4##(1991-11#1)(1994-6#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#1)
of this method can##4##4##(2005-11#1)(2008-1#1)(2011-1#1)(2012-12#1)
of this method for the##5##5##(1994-5#1)(1997-1#1)(2008-10#1)(2008-12#1)(2012-3#1)
of this method for##17##4##(1993-12#1)(1994-5#1)(1995-8#1)(1996-4#1)(1996-8#1)(1997-1#1)(2006-7#1)(2008-10#4)(2008-12#1)(2008-3#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
of this method in the##2##5##(2006-10#1)(2010-12#1)
of this method in##7##4##(1990-4#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-12#1)
of this method include##4##4##(1994-8#1)(2008-10#1)(2012-12#1)(2012-3#1)
of this method is demonstrated by##3##6##(2007-11#1)(2007-12#1)(2008-10#1)
of this method is demonstrated for##2##6##(2008-2#1)(2009-2#1)
of this method is demonstrated##9##5##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2009-2#1)
of this method is further##2##5##(2007-11#1)(2008-10#1)
of this method is its##3##5##(2007-11#1)(2007-12#1)(2008-11#1)
of this method is that it##3##6##(2008-10#1)(2008-2#1)(2008-3#1)
of this method is that##8##5##(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2011-2#1)
of this method is the##2##5##(1996-3#1)(2007-7#1)
of this method is##43##4##(1996-2#1)(1996-3#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#11)(2008-11#1)(2008-2#3)(2008-3#7)(2009-2#1)(2010-11#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
of this method of##2##4##(2008-11#1)(2008-3#1)
of this method on##2##4##(2008-10#1)(2008-7#1)
of this method to be##2##5##(2008-1#1)(2008-2#1)
of this method to##14##4##(1990-3#1)(1994-9#1)(1995-5#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#1)(2011-1#1)
of this method was demonstrated by##4##6##(1990-9#1)(2008-10#3)
of this method was found to be##2##7##(1996-6#1)(2008-10#1)
of this method was tested by##2##6##(1993-2#1)(2008-10#1)
of this method was tested##4##5##(1993-2#1)(2008-10#3)
of this method was##24##4##(1990-2#1)(1990-9#1)(1993-2#1)(1996-6#1)(2005-4#3)(2008-10#14)(2008-11#1)(2008-7#1)(2008-8#1)
of this method were##2##4##(2007-7#1)(2013-8#1)
of this method with##3##4##(2007-12#1)(2008-10#2)
of this method##184##3##(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-3#1)(1993-12#1)(1993-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(2004-11#1)(2005-11#1)(2005-4#3)(2006-10#1)(2006-6#1)(2006-7#2)(2007-10#1)(2007-11#6)(2007-12#11)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#49)(2008-11#6)(2008-12#1)(2008-2#13)(2008-3#18)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#2)(2009-5#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
of this methodology and##2##4##(2007-4#1)(2008-12#1)
of this methodology is##3##4##(2005-5#1)(2006-12#1)(2008-2#1)
of this methodology to##5##4##(2007-11#1)(2008-10#1)(2009-11#1)(2009-12#1)(2012-2#1)
of this methodology##20##3##(2005-5#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-4#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-9#1)(2009-11#2)(2009-12#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
of this microorganism##2##3##(2006-10#1)(2009-3#1)
of this minimally invasive##3##4##(1991-6#1)(2006-12#1)(2011-2#1)
of this mixture##4##3##(1996-8#1)(1997-3#1)(1997-7#1)(2008-10#1)
of this mode of##3##4##(1996-8#1)(2008-2#1)(2010-9#1)
of this mode##5##3##(1995-1#1)(1996-8#1)(2007-12#1)(2008-2#1)(2010-9#1)
of this model and##2##4##(1993-2#1)(2007-12#1)
of this model are##3##4##(2007-9#1)(2008-2#1)(2008-4#1)
of this model for##2##4##(1991-6#1)(1993-11#1)
of this model is##6##4##(1997-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-3#1)
of this model to##7##4##(1993-9#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-12#1)(2011-2#1)
of this model##47##3##(1990-4#1)(1990-7#1)(1991-6#1)(1992-4#1)(1993-11#1)(1993-2#1)(1993-9#1)(1995-6#1)(1996-10#1)(1996-3#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-1#1)(2006-1#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#3)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2013-1#2)(2013-8#1)
of this modeling##2##3##(1990-7#1)(2008-8#1)
of this modification##5##3##(1994-12#1)(1994-8#1)(1997-8#1)(2007-2#1)(2008-11#1)
of this modified##4##3##(1993-6#1)(1994-12#1)(1995-10#1)(2008-2#1)
of this modulation is##2##4##(2008-3#1)(2013-8#1)
of this module is##2##4##(2008-11#1)(2008-12#1)
of this module##3##3##(2008-11#2)(2008-12#1)
of this molecular##3##3##(2007-12#1)(2008-10#2)
of this molecule##10##3##(1990-2#1)(1992-6#1)(1995-1#1)(1996-2#1)(1996-9#1)(2004-12#1)(2008-5#1)(2008-7#1)(2012-12#2)
of this most##2##3##(1993-3#1)(2013-1#1)
of this motif##5##3##(1991-7#1)(1992-4#1)(1994-12#1)(1995-5#1)(1997-6#1)
of this mucin##2##3##(1992-11#2)
of this multivariate##2##3##(1992-12#1)(2008-10#1)
of this muscle##2##3##(2005-1#1)(2009-5#1)
of this mushroom##2##3##(1997-2#1)(2008-12#1)
of this mutant##10##3##(1990-5#1)(1991-2#1)(1994-10#3)(1994-11#1)(1995-1#1)(1995-11#1)(1996-5#1)(1997-2#1)
of this mutation is##3##4##(1992-3#1)(1997-2#1)(2006-8#1)
of this mutation on##2##4##(1991-9#1)(2005-1#1)
of this mutation##14##3##(1990-5#1)(1991-8#2)(1991-9#1)(1992-3#1)(1993-4#1)(1995-2#1)(1995-9#1)(1997-2#1)(2005-1#2)(2006-8#1)(2008-2#2)
of this mycoparasite##2##3##(2008-10#2)
of this narrative review##3##4##(2012-1#1)(2012-12#1)(2013-8#1)
of this national##2##3##(1990-10#1)(2011-1#1)
of this naturalistic study was to##2##6##(1993-12#1)(2009-11#1)
of this naturalistic##3##3##(1993-12#1)(2007-11#1)(2009-11#1)
of this nature##6##3##(1992-11#1)(1992-12#1)(1995-11#1)(2008-1#1)(2008-2#1)(2008-7#1)
of this need##2##3##(1997-3#1)(2008-4#1)
of this neoplasm and##2##4##(1992-5#1)(1994-2#1)
of this neoplasm##9##3##(1992-2#1)(1992-4#1)(1992-5#1)(1994-2#1)(2006-10#2)(2007-2#1)(2007-4#1)(2008-9#1)
of this network is##2##4##(1992-9#1)(2008-4#1)
of this network##5##3##(1992-9#1)(2008-2#1)(2008-4#1)(2009-4#1)(2012-12#1)
of this neuron##2##3##(1993-2#1)(2007-12#1)
of this neuronal##2##3##(1993-5#1)(1994-11#1)
of this neuropeptide##3##3##(1991-1#1)(1996-5#1)(1997-8#1)
of this neurotransmitter##2##3##(1992-11#1)(2007-12#1)
of this new algorithm are##2##5##(2008-2#1)(2008-3#1)
of this new algorithm##3##4##(2008-2#1)(2008-3#2)
of this new approach in##2##5##(1993-4#1)(2008-12#1)
of this new century##2##4##(2008-1#1)(2013-1#1)
of this new class of##3##5##(2006-12#1)(2007-12#1)(2008-8#1)
of this new formulation##2##4##(1992-4#1)(1992-8#1)
of this new generation of##2##5##(2005-7#1)(2008-10#1)
of this new instrument##2##4##(2004-3#1)(2006-6#1)
of this new knowledge##2##4##(2007-2#1)(2009-3#1)
of this new law##2##4##(1990-3#1)(2013-1#1)
of this new method are##2##5##(1994-6#1)(1996-11#1)
of this new method for##2##5##(2007-12#1)(2010-9#1)
of this new method have been##2##6##(2007-8#1)(2008-10#1)
of this new method is##3##5##(2007-11#1)(2007-12#1)(2008-10#1)
of this new method##12##4##(1994-6#1)(1996-11#1)(1997-7#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#2)(2010-5#1)(2010-9#1)
of this new model##3##4##(1995-1#1)(2007-12#1)(2008-2#1)
of this new system##2##4##(2006-6#1)(2008-10#1)
of this new technique##2##4##(1990-3#1)(2007-11#1)
of this new technology##3##4##(1997-5#1)(2007-11#1)(2012-1#1)
of this new##89##3##(1990-11#1)(1990-3#2)(1991-12#1)(1991-7#2)(1992-4#1)(1992-5#1)(1992-8#1)(1993-4#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-6#1)(1996-11#3)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-3#1)(2005-7#1)(2006-12#2)(2006-2#1)(2006-6#2)(2007-11#5)(2007-12#6)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#6)(2008-3#7)(2008-4#2)(2008-5#1)(2008-8#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-5#1)(2010-9#1)(2012-1#5)(2013-1#3)
of this newly developed method was##4##6##(2008-10#4)
of this newly developed##6##4##(2007-7#1)(2008-10#4)(2008-3#1)
of this newly##11##3##(1993-4#1)(1996-5#1)(2007-7#1)(2008-10#6)(2008-3#2)
of this noble##2##3##(2007-6#1)(2008-1#1)
of this novel agent##2##4##(2005-11#1)(2007-2#1)
of this novel approach to##2##5##(2008-2#1)(2008-8#1)
of this novel approach##3##4##(2008-2#1)(2008-8#1)(2008-9#1)
of this novel class of compounds##2##6##(1996-5#1)(1997-1#1)
of this novel class of##3##5##(1996-5#1)(1997-1#1)(2005-8#1)
of this novel type##2##4##(1990-2#1)(1996-2#1)
of this novel##34##3##(1990-12#1)(1990-2#1)(1992-12#1)(1994-6#1)(1994-9#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#2)(2005-11#2)(2005-8#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-8#2)(2008-9#1)(2010-9#1)(2011-1#1)(2012-11#2)
of this nutrient in##2##4##(2008-10#1)(2013-1#1)
of this objective is##2##4##(2008-3#1)(2010-12#1)
of this observation are##2##4##(1991-6#1)(2008-3#1)
of this observation is discussed##2##5##(1993-6#1)(1995-12#1)
of this observation is##4##4##(1992-9#1)(1993-6#1)(1995-12#1)(2007-4#1)
of this observation##12##3##(1991-10#1)(1991-11#1)(1991-6#1)(1992-9#1)(1993-6#1)(1995-12#1)(2006-7#1)(2007-4#1)(2008-3#2)(2011-2#1)(2012-12#1)
of this oil##3##3##(2008-12#1)(2008-3#1)(2010-5#1)
of this on##2##3##(2008-10#1)(2008-3#1)
of this open##3##3##(1990-4#1)(2008-6#1)(2013-1#1)
of this opening##2##3##(2008-1#1)(2013-7#1)
of this operation##7##3##(1990-6#1)(1990-9#1)(1991-5#1)(1994-3#1)(2006-10#1)(2006-6#1)(2008-3#1)
of this opportunity##2##3##(1993-12#1)(1993-2#1)
of this optical##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2010-4#1)
of this optimized##2##3##(2008-11#1)(2011-1#1)
of this optode##2##3##(2008-10#2)
of this organ##7##3##(1991-4#1)(2007-12#2)(2008-10#2)(2008-5#1)(2009-2#1)
of this organelle##6##3##(2007-8#2)(2007-9#1)(2008-11#2)(2008-9#1)
of this organism causing##2##4##(2007-7#1)(2012-12#1)
of this organism##32##3##(1991-11#1)(1993-11#1)(1996-10#1)(1996-8#1)(1997-1#1)(2005-8#1)(2007-7#1)(2008-10#2)(2009-2#1)(2009-9#1)(2011-1#1)(2011-2#19)(2012-12#1)
of this organism's##2##3##(2008-3#1)(2012-2#1)
of this organization##3##3##(1991-2#1)(2007-12#1)(2008-11#1)
of this outbreak##2##3##(1996-3#1)(2007-7#1)
of this pain##4##3##(1995-2#1)(2007-2#1)(2009-12#1)(2012-2#1)
of this paper are to##7##5##(1994-6#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-2#1)(2008-3#1)(2013-8#1)
of this paper are##11##4##(1994-6#1)(2006-6#1)(2007-4#1)(2007-5#1)(2007-7#2)(2008-2#1)(2008-3#1)(2010-3#1)(2011-1#1)(2013-8#1)
of this paper is an##2##5##(2007-11#1)(2012-2#1)
of this paper is that##2##5##(1994-11#1)(2008-11#1)
of this paper is the##3##5##(2008-10#2)(2010-12#1)
of this paper is to analyze##2##6##(2006-2#1)(2009-10#1)
of this paper is to assess the##3##7##(2007-7#1)(2008-9#1)(2010-5#1)
of this paper is to compare##2##6##(2008-11#1)(2008-3#1)
of this paper is to describe a##3##7##(1997-5#1)(2008-9#1)(2009-4#1)
of this paper is to describe the##11##7##(1992-1#1)(1992-2#1)(2006-2#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-5#1)(2012-1#1)(2012-2#1)
of this paper is to describe##17##6##(1992-1#1)(1992-2#1)(1997-5#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-5#1)(2008-9#2)(2009-4#1)(2010-11#1)(2012-1#1)(2012-2#1)
of this paper is to determine##2##6##(2007-7#1)(2011-1#1)
of this paper is to discuss the##4##7##(2004-10#1)(2008-11#1)(2009-10#1)(2012-12#1)
of this paper is to discuss##5##6##(2004-10#1)(2008-11#1)(2009-10#1)(2012-12#1)(2012-3#1)
of this paper is to document##4##6##(2007-3#1)(2007-6#1)(2008-6#1)(2011-1#1)
of this paper is to evaluate the##3##7##(1991-4#1)(2011-2#1)(2013-1#1)
of this paper is to evaluate##4##6##(1991-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
of this paper is to examine##2##6##(2007-8#1)(2012-2#1)
of this paper is to illustrate##3##6##(1995-6#1)(2008-7#1)(2012-2#1)
of this paper is to increase the awareness of##2##9##(2006-6#1)(2011-2#1)
of this paper is to present a##2##7##(2012-12#1)(2012-3#1)
of this paper is to present an overview of##2##9##(2010-5#1)(2013-1#1)
of this paper is to present an##3##7##(2007-7#1)(2010-5#1)(2013-1#1)
of this paper is to present the##3##7##(2007-7#1)(2007-8#1)(2011-2#1)
of this paper is to present##12##6##(2007-7#2)(2007-8#1)(2008-11#1)(2008-4#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
of this paper is to provide a##2##7##(1996-3#1)(2012-12#1)
of this paper is to provide an overview of the##2##10##(2011-2#2)
of this paper is to provide an overview of##3##9##(2007-4#1)(2011-2#2)
of this paper is to provide an##4##7##(2007-4#1)(2011-2#2)(2013-8#1)
of this paper is to provide##9##6##(1992-3#1)(1996-3#1)(2006-11#1)(2007-2#1)(2007-4#1)(2011-2#2)(2012-12#1)(2013-8#1)
of this paper is to report on##3##7##(2008-11#2)(2010-3#1)
of this paper is to report the##3##7##(2007-11#1)(2013-1#2)
of this paper is to report##6##6##(2007-11#1)(2008-11#2)(2010-3#1)(2013-1#2)
of this paper is to review the##8##7##(1993-5#1)(2006-10#1)(2006-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-10#1)(2013-1#1)
of this paper is to review##14##6##(1993-5#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-3#1)(2008-6#2)(2008-8#1)(2009-10#2)(2010-12#1)(2011-2#1)(2012-11#1)(2013-1#1)
of this paper is to show##2##6##(1997-6#1)(2008-10#1)
of this paper is to summarize the##3##7##(2008-5#1)(2009-4#1)(2012-12#1)
of this paper is to##125##5##(1991-4#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-5#1)(1995-6#1)(1995-8#1)(1996-3#1)(1997-1#1)(1997-5#1)(1997-6#1)(2004-10#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-2#5)(2006-5#1)(2006-6#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#6)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#8)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#5)(2009-2#1)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#3)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#3)(2012-3#3)(2013-1#9)(2013-8#1)
of this paper is##140##4##(1990-8#1)(1991-4#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-5#1)(1994-11#1)(1995-6#1)(1995-8#1)(1996-3#1)(1997-1#1)(1997-5#1)(1997-6#1)(2004-10#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-2#5)(2006-3#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#6)(2007-8#3)(2008-1#1)(2008-10#4)(2008-11#9)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#5)(2009-2#1)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#2)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#7)(2012-1#3)(2012-11#1)(2012-12#6)(2012-2#4)(2012-3#3)(2013-1#9)(2013-8#1)
of this paper was to design##2##6##(2006-5#1)(2010-4#1)
of this paper was to determine##2##6##(2011-2#1)(2013-1#1)
of this paper was to investigate##2##6##(2013-1#2)
of this paper was to present##3##6##(2008-11#1)(2008-5#2)
of this paper was to##21##5##(1992-2#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-5#3)(2009-8#2)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2013-1#3)
of this paper##202##3##(1990-8#1)(1991-4#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#2)(1993-1#1)(1993-5#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-6#1)(1995-8#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-10#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#5)(2006-3#1)(2006-5#2)(2006-6#5)(2006-8#2)(2007-11#4)(2007-12#3)(2007-2#3)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#9)(2007-8#3)(2008-1#1)(2008-10#5)(2008-11#11)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#5)(2009-2#2)(2009-4#7)(2009-6#1)(2009-8#3)(2009-9#2)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#4)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#5)(2011-2#10)(2012-1#4)(2012-11#2)(2012-12#6)(2012-2#5)(2012-3#4)(2013-1#13)(2013-7#1)(2013-8#2)
of this parameter##7##3##(1992-11#1)(1995-6#1)(2008-10#1)(2008-3#1)(2009-1#1)(2011-2#1)(2012-3#1)
of this parasite##4##3##(1996-8#1)(2007-2#1)(2008-10#1)(2009-5#1)
of this particular type of##3##5##(1990-11#1)(2008-2#1)(2010-1#1)
of this particular##10##3##(1990-11#1)(1996-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-4#1)(2010-1#1)(2010-3#1)
of this pathogen in the##2##5##(2008-9#1)(2012-2#1)
of this pathogen in##4##4##(2008-10#2)(2008-9#1)(2012-2#1)
of this pathogen##18##3##(2007-5#1)(2008-10#14)(2008-9#2)(2012-2#1)
of this pathology##14##3##(1990-10#1)(1990-5#2)(1991-1#1)(1991-3#1)(1991-6#1)(1992-8#1)(2007-2#1)(2007-8#1)(2009-3#1)(2010-12#1)(2013-1#3)
of this pathway in##3##4##(1993-3#1)(2009-8#1)(2010-3#1)
of this pathway##16##3##(1993-3#1)(1995-1#1)(1996-7#1)(2005-11#2)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#1)
of this patient population##3##4##(1992-5#1)(2008-12#1)(2013-1#1)
of this patient##15##3##(1992-5#1)(2004-3#2)(2006-10#2)(2007-2#1)(2008-11#1)(2008-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
of this patient's##3##3##(1992-3#1)(1994-3#1)(2006-4#1)
of this pattern##3##3##(1996-7#1)(2007-9#1)(2008-3#1)
of this peptide fragment##2##4##(1992-6#1)(2008-10#1)
of this peptide in the##2##5##(1996-5#1)(2008-10#1)
of this peptide in##4##4##(1990-12#1)(1992-11#1)(1996-5#1)(2008-10#1)
of this peptide on##2##4##(1991-2#1)(2012-1#1)
of this peptide to##3##4##(1990-7#1)(1995-2#1)(1996-5#1)
of this peptide was##3##4##(1997-3#2)(1997-8#1)
of this peptide were##2##4##(1991-9#1)(1992-9#1)
of this peptide##26##3##(1990-12#1)(1990-7#2)(1991-2#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-5#2)(1997-3#2)(1997-8#2)(2008-10#2)(2010-10#1)(2012-1#1)
of this period##5##3##(1992-6#1)(2006-4#1)(2008-5#1)(2008-8#1)(2009-2#1)
of this peripheral##2##3##(1993-12#1)(1994-5#1)
of this phase II study##2##5##(2008-10#1)(2008-6#1)
of this phase##6##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)
of this phenomenon in##2##4##(1997-8#1)(2013-1#1)
of this phenomenon is##4##4##(2006-5#1)(2008-2#1)(2008-7#1)(2010-10#1)
of this phenomenon remains##2##4##(2008-12#1)(2012-3#1)
of this phenomenon##35##3##(1990-12#1)(1990-5#1)(1991-6#1)(1992-1#1)(1994-6#1)(1997-6#1)(1997-8#2)(2006-10#1)(2006-5#2)(2006-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#2)(2009-5#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
of this phylum##2##3##(2008-10#1)(2013-8#1)
of this pictorial essay is to##4##6##(1997-8#1)(2012-2#3)
of this pictorial review is to##3##6##(2012-2#3)
of this pictorial##7##3##(1997-8#1)(2012-2#6)
of this pilot study was to compare##3##7##(1996-3#1)(2007-2#1)(2013-1#1)
of this pilot study was to describe the##2##8##(1992-8#1)(2013-1#1)
of this pilot study was to investigate##3##7##(2008-12#2)(2011-2#1)
of this pilot study was to##16##6##(1992-8#1)(1995-3#1)(1996-3#1)(2007-2#2)(2008-11#1)(2008-12#4)(2010-9#1)(2011-2#2)(2012-1#1)(2013-1#2)
of this pilot study##24##4##(1992-8#1)(1993-1#1)(1995-3#1)(1996-3#1)(2006-10#1)(2006-11#1)(2007-2#2)(2007-5#1)(2008-11#1)(2008-12#5)(2008-7#1)(2010-8#1)(2010-9#2)(2011-2#2)(2012-1#1)(2013-1#2)
of this pilot##28##3##(1992-8#1)(1993-1#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-3#1)(2006-10#1)(2006-11#1)(2007-2#2)(2007-5#1)(2008-11#1)(2008-12#5)(2008-7#2)(2010-8#1)(2010-9#2)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#2)
of this plant and##2##4##(2008-11#1)(2011-10#1)
of this plant##23##3##(1991-8#1)(1992-2#2)(1994-6#1)(2006-12#1)(2007-1#1)(2007-3#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-11#1)(2012-12#1)
of this plasmid to##2##4##(1991-9#1)(1993-12#1)
of this plasmid##8##3##(1990-4#1)(1991-9#1)(1993-12#3)(1993-9#1)(1996-2#1)(2008-10#1)
of this point##3##3##(1994-6#1)(2008-10#1)(2008-3#1)
of this polarimeter is##2##4##(2008-2#2)
of this polarization##3##3##(2007-12#1)(2007-8#1)(2008-2#1)
of this policy##3##3##(1992-1#1)(2007-8#1)(2008-10#1)
of this polymer##2##3##(1996-5#1)(2011-1#1)
of this polymorphism##3##3##(1994-11#1)(1995-9#1)(2006-6#1)
of this poorly##2##3##(2007-12#1)(2009-7#1)
of this popular##2##3##(2008-4#1)(2008-7#1)
of this population and##3##4##(1993-12#1)(2008-10#1)(2010-2#1)
of this population is##6##4##(1994-2#1)(1994-6#1)(2008-10#1)(2009-5#1)(2010-9#1)(2012-12#1)
of this population was##2##4##(1991-6#1)(1992-8#1)
of this population##28##3##(1991-6#2)(1992-8#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-1#1)(2006-2#1)(2007-2#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-5#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-12#2)(2013-1#2)
of this position##2##3##(1992-11#1)(2006-5#1)
of this positive##2##3##(2008-11#1)(2012-1#1)
of this possibility##2##3##(1990-11#1)(1995-1#1)
of this possible complication##2##4##(2008-12#1)(2012-3#1)
of this possible##5##3##(1990-11#1)(2008-12#2)(2012-3#1)(2012-5#1)
of this potential##7##3##(1991-11#1)(1995-6#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-7#1)
of this potentially fatal##3##4##(2007-4#1)(2009-9#1)(2012-3#1)
of this potentially lethal##2##4##(2008-5#1)(2010-3#1)
of this potentially##7##3##(2007-11#1)(2007-4#1)(2007-7#1)(2008-5#1)(2009-9#1)(2010-3#1)(2012-3#1)
of this powerful##3##3##(1996-10#1)(1996-2#1)(2011-1#1)
of this practice##5##3##(1991-11#1)(2004-10#1)(2006-10#1)(2009-11#1)(2012-12#1)
of this precursor is not##2##5##(1991-2#1)(1994-2#1)
of this precursor##6##3##(1990-7#1)(1991-1#1)(1991-2#2)(1994-2#1)(1997-7#1)
of this prediction##2##3##(2007-12#1)(2013-8#1)
of this preliminary study##5##4##(1992-7#1)(1993-12#1)(1996-5#1)(2007-12#1)(2013-1#1)
of this preliminary##8##3##(1992-7#1)(1993-12#1)(1996-5#1)(2007-12#1)(2008-12#2)(2008-5#1)(2013-1#1)
of this preparation##5##3##(1990-12#1)(1996-7#1)(2008-11#1)(2008-7#1)(2012-1#1)
of this present study##3##4##(2004-12#2)(2011-12#1)
of this present##4##3##(2004-12#2)(2010-10#1)(2011-12#1)
of this presentation is to##4##5##(2007-8#1)(2008-7#1)(2011-1#1)(2012-2#1)
of this presentation is##5##4##(2007-8#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-2#1)
of this probe##3##3##(1990-11#1)(2008-10#1)(2012-1#1)
of this problem and##5##4##(1995-7#1)(2005-10#1)(2005-7#1)(2008-8#1)(2013-1#1)
of this problem is##2##4##(1993-9#1)(2008-2#1)
of this problem##19##3##(1991-6#1)(1993-9#1)(1995-5#1)(1995-7#1)(1997-7#1)(2005-10#1)(2005-7#1)(2007-1#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
of this procedure are presented##2##5##(1990-9#1)(2005-10#1)
of this procedure are##3##4##(1990-9#1)(2005-10#1)(2007-11#1)
of this procedure for a##2##5##(2008-2#1)(2009-10#1)
of this procedure for##3##4##(2006-8#1)(2008-2#1)(2009-10#1)
of this procedure in the##2##5##(2007-8#2)
of this procedure in##3##4##(1993-9#1)(2007-8#2)
of this procedure is demonstrated by the##2##7##(2008-10#1)(2009-2#1)
of this procedure is to##2##5##(2008-11#1)(2008-4#1)
of this procedure is##7##4##(2006-3#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-2#1)(2012-12#1)
of this procedure to##4##4##(1991-8#1)(2008-10#1)(2008-4#1)(2011-2#1)
of this procedure##45##3##(1990-9#1)(1991-8#1)(1993-9#1)(1996-7#1)(1997-2#1)(2004-2#1)(2005-10#1)(2005-4#1)(2005-5#1)(2006-10#1)(2006-3#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-5#1)(2007-8#4)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-11#1)(2011-2#4)(2012-12#2)(2013-1#1)
of this process and##2##4##(1996-7#1)(2008-2#1)
of this process are##3##4##(1996-9#1)(2006-10#1)(2009-8#1)
of this process can##2##4##(1992-3#1)(2010-8#1)
of this process has##2##4##(1993-3#1)(1993-4#1)
of this process have##2##4##(1995-2#1)(2006-12#1)
of this process in##4##4##(2008-10#1)(2008-11#1)(2008-4#1)(2011-1#1)
of this process is##9##4##(1994-11#1)(2005-10#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#1)
of this process were##2##4##(1991-3#1)(2008-10#1)
of this process##49##3##(1990-11#1)(1990-8#1)(1991-3#1)(1991-6#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-4#1)(1993-8#2)(1994-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-4#1)(2004-12#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2009-8#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)
of this product##6##3##(1996-6#1)(2007-11#1)(2008-10#2)(2008-5#1)(2010-8#1)
of this program is##2##4##(1993-1#1)(2008-11#1)
of this program were##2##4##(2012-12#1)(2012-3#1)
of this program##17##3##(1993-1#1)(1996-2#2)(1997-1#1)(2006-10#1)(2006-11#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-5#1)(2012-1#1)(2012-12#2)(2012-3#1)
of this programme##6##3##(1990-11#1)(2004-2#1)(2006-10#1)(2008-11#2)(2008-7#1)
of this project is##2##4##(2008-11#1)(2010-7#1)
of this project was to develop##3##6##(1991-9#1)(2008-1#1)(2009-4#1)
of this project was to##14##5##(1991-9#1)(1994-3#1)(1995-3#2)(2007-10#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-4#1)(2011-2#1)(2013-1#1)
of this project was##16##4##(1991-9#1)(1994-3#1)(1995-3#2)(1996-2#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-4#1)(2011-2#1)(2013-1#1)
of this project##23##3##(1991-9#1)(1994-3#1)(1995-3#3)(1996-2#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-4#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-7#2)(2009-10#1)(2009-4#1)(2010-7#1)(2011-2#2)(2013-1#1)
of this projection##2##3##(1996-1#1)(1996-9#1)
of this promoter##2##3##(1993-6#1)(1996-10#1)
of this property of the##2##5##(2008-11#1)(2008-3#1)
of this property##3##3##(2006-12#1)(2008-11#1)(2008-3#1)
of this proposal##2##3##(1991-4#1)(2008-3#1)
of this proposed##2##3##(2006-3#1)(2009-9#1)
of this prospective study was to##2##6##(2006-8#1)(2007-3#1)
of this prospective study##3##4##(2006-8#1)(2007-3#1)(2010-5#1)
of this prospective##9##3##(1997-3#2)(2006-8#1)(2007-10#1)(2007-3#1)(2010-5#2)(2011-2#2)
of this protection##5##3##(1996-1#1)(2007-7#1)(2008-10#1)(2011-12#1)(2011-2#1)
of this protein and##3##4##(1991-5#1)(1994-6#1)(1997-4#1)
of this protein family##2##4##(2007-1#1)(2009-8#1)
of this protein in the##3##5##(1993-11#1)(1997-2#1)(2010-12#1)
of this protein in##11##4##(1990-5#1)(1992-11#1)(1992-12#1)(1993-1#1)(1993-11#1)(1993-9#1)(1994-8#1)(1997-2#1)(2010-12#1)(2012-2#2)
of this protein is##10##4##(1991-9#1)(1992-12#1)(1993-4#1)(1994-11#3)(1994-9#1)(1996-9#1)(2008-8#1)(2012-12#1)
of this protein on the##2##5##(1990-3#1)(1994-3#1)
of this protein on##3##4##(1990-3#1)(1994-3#1)(2008-7#1)
of this protein to##4##4##(1990-11#1)(1992-12#1)(1992-8#1)(1993-6#1)
of this protein was##4##4##(1991-1#1)(1994-3#1)(1994-9#1)(1995-2#1)
of this protein##85##3##(1990-11#3)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#3)(1992-12#3)(1992-2#1)(1992-6#1)(1992-7#3)(1992-8#2)(1993-1#2)(1993-11#1)(1993-12#4)(1993-3#1)(1993-4#2)(1993-6#2)(1993-9#1)(1994-11#5)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#4)(1994-9#2)(1995-10#1)(1995-2#1)(1995-5#1)(1995-8#2)(1996-11#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-8#1)(2007-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
of this protein(s)##2##3##(1993-2#1)(1994-12#1)
of this proteolytic##3##3##(1992-12#1)(2005-8#1)(2006-9#1)
of this protocol is##2##4##(2008-2#1)(2008-9#1)
of this protocol##4##3##(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)
of this publication##2##3##(2008-5#1)(2011-1#1)
of this pump##2##3##(1997-5#1)(2008-2#1)
of this putative##2##3##(1994-9#1)(1995-5#1)
of this qualitative study was to explore##3##7##(2008-12#1)(2009-9#1)(2010-10#1)
of this qualitative study was to##5##6##(2008-12#1)(2009-7#1)(2009-9#1)(2010-10#1)(2011-2#1)
of this qualitative##8##3##(2005-10#1)(2008-12#1)(2009-7#1)(2009-9#1)(2010-10#2)(2011-2#1)(2012-12#1)
of this quantitative##2##3##(2007-9#1)(2008-10#1)
of this quantity##3##3##(1995-5#1)(2007-11#1)(2007-12#1)
of this questionnaire##3##3##(2010-4#1)(2013-1#1)(2013-8#1)
of this randomized##3##3##(2007-8#1)(2009-12#1)(2011-2#1)
of this range##4##3##(1991-11#1)(2008-2#1)(2008-3#1)(2008-9#1)
of this rapidly##3##3##(2006-6#1)(2013-1#2)
of this rare combination of anomalies##2##6##(1993-12#1)(2008-4#1)
of this rare complication of##2##5##(2007-10#1)(2012-12#1)
of this rare complication##3##4##(2007-10#1)(2008-2#1)(2012-12#1)
of this rare condition##3##4##(2006-10#1)(2008-10#1)(2012-3#1)
of this rare disease##7##4##(1990-9#1)(1992-10#1)(2005-11#1)(2011-2#1)(2013-1#3)
of this rare entity##3##4##(2005-10#1)(2007-7#1)(2012-2#1)
of this rare lesion are##2##5##(2006-12#1)(2013-1#1)
of this rare lesion##4##4##(2006-10#1)(2006-12#1)(2012-12#1)(2013-1#1)
of this rare neoplasm##3##4##(1991-5#1)(1993-8#1)(2007-6#1)
of this rare tumor##6##4##(1991-6#1)(2005-12#1)(2010-3#1)(2011-2#1)(2012-2#2)
of this rare##53##3##(1990-9#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-10#1)(1993-12#1)(1993-8#1)(1994-2#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-12#2)(2007-10#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-8#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#4)
of this rat##2##3##(2008-4#1)(2008-5#1)
of this rate##2##3##(1993-9#1)(2008-2#1)
of this ratio##4##3##(1990-8#1)(1992-7#1)(1997-2#1)(2005-11#1)
of this reaction are##2##4##(1990-1#1)(2009-10#1)
of this reaction by##2##4##(1997-4#1)(2008-10#1)
of this reaction was##2##4##(1992-5#1)(1995-6#1)
of this reaction were##2##4##(1992-4#1)(2004-8#1)
of this reaction##21##3##(1990-1#1)(1991-9#1)(1992-4#1)(1992-5#1)(1994-8#1)(1995-6#1)(1996-5#1)(1997-4#1)(2004-8#1)(2005-12#1)(2007-11#1)(2008-10#7)(2009-10#2)(2010-5#1)
of this reagent##2##3##(1995-11#1)(2008-10#1)
of this recently##2##3##(2006-10#1)(2009-3#1)
of this receptor by##2##4##(1990-7#1)(1991-3#1)
of this receptor gene##3##4##(1991-5#3)
of this receptor in##4##4##(1990-11#1)(1991-2#1)(2007-12#1)(2008-5#1)
of this receptor is##2##4##(1990-12#1)(2010-12#1)
of this receptor##28##3##(1990-11#1)(1990-12#1)(1990-7#2)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#4)(1994-12#1)(1994-5#3)(1994-8#2)(1995-10#2)(1995-11#1)(1996-5#1)(2005-11#1)(2005-9#1)(2007-12#1)(2008-4#2)(2008-5#1)(2010-12#1)
of this reconstituted##2##3##(1992-8#1)(1994-8#1)
of this reduction##5##3##(1991-6#1)(2005-10#1)(2007-12#1)(2008-10#2)
of this reflex##3##3##(1992-4#1)(2005-10#1)(2008-2#1)
of this regime##2##3##(2007-12#1)(2008-6#1)
of this regimen##5##3##(1990-12#1)(1996-12#1)(2008-10#1)(2010-4#1)(2013-1#1)
of this region can be##2##5##(1993-9#1)(2006-6#1)
of this region in our##2##5##(1990-6#1)(1997-5#1)
of this region in##4##4##(1990-6#1)(1994-2#1)(1997-5#1)(2009-4#1)
of this region is##3##4##(1990-4#1)(1995-6#1)(1996-5#1)
of this region revealed##2##4##(1990-2#1)(1997-3#1)
of this region should##2##4##(1996-11#1)(2010-12#1)
of this region##43##3##(1990-2#1)(1990-4#1)(1990-6#1)(1991-3#1)(1991-5#1)(1992-8#1)(1993-3#2)(1993-8#2)(1993-9#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-5#1)(1996-9#1)(1997-3#2)(1997-5#1)(2006-12#2)(2006-6#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-4#1)(2010-12#1)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
of this regulation##2##3##(1996-11#1)(2008-8#1)
of this regulatory##6##3##(1990-9#1)(1991-2#1)(1995-2#1)(1995-8#1)(1997-9#1)(2007-12#1)
of this relationship are discussed##2##5##(1995-3#1)(2008-2#1)
of this relationship are##3##4##(1995-3#1)(2008-10#1)(2008-2#1)
of this relationship has not been##2##6##(1994-2#1)(2010-10#1)
of this relationship##15##3##(1990-3#1)(1993-12#1)(1994-2#1)(1994-5#1)(1995-3#1)(2006-7#1)(2007-6#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-9#1)(2010-10#1)(2012-2#1)(2013-1#1)
of this relatively##3##3##(1992-5#1)(1996-6#1)(2011-1#1)
of this remarkable##4##3##(1990-2#1)(1992-3#1)(2009-2#1)(2012-2#1)
of this report are##2##4##(1993-11#1)(2008-10#1)
of this report is to describe a case##2##8##(2007-3#1)(2007-5#1)
of this report is to describe a##3##7##(2006-10#1)(2007-3#1)(2007-5#1)
of this report is to describe##4##6##(2006-10#1)(2007-3#1)(2007-5#1)(2008-10#1)
of this report is to##18##5##(1992-12#1)(2004-1#1)(2006-10#1)(2007-10#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-3#1)
of this report is##19##4##(1992-12#1)(2004-1#1)(2006-10#1)(2007-10#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-12#2)(2012-3#1)
of this report was to study the##3##7##(2007-2#1)(2007-3#2)
of this report was to##10##5##(2004-9#1)(2006-2#1)(2007-2#1)(2007-3#2)(2008-5#1)(2008-6#1)(2009-4#1)(2011-1#1)(2011-2#1)
of this report was##11##4##(2004-9#1)(2006-2#1)(2007-2#2)(2007-3#2)(2008-5#1)(2008-6#1)(2009-4#1)(2011-1#1)(2011-2#1)
of this report##41##3##(1991-2#2)(1992-12#1)(1993-11#1)(1995-1#1)(2004-1#1)(2004-9#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-2#2)(2007-3#3)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-3#3)
of this research has been##2##5##(2006-2#1)(2008-3#1)
of this research is the##4##5##(1994-3#1)(1995-6#1)(2008-10#1)(2008-2#1)
of this research is to##8##5##(1994-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)
of this research is##17##4##(1994-3#1)(1994-8#1)(1995-6#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-6#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)
of this research on##2##4##(2004-3#1)(2010-5#1)
of this research study was to##2##6##(2007-12#1)(2011-1#1)
of this research was the##4##5##(2008-10#1)(2008-5#1)(2011-1#1)(2012-12#1)
of this research was to assess##2##6##(2007-7#1)(2008-3#1)
of this research was to determine##3##6##(1994-3#1)(2008-12#1)(2008-7#1)
of this research was to develop##2##6##(2008-5#1)(2012-2#1)
of this research was to evaluate the##3##7##(2007-2#1)(2008-10#1)(2013-7#1)
of this research was to evaluate##5##6##(2006-5#1)(2007-2#1)(2008-10#1)(2011-2#1)(2013-7#1)
of this research was to investigate the##2##7##(2006-11#1)(2006-8#1)
of this research was to investigate##3##6##(2006-11#1)(2006-8#1)(2012-12#1)
of this research was to study##5##6##(1990-9#1)(1993-6#1)(2007-2#1)(2010-4#1)(2011-2#1)
of this research was to##34##5##(1990-9#1)(1993-6#1)(1994-3#1)(2006-11#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-10#5)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2010-4#2)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
of this research was##40##4##(1990-9#1)(1993-6#1)(1994-3#1)(2006-11#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-7#1)(2008-10#6)(2008-12#2)(2008-3#2)(2008-5#3)(2008-7#1)(2010-4#2)(2011-1#4)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
of this research were##7##4##(1995-2#1)(2008-1#1)(2008-10#4)(2010-3#1)
of this research##90##3##(1990-3#1)(1990-9#1)(1991-2#1)(1992-1#1)(1992-7#1)(1993-6#1)(1994-3#2)(1994-8#1)(1995-2#1)(1995-6#1)(1997-1#1)(2004-3#1)(2006-11#1)(2006-2#2)(2006-5#1)(2006-8#1)(2007-11#4)(2007-12#2)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#14)(2008-12#4)(2008-2#1)(2008-3#4)(2008-5#4)(2008-7#2)(2008-8#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#6)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#1)
of this residue by##2##4##(1991-9#1)(1995-5#1)
of this residue to##3##4##(1992-7#1)(1995-11#1)(1995-5#1)
of this residue##13##3##(1990-12#1)(1990-2#1)(1991-9#1)(1992-7#1)(1993-6#1)(1994-5#1)(1995-11#1)(1995-2#2)(1995-5#2)(1996-2#1)(2006-12#1)
of this resistance##8##3##(1995-7#1)(2006-11#1)(2008-10#3)(2008-2#1)(2011-2#1)(2012-3#1)
of this resolution##2##3##(2008-3#1)(2012-12#1)
of this resource##3##3##(2011-2#1)(2013-1#2)
of this response##7##3##(1993-12#1)(1993-8#1)(1995-3#1)(2006-10#1)(2007-9#1)(2008-12#1)(2010-1#1)
of this result and the##2##5##(1995-9#1)(2008-9#1)
of this result##9##3##(1992-3#1)(1995-9#1)(2007-9#1)(2008-12#1)(2008-2#2)(2008-8#1)(2008-9#2)
of this retrospective study was to evaluate##3##7##(1992-12#1)(2007-8#1)(2009-4#1)
of this retrospective study was to##11##6##(1992-12#1)(2007-7#1)(2007-8#4)(2008-3#1)(2009-4#1)(2011-2#2)(2012-1#1)
of this retrospective study##13##4##(1992-12#1)(2007-7#1)(2007-8#4)(2008-3#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)
of this retrospective##19##3##(1992-12#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-7#1)(2007-8#4)(2008-3#1)(2008-5#1)(2009-4#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)
of this review are to##4##5##(1990-11#1)(2007-8#1)(2008-8#1)(2012-2#1)
of this review are##5##4##(1990-11#1)(2007-8#1)(2008-8#1)(2009-5#1)(2012-2#1)
of this review article is to##7##6##(2006-9#2)(2007-4#1)(2009-4#1)(2010-6#1)(2012-2#1)(2013-7#1)
of this review article##10##4##(2006-12#1)(2006-9#2)(2007-4#1)(2009-4#1)(2010-6#1)(2012-2#2)(2013-1#1)(2013-7#1)
of this review focuses##2##4##(1997-2#1)(2012-12#1)
of this review is not##2##5##(2007-11#1)(2010-7#1)
of this review is that##2##5##(2008-8#1)(2008-9#1)
of this review is to analyze##3##6##(2011-1#1)(2013-1#2)
of this review is to describe##5##6##(2006-1#1)(2006-10#1)(2008-1#1)(2008-8#1)(2010-11#1)
of this review is to discuss the##5##7##(2007-4#1)(2008-3#1)(2008-7#1)(2008-8#1)(2013-1#1)
of this review is to discuss##6##6##(2004-4#1)(2007-4#1)(2008-3#1)(2008-7#1)(2008-8#1)(2013-1#1)
of this review is to elaborate##2##6##(2010-5#1)(2013-1#1)
of this review is to evaluate the evidence##2##8##(2010-6#1)(2012-2#1)
of this review is to evaluate the##3##7##(2008-3#1)(2010-6#1)(2012-2#1)
of this review is to evaluate##4##6##(2007-8#1)(2008-3#1)(2010-6#1)(2012-2#1)
of this review is to examine the##3##7##(2007-7#1)(2008-5#1)(2009-12#1)
of this review is to examine##7##6##(2006-10#2)(2007-1#1)(2007-7#1)(2008-5#1)(2009-12#1)(2012-12#1)
of this review is to give##3##6##(2008-1#1)(2008-5#1)(2011-3#1)
of this review is to illustrate the##3##7##(2008-7#1)(2012-2#2)
of this review is to illustrate##4##6##(2008-7#1)(2008-8#1)(2012-2#2)
of this review is to present the##3##7##(2006-10#1)(2011-1#1)(2012-2#1)
of this review is to present##8##6##(1997-6#1)(2006-10#1)(2008-10#1)(2008-3#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
of this review is to provide##9##6##(2006-10#1)(2007-11#1)(2008-11#1)(2009-6#1)(2012-12#2)(2012-2#2)(2013-8#1)
of this review is to summarize recent##2##7##(2006-12#1)(2008-10#1)
of this review is to summarize the##5##7##(2008-1#1)(2009-3#1)(2010-2#1)(2012-11#1)(2012-12#1)
of this review is to summarize##7##6##(2006-12#1)(2008-1#1)(2008-10#1)(2009-3#1)(2010-2#1)(2012-11#1)(2012-12#1)
of this review is to##86##5##(1993-12#1)(1996-9#1)(1997-6#1)(2004-4#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-8#2)(2007-1#1)(2007-11#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#6)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#2)(2011-3#2)(2012-11#1)(2012-12#4)(2012-2#7)(2012-3#1)(2013-1#7)(2013-8#1)
of this review is##94##4##(1993-12#1)(1996-9#1)(1997-6#1)(2004-4#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-8#2)(2007-1#1)(2007-11#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#4)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#7)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#3)(2011-3#2)(2012-11#1)(2012-12#4)(2012-2#7)(2012-3#1)(2013-1#7)(2013-8#1)
of this review suggest##2##4##(2011-2#2)
of this review to provide the##2##6##(2007-7#1)(2012-12#1)
of this review to##5##4##(2005-10#1)(2005-7#1)(2007-7#1)(2010-5#1)(2012-12#1)
of this review was to investigate the##2##7##(2009-11#1)(2013-1#1)
of this review was to##9##5##(1996-6#1)(2007-12#1)(2008-5#1)(2009-11#1)(2010-6#1)(2011-2#1)(2013-1#3)
of this review was##11##4##(1996-6#1)(2007-12#1)(2008-5#1)(2009-11#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#3)
of this review will be##3##5##(2008-10#1)(2008-6#1)(2011-1#1)
of this review##176##3##(1990-11#1)(1991-4#1)(1993-12#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(2004-4#1)(2005-10#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#10)(2006-11#1)(2006-12#3)(2006-8#3)(2006-9#3)(2007-1#1)(2007-11#4)(2007-12#3)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#6)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#8)(2008-9#1)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#2)(2010-5#3)(2010-6#4)(2010-7#1)(2011-1#5)(2011-12#3)(2011-2#5)(2011-3#2)(2012-11#1)(2012-12#6)(2012-2#12)(2012-3#2)(2013-1#14)(2013-7#1)(2013-8#1)
of this ribozyme##2##3##(1992-7#1)(2008-9#1)
of this risk##3##3##(1997-4#1)(2011-12#1)(2011-2#1)
of this role##4##3##(1993-3#2)(2008-12#1)(2009-8#1)
of this route##2##3##(2008-10#1)(2008-3#1)
of this rule##3##3##(2008-2#1)(2008-5#1)(2012-2#1)
of this sample##3##3##(1997-2#1)(2008-10#1)(2008-7#1)
of this scale in##2##4##(2007-12#1)(2008-6#1)
of this scale##4##3##(1995-7#1)(2007-12#1)(2008-6#1)(2012-12#1)
of this schedule##2##3##(1990-8#1)(1995-8#1)
of this scheme are##3##4##(1995-2#1)(2007-12#1)(2008-2#1)
of this scheme for##2##4##(2007-12#1)(2008-3#1)
of this scheme is given##2##5##(2008-2#1)(2008-3#1)
of this scheme is##3##4##(2008-2#2)(2008-3#1)
of this scheme to##2##4##(2007-12#1)(2008-2#1)
of this scheme##12##3##(1995-2#1)(2007-12#3)(2008-2#4)(2008-3#2)(2013-1#2)
of this science##2##3##(2010-2#1)(2012-12#1)
of this second messenger##2##4##(1991-6#1)(1992-5#1)
of this secondary##2##3##(1993-11#1)(2007-1#1)
of this segment##3##3##(1995-3#1)(2007-12#1)(2008-9#1)
of this sensitivity##2##3##(1992-6#1)(2007-12#1)
of this sensor##10##3##(2007-11#1)(2008-10#6)(2008-2#2)(2008-3#1)
of this sensory##3##3##(1996-10#1)(2009-12#1)(2011-2#1)
of this sequence has##2##4##(1996-12#1)(1997-3#1)
of this sequence in##2##4##(1991-3#1)(1996-4#1)
of this sequence reveals##2##4##(1991-2#1)(1995-8#1)
of this sequence to##2##4##(1994-9#1)(2008-10#1)
of this sequence with##2##4##(1991-6#1)(1991-7#1)
of this sequence##23##3##(1990-5#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1993-11#1)(1993-9#1)(1994-9#2)(1995-1#1)(1995-3#2)(1995-8#1)(1996-12#1)(1996-4#1)(1997-3#1)(1997-4#1)(1997-9#1)(2007-6#1)(2008-10#1)(2009-8#1)
of this series of##3##4##(1996-8#1)(2008-10#1)(2012-3#1)
of this series##14##3##(1992-10#1)(1995-9#1)(1996-8#1)(1996-9#1)(2005-10#1)(2006-5#1)(2006-9#1)(2008-10#2)(2008-11#2)(2012-12#2)(2012-3#1)
of this serious condition##2##4##(1993-8#1)(2011-2#1)
of this serious##6##3##(1993-8#1)(2007-11#1)(2011-2#1)(2012-11#1)(2013-1#2)
of this set of##2##4##(2007-11#1)(2007-8#1)
of this set##3##3##(2007-11#1)(2007-8#1)(2008-7#1)
of this setup##2##3##(2007-12#1)(2008-3#1)
of this shift##2##3##(1992-12#1)(2008-8#1)
of this short##4##3##(2008-7#2)(2011-12#1)(2012-11#1)
of this signal##2##3##(1997-5#1)(2012-3#1)
of this signaling##2##3##(1997-4#1)(2009-6#1)
of this significance##2##3##(1993-5#1)(1997-8#1)
of this significant##2##3##(2005-9#1)(2012-12#1)
of this simple##7##3##(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)
of this simulation##2##3##(2008-2#2)
of this single##3##3##(1992-8#1)(1993-11#1)(2008-2#1)
of this site for##2##4##(1990-8#1)(2010-2#1)
of this site##9##3##(1990-8#1)(1995-3#1)(1996-8#2)(1997-4#1)(2007-11#1)(2010-2#1)(2011-2#1)(2013-8#1)
of this size##2##3##(2005-11#1)(2012-12#1)
of this small study##2##4##(2007-10#1)(2008-11#1)
of this small##6##3##(1996-12#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-11#2)
of this solution##7##3##(1994-6#1)(2006-10#1)(2008-10#3)(2008-2#1)(2008-9#1)
of this sort##3##3##(1995-3#1)(1996-12#1)(2008-3#1)
of this source##6##3##(1995-12#1)(2007-12#1)(2008-1#1)(2008-2#3)
of this space##3##3##(1991-2#1)(2007-12#1)(2008-3#1)
of this spatial##2##3##(1994-6#1)(2011-12#1)
of this special issue of##2##5##(2009-8#1)(2011-1#1)
of this special issue##4##4##(2008-8#1)(2009-8#1)(2010-4#1)(2011-1#1)
of this special##7##3##(2008-8#2)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
of this species and##2##4##(2007-7#1)(2010-8#1)
of this species are not##2##5##(2008-8#1)(2013-1#1)
of this species are##4##4##(2008-5#1)(2008-8#2)(2013-1#1)
of this species in the laboratory##2##6##(2007-5#1)(2008-11#1)
of this species in the##5##5##(2007-5#1)(2008-11#1)(2008-5#1)(2008-6#1)(2013-7#1)
of this species in##7##4##(2007-3#1)(2007-5#1)(2008-11#1)(2008-5#2)(2008-6#1)(2013-7#1)
of this species is##4##4##(2007-3#1)(2008-12#2)(2008-5#1)
of this species on##2##4##(2006-12#1)(2008-10#1)
of this species to##2##4##(2007-3#1)(2008-5#1)
of this species##55##3##(1996-6#1)(2004-11#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-3#4)(2007-5#3)(2007-7#2)(2008-10#7)(2008-11#2)(2008-12#4)(2008-4#1)(2008-5#12)(2008-6#2)(2008-8#2)(2010-8#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#3)
of this specific##6##3##(1992-7#1)(1994-6#1)(1994-8#1)(1996-6#1)(2009-10#1)(2011-2#1)
of this spectrometer##2##3##(2008-2#1)(2008-3#1)
of this spectrum##3##3##(1994-5#1)(2008-3#1)(2008-4#1)
of this stabilization##2##3##(1994-11#1)(2007-12#1)
of this state##2##3##(2008-10#1)(2009-9#1)
of this stochastic##2##3##(1991-6#1)(2008-2#1)
of this strain##9##3##(1994-7#1)(1996-1#1)(2005-11#1)(2006-3#1)(2007-12#1)(2008-10#1)(2011-2#1)(2012-2#2)
of this strategy are##2##4##(1996-2#1)(2006-10#1)
of this strategy is##3##4##(2007-11#1)(2010-7#1)(2012-12#1)
of this strategy##9##3##(1996-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-8#1)(2009-4#1)(2010-7#1)(2012-12#1)
of this stress##2##3##(1992-12#1)(1994-3#1)
of this structural##3##3##(1992-12#1)(1996-1#1)(2008-8#1)
of this structure##12##3##(1991-5#2)(1991-6#1)(1992-12#1)(1992-4#1)(1993-2#1)(1993-6#1)(1995-8#2)(2006-3#1)(2007-11#1)(2007-12#1)
of this study and##6##4##(1990-6#1)(1994-6#1)(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#1)
of this study are consistent with the##2##7##(2007-12#1)(2008-11#1)
of this study are discussed##3##5##(1993-1#1)(2007-11#1)(2008-3#1)
of this study are of interest for##2##7##(1993-9#1)(2008-3#1)
of this study are to determine##3##6##(2005-11#1)(2008-6#1)(2012-2#1)
of this study are to##6##5##(2005-11#1)(2008-5#1)(2008-6#1)(2010-8#1)(2012-2#1)(2013-1#1)
of this study are##28##4##(1992-8#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(2005-11#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2010-8#1)(2011-1#2)(2012-2#1)(2013-1#1)
of this study can be##2##5##(1995-9#1)(2013-1#1)
of this study can##3##4##(1995-9#1)(2010-12#1)(2013-1#1)
of this study demonstrate that there##2##6##(1992-11#1)(2008-6#1)
of this study demonstrate that##9##5##(1992-11#1)(1994-3#1)(1994-6#1)(2005-10#1)(2008-10#2)(2008-5#1)(2008-6#1)(2012-11#1)
of this study demonstrate##15##4##(1992-11#1)(1994-3#1)(1994-6#1)(1997-3#1)(2005-10#1)(2006-12#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)(2012-11#1)(2013-1#2)
of this study demonstrated##7##4##(1992-9#1)(2007-10#1)(2008-10#1)(2008-7#1)(2008-9#1)(2013-1#1)(2013-8#1)
of this study for##2##4##(1993-1#1)(2007-6#1)
of this study has been to determine the##2##8##(2008-5#2)
of this study has##3##4##(2008-5#2)(2009-7#1)
of this study have##3##4##(2004-9#1)(2008-10#2)
of this study highlight the##4##5##(1995-1#1)(2007-12#1)(2010-4#1)(2012-3#1)
of this study highlight##5##4##(1995-1#1)(2007-12#1)(2008-12#1)(2010-4#1)(2012-3#1)
of this study indicate that##34##5##(1990-4#1)(1990-5#1)(1990-6#1)(1991-11#1)(1992-8#1)(1993-4#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-8#1)(2005-8#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-5#1)(2007-7#1)(2008-10#3)(2008-6#2)(2009-2#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#2)(2013-8#2)
of this study indicate##38##4##(1990-4#1)(1990-5#1)(1990-6#1)(1991-11#1)(1992-8#1)(1993-4#2)(1994-8#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-8#1)(2005-8#1)(2006-1#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-6#2)(2009-2#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#2)(2013-8#2)
of this study indicated that##8##5##(1993-12#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-5#1)
of this study indicated##9##4##(1993-12#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-5#1)(2011-2#1)
of this study is a##2##5##(2007-9#1)(2009-7#1)
of this study is that##3##5##(1997-8#1)(2008-3#1)(2013-1#1)
of this study is the##4##5##(2007-8#1)(2008-10#1)(2008-3#1)(2011-1#1)
of this study is to analyze##4##6##(2007-8#1)(2008-4#1)(2008-9#1)(2009-2#1)
of this study is to assess the##9##7##(1993-7#1)(2005-10#1)(2007-9#1)(2008-11#1)(2008-5#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
of this study is to assess##10##6##(1993-7#1)(2005-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
of this study is to compare the##4##7##(2007-8#1)(2010-5#1)(2011-2#1)(2012-12#1)
of this study is to compare##7##6##(2007-7#2)(2007-8#1)(2008-10#1)(2010-5#1)(2011-2#1)(2012-12#1)
of this study is to demonstrate the##2##7##(2007-7#2)
of this study is to describe the##9##7##(1995-4#1)(2006-7#2)(2007-8#1)(2009-5#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
of this study is to describe##11##6##(1995-4#1)(2006-7#2)(2007-3#1)(2007-8#1)(2008-11#1)(2009-5#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
of this study is to determine if##3##7##(2008-9#1)(2010-9#1)(2011-2#1)
of this study is to determine the##2##7##(2011-12#1)(2011-2#1)
of this study is to determine##12##6##(2004-2#1)(2007-12#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-9#1)(2011-12#1)(2011-2#3)(2013-1#1)(2013-8#1)
of this study is to develop a##2##7##(2011-1#1)(2013-8#1)
of this study is to develop##4##6##(2008-10#1)(2010-8#1)(2011-1#1)(2013-8#1)
of this study is to discuss the##2##7##(2008-7#1)(2013-8#1)
of this study is to elucidate##3##6##(1991-12#1)(2006-10#1)(2010-5#1)
of this study is to establish##4##6##(1992-10#1)(2007-4#1)(2007-8#1)(2008-3#1)
of this study is to evaluate the##22##7##(1991-4#1)(2006-8#1)(2007-10#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#1)(2009-2#1)(2010-8#3)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)
of this study is to evaluate##31##6##(1991-4#1)(2006-8#2)(2007-10#1)(2007-4#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-8#3)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#2)
of this study is to examine##8##6##(1994-2#1)(2006-9#1)(2008-10#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
of this study is to explore the##2##7##(2010-10#1)(2011-2#1)
of this study is to explore##4##6##(2010-10#1)(2011-2#1)(2012-1#2)
of this study is to highlight##2##6##(2011-2#2)
of this study is to identify##7##6##(2005-12#1)(2007-12#1)(2008-12#1)(2010-2#1)(2012-3#1)(2013-8#2)
of this study is to investigate the##9##7##(2007-1#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-3#1)(2012-2#1)(2013-1#1)
of this study is to investigate##12##6##(1995-12#1)(2007-1#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-8#2)(2011-3#1)(2012-2#1)(2013-1#1)
of this study is to observe the##2##7##(2007-7#1)(2008-12#1)
of this study is to present a##4##7##(1992-10#1)(2009-6#1)(2011-2#1)(2012-12#1)
of this study is to present##7##6##(1992-10#1)(1996-1#1)(2008-10#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-7#1)
of this study is to provide a##2##7##(2009-7#1)(2011-2#1)
of this study is to provide##5##6##(2007-4#1)(2008-6#1)(2009-7#1)(2011-2#1)(2012-12#1)
of this study is to report the##2##7##(1996-12#1)(2008-7#1)
of this study is to review the##3##7##(2007-12#1)(2008-9#1)(2009-10#1)
of this study is to review##4##6##(2007-12#1)(2008-7#1)(2008-9#1)(2009-10#1)
of this study is to##182##5##(1991-12#1)(1991-4#1)(1992-10#2)(1992-12#1)(1992-2#1)(1993-12#1)(1993-7#1)(1994-2#1)(1995-12#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-8#1)(2004-2#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#3)(2007-3#1)(2007-4#4)(2007-6#1)(2007-7#8)(2007-8#12)(2007-9#2)(2008-1#6)(2008-10#8)(2008-11#3)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#7)(2008-9#5)(2009-10#1)(2009-2#2)(2009-5#1)(2009-6#2)(2009-7#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#3)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#18)(2011-3#1)(2012-1#6)(2012-12#5)(2012-2#6)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#8)
of this study is##199##4##(1991-12#1)(1991-4#1)(1992-10#2)(1992-12#1)(1992-2#1)(1993-12#1)(1993-7#1)(1994-2#1)(1995-12#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-8#1)(1997-8#1)(2004-2#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#4)(2007-6#1)(2007-7#8)(2007-8#13)(2007-9#3)(2008-1#6)(2008-10#9)(2008-11#3)(2008-12#4)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#7)(2008-9#5)(2009-10#1)(2009-2#2)(2009-5#1)(2009-6#2)(2009-7#3)(2010-10#2)(2010-12#2)(2010-2#2)(2010-5#3)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#18)(2011-3#1)(2012-1#6)(2012-12#5)(2012-2#6)(2012-3#3)(2013-1#10)(2013-7#1)(2013-8#8)
of this study provide##7##4##(1991-8#1)(1993-2#1)(2006-11#1)(2007-2#2)(2007-4#1)(2011-1#1)
of this study revealed that##3##5##(1997-8#1)(2007-12#1)(2008-5#1)
of this study should be##2##5##(1995-5#1)(2010-4#1)
of this study show that##12##5##(1990-12#1)(2005-11#1)(2006-12#1)(2006-8#2)(2006-9#1)(2007-10#1)(2008-10#1)(2008-7#1)(2010-2#1)(2011-2#1)(2013-1#1)
of this study show##15##4##(1990-12#1)(2005-11#1)(2006-12#1)(2006-8#2)(2006-9#1)(2007-10#1)(2008-10#1)(2008-7#1)(2010-2#1)(2010-3#1)(2011-2#1)(2013-1#3)
of this study showed that the##5##6##(2006-10#1)(2007-10#1)(2008-12#1)(2008-7#1)(2011-12#1)
of this study showed that##14##5##(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#2)(2008-12#3)(2008-7#1)(2010-8#1)(2011-12#1)(2013-1#2)(2013-8#1)
of this study showed##18##4##(2006-10#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#4)(2008-12#3)(2008-7#1)(2008-8#1)(2010-8#1)(2011-12#1)(2013-1#2)(2013-8#1)
of this study shows that##2##5##(1995-6#1)(2008-12#1)
of this study shows##3##4##(1995-6#1)(2008-12#1)(2008-7#1)
of this study suggest that the use of##2##8##(2008-6#1)(2009-7#1)
of this study suggest that the##6##6##(1990-2#1)(1994-2#1)(2008-6#2)(2009-7#1)(2013-1#1)
of this study suggest that##33##5##(1990-2#1)(1991-3#1)(1992-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-3#2)(2006-12#1)(2007-10#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#2)
of this study suggest##38##4##(1990-2#1)(1991-3#2)(1992-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-3#2)(1996-11#1)(1996-6#1)(2006-12#1)(2007-10#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
of this study suggested that##3##5##(1992-2#1)(1995-4#1)(2011-3#1)
of this study suggested##4##4##(1992-2#1)(1995-4#1)(2009-5#1)(2011-3#1)
of this study thus##2##4##(2008-4#1)(2009-4#1)
of this study to identify##2##5##(1990-11#1)(2012-12#1)
of this study to##7##4##(1990-11#1)(1995-12#1)(2007-4#1)(2008-11#1)(2008-3#1)(2009-10#1)(2012-12#1)
of this study was a##5##5##(1993-3#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-7#1)
of this study was an evaluation of##2##7##(2007-2#1)(2008-11#1)
of this study was that##3##5##(2006-9#1)(2008-10#1)(2009-7#1)
of this study was the determination of the##2##8##(1992-8#1)(2007-8#1)
of this study was the##7##5##(1992-8#1)(1993-4#1)(2007-4#1)(2007-7#1)(2007-8#2)(2013-1#1)
of this study was to analyse the##5##7##(2007-8#1)(2008-6#1)(2009-2#1)(2010-3#1)(2013-8#1)
of this study was to analyse##7##6##(2007-11#1)(2007-8#2)(2008-6#1)(2009-2#1)(2010-3#1)(2013-8#1)
of this study was to analyze the##14##7##(2006-11#1)(2006-5#1)(2007-3#1)(2007-6#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-3#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-3#1)
of this study was to analyze##20##6##(2005-5#1)(2006-11#1)(2006-5#1)(2007-3#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-3#1)(2009-4#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-3#2)(2013-1#1)
of this study was to apply##3##6##(2008-10#1)(2008-5#1)(2013-1#1)
of this study was to ascertain if##2##7##(1992-3#1)(2008-3#1)
of this study was to ascertain##4##6##(1992-3#1)(2008-3#1)(2008-9#1)(2010-7#1)
of this study was to assess the effect of##7##9##(1993-3#1)(2006-9#1)(2007-8#1)(2008-3#1)(2008-8#1)(2010-9#1)(2013-8#1)
of this study was to assess the effectiveness of##4##9##(1993-9#1)(2007-7#1)(2012-12#1)(2012-3#1)
of this study was to assess the effectiveness##5##8##(1993-9#1)(2007-7#1)(2008-3#1)(2012-12#1)(2012-3#1)
of this study was to assess the feasibility and##2##9##(2006-6#1)(2007-10#1)
of this study was to assess the feasibility##3##8##(1997-8#1)(2006-6#1)(2007-10#1)
of this study was to assess the influence of##3##9##(2008-5#1)(2010-10#1)(2013-7#1)
of this study was to assess the potential use of##2##10##(2008-5#2)
of this study was to assess the potential##3##8##(1996-9#1)(2008-5#2)
of this study was to assess the prevalence of##2##9##(2010-12#1)(2012-3#1)
of this study was to assess the##60##7##(1990-6#1)(1992-10#2)(1992-12#1)(1993-3#1)(1993-9#1)(1996-12#1)(1996-9#2)(1997-8#1)(2004-12#1)(2004-9#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#3)(2007-8#5)(2007-9#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-7#1)(2013-8#1)
of this study was to assess whether##7##7##(1991-6#1)(2006-7#1)(2006-8#2)(2007-7#1)(2008-5#1)(2008-7#1)
of this study was to assess##83##6##(1990-6#1)(1991-6#1)(1992-10#2)(1992-12#1)(1993-3#1)(1993-9#1)(1994-3#1)(1996-12#1)(1996-9#2)(1997-8#1)(2004-12#1)(2004-9#1)(2006-10#3)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-7#4)(2007-8#5)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-7#1)(2013-8#1)
of this study was to characterize the##3##7##(2007-8#1)(2008-11#1)(2012-12#1)
of this study was to characterize##8##6##(1994-8#1)(1996-11#1)(2007-8#1)(2008-11#2)(2008-5#1)(2009-11#1)(2012-12#1)
of this study was to clarify the##2##7##(2011-2#1)(2013-8#1)
of this study was to clarify##3##6##(2007-2#1)(2011-2#1)(2013-8#1)
of this study was to classify##2##6##(2006-5#1)(2010-4#1)
of this study was to compare the effects of##2##9##(2006-11#1)(2007-8#1)
of this study was to compare the incidence of##2##9##(2008-7#1)(2009-7#1)
of this study was to compare the quality of##2##9##(2011-2#2)
of this study was to compare the##36##7##(1992-10#1)(1996-6#1)(1997-8#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2007-10#2)(2007-4#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-7#1)(2009-8#1)(2010-1#1)(2010-9#1)(2011-2#4)(2013-8#2)
of this study was to compare##60##6##(1992-10#1)(1994-12#1)(1994-2#1)(1996-6#1)(1997-8#1)(2004-1#1)(2004-9#1)(2005-8#1)(2006-10#2)(2006-11#2)(2006-12#1)(2007-10#2)(2007-4#1)(2007-7#2)(2007-8#6)(2007-9#1)(2008-10#1)(2008-12#4)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#4)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#3)
of this study was to conduct a##2##7##(2007-8#1)(2008-10#1)
of this study was to confirm these##2##7##(2006-4#1)(2007-8#1)
of this study was to confirm##3##6##(2006-4#1)(2007-8#1)(2012-2#1)
of this study was to contribute##3##6##(2011-2#1)(2012-2#1)(2013-7#1)
of this study was to define the effects##2##8##(1995-2#1)(1997-7#1)
of this study was to define the##3##7##(1995-2#1)(1997-7#1)(2011-2#1)
of this study was to define##7##6##(1995-2#1)(1997-7#1)(2006-11#1)(2008-9#1)(2011-2#1)(2013-1#2)
of this study was to describe and##3##7##(2007-1#1)(2009-5#1)(2012-12#1)
of this study was to describe the clinical##2##8##(2007-2#1)(2010-5#1)
of this study was to describe the##10##7##(2006-7#1)(2007-2#1)(2009-3#1)(2010-5#1)(2011-1#1)(2012-12#2)(2013-1#2)(2013-7#1)
of this study was to describe##19##6##(2006-10#1)(2006-7#1)(2007-1#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-4#1)(2009-3#1)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-12#3)(2013-1#2)(2013-7#1)
of this study was to detect##4##6##(1997-8#1)(2010-8#1)(2011-1#1)(2013-1#1)
of this study was to determine how##2##7##(1996-2#1)(2007-7#1)
of this study was to determine if the##3##8##(2006-7#1)(2008-10#1)(2010-10#1)
of this study was to determine if##13##7##(1995-2#1)(1995-6#1)(1996-5#1)(2006-1#1)(2006-7#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-10#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)
of this study was to determine the accuracy of##2##9##(2012-1#1)(2012-2#1)
of this study was to determine the effect of##5##9##(1991-8#1)(1994-2#1)(2007-1#1)(2008-10#1)(2011-2#1)
of this study was to determine the effect##6##8##(1991-8#1)(1994-2#1)(2007-1#1)(2008-10#1)(2008-8#1)(2011-2#1)
of this study was to determine the effects of##10##9##(2005-12#1)(2007-2#1)(2008-10#1)(2008-5#3)(2010-4#1)(2010-6#1)(2013-1#1)(2013-8#1)
of this study was to determine the efficacy of##2##9##(2006-5#1)(2007-7#1)
of this study was to determine the efficacy##3##8##(2006-5#1)(2007-7#1)(2008-6#1)
of this study was to determine the extent##2##8##(1996-12#1)(2006-8#1)
of this study was to determine the incidence##2##8##(1991-11#1)(2005-12#1)
of this study was to determine the influence of##7##9##(2004-11#1)(2006-8#1)(2007-11#1)(2007-8#1)(2009-2#1)(2009-5#1)(2011-2#1)
of this study was to determine the prevalence of##7##9##(1993-12#1)(2006-8#1)(2007-2#1)(2008-12#2)(2008-3#1)(2013-1#1)
of this study was to determine the prevalence##9##8##(1993-12#1)(2006-8#2)(2007-2#1)(2008-12#2)(2008-3#1)(2013-1#1)(2013-8#1)
of this study was to determine the proportion##2##8##(1997-6#1)(2012-12#1)
of this study was to determine the relationship between the##3##10##(2008-12#1)(2010-2#1)(2013-8#1)
of this study was to determine the relationship between##6##9##(2007-3#1)(2008-10#1)(2008-12#1)(2010-2#1)(2012-2#1)(2013-8#1)
of this study was to determine the relationship##7##8##(2007-3#1)(2008-10#1)(2008-12#1)(2009-5#1)(2010-2#1)(2012-2#1)(2013-8#1)
of this study was to determine the relative##3##8##(1992-11#1)(1996-12#1)(2010-8#1)
of this study was to determine the##115##7##(1990-12#1)(1991-11#1)(1991-8#1)(1992-11#1)(1993-12#1)(1994-2#1)(1994-5#1)(1996-12#2)(1996-4#1)(1996-9#1)(1997-6#1)(2004-10#1)(2004-11#1)(2005-12#2)(2005-8#1)(2006-10#2)(2006-12#1)(2006-5#2)(2006-8#5)(2007-1#1)(2007-11#1)(2007-2#9)(2007-3#2)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-2#2)(2009-5#3)(2009-6#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#6)(2013-3#1)(2013-7#1)(2013-8#7)
of this study was to determine whether there are##2##9##(2008-7#1)(2010-7#1)
of this study was to determine whether there##3##8##(2007-10#1)(2008-7#1)(2010-7#1)
of this study was to determine whether##37##7##(1990-10#1)(1990-3#1)(1991-2#1)(1992-11#1)(1992-7#1)(1993-3#1)(1993-9#1)(1994-11#1)(1995-3#2)(1997-8#1)(2006-12#1)(2006-5#2)(2006-8#1)(2007-10#4)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#1)(2013-7#1)
of this study was to determine which##5##7##(1995-5#1)(2006-1#1)(2009-2#1)(2012-2#1)(2013-1#1)
of this study was to determine##191##6##(1990-10#1)(1990-12#1)(1990-3#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-11#2)(1992-7#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-12#3)(1996-2#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-6#1)(1997-8#1)(2004-10#1)(2004-11#1)(2005-12#2)(2005-8#1)(2006-1#2)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#1)(2006-5#4)(2006-7#1)(2006-8#6)(2007-1#1)(2007-10#5)(2007-11#1)(2007-2#13)(2007-3#2)(2007-4#2)(2007-7#5)(2007-8#4)(2007-9#3)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#4)(2008-3#1)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#4)(2009-2#3)(2009-5#4)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#3)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#12)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#8)(2013-3#1)(2013-7#2)(2013-8#9)
of this study was to develop a new##2##8##(1993-11#1)(2008-5#1)
of this study was to develop a##20##7##(1993-11#1)(1993-12#1)(1997-3#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-4#2)(2007-9#1)(2008-4#1)(2008-5#2)(2008-6#1)(2010-2#1)(2012-1#2)(2012-2#1)(2012-4#1)(2013-1#2)
of this study was to develop an##8##7##(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#3)
of this study was to develop and evaluate##3##8##(2008-10#2)(2012-2#1)
of this study was to develop and test##3##8##(2007-7#1)(2011-2#1)(2012-1#1)
of this study was to develop and validate a##2##9##(2006-11#1)(2012-1#1)
of this study was to develop and validate##3##8##(2006-11#1)(2012-1#2)
of this study was to develop and##10##7##(2006-11#1)(2007-7#1)(2008-10#2)(2010-9#1)(2011-2#1)(2012-1#3)(2012-2#1)
of this study was to develop##45##6##(1993-11#1)(1993-12#1)(1997-3#1)(2006-11#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-4#2)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-5#5)(2008-6#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-1#5)(2012-2#3)(2012-4#1)(2013-1#5)
of this study was to document##2##6##(2006-10#1)(2006-2#1)
of this study was to elucidate the relationship between##2##9##(2005-10#1)(2008-10#1)
of this study was to elucidate the##6##7##(1995-6#1)(2005-10#1)(2006-11#1)(2008-10#1)(2008-8#1)(2013-8#1)
of this study was to elucidate##8##6##(1995-6#1)(2005-10#1)(2006-11#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-8#1)(2013-8#1)
of this study was to establish the##4##7##(1994-2#1)(2007-11#1)(2007-3#1)(2013-7#1)
of this study was to establish##10##6##(1992-8#1)(1994-2#1)(1997-8#1)(2004-9#1)(2006-8#1)(2007-11#1)(2007-3#1)(2008-11#1)(2013-1#1)(2013-7#1)
of this study was to estimate the##9##7##(1996-1#1)(2007-2#1)(2007-3#1)(2008-3#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#1)
of this study was to estimate##11##6##(1996-1#1)(2006-8#1)(2007-2#1)(2007-3#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#1)
of this study was to evaluate a##4##7##(2008-10#1)(2008-7#1)(2009-5#1)(2013-8#1)
of this study was to evaluate the early and##2##9##(2007-8#1)(2008-12#1)
of this study was to evaluate the effect of##11##9##(1992-8#1)(1996-2#1)(2004-1#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-5#1)(2012-2#3)
of this study was to evaluate the effect##12##8##(1992-8#1)(1996-2#1)(2004-1#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-5#1)(2010-4#1)(2012-2#3)
of this study was to evaluate the effectiveness of##2##9##(2006-2#1)(2006-8#1)
of this study was to evaluate the effects of different##2##10##(2013-1#1)(2013-8#1)
of this study was to evaluate the effects of##7##9##(1993-12#1)(2007-8#1)(2008-12#1)(2009-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
of this study was to evaluate the efficacy of##4##9##(2008-5#2)(2009-8#1)(2013-1#1)
of this study was to evaluate the impact of##3##9##(1996-1#1)(2007-11#1)(2008-12#1)
of this study was to evaluate the influence of##6##9##(2006-10#1)(2006-9#1)(2008-12#1)(2009-8#1)(2013-1#1)(2013-8#1)
of this study was to evaluate the prevalence of##5##9##(2008-12#2)(2008-7#1)(2011-2#1)(2012-3#1)
of this study was to evaluate the prognostic##3##8##(1997-8#1)(2007-8#1)(2010-6#1)
of this study was to evaluate the results of##3##9##(2007-11#1)(2008-9#1)(2011-2#1)
of this study was to evaluate the role of##5##9##(2005-10#1)(2007-7#1)(2007-8#1)(2008-5#1)(2013-1#1)
of this study was to evaluate the suitability of##2##9##(2010-4#1)(2010-9#1)
of this study was to evaluate the use of##2##9##(1990-11#1)(2013-1#1)
of this study was to evaluate the##116##7##(1990-11#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-11#1)(1996-1#1)(1996-2#1)(1997-6#1)(1997-8#2)(2004-1#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#8)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#8)(2008-3#2)(2008-4#1)(2008-5#7)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#5)(2010-6#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#2)(2012-2#7)(2012-3#1)(2013-1#11)(2013-8#2)
of this study was to evaluate whether the##2##8##(2006-8#1)(2013-8#1)
of this study was to evaluate whether##8##7##(2006-10#1)(2006-8#1)(2007-11#1)(2008-11#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
of this study was to evaluate##167##6##(1990-11#1)(1991-5#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-8#4)(2004-1#1)(2005-10#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#10)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#9)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#11)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#5)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#8)(2012-1#2)(2012-12#1)(2012-2#10)(2012-3#1)(2013-1#13)(2013-8#7)
of this study was to examine the effects of##5##9##(1991-12#1)(2005-11#1)(2008-5#1)(2009-7#1)(2013-8#1)
of this study was to examine the experiences of##2##9##(1995-1#1)(2010-12#1)
of this study was to examine the feasibility of##2##9##(1995-2#1)(2007-8#1)
of this study was to examine the possible##2##8##(1996-2#1)(2011-2#1)
of this study was to examine the relationship between##3##9##(1997-7#1)(2007-1#1)(2010-2#1)
of this study was to examine the safety and efficacy of##2##11##(2004-1#1)(2008-5#1)
of this study was to examine the##48##7##(1991-12#1)(1992-6#1)(1995-1#1)(1995-10#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-3#1)(1997-7#1)(2004-1#1)(2005-11#1)(2006-7#1)(2006-8#2)(2007-1#2)(2007-10#2)(2007-7#1)(2007-8#1)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-7#2)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#2)
of this study was to examine##66##6##(1991-12#1)(1992-2#1)(1992-6#1)(1995-1#1)(1995-10#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-1#1)(2005-11#1)(2006-7#3)(2006-8#2)(2007-1#2)(2007-10#2)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#2)(2009-7#3)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-11#1)(2012-12#1)(2013-1#2)(2013-8#2)
of this study was to explore and##2##7##(2008-11#1)(2012-12#1)
of this study was to explore the##16##7##(2004-9#1)(2007-10#2)(2007-3#1)(2007-7#1)(2008-12#1)(2008-7#2)(2009-11#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
of this study was to explore##27##6##(2004-9#1)(2006-9#1)(2007-10#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-11#1)(2008-12#2)(2008-7#2)(2009-11#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
of this study was to find out##3##7##(2007-1#1)(2007-3#1)(2007-6#1)
of this study was to find##4##6##(2007-1#1)(2007-3#1)(2007-6#1)(2008-6#1)
of this study was to formulate an##2##7##(2008-5#1)(2012-7#1)
of this study was to further characterize the##3##8##(1992-12#1)(2008-10#1)(2009-5#1)
of this study was to further##6##6##(1992-12#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-5#1)
of this study was to identify the incidence##2##8##(2007-11#1)(2010-9#1)
of this study was to identify the##14##7##(2006-12#1)(2007-11#2)(2007-2#2)(2007-3#1)(2008-1#1)(2008-12#1)(2008-5#1)(2009-2#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-11#1)
of this study was to identify##34##6##(1990-2#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-2#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#1)
of this study was to improve the##2##7##(2008-11#1)(2012-3#1)
of this study was to improve##3##6##(2008-11#1)(2009-4#1)(2012-3#1)
of this study was to investigate how##4##7##(1996-6#1)(1997-8#1)(2008-9#1)(2013-7#1)
of this study was to investigate possible##3##7##(1995-12#1)(2008-10#1)(2012-2#1)
of this study was to investigate the effect of##16##9##(1995-3#1)(2005-8#1)(2007-10#1)(2007-8#1)(2008-12#1)(2008-5#2)(2008-7#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-11#1)(2011-12#1)(2012-2#1)
of this study was to investigate the effectiveness of##2##9##(2007-3#1)(2013-1#1)
of this study was to investigate the effects of##9##9##(1990-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
of this study was to investigate the effects##10##8##(1990-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
of this study was to investigate the expression of##2##9##(1992-8#1)(2008-10#1)
of this study was to investigate the in##2##8##(2008-4#1)(2008-5#1)
of this study was to investigate the influence of##4##9##(2007-2#1)(2008-12#1)(2010-2#1)(2011-1#1)
of this study was to investigate the occurrence of##2##9##(2008-7#1)(2013-1#1)
of this study was to investigate the potential##3##8##(2008-6#1)(2010-10#1)(2010-12#1)
of this study was to investigate the prevalence of##3##9##(2006-1#1)(2007-8#1)(2008-7#1)
of this study was to investigate the prevalence##5##8##(2006-1#1)(2007-2#1)(2007-8#1)(2008-7#1)(2012-1#1)
of this study was to investigate the relationship between##4##9##(2006-7#1)(2009-7#1)(2011-2#1)(2013-1#1)
of this study was to investigate the relationships between##2##9##(2008-10#1)(2013-1#1)
of this study was to investigate the##99##7##(1990-8#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-3#1)(1994-12#1)(1995-3#1)(1996-10#1)(1996-3#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-7#1)(2007-10#3)(2007-2#2)(2007-3#1)(2007-4#2)(2007-6#1)(2007-8#6)(2008-1#1)(2008-10#7)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#4)(2011-11#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#4)(2013-1#8)(2013-7#1)(2013-8#1)
of this study was to investigate whether the##4##8##(1995-4#1)(1997-7#1)(2007-10#1)(2010-7#1)
of this study was to investigate whether##15##7##(1995-4#1)(1995-9#1)(1997-7#1)(2006-5#1)(2007-10#1)(2008-5#1)(2008-6#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
of this study was to investigate##138##6##(1990-8#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-9#1)(1996-10#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-7#1)(1997-8#2)(2005-11#1)(2005-8#1)(2006-1#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#3)(2007-10#4)(2007-2#3)(2007-3#1)(2007-4#2)(2007-6#2)(2007-8#6)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#2)(2011-1#5)(2011-11#1)(2011-12#2)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#10)(2013-7#3)(2013-8#1)
of this study was to isolate##3##6##(1991-7#1)(1993-8#1)(2008-10#1)
of this study was to localize##2##6##(1993-8#1)(2006-8#1)
of this study was to measure the##6##7##(1990-8#1)(2007-1#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)
of this study was to measure##9##6##(1990-8#1)(1992-3#1)(2007-1#1)(2009-7#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#2)
of this study was to obtain##5##6##(1993-1#1)(1997-3#1)(2006-10#1)(2006-8#1)(2008-10#1)
of this study was to perform##3##6##(2007-7#1)(2009-8#1)(2011-2#1)
of this study was to prepare##4##6##(2008-5#3)(2012-12#1)
of this study was to present##6##6##(1994-2#1)(2005-10#1)(2008-10#2)(2008-6#1)(2011-2#1)
of this study was to provide a##3##7##(1995-2#1)(2007-8#1)(2009-5#1)
of this study was to provide##7##6##(1995-2#1)(2004-3#1)(2007-2#1)(2007-8#1)(2009-5#1)(2011-1#1)(2013-8#1)
of this study was to quantify the##6##7##(2007-1#1)(2007-10#1)(2007-4#2)(2008-10#1)(2009-5#1)
of this study was to quantify##7##6##(2007-1#1)(2007-10#1)(2007-4#2)(2008-10#1)(2009-5#1)(2010-9#1)
of this study was to report##4##6##(2008-9#2)(2013-8#2)
of this study was to retrospectively evaluate##2##7##(2011-2#1)(2012-1#1)
of this study was to review the##4##7##(2006-10#1)(2006-2#1)(2007-2#1)(2012-12#1)
of this study was to review##10##6##(2005-4#1)(2006-10#2)(2006-2#1)(2007-2#2)(2007-3#1)(2012-1#1)(2012-12#1)(2013-8#1)
of this study was to show##3##6##(1995-7#1)(2006-8#1)(2007-11#1)
of this study was to study the effect of##2##9##(2006-11#1)(2012-2#1)
of this study was to study the##4##7##(2006-11#1)(2007-10#1)(2012-2#1)(2013-8#1)
of this study was to study##6##6##(2006-11#1)(2007-10#1)(2008-3#1)(2012-1#1)(2012-2#1)(2013-8#1)
of this study was to synthesize##2##6##(2008-5#1)(2012-11#1)
of this study was to test the hypothesis that##3##9##(1993-12#1)(2006-9#1)(2007-10#1)
of this study was to test the##6##7##(1993-12#1)(2006-9#1)(2007-10#1)(2008-2#1)(2008-8#1)(2010-3#1)
of this study was to test##11##6##(1993-12#2)(2006-9#1)(2007-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2009-1#1)(2010-3#1)(2012-3#1)
of this study was to translate##2##6##(2007-12#1)(2011-1#1)
of this study was to understand the##5##7##(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#2)
of this study was to understand##6##6##(2008-11#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)
of this study was to use##9##6##(1993-12#1)(2006-3#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
of this study was to validate the##3##7##(2007-8#1)(2008-12#1)(2008-9#1)
of this study was to validate##4##6##(2007-8#1)(2008-12#1)(2008-8#1)(2008-9#1)
of this study was to verify the##4##7##(2008-6#2)(2008-7#2)
of this study was to verify whether the##2##8##(1997-1#1)(2010-9#1)
of this study was to verify##7##6##(1996-3#1)(1997-1#1)(2008-6#2)(2008-7#2)(2010-9#1)
of this study was to##1127##5##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-10#3)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#4)(1992-6#1)(1992-7#1)(1992-8#3)(1993-1#1)(1993-11#1)(1993-12#7)(1993-2#1)(1993-3#3)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#2)(1994-8#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#1)(1996-12#6)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#2)(1996-9#4)(1997-1#1)(1997-2#2)(1997-3#3)(1997-6#2)(1997-7#3)(1997-8#13)(2004-1#3)(2004-10#1)(2004-11#1)(2004-12#1)(2004-3#1)(2004-9#4)(2005-10#5)(2005-11#2)(2005-12#2)(2005-4#1)(2005-5#1)(2005-8#3)(2006-1#3)(2006-10#17)(2006-11#10)(2006-12#5)(2006-2#7)(2006-3#1)(2006-4#1)(2006-5#9)(2006-6#2)(2006-7#8)(2006-8#24)(2006-9#4)(2007-1#8)(2007-10#25)(2007-11#15)(2007-12#5)(2007-2#30)(2007-3#11)(2007-4#10)(2007-5#2)(2007-6#7)(2007-7#19)(2007-8#45)(2007-9#11)(2008-1#4)(2008-10#44)(2008-11#20)(2008-12#30)(2008-2#4)(2008-3#14)(2008-4#13)(2008-5#52)(2008-6#21)(2008-7#26)(2008-8#15)(2008-9#25)(2009-1#1)(2009-10#2)(2009-11#4)(2009-12#2)(2009-2#8)(2009-3#4)(2009-4#7)(2009-5#11)(2009-6#2)(2009-7#8)(2009-8#6)(2009-9#4)(2010-1#2)(2010-10#6)(2010-11#2)(2010-12#13)(2010-2#6)(2010-3#10)(2010-4#13)(2010-5#3)(2010-6#5)(2010-7#6)(2010-8#9)(2010-9#8)(2011-1#24)(2011-11#1)(2011-12#6)(2011-2#61)(2011-7#1)(2012-1#19)(2012-11#4)(2012-12#19)(2012-2#30)(2012-3#15)(2012-4#1)(2012-7#1)(2013-1#54)(2013-3#1)(2013-7#11)(2013-8#33)
of this study was twofold##2##5##(1994-1#1)(2010-8#1)
of this study was##1158##4##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-10#3)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#4)(1992-6#1)(1992-7#1)(1992-8#4)(1993-1#1)(1993-11#1)(1993-12#7)(1993-2#1)(1993-3#4)(1993-4#2)(1993-8#2)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#4)(1994-3#1)(1994-5#2)(1994-8#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#1)(1996-12#6)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#2)(1996-9#4)(1997-1#1)(1997-2#2)(1997-3#4)(1997-6#3)(1997-7#3)(1997-8#13)(2004-1#3)(2004-10#1)(2004-11#1)(2004-12#1)(2004-3#1)(2004-9#4)(2005-10#5)(2005-11#2)(2005-12#2)(2005-4#1)(2005-5#1)(2005-8#3)(2006-1#3)(2006-10#17)(2006-11#10)(2006-12#5)(2006-2#7)(2006-3#1)(2006-4#1)(2006-5#9)(2006-6#3)(2006-7#8)(2006-8#24)(2006-9#6)(2007-1#8)(2007-10#25)(2007-11#16)(2007-12#5)(2007-2#31)(2007-3#11)(2007-4#11)(2007-5#2)(2007-6#8)(2007-7#22)(2007-8#48)(2007-9#11)(2008-1#4)(2008-10#45)(2008-11#21)(2008-12#30)(2008-2#4)(2008-3#14)(2008-4#13)(2008-5#52)(2008-6#21)(2008-7#28)(2008-8#15)(2008-9#25)(2009-1#1)(2009-10#2)(2009-11#4)(2009-12#2)(2009-2#8)(2009-3#4)(2009-4#7)(2009-5#11)(2009-6#3)(2009-7#9)(2009-8#6)(2009-9#4)(2010-1#2)(2010-10#6)(2010-11#2)(2010-12#14)(2010-2#6)(2010-3#10)(2010-4#13)(2010-5#3)(2010-6#5)(2010-7#6)(2010-8#10)(2010-9#8)(2011-1#24)(2011-11#1)(2011-12#6)(2011-2#61)(2011-7#1)(2012-1#19)(2012-11#4)(2012-12#19)(2012-2#30)(2012-3#15)(2012-4#1)(2012-7#1)(2013-1#56)(2013-3#1)(2013-7#11)(2013-8#33)
of this study we##3##4##(1994-5#1)(2007-7#1)(2011-2#1)
of this study were (i) to##2##6##(2008-5#1)(2008-8#1)
of this study were to (a)##2##6##(2010-2#1)(2010-4#1)
of this study were to (i)##4##6##(2008-10#2)(2010-12#1)(2013-1#1)
of this study were to assess##3##6##(2007-7#1)(2011-2#1)(2012-12#1)
of this study were to characterize##3##6##(2008-10#1)(2013-1#1)(2013-8#1)
of this study were to compare##3##6##(2006-8#1)(2010-8#1)(2013-1#1)
of this study were to describe the##3##7##(2006-10#1)(2008-6#1)(2013-1#1)
of this study were to describe##4##6##(2006-10#1)(2008-6#1)(2009-5#1)(2013-1#1)
of this study were to determine the prevalence of##3##9##(2008-12#1)(2008-3#1)(2008-8#1)
of this study were to determine the##9##7##(1996-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-11#1)
of this study were to determine##14##6##(1996-1#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
of this study were to evaluate##6##6##(2008-10#2)(2008-12#1)(2008-5#1)(2009-8#1)(2010-3#1)
of this study were to examine##3##6##(2007-10#1)(2008-6#1)(2010-11#1)
of this study were to identify##4##6##(2008-10#1)(2008-11#1)(2009-9#1)(2013-1#1)
of this study were to investigate##5##6##(1995-10#1)(2008-12#1)(2010-12#1)(2010-2#1)(2011-2#1)
of this study were to##71##5##(1995-10#1)(1996-1#1)(2006-10#2)(2006-8#2)(2007-10#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#3)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#10)(2013-7#1)(2013-8#1)
of this study were##91##4##(1990-8#1)(1991-2#1)(1993-12#1)(1995-10#1)(1995-7#1)(1996-1#1)(1997-2#1)(2006-10#2)(2006-8#2)(2007-10#4)(2007-12#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#6)(2008-12#3)(2008-3#1)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#2)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#1)
of this study with##4##4##(2005-11#1)(2008-11#1)(2009-5#1)(2009-7#1)
of this study##1791##3##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#3)(1990-8#4)(1991-11#2)(1991-12#4)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#1)(1992-10#5)(1992-11#4)(1992-12#4)(1992-2#5)(1992-3#5)(1992-6#1)(1992-7#1)(1992-8#6)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#10)(1993-2#3)(1993-3#5)(1993-4#4)(1993-7#1)(1993-8#2)(1993-9#4)(1994-1#1)(1994-11#2)(1994-12#4)(1994-2#6)(1994-3#3)(1994-5#3)(1994-6#2)(1994-8#3)(1995-1#5)(1995-10#2)(1995-11#1)(1995-12#3)(1995-2#7)(1995-3#5)(1995-4#3)(1995-5#2)(1995-6#5)(1995-7#2)(1995-9#2)(1996-1#6)(1996-10#1)(1996-11#3)(1996-12#9)(1996-2#4)(1996-3#4)(1996-4#2)(1996-5#2)(1996-6#4)(1996-8#1)(1996-9#4)(1997-1#1)(1997-2#6)(1997-3#5)(1997-4#1)(1997-6#3)(1997-7#3)(1997-8#17)(2004-1#3)(2004-10#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-3#1)(2004-9#6)(2005-10#7)(2005-11#5)(2005-12#4)(2005-4#1)(2005-5#1)(2005-8#4)(2006-1#4)(2006-10#21)(2006-11#13)(2006-12#10)(2006-2#8)(2006-3#1)(2006-4#2)(2006-5#9)(2006-6#4)(2006-7#10)(2006-8#35)(2006-9#8)(2007-1#11)(2007-10#36)(2007-11#18)(2007-12#14)(2007-2#44)(2007-3#13)(2007-4#19)(2007-5#5)(2007-6#11)(2007-7#37)(2007-8#63)(2007-9#15)(2008-1#11)(2008-10#96)(2008-11#41)(2008-12#51)(2008-2#4)(2008-3#25)(2008-4#20)(2008-5#75)(2008-6#33)(2008-7#44)(2008-8#22)(2008-9#32)(2009-1#1)(2009-10#6)(2009-11#4)(2009-12#2)(2009-2#12)(2009-3#4)(2009-4#10)(2009-5#16)(2009-6#6)(2009-7#17)(2009-8#7)(2009-9#5)(2010-1#3)(2010-10#9)(2010-11#3)(2010-12#23)(2010-2#11)(2010-3#14)(2010-4#16)(2010-5#8)(2010-6#5)(2010-7#7)(2010-8#21)(2010-9#9)(2011-1#37)(2011-11#1)(2011-12#10)(2011-2#93)(2011-3#2)(2011-7#1)(2012-1#28)(2012-11#7)(2012-12#28)(2012-2#40)(2012-3#24)(2012-4#1)(2012-7#1)(2013-1#98)(2013-3#1)(2013-7#13)(2013-8#46)
of this subgroup##2##3##(2007-9#1)(2012-3#1)
of this subject##5##3##(2008-1#2)(2008-10#1)(2008-11#1)(2008-8#1)
of this subset##2##3##(2008-9#1)(2010-12#1)
of this substance##3##3##(2006-3#1)(2008-11#2)
of this substitution##2##3##(1994-9#1)(2007-8#1)
of this substrate##3##3##(1994-5#1)(1996-12#1)(1996-9#1)
of this subunit##6##3##(1992-11#2)(1995-2#1)(1995-8#1)(1996-8#1)(2009-7#1)
of this superfamily##2##3##(1996-8#1)(2006-10#1)
of this surface##2##3##(2008-10#1)(2008-2#1)
of this surgery##2##3##(2011-2#1)(2012-2#1)
of this surgical##5##3##(2006-5#1)(2007-7#1)(2007-8#1)(2013-1#1)(2013-8#1)
of this survey are##2##4##(1996-3#1)(2006-4#1)
of this survey indicate a##2##5##(1995-1#1)(2008-12#1)
of this survey indicate##3##4##(1990-3#1)(1995-1#1)(2008-12#1)
of this survey was to##5##5##(1991-12#1)(1993-5#1)(2006-8#1)(2007-5#1)(2011-2#1)
of this survey##18##3##(1990-3#1)(1991-12#1)(1993-5#1)(1995-1#1)(1996-1#1)(1996-3#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-9#1)(2009-11#1)(2011-2#2)(2012-1#1)
of this symposium##2##3##(2005-7#1)(2009-9#1)
of this syndrome are##2##4##(2006-7#1)(2013-1#1)
of this syndrome is##6##4##(2006-10#1)(2007-7#1)(2008-12#2)(2008-9#1)(2012-12#1)
of this syndrome##30##3##(1992-11#1)(1994-8#1)(1995-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(2006-10#3)(2006-4#1)(2006-7#1)(2006-9#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-12#2)(2008-3#3)(2008-5#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#3)
of this synergy##2##3##(1995-3#1)(1997-2#1)
of this synthetic##5##3##(1994-3#1)(1995-2#1)(2006-12#1)(2008-10#1)(2012-2#1)
of this system are##5##4##(1990-11#1)(2007-12#2)(2008-10#1)(2008-3#1)
of this system for##8##4##(1994-12#1)(1997-3#1)(1997-4#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-3#1)
of this system in the##3##5##(2008-5#1)(2011-12#2)
of this system in##7##4##(1997-3#1)(2007-12#1)(2008-2#1)(2008-5#1)(2011-1#1)(2011-12#2)
of this system is##12##4##(1992-3#1)(1997-3#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#4)
of this system to##2##4##(1993-12#1)(2010-5#1)
of this system was##3##4##(1991-9#1)(1997-8#1)(2008-3#1)
of this system##68##3##(1990-11#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-12#3)(1995-2#1)(1996-4#1)(1997-3#3)(1997-4#1)(1997-8#1)(2004-1#1)(2006-10#1)(2006-12#1)(2006-5#2)(2007-11#1)(2007-12#6)(2007-5#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#8)(2008-3#9)(2008-4#1)(2008-5#2)(2008-7#1)(2009-2#1)(2009-9#1)(2010-2#1)(2010-5#1)(2011-1#3)(2011-12#2)
of this systematic review is to##2##6##(2006-8#1)(2013-8#1)
of this systematic review was to##4##6##(2005-8#1)(2008-10#1)(2012-2#1)(2012-3#1)
of this systematic review##7##4##(2005-8#1)(2006-8#2)(2008-10#1)(2012-2#1)(2012-3#1)(2013-8#1)
of this systematic##8##3##(2005-8#1)(2006-8#2)(2008-10#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
of this target##2##3##(2008-2#1)(2008-9#1)
of this task##4##3##(1994-3#1)(1996-1#1)(2009-10#1)(2011-1#1)
of this technique and the##2##5##(1993-12#1)(2008-8#1)
of this technique and##4##4##(1993-12#1)(2008-7#2)(2008-8#1)
of this technique are discussed##2##5##(1993-10#1)(2007-11#1)
of this technique are##6##4##(1993-10#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)
of this technique as a##5##5##(1994-5#1)(2007-12#1)(2008-10#2)(2008-5#1)
of this technique by##2##4##(2007-12#1)(2008-3#1)
of this technique compared with the##2##6##(2006-8#1)(2008-3#1)
of this technique compared with##3##5##(2006-8#1)(2008-2#1)(2008-3#1)
of this technique for##8##4##(1991-2#1)(2005-7#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
of this technique has been##2##5##(2007-1#1)(2007-7#1)
of this technique has##4##4##(2007-1#1)(2007-7#1)(2008-4#1)(2011-2#1)
of this technique in the##2##5##(2008-2#1)(2013-1#1)
of this technique in##15##4##(1993-10#1)(1997-6#1)(2007-6#1)(2008-1#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2013-1#3)(2013-8#1)
of this technique include##4##4##(2007-11#1)(2008-2#2)(2010-7#1)
of this technique is##10##4##(2007-12#4)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2011-2#1)
of this technique to##12##4##(1991-8#1)(1991-9#1)(1993-3#1)(2007-12#3)(2007-8#2)(2008-2#1)(2008-3#1)(2009-9#1)(2012-1#1)
of this technique we##2##4##(2007-11#1)(2007-12#1)
of this technique##126##3##(1991-2#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-7#1)(1993-10#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-5#1)(1996-5#1)(1997-6#1)(2005-7#2)(2006-10#4)(2006-12#1)(2006-2#1)(2006-8#1)(2007-1#3)(2007-10#1)(2007-11#6)(2007-12#17)(2007-6#1)(2007-7#1)(2007-8#6)(2008-1#4)(2008-10#8)(2008-11#2)(2008-2#13)(2008-3#13)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-2#4)(2012-1#1)(2012-12#1)(2013-1#5)(2013-7#1)(2013-8#2)
of this technology and##2##4##(2010-5#1)(2011-2#1)
of this technology for##3##4##(2008-6#1)(2008-7#2)
of this technology has##2##4##(2007-11#1)(2007-12#1)
of this technology in##8##4##(1991-11#1)(1996-1#1)(2006-10#1)(2007-3#1)(2008-10#1)(2009-6#1)(2013-1#2)
of this technology is##2##4##(2008-7#1)(2012-3#1)
of this technology to##3##4##(1996-2#1)(2008-10#1)(2013-8#1)
of this technology##30##3##(1991-11#1)(1995-7#1)(1996-1#1)(1996-2#1)(1996-5#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-3#2)(2008-10#3)(2008-6#1)(2008-7#3)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-3#1)(2013-1#3)(2013-8#1)
of this term##3##3##(2012-2#1)(2013-1#2)
of this test in##2##4##(1992-2#1)(2008-7#1)
of this test##13##3##(1992-2#1)(1997-2#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#2)
of this theory in##2##4##(2011-1#2)
of this theory##6##3##(2006-10#1)(2008-7#1)(2010-10#1)(2011-1#2)(2011-2#1)
of this therapeutic method##2##4##(1992-10#1)(1995-5#1)
of this therapeutic modality##2##4##(2006-10#1)(2006-6#1)
of this therapeutic##7##3##(1991-12#1)(1992-10#1)(1995-4#1)(1995-5#1)(2006-10#1)(2006-6#1)(2007-12#1)
of this therapy in##4##4##(2006-10#1)(2007-11#1)(2008-3#1)(2010-12#1)
of this therapy is##2##4##(2012-12#1)(2013-8#1)
of this therapy##19##3##(1991-10#1)(1993-11#1)(2006-10#2)(2006-11#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-3#1)(2009-7#1)(2010-12#2)(2010-6#1)(2012-12#1)(2012-2#1)(2013-8#2)
of this tissue is##2##4##(1995-12#1)(2007-11#1)
of this tissue##5##3##(1991-10#1)(1992-9#2)(1995-12#1)(2007-11#1)
of this tolerance##2##3##(1992-2#1)(1993-12#1)
of this tool for##3##4##(2008-2#1)(2008-9#1)(2013-1#1)
of this tool##10##3##(1995-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-1#1)(2011-12#1)(2012-7#1)(2013-1#1)
of this topic##2##3##(2010-12#1)(2012-2#1)
of this toxicity##2##3##(2008-10#1)(2010-5#1)
of this trade-off##3##3##(2008-8#3)
of this traditional##2##3##(2008-10#1)(2009-7#1)
of this transcription factor##5##4##(1990-5#1)(1994-8#1)(1995-2#1)(2009-8#2)
of this transfer##2##3##(1994-11#1)(2012-12#1)
of this transition##2##3##(2008-5#1)(2011-2#1)
of this transporter is##2##4##(1994-10#1)(1996-5#1)
of this transporter##4##3##(1991-3#1)(1994-10#1)(1995-8#1)(1996-5#1)
of this transposon##2##3##(1994-8#1)(2008-10#1)
of this treatment approach##3##4##(1990-10#1)(2006-10#1)(2012-3#1)
of this treatment are##3##4##(2006-10#1)(2008-8#1)(2011-1#1)
of this treatment in##2##4##(1994-12#1)(2008-11#1)
of this treatment modality##6##4##(1990-4#2)(1992-10#1)(2006-10#1)(2007-7#1)(2011-1#1)
of this treatment were##2##4##(1991-3#1)(2006-9#1)
of this treatment##35##3##(1990-10#1)(1990-12#1)(1990-4#2)(1991-3#1)(1992-1#1)(1992-10#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-2#1)(2006-10#4)(2006-3#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2010-10#1)(2010-12#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
of this trend##5##3##(1995-11#1)(1996-5#1)(2008-12#1)(2010-7#1)(2012-2#1)
of this trial##4##3##(1991-9#1)(1996-3#1)(2004-1#1)(2011-2#1)
of this tumor and##3##4##(2013-1#2)(2013-7#1)
of this tumor in the##2##5##(2008-9#1)(2013-7#1)
of this tumor in##4##4##(1991-10#1)(2008-5#1)(2008-9#1)(2013-7#1)
of this tumor with##2##4##(1992-1#1)(2009-5#1)
of this tumor##22##3##(1990-9#1)(1991-10#1)(1992-1#1)(1992-6#1)(2006-2#1)(2006-8#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#2)
of this tumour##8##3##(1992-5#1)(1993-10#1)(2010-9#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
of this two-part series##3##4##(1993-2#1)(1996-2#1)(2011-1#1)
of this two-part##4##3##(1993-2#1)(1996-2#1)(2007-6#1)(2011-1#1)
of this type are##4##4##(1994-5#1)(2008-3#2)(2009-5#1)
of this type in##2##4##(1994-8#1)(2012-12#1)
of this type is##3##4##(1990-5#1)(2008-10#1)(2011-2#1)
of this type of cancer##2##5##(1996-3#1)(2011-2#1)
of this type of filter##2##5##(2007-11#1)(2008-3#1)
of this type of intervention by##2##6##(2008-9#1)(2012-2#1)
of this type of intervention##4##5##(1994-1#1)(2008-7#1)(2008-9#1)(2012-2#1)
of this type of##46##4##(1990-4#2)(1991-7#1)(1993-1#1)(1994-1#1)(1994-6#1)(1994-8#1)(1996-3#1)(1997-2#1)(1997-8#2)(2004-4#1)(2005-12#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#3)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#3)(2010-12#1)(2010-4#2)(2010-6#1)(2010-8#2)(2011-2#3)(2011-3#1)(2012-2#2)
of this type were##2##4##(1991-11#1)(2008-3#1)
of this type##76##3##(1990-4#2)(1990-5#1)(1991-11#1)(1991-4#1)(1991-7#1)(1992-1#1)(1993-1#1)(1994-1#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#2)(1995-1#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(2004-4#1)(2005-12#1)(2006-10#2)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#3)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#8)(2008-5#1)(2008-7#1)(2008-9#3)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#2)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#2)
of this tyrosine kinase##2##4##(2009-3#1)(2012-2#1)
of this tyrosine##3##3##(1991-9#1)(2009-3#1)(2012-2#1)
of this uncommon clinical##2##4##(2007-4#1)(2007-7#1)
of this uncommon disease##3##4##(1993-5#1)(2008-12#1)(2008-7#1)
of this uncommon##14##3##(1993-5#1)(2005-9#1)(2007-4#1)(2007-7#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#2)(2013-1#1)(2013-7#1)
of this understanding##2##3##(2008-12#2)
of this unique enzyme##2##4##(1996-2#1)(1997-9#1)
of this unique##12##3##(1993-11#1)(1994-10#1)(1996-2#1)(1997-9#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-7#1)(2013-1#1)
of this unit is to describe##2##6##(2008-4#2)
of this unit is to provide a##2##7##(2008-1#1)(2008-4#1)
of this unit is to provide an##2##7##(2008-4#1)(2008-9#1)
of this unit is to provide##4##6##(2008-1#1)(2008-4#2)(2008-9#1)
of this unit is to##14##5##(2008-1#1)(2008-4#9)(2008-9#4)
of this unit is##19##4##(2008-1#1)(2008-4#13)(2008-9#5)
of this unit##29##3##(1994-11#1)(2008-1#1)(2008-2#2)(2008-4#20)(2008-9#5)
of this unusual neoplasm##2##4##(2008-10#1)(2009-3#1)
of this unusual##15##3##(1997-6#1)(2006-10#1)(2006-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-6#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-7#1)(2011-1#1)(2012-1#1)
of this vaccine##2##3##(2007-11#1)(2012-3#1)
of this value##2##3##(1997-2#1)(2008-3#1)
of this variability##3##3##(1993-12#1)(1996-8#1)(2009-4#1)
of this variable##2##3##(2008-8#1)(2011-2#1)
of this variation##7##3##(2004-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#1)(2011-3#1)(2012-2#1)
of this variety##5##3##(1993-2#1)(1995-11#1)(1996-3#1)(2008-5#2)
of this vector##3##3##(1996-11#1)(1997-4#1)(2008-8#1)
of this very rare##2##4##(2008-6#1)(2008-9#1)
of this very##7##3##(1992-10#1)(1993-7#1)(1995-12#1)(2008-6#1)(2008-8#1)(2008-9#2)
of this viral##3##3##(1992-9#1)(1997-3#1)(2005-8#1)
of this virus and##2##4##(2008-10#1)(2013-8#1)
of this virus as a##2##5##(2011-2#1)(2013-8#1)
of this virus##11##3##(2008-10#2)(2008-5#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#2)(2013-8#2)
of this vitamin##3##3##(2007-7#2)(2010-6#1)
of this volume##2##3##(1994-6#1)(1997-8#1)
of this was##4##3##(1991-9#1)(1995-1#1)(1996-12#1)(1997-8#1)
of this wavelength##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
of this we##2##3##(1991-4#1)(2008-7#1)
of this well-attended##2##3##(1990-7#1)(2005-7#1)
of this widely##2##3##(2006-12#1)(2007-8#1)
of this work has##5##4##(2006-10#2)(2008-10#1)(2009-3#1)(2012-3#1)
of this work is that##4##5##(1990-7#1)(2008-5#1)(2008-7#1)(2010-2#1)
of this work is the development##2##6##(2008-10#1)(2008-5#1)
of this work is the##6##5##(2008-10#3)(2008-4#1)(2008-5#1)(2012-1#1)
of this work is to compare##3##6##(2004-2#1)(2010-2#1)(2013-1#1)
of this work is to evaluate##5##6##(2007-11#2)(2007-7#1)(2008-8#1)(2009-8#1)
of this work is to find##2##6##(2008-5#1)(2009-6#1)
of this work is to##37##5##(1991-5#1)(1993-10#1)(1996-8#1)(2004-2#1)(2005-10#1)(2006-2#2)(2007-11#3)(2007-7#1)(2008-10#5)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-6#1)(2009-8#1)(2010-2#2)(2011-2#2)(2012-2#3)(2013-1#2)(2013-7#1)
of this work is##51##4##(1990-7#1)(1991-12#1)(1991-5#1)(1993-10#1)(1996-8#1)(2004-2#1)(2005-10#1)(2006-2#2)(2007-11#3)(2007-7#1)(2008-10#9)(2008-2#2)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#2)(2009-3#1)(2009-6#1)(2009-8#1)(2010-2#3)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#2)(2013-7#1)
of this work was the##4##5##(2005-9#1)(2007-11#1)(2008-1#1)(2008-10#1)
of this work was to compare##4##6##(1993-12#1)(1996-5#1)(2010-4#1)(2013-8#1)
of this work was to determine##6##6##(1995-2#1)(2007-11#1)(2007-5#1)(2008-12#1)(2010-4#1)(2010-5#1)
of this work was to develop a##2##7##(1997-2#1)(2007-4#1)
of this work was to develop##5##6##(1997-2#1)(2007-4#1)(2010-12#1)(2012-2#2)
of this work was to establish the##2##7##(2006-10#1)(2010-12#1)
of this work was to establish##3##6##(2005-10#1)(2006-10#1)(2010-12#1)
of this work was to evaluate the##6##7##(1997-8#1)(2007-12#1)(2008-10#1)(2008-5#2)(2013-1#1)
of this work was to evaluate##9##6##(1997-8#1)(2007-12#1)(2008-10#2)(2008-5#3)(2013-1#1)(2013-8#1)
of this work was to investigate the##3##7##(2007-12#1)(2012-11#1)(2012-12#1)
of this work was to investigate##4##6##(2007-12#1)(2008-5#1)(2012-11#1)(2012-12#1)
of this work was to optimize##2##6##(2008-5#1)(2013-1#1)
of this work was to study the##8##7##(2007-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-7#1)
of this work was to study##12##6##(2007-1#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-7#2)
of this work was to test##2##6##(1991-11#1)(1997-3#1)
of this work was to##73##5##(1991-11#1)(1993-11#1)(1993-12#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-10#2)(2005-11#1)(2006-10#2)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#13)(2008-6#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-4#4)(2010-5#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#3)(2013-8#2)
of this work was##78##4##(1991-11#1)(1993-11#1)(1993-12#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-10#2)(2005-11#1)(2005-9#1)(2006-10#2)(2007-1#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#14)(2008-6#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-4#4)(2010-5#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#3)(2013-8#2)
of this work were to##4##5##(2008-10#3)(2008-5#1)
of this work were##6##4##(1994-6#1)(2008-10#3)(2008-5#1)(2010-4#1)
of this work##166##3##(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-4#1)(1993-10#1)(1993-11#1)(1993-12#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#3)(1996-5#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-2#1)(2005-10#4)(2005-11#1)(2005-9#1)(2006-10#4)(2006-2#2)(2007-1#2)(2007-10#1)(2007-11#6)(2007-12#3)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#24)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#21)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#2)(2010-2#3)(2010-4#7)(2010-5#2)(2010-8#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#5)(2013-8#2)
of this year's American##2##4##(2005-6#1)(2005-8#1)
of this year's##5##3##(2005-6#1)(2005-8#1)(2005-9#1)(2006-10#1)(2007-9#1)
of this yeast##2##3##(1992-12#1)(1996-12#1)
of this zone##3##3##(1991-1#1)(1997-4#1)(2013-7#1)
of this##9110##2##(1990-1#3)(1990-10#10)(1990-11#39)(1990-12#38)(1990-2#28)(1990-3#22)(1990-4#22)(1990-5#31)(1990-6#23)(1990-7#25)(1990-8#24)(1990-9#19)(1991-1#18)(1991-10#14)(1991-11#21)(1991-12#31)(1991-2#36)(1991-3#31)(1991-4#13)(1991-5#33)(1991-6#30)(1991-7#25)(1991-8#20)(1991-9#38)(1992-1#16)(1992-10#18)(1992-11#33)(1992-12#36)(1992-2#24)(1992-3#32)(1992-4#17)(1992-5#19)(1992-6#25)(1992-7#17)(1992-8#30)(1992-9#15)(1993-1#18)(1993-10#10)(1993-11#24)(1993-12#53)(1993-2#35)(1993-3#30)(1993-4#21)(1993-5#7)(1993-6#24)(1993-7#6)(1993-8#26)(1993-9#22)(1994-1#8)(1994-10#11)(1994-11#34)(1994-12#38)(1994-2#34)(1994-3#48)(1994-4#2)(1994-5#29)(1994-6#36)(1994-7#4)(1994-8#52)(1994-9#26)(1995-1#33)(1995-10#9)(1995-11#31)(1995-12#25)(1995-2#49)(1995-3#38)(1995-4#11)(1995-5#26)(1995-6#34)(1995-7#9)(1995-8#39)(1995-9#13)(1996-1#29)(1996-10#15)(1996-11#16)(1996-12#34)(1996-2#39)(1996-3#26)(1996-4#17)(1996-5#35)(1996-6#16)(1996-7#15)(1996-8#24)(1996-9#24)(1997-1#28)(1997-2#44)(1997-3#40)(1997-4#33)(1997-5#10)(1997-6#24)(1997-7#28)(1997-8#50)(1997-9#3)(2004-1#8)(2004-10#6)(2004-11#9)(2004-12#13)(2004-2#6)(2004-3#9)(2004-4#2)(2004-7#1)(2004-8#2)(2004-9#9)(2005-1#3)(2005-10#31)(2005-11#38)(2005-12#10)(2005-3#1)(2005-4#7)(2005-5#5)(2005-6#1)(2005-7#26)(2005-8#41)(2005-9#8)(2006-1#8)(2006-10#157)(2006-11#30)(2006-12#63)(2006-2#40)(2006-3#19)(2006-4#17)(2006-5#36)(2006-6#34)(2006-7#32)(2006-8#72)(2006-9#34)(2007-1#33)(2007-10#67)(2007-11#156)(2007-12#211)(2007-2#93)(2007-3#43)(2007-4#48)(2007-5#38)(2007-6#28)(2007-7#117)(2007-8#161)(2007-9#53)(2008-1#104)(2008-10#676)(2008-11#183)(2008-12#145)(2008-2#214)(2008-3#251)(2008-4#131)(2008-5#265)(2008-6#104)(2008-7#178)(2008-8#133)(2008-9#139)(2009-1#5)(2009-10#38)(2009-11#19)(2009-12#19)(2009-2#39)(2009-3#27)(2009-4#53)(2009-5#48)(2009-6#29)(2009-7#41)(2009-8#48)(2009-9#38)(2010-1#15)(2010-10#28)(2010-11#26)(2010-12#102)(2010-2#46)(2010-3#42)(2010-4#48)(2010-5#54)(2010-6#26)(2010-7#32)(2010-8#54)(2010-9#27)(2011-1#141)(2011-10#1)(2011-11#1)(2011-12#33)(2011-2#295)(2011-3#11)(2011-7#4)(2012-1#92)(2012-11#28)(2012-12#156)(2012-2#180)(2012-3#101)(2012-4#1)(2012-5#1)(2012-7#2)(2012-8#1)(2013-1#308)(2013-3#1)(2013-7#42)(2013-8#117)
of thl##2##2##(1995-2#2)
of thoracic and lumbar##2##4##(2008-12#1)(2008-7#1)
of thoracic and##3##3##(2008-12#1)(2008-7#1)(2012-12#1)
of thoracic aorta##4##3##(2008-10#1)(2009-8#1)(2013-7#2)
of thoracic aortic##2##3##(2007-8#1)(2008-11#1)
of thoracic disc disease##7##4##(2006-7#7)
of thoracic disc herniation##2##4##(2006-7#2)
of thoracic disc##12##3##(2006-7#12)
of thoracic diseases##2##3##(2004-2#1)(2010-8#1)
of thoracic epidural anaesthesia##2##4##(2006-10#1)(2007-8#1)
of thoracic epidural##3##3##(2006-10#1)(2007-8#1)(2012-2#1)
of thoracic injuries in##2##4##(2006-11#1)(2007-1#1)
of thoracic injuries##5##3##(1992-2#1)(2006-11#1)(2007-1#1)(2007-8#1)(2010-9#1)
of thoracic injury risk for all##2##6##(2006-11#1)(2007-4#1)
of thoracic injury##5##3##(2006-11#3)(2007-1#1)(2007-4#1)
of thoracic irradiation##2##3##(2004-1#2)
of thoracic kyphosis and lumbar lordosis##2##6##(2007-7#2)
of thoracic kyphosis##3##3##(2007-7#3)
of thoracic sclerites of mosquitoes (Diptera##2##6##(2013-1#2)
of thoracic sclerites##3##3##(2013-1#3)
of thoracic surgeons##3##3##(2007-8#3)
of thoracic sympathectomy##2##3##(2011-2#1)(2012-12#1)
of thoracic##78##2##(1990-10#1)(1991-3#1)(1992-11#1)(1992-2#2)(1993-1#1)(1994-3#1)(1994-6#1)(1997-8#1)(2004-1#2)(2004-2#1)(2006-10#3)(2006-11#6)(2006-3#1)(2006-7#13)(2007-1#2)(2007-11#1)(2007-4#1)(2007-7#3)(2007-8#9)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2009-2#1)(2009-3#1)(2009-8#1)(2010-8#2)(2010-9#1)(2011-2#2)(2012-12#3)(2012-2#5)(2013-1#3)(2013-7#2)
of thoraco-abdominal aneurysms##2##3##(2012-12#2)
of thoraco-omphalopagus twins in a rural secondary hospital##2##8##(2013-1#2)
of thoracoabdominal aortic aneurysm##2##4##(2008-12#1)(2012-12#1)
of thoracoabdominal aortic##3##3##(2005-10#1)(2008-12#1)(2012-12#1)
of thoracoabdominal##4##2##(2005-10#1)(2008-12#1)(2008-3#1)(2012-12#1)
of thoracolumbar##8##2##(2006-10#1)(2006-7#1)(2006-8#2)(2008-8#1)(2010-1#1)(2010-8#1)(2013-7#1)
of thoracoscopic##3##2##(2006-7#1)(2010-8#1)(2012-1#1)
of thorium and##4##3##(2008-10#4)
of thorium##14##2##(2008-10#14)
of thorium(IV)##4##2##(2008-10#4)
of thoroughly##3##2##(2007-9#1)(2011-1#1)(2012-3#1)
of those affected##2##3##(1995-1#1)(2010-5#1)
of those aged##2##3##(1990-12#1)(1992-5#1)
of those agents##3##3##(1990-2#1)(2006-5#1)(2007-11#1)
of those are##2##3##(2006-10#1)(2007-7#1)
of those associated with##2##4##(2007-11#1)(2007-9#1)
of those at the##3##4##(2004-3#1)(2008-12#1)(2008-8#1)
of those at##6##3##(1991-10#1)(2004-3#1)(2007-10#1)(2008-12#1)(2008-8#1)(2011-2#1)
of those cases##3##3##(1992-12#1)(1995-11#1)(2006-10#1)
of those cells##3##3##(1991-3#1)(2007-12#1)(2008-9#1)
of those changes##3##3##(1993-1#1)(1993-12#1)(2009-10#1)
of those children##2##3##(1993-3#1)(2010-11#1)
of those clones##2##3##(1992-8#1)(2008-11#1)
of those data##2##3##(2008-7#1)(2011-12#1)
of those diagnosed with##2##4##(2007-8#1)(2008-7#1)
of those diagnosed##3##3##(2004-2#1)(2007-8#1)(2008-7#1)
of those discharged from##2##4##(2007-9#1)(2008-10#1)
of those diseases##2##3##(1996-8#1)(2008-7#1)
of those evaluated by##2##4##(2006-8#2)
of those events##2##3##(1994-9#1)(2010-3#1)
of those experiences##2##3##(2007-9#1)(2012-2#1)
of those exposed##3##3##(1996-12#1)(2008-4#1)(2009-12#1)
of those factors##4##3##(1992-3#1)(2005-11#1)(2007-12#1)(2011-2#1)
of those from##5##3##(1990-2#1)(1991-1#1)(1994-8#1)(2008-10#2)
of those genes##2##3##(2008-7#1)(2012-3#1)
of those having##3##3##(2006-6#1)(2008-3#1)(2009-6#1)
of those in##5##3##(1990-2#2)(2008-4#1)(2010-10#1)(2011-2#1)
of those individuals##2##3##(2006-10#1)(2007-7#1)
of those infected##3##3##(2006-10#1)(2007-7#1)(2011-1#1)
of those interviewed##4##3##(1991-2#1)(1997-5#1)(2008-7#1)(2012-2#1)
of those involved in##3##4##(1995-8#1)(2005-5#1)(2012-3#1)
of those involved##6##3##(1994-1#1)(1995-8#1)(1996-9#1)(2004-7#1)(2005-5#1)(2012-3#1)
of those is##2##3##(2007-8#1)(2008-8#1)
of those lines##2##3##(2008-10#2)
of those methods##3##3##(1994-3#1)(2007-12#1)(2010-10#1)
of those mice##2##3##(1995-12#1)(1996-12#1)
of those molecules##2##3##(1990-3#1)(1990-8#1)
of those new##3##3##(1991-2#1)(2008-11#1)(2010-8#1)
of those not##5##3##(1990-6#1)(1993-1#1)(2006-8#2)(2008-3#1)
of those obtained##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
of those of the##2##4##(1993-11#1)(1994-3#1)
of those of##4##3##(1993-11#1)(1994-3#1)(2005-11#1)(2007-9#1)
of those on##6##3##(1991-2#1)(1996-3#1)(2007-2#1)(2008-11#2)(2008-6#1)
of those patients were adequately controlled with topical calcineurin inhibitors##2##10##(2010-8#2)
of those patients with##3##4##(2006-6#1)(2008-9#1)(2011-2#1)
of those patients##13##3##(2006-6#1)(2007-11#1)(2007-8#3)(2008-1#1)(2008-9#1)(2010-8#2)(2011-2#1)(2012-12#1)(2013-8#2)
of those presenting##3##3##(2007-10#1)(2008-1#1)(2008-3#1)
of those principles##2##3##(1996-2#2)
of those problems##4##3##(1997-1#1)(2011-2#1)(2013-1#2)
of those produced##2##3##(2004-9#1)(2008-10#1)
of those proteins##6##3##(1990-7#1)(1992-6#1)(1995-7#1)(2007-2#1)(2008-4#1)(2009-12#1)
of those receiving disability benefits##2##5##(2006-10#2)
of those receiving disability##3##4##(2006-10#2)(2006-8#1)
of those receiving##5##3##(2006-1#1)(2006-10#2)(2006-8#1)(2007-2#1)
of those receptors##3##3##(1991-6#1)(2008-4#2)
of those regions##2##3##(1991-9#1)(1996-3#1)
of those released from##2##4##(2008-11#2)
of those species have been##2##5##(2007-5#1)(2008-10#1)
of those species##3##3##(2007-5#1)(2008-10#2)
of those students##2##3##(2006-5#1)(2007-1#1)
of those subjects##3##3##(1992-3#1)(1993-7#1)(2006-10#1)
of those surveyed##3##3##(1997-3#1)(2008-1#1)(2012-2#1)
of those systems##3##3##(2006-10#1)(2008-2#1)(2012-2#1)
of those tested##2##3##(1990-5#1)(1997-2#1)
of those that have##2##4##(1996-1#1)(2009-10#1)
of those that##6##3##(1991-5#1)(1996-1#1)(2007-2#1)(2009-10#1)(2010-10#1)(2011-2#1)
of those treated for##2##4##(2008-6#1)(2012-12#1)
of those treated with##10##4##(1991-11#1)(1991-7#2)(1993-2#1)(1997-8#1)(2004-12#2)(2008-3#1)(2008-6#1)(2013-1#1)
of those treated##15##3##(1991-11#1)(1991-7#2)(1992-9#1)(1993-2#1)(1997-8#1)(2004-12#2)(2007-8#1)(2008-3#1)(2008-5#1)(2008-6#2)(2012-12#1)(2013-1#1)
of those under##2##3##(1993-2#1)(2011-2#1)
of those we##2##3##(2006-8#1)(2008-8#1)
of those were##3##3##(2008-12#1)(2011-2#1)(2012-2#1)
of those who are##6##4##(1990-12#1)(1992-2#1)(1994-1#1)(2007-12#1)(2008-10#1)(2011-2#1)
of those who experienced##2##4##(1992-1#1)(2012-11#1)
of those who had##6##4##(1990-12#1)(1990-4#1)(1991-12#1)(2012-12#1)(2012-3#1)(2013-7#1)
of those who may be##2##5##(2012-1#1)(2013-8#1)
of those who received##2##4##(1993-3#1)(2010-8#1)
of those who seek##2##4##(2009-5#1)(2010-2#1)
of those who were##7##4##(1991-9#1)(1993-3#1)(1997-8#1)(2010-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
of those who##53##3##(1990-12#2)(1990-4#1)(1990-6#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-1#2)(1992-2#1)(1992-5#1)(1993-3#2)(1994-1#1)(1994-3#3)(1997-8#1)(2004-10#1)(2006-10#2)(2006-5#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-10#1)(2010-2#2)(2010-4#1)(2010-6#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
of those whose##3##3##(2008-3#1)(2011-1#1)(2013-8#1)
of those with a##5##4##(1993-2#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-2#1)
of those with febrile##2##4##(1990-3#1)(2011-2#1)
of those with known##2##4##(2008-11#1)(2011-1#1)
of those with the##5##4##(1993-10#2)(2006-8#1)(2007-11#1)(2008-3#1)
of those with##45##3##(1990-3#1)(1990-4#1)(1990-6#2)(1990-9#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-10#2)(1993-2#1)(1996-3#1)(1997-5#1)(2004-10#2)(2005-8#1)(2006-10#2)(2006-8#1)(2007-11#1)(2008-1#2)(2008-11#1)(2008-3#2)(2008-4#2)(2008-7#1)(2009-11#1)(2009-2#2)(2010-1#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)
of those without##4##3##(1990-8#1)(1990-9#1)(1993-8#1)(2006-10#1)
of those words##2##3##(2010-2#1)(2012-2#1)
of those##518##2##(1990-10#1)(1990-11#3)(1990-12#7)(1990-2#6)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#4)(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#4)(1991-5#2)(1991-6#3)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#4)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#3)(1992-8#2)(1992-9#1)(1993-1#3)(1993-10#2)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#3)(1993-4#1)(1993-7#1)(1993-8#2)(1994-1#3)(1994-11#1)(1994-12#3)(1994-3#7)(1994-8#2)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#4)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#1)(1997-3#2)(1997-5#3)(1997-6#1)(1997-8#4)(2004-10#3)(2004-12#2)(2004-2#1)(2004-3#1)(2004-7#1)(2004-9#2)(2005-11#3)(2005-5#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#21)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#4)(2006-6#7)(2006-7#2)(2006-8#9)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#7)(2007-12#10)(2007-2#6)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#9)(2007-9#5)(2008-1#9)(2008-10#27)(2008-11#11)(2008-12#3)(2008-2#5)(2008-3#13)(2008-4#10)(2008-5#11)(2008-6#5)(2008-7#13)(2008-8#7)(2008-9#3)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#3)(2009-5#3)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#5)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#8)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#18)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#13)(2012-3#6)(2013-1#12)(2013-7#1)(2013-8#10)
of thought regarding##2##3##(2009-4#1)(2013-8#1)
of thought suppression##2##3##(2009-11#2)
of thought##15##2##(1996-2#1)(1997-2#1)(2005-7#1)(2006-9#1)(2008-11#1)(2008-2#2)(2008-4#1)(2009-11#2)(2009-4#1)(2010-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
of thoughts##2##2##(2010-6#1)(2012-12#1)
of thousands of genes simultaneously##2##5##(2008-7#1)(2010-2#1)
of thousands of genes##6##4##(2007-12#1)(2008-2#1)(2008-7#2)(2010-2#1)(2011-3#1)
of thousands of##32##3##(1991-9#1)(1995-10#1)(2005-11#1)(2005-9#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-1#2)(2008-10#1)(2008-2#3)(2008-4#2)(2008-6#1)(2008-7#6)(2009-4#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#1)
of thousands##33##2##(1991-9#1)(1995-10#1)(2005-11#1)(2005-9#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-1#2)(2008-10#1)(2008-2#3)(2008-4#2)(2008-6#1)(2008-7#6)(2009-4#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#1)
of threat##8##2##(1991-10#1)(1991-4#1)(2007-11#1)(2007-8#1)(2011-1#1)(2012-2#3)
of threatened##3##2##(1991-9#1)(1993-6#1)(2012-1#1)
of threatening##3##2##(1992-8#1)(1993-3#1)(1996-10#1)
of threats and violence##2##4##(2011-1#2)
of threats to##2##3##(2011-2#1)(2012-1#1)
of threats##4##2##(2011-1#2)(2011-2#1)(2012-1#1)
of three Baccharis species##2##4##(2007-1#2)
of three additional##2##3##(1991-4#1)(2006-11#1)
of three amino acid residues##2##5##(1993-11#1)(2008-8#1)
of three amino##3##3##(1993-11#1)(1994-12#1)(2008-8#1)
of three and four##2##4##(1991-8#1)(2008-10#1)
of three and##6##3##(1990-6#1)(1991-8#1)(1992-8#1)(2007-1#1)(2008-10#1)(2013-1#1)
of three articles##3##3##(1991-4#1)(1996-12#1)(1996-3#1)
of three bacterial##2##3##(2008-10#1)(2011-1#1)
of three basic##5##3##(1994-9#1)(2007-11#1)(2007-12#1)(2008-7#1)(2010-2#1)
of three brands##2##3##(2008-2#1)(2013-1#1)
of three broad##2##3##(2006-12#1)(2011-2#1)
of three case studies##3##4##(1991-1#1)(1991-12#1)(2010-12#1)
of three cases from##2##4##(2007-2#1)(2009-6#1)
of three cases of##3##4##(1996-3#1)(2008-8#1)(2011-12#1)
of three cases##36##3##(1991-12#1)(1991-6#1)(1992-4#1)(1993-10#1)(1996-12#2)(1996-3#1)(2005-10#1)(2006-12#1)(2006-4#2)(2006-7#1)(2007-2#3)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-6#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
of three chemical##2##3##(2008-10#1)(2008-5#1)
of three children with##2##4##(1993-5#1)(2006-12#1)
of three classes of##2##4##(1994-9#1)(1995-2#1)
of three clinical trials that##2##5##(1996-8#1)(2008-6#1)
of three clinical trials##4##4##(1996-8#1)(2008-6#1)(2008-8#1)(2012-3#1)
of three clinical##5##3##(1996-8#1)(2008-10#1)(2008-6#1)(2008-8#1)(2012-3#1)
of three commercial##3##3##(1992-2#1)(2008-5#1)(2012-3#1)
of three commercially available##2##4##(1992-8#1)(2013-8#1)
of three commercially##3##3##(1992-8#1)(2013-7#1)(2013-8#1)
of three common##4##3##(1997-4#1)(2006-8#1)(2008-10#1)(2011-2#1)
of three complementary##2##3##(2005-11#1)(2006-7#1)
of three compounds##2##3##(2007-1#1)(2007-5#1)
of three consecutive##4##3##(1994-4#1)(2008-9#1)(2010-1#1)(2010-8#1)
of three conserved##2##3##(1996-12#1)(1997-7#1)
of three dental##2##3##(2012-2#1)(2013-1#1)
of three different dopaminergic##2##4##(1996-12#1)(1996-5#1)
of three different restriction enzymes##2##5##(2008-10#2)
of three different short##2##4##(2007-12#1)(2012-11#1)
of three different types of##2##5##(2008-10#1)(2010-8#1)
of three different##61##3##(1990-11#1)(1990-12#2)(1991-10#1)(1991-2#1)(1992-2#1)(1992-3#2)(1993-11#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-8#1)(1995-10#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-5#1)(2005-11#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-6#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#1)(2008-5#2)(2009-2#1)(2009-4#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
of three differently##2##3##(1997-4#1)(2008-10#1)
of three dimensional transesophageal echocardiography##2##5##(2010-7#2)
of three dimensional##7##3##(1995-8#1)(2010-7#4)(2012-2#1)(2012-3#1)
of three distinct##10##3##(1994-2#1)(1994-5#1)(1995-4#1)(1995-8#1)(1996-10#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2009-4#1)
of three domains##3##3##(1993-3#1)(1997-5#1)(2009-6#1)
of three doses of##6##4##(1992-9#1)(1995-12#1)(1995-3#1)(1996-1#1)(2007-2#1)(2011-2#1)
of three doses##7##3##(1992-9#1)(1995-12#1)(1995-3#1)(1996-1#1)(2007-2#1)(2011-2#1)(2013-8#1)
of three drugs##2##3##(2008-10#1)(2008-5#1)
of three dyes##2##3##(2008-10#2)
of three enzymes##4##3##(2008-10#2)(2008-11#1)(2009-10#1)
of three exons and two introns##2##6##(1990-8#1)(1991-2#1)
of three exons##3##3##(1990-8#1)(1991-2#1)(1992-1#1)
of three experiments##3##3##(2008-10#2)(2008-2#1)
of three flavonoids##2##3##(2008-10#2)
of three forms of##2##4##(1991-10#1)(1991-8#1)
of three forms##3##3##(1991-10#1)(1991-8#2)
of three functional##2##3##(1994-12#1)(2007-12#1)
of three genes##4##3##(1994-12#1)(1995-8#1)(1996-5#1)(1997-4#1)
of three genetically##2##3##(1995-7#1)(2013-1#1)
of three groups of##2##4##(1994-1#1)(2009-5#1)
of three groups##8##3##(1991-1#1)(1994-1#1)(2006-9#1)(2008-1#1)(2008-10#2)(2008-4#1)(2009-5#1)
of three healthy##2##3##(1996-12#1)(2006-8#1)
of three highly##3##3##(2008-10#1)(2008-3#2)
of three hours##2##3##(1996-6#1)(2011-1#1)
of three human##9##3##(1991-6#1)(1992-8#1)(1994-11#1)(2006-12#1)(2007-1#1)(2007-6#1)(2008-11#2)(2008-6#1)
of three identified##2##3##(2007-12#1)(2010-11#1)
of three important##3##3##(1992-11#1)(2008-10#1)(2008-3#1)
of three independent experiments##2##4##(2007-6#2)
of three independent##9##3##(1995-5#1)(2007-11#2)(2007-6#2)(2008-10#3)(2009-2#1)
of three instruments##2##3##(2008-3#1)(2013-1#1)
of three interrelated##2##3##(2010-8#1)(2013-1#1)
of three isoforms##2##3##(1995-3#1)(2008-10#1)
of three isolates of##2##4##(2008-12#1)(2008-6#1)
of three isolates##5##3##(2008-10#2)(2008-12#1)(2008-6#1)(2011-1#1)
of three key##4##3##(1995-2#1)(2006-8#1)(2007-4#1)(2008-11#1)
of three kinds of##4##4##(1992-8#1)(2005-4#1)(2008-10#1)(2008-7#1)
of three large##3##3##(1994-9#1)(1995-12#1)(2011-2#1)
of three layers##8##3##(2007-1#1)(2008-10#4)(2008-11#1)(2010-8#2)
of three levels of##2##4##(2007-9#1)(2008-2#1)
of three ligands##2##3##(1995-11#1)(1996-2#1)
of three lipid##2##3##(1994-3#1)(1994-5#1)
of three main##6##3##(1994-8#1)(1996-1#1)(1997-2#1)(1997-4#1)(2008-10#2)
of three major##8##3##(1991-9#1)(1993-12#1)(1997-8#2)(2008-10#1)(2008-4#1)(2010-3#1)(2013-7#1)
of three members##2##3##(1993-12#1)(2009-6#1)
of three membrane##2##3##(1990-11#1)(2009-7#1)
of three methods for the##2##5##(1990-12#1)(1994-12#1)
of three methods for##3##4##(1990-12#1)(1994-12#1)(2008-6#1)
of three methods##6##3##(1990-12#1)(1993-1#1)(1994-12#1)(2008-6#1)(2010-8#1)(2013-7#1)
of three models##2##3##(2012-2#1)(2012-3#1)
of three months and##3##4##(1991-11#1)(1993-6#1)(2008-11#1)
of three months##13##3##(1990-2#1)(1991-11#1)(1991-4#1)(1991-6#1)(1992-11#1)(1993-6#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-11#1)(2010-4#1)(2013-1#2)
of three new##6##3##(1993-11#1)(1997-3#1)(2006-12#1)(2007-1#1)(2008-10#2)
of three novel##5##3##(1996-12#1)(1997-7#1)(2012-3#1)(2013-1#2)
of three nuclear##2##3##(1993-3#1)(2007-12#1)
of three of the##7##4##(1990-6#1)(1994-12#1)(1994-5#1)(2006-10#1)(2006-9#1)(2008-5#1)(2010-6#1)
of three of them##2##4##(1992-7#1)(2009-11#1)
of three of these##2##4##(2008-5#1)(2010-5#1)
of three of##11##3##(1990-6#1)(1992-7#1)(1994-12#1)(1994-5#1)(2006-10#1)(2006-9#1)(2008-5#2)(2009-11#1)(2010-5#1)(2010-6#1)
of three on##2##3##(1992-10#1)(1997-8#1)
of three or more##3##4##(2006-10#1)(2008-11#1)(2008-3#1)
of three or##6##3##(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-11#1)
of three pairs of##2##4##(2007-12#1)(2008-7#1)
of three para-benzoquinone mono-oximes and##2##5##(2007-10#2)
of three patients with##2##4##(1990-8#1)(1996-3#1)
of three patients##11##3##(1990-8#1)(1990-9#1)(1991-8#1)(1995-11#1)(1996-3#1)(2007-11#1)(2007-7#1)(2008-11#2)(2012-2#1)(2013-1#1)
of three pediatric patients with##2##5##(2011-1#1)(2013-8#1)
of three peptides##2##3##(1992-2#1)(1996-12#1)
of three phase##2##3##(2008-3#1)(2008-7#1)
of three phases##4##3##(1991-6#1)(1993-12#1)(1993-3#1)(1997-6#1)
of three plant##2##3##(2008-10#1)(2013-8#1)
of three populations##2##3##(2005-11#1)(2008-10#1)
of three protein##2##3##(1995-2#1)(2011-1#1)
of three related##2##3##(1991-7#1)(2008-10#1)
of three selected##3##3##(1993-11#1)(2008-10#1)(2009-8#1)
of three selective serotonin reuptake inhibitors##2##6##(2007-8#1)(2010-2#1)
of three separate##2##3##(1996-2#1)(2008-10#1)
of three sequential##3##3##(1994-5#1)(1996-5#1)(2008-10#1)
of three series##2##3##(2008-5#1)(2009-9#1)
of three sites##2##3##(1995-1#1)(2013-7#1)
of three species of##8##4##(1993-9#1)(2007-12#2)(2008-10#1)(2008-5#1)(2008-9#1)(2010-2#1)(2013-8#1)
of three species##11##3##(1993-9#1)(2007-12#2)(2008-10#3)(2008-5#1)(2008-9#1)(2010-2#1)(2011-2#1)(2013-8#1)
of three specific##2##3##(1995-10#1)(2007-12#1)
of three stages##4##3##(1996-3#1)(1996-6#1)(2008-6#1)(2009-5#1)
of three strains of the##2##5##(2008-10#1)(2008-11#1)
of three strains of##5##4##(1994-2#1)(2008-10#3)(2008-11#1)
of three structurally##3##3##(1992-8#1)(1995-5#1)(1997-3#1)
of three substituted##2##3##(2007-10#1)(2008-10#1)
of three subunits##2##3##(1992-11#1)(1997-4#1)
of three such##2##3##(2007-11#1)(2007-12#1)
of three surfactants##2##3##(2005-11#1)(2008-10#1)
of three surgical procedures##2##4##(1993-5#1)(1995-12#1)
of three surgical##3##3##(1993-5#1)(1994-3#1)(1995-12#1)
of three tissues##2##3##(2008-3#2)
of three to five##4##4##(1994-9#1)(2008-1#1)(2008-2#1)(2009-8#1)
of three to##7##3##(1994-9#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-5#1)(2009-8#1)
of three trials##2##3##(2008-1#1)(2008-10#1)
of three trials)##2##3##(2008-10#2)
of three types of##11##4##(1991-7#1)(1992-4#1)(1993-11#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#2)(2009-3#1)(2013-1#1)
of three types##12##3##(1991-7#1)(1992-4#1)(1993-11#1)(1995-5#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#2)(2009-3#1)(2013-1#1)
of three very##2##3##(1992-2#1)(2007-3#1)
of three was##3##3##(1990-6#1)(2008-10#2)
of three weeks##2##3##(1991-3#1)(1996-6#1)
of three whitefly-borne closteroviruses##2##4##(2008-10#2)
of three widely used##3##4##(2008-10#1)(2013-1#2)
of three with##2##3##(2008-5#1)(2008-6#1)
of three years##12##3##(1991-6#1)(1993-9#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-8#1)(2009-5#1)(2009-6#1)(2010-10#1)(2011-1#1)(2012-2#1)
of three##1017##2##(1990-10#3)(1990-11#2)(1990-12#9)(1990-2#2)(1990-3#2)(1990-5#2)(1990-6#3)(1990-7#2)(1990-8#6)(1990-9#1)(1991-1#3)(1991-10#3)(1991-11#2)(1991-12#4)(1991-2#5)(1991-3#3)(1991-4#3)(1991-6#7)(1991-7#2)(1991-8#8)(1991-9#4)(1992-1#3)(1992-10#1)(1992-11#8)(1992-12#1)(1992-2#6)(1992-3#4)(1992-4#3)(1992-5#4)(1992-6#1)(1992-7#3)(1992-8#10)(1992-9#4)(1993-1#1)(1993-10#1)(1993-11#10)(1993-12#6)(1993-2#1)(1993-3#7)(1993-4#2)(1993-5#2)(1993-6#4)(1993-9#7)(1994-1#1)(1994-11#4)(1994-12#6)(1994-2#2)(1994-3#5)(1994-4#1)(1994-5#5)(1994-6#2)(1994-8#6)(1994-9#6)(1995-1#3)(1995-10#2)(1995-11#4)(1995-12#6)(1995-2#6)(1995-3#3)(1995-4#1)(1995-5#3)(1995-6#2)(1995-7#2)(1995-8#8)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#2)(1996-12#10)(1996-2#6)(1996-3#6)(1996-5#6)(1996-6#7)(1996-7#3)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#3)(1997-3#3)(1997-4#10)(1997-5#6)(1997-6#3)(1997-7#4)(1997-8#4)(2004-11#3)(2004-8#1)(2005-1#1)(2005-10#1)(2005-11#14)(2005-4#1)(2005-8#1)(2006-10#9)(2006-11#2)(2006-12#10)(2006-2#1)(2006-4#4)(2006-5#2)(2006-6#2)(2006-7#4)(2006-8#5)(2006-9#2)(2007-1#12)(2007-10#3)(2007-11#11)(2007-12#30)(2007-2#7)(2007-3#5)(2007-4#4)(2007-5#1)(2007-6#6)(2007-7#6)(2007-8#9)(2007-9#6)(2008-1#10)(2008-10#149)(2008-11#26)(2008-12#8)(2008-2#31)(2008-3#24)(2008-4#10)(2008-5#31)(2008-6#15)(2008-7#14)(2008-8#9)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#4)(2009-2#3)(2009-3#1)(2009-4#3)(2009-5#4)(2009-6#5)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#4)(2010-2#13)(2010-3#2)(2010-4#8)(2010-5#5)(2010-6#1)(2010-7#5)(2010-8#7)(2010-9#1)(2011-1#14)(2011-11#1)(2011-12#3)(2011-2#16)(2012-1#3)(2012-11#1)(2012-12#7)(2012-2#14)(2012-3#7)(2012-5#2)(2013-1#31)(2013-7#5)(2013-8#10)
of three)##2##2##(1990-2#1)(2007-8#1)
of three-##2##2##(2008-10#1)(2010-4#1)
of three-dimensional (3-D)##3##3##(2007-12#1)(2008-2#1)(2011-1#1)
of three-dimensional (3D)##8##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2009-2#1)(2010-10#1)(2013-1#1)
of three-dimensional images##2##3##(2007-11#2)
of three-dimensional object##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
of three-dimensional objects##5##3##(1996-2#1)(2007-12#1)(2008-2#1)(2008-3#2)
of three-dimensional structures##3##3##(1993-6#1)(2007-11#1)(2007-12#1)
of three-dimensional topological##2##3##(2008-2#1)(2012-2#1)
of three-dimensional##74##2##(1991-1#1)(1991-5#1)(1993-6#1)(1995-8#1)(1996-2#1)(2006-2#1)(2007-11#11)(2007-12#13)(2007-4#1)(2007-8#3)(2008-11#1)(2008-2#15)(2008-3#8)(2008-6#1)(2008-7#1)(2009-12#1)(2009-2#2)(2010-10#1)(2010-9#2)(2011-1#2)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
of three-spined stickleback Gasterosteus aculeatus##2##5##(2010-8#2)
of three-spined sticklebacks Gasterosteus aculeatus##2##5##(2010-8#2)
of three-spined##4##2##(2010-8#4)
of three-wave##2##2##(2007-12#1)(2008-2#1)
of three-way data##2##3##(2008-10#2)
of three-way##9##2##(2007-10#1)(2008-10#8)
of threedimensional##2##2##(1995-11#1)(2013-1#1)
of threonine##6##2##(1991-10#1)(1994-9#1)(1995-1#1)(2006-7#1)(2006-8#1)(2008-11#1)
of threshold logic##2##3##(2008-2#2)
of threshold##12##2##(1993-12#1)(1996-4#1)(2006-4#1)(2008-2#4)(2008-3#3)(2008-8#1)(2008-9#1)
of thresholds##3##2##(2008-7#1)(2009-9#1)(2012-1#1)
of thrips##3##2##(2008-10#3)
of thrombi in the##2##4##(2008-1#1)(2008-5#1)
of thrombi##7##2##(1990-12#1)(2008-1#1)(2008-12#1)(2008-5#2)(2011-1#1)(2012-12#1)
of thrombin and##5##3##(1994-11#1)(1994-12#1)(2005-7#2)(2007-10#1)
of thrombin generation##2##3##(2005-8#1)(2007-9#1)
of thrombin in the##2##4##(1994-12#1)(2008-4#1)
of thrombin inhibition##3##3##(1994-11#1)(1994-12#1)(2009-3#1)
of thrombin on##2##3##(1991-9#1)(1996-8#1)
of thrombin to##2##3##(1990-11#1)(2010-12#1)
of thrombin with##3##3##(1991-6#1)(1996-5#1)(2007-8#1)
of thrombin##55##2##(1990-11#4)(1990-7#1)(1991-6#5)(1991-9#2)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-11#2)(1994-12#6)(1994-3#1)(1994-5#1)(1996-2#1)(1996-5#1)(1996-8#3)(1997-1#3)(1997-2#1)(1997-4#2)(2004-11#1)(2005-7#2)(2005-8#1)(2007-10#2)(2007-8#2)(2007-9#1)(2008-4#1)(2009-12#2)(2009-3#1)(2010-12#1)(2012-1#3)
of thrombin-induced##3##2##(1990-10#1)(1995-11#1)(1996-8#1)
of thrombin-stimulated##3##2##(1990-12#1)(1990-5#1)(1993-8#1)
of thrombo-embolic##2##2##(1997-6#2)
of thrombocyte concentrates##3##3##(1996-1#3)
of thrombocyte##4##2##(1991-11#1)(1996-1#3)
of thrombocytes and##2##3##(1996-1#1)(2007-9#1)
of thrombocytes in##2##3##(2013-1#2)
of thrombocytes##7##2##(1996-1#2)(2007-9#1)(2013-1#4)
of thrombocytopaenia##2##2##(2008-8#1)(2013-8#1)
of thrombocytopenia in##2##3##(1990-12#1)(2006-9#1)
of thrombocytopenia##10##2##(1990-10#1)(1990-12#1)(1990-6#1)(2006-9#1)(2007-11#1)(2008-8#3)(2011-12#1)(2013-1#1)
of thrombocytosis##5##2##(1990-12#4)(2005-10#1)
of thromboelastography##3##2##(2007-8#2)(2013-1#1)
of thromboembolic complications in patients with##2##6##(1990-12#1)(2007-8#1)
of thromboembolic complications in##3##4##(1990-12#1)(2007-11#1)(2007-8#1)
of thromboembolic complications##8##3##(1990-12#1)(1991-7#1)(1997-5#1)(1997-6#1)(2007-11#1)(2007-8#3)
of thromboembolic disease##4##3##(2005-1#1)(2008-1#1)(2008-5#1)(2012-2#1)
of thromboembolic diseases##2##3##(1992-9#1)(2010-3#1)
of thromboembolic disorders##3##3##(2005-7#3)
of thromboembolic events##4##3##(1994-3#1)(1996-4#1)(2007-12#1)(2008-10#1)
of thromboembolic risk##2##3##(2007-9#1)(2010-7#1)
of thromboembolic##28##2##(1990-12#1)(1991-3#1)(1991-7#1)(1992-9#1)(1994-3#1)(1996-4#1)(1997-5#1)(1997-6#1)(2005-1#1)(2005-12#1)(2005-7#3)(2007-11#1)(2007-12#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-3#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
of thromboembolism and##2##3##(2007-8#1)(2008-7#1)
of thromboembolism in##3##3##(2006-8#1)(2007-8#2)
of thromboembolism were##2##3##(1990-12#2)
of thromboembolism##18##2##(1990-12#2)(1997-1#2)(2005-1#1)(2006-10#2)(2006-8#1)(2007-8#5)(2008-5#1)(2008-7#1)(2010-12#1)(2010-6#1)(2012-12#1)
of thrombolysis in##3##3##(2007-10#1)(2007-9#1)(2009-11#1)
of thrombolysis##9##2##(1990-3#1)(1994-3#2)(2007-10#3)(2007-9#2)(2009-11#1)
of thrombolytic agents in##3##4##(1990-12#1)(2006-10#1)(2007-7#1)
of thrombolytic therapy in acute##2##5##(1997-1#1)(2010-8#1)
of thrombolytic therapy in##3##4##(1995-9#1)(1997-1#1)(2010-8#1)
of thrombolytic therapy##16##3##(1990-6#1)(1993-9#1)(1995-6#1)(1995-9#2)(1997-1#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-8#1)(2013-7#1)
of thrombolytic treatment##2##3##(1990-12#1)(2007-9#1)
of thrombolytic##24##2##(1990-12#2)(1990-6#1)(1993-9#1)(1995-6#1)(1995-9#2)(1997-1#1)(1997-8#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-7#1)(2008-8#2)(2009-11#1)(2010-8#1)(2013-7#2)
of thrombolytics is##2##3##(2006-7#1)(2007-11#1)
of thrombolytics##7##2##(1997-3#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-9#1)(2008-3#1)
of thrombomodulin##3##2##(1990-5#1)(1995-5#1)(1997-2#1)
of thrombopoiesis##2##2##(2006-6#2)
of thrombopoietin##5##2##(1997-4#2)(2008-5#1)(2008-8#2)
of thromboprophylaxis##2##2##(2005-1#1)(2013-1#1)
of thrombosed polytetrafluoroethylene (PTFE) grafts##2##5##(2007-7#2)
of thrombosed##3##2##(2007-7#3)
of thromboses##5##2##(1990-6#2)(2005-1#1)(2006-10#1)(2008-1#1)
of thrombosis and##2##3##(2006-10#1)(2007-8#1)
of thrombosis in the##2##4##(1992-3#1)(1993-5#1)
of thrombosis of##2##3##(1996-6#1)(1997-3#1)
of thrombosis##36##2##(1990-11#2)(1992-3#3)(1993-5#1)(1994-4#1)(1996-4#1)(1996-6#1)(1997-3#1)(2005-10#1)(2005-7#5)(2006-10#3)(2007-10#2)(2007-2#1)(2007-7#4)(2007-8#2)(2008-12#1)(2008-3#1)(2008-7#5)(2011-2#1)
of thrombospondin 1##3##3##(1994-5#1)(1995-3#1)(1996-7#1)
of thrombospondin##6##2##(1993-6#1)(1993-9#1)(1994-5#1)(1995-3#1)(1996-7#1)(1997-7#1)
of thrombotic complications##2##3##(1995-1#1)(2011-12#1)
of thrombotic disorders##3##3##(1991-9#1)(2005-8#1)(2007-11#1)
of thrombotic microangiopathy##2##3##(2005-11#1)(2006-10#1)
of thrombotic thrombocytopenic purpura##3##4##(1991-3#1)(1995-3#1)(2006-4#1)
of thrombotic##18##2##(1991-3#1)(1991-9#1)(1995-1#1)(1995-3#1)(1996-2#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-4#2)(2007-11#1)(2007-12#2)(2010-6#1)(2011-12#1)(2011-2#2)(2013-1#1)
of thromboxane A2##6##3##(1990-3#1)(1990-8#1)(1991-5#1)(1992-1#1)(1993-11#2)
of thromboxane B2##4##3##(1990-12#1)(1990-3#1)(1991-8#1)(1993-8#1)
of thromboxane formation##2##3##(1996-12#1)(2010-12#1)
of thromboxane##19##2##(1990-11#1)(1990-12#1)(1990-3#2)(1990-8#1)(1991-5#2)(1991-8#1)(1992-1#1)(1992-8#1)(1993-11#2)(1993-3#2)(1993-8#1)(1995-2#1)(1996-12#1)(2010-12#2)
of thrombus formation##3##3##(1990-12#1)(2006-6#1)(2008-11#1)
of thrombus##8##2##(1990-12#1)(2006-6#1)(2007-8#1)(2008-11#2)(2008-9#1)(2010-12#1)(2013-1#1)
of thulium laser##2##3##(2008-2#1)(2008-3#1)
of thumb for##3##3##(2006-5#1)(2008-3#1)(2008-8#1)
of thumb##13##2##(2006-5#1)(2008-2#1)(2008-3#3)(2008-8#3)(2008-9#4)(2009-10#1)
of thylakoid membranes##2##3##(1994-12#1)(2009-10#1)
of thylakoid##5##2##(1994-10#1)(1994-12#1)(2008-8#2)(2009-10#1)
of thylakoids##3##2##(1991-12#2)(2009-10#1)
of thyme##2##2##(2010-3#1)(2012-2#1)
of thymectomy##2##2##(1997-5#1)(2012-2#1)
of thymic epithelial cells##2##4##(1992-12#1)(2008-4#1)
of thymic involution##2##3##(1991-11#1)(2013-7#1)
of thymic macrophages##2##3##(1991-7#2)
of thymic stromal##2##3##(2008-5#1)(2012-2#1)
of thymic##17##2##(1991-11#1)(1991-7#2)(1992-12#1)(1992-2#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
of thymidine analogues##2##3##(1994-10#1)(1995-6#1)
of thymidine incorporation##3##3##(1990-10#1)(1990-9#1)(1992-7#1)
of thymidine into##2##3##(1991-5#1)(1992-8#1)
of thymidine kinase mRNA##2##4##(1992-4#2)
of thymidine kinase##3##3##(1992-4#2)(1994-5#1)
of thymidine##21##2##(1990-10#1)(1990-9#1)(1991-5#1)(1992-2#1)(1992-4#2)(1992-7#1)(1992-8#1)(1993-12#5)(1994-10#1)(1994-5#1)(1995-6#1)(1996-11#1)(1997-8#2)(2008-5#1)(2008-9#1)
of thymidylate synthase (TS)##3##4##(1990-7#1)(1994-9#1)(1995-6#1)
of thymidylate synthase and thymidine kinase##3##6##(1997-8#3)
of thymidylate synthase##12##3##(1990-7#1)(1992-5#1)(1993-11#2)(1993-9#1)(1994-9#1)(1995-6#1)(1997-2#1)(1997-8#3)(2005-7#1)
of thymidylate##13##2##(1990-7#1)(1992-5#1)(1993-11#2)(1993-9#2)(1994-9#1)(1995-6#1)(1997-2#1)(1997-8#3)(2005-7#1)
of thymine##7##2##(1992-2#1)(1992-6#1)(1994-7#2)(1994-9#1)(1997-6#1)(2006-10#1)
of thymocyte development##2##3##(1991-12#1)(2008-10#1)
of thymocyte##4##2##(1991-12#1)(2008-10#3)
of thymocytes and##2##3##(1991-12#1)(2013-7#1)
of thymocytes by##2##3##(1990-5#1)(2008-8#1)
of thymocytes in##2##3##(2008-10#1)(2008-8#1)
of thymocytes is##3##3##(1993-7#1)(2008-8#2)
of thymocytes##24##2##(1990-5#2)(1990-8#1)(1991-11#1)(1991-12#4)(1993-7#1)(1995-5#1)(1997-6#1)(2005-10#3)(2008-10#1)(2008-5#1)(2008-8#7)(2013-7#1)
of thymol##4##2##(1997-2#1)(2008-10#1)(2010-4#2)
of thymolipoma is##2##3##(2009-5#2)
of thymolipoma##3##2##(2009-5#3)
of thymoma##4##2##(1991-4#1)(2007-8#2)(2008-7#1)
of thymomas##5##2##(2007-8#1)(2008-12#1)(2008-7#3)
of thymopentin##2##2##(1990-2#1)(1991-3#1)
of thymopoiesis##3##2##(2008-4#3)
of thymostimulin##2##2##(1991-5#2)
of thymus and##3##3##(1995-12#1)(2008-5#1)(2012-1#1)
of thymus##13##2##(1990-4#1)(1995-12#3)(2005-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2012-1#2)
of thyrocytes##3##2##(1996-9#1)(2012-3#1)(2013-8#1)
of thyroglobulin mRNA##2##3##(1991-7#1)(1993-3#1)
of thyroglobulin##9##2##(1990-10#1)(1991-5#1)(1991-7#1)(1992-12#3)(1993-3#1)(1994-3#1)(1995-12#1)
of thyroid autoimmunity in##2##4##(2007-2#1)(2008-7#1)
of thyroid autoimmunity##3##3##(2007-2#1)(2008-7#2)
of thyroid cancer and##3##4##(1991-5#1)(2008-3#1)(2008-5#1)
of thyroid cancer has##2##4##(2006-9#1)(2013-8#1)
of thyroid cancer##15##3##(1990-3#1)(1991-5#2)(1995-5#1)(2006-9#3)(2007-11#1)(2008-3#1)(2008-5#1)(2012-2#1)(2013-8#4)
of thyroid carcinoma is##2##4##(1990-8#1)(2013-1#1)
of thyroid carcinoma##6##3##(1990-8#2)(2008-5#1)(2009-2#1)(2012-3#1)(2013-1#1)
of thyroid carcinomas##3##3##(1993-10#1)(1993-3#1)(2008-5#1)
of thyroid disorders##2##3##(2006-4#1)(2011-1#1)
of thyroid dysfunction##2##3##(1991-8#1)(2008-6#1)
of thyroid function in##3##4##(2008-11#1)(2008-4#2)
of thyroid function tests in##2##5##(2006-10#1)(2008-4#1)
of thyroid function tests##3##4##(2006-10#2)(2008-4#1)
of thyroid function##13##3##(2006-10#2)(2008-11#1)(2008-4#4)(2008-6#3)(2012-2#1)(2013-1#2)
of thyroid gland diseases##2##4##(2013-1#2)
of thyroid gland##8##3##(1993-4#1)(2008-12#1)(2008-9#2)(2012-12#2)(2013-1#2)
of thyroid hormone in##2##4##(1994-11#1)(2007-1#1)
of thyroid hormone on##2##4##(1996-5#1)(2013-8#1)
of thyroid hormone##18##3##(1990-10#1)(1991-7#1)(1994-11#2)(1994-9#3)(1995-2#2)(1995-6#1)(1996-4#1)(1996-5#1)(1997-7#1)(2006-11#1)(2007-1#1)(2009-5#1)(2013-7#1)(2013-8#1)
of thyroid hormones and##3##4##(1995-8#1)(1997-3#1)(2011-2#1)
of thyroid hormones in##3##4##(1994-12#1)(2007-7#1)(2012-2#1)
of thyroid hormones on the##2##5##(2008-6#1)(2013-8#1)
of thyroid hormones on##5##4##(1993-12#1)(1995-7#1)(2006-12#1)(2008-6#1)(2013-8#1)
of thyroid hormones were##2##4##(1990-3#1)(2012-2#1)
of thyroid hormones##19##3##(1990-3#1)(1991-10#1)(1991-8#1)(1993-12#1)(1994-12#1)(1994-6#1)(1995-7#1)(1995-8#1)(1997-3#1)(2006-12#1)(2007-7#1)(2007-9#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#2)(2013-8#1)
of thyroid lobes##2##3##(1991-12#1)(2012-3#1)
of thyroid nodules##5##3##(2006-7#1)(2007-11#1)(2011-1#1)(2011-12#1)(2013-7#1)
of thyroid stimulating hormone (TSH)##3##5##(1990-8#1)(1994-9#1)(1995-5#1)
of thyroid stimulating##4##3##(1990-8#1)(1990-9#1)(1994-9#1)(1995-5#1)
of thyroid surgery##3##3##(1990-4#1)(2005-8#1)(2006-12#1)
of thyroid##142##2##(1990-10#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-8#3)(1990-9#1)(1991-10#1)(1991-12#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-6#1)(1993-10#1)(1993-12#2)(1993-3#1)(1993-4#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-6#1)(1994-9#4)(1995-10#1)(1995-12#1)(1995-2#2)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-7#1)(2005-8#1)(2006-10#2)(2006-11#2)(2006-12#3)(2006-4#2)(2006-7#1)(2006-9#4)(2007-1#1)(2007-11#3)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#4)(2008-5#4)(2008-6#7)(2008-7#4)(2008-9#2)(2009-10#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-7#1)(2010-12#1)(2011-1#2)(2011-12#2)(2011-2#1)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#9)(2013-7#2)(2013-8#7)
of thyrotoxicosis and##2##3##(2006-10#1)(2007-2#1)
of thyrotoxicosis##8##2##(2006-10#1)(2006-4#2)(2007-2#1)(2007-5#1)(2008-7#2)(2011-2#1)
of thyrotropin and##2##3##(1994-11#1)(1994-6#1)
of thyrotropin receptor##4##3##(1990-11#2)(1994-11#2)
of thyrotropin##12##2##(1990-11#2)(1991-10#1)(1991-12#1)(1992-8#2)(1994-11#3)(1994-6#2)(2011-1#1)
of thyrotropin-releasing hormone (TRH)##2##4##(1991-2#1)(1996-9#1)
of thyrotropin-releasing hormone##7##3##(1991-2#1)(1992-3#1)(1992-8#1)(1995-5#1)(1996-9#2)(2013-7#1)
of thyroxine (T4)##3##3##(1991-10#1)(2008-6#1)(2008-7#1)
of thyroxine preparations##2##3##(2006-9#2)
of thyroxine##12##2##(1991-10#1)(1991-5#1)(1993-12#2)(1997-5#1)(2006-9#2)(2007-8#1)(2008-6#1)(2008-7#2)(2013-8#1)
of tiadenol##2##2##(1990-2#2)
of tianeptine##3##2##(1991-5#3)
of tibia and femur##2##4##(2007-11#1)(2007-4#1)
of tibia and##3##3##(2007-11#1)(2007-4#1)(2008-12#1)
of tibia##11##2##(2007-11#3)(2007-4#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-6#1)(2010-11#1)(2012-2#2)
of tibial dyschondroplasia##2##3##(1991-9#1)(1997-3#1)
of tibial shaft##3##3##(1995-3#1)(2010-11#2)
of tibial##19##2##(1990-6#1)(1991-3#1)(1991-9#1)(1995-3#1)(1997-3#1)(2007-11#2)(2008-12#2)(2008-4#1)(2008-8#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-3#1)(2011-2#1)(2012-3#1)
of ticarcillin##2##2##(2007-2#2)
of tick##9##2##(1994-3#2)(2004-11#2)(2008-8#1)(2010-10#2)(2010-9#1)(2011-1#1)
of tick-borne encephalitis virus##2##4##(2007-2#1)(2008-8#1)
of tick-borne encephalitis##3##3##(2007-2#1)(2008-8#2)
of tick-borne##6##2##(2007-2#1)(2008-8#2)(2010-1#1)(2010-2#1)(2010-9#1)
of ticks##10##2##(1997-7#1)(2004-11#4)(2006-10#1)(2008-8#2)(2010-1#1)(2012-2#1)
of ticlopidine and aspirin##2##4##(2007-10#1)(2007-9#1)
of ticlopidine and##3##3##(1991-3#1)(2007-10#1)(2007-9#1)
of ticlopidine##8##2##(1991-3#2)(1996-3#1)(2006-10#1)(2007-10#3)(2007-9#1)
of tics##2##2##(1996-5#1)(2011-2#1)
of tigers##2##2##(2007-8#1)(2009-4#1)
of tight junction##2##3##(2007-11#1)(2012-2#1)
of tight junctions##2##3##(2006-10#1)(2011-2#1)
of tight##10##2##(1993-1#1)(1995-6#1)(1996-5#1)(2005-10#1)(2006-10#1)(2007-11#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-2#1)
of tightly bound##5##3##(1990-10#1)(1991-5#1)(1994-5#1)(1994-9#1)(1997-4#1)
of tightly##8##2##(1990-10#1)(1991-5#2)(1994-5#1)(1994-9#1)(1997-4#1)(2005-11#1)(2008-3#1)
of tilapia (Oreochromis##2##3##(1996-7#1)(2007-3#1)
of tilapia##5##2##(1996-7#1)(2007-3#1)(2008-5#3)
of tillage practices##3##3##(2008-10#3)
of tillage##5##2##(2008-10#4)(2013-8#1)
of tillers##2##2##(2008-10#2)
of tilmicosin##2##2##(2008-5#2)
of tilt##7##2##(2006-9#2)(2008-2#5)
of tilted##2##2##(2008-2#1)(2011-7#1)
of tilting##2##2##(1996-2#1)(2007-11#1)
of time (2##2##3##(1996-7#1)(2008-10#1)
of time (i##2##3##(2008-10#1)(2008-4#1)
of time after##5##3##(1991-5#1)(1992-3#1)(1994-2#1)(1996-11#1)(2008-10#1)
of time and resources##2##4##(2008-11#1)(2013-1#1)
of time and##33##3##(1991-5#1)(1992-3#1)(1996-11#1)(1997-3#2)(2004-11#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-4#1)(2008-8#1)(2009-11#1)(2010-8#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
of time as a##2##4##(2007-12#1)(2011-2#1)
of time as the##3##4##(1995-6#1)(2006-8#1)(2008-3#1)
of time as##7##3##(1995-6#1)(2006-8#1)(2007-12#1)(2008-12#1)(2008-3#1)(2010-2#1)(2011-2#1)
of time averaging##2##3##(2008-3#2)
of time before##2##3##(2008-3#1)(2009-9#1)
of time between##3##3##(2008-5#1)(2008-6#1)(2012-2#1)
of time but##2##3##(2009-6#1)(2012-2#1)
of time by a##2##4##(2008-10#1)(2008-11#1)
of time by##4##3##(2006-7#1)(2008-10#1)(2008-11#2)
of time can be##2##4##(2008-11#1)(2008-6#1)
of time can##4##3##(1996-1#1)(2005-11#1)(2008-11#1)(2008-6#1)
of time delay and##2##4##(2008-1#1)(2008-10#1)
of time during the##2##4##(2008-9#1)(2009-6#1)
of time during##4##3##(2007-9#1)(2008-3#1)(2008-9#1)(2009-6#1)
of time following##2##3##(1995-5#1)(2011-12#1)
of time for##5##3##(1995-12#1)(2008-10#1)(2008-11#2)(2011-2#1)
of time from##2##3##(2008-10#1)(2012-12#1)
of time in a##2##4##(2008-4#1)(2009-7#1)
of time in order to obtain##3##6##(1996-5#2)(2008-11#1)
of time in order##4##4##(1996-5#2)(2008-11#1)(2010-5#1)
of time in the##6##4##(1992-4#1)(1994-3#1)(1996-3#1)(1997-2#1)(2009-11#1)(2010-3#1)
of time in##20##3##(1991-9#1)(1992-4#1)(1993-2#1)(1994-3#1)(1996-3#1)(1996-5#2)(1997-2#1)(2006-6#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-11#1)(2009-7#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-11#1)
of time intervals##3##3##(2006-2#1)(2008-9#1)(2009-3#1)
of time is##3##3##(2007-7#1)(2011-1#1)(2013-1#1)
of time of##7##3##(1993-12#1)(1995-12#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-3#1)
of time on##2##3##(1995-6#1)(1996-2#1)
of time or##3##3##(1997-8#1)(2008-1#1)(2008-10#1)
of time series data##2##4##(1992-2#1)(2008-8#1)
of time series##5##3##(1991-10#1)(1992-2#1)(2008-8#2)(2013-8#1)
of time since##5##3##(1996-2#1)(1996-7#1)(2007-2#1)(2008-7#1)(2012-11#1)
of time spent in##3##4##(1997-4#1)(2008-8#1)(2011-2#1)
of time spent on##3##4##(1993-9#1)(2008-5#1)(2011-2#1)
of time spent##11##3##(1993-9#1)(1997-4#1)(2008-2#1)(2008-5#1)(2008-8#2)(2011-2#2)(2012-1#1)(2012-2#2)
of time that##7##3##(1991-11#1)(1991-6#1)(1991-9#1)(2007-9#1)(2008-11#1)(2013-1#2)
of time the##4##3##(1994-11#1)(2005-11#1)(2007-9#1)(2008-8#1)
of time to##21##3##(1995-3#1)(1995-9#1)(1996-3#2)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2009-10#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
of time was##5##3##(1990-4#1)(1995-1#1)(2007-11#1)(2008-11#1)(2008-2#1)
of time were##2##3##(2006-6#1)(2007-8#1)
of time when##4##3##(1993-2#1)(2008-10#1)(2008-11#1)(2008-2#1)
of time with##4##3##(1995-3#1)(2005-11#1)(2008-1#1)(2011-3#1)
of time##430##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#3)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#3)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#4)(1993-5#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1995-1#3)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#4)(1995-8#3)(1995-9#2)(1996-1#2)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#4)(1996-4#2)(1996-5#5)(1996-7#2)(1997-2#1)(1997-3#3)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-10#1)(2004-11#1)(2005-10#1)(2005-11#8)(2006-1#2)(2006-10#3)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#3)(2006-8#1)(2006-9#3)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#2)(2007-7#6)(2007-8#5)(2007-9#5)(2008-1#12)(2008-10#44)(2008-11#25)(2008-12#5)(2008-2#15)(2008-3#10)(2008-4#6)(2008-5#13)(2008-6#2)(2008-7#5)(2008-8#10)(2008-9#7)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#4)(2009-3#2)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#3)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#8)(2011-11#1)(2011-12#3)(2011-2#9)(2011-3#1)(2012-1#4)(2012-11#2)(2012-12#3)(2012-2#12)(2012-3#3)(2013-1#10)(2013-7#1)(2013-8#2)
of time)##3##2##(1996-5#1)(2007-12#1)(2010-6#1)
of time-delayed##2##2##(2007-11#1)(2007-12#1)
of time-dependent##8##2##(1993-8#1)(2006-3#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)
of time-resolved fluorescence##2##3##(2008-10#1)(2008-9#1)
of time-resolved optical tomography##2##4##(2008-3#2)
of time-resolved reflectance##2##3##(2007-12#2)
of time-resolved transmittance##2##3##(2008-2#1)(2008-3#1)
of time-resolved##19##2##(1994-8#1)(2006-5#1)(2007-12#3)(2008-10#3)(2008-2#3)(2008-3#6)(2008-9#1)(2009-5#1)
of time-varying##2##2##(1992-3#1)(2008-3#1)
of time?##2##2##(1992-2#1)(2003-11#1)
of timely detection of##2##4##(2010-12#1)(2011-2#1)
of timely##9##2##(1995-3#1)(2008-12#1)(2008-3#1)(2009-2#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
of times a##2##3##(1993-2#1)(2006-4#1)
of times larger than##2##4##(2007-12#1)(2008-2#1)
of times##26##2##(1990-5#1)(1991-6#2)(1993-10#1)(1993-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-7#1)(2005-10#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2009-2#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-3#1)
of timing and##5##3##(2007-7#1)(2008-10#1)(2008-12#2)(2009-9#1)
of timing jitter##2##3##(2007-12#2)
of timing##10##2##(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-12#2)(2009-9#1)(2011-1#1)
of timolol in##2##3##(1990-11#1)(1990-9#1)
of timothy grass##2##3##(1994-2#2)
of tin (IV)##2##3##(2007-12#1)(2008-10#1)
of tin and##3##3##(2008-10#3)
of tin in##8##3##(2007-8#1)(2008-10#7)
of tin oxide thin##2##4##(2008-10#2)
of tin oxide##4##3##(2008-10#4)
of tin##33##2##(2005-4#3)(2006-12#1)(2007-12#1)(2007-8#6)(2008-10#22)
of tin(IV)##3##2##(2008-10#3)
of tinea capitis in##2##4##(2008-5#1)(2010-11#1)
of tinea capitis##4##3##(2007-7#1)(2008-5#2)(2010-11#1)
of tinea corporis##2##3##(2006-3#1)(2012-3#1)
of tinea##12##2##(2005-11#1)(2006-3#1)(2007-7#3)(2007-8#1)(2008-5#4)(2010-11#1)(2012-3#1)
of tinned##2##2##(2008-1#2)
of tinnitus and##3##3##(1996-6#1)(2010-12#1)(2010-3#1)
of tinnitus##13##2##(1995-6#1)(1996-6#2)(2007-8#1)(2007-9#2)(2008-4#1)(2010-12#2)(2010-3#3)(2010-7#1)
of tiny##4##2##(1991-9#1)(2005-11#1)(2008-11#1)(2008-3#1)
of tip##5##2##(2005-11#1)(2008-10#2)(2008-3#1)(2008-8#1)
of tipifarnib##3##2##(2009-8#3)
of tipranavir in the##2##4##(2008-5#2)
of tips##2##2##(1992-1#1)(2007-7#1)
of tirilazad##4##2##(2007-9#4)
of tissue Doppler##2##3##(2009-10#1)(2011-2#1)
of tissue TG induction##2##4##(1991-2#2)
of tissue TG##4##3##(1991-2#4)
of tissue absorption coefficients##2##4##(2008-2#2)
of tissue and##5##3##(1995-2#2)(2006-10#1)(2007-11#1)(2013-1#1)
of tissue at the##2##4##(1992-12#1)(2008-11#1)
of tissue autofluorescence##2##3##(2011-1#1)(2012-12#1)
of tissue balancing##2##3##(2013-1#2)
of tissue construction##2##3##(2007-8#2)
of tissue culture##8##3##(1992-8#1)(2008-11#1)(2008-12#1)(2008-4#4)(2008-9#1)
of tissue cultures##2##3##(2007-1#1)(2007-11#1)
of tissue damage in##3##4##(1996-2#1)(2006-10#1)(2011-2#1)
of tissue damage##10##3##(1990-12#1)(1992-12#1)(1996-2#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-2#1)(2011-2#1)(2012-12#1)
of tissue development##2##3##(2010-10#1)(2012-2#1)
of tissue differentiation##3##3##(2008-2#1)(2008-4#1)(2010-3#1)
of tissue engineered##3##3##(2006-5#1)(2010-8#1)(2012-3#1)
of tissue engineering and regenerative##2##5##(2010-10#1)(2012-12#1)
of tissue engineering and##4##4##(2006-6#2)(2010-10#1)(2012-12#1)
of tissue engineering in##2##4##(2012-12#1)(2013-7#1)
of tissue engineering strategies##2##4##(2009-4#1)(2012-2#1)
of tissue engineering##15##3##(2006-6#3)(2007-11#1)(2009-11#1)(2009-4#1)(2009-9#1)(2010-10#2)(2010-9#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)
of tissue extracts##3##3##(1996-3#1)(2007-8#1)(2012-1#1)
of tissue factor##3##3##(1994-9#1)(1995-8#1)(2008-10#1)
of tissue fluid##2##3##(2004-9#2)
of tissue for##6##3##(1996-8#1)(2006-6#1)(2008-1#1)(2008-3#2)(2009-6#1)
of tissue formation##2##3##(2006-6#1)(2009-8#1)
of tissue from##3##3##(2007-8#1)(2008-10#2)
of tissue homeostasis and##2##4##(2007-10#1)(2008-5#1)
of tissue homeostasis##4##3##(2007-10#1)(2008-5#1)(2009-3#1)(2010-3#1)
of tissue in the##2##4##(2008-5#1)(2009-7#1)
of tissue in##5##3##(1996-5#1)(2008-5#1)(2009-7#1)(2010-8#1)(2011-1#1)
of tissue inflammation and##2##4##(2011-2#1)(2012-11#1)
of tissue inflammation##3##3##(2010-5#1)(2011-2#1)(2012-11#1)
of tissue inhibitor of metalloproteinases (TIMP)##2##6##(1990-7#2)
of tissue inhibitor of##7##4##(1990-7#2)(1994-5#1)(1997-4#2)(2006-9#2)
of tissue injury##6##3##(1994-11#1)(1995-2#1)(1996-7#1)(2006-10#1)(2007-9#1)(2012-12#1)
of tissue integrity##2##3##(2008-4#1)(2012-12#1)
of tissue is##3##3##(1991-9#1)(2004-2#1)(2008-3#1)
of tissue layers##2##3##(2012-1#1)(2013-1#1)
of tissue levels of##2##4##(1990-7#1)(2010-5#1)
of tissue morphology and##2##4##(2008-5#1)(2011-12#1)
of tissue necrosis##4##3##(1996-5#1)(2006-10#1)(2007-8#1)(2008-10#1)
of tissue optical properties from##2##5##(2008-2#1)(2008-3#1)
of tissue optical properties##9##4##(2008-2#3)(2008-3#5)(2011-1#1)
of tissue optical##11##3##(1997-6#1)(2008-2#3)(2008-3#6)(2011-1#1)
of tissue or##3##3##(1991-12#1)(2008-2#1)(2008-5#1)
of tissue perfusion##2##3##(2007-10#1)(2007-7#1)
of tissue plasminogen activator (t-PA)##3##5##(1990-11#2)(2007-10#1)
of tissue plasminogen activator and##2##5##(1990-11#1)(1997-2#1)
of tissue plasminogen activator in##2##5##(1990-11#1)(2007-9#1)
of tissue plasminogen activator##12##4##(1990-11#4)(1990-9#1)(1991-2#1)(1997-2#1)(2007-10#1)(2007-9#4)
of tissue regeneration##4##3##(1993-2#1)(1997-3#1)(2006-6#1)(2013-8#1)
of tissue remodeling##2##3##(2012-12#1)(2012-3#1)
of tissue repair##8##3##(1993-2#2)(1997-3#5)(2006-10#1)
of tissue samples##8##3##(1997-3#1)(2006-10#1)(2006-5#1)(2008-10#1)(2008-4#3)(2012-3#1)
of tissue sections##5##3##(1990-7#1)(2007-11#1)(2008-4#3)
of tissue specificity##2##3##(2006-12#1)(2008-10#1)
of tissue specimens##6##3##(1994-2#1)(1994-9#1)(2008-1#1)(2008-5#1)(2012-12#1)(2013-8#1)
of tissue storage##2##3##(2010-8#2)
of tissue structure##3##3##(2007-11#2)(2009-12#1)
of tissue that##2##3##(2008-10#1)(2008-11#1)
of tissue thickness##2##3##(2008-3#2)
of tissue to##3##3##(1996-12#1)(2010-8#1)(2012-2#1)
of tissue transglutaminase##3##3##(1991-2#1)(1994-9#1)(2008-1#1)
of tissue types##4##3##(1992-5#1)(1996-12#1)(2008-1#2)
of tissue viability##4##3##(1997-6#3)(2007-7#1)
of tissue water##2##3##(1996-5#1)(2008-2#1)
of tissue with##3##3##(2008-11#1)(2008-3#1)(2010-3#1)
of tissue##369##2##(1990-11#4)(1990-12#2)(1990-2#2)(1990-4#1)(1990-7#4)(1990-8#1)(1990-9#3)(1991-10#1)(1991-12#3)(1991-2#9)(1991-3#1)(1991-8#4)(1991-9#1)(1992-1#1)(1992-12#3)(1992-3#2)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#3)(1993-4#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-9#3)(1995-2#4)(1995-3#3)(1995-4#2)(1995-5#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#5)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#7)(1997-4#2)(1997-6#5)(1997-7#1)(1997-8#2)(2004-2#1)(2004-9#5)(2005-7#1)(2006-10#8)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#8)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#9)(2007-12#6)(2007-3#3)(2007-5#1)(2007-7#5)(2007-8#6)(2007-9#6)(2008-1#5)(2008-10#14)(2008-11#8)(2008-12#1)(2008-2#18)(2008-3#20)(2008-4#17)(2008-5#10)(2008-6#1)(2008-7#3)(2008-9#4)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#3)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#3)(2010-8#7)(2010-9#3)(2011-1#9)(2011-12#1)(2011-2#6)(2012-1#3)(2012-11#1)(2012-12#11)(2012-2#4)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#3)
of tissue)##2##2##(2010-12#1)(2011-2#1)
of tissue-plasminogen activator##2##3##(1990-11#2)
of tissue-specific##8##2##(1991-6#1)(1992-6#1)(1994-12#1)(2006-12#1)(2008-1#1)(2008-7#2)(2012-12#1)
of tissue-type plasminogen activator (t-PA) in##2##6##(1995-3#1)(1995-8#1)
of tissue-type plasminogen activator (t-PA)##5##5##(1990-11#2)(1991-1#1)(1995-3#1)(1995-8#1)
of tissue-type plasminogen activator##9##4##(1990-11#2)(1991-1#1)(1991-3#1)(1992-12#1)(1995-3#1)(1995-8#1)(1997-1#1)(2008-5#1)
of tissue-type plasminogen##10##3##(1990-11#2)(1991-1#1)(1991-3#1)(1992-12#1)(1995-3#1)(1995-8#2)(1997-1#1)(2008-5#1)
of tissue-type##11##2##(1990-11#2)(1991-1#2)(1991-3#1)(1992-12#1)(1995-3#1)(1995-8#2)(1997-1#1)(2008-5#1)
of tissuelike turbid media##2##4##(2008-2#1)(2008-3#1)
of tissuelike##3##2##(2008-2#1)(2008-3#2)
of tissues and cell lines##2##5##(1992-1#1)(1994-6#1)
of tissues and organs##4##4##(1996-3#1)(1996-6#1)(1997-5#1)(2008-8#1)
of tissues and##13##3##(1990-6#1)(1992-1#1)(1992-9#1)(1994-6#1)(1996-10#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-9#1)(2008-8#1)(2010-12#1)
of tissues are##2##3##(1994-11#1)(2008-1#1)
of tissues at##3##3##(2007-2#1)(2012-11#2)
of tissues from##3##3##(1993-3#1)(1994-11#1)(2008-3#1)
of tissues in##4##3##(1994-3#1)(1997-4#1)(2008-2#1)(2010-2#1)
of tissues including the##2##4##(2008-1#1)(2008-11#1)
of tissues including##3##3##(2008-1#1)(2008-11#2)
of tissues to biomaterials##2##4##(2004-9#2)
of tissues to##4##3##(1994-11#1)(1995-6#1)(2004-9#2)
of tissues with##3##3##(2008-4#1)(2008-5#1)(2008-9#1)
of tissues##81##2##(1990-11#2)(1990-6#1)(1990-9#1)(1991-12#1)(1992-1#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-10#1)(1994-11#3)(1994-3#1)(1994-6#1)(1995-11#1)(1995-6#1)(1996-10#1)(1996-3#1)(1996-6#1)(1997-3#3)(1997-4#4)(1997-5#1)(1997-8#1)(2004-12#1)(2004-9#2)(2005-8#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#5)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2012-11#2)(2012-12#1)(2013-1#2)
of titania##7##2##(2005-11#4)(2007-11#1)(2008-2#2)
of titanium alloy##2##3##(2004-9#2)
of titanium alloys##3##3##(2004-9#1)(2009-7#1)(2010-8#1)
of titanium and##2##3##(2009-7#1)(2010-12#1)
of titanium dioxide##7##3##(2007-12#1)(2008-1#1)(2008-10#2)(2011-2#2)(2012-12#1)
of titanium implants##2##3##(2004-9#2)
of titanium oxide films##4##4##(2008-2#3)(2008-8#1)
of titanium oxide##5##3##(2008-2#3)(2008-3#1)(2008-8#1)
of titanium phosphate##2##3##(2008-10#2)
of titanium##45##2##(1991-1#1)(2004-9#5)(2005-11#2)(2006-3#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#11)(2008-2#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-7#4)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
of titanium(IV)##4##2##(2005-11#2)(2008-10#2)
of titles##2##2##(2005-7#1)(2008-11#1)
of titrant##4##2##(2008-10#4)
of titration##6##2##(1990-11#1)(2005-11#1)(2006-6#1)(2008-10#3)
of titrations##2##2##(1996-12#1)(2008-10#1)
of tizanidine##2##2##(2006-8#2)
of to##3##2##(1997-6#1)(2008-12#1)(2010-1#1)
of tobacco and##4##3##(1994-3#1)(1996-3#1)(2009-8#1)(2013-1#1)
of tobacco blue mold##2##4##(2008-10#2)
of tobacco by##2##3##(2008-10#1)(2008-6#1)
of tobacco cells##4##3##(2009-6#4)
of tobacco control##3##3##(2009-12#2)(2012-1#1)
of tobacco dependence##2##3##(1997-3#1)(2008-8#1)
of tobacco in##2##3##(2008-10#2)
of tobacco mosaic virus (TMV)##2##5##(1993-5#1)(2008-10#1)
of tobacco mosaic virus##5##4##(1993-5#1)(1997-6#1)(2008-10#1)(2008-8#1)(2008-9#1)
of tobacco mosaic##6##3##(1991-8#1)(1993-5#1)(1997-6#1)(2008-10#1)(2008-8#1)(2008-9#1)
of tobacco products##2##3##(1996-11#1)(2012-1#1)
of tobacco protoplasts or leaf##2##5##(2008-10#2)
of tobacco smoke##4##3##(1990-9#1)(1991-4#1)(2012-11#1)(2013-1#1)
of tobacco smoking##2##3##(2009-5#1)(2012-11#1)
of tobacco thrips##3##3##(2008-10#3)
of tobacco use##12##3##(1991-5#2)(1994-3#1)(1997-1#1)(2006-2#3)(2007-5#1)(2008-8#1)(2010-9#1)(2011-2#1)(2012-1#1)
of tobacco##94##2##(1990-8#1)(1990-9#1)(1991-4#2)(1991-5#3)(1991-8#1)(1992-6#1)(1992-8#1)(1993-5#2)(1994-3#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(2005-10#2)(2006-2#4)(2006-8#2)(2007-5#1)(2008-10#21)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#3)(2009-12#4)(2009-3#1)(2009-5#1)(2009-6#4)(2009-7#2)(2009-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#3)(2012-11#2)(2012-12#1)(2012-2#2)(2013-1#5)
of toborinone in##2##3##(2008-5#2)
of toborinone##3##2##(2008-5#3)
of tobramycin##5##2##(2007-8#5)
of tocolytic therapy##2##3##(1992-12#1)(1993-4#1)
of tocopherol acetate into SLN leads to an##2##8##(2008-5#2)
of tocopherol##8##2##(1990-11#1)(2008-10#1)(2008-5#4)(2011-1#1)(2012-2#1)
of tocopherols and##2##3##(2007-8#1)(2012-2#1)
of tocopherols in##2##3##(2008-5#1)(2012-2#1)
of tocopherols##6##2##(1992-9#1)(2007-8#1)(2008-5#2)(2012-2#2)
of tocoretinate##2##2##(2011-1#2)
of today##14##2##(1990-12#1)(1992-3#2)(1992-6#1)(1996-3#1)(2006-11#1)(2007-4#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-9#1)(2012-2#1)(2013-7#1)
of today's##12##2##(1994-10#1)(1996-2#1)(2007-4#1)(2007-8#3)(2007-9#1)(2008-10#2)(2008-9#1)(2010-5#1)(2011-2#1)
of toddlers##2##2##(2008-4#1)(2009-4#1)
of toe##2##2##(2009-2#1)(2010-3#1)
of toes##3##2##(1997-1#1)(2008-1#1)(2011-2#1)
of toilet sanitizers and##2##4##(1996-9#2)
of tokens##5##2##(2008-7#1)(2013-1#4)
of tolbutamide with##2##3##(1991-3#1)(2007-10#1)
of tolbutamide##6##2##(1991-12#2)(1991-3#2)(2007-10#2)
of tolcapone##2##2##(1995-5#2)
of tolerability of##4##3##(1996-4#1)(1997-8#3)
of tolerability##6##2##(1990-7#1)(1996-4#1)(1997-8#3)(2007-11#1)
of tolerable##3##2##(2005-3#1)(2007-8#1)(2008-10#1)
of tolerance and##4##3##(1991-1#1)(1996-4#1)(2008-4#2)
of tolerance to the##4##4##(1990-5#2)(1992-3#1)(2011-1#1)
of tolerance to##15##3##(1990-5#2)(1990-8#1)(1991-12#1)(1992-3#1)(1994-11#1)(1995-11#1)(1996-2#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2009-7#1)(2011-1#1)(2012-11#1)
of tolerance##50##2##(1990-11#1)(1990-5#4)(1990-8#1)(1991-1#2)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-5#1)(1994-11#1)(1995-11#1)(1996-10#2)(1996-2#3)(1996-4#1)(1997-1#1)(1997-8#1)(2005-9#1)(2007-11#3)(2007-12#1)(2007-5#3)(2008-10#5)(2008-3#2)(2008-4#4)(2009-7#1)(2009-9#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)
of tolerance)##2##2##(2006-10#1)(2008-5#1)
of tolerating a##2##3##(2008-2#1)(2010-6#1)
of tolerating##3##2##(2007-8#1)(2008-2#1)(2010-6#1)
of tolerogenic##3##2##(2007-11#1)(2009-8#1)(2011-2#1)
of toll-like receptor##2##3##(2013-7#1)(2013-8#1)
of toll-like##3##2##(2009-3#1)(2013-7#1)(2013-8#1)
of tolmetin##2##2##(1992-3#2)
of tolterodine##2##2##(1997-5#2)
of toluene 2-monooxygenase##2##3##(1995-10#2)
of toluene and##2##3##(2005-12#1)(2008-10#1)
of toluene in##3##3##(2005-11#1)(2008-10#1)(2008-7#1)
of toluene##22##2##(1990-5#1)(1994-7#1)(1995-10#3)(1995-2#1)(2005-11#2)(2005-12#2)(2008-10#7)(2008-6#1)(2008-7#4)
of toluidine##2##2##(2008-10#2)
of tomato (Lycopersicon esculentum)##2##4##(2008-10#1)(2013-8#1)
of tomato and##5##3##(1997-1#1)(2008-10#4)
of tomato by##3##3##(2008-10#3)
of tomato carotenoids##2##3##(2008-12#2)
of tomato caused by##2##4##(2008-10#2)
of tomato chromosome##3##3##(2008-10#1)(2008-5#2)
of tomato have##2##3##(2008-10#2)
of tomato in##2##3##(2008-10#2)
of tomato leaves by##2##4##(2008-10#1)(2013-8#1)
of tomato leaves##4##3##(2008-10#2)(2013-8#2)
of tomato mottle##2##3##(2008-10#2)
of tomato plants##10##3##(2008-10#7)(2009-8#2)(2013-8#1)
of tomato spotted wilt virus##2##5##(2008-10#2)
of tomato spotted wilt##3##4##(2008-10#3)
of tomato under##3##3##(2008-10#3)
of tomato yellow leaf curl##2##5##(2008-10#2)
of tomato##86##2##(1992-8#1)(1993-9#1)(1996-8#3)(1997-1#1)(2008-10#61)(2008-12#2)(2008-5#5)(2008-7#2)(2008-8#1)(2009-8#3)(2011-12#1)(2013-8#5)
of tomographic##5##2##(1991-2#1)(1992-10#1)(1992-5#1)(2007-12#1)(2008-2#1)
of tomography##2##2##(2007-12#1)(2008-2#1)
of tomorrow##4##2##(1993-2#1)(2007-3#1)(2009-9#1)(2012-12#1)
of tonal##2##2##(2013-8#2)
of tone##5##2##(1990-4#1)(2007-1#1)(2008-9#2)(2013-8#1)
of tongue##24##2##(1995-8#1)(2006-2#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#3)(2010-9#1)(2012-1#1)(2012-3#1)(2013-1#10)(2013-7#1)
of tonic##6##2##(1991-1#1)(1991-3#1)(1991-9#1)(1995-12#1)(2010-12#2)
of tonsil##2##2##(2008-4#1)(2013-8#1)
of tonsillar##2##2##(1990-6#1)(2008-9#1)
of too##4##2##(2007-11#1)(2008-10#2)(2013-8#1)
of tool##3##2##(1991-11#1)(2009-2#1)(2012-2#1)
of tools and##3##3##(2007-1#1)(2008-7#1)(2012-12#1)
of tools for##7##3##(2007-12#1)(2008-4#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#2)
of tools that##4##3##(1996-2#1)(2008-11#1)(2013-1#2)
of tools to##4##3##(1994-3#1)(1995-2#1)(2011-12#1)(2012-3#1)
of tools##27##2##(1994-3#1)(1995-2#1)(1996-2#1)(2005-8#1)(2006-6#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#4)(2013-8#1)
of tooth avulsion##2##3##(2008-12#2)
of tooth decay##4##3##(2005-11#3)(2012-12#1)
of tooth developmental##2##3##(2008-5#1)(2013-1#1)
of tooth structure##2##3##(1990-3#1)(1991-2#1)
of tooth wear##2##3##(2011-1#1)(2013-1#1)
of tooth##29##2##(1990-3#1)(1991-2#1)(1993-9#1)(2005-11#3)(2006-8#1)(2007-12#1)(2008-12#3)(2008-5#2)(2008-7#1)(2009-8#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#2)(2013-1#6)(2013-8#1)
of toothless##2##2##(2013-1#2)
of toothpaste##5##2##(2006-2#2)(2008-5#1)(2011-1#1)(2011-2#1)
of toothpick##2##2##(2008-12#1)(2011-2#1)
of toothwear##2##2##(2008-1#2)
of top##9##2##(1993-12#2)(1994-12#1)(2007-10#1)(2008-10#1)(2008-12#1)(2009-4#1)(2012-1#1)(2012-12#1)
of top-down##2##2##(1997-8#1)(2013-8#1)
of top1-cleavable complexes##2##3##(1995-5#2)
of top3##2##2##(2010-2#2)
of topic defibrillation##2##3##(2007-8#2)
of topical agents##3##3##(2007-1#1)(2007-11#2)
of topical and##2##3##(2006-2#1)(2008-5#1)
of topical application of##2##4##(2006-12#1)(2008-5#1)
of topical calcineurin inhibitors##2##4##(2008-3#1)(2010-8#1)
of topical corticosteroids##2##3##(2007-11#2)
of topical drug delivery##2##4##(1996-2#1)(2012-2#1)
of topical drug##3##3##(1996-2#1)(2012-2#2)
of topical photodynamic therapy##2##4##(2006-12#2)
of topical therapeutics##2##3##(2011-1#2)
of topical tranexamic acid in##2##5##(2007-8#2)
of topical tranexamic acid##4##4##(2007-8#4)
of topical##60##2##(1990-4#1)(1992-8#1)(1996-2#1)(1997-8#1)(2005-8#1)(2006-10#2)(2006-12#4)(2006-2#1)(2007-1#1)(2007-11#7)(2007-12#1)(2007-7#3)(2007-8#8)(2008-12#1)(2008-3#2)(2008-5#9)(2009-8#2)(2010-3#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-10#1)(2012-2#2)
of topically applied##5##3##(2008-5#5)
of topics in the##2##4##(1994-2#1)(2008-5#1)
of topics related to##2##4##(2007-5#1)(2008-5#1)
of topics##14##2##(1994-12#1)(1994-2#1)(1996-11#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-5#1)(2008-5#3)(2009-10#1)(2012-2#1)(2013-1#2)
of topiramate therapy##2##3##(2008-7#2)
of topiramate##4##2##(2008-7#4)
of topographic##5##2##(1991-1#1)(1992-3#1)(1993-9#1)(2007-3#1)(2011-1#1)
of topographical##6##2##(2008-11#1)(2008-2#2)(2008-3#1)(2011-2#1)(2013-1#1)
of topography##2##2##(2005-8#1)(2008-3#1)
of topoisomerase I##10##3##(1990-7#1)(1993-8#2)(1994-8#1)(1997-5#1)(2005-8#2)(2008-11#2)(2008-8#1)
of topoisomerase II and##2##4##(1992-8#1)(1995-1#1)
of topoisomerase II in a##2##5##(1991-11#1)(1996-7#1)
of topoisomerase II in##4##4##(1991-11#1)(1993-8#1)(1994-12#1)(1996-7#1)
of topoisomerase II##12##3##(1991-11#2)(1991-5#1)(1992-8#1)(1993-3#1)(1993-8#2)(1994-12#1)(1995-1#2)(1996-7#2)
of topoisomerase##23##2##(1990-7#1)(1991-11#2)(1991-2#1)(1991-5#1)(1992-8#1)(1993-3#1)(1993-8#4)(1994-12#1)(1994-8#1)(1995-1#2)(1996-7#2)(1997-5#1)(2005-8#2)(2008-11#2)(2008-8#1)
of topological defects##2##3##(2008-7#1)(2009-11#1)
of topological##8##2##(1994-10#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-11#1)
of topsoil##2##2##(2008-10#1)(2012-2#1)
of toroidal surfaces##2##3##(2008-3#2)
of torque##2##2##(2007-10#1)(2007-4#1)
of torsades de pointes##2##4##(1997-1#1)(2009-10#1)
of torsion##2##2##(1995-8#1)(2008-10#1)
of torsional##2##2##(1993-11#1)(2007-3#1)
of tort reform in##2##4##(1991-1#1)(2008-4#1)
of tort reform##3##3##(1991-1#2)(2008-4#1)
of torture##9##2##(1990-6#1)(1995-11#3)(1996-3#2)(2008-7#3)
of tospovirus##3##2##(2008-10#3)
of tospoviruses##4##2##(2008-10#4)
of total (free plus##2##4##(1993-2#1)(1997-7#1)
of total A##2##3##(1994-11#1)(1995-3#1)
of total APP##3##3##(1996-12#3)
of total As##3##3##(2008-10#3)
of total C4BP and PS-C4BP complex##2##6##(1995-1#2)
of total Cr##2##3##(2008-10#2)
of total DNA##4##3##(1990-5#1)(2008-10#2)(2012-3#1)
of total FA content in##2##5##(2012-1#2)
of total FA)##2##3##(1996-11#2)
of total Hg##2##3##(2004-4#1)(2008-10#1)
of total N##2##3##(2008-5#2)
of total RNA from##3##4##(1993-2#1)(2009-12#1)(2010-2#1)
of total RNA##14##3##(1991-5#1)(1991-8#2)(1992-7#1)(1993-2#1)(1994-11#1)(1996-10#1)(2008-1#1)(2008-4#2)(2009-12#2)(2010-2#1)(2011-2#1)
of total acidity##2##3##(2008-10#1)(2012-2#1)
of total adenine compounds##2##4##(1990-6#2)
of total and LDL cholesterol##2##5##(2005-10#2)
of total and dissolved##2##4##(2008-10#2)
of total and free##6##4##(1990-1#1)(1992-6#1)(1995-1#1)(1995-12#2)(2007-7#1)
of total and protein-bound homocysteine in##2##6##(2008-10#2)
of total and##24##3##(1990-1#1)(1991-6#1)(1991-7#2)(1991-8#1)(1992-6#1)(1994-12#1)(1995-1#1)(1995-12#2)(1995-3#1)(2004-4#1)(2005-10#4)(2007-2#1)(2007-7#1)(2008-10#5)(2008-5#1)
of total ankle##2##3##(2009-7#2)
of total antioxidant activity##2##4##(2007-8#1)(2011-1#1)
of total antioxidant capacity in green tea##2##7##(2008-10#2)
of total antioxidant capacity##3##4##(2008-10#3)
of total antioxidant##5##3##(2007-8#1)(2008-10#3)(2011-1#1)
of total arsenic##7##3##(1995-11#1)(2008-10#6)
of total bacteria and##2##4##(2008-10#2)
of total bacteria##3##3##(2008-10#2)(2009-4#1)
of total bacterial population##2##4##(2007-7#1)(2008-10#1)
of total bacterial##4##3##(1992-12#1)(2007-7#1)(2008-10#1)(2008-4#1)
of total bilirubin##4##3##(2008-10#2)(2013-1#2)
of total body##4##3##(1995-4#1)(2007-11#1)(2008-10#1)(2010-3#1)
of total calories##2##3##(1991-11#1)(2013-7#1)
of total cases##2##3##(2005-10#1)(2008-4#1)
of total cell protein##2##4##(2008-11#2)
of total cell##4##3##(1994-3#1)(2008-11#2)(2009-3#1)
of total cells and##2##4##(1994-11#1)(2008-10#1)
of total cells##4##3##(1994-11#1)(2008-10#1)(2008-7#2)
of total cellular RNA##2##4##(1994-12#1)(2008-4#1)
of total cellular protein##4##4##(1990-5#2)(1995-1#1)(1995-3#1)
of total cellular proteins##2##4##(1994-8#1)(2008-4#1)
of total cellular##10##3##(1990-5#2)(1990-8#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-3#2)(2008-4#2)
of total cholesterol and##4##4##(1991-11#1)(1992-8#1)(1993-12#1)(2008-7#1)
of total cholesterol in##4##4##(1990-12#1)(1995-1#1)(1995-4#1)(2012-2#1)
of total cholesterol##20##3##(1990-12#1)(1990-5#1)(1991-11#2)(1991-2#1)(1992-8#1)(1993-12#1)(1994-12#1)(1995-1#1)(1995-4#1)(1996-11#1)(1996-4#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#3)(2013-1#1)
of total chromium in##4##4##(2008-10#4)
of total chromium##5##3##(2008-10#5)
of total cost##2##3##(2006-12#1)(2007-8#1)
of total costs##3##3##(2008-12#1)(2013-1#2)
of total coverings##3##3##(1990-2#3)
of total creatine##2##3##(1996-5#1)(2008-5#1)
of total culturable##3##3##(2008-10#2)(2010-4#1)
of total developmental time spent in a particular##2##8##(2008-8#2)
of total dissolved##3##3##(2008-10#3)
of total dose##3##3##(2006-7#1)(2007-4#2)
of total energy intake##3##4##(1990-2#1)(2006-6#1)(2008-5#1)
of total energy##5##3##(1990-2#1)(1996-11#1)(2006-6#1)(2008-3#1)(2008-5#1)
of total fatty##2##3##(1991-7#1)(2012-11#1)
of total flavones from##3##4##(2011-1#1)(2012-3#1)(2013-8#1)
of total flavonoids##2##3##(2006-12#1)(2012-12#1)
of total fluorine in##3##4##(2008-10#3)
of total gaseous selenium in##2##5##(2008-10#2)
of total genomic DNA##3##4##(2008-1#1)(2008-10#2)
of total glycoalkaloids content in##2##5##(2008-10#2)
of total glycoalkaloids content##4##4##(2008-10#4)
of total hemoglobin##3##3##(1996-12#2)(2013-1#1)
of total hip arthroplasty (THA)##2##5##(2013-1#2)
of total hip arthroplasty##7##4##(2004-9#1)(2007-8#1)(2008-3#1)(2008-8#2)(2013-1#2)
of total hip replacement in##2##5##(2007-7#2)
of total hip replacement##3##4##(2007-11#1)(2007-7#2)
of total hip##18##3##(1996-6#1)(2004-9#1)(2007-11#3)(2007-7#2)(2007-8#1)(2008-3#2)(2008-8#3)(2009-12#1)(2009-3#1)(2013-1#3)
of total homocysteine##2##3##(2008-8#2)
of total hospital##3##3##(1992-2#1)(1993-1#1)(1995-1#1)
of total human##2##3##(1997-2#1)(2008-12#1)
of total inorganic arsenic##2##4##(2008-10#2)
of total inorganic##5##3##(2008-10#5)
of total internal reflection##9##4##(2007-11#2)(2007-12#2)(2008-1#1)(2008-2#4)
of total knee##3##3##(2007-8#1)(2013-1#2)
of total lipid##2##3##(1996-1#1)(2007-3#1)
of total lipids)##2##3##(2008-11#2)
of total liver##2##3##(1991-2#2)
of total membrane##2##3##(1992-7#1)(1993-3#1)
of total mercury in##5##4##(2008-10#5)
of total mercury##12##3##(2008-10#12)
of total nitrogen##2##3##(2008-10#2)
of total nucleated cells##2##4##(2008-11#1)(2008-8#1)
of total nucleic##2##3##(2008-10#1)(2008-9#1)
of total or##2##3##(2007-11#1)(2008-10#1)
of total organic##3##3##(2005-11#2)(2008-10#1)
of total parenteral nutrition##4##4##(2004-11#2)(2006-10#1)(2009-5#1)
of total phenolics##2##3##(2011-2#1)(2013-1#1)
of total phosphorus in soya food##2##6##(2008-10#2)
of total phosphorus in##3##4##(2008-10#3)
of total phosphorus##6##3##(2008-10#6)
of total plasma##6##3##(1990-11#1)(1992-2#1)(1993-11#2)(2008-1#1)(2008-4#1)
of total polar parts##2##4##(2008-10#2)
of total protein and##2##4##(1992-6#1)(2008-4#1)
of total protein in human serum samples##2##7##(2008-10#2)
of total protein in human serum##3##6##(2008-10#3)
of total protein in##4##4##(2008-10#3)(2008-4#1)
of total protein##18##3##(1990-4#1)(1991-6#1)(1992-4#1)(1992-6#1)(1993-5#1)(2008-1#2)(2008-10#4)(2008-3#1)(2008-4#3)(2008-5#1)(2008-8#1)(2010-3#1)
of total proteins in##2##4##(2008-10#1)(2008-12#1)
of total proteins##9##3##(2004-11#1)(2005-8#1)(2008-10#4)(2008-12#1)(2011-1#2)
of total quality management (TQM) and##2##6##(1993-3#1)(1995-3#1)
of total quality management (TQM)##3##5##(1993-3#1)(1995-1#1)(1995-3#1)
of total quality management##9##4##(1993-3#1)(1994-1#2)(1995-1#1)(1995-3#3)(1996-2#1)(2008-12#1)
of total quality##10##3##(1993-3#1)(1994-1#2)(1995-1#1)(1995-3#3)(1996-2#1)(2007-8#1)(2008-12#1)
of total radioactivity##2##3##(1990-3#1)(1994-8#1)
of total rat##2##3##(1994-5#1)(2004-12#1)
of total reflection##4##3##(2008-2#1)(2008-3#3)
of total saturated##3##3##(2006-12#2)(2010-4#1)
of total serum cholesterol##3##4##(1991-11#1)(2007-1#1)(2011-1#1)
of total serum##5##3##(1991-10#1)(1991-11#1)(2007-1#1)(2010-12#1)(2011-1#1)
of total sialic acids##2##4##(2008-11#2)
of total sialic##3##3##(1995-12#1)(2008-11#2)
of total soluble phenolic compounds##2##5##(2008-10#2)
of total soluble protein in##2##5##(1993-9#1)(2006-12#1)
of total soluble protein##5##4##(1993-6#1)(1993-9#1)(2006-11#1)(2006-12#2)
of total soluble sugars##2##4##(2008-12#2)
of total soluble##11##3##(1993-6#1)(1993-9#1)(2006-11#1)(2006-12#2)(2008-10#2)(2008-12#3)(2011-2#1)
of total spending##3##3##(1992-3#1)(1996-2#1)(2010-11#1)
of total tRNA from##2##4##(2008-4#2)
of total thallium##2##3##(2008-10#2)
of total time##3##3##(1994-4#2)(2008-5#1)
of total variance##2##3##(2012-3#1)(2013-1#1)
of total viable##2##3##(1997-4#1)(2006-5#1)
of total water##3##3##(2008-10#1)(2008-5#2)
of total white blood cells##2##5##(1991-9#1)(2012-12#1)
of total##678##2##(1990-1#1)(1990-11#2)(1990-12#3)(1990-2#5)(1990-3#1)(1990-4#1)(1990-5#5)(1990-6#3)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#5)(1991-12#5)(1991-2#4)(1991-3#1)(1991-4#2)(1991-5#4)(1991-6#2)(1991-7#3)(1991-8#4)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#4)(1992-4#2)(1992-6#5)(1992-7#3)(1992-8#5)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#2)(1993-2#3)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#3)(1994-1#3)(1994-10#1)(1994-11#4)(1994-12#4)(1994-2#1)(1994-3#2)(1994-4#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#9)(1995-11#2)(1995-12#4)(1995-2#3)(1995-3#10)(1995-4#2)(1995-5#2)(1995-7#2)(1995-8#2)(1996-1#2)(1996-10#1)(1996-11#5)(1996-12#5)(1996-2#2)(1996-3#1)(1996-4#3)(1996-5#1)(1996-6#1)(1996-8#3)(1996-9#1)(1997-1#7)(1997-2#7)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#2)(2004-11#3)(2004-12#1)(2004-4#4)(2004-9#2)(2005-10#9)(2005-11#2)(2005-8#4)(2006-10#2)(2006-11#1)(2006-12#8)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#4)(2007-11#9)(2007-12#5)(2007-2#4)(2007-3#2)(2007-4#2)(2007-5#2)(2007-7#8)(2007-8#16)(2007-9#1)(2008-1#7)(2008-10#143)(2008-11#12)(2008-12#9)(2008-2#7)(2008-3#14)(2008-4#14)(2008-5#12)(2008-6#3)(2008-7#10)(2008-8#17)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#3)(2009-3#3)(2009-4#1)(2009-5#4)(2009-7#3)(2010-10#1)(2010-11#4)(2010-12#3)(2010-2#3)(2010-3#3)(2010-4#5)(2010-5#2)(2010-7#1)(2010-8#3)(2011-1#9)(2011-2#15)(2012-1#4)(2012-11#1)(2012-12#8)(2012-2#9)(2012-3#4)(2012-5#1)(2013-1#18)(2013-7#3)(2013-8#2)
of totally endoscopic single##2##4##(2007-8#2)
of totally implanted##2##3##(2007-7#2)
of totally##8##2##(2007-3#2)(2007-7#3)(2007-8#2)(2007-9#1)
of touch##10##2##(1995-8#1)(1995-9#1)(2007-10#1)(2007-12#1)(2007-5#2)(2008-1#2)(2008-7#1)(2008-9#1)
of toughness##2##2##(2012-2#1)(2013-1#1)
of tourists##2##2##(2007-2#1)(2007-3#1)
of tourniquet ischemia on##2##4##(2006-12#2)
of tourniquet ischemia##4##3##(2006-12#4)
of tourniquet##5##2##(2006-12#5)
of town##3##2##(1994-12#1)(1996-8#1)(2011-2#1)
of toxA##3##2##(1995-2#3)
of toxic and##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
of toxic chemicals##2##3##(2008-11#1)(2011-1#1)
of toxic compounds##5##3##(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)
of toxic effects##9##3##(1992-3#1)(1995-8#1)(1996-3#1)(1996-8#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-8#1)(2010-4#1)
of toxic gene products##2##4##(1996-10#1)(2008-6#1)
of toxic intermediary##2##3##(2007-5#1)(2008-11#1)
of toxic metal##3##3##(2008-10#2)(2009-7#1)
of toxic metals in##3##4##(1992-6#1)(2008-10#2)
of toxic metals##4##3##(1992-6#2)(2008-10#2)
of toxic species##3##3##(2008-10#2)(2012-1#1)
of toxic substances such as##2##5##(2007-8#1)(2008-10#1)
of toxic substances##8##3##(1992-2#1)(1992-6#1)(2007-8#1)(2008-10#2)(2008-11#2)(2011-1#1)
of toxic##97##2##(1991-10#1)(1991-12#1)(1991-3#2)(1991-8#1)(1992-2#1)(1992-3#1)(1992-6#3)(1993-3#1)(1994-11#2)(1994-6#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-10#2)(1996-12#4)(1996-3#1)(1996-8#1)(1997-2#2)(1997-3#2)(2005-6#1)(2005-7#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#20)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2009-12#1)(2009-7#1)(2009-8#1)(2010-12#3)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
of toxicant##4##2##(1996-12#1)(2008-10#1)(2008-9#1)(2012-12#1)
of toxicants##11##2##(2008-10#4)(2008-11#2)(2008-7#1)(2010-2#1)(2010-9#1)(2012-12#1)(2012-2#1)
of toxicities due to##2##4##(2008-5#1)(2008-8#1)
of toxicities##6##2##(1993-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)
of toxicity and##5##3##(2007-11#1)(2008-5#2)(2008-7#1)(2012-2#1)
of toxicity as##2##3##(2008-10#2)
of toxicity associated with##2##4##(2005-9#1)(2012-1#1)
of toxicity in##3##3##(1995-10#1)(2005-7#1)(2007-8#1)
of toxicity of the##2##4##(1991-8#1)(2008-11#1)
of toxicity of##6##3##(1991-8#1)(1992-9#1)(1996-8#1)(2005-8#1)(2007-11#1)(2008-11#1)
of toxicity##72##2##(1990-5#2)(1991-1#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-9#1)(1994-5#1)(1994-6#1)(1995-10#1)(1996-12#3)(1996-8#2)(1997-2#1)(1997-3#2)(1997-8#1)(2004-4#3)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2007-1#1)(2007-11#3)(2007-8#3)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#3)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#1)(2011-1#3)(2011-12#1)(2012-1#2)(2012-2#2)(2012-3#1)(2012-7#1)
of toxicologic##2##2##(2010-5#1)(2012-1#1)
of toxicological##5##2##(2007-8#1)(2010-9#1)(2011-1#1)(2012-1#2)
of toxicology##6##2##(1994-12#1)(2005-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2012-1#1)
of toxics in##2##3##(2005-12#1)(2008-5#1)
of toxigenic Fusarium##2##3##(2008-10#1)(2010-10#1)
of toxigenic##5##2##(2005-11#1)(2006-8#1)(2008-10#1)(2010-10#1)(2011-2#1)
of toxin A##6##3##(1997-4#2)(2006-8#2)(2007-12#2)
of toxin B##5##3##(2006-8#1)(2007-12#4)
of toxin binding##2##3##(1994-3#2)
of toxin in##2##3##(2008-10#1)(2008-5#1)
of toxin production##3##3##(2007-12#1)(2008-10#1)(2011-2#1)
of toxin synthesis##2##3##(1995-2#1)(2008-10#1)
of toxin##32##2##(1991-10#1)(1994-2#2)(1994-3#2)(1995-2#1)(1997-4#2)(2006-12#1)(2006-7#1)(2006-8#3)(2007-12#7)(2008-10#6)(2008-5#3)(2011-1#1)(2011-2#1)(2013-1#1)
of toxins and##3##3##(1997-6#1)(2008-10#1)(2012-12#1)
of toxins from##2##3##(2006-10#1)(2011-12#1)
of toxins in##2##3##(2006-8#1)(2008-11#1)
of toxins into the##2##4##(2004-11#1)(2008-12#1)
of toxins or##2##3##(2008-10#1)(2008-7#1)
of toxins##19##2##(1993-3#1)(1994-5#1)(1997-6#2)(2004-11#1)(2005-8#1)(2006-10#2)(2006-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2011-12#1)(2012-12#1)
of toxoplasma##4##2##(1990-5#1)(1993-2#1)(2011-1#2)
of toxoplasmic encephalitis##2##3##(1993-5#2)
of toxoplasmosis during pregnancy##2##4##(2007-7#1)(2008-4#1)
of toxoplasmosis in patients with##2##5##(1991-2#1)(1994-4#1)
of toxoplasmosis in##7##3##(1991-2#1)(1992-2#1)(1994-4#1)(2007-10#1)(2007-7#2)(2008-4#1)
of toxoplasmosis##20##2##(1991-2#1)(1991-6#1)(1992-2#1)(1994-4#1)(1995-9#1)(2006-10#1)(2006-7#2)(2007-10#1)(2007-2#2)(2007-7#3)(2007-9#1)(2008-4#3)(2009-7#1)(2013-8#1)
of trabecular bone##4##3##(1993-11#1)(2008-6#1)(2008-7#1)(2009-7#1)
of trabecular rod strength##2##4##(2010-10#2)
of trabecular##8##2##(1993-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-7#1)(2010-10#2)
of trace Cd and Pb in environmental and biological samples##2##10##(2008-10#2)
of trace Cd and Pb##3##5##(2008-10#3)
of trace Cd##4##3##(2008-10#4)
of trace aluminium by##2##4##(2005-4#1)(2008-10#1)
of trace amount of##24##4##(2005-4#1)(2007-8#1)(2008-10#22)
of trace amount##25##3##(2005-4#1)(2007-8#1)(2008-10#23)
of trace amounts of NADH##2##5##(2008-10#2)
of trace amounts of beryllium##3##5##(2008-10#3)
of trace amounts of bromide##3##5##(2008-10#3)
of trace amounts of copper in##2##6##(2008-10#2)
of trace amounts of copper##5##5##(2008-10#5)
of trace amounts of formaldehyde in air##3##7##(2008-10#3)
of trace amounts of germanium by##2##6##(2008-10#2)
of trace amounts of iron and##2##6##(1990-9#1)(2008-10#1)
of trace amounts of iron##3##5##(1990-9#1)(2008-10#2)
of trace amounts of zinc##3##5##(2005-4#1)(2008-10#2)
of trace amounts of##98##4##(1990-9#1)(1992-7#1)(2005-4#2)(2007-8#1)(2008-10#92)(2013-7#1)
of trace and##5##3##(2008-10#5)
of trace arsenic##3##3##(2005-4#1)(2008-10#2)
of trace cadmium##2##3##(2008-10#2)
of trace chromium##2##3##(2005-4#1)(2008-10#1)
of trace chromium(VI)##2##3##(2008-10#2)
of trace cobalt##4##3##(2008-10#4)
of trace constituents##5##3##(2006-12#2)(2008-10#2)(2008-2#1)
of trace copper and lead in highly pure samaria by##2##10##(2005-4#2)
of trace copper and##5##4##(2005-4#4)(2008-10#1)
of trace copper##7##3##(2005-4#4)(2008-10#3)
of trace element##5##3##(2007-8#1)(2008-10#1)(2010-12#1)(2011-2#2)
of trace elements in rainwater##3##5##(2007-8#3)
of trace elements in solid##2##5##(2008-10#2)
of trace elements in the##3##5##(2008-10#2)(2010-12#1)
of trace elements in##25##4##(2007-8#5)(2008-10#17)(2010-12#1)(2011-2#1)(2013-8#1)
of trace elements is##2##4##(2008-10#2)
of trace elements were##2##4##(2008-10#2)
of trace elements##46##3##(2007-8#7)(2008-10#35)(2010-11#1)(2010-12#1)(2011-2#1)(2013-8#1)
of trace gases in the atmosphere##2##6##(2008-2#1)(2008-3#1)
of trace gases in the##3##5##(2008-2#1)(2008-3#2)
of trace gases in##4##4##(2008-2#1)(2008-3#3)
of trace gases##7##3##(2007-12#1)(2008-2#2)(2008-3#4)
of trace heavy metals in##3##5##(2008-10#2)(2009-6#1)
of trace heavy metals##5##4##(2008-10#4)(2009-6#1)
of trace impurities in##2##4##(2008-10#2)
of trace iron in beer##2##5##(2008-10#2)
of trace iron##3##3##(2005-4#1)(2008-10#2)
of trace lead in water##3##5##(2008-10#2)(2013-8#1)
of trace lead##11##3##(2005-4#2)(2008-10#6)(2013-8#3)
of trace level##3##3##(1997-2#1)(2008-10#2)
of trace levels of##22##4##(1990-8#1)(2008-10#21)
of trace magnesium and lead##2##5##(2005-4#2)
of trace manganese##7##3##(2008-10#7)
of trace mercury by##3##4##(2008-10#3)
of trace mercury##12##3##(2008-10#12)
of trace metal ions in##2##5##(2008-10#2)
of trace metal ions##5##4##(2008-10#5)
of trace metal##9##3##(2008-10#8)(2012-2#1)
of trace metals and##2##4##(1994-8#1)(2008-10#1)
of trace metals by anodic stripping voltammetry##2##7##(2007-8#1)(2008-10#1)
of trace metals by##6##4##(2007-8#1)(2008-10#5)
of trace metals from##2##4##(2008-10#1)(2012-2#1)
of trace metals in water##2##5##(2008-10#2)
of trace metals in##18##4##(1994-6#1)(2008-10#16)(2008-3#1)
of trace metals using a##2##5##(2008-10#2)
of trace metals##43##3##(1994-6#2)(1994-8#1)(2005-4#1)(2007-8#1)(2008-10#33)(2008-3#1)(2012-2#4)
of trace rare earth impurities in the high-purity##2##8##(2005-4#2)
of trace rare earth##3##4##(2005-4#2)(2008-10#1)
of trace species##2##3##(2008-2#2)
of trace vanadium##3##3##(2008-10#3)
of trace water in##3##4##(2008-10#3)
of trace zinc in milk##2##5##(2005-4#2)
of trace##454##2##(1990-8#1)(1990-9#1)(1991-8#1)(1992-7#1)(1994-6#2)(1994-8#1)(1997-2#1)(2005-4#34)(2006-12#2)(2006-4#1)(2007-12#1)(2007-8#13)(2008-10#360)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#6)(2008-6#1)(2009-6#1)(2010-11#1)(2010-12#2)(2011-2#3)(2012-2#5)(2013-7#1)(2013-8#6)
of traceability##3##2##(2008-10#1)(2010-4#2)
of tracer eluted##2##3##(1990-12#2)
of tracer into##2##3##(1990-5#1)(1995-10#1)
of tracer##13##2##(1990-12#2)(1990-5#2)(1993-11#1)(1994-12#1)(1995-10#1)(1996-12#1)(1996-9#1)(2010-12#3)(2011-2#1)
of tracers##4##2##(1997-8#1)(2008-10#1)(2008-7#1)(2010-7#1)
of traces of Ni in##2##5##(2008-10#2)
of traces of Ni##3##4##(2008-10#3)
of traces of cobalt##2##4##(2008-10#2)
of traces of gold##2##4##(2008-10#2)
of traces of silver ions onto polyurethane foam##2##8##(2008-10#2)
of traces of##28##3##(2007-1#1)(2007-8#1)(2008-10#24)(2009-3#1)(2013-1#1)
of traces##30##2##(2007-1#1)(2007-8#1)(2008-10#26)(2009-3#1)(2013-1#1)
of trachea##4##2##(2007-12#1)(2010-7#1)(2013-1#2)
of tracheae##2##2##(2007-12#2)
of tracheal intubation with##2##4##(2007-8#1)(2013-8#1)
of tracheal obstruction##2##3##(2013-1#2)
of tracheal tube##2##3##(2009-5#1)(2011-2#1)
of tracheal##17##2##(1991-2#1)(1994-10#1)(2006-9#1)(2007-12#1)(2007-8#3)(2008-4#1)(2008-5#2)(2009-2#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
of tracheoesophageal fistula and##2##4##(1996-6#1)(2010-12#1)
of tracheostomy##5##2##(1991-11#1)(2007-8#2)(2013-1#1)(2013-8#1)
of trachoma in##2##3##(2010-8#1)(2013-1#1)
of trachoma##4##2##(1995-9#1)(2010-8#2)(2013-1#1)
of track offset##3##3##(2008-2#3)
of tracking##10##2##(1993-11#1)(1995-12#1)(2005-8#1)(2006-9#1)(2007-5#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-1#1)(2012-1#1)
of traction induced##2##3##(2008-9#2)
of traction##5##2##(2005-10#1)(2006-9#1)(2008-11#1)(2008-9#2)
of trade in##3##3##(2007-12#1)(2008-7#1)(2008-9#1)
of trade##8##2##(1990-7#1)(1993-10#1)(2005-5#1)(2007-12#1)(2008-12#2)(2008-7#1)(2008-9#1)
of trading##2##2##(2008-2#1)(2008-4#1)
of tradition##2##2##(1995-1#1)(2007-3#1)
of traditional Chinese medicine injections##3##5##(2011-2#2)(2011-3#1)
of traditional Chinese medicine##6##4##(2007-8#1)(2011-2#3)(2011-3#1)(2013-1#1)
of traditional Chinese##12##3##(1997-2#1)(2007-8#2)(2011-2#4)(2011-3#1)(2012-3#1)(2013-1#3)
of traditional and##4##3##(2006-10#1)(2010-2#1)(2012-12#1)(2013-1#1)
of traditional cardiovascular risk factors##3##5##(1990-5#1)(2007-10#1)(2008-3#1)
of traditional healers##2##3##(2007-7#1)(2008-4#1)
of traditional medical##2##3##(1994-1#1)(2009-7#1)
of traditional medicine in a##2##5##(2007-4#1)(2011-1#1)
of traditional medicine##4##3##(1992-5#1)(2007-4#1)(2008-1#1)(2011-1#1)
of traditional practices##2##3##(1997-7#2)
of traditional risk factors##2##4##(2013-1#1)(2013-7#1)
of traditional techniques##2##3##(2008-12#1)(2010-8#1)
of traditional##94##2##(1990-10#1)(1990-5#1)(1991-12#1)(1992-12#1)(1992-4#1)(1992-5#1)(1994-1#1)(1994-12#1)(1994-4#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#3)(2005-11#1)(2005-12#1)(2005-6#1)(2006-10#2)(2006-12#1)(2007-10#2)(2007-11#2)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#3)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#1)
of traditionally##2##2##(2007-2#1)(2010-2#1)
of traffic##10##2##(1992-2#1)(1992-6#1)(1995-12#1)(2006-11#1)(2006-12#1)(2008-11#2)(2008-3#1)(2011-2#1)(2012-1#1)
of trained nurses##3##3##(2008-2#1)(2009-4#2)
of trained rats##2##3##(1993-5#1)(1997-7#1)
of trained##15##2##(1993-11#1)(1993-5#1)(1997-7#1)(2005-10#1)(2005-8#1)(2007-2#1)(2007-4#2)(2008-2#1)(2009-4#2)(2010-4#1)(2010-8#1)(2011-2#2)
of trainees##5##2##(1994-12#1)(2006-10#1)(2006-6#1)(2009-4#1)(2010-8#1)
of training and##13##3##(1993-9#1)(1995-6#1)(1997-5#1)(2006-7#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-10#1)(2011-2#2)(2012-1#1)
of training for##3##3##(1991-3#1)(1994-3#1)(1997-2#1)
of training images##3##3##(2007-12#1)(2008-2#2)
of training in##4##3##(1990-4#1)(2006-10#1)(2008-1#1)(2010-12#1)
of training may##2##3##(2009-3#1)(2012-1#1)
of training of##4##3##(1994-3#1)(1996-12#1)(2006-9#1)(2008-7#1)
of training programs##3##3##(1992-12#1)(2007-12#1)(2011-1#1)
of training set##2##3##(2008-10#2)
of training the##3##3##(1993-5#1)(2005-1#1)(2012-1#1)
of training##97##2##(1990-4#1)(1991-11#1)(1991-3#2)(1992-12#3)(1992-2#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-5#1)(1993-9#6)(1994-12#1)(1994-3#5)(1995-2#1)(1995-6#1)(1995-8#2)(1996-12#1)(1997-2#1)(1997-5#1)(2005-1#2)(2005-10#1)(2005-8#1)(2006-10#3)(2006-7#1)(2006-9#2)(2007-10#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#3)(2010-1#1)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#6)(2012-1#5)(2012-3#1)(2013-1#4)(2013-8#2)
of trains of##3##3##(2008-2#2)(2010-12#1)
of trait anxiety##3##3##(1990-8#1)(1994-12#1)(2009-9#1)
of trait##12##2##(1990-8#1)(1994-12#1)(2007-12#1)(2008-11#2)(2008-7#1)(2009-12#1)(2009-8#1)(2009-9#1)(2012-3#3)
of traits that##5##3##(2006-5#1)(2008-10#1)(2008-11#1)(2008-8#2)
of traits##20##2##(1997-4#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-8#9)(2008-9#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#2)
of trajectories##5##2##(2008-11#1)(2008-3#1)(2008-7#1)(2010-2#1)(2011-2#1)
of trajectory##2##2##(2008-12#1)(2008-3#1)
of trajectory-specific##2##2##(1994-8#2)
of tramadol in##3##3##(1996-5#2)(2006-10#1)
of tramadol##13##2##(1993-2#2)(1996-5#3)(1996-7#2)(2006-10#1)(2007-2#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-7#1)
of tranilast on##2##3##(1995-11#1)(1996-12#1)
of tranilast##4##2##(1995-11#1)(1996-12#1)(2008-5#2)
of trans fatty acids##4##4##(2006-7#4)
of trans##9##2##(1991-4#1)(1992-2#1)(2006-7#5)(2007-8#2)
of trans-EE##2##2##(2008-5#2)
of trans-acting##4##2##(1994-8#1)(1995-8#1)(1997-6#1)(2010-5#1)
of trans-anethole##2##2##(2007-1#2)
of trans-beta-carotene in rat and beef livers##2##7##(2008-10#2)
of trans-beta-carotene in##3##3##(2008-10#3)
of trans-beta-carotene##4##2##(2008-10#4)
of trans-tamoxifen##2##2##(2008-11#2)
of transactional##3##2##(2006-3#1)(2007-7#1)(2013-7#1)
of transactions##2##2##(2008-11#1)(2012-3#1)
of transaldolase and phosphoglycerate mutase I##2##6##(2010-12#2)
of transaminases in##2##3##(1992-5#1)(1994-11#1)
of transaminases##7##2##(1992-5#1)(1994-11#1)(1996-11#1)(2008-5#1)(2009-5#1)(2012-12#1)(2012-2#1)
of transbronchial##2##2##(2009-7#1)(2010-8#1)
of transcallosal##2##2##(1996-10#1)(2006-5#1)
of transcatheter##2##2##(2008-4#1)(2013-1#1)
of transcendence##2##2##(2010-8#1)(2011-1#1)
of transcolonic NOTES##2##3##(2010-12#2)
of transcranial Doppler ultrasound (TCD)##2##5##(2007-10#1)(2012-3#1)
of transcranial Doppler##4##3##(1992-10#1)(2006-10#1)(2007-10#1)(2012-3#1)
of transcranial magnetic##2##3##(1996-6#1)(2011-1#1)
of transcranial##11##2##(1992-10#1)(1996-2#1)(1996-3#1)(1996-6#1)(2006-10#1)(2007-10#1)(2007-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
of transcribed##3##2##(1997-1#1)(2008-8#1)(2009-5#1)
of transcript abundance##5##3##(1996-7#2)(2008-11#1)(2008-7#1)(2013-8#1)
of transcript##13##2##(1994-12#1)(1996-7#2)(1997-6#1)(2008-10#3)(2008-11#1)(2008-7#3)(2009-8#1)(2013-8#1)
of transcription (STAT)##4##3##(2011-2#2)(2012-3#2)
of transcription 1 (STAT1)##2##4##(2008-10#1)(2011-2#1)
of transcription 3##3##3##(1996-5#1)(2009-9#1)(2013-1#1)
of transcription and##3##3##(1993-3#1)(1994-11#1)(1997-1#1)
of transcription are##3##3##(1991-7#1)(1996-7#1)(2007-12#1)
of transcription by##8##3##(1990-11#1)(1992-8#1)(1993-6#1)(1994-9#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-7#1)
of transcription complexes##3##3##(1995-2#1)(1995-6#1)(1997-5#1)
of transcription factor NF-kappa B##2##5##(1997-3#1)(2008-9#1)
of transcription factor expression##2##4##(2012-1#1)(2013-1#1)
of transcription factor##16##3##(1993-2#1)(1994-8#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-6#1)(2003-11#1)(2008-9#2)(2009-2#1)(2010-3#1)(2010-8#1)(2012-1#1)(2013-1#1)(2013-7#1)
of transcription factors and##5##4##(1993-11#1)(1996-10#1)(2009-10#1)(2009-8#1)(2013-1#1)
of transcription factors as##2##4##(1994-8#1)(2011-12#1)
of transcription factors binding##2##4##(2008-7#1)(2008-9#1)
of transcription factors with##2##4##(1994-10#1)(2008-4#1)
of transcription factors##50##3##(1991-12#1)(1991-5#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#3)(1994-9#2)(1995-1#1)(1995-2#1)(1995-3#4)(1995-8#1)(1996-10#1)(1996-11#1)(1996-5#2)(2005-6#1)(2005-7#1)(2006-10#1)(2007-12#2)(2008-4#4)(2008-7#4)(2008-9#1)(2009-10#1)(2009-8#2)(2010-2#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#1)
of transcription from##2##3##(1990-7#1)(1997-4#1)
of transcription in the##2##4##(1994-9#1)(2009-3#1)
of transcription in##5##3##(1994-3#1)(1994-9#1)(2007-12#1)(2008-11#1)(2009-3#1)
of transcription initiation##7##3##(1991-11#1)(1992-4#1)(1993-9#1)(1996-11#1)(1997-2#1)(1997-7#1)(1997-8#1)
of transcription is##3##3##(1993-9#1)(1996-8#1)(2012-3#1)
of transcription of the##10##4##(1991-2#2)(1991-7#2)(1992-1#1)(1992-12#1)(1997-2#1)(1997-7#2)(2006-12#1)
of transcription of##19##3##(1990-9#1)(1991-2#2)(1991-7#3)(1992-1#1)(1992-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-7#2)(2006-12#1)(2008-11#1)(2008-9#2)
of transcription past##2##3##(1996-11#2)
of transcription proteins##3##3##(2008-4#3)
of transcription termination##2##3##(1996-7#1)(2008-11#1)
of transcription under##2##3##(1993-3#1)(1994-12#1)
of transcription with##2##3##(1992-6#1)(1993-9#1)
of transcription##208##2##(1990-11#1)(1990-5#1)(1990-6#2)(1990-7#5)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#3)(1991-7#5)(1992-1#2)(1992-12#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#2)(1993-9#5)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#4)(1994-8#5)(1994-9#6)(1995-1#1)(1995-2#3)(1995-3#8)(1995-6#5)(1995-8#1)(1996-10#1)(1996-11#4)(1996-2#4)(1996-4#2)(1996-5#7)(1996-7#3)(1996-8#3)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#3)(1997-6#1)(1997-7#4)(1997-8#1)(2003-11#1)(2005-10#1)(2005-6#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-12#6)(2008-1#1)(2008-10#2)(2008-11#6)(2008-4#8)(2008-7#7)(2008-8#3)(2008-9#5)(2009-10#1)(2009-2#1)(2009-3#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#2)
of transcription)##5##2##(1991-5#1)(1996-5#1)(1996-7#1)(2008-1#1)(2009-3#1)
of transcriptional activation by##2##4##(1990-6#1)(1991-11#1)
of transcriptional activation of##3##4##(1990-8#1)(1992-8#1)(1994-11#1)
of transcriptional activation##8##3##(1990-6#1)(1990-8#1)(1991-11#1)(1992-8#1)(1994-11#1)(1995-12#1)(1997-2#1)(2008-9#1)
of transcriptional activators##2##3##(1995-2#1)(1996-4#1)
of transcriptional activity##4##3##(1991-9#1)(1992-11#1)(1992-5#1)(1995-2#1)
of transcriptional and##2##3##(2005-9#1)(2008-11#1)
of transcriptional changes##2##3##(2010-11#1)(2012-2#1)
of transcriptional control##4##3##(1991-8#1)(2008-11#1)(2008-7#1)(2012-2#1)
of transcriptional corepressors##2##3##(2012-12#2)
of transcriptional factors##3##3##(1994-6#1)(2012-2#2)
of transcriptional regulation by##3##4##(1995-8#1)(1996-4#1)(2006-11#1)
of transcriptional regulation##8##3##(1991-2#1)(1992-8#1)(1995-8#1)(1996-4#1)(2006-11#1)(2008-11#1)(2008-9#1)(2012-3#1)
of transcriptional regulators##2##3##(1991-11#1)(2006-9#1)
of transcriptional regulatory pathways##2##4##(1995-2#1)(2012-12#1)
of transcriptional regulatory##5##3##(1995-2#1)(2006-9#1)(2007-12#1)(2008-7#1)(2012-12#1)
of transcriptional responses##2##3##(1991-7#1)(2012-12#1)
of transcriptional start##2##3##(1995-6#1)(2008-4#1)
of transcriptional##69##2##(1990-6#1)(1990-8#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-5#1)(1992-8#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#3)(1995-6#2)(1995-8#3)(1996-4#2)(1997-2#1)(1997-4#2)(2005-9#1)(2006-11#1)(2006-9#2)(2007-12#1)(2008-11#5)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-8#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-12#7)(2012-2#4)(2012-3#2)(2013-8#1)
of transcriptionally active gene chromatin##2##5##(1992-5#2)
of transcriptionally active##7##3##(1990-12#2)(1990-7#1)(1992-5#2)(1995-3#1)(2008-2#1)
of transcriptome##3##2##(2009-10#1)(2012-3#1)(2013-1#1)
of transcripts encoding##2##3##(1994-3#1)(2008-10#1)
of transcripts for##3##3##(1992-9#1)(1995-8#1)(2008-4#1)
of transcripts from##4##3##(1992-11#1)(1992-6#1)(1994-8#1)(2008-10#1)
of transcripts in##2##3##(1996-12#1)(2011-2#1)
of transcripts of the##2##4##(1992-5#1)(2008-8#1)
of transcripts of##7##3##(1992-5#1)(1995-3#1)(2008-10#1)(2008-8#1)(2012-1#1)(2012-12#2)
of transcripts##44##2##(1990-2#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-3#2)(1995-4#1)(1995-8#1)(1996-12#1)(1997-2#2)(1997-7#1)(2006-12#1)(2008-1#1)(2008-10#6)(2008-2#3)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#2)
of transcultural psychiatry##2##3##(2008-2#2)
of transcutaneous electrical##2##3##(2011-12#1)(2012-3#1)
of transcutaneous##5##2##(2004-9#1)(2008-4#1)(2011-12#1)(2011-2#1)(2012-3#1)
of transdermal fentanyl##2##3##(2009-6#2)
of transdermal glyceryl trinitrate##2##4##(2007-10#1)(2008-8#1)
of transdermal granisetron in##2##4##(2010-12#2)
of transdermal granisetron##3##3##(2010-12#3)
of transdermal##15##2##(1991-8#1)(1992-12#2)(2004-12#1)(2007-10#1)(2007-2#1)(2008-8#1)(2009-3#1)(2009-6#2)(2010-12#3)(2012-12#1)(2013-8#1)
of transduced cells##2##3##(2007-12#1)(2008-11#1)
of transduced##3##2##(1997-4#1)(2007-12#1)(2008-11#1)
of transducers##2##2##(2008-10#1)(2008-3#1)
of transducin##7##2##(1990-2#1)(1990-7#4)(1993-3#1)(1994-11#1)
of transducing##2##2##(1990-9#1)(2008-11#1)
of transduction in##2##3##(1993-7#1)(2010-10#1)
of transduction##5##2##(1993-7#1)(1996-2#1)(2008-11#1)(2008-8#1)(2010-10#1)
of transected##2##2##(1990-4#1)(2008-9#1)
of transepidermal water loss##2##4##(2008-5#2)
of transepidermal##3##2##(2007-7#1)(2008-5#2)
of transesophageal##3##2##(1993-10#1)(1995-9#2)
of transesterification##3##2##(1996-5#1)(2008-7#1)(2013-1#1)
of transfected Chinese hamster##2##4##(1995-12#1)(2008-11#1)
of transfected cells with##3##4##(1991-11#1)(1992-3#1)(1996-5#1)
of transfected cells##11##3##(1991-11#1)(1991-9#1)(1992-3#1)(1995-10#1)(1995-5#1)(1996-5#1)(1997-7#1)(2007-11#1)(2007-6#1)(2008-11#1)(2008-2#1)
of transfected##27##2##(1991-11#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-9#1)(1993-4#1)(1994-10#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#2)(1996-5#1)(1997-7#1)(2007-11#1)(2007-6#1)(2008-11#3)(2008-2#2)(2008-9#1)
of transfection##12##2##(1992-6#1)(1994-9#1)(1997-5#1)(2007-11#1)(2008-1#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-6#1)(2012-12#1)
of transfemoral##3##2##(2012-1#2)(2013-1#1)
of transfer RNA##2##3##(1990-8#1)(1994-11#1)
of transfer for##2##3##(2008-2#1)(2010-5#1)
of transfer from the##2##4##(1990-11#1)(1994-3#1)
of transfer function coefficients##2##4##(2011-2#2)
of transfer of learning##2##4##(2008-11#2)
of transfer of the##5##4##(1990-11#1)(1990-9#1)(1993-11#1)(1993-8#1)(2008-10#1)
of transfer of##13##3##(1990-11#1)(1990-9#1)(1992-5#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1995-7#1)(1997-4#1)(2004-4#1)(2008-10#1)(2008-11#2)
of transfer to the##2##4##(2008-2#1)(2008-3#1)
of transfer to##4##3##(2008-2#1)(2008-3#1)(2011-2#2)
of transfer was##2##3##(1990-11#1)(2010-2#1)
of transfer##52##2##(1990-11#3)(1990-4#1)(1990-8#3)(1990-9#1)(1991-4#1)(1991-7#1)(1992-12#2)(1992-3#1)(1992-5#1)(1993-11#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-7#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-7#1)(2004-4#1)(2006-10#2)(2006-3#1)(2006-5#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#2)(2010-2#1)(2010-5#1)(2011-2#6)(2012-1#1)(2013-1#1)
of transferred##4##2##(1993-11#1)(1993-3#1)(2006-3#1)(2010-9#1)
of transferrin (Tf)##2##3##(1994-10#1)(2013-7#1)
of transferrin and##2##3##(1995-11#1)(1995-6#1)
of transferrin in##2##3##(1992-8#1)(1995-3#1)
of transferrin receptor##3##3##(1994-8#1)(1995-2#1)(1995-5#1)
of transferrin saturation##2##3##(1992-5#1)(2007-2#1)
of transferrin##21##2##(1990-7#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-8#2)(1994-10#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-11#1)(2007-2#1)(2008-10#3)(2013-7#1)
of transferring##5##2##(1996-11#1)(2005-10#1)(2008-3#1)(2009-10#1)(2011-12#1)
of transforaminal epidural injections##5##4##(2006-7#1)(2006-8#4)
of transforaminal epidural##7##3##(2006-7#1)(2006-8#6)
of transformants obtained##2##3##(1993-11#1)(2008-10#1)
of transformants##11##2##(1990-5#1)(1993-11#1)(1995-8#1)(1997-1#1)(2006-12#1)(2008-10#5)(2011-1#1)
of transformation and##2##3##(2008-11#1)(2013-8#1)
of transformation efficiency##2##3##(1996-4#1)(2008-11#1)
of transformation in##3##3##(1993-12#1)(2008-11#1)(2011-2#1)
of transformation of##3##3##(1997-6#1)(2008-10#1)(2008-2#1)
of transformation using##2##3##(1997-7#1)(2008-11#1)
of transformation zone##2##3##(2012-3#2)
of transformation##26##2##(1990-9#1)(1991-8#1)(1992-2#1)(1992-9#1)(1993-12#1)(1994-12#1)(1996-4#1)(1997-6#1)(1997-7#1)(2004-4#1)(2006-11#1)(2006-12#1)(2008-10#2)(2008-11#4)(2008-2#2)(2011-2#1)(2012-2#1)(2012-3#3)(2013-8#1)
of transformations##6##2##(1996-3#1)(1997-3#1)(2004-4#1)(2008-6#1)(2008-7#1)(2010-4#1)
of transformed B cells##2##4##(1995-1#2)
of transformed cells##8##3##(1991-1#1)(1991-2#1)(1991-7#1)(1993-11#1)(1994-11#1)(1996-4#1)(2008-10#1)(2011-2#1)
of transformed human##2##3##(1994-12#1)(2008-10#1)
of transformed mouse##2##3##(1991-2#1)(2008-11#1)
of transformed phenotype##3##3##(1991-8#1)(1995-9#1)(2008-11#1)
of transformed##38##2##(1990-10#1)(1990-7#1)(1991-1#1)(1991-2#2)(1991-7#1)(1991-8#2)(1992-5#1)(1993-11#2)(1993-5#1)(1994-11#2)(1994-12#1)(1995-1#2)(1995-2#1)(1995-9#1)(1996-12#1)(1996-4#1)(1996-5#2)(1997-4#1)(2006-12#1)(2008-10#5)(2008-11#4)(2008-4#1)(2008-9#1)(2011-2#2)
of transformer oil##2##3##(2008-10#2)
of transformer##3##2##(2008-10#3)
of transforming DNA##2##3##(1993-11#2)
of transforming a##2##3##(2008-10#1)(2008-3#1)
of transforming growth factor alpha##2##5##(1990-3#1)(1993-3#1)
of transforming growth factor beta (TGF-beta)##3##6##(1995-2#1)(2008-11#1)(2008-12#1)
of transforming growth factor beta##10##5##(1991-1#1)(1991-10#2)(1993-12#1)(1995-2#2)(1996-4#1)(2008-11#2)(2008-12#1)
of transforming growth factor##16##4##(1990-3#1)(1991-1#1)(1991-10#2)(1992-8#1)(1993-12#1)(1993-3#1)(1995-2#2)(1996-4#1)(1996-5#1)(2008-11#2)(2008-12#1)(2010-12#1)(2012-2#1)
of transforming growth factor-beta (TGF-beta)##2##5##(1990-12#1)(1995-12#1)
of transforming growth factor-beta receptor type II and Smad3##2##9##(2007-12#2)
of transforming growth factor-beta##10##4##(1990-12#1)(1990-2#2)(1995-12#1)(1995-3#1)(2005-8#1)(2006-10#1)(2007-12#2)(2009-9#1)
of transforming growth factor-beta1##4##4##(1996-5#1)(2006-9#1)(2007-9#1)(2009-2#1)
of transforming growth##33##3##(1990-12#1)(1990-2#2)(1990-3#1)(1991-1#1)(1991-10#2)(1992-8#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-4#1)(1996-5#2)(1997-7#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-12#2)(2007-9#1)(2008-11#2)(2008-12#1)(2009-2#1)(2009-9#1)(2010-12#1)(2012-12#1)(2012-2#1)
of transforming##44##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1991-1#1)(1991-10#3)(1991-8#1)(1991-9#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-2#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-4#1)(1996-5#2)(1997-7#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-12#3)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-2#1)(2009-9#1)(2010-12#1)(2012-12#1)(2012-2#1)
of transfused##4##2##(1990-12#1)(1991-8#2)(2011-2#1)
of transfusion##13##2##(1990-3#1)(1994-12#1)(1995-9#1)(1996-9#1)(1997-5#1)(2006-10#1)(2007-7#3)(2007-9#1)(2008-10#1)(2008-12#1)(2011-2#1)
of transfusion-associated##3##2##(1996-6#1)(2006-2#1)(2012-12#1)
of transfusion-transmitted##4##2##(2005-10#1)(2012-12#2)(2012-2#1)
of transfusions##2##2##(2007-8#1)(2008-7#1)
of transgene and##2##3##(2005-6#1)(2006-11#1)
of transgene expression from##2##4##(2007-12#1)(2009-10#1)
of transgene expression##12##3##(1993-2#1)(1994-3#1)(1997-1#1)(1997-8#1)(2007-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2009-10#3)
of transgene integration##2##3##(1995-2#1)(2008-11#1)
of transgene##23##2##(1990-8#1)(1993-2#1)(1994-3#1)(1995-2#1)(1997-1#1)(1997-8#1)(2005-6#1)(2006-11#2)(2006-12#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-10#4)(2010-10#1)
of transgenes in##3##3##(1993-6#2)(2012-3#1)
of transgenes##12##2##(1993-6#2)(1997-4#1)(2006-10#1)(2006-12#2)(2008-11#1)(2008-4#1)(2008-9#2)(2009-10#1)(2012-3#1)
of transgenesis in N##2##4##(2012-3#2)
of transgenic D##3##3##(2013-1#3)
of transgenic animals and##2##4##(2005-8#1)(2013-8#1)
of transgenic animals##8##3##(1993-12#1)(1993-6#1)(1994-5#2)(1995-2#1)(2005-8#1)(2008-11#1)(2013-8#1)
of transgenic crops##3##3##(2006-11#1)(2010-10#1)(2011-2#1)
of transgenic lines##2##3##(2008-10#2)
of transgenic livestock##3##3##(1995-2#1)(2008-11#2)
of transgenic mice and##4##4##(2007-10#1)(2007-3#1)(2008-4#1)(2009-4#1)
of transgenic mice expressing##2##4##(1994-8#1)(1997-7#1)
of transgenic mice##28##3##(1990-11#1)(1990-5#1)(1993-5#1)(1994-2#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-8#3)(1996-10#1)(1996-4#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-3#1)(2008-11#1)(2008-2#2)(2008-4#5)(2009-4#1)(2012-12#2)
of transgenic mouse##2##3##(1996-3#1)(2005-8#1)
of transgenic plant##2##3##(2008-5#1)(2008-7#1)
of transgenic plants containing the##2##5##(2008-9#2)
of transgenic plants containing##3##4##(2008-9#3)
of transgenic plants was##2##4##(2006-12#1)(2008-8#1)
of transgenic plants##14##3##(1994-3#1)(1997-2#1)(2006-11#1)(2006-12#2)(2006-4#1)(2007-1#1)(2008-8#3)(2008-9#4)
of transgenic rabbits##3##3##(2008-11#1)(2008-12#2)
of transgenic rice##2##3##(2006-11#1)(2008-12#1)
of transgenic tobacco plants expressing##2##5##(1994-3#1)(2008-10#1)
of transgenic tobacco plants##4##4##(1991-7#1)(1994-3#1)(1995-8#1)(2008-10#1)
of transgenic tobacco##6##3##(1991-7#1)(1994-3#1)(1995-8#1)(2006-12#2)(2008-10#1)
of transgenic tomato##3##3##(2008-10#3)
of transgenic##110##2##(1990-11#1)(1990-5#1)(1991-7#1)(1993-12#1)(1993-5#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#2)(1994-8#1)(1995-1#2)(1995-10#1)(1995-2#2)(1995-8#4)(1996-10#1)(1996-11#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-4#2)(1997-7#1)(2005-11#1)(2005-6#1)(2005-8#2)(2006-11#5)(2006-12#9)(2006-4#1)(2007-1#1)(2007-10#1)(2007-3#1)(2008-10#8)(2008-11#6)(2008-12#3)(2008-2#2)(2008-4#8)(2008-5#2)(2008-7#3)(2008-8#6)(2008-9#5)(2009-4#1)(2009-5#1)(2010-10#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-12#2)(2013-1#3)(2013-8#1)
of transglutaminase in##3##3##(1990-12#1)(1994-9#1)(2008-5#1)
of transglutaminase is##2##3##(1992-8#1)(1994-9#1)
of transglutaminase##12##2##(1990-12#2)(1991-11#1)(1992-8#4)(1994-9#4)(2008-5#1)
of transglutaminase-catalyzed reactions in growth and##2##6##(1990-12#2)
of transglutaminases##2##2##(1991-11#1)(1994-11#1)
of transgression##2##2##(2008-10#1)(2008-12#1)
of transhiatal##2##2##(2006-10#2)
of transient CH##2##3##(2006-9#2)
of transient absorption##3##3##(2008-10#1)(2008-3#2)
of transient acoustic fields##2##4##(2008-2#2)
of transient and sustained##2##4##(1997-1#2)
of transient and##4##3##(1997-1#2)(2007-11#1)(2012-11#1)
of transient currents##2##3##(2007-11#1)(2008-3#1)
of transient expression##3##3##(2008-2#1)(2008-4#1)(2009-4#1)
of transient forebrain ischemia##2##4##(1990-5#1)(1997-7#1)
of transient gene expression in##2##5##(2008-11#2)
of transient gene expression##3##4##(2008-11#2)(2008-4#1)
of transient global amnesia##2##4##(2007-9#1)(2009-6#1)
of transient ischemic attack before##2##5##(2007-9#2)
of transient ischemic attack##7##4##(2007-10#2)(2007-7#1)(2007-9#4)
of transient ischemic##8##3##(1995-9#1)(2007-10#2)(2007-7#1)(2007-9#4)
of transient middle cerebral artery occlusion (MCAO)##2##7##(2007-10#1)(2007-9#1)
of transient middle cerebral artery occlusion##3##6##(2007-10#1)(2007-9#2)
of transient pores##2##3##(2010-10#1)(2011-1#1)
of transient receptor potential##3##4##(2009-12#1)(2009-9#1)(2013-1#1)
of transient species##2##3##(2005-4#1)(2012-1#1)
of transient##86##2##(1990-5#1)(1991-12#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-8#1)(1993-12#1)(1993-9#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-9#1)(1997-1#2)(1997-7#1)(2005-4#1)(2006-12#1)(2006-4#2)(2006-5#2)(2006-8#1)(2006-9#2)(2007-10#4)(2007-11#3)(2007-12#4)(2007-7#2)(2007-8#1)(2007-9#8)(2008-10#2)(2008-11#2)(2008-2#8)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-4#2)(2009-6#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-3#2)(2013-1#3)
of transistor##2##2##(2008-2#1)(2013-8#1)
of transition and##2##3##(1996-4#1)(2008-10#1)
of transition from##4##3##(1991-12#1)(1997-8#1)(2010-12#1)(2011-1#1)
of transition metal ions##2##4##(2008-10#1)(2010-11#1)
of transition metal##5##3##(2008-10#3)(2008-3#1)(2010-11#1)
of transition metals in human hair##2##6##(2008-10#2)
of transition metals in##4##4##(2008-10#2)(2008-5#1)(2010-11#1)
of transition metals##8##3##(1991-4#1)(2005-11#1)(2008-10#3)(2008-5#1)(2010-11#1)(2011-1#1)
of transition protein 2##3##4##(1993-11#1)(2012-12#2)
of transition to##2##3##(2006-7#1)(2009-8#1)
of transition##34##2##(1990-4#1)(1990-5#1)(1991-12#2)(1991-2#1)(1991-4#1)(1993-11#1)(1993-3#1)(1995-4#1)(1996-4#1)(1997-2#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-7#1)(2007-4#1)(2008-1#1)(2008-10#7)(2008-3#1)(2008-5#1)(2009-8#1)(2010-11#2)(2010-12#1)(2011-1#2)(2012-12#2)
of transition-state analogues##2##3##(1992-5#1)(1995-5#1)
of transitional cell carcinoma of the bladder##2##7##(1992-6#1)(2007-10#1)
of transitional cell carcinoma of the human urinary bladder##2##9##(1991-12#2)
of transitional cell carcinoma of the##4##6##(1991-12#2)(1992-6#1)(2007-10#1)
of transitional cell carcinoma##7##4##(1991-12#2)(1992-6#1)(2006-9#2)(2007-10#1)(2011-2#1)
of transitional##9##2##(1991-12#2)(1992-6#1)(1993-12#1)(2006-9#2)(2007-10#1)(2008-4#1)(2011-2#1)
of transitions between##2##3##(2013-7#1)(2013-8#1)
of transitions##5##2##(2006-5#1)(2008-9#1)(2009-10#1)(2013-7#1)(2013-8#1)
of transitive##2##2##(2009-8#1)(2010-2#1)
of transitory##2##2##(2011-1#1)(2013-1#1)
of transketolase##3##2##(1990-10#1)(1992-12#1)(1996-2#1)
of translated##2##2##(2008-10#1)(2010-1#1)
of translating the##2##3##(2008-3#1)(2009-10#1)
of translating##8##2##(1995-6#1)(2008-1#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-9#1)(2010-6#1)(2012-11#1)
of translation and##2##3##(2008-11#1)(2012-2#1)
of translation elongation factor##3##4##(2008-10#2)(2008-8#1)
of translation elongation##4##3##(1995-6#1)(2008-10#2)(2008-8#1)
of translation in eukaryotic cells##2##5##(1994-6#1)(1995-2#1)
of translation in the##2##4##(1990-7#1)(2007-12#1)
of translation in##6##3##(1990-7#1)(1994-6#1)(1995-2#1)(2005-10#1)(2007-12#1)(2008-11#1)
of translation initiation factor##2##4##(1994-6#1)(1997-6#1)
of translation initiation sites##2##4##(1997-6#2)
of translation initiation##6##3##(1994-6#1)(1997-6#3)(2005-10#1)(2008-11#1)
of translation of the##2##4##(1990-10#1)(1997-3#1)
of translation of##6##3##(1990-10#1)(1995-12#1)(1995-9#1)(1997-3#1)(2008-2#1)(2010-9#1)
of translation##54##2##(1990-10#1)(1990-7#1)(1991-1#4)(1991-11#1)(1991-12#2)(1992-12#1)(1992-6#1)(1994-11#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1995-9#1)(1997-3#1)(1997-6#3)(2005-10#2)(2007-11#1)(2007-12#3)(2008-10#3)(2008-11#7)(2008-2#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#1)
of translational control mechanisms in##2##5##(1997-1#1)(2013-8#1)
of translational control##4##3##(1997-1#1)(2007-12#1)(2013-8#2)
of translational diffusion##2##3##(1991-9#1)(1993-11#1)
of translational initiation##2##3##(2008-5#1)(2008-8#1)
of translational regulation##4##3##(1992-8#1)(2008-9#1)(2009-3#2)
of translational research in##2##4##(2010-10#2)
of translational research##3##3##(2010-10#2)(2012-3#1)
of translational##33##2##(1990-2#2)(1990-3#2)(1991-9#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-12#1)(1995-9#1)(1997-1#1)(2005-11#2)(2007-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#2)(2010-10#2)(2010-4#1)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#2)
of translocated##4##2##(1992-8#1)(2006-7#2)(2013-8#1)
of translocation of##2##3##(1994-12#1)(1996-2#1)
of translocation##12##2##(1990-2#1)(1991-12#1)(1993-3#1)(1993-9#1)(1994-12#2)(1994-2#1)(1995-3#1)(1996-2#1)(2008-7#1)(2008-8#1)(2012-1#1)
of translocations in##2##3##(2011-1#1)(2012-1#1)
of translocations##4##2##(2008-8#1)(2011-1#1)(2012-1#2)
of translucent##3##2##(1991-12#1)(2008-2#1)(2008-3#1)
of transluminal##2##2##(2006-11#1)(2009-6#1)
of transmembrane domains##2##3##(1994-5#1)(2008-4#1)
of transmembrane potential##4##3##(1990-3#3)(1994-12#1)
of transmembrane proteins are##2##4##(1994-12#1)(2012-2#1)
of transmembrane proteins that##2##4##(2008-9#1)(2012-3#1)
of transmembrane proteins##10##3##(1994-12#1)(2005-7#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-8#2)(2012-2#2)(2012-3#1)
of transmembrane signaling##2##3##(1991-12#1)(2008-9#1)
of transmembrane topology##2##3##(2012-2#2)
of transmembrane##37##2##(1990-3#3)(1990-6#1)(1991-12#1)(1991-7#2)(1992-12#1)(1993-11#1)(1993-12#1)(1994-12#3)(1994-5#2)(1994-9#2)(2005-7#2)(2007-1#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-8#2)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#5)(2012-3#1)
of transmissible spongiform encephalopathies##2##4##(1996-5#1)(2006-10#1)
of transmissible##5##2##(1996-5#1)(2005-5#1)(2006-10#1)(2008-10#1)(2008-5#1)
of transmission among##3##3##(2012-2#1)(2013-8#2)
of transmission and reflection##2##4##(2008-3#2)
of transmission and##5##3##(2006-10#1)(2006-8#1)(2008-3#2)(2013-1#1)
of transmission at##2##3##(1997-2#1)(1997-5#1)
of transmission by##2##3##(1995-6#1)(2008-10#1)
of transmission electron microscopy (TEM)##2##5##(2008-10#1)(2008-5#1)
of transmission electron microscopy##4##4##(2008-10#1)(2008-2#1)(2008-5#1)(2010-7#1)
of transmission from##2##3##(2008-10#1)(2012-3#1)
of transmission is##4##3##(2006-10#2)(2006-4#1)(2007-12#1)
of transmission of HIV infection##2##5##(1993-3#1)(2007-8#1)
of transmission of infection##3##4##(2009-5#1)(2010-5#2)
of transmission of pathogens##2##4##(2007-7#1)(2013-1#1)
of transmission of the##4##4##(1991-11#1)(1994-3#1)(1996-11#1)(1997-7#1)
of transmission of##21##3##(1991-11#1)(1993-3#1)(1994-3#1)(1996-11#1)(1996-2#1)(1997-7#1)(2004-10#1)(2005-7#1)(2006-6#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2009-5#1)(2010-4#1)(2010-5#2)(2012-1#2)(2012-12#1)(2013-1#1)
of transmission through##2##3##(2007-11#1)(2008-10#1)
of transmission was##2##3##(1996-3#1)(2007-7#1)
of transmission##106##2##(1991-11#1)(1992-6#2)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-4#1)(1995-6#1)(1996-1#1)(1996-11#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-5#3)(1997-7#2)(2004-10#1)(2005-7#1)(2006-10#7)(2006-4#5)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#6)(2007-8#1)(2008-10#13)(2008-2#6)(2008-3#4)(2008-5#3)(2008-8#1)(2008-9#2)(2009-5#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
of transmission-type holographic##2##3##(2008-2#2)
of transmittance##5##2##(2008-2#1)(2008-3#3)(2008-5#1)
of transmitted K65R and other tenofovir resistance mutations across##2##9##(2013-1#2)
of transmitted##8##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2013-1#3)
of transmitter release##2##3##(1990-5#1)(1994-9#1)
of transmitter##5##2##(1990-5#1)(1994-9#1)(2008-11#1)(2013-8#2)
of transmitters##4##2##(1991-5#1)(1992-6#1)(2006-10#1)(2013-8#1)
of transmitting the##3##3##(2008-10#2)(2012-11#1)
of transmitting##8##2##(1992-9#1)(2006-10#1)(2007-12#2)(2008-10#2)(2008-2#1)(2012-11#1)
of transmural##2##2##(2008-11#1)(2012-2#1)
of transmyocardial##3##2##(2007-8#3)
of transnational##2##2##(2005-10#1)(2012-3#1)
of transoesophageal echocardiography##3##3##(1993-12#1)(1994-11#1)(2006-10#1)
of transparency and##2##3##(2008-11#1)(2013-1#1)
of transparency##6##2##(2006-5#1)(2007-11#1)(2008-11#1)(2011-2#2)(2013-1#1)
of transparent and##2##3##(1994-3#1)(2007-12#1)
of transparent plates by##2##4##(2007-12#2)
of transparent plates##4##3##(2007-12#2)(2008-3#2)
of transparent##24##2##(1994-3#1)(2006-2#1)(2007-11#2)(2007-12#5)(2008-10#2)(2008-11#1)(2008-2#6)(2008-3#5)(2009-11#1)
of transpedicular screw##3##3##(2007-11#3)
of transpedicular screws##3##3##(2007-11#3)
of transpedicular spine##2##3##(2007-11#2)
of transpedicular##8##2##(2007-11#8)
of transplant recipients with##2##4##(2007-11#2)
of transplant recipients##6##3##(1995-2#1)(2006-10#2)(2007-11#2)(2008-4#1)
of transplant rejection##3##3##(1995-2#2)(2008-10#1)
of transplant renal artery stenosis##2##5##(2008-1#1)(2008-4#1)
of transplant##22##2##(1991-5#1)(1995-12#2)(1995-2#3)(2006-10#3)(2007-11#2)(2008-1#2)(2008-10#1)(2008-4#3)(2008-5#1)(2008-9#1)(2011-2#2)(2011-3#1)
of transplantable##4##2##(1991-3#2)(1992-1#1)(2008-1#1)
of transplantation and##4##3##(1993-1#1)(2007-8#1)(2008-10#1)(2008-4#1)
of transplantation for##2##3##(2006-10#1)(2012-11#1)
of transplantation in a##2##4##(1991-11#1)(2004-11#1)
of transplantation in##3##3##(1991-11#1)(2004-11#1)(2008-12#1)
of transplantation of mesenchymal stem cells on neuronal survival##2##9##(2012-1#2)
of transplantation of##5##3##(1996-5#1)(2010-12#2)(2012-1#2)
of transplantation was##2##3##(2008-1#1)(2008-8#1)
of transplantation##41##2##(1991-11#1)(1991-7#1)(1993-1#1)(1995-12#1)(1995-2#2)(1996-12#1)(1996-5#1)(2004-11#1)(2006-10#6)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#1)(2008-12#1)(2008-4#2)(2008-8#2)(2008-9#1)(2010-12#3)(2012-1#2)(2012-11#2)(2012-12#2)(2012-7#1)(2013-8#1)
of transplanted bone marrow cells##3##5##(2008-4#1)(2010-11#2)
of transplanted cells##2##3##(2008-3#1)(2008-4#1)
of transplanted organs##3##3##(1991-12#1)(2005-11#1)(2008-4#1)
of transplanted patients##2##3##(2007-4#1)(2008-8#1)
of transplanted##21##2##(1991-12#1)(1991-3#1)(2005-11#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-4#3)(2008-8#1)(2009-10#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)
of transplants##4##2##(2007-11#1)(2008-10#1)(2009-3#1)(2011-2#1)
of transport and##4##3##(2006-10#1)(2007-7#1)(2010-8#1)(2012-12#1)
of transport at##2##3##(1991-9#1)(2010-8#1)
of transport for##2##3##(2008-5#1)(2008-8#1)
of transport in the##3##4##(1996-8#1)(2012-12#2)
of transport in##7##3##(1991-9#1)(1995-10#1)(1996-8#1)(2008-7#1)(2010-2#1)(2012-12#2)
of transport is##2##3##(2008-10#2)
of transport of the##2##4##(1993-4#1)(2010-8#1)
of transport of##8##3##(1991-9#2)(1993-4#1)(1994-6#1)(1995-11#1)(2007-8#1)(2009-8#1)(2010-8#1)
of transport properties##2##3##(2010-2#2)
of transport proteins in##2##4##(2008-7#1)(2012-12#1)
of transport proteins##5##3##(1991-3#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-12#1)
of transport to##2##3##(1993-4#1)(2007-9#1)
of transport was##3##3##(1990-3#1)(1995-11#1)(2008-10#1)
of transport were##2##3##(1990-3#1)(2008-10#1)
of transport with##2##3##(1990-3#1)(1991-9#1)
of transport##68##2##(1990-11#2)(1990-12#1)(1990-3#3)(1991-3#2)(1991-4#1)(1991-9#6)(1993-3#1)(1993-4#2)(1994-12#1)(1994-6#1)(1995-10#1)(1995-11#2)(1996-11#1)(1996-8#1)(1997-8#1)(2005-11#1)(2006-10#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2009-9#1)(2010-2#3)(2010-4#1)(2010-8#4)(2011-2#4)(2012-12#4)
of transportation##8##2##(1992-5#1)(1993-5#1)(2005-8#1)(2008-5#2)(2008-9#1)(2010-4#1)(2013-1#1)
of transported##2##2##(2006-8#1)(2008-5#1)
of transporter##4##2##(1993-3#1)(1995-6#1)(1996-5#1)(2006-10#1)
of transporters##8##2##(1990-10#1)(1994-12#1)(1994-9#1)(1995-11#1)(2005-8#1)(2008-11#1)(2009-5#1)(2010-12#1)
of transporting##6##2##(1994-2#1)(2007-12#2)(2008-5#2)(2008-9#1)
of transposable elements and##2##4##(2009-10#1)(2009-6#1)
of transposable elements in plants##2##5##(2009-6#2)
of transposable elements in##3##4##(2009-6#2)(2010-5#1)
of transposable elements##14##3##(1994-6#1)(1994-8#1)(2006-12#1)(2008-10#2)(2008-11#1)(2009-10#3)(2009-6#4)(2010-5#1)
of transposable##17##2##(1994-6#1)(1994-8#1)(1995-12#1)(2006-12#1)(2008-10#2)(2008-11#3)(2009-10#3)(2009-6#4)(2010-5#1)
of transposase##3##2##(1990-3#1)(1995-8#1)(2011-12#1)
of transposition activity##2##3##(1990-3#1)(1995-8#1)
of transposition##12##2##(1990-3#2)(1991-7#2)(1993-10#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-8#3)(2008-10#1)
of transposition)##2##2##(1993-10#1)(1994-12#1)
of transposon insertions in the genome of Caenorhabditis elegans##2##9##(2008-7#2)
of transposon##10##2##(1991-9#1)(1995-8#4)(1996-12#1)(2008-10#1)(2008-7#2)(2010-5#1)
of transracial##2##2##(2008-5#2)
of transradial approach for##2##4##(2011-2#2)
of transradial approach##3##3##(2011-2#3)
of transradial##7##2##(2011-2#7)
of transrectal sonography in##2##4##(1991-12#1)(2011-2#1)
of transrectal sonography##3##3##(1991-12#1)(2011-2#2)
of transrectal##6##2##(1991-12#1)(1997-8#1)(2007-3#1)(2007-6#1)(2011-2#2)
of transthyretin gene in##2##4##(1990-5#1)(1990-6#1)
of transthyretin gene##3##3##(1990-5#1)(1990-6#2)
of transthyretin in##2##3##(1991-2#2)
of transthyretin##9##2##(1990-5#2)(1990-6#4)(1991-2#3)
of transumbilical##2##2##(2012-12#1)(2013-1#1)
of transurethral resection of##2##4##(2006-8#1)(2011-1#1)
of transvaginal##5##2##(1991-11#1)(1995-3#1)(1996-12#1)(2007-3#2)
of transversal##4##2##(2008-9#1)(2009-2#2)(2011-1#1)
of transversally##2##2##(2007-8#1)(2008-10#1)
of transverse myelitis##4##3##(2012-11#1)(2012-12#1)(2012-3#2)
of transverse##12##2##(1990-5#1)(1994-5#1)(2007-12#1)(2008-2#1)(2008-7#1)(2011-12#1)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
of transverse-sigmoid sinus dural arteriovenous malformations##2##6##(2006-12#1)(2008-7#1)
of transversely##2##2##(2007-12#1)(2008-10#1)
of trap trees##2##3##(2011-2#2)
of trapped intermediates##3##3##(2008-4#1)(2009-2#1)(2010-4#1)
of trapped##5##2##(2004-11#1)(2008-3#1)(2008-4#1)(2009-2#1)(2010-4#1)
of trapping##8##2##(1996-4#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-7#1)(2010-4#1)
of traps and pitfalls##2##4##(1994-3#1)(2012-2#1)
of traps was##2##3##(2013-7#2)
of traps##7##2##(1994-3#1)(1997-7#1)(2012-2#1)(2013-7#4)
of trastuzumab and##2##3##(2008-10#1)(2010-1#1)
of trastuzumab in##2##3##(2007-11#1)(2008-5#1)
of trastuzumab##12##2##(2007-11#1)(2008-10#1)(2008-5#2)(2010-1#1)(2011-2#1)(2012-12#2)(2013-1#4)
of trauma and##3##3##(2007-8#1)(2008-5#1)(2009-9#1)
of trauma care##4##3##(1992-2#1)(2006-10#2)(2007-7#1)
of trauma exposure##2##3##(2009-4#1)(2012-12#1)
of trauma in the##2##4##(2006-10#1)(2007-10#1)
of trauma or##3##3##(1990-9#1)(2007-11#1)(2013-1#1)
of trauma surgery and##2##4##(2006-10#1)(2008-8#1)
of trauma to the##3##4##(2007-4#1)(2012-2#1)(2013-1#1)
of trauma to##5##3##(2006-10#1)(2007-4#1)(2010-6#1)(2012-2#1)(2013-1#1)
of trauma victims##3##3##(2006-10#2)(2008-3#1)
of trauma##51##2##(1990-9#1)(1992-2#2)(2006-10#11)(2006-2#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#2)(2009-6#2)(2009-9#1)(2010-6#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-12#3)(2012-2#2)(2013-1#2)(2013-8#1)
of trauma-focused research on##2##4##(2009-4#2)
of trauma-focused research##3##3##(2009-4#3)
of trauma-related##3##2##(2008-8#1)(2012-2#2)
of traumatic aortic##2##3##(2006-4#1)(2009-8#1)
of traumatic brain injury (TBI)##4##5##(1993-12#1)(2007-10#1)(2008-9#1)(2012-2#1)
of traumatic brain injury##13##4##(1990-12#2)(1993-12#1)(2006-10#2)(2006-4#2)(2007-10#1)(2007-4#1)(2008-9#1)(2012-2#1)(2013-1#2)
of traumatic brain##14##3##(1990-12#3)(1993-12#1)(2006-10#2)(2006-4#2)(2007-10#1)(2007-4#1)(2008-9#1)(2012-2#1)(2013-1#2)
of traumatic events##2##3##(2008-9#1)(2009-4#1)
of traumatic injuries##3##3##(2006-10#1)(2008-8#1)(2012-2#1)
of traumatic nasal bone fracture##2##5##(2011-2#2)
of traumatic rupture of##2##4##(2008-12#1)(2010-8#1)
of traumatic##55##2##(1990-12#3)(1993-1#1)(1993-12#1)(2006-10#3)(2006-11#2)(2006-4#4)(2007-10#1)(2007-11#7)(2007-4#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-12#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-2#3)(2013-1#4)(2013-8#1)
of travel health advice and##3##5##(2007-2#3)
of travel insurance and##2##4##(2007-2#2)
of travel medicine##7##3##(2006-10#1)(2007-2#6)
of travel of the##2##4##(2007-12#1)(2008-10#1)
of travel related##2##3##(2007-2#2)
of travel##23##2##(2006-10#1)(2007-12#1)(2007-2#17)(2008-1#1)(2008-10#1)(2008-9#1)(2011-2#1)
of travel-related##2##2##(2007-2#1)(2011-2#1)
of traveler's diarrhea##2##3##(1993-3#1)(2008-8#1)
of travelers who have##2##4##(2007-2#1)(2008-10#1)
of travelers who##3##3##(1996-8#1)(2007-2#1)(2008-10#1)
of travelers##7##2##(1996-8#1)(2007-2#2)(2008-10#2)(2010-12#1)(2011-2#1)
of traveling waves##2##3##(1990-3#1)(2007-12#1)
of traveling##5##2##(1990-3#1)(2007-12#2)(2009-5#1)(2013-1#1)
of travellers##8##2##(1996-8#1)(2007-2#7)
of travellers'##2##2##(1992-12#1)(2007-2#1)
of travelling waves##2##3##(2008-2#1)(2013-8#1)
of travelling##4##2##(1990-6#1)(2008-2#1)(2011-2#1)(2013-8#1)
of trawling disturbance##3##3##(2006-6#3)
of trawling##4##2##(2006-6#4)
of trazodone##7##2##(1990-2#5)(1995-2#1)(2008-10#1)
of treadmill running on##2##4##(2008-12#2)
of treadmill running##3##3##(2008-12#2)(2013-1#1)
of treadmill##6##2##(1990-2#1)(2008-12#2)(2010-12#1)(2011-2#1)(2013-1#1)
of treatable##2##2##(1997-3#1)(2006-10#1)
of treated and untreated##3##4##(1995-6#1)(2006-8#1)(2008-3#1)
of treated and##5##3##(1995-6#1)(2006-8#1)(2008-10#1)(2008-3#1)(2010-6#1)
of treated animals##3##3##(1993-4#1)(1994-8#1)(2008-10#1)
of treated cells##2##3##(1994-6#1)(2008-9#1)
of treated end-stage renal disease##3##5##(2007-7#1)(2008-4#2)
of treated hypertensives##2##3##(2008-10#2)
of treated lesions##3##3##(2004-1#1)(2012-12#2)
of treated patients was##2##4##(2007-11#1)(2011-1#1)
of treated patients##8##3##(1990-3#1)(1990-4#1)(1991-2#1)(1993-9#1)(2007-11#1)(2008-7#1)(2011-1#1)(2013-1#1)
of treated plants##3##3##(2008-10#3)
of treated rats##2##3##(1993-12#1)(2013-8#1)
of treated waste water##2##4##(2008-10#1)(2012-2#1)
of treated##62##2##(1990-10#2)(1990-3#1)(1990-4#1)(1991-2#1)(1992-5#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-6#1)(1997-4#2)(2004-1#1)(2004-11#1)(2006-5#2)(2006-8#1)(2007-11#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#1)
of treating a##3##3##(1995-6#1)(2006-9#1)(2012-12#1)
of treating hypertension##2##3##(1992-6#1)(2009-9#1)
of treating patients with##3##4##(2006-8#2)(2008-7#1)
of treating patients##5##3##(2006-8#2)(2007-8#1)(2008-7#1)(2009-6#1)
of treating the##5##3##(1990-8#1)(1992-5#1)(2008-12#1)(2013-1#2)
of treating##68##2##(1990-10#1)(1990-4#2)(1990-8#1)(1991-12#1)(1991-2#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1994-3#1)(1994-7#1)(1995-6#2)(1996-11#1)(1997-2#1)(2004-1#1)(2004-3#1)(2005-6#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-3#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-6#2)(2009-8#1)(2009-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#4)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
of treatment (prednisolone##2##3##(2008-1#2)
of treatment a##2##3##(1990-11#1)(2007-7#1)
of treatment and follow-up##2##4##(1992-3#1)(2011-2#1)
of treatment and prognosis##2##4##(2006-8#1)(2007-12#1)
of treatment and the##6##4##(1991-6#1)(1993-5#1)(1996-11#1)(2005-3#1)(2012-12#1)(2013-7#1)
of treatment and##50##3##(1990-5#1)(1991-10#1)(1991-6#1)(1992-3#2)(1992-9#1)(1993-5#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-3#1)(2004-4#1)(2005-3#1)(2005-6#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-6#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#4)(2008-8#2)(2009-12#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)
of treatment approaches##2##3##(2005-7#1)(2011-2#1)
of treatment are often##2##4##(1995-9#1)(2007-11#1)
of treatment are reviewed##2##4##(1990-9#1)(1995-7#1)
of treatment are##19##3##(1990-9#1)(1991-1#1)(1992-4#1)(1993-9#1)(1995-7#1)(1995-9#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-2#2)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
of treatment as##3##3##(2008-2#1)(2008-3#1)(2010-5#1)
of treatment at##7##3##(1991-7#1)(2005-11#1)(2007-12#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#1)
of treatment based on##2##4##(2007-8#1)(2009-3#1)
of treatment being##2##3##(2007-11#1)(2008-5#1)
of treatment but##2##3##(2006-6#1)(2006-7#1)
of treatment by this method##2##5##(1993-10#1)(2007-8#1)
of treatment by##11##3##(1993-10#1)(1996-7#1)(2006-10#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-2#1)
of treatment can be##2##4##(1996-11#1)(2007-11#1)
of treatment can##3##3##(1995-6#1)(1996-11#1)(2007-11#1)
of treatment cannot##2##3##(1993-2#1)(2012-12#1)
of treatment completion##2##3##(2007-10#1)(2008-2#1)
of treatment delivery##2##3##(2008-6#1)(2013-1#1)
of treatment discontinuations##2##3##(2008-11#1)(2008-3#1)
of treatment during##2##3##(2008-10#1)(2013-1#1)
of treatment effect##3##3##(1997-3#1)(2012-2#1)(2013-1#1)
of treatment effectiveness##2##3##(1993-12#1)(2008-6#1)
of treatment effects in##2##4##(2008-11#1)(2010-2#1)
of treatment effects##14##3##(1996-12#1)(1996-6#1)(1996-7#1)(1997-2#1)(2006-5#1)(2007-5#1)(2008-11#1)(2008-7#1)(2009-8#1)(2009-9#2)(2010-2#1)(2012-2#1)(2012-6#1)
of treatment efficacy##2##3##(2005-3#1)(2006-12#1)
of treatment facilities##2##3##(2007-2#2)
of treatment failure##4##3##(2006-11#1)(2008-6#1)(2008-7#1)(2012-12#1)
of treatment for children with##2##5##(2007-7#1)(2009-4#1)
of treatment for children##3##4##(2007-7#1)(2009-4#1)(2011-2#1)
of treatment for chronic##2##4##(2008-10#1)(2013-1#1)
of treatment for most##2##4##(2007-11#1)(2008-11#1)
of treatment for patients with##6##5##(1992-9#1)(1994-5#1)(2005-6#1)(2007-11#1)(2008-11#1)(2009-5#1)
of treatment for primary and##2##5##(2006-7#1)(2008-9#1)
of treatment for primary##3##4##(2006-7#1)(2008-9#1)(2010-5#1)
of treatment for renal##2##4##(1991-12#1)(2007-7#1)
of treatment for the##2##4##(1990-12#1)(2005-10#1)
of treatment for this condition##2##5##(2006-9#1)(2007-7#1)
of treatment for this##3##4##(2006-9#1)(2007-7#1)(2009-11#1)
of treatment for various##2##4##(1993-3#1)(1996-2#1)
of treatment for##74##3##(1990-12#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-9#1)(1993-3#3)(1994-5#1)(1995-4#1)(1996-2#1)(1997-7#1)(2005-10#1)(2005-6#1)(2006-10#4)(2006-3#1)(2006-5#1)(2006-7#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-7#7)(2007-8#2)(2008-10#1)(2008-11#2)(2008-4#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#2)(2009-5#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#4)(2013-8#2)
of treatment from##3##3##(2008-10#1)(2010-7#1)(2011-1#1)
of treatment goal##2##3##(2006-5#1)(2011-7#1)
of treatment guidelines##2##3##(2006-9#1)(2011-10#1)
of treatment has##3##3##(2006-8#1)(2007-8#2)
of treatment have##3##3##(1990-4#1)(1992-3#1)(1997-1#1)
of treatment in a##6##4##(1990-5#1)(1995-5#1)(1996-1#1)(1996-3#1)(2007-1#1)(2010-5#1)
of treatment in critically ill patients##2##6##(2006-10#2)
of treatment in most##2##4##(2008-7#1)(2008-9#1)
of treatment in patients with##4##5##(1994-12#1)(2006-12#1)(2008-10#1)(2011-2#1)
of treatment in the##6##4##(1993-8#1)(2006-5#1)(2007-11#1)(2008-10#1)(2010-11#1)(2010-12#1)
of treatment in##47##3##(1990-5#1)(1991-12#1)(1992-3#1)(1992-5#1)(1993-8#1)(1994-12#1)(1994-4#1)(1995-5#1)(1996-1#1)(1996-3#1)(1996-7#1)(1997-3#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-1#3)(2007-11#5)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#2)
of treatment include##2##3##(2006-11#1)(2007-12#1)
of treatment including##2##3##(1992-5#1)(2006-8#1)
of treatment interruption##2##3##(2009-4#1)(2011-2#1)
of treatment interventions##2##3##(2007-10#1)(2009-11#1)
of treatment is based on##2##5##(1990-10#1)(2011-1#1)
of treatment is determined by##2##5##(1991-6#1)(2013-1#1)
of treatment is often##2##4##(2006-4#1)(2013-1#1)
of treatment is the##3##4##(1997-2#1)(2006-7#1)(2013-1#1)
of treatment is to##2##4##(2008-3#1)(2009-9#1)
of treatment is##34##3##(1990-10#2)(1991-6#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-4#1)(1995-2#1)(1997-2#1)(2004-11#1)(2005-8#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-11#3)(2007-4#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-5#1)(2011-1#1)(2013-1#5)
of treatment it##2##3##(1995-9#1)(2013-8#1)
of treatment method##2##3##(2007-11#1)(2011-2#1)
of treatment modalities##11##3##(1992-3#1)(1996-1#1)(2005-7#2)(2006-10#1)(2007-11#2)(2008-6#1)(2008-7#1)(2011-2#2)
of treatment must be##2##4##(1991-11#1)(2006-5#1)
of treatment of Hodgkin's disease##2##5##(2009-2#2)
of treatment of chronic##2##4##(1991-6#1)(2011-2#1)
of treatment of hypertension##2##4##(2008-7#1)(2009-9#1)
of treatment of patients with##4##5##(2005-1#1)(2009-2#1)(2011-1#1)(2012-3#1)
of treatment of patients##5##4##(2005-1#1)(2008-3#1)(2009-2#1)(2011-1#1)(2012-3#1)
of treatment of the##9##4##(1991-12#1)(1992-2#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2011-2#1)(2013-1#1)
of treatment of these##3##4##(1993-12#1)(2006-2#1)(2007-11#1)
of treatment of this##2##4##(1992-8#1)(2012-12#1)
of treatment of##94##3##(1990-2#1)(1991-12#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-7#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-8#1)(2005-1#2)(2005-10#1)(2006-10#4)(2006-2#1)(2006-5#1)(2006-6#5)(2006-8#1)(2007-1#1)(2007-11#9)(2007-12#1)(2007-8#5)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-2#8)(2009-3#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#6)
of treatment on the##2##4##(1992-9#1)(2008-11#1)
of treatment on##17##3##(1991-10#1)(1992-4#1)(1992-9#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-11#1)(2010-8#2)(2013-1#3)
of treatment options##8##3##(1993-1#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2009-3#1)(2010-12#1)(2012-1#1)
of treatment or##3##3##(1992-5#1)(2007-8#1)(2008-7#1)
of treatment outcome in##4##4##(2007-7#1)(2007-8#3)
of treatment outcome##9##3##(2005-6#1)(2006-7#1)(2007-7#1)(2007-8#3)(2008-9#1)(2011-2#2)
of treatment outcomes##3##3##(1997-2#1)(2010-12#1)(2011-2#1)
of treatment parameters##3##3##(2007-4#1)(2008-10#1)(2010-9#1)
of treatment planning##3##3##(1994-8#1)(2009-11#1)(2011-1#1)
of treatment programs##3##3##(2007-2#1)(2012-2#2)
of treatment protocols for patient##3##5##(2012-12#3)
of treatment protocols##6##3##(1995-8#1)(2006-12#1)(2009-6#1)(2012-12#3)
of treatment provided##2##3##(2007-8#1)(2012-3#1)
of treatment responders##2##3##(2007-11#2)
of treatment response in##2##4##(2007-2#1)(2013-7#1)
of treatment response##11##3##(1995-2#1)(2006-10#1)(2006-9#2)(2007-2#1)(2010-12#2)(2010-6#1)(2011-2#2)(2013-7#1)
of treatment results##3##3##(1994-4#1)(2007-8#1)(2011-2#1)
of treatment should be##2##4##(2007-11#2)
of treatment should##4##3##(2007-11#2)(2008-3#1)(2009-8#1)
of treatment side##2##3##(2008-2#1)(2012-1#1)
of treatment strategies##4##3##(2008-8#2)(2010-11#1)(2012-1#1)
of treatment strategy##2##3##(2009-6#1)(2011-1#1)
of treatment targets##2##3##(2010-1#1)(2010-12#1)
of treatment there##2##3##(2007-11#1)(2012-12#1)
of treatment to the##2##4##(2007-8#1)(2008-4#1)
of treatment to##9##3##(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-4#1)(2011-1#1)(2013-1#2)
of treatment used##3##3##(1991-4#1)(2007-3#1)(2007-7#1)
of treatment using##4##3##(2007-7#1)(2008-2#1)(2008-7#1)(2013-1#1)
of treatment was##26##3##(1990-4#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-8#1)(1992-3#1)(1992-4#1)(1993-9#2)(1994-2#1)(1995-5#1)(1997-3#1)(1997-6#1)(2004-12#1)(2007-6#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-2#1)(2010-8#1)(2011-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
of treatment were##16##3##(1995-10#1)(1996-12#2)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#2)(2011-1#1)(2012-12#1)(2012-3#1)
of treatment which##2##3##(1997-6#1)(2013-8#1)
of treatment will##3##3##(1997-2#1)(2008-12#1)(2008-5#1)
of treatment with L-deprenyl on##2##5##(1996-7#2)
of treatment with L-deprenyl##3##4##(1994-6#1)(1996-7#2)
of treatment with a##3##4##(1990-11#1)(2006-8#1)(2013-1#1)
of treatment with an##2##4##(2007-7#1)(2008-4#1)
of treatment with either##2##4##(2010-12#1)(2012-2#1)
of treatment with flexion-rotation exercises##2##5##(2007-8#2)
of treatment with imatinib mesylate##2##5##(2008-6#2)
of treatment with the##10##4##(1990-10#1)(1992-4#1)(1995-1#1)(1995-5#1)(2007-8#2)(2008-5#3)(2008-6#1)
of treatment with##85##3##(1990-10#1)(1990-11#1)(1990-5#2)(1991-5#1)(1991-7#3)(1992-11#2)(1992-12#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-11#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-5#1)(1995-8#2)(1996-11#1)(1996-4#1)(1996-7#2)(1996-9#1)(1997-4#1)(1997-5#1)(2004-10#1)(2004-3#2)(2004-4#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-6#2)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#4)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-8#2)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
of treatment without##2##3##(1993-11#1)(2010-10#1)
of treatment##1163##2##(1990-1#1)(1990-10#3)(1990-11#2)(1990-12#3)(1990-2#4)(1990-3#3)(1990-4#5)(1990-5#8)(1990-6#3)(1990-8#2)(1990-9#4)(1991-1#2)(1991-10#4)(1991-11#5)(1991-12#6)(1991-2#3)(1991-3#2)(1991-4#4)(1991-5#3)(1991-6#6)(1991-7#4)(1991-8#5)(1991-9#1)(1992-1#2)(1992-10#4)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#10)(1992-4#4)(1992-5#4)(1992-7#2)(1992-8#5)(1992-9#6)(1993-1#5)(1993-10#2)(1993-11#7)(1993-12#3)(1993-2#5)(1993-3#5)(1993-5#3)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#8)(1994-10#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-4#3)(1994-5#3)(1994-6#5)(1994-7#2)(1994-8#1)(1994-9#2)(1995-1#3)(1995-10#2)(1995-11#5)(1995-12#3)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#4)(1995-6#1)(1995-7#1)(1995-8#5)(1995-9#4)(1996-1#3)(1996-11#6)(1996-12#5)(1996-2#4)(1996-3#4)(1996-4#5)(1996-5#2)(1996-6#4)(1996-7#6)(1996-8#1)(1996-9#5)(1997-1#3)(1997-2#6)(1997-3#7)(1997-4#2)(1997-5#2)(1997-6#4)(1997-7#1)(1997-8#1)(2004-1#2)(2004-10#1)(2004-11#1)(2004-12#2)(2004-3#3)(2004-4#2)(2005-1#2)(2005-10#4)(2005-11#1)(2005-12#2)(2005-3#2)(2005-6#3)(2005-7#7)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#29)(2006-11#5)(2006-12#7)(2006-2#6)(2006-3#1)(2006-4#2)(2006-5#7)(2006-6#15)(2006-7#6)(2006-8#12)(2006-9#4)(2007-1#5)(2007-10#9)(2007-11#59)(2007-12#18)(2007-2#9)(2007-3#2)(2007-4#7)(2007-5#2)(2007-6#4)(2007-7#30)(2007-8#49)(2007-9#5)(2008-1#8)(2008-10#23)(2008-11#14)(2008-12#14)(2008-2#11)(2008-3#24)(2008-4#16)(2008-5#27)(2008-6#22)(2008-7#34)(2008-8#14)(2008-9#8)(2009-1#1)(2009-10#4)(2009-11#6)(2009-12#2)(2009-2#13)(2009-3#4)(2009-4#3)(2009-5#2)(2009-6#5)(2009-7#1)(2009-8#5)(2009-9#4)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#19)(2010-2#6)(2010-3#3)(2010-4#4)(2010-5#8)(2010-6#6)(2010-7#2)(2010-8#11)(2010-9#6)(2011-1#21)(2011-10#1)(2011-12#3)(2011-2#39)(2011-3#1)(2011-7#1)(2012-1#6)(2012-10#1)(2012-11#2)(2012-12#24)(2012-2#16)(2012-3#15)(2012-6#1)(2013-1#49)(2013-7#5)(2013-8#16)
of treatment)##2##2##(2008-10#1)(2011-2#1)
of treatment-emergent##2##2##(2004-3#1)(2013-1#1)
of treatment-related##7##2##(2006-6#1)(2007-8#1)(2008-6#1)(2008-7#2)(2008-9#1)(2012-12#1)
of treatment-resistant##4##2##(2008-12#1)(2012-12#3)
of treatment]##3##2##(1990-4#1)(1991-1#1)(2011-2#1)
of treatments as##2##3##(2006-8#1)(2007-11#1)
of treatments for##10##3##(2004-1#1)(2006-12#2)(2006-3#1)(2007-11#2)(2007-8#1)(2008-7#1)(2009-3#1)(2010-12#1)
of treatments on##2##3##(1997-4#1)(2008-9#1)
of treatments to##3##3##(1995-12#1)(2006-12#1)(2009-8#1)
of treatments used##2##3##(1990-10#1)(2006-10#1)
of treatments was##3##3##(2008-10#2)(2010-2#1)
of treatments##59##2##(1990-10#1)(1990-2#2)(1990-4#1)(1990-7#1)(1993-5#1)(1995-12#2)(1995-2#1)(1996-2#1)(1997-4#1)(2004-1#1)(2006-10#1)(2006-12#3)(2006-3#1)(2006-5#1)(2006-8#4)(2007-11#3)(2007-12#1)(2007-6#1)(2007-8#2)(2008-10#6)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2009-6#2)(2009-8#1)(2010-12#2)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)
of tree growth##2##3##(2004-4#1)(2010-4#1)
of tree seedlings##2##3##(2008-10#1)(2008-5#1)
of tree species##5##3##(2007-3#3)(2009-8#1)(2012-6#1)
of tree##21##2##(2004-4#1)(2005-10#1)(2006-12#1)(2006-5#1)(2007-3#3)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#3)(2008-9#2)(2009-8#1)(2010-4#1)(2012-6#1)
of trees at##2##3##(2008-10#1)(2008-9#1)
of trees from##2##3##(2007-1#1)(2011-10#1)
of trees in the##2##4##(2008-10#1)(2011-12#1)
of trees in##3##3##(2008-10#2)(2011-12#1)
of trees to##3##3##(2008-10#2)(2012-8#1)
of trees##22##2##(2007-1#1)(2008-10#13)(2008-2#1)(2008-5#1)(2008-9#1)(2010-4#1)(2011-10#1)(2011-12#1)(2012-8#1)(2013-7#1)
of trehalose##11##2##(1991-9#2)(1993-8#1)(1997-2#2)(2006-5#1)(2007-12#1)(2008-10#2)(2013-1#2)
of trematode##3##2##(2008-4#1)(2011-1#2)
of tremendous##6##2##(2008-11#1)(2008-4#3)(2008-7#1)(2008-9#1)
of tremolite##6##2##(1991-12#6)
of tremor and##3##3##(2006-12#1)(2008-11#1)(2008-7#1)
of tremor##12##2##(1990-5#1)(2006-12#1)(2008-11#3)(2008-7#7)
of trends in HIV##2##4##(1996-8#2)
of trends in##7##3##(1991-2#1)(1993-1#1)(1995-3#1)(1996-8#2)(2007-7#1)(2008-1#1)
of trends##13##2##(1991-1#1)(1991-2#1)(1992-2#1)(1993-1#1)(1993-6#2)(1995-3#1)(1996-8#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-8#1)
of tretinoin to##2##3##(2010-12#2)
of tretinoin##5##2##(1993-12#1)(2010-12#4)
of tri- and##4##3##(1990-12#1)(1992-12#1)(2008-10#1)(2009-6#1)
of tri-##5##2##(1990-12#1)(1992-12#1)(2008-10#1)(2008-4#1)(2009-6#1)
of tri-Calciphor (trimer of 16##2##5##(1994-6#2)
of tri-iodothyronine##2##2##(1991-7#1)(1996-5#1)
of triacylglycerol##5##2##(1990-2#1)(1991-2#1)(1992-4#1)(1995-1#1)(2006-10#1)
of triacylglycerol-rich##2##2##(1995-4#1)(1997-4#1)
of triacylglycerols in##2##3##(2004-8#1)(2008-5#1)
of triacylglycerols##5##2##(1990-9#1)(1997-3#1)(2004-8#1)(2008-11#1)(2008-5#1)
of triadic##2##2##(1995-6#1)(2012-1#1)
of triage##3##2##(2006-10#1)(2006-2#1)(2007-12#1)
of trial participants##2##3##(1991-10#1)(2009-6#1)
of trial##13##2##(1991-10#1)(1993-12#1)(1993-3#1)(1993-9#1)(1995-1#1)(1995-9#1)(2005-7#1)(2007-10#1)(2007-9#1)(2008-5#2)(2009-6#1)(2012-2#1)
of trials comparing##3##3##(1995-9#2)(2008-10#1)
of trials in the##2##4##(1990-11#1)(2007-11#1)
of trials in which##2##4##(2007-5#1)(2009-9#1)
of trials in##8##3##(1990-11#1)(1990-12#1)(1994-2#2)(2005-11#1)(2007-11#1)(2007-5#1)(2009-9#1)
of trials to##3##3##(1993-2#1)(1993-3#1)(1995-12#1)
of trials with##2##3##(1993-5#1)(2006-10#1)
of trials##42##2##(1990-11#2)(1990-12#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1994-2#2)(1995-1#1)(1995-12#1)(1995-9#2)(1996-10#1)(1996-3#1)(1997-2#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-5#2)(2008-8#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#2)
of triamcinolone acetonide##9##3##(1991-9#1)(1996-6#6)(2006-10#1)(2010-12#1)
of triamcinolone in the##2##4##(2008-1#1)(2011-2#1)
of triamcinolone##13##2##(1991-9#1)(1992-5#1)(1996-3#1)(1996-6#6)(2006-10#1)(2008-1#1)(2010-12#1)(2011-2#1)
of triangle##2##2##(2008-10#1)(2008-6#1)
of triangles##2##2##(2008-2#1)(2008-5#1)
of triangular##7##2##(2005-1#1)(2008-3#3)(2008-5#1)(2010-5#2)
of triazine##4##2##(1991-8#1)(2008-10#2)(2010-8#1)
of triazines and##2##3##(1991-8#1)(2008-10#1)
of triazines from soils##2##4##(2008-10#2)
of triazines##5##2##(1991-8#1)(2008-10#4)
of tribological##2##2##(2004-9#1)(2010-4#1)
of tributyltin (TBT)##3##3##(2004-4#1)(2007-8#1)(2010-5#1)
of tributyltin chloride (TBTCl)##2##4##(1995-2#1)(1996-12#1)
of tributyltin chloride##3##3##(1995-2#2)(1996-12#1)
of tributyltin##11##2##(1992-6#1)(1995-2#2)(1996-12#1)(2004-4#1)(2007-8#2)(2008-10#1)(2008-4#1)(2009-12#1)(2010-5#1)
of trichinosis##2##2##(2008-10#2)
of trichlorfon##2##2##(1993-2#1)(2008-10#1)
of trichloroacetic acid (TCA)##2##4##(2008-10#2)
of trichloroacetic acid##4##3##(1997-1#1)(2008-10#3)
of trichloroethene (TCE)##2##3##(2006-3#1)(2008-10#1)
of trichloroethylene (TCE)##3##3##(2008-10#2)(2010-4#1)
of trichloroethylene in##2##3##(1992-5#1)(2008-10#1)
of trichloroethylene##9##2##(1992-5#1)(2008-10#6)(2008-7#1)(2010-4#1)
of trichodiene synthase##3##3##(1995-2#3)
of trichomoniasis##2##2##(2008-10#1)(2008-5#1)
of trichotillomania##2##2##(2007-12#1)(2012-11#1)
of triclosan##2##2##(2008-5#2)
of tricuspid##2##2##(1994-3#1)(2007-8#1)
of tricyclic antidepressant##2##3##(2008-10#1)(2010-1#1)
of tricyclic antidepressants##5##3##(1991-11#2)(2006-10#1)(2008-10#1)(2012-2#1)
of tricyclic##10##2##(1990-11#1)(1991-11#2)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#2)(2010-1#1)(2012-2#1)
of tricycloillicinone##3##2##(2009-11#3)
of triethanolamine (TEA)##2##3##(2008-10#2)
of triethanolamine##4##2##(2008-10#3)(2008-4#1)
of triethylamine##8##2##(1990-8#1)(1996-5#1)(2007-11#2)(2008-10#1)(2008-7#2)(2010-6#1)
of trifluoperazine##3##2##(1990-7#1)(1991-8#1)(1994-12#1)
of trifluoroacetic acid##2##3##(1990-12#1)(1995-3#1)
of trifluoroethanol##5##2##(1995-2#2)(1996-5#1)(1997-4#1)(2009-8#1)
of triflupromazine##2##2##(2008-10#2)
of trifluridine##2##2##(1994-8#2)
of trifoliate orange##4##3##(2008-10#4)
of trifunctional##2##2##(1996-2#2)
of trigeminal nerve root##3##4##(2011-1#3)
of trigeminal nerve##6##3##(1996-5#1)(2007-12#1)(2011-1#4)
of trigeminal neuralgia##3##3##(2006-12#1)(2010-12#1)(2011-2#1)
of trigeminal##14##2##(1990-4#1)(1990-9#1)(1995-5#1)(1996-5#1)(2006-11#1)(2006-12#2)(2007-12#1)(2010-12#1)(2011-1#4)(2011-2#1)
of trigger##9##2##(1996-4#1)(2006-6#1)(2008-12#1)(2008-2#1)(2008-9#2)(2009-7#1)(2009-8#1)(2010-9#1)
of triggering##6##2##(1992-3#1)(2007-12#1)(2007-7#1)(2008-1#1)(2011-1#1)(2012-7#1)
of triggers##3##2##(2006-7#1)(2008-10#1)(2008-11#1)
of triglyceride##3##2##(1996-4#1)(1997-2#1)(2004-11#1)
of triglyceride-rich lipoproteins##4##3##(1995-6#4)
of triglyceride-rich##5##2##(1995-6#4)(2008-6#1)
of triglycerides and##2##3##(1992-4#1)(2008-8#1)
of triglycerides in##4##3##(1992-12#1)(2005-10#1)(2010-12#2)
of triglycerides##16##2##(1992-12#1)(1992-3#1)(1992-4#1)(1995-6#2)(1997-2#1)(1997-8#1)(2005-10#1)(2006-6#1)(2006-9#1)(2008-12#1)(2008-6#1)(2008-8#1)(2010-12#2)(2012-2#1)
of trihalomethanes (THMs)##3##3##(2007-8#1)(2008-10#2)
of trihalomethanes in##4##3##(2007-8#1)(2008-10#3)
of trihalomethanes##10##2##(1994-3#1)(2007-8#2)(2008-10#7)
of triiodothyronine##2##2##(1994-9#2)
of trilobites##3##2##(2007-12#3)
of trimebutine maleate##2##3##(1990-7#2)
of trimebutine##3##2##(1990-7#3)
of trimellitic##2##2##(2008-10#2)
of trimeperidine##2##2##(2012-3#2)
of trimeric G##2##3##(1992-11#1)(1994-9#1)
of trimeric G-proteins##2##3##(1994-8#2)
of trimeric##5##2##(1992-11#1)(1994-8#2)(1994-9#1)(2008-4#1)
of trimethylamine dehydrogenase##2##3##(1995-2#2)
of trimethylamine in##2##3##(2008-10#2)
of trimethylamine##5##2##(1995-2#2)(2008-10#3)
of trimethylolpropane triacrylate##2##3##(2008-9#2)
of trimethylphosphine binding to##2##4##(1990-8#2)
of trimming##2##2##(1992-3#1)(2010-12#1)
of trimyristin##2##2##(2010-1#1)(2010-11#1)
of trinitrophenol##2##2##(2008-10#2)
of trinitrotoluene (TNT)##2##3##(2008-10#2)
of trinitrotoluene##3##2##(2008-10#3)
of trinucleotide repeat##2##3##(1995-11#1)(1997-3#1)
of trinucleotide##3##2##(1994-11#1)(1995-11#1)(1997-3#1)
of triosephosphates##2##2##(2008-1#2)
of triphenylphosphane##2##2##(2013-1#2)
of triphosphate##2##2##(1995-6#1)(1997-6#1)
of triple combination therapy##3##4##(2006-2#1)(2013-1#2)
of triple helix formation##2##4##(1995-5#1)(2006-10#1)
of triple##10##2##(1994-5#1)(1995-5#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-8#1)(2009-12#1)(2012-2#1)(2013-1#2)
of triple-helix formation##2##3##(1992-9#1)(2008-4#1)
of triplet##7##2##(1992-8#2)(1995-8#1)(2006-5#1)(2008-10#1)(2008-3#1)(2012-11#1)
of triplex formation##2##3##(1995-5#1)(1996-4#1)
of triplex##5##2##(1995-5#3)(1996-4#1)(2006-10#1)
of triplexes##3##2##(1993-8#1)(1994-9#1)(2008-8#1)
of triploid crucian carp##2##4##(2010-5#2)
of triploid##3##2##(2009-12#1)(2010-5#2)
of tripropylamine##2##2##(2008-10#1)(2010-7#1)
of tris(2##6##2##(2005-11#1)(2008-10#5)
of tris-(2##3##2##(2007-8#1)(2008-10#2)
of trisomy 18##2##3##(2007-2#1)(2012-3#1)
of trisomy 21##3##3##(1997-4#1)(2009-10#1)(2012-3#1)
of trisomy X##2##3##(1997-5#1)(2012-3#1)
of trisomy##10##2##(1996-12#1)(1997-4#1)(1997-5#1)(2007-2#1)(2009-10#1)(2012-3#5)
of triterpenic derivatives##2##3##(2008-5#2)
of tritiated thymidine##2##3##(1991-10#1)(2007-1#1)
of tritiated water##2##3##(1991-2#1)(2008-11#1)
of tritiated##6##2##(1990-2#1)(1991-10#1)(1991-2#1)(2007-1#1)(2008-11#1)(2008-9#1)
of tritium in##3##3##(1990-7#2)(1994-5#1)
of tritium##8##2##(1990-7#3)(1991-2#1)(1991-5#1)(1994-5#1)(1994-9#1)(1995-10#1)
of tritrophic food chains##2##4##(2008-9#2)
of trivalent and##2##3##(2008-10#1)(2012-2#1)
of trivalent rare##2##3##(2005-4#1)(2008-10#1)
of trivalent##15##2##(1995-9#1)(2005-4#1)(2008-10#10)(2011-2#2)(2012-2#1)
of trk receptors##2##3##(1996-3#2)
of trk##3##2##(1996-12#1)(1996-3#2)
of trkA##3##2##(1996-12#1)(1997-5#1)(1997-6#1)
of trkB##4##2##(1995-11#1)(1996-12#3)
of trolox##3##2##(2006-10#1)(2008-10#1)(2008-5#1)
of trophectoderm##4##2##(1991-12#1)(2006-5#1)(2012-12#2)
of trophic cascades##4##3##(2008-8#4)
of trophic factors##4##3##(1990-7#1)(1996-2#1)(2008-8#1)(2012-1#1)
of trophic##21##2##(1990-3#1)(1990-7#1)(1991-10#1)(1991-3#1)(1996-1#1)(1996-2#2)(1997-6#1)(2007-3#1)(2007-7#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-8#1)(2010-6#1)(2012-1#1)(2012-3#1)
of trophozoite##2##2##(1990-2#2)
of tropical Africa##3##3##(2006-10#1)(2006-4#1)(2008-12#1)
of tropical and##2##3##(2008-9#1)(2013-8#1)
of tropical countries##2##3##(1995-9#1)(2013-1#1)
of tropical diseases##3##3##(2011-2#2)(2012-2#1)
of tropical medicine##5##3##(1995-9#1)(2006-10#1)(2007-2#1)(2010-1#2)
of tropical##40##2##(1992-7#1)(1994-3#1)(1995-9#2)(2006-10#2)(2006-4#1)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#4)(2008-9#1)(2009-8#1)(2010-1#2)(2010-7#1)(2011-2#3)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
of tropisetron##2##2##(1994-12#1)(1996-3#1)
of tropomyosin to##2##3##(1992-8#1)(1995-5#1)
of tropomyosin##6##2##(1992-8#1)(1992-9#3)(1995-5#1)(1996-5#1)
of troponin C##7##3##(1991-2#1)(1991-4#1)(1994-11#2)(1995-5#1)(1997-2#2)
of troponin I##2##3##(1995-5#1)(1995-8#1)
of troponin##15##2##(1990-12#2)(1991-2#1)(1991-4#1)(1994-11#2)(1994-3#1)(1995-5#2)(1995-8#1)(1997-2#2)(2005-9#1)(2008-6#1)(2012-3#1)
of troponin-I release##2##3##(2008-6#2)
of troponin-I##5##2##(2007-8#1)(2008-6#4)
of tropospheric aerosols##3##3##(2008-2#2)(2008-3#1)
of tropospheric and stratospheric##2##4##(2008-11#1)(2008-3#1)
of tropospheric ozone##5##3##(1992-3#1)(2008-2#2)(2008-3#2)
of tropospheric particle size distributions##3##5##(2008-3#3)
of tropospheric##14##2##(1992-3#1)(2008-11#1)(2008-2#4)(2008-3#8)
of trouble##3##2##(2008-10#1)(2008-6#1)(2010-2#1)
of trout##5##2##(1990-10#1)(1991-4#1)(1992-6#1)(2008-11#1)(2008-7#1)
of troutCYP1A gene##2##3##(2008-11#2)
of trp aporepressor from Escherichia coli##3##6##(1990-7#2)(1994-8#1)
of trp aporepressor##4##3##(1990-7#2)(1994-8#2)
of trp##5##2##(1990-7#2)(1990-9#1)(1994-8#2)
of true and##2##3##(2008-3#1)(2010-2#1)
of true##34##2##(1990-5#1)(1990-8#1)(1991-6#1)(1992-6#1)(1993-7#1)(1996-12#1)(1997-2#1)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-6#1)(2010-2#2)(2010-8#1)(2011-1#1)(2013-1#5)
of truly##6##2##(2007-11#1)(2008-10#2)(2008-5#1)(2010-11#1)(2012-3#1)
of truncal##2##2##(2006-6#1)(2007-11#1)
of truncated and##2##3##(2008-11#1)(2008-8#1)
of truncated forms of##2##4##(1997-4#2)
of truncated##17##2##(1990-4#1)(1991-10#1)(1991-12#1)(1991-9#1)(1992-2#2)(1994-9#1)(1995-3#1)(1997-4#2)(2006-10#1)(2007-12#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-4#1)(2013-8#1)
of truncating##2##2##(1990-5#1)(2008-3#1)
of trunk strength and stability##2##5##(2008-12#2)
of trunk##10##2##(1996-1#1)(2006-6#2)(2007-12#1)(2007-7#1)(2008-12#2)(2012-12#1)(2013-1#2)
of trust and##4##3##(1995-12#1)(2006-6#1)(2008-1#1)(2012-12#1)
of trust between##3##3##(1996-1#1)(2004-12#1)(2007-4#1)
of trust in##6##3##(2007-11#1)(2007-4#1)(2008-3#1)(2009-6#2)(2011-2#1)
of trust##18##2##(1994-2#1)(1995-12#1)(1996-1#1)(1997-3#1)(2004-12#1)(2006-6#1)(2007-11#1)(2007-4#2)(2008-1#1)(2008-11#1)(2008-3#1)(2009-6#2)(2009-9#1)(2010-5#1)(2011-2#1)(2012-12#1)
of trustees##2##2##(1993-2#2)
of trying##3##2##(1994-6#1)(2009-1#1)(2010-8#1)
of trypan##2##2##(2008-10#1)(2008-11#1)
of trypanosome##3##2##(1993-9#1)(1995-8#1)(2007-6#1)
of trypanosomes##4##2##(1990-7#1)(1994-6#1)(2006-12#1)(2010-2#1)
of trypanosomiasis in##2##3##(2013-1#2)
of trypanosomiasis##5##2##(2007-6#2)(2013-1#3)
of trypanosomosis##2##2##(1997-7#1)(2007-8#1)
of trypanozoon infection##5##3##(2011-2#5)
of trypsin and chymotrypsin##2##4##(1992-9#1)(1996-9#1)
of trypsin and##5##3##(1992-12#2)(1992-9#1)(1993-3#1)(1996-9#1)
of trypsin by##2##3##(1990-9#1)(2008-7#1)
of trypsin was##2##3##(1990-9#1)(2008-7#1)
of trypsin##26##2##(1990-5#1)(1990-8#2)(1990-9#3)(1991-3#2)(1991-5#1)(1992-12#3)(1992-3#2)(1992-9#2)(1993-3#1)(1994-6#1)(1996-9#1)(1997-2#2)(2006-10#1)(2008-11#1)(2008-7#3)
of trypsin-derived##2##2##(1991-7#1)(1993-8#1)
of trypsin-like serine##2##3##(1995-5#1)(1996-2#1)
of trypsin-like##3##2##(1994-3#1)(1995-5#1)(1996-2#1)
of tryptase and chymase##3##4##(1997-7#3)
of tryptase##6##2##(1994-6#1)(1997-7#3)(2008-1#1)(2012-12#1)
of tryptic fragments##2##3##(1992-3#1)(2006-12#1)
of tryptic peptides##3##3##(1990-7#1)(1992-7#1)(2007-8#1)
of tryptic##8##2##(1990-7#1)(1992-3#1)(1992-7#1)(1995-6#1)(2006-12#1)(2007-8#1)(2008-10#1)(2009-12#1)
of tryptophan and histidine##5##4##(2007-8#5)
of tryptophan and##9##3##(1993-11#1)(1995-11#1)(2007-12#1)(2007-8#5)(2009-8#1)
of tryptophan fluorescence##3##3##(1995-2#1)(2006-10#1)(2008-4#1)
of tryptophan from the##2##4##(1994-11#1)(2007-8#1)
of tryptophan hydroxylase##4##3##(1990-5#1)(1994-11#1)(1996-5#2)
of tryptophan in##3##3##(1993-2#1)(2006-1#1)(2009-8#1)
of tryptophan pyrrolase##3##3##(2006-1#3)
of tryptophan residues in##2##4##(1992-8#1)(1995-6#1)
of tryptophan residues##9##3##(1990-8#1)(1992-6#1)(1992-8#2)(1993-8#1)(1995-2#1)(1995-6#1)(1997-8#1)(2008-6#1)
of tryptophan side-chain analogs##2##4##(1992-12#1)(1993-6#1)
of tryptophan synthase##6##3##(1990-2#3)(1991-4#2)(1996-8#1)
of tryptophan to##2##3##(1990-8#1)(1994-3#1)
of tryptophan##62##2##(1990-2#3)(1990-5#1)(1990-8#2)(1991-4#2)(1991-7#1)(1992-12#1)(1992-2#2)(1992-6#3)(1992-8#2)(1993-11#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-3#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-6#1)(1996-5#2)(1996-8#1)(1997-3#1)(1997-8#1)(2006-1#4)(2006-10#1)(2007-12#3)(2007-8#6)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-8#3)(2012-3#1)
of tryptophane##2##2##(2007-8#2)
of tryptophans in##2##3##(1991-12#1)(1997-1#1)
of tryptophans##3##2##(1991-12#1)(1993-11#1)(1997-1#1)
of ts mutants##2##3##(2008-10#2)
of tsetse flies##2##3##(2013-8#2)
of tsetse##3##2##(2006-10#1)(2013-8#2)
of tuatara##2##2##(2010-3#2)
of tub2##2##2##(1994-3#2)
of tubal pregnancy##3##3##(1992-8#1)(1994-3#2)
of tubal sterility##2##3##(1994-12#2)
of tubal##12##2##(1991-11#1)(1991-12#1)(1992-8#2)(1994-11#1)(1994-12#2)(1994-3#2)(2011-1#2)(2011-2#1)
of tube##7##2##(2006-10#1)(2007-7#1)(2007-9#1)(2008-1#1)(2009-8#1)(2012-12#1)(2012-2#1)
of tuber##2##2##(2008-9#1)(2010-2#1)
of tuber-borne sclerotia##2##3##(2008-10#2)
of tuber-borne##3##2##(2008-10#3)
of tubercular##6##2##(1997-8#2)(2008-1#1)(2008-4#1)(2010-8#1)(2012-12#1)
of tuberculin##3##2##(1990-6#1)(1993-7#1)(2013-1#1)
of tuberculosis (TB) is##2##4##(2007-11#1)(2008-1#1)
of tuberculosis (TB)##11##3##(1991-3#1)(1996-11#1)(2005-9#1)(2006-8#1)(2007-11#1)(2008-1#1)(2009-4#1)(2010-10#1)(2012-2#2)(2013-1#1)
of tuberculosis among people living with HIV/AIDS##5##7##(2011-1#5)
of tuberculosis and##7##3##(1993-7#1)(1996-3#1)(2006-8#1)(2008-4#1)(2008-5#1)(2009-4#1)(2012-2#1)
of tuberculosis at##2##3##(2009-7#1)(2011-2#1)
of tuberculosis cases##2##3##(1995-9#1)(2013-8#1)
of tuberculosis during##2##3##(2006-10#1)(2013-1#1)
of tuberculosis in children##2##4##(2006-10#1)(2012-3#1)
of tuberculosis in humans##2##4##(2010-12#1)(2013-1#1)
of tuberculosis in patients##2##4##(1991-1#1)(1996-3#1)
of tuberculosis in the##5##4##(1995-3#1)(2006-6#1)(2007-11#1)(2008-7#1)(2009-7#1)
of tuberculosis in this##4##4##(2007-7#1)(2010-12#1)(2013-1#2)
of tuberculosis in##24##3##(1991-1#1)(1995-3#1)(1996-3#1)(2005-7#1)(2006-10#1)(2006-6#2)(2007-11#1)(2007-7#1)(2008-1#1)(2008-7#1)(2009-7#1)(2010-12#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#5)
of tuberculosis infection##8##3##(1990-6#2)(2007-4#2)(2007-7#1)(2008-10#1)(2008-9#1)(2010-11#1)
of tuberculosis of the##2##4##(2007-7#1)(2008-4#1)
of tuberculosis of##4##3##(2007-7#1)(2007-8#1)(2008-4#1)(2010-4#1)
of tuberculosis patients##3##3##(1996-3#1)(2005-9#1)(2008-8#1)
of tuberculosis treatment##2##3##(2007-12#1)(2007-2#1)
of tuberculosis was##6##3##(1990-9#1)(1993-7#3)(2007-2#1)(2012-3#1)
of tuberculosis##126##2##(1990-12#2)(1990-6#3)(1990-9#1)(1991-1#1)(1991-3#1)(1992-2#1)(1993-11#1)(1993-7#4)(1994-4#1)(1994-7#2)(1995-10#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-11#3)(1996-3#5)(2005-10#1)(2005-11#1)(2005-7#1)(2005-9#2)(2006-10#3)(2006-6#3)(2006-8#2)(2007-11#4)(2007-12#3)(2007-2#2)(2007-4#2)(2007-7#6)(2007-8#1)(2008-1#3)(2008-10#2)(2008-12#2)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-4#2)(2009-7#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-4#2)(2010-7#1)(2011-1#6)(2011-2#8)(2012-2#5)(2012-3#4)(2013-1#10)(2013-8#2)
of tuberculosis]##2##2##(1995-3#1)(1996-12#1)
of tuberculous gonitis##3##3##(2007-8#3)
of tuberculous infection##2##3##(1990-6#1)(1993-4#1)
of tuberculous lymphadenitis##3##3##(1996-6#1)(2006-8#1)(2007-7#1)
of tuberculous meningitis##3##3##(2011-2#2)(2013-7#1)
of tuberculous spinal cord compression##2##5##(2008-7#2)
of tuberculous##20##2##(1990-6#1)(1993-4#1)(1996-6#1)(2006-10#1)(2006-8#1)(2007-7#1)(2007-8#5)(2008-7#2)(2009-4#1)(2009-5#1)(2011-2#3)(2012-2#1)(2013-7#1)
of tuberous sclerosis##2##3##(2008-1#1)(2010-6#1)
of tuberous##4##2##(2007-7#1)(2008-1#1)(2008-11#1)(2010-6#1)
of tubers##2##2##(2008-10#2)
of tubes##5##2##(1991-12#1)(1996-2#1)(2008-10#1)(2009-2#1)(2013-1#1)
of tubing##4##2##(1997-3#3)(2008-10#1)
of tubular cells##2##3##(2008-6#1)(2011-2#1)
of tubular damage##2##3##(1990-4#1)(1991-11#1)
of tubular degeneration##2##3##(2008-5#1)(2008-9#1)
of tubular epithelial##2##3##(1990-5#1)(2011-2#1)
of tubular transporters##2##3##(2009-12#2)
of tubular##19##2##(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1992-9#1)(1993-2#1)(1993-4#1)(1996-12#1)(2007-12#1)(2007-9#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#2)(2011-2#2)
of tubules##6##2##(1991-2#1)(1996-1#1)(2007-12#1)(2008-7#2)(2010-4#1)
of tubulin and##2##3##(1992-6#1)(1995-3#1)
of tubulin polymerization and##2##4##(1992-9#1)(1994-9#1)
of tubulin to##3##3##(1990-5#3)
of tubulin with##2##3##(1993-3#1)(1994-3#1)
of tubulin##28##2##(1990-5#4)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#4)(1994-3#2)(1994-5#3)(1994-9#1)(1995-3#1)(1995-5#4)(1997-4#1)(2004-12#1)(2006-12#1)(2010-7#1)
of tumor aggressiveness##3##3##(1990-10#1)(2006-6#1)(2011-2#1)
of tumor and normal##3##4##(1993-9#1)(2008-1#1)(2011-1#1)
of tumor and##14##3##(1990-2#1)(1993-11#1)(1993-9#1)(1996-11#1)(2006-6#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-6#1)(2009-2#1)(2009-3#1)(2011-1#1)(2012-3#1)
of tumor angiogenesis in##2##4##(2007-8#1)(2008-1#1)
of tumor angiogenesis##5##3##(1993-9#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#1)
of tumor cell adhesion to##2##5##(2008-1#1)(2009-3#1)
of tumor cell growth##4##4##(2007-5#1)(2008-4#2)(2008-6#1)
of tumor cell invasion##2##4##(1993-4#1)(2008-11#1)
of tumor cell lines##7##4##(1990-6#1)(1991-7#1)(1992-11#1)(1992-9#1)(2008-5#1)(2012-12#2)
of tumor cell proliferation##3##4##(1997-7#1)(2012-11#2)
of tumor cell##27##3##(1990-6#1)(1991-12#1)(1991-7#1)(1992-11#1)(1992-9#1)(1993-4#1)(1996-11#1)(1996-4#1)(1996-6#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2012-1#1)(2012-11#2)(2012-12#2)(2012-3#1)
of tumor cells and the##2##5##(1992-3#1)(2011-1#1)
of tumor cells and##6##4##(1992-3#1)(1993-4#1)(1993-7#1)(2011-1#2)(2012-2#1)
of tumor cells as##2##4##(1990-4#1)(2009-2#1)
of tumor cells for##2##4##(1992-8#1)(1994-12#1)
of tumor cells in the##2##5##(1990-4#1)(2008-11#1)
of tumor cells in vitro##2##5##(1995-8#1)(2009-3#1)
of tumor cells in##7##4##(1990-4#1)(1991-4#1)(1995-8#1)(1996-3#1)(2008-11#1)(2008-4#1)(2009-3#1)
of tumor cells may##2##4##(1993-4#1)(1994-5#1)
of tumor cells that##2##4##(2005-10#1)(2010-2#1)
of tumor cells to##7##4##(1991-2#1)(1992-7#1)(1993-10#1)(1994-2#1)(2008-10#1)(2008-11#1)(2009-9#1)
of tumor cells with##3##4##(1994-6#1)(1996-10#1)(2007-10#1)
of tumor cells##76##3##(1990-4#2)(1991-2#1)(1991-4#1)(1991-7#1)(1992-3#1)(1992-7#3)(1992-8#4)(1993-10#1)(1993-4#4)(1993-7#1)(1993-9#2)(1994-12#1)(1994-2#2)(1994-5#2)(1994-6#2)(1995-1#1)(1995-10#1)(1995-8#1)(1996-10#1)(1996-3#1)(1997-2#1)(1997-4#2)(2005-10#1)(2005-6#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#6)(2008-4#5)(2008-5#1)(2008-6#2)(2008-9#2)(2009-2#1)(2009-3#2)(2009-9#1)(2010-1#1)(2010-2#1)(2010-3#3)(2011-1#5)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
of tumor development##4##3##(1992-5#1)(1993-7#1)(1993-8#1)(2008-10#1)
of tumor formation##3##3##(1991-10#1)(2008-8#1)(2013-8#1)
of tumor growth and##5##4##(1995-5#1)(2005-11#1)(2007-11#1)(2009-3#1)(2012-2#1)
of tumor growth in##2##4##(1997-7#1)(2005-10#1)
of tumor growth of##2##4##(1990-7#1)(2007-8#1)
of tumor growth##24##3##(1990-7#1)(1993-1#1)(1994-11#1)(1995-5#1)(1997-7#2)(2005-10#1)(2005-11#1)(2006-11#1)(2007-11#1)(2007-8#2)(2008-3#1)(2009-3#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
of tumor immunology##3##3##(2005-10#1)(2006-10#2)
of tumor in##3##3##(2008-3#1)(2012-3#1)(2013-1#1)
of tumor induction in##2##4##(2008-8#1)(2009-10#1)
of tumor induction##3##3##(2008-8#2)(2009-10#1)
of tumor invasion##4##3##(2006-12#1)(2008-11#2)(2013-8#1)
of tumor lysis syndrome in adults with hematologic malignancies##2##9##(2008-7#2)
of tumor malignancy##3##3##(1993-8#1)(2012-2#1)(2013-1#1)
of tumor markers##4##3##(1990-10#2)(1994-7#1)(1996-2#1)
of tumor metastasis##3##3##(1991-2#1)(1992-8#2)
of tumor necrosis factor (TNF) in##2##6##(1996-1#1)(1997-5#1)
of tumor necrosis factor (TNF)##9##5##(1990-2#1)(1991-1#1)(1994-2#1)(1994-8#1)(1995-8#1)(1995-9#1)(1996-1#1)(1997-5#1)(1997-6#1)
of tumor necrosis factor alpha (TNFalpha)##2##6##(1997-4#1)(2006-3#1)
of tumor necrosis factor alpha and##2##6##(2008-4#1)(2011-2#1)
of tumor necrosis factor alpha##10##5##(1992-7#1)(1994-9#1)(1995-3#1)(1997-4#1)(2006-12#1)(2006-3#1)(2008-4#1)(2010-9#1)(2011-2#1)(2012-3#1)
of tumor necrosis factor and##2##5##(2006-10#1)(2006-8#1)
of tumor necrosis factor in##3##5##(1990-12#1)(2006-10#1)(2013-7#1)
of tumor necrosis factor##38##4##(1990-12#1)(1990-2#2)(1991-1#1)(1992-3#1)(1992-7#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#2)(1997-4#1)(1997-5#2)(1997-6#1)(2006-10#4)(2006-12#1)(2006-3#1)(2006-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-7#1)
of tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6)##2##8##(1992-8#1)(2008-10#1)
of tumor necrosis factor-alpha (TNF-alpha) and##3##6##(1992-8#1)(2007-8#1)(2008-10#1)
of tumor necrosis factor-alpha (TNF-alpha) on##2##6##(1992-3#1)(2008-9#1)
of tumor necrosis factor-alpha (TNF-alpha)##11##5##(1992-12#1)(1992-3#1)(1992-8#1)(1993-6#1)(1994-5#1)(1995-9#1)(2006-2#1)(2007-8#1)(2008-10#2)(2008-9#1)
of tumor necrosis factor-alpha and interleukin-6##3##6##(1995-12#1)(1995-3#1)(2008-5#1)
of tumor necrosis factor-alpha and##6##5##(1994-11#1)(1995-10#1)(1995-12#1)(1995-3#1)(2008-3#1)(2008-5#1)
of tumor necrosis factor-alpha##21##4##(1992-12#1)(1992-3#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-9#1)(1997-7#1)(2006-2#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-2#1)(2012-2#1)
of tumor necrosis factor-α##3##4##(2011-1#1)(2013-1#2)
of tumor necrosis##65##3##(1990-12#1)(1990-2#2)(1991-1#1)(1992-12#1)(1992-3#3)(1992-7#1)(1992-8#1)(1993-6#1)(1994-10#1)(1994-11#2)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#3)(1995-3#2)(1995-8#1)(1995-9#2)(1996-1#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-3#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-2#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
of tumor progression and metastasis##2##5##(1997-4#1)(2012-1#1)
of tumor progression and##3##4##(1997-4#1)(2007-6#1)(2012-1#1)
of tumor progression##9##3##(1991-2#1)(1993-9#1)(1997-4#1)(2007-6#1)(2009-3#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-3#1)
of tumor promotion in##2##4##(1992-7#1)(1993-8#1)
of tumor recurrence after##2##4##(2009-1#1)(2011-2#1)
of tumor recurrence##9##3##(1991-4#1)(2006-12#1)(2006-5#1)(2007-12#1)(2009-1#1)(2009-5#1)(2011-2#2)(2012-2#1)
of tumor regression##3##3##(1992-12#1)(1994-5#1)(1995-9#1)
of tumor resection##3##3##(2007-11#1)(2011-1#1)(2011-2#1)
of tumor response to##5##4##(1995-9#1)(1997-4#1)(2006-12#1)(2008-12#1)(2010-3#1)
of tumor response##6##3##(1995-9#1)(1997-4#1)(2006-12#1)(2006-6#1)(2008-12#1)(2010-3#1)
of tumor samples##3##3##(1994-6#1)(1997-7#1)(2008-1#1)
of tumor size and##3##4##(1994-4#2)(2009-2#1)
of tumor size in##2##4##(2009-1#1)(2009-5#1)
of tumor size##6##3##(1994-4#2)(2009-1#1)(2009-2#1)(2009-5#1)(2010-10#1)
of tumor spread##2##3##(1992-8#1)(2005-11#1)
of tumor stage##6##3##(1990-12#1)(2008-1#1)(2013-8#4)
of tumor staging##3##3##(2005-5#3)
of tumor suppressor gene##2##4##(1997-4#1)(2008-10#1)
of tumor suppressor genes##4##4##(1990-12#1)(2007-11#1)(2009-12#1)(2011-2#1)
of tumor suppressor##8##3##(1990-12#1)(1995-6#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-6#1)(2009-12#1)(2011-2#1)
of tumor tissue##4##3##(1997-8#1)(2006-6#1)(2007-11#1)(2008-4#1)
of tumor types##6##3##(1990-4#1)(2005-11#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-2#1)
of tumor vasculature##2##3##(1993-9#1)(2008-3#1)
of tumor volume##3##3##(2007-4#1)(2012-11#2)
of tumor with##3##3##(2006-10#1)(2008-3#1)(2013-8#1)
of tumor##439##2##(1990-10#3)(1990-12#4)(1990-2#4)(1990-4#3)(1990-6#2)(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#5)(1991-4#2)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#1)(1992-7#5)(1992-8#11)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#3)(1993-4#6)(1993-5#1)(1993-6#1)(1993-7#2)(1993-8#3)(1993-9#7)(1994-10#1)(1994-11#4)(1994-12#1)(1994-2#4)(1994-3#1)(1994-4#3)(1994-5#5)(1994-6#4)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-12#3)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#3)(1995-9#6)(1996-1#2)(1996-10#1)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#5)(1996-4#1)(1996-6#1)(1997-2#1)(1997-4#6)(1997-5#2)(1997-6#1)(1997-7#6)(1997-8#1)(2005-10#3)(2005-11#4)(2005-12#1)(2005-5#4)(2005-6#1)(2006-10#11)(2006-11#1)(2006-12#6)(2006-2#2)(2006-3#1)(2006-5#2)(2006-6#7)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#3)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#6)(2008-1#7)(2008-10#6)(2008-11#12)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#9)(2008-5#7)(2008-6#7)(2008-7#3)(2008-8#6)(2008-9#5)(2009-1#2)(2009-10#1)(2009-11#2)(2009-12#3)(2009-2#4)(2009-3#7)(2009-5#4)(2009-6#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#5)(2010-8#1)(2010-9#2)(2011-1#15)(2011-12#1)(2011-2#14)(2012-1#4)(2012-11#6)(2012-12#3)(2012-2#10)(2012-3#8)(2013-1#10)(2013-7#3)(2013-8#10)
of tumor-associated antigens##5##3##(1991-9#1)(1993-11#1)(1996-10#1)(2006-10#1)(2010-2#1)
of tumor-associated macrophages##3##3##(1991-9#1)(2012-1#2)
of tumor-associated##11##2##(1991-9#2)(1993-11#1)(1996-10#1)(1996-3#1)(2006-10#1)(2008-6#1)(2010-1#1)(2010-2#1)(2012-1#2)
of tumor-bearing mice and##3##4##(1992-7#1)(1994-3#1)(2012-1#1)
of tumor-bearing mice##11##3##(1990-7#4)(1992-7#1)(1994-3#1)(1996-11#1)(2008-3#1)(2008-9#2)(2012-1#1)
of tumor-bearing##12##2##(1990-2#1)(1990-7#4)(1992-7#1)(1994-3#1)(1996-11#1)(2008-3#1)(2008-9#2)(2012-1#1)
of tumor-derived##3##2##(1996-10#1)(2008-7#1)(2012-12#1)
of tumor-immune##3##2##(2013-8#3)
of tumor-induced##4##2##(1994-12#1)(1995-3#1)(2008-11#1)(2008-7#1)
of tumor-infiltrating lymphocytes##2##3##(1991-7#1)(2012-2#1)
of tumor-infiltrating##3##2##(1991-7#1)(2011-1#1)(2012-2#1)
of tumor-reactive##2##2##(1995-5#1)(2012-2#1)
of tumor-related genes##2##3##(2008-4#1)(2008-7#1)
of tumor-related##6##2##(1990-12#1)(2006-8#1)(2008-4#1)(2008-6#2)(2008-7#1)
of tumor-specific lymphocytes##2##3##(1993-12#1)(2011-1#1)
of tumor-specific##4##2##(1993-12#1)(1994-5#1)(2007-8#1)(2011-1#1)
of tumor-suppressor genes##2##3##(2006-10#1)(2008-9#1)
of tumoral##4##2##(1990-6#1)(1990-8#1)(2007-11#1)(2010-9#1)
of tumorigenesis and##3##3##(2007-10#1)(2012-12#1)(2012-3#1)
of tumorigenesis induced by##2##4##(2008-11#2)
of tumorigenesis##14##2##(1994-11#1)(1995-10#1)(1995-9#1)(2007-10#2)(2007-5#1)(2008-11#2)(2008-3#1)(2008-7#1)(2012-12#2)(2012-3#1)(2013-1#1)
of tumorigenic##4##2##(1995-9#1)(1997-1#1)(2009-12#1)(2009-3#1)
of tumorigenicity##3##2##(1991-9#1)(1992-2#1)(2008-9#1)
of tumorous##3##2##(1993-8#1)(2008-5#1)(2009-10#1)
of tumors and tumor-like##2##4##(2007-8#1)(2010-7#1)
of tumors and##12##3##(2006-4#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-2#1)
of tumors as##3##3##(1993-7#1)(2010-2#1)(2013-8#1)
of tumors in the proximal##2##5##(2010-3#2)
of tumors in the##7##4##(1995-2#1)(2007-8#1)(2008-2#1)(2010-3#3)(2011-2#1)
of tumors in##12##3##(1994-8#1)(1995-2#1)(1995-8#1)(2007-8#1)(2008-2#1)(2010-3#3)(2011-2#1)(2012-1#2)(2012-2#1)
of tumors is##3##3##(1991-12#1)(2007-8#1)(2013-7#1)
of tumors of the##5##4##(1991-10#1)(1991-5#1)(2009-2#1)(2009-7#1)(2011-1#1)
of tumors of##9##3##(1991-10#1)(1991-5#1)(1995-1#1)(2009-2#1)(2009-7#1)(2010-1#1)(2011-1#1)(2012-1#1)(2013-8#1)
of tumors to##3##3##(1997-5#1)(2013-7#2)
of tumors was##2##3##(1996-11#1)(2007-8#1)
of tumors with a##2##4##(1991-4#1)(2010-12#1)
of tumors with##4##3##(1990-2#1)(1991-4#1)(2007-12#1)(2010-12#1)
of tumors##114##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1991-10#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-7#4)(1993-7#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-11#3)(1997-5#1)(1997-7#2)(2005-10#1)(2005-11#1)(2005-9#1)(2006-4#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#4)(2008-1#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-9#2)(2009-11#1)(2009-2#2)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-12#4)(2010-2#1)(2010-3#6)(2010-7#2)(2011-1#3)(2011-2#8)(2012-1#4)(2012-12#1)(2012-2#4)(2013-1#2)(2013-7#3)(2013-8#3)
of tumors/mouse##2##2##(1993-9#1)(1994-2#1)
of tumour and##7##3##(1990-4#1)(1991-4#1)(1992-10#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-6#1)
of tumour cell##2##3##(2008-11#1)(2009-4#1)
of tumour cells##11##3##(1992-9#4)(1997-3#1)(2005-12#1)(2007-7#1)(2008-5#1)(2009-9#1)(2011-1#1)(2011-2#1)
of tumour growth##7##3##(1993-8#1)(1993-9#1)(2004-1#1)(2006-8#1)(2007-11#1)(2008-5#1)(2011-2#1)
of tumour hypoxia and the##2##5##(2009-4#1)(2011-2#1)
of tumour hypoxia and##3##4##(2009-4#1)(2011-2#2)
of tumour hypoxia##5##3##(1993-4#1)(2009-4#2)(2011-2#2)
of tumour markers##3##3##(1992-2#1)(2005-12#1)(2008-3#1)
of tumour necrosis factor##3##4##(2007-11#2)(2012-11#1)
of tumour necrosis factor-alpha (TNF-alpha)##2##5##(1992-8#1)(2010-9#1)
of tumour necrosis factor-alpha##6##4##(1992-8#1)(2007-11#3)(2010-9#2)
of tumour necrosis##12##3##(1992-8#1)(2007-11#5)(2007-12#1)(2008-10#1)(2010-9#2)(2012-1#1)(2012-11#1)
of tumour of##2##3##(1990-4#1)(2011-12#1)
of tumour perfusion##2##3##(2008-7#2)
of tumour progression##3##3##(2008-4#1)(2013-1#2)
of tumour recurrence##5##3##(1993-2#1)(1993-3#1)(2008-3#1)(2008-7#1)(2013-1#1)
of tumour spread##4##3##(1991-7#1)(2008-1#1)(2012-2#2)
of tumour suppressor genes##2##4##(2007-11#1)(2009-4#1)
of tumour was##2##3##(2008-6#1)(2009-10#1)
of tumour##111##2##(1990-11#1)(1990-4#2)(1991-4#1)(1991-7#2)(1992-10#1)(1992-2#2)(1992-6#1)(1992-8#1)(1992-9#4)(1993-1#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-8#1)(1993-9#1)(1994-6#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-1#1)(2005-12#2)(2005-7#3)(2006-8#6)(2007-11#9)(2007-12#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#10)(2008-7#5)(2009-10#1)(2009-2#1)(2009-4#4)(2009-9#1)(2010-12#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-2#3)(2013-1#3)(2013-8#1)
of tumourigenesis##2##2##(2008-1#1)(2013-1#1)
of tumours and##2##3##(2007-11#1)(2007-6#1)
of tumours of the##2##4##(2007-11#1)(2008-6#1)
of tumours##23##2##(1991-11#1)(1991-4#1)(1991-7#1)(1993-9#2)(1994-6#1)(1997-2#1)(2006-8#1)(2007-11#3)(2007-6#1)(2008-2#1)(2008-4#1)(2008-6#3)(2008-7#2)(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#1)
of tumstatin##2##2##(2008-11#2)
of tuna ferrocytochrome c##2##4##(1994-5#2)
of tuna##3##2##(1994-5#2)(2011-2#1)
of tunable diode lasers##3##4##(2007-12#1)(2008-3#2)
of tunable far-infrared##2##3##(2007-11#1)(2008-2#1)
of tunable##30##2##(2007-11#5)(2007-12#6)(2008-1#2)(2008-2#8)(2008-3#5)(2012-11#2)(2012-2#1)(2013-8#1)
of tungsten and##2##3##(2007-5#1)(2008-10#1)
of tungsten carbide##2##3##(2005-8#1)(2007-12#1)
of tungsten in tobacco##2##4##(2008-10#2)
of tungsten in##7##3##(2008-10#7)
of tungsten##24##2##(1994-6#1)(2005-11#1)(2005-4#2)(2005-8#1)(2007-12#1)(2007-5#1)(2008-10#17)
of tunicamycin##6##2##(1993-6#1)(1994-8#1)(1994-9#1)(1997-1#1)(2008-11#1)(2013-1#1)
of tuning the##2##3##(2007-11#1)(2007-12#1)
of tuning##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
of tunnel length##2##3##(2013-1#2)
of tunnel##4##2##(2011-2#2)(2013-1#2)
of tunneling##4##2##(1992-11#1)(1992-3#1)(2007-11#1)(2008-3#1)
of tunnels##4##2##(2009-10#1)(2011-2#3)
of turbid biological##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
of turbid media##10##3##(2007-12#2)(2008-2#1)(2008-3#6)(2009-10#1)
of turbid samples##2##3##(2008-3#2)
of turbid water##2##3##(2008-2#2)
of turbid##18##2##(1995-2#1)(2007-12#3)(2008-2#4)(2008-3#9)(2009-10#1)
of turbidity##2##2##(1990-11#1)(2008-2#1)
of turbine design##2##3##(2008-6#2)
of turbot Psetta maxima##2##4##(2010-8#2)
of turbot##4##2##(2010-5#1)(2010-8#2)(2012-2#1)
of turbulence by##2##3##(2007-12#1)(2008-3#1)
of turbulence##13##2##(2007-12#2)(2008-12#1)(2008-2#2)(2008-3#8)
of turbulence-induced phase dislocations##2##4##(2008-2#2)
of turbulence-induced phase distortions##2##4##(2008-3#2)
of turbulence-induced phase##4##3##(2008-2#2)(2008-3#2)
of turbulence-induced##7##2##(2008-2#2)(2008-3#5)
of turbulent and##2##3##(2008-2#2)
of turbulent##6##2##(2007-12#1)(2008-2#2)(2008-3#2)(2008-8#1)
of turkey rhinotracheitis virus##2##4##(2008-5#2)
of turkey##10##2##(1990-12#1)(1993-3#1)(1997-6#2)(2004-11#1)(2008-5#2)(2010-4#1)(2013-8#2)
of turkeys##14##2##(1992-10#1)(2004-11#1)(2007-6#1)(2007-8#1)(2008-5#1)(2013-1#1)(2013-8#8)
of turmeric##2##2##(1992-9#1)(2010-12#1)
of turning##3##2##(1996-1#1)(2008-9#1)(2011-1#1)
of turnip mosaic virus##2##4##(2008-10#2)
of turnip yellow mosaic virus RNA##2##6##(1992-9#2)
of turnip yellow mosaic virus##3##5##(1992-9#2)(1997-3#1)
of turnip##5##2##(1992-9#2)(1997-3#1)(2008-10#2)
of turnover is##2##3##(1996-2#1)(1996-9#1)
of turnover##10##2##(1990-12#1)(1991-1#1)(1992-4#1)(1992-6#1)(1994-12#1)(1995-3#1)(1996-2#1)(1996-9#1)(2007-12#1)(2008-4#1)
of turns##6##2##(1991-4#2)(2008-9#1)(2012-12#3)
of turpentine##2##2##(1991-7#1)(1994-8#1)
of twelve##21##2##(1990-10#1)(1990-3#1)(1992-4#1)(1993-9#1)(1996-6#2)(2006-12#1)(2007-1#1)(2007-5#2)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#3)(2013-1#1)
of twenty six##2##3##(2005-4#2)
of twenty##16##2##(1990-10#1)(1991-3#1)(1992-1#1)(2005-4#3)(2006-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#1)
of twenty-five##4##2##(1990-3#1)(1993-2#1)(2008-7#1)(2011-2#1)
of twenty-four##2##2##(2006-11#1)(2008-8#1)
of twenty-one##3##2##(1993-12#1)(1996-12#1)(2007-12#1)
of twice##3##2##(1991-2#1)(2008-2#1)(2008-3#1)
of twice-daily##2##2##(2006-5#1)(2010-8#1)
of twin beams##3##3##(2007-11#2)(2007-12#1)
of twin births##4##3##(1990-6#3)(2004-10#1)
of twin neonates and##2##4##(1993-1#2)
of twin neonates##3##3##(1993-1#3)
of twin##17##2##(1990-6#3)(1991-3#1)(1993-1#3)(1994-10#1)(1995-6#1)(2004-10#2)(2007-11#2)(2007-12#1)(2010-8#2)(2012-2#1)
of twins##7##2##(1992-12#1)(1993-9#2)(1997-7#1)(2008-7#1)(2009-9#2)
of twisted##4##2##(1994-8#1)(2007-12#1)(2008-2#1)(2010-9#1)
of two Ca2+##2##3##(1994-5#1)(1995-1#1)
of two Chinese-version sexual##2##4##(2010-5#2)
of two Chinese-version##3##3##(2010-5#3)
of two Cynara species##2##4##(2007-1#2)
of two Egyptian species of bats##2##6##(1994-11#2)
of two Indian##2##3##(2007-1#1)(2007-7#1)
of two SNPs##2##3##(2009-4#1)(2012-3#1)
of two active##7##3##(1991-12#1)(1995-11#1)(1995-5#1)(1997-7#1)(2008-1#1)(2008-10#2)
of two additional##4##3##(1991-9#1)(1996-9#1)(2005-11#1)(2007-2#1)
of two adenosine##3##3##(1990-4#1)(1990-6#1)(1991-10#1)
of two adjacent##6##3##(1990-5#2)(1991-7#1)(1993-9#1)(1996-7#1)(2007-12#1)
of two adjuvant##2##3##(1990-4#1)(1997-7#1)
of two adult##2##3##(1990-2#1)(1996-11#1)
of two alternative##4##3##(2007-12#1)(2008-3#1)(2008-8#2)
of two and##4##3##(1990-3#1)(2005-4#1)(2007-7#1)(2013-8#1)
of two angiotensin II receptor##2##5##(1990-6#1)(2008-10#1)
of two angiotensin##3##3##(1990-6#1)(1992-5#1)(2008-10#1)
of two antigens##2##3##(1990-12#1)(2009-8#1)
of two automatic##2##3##(2006-2#1)(2008-10#1)
of two bacterial##2##3##(1995-5#1)(2008-10#1)
of two basic##2##3##(2008-4#1)(2013-1#1)
of two binary##3##3##(2007-10#1)(2008-3#2)
of two binding sites##3##4##(1995-5#1)(1996-6#1)(2008-10#1)
of two binomial##3##3##(1994-9#1)(1997-6#2)
of two biological##2##3##(2008-4#1)(2011-1#1)
of two broad##3##3##(1996-7#1)(2008-12#1)(2009-12#1)
of two brothers##2##3##(2009-5#1)(2009-9#1)
of two cDNAs encoding##3##4##(1993-2#1)(2008-7#2)
of two calibration##2##3##(2008-10#2)
of two case reports##2##4##(1990-12#1)(1996-3#1)
of two cases and review of the literature##6##8##(1992-12#1)(1994-10#1)(2006-8#1)(2007-9#1)(2009-4#1)(2011-2#1)
of two cases and review of the##7##7##(1992-12#1)(1994-10#1)(2006-8#1)(2007-9#1)(2009-4#1)(2011-2#1)(2012-3#1)
of two cases and review of##8##6##(1992-12#1)(1994-10#1)(2006-8#1)(2007-9#1)(2009-4#1)(2010-9#1)(2011-2#1)(2012-3#1)
of two cases and##10##4##(1992-12#1)(1994-10#1)(2006-8#1)(2007-9#1)(2008-7#1)(2009-4#1)(2010-9#1)(2011-2#2)(2012-3#1)
of two cases of##9##4##(1990-2#1)(1994-6#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-4#1)(2011-2#1)(2013-1#1)(2013-7#1)
of two cases##86##3##(1990-10#1)(1990-2#1)(1990-4#1)(1990-5#1)(1991-6#1)(1992-10#2)(1992-12#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-6#2)(2005-10#2)(2005-2#1)(2006-10#2)(2006-11#1)(2006-12#5)(2006-2#2)(2006-4#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#2)(2009-4#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#2)
of two cases]##5##3##(2008-4#1)(2012-2#1)(2013-1#3)
of two central##2##3##(1990-2#1)(2011-2#1)
of two channels##2##3##(1990-5#1)(2008-10#1)
of two chaotic laser##2##4##(2007-12#2)
of two cis##2##3##(2006-12#1)(2009-8#1)
of two classes of##9##4##(1990-3#1)(1993-1#1)(1994-3#1)(1994-6#1)(1994-8#1)(1996-10#1)(1996-3#1)(2006-9#1)(2008-10#1)
of two clinical cases]##3##4##(2006-2#1)(2008-10#1)(2013-8#1)
of two clinical##7##3##(1992-6#1)(2006-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2013-8#1)
of two closely related##2##4##(1990-12#1)(2008-8#1)
of two closely spaced##2##4##(2008-10#1)(2008-2#1)
of two closely##4##3##(1990-12#1)(2008-10#1)(2008-2#1)(2008-8#1)
of two clusters of##3##4##(1994-5#1)(2008-10#2)
of two clusters##4##3##(1994-5#1)(2008-10#2)(2008-11#1)
of two coherent##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
of two cohorts of patients with##2##6##(2012-2#1)(2013-1#1)
of two cohorts of##3##4##(2008-11#1)(2012-2#1)(2013-1#1)
of two cohorts##4##3##(2008-11#1)(2012-2#2)(2013-1#1)
of two collections of##2##4##(2008-10#1)(2008-7#1)
of two commercial##9##3##(1997-8#1)(2005-9#1)(2008-10#4)(2008-3#1)(2011-1#1)(2011-12#1)
of two commercially available##5##4##(1994-9#1)(2007-7#1)(2008-5#2)(2013-1#1)
of two common##6##3##(2007-10#1)(2007-12#1)(2008-10#2)(2008-12#1)(2010-5#1)
of two communities##2##3##(2008-9#1)(2010-4#1)
of two competing##2##3##(2007-12#1)(2008-8#1)
of two complementary##5##3##(1992-6#1)(1995-4#1)(1995-5#1)(1996-7#1)(2005-11#1)
of two complete##2##3##(1994-3#1)(2006-10#1)
of two complexes##4##3##(1992-12#1)(1995-8#2)(2005-4#1)
of two components##6##3##(1992-5#1)(1997-7#1)(2005-4#1)(2008-10#1)(2008-2#1)(2008-8#1)
of two concentric##2##3##(2007-11#1)(2008-2#1)
of two conditions##2##3##(1991-2#1)(1994-5#1)
of two conformational isomers##2##4##(2006-12#2)
of two conformations##3##3##(2005-4#2)(2010-7#1)
of two consecutive##5##3##(1994-8#2)(2007-9#1)(2008-10#2)
of two conserved##2##3##(1995-1#1)(1996-5#1)
of two control##2##3##(1997-4#1)(2008-10#1)
of two conventional##2##3##(2008-2#1)(2008-3#1)
of two copies##2##3##(1994-5#1)(2008-9#1)
of two copper##2##3##(1997-1#1)(2006-8#1)
of two coupled##5##3##(2006-10#2)(2008-3#1)(2009-8#1)(2013-8#1)
of two critical##2##3##(1992-2#1)(2011-2#1)
of two cw##2##3##(2007-12#1)(2008-2#1)
of two cyanine dye films##2##5##(2008-3#2)
of two cyanine##3##3##(2005-11#1)(2008-3#2)
of two cyclic##2##3##(1993-5#1)(2008-10#1)
of two cysteine residues##3##4##(1992-8#1)(1995-2#1)(2009-10#1)
of two day##2##3##(2008-11#1)(2008-12#1)
of two different approaches##2##4##(1996-11#1)(2010-12#1)
of two different extraction methods##2##5##(2008-10#2)
of two different forms of##2##5##(2006-9#1)(2010-5#1)
of two different ligands##3##4##(1995-2#2)(2008-10#1)
of two different polyamines##3##4##(2008-12#3)
of two different proteins##2##4##(1996-7#1)(2008-2#1)
of two different sizes##2##4##(1995-8#1)(2008-6#1)
of two different subunits##3##4##(1991-10#2)(1994-2#1)
of two different thin##2##4##(2009-7#2)
of two different types of##2##5##(1996-10#1)(2007-12#1)
of two different##112##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-7#1)(1991-10#2)(1991-2#1)(1991-3#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-4#1)(1994-11#2)(1994-2#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#3)(1995-8#1)(1996-10#1)(1996-11#2)(1996-2#1)(1996-7#3)(1997-2#1)(2004-1#1)(2004-9#1)(2005-12#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-9#2)(2007-11#2)(2007-12#5)(2007-8#3)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#1)(2009-1#1)(2009-3#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#2)(2012-2#4)(2012-3#1)(2013-7#1)
of two dimensional##2##3##(1997-6#1)(2009-9#1)
of two diode lasers##2##4##(2007-11#1)(2007-12#1)
of two discrete##2##3##(1993-3#1)(2010-12#1)
of two disorders##2##3##(1997-5#1)(2013-1#1)
of two dissimilar##3##3##(1990-2#1)(1993-11#1)(2008-3#1)
of two distinct forms##2##4##(1994-8#1)(1997-4#1)
of two distinct sets of##2##5##(1991-2#1)(1994-12#1)
of two distinct types##2##4##(2006-10#1)(2008-10#1)
of two distinct##42##3##(1990-11#1)(1990-4#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-4#1)(1992-8#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1997-1#1)(1997-4#2)(1997-6#1)(2004-9#1)(2005-8#1)(2006-10#1)(2006-8#2)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-4#1)(2010-6#1)(2013-1#1)(2013-8#1)
of two districts##2##3##(2008-10#1)(2008-3#1)
of two divergent##4##3##(1995-5#1)(1995-8#1)(2008-10#1)(2012-12#1)
of two diverse##2##3##(2008-2#1)(2013-7#1)
of two domains##5##3##(1995-1#1)(1997-3#1)(2007-11#1)(2008-4#1)(2009-10#1)
of two doses of##3##4##(1991-10#1)(1997-1#1)(2012-1#1)
of two doses##4##3##(1991-10#1)(1993-4#1)(1997-1#1)(2012-1#1)
of two drugs##4##3##(1990-5#1)(1994-11#1)(2008-10#1)(2012-12#1)
of two effects##2##3##(2006-10#1)(2008-10#1)
of two experimental##2##3##(1991-10#1)(1994-9#1)
of two experiments##2##3##(2008-10#1)(2008-3#1)
of two factors##3##3##(2006-12#1)(2008-10#2)
of two families of##2##4##(2009-2#1)(2012-1#1)
of two fiber##2##3##(2007-12#1)(2008-3#1)
of two fields##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
of two fish species##2##4##(2012-2#2)
of two fluoquinolones##2##3##(2008-10#2)
of two forms of##9##4##(1991-5#1)(1992-12#1)(1992-6#1)(1994-11#1)(1994-8#1)(1995-5#1)(2008-7#1)(2008-9#2)
of two formulations##2##3##(1993-6#1)(2008-10#1)
of two fragments##2##3##(1997-7#1)(2008-3#1)
of two further##3##3##(1990-5#1)(1991-10#1)(2008-10#1)
of two genes of the##2##5##(1993-11#1)(2008-10#1)
of two genes##10##3##(1990-5#1)(1991-6#1)(1992-2#1)(1993-11#1)(1993-3#1)(1994-3#1)(2007-8#1)(2008-10#2)(2008-4#1)
of two genotypes of##3##4##(2007-1#1)(2008-10#2)
of two genotypes##4##3##(2007-1#1)(2008-10#2)(2011-1#1)
of two glucose##3##3##(1994-12#2)(2006-12#1)
of two group treatments##2##4##(2011-1#2)
of two groups of##7##4##(1991-1#1)(1994-6#1)(1996-8#1)(2007-8#1)(2008-10#1)(2008-4#1)(2013-1#1)
of two groups##16##3##(1990-12#1)(1991-1#1)(1992-2#1)(1994-6#1)(1995-1#1)(1995-6#1)(1996-8#2)(2007-8#1)(2008-10#3)(2008-4#1)(2010-4#1)(2013-1#1)(2013-7#1)
of two high-resolution##3##3##(2008-2#2)(2008-4#1)
of two highly##7##3##(1990-6#1)(1992-5#1)(1995-3#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)
of two histidines##2##3##(1991-2#1)(1991-7#1)
of two homologous##4##3##(1994-12#1)(1997-2#1)(1997-7#2)
of two human##7##3##(1993-5#1)(1993-8#1)(1993-9#1)(1994-6#1)(2008-10#1)(2008-11#1)(2009-2#1)
of two identical subunits of##2##5##(1990-3#1)(1993-3#1)
of two identical subunits##4##4##(1990-3#1)(1991-9#1)(1993-3#1)(2009-8#1)
of two identical##13##3##(1990-2#2)(1990-3#1)(1991-9#1)(1992-6#1)(1993-3#1)(1994-8#1)(1997-2#1)(2007-11#1)(2008-12#1)(2008-2#2)(2009-8#1)
of two immiscible##2##3##(1993-8#1)(2008-10#1)
of two important##5##3##(2007-11#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
of two in##3##3##(1993-5#1)(1996-12#1)(2008-10#1)
of two independent##16##3##(1991-12#1)(1992-5#1)(2005-11#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2012-12#1)(2012-3#1)(2013-1#1)
of two independently##3##3##(1997-7#1)(2008-3#1)(2009-7#1)
of two interacting##2##3##(2009-8#1)(2011-2#1)
of two interspecific##2##3##(2008-10#2)
of two inverted##2##3##(1996-7#1)(2008-8#1)
of two isoforms of a##2##5##(1992-11#1)(1995-2#1)
of two isoforms of the##4##5##(1991-1#1)(1992-8#1)(1994-8#1)(1995-3#1)
of two isoforms of##9##4##(1991-1#1)(1992-11#1)(1992-8#1)(1994-3#2)(1994-8#2)(1995-2#1)(1995-3#1)
of two isoforms##10##3##(1991-1#1)(1992-1#1)(1992-11#1)(1992-8#1)(1994-3#2)(1994-8#2)(1995-2#1)(1995-3#1)
of two isolates of##2##4##(2008-10#1)(2011-12#1)
of two isolates##6##3##(2008-10#5)(2011-12#1)
of two isomers##3##3##(2006-1#1)(2008-10#2)
of two kinds of##7##4##(1996-8#1)(1997-7#1)(2005-4#1)(2006-10#1)(2008-11#1)(2008-8#1)(2010-11#1)
of two kinds##8##3##(1996-8#1)(1997-7#1)(2005-4#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-8#1)(2010-11#1)
of two known##2##3##(1990-1#1)(1994-12#1)
of two large##3##3##(1994-12#1)(1997-4#1)(2009-3#1)
of two layers of##3##4##(2008-10#2)(2008-2#1)
of two layers##5##3##(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)
of two ligands##2##3##(2008-10#2)
of two lignin##2##3##(1990-2#1)(2008-11#1)
of two low##3##3##(1991-8#1)(2007-3#1)(2011-2#1)
of two main components##2##4##(2006-6#1)(2008-1#1)
of two main##7##3##(2006-6#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-5#1)
of two major##12##3##(1990-8#1)(1991-2#1)(1994-8#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-4#1)(2009-8#1)(2011-2#1)(2012-2#1)
of two mechanisms##4##3##(1993-6#1)(2008-7#1)(2010-5#1)(2012-2#1)
of two members of the##5##5##(1991-6#1)(1995-2#1)(1996-5#1)(2012-12#2)
of two members of##6##4##(1991-6#1)(1995-2#1)(1996-5#1)(1996-8#1)(2012-12#2)
of two metabolites##2##3##(1995-3#1)(2008-10#1)
of two metal##2##3##(2008-10#2)
of two methods in##2##4##(2011-12#1)(2013-7#1)
of two methods##12##3##(1997-2#1)(2004-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-11#1)(2010-2#1)(2011-12#1)(2011-2#1)(2013-7#1)
of two mirrors##2##3##(2008-2#1)(2008-3#1)
of two missense##2##3##(1995-8#1)(1997-7#1)
of two model##3##3##(2004-4#1)(2005-11#1)(2013-7#1)
of two models##2##3##(2007-11#1)(2007-2#1)
of two modes of##3##4##(1990-9#1)(2008-2#1)(2008-8#1)
of two molecular##3##3##(2008-11#1)(2008-4#1)(2012-12#1)
of two molecules of collagenase##2##5##(1992-2#2)
of two molecules of##5##4##(1990-11#1)(1992-2#2)(1992-3#1)(1994-9#1)
of two molecules##6##3##(1990-11#1)(1990-3#1)(1992-2#2)(1992-3#1)(1994-9#1)
of two monoclonal antibodies##4##4##(1990-12#1)(1992-2#1)(1994-5#1)(1996-9#1)
of two months duration##2##4##(2008-7#1)(2009-2#1)
of two months##9##3##(1991-4#1)(1995-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-11#1)(2009-2#1)(2010-4#1)(2013-1#1)
of two mosquito##2##3##(2007-5#1)(2008-5#1)
of two mutually##3##3##(2007-11#1)(2008-11#1)(2008-8#1)
of two neighboring##2##3##(2007-11#1)(2008-3#1)
of two new##21##3##(1992-2#1)(1992-6#1)(1993-6#1)(1993-8#1)(1996-2#1)(1997-7#2)(2005-8#1)(2006-12#1)(2007-1#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-12#1)
of two newly##2##3##(1991-2#1)(2012-2#1)
of two nonidentical subunits##3##4##(1992-4#1)(1992-9#1)(2008-8#1)
of two normally##2##3##(1990-10#1)(2007-11#1)
of two novel##12##3##(1990-4#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-3#1)(2007-10#1)(2007-11#2)(2008-10#1)(2008-9#2)(2011-2#1)
of two nuclear##4##3##(1990-11#1)(1995-2#1)(1996-5#1)(2004-1#1)
of two of the major##2##5##(1995-7#1)(2008-10#1)
of two of the##11##4##(1990-3#1)(1993-6#1)(1993-9#1)(1995-6#1)(1995-7#1)(2006-8#1)(2007-9#1)(2008-10#3)(2008-8#1)
of two of these##6##4##(1990-12#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-3#1)(2012-11#1)
of two of##19##3##(1990-12#1)(1990-3#1)(1993-6#1)(1993-9#1)(1995-6#2)(1995-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-8#1)(2012-11#1)
of two or more##25##4##(1991-1#1)(1991-12#1)(1992-12#1)(1992-7#1)(1993-11#1)(1993-2#1)(1994-5#1)(1995-10#1)(1995-4#1)(1997-2#1)(1997-4#1)(2006-10#1)(2006-5#1)(2006-8#1)(2008-10#2)(2008-3#3)(2008-4#2)(2009-5#1)(2010-1#1)(2010-8#1)(2011-2#1)
of two or##31##3##(1991-1#1)(1991-12#1)(1992-12#1)(1992-7#1)(1993-11#1)(1993-2#1)(1994-5#1)(1995-10#1)(1995-11#2)(1995-4#1)(1997-2#1)(1997-4#1)(2006-10#2)(2006-5#1)(2006-8#1)(2008-10#3)(2008-3#3)(2008-4#2)(2009-5#1)(2010-1#1)(2010-8#1)(2011-2#2)(2012-2#1)
of two orchid viruses##3##4##(2008-10#3)
of two orders of magnitude##3##5##(2008-10#3)
of two organic##2##3##(1996-5#1)(2006-3#1)
of two orthogonal##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
of two other##14##3##(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-12#1)(1996-4#1)(1997-2#1)(2007-8#1)(2009-4#1)
of two overlapping##2##3##(1991-5#1)(1996-10#1)
of two pairs of##3##4##(2007-1#1)(2007-12#1)(2008-10#1)
of two parallel##3##3##(2005-9#1)(2008-2#1)(2011-1#1)
of two parental##2##3##(1994-8#1)(2008-9#1)
of two partially##2##3##(2008-2#1)(2009-6#1)
of two particles##2##3##(2005-11#1)(2008-3#1)
of two parts##10##3##(1993-1#1)(2006-7#1)(2008-2#2)(2008-7#1)(2008-9#1)(2013-1#4)
of two patients who##3##4##(1997-8#1)(2008-6#1)(2012-12#1)
of two patients with##6##4##(1996-9#1)(2008-10#1)(2008-5#1)(2010-7#1)(2012-12#1)(2013-1#1)
of two patients##16##3##(1990-3#1)(1992-5#1)(1996-9#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-7#1)(2011-2#2)(2012-11#1)(2012-12#3)(2013-1#1)
of two peaks##4##3##(1990-8#2)(1991-12#1)(2011-1#1)
of two peptide##3##3##(1992-10#1)(1994-11#1)(2008-10#1)
of two peptides##2##3##(1993-6#1)(1995-6#1)
of two perpendicular##2##3##(1990-9#1)(2008-3#1)
of two phase##2##3##(1994-9#1)(2007-12#1)
of two phases##8##3##(1996-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2011-2#1)(2012-11#1)
of two phenolic##2##3##(2008-10#1)(2011-1#1)
of two phosphoproteins##2##3##(1990-11#1)(1994-11#1)
of two physically##3##3##(2005-11#1)(2008-11#1)(2009-12#1)
of two plane waves##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
of two plane##5##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
of two plant##2##3##(1994-3#2)
of two point##3##3##(2008-2#2)(2008-3#1)
of two polypeptides##2##3##(1994-5#1)(1994-8#1)
of two populations of##3##4##(1993-5#1)(2008-4#1)(2008-5#1)
of two populations##4##3##(1993-5#1)(2008-12#1)(2008-4#1)(2008-5#1)
of two potential##4##3##(1991-9#1)(1994-11#1)(2008-10#1)(2008-7#1)
of two previously##2##3##(2008-10#1)(2013-1#1)
of two processes##5##3##(2005-11#1)(2006-10#1)(2007-8#1)(2008-10#1)(2012-2#1)
of two protein##3##3##(1991-2#1)(1993-3#1)(1997-4#1)
of two proteins##10##3##(1990-6#1)(1990-8#1)(1991-10#1)(1992-9#1)(1993-12#1)(1995-10#1)(1995-3#1)(1996-11#1)(2008-4#1)(2010-12#1)
of two protons##3##3##(1991-9#1)(1994-10#1)(1994-9#1)
of two putative##6##3##(1992-3#1)(1992-9#2)(1993-9#1)(1994-12#1)(1996-5#1)
of two rabbit##2##3##(1991-2#1)(1994-12#1)
of two reading interventions##2##4##(2004-10#2)
of two recent##3##3##(1991-4#1)(2007-9#1)(2008-2#1)
of two recently##4##3##(1995-3#1)(1997-4#1)(2008-3#1)(2013-1#1)
of two receptor##2##3##(1991-8#1)(1992-5#1)
of two recombinant##2##3##(1995-1#1)(2006-10#1)
of two related##3##3##(1992-1#1)(1993-12#1)(2008-7#1)
of two representative##2##3##(2008-10#2)
of two residues##2##3##(1991-2#1)(1993-8#1)
of two resin based fissure sealants##2##6##(2012-12#2)
of two resin##4##3##(2004-9#1)(2009-8#1)(2012-12#2)
of two restriction##2##3##(1990-12#1)(2008-2#1)
of two rice##2##3##(1997-8#1)(2008-10#1)
of two sample##4##3##(1992-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
of two samples##2##3##(1993-1#1)(2008-10#1)
of two second-order##2##3##(2007-11#1)(2008-6#1)
of two segments##2##3##(1993-3#1)(1997-6#1)
of two sensory##2##3##(1993-12#1)(2008-7#1)
of two separate##15##3##(1992-1#1)(1992-6#2)(1992-8#1)(1994-12#1)(1995-5#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-9#1)(2009-3#1)(2011-2#1)(2012-1#1)(2012-2#1)
of two series of##4##4##(1995-3#1)(1997-7#1)(2005-11#1)(2008-10#1)
of two sets of##5##4##(1992-5#1)(1996-2#1)(2007-5#1)(2008-3#1)(2008-7#1)
of two similar##3##3##(1991-11#1)(1995-2#1)(2008-11#1)
of two single-mode##2##3##(2007-11#1)(2008-3#1)
of two sites##3##3##(1992-6#1)(1997-3#1)(2011-1#1)
of two small##2##3##(1994-12#1)(1994-5#1)
of two spatial##2##3##(2008-10#1)(2008-8#1)
of two spatially##2##3##(2007-12#1)(2008-10#1)
of two species of##14##4##(1991-10#1)(1994-6#1)(2005-11#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-8#2)(2013-1#1)
of two species##20##3##(1991-10#1)(1994-6#1)(1997-6#1)(2005-11#1)(2007-12#2)(2007-5#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-8#2)(2013-1#1)(2013-7#1)
of two specific##5##3##(1994-11#1)(2007-8#1)(2008-3#1)(2008-5#1)(2011-1#1)
of two splice##2##3##(1992-3#1)(2013-8#1)
of two standard reference materials##3##5##(2005-4#1)(2008-10#2)
of two states of##2##4##(1997-4#1)(2011-1#1)
of two steps##2##3##(2005-11#1)(2008-3#1)
of two stocks of the##2##5##(2010-8#2)
of two strains of##9##4##(1997-3#2)(2006-10#1)(2008-10#2)(2008-6#1)(2008-8#1)(2013-8#2)
of two streams of##2##4##(1996-1#1)(2008-10#1)
of two structurally##3##3##(1992-5#1)(2008-10#1)(2008-7#1)
of two structures##2##3##(2008-5#1)(2010-6#1)
of two studies##5##3##(2006-10#1)(2008-12#1)(2008-2#1)(2011-2#1)(2013-1#1)
of two subgroups##2##3##(2008-10#1)(2008-5#1)
of two subunits of##3##4##(1990-3#1)(1992-2#1)(1995-6#1)
of two subunits##9##3##(1990-1#2)(1990-3#1)(1992-2#1)(1993-11#1)(1995-6#1)(1995-8#1)(2008-1#1)(2012-12#1)
of two such##2##3##(2007-12#1)(2008-11#1)
of two surface##3##3##(1992-12#1)(2008-3#1)(2008-6#1)
of two surgical##2##3##(2009-6#1)(2011-2#1)
of two synchronized##2##3##(2007-11#1)(2008-3#1)
of two synthetic##2##3##(2008-5#2)
of two systems##2##3##(1990-8#1)(2007-8#1)
of two tandem##3##3##(1991-9#1)(1994-12#1)(2008-9#1)
of two techniques##4##3##(2005-10#1)(2007-11#1)(2008-10#1)(2008-6#1)
of two terms##3##3##(2005-11#1)(2008-2#1)(2008-3#1)
of two test##3##3##(1994-5#1)(1997-3#1)(2007-7#1)
of two tissue##3##3##(2006-6#1)(2008-5#1)(2012-2#1)
of two to three##3##4##(1991-12#1)(1992-1#1)(1996-8#1)
of two to##5##3##(1991-12#1)(1992-1#1)(1996-8#1)(2008-10#1)(2008-6#1)
of two tones##3##3##(1995-12#1)(2008-4#1)(2013-8#1)
of two treatment##4##3##(1992-3#1)(2007-8#1)(2008-5#1)(2012-2#1)
of two treatments##4##3##(1995-2#1)(1995-9#1)(1996-7#1)(2008-9#1)
of two types of##36##4##(1990-12#1)(1991-4#1)(1991-5#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1995-1#1)(1995-11#1)(1996-3#1)(1996-7#1)(2005-11#1)(2005-12#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#3)(2009-3#1)(2010-2#1)(2010-9#1)(2012-1#1)(2012-2#1)(2013-7#1)
of two types##42##3##(1990-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1995-1#1)(1995-11#1)(1996-3#1)(1996-7#1)(1996-9#1)(2005-11#1)(2005-12#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-9#1)(2009-3#1)(2010-2#1)(2010-9#1)(2012-1#1)(2012-2#1)(2013-7#1)
of two typical##2##3##(2005-11#1)(2008-9#1)
of two unrelated##2##3##(1990-8#1)(1994-12#1)
of two values##2##3##(1991-6#1)(2008-11#1)
of two variants of##2##4##(1990-7#1)(2012-1#1)
of two viruses that##2##4##(2008-10#2)
of two viruses##3##3##(1995-2#1)(2008-10#2)
of two visible##2##3##(2006-10#1)(2007-12#1)
of two wavelengths are##2##4##(2008-2#1)(2008-3#1)
of two wavelengths##6##3##(2008-2#1)(2008-3#5)
of two ways##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
of two weeks##11##3##(1990-6#1)(1990-9#1)(1991-12#1)(1992-2#1)(1993-5#1)(1995-8#1)(1996-1#1)(2008-4#1)(2008-8#1)(2010-2#2)
of two wheat##2##3##(2008-12#1)(2008-8#1)
of two years of therapy##2##5##(2008-1#2)
of two years of##4##4##(2007-7#1)(2008-1#2)(2012-3#1)
of two years##14##3##(1991-12#1)(1993-1#1)(1995-5#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-5#2)(2012-2#1)(2012-3#1)(2013-8#1)
of two zinc##2##3##(1994-11#1)(2008-3#1)
of two##2231##2##(1990-1#3)(1990-10#5)(1990-11#6)(1990-12#18)(1990-2#9)(1990-3#13)(1990-4#9)(1990-5#11)(1990-6#7)(1990-7#10)(1990-8#12)(1990-9#5)(1991-1#7)(1991-10#10)(1991-11#4)(1991-12#14)(1991-2#15)(1991-3#4)(1991-4#3)(1991-5#13)(1991-6#5)(1991-7#6)(1991-8#7)(1991-9#8)(1992-1#6)(1992-10#4)(1992-11#5)(1992-12#9)(1992-2#13)(1992-3#9)(1992-4#5)(1992-5#9)(1992-6#14)(1992-7#3)(1992-8#10)(1992-9#12)(1993-1#8)(1993-10#1)(1993-11#11)(1993-12#9)(1993-2#5)(1993-3#10)(1993-4#3)(1993-5#7)(1993-6#10)(1993-7#5)(1993-8#9)(1993-9#6)(1994-10#6)(1994-11#18)(1994-12#20)(1994-2#6)(1994-3#16)(1994-4#2)(1994-5#14)(1994-6#11)(1994-8#21)(1994-9#13)(1995-1#10)(1995-10#4)(1995-11#9)(1995-12#2)(1995-2#16)(1995-3#17)(1995-4#4)(1995-5#12)(1995-6#8)(1995-7#2)(1995-8#11)(1995-9#1)(1996-1#3)(1996-10#7)(1996-11#5)(1996-12#1)(1996-2#9)(1996-3#5)(1996-4#7)(1996-5#14)(1996-6#5)(1996-7#14)(1996-8#6)(1996-9#6)(1997-1#5)(1997-2#13)(1997-3#16)(1997-4#17)(1997-5#2)(1997-6#12)(1997-7#24)(1997-8#7)(2004-1#2)(2004-10#2)(2004-11#1)(2004-4#4)(2004-9#5)(2005-10#8)(2005-11#25)(2005-12#2)(2005-2#1)(2005-4#10)(2005-7#1)(2005-8#4)(2005-9#3)(2006-1#2)(2006-10#21)(2006-11#2)(2006-12#23)(2006-2#5)(2006-3#2)(2006-4#4)(2006-5#3)(2006-6#5)(2006-7#4)(2006-8#17)(2006-9#5)(2007-1#8)(2007-10#4)(2007-11#47)(2007-12#95)(2007-2#9)(2007-3#3)(2007-5#7)(2007-6#2)(2007-7#12)(2007-8#26)(2007-9#11)(2008-1#15)(2008-10#246)(2008-11#40)(2008-12#29)(2008-2#71)(2008-3#100)(2008-4#29)(2008-5#56)(2008-6#18)(2008-7#28)(2008-8#35)(2008-9#32)(2009-1#1)(2009-10#7)(2009-11#4)(2009-12#5)(2009-2#6)(2009-3#6)(2009-4#9)(2009-5#3)(2009-6#2)(2009-7#3)(2009-8#16)(2009-9#5)(2010-1#2)(2010-11#2)(2010-12#6)(2010-2#7)(2010-3#1)(2010-4#9)(2010-5#7)(2010-6#4)(2010-7#5)(2010-8#10)(2010-9#2)(2011-1#21)(2011-12#7)(2011-2#36)(2011-3#1)(2012-1#13)(2012-11#5)(2012-12#24)(2012-2#41)(2012-3#10)(2012-5#1)(2013-1#48)(2013-7#11)(2013-8#19)
of two- and three-dimensional##2##4##(2008-2#1)(2008-3#1)
of two- and##4##3##(2008-2#1)(2008-3#2)(2010-4#1)
of two-##6##2##(1995-12#1)(1995-4#1)(2008-2#1)(2008-3#2)(2010-4#1)
of two-beam##2##2##(2007-12#1)(2008-3#1)
of two-chain FVIII gene##2##4##(2012-3#2)
of two-chain##4##2##(1990-11#1)(1991-1#1)(2012-3#2)
of two-color##10##2##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-8#1)
of two-component##3##2##(1995-1#1)(1997-4#1)(2008-3#1)
of two-dimensional (2D)##6##3##(1991-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#2)
of two-dimensional arrays##2##3##(2008-3#1)(2008-4#1)
of two-dimensional echocardiography##2##3##(2007-8#1)(2011-2#1)
of two-dimensional gel electrophoresis##2##4##(1993-9#1)(2008-7#1)
of two-dimensional gel##3##3##(1990-7#1)(1993-9#1)(2008-7#1)
of two-dimensional images##4##3##(1992-9#1)(2007-12#1)(2008-2#2)
of two-dimensional patterns##2##3##(1996-4#1)(2008-7#1)
of two-dimensional phase##2##3##(2008-3#2)
of two-dimensional photonic crystal slabs##2##5##(2007-12#1)(2008-7#1)
of two-dimensional strain distributions##2##4##(2008-2#2)
of two-dimensional##66##2##(1990-11#1)(1990-7#1)(1991-4#1)(1992-1#1)(1992-9#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-7#1)(1996-2#2)(1996-4#1)(1996-7#1)(1997-6#1)(2005-11#2)(2006-10#1)(2007-11#1)(2007-12#9)(2007-3#1)(2007-8#1)(2008-1#1)(2008-2#11)(2008-3#15)(2008-4#2)(2008-7#3)(2011-2#1)
of two-layered turbid media##2##4##(2008-2#2)
of two-level##2##2##(2007-12#2)
of two-photon absorption and##2##4##(2007-11#1)(2007-12#1)
of two-photon absorption coefficients for CdSe and GaSe##2##8##(2008-3#2)
of two-photon absorption in a photorefractive crystal for##2##8##(2007-12#2)
of two-photon absorption in a##4##5##(2007-11#2)(2007-12#2)
of two-photon absorption in##5##4##(2007-11#2)(2007-12#2)(2008-2#1)
of two-photon absorption##11##3##(2007-11#5)(2007-12#3)(2008-2#1)(2008-3#2)
of two-photon excitation##10##3##(2007-11#3)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)(2011-1#2)
of two-photon excited fluorescence (TPF)##2##5##(2008-10#1)(2008-3#1)
of two-photon excited##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
of two-photon fluorescence imaging through a scattering medium##2##8##(2008-2#2)
of two-photon fluorescence##4##3##(2008-2#2)(2008-3#2)
of two-photon##31##2##(2007-11#10)(2007-12#4)(2008-1#2)(2008-10#1)(2008-2#4)(2008-3#8)(2011-1#2)
of two-photon-excited fluorescence (TPF)##2##4##(2008-2#1)(2008-3#1)
of two-photon-excited fluorescence##3##3##(2008-2#2)(2008-3#1)
of two-photon-excited##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
of two-photon-induced##2##2##(2008-1#1)(2008-3#1)
of two-stage repair##3##3##(2008-10#1)(2009-5#2)
of two-stage##7##2##(2007-8#1)(2008-10#3)(2008-8#1)(2009-5#2)
of two-state##3##2##(1992-9#1)(1996-11#1)(2008-7#1)
of two-step adsorption kinetics on##2##5##(2005-11#2)
of two-step##4##2##(2005-11#2)(2010-6#1)(2012-2#1)
of two-stranded##2##2##(1995-4#1)(1995-6#1)
of two-wave mixing##2##3##(2007-12#1)(2008-1#1)
of two-wave##4##2##(2007-12#2)(2008-1#1)(2008-2#1)
of two-way##3##2##(2008-10#1)(2010-8#1)(2011-1#1)
of tyloses##2##2##(2008-10#2)
of tymoviruses##2##2##(2008-10#2)
of tympanic membrane##2##3##(2009-7#1)(2012-8#1)
of type 1 allergy##2##4##(2007-2#2)
of type 1 and##2##4##(2006-3#1)(2011-1#1)
of type 1 collagen##2##4##(2007-3#2)
of type 1 diabetes mellitus##5##5##(1990-6#1)(2006-1#1)(2007-5#1)(2008-1#1)(2008-10#1)
of type 1 diabetes##24##4##(1990-6#1)(1991-3#2)(1993-11#1)(2005-10#2)(2006-1#1)(2007-5#9)(2008-1#3)(2008-10#1)(2008-3#1)(2010-5#1)(2011-1#1)(2011-2#1)
of type 1 protein phosphatase##2##5##(1993-6#1)(1993-7#1)
of type 1##49##3##(1990-6#1)(1990-7#1)(1991-3#2)(1992-6#2)(1993-11#1)(1993-6#3)(1993-7#1)(1994-4#1)(1995-6#1)(1996-10#1)(2004-2#1)(2005-10#3)(2006-1#1)(2006-3#1)(2007-11#1)(2007-2#2)(2007-3#2)(2007-5#9)(2008-1#3)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-4#1)
of type 2 and##2##4##(1994-2#1)(2008-10#1)
of type 2 cytokines##3##4##(2005-10#3)
of type 2 diabetes (T2D) and##2##6##(2008-1#1)(2013-8#1)
of type 2 diabetes (T2D)##3##5##(2008-1#1)(2009-3#1)(2013-8#1)
of type 2 diabetes and coronary heart disease##2##8##(2008-10#1)(2012-2#1)
of type 2 diabetes and##10##5##(2005-10#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-4#1)(2012-2#1)(2013-1#1)
of type 2 diabetes in an##2##6##(2008-11#1)(2008-5#1)
of type 2 diabetes in##11##5##(1994-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
of type 2 diabetes mellitus (T2DM)##4##6##(2008-1#1)(2008-3#1)(2009-11#1)(2009-9#1)
of type 2 diabetes mellitus and metabolic syndrome##2##8##(2008-1#1)(2008-3#1)
of type 2 diabetes mellitus and##5##6##(2008-1#1)(2008-3#1)(2008-5#1)(2012-2#2)
of type 2 diabetes mellitus in##3##6##(2008-1#1)(2008-3#1)(2009-7#1)
of type 2 diabetes mellitus is##2##6##(2008-1#1)(2008-3#1)
of type 2 diabetes mellitus##30##5##(2006-12#1)(2007-5#1)(2008-1#7)(2008-10#1)(2008-3#8)(2008-5#1)(2009-11#1)(2009-7#1)(2009-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-7#1)
of type 2 diabetes patients##2##5##(2011-2#1)(2013-7#1)
of type 2 diabetes##93##4##(1992-5#3)(1994-12#1)(1994-4#1)(1996-11#1)(2005-10#2)(2006-10#1)(2006-12#1)(2006-2#2)(2007-5#3)(2008-1#21)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#15)(2008-4#1)(2008-5#3)(2008-7#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-4#1)(2010-8#2)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
of type 2 diabetic patients##3##5##(2005-10#1)(2006-2#1)(2009-8#1)
of type 2 diabetic##5##4##(2005-10#1)(2006-2#1)(2008-1#2)(2009-8#1)
of type 2 lepra reaction##3##5##(2009-5#3)
of type 2##112##3##(1992-5#3)(1994-12#1)(1994-2#1)(1994-4#1)(1995-6#1)(1996-11#1)(2005-10#7)(2006-10#1)(2006-12#1)(2006-2#3)(2006-9#1)(2007-5#3)(2008-1#23)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#15)(2008-4#1)(2008-5#3)(2008-7#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
of type 2A protein phosphatase in rat brain##2##8##(1991-4#2)
of type 2A protein phosphatase##3##5##(1991-4#2)(1995-5#1)
of type 2A##4##3##(1991-4#2)(1993-12#1)(1995-5#1)
of type 3##2##3##(1994-2#1)(1995-6#1)
of type 4##2##3##(1995-6#1)(2007-11#1)
of type A aortic##2##4##(2007-8#2)
of type A##7##3##(1990-5#2)(1994-2#1)(2007-8#2)(2013-1#2)
of type B##7##3##(1995-9#1)(1997-6#2)(2008-10#2)(2008-7#1)(2009-5#1)
of type E##2##3##(1990-5#1)(2006-5#1)
of type I and type II receptors##2##7##(1994-11#1)(1996-5#1)
of type I and type II##4##6##(1994-11#1)(1996-5#1)(2005-10#1)(2010-2#1)
of type I and##6##4##(1991-1#1)(1994-11#1)(1994-5#1)(1996-5#1)(2005-10#1)(2010-2#1)
of type I collagen in##3##5##(1995-6#1)(1996-4#1)(2008-9#1)
of type I collagen##17##4##(1995-5#1)(1995-6#1)(1996-4#4)(1996-7#1)(1997-1#2)(1997-8#1)(2005-11#1)(2008-1#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-3#1)
of type I diabetes##2##4##(1993-12#1)(2008-9#1)
of type I endoleaks##2##4##(2007-8#2)
of type I error##5##4##(2008-10#3)(2012-3#1)(2013-1#1)
of type I integral membrane proteins##2##6##(1995-3#1)(2008-8#1)
of type I interferon##2##4##(2010-2#1)(2011-1#1)
of type I iodothyronine 5'-deiodinase##2##5##(1990-12#2)
of type I von##2##4##(1990-11#2)
of type I##62##3##(1990-11#2)(1990-12#2)(1991-1#2)(1991-10#2)(1991-6#1)(1992-11#1)(1992-8#1)(1993-11#2)(1993-12#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-7#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-10#1)(1996-4#4)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-11#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-3#1)(2010-2#2)(2011-1#1)(2012-3#1)(2013-1#1)
of type IA##2##3##(2011-2#1)(2013-7#1)
of type II DM##5##4##(2007-2#5)
of type II and type##2##5##(2006-10#1)(2008-11#1)
of type II diabetes mellitus (DM)##2##6##(2007-2#2)
of type II diabetes mellitus##4##5##(1996-11#1)(2007-2#2)(2008-7#1)
of type II diabetes##7##4##(1991-5#1)(1996-11#1)(1996-9#1)(2007-2#2)(2008-7#1)(2012-1#1)
of type II procollagen in##2##5##(1994-8#1)(1997-2#1)
of type II procollagen##3##4##(1994-8#2)(1997-2#1)
of type II##39##3##(1991-12#1)(1991-5#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-8#4)(1996-11#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-4#1)(2006-10#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-2#7)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-1#1)
of type III procollagen##3##4##(1991-1#1)(1993-6#1)(2006-2#1)
of type III##13##3##(1991-1#2)(1991-4#1)(1991-7#1)(1992-2#4)(1993-6#1)(2006-2#1)(2007-2#1)(2010-4#1)(2013-8#1)
of type IV Ehlers-Danlos syndrome##2##5##(2004-10#2)
of type IV collagen in the##2##6##(1994-7#2)
of type IV collagen in##3##5##(1994-7#2)(2010-11#1)
of type IV collagen##5##4##(1991-9#1)(1994-7#3)(2010-11#1)
of type IV collagenase##3##4##(2008-11#1)(2008-8#2)
of type IV##13##3##(1991-9#1)(1993-9#1)(1994-7#3)(2004-10#2)(2008-11#1)(2008-8#2)(2010-11#1)(2010-4#1)(2011-3#1)
of type VII collagen##4##4##(1991-10#1)(1992-3#3)
of type VIII collagen##2##4##(1990-8#2)
of type and##2##3##(2007-12#1)(2007-7#1)
of type of##8##3##(1994-3#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-9#1)(2010-2#1)(2012-3#1)
of type##355##2##(1990-11#2)(1990-12#3)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#4)(1991-10#3)(1991-12#1)(1991-3#2)(1991-4#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#4)(1992-3#3)(1992-5#3)(1992-6#2)(1992-8#1)(1993-11#3)(1993-12#4)(1993-3#1)(1993-6#4)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#2)(1994-4#2)(1994-5#4)(1994-7#4)(1994-8#4)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#5)(1995-7#1)(1995-9#1)(1996-10#2)(1996-11#2)(1996-12#1)(1996-4#4)(1996-5#1)(1996-7#2)(1996-9#2)(1997-1#2)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-10#2)(2004-2#1)(2005-10#11)(2005-11#1)(2005-12#1)(2006-1#1)(2006-10#2)(2006-12#2)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-11#4)(2007-12#5)(2007-2#10)(2007-3#2)(2007-5#12)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#28)(2008-10#17)(2008-11#5)(2008-12#2)(2008-3#16)(2008-4#2)(2008-5#6)(2008-7#6)(2008-8#5)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#7)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#4)(2011-2#10)(2011-3#2)(2012-1#3)(2012-12#4)(2012-2#6)(2012-3#3)(2012-4#1)(2013-1#5)(2013-7#3)(2013-8#4)
of types of##6##3##(2008-10#1)(2008-11#1)(2008-9#1)(2009-9#1)(2012-1#1)(2012-2#1)
of types##16##2##(1990-12#1)(1991-4#1)(1993-9#1)(1994-9#1)(1997-6#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-4#1)(2009-9#1)(2012-1#1)(2012-2#1)
of typhoid by##2##3##(2007-2#2)
of typhoid##11##2##(2004-9#1)(2006-1#1)(2007-2#9)
of typical and atypical##3##4##(1990-5#1)(1996-12#1)(2011-1#1)
of typical and##6##3##(1990-5#1)(1994-9#1)(1996-12#1)(2008-10#1)(2011-1#1)(2011-2#1)
of typical imaging features##2##4##(2012-3#1)(2013-8#1)
of typical symptoms##2##3##(2009-4#1)(2009-9#1)
of typical##53##2##(1990-3#1)(1990-5#2)(1992-4#1)(1992-6#1)(1994-1#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-2#1)(2004-12#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
of typically developing##3##3##(2009-4#1)(2011-2#1)(2012-1#1)
of typically##5##2##(2008-3#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-12#1)
of tyramine oxidase##2##3##(2009-9#2)
of tyramine##3##2##(1997-6#1)(2009-9#2)
of tyrosinase activity##2##3##(1992-3#2)
of tyrosinase and DOPA auto-oxidation##2##5##(2008-5#2)
of tyrosinase and##4##3##(1995-2#1)(2008-5#3)
of tyrosinase enzyme##2##3##(2008-10#1)(2008-5#1)
of tyrosinase##21##2##(1991-7#1)(1992-3#2)(1995-2#1)(1995-8#1)(2006-12#1)(2007-10#1)(2007-9#1)(2008-10#5)(2008-5#6)(2013-1#2)
of tyrosine 252##3##3##(2008-4#3)
of tyrosine aminotransferase (TAT)##2##4##(1994-12#1)(1997-4#1)
of tyrosine aminotransferase##5##3##(1991-2#2)(1994-12#2)(1997-4#1)
of tyrosine and##2##3##(1991-7#1)(1995-3#1)
of tyrosine by##2##3##(1990-5#1)(2008-5#1)
of tyrosine hydroxylase (TH) mRNA##3##5##(1990-12#1)(1993-8#1)(1997-2#1)
of tyrosine hydroxylase (TH)##6##4##(1990-12#1)(1992-8#1)(1993-8#1)(1997-2#1)(1997-5#1)(2008-10#1)
of tyrosine hydroxylase immunoreactivity##3##4##(1990-5#1)(1994-2#1)(1995-11#1)
of tyrosine hydroxylase##18##3##(1990-12#1)(1990-5#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-8#2)(1994-2#1)(1995-11#2)(1995-7#2)(1996-9#1)(1997-2#1)(1997-5#3)(2008-10#1)
of tyrosine hydroxylase-immunoreactive##3##3##(1996-1#1)(1996-5#1)(1996-6#1)
of tyrosine hydroxylase-positive##3##3##(1996-1#1)(1997-6#1)(2008-3#1)
of tyrosine kinase activity##4##4##(1994-8#1)(1994-9#2)(2008-3#1)
of tyrosine kinase inhibitors##2##4##(2010-12#1)(2012-2#1)
of tyrosine kinase##13##3##(1992-3#1)(1994-3#1)(1994-8#2)(1994-9#2)(1995-2#1)(1996-5#1)(2008-3#1)(2010-12#1)(2011-2#2)(2012-2#1)
of tyrosine kinases##10##3##(1992-12#2)(1993-7#1)(1993-8#1)(1994-6#1)(1995-6#1)(1997-3#1)(2005-8#1)(2006-6#1)(2013-1#1)
of tyrosine on##2##3##(1997-2#2)
of tyrosine phosphorylated proteins##2##4##(1990-7#1)(1993-6#1)
of tyrosine phosphorylated##3##3##(1990-7#1)(1993-3#1)(1993-6#1)
of tyrosine phosphorylation and activation of##2##6##(1995-3#1)(1996-5#1)
of tyrosine phosphorylation and##4##4##(1994-6#2)(1995-3#1)(1996-5#1)
of tyrosine phosphorylation in the##4##5##(1994-12#1)(1994-6#1)(1995-5#1)(2010-8#1)
of tyrosine phosphorylation in##10##4##(1990-3#1)(1991-12#1)(1992-3#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-5#1)(2008-4#1)(2010-8#1)(2012-3#1)
of tyrosine phosphorylation##22##3##(1990-11#1)(1990-3#1)(1991-1#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-12#1)(1994-6#3)(1994-9#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-2#2)(1996-5#1)(2008-4#1)(2010-8#1)(2012-3#1)
of tyrosine protein kinases##2##4##(1991-5#1)(1992-8#1)
of tyrosine protein##3##3##(1991-5#1)(1992-8#1)(2008-4#1)
of tyrosine residue##2##3##(1995-11#1)(1996-6#1)
of tyrosine residues of##6##4##(1990-3#1)(1990-5#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)
of tyrosine residues##11##3##(1990-3#2)(1990-5#1)(1997-9#1)(2005-7#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#2)(2012-3#1)
of tyrosine sulfate in##7##4##(1990-3#7)
of tyrosine##124##2##(1990-11#1)(1990-12#1)(1990-3#10)(1990-5#5)(1990-7#2)(1991-1#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-7#2)(1992-12#5)(1992-3#3)(1992-8#2)(1993-12#2)(1993-3#2)(1993-6#1)(1993-7#1)(1993-8#3)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#4)(1994-8#2)(1994-9#4)(1995-11#3)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#2)(1996-1#2)(1996-2#2)(1996-5#3)(1996-6#2)(1996-9#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#1)(1997-9#1)(2005-7#1)(2005-8#1)(2006-11#1)(2006-6#1)(2008-1#1)(2008-10#4)(2008-3#2)(2008-4#6)(2008-5#2)(2008-7#1)(2008-8#2)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
of tyrosine-63 in the catalytic action of human lysozyme##2##9##(1992-9#2)
of tyrosine-phosphorylated##3##2##(1995-1#1)(1995-3#1)(2008-4#1)
of tyrosines##3##2##(1991-1#1)(1992-12#2)
of tyrosyl##5##2##(1990-7#1)(1997-7#1)(2008-1#1)(2008-2#1)(2008-8#1)
of u-PA with##2##3##(1990-11#1)(2008-11#1)
of u-PA##7##2##(1990-11#2)(1991-1#1)(1993-3#1)(1993-4#1)(1996-9#1)(2008-11#1)
of uPA##6##2##(1990-12#2)(1997-7#3)(2008-11#1)
of uPAR##2##2##(1995-5#1)(1997-7#1)
of ubiquinol##2##2##(1994-5#1)(1997-6#1)
of ubiquinol-10##6##2##(1997-2#6)
of ubiquinone with the##2##4##(1992-3#2)
of ubiquinone##6##2##(1992-3#2)(1994-11#1)(1996-3#1)(1996-7#2)
of ubiquitin and##2##3##(1994-9#1)(1995-5#1)
of ubiquitin conjugates##2##3##(1991-1#1)(1994-2#1)
of ubiquitin in##2##3##(1994-9#1)(1995-3#1)
of ubiquitin##19##2##(1991-1#2)(1993-7#1)(1994-2#1)(1994-9#2)(1995-3#2)(1995-5#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-11#1)(2012-12#1)(2012-3#3)
of ubiquitin-activating enzyme##2##3##(1991-1#1)(2012-2#1)
of ubiquitin-mediated##2##2##(1992-11#1)(2007-12#1)
of ubiquitin-protein conjugates##5##3##(1990-2#2)(1991-1#1)(1994-2#1)(2008-4#1)
of ubiquitin-protein ligases##4##3##(1995-6#2)(2007-12#2)
of ubiquitin-protein##10##2##(1990-2#2)(1991-1#1)(1991-7#1)(1994-2#1)(1995-6#2)(2007-12#2)(2008-4#1)
of ubiquitinated##3##2##(1994-8#2)(1997-7#1)
of ulcer healing in##2##4##(2007-11#1)(2008-12#1)
of ulcer healing##3##3##(2007-11#2)(2008-12#1)
of ulcer##11##2##(1996-11#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
of ulceration##2##2##(2008-1#1)(2012-12#1)
of ulcerative colitis and##4##4##(2006-10#2)(2008-12#1)(2012-11#1)
of ulcerative colitis has##2##4##(2006-10#2)
of ulcerative colitis##25##3##(1990-7#1)(1996-8#1)(2006-10#9)(2006-2#2)(2006-9#1)(2007-10#2)(2008-12#2)(2008-5#4)(2009-4#1)(2010-12#1)(2012-11#1)
of ulcerative colitis]##3##3##(2007-9#1)(2008-12#1)(2013-8#1)
of ulcerative rectocolitis]##2##3##(1991-9#1)(1992-3#1)
of ulcerative##31##2##(1990-7#1)(1991-9#1)(1992-3#2)(1996-8#1)(2006-10#9)(2006-2#2)(2006-9#1)(2007-10#2)(2007-9#1)(2008-12#3)(2008-5#4)(2009-4#1)(2010-12#1)(2012-11#1)(2013-8#1)
of ulcers##5##2##(2007-10#1)(2009-5#1)(2010-9#1)(2013-8#2)
of ulnar nerve compression##2##4##(2006-4#1)(2008-9#1)
of ulnar nerve##3##3##(2006-3#1)(2006-4#1)(2008-9#1)
of ulnar##7##2##(2006-3#2)(2006-4#1)(2007-11#1)(2007-6#1)(2008-9#1)(2011-2#1)
of ultimate##3##2##(1993-9#1)(2007-9#1)(2008-5#1)
of ultra high##2##3##(2004-9#1)(2010-4#1)
of ultra trace amounts of##8##5##(2008-10#8)
of ultra trace##14##3##(2008-10#14)
of ultra##16##2##(2004-9#1)(2008-10#14)(2010-4#1)
of ultra-high molecular weight polyethylene##2##5##(2008-12#1)(2009-4#1)
of ultra-micro amounts of sulfur in igneous##2##7##(2008-10#2)
of ultra-trace elements##2##3##(2008-10#2)
of ultra-trace level##2##3##(2008-10#2)
of ultra-trace##14##2##(2008-10#13)(2008-3#1)
of ultrabrief pulse width##2##4##(2012-12#2)
of ultrabroadband##2##2##(2007-12#1)(2008-2#1)
of ultracold##2##2##(2007-11#1)(2012-2#1)
of ultrafast optical waveforms##2##4##(2007-12#2)
of ultrafast##15##2##(2007-11#6)(2007-12#9)
of ultrafiltration for##2##3##(2008-10#2)
of ultrafiltration in##2##3##(2008-1#1)(2012-1#1)
of ultrafiltration##17##2##(2007-12#1)(2008-1#6)(2008-10#7)(2008-7#1)(2012-1#1)(2012-3#1)
of ultrapure water##2##3##(2008-1#1)(2008-10#1)
of ultrapure##3##2##(2008-1#2)(2008-10#1)
of ultrashort laser pulses##4##4##(2007-12#1)(2008-3#3)
of ultrashort light pulses##2##4##(2007-11#2)
of ultrashort optical pulses by##2##5##(2007-12#2)
of ultrashort optical pulses##8##4##(2007-11#2)(2007-12#6)
of ultrashort pulses by use of##3##6##(2007-12#2)(2008-1#1)
of ultrashort pulses by##4##4##(2007-12#3)(2008-1#1)
of ultrashort pulses##12##3##(2007-11#1)(2007-12#9)(2008-1#1)(2008-3#1)
of ultrashort##33##2##(2007-11#7)(2007-12#19)(2008-1#2)(2008-2#1)(2008-3#4)
of ultrasmooth nanostructured diamond films##2##5##(2008-10#2)
of ultrasonic and thermo-chemical pre-treatments on##2##6##(2013-1#2)
of ultrasonic fields##2##3##(2007-12#1)(2008-2#1)
of ultrasonic modulation##2##3##(2007-12#1)(2008-2#1)
of ultrasonic waves##2##3##(2004-9#1)(2005-12#1)
of ultrasonic##21##2##(1993-2#2)(2004-9#1)(2005-12#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-5#1)(2013-1#2)(2013-8#1)
of ultrasonically-guided##2##2##(1990-10#2)
of ultrasonographic##2##2##(2008-8#1)(2009-4#1)
of ultrasonography and##7##3##(1992-8#1)(2007-3#2)(2008-10#1)(2010-12#2)(2011-2#1)
of ultrasonography as##2##3##(1991-6#1)(2006-12#1)
of ultrasonography in the diagnosis of##3##6##(2006-1#2)(2007-8#1)
of ultrasonography in the##5##4##(1993-5#1)(2006-1#2)(2007-8#1)(2010-12#1)
of ultrasonography in##8##3##(1993-5#1)(2006-1#2)(2007-11#1)(2007-8#3)(2010-12#1)
of ultrasonography is##2##3##(2007-7#1)(2011-2#1)
of ultrasonography##25##2##(1991-4#1)(1991-6#1)(1992-8#2)(1993-5#2)(2006-1#2)(2006-12#1)(2007-11#1)(2007-3#2)(2007-7#1)(2007-8#4)(2008-10#1)(2009-8#1)(2010-12#4)(2011-2#2)
of ultrasound (US)##2##3##(1992-7#1)(2010-12#1)
of ultrasound and##5##3##(2006-10#1)(2006-11#1)(2007-12#1)(2007-7#1)(2011-2#1)
of ultrasound contrast##2##3##(2007-9#1)(2012-2#1)
of ultrasound examinations##2##3##(2007-11#1)(2007-4#1)
of ultrasound guidance##2##3##(2011-2#1)(2013-1#1)
of ultrasound in the##2##4##(2007-8#1)(2008-1#1)
of ultrasound in##9##3##(1994-6#1)(2006-6#1)(2007-8#1)(2008-1#2)(2008-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
of ultrasound study in the##2##5##(2008-7#1)(2013-7#1)
of ultrasound to##3##3##(1992-12#1)(2013-1#2)
of ultrasound##52##2##(1990-3#1)(1991-8#2)(1992-12#1)(1992-7#1)(1994-6#1)(1995-12#1)(2005-12#1)(2006-10#4)(2006-11#1)(2006-6#3)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#5)(2013-7#2)
of ultrasound-assisted extraction##4##3##(2008-10#3)(2013-1#1)
of ultrasound-assisted##5##2##(2008-10#4)(2013-1#1)
of ultrasound-guided##6##2##(2008-8#1)(2009-4#1)(2012-12#1)(2012-2#2)(2013-7#1)
of ultrasounds##2##2##(2008-10#1)(2008-5#1)
of ultrastructural##3##2##(1994-11#1)(2007-5#1)(2009-2#1)
of ultrathin films##2##3##(1990-2#1)(2008-12#1)
of ultrathin##11##2##(1990-2#1)(1990-4#1)(2006-12#1)(2006-4#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-4#1)
of ultratrace amounts of##2##4##(2008-10#2)
of ultratrace##4##2##(2007-8#1)(2008-10#3)
of ultraviolet (UV)##6##3##(1991-6#1)(1997-1#1)(2008-3#1)(2008-5#1)(2010-4#1)(2012-12#1)
of ultraviolet A##2##3##(1991-12#1)(1997-1#1)
of ultraviolet radiation##4##3##(2005-11#1)(2008-11#1)(2008-3#1)(2008-5#1)
of ultraviolet##25##2##(1991-12#1)(1991-6#1)(1995-5#1)(1997-1#2)(2005-11#1)(2005-4#1)(2007-11#1)(2007-12#5)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#3)(2010-4#1)(2011-2#1)(2012-12#1)
of ultraweak light##2##3##(1991-7#1)(2008-3#1)
of ultraweak##3##2##(1991-7#1)(2008-3#1)(2008-5#1)
of ultrawideband##2##2##(2007-12#2)
of umbilical cord blood##2##4##(2007-8#1)(2012-12#1)
of umbilical cord##8##3##(2006-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2009-8#1)(2012-12#2)
of umbilical venous##2##3##(1992-1#1)(2008-4#1)
of umbilical##16##2##(1990-8#1)(1992-1#1)(1994-3#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#2)(2009-8#1)(2011-1#1)(2012-12#2)
of unaffected##6##2##(1992-9#1)(1997-5#1)(2007-2#1)(2008-5#2)(2012-3#1)
of unanesthetized rats##3##3##(1992-3#1)(1997-2#2)
of unanswered questions##3##3##(1995-12#1)(2007-12#1)(2008-2#1)
of unanswered##4##2##(1995-12#1)(2007-12#1)(2007-9#1)(2008-2#1)
of unanticipated admission##3##3##(2006-10#3)
of unanticipated##4##2##(2006-10#3)(2008-9#1)
of unbalanced##5##2##(1994-8#1)(2007-12#1)(2008-10#1)(2008-9#1)(2011-2#1)
of unbiased##2##2##(1997-2#1)(2007-3#1)
of unbound HI 6 in##2##5##(1997-7#2)
of unbound##6##2##(1991-9#1)(1996-4#2)(1997-7#2)(2008-10#1)
of uncalibrated##3##2##(2008-10#2)(2008-6#1)
of uncapped##2##2##(2008-10#2)
of uncertain origin##4##3##(1990-3#1)(1995-8#1)(2004-10#1)(2006-12#1)
of uncertain value##3##3##(2007-10#3)
of uncertain##15##2##(1990-3#1)(1993-10#1)(1995-8#1)(1997-8#1)(2004-10#1)(2006-10#1)(2006-12#1)(2007-10#3)(2007-9#1)(2008-2#1)(2011-2#1)(2012-2#1)(2013-8#1)
of uncertainties in##2##3##(1996-12#1)(2008-11#1)
of uncertainty and##2##3##(2008-8#1)(2011-2#1)
of uncertainty associated with the##2##5##(2008-10#1)(2009-11#1)
of uncertainty in the##4##4##(1992-2#1)(2008-3#1)(2008-7#1)(2009-11#1)
of uncertainty in##9##3##(1992-2#1)(1996-12#1)(2008-10#3)(2008-3#1)(2008-7#2)(2009-11#1)
of uncertainty##37##2##(1992-12#1)(1992-2#1)(1993-12#1)(1996-12#1)(2006-9#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#6)(2008-7#3)(2008-8#2)(2009-11#2)(2009-3#1)(2009-4#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
of unchanged##2##2##(1992-6#1)(1995-6#1)
of unclear##3##2##(1992-9#1)(2007-10#1)(2011-2#1)
of uncommon##6##2##(1992-6#1)(2006-4#1)(2007-7#1)(2010-12#1)(2011-7#1)(2012-12#1)
of uncompensated care##2##3##(1996-1#1)(2008-11#1)
of uncomplicated malaria##5##3##(2005-8#1)(2006-2#2)(2007-2#1)(2010-12#1)
of uncomplicated urinary tract infections in women##2##7##(1992-9#1)(1993-1#1)
of uncomplicated##15##2##(1992-9#1)(1993-1#1)(1993-2#1)(2005-8#1)(2006-2#2)(2007-2#1)(2007-4#1)(2008-3#1)(2008-9#1)(2009-6#1)(2010-12#2)(2010-8#1)(2013-1#1)
of unconditioned##2##2##(1993-2#2)
of unconjugated bile acids##2##4##(1996-4#2)
of unconjugated bilirubin between##2##4##(1992-3#2)
of unconjugated estrogens in##3##4##(2006-5#3)
of unconjugated##10##2##(1990-12#1)(1991-5#1)(1992-3#2)(1996-4#3)(2006-5#3)
of unconscious##2##2##(2008-12#1)(2011-1#1)
of unconsciousness##3##2##(1995-3#1)(2012-12#1)(2012-3#1)
of uncontrolled studies##2##3##(2006-10#1)(2007-11#1)
of uncontrolled##14##2##(1992-10#1)(2005-7#1)(2006-10#2)(2006-6#1)(2006-8#2)(2007-11#2)(2008-10#2)(2009-8#1)(2012-1#1)(2013-1#1)
of uncorrelated##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
of uncoupler##2##2##(1991-12#1)(1991-2#1)
of uncoupling##2##2##(2005-8#1)(2012-1#1)
of uncrosslinked##2##2##(1991-8#1)(2011-2#1)
of uncultivated##3##2##(1991-11#1)(2012-3#1)(2013-7#1)
of uncultured##3##2##(1991-9#1)(2008-10#1)(2008-11#1)
of undefined##3##2##(2008-10#3)
of under##12##2##(1990-12#1)(1991-7#1)(1991-9#1)(2004-9#1)(2006-10#1)(2008-10#2)(2008-8#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-7#1)
of under-five##2##2##(2008-2#1)(2012-12#1)
of underarm##2##2##(2008-5#2)
of underdeveloped##2##2##(1990-2#1)(2008-11#1)
of underdiagnosis##2##2##(2006-10#2)
of undergoing a##3##3##(1996-12#1)(2007-12#1)(2008-11#1)
of undergoing##9##2##(1991-10#1)(1994-2#1)(1996-12#1)(1996-5#1)(2006-10#1)(2006-9#1)(2007-12#2)(2008-11#1)
of undergraduate education##2##3##(2010-3#2)
of undergraduate health##2##3##(1993-2#1)(2011-2#1)
of undergraduate medical students##2##4##(2006-1#1)(2013-1#1)
of undergraduate nurses to##2##4##(2008-12#1)(2012-3#1)
of undergraduate nursing##2##3##(2008-11#1)(2008-12#1)
of undergraduate##16##2##(1993-2#1)(1997-5#1)(2006-1#1)(2008-11#2)(2008-12#6)(2010-3#2)(2011-2#1)(2012-3#1)(2013-1#1)
of underground drinking water##2##4##(2007-10#1)(2008-10#1)
of underground##4##2##(2007-10#1)(2008-10#1)(2008-6#2)
of underivatized amino acids in##3##5##(2008-10#3)
of underivatized amino acids##5##4##(2008-10#5)
of underivatized##9##2##(1993-1#1)(1993-2#1)(1997-8#1)(2008-10#5)(2010-7#1)
of underlying disease##4##3##(2008-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
of underlying genetic##2##3##(2006-5#1)(2012-2#1)
of underlying mechanisms##4##3##(2006-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
of underlying##33##2##(1992-2#1)(1995-9#1)(1996-10#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-8#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#1)
of undernutrition##2##2##(2006-4#1)(2011-2#1)
of underreporting##3##2##(1991-6#1)(1997-3#2)
of understanding and##2##3##(2004-10#1)(2008-4#1)
of understanding how##4##3##(2005-8#1)(2008-5#1)(2009-4#1)(2011-2#1)
of understanding of the##5##4##(2006-10#1)(2006-8#1)(2008-1#1)(2008-11#1)(2008-7#1)
of understanding of##8##3##(2006-10#1)(2006-2#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
of understanding self##2##3##(2007-3#1)(2013-7#1)
of understanding the##20##3##(1990-5#1)(1991-12#1)(1993-11#1)(1995-10#1)(1996-12#1)(2006-4#1)(2006-9#2)(2007-8#1)(2008-4#1)(2009-4#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
of understanding##67##2##(1990-5#1)(1991-12#1)(1991-9#1)(1993-11#1)(1995-10#1)(1996-12#1)(1996-2#1)(1996-9#1)(2004-10#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-7#2)(2006-8#1)(2006-9#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-4#3)(2008-5#2)(2008-7#5)(2009-12#1)(2009-4#2)(2009-5#1)(2010-12#2)(2010-2#1)(2010-3#2)(2011-2#3)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
of understory##2##2##(2007-3#1)(2008-5#1)
of undertaking##3##2##(2008-11#3)
of underwater##3##2##(2008-2#2)(2008-3#1)
of underweight##3##2##(2007-12#1)(2010-7#1)(2011-1#1)
of underwriting##2##2##(1993-3#1)(1997-8#1)
of undesirable side effects##2##4##(1993-12#1)(2006-10#1)
of undesirable##7##2##(1993-12#1)(2006-10#2)(2007-8#1)(2008-10#1)(2008-2#1)(2010-4#1)
of undesired effects##3##3##(1995-2#1)(2004-3#1)(2006-2#1)
of undesired##10##2##(1994-12#1)(1995-2#1)(1996-4#2)(2004-3#1)(2006-12#1)(2006-2#1)(2007-12#1)(2008-5#1)(2008-6#1)
of undetected##2##2##(1995-12#1)(2012-2#1)
of undetermined significance##13##3##(1991-7#1)(1997-7#1)(2006-10#6)(2007-12#1)(2008-1#2)(2008-9#1)(2013-8#1)
of undetermined##16##2##(1991-7#1)(1997-7#1)(2006-10#6)(2006-2#1)(2007-12#1)(2008-1#3)(2008-9#1)(2013-8#2)
of undiagnosed##4##2##(2004-7#1)(2006-10#1)(2007-8#1)(2013-1#1)
of undifferentiated ES cells##2##4##(2008-11#1)(2008-9#1)
of undifferentiated cells##3##3##(2008-11#1)(2009-4#1)(2009-8#1)
of undifferentiated connective tissue dysplasia##2##5##(2010-12#1)(2012-1#1)
of undifferentiated fever##2##3##(2013-8#2)
of undifferentiated##18##2##(1990-6#1)(2007-12#1)(2008-1#1)(2008-11#4)(2008-9#2)(2009-12#1)(2009-4#1)(2009-8#1)(2010-12#1)(2012-1#2)(2013-1#1)(2013-8#2)
of undigested##5##2##(1993-11#1)(2006-2#1)(2008-10#2)(2008-12#1)
of undiluted##2##2##(2005-8#1)(2013-1#1)
of undoped##5##2##(2005-4#2)(2007-12#1)(2008-10#1)(2008-2#1)
of unembalmed##2##2##(2007-4#2)
of unemployed workers##4##3##(2013-1#4)
of unemployed##5##2##(2013-1#5)
of unemployment on##2##3##(1996-10#1)(1997-2#1)
of unemployment or economic inactivity##2##5##(2013-1#2)
of unemployment##8##2##(1990-4#1)(1996-10#1)(1997-2#1)(1997-3#1)(2008-1#1)(2013-1#3)
of unenhanced##2##2##(1995-6#2)
of unequal##8##2##(1992-12#1)(1992-7#1)(1994-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-8#1)(2010-12#1)
of uneven##2##2##(2007-11#1)(2007-8#1)
of unexpected and##2##3##(1994-3#1)(1996-6#1)
of unexpected death##2##3##(2005-8#2)
of unexpected##15##2##(1994-3#1)(1994-6#1)(1996-6#1)(2005-8#2)(2006-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-7#1)
of unexplained##7##2##(1992-11#1)(2004-11#1)(2007-10#1)(2007-7#1)(2007-8#1)(2009-8#1)(2013-8#1)
of unfamiliar##5##2##(1996-5#1)(2006-3#1)(2008-11#1)(2009-4#1)(2010-2#1)
of unfamiliarity with##2##3##(1990-12#1)(2009-10#1)
of unfavorable##2##2##(2009-2#2)
of unfed larvae and adult mites of Platytrombidium fasciatum (C##2##10##(2007-12#2)
of unfed##4##2##(2004-11#2)(2007-12#2)
of unfertilized eggs##3##3##(1993-6#2)(2008-9#1)
of unfertilized##4##2##(1993-6#2)(2008-9#1)(2011-2#1)
of unfilled##2##2##(1991-2#1)(1993-6#1)
of unfixed##2##2##(2008-4#2)
of unfolded##2##2##(1997-4#1)(2010-5#1)
of unfolding for##3##3##(1995-10#1)(1995-5#1)(2006-10#1)
of unfolding##15##2##(1991-6#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-6#2)(1995-10#2)(1995-5#3)(1995-8#1)(1996-11#1)(2006-10#1)(2008-4#1)
of unfractionated heparin##4##3##(1997-2#1)(2009-8#1)(2013-8#2)
of unfractionated##5##2##(1993-11#1)(1997-2#1)(2009-8#1)(2013-8#2)
of unhealthy weight##4##3##(2008-11#1)(2012-2#3)
of unhealthy##7##2##(2008-11#2)(2011-2#1)(2012-11#1)(2012-2#3)
of uniaxial##6##2##(2008-1#2)(2008-11#1)(2008-3#1)(2011-2#1)(2012-7#1)
of unicellular##2##2##(2008-12#1)(2013-1#1)
of unidentified cadavers##4##3##(2008-12#4)
of unidentified human genes##7##4##(1995-8#2)(1996-10#1)(1996-2#3)(1997-4#1)
of unidentified##16##2##(1990-2#1)(1993-9#1)(1995-8#2)(1996-10#1)(1996-2#3)(1997-4#1)(2007-8#1)(2008-12#4)(2011-2#1)(2012-12#1)
of uniform anatase TiO2 nanoparticles##3##5##(2005-11#3)
of uniform cells##2##3##(1991-8#1)(2009-12#1)
of uniform output couplers for far-infrared lasers##2##7##(2007-12#2)
of uniform size##2##3##(1994-3#1)(1995-2#1)
of uniform##25##2##(1991-8#1)(1992-7#1)(1994-3#1)(1995-2#1)(2004-11#1)(2005-11#3)(2007-12#5)(2007-2#1)(2007-8#2)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#2)(2009-12#1)(2009-3#1)(2012-12#1)
of uniformity##2##2##(2008-10#1)(2008-8#1)
of uniformly##6##2##(1990-3#1)(1995-12#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-3#1)
of unilamellar liposomes##2##3##(1995-2#1)(2008-9#1)
of unilateral stereotactic pallidotomy##2##4##(2008-7#2)
of unilateral##30##2##(1992-9#1)(1995-10#1)(1995-12#1)(1995-7#2)(1997-2#1)(2006-10#2)(2008-10#2)(2008-7#4)(2008-9#1)(2010-2#1)(2011-1#3)(2011-2#2)(2012-2#3)(2013-1#5)(2013-8#1)
of unincubated##2##2##(1992-6#1)(1994-12#1)
of uninfected##7##2##(1994-11#2)(1996-12#1)(2008-10#2)(2008-7#1)(2011-12#1)
of uninformed##2##2##(1991-10#1)(1992-12#1)
of uninoculated##2##2##(2008-10#2)
of uninsured patients##2##3##(1995-1#2)
of uninsured##8##2##(1990-12#1)(1993-12#1)(1994-12#1)(1995-1#2)(1997-2#1)(2013-1#2)
of unintended childbearing in##2##4##(2007-7#2)
of unintended childbearing##3##3##(2007-7#3)
of unintended consequences##3##3##(2007-4#1)(2013-1#2)
of unintended##12##2##(1992-12#1)(2006-8#1)(2007-4#1)(2007-7#4)(2008-10#1)(2008-3#1)(2008-5#1)(2013-1#2)
of unintentional##3##2##(2005-8#1)(2006-12#1)(2013-1#1)
of uninterrupted sleep##2##3##(2008-8#1)(2012-12#1)
of uninterrupted##4##2##(1994-8#1)(2008-10#1)(2008-8#1)(2012-12#1)
of union##5##2##(1994-3#1)(2007-11#1)(2012-2#2)(2013-1#1)
of unique##43##2##(1990-5#1)(1991-10#1)(1992-7#1)(1995-2#1)(1996-2#6)(1996-5#1)(1997-4#1)(1997-6#1)(2005-10#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-3#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#4)(2011-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
of uniqueness##3##2##(2007-12#2)(2008-3#1)
of unirradiated##4##2##(1995-2#1)(1996-11#1)(1997-1#1)(2008-6#1)
of unit##2##2##(1991-6#1)(1995-7#1)
of unitary##2##2##(1992-11#1)(2009-6#1)
of units of##4##3##(2007-7#1)(2008-1#1)(2008-12#1)(2012-3#1)
of units##19##2##(1992-12#1)(1994-11#2)(1994-2#1)(1996-2#1)(2005-12#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-4#2)(2008-9#1)(2011-2#1)(2012-3#1)
of unity##7##2##(1990-11#1)(1994-8#1)(2008-2#1)(2008-3#3)(2011-2#1)
of univalent metal##3##3##(2008-10#3)
of univariate and##2##3##(2009-10#1)(2013-1#1)
of univariate##6##2##(1993-12#1)(2008-10#1)(2008-6#1)(2009-10#1)(2010-2#1)(2013-1#1)
of universal access##3##3##(1994-2#1)(2010-2#2)
of universal cholesterol screening##2##4##(2013-1#2)
of universal guidelines##2##3##(2010-11#1)(2010-3#1)
of universal health##2##3##(1991-2#1)(1996-2#1)
of universal human##2##3##(1995-9#1)(2009-10#1)
of universal precautions##5##3##(1996-1#1)(2006-8#1)(2007-12#1)(2012-2#2)
of universal##32##2##(1991-2#1)(1994-2#1)(1995-9#1)(1996-1#1)(1996-2#1)(1997-5#1)(1997-6#1)(2005-11#1)(2006-11#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-8#2)(2009-10#1)(2009-11#1)(2010-11#1)(2010-2#2)(2010-3#1)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#4)
of universe##2##2##(2013-1#2)
of university and##2##3##(2007-2#1)(2011-1#1)
of university programs in health administration##2##6##(1994-1#1)(1996-3#1)
of university students##7##3##(1995-11#1)(2006-7#1)(2007-1#1)(2009-7#1)(2010-12#1)(2011-1#1)(2012-12#1)
of university##24##2##(1994-1#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-3#1)(1997-3#1)(2006-7#1)(2007-1#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-5#1)(2009-4#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-7#1)
of unknown aetiology##3##3##(1994-4#1)(1996-3#1)(2010-3#1)
of unknown cause was##2##4##(1995-2#1)(2008-5#1)
of unknown cause##15##3##(1990-6#1)(1990-8#1)(1992-8#1)(1994-9#1)(1995-2#1)(2004-11#1)(2006-10#2)(2007-10#1)(2007-8#1)(2008-5#1)(2008-7#2)(2010-12#1)(2012-2#1)
of unknown composition##3##3##(1992-12#1)(2008-10#2)
of unknown etiology and##2##4##(2006-10#1)(2010-4#1)
of unknown etiology characterized by##5##5##(2010-12#1)(2011-2#2)(2012-2#1)(2013-8#1)
of unknown etiology that##4##4##(2005-8#1)(2006-10#1)(2008-10#1)(2010-11#1)
of unknown etiology##39##3##(1991-2#1)(1992-8#1)(1993-7#1)(1994-2#1)(1995-6#1)(1997-8#1)(2005-12#1)(2005-8#2)(2006-10#4)(2006-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-3#1)(2010-11#2)(2010-12#3)(2010-4#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
of unknown function in##2##4##(1995-8#1)(1997-1#1)
of unknown function on##2##4##(1994-6#1)(1995-8#1)
of unknown function that is##2##5##(1991-6#1)(2010-10#1)
of unknown function which##2##4##(1990-7#2)
of unknown function##31##3##(1990-7#3)(1991-6#1)(1991-7#1)(1992-12#2)(1992-9#1)(1993-11#1)(1994-10#1)(1994-6#1)(1995-8#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-10#4)(2008-7#3)(2008-9#2)(2009-10#1)(2010-10#3)
of unknown identity##2##3##(1995-9#1)(2008-10#1)
of unknown origin and##4##4##(1995-9#1)(1996-4#1)(2007-8#1)(2008-1#1)
of unknown origin in##2##4##(1996-6#1)(2008-11#1)
of unknown origin##40##3##(1990-2#1)(1991-10#1)(1991-5#1)(1995-9#1)(1996-11#1)(1996-4#1)(1996-6#1)(2006-10#11)(2006-11#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-11#1)(2009-4#1)(2009-5#2)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of unknown primary site##2##4##(1992-2#1)(1993-10#1)
of unknown primary##5##3##(1992-2#1)(1993-10#1)(2008-4#1)(2011-2#1)(2013-8#1)
of unknown##173##2##(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-8#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#3)(1995-9#2)(1996-11#1)(1996-3#2)(1996-4#1)(1996-6#2)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-12#1)(2005-4#1)(2005-8#2)(2006-10#17)(2006-11#1)(2006-2#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-7#4)(2007-8#5)(2008-1#3)(2008-10#16)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#5)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#2)(2010-10#4)(2010-11#3)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#4)
of unknowns##2##2##(2008-10#1)(2010-11#1)
of unlabeled GDNF##2##3##(1995-8#2)
of unlabeled peptide##2##3##(1996-5#2)
of unlabeled##20##2##(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#2)(1992-6#1)(1992-9#1)(1993-3#1)(1993-9#1)(1995-2#1)(1995-8#3)(1996-2#1)(1996-5#2)(2008-4#3)(2008-9#1)
of unlabelled##8##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-4#2)(1991-6#1)(1994-8#1)(1997-1#1)
of unliganded##4##2##(1990-7#1)(1991-2#2)(1996-11#1)
of unloaded##2##2##(1992-10#1)(2013-1#1)
of unmatched##2##2##(1992-9#1)(2008-9#1)
of unmet need for contraception##2##5##(2007-7#2)
of unmet need for spacing##2##5##(2007-7#2)
of unmet need for##5##4##(2007-7#4)(2008-7#1)
of unmet need##6##3##(2007-7#4)(2008-7#1)(2010-8#1)
of unmet##10##2##(1993-2#1)(2007-11#1)(2007-7#4)(2008-7#1)(2010-8#1)(2012-12#1)(2013-1#1)
of unmethylated##3##2##(2007-11#2)(2007-8#1)
of unmodified##11##2##(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-8#1)(2005-8#1)(2008-10#2)(2008-4#2)(2011-2#1)
of unmyelinated##5##2##(1993-12#4)(1996-3#1)
of unnatural##4##2##(2008-4#3)(2008-7#1)
of unnecessary##14##2##(1995-12#1)(2005-8#1)(2007-1#1)(2007-4#2)(2008-10#2)(2008-3#1)(2008-4#1)(2009-6#1)(2011-2#2)(2013-1#2)
of unobserved modes##2##3##(2008-2#2)
of unobserved##4##2##(2008-2#2)(2009-5#1)(2010-11#1)
of unoriented##4##2##(1991-9#1)(1995-10#1)(2010-4#2)
of unpackaged##2##2##(1991-5#1)(1992-8#1)
of unparallel grating planes in##2##5##(2008-3#2)
of unphosphorylated##4##2##(1990-2#1)(1990-7#1)(1995-1#1)(2013-8#1)
of unplanned##3##2##(2007-11#1)(2007-7#1)(2010-6#1)
of unpleasant##2##2##(2007-1#1)(2008-4#1)
of unpolarized light##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
of unpolluted##2##2##(2008-5#1)(2008-7#1)
of unprecedented##3##2##(1996-2#1)(2008-7#1)(2011-1#1)
of unpredictable##3##2##(1992-11#1)(1994-5#1)(2008-7#1)
of unprocessed##4##2##(1994-8#1)(1997-4#1)(2012-12#2)
of unprotected##7##2##(1992-10#1)(2008-1#1)(2008-12#1)(2008-3#1)(2011-1#1)(2013-1#2)
of unproven##4##2##(2005-8#1)(2008-12#1)(2008-4#2)
of unraveling the##2##3##(2006-8#1)(2007-8#1)
of unraveling##3##2##(2006-8#1)(2007-8#1)(2013-8#1)
of unrealistic##2##2##(2008-8#1)(2009-9#1)
of unrecognized##2##2##(2008-10#1)(2009-6#1)
of unregulated##3##2##(1995-12#1)(2007-8#1)(2008-8#1)
of unrelated fungi##2##3##(2008-10#2)
of unrelated individuals in##2##4##(2012-3#2)
of unrelated individuals##4##3##(2012-3#4)
of unrelated subjects##3##3##(2012-3#3)
of unrelated##20##2##(1990-8#1)(1994-11#1)(1994-12#1)(1997-3#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-8#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#7)
of unresectable or metastatic##3##4##(1994-2#1)(2008-6#2)
of unresectable##9##2##(1994-2#1)(1995-4#1)(2006-6#1)(2008-6#4)(2010-12#1)(2010-3#1)
of unresolved##3##2##(1995-12#1)(2008-8#1)(2010-8#1)
of unrestrained##2##2##(1995-2#2)
of unripe fruit extract of##2##5##(2005-11#2)
of unripe##3##2##(1992-1#1)(2005-11#2)
of unruptured##7##2##(1995-11#1)(1996-12#2)(2008-6#1)(2008-7#1)(2009-7#1)(2013-7#1)
of unsafe abortion and##2##4##(2011-1#2)
of unsafe abortion##3##3##(2011-1#2)(2012-12#1)
of unsatisfactory##3##2##(1993-2#1)(2007-11#1)(2011-2#1)
of unsaturated fatty acid residues##2##5##(2006-10#2)
of unsaturated fatty acid##3##4##(1993-6#1)(2006-10#2)
of unsaturated fatty acids##9##4##(1990-10#1)(1990-11#1)(1993-6#1)(1996-11#1)(1996-3#1)(1996-7#2)(2005-10#1)(2006-7#1)
of unsaturated fatty##12##3##(1990-10#1)(1990-11#1)(1993-6#2)(1996-11#1)(1996-3#1)(1996-7#2)(2005-10#1)(2006-10#2)(2006-7#1)
of unsaturated##18##2##(1990-10#1)(1990-11#1)(1993-6#2)(1994-3#1)(1995-7#1)(1996-11#1)(1996-3#1)(1996-7#3)(2005-10#1)(2006-10#2)(2006-7#1)(2007-11#1)(2010-4#2)
of unsaturation of the##2##4##(1995-5#1)(2010-4#1)
of unsaturation##10##2##(1990-11#1)(1990-2#1)(1990-5#1)(1993-11#1)(1995-11#2)(1995-5#1)(1996-5#1)(2008-10#1)(2010-4#1)
of unsedated colonoscopy for##2##4##(2010-12#2)
of unsedated colonoscopy##3##3##(2010-12#3)
of unsedated##4##2##(2006-10#1)(2010-12#3)
of unspecified##3##2##(1990-4#1)(1994-11#1)(2008-4#1)
of unspliced##3##2##(1990-4#1)(1994-3#1)(2011-3#1)
of unstable angina and non-ST elevation myocardial infarction##2##8##(2008-3#2)
of unstable angina and##4##4##(2005-7#1)(2007-11#1)(2008-3#2)
of unstable angina pectoris and acute myocardial infarction##3##8##(1991-9#3)
of unstable angina##9##3##(1991-9#3)(2005-7#1)(2007-11#1)(2008-3#3)(2010-12#1)
of unstable atherosclerotic plaques##2##4##(2008-4#2)
of unstable distal radius##2##4##(2006-3#1)(2008-9#1)
of unstable or##2##3##(2006-5#1)(2008-10#1)
of unstable resonators##2##3##(2008-2#1)(2008-3#1)
of unstable spinal##2##3##(2007-1#1)(2012-2#1)
of unstable thoracolumbar burst fractures##3##5##(2006-8#3)
of unstable##39##2##(1991-9#3)(1993-5#1)(1993-6#1)(1994-11#1)(1995-5#1)(2005-11#1)(2005-7#1)(2006-3#2)(2006-5#1)(2006-8#4)(2007-1#2)(2007-11#2)(2007-8#3)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-9#2)(2010-12#2)(2012-2#1)
of unstained##4##2##(2007-12#1)(2008-2#1)(2011-1#1)(2012-1#1)
of unstimulated platelets##2##3##(1990-12#1)(1990-5#1)
of unstimulated##10##2##(1990-12#1)(1990-5#1)(1991-2#1)(1992-12#1)(1992-4#1)(1992-6#1)(1996-2#1)(2007-10#2)(2007-2#1)
of unstirred##2##2##(2008-10#1)(2008-11#1)
of unsubstituted##3##2##(1991-3#1)(1997-3#1)(2008-10#1)
of unsuccessful attempts##2##3##(2007-7#1)(2010-12#1)
of unsuccessful##4##2##(2006-5#1)(2007-7#1)(2008-7#1)(2010-12#1)
of unsymmetrical##3##2##(2007-11#1)(2008-5#2)
of untagged##2##2##(1997-3#1)(2009-10#1)
of untoward##2##2##(1990-2#1)(1990-4#1)
of untransformed##2##2##(1995-5#1)(2006-12#1)
of untreated CIN 2##3##4##(2006-10#3)
of untreated and##2##3##(1992-12#1)(2005-7#1)
of untreated patients##4##3##(2007-11#2)(2008-3#1)(2013-8#1)
of untreated##34##2##(1991-1#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1996-10#2)(1996-11#1)(1997-4#2)(2004-3#1)(2005-7#1)(2006-10#4)(2006-2#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
of unusual mortality##2##3##(1996-11#2)
of unusual##25##2##(1990-6#1)(1992-2#1)(1996-11#3)(2005-11#1)(2006-10#1)(2006-12#2)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-1#1)(2010-4#1)(2010-7#1)(2011-1#2)(2012-12#1)(2012-2#1)
of unusually##3##2##(2009-10#1)(2009-12#1)(2009-7#1)
of unvaccinated##2##2##(1994-9#1)(2009-5#1)
of unwanted cell##2##3##(2008-11#1)(2010-2#1)
of unwanted cells##2##3##(2008-9#1)(2009-10#1)
of unwanted immunogenicity##4##3##(2008-10#4)
of unwanted modes##2##3##(2008-2#1)(2008-3#1)
of unwanted pregnancy in##2##4##(2007-3#2)
of unwanted##25##2##(1991-3#1)(1993-10#1)(1993-2#1)(1995-7#1)(2007-2#1)(2007-3#2)(2008-10#6)(2008-11#2)(2008-2#3)(2008-3#2)(2008-9#2)(2009-10#1)(2010-2#1)(2010-6#1)
of unwinding##2##2##(1995-3#1)(1997-4#1)
of unwrapping##2##2##(2008-3#2)
of up to 0##2##4##(2006-11#1)(2012-1#1)
of up to 1##9##4##(1991-10#1)(1994-11#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
of up to 10 mg/kg/day##2##5##(1992-11#2)
of up to 10##5##4##(1990-8#1)(1992-11#2)(2006-3#1)(2008-5#1)
of up to 100##4##4##(1991-2#1)(2006-8#1)(2007-12#1)(2008-10#1)
of up to 100%##2##4##(1994-2#1)(2008-10#1)
of up to 12##2##4##(2007-8#1)(2008-9#1)
of up to 15##3##4##(1994-6#1)(1997-4#1)(2008-10#1)
of up to 15%##2##4##(2010-5#1)(2011-2#1)
of up to 150##2##4##(2007-10#1)(2007-12#1)
of up to 18##2##4##(2007-12#1)(2011-2#1)
of up to 2##7##4##(1996-2#1)(2005-7#1)(2007-12#1)(2008-10#2)(2008-7#1)(2013-8#1)
of up to 20##4##4##(1990-2#1)(1994-8#1)(2006-10#1)(2008-4#1)
of up to 20%##2##4##(2007-2#1)(2010-8#1)
of up to 25%##3##4##(2006-12#1)(2010-9#1)(2013-1#1)
of up to 3##4##4##(1996-7#1)(2008-11#1)(2009-11#1)(2012-3#1)
of up to 30 days##3##5##(1995-11#1)(1997-4#1)(2010-8#1)
of up to 30##12##4##(1990-3#1)(1992-3#1)(1994-8#1)(1995-11#1)(1997-1#1)(1997-4#1)(2007-12#2)(2008-10#2)(2010-8#1)(2011-1#1)
of up to 350##2##4##(2007-12#1)(2008-3#1)
of up to 4##2##4##(2007-10#1)(2010-5#1)
of up to 40%##3##4##(2008-10#1)(2008-7#1)(2010-12#1)
of up to 5##2##4##(2007-11#1)(2008-3#1)
of up to 50##2##4##(2007-11#1)(2008-3#1)
of up to 6##4##4##(1990-10#1)(1996-6#1)(2008-10#1)(2012-1#1)
of up to 7##2##4##(2006-12#1)(2007-12#1)
of up to 80##2##4##(1990-12#1)(2006-4#1)
of up to 85##2##4##(2008-10#1)(2008-11#1)
of up to 90##4##4##(2006-10#1)(2007-11#1)(2007-9#1)(2008-2#1)
of up to 90%##2##4##(2007-12#1)(2008-5#1)
of up to a##2##4##(2006-8#1)(2008-2#1)
of up to approximately##2##4##(2008-11#1)(2008-7#1)
of up to four##3##4##(1991-5#1)(2008-2#1)(2012-2#1)
of up to three##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
of up to##185##3##(1990-10#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-11#2)(1992-3#1)(1992-6#3)(1993-11#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-6#1)(1995-7#3)(1996-1#2)(1996-12#1)(1996-2#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-4#3)(1997-6#1)(1997-8#2)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#4)(2006-3#1)(2006-4#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#21)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#22)(2008-11#5)(2008-12#1)(2008-2#6)(2008-3#4)(2008-4#4)(2008-5#7)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#2)(2009-11#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#4)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
of up-regulation of##2##3##(1995-9#1)(1997-8#1)
of up-regulation##3##2##(1995-9#1)(1997-8#1)(2006-4#1)
of upcoming##2##2##(2006-9#1)(2012-2#1)
of updating the##2##3##(2006-9#1)(2011-12#1)
of updating##5##2##(2006-9#1)(2008-7#1)(2010-6#1)(2011-12#1)(2012-2#1)
of upgrading##2##2##(2010-8#1)(2011-1#1)
of upland red##2##3##(2013-8#2)
of upland##4##2##(2008-10#1)(2008-9#1)(2013-8#2)
of upper abdominal##3##3##(1991-12#1)(2008-3#1)(2013-7#1)
of upper airway obstruction##4##4##(1995-8#1)(2007-8#2)(2008-11#1)
of upper airway##6##3##(1995-8#1)(1997-6#1)(2004-2#1)(2007-8#2)(2008-11#1)
of upper and lower layers##2##5##(2008-3#2)
of upper and lower##9##4##(2008-3#3)(2010-8#1)(2011-1#2)(2012-12#2)(2012-3#1)
of upper cervical##2##3##(2007-4#1)(2008-12#1)
of upper extremity function##2##4##(2006-4#1)(2012-1#1)
of upper extremity##7##3##(2006-3#1)(2006-4#1)(2007-7#1)(2011-2#2)(2012-1#2)
of upper gastrointestinal bleeding##3##4##(2006-8#1)(2013-8#2)
of upper gastrointestinal##12##3##(1991-8#1)(2006-10#2)(2006-8#3)(2007-2#1)(2007-7#1)(2011-2#1)(2012-2#1)(2013-8#2)
of upper limb##6##3##(2006-3#1)(2007-11#1)(2007-8#2)(2012-1#2)
of upper limbs##2##3##(2006-10#1)(2013-1#1)
of upper respiratory disease##2##4##(2010-2#1)(2013-8#1)
of upper respiratory symptoms##2##4##(2009-4#1)(2013-8#1)
of upper respiratory tract##3##4##(2008-5#1)(2011-2#1)(2012-12#1)
of upper respiratory##7##3##(2008-5#1)(2009-4#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-8#2)
of upper##74##2##(1990-2#1)(1990-6#1)(1991-12#1)(1991-8#1)(1992-10#1)(1995-10#1)(1995-8#1)(1996-3#1)(1997-6#1)(2004-2#1)(2006-10#3)(2006-3#2)(2006-4#1)(2006-8#3)(2006-9#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-11#1)(2008-12#3)(2008-3#4)(2008-5#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-1#5)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#5)
of upper- and lower-limb##2##4##(2011-2#2)
of upper-limb##2##2##(2009-3#1)(2010-9#1)
of uppercase##2##2##(2008-6#2)
of upregulated##3##2##(2008-11#1)(2009-8#2)
of upstream and downstream##2##4##(2006-5#1)(2012-2#1)
of upstream##9##2##(1990-5#1)(1991-7#1)(1992-3#1)(1997-7#1)(2006-5#1)(2008-11#2)(2010-8#1)(2012-2#1)
of uptake and##5##3##(1992-9#1)(1995-11#1)(2006-7#1)(2008-10#2)
of uptake##24##2##(1990-12#1)(1990-3#1)(1991-3#2)(1991-5#1)(1992-6#1)(1992-9#1)(1995-1#1)(1995-11#3)(1997-5#1)(2006-7#1)(2007-10#1)(2008-10#6)(2008-5#1)(2008-7#2)(2013-8#1)
of upto##3##2##(1991-3#1)(2008-7#2)
of upward##3##2##(2007-10#1)(2008-4#1)(2009-3#1)
of upwelling ecosystems##2##3##(2008-5#2)
of upwelling##4##2##(2008-2#1)(2008-3#1)(2008-5#2)
of urachal cyst associated with##3##5##(2009-5#3)
of urachal##5##2##(2008-6#1)(2009-5#3)(2010-2#1)
of urachal-sigmoid fistula associated with diverticular disease##2##7##(2008-6#2)
of uracil##2##2##(1990-4#1)(1994-7#1)
of uranium (VI)##6##3##(2005-11#2)(2008-10#4)
of uranium and##3##3##(2008-10#3)
of uranium at##2##3##(2008-10#2)
of uranium by##5##3##(2008-10#5)
of uranium from##5##3##(2008-10#5)
of uranium in##8##3##(2008-10#8)
of uranium is##3##3##(2006-4#1)(2008-10#2)
of uranium isotopes##2##3##(2008-10#2)
of uranium with##4##3##(2006-4#1)(2008-10#3)
of uranium##53##2##(1995-7#1)(2005-11#2)(2005-4#1)(2006-4#3)(2008-10#44)(2010-5#1)(2013-1#1)
of uranium(VI) and thorium(IV)##3##4##(2008-10#3)
of uranium(VI) and##4##3##(2008-10#4)
of uranium(VI) from##2##3##(2008-10#2)
of uranium(VI) in##2##3##(2008-10#2)
of uranium(VI) present in 1000ml##2##5##(2008-10#2)
of uranium(VI) present in##3##4##(2008-10#3)
of uranium(VI) with##2##3##(2008-10#2)
of uranium(VI)##18##2##(2008-10#18)
of uranium(VI)-tributylphosphate##2##2##(2008-10#2)
of uranyl ion from aqueous##2##5##(2008-10#2)
of uranyl ion##4##3##(2008-10#4)
of uranyl##12##2##(1993-4#1)(2005-11#1)(2008-10#10)
of urapidil##2##2##(1990-5#1)(1991-3#1)
of urate and##5##3##(1993-2#1)(2006-10#3)(2008-10#1)
of urate oxidase crystal growth##2##5##(2008-10#2)
of urate oxidase##4##3##(1991-12#1)(2008-10#3)
of urate##17##2##(1991-12#1)(1992-4#1)(1993-2#1)(1997-8#1)(2006-10#6)(2007-11#1)(2008-10#5)(2010-2#1)
of urban African##2##3##(2008-3#1)(2013-8#1)
of urban and rural##4##4##(1992-12#2)(2011-11#1)(2012-2#1)
of urban and##5##3##(1992-12#2)(2011-11#1)(2012-2#1)(2013-1#1)
of urban##30##2##(1992-12#4)(1995-11#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-3#3)(2008-6#1)(2009-7#3)(2009-8#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-11#2)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
of urban-rural differences in##2##4##(1992-12#1)(2008-11#1)
of urbanization##4##2##(1992-4#1)(2008-5#1)(2008-6#2)
of urchins##4##2##(2007-5#4)
of urea (1##2##3##(2008-10#2)
of urea and potassium##3##4##(2008-10#3)
of urea and##8##3##(1990-8#1)(2008-10#5)(2008-4#1)(2013-8#1)
of urea by##3##3##(1992-11#1)(1995-3#1)(2008-10#1)
of urea concentration in##3##4##(2007-8#1)(2008-1#2)
of urea concentration##6##3##(1993-11#1)(2007-8#1)(2008-1#3)(2008-10#1)
of urea cycle##2##3##(1992-7#1)(2008-7#1)
of urea determination##2##3##(2007-8#1)(2008-10#1)
of urea from##2##3##(1991-9#1)(2008-10#1)
of urea in alcoholic beverages##2##5##(2008-10#2)
of urea in blood##2##4##(1993-4#1)(2008-10#1)
of urea in##5##3##(1993-4#1)(2008-10#4)
of urea or##2##3##(1995-5#1)(2006-8#1)
of urea with##3##3##(1997-7#1)(2008-10#2)
of urea##66##2##(1990-10#1)(1990-8#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-7#1)(1993-11#2)(1993-4#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1997-7#2)(2004-12#1)(2006-2#1)(2006-8#1)(2007-8#2)(2008-1#6)(2008-10#25)(2008-2#1)(2008-4#5)(2008-7#1)(2011-1#1)(2013-8#5)
of urease##8##2##(1994-6#1)(2007-8#1)(2008-10#4)(2008-5#1)(2013-1#1)
of uredinia##2##2##(2008-10#2)
of urediniospores##4##2##(2008-10#4)
of uremic patients##2##3##(2007-7#1)(2008-1#1)
of uremic##5##2##(2007-7#1)(2008-1#1)(2008-5#1)(2013-1#2)
of ureter##5##2##(1990-12#1)(2007-6#1)(2008-3#1)(2011-2#1)(2013-7#1)
of ureteral obstruction secondary to##2##5##(2007-10#2)
of ureteral obstruction##4##3##(1992-4#1)(2007-10#2)(2011-1#1)
of ureteral##13##2##(1990-11#1)(1991-11#1)(1992-4#1)(1997-4#1)(2006-7#1)(2007-10#2)(2008-1#1)(2008-10#1)(2008-7#1)(2009-1#1)(2011-1#1)(2013-1#1)
of ureteric##8##2##(1991-9#1)(1997-3#2)(2006-10#1)(2008-1#1)(2008-8#2)(2013-1#1)
of ureteropelvic junction obstruction##2##4##(2006-10#1)(2008-10#1)
of ureters with##2##3##(2008-10#2)
of urethan##3##2##(1992-5#3)
of urethane-anesthetized##3##2##(1993-2#2)(1997-5#1)
of urethral diverticulum##2##3##(2008-10#2)
of urethral plate##2##3##(2009-5#2)
of urethral##11##2##(1990-4#1)(1990-7#1)(2007-8#1)(2008-10#3)(2009-5#2)(2011-1#2)(2013-1#1)
of urge urinary incontinence##2##4##(2008-3#2)
of urgency##3##2##(2006-10#1)(2008-11#1)(2008-7#1)
of urgent##5##2##(2007-8#2)(2008-10#1)(2011-1#1)(2012-1#1)
of uric acid (UA)##3##4##(2008-10#3)
of uric acid and##6##4##(1991-2#1)(2006-10#1)(2008-10#3)(2009-6#1)
of uric acid by##2##4##(2008-10#1)(2011-2#1)
of uric acid in human urine##2##6##(1997-2#1)(2008-10#1)
of uric acid in##9##4##(1997-2#1)(2007-2#1)(2008-10#7)
of uric acid is##2##4##(2008-10#2)
of uric acid were##2##4##(1990-4#1)(2011-2#1)
of uric acid##38##3##(1990-4#1)(1991-2#2)(1997-2#1)(2006-10#2)(2006-5#1)(2007-2#1)(2007-8#1)(2008-10#21)(2008-4#2)(2008-5#2)(2009-6#1)(2011-2#3)
of uric##39##2##(1990-4#1)(1991-2#2)(1997-2#1)(2006-10#2)(2006-5#1)(2007-2#1)(2007-8#1)(2008-10#22)(2008-4#2)(2008-5#2)(2009-6#1)(2011-2#3)
of uricase##5##2##(1990-11#2)(1992-8#2)(1995-3#1)
of uridine diphosphate##2##3##(1995-8#2)
of uridine residues##2##3##(1995-3#1)(1997-5#1)
of uridine##18##2##(1991-3#1)(1993-11#1)(1993-8#1)(1994-6#1)(1995-3#1)(1995-8#2)(1996-6#8)(1997-5#1)(2005-11#1)(2008-4#1)
of uridylate##2##2##(1990-5#1)(1996-8#1)
of urinary 8OHdG##2##3##(2008-10#2)
of urinary Hg##2##3##(1993-8#2)
of urinary LH##2##3##(1992-1#2)
of urinary NAG##2##3##(1990-11#1)(1997-8#1)
of urinary apo(a)##3##3##(1997-2#3)
of urinary beta-core##2##3##(1996-12#2)
of urinary bladder and##2##4##(2008-7#1)(2008-9#1)
of urinary bladder cancer##4##4##(2006-10#2)(2007-7#1)(2008-4#1)
of urinary bladder diverticulum##3##4##(2011-2#3)
of urinary bladder##20##3##(1992-11#1)(1997-5#1)(2006-10#2)(2006-7#1)(2007-3#1)(2007-7#1)(2008-4#2)(2008-7#2)(2008-9#1)(2009-5#1)(2009-7#1)(2011-2#3)(2012-1#3)
of urinary calcium excretion##2##4##(2007-9#2)
of urinary calculi##3##3##(2007-10#1)(2008-1#1)(2010-2#1)
of urinary catecholamines and cortisol##2##5##(2007-4#2)
of urinary catecholamines##3##3##(1990-8#1)(2007-4#2)
of urinary cobalt##4##3##(1994-6#3)(2008-10#1)
of urinary column##3##3##(2006-7#3)
of urinary concentrations of##2##4##(1996-6#1)(2010-4#1)
of urinary creatinine##2##3##(1997-8#1)(2009-6#1)
of urinary dolichols##2##3##(1991-12#2)
of urinary excretion of##2##4##(1992-1#1)(1993-2#1)
of urinary excretion##3##3##(1992-1#1)(1993-2#1)(1997-8#1)
of urinary free noradrenaline##2##4##(1990-8#2)
of urinary incontinence in##4##4##(1992-2#1)(2006-7#1)(2008-10#1)(2012-3#1)
of urinary incontinence##16##3##(1992-2#1)(1994-5#1)(1994-7#1)(1996-2#1)(2005-9#1)(2006-7#3)(2006-9#1)(2007-8#1)(2008-10#2)(2008-3#1)(2011-1#1)(2012-3#2)
of urinary metabolites of##2##4##(1990-11#1)(2013-7#1)
of urinary neopterin and serum##2##5##(2008-10#2)
of urinary nucleosides##3##3##(1990-8#1)(1997-2#2)
of urinary pseudouridine and 1-methyladenosine##2##5##(1992-3#2)
of urinary schistosomiasis##6##3##(1996-12#1)(2007-2#4)(2008-10#1)
of urinary steroid##2##3##(1994-10#1)(1995-4#1)
of urinary stone##3##3##(1992-4#1)(2006-10#1)(2008-4#1)
of urinary symptoms and##2##4##(2004-10#1)(2012-12#1)
of urinary symptoms##3##3##(2004-10#1)(2008-12#1)(2012-12#1)
of urinary tract infection among##2##5##(2008-4#1)(2010-8#1)
of urinary tract infection##15##4##(1996-1#1)(1996-12#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-5#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
of urinary tract infections and##3##5##(1991-12#1)(2009-5#1)(2011-2#1)
of urinary tract infections in##4##5##(1996-12#1)(2006-9#1)(2007-10#2)
of urinary tract infections##15##4##(1991-12#3)(1993-2#1)(1996-12#1)(1997-4#1)(2006-9#1)(2007-10#2)(2007-7#1)(2009-5#1)(2010-3#1)(2011-2#2)(2013-8#1)
of urinary tract##39##3##(1991-12#3)(1991-5#2)(1992-12#1)(1992-6#1)(1993-2#1)(1996-1#1)(1996-12#2)(1997-4#1)(2006-10#1)(2006-9#1)(2007-10#2)(2007-12#1)(2007-7#3)(2008-1#2)(2008-10#2)(2008-4#1)(2009-5#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of urinary##209##2##(1990-11#3)(1990-3#1)(1990-7#1)(1990-8#6)(1991-11#1)(1991-12#5)(1991-3#1)(1991-5#4)(1991-8#1)(1991-9#1)(1992-1#4)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#3)(1993-2#2)(1993-8#3)(1993-9#2)(1994-10#2)(1994-12#1)(1994-5#1)(1994-6#4)(1994-7#1)(1995-1#2)(1995-11#1)(1995-3#1)(1995-4#1)(1995-7#2)(1996-1#2)(1996-12#6)(1996-2#1)(1996-3#3)(1996-6#1)(1996-7#1)(1997-2#7)(1997-3#3)(1997-4#1)(1997-5#2)(1997-8#4)(2004-10#1)(2004-12#1)(2005-10#1)(2005-12#1)(2005-9#1)(2006-10#4)(2006-4#1)(2006-7#7)(2006-9#2)(2007-10#3)(2007-12#1)(2007-2#5)(2007-3#1)(2007-4#2)(2007-7#4)(2007-8#2)(2007-9#3)(2008-1#4)(2008-10#15)(2008-12#1)(2008-3#1)(2008-4#4)(2008-7#2)(2008-9#1)(2009-5#3)(2009-6#5)(2009-7#1)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#7)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#4)
of urination##2##2##(1990-10#1)(2006-7#1)
of urine and plasma##2##4##(1996-5#1)(2010-11#1)
of urine and##7##3##(1990-4#1)(1993-12#1)(1996-5#2)(2006-12#1)(2008-10#1)(2010-11#1)
of urine as##2##3##(2008-10#1)(2011-2#1)
of urine from##4##3##(1993-2#1)(2004-11#1)(2010-2#1)(2012-3#1)
of urine in##4##3##(2004-11#2)(2008-1#1)(2012-3#1)
of urine is##2##3##(1996-8#1)(2011-2#1)
of urine sample##2##3##(2008-10#2)
of urine samples from##3##4##(1990-2#1)(1993-2#1)(1996-9#1)
of urine samples of##2##4##(1993-8#1)(2008-10#1)
of urine samples##14##3##(1990-12#1)(1990-2#1)(1990-8#1)(1991-5#1)(1992-2#1)(1993-11#1)(1993-2#1)(1993-8#1)(1996-6#1)(1996-9#1)(2008-10#2)(2010-4#1)(2013-8#1)
of urine were##2##3##(2008-10#2)
of urine##78##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-8#1)(1995-1#1)(1995-2#1)(1996-12#3)(1996-5#4)(1996-6#1)(1996-8#1)(1996-9#1)(1997-8#1)(2004-11#4)(2006-10#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-10#2)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#3)(2008-10#14)(2008-2#1)(2009-3#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-11#1)(2012-2#1)(2012-3#2)(2013-8#2)
of urine)##2##2##(1997-3#1)(2007-8#1)
of urodynamic##4##2##(1995-9#1)(2008-7#1)(2011-1#1)(2012-12#1)
of urogenital atrophy##2##3##(2004-10#2)
of urogenital sinus##2##3##(1995-11#1)(2008-10#1)
of urogenital##11##2##(1990-9#1)(1991-11#1)(1994-11#1)(1995-11#1)(1997-3#1)(1997-6#1)(2004-10#2)(2006-7#1)(2008-10#1)(2009-4#1)
of urokinase is##2##3##(1994-11#1)(2005-7#1)
of urokinase##14##2##(1990-12#1)(1993-11#1)(1994-11#1)(1996-2#1)(1997-4#1)(2005-7#4)(2007-9#2)(2008-5#1)(2008-7#2)
of urokinase-type plasminogen activator##3##4##(1990-12#1)(1992-6#1)(1993-12#1)
of urologic##2##2##(2008-7#1)(2013-8#1)
of urological complications##3##3##(2008-1#3)
of urological##5##2##(1991-8#1)(2007-5#1)(2008-1#3)
of urology##3##2##(2006-9#1)(2008-1#1)(2011-2#1)
of uronic acids##2##3##(2006-12#2)
of uropathogenic E##2##3##(1995-2#1)(1996-8#1)
of uropathogenic Escherichia coli##3##4##(1996-8#1)(2007-7#1)(2013-8#1)
of uropathogenic##5##2##(1995-2#1)(1996-8#2)(2007-7#1)(2013-8#1)
of uroporphyrinogen III##3##3##(1991-5#2)(1995-4#1)
of urothelial##3##2##(2006-9#1)(2012-2#2)
of ursodeoxycholic acid##7##3##(1996-4#1)(2004-11#1)(2005-12#1)(2006-10#3)(2008-8#1)
of us in the##2##4##(2009-4#1)(2010-3#1)
of us in##3##3##(2007-4#1)(2009-4#1)(2010-3#1)
of us##28##2##(1994-1#3)(1994-2#4)(1995-2#1)(1996-2#1)(1996-8#1)(2005-11#1)(2006-7#3)(2007-2#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-4#1)(2010-3#1)(2010-8#1)(2010-9#1)(2012-8#1)(2013-7#1)
of usability##4##2##(2007-4#2)(2013-1#2)
of usable##3##2##(1993-12#1)(2007-11#1)(2008-3#1)
of usage of##2##3##(2005-3#1)(2010-12#1)
of usage##8##2##(1991-8#1)(1994-2#1)(1997-1#1)(2004-10#1)(2005-3#1)(2007-6#1)(2010-12#1)(2012-3#1)
of use and the##2##4##(2005-11#1)(2006-6#1)
of use and##11##3##(1991-5#1)(1994-3#1)(2004-4#1)(2005-11#1)(2006-12#1)(2006-6#1)(2007-4#1)(2008-10#1)(2010-12#1)(2012-1#1)(2013-8#1)
of use are##3##3##(1993-5#1)(2008-11#1)(2009-10#1)
of use as##2##3##(1996-6#1)(2007-10#1)
of use for##8##3##(1996-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-8#1)(2013-1#2)
of use in a##3##4##(2005-6#2)(2008-5#1)
of use in the##8##4##(1997-1#1)(2005-9#1)(2006-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2009-2#1)(2013-7#1)
of use in##21##3##(1994-10#1)(1996-9#1)(1997-1#1)(2005-6#2)(2005-8#1)(2005-9#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2009-2#1)(2010-11#1)(2012-3#1)(2013-7#1)
of use is##2##3##(2008-1#1)(2011-1#1)
of use of external##2##4##(2007-11#2)
of use of the##7##4##(1991-1#1)(1994-2#1)(1994-3#1)(2007-11#2)(2008-10#1)(2012-3#1)
of use of this##4##4##(1991-12#1)(2007-5#1)(2008-7#1)(2010-12#1)
of use of various##2##4##(2006-12#1)(2008-10#1)
of use of##45##3##(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1992-1#1)(1994-2#1)(1994-3#1)(2004-4#1)(2006-10#3)(2006-12#1)(2006-8#1)(2007-11#6)(2007-5#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-7#1)(2009-12#1)(2010-12#1)(2010-3#3)(2010-6#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)
of use to##2##3##(2006-8#1)(2009-6#1)
of use which##2##3##(1991-3#1)(2012-2#1)
of use##153##2##(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-3#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-5#1)(1993-6#2)(1994-10#1)(1994-2#2)(1994-3#2)(1994-9#1)(1996-3#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-5#1)(2004-4#2)(2005-11#1)(2005-6#2)(2005-8#1)(2005-9#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-6#2)(2006-8#5)(2006-9#1)(2007-10#1)(2007-11#7)(2007-12#3)(2007-2#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-6#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#3)(2010-6#1)(2010-8#3)(2011-1#3)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#13)(2013-7#1)(2013-8#1)
of used##8##2##(1995-11#1)(2008-10#3)(2008-11#1)(2008-4#1)(2011-2#2)
of useful applications##2##3##(2008-3#1)(2012-3#1)
of useful patterns##2##3##(2008-2#2)
of useful##21##2##(1992-8#1)(1994-11#1)(1996-10#1)(1996-12#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#2)(2010-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
of user##4##2##(2008-2#1)(2008-3#1)(2008-7#1)(2012-3#1)
of user-friendly##4##2##(1991-3#1)(1993-9#1)(2008-10#1)(2008-7#1)
of users of##4##3##(1991-1#1)(2011-1#1)(2012-3#2)
of users to##2##3##(1993-4#1)(2010-8#1)
of users##21##2##(1991-1#4)(1993-3#1)(1993-4#1)(2005-8#1)(2008-1#1)(2008-11#1)(2008-2#3)(2008-7#1)(2008-9#1)(2010-8#2)(2011-1#1)(2012-1#1)(2012-3#2)(2013-8#1)
of uses##4##2##(2007-2#1)(2007-6#1)(2008-8#1)(2012-12#1)
of using PBL in a##2##5##(2008-12#2)
of using a##40##3##(1997-2#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-12#4)(2007-5#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-2#7)(2008-3#7)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-7#1)
of using an##8##3##(2005-7#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-1#2)
of using both the##2##4##(2008-10#1)(2008-3#1)
of using both##3##3##(2008-10#2)(2008-3#1)
of using carbon##2##3##(1994-12#1)(2012-3#1)
of using existing##3##3##(2007-4#1)(2008-1#1)(2013-8#1)
of using hemoglobin A1C measurement in endemic area of hemoglobinopathy##2##10##(2008-7#2)
of using it in##2##4##(2010-12#1)(2012-12#1)
of using it##4##3##(2010-12#1)(2012-12#1)(2012-3#1)(2013-8#1)
of using laser##2##3##(2008-10#2)
of using magnetic##2##3##(2005-11#1)(2011-2#1)
of using robots##2##3##(2006-6#1)(2012-1#1)
of using such##4##3##(1996-12#1)(2007-12#1)(2013-1#2)
of using the method##2##4##(2007-11#1)(2008-10#1)
of using the##45##3##(1990-4#1)(1992-3#1)(1992-5#1)(1992-8#1)(1995-1#1)(1995-3#1)(1996-12#1)(1996-2#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-11#5)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-2#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
of using them##2##3##(1995-6#1)(2011-2#1)
of using these##6##3##(2004-4#1)(2006-10#1)(2007-1#1)(2008-10#1)(2008-5#1)(2013-7#1)
of using this method##2##4##(2008-10#1)(2012-3#1)
of using this technique for##2##5##(2008-10#2)
of using this technique##3##4##(2008-10#2)(2008-2#1)
of using this##17##3##(1994-6#1)(2006-5#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2009-2#1)(2012-3#1)
of using tissue##2##3##(2009-2#1)(2012-3#1)
of using two##4##3##(2007-11#2)(2007-8#1)(2011-12#1)
of using very small##3##4##(1990-6#1)(2008-4#1)(2008-9#1)
of using##394##2##(1990-1#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#2)(1993-3#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-12#3)(1996-2#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-12#1)(2004-4#1)(2004-7#1)(2005-10#3)(2005-11#1)(2005-7#3)(2006-10#8)(2006-11#1)(2006-12#6)(2006-2#3)(2006-3#1)(2006-5#3)(2006-6#2)(2006-7#1)(2007-1#2)(2007-10#2)(2007-11#11)(2007-12#16)(2007-2#1)(2007-4#3)(2007-5#2)(2007-6#2)(2007-7#4)(2007-8#8)(2007-9#1)(2008-1#4)(2008-10#42)(2008-11#17)(2008-12#4)(2008-2#20)(2008-3#28)(2008-4#6)(2008-5#7)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#8)(2009-11#2)(2009-12#2)(2009-2#5)(2009-3#1)(2009-4#2)(2009-5#4)(2009-7#1)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#3)(2011-1#7)(2011-12#3)(2011-2#12)(2011-3#1)(2012-1#9)(2012-12#5)(2012-2#3)(2012-3#6)(2013-1#14)(2013-7#4)(2013-8#5)
of usp and##2##3##(1997-7#2)
of usp##4##2##(1997-7#4)
of usual interstitial pneumonia##2##4##(2005-8#1)(2010-12#1)
of usual##8##2##(1991-12#1)(1996-7#1)(2005-8#1)(2006-7#1)(2008-10#1)(2009-7#1)(2010-12#1)(2011-2#1)
of uterine LMS##2##3##(2011-1#2)
of uterine arteries##2##3##(1994-9#2)
of uterine blood flow##2##4##(1994-9#1)(2006-10#1)
of uterine cancer##3##3##(1991-12#3)
of uterine cervical cancer##2##4##(2011-2#2)
of uterine cervical carcinoma##2##4##(1994-8#1)(2007-4#1)
of uterine cervical##6##3##(1994-8#1)(2007-4#1)(2011-2#3)(2012-12#1)
of uterine cervix##5##3##(1993-11#1)(2007-11#4)
of uterine epithelial cells is##2##5##(2008-6#2)
of uterine epithelial cells##5##4##(2008-6#5)
of uterine##58##2##(1991-12#3)(1991-4#1)(1991-9#3)(1992-4#4)(1993-11#1)(1993-4#1)(1994-3#1)(1994-8#1)(1994-9#6)(1996-1#1)(2006-1#1)(2006-10#3)(2007-11#4)(2007-2#1)(2007-4#1)(2008-4#1)(2008-6#5)(2008-8#1)(2009-8#1)(2010-1#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#2)(2013-7#1)
of uterus and##2##3##(2007-7#1)(2008-11#1)
of uterus##5##2##(2006-12#1)(2007-7#1)(2008-11#1)(2012-3#1)(2013-7#1)
of utilising##2##2##(2008-1#1)(2013-1#1)
of utility##3##2##(1991-7#1)(2008-3#1)(2011-2#1)
of utilization and##3##3##(1991-3#1)(1995-12#1)(1996-12#1)
of utilization management##3##3##(1995-2#1)(1997-2#2)
of utilization review##3##3##(1991-3#2)(1996-12#1)
of utilization##21##2##(1991-3#3)(1992-3#2)(1993-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-12#2)(1996-3#1)(1997-2#2)(2007-10#1)(2012-12#1)(2012-2#1)(2013-1#4)
of utilizing the##2##3##(2007-12#1)(2008-2#1)
of utilizing##18##2##(1990-8#1)(2006-3#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-6#1)(2011-1#1)(2013-1#3)(2013-8#1)
of utmost importance for the##3##5##(2008-10#1)(2011-1#1)(2012-12#1)
of utmost importance for##5##4##(2007-8#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-12#1)
of utmost importance in the##5##5##(1993-3#1)(2006-4#1)(2008-10#1)(2011-2#1)(2013-8#1)
of utmost importance in##6##4##(1993-3#1)(2006-4#1)(2008-10#1)(2008-2#1)(2011-2#1)(2013-8#1)
of utmost importance since##2##4##(1996-10#1)(2008-5#1)
of utmost importance##24##3##(1990-12#1)(1991-6#1)(1993-3#1)(1996-10#1)(2006-10#1)(2006-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#2)(2010-12#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of utmost##26##2##(1990-12#1)(1991-6#1)(1993-3#1)(1996-10#1)(2006-10#1)(2006-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#2)(2010-12#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of uv-LDL##2##2##(1997-2#2)
of uveal melanoma##2##3##(1991-6#1)(2008-7#1)
of uveal##3##2##(1991-6#1)(2008-7#1)(2013-8#1)
of uveitis and##4##3##(2007-11#1)(2007-3#1)(2011-2#1)(2013-7#1)
of uveitis is##2##3##(2006-10#1)(2013-7#1)
of uveitis##23##2##(2006-10#6)(2007-11#2)(2007-3#1)(2009-2#1)(2011-2#1)(2012-12#2)(2013-7#10)
of uveitis]##3##2##(2013-7#3)
of uvomorulin##3##2##(1990-11#1)(1994-6#2)
of v was##2##3##(1995-8#1)(2008-10#1)
of v##7##2##(1995-8#1)(2006-5#1)(2008-10#3)(2008-5#1)(2013-8#1)
of v(i) and v(j)##2##4##(2008-10#2)
of vWF and##2##3##(2008-11#1)(2013-8#1)
of vWF##3##2##(1990-12#1)(2008-11#1)(2013-8#1)
of vWf##5##2##(1990-11#1)(1992-1#3)(2007-10#1)
of vacant sites##2##3##(2008-10#2)
of vacant##6##2##(1991-11#1)(2008-10#4)(2008-9#1)
of vaccinated##6##2##(1992-10#1)(1995-5#1)(2007-2#1)(2008-5#1)(2010-4#1)(2012-12#1)
of vaccinating##2##2##(2007-11#1)(2013-1#1)
of vaccination against##5##3##(2006-10#1)(2012-12#2)(2013-1#2)
of vaccination as##2##3##(2007-6#1)(2011-1#1)
of vaccination coverage##2##3##(1997-2#1)(2012-12#1)
of vaccination for##2##3##(1990-2#1)(2006-10#1)
of vaccination in##6##3##(1992-11#1)(2008-5#4)(2013-1#1)
of vaccination is##2##3##(1994-3#1)(1996-3#1)
of vaccination on##2##3##(1996-3#2)
of vaccination scores##2##3##(1993-3#2)
of vaccination with##2##3##(2008-5#1)(2013-8#1)
of vaccination##48##2##(1990-2#4)(1992-10#1)(1992-11#1)(1993-3#2)(1994-3#2)(1995-3#1)(1996-3#3)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-10#2)(2006-12#1)(2007-2#2)(2007-6#1)(2008-4#5)(2008-5#5)(2008-7#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#3)(2013-1#3)(2013-8#1)
of vaccinations in##2##3##(1997-3#1)(2007-11#1)
of vaccinations##3##2##(1997-3#1)(2007-11#1)(2012-12#1)
of vaccine and##5##3##(1995-5#1)(2007-2#1)(2009-9#1)(2011-1#1)(2013-1#1)
of vaccine efficacy##4##3##(1994-2#2)(1995-5#1)(2006-4#1)
of vaccine had##2##3##(2006-10#1)(2007-2#1)
of vaccine protection##3##3##(1994-2#1)(2007-2#1)(2013-8#1)
of vaccine safety##2##3##(1995-5#2)
of vaccine strain##2##3##(2008-11#1)(2013-8#1)
of vaccine##51##2##(1993-3#1)(1993-4#1)(1994-2#3)(1995-5#5)(1997-8#1)(2005-7#1)(2005-9#2)(2006-1#1)(2006-10#2)(2006-4#1)(2007-11#3)(2007-2#3)(2007-7#1)(2008-11#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
of vaccine-induced##2##2##(2009-4#2)
of vaccine-preventable diseases##2##3##(1995-3#1)(2010-9#1)
of vaccine-preventable##3##2##(1995-3#1)(2010-9#2)
of vaccinees##2##2##(1995-4#1)(2008-4#1)
of vaccines against##4##3##(1994-11#1)(2006-10#1)(2007-11#1)(2008-11#1)
of vaccines are##2##3##(2008-5#1)(2011-2#1)
of vaccines for##3##3##(1990-7#1)(2007-11#1)(2007-2#1)
of vaccines in##2##3##(2007-6#1)(2007-8#1)
of vaccines to##3##3##(2006-10#2)(2008-5#1)
of vaccines##34##2##(1990-7#1)(1992-12#1)(1993-3#1)(1994-11#1)(1994-9#1)(1995-5#3)(1995-9#1)(2005-7#1)(2006-10#3)(2007-11#3)(2007-2#1)(2007-6#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-5#2)(2009-4#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#4)
of vaccinia##2##2##(1996-5#1)(2008-2#1)
of vacuma##2##2##(2008-10#2)
of vacuolar ATPase##2##3##(1995-6#2)
of vacuolar type##3##3##(1990-7#1)(1991-10#1)(1994-8#1)
of vacuolar##6##2##(1990-7#1)(1991-10#1)(1994-8#1)(1995-6#2)(2009-10#1)
of vacuolated##2##2##(1996-4#1)(2007-10#1)
of vacuoles##4##2##(1996-9#1)(2007-12#2)(2008-7#1)
of vacuum ultraviolet##3##3##(2008-2#3)
of vacuum##9##2##(1991-6#2)(2004-9#1)(2006-12#1)(2008-10#2)(2008-2#3)
of vacuum-assisted venous drainage##2##4##(2010-12#1)(2012-3#1)
of vacuum-assisted##3##2##(2007-8#1)(2010-12#1)(2012-3#1)
of vacuum-ultraviolet##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
of vagal sensory neurones##2##4##(1992-9#2)
of vagal##5##2##(1992-9#2)(1993-11#1)(2012-2#2)
of vaginal birth after##2##4##(2007-2#1)(2011-12#1)
of vaginal cylinders##2##3##(2009-2#2)
of vaginal discharge in##3##4##(2007-7#3)
of vaginal discharge##5##3##(2007-7#5)
of vaginal hysterectomy##3##3##(1995-12#1)(1996-2#1)(2010-3#1)
of vaginal misoprostol##2##3##(2007-8#1)(2009-7#1)
of vaginal##42##2##(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-1#1)(1995-12#1)(1996-2#1)(2005-8#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-10#3)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#6)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#2)(2009-2#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
of vaginitis##2##2##(1997-4#1)(2011-2#1)
of vaginocervical##2##2##(1992-9#2)
of vague and##2##3##(1993-3#1)(2010-4#1)
of vague##4##2##(1993-3#1)(2009-4#1)(2010-4#1)(2013-1#1)
of valaciclovir##2##2##(1995-6#2)
of valid##9##2##(1994-3#1)(2006-8#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-12#1)
of validated##3##2##(2008-11#1)(2009-11#1)(2013-1#1)
of validation##9##2##(1996-5#1)(1997-8#1)(2006-11#1)(2008-10#4)(2008-7#1)(2010-10#1)
of validity of the first Born##2##6##(2008-2#2)
of validity of the##8##4##(2008-11#1)(2008-2#4)(2008-3#3)
of validity of##13##3##(2006-10#1)(2008-11#1)(2008-2#5)(2008-3#5)(2012-1#1)
of validity##17##2##(2006-10#2)(2007-12#1)(2008-11#1)(2008-2#5)(2008-3#6)(2012-1#1)(2012-12#1)
of valine##4##2##(1992-1#1)(1992-2#2)(1993-12#1)
of valinomycin##4##2##(1990-2#1)(1992-12#1)(1992-4#1)(1994-12#1)
of valproate in##4##3##(1996-6#2)(2008-3#1)(2010-12#1)
of valproate##9##2##(1990-5#3)(1996-1#1)(1996-6#2)(2008-3#1)(2010-12#2)
of valproic acid and##2##4##(1996-6#1)(2010-3#1)
of valproic acid##10##3##(1996-6#1)(2007-10#2)(2010-10#2)(2010-3#1)(2011-12#1)(2013-1#3)
of valproic##11##2##(1996-6#1)(2007-10#2)(2010-10#2)(2010-3#1)(2011-1#1)(2011-12#1)(2013-1#3)
of valsartan##3##2##(2010-2#1)(2011-1#2)
of valuable##6##2##(2006-12#1)(2008-10#1)(2010-5#1)(2012-11#1)(2013-1#2)
of value at##2##3##(2008-5#1)(2010-12#1)
of value for##7##3##(1990-12#1)(1997-2#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-5#1)
of value in the##11##4##(1990-12#1)(1991-8#1)(1994-6#1)(2006-11#1)(2007-11#2)(2007-9#1)(2008-3#1)(2008-5#1)(2008-9#2)
of value in##28##3##(1990-12#1)(1991-8#1)(1992-1#1)(1993-10#1)(1993-11#1)(1993-4#1)(1994-6#1)(1997-8#1)(2006-10#2)(2006-11#2)(2006-2#1)(2007-11#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#4)(2012-2#1)(2013-8#1)
of value of##2##3##(2011-2#1)(2013-7#1)
of value resin composites##2##4##(2012-2#2)
of value to the##3##4##(1997-4#1)(2005-8#1)(2008-1#1)
of value to##11##3##(1992-1#1)(1997-3#1)(1997-4#1)(2005-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-8#1)(2012-3#1)(2013-1#2)
of value##64##2##(1990-12#2)(1991-8#1)(1992-1#2)(1993-10#1)(1993-11#1)(1993-2#1)(1993-4#1)(1994-6#1)(1995-12#1)(1996-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-11#1)(2005-8#1)(2006-10#3)(2006-11#2)(2006-2#1)(2007-11#4)(2007-9#1)(2008-1#5)(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#4)(2010-12#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
of values for the##4##4##(1994-11#1)(2006-6#1)(2008-2#1)(2008-3#1)
of values for##7##3##(1994-11#1)(2006-6#1)(2007-12#1)(2008-2#2)(2008-3#1)(2010-2#1)
of values obtained for##2##4##(2008-2#1)(2012-2#1)
of values of##6##3##(1997-1#1)(2006-10#1)(2008-2#1)(2008-3#1)(2013-1#2)
of values was##2##3##(2008-3#1)(2008-7#1)
of values##44##2##(1990-2#2)(1990-4#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-3#1)(1995-6#1)(1997-1#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#7)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#2)(2010-2#1)(2010-5#1)(2012-2#1)(2012-3#2)(2013-1#3)
of valve##11##2##(1990-6#1)(1992-4#1)(2006-8#2)(2007-8#1)(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
of valvular##6##2##(1990-6#2)(2005-9#1)(2008-10#1)(2013-1#2)
of van der Waals forces##3##5##(1993-4#1)(2005-11#1)(2009-11#1)
of van der Waals##5##4##(1993-4#1)(2005-11#1)(2008-10#2)(2009-11#1)
of van der##6##3##(1993-4#1)(2005-11#1)(2008-10#2)(2009-11#1)(2011-1#1)
of vanadate to##2##3##(1990-2#2)
of vanadate##10##2##(1990-2#2)(1991-9#1)(1992-10#1)(1994-11#1)(1994-12#1)(1995-7#1)(1997-1#1)(1997-7#1)(2008-10#1)
of vanadium (V)##4##3##(1993-12#1)(2008-10#1)(2008-5#1)(2011-2#1)
of vanadium accumulation##2##3##(1990-2#1)(1990-5#1)
of vanadium and molybdenum##3##4##(2008-10#3)
of vanadium and##9##3##(2007-11#1)(2008-10#8)
of vanadium by##3##3##(2008-10#3)
of vanadium from the##2##4##(2008-10#1)(2008-5#1)
of vanadium from##3##3##(2008-10#2)(2008-5#1)
of vanadium in a##2##4##(2008-10#2)
of vanadium in parenteral##2##4##(2008-10#2)
of vanadium in soil##2##4##(2008-10#2)
of vanadium in the range##2##5##(2008-10#2)
of vanadium in the##4##4##(2008-10#4)
of vanadium in water##2##4##(2008-10#2)
of vanadium in##26##3##(2008-10#26)
of vanadium pentoxide##2##3##(1996-2#2)
of vanadium species##2##3##(2008-10#2)
of vanadium##74##2##(1990-2#1)(1990-5#4)(1992-4#1)(1993-12#1)(1996-2#3)(2007-11#1)(2008-10#58)(2008-5#4)(2011-2#1)
of vanadium(IV) and total vanadium##3##5##(2008-10#3)
of vanadium(IV)##5##2##(2008-10#4)(2010-5#1)
of vanadium(V) and##2##3##(2008-10#2)
of vanadium(V) with##3##3##(2008-10#3)
of vanadium(V)##10##2##(2008-10#10)
of vanadyl sulfate##2##3##(1993-12#1)(1994-6#1)
of vanadyl##5##2##(1990-2#1)(1993-12#1)(1994-6#1)(2008-10#1)(2008-3#1)
of vancomycin and its##2##4##(2008-10#2)
of vancomycin and##5##3##(2006-10#1)(2008-10#3)(2011-2#1)
of vancomycin associated renal toxicity##2##5##(2012-12#2)
of vancomycin in##2##3##(2007-7#1)(2008-10#1)
of vancomycin resistance##2##3##(1991-2#1)(2006-10#1)
of vancomycin##18##2##(1991-2#1)(2006-10#2)(2007-12#2)(2007-7#2)(2008-10#6)(2011-2#1)(2012-12#3)(2013-1#1)
of vancomycin-resistant enterococci##2##3##(2005-8#1)(2006-10#1)
of vancomycin-resistant##4##2##(2005-8#1)(2006-10#1)(2007-12#1)(2009-5#1)
of vanillin and PHB##2##4##(2008-10#2)
of vanillin and##4##3##(2008-10#4)
of vanillin##8##2##(1993-2#1)(2007-1#1)(2008-10#6)
of vanishing bone disease##3##4##(2007-7#2)(2009-3#1)
of vanishing##4##2##(2005-11#1)(2007-7#2)(2009-3#1)
of vapor##6##2##(2008-10#2)(2008-3#2)(2008-4#1)(2013-1#1)
of vaporization##2##2##(2008-3#1)(2010-4#1)
of vapors##3##2##(2008-10#2)(2008-3#1)
of vapreotide in the treatment of##2##6##(2005-7#2)
of var genes##2##3##(2012-3#2)
of var##3##2##(2009-10#1)(2012-3#2)
of variability between##2##3##(1993-12#1)(2012-3#1)
of variability in the##6##4##(2005-8#1)(2008-1#1)(2008-10#3)(2009-6#1)
of variability in##18##3##(1993-3#1)(1997-8#1)(2005-8#1)(2008-1#1)(2008-10#4)(2008-8#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-12#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
of variability of##2##3##(2008-10#1)(2008-6#1)
of variability such as##2##4##(2008-3#1)(2011-1#1)
of variability which##2##3##(2008-10#1)(2013-7#1)
of variability##49##2##(1990-2#1)(1991-12#1)(1993-12#1)(1993-3#2)(1994-8#2)(1997-8#2)(2005-8#1)(2006-7#1)(2007-4#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-6#1)(2009-7#1)(2010-12#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#4)
of variable length##4##3##(1992-6#1)(2008-10#3)
of variable local density and anisotropy##2##6##(2010-1#2)
of variable regions##3##3##(1992-11#1)(2008-10#1)(2008-8#1)
of variable selection##3##3##(1994-9#2)(2010-1#1)
of variable size##5##3##(2008-10#2)(2008-3#1)(2008-6#1)(2011-12#1)
of variable sizes##2##3##(2006-4#1)(2008-1#1)
of variable thickness##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
of variable##61##2##(1990-12#1)(1990-5#1)(1991-12#1)(1992-11#1)(1992-6#1)(1993-4#1)(1993-5#1)(1994-11#1)(1994-9#2)(1995-2#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-4#1)(1997-6#2)(2005-11#1)(2006-4#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#2)(2009-8#1)(2010-1#3)(2010-4#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-3#1)
of variable-angle screws in transpedicular fixation##2##6##(2006-8#2)
of variable-angle##3##2##(2006-8#2)(2008-2#1)
of variables and##3##3##(1995-9#1)(2008-1#1)(2008-10#1)
of variables in##2##3##(2008-10#1)(2008-4#1)
of variables influencing##2##3##(1996-8#1)(2013-8#1)
of variables is##2##3##(2008-3#1)(2012-2#1)
of variables that are##2##4##(2008-10#1)(2008-2#1)
of variables that##3##3##(1992-2#1)(2008-10#1)(2008-2#1)
of variables was##3##3##(1992-2#1)(2008-10#2)
of variables##46##2##(1992-2#2)(1994-3#1)(1995-9#1)(1996-8#1)(1997-8#1)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-10#3)(2010-2#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
of variably##2##2##(1996-11#1)(2007-7#1)
of variance (ANOVA) was##2##4##(1994-2#1)(2008-10#1)
of variance (ANOVA)##16##3##(1994-2#1)(1995-2#1)(1996-2#1)(1996-6#1)(2008-10#6)(2008-7#1)(2009-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
of variance and##9##3##(1990-3#1)(1993-5#2)(1997-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2013-1#2)
of variance in the##3##4##(1995-12#1)(2007-12#1)(2007-9#1)
of variance in##13##3##(1990-12#1)(1995-12#1)(1995-2#1)(2004-11#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-12#2)(2008-3#1)(2010-3#1)(2010-5#1)(2013-8#1)
of variance revealed##4##3##(2004-11#1)(2009-11#1)(2012-3#1)(2013-1#1)
of variance showed that the##2##5##(1993-2#1)(2013-1#1)
of variance showed that##4##4##(1990-10#1)(1993-2#2)(2013-1#1)
of variance showed##6##3##(1990-10#1)(1993-2#2)(1996-1#1)(2008-5#1)(2013-1#1)
of variance to##4##3##(2007-7#1)(2007-8#1)(2009-7#1)(2009-9#1)
of variance was used to##5##5##(1991-2#1)(2008-1#1)(2008-5#1)(2008-6#1)(2013-1#1)
of variance was##6##3##(1991-2#1)(2008-1#1)(2008-5#1)(2008-6#1)(2009-9#1)(2013-1#1)
of variance were##3##3##(1990-12#1)(2008-12#1)(2012-12#1)
of variance with##2##3##(2008-10#1)(2008-4#1)
of variance##118##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-6#1)(1990-8#1)(1991-2#1)(1992-2#1)(1993-12#1)(1993-2#2)(1993-5#2)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#3)(1995-12#1)(1995-2#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-5#2)(2004-11#3)(2006-12#1)(2006-5#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#3)(2008-1#2)(2008-10#21)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-11#1)(2009-2#2)(2009-4#1)(2009-7#1)(2009-9#3)(2010-3#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#2)
of variance)##3##2##(2007-10#1)(2008-10#1)(2008-3#1)
of variances##3##2##(2006-8#1)(2008-10#2)
of variant##7##2##(1991-12#1)(1993-3#1)(1993-7#1)(1994-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
of variants of##4##3##(2006-10#1)(2008-10#1)(2008-2#1)(2010-5#1)
of variants##10##2##(1991-12#1)(1994-2#1)(2006-10#1)(2008-10#1)(2008-2#1)(2010-2#1)(2010-5#1)(2012-3#3)
of variation &lt##3##3##(2008-10#1)(2008-7#2)
of variation (C##7##3##(1990-6#1)(1993-8#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-8#1)
of variation (CV)##13##3##(1990-12#1)(1991-3#2)(1991-8#2)(1993-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-8#1)(2009-8#1)(2010-8#1)(2013-1#1)
of variation among##2##3##(1995-5#1)(2008-1#1)
of variation and##3##3##(1996-6#1)(2010-5#1)(2012-3#1)
of variation at##2##3##(1996-6#1)(2010-5#1)
of variation between##5##3##(1991-9#1)(1996-2#1)(2008-10#1)(2009-8#1)(2011-2#1)
of variation for each##2##4##(1991-8#1)(1997-3#1)
of variation for the##3##4##(1996-6#1)(1996-9#1)(2008-10#1)
of variation for##18##3##(1990-2#1)(1990-6#1)(1991-8#1)(1993-8#1)(1994-3#1)(1996-3#1)(1996-6#1)(1996-9#2)(1997-3#1)(1997-8#1)(2004-11#1)(2007-8#1)(2008-10#4)(2008-5#1)
of variation in body##2##4##(2008-9#1)(2013-7#1)
of variation in disease severity##2##5##(2008-10#2)
of variation in the##8##4##(2006-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-8#1)(2011-2#1)
of variation in##39##3##(1990-8#1)(1990-9#1)(1995-11#1)(1997-1#1)(2004-3#1)(2006-5#2)(2007-5#1)(2007-8#1)(2008-10#5)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#2)(2013-1#2)(2013-7#1)
of variation is##7##3##(1990-10#1)(1992-3#1)(1994-9#1)(1996-3#1)(2006-9#1)(2010-8#1)(2011-2#1)
of variation less than##6##4##(1990-6#1)(2008-10#3)(2011-2#1)(2012-12#1)
of variation of 1##2##4##(2008-10#2)
of variation of 2##2##4##(1992-2#1)(1995-1#1)
of variation of 3##3##4##(1994-10#1)(1995-2#1)(2007-4#1)
of variation of 5##2##4##(2008-10#2)
of variation of the##6##4##(1990-8#1)(1997-8#1)(2008-10#3)(2008-7#1)
of variation of##30##3##(1990-8#1)(1992-2#1)(1992-8#1)(1994-10#1)(1994-4#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-8#2)(2007-4#2)(2007-8#1)(2008-10#11)(2008-2#1)(2008-7#1)(2012-2#1)
of variation ranged from##4##4##(1990-11#1)(1996-4#1)(1996-8#1)(2008-10#1)
of variation values##2##3##(2007-1#1)(2008-10#1)
of variation was##9##3##(1994-3#1)(1994-9#1)(2005-4#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-3#1)(2012-12#1)
of variation were estimated##2##4##(2008-10#2)
of variation were##19##3##(1990-12#1)(1990-6#1)(1993-2#1)(1995-12#1)(1996-4#1)(1996-8#1)(1997-3#1)(2008-10#10)(2008-3#1)(2010-5#1)
of variation##227##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-6#4)(1990-8#2)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-8#3)(1991-9#2)(1992-2#2)(1992-3#2)(1992-6#1)(1992-8#1)(1993-2#2)(1993-3#1)(1993-8#2)(1994-10#1)(1994-3#2)(1994-4#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-2#2)(1996-3#6)(1996-4#2)(1996-5#2)(1996-6#4)(1996-8#3)(1996-9#2)(1997-1#1)(1997-3#2)(1997-8#4)(2004-11#2)(2004-3#1)(2005-12#1)(2005-4#1)(2006-10#1)(2006-5#2)(2006-9#2)(2007-1#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#50)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#7)(2008-8#8)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#4)(2010-8#4)(2011-1#1)(2011-2#8)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#4)(2013-7#2)(2013-8#1)
of variation)##3##2##(1991-5#1)(1995-2#1)(2008-8#1)
of variations and##2##3##(2010-1#1)(2010-12#1)
of variations in the##6##4##(1992-3#1)(1997-5#1)(2006-12#2)(2007-12#1)(2012-11#1)
of variations in##14##3##(1992-3#1)(1995-8#1)(1997-5#1)(2005-11#1)(2006-12#2)(2006-5#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-7#2)(2012-1#1)(2012-11#1)
of variations of the human coronary arteries##2##7##(2005-10#2)
of variations of the##5##4##(2005-10#3)(2005-8#1)(2008-7#1)
of variations of##8##3##(1990-12#1)(2005-10#3)(2005-8#1)(2008-12#1)(2008-7#1)(2012-3#1)
of variations on##2##3##(2008-11#1)(2013-8#1)
of variations##34##2##(1990-12#1)(1992-3#1)(1995-8#1)(1997-5#1)(2005-10#3)(2005-11#1)(2005-8#1)(2006-12#2)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-2#1)(2010-1#1)(2010-12#1)(2012-1#1)(2012-11#1)(2012-3#1)(2013-8#1)
of variceal bleeding##3##3##(1995-9#2)(2012-2#1)
of varicella and##3##3##(2008-4#3)
of varicella##12##2##(1997-5#1)(2007-9#3)(2008-12#2)(2008-4#3)(2008-7#1)(2009-5#1)(2010-8#1)
of varices##4##2##(1991-5#1)(2009-8#1)(2009-9#2)
of varicocele in##2##3##(1990-3#1)(2006-9#1)
of varicocele##5##2##(1990-3#3)(2006-10#1)(2006-9#1)
of varicose veins##5##3##(2005-10#1)(2006-6#1)(2009-4#1)(2011-3#2)
of varicose##7##2##(1997-3#1)(2005-10#1)(2006-6#2)(2009-4#1)(2011-3#2)
of varicosities##2##2##(1996-9#1)(2007-10#1)
of varied##16##2##(1994-6#1)(2005-12#1)(2005-7#1)(2006-1#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-1#4)
of varieties##2##2##(2008-12#1)(2009-6#1)
of variety of##4##3##(1997-3#1)(2007-11#1)(2007-9#1)(2009-7#1)
of variola##3##2##(2009-9#3)
of various DNA##2##3##(1997-7#1)(2008-11#1)
of various NADH-ubiquinone oxidoreductases##2##4##(1996-9#2)
of various age groups##4##4##(2010-12#3)(2012-2#1)
of various agents##4##3##(1992-4#1)(1992-5#1)(2008-5#1)(2008-6#1)
of various ages and##2##4##(1993-7#1)(2006-5#1)
of various ages##8##3##(1991-10#1)(1992-5#1)(1993-7#1)(1993-9#1)(1995-9#1)(2006-5#1)(2007-8#1)(2008-10#1)
of various ailments##2##3##(2007-6#1)(2008-7#1)
of various antigens##2##3##(1995-5#1)(2008-4#1)
of various aspects of the##2##5##(2007-9#1)(2009-10#1)
of various aspects of##5##4##(2006-5#1)(2006-8#1)(2007-9#1)(2008-11#1)(2009-10#1)
of various aspects##7##3##(1994-2#1)(2006-5#1)(2006-8#1)(2007-9#1)(2008-11#1)(2008-5#1)(2009-10#1)
of various base metals##2##4##(2008-10#2)
of various biochemical parameters##3##4##(2008-5#1)(2010-12#1)(2012-2#1)
of various biological##4##3##(2007-8#1)(2008-11#1)(2008-9#1)(2012-1#1)
of various biomolecules##4##3##(2008-10#1)(2008-9#1)(2010-5#1)(2011-2#1)
of various body parts##3##4##(1992-3#1)(2006-11#1)(2007-12#1)
of various body##4##3##(1992-3#1)(2006-11#1)(2007-12#1)(2013-1#1)
of various brands of##2##4##(1996-8#1)(2008-10#1)
of various cancers##3##3##(2008-9#1)(2010-8#1)(2012-2#1)
of various carbohydrates##3##3##(2007-7#1)(2008-10#2)
of various cations and anions##2##5##(2008-10#2)
of various cations and##3##4##(1997-7#1)(2008-10#2)
of various cations##4##3##(1997-7#1)(2008-10#3)
of various causes of vaginal discharge##2##6##(2007-7#2)
of various causes##3##3##(2007-7#2)(2013-1#1)
of various cell lines##3##4##(1993-3#1)(2007-2#1)(2008-11#1)
of various cell types##8##4##(1991-10#1)(1994-11#1)(2010-7#1)(2011-1#1)(2012-11#2)(2012-3#1)(2013-8#1)
of various cell##14##3##(1991-10#1)(1992-10#1)(1993-3#1)(1994-11#1)(1994-12#1)(2007-2#1)(2008-11#1)(2010-7#1)(2011-1#1)(2012-11#2)(2012-3#1)(2013-1#1)(2013-8#1)
of various cellular##2##3##(2007-8#1)(2012-3#1)
of various chemical modifiers##2##4##(2008-10#2)
of various chemical##3##3##(2007-12#1)(2008-10#2)
of various classes##3##3##(1991-8#1)(1995-10#1)(2012-1#1)
of various cleansing##2##3##(1990-8#2)
of various clinical conditions##2##4##(1992-4#1)(2008-4#1)
of various clinical##4##3##(1992-4#1)(2006-8#1)(2007-8#1)(2008-4#1)
of various combinations of##4##4##(1996-12#1)(2007-11#1)(2008-2#1)(2010-4#1)
of various commercially available##2##4##(2008-3#1)(2012-2#1)
of various complexes##2##3##(2005-11#1)(2008-10#1)
of various components of##2##4##(1991-2#1)(1996-4#1)
of various components##7##3##(1991-2#1)(1996-4#1)(2008-10#3)(2008-2#1)(2008-3#1)
of various compositions##3##3##(1991-3#1)(2008-10#2)
of various compounds##5##3##(1990-7#1)(2005-10#1)(2008-10#3)
of various concentrations of##7##4##(1990-9#1)(1991-6#1)(1992-5#1)(1992-8#1)(1996-5#1)(2007-8#1)(2008-12#1)
of various concentrations##9##3##(1990-9#1)(1991-6#1)(1992-5#1)(1992-8#1)(1996-5#1)(2005-11#1)(2007-8#1)(2008-12#1)(2008-5#1)
of various culture##2##3##(2007-12#1)(2008-11#1)
of various cytokines##3##3##(1993-8#1)(1997-8#1)(2008-4#1)
of various cytotoxic##2##3##(1997-7#1)(2008-3#1)
of various degrees##2##3##(2005-10#1)(2008-5#1)
of various dietary##3##3##(1993-5#1)(2006-10#1)(2008-5#1)
of various dipeptides##2##3##(1993-12#1)(2011-2#1)
of various disease##2##3##(2007-1#1)(2010-12#1)
of various diseases##12##3##(1991-12#1)(1997-2#1)(1997-6#1)(2005-3#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)(2010-1#1)(2012-3#1)
of various domains of##2##4##(2008-7#1)(2012-2#1)
of various doses of##3##4##(1993-6#1)(1994-3#1)(2008-11#1)
of various doses##4##3##(1993-6#1)(1994-3#1)(2008-11#1)(2009-3#1)
of various drugs##5##3##(2008-2#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
of various environmental##2##3##(2005-12#1)(2008-10#1)
of various experimental##4##3##(2007-4#1)(2007-9#1)(2008-10#2)
of various external##2##3##(1993-11#1)(2008-5#1)
of various factors on##4##4##(2007-8#1)(2008-10#1)(2008-5#1)(2013-8#1)
of various factors to##2##4##(2008-11#1)(2009-4#1)
of various factors##9##3##(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2009-4#1)(2013-8#1)
of various features of##2##4##(2008-3#1)(2010-2#1)
of various foreign##3##3##(2008-10#3)
of various forms of##10##4##(1990-1#1)(1990-5#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-2#1)(2007-8#1)(2008-5#1)(2013-8#1)
of various forms##11##3##(1990-1#1)(1990-5#1)(1997-6#1)(2005-8#1)(2006-10#2)(2006-5#1)(2007-2#1)(2007-8#1)(2008-5#1)(2013-8#1)
of various formulations##2##3##(2006-12#1)(2008-5#1)
of various functional##3##3##(1994-6#1)(2008-11#1)(2012-11#1)
of various genes##3##3##(2009-8#1)(2011-2#2)
of various genomic##2##3##(2008-7#1)(2009-5#1)
of various geometries##2##3##(2008-7#1)(2011-1#1)
of various health##2##3##(1996-1#1)(2013-7#1)
of various heavy metals##2##4##(2011-12#2)
of various human##4##3##(1992-12#1)(1993-3#2)(2008-2#1)
of various immunological##2##3##(2005-8#1)(2010-7#1)
of various infections##2##3##(2006-7#1)(2008-7#1)
of various inflammatory##4##3##(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#1)
of various ions was##2##4##(2007-8#1)(2008-10#1)
of various ions##5##3##(2007-8#1)(2008-10#4)
of various kinds of##7##4##(1991-5#1)(1993-9#1)(1994-6#1)(1995-2#1)(2007-8#1)(2008-3#1)(2008-4#1)
of various kinds##8##3##(1991-5#1)(1993-9#1)(1994-6#1)(1995-2#1)(2007-8#1)(2008-3#1)(2008-4#1)(2009-6#1)
of various lengths##4##3##(1995-8#1)(1996-5#1)(2008-9#1)(2012-12#1)
of various levels of social anxiety##2##6##(2008-2#2)
of various levels of##3##4##(2008-2#2)(2009-2#1)
of various ligands##2##3##(1993-7#1)(2008-10#1)
of various malignancies##2##3##(2010-10#1)(2010-12#1)
of various mammals##2##3##(1992-11#1)(2008-7#1)
of various manifestations of##2##4##(1990-12#1)(1993-9#1)
of various measures##2##3##(1992-11#1)(2011-2#1)
of various mechanisms##2##3##(2008-11#1)(2008-4#1)
of various metabolic##3##3##(1997-5#1)(2005-3#1)(2011-1#1)
of various metal ions##4##4##(1997-4#1)(2005-11#1)(2008-10#2)
of various metal##5##3##(1997-4#1)(2005-11#1)(2008-10#3)
of various methods##7##3##(2004-10#1)(2005-11#1)(2007-8#1)(2008-2#1)(2008-7#1)(2012-1#1)(2012-3#1)
of various model##2##3##(1990-2#1)(1992-2#1)
of various molecular##3##3##(2007-9#1)(2008-10#1)(2013-1#1)
of various mutants##2##3##(1993-2#1)(1994-8#1)
of various neurotransmitter##2##3##(1991-10#1)(1993-11#1)
of various novel##2##3##(2008-8#1)(2009-7#1)
of various optical##2##3##(2008-2#1)(2008-3#1)
of various optimization##2##3##(2004-8#1)(2009-2#1)
of various organic##4##3##(2008-10#3)(2009-8#1)
of various organs##5##3##(1991-12#1)(1994-4#1)(1997-8#1)(2005-8#1)(2008-10#1)
of various origin in the##2##5##(1995-5#1)(2008-5#1)
of various origin##5##3##(1990-11#1)(1995-5#1)(2008-5#1)(2009-4#2)
of various origins##3##3##(2005-11#1)(2008-5#1)(2012-2#1)
of various other##5##3##(1990-3#1)(1995-1#1)(2006-9#1)(2007-7#1)(2010-9#1)
of various oxidative##2##3##(2008-10#1)(2010-4#1)
of various parameters on##2##4##(2008-10#1)(2013-1#1)
of various parameters such as pH##4##6##(2006-12#1)(2007-8#1)(2008-10#1)(2008-5#1)
of various parameters such as##5##5##(2006-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
of various parameters##15##3##(2006-12#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-5#2)(2008-7#1)(2009-6#1)(2011-2#1)(2013-1#1)
of various parts of the##2##5##(2008-10#1)(2009-9#1)
of various physico-chemical parameters##2##4##(2008-10#1)(2008-5#1)
of various physicochemical##2##3##(2008-10#1)(2012-2#1)
of various procedures##2##3##(2007-12#2)
of various promoter##2##3##(1996-5#1)(1997-2#1)
of various proportions##2##3##(2008-10#2)
of various protease inhibitors##2##4##(1991-1#1)(1991-2#1)
of various protein##2##3##(2008-2#1)(2010-12#1)
of various proteins in##2##4##(1991-12#1)(2010-12#1)
of various proteins##5##3##(1991-12#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-12#1)
of various radiation##2##3##(2008-2#1)(2008-7#1)
of various recombinant##2##3##(1994-8#1)(2008-11#1)
of various regions##2##3##(1997-7#1)(2007-6#1)
of various risk factors##4##4##(2006-6#1)(2007-11#1)(2008-7#1)(2011-1#1)
of various risk##5##3##(2006-6#1)(2007-11#1)(2008-7#1)(2008-8#1)(2011-1#1)
of various salts on the##2##5##(1990-2#1)(2005-11#1)
of various scattering media (aerosols##2##5##(2008-3#2)
of various signals##2##3##(2006-10#1)(2008-2#1)
of various sites##2##3##(1990-8#1)(2008-8#1)
of various size##2##3##(1993-9#1)(2008-1#1)
of various sizes and##3##4##(1997-3#1)(2006-11#1)(2013-1#1)
of various sizes##16##3##(1993-3#1)(1993-9#1)(1995-1#1)(1997-3#1)(1997-8#1)(2006-11#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#2)(2008-9#1)(2012-2#1)(2013-1#1)
of various skin##2##3##(1991-6#1)(2006-12#1)
of various solvents##2##3##(2008-10#2)
of various species of##2##4##(1992-1#1)(2007-8#1)
of various species##6##3##(1991-12#1)(1991-6#1)(1992-1#1)(2007-8#1)(2008-10#1)(2008-8#1)
of various stages##3##3##(1996-6#1)(1997-4#1)(2008-5#1)
of various strains of##2##4##(1994-2#1)(2008-8#1)
of various studies##2##3##(2010-12#1)(2012-3#1)
of various substances##2##3##(1997-8#1)(2010-12#1)
of various substrates##4##3##(1992-6#1)(2005-11#1)(2006-6#1)(2011-12#1)
of various systems##2##3##(2007-1#1)(2012-11#1)
of various technical##2##3##(2008-9#1)(2010-2#1)
of various techniques of spinal anesthesia in day##2##8##(2012-3#2)
of various techniques of##3##4##(2007-11#1)(2012-3#2)
of various techniques##10##3##(2006-10#1)(2007-11#1)(2008-2#1)(2008-9#1)(2009-5#1)(2010-7#1)(2010-9#2)(2012-3#2)
of various thoracic##2##3##(2007-4#1)(2007-6#1)
of various tissues##7##3##(1992-6#1)(1993-12#1)(1996-4#1)(1997-2#1)(2008-4#1)(2012-2#1)(2013-1#1)
of various treatment options##2##4##(2006-12#1)(2007-12#1)
of various treatment##3##3##(2006-12#1)(2007-12#1)(2009-8#1)
of various trophic factors##2##4##(2008-1#1)(2008-11#1)
of various types of cancer##2##5##(2008-8#1)(2013-8#1)
of various types of##20##4##(1994-11#1)(2007-5#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-4#1)(2010-4#1)(2012-2#1)(2013-8#1)
of various types##24##3##(1994-11#1)(2004-12#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-4#1)(2010-4#1)(2012-2#1)(2013-8#1)
of various water##2##3##(2008-1#1)(2008-5#1)
of various xenobiotics##2##3##(1994-6#1)(2010-9#1)
of various##948##2##(1990-1#1)(1990-10#1)(1990-11#6)(1990-12#2)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#3)(1990-8#6)(1990-9#2)(1991-1#2)(1991-10#4)(1991-12#6)(1991-2#5)(1991-3#1)(1991-4#3)(1991-5#2)(1991-6#4)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#2)(1992-5#3)(1992-6#5)(1992-7#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#7)(1993-2#2)(1993-3#4)(1993-5#2)(1993-6#4)(1993-7#2)(1993-8#2)(1993-9#7)(1994-11#3)(1994-12#3)(1994-2#6)(1994-3#6)(1994-4#1)(1994-5#3)(1994-6#5)(1994-7#1)(1994-8#2)(1994-9#4)(1995-1#2)(1995-10#1)(1995-12#3)(1995-2#2)(1995-3#4)(1995-5#4)(1995-8#2)(1995-9#1)(1996-1#5)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-4#4)(1996-5#9)(1996-6#4)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#6)(1997-3#2)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#6)(1997-8#8)(2004-10#1)(2004-11#1)(2004-12#1)(2004-3#1)(2004-4#1)(2004-8#1)(2005-10#2)(2005-11#13)(2005-12#1)(2005-3#2)(2005-8#4)(2005-9#1)(2006-10#13)(2006-11#2)(2006-12#7)(2006-2#1)(2006-4#2)(2006-5#5)(2006-6#3)(2006-7#2)(2006-8#5)(2006-9#3)(2007-1#5)(2007-10#4)(2007-11#13)(2007-12#13)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#4)(2007-7#8)(2007-8#20)(2007-9#4)(2008-1#12)(2008-10#114)(2008-11#31)(2008-12#5)(2008-2#35)(2008-3#33)(2008-4#21)(2008-5#36)(2008-6#5)(2008-7#24)(2008-8#14)(2008-9#10)(2009-10#5)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#3)(2009-4#5)(2009-5#4)(2009-6#3)(2009-7#2)(2009-8#6)(2009-9#2)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#22)(2010-2#3)(2010-3#6)(2010-4#6)(2010-5#5)(2010-6#1)(2010-7#4)(2010-8#3)(2010-9#5)(2011-1#12)(2011-12#4)(2011-2#19)(2012-1#6)(2012-11#5)(2012-12#6)(2012-2#19)(2012-3#14)(2012-7#1)(2013-1#22)(2013-7#2)(2013-8#11)
of varying amounts of##2##4##(1994-11#1)(1995-1#1)
of varying amounts##3##3##(1994-11#1)(1995-1#1)(2008-9#1)
of varying chain length##2##4##(2007-11#1)(2008-4#1)
of varying composition##2##3##(1995-5#1)(2008-10#1)
of varying concentrations of##4##4##(1995-10#1)(2006-1#1)(2008-10#1)(2011-1#1)
of varying concentrations##6##3##(1995-10#1)(1995-7#1)(2006-1#1)(2008-10#1)(2008-12#1)(2011-1#1)
of varying degrees of##4##4##(1991-6#1)(2006-10#1)(2008-5#1)(2008-7#1)
of varying dilutions##2##3##(2011-12#2)
of varying etiology##4##3##(1992-10#1)(2007-11#2)(2008-4#1)
of varying intensity##2##3##(2009-3#1)(2012-2#1)
of varying length##2##3##(2005-11#1)(2007-5#1)
of varying lengths and##2##4##(1993-4#1)(1994-6#1)
of varying lengths##4##3##(1993-4#1)(1994-6#1)(1995-6#1)(2008-11#1)
of varying proportions of##2##4##(1993-8#1)(2008-7#1)
of varying proportions##3##3##(1993-8#1)(2008-10#1)(2008-7#1)
of varying severity##7##3##(1995-12#1)(2007-2#1)(2009-6#1)(2011-2#3)(2012-2#1)
of varying size##2##3##(1995-3#1)(2008-10#1)
of varying the##13##3##(1990-6#1)(1991-1#1)(1994-9#1)(1995-8#1)(2008-3#4)(2010-6#1)(2011-2#2)(2012-1#1)(2012-2#1)
of varying##116##2##(1990-12#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-6#1)(1992-10#1)(1992-9#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-8#1)(1997-6#1)(1997-7#1)(2004-8#1)(2005-11#2)(2005-9#1)(2006-1#1)(2006-10#1)(2007-11#6)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#15)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#11)(2008-4#2)(2008-5#4)(2008-7#2)(2008-9#4)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#6)(2012-1#1)(2012-2#5)(2012-3#1)(2012-4#1)(2013-8#1)
of varying-coefficient models##2##3##(1997-7#2)
of vas##2##2##(1997-8#1)(2010-4#1)
of vascular access for hemodialysis##2##5##(2007-7#2)
of vascular access in##4##4##(2007-7#4)
of vascular access thrombosis and##2##5##(2006-5#1)(2007-7#1)
of vascular access##19##3##(2006-5#1)(2007-7#16)(2007-8#1)(2013-1#1)
of vascular accesses##2##3##(2007-7#1)(2008-4#1)
of vascular anatomy##2##3##(2008-7#1)(2012-2#1)
of vascular and##5##3##(2006-5#1)(2007-12#1)(2008-1#1)(2011-2#1)(2013-1#1)
of vascular bed lesion in##2##5##(2008-6#2)
of vascular bundle implantation##2##4##(2009-3#2)
of vascular calcification##3##3##(2007-8#1)(2009-1#1)(2012-12#1)
of vascular cells##2##3##(1994-5#1)(2006-5#1)
of vascular complications in##6##4##(2007-8#1)(2007-9#1)(2008-1#3)(2011-1#1)
of vascular complications##9##3##(2007-8#1)(2007-9#1)(2008-1#4)(2011-1#1)(2011-2#2)
of vascular corrosion casts##3##4##(2011-2#3)
of vascular damage##2##3##(1996-10#1)(2007-10#1)
of vascular dementia in##2##4##(2007-10#2)
of vascular dementia##6##3##(1996-11#1)(2007-10#3)(2007-9#1)(2008-7#1)
of vascular disease##8##3##(1990-3#1)(1993-2#1)(1997-8#1)(2005-10#1)(2005-12#1)(2008-3#1)(2010-12#2)
of vascular diseases of the##2##5##(1992-10#1)(2010-12#1)
of vascular diseases##10##3##(1991-11#1)(1992-10#1)(2006-10#1)(2008-1#1)(2008-5#1)(2010-12#1)(2010-4#2)(2013-1#2)
of vascular endothelial cell##3##4##(1990-4#1)(1994-5#1)(1996-12#1)
of vascular endothelial cells##7##4##(1996-12#3)(1997-1#1)(2008-3#1)(2009-3#1)(2012-2#1)
of vascular endothelial growth factor (VEGF) and##2##7##(2008-7#1)(2009-5#1)
of vascular endothelial growth factor (VEGF) has been##2##8##(2005-7#1)(2012-12#1)
of vascular endothelial growth factor (VEGF) in##3##7##(2008-2#1)(2008-9#1)(2013-1#1)
of vascular endothelial growth factor (VEGF)##10##6##(1995-1#1)(2005-7#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
of vascular endothelial growth factor and its receptor##2##8##(2008-9#1)(2009-5#1)
of vascular endothelial growth factor and##3##6##(2008-9#1)(2009-5#1)(2011-2#1)
of vascular endothelial growth factor in##2##6##(2008-9#1)(2011-2#1)
of vascular endothelial growth factor##19##5##(1995-1#2)(1997-7#1)(2005-7#1)(2008-2#1)(2008-7#1)(2008-9#3)(2009-5#2)(2010-12#2)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)
of vascular endothelial growth##21##4##(1995-1#3)(1997-7#1)(2005-7#1)(2008-2#1)(2008-7#1)(2008-9#3)(2009-5#2)(2009-8#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)
of vascular endothelial##32##3##(1990-4#1)(1994-5#1)(1995-1#3)(1996-12#4)(1997-1#1)(1997-7#1)(2005-7#1)(2007-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#3)(2009-3#1)(2009-5#2)(2009-8#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
of vascular endothelium##3##3##(1994-8#1)(2009-5#1)(2013-8#1)
of vascular events##2##3##(2005-10#1)(2007-10#1)
of vascular function##2##3##(1993-6#1)(2013-8#1)
of vascular growth##2##3##(1994-12#1)(1995-8#1)
of vascular injury##11##3##(1992-12#2)(1994-11#1)(1994-5#1)(2007-10#4)(2009-8#1)(2012-2#1)(2013-1#1)
of vascular integrity##2##3##(2008-1#1)(2012-3#1)
of vascular invasion##4##3##(1990-10#1)(1990-6#1)(2007-8#1)(2011-2#1)
of vascular lesions##7##3##(1992-4#1)(2007-6#5)(2007-9#1)
of vascular malformations##3##3##(2007-6#1)(2007-9#2)
of vascular pathology##2##3##(2008-10#1)(2013-8#1)
of vascular pericytes##2##3##(1993-3#2)
of vascular permeability factor##3##4##(1991-2#1)(1991-9#2)
of vascular permeability##4##3##(1991-2#1)(1991-9#2)(1994-12#1)
of vascular plants##3##3##(2008-9#2)(2009-8#1)
of vascular remodeling##6##3##(1994-9#1)(2012-12#4)(2012-2#1)
of vascular risk factors##4##4##(2007-10#2)(2008-7#1)(2010-9#1)
of vascular smooth muscle and##2##5##(1990-8#1)(1997-4#1)
of vascular smooth muscle cells (VSMC)##3##6##(1990-12#1)(1995-3#1)(2008-1#1)
of vascular smooth muscle cells##10##5##(1990-12#2)(1990-7#1)(1992-8#1)(1994-11#1)(1994-9#2)(1995-3#1)(2008-1#1)(2008-5#1)
of vascular smooth muscle##19##4##(1990-12#3)(1990-7#1)(1990-8#2)(1991-10#1)(1991-12#1)(1992-8#1)(1994-11#2)(1994-9#2)(1995-3#1)(1997-4#1)(2008-1#1)(2008-5#1)(2009-5#1)(2010-12#1)
of vascular smooth##20##3##(1990-12#3)(1990-7#1)(1990-8#2)(1991-10#1)(1991-12#1)(1992-8#1)(1994-11#2)(1994-9#2)(1995-3#1)(1997-4#1)(2005-1#1)(2008-1#1)(2008-5#1)(2009-5#1)(2010-12#1)
of vascular structures##2##3##(2007-9#1)(2010-9#1)
of vascular surgery##2##3##(2004-7#1)(2011-3#1)
of vascular tissues##3##3##(1993-8#1)(2008-5#1)(2008-9#1)
of vascular tone##3##3##(2008-1#1)(2008-5#1)(2009-4#1)
of vascular wall##4##3##(1997-2#1)(2005-7#1)(2006-6#1)(2009-7#1)
of vascular##271##2##(1990-10#4)(1990-12#4)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-9#2)(1992-10#1)(1992-12#3)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-10#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#3)(1994-12#3)(1994-5#4)(1994-8#1)(1994-9#4)(1995-1#4)(1995-11#1)(1995-2#1)(1995-3#3)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#4)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-7#1)(2005-1#1)(2005-10#2)(2005-11#1)(2005-12#2)(2005-7#2)(2005-8#1)(2006-10#2)(2006-5#4)(2006-6#2)(2007-10#12)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#8)(2007-7#18)(2007-8#4)(2007-9#6)(2008-1#12)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#6)(2008-9#6)(2009-1#1)(2009-3#4)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#4)(2010-12#7)(2010-4#3)(2010-7#1)(2010-9#4)(2011-1#2)(2011-2#12)(2011-3#2)(2012-1#1)(2012-12#7)(2012-2#7)(2012-3#2)(2013-1#8)(2013-8#5)
of vascularization##2##2##(2006-5#1)(2008-10#1)
of vasculature in##3##3##(2008-2#1)(2008-9#1)(2013-1#1)
of vasculature##4##2##(2008-2#2)(2008-9#1)(2013-1#1)
of vasculitis and##3##3##(2006-10#1)(2010-6#1)(2011-2#1)
of vasculitis in##2##3##(2006-10#1)(2008-1#1)
of vasculitis##17##2##(1997-8#1)(2005-8#2)(2006-10#6)(2007-10#1)(2007-7#1)(2008-1#2)(2008-3#1)(2010-6#2)(2011-2#1)
of vasoactive agents##2##3##(2006-10#1)(2009-8#1)
of vasoactive drugs##2##3##(1990-3#1)(2006-10#1)
of vasoactive intestinal peptide (VIP)##2##5##(1994-3#1)(2006-6#1)
of vasoactive intestinal peptide receptors##2##5##(1994-3#1)(1994-9#1)
of vasoactive intestinal peptide##4##4##(1994-3#2)(1994-9#1)(2006-6#1)
of vasoactive intestinal polypeptide##2##4##(1990-5#1)(1997-8#1)
of vasoactive intestinal##9##3##(1990-5#1)(1991-2#1)(1993-7#1)(1994-3#2)(1994-9#1)(1997-8#1)(2006-6#1)(2012-3#1)
of vasoactive mediators and##2##4##(1996-2#1)(2006-8#1)
of vasoactive mediators##3##3##(1996-2#1)(2006-10#1)(2006-8#1)
of vasoactive##23##2##(1990-3#1)(1990-5#1)(1991-2#1)(1991-5#1)(1993-7#1)(1993-8#1)(1994-3#2)(1994-9#2)(1995-4#1)(1996-2#1)(1997-8#1)(2006-10#3)(2006-6#1)(2006-8#1)(2009-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)
of vasoconstriction##3##2##(1990-2#1)(1993-3#1)(2006-10#1)
of vasoconstrictor##3##2##(1991-3#1)(1993-1#1)(2008-10#1)
of vasodilation##2##2##(1991-9#1)(1997-2#1)
of vasodilator##4##2##(1990-9#2)(1996-6#1)(2008-3#1)
of vasodilators in##2##3##(2007-8#1)(2008-3#1)
of vasodilators##4##2##(1995-11#1)(2007-8#1)(2008-3#2)
of vasodilatory##2##2##(1997-1#1)(2007-9#1)
of vasomotor symptoms##2##3##(2007-6#1)(2008-11#1)
of vasomotor##3##2##(1990-7#1)(2007-6#1)(2008-11#1)
of vasopressin and##3##3##(1992-5#1)(1993-4#1)(1994-9#1)
of vasopressin from##2##3##(1994-10#1)(2013-1#1)
of vasopressin in##3##3##(1991-7#1)(2006-4#1)(2007-9#1)
of vasopressin on##2##3##(1990-11#1)(1997-4#1)
of vasopressin receptor##2##3##(2008-2#1)(2013-8#1)
of vasopressin receptors##3##3##(1991-3#1)(1994-2#1)(1995-12#1)
of vasopressin##32##2##(1990-11#1)(1991-3#1)(1991-7#1)(1992-5#2)(1993-2#1)(1993-4#3)(1994-10#4)(1994-12#1)(1994-2#1)(1994-9#2)(1995-12#2)(1995-7#1)(1995-9#2)(1997-4#2)(2006-4#1)(2006-8#1)(2007-9#1)(2008-2#1)(2009-8#1)(2013-1#2)(2013-8#1)
of vasopressin-containing cells##2##3##(1993-12#2)
of vasopressin-secreting##2##2##(1993-4#2)
of vasopressors##3##2##(2012-3#1)(2013-1#2)
of vasospasm and##3##3##(2006-11#1)(2007-9#1)(2008-7#1)
of vasospasm in##2##3##(1991-3#1)(2006-11#1)
of vasospasm was##2##3##(2007-10#1)(2012-3#1)
of vasospasm##14##2##(1991-3#1)(1994-11#1)(1997-3#1)(2006-11#3)(2007-10#1)(2007-9#2)(2008-3#2)(2008-7#1)(2012-3#2)
of vasovagal syncope##4##3##(2006-9#4)
of vast##3##2##(2008-9#1)(2012-12#1)(2013-1#1)
of vector and##3##3##(1994-8#1)(2006-4#1)(2008-10#1)
of vector control##4##3##(2007-2#1)(2007-6#1)(2010-1#2)
of vector translation coefficients##2##4##(2008-2#2)
of vector transmission##2##3##(2008-10#2)
of vector##34##2##(1994-8#1)(2004-11#1)(2006-4#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-6#2)(2007-9#1)(2008-10#6)(2008-11#2)(2008-2#5)(2008-3#2)(2008-8#1)(2010-1#2)(2011-1#1)(2013-1#1)(2013-7#1)
of vector-borne diseases##2##3##(2008-11#1)(2010-1#1)
of vector-borne##4##2##(2006-10#1)(2008-11#1)(2008-8#1)(2010-1#1)
of vectors carrying##3##3##(2008-10#1)(2008-11#2)
of vectors has##2##3##(1992-7#1)(1997-4#1)
of vectors in##2##3##(2007-8#1)(2008-2#1)
of vectors that##2##3##(1994-5#1)(2008-11#1)
of vectors to##2##3##(2008-11#1)(2012-3#1)
of vectors##23##2##(1990-3#1)(1992-7#1)(1994-12#1)(1994-5#1)(1995-5#1)(1997-4#1)(2006-4#1)(2007-8#1)(2008-10#3)(2008-11#6)(2008-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
of vecuronium##2##2##(2009-6#1)(2010-7#1)
of vegetable oil##2##3##(2006-10#1)(2012-2#1)
of vegetable oils in##4##4##(2008-7#1)(2013-1#3)
of vegetable oils##7##3##(1990-8#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#3)
of vegetable##14##2##(1990-8#1)(1991-5#1)(1997-4#1)(2006-10#1)(2008-10#3)(2008-3#1)(2008-7#1)(2012-2#2)(2013-1#3)
of vegetables and fruits##3##4##(1991-5#1)(2009-8#1)(2012-2#1)
of vegetables and##7##3##(1991-5#1)(1993-9#1)(2009-8#1)(2011-2#1)(2012-12#2)(2012-2#1)
of vegetables##14##2##(1991-5#1)(1992-12#1)(1992-8#1)(1993-9#1)(2007-9#2)(2008-10#3)(2009-8#1)(2011-2#1)(2012-12#2)(2012-2#1)
of vegetal##3##2##(2005-10#1)(2008-10#1)(2008-5#1)
of vegetation and##2##3##(2008-3#1)(2008-9#1)
of vegetation heterogeneity##2##3##(2008-8#2)
of vegetation on##3##3##(2008-5#1)(2008-8#1)(2011-12#1)
of vegetation##17##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#4)(2008-9#2)(2011-12#2)(2013-7#1)(2013-8#3)
of vegetative activation##2##3##(1991-1#1)(1991-10#1)
of vegetative and##2##3##(2009-10#1)(2010-9#1)
of vegetative compatibility groups##2##4##(2008-10#2)
of vegetative compatibility##3##3##(2008-10#3)
of vegetative tissues##2##3##(1994-3#1)(2006-12#1)
of vegetative##14##2##(1991-1#1)(1991-10#1)(1994-3#1)(2006-12#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-12#1)(2009-10#1)(2010-9#1)
of vegetatively##2##2##(2008-10#2)
of vehicle controls##3##3##(1991-1#1)(2008-9#2)
of vehicle kilometres##2##3##(2011-2#2)
of vehicle or##2##3##(1992-11#1)(1996-1#1)
of vehicle##14##2##(1991-1#1)(1992-11#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-1#1)(2008-2#1)(2008-9#3)(2011-2#3)(2012-12#1)
of vehicle-treated##2##2##(1991-2#1)(1996-11#1)
of vehicles##5##2##(2006-11#1)(2008-5#1)(2009-6#1)(2010-5#2)
of vein formation##2##3##(2009-6#2)
of vein graft##2##3##(1996-2#1)(2011-3#1)
of vein##7##2##(1996-2#1)(2009-4#1)(2009-6#3)(2011-2#1)(2011-3#1)
of veins##5##2##(1990-11#2)(1991-9#1)(2008-7#1)(2009-6#1)
of velocities##2##2##(2007-12#2)
of velocity and##3##3##(2007-4#1)(2008-2#1)(2008-3#1)
of velocity##14##2##(1990-5#1)(1993-5#1)(1996-5#1)(2006-11#1)(2007-4#2)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#4)
of velvet##3##2##(2008-2#3)
of veneering porcelain##2##3##(2010-12#1)(2013-8#1)
of venereal##2##2##(1992-2#1)(2013-1#1)
of venlafaxine and##2##3##(2010-5#1)(2011-1#1)
of venlafaxine##3##2##(2008-8#1)(2010-5#1)(2011-1#1)
of venomous##3##2##(2009-6#2)(2013-7#1)
of venous and arterial##3##4##(2005-7#1)(2008-10#1)(2011-3#1)
of venous blood samples##2##4##(2008-7#1)(2013-7#1)
of venous blood##4##3##(2008-7#1)(2008-9#1)(2009-6#1)(2013-7#1)
of venous catheter##2##3##(2007-7#1)(2010-6#1)
of venous congestion##4##3##(1997-6#1)(2007-7#3)
of venous drainage##2##3##(2010-8#1)(2012-12#1)
of venous insufficiency##2##3##(2005-10#1)(2006-12#1)
of venous leg##3##3##(1990-6#1)(1997-3#1)(2012-12#1)
of venous pressure##2##3##(2007-7#2)
of venous stroke##3##3##(2007-10#3)
of venous thromboembolic disease in primary care]##2##7##(1996-3#1)(1996-9#1)
of venous thromboembolic##3##3##(1996-3#1)(1996-9#1)(2012-3#1)
of venous thromboembolism (VTE)##3##4##(2006-2#1)(2011-2#1)(2013-1#1)
of venous thromboembolism associated with##3##5##(1996-11#1)(2007-2#1)(2010-12#1)
of venous thromboembolism in##5##4##(1993-5#1)(2006-2#2)(2010-11#2)
of venous thromboembolism prophylaxis##2##4##(2011-2#1)(2012-2#1)
of venous thromboembolism##23##3##(1993-5#2)(1996-11#2)(2006-2#3)(2007-10#2)(2007-12#1)(2007-2#1)(2010-11#3)(2010-12#2)(2010-7#1)(2011-2#3)(2012-2#1)(2013-1#2)
of venous thrombosis in##3##4##(2006-10#2)(2010-11#1)
of venous thrombosis##10##3##(1994-9#1)(1997-3#1)(2005-1#1)(2006-10#2)(2007-11#1)(2007-9#1)(2010-11#1)(2010-2#1)(2013-7#1)
of venous vascular##2##3##(2007-7#2)
of venous##91##2##(1990-3#2)(1990-6#2)(1992-5#1)(1993-2#1)(1993-5#2)(1994-9#1)(1996-11#2)(1996-3#1)(1996-9#1)(1997-3#2)(1997-6#1)(2005-1#1)(2005-10#1)(2005-7#1)(2006-10#3)(2006-12#2)(2006-2#3)(2006-6#2)(2007-10#6)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#10)(2007-8#3)(2007-9#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-6#1)(2009-8#1)(2010-11#4)(2010-12#4)(2010-2#1)(2010-6#2)(2010-7#3)(2010-8#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#2)(2013-8#1)
of ventilation in##3##3##(1995-7#1)(2005-9#1)(2012-2#1)
of ventilation##16##2##(1994-6#1)(1995-7#1)(1996-12#1)(1997-1#1)(1997-4#1)(2005-9#1)(2006-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-7#1)(2012-2#4)
of ventilator-assisted children##4##3##(2010-7#4)
of ventilator-associated pneumonia##2##3##(2006-10#1)(2013-1#1)
of ventilatory support##5##3##(2005-11#1)(2005-8#2)(2006-9#2)
of ventilatory##11##2##(1994-6#1)(1997-4#1)(2005-11#1)(2005-8#2)(2006-10#2)(2006-9#2)(2007-8#1)(2009-10#1)
of ventral striatal dopamine##2##4##(1993-6#2)
of ventral striatal##4##3##(1992-10#1)(1993-6#2)(2012-1#1)
of ventral##20##2##(1991-2#1)(1991-6#1)(1992-10#1)(1992-9#1)(1993-2#1)(1993-6#3)(1994-12#1)(1995-9#1)(1996-12#1)(1996-6#1)(2008-5#1)(2009-5#2)(2009-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
of ventricle##2##2##(2007-8#1)(2011-2#1)
of ventricular activation time##2##4##(2008-7#2)
of ventricular arrhythmias in##2##4##(1997-8#2)
of ventricular arrhythmias##6##3##(1997-8#2)(2007-2#1)(2008-11#1)(2009-10#1)(2012-3#1)
of ventricular assist devices##2##4##(2010-6#2)
of ventricular contraction##2##3##(1991-2#1)(2006-9#1)
of ventricular dysfunction##2##3##(1994-3#1)(1996-6#1)
of ventricular fibrillation##6##3##(1993-8#1)(1995-12#1)(2006-10#1)(2006-9#1)(2010-1#1)(2010-2#1)
of ventricular function##2##3##(2008-10#1)(2010-7#1)
of ventricular late potentials##3##4##(1996-4#3)
of ventricular repolarization##4##3##(1997-8#3)(2012-3#1)
of ventricular restoration##2##3##(2010-11#2)
of ventricular septal defects##2##4##(2008-4#1)(2010-9#1)
of ventricular septal##4##3##(2008-4#2)(2010-9#1)(2013-7#1)
of ventricular tachycardia and##2##4##(1995-12#1)(2004-11#1)
of ventricular tachycardia##12##3##(1991-2#1)(1993-8#1)(1995-12#1)(1995-6#1)(2004-11#1)(2006-4#2)(2006-9#2)(2009-10#1)(2009-2#1)(2009-4#1)
of ventricular volume##2##3##(1996-3#1)(2005-12#1)
of ventricular##76##2##(1990-9#1)(1991-2#2)(1991-9#1)(1992-5#1)(1992-8#1)(1993-1#2)(1993-8#2)(1994-12#1)(1994-3#2)(1994-8#1)(1995-12#2)(1995-6#2)(1996-3#2)(1996-4#3)(1996-6#1)(1996-9#1)(1997-8#5)(2004-11#1)(2005-12#1)(2006-10#1)(2006-4#2)(2006-9#4)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-7#5)(2008-8#1)(2009-10#3)(2009-2#1)(2009-4#1)(2010-1#1)(2010-11#6)(2010-2#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-3#2)(2013-7#2)
of ventriculoperitoneal shunt##2##3##(2012-12#1)(2012-2#1)
of verapamil and nifedipine on cholesteryl ester##2##7##(1995-1#2)
of verapamil and nifedipine##3##4##(1995-1#3)
of verapamil and##5##3##(1995-1#3)(1995-11#1)(1996-3#1)
of verapamil in##2##3##(1990-6#1)(1991-8#1)
of verapamil##17##2##(1990-3#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-8#1)(1994-8#2)(1995-1#3)(1995-11#1)(1996-1#4)(1996-3#1)(2007-12#1)
of veratridine##3##2##(1992-3#1)(1992-8#1)(1994-3#1)
of verb##2##2##(2007-8#1)(2010-2#1)
of verbal and physical##2##4##(2009-7#1)(2012-11#1)
of verbal and##3##3##(2008-11#1)(2009-7#1)(2012-11#1)
of verbal behavior##2##3##(2006-7#1)(2011-2#1)
of verbal descriptors of dyspnea##2##5##(2008-10#2)
of verbal fluency##3##3##(2008-8#1)(2008-9#1)(2009-1#1)
of verbal##31##2##(1993-11#1)(1995-12#2)(1997-8#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-7#1)(2009-9#1)(2010-7#1)(2011-2#2)(2012-11#1)(2013-1#2)(2013-7#2)(2013-8#1)
of verbascoside##2##2##(2008-8#2)
of verbatim##2##2##(2008-1#1)(2009-7#1)
of verbs##2##2##(2010-2#1)(2012-1#1)
of verifying##5##2##(1994-6#1)(2005-9#1)(2007-11#1)(2007-7#1)(2008-10#1)
of versican gene##2##3##(1990-9#2)
of versican##6##2##(1990-9#4)(1994-12#2)
of vertebra##2##2##(2007-11#2)
of vertebrae##11##2##(1992-1#1)(1994-12#1)(1995-8#1)(2006-8#1)(2006-9#1)(2007-11#4)(2007-7#1)(2008-4#1)
of vertebral and##2##3##(2008-3#1)(2008-8#1)
of vertebral artery dissection##2##4##(1991-8#1)(2011-2#1)
of vertebral artery##7##3##(1991-8#1)(2008-12#1)(2008-7#2)(2011-2#1)(2013-1#1)(2013-8#1)
of vertebral bodies##2##3##(2006-10#1)(2007-8#1)
of vertebral body with##2##4##(2008-6#1)(2012-2#1)
of vertebral body##9##3##(2007-8#5)(2008-6#1)(2008-7#2)(2012-2#1)
of vertebral bone##2##3##(2009-4#1)(2012-12#1)
of vertebral fracture##2##3##(1993-2#1)(2010-10#1)
of vertebral fractures treatment##2##4##(2007-11#2)
of vertebral fractures##10##3##(1992-10#1)(2007-11#2)(2007-8#1)(2008-11#2)(2008-8#2)(2010-10#2)
of vertebral##49##2##(1991-8#1)(1992-10#1)(1993-2#1)(1995-3#1)(2006-10#2)(2006-6#1)(2006-8#2)(2007-11#5)(2007-8#9)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#4)(2008-8#5)(2009-4#1)(2010-10#4)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
of vertebrate and invertebrate##2##4##(1996-7#1)(2008-10#1)
of vertebrate and##3##3##(1990-2#1)(1996-7#1)(2008-10#1)
of vertebrate cells##2##3##(1996-2#1)(2010-2#1)
of vertebrate hard tissues##2##4##(1992-5#2)
of vertebrate lactate dehydrogenase##2##4##(1990-4#2)
of vertebrate movement##2##3##(2008-12#1)(2012-1#1)
of vertebrate retinal##2##3##(1990-2#1)(1996-9#1)
of vertebrate striated muscle##2##4##(1995-6#1)(1995-8#1)
of vertebrate##40##2##(1990-10#1)(1990-11#1)(1990-2#4)(1990-4#2)(1990-5#1)(1990-6#1)(1992-5#2)(1992-8#1)(1993-11#1)(1994-11#1)(1994-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-9#1)(2006-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
of vertebrates and##2##3##(2008-7#2)
of vertebrates have been studied##3##5##(2007-3#3)
of vertebrates have been##4##4##(1992-5#1)(2007-3#3)
of vertebrates##29##2##(1990-6#1)(1992-5#1)(1993-2#1)(1994-3#1)(1995-11#1)(1996-4#1)(1996-5#1)(1996-9#1)(2007-12#1)(2007-2#1)(2007-3#9)(2008-4#1)(2008-7#3)(2008-8#2)(2009-5#1)(2010-3#2)(2010-5#1)
of vertebro- and kyphoplasty##2##4##(2007-8#2)
of vertebrobasilar insufficiency##3##3##(1993-3#1)(2006-11#2)
of vertebrobasilar stroke##2##3##(1996-2#1)(2007-10#1)
of vertebrobasilar##8##2##(1993-3#1)(1996-2#2)(2006-11#2)(2007-10#1)(2007-11#1)(2011-2#1)
of vertebroplasty and kyphoplasty##2##4##(2008-7#2)
of vertebroplasty in##3##3##(2006-2#2)(2008-7#1)
of vertebroplasty##6##2##(2006-2#2)(2007-8#1)(2008-7#3)
of vertical profiles##2##3##(2008-3#2)
of vertical transmission of HBV from HBsAg-positive father to infant##2##10##(2011-1#2)
of vertical transmission of HBV##3##5##(2011-1#3)
of vertical transmission##5##3##(2006-8#1)(2011-1#3)(2011-3#1)
of vertical##26##2##(1991-1#1)(1991-10#1)(1996-3#1)(2006-8#1)(2008-1#1)(2008-2#1)(2008-3#7)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#3)(2011-12#2)(2011-2#1)(2011-3#2)(2012-1#1)(2013-1#1)
of vertical-cavity lasers##2##3##(2008-2#1)(2008-3#1)
of vertical-cavity surface-emitting laser##3##4##(2007-12#1)(2008-3#2)
of vertical-cavity surface-emitting lasers (VCSEL's)##2##5##(2008-3#2)
of vertical-cavity surface-emitting lasers##7##4##(2007-11#1)(2008-1#1)(2008-3#5)
of vertical-cavity surface-emitting##10##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#7)
of vertical-cavity##12##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#8)
of vertically##2##2##(2007-11#1)(2009-5#1)
of vertiginous##3##2##(2008-2#2)(2009-5#1)
of vertigo##3##2##(2012-2#2)(2012-3#1)
of very complex##2##3##(1996-5#1)(2008-2#1)
of very different##2##3##(2007-8#1)(2011-1#1)
of very diverse##2##3##(1995-8#1)(2008-10#1)
of very early##2##3##(2008-11#1)(2009-11#1)
of very elderly patients##2##4##(2006-10#2)
of very few##2##3##(2008-10#1)(2008-4#1)
of very good and good results##2##6##(2007-11#1)(2007-7#1)
of very good##3##3##(2007-11#1)(2007-7#1)(2007-9#1)
of very high concentration##2##4##(2008-10#1)(2011-1#1)
of very high molecular weight##3##5##(1991-12#1)(1991-2#1)(1996-6#1)
of very high purity##2##4##(2008-1#1)(2008-7#1)
of very high##16##3##(1991-12#1)(1991-2#1)(1992-9#1)(1994-11#1)(1996-6#1)(2005-8#1)(2006-3#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-7#1)(2011-1#1)(2011-2#1)
of very important##2##3##(1995-10#1)(2008-7#1)
of very large##6##3##(1994-12#1)(1996-1#1)(2006-4#1)(2007-11#1)(2008-2#1)(2008-3#1)
of very late##4##3##(1997-3#1)(1997-4#1)(2008-11#1)(2009-12#1)
of very limited##3##3##(1995-1#1)(2006-6#1)(2008-10#1)
of very long chain fatty acids##4##6##(1990-11#2)(1994-6#2)
of very low birth weight##4##5##(1993-5#1)(2006-10#1)(2007-8#1)(2010-6#1)
of very low density lipoprotein##4##5##(1993-8#1)(1995-6#2)(2008-10#1)
of very low density lipoproteins##3##5##(1991-12#1)(1992-12#2)
of very low density##8##4##(1991-12#1)(1992-12#2)(1993-8#1)(1995-6#2)(2008-10#1)(2013-1#1)
of very low levels of##2##5##(1990-12#1)(2008-10#1)
of very low levels##3##4##(1990-12#1)(2008-10#2)
of very low##28##3##(1990-12#1)(1990-5#1)(1991-11#1)(1991-12#1)(1992-12#2)(1993-3#1)(1993-5#1)(1993-8#1)(1995-6#2)(2005-11#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#2)(2010-10#2)(2010-6#1)(2010-7#1)(2013-1#1)
of very premature infants##2##4##(1993-5#1)(2011-2#1)
of very premature##3##3##(1993-5#2)(2011-2#1)
of very small amounts of##2##5##(2008-10#1)(2008-9#1)
of very small##6##3##(1990-3#1)(1991-12#1)(1996-12#1)(2008-10#2)(2008-9#1)
of very thin##2##3##(2008-3#1)(2008-5#1)
of very weak##2##3##(2007-11#1)(2008-10#1)
of very##122##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-7#1)(1992-12#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#3)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-4#1)(1994-6#2)(1995-1#1)(1995-10#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#2)(2005-11#1)(2005-8#1)(2006-10#4)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#5)(2007-12#3)(2007-3#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#18)(2008-11#4)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2010-10#2)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#4)(2013-1#1)(2013-8#1)
of very-long-chain##3##2##(1993-9#2)(1995-2#1)
of very-low-density lipoprotein##2##3##(1991-2#1)(2008-6#1)
of vesamicol and##2##3##(1992-6#2)
of vesamicol##3##2##(1992-6#3)
of vesical##3##2##(1997-7#1)(2008-7#1)(2012-3#1)
of vesicle exocytosis##2##3##(2008-4#1)(2011-2#1)
of vesicle##12##2##(1990-4#1)(1995-5#1)(1995-8#1)(1996-7#2)(1997-2#1)(2008-4#1)(2008-8#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-2#1)
of vesicles and##2##3##(2007-10#1)(2008-4#1)
of vesicles by##2##3##(1992-6#1)(2013-7#1)
of vesicles from##2##3##(1990-2#1)(1992-7#1)
of vesicles of##2##3##(2007-9#1)(2008-1#1)
of vesicles with##2##3##(1990-12#1)(1997-3#1)
of vesicles##35##2##(1990-12#1)(1990-2#2)(1991-8#1)(1992-6#2)(1992-7#1)(1995-1#1)(1995-11#1)(1995-8#1)(1996-1#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(2005-11#1)(2007-10#1)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#3)(2008-8#2)(2012-2#1)(2013-7#1)
of vesico-ureteric##2##2##(2008-4#1)(2012-3#1)
of vesicoureteral reflux in##2##4##(2008-10#1)(2012-2#1)
of vesicoureteral reflux##11##3##(2006-9#2)(2007-9#1)(2008-1#1)(2008-10#4)(2012-11#2)(2012-2#1)
of vesicular intracellular##2##3##(1994-3#1)(1996-5#1)
of vesicular lesions##2##3##(2009-5#1)(2012-12#1)
of vesicular stomatitis virus##4##4##(1990-2#1)(1992-12#1)(1993-6#1)(1994-8#1)
of vesicular stomatitis##5##3##(1990-2#1)(1992-12#1)(1993-6#1)(1994-8#1)(2008-1#1)
of vesicular##15##2##(1990-2#1)(1990-5#1)(1990-7#1)(1992-12#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-12#1)(1996-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2009-5#1)(2012-12#1)(2012-2#1)
of vessel occlusion##3##3##(2005-11#2)(2012-2#1)
of vessel wall##5##3##(1996-1#1)(2005-10#1)(2008-7#1)(2009-10#1)(2013-1#1)
of vessel walls##2##3##(1994-9#1)(2008-11#1)
of vessel##17##2##(1994-9#2)(1995-2#1)(1996-1#1)(2005-10#1)(2005-11#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2009-10#1)(2012-2#1)(2013-1#1)
of vessels and##2##3##(2005-10#1)(2008-11#1)
of vessels in##2##3##(2008-10#1)(2013-8#1)
of vessels into##2##3##(2009-2#2)
of vessels which##2##3##(2008-10#1)(2011-1#1)
of vessels##25##2##(1990-8#2)(1992-1#1)(1995-2#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-3#1)(2009-2#2)(2009-7#1)(2010-6#1)(2011-1#2)(2012-1#1)(2012-3#1)(2013-8#2)
of vestibular compensation##4##3##(1991-2#1)(1995-12#1)(1996-9#1)(1997-7#1)
of vestibular rehabilitation##2##3##(2011-2#1)(2012-3#1)
of vestibular stimulation##2##3##(1995-8#1)(1997-2#1)
of vestibular symptoms##2##3##(2012-2#2)
of vestibular##20##2##(1991-2#1)(1993-5#1)(1995-12#1)(1995-8#1)(1996-9#1)(1997-2#1)(1997-7#1)(2006-11#1)(2006-12#2)(2009-5#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-2#3)(2012-3#2)
of veterans of the##2##4##(2004-7#1)(2007-10#1)
of veterans##6##2##(2004-7#1)(2007-10#1)(2007-7#1)(2013-1#3)
of veterinary care##2##3##(2005-5#1)(2008-3#1)
of veterinary science##2##3##(2005-5#1)(2010-3#1)
of veterinary services##2##3##(2007-8#1)(2008-3#1)
of veterinary##17##2##(1997-7#2)(2005-5#4)(2007-8#1)(2008-10#2)(2008-3#2)(2009-3#1)(2010-11#1)(2010-3#1)(2010-4#2)(2011-2#1)
of vgf##2##2##(1995-2#1)(2008-10#1)
of viability and##2##3##(2008-11#2)
of viability of##3##3##(2008-11#1)(2008-9#1)(2012-3#1)
of viability##22##2##(1993-7#1)(1995-12#1)(1995-2#1)(1995-8#1)(2007-6#1)(2008-11#7)(2008-7#2)(2008-9#2)(2012-2#4)(2012-3#1)(2013-1#1)
of viable and##2##3##(2007-8#1)(2008-9#1)
of viable bacteria##4##3##(1995-2#1)(2006-8#2)(2008-9#1)
of viable cell concentration##2##4##(2008-11#1)(2008-7#1)
of viable cell##4##3##(2008-11#3)(2008-7#1)
of viable cells in a##2##5##(2008-11#2)
of viable cells in##6##4##(2008-11#5)(2012-12#1)
of viable cells##20##3##(1994-2#1)(2006-11#1)(2008-10#1)(2008-11#6)(2008-2#1)(2008-4#3)(2008-7#1)(2008-9#2)(2010-4#1)(2012-12#1)(2012-2#2)
of viable myocardium##2##3##(1997-1#1)(2007-8#1)
of viable neurons##2##3##(2006-5#1)(2011-2#1)
of viable sclerotia##2##3##(2008-10#2)
of viable spores##3##3##(2006-8#1)(2008-10#1)(2011-2#1)
of viable##83##2##(1990-8#1)(1991-7#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-1#1)(2005-12#1)(2005-7#1)(2006-11#1)(2006-12#1)(2006-5#3)(2006-8#3)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#10)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#5)(2008-7#2)(2008-9#8)(2009-12#1)(2010-4#1)(2011-12#2)(2011-2#4)(2012-12#1)(2012-2#3)
of vibration##5##2##(2005-11#1)(2008-3#4)
of vibrational##8##2##(1996-4#1)(2006-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2010-12#2)(2012-1#1)
of vibrationally excited##2##3##(2008-3#2)
of vibrations on the##2##4##(2008-10#1)(2008-3#1)
of vibrations##4##2##(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)
of vibrio##2##2##(2007-12#1)(2007-7#1)
of vicarious##2##2##(1991-3#1)(2012-12#1)
of vice##2##2##(2011-2#1)(2012-3#1)
of vicinal##3##2##(1994-9#1)(2008-4#1)(2010-2#1)
of victimization##6##2##(2008-10#1)(2008-12#1)(2009-7#1)(2012-12#3)
of victims of crime##2##4##(2011-1#2)
of victims of violence##2##4##(2005-8#1)(2010-6#1)
of victims of##7##3##(1990-5#1)(1992-1#1)(2005-8#1)(2010-6#2)(2011-1#2)
of victims##16##2##(1990-5#1)(1992-1#1)(2005-8#2)(2007-12#1)(2008-2#3)(2008-3#1)(2008-8#1)(2008-9#1)(2010-6#2)(2011-1#2)(2013-8#1)
of video for##2##3##(2008-8#1)(2009-3#1)
of video game play##2##4##(2013-1#2)
of video game##3##3##(2012-12#1)(2013-1#2)
of video recordings##2##3##(2008-3#1)(2012-1#1)
of video##14##2##(1991-6#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-3#1)(2012-1#1)(2012-12#1)(2013-1#2)
of video-assisted thoracic surgery lobectomy##2##5##(2007-8#1)(2012-1#1)
of video-assisted thoracic surgery##6##4##(2004-2#1)(2007-8#4)(2012-1#1)
of video-assisted thoracoscopic surgery##3##4##(2006-10#2)(2007-8#1)
of video-assisted##12##2##(2004-2#1)(2006-10#2)(2006-7#1)(2007-8#7)(2012-1#1)
of videoconferencing##3##2##(2008-11#3)
of videotaped##2##2##(1993-2#1)(2008-8#1)
of videotapes##2##2##(1993-12#1)(1993-2#1)
of view and##15##3##(1992-6#1)(2005-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-3#3)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)
of view are##2##3##(2008-3#1)(2008-4#1)
of view in##5##3##(1991-2#1)(2008-12#1)(2008-2#2)(2013-1#1)
of view is##9##3##(2006-12#1)(2007-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2010-4#1)
of view of a##3##4##(1992-3#1)(2007-11#1)(2008-6#1)
of view of an##2##4##(2006-6#1)(2007-11#1)
of view of the##12##4##(1991-6#1)(1992-11#1)(1992-3#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2012-3#1)
of view of##48##3##(1990-3#1)(1990-9#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-3#2)(1993-1#1)(1993-3#1)(1994-2#1)(1994-3#2)(1995-11#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-5#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-8#1)(2009-9#1)(2012-1#1)(2012-3#1)(2013-8#2)
of view or from##2##4##(2008-11#1)(2008-3#1)
of view was##3##3##(2008-2#1)(2008-3#1)(2012-12#1)
of view##289##2##(1990-10#1)(1990-11#2)(1990-2#2)(1990-3#2)(1990-5#2)(1990-9#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#3)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1994-2#3)(1994-3#3)(1994-5#1)(1994-7#1)(1995-11#1)(1995-2#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(2004-12#1)(2004-9#1)(2005-10#2)(2005-11#5)(2005-12#1)(2005-4#1)(2005-5#1)(2005-7#2)(2005-8#1)(2006-12#3)(2006-2#1)(2006-4#1)(2006-6#3)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#9)(2007-12#5)(2007-2#1)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#26)(2008-3#38)(2008-4#1)(2008-5#5)(2008-6#5)(2008-7#9)(2008-8#2)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#2)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-8#1)(2011-1#3)(2011-2#3)(2011-3#1)(2012-1#2)(2012-11#3)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#9)(2013-8#8)
of viewing angles##2##3##(2008-2#1)(2008-3#1)
of viewing##7##2##(1992-9#1)(1997-8#1)(2008-2#2)(2008-3#3)
of views and##2##3##(1994-1#1)(2012-3#1)
of views##9##2##(1990-7#1)(1994-1#1)(2007-7#1)(2008-12#1)(2008-3#1)(2009-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
of vigabatrin in##2##3##(1992-3#2)
of vigabatrin##5##2##(1992-3#2)(2007-11#1)(2013-1#2)
of vigilance##2##2##(2006-10#1)(2012-12#1)
of vigor##2##2##(2008-10#1)(2008-9#1)
of vigorous##4##2##(1992-8#1)(2010-10#1)(2010-11#1)(2013-1#1)
of village-level##2##2##(2007-6#1)(2011-2#1)
of villages##2##2##(2008-8#1)(2011-12#1)
of villi##2##2##(1997-8#2)
of villous##3##2##(1990-10#1)(2013-1#2)
of vimentin and##3##3##(1990-4#1)(2012-12#2)
of vimentin##11##2##(1990-4#1)(1991-3#1)(1992-5#1)(2008-8#1)(2008-9#2)(2012-12#2)(2012-2#3)
of vinblastine##3##2##(1994-11#2)(1994-6#1)
of vincristine##7##2##(1990-11#1)(1990-12#1)(1991-7#1)(1993-9#2)(1997-5#1)(2012-2#1)
of vines infected with##2##4##(2008-10#2)
of vines infected##4##3##(2008-10#4)
of vines with##2##3##(2008-10#2)
of vines##8##2##(2008-10#8)
of vinorelbine##2##2##(1994-8#2)
of vinpocetine##2##2##(2010-12#2)
of vinyl aziridines and aziridinylen-ynes##2##5##(2009-12#2)
of vinyl carbamate##2##3##(1990-6#2)
of vinyl##10##2##(1990-6#2)(2006-3#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-12#2)(2009-5#1)
of violating the##3##3##(1993-6#1)(2008-7#2)
of violations of##3##3##(2010-5#1)(2013-1#1)(2013-8#1)
of violence against##3##3##(2008-4#1)(2008-9#1)(2009-2#1)
of violence and the##2##4##(1991-6#1)(2013-8#1)
of violence and##7##3##(1991-12#1)(1991-6#1)(2006-9#1)(2009-7#1)(2010-6#1)(2013-1#1)(2013-8#1)
of violence in the##4##4##(1991-12#1)(2006-9#1)(2013-1#2)
of violence in##7##3##(1991-12#1)(1993-3#1)(2006-9#1)(2008-8#1)(2011-2#1)(2013-1#2)
of violence is##2##3##(1991-12#1)(2013-8#1)
of violence they##2##3##(2008-2#1)(2009-5#1)
of violence##53##2##(1991-12#3)(1991-6#1)(1991-9#2)(1993-3#2)(1995-2#1)(1996-6#1)(1997-8#1)(2005-8#4)(2006-7#1)(2006-9#6)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-12#1)(2011-2#3)(2012-12#1)(2013-1#6)(2013-8#2)
of violent behavior##2##3##(1996-2#1)(2007-8#1)
of violent death##2##3##(1991-6#1)(2011-1#1)
of violent incidents##2##3##(1993-12#1)(2012-3#1)
of violent media use##2##4##(2009-7#2)
of violent media##5##3##(2009-7#5)
of violent##19##2##(1990-6#1)(1991-6#1)(1993-12#1)(1993-9#1)(1996-2#2)(2007-8#1)(2008-11#1)(2009-7#6)(2010-4#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
of viraemia##3##2##(1991-3#1)(1994-5#1)(2008-5#1)
of viral DNA and##4##4##(1996-2#1)(2007-12#1)(2008-4#1)(2009-8#1)
of viral DNA replication##3##4##(1990-6#1)(1995-6#1)(1997-3#1)
of viral DNA##18##3##(1990-6#1)(1992-11#1)(1993-8#1)(1994-8#1)(1995-6#1)(1996-11#1)(1996-2#1)(1997-3#1)(1997-5#1)(2007-12#1)(2008-4#2)(2008-5#1)(2009-11#1)(2009-8#1)(2011-1#1)(2011-12#1)(2011-2#1)
of viral RNA was##2##4##(2008-10#1)(2012-3#1)
of viral RNA##17##3##(1990-2#1)(1990-6#1)(1993-5#1)(1994-9#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#3)(2008-9#2)(2009-2#1)(2010-5#1)(2012-3#1)
of viral RNAs##3##3##(1997-3#1)(2008-9#2)
of viral and cellular##2##4##(1994-3#1)(2007-11#1)
of viral and##7##3##(1992-3#1)(1994-3#1)(1995-2#1)(2007-11#2)(2008-11#2)
of viral antigen##3##3##(1990-5#1)(1997-6#2)
of viral antigens##2##3##(1997-4#1)(2007-11#1)
of viral coat protein##2##4##(2008-10#2)
of viral contamination##3##3##(1990-2#1)(2008-11#1)(2008-4#1)
of viral disease in the operating room##2##7##(2006-10#2)
of viral gene expression##2##4##(1997-6#1)(2008-8#1)
of viral gene##3##3##(1997-4#1)(1997-6#1)(2008-8#1)
of viral genes##4##3##(2008-6#1)(2008-9#2)(2013-8#1)
of viral genomes##3##3##(1996-4#1)(2008-11#1)(2008-9#1)
of viral hemorrhagic##3##3##(2011-1#1)(2012-3#1)(2013-8#1)
of viral hepatitis and##3##4##(2005-7#1)(2006-10#1)(2007-7#1)
of viral hepatitis to cirrhosis with more##2##7##(2011-1#2)
of viral hepatitis##11##3##(1992-2#1)(2005-6#1)(2005-7#1)(2006-10#3)(2006-6#1)(2007-7#1)(2008-7#1)(2011-1#2)
of viral infection and##6##4##(2008-11#1)(2008-9#2)(2012-1#1)(2012-12#2)
of viral infection##17##3##(2006-10#2)(2007-11#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#2)(2009-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#1)
of viral infections is##2##4##(2007-12#1)(2010-7#1)
of viral infections##12##3##(1997-6#1)(2005-8#1)(2007-12#2)(2007-9#2)(2008-11#1)(2008-5#1)(2010-5#1)(2010-7#2)(2013-1#1)
of viral load##5##3##(2006-1#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-6#1)
of viral loads##2##3##(2008-11#1)(2009-5#1)
of viral lysis and##2##4##(2005-12#2)
of viral mRNA##3##3##(1991-2#2)(1995-9#1)
of viral miRNAs##3##3##(2013-1#3)
of viral myocarditis and##2##4##(2010-5#1)(2011-2#1)
of viral particles##2##3##(2008-4#1)(2011-3#1)
of viral polyproteins##2##3##(2011-1#2)
of viral populations##2##3##(2008-10#1)(2012-2#1)
of viral protein and##2##4##(2011-2#1)(2013-1#1)
of viral protein##5##3##(1992-12#1)(1994-8#1)(2009-2#1)(2011-2#1)(2013-1#1)
of viral proteins##2##3##(1991-12#1)(2008-11#1)
of viral quasispecies##4##3##(2013-8#4)
of viral replication and##3##4##(1990-2#1)(2005-7#1)(2007-8#1)
of viral replication##10##3##(1990-2#1)(1997-3#1)(2005-7#2)(2006-10#1)(2007-8#1)(2008-5#1)(2009-11#2)(2011-3#1)
of viral resistance##2##3##(2008-10#1)(2012-2#1)
of viral variants##2##3##(2009-11#1)(2013-1#1)
of viral vectors##2##3##(2008-11#2)
of viral##231##2##(1990-2#4)(1990-4#1)(1990-5#1)(1990-6#3)(1991-1#1)(1991-12#2)(1991-2#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#3)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-4#4)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#4)(1997-5#1)(1997-6#6)(1997-7#1)(1997-8#1)(2005-12#2)(2005-6#1)(2005-7#3)(2005-8#1)(2006-1#2)(2006-10#10)(2006-6#1)(2007-1#1)(2007-11#5)(2007-12#4)(2007-3#1)(2007-7#1)(2007-8#3)(2007-9#3)(2008-1#2)(2008-10#14)(2008-11#13)(2008-12#1)(2008-4#9)(2008-5#4)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#13)(2009-11#4)(2009-12#1)(2009-2#3)(2009-5#1)(2009-7#1)(2009-8#2)(2010-5#3)(2010-7#2)(2011-1#7)(2011-12#1)(2011-2#8)(2011-3#2)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#9)(2013-8#9)
of viral-cellular interactions##2##3##(2006-10#1)(2008-9#1)
of viremia##6##2##(2006-10#1)(2006-2#1)(2007-8#2)(2012-12#1)(2012-2#1)
of virgin and##2##3##(1991-12#1)(1996-3#1)
of virgin##6##2##(1991-12#1)(1994-3#1)(1996-3#1)(1997-4#1)(2012-2#1)(2013-1#1)
of virion sense##2##3##(2008-9#2)
of virion##5##2##(1991-6#1)(1993-12#1)(2008-10#1)(2008-9#2)
of viroid##2##2##(2008-10#1)(2008-9#1)
of virologic failure##2##3##(2007-1#2)
of virologic##3##2##(2007-1#2)(2009-11#1)
of virological##4##2##(1996-2#1)(2010-8#1)(2012-2#1)(2013-1#1)
of virology##2##2##(2005-7#1)(2007-6#1)
of virosomes##2##2##(1990-2#2)
of virtual colonoscopy##2##3##(2006-2#1)(2008-6#1)
of virtual reality##2##3##(2010-1#1)(2010-4#1)
of virtual##12##2##(2006-2#1)(2006-5#1)(2006-6#1)(2007-4#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-6#2)(2010-1#1)(2010-4#1)(2012-1#1)
of virtually all the##2##4##(1996-12#1)(2012-1#1)
of virtually all##7##3##(1996-12#1)(2006-10#1)(2007-5#1)(2008-10#1)(2008-7#1)(2009-12#1)(2012-1#1)
of virtually any##2##3##(1997-7#1)(2011-2#1)
of virtually##10##2##(1990-9#1)(1996-12#1)(1997-7#1)(2006-10#1)(2007-5#1)(2008-10#1)(2008-7#1)(2009-12#1)(2011-2#1)(2012-1#1)
of virulence among##3##3##(2008-10#2)(2008-11#1)
of virulence and##6##3##(1991-12#1)(1995-2#1)(2008-10#3)(2013-8#1)
of virulence by##2##3##(2008-10#1)(2009-8#1)
of virulence factor expression##3##4##(1996-8#1)(2006-10#1)(2009-8#1)
of virulence factors after##2##4##(1996-8#2)
of virulence factors and##2##4##(1995-8#1)(2013-1#1)
of virulence factors##12##3##(1995-8#1)(1996-8#2)(2005-8#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-2#2)(2009-8#1)(2013-1#2)
of virulence genes##2##3##(1996-8#1)(2008-4#1)
of virulence in the##2##4##(2008-10#2)
of virulence in##4##3##(2008-10#2)(2008-8#1)(2013-1#1)
of virulence is##2##3##(2008-10#2)
of virulence phenotypes##2##3##(2008-10#2)
of virulence were##3##3##(2008-10#3)
of virulence##62##2##(1991-12#1)(1995-2#1)(1995-8#1)(1996-8#4)(2005-8#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#30)(2008-11#2)(2008-4#1)(2008-8#4)(2008-9#1)(2009-2#2)(2009-8#3)(2010-12#2)(2013-1#3)(2013-8#3)
of virulent C##2##3##(1996-12#1)(2008-10#1)
of virulent and non-virulent##2##4##(2008-5#2)
of virulent and##3##3##(2008-5#2)(2013-8#1)
of virulent##13##2##(1994-5#2)(1996-12#1)(1996-2#1)(2007-2#1)(2008-10#2)(2008-5#2)(2008-9#1)(2010-12#1)(2013-8#2)
of viruliferous aphids##2##3##(2008-10#2)
of viruliferous nematodes##2##3##(2008-10#2)
of viruliferous##7##2##(2008-10#7)
of virus accumulation##4##3##(2008-10#4)
of virus and##5##3##(1995-3#1)(2008-10#3)(2008-5#1)
of virus from##3##3##(1992-11#1)(1997-6#1)(2008-4#1)
of virus in the##2##4##(1995-5#1)(1997-4#1)
of virus in##9##3##(1995-5#2)(1997-4#1)(2006-2#1)(2008-10#4)(2012-11#1)
of virus infection and##2##4##(2008-10#1)(2008-5#1)
of virus infection##6##3##(2007-2#1)(2008-10#2)(2008-5#1)(2008-9#1)(2012-2#1)
of virus infections##2##3##(1990-6#1)(2008-7#1)
of virus isolation##2##3##(2008-5#2)
of virus movement##2##3##(2008-10#1)(2008-9#1)
of virus neutralization assays##2##4##(1992-6#2)
of virus particle##2##3##(1997-3#1)(2011-2#1)
of virus particles##4##3##(1997-3#1)(1997-4#1)(2008-10#2)
of virus replication##4##3##(1994-11#2)(2008-5#1)(2011-1#1)
of virus structure##2##3##(2008-10#2)
of virus transmission##2##3##(2008-10#1)(2008-12#1)
of virus was##5##3##(2004-11#1)(2007-1#1)(2008-10#1)(2012-3#2)
of virus##116##2##(1990-11#2)(1990-6#2)(1992-11#2)(1992-6#3)(1992-8#1)(1993-12#1)(1993-5#1)(1994-10#1)(1994-11#3)(1994-8#1)(1995-3#1)(1995-5#2)(1996-2#1)(1996-6#1)(1997-3#2)(1997-4#3)(1997-6#3)(2004-11#1)(2005-11#1)(2006-1#1)(2006-2#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-2#2)(2008-10#36)(2008-11#3)(2008-12#2)(2008-4#6)(2008-5#8)(2008-7#2)(2008-9#4)(2010-1#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#4)
of virus-infected cells##3##3##(1994-11#1)(1997-3#1)(2008-11#1)
of virus-infected##4##2##(1994-11#1)(1997-3#1)(2008-10#1)(2008-11#1)
of virus-specific##4##2##(1992-8#1)(1996-11#1)(2008-10#1)(2010-5#1)
of virus-virus interactions##2##3##(1997-3#1)(2008-10#1)
of viruses and##2##3##(2007-11#1)(2008-11#1)
of viruses from##2##3##(2006-10#1)(2013-1#1)
of viruses in the##2##4##(1997-4#1)(2008-10#1)
of viruses in##5##3##(1994-8#1)(1997-4#1)(2005-8#1)(2006-3#1)(2008-10#1)
of viruses is##2##3##(1995-2#1)(2012-2#1)
of viruses##34##2##(1993-8#1)(1994-11#2)(1994-8#2)(1994-9#1)(1995-2#1)(1995-9#1)(1996-2#1)(1997-4#1)(1997-6#1)(2005-8#1)(2006-10#3)(2006-3#1)(2007-11#1)(2008-10#2)(2008-11#3)(2008-7#2)(2008-9#3)(2009-6#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#3)
of visceral afferent##2##3##(1992-2#1)(1993-11#1)
of visceral and##2##3##(2007-6#1)(2008-5#1)
of visceral fat to##3##4##(2012-11#1)(2012-2#2)
of visceral fat##6##3##(2005-10#1)(2008-1#1)(2008-11#1)(2012-11#1)(2012-2#2)
of visceral larva migrans##2##4##(2012-2#2)
of visceral leishmaniasis in##8##4##(2004-11#2)(2005-8#1)(2007-12#2)(2008-4#1)(2008-7#1)(2012-2#1)
of visceral leishmaniasis##20##3##(1990-9#1)(2004-11#3)(2005-8#1)(2005-9#1)(2006-10#2)(2007-12#4)(2007-7#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-12#1)(2012-12#1)(2012-2#1)
of visceral metastases##2##3##(1996-6#1)(2013-7#1)
of visceral obesity on the##2##5##(2013-8#2)
of visceral obesity with##2##4##(2013-8#2)
of visceral obesity##5##3##(2005-10#1)(2013-8#4)
of visceral##54##2##(1990-10#2)(1990-9#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-2#2)(1993-11#1)(1996-6#1)(1997-8#1)(2004-11#3)(2005-10#2)(2005-8#1)(2005-9#1)(2006-10#4)(2006-11#1)(2007-12#4)(2007-6#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-7#1)(2010-11#1)(2010-12#1)(2012-11#1)(2012-12#2)(2012-2#6)(2013-7#1)(2013-8#4)
of viscoelastic##2##2##(2009-9#2)
of viscosity in##2##3##(1994-8#1)(2011-2#1)
of viscosity of the##2##4##(2005-11#1)(2006-6#1)
of viscosity on##2##3##(2006-12#1)(2009-10#1)
of viscosity##10##2##(1994-8#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-6#1)(2007-6#1)(2008-10#1)(2009-10#1)(2009-6#1)(2011-2#1)
of viscotoxins##2##2##(1990-5#1)(2007-1#1)
of viscous##6##2##(1990-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2009-10#1)(2011-1#1)
of visibility##2##2##(2008-2#1)(2008-5#1)
of visible and near infrared reflectance##2##6##(2010-4#2)
of visible and##5##3##(2008-2#1)(2010-2#1)(2010-4#2)(2012-12#1)
of visible light##10##3##(1994-5#1)(1995-6#1)(1996-7#1)(2006-7#2)(2008-1#1)(2008-2#1)(2008-3#3)
of visible symptoms##2##3##(2008-10#2)
of visible##37##2##(1993-12#1)(1994-5#1)(1995-6#1)(1995-7#1)(1996-7#1)(2006-12#1)(2006-3#1)(2006-7#2)(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#4)(2008-3#6)(2008-5#3)(2009-5#1)(2010-2#1)(2010-3#1)(2010-4#2)(2011-2#1)(2012-12#1)(2012-9#1)(2013-1#1)
of vision and##5##3##(1994-1#1)(2005-11#1)(2007-2#1)(2008-9#1)(2013-8#1)
of vision are##2##3##(1991-2#1)(1997-8#1)
of vision in##5##3##(1994-8#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-2#1)
of vision loss##5##3##(2008-1#2)(2011-1#2)(2012-1#1)
of vision on##2##3##(1994-6#1)(1995-1#1)
of vision##42##2##(1991-2#1)(1992-7#1)(1993-12#1)(1994-1#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1997-8#1)(2005-11#2)(2006-10#1)(2006-12#1)(2007-1#1)(2007-12#1)(2007-2#1)(2008-1#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#3)(2009-7#1)(2009-8#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-2#5)(2013-1#2)(2013-8#1)
of visit##3##2##(1992-2#1)(2005-10#1)(2011-1#1)
of visiting##3##2##(1990-9#1)(2008-12#1)(2012-2#1)
of visits and##2##3##(1992-6#1)(2008-11#1)
of visits by##2##3##(2006-8#2)
of visits to the##2##4##(1992-5#1)(2008-7#1)
of visits to##5##3##(1990-9#1)(1992-5#1)(2008-7#3)
of visits##23##2##(1990-9#1)(1991-12#1)(1992-5#1)(1992-6#1)(1993-6#2)(1995-3#2)(2006-8#5)(2007-3#1)(2008-1#1)(2008-11#1)(2008-7#3)(2009-12#2)(2009-4#1)(2010-11#1)
of visual acuity##8##3##(1992-7#3)(2005-10#1)(2007-3#1)(2008-1#1)(2008-4#1)(2009-2#1)
of visual analog##2##3##(2007-12#1)(2011-1#1)
of visual analogue##2##3##(2007-11#1)(2007-12#1)
of visual and##2##3##(2008-8#1)(2009-9#1)
of visual attention##5##3##(2008-11#2)(2008-9#1)(2010-5#1)(2012-12#1)
of visual cortex##5##3##(1994-8#1)(2007-8#1)(2008-11#1)(2012-2#1)(2013-7#1)
of visual cortical areas##2##4##(2009-10#1)(2009-3#1)
of visual cortical neurons##4##4##(1990-4#1)(1991-5#1)(1994-3#2)
of visual cortical##7##3##(1990-4#1)(1991-5#1)(1994-3#2)(1997-8#1)(2009-10#1)(2009-3#1)
of visual development##2##3##(1990-2#1)(2012-2#1)
of visual disturbance##2##3##(2006-12#1)(2008-7#1)
of visual field##3##3##(1994-5#1)(2007-6#1)(2011-2#1)
of visual function##8##3##(1992-7#1)(2007-6#1)(2011-7#1)(2013-1#5)
of visual hallucinations##2##3##(2011-2#1)(2013-8#1)
of visual impairment and blindness##3##5##(2011-2#1)(2012-11#2)
of visual impairment were##2##4##(2005-10#1)(2007-1#1)
of visual impairment##8##3##(2005-10#2)(2007-1#1)(2011-2#1)(2012-11#2)(2012-12#1)(2013-1#1)
of visual information processing##2##4##(1996-2#1)(2004-11#1)
of visual information##3##3##(1996-2#1)(2004-11#1)(2010-6#1)
of visual inspection##2##3##(2008-12#1)(2010-9#1)
of visual loss and##2##4##(2006-4#1)(2013-7#1)
of visual loss in##4##4##(2008-1#1)(2009-2#1)(2009-8#1)(2012-2#1)
of visual loss##9##3##(2006-11#1)(2006-4#1)(2008-1#1)(2008-8#1)(2009-2#1)(2009-4#1)(2009-8#1)(2012-2#1)(2013-7#1)
of visual motion##3##3##(1992-2#1)(1992-9#1)(1993-2#1)
of visual perception##6##3##(1997-5#1)(2008-4#2)(2010-9#1)(2012-11#1)(2013-1#1)
of visual processing##5##3##(1995-11#1)(1995-5#1)(1997-8#1)(2008-4#1)(2012-2#1)
of visual recognition##3##3##(1996-1#1)(1997-8#1)(2008-4#1)
of visual sense organ development##2##5##(2007-12#2)
of visual space##2##3##(1994-2#1)(1995-11#1)
of visual stimuli##7##3##(1990-10#1)(1995-8#1)(1997-1#1)(1997-8#1)(2008-4#1)(2008-5#1)(2008-8#1)
of visual symptoms##2##3##(2008-10#2)
of visual##154##2##(1990-10#4)(1990-2#1)(1990-4#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-7#6)(1992-9#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-2#2)(1996-6#1)(1997-1#1)(1997-5#1)(1997-8#6)(2004-11#1)(2005-10#3)(2006-11#1)(2006-12#1)(2006-4#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-6#2)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#9)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#3)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-6#1)(2010-9#3)(2011-1#2)(2011-2#7)(2011-7#2)(2012-1#4)(2012-11#4)(2012-12#3)(2012-2#5)(2013-1#7)(2013-7#3)(2013-8#3)
of visualization and##3##3##(1991-11#1)(2008-11#1)(2013-7#1)
of visualization of##4##3##(2006-7#1)(2007-9#1)(2008-11#1)(2008-2#1)
of visualization##11##2##(1991-11#1)(2006-5#1)(2006-7#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-6#1)(2009-10#1)(2013-7#1)
of visualizing the##3##3##(2007-12#1)(2008-10#1)(2010-2#1)
of visualizing##5##2##(2007-12#1)(2008-10#1)(2008-7#1)(2010-2#1)(2012-2#1)
of visually evoked responses##2##4##(1990-4#1)(1992-9#1)
of visually presented##2##3##(1995-2#1)(2009-4#1)
of visually##8##2##(1990-4#1)(1992-9#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-4#1)(2010-10#1)
of vital importance##8##3##(1993-1#1)(1993-3#1)(1994-10#1)(1994-2#1)(2008-5#2)(2009-6#1)(2009-8#1)
of vital processes##2##3##(2009-2#1)(2009-4#1)
of vital##33##2##(1993-1#1)(1993-2#1)(1993-3#1)(1994-10#1)(1994-2#1)(1994-7#1)(1995-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-8#1)
of vitamin A acetate for##3##5##(2008-11#3)
of vitamin A acetate##5##4##(2008-11#5)
of vitamin A and##4##4##(1993-12#1)(1993-3#1)(1993-6#1)(2011-2#1)
of vitamin A capsule##2##4##(2007-11#2)
of vitamin A deficiency##6##4##(1991-8#3)(2006-10#1)(2008-7#2)
of vitamin A to##2##4##(1994-12#1)(1995-9#1)
of vitamin A##35##3##(1991-8#3)(1992-9#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-12#2)(1995-1#2)(1995-9#1)(1996-5#1)(1997-8#1)(2006-10#3)(2007-11#2)(2007-7#2)(2008-11#5)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
of vitamin A-deficient rats##2##4##(1992-9#1)(1993-12#1)
of vitamin B(2)##2##3##(2008-10#2)
of vitamin B12 and##3##4##(1990-5#1)(1991-2#1)(1993-12#1)
of vitamin B12 deficiency##2##4##(2006-2#1)(2013-7#1)
of vitamin B12 on##2##4##(1993-12#1)(2010-1#1)
of vitamin B12##21##3##(1990-3#1)(1990-5#1)(1991-2#2)(1992-12#2)(1992-9#1)(1993-12#4)(1994-6#1)(1997-2#1)(2006-12#1)(2006-2#1)(2010-1#3)(2010-12#2)(2013-7#1)
of vitamin B6##7##3##(1991-8#3)(1994-12#1)(2004-11#1)(2013-1#2)
of vitamin C (P &lt##3##5##(1994-10#2)(1995-7#1)
of vitamin C and##4##4##(2007-11#1)(2008-5#1)(2010-11#1)(2011-1#1)
of vitamin C from##2##4##(2010-12#1)(2011-1#1)
of vitamin C in orange juice and pharmaceutical preparations##2##9##(2006-1#2)
of vitamin C in##6##4##(1995-7#1)(2006-1#2)(2008-10#3)
of vitamin C loss##2##4##(2006-10#1)(2012-2#1)
of vitamin C on##3##4##(1992-9#1)(2013-8#2)
of vitamin C supplementation on hepatic cytochrome P450##2##8##(1996-12#2)
of vitamin C supplementation on##3##5##(1996-12#2)(1997-3#1)
of vitamin C##48##3##(1992-9#4)(1994-10#2)(1994-2#1)(1995-7#2)(1996-12#2)(1997-3#1)(2006-1#2)(2006-10#2)(2007-11#1)(2007-9#1)(2008-10#6)(2008-12#1)(2008-5#3)(2010-11#1)(2010-12#2)(2011-1#7)(2012-2#4)(2013-7#1)(2013-8#5)
of vitamin D and##4##4##(2008-10#1)(2010-10#1)(2012-3#1)(2013-7#1)
of vitamin D deficiency in##4##5##(1993-8#1)(2012-1#1)(2013-1#2)
of vitamin D deficiency##8##4##(1993-8#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
of vitamin D in##5##4##(2010-10#1)(2010-7#1)(2012-12#2)(2012-2#1)
of vitamin D levels##2##4##(2010-12#1)(2013-1#1)
of vitamin D may##2##4##(1994-3#1)(2012-12#1)
of vitamin D receptor (VDR)##3##5##(1993-6#1)(2010-7#1)(2012-2#1)
of vitamin D receptor##5##4##(1993-6#1)(2010-7#2)(2012-2#2)
of vitamin D status in##4##5##(2010-7#1)(2012-12#1)(2013-7#2)
of vitamin D through##2##4##(2008-7#1)(2012-3#1)
of vitamin D with##2##4##(2010-12#2)
of vitamin D##68##3##(1991-11#1)(1992-1#3)(1992-9#3)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#2)(1995-2#1)(1995-4#1)(1995-8#1)(2008-1#1)(2008-10#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2010-10#2)(2010-12#5)(2010-7#6)(2011-1#1)(2012-1#2)(2012-12#5)(2012-2#6)(2012-3#5)(2013-1#4)(2013-7#3)(2013-8#1)
of vitamin D(2)##5##3##(2008-10#5)
of vitamin D(3)##3##3##(2008-10#2)(2012-12#1)
of vitamin D-deficiency##2##3##(2010-9#2)
of vitamin D3##3##3##(1994-12#1)(2005-1#1)(2008-8#1)
of vitamin E in the##2##5##(1994-6#1)(2008-10#1)
of vitamin E in##8##4##(1992-9#4)(1994-6#1)(2008-10#2)(2008-5#1)
of vitamin E on##4##4##(1990-2#1)(1993-6#1)(2008-8#1)(2011-1#1)
of vitamin E with##2##4##(1992-9#1)(2008-10#1)
of vitamin E##40##3##(1990-2#2)(1990-8#1)(1992-9#6)(1993-6#3)(1994-5#2)(1994-6#1)(1995-3#2)(1995-8#1)(2007-2#1)(2008-10#6)(2008-5#2)(2008-7#3)(2008-8#4)(2009-6#1)(2010-12#1)(2011-1#2)(2013-1#1)(2013-8#1)
of vitamin E-modified dialyzers##4##4##(2007-7#2)(2008-1#2)
of vitamin E-modified##6##3##(2007-7#3)(2008-1#3)
of vitamin K##3##3##(1990-11#1)(1995-1#2)
of vitamin K(1)##3##3##(2008-10#3)
of vitamin K-dependent##2##3##(1997-4#1)(2009-4#1)
of vitamin K2##2##3##(2008-8#2)
of vitamin K3##3##3##(1991-12#1)(2005-4#1)(2008-10#1)
of vitamin and mineral supplementation##2##5##(1990-3#2)
of vitamin and mineral##3##4##(1990-3#2)(2008-11#1)
of vitamin and##4##3##(1990-3#2)(2008-10#1)(2008-11#1)
of vitamin d##2##3##(2008-5#1)(2011-1#1)
of vitamin e on##2##4##(2007-2#1)(2011-1#1)
of vitamin pills##3##3##(1996-8#1)(2008-10#2)
of vitamin supplements##2##3##(1992-9#1)(2005-10#1)
of vitamin##283##2##(1990-11#1)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-8#6)(1992-1#3)(1992-12#3)(1992-9#17)(1993-12#6)(1993-3#2)(1993-6#5)(1993-8#1)(1994-10#2)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#2)(1995-1#4)(1995-2#1)(1995-3#2)(1995-4#1)(1995-7#2)(1995-8#2)(1995-9#1)(1996-12#2)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-11#1)(2005-1#2)(2005-10#1)(2005-4#1)(2005-9#1)(2006-1#2)(2006-10#5)(2006-12#2)(2006-2#1)(2007-11#3)(2007-2#2)(2007-7#6)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#33)(2008-11#6)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#9)(2008-7#9)(2008-8#9)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#10)(2010-7#6)(2010-9#2)(2011-1#12)(2011-2#2)(2012-1#3)(2012-12#8)(2012-2#10)(2012-3#5)(2013-1#8)(2013-7#5)(2013-8#7)
of vitamins A and E##5##5##(2006-10#1)(2007-7#1)(2008-10#1)(2008-4#2)
of vitamins A##7##3##(2006-10#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-4#2)
of vitamins E and C##5##5##(2008-6#4)(2009-6#1)
of vitamins E and##6##4##(1992-9#1)(2008-6#4)(2009-6#1)
of vitamins E##7##3##(1992-9#1)(2006-10#1)(2008-6#4)(2009-6#1)
of vitamins and amino acids##2##5##(2008-11#2)
of vitamins and##4##3##(2006-10#1)(2008-11#2)(2013-1#1)
of vitamins in the##4##4##(2011-2#3)(2013-7#1)
of vitamins in##5##3##(2007-11#1)(2011-2#3)(2013-7#1)
of vitamins##41##2##(1991-5#1)(1992-9#5)(1994-2#1)(1997-3#2)(2006-10#5)(2006-8#1)(2007-11#3)(2007-7#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-6#4)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-1#1)(2011-2#3)(2013-1#2)(2013-7#1)
of vitellin##2##2##(2007-12#1)(2008-6#1)
of vitellogenesis the##2##3##(2007-12#2)
of vitellogenesis##5##2##(2007-12#2)(2008-12#1)(2008-5#1)(2008-7#1)
of vitellogenin mRNA##2##3##(1995-10#1)(2008-6#1)
of vitellogenin##6##2##(1995-10#1)(2007-12#1)(2008-6#1)(2009-4#2)(2010-4#1)
of vitiligo and##2##3##(2007-7#1)(2010-6#1)
of vitiligo patients##2##3##(2007-7#1)(2009-6#1)
of vitiligo##24##2##(1992-6#1)(2006-12#1)(2007-2#1)(2007-7#10)(2007-8#5)(2009-1#1)(2009-6#3)(2010-6#1)(2013-1#1)
of vitiligo]##2##2##(1991-6#1)(2009-5#1)
of vitreous##9##2##(2006-1#1)(2008-11#1)(2008-3#2)(2008-5#3)(2009-4#1)(2011-2#1)
of vitronectin##3##2##(1990-3#1)(1996-5#2)
of vivax malaria##3##3##(2007-2#1)(2012-12#2)
of vivax##4##2##(2007-12#1)(2007-2#1)(2012-12#2)
of vocabularies##2##2##(2008-7#2)
of vocabulary and##3##3##(2008-12#1)(2008-9#1)(2011-2#1)
of vocabulary##5##2##(2008-12#1)(2008-9#2)(2011-2#2)
of vocal folds##4##3##(2007-9#2)(2012-2#2)
of vocal##12##2##(1990-4#1)(2007-9#2)(2008-9#1)(2009-2#2)(2010-2#2)(2012-1#1)(2012-2#3)
of vocalization##3##2##(1994-6#1)(1994-8#1)(2010-2#1)
of vocational rehabilitation##3##3##(1992-3#1)(2009-10#1)(2010-2#1)
of vocational##6##2##(1990-5#1)(1992-3#1)(1996-8#1)(2009-10#1)(2010-2#2)
of voice and speech##2##4##(2009-2#1)(2011-1#1)
of voice and##3##3##(2007-9#1)(2009-2#1)(2011-1#1)
of voice##15##2##(2007-7#2)(2007-8#1)(2007-9#2)(2008-11#1)(2008-4#1)(2008-9#1)(2009-2#1)(2009-7#1)(2009-9#2)(2011-1#1)(2012-2#1)(2013-8#1)
of void##2##2##(2008-2#1)(2010-1#1)
of voiding dysfunction##2##3##(2008-10#1)(2008-6#1)
of voiding##3##2##(2008-10#1)(2008-6#1)(2012-3#1)
of volar##2##2##(2008-9#2)
of volatile anaesthetics##2##3##(2006-10#1)(2010-12#1)
of volatile and semivolatile pollutants in##2##6##(2008-10#2)
of volatile and semivolatile##3##4##(2008-10#3)
of volatile and##5##3##(2008-10#4)(2009-8#1)
of volatile chloro-organic compounds in##2##5##(2008-10#2)
of volatile compounds from##2##4##(2008-10#1)(2009-8#1)
of volatile compounds##8##3##(2008-10#4)(2009-8#1)(2010-4#1)(2011-1#1)(2011-10#1)
of volatile elements##2##3##(2008-10#2)
of volatile fatty acids##2##4##(2008-5#1)(2013-1#1)
of volatile fatty##3##3##(2008-5#1)(2012-3#1)(2013-1#1)
of volatile metabolites##2##3##(2007-7#1)(2008-10#1)
of volatile nitrosamines in##2##4##(2008-10#1)(2013-7#1)
of volatile oil##2##3##(2011-1#1)(2013-8#1)
of volatile oils##5##3##(2007-1#1)(2008-11#3)(2012-1#1)
of volatile organic compounds (VOCs)##4##5##(2006-12#1)(2008-10#3)
of volatile organic compounds in##3##5##(1992-4#1)(2008-10#1)(2008-11#1)
of volatile organic compounds##14##4##(1992-4#1)(1995-6#1)(2006-12#2)(2008-10#8)(2008-11#1)(2008-3#1)
of volatile organic##17##3##(1992-4#1)(1995-6#1)(2006-12#2)(2008-10#10)(2008-11#1)(2008-3#2)
of volatile products##3##3##(2007-8#1)(2008-10#2)
of volatile sulfur##2##3##(2005-9#1)(2006-12#1)
of volatile sulphur##2##3##(2006-2#1)(2013-8#1)
of volatile##86##2##(1990-2#1)(1992-1#1)(1992-3#1)(1992-4#1)(1993-2#1)(1995-6#1)(1997-4#1)(1997-8#3)(2005-12#1)(2005-9#1)(2006-10#1)(2006-12#3)(2006-2#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#2)(2008-10#35)(2008-11#5)(2008-12#1)(2008-3#2)(2008-5#2)(2009-8#3)(2010-12#1)(2010-4#1)(2011-1#3)(2011-10#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
of volatiles and##2##3##(2008-10#2)
of volatiles from##3##3##(2008-10#2)(2013-8#1)
of volatiles##9##2##(2005-12#1)(2008-10#6)(2009-8#1)(2013-8#1)
of volcanic##2##2##(1993-7#1)(2008-10#1)
of voles##2##2##(1996-6#1)(2012-1#1)
of volition##2##2##(1991-5#1)(2008-6#1)
of voltage and##2##3##(1992-11#1)(2013-8#1)
of voltage dependent##2##3##(1997-4#1)(2009-12#1)
of voltage##9##2##(1992-11#1)(1995-12#1)(1996-11#1)(1997-4#1)(2008-11#1)(2008-3#1)(2009-12#1)(2010-10#1)(2013-8#1)
of voltage-activated calcium##2##3##(1993-12#1)(1996-5#1)
of voltage-activated##6##2##(1993-12#1)(1994-3#1)(1996-1#1)(1996-3#1)(1996-5#1)(2008-8#1)
of voltage-dependent Ca2+ channels##3##4##(1995-12#1)(1996-5#1)(2008-8#1)
of voltage-dependent Cl(-)-channels of##2##4##(1993-3#2)
of voltage-dependent calcium channels##2##4##(1996-2#1)(2008-8#1)
of voltage-dependent calcium##3##3##(1996-2#1)(1997-7#1)(2008-8#1)
of voltage-dependent potassium channel##2##4##(1996-5#2)
of voltage-dependent potassium##3##3##(1996-2#1)(1996-5#2)
of voltage-dependent sodium channels##2##4##(2005-8#1)(2008-8#1)
of voltage-dependent sodium##3##3##(1995-12#1)(2005-8#1)(2008-8#1)
of voltage-dependent##18##2##(1992-7#2)(1993-3#3)(1995-12#2)(1996-2#2)(1996-5#3)(1997-7#1)(2005-8#1)(2008-8#3)(2009-8#1)
of voltage-gated Ca2+##3##3##(1992-12#1)(1994-5#1)(2009-7#1)
of voltage-gated calcium channels##4##4##(1994-2#1)(2008-12#1)(2008-8#1)(2008-9#1)
of voltage-gated calcium##5##3##(1993-9#1)(1994-2#1)(2008-12#1)(2008-8#1)(2008-9#1)
of voltage-gated potassium##2##3##(2006-2#1)(2010-12#1)
of voltage-gated sodium channels##5##4##(2006-10#3)(2008-5#1)(2012-3#1)
of voltage-gated sodium##6##3##(2006-10#3)(2008-5#1)(2012-12#1)(2012-3#1)
of voltage-gated##20##2##(1992-12#1)(1993-9#1)(1994-2#1)(1994-5#2)(1996-1#1)(2006-10#3)(2006-2#1)(2007-10#1)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-12#1)(2012-12#1)(2012-3#1)
of voltage-sensitive calcium channels##3##4##(1990-7#2)(1995-11#1)
of voltage-sensitive calcium##4##3##(1990-7#2)(1993-2#1)(1995-11#1)
of voltage-sensitive##7##2##(1990-7#2)(1991-9#1)(1993-11#1)(1993-2#1)(1995-11#1)(2008-8#1)
of voltammetric##6##2##(2008-10#6)
of voltammetry##2##2##(2008-10#2)
of volume density and absolute volume of syncytiotrophoblast in resorption villi of##2##12##(2011-1#2)
of volume fraction##3##3##(2005-11#1)(2008-3#1)(2009-6#1)
of volume holograms in##2##4##(2008-2#1)(2008-3#1)
of volume holograms##5##3##(2008-2#1)(2008-3#4)
of volume holographic##4##3##(2008-2#2)(2008-3#2)
of volume phase##2##3##(1993-6#1)(2008-2#1)
of volume rendering technique##2##4##(2007-11#2)
of volume##48##2##(1992-5#1)(1993-6#1)(1994-9#1)(2005-11#2)(2007-1#1)(2007-11#3)(2007-9#1)(2008-11#3)(2008-2#8)(2008-3#9)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-6#2)(2010-2#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#4)
of volumes##3##2##(2007-12#1)(2008-10#1)(2008-9#1)
of volumetric apparatus##2##3##(2008-10#2)
of volumetric##13##2##(1996-2#1)(1997-8#1)(2005-11#1)(2008-10#6)(2008-5#3)(2011-7#1)
of voluntary alcohol consumption##2##4##(1993-12#2)
of voluntary counselling and testing (VCT)##2##6##(2007-7#2)
of voluntary counselling and testing##3##5##(2007-7#2)(2013-1#1)
of voluntary exercise on azoxymethane-induced hepatocarcinogenesis##2##6##(1992-3#2)
of voluntary organizations##2##3##(1996-2#2)
of voluntary##23##2##(1992-3#2)(1993-12#3)(1996-2#2)(2006-3#2)(2006-4#1)(2006-7#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-11#2)(2010-9#1)(2011-1#1)(2012-1#1)(2013-1#3)
of volunteer administrators##2##3##(1993-1#1)(1993-2#1)
of volunteer management##2##3##(1994-3#2)
of volunteer services##2##3##(1993-1#1)(1994-3#1)
of volunteer work##2##3##(1994-2#1)(1995-2#1)
of volunteer##25##2##(1992-12#1)(1992-3#2)(1993-1#4)(1993-12#1)(1993-2#1)(1994-2#1)(1994-3#8)(1995-2#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(2008-2#1)(2011-2#1)
of volunteerism##2##2##(1992-3#1)(1993-2#1)
of volunteers and##2##3##(1992-3#1)(2008-7#1)
of volunteers are##2##3##(1993-2#1)(1994-2#1)
of volunteers in##2##3##(1995-12#1)(2008-4#1)
of volunteers##24##2##(1992-3#1)(1993-12#1)(1993-2#2)(1994-2#2)(1994-3#5)(1995-12#1)(1996-3#1)(1997-2#1)(1997-4#1)(2005-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#1)
of vomiting##16##2##(1990-8#1)(1991-11#1)(1991-5#1)(1995-9#1)(1997-7#2)(2005-12#1)(2006-10#1)(2006-4#2)(2007-12#1)(2008-12#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
of von Recklinghausen##2##3##(1992-9#1)(2013-7#1)
of von Recklinghausen's disease##3##4##(1991-2#1)(1992-9#1)(2006-10#1)
of von Willebrand factor and##2##5##(1994-11#1)(2007-11#1)
of von Willebrand factor##11##4##(1990-11#1)(1990-12#2)(1992-1#2)(1992-12#2)(1994-11#1)(2007-11#2)(2008-7#1)
of von Willebrand##13##3##(1990-11#1)(1990-12#2)(1992-1#2)(1992-12#2)(1993-9#1)(1994-11#2)(2007-11#2)(2008-7#1)
of von Willebrand's disease##3##4##(1990-11#1)(1992-11#1)(2011-1#1)
of von Willebrand's##5##3##(1990-11#1)(1992-11#1)(2010-12#1)(2011-1#2)
of von##27##2##(1990-11#2)(1990-12#2)(1991-2#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-9#2)(1993-9#1)(1994-11#2)(2006-10#1)(2006-12#1)(2007-11#2)(2008-7#1)(2010-12#2)(2011-1#2)(2011-2#1)(2012-3#1)(2013-7#1)
of voriconazole##3##2##(2007-12#1)(2008-3#1)(2009-5#1)
of vortex##2##2##(1995-7#1)(2007-12#1)
of vortices in##2##3##(1994-10#1)(1995-10#1)
of vortices##4##2##(1993-8#1)(1994-10#1)(1995-10#1)(2008-2#1)
of vowel-to-vowel coarticulation##3##3##(2010-12#1)(2013-8#2)
of voxels##2##2##(2008-2#1)(2009-10#1)
of vulnerability and##4##3##(1994-2#1)(1996-1#1)(2011-1#1)(2012-11#1)
of vulnerability to schizophrenia##2##4##(1997-8#2)
of vulnerability to##5##3##(1994-2#1)(1997-8#2)(2008-9#1)(2012-2#1)
of vulnerability##16##2##(1990-5#1)(1994-2#2)(1996-1#1)(1997-8#2)(2008-2#1)(2008-5#1)(2008-9#1)(2009-4#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-1#3)
of vulnerable plaque##2##3##(2008-10#1)(2012-2#1)
of vulnerable plaques##3##3##(2008-10#2)(2008-7#1)
of vulnerable populations##3##3##(1995-2#1)(2009-7#1)(2012-2#1)
of vulnerable##12##2##(1995-2#1)(2008-10#5)(2008-7#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-2#2)
of vulpia residues##4##3##(2004-2#4)
of vulva##3##2##(1993-1#2)(2007-7#1)
of vulval##4##2##(2007-12#4)
of vulvar Paget disease##2##4##(2006-10#2)
of vulvar##6##2##(1990-10#1)(1993-9#2)(2006-10#3)
of w-3##3##2##(2006-10#1)(2008-9#2)
of wa-2##2##2##(1995-2#2)
of wage##2##2##(1992-1#1)(1994-12#1)
of waist circumference##2##3##(1996-8#1)(2011-2#1)
of waist##3##2##(1996-8#1)(2011-2#2)
of waiting for##3##3##(1991-4#1)(1997-4#1)(2006-10#1)
of waiting list data##2##4##(1991-11#1)(1993-2#1)
of waiting list##4##3##(1991-11#3)(1993-2#1)
of waiting lists##4##3##(1991-11#1)(1993-2#1)(2006-12#1)(2006-8#1)
of waiting time##3##3##(1990-8#1)(1991-11#1)(2007-8#1)
of waiting##19##2##(1990-8#1)(1991-11#6)(1991-4#1)(1993-2#2)(1996-1#1)(1997-4#1)(2006-10#2)(2006-12#1)(2006-8#2)(2007-7#1)(2007-8#1)
of wakefulness and##2##3##(1994-2#1)(2010-10#1)
of wakefulness##3##2##(1994-2#1)(2010-10#1)(2012-2#1)
of waking##4##2##(1992-10#1)(2007-8#2)(2013-8#1)
of walking ability##5##3##(1996-9#1)(2007-10#2)(2010-10#1)(2012-1#1)
of walking distance##2##3##(1990-11#1)(1995-2#1)
of walking##19##2##(1990-11#1)(1993-12#2)(1995-2#1)(1995-7#1)(1996-9#1)(2007-10#2)(2007-11#1)(2009-4#1)(2010-10#1)(2012-1#5)(2013-1#2)(2013-8#1)
of walkway length and turning direction on the distance covered in the 6-minute walk test##2##15##(2012-12#2)
of wall appositions##2##3##(2008-10#2)
of wall tilt on the##2##5##(2007-11#2)
of wall##11##2##(1997-3#1)(2007-11#3)(2008-10#4)(2008-5#1)(2008-6#1)(2011-2#1)
of war##10##2##(1990-12#2)(1992-2#1)(1993-1#1)(1993-10#2)(1997-5#1)(2005-8#1)(2011-2#1)(2012-1#1)
of warfarin and##5##3##(1995-1#1)(2007-10#3)(2013-8#1)
of warfarin anticoagulation##2##3##(2006-10#1)(2006-8#1)
of warfarin in patients##2##4##(1990-12#1)(2006-8#1)
of warfarin in##4##3##(1990-12#1)(2006-8#1)(2010-4#1)(2011-1#1)
of warfarin therapy##2##3##(2007-3#1)(2012-1#1)
of warfarin##24##2##(1990-12#4)(1990-9#1)(1995-1#4)(2005-7#1)(2006-10#1)(2006-8#3)(2007-10#3)(2007-3#1)(2010-4#1)(2011-1#2)(2012-1#1)(2012-12#1)(2013-8#1)
of warm induction and reperfusion blood cardioplegia##2##7##(2007-8#2)
of warm##10##2##(1993-12#1)(1995-9#1)(2007-8#3)(2008-8#1)(2009-3#1)(2009-9#1)(2011-12#2)
of warming##3##2##(2007-8#1)(2007-9#1)(2009-4#1)
of warmth##2##2##(2008-1#1)(2009-11#1)
of warts##3##2##(1996-1#1)(2007-11#2)
of washed##9##2##(1994-12#1)(1994-8#1)(1994-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#2)(2012-12#1)
of washes##2##2##(1994-11#1)(2008-10#1)
of washing and##2##3##(2009-2#1)(2013-1#1)
of washing##5##2##(2009-2#4)(2013-1#1)
of waste analysis##2##3##(2008-10#2)
of waste generated##2##3##(2005-11#2)
of waste management##2##3##(1996-1#1)(2008-12#1)
of waste plastics##2##3##(2005-11#1)(2008-10#1)
of waste polymers##3##3##(2008-10#3)
of waste water##6##3##(1992-6#1)(1993-9#1)(2008-10#3)(2008-6#1)
of waste##27##2##(1991-4#1)(1992-6#1)(1993-9#1)(1995-7#1)(1996-1#1)(2005-11#3)(2006-3#1)(2008-10#13)(2008-12#1)(2008-6#1)(2009-2#1)(2010-9#1)(2011-2#1)
of wastes##2##2##(1991-4#1)(2008-10#1)
of wastewater treatment##2##3##(2008-10#2)
of wastewater##7##2##(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2012-2#1)
of wastewaters##3##2##(2007-8#1)(2008-10#1)(2012-2#1)
of wasting##4##2##(2006-9#2)(2008-12#1)(2013-1#1)
of water activity##2##3##(1994-9#1)(2008-7#1)
of water and acetonitrile##2##4##(2008-10#1)(2012-12#1)
of water and other##2##4##(2007-2#1)(2008-10#1)
of water and the##3##4##(1990-8#1)(2007-7#1)(2008-10#1)
of water and then##2##4##(1992-2#1)(2008-4#1)
of water and wastewater##2##4##(2008-10#2)
of water and##45##3##(1990-5#1)(1990-8#1)(1992-2#2)(1993-12#1)(1994-11#1)(1995-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(2004-4#1)(2005-11#2)(2006-12#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#9)(2008-3#5)(2008-4#1)(2008-8#1)(2009-10#1)(2009-6#2)(2009-8#1)(2012-12#2)(2012-2#1)(2012-3#1)
of water are##3##3##(2008-2#1)(2010-4#1)(2011-2#1)
of water as##2##3##(1992-12#1)(2008-7#1)
of water at##4##3##(1992-12#1)(1993-12#1)(2008-2#1)(2008-5#1)
of water binding##2##3##(2006-10#1)(2007-7#1)
of water by##4##3##(2007-12#2)(2008-10#1)(2009-6#1)
of water deprivation on##2##4##(1995-7#1)(2012-2#1)
of water deprivation##3##3##(1994-10#1)(1995-7#1)(2012-2#1)
of water environment##3##3##(2013-8#3)
of water flow##3##3##(2005-11#2)(2008-2#1)
of water fluoridation in Gauteng##3##5##(2006-8#3)
of water fluoridation in##4##4##(2006-8#4)
of water fluoridation##5##3##(2006-8#5)
of water for the##3##4##(2008-10#1)(2008-5#1)(2008-7#1)
of water for##7##3##(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)
of water from the##2##4##(2008-10#1)(2008-3#1)
of water from##5##3##(1992-3#1)(2005-10#1)(2006-1#1)(2008-10#1)(2008-3#1)
of water has##2##3##(2008-5#1)(2012-2#1)
of water have been##3##4##(1992-9#1)(2008-10#1)(2012-5#1)
of water ice##3##3##(2008-3#3)
of water in the##11##4##(1990-7#1)(1991-3#1)(1993-4#1)(1995-1#1)(2006-10#1)(2007-6#2)(2008-10#3)(2011-1#1)
of water in##24##3##(1990-7#1)(1991-3#1)(1992-9#1)(1993-12#1)(1993-4#1)(1995-1#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-8#1)(2007-6#2)(2008-10#6)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-12#1)
of water into the##2##4##(2008-3#1)(2009-11#1)
of water is##6##3##(1991-8#1)(1995-5#1)(2007-11#1)(2008-10#2)(2013-1#1)
of water levels##2##3##(1996-6#1)(2008-5#1)
of water loss##2##3##(2009-8#1)(2010-4#1)
of water molecules adsorbed##2##4##(2005-11#2)
of water molecules around##3##4##(2006-10#2)(2008-10#1)
of water molecules in##2##4##(2006-10#1)(2008-10#1)
of water molecules##18##3##(1992-12#1)(1994-8#1)(1995-11#1)(1995-3#1)(1997-2#1)(2005-11#2)(2006-10#4)(2008-10#5)(2008-2#1)(2010-12#1)
of water movement##2##3##(2007-12#1)(2008-10#1)
of water on##7##3##(1995-5#1)(1995-6#1)(1996-5#1)(2007-1#1)(2008-2#1)(2008-3#1)(2010-4#1)
of water or##3##3##(1990-3#1)(1991-2#1)(2006-8#1)
of water oxidation##4##3##(1997-6#2)(2009-2#2)
of water per##3##3##(1995-11#1)(2008-5#1)(2011-2#1)
of water quality of Taoranting Lake##2##6##(2013-8#2)
of water quality##7##3##(2008-1#2)(2008-10#1)(2008-5#1)(2012-3#1)(2013-8#2)
of water salinity##2##3##(2008-10#1)(2013-7#1)
of water sample in the presence of 1% non-ionic surfactant##2##10##(2008-10#2)
of water sample##4##3##(2008-10#4)
of water samples and##3##4##(2008-10#3)
of water samples##18##3##(1996-3#1)(2007-8#2)(2008-10#12)(2008-11#1)(2008-3#1)(2012-2#1)
of water scarcity##2##3##(2009-8#1)(2012-2#1)
of water should be##2##4##(2006-2#1)(2008-10#1)
of water soluble##3##3##(2008-10#1)(2008-3#1)(2009-3#1)
of water stress##3##3##(2008-12#2)(2009-8#1)
of water supply##2##3##(2008-11#1)(2011-2#1)
of water through##4##3##(2005-11#2)(2007-8#1)(2011-2#1)
of water to##9##3##(1991-6#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-4#1)
of water transport##3##3##(2006-10#1)(2007-7#1)(2009-12#1)
of water treatment##3##3##(2008-1#1)(2008-10#1)(2013-1#1)
of water vapor in air##2##5##(2008-3#2)
of water vapor in the##2##5##(2008-3#2)
of water vapor in##5##4##(2008-3#5)
of water vapor##12##3##(2005-11#1)(2008-2#3)(2008-3#7)(2013-8#1)
of water was passed##2##4##(1991-8#1)(2008-10#1)
of water was##6##3##(1991-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-6#1)(2010-9#1)
of water with##8##3##(1990-9#1)(1996-6#2)(1997-1#1)(2007-5#1)(2008-2#1)(2008-3#1)(2012-2#1)
of water##416##2##(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#2)(1992-12#4)(1992-2#2)(1992-3#1)(1992-9#3)(1993-12#4)(1993-4#1)(1994-10#1)(1994-11#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-3#2)(1995-5#5)(1995-6#1)(1995-7#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#4)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-6#4)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#17)(2006-1#1)(2006-10#12)(2006-12#2)(2006-2#3)(2006-3#1)(2006-5#1)(2006-7#2)(2006-8#9)(2007-1#4)(2007-10#3)(2007-11#1)(2007-12#6)(2007-2#2)(2007-3#2)(2007-5#3)(2007-6#3)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#5)(2008-10#83)(2008-11#8)(2008-12#9)(2008-2#18)(2008-3#33)(2008-4#1)(2008-5#15)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#4)(2009-3#1)(2009-5#1)(2009-6#4)(2009-8#5)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#5)(2012-5#1)(2012-7#1)(2013-1#5)(2013-7#6)(2013-8#9)
of water)##3##2##(2006-8#1)(2008-10#1)(2008-5#1)
of water-ice films##2##3##(2008-2#2)
of water-insoluble Curdlan##3##3##(2007-8#3)
of water-insoluble##8##2##(1995-12#1)(2006-11#1)(2007-8#3)(2008-10#1)(2008-5#2)
of water-leaving radiance##4##3##(2008-2#2)(2008-3#2)
of water-leaving radiances##3##3##(2008-2#1)(2008-3#2)
of water-leaving reflectance##2##3##(2008-2#1)(2008-3#1)
of water-leaving##10##2##(2008-2#5)(2008-3#5)
of water-soluble and##2##3##(2005-11#1)(2008-10#1)
of water-soluble organic##2##3##(2008-10#2)
of water-soluble polymers##2##3##(2005-11#1)(2008-10#1)
of water-soluble trace metal##2##4##(2007-8#2)
of water-soluble vitamins excreted in##2##5##(2008-10#2)
of water-soluble vitamins##5##3##(2008-10#5)
of water-soluble##33##2##(1990-12#1)(1990-9#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-4#1)(1996-4#1)(2004-9#1)(2005-11#3)(2005-8#1)(2006-8#1)(2007-8#4)(2008-10#12)(2008-11#1)(2008-5#1)(2009-12#1)(2012-2#1)
of water-specific##2##2##(2012-12#2)
of water-stressed tomato leaves was##2##5##(2013-8#2)
of water-vapor measurements by##2##4##(2008-2#1)(2008-3#1)
of water-vapor##3##2##(2008-2#2)(2008-3#1)
of waterborne##4##2##(1996-6#1)(2007-10#1)(2010-4#2)
of watermelon seedlings##2##3##(2008-10#2)
of watermelon##7##2##(1993-12#1)(2008-10#6)
of waters##11##2##(1993-9#1)(2007-7#1)(2008-10#6)(2008-3#1)(2008-9#1)(2013-8#1)
of watts##2##2##(2007-12#1)(2008-2#1)
of wave fronts of##2##4##(2007-11#1)(2008-3#1)
of wave fronts##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
of wave propagation in##4##4##(2007-12#1)(2008-3#2)(2008-7#1)
of wave propagation##7##3##(1990-3#1)(2007-12#3)(2008-3#2)(2008-7#1)
of wave##18##2##(1990-3#1)(2007-11#2)(2007-12#5)(2008-2#1)(2008-3#6)(2008-5#1)(2008-7#1)(2012-1#1)
of wave-front distortions##2##3##(2008-3#2)
of wave-front generation##2##3##(2007-12#1)(2008-3#1)
of wave-front##9##2##(2007-12#3)(2008-2#2)(2008-3#4)
of waveforms##2##2##(2007-12#1)(2008-3#1)
of waveguide##10##2##(2007-11#2)(2007-12#2)(2008-2#6)
of waveguides and##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
of waveguides is##2##3##(2008-1#1)(2008-2#1)
of waveguides with a##2##4##(2007-11#1)(2007-12#1)
of waveguides##10##2##(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#5)(2008-3#1)
of wavelength and##3##3##(2010-2#1)(2013-1#2)
of wavelength change##2##3##(2007-12#2)
of wavelength modulation##3##3##(2008-2#2)(2008-3#1)
of wavelength##40##2##(2006-12#1)(2007-11#4)(2007-12#6)(2008-10#3)(2008-2#12)(2008-3#11)(2010-2#1)(2013-1#2)
of wavelength-modulation##2##2##(2008-3#2)
of wavelengths in##2##3##(2007-11#1)(2008-3#1)
of wavelengths of##2##3##(2007-12#1)(2011-2#1)
of wavelengths##24##2##(2007-11#4)(2007-12#3)(2008-10#3)(2008-2#1)(2008-3#11)(2011-2#1)(2012-11#1)
of wavelet coefficients##5##3##(2008-2#4)(2008-3#1)
of wavelet transform##5##3##(2008-10#1)(2008-2#2)(2008-3#2)
of wavelet##14##2##(2008-10#2)(2008-2#8)(2008-3#4)
of wavelet-based##2##2##(2008-2#2)
of waves##8##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#2)(2013-1#1)
of wax and oil##3##4##(2008-5#3)
of wax##8##2##(2006-1#1)(2007-8#1)(2008-5#5)(2011-2#1)
of ways by##2##3##(1991-11#1)(1997-2#1)
of ways in which##4##4##(2005-7#1)(2007-7#1)(2008-10#2)
of ways of##3##3##(2006-7#1)(2007-2#1)(2010-12#1)
of ways to##6##3##(1994-1#1)(2006-2#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
of ways##39##2##(1991-11#1)(1992-12#1)(1992-3#2)(1994-1#1)(1994-12#1)(1996-3#1)(1997-2#2)(1997-4#1)(1997-5#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#2)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
of weak acids in##3##4##(2008-10#3)
of weak acids##6##3##(2008-10#5)(2008-9#1)
of weak nucleophiles in high-performance liquid##2##6##(1990-8#2)
of weak optical##2##3##(2007-12#2)
of weak##38##2##(1990-8#2)(1993-4#1)(1993-8#1)(1997-2#1)(2005-10#1)(2006-10#2)(2007-11#1)(2007-12#6)(2007-8#1)(2008-10#9)(2008-2#2)(2008-3#2)(2008-5#1)(2008-9#2)(2009-9#1)(2010-3#1)(2011-1#1)(2012-3#1)(2013-8#2)
of weak-light photoinhibition##2##3##(1990-5#1)(1991-7#1)
of weaker##3##2##(1995-5#1)(2008-11#1)(2012-2#1)
of weakly absorbing##2##3##(2008-2#1)(2008-3#1)
of weakly##13##2##(1990-8#1)(1995-2#1)(1996-5#2)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)
of weakness and##5##3##(1994-6#1)(2008-12#1)(2008-6#1)(2012-2#2)
of weakness of##2##3##(2009-5#1)(2010-8#1)
of weakness##10##2##(1994-6#1)(1996-9#1)(2005-12#1)(2008-12#1)(2008-6#1)(2009-2#1)(2009-5#1)(2010-8#1)(2012-2#2)
of wealth##3##2##(1994-2#1)(2008-9#1)(2010-12#1)
of weaned##2##2##(2008-7#1)(2008-9#1)
of weaning and##2##3##(2005-11#1)(2013-1#1)
of weaning from##2##3##(1997-3#1)(2007-6#1)
of weaning##10##2##(1992-11#1)(1995-12#1)(1996-2#1)(1997-3#1)(2005-11#2)(2007-6#1)(2008-2#1)(2013-1#2)
of wear debris##3##3##(2004-9#2)(2008-8#1)
of wear metals in##3##4##(2008-10#3)
of wear##16##2##(1993-8#1)(2004-9#4)(2005-11#1)(2008-10#3)(2008-8#6)(2012-12#1)
of weasel##2##2##(1994-8#2)
of weather conditions##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
of weather variables##2##3##(2008-10#2)
of weather##10##2##(2006-11#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-8#1)
of weathered##2##2##(2008-10#1)(2008-11#1)
of weathering##2##2##(2007-2#1)(2010-7#1)
of web##4##2##(2006-3#1)(2007-12#1)(2008-7#1)(2008-9#1)
of web-based##2##2##(2008-10#2)
of websites##3##2##(2007-8#1)(2011-2#2)
of wedge##2##2##(1990-2#1)(2008-3#1)
of wedlock##2##2##(2007-1#1)(2008-2#1)
of weed emergence##2##3##(2008-12#2)
of weed##5##2##(2005-11#1)(2008-10#1)(2008-12#3)
of weeds and##2##3##(2008-10#1)(2008-12#1)
of weeds##7##2##(2008-10#4)(2008-12#1)(2013-8#2)
of weekly##7##2##(1992-10#1)(1994-2#1)(1995-4#1)(2004-11#1)(2008-7#1)(2011-2#1)(2013-8#1)
of weeks##6##2##(1991-2#1)(1991-3#2)(1996-11#1)(2008-7#1)(2010-12#1)
of weevils##2##2##(2008-7#1)(2011-2#1)
of weight and##7##3##(1990-9#1)(1991-4#1)(1993-1#1)(1993-3#1)(2006-8#1)(2012-2#1)(2013-1#1)
of weight bearing##4##3##(2006-10#1)(2007-11#1)(2008-9#1)(2010-3#1)
of weight gain and##2##4##(2006-10#2)
of weight gain##10##3##(1991-7#1)(1994-6#1)(2004-3#2)(2006-10#2)(2006-7#1)(2007-2#1)(2008-3#2)
of weight in fat##2##4##(2010-12#2)
of weight loss and##2##4##(1993-1#1)(2006-8#1)
of weight loss on##2##4##(2008-3#1)(2013-8#1)
of weight loss##14##3##(1993-1#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-12#1)(2008-1#2)(2008-3#3)(2009-12#1)(2010-8#1)(2011-2#1)(2013-8#1)
of weight was##3##3##(1993-3#1)(1996-8#1)(2008-3#1)
of weight were##2##3##(1991-2#1)(2013-7#1)
of weight##65##2##(1990-4#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-4#1)(1991-7#1)(1992-11#1)(1993-1#3)(1993-2#1)(1993-3#2)(1994-6#1)(1996-8#1)(2004-3#2)(2006-10#5)(2006-12#1)(2006-7#4)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#4)(2007-2#1)(2008-1#3)(2008-2#1)(2008-3#7)(2008-7#1)(2008-9#1)(2009-12#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
of weight-for-height##2##2##(1991-12#2)
of weight-related words##2##3##(2007-12#2)
of weight-related##3##2##(2007-12#3)
of weighted DWD##2##3##(2010-12#2)
of weighted##6##2##(1992-3#1)(1994-6#1)(2008-2#2)(2010-12#2)
of weighting##3##2##(1990-8#1)(2008-2#1)(2011-1#1)
of welders##3##2##(2008-4#3)
of welfare reform##2##3##(2007-12#1)(2011-12#1)
of welfare##8##2##(1994-3#1)(1994-4#1)(1996-2#1)(2007-12#1)(2008-2#1)(2008-9#1)(2011-12#1)(2013-8#1)
of well characterized##2##3##(1992-6#1)(2008-11#1)
of well defined##3##3##(1991-7#1)(2006-10#1)(2006-2#1)
of well designed##2##3##(1997-3#1)(2008-4#1)
of well differentiated##2##3##(1992-2#1)(2011-2#1)
of well trained##2##3##(1993-11#1)(1994-8#1)
of well##24##2##(1991-7#1)(1992-2#1)(1992-6#1)(1993-11#1)(1994-8#1)(1997-3#1)(2005-8#1)(2006-10#1)(2006-2#2)(2006-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-7#2)(2009-4#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-1#1)
of well-being and##2##3##(1996-7#1)(2006-10#1)
of well-being in##2##3##(1996-7#1)(2011-2#1)
of well-being which##2##3##(2008-12#1)(2011-2#1)
of well-being##23##2##(1995-2#1)(1996-11#1)(1996-4#1)(1996-7#2)(2006-10#1)(2006-8#1)(2006-9#4)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#5)(2011-2#3)(2012-3#1)
of well-characterized patients##2##3##(2010-5#1)(2012-3#1)
of well-characterized##7##2##(1995-5#1)(2006-12#1)(2007-12#1)(2008-3#1)(2008-7#1)(2010-5#1)(2012-3#1)
of well-child care##2##3##(1996-1#1)(2010-8#1)
of well-defined redox peaks##2##4##(2008-10#2)
of well-defined redox##4##3##(2008-10#4)
of well-defined##19##2##(2006-11#1)(2007-6#1)(2008-10#7)(2008-12#1)(2008-2#2)(2008-5#1)(2009-2#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
of well-developed##2##2##(2007-12#1)(2008-7#1)
of well-differentiated##7##2##(1993-8#1)(2007-2#1)(2008-5#1)(2009-10#1)(2009-3#1)(2012-12#1)(2012-3#1)
of well-documented##3##2##(1993-11#1)(1996-4#1)(2008-4#1)
of well-established##5##2##(1997-7#1)(2007-2#1)(2008-7#1)(2011-12#1)(2013-1#1)
of well-formed##2##2##(2008-5#1)(2009-6#1)
of well-known##2##2##(2007-12#1)(2011-2#1)
of wellbeing##4##2##(2008-10#2)(2008-7#1)(2013-1#1)
of wellness##3##2##(2005-8#1)(2006-2#1)(2011-2#1)
of wells##5##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)
of west##2##2##(2007-12#1)(2011-2#1)
of western white pine##4##4##(2008-10#4)
of western##23##2##(1990-12#2)(1993-9#1)(2007-12#1)(2007-2#2)(2007-6#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#4)(2012-2#1)
of wet tissue##4##3##(1992-8#1)(1997-8#1)(2008-10#1)(2010-12#1)
of wet tissue)##2##3##(1992-8#1)(1996-11#1)
of wet weight##3##3##(1990-4#1)(1991-9#1)(2009-4#1)
of wet##23##2##(1990-4#1)(1991-9#1)(1992-2#1)(1992-8#2)(1996-11#1)(1997-4#1)(1997-8#1)(2006-2#1)(2008-10#6)(2008-4#1)(2008-5#3)(2009-4#2)(2010-12#1)(2011-1#1)
of wet-dog shakes##5##3##(1991-5#1)(1993-2#2)(1995-12#2)
of wetland landscape pattern##4##4##(2013-8#4)
of wetland##5##2##(2007-5#1)(2013-8#4)
of wetness or##2##3##(2008-10#2)
of wetness was##2##3##(2008-10#2)
of wetness##14##2##(2008-10#14)
of wetted and##2##3##(2008-10#1)(2008-3#1)
of wetting and drying##3##4##(2008-10#3)
of wetting##9##2##(1992-12#1)(2005-11#1)(2008-10#6)(2013-8#1)
of wh-questions in##2##3##(2011-1#2)
of wh-questions##4##2##(2011-1#4)
of what a##2##3##(1996-12#1)(2007-9#1)
of what are##2##3##(1992-6#1)(2008-2#1)
of what can be##2##4##(2008-2#1)(2008-7#1)
of what can##3##3##(2008-2#1)(2008-7#1)(2009-6#1)
of what constitutes a##2##4##(1992-9#1)(2010-10#1)
of what constitutes##4##3##(1992-9#1)(2010-10#1)(2013-1#2)
of what could##2##3##(2011-1#1)(2011-2#1)
of what has been termed##2##5##(2006-10#1)(2007-11#1)
of what has been##7##4##(1990-8#1)(2006-10#1)(2007-11#1)(2008-2#1)(2008-8#2)(2008-9#1)
of what is happening##2##4##(1997-2#1)(2006-12#1)
of what is known about##4##5##(1992-1#1)(2008-11#1)(2008-5#1)(2012-1#1)
of what is known##6##4##(1991-4#1)(1992-1#1)(1993-9#1)(2008-11#1)(2008-5#1)(2012-1#1)
of what is required to##2##5##(1996-5#1)(2008-11#1)
of what is to##2##4##(2007-12#2)
of what is##26##3##(1991-4#1)(1992-1#1)(1992-12#1)(1992-4#1)(1993-9#1)(1996-3#1)(1996-5#1)(1997-2#1)(2006-12#1)(2006-4#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-7#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2012-1#1)
of what may be a##2##5##(2006-12#1)(2008-6#1)
of what may##5##3##(1995-11#1)(1995-6#1)(2006-12#1)(2008-6#1)(2013-8#1)
of what the##3##3##(1991-3#1)(2007-9#1)(2008-11#1)
of what they##3##3##(1993-6#1)(2008-11#1)(2010-4#1)
of what was##2##3##(2008-6#1)(2012-2#1)
of what we believe to be##2##6##(2007-4#1)(2008-9#1)
of what we believe##3##4##(2007-4#1)(2008-3#1)(2008-9#1)
of what we need to##2##5##(2006-2#1)(2008-4#1)
of what we##11##3##(1991-12#1)(2004-2#1)(2006-2#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)
of what##117##2##(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#2)(1992-1#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#2)(1995-11#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(2004-2#1)(2004-7#1)(2004-9#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#2)(2006-8#1)(2007-11#4)(2007-12#4)(2007-4#5)(2007-7#1)(2007-9#3)(2008-1#3)(2008-10#2)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#6)(2008-8#2)(2008-9#5)(2009-10#1)(2009-3#1)(2009-6#1)(2010-10#3)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#4)(2013-8#1)
of wheat (Triticum aestivum)##3##4##(2008-10#2)(2008-11#1)
of wheat (Triticum##4##3##(2008-10#3)(2008-11#1)
of wheat and barley##4##4##(2008-10#4)
of wheat and wild oats##2##5##(2008-10#2)
of wheat and##12##3##(1990-4#1)(2008-10#10)(2008-11#1)
of wheat are##2##3##(2008-10#2)
of wheat bugs##4##3##(2013-8#4)
of wheat by##2##3##(2008-10#2)
of wheat chromosomes##2##3##(2008-5#1)(2008-8#1)
of wheat germ agglutinin (WGA)##3##5##(1991-12#1)(1996-9#1)(1997-8#1)
of wheat germ agglutinin##4##4##(1991-12#1)(1996-9#1)(1997-8#1)(2008-7#1)
of wheat germ##7##3##(1991-10#1)(1991-12#1)(1996-11#1)(1996-9#1)(1997-8#1)(2008-7#1)(2008-9#1)
of wheat grown##3##3##(2008-10#2)(2008-12#1)
of wheat in the##2##4##(2008-10#1)(2011-2#1)
of wheat in##11##3##(2008-10#7)(2011-2#2)(2012-2#1)(2013-8#1)
of wheat is caused by the##2##6##(2008-10#2)
of wheat is caused by##4##5##(2008-10#4)
of wheat is##5##3##(2008-10#5)
of wheat leaf##2##3##(2008-10#2)
of wheat lines##2##3##(2008-10#2)
of wheat plants##2##3##(2008-12#2)
of wheat production##2##3##(2008-10#1)(2008-12#1)
of wheat seed germination##2##4##(2008-12#2)
of wheat seed##3##3##(2008-10#1)(2008-12#2)
of wheat streak mosaic virus (WSMV) has been##2##8##(2008-10#2)
of wheat stripe rust##3##4##(2008-10#3)
of wheat that is##2##4##(2008-10#2)
of wheat that##4##3##(2008-10#4)
of wheat to##4##3##(2008-10#3)(2010-6#1)
of wheat worldwide##3##3##(2008-10#2)(2011-10#1)
of wheat##174##2##(1990-4#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-7#2)(1996-11#1)(1996-9#1)(1997-8#2)(2006-4#1)(2007-7#3)(2008-10#118)(2008-11#2)(2008-12#11)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-8#1)(2010-6#1)(2011-10#1)(2011-2#3)(2012-1#2)(2012-2#2)(2013-1#1)(2013-8#5)
of wheat-germ##2##2##(1991-5#1)(1994-12#1)
of wheatgrass chromosomes##2##3##(2008-8#2)
of wheelchair##6##2##(2007-10#2)(2013-1#4)
of wheeze was##2##3##(2008-12#1)(2012-12#1)
of wheeze##4##2##(1991-11#1)(2008-12#1)(2012-12#2)
of wheezing##4##2##(2005-8#1)(2006-8#1)(2007-2#1)(2008-10#1)
of when to##2##3##(2008-4#1)(2010-4#1)
of when##10##2##(1994-6#1)(1997-8#1)(2004-10#1)(2005-11#1)(2008-2#1)(2008-4#1)(2010-4#1)(2012-1#1)(2012-2#1)(2012-3#1)
of where##12##2##(1994-8#1)(1996-1#1)(2006-10#1)(2007-7#1)(2008-12#1)(2008-5#1)(2009-11#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)
of whether a##9##3##(1991-2#1)(1991-3#1)(1996-12#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2009-5#1)
of whether an##2##3##(2008-5#1)(2011-2#1)
of whether it was##4##4##(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#1)
of whether it##6##3##(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)
of whether or not the##2##5##(1994-2#1)(2012-12#1)
of whether or not##10##4##(1994-2#3)(2006-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2012-12#1)(2012-2#1)
of whether the##36##3##(1990-2#1)(1991-5#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-4#2)(2004-9#1)(2005-10#1)(2006-11#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-5#1)(2010-7#1)(2011-12#1)(2012-1#1)(2012-2#1)(2012-3#1)
of whether there is a##2##5##(2007-2#1)(2010-6#1)
of whether there is##3##4##(2006-2#1)(2007-2#1)(2010-6#1)
of whether there##4##3##(2006-2#1)(2007-2#1)(2010-6#1)(2012-2#1)
of whether these##3##3##(1995-2#1)(1997-1#1)(2008-12#1)
of whether they are##4##4##(1994-9#1)(2006-2#1)(2007-12#1)(2009-4#1)
of whether they were##3##4##(1990-4#1)(2008-10#1)(2010-3#1)
of whether they##8##3##(1990-4#1)(1994-9#1)(1996-4#1)(2006-2#1)(2007-12#1)(2008-10#1)(2009-4#1)(2010-3#1)
of whether this##3##3##(1996-4#1)(2010-12#1)(2011-2#1)
of whether to##4##3##(1996-2#1)(1997-1#1)(2008-7#1)(2008-9#1)
of whether##142##2##(1990-12#2)(1990-2#1)(1990-4#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#1)(1994-1#1)(1994-2#5)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-4#4)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-6#1)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-6#1)(2006-10#5)(2006-11#2)(2006-12#3)(2006-2#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-12#5)(2007-2#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#3)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-12#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
of whey proteins##5##3##(1997-8#1)(2008-10#1)(2008-7#3)
of whey##8##2##(1997-8#1)(2008-10#2)(2008-5#1)(2008-7#4)
of which 10 presented the best evidence to answer the clinical question##2##12##(2007-8#2)
of which 10##3##3##(2007-8#3)
of which 11##6##3##(1993-9#1)(2007-12#1)(2007-2#1)(2007-8#2)(2010-9#1)
of which 12 presented the best evidence to answer the clinical question##4##12##(2007-8#4)
of which 12##6##3##(1994-5#1)(2007-8#5)
of which 13 represented the best evidence to answer the clinical question##2##12##(2007-8#2)
of which 13 represented the best evidence##3##7##(2007-8#3)
of which 13##5##3##(2007-8#4)(2011-2#1)
of which 14 represented the best evidence##2##7##(2007-8#2)
of which 14##6##3##(2007-8#4)(2008-12#1)(2012-1#1)
of which 15 had##2##4##(1991-9#1)(1994-2#1)
of which 15##5##3##(1991-9#1)(1994-2#1)(2007-7#1)(2007-8#2)
of which 16##4##3##(2007-8#2)(2008-7#1)(2013-8#1)
of which 17##3##3##(2007-8#1)(2008-12#1)(2011-2#1)
of which 172 concepts (50##2##5##(2013-1#2)
of which 18 presented the best evidence to answer the clinical question##2##12##(2007-8#2)
of which 18##4##3##(2007-8#2)(2008-10#1)(2012-2#1)
of which 21##2##3##(2007-8#1)(2013-7#1)
of which 4##5##3##(2006-5#1)(2007-7#1)(2007-8#1)(2008-9#2)
of which 48##2##3##(2007-10#1)(2007-7#1)
of which 5##4##3##(1994-8#1)(2007-8#1)(2008-11#1)(2011-1#1)
of which 50 were##2##4##(2007-6#1)(2011-12#1)
of which 50##3##3##(2007-6#1)(2010-10#1)(2011-12#1)
of which 51##2##3##(2007-9#1)(2008-8#1)
of which 55##2##3##(2004-11#1)(2012-12#1)
of which 6 were##2##4##(2008-12#1)(2013-8#1)
of which 6##5##3##(2007-8#3)(2008-12#1)(2013-8#1)
of which 6% were##2##4##(1994-8#1)(2012-2#1)
of which 61##2##3##(2005-8#1)(2013-8#1)
of which 8 represented the best evidence##2##7##(2007-8#2)
of which 8##6##3##(2007-8#5)(2013-8#1)
of which 9##3##3##(1992-6#1)(2007-8#1)(2008-12#1)
of which L-689##2##3##(1993-11#2)
of which a##8##3##(1992-9#1)(1993-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-3#2)(2013-8#1)
of which also controlled resistance to isolate MG96-36##2##8##(2008-10#2)
of which also##8##3##(1994-6#1)(2007-12#1)(2008-10#3)(2008-7#1)(2009-8#1)(2013-8#1)
of which appear to##2##4##(1995-12#1)(2007-8#1)
of which appear##3##3##(1995-12#1)(1997-4#1)(2007-8#1)
of which approximately##2##3##(1992-11#1)(1992-3#1)
of which are also##3##4##(2006-10#1)(2010-10#1)(2010-12#1)
of which are characterized by a##2##6##(2007-12#1)(2007-2#1)
of which are described in this##2##6##(1996-2#1)(2008-4#1)
of which are described##5##4##(1996-2#1)(2008-4#2)(2008-9#1)(2011-1#1)
of which are designed##2##4##(2007-12#1)(2010-2#1)
of which are difficult to##3##5##(2007-8#1)(2010-3#1)(2012-2#1)
of which are discussed##2##4##(1990-9#1)(2013-1#1)
of which are highly##2##4##(2008-10#1)(2010-12#1)
of which are identical##2##4##(1994-2#1)(1997-7#1)
of which are in the##2##5##(2008-10#1)(2008-11#1)
of which are in##6##4##(1990-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#1)
of which are involved in##2##5##(1995-12#1)(1995-6#1)
of which are known to##5##5##(1994-10#1)(1995-12#1)(1995-2#1)(1996-7#1)(2005-10#1)
of which are known##6##4##(1992-5#1)(1994-10#1)(1995-12#1)(1995-2#1)(1996-7#1)(2005-10#1)
of which are not##4##4##(1991-12#1)(1995-1#1)(2012-1#1)(2013-7#1)
of which are of##2##4##(1992-8#1)(2008-5#1)
of which are present at the##2##6##(1996-8#1)(2008-4#1)
of which are present in the##2##6##(1993-11#1)(1993-3#1)
of which are present##4##4##(1993-11#1)(1993-3#1)(1996-8#1)(2008-4#1)
of which are presented##3##4##(2006-2#1)(2006-9#1)(2007-11#1)
of which are regulated##2##4##(1995-2#1)(2013-1#1)
of which are the##2##4##(2008-2#1)(2008-5#1)
of which are used in##2##5##(2007-12#1)(2008-11#1)
of which are used##4##4##(1993-5#1)(2007-12#1)(2008-11#1)(2010-7#1)
of which are##156##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#2)(1992-10#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#2)(1995-1#2)(1995-12#2)(1995-2#2)(1995-6#1)(1995-7#1)(1996-2#3)(1996-3#1)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-10#2)(2005-12#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#3)(2007-2#4)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#7)(2008-11#10)(2008-12#2)(2008-2#2)(2008-4#9)(2008-5#7)(2008-7#1)(2008-8#3)(2008-9#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
of which belonged to##2##4##(2008-5#1)(2012-3#1)
of which bind##3##3##(1991-11#1)(1997-2#2)
of which can be detected##2##5##(2007-11#1)(2009-7#1)
of which can be prevented##3##5##(2008-7#1)(2012-11#1)(2013-1#1)
of which can be used##2##5##(2008-4#1)(2012-3#1)
of which can be##16##4##(1992-4#1)(1993-3#1)(1993-9#1)(1994-2#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-7#1)(2012-11#2)(2012-3#1)(2013-1#1)
of which can##26##3##(1992-4#1)(1993-3#1)(1993-9#2)(1994-2#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-7#1)(2012-11#2)(2012-3#1)(2013-1#1)
of which carries##2##3##(1991-12#1)(2011-12#1)
of which caused##2##3##(2006-11#1)(2008-10#1)
of which consists of##2##4##(1997-7#1)(2007-11#1)
of which contain the##2##4##(1991-5#1)(1995-11#1)
of which contain##6##3##(1991-5#1)(1994-9#1)(1995-11#1)(2008-10#2)(2010-2#1)
of which contained##5##3##(1992-2#1)(1995-11#1)(2008-10#1)(2010-10#1)(2012-2#1)
of which contains##7##3##(1990-11#1)(1991-3#1)(1992-8#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-11#1)
of which contribute to##3##4##(1996-9#1)(2007-1#1)(2008-8#1)
of which contribute##4##3##(1996-9#1)(2007-1#1)(2008-10#1)(2008-8#1)
of which correspond to##4##4##(1995-9#3)(1996-3#1)
of which corresponded to##2##4##(1995-4#1)(2006-12#1)
of which could be##6##4##(1991-3#1)(1994-9#1)(2006-12#1)(2007-11#1)(2008-10#1)(2011-1#1)
of which could##9##3##(1990-10#1)(1991-3#1)(1994-9#1)(2006-12#1)(2007-11#1)(2007-4#1)(2008-10#1)(2009-4#1)(2011-1#1)
of which decreases##2##3##(1990-2#1)(2010-11#1)
of which defines##3##3##(1991-4#2)(2012-2#1)
of which depend on the##4##5##(1996-4#1)(1996-5#1)(1997-1#1)(2008-2#1)
of which depend##5##3##(1994-2#1)(1996-4#1)(1996-5#1)(1997-1#1)(2008-2#1)
of which depends on the##2##5##(1991-9#1)(2008-3#1)
of which depends on##4##4##(1991-11#1)(1991-9#1)(2007-12#1)(2008-3#1)
of which determines the##2##4##(1994-7#1)(2008-7#1)
of which did not##2##4##(2009-12#1)(2010-1#1)
of which differed##2##3##(1992-12#1)(2008-8#1)
of which display##3##3##(1996-5#1)(2008-7#1)(2010-5#1)
of which do not##2##4##(2010-5#1)(2010-7#1)
of which eight presented the best evidence to answer the clinical question##2##12##(2007-8#2)
of which eight presented the best evidence to answer the##3##10##(2007-8#3)
of which eight##4##3##(1992-8#1)(2007-8#3)
of which encode proteins with##2##5##(1993-12#1)(1994-3#1)
of which encode proteins##3##4##(1993-12#1)(1994-3#1)(1996-3#1)
of which encode##5##3##(1993-12#1)(1994-3#1)(1995-11#1)(1996-2#1)(1996-3#1)
of which express##3##3##(1993-8#1)(1994-12#1)(2008-4#1)
of which five presented the best evidence to answer the clinical question##2##12##(2007-8#2)
of which five##4##3##(1994-3#1)(2006-9#1)(2007-8#2)
of which form##4##3##(1990-12#1)(1996-5#1)(2008-9#1)(2010-3#1)
of which four##2##3##(2007-8#1)(2008-10#1)
of which gives##2##3##(1994-5#1)(2009-5#1)
of which had a##4##4##(2008-7#1)(2010-5#1)(2010-8#1)(2012-12#1)
of which had been##3##4##(1993-7#1)(2006-8#1)(2008-10#1)
of which had not been##2##5##(1995-6#1)(2008-10#1)
of which had##20##3##(1993-5#1)(1993-7#1)(1994-2#1)(1995-6#2)(1997-2#1)(2006-8#1)(2006-9#1)(2007-3#1)(2008-10#2)(2008-7#2)(2009-9#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)
of which has a##4##4##(1993-2#1)(1995-8#1)(1997-2#1)(2005-6#1)
of which has been##3##4##(1997-1#1)(1997-4#1)(2008-2#1)
of which has the##2##4##(2008-11#1)(2008-3#1)
of which has##17##3##(1990-11#1)(1991-2#1)(1991-7#1)(1993-2#1)(1994-3#1)(1995-8#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-6#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-3#1)(2013-1#1)
of which have been shown to##2##6##(2008-8#2)
of which have been##11##4##(1991-5#1)(1992-5#1)(1992-9#1)(1993-11#1)(1996-6#1)(1997-5#1)(2006-9#1)(2008-10#1)(2008-8#2)(2010-10#1)
of which have##41##3##(1990-4#1)(1991-5#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1994-10#1)(1995-1#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-6#1)(1997-5#1)(2004-7#1)(2005-10#1)(2006-9#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#2)(2010-10#1)(2010-5#1)(2011-10#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
of which in the##2##4##(2008-10#2)
of which in##5##3##(1990-5#1)(2008-10#2)(2008-3#1)(2011-3#1)
of which include##2##3##(2008-5#1)(2008-9#1)
of which includes the##2##4##(2008-12#1)(2010-12#1)
of which includes##4##3##(1990-12#1)(2008-10#1)(2008-12#1)(2010-12#1)
of which increases in##2##4##(1996-4#1)(2011-2#1)
of which increases##4##3##(1990-2#1)(1996-4#1)(2008-4#1)(2011-2#1)
of which involved injury)##2##4##(1991-2#2)
of which involved##3##3##(1991-2#3)
of which is a##8##4##(1992-12#1)(1992-8#1)(1993-3#1)(1993-4#1)(1993-5#1)(1994-9#1)(2007-9#1)(2009-8#1)
of which is an##2##4##(1994-9#1)(1996-5#1)
of which is based on##2##5##(2008-3#1)(2012-2#1)
of which is believed to be##2##6##(1994-5#1)(1997-2#1)
of which is believed to##3##5##(1994-5#1)(1997-2#1)(2008-11#1)
of which is bound to##2##5##(1991-2#1)(1997-1#1)
of which is controlled by##2##5##(2007-11#1)(2008-1#1)
of which is dependent on the##2##6##(2005-11#1)(2008-8#1)
of which is dependent on##4##5##(1990-11#1)(1995-7#1)(2005-11#1)(2008-8#1)
of which is discussed in##2##5##(1990-3#1)(2008-3#1)
of which is found in the##2##6##(1990-7#1)(1990-8#1)
of which is found##3##4##(1990-7#1)(1990-8#1)(1993-6#1)
of which is in##2##4##(1992-11#1)(2006-5#1)
of which is largely unknown##2##5##(2008-11#1)(2008-4#1)
of which is not##3##4##(1992-4#1)(2008-10#1)(2009-5#1)
of which is regulated by##2##5##(1992-9#1)(1993-12#1)
of which is stimulated by##2##5##(1994-8#1)(1995-10#1)
of which is the##10##4##(1991-1#1)(1991-9#1)(1997-1#2)(2005-11#1)(2005-7#1)(2005-8#1)(2008-5#1)(2009-12#1)(2009-7#1)
of which is to##4##4##(1993-6#1)(1994-12#1)(2007-4#1)(2012-3#1)
of which is unknown##2##4##(2007-11#1)(2008-7#1)
of which is##141##3##(1990-1#1)(1990-11#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#2)(1993-5#2)(1993-6#2)(1993-9#1)(1994-12#3)(1994-2#3)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-6#2)(1995-7#1)(1995-8#2)(1996-11#1)(1996-5#1)(1996-7#1)(1997-1#3)(1997-2#1)(2004-4#1)(2005-1#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#4)(2007-12#3)(2007-4#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#4)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#2)(2009-7#1)(2009-8#2)(2010-11#1)(2010-7#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
of which it##2##3##(2007-11#1)(2008-1#1)
of which lies##2##3##(1990-11#1)(1995-2#1)
of which may be##11##4##(1990-8#1)(1994-2#2)(1996-5#1)(1997-5#1)(2006-10#1)(2006-4#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-11#1)
of which may result in##2##5##(2008-9#1)(2009-7#1)
of which may result##3##4##(1990-12#1)(2008-9#1)(2009-7#1)
of which may##25##3##(1990-12#1)(1990-5#1)(1990-8#1)(1994-2#2)(1996-5#1)(1996-6#1)(1997-4#1)(1997-5#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-8#1)
of which might##3##3##(1990-2#1)(2007-12#1)(2008-5#1)
of which more than##2##4##(2009-2#1)(2011-2#1)
of which must be##3##4##(1991-11#1)(1994-8#1)(2008-9#1)
of which nine presented the best evidence to answer the clinical question##2##12##(2007-8#2)
of which nine##3##3##(1993-7#1)(2007-8#2)
of which occurred##2##3##(1995-2#1)(2007-8#1)
of which occurs##2##3##(1993-2#1)(1995-6#1)
of which one##3##3##(1993-5#1)(2008-10#2)
of which only about##2##4##(2007-5#1)(2008-10#1)
of which only four##2##4##(2010-1#1)(2011-1#1)
of which only one##3##4##(1990-11#1)(2007-8#1)(2009-6#1)
of which only##12##3##(1990-11#2)(2007-5#1)(2007-8#2)(2008-10#1)(2009-6#1)(2009-9#1)(2010-1#1)(2011-1#1)(2012-12#1)(2012-2#1)
of which play a role in##2##6##(2008-3#1)(2010-7#1)
of which play##4##3##(2007-1#1)(2008-3#1)(2010-7#1)(2012-12#1)
of which possess##2##3##(2006-12#1)(2009-12#1)
of which produces a##3##4##(1995-8#1)(2008-10#2)
of which produces##4##3##(1995-8#2)(2008-10#2)
of which remains##3##3##(1997-7#1)(2008-7#1)(2010-10#1)
of which require##3##3##(2008-11#1)(2008-4#2)
of which respond##2##3##(2007-11#1)(2011-1#1)
of which result from##2##4##(2006-10#1)(2011-1#1)
of which result in##3##4##(1994-11#1)(2009-10#1)(2009-9#1)
of which result##5##3##(1994-11#1)(2006-10#1)(2009-10#1)(2009-9#1)(2011-1#1)
of which resulted in##2##4##(1995-11#1)(2012-3#1)
of which results in the##2##5##(1993-7#1)(2012-1#1)
of which results in##5##4##(1993-7#1)(2006-10#1)(2011-1#1)(2012-1#1)(2012-12#1)
of which secreted##2##3##(1994-9#1)(1995-1#1)
of which serves as a##2##5##(2008-10#2)
of which seven presented the best evidence to answer the clinical question##5##12##(2007-8#5)
of which seven##6##3##(2007-8#5)(2008-4#1)
of which should be##2##4##(1990-4#1)(2007-8#1)
of which show##2##3##(2007-11#1)(2011-12#1)
of which showed##11##3##(1990-11#1)(1991-3#1)(1992-8#1)(1993-12#1)(1994-12#1)(1996-11#1)(2007-7#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
of which six##2##3##(2007-1#1)(2007-8#1)
of which the first##2##4##(1994-12#1)(1996-6#1)
of which the most##3##4##(1991-4#1)(2007-7#1)(2008-1#1)
of which the##41##3##(1990-4#1)(1990-5#1)(1991-4#1)(1991-8#1)(1992-2#1)(1993-9#1)(1994-12#2)(1994-2#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-6#1)(2006-1#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-8#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#1)
of which there##2##3##(1997-6#1)(2008-3#1)
of which they##3##3##(1992-6#1)(1997-5#1)(2013-1#1)
of which three##6##3##(1993-11#1)(1994-2#1)(2007-8#2)(2008-10#1)(2008-5#1)
of which two##7##3##(1992-12#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-2#1)
of which was determined by##2##5##(2006-12#1)(2008-2#1)
of which was determined##3##4##(2006-12#1)(2008-2#1)(2008-7#1)
of which was found to be##2##6##(1996-3#1)(1996-7#1)
of which was greater##2##4##(1991-12#1)(2008-10#1)
of which was not##2##4##(2005-9#1)(2009-10#1)
of which was##45##3##(1990-4#1)(1991-12#2)(1991-5#1)(1991-9#1)(1992-1#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-3#2)(1994-6#1)(1995-2#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-7#1)(2004-12#1)(2005-9#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-8#3)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-7#1)(2011-1#1)(2011-2#1)
of which we are aware##2##5##(1995-8#1)(2007-12#1)
of which we##3##3##(1995-8#1)(2007-12#1)(2010-12#1)
of which were also##3##4##(1994-7#1)(2006-4#1)(2008-10#1)
of which were associated with##2##5##(1996-3#1)(2010-8#1)
of which were closely##3##4##(1992-12#1)(2006-8#1)(2008-10#1)
of which were confirmed##2##4##(1997-2#1)(2012-12#1)
of which were found##3##4##(1994-9#1)(1997-2#1)(2008-10#1)
of which were in##5##4##(1990-11#1)(2006-8#1)(2008-7#1)(2010-8#1)(2011-2#1)
of which were measured##2##4##(1995-12#1)(2008-3#1)
of which were not##2##4##(1991-11#1)(2008-10#1)
of which were of##2##4##(1992-8#1)(2012-12#1)
of which were related to##3##5##(2005-11#1)(2007-8#1)(2008-3#1)
of which were successfully##2##4##(2007-1#1)(2013-1#1)
of which were used##3##4##(1995-2#1)(1995-7#1)(2012-2#1)
of which were##105##3##(1990-11#1)(1990-12#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-12#2)(1994-7#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-3#3)(1996-5#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2004-3#1)(2005-11#1)(2005-12#2)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#12)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#2)(2010-8#2)(2010-9#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)
of which will##4##3##(1996-1#1)(2006-10#2)(2008-5#1)
of which##1325##2##(1990-1#2)(1990-10#3)(1990-11#11)(1990-12#5)(1990-2#3)(1990-3#2)(1990-4#5)(1990-5#6)(1990-6#2)(1990-7#2)(1990-8#2)(1990-9#3)(1991-1#3)(1991-11#4)(1991-12#6)(1991-2#9)(1991-3#6)(1991-4#3)(1991-5#7)(1991-6#2)(1991-7#4)(1991-8#3)(1991-9#7)(1992-1#3)(1992-10#1)(1992-11#6)(1992-12#9)(1992-2#2)(1992-3#3)(1992-4#2)(1992-5#5)(1992-6#6)(1992-8#8)(1992-9#5)(1993-1#1)(1993-10#1)(1993-11#5)(1993-12#5)(1993-2#10)(1993-3#6)(1993-4#2)(1993-5#6)(1993-6#4)(1993-7#3)(1993-8#6)(1993-9#8)(1994-10#3)(1994-11#6)(1994-12#16)(1994-2#14)(1994-3#7)(1994-5#4)(1994-6#5)(1994-7#3)(1994-8#8)(1994-9#9)(1995-1#8)(1995-10#1)(1995-11#6)(1995-12#5)(1995-2#7)(1995-3#3)(1995-4#2)(1995-5#2)(1995-6#9)(1995-7#3)(1995-8#11)(1995-9#3)(1996-1#3)(1996-10#3)(1996-11#4)(1996-12#5)(1996-2#6)(1996-3#10)(1996-4#4)(1996-5#7)(1996-6#6)(1996-7#5)(1996-8#3)(1996-9#5)(1997-1#7)(1997-2#10)(1997-3#1)(1997-4#9)(1997-5#4)(1997-6#3)(1997-7#9)(1997-8#3)(2004-10#1)(2004-11#1)(2004-12#1)(2004-2#2)(2004-3#2)(2004-4#2)(2004-7#1)(2004-8#1)(2005-1#2)(2005-10#3)(2005-11#5)(2005-12#5)(2005-4#1)(2005-6#1)(2005-7#2)(2005-8#9)(2005-9#1)(2006-1#2)(2006-10#20)(2006-11#2)(2006-12#10)(2006-2#3)(2006-3#1)(2006-4#3)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#10)(2006-9#5)(2007-1#7)(2007-10#5)(2007-11#21)(2007-12#24)(2007-2#7)(2007-3#7)(2007-4#6)(2007-5#4)(2007-6#4)(2007-7#16)(2007-8#75)(2007-9#6)(2008-1#12)(2008-10#82)(2008-11#32)(2008-12#15)(2008-2#17)(2008-3#28)(2008-4#30)(2008-5#38)(2008-6#4)(2008-7#29)(2008-8#21)(2008-9#20)(2009-10#2)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#3)(2009-4#6)(2009-5#5)(2009-6#4)(2009-7#4)(2009-8#10)(2009-9#5)(2010-1#3)(2010-10#5)(2010-11#4)(2010-12#5)(2010-2#7)(2010-3#2)(2010-4#3)(2010-5#6)(2010-7#6)(2010-8#5)(2010-9#2)(2011-1#19)(2011-10#1)(2011-12#6)(2011-2#25)(2011-3#4)(2012-1#8)(2012-11#5)(2012-12#19)(2012-2#24)(2012-3#14)(2013-1#23)(2013-7#4)(2013-8#18)
of whiplash injury##3##3##(2007-1#1)(2007-4#2)
of whiplash##6##2##(1993-9#1)(2006-11#1)(2006-8#1)(2007-1#1)(2007-4#2)
of whirlpools##3##2##(1992-11#3)
of whispering-gallery modes##3##3##(2007-12#3)
of whistleblowing##3##2##(2011-1#3)
of white blood cells##2##4##(2008-9#1)(2012-2#1)
of white blood##3##3##(2008-9#1)(2010-12#1)(2012-2#1)
of white fir trees##2##4##(2008-10#2)
of white light##4##3##(2007-12#2)(2008-2#1)(2008-5#1)
of white matter##12##3##(1991-12#1)(1992-12#2)(2007-5#2)(2009-9#2)(2010-12#2)(2011-1#1)(2012-1#1)(2013-1#1)
of white oak##3##3##(2004-4#3)
of white pine blister rust##4##5##(2008-10#4)
of white plague##2##3##(2007-3#1)(2007-5#1)
of white shrimp##2##3##(2008-5#2)
of white spot lesion formation##2##5##(2009-7#2)
of white spot##3##3##(2009-7#3)
of white wines##2##3##(2008-10#2)
of white##64##2##(1991-11#1)(1991-12#1)(1992-12#2)(1996-1#1)(1996-2#1)(1997-1#3)(2004-4#3)(2006-12#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#3)(2008-10#15)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-9#2)(2009-7#4)(2009-9#2)(2010-12#4)(2010-8#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
of white-light##4##2##(2007-11#2)(2008-2#2)
of whiteflies##5##2##(2007-6#2)(2008-10#1)(2011-12#1)(2011-2#1)
of whites##3##2##(1993-12#1)(1997-3#1)(2010-11#1)
of whitish##2##2##(2008-10#1)(2012-12#1)
of who##5##2##(1995-5#1)(2007-4#1)(2009-5#1)(2010-12#1)(2013-7#1)
of whole blood at##2##4##(1992-8#1)(2008-10#1)
of whole blood or##2##4##(1990-12#1)(2013-8#1)
of whole blood##16##3##(1990-12#3)(1990-2#1)(1992-8#1)(1994-3#1)(1994-4#1)(1996-2#1)(1997-6#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-4#1)(2010-12#1)(2013-1#1)(2013-8#1)
of whole body##7##3##(1991-1#1)(1991-2#1)(1993-9#1)(1996-5#1)(1996-8#1)(2006-8#1)(2008-5#1)
of whole cell##5##3##(1991-5#1)(1994-11#2)(1994-8#1)(2008-5#1)
of whole cells##4##3##(1991-3#1)(2006-8#1)(2008-10#1)(2008-9#1)
of whole genome##2##3##(2008-10#1)(2009-10#1)
of whole genomes##3##3##(2006-11#1)(2008-4#1)(2012-3#1)
of whole grain##3##3##(2010-2#3)
of whole grains##6##3##(2010-1#1)(2010-2#4)(2012-1#1)
of whole lung lavage##2##4##(2010-7#1)(2012-2#1)
of whole mount##2##3##(2008-5#1)(2009-5#1)
of whole plasma##2##3##(2008-10#1)(2008-3#1)
of whole saliva##3##3##(2006-2#1)(2006-4#2)
of whole##87##2##(1990-12#3)(1990-2#1)(1991-1#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-7#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-3#1)(1994-4#1)(1994-8#1)(1995-12#2)(1996-2#1)(1996-5#1)(1996-8#1)(1997-6#1)(2006-11#1)(2006-2#1)(2006-4#2)(2006-8#2)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#9)(2008-3#4)(2008-4#4)(2008-5#6)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#2)(2010-1#1)(2010-12#1)(2010-2#7)(2010-7#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
of whole-body RNA##2##3##(1993-9#1)(1996-8#1)
of whole-body##8##2##(1993-9#1)(1996-8#1)(2008-5#1)(2008-9#1)(2010-2#1)(2012-2#1)(2013-8#2)
of whole-cell##2##2##(2008-8#1)(2011-3#1)
of whole-genome##4##2##(2008-4#1)(2008-7#2)(2012-3#1)
of whom 1##4##3##(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
of whom 104##2##3##(1995-6#1)(2007-8#1)
of whom 14##2##3##(1990-8#1)(2008-4#1)
of whom 27##2##3##(2007-7#1)(2008-3#1)
of whom are##13##3##(1990-6#1)(1993-6#1)(1995-9#1)(1996-2#2)(2006-10#1)(2006-5#1)(2007-11#1)(2007-8#1)(2007-9#1)(2009-5#1)(2012-12#1)(2012-3#1)
of whom became##2##3##(1991-11#1)(1996-7#1)
of whom developed##3##3##(1991-3#1)(1991-9#1)(2007-8#1)
of whom had a##3##4##(2004-11#1)(2005-5#1)(2007-9#1)
of whom had at least##2##5##(2006-10#1)(2011-1#1)
of whom had been##2##4##(1991-6#1)(2007-2#1)
of whom had##29##3##(1991-11#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-6#1)(2004-11#1)(2004-2#1)(2005-5#2)(2005-7#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-5#1)(2010-3#1)(2011-1#2)(2011-2#1)
of whom have##2##3##(1997-2#1)(2013-1#1)
of whom presented##2##3##(1990-4#1)(2006-5#1)
of whom received##2##3##(1992-10#1)(2010-3#1)
of whom sustained##2##3##(2007-7#1)(2013-1#1)
of whom the##3##3##(1991-2#1)(2008-4#1)(2012-12#1)
of whom underwent##3##3##(2007-8#1)(2008-11#1)(2011-2#1)
of whom was##2##3##(1992-2#1)(2013-8#1)
of whom were examined##3##4##(1991-4#1)(2006-10#2)
of whom were in the control group##2##7##(2006-6#2)
of whom were treated by##2##5##(2007-7#1)(2008-10#1)
of whom were##32##3##(1990-5#1)(1991-3#1)(1991-4#1)(1992-2#1)(1993-2#1)(1994-6#1)(1995-1#1)(1995-11#1)(1996-6#1)(1996-7#1)(2004-10#1)(2005-8#1)(2006-10#2)(2006-6#2)(2007-2#2)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#3)(2009-7#1)(2010-7#1)(2010-9#1)(2011-1#1)(2013-1#2)
of whom##186##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#3)(1991-10#1)(1991-11#3)(1991-2#1)(1991-3#2)(1991-4#3)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#2)(1992-10#2)(1992-2#2)(1992-6#1)(1992-9#1)(1993-2#2)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#3)(1994-6#1)(1995-1#1)(1995-11#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-7#2)(1996-8#1)(1997-2#2)(1997-6#3)(2004-10#1)(2004-11#1)(2004-2#2)(2004-3#1)(2005-5#2)(2005-7#2)(2005-8#3)(2006-10#5)(2006-5#2)(2006-6#2)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#4)(2007-5#1)(2007-6#1)(2007-7#8)(2007-8#7)(2007-9#3)(2008-1#7)(2008-10#1)(2008-11#3)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#4)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#1)
of whooping cough in##2##4##(1990-2#2)
of whooping cough##9##3##(1990-2#6)(1990-6#1)(1997-8#1)(2008-8#1)
of whooping##10##2##(1990-2#6)(1990-6#1)(1997-8#1)(2004-10#1)(2008-8#1)
of whose##8##2##(1990-12#1)(1991-7#1)(1994-12#1)(2006-10#1)(2007-10#1)(2007-12#1)(2009-4#1)(2011-1#1)
of why the##4##3##(1992-9#1)(1996-4#1)(2008-11#1)(2008-9#1)
of why##13##2##(1992-9#1)(1993-1#1)(1995-8#1)(1996-4#1)(1997-3#1)(2008-11#2)(2008-2#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-8#1)(2013-7#1)
of wide local excision##2##4##(1990-2#1)(2008-6#1)
of wide ranging##2##3##(2006-12#1)(2009-8#1)
of wide##21##2##(1990-2#1)(1991-3#1)(1992-10#1)(1993-7#1)(2006-10#1)(2006-12#2)(2006-9#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-3#1)
of wide-gap semiconductors##2##3##(2006-12#2)
of widely distributed##3##3##(1994-12#1)(1995-12#1)(2009-8#1)
of widely used##4##3##(2013-1#3)(2013-8#1)
of widely##14##2##(1991-12#1)(1994-12#1)(1995-12#1)(1996-12#1)(2008-2#1)(2008-3#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2013-1#3)(2013-8#1)
of wider##4##2##(2005-9#1)(2008-9#1)(2011-2#1)(2012-2#1)
of widespread disease##2##3##(2008-3#2)
of widespread genetic##2##3##(1997-8#1)(2008-8#1)
of widespread metastasis##2##3##(2007-7#1)(2012-1#1)
of widespread pain with##2##4##(2009-7#1)(2011-2#1)
of widespread use##2##3##(2006-10#2)
of widespread##26##2##(1991-5#1)(1991-8#2)(1997-3#1)(1997-8#1)(2006-10#5)(2006-7#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
of width##2##2##(2007-11#1)(2008-10#1)
of widths##2##2##(2008-1#1)(2008-7#1)
of wife-battering##2##2##(1993-5#2)
of wigs##3##2##(2012-3#3)
of wild and cultivated##3##4##(2007-1#1)(2008-10#1)(2013-8#1)
of wild and domestic##3##4##(2007-3#1)(2012-12#1)(2013-1#1)
of wild and##8##3##(2007-1#2)(2007-3#1)(2008-10#1)(2009-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
of wild animals and##2##4##(2013-7#2)
of wild birds##3##3##(2007-2#1)(2008-5#1)(2011-2#1)
of wild boar##2##3##(2010-4#2)
of wild mice##2##3##(1995-9#1)(1997-5#1)
of wild type Escherichia coli##2##5##(2008-6#1)(2013-1#1)
of wild type and##4##4##(1990-3#1)(1991-4#1)(2008-8#1)(2009-4#1)
of wild type enzyme##3##4##(1991-8#2)(2008-6#1)
of wild type p53##3##4##(2005-12#2)(2008-5#1)
of wild type##32##3##(1990-3#1)(1991-12#1)(1991-4#1)(1991-7#2)(1991-8#2)(1993-11#1)(1994-10#2)(1995-10#1)(1997-3#3)(1997-4#1)(1997-7#1)(2005-12#2)(2007-12#2)(2008-5#2)(2008-6#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-8#1)(2010-12#1)(2012-3#1)(2013-1#1)
of wild##73##2##(1990-3#1)(1991-12#1)(1991-4#1)(1991-7#2)(1991-8#2)(1993-11#1)(1994-10#2)(1995-10#1)(1995-2#1)(1995-9#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-12#2)(2007-1#2)(2007-12#2)(2007-2#2)(2007-3#1)(2007-6#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-5#3)(2008-6#2)(2008-8#4)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#1)
of wild-caught##2##2##(2008-8#1)(2009-5#1)
of wild-type CN##2##3##(2008-9#2)
of wild-type CPAP##2##3##(2012-12#2)
of wild-type TRbeta1##2##3##(1995-8#2)
of wild-type activity##2##3##(1995-10#2)
of wild-type and mutant proteins##2##5##(1990-8#1)(1991-6#1)
of wild-type and mutant##9##4##(1990-5#1)(1990-8#1)(1991-6#1)(1992-4#1)(1995-1#1)(1997-2#1)(2007-9#1)(2008-7#2)
of wild-type and mutated##2##4##(1994-11#1)(2008-10#1)
of wild-type and##14##3##(1990-5#1)(1990-8#1)(1991-1#1)(1991-6#1)(1992-4#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-2#1)(1997-2#1)(2007-9#1)(2008-10#1)(2008-7#2)
of wild-type antithrombin##2##3##(1994-11#2)
of wild-type bR##2##3##(1993-11#1)(1995-11#1)
of wild-type enzyme##3##3##(1992-9#1)(1995-6#1)(1997-7#1)
of wild-type histidase##2##3##(1994-11#1)(1994-5#1)
of wild-type p53##5##3##(1991-5#1)(1993-4#1)(1995-8#1)(2007-9#2)
of wild-type thioredoxin##2##3##(1991-7#2)
of wild-type yeast##4##3##(1995-2#1)(1996-5#2)(1997-6#1)
of wild-type##96##2##(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#2)(1992-1#1)(1992-4#1)(1992-6#3)(1992-9#2)(1993-11#1)(1993-12#2)(1993-4#1)(1994-11#8)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#4)(1995-5#1)(1995-6#2)(1995-8#3)(1996-11#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#4)(1997-7#1)(2006-12#2)(2006-3#1)(2007-11#2)(2007-9#3)(2008-10#7)(2008-7#2)(2008-8#3)(2008-9#2)(2009-9#1)(2010-10#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
of wildlife research##3##3##(2013-8#3)
of wildlife##14##2##(1990-3#1)(2008-12#1)(2008-9#1)(2011-1#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#4)
of willingness to##2##3##(2012-12#1)(2013-1#1)
of wilt symptoms##2##3##(2008-10#2)
of wilt##5##2##(2008-10#5)
of wilting##3##2##(2008-10#2)(2008-12#1)
of wind on##2##3##(2008-3#1)(2011-12#1)
of wind speed##3##3##(2008-3#2)(2008-5#1)
of wind##11##2##(2007-12#2)(2008-2#3)(2008-3#3)(2008-5#2)(2011-12#1)
of wind-dispersed ascospores##2##3##(2008-10#2)
of windborne##2##2##(1990-6#1)(2008-10#1)
of windowing##2##2##(2008-2#1)(2008-3#1)
of windows##2##2##(2008-3#1)(2008-6#1)
of wine and olive oil##2##5##(2007-8#2)
of wine and##4##3##(2006-2#1)(2007-8#2)(2008-7#1)
of wine samples##2##3##(2008-10#2)
of wine yeast##2##3##(2012-3#2)
of wine##20##2##(1993-9#1)(2005-10#1)(2006-2#1)(2007-8#2)(2008-10#11)(2008-7#2)(2012-3#2)
of wines and##2##3##(2008-10#2)
of wines##7##2##(2008-10#6)(2008-6#1)
of wing##4##2##(2005-10#2)(2007-12#2)
of winning##3##2##(1996-3#1)(2007-9#1)(2009-9#1)
of winter barley##4##3##(2008-10#2)(2008-11#2)
of winter wheat (Triticum aestivum)##2##5##(2008-10#1)(2008-12#1)
of winter wheat##12##3##(2008-10#5)(2008-12#2)(2013-8#5)
of winter##21##2##(2008-10#8)(2008-11#2)(2008-12#2)(2010-8#1)(2012-12#1)(2012-4#1)(2013-7#1)(2013-8#5)
of wire##8##2##(2007-7#1)(2007-8#6)(2011-2#1)
of wired sternotomy closures##2##4##(2007-8#2)
of wireless##6##2##(2006-6#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-7#1)(2010-8#1)
of wisdom##17##2##(1992-5#1)(2007-12#4)(2010-10#11)(2010-8#1)
of witches'-broom##2##2##(2008-10#2)
of with##2##2##(1997-7#1)(2010-2#1)
of withdrawal among birth limiters##2##5##(2012-11#2)
of withdrawal in##3##3##(1996-10#1)(2005-9#1)(2007-11#1)
of withdrawal of##6##3##(1992-3#1)(1996-2#1)(2005-8#1)(2006-4#1)(2007-10#1)(2010-11#1)
of withdrawal use##3##3##(2012-11#3)
of withdrawal##35##2##(1991-12#1)(1992-11#1)(1992-3#2)(1995-1#1)(1995-12#3)(1996-10#2)(1996-12#1)(1996-2#1)(1996-7#1)(2005-8#1)(2005-9#1)(2006-4#1)(2007-10#1)(2007-11#4)(2007-2#2)(2007-9#1)(2008-7#1)(2009-3#1)(2010-11#1)(2011-2#2)(2012-11#6)
of withdrawals##2##2##(2008-8#2)
of withdrawing##2##2##(2007-10#1)(2008-3#1)
of within- and##3##3##(1993-1#1)(2007-12#1)(2012-3#1)
of within-field##3##2##(2008-10#3)
of within-pair##2##2##(1997-5#2)
of within-population##2##2##(2005-10#1)(2008-8#1)
of wobbly possum disease in##2##5##(1997-8#2)
of wobbly possum disease##3##4##(1997-8#2)(2005-7#1)
of wolfberry fruit##2##3##(2013-8#2)
of women about##3##3##(1990-6#1)(2008-9#1)(2011-2#1)
of women affected by##2##4##(1991-2#1)(2011-2#1)
of women after##3##3##(2006-7#1)(2009-12#1)(2011-2#1)
of women aged##10##3##(1990-12#1)(1990-6#1)(1990-8#1)(1991-8#1)(1992-1#1)(1996-6#1)(1996-8#1)(2004-2#1)(2007-10#1)(2008-5#1)
of women and children in##2##5##(1990-2#1)(2009-9#1)
of women and children##4##4##(1990-2#2)(2009-9#1)(2011-2#1)
of women and men aged 40-42##2##6##(1991-6#2)
of women and men##3##4##(1991-6#2)(2010-1#1)
of women and the##3##4##(1995-9#1)(1996-12#1)(2007-7#1)
of women and their families##3##5##(2007-2#2)(2012-3#1)
of women and##26##3##(1990-2#2)(1991-6#3)(1995-6#1)(1995-9#1)(1996-12#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-2#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-3#2)(2008-7#1)(2009-9#1)(2010-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
of women as##3##3##(1991-6#1)(2008-3#1)(2011-1#1)
of women at##4##3##(1992-2#1)(1996-3#1)(2006-10#1)(2006-7#1)
of women by##2##3##(1993-6#1)(2009-2#1)
of women for##3##3##(1996-2#1)(2008-8#1)(2010-7#1)
of women from different ethnic groups##2##6##(2008-5#2)
of women from different ethnic##3##5##(2008-5#3)
of women from##6##3##(1994-12#1)(2006-4#1)(2007-2#1)(2008-5#3)
of women had had##2##4##(1990-6#1)(1992-2#1)
of women had symptoms suggestive of##2##6##(1993-12#2)
of women had##9##3##(1990-6#1)(1992-2#1)(1993-12#3)(2006-10#1)(2008-3#1)(2011-2#2)
of women has##2##3##(1991-6#1)(2007-6#1)
of women have##2##3##(2010-12#1)(2013-1#1)
of women in each group##3##5##(1993-4#3)
of women in the##12##4##(1993-6#2)(1994-12#1)(1996-9#1)(2006-1#1)(2007-2#1)(2007-3#1)(2008-1#1)(2009-4#1)(2010-3#1)(2011-2#1)(2013-1#1)
of women in this##2##4##(2012-3#1)(2013-1#1)
of women in##37##3##(1992-12#1)(1992-2#1)(1993-4#3)(1993-6#4)(1994-12#2)(1994-2#1)(1995-5#1)(1996-6#1)(1996-9#1)(2006-1#1)(2006-4#1)(2006-7#1)(2006-9#1)(2007-2#2)(2007-3#1)(2007-5#1)(2007-9#1)(2008-1#1)(2009-10#1)(2009-4#2)(2010-3#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
of women into##2##3##(2009-4#1)(2011-2#1)
of women of childbearing age##3##5##(2007-9#1)(2010-4#1)(2013-1#1)
of women of##7##3##(1992-9#1)(1996-12#1)(2006-4#1)(2006-6#1)(2007-9#1)(2010-4#1)(2013-1#1)
of women on the##2##4##(2008-2#1)(2011-1#1)
of women on##3##3##(2008-2#1)(2011-1#2)
of women regarding##2##3##(1990-8#1)(1997-3#1)
of women reporting cervical##2##4##(1990-12#2)
of women residing in two regions of##2##7##(2007-8#2)
of women submitted to##2##4##(2010-8#1)(2012-3#1)
of women taking##3##3##(1990-11#2)(2008-11#1)
of women to##9##3##(1996-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-4#1)(2013-1#2)
of women treated##3##3##(1992-3#1)(1993-2#1)(1994-12#1)
of women undergoing##4##3##(1994-9#1)(1995-12#1)(2008-4#1)(2008-7#1)
of women was significantly##3##4##(2004-11#2)(2012-12#1)
of women was##7##3##(2004-11#2)(2004-2#1)(2008-12#1)(2010-3#1)(2011-1#1)(2012-12#1)
of women were##2##3##(2006-4#1)(2007-11#1)
of women who are##3##4##(2004-10#1)(2004-3#1)(2007-2#1)
of women who had##4##4##(1991-11#1)(2007-12#1)(2007-2#1)(2011-2#1)
of women who have##4##4##(2006-10#2)(2008-2#1)(2011-2#1)
of women who opt for##2##5##(2006-10#1)(2013-1#1)
of women who##27##3##(1991-11#1)(1991-6#1)(1992-2#1)(1996-12#1)(2004-10#2)(2004-3#1)(2006-10#4)(2007-12#1)(2007-2#4)(2008-2#1)(2008-5#1)(2009-4#1)(2009-9#1)(2011-2#4)(2013-1#3)
of women will##2##3##(1996-2#1)(2007-8#1)
of women with a##3##4##(2006-10#1)(2007-2#1)(2012-3#1)
of women with advanced##3##4##(1992-2#1)(1992-5#1)(2010-12#1)
of women with breast cancer##2##5##(2008-10#1)(2012-12#1)
of women with breast##3##4##(2008-10#1)(2012-12#1)(2012-2#1)
of women with bulimia nervosa##2##5##(2006-7#2)
of women with cervical##3##4##(2006-10#2)(2007-12#1)
of women with endometriosis##5##4##(1992-9#2)(2007-10#3)
of women with epilepsy##2##4##(2008-11#1)(2013-8#1)
of women with genital prolapse##2##5##(2006-4#2)
of women with polycystic ovary syndrome (PCOS)##2##7##(2010-10#1)(2011-1#1)
of women with the##2##4##(2006-10#1)(2008-3#1)
of women with urinary##2##4##(1992-12#1)(1995-5#1)
of women with##65##3##(1990-9#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-9#3)(1993-4#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-5#3)(1996-12#2)(1996-6#1)(2004-2#1)(2006-10#6)(2006-4#2)(2006-7#2)(2007-10#3)(2007-12#3)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-3#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-8#1)
of women working in##2##4##(2009-7#1)(2013-1#1)
of women##373##2##(1990-11#2)(1990-12#3)(1990-2#4)(1990-6#4)(1990-8#2)(1990-9#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-6#6)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#6)(1992-3#2)(1992-5#1)(1992-9#4)(1993-10#1)(1993-12#3)(1993-2#1)(1993-4#5)(1993-6#7)(1993-8#2)(1994-12#5)(1994-2#1)(1994-7#1)(1994-9#2)(1995-11#2)(1995-12#2)(1995-5#4)(1995-6#1)(1995-9#3)(1996-11#2)(1996-12#5)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#3)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-7#1)(1997-8#2)(2004-10#3)(2004-11#3)(2004-2#3)(2004-3#1)(2005-3#1)(2006-1#3)(2006-10#17)(2006-12#1)(2006-2#1)(2006-4#7)(2006-6#2)(2006-7#7)(2006-9#1)(2007-10#4)(2007-11#3)(2007-12#9)(2007-2#14)(2007-3#3)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#10)(2007-9#4)(2008-1#6)(2008-10#2)(2008-11#5)(2008-12#3)(2008-2#3)(2008-3#8)(2008-4#6)(2008-5#9)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#3)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#7)(2009-6#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#3)(2010-3#3)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#11)(2011-12#2)(2011-2#18)(2012-12#3)(2012-2#3)(2012-3#11)(2013-1#18)(2013-7#1)(2013-8#3)
of women's employment##3##3##(2008-5#3)
of women's experiences##2##3##(2012-1#1)(2013-8#1)
of women's health##7##3##(1994-3#2)(1996-3#1)(1997-4#1)(2006-8#1)(2010-6#1)(2010-7#1)
of women's##34##2##(1991-6#3)(1994-3#2)(1996-1#1)(1996-3#2)(1997-4#2)(2006-4#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-5#4)(2009-3#2)(2009-5#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
of women)##2##2##(1990-4#1)(2008-3#1)
of wood and##3##3##(1992-10#1)(2007-9#1)(2008-10#1)
of wood is##2##3##(2010-4#1)(2013-1#1)
of wood that##2##3##(2012-12#1)(2013-1#1)
of wood##17##2##(1992-10#1)(1997-6#1)(2005-10#1)(2005-11#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-5#1)(2010-4#3)(2012-12#1)(2013-1#2)
of wood-rotting##2##2##(2008-10#2)
of wooden artifacts##2##3##(2008-2#2)
of wooden##5##2##(2007-10#1)(2008-10#2)(2008-2#2)
of woody and##2##3##(2006-12#1)(2012-6#1)
of woody plants##3##3##(2008-10#2)(2008-9#1)
of woody vegetation##2##3##(2013-8#2)
of woody##11##2##(2006-12#1)(2007-3#1)(2008-10#4)(2008-8#1)(2008-9#1)(2012-6#1)(2013-8#2)
of wool##2##2##(2008-10#1)(2008-5#1)
of word##14##2##(2004-10#3)(2007-3#1)(2008-11#5)(2008-4#1)(2009-2#2)(2012-3#1)(2013-8#1)
of words and##3##3##(1993-9#1)(2008-10#1)(2009-8#1)
of words##30##2##(1990-8#2)(1991-2#1)(1993-9#1)(1996-2#1)(2005-7#1)(2006-3#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-7#1)(2009-11#2)(2009-5#1)(2009-8#1)(2010-7#1)(2012-1#1)(2012-3#2)(2013-1#4)(2013-8#3)
of work and##8##3##(1993-3#1)(1994-6#1)(2006-11#1)(2007-10#1)(2007-12#1)(2008-11#1)(2010-9#1)(2011-2#1)
of work are##2##3##(2008-2#1)(2012-12#1)
of work has been done##3##5##(1994-11#1)(2006-10#1)(2007-10#1)
of work has been##4##4##(1994-11#1)(2006-10#1)(2007-10#1)(2008-10#1)
of work in the##3##4##(2007-8#1)(2009-10#1)(2009-6#1)
of work in##8##3##(1997-8#1)(2007-8#1)(2008-10#1)(2009-10#1)(2009-6#2)(2011-2#1)(2013-1#1)
of work it is##2##4##(2007-10#1)(2008-10#1)
of work of adhesion##2##4##(2008-7#2)
of work of##4##3##(2008-11#1)(2008-7#2)(2011-2#1)
of work on##3##3##(1991-1#1)(2006-12#1)(2012-3#1)
of work organization##2##3##(2008-2#1)(2013-1#1)
of work overload##2##3##(2004-10#2)
of work processes##2##3##(2011-1#1)(2012-12#1)
of work settings##2##3##(2005-11#1)(2008-12#1)
of work time##2##3##(1992-12#1)(2007-7#1)
of work##104##2##(1990-12#1)(1990-3#1)(1990-4#1)(1991-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#4)(1994-11#1)(1994-3#1)(1994-6#2)(1995-9#1)(1996-1#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-8#1)(2004-10#2)(2004-3#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-8#2)(2007-10#3)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#5)(2008-4#1)(2008-7#4)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-6#4)(2009-9#1)(2010-11#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#7)(2012-1#3)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#8)(2013-8#1)
of work-related##5##2##(1996-2#3)(2006-11#1)(2012-2#1)
of work]##2##2##(1991-11#1)(1992-5#1)
of worker##6##2##(1997-3#1)(2008-11#1)(2008-8#2)(2011-1#1)(2013-1#1)
of workers and##4##3##(2008-4#1)(2008-5#1)(2009-12#1)(2013-1#1)
of workers at##2##3##(1994-6#1)(2007-10#1)
of workers exposed to asbestos##2##5##(2010-9#2)
of workers exposed to##4##4##(2006-1#1)(2008-4#1)(2010-9#2)
of workers exposed##6##3##(2006-1#1)(2008-4#1)(2010-8#2)(2010-9#2)
of workers from the##3##4##(2006-10#1)(2010-9#2)
of workers from##5##3##(2006-10#2)(2010-9#2)(2012-3#1)
of workers in SVF##2##4##(2010-8#2)
of workers in##7##3##(2006-10#2)(2008-1#1)(2010-12#1)(2010-8#2)(2013-7#1)
of workers occupationally exposed to asbestos from##2##7##(2010-9#2)
of workers occupationally exposed to asbestos##5##6##(2010-9#5)
of workers occupationally exposed to cobalt##2##6##(1994-6#2)
of workers occupationally exposed to##7##5##(1994-6#2)(2010-9#5)
of workers on the##2##4##(1992-2#1)(2008-8#1)
of workers who lost their job in the city of Medellin##2##11##(2013-1#2)
of workers##55##2##(1992-2#1)(1994-5#1)(1994-6#8)(1996-8#1)(2006-1#1)(2006-10#4)(2006-12#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#2)(2009-12#3)(2010-12#1)(2010-8#4)(2010-9#9)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
of workers' health##2##3##(2011-2#1)(2013-1#1)
of workers'##4##2##(1995-2#1)(2010-5#1)(2011-2#1)(2013-1#1)
of workforce##3##2##(2008-1#1)(2011-1#2)
of working age##2##3##(1993-5#1)(2010-2#1)
of working and##2##3##(1992-2#1)(1992-9#1)
of working conditions##3##3##(2008-10#1)(2012-1#1)(2012-12#1)
of working day losses##2##4##(2011-1#2)
of working electrode##4##3##(2008-10#4)
of working in a##2##4##(2008-11#2)
of working in##5##3##(1997-4#1)(2008-11#2)(2008-2#1)(2011-1#1)
of working life##4##3##(1992-3#1)(2008-11#2)(2008-9#1)
of working memory functions##2##4##(1994-8#1)(2012-3#1)
of working memory##17##3##(1992-10#1)(1993-12#1)(1993-3#3)(1993-5#1)(1994-8#1)(1995-12#2)(1996-12#1)(1997-8#1)(2006-9#1)(2007-8#1)(2007-9#1)(2008-8#1)(2012-3#2)
of working with##4##3##(1997-1#1)(2006-2#1)(2011-2#1)(2013-1#1)
of working##77##2##(1990-11#1)(1992-10#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-5#2)(1994-10#1)(1994-12#1)(1994-8#1)(1995-12#2)(1995-6#1)(1995-8#1)(1996-12#2)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-8#1)(2006-10#1)(2006-2#2)(2006-9#1)(2007-8#3)(2007-9#1)(2008-10#13)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#5)
of workload and##2##3##(2004-10#2)
of workload##6##2##(1996-1#1)(2004-10#3)(2011-2#2)
of workplace conversations##2##3##(2011-1#2)
of workplace violence##5##3##(1996-12#1)(1996-2#1)(1997-2#1)(2008-7#2)
of workplace##17##2##(1996-12#1)(1996-2#2)(1997-2#1)(2008-11#1)(2008-12#1)(2008-7#3)(2010-2#2)(2010-5#1)(2011-1#3)(2012-12#1)(2013-8#1)
of works##4##2##(2007-11#1)(2008-2#1)(2009-2#1)(2011-12#1)
of workshops and##2##3##(2006-4#1)(2007-8#1)
of workshops##5##2##(2005-8#1)(2006-4#1)(2007-8#1)(2008-12#1)(2008-5#1)
of world population##2##3##(1992-10#1)(2008-10#1)
of world wide##2##3##(2007-3#1)(2008-5#1)
of world##9##2##(1991-6#1)(1992-10#1)(2004-9#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-11#1)
of worldwide##7##2##(1994-3#1)(1997-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)
of worm##3##2##(1996-12#3)
of worms##4##2##(1996-10#1)(1996-12#1)(2007-7#1)(2011-12#1)
of worn##2##2##(2004-9#1)(2008-5#1)
of worry##3##2##(2006-12#1)(2010-1#1)(2010-2#1)
of worse##5##2##(1991-11#1)(2006-6#1)(2012-12#1)(2013-8#2)
of worsening##10##2##(1996-12#1)(2004-3#4)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-1#1)
of worship##2##2##(2010-10#2)
of wortmannin##7##2##(1994-8#1)(1996-5#1)(1997-3#4)(1997-7#1)
of wound area##2##3##(1996-7#1)(2008-11#1)
of wound closure##4##3##(2006-9#1)(2010-2#1)(2011-2#2)
of wound dressing##3##3##(2011-2#3)
of wound healing in##2##4##(2008-5#1)(2008-7#1)
of wound healing##17##3##(1990-9#1)(1995-3#1)(2005-7#1)(2006-9#3)(2007-12#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)
of wound infection after##3##4##(2006-10#1)(2006-2#1)(2007-8#1)
of wound infection##10##3##(1990-3#1)(2006-10#1)(2006-2#2)(2006-6#1)(2007-8#2)(2008-7#1)(2011-2#1)(2012-10#1)
of wound infections##3##3##(1990-3#1)(2007-8#1)(2012-2#1)
of wound repair##2##3##(2012-12#2)
of wound##53##2##(1990-12#1)(1990-3#2)(1990-9#1)(1995-3#1)(1996-3#1)(1996-7#1)(2005-7#1)(2006-10#1)(2006-2#2)(2006-6#1)(2006-9#4)(2007-12#2)(2007-2#1)(2007-8#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2011-2#8)(2012-10#2)(2012-12#3)(2012-2#1)
of wounded##5##2##(1997-2#2)(2008-10#3)
of wounding##2##2##(2006-9#1)(2008-10#1)
of wounds in##3##3##(2008-11#1)(2008-4#1)(2008-5#1)
of wounds or##2##3##(2008-10#1)(2008-11#1)
of wounds to##2##3##(2011-2#1)(2012-3#1)
of wounds##21##2##(1991-7#1)(1996-7#1)(2006-6#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-9#1)(2011-2#3)(2012-3#1)(2013-1#1)
of wrinkle detection##2##3##(2008-5#2)
of wrinkles##12##2##(1991-6#1)(2007-12#1)(2008-5#9)(2011-2#1)
of wrist joint##4##3##(2012-1#2)(2012-2#2)
of wrist pain##3##3##(2008-9#2)(2012-3#1)
of wrist##12##2##(2006-10#1)(2006-3#1)(2007-7#1)(2008-10#1)(2008-9#2)(2010-9#1)(2012-1#2)(2012-2#2)(2012-3#1)
of writing an abstract##2##4##(2008-12#1)(2011-2#1)
of writing apprehension##2##3##(2006-12#2)
of writing##16##2##(1992-9#1)(1993-2#1)(2006-10#1)(2006-12#2)(2007-12#1)(2008-12#2)(2008-2#1)(2008-3#1)(2009-4#1)(2011-2#2)(2012-1#2)(2013-7#1)
of written composition##2##3##(2012-1#2)
of written guidelines##2##3##(1993-5#1)(2006-5#1)
of written language##3##3##(2009-7#1)(2009-9#1)(2012-1#1)
of written##15##2##(1993-5#1)(1995-2#1)(1996-1#1)(2006-5#1)(2006-7#1)(2007-2#1)(2007-5#1)(2008-8#1)(2009-7#1)(2009-9#1)(2010-3#1)(2012-1#3)(2013-8#1)
of wrong##2##2##(2008-10#1)(2008-5#1)
of wt-p53##2##2##(1993-11#2)
of www##2##2##(2006-6#1)(2008-7#1)
of x rays in##3##4##(2008-3#3)
of x rays##7##3##(2007-11#1)(2007-12#1)(2008-3#5)
of x##8##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#5)
of x-ray absorption##2##3##(1993-3#1)(2012-2#1)
of x-ray scattering##2##3##(1995-3#1)(2010-2#1)
of x-ray##22##2##(1990-7#1)(1991-12#1)(1992-3#1)(1992-4#1)(1993-3#1)(1994-3#1)(1995-3#1)(2006-10#1)(2007-11#4)(2007-8#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-2#1)(2012-2#1)
of x-rays##5##2##(2007-11#1)(2008-9#1)(2013-1#3)
of xanthalongin##2##2##(2007-1#2)
of xanthine oxidase with xanthine##2##5##(1994-8#1)(1996-9#1)
of xanthine oxidase with##3##4##(1994-8#2)(1996-9#1)
of xanthine oxidase##7##3##(1991-9#1)(1992-5#1)(1994-8#3)(1996-9#1)(2007-1#1)
of xanthine##12##2##(1991-9#4)(1992-5#1)(1994-3#1)(1994-8#3)(1996-9#1)(1997-3#1)(2007-1#1)
of xanthines##2##2##(1990-10#1)(1990-5#1)
of xanthogranulomatous##2##2##(1991-8#1)(2013-1#1)
of xanthones##2##2##(2009-3#2)
of xanthophores##2##2##(2008-5#2)
of xenobiotic metabolism##2##3##(1996-3#1)(2010-5#1)
of xenobiotic##5##2##(1993-11#1)(1996-3#1)(2008-6#1)(2010-5#1)(2011-2#1)
of xenobiotic-metabolizing##2##2##(1995-3#2)
of xenobiotics and##2##3##(2008-12#1)(2010-11#1)
of xenobiotics in the##4##4##(1990-6#1)(2008-10#1)(2008-11#2)
of xenobiotics in##5##3##(1990-6#1)(1993-2#1)(2008-10#1)(2008-11#2)
of xenobiotics##16##2##(1990-6#1)(1993-2#1)(1996-3#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-7#1)(2010-11#1)(2010-2#3)
of xenogeneic##5##2##(2005-8#1)(2011-2#2)(2012-3#1)(2013-7#1)
of xenogenic cerebrospinal fluid##2##4##(2008-4#2)
of xenograft rejection##2##3##(2005-7#1)(2007-11#1)
of xenon##3##2##(2006-1#1)(2010-12#2)
of xeroderma pigmentosa##2##3##(2007-7#2)
of xeroderma pigmentosum##4##3##(2005-11#3)(2007-8#1)
of xeroderma##6##2##(2005-11#3)(2007-7#2)(2007-8#1)
of xerophthalmia##2##2##(1991-8#1)(2006-10#1)
of xerosis##2##2##(2008-5#2)
of xerostomia##2##2##(2006-10#1)(2007-9#1)
of xerotic##2##2##(2008-5#2)
of xinfeng capsule on##2##4##(2013-1#1)(2013-8#1)
of xipamide##2##2##(1990-11#1)(1991-8#1)
of xylan hydrolysis in co- and countercurrent##2##7##(2013-1#2)
of xylan##6##2##(2008-5#1)(2008-8#1)(2013-1#4)
of xylanase##8##2##(1993-3#2)(1995-1#1)(2005-12#1)(2008-6#4)
of xylans##2##2##(2006-8#2)
of xylazine##3##2##(1993-12#1)(2012-3#1)(2013-1#1)
of xylem and phloem##2##4##(2008-10#1)(2012-8#1)
of xylem cavitation caused by pine wilt disease##2##8##(2008-10#2)
of xylem parenchyma cells##2##4##(2008-10#1)(2008-11#1)
of xylem vessels##2##3##(2008-10#2)
of xylem##10##2##(2008-10#8)(2008-11#1)(2012-8#1)
of xylenol orange##2##3##(2008-10#2)
of xylitol##5##2##(2005-11#1)(2008-6#3)(2012-2#1)
of xyloglucan##2##2##(1996-10#1)(1996-4#1)
of xylose and arabinose##2##4##(2008-5#1)(2008-6#1)
of xylose and##3##3##(2008-5#2)(2008-6#1)
of xylose fermentation##2##3##(2005-11#1)(2008-6#1)
of xylose##14##2##(1991-7#1)(2005-11#2)(2006-12#1)(2008-10#1)(2008-5#3)(2008-6#6)
of xylose-2-phosphate derivatives by##2##4##(2006-12#2)
of xylose-fermenting Zymomonas mobilis##2##4##(2008-6#2)
of yak meat##2##3##(2010-4#2)
of yak##3##2##(2010-4#3)
of year##7##2##(2008-10#3)(2008-5#1)(2008-7#1)(2010-3#1)(2012-3#1)
of years ago##3##3##(2007-2#1)(2008-1#1)(2009-12#1)
of years and##2##3##(2008-9#1)(2012-3#1)
of years in##2##3##(1993-12#1)(2009-1#1)
of years of##9##3##(1991-12#1)(1991-8#1)(1993-12#2)(1994-6#1)(2006-7#1)(2009-6#1)(2011-1#1)(2011-2#1)
of years old##2##3##(1991-9#1)(2006-5#1)
of years the##2##3##(1995-8#1)(2006-7#1)
of years##54##2##(1991-12#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#1)(1993-12#3)(1993-3#1)(1994-6#2)(1995-8#1)(1996-11#1)(1996-8#1)(1996-9#1)(2004-11#1)(2005-10#1)(2006-5#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-2#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#1)
of yeast and##3##3##(1996-7#1)(2007-7#1)(2008-10#1)
of yeast cell walls##2##4##(2008-5#1)(2011-2#1)
of yeast cells in##2##4##(1994-11#1)(2011-1#1)
of yeast cells##10##3##(1991-7#1)(1991-9#1)(1994-11#1)(1996-5#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-12#1)(2011-1#1)
of yeast chromosome XIV##2##4##(1995-9#1)(1996-3#1)
of yeast chromosome##5##3##(1995-9#1)(1996-3#1)(1996-6#1)(1997-3#2)
of yeast cytochrome##3##3##(1994-11#1)(1995-6#1)(1997-4#1)
of yeast extract (YE)##2##4##(2004-8#1)(2008-6#1)
of yeast extract##7##3##(2004-8#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-7#1)
of yeast in##2##3##(1995-9#1)(2008-8#1)
of yeast iso-1-cytochrome c and horse cytochrome c##2##8##(1990-7#2)
of yeast mitochondrial ATP synthase##2##5##(1992-11#2)
of yeast mitochondrial##3##3##(1992-11#2)(1997-8#1)
of yeast mtDNA##2##3##(1992-12#1)(1995-6#1)
of yeast phosphoglycerate##3##3##(1991-2#2)(1993-3#1)
of yeast strains##4##3##(1992-10#1)(2008-10#1)(2008-8#1)(2009-12#1)
of yeast tRNA(Ala)##2##3##(2008-8#2)
of yeast tRNA(phe)##2##3##(1993-3#2)
of yeast to##2##3##(2008-12#1)(2011-1#1)
of yeast##160##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#2)(1990-7#3)(1990-8#2)(1991-1#1)(1991-11#1)(1991-2#3)(1991-4#2)(1991-5#2)(1991-7#3)(1991-8#1)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#2)(1992-6#2)(1992-7#2)(1992-8#2)(1993-3#4)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#2)(1994-3#1)(1994-6#3)(1994-8#2)(1994-9#1)(1995-2#1)(1995-6#5)(1995-8#1)(1995-9#5)(1996-3#2)(1996-5#1)(1996-6#2)(1996-7#6)(1996-9#2)(1997-2#1)(1997-3#2)(1997-4#3)(1997-6#5)(1997-8#2)(2004-8#1)(2005-4#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#4)(2008-2#1)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#9)(2009-12#2)(2009-7#1)(2011-1#2)(2011-2#1)(2012-3#2)(2013-7#1)
of yeasts and##2##3##(2008-3#1)(2011-2#1)
of yeasts##15##2##(1990-4#1)(1997-4#1)(2007-7#3)(2008-3#1)(2008-5#5)(2008-9#2)(2009-2#1)(2011-2#1)
of yellow gene##3##3##(2008-8#3)
of yellow oleander##2##3##(2008-12#2)
of yellow pages##2##3##(1993-12#1)(1997-1#1)
of yellow pigment##2##3##(2006-11#1)(2008-5#1)
of yellow rust##2##3##(2008-10#2)
of yellow##20##2##(1993-12#1)(1997-1#1)(2005-12#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-12#2)(2008-5#1)(2008-8#3)(2012-12#1)(2013-7#1)
of yellowish##2##2##(1993-3#1)(2008-5#1)
of yet another##2##3##(2006-8#1)(2008-1#1)
of yet##5##2##(2006-10#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-5#1)
of yield losses##2##3##(2008-10#2)
of yield strength##2##3##(2009-11#1)(2009-7#1)
of yield##10##2##(2008-10#6)(2008-4#1)(2008-5#1)(2009-11#1)(2009-7#1)
of yielding##3##2##(2007-8#1)(2009-7#1)(2010-4#1)
of yoga for menopausal symptoms##2##5##(2013-1#2)
of yoga for##3##3##(2013-1#3)
of yoga##4##2##(2013-1#4)
of yolk DNA##2##3##(2008-4#2)
of yolk sac tumour##2##4##(2012-2#2)
of yolk##7##2##(1994-9#1)(2008-4#2)(2008-6#1)(2010-5#1)(2012-2#2)
of you##2##2##(2006-10#1)(2008-6#1)
of young adolescents##3##3##(2010-2#1)(2012-1#1)(2012-2#1)
of young adult##2##3##(1997-5#1)(2008-7#1)
of young adults in the##2##5##(2007-11#1)(2013-1#1)
of young adults with##2##4##(2010-12#1)(2013-1#1)
of young adults##16##3##(1991-1#1)(2004-11#1)(2007-11#1)(2009-12#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
of young age##3##3##(1994-8#1)(2006-7#1)(2012-2#1)
of young and adult##2##4##(1992-11#1)(1997-9#1)
of young and aged rats were##2##6##(1990-5#1)(1990-7#1)
of young and aged##3##4##(1990-5#1)(1990-7#1)(2008-5#1)
of young and old rats##4##5##(1994-6#1)(1995-12#1)(2008-7#1)(2009-12#1)
of young and old##5##4##(1990-3#1)(1994-6#1)(1995-12#1)(2008-7#1)(2009-12#1)
of young and##16##3##(1990-3#1)(1990-5#1)(1990-7#1)(1992-11#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-7#1)(1997-9#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2011-1#1)(2012-2#1)
of young animals##6##3##(1990-5#1)(1990-7#2)(1991-12#1)(1996-9#1)(2009-12#1)
of young children to##2##4##(1993-6#1)(2008-6#1)
of young children##14##3##(1993-6#1)(1994-11#1)(1994-3#1)(1995-2#1)(1996-3#1)(2005-7#1)(2006-8#1)(2008-6#1)(2008-9#4)(2009-9#1)(2012-2#1)
of young commercial chickens##2##4##(2008-5#2)
of young individuals##2##3##(1993-1#1)(2008-9#1)
of young male offspring of rat dams with diabetes induced by streptozotocin##2##12##(2012-3#2)
of young males##5##3##(1991-6#1)(1996-6#1)(2007-7#1)(2009-5#1)(2013-7#1)
of young men who have sex with men (YMSM)##2##9##(2010-9#1)(2012-11#1)
of young men##6##3##(1992-8#1)(1997-2#1)(2009-5#1)(2010-9#1)(2011-2#1)(2012-11#1)
of young ones##2##3##(1992-12#1)(1994-6#1)
of young patients##6##3##(1993-7#1)(1995-12#1)(2010-7#3)(2012-11#1)
of young people and##2##4##(2006-10#1)(2010-5#1)
of young people in##5##4##(2006-7#2)(2008-9#1)(2010-8#1)(2012-2#1)
of young people who##3##4##(1996-2#1)(2011-1#1)(2012-2#1)
of young people##17##3##(1996-2#1)(2006-10#1)(2006-7#2)(2007-3#1)(2007-7#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#2)(2012-2#2)
of young pigs##2##3##(2013-1#1)(2013-8#1)
of young rats was##2##4##(1995-12#1)(1995-3#1)
of young rats##9##3##(1990-5#1)(1992-1#1)(1992-10#2)(1995-12#1)(1995-3#1)(1996-5#2)(2009-8#1)
of young seedlings##2##3##(2008-10#1)(2013-1#1)
of young urologists##2##3##(2011-2#2)
of young women##8##3##(1991-6#1)(1996-12#1)(1997-7#1)(2007-12#1)(2009-10#1)(2010-9#1)(2011-2#1)(2012-2#1)
of young##198##2##(1990-3#2)(1990-5#4)(1990-7#3)(1991-1#1)(1991-12#1)(1991-6#3)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#2)(1992-8#1)(1993-1#2)(1993-2#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#4)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#2)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#3)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#2)(1997-2#4)(1997-3#1)(1997-5#1)(1997-7#1)(1997-9#1)(2004-11#1)(2004-4#1)(2005-7#3)(2006-10#2)(2006-7#4)(2006-8#4)(2007-11#1)(2007-12#1)(2007-3#2)(2007-4#1)(2007-7#3)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#5)(2008-6#2)(2008-7#4)(2008-9#11)(2009-10#1)(2009-12#3)(2009-2#1)(2009-4#1)(2009-5#4)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#2)(2010-5#2)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#6)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#15)(2012-3#3)(2012-9#1)(2013-1#8)(2013-7#1)(2013-8#2)
of younger and##2##3##(2009-12#1)(2013-7#1)
of younger occupants##2##3##(2006-11#2)
of younger patients##4##3##(1997-7#1)(2007-7#2)(2008-11#1)
of younger women##2##3##(1992-4#1)(1997-7#1)
of younger##22##2##(1990-3#1)(1992-1#1)(1992-4#1)(1993-3#1)(1994-4#1)(1997-7#2)(2005-10#1)(2006-11#2)(2007-7#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-12#2)(2009-4#1)(2010-12#1)(2010-4#1)(2012-12#1)(2013-7#1)
of your Patient Focused##2##4##(1994-1#1)(1994-2#1)
of your staff##2##3##(1991-3#1)(1997-2#1)
of your##29##2##(1991-1#2)(1991-3#1)(1992-1#1)(1992-4#1)(1993-2#1)(1994-1#1)(1994-12#2)(1994-2#3)(1994-3#2)(1995-12#1)(1995-2#1)(1997-2#1)(1997-3#1)(2005-8#1)(2007-10#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
of youth and##2##3##(1990-1#1)(1993-10#1)
of youth in##3##3##(2008-11#1)(2008-7#1)(2012-12#1)
of youth to##2##3##(2007-10#1)(2012-12#1)
of youth who##2##3##(1994-2#1)(2008-11#1)
of youth with##2##3##(1992-3#1)(2010-11#1)
of youth##28##2##(1990-1#1)(1990-12#1)(1992-3#1)(1993-10#1)(1994-2#1)(2005-9#1)(2007-1#1)(2007-10#1)(2007-3#1)(2008-11#2)(2008-7#3)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-12#2)
of youth's##2##2##(2009-7#2)
of youths##2##2##(2008-12#2)
of ytterbium##4##2##(2007-12#3)(2008-10#1)
of ytterbium-doped##3##2##(2007-12#1)(2008-3#2)
of yttrium and##2##3##(1992-11#1)(2005-11#1)
of yttrium from heavy lanthanide by##2##6##(2008-10#2)
of yttrium##8##2##(1992-11#1)(2005-11#1)(2008-10#6)
of z##2##2##(1996-2#1)(2007-12#1)
of zearalenone##2##2##(1997-6#1)(2008-10#1)
of zeaxanthin and##2##3##(2008-11#1)(2008-12#1)
of zeaxanthin##5##2##(1997-1#2)(2008-11#1)(2008-12#2)
of zebra##4##2##(1997-2#1)(2005-7#1)(2007-2#1)(2010-1#1)
of zebrafish##15##2##(1992-9#3)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2011-1#1)(2012-12#2)(2012-3#1)
of zeolite on the##2##4##(1992-3#2)
of zeolite##5##2##(1992-3#3)(2008-10#2)
of zero charge##3##3##(2005-11#1)(2008-10#1)(2010-5#1)
of zero##20##2##(1992-5#1)(1997-2#1)(2005-11#2)(2007-11#1)(2007-12#2)(2008-10#1)(2008-12#2)(2008-2#3)(2008-3#4)(2010-5#1)(2011-1#1)(2011-2#1)
of zero-order##3##2##(2008-2#1)(2008-3#1)(2012-3#1)
of zeta PKC##5##3##(1994-12#2)(1995-6#3)
of zeta potential##4##3##(2005-11#1)(2008-5#1)(2009-11#1)(2013-8#1)
of zeta potentials##2##3##(1990-3#1)(2013-8#1)
of zeta##11##2##(1990-3#1)(1994-12#2)(1995-6#3)(2005-11#1)(2008-5#1)(2009-11#1)(2013-8#2)
of zeta-crystallin##2##2##(1993-3#1)(1995-5#1)
of zeta-crystallin/quinone reductase##2##3##(1992-11#1)(1993-3#1)
of zidovudine in##2##3##(1990-10#1)(1995-7#1)
of zidovudine##8##2##(1990-10#1)(1990-8#1)(1993-3#1)(1995-3#3)(1995-7#1)(2007-11#1)
of zigzag patterns##2##3##(2008-10#2)
of zigzag##4##2##(2008-10#2)(2009-11#1)(2010-7#1)
of zileuton##3##2##(1993-11#2)(2007-11#1)
of zinc (Zn)##2##3##(2010-2#1)(2012-2#1)
of zinc acetate##3##3##(2008-7#1)(2010-10#2)
of zinc and##6##3##(2008-10#5)(2013-7#1)
of zinc binding motif##2##4##(2008-1#2)
of zinc binding##4##3##(2008-1#2)(2008-10#2)
of zinc by##2##3##(2008-1#1)(2008-10#1)
of zinc can##2##3##(2008-10#1)(2008-7#1)
of zinc compounds by##2##4##(2008-10#2)
of zinc compounds##3##3##(2008-10#3)
of zinc deficiency in##2##4##(2007-12#1)(2012-2#1)
of zinc deficiency##7##3##(2007-12#1)(2008-10#4)(2012-2#2)
of zinc finger domains##2##4##(1991-2#1)(1991-4#1)
of zinc finger proteins##3##4##(1991-4#2)(2010-4#1)
of zinc finger##9##3##(1991-2#1)(1991-4#3)(1991-5#1)(1995-11#2)(1995-6#1)(2010-4#1)
of zinc from the##2##4##(2008-10#2)
of zinc from##5##3##(2008-10#5)
of zinc in human##2##4##(2007-10#1)(2008-10#1)
of zinc in nickel electrolyte##2##5##(2005-4#2)
of zinc in plant##2##4##(2008-10#2)
of zinc in##26##3##(1991-3#1)(1991-4#1)(1995-5#1)(1995-8#1)(1996-3#1)(1996-7#1)(2005-4#2)(2007-10#1)(2008-10#14)(2010-2#1)(2012-3#1)(2013-8#1)
of zinc into##2##3##(2008-10#2)
of zinc ions in##2##4##(2005-11#1)(2008-10#1)
of zinc ions##7##3##(1991-10#1)(1992-6#1)(2005-11#1)(2008-10#2)(2008-11#1)(2010-11#1)
of zinc is##4##3##(1997-3#1)(2008-10#2)(2013-7#1)
of zinc myoglobin##3##3##(1997-7#3)
of zinc on cadmium##2##4##(2008-7#2)
of zinc on##4##3##(2008-10#1)(2008-5#1)(2008-7#2)
of zinc oxide##4##3##(2005-11#2)(2007-9#1)(2008-3#1)
of zinc per enzyme subunit##2##5##(1994-5#1)(1994-6#1)
of zinc per##4##3##(1994-5#3)(1994-6#1)
of zinc pyrithione##2##3##(2008-10#1)(2008-5#1)
of zinc status##3##3##(2004-11#2)(2005-10#1)
of zinc sulfate and##2##4##(1995-5#1)(1997-3#1)
of zinc sulfate##3##3##(1990-5#1)(1995-5#1)(1997-3#1)
of zinc supplementation on serum zinc and calcium levels in postmenopausal osteoporotic women##2##13##(2013-7#2)
of zinc traces##4##3##(2008-10#4)
of zinc uptake##5##3##(1994-10#1)(2004-11#4)
of zinc using##3##3##(2008-10#2)(2008-5#1)
of zinc was##2##3##(1997-3#1)(2008-10#1)
of zinc with##2##3##(2008-10#1)(2008-5#1)
of zinc##182##2##(1990-11#1)(1990-5#4)(1991-10#1)(1991-2#1)(1991-3#1)(1991-4#5)(1991-5#1)(1991-9#2)(1992-12#1)(1992-3#1)(1992-6#2)(1993-2#1)(1993-9#1)(1994-10#2)(1994-12#1)(1994-5#5)(1994-6#4)(1995-10#1)(1995-11#3)(1995-5#2)(1995-6#1)(1995-8#3)(1996-3#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#5)(1997-4#1)(1997-7#3)(2004-11#6)(2004-4#1)(2005-10#1)(2005-11#3)(2005-4#4)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#3)(2008-10#69)(2008-11#1)(2008-3#1)(2008-5#5)(2008-7#4)(2009-2#1)(2010-10#3)(2010-11#1)(2010-2#2)(2010-4#1)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#4)(2013-8#1)
of zinc(II) and##4##3##(1992-11#1)(2008-10#1)(2008-3#1)(2010-11#1)
of zinc(II)##11##2##(1991-4#1)(1992-11#1)(2008-10#6)(2008-3#1)(2008-5#1)(2010-11#1)
of ziprasidone##5##2##(2005-6#2)(2008-6#3)
of ziram and zineb##2##4##(2008-10#2)
of ziram and##3##3##(2008-10#3)
of zirconia framework on##2##4##(2013-8#2)
of zirconia##10##2##(1993-12#3)(2005-11#1)(2008-10#1)(2009-8#3)(2013-8#2)
of zirconia's surface chemistry##2##4##(1993-12#2)
of zirconia's surface##3##3##(1993-12#3)
of zirconium and hafnium##2##4##(2008-10#2)
of zirconium and##3##3##(2008-10#3)
of zirconium##17##2##(1990-5#3)(1993-12#1)(2005-11#2)(2008-10#11)
of zirconium(IV) iodovanadate##2##3##(2008-10#2)
of zirconium(IV) with##3##3##(2006-12#2)(2008-10#1)
of zirconium(IV)##8##2##(2006-12#2)(2008-10#6)
of zitter rats##2##3##(1991-9#2)
of zoledronic acid##5##3##(2008-7#3)(2013-1#2)
of zoledronic##8##2##(2008-7#4)(2013-1#4)
of zolpidem and zopiclone##2##4##(2004-11#2)
of zolpidem##7##2##(2004-11#2)(2008-8#2)(2011-2#3)
of zona##3##2##(1991-5#1)(2013-1#2)
of zonal##2##2##(2009-12#1)(2012-12#1)
of zone##3##2##(2006-4#1)(2008-10#1)(2008-2#1)
of zone-circulating flow injection analysis##2##5##(2008-10#2)
of zones##2##2##(2008-10#1)(2008-2#1)
of zonisamide in##2##3##(2006-12#1)(2010-12#1)
of zonisamide##3##2##(2006-12#1)(2010-12#2)
of zoonoses##3##2##(2005-5#1)(2006-2#1)(2007-12#1)
of zoonotic cutaneous##2##3##(2007-2#1)(2011-1#1)
of zoonotic importance##2##3##(2008-3#1)(2012-2#1)
of zoonotic parasites##2##3##(2011-2#2)
of zoonotic##14##2##(2007-2#1)(2008-12#2)(2008-3#1)(2011-1#4)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
of zooplankton##5##2##(2007-5#1)(2007-9#2)(2012-2#2)
of zoosporangia and##2##3##(2008-10#2)
of zoosporangia##4##2##(2008-10#4)
of zoospores##5##2##(2008-10#4)(2010-4#1)
of zopiclone and##2##3##(1996-9#2)
of zopiclone##3##2##(1996-9#3)
of zoster and##2##3##(2008-4#1)(2008-5#1)
of zoster is##2##3##(1992-11#1)(2008-5#1)
of zoster##9##2##(1992-11#1)(1993-9#1)(2007-9#1)(2008-4#2)(2008-5#4)
of zwitterionic##2##2##(1990-3#1)(1994-9#1)
of zygomycosis##2##2##(2008-5#2)
of zygotic##2##2##(1992-12#1)(2009-12#1)
of zymogen granules##4##3##(1991-1#1)(2006-10#2)(2012-1#1)
of zymogen##5##2##(1991-1#1)(1995-6#1)(2006-10#2)(2012-1#1)
of zymosan##3##2##(1991-12#1)(2008-12#2)
of {[HC(3##2##2##(1996-2#2)
of ~0##16##2##(2007-11#2)(2007-12#10)(2008-2#3)(2008-3#1)
of ~1##13##2##(2007-11#1)(2007-12#6)(2008-2#2)(2008-3#2)(2011-1#1)(2012-11#1)
of ~10 mum##2##3##(2007-12#1)(2008-2#1)
of ~10##6##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
of ~10(-5)##2##2##(2007-11#1)(2008-3#1)
of ~100 MHz##2##3##(2007-12#2)
of ~100##6##2##(2007-11#1)(2007-12#3)(2008-1#1)(2008-3#1)
of ~11##2##2##(2007-11#1)(2008-3#1)
of ~15##2##2##(2007-11#1)(2007-12#1)
of ~150##2##2##(2008-2#1)(2009-9#1)
of ~2##4##2##(2007-12#1)(2008-1#1)(2008-2#2)
of ~20##3##2##(2007-12#1)(2008-3#1)(2010-4#1)
of ~26##2##2##(2007-11#1)(2007-12#1)
of ~3##4##2##(2007-11#2)(2008-3#2)
of ~30 nm##2##3##(2007-11#1)(2009-2#1)
of ~30##7##2##(2007-11#1)(2007-12#3)(2009-2#1)(2009-6#1)(2011-1#1)
of ~4##2##2##(2007-12#1)(2008-2#1)
of ~40##2##2##(2007-12#1)(2008-2#1)
of ~5##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
of ~50##5##2##(2007-12#1)(2008-2#1)(2008-3#2)(2009-5#1)
of ~6##4##2##(2007-11#3)(2008-2#1)
of ~8##3##2##(2007-11#1)(2008-2#1)(2010-2#1)
of α##3##2##(2011-2#1)(2012-2#1)(2013-1#1)
of α-helical##2##2##(2011-1#1)(2011-2#1)
of α-synuclein in peripheral blood leukocytes of patients with##2##9##(2012-1#2)
of α-synuclein in##3##3##(2012-1#3)
of α-synuclein level##2##3##(2012-1#2)
of α-synuclein##5##2##(2012-1#5)
of α-tocopherol##4##2##(2011-12#3)(2013-1#1)
of α7 nAChRs in the##2##5##(2011-1#2)
of αNAC##2##2##(2011-1#2)
of β##2##2##(2011-1#1)(2013-1#1)
of β-catenin##6##2##(2012-2#3)(2013-1#3)
of β-cell##6##2##(2010-11#4)(2012-12#1)(2013-7#1)
of β-lactam##4##2##(2011-1#1)(2012-12#1)(2013-1#2)
of β-peptides##2##2##(2011-1#2)
of β4##2##2##(2012-12#2)
of β4-regulated##2##2##(2012-12#2)
of γ rays##2##3##(2013-1#2)
of γ-aminobutyric acid (GABA)##2##4##(2012-12#1)(2012-2#1)
of γ-aminobutyric acid##3##3##(2012-12#1)(2012-2#1)(2013-1#1)
of γ-tubulin##4##2##(2012-12#4)
of μ-opioid receptor##2##3##(2010-12#1)(2012-1#1)
of μ-opioid##3##2##(2010-12#1)(2012-1#2)
of ϕTMA##2##2##(2011-12#2)
of ∼30##2##2##(2011-2#2)
of ≥##2##2##(2011-2#1)(2013-1#1)
of##607343##1##(1990-1#244)(1990-10#1428)(1990-11#2321)(1990-12#2987)(1990-2#2306)(1990-3#1933)(1990-4#1497)(1990-5#2615)(1990-6#1447)(1990-7#2026)(1990-8#2094)(1990-9#1560)(1991-1#1332)(1991-10#1286)(1991-11#1605)(1991-12#2781)(1991-2#2720)(1991-3#1967)(1991-4#1427)(1991-5#2331)(1991-6#1680)(1991-7#1738)(1991-8#2020)(1991-9#2489)(1992-1#1464)(1992-10#884)(1992-11#1798)(1992-12#2449)(1992-2#1855)(1992-3#2647)(1992-4#1113)(1992-5#1488)(1992-6#2388)(1992-7#1336)(1992-8#2385)(1992-9#2149)(1993-1#929)(1993-10#567)(1993-11#2339)(1993-12#3006)(1993-2#1934)(1993-3#2531)(1993-4#1087)(1993-5#1133)(1993-6#2129)(1993-7#880)(1993-8#1783)(1993-9#2215)(1994-1#461)(1994-10#817)(1994-11#2570)(1994-12#3339)(1994-2#2785)(1994-3#3294)(1994-4#394)(1994-5#2094)(1994-6#2339)(1994-7#507)(1994-8#3002)(1994-9#2926)(1995-1#2209)(1995-10#1019)(1995-11#2230)(1995-12#2898)(1995-2#3050)(1995-3#3199)(1995-4#775)(1995-5#2319)(1995-6#2552)(1995-7#803)(1995-8#2481)(1995-9#887)(1996-1#1663)(1996-10#1146)(1996-11#1700)(1996-12#2982)(1996-2#2702)(1996-3#2407)(1996-4#1466)(1996-5#3207)(1996-6#1746)(1996-7#1566)(1996-8#1881)(1996-9#1726)(1997-1#2273)(1997-2#3421)(1997-3#2652)(1997-4#3093)(1997-5#1839)(1997-6#2445)(1997-7#2787)(1997-8#2704)(1997-9#82)(2003-11#75)(2004-1#231)(2004-10#332)(2004-11#745)(2004-12#550)(2004-2#328)(2004-3#248)(2004-4#419)(2004-5#6)(2004-7#67)(2004-8#92)(2004-9#678)(2005-1#317)(2005-10#1876)(2005-11#4831)(2005-12#974)(2005-2#35)(2005-3#164)(2005-4#738)(2005-5#333)(2005-6#212)(2005-7#1652)(2005-8#2086)(2005-9#629)(2006-1#579)(2006-10#10033)(2006-11#1513)(2006-12#3991)(2006-2#2052)(2006-3#1027)(2006-4#1627)(2006-5#2043)(2006-6#2310)(2006-7#1566)(2006-8#3464)(2006-9#1528)(2007-1#1853)(2007-10#3271)(2007-11#11962)(2007-12#14584)(2007-2#3349)(2007-3#2239)(2007-4#1977)(2007-5#1965)(2007-6#1496)(2007-7#6027)(2007-8#8900)(2007-9#3352)(2008-1#6918)(2008-10#61994)(2008-11#12921)(2008-12#5393)(2008-2#14122)(2008-3#17799)(2008-4#10211)(2008-5#14108)(2008-6#5105)(2008-7#12317)(2008-8#9383)(2008-9#8291)(2009-1#379)(2009-10#2326)(2009-11#1253)(2009-12#1590)(2009-2#2253)(2009-3#2047)(2009-4#2775)(2009-5#2434)(2009-6#1683)(2009-7#1973)(2009-8#2897)(2009-9#1848)(2010-1#974)(2010-10#1490)(2010-11#1690)(2010-12#5608)(2010-2#2987)(2010-3#1889)(2010-4#3152)(2010-5#2457)(2010-6#1441)(2010-7#1907)(2010-8#3142)(2010-9#1606)(2011-1#7914)(2011-10#68)(2011-11#98)(2011-12#1924)(2011-2#15361)(2011-3#628)(2011-4#13)(2011-5#3)(2011-6#4)(2011-7#127)(2011-8#12)(2011-9#20)(2012-1#4302)(2012-10#17)(2012-11#1446)(2012-12#8337)(2012-2#10518)(2012-3#6682)(2012-4#39)(2012-5#80)(2012-6#65)(2012-7#86)(2012-8#59)(2012-9#31)(2013-1#15049)(2013-2#4)(2013-3#8)(2013-4#8)(2013-7#3057)(2013-8#7933)
of&gt##2##1##(2007-5#2)
of&lt##2##1##(2007-5#1)(2008-1#1)
of) the##5##2##(1990-11#1)(1993-9#1)(1994-8#1)(1995-8#1)(2010-4#1)
of)##10##1##(1990-11#1)(1990-8#1)(1993-9#1)(1994-8#1)(1995-3#1)(1995-8#1)(2006-10#1)(2008-10#2)(2010-4#1)
of1 approximately 15 were##2##4##(2008-11#2)
of1##5##1##(2008-11#4)(2013-8#1)
of8##2##1##(2008-11#1)(2013-1#1)
ofA##9##1##(2008-5#4)(2008-7#1)(2008-8#3)(2013-7#1)
ofADHD in adults##2##3##(2013-7#2)
ofADHD in##3##2##(2013-7#3)
ofAFM1 in##2##2##(2008-12#2)
ofAFM1##3##1##(2008-12#3)
ofAplysia##2##1##(2008-7#2)
ofBacillus##2##1##(2008-8#2)
ofE##2##1##(2008-11#1)(2008-5#1)
ofE6##2##1##(2008-8#2)
ofEurycoma longifolia Jack##2##3##(2008-11#2)
ofGanoderma lucidum##2##2##(2008-11#2)
ofGossypium##3##1##(2008-8#3)
ofHydrodictyon reticulatum##2##2##(2008-5#2)
ofLentinula edodes and##2##3##(2008-11#2)
ofLycium chinense##2##2##(2008-11#2)
ofNfbp6##2##1##(2008-8#2)
ofO##6##1##(2008-5#4)(2008-8#2)
ofP##3##1##(2008-11#1)(2008-4#1)(2008-5#1)
ofPTSD was##2##2##(2013-8#2)
ofPhaffia rhodozyma##2##2##(2008-5#2)
ofRhizobium meliloti##2##2##(2008-8#2)
ofS##3##1##(2008-11#1)(2008-9#1)(2013-7#1)
ofSalvia miltiorrhiza##2##2##(2008-11#2)
ofXa4##2##1##(2008-8#2)
ofa##12##1##(2008-11#3)(2008-5#2)(2009-8#2)(2013-7#1)(2013-8#4)
ofasyip gene##2##2##(2008-8#2)
ofcell##2##1##(2008-11#1)(2008-9#1)
ofcells in the##2##3##(2008-11#2)
ofcells in##3##2##(2008-11#3)
ofcells##5##1##(2008-11#5)
off a##12##2##(1992-11#1)(1993-9#1)(1996-12#1)(2004-9#1)(2005-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-3#1)(2012-2#1)
off after##3##2##(1994-9#1)(1996-12#1)(2013-8#1)
off all##2##2##(2007-7#1)(2007-9#1)
off and on##5##3##(2006-9#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-4#1)
off and the##2##3##(2008-10#1)(2008-2#1)
off and##12##2##(1997-3#1)(2006-10#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-4#1)(2012-1#1)
off any##2##2##(1993-1#1)(2006-9#1)
off at##4##2##(1990-2#1)(2005-11#1)(2007-11#1)(2013-1#1)
off axis##5##2##(2008-2#2)(2008-3#3)
off by##3##2##(1993-12#1)(2007-10#1)(2007-12#1)
off during##4##2##(1992-3#1)(1993-2#1)(2006-6#1)(2009-4#1)
off for##5##2##(1996-3#1)(2006-10#1)(2007-10#1)(2010-8#1)(2013-1#1)
off from the##6##3##(1997-4#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)
off from##9##2##(1997-4#1)(2004-9#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)
off gradually##2##2##(2005-11#1)(2008-10#1)
off in a##4##3##(2008-4#1)(2009-6#1)(2010-9#1)(2012-12#1)
off in the##5##3##(1991-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-4#1)
off in##12##2##(1991-10#1)(1991-11#1)(1992-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-4#1)(2010-9#1)(2012-12#1)
off of a##2##3##(1994-3#1)(2009-3#1)
off of captured animals##2##4##(2004-11#2)
off of the##3##3##(1990-11#1)(1992-9#1)(2008-10#1)
off of##12##2##(1990-11#1)(1992-9#1)(1994-3#1)(1995-6#2)(2004-11#3)(2007-7#1)(2008-10#1)(2008-11#1)(2009-3#1)
off on##3##2##(1996-1#1)(2008-2#1)(2011-2#1)
off or##3##2##(1997-7#2)(2013-7#1)
off phase matching##2##3##(2007-11#2)
off pump coronary artery bypass grafting##3##6##(2007-8#3)
off pump coronary artery bypass##5##5##(2007-8#5)
off pump coronary##7##3##(2007-8#7)
off pump##10##2##(2007-8#9)(2013-1#1)
off road driving]##4##3##(1990-6#4)
off road##5##2##(1990-6#5)
off than##4##2##(1993-2#1)(2006-4#2)(2006-8#1)
off the coast of##5##4##(1993-7#1)(2007-2#1)(2007-3#1)(2007-8#1)(2012-1#1)
off the substrate##2##3##(2007-12#1)(2008-5#1)
off the ventilator##3##3##(2009-6#1)(2012-2#2)
off the##71##2##(1990-3#1)(1990-4#1)(1990-8#1)(1991-6#1)(1992-11#1)(1993-7#1)(1995-12#1)(1996-2#1)(2004-8#1)(2005-11#1)(2006-10#3)(2006-8#2)(2007-12#6)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#2)(2008-11#3)(2008-2#6)(2008-3#6)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2009-11#2)(2009-6#2)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#2)(2013-8#1)
off time##2##2##(2013-1#1)(2013-7#1)
off to a##2##3##(1991-5#1)(1994-3#1)
off to##5##2##(1991-5#1)(1994-3#1)(2005-11#1)(2008-10#1)(2008-4#1)
off with##5##2##(1991-5#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-5#1)
off work##8##2##(1990-4#1)(1992-2#1)(1992-3#3)(1993-2#1)(2008-5#1)(2011-2#1)
off##380##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#3)(1990-6#5)(1990-8#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-11#4)(1992-2#3)(1992-3#8)(1992-6#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#4)(1993-6#1)(1993-7#1)(1993-9#2)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-9#3)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#1)(2003-11#1)(2004-11#3)(2004-8#1)(2004-9#2)(2005-11#9)(2005-9#1)(2006-10#6)(2006-12#1)(2006-4#2)(2006-6#1)(2006-7#2)(2006-8#3)(2006-9#4)(2007-10#3)(2007-11#6)(2007-12#11)(2007-2#3)(2007-3#3)(2007-6#1)(2007-7#4)(2007-8#19)(2007-9#6)(2008-1#2)(2008-10#19)(2008-11#9)(2008-12#5)(2008-2#16)(2008-3#22)(2008-4#8)(2008-5#13)(2008-6#8)(2008-7#4)(2008-8#5)(2008-9#3)(2009-10#1)(2009-11#2)(2009-3#2)(2009-4#2)(2009-6#3)(2009-8#2)(2010-3#2)(2010-4#3)(2010-5#1)(2010-8#4)(2010-9#2)(2011-1#2)(2011-12#3)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#9)(2012-3#7)(2013-1#5)(2013-7#3)(2013-8#5)
off&quot##5##1##(1990-8#1)(1997-2#1)(2008-7#1)(2011-1#1)(2012-1#1)
off)##3##1##(1993-9#1)(1995-3#1)(2008-9#1)
off-##4##1##(1991-3#2)(2007-8#1)(2013-1#1)
off-axis Hermite-Gaussian##2##2##(2008-3#2)
off-axis alignment##2##2##(2008-3#2)
off-axis angle##2##2##(2008-2#1)(2008-3#1)
off-axis angles##4##2##(2008-2#1)(2008-3#3)
off-axis detectors in##2##3##(2008-3#2)
off-axis detectors##3##2##(2008-3#3)
off-axis higher-order##2##2##(2008-2#2)
off-axis holographic recording##2##3##(2007-11#1)(2008-3#1)
off-axis holography##2##2##(2007-11#1)(2008-3#1)
off-axis lens##2##2##(2008-3#2)
off-axis parabolic##2##2##(2007-12#1)(2008-3#1)
off-axis position##2##2##(2007-11#1)(2008-3#1)
off-axis reconstruction##2##2##(2008-2#1)(2008-3#1)
off-axis##76##1##(1991-3#1)(1995-11#1)(2006-12#1)(2007-11#5)(2007-12#4)(2008-2#18)(2008-3#46)
off-broadside##2##1##(2008-2#2)
off-chip memory##2##2##(2008-2#1)(2009-5#1)
off-diagonal##4##1##(1994-5#1)(2008-2#1)(2008-3#1)(2008-8#1)
off-label indications##3##2##(2008-11#1)(2011-12#2)
off-label use of##3##3##(2009-5#1)(2011-12#1)(2012-2#1)
off-label use##5##2##(2008-8#1)(2009-5#1)(2011-12#2)(2012-2#1)
off-label##26##1##(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-7#5)(2011-12#8)(2012-2#1)(2013-1#2)
off-lattice simulations##4##2##(2005-11#4)
off-lattice##6##1##(2005-11#5)(2012-2#1)
off-line analyses##2##2##(1996-11#1)(1996-12#1)
off-line analysis of##2##3##(2008-2#1)(2013-8#1)
off-line and##2##2##(2008-10#1)(2008-11#1)
off-line by##2##2##(2008-10#1)(2008-7#1)
off-line derivatizations of##2##3##(1990-8#2)
off-line health literacy##2##3##(2008-7#2)
off-line methods##3##2##(2008-11#2)(2008-3#1)
off-line sample##2##2##(2008-10#2)
off-line with##2##2##(2008-10#2)
off-line##54##1##(1990-6#1)(1990-8#2)(1996-11#1)(1996-12#1)(1996-5#1)(1997-3#1)(2007-12#1)(2007-8#4)(2008-10#20)(2008-11#6)(2008-2#1)(2008-3#2)(2008-7#8)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#1)(2013-8#1)
off-loading##2##1##(2011-1#2)
off-normal##2##1##(2008-3#2)
off-pathway reactions##2##2##(1995-4#1)(1995-8#1)
off-plane##2##1##(1996-2#1)(2008-2#1)
off-pump CABG##4##2##(2007-8#4)
off-pump and##4##2##(2006-6#1)(2007-8#2)(2008-6#1)
off-pump bypass grafting##3##3##(2007-8#3)
off-pump coronary artery bypass grafting##6##5##(2007-8#5)(2010-8#1)
off-pump coronary artery bypass surgery##4##5##(2006-10#1)(2007-8#1)(2007-9#1)(2010-7#1)
off-pump coronary artery bypass##15##4##(2006-10#1)(2006-12#1)(2007-8#8)(2007-9#1)(2010-7#2)(2010-8#2)
off-pump coronary artery surgery##4##4##(2007-8#3)(2008-5#1)
off-pump coronary artery##20##3##(2006-10#1)(2006-12#1)(2007-8#12)(2007-9#1)(2008-5#1)(2010-7#2)(2010-8#2)
off-pump coronary bypass##2##3##(2007-8#2)
off-pump coronary surgery##3##3##(2007-8#2)(2013-8#1)
off-pump coronary##25##2##(2006-10#1)(2006-12#1)(2007-8#16)(2007-9#1)(2008-5#1)(2010-7#2)(2010-8#2)(2013-8#1)
off-pump group##4##2##(2007-8#4)
off-pump patients##2##2##(2007-8#2)
off-pump technique##2##2##(2007-8#2)
off-pump##62##1##(2006-10#1)(2006-12#1)(2006-6#1)(2007-8#49)(2007-9#1)(2008-5#1)(2008-6#2)(2010-7#2)(2010-8#2)(2011-2#1)(2013-8#1)
off-rate is##2##2##(1995-11#2)
off-rate##6##1##(1992-9#1)(1995-11#2)(1995-8#2)(2005-7#1)
off-rates##3##1##(1992-4#1)(1992-9#2)
off-resonance##3##1##(2007-11#1)(2008-3#1)(2008-9#1)
off-resonant##5##1##(2007-11#1)(2007-12#2)(2008-1#2)
off-shore##2##1##(2007-5#1)(2011-2#1)
off-site PCI##2##2##(2008-3#2)
off-site##10##1##(2005-10#2)(2007-5#1)(2008-2#1)(2008-3#6)
off-specular peak in the forward scattering direction##2##7##(2008-2#2)
off-state UPDRS motor##2##3##(2008-7#2)
off-state##3##1##(2008-3#1)(2008-7#2)
off-target##2##1##(2009-4#1)(2011-2#1)
off-the-shelf optics##2##2##(2008-3#2)
off-the-shelf##12##1##(2007-11#1)(2008-11#1)(2008-3#4)(2009-3#1)(2010-12#1)(2011-1#1)(2012-1#1)(2013-1#2)
off?##2##1##(2006-10#1)(2008-7#1)
offence##5##1##(1995-3#1)(2005-8#1)(2007-4#1)(2008-9#1)(2011-2#1)
offences##5##1##(1990-8#1)(2005-8#2)(2010-12#1)(2013-7#1)
offender##6##1##(2007-7#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-9#1)(2011-2#1)
offenders are##3##2##(2009-12#1)(2010-12#1)(2012-12#1)
offenders in domestic homicide cases were##2##6##(2011-2#2)
offenders in##4##2##(1996-9#1)(2008-11#1)(2011-2#2)
offenders with##3##2##(2009-7#2)(2010-6#1)
offenders##36##1##(1990-12#1)(1993-10#3)(1996-9#1)(2007-9#1)(2008-11#3)(2008-12#2)(2008-6#2)(2008-7#1)(2009-12#3)(2009-7#4)(2010-12#2)(2010-6#1)(2010-9#1)(2011-2#7)(2012-12#2)(2012-3#1)(2013-7#1)
offending agents##3##2##(1990-12#1)(2005-11#1)(2007-8#1)
offending behavior##3##2##(2008-12#2)(2009-7#1)
offending drug##6##2##(1993-6#1)(2008-7#2)(2008-8#3)
offending drugs##4##2##(2007-11#1)(2007-8#2)(2008-7#1)
offending foods##2##2##(2011-1#2)
offending in##2##2##(2009-7#1)(2012-12#1)
offending patterns##3##2##(2009-7#3)
offending##51##1##(1990-12#1)(1993-6#1)(1994-6#1)(1996-8#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-8#4)(2007-9#2)(2008-12#3)(2008-7#3)(2008-8#3)(2009-7#15)(2009-8#4)(2010-5#1)(2011-1#2)(2012-12#5)
offense##7##1##(1992-1#1)(1996-12#1)(1996-5#1)(2007-8#1)(2008-9#2)(2011-2#1)
offenses##11##1##(1990-12#1)(1991-10#1)(1992-9#1)(1994-2#1)(1996-5#3)(2006-8#1)(2007-1#1)(2011-2#1)(2013-8#1)
offensive and##2##2##(2008-9#1)(2009-6#1)
offensive from##2##2##(1992-12#2)
offensive type##3##2##(2004-11#3)
offensive##21##1##(1992-12#6)(1993-2#1)(1995-6#1)(1996-6#1)(1997-4#1)(2004-11#5)(2008-11#1)(2008-9#1)(2009-6#2)(2012-3#2)
offer a better##2##3##(2006-2#1)(2008-5#1)
offer a chance of cure##2##5##(2007-8#1)(2012-12#1)
offer a complementary##2##3##(2008-2#1)(2011-2#1)
offer a good##2##3##(2008-4#1)(2012-12#1)
offer a high##2##3##(2008-5#1)(2012-2#1)
offer a means of##2##4##(1996-1#1)(2008-10#1)
offer a means##3##3##(1996-1#1)(2008-10#1)(2008-11#1)
offer a model for##2##4##(1991-1#1)(2013-7#1)
offer a more natural##2##4##(2007-12#1)(2008-11#1)
offer a more##5##3##(2006-6#1)(2007-12#1)(2008-11#1)(2008-5#1)(2010-12#1)
offer a new##6##3##(1994-5#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-7#1)(2013-7#1)
offer a novel##4##3##(2005-7#1)(2011-1#1)(2011-7#1)(2012-1#1)
offer a paradigm##3##3##(2008-11#1)(2012-12#2)
offer a potential##3##3##(1991-10#1)(2008-1#1)(2008-8#1)
offer a potentially##2##3##(1990-12#1)(1996-1#1)
offer a rapid##2##3##(2007-12#1)(2008-3#1)
offer a route to##2##4##(2008-1#1)(2008-7#1)
offer a safe##2##3##(1992-2#1)(2011-2#1)
offer a significant##2##3##(1990-4#1)(2006-6#1)
offer a simple##2##3##(1990-11#1)(1992-4#1)
offer a theoretical##2##3##(2007-8#1)(2008-9#1)
offer a unique opportunity to##2##5##(2008-7#1)(2010-2#1)
offer a unique opportunity##3##4##(1991-3#1)(2008-7#1)(2010-2#1)
offer a unique##4##3##(1991-3#1)(2008-7#1)(2009-6#1)(2010-2#1)
offer a variety of##3##4##(1991-4#1)(1992-4#1)(1996-1#1)
offer a very##3##3##(1997-4#1)(2008-5#1)(2008-8#1)
offer a wide range of##2##5##(2006-12#1)(2008-10#1)
offer a##143##2##(1990-11#1)(1990-12#1)(1990-4#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#2)(1991-4#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-4#2)(1993-10#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-1#3)(1996-11#1)(1997-1#1)(1997-4#1)(2004-4#1)(2005-7#2)(2006-10#2)(2006-12#1)(2006-2#2)(2006-5#1)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#5)(2007-9#2)(2008-1#3)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#3)(2009-1#1)(2009-2#1)(2009-6#3)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#7)(2011-7#1)(2012-1#2)(2012-12#5)(2012-2#4)(2013-1#1)(2013-7#2)
offer additional##4##2##(2006-10#1)(2009-11#1)(2009-3#1)(2010-11#1)
offer advantages over##3##3##(2004-2#1)(2005-11#1)(2008-5#1)
offer advantages##7##2##(2004-2#1)(2005-11#1)(2007-10#1)(2008-5#1)(2009-3#1)(2012-12#2)
offer an advantage over##2##4##(2007-8#2)
offer an advantage##4##3##(2007-8#2)(2008-11#1)(2008-2#1)
offer an alternative to##4##4##(1997-4#1)(2008-1#1)(2008-10#2)
offer an alternative##6##3##(1997-4#1)(2005-10#1)(2008-1#1)(2008-10#2)(2008-4#1)
offer an approach##2##3##(1995-6#1)(2012-12#1)
offer an array of##2##4##(1995-1#1)(2010-11#1)
offer an effective##2##3##(1997-5#1)(2008-8#1)
offer an important##2##3##(2008-1#1)(2013-8#1)
offer an opportunity to##3##4##(1996-3#1)(2004-12#1)(2006-7#1)
offer an##44##2##(1994-12#1)(1994-9#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-4#1)(1997-4#1)(1997-5#1)(2004-12#1)(2005-10#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-4#1)(2007-8#2)(2008-1#6)(2008-10#3)(2008-11#3)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-3#1)(2010-11#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
offer any advantage over##2##4##(1991-2#1)(2006-10#1)
offer any##6##2##(1991-2#1)(1993-9#1)(1997-3#1)(2006-10#1)(2007-8#1)(2008-9#1)
offer as a##2##3##(1996-5#1)(2012-12#1)
offer benefits##3##2##(2006-10#2)(2011-1#1)
offer better##10##2##(1991-6#1)(1995-8#1)(2006-10#3)(2007-8#1)(2008-2#1)(2008-4#1)(2009-9#1)(2010-5#1)
offer broad##2##2##(2007-1#1)(2007-12#1)
offer certain##2##2##(2006-2#1)(2010-2#1)
offer clear##3##2##(2008-5#1)(2010-11#1)(2010-4#1)
offer clinicians##2##2##(2008-7#1)(2012-2#1)
offer compelling evidence##2##3##(1996-12#1)(2011-1#1)
offer considerable##3##2##(2008-2#1)(2009-9#1)(2011-2#1)
offer coverage to##2##3##(1995-6#1)(1996-3#1)
offer different##2##2##(2006-5#1)(2008-10#1)
offer enhanced##3##2##(2006-5#1)(2007-5#1)(2013-7#1)
offer excellent##3##2##(2008-3#1)(2012-11#1)(2012-2#1)
offer extensive##2##2##(1996-3#1)(2008-8#1)
offer formal##2##2##(1992-12#1)(1994-12#1)
offer future##3##2##(2006-7#1)(2008-11#1)(2008-7#1)
offer good##2##2##(1997-8#1)(2008-2#1)
offer great potential##2##3##(1992-12#1)(2008-1#1)
offer great##4##2##(1992-12#1)(2008-1#1)(2008-10#1)(2012-12#1)
offer greater##3##2##(1994-6#1)(2008-2#1)(2012-12#1)
offer health care##2##3##(1995-1#1)(1996-3#1)
offer important advantages in##2##4##(1997-5#1)(2007-11#1)
offer important##6##2##(1997-5#1)(2007-11#1)(2010-5#1)(2011-2#2)(2012-12#1)
offer improved##5##2##(2006-7#1)(2008-10#1)(2010-4#1)(2010-8#1)(2013-1#1)
offer in##6##2##(1996-9#1)(2005-9#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-12#1)
offer information##3##2##(1996-6#1)(2005-11#1)(2009-3#1)
offer insight into##4##3##(2009-11#1)(2009-4#1)(2009-7#1)(2011-1#1)
offer insights into##4##3##(1994-3#1)(2004-11#1)(2006-10#1)(2013-1#1)
offer insights##6##2##(1994-3#1)(2004-11#1)(2006-10#1)(2009-4#1)(2013-1#2)
offer large##2##2##(2007-7#1)(2009-4#1)
offer little##2##2##(2004-9#1)(2007-6#1)
offer low##2##2##(1990-5#1)(2011-1#1)
offer many advantages over##3##4##(2007-12#1)(2008-7#1)(2009-11#1)
offer many advantages##4##3##(2007-12#1)(2008-7#2)(2009-11#1)
offer many of##2##3##(1994-2#1)(2005-11#1)
offer many##11##2##(1994-2#1)(2005-11#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-7#3)(2009-11#1)
offer medical##2##2##(1996-1#1)(2006-1#1)
offer minimal##2##2##(2006-11#1)(2007-11#1)
offer more##5##2##(2006-10#1)(2007-12#1)(2007-8#1)(2011-2#1)(2013-1#1)
offer much##2##2##(2007-7#1)(2008-8#1)
offer nearly the same accuracy##2##5##(2010-12#2)
offer new opportunities##2##3##(2006-10#1)(2010-3#1)
offer new therapeutic##2##3##(2008-7#1)(2012-2#1)
offer new##19##2##(1990-7#1)(1993-8#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#4)(2010-3#1)(2010-7#1)(2012-2#1)(2013-1#4)
offer no##6##2##(1991-11#1)(1992-3#1)(2005-11#1)(2005-8#1)(2007-7#1)(2008-10#1)
offer novel therapeutic##3##3##(1993-11#1)(2005-8#1)(2006-10#1)
offer novel##5##2##(1993-11#1)(2005-8#1)(2006-10#1)(2009-7#1)(2010-12#1)
offer of##6##2##(1992-5#1)(1994-6#1)(1997-2#1)(2007-3#1)(2011-2#1)(2012-2#1)
offer one##2##2##(2006-12#1)(2008-7#1)
offer opportunities for##4##3##(2005-11#1)(2006-10#1)(2007-3#1)(2013-1#1)
offer opportunities to##3##3##(1993-2#1)(1996-7#1)(2010-3#1)
offer opportunities##7##2##(1993-2#1)(1996-7#1)(2005-11#1)(2006-10#1)(2007-3#1)(2010-3#1)(2013-1#1)
offer point-of-service##2##2##(1991-3#1)(1995-8#1)
offer possible##2##2##(2006-10#1)(2007-12#1)
offer potential as a##2##4##(2007-11#1)(2009-10#1)
offer potential##5##2##(1991-12#1)(2007-11#1)(2008-10#1)(2009-10#1)(2011-2#1)
offer powerful##2##2##(2008-10#1)(2008-8#1)
offer programs##2##2##(1990-4#1)(1995-8#1)
offer promising options for##2##4##(2008-10#1)(2010-8#1)
offer promising##3##2##(2008-10#1)(2009-3#1)(2010-8#1)
offer protection against the##2##4##(2008-12#1)(2013-1#1)
offer protection against##4##3##(1993-11#1)(2008-1#1)(2008-12#1)(2013-1#1)
offer protection##7##2##(1993-11#1)(2004-9#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2013-1#1)
offer quality##2##2##(1997-2#1)(2011-2#1)
offer recommendations##3##2##(1993-1#1)(2006-10#1)(2006-11#1)
offer several advantages like##2##4##(2010-12#1)(2010-5#1)
offer several advantages over the##2##5##(1997-8#1)(2008-10#1)
offer several advantages##4##3##(1997-8#1)(2008-10#1)(2010-12#1)(2010-5#1)
offer several##8##2##(1997-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-12#1)(2010-5#1)
offer significant advantages##3##3##(1997-4#1)(2006-7#1)(2008-7#1)
offer significant##6##2##(1992-1#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-7#1)(2008-7#1)
offer solutions##2##2##(2008-2#1)(2010-4#1)
offer some protection against##2##4##(1996-4#1)(2010-8#1)
offer some##21##2##(1990-10#1)(1994-9#1)(1995-1#1)(1996-4#1)(2005-7#2)(2005-8#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-3#1)(2006-9#1)(2008-10#1)(2008-7#1)(2009-12#1)(2010-12#1)(2010-8#1)(2011-3#1)(2012-1#1)(2012-3#1)
offer such a##2##3##(2005-7#1)(2008-10#1)
offer such##3##2##(2005-7#1)(2008-10#1)(2012-2#1)
offer survival##2##2##(2007-3#1)(2010-3#1)
offer the advantage of##2##4##(2008-10#1)(2008-9#1)
offer the best chance##2##4##(1994-6#1)(2010-2#1)
offer the best##9##3##(1994-6#1)(2005-8#1)(2006-10#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-2#1)(2010-2#1)(2012-12#1)
offer the highest##2##3##(2007-1#1)(2008-2#1)
offer the most##5##3##(1995-3#1)(2006-10#1)(2011-1#1)(2011-2#1)(2012-1#1)
offer the only##2##3##(1996-12#1)(2008-10#1)
offer the opportunity##2##3##(2008-8#1)(2008-9#1)
offer the possibility of##7##4##(2006-10#1)(2006-11#1)(2008-10#2)(2008-7#1)(2008-8#1)(2012-12#1)
offer the possibility to##3##4##(1996-6#1)(2008-10#1)(2009-6#1)
offer the possibility##10##3##(1996-6#1)(2006-10#1)(2006-11#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-6#1)(2012-12#1)
offer the potential for##8##4##(1995-8#1)(2006-10#1)(2006-12#1)(2008-8#1)(2009-12#1)(2009-3#1)(2010-2#1)(2013-1#1)
offer the potential to improve##3##5##(1993-6#1)(2013-1#2)
offer the potential to##5##4##(1993-6#1)(1994-8#1)(2007-10#1)(2013-1#2)
offer the potential##14##3##(1993-6#1)(1994-8#1)(1995-8#1)(2006-10#1)(2006-12#1)(2007-10#1)(2008-8#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-2#1)(2013-1#3)
offer the promise of##3##4##(2008-5#1)(2008-7#1)(2009-12#1)
offer the##63##2##(1990-8#1)(1991-3#1)(1991-4#1)(1992-2#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-6#1)(2005-7#1)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#7)(2008-2#2)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#3)
offer their own##2##3##(1994-3#1)(2008-4#1)
offer their views on##2##4##(2006-10#1)(2007-8#1)
offer their##5##2##(1994-3#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-4#1)
offer them##2##2##(1990-8#1)(2008-6#1)
offer theoretical##2##2##(1993-1#1)(2008-5#1)
offer therapeutic##2##2##(2006-10#1)(2008-5#1)
offer this##4##2##(1992-9#1)(1997-8#1)(2004-12#1)(2007-2#1)
offer to##4##2##(1991-6#1)(2005-11#1)(2008-7#1)(2009-5#1)
offer up##2##2##(1995-4#1)(2009-10#1)
offer useful##5##2##(2007-10#1)(2008-3#1)(2009-5#1)(2010-12#1)(2011-1#1)
offer valuable##6##2##(1997-5#1)(2006-10#1)(2008-10#1)(2008-8#1)(2010-7#1)(2012-2#1)
offer various##2##2##(2008-2#1)(2008-7#1)
offer wide##2##2##(1997-3#1)(2009-8#1)
offer women##2##2##(1991-6#1)(2007-12#1)
offer##721##1##(1990-10#1)(1990-11#1)(1990-12#4)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#2)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#6)(1991-4#2)(1991-6#3)(1991-8#1)(1992-1#2)(1992-12#3)(1992-2#3)(1992-3#2)(1992-4#2)(1992-5#1)(1992-9#1)(1993-1#3)(1993-10#2)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#4)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#4)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#2)(1995-5#1)(1995-6#2)(1995-8#6)(1996-1#9)(1996-11#1)(1996-12#2)(1996-3#7)(1996-4#2)(1996-5#3)(1996-6#4)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#3)(1997-5#3)(1997-7#1)(1997-8#3)(2004-10#1)(2004-11#1)(2004-12#2)(2004-2#1)(2004-4#1)(2004-9#2)(2005-10#1)(2005-11#8)(2005-6#1)(2005-7#7)(2005-8#6)(2005-9#2)(2006-1#1)(2006-10#35)(2006-11#4)(2006-12#6)(2006-2#5)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#6)(2006-7#8)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#7)(2007-11#11)(2007-12#9)(2007-2#8)(2007-3#5)(2007-4#3)(2007-5#2)(2007-6#2)(2007-7#8)(2007-8#14)(2007-9#5)(2008-1#17)(2008-10#34)(2008-11#20)(2008-12#7)(2008-2#18)(2008-3#14)(2008-4#8)(2008-5#11)(2008-6#6)(2008-7#32)(2008-8#16)(2008-9#9)(2009-1#1)(2009-10#3)(2009-11#4)(2009-12#4)(2009-2#2)(2009-3#7)(2009-4#5)(2009-5#3)(2009-6#5)(2009-7#3)(2009-8#3)(2009-9#2)(2010-10#1)(2010-11#3)(2010-12#11)(2010-2#6)(2010-3#5)(2010-4#4)(2010-5#6)(2010-7#4)(2010-8#5)(2010-9#3)(2011-1#11)(2011-12#1)(2011-2#21)(2011-3#1)(2011-7#1)(2012-1#5)(2012-11#2)(2012-12#16)(2012-2#16)(2012-3#5)(2013-1#20)(2013-7#5)(2013-8#1)
offered a new##2##3##(2008-9#1)(2010-12#1)
offered a number of##2##4##(2008-11#1)(2008-5#1)
offered a##24##2##(1992-1#1)(1992-8#1)(1993-3#1)(1995-8#1)(1997-4#1)(2005-10#1)(2005-4#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#2)(2009-2#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
offered an##3##2##(1995-3#1)(2008-12#1)(2008-2#1)
offered and##7##2##(1993-8#3)(2006-6#1)(2006-8#1)(2008-11#1)(2010-9#1)
offered any##2##2##(1997-5#1)(2008-7#1)
offered as a##2##3##(1991-1#1)(1994-12#1)
offered as part of##2##4##(1993-12#1)(2008-9#1)
offered as##7##2##(1991-1#1)(1993-12#1)(1994-12#1)(1995-2#1)(2008-11#1)(2008-9#1)(2011-1#1)
offered at##6##2##(1992-2#1)(1994-12#1)(1996-1#1)(2007-2#1)(2008-11#1)(2013-1#1)
offered better##2##2##(2008-10#1)(2010-12#1)
offered bilateral##2##2##(2004-2#1)(2012-2#1)
offered by a##4##3##(1993-12#1)(2006-7#1)(2007-11#1)(2007-2#1)
offered by the treatment##2##4##(2006-7#1)(2012-2#1)
offered by the##18##3##(1990-3#1)(1996-2#1)(1997-4#1)(2006-7#1)(2007-11#1)(2007-4#1)(2008-10#3)(2008-4#2)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
offered by this##2##3##(2007-4#1)(2008-11#1)
offered by##56##2##(1990-3#1)(1990-4#1)(1990-9#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-4#2)(2006-6#1)(2006-7#2)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#4)
offered for consideration##2##3##(2008-10#1)(2008-5#1)
offered for each##2##3##(2007-3#1)(2010-9#1)
offered for##18##2##(1990-9#1)(1992-12#2)(1993-3#1)(2005-10#1)(2006-1#1)(2006-11#1)(2007-2#1)(2007-3#2)(2008-10#1)(2008-4#1)(2008-5#2)(2010-2#1)(2010-9#1)(2013-1#1)(2013-7#1)
offered from##2##2##(1996-3#1)(2008-9#1)
offered good##3##2##(2007-8#1)(2008-10#2)
offered high##2##2##(2012-12#2)
offered in##17##2##(1990-12#1)(1993-10#1)(1994-3#1)(1994-8#1)(2006-2#1)(2007-7#1)(2008-12#2)(2008-4#2)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
offered no##3##2##(1991-6#1)(1995-7#1)(2006-5#1)
offered not only##2##3##(1992-3#1)(2007-11#1)
offered on##3##2##(1996-1#1)(2008-10#1)(2008-12#1)
offered palliative##3##2##(1993-3#1)(2008-6#1)(2012-2#1)
offered psychotherapy##2##2##(1991-9#1)(2006-2#1)
offered routinely##2##2##(1994-7#1)(2013-1#1)
offered surgery##2##2##(1992-9#1)(2011-2#1)
offered surgical##2##2##(2008-9#1)(2013-1#1)
offered the possibility of##2##4##(2007-11#1)(2008-10#1)
offered the##13##2##(1991-2#1)(1992-3#1)(1993-12#1)(1995-6#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#1)
offered three##2##2##(2006-5#1)(2008-12#1)
offered through##3##2##(1995-1#1)(2008-8#1)(2013-1#1)
offered to all##3##3##(2006-4#1)(2006-6#1)(2007-2#1)
offered to explain##2##3##(2008-10#1)(2008-7#1)
offered to families##3##3##(1991-12#2)(2007-2#1)
offered to patients with##4##4##(2006-6#1)(2007-9#1)(2008-5#1)(2009-6#1)
offered to patients##7##3##(1992-12#1)(1994-3#1)(2006-6#1)(2007-9#1)(2008-5#1)(2009-6#1)(2011-1#1)
offered to physicians##3##3##(1992-3#1)(1993-3#1)(2008-11#1)
offered to the##10##3##(1991-2#1)(1995-6#1)(2006-2#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-6#1)(2009-3#1)(2010-3#1)(2011-2#1)
offered to##57##2##(1990-4#1)(1991-12#2)(1991-2#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-6#1)(1997-3#1)(1997-5#1)(2004-2#1)(2004-3#1)(2005-12#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-6#2)(2007-12#2)(2007-2#3)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
offered##379##1##(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#3)(1990-8#1)(1990-9#2)(1991-1#2)(1991-12#2)(1991-2#3)(1991-4#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-12#5)(1992-2#3)(1992-3#4)(1992-5#1)(1992-8#3)(1992-9#3)(1993-10#1)(1993-12#5)(1993-3#4)(1993-8#5)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#6)(1994-3#2)(1994-4#1)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#4)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#4)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-5#2)(2004-2#2)(2004-3#1)(2005-10#3)(2005-12#2)(2005-4#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#3)(2006-4#3)(2006-5#4)(2006-6#5)(2006-7#3)(2006-8#4)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-2#8)(2007-3#2)(2007-4#4)(2007-6#1)(2007-7#4)(2007-8#6)(2007-9#4)(2008-1#6)(2008-10#28)(2008-11#12)(2008-12#12)(2008-2#8)(2008-3#4)(2008-4#7)(2008-5#8)(2008-6#4)(2008-7#5)(2008-8#4)(2008-9#8)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#6)(2010-2#2)(2010-3#1)(2010-5#2)(2010-8#3)(2010-9#2)(2011-1#5)(2011-2#8)(2012-1#2)(2012-12#9)(2012-2#10)(2012-3#2)(2013-1#15)(2013-7#1)(2013-8#3)
offering a##20##2##(1992-1#1)(1992-2#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-8#1)
offering an##7##2##(1991-11#1)(2007-2#1)(2008-10#1)(2009-6#1)(2010-5#1)(2013-1#2)
offering health##3##2##(1994-3#1)(2008-7#1)(2010-3#1)
offering high resolution##2##3##(2008-3#1)(2008-7#1)
offering new##2##2##(2008-5#1)(2009-2#1)
offering of##2##2##(2010-9#1)(2012-12#1)
offering or##2##2##(2007-4#1)(2011-2#1)
offering primary care##2##3##(2006-10#1)(2008-2#1)
offering recommendations for##2##3##(2008-11#1)(2012-2#1)
offering the possibility of##2##4##(2008-2#1)(2008-5#1)
offering the possibility to##2##4##(1996-11#1)(2008-2#1)
offering the possibility##4##3##(1996-11#1)(2008-2#2)(2008-5#1)
offering the potential for##2##4##(2009-2#1)(2009-3#1)
offering the##18##2##(1991-1#1)(1995-1#1)(1995-8#1)(1996-11#1)(2006-9#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-5#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#1)
offering them##3##2##(1993-12#1)(2013-1#2)
offering this##2##2##(2010-9#1)(2011-2#1)
offering unique##2##2##(2006-10#1)(2008-7#1)
offering##147##1##(1990-12#1)(1991-1#1)(1991-11#1)(1992-1#1)(1992-2#1)(1993-12#1)(1994-3#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-8#1)(2005-12#1)(2006-10#3)(2006-2#1)(2006-3#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#4)(2007-6#1)(2007-8#4)(2007-9#4)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#4)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#5)(2010-3#1)(2010-4#1)(2010-5#4)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#8)(2012-1#3)(2012-11#2)(2012-12#4)(2012-2#3)(2013-1#12)(2013-8#1)
offerings to##2##2##(1994-3#1)(1997-2#1)
offerings##11##1##(1990-12#1)(1992-12#1)(1992-3#1)(1994-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#3)(2012-2#1)
offers a brief discussion of##2##5##(2007-11#1)(2008-11#1)
offers a brief##4##3##(2007-11#1)(2008-11#1)(2010-7#1)(2012-12#1)
offers a clear advantage over##2##5##(2006-12#1)(2006-7#1)
offers a comprehensive##2##3##(1992-12#1)(2010-4#1)
offers a convenient##4##3##(1991-2#1)(2007-11#1)(2008-2#1)(2008-8#1)
offers a critical analysis of##2##5##(2010-7#2)
offers a critical##3##3##(2008-10#1)(2010-7#2)
offers a detailed##2##3##(1996-6#1)(2008-4#1)
offers a fast##2##3##(1995-3#1)(2008-4#1)
offers a general##4##3##(2006-10#1)(2008-4#2)(2010-12#1)
offers a glimpse##2##3##(2007-9#1)(2008-12#1)
offers a good##3##3##(1994-9#1)(2008-10#1)(2008-5#1)
offers a great##2##3##(2006-12#1)(2008-8#1)
offers a highly##2##3##(2008-10#1)(2008-11#1)
offers a less##2##3##(2006-9#1)(2008-5#1)
offers a low-cost##2##3##(2008-11#1)(2010-5#1)
offers a more##5##3##(2007-2#1)(2008-10#1)(2008-2#1)(2010-7#1)(2012-12#1)
offers a new##10##3##(1994-6#1)(2006-7#1)(2007-12#1)(2007-7#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
offers a novel approach##2##4##(1994-10#1)(2006-5#1)
offers a novel##9##3##(1992-8#1)(1994-10#1)(1994-5#1)(2006-5#1)(2007-8#1)(2008-10#1)(2010-6#1)(2013-1#2)
offers a number of advantages over##5##6##(2007-11#1)(2007-7#1)(2008-2#1)(2008-4#1)(2013-8#1)
offers a number of advantages##6##5##(2007-11#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-4#1)(2013-8#1)
offers a number of potential##2##5##(2007-12#1)(2012-12#1)
offers a number of##12##4##(2007-11#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-2#2)(2008-4#2)(2012-12#1)(2013-1#2)(2013-8#1)
offers a potential##7##3##(2006-7#1)(2007-12#1)(2008-10#2)(2008-3#1)(2009-3#1)(2012-3#1)
offers a powerful##4##3##(1991-5#1)(1995-2#1)(2010-5#1)(2012-11#1)
offers a practical method for##2##5##(2007-11#1)(2008-3#1)
offers a practical##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
offers a promising##2##3##(2007-11#1)(2008-1#1)
offers a quick##2##3##(1990-8#1)(2008-2#1)
offers a relatively##2##3##(2006-10#1)(2008-10#1)
offers a simple and##3##4##(1990-12#1)(2008-2#1)(2010-4#1)
offers a simple##11##3##(1990-12#1)(1991-7#1)(2006-5#1)(2007-12#2)(2008-2#2)(2008-3#1)(2008-9#1)(2010-10#1)(2010-4#1)
offers a solution to##2##4##(2007-4#1)(2008-4#1)
offers a unique opportunity to##3##5##(1992-10#1)(2008-7#1)(2009-6#1)
offers a unique##7##3##(1992-10#1)(1994-3#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)
offers a valuable way in which N low-power laser elements##2##10##(2008-3#2)
offers a valuable##6##3##(2005-10#1)(2006-3#1)(2007-8#1)(2008-3#2)(2012-2#1)
offers a##209##2##(1990-12#1)(1990-5#1)(1990-8#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-6#1)(1997-4#1)(2005-10#1)(2005-4#1)(2006-10#3)(2006-12#2)(2006-3#1)(2006-5#2)(2006-7#3)(2006-9#2)(2007-10#1)(2007-11#9)(2007-12#9)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#17)(2008-11#10)(2008-12#2)(2008-2#15)(2008-3#7)(2008-4#12)(2008-5#2)(2008-7#4)(2008-8#3)(2008-9#4)(2009-10#3)(2009-12#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#6)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#7)(2013-8#3)
offers additional##2##2##(1991-12#1)(2007-8#1)
offers advantages in##3##3##(2008-2#1)(2008-7#1)(2009-12#1)
offers advantages##7##2##(1996-1#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-12#1)
offers advice on##3##3##(1991-12#1)(2008-4#2)
offers advice##5##2##(1991-12#1)(1992-6#1)(2007-2#1)(2008-4#2)
offers an acceptable alternative##2##4##(1994-12#1)(2011-2#1)
offers an advantage##3##3##(1994-6#1)(2012-12#2)
offers an alternative to biopsy##2##5##(2012-2#2)
offers an alternative to##6##4##(1996-12#1)(1997-3#1)(2006-10#1)(2008-11#1)(2012-2#2)
offers an alternative##13##3##(1993-11#1)(1996-12#1)(1996-5#1)(1997-3#1)(2004-9#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-11#1)(2010-12#1)(2012-2#3)
offers an approach##2##3##(2007-12#1)(2008-5#1)
offers an attractive##7##3##(1992-11#1)(2007-11#1)(2007-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-11#1)
offers an easy and##2##4##(2008-7#1)(2011-1#1)
offers an easy##4##3##(1995-2#1)(2008-10#1)(2008-7#1)(2011-1#1)
offers an effective##2##3##(2009-5#1)(2013-1#1)
offers an efficacious##2##3##(2008-3#2)
offers an example of##3##4##(1996-8#1)(2005-7#1)(2008-10#1)
offers an experimental##2##3##(2005-4#1)(2008-3#1)
offers an explanation for the##2##5##(2007-4#1)(2008-9#1)
offers an explanation for##3##4##(2007-4#1)(2008-9#1)(2010-12#1)
offers an ideal##4##3##(2008-10#1)(2008-4#1)(2008-8#1)(2012-12#1)
offers an overview of the##3##5##(1993-11#1)(2007-4#1)(2013-1#1)
offers an overview of these##2##5##(2007-5#1)(2008-4#1)
offers an overview of##10##4##(1993-11#1)(1996-12#1)(2007-4#1)(2007-5#1)(2008-4#3)(2008-9#1)(2010-7#1)(2013-1#1)
offers an##80##2##(1992-11#1)(1992-8#1)(1993-11#2)(1994-12#1)(1994-6#1)(1995-2#2)(1996-12#2)(1996-5#1)(1996-8#1)(1997-2#2)(1997-3#1)(2004-9#1)(2005-4#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-4#2)(2007-5#1)(2007-8#2)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-5#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#4)
offers better##4##2##(1992-9#1)(2008-10#1)(2008-7#1)(2011-1#1)
offers comprehensive##2##2##(2008-2#1)(2008-6#1)
offers considerable promise##2##3##(1994-3#1)(2008-10#1)
offers considerable##3##2##(1994-3#1)(2008-10#1)(2008-7#1)
offers convenient measurement of##2##4##(2007-8#1)(2008-3#1)
offers convenient##3##2##(2007-8#1)(2008-3#1)(2008-4#1)
offers distinct##2##2##(1993-3#1)(2008-10#1)
offers enormous##2##2##(2007-11#1)(2008-1#1)
offers excellent##3##2##(2006-12#1)(2012-2#1)(2013-7#1)
offers exciting##2##2##(2007-12#1)(2010-9#1)
offers extremely##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
offers favourable##2##2##(1994-2#1)(2008-10#1)
offers for##3##2##(1996-12#1)(2006-10#1)(2007-12#1)
offers good##6##2##(2007-5#1)(2008-10#1)(2009-7#1)(2012-12#2)(2012-2#1)
offers great potential##2##3##(1997-4#1)(2006-11#1)
offers great promise for##3##4##(2006-10#2)(2008-10#1)
offers great sensitivity##2##3##(2008-10#1)(2008-3#1)
offers great##8##2##(1997-4#1)(2006-10#2)(2006-11#1)(2008-10#2)(2008-3#1)(2012-11#1)
offers greater##3##2##(1994-8#1)(2010-4#1)(2011-2#1)
offers guidance for interpreting##2##4##(2008-4#2)
offers guidance for##3##3##(2007-4#1)(2008-4#2)
offers guidance##4##2##(2007-4#1)(2008-4#2)(2010-9#1)
offers guidelines##2##2##(2007-10#1)(2009-9#1)
offers high##3##2##(2008-10#3)
offers hope for##2##3##(2005-8#1)(2006-10#1)
offers hope##3##2##(1994-10#1)(2005-8#1)(2006-10#1)
offers improved##6##2##(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-2#1)
offers insight into the##2##4##(2008-3#1)(2010-9#1)
offers insight into##3##3##(2008-3#1)(2010-2#1)(2010-9#1)
offers insight##4##2##(2008-10#1)(2008-3#1)(2010-2#1)(2010-9#1)
offers insights into##2##3##(2011-2#1)(2012-3#1)
offers many advantages for##2##4##(2007-7#1)(2008-2#1)
offers many advantages over other##2##5##(1994-5#1)(2012-2#1)
offers many advantages over##5##4##(1994-5#1)(2008-10#1)(2008-8#1)(2012-2#1)(2012-3#1)
offers many advantages##9##3##(1994-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2012-2#1)(2012-3#1)
offers many potential advantages##4##4##(2007-5#1)(2007-8#1)(2008-1#1)(2008-4#1)
offers many##18##2##(1994-5#1)(1996-2#1)(2006-10#1)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2012-2#1)(2012-3#1)
offers more##3##2##(2006-9#1)(2008-4#1)(2010-6#1)
offers much##4##2##(1993-6#1)(2007-12#1)(2008-2#1)(2008-4#1)
offers multiple##2##2##(2007-11#1)(2007-2#1)
offers new insights into##2##4##(2010-3#1)(2012-12#1)
offers new opportunities##2##3##(1997-8#1)(2006-3#1)
offers new potentialities for##2##4##(1991-11#1)(1995-12#1)
offers new##13##2##(1991-11#1)(1995-12#1)(1997-8#1)(2005-6#1)(2006-3#1)(2007-8#1)(2008-12#1)(2008-2#1)(2010-12#1)(2010-3#1)(2012-12#3)
offers no##6##2##(1994-1#2)(1996-12#1)(1996-2#1)(2010-2#1)(2013-1#1)
offers novel##2##2##(2008-9#1)(2013-1#1)
offers numerous##3##2##(2007-11#1)(2008-10#1)(2012-11#1)
offers opportunities to##2##3##(1992-9#1)(2006-3#1)
offers opportunities##4##2##(1992-9#1)(2006-3#1)(2008-2#1)(2008-4#1)
offers possible##2##2##(1992-3#1)(1993-1#1)
offers potential##4##2##(1996-8#1)(2004-11#1)(2008-3#1)(2012-2#1)
offers practical suggestions##2##3##(2007-2#1)(2007-4#1)
offers practical##4##2##(1994-12#1)(2007-2#1)(2007-4#1)(2011-2#1)
offers promise as a##2##4##(1994-5#1)(2007-11#1)
offers promise for##2##3##(1993-11#1)(2008-7#1)
offers promise##5##2##(1993-11#1)(1994-5#1)(1997-3#1)(2007-11#1)(2008-7#1)
offers promising##2##2##(2005-11#1)(2011-2#1)
offers protection##3##2##(1991-5#1)(2010-8#1)(2012-2#1)
offers recommendations##3##2##(1996-1#1)(2009-5#1)(2011-2#1)
offers safety##2##2##(2008-10#1)(2012-2#1)
offers several advantages over conventional##2##5##(2008-1#1)(2008-10#1)
offers several advantages over##6##4##(1991-9#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-3#1)
offers several advantages##10##3##(1991-9#1)(1997-2#1)(1997-7#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)
offers several significant##2##3##(2007-7#1)(2012-1#1)
offers several##18##2##(1991-9#1)(1997-2#1)(1997-7#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-4#2)(2008-5#1)(2012-1#1)
offers short-term##2##2##(2006-8#1)(2011-2#1)
offers significant advantages in the##2##5##(1993-8#1)(2008-10#1)
offers significant advantages##3##3##(1993-8#1)(2007-9#1)(2008-10#1)
offers significant##9##2##(1993-8#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-8#1)
offers some advantages##2##3##(2006-10#1)(2008-10#1)
offers some practical##2##3##(1992-12#1)(2007-7#1)
offers some##14##2##(1990-12#1)(1991-2#1)(1992-12#2)(1992-2#1)(1992-8#1)(1993-1#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-9#1)
offers suggestions for##3##3##(1991-2#1)(1992-12#1)(2007-7#1)
offers suggestions##5##2##(1991-2#1)(1992-12#1)(1995-1#1)(1995-12#1)(2007-7#1)
offers the ability to##2##4##(2008-11#1)(2008-9#1)
offers the advantage of##7##4##(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)
offers the advantage that##3##4##(2004-9#1)(2007-12#1)(2008-11#1)
offers the advantage##10##3##(2004-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
offers the advantages of##5##4##(2007-11#1)(2008-10#2)(2008-2#1)(2010-7#1)
offers the advantages##6##3##(1997-6#1)(2007-11#1)(2008-10#2)(2008-2#1)(2010-7#1)
offers the best##8##3##(1991-2#1)(1996-3#1)(1996-7#1)(2006-2#1)(2007-9#1)(2008-2#1)(2008-9#1)(2009-2#1)
offers the first##2##3##(2005-7#1)(2008-7#1)
offers the flexibility##2##3##(2011-1#1)(2012-1#1)
offers the following##2##3##(1997-4#1)(2008-10#1)
offers the greatest##2##3##(2005-11#1)(2008-6#1)
offers the most##5##3##(1996-1#1)(2005-7#1)(2007-6#1)(2007-7#1)(2008-3#1)
offers the opportunity for##2##4##(2010-11#1)(2012-2#1)
offers the opportunity to##3##4##(1993-4#1)(2007-7#1)(2008-1#1)
offers the opportunity##5##3##(1993-4#1)(2007-7#1)(2008-1#1)(2010-11#1)(2012-2#1)
offers the possibility of##11##4##(1997-4#1)(2004-2#1)(2006-2#1)(2007-11#3)(2007-6#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#1)
offers the possibility to##2##4##(2008-5#1)(2009-5#1)
offers the possibility##14##3##(1997-4#1)(2004-2#1)(2006-2#1)(2007-11#3)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)
offers the potential for##6##4##(1996-12#1)(2005-7#1)(2006-7#1)(2008-11#2)(2008-4#1)
offers the potential of##4##4##(1997-2#1)(2007-9#1)(2008-10#1)(2008-8#1)
offers the potential to##2##4##(1994-9#1)(2006-4#1)
offers the potential##14##3##(1994-9#1)(1996-12#1)(1997-2#1)(2005-7#1)(2006-4#1)(2006-7#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#1)
offers the unique##4##3##(2007-12#1)(2008-4#1)(2008-9#1)(2011-7#1)
offers the##98##2##(1990-5#1)(1991-2#1)(1991-3#1)(1993-4#1)(1994-9#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-4#2)(1997-6#1)(2004-12#1)(2004-2#1)(2004-9#1)(2005-11#1)(2005-7#3)(2006-10#1)(2006-2#3)(2006-3#1)(2006-4#1)(2006-7#1)(2007-11#5)(2007-12#2)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#10)(2008-11#6)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-2#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-2#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#3)(2012-2#1)
offers to##3##2##(1991-5#1)(1994-11#1)(2012-12#1)
offers two##3##2##(2005-10#1)(2008-4#1)(2012-3#1)
offers unique advantages for##2##4##(1990-5#1)(2007-12#1)
offers unique##5##2##(1990-5#1)(2007-11#1)(2007-12#1)(2008-8#1)(2009-9#1)
offers us##3##2##(1995-12#1)(2008-9#1)(2012-2#1)
offers valuable##3##2##(2006-6#1)(2013-1#2)
offers very##3##2##(2008-3#1)(2008-4#1)(2012-2#1)
offers##762##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#4)(1990-8#2)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#5)(1991-3#2)(1991-5#3)(1991-7#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#6)(1992-2#2)(1992-3#4)(1992-5#2)(1992-6#1)(1992-8#3)(1992-9#2)(1993-1#2)(1993-11#4)(1993-12#3)(1993-3#2)(1993-4#3)(1993-6#2)(1993-8#1)(1994-1#2)(1994-10#2)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#3)(1994-4#1)(1994-5#3)(1994-6#3)(1994-8#2)(1994-9#2)(1995-1#2)(1995-12#5)(1995-2#4)(1995-3#3)(1995-8#1)(1995-9#1)(1996-1#3)(1996-12#5)(1996-2#4)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#6)(1997-3#4)(1997-4#4)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#1)(2004-12#2)(2004-2#1)(2004-9#2)(2005-10#2)(2005-11#2)(2005-4#2)(2005-6#1)(2005-7#4)(2005-8#2)(2006-1#2)(2006-10#15)(2006-11#1)(2006-12#6)(2006-2#5)(2006-3#4)(2006-4#1)(2006-5#4)(2006-6#1)(2006-7#5)(2006-8#3)(2006-9#3)(2007-1#1)(2007-10#3)(2007-11#22)(2007-12#24)(2007-2#8)(2007-3#2)(2007-4#6)(2007-5#4)(2007-6#2)(2007-7#11)(2007-8#14)(2007-9#9)(2008-1#11)(2008-10#63)(2008-11#24)(2008-12#4)(2008-2#35)(2008-3#27)(2008-4#39)(2008-5#11)(2008-6#5)(2008-7#14)(2008-8#9)(2008-9#14)(2009-10#7)(2009-12#4)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#5)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#6)(2010-2#7)(2010-3#2)(2010-4#4)(2010-5#3)(2010-6#4)(2010-7#8)(2010-8#5)(2010-9#4)(2011-1#8)(2011-12#1)(2011-2#13)(2011-7#1)(2012-1#8)(2012-11#4)(2012-12#13)(2012-2#17)(2012-3#6)(2013-1#19)(2013-7#2)(2013-8#4)
office and##7##2##(1991-2#1)(1993-1#1)(1996-12#1)(2007-12#1)(2009-8#1)(2010-7#1)(2012-12#1)
office are##2##2##(1991-12#1)(2006-11#1)
office as##2##2##(1996-1#1)(2006-10#1)
office based##2##2##(2006-6#1)(2006-8#1)
office building##2##2##(1997-3#1)(2008-5#1)
office by##2##2##(1993-1#1)(2006-10#1)
office for##3##2##(1997-2#1)(2007-12#1)(2008-11#1)
office in##2##2##(1996-5#1)(2012-2#1)
office is##2##2##(1996-1#1)(2009-5#1)
office of the##2##3##(2006-8#1)(2007-10#1)
office or##5##2##(1992-4#2)(1995-12#1)(2006-2#1)(2010-5#1)
office paper&gt##2##2##(2008-10#2)
office settings##2##2##(2009-5#1)(2012-12#1)
office staff##3##2##(1991-12#1)(1993-2#1)(2010-5#1)
office to##2##2##(1990-4#1)(2007-10#1)
office visit##4##2##(1997-3#1)(2003-11#1)(2006-12#1)(2006-9#1)
office visits and##2##3##(1995-3#1)(2008-5#1)
office visits to##3##3##(2004-3#1)(2008-6#1)(2010-8#1)
office visits##11##2##(1995-3#1)(1997-2#1)(2004-3#1)(2006-10#1)(2006-8#1)(2008-5#1)(2008-6#2)(2009-6#1)(2010-8#2)
office was##3##2##(1995-12#1)(2008-1#2)
office were##2##2##(1991-6#1)(2011-1#1)
office##155##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-4#3)(1990-5#1)(1990-8#1)(1991-1#3)(1991-12#4)(1991-2#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#6)(1993-1#3)(1993-2#1)(1993-3#1)(1993-4#1)(1994-12#2)(1994-2#1)(1994-3#7)(1994-8#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-1#5)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#1)(1997-2#2)(1997-3#2)(1997-5#1)(2003-11#1)(2004-3#1)(2005-5#1)(2006-10#8)(2006-11#1)(2006-12#1)(2006-2#3)(2006-6#2)(2006-8#6)(2006-9#1)(2007-10#2)(2007-12#4)(2007-2#1)(2007-6#2)(2007-7#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2009-10#1)(2009-4#2)(2009-5#5)(2009-6#1)(2009-7#1)(2009-8#2)(2010-2#1)(2010-5#4)(2010-7#2)(2010-8#2)(2011-1#4)(2011-2#2)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
office-based anesthesia##4##2##(2006-10#2)(2012-12#2)
office-based cosmetic surgery##2##3##(2012-12#2)
office-based physicians was conducted##2##4##(2008-11#1)(2011-1#1)
office-based physicians##3##2##(2008-11#1)(2011-1#2)
office-based surgery and anesthesia##3##4##(2006-10#2)(2010-9#1)
office-based surgery##5##2##(2006-10#2)(2007-3#1)(2008-4#1)(2010-9#1)
office-based surgical safety##2##3##(2013-1#2)
office-based surgical##4##2##(2010-9#1)(2013-1#3)
office-based##29##1##(1992-5#1)(1994-2#1)(2004-11#1)(2006-10#4)(2007-12#1)(2007-3#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-9#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#5)(2013-1#5)
office?##2##1##(2012-3#2)
office]##6##1##(1990-3#1)(1991-11#1)(1993-10#1)(1995-5#1)(1995-9#1)(1997-2#1)
officer in##4##2##(1992-1#1)(1993-2#1)(1995-6#1)(1996-3#1)
officer of##4##2##(1995-5#1)(1995-6#1)(1997-7#1)(2008-7#1)
officer will##2##2##(1997-5#1)(2006-8#1)
officer##36##1##(1990-12#1)(1991-1#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-2#3)(1993-8#1)(1994-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#3)(1997-5#1)(1997-7#1)(2006-8#2)(2007-2#1)(2007-6#1)(2007-9#1)(2008-7#1)(2010-2#2)(2011-2#1)
officer&quot##3##1##(1993-2#3)
officer-involved##2##1##(2009-2#2)
officers and##6##2##(1993-1#1)(1993-3#1)(2005-12#1)(2008-1#1)(2008-6#1)(2013-8#1)
officers in##5##2##(1990-3#1)(1992-12#1)(1995-5#1)(1996-9#1)(2008-1#1)
officers of##2##2##(1995-3#1)(2009-7#1)
officers were##2##2##(1995-6#1)(2013-1#1)
officers##80##1##(1990-3#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#3)(1992-12#2)(1992-2#2)(1993-1#1)(1993-2#2)(1993-3#2)(1993-4#1)(1994-2#1)(1995-3#1)(1995-5#3)(1995-6#8)(1996-12#3)(1996-2#2)(1996-9#1)(1997-2#2)(1997-8#2)(2004-7#1)(2005-12#1)(2005-8#2)(2005-9#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#9)(2008-12#1)(2008-3#1)(2008-6#7)(2008-7#1)(2008-9#1)(2009-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
offices across##2##2##(2010-6#1)(2010-9#1)
offices in##3##2##(1990-4#1)(2008-11#1)(2009-11#1)
offices of the##3##3##(1990-4#1)(2009-4#1)(2010-12#1)
offices of##4##2##(1990-4#1)(1996-1#1)(2009-4#1)(2010-12#1)
offices were##3##2##(1990-4#2)(1991-5#1)
offices##37##1##(1990-4#4)(1991-5#3)(1992-1#1)(1992-3#1)(1993-10#1)(1994-2#2)(1995-5#1)(1996-1#2)(1996-2#2)(2005-11#1)(2008-10#1)(2008-11#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-11#3)(2010-12#5)(2010-6#2)(2010-9#1)(2012-3#1)(2013-1#1)
official Veterinary Services##3##3##(2005-5#2)(2011-2#1)
official and reported methods##2##4##(2008-10#2)
official and##3##2##(2008-10#2)(2012-3#1)
official guidelines##3##2##(1995-6#1)(2007-2#1)(2008-1#1)
official method of the##3##4##(2008-10#3)
official method of##4##3##(2008-10#4)
official method##18##2##(2008-10#18)
official methods for##3##3##(2008-10#2)(2011-1#1)
official methods##9##2##(2008-10#6)(2008-11#1)(2008-5#1)(2011-1#1)
official records##3##2##(2008-12#2)(2009-10#1)
official sources and##2##3##(2009-7#1)(2013-8#1)
official statistics##4##2##(1990-6#1)(1991-9#1)(2007-2#1)(2009-5#1)
official tariff##2##2##(2012-12#2)
official veterinarians##2##2##(2005-5#2)
official##115##1##(1990-10#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-5#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-5#1)(1997-6#3)(2004-2#1)(2005-5#4)(2006-7#1)(2007-2#2)(2007-9#2)(2008-1#2)(2008-10#34)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#5)(2008-7#2)(2008-9#1)(2009-10#4)(2009-11#1)(2009-5#1)(2009-7#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-11#1)(2012-12#6)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
officialdom##2##1##(2008-7#1)(2009-10#1)
officially accepted##2##2##(1996-3#1)(2008-5#1)
officially in##2##2##(1990-3#1)(2007-4#1)
officially##15##1##(1990-3#1)(1993-6#1)(1994-12#1)(1995-9#1)(1996-3#1)(1997-8#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#2)(2010-12#1)(2010-4#1)
officials and community##2##3##(1996-1#1)(2007-4#1)
officials and other##2##3##(2008-2#1)(2013-7#1)
officials and##12##2##(1990-12#1)(1995-12#1)(1996-1#2)(1996-12#1)(2007-4#1)(2008-1#1)(2008-2#1)(2009-10#1)(2011-2#1)(2012-12#1)(2013-7#1)
officials are##2##2##(1995-12#1)(2008-6#1)
officials as##2##2##(1994-3#1)(2008-10#1)
officials come to##2##3##(1995-6#2)
officials from##5##2##(2008-1#1)(2008-11#1)(2009-12#1)(2012-1#1)(2013-7#1)
officials have##5##2##(1994-12#1)(1994-4#1)(2007-8#1)(2007-9#2)
officials in##4##2##(1990-4#1)(1991-6#1)(1996-11#1)(1996-3#1)
officials said##2##2##(1992-3#1)(2007-9#1)
officials sought##2##2##(1991-1#1)(2011-2#1)
officials to##7##2##(1996-5#1)(2007-9#2)(2008-1#1)(2009-5#1)(2012-12#1)(2013-7#1)
officials who##2##2##(2006-5#1)(2007-9#1)
officials##92##1##(1990-12#1)(1990-2#2)(1990-4#1)(1991-1#1)(1991-6#1)(1992-3#1)(1992-6#2)(1993-1#2)(1993-6#1)(1994-10#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#1)(1995-1#2)(1995-12#4)(1995-6#6)(1996-1#3)(1996-11#2)(1996-12#3)(1996-3#2)(1996-5#2)(1997-6#1)(2004-3#1)(2005-3#1)(2006-5#1)(2007-4#2)(2007-8#3)(2007-9#10)(2008-1#4)(2008-10#2)(2008-11#1)(2008-2#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#2)(2009-5#2)(2010-12#1)(2011-2#5)(2012-1#1)(2012-12#3)(2013-7#3)(2013-8#1)
officinale##2##1##(2008-10#1)(2010-3#1)
officinalis L##7##2##(2007-1#1)(2008-7#2)(2010-12#1)(2012-12#3)
officinalis and##3##2##(1992-2#2)(2008-7#1)
officinalis dry extract##2##3##(2012-12#2)
officinalis flower extract##2##3##(2011-2#2)
officinalis seeds##4##2##(2012-3#4)
officinalis##50##1##(1990-11#1)(1992-2#2)(2006-12#3)(2007-1#9)(2007-3#1)(2007-6#2)(2008-10#2)(2008-12#1)(2008-5#2)(2008-7#3)(2010-12#1)(2010-4#1)(2011-2#8)(2012-12#8)(2012-3#5)(2013-1#1)
officinalis)##3##1##(2008-10#2)(2008-5#1)
offline measurement##2##2##(2005-11#2)
offline version##2##2##(2005-7#2)
offline##25##1##(1991-2#1)(2005-11#3)(2005-7#4)(2007-12#1)(2008-4#2)(2008-6#2)(2008-9#1)(2010-4#3)(2010-7#1)(2010-8#1)(2012-1#2)(2012-12#3)(2013-8#1)
offloading##2##1##(2010-11#1)(2011-2#1)
offset and##6##2##(1996-9#1)(2006-11#1)(2007-12#1)(2008-3#1)(2008-7#1)(2011-2#1)
offset any##2##2##(2008-4#1)(2012-3#1)
offset at##2##2##(1996-4#1)(2008-3#1)
offset between##2##2##(2007-7#1)(2008-3#1)
offset by a##3##3##(1992-12#1)(1997-1#1)(2008-8#1)
offset by an##2##3##(1992-12#1)(1993-12#1)
offset by increased##2##3##(1993-12#1)(2008-8#1)
offset by the##5##3##(2006-10#1)(2007-1#1)(2008-1#1)(2013-1#2)
offset by##23##2##(1992-12#2)(1993-12#2)(1993-3#1)(1995-1#1)(1996-5#1)(1997-1#1)(1997-7#2)(1997-8#1)(2006-10#2)(2007-1#1)(2008-1#1)(2008-3#2)(2008-8#2)(2013-1#2)(2013-7#1)(2013-8#1)
offset frequency##3##2##(2007-11#3)
offset from the##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2011-2#1)
offset in the##2##3##(2008-2#1)(2008-3#1)
offset in##7##2##(1990-12#1)(1994-9#1)(1995-1#1)(2008-2#2)(2008-3#1)(2011-2#1)
offset of 0##2##3##(2008-2#2)
offset of a##2##3##(1996-5#1)(2008-2#1)
offset of the##3##3##(1996-12#1)(2007-11#1)(2008-3#1)
offset of##8##2##(1996-12#1)(1996-5#1)(2007-11#1)(2008-2#3)(2008-3#2)
offset the##10##2##(1997-3#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-2#2)(2012-12#1)
offset to the##3##3##(1994-12#1)(1995-8#1)(2008-6#1)
offset to##4##2##(1994-12#1)(1995-8#1)(2006-10#1)(2008-6#1)
offset was##3##2##(1995-1#1)(1995-8#1)(2009-3#1)
offset##130##1##(1990-12#1)(1992-12#3)(1992-3#1)(1993-12#3)(1993-3#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#4)(1995-8#3)(1996-12#1)(1996-4#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#3)(1997-8#1)(2006-10#3)(2006-11#2)(2006-2#1)(2007-1#1)(2007-11#10)(2007-12#5)(2007-4#4)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#15)(2008-3#22)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-12#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-8#1)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
offsets in##2##2##(2008-2#2)
offsets of##3##2##(2008-3#2)(2011-2#1)
offsets that##2##2##(2008-2#1)(2008-3#1)
offsets the##2##2##(1992-12#1)(2013-1#1)
offsets##26##1##(1992-12#1)(1995-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-2#8)(2008-3#9)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
offsetting##2##1##(1993-12#1)(2008-3#1)
offshoot of##2##2##(2011-2#1)(2012-2#1)
offshore ecosystem health##4##3##(2013-8#4)
offshore ecosystem##5##2##(2013-8#5)
offshore platforms##2##2##(1990-11#2)
offshore teleradiology##2##2##(2007-4#2)
offshore water##2##2##(2007-5#2)
offshore##27##1##(1990-11#2)(2007-4#2)(2007-5#2)(2007-7#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-10#3)(2010-8#2)(2011-2#4)(2013-7#2)(2013-8#5)
offspring and##9##2##(2006-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2013-1#1)(2013-8#1)
offspring are##3##2##(1995-1#1)(1996-3#1)(2008-9#1)
offspring at##4##2##(1996-10#1)(2008-10#1)(2008-9#2)
offspring density##3##2##(2008-9#3)
offspring do##2##2##(2006-5#1)(2008-8#1)
offspring environment##2##2##(2008-8#2)
offspring fitness##4##2##(2008-8#4)
offspring fitness/propagule size##2##3##(2008-8#2)
offspring from each group##2##4##(2008-5#1)(2012-3#1)
offspring from the##4##3##(2005-10#1)(2008-10#1)(2012-12#2)
offspring from##7##2##(1996-10#1)(2005-10#1)(2008-10#1)(2008-5#1)(2012-12#2)(2012-3#1)
offspring had##3##2##(1993-11#1)(1996-4#1)(2013-8#1)
offspring in##2##2##(2008-8#1)(2010-2#1)
offspring is##3##2##(2008-5#1)(2008-8#1)(2008-9#1)
offspring of AD##2##3##(1997-4#2)
offspring of DM2 parents##2##4##(2006-9#2)
offspring of DM2 subjects##2##4##(2006-9#2)
offspring of DM2##4##3##(2006-9#4)
offspring of diabetic##2##3##(2007-2#1)(2012-3#1)
offspring of other##2##3##(2008-8#1)(2013-8#1)
offspring of patients with##2##4##(2006-9#1)(2007-5#1)
offspring of rats that consumed##2##5##(2009-5#2)
offspring of the##7##3##(1996-10#3)(2008-10#2)(2008-7#1)(2008-8#1)
offspring of##62##2##(1990-12#2)(1990-9#1)(1991-9#1)(1993-7#1)(1995-8#1)(1996-10#3)(1996-4#2)(1997-2#1)(1997-4#3)(2005-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-9#8)(2007-11#1)(2007-2#4)(2007-5#3)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#3)(2009-5#3)(2009-8#2)(2010-4#1)(2012-1#2)(2012-2#2)(2012-3#3)(2013-8#2)
offspring or##2##2##(2008-9#2)
offspring produced##2##2##(2008-5#1)(2013-8#1)
offspring retention##3##2##(2008-8#3)
offspring survival##7##2##(2008-8#6)(2008-9#1)
offspring survivorship and growth in the lined seahorse##2##8##(2012-12#2)
offspring survivorship and growth over births by the same male seahorses##2##11##(2012-12#2)
offspring survivorship and growth##6##4##(2012-12#6)
offspring to##3##2##(2008-4#1)(2008-8#2)
offspring was##4##2##(1990-9#1)(1995-12#1)(2012-12#2)
offspring were produced##2##3##(2008-10#1)(2008-9#1)
offspring were##8##2##(1991-1#1)(1997-4#1)(2008-10#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#1)
offspring with##7##2##(1993-9#2)(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#1)(2013-8#1)
offspring##299##1##(1990-12#2)(1990-9#9)(1991-1#2)(1991-5#2)(1991-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-7#1)(1993-9#2)(1995-1#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-10#7)(1996-12#1)(1996-3#1)(1996-4#5)(1996-5#1)(1996-6#2)(1997-2#1)(1997-4#4)(1997-5#1)(1997-7#3)(2004-2#1)(2005-10#1)(2005-7#2)(2006-10#3)(2006-12#1)(2006-5#3)(2006-9#10)(2007-11#1)(2007-12#4)(2007-2#5)(2007-3#1)(2007-5#3)(2007-6#1)(2008-1#3)(2008-10#16)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#7)(2008-7#5)(2008-8#50)(2008-9#33)(2009-12#2)(2009-2#1)(2009-3#2)(2009-5#7)(2009-8#3)(2009-9#5)(2010-10#1)(2010-12#1)(2010-2#5)(2010-4#4)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#3)(2012-12#14)(2012-2#3)(2012-3#9)(2013-1#10)(2013-8#10)
offspring)##6##1##(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)
offsprings of##6##2##(2008-4#2)(2013-8#4)
offsprings##12##1##(2008-1#1)(2008-4#4)(2013-8#7)
ofglaA##3##1##(2008-8#3)
ofglutamine##2##1##(2008-11#2)
ofglycosylation##2##1##(2008-11#2)
ofin vitro##2##2##(2008-11#1)(2008-8#1)
ofinterest in##2##2##(2008-11#1)(2013-8#1)
ofinterest##3##1##(2008-11#1)(2013-8#2)
ofjoint##2##1##(2008-11#1)(2013-1#1)
ofloxacin (OFLO) and##2##3##(2008-10#2)
ofloxacin (OFLX)##2##2##(1995-6#1)(2008-10#1)
ofloxacin and##2##2##(2008-7#1)(2012-3#1)
ofloxacin in##5##2##(2008-10#5)
ofloxacin is##2##2##(1990-2#1)(2008-10#1)
ofloxacin was##4##2##(1996-2#1)(2008-5#2)(2009-5#1)
ofloxacin##67##1##(1990-2#2)(1991-12#6)(1991-7#6)(1994-3#1)(1995-6#2)(1996-2#1)(2006-11#1)(2006-12#1)(2007-7#2)(2008-10#26)(2008-11#2)(2008-5#5)(2008-7#2)(2009-4#1)(2009-5#2)(2010-10#1)(2010-5#1)(2011-2#2)(2012-3#3)
ofloxacin)##2##1##(2008-5#1)(2008-7#1)
ofobject##2##1##(2008-2#2)
ofoperation##2##1##(2008-11#1)(2008-2#1)
ofsuch##2##1##(2008-11#1)(2013-8#1)
ofsufficient##2##1##(2008-11#1)(2013-8#1)
ofsunny and cloudy days##2##4##(2013-8#2)
oft##2##1##(2007-7#1)(2008-11#1)
often a &quot##2##3##(2007-1#1)(2012-2#1)
often a##45##2##(1990-10#1)(1990-8#1)(1991-3#1)(1993-1#1)(1993-11#1)(1995-1#2)(1995-8#1)(1996-12#1)(1996-9#1)(2004-3#1)(2004-4#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
often accompanied by damage to##2##5##(2007-7#1)(2007-8#1)
often accompanied by##15##3##(1990-8#1)(1994-11#1)(2006-10#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-4#2)(2009-5#1)(2010-12#1)(2010-6#1)
often accompanied##16##2##(1990-8#1)(1994-11#1)(2006-10#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#2)(2009-5#1)(2010-12#1)(2010-6#1)
often accompany##6##2##(1991-8#1)(1994-5#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
often achieve##3##2##(2006-5#1)(2008-11#1)(2008-9#1)
often achieved by##2##3##(2007-4#1)(2008-10#1)
often achieved##3##2##(1993-2#1)(2007-4#1)(2008-10#1)
often administered to##2##3##(2007-8#1)(2013-8#1)
often administered##3##2##(2007-8#1)(2013-8#2)
often advocated##2##2##(1997-1#1)(2008-11#1)
often affected by##3##3##(1995-2#1)(2008-1#1)(2008-5#1)
often affected##8##2##(1990-6#1)(1995-2#1)(2006-11#1)(2007-2#1)(2008-1#1)(2008-5#1)(2010-11#1)(2011-2#1)
often affects the##2##3##(2010-12#1)(2011-2#1)
often after##2##2##(1993-1#1)(1993-5#1)
often also##3##2##(1990-10#1)(2008-4#1)(2013-1#1)
often ambiguous##4##2##(2007-4#1)(2008-7#1)(2013-1#2)
often an##4##2##(2006-6#1)(2008-9#1)(2009-10#1)(2009-11#1)
often and##8##2##(1995-9#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-7#1)(2008-9#1)(2013-1#1)
often appear##3##2##(2006-10#1)(2008-9#1)(2010-10#1)
often appears##2##2##(2006-12#1)(2013-8#1)
often applied to##2##3##(2008-5#1)(2009-11#1)
often applied##6##2##(2007-7#1)(2008-11#1)(2008-5#1)(2009-11#1)(2009-8#1)(2012-1#1)
often approximated##3##2##(2006-10#1)(2008-10#1)(2008-2#1)
often are not##2##3##(1992-2#1)(2009-4#1)
often are##21##2##(1990-6#1)(1991-11#1)(1992-2#1)(1993-12#1)(1993-2#1)(1994-2#1)(1996-12#1)(1997-3#1)(2004-9#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-7#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
often arise##5##2##(2005-10#1)(2006-10#1)(2008-5#1)(2008-7#1)(2013-7#1)
often as a##4##3##(1990-5#1)(2007-11#1)(2009-12#1)(2010-4#1)
often as an##2##3##(1994-11#1)(2010-11#1)
often as##16##2##(1990-5#1)(1992-10#1)(1993-7#1)(1994-11#1)(1994-3#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-11#1)(2008-2#1)(2008-4#1)(2009-12#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-3#1)
often ask##2##2##(1997-1#1)(2013-1#1)
often asked##4##2##(1995-4#1)(2008-10#1)(2008-2#1)(2012-12#1)
often associated with a poor##2##5##(2004-10#1)(2013-1#1)
often associated with a##9##4##(1997-5#1)(2004-10#1)(2004-12#1)(2007-10#1)(2007-12#1)(2008-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
often associated with multiple##3##4##(1991-12#1)(2013-1#2)
often associated with skin##2##4##(2010-7#1)(2010-9#1)
often associated with the##6##4##(1992-4#1)(2005-8#1)(2008-6#1)(2012-1#1)(2012-12#1)(2012-3#1)
often associated with##88##3##(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-4#1)(1992-7#1)(1993-11#1)(1993-12#1)(1995-12#1)(1995-5#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-5#1)(2004-1#1)(2004-10#1)(2004-12#2)(2004-3#1)(2005-3#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#3)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#2)(2010-9#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#10)(2013-7#2)
often associated##91##2##(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-4#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-9#1)(1995-12#1)(1995-5#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-5#1)(2004-1#1)(2004-10#1)(2004-12#2)(2004-3#1)(2005-3#1)(2005-8#3)(2006-10#1)(2006-11#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#3)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#2)(2010-9#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#10)(2013-7#2)
often associates with##2##3##(2007-10#1)(2008-8#1)
often assumed to be##6##4##(1997-7#1)(2005-10#1)(2005-11#1)(2008-9#1)(2013-1#1)(2013-7#1)
often assumed to##7##3##(1997-7#1)(2005-10#1)(2005-11#1)(2008-9#1)(2012-12#1)(2013-1#1)(2013-7#1)
often assumed##12##2##(1990-12#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-7#1)(2008-11#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
often asymptomatic##10##2##(1993-10#1)(1994-11#1)(2007-2#1)(2007-7#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
often at high##2##3##(2008-10#1)(2011-2#1)
often at the##5##3##(1990-11#1)(2007-1#1)(2007-4#1)(2012-2#1)(2012-3#1)
often at##13##2##(1990-11#1)(1990-12#1)(2006-10#1)(2007-1#1)(2007-3#1)(2007-4#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-2#2)(2012-3#1)
often attempt##2##2##(2008-10#1)(2008-5#1)
often avoiding##2##2##(2005-11#1)(2012-2#1)
often based on##13##3##(1990-6#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-4#1)(2010-5#1)(2011-2#3)(2012-2#1)
often be successfully##2##3##(2008-3#1)(2010-11#1)
often be##45##2##(1991-6#1)(1991-8#1)(1993-2#1)(1993-3#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-3#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#3)(2008-7#2)(2008-9#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#3)(2013-8#3)
often became##2##2##(1992-11#1)(1995-12#1)
often becomes##3##2##(1996-2#1)(2008-1#1)(2010-4#1)
often been called##2##3##(2006-3#1)(2008-9#1)
often been considered##2##3##(2008-3#1)(2012-2#1)
often been reported##3##3##(1994-6#1)(2008-7#1)(2012-2#1)
often been used##3##3##(1992-2#1)(2007-1#1)(2009-11#1)
often been##38##2##(1990-10#1)(1990-2#1)(1992-1#1)(1992-2#1)(1992-8#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-4#1)(2004-4#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-3#1)(2007-1#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
often being##3##2##(1992-8#1)(2008-10#1)(2009-8#1)
often benign##2##2##(1996-12#1)(2013-1#1)
often better##2##2##(1993-2#1)(2005-11#1)
often breaks##2##2##(2008-6#1)(2010-3#1)
often called &quot##2##3##(2008-1#1)(2011-7#1)
often called##5##2##(2007-8#1)(2008-1#2)(2011-7#1)(2012-12#1)
often can be##7##3##(1992-12#1)(1992-2#1)(1992-3#1)(2006-5#1)(2008-12#1)(2008-3#1)(2012-1#1)
often can##8##2##(1992-12#1)(1992-2#1)(1992-3#1)(1994-9#1)(2006-5#1)(2008-12#1)(2008-3#1)(2012-1#1)
often cannot be##4##3##(1992-3#1)(2006-10#2)(2011-2#1)
often carried out##3##3##(1992-11#1)(2008-12#1)(2010-11#1)
often carry##2##2##(1996-6#1)(2010-2#1)
often cause##7##2##(2006-10#1)(2007-11#2)(2007-9#1)(2009-4#1)(2010-5#1)(2011-2#1)
often caused by##8##3##(1990-9#1)(1996-11#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-6#1)(2012-3#1)
often caused##10##2##(1990-9#1)(1994-11#1)(1996-11#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-6#1)(2011-1#1)(2012-3#1)
often causes##5##2##(1991-3#1)(1993-9#1)(2008-10#1)(2010-5#1)(2012-12#1)
often causing##2##2##(2008-10#1)(2010-12#1)
often characterized by##5##3##(2006-2#1)(2008-10#1)(2008-4#1)(2011-2#1)(2013-8#1)
often characterized##6##2##(2006-2#1)(2007-4#1)(2008-10#1)(2008-4#1)(2011-2#1)(2013-8#1)
often cited##3##2##(1992-8#1)(2006-10#1)(2008-5#1)
often clustered##2##2##(2008-10#1)(2009-5#1)
often combined with##2##3##(2006-3#1)(2013-1#1)
often combined##3##2##(2006-3#1)(2010-11#1)(2013-1#1)
often come from##2##3##(2011-1#1)(2011-2#1)
often come##3##2##(2005-8#1)(2011-1#1)(2011-2#1)
often comorbid##2##2##(1996-7#1)(2007-4#1)
often complex##4##2##(2005-11#1)(2013-1#3)
often complicated by##9##3##(1994-11#1)(1997-2#1)(2007-7#2)(2009-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-7#1)
often composed of##2##3##(2008-11#1)(2008-2#1)
often confined to##2##3##(1991-4#1)(1992-7#1)
often conflicting##5##2##(1990-8#1)(1996-1#1)(2005-10#1)(2007-11#1)(2013-8#1)
often confronted##2##2##(1992-2#1)(2012-2#1)
often confused with##2##3##(2006-10#1)(2012-12#1)
often confused##3##2##(2006-10#1)(2011-2#1)(2012-12#1)
often confusing##3##2##(2008-12#1)(2008-8#1)(2013-1#1)
often consider##2##2##(2012-12#1)(2012-2#1)
often considered a##2##3##(2006-10#1)(2007-2#1)
often considered an##2##3##(2008-12#1)(2010-12#1)
often considered as##2##3##(2008-10#1)(2010-2#1)
often considered to be##2##4##(1996-2#1)(2009-7#1)
often considered to##4##3##(1996-2#1)(2007-9#1)(2008-4#1)(2009-7#1)
often considered##15##2##(1996-12#1)(1996-2#1)(2006-10#2)(2007-2#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-12#2)(2010-2#1)(2011-2#1)
often contain##3##2##(1991-9#1)(2008-12#1)(2012-3#1)
often contains##3##2##(2008-4#1)(2008-5#1)(2010-5#1)
often contaminated with##2##3##(1991-12#1)(2012-2#1)
often continue to##2##3##(2006-9#1)(2008-2#1)
often contradictory##5##2##(2006-5#1)(2007-1#1)(2007-11#1)(2010-12#1)(2013-8#1)
often controversial##3##2##(2005-8#1)(2006-4#1)(2012-2#1)
often correlate##2##2##(2006-12#1)(2011-2#1)
often correlated with##3##3##(1996-2#1)(2008-11#1)(2011-1#1)
often coupled to##2##3##(1993-11#1)(2007-8#1)
often crucial for##2##3##(2007-11#1)(2007-7#1)
often debilitating##3##2##(2007-11#1)(2008-8#1)(2008-9#1)
often delayed##9##2##(1997-8#1)(2006-10#1)(2007-7#1)(2008-4#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
often demonstrate##2##2##(1990-11#1)(2013-1#1)
often depend on the##2##4##(2006-4#1)(2008-4#1)
often depends on##4##3##(2005-7#1)(2008-7#1)(2013-1#2)
often derived##2##2##(2008-10#1)(2008-6#1)
often described as##5##3##(1994-11#1)(2006-7#1)(2008-11#1)(2008-7#1)(2012-12#1)
often described##8##2##(1994-11#1)(2005-11#1)(2006-7#1)(2008-11#1)(2008-7#1)(2009-10#1)(2012-12#1)(2012-2#1)
often desired##2##2##(1997-6#1)(2010-2#1)
often detect##2##2##(2007-4#1)(2010-6#1)
often detected in##2##3##(2010-12#1)(2010-8#1)
often detected##5##2##(1995-6#1)(2007-6#1)(2010-12#2)(2010-8#1)
often determine##2##2##(1994-12#1)(1997-3#1)
often determines the##2##3##(1994-8#1)(2008-2#1)
often determines##4##2##(1994-8#1)(2007-4#1)(2008-2#1)(2010-4#1)
often devastating##2##2##(1997-8#1)(2012-12#1)
often develop##4##2##(1990-2#1)(2008-1#2)(2008-10#1)
often develops##2##2##(1996-8#1)(2008-10#1)
often diagnosed as##2##3##(1992-8#1)(2007-8#1)
often diagnosed in the##2##4##(1991-9#1)(2006-10#1)
often diagnosed in##4##3##(1991-9#1)(2006-10#1)(2011-2#1)(2013-1#1)
often diagnosed##12##2##(1991-9#1)(1992-8#1)(1993-3#1)(1997-8#1)(2006-10#2)(2006-2#1)(2006-9#1)(2007-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
often did not##3##3##(1997-2#1)(2008-7#1)(2012-3#1)
often differ in##2##3##(1995-5#1)(2008-9#1)
often differ##4##2##(1995-5#1)(2007-4#1)(2008-10#1)(2008-9#1)
often different##3##2##(1992-1#1)(1994-12#1)(2009-11#1)
often difficult because##3##3##(2007-9#1)(2008-10#1)(2008-7#1)
often difficult to diagnose##3##4##(1990-8#1)(2007-8#1)(2010-5#1)
often difficult to##17##3##(1990-8#1)(2005-11#1)(2006-12#1)(2006-7#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2010-5#2)(2011-1#1)(2013-7#1)
often difficult##32##2##(1990-8#1)(1993-2#1)(1997-3#1)(1997-7#1)(2004-10#1)(2005-11#2)(2006-12#1)(2006-7#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#2)(2010-4#1)(2010-5#2)(2011-1#1)(2011-12#1)(2012-3#1)(2013-7#2)
often discussed##2##2##(1993-12#1)(1997-3#1)
often disfiguring##2##2##(1991-11#1)(2012-12#1)
often display##2##2##(1995-11#1)(2008-8#1)
often divided into two##2##4##(2008-4#1)(2008-7#1)
often divided into##4##3##(1997-8#1)(2008-11#1)(2008-4#1)(2008-7#1)
often do not##12##3##(1991-12#1)(1991-2#1)(1994-9#1)(2006-2#1)(2007-1#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
often do##13##2##(1991-12#1)(1991-2#1)(1994-9#1)(2006-2#1)(2007-1#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-3#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
often does not##5##3##(1991-2#1)(2006-10#1)(2006-2#1)(2008-8#1)(2010-12#1)
often does##6##2##(1991-2#1)(1992-11#1)(2006-10#1)(2006-2#1)(2008-8#1)(2010-12#1)
often dominated by##2##3##(1993-6#1)(2008-8#1)
often drives##2##2##(2008-5#1)(2012-1#1)
often due to the##2##4##(2009-10#1)(2012-2#1)
often due to##10##3##(2005-11#1)(2006-12#1)(2007-7#1)(2007-8#1)(2009-10#1)(2009-3#1)(2011-2#1)(2012-2#2)(2013-1#1)
often effective##5##2##(1991-12#1)(2006-12#1)(2006-3#1)(2006-8#1)(2011-12#1)
often employed for##3##3##(2007-8#1)(2008-3#1)(2010-6#1)
often employed in##2##3##(2005-11#1)(2012-2#1)
often employed##8##2##(1996-5#1)(2005-11#1)(2007-8#1)(2008-3#2)(2008-8#1)(2010-6#1)(2012-2#1)
often encounter patients##2##3##(2009-7#1)(2013-1#1)
often encounter##4##2##(2008-5#1)(2009-7#1)(2011-1#1)(2013-1#1)
often encountered in##9##3##(1993-8#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-3#2)(2009-5#1)(2010-12#1)(2010-2#1)
often encountered when##2##3##(2008-10#1)(2008-4#1)
often encountered##13##2##(1991-4#1)(1993-3#1)(1993-8#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-4#1)(2009-5#1)(2010-12#1)(2010-2#1)
often encouraged##2##2##(1997-3#1)(2013-1#1)
often enhances##2##2##(2006-12#1)(2008-7#1)
often essential##2##2##(2006-2#1)(2008-2#1)
often evaluate##2##2##(1994-12#1)(2008-9#1)
often evaluated##3##2##(2006-3#1)(2006-8#1)(2013-1#1)
often exceeded##2##2##(2008-10#1)(2012-3#1)
often excessively##2##2##(2012-12#1)(2013-8#1)
often exhibit##12##2##(1993-1#1)(1997-8#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-7#1)(2008-8#2)(2011-2#1)(2013-8#1)
often experience a lack of involvement##2##6##(2011-2#2)
often experience##6##2##(1993-12#1)(2007-2#1)(2008-7#1)(2010-8#1)(2011-2#2)
often experienced##2##2##(2009-7#1)(2012-2#1)
often extremely##3##2##(2008-11#1)(2008-4#1)(2010-12#1)
often face##3##2##(1996-8#1)(2007-6#1)(2011-2#1)
often faced with##4##3##(1992-1#1)(2006-10#1)(2007-2#2)
often fail to##5##3##(1990-8#1)(1991-12#1)(2006-3#1)(2013-1#2)
often fail##7##2##(1990-8#1)(1991-12#1)(2006-3#1)(2010-10#1)(2011-2#1)(2013-1#2)
often failed to achieve##2##4##(2007-12#1)(2011-2#1)
often fails to meet the##2##5##(1997-1#1)(2011-2#1)
often fails to##5##3##(1991-6#1)(1991-9#1)(1997-1#1)(2008-4#1)(2011-2#1)
often fails##8##2##(1991-6#1)(1991-9#1)(1997-1#1)(2007-8#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-3#1)
often falls##2##2##(2007-11#1)(2009-3#1)
often fatal##11##2##(1991-2#1)(2005-12#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2010-2#1)(2012-1#2)
often feel##5##2##(1992-2#1)(1997-5#1)(2007-11#1)(2008-1#1)(2008-2#1)
often find themselves##2##3##(1992-12#1)(1993-12#1)
often find##5##2##(1992-12#1)(1993-12#1)(2005-7#1)(2009-6#1)(2013-8#1)
often focuses on##3##3##(1990-11#1)(2013-1#2)
often followed by##2##3##(2006-12#1)(2006-5#1)
often for##5##2##(1995-12#1)(2005-7#2)(2006-10#1)(2006-6#1)
often forgotten##3##2##(2010-2#1)(2013-1#1)(2013-8#1)
often form##3##2##(1996-2#1)(2008-11#1)(2012-12#1)
often formed multicellular complexes##2##4##(2008-5#2)
often formed##4##2##(2005-11#2)(2008-5#2)
often forms##2##2##(2005-11#1)(2005-12#1)
often found among##2##3##(2008-7#1)(2009-1#1)
often found as##2##3##(2006-3#1)(2008-8#1)
often found in the##2##4##(2006-11#1)(2008-8#1)
often found in##10##3##(1993-12#1)(1993-3#1)(1994-9#1)(2005-6#1)(2006-11#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-1#1)
often found on the##3##4##(1993-1#1)(2008-10#1)(2012-2#1)
often found on##4##3##(1993-1#1)(2008-10#2)(2012-2#1)
often found to be##3##4##(1990-10#1)(1993-12#1)(2012-1#1)
often found to##4##3##(1990-10#1)(1993-12#1)(2007-2#1)(2012-1#1)
often found with##2##3##(1990-12#1)(2005-12#1)
often found##33##2##(1990-10#1)(1990-12#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-9#1)(2005-12#1)(2005-6#1)(2006-11#1)(2006-3#1)(2007-2#1)(2007-9#1)(2008-10#8)(2008-5#3)(2008-7#2)(2008-8#2)(2009-1#1)(2010-4#1)(2012-1#2)(2012-2#1)
often from##2##2##(1990-7#1)(2012-1#1)
often generate##2##2##(2007-4#1)(2008-5#1)
often generated##2##2##(2008-10#2)
often give##3##2##(1996-5#1)(2007-9#1)(2008-4#1)
often given##6##2##(1990-4#1)(1992-8#1)(1997-2#1)(2006-10#1)(2006-9#1)(2013-1#1)
often go##4##2##(1990-5#1)(2007-6#1)(2008-6#1)(2012-3#1)
often greatly##2##2##(2006-10#1)(2012-3#1)
often had##8##2##(1991-11#1)(1994-12#1)(1996-12#1)(2007-9#1)(2008-10#1)(2008-8#1)(2010-12#1)(2011-2#1)
often hampered by the##3##4##(1990-12#1)(2008-2#1)(2011-3#1)
often hampered by##6##3##(1990-12#1)(1992-9#1)(2005-9#1)(2008-10#1)(2008-2#1)(2011-3#1)
often happens##4##2##(2008-1#1)(2009-2#1)(2012-2#1)(2013-1#1)
often hard to##3##3##(1991-4#1)(1993-7#1)(2009-4#1)
often has been##3##3##(2008-10#3)
often has##10##2##(1995-4#1)(2006-9#1)(2007-8#1)(2008-10#3)(2010-12#1)(2010-6#1)(2012-12#2)
often have a##6##3##(2008-4#1)(2010-1#1)(2010-4#1)(2010-6#1)(2012-12#1)(2013-1#1)
often have greater##2##3##(2008-8#1)(2010-8#1)
often have high##2##3##(2008-4#1)(2010-9#1)
often have limited##2##3##(1992-8#1)(2008-7#1)
often have##42##2##(1990-12#1)(1991-12#2)(1991-8#1)(1992-8#1)(1994-5#1)(1996-12#1)(1996-7#1)(2004-3#1)(2005-10#2)(2006-11#1)(2006-6#2)(2007-11#1)(2007-8#1)(2008-10#2)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-4#1)(2010-1#1)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
often hidden##2##2##(2007-4#1)(2008-10#1)
often higher in##2##3##(2008-10#1)(2008-5#1)
often higher##3##2##(2008-10#1)(2008-5#1)(2010-4#1)
often highly##4##2##(1991-3#1)(1995-6#1)(2006-12#1)(2008-2#1)
often identified##3##2##(2005-8#1)(2008-12#1)(2013-1#1)
often idiopathic##2##2##(1990-9#1)(2006-10#1)
often ignored##7##2##(1992-3#1)(1993-12#1)(1996-8#1)(2007-9#1)(2008-4#1)(2013-1#2)
often important##2##2##(1992-12#1)(2005-3#1)
often impossible##3##2##(1990-4#1)(2007-7#1)(2009-6#1)
often impractical##2##2##(2008-3#1)(2010-10#1)
often in a##3##3##(1994-8#1)(2006-10#1)(2006-2#1)
often in children##3##3##(1992-4#1)(2007-11#1)(2013-1#1)
often in combination##2##3##(2012-3#1)(2013-1#1)
often in patients who##2##4##(2006-9#1)(2012-3#1)
often in patients##6##3##(2006-10#2)(2006-9#1)(2007-10#2)(2012-3#1)
often in the elderly##2##4##(1991-6#1)(1994-6#1)
often in the form of##2##5##(2011-1#1)(2013-7#1)
often in the##13##3##(1991-6#1)(1994-6#1)(1996-11#1)(2007-8#1)(2008-4#1)(2009-12#1)(2009-8#2)(2011-1#2)(2013-1#2)(2013-7#1)
often in women##2##3##(1992-3#1)(2011-1#1)
often in young##2##3##(2011-2#1)(2013-7#1)
often in##68##2##(1990-5#1)(1990-6#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-7#1)(2005-8#1)(2006-10#5)(2006-2#1)(2006-4#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#2)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#8)(2013-7#2)(2013-8#1)
often inadequate to##2##3##(2011-2#1)(2013-7#1)
often inadequate##6##2##(2006-12#1)(2007-3#1)(2008-6#1)(2010-10#1)(2011-2#1)(2013-7#1)
often inadequately##3##2##(2006-10#1)(2006-7#1)(2008-7#1)
often include##10##2##(2004-11#1)(2006-10#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-2#2)(2010-12#1)(2011-2#1)(2012-3#1)
often includes##3##2##(2008-5#1)(2008-7#1)(2012-2#1)
often incomplete##2##2##(1990-7#1)(1992-11#1)
often incongruent with##2##3##(2010-7#1)(2012-2#1)
often inconsistent##2##2##(2007-4#1)(2008-11#1)
often increase##2##2##(2006-7#1)(2008-8#1)
often increased##2##2##(1993-12#1)(1995-10#1)
often indicated##4##2##(1991-6#1)(2007-11#1)(2007-7#1)(2011-2#1)
often induced##2##2##(2006-6#1)(2009-12#1)
often ineffective##3##2##(1992-9#1)(1996-11#1)(2008-4#1)
often infiltrated##2##2##(1994-12#1)(2012-1#1)
often informal##2##2##(2006-1#1)(2009-5#1)
often initiated##2##2##(2007-11#1)(2008-6#1)
often insufficient##6##2##(1993-3#1)(2007-11#1)(2007-2#1)(2012-11#1)(2012-3#1)(2013-7#1)
often involve a##2##3##(1992-9#1)(2012-1#1)
often involve##12##2##(1992-9#1)(1993-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2012-1#1)(2012-12#1)(2013-1#2)
often involved in the##2##4##(2006-2#1)(2010-12#1)
often involved in##9##3##(1997-8#1)(2006-2#1)(2007-10#2)(2007-2#1)(2008-1#2)(2010-12#1)(2010-5#1)
often involved##13##2##(1997-8#1)(2006-10#1)(2006-2#1)(2007-10#2)(2007-2#1)(2007-9#1)(2008-1#2)(2008-7#1)(2010-1#1)(2010-12#1)(2010-5#1)
often involves the##5##3##(1994-6#1)(2005-11#1)(2006-12#1)(2008-4#1)(2008-5#1)
often involves##15##2##(1994-6#1)(1995-12#1)(1997-1#1)(1997-7#1)(2005-11#1)(2006-12#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-9#1)(2010-6#1)(2012-2#1)(2013-1#1)
often is accompanied by##2##4##(2008-9#1)(2009-3#1)
often is not##2##3##(1994-4#1)(2006-11#1)
often is##27##2##(1990-9#1)(1991-9#1)(1994-4#1)(2004-4#1)(2006-10#2)(2006-11#2)(2006-5#1)(2006-6#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#2)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
often isolated##4##2##(1996-12#1)(2006-10#1)(2008-10#1)(2008-5#1)
often lack##4##2##(1996-3#1)(2010-3#1)(2011-2#1)(2013-8#1)
often lacking##2##2##(1992-4#1)(2009-4#1)
often lacks##2##2##(2006-10#1)(2010-1#1)
often large##4##2##(1993-9#1)(1996-3#1)(2006-5#1)(2007-4#1)
often larger than##2##3##(2008-2#1)(2008-9#1)
often lead to the##3##4##(2005-10#1)(2008-1#1)(2009-4#1)
often lead to##12##3##(1997-4#1)(2005-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-5#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-6#1)(2012-11#1)(2012-2#1)
often lead##14##2##(1993-10#1)(1997-4#1)(2005-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-5#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-6#1)(2012-11#1)(2012-2#1)
often leading to##4##3##(2006-10#1)(2008-1#1)(2012-12#1)(2013-1#1)
often leads to poor##2##4##(2008-9#1)(2013-7#1)
often leads to the##2##4##(1994-2#1)(2009-2#1)
often leads to##20##3##(1994-2#1)(1995-9#1)(1996-11#1)(2006-11#1)(2006-6#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-4#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-12#1)(2012-3#2)(2013-7#2)
often leads##21##2##(1994-2#1)(1995-9#1)(1996-11#1)(2006-11#1)(2006-6#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-4#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-12#1)(2012-2#1)(2012-3#2)(2013-7#2)
often leave##3##2##(2006-1#1)(2006-10#1)(2007-2#1)
often led to##2##3##(2008-10#1)(2012-12#1)
often less##2##2##(1995-6#1)(2008-9#1)
often lethal##4##2##(1995-2#1)(2007-2#1)(2008-5#1)(2008-9#1)
often life-threatening##2##2##(1990-10#1)(2008-7#1)
often limited because##2##3##(2008-1#1)(2012-12#1)
often limited by the##4##4##(2006-2#1)(2008-10#1)(2009-11#1)(2011-1#1)
often limited by##8##3##(1995-5#1)(2006-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-11#1)(2011-1#1)(2011-2#1)
often limited to##4##3##(1996-12#1)(2008-9#1)(2013-1#2)
often limited##22##2##(1994-12#1)(1995-5#1)(1996-12#1)(2006-2#1)(2008-1#2)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-12#1)(2013-1#4)
often linked to##5##3##(1996-6#1)(1997-2#1)(2006-10#1)(2010-12#1)(2012-2#1)
often linked##7##2##(1996-6#1)(1997-2#1)(2006-10#1)(2008-1#1)(2009-7#1)(2010-12#1)(2012-2#1)
often low##6##2##(1990-9#1)(2006-4#1)(2010-12#1)(2011-2#1)(2012-3#2)
often made by##4##3##(1993-12#1)(2005-11#1)(2006-10#1)(2013-8#1)
often made##13##2##(1991-4#1)(1993-12#1)(1997-2#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#2)(2009-6#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
often maintain a##3##3##(1997-1#1)(2013-1#2)
often make##4##2##(1997-7#1)(2005-4#1)(2007-1#1)(2010-4#1)
often makes it##2##3##(2008-11#1)(2008-12#1)
often makes##4##2##(1991-2#1)(2007-5#1)(2008-11#1)(2008-12#1)
often male##2##2##(2010-7#1)(2012-2#1)
often manifest##3##2##(2005-9#1)(2008-4#1)(2009-6#1)
often mediate##2##2##(2007-11#1)(2013-1#1)
often misdiagnosed and##2##3##(1996-7#1)(2007-6#1)
often misdiagnosed##7##2##(1996-7#1)(2007-11#1)(2007-6#1)(2008-1#1)(2009-9#1)(2010-10#1)(2013-7#1)
often misleading##2##2##(2006-10#1)(2013-1#1)
often missed by##2##3##(1996-2#1)(2011-2#1)
often missed##5##2##(1996-2#1)(2006-7#1)(2008-7#1)(2010-4#1)(2011-2#1)
often missing##2##2##(1992-8#1)(1996-2#1)
often mistakenly##2##2##(2006-8#1)(2011-1#1)
often more##10##2##(1990-5#1)(1993-10#1)(1994-8#1)(1995-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2012-11#1)(2012-12#1)
often most##2##2##(2007-1#1)(2011-2#1)
often much##2##2##(2008-9#1)(2010-3#1)
often must##4##2##(2005-11#1)(2008-11#1)(2011-2#1)(2012-1#1)
often need to##4##3##(1992-1#1)(2005-6#1)(2008-4#1)(2012-2#1)
often need##5##2##(1992-1#1)(2005-6#1)(2008-4#1)(2011-2#1)(2012-2#1)
often needed##6##2##(1996-9#1)(2006-4#1)(2008-4#2)(2008-8#1)(2013-1#1)
often needs##2##2##(2009-12#1)(2010-8#1)
often neglected##10##2##(1993-3#1)(1993-9#1)(1995-2#1)(2005-4#1)(2006-10#1)(2006-2#1)(2007-7#1)(2008-12#1)(2012-3#1)(2013-1#1)
often neglecting##2##2##(2007-12#1)(2012-12#1)
often no##3##2##(2005-9#1)(2007-7#1)(2007-8#1)
often normal##3##2##(2007-9#2)(2013-1#1)
often not considered##2##3##(2008-11#1)(2011-12#1)
often not##37##2##(1990-3#1)(1991-1#1)(1992-3#1)(1992-7#1)(1993-11#1)(1994-3#1)(2006-12#1)(2006-4#2)(2007-12#2)(2007-6#1)(2007-7#1)(2007-9#2)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-9#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
often noted##3##2##(1993-9#1)(2008-10#1)(2008-6#1)
often obscured##2##2##(1993-9#1)(2012-3#1)
often observed in patients##2##4##(2007-9#1)(2008-1#1)
often observed in the##2##4##(1996-3#1)(2011-2#1)
often observed in##6##3##(1993-12#1)(1996-3#1)(2007-9#1)(2008-1#1)(2011-2#1)(2013-1#1)
often observed##16##2##(1990-2#1)(1993-12#1)(1996-3#1)(1996-6#1)(2004-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
often obtained by##2##3##(2006-10#1)(2008-7#1)
often obtained##6##2##(2006-10#1)(2007-4#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-9#1)
often occur as##3##3##(2008-8#2)(2012-1#1)
often occur in##5##3##(1994-3#1)(2005-7#1)(2008-7#1)(2011-2#1)(2012-2#1)
often occur together##2##3##(2006-1#1)(2008-10#1)
often occur##18##2##(1992-8#1)(1994-3#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
often occurred in##3##3##(1992-7#1)(1994-5#1)(2013-8#1)
often occurred##6##2##(1992-7#1)(1993-12#1)(1994-5#1)(1995-2#1)(1996-1#1)(2013-8#1)
often occurs after##2##3##(2005-7#1)(2008-11#1)
often occurs at##2##3##(2008-2#1)(2011-2#1)
often occurs in##4##3##(2007-8#1)(2008-8#1)(2010-12#1)(2012-1#1)
often occurs##15##2##(1992-10#1)(1993-10#1)(1993-3#1)(1994-5#1)(2005-10#1)(2005-7#1)(2005-8#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-12#1)(2011-2#2)(2012-1#1)
often of##7##2##(2005-7#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-7#1)(2009-5#1)(2010-2#1)
often on the##2##3##(1992-1#1)(2008-9#1)
often on##3##2##(1992-1#1)(2008-8#1)(2008-9#1)
often only##5##2##(1990-5#1)(1997-3#1)(2008-2#1)(2008-9#1)(2013-7#1)
often overlap##4##2##(2007-6#1)(2008-1#1)(2008-8#1)(2012-3#1)
often overlooked##19##2##(1993-12#1)(1996-7#1)(2005-11#1)(2007-4#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-2#1)(2010-4#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-7#1)(2013-8#1)
often override##2##2##(2007-5#1)(2008-8#1)
often painful##2##2##(1994-5#1)(2007-11#1)
often perceived as##3##3##(2006-2#1)(2012-1#1)(2012-3#1)
often perceived##4##2##(2006-2#1)(2010-5#1)(2012-1#1)(2012-3#1)
often performed in##3##3##(2006-8#1)(2006-9#1)(2008-5#1)
often performed##10##2##(1990-12#1)(1991-4#1)(2006-8#2)(2006-9#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-12#1)(2012-3#1)
often placed##2##2##(2011-2#2)
often poor##4##2##(2007-11#1)(2008-11#1)(2008-8#1)(2010-1#1)
often poorly##3##2##(1995-2#1)(2008-4#1)(2008-7#1)
often precedes##3##2##(1997-8#1)(2007-5#1)(2011-2#1)
often preferred##4##2##(2007-11#1)(2008-4#1)(2011-2#1)(2013-1#1)
often prescribed##7##2##(2006-10#1)(2006-9#1)(2007-11#1)(2008-11#1)(2009-5#1)(2013-8#2)
often present at##2##3##(1997-2#1)(2008-10#1)
often present in the##2##4##(2007-12#1)(2008-1#1)
often present in##8##3##(2006-2#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)
often present with a##3##4##(2005-2#1)(2008-10#1)(2010-9#1)
often present with##6##3##(2005-2#1)(2008-10#1)(2008-11#1)(2010-9#1)(2011-1#1)(2013-7#1)
often present##32##2##(1991-8#1)(1992-3#1)(1997-2#1)(2005-2#1)(2006-12#1)(2006-2#2)(2007-10#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-10#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-7#2)
often presented##4##2##(2006-7#1)(2007-11#1)(2008-2#1)(2010-11#1)
often presents as a##3##4##(2007-6#1)(2011-2#1)(2012-3#1)
often presents as##4##3##(2007-6#1)(2008-12#1)(2011-2#1)(2012-3#1)
often presents with##2##3##(2004-12#1)(2007-7#1)
often presents##16##2##(1992-6#1)(2004-12#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2009-10#2)(2011-2#2)(2012-3#1)
often produce##3##2##(2006-5#1)(2007-12#1)(2008-3#1)
often produced##2##2##(2008-12#1)(2008-9#1)
often provide##4##2##(1992-4#1)(1993-2#1)(1996-1#1)(2006-12#1)
often provides##3##2##(2006-8#1)(2008-10#1)(2009-8#1)
often quite##3##2##(2007-11#1)(2008-5#1)(2008-8#1)
often raise##2##2##(2007-4#1)(2008-11#1)
often raises##2##2##(2008-3#1)(2011-2#1)
often rapidly fatal##2##3##(2010-12#1)(2012-2#1)
often rapidly##3##2##(2008-6#1)(2010-12#1)(2012-2#1)
often rather##2##2##(1990-10#1)(2006-12#1)
often reached##3##2##(1990-12#1)(2006-8#1)(2008-3#1)
often recalcitrant##2##2##(2004-4#1)(2006-10#1)
often receive##4##2##(1992-4#1)(2007-2#1)(2008-5#1)(2012-1#1)
often reduced or##2##3##(1997-7#1)(2008-9#1)
often reduced##4##2##(1997-7#1)(2008-3#1)(2008-7#1)(2008-9#1)
often referred to as an##2##5##(2007-8#1)(2010-10#1)
often referred to as##10##4##(2007-8#1)(2007-9#1)(2008-3#1)(2008-5#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-11#1)(2013-7#1)
often referred to##12##3##(2006-10#1)(2006-2#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-5#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-11#1)(2013-7#1)
often referred##13##2##(2006-10#1)(2006-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-11#1)(2013-7#1)
often related to##10##3##(1991-9#1)(1993-12#1)(1993-9#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
often relatively##3##2##(2007-7#1)(2008-8#1)(2012-2#1)
often relied##2##2##(2005-10#1)(2006-4#1)
often remain##3##2##(1997-3#1)(2007-6#1)(2009-8#1)
often remains##5##2##(2008-1#1)(2008-6#1)(2010-12#1)(2012-11#1)(2013-1#1)
often report that##2##3##(1994-12#1)(2010-9#1)
often report##5##2##(1994-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-9#1)
often reported in##4##3##(1991-12#1)(1997-3#1)(2011-1#1)(2013-8#1)
often reported to be##2##4##(2008-10#1)(2009-4#1)
often reported##12##2##(1991-12#1)(1992-3#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-4#1)(2009-5#1)(2010-2#1)(2011-1#1)(2013-8#1)
often represent##2##2##(2008-8#1)(2009-10#1)
often represented in##2##3##(1997-8#1)(2011-12#1)
often represented##3##2##(1997-8#1)(2005-8#1)(2011-12#1)
often require orthopedic##2##3##(2008-7#1)(2008-8#1)
often require##20##2##(1996-12#1)(1997-4#1)(1997-5#1)(2006-11#1)(2007-7#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-3#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-8#1)
often required in##5##3##(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
often required to##3##3##(2008-11#1)(2008-7#1)(2013-1#1)
often required##18##2##(1994-3#1)(1997-3#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#3)(2009-4#1)(2010-2#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
often requires a##2##3##(2006-11#1)(2007-11#1)
often requires the##2##3##(2006-10#1)(2007-4#1)
often requires##21##2##(1994-9#1)(1997-4#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#3)(2013-1#4)(2013-8#1)
often requiring##4##2##(2005-10#1)(2008-1#1)(2008-4#1)(2013-7#1)
often resistant to##8##3##(1992-10#1)(2006-10#1)(2006-3#1)(2007-11#1)(2008-7#1)(2009-10#1)(2012-2#1)(2013-1#1)
often resolves spontaneously##2##3##(2007-8#1)(2011-1#1)
often respond to##3##3##(2007-11#1)(2009-8#1)(2012-12#1)
often respond##6##2##(2007-11#1)(2007-12#1)(2009-8#1)(2012-12#1)(2013-1#2)
often responsible for##2##3##(2008-1#1)(2011-2#1)
often result from##2##3##(2006-4#1)(2011-2#1)
often result in a##2##4##(2008-12#1)(2010-2#1)
often result in##4##3##(1993-12#1)(2008-12#1)(2010-2#1)(2012-2#1)
often result##6##2##(1993-12#1)(2006-4#1)(2008-12#1)(2010-2#1)(2011-2#1)(2012-2#1)
often resulting in##7##3##(1990-4#1)(2006-10#1)(2006-12#1)(2006-6#1)(2008-10#1)(2008-8#1)(2012-2#1)
often results from##4##3##(2007-7#1)(2008-10#1)(2008-2#1)(2008-8#1)
often results in a##4##4##(2006-10#1)(2008-6#1)(2011-2#1)(2012-2#1)
often results in##17##3##(1991-3#1)(1994-11#1)(1996-8#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-7#1)(2007-9#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-3#1)(2011-2#2)(2012-2#1)
often results##24##2##(1991-3#1)(1994-11#1)(1996-7#1)(1996-8#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#2)
often reveal##2##2##(1995-2#1)(2011-2#1)
often revealed##2##2##(1994-8#1)(2012-2#1)
often reveals##2##2##(1994-7#1)(2008-3#1)
often run##2##2##(2008-2#1)(2012-2#1)
often secondary to##2##3##(2007-7#1)(2012-3#1)
often seek##2##2##(2007-5#1)(2010-2#1)
often seen as##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
often seen in patients##2##4##(1992-5#1)(2007-11#1)
often seen in the##2##4##(2008-1#1)(2008-12#1)
often seen in these patients##2##5##(2007-1#1)(2009-5#1)
often seen in##15##3##(1992-5#1)(1995-8#1)(1997-8#1)(2005-11#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-12#1)(2008-7#1)(2009-5#1)(2010-7#1)(2012-12#1)
often seen on##3##3##(2008-1#1)(2009-9#1)(2012-12#1)
often seen with##2##3##(2007-8#1)(2008-7#1)
often seen##26##2##(1992-5#1)(1995-8#1)(1996-11#1)(1997-8#1)(2005-11#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2009-5#1)(2009-9#1)(2010-3#1)(2010-7#1)(2011-12#1)(2012-12#2)(2013-8#1)
often selected##3##2##(2005-9#1)(2008-10#1)(2008-12#1)
often should##2##2##(2003-11#1)(2009-9#1)
often show a##3##3##(2008-11#1)(2008-9#1)(2009-8#1)
often show##9##2##(1997-3#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-5#1)
often shows##2##2##(1997-3#1)(2008-12#1)
often social##2##2##(1992-8#1)(2010-3#1)
often start##2##2##(1990-2#1)(2008-11#1)
often stated##2##2##(1997-4#1)(2007-4#1)
often studied using##2##3##(2007-6#1)(2013-1#1)
often studied##3##2##(2007-6#1)(2008-9#1)(2013-1#1)
often subjected to##2##3##(2008-4#1)(2013-1#1)
often subjective##2##2##(1995-6#1)(2005-8#1)
often subtle##2##2##(2006-3#1)(2006-7#1)
often successful##2##2##(2008-6#1)(2010-7#1)
often suffer from##6##3##(1997-7#1)(2006-8#1)(2008-11#1)(2008-2#1)(2013-1#1)(2013-7#1)
often suffer##7##2##(1997-7#1)(2006-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2013-1#1)(2013-7#1)
often sufficient##2##2##(1992-5#1)(2008-2#1)
often suggested##3##2##(1997-3#1)(2008-10#1)(2011-2#1)
often suggests##2##2##(1997-3#1)(2009-9#1)
often surgically##2##2##(2007-8#1)(2008-4#1)
often suspected##2##2##(1990-4#1)(1993-5#1)
often take##3##2##(2007-5#1)(2009-12#1)(2010-4#1)
often taken##4##2##(1997-4#1)(2008-8#1)(2012-12#1)(2013-1#1)
often tend to##2##3##(1993-3#1)(2008-6#1)
often than not##3##3##(2008-1#1)(2008-10#1)(2013-1#1)
often than##41##2##(1990-12#1)(1990-8#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-12#2)(1996-3#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-10#1)(2006-12#2)(2006-8#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2009-11#1)(2010-2#2)(2011-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
often the case##5##3##(1995-1#1)(2006-10#1)(2008-4#1)(2009-11#1)(2011-2#1)
often the data##2##3##(1991-12#1)(1992-9#1)
often the diagnosis##2##3##(2006-12#1)(2011-2#1)
often the first##10##3##(1993-2#1)(2007-11#2)(2008-2#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
often the most##2##3##(1991-7#1)(2011-1#1)
often the only##3##3##(2006-6#1)(2011-2#1)(2012-5#1)
often the primary##3##3##(2007-4#1)(2008-3#1)(2012-2#1)
often the result of##4##4##(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)
often the same##2##3##(2009-8#1)(2012-12#1)
often the##65##2##(1990-12#1)(1991-12#1)(1991-7#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-7#1)(1995-1#2)(1997-5#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-2#5)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#4)
often these##2##2##(1995-3#1)(2012-12#1)
often thought to be##4##4##(1997-8#1)(2004-10#1)(2009-8#1)(2012-2#1)
often thought to##5##3##(1997-8#1)(2004-10#1)(2008-9#1)(2009-8#1)(2012-2#1)
often thought##7##2##(1997-8#1)(2004-10#1)(2005-8#1)(2008-9#1)(2009-8#1)(2010-8#1)(2012-2#1)
often to##6##2##(1997-4#1)(1997-5#1)(2008-11#2)(2008-3#1)(2013-1#1)
often too##3##2##(1993-9#1)(2006-2#1)(2008-9#1)
often toxic##2##2##(2006-12#1)(2008-1#1)
often treatable##3##2##(1993-7#1)(1997-2#1)(2006-8#1)
often treated with a##2##4##(2005-10#1)(2010-12#1)
often treated with##7##3##(1993-1#1)(2005-10#1)(2005-6#1)(2007-12#1)(2007-7#1)(2010-12#1)(2013-1#1)
often treated##12##2##(1993-1#1)(2005-10#1)(2005-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2010-12#1)(2010-2#1)(2013-1#1)
often triggered by##3##3##(1991-5#1)(2009-6#1)(2009-7#1)
often turn##2##2##(1992-8#1)(2013-8#1)
often unavailable##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
often unclear and##2##3##(2007-8#1)(2012-2#1)
often unclear##6##2##(1995-8#1)(2007-8#1)(2009-5#1)(2009-6#1)(2012-2#1)(2013-8#1)
often underestimated##6##2##(1997-3#1)(2006-10#1)(2007-7#1)(2010-5#1)(2012-12#1)(2013-8#1)
often undergo##4##2##(2008-8#1)(2009-3#1)(2012-2#2)
often unfamiliar##2##2##(2006-8#1)(2007-4#1)
often unique##3##2##(1994-8#1)(2007-8#1)(2010-7#1)
often unknown##6##2##(1996-2#1)(2005-11#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-3#1)
often unpredictable##2##2##(1993-12#1)(2007-12#1)
often unrecognised##2##2##(1990-3#1)(1992-9#1)
often unrecognized##2##2##(2007-4#1)(2010-7#1)
often unsuitable for##2##3##(1992-2#1)(1993-4#1)
often untreated##2##2##(2007-12#1)(2013-8#1)
often use a##2##3##(1996-7#1)(2012-2#1)
often use##8##2##(1996-3#1)(1996-7#1)(2004-9#1)(2006-10#1)(2008-2#1)(2009-4#1)(2012-2#2)
often used as a##6##4##(1996-3#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2013-1#1)
often used as an##3##4##(1995-1#1)(2005-7#1)(2008-2#1)
often used as the##4##4##(2007-12#1)(2008-10#1)(2010-12#2)
often used as##18##3##(1992-3#1)(1995-1#1)(1996-3#1)(2005-7#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-4#2)(2008-6#1)(2010-12#2)(2013-1#1)
often used by##2##3##(2007-11#1)(2008-6#1)
often used for##9##3##(2008-10#1)(2008-2#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-12#2)(2013-1#2)
often used in combination with##2##5##(2013-1#2)
often used in combination##3##4##(2005-7#1)(2013-1#2)
often used in the##3##4##(2006-4#1)(2012-2#1)(2013-7#1)
often used in these patients##2##5##(2006-10#1)(2011-2#1)
often used in##22##3##(2005-7#1)(2006-10#1)(2006-4#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-7#1)(2009-2#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
often used to describe the##2##5##(2007-11#1)(2008-11#1)
often used to treat##3##4##(2006-10#1)(2008-10#1)(2011-1#1)
often used to##25##3##(1991-7#1)(1993-2#1)(1995-8#1)(1996-5#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#2)
often used##94##2##(1991-7#1)(1991-8#1)(1992-3#1)(1993-2#1)(1995-1#1)(1995-11#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-6#1)(2005-7#2)(2005-8#1)(2006-10#2)(2006-4#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#2)(2007-8#2)(2007-9#1)(2008-10#12)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#5)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#7)(2013-7#1)
often utilized##2##2##(1996-8#1)(2008-10#1)
often varies##2##2##(2008-3#1)(2008-9#1)
often very##6##2##(1996-12#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
often via##2##2##(2008-6#1)(2012-2#1)
often was##4##2##(1995-11#1)(2008-10#2)(2008-12#1)
often were##8##2##(2008-10#6)(2011-1#1)(2012-11#1)
often with an##2##3##(1992-3#1)(2007-4#1)
often with microhemorrhages##2##3##(2013-1#2)
often with##22##2##(1992-3#1)(1992-7#1)(1993-7#1)(1997-1#1)(1997-3#1)(1997-8#1)(2005-10#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-4#2)(2007-8#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-1#4)
often without##2##2##(1994-4#1)(2011-3#1)
often work##2##2##(2008-6#1)(2008-7#1)
often write##2##2##(2007-9#1)(2010-9#1)
often young##2##2##(1997-6#1)(2013-1#1)
often##3079##1##(1990-10#6)(1990-11#4)(1990-12#10)(1990-2#5)(1990-3#5)(1990-4#9)(1990-5#9)(1990-6#4)(1990-7#4)(1990-8#7)(1990-9#4)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#10)(1991-2#5)(1991-3#7)(1991-4#7)(1991-5#2)(1991-6#6)(1991-7#2)(1991-8#5)(1991-9#7)(1992-1#6)(1992-10#4)(1992-11#5)(1992-12#6)(1992-2#8)(1992-3#12)(1992-4#7)(1992-5#7)(1992-6#1)(1992-7#5)(1992-8#17)(1992-9#10)(1993-1#7)(1993-10#9)(1993-11#8)(1993-12#20)(1993-2#11)(1993-3#11)(1993-4#1)(1993-5#4)(1993-6#3)(1993-7#4)(1993-8#3)(1993-9#12)(1994-1#2)(1994-11#9)(1994-12#10)(1994-2#5)(1994-3#10)(1994-4#2)(1994-5#6)(1994-6#5)(1994-7#3)(1994-8#6)(1994-9#5)(1995-1#7)(1995-10#2)(1995-11#4)(1995-12#7)(1995-2#10)(1995-3#4)(1995-4#2)(1995-5#5)(1995-6#7)(1995-7#1)(1995-8#6)(1995-9#5)(1996-1#7)(1996-11#6)(1996-12#16)(1996-2#14)(1996-3#10)(1996-4#2)(1996-5#4)(1996-6#6)(1996-7#10)(1996-8#7)(1996-9#3)(1997-1#7)(1997-2#14)(1997-3#22)(1997-4#13)(1997-5#7)(1997-6#6)(1997-7#9)(1997-8#19)(2003-11#1)(2004-1#1)(2004-10#3)(2004-11#2)(2004-12#4)(2004-3#4)(2004-4#5)(2004-9#2)(2005-10#13)(2005-11#28)(2005-12#3)(2005-2#1)(2005-3#2)(2005-4#2)(2005-6#3)(2005-7#11)(2005-8#22)(2005-9#4)(2006-1#5)(2006-10#88)(2006-11#11)(2006-12#21)(2006-2#19)(2006-3#13)(2006-4#16)(2006-5#16)(2006-6#13)(2006-7#14)(2006-8#27)(2006-9#11)(2007-1#12)(2007-10#15)(2007-11#55)(2007-12#39)(2007-2#25)(2007-3#7)(2007-4#30)(2007-5#12)(2007-6#15)(2007-7#44)(2007-8#44)(2007-9#25)(2008-1#44)(2008-10#144)(2008-11#72)(2008-12#31)(2008-2#59)(2008-3#48)(2008-4#66)(2008-5#56)(2008-6#31)(2008-7#72)(2008-8#74)(2008-9#64)(2009-1#2)(2009-10#11)(2009-11#9)(2009-12#10)(2009-2#8)(2009-3#15)(2009-4#20)(2009-5#17)(2009-6#18)(2009-7#12)(2009-8#21)(2009-9#15)(2010-1#8)(2010-10#14)(2010-11#10)(2010-12#48)(2010-2#28)(2010-3#12)(2010-4#22)(2010-5#21)(2010-6#12)(2010-7#12)(2010-8#15)(2010-9#11)(2011-1#37)(2011-12#14)(2011-2#116)(2011-3#4)(2011-7#4)(2012-1#34)(2012-11#9)(2012-12#63)(2012-2#87)(2012-3#52)(2012-4#1)(2012-5#2)(2012-7#1)(2013-1#149)(2013-7#28)(2013-8#49)
often)##3##1##(2010-8#1)(2011-2#2)
often-cited##3##1##(2008-1#1)(2008-9#1)(2012-2#1)
oftener##6##1##(2013-1#6)
oftenly##2##1##(2007-8#2)
oftentimes##2##1##(2008-7#1)(2013-1#1)
ofthe DMN and its##2##4##(2013-8#2)
ofthe DMN##3##2##(2013-8#3)
ofthe artery##2##2##(2013-8#2)
ofthe disease##2##2##(2013-8#2)
ofthe##49##1##(2008-11#17)(2008-2#6)(2008-9#2)(2009-8#1)(2010-7#1)(2013-7#1)(2013-8#21)
ofthese##3##1##(2008-2#1)(2013-8#2)
ogt##4##1##(1992-8#4)
oh##2##1##(2009-4#1)(2013-1#1)
oh8Gua##9##1##(1997-1#9)
ohio##2##1##(2008-10#1)(2012-2#1)
ohmic loss in the##2##4##(2012-11#2)
ohmic loss##3##2##(2012-11#3)
ohmic##7##1##(1996-1#1)(2007-11#1)(2008-10#1)(2008-5#1)(2012-11#3)
oil (18##2##2##(1991-2#2)
oil (CO)##2##2##(1991-2#1)(2013-1#1)
oil (SFO)##3##2##(1992-5#1)(2010-4#1)(2013-1#1)
oil adulteration with##2##3##(2007-8#1)(2008-10#1)
oil adulteration##4##2##(2007-8#2)(2008-10#2)
oil alone or##2##3##(1993-8#1)(2005-9#1)
oil alone##3##2##(1993-8#2)(2005-9#1)
oil and either##2##3##(1996-10#1)(2004-12#1)
oil and grease (FOG)##2##4##(2013-1#2)
oil and its##2##3##(2005-4#1)(2012-11#1)
oil and spikenard extract##2##4##(2008-4#2)
oil and the##3##3##(2007-1#1)(2008-5#1)(2010-12#1)
oil and##62##2##(1990-7#2)(1991-2#1)(1993-8#3)(1996-10#1)(1996-6#1)(2004-1#1)(2004-12#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-3#1)(2006-5#1)(2007-1#3)(2007-11#1)(2007-8#1)(2008-10#16)(2008-11#1)(2008-2#3)(2008-4#3)(2008-5#1)(2010-12#2)(2010-3#1)(2010-4#5)(2010-5#1)(2010-6#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-1#5)
oil are##3##2##(2008-3#1)(2012-2#1)(2013-1#1)
oil as a##2##3##(2008-6#2)
oil as the##3##3##(1992-2#1)(2008-10#1)(2008-6#1)
oil as##13##2##(1991-2#1)(1992-2#1)(1996-5#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-5#1)(2008-6#3)(2011-2#1)
oil based##3##2##(2004-9#2)(2010-5#1)
oil bearing##2##2##(2007-11#1)(2009-3#1)
oil biodiesel##2##2##(2009-3#2)
oil bodies##7##2##(2009-10#6)(2011-2#1)
oil body##2##2##(2009-10#2)
oil by gas##2##3##(2005-11#1)(2008-10#1)
oil by##13##2##(2005-11#1)(2005-4#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-9#5)
oil coated fiber##2##3##(2008-10#2)
oil combinations##2##2##(2008-8#2)
oil concentration##3##2##(2008-10#3)
oil concentrations##2##2##(2005-11#1)(2008-3#1)
oil consumption##2##2##(2007-9#2)
oil contained##2##2##(2006-12#1)(2008-5#1)
oil content and##2##3##(2008-5#1)(2012-2#1)
oil content##5##2##(2004-4#2)(2007-9#1)(2008-5#1)(2012-2#1)
oil could be##2##3##(2010-12#1)(2010-5#1)
oil degradation##2##2##(2004-4#1)(2008-10#1)
oil deodorized distillate##3##3##(2008-5#2)(2008-6#1)
oil did not##2##3##(2008-5#1)(2008-7#1)
oil diet##6##2##(1991-2#4)(2009-5#2)
oil diets for##2##3##(1997-1#1)(2009-5#1)
oil diets##6##2##(1991-2#1)(1994-2#1)(1997-1#1)(2009-5#3)
oil does not significantly##2##4##(2004-1#1)(2006-10#1)
oil droplet size##2##3##(2008-7#2)
oil droplet##3##2##(2005-11#1)(2008-7#2)
oil droplets in the##2##4##(2005-11#1)(2008-3#1)
oil droplets##8##2##(1992-7#1)(2005-11#2)(2008-10#1)(2008-3#1)(2008-5#3)
oil drops##2##2##(2005-11#2)
oil emulsions##2##2##(1991-10#1)(2005-9#1)
oil enriched diet##4##3##(2006-10#4)
oil exhibited##3##2##(2008-5#1)(2008-6#1)(2010-12#1)
oil extracted from the##4##4##(2008-5#3)(2013-1#1)
oil extracted from##5##3##(2008-5#3)(2010-3#1)(2013-1#1)
oil extracted##6##2##(2008-10#1)(2008-5#3)(2010-3#1)(2013-1#1)
oil fed rats##2##3##(1994-2#1)(1997-1#1)
oil fed##5##2##(1990-7#1)(1994-2#1)(1997-1#1)(2009-5#2)
oil feeding##2##2##(1997-1#2)
oil field samples##3##3##(2006-8#3)
oil field separator##2##3##(2006-8#2)
oil field##8##2##(2006-8#6)(2008-11#1)(2011-2#1)
oil film##2##2##(2008-3#2)
oil flowers##3##2##(2006-12#2)(2008-12#1)
oil for##9##2##(1990-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#2)(2009-3#1)(2012-2#1)(2013-1#1)
oil formulation##2##2##(2006-12#1)(2010-5#1)
oil formulations were##2##3##(2008-10#1)(2012-12#1)
oil from a##2##3##(2008-4#1)(2009-3#1)
oil from the##5##3##(2007-3#1)(2008-10#1)(2008-8#2)(2011-1#1)
oil from##21##2##(1990-9#1)(2004-4#1)(2005-11#3)(2006-12#1)(2007-1#2)(2007-11#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#2)(2009-3#1)(2010-5#1)(2011-1#1)(2012-11#1)(2012-3#1)(2013-8#1)
oil group##2##2##(1994-2#2)
oil had##2##2##(1994-2#1)(2008-10#1)
oil has a##2##3##(2005-11#1)(2008-5#1)
oil has been##3##3##(2007-8#1)(2008-10#1)(2008-5#1)
oil has##6##2##(2005-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#2)
oil hydrocarbons##2##2##(2008-4#1)(2011-1#1)
oil immersion##2##2##(2007-11#1)(2013-1#1)
oil improves##3##2##(2008-5#1)(2012-11#1)(2013-1#1)
oil in the##7##3##(2004-8#1)(2005-11#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)
oil in their##2##3##(1997-1#1)(2011-12#1)
oil in water##2##3##(2008-5#2)
oil in water&quot##2##3##(2008-10#2)
oil in##34##2##(1992-2#3)(1996-10#1)(1997-1#1)(2004-8#1)(2005-11#5)(2007-9#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-5#4)(2008-6#1)(2008-8#1)(2010-4#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-8#1)
oil industry##12##2##(1993-2#1)(2006-2#4)(2008-10#1)(2010-2#2)(2011-1#2)(2011-11#1)(2013-1#1)
oil into the##2##3##(2008-10#1)(2010-9#1)
oil into##4##2##(2008-10#3)(2010-9#1)
oil is a##2##3##(2009-5#1)(2013-1#1)
oil is##10##2##(2005-11#1)(2006-10#2)(2007-8#1)(2008-10#1)(2008-6#1)(2009-5#1)(2012-2#1)(2013-1#2)
oil lamps found in##2##4##(2008-10#2)
oil lamps##4##2##(2008-10#4)
oil layer##3##2##(1990-2#1)(2006-7#1)(2008-5#1)
oil medium##3##2##(2008-10#1)(2009-5#2)
oil mill##2##2##(2008-12#1)(2012-2#1)
oil mixtures##3##2##(2008-10#2)(2008-3#1)
oil obtained##2##2##(2007-11#1)(2008-12#1)
oil of O##2##3##(2007-1#2)
oil of ajedra##2##3##(2008-5#2)
oil of the##14##3##(2008-11#7)(2008-12#2)(2010-12#5)
oil of##40##2##(2004-1#1)(2004-8#1)(2006-12#2)(2007-1#7)(2008-11#17)(2008-12#2)(2008-5#4)(2010-12#6)
oil on the##2##3##(1992-9#1)(2008-10#1)
oil on##22##2##(1992-2#1)(1992-9#1)(1993-8#1)(2004-1#2)(2006-10#2)(2007-8#1)(2007-9#3)(2008-10#2)(2008-11#1)(2008-9#2)(2009-5#1)(2010-4#2)(2010-8#1)(2012-2#1)(2013-8#1)
oil or##11##2##(1991-10#1)(1993-9#2)(2004-4#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-4#1)(2012-1#1)(2012-2#2)
oil palm biosolid extract##3##4##(2011-2#3)
oil palm shell##2##3##(2013-1#2)
oil palm##12##2##(1996-7#4)(2006-4#1)(2008-10#2)(2011-2#3)(2013-1#2)
oil particles##2##2##(2005-11#2)
oil phase##13##2##(2004-12#1)(2005-11#1)(2008-5#7)(2008-6#1)(2012-12#3)
oil plus##3##2##(1993-9#2)(2008-5#1)
oil pollution in##2##3##(2006-12#1)(2011-1#1)
oil pollution##3##2##(2006-12#1)(2011-1#2)
oil polyurethane composite##3##3##(2008-10#3)
oil produced##2##2##(2008-10#1)(2010-4#1)
oil production##4##2##(2006-2#1)(2007-11#1)(2008-10#2)
oil products##4##2##(1990-4#2)(2008-10#2)
oil recovery##6##2##(2005-11#4)(2008-5#1)(2011-2#1)
oil refinery##4##2##(2008-10#2)(2011-2#1)(2013-7#1)
oil sample is##2##3##(1992-1#1)(2008-10#1)
oil sample##6##2##(1992-1#1)(2008-10#5)
oil samples in##3##3##(2008-10#3)
oil samples varied in all cases between 1##2##8##(2008-10#2)
oil samples was##2##3##(2008-10#2)
oil samples were##2##3##(2007-1#1)(2008-10#1)
oil samples##26##2##(2007-1#1)(2007-8#5)(2008-10#18)(2011-2#2)
oil seeps##2##2##(2007-7#2)
oil should be##2##3##(1990-2#1)(2008-5#1)
oil showed a##2##3##(2007-9#1)(2008-3#1)
oil showed##6##2##(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-5#1)(2012-11#1)
oil solution##2##2##(2008-2#1)(2012-2#1)
oil spill##6##2##(1997-4#3)(2008-10#2)(2008-11#1)
oil spillage##2##2##(2006-12#2)
oil supplementation##7##2##(1994-2#3)(2006-7#1)(2010-1#2)(2012-1#1)
oil syndrome##4##2##(2008-10#4)
oil tank##2##2##(2007-7#1)(2008-10#1)
oil that##2##2##(2004-8#1)(2008-5#1)
oil to##5##2##(1997-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-4#1)
oil treatment##5##2##(1992-2#1)(2007-11#1)(2007-2#1)(2008-9#2)
oil type##2##2##(2005-11#1)(2008-10#1)
oil types##3##2##(2005-11#1)(2006-12#1)(2008-10#1)
oil used##2##2##(2005-11#1)(2012-2#1)
oil was added to the##2##5##(1991-2#1)(2008-10#1)
oil was found to##2##4##(2008-11#1)(2009-3#1)
oil was used for##2##4##(2008-11#1)(2010-5#1)
oil was used##4##3##(2005-11#1)(2008-10#1)(2008-11#1)(2010-5#1)
oil was##23##2##(1991-2#1)(2004-8#1)(2005-11#3)(2005-4#1)(2007-3#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#2)(2009-3#2)(2009-5#1)(2010-5#1)(2011-2#1)(2012-3#1)
oil were##8##2##(2004-8#1)(2005-11#1)(2007-1#1)(2008-10#2)(2008-4#1)(2012-3#2)
oil with##8##2##(1990-8#2)(2004-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2010-4#1)
oil without##2##2##(2011-1#1)(2013-7#1)
oil yield##5##2##(2007-11#1)(2007-3#1)(2010-12#2)(2013-1#1)
oil##1010##1##(1990-11#2)(1990-2#3)(1990-3#1)(1990-4#8)(1990-5#2)(1990-7#3)(1990-8#4)(1990-9#1)(1991-10#2)(1991-2#17)(1991-7#1)(1991-8#3)(1992-1#1)(1992-2#7)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-2#2)(1993-4#1)(1993-6#1)(1993-8#8)(1993-9#4)(1994-2#11)(1994-6#1)(1995-11#1)(1995-5#3)(1996-1#1)(1996-10#3)(1996-11#2)(1996-5#2)(1996-6#1)(1996-7#4)(1996-8#2)(1997-1#8)(1997-2#3)(1997-3#1)(1997-4#3)(2004-1#5)(2004-11#3)(2004-12#3)(2004-4#6)(2004-8#8)(2004-9#3)(2005-11#50)(2005-4#4)(2005-7#2)(2005-9#3)(2006-10#12)(2006-12#22)(2006-2#5)(2006-3#3)(2006-4#1)(2006-5#2)(2006-7#3)(2006-8#7)(2006-9#1)(2007-1#24)(2007-11#11)(2007-2#2)(2007-3#6)(2007-5#1)(2007-7#4)(2007-8#32)(2007-9#20)(2008-10#195)(2008-11#32)(2008-12#10)(2008-2#7)(2008-3#19)(2008-4#11)(2008-5#79)(2008-6#20)(2008-7#6)(2008-8#6)(2008-9#10)(2009-10#12)(2009-2#3)(2009-3#14)(2009-5#17)(2009-8#4)(2010-1#3)(2010-12#18)(2010-2#2)(2010-3#6)(2010-4#25)(2010-5#10)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#17)(2011-11#5)(2011-12#2)(2011-2#21)(2012-1#2)(2012-10#1)(2012-11#7)(2012-12#11)(2012-2#19)(2012-3#6)(2013-1#28)(2013-7#6)(2013-8#6)
oil) and##6##2##(1990-7#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2013-1#1)
oil) were##2##2##(2008-10#1)(2008-6#1)
oil)##22##1##(1990-7#1)(1991-6#1)(1994-2#1)(1994-5#1)(2006-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-5#1)(2008-6#1)(2008-8#1)(2010-7#1)(2013-1#1)
oil-based emulsions are##2##3##(2012-2#2)
oil-based##8##1##(1991-2#1)(1995-2#1)(1997-6#1)(2005-10#1)(2007-11#1)(2012-2#3)
oil-contaminated sites##2##2##(2004-4#1)(2008-4#1)
oil-contaminated soil was##2##3##(2004-4#2)
oil-contaminated soil##5##2##(2004-4#4)(2008-11#1)
oil-contaminated##10##1##(2004-4#5)(2005-11#1)(2008-11#1)(2008-4#1)(2011-1#2)
oil-fed groups##2##2##(2009-5#2)
oil-fed##5##1##(1991-2#1)(2009-5#4)
oil-film##2##1##(2008-3#2)
oil-immersion objective##3##2##(2007-12#1)(2008-3#2)
oil-immersion##5##1##(2007-12#2)(2008-3#3)
oil-in-water (o/w)##2##2##(2008-11#1)(2008-5#1)
oil-in-water emulsion##5##2##(1990-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
oil-in-water emulsions##7##2##(2005-11#5)(2008-10#1)(2008-5#1)
oil-in-water microemulsion##2##2##(2005-11#1)(2008-11#1)
oil-in-water##19##1##(1990-2#1)(1992-9#1)(2005-11#6)(2008-10#2)(2008-11#3)(2008-5#5)(2013-1#1)
oil-rich##2##1##(2007-9#1)(2008-3#1)
oil-soluble##7##1##(2005-11#5)(2008-10#1)(2012-12#1)
oil-spill-polluted##3##1##(2006-12#3)
oil-treated##2##1##(1993-6#1)(2008-9#1)
oil-water interface##5##2##(1992-7#1)(2005-11#2)(2008-5#2)
oil-water##8##1##(1992-7#2)(2005-11#2)(2008-10#2)(2008-5#2)
oil/water##4##1##(2005-11#3)(2008-5#1)
oils against##2##2##(2007-5#1)(2008-8#1)
oils also##2##2##(2008-10#1)(2008-12#1)
oils and fats##3##3##(1992-4#1)(2007-8#1)(2008-10#1)
oils and their main components##2##5##(2008-10#1)(2008-11#1)
oils and their##6##3##(2008-10#3)(2008-11#1)(2008-5#2)
oils and##31##2##(1992-4#1)(2007-7#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-3#1)(2008-5#6)(2008-7#1)(2009-3#1)(2010-4#2)(2012-1#1)(2012-12#1)(2012-2#1)
oils as##4##2##(2006-9#1)(2008-2#1)(2009-3#2)
oils at##3##2##(2006-9#1)(2008-9#1)(2013-1#1)
oils by##12##2##(2007-11#1)(2008-10#9)(2008-5#2)
oils extracted from##3##3##(2008-10#1)(2010-3#1)(2013-1#1)
oils extracted##4##2##(2008-10#1)(2010-3#1)(2013-1#2)
oils from##12##2##(2006-12#1)(2007-1#3)(2008-10#4)(2008-12#1)(2010-3#1)(2011-1#1)(2011-2#1)
oils has##2##2##(2008-10#2)
oils have##2##2##(2008-11#1)(2009-3#1)
oils in excess methanol##4##4##(2013-1#4)
oils in the##2##3##(2008-12#1)(2008-7#1)
oils in##16##2##(1992-5#1)(1997-2#1)(2006-12#2)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#3)(2013-1#5)
oils is##4##2##(2007-7#1)(2008-10#3)
oils obtained from the##2##4##(2007-1#1)(2008-11#1)
oils obtained##4##2##(2007-1#1)(2007-11#2)(2008-11#1)
oils of##19##2##(2006-12#1)(2006-9#1)(2007-1#6)(2008-10#2)(2008-11#3)(2008-12#2)(2008-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
oils on the basis of##2##5##(2008-10#2)
oils on##3##2##(2006-9#1)(2008-10#2)
oils or##2##2##(1994-2#1)(1994-6#1)
oils resulted##2##2##(1993-8#1)(2013-1#1)
oils showed a##2##3##(2006-9#1)(2007-11#1)
oils studied##2##2##(2007-1#1)(2008-10#1)
oils the##2##2##(2008-10#1)(2008-5#1)
oils used##2##2##(2008-10#2)
oils using##2##2##(2008-10#2)
oils was##3##2##(2006-9#1)(2008-11#1)(2012-12#1)
oils were collected##2##3##(2006-12#1)(2007-3#1)
oils were determined##2##3##(2008-11#1)(2008-5#1)
oils were identified##2##3##(2007-1#1)(2008-12#1)
oils were prepared##2##3##(2008-10#2)
oils were tested##2##3##(2008-10#1)(2008-11#1)
oils were##23##2##(2006-12#1)(2007-1#6)(2007-3#1)(2008-10#5)(2008-11#3)(2008-12#3)(2008-5#2)(2012-12#1)(2012-2#1)
oils with##2##2##(2008-10#1)(2008-5#1)
oils without titration##3##3##(2008-10#3)
oils##291##1##(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-4#1)(1992-5#1)(1993-8#1)(1994-2#1)(1994-6#1)(1995-5#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-11#1)(2006-12#11)(2006-7#1)(2006-9#8)(2007-1#21)(2007-11#5)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#8)(2008-10#94)(2008-11#20)(2008-12#9)(2008-2#2)(2008-3#4)(2008-5#21)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#1)(2009-3#4)(2009-6#2)(2010-1#1)(2010-3#4)(2010-4#3)(2011-1#2)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#10)(2012-2#5)(2013-1#13)
oils)##2##1##(2007-6#1)(2012-12#1)
oils]##2##1##(1990-4#1)(2012-12#1)
oilseed poppy##2##2##(2008-10#2)
oilseed radish##2##2##(2008-10#2)
oilseed rape (Brassica napus)##2##4##(2006-12#1)(2008-10#1)
oilseed rape (Brassica##3##3##(2006-12#1)(2008-10#2)
oilseed rape##15##2##(2006-12#2)(2008-10#12)(2011-2#1)
oilseed##24##1##(2006-12#4)(2008-10#19)(2011-2#1)
oilseeds##4##1##(2008-10#3)(2010-7#1)
oily droplets##3##2##(2006-12#3)
oily paste extracts##2##3##(2008-10#2)
oily phase##2##2##(2008-5#2)
oily##18##1##(1991-6#1)(2005-11#1)(2006-12#3)(2007-3#2)(2008-10#3)(2008-3#2)(2008-4#1)(2008-5#3)(2012-12#2)
ointment and control##2##3##(2006-10#1)(2012-2#1)
ointment and##4##2##(2006-10#1)(2012-2#1)(2013-1#1)(2013-7#1)
ointment base##4##2##(2010-2#4)
ointment bases##4##2##(2008-5#2)(2010-12#1)(2010-2#1)
ointment containing##2##2##(2007-8#1)(2012-2#1)
ointment in##5##2##(2006-10#1)(2007-7#2)(2012-2#1)(2013-7#1)
ointment prepared from ethanolic extract of Lemon verbena##2##8##(2008-12#2)
ointment samples##2##2##(1997-2#1)(2007-8#1)
ointment to##2##2##(2006-10#2)
ointment topically##2##2##(1995-9#1)(2007-7#1)
ointment was##3##2##(2006-10#1)(2008-10#1)(2012-12#1)
ointment##46##1##(1993-11#1)(1995-9#1)(1997-2#1)(2006-10#5)(2007-12#1)(2007-7#9)(2007-8#3)(2008-10#1)(2008-12#2)(2008-5#2)(2010-12#3)(2010-2#5)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#5)(2013-1#1)(2013-7#3)
ointments or##2##2##(1995-5#1)(2010-12#1)
ointments##9##1##(1990-9#1)(1995-5#1)(1997-2#2)(2007-11#1)(2007-8#1)(2008-3#1)(2010-12#2)
okadaic acid (IC50 =##2##4##(1995-8#2)
okadaic acid (OA)##4##3##(1993-8#1)(1994-11#1)(1994-8#1)(1996-5#1)
okadaic acid and the##2##4##(1993-8#1)(1994-6#1)
okadaic acid and##10##3##(1991-9#1)(1992-12#2)(1993-7#1)(1993-8#1)(1994-12#1)(1994-6#2)(1995-3#1)(1997-6#1)
okadaic acid on##5##3##(1991-7#1)(1992-12#1)(1992-8#1)(1993-7#1)(1993-8#1)
okadaic acid was##2##3##(1993-7#2)
okadaic acid##70##2##(1990-12#1)(1991-3#1)(1991-5#3)(1991-7#1)(1991-9#2)(1992-12#4)(1992-8#5)(1992-9#3)(1993-12#2)(1993-7#9)(1993-8#4)(1994-11#3)(1994-12#1)(1994-2#4)(1994-6#4)(1994-8#2)(1994-9#1)(1995-11#1)(1995-3#3)(1995-5#1)(1995-8#4)(1996-5#3)(1997-6#3)(2008-2#1)(2008-4#2)(2009-6#1)(2013-7#1)
okadaic acid-sensitive##2##2##(1991-10#1)(1992-9#1)
okadaic##74##1##(1990-12#1)(1991-10#1)(1991-3#1)(1991-5#3)(1991-7#1)(1991-9#2)(1992-12#4)(1992-8#5)(1992-9#5)(1993-12#2)(1993-7#9)(1993-8#4)(1994-11#3)(1994-12#1)(1994-2#5)(1994-6#4)(1994-8#2)(1994-9#1)(1995-11#1)(1995-3#3)(1995-5#1)(1995-8#4)(1996-5#3)(1997-6#3)(2008-2#1)(2008-4#2)(2009-6#1)(2013-7#1)
olanzapine and risperidone##4##3##(2004-3#4)
olanzapine and##8##2##(2004-3#4)(2006-12#1)(2008-3#1)(2008-6#1)(2011-1#1)
olanzapine is##2##2##(2006-12#1)(2008-6#1)
olanzapine versus##2##2##(2004-3#1)(2006-12#1)
olanzapine were##2##2##(2005-10#1)(2009-4#1)
olanzapine##34##1##(2004-3#8)(2005-10#2)(2005-8#1)(2006-12#4)(2006-2#1)(2008-3#6)(2008-6#4)(2008-7#1)(2009-4#3)(2010-2#3)(2011-1#1)
olbetam##5##1##(2006-6#5)
old (&gt##2##2##(2007-9#1)(2010-3#1)
old (20##2##2##(2008-3#1)(2013-7#1)
old (41##2##2##(2010-12#1)(2013-8#1)
old (52##2##2##(2010-12#1)(2010-7#1)
old Caucasian woman##2##3##(1993-11#1)(2010-2#1)
old Caucasian##5##2##(1993-11#1)(2007-8#1)(2010-2#1)(2012-2#1)(2013-1#1)
old P##3##2##(2013-8#3)
old WAG/Rij rats##2##3##(1990-2#2)
old Wistar##2##2##(1995-8#1)(2011-1#1)
old adults##4##2##(1990-4#1)(2008-11#2)(2010-12#1)
old age and##4##3##(1990-2#1)(1995-5#1)(2006-10#1)(2006-2#1)
old age are##2##3##(2012-1#1)(2012-3#1)
old age group##3##3##(1996-8#2)(2013-8#1)
old age in##2##3##(1994-6#1)(2010-2#1)
old age is##5##3##(1990-11#2)(2005-10#1)(2012-1#1)(2013-7#1)
old age##81##2##(1990-11#4)(1990-2#1)(1990-3#3)(1990-5#1)(1991-1#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-5#1)(1993-1#3)(1993-5#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-10#2)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-3#2)(1996-5#1)(1996-8#2)(1997-3#1)(1997-5#2)(2005-10#2)(2006-10#1)(2006-2#1)(2006-9#1)(2007-7#1)(2008-1#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#7)(2008-9#1)(2009-1#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-2#6)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
old and new##5##3##(1993-12#1)(1995-6#1)(2006-10#1)(2010-7#1)(2011-2#1)
old and older##3##3##(2006-7#1)(2008-10#1)(2008-4#1)
old and recent##3##3##(2006-8#1)(2008-11#1)(2011-2#1)
old and the##4##3##(1990-10#1)(1992-12#1)(2006-1#1)(2007-4#1)
old and were##2##3##(2006-7#1)(2008-5#1)
old and young larvae##2##4##(2008-12#2)
old and young rats##2##4##(1993-4#1)(2010-12#1)
old and young##9##3##(1993-4#1)(1994-6#1)(2008-12#2)(2009-10#2)(2009-12#1)(2009-8#1)(2010-12#1)
old and##59##2##(1990-10#1)(1990-4#1)(1991-9#1)(1992-12#1)(1993-12#1)(1993-4#1)(1994-6#1)(1995-6#1)(1996-1#1)(1997-4#1)(1997-6#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-8#1)(2010-12#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#1)
old animals##16##2##(1990-3#1)(1990-5#2)(1991-12#1)(1991-2#1)(1993-11#1)(1993-12#1)(1994-6#1)(1995-6#1)(1996-3#1)(1996-5#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-12#1)(2013-1#1)
old as##4##2##(1991-12#2)(1996-3#1)(2008-9#1)
old at##5##2##(2007-10#1)(2008-10#1)(2008-6#1)(2011-1#1)(2012-2#1)
old baby##4##2##(1992-4#1)(2010-4#2)(2010-7#1)
old boy who##3##3##(1996-6#1)(2009-4#1)(2010-10#1)
old boy with##10##3##(1991-11#1)(1993-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#2)
old boy##25##2##(1991-11#1)(1993-10#1)(1993-6#1)(1996-6#2)(2005-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-4#2)(2009-7#1)(2010-10#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#4)(2012-3#1)(2013-8#1)
old boys##3##2##(1990-8#1)(1993-3#1)(2006-10#1)
old but##5##2##(1990-3#2)(1996-9#1)(2006-2#1)(2007-8#1)
old by##2##2##(1990-3#1)(1995-8#1)
old cells##9##2##(1992-3#5)(1994-5#2)(1996-11#1)(2008-7#1)
old challenges##2##2##(2008-7#1)(2010-12#1)
old child who##3##3##(2007-7#1)(2010-5#1)(2013-1#1)
old child##11##2##(1993-9#1)(1995-11#1)(2006-9#1)(2007-4#1)(2007-7#2)(2007-8#1)(2010-5#1)(2011-12#1)(2012-12#1)(2013-1#1)
old children with##3##3##(2006-10#2)(2013-1#1)
old children##17##2##(1992-1#1)(1992-10#5)(2006-10#2)(2006-8#1)(2008-1#1)(2008-4#2)(2009-11#1)(2009-4#1)(2010-9#1)(2013-1#2)
old cultures##2##2##(1993-12#2)
old cuticle##3##2##(2008-7#3)
old donors##6##2##(1992-12#5)(2008-11#1)
old drug##6##2##(1996-3#1)(2006-10#3)(2006-8#1)(2008-1#1)
old drugs##4##2##(2006-10#2)(2008-1#1)(2012-1#1)
old enough to##2##3##(2006-7#1)(2008-1#1)
old female patient presented with a##2##6##(2010-12#1)(2011-2#1)
old female patient presented with##3##5##(2007-7#1)(2010-12#1)(2011-2#1)
old female patient who had##2##5##(2005-12#1)(2007-10#1)
old female patient who##4##4##(2005-12#1)(2007-10#1)(2010-4#1)(2013-8#1)
old female patient with##4##4##(2008-1#1)(2009-4#1)(2010-9#1)(2011-2#1)
old female patient##19##3##(1993-1#1)(2005-12#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2009-4#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#3)(2013-8#3)
old female presented to##3##4##(2007-7#1)(2011-2#1)(2013-1#1)
old female presented with##3##4##(2006-9#1)(2007-7#1)(2012-3#1)
old female presented##7##3##(1994-7#1)(2006-9#1)(2007-7#2)(2011-2#1)(2012-3#1)(2013-1#1)
old female was##2##3##(1997-6#1)(2011-1#1)
old female who presented with##4##5##(2007-2#1)(2009-7#1)(2011-1#1)(2011-2#1)
old female with##11##3##(1993-11#1)(2006-6#1)(2007-12#1)(2007-7#1)(2009-8#1)(2010-12#3)(2011-1#1)(2011-2#1)(2012-2#1)
old female##68##2##(1990-4#1)(1993-1#1)(1993-11#1)(1993-5#1)(1994-7#1)(1995-3#1)(1996-11#1)(1996-9#1)(1997-6#1)(2005-12#1)(2006-11#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#4)(2007-8#3)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#4)(2010-4#1)(2010-9#1)(2011-1#3)(2011-12#3)(2011-2#11)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#3)
old fetuses##2##2##(2007-11#2)
old for##6##2##(1996-11#1)(1996-9#2)(2011-12#1)(2013-1#2)
old gentleman presented##2##3##(2006-8#1)(2010-5#1)
old gentleman##3##2##(2006-8#1)(2007-8#1)(2010-5#1)
old girl and##2##3##(2007-8#1)(2012-2#1)
old girl is##2##3##(2009-4#1)(2011-2#1)
old girl who was##2##4##(2006-8#1)(2011-2#1)
old girl who##3##3##(2006-8#1)(2011-12#1)(2011-2#1)
old girl with##3##3##(2006-1#1)(2006-9#1)(2007-2#1)
old girl##20##2##(1994-2#1)(2006-1#1)(2006-11#3)(2006-8#1)(2006-9#1)(2007-2#2)(2007-8#1)(2008-7#1)(2009-4#1)(2010-12#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-2#2)
old group##2##2##(1996-3#1)(2007-2#1)
old had##2##2##(1990-6#1)(2013-8#1)
old healthy##3##2##(1995-11#1)(2008-4#1)(2011-1#1)
old hearts##8##2##(2010-7#8)
old hens was##2##3##(2012-1#2)
old hens##3##2##(2012-1#3)
old in##8##2##(1994-6#1)(1997-4#1)(1997-7#1)(2010-3#2)(2011-1#1)(2011-2#2)
old individuals##2##2##(1992-12#2)
old infant##4##2##(1994-6#1)(2012-2#3)
old is##2##2##(2006-4#1)(2011-2#1)
old lacquer-ware##2##2##(2008-10#2)
old lady who presented with##2##5##(2012-2#2)
old lady who##6##3##(2005-1#1)(2007-2#1)(2008-7#1)(2011-12#1)(2012-2#2)
old lady##14##2##(2005-1#1)(2006-1#2)(2007-11#1)(2007-2#1)(2007-7#2)(2008-6#1)(2008-7#1)(2010-12#1)(2011-12#1)(2012-2#2)(2013-7#1)
old male Wistar rats##2##4##(1995-12#1)(2013-1#1)
old male and##3##3##(2006-10#1)(2012-12#2)
old male child who##2##4##(2009-4#1)(2010-4#1)
old male child##4##3##(2009-4#1)(2010-4#1)(2012-2#1)(2013-1#1)
old male is##2##3##(2007-7#1)(2008-8#1)
old male patient with##4##4##(1993-8#1)(2006-8#1)(2011-2#1)(2013-8#1)
old male patient##11##3##(1993-8#1)(2005-12#1)(2006-8#1)(2007-7#1)(2008-1#1)(2009-9#1)(2011-2#1)(2012-2#2)(2013-8#2)
old male presented with##3##4##(2007-11#1)(2008-7#1)(2010-12#1)
old male rats##4##3##(1993-4#1)(1997-5#1)(2008-7#2)
old male was admitted##2##4##(2012-2#1)(2013-1#1)
old male was##3##3##(2011-1#1)(2012-2#1)(2013-1#1)
old male who##5##3##(1994-4#1)(2008-7#1)(2011-12#1)(2012-12#1)(2012-2#1)
old male with a##2##4##(2008-6#1)(2011-2#1)
old male with##8##3##(2006-7#1)(2007-7#1)(2007-9#1)(2008-6#2)(2010-3#1)(2011-2#1)(2012-3#1)
old male##63##2##(1990-11#1)(1993-4#1)(1993-8#1)(1994-4#1)(1995-12#1)(1997-5#1)(1997-6#2)(2005-12#1)(2006-10#1)(2006-4#2)(2006-7#1)(2006-8#1)(2007-11#1)(2007-7#3)(2007-9#1)(2008-1#1)(2008-12#1)(2008-6#2)(2008-7#6)(2008-8#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#5)(2013-8#2)
old males##4##2##(1991-3#2)(1995-6#1)(2011-2#1)
old man after##2##3##(2006-4#1)(2012-3#1)
old man and##2##3##(1993-8#1)(2010-6#1)
old man developed##2##3##(1990-9#1)(1993-8#1)
old man in##2##3##(2011-1#1)(2013-1#1)
old man presented with##7##4##(1995-6#1)(2006-12#2)(2007-7#2)(2008-7#1)(2009-9#1)
old man presented##8##3##(1995-6#1)(2006-12#2)(2007-7#2)(2008-7#1)(2009-9#1)(2012-2#1)
old man was admitted##2##4##(2012-2#1)(2013-1#1)
old man was##4##3##(2006-12#1)(2012-2#1)(2013-1#2)
old man who presented##2##4##(1991-11#1)(2011-2#1)
old man who##6##3##(1991-11#1)(1993-10#1)(2005-10#1)(2009-1#1)(2011-2#2)
old man with a##7##4##(1997-6#1)(2006-10#1)(2006-4#1)(2007-2#1)(2008-6#1)(2012-12#1)(2013-7#1)
old man with##17##3##(1997-6#1)(2006-10#1)(2006-4#5)(2007-2#2)(2007-6#1)(2008-10#1)(2008-6#1)(2009-8#1)(2010-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
old man##63##2##(1990-9#1)(1991-11#1)(1992-9#1)(1993-10#3)(1993-2#1)(1993-3#1)(1993-8#2)(1994-8#1)(1995-6#1)(1997-6#1)(2005-10#1)(2006-10#1)(2006-12#3)(2006-4#9)(2006-8#1)(2006-9#1)(2007-2#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
old men##2##2##(2006-10#1)(2007-7#1)
old mice by##2##3##(1994-5#1)(2013-7#1)
old mice##19##2##(1990-5#2)(1991-12#2)(1991-4#1)(1992-12#1)(1993-11#1)(1994-5#2)(1995-12#1)(1996-7#1)(1996-9#1)(2012-2#2)(2013-1#2)(2013-7#3)
old mouse##2##2##(1990-3#1)(1994-5#1)
old myocardial infarction##2##3##(1992-8#1)(2008-10#1)
old of##3##2##(2008-12#2)(2010-7#1)
old one##2##2##(2005-12#1)(2008-2#1)
old ones##5##2##(2007-12#1)(2008-7#2)(2008-8#1)(2010-2#1)
old or##8##2##(1991-9#1)(1992-1#1)(1996-2#1)(2008-3#1)(2009-4#1)(2011-1#1)(2011-2#2)
old para##2##2##(2012-11#1)(2013-8#1)
old patient who##3##3##(2011-1#1)(2012-12#1)(2012-2#1)
old patient with##11##3##(1994-5#1)(1997-4#1)(2007-11#1)(2008-10#1)(2009-11#1)(2010-12#2)(2010-3#1)(2010-8#1)(2012-12#1)(2012-2#1)
old patient##27##2##(1990-10#1)(1993-1#1)(1994-5#1)(1996-12#1)(1997-4#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-11#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)
old patients##6##2##(2006-10#1)(2007-2#1)(2008-7#1)(2013-1#3)
old people in##2##3##(1990-11#1)(1993-5#1)
old people##13##2##(1990-11#1)(1990-8#1)(1992-1#2)(1993-5#1)(1994-6#2)(2007-11#2)(2008-7#1)(2008-9#1)(2011-2#2)
old persistent-estrous##2##2##(1995-9#2)
old population##5##2##(1992-12#1)(2007-1#1)(2008-10#1)(2008-4#2)
old problem##3##2##(1990-3#1)(1993-8#1)(2010-8#1)
old problems##2##2##(1991-3#1)(2006-6#1)
old questions##2##2##(2008-11#1)(2012-2#1)
old rat##4##2##(1994-8#1)(1996-12#1)(2008-8#1)(2009-12#1)
old rats than in##2##4##(1990-5#1)(1990-7#1)
old rats the TATmRNA##2##4##(1991-2#2)
old rats the##3##3##(1991-2#2)(2008-7#1)
old rats were more##2##4##(1994-6#1)(2013-1#1)
old rats were##5##3##(1991-12#1)(1994-6#1)(2010-12#1)(2010-7#1)(2013-1#1)
old rats##59##2##(1990-3#1)(1990-5#2)(1990-7#1)(1991-12#4)(1991-2#3)(1992-12#1)(1993-4#3)(1994-10#1)(1994-11#1)(1994-2#1)(1994-6#9)(1994-8#1)(1995-1#4)(1995-12#1)(1995-9#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-5#1)(2008-7#12)(2009-12#1)(2010-12#3)(2010-7#3)(2013-1#1)
old renal transplant recipient##2##4##(2008-1#2)
old seedlings##3##2##(2008-5#1)(2011-12#2)
old septal deviation##5##3##(2011-2#5)
old strategies##2##2##(1994-3#1)(2006-10#1)
old subjects were##3##3##(1990-4#1)(1996-2#1)(2013-8#1)
old subjects##9##2##(1990-4#1)(1991-5#1)(1994-6#1)(1995-11#1)(1996-2#1)(1996-8#1)(2006-9#1)(2008-7#1)(2013-8#1)
old suffering from##3##3##(2007-2#2)(2008-7#1)
old test##3##2##(2007-7#1)(2008-10#2)
old than in##7##3##(1990-3#1)(1995-12#3)(1996-9#1)(2008-7#2)
old than##8##2##(1990-3#1)(1995-12#3)(1996-9#1)(2008-7#2)(2010-8#1)
old tissues##2##2##(1994-5#2)
old to##3##2##(1995-2#1)(2007-5#1)(2013-8#1)
old were used##2##3##(1995-9#1)(2009-2#1)
old were##15##2##(1995-9#2)(1997-6#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-2#1)(2009-2#1)(2011-2#3)(2012-12#2)
old while##2##2##(1991-12#1)(2008-3#1)
old white##2##2##(2006-10#1)(2006-12#1)
old who attended a##2##4##(2008-8#1)(2010-10#1)
old who##4##2##(2007-2#1)(2008-7#1)(2008-8#1)(2010-10#1)
old with a##2##3##(1990-10#1)(2007-7#1)
old with##6##2##(1990-10#1)(2007-7#1)(2008-6#1)(2008-9#1)(2012-2#1)(2013-8#1)
old woman admitted##5##3##(2005-1#1)(2005-12#1)(2006-4#3)
old woman and##2##3##(1990-2#1)(2009-1#1)
old woman developed##2##3##(1995-11#1)(2005-11#1)
old woman had##2##3##(1993-8#1)(1997-7#1)
old woman is presented##3##4##(1990-6#1)(1991-5#1)(2007-8#1)
old woman presented with##5##4##(1990-6#1)(2007-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
old woman presented##6##3##(1990-6#1)(2007-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
old woman was admitted##2##4##(2005-12#1)(2012-3#1)
old woman was##3##3##(1993-6#1)(2005-12#1)(2012-3#1)
old woman who presented with##3##5##(2006-2#1)(2010-12#1)(2013-8#1)
old woman who##7##3##(1997-6#1)(2006-2#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-8#1)
old woman with a##5##4##(1991-6#1)(2006-4#4)
old woman with##9##3##(1990-12#1)(1991-6#2)(2006-4#4)(2008-8#1)(2013-1#1)
old woman##65##2##(1990-12#2)(1990-2#2)(1990-6#2)(1991-5#2)(1991-6#2)(1991-8#1)(1992-10#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-11#1)(1997-6#2)(1997-7#1)(2005-1#1)(2005-11#1)(2005-12#2)(2006-10#1)(2006-2#1)(2006-4#8)(2007-12#1)(2007-7#1)(2007-8#5)(2008-5#1)(2008-8#1)(2009-1#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#5)(2012-2#3)(2012-3#4)(2013-1#2)(2013-8#3)
old women used OCs##2##4##(1992-2#2)
old women##6##2##(1992-2#2)(1997-4#1)(2005-1#1)(2007-8#1)(2008-10#1)
old world##2##2##(2012-12#1)(2013-1#1)
old##1398##1##(1990-10#5)(1990-11#6)(1990-12#4)(1990-2#5)(1990-3#15)(1990-4#7)(1990-5#9)(1990-6#8)(1990-7#2)(1990-8#3)(1990-9#3)(1991-1#5)(1991-10#2)(1991-11#5)(1991-12#13)(1991-2#9)(1991-3#8)(1991-4#4)(1991-5#3)(1991-6#2)(1991-8#4)(1991-9#5)(1992-1#9)(1992-10#8)(1992-11#2)(1992-12#15)(1992-2#5)(1992-3#6)(1992-4#5)(1992-5#2)(1992-6#1)(1992-7#4)(1992-8#1)(1992-9#2)(1993-1#6)(1993-10#5)(1993-11#5)(1993-12#6)(1993-2#5)(1993-3#3)(1993-4#6)(1993-5#5)(1993-6#4)(1993-7#2)(1993-8#5)(1993-9#7)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#4)(1994-3#5)(1994-4#1)(1994-5#13)(1994-6#23)(1994-7#1)(1994-8#6)(1994-9#2)(1995-1#4)(1995-10#4)(1995-11#5)(1995-12#8)(1995-2#1)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#6)(1995-8#3)(1995-9#12)(1996-1#7)(1996-11#3)(1996-12#4)(1996-2#4)(1996-3#10)(1996-5#4)(1996-6#6)(1996-7#2)(1996-8#4)(1996-9#10)(1997-1#3)(1997-2#4)(1997-3#6)(1997-4#5)(1997-5#5)(1997-6#14)(1997-7#2)(1997-8#1)(2004-4#3)(2005-1#3)(2005-10#3)(2005-11#2)(2005-12#6)(2005-3#1)(2005-7#3)(2005-9#1)(2006-1#4)(2006-10#22)(2006-11#5)(2006-12#6)(2006-2#7)(2006-4#24)(2006-5#2)(2006-6#5)(2006-7#8)(2006-8#10)(2006-9#8)(2007-1#3)(2007-10#5)(2007-11#13)(2007-12#11)(2007-2#18)(2007-4#3)(2007-5#1)(2007-6#3)(2007-7#21)(2007-8#27)(2007-9#6)(2008-1#23)(2008-10#40)(2008-11#11)(2008-12#20)(2008-2#5)(2008-3#11)(2008-4#10)(2008-5#19)(2008-6#12)(2008-7#65)(2008-8#20)(2008-9#16)(2009-1#6)(2009-10#2)(2009-11#2)(2009-12#3)(2009-2#5)(2009-3#1)(2009-4#13)(2009-5#1)(2009-6#1)(2009-7#5)(2009-8#6)(2009-9#5)(2010-1#1)(2010-10#4)(2010-11#4)(2010-12#29)(2010-2#12)(2010-3#5)(2010-4#7)(2010-5#3)(2010-6#5)(2010-7#18)(2010-8#7)(2010-9#4)(2011-1#23)(2011-12#12)(2011-2#74)(2012-1#17)(2012-11#6)(2012-12#27)(2012-2#49)(2012-3#19)(2012-5#1)(2013-1#44)(2013-7#10)(2013-8#31)
old&quot##6##1##(1994-5#1)(2008-10#1)(2008-8#1)(2012-2#2)(2013-1#1)
old'##2##1##(1996-7#1)(2008-7#1)
old) and aged rats##2##4##(1995-7#1)(2009-5#1)
old) and##14##2##(1990-5#1)(1992-8#1)(1993-12#1)(1994-6#1)(1995-7#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-7#2)(2009-5#1)(2010-11#1)(2010-12#1)(2013-8#1)
old) given##2##2##(2009-5#1)(2012-3#1)
old) or##2##2##(1992-11#1)(2006-5#1)
old) than in##2##3##(1995-12#1)(1995-9#1)
old) were##9##2##(1997-5#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-9#1)(2010-12#1)(2012-2#1)
old) with##5##2##(2006-10#1)(2008-6#1)(2012-12#1)(2013-1#2)
old)##100##1##(1990-10#1)(1990-5#3)(1991-12#1)(1992-11#2)(1992-2#1)(1992-8#2)(1993-12#4)(1993-2#1)(1994-10#1)(1994-6#2)(1995-12#2)(1995-7#2)(1995-9#2)(1996-5#1)(1996-8#1)(1997-5#1)(1997-7#2)(2004-3#1)(2005-12#1)(2006-10#1)(2006-5#2)(2006-7#1)(2006-9#1)(2007-1#1)(2007-2#1)(2007-8#6)(2008-10#7)(2008-12#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#4)(2009-5#2)(2009-8#2)(2010-11#1)(2010-12#3)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#4)
old-aged##2##1##(2008-12#1)(2013-8#1)
old-fashioned##2##1##(1991-2#1)(2006-2#1)
old]##5##1##(1990-2#1)(1991-8#1)(1995-2#1)(2008-9#1)(2012-3#1)
older (&gt##4##2##(2007-10#1)(2007-12#1)(2007-8#1)(2009-8#1)
older (20##3##2##(1992-9#1)(1993-10#1)(1993-2#1)
older AI/AN adults##2##3##(2013-1#2)
older Americans##3##2##(1994-1#1)(1996-12#1)(2005-10#1)
older Australians##2##2##(2010-12#1)(2012-12#1)
older HIV-infected##2##2##(2009-11#2)
older Maori##4##2##(2008-1#4)
older Māori##2##2##(2012-12#2)
older New##2##2##(2012-12#2)
older adolescents##4##2##(2010-1#2)(2010-12#1)(2013-1#1)
older adult drug users##2##4##(2012-11#2)
older adult males and females##2##5##(2007-1#1)(2013-7#1)
older adult males##4##3##(2006-12#2)(2007-1#1)(2013-7#1)
older adult patients##2##3##(2010-10#1)(2011-2#1)
older adult##17##2##(1996-2#1)(2006-12#2)(2007-1#1)(2008-10#1)(2009-12#2)(2010-10#2)(2011-2#1)(2012-11#2)(2013-1#4)(2013-7#1)
older adulthood##2##2##(2010-3#1)(2012-2#1)
older adults and##4##3##(2007-11#1)(2010-8#1)(2013-1#2)
older adults are##5##3##(1992-1#1)(1996-1#1)(2007-12#1)(2013-1#2)
older adults in##8##3##(2008-12#1)(2008-4#1)(2008-5#1)(2010-6#1)(2010-8#1)(2012-12#3)
older adults living##2##3##(2008-5#2)
older adults to##5##3##(1990-4#1)(2005-3#1)(2008-1#1)(2010-4#1)(2013-1#1)
older adults were##2##3##(2008-12#1)(2011-1#1)
older adults who are##4##4##(2008-4#1)(2011-1#3)
older adults who have##2##4##(2007-12#1)(2010-2#1)
older adults who##6##3##(2007-12#1)(2008-4#1)(2010-2#1)(2011-1#3)
older adults with cancer##2##4##(2010-11#1)(2011-1#1)
older adults with##14##3##(1992-1#1)(1992-6#1)(2010-11#4)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)
older adults##158##2##(1990-4#2)(1991-12#1)(1992-1#4)(1992-12#1)(1992-6#2)(1995-12#1)(1996-1#1)(1996-3#1)(1997-3#1)(2005-3#1)(2007-1#4)(2007-11#1)(2007-12#6)(2007-7#3)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#6)(2008-12#3)(2008-3#2)(2008-4#4)(2008-5#4)(2008-7#4)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#3)(2009-5#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#6)(2010-12#1)(2010-2#2)(2010-4#3)(2010-6#1)(2010-7#2)(2010-8#6)(2011-1#15)(2011-2#7)(2012-1#4)(2012-11#4)(2012-12#7)(2012-2#1)(2012-3#2)(2013-1#20)(2013-7#1)(2013-8#1)
older adults' health##2##3##(2009-7#1)(2010-10#1)
older adults'##10##2##(2008-1#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-7#3)(2010-10#1)(2010-11#1)(2013-1#1)
older age (&gt##2##3##(2007-7#1)(2013-8#1)
older age (OR##2##3##(2010-11#1)(2010-4#1)
older age and##2##3##(2005-12#1)(2012-11#1)
older age at##2##3##(2007-1#1)(2007-10#1)
older age group##6##3##(1994-4#1)(1996-11#1)(2007-3#1)(2007-7#1)(2008-9#1)(2012-2#1)
older age groups##14##3##(2005-11#1)(2005-12#1)(2005-9#1)(2006-2#2)(2006-4#1)(2007-10#1)(2007-7#1)(2008-5#1)(2008-9#1)(2009-7#1)(2011-2#1)(2013-1#2)
older age##47##2##(1993-12#1)(1994-4#1)(1995-10#1)(1996-11#1)(1997-5#1)(2005-11#1)(2005-12#2)(2005-9#1)(2006-10#1)(2006-2#2)(2006-4#1)(2006-7#1)(2007-1#1)(2007-10#4)(2007-3#1)(2007-7#3)(2008-1#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-4#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
older age-groups##2##2##(1997-7#1)(2009-5#1)
older agents##3##2##(1993-12#1)(2006-10#1)(2008-3#1)
older ages and##2##3##(1991-5#1)(2011-2#1)
older ages##10##2##(1990-4#1)(1991-5#1)(1992-6#2)(1992-9#2)(2007-7#1)(2009-7#2)(2011-2#1)
older and had higher##2##4##(2007-8#1)(2008-3#1)
older and had##3##3##(1994-12#1)(2007-8#1)(2008-3#1)
older and have##3##3##(2007-1#1)(2008-4#1)(2011-2#1)
older and more##5##3##(1997-1#1)(2007-8#1)(2008-1#1)(2008-10#1)(2010-12#1)
older and younger##5##3##(1994-6#1)(2006-8#1)(2007-1#1)(2009-8#2)
older and##34##2##(1990-5#1)(1992-6#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-2#1)(1996-3#1)(1997-1#1)(2005-4#1)(2006-12#1)(2006-8#1)(2007-1#2)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-4#1)(2009-8#2)(2010-12#1)(2011-2#7)(2012-3#1)(2013-8#1)
older animals##10##2##(1990-3#1)(1991-6#1)(1993-12#1)(1994-5#2)(1995-12#1)(2008-3#1)(2009-12#1)(2010-2#1)(2012-2#1)
older antidepressant##2##2##(2008-7#2)
older antidepressants##2##2##(2004-3#1)(2005-10#1)
older as##2##2##(2009-5#1)(2010-3#1)
older at##4##2##(2006-10#1)(2010-11#2)(2010-4#1)
older athletes##4##2##(2013-1#4)
older berries##5##2##(2008-10#5)
older brother##3##2##(1994-2#1)(2004-11#2)
older cells##2##2##(1994-5#2)
older chickens##2##2##(2005-9#1)(2008-5#1)
older child##3##2##(2005-11#1)(2008-2#1)(2008-9#1)
older children and adolescents##5##4##(1995-12#2)(2006-8#1)(2010-7#1)(2011-2#1)
older children and adults##9##4##(1992-10#2)(1996-2#1)(2008-11#1)(2008-4#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
older children and##17##3##(1992-10#2)(1995-12#2)(1996-2#1)(2006-5#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-11#1)(2009-9#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#1)
older children with##5##3##(1991-2#2)(1995-4#1)(2007-8#1)(2013-1#1)
older children##49##2##(1991-2#2)(1992-10#2)(1992-3#1)(1993-3#1)(1994-12#1)(1995-12#2)(1995-2#1)(1995-4#1)(1996-2#2)(1996-3#1)(2005-11#1)(2005-2#1)(2005-8#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-11#2)(2009-3#1)(2009-4#2)(2009-9#1)(2010-10#1)(2010-3#2)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#4)
older compared to younger##2##4##(2010-2#1)(2012-2#1)
older control##4##2##(2008-10#4)
older counterparts##2##2##(2006-11#1)(2010-9#1)
older discourse of art##2##4##(2013-1#2)
older dogs##3##2##(1996-12#1)(2012-3#2)
older donors##2##2##(2011-2#2)
older drivers##5##2##(1992-6#1)(2012-12#4)
older drivers' simulator performance##2##4##(2012-12#2)
older drivers'##5##2##(2012-12#5)
older drug##2##2##(2005-9#1)(2012-11#1)
older females##3##2##(2008-4#2)(2012-12#1)
older formulations##2##2##(2008-2#1)(2008-4#1)
older group had##2##3##(2006-8#1)(2010-2#1)
older group##9##2##(2006-10#2)(2006-8#1)(2007-1#1)(2007-9#1)(2008-6#1)(2010-2#1)(2011-2#1)(2012-12#1)
older groups##4##2##(2006-10#1)(2007-9#1)(2008-6#2)
older healthy##4##2##(1992-9#1)(1994-4#1)(2006-6#1)(2013-1#1)
older in##3##2##(2011-1#1)(2011-2#1)(2012-3#1)
older individual##2##2##(1990-3#1)(2011-2#1)
older individuals with##3##3##(2007-12#1)(2008-7#1)(2008-8#1)
older individuals##18##2##(1993-9#1)(1995-5#1)(2006-3#1)(2007-12#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-9#5)(2012-1#1)
older infants and##2##3##(2006-10#1)(2010-12#1)
older infants##5##2##(1992-7#1)(2006-10#1)(2006-7#1)(2007-11#1)(2010-12#1)
older leaves##2##2##(2008-10#2)
older males##2##2##(1992-4#1)(2013-8#1)
older men and women##6##4##(1991-11#1)(1995-3#1)(2007-11#1)(2009-11#1)(2009-5#1)(2012-12#1)
older men and##8##3##(1991-11#1)(1995-3#1)(2006-10#1)(2007-11#1)(2009-11#1)(2009-5#2)(2012-12#1)
older men with heart trouble##2##5##(2009-7#2)
older men with##5##3##(2008-4#2)(2009-6#1)(2009-7#2)
older men##20##2##(1991-11#1)(1995-3#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-7#1)(2009-11#1)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#2)(2012-12#1)
older mothers##4##2##(1997-3#2)(2010-2#2)
older observers##2##2##(2012-11#2)
older ones##3##2##(1991-2#1)(1992-8#1)(1995-5#1)
older participants##4##2##(2005-10#1)(2009-3#1)(2012-1#1)(2012-12#1)
older patient##2##2##(2009-11#1)(2010-10#1)
older patients and##4##3##(2007-11#1)(2007-12#1)(2010-2#1)(2011-2#1)
older patients as##2##3##(2010-12#1)(2011-2#1)
older patients with cancer##5##4##(2008-7#2)(2010-11#3)
older patients with type 2 diabetes mellitus##2##7##(2013-1#2)
older patients with##23##3##(1991-1#1)(1992-9#2)(1996-7#1)(2007-7#1)(2007-8#2)(2008-5#1)(2008-7#2)(2010-10#1)(2010-11#4)(2010-8#1)(2011-1#1)(2011-2#3)(2012-11#1)(2013-1#2)
older patients##80##2##(1990-12#1)(1991-1#2)(1991-12#1)(1992-9#2)(1995-10#2)(1995-5#1)(1996-3#1)(1996-7#2)(1996-9#1)(1997-1#2)(2004-2#1)(2006-11#1)(2006-12#1)(2006-7#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2009-11#3)(2010-10#2)(2010-11#4)(2010-12#3)(2010-2#2)(2010-3#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#11)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#2)
older people and their##3##4##(1997-3#1)(2010-10#1)(2011-1#1)
older people and##5##3##(1997-3#1)(2010-10#2)(2011-1#1)(2013-1#1)
older people as well as##2##5##(2010-10#2)
older people as##3##3##(2010-10#3)
older people experience a##2##4##(2013-8#2)
older people in the##2##4##(2008-6#1)(2011-2#1)
older people in their own##2##5##(2010-10#2)
older people in##11##3##(1991-2#1)(2006-4#2)(2008-6#1)(2008-7#1)(2009-3#1)(2010-10#4)(2011-2#1)
older people is##2##3##(2008-3#1)(2010-10#1)
older people to remain##3##4##(2010-10#1)(2013-1#2)
older people to##4##3##(2010-10#2)(2013-1#2)
older people with dementia##2##4##(1991-1#1)(2011-2#1)
older people with##5##3##(1991-1#1)(2007-1#1)(2010-8#1)(2011-2#1)(2013-8#1)
older people##98##2##(1991-1#1)(1991-2#1)(1994-12#1)(1994-7#1)(1995-3#1)(1996-11#4)(1997-3#3)(2006-4#2)(2007-1#1)(2007-7#2)(2008-1#2)(2008-2#1)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#4)(2009-3#2)(2009-4#1)(2010-10#32)(2010-3#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#8)(2012-12#3)(2012-3#3)(2013-1#3)(2013-8#7)
older people's dignity##2##3##(2010-10#2)
older people's lived experiences##2##4##(2010-10#2)
older people's##6##2##(2010-10#5)(2011-2#1)
older person with##2##3##(2005-4#1)(2011-1#1)
older person##10##2##(1995-1#1)(2005-4#3)(2010-10#5)(2011-1#1)
older persons and##2##3##(1990-12#1)(2012-2#1)
older persons in the##2##4##(1997-3#1)(2009-1#1)
older persons in##6##3##(1995-1#1)(1997-2#1)(1997-3#1)(2009-1#1)(2010-10#2)
older persons##21##2##(1990-12#2)(1993-10#1)(1994-2#1)(1995-1#2)(1997-2#1)(1997-3#1)(2006-10#3)(2008-3#2)(2009-1#1)(2010-10#4)(2011-1#1)(2011-2#1)(2012-2#1)
older population in##2##3##(2006-2#1)(2011-2#1)
older population##10##2##(1991-6#1)(2006-2#1)(2008-3#1)(2009-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)
older populations##2##2##(1990-11#1)(2011-2#1)
older pregnant women##2##3##(2011-1#2)
older rats##4##2##(1990-3#1)(1993-12#1)(1993-2#1)(1995-12#1)
older recipient age##2##3##(2007-11#1)(2007-8#1)
older siblings##2##2##(2006-10#1)(2008-9#1)
older sisters##3##2##(1992-12#1)(2006-7#2)
older subjects were##3##3##(2006-9#1)(2007-9#1)(2008-7#1)
older subjects##16##2##(1995-5#1)(1996-2#1)(2005-10#1)(2006-9#5)(2007-9#2)(2008-10#1)(2008-3#2)(2008-6#1)(2008-7#2)
older taxa have older##2##4##(2008-11#2)
older techniques##2##2##(2006-10#2)
older than 1 year##2##4##(2006-7#1)(2013-1#1)
older than 12##2##3##(2008-7#1)(2011-2#1)
older than 18 years##2##4##(2010-5#1)(2011-1#1)
older than 2 years##2##4##(2007-9#2)
older than 2##3##3##(2007-9#2)(2011-2#1)
older than 30##3##3##(2006-10#1)(2008-10#1)(2008-7#1)
older than 35##2##3##(2007-8#1)(2013-1#1)
older than 50 years##3##4##(1993-8#1)(2007-12#1)(2012-1#1)
older than 60 years of age##2##6##(1996-11#1)(2007-12#1)
older than 60 years##13##4##(1990-12#1)(1990-5#1)(1992-7#1)(1995-9#1)(1996-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2009-12#1)(2011-2#3)(2012-3#1)
older than 60##15##3##(1990-12#1)(1990-5#1)(1992-7#1)(1995-9#1)(1996-1#1)(1996-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-4#1)(2009-12#1)(2011-2#3)(2012-3#1)
older than 65 years of age##5##6##(2010-3#1)(2010-9#1)(2011-2#3)
older than 65 years##17##4##(1992-5#1)(1995-10#1)(2006-8#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#6)(2012-3#1)(2013-1#1)
older than 65##21##3##(1990-2#1)(1992-5#1)(1995-10#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-3#1)(2010-4#2)(2010-9#1)(2011-2#6)(2012-3#1)(2013-1#1)
older than 70 years##5##4##(1996-2#1)(2007-8#2)(2010-12#1)(2011-2#1)
older than 75 years##3##4##(2005-2#1)(2008-3#1)(2008-4#1)
older than 75##4##3##(1992-6#1)(2005-2#1)(2008-3#1)(2008-4#1)
older than age##3##3##(1997-3#1)(2006-5#1)(2007-12#1)
older than the##6##3##(1990-3#1)(1994-6#1)(1996-9#1)(2007-8#1)(2008-12#1)(2009-2#1)
older than two##2##3##(1994-6#1)(2010-10#1)
older than##105##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-8#1)(1994-3#1)(1994-6#3)(1995-10#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-3#1)(2005-2#1)(2006-10#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#7)(2007-9#5)(2008-1#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#6)(2008-8#1)(2009-1#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#14)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
older the##2##2##(1992-6#1)(1993-3#1)
older units of PRBC##2##4##(2010-7#2)
older users##2##2##(2012-11#2)
older volunteers##3##2##(1991-12#1)(1996-3#1)(2008-3#1)
older were##4##2##(1992-5#1)(2006-8#1)(2009-4#1)(2009-8#1)
older white men##2##3##(2009-5#1)(2009-7#1)
older with##6##2##(2007-10#1)(2008-4#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-2#1)
older women in##2##3##(2006-7#1)(2008-3#1)
older women##43##2##(1992-4#1)(1994-2#1)(1996-8#1)(2004-10#2)(2005-12#1)(2005-3#1)(2005-7#2)(2006-7#1)(2008-1#1)(2008-10#1)(2008-3#7)(2008-7#2)(2009-10#1)(2010-10#4)(2010-8#1)(2011-1#2)(2011-2#5)(2012-12#4)(2012-2#1)(2013-1#4)
older workers##3##2##(2008-6#3)
older##1243##1##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#10)(1990-2#1)(1990-3#7)(1990-4#3)(1990-5#3)(1990-6#1)(1990-9#1)(1991-1#6)(1991-10#2)(1991-11#4)(1991-12#4)(1991-2#5)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#4)(1992-10#3)(1992-12#5)(1992-3#4)(1992-4#3)(1992-5#2)(1992-6#9)(1992-7#3)(1992-8#1)(1992-9#8)(1993-1#1)(1993-10#3)(1993-12#6)(1993-2#5)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#3)(1994-2#4)(1994-3#4)(1994-4#3)(1994-5#4)(1994-6#5)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#3)(1995-10#4)(1995-11#1)(1995-12#7)(1995-2#3)(1995-3#3)(1995-4#1)(1995-5#5)(1995-8#1)(1995-9#3)(1996-1#2)(1996-11#6)(1996-12#2)(1996-2#7)(1996-3#6)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#4)(1997-2#2)(1997-3#9)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-10#4)(2004-11#5)(2004-2#1)(2004-3#1)(2005-10#7)(2005-11#3)(2005-12#3)(2005-2#2)(2005-3#2)(2005-4#4)(2005-7#2)(2005-8#1)(2005-9#3)(2006-10#24)(2006-11#2)(2006-12#5)(2006-2#4)(2006-3#3)(2006-4#3)(2006-5#3)(2006-6#3)(2006-7#12)(2006-8#9)(2006-9#7)(2007-1#13)(2007-10#12)(2007-11#11)(2007-12#18)(2007-2#2)(2007-3#3)(2007-4#2)(2007-5#1)(2007-7#18)(2007-8#18)(2007-9#12)(2008-1#14)(2008-10#39)(2008-11#18)(2008-12#7)(2008-2#4)(2008-3#37)(2008-4#26)(2008-5#12)(2008-6#12)(2008-7#28)(2008-8#4)(2008-9#9)(2009-1#2)(2009-10#3)(2009-11#14)(2009-12#7)(2009-2#2)(2009-3#7)(2009-4#15)(2009-5#11)(2009-6#4)(2009-7#11)(2009-8#8)(2009-9#2)(2010-1#5)(2010-10#68)(2010-11#14)(2010-12#11)(2010-2#14)(2010-3#9)(2010-4#8)(2010-5#3)(2010-6#3)(2010-7#8)(2010-8#16)(2010-9#7)(2011-1#39)(2011-11#2)(2011-12#1)(2011-2#79)(2012-1#13)(2012-11#14)(2012-12#43)(2012-2#25)(2012-3#14)(2013-1#74)(2013-7#3)(2013-8#20)
older) were enrolled##2##3##(1990-3#1)(1995-9#1)
older) were##3##2##(1990-3#1)(1993-2#1)(1995-9#1)
older)##13##1##(1990-3#1)(1991-9#1)(1992-1#1)(1993-2#1)(1995-9#1)(2006-1#1)(2006-10#1)(2007-1#1)(2007-7#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-11#1)
older-generation intermittent pneumatic compression devices##2##5##(2010-2#2)
older-specific##4##1##(2013-1#4)
olderthan##2##1##(2009-8#2)
oldest age groups##2##3##(1993-12#1)(2008-7#1)
oldest age##7##2##(1992-8#1)(1993-12#1)(2006-8#1)(2008-7#1)(2011-2#1)(2012-3#2)
oldest child##2##2##(2011-2#1)(2013-1#1)
oldest known##8##2##(1990-3#1)(1997-1#1)(2006-7#1)(2007-7#1)(2007-9#2)(2008-1#1)(2010-4#1)
oldest old##9##2##(1994-5#2)(1994-6#2)(2007-10#1)(2010-12#1)(2010-3#3)
oldest##96##1##(1990-3#3)(1991-6#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-4#1)(1994-11#1)(1994-5#2)(1994-6#2)(1994-9#1)(1995-7#1)(1996-11#3)(1996-2#1)(1996-6#1)(1997-1#2)(2006-1#1)(2006-10#5)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#5)(2008-1#2)(2008-10#4)(2008-7#3)(2009-4#3)(2009-7#2)(2010-10#1)(2010-12#2)(2010-3#5)(2010-4#2)(2010-7#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#2)
olds and##4##2##(2006-10#1)(2007-2#2)(2009-2#1)
olds in##2##2##(1996-2#1)(2010-11#1)
olds##21##1##(1996-2#1)(1997-6#1)(1997-8#1)(2006-10#2)(2006-8#1)(2007-2#7)(2009-10#1)(2009-2#1)(2010-11#1)(2010-3#1)(2011-2#2)(2013-1#1)(2013-8#1)
oleaginous yeast Cryptococcus curvatus##2##4##(1996-6#2)
oleaginous yeast##5##2##(1996-6#2)(2011-1#2)(2013-1#1)
oleaginous##7##1##(1996-6#2)(2011-1#2)(2013-1#3)
oleander leaf##3##2##(2008-10#3)
oleander##11##1##(2008-10#9)(2008-12#2)
oleanders##2##1##(2008-10#2)
oleandomycin##3##1##(1993-11#3)
oleane type##2##2##(1991-10#2)
oleanolate##2##1##(1994-3#1)(2007-1#1)
oleanolic acid and##2##3##(2007-1#1)(2012-12#1)
oleanolic acid##10##2##(1994-3#3)(2007-1#2)(2008-5#1)(2011-1#1)(2012-12#2)(2012-2#1)
oleate (18##2##2##(1990-2#1)(1991-2#1)
oleate was##2##2##(1990-8#2)
oleate with a##2##3##(1991-8#1)(1994-8#1)
oleate with##3##2##(1991-8#1)(1994-8#1)(1995-11#1)
oleate##38##1##(1990-2#1)(1990-8#4)(1991-2#1)(1991-8#3)(1992-3#1)(1992-8#3)(1993-11#2)(1993-9#5)(1994-8#4)(1994-9#2)(1995-1#2)(1995-11#2)(2005-11#2)(2005-7#1)(2007-1#1)(2007-9#1)(2008-10#1)(2010-12#1)(2010-7#1)
olecranon##10##1##(2006-10#2)(2006-3#1)(2007-2#1)(2009-3#1)(2011-2#1)(2013-8#4)
olefin metathesis##2##2##(2006-4#1)(2009-10#1)
olefin polymer-coated silver##2##3##(2007-12#1)(2008-2#1)
olefin##11##1##(1995-10#1)(1996-5#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-2#2)(2009-10#1)(2009-6#1)
olefination##2##1##(2007-11#1)(2008-8#1)
olefinic##2##1##(1995-11#1)(1997-4#1)
olefins##13##1##(1997-7#1)(2006-12#2)(2007-10#1)(2007-11#2)(2008-10#1)(2008-8#1)(2010-2#1)(2010-4#1)(2010-6#2)(2011-2#1)
oleic (C18##2##2##(2008-10#1)(2008-11#1)
oleic acid (0##2##3##(1992-2#1)(2008-10#1)
oleic acid (18##3##3##(1993-6#1)(2006-12#1)(2007-8#1)
oleic acid and##4##3##(1996-4#1)(2005-11#1)(2010-4#1)(2010-7#1)
oleic acid in##3##3##(1990-5#1)(1990-7#1)(2004-8#1)
oleic acid on the##2##4##(2005-11#1)(2009-2#1)
oleic acid on##5##3##(1992-2#1)(2005-11#3)(2009-2#1)
oleic acid to##3##3##(1992-12#1)(1993-9#1)(1996-6#1)
oleic acid##64##2##(1990-2#1)(1990-4#2)(1990-5#2)(1990-7#3)(1990-8#1)(1991-8#1)(1992-12#1)(1992-2#4)(1992-8#1)(1993-6#4)(1993-9#4)(1994-2#1)(1994-3#1)(1996-4#2)(1996-5#1)(1996-6#2)(2004-11#3)(2004-8#2)(2005-11#10)(2006-11#2)(2006-12#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-12#1)(2010-4#1)(2010-7#1)(2012-12#1)
oleic acid)##2##2##(2008-10#1)(2009-11#1)
oleic acid-responsive##4##2##(1991-8#4)
oleic and##4##2##(1994-8#1)(1996-4#1)(2008-11#1)(2008-12#1)
oleic or##2##2##(1994-2#1)(1994-8#1)
oleic##93##1##(1990-2#3)(1990-4#2)(1990-5#2)(1990-7#3)(1990-8#1)(1991-5#1)(1991-8#5)(1992-12#1)(1992-2#4)(1992-8#1)(1993-6#4)(1993-9#4)(1994-11#1)(1994-2#2)(1994-3#1)(1994-8#2)(1995-7#1)(1996-4#3)(1996-5#1)(1996-6#2)(2004-11#3)(2004-8#2)(2005-11#10)(2006-11#2)(2006-12#3)(2006-9#1)(2007-11#1)(2007-8#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-2#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-7#1)(2012-12#1)(2013-1#2)
oleophila##10##1##(2008-10#10)
oleophobic##3##1##(2005-11#2)(2010-4#1)
oleosin knockdown shows##2##3##(2009-10#2)
oleosin knockdown##4##2##(2009-10#4)
oleosin##11##1##(2006-12#1)(2009-10#8)(2011-2#2)
oleoyl and##2##2##(2004-8#2)
oleoyl##4##1##(1994-11#1)(2004-8#3)
oleracea##17##1##(1992-12#1)(1994-9#1)(2008-10#10)(2008-8#1)(2012-3#3)(2013-1#1)
oleracea)##5##1##(1994-9#1)(2008-10#4)
oleuropein and hydroxytyrosol##3##3##(2006-12#3)
oleuropein and##4##2##(2006-12#3)(2010-12#1)
oleuropein##5##1##(2006-12#3)(2010-12#2)
oleyl##2##1##(1990-7#1)(2013-7#1)
olfaction and##2##2##(2008-9#2)
olfaction##10##1##(1991-1#1)(1993-3#1)(2006-12#1)(2008-11#1)(2008-2#1)(2008-9#3)(2012-2#2)
olfactive character##2##2##(2008-5#2)
olfactive##4##1##(1992-9#1)(2006-12#1)(2008-5#2)
olfactometer##7##1##(2004-11#3)(2007-6#1)(2009-8#1)(2011-12#1)(2013-8#1)
olfactorily##2##1##(1997-7#1)(2006-12#1)
olfactory and male reproductive##2##4##(1996-10#2)
olfactory and##7##2##(1990-2#1)(1994-3#1)(1996-10#2)(1996-9#1)(1997-3#1)(2007-11#1)
olfactory axons##3##2##(1992-8#1)(1993-6#2)
olfactory bulb (OB)##8##3##(1990-7#1)(1991-9#1)(1992-8#1)(1996-7#2)(2009-10#1)(2012-2#1)(2013-1#1)
olfactory bulb and##11##3##(1990-6#1)(1990-7#1)(1991-9#1)(1992-8#1)(1997-4#1)(2008-11#1)(2009-12#2)(2013-1#3)
olfactory bulb during##2##3##(1996-3#2)
olfactory bulb in vitro##3##4##(1996-5#1)(1996-7#2)
olfactory bulb in##4##3##(1996-5#1)(1996-7#2)(2009-12#1)
olfactory bulb of##7##3##(1995-12#1)(1995-5#1)(1997-7#1)(2008-7#4)
olfactory bulb synaptosomes##2##3##(1995-5#2)
olfactory bulb##99##2##(1990-10#1)(1990-11#2)(1990-2#2)(1990-6#2)(1990-7#4)(1991-6#2)(1991-9#2)(1992-3#2)(1992-7#1)(1992-8#9)(1993-3#1)(1993-6#2)(1993-7#3)(1994-10#1)(1995-11#1)(1995-12#3)(1995-5#11)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-7#4)(1997-3#4)(1997-4#1)(1997-7#4)(2006-6#1)(2007-5#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#5)(2009-10#1)(2009-12#7)(2012-2#3)(2013-1#5)
olfactory bulbs and##2##3##(1993-6#1)(1997-3#1)
olfactory bulbs of##2##3##(1992-5#1)(2008-7#1)
olfactory bulbs##12##2##(1992-5#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-5#2)(1996-10#1)(1996-5#2)(1997-3#1)(2008-7#1)
olfactory conditioning##2##2##(1994-8#2)
olfactory cortex##2##2##(1991-9#1)(2011-2#1)
olfactory cortical##2##2##(1991-9#1)(1996-3#1)
olfactory cues##7##2##(1992-9#1)(2007-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2012-2#1)
olfactory deficits##2##2##(1996-3#1)(2008-11#1)
olfactory deprivation##2##2##(1995-12#2)
olfactory ensheathing cells (OECs)##2##4##(2006-6#1)(2008-7#1)
olfactory ensheathing cells##5##3##(2006-6#2)(2008-7#3)
olfactory ensheathing##7##2##(2006-6#2)(2008-7#5)
olfactory epithelium by##2##3##(1994-5#1)(2008-5#1)
olfactory epithelium of##2##3##(2012-2#2)
olfactory epithelium##18##2##(1991-5#1)(1993-6#1)(1994-5#3)(1995-12#1)(1997-4#3)(2008-5#3)(2008-6#1)(2012-1#2)(2012-2#3)
olfactory function##3##2##(1997-8#1)(2007-12#1)(2008-3#1)
olfactory groove meningioma##3##3##(2006-12#2)(2008-8#1)
olfactory groove meningiomas##3##3##(2006-12#3)
olfactory groove##9##2##(2006-12#8)(2008-8#1)
olfactory identification##4##2##(1997-8#4)
olfactory information##5##2##(1992-5#1)(1992-8#1)(1996-6#3)
olfactory learning in##2##3##(2009-8#1)(2012-2#1)
olfactory learning##12##2##(1991-1#1)(1994-3#1)(1995-5#1)(2007-12#1)(2009-8#3)(2011-2#1)(2012-2#4)
olfactory lobe##2##2##(2007-12#2)
olfactory lobes of ethanol treated male rats##2##7##(1993-6#2)
olfactory memory formation##3##3##(1997-7#3)
olfactory memory##5##2##(1994-2#1)(1997-7#3)(2008-4#1)
olfactory mucosa##3##2##(1991-2#3)
olfactory nerve input is##2##4##(1992-8#2)
olfactory nerve input##3##3##(1992-8#3)
olfactory nerve##17##2##(1992-8#7)(1993-3#1)(1995-12#4)(1996-3#1)(1996-7#2)(2008-5#2)
olfactory neuroblastoma##3##2##(1992-8#1)(2010-7#2)
olfactory neuroblasts##2##2##(1995-5#2)
olfactory neuroepithelium##3##2##(1991-2#1)(1997-2#2)
olfactory neurons##5##2##(1991-5#2)(1995-5#2)(2006-12#1)
olfactory notes##2##2##(2012-2#2)
olfactory nuclei##3##2##(1995-5#3)
olfactory organs##2##2##(2007-12#2)
olfactory pathway of##2##3##(2007-12#1)(2013-8#1)
olfactory pathway##5##2##(2007-12#3)(2012-2#1)(2013-8#1)
olfactory properties##3##2##(2006-12#3)
olfactory receptor gene family##2##4##(1996-10#2)
olfactory receptor neurons (ORNs)##2##4##(2007-12#2)
olfactory receptor neurons##5##3##(2007-12#4)(2009-12#1)
olfactory receptor##11##2##(1996-10#3)(1997-4#1)(2007-12#5)(2009-12#2)
olfactory receptors##2##2##(1992-8#1)(2006-12#1)
olfactory regions##2##2##(1995-5#2)
olfactory responses##2##2##(1994-5#2)
olfactory sense##2##2##(2008-5#1)(2012-2#1)
olfactory sensilla##6##2##(2007-12#4)(2008-7#1)(2013-8#1)
olfactory sensory units##3##3##(2007-12#3)
olfactory sensory##4##2##(2007-12#3)(2013-8#1)
olfactory signal termination##2##3##(1991-2#2)
olfactory stimulation##2##2##(1994-8#1)(2008-10#1)
olfactory stimuli##2##2##(1993-7#1)(1995-12#1)
olfactory system##20##2##(1990-5#1)(1991-11#3)(1993-6#1)(1994-10#2)(1995-5#1)(1997-3#1)(1997-4#1)(2007-12#3)(2008-11#2)(2008-6#1)(2008-7#2)(2009-12#1)(2012-2#1)
olfactory systems##4##2##(2006-12#1)(2007-12#1)(2008-7#1)(2009-10#1)
olfactory tests##2##2##(2012-2#2)
olfactory tract transection##2##3##(2013-1#2)
olfactory tract##10##2##(1994-10#1)(1995-5#1)(1996-7#1)(1997-3#2)(1997-6#1)(2008-6#1)(2013-1#3)
olfactory tubercle and##2##3##(1996-12#1)(1996-4#1)
olfactory tubercle##10##2##(1991-2#2)(1991-5#1)(1992-7#1)(1993-6#1)(1996-12#4)(1996-4#1)
olfactory##411##1##(1990-10#2)(1990-11#3)(1990-2#3)(1990-5#3)(1990-6#2)(1990-7#4)(1991-1#2)(1991-11#3)(1991-2#13)(1991-5#4)(1991-6#2)(1991-9#6)(1992-3#2)(1992-5#3)(1992-7#2)(1992-8#23)(1992-9#1)(1993-12#1)(1993-3#5)(1993-6#11)(1993-7#4)(1994-10#4)(1994-2#2)(1994-3#3)(1994-5#6)(1994-8#3)(1995-11#1)(1995-12#13)(1995-3#1)(1995-5#29)(1996-10#8)(1996-12#6)(1996-3#10)(1996-4#2)(1996-5#5)(1996-6#3)(1996-7#7)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#10)(1997-4#6)(1997-5#1)(1997-6#1)(1997-7#9)(1997-8#6)(2006-12#19)(2006-2#1)(2006-5#1)(2006-6#3)(2007-11#1)(2007-12#37)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#7)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#11)(2008-6#6)(2008-7#16)(2008-8#1)(2009-10#2)(2009-12#10)(2009-8#3)(2010-7#2)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#2)(2012-2#22)(2013-1#8)(2013-8#3)
olfactory-specific##4##1##(1991-2#4)
oligandrin treatment##2##2##(2008-10#2)
oligandrin##6##1##(2008-10#6)
oligandrum and##4##2##(2008-10#4)
oligandrum isolates##2##2##(2008-10#2)
oligandrum or oligandrin were##2##4##(2008-10#2)
oligandrum or##3##2##(2008-10#3)
oligandrum was##3##2##(2008-10#3)
oligandrum##29##1##(2008-10#29)
oligo allows##2##2##(1991-7#2)
oligo decoys##2##2##(2008-9#2)
oligo##21##1##(1990-10#2)(1990-5#1)(1991-7#4)(1991-8#3)(1992-11#1)(1996-5#1)(2007-12#1)(2007-2#4)(2008-10#1)(2008-9#3)
oligo(dN)##5##1##(1991-12#5)
oligo(dT)##8##1##(1990-7#3)(1991-12#1)(1993-11#1)(1996-2#1)(2008-10#1)(2008-4#1)
oligo(ethylene oxide) dodecyl ethers##2##4##(1994-12#2)
oligo(ethylene##4##1##(1994-12#2)(2008-10#1)(2008-4#1)
oligo- and##4##2##(1993-6#1)(1997-1#1)(2008-5#2)
oligo-##6##1##(1993-6#1)(1997-1#1)(2005-12#1)(2008-5#2)(2008-6#1)
oligo-1##4##1##(1997-5#4)
oligo-anuric##3##1##(2005-12#1)(2008-4#2)
oligo-gene##2##1##(2007-12#2)
oligoadenylates##2##1##(1994-11#2)
oligoanovulation##2##1##(1994-11#1)(2009-3#1)
oligoarthritis in##2##2##(2006-10#1)(2007-11#1)
oligoarthritis##10##1##(1990-6#1)(1992-11#2)(2006-10#3)(2007-11#1)(2008-7#1)(2012-2#2)
oligochaeta##2##1##(2011-1#2)
oligoclonal bands##2##2##(1997-8#1)(2009-10#1)
oligoclonal expansions of CD8+ T cells##2##6##(1996-4#2)
oligoclonal##9##1##(1991-12#1)(1996-4#2)(1997-8#1)(2008-11#2)(2009-10#1)(2011-1#1)(2011-2#1)
oligodendrocyte development##2##2##(1996-12#1)(2012-2#1)
oligodendrocyte differentiation##3##2##(2008-7#1)(2009-9#1)(2012-2#1)
oligodendrocyte precursor cells##3##3##(2007-9#1)(2008-7#2)
oligodendrocyte precursor##4##2##(2007-9#1)(2008-7#2)(2012-2#1)
oligodendrocyte progenitor##3##2##(2008-12#1)(2008-7#1)(2010-12#1)
oligodendrocyte progenitors##4##2##(1996-12#2)(2008-7#2)
oligodendrocyte##29##1##(1995-12#1)(1996-12#6)(1996-5#1)(1996-8#3)(2006-11#1)(2007-9#1)(2008-12#1)(2008-7#8)(2009-9#1)(2010-12#1)(2012-12#1)(2012-2#4)
oligodendrocytes (OLs)##2##2##(2006-9#1)(2008-7#1)
oligodendrocytes and astrocytes##6##3##(1996-5#3)(1996-8#1)(2008-11#1)(2008-7#1)
oligodendrocytes and neurons##2##3##(1994-6#1)(2008-7#1)
oligodendrocytes and##14##2##(1994-6#1)(1994-9#1)(1996-5#4)(1996-8#2)(2006-11#1)(2006-8#1)(2008-11#1)(2008-7#3)
oligodendrocytes as##2##2##(1991-5#1)(2007-10#1)
oligodendrocytes but##3##2##(1995-7#1)(1997-4#1)(2009-6#1)
oligodendrocytes from##2##2##(1991-5#1)(2008-7#1)
oligodendrocytes in##6##2##(1991-5#1)(1995-5#1)(2007-10#2)(2012-2#1)(2013-8#1)
oligodendrocytes##80##1##(1990-7#1)(1991-5#4)(1994-6#1)(1994-9#4)(1995-12#3)(1995-5#3)(1995-7#1)(1996-12#2)(1996-2#1)(1996-5#13)(1996-6#1)(1996-8#4)(1997-4#6)(2006-11#1)(2006-8#1)(2006-9#2)(2007-10#6)(2007-9#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#11)(2009-4#2)(2009-6#2)(2012-2#1)(2013-8#2)
oligodendrogenesis and##2##2##(2008-7#1)(2012-2#1)
oligodendrogenesis##5##1##(2008-7#3)(2012-2#2)
oligodendroglia and microglia in##2##4##(1997-5#2)
oligodendroglia##3##1##(1997-5#3)
oligodendroglial and endothelial progenitor cells##2##5##(2010-12#2)
oligodendroglial##5##1##(1991-5#2)(2008-7#1)(2010-12#2)
oligodendroglioma##14##1##(1994-8#2)(1996-4#1)(2005-10#1)(2006-12#3)(2007-10#3)(2011-1#3)(2012-1#1)
oligodendrogliomas##3##1##(1991-8#1)(2006-12#1)(2008-11#1)
oligodeoxynucleotide decoys##2##2##(2008-9#2)
oligodeoxynucleotide phosphorothioate##2##2##(1995-3#2)
oligodeoxynucleotide##32##1##(1990-10#1)(1990-2#2)(1990-9#1)(1991-1#1)(1991-6#2)(1992-9#1)(1993-6#1)(1994-11#1)(1995-10#4)(1995-12#1)(1995-3#5)(1996-1#3)(2007-1#1)(2008-11#2)(2008-4#1)(2008-9#3)(2011-2#1)(2012-2#1)
oligodeoxynucleotides (ODNs)##3##2##(1996-12#1)(2008-10#2)
oligodeoxynucleotides containing##3##2##(1995-8#1)(2008-4#1)(2009-3#1)
oligodeoxynucleotides in##2##2##(1990-11#1)(2008-4#1)
oligodeoxynucleotides with##2##2##(1995-1#1)(2008-4#1)
oligodeoxynucleotides##44##1##(1990-11#2)(1990-2#1)(1991-12#1)(1992-6#3)(1993-3#3)(1993-6#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#5)(1996-12#1)(1996-7#1)(2007-2#1)(2008-10#8)(2008-11#1)(2008-4#6)(2008-9#1)(2009-3#2)(2011-2#1)(2013-8#1)
oligodeoxyribonucleotide (oligo)##2##2##(1991-7#1)(1993-12#1)
oligodeoxyribonucleotide primers##7##2##(1990-11#1)(1991-12#1)(1991-5#1)(1993-7#1)(1993-9#1)(1994-12#2)
oligodeoxyribonucleotide synthesis##3##2##(1991-8#1)(2008-4#2)
oligodeoxyribonucleotide##28##1##(1990-11#3)(1990-5#3)(1991-12#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-7#1)(1993-9#1)(1994-12#2)(1995-3#1)(1995-5#1)(1997-4#1)(1997-7#1)(2005-11#1)(2008-4#3)
oligodeoxyribonucleotides (oligos) designed##2##3##(1993-6#1)(1995-2#1)
oligodeoxyribonucleotides (oligos)##6##2##(1990-10#1)(1991-12#1)(1991-7#1)(1991-8#1)(1993-6#1)(1995-2#1)
oligodeoxyribonucleotides derived from##2##3##(1994-12#1)(1996-11#1)
oligodeoxyribonucleotides to##2##2##(1994-12#1)(2008-4#1)
oligodeoxyribonucleotides##40##1##(1990-10#1)(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-2#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#3)(1995-2#1)(1995-8#1)(1996-11#1)(1997-2#1)(2005-11#2)(2006-12#2)(2008-4#12)
oligodontia##4##1##(2008-5#1)(2011-1#3)
oligodontia)##2##1##(2011-1#2)
oligoelements##2##1##(2004-12#1)(2011-2#1)
oligofructose and##2##2##(2006-8#2)
oligogenic##2##1##(2008-10#1)(2008-4#1)
oligoglycosyl fragments##2##2##(1991-9#2)
oligoglycosyl##3##1##(1991-9#3)
oligohydramnios##8##1##(1996-6#1)(2008-7#2)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
oligohydramnious##2##1##(2011-2#2)
oligomannose##3##1##(1990-2#1)(1993-11#1)(1994-9#1)
oligomannose-type##3##1##(1990-2#1)(1990-7#2)
oligomannosyl oligosaccharides##3##2##(1990-4#3)
oligomer alone##2##2##(1991-8#2)
oligomer and##3##2##(1997-6#1)(2010-12#1)(2011-1#1)
oligomer by##3##2##(1995-3#1)(2004-9#1)(2008-4#1)
oligomer can##2##2##(1990-7#2)
oligomer formation was##2##3##(1994-11#1)(1994-9#1)
oligomer formation##4##2##(1990-8#1)(1994-11#1)(1994-9#1)(2011-1#1)
oligomer in##2##2##(1994-5#1)(1997-6#1)
oligomer length##2##2##(2006-10#1)(2009-10#1)
oligomer of##3##2##(1990-3#1)(1994-8#1)(1994-9#1)
oligomer resulted in##2##3##(1990-9#1)(1995-3#1)
oligomer states##2##2##(1993-4#1)(2010-8#1)
oligomer structure##2##2##(1994-11#1)(2008-9#1)
oligomer was##4##2##(1992-11#1)(1993-3#1)(2007-8#1)(2009-10#1)
oligomer were##2##2##(1992-11#1)(2007-8#1)
oligomer##80##1##(1990-11#4)(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#5)(1990-8#1)(1990-9#2)(1991-5#1)(1991-7#2)(1991-8#5)(1992-11#5)(1992-6#1)(1993-3#3)(1993-4#1)(1993-8#1)(1994-11#2)(1994-5#5)(1994-6#1)(1994-8#1)(1994-9#3)(1995-3#3)(1995-6#1)(1995-8#3)(1997-3#1)(1997-4#1)(1997-6#2)(2004-9#1)(2005-11#2)(2006-10#1)(2007-8#2)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#2)(2010-12#2)(2010-8#2)(2011-1#2)(2011-2#1)(2012-2#1)
oligomeric complexes##3##2##(1994-8#1)(1995-3#1)(2008-8#1)
oligomeric form of##3##3##(1990-4#1)(1995-2#1)(1995-8#1)
oligomeric form##4##2##(1990-4#1)(1993-8#1)(1995-2#1)(1995-8#1)
oligomeric matrix protein (COMP)##2##4##(2007-11#1)(2010-8#1)
oligomeric protein##4##2##(1991-5#1)(1994-8#1)(1995-8#1)(2010-9#1)
oligomeric proteins##7##2##(1993-11#1)(1993-9#2)(1995-4#1)(1996-7#3)
oligomeric stilbenes##2##2##(2008-10#2)
oligomeric structure of the##3##4##(1992-7#1)(1994-12#1)(1994-6#1)
oligomeric structure of##6##3##(1991-5#1)(1992-7#1)(1994-12#1)(1994-6#1)(1997-3#1)(1997-8#1)
oligomeric structure with##2##3##(2008-4#1)(2012-1#1)
oligomeric structure##9##2##(1991-5#1)(1992-7#1)(1994-12#1)(1994-6#1)(1997-3#1)(1997-8#1)(2008-4#2)(2012-1#1)
oligomeric##56##1##(1990-12#1)(1990-4#2)(1990-8#1)(1991-10#2)(1991-5#3)(1991-7#1)(1992-11#1)(1992-4#1)(1992-7#1)(1993-11#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-10#2)(1995-2#2)(1995-3#1)(1995-4#1)(1995-8#2)(1996-7#3)(1997-1#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-4#5)(2008-8#1)(2010-10#1)(2010-8#1)(2010-9#2)(2011-12#1)(2011-2#1)(2012-1#1)(2013-8#2)
oligomerisation and polymerisation##2##3##(2010-5#2)
oligomerization and##3##2##(1991-10#1)(2010-8#1)(2011-1#1)
oligomerization domain##4##2##(1990-11#1)(2008-4#1)(2011-1#1)(2013-8#1)
oligomerization of the##3##3##(1990-2#1)(1991-5#1)(1994-11#1)
oligomerization of##5##2##(1990-2#1)(1991-5#1)(1994-11#1)(1994-8#1)(1995-5#1)
oligomerization state##2##2##(2008-3#1)(2011-1#1)
oligomerization##35##1##(1990-11#2)(1990-2#1)(1990-4#1)(1991-10#2)(1991-5#1)(1992-12#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1997-1#1)(1997-5#1)(2004-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-5#1)(2010-8#1)(2011-1#5)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
oligomerize##4##1##(1994-12#1)(2008-10#1)(2011-1#1)(2011-2#1)
oligomerized##2##1##(2008-10#1)(2008-7#1)
oligomers and##2##2##(2007-12#1)(2008-10#1)
oligomers appear to##2##3##(2006-12#1)(2011-2#1)
oligomers are##3##2##(1994-11#1)(1994-8#1)(2011-1#1)
oligomers containing##5##2##(1991-5#1)(2008-11#4)
oligomers have##2##2##(1995-11#1)(2010-8#1)
oligomers is##2##2##(1996-4#1)(2008-4#1)
oligomers of##7##2##(1991-5#1)(1995-11#2)(1995-5#1)(1997-7#1)(2006-12#1)(2008-10#1)
oligomers on the##2##3##(1991-8#1)(1996-1#1)
oligomers that have##2##3##(2008-4#2)
oligomers that##4##2##(2006-10#1)(2008-4#2)(2008-7#1)
oligomers to##3##2##(1992-7#1)(2005-11#1)(2008-5#1)
oligomers were##3##2##(1992-6#1)(1994-11#1)(1997-4#1)
oligomers with##5##2##(1993-3#1)(2004-9#1)(2006-10#1)(2008-10#1)(2008-4#1)
oligomers##92##1##(1990-11#1)(1990-3#1)(1990-7#1)(1991-5#4)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-3#6)(1994-11#2)(1994-12#1)(1994-8#2)(1995-11#4)(1995-5#1)(1996-1#3)(1996-4#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-6#2)(1997-7#1)(2004-9#4)(2005-11#2)(2006-10#2)(2006-12#4)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#4)(2008-4#9)(2008-5#1)(2008-7#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#1)(2013-1#3)(2013-8#2)
oligomers)##2##1##(2008-5#2)
oligomycin##14##1##(1990-11#1)(1990-3#2)(1991-3#2)(1994-9#1)(1995-1#2)(1996-5#1)(1997-2#2)(1997-4#2)(1997-6#1)
oligomycin-resistant##3##1##(1997-4#3)
oligonucleoside##2##1##(2005-11#1)(2008-4#1)
oligonucleosomal##3##1##(1996-6#1)(2008-10#1)(2008-8#1)
oligonucleosomes##3##1##(1993-6#3)
oligonucleotide &quot##2##2##(2008-1#1)(2008-9#1)
oligonucleotide (ASO)##2##2##(1996-7#1)(2008-4#1)
oligonucleotide and peptide##2##3##(1995-7#1)(2008-4#1)
oligonucleotide and##8##2##(1992-6#1)(1995-7#1)(1995-8#1)(1996-7#1)(2008-4#3)(2009-12#1)
oligonucleotide array##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
oligonucleotide conjugate##3##2##(2007-10#2)(2008-4#1)
oligonucleotide conjugates##2##2##(2008-4#2)
oligonucleotide containing a single##2##4##(1995-3#1)(1995-5#1)
oligonucleotide containing a##3##3##(1995-3#2)(1995-5#1)
oligonucleotide containing##8##2##(1991-3#1)(1992-9#1)(1993-11#1)(1994-8#1)(1995-3#2)(1995-5#1)(1996-8#1)
oligonucleotide designed to bind##2##4##(1992-12#1)(2008-5#1)
oligonucleotide designed to##5##3##(1992-12#1)(2006-12#1)(2008-10#2)(2008-5#1)
oligonucleotide directed##2##2##(1991-1#1)(2008-8#1)
oligonucleotide duplex##6##2##(1993-11#2)(1997-1#2)(2005-11#2)
oligonucleotide fingerprinting##2##2##(1994-6#1)(2008-10#1)
oligonucleotide hybridization##2##2##(1992-11#1)(1995-12#1)
oligonucleotide hybridizations##2##2##(1990-6#1)(1996-6#1)
oligonucleotide in##4##2##(1993-11#1)(1995-1#1)(1997-8#1)(2008-11#1)
oligonucleotide is##4##2##(1992-9#1)(2008-4#3)
oligonucleotide microarray##7##2##(2008-10#1)(2008-4#2)(2008-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
oligonucleotide microarrays##4##2##(2008-10#1)(2009-12#1)(2011-2#1)(2012-12#1)
oligonucleotide of##2##2##(1996-7#1)(2008-10#1)
oligonucleotide primer pairs##2##3##(2007-1#1)(2008-5#1)
oligonucleotide primer##6##2##(1996-12#1)(1997-6#1)(2007-1#1)(2008-10#1)(2008-4#1)(2008-5#1)
oligonucleotide primers derived from##4##4##(1992-5#1)(1995-8#1)(1997-6#1)(2008-10#1)
oligonucleotide primers designed##2##3##(1995-11#1)(2008-10#1)
oligonucleotide primers for##2##3##(2008-10#2)
oligonucleotide primers were designed##2##4##(2005-11#1)(2008-10#1)
oligonucleotide primers##28##2##(1990-8#1)(1991-10#1)(1991-9#1)(1992-3#1)(1992-5#1)(1993-3#1)(1994-12#1)(1995-11#1)(1995-8#1)(1996-12#1)(1997-4#1)(1997-6#1)(2005-11#2)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-9#1)(2012-2#1)
oligonucleotide probe based on the##2##5##(1990-5#1)(1994-9#1)
oligonucleotide probe corresponding to the##3##5##(1991-7#1)(1995-1#1)(1996-5#1)
oligonucleotide probe for##2##3##(1990-4#1)(1992-8#1)
oligonucleotide probe##22##2##(1990-4#1)(1990-5#2)(1991-10#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-9#1)(1995-1#1)(1996-2#1)(1996-5#1)(1997-8#2)(2007-8#1)(2008-10#3)(2008-5#1)(2008-9#1)
oligonucleotide probes are##3##3##(2008-10#1)(2008-4#2)
oligonucleotide probes for##2##3##(1991-9#1)(2008-4#1)
oligonucleotide probes to##2##3##(2007-2#1)(2008-10#1)
oligonucleotide probes were##3##3##(1990-7#1)(1997-4#1)(2008-10#1)
oligonucleotide probes##32##2##(1990-7#1)(1991-1#2)(1991-3#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-8#1)(1996-12#2)(1996-3#1)(1997-2#2)(1997-4#1)(1997-6#1)(2006-12#1)(2007-2#1)(2008-10#6)(2008-4#5)(2008-9#2)
oligonucleotide sequences##5##2##(1993-12#1)(1996-11#1)(2008-10#1)(2008-4#2)
oligonucleotide specific for##2##3##(1992-2#1)(1994-12#1)
oligonucleotide strands##2##2##(2008-4#2)
oligonucleotide substrates##2##2##(1995-8#1)(1997-4#1)
oligonucleotide synthesis##9##2##(1997-7#1)(2008-4#8)
oligonucleotide that##3##2##(1995-10#1)(1995-12#1)(2008-10#1)
oligonucleotide to GABAA receptor gamma 2 subunit##2##7##(1995-11#1)(1995-12#1)
oligonucleotide to##7##2##(1995-11#3)(1995-12#1)(1995-8#1)(1997-1#1)(2007-8#1)
oligonucleotide triplex##2##2##(1995-1#2)
oligonucleotide was##7##2##(1990-7#1)(1995-3#1)(1995-5#1)(1995-8#2)(2007-11#1)(2008-10#1)
oligonucleotide which##2##2##(1994-9#1)(1995-2#1)
oligonucleotide with##2##2##(1990-7#1)(2008-4#1)
oligonucleotide##339##1##(1990-10#1)(1990-2#3)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#3)(1990-8#1)(1991-1#4)(1991-10#2)(1991-12#1)(1991-3#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#4)(1993-1#2)(1993-11#7)(1993-12#2)(1993-3#3)(1993-6#1)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#5)(1994-9#3)(1995-1#10)(1995-10#1)(1995-11#10)(1995-12#5)(1995-2#2)(1995-3#4)(1995-5#4)(1995-7#1)(1995-8#7)(1996-11#3)(1996-12#4)(1996-2#1)(1996-3#2)(1996-4#3)(1996-5#3)(1996-6#1)(1996-7#7)(1996-8#1)(1997-1#7)(1997-2#4)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#6)(1997-8#5)(2005-11#5)(2005-8#1)(2005-9#1)(2006-12#8)(2007-1#1)(2007-10#2)(2007-11#3)(2007-2#1)(2007-3#1)(2007-8#3)(2008-1#2)(2008-10#39)(2008-11#7)(2008-2#1)(2008-4#59)(2008-5#9)(2008-7#2)(2008-8#1)(2008-9#6)(2009-12#2)(2009-4#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)
oligonucleotide-carbohydrate conjugates are##3##3##(2006-12#3)
oligonucleotide-carbohydrate conjugates##5##2##(2006-12#5)
oligonucleotide-directed mutagenesis##6##2##(1990-10#1)(1991-2#1)(1992-3#1)(1995-2#1)(1995-5#1)(1997-2#1)
oligonucleotide-directed##7##1##(1990-10#1)(1991-2#1)(1992-11#1)(1992-3#1)(1995-2#1)(1995-5#1)(1997-2#1)
oligonucleotide-peptide conjugates##3##2##(2006-12#3)
oligonucleotides abolished##2##2##(1995-2#1)(1995-3#1)
oligonucleotides and the##2##3##(1993-9#1)(2011-1#1)
oligonucleotides and their analogs##2##4##(2008-4#2)
oligonucleotides and their##3##3##(2006-12#1)(2008-4#2)
oligonucleotides and triphosphates##2##3##(2008-2#1)(2008-4#1)
oligonucleotides and##22##2##(1993-9#1)(1996-3#1)(1996-5#1)(1996-7#1)(2006-12#1)(2007-11#4)(2008-10#1)(2008-2#2)(2008-4#6)(2010-1#1)(2011-1#1)(2012-1#2)
oligonucleotides are##6##2##(1990-7#1)(1997-1#2)(2008-4#2)(2009-3#1)
oligonucleotides as##2##2##(1991-5#1)(2008-11#1)
oligonucleotides based on##2##3##(1991-2#1)(1993-8#1)
oligonucleotides by##5##2##(1997-2#1)(2006-12#2)(2008-4#1)(2012-1#1)
oligonucleotides can be##2##3##(2008-4#2)
oligonucleotides can##3##2##(1991-1#1)(2008-4#2)
oligonucleotides carrying an##2##3##(2006-12#2)
oligonucleotides carrying##5##2##(2006-12#4)(2008-10#1)
oligonucleotides containing the##5##3##(1991-3#1)(1992-3#1)(1994-9#1)(1996-5#1)(1997-5#1)
oligonucleotides containing##11##2##(1991-3#1)(1992-3#1)(1993-11#1)(1994-9#1)(1995-2#1)(1996-5#2)(1997-5#1)(2008-4#2)(2008-5#1)
oligonucleotides corresponding to the##3##4##(1993-6#1)(1993-9#1)(1995-3#1)
oligonucleotides corresponding to##4##3##(1991-1#1)(1993-6#1)(1993-9#1)(1995-3#1)
oligonucleotides derived from the##2##4##(1996-8#1)(2008-10#1)
oligonucleotides derived from##3##3##(1994-11#1)(1996-8#1)(2008-10#1)
oligonucleotides designed from##3##3##(1992-9#1)(1996-10#1)(1996-8#1)
oligonucleotides designed on the basis of##2##6##(1993-8#1)(1997-2#1)
oligonucleotides designed##6##2##(1992-9#1)(1993-8#1)(1996-10#1)(1996-8#1)(1997-2#1)(2008-10#1)
oligonucleotides did not##2##3##(1995-3#1)(2008-4#1)
oligonucleotides for the##2##3##(1995-7#1)(1997-1#1)
oligonucleotides for##7##2##(1994-12#1)(1995-7#1)(1997-1#1)(2005-8#1)(2006-12#1)(2007-3#1)(2008-4#1)
oligonucleotides form##2##2##(1994-9#1)(2008-4#1)
oligonucleotides from##2##2##(2008-10#1)(2008-4#1)
oligonucleotides has been##2##3##(1993-3#1)(2006-5#1)
oligonucleotides have##3##2##(1990-7#1)(1997-1#1)(2008-1#1)
oligonucleotides in a##3##3##(2008-2#1)(2008-4#2)
oligonucleotides in the##2##3##(1990-2#1)(2006-10#1)
oligonucleotides in##12##2##(1990-2#1)(1992-11#1)(1992-2#1)(1996-5#1)(1997-1#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-2#1)(2008-4#3)
oligonucleotides into the##2##3##(2007-1#1)(2008-10#1)
oligonucleotides into##5##2##(1994-12#1)(1994-6#1)(2007-1#1)(2008-10#1)(2008-4#1)
oligonucleotides is##2##2##(2007-11#1)(2008-4#1)
oligonucleotides of the same##2##4##(2004-1#1)(2008-4#1)
oligonucleotides of##4##2##(1995-1#1)(2004-1#1)(2008-4#2)
oligonucleotides on crosslinked poly(vinyl alcohol)##2##5##(2008-10#2)
oligonucleotides on##3##2##(2008-10#3)
oligonucleotides or##2##2##(2008-10#1)(2011-2#1)
oligonucleotides selected##2##2##(1997-5#1)(2007-11#1)
oligonucleotides specific for##3##3##(1992-2#1)(1997-2#1)(2008-4#1)
oligonucleotides specifically##2##2##(1992-7#1)(1996-7#1)
oligonucleotides that are##4##3##(2007-12#1)(2008-4#3)
oligonucleotides that##7##2##(2006-8#1)(2007-12#1)(2008-10#1)(2008-4#4)
oligonucleotides to the##2##3##(2008-2#1)(2010-4#1)
oligonucleotides to##5##2##(1991-12#1)(1991-7#1)(1994-10#1)(2008-2#1)(2010-4#1)
oligonucleotides via##2##2##(2008-4#2)
oligonucleotides was##3##2##(1994-11#1)(2008-10#1)(2008-11#1)
oligonucleotides were synthesized##3##3##(1991-6#1)(1995-3#1)(1996-7#1)
oligonucleotides were##10##2##(1991-6#1)(1993-8#1)(1994-12#1)(1995-3#1)(1996-7#2)(1997-4#1)(2008-10#2)(2011-2#1)
oligonucleotides with##13##2##(1990-7#1)(1994-11#1)(1996-4#1)(2006-12#3)(2007-11#1)(2008-10#2)(2008-4#4)
oligonucleotides##306##1##(1990-11#1)(1990-2#1)(1990-5#2)(1990-7#4)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#4)(1991-5#2)(1991-6#3)(1991-7#1)(1991-9#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-3#6)(1993-6#1)(1993-8#5)(1993-9#2)(1994-10#1)(1994-11#7)(1994-12#5)(1994-5#2)(1994-6#6)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#8)(1995-3#7)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-11#2)(1996-3#2)(1996-4#1)(1996-5#7)(1996-7#5)(1996-8#2)(1997-1#7)(1997-2#6)(1997-4#1)(1997-5#2)(1997-7#1)(2004-1#1)(2005-11#1)(2005-7#2)(2005-8#2)(2006-10#5)(2006-12#20)(2006-5#2)(2006-8#2)(2007-1#2)(2007-11#11)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#28)(2008-11#2)(2008-2#4)(2008-4#56)(2008-5#3)(2008-6#1)(2008-7#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#10)(2012-1#4)(2012-2#2)(2013-1#1)
oligopeptide corresponding to##2##3##(1996-1#1)(1996-2#1)
oligopeptide substrates##5##2##(1991-9#5)
oligopeptide##22##1##(1991-9#5)(1992-11#1)(1992-4#1)(1994-9#1)(1996-1#1)(1996-2#1)(1996-6#3)(1997-4#4)(2006-10#1)(2008-5#1)(2008-8#3)
oligopeptides and##2##2##(1995-12#1)(1997-4#1)
oligopeptides##26##1##(1990-11#2)(1990-12#1)(1990-2#1)(1991-2#3)(1992-12#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-11#1)(1995-10#1)(1995-12#1)(1997-4#7)(2007-8#2)(2008-10#1)(2008-5#1)(2010-10#1)
oligopolies##2##1##(1996-12#1)(1997-2#1)
oligopurine##2##1##(1996-4#1)(2006-12#1)
oligoribonucleotide synthesis##3##2##(2008-4#3)
oligoribonucleotide##6##1##(2008-4#6)
oligoribonucleotides containing N(6)-alkyladenosines##2##3##(2008-4#2)
oligoribonucleotides containing##6##2##(1991-11#1)(2008-4#5)
oligoribonucleotides##9##1##(1991-11#1)(2008-4#8)
oligos##3##1##(1991-12#1)(1991-7#1)(2012-12#1)
oligosaccharide at##2##2##(1991-9#1)(1997-4#1)
oligosaccharide binding##3##2##(1993-8#1)(1994-11#1)(1995-5#1)
oligosaccharide biosynthesis##4##2##(1994-11#2)(2008-7#2)
oligosaccharide chain##5##2##(1994-3#1)(1994-8#1)(1994-9#1)(1995-5#1)(2008-4#1)
oligosaccharide chains##15##2##(1990-7#1)(1991-2#1)(1992-12#1)(1992-7#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-9#2)(1995-3#1)(2008-11#1)(2008-4#3)
oligosaccharide distribution##2##2##(2008-7#2)
oligosaccharide from##3##2##(1994-3#1)(1994-8#2)
oligosaccharide is##2##2##(1993-6#1)(1995-4#1)
oligosaccharide moiety##3##2##(1990-12#1)(1994-8#1)(1996-5#1)
oligosaccharide on##4##2##(1991-9#1)(1992-12#3)
oligosaccharide preparation##3##2##(1992-9#1)(2008-12#2)
oligosaccharide processing##2##2##(1990-12#1)(2008-4#1)
oligosaccharide residues recognized by##2##4##(1990-7#2)
oligosaccharide side chains##3##3##(1993-7#1)(1994-11#1)(1995-11#1)
oligosaccharide structure##4##2##(1991-3#1)(1993-9#1)(1994-11#2)
oligosaccharide structures##4##2##(1991-2#2)(1994-11#2)
oligosaccharide substrates##2##2##(1990-7#1)(2008-7#1)
oligosaccharide subunits##2##2##(1996-10#2)
oligosaccharide synthesis##4##2##(1997-4#2)(2009-10#2)
oligosaccharide was##2##2##(1992-12#1)(1996-10#1)
oligosaccharide##148##1##(1990-11#1)(1990-12#2)(1990-4#1)(1990-7#7)(1990-9#1)(1991-12#2)(1991-2#6)(1991-3#1)(1991-9#3)(1992-10#1)(1992-12#10)(1992-3#1)(1992-7#1)(1992-9#2)(1993-11#9)(1993-12#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#9)(1994-3#3)(1994-5#2)(1994-8#11)(1994-9#5)(1995-11#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#1)(1996-10#6)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#7)(1997-7#1)(1997-8#1)(2005-11#2)(2005-9#1)(2006-12#2)(2006-8#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-4#10)(2008-5#1)(2008-7#8)(2009-10#2)(2009-8#1)(2012-2#1)
oligosaccharide-lipid synthesis##3##2##(1991-1#3)
oligosaccharide-lipid##5##1##(1991-1#5)
oligosaccharides and##8##2##(1991-12#1)(1993-12#1)(1995-7#1)(1997-4#1)(1997-8#1)(2009-2#1)(2010-11#1)(2010-2#1)
oligosaccharides are##9##2##(1995-3#1)(1995-6#1)(1997-4#3)(2008-11#1)(2008-6#1)(2012-2#2)
oligosaccharides by the##3##3##(1990-4#1)(1993-11#1)(1995-3#1)
oligosaccharides by##5##2##(1990-4#1)(1993-11#2)(1994-8#1)(1995-3#1)
oligosaccharides can##2##2##(1990-2#1)(1996-2#1)
oligosaccharides composed of##2##3##(1995-6#2)
oligosaccharides containing##3##2##(1990-12#1)(1995-3#1)(2008-11#1)
oligosaccharides found##2##2##(1997-4#2)
oligosaccharides from the##2##3##(1990-12#1)(2007-1#1)
oligosaccharides from##5##2##(1990-12#1)(1990-7#1)(1993-11#1)(1994-5#1)(2007-1#1)
oligosaccharides have been##2##3##(1994-11#1)(1995-6#1)
oligosaccharides have##3##2##(1993-11#1)(1994-11#1)(1995-6#1)
oligosaccharides having##4##2##(1994-5#2)(1995-2#1)(2006-12#1)
oligosaccharides in the##2##3##(1990-7#1)(1991-4#1)
oligosaccharides in##9##2##(1990-7#1)(1991-12#1)(1991-4#1)(1993-11#1)(1994-9#1)(1995-2#1)(1996-4#2)(2012-2#1)
oligosaccharides is##2##2##(1991-3#1)(1997-4#1)
oligosaccharides isolated from##2##3##(1997-8#1)(2012-2#1)
oligosaccharides larger than##2##3##(1995-4#1)(1996-2#1)
oligosaccharides obtained##3##2##(1990-9#2)(1992-12#1)
oligosaccharides of##7##2##(1990-12#1)(1991-10#1)(1992-12#1)(1997-4#1)(1997-7#1)(2005-7#1)(2008-5#1)
oligosaccharides on an ovarian cystadenoma glycoprotein##2##6##(1992-9#2)
oligosaccharides on the##2##3##(1990-10#1)(1990-3#1)
oligosaccharides on##7##2##(1990-10#1)(1990-3#1)(1992-10#2)(1992-9#2)(2008-4#1)
oligosaccharides released##3##2##(1991-12#1)(1992-9#1)(1996-4#1)
oligosaccharides results in##2##3##(1996-2#1)(2005-7#1)
oligosaccharides showed##2##2##(1991-12#1)(1993-11#1)
oligosaccharides tested##3##2##(1995-5#1)(1996-2#1)(2006-5#1)
oligosaccharides that##3##2##(1994-3#1)(1997-7#1)(2012-2#1)
oligosaccharides to the##2##3##(1994-8#1)(1996-8#1)
oligosaccharides to##4##2##(1993-11#1)(1994-8#1)(1996-8#1)(2005-7#1)
oligosaccharides was##2##2##(2008-10#1)(2008-12#1)
oligosaccharides were##8##2##(1990-9#1)(1991-3#1)(1993-11#2)(1994-9#1)(1997-8#2)(2008-7#1)
oligosaccharides which##2##2##(1994-8#1)(2006-5#1)
oligosaccharides with##6##2##(1991-9#1)(1993-11#1)(1994-9#1)(1996-2#1)(1997-7#1)(2008-10#1)
oligosaccharides##213##1##(1990-10#2)(1990-12#5)(1990-2#2)(1990-3#2)(1990-4#4)(1990-7#7)(1990-9#3)(1991-10#1)(1991-12#5)(1991-3#3)(1991-4#1)(1991-5#1)(1991-7#2)(1991-9#1)(1992-10#7)(1992-12#4)(1992-9#4)(1993-1#1)(1993-11#16)(1993-12#1)(1993-8#1)(1994-11#4)(1994-3#2)(1994-5#4)(1994-8#5)(1994-9#4)(1995-10#1)(1995-2#4)(1995-3#7)(1995-4#5)(1995-5#3)(1995-6#8)(1995-7#1)(1995-8#1)(1996-2#7)(1996-4#5)(1996-8#2)(1997-2#1)(1997-4#18)(1997-7#5)(1997-8#4)(2005-11#1)(2005-7#3)(2006-12#2)(2006-5#5)(2006-8#2)(2007-1#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#2)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#3)(2009-2#1)(2009-8#1)(2010-11#1)(2010-2#1)(2012-2#7)
oligosaccharides)##2##1##(1994-11#1)(1996-5#1)
oligospora##2##1##(2008-10#2)
oligosymptomatic##2##1##(1996-8#1)(2007-2#1)
oligothiophenes##2##1##(2011-2#2)
oligotrophic lake##2##2##(2007-3#1)(2008-5#1)
oligotrophic##18##1##(1991-11#1)(2004-4#4)(2007-3#2)(2007-7#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#2)
oligotyping##2##1##(1996-11#2)
oliguria##2##1##(1995-5#1)(2008-4#1)
oliguric##6##1##(1990-6#1)(1991-6#1)(1993-12#1)(2008-1#1)(2008-4#2)
olivacea##5##1##(2008-5#2)(2008-8#3)
olivaceus##6##1##(1995-2#1)(2008-6#2)(2010-8#3)
olivary nucleus##5##2##(1997-3#4)(2006-10#1)
olivary##11##1##(1991-3#3)(1994-2#1)(1997-2#1)(1997-3#4)(1997-5#1)(2006-10#1)
olive (Olea##2##2##(2008-10#2)
olive crops##2##2##(2013-8#2)
olive fruit fly pheromone##3##4##(2008-3#3)
olive fruit fly##4##3##(2008-3#3)(2013-8#1)
olive fruit##7##2##(2008-3#6)(2013-8#1)
olive groves##2##2##(2013-8#2)
olive knot disease##2##3##(2008-10#2)
olive leaf extract&gt##2##3##(2010-4#2)
olive leaf samples##2##3##(2008-10#2)
olive leaf##9##2##(2006-12#1)(2008-10#2)(2010-4#6)
olive leaves##2##2##(2008-10#1)(2008-12#1)
olive mill wastewater##2##3##(2006-8#2)
olive oil adulteration##3##3##(2007-8#2)(2008-10#1)
olive oil and chilled storage##2##5##(2010-4#2)
olive oil and seaweed##2##4##(2010-4#2)
olive oil and##7##3##(2010-12#1)(2010-4#4)(2012-2#1)(2013-1#1)
olive oil by##2##3##(2007-8#1)(2008-10#1)
olive oil or##2##3##(2010-4#1)(2012-2#1)
olive oil production##2##3##(2008-10#2)
olive oil samples##3##3##(2007-8#3)
olive oil was##2##3##(2008-10#2)
olive oil##59##2##(1990-8#1)(1991-2#1)(1991-8#2)(1994-2#4)(1995-11#1)(1996-5#2)(2004-11#1)(2007-8#8)(2008-10#14)(2008-5#3)(2009-3#1)(2009-5#2)(2010-12#3)(2010-4#9)(2012-2#4)(2013-1#3)
olive oil)##2##2##(1994-5#1)(2008-8#1)
olive oils##7##2##(1994-2#1)(2006-12#1)(2007-8#4)(2010-4#1)
olive plants##5##2##(2008-10#5)
olive production##2##2##(2007-8#1)(2013-8#1)
olive tree pollen##3##3##(1997-6#3)
olive tree##6##2##(1997-6#3)(2004-4#1)(2008-5#2)
olive trees##5##2##(2008-10#5)
olive##144##1##(1990-10#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-8#2)(1993-12#4)(1993-4#2)(1994-2#6)(1994-5#1)(1995-11#1)(1995-5#1)(1996-5#2)(1996-9#1)(1997-6#3)(2004-11#1)(2004-4#1)(2006-12#2)(2006-8#2)(2007-7#1)(2007-8#13)(2008-10#39)(2008-12#3)(2008-3#6)(2008-5#8)(2008-8#1)(2009-3#1)(2009-5#2)(2010-12#3)(2010-4#16)(2012-2#5)(2013-1#3)(2013-8#9)
olives##2##1##(1996-9#1)(2008-10#1)
olivine##3##1##(2008-10#3)
olivo-cerebellar##2##1##(1994-2#2)
olivocerebellar##2##1##(1992-6#1)(2013-8#1)
olivocochlear##2##1##(2012-2#2)
olmesartan medoxomil##3##2##(2008-11#3)
olopatadine hydrochloride 0##3##3##(2009-8#3)
olopatadine hydrochloride##5##2##(2009-8#5)
olopatadine##7##1##(2009-8#7)
oltipraz and##3##2##(1995-1#3)
oltipraz##4##1##(1995-1#4)
om##4##1##(1995-6#1)(2008-11#1)(2012-12#2)
omalizumab in##2##2##(2010-5#2)
omalizumab##10##1##(2008-5#3)(2009-6#2)(2010-5#5)
oman##4##1##(2008-10#1)(2008-4#1)(2012-12#1)(2012-2#1)
omasum##2##1##(2011-2#2)
ombudsman##4##1##(1990-12#1)(1992-4#1)(1993-12#1)(1996-2#1)
ombudsmen##3##1##(1996-2#3)
omega 0##3##2##(1995-2#3)
omega 5-anacardic##3##2##(1991-4#3)
omega =##3##2##(1990-5#1)(2007-3#1)(2008-9#1)
omega and##5##2##(1990-6#1)(1991-2#2)(2008-1#1)(2009-2#1)
omega function##2##2##(1991-4#2)
omega values##2##2##(2007-10#2)
omega##58##1##(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-2#2)(1991-4#7)(1991-5#1)(1991-9#1)(1992-8#6)(1993-2#1)(1993-5#4)(1995-11#1)(1995-2#4)(1996-11#1)(1996-4#1)(1997-2#1)(1997-3#3)(2004-11#1)(2005-11#3)(2006-10#1)(2006-5#1)(2007-10#3)(2007-3#3)(2007-8#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-9#2)(2009-2#1)(2010-7#1)
omega(0)##3##1##(2008-2#1)(2008-3#2)
omega(1)##2##1##(2010-7#2)
omega(2)##2##1##(2010-7#2)
omega) and the##2##3##(1994-12#1)(2006-10#1)
omega)##7##1##(1993-2#1)(1993-5#1)(1994-12#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)
omega-1 hydroxylation##3##2##(1993-4#3)
omega-3 PUFA##8##2##(2007-8#4)(2010-4#3)(2011-2#1)
omega-3 and omega-6 polyunsaturated##2##4##(1993-9#1)(2010-4#1)
omega-3 and##4##2##(1993-9#1)(2010-4#1)(2013-7#2)
omega-3 ethyl ester concentrate##6##4##(2008-3#6)
omega-3 fatty acid##2##3##(2012-1#1)(2013-1#1)
omega-3 fatty acids may##2##4##(2007-8#2)
omega-3 fatty acids##13##3##(1990-2#1)(1990-5#2)(1993-9#1)(2006-10#3)(2007-11#1)(2007-8#4)(2008-6#1)
omega-3 fatty##15##2##(1990-2#1)(1990-5#2)(1993-9#1)(2006-10#3)(2007-11#1)(2007-8#4)(2008-6#1)(2012-1#1)(2013-1#1)
omega-3 polyunsaturated fatty acids (n-3##2##5##(2012-1#1)(2013-1#1)
omega-3 polyunsaturated fatty acids##13##4##(2006-7#5)(2007-8#2)(2008-5#1)(2011-2#1)(2012-1#1)(2013-1#3)
omega-3 polyunsaturated##14##2##(2006-7#5)(2007-8#2)(2008-5#1)(2010-1#1)(2011-2#1)(2012-1#1)(2013-1#3)
omega-3 supplementation##4##2##(2007-8#3)(2013-7#1)
omega-3##68##1##(1990-2#1)(1990-5#3)(1993-9#2)(2006-10#3)(2006-2#2)(2006-7#5)(2007-11#1)(2007-8#14)(2008-3#6)(2008-5#1)(2008-6#1)(2010-1#2)(2010-4#8)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#9)
omega-6##5##1##(1990-5#1)(1993-9#1)(2010-4#2)(2012-1#1)
omega-Aga-IIIA##2##1##(1993-11#2)
omega-Aga-IVA##2##1##(1993-11#2)
omega-agatoxin IVA##5##2##(1996-10#4)(1996-5#1)
omega-bis(dimethylalkylammonium bromide) surfactants##3##3##(2005-11#3)
omega-bis(sodium##2##1##(2005-11#2)
omega-conopeptides##2##1##(1994-2#2)
omega-conotoxin GVIA and##2##3##(1990-7#1)(1996-5#1)
omega-conotoxin GVIA##14##2##(1990-7#1)(1993-2#1)(1993-7#1)(1993-9#1)(1994-9#2)(1996-5#3)(1997-5#1)(1997-8#4)
omega-conotoxin##32##1##(1990-7#7)(1992-7#1)(1993-2#1)(1993-3#1)(1993-7#1)(1993-9#2)(1994-3#5)(1994-5#2)(1994-9#2)(1996-11#1)(1996-5#4)(1997-5#1)(1997-8#4)
omega-triphenylalcohols and##2##2##(1992-8#2)
omens##2##1##(1990-12#1)(1996-3#1)
omenta##3##1##(2008-1#3)
omental cakes##4##2##(2012-2#4)
omental fat##2##2##(2010-4#2)
omental flap##2##2##(2009-7#1)(2012-2#1)
omental mass##3##2##(2008-6#3)
omental transfer##6##2##(2007-8#6)
omental##27##1##(1990-2#1)(1992-10#1)(1992-2#1)(1993-11#3)(2005-12#1)(2006-10#2)(2006-6#1)(2007-8#6)(2008-6#3)(2009-7#1)(2010-4#2)(2012-2#5)
omentectomy##3##1##(1992-4#1)(2013-1#1)(2013-8#1)
omentoplastic##2##1##(2008-9#2)
omentoplasty##2##1##(2013-8#2)
omentum and a##2##3##(1990-5#1)(2013-7#1)
omentum and the##2##3##(2008-3#1)(2012-1#1)
omentum and##6##2##(1990-5#1)(2008-3#2)(2012-1#1)(2013-1#1)(2013-7#1)
omentum majus##3##2##(2005-12#2)(2007-11#1)
omentum or##2##2##(2007-8#1)(2008-8#1)
omentum was##2##2##(2006-10#1)(2012-1#1)
omentum##36##1##(1990-11#1)(1990-5#1)(1993-11#1)(1994-2#2)(1995-11#3)(2005-12#3)(2006-10#3)(2006-6#1)(2007-11#1)(2007-2#2)(2007-8#6)(2008-1#1)(2008-12#1)(2008-3#2)(2008-8#1)(2012-1#2)(2012-2#2)(2013-1#2)(2013-7#1)
omentum-derived mesothelial cells##2##3##(2013-1#2)
omeprasole and lansoprasole on##2##4##(2008-8#2)
omeprasole and lansoprasole##8##3##(2008-8#8)
omeprasole##9##1##(2008-8#9)
omeprazole 20 mg##3##3##(2008-5#3)
omeprazole administration)##2##2##(2012-2#2)
omeprazole and lansoprazole##2##3##(2008-5#1)(2010-12#1)
omeprazole and##3##2##(2008-5#1)(2008-7#1)(2010-12#1)
omeprazole##39##1##(1991-2#1)(1993-11#6)(1996-11#1)(1997-1#2)(2006-10#3)(2006-2#1)(2006-6#3)(2008-11#2)(2008-12#1)(2008-5#5)(2008-7#1)(2009-5#1)(2010-12#3)(2012-2#8)(2012-3#1)
omic##2##1##(2007-12#1)(2008-11#1)
omics data##2##2##(2010-2#1)(2012-3#1)
omics##4##1##(2009-12#1)(2010-2#1)(2010-5#1)(2012-3#1)
omics&quot##2##1##(2012-3#1)(2013-8#1)
omiganan##4##1##(2008-1#4)
ominidirectional reflection##2##2##(2007-12#2)
ominous##5##1##(1994-6#1)(2006-10#1)(2006-8#1)(2008-3#1)(2010-11#1)
omission of Ca2+ from the##2##5##(1992-7#1)(1995-11#1)
omission of##11##2##(1990-8#1)(1992-7#1)(1992-9#1)(1995-11#1)(2006-3#1)(2008-1#2)(2008-11#1)(2009-11#1)(2009-8#1)(2013-1#1)
omission##27##1##(1990-12#1)(1990-8#1)(1991-1#1)(1992-7#1)(1992-9#1)(1994-12#1)(1994-9#3)(1995-11#1)(1996-3#1)(1997-7#1)(2005-7#1)(2006-3#2)(2006-5#1)(2008-1#2)(2008-10#2)(2008-11#1)(2009-11#1)(2009-8#1)(2013-1#1)(2013-8#3)
omissions in##2##2##(2009-8#1)(2010-8#1)
omissions of##2##2##(2013-8#2)
omissions##9##1##(2006-5#1)(2009-8#1)(2010-8#1)(2012-1#1)(2013-1#1)(2013-8#4)
omit##6##1##(1990-11#1)(1996-3#1)(1996-6#1)(2005-1#1)(2007-3#1)(2008-10#1)
omitted as##2##2##(2005-8#1)(2006-10#1)
omitted from the##4##3##(1993-2#1)(1993-7#1)(2008-11#1)(2008-6#1)
omitted from##5##2##(1993-2#1)(1993-7#1)(1997-7#1)(2008-11#1)(2008-6#1)
omitted in##2##2##(2007-7#1)(2008-10#1)
omitted or##2##2##(1994-9#1)(2008-10#1)
omitted variable##2##2##(1992-6#1)(2009-12#1)
omitted variables##3##2##(1992-6#3)
omitted##39##1##(1990-7#1)(1990-8#1)(1991-10#1)(1991-3#1)(1992-2#1)(1992-5#1)(1992-6#5)(1993-1#2)(1993-2#1)(1993-7#1)(1994-9#2)(1996-11#1)(1996-3#1)(1997-7#1)(2005-4#1)(2005-8#1)(2006-10#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#2)(2008-6#1)(2009-12#1)(2011-2#1)(2013-7#1)(2013-8#1)
omitting a switch##2##3##(2008-3#2)
omitting##9##1##(1991-8#1)(1995-2#1)(2008-10#1)(2008-3#3)(2008-6#1)(2009-3#1)(2009-8#1)
ommata##2##1##(1993-12#2)
ommatidia##7##1##(2007-12#7)
ommatidial##2##1##(2007-12#2)
omnibus##4##1##(1992-6#1)(1996-3#1)(1997-2#1)(2006-7#1)
omnidirectional mirror##2##2##(2007-12#2)
omnidirectional ranges##2##2##(2007-12#2)
omnidirectional reflection##3##2##(2008-3#3)
omnidirectional reflectors##2##2##(2008-3#2)
omnidirectional##21##1##(2007-12#10)(2008-10#1)(2008-3#10)
omnipresent##3##1##(1994-9#1)(2008-10#1)(2009-4#1)
omnivora##5##1##(2010-3#5)
omnivores##2##1##(2008-5#1)(2009-4#1)
omnivorous species##2##2##(2007-3#1)(2008-8#1)
omnivorous##5##1##(2007-3#3)(2008-10#1)(2008-8#1)
omnivory##7##1##(2007-3#1)(2008-8#1)(2008-9#5)
omp1##2##1##(1993-9#2)
ompA gene##2##2##(2012-12#2)
ompA##4##1##(1993-3#1)(2005-11#1)(2012-12#2)
ompH##5##1##(1990-11#2)(1990-3#3)
omphalitis and##2##2##(2011-2#1)(2012-2#1)
omphalitis##3##1##(2011-2#2)(2012-2#1)
omphalocele with##3##2##(1997-3#1)(2008-10#1)(2010-8#1)
omphalocele##12##1##(1990-9#1)(1996-12#1)(1997-3#3)(2008-10#4)(2009-6#1)(2010-8#2)
on &quot##118##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-12#2)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#4)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#3)(1993-5#2)(1993-6#3)(1993-8#1)(1994-2#2)(1994-4#1)(1994-5#2)(1995-1#1)(1995-11#1)(1995-2#3)(1995-5#3)(1995-7#6)(1995-8#2)(1996-12#1)(1996-7#3)(1996-9#3)(2005-10#1)(2005-11#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-3#1)(2007-4#4)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#4)(2008-11#1)(2008-3#9)(2008-4#3)(2008-5#3)(2008-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-11#9)(2012-2#2)(2013-8#1)
on 'Harbin'##2##2##(2008-10#2)
on 'Picra'##2##2##(2008-10#2)
on 'Seri 82'##2##3##(2008-10#2)
on 'Sumner'##2##2##(2008-10#2)
on 'The##5##2##(2006-11#2)(2008-11#3)
on (1) the##2##3##(2007-9#1)(2012-2#1)
on (1)##12##2##(1993-12#1)(1994-12#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-3#2)(2008-4#1)(2009-5#2)(2012-2#1)
on (a) the##4##3##(1995-1#1)(1996-8#1)(2008-1#1)(2011-1#1)
on (a)##6##2##(1995-1#1)(1996-8#1)(2004-12#1)(2008-1#1)(2008-11#1)(2011-1#1)
on (i)##5##2##(1991-12#1)(1993-6#1)(1997-4#1)(2008-10#1)(2012-12#1)
on 0##4##2##(1992-2#1)(1995-8#1)(2008-10#1)(2008-3#1)
on 1 January 1991##2##4##(1992-9#1)(1997-8#1)
on 1 January##4##3##(1992-9#1)(1997-8#1)(2005-7#1)(2008-8#1)
on 1 T##2##3##(2006-10#2)
on 1 of##2##3##(2008-10#1)(2013-1#1)
on 1##36##2##(1992-2#1)(1992-9#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-8#1)(2005-7#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#2)
on 1(st)##3##2##(2011-2#2)(2012-2#1)
on 1)##3##2##(2006-12#1)(2008-10#1)(2010-10#1)
on 1-year-old##2##2##(2008-10#2)
on 1/T1 of##3##3##(1991-7#2)(1993-6#1)
on 1/T1##6##2##(1991-7#3)(1993-6#3)
on 10 plants##2##3##(2008-10#2)
on 10##29##2##(1991-3#1)(1992-10#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-7#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#6)(2008-12#1)(2008-3#2)(2008-9#1)(2009-1#1)(2010-12#1)(2010-5#1)(2011-2#2)(2013-1#1)(2013-7#1)
on 10-day-old##2##2##(1995-9#1)(2008-10#1)
on 100 cases##2##3##(2005-11#1)(2006-4#1)
on 100 mg##2##3##(2008-10#1)(2008-5#1)
on 100##10##2##(1992-5#1)(2005-11#1)(2006-4#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-8#2)
on 105##2##2##(1997-3#1)(2007-11#1)
on 106##2##2##(2006-6#2)
on 11 patients##3##3##(2008-6#1)(2008-9#1)(2009-8#1)
on 11##10##2##(1991-10#1)(1997-7#1)(2007-9#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#1)(2011-2#1)
on 112##2##2##(1992-10#1)(2007-12#1)
on 12 October 2002##2##4##(2007-2#1)(2008-10#1)
on 12 October##3##3##(2007-2#1)(2008-10#1)(2008-3#1)
on 12##12##2##(1991-9#1)(1992-10#1)(1997-1#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#2)(2013-7#1)
on 12-lipoxygenase##2##2##(1991-8#1)(1994-8#1)
on 12-month##2##2##(2010-5#1)(2013-1#1)
on 123##2##2##(1990-3#1)(2008-10#1)
on 125##3##2##(2004-10#1)(2007-7#1)(2007-8#1)
on 13##6##2##(1997-1#1)(2007-1#1)(2007-8#1)(2009-12#1)(2009-2#1)(2011-1#1)
on 131##2##2##(2007-8#1)(2008-5#1)
on 136##2##2##(1996-3#1)(2007-10#1)
on 13C##3##2##(1990-11#1)(1991-5#1)(1997-5#1)
on 14 patients##4##3##(2007-11#1)(2007-2#1)(2008-8#1)(2011-2#1)
on 14##10##2##(2007-11#1)(2007-2#2)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-4#1)(2011-2#1)
on 14-3-3##3##2##(2008-11#2)(2010-12#1)
on 15 healthy##2##3##(2008-5#1)(2013-1#1)
on 15 patients##3##3##(2007-8#1)(2008-2#1)(2012-12#1)
on 15##14##2##(1996-4#1)(1997-4#1)(2006-11#1)(2007-8#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-4#1)(2011-12#1)(2012-12#1)(2013-1#1)
on 150##5##2##(1991-6#1)(1992-1#1)(1994-6#1)(1996-3#1)(2012-2#1)
on 156##2##2##(2007-2#1)(2007-4#1)
on 157##2##2##(1995-10#1)(2008-12#1)
on 16##7##2##(2007-8#2)(2008-11#1)(2008-5#1)(2008-7#1)(2012-1#1)(2013-1#1)
on 168 field sera##2##4##(2008-5#2)
on 168##4##2##(2007-4#1)(2008-5#3)
on 17 occasions##2##3##(1990-11#1)(2004-11#1)
on 17##10##2##(1990-11#1)(1991-9#1)(2004-11#1)(2006-11#1)(2006-8#1)(2008-10#1)(2008-5#1)(2009-4#1)(2010-12#1)(2013-1#1)
on 17p##3##2##(1990-9#1)(1994-12#1)(2008-4#1)
on 17th day##2##3##(1997-7#1)(2008-10#1)
on 18##16##2##(1991-9#1)(1992-7#1)(1993-2#1)(1994-3#1)(1994-7#1)(1997-2#1)(2007-10#1)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#2)(2008-9#1)
on 180##2##2##(2007-7#1)(2010-8#1)
on 19 May##2##3##(2008-11#1)(2008-4#1)
on 19##8##2##(1996-6#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2012-12#1)
on 1st##2##2##(2007-10#1)(2011-1#1)
on 2 cases##2##3##(2008-5#1)(2009-2#1)
on 2##28##2##(1991-6#1)(1991-7#1)(1992-10#2)(1992-12#1)(1996-11#1)(1997-2#2)(2006-11#1)(2006-3#1)(2007-1#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#1)(2009-2#1)(2009-5#1)(2010-12#1)(2011-1#1)(2012-11#1)(2013-1#3)
on 2-##2##2##(2005-11#1)(2008-10#1)
on 2-D##2##2##(1990-4#1)(2007-12#1)
on 2-dimensional##2##2##(1991-4#1)(2009-6#1)
on 20 July 1997##2##4##(2008-3#2)
on 20 June##3##3##(2007-9#1)(2008-3#2)
on 20##11##2##(1993-5#1)(1994-7#1)(1996-9#1)(2007-9#1)(2008-3#5)(2009-8#1)(2010-12#1)
on 20%##2##2##(2008-10#1)(2009-3#1)
on 200##2##2##(2008-2#1)(2008-3#1)
on 21 patients with##2##4##(1993-9#1)(2007-8#1)
on 21 patients##6##3##(1991-4#1)(1991-5#1)(1993-9#1)(2007-7#2)(2007-8#1)
on 21##10##2##(1991-4#1)(1991-5#1)(1993-9#1)(2007-7#2)(2007-8#1)(2008-5#2)(2009-2#1)(2011-2#1)
on 22##10##2##(1991-4#1)(1994-5#2)(2005-10#1)(2006-5#1)(2007-11#1)(2008-10#2)(2008-7#1)(2012-12#1)
on 23##2##2##(1994-7#1)(1996-1#1)
on 23Na and##2##3##(1994-5#1)(1995-1#1)
on 23rd##2##2##(2008-1#1)(2008-10#1)
on 24##9##2##(1990-11#1)(2006-12#1)(2007-1#1)(2007-4#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-9#1)(2013-1#1)
on 24-OHase mRNA##2##3##(1994-11#2)
on 25##7##2##(1991-3#1)(2006-8#1)(2007-1#1)(2008-10#2)(2008-3#1)(2012-3#1)
on 26##5##2##(1993-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2012-2#1)
on 27##3##2##(1990-3#1)(1996-3#1)(2008-4#1)
on 28##5##2##(2007-2#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-12#1)
on 29##3##2##(2006-3#1)(2008-10#1)(2008-5#1)
on 3 consecutive days##2##4##(1995-5#1)(2007-7#1)
on 3##19##2##(1992-2#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-3#1)(1997-8#1)(2005-10#1)(2006-2#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-1#1)(2013-1#1)
on 3- to##2##3##(2006-11#1)(2008-10#1)
on 30 patients##2##3##(2006-6#1)(2013-1#1)
on 30##10##2##(1990-12#1)(1993-3#1)(1996-1#1)(1997-2#1)(1997-5#1)(2006-6#1)(2008-11#1)(2008-5#2)(2013-1#1)
on 31 January 1998##2##4##(2008-3#2)
on 31 October##2##3##(2004-3#1)(2008-3#1)
on 31##6##2##(2004-3#1)(2008-3#3)(2008-5#1)(2013-1#1)
on 31P##2##2##(1993-6#1)(2009-12#1)
on 321##2##2##(2007-2#1)(2007-7#1)
on 33##4##2##(1991-6#1)(2008-5#1)(2008-7#1)(2013-1#1)
on 34##4##2##(1991-12#1)(1994-2#1)(2008-10#1)(2008-12#1)
on 350##2##2##(1992-7#1)(2011-2#1)
on 36 patients##2##3##(2007-8#1)(2013-1#1)
on 36##4##2##(2006-8#1)(2007-8#1)(2008-12#1)(2013-1#1)
on 39##3##2##(1995-6#1)(2007-8#1)(2010-9#1)
on 4##13##2##(1991-8#1)(1992-2#1)(1995-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-3#2)(2008-7#1)(2009-7#1)(2010-1#1)
on 40 patients with##2##4##(2004-1#1)(2008-3#1)
on 40##7##2##(2004-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-4#1)(2012-3#1)
on 42 patients##2##3##(1997-2#1)(2011-2#1)
on 42##5##2##(1990-2#1)(1991-9#1)(1997-2#1)(2008-10#1)(2011-2#1)
on 42nd Street##2##3##(2008-8#2)
on 43##3##2##(2007-11#1)(2008-1#1)(2010-12#1)
on 44##2##2##(1991-9#1)(2012-12#1)
on 45##6##2##(1991-9#2)(2007-10#1)(2007-2#1)(2008-10#1)(2013-1#1)
on 45Ca##2##2##(1991-3#1)(1997-5#1)
on 5##15##2##(1991-12#1)(1992-12#1)(1992-5#1)(1996-5#1)(2006-10#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#1)(2012-12#1)(2013-1#1)
on 5-HT metabolism##2##3##(1993-7#2)
on 5-HT##5##2##(1993-7#2)(1995-12#1)(1996-12#1)(2008-8#1)
on 5-HT2##2##2##(1995-12#1)(1995-3#1)
on 50 cases##2##3##(2009-7#1)(2013-8#1)
on 50##10##2##(1994-4#1)(2006-8#1)(2007-5#1)(2008-10#1)(2008-5#2)(2009-6#1)(2009-7#1)(2012-2#1)(2013-8#1)
on 50% of trials at random##2##6##(2008-11#2)
on 50% of##3##3##(2008-11#3)
on 51##2##2##(2007-6#1)(2011-1#1)
on 540 individuals##2##3##(1997-5#2)
on 540##3##2##(1997-5#3)
on 55##2##2##(2007-8#1)(2008-10#1)
on 56##2##2##(1993-1#1)(1996-3#1)
on 57##2##2##(2006-7#1)(2008-10#1)
on 58##2##2##(2007-7#1)(2008-10#1)
on 6##6##2##(1990-12#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-12#1)(2009-5#1)
on 60 and##2##3##(1991-12#1)(2008-4#1)
on 60##8##2##(1991-12#1)(2008-10#1)(2008-4#1)(2011-1#1)(2011-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
on 600##2##2##(2006-8#1)(2008-7#1)
on 62##2##2##(1994-6#1)(2006-12#1)
on 63##2##2##(1996-11#1)(1997-8#1)
on 64##2##2##(2007-6#1)(2008-5#1)
on 65##2##2##(2007-8#1)(2011-2#1)
on 6th##2##2##(2007-8#1)(2013-1#1)
on 7##9##2##(1992-9#1)(1993-1#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-8#1)(2011-2#1)(2012-1#1)
on 70##3##2##(2009-3#1)(2011-1#1)(2011-2#1)
on 72##2##2##(2006-11#1)(2008-12#1)
on 75##2##2##(1990-9#1)(1997-3#1)
on 76##2##2##(1995-4#1)(2008-10#1)
on 79##2##2##(1992-9#1)(2008-7#1)
on 7A of##2##3##(2008-10#2)
on 8 patients##2##3##(2006-8#1)(2007-7#1)
on 8##4##2##(1992-3#1)(2006-8#1)(2007-7#1)(2012-1#1)
on 80##4##2##(2007-11#1)(2008-1#1)(2008-10#1)(2009-6#1)
on 83##2##2##(2008-12#1)(2011-1#1)
on 84##2##2##(2007-8#1)(2013-1#1)
on 9##6##2##(1991-5#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-1#1)(2010-8#1)
on 9-15##2##2##(2008-7#1)(2013-1#1)
on 93 patients##2##3##(2007-10#2)
on 94##2##2##(2006-10#1)(2012-2#1)
on 96-well##4##2##(1992-8#1)(1993-12#1)(1993-9#1)(1994-9#1)
on A gossypii##2##3##(2008-6#2)
on A##14##2##(1995-7#1)(2007-4#3)(2007-7#1)(2008-10#1)(2008-6#7)(2009-8#1)
on AC##2##2##(2008-10#2)
on ACC##2##2##(2005-11#1)(2008-10#1)
on ACE##2##2##(1993-12#1)(2013-1#1)
on ACL reconstructed knees##2##4##(2013-1#2)
on ACL##3##2##(2013-1#3)
on AChE activity##2##3##(1994-3#1)(2008-11#1)
on AChE##3##2##(1994-3#1)(2008-10#1)(2008-11#1)
on AD##3##2##(1992-12#2)(2008-7#1)
on ADHD and##2##3##(2011-12#1)(2012-2#1)
on ADHD##3##2##(2008-4#1)(2011-12#1)(2012-2#1)
on AFH##2##2##(2005-11#2)
on AIDS in##2##3##(1993-5#1)(1996-11#1)
on AIDS mortality##2##3##(2007-7#2)
on AIDS##16##2##(1990-10#1)(1991-11#1)(1991-4#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-7#1)(1993-5#1)(1996-11#1)(1997-7#1)(2005-10#1)(2006-8#1)(2007-7#3)
on AIP##2##2##(2005-8#1)(2013-1#1)
on AP-1##2##2##(1997-6#1)(2008-9#1)
on APC##4##2##(1991-12#1)(1993-11#1)(1997-2#2)
on APP processing##2##3##(1995-12#1)(2012-12#1)
on APP##4##2##(1992-12#1)(1994-9#1)(1995-12#1)(2012-12#1)
on AQP2##2##2##(2012-12#2)
on AR##2##2##(2008-3#1)(2012-2#1)
on ART at##3##3##(2009-3#2)(2010-8#1)
on ART##11##2##(2009-10#1)(2009-3#4)(2010-8#2)(2011-1#1)(2012-12#3)
on ATP concentration##2##3##(1997-6#1)(2008-5#1)
on ATP##5##2##(1990-2#1)(1994-2#1)(1997-6#1)(2008-4#1)(2008-5#1)
on ATPase##2##2##(2008-8#2)
on Acb##2##2##(2007-8#2)
on Accreditation##6##2##(1990-12#1)(1993-2#1)(1995-3#1)(2007-12#1)(2007-4#1)(2007-5#1)
on Achatina##2##2##(1991-2#2)
on Acute##3##2##(2007-7#1)(2008-1#1)(2013-1#1)
on Adult##3##2##(2008-10#2)(2010-8#1)
on Aedes aegypti##2##3##(2007-4#1)(2011-2#1)
on Aerosols##2##2##(1995-3#1)(1996-2#1)
on African American##2##3##(2009-5#1)(2012-12#1)
on African##5##2##(2006-10#1)(2009-11#1)(2009-5#1)(2012-12#1)(2012-3#1)
on Aging##5##2##(1994-2#1)(1995-3#1)(2008-7#1)(2009-5#1)(2010-5#1)
on Al##6##2##(1996-8#5)(2008-2#1)
on Alfalfa##2##2##(2008-10#2)
on Alzheimer's disease##2##3##(2008-5#1)(2011-3#1)
on Alzheimer's##4##2##(1992-12#1)(2008-5#1)(2011-3#1)(2012-3#1)
on Amberlite XAD-16##2##3##(2008-10#2)
on Amberlite XAD-2##4##3##(1990-9#1)(1992-1#1)(1994-12#1)(2008-10#1)
on Amberlite XAD-4 resin##2##4##(2008-10#2)
on Amberlite XAD-4##4##3##(2008-10#4)
on Amberlite##15##2##(1990-9#1)(1992-1#1)(1992-7#1)(1994-12#1)(2008-10#11)
on American##7##2##(1994-12#1)(1994-7#1)(1995-6#1)(1997-3#1)(2007-10#1)(2008-10#1)(2008-8#1)
on Animal##2##2##(2008-7#1)(2013-1#1)
on Antimicrobial##4##2##(1995-9#1)(2007-1#1)(2008-5#1)(2013-8#1)
on Antiretroviral Therapy##2##3##(2009-12#1)(2013-1#1)
on Antiretroviral##3##2##(2008-6#1)(2009-12#1)(2013-1#1)
on Aphis gossypii Glover##2##4##(2008-6#2)
on Apple##2##2##(2008-10#2)
on April 7##2##3##(2009-10#1)(2009-5#1)
on April##8##2##(2006-10#1)(2006-8#2)(2008-5#1)(2009-10#1)(2009-5#1)(2012-2#1)(2013-8#1)
on Arabidopsis##4##2##(2007-12#1)(2008-10#2)(2009-8#1)
on Asian##3##2##(2008-10#2)(2008-8#1)
on Aspergillus fumigatus immobilized Diaion HP-2MG##2##6##(2008-10#2)
on Au nanocrystalline films##3##4##(2009-11#3)
on Au substrates##2##3##(2008-10#2)
on Au##14##2##(1994-5#1)(1996-11#1)(2005-11#1)(2006-12#2)(2008-10#3)(2008-7#1)(2009-11#3)(2010-7#2)
on Au111##3##2##(2010-4#3)
on August##4##2##(2006-12#1)(2006-8#1)(2007-7#1)(2010-12#1)
on B cell##4##3##(1990-12#1)(2008-4#2)(2008-9#1)
on B cells##3##3##(1991-11#1)(1994-6#1)(2012-3#1)
on B##11##2##(1990-12#1)(1991-11#1)(1992-7#1)(1994-6#1)(1995-3#1)(2008-10#1)(2008-4#2)(2008-9#1)(2012-3#1)(2013-7#1)
on BAL##2##2##(1994-6#1)(2013-1#1)
on BALB/c mice with##2##4##(2012-1#1)(2013-7#1)
on BD##2##2##(2007-12#2)
on BF##2##2##(2005-11#2)
on BMCTV-infected##2##2##(2008-10#2)
on BMD in##2##3##(2006-8#1)(2012-2#1)
on BMI##4##2##(2007-2#1)(2007-8#1)(2012-2#1)(2012-3#1)
on BP##2##2##(2010-7#2)
on BSA##2##2##(1991-5#1)(2008-10#1)
on BSE##2##2##(1997-7#1)(2011-2#1)
on Bacillus##2##2##(1992-12#1)(1997-6#1)
on Bio-Gel P-60##2##3##(1990-5#1)(1992-9#1)
on Biological##4##2##(1994-3#1)(2008-10#1)(2008-5#2)
on Biomedical##2##2##(1996-5#1)(2007-4#1)
on Blanquilla pears##2##3##(2008-10#2)
on Blood##6##2##(1993-9#1)(2004-3#1)(2005-7#2)(2008-3#1)(2008-6#1)
on Body##2##2##(2007-12#1)(2011-1#1)
on Brassica napus##2##3##(2008-10#2)
on Brassica##3##2##(2008-10#3)
on Breast Cancer##2##3##(2011-2#1)(2012-2#1)
on British##3##2##(1991-1#1)(2013-1#1)(2013-7#1)
on C and##2##3##(1993-6#1)(2008-10#1)
on C##18##2##(1993-6#1)(2007-12#2)(2007-5#5)(2008-10#4)(2008-6#3)(2011-12#2)(2013-8#1)
on C(18) bonded##2##3##(2008-10#2)
on C(18)##5##2##(2008-10#5)
on C18##6##2##(1990-6#1)(1992-12#1)(1996-5#1)(1997-8#1)(2008-10#1)(2010-11#1)
on C2##2##2##(2007-11#1)(2008-8#1)
on C2C12##2##2##(2008-4#1)(2009-6#1)
on C4 of the GalNAc##2##5##(1995-3#2)
on C4##4##2##(1990-7#1)(1995-3#2)(2008-10#1)
on CA##2##2##(1995-12#2)
on CA3 pyramidal cells##2##4##(1994-10#2)
on CA3##4##2##(1994-10#4)
on CAB##2##2##(2008-5#1)(2010-8#1)
on CABS can##2##3##(2008-10#2)
on CABS was##2##3##(2008-10#2)
on CABS were##2##3##(2008-10#2)
on CABS##8##2##(2008-10#8)
on CAD##2##2##(1992-4#1)(2008-12#1)
on CAPD##3##2##(2008-1#1)(2008-4#1)(2011-2#1)
on CBF##2##2##(1997-5#1)(2008-7#1)
on CCK##2##2##(1990-12#1)(1996-12#1)
on CD##4##2##(1991-1#1)(2006-12#1)(2007-4#1)(2008-7#1)
on CD-ROM##4##2##(1991-1#3)(1995-3#1)
on CD4+ T cells##3##4##(1995-12#1)(2008-4#1)(2008-8#1)
on CD4+##6##2##(1995-12#1)(1996-3#3)(2008-4#1)(2008-8#1)
on CD4-##2##2##(2008-4#1)(2008-8#1)
on CEM##2##2##(1993-9#1)(2008-11#1)
on CGRP##2##2##(1992-6#1)(1997-5#1)
on CHD##4##2##(2005-10#1)(2006-8#1)(2013-1#2)
on CHO cell##2##3##(1992-7#1)(2011-2#1)
on CHO##5##2##(1992-7#1)(2006-10#1)(2008-11#2)(2011-2#1)
on CHROMagar Candida##2##3##(2008-5#2)
on CI 13227##3##3##(2008-10#3)
on CI##5##2##(2008-10#4)(2008-8#1)
on CNS##4##2##(1990-9#1)(1992-9#1)(2008-12#1)(2008-5#1)
on CO(2) laser##2##3##(2007-12#1)(2012-12#1)
on COX-1##2##2##(2008-10#2)
on CPB##5##2##(2007-8#2)(2007-9#2)(2008-11#1)
on CS##3##2##(1995-3#1)(1995-5#1)(2012-2#1)
on CSF##2##2##(2011-2#1)(2013-7#1)
on CT and##4##3##(2006-1#1)(2007-10#1)(2011-1#1)(2012-12#1)
on CT or##3##3##(2008-1#1)(2008-9#1)(2012-12#1)
on CT scan##6##3##(2005-9#1)(2006-4#1)(2006-9#1)(2009-9#1)(2010-12#1)(2011-1#1)
on CT##35##2##(1990-3#1)(1993-5#1)(1996-7#3)(1997-8#3)(2005-9#1)(2006-1#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-12#1)(2011-1#2)(2012-12#3)(2012-2#3)(2012-3#2)
on CT-scan##2##2##(1997-3#1)(2006-8#1)
on CVD biomarkers##2##3##(2010-2#2)
on CVD##9##2##(2008-7#1)(2009-4#1)(2010-2#2)(2012-2#1)(2013-1#4)
on CVP##2##2##(2008-10#2)
on CYP2E expression##2##3##(1996-12#2)
on Ca##3##2##(2006-10#1)(2008-10#1)(2010-2#1)
on Ca2+ and##2##3##(1993-8#1)(1997-7#1)
on Ca2+ movements and contractions##2##5##(1995-12#2)
on Ca2+##20##2##(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-6#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-8#1)(1995-11#2)(1995-12#2)(1996-2#2)(1996-6#1)(1997-7#2)
on CaMKII##2##2##(1991-12#2)
on Caco-2 cells##2##3##(2008-11#1)(2011-2#1)
on Caco-2##3##2##(2008-11#1)(2011-2#1)(2012-2#1)
on Canadian##2##2##(2007-12#1)(2007-7#1)
on Cancer##4##2##(2007-3#1)(2009-4#1)(2012-2#1)(2013-1#1)
on Cao-Nai exchange##2##3##(1990-11#2)
on Cardiac##2##2##(2008-8#1)(2011-2#1)
on Cardiovascular##2##2##(2012-2#1)(2013-1#1)
on Cell##3##2##(2008-11#1)(2008-9#1)(2009-11#1)
on Cerebral##2##2##(2008-10#1)(2008-8#1)
on Chickpea##2##2##(2008-10#2)
on Chiclayo##2##2##(2013-1#2)
on Child##2##2##(2006-9#1)(2011-12#1)
on Children's##3##2##(2008-9#1)(2012-2#1)(2013-1#1)
on Chinese##8##2##(1995-11#1)(2005-9#1)(2008-10#3)(2009-7#1)(2011-2#2)
on Chiralpak IA and Chiralpak IB columns##2##7##(2008-10#2)
on Chiropractic##2##2##(2007-6#1)(2008-5#1)
on Chr##2##2##(1994-12#1)(2008-9#1)
on Chromosome##3##2##(2008-10#2)(2010-2#1)
on Chrs 7 and 12##2##5##(2012-11#2)
on Circulating##2##2##(2012-3#2)
on Cl-##3##2##(1992-4#1)(1992-7#1)(1994-12#1)
on Clinical##14##2##(2007-1#10)(2008-5#1)(2010-2#1)(2012-11#1)(2012-12#1)
on Clinton plan##2##3##(1994-2#2)
on Complex##2##2##(1994-12#1)(2013-8#1)
on Computational##2##2##(2008-7#1)(2013-8#1)
on Con##2##2##(1994-8#1)(2006-6#1)
on Concanavalin##2##2##(1990-10#1)(1997-3#1)
on Conidial Germination##2##3##(2008-10#2)
on Cotton##2##2##(2008-10#2)
on Cu(111)##2##2##(1994-10#1)(1995-5#1)
on D##2##2##(1990-2#1)(1992-6#1)
on DA##4##2##(1994-2#1)(2007-12#1)(2013-1#2)
on DC activation##2##3##(2008-10#1)(2009-9#1)
on DC##4##2##(2008-10#2)(2009-9#1)(2013-8#1)
on DCT domain for biomedical##2##5##(2010-8#2)
on DCT domain##3##3##(2010-8#3)
on DCs##5##2##(2007-11#1)(2008-10#1)(2008-11#1)(2009-9#1)(2010-12#1)
on DDP accumulation##2##3##(1991-7#2)
on DDP cytotoxicity##2##3##(1991-7#1)(1992-2#1)
on DDP##4##2##(1991-7#3)(1992-2#1)
on DE52##2##2##(1992-9#1)(1994-12#1)
on DEAE##4##2##(1991-1#1)(1991-3#1)(2008-4#1)(2008-8#1)
on DEAE-Sephacel##4##2##(1991-11#1)(1991-4#1)(1992-12#1)(1996-7#1)
on DEAE-Sepharose##5##2##(1991-11#2)(1991-12#1)(1996-6#1)(2009-9#1)
on DEAE-cellulose##3##2##(1990-2#1)(1994-8#1)(1994-9#1)
on DI##2##2##(2008-10#2)
on DIV21##2##2##(2008-11#2)
on DNA and their antibacterial activity##2##6##(2008-3#2)
on DNA and##4##3##(1992-7#1)(2008-3#2)(2008-5#1)
on DNA extracted from##3##4##(1993-7#1)(2008-10#2)
on DNA molecules##3##3##(2008-10#1)(2010-12#2)
on DNA polymerase##2##3##(1994-2#1)(2008-5#1)
on DNA sequences##2##3##(2007-11#1)(2008-10#1)
on DNA synthesis and cell proliferation##2##6##(1990-12#1)(1995-11#1)
on DNA synthesis and cell##3##5##(1990-12#1)(1993-8#1)(1995-11#1)
on DNA synthesis in##2##4##(1991-7#1)(1992-3#1)
on DNA synthesis##13##3##(1990-12#1)(1990-7#1)(1991-7#1)(1992-3#1)(1992-7#1)(1993-6#1)(1993-8#2)(1995-10#1)(1995-11#1)(1997-2#1)(1997-7#1)(2008-4#1)
on DNA to##2##3##(1996-8#1)(2008-1#1)
on DNA##77##2##(1990-12#1)(1990-7#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-3#1)(1992-7#2)(1993-11#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-11#2)(1995-8#1)(1996-10#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#2)(2005-10#1)(2005-8#1)(2006-8#2)(2007-11#1)(2008-1#2)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-7#2)(2008-8#3)(2008-9#3)(2009-4#1)(2009-6#1)(2010-12#2)(2010-5#1)(2012-2#1)
on DNA-protein##2##2##(1995-1#1)(1997-2#1)
on DOWEX 50W-X8 resin##4##4##(2007-8#4)
on DPPC liposomes##2##3##(1996-1#1)(2008-10#1)
on DPPC##4##2##(1996-1#1)(2006-10#1)(2008-10#2)
on DPPH##2##2##(2008-11#1)(2012-11#1)
on DRG##3##2##(1991-2#1)(1995-12#1)(2013-1#1)
on DSKNPH in##3##3##(2008-10#3)
on DWI##2##2##(2007-10#1)(2009-11#1)
on Daudi##2##2##(1990-11#1)(1992-11#1)
on Day 0##2##3##(2006-11#1)(2013-1#1)
on Day 10##2##3##(2006-5#1)(2013-1#1)
on Day 14##2##3##(2008-10#1)(2008-9#1)
on Day 2##3##3##(1992-1#1)(2006-5#1)(2008-9#1)
on Day 21##2##3##(2008-9#2)
on Day 6##2##3##(1995-3#1)(2006-5#1)
on Day 7##3##3##(2006-5#1)(2008-10#1)(2008-11#1)
on Day##23##2##(1992-1#1)(1995-3#1)(2006-11#1)(2006-5#9)(2008-10#2)(2008-11#2)(2008-3#1)(2008-9#4)(2013-1#2)
on Days 0 and##2##4##(2008-10#1)(2013-1#1)
on Days##8##2##(2006-5#2)(2008-10#2)(2008-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
on December##8##2##(1996-11#1)(2007-12#1)(2007-2#1)(2009-3#1)(2010-1#1)(2010-12#3)
on Deoxycholate Agar##2##3##(2006-10#2)
on Detection##5##2##(1993-12#1)(1996-9#2)(2008-3#2)
on Development of Fusarium Wilt##2##5##(2008-10#2)
on Development of##4##3##(2008-10#3)(2013-1#1)
on Development##5##2##(2008-10#3)(2008-5#1)(2013-1#1)
on Dowex-50WX8##2##2##(2008-10#2)
on Drosophila##2##2##(2008-9#1)(2012-3#1)
on Drug Abuse##4##3##(1996-4#2)(2006-8#1)(2007-11#1)
on Drug##6##2##(1996-4#2)(2006-8#1)(2007-11#1)(2009-7#1)(2011-2#1)
on Drugs##2##2##(2006-10#1)(2009-9#1)
on E##9##2##(1994-5#1)(2010-2#3)(2010-3#1)(2010-4#3)(2012-3#1)
on E11##2##2##(1997-6#2)
on ECG##7##2##(2006-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#2)(2013-1#1)
on EGFR##3##2##(1996-5#1)(2008-7#1)(2013-8#1)
on EI##2##2##(2012-1#1)(2013-1#1)
on ELBW infants##2##3##(2006-7#1)(2006-8#1)
on ELISA##3##2##(1994-2#1)(1996-12#1)(2009-6#1)
on EMG##4##2##(2010-5#1)(2012-1#2)(2012-12#1)
on EPO##3##2##(2007-7#1)(2008-1#1)(2008-11#1)
on ER##2##2##(2008-8#1)(2009-4#1)
on EUS##3##2##(2006-10#2)(2008-5#1)
on Earth##18##2##(1991-12#1)(1993-7#1)(1994-7#1)(1995-12#1)(1996-5#1)(1997-5#1)(2006-5#1)(2007-8#2)(2007-9#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2009-9#1)(2012-3#1)
on Earth's##2##2##(2007-9#2)
on Education##2##2##(1997-3#1)(2006-8#1)
on Embase##2##2##(2007-8#2)
on Environmental##4##2##(2006-12#1)(2007-10#1)(2008-3#1)(2008-5#1)
on Erikson's##2##2##(2008-12#2)
on Escherichia coli##7##3##(1990-1#1)(1990-3#1)(1990-5#1)(2008-4#1)(2011-3#1)(2012-2#1)(2013-7#1)
on Ethics##3##2##(1991-8#1)(2007-4#2)
on Eucalyptus##3##2##(2008-10#1)(2010-3#2)
on European##3##2##(1994-6#1)(2008-8#2)
on Expressed##2##2##(1997-8#1)(2007-8#1)
on Expression of##2##3##(2010-10#1)(2012-2#1)
on Exubera##2##2##(2008-8#1)(2009-12#1)
on F##3##2##(1991-7#1)(2008-10#2)
on F-actin##2##2##(1990-4#1)(1996-5#1)
on F1 and F2##2##4##(2008-10#1)(2010-12#1)
on F1##3##2##(2008-10#1)(2010-12#1)(2013-1#1)
on FDA##2##2##(2005-10#1)(2005-11#1)
on FIV##3##2##(2007-11#2)(2012-2#1)
on FN expression##2##3##(1994-9#2)
on FN##5##2##(1992-6#1)(1993-9#1)(1994-9#2)(2012-2#1)
on FN- and##2##3##(2009-11#2)
on FPGAs##3##2##(2008-12#1)(2008-2#2)
on Factor Xa##2##3##(2005-8#2)
on February 25##2##3##(1992-3#1)(1997-2#1)
on February##4##2##(1992-3#1)(1997-2#2)(2013-8#1)
on Federal##2##2##(1994-1#1)(1996-1#1)
on Food##2##2##(2008-4#1)(2012-12#1)
on Fresnel##2##2##(2007-12#1)(2008-3#1)
on Fru 2##2##3##(1994-3#2)
on Functional Genomics##6##3##(2008-7#6)
on Fusarium head blight##3##4##(2008-10#3)
on Fusarium##6##2##(2007-7#1)(2008-10#5)
on G##2##2##(1996-4#1)(2010-8#1)
on G-actin##3##2##(1992-4#2)(2008-1#1)
on G-proteins##2##2##(1995-3#2)
on GABA##3##2##(1992-7#1)(1994-12#1)(1995-6#1)
on GABAB receptors##2##3##(1992-3#1)(1996-10#1)
on GABAergic##2##2##(1991-1#1)(1996-12#1)
on GAL##2##2##(1995-2#1)(1996-12#1)
on GC electrode##2##3##(2008-10#2)
on GC##3##2##(2006-9#1)(2008-10#2)
on GD##3##2##(1994-11#2)(2006-4#1)
on GDP##4##2##(2007-2#4)
on GH secretion##2##3##(2007-7#2)
on GH##7##2##(1996-10#1)(2006-9#1)(2007-7#3)(2010-8#1)(2013-1#1)
on GI##3##2##(2008-5#1)(2013-1#2)
on GR##3##2##(1996-4#1)(2009-8#1)(2012-3#1)
on Ge plate##2##3##(1991-9#2)
on Ge##3##2##(1991-9#2)(2008-2#1)
on Gene##2##2##(2005-9#1)(2010-8#1)
on Genetic##4##2##(1993-9#1)(2008-10#1)(2008-5#1)(2013-1#1)
on Germination##2##2##(2008-10#2)
on Glucose##2##2##(2008-4#1)(2010-8#1)
on GnRH##3##2##(1994-8#1)(1995-10#1)(2006-10#1)
on Golgi##4##2##(1994-9#1)(1997-4#2)(2009-10#1)
on Google##3##2##(2010-8#1)(2011-2#1)(2013-1#1)
on Growth Rate##2##3##(2008-10#1)(2013-8#1)
on Growth and##2##3##(2008-10#1)(2010-8#1)
on Growth##4##2##(2008-10#2)(2010-8#1)(2013-8#1)
on Guam##5##2##(2008-1#5)
on H##4##2##(2008-10#2)(2008-11#1)(2011-12#1)
on HA##4##2##(2008-5#1)(2009-7#1)(2011-1#1)(2012-3#1)
on HAART##5##2##(2007-7#1)(2010-9#1)(2012-2#2)(2013-8#1)
on HBV##4##2##(2007-11#1)(2007-12#1)(2011-1#1)(2012-12#1)
on HCC risk##3##3##(2010-12#3)
on HCC##5##2##(2008-3#1)(2008-8#1)(2010-12#3)
on HD##14##2##(2007-7#9)(2007-8#1)(2008-1#3)(2012-12#1)
on HIV and AIDS##2##4##(2007-8#1)(2012-12#1)
on HIV and##5##3##(2004-9#1)(2007-8#1)(2008-4#1)(2011-2#1)(2012-12#1)
on HIV infection##2##3##(1996-12#1)(2013-8#1)
on HIV prevention in##2##4##(1996-4#1)(2007-12#1)
on HIV prevention##5##3##(1990-6#1)(1994-4#1)(1996-4#1)(2007-12#1)(2008-1#1)
on HIV transmission##2##3##(2013-8#2)
on HIV##27##2##(1990-6#1)(1991-11#1)(1994-4#1)(1995-2#1)(1995-9#1)(1996-12#1)(1996-4#1)(2004-9#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-4#1)(2009-12#1)(2009-5#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#3)
on HIV-1 transmission##2##3##(1992-8#1)(2013-8#1)
on HIV-1##15##2##(1992-8#1)(1997-2#2)(2006-11#1)(2006-4#2)(2007-11#1)(2011-3#6)(2013-1#1)(2013-8#1)
on HIV-1(IIIB)##2##2##(2011-3#2)
on HIV-infected##2##2##(1991-5#1)(2010-5#1)
on HIV/AIDS and##4##3##(2007-7#1)(2008-2#1)(2008-7#1)(2010-8#1)
on HIV/AIDS##19##2##(1990-10#1)(1994-10#1)(1995-12#2)(1995-6#2)(1997-3#1)(2006-8#2)(2007-7#1)(2008-2#4)(2008-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
on HL-60 cells##2##3##(1996-2#1)(2008-11#1)
on HLA##3##2##(1997-9#1)(2008-8#1)(2011-2#1)
on HMOs##2##2##(1991-1#1)(1993-6#1)
on HPLC fingerprint of##2##4##(2012-12#1)(2012-3#1)
on HPLC##14##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-7#1)(1992-7#2)(1993-4#1)(1994-6#1)(2008-10#1)(2009-8#1)(2010-12#1)(2012-12#2)(2012-3#1)
on HPV##3##2##(2011-1#1)(2011-2#2)
on HRCT##2##2##(2012-2#2)
on HRP##3##2##(2008-10#2)(2012-4#1)
on HRQL##4##2##(2007-11#2)(2012-12#2)
on HRT##4##2##(2008-5#4)
on HSA 21q22##2##3##(2008-7#2)
on HSA##3##2##(2006-12#1)(2008-7#2)
on HT-1080##2##2##(2012-3#2)
on HT29-D4 cells##3##3##(1990-7#1)(1994-12#2)
on HUVEC##2##2##(1993-6#1)(2008-11#1)
on HaCat##2##2##(2011-3#2)
on He##2##2##(2006-4#1)(2008-3#1)
on HeLa cell line##4##4##(2012-11#4)
on HeLa cell##5##3##(2009-6#1)(2012-11#4)
on HeLa##7##2##(2008-11#1)(2009-6#1)(2010-12#1)(2012-11#4)
on Health Research##3##3##(2010-5#1)(2011-2#1)(2012-2#1)
on Health##17##2##(1991-2#1)(1994-12#4)(1995-6#1)(1996-1#1)(1996-12#1)(1997-8#1)(2008-12#1)(2009-4#3)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
on Heartland##2##2##(2008-10#2)
on Helicobacter pylori##2##3##(2006-10#1)(2012-12#1)
on High##4##2##(1992-4#1)(1994-9#1)(1997-2#1)(2008-7#1)
on Human Resources##2##3##(1990-12#1)(2012-11#1)
on Human Rights##2##3##(1996-11#1)(2005-11#1)
on Human##16##2##(1990-12#1)(1996-10#1)(1996-11#1)(1996-5#1)(2005-11#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-4#1)(2009-10#1)(2010-2#1)(2011-2#2)(2012-11#1)(2012-2#1)
on Hybrid##2##2##(2008-10#1)(2013-8#1)
on Hypertension##4##2##(2005-8#1)(2007-12#1)(2008-7#1)(2011-2#1)
on I##5##2##(2007-5#2)(2008-10#3)
on IBD##2##2##(2006-2#1)(2008-9#1)
on ICAM-1##2##2##(1995-2#1)(2007-9#1)
on ICH##2##2##(2007-10#1)(2008-10#1)
on ICP##3##2##(1996-9#1)(2008-7#1)(2013-8#1)
on IECs##2##2##(2006-10#2)
on IFN##3##2##(1993-2#1)(2008-11#1)(2009-8#1)
on IL-1 beta##2##3##(1996-12#1)(2007-2#1)
on IL-1##5##2##(1992-5#2)(1996-12#1)(2007-2#2)
on IL-2##2##2##(2004-12#1)(2008-8#1)
on IL-3##2##2##(1994-10#1)(2008-5#1)
on IL-6 production##2##3##(2008-10#2)
on IL-6##5##2##(2008-10#2)(2008-4#1)(2010-12#1)(2012-2#1)
on IOP##2##2##(2008-3#1)(2009-8#1)
on IP3##2##2##(1992-9#1)(1995-3#1)
on IPV##2##2##(1995-5#1)(2009-5#1)
on IR##4##2##(2010-4#1)(2013-1#1)(2013-8#2)
on ITO##2##2##(2008-12#1)(2010-4#1)
on ITS##3##2##(2008-10#3)
on IgE##2##2##(2007-6#1)(2008-11#1)
on IgE-mediated##2##2##(2006-10#1)(2007-2#1)
on IgG-Sepharose and nickel##2##4##(1996-12#2)
on In##2##2##(2008-10#1)(2011-1#1)
on Indian##4##2##(1991-5#1)(2008-10#1)(2008-4#1)(2010-12#1)
on Infant##2##2##(2012-2#1)(2013-1#1)
on Infection of##4##3##(2008-10#4)
on Infection##6##2##(2008-10#6)
on Ins(1##2##2##(1991-2#2)
on Insulin Resistance##2##3##(2005-7#1)(2008-3#1)
on Insulin##3##2##(2005-7#1)(2008-3#1)(2009-3#1)
on Interaction with##2##3##(2007-2#1)(2008-10#1)
on Italian##4##2##(1994-2#1)(2007-9#1)(2008-5#1)(2013-8#1)
on January 1##3##3##(1994-1#1)(1996-3#1)(2008-11#1)
on January##9##2##(1994-1#1)(1996-3#1)(1997-1#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2009-8#1)
on Japanese##4##2##(2006-10#1)(2008-10#1)(2010-8#1)(2013-1#1)
on Jeffrey pine in Lake Tahoe##2##6##(2008-10#2)
on Jeffrey pine##3##3##(2008-10#3)
on July##3##2##(1991-12#1)(2009-5#1)(2012-2#1)
on June 11-12##2##3##(2009-11#1)(2009-2#1)
on June 13##2##3##(1995-6#1)(1996-6#1)
on June 17##2##3##(1996-6#1)(2004-12#1)
on June##14##2##(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#3)(2004-12#1)(2004-3#1)(2004-9#1)(2006-8#1)(2009-11#1)(2009-2#1)(2009-7#1)(2011-12#1)
on K##2##2##(1991-11#1)(1994-8#1)
on K+##2##2##(1996-10#1)(1996-6#1)
on K1a##2##2##(2008-6#2)
on KCl-induced##2##2##(1995-12#1)(1995-7#1)
on KI##2##2##(2005-4#1)(2008-10#1)
on Kevlar##2##2##(2005-11#2)
on Kleinert's##2##2##(2009-9#2)
on L##5##2##(2008-10#2)(2009-8#1)(2013-8#2)
on L-6 cells from rat skeletal muscle##2##7##(1995-8#2)
on L-thyroxine##2##2##(2006-10#1)(2011-1#1)
on L5-S1##3##2##(2007-11#3)
on L5178Y##2##2##(1991-9#2)
on LAT cell##3##3##(1990-6#3)
on LATVs##2##2##(2013-1#2)
on LC##2##2##(1997-8#1)(2008-10#1)
on LDL oxidation##2##3##(1992-9#1)(1995-12#1)
on LDL##8##2##(1992-9#1)(1993-6#2)(1994-8#1)(1995-12#1)(1997-2#1)(2008-3#1)(2011-1#1)
on LG10##2##2##(2008-10#2)
on LG7##3##2##(2008-10#3)
on LGs 3##2##3##(2008-10#2)
on LH##3##2##(1994-6#1)(1995-9#1)(1996-7#1)
on LHR##2##2##(1996-5#2)
on LHRH##2##2##(1996-4#1)(2008-4#1)
on LM##2##2##(1992-5#1)(2008-3#1)
on LPS-induced cytokine production and##2##5##(2008-10#2)
on LPS-induced cytokine production##3##4##(2008-10#3)
on LPS-induced##4##2##(2008-10#3)(2008-11#1)
on LTS##2##2##(1990-3#2)
on Lactobacillus##2##2##(2005-12#1)(2009-9#1)
on Langmuir-Blodgett (LB)##2##3##(2008-11#1)(2010-10#1)
on Langmuir-Blodgett##3##2##(2008-10#1)(2008-11#1)(2010-10#1)
on Leaves##2##2##(2008-10#2)
on Lee##2##2##(2007-9#1)(2008-2#1)
on Lemna minor##2##3##(2008-10#1)(2011-1#1)
on Lettuce##5##2##(2008-10#5)
on Leydig cell##2##3##(1992-12#1)(2008-4#1)
on LiTaO(3)##2##2##(2008-10#1)(2008-3#1)
on Linux##2##2##(2008-4#1)(2012-2#1)
on Long-term##2##2##(2007-7#1)(2010-9#1)
on Lr26##3##2##(2008-10#3)
on Lung##2##2##(2010-8#2)
on Lyme disease##2##3##(1991-3#1)(2008-11#1)
on Lyme##3##2##(1991-3#1)(2008-11#2)
on Lys13##2##2##(1990-7#2)
on M##7##2##(2008-10#2)(2009-12#1)(2010-8#1)(2011-2#1)(2013-7#2)
on MAO##2##2##(1995-11#1)(1996-7#1)
on MAPK##2##2##(1995-6#2)
on MATLAB##3##2##(2008-1#1)(2012-2#2)
on MCF-7##2##2##(1991-5#1)(2010-1#1)
on MCI GEL ProtEx##2##4##(1997-2#2)
on MDR##2##2##(1996-9#1)(2010-12#1)
on MIN and##2##3##(2008-10#2)
on MIN##5##2##(2008-10#5)
on MIR604##6##2##(2011-2#6)
on MK-1 cells##2##3##(1992-4#2)
on MLC601##3##2##(2013-1#3)
on MMP-1 and TIMP-1##2##4##(2008-5#2)
on MMP-1##3##2##(2006-9#1)(2008-5#2)
on MMP-2 activity##3##3##(2007-2#3)
on MMPs##3##2##(1990-7#1)(2007-2#2)
on MR images##5##3##(1997-8#4)(2007-11#1)
on MR imaging##4##3##(1997-8#3)(2006-9#1)
on MR mammography and the##2##5##(1997-8#2)
on MR##15##2##(1997-8#10)(2006-4#1)(2006-9#1)(2007-11#1)(2007-4#1)(2008-6#1)
on MRI have##2##3##(2006-6#1)(2012-12#1)
on MRI##26##2##(1995-6#1)(2006-1#1)(2006-3#2)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-12#3)(2012-2#5)(2013-1#1)(2013-8#1)
on MRS##2##2##(2006-8#1)(2007-9#1)
on MS medium containing sucrose##3##5##(2013-1#3)
on MS medium containing##4##4##(2007-1#1)(2013-1#3)
on MS medium##6##3##(2007-1#2)(2008-12#1)(2013-1#3)
on MS##8##2##(2007-1#2)(2008-12#1)(2011-1#1)(2011-2#1)(2013-1#3)
on MSH binding to##2##4##(1991-3#2)
on MSH binding##4##3##(1990-5#1)(1991-3#3)
on MSV-infected##2##2##(2008-10#2)
on MTSC4##2##2##(2008-8#2)
on March 22##2##3##(1991-11#1)(1996-12#1)
on March##11##2##(1991-11#1)(1996-12#1)(1996-3#1)(1997-2#1)(2004-12#1)(2007-11#1)(2007-5#1)(2010-6#1)(2012-2#3)
on Markov##3##2##(2008-6#1)(2008-8#1)(2012-2#1)
on Mars##13##2##(1990-8#2)(1995-10#1)(1995-3#1)(2006-4#2)(2007-9#4)(2008-10#1)(2008-4#1)(2010-5#1)
on Mass Spectrometry##2##3##(2007-2#1)(2008-7#1)
on Matrigel##3##2##(1995-2#1)(2008-11#1)(2012-5#1)
on Mauna Kea##2##3##(1996-5#1)(2008-2#1)
on May 12##2##3##(1997-2#1)(2012-1#1)
on May 14##3##3##(1996-5#2)(1996-6#1)
on May##14##2##(1995-6#1)(1996-5#5)(1996-6#1)(1997-2#1)(2008-5#1)(2009-6#1)(2010-10#1)(2011-2#1)(2012-1#1)(2013-8#1)
on Medicaid##3##2##(1992-6#1)(1993-3#1)(1994-2#1)
on Medicare##8##2##(1990-4#1)(1992-1#1)(1992-2#1)(1994-1#1)(1994-2#1)(1997-7#1)(2007-4#1)(2012-2#1)
on Medicare/Medicaid issues in health care##2##6##(2008-11#2)
on Medline and##2##3##(2007-8#1)(2012-12#1)
on Medline##3##2##(2007-8#2)(2012-12#1)
on Mg2+##2##2##(1990-7#1)(2008-8#1)
on MgO##2##2##(1991-3#1)(2004-9#1)
on Mono Q##2##3##(1991-11#2)
on Mono S##3##3##(1990-7#1)(1991-11#1)(1991-12#1)
on Mono##5##2##(1990-7#1)(1991-11#3)(1991-12#1)
on Mount##2##2##(2007-3#1)(2007-8#1)
on Murashige and Skoog medium##3##5##(2007-3#1)(2010-2#2)
on Muscari armeniacum##2##3##(2013-7#2)
on Muscari##4##2##(2013-7#4)
on Mycobacterium tuberculosis##3##3##(2007-9#1)(2009-7#2)
on N##13##2##(1992-3#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-8#1)
on N-methyl-D-aspartate (NMDA)-induced##3##3##(1990-5#1)(1996-1#1)(1996-12#1)
on N-methyl-D-aspartate##5##2##(1990-5#2)(1996-1#1)(1996-12#1)(2005-7#1)
on NADH##2##2##(1991-8#1)(1995-1#1)
on NAND##2##2##(2009-3#2)
on NF-kappa B##2##3##(1994-8#1)(1995-6#1)
on NMDA and##2##3##(1993-2#1)(1995-12#1)
on NMDA receptors##2##3##(1997-3#1)(2011-1#1)
on NMDA##6##2##(1993-2#1)(1994-2#1)(1994-5#1)(1995-12#1)(1997-3#1)(2011-1#1)
on NO production##6##3##(1992-11#2)(2008-10#1)(2008-8#2)(2013-1#1)
on NO##8##2##(1991-3#1)(1992-11#2)(1992-5#1)(2008-10#1)(2008-8#2)(2013-1#1)
on NP##2##2##(2010-5#1)(2012-3#1)
on NPY##2##2##(1996-1#1)(1996-12#1)
on Na(+) concentration##2##3##(2006-10#1)(2008-10#1)
on Na(+)##3##2##(2006-10#1)(2008-10#1)(2008-8#1)
on Na+ kinetics##2##3##(1990-11#2)
on Na+##6##2##(1990-11#3)(1990-2#1)(1992-6#1)(2008-8#1)
on Na+/H+ exchange activity##2##4##(1991-9#1)(1992-10#1)
on Na-Ca exchange fluxes##2##4##(1990-11#2)
on Nanoparticle##2##2##(2012-3#2)
on National##3##2##(1996-11#1)(2008-3#1)(2012-12#1)
on Nef##2##2##(2005-7#1)(2011-2#1)
on New York##2##3##(2008-10#1)(2009-4#1)
on New##5##2##(2005-7#1)(2006-5#1)(2008-10#1)(2008-11#1)(2009-4#1)
on Ni##2##2##(2007-8#1)(2008-10#1)
on Northern blot##2##3##(1996-11#1)(1997-7#1)
on Northern blotting##2##3##(1993-6#1)(1994-9#1)
on Northern##5##2##(1993-5#1)(1993-6#1)(1994-9#1)(1996-11#1)(1997-7#1)
on Norway spruce seedlings##2##4##(2008-10#2)
on Norway spruce##3##3##(2008-10#3)
on November##10##2##(1995-2#1)(1996-11#1)(2004-9#1)(2005-7#1)(2006-8#1)(2007-12#2)(2008-10#1)(2008-4#1)(2010-12#1)
on O2##2##2##(1992-11#1)(1994-3#1)
on OC symptom##2##3##(2008-6#2)
on ODS##2##2##(2008-10#2)
on Obesity##3##2##(2005-7#1)(2005-8#1)(2008-3#1)
on October##9##2##(1991-1#1)(1991-10#1)(1994-9#1)(2006-2#1)(2007-3#1)(2009-5#1)(2011-1#1)(2012-11#1)(2012-12#1)
on Olive##2##2##(2008-10#1)(2008-12#1)
on P##21##2##(1996-9#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-6#1)(2010-3#1)(2010-8#3)(2011-12#1)(2011-2#7)
on P-glycoprotein##2##2##(1992-8#1)(2008-11#1)
on P-gp##2##2##(1993-6#1)(2011-2#1)
on P1##2##2##(1996-2#1)(2013-8#1)
on P2Y##2##2##(2008-4#2)
on PA##2##2##(2004-2#1)(2011-1#1)
on PBL##2##2##(2008-12#1)(2013-1#1)
on PC12 cell differentiation##2##4##(1992-11#1)(2008-11#1)
on PC12##3##2##(1991-1#1)(1992-11#1)(2008-11#1)
on PCR##5##2##(1990-12#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
on PCR-RFLP##2##2##(2006-8#1)(2008-10#1)
on PCs##2##2##(1994-2#1)(2008-9#1)
on PD##4##2##(2008-1#1)(2011-2#3)
on PDA##3##2##(2008-10#3)
on PDMS Channel textures##3##4##(2006-4#3)
on PI 88788##2##3##(2009-3#2)
on PI##6##2##(1992-1#1)(2009-3#4)(2009-6#1)
on PKA##2##2##(1992-3#1)(1997-7#1)
on PKC activity##3##3##(1991-8#1)(1993-8#1)(1995-7#1)
on PKC##10##2##(1990-4#1)(1991-5#1)(1991-8#1)(1992-6#1)(1993-8#1)(1994-11#1)(1995-7#1)(1996-5#1)(2008-8#2)
on PLC-PI##2##2##(1991-7#2)
on PLD activity##2##3##(1996-5#1)(1997-3#1)
on PLD##3##2##(1996-5#1)(1997-3#2)
on PM##2##2##(1990-4#1)(2013-7#1)
on PMET##2##2##(2009-9#2)
on PND 7##2##3##(1993-11#2)
on PND##4##2##(1993-11#3)(1996-3#1)
on POMC##3##2##(1993-5#1)(2008-4#2)
on PPV-infected peach##2##3##(2008-10#2)
on PRL##2##2##(1991-7#1)(1994-3#1)
on PS##2##2##(2004-9#1)(2013-7#1)
on PTH##2##2##(1991-4#1)(2005-10#1)
on PTSD##2##2##(2005-10#1)(2009-11#1)
on PVC##2##2##(2005-11#1)(2008-10#1)
on Pap##3##2##(2006-10#2)(2011-2#1)
on Parkinson's disease and related disorders##2##6##(2008-11#2)
on Parkinson's disease##3##3##(2008-11#2)(2008-7#1)
on Pd##3##2##(2007-8#1)(2008-11#1)(2010-4#1)
on Peach##2##2##(2008-10#2)
on Percoll##2##2##(1991-11#1)(2008-11#1)
on Petri dishes##2##3##(1995-8#1)(2007-7#1)
on Pf##2##2##(1993-3#1)(1996-10#1)
on Phe8##2##2##(1995-10#2)
on Physical Activity and##2##4##(2008-12#1)(2011-2#1)
on Physical##5##2##(2006-10#1)(2007-12#1)(2008-12#1)(2010-1#1)(2011-2#1)
on Pi##2##2##(1994-3#1)(2010-8#1)
on Plant##2##2##(1990-8#1)(2009-8#1)
on Polish##2##2##(2007-11#1)(2007-8#1)
on Population##5##2##(1994-9#2)(2007-4#1)(2008-10#1)(2008-11#1)
on Populus deltoides##2##3##(2008-10#1)(2011-2#1)
on Populus##3##2##(2008-10#2)(2011-2#1)
on Prevention and##2##3##(2006-9#1)(2013-8#1)
on Primary##3##2##(2006-3#1)(2009-4#2)
on Prince Edward Island##2##4##(2006-2#1)(2012-3#1)
on Professional##2##2##(1993-3#1)(1995-2#1)
on Prunus spp##2##3##(2008-10#2)
on Prunus##3##2##(2008-10#2)(2011-2#1)
on Pseudomonas##2##2##(2008-10#2)
on PtBMA##2##2##(2008-5#2)
on PubMed##4##2##(2009-5#1)(2012-3#2)(2013-1#1)
on Public Health##2##3##(1997-2#1)(2009-5#1)
on Pulmonary##2##2##(2012-12#1)(2012-2#1)
on Purkinje##2##2##(1993-11#1)(1996-2#1)
on Pythium root rot##2##4##(2008-10#2)
on Q##2##2##(1991-12#1)(2012-6#1)
on Q-Sepharose##2##2##(1993-12#1)(1997-4#1)
on QOL##7##2##(2006-11#1)(2006-9#1)(2007-8#2)(2008-7#1)(2011-2#2)
on QT prolongation##2##3##(2008-8#2)
on QoL in##2##3##(2008-10#1)(2008-5#1)
on QoL##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
on Quality of Life##3##4##(2011-1#1)(2013-1#2)
on Quality of##5##3##(2010-8#1)(2011-1#2)(2013-1#2)
on Quality##8##2##(1995-12#1)(1996-3#1)(2006-5#1)(2010-8#1)(2011-1#2)(2013-1#2)
on R##4##2##(2008-10#3)(2011-1#1)
on RAPD##7##2##(2005-11#1)(2008-10#6)
on RBC##2##2##(1995-1#1)(1996-3#1)
on RCC##2##2##(1995-5#2)
on RFID##2##2##(2007-11#2)
on RGS(003)##2##2##(2011-2#2)
on RL##3##2##(2008-10#3)
on RNA isolated##2##3##(1996-10#1)(2008-5#1)
on RNA##13##2##(1990-3#1)(1996-10#1)(1996-8#1)(2006-7#1)(2007-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
on ROS 17/2##2##3##(1990-7#2)
on RRT##3##2##(2007-7#3)
on RTXd35##3##2##(2013-8#3)
on Radiation Protection##5##3##(1994-12#1)(1995-1#1)(1995-2#2)(1996-6#1)
on Raman##4##2##(2007-12#1)(2010-10#1)(2011-1#1)(2012-2#1)
on Repeated##2##2##(2008-10#1)(2011-2#1)
on Research##3##2##(2007-12#1)(2008-11#1)(2009-4#1)
on Rhodnius neglectus##2##3##(2013-7#2)
on Rice##2##2##(2008-10#2)
on Risk##2##2##(2011-2#1)(2012-3#1)
on Réunion Island##3##3##(1996-3#1)(2007-6#1)(2008-10#1)
on S##8##2##(1991-5#1)(2006-8#1)(2008-10#4)(2010-12#1)(2011-12#1)
on S180##2##2##(2008-9#1)(2012-12#1)
on SAH-hydrolase activity##2##3##(1994-8#2)
on SAPC##2##2##(1997-2#2)
on SAT-1 activity##2##3##(1991-2#2)
on SC##3##2##(2008-5#3)
on SCEs##2##2##(1990-6#1)(2008-4#1)
on SDS gels##4##3##(1990-2#1)(1994-9#1)(1995-3#1)(2008-4#1)
on SDS##5##2##(1990-2#1)(1994-9#1)(1995-3#1)(1997-7#1)(2008-4#1)
on SDS-PAGE and##2##3##(1990-4#1)(1993-6#1)
on SDS-PAGE with a##2##4##(1992-12#2)
on SDS-PAGE##27##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#2)(1990-8#1)(1991-1#2)(1991-10#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-12#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-5#1)(1995-5#1)(1995-8#1)(1996-10#1)(1997-2#1)(1997-7#1)(2006-8#1)(2008-8#1)(2009-9#1)
on SDS-containing polyacrylamide gels##2##4##(1990-12#2)
on SDS-polyacrylamide gel electrophoresis with##2##5##(1992-8#1)(1996-5#1)
on SDS-polyacrylamide gel electrophoresis##7##4##(1990-6#1)(1991-5#1)(1992-8#1)(1994-9#1)(1996-5#2)(1997-4#1)
on SDS-polyacrylamide gels##4##3##(1992-12#1)(1994-12#1)(1994-5#1)(1997-4#1)
on SDS-polyacrylamide##12##2##(1990-6#1)(1991-5#1)(1992-12#1)(1992-8#1)(1994-12#1)(1994-5#1)(1994-9#1)(1996-5#2)(1997-4#2)(2008-11#1)
on SDS/PAGE##3##2##(1990-12#1)(1991-12#1)(1994-3#1)
on SDS/polyacrylamide gels##2##3##(1995-2#1)(1996-4#1)
on SDS/polyacrylamide##3##2##(1990-4#1)(1995-2#1)(1996-4#1)
on SG assembly##2##3##(2012-12#2)
on SLM(046)##3##2##(2011-2#3)
on SO(2)##2##2##(2008-3#1)(2011-1#1)
on SOHO##3##2##(2008-2#1)(2008-3#2)
on SPARC##2##2##(2009-4#2)
on SPE##2##2##(2008-10#2)
on SPSS##2##2##(2008-12#1)(2009-4#1)
on SRC-1 and SRC-3 expression in##2##6##(2010-10#2)
on SSR##3##2##(2008-10#3)
on Sabouraud dextrose agar##2##4##(2007-7#2)
on Sabouraud##3##2##(2007-7#2)(2008-5#1)
on Sabouraud's dextrose agar##2##4##(2007-7#1)(2008-5#1)
on Sabouraud's##3##2##(2007-7#1)(2008-5#1)(2009-11#1)
on Saccharomyces cerevisiae immobilized sepiolite##2##5##(2008-10#2)
on Saccharomyces cerevisiae immobilized##3##4##(2008-10#3)
on Saccharomyces cerevisiae##8##3##(1990-7#1)(1995-8#1)(1996-3#1)(2007-2#1)(2008-10#3)(2011-2#1)
on Salmonella##2##2##(2007-12#1)(2008-5#1)
on Santa##2##2##(2007-3#1)(2008-8#1)
on Schwann cells##2##3##(1991-9#1)(1995-2#1)
on Schwann##3##2##(1991-9#1)(1994-3#1)(1995-2#1)
on Science##2##2##(2007-9#1)(2010-6#1)
on Sephacryl S-200##2##3##(1992-7#1)(1997-4#1)
on Sephacryl##4##2##(1992-7#1)(1996-5#1)(1997-4#1)(2012-12#1)
on Sephadex G-200##2##3##(1992-3#2)
on Sephadex G-50##5##3##(1990-12#2)(1990-2#2)(1993-12#1)
on Sephadex G-75##2##3##(1990-7#1)(1995-6#1)
on Sephadex G50##2##3##(1995-5#1)(2008-5#1)
on Sephadex##17##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-5#1)(1990-7#1)(1992-3#2)(1993-12#1)(1995-5#1)(1995-6#1)(2008-10#3)(2008-5#1)
on September 11##3##3##(2006-7#1)(2007-3#1)(2009-4#1)
on September##10##2##(2004-12#1)(2006-10#1)(2006-7#1)(2007-3#1)(2007-5#1)(2008-5#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-11#1)
on Ser##4##2##(1993-4#1)(1996-2#2)(2008-9#1)
on Ser-139##2##2##(2008-9#2)
on Sf9##2##2##(2008-11#2)
on Si wafers we show that##2##6##(2008-3#2)
on Si wafers##3##3##(2008-2#1)(2008-3#2)
on Si##11##2##(2006-4#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#4)(2009-11#2)
on SiO(2)##3##2##(2005-11#1)(2009-12#1)(2012-11#1)
on SiO2##2##2##(2007-12#1)(2008-11#1)
on Social Security##2##3##(1993-3#1)(2007-1#1)
on Social##5##2##(1993-3#1)(2007-1#1)(2007-7#1)(2011-1#2)
on Solanum##3##2##(2008-10#1)(2008-7#1)(2012-12#1)
on Solar##2##2##(2008-4#2)
on South##2##2##(2009-11#1)(2013-8#1)
on Southern##4##2##(1993-4#1)(2008-5#1)(2010-12#1)(2012-2#1)
on Spore##2##2##(2008-10#2)
on Sporulation of##3##3##(2008-10#3)
on SrTiO(3) (100)##2##3##(1990-9#1)(2008-2#1)
on St##4##2##(1996-6#1)(2008-10#2)(2008-11#1)
on Standards##2##2##(2008-10#1)(2008-7#1)
on Staphylococcus##2##2##(2008-2#1)(2008-5#1)
on State##2##2##(1994-2#1)(2008-1#1)
on Stellaria media##2##3##(2008-10#2)
on Streptococcus##2##2##(2012-12#1)(2012-2#1)
on Stress##3##2##(1995-12#1)(2008-10#1)(2012-1#1)
on Stroke##4##2##(2007-9#2)(2008-8#2)
on Stroop##2##2##(2007-1#1)(2013-1#1)
on Sw 72469-6##3##3##(2008-10#3)
on Swiss##2##2##(2008-10#1)(2010-1#1)
on T and B##2##4##(2008-4#1)(2009-6#1)
on T and##4##3##(1994-6#1)(2008-4#1)(2008-7#1)(2009-6#1)
on T cell##5##3##(1991-9#1)(1992-2#1)(2007-11#1)(2007-8#1)(2012-3#1)
on T cells##7##3##(1991-12#2)(1995-12#1)(1996-10#1)(2007-5#1)(2008-5#1)(2013-7#1)
on T lymphocytes##3##3##(1993-9#1)(1994-3#1)(1994-8#1)
on T##27##2##(1991-12#2)(1991-6#1)(1991-9#1)(1992-2#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1996-10#1)(1996-12#1)(1997-8#2)(2007-11#2)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-7#1)(2012-3#1)(2013-7#1)
on T-cell proliferation##3##3##(1990-5#1)(1992-5#1)(2008-11#1)
on T-cell##8##2##(1990-5#1)(1992-5#1)(1993-12#1)(1993-6#1)(1993-9#1)(1995-5#1)(2004-12#1)(2008-11#1)
on T-cells##2##2##(1994-12#1)(2009-9#1)
on T1 and##2##3##(1991-11#1)(2007-4#1)
on T1-weighted and##2##3##(2005-10#1)(2006-12#1)
on T1-weighted images and high##2##5##(1991-11#1)(2007-12#1)
on T1-weighted images and##4##4##(1991-11#1)(2006-5#1)(2007-11#1)(2007-12#1)
on T1-weighted images##8##3##(1991-11#1)(2006-5#3)(2007-11#1)(2007-12#1)(2008-7#2)
on T1-weighted##15##2##(1991-11#1)(2004-11#1)(2005-10#1)(2006-12#1)(2006-5#3)(2007-11#1)(2007-12#1)(2008-7#2)(2012-12#1)(2012-2#2)(2012-3#1)
on T2- and##2##3##(2008-10#1)(2009-11#1)
on T2-WI##3##2##(1997-8#3)
on T2-weighted and##2##3##(2006-10#1)(2012-3#1)
on T2-weighted images##6##3##(1991-11#1)(2006-1#1)(2008-6#4)
on T2-weighted##12##2##(1991-11#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-12#1)(2008-6#4)(2009-11#1)(2012-12#1)(2012-3#1)
on T7##2##2##(1997-4#1)(2008-8#1)
on TB##2##2##(2010-4#1)(2010-5#1)
on TCPS##5##2##(2004-9#4)(2012-5#1)
on TF##2##2##(1994-11#1)(1994-9#1)
on TLC##3##2##(1994-8#1)(2008-2#1)(2012-12#1)
on TNF-alpha##2##2##(1992-8#1)(1996-4#1)
on TPH degradation##2##3##(2008-6#2)
on TPMT activity##2##3##(1996-3#2)
on TSH##3##2##(1991-8#1)(1992-12#1)(2008-5#1)
on TSK##2##2##(1992-11#1)(1996-5#1)
on TSPO##2##2##(2012-2#2)
on TSWV-infected plants##4##3##(2008-10#4)
on Tc##2##2##(1993-5#1)(1996-2#1)
on Teflon##2##2##(2008-10#1)(2008-5#1)
on Tf##2##2##(1994-10#1)(1994-6#1)
on The##4##2##(1995-6#1)(1996-1#1)(2008-3#1)(2008-7#1)
on Their##4##2##(2008-10#2)(2008-5#1)(2013-8#1)
on Theobroma##2##2##(2008-10#1)(2011-12#1)
on Thrombosis##4##2##(1993-6#1)(1996-2#1)(2005-8#1)(2010-12#1)
on Ti and Au##2##4##(2005-11#1)(2010-4#1)
on Ti##7##2##(2005-11#1)(2008-3#3)(2010-4#1)(2012-11#2)
on TiO2##4##2##(2007-12#2)(2008-10#1)(2010-1#1)
on Tissue##2##2##(2007-12#1)(2011-1#1)
on Tobacco##5##2##(2008-10#4)(2009-12#1)
on Tomato and Potato in##2##5##(2008-10#2)
on Turkish##3##2##(2008-1#1)(2008-10#1)(2011-2#1)
on Tw##2##2##(2005-11#2)
on Tyr and##2##3##(1995-3#1)(1996-2#1)
on Tyr##4##2##(1995-3#1)(1996-2#2)(2005-4#1)
on U##2##2##(1992-1#1)(2008-11#1)
on U-937 cells##2##3##(1994-2#2)
on UI##3##2##(2011-1#3)
on US hospitals##3##3##(2008-11#3)
on US##6##2##(2008-1#1)(2008-11#3)(2008-8#1)(2012-12#1)
on UV-induced##3##2##(1992-8#1)(2008-5#1)(2010-7#1)
on United##2##2##(1995-1#1)(2008-12#1)
on Unix/Linux computers##2##3##(2008-4#2)
on Urinary##3##2##(2007-1#1)(2012-1#1)(2013-8#1)
on V of##2##3##(1992-3#1)(1994-11#1)
on V##6##2##(1990-12#1)(1992-3#2)(1994-11#1)(1995-5#2)
on V/K##4##2##(1992-3#3)(1995-10#1)
on V8 agar##2##3##(2008-10#2)
on VEGF-induced##2##2##(2008-10#2)
on VRCs and##2##3##(2008-11#2)
on VSMCs##3##2##(1994-6#2)(1994-8#1)
on Vancouver Island##3##3##(2008-10#2)(2010-12#1)
on Vero##2##2##(1997-2#1)(2009-3#1)
on Verticillium dahliae##2##3##(2008-10#2)
on Verticillium wilt##2##3##(2008-10#2)
on Verticillium##4##2##(2008-10#4)
on Vibrio fischeri##3##3##(2008-10#2)(2012-3#1)
on WR##2##2##(2008-6#2)
on Waters##2##2##(2008-10#1)(2011-1#1)
on Western blot##4##3##(1993-12#1)(1995-2#2)(1997-7#1)
on Western blots by##2##4##(1990-9#1)(1991-2#1)
on Western blots of##2##4##(1990-8#1)(1992-3#1)
on Western blots with##3##4##(1992-8#1)(1993-8#1)(1995-12#1)
on Western blots##11##3##(1990-8#1)(1990-9#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-8#1)(1995-11#1)(1995-12#2)(1995-6#1)
on Western##18##2##(1990-8#1)(1990-9#1)(1991-2#1)(1992-12#2)(1992-3#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-8#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-6#1)(1997-7#1)(2010-9#1)
on Wheat Seedlings##2##3##(2008-10#2)
on Wheat##6##2##(2008-10#6)
on Wild##2##2##(2008-10#2)
on Winter Wheat##2##3##(2008-10#2)
on Winter##4##2##(2008-10#4)
on Wistar rats##3##3##(2005-10#2)(2012-1#1)
on Wnt/β-catenin signaling##2##3##(2013-1#2)
on Women's Health##2##3##(1994-12#1)(2012-12#1)
on World##3##2##(1994-12#1)(2007-8#1)(2008-3#1)
on Wound Healing##2##3##(2008-10#1)(2009-12#1)
on X##2##2##(2006-8#1)(2008-10#1)
on X-ray film##2##3##(1991-12#1)(2012-3#1)
on X-ray##8##2##(1991-12#1)(1993-5#1)(2007-11#1)(2007-7#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-8#1)
on X-rays##2##2##(2008-7#1)(2011-12#1)
on XAD-4##2##2##(1993-9#1)(2008-10#1)
on XGal plates##2##3##(1993-12#1)(1997-4#1)
on Xenopus oocytes##2##3##(1995-11#1)(1997-2#1)
on Yield##2##2##(2008-10#2)
on Z-drugs##2##2##(2013-8#2)
on Zhiyang##2##2##(2006-4#2)
on [3H]DTG binding##2##3##(1993-11#2)
on [3H]PDBu binding##2##3##(1994-10#2)
on [3H]norepinephrine##3##2##(1991-2#2)(1995-7#1)
on [3H]thymidine##3##2##(1990-9#1)(1996-12#1)(1996-8#1)
on [Ca2+]c##2##2##(1991-12#1)(1995-8#1)
on [Ca2+]i##5##2##(1991-2#3)(1992-9#1)(1993-4#1)
on [Formula##2##2##(2008-11#1)(2013-1#1)
on [Na+]i##2##2##(1990-11#1)(1991-9#1)
on [rhodopsin]##3##2##(1990-7#3)
on a &quot##6##3##(1990-9#1)(1992-12#1)(1995-2#1)(2006-5#1)(2012-2#1)(2013-1#1)
on a 'beating heart'##2##4##(2007-9#2)
on a 0##4##3##(2006-12#1)(2006-5#1)(2007-11#1)(2008-2#1)
on a 1##8##3##(1991-5#1)(1992-11#1)(2007-12#1)(2007-9#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-2#1)
on a 12-lead##2##3##(2006-8#1)(2009-10#1)
on a 14-month-old##2##3##(1996-3#1)(1997-3#1)
on a 2##4##3##(1992-3#1)(2007-4#1)(2008-3#1)(2012-2#1)
on a 24##2##3##(2006-11#1)(2008-7#1)
on a 2D##2##3##(2007-5#1)(2012-1#1)
on a 3##3##3##(1990-9#1)(1993-6#1)(2008-10#1)
on a 5##2##3##(1995-8#1)(2006-5#1)
on a 50##3##3##(1996-5#1)(2007-5#1)(2008-10#1)
on a 55-year-old##2##3##(2008-2#1)(2010-5#1)
on a 6##2##3##(1997-4#1)(2008-3#1)
on a 6-year-old##2##3##(1996-12#1)(2007-8#1)
on a Au(111)##2##3##(2008-10#2)
on a Brassica##2##3##(2008-10#2)
on a C(18) column and##2##5##(2008-10#1)(2012-2#1)
on a C(18) column##5##4##(2008-10#4)(2012-2#1)
on a C(18)##8##3##(2008-10#7)(2012-2#1)
on a C-18##3##3##(2007-1#1)(2008-10#2)
on a C18 column using##2##5##(1995-6#1)(2008-10#1)
on a C18 column with##4##5##(1990-8#1)(1997-3#1)(2010-12#1)(2011-1#1)
on a C18 column##11##4##(1990-8#1)(1992-2#2)(1993-9#1)(1995-6#1)(1997-3#1)(1997-6#1)(2005-12#1)(2008-10#1)(2010-12#1)(2011-1#1)
on a C18##17##3##(1990-6#2)(1990-8#1)(1992-2#3)(1993-2#1)(1993-9#1)(1995-6#1)(1997-3#1)(1997-6#1)(2005-12#1)(2007-8#1)(2008-10#1)(2010-12#1)(2011-1#1)(2011-3#1)
on a CCD chip##3##4##(2008-2#2)(2008-3#1)
on a CCD##7##3##(2007-12#1)(2008-2#2)(2008-3#4)
on a CT##2##3##(2007-8#1)(2010-2#1)
on a DNA##5##3##(1994-8#1)(1995-1#1)(2008-10#1)(2008-5#2)
on a FR5 schedule of reinforcement##2##6##(1993-6#2)
on a FR5 schedule##3##4##(1993-6#3)
on a Mono Q##3##4##(1991-11#1)(1997-7#1)(2008-10#1)
on a Mono##4##3##(1991-11#2)(1997-7#1)(2008-10#1)
on a Nova-Pak##2##3##(1997-3#1)(2005-12#1)
on a Sepharose##2##3##(1992-6#1)(1994-8#1)
on a Si substrate##3##4##(2007-11#1)(2008-2#2)
on a Spherisorb##3##3##(1996-5#1)(1997-8#1)(2008-10#1)
on a Supelcosil##2##3##(1997-3#1)(2008-10#1)
on a Superdex##4##3##(1991-11#2)(1995-11#1)(1997-6#1)
on a Superose 12 column##2##5##(1990-2#1)(1991-11#1)
on a Superose##4##3##(1990-2#1)(1991-11#1)(1993-4#1)(1993-9#1)
on a Waters Acquity UPLC BEH C18##2##7##(2012-12#2)
on a Waters Acquity##4##4##(2011-1#1)(2012-12#3)
on a Waters##5##3##(2011-1#1)(2012-12#4)
on a Zorbax Eclipse##2##4##(2010-2#1)(2011-1#1)
on a Zorbax##8##3##(1993-2#1)(1996-8#2)(2007-8#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-12#1)
on a background of chronic##2##5##(2009-3#1)(2010-2#1)
on a background of##6##4##(2007-2#1)(2008-1#1)(2008-4#1)(2009-3#1)(2010-2#1)(2012-2#1)
on a balance##2##3##(2007-10#1)(2011-2#1)
on a balanced##2##3##(1996-10#1)(2007-12#1)
on a battery of##3##4##(1996-3#1)(2009-4#1)(2012-1#1)
on a behavioral##2##3##(1990-2#1)(2012-2#1)
on a benchmarking##2##3##(1997-1#1)(2005-12#1)
on a better##4##3##(2006-10#1)(2007-8#1)(2008-1#1)(2010-4#1)
on a bibliographic##2##3##(2008-11#1)(2010-7#1)
on a bicycle ergometer##3##4##(1991-2#1)(2005-1#1)(2008-7#1)
on a bicycle##4##3##(1991-2#1)(2005-1#1)(2008-6#1)(2008-7#1)
on a binary##2##3##(2008-10#1)(2008-3#1)
on a bone##2##3##(2009-4#1)(2010-12#1)
on a breast##2##3##(2007-5#1)(2009-3#1)
on a broad range of##4##5##(2008-10#2)(2008-2#1)(2011-1#1)
on a broad##7##3##(2005-11#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-2#1)(2011-1#1)
on a budget##2##3##(2007-9#1)(2011-2#1)
on a bulk##4##3##(2005-11#1)(2007-12#1)(2008-10#1)(2009-2#1)
on a cDNA##2##3##(1991-12#1)(2006-10#1)
on a capillary##4##3##(1990-6#1)(2007-8#1)(2008-10#1)(2008-3#1)
on a capillary-assembled microchip##2##4##(2007-8#2)
on a carbohydrate##2##3##(1997-1#1)(2010-12#1)
on a careful##2##3##(2007-3#1)(2008-3#1)
on a case by case basis##2##6##(1993-9#1)(2008-8#1)
on a case mix##2##4##(1991-12#1)(1996-2#1)
on a case of##11##4##(2005-11#1)(2007-10#1)(2007-4#1)(2007-9#1)(2008-8#1)(2009-8#1)(2010-6#3)(2011-1#1)(2013-1#1)
on a case report]##2##4##(1992-10#1)(1994-11#1)
on a case##20##3##(1991-12#1)(1992-10#1)(1993-9#1)(1994-11#1)(1996-2#1)(1997-5#1)(2005-11#1)(2007-10#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-8#2)(2009-8#1)(2010-6#3)(2011-1#1)(2011-2#1)(2013-1#1)
on a case-by-case basis##9##4##(1994-3#1)(2006-8#2)(2007-8#1)(2008-10#1)(2008-5#1)(2011-1#2)(2012-2#1)
on a cell membrane##2##4##(2009-4#2)
on a cell##4##3##(1995-11#1)(2008-9#1)(2009-4#2)
on a cellular##2##3##(1990-10#1)(2008-10#1)
on a chelating resin##2##4##(2008-10#2)
on a child##2##3##(2008-9#1)(2009-12#1)
on a chip##8##3##(2006-2#1)(2008-10#4)(2008-11#1)(2008-3#1)(2011-1#1)
on a chromosome##2##3##(2005-10#1)(2008-5#1)
on a circular##2##3##(2008-3#1)(2009-7#1)
on a clear##2##3##(1990-2#1)(2009-10#1)
on a clinical basis##2##4##(1990-3#1)(2010-10#1)
on a clinical##7##3##(1990-3#1)(1996-12#1)(1997-3#1)(2008-3#1)(2009-9#1)(2010-10#1)(2012-1#1)
on a clonal##2##3##(1994-6#1)(2007-8#1)
on a cohort of##5##4##(2007-7#1)(2008-12#1)(2008-4#1)(2010-8#1)(2011-1#1)
on a collection of##3##4##(2008-10#1)(2008-5#1)(2009-10#1)
on a column containing##4##4##(1992-2#1)(1992-5#1)(1996-9#1)(2008-10#1)
on a column of##5##4##(1990-11#1)(1990-8#1)(1992-11#1)(2008-10#1)(2008-4#1)
on a column##12##3##(1990-11#1)(1990-8#1)(1992-11#1)(1992-2#1)(1992-5#1)(1996-9#1)(2008-10#5)(2008-4#1)
on a combination of characteristics##2##5##(2008-8#1)(2008-9#1)
on a combination of the##5##5##(2007-12#1)(2008-10#2)(2008-3#1)(2012-1#1)
on a combination of##31##4##(1997-7#1)(2005-10#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-6#1)(2010-12#1)(2011-2#3)(2012-1#1)(2013-1#3)
on a combined##3##3##(1997-4#1)(2005-5#1)(2007-7#1)
on a commercial scale##2##4##(2007-5#1)(2011-2#1)
on a commercial##8##3##(1997-5#1)(2005-7#1)(2007-12#1)(2007-5#1)(2008-3#1)(2008-5#1)(2010-4#1)(2011-2#1)
on a commodity##3##3##(2008-6#2)(2009-6#1)
on a common substrate##2##4##(1991-11#1)(1994-11#1)
on a common##9##3##(1991-11#1)(1994-11#1)(1996-1#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2013-8#1)
on a compact##2##3##(2007-12#2)
on a comparative##3##3##(2008-11#1)(2008-3#1)(2008-9#1)
on a comparison of the##3##5##(1991-9#1)(2007-2#1)(2012-12#1)
on a comparison of two cohorts##2##6##(2012-2#2)
on a comparison of##6##4##(1991-9#1)(1994-3#1)(2007-2#1)(2012-12#1)(2012-2#2)
on a comparison##8##3##(1991-9#1)(1994-3#1)(2006-12#1)(2007-2#1)(2008-3#1)(2012-12#1)(2012-2#2)
on a complete##2##3##(2008-3#1)(2011-2#1)
on a complex##5##3##(1996-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2012-3#1)
on a comprehensive##6##3##(1991-11#1)(1995-5#1)(2007-9#1)(2008-1#1)(2008-4#1)(2012-3#1)
on a computer screen##2##4##(1997-2#1)(2008-2#1)
on a computer##7##3##(1995-3#1)(1995-6#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-2#1)(2011-2#1)
on a computerized##2##3##(2008-2#1)(2008-7#1)
on a concomitant##2##3##(1994-6#1)(2007-2#1)
on a concurrent##2##3##(1994-6#1)(1995-3#1)
on a conditional##2##3##(1997-1#1)(2011-2#1)
on a cone##2##3##(2007-12#1)(2011-1#1)
on a conference##3##3##(1990-8#1)(1990-9#1)(2012-12#1)
on a confocal##2##3##(2008-11#1)(2010-10#1)
on a consecutive series of##4##5##(1990-8#1)(1991-8#1)(2012-5#1)(2013-1#1)
on a consecutive##5##3##(1990-12#1)(1990-8#1)(1991-8#1)(2012-5#1)(2013-1#1)
on a constant##2##3##(2008-2#1)(2008-3#1)
on a continuous##8##3##(1990-2#1)(1992-2#1)(1993-2#1)(2008-10#4)(2009-3#1)
on a continuum of##4##4##(1992-1#1)(2006-11#1)(2007-6#1)(2008-12#1)
on a continuum##8##3##(1992-1#1)(1992-3#1)(2006-11#1)(2007-6#1)(2008-12#1)(2008-4#1)(2010-8#1)(2011-1#1)
on a control##2##3##(1994-6#1)(1996-11#1)
on a conventional##9##3##(1993-9#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#3)(2010-12#1)
on a copper##2##3##(2006-12#1)(2007-9#1)
on a corpus of##4##4##(2013-1#4)
on a correlation between##2##4##(2006-10#1)(2008-10#1)
on a correlation##3##3##(2006-10#1)(2008-10#1)(2008-2#1)
on a coverslip##3##3##(2007-12#1)(2008-11#1)(2008-7#1)
on a critical review of##2##5##(1992-8#1)(2005-7#1)
on a critical##5##3##(1992-8#1)(2005-7#1)(2008-10#1)(2011-1#1)(2013-1#1)
on a curved##2##3##(2007-12#1)(2008-10#1)
on a cycle-by-cycle basis##2##4##(1995-3#1)(2007-11#1)
on a daily basis##15##4##(1991-12#1)(1993-9#1)(1995-3#1)(2006-1#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-1#1)(2008-2#2)(2008-7#1)(2008-8#1)(2010-2#1)(2010-3#1)(2012-2#1)
on a daily##18##3##(1991-12#1)(1993-9#1)(1995-3#1)(2005-11#1)(2006-1#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-1#1)(2008-2#2)(2008-7#1)(2008-8#1)(2010-2#1)(2010-3#1)(2011-9#1)(2012-1#1)(2012-2#1)
on a dairy farm in##2##5##(1992-10#1)(2005-7#1)
on a dairy farm##3##4##(1991-8#1)(1992-10#1)(2005-7#1)
on a dark##2##3##(2007-12#1)(2008-1#1)
on a data set from##2##5##(1996-9#1)(2008-3#1)
on a data set##5##4##(1995-4#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-3#1)
on a database of##2##4##(2008-2#1)(2010-8#1)
on a decade##2##3##(2010-4#1)(2011-2#1)
on a delayed##4##3##(1991-3#1)(1993-2#1)(1994-2#1)(1994-3#1)
on a desktop##2##3##(2007-12#1)(2007-8#1)
on a detailed##3##3##(1996-2#1)(2007-4#1)(2012-2#1)
on a developmental##2##3##(2007-1#1)(2008-4#1)
on a device##2##3##(2008-10#1)(2008-2#1)
on a dielectric sphere in##3##5##(2008-2#1)(2008-3#2)
on a dielectric sphere##4##4##(2008-2#2)(2008-3#2)
on a dielectric substrate##2##4##(2008-3#1)(2013-7#1)
on a dielectric##6##3##(2008-2#2)(2008-3#3)(2013-7#1)
on a diet containing##3##4##(1995-9#1)(2010-10#1)(2010-4#1)
on a diet of##2##4##(2010-8#1)(2012-2#1)
on a diet##5##3##(1995-9#1)(2010-10#1)(2010-4#1)(2010-8#1)(2012-2#1)
on a different##11##3##(1992-12#1)(1993-2#1)(1995-3#2)(1996-11#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)
on a diffraction grating##2##4##(2007-12#1)(2008-2#1)
on a digital##2##3##(2007-12#1)(2008-2#1)
on a direct##4##3##(1997-2#1)(2006-12#1)(2007-11#1)(2011-1#1)
on a discontinuous##2##3##(1996-2#1)(2008-10#1)
on a disease##3##3##(1993-3#1)(2008-10#1)(2013-8#1)
on a distinct##3##3##(1997-7#1)(2006-12#1)(2012-2#1)
on a dry weight basis##2##5##(2004-2#1)(2008-7#1)
on a dry weight##3##4##(1992-3#1)(2004-2#1)(2008-7#1)
on a dry##5##3##(1992-3#1)(2004-2#1)(2008-10#1)(2008-7#1)(2012-12#1)
on a dynamic##3##3##(2007-12#1)(2008-3#1)(2008-5#1)
on a family of##3##4##(1994-8#1)(2008-2#1)(2009-9#1)
on a farm##2##3##(2008-10#1)(2012-2#1)
on a few selected##2##4##(2010-10#1)(2011-2#1)
on a few##4##3##(1990-12#1)(2008-5#1)(2010-10#1)(2011-2#1)
on a field programmable gate array##2##6##(2008-2#2)
on a field##3##3##(2008-2#2)(2008-9#1)
on a filter##4##3##(1994-12#1)(2008-10#2)(2008-3#1)
on a five-point Likert scale##2##5##(2005-4#1)(2013-8#1)
on a fixed ratio##2##4##(1992-9#1)(2008-11#1)
on a fixed##3##3##(1992-9#1)(2008-11#1)(2008-2#1)
on a flat##4##3##(1996-12#1)(2008-2#2)(2012-2#1)
on a flexible##2##3##(2008-10#1)(2010-1#1)
on a flow cytometer##3##4##(2006-6#1)(2008-9#2)
on a flow##6##3##(2006-6#1)(2008-10#3)(2008-9#2)
on a flow-through##3##3##(1990-3#1)(2008-10#2)
on a fluorescence##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
on a follow-up##2##3##(1995-8#1)(2009-10#1)
on a force platform##2##4##(1995-5#1)(2007-4#1)
on a free##2##3##(1994-2#1)(1994-8#1)
on a frequency-doubled##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
on a fully##2##3##(2008-3#2)
on a functional##4##3##(1990-7#1)(1992-3#1)(1994-12#1)(1995-1#1)
on a fused-silica capillary column coated with##2##7##(1990-11#1)(2008-5#1)
on a fused-silica##3##3##(1990-11#1)(2007-12#1)(2008-5#1)
on a gas##2##3##(2008-10#2)
on a gel##4##3##(1990-8#1)(1995-3#1)(2008-4#1)(2008-5#1)
on a gene##2##3##(1990-11#1)(1995-6#1)
on a general##2##3##(1992-1#1)(2009-11#1)
on a genetic algorithm##2##4##(2008-3#1)(2008-8#1)
on a genetic##5##3##(2005-11#1)(2006-10#1)(2008-3#2)(2008-8#1)
on a genome##2##3##(2008-8#1)(2009-12#1)
on a genome-wide basis##3##4##(2008-1#1)(2008-2#1)(2011-2#1)
on a genome-wide scale##3##4##(2008-7#1)(2010-12#1)(2012-3#1)
on a genome-wide##6##3##(2008-1#1)(2008-2#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)
on a genomic scale##3##4##(1995-7#2)(2008-7#1)
on a genomic##4##3##(1995-7#2)(2008-10#1)(2008-7#1)
on a given day##2##4##(1997-4#1)(2008-8#1)
on a given##14##3##(1992-9#1)(1995-4#1)(1996-2#1)(1997-4#1)(2005-11#2)(2007-11#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-8#1)(2012-3#1)
on a glass plate##3##4##(2006-5#1)(2008-2#1)(2008-3#1)
on a glass substrate##3##4##(1994-11#1)(2007-11#1)(2010-4#1)
on a glass##12##3##(1994-11#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-4#1)
on a glassy carbon disc electrode##2##6##(2008-10#2)
on a glassy carbon electrode (GCE)##3##6##(2008-10#3)
on a glassy carbon electrode and##3##6##(2008-10#2)(2013-1#1)
on a glassy carbon electrode surface##2##6##(2008-10#2)
on a glassy carbon electrode was##2##6##(2008-10#2)
on a glassy carbon electrode##20##5##(2008-10#19)(2013-1#1)
on a glassy carbon##24##4##(2007-8#1)(2008-10#22)(2013-1#1)
on a global scale##7##4##(2007-11#1)(2007-4#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-12#1)(2013-8#1)
on a global##13##3##(2007-11#1)(2007-4#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-9#1)(2010-12#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
on a gold electrode surface##2##5##(2005-11#1)(2008-10#1)
on a gold electrode##5##4##(2005-11#1)(2008-10#4)
on a gold substrate##2##4##(2009-7#1)(2010-4#1)
on a gold##14##3##(2005-11#1)(2008-10#10)(2009-7#1)(2010-4#1)(2012-3#1)
on a graphical##2##3##(2008-6#1)(2011-2#1)
on a graphics tablet##2##4##(1997-2#1)(2008-6#1)
on a graphics##3##3##(1997-2#1)(2008-6#1)(2011-1#1)
on a graphite##4##3##(2006-12#2)(2007-12#1)(2008-10#1)
on a grid##3##3##(2006-2#1)(2008-10#1)(2008-2#1)
on a group of patients##2##5##(2006-6#1)(2013-1#1)
on a group of##10##4##(1990-10#1)(1996-9#1)(2006-6#1)(2007-8#1)(2007-9#1)(2008-4#1)(2009-3#1)(2011-1#1)(2012-12#1)(2013-1#1)
on a group##11##3##(1990-10#1)(1996-9#1)(1997-2#1)(2006-6#1)(2007-8#1)(2007-9#1)(2008-4#1)(2009-3#1)(2011-1#1)(2012-12#1)(2013-1#1)
on a growing##2##3##(2007-9#1)(2008-4#1)
on a hanging mercury drop electrode (HMDE)##4##7##(2008-10#4)
on a hanging mercury drop electrode##10##6##(2005-11#1)(2007-8#1)(2008-10#8)
on a heterodyne##2##3##(2008-2#1)(2008-3#1)
on a high level of##3##5##(1993-6#1)(1996-7#1)(2011-2#1)
on a high##8##3##(1993-6#1)(1996-7#1)(1997-4#1)(2006-5#1)(2007-11#1)(2007-9#1)(2011-2#2)
on a high-performance##2##3##(1991-8#1)(2007-12#1)
on a high-power##2##3##(2008-3#2)
on a high-resolution##2##3##(1997-4#1)(2012-3#1)
on a highly##4##3##(1990-8#1)(2007-12#1)(2008-10#2)
on a holistic##3##3##(1992-2#1)(2013-1#2)
on a homogeneous##3##3##(1997-3#1)(2008-10#1)(2008-11#1)
on a horizontal##3##3##(2007-1#1)(2012-1#1)(2013-7#1)
on a host##3##3##(1997-5#1)(2008-10#2)
on a hot plate##3##4##(1995-10#1)(2008-10#2)
on a hot##4##3##(1995-10#1)(2008-10#2)(2008-7#1)
on a human##8##3##(1990-11#1)(1990-2#1)(1991-6#1)(1994-2#1)(1994-6#1)(2008-10#1)(2008-3#2)
on a hybrid##3##3##(2007-12#1)(2008-10#1)(2008-12#1)
on a hydrophobic##3##3##(1990-3#1)(2005-11#1)(2008-4#1)
on a kind of##2##4##(2008-10#1)(2008-5#1)
on a large data##2##4##(1994-3#1)(1994-8#1)
on a large scale##12##4##(1994-6#1)(1997-3#1)(2006-12#1)(2007-11#1)(2008-10#3)(2008-5#2)(2009-12#1)(2013-8#2)
on a large set of##4##5##(2008-2#1)(2009-10#1)(2013-1#2)
on a large##31##3##(1993-7#1)(1994-3#1)(1994-6#1)(1994-8#1)(1997-3#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-10#1)(2009-11#1)(2009-12#1)(2011-2#1)(2013-1#3)(2013-8#2)
on a large-scale##2##3##(2008-10#1)(2012-2#1)
on a larger scale##2##4##(1992-5#1)(2008-1#1)
on a larger##8##3##(1992-5#1)(2005-12#1)(2006-5#1)(2008-1#1)(2008-11#1)(2009-10#1)(2011-2#1)(2012-1#1)
on a leaf##2##3##(2004-2#1)(2008-10#1)
on a less##2##3##(1992-9#1)(2007-7#1)
on a lexical decision task##2##5##(2007-12#1)(2007-9#1)
on a lidar##2##3##(2008-3#2)
on a life##2##3##(1993-12#1)(1996-4#1)
on a likelihood##5##3##(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2010-8#1)
on a limited##2##3##(2008-6#1)(2009-7#1)
on a linear##7##3##(1990-10#1)(1996-12#1)(2008-2#1)(2008-8#1)(2009-10#1)(2012-3#2)
on a lipophilic##2##3##(2008-10#2)
on a liquid##3##3##(2008-2#1)(2008-3#1)(2008-4#1)
on a liquid-crystal display##3##4##(2007-12#2)(2010-9#1)
on a liquid-crystal##4##3##(2007-12#2)(2008-3#1)(2010-9#1)
on a literature##4##3##(1991-6#1)(2006-8#1)(2008-7#1)(2009-4#1)
on a local basis##2##4##(2008-2#2)
on a local scale##4##4##(2008-10#1)(2008-8#1)(2009-4#1)(2011-1#1)
on a local##9##3##(1997-7#1)(2007-4#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-8#1)(2009-4#1)(2011-1#1)
on a logarithmic scale##2##4##(2008-10#1)(2011-1#1)
on a long term basis##2##5##(2007-6#1)(2013-7#1)
on a long##4##3##(2007-4#1)(2007-6#1)(2010-4#1)(2013-7#1)
on a long-term basis##3##4##(2008-11#1)(2008-2#1)(2008-4#1)
on a longitudinal##2##3##(1993-5#1)(1997-8#1)
on a low##2##3##(1990-11#1)(2008-8#1)
on a lower##2##3##(2008-7#1)(2008-9#1)
on a macroporous##3##3##(2008-10#3)
on a major##2##3##(1990-6#1)(2008-7#1)
on a mass basis##2##4##(2008-10#2)
on a mass##3##3##(2007-9#1)(2008-10#2)
on a mathematical model##2##4##(2008-3#2)
on a measure of##3##4##(2007-7#1)(2009-9#1)(2010-10#1)
on a measure##5##3##(2007-7#1)(2009-9#1)(2010-10#1)(2013-1#2)
on a medical##2##3##(1994-3#1)(2008-3#1)
on a medium containing##3##4##(2006-8#1)(2007-1#1)(2008-10#1)
on a medium##5##3##(1994-9#1)(2006-8#1)(2007-1#1)(2008-10#1)(2009-8#1)
on a melamine-formaldehyde resin##2##4##(2008-10#2)
on a membrane##3##3##(1994-5#1)(2008-10#1)(2008-4#1)
on a metal##2##3##(1994-2#1)(2008-10#1)
on a metallic##2##3##(2007-12#1)(2008-7#1)
on a method##2##3##(2006-12#1)(2008-11#1)
on a microcolumn packed with##3##5##(2008-10#3)
on a microcolumn##4##3##(2008-10#4)
on a microscope slide##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
on a microscopic##3##3##(1992-5#1)(2008-3#2)
on a mini-column packed with##3##5##(2005-4#1)(2008-10#2)
on a minicolumn##2##3##(2008-10#2)
on a minimal medium##2##4##(2008-10#2)
on a minimum##3##3##(1991-5#1)(1992-6#1)(2013-1#1)
on a mixture of##4##4##(2007-9#1)(2008-6#1)(2008-7#1)(2011-12#1)
on a model of##3##4##(2005-7#1)(2006-10#1)(2007-5#1)
on a model that##4##4##(2006-6#1)(2007-6#1)(2008-3#1)(2013-1#1)
on a model##10##3##(2005-7#1)(2006-10#1)(2006-6#1)(2007-12#2)(2007-5#1)(2007-6#1)(2008-3#1)(2012-1#1)(2013-1#1)
on a modern##4##3##(1994-2#1)(2007-9#1)(2008-3#1)(2009-6#1)
on a modified##14##3##(1995-6#1)(1995-8#1)(2006-3#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#3)(2009-10#1)
on a molar basis##6##4##(1990-12#1)(1992-12#1)(1992-2#1)(1993-9#1)(1994-12#1)(2008-6#1)
on a molecular level##5##4##(1990-2#1)(2005-11#2)(2010-9#2)
on a molecular##11##3##(1990-2#1)(1991-2#1)(2005-11#2)(2006-12#1)(2007-12#1)(2008-10#2)(2010-9#2)(2013-1#1)
on a molecularly imprinted##2##4##(2008-10#2)
on a monitor##2##3##(2008-5#1)(2008-9#1)
on a monthly basis##5##4##(2006-2#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-11#1)
on a more detailed##2##4##(2007-8#1)(2010-3#1)
on a more##6##3##(2007-10#1)(2007-8#1)(2008-2#1)(2009-6#1)(2010-3#1)(2010-9#1)
on a motor-driven treadmill##2##4##(1990-4#1)(1994-8#1)
on a mouse##3##3##(2008-11#2)(2009-4#1)
on a moving##3##3##(2007-11#1)(2008-2#1)(2013-1#1)
on a much larger##2##4##(1991-11#1)(1996-7#1)
on a much##3##3##(1991-11#1)(1996-7#1)(2008-7#1)
on a multicopy plasmid##6##4##(1990-10#2)(1990-3#1)(1991-4#1)(1997-3#1)(1997-4#1)
on a multidisciplinary##3##3##(1995-12#1)(2007-9#1)(2012-2#1)
on a nanometer scale##2##4##(2007-12#1)(2008-3#1)
on a national level##3##4##(1994-2#1)(2004-10#1)(2008-3#1)
on a national scale##2##4##(1997-1#1)(2008-10#1)
on a national##7##3##(1994-2#1)(1997-1#1)(2004-10#1)(2006-8#1)(2007-5#1)(2008-10#1)(2008-3#1)
on a nationwide basis##2##4##(1997-2#1)(2010-2#1)
on a native##3##3##(1997-2#1)(2005-12#1)(2007-8#1)
on a natural##3##3##(2006-2#1)(2008-5#2)
on a network of##3##4##(1995-12#1)(2007-7#1)(2008-1#1)
on a new p-tert-butyl-calix[8]arene-bonded silica gel stationary phase##2##8##(2008-10#2)
on a new##29##3##(1991-3#1)(1994-6#1)(1995-9#1)(1996-2#1)(2006-4#1)(2007-11#3)(2007-12#1)(2007-9#1)(2008-10#4)(2008-2#5)(2008-3#2)(2008-6#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
on a newly##3##3##(2008-10#2)(2012-1#1)
on a nickel##2##3##(1997-6#1)(2008-10#1)
on a normal diet##2##4##(1994-5#1)(1996-12#1)
on a normal##4##3##(1994-5#1)(1996-12#1)(2005-11#1)(2008-4#1)
on a novel##21##3##(1990-7#1)(1991-11#1)(1995-3#1)(2005-8#1)(2006-5#1)(2007-12#7)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2011-1#1)(2013-1#1)
on a number of different##3##5##(1991-7#1)(1992-12#1)(2007-12#1)
on a number of important##2##5##(2008-10#1)(2011-2#1)
on a number of##25##4##(1991-5#1)(1991-7#1)(1992-11#1)(1992-12#1)(1995-11#1)(1997-3#1)(1997-5#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-11#1)(2010-1#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
on a number##26##3##(1991-5#1)(1991-7#1)(1992-11#1)(1992-12#1)(1995-11#1)(1997-3#1)(1997-5#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-11#1)(2010-1#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
on a nutritional##2##3##(2010-9#1)(2012-12#1)
on a nylon membrane##2##4##(1994-5#1)(2008-10#1)
on a nylon##3##3##(1994-5#1)(2008-10#1)(2008-7#1)
on a one-dimensional##3##3##(2007-12#1)(2008-2#2)
on a packed##3##3##(1990-8#1)(2008-10#2)
on a panel of##2##4##(1994-3#1)(2009-4#1)
on a par with##4##4##(1993-1#1)(2008-11#1)(2010-12#1)(2012-2#1)
on a par##5##3##(1993-1#1)(2008-11#1)(2008-7#1)(2010-12#1)(2012-2#1)
on a particular##7##3##(1994-11#1)(1995-3#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-8#1)(2013-7#1)
on a patient who##6##4##(1993-9#1)(1996-6#1)(2007-8#2)(2007-9#1)(2011-2#1)
on a patient with a##2##5##(2006-12#1)(2007-10#1)
on a patient with##12##4##(1996-3#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-3#1)(2007-6#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-2#1)(2011-3#1)(2013-7#1)
on a patient##22##3##(1993-9#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-3#1)(2007-6#1)(2007-8#3)(2007-9#1)(2008-7#2)(2009-10#1)(2009-4#1)(2010-2#1)(2011-2#1)(2011-3#1)(2013-7#1)
on a patient's##4##3##(1994-12#1)(2008-10#1)(2008-7#1)(2012-3#1)
on a per cell basis##3##5##(1990-4#1)(1995-8#1)(2008-7#1)
on a per million cell##2##5##(1994-3#2)
on a per##16##3##(1990-4#1)(1992-1#1)(1994-3#3)(1994-9#2)(1995-12#1)(1995-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)
on a perfect##3##3##(1990-3#1)(2008-3#2)
on a period of##2##4##(1997-2#1)(2011-1#1)
on a person's##2##3##(1993-5#2)
on a personal##3##3##(1993-3#1)(2008-10#1)(2008-2#1)
on a phantom##2##3##(2007-5#1)(2008-3#1)
on a phenyl column##2##4##(1996-3#1)(1996-8#1)
on a phylogenetic##2##3##(1996-6#1)(2010-6#1)
on a physical##2##3##(1997-4#1)(2008-3#1)
on a piezoelectric transducer##2##4##(2008-10#1)(2008-3#1)
on a piezoelectric##3##3##(2008-10#2)(2008-3#1)
on a planar substrate##2##4##(2006-5#1)(2008-3#1)
on a planar##6##3##(2006-5#1)(2007-12#1)(2008-10#2)(2008-3#2)
on a plane##5##3##(2008-2#2)(2008-3#2)(2008-7#1)
on a plant##3##3##(2008-10#2)(2008-7#1)
on a plasmid vector##2##4##(1990-10#1)(2006-8#1)
on a plasmid##4##3##(1990-10#1)(1990-12#1)(2006-8#1)(2008-10#1)
on a plastic##4##3##(1992-8#1)(2007-11#1)(2007-2#1)(2008-5#1)
on a plasticized##2##3##(2008-10#2)
on a platinum (Pt) electrode##2##5##(2008-10#2)
on a platinum electrode##2##4##(2008-10#2)
on a platinum##5##3##(2008-10#5)
on a plot##3##3##(2008-3#2)(2012-2#1)
on a polycarbonate chip##2##4##(2008-10#2)
on a polydimethylsiloxane##2##3##(2008-10#2)
on a polymeric##3##3##(2008-10#2)(2010-7#1)
on a polystyrene sphere##2##4##(2008-2#1)(2010-4#1)
on a polystyrene##4##3##(2008-11#2)(2008-2#1)(2010-4#1)
on a poor##2##3##(2013-1#2)
on a population basis##5##4##(1994-7#1)(1995-12#1)(2008-5#1)(2008-7#1)(2008-9#1)
on a population of##2##4##(1992-7#1)(2009-5#1)
on a population##10##3##(1992-7#1)(1994-7#1)(1995-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)
on a porous graphitized carbon##2##5##(1996-5#2)
on a porous##5##3##(1996-5#2)(2005-11#2)(2012-4#1)
on a positive##2##3##(1991-4#1)(2010-10#1)
on a possible##5##3##(1997-5#1)(2008-3#1)(2010-4#1)(2011-1#1)(2013-1#1)
on a potential##3##3##(1994-12#1)(2008-10#1)(2009-1#1)
on a power analysis##2##4##(2008-9#1)(2013-1#1)
on a preexisting##2##3##(2007-10#1)(2007-11#1)
on a preparative scale##2##4##(1990-3#1)(2011-1#1)
on a presentation##2##3##(1995-12#1)(2012-2#1)
on a pressed##2##3##(2008-11#1)(2008-2#1)
on a pretreated##4##3##(2008-10#3)(2008-5#1)
on a previous##5##3##(1990-5#1)(1995-3#1)(2007-4#1)(2008-10#1)(2010-10#1)
on a previously reported##3##4##(1993-3#1)(1997-1#1)(2008-3#1)
on a previously##4##3##(1993-3#1)(1994-12#1)(1997-1#1)(2008-3#1)
on a priori##3##3##(1997-2#1)(1997-8#1)(2007-12#1)
on a process##2##3##(2007-11#1)(2010-11#1)
on a project##3##3##(1995-2#1)(2006-10#1)(2006-5#1)
on a proposed##2##3##(1993-1#1)(2011-2#1)
on a prospective##2##3##(1996-2#1)(2007-9#1)
on a protein##3##3##(1995-11#1)(2008-4#1)(2012-3#1)
on a proteome-wide##2##3##(2008-7#1)(2009-4#1)
on a public health##4##4##(2011-1#2)(2012-12#2)
on a public##5##3##(1993-3#1)(2011-1#2)(2012-12#2)
on a puréed diet##2##4##(1995-3#2)
on a qualitative##4##3##(2008-1#1)(2008-9#1)(2009-5#1)(2013-8#1)
on a quantitative##3##3##(2008-8#1)(2010-5#1)(2013-1#1)
on a quartz substrate##2##4##(2007-12#2)
on a quartz##5##3##(2007-12#2)(2008-10#3)
on a questionnaire##4##3##(1993-5#1)(2013-8#3)
on a random sample of##3##5##(2010-6#1)(2012-1#2)
on a random sample##4##4##(2008-7#1)(2010-6#1)(2012-1#2)
on a random##5##3##(1995-4#1)(2008-7#1)(2010-6#1)(2012-1#2)
on a range of##11##4##(1991-7#1)(1995-1#1)(2005-5#1)(2005-7#1)(2006-2#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-7#2)
on a rare case of a##2##6##(2007-8#1)(2012-12#1)
on a rare case of##7##5##(2007-3#1)(2007-8#1)(2008-2#1)(2010-6#1)(2012-12#1)(2012-3#1)(2013-8#1)
on a rare##9##3##(2007-3#1)(2007-8#1)(2008-2#1)(2010-6#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
on a rat##2##3##(1992-12#1)(2011-1#1)
on a real##3##3##(2007-11#1)(2008-2#1)(2008-4#1)
on a reasonably##2##3##(1993-12#1)(1996-12#1)
on a recent##5##3##(1991-10#1)(1992-1#1)(1993-6#1)(2005-6#1)(2010-11#1)
on a recently##4##3##(1996-7#1)(2008-10#3)
on a reference material##2##4##(2008-10#2)
on a reference##3##3##(2008-10#2)(2008-9#1)
on a reflective##4##3##(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)
on a regional basis##5##4##(1994-3#1)(1995-5#1)(2006-12#1)(2007-5#1)(2008-3#1)
on a regional level##3##4##(1994-2#1)(2008-10#2)
on a regional scale##3##4##(2008-10#1)(2008-8#1)(2011-2#1)
on a regional##14##3##(1993-12#1)(1994-2#1)(1994-3#1)(1995-5#1)(1997-1#1)(2006-12#1)(2007-5#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)
on a regular basis and##2##5##(1997-5#1)(2009-4#1)
on a regular basis in##2##5##(2005-8#1)(2007-11#1)
on a regular basis to##2##5##(1997-8#1)(2011-2#1)
on a regular basis##26##4##(1994-3#1)(1995-2#1)(1997-5#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-2#2)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#2)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-9#1)(2011-2#2)
on a regular##31##3##(1994-3#1)(1995-2#1)(1997-5#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-2#2)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-9#1)(2011-2#4)(2012-2#1)
on a relatively##3##3##(1995-9#1)(1996-4#1)(2008-9#1)
on a relevant##3##3##(2008-8#2)(2011-1#1)
on a report from##2##4##(1997-2#1)(2007-9#1)
on a report##3##3##(1994-1#1)(1997-2#1)(2007-9#1)
on a representative sample of##3##5##(2006-8#1)(2008-12#1)(2013-1#1)
on a representative##5##3##(2006-8#1)(2008-10#1)(2008-12#1)(2012-2#1)(2013-1#1)
on a research project##2##4##(1994-4#1)(2012-3#1)
on a research##4##3##(1994-4#1)(2010-1#1)(2011-1#1)(2012-3#1)
on a response##2##3##(1992-11#1)(2006-7#1)
on a retrospective analysis of##2##5##(1990-9#1)(2005-5#1)
on a retrospective##4##3##(1990-9#1)(1992-8#1)(1993-6#1)(2005-5#1)
on a reverse phase C(18) column##2##6##(2008-10#1)(2011-2#1)
on a reversed-phase C18 column with a mobile phase consisting of##2##11##(1990-11#1)(1997-8#1)
on a reversed-phase C18 column with##3##6##(1990-11#1)(1997-8#1)(2008-10#1)
on a reversed-phase C18 column##4##5##(1990-11#1)(1992-2#1)(1997-8#1)(2008-10#1)
on a reversed-phase C18##6##4##(1990-11#1)(1992-2#1)(1997-8#1)(2008-10#2)(2012-12#1)
on a reversed-phase column with##2##5##(1996-8#1)(1997-2#1)
on a reversed-phase column##8##4##(1990-12#1)(1990-8#3)(1992-2#1)(1993-2#1)(1996-8#1)(1997-2#1)
on a reversed-phase##19##3##(1990-11#1)(1990-12#1)(1990-8#4)(1992-2#2)(1993-2#1)(1996-8#2)(1997-2#1)(1997-8#1)(2007-11#1)(2008-10#4)(2012-12#1)
on a review of the literature##4##6##(1993-6#1)(1994-3#1)(2008-12#1)(2008-9#1)
on a review of the##7##5##(1993-6#1)(1994-3#1)(1996-2#1)(2005-6#1)(2007-9#1)(2008-12#1)(2008-9#1)
on a review of##12##4##(1993-6#1)(1994-1#1)(1994-3#1)(1996-2#1)(1997-2#1)(2005-6#1)(2006-7#1)(2007-9#1)(2008-12#2)(2008-9#1)(2011-2#1)
on a review##13##3##(1993-6#1)(1994-1#1)(1994-3#1)(1995-12#1)(1996-2#1)(1997-2#1)(2005-6#1)(2006-7#1)(2007-9#1)(2008-12#2)(2008-9#1)(2011-2#1)
on a rigid##3##3##(2006-11#1)(2007-4#1)(2008-3#1)
on a ring##3##3##(1995-10#1)(2007-11#1)(2008-2#1)
on a rotating##8##3##(1990-12#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-5#1)
on a rough##2##3##(2007-11#1)(2007-12#1)
on a routine basis##7##4##(2006-10#1)(2007-12#1)(2008-3#3)(2008-4#1)(2009-7#1)
on a routine##10##3##(2006-10#1)(2007-12#2)(2007-2#1)(2008-3#3)(2008-4#1)(2009-7#1)(2011-12#1)
on a sample of 15##2##5##(2006-2#1)(2010-11#1)
on a sample of 18##3##5##(1997-5#1)(2006-12#1)(2008-10#1)
on a sample of##19##4##(1990-8#1)(1994-6#1)(1997-5#1)(1997-8#1)(2006-12#1)(2006-2#1)(2008-10#3)(2008-12#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2013-1#1)
on a sample##22##3##(1990-8#1)(1994-6#1)(1997-5#1)(1997-8#2)(2006-12#1)(2006-2#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2013-1#1)
on a satellite##3##3##(2008-3#2)(2010-9#1)
on a scale from 0 to 100##2##7##(2008-9#1)(2010-9#1)
on a scale from 0 to##3##6##(1995-8#1)(2008-9#1)(2010-9#1)
on a scale from 1 to 5##2##7##(1992-3#1)(2008-7#1)
on a scale from##5##4##(1992-3#1)(1995-8#1)(2008-7#1)(2008-9#1)(2010-9#1)
on a scale of 0 to##2##6##(2007-7#1)(2008-10#1)
on a scale of 0-10##3##5##(2008-7#1)(2013-1#2)
on a scale of##8##4##(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-3#1)(2013-1#2)
on a scale##18##3##(1992-3#1)(1995-8#1)(1997-3#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
on a scanning##3##3##(2008-3#2)(2008-9#1)
on a screen##3##3##(1996-2#1)(2008-3#1)(2009-5#1)
on a screen-printed##2##3##(2008-10#2)
on a seasonal basis##2##4##(2008-5#2)
on a second##7##3##(1993-12#1)(1993-2#1)(1997-2#1)(2008-12#1)(2011-2#1)(2013-1#2)
on a selectin##2##3##(1991-5#2)
on a selective medium##3##4##(2008-10#3)
on a selective##6##3##(2008-10#3)(2008-2#2)(2011-2#1)
on a self-assembled monolayer##2##4##(2005-11#1)(2007-8#1)
on a self-assembled##4##3##(1990-4#1)(2005-11#1)(2007-8#1)(2008-10#1)
on a semiconductor##5##3##(1992-2#1)(2007-12#2)(2008-2#1)(2008-3#1)
on a sensor##2##3##(2007-8#1)(2008-11#1)
on a separate occasion##2##4##(1991-6#1)(2008-3#1)
on a separate##5##3##(1991-6#1)(1994-12#1)(2008-2#1)(2008-3#2)
on a series of##17##4##(1990-4#1)(1992-10#1)(1992-12#2)(1993-5#1)(1995-11#1)(1995-12#1)(1996-2#1)(1997-2#2)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
on a set of##25##4##(1991-9#1)(1996-3#1)(1997-5#1)(2006-2#1)(2006-5#1)(2007-12#1)(2008-10#5)(2008-2#3)(2008-3#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-3#1)(2012-1#1)(2013-1#4)
on a shared##2##3##(2008-2#1)(2012-2#1)
on a sheep##2##3##(2011-2#2)
on a shelf##2##3##(1992-1#1)(2012-1#1)
on a ship##2##3##(2007-12#1)(2008-3#1)
on a short-term basis##2##4##(1996-3#1)(2008-2#1)
on a shoulder##3##3##(2010-5#1)(2012-1#2)
on a side##3##3##(2007-4#1)(2008-2#1)(2008-8#1)
on a sidearm##2##3##(2008-3#2)
on a significant##2##3##(2008-3#1)(2008-8#1)
on a silica gel column##2##5##(1991-9#1)(1995-1#1)
on a silica##6##3##(1991-9#1)(1995-1#1)(2008-10#4)
on a silica-based##4##3##(1991-3#1)(1992-1#1)(2007-8#1)(2008-2#1)
on a silicon##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
on a silver##3##3##(2008-10#1)(2008-3#2)
on a similar##4##3##(2006-3#1)(2008-10#1)(2008-5#1)(2010-10#1)
on a simple##20##3##(1995-7#1)(1996-5#1)(2006-2#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2012-2#1)
on a simulated##2##3##(2009-11#1)(2012-12#1)
on a single crystal of##2##5##(2006-5#1)(2008-2#1)
on a single day##2##4##(2008-12#1)(2013-8#1)
on a single occasion##2##4##(1996-3#1)(2008-10#1)
on a single slide##2##4##(2008-4#1)(2008-7#1)
on a single substrate##2##4##(2008-3#2)
on a single time##2##4##(2012-1#1)(2012-3#1)
on a single##76##3##(1990-5#1)(1991-6#1)(1992-1#1)(1992-6#1)(1994-3#1)(1994-9#1)(1995-8#1)(1996-3#1)(1997-3#1)(1997-8#4)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#6)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-2#8)(2008-3#8)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-3#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
on a single-crystal##2##3##(2007-12#1)(2009-11#1)
on a single-shot basis##2##4##(2007-11#1)(2007-12#1)
on a slide glass##2##4##(1991-5#1)(2007-11#1)
on a small number of##6##5##(1991-9#1)(1992-7#1)(1995-5#1)(2010-7#1)(2012-2#2)
on a small##18##3##(1991-9#1)(1992-7#1)(1993-9#1)(1995-5#1)(1996-12#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-7#1)(2010-7#1)(2010-8#1)(2012-2#2)
on a smectic liquid crystalline polysiloxane stationary phase##2##8##(1992-1#2)
on a solid phase##2##4##(2008-10#1)(2008-11#1)
on a solid support##10##4##(1994-11#2)(2008-10#2)(2008-2#1)(2008-4#4)(2009-12#1)
on a solid##16##3##(1994-11#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#4)(2008-7#2)(2009-12#1)(2010-7#1)
on a soluble##2##3##(2008-10#1)(2008-7#1)
on a spatial##5##3##(1993-3#1)(1993-4#1)(1994-5#1)(2011-1#1)(2012-2#1)
on a special##4##3##(1992-3#1)(2008-10#1)(2008-3#1)(2010-12#1)
on a specialized##2##3##(1996-1#1)(2008-7#1)
on a specific diagnosis##2##4##(1996-6#1)(2007-12#1)
on a specific##12##3##(1991-2#2)(1994-12#1)(1996-6#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)
on a spectral##2##3##(2007-11#1)(2008-3#1)
on a spherical##4##3##(2005-11#1)(2008-2#1)(2008-3#2)
on a split-belt treadmill##2##4##(2012-1#2)
on a stable##7##3##(1994-11#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-12#1)(2011-2#1)(2013-8#1)
on a standard##16##3##(2006-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#2)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#1)(2009-3#2)(2013-1#1)
on a statistical##7##3##(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2010-8#1)(2012-3#1)
on a stranger##2##3##(2006-10#2)
on a stratified##2##3##(1995-9#1)(1997-3#1)
on a strong##4##3##(2008-10#2)(2008-3#1)(2012-2#1)
on a structured##2##3##(2006-5#1)(2009-12#1)
on a study of##3##4##(2005-11#1)(2008-9#1)(2009-5#1)
on a study##5##3##(1996-12#1)(2005-11#1)(2007-1#1)(2008-9#1)(2009-5#1)
on a sub-sample of##2##4##(2008-4#1)(2013-1#1)
on a subject##2##3##(1991-1#1)(2007-4#1)
on a subjective##2##3##(1991-12#1)(2011-1#1)
on a subsequent##2##3##(2008-10#2)
on a subset of the##3##5##(1996-7#1)(2008-10#1)(2011-2#1)
on a subset of##8##4##(1990-12#1)(1996-7#1)(2005-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-8#1)(2011-2#1)
on a substrate##6##3##(1996-12#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-3#1)
on a successful##2##3##(1994-12#1)(2012-1#1)
on a sufficient##3##3##(2007-12#1)(2008-10#2)
on a support##2##3##(2007-10#1)(2008-10#1)
on a surface and##2##4##(1992-11#1)(2010-4#1)
on a surface of a glass##2##6##(1991-5#1)(2008-2#1)
on a surface of a##3##5##(1991-5#1)(2008-2#1)(2008-5#1)
on a surface without##2##4##(2008-7#1)(2010-4#1)
on a surface##14##3##(1991-5#1)(1992-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2010-2#1)(2010-4#2)(2012-1#1)
on a survey of##4##4##(1993-1#1)(1995-1#1)(1997-3#1)(1997-5#1)
on a survey##6##3##(1993-1#1)(1995-1#1)(1996-1#1)(1997-3#1)(1997-5#1)(2008-9#1)
on a susceptible##5##3##(2008-10#5)
on a synchrotron##2##3##(2006-5#1)(2008-2#1)
on a synthetic##5##3##(1991-1#1)(1991-7#1)(1992-12#1)(1992-9#1)(2009-9#1)
on a system of particles##2##5##(2007-12#2)
on a system of##4##4##(2007-12#2)(2008-3#1)(2013-8#1)
on a system##5##3##(2007-12#2)(2008-3#1)(2010-12#1)(2013-8#1)
on a systematic literature##2##4##(2011-2#1)(2012-12#1)
on a systematic##6##3##(1991-9#1)(1992-2#1)(1996-12#1)(2008-10#1)(2011-2#1)(2012-12#1)
on a systemic##3##3##(1996-1#1)(2007-11#2)
on a table##2##3##(2007-1#1)(2008-12#1)
on a tandem##2##3##(1994-12#1)(2011-1#1)
on a target##2##3##(1994-2#1)(2007-12#1)
on a task that##2##4##(1992-9#1)(2008-2#1)
on a task##4##3##(1992-9#1)(2006-3#1)(2008-1#1)(2008-2#1)
on a television##2##3##(1993-7#1)(2008-2#1)
on a test of##4##4##(1993-3#1)(2007-12#1)(2009-4#1)(2010-7#1)
on a test##9##3##(1991-11#1)(1993-3#1)(2007-12#1)(2008-1#1)(2008-3#3)(2009-4#1)(2010-7#1)
on a theoretical model##2##4##(2007-12#1)(2009-9#1)
on a theoretical##4##3##(2007-11#1)(2007-12#2)(2009-9#1)
on a thin##4##3##(1991-4#1)(2007-12#1)(2008-3#1)(2008-7#1)
on a thorough history and physical examination##2##7##(2008-8#1)(2012-2#1)
on a thorough##5##3##(2008-1#1)(2008-3#1)(2008-8#1)(2010-5#1)(2012-2#1)
on a three##2##3##(1990-11#1)(2010-3#1)
on a three-dimensional##4##3##(1993-3#1)(2005-7#1)(2007-8#1)(2008-10#1)
on a time scale of##5##5##(1990-10#1)(1992-9#1)(1993-3#1)(1994-11#1)(1997-2#1)
on a time scale##9##4##(1990-10#2)(1990-2#1)(1992-9#2)(1993-3#1)(1994-11#1)(1995-1#1)(1997-2#1)
on a time##11##3##(1990-10#2)(1990-2#1)(1992-9#2)(1993-3#1)(1994-11#1)(1995-1#1)(1997-2#2)(2008-2#1)
on a timely basis##2##4##(1996-2#1)(1997-2#1)
on a tissue culture##2##4##(1994-6#1)(2005-11#1)
on a total of##8##4##(1991-4#1)(1991-5#1)(2007-12#1)(2007-3#1)(2008-5#1)(2009-12#1)(2010-4#1)(2012-12#1)
on a training set of##2##5##(2010-12#1)(2011-1#1)
on a training##4##3##(2006-6#1)(2008-7#1)(2010-12#1)(2011-1#1)
on a transparent##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
on a treadmill##14##3##(1990-4#2)(1991-3#1)(2005-8#1)(2007-10#1)(2008-10#1)(2009-5#1)(2012-1#4)(2013-1#2)(2013-8#1)
on a treatment##2##3##(1990-12#1)(1991-1#1)
on a triple##2##3##(1995-2#1)(2008-1#1)
on a tunable##3##3##(1992-6#1)(2007-12#1)(2009-4#1)
on a tungsten wire##2##4##(2008-10#2)
on a two##2##3##(1990-3#1)(2008-10#1)
on a two-dimensional##5##3##(1991-4#1)(2007-11#3)(2008-2#1)
on a two-layer##2##3##(2008-11#1)(2011-1#1)
on a two-phase##2##3##(2005-11#1)(2008-10#1)
on a two-step##4##3##(1991-8#1)(2006-2#1)(2008-10#1)(2008-3#1)
on a unique##3##3##(1996-11#1)(2007-12#1)(2007-5#1)
on a variant##2##3##(1995-2#1)(2008-5#1)
on a variety of cell types##2##6##(2005-12#1)(2008-4#1)
on a variety of cell##3##5##(1992-12#1)(2005-12#1)(2008-4#1)
on a variety of substrates##2##5##(2007-12#1)(2010-4#1)
on a variety of surfaces##2##5##(2007-11#1)(2008-7#1)
on a variety of##35##4##(1991-4#1)(1992-11#1)(1992-12#1)(1993-7#1)(1994-2#1)(1996-2#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-9#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#2)
on a vector##2##3##(1995-4#1)(2007-11#1)
on a versatile##2##3##(2007-10#1)(2012-1#1)
on a vertical##5##3##(2008-10#1)(2008-11#1)(2008-2#2)(2013-7#1)
on a very large##2##4##(2004-12#1)(2010-4#1)
on a very##8##3##(1990-2#1)(1993-8#1)(1995-11#1)(2004-12#1)(2007-4#1)(2008-10#1)(2008-5#1)(2010-4#1)
on a victim's##2##3##(2008-10#1)(2008-11#1)
on a visual analog scale##4##5##(2006-10#1)(2006-3#1)(2009-3#1)(2010-7#1)
on a visual##7##3##(1991-2#2)(2006-10#1)(2006-3#1)(2006-9#1)(2009-3#1)(2010-7#1)
on a voluntary basis##2##4##(1994-3#1)(2008-10#1)
on a voluntary##3##3##(1990-6#1)(1994-3#1)(2008-10#1)
on a voxel-by-voxel basis##2##4##(2008-11#2)
on a waiting list##3##4##(1991-4#1)(2007-7#1)(2008-5#1)
on a water##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
on a wave-front##3##3##(2008-3#3)
on a weak##3##3##(1996-8#1)(2007-11#1)(2008-10#1)
on a weekly basis##6##4##(1997-4#2)(2006-2#1)(2008-5#1)(2011-2#1)(2012-1#1)
on a weekly##7##3##(1997-4#2)(2006-2#1)(2007-7#1)(2008-5#1)(2011-2#1)(2012-1#1)
on a wet weight basis##2##5##(1990-2#1)(1991-9#1)
on a wet##3##3##(1990-2#1)(1991-9#1)(2008-11#1)
on a wide range of##8##5##(1991-10#1)(1991-2#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
on a wide variety of##4##5##(1991-8#1)(2006-10#1)(2008-4#1)(2008-9#1)
on a wide##16##3##(1991-10#1)(1991-2#1)(1991-8#1)(2005-11#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-6#1)(2013-1#1)(2013-8#1)
on a widely##2##3##(2006-10#1)(2008-2#1)
on a wider##2##3##(2005-11#1)(2008-12#1)
on a woman##2##3##(1996-6#1)(2010-9#1)
on a woman's##4##3##(1995-9#1)(1996-8#1)(1997-7#1)(2010-12#1)
on a wooden##2##3##(1993-9#1)(2008-3#1)
on a worldwide##5##3##(2005-8#1)(2008-10#3)(2012-12#1)
on a young##2##3##(2008-5#1)(2012-12#1)
on a##3672##2##(1990-1#1)(1990-10#10)(1990-11#10)(1990-12#16)(1990-2#11)(1990-3#7)(1990-4#6)(1990-5#8)(1990-6#14)(1990-7#3)(1990-8#18)(1990-9#5)(1991-1#4)(1991-10#2)(1991-11#13)(1991-12#8)(1991-2#11)(1991-3#6)(1991-4#7)(1991-5#12)(1991-6#4)(1991-7#6)(1991-8#5)(1991-9#7)(1992-1#10)(1992-10#7)(1992-11#7)(1992-12#13)(1992-2#21)(1992-3#14)(1992-4#1)(1992-5#4)(1992-6#8)(1992-7#3)(1992-8#5)(1992-9#10)(1993-1#6)(1993-10#1)(1993-12#8)(1993-2#12)(1993-3#16)(1993-4#4)(1993-5#8)(1993-6#10)(1993-7#3)(1993-8#3)(1993-9#12)(1994-1#3)(1994-11#9)(1994-12#16)(1994-2#14)(1994-3#19)(1994-4#1)(1994-5#7)(1994-6#18)(1994-7#1)(1994-8#9)(1994-9#5)(1995-1#12)(1995-10#2)(1995-11#9)(1995-12#13)(1995-2#16)(1995-3#17)(1995-4#4)(1995-5#5)(1995-6#10)(1995-7#4)(1995-8#10)(1995-9#6)(1996-1#5)(1996-10#3)(1996-11#6)(1996-12#21)(1996-2#19)(1996-3#18)(1996-4#4)(1996-5#10)(1996-6#7)(1996-7#8)(1996-8#11)(1996-9#6)(1997-1#12)(1997-2#29)(1997-3#24)(1997-4#14)(1997-5#14)(1997-6#7)(1997-7#8)(1997-8#21)(2004-10#2)(2004-11#3)(2004-12#2)(2004-2#3)(2004-9#1)(2005-1#1)(2005-10#8)(2005-11#38)(2005-12#10)(2005-3#1)(2005-4#2)(2005-5#4)(2005-6#2)(2005-7#7)(2005-8#8)(2005-9#1)(2006-1#1)(2006-10#30)(2006-11#6)(2006-12#20)(2006-2#23)(2006-3#7)(2006-4#5)(2006-5#25)(2006-6#10)(2006-7#4)(2006-8#14)(2006-9#2)(2007-1#12)(2007-10#12)(2007-11#90)(2007-12#177)(2007-2#15)(2007-3#7)(2007-4#17)(2007-5#20)(2007-6#8)(2007-7#14)(2007-8#49)(2007-9#32)(2008-1#34)(2008-10#543)(2008-11#63)(2008-12#31)(2008-2#202)(2008-3#261)(2008-4#64)(2008-5#59)(2008-6#35)(2008-7#81)(2008-8#46)(2008-9#41)(2009-1#1)(2009-10#14)(2009-11#10)(2009-12#8)(2009-2#3)(2009-3#14)(2009-4#16)(2009-5#7)(2009-6#7)(2009-7#5)(2009-8#9)(2009-9#8)(2010-1#7)(2010-10#10)(2010-11#6)(2010-12#27)(2010-2#10)(2010-3#10)(2010-4#25)(2010-5#10)(2010-6#11)(2010-7#8)(2010-8#15)(2010-9#13)(2011-1#54)(2011-12#2)(2011-2#55)(2011-3#4)(2011-9#1)(2012-1#42)(2012-11#4)(2012-12#38)(2012-2#59)(2012-3#29)(2012-4#1)(2012-5#1)(2013-1#88)(2013-7#15)(2013-8#35)
on ab##2##2##(2008-11#1)(2010-12#1)
on abdominal CT##2##3##(2007-3#1)(2008-12#1)
on abdominal and##2##3##(1995-3#1)(2012-2#1)
on abdominal fat accumulation##2##4##(2008-3#1)(2008-8#1)
on abdominal segment##2##3##(2007-12#1)(2007-3#1)
on abdominal##13##2##(1995-3#1)(2007-12#3)(2007-3#2)(2008-12#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
on abiotic##2##2##(2006-11#1)(2006-12#1)
on abortion is##2##3##(1993-5#1)(2008-11#1)
on abortion##14##2##(1990-10#1)(1990-3#1)(1992-12#1)(1993-5#1)(1994-2#2)(1996-5#1)(1997-5#1)(2006-5#1)(2008-11#3)(2008-4#1)(2010-12#1)
on about 50% of##2##4##(1990-12#1)(2011-1#1)
on about##5##2##(1990-12#1)(2006-4#1)(2008-7#1)(2008-8#1)(2011-1#1)
on absolute##6##2##(1991-2#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
on absorbance##4##2##(2007-11#1)(2008-10#2)(2010-5#1)
on absorption signal of Cs##2##5##(2005-4#2)
on absorption##16##2##(2005-4#2)(2006-10#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#3)(2009-10#1)
on abundant##2##2##(1991-11#1)(1994-11#1)
on academic performance##2##3##(2006-8#2)
on academic##12##2##(1996-3#1)(1997-1#1)(1997-2#1)(2005-8#1)(2006-8#2)(2007-4#1)(2007-9#1)(2009-4#1)(2009-7#1)(2010-3#1)(2012-2#1)
on access and utilization##2##4##(1994-1#1)(2008-7#1)
on access and##4##3##(1991-1#1)(1994-1#1)(2008-7#1)(2009-4#1)
on access to care for##2##5##(1995-12#1)(2007-10#1)
on access to care##4##4##(1995-12#2)(1996-1#1)(2007-10#1)
on access to##8##3##(1992-2#1)(1994-1#1)(1995-12#2)(1996-1#1)(1996-3#1)(2006-2#1)(2007-10#1)
on access##15##2##(1990-12#1)(1991-1#1)(1992-2#1)(1994-1#2)(1994-12#1)(1995-12#2)(1996-1#1)(1996-3#1)(1997-2#1)(2006-2#1)(2007-10#1)(2008-7#1)(2009-4#1)
on acclimatization##2##2##(2009-6#2)
on account of a##2##4##(2008-2#1)(2011-2#1)
on account of its##2##4##(1997-4#1)(2011-1#1)
on account of suspected##2##4##(1990-12#1)(1990-2#1)
on account of the high##2##5##(1992-11#1)(1993-8#1)
on account of the##10##4##(1990-10#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-5#1)(1993-3#1)(1993-8#1)(1995-2#1)(1995-3#1)(2007-11#1)
on account of##33##3##(1990-10#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-12#3)(1991-2#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-3#2)(1992-5#1)(1993-3#1)(1993-6#1)(1993-8#1)(1995-2#1)(1995-3#1)(1997-4#1)(2005-1#1)(2006-10#1)(2007-11#1)(2008-2#2)(2011-1#2)(2011-2#1)(2012-2#1)
on accreditation##2##2##(1993-12#1)(1996-12#1)
on accumulated##3##2##(1990-9#1)(2008-5#1)(2010-3#1)
on accumulation of##6##3##(1996-9#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)
on accumulation##7##2##(1996-9#1)(1997-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)
on accuracy##6##2##(2006-2#1)(2008-10#3)(2010-2#1)(2012-2#1)
on accurate##5##2##(1990-10#1)(2007-12#1)(2008-4#1)(2010-12#1)(2010-8#1)
on acetate##5##2##(2005-12#1)(2006-3#1)(2008-6#1)(2008-7#2)
on acetylation##3##2##(1995-1#1)(2010-2#1)(2011-1#1)
on acetylcholine release##2##3##(1993-5#1)(1996-11#1)
on acetylcholine##4##2##(1993-5#1)(1996-11#1)(1997-1#1)(2008-10#1)
on acetylcholinesterase##2##2##(1994-5#1)(2005-11#1)
on achieving##4##2##(1994-2#1)(2005-8#1)(2007-8#1)(2010-4#1)
on acid and pepsin secretion##2##5##(1997-1#2)
on acid production##2##3##(1990-10#2)
on acid##10##2##(1990-10#2)(1997-1#3)(2005-12#1)(2007-1#1)(2008-10#3)
on acid-base##3##2##(2007-8#1)(2008-10#2)
on acidic##4##2##(1990-2#1)(2006-3#1)(2008-10#1)(2012-6#1)
on acidified##2##2##(2008-10#2)
on acne##3##2##(2006-12#1)(2011-1#1)(2013-8#1)
on acoustic##4##2##(2006-10#1)(2007-12#1)(2010-12#1)(2012-2#1)
on acquisition and retention of##2##5##(1993-12#1)(2012-2#1)
on acquisition of##2##3##(1991-2#1)(1993-7#1)
on acquisition##6##2##(1991-2#1)(1993-12#1)(1993-3#1)(1993-7#1)(2012-2#2)
on acrocentric##2##2##(1996-4#1)(2011-12#1)
on acrosome##2##2##(2006-5#1)(2012-2#1)
on actin##4##2##(1992-12#1)(1992-4#1)(1994-11#1)(1994-5#1)
on action naming##2##3##(2007-7#2)
on action potential duration##2##4##(1993-3#1)(1994-3#1)
on action potential##4##3##(1993-3#1)(1994-3#1)(2008-4#2)
on action##9##2##(1990-11#1)(1993-3#1)(1994-3#1)(1995-3#1)(2007-6#1)(2007-7#2)(2008-4#2)
on actions##2##2##(2006-10#1)(2010-5#1)
on activated T##3##3##(1992-7#1)(1996-10#1)(2005-10#1)
on activated carbon (AC) as##2##5##(2008-10#2)
on activated carbon and##2##4##(2008-10#2)
on activated carbon cloth##2##4##(2005-11#2)
on activated carbon##19##3##(2005-11#3)(2008-10#16)
on activated carbons##4##3##(2005-11#4)
on activated macrophages##2##3##(1991-8#1)(2007-11#1)
on activated##32##2##(1991-8#1)(1992-7#1)(1992-8#1)(1996-10#1)(2005-10#1)(2005-11#7)(2007-11#1)(2008-10#17)(2008-5#1)(2013-1#1)
on activation and##2##3##(1992-1#1)(2010-3#1)
on activation of the##3##4##(1994-7#1)(1997-2#1)(2008-4#1)
on activation of##10##3##(1990-12#1)(1990-5#1)(1992-5#1)(1994-7#1)(1995-3#1)(1996-10#1)(1997-2#1)(2008-4#2)(2008-8#1)
on activation##17##2##(1990-12#1)(1990-5#1)(1991-11#1)(1992-1#1)(1992-5#1)(1994-3#1)(1994-7#1)(1995-3#1)(1996-10#1)(1997-2#1)(2006-9#1)(2007-2#1)(2008-4#3)(2008-8#1)(2010-3#1)
on activator protein-1##2##3##(1994-6#1)(1996-10#1)
on active illumination##2##3##(2008-3#1)(2011-1#1)
on active patches##2##3##(2008-6#2)
on active range of##2##4##(2008-12#2)
on active##18##2##(1994-6#1)(1996-9#1)(2006-10#2)(2007-12#2)(2008-1#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#2)(2008-8#1)(2009-11#1)(2010-7#1)(2011-1#1)(2012-1#1)
on activities of daily living##3##5##(1994-6#1)(2011-2#1)(2012-1#1)
on activities of daily##4##4##(1994-6#1)(2011-2#1)(2012-1#1)(2012-2#1)
on activities of the Canadian Committee on Antibiotic Resistance##2##9##(2007-12#2)
on activities of##7##3##(1994-6#1)(2007-12#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
on activities##10##2##(1992-3#1)(1994-6#1)(1995-2#1)(1996-3#1)(2007-12#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
on activity and##2##3##(2008-8#1)(2010-12#1)
on activity of##5##3##(1992-11#1)(1992-5#1)(2006-6#1)(2008-10#1)(2013-7#1)
on activity##16##2##(1990-3#2)(1990-6#1)(1992-11#1)(1992-12#2)(1992-5#1)(1994-9#1)(2006-6#1)(2008-10#1)(2008-8#4)(2010-12#1)(2013-7#1)
on actual##6##2##(2008-11#1)(2008-3#2)(2008-7#1)(2010-12#1)(2011-3#1)
on acupuncture skills##3##3##(2012-3#3)
on acupuncture##8##2##(2007-4#1)(2008-10#2)(2010-5#1)(2012-3#3)(2013-7#1)
on acute medical##3##3##(2008-6#1)(2010-7#2)
on acute myocardial##2##3##(2012-12#1)(2012-3#1)
on acute pulmonary##2##3##(2010-10#1)(2012-2#1)
on acute##27##2##(1990-10#1)(1993-10#1)(1994-12#1)(1995-12#3)(1996-10#1)(1996-3#1)(2006-6#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-10#1)(2010-12#1)(2010-7#2)(2011-12#3)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
on adaptive##8##2##(2008-2#1)(2008-5#1)(2008-9#2)(2010-2#1)(2010-8#1)(2011-1#1)(2012-1#1)
on added##2##2##(1991-6#1)(2008-3#1)
on addition of##12##3##(1990-11#1)(1991-2#1)(1992-3#1)(1992-8#1)(1993-11#1)(1994-6#1)(1996-1#1)(1997-4#1)(2008-2#1)(2008-8#1)(2010-7#1)(2012-3#1)
on additional##3##2##(1993-8#1)(2007-1#1)(2011-2#1)
on addressing##2##2##(2010-10#1)(2010-2#1)
on adequate##4##2##(1990-6#1)(1992-8#1)(2007-9#1)(2010-6#1)
on adherence and##2##3##(1997-6#1)(2009-9#1)
on adherence##5##2##(1997-6#1)(2006-6#1)(2007-12#1)(2009-9#1)(2011-1#1)
on adherent##2##2##(2008-4#1)(2012-4#1)
on adhesion of##3##3##(1992-8#1)(1997-7#1)(2008-5#1)
on adhesion##5##2##(1992-12#1)(1992-8#1)(1997-7#1)(2008-5#1)(2008-9#1)
on adhesive##2##2##(1994-8#1)(2010-8#1)
on adiponectin##2##2##(2006-1#1)(2007-8#1)
on adipose and##2##3##(2007-12#1)(2008-3#1)
on adipose##4##2##(1996-5#1)(2007-12#1)(2008-1#1)(2008-3#1)
on adjacent##7##2##(1997-7#1)(2008-10#2)(2008-5#1)(2008-7#2)(2011-3#1)
on adjuvant treatment of##2##4##(1992-8#1)(2008-5#1)
on adjuvant##6##2##(1992-8#1)(2004-2#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
on administration of##3##3##(1997-4#1)(1997-6#1)(2006-6#1)
on administration##4##2##(1997-4#1)(1997-6#1)(2006-6#1)(2011-1#1)
on administrative##2##2##(1995-6#1)(2010-5#1)
on admission and after##2##4##(1993-12#1)(2005-6#1)
on admission and discharge##3##4##(1992-1#1)(2007-9#1)(2008-6#1)
on admission and on discharge##2##5##(2013-8#2)
on admission and##16##3##(1991-7#1)(1992-1#1)(1993-12#1)(1994-10#1)(2005-6#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-9#2)(2008-6#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#2)
on admission to a##2##4##(1994-2#1)(2006-12#1)
on admission to hospital##2##4##(1991-2#1)(1992-8#1)
on admission to##6##3##(1991-2#1)(1992-8#1)(1994-2#1)(2006-12#1)(2007-7#1)(2008-3#1)
on admission was##2##3##(1992-6#1)(2007-9#1)
on admission##66##2##(1990-8#3)(1991-2#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-6#2)(1992-8#1)(1993-12#2)(1994-10#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-9#2)(1997-8#1)(2005-6#1)(2006-12#2)(2006-2#1)(2006-6#1)(2007-10#6)(2007-7#2)(2007-8#1)(2007-9#4)(2008-10#1)(2008-11#1)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#5)(2009-7#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#4)(2013-1#3)(2013-8#2)
on adolescent boys' body image##2##5##(2007-12#2)
on adolescent smoking##2##3##(2009-9#1)(2013-1#1)
on adolescent##16##2##(1994-2#1)(2007-12#4)(2008-3#2)(2008-7#1)(2008-9#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-7#1)(2013-1#2)
on adolescents'##4##2##(2009-7#4)
on adsorption of##2##3##(2005-11#1)(2008-10#1)
on adsorption properties##2##3##(2005-11#2)
on adsorption##11##2##(1992-7#1)(2005-11#7)(2008-10#3)
on adult fecundity##2##3##(2008-11#2)
on adult male##3##3##(1997-2#1)(2008-5#1)(2008-8#1)
on adult##26##2##(1993-7#1)(1994-8#1)(1995-11#1)(1995-8#1)(1997-2#1)(2005-7#1)(2007-1#1)(2007-11#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-8#2)(2008-9#2)(2009-2#1)(2010-11#1)(2010-8#1)(2011-1#2)(2012-2#1)(2012-3#1)
on adult-born##3##2##(2012-2#3)
on adults with##2##3##(2012-12#1)(2013-1#1)
on adults##8##2##(2008-9#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#4)
on adults'##2##2##(2007-12#1)(2009-7#1)
on advance##2##2##(1993-2#1)(2012-3#1)
on advanced##6##2##(1992-8#1)(2006-5#1)(2007-9#1)(2008-3#1)(2011-2#1)(2012-3#1)
on advances in the##4##4##(2006-10#2)(2012-11#2)
on advances in##7##3##(2005-8#1)(2006-10#3)(2012-11#2)(2012-2#1)
on advantages and disadvantages of##2##5##(2007-11#1)(2010-3#1)
on adverse effects##2##3##(2007-11#1)(2008-6#1)
on adverse events##3##3##(1994-2#1)(2007-7#1)(2008-10#1)
on adverse reactions related to topical##2##6##(1997-5#2)
on adverse##10##2##(1994-2#1)(1994-6#1)(1997-5#2)(2007-11#1)(2007-7#1)(2008-10#1)(2008-6#1)(2011-1#1)(2011-2#1)
on aerobic##3##2##(2006-8#1)(2009-4#1)(2011-1#1)
on aerosol##4##2##(1997-1#1)(2008-11#1)(2008-3#2)
on affect regulation##4##3##(2013-1#4)
on affected patients##2##3##(2007-10#1)(2008-7#1)
on affected##3##2##(2007-10#1)(2008-7#1)(2012-12#1)
on affinity for##2##3##(1996-7#1)(2005-11#1)
on affinity##8##2##(1991-3#1)(1992-8#1)(1993-9#1)(1995-3#1)(1996-7#2)(2005-11#1)(2007-9#1)
on aflatoxicosis##2##2##(2008-5#1)(2010-4#1)
on aflatoxin production##2##3##(1992-9#2)
on aflatoxin##4##2##(1992-9#2)(2008-10#1)(2009-3#1)
on agar media##3##3##(2008-10#3)
on agar plates using##2##4##(1990-5#1)(2010-4#1)
on agar plates##4##3##(1990-5#1)(2008-10#1)(2010-4#1)(2011-1#1)
on agar##13##2##(1990-5#1)(1993-8#1)(2008-10#7)(2008-5#1)(2010-4#1)(2011-1#1)(2012-2#1)
on agarose gel electrophoresis##3##4##(1991-5#1)(1996-12#1)(1997-7#1)
on agarose gel##5##3##(1991-5#1)(1993-11#1)(1996-12#1)(1997-7#1)(2006-8#1)
on agarose gels##4##3##(1991-3#1)(1992-3#1)(2004-11#1)(2008-10#1)
on agarose##10##2##(1991-3#1)(1991-5#1)(1992-3#1)(1993-11#1)(1996-12#1)(1997-7#1)(2004-11#1)(2006-12#1)(2006-8#1)(2008-10#1)
on age and sex##2##4##(2005-10#1)(2008-11#1)
on age and##5##3##(2005-10#1)(2006-7#1)(2006-8#1)(2008-11#1)(2008-5#1)
on age at##4##3##(1994-11#1)(2007-7#1)(2008-8#2)
on age##35##2##(1991-10#1)(1991-5#1)(1991-6#1)(1992-2#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-9#1)(1997-2#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-3#1)(2011-3#1)(2012-2#1)
on age-related changes in##2##4##(1995-1#1)(2008-3#1)
on age-related##3##2##(1995-1#1)(2008-3#1)(2010-10#1)
on age-specific##2##2##(1994-12#1)(2008-4#1)
on ageing##4##2##(2008-10#1)(2009-4#1)(2010-10#1)(2010-12#1)
on agency##2##2##(1995-3#1)(1997-3#1)
on aggregation of##2##3##(1997-3#1)(2008-1#1)
on aggregation##4##2##(1997-3#1)(2005-11#1)(2008-1#1)(2008-8#1)
on aggression##2##2##(2010-2#2)
on aggressive##2##2##(1995-2#1)(2008-1#1)
on aging processes##2##3##(2008-10#1)(2013-7#1)
on aging##8##2##(1990-12#1)(1996-11#1)(2007-10#1)(2008-10#1)(2009-5#2)(2013-1#1)(2013-7#1)
on agonist##2##2##(1990-2#1)(1991-1#1)
on air##4##2##(1995-3#1)(2008-1#1)(2008-10#1)(2008-11#1)
on airway##6##2##(1991-4#1)(1996-12#1)(2005-10#1)(2005-8#1)(2006-4#1)(2008-4#1)
on albino##2##2##(2006-9#1)(2010-12#1)
on albumin##2##2##(1994-8#1)(2012-1#1)
on alcohol and##2##3##(1994-2#1)(2008-1#1)
on alcohol consumption##4##3##(1994-2#2)(2009-12#2)
on alcohol dependence##2##3##(1996-6#1)(2012-2#1)
on alcohol intake##2##3##(2008-2#1)(2013-1#1)
on alcohol##17##2##(1994-2#3)(1996-6#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-12#3)(2010-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
on alcoholic##2##2##(1990-8#1)(2007-12#1)
on alfalfa (Medicago##2##3##(2008-10#1)(2011-2#1)
on alfalfa and##2##3##(2008-10#2)
on alfalfa##4##2##(2008-10#3)(2011-2#1)
on algal##2##2##(1990-7#1)(1991-3#1)
on aligned##3##2##(2008-11#1)(2009-9#2)
on alignment of##2##3##(1996-12#1)(2008-10#1)
on alignment##3##2##(1996-12#1)(2007-12#1)(2008-10#1)
on alkaline hydrolysis##3##3##(2008-10#2)(2008-5#1)
on alkaline##6##2##(1992-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)
on alkane##3##2##(1991-9#2)(2007-9#1)
on all 6##2##3##(2008-12#1)(2013-1#1)
on all aspects of##2##4##(1996-1#1)(2006-4#1)
on all aspects##3##3##(1996-1#1)(2006-4#1)(2012-1#1)
on all but##2##3##(1991-6#1)(2012-2#1)
on all dimensions##2##3##(2007-12#1)(2013-8#1)
on all findings##2##3##(2008-7#1)(2011-2#1)
on all five##2##3##(1997-6#1)(2008-10#1)
on all four##2##3##(2008-1#1)(2011-1#1)
on all fronts##2##3##(2007-2#1)(2007-8#1)
on all of the##6##4##(1990-4#1)(1992-11#1)(1993-12#1)(2007-11#1)(2008-10#1)(2009-2#1)
on all of these##3##4##(1997-3#1)(2008-11#1)(2009-11#1)
on all of##11##3##(1990-4#1)(1992-11#1)(1993-12#1)(1997-3#1)(2006-5#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-11#1)(2009-2#1)
on all other##2##3##(1992-8#1)(2008-11#1)
on all patients##9##3##(2006-8#2)(2007-11#1)(2007-7#3)(2008-6#2)(2012-2#1)
on all samples##2##3##(1992-12#1)(1994-12#1)
on all segments##2##3##(2007-12#1)(2008-10#1)
on all six##2##3##(2008-12#1)(2008-3#1)
on all surfaces##2##3##(2006-4#1)(2008-10#1)
on all the##16##3##(1990-3#1)(1990-6#1)(1992-2#2)(1992-8#1)(1993-12#1)(1995-1#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-1#1)
on all these##3##3##(1990-11#1)(2008-10#1)(2011-1#1)
on all three##5##3##(1993-5#1)(2004-9#1)(2008-10#1)(2012-12#1)(2012-2#1)
on all variables##2##3##(2007-11#1)(2008-3#1)
on all##147##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-8#2)(1993-12#3)(1993-5#1)(1993-6#1)(1994-12#1)(1995-1#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-11#1)(2004-9#2)(2006-1#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#3)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#24)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#3)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#2)(2009-4#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#4)(2011-2#3)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#2)
on allele frequencies##5##3##(1997-4#1)(2008-10#1)(2009-8#3)
on allele##7##2##(1994-3#1)(1997-4#1)(2008-10#1)(2009-4#1)(2009-8#3)
on allergic diseases##2##3##(2005-9#1)(2007-2#1)
on allergic##5##2##(2005-9#2)(2007-2#1)(2007-3#1)(2008-10#1)
on allergies##3##2##(1994-2#1)(1994-5#1)(2010-5#1)
on alleviating pain##2##3##(2008-7#1)(2009-10#1)
on allogeneic##4##2##(1995-1#1)(2008-8#1)(2011-2#1)(2012-2#1)
on almost all##3##3##(2006-8#1)(2010-3#2)
on alpha##9##2##(1992-11#1)(1993-11#1)(1993-3#1)(1993-7#1)(1995-11#1)(2008-10#2)(2008-8#1)(2009-12#1)
on alterations in##3##3##(2008-5#2)(2010-11#1)
on alterations##4##2##(2008-5#2)(2008-7#1)(2010-11#1)
on altered##2##2##(2008-1#1)(2008-7#1)
on alternate days during the##2##5##(1991-7#1)(1994-3#1)
on alternate days##4##3##(1991-6#1)(1991-7#1)(1993-7#1)(1994-3#1)
on alternate##5##2##(1991-6#1)(1991-7#1)(1992-2#1)(1993-7#1)(1994-3#1)
on alternative medicine##2##3##(1997-6#1)(2007-8#1)
on alternative##9##2##(1996-2#1)(1997-6#1)(2006-10#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-7#1)
on alumina##5##2##(2007-11#1)(2008-10#4)
on aluminium##3##2##(2007-11#2)(2008-5#1)
on aluminum##3##2##(1992-11#1)(2005-10#1)(2009-12#1)
on ambulation##2##2##(1994-3#1)(2006-10#1)
on ambulatory blood##2##3##(1994-6#1)(2010-12#1)
on ambulatory##3##2##(1994-6#1)(1997-3#1)(2010-12#1)
on amine##2##2##(1992-7#1)(2010-9#1)
on amino acid sequence##4##4##(1991-5#1)(2008-10#1)(2009-8#1)(2012-2#1)
on amino acid##7##3##(1990-12#1)(1991-5#1)(1992-4#1)(2006-8#1)(2008-10#1)(2009-8#1)(2012-2#1)
on amino##9##2##(1990-12#1)(1991-5#1)(1991-9#1)(1992-4#1)(2006-10#1)(2006-8#1)(2008-10#1)(2009-8#1)(2012-2#1)
on aminopropyl-glass##2##2##(2008-10#2)
on aminopyrine accumulation in##3##4##(1993-6#3)
on aminopyrine accumulation##4##3##(1993-6#4)
on amiodarone##2##2##(2010-7#2)
on ammonium##3##2##(2008-10#3)
on amorphous##7##2##(2005-11#3)(2007-5#1)(2008-2#2)(2011-2#1)
on amperometric##2##2##(2008-10#2)
on amplified fragment length polymorphism (AFLP)##2##6##(2008-10#2)
on amplified fragment length polymorphism##4##5##(2008-10#4)
on amylase release from##2##4##(1990-3#1)(1992-12#1)
on amylase release##3##3##(1990-3#1)(1992-12#2)
on amylase secretion##2##3##(1994-11#1)(1994-6#1)
on amylase##6##2##(1990-3#1)(1992-12#2)(1994-11#1)(1994-6#1)(2008-12#1)
on an &quot##2##3##(1993-11#1)(2008-6#1)
on an ABI##3##3##(2007-7#1)(2008-12#1)(2010-9#1)
on an Agilent##2##3##(2011-1#1)(2013-7#1)
on an Au##2##3##(2005-11#1)(2008-10#1)
on an E##2##3##(1993-9#1)(1994-11#1)
on an InP substrate##2##4##(2007-12#1)(2008-3#1)
on an Internet##2##3##(2006-6#1)(2008-5#1)
on an Ultimate##2##3##(2011-1#1)(2011-2#1)
on an active##3##3##(2008-11#2)(2009-9#1)
on an alignment##2##3##(1992-12#1)(2013-1#1)
on an analogy##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
on an analysis of the##4##5##(1990-11#1)(1990-6#1)(2006-11#1)(2008-9#1)
on an analysis of##11##4##(1990-11#1)(1990-6#2)(1993-12#1)(2006-11#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-9#2)(2009-8#1)
on an analysis##12##3##(1990-11#1)(1990-6#2)(1993-12#1)(2006-11#1)(2006-2#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-9#2)(2009-8#1)
on an analytical##2##3##(1991-10#1)(2008-10#1)
on an animal##2##3##(1991-11#1)(2010-1#1)
on an anion##2##3##(2008-10#2)
on an anion-exchange column##5##4##(1990-4#1)(2008-10#4)
on an anion-exchange resin loaded with 1##2##7##(2008-10#2)
on an anion-exchange resin##6##4##(2008-10#6)
on an anion-exchange##11##3##(1990-4#1)(2008-10#10)
on an annual basis in the##2##6##(1993-3#1)(2006-8#1)
on an approach##2##3##(2006-10#1)(2010-2#1)
on an appropriate##6##3##(1990-12#1)(2005-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)
on an area##2##3##(1992-12#1)(1992-2#1)
on an array of##7##4##(2008-10#4)(2008-2#2)(2008-3#1)
on an array##8##3##(2008-10#4)(2008-2#2)(2008-3#1)(2008-7#1)
on an as-needed##2##3##(2008-8#2)
on an association##2##3##(1993-12#1)(1997-5#1)
on an asymmetric##2##3##(2008-3#1)(2009-9#1)
on an atomic##2##3##(1992-2#1)(2008-7#1)
on an automated##3##3##(1994-2#1)(2006-12#1)(2008-4#1)
on an average##11##3##(2007-2#1)(2007-9#1)(2008-3#1)(2008-7#1)(2008-8#4)(2010-6#1)(2010-8#1)(2012-2#1)
on an axisymmetric##2##3##(2007-12#1)(2008-7#1)
on an earlier##2##3##(1997-3#1)(2013-8#1)
on an efficient##2##3##(2008-2#1)(2008-3#1)
on an electrode##2##3##(2008-10#2)
on an emergency basis##4##4##(1992-1#1)(2007-8#2)(2011-1#1)
on an empirical##3##3##(2006-2#1)(2008-3#1)(2010-5#1)
on an endemic diet##3##4##(1994-3#3)
on an enzyme##2##3##(1994-8#1)(1995-3#1)
on an erbium-doped fiber amplifier##2##5##(2008-2#2)
on an evaluation of##4##4##(1993-12#1)(1994-1#1)(2008-10#1)(2008-12#1)
on an evaluation##5##3##(1993-12#1)(1994-1#1)(2008-10#1)(2008-12#1)(2008-3#1)
on an evolutionarily##2##3##(1997-1#1)(2010-1#1)
on an existing##5##3##(2006-5#1)(2008-3#2)(2012-11#1)(2012-3#1)
on an experimental##5##3##(2006-6#1)(2007-1#1)(2007-11#1)(2008-2#1)(2008-3#1)
on an expression##2##3##(1991-2#1)(2008-3#1)
on an extraction##2##3##(1996-6#1)(2008-10#1)
on an hourly basis##2##4##(1992-3#1)(2007-9#1)
on an hourly##3##3##(1992-3#1)(2007-9#1)(2008-8#1)
on an image##4##3##(2006-5#1)(2008-2#1)(2008-7#1)(2009-2#1)
on an immobilized##4##3##(1996-3#1)(2007-8#1)(2008-10#1)(2010-1#1)
on an improved understanding of##2##5##(2005-7#1)(2013-1#1)
on an improved##4##3##(2005-7#1)(2007-12#1)(2011-3#1)(2013-1#1)
on an in situ##3##4##(2008-11#1)(2008-2#2)
on an in vitro model##2##5##(1992-8#1)(2008-10#1)
on an in vitro##4##4##(1990-4#1)(1992-8#1)(2008-10#1)(2008-5#1)
on an in##8##3##(1990-4#1)(1992-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2009-8#1)
on an in-depth##2##3##(1991-3#1)(2012-2#1)
on an in-line##3##3##(1993-2#1)(2007-8#1)(2008-2#1)
on an increase##2##3##(2008-3#1)(2008-4#1)
on an independent##2##3##(1994-5#1)(2008-2#1)
on an individual basis and##2##5##(1996-4#1)(2006-10#1)
on an individual basis##12##4##(1991-8#1)(1995-2#1)(1996-4#1)(2004-10#1)(2006-10#1)(2007-11#2)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)
on an individual##24##3##(1991-8#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-4#1)(1997-2#1)(2004-10#1)(2006-10#1)(2006-8#2)(2007-11#2)(2007-9#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
on an individual's##4##3##(1994-3#1)(1997-8#1)(2010-12#1)(2013-8#1)
on an individualized##2##3##(2007-7#1)(2010-12#1)
on an industrial scale##5##4##(2007-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)
on an inert##2##3##(1990-7#1)(2008-10#1)
on an inexpensive##2##3##(2007-4#1)(2008-10#1)
on an initial##4##3##(1997-5#2)(2008-11#1)(2008-5#1)
on an inpatient##4##3##(1994-9#1)(1995-2#1)(1996-5#1)(2010-8#1)
on an integrated##3##3##(2007-11#1)(2008-10#2)
on an intermediate##4##3##(1990-5#1)(2007-11#1)(2008-1#1)(2008-10#1)
on an international##3##3##(1990-1#1)(2005-7#1)(2006-7#1)
on an interval scale##2##4##(1995-4#1)(1996-7#1)
on an interval##3##3##(1995-4#1)(1996-7#1)(2008-10#1)
on an inventory##2##3##(1990-12#1)(2007-6#1)
on an investigation##2##3##(2008-3#1)(2009-1#1)
on an ion##2##3##(2008-10#2)
on an issue##2##3##(2008-11#1)(2008-12#1)
on an observation##2##3##(1990-3#1)(1995-8#1)
on an octylsilica gel column##2##5##(1996-5#2)
on an old##4##3##(1991-2#1)(1995-9#1)(2005-7#1)(2006-10#1)
on an ongoing basis to##2##5##(1991-12#1)(1993-12#1)
on an ongoing basis##4##4##(1991-12#1)(1993-12#2)(2007-7#1)
on an ongoing##6##3##(1991-12#1)(1993-12#2)(2007-7#1)(2010-12#1)(2010-9#1)
on an open##3##3##(1993-2#1)(2007-11#1)(2007-8#1)
on an optical disk##4##4##(2008-3#4)
on an optical fractal synthesizer##2##5##(2008-3#2)
on an optical##16##3##(1997-2#1)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#8)
on an optically addressed liquid-crystal##2##5##(2007-11#1)(2007-12#1)
on an optically##4##3##(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)
on an optimal##2##3##(2008-12#1)(2008-7#1)
on an ordinal scale##3##4##(1996-2#1)(2008-5#1)(2012-1#1)
on an organic##2##3##(2008-3#1)(2012-8#1)
on an orthonormal##2##3##(2008-1#1)(2008-2#1)
on an otherwise##2##3##(2006-10#1)(2008-2#1)
on an out-patient basis##4##4##(1991-12#1)(2007-8#2)(2008-9#1)
on an out-patient##5##3##(1991-12#1)(2007-8#2)(2008-5#1)(2008-9#1)
on an outpatient basis and##2##5##(1993-6#1)(1994-2#1)
on an outpatient basis is##2##5##(1995-12#1)(2004-10#1)
on an outpatient basis##25##4##(1990-8#1)(1991-12#1)(1991-5#1)(1992-4#1)(1993-6#1)(1993-7#1)(1994-2#1)(1995-12#1)(1996-3#1)(2004-10#3)(2006-10#1)(2006-7#1)(2006-8#4)(2007-11#1)(2007-3#2)(2007-8#1)(2008-11#1)(2012-2#1)(2013-1#1)
on an outpatient##27##3##(1990-8#1)(1991-12#1)(1991-5#1)(1992-4#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-2#1)(1995-12#1)(1996-3#1)(2004-10#3)(2006-10#1)(2006-7#1)(2006-8#5)(2007-11#1)(2007-3#2)(2007-8#1)(2008-11#1)(2012-2#1)(2013-1#1)
on an underlying##3##3##(1997-4#1)(2006-10#1)(2010-11#1)
on an understanding of##3##4##(1996-12#1)(2008-10#1)(2009-9#1)
on an untreated##2##3##(2008-10#1)(2008-6#1)
on an unusual case of##3##5##(2007-4#1)(2010-6#1)(2013-1#1)
on an unusual##4##3##(2007-4#1)(2009-3#1)(2010-6#1)(2013-1#1)
on an##674##2##(1990-1#1)(1990-10#1)(1990-11#4)(1990-12#5)(1990-3#2)(1990-4#4)(1990-5#2)(1990-6#3)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#2)(1991-3#2)(1991-5#6)(1991-6#3)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#3)(1992-2#3)(1992-3#3)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#3)(1993-10#1)(1993-11#3)(1993-12#8)(1993-2#5)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#4)(1994-1#1)(1994-11#1)(1994-2#5)(1994-3#7)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#5)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-4#2)(1995-5#3)(1995-6#5)(1995-8#2)(1995-9#2)(1996-1#1)(1996-12#6)(1996-2#2)(1996-3#4)(1996-4#2)(1996-5#6)(1996-6#4)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#4)(1997-3#5)(1997-4#2)(1997-5#3)(1997-6#2)(1997-8#2)(2004-10#4)(2005-1#1)(2005-11#2)(2005-12#2)(2005-7#3)(2005-8#2)(2006-10#9)(2006-11#3)(2006-12#2)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#4)(2006-6#3)(2006-7#5)(2006-8#9)(2006-9#1)(2007-1#1)(2007-11#13)(2007-12#23)(2007-2#3)(2007-3#3)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#15)(2007-9#6)(2008-1#5)(2008-10#83)(2008-11#14)(2008-12#10)(2008-2#35)(2008-3#42)(2008-4#8)(2008-5#12)(2008-6#6)(2008-7#11)(2008-8#11)(2008-9#8)(2009-1#4)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#3)(2010-1#4)(2010-10#2)(2010-11#2)(2010-12#5)(2010-2#4)(2010-3#2)(2010-4#1)(2010-5#5)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#6)(2011-12#1)(2011-2#8)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#5)(2012-2#12)(2012-3#5)(2012-8#1)(2013-1#7)(2013-7#6)(2013-8#5)
on anaerobic##2##2##(2007-6#1)(2008-7#1)
on analgesia##2##2##(1990-2#1)(2006-10#1)
on analyses##4##2##(2008-10#2)(2008-8#1)(2009-9#1)
on analysis of the##4##4##(1992-3#1)(2010-8#1)(2011-2#2)
on analysis of##19##3##(1992-3#1)(1997-6#1)(2006-11#2)(2007-12#2)(2007-8#1)(2008-10#6)(2008-8#1)(2009-5#1)(2010-8#1)(2011-2#2)(2012-3#1)
on analysis##23##2##(1992-3#1)(1997-6#1)(2005-10#1)(2006-11#2)(2007-1#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-8#1)(2011-2#2)(2012-3#1)
on analytes##2##2##(2008-10#2)
on analytical applications of##2##4##(2007-8#1)(2007-9#1)
on analytical##7##2##(2007-8#2)(2007-9#1)(2008-10#4)
on analyzing the##2##3##(2011-2#2)
on analyzing##4##2##(2008-8#1)(2011-2#2)(2013-1#1)
on anatomic##3##2##(2007-7#2)(2009-6#1)
on anatomical and surgical aspects##2##5##(2009-8#1)(2012-12#1)
on anatomical##9##2##(1990-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-12#1)
on ancient human remains##2##4##(2013-1#2)
on ancient##4##2##(2008-10#1)(2012-2#1)(2013-1#2)
on ancillary##2##2##(2007-10#1)(2010-8#1)
on and off in##2##4##(1991-10#1)(1991-11#1)
on and off states##2##4##(2008-2#1)(2008-3#1)
on and off years##2##4##(2008-12#2)
on and off##17##3##(1991-10#1)(1991-11#1)(1995-6#1)(2007-11#2)(2007-12#1)(2008-12#2)(2008-2#3)(2008-3#3)(2008-8#1)(2008-9#1)(2011-1#1)
on and##54##2##(1990-10#1)(1990-12#1)(1990-5#1)(1991-10#1)(1991-11#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-1#1)(1994-2#2)(1995-1#1)(1995-6#1)(1995-8#1)(1997-3#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-6#1)(2006-7#1)(2007-11#4)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#5)(2008-5#2)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-11#1)(2013-1#3)(2013-8#1)
on androgen##4##2##(1996-11#1)(2006-9#2)(2010-1#1)
on angina pectoris##2##3##(1995-4#1)(2006-4#1)
on angiogenesis in##3##3##(2006-9#2)(2008-10#1)
on angiogenesis of##2##3##(2008-11#1)(2011-2#1)
on angiogenesis##9##2##(2006-9#4)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
on angiographic##3##2##(1997-8#1)(2007-7#1)(2007-8#1)
on angiography was##2##3##(2006-10#1)(2008-7#1)
on angiography##7##2##(2006-10#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-5#3)
on angiotensin II-stimulated##2##3##(1990-11#1)(1990-2#1)
on angiotensin##5##2##(1990-11#1)(1990-2#1)(1991-4#1)(2008-1#1)(2008-12#1)
on animal model of##2##4##(2008-12#1)(2012-2#1)
on animal model##3##3##(2008-12#1)(2008-8#1)(2012-2#1)
on animal models##3##3##(2006-6#1)(2009-2#1)(2009-3#1)
on animal welfare##3##3##(1992-2#2)(2013-8#1)
on animal##20##2##(1992-2#2)(1993-11#1)(1994-6#1)(2005-10#1)(2005-5#1)(2006-6#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#2)
on animals and##2##3##(2010-4#1)(2013-1#1)
on animals##10##2##(1994-6#2)(1994-7#1)(2007-3#1)(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#2)
on anionic##2##2##(2005-11#1)(2008-5#1)
on anisotropic##3##2##(2008-2#1)(2009-3#1)(2012-1#1)
on annual##4##2##(1997-1#1)(2007-7#1)(2008-10#1)(2008-4#1)
on another##9##2##(1991-5#1)(1994-6#1)(2004-12#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-12#1)(2011-2#1)
on antagonist##2##2##(1990-2#1)(2008-10#1)
on antenatal ultrasound##2##3##(2006-10#1)(2012-2#1)
on antenatal##5##2##(1994-9#1)(2006-10#1)(2009-9#1)(2010-9#1)(2012-2#1)
on anti-aging##2##2##(2008-5#1)(2009-12#1)
on anti-inflammatory activity##2##3##(2007-1#1)(2009-12#1)
on anti-inflammatory##4##2##(2007-1#1)(2009-12#1)(2010-3#1)(2010-9#1)
on antibacterial##2##2##(2008-12#1)(2010-1#1)
on antibiotic resistance##2##3##(2013-1#2)
on antibiotic therapy##2##3##(2010-12#1)(2012-2#1)
on antibiotic use##2##3##(1996-11#1)(2013-8#1)
on antibiotic##8##2##(1996-11#1)(2010-12#2)(2010-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
on antibody production##5##3##(1993-12#1)(1996-10#1)(2006-12#1)(2008-11#2)
on antibody##10##2##(1993-12#1)(1994-9#1)(1996-10#1)(2005-7#1)(2006-12#1)(2008-11#3)(2008-5#1)(2009-6#1)
on anticancer##2##2##(1991-8#1)(2013-1#1)
on anticoagulant therapy##2##3##(1993-10#1)(2010-7#1)
on anticoagulation##2##2##(2006-10#1)(2011-2#1)
on antifungal##2##2##(2008-5#1)(2009-9#1)
on antigen presentation##4##3##(1995-8#2)(2008-10#2)
on antigen##9##2##(1990-12#1)(1993-3#1)(1995-8#2)(2005-12#1)(2008-10#2)(2008-11#1)(2009-9#1)
on antigen-induced##3##2##(1991-12#1)(1992-3#1)(1997-7#1)
on antigen-presenting cells##2##3##(1996-4#1)(2007-11#1)
on antigenic##2##2##(1994-8#1)(2007-12#1)
on antihypertensive therapy##2##3##(2007-1#1)(2007-9#1)
on antihypertensive##3##2##(2007-1#1)(2007-9#1)(2010-12#1)
on antimicrobial susceptibility##2##3##(2007-7#1)(2009-5#1)
on antimicrobial##8##2##(2005-8#1)(2006-7#1)(2007-7#1)(2008-1#1)(2008-8#1)(2009-5#1)(2010-6#1)(2013-1#1)
on antiobesity drugs##2##3##(2004-12#2)
on antioxidant##5##2##(1994-6#1)(1997-6#1)(2008-4#1)(2011-1#1)(2011-2#1)
on antiretroviral therapy (ART)##3##4##(2011-1#1)(2011-2#1)(2012-12#1)
on antiretroviral therapy in##2##4##(2009-7#1)(2012-12#1)
on antiretroviral therapy##7##3##(2008-1#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#2)
on antiretroviral##11##2##(1991-8#1)(2007-8#1)(2008-1#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
on anxiety and depression##2##4##(2008-6#1)(2009-3#1)
on anxiety and##3##3##(2008-6#1)(2009-3#1)(2013-1#1)
on anxiety##8##2##(1991-2#1)(2008-12#1)(2008-6#1)(2009-12#1)(2009-3#1)(2012-2#2)(2013-1#1)
on any IBM compatible##2##4##(1993-9#1)(2008-10#1)
on any of the##8##4##(1991-3#1)(1993-1#1)(1993-3#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-12#1)(2012-2#1)
on any of##11##3##(1991-3#1)(1993-1#1)(1993-3#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2012-2#1)
on any##31##2##(1991-3#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-9#1)(1996-7#1)(1996-9#1)(2004-12#1)(2006-10#1)(2006-9#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
on aortic##5##2##(1990-7#1)(1994-12#1)(2007-9#1)(2009-12#1)(2011-2#1)
on aperture shape##2##3##(2008-3#2)
on apo##3##2##(1990-4#1)(1991-8#1)(1993-9#1)
on apoptosis in##2##3##(2005-10#1)(2008-10#1)
on apoptosis induction##2##3##(2008-8#1)(2009-3#1)
on apoptosis of pancreatic##2##4##(2010-12#1)(2012-3#1)
on apoptosis of##3##3##(1992-7#1)(2010-12#1)(2012-3#1)
on apoptosis##11##2##(1992-7#1)(1994-10#1)(2005-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#2)(2009-3#1)(2010-12#1)(2012-3#1)
on apoptotic cell death##2##4##(1996-12#1)(2008-8#1)
on apoptotic##5##2##(1996-12#1)(2008-11#2)(2008-8#1)(2011-1#1)
on apparent##3##2##(1991-2#1)(2008-12#1)(2012-2#1)
on appeal##3##2##(1991-3#1)(1997-5#2)
on appearance##5##2##(2007-12#3)(2008-10#1)(2009-9#1)
on apple leaves##2##3##(2008-10#2)
on apple##15##2##(2008-10#14)(2012-2#1)
on apples##7##2##(2008-10#7)
on application of##5##3##(2005-4#1)(2008-2#1)(2008-8#1)(2012-3#1)(2013-1#1)
on application##6##2##(2005-10#1)(2005-4#1)(2008-2#1)(2008-8#1)(2012-3#1)(2013-1#1)
on applications in##2##3##(2009-4#1)(2010-12#1)
on applications of##3##3##(2005-11#1)(2007-8#1)(2011-1#1)
on applications##6##2##(2005-10#1)(2005-11#1)(2007-8#1)(2009-4#1)(2010-12#1)(2011-1#1)
on applying a##2##3##(2008-5#1)(2009-11#1)
on applying##4##2##(2008-10#1)(2008-5#1)(2009-11#1)(2010-11#1)
on appressorium formation of##2##4##(2008-10#2)
on approaches that##2##3##(2008-9#1)(2010-7#1)
on appropriate##12##2##(1991-3#1)(1991-7#1)(1994-12#1)(1995-5#1)(2005-8#1)(2007-7#1)(2007-9#1)(2008-5#1)(2008-7#2)(2010-11#1)(2013-1#1)
on approved##3##2##(2011-1#1)(2013-1#2)
on approximately##2##2##(2008-10#1)(2009-4#1)
on apricot and##2##3##(2008-10#2)
on aquatic##3##2##(1993-9#1)(2007-7#2)
on aqueous and##2##3##(1994-6#1)(2006-4#1)
on aqueous##6##2##(1990-7#1)(1994-6#1)(2006-4#1)(2008-10#2)(2012-1#1)
on arachidonic acid metabolism##3##4##(1994-8#2)(1995-7#1)
on arachidonic acid##4##3##(1994-8#2)(1995-7#1)(2008-11#1)
on arbitrarily primed##2##3##(1996-2#1)(2008-10#1)
on arbitrary surfaces##3##3##(2008-6#3)
on arbitrary##5##2##(2008-3#1)(2008-6#3)(2010-2#1)
on archival##2##2##(2013-8#2)
on arctic##2##2##(1992-7#1)(1997-4#1)
on areas##6##2##(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#1)(2010-3#1)(2012-3#1)
on arm##2##2##(2009-1#1)(2012-1#1)
on armaments##3##2##(1990-2#2)(2013-1#1)
on arousal##2##2##(1993-7#1)(2013-7#1)
on array##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
on arrays##6##2##(2006-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-12#1)
on arrival in the##2##4##(2010-7#1)(2013-1#1)
on arrival to the##2##4##(2006-8#1)(2007-12#1)
on arrival##6##2##(2005-7#1)(2006-8#1)(2007-12#1)(2010-7#1)(2012-2#1)(2013-1#1)
on artemisinin##5##2##(1995-3#1)(2009-6#4)
on arterial##8##2##(1990-10#1)(1995-2#1)(1997-5#1)(2007-8#1)(2011-2#2)(2012-12#1)(2013-8#1)
on arthropods##2##2##(2007-12#1)(2011-2#1)
on articular cartilage##4##3##(2007-11#3)(2009-10#1)
on articular##5##2##(2007-11#3)(2007-7#1)(2009-10#1)
on artificial diet##2##3##(2004-2#2)
on artificial##10##2##(1991-5#1)(1991-8#1)(2004-2#3)(2006-5#1)(2007-8#1)(2008-5#1)(2011-2#1)(2012-2#1)
on as##3##2##(1992-3#1)(1994-2#1)(2008-10#1)
on ascospore release##3##3##(2008-10#3)
on ascospore##5##2##(2008-10#5)
on aspects of the##2##4##(1994-8#1)(1995-1#1)
on aspects of##9##3##(1993-1#1)(1994-8#1)(1995-1#1)(1996-1#1)(2004-10#1)(2006-10#1)(2007-2#1)(2009-6#1)(2011-2#1)
on aspects that##2##3##(2006-10#1)(2012-2#1)
on aspects##12##2##(1993-1#1)(1994-8#1)(1995-1#1)(1996-1#1)(2004-10#1)(2006-10#2)(2007-2#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-2#1)
on aspiration##2##2##(1990-2#1)(2011-1#1)
on aspirin##4##2##(2006-1#1)(2006-8#1)(2007-10#1)(2011-1#1)
on assay##2##2##(2008-10#1)(2009-6#1)
on assembly##3##2##(1995-8#1)(2013-8#2)
on assessing the##2##3##(2007-12#1)(2008-5#1)
on assessing##5##2##(2007-12#1)(2007-4#1)(2008-5#1)(2010-8#1)(2011-2#1)
on assessment and##3##3##(1994-11#1)(1996-1#1)(2006-10#1)
on assessment of##3##3##(2004-10#1)(2013-1#2)
on assessment##8##2##(1994-11#1)(1994-2#1)(1996-1#1)(2004-10#1)(2006-10#1)(2013-1#2)(2013-7#1)
on assessments##2##2##(2008-10#1)(2012-3#1)
on assisted##2##2##(2006-12#1)(2008-7#1)
on assisting the##2##3##(2007-12#1)(2012-2#1)
on assisting##3##2##(2007-12#1)(2010-9#1)(2012-2#1)
on associated##3##2##(1996-6#1)(1997-8#1)(2006-10#1)
on association##7##2##(1990-7#1)(1995-2#1)(2005-11#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
on associations between##5##3##(1993-7#1)(2005-7#1)(2007-1#1)(2012-1#2)
on assumptions about the##2##4##(1996-12#1)(2008-8#1)
on assumptions##3##2##(1996-12#1)(2008-10#1)(2008-8#1)
on asthma severity##2##3##(2005-8#2)
on asthma##10##2##(2005-8#3)(2007-3#1)(2008-10#2)(2010-9#1)(2012-12#2)(2013-1#1)
on astrocytes and##2##3##(1994-2#1)(2008-4#1)
on astrocytes##6##2##(1994-2#1)(1996-1#1)(2008-4#2)(2011-12#2)
on asymptomatic##2##2##(2008-10#1)(2009-5#1)
on asymptotic##2##2##(1993-4#1)(2007-12#1)
on asynchronous##2##2##(1994-8#1)(2008-2#1)
on at least one##2##4##(1993-1#1)(2013-8#1)
on at least two##2##4##(2006-7#1)(2008-10#1)
on at least##12##3##(1991-11#1)(1992-8#1)(1993-1#1)(1994-12#1)(1996-3#1)(2006-7#1)(2008-10#2)(2008-3#1)(2011-12#1)(2011-2#1)(2013-8#1)
on at the##3##3##(1992-8#1)(2006-7#1)(2007-8#1)
on at##15##2##(1991-11#1)(1992-8#2)(1993-1#1)(1994-12#1)(1996-3#1)(2006-7#2)(2007-8#1)(2008-10#2)(2008-3#1)(2011-12#1)(2011-2#1)(2013-8#1)
on at-risk##2##2##(2007-2#1)(2009-4#1)
on atherogenesis##2##2##(1991-7#1)(1995-2#1)
on atherogenic dyslipidaemia##2##3##(2012-2#2)
on atheromatous##2##2##(1995-4#1)(2010-4#1)
on atherosclerosis##5##2##(1993-9#1)(1994-9#1)(1996-3#1)(2010-1#1)(2012-2#1)
on athletic performance##3##3##(2012-3#2)(2013-1#1)
on atmospheric##8##2##(1997-5#1)(2008-11#2)(2008-2#3)(2008-5#1)(2011-2#1)
on atom probe microanalysis##2##4##(2012-2#2)
on atomic##4##2##(1990-7#1)(1995-2#1)(2005-4#1)(2010-4#1)
on atrial fibrillation##3##3##(2007-10#1)(2007-9#1)(2013-1#1)
on atrial##7##2##(1997-1#1)(2007-10#1)(2007-9#1)(2008-4#1)(2013-1#2)(2013-8#1)
on attachment##4##2##(1990-8#1)(2007-12#1)(2008-10#2)
on attainment of##2##3##(2008-3#1)(2012-5#1)
on attention##3##2##(1994-6#1)(2008-6#1)(2012-12#1)
on attitudes and##2##3##(2008-1#1)(2008-11#1)
on attitudes towards##2##3##(2007-12#1)(2011-2#1)
on attitudes##8##2##(1997-5#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-11#1)(2010-10#1)(2011-2#1)(2013-7#1)
on auditory##3##2##(1992-9#1)(2008-9#1)(2010-12#1)
on autocorrelation##4##2##(2006-10#1)(2008-1#1)(2008-10#1)(2008-3#1)
on autograft##2##2##(2007-8#1)(2009-3#1)
on autoimmune##3##2##(1996-10#1)(2007-11#1)(2011-2#1)
on autoimmunity##3##2##(2006-10#1)(2007-5#2)
on automated coagulation analysers##2##4##(2008-10#2)
on automated##8##2##(1991-5#1)(1993-5#1)(2008-10#2)(2008-9#1)(2010-2#1)(2013-1#2)
on autonomic##5##2##(2005-8#1)(2007-10#1)(2011-1#1)(2013-8#2)
on autonomy##3##2##(1995-2#1)(1996-2#1)(2008-9#1)
on autopsy##4##2##(2006-8#1)(2010-9#1)(2012-11#1)(2013-7#1)
on availability##2##2##(2007-11#1)(2008-1#1)
on available##10##2##(1996-12#1)(2007-11#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2011-3#1)
on average 0##3##3##(1996-2#1)(2008-7#1)(2012-2#1)
on average 10##2##3##(1990-5#1)(1992-1#1)
on average 25%##2##3##(2008-3#1)(2008-9#1)
on average 3##2##3##(2006-5#1)(2007-10#1)
on average 4##3##3##(1994-2#1)(2008-5#1)(2008-6#1)
on average a##2##3##(1996-10#1)(2008-11#1)
on average below 5##2##4##(2008-5#2)
on average between##2##3##(2008-10#1)(2008-5#1)
on average by##3##3##(2005-1#1)(2006-6#1)(2008-5#1)
on average for a##2##4##(1991-2#1)(2008-10#1)
on average for##7##3##(1991-2#1)(2005-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-6#1)(2011-2#1)
on average in##6##3##(1996-2#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-12#1)(2013-8#1)
on average of##2##3##(2006-7#1)(2010-3#1)
on average than##3##3##(1994-2#1)(2008-3#2)
on average two##2##3##(1991-8#1)(1994-9#1)
on average##175##2##(1990-5#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#3)(1992-1#2)(1992-12#1)(1992-2#1)(1992-6#2)(1994-1#1)(1994-2#5)(1994-3#1)(1994-9#1)(1995-12#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#2)(1996-2#2)(1996-3#4)(1996-4#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#2)(2004-1#1)(2005-1#1)(2005-12#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#2)(2007-2#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#9)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#7)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#2)(2009-7#1)(2009-8#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#10)(2012-12#9)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#5)
on average)##10##2##(1992-5#1)(1995-11#1)(1996-6#1)(1997-2#3)(2010-7#1)(2011-2#3)
on averaging the##2##3##(2008-10#1)(2008-3#1)
on aversive##2##2##(1990-2#1)(1993-12#1)
on avian##2##2##(2009-2#1)(2009-4#1)
on avoidance##2##2##(2007-12#1)(2008-6#1)
on awakening##2##2##(1992-10#1)(2007-11#1)
on awareness and##2##3##(2007-10#1)(2012-12#1)
on awareness##4##2##(2007-10#1)(2008-1#1)(2008-8#1)(2012-12#1)
on axial##2##2##(1991-11#1)(2012-2#1)
on axillary skin##4##3##(2008-5#4)
on axillary##6##2##(2008-5#5)(2009-8#1)
on axis##3##2##(2008-2#1)(2008-3#2)
on axons of##2##3##(2008-4#1)(2008-7#1)
on azathioprine##2##2##(2007-8#1)(2008-4#1)
on azoxymethane-induced##3##2##(1992-3#2)(1992-9#1)
on baccalaureate##2##2##(1991-1#1)(2012-3#1)
on back##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
on bacteria and##2##3##(2008-10#1)(2012-2#1)
on bacteria##6##2##(1997-2#2)(2007-11#1)(2007-3#1)(2008-10#1)(2012-2#1)
on bacterial growth##6##3##(1990-10#1)(2006-10#2)(2006-8#1)(2008-5#1)(2011-12#1)
on bacterial resistance##2##3##(2012-2#1)(2013-1#1)
on bacterial##26##2##(1990-10#1)(1993-8#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-2#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-8#2)(2010-1#1)(2011-12#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
on bacteriorhodopsin##4##2##(1995-6#1)(1997-3#1)(2007-12#1)(2008-2#1)
on baculovirus##2##2##(2013-8#2)
on baker's yeast##3##3##(2010-7#3)
on balance##4##2##(1990-9#1)(1996-7#2)(2005-3#1)
on balanced##3##2##(2007-11#1)(2008-2#1)(2012-12#1)
on banana##3##2##(2008-10#3)
on band 3 protein-mediated anion##2##5##(1997-1#2)
on band 3##4##3##(1994-5#2)(1997-1#2)
on band##9##2##(1992-7#1)(1994-5#2)(1997-1#2)(1997-8#1)(2007-11#1)(2008-10#1)(2008-3#1)
on bare##6##2##(1992-1#1)(2007-9#1)(2008-10#3)(2008-7#1)
on barium##2##2##(1993-9#1)(2008-8#1)
on barley and##2##3##(2008-10#2)
on barley##10##2##(2008-10#9)(2008-5#1)
on barrier function##3##3##(2008-5#3)
on barrier##4##2##(2008-5#3)(2008-7#1)
on barriers to##3##3##(2007-12#1)(2008-1#1)(2012-3#1)
on basal PGI2 release##2##4##(1995-11#2)
on basal and##6##3##(1990-3#1)(1990-8#1)(1991-2#1)(1992-7#1)(1994-12#2)
on basal##23##2##(1990-3#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-7#1)(1994-10#1)(1994-12#2)(1994-3#1)(1995-11#2)(1995-12#1)(1995-7#1)(1997-7#1)(2008-11#1)(2008-6#3)(2011-2#1)(2012-12#1)(2012-3#1)
on baseline##10##2##(1995-12#1)(2007-10#1)(2008-10#1)(2008-3#2)(2009-5#1)(2009-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
on basic and applied research##2##5##(2006-4#1)(2008-11#1)
on basic science and##2##4##(2007-12#1)(2009-3#1)
on basic science##4##3##(2007-12#1)(2008-6#1)(2009-3#1)(2011-2#1)
on basic##23##2##(1991-12#1)(1992-3#1)(1996-10#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-9#2)(2009-3#1)(2009-4#1)(2010-1#1)(2010-5#1)(2011-2#1)(2012-3#2)(2013-1#2)
on basidiomycete sources of##2##4##(2013-1#2)
on basis of##6##3##(1996-2#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-2#1)
on beach water E##2##4##(2010-2#2)
on beam##4##2##(2007-11#1)(2008-3#3)
on beamline##2##2##(2006-4#1)(2006-5#1)
on bean leaf##2##3##(2008-10#2)
on bean##10##2##(2008-10#8)(2008-8#2)
on beans##2##2##(2008-10#2)
on beating heart##3##3##(2007-8#1)(2007-9#1)(2012-3#1)
on beating hearts##2##3##(2006-6#2)
on beating##7##2##(2006-6#2)(2007-4#1)(2007-8#1)(2007-9#1)(2012-3#2)
on because##3##2##(2006-8#1)(2013-1#2)
on behalf of the National##2##5##(1995-6#1)(1997-7#1)
on behalf of the##8##4##(1991-2#1)(1994-1#1)(1995-6#1)(1996-6#1)(1997-7#1)(2006-7#1)(2011-1#1)(2013-8#1)
on behalf of their##4##4##(1992-1#1)(2005-7#1)(2008-11#1)(2008-12#1)
on behalf of##23##3##(1991-2#1)(1992-1#1)(1992-3#1)(1994-1#1)(1995-6#3)(1996-6#1)(1997-5#1)(1997-7#1)(2005-7#1)(2006-7#1)(2006-8#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
on behavior and##5##3##(1995-12#1)(2007-12#1)(2008-8#1)(2011-2#1)(2013-1#1)
on behavior of##2##3##(2008-10#1)(2011-2#1)
on behavior##19##2##(1995-12#5)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-9#1)(2011-2#3)(2012-2#1)(2013-1#1)
on behavioral and##5##3##(1991-5#1)(1993-2#1)(1994-2#1)(2005-10#1)(2008-1#1)
on behavioral sensitization to methamphetamine##2##5##(1993-3#2)
on behavioral##16##2##(1991-5#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-2#1)(1997-2#1)(2005-10#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-4#1)(2009-11#1)(2012-2#1)(2013-1#1)
on behaviour and##2##3##(1992-10#1)(1997-5#1)
on behaviour change##2##3##(2007-7#1)(2010-2#1)
on behaviour##11##2##(1992-10#1)(1995-12#1)(1997-5#1)(2007-7#1)(2008-12#1)(2008-5#1)(2009-6#2)(2010-2#1)(2010-3#1)(2012-12#1)
on behavioural##5##2##(1996-2#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-4#1)
on being##4##2##(1995-4#1)(2005-11#1)(2007-10#1)(2007-9#1)
on benchmarking##3##2##(1997-1#2)(2007-9#1)
on beneficial##2##2##(1991-9#1)(2011-12#1)
on benefits##3##2##(1997-5#1)(2013-8#2)
on benthic##2##2##(2007-3#1)(2012-1#1)
on benzodiazepines##3##2##(1991-12#2)(2010-1#1)
on best##2##2##(2008-4#1)(2011-2#1)
on beta##4##2##(1991-10#1)(1992-12#1)(2008-2#2)
on beta-cyclodextrin##2##2##(2008-10#2)
on beta-glucans##2##2##(1991-5#2)
on better understanding of##2##4##(2006-10#1)(2008-11#1)
on bias##2##2##(1997-3#1)(2008-2#1)
on bilayer##3##2##(1991-4#1)(1994-12#1)(1994-8#1)
on bilayers##2##2##(1991-5#1)(1992-9#1)
on bile##3##2##(1993-3#1)(2006-5#1)(2012-2#1)
on biliary##3##2##(2006-10#1)(2006-2#1)(2008-4#1)
on binary##3##2##(1997-7#1)(2008-4#1)(2008-7#1)
on binding of##8##3##(1993-6#1)(1994-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-4#1)(2008-10#1)(2009-7#1)
on binding properties##2##3##(1990-2#1)(1995-11#1)
on binding to the##2##4##(1992-3#1)(1995-10#1)
on binding##21##2##(1990-2#2)(1990-7#1)(1992-3#1)(1993-6#1)(1994-11#2)(1994-12#1)(1995-10#1)(1995-11#2)(1995-3#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-4#1)(2008-10#1)(2009-7#1)
on bioactive##2##2##(2008-7#1)(2011-1#1)
on bioactivity##3##2##(2004-9#1)(2009-7#1)(2010-12#1)
on biochemical and##3##3##(1997-7#1)(2009-8#1)(2012-3#1)
on biochemical indices of neuronal gene expression in Wistar albino rats##2##11##(2008-4#2)
on biochemical pathways##2##3##(2008-1#1)(2008-7#1)
on biochemical##17##2##(1994-12#1)(1995-1#1)(1997-1#1)(1997-7#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-4#2)(2008-7#2)(2009-8#1)(2011-2#1)(2012-3#2)
on biocontrol##3##2##(2008-10#3)
on biodegradable##3##2##(2008-5#1)(2012-11#2)
on biofilm formation##2##3##(2011-11#1)(2013-1#1)
on biofilm##3##2##(1995-12#1)(2011-11#1)(2013-1#1)
on biogeography##2##2##(2009-2#2)
on biologic##4##2##(1995-1#1)(2008-11#1)(2013-1#1)(2013-7#1)
on biological agents##3##3##(1992-12#3)
on biological and##2##3##(2010-8#1)(2011-2#1)
on biological control of fire blight##2##6##(2008-10#2)
on biological control of##7##4##(1994-3#1)(2008-10#6)
on biological control##8##3##(1994-3#1)(2008-10#6)(2011-2#1)
on biological mechanisms##3##3##(2008-7#1)(2009-5#1)(2013-1#1)
on biological systems and##4##4##(2008-4#1)(2011-2#3)
on biological systems##5##3##(1995-5#1)(2008-4#1)(2011-2#3)
on biological tissues##4##3##(1995-6#1)(2008-2#1)(2008-3#2)
on biological##50##2##(1990-12#1)(1991-11#1)(1992-12#3)(1994-3#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-4#1)(2005-6#1)(2006-9#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-7#2)(2008-8#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#2)(2010-8#1)(2011-12#1)(2011-2#7)(2012-2#2)(2012-3#1)(2013-1#1)
on biology##3##2##(2007-11#1)(2008-9#1)(2013-7#1)
on biomass##2##2##(2005-11#1)(2008-12#1)
on biomaterials##3##2##(2012-11#2)(2013-7#1)
on biomechanical##3##2##(1993-7#1)(2007-4#1)(2012-12#1)
on biomedical and##2##3##(1997-7#1)(2008-7#1)
on biomedical##9##2##(1997-7#1)(2008-12#1)(2008-7#3)(2009-11#1)(2012-12#1)(2013-1#2)
on biopsy##4##2##(2007-8#1)(2008-6#1)(2009-8#1)(2010-12#1)
on bioremediation##2##2##(2008-5#1)(2008-6#1)
on biosensors##2##2##(2008-10#2)
on biosynthesis of##2##3##(1991-3#1)(2005-11#1)
on biosynthesis##3##2##(1991-3#1)(1992-2#1)(2005-11#1)
on biotechnology##2##2##(1996-2#1)(2008-5#1)
on biotin transport##3##3##(1992-6#2)(2006-10#1)
on biphenyl##2##2##(2011-12#2)
on bird##2##2##(2008-5#1)(2008-8#1)
on birds##2##2##(2009-2#1)(2011-2#1)
on birth weight of the##2##5##(2011-1#2)
on birth weight##7##3##(1990-9#1)(2008-3#2)(2008-8#1)(2011-1#3)
on birth##14##2##(1990-4#1)(1990-9#1)(1991-6#1)(1997-6#1)(1997-7#2)(2008-3#2)(2008-8#1)(2011-1#3)(2012-12#2)
on births##2##2##(2006-8#1)(2012-12#1)
on bispectral index##2##3##(2012-12#2)
on bitumen##2##2##(2005-11#2)
on black##7##2##(1996-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#1)(2013-7#1)
on bladder##6##2##(1990-8#1)(1992-3#1)(1997-7#1)(2008-10#1)(2010-8#2)
on blocking##3##2##(2008-1#1)(2008-3#1)(2008-5#1)
on blood agar plates##3##4##(1996-11#2)(2006-8#1)
on blood agar##8##3##(1996-11#2)(2006-8#4)(2012-12#1)(2012-2#1)
on blood and##3##3##(1991-1#1)(2004-11#1)(2007-11#1)
on blood flow##3##3##(2007-12#1)(2008-12#2)
on blood gases##2##3##(2008-7#1)(2009-1#1)
on blood glucose levels##4##4##(1997-2#1)(2005-10#1)(2008-4#1)(2008-7#1)
on blood glucose##12##3##(1993-12#1)(1993-8#1)(1997-2#1)(2005-10#1)(2007-9#2)(2008-4#1)(2008-7#1)(2009-4#1)(2010-4#1)(2010-5#1)(2010-6#1)
on blood pressure (BP)##3##4##(2007-1#1)(2008-4#1)(2010-4#1)
on blood pressure and heart rate##4##6##(1991-2#1)(1993-4#2)(2005-11#1)
on blood pressure and heart##5##5##(1991-2#1)(1993-4#2)(1997-8#1)(2005-11#1)
on blood pressure and##14##4##(1991-2#1)(1991-6#1)(1992-4#1)(1993-4#2)(1995-11#1)(1997-8#1)(2005-11#1)(2007-10#1)(2008-7#3)(2012-12#2)
on blood pressure in##3##4##(2008-1#1)(2008-7#1)(2011-2#1)
on blood pressure##37##3##(1991-2#1)(1991-6#2)(1992-4#1)(1993-2#1)(1993-3#3)(1993-4#3)(1995-10#1)(1995-11#1)(1997-8#1)(2005-11#1)(2007-1#1)(2007-10#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#7)(2008-8#1)(2010-4#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
on blood samples from##4##4##(1992-6#1)(1994-6#1)(1995-3#1)(1996-7#1)
on blood samples##5##3##(1991-9#1)(1992-6#1)(1994-6#1)(1995-3#1)(1996-7#1)
on blood vessel##2##3##(1994-11#1)(2011-2#1)
on blood vessels##5##3##(1993-12#1)(1994-9#1)(1997-6#1)(2004-12#1)(2008-5#1)
on blood##113##2##(1990-12#2)(1990-2#1)(1991-1#1)(1991-2#1)(1991-6#2)(1991-9#2)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#3)(1993-8#1)(1993-9#1)(1994-11#2)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-11#2)(1996-12#2)(1996-3#1)(1996-7#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-8#1)(2004-11#1)(2004-12#1)(2005-10#2)(2005-11#1)(2005-12#1)(2006-2#1)(2006-6#2)(2006-8#4)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#2)(2008-12#2)(2008-4#3)(2008-5#1)(2008-7#10)(2008-8#1)(2009-1#1)(2009-4#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#2)(2011-2#3)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#5)
on blossoms##5##2##(2008-10#5)
on board UK##3##3##(2007-2#3)
on board in##2##3##(2007-2#1)(2007-7#1)
on board the##5##3##(2006-4#1)(2008-3#2)(2008-5#1)(2011-2#1)
on board##22##2##(1991-1#1)(2006-4#1)(2007-2#5)(2007-7#2)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#1)(2009-10#1)(2010-2#1)(2010-5#1)(2011-2#4)
on body balance##3##3##(2008-12#2)(2010-9#1)
on body composition and features of the metabolic syndrome##2##9##(2008-5#2)
on body composition and##5##4##(2006-6#1)(2008-5#3)(2012-3#1)
on body composition##10##3##(2004-11#1)(2006-6#1)(2008-5#5)(2008-7#1)(2010-8#1)(2012-3#1)
on body dissatisfaction and##2##4##(2007-12#2)
on body dissatisfaction##5##3##(2006-7#1)(2007-12#4)
on body growth and##2##4##(1995-1#1)(1997-5#1)
on body growth##3##3##(1995-1#2)(1997-5#1)
on body image and##7##4##(2007-12#5)(2008-3#1)(2011-1#1)
on body image is##2##4##(2007-12#2)
on body image##16##3##(2007-12#14)(2008-3#1)(2011-1#1)
on body mass index (BMI)##2##5##(2012-2#1)(2013-1#1)
on body mass index##5##4##(1991-10#1)(2009-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
on body mass##8##3##(1991-10#1)(2007-9#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
on body size##2##3##(2008-8#1)(2012-2#1)
on body temperature and##2##4##(1995-3#1)(2008-4#1)
on body temperature##5##3##(1990-5#1)(1995-3#1)(1997-5#1)(2007-10#1)(2008-4#1)
on body weight and##2##4##(2007-12#1)(2012-2#1)
on body weight or##2##4##(2008-6#1)(2012-2#1)
on body weight##8##3##(1997-1#1)(2007-12#1)(2008-5#1)(2008-6#1)(2009-2#1)(2012-1#1)(2012-2#2)
on body##75##2##(1990-5#1)(1991-1#2)(1991-10#1)(1995-1#2)(1995-3#1)(1997-1#1)(1997-5#2)(1997-7#1)(2004-11#1)(2006-2#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-12#21)(2007-4#2)(2007-6#2)(2007-9#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-1#2)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#1)
on bond##2##2##(1994-11#1)(2007-11#1)
on bone and##4##3##(2005-3#1)(2007-11#1)(2008-1#1)(2011-1#1)
on bone formation and##2##4##(1996-8#1)(2005-3#1)
on bone loss in##2##4##(1993-11#1)(2010-10#1)
on bone loss##3##3##(1993-11#1)(2010-10#1)(2011-1#1)
on bone marrow##8##3##(1991-10#2)(1993-3#1)(1997-8#1)(2007-2#1)(2010-10#1)(2012-12#2)
on bone mass##3##3##(2008-7#1)(2009-4#1)(2010-3#1)
on bone metabolism##5##3##(1990-7#1)(2006-8#1)(2007-7#1)(2008-7#2)
on bone mineral density (BMD)##2##5##(2011-2#2)
on bone mineral density and##4##5##(1995-11#1)(2006-10#2)(2008-11#1)
on bone mineral density in##2##5##(2005-10#1)(2012-2#1)
on bone mineral density##9##4##(1995-11#1)(2005-10#1)(2006-10#2)(2008-11#1)(2011-2#3)(2012-2#1)
on bone resorption in neonatal mouse calvaria##2##7##(1991-7#2)
on bone resorption in##4##4##(1991-7#2)(1993-6#1)(1995-3#1)
on bone samples##2##3##(2008-1#1)(2009-4#1)
on bone scan##2##3##(1991-11#1)(2007-3#1)
on bone tissue##2##3##(1995-9#1)(2007-8#1)
on bone tunnel surface##2##4##(2013-1#2)
on bone turnover##2##3##(1992-5#1)(2009-3#1)
on bone union processes##2##4##(2007-11#2)
on bone##83##2##(1990-7#1)(1991-10#2)(1991-11#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#2)(1992-5#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-3#1)(1995-11#1)(1995-3#1)(1995-9#2)(1996-8#2)(1997-1#1)(1997-6#1)(1997-7#3)(1997-8#1)(2004-9#2)(2005-10#1)(2005-3#2)(2005-7#1)(2006-10#4)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#3)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-11#1)(2008-12#1)(2008-7#4)(2009-3#2)(2009-4#4)(2009-7#1)(2010-10#3)(2010-3#1)(2011-1#2)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#1)
on boron-doped diamond##2##3##(2008-10#2)
on both RNA##2##3##(2008-4#1)(2013-8#1)
on both a##3##3##(1995-3#1)(2007-8#1)(2008-7#1)
on both alleles##2##3##(1994-9#1)(1995-1#1)
on both apertures##2##3##(2007-11#2)
on both blood##2##3##(1994-9#1)(2008-4#1)
on both columns##2##3##(2008-10#2)
on both crops##3##3##(2008-10#3)
on both cultivars##4##3##(2008-10#4)
on both eyes##2##3##(2011-2#1)(2012-2#1)
on both general##2##3##(1991-2#1)(2012-2#1)
on both host##2##3##(2008-10#1)(2008-8#1)
on both hosts##3##3##(2008-10#3)
on both human##2##3##(2007-5#1)(2012-2#1)
on both legs##2##3##(2005-11#1)(2007-7#1)
on both of these##6##4##(1991-12#1)(1996-11#1)(1996-7#1)(2008-11#1)(2011-2#1)(2012-2#1)
on both of##7##3##(1991-12#1)(1996-11#1)(1996-7#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
on both patient##2##3##(2006-9#1)(2012-2#1)
on both patients and##2##4##(2007-11#1)(2008-8#1)
on both patients##3##3##(2007-11#1)(2008-8#1)(2013-1#1)
on both side of##2##4##(2008-11#1)(2012-2#1)
on both sides and##2##4##(1996-2#1)(2012-2#1)
on both sides of the Atlantic##2##6##(1991-8#1)(2007-9#1)
on both sides of the filter##2##6##(2008-2#2)
on both sides of the membrane##2##6##(1990-11#1)(1995-6#1)
on both sides of the pelvis##3##6##(2011-2#3)
on both sides of the spinal cord##2##7##(1995-11#1)(1995-7#1)
on both sides of the##28##5##(1990-11#1)(1990-2#1)(1991-8#1)(1994-12#1)(1995-11#1)(1995-6#1)(1995-7#1)(1995-8#1)(2005-11#1)(2006-11#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#4)(2012-1#1)(2012-12#2)(2013-7#1)
on both sides##47##3##(1990-11#1)(1990-2#1)(1991-8#1)(1993-12#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-2#1)(2005-11#1)(2006-11#2)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-1#1)(2009-6#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
on both simulated and##2##4##(2006-10#1)(2008-10#1)
on both strands of##2##4##(1991-7#1)(1995-7#1)
on both strands##4##3##(1991-7#1)(1995-7#2)(2009-3#1)
on both surfaces##3##3##(2007-12#1)(2010-10#1)(2013-7#1)
on both synthetic and real data##2##6##(2008-2#1)(2013-1#1)
on both synthetic##3##3##(2008-2#1)(2008-5#1)(2013-1#1)
on both the rate of##2##5##(1996-9#1)(2008-10#1)
on both the relative##2##4##(1995-5#1)(2008-8#1)
on both the##83##3##(1990-11#1)(1990-12#2)(1990-3#1)(1990-7#1)(1990-8#1)(1991-10#2)(1991-2#2)(1992-4#1)(1994-10#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-5#2)(1996-9#1)(1997-2#2)(1997-4#1)(1997-8#1)(2005-11#4)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#2)(2007-1#1)(2007-11#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-4#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#1)
on both types of##3##4##(1990-12#1)(1997-5#1)(2013-1#1)
on both types##4##3##(1990-12#1)(1997-5#1)(2008-9#1)(2013-1#1)
on both##415##2##(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#2)(1990-8#2)(1991-10#3)(1991-12#2)(1991-2#5)(1991-3#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-7#2)(1993-12#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#4)(1995-11#3)(1995-12#4)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#3)(1995-7#3)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#4)(1996-2#1)(1996-4#1)(1996-5#2)(1996-7#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-11#10)(2005-7#2)(2005-8#2)(2006-10#5)(2006-11#4)(2006-12#4)(2006-2#1)(2006-5#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#2)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#5)(2007-9#3)(2008-1#5)(2008-10#63)(2008-11#9)(2008-2#13)(2008-3#10)(2008-4#7)(2008-5#12)(2008-6#2)(2008-7#10)(2008-8#9)(2008-9#6)(2009-1#1)(2009-10#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#3)(2009-6#1)(2009-9#3)(2010-10#2)(2010-12#3)(2010-2#3)(2010-3#2)(2010-4#4)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#1)(2011-2#12)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#8)(2012-2#11)(2012-3#3)(2012-6#1)(2013-1#8)(2013-7#3)(2013-8#3)
on bovine adrenal##2##3##(1994-5#1)(1994-8#1)
on bovine brain capillary##2##4##(1991-4#2)
on bovine serum albumin##2##4##(2008-10#1)(2013-8#1)
on bovine##14##2##(1991-4#2)(1992-11#2)(1992-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1997-8#1)(2005-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-8#1)
on bradykinin- and platelet-activating##2##4##(1992-3#2)
on brain development##2##3##(1996-3#1)(1996-4#1)
on brain function##4##3##(2007-11#1)(2008-10#3)
on brain imaging##3##3##(2007-10#1)(2009-6#1)(2010-9#1)
on brain metabolism##2##3##(1994-2#1)(2012-12#1)
on brain size##2##3##(2008-3#1)(2012-3#1)
on brain stem##2##3##(1993-5#1)(2011-2#1)
on brain##68##2##(1991-9#1)(1992-2#2)(1993-2#1)(1993-4#1)(1993-5#1)(1994-10#1)(1994-2#4)(1994-3#1)(1994-5#1)(1994-8#2)(1995-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-9#2)(1997-7#1)(2005-8#1)(2006-10#2)(2006-4#1)(2007-10#3)(2007-11#3)(2007-12#2)(2007-9#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#2)
on branches of##2##3##(2004-11#1)(2008-10#1)
on branches##5##2##(2004-11#3)(2008-10#1)(2010-10#1)
on breast cancer cell##3##4##(1992-9#1)(1994-12#1)(2012-3#1)
on breast cancer##14##3##(1990-6#1)(1992-9#1)(1993-6#1)(1994-12#1)(1996-4#1)(2007-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
on breast##20##2##(1990-6#2)(1992-4#1)(1992-9#1)(1993-6#1)(1994-12#1)(1996-4#1)(2004-1#1)(2004-2#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
on breastfeeding and##2##3##(2006-9#1)(2008-6#1)
on breastfeeding##7##2##(2006-9#1)(2007-2#2)(2008-11#1)(2008-6#1)(2009-4#1)(2012-2#1)
on breath hydrogen excretion##2##4##(1996-6#2)
on breeding##3##2##(1992-10#1)(2008-8#1)(2008-9#1)
on brief##2##2##(1996-5#1)(2012-1#1)
on bringing##2##2##(2008-10#1)(2010-12#1)
on broader indications than##2##4##(1993-6#2)
on broader##4##2##(1993-6#2)(1997-2#1)(2008-2#1)
on broiler##2##2##(1995-9#1)(1997-3#1)
on bronchial##2##2##(1990-5#1)(2008-10#1)
on bronchoalveolar lavage##2##3##(1991-12#1)(2013-1#1)
on bud break were##2##4##(2012-4#2)
on bud break##3##3##(2012-4#3)
on budget##2##2##(1991-1#1)(2011-2#1)
on building materials##2##3##(2008-10#2)
on building##11##2##(2006-10#1)(2007-9#1)(2008-10#3)(2009-5#1)(2010-2#1)(2012-3#1)(2013-1#3)
on bulk metals##2##3##(2008-7#2)
on bulk##6##2##(2007-12#1)(2007-7#1)(2008-2#1)(2008-7#2)(2013-8#1)
on burnout in##2##3##(1991-3#1)(2009-7#1)
on burnout##3##2##(1991-3#1)(2009-5#1)(2009-7#1)
on business##2##2##(1996-2#1)(1997-2#1)
on by VATS##2##3##(2008-10#2)
on by a##2##3##(1996-8#1)(2012-2#1)
on by the##5##3##(1991-3#1)(1996-5#1)(1996-8#1)(2006-12#1)(2009-4#1)
on by##22##2##(1990-11#1)(1990-12#1)(1991-3#1)(1991-4#1)(1992-3#1)(1993-3#1)(1995-2#1)(1996-3#1)(1996-5#1)(1996-8#2)(2006-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
on bypass##2##2##(2005-12#1)(2007-8#1)
on c-fos##3##2##(1991-11#1)(1994-10#1)(1994-11#1)
on c-myc##4##2##(1992-1#2)(1992-3#1)(1997-2#1)
on cAMP levels##2##3##(1992-4#1)(1993-3#1)
on cAMP production##3##3##(1993-3#1)(1994-11#2)
on cAMP##8##2##(1992-4#1)(1993-3#2)(1994-11#3)(1994-12#1)(1995-10#1)
on cDNA##3##2##(1992-11#1)(2007-6#1)(2008-4#1)
on cacao##3##2##(2008-10#1)(2011-12#2)
on cadaver##4##2##(2007-11#1)(2008-3#1)(2012-2#2)
on cadaveric##4##2##(2006-11#1)(2007-4#1)(2009-4#1)(2011-2#1)
on cadmium toxicity##3##3##(1993-12#2)(2008-7#1)
on cadmium##7##2##(1993-12#3)(1996-7#1)(2008-10#1)(2008-7#2)
on calcareous##2##2##(2012-6#1)(2012-9#1)
on calcineurin##2##2##(2008-1#1)(2008-9#1)
on calcitonin gene-related##3##3##(1990-7#1)(2012-3#2)
on calcium and##2##3##(1995-7#1)(1996-3#1)
on calcium binding##2##3##(1991-1#1)(1995-11#1)
on calcium channel##2##3##(1992-12#1)(1995-2#1)
on calcium influx##2##3##(1995-10#1)(1996-11#1)
on calcium phosphate##2##3##(2008-5#1)(2012-1#1)
on calcium##26##2##(1991-1#1)(1991-2#1)(1992-12#1)(1992-9#1)(1993-11#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-7#2)(1996-11#1)(1996-3#1)(1996-8#3)(1997-5#1)(1997-7#2)(2005-3#1)(2007-9#1)(2008-5#2)(2012-1#1)(2012-3#1)
on calcium-dependent##2##2##(1990-7#1)(1994-3#1)
on calculated##4##2##(1992-9#1)(2007-11#1)(2008-10#1)(2008-9#1)
on calculating##2##2##(2008-2#2)
on calibrated##2##2##(1990-2#1)(2008-3#1)
on calibration##7##2##(1992-6#1)(2008-10#2)(2008-12#1)(2008-2#1)(2010-11#1)(2011-2#1)
on call in##2##3##(2008-8#2)
on call##3##2##(2007-7#1)(2008-8#2)
on calli##2##2##(2007-1#2)
on calmodulin##2##2##(1992-3#1)(1992-7#1)
on calpain##2##2##(1994-9#1)(2004-12#1)
on cancer cell lines##2##4##(2007-11#1)(2011-1#1)
on cancer cell##4##3##(2007-11#1)(2008-1#2)(2011-1#1)
on cancer cells and##2##4##(2008-11#1)(2009-3#1)
on cancer cells##6##3##(1994-2#1)(2008-11#1)(2008-5#1)(2009-12#1)(2009-3#1)(2013-8#1)
on cancer chemotherapy##2##3##(1990-9#1)(2007-12#1)
on cancer growth##2##3##(1992-9#1)(2008-1#1)
on cancer incidence in##2##4##(2011-2#2)
on cancer incidence##4##3##(1997-3#1)(2011-2#3)
on cancer research##3##3##(1990-2#1)(2009-4#1)(2010-9#1)
on cancer risk##3##3##(2011-2#1)(2012-2#1)(2012-6#1)
on cancer vaccines##2##3##(2006-10#1)(2010-5#1)
on cancer##50##2##(1990-2#1)(1990-8#1)(1990-9#1)(1992-3#1)(1992-8#1)(1992-9#1)(1994-2#1)(1997-2#1)(1997-3#1)(1997-5#2)(2006-10#1)(2006-11#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-1#5)(2008-11#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-3#4)(2009-4#1)(2010-1#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-6#1)(2013-8#1)
on cancers##2##2##(1990-8#1)(2009-10#1)
on canine rabies##2##3##(2011-2#2)
on canine##9##2##(1990-11#1)(1996-12#2)(1997-5#1)(2008-12#2)(2011-2#2)(2012-12#1)
on cannabis use##3##3##(2008-1#1)(2013-1#2)
on cannabis##6##2##(2008-1#1)(2008-12#1)(2009-6#1)(2013-1#3)
on canola##3##2##(2008-10#2)(2011-2#1)
on cantaloupe##2##2##(2008-10#2)
on capacity##4##2##(2007-2#1)(2008-10#1)(2008-12#1)(2012-12#1)
on capillary##11##2##(1991-7#1)(1996-11#1)(1996-5#1)(2006-10#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)
on capsular##2##2##(2010-4#1)(2013-1#1)
on capsules extended##3##3##(1997-3#3)
on capsules##4##2##(1997-3#4)
on captopril##2##2##(2004-12#1)(2007-7#1)
on capture##2##2##(2008-5#1)(2011-12#1)
on carbachol-stimulated inositol##2##3##(1996-6#1)(1997-1#1)
on carbachol-stimulated##5##2##(1990-10#1)(1994-10#1)(1996-6#1)(1997-1#2)
on carbamazepine##2##2##(1993-11#1)(2007-11#1)
on carbohydrate##4##2##(1991-12#1)(1996-9#1)(2009-10#1)(2012-2#1)
on carbon and##2##3##(2008-10#1)(2011-12#1)
on carbon fibers##3##3##(2005-11#2)(2008-10#1)
on carbon film electrodes##2##4##(2008-10#2)
on carbon nanotubes##5##3##(2007-8#1)(2007-9#1)(2008-7#1)(2010-7#1)(2011-2#1)
on carbon paste##4##3##(2007-2#1)(2008-10#3)
on carbon##31##2##(1994-9#1)(1995-5#1)(1997-6#2)(2005-11#2)(2006-6#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#12)(2008-7#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-1#1)
on carcass and meat quality##2##5##(2010-4#1)(2012-2#1)
on carcass traits and fatty acid compositions in Japanese Black cattle##2##11##(2010-2#2)
on carcass##6##2##(2010-2#2)(2010-4#2)(2012-2#2)
on carcinogenesis in various organs##2##5##(1992-9#2)
on carcinogenesis##3##2##(1992-9#2)(2012-1#1)
on cardenolide accumulation in##2##4##(2007-1#2)
on cardiac function and##2##4##(2011-2#2)
on cardiac function##6##3##(1996-10#1)(2006-9#3)(2011-2#2)
on cardiac myocytes##3##3##(1992-3#1)(2005-12#1)(2008-8#1)
on cardiac performance##2##3##(1993-12#1)(2008-10#1)
on cardiac##32##2##(1991-2#1)(1991-6#1)(1992-3#2)(1993-12#2)(1994-5#1)(1995-9#1)(1996-10#1)(1996-6#1)(2005-12#1)(2006-10#2)(2006-9#3)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-4#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
on cardiocytes impaired by##2##4##(2011-3#2)
on cardiometabolic##2##2##(2010-5#1)(2012-12#1)
on cardiomyocytes##4##2##(2009-2#2)(2012-12#1)(2013-8#1)
on cardiopulmonary bypass##9##3##(2006-10#1)(2007-8#6)(2008-4#1)(2012-2#1)
on cardiorespiratory fitness in pregnant women##3##6##(2012-11#3)
on cardiorespiratory fitness##4##3##(2008-3#1)(2012-11#3)
on cardiovascular disease##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2009-9#1)
on cardiovascular diseases##2##3##(2006-7#1)(2011-2#1)
on cardiovascular function##2##3##(2009-6#1)(2013-1#1)
on cardiovascular morbidity and mortality##2##5##(2008-7#2)
on cardiovascular outcomes##3##3##(2008-3#1)(2010-4#1)(2011-2#1)
on cardiovascular risk factors##3##4##(2005-10#1)(2006-10#1)(2007-10#1)
on cardiovascular risk##7##3##(1995-9#1)(2005-10#1)(2006-10#1)(2007-10#1)(2008-3#1)(2010-8#1)(2011-2#1)
on cardiovascular system##2##3##(2013-1#2)
on cardiovascular##35##2##(1995-9#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-7#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-3#4)(2008-7#3)(2008-8#1)(2009-2#1)(2009-6#1)(2009-9#2)(2010-1#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
on care of##2##3##(1995-2#1)(2005-1#1)
on care provided##2##3##(2008-8#1)(2012-3#1)
on care##12##2##(1991-10#1)(1992-1#1)(1995-2#1)(1997-1#1)(2005-1#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-9#1)(2012-3#3)
on careful##3##2##(1994-12#1)(1994-6#1)(2012-3#1)
on caregivers##3##2##(1995-2#1)(2006-12#1)(2008-6#1)
on caring for the##2##4##(2007-2#1)(2012-12#1)
on caring for##3##3##(1992-3#1)(2007-2#1)(2012-12#1)
on caring##5##2##(1992-3#1)(2007-2#1)(2009-5#1)(2012-12#1)(2012-3#1)
on carnation##4##2##(2008-10#4)
on carnitine palmitoyltransferase##2##3##(1991-6#1)(1991-7#1)
on carnitine##4##2##(1991-6#1)(1991-7#1)(1994-9#2)
on carotid body##2##3##(1990-7#1)(1994-6#1)
on carotid##4##2##(1990-7#1)(1994-6#1)(2006-11#1)(2008-11#1)
on carpogenic germination##2##3##(2007-7#1)(2008-10#1)
on carrier-envelope phase##2##3##(2007-11#2)
on carrot##3##2##(2008-10#3)
on cartilage##2##2##(2008-5#1)(2011-2#1)
on case management##2##3##(1997-2#1)(2012-2#1)
on case reports##2##3##(2008-6#1)(2011-2#1)
on case studies##2##3##(1996-3#1)(2006-5#1)
on case##10##2##(1990-9#1)(1996-3#1)(1997-2#1)(1997-3#2)(2006-5#1)(2007-11#1)(2008-6#1)(2011-2#1)(2012-2#1)
on cases of##2##3##(1993-8#1)(2011-2#1)
on cases with##2##3##(2013-1#1)(2013-7#1)
on cases##6##2##(1993-12#1)(1993-8#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
on cash##3##2##(1993-3#1)(2007-1#1)(2008-9#1)
on cassava##3##2##(1991-12#1)(2008-10#2)
on castor##3##2##(2005-11#1)(2008-12#1)(2008-6#1)
on cat##2##2##(1993-5#1)(1997-2#1)
on catalyst##2##2##(2009-3#1)(2012-1#1)
on catalytic##3##2##(1994-3#1)(2005-4#1)(2008-10#1)
on catecholamine##2##2##(1991-12#1)(1992-8#1)
on catheter##3##2##(2007-7#1)(2010-9#1)(2011-2#1)
on cation-exchange##2##2##(1992-2#1)(2008-10#1)
on cationic##5##2##(2005-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)
on cats##2##2##(1990-2#1)(1993-8#1)
on caudate##2##2##(1996-5#1)(2008-7#1)
on cauliflower plants##2##3##(2008-10#1)(2011-2#1)
on cauliflower##6##2##(2008-10#5)(2011-2#1)
on causes of##2##3##(1990-8#1)(2007-2#1)
on celery##2##2##(2008-10#2)
on cell adhesion##3##3##(1991-5#1)(1997-7#1)(2012-12#1)
on cell attachment and##2##4##(2008-5#1)(2009-12#1)
on cell attachment##3##3##(1990-2#1)(2008-5#1)(2009-12#1)
on cell biology##2##3##(2007-8#1)(2009-4#1)
on cell culture##4##3##(2008-11#2)(2009-5#1)(2013-1#1)
on cell cycle and##2##4##(2010-12#1)(2011-2#1)
on cell cycle progression##5##4##(1994-11#1)(1994-8#1)(1996-3#1)(2008-9#1)(2012-2#1)
on cell cycle##10##3##(1994-11#1)(1994-2#1)(1994-8#1)(1996-3#1)(2008-11#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
on cell death##5##3##(1992-12#1)(1993-7#1)(2008-1#1)(2011-1#1)(2011-2#1)
on cell differentiation##2##3##(1995-1#1)(2006-10#1)
on cell division were##2##4##(1992-9#1)(2009-8#1)
on cell division##3##3##(1992-9#1)(2008-1#1)(2009-8#1)
on cell growth and proliferation##3##5##(1995-6#1)(2012-11#2)
on cell growth and##11##4##(1993-12#1)(1994-4#1)(1994-8#1)(1995-6#1)(1996-2#1)(2008-11#2)(2011-2#2)(2012-11#2)
on cell growth in##3##4##(1994-12#1)(2008-11#1)(2010-8#1)
on cell growth inhibition##3##4##(1990-8#2)(2008-4#1)
on cell growth of##2##4##(2008-11#2)
on cell growth##33##3##(1990-5#1)(1990-8#2)(1993-12#1)(1994-11#1)(1994-12#1)(1994-4#1)(1994-8#1)(1995-2#1)(1995-6#2)(1996-2#1)(2008-11#11)(2008-4#2)(2008-7#1)(2010-8#3)(2011-2#2)(2012-11#2)
on cell membranes##4##3##(1990-12#1)(1991-9#1)(1993-2#1)(2008-8#1)
on cell morphology##3##3##(1990-3#1)(2007-11#1)(2008-11#1)
on cell proliferation and##7##4##(1990-9#1)(1992-8#1)(1993-7#1)(1994-2#1)(1995-11#1)(1997-7#1)(2010-12#1)
on cell proliferation were studied in human breast cancer cells##2##10##(2008-11#2)
on cell proliferation were##4##4##(2008-11#4)
on cell proliferation whereas##2##4##(1991-9#1)(1992-1#1)
on cell proliferation##25##3##(1990-11#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-7#1)(1992-8#1)(1993-7#1)(1994-2#1)(1995-11#1)(1995-2#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-11#6)(2010-12#1)(2012-2#1)
on cell recognition##2##3##(1996-5#2)
on cell surface##7##3##(1991-2#1)(1994-2#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-1#1)
on cell surfaces##10##3##(1990-12#1)(1991-5#1)(1991-9#2)(1995-5#1)(2006-12#1)(2008-4#1)(2008-8#1)(2011-12#1)(2012-11#1)
on cell survival##3##3##(1994-2#1)(1996-4#1)(2008-11#1)
on cell type and##2##4##(2009-3#1)(2012-12#1)
on cell type##3##3##(2009-3#1)(2009-8#1)(2012-12#1)
on cell viability and##4##4##(1994-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
on cell viability##8##3##(1994-3#1)(1995-10#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-12#1)(2011-2#1)(2012-2#1)
on cell wall##2##3##(2008-5#2)
on cell walls##2##3##(2008-1#1)(2008-2#1)
on cell##174##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#3)(1991-8#1)(1991-9#4)(1992-1#1)(1992-12#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-7#2)(1994-11#2)(1994-12#1)(1994-2#4)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#2)(1995-7#1)(1996-1#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#3)(2006-10#2)(2006-12#1)(2007-11#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#29)(2008-2#1)(2008-4#3)(2008-5#6)(2008-7#4)(2008-8#3)(2008-9#3)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-12#3)(2010-2#1)(2010-8#4)(2011-1#2)(2011-12#3)(2011-2#6)(2012-11#3)(2012-12#2)(2012-2#3)(2013-1#2)(2013-7#1)
on cell-mediated immunity##2##3##(2007-2#1)(2008-10#1)
on cells from##5##3##(1990-7#1)(1992-1#1)(1994-3#1)(2007-11#1)(2008-8#1)
on cells grown##2##3##(1991-4#1)(1995-5#1)
on cells in##4##3##(1992-2#1)(1992-8#1)(1994-10#1)(2008-11#1)
on cells of the human##2##5##(1996-2#1)(2011-2#1)
on cells of the immune system##3##6##(1991-1#1)(2010-12#1)(2012-2#1)
on cells of the##9##4##(1991-1#1)(1993-7#2)(1994-2#1)(1996-2#1)(2006-10#1)(2010-12#1)(2011-2#1)(2012-2#1)
on cells of##11##3##(1991-1#1)(1993-7#2)(1994-2#1)(1996-2#1)(2006-10#1)(2008-1#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
on cells##36##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-3#1)(1991-4#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-7#2)(1993-9#1)(1994-10#1)(1994-2#1)(1994-3#1)(1995-12#2)(1995-5#1)(1996-11#1)(1996-2#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-8#2)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
on cellular and humoral immunity##2##5##(2006-10#1)(2008-10#1)
on cellular and##3##3##(2006-10#2)(2008-10#1)
on cellular calcium##2##3##(1991-12#1)(1995-5#1)
on cellular expression##2##3##(1993-9#1)(1995-12#1)
on cellular growth##3##3##(1994-11#1)(1995-8#1)(1996-5#1)
on cellular immune##2##3##(1993-9#1)(2007-11#1)
on cellular metabolism##3##3##(1990-8#1)(2007-2#1)(2008-4#1)
on cellular processes##2##3##(2010-7#1)(2011-2#1)
on cellular proliferation##6##3##(1991-9#1)(2008-11#2)(2008-7#1)(2013-7#2)
on cellular radiation##2##3##(2008-9#2)
on cellular##51##2##(1990-8#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-9#2)(1992-5#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-8#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#3)(2006-10#2)(2007-11#2)(2007-2#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2013-7#2)
on cellulose nitrate##2##3##(1992-6#1)(2008-10#1)
on cellulose via##2##3##(2008-10#2)
on cellulose##10##2##(1991-12#1)(1992-6#1)(1996-11#1)(2006-3#1)(2008-10#5)(2008-5#1)
on cement##2##2##(2004-9#2)
on centenarians##2##2##(1996-3#1)(2008-7#1)
on central nervous system##6##4##(1991-10#1)(1992-6#1)(1997-5#1)(2006-10#1)(2011-2#1)(2011-3#1)
on central##13##2##(1991-10#1)(1992-6#1)(1992-9#1)(1994-11#1)(1997-5#1)(2006-10#1)(2007-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
on centroids##2##2##(2008-10#1)(2008-3#1)
on ceramic##3##2##(1997-4#1)(2006-4#1)(2008-10#1)
on cerebellar##5##2##(1995-5#1)(1995-7#1)(1996-5#1)(2007-10#1)(2012-2#1)
on cerebral blood flow in##2##5##(2007-10#2)
on cerebral blood flow##7##4##(2007-10#5)(2007-8#1)(2008-7#1)
on cerebral hemodynamics in##3##4##(1996-12#2)(2006-6#1)
on cerebral metabolic##2##3##(1991-1#2)
on cerebral metabolism##3##3##(1991-5#1)(1994-2#1)(1997-7#1)
on cerebral##33##2##(1990-5#1)(1991-1#2)(1991-5#1)(1993-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1996-10#1)(1996-12#2)(1996-9#1)(1997-7#1)(2005-10#1)(2006-4#1)(2006-6#1)(2007-10#7)(2007-8#3)(2007-9#2)(2008-7#2)(2009-1#1)(2012-3#1)(2013-1#1)
on certain##21##2##(1990-12#1)(1990-4#1)(1994-8#1)(1995-2#1)(1996-10#1)(1997-8#1)(2005-11#1)(2006-12#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#2)(2010-11#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
on cervical cancer##2##3##(1992-10#1)(2011-1#1)
on cervical##10##2##(1992-10#2)(2006-10#2)(2007-1#1)(2008-12#1)(2008-7#1)(2009-5#1)(2011-1#1)(2012-12#1)
on cesium##2##2##(1993-8#1)(1994-8#1)
on chain##2##2##(1993-1#1)(2009-10#1)
on change in##5##3##(1995-11#1)(2009-7#1)(2010-10#1)(2013-7#1)(2013-8#1)
on change##6##2##(1995-11#1)(2009-7#1)(2010-1#1)(2010-10#1)(2013-7#1)(2013-8#1)
on changes in cell##2##4##(1994-11#1)(2012-2#1)
on changes in the##6##4##(1996-12#1)(1997-6#1)(2006-10#1)(2006-7#1)(2007-11#1)(2012-2#1)
on changes in##24##3##(1991-11#1)(1992-1#1)(1992-7#1)(1993-11#1)(1994-11#1)(1994-12#1)(1996-12#2)(1997-6#1)(1997-8#1)(2005-11#2)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-3#1)(2008-8#1)(2010-10#2)(2011-1#1)(2012-2#2)(2013-8#1)
on changes of##8##3##(1997-6#2)(2008-10#1)(2008-12#1)(2009-9#1)(2011-2#1)(2012-3#2)
on changes##33##2##(1991-11#1)(1992-1#1)(1992-7#1)(1993-11#1)(1994-11#1)(1994-12#1)(1996-12#2)(1997-6#3)(1997-8#1)(2005-11#2)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-9#1)(2010-10#2)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-8#1)
on changing##3##2##(1990-5#1)(1995-6#1)(2007-11#1)
on channel activity##2##3##(2008-8#2)
on channel##7##2##(1995-5#1)(1996-10#1)(2007-9#1)(2008-3#1)(2008-8#3)
on chaotic##2##2##(2007-12#1)(2008-2#1)
on characteristic##2##2##(2008-11#1)(2011-2#1)
on characteristics of##4##3##(2008-7#1)(2009-12#1)(2009-7#1)(2012-3#1)
on characteristics##6##2##(2008-11#1)(2008-7#1)(2009-12#1)(2009-7#1)(2012-3#2)
on characterization of##2##3##(1991-8#1)(2010-12#1)
on characterization##4##2##(1991-8#1)(2007-7#1)(2008-1#1)(2010-12#1)
on characterizing##2##2##(1992-1#1)(2008-10#1)
on charge##3##2##(2006-4#1)(2008-10#2)
on charity##2##2##(1992-3#1)(1995-2#1)
on chemical analysis##3##3##(1994-5#1)(2008-10#1)(2010-12#1)
on chemical constituents of##4##4##(2012-3#2)(2013-8#2)
on chemical constituents##5##3##(2012-12#1)(2012-3#2)(2013-8#2)
on chemical##25##2##(1990-10#1)(1991-9#1)(1994-5#1)(2006-12#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#2)(2012-12#1)(2012-3#3)(2013-8#2)
on chemically modified##7##3##(2008-10#7)
on chemically synthesized collagen##2##4##(2013-8#2)
on chemically##12##2##(1995-4#1)(1995-9#1)(2006-5#1)(2008-10#7)(2013-8#2)
on chemiluminescence of the##2##4##(2008-10#1)(2008-4#1)
on chemiluminescence##4##2##(2008-10#3)(2008-4#1)
on chemokines##2##2##(2006-10#1)(2008-1#1)
on chemotactic##2##2##(1991-2#1)(2010-8#1)
on chemotherapy and##2##3##(2007-5#1)(2010-9#1)
on chemotherapy##7##2##(2007-5#2)(2007-7#1)(2010-11#1)(2010-9#1)(2012-1#1)(2012-3#1)
on chest X-ray##5##3##(1991-12#3)(2007-8#1)(2008-1#1)
on chest radiograph##2##3##(2012-2#1)(2013-7#1)
on chest radiography and##2##4##(2005-8#1)(2013-1#1)
on chest radiography##3##3##(2005-8#1)(2013-1#2)
on chest roentgenograms##2##3##(1993-6#2)
on chest x-ray##4##3##(2006-10#2)(2010-7#1)(2011-2#1)
on chest##21##2##(1991-10#1)(1991-12#3)(1993-6#2)(1994-4#1)(2005-8#1)(2006-10#2)(2007-8#3)(2008-1#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-7#1)
on chicken##9##2##(1991-6#1)(1994-3#1)(1996-5#2)(2006-4#1)(2007-6#1)(2008-12#1)(2008-8#1)(2011-1#1)
on child and##2##3##(2007-5#1)(2009-5#1)
on child health##3##3##(1995-1#1)(2008-11#1)(2012-3#1)
on child survival in##3##4##(2007-6#1)(2011-1#2)
on child survival##4##3##(2007-6#1)(2011-1#3)
on child##19##2##(1995-1#1)(1996-2#1)(2006-12#1)(2007-5#1)(2007-6#1)(2008-11#2)(2008-2#1)(2008-7#1)(2009-5#1)(2009-9#1)(2010-5#1)(2011-1#4)(2011-2#1)(2012-2#1)(2012-3#1)
on child/adolescent outcomes##2##3##(2010-3#2)
on childbirth##2##2##(2013-1#2)
on childhood##7##2##(1995-12#1)(2007-3#1)(2008-11#1)(2008-2#1)(2010-6#2)(2012-2#1)
on children and adolescents##2##4##(2008-11#1)(2011-12#1)
on children and##7##3##(2008-11#3)(2008-9#1)(2010-9#1)(2011-12#1)(2012-3#1)
on children with##4##3##(1995-3#1)(1995-5#1)(2009-9#1)(2011-1#1)
on children##25##2##(1992-3#1)(1993-8#1)(1994-8#1)(1995-3#1)(1995-5#2)(2006-4#1)(2006-9#1)(2007-11#1)(2008-11#3)(2008-9#2)(2009-12#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-3#1)
on children's health##2##3##(2008-11#1)(2013-1#1)
on children's social##2##3##(1996-1#1)(2009-10#1)
on children's##17##2##(1991-10#1)(1992-3#1)(1996-1#1)(2007-11#1)(2008-11#2)(2008-12#1)(2008-9#1)(2009-10#2)(2009-4#2)(2009-9#1)(2010-1#1)(2010-6#1)(2013-1#2)
on chip##9##2##(2008-2#2)(2008-7#1)(2009-10#2)(2010-11#1)(2010-8#2)(2011-1#1)
on chiral stationary phases##2##4##(1990-12#1)(2008-10#1)
on chiral##4##2##(1990-12#1)(1990-7#1)(2008-10#2)
on chitin##3##2##(2008-10#2)(2009-8#1)
on chitosan and##2##3##(2005-11#1)(2008-10#1)
on chitosan##8##2##(2005-11#2)(2008-10#4)(2012-11#2)
on chloride##3##2##(1990-2#2)(1993-6#1)
on choice of##3##3##(1995-1#1)(2008-10#1)(2008-5#1)
on cholangiocarcinoma##2##2##(2008-5#1)(2010-12#1)
on cholesterol level##2##3##(1997-6#1)(2006-10#1)
on cholesterol##10##2##(1990-8#1)(1991-1#1)(1994-8#1)(1995-12#2)(1995-5#1)(1997-6#1)(2006-10#1)(2008-4#1)(2012-3#1)
on cholinergic neurons##3##3##(1994-3#1)(1996-12#1)(2009-3#1)
on cholinergic##9##2##(1991-9#1)(1993-12#1)(1993-9#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-3#2)(2009-3#1)
on cholinesterase##2##2##(2008-10#2)
on chondrocytes and##2##3##(1993-12#1)(2007-11#1)
on chondroitin##2##2##(1994-3#1)(2011-1#1)
on choosing##3##2##(1994-7#1)(2008-11#1)(2008-7#1)
on chromatin structure##3##3##(1995-2#1)(1996-5#1)(1996-7#1)
on chromatin##7##2##(1990-2#1)(1995-2#1)(1996-5#1)(1996-7#1)(2008-4#1)(2009-12#1)(2012-1#1)
on chromatographic##4##2##(2007-8#1)(2008-10#1)(2008-5#1)(2011-1#1)
on chromatography##2##2##(1990-8#1)(2006-11#1)
on chromogenic##2##2##(1997-4#1)(2005-4#1)
on chromosomal##5##2##(2008-1#1)(2008-2#1)(2012-12#2)(2013-8#1)
on chromosome 1##15##3##(1995-8#3)(1996-10#4)(1996-9#1)(2008-10#4)(2008-7#1)(2009-10#1)(2012-2#1)
on chromosome 10##4##3##(1990-3#1)(1992-9#1)(2009-5#1)(2012-3#1)
on chromosome 11##9##3##(1991-6#1)(1993-3#1)(1997-1#1)(1997-4#1)(2008-10#2)(2008-8#3)
on chromosome 11p15##2##3##(2008-1#1)(2008-7#1)
on chromosome 11q13##2##3##(1997-8#2)
on chromosome 12##6##3##(1996-12#1)(1996-6#1)(2008-10#4)
on chromosome 12p and##2##4##(1997-5#2)
on chromosome 14##6##3##(1993-11#1)(1995-12#1)(1996-2#1)(2008-4#2)(2011-2#1)
on chromosome 15##2##3##(1996-12#1)(2012-2#1)
on chromosome 16##4##3##(1993-12#1)(1996-2#2)(2008-4#1)
on chromosome 17##6##3##(1990-9#2)(1993-3#1)(2008-10#1)(2008-4#1)(2012-2#1)
on chromosome 17p13##2##3##(1993-11#1)(2010-3#1)
on chromosome 17q21##2##3##(1994-9#1)(2008-11#1)
on chromosome 18##4##3##(1995-11#2)(2010-2#2)
on chromosome 1AS##2##3##(2008-10#2)
on chromosome 1H##2##3##(2008-10#2)
on chromosome 2 and##2##4##(1995-6#1)(2008-10#1)
on chromosome 2##10##3##(1993-10#1)(1993-2#1)(1993-3#1)(1995-6#1)(1996-6#1)(1996-9#1)(1997-5#1)(2006-8#1)(2008-10#1)(2008-9#1)
on chromosome 2(2H)##2##3##(2008-10#2)
on chromosome 21##3##3##(1993-11#1)(1996-2#1)(1996-6#1)
on chromosome 22##2##3##(1991-12#1)(2012-1#1)
on chromosome 22q11##2##3##(1996-11#1)(2009-5#1)
on chromosome 3##14##3##(1990-12#1)(1990-5#2)(1994-8#1)(1996-6#1)(1997-5#1)(1997-7#1)(2008-10#1)(2008-8#2)(2008-9#1)(2010-2#1)(2012-11#1)(2012-3#1)
on chromosome 4##12##3##(1990-7#1)(1994-8#2)(1994-9#1)(1997-2#1)(2006-11#1)(2008-10#1)(2008-9#2)(2009-10#1)(2010-3#1)(2012-3#1)
on chromosome 4q##2##3##(2012-3#2)
on chromosome 5 and is##2##5##(1993-2#1)(2005-11#1)
on chromosome 5 explained##2##4##(2008-10#2)
on chromosome 5##11##3##(1991-4#1)(1993-2#1)(1996-10#2)(1997-6#1)(1997-8#1)(2005-11#1)(2008-10#3)(2009-11#1)
on chromosome 5(1H)##2##3##(2008-10#2)
on chromosome 5BL##2##3##(2008-10#2)
on chromosome 6 in##2##4##(1996-11#2)
on chromosome 6 was##2##4##(1996-11#1)(1996-2#1)
on chromosome 6##13##3##(1994-2#1)(1996-11#7)(1996-2#2)(1997-5#1)(2008-9#1)(2012-1#1)
on chromosome 6p21##2##3##(2008-1#2)
on chromosome 6q##5##3##(2008-5#2)(2009-4#1)(2012-3#2)
on chromosome 7 at##2##4##(2008-4#2)
on chromosome 7##6##3##(1994-12#1)(1994-8#1)(1995-1#1)(2008-4#2)(2009-10#1)
on chromosome 7(5H) at a distance of##2##7##(2008-10#2)
on chromosome 7(5H)##3##3##(2008-10#3)
on chromosome 7A##2##3##(2008-10#2)
on chromosome 7DL##2##3##(2008-10#2)
on chromosome 7DS in##2##4##(2008-10#2)
on chromosome 7DS##3##3##(2008-10#3)
on chromosome 8##9##3##(1992-9#2)(1993-2#1)(1996-3#1)(2006-11#1)(2007-12#1)(2008-8#1)(2008-9#2)
on chromosome 9##4##3##(1994-9#1)(2009-6#1)(2010-3#1)(2011-2#1)
on chromosome 9p21##2##3##(1997-7#1)(2009-12#1)
on chromosome II and##2##4##(1993-12#1)(1996-6#1)
on chromosome II##5##3##(1992-1#1)(1993-12#1)(1995-4#2)(1996-6#1)
on chromosome IV##5##3##(1996-6#2)(1997-8#1)(2008-5#1)(2012-3#1)
on chromosome IX##2##3##(1996-3#2)
on chromosome VI##4##3##(1995-8#1)(1997-6#3)
on chromosome VII##2##3##(1996-6#1)(1996-7#1)
on chromosome X of Saccharomyces cerevisiae##2##6##(1994-9#1)(1995-6#1)
on chromosome XV##3##3##(1995-6#2)(1996-3#1)
on chromosome arm##3##3##(2008-10#1)(2012-3#2)
on chromosome##266##2##(1990-12#1)(1990-3#1)(1990-5#2)(1990-7#1)(1990-9#3)(1991-10#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-5#1)(1992-7#1)(1992-9#4)(1993-10#1)(1993-11#6)(1993-12#2)(1993-2#3)(1993-3#3)(1993-5#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#5)(1994-9#5)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-4#2)(1995-6#4)(1995-8#6)(1996-10#6)(1996-11#8)(1996-12#2)(1996-2#6)(1996-3#4)(1996-6#8)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#6)(1997-6#4)(1997-7#2)(1997-8#4)(2005-11#1)(2006-11#2)(2006-8#1)(2007-12#3)(2007-6#1)(2007-7#2)(2008-1#6)(2008-10#52)(2008-11#2)(2008-4#6)(2008-5#4)(2008-7#4)(2008-8#6)(2008-9#8)(2009-10#3)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#3)(2009-6#1)(2010-12#1)(2010-2#4)(2010-3#4)(2011-2#4)(2012-1#2)(2012-11#1)(2012-2#3)(2012-3#14)
on chromosomes 1 and##2##4##(1996-10#1)(2008-10#1)
on chromosomes 1##11##3##(1996-10#1)(1996-12#1)(1997-5#2)(2008-10#4)(2008-8#2)(2008-9#1)
on chromosomes 10 and 12##2##5##(1996-12#2)
on chromosomes 10 and##3##4##(1996-12#3)
on chromosomes 10##4##3##(1996-12#3)(2008-10#1)
on chromosomes 1AS##2##3##(2008-10#2)
on chromosomes 2##4##3##(1997-5#1)(2008-10#2)(2013-8#1)
on chromosomes 3 and##2##4##(1997-4#1)(2008-10#1)
on chromosomes 3##5##3##(1994-4#1)(1997-4#1)(2008-10#2)(2008-8#1)
on chromosomes 4q##2##3##(2012-3#2)
on chromosomes##42##2##(1992-1#1)(1994-4#1)(1994-8#1)(1995-6#1)(1996-10#1)(1996-12#4)(1997-3#1)(1997-4#1)(1997-5#4)(2008-10#15)(2008-4#1)(2008-5#2)(2008-8#3)(2008-9#2)(2012-11#1)(2012-3#2)(2013-8#1)
on chronic dialysis##6##3##(2006-10#1)(2007-7#1)(2007-8#2)(2008-1#1)(2013-1#1)
on chronic hemodialysis##7##3##(2006-8#1)(2008-1#2)(2013-1#1)(2013-7#1)(2013-8#2)
on chronic hepatitis##2##3##(2009-8#1)(2010-12#1)
on chronic##42##2##(1991-5#1)(1991-8#1)(1992-9#1)(1993-2#1)(1994-1#1)(1997-1#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#3)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-12#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#3)
on cigarette##2##2##(1990-2#1)(2008-8#1)
on circular##2##2##(1991-7#1)(1995-1#1)
on circulating##7##2##(1994-5#1)(2004-11#1)(2007-11#1)(2007-8#1)(2008-1#1)(2009-6#1)(2010-5#1)
on circulatory##2##2##(1996-8#1)(2010-12#1)
on circumcision##2##2##(1997-5#1)(2006-9#1)
on citrus fruit##2##3##(2008-10#2)
on citrus##8##2##(2008-10#8)
on civil##2##2##(2011-1#1)(2011-2#1)
on classic##2##2##(2010-9#1)(2013-1#1)
on classical##5##2##(1996-4#1)(2006-10#1)(2007-11#1)(2008-8#1)(2012-3#1)
on classification##3##2##(2006-10#1)(2008-6#1)(2011-1#1)
on clear##3##2##(1994-1#1)(2006-10#1)(2008-3#1)
on cleavage##3##2##(1995-1#1)(1996-8#2)
on cleft##2##2##(2008-4#1)(2013-1#1)
on clientele##2##2##(2008-2#2)
on clients##2##2##(1990-5#1)(2012-12#1)
on climatic##2##2##(2008-10#1)(2008-7#1)
on clinical and radiographic##2##4##(2006-8#1)(2012-2#1)
on clinical and##11##3##(1992-3#1)(2006-8#2)(2006-9#1)(2007-9#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-8#1)
on clinical applications##2##3##(1997-2#1)(2012-2#1)
on clinical criteria##2##3##(2006-10#1)(2009-10#1)
on clinical examination##4##3##(2006-6#1)(2007-7#1)(2008-12#1)(2010-9#1)
on clinical features and##2##4##(2007-7#1)(2012-3#1)
on clinical features##4##3##(2007-7#2)(2010-11#1)(2012-3#1)
on clinical grounds and##2##4##(2008-8#1)(2013-8#1)
on clinical grounds##6##3##(1994-7#1)(2006-10#1)(2007-7#1)(2008-7#1)(2008-8#1)(2013-8#1)
on clinical history##2##3##(2006-8#1)(2011-1#1)
on clinical indication##5##3##(1996-12#4)(2008-10#1)
on clinical management##3##3##(2008-4#1)(2011-2#1)(2012-1#1)
on clinical material##2##3##(2007-11#1)(2008-5#1)
on clinical outcome in##3##4##(2007-12#1)(2007-8#1)(2008-7#1)
on clinical outcome of##2##4##(2006-10#1)(2013-1#1)
on clinical outcome##8##3##(2006-10#1)(2007-12#1)(2007-8#2)(2008-3#2)(2008-7#1)(2013-1#1)
on clinical outcomes##3##3##(1994-1#1)(2009-12#1)(2011-2#1)
on clinical practice in the##2##5##(1993-7#1)(2008-11#1)
on clinical practice##8##3##(1993-7#1)(2006-10#2)(2007-11#1)(2008-11#4)
on clinical suspicion of##2##4##(2007-7#1)(2010-12#1)
on clinical symptoms##2##3##(2007-11#1)(2011-1#1)
on clinical trial##2##3##(1995-5#1)(2007-10#1)
on clinical trials and##2##4##(2008-8#1)(2011-1#1)
on clinical trials##6##3##(2006-11#1)(2006-4#1)(2007-11#1)(2008-8#1)(2010-12#1)(2011-1#1)
on clinical##149##2##(1990-12#1)(1991-3#2)(1992-12#1)(1992-3#1)(1992-4#1)(1993-3#1)(1993-7#1)(1994-1#2)(1994-5#1)(1994-7#1)(1995-5#1)(1996-1#1)(1996-12#4)(1997-2#2)(1997-4#1)(2004-11#1)(2004-9#1)(2005-8#2)(2006-10#9)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#2)(2006-6#1)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#8)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#6)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#6)(2008-12#3)(2008-3#3)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-2#5)(2012-3#5)(2013-1#8)(2013-7#3)(2013-8#2)
on clinically diagnosed##2##3##(2004-1#1)(2010-8#1)
on clinically relevant##2##3##(2006-10#1)(2008-11#1)
on clinically##5##2##(2004-1#1)(2006-10#1)(2008-11#1)(2010-8#1)(2011-1#1)
on clinician-rated##2##2##(2009-11#1)(2012-12#1)
on cloning efficiency##2##3##(2008-9#2)
on cloning##3##2##(2008-5#1)(2008-9#2)
on cloud##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
on cloudy days##2##3##(2008-10#2)
on cluster##4##2##(2008-1#1)(2008-10#3)
on clustering##2##2##(2008-7#1)(2009-11#1)
on clusters##2##2##(2008-10#1)(2010-10#1)
on coagulation factors##2##3##(1993-6#2)
on coagulation time##2##3##(2008-9#2)
on coagulation##10##2##(1990-12#2)(1993-6#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-9#2)(2009-4#1)
on coal##4##2##(2005-11#4)
on coarse spatial scales##2##4##(2008-8#2)
on coarse##4##2##(2008-8#3)(2009-8#1)
on cobalt##7##2##(1994-6#3)(2007-8#1)(2008-10#3)
on cocaine self-administration##3##3##(1991-1#2)(2011-12#1)
on cocaine##5##2##(1991-1#3)(1994-11#1)(2011-12#1)
on cocoa##2##2##(2008-10#2)
on coding##3##2##(2008-7#1)(2013-1#2)
on coffee leaves##2##3##(2008-10#2)
on cognition and##3##3##(1991-6#1)(2011-2#1)(2012-3#1)
on cognition##13##2##(1991-6#1)(2005-10#1)(2006-9#4)(2007-11#1)(2009-12#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
on cognitive and##2##3##(2004-11#1)(2007-11#1)
on cognitive function and##2##4##(2004-11#1)(2006-10#1)
on cognitive function in##2##4##(2012-2#1)(2012-3#1)
on cognitive function##8##3##(2004-11#1)(2006-10#1)(2008-6#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
on cognitive functioning##2##3##(1990-3#1)(2008-10#1)
on cognitive functions##3##3##(1991-12#1)(1996-9#1)(2008-7#1)
on cognitive performance##3##3##(2008-9#1)(2011-1#1)(2012-12#1)
on cognitive skills and##2##4##(2006-10#1)(2008-11#1)
on cognitive##33##2##(1990-3#1)(1991-12#1)(1996-11#1)(1996-9#1)(2004-11#3)(2006-10#2)(2006-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-10#1)(2009-7#2)(2010-10#1)(2011-1#2)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
on coherence##2##2##(2008-2#2)
on coherent##4##2##(2007-12#2)(2008-3#2)
on cohorts##2##2##(2008-10#1)(2012-3#1)
on cold##5##2##(1990-2#2)(2008-10#2)(2009-6#1)
on collaborative##4##2##(1995-1#1)(1995-2#1)(2008-6#1)(2012-11#1)
on collagen gel was##2##4##(1994-8#2)
on collagen gel##4##3##(1994-8#4)
on collagen metabolism##2##3##(1994-8#1)(2012-2#1)
on collagen synthesis##4##3##(1994-2#1)(2008-5#1)(2008-9#1)(2012-2#1)
on collagen type##2##3##(1990-12#1)(2008-11#1)
on collagen##21##2##(1990-12#1)(1993-12#1)(1994-2#1)(1994-8#7)(2004-9#1)(2008-11#3)(2008-5#3)(2008-9#1)(2012-2#2)(2013-8#1)
on collagen-coated##2##2##(2008-11#2)
on collapsing##3##2##(2008-10#1)(2012-3#2)
on collected##2##2##(2008-2#1)(2011-10#1)
on collecting information on##2##4##(1996-2#1)(2008-10#1)
on colloidal##3##2##(2005-11#1)(2008-10#1)(2008-8#1)
on colonization of the##2##4##(1992-12#1)(2008-5#1)
on colonization##3##2##(1992-12#1)(2008-5#1)(2008-8#1)
on colonoscopy##3##2##(2008-10#1)(2010-12#1)(2011-2#1)
on colony##5##2##(1992-11#1)(2008-10#3)(2009-8#1)
on color##6##2##(2008-2#2)(2010-4#1)(2010-8#2)(2012-6#1)
on colorectal cancer##2##3##(2006-10#1)(2008-10#1)
on colorectal##5##2##(1993-7#1)(2006-10#2)(2008-10#1)(2008-11#1)
on colour change##2##3##(2010-2#2)
on colour##4##2##(1990-12#1)(2008-5#1)(2010-2#2)
on column##3##2##(1996-8#1)(2008-10#1)(2008-6#1)
on columns containing##3##3##(1992-5#2)(1992-6#1)
on columns of##5##3##(1992-12#1)(1994-12#1)(1995-10#1)(1996-5#1)(2008-5#1)
on columns##9##2##(1992-12#1)(1992-5#2)(1992-6#1)(1994-12#1)(1995-10#1)(1996-5#1)(1996-8#1)(2008-5#1)
on combination##3##2##(2010-2#1)(2011-2#1)(2013-1#1)
on combinations of##2##3##(2008-7#1)(2010-10#1)
on combined##3##2##(2008-10#1)(2009-7#1)(2010-1#1)
on combining##8##2##(2005-11#1)(2005-7#1)(2007-12#1)(2008-1#1)(2008-3#2)(2008-5#1)(2008-7#1)
on combustion products##2##3##(1996-12#2)
on combustion##3##2##(1996-12#2)(2008-11#1)
on commercial##9##2##(2005-7#1)(2007-11#1)(2008-10#4)(2008-6#1)(2008-7#1)(2011-2#1)
on commercially available##2##3##(2008-3#1)(2008-4#1)
on commercially pure titanium##3##4##(2008-11#1)(2008-5#2)
on commercially##6##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)
on common bean##4##3##(2008-10#4)
on common##20##2##(1996-3#1)(2005-10#1)(2006-10#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2011-2#2)(2012-3#4)(2013-8#1)
on communication##5##2##(1997-2#1)(2007-11#1)(2007-12#1)(2012-2#1)(2012-3#1)
on communications##3##2##(1993-12#1)(1994-2#1)(2007-4#1)
on communities##3##2##(2010-8#2)(2013-1#1)
on community care##2##3##(2007-8#1)(2010-10#1)
on community engagement##2##3##(2009-6#1)(2009-8#1)
on community health##2##3##(1993-1#1)(2008-11#1)
on community##15##2##(1990-6#1)(1993-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(2005-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-6#1)(2009-8#1)(2010-10#1)(2011-1#1)(2013-1#1)
on comorbid##2##2##(2012-2#2)
on compact##2##2##(2008-2#2)
on comparative##5##2##(2008-10#1)(2008-4#1)(2008-7#2)(2012-2#1)
on comparing##2##2##(2008-7#1)(2012-2#1)
on comparison of##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
on comparison with##3##3##(1997-6#1)(2007-8#1)(2008-5#1)
on comparison##7##2##(1997-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#2)
on comparisons of##2##3##(1996-12#1)(2007-11#1)
on comparisons##3##2##(1991-9#1)(1996-12#1)(2007-11#1)
on compensation of##2##3##(2007-11#1)(2010-9#1)
on competition for##2##3##(2008-8#1)(2008-9#1)
on competition##5##2##(1991-1#1)(1993-6#1)(2008-8#1)(2008-9#2)
on competitive##4##2##(1994-7#1)(1995-9#1)(2006-7#1)(2008-10#1)
on complementary and alternative##2##4##(2008-10#2)
on complementary##5##2##(2008-10#4)(2012-3#1)
on complete##4##2##(1990-3#1)(1996-6#1)(2008-10#1)(2011-2#1)
on completion of the##2##4##(1991-1#1)(2007-8#1)
on completion of##4##3##(1991-1#1)(2007-8#1)(2009-12#1)(2012-3#1)
on complex formation##3##3##(1995-11#1)(1995-2#2)
on complex##15##2##(1992-6#1)(1995-11#1)(1995-2#2)(1996-2#1)(2006-9#1)(2007-4#1)(2008-2#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#1)(2009-5#1)(2013-1#1)
on complexation of##2##3##(2008-10#2)
on complexation##5##2##(2008-10#5)
on complexes that##2##3##(2010-5#1)(2012-3#1)
on complexes##4##2##(2009-2#1)(2010-5#1)(2012-3#1)(2013-1#1)
on compliance with treatment##2##4##(2008-4#1)(2010-8#1)
on compliance with##3##3##(2008-4#2)(2010-8#1)
on compliance##4##2##(2005-5#1)(2008-4#2)(2010-8#1)
on complication##2##2##(2007-11#1)(2010-4#1)
on component##2##2##(2008-1#1)(2008-10#1)
on components of##3##3##(2008-10#1)(2008-12#1)(2008-3#1)
on components##6##2##(1996-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-7#1)
on composite##6##2##(2007-12#1)(2008-10#1)(2008-2#1)(2009-6#1)(2011-12#1)(2011-2#1)
on compound##4##2##(1997-7#1)(2008-4#1)(2008-5#1)(2010-12#1)
on compounds##4##2##(2005-8#1)(2008-1#1)(2008-5#1)(2013-1#1)
on compression##3##2##(1991-9#1)(1995-3#1)(1996-8#1)
on computed tomography (CT) is##2##5##(2005-8#1)(2007-10#1)
on computed tomography (CT) scan##2##5##(2008-7#1)(2011-2#1)
on computed tomography (CT)##9##4##(1991-3#1)(2005-8#1)(2007-10#1)(2007-9#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-2#2)
on computed tomography scan##2##4##(2008-7#1)(2013-1#1)
on computed tomography##19##3##(1991-3#1)(2005-8#1)(2007-10#2)(2007-9#1)(2008-3#1)(2008-7#3)(2009-3#1)(2009-6#1)(2010-9#1)(2011-2#2)(2012-2#2)(2013-1#3)
on computed##21##2##(1991-3#1)(2005-8#1)(2006-11#1)(2007-10#2)(2007-9#2)(2008-3#1)(2008-7#3)(2009-3#1)(2009-6#1)(2010-9#1)(2011-2#2)(2012-2#2)(2013-1#3)
on computer##6##2##(1992-12#1)(2006-11#1)(2007-8#1)(2008-2#1)(2009-7#1)(2012-3#1)
on computer-aided##2##2##(1990-12#1)(2008-2#1)
on computer-generated##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
on computerized##5##2##(1996-12#1)(2006-4#1)(2008-1#1)(2008-2#1)(2008-4#1)
on concave and convex##2##4##(2007-8#2)
on concave##3##2##(2007-8#3)
on concentration of##2##3##(2008-9#1)(2012-1#1)
on concentration##8##2##(1990-12#1)(1991-7#2)(2005-11#1)(2008-7#1)(2008-9#1)(2010-2#1)(2012-1#1)
on concentrations of##3##3##(1995-11#1)(2004-12#1)(2009-2#1)
on concentrations##4##2##(1995-11#1)(2004-12#1)(2008-10#1)(2009-2#1)
on concepts##3##2##(2008-11#1)(2008-5#1)(2009-4#1)
on concerns##2##2##(2006-10#1)(2012-12#1)
on concomitant##2##2##(1990-9#1)(1995-10#1)
on concordance##2##2##(1997-5#1)(2007-5#1)
on concurrent##2##2##(1993-12#1)(1994-6#1)
on condition that##2##3##(1990-12#1)(1993-9#1)
on conditional##4##2##(1995-9#1)(1997-2#1)(2008-5#1)(2012-2#1)
on conditioned##3##2##(1993-5#1)(2008-6#2)
on conditions##6##2##(1991-9#1)(2007-9#1)(2008-8#1)(2009-3#1)(2010-9#2)
on condom use and##2##4##(2007-7#1)(2012-3#1)
on condom use##6##3##(2007-7#1)(2012-3#4)(2013-7#1)
on conducting##3##2##(1996-12#1)(1996-3#1)(2008-10#1)
on conductive##2##2##(2010-4#2)
on cone beam computed tomography##2##5##(2009-10#1)(2009-12#1)
on cone##3##2##(2006-10#1)(2009-10#1)(2009-12#1)
on cones##2##2##(1992-7#1)(2008-8#1)
on conformation and##2##3##(2008-8#2)
on conformation##3##2##(1990-3#1)(2008-8#2)
on conformational##2##2##(2008-10#1)(2013-8#1)
on congenital##2##2##(1994-9#1)(2007-10#1)
on conidia germination##2##3##(2008-10#2)
on conidia##3##2##(2008-10#3)
on conidial germination and appressorium formation##2##6##(2008-10#2)
on conidial##4##2##(2008-10#4)
on conscious##2##2##(1995-2#1)(2010-3#1)
on consecutive##3##2##(1997-8#1)(2006-8#1)(2013-7#1)
on conservative##2##2##(1990-2#1)(2011-2#1)
on conserved##5##2##(1992-4#1)(2008-7#1)(2009-8#1)(2011-1#1)(2012-12#1)
on considerations##2##2##(2008-10#1)(2009-9#1)
on consolidation##2##2##(1991-7#1)(1994-10#1)
on constant##2##2##(1990-10#1)(2007-8#1)
on constipation in the elderly##2##5##(2010-12#2)
on constitutive##4##2##(1997-6#1)(2006-6#2)(2009-4#1)
on construction of##4##3##(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)
on construction##5##2##(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)
on consumer##5##2##(1997-3#1)(2008-12#1)(2008-7#1)(2012-3#1)(2013-8#1)
on consumers'##5##2##(2008-12#1)(2010-4#1)(2011-1#1)(2013-1#2)
on consumption of##3##3##(1996-12#1)(2008-10#1)(2012-1#1)
on consumption##6##2##(1996-12#1)(2008-10#1)(2011-2#3)(2012-1#1)
on contact##3##2##(1995-12#1)(2004-12#1)(2010-4#1)
on contaminated##2##2##(2008-11#1)(2008-6#1)
on contamination##2##2##(2008-10#1)(2008-7#1)
on contemporary##4##2##(1990-8#1)(2008-12#1)(2009-8#1)(2013-7#1)
on content of##2##3##(2012-1#1)(2012-3#1)
on content words##2##3##(2008-2#2)
on content##5##2##(2008-2#2)(2012-1#1)(2012-3#2)
on context##3##2##(2006-12#1)(2012-1#1)(2012-3#1)
on contextual##3##2##(2008-10#1)(2010-8#1)(2012-11#1)
on continuity of care##4##4##(1990-12#1)(1993-1#1)(2008-2#1)(2012-2#1)
on continuous ambulatory peritoneal dialysis (CAPD)##2##6##(2007-12#1)(2008-1#1)
on continuous ambulatory peritoneal dialysis##7##5##(1991-8#1)(1995-6#1)(2007-12#4)(2008-1#1)
on continuous ambulatory##8##3##(1991-8#1)(1995-6#1)(1997-8#1)(2007-12#4)(2008-1#1)
on continuous##28##2##(1991-5#1)(1991-8#1)(1993-2#1)(1995-6#1)(1997-8#1)(2006-6#3)(2007-12#4)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-7#1)(2009-12#1)(2013-1#2)
on contraceptive##2##2##(1996-11#1)(2006-4#1)
on contractile responses##4##3##(1993-11#2)(1993-3#1)(2005-11#1)
on contractile##6##2##(1993-11#2)(1993-3#1)(2005-11#1)(2010-2#1)(2013-8#1)
on contraction##2##2##(1991-12#1)(1994-11#1)
on contralateral##2##2##(1993-11#1)(2013-1#1)
on contrast##5##2##(2006-12#1)(2007-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
on control CT##2##3##(2006-4#1)(2011-1#1)
on control and##2##3##(1993-4#1)(1993-8#1)
on control of##3##3##(1991-7#1)(2011-12#2)
on control##16##2##(1991-7#1)(1992-11#1)(1992-3#1)(1993-4#1)(1993-8#1)(2006-4#1)(2006-5#1)(2008-10#2)(2008-5#1)(2009-11#1)(2010-4#1)(2011-1#1)(2011-12#2)(2012-1#1)
on controlled pore glass##9##4##(2008-10#7)(2008-3#2)
on controlled##18##2##(2005-11#1)(2007-12#1)(2008-10#10)(2008-3#2)(2010-12#2)(2010-4#1)(2012-1#1)
on controlled-pore glass##2##3##(1995-3#1)(2008-10#1)
on controlled-pore##3##2##(1995-3#1)(2008-10#2)
on controlling the##2##3##(2008-7#1)(2012-1#1)
on controlling##7##2##(2004-3#1)(2007-8#1)(2008-7#1)(2010-2#1)(2012-1#1)(2012-3#2)
on controversial##2##2##(2013-1#1)(2013-7#1)
on conventional##15##2##(1991-11#1)(1993-8#1)(1996-11#1)(1996-7#1)(1997-8#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2013-1#1)
on conversion##2##2##(1995-1#1)(2008-5#1)
on converting##3##2##(1990-1#1)(1991-7#1)(2011-2#1)
on convulsions and##2##3##(1993-4#1)(1996-1#1)
on convulsions##3##2##(1993-11#1)(1993-4#1)(1996-1#1)
on cooling##5##2##(1990-7#1)(1996-2#1)(2006-10#2)(2007-3#1)
on cooperative##2##2##(1995-6#1)(2007-10#1)
on coordination and decision-making in##2##5##(2011-12#2)
on coordination and##3##3##(2008-5#1)(2011-12#2)
on coordination##6##2##(2008-12#1)(2008-2#1)(2008-5#2)(2011-12#2)
on coping##2##2##(2007-3#1)(2008-11#1)
on copper##2##2##(2006-10#1)(2008-10#1)
on coral reef##2##3##(2007-5#2)
on coral##3##2##(2007-5#2)(2011-2#1)
on core##2##2##(2008-9#1)(2013-8#1)
on corn and##2##3##(2008-10#2)
on corn meal agar##2##4##(2008-10#1)(2008-5#1)
on corn##13##2##(2007-10#1)(2008-10#8)(2008-5#2)(2011-2#2)
on corneal epithelial##4##3##(2005-11#3)(2006-11#1)
on corneal##8##2##(2005-11#3)(2006-11#1)(2007-1#2)(2007-3#1)(2009-10#1)
on cornmeal agar##2##3##(2008-10#2)
on coronal##2##2##(1995-11#1)(2007-12#1)
on coronary artery bypass graft##2##5##(1992-11#1)(2008-12#1)
on coronary artery##5##3##(1992-11#1)(2008-12#1)(2008-4#1)(2010-2#1)(2010-8#1)
on coronary heart disease##3##4##(1994-6#1)(2008-3#1)(2010-8#1)
on coronary mortality##2##3##(1996-1#1)(2009-9#1)
on coronary##18##2##(1991-7#1)(1992-11#1)(1994-6#1)(1996-1#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2009-9#1)(2010-2#1)(2010-4#1)(2010-8#2)(2013-4#1)
on correct##11##2##(1991-1#1)(1996-2#1)(2007-12#2)(2008-10#2)(2010-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
on correcting##2##2##(2010-8#1)(2013-1#1)
on correlation between##3##3##(2007-11#1)(2010-5#1)(2012-12#1)
on cortical cells##3##3##(1995-5#1)(2008-11#2)
on cortical##13##2##(1991-12#1)(1991-8#1)(1991-9#1)(1995-5#1)(1996-3#1)(1997-2#1)(2008-11#2)(2008-6#2)(2009-7#1)(2010-9#1)(2012-2#1)
on corticosteroid therapy##3##3##(2006-7#1)(2007-5#1)(2012-12#1)
on corticosteroid##4##2##(2006-2#1)(2006-7#1)(2007-5#1)(2012-12#1)
on corticosteroids##4##2##(2004-3#1)(2006-10#1)(2012-2#2)
on corticosterone level##2##3##(2013-1#2)
on corticosterone##3##2##(2007-11#1)(2013-1#2)
on corticostriatal##2##2##(1995-12#1)(2009-12#1)
on corticotrophs##2##2##(1990-2#1)(1997-5#1)
on cortisol##2##2##(1990-12#1)(2010-4#1)
on cosmetic##2##2##(1995-8#1)(2010-8#1)
on cost and##4##3##(1993-1#1)(2006-10#1)(2007-8#1)(2009-8#1)
on cost of##2##3##(2007-8#1)(2010-8#1)
on cost##11##2##(1992-1#1)(1993-1#1)(1993-3#1)(1996-3#1)(2006-10#1)(2007-7#1)(2007-8#2)(2009-8#1)(2010-8#1)(2011-2#1)
on cost-effectiveness##2##2##(2011-12#1)(2012-1#1)
on costs and##3##3##(1991-1#1)(1993-12#1)(1994-3#1)
on costs of##3##3##(1991-1#1)(2006-5#1)(2008-10#1)
on costs##9##2##(1991-1#2)(1993-12#1)(1994-3#1)(1995-1#1)(1995-7#1)(1996-2#1)(2006-5#1)(2008-10#1)
on cotton##11##2##(2005-11#4)(2008-10#3)(2008-6#1)(2011-12#1)(2011-2#2)
on cotyledons##2##2##(2008-10#2)
on cough##3##2##(1993-12#2)(2011-1#1)
on coulometric titration##2##3##(2008-10#2)
on counting##3##2##(2004-11#1)(2006-4#1)(2008-3#1)
on coupled##5##2##(1992-11#1)(2007-12#2)(2008-3#1)(2008-8#1)
on coupling##9##2##(1996-4#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#2)
on course of##3##3##(2005-10#1)(2007-9#1)(2008-7#1)
on course##4##2##(1992-3#1)(2005-10#1)(2007-9#1)(2008-7#1)
on covalent##2##2##(2007-8#1)(2008-10#1)
on coverage##2##2##(2010-1#1)(2011-2#1)
on coverslips##3##2##(1997-1#1)(2008-11#1)(2008-5#1)
on cowpea##3##2##(2008-10#3)
on cranial##4##2##(1990-4#1)(2007-10#2)(2012-3#1)
on craniofacial##2##2##(2007-12#2)
on creating##3##2##(1995-1#1)(2007-12#1)(2008-12#1)
on criteria for##2##3##(1997-5#1)(2005-8#1)
on criteria of##2##3##(1990-3#1)(2008-5#1)
on criteria##9##2##(1990-3#1)(1991-12#1)(1993-4#1)(1996-9#1)(1997-5#1)(2005-8#1)(2008-5#1)(2011-2#1)(2012-1#1)
on critical flux values##2##4##(2011-2#2)
on critical##13##2##(1993-2#1)(1996-7#1)(2006-6#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-4#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
on critically ill patients##2##4##(2008-10#1)(2009-9#1)
on critically##3##2##(2007-4#1)(2008-10#1)(2009-9#1)
on crop##2##2##(2008-10#1)(2009-8#1)
on cross##2##2##(2007-12#1)(2010-4#1)
on cross-linked##3##2##(1993-5#1)(2005-11#1)(2008-7#1)
on cross-modal##2##2##(2008-8#1)(2012-1#1)
on crosslinked##3##2##(2008-10#3)
on crude##3##2##(1990-9#1)(1994-9#1)(1995-2#1)
on cryostat sections of##2##4##(1994-3#1)(2008-10#1)
on cryostat##3##2##(1990-2#1)(1994-3#1)(2008-10#1)
on crystal##3##2##(1991-8#1)(2008-7#1)(2008-8#1)
on crystalline##3##2##(2008-2#1)(2008-3#1)(2013-1#1)
on crystallization##2##2##(2004-9#1)(2007-12#1)
on cucumber seedlings##2##3##(2008-10#1)(2013-8#1)
on cucumber##12##2##(2008-10#8)(2008-12#1)(2009-12#1)(2013-8#2)
on cucurbit##2##2##(2008-10#2)
on cucurbits##2##2##(2008-10#1)(2013-8#1)
on cultivars##2##2##(2008-10#2)
on cultivated##3##2##(2008-10#2)(2012-3#1)
on cultural##6##2##(1996-1#1)(2004-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
on culture media##3##3##(2008-10#2)(2010-12#1)
on culture##11##2##(1991-8#2)(1993-2#1)(2005-7#1)(2007-7#1)(2007-8#1)(2008-10#2)(2010-10#1)(2010-12#1)(2010-8#1)
on cultured cells##2##3##(1992-5#1)(2008-2#1)
on cultured human##2##3##(1994-9#1)(2008-6#1)
on cultured rat##3##3##(1992-3#1)(1993-12#1)(2011-12#1)
on cultured##22##2##(1992-12#2)(1992-3#1)(1992-5#2)(1992-9#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-9#1)(1995-12#1)(1997-1#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2011-12#1)(2012-2#1)(2013-1#1)
on cumulative feed consumption##2##4##(2008-12#2)
on cumulative##5##2##(2004-2#1)(2005-8#1)(2008-12#2)(2009-3#1)
on curcumin##2##2##(2008-10#1)(2013-1#1)
on curing##2##2##(2008-10#1)(2011-2#1)
on current data##3##3##(2009-8#1)(2010-5#1)(2013-8#1)
on current knowledge##3##3##(2005-11#1)(2008-7#1)(2013-7#1)
on current research##2##3##(2005-6#1)(2008-10#1)
on current studies##2##3##(2007-11#1)(2012-12#1)
on current##38##2##(1992-6#1)(1993-2#1)(1995-1#1)(1996-11#1)(1997-2#1)(2005-11#1)(2005-6#1)(2005-8#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-11#4)(2007-7#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#2)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#2)(2011-1#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
on currently available##4##3##(2005-10#1)(2008-10#1)(2008-11#1)(2008-7#1)
on currently##6##2##(2005-10#1)(2005-6#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)
on curriculum##2##2##(2006-2#1)(2008-12#1)
on curved surfaces##6##3##(2008-2#5)(2008-3#1)
on customer##2##2##(1995-12#1)(1996-3#1)
on cut##3##2##(2008-10#1)(2010-12#1)(2011-2#1)
on cutaneous##5##2##(1992-6#1)(2005-11#1)(2007-2#1)(2007-7#1)(2009-6#1)
on cv##11##2##(2008-10#10)(2008-6#1)
on cvs##4##2##(2008-10#3)(2008-6#1)
on cyclic AMP accumulation##2##4##(1995-12#2)
on cyclic AMP##8##3##(1992-9#1)(1993-5#1)(1995-11#1)(1995-12#3)(1996-5#1)(1997-4#1)
on cyclic##12##2##(1992-9#1)(1993-5#1)(1995-11#2)(1995-12#3)(1996-5#1)(1997-4#1)(2008-10#1)(2008-4#1)(2010-4#1)
on cyclin##3##2##(1993-9#1)(2007-9#1)(2008-4#1)
on cyclooxygenase-2##2##2##(1997-5#1)(2007-8#1)
on cyclosporin##2##2##(1991-3#1)(2007-12#1)
on cyclosporine##5##2##(1995-2#2)(2009-4#2)(2013-8#1)
on cylindrical##2##2##(2005-11#1)(2008-3#1)
on cytochrome##3##2##(1991-12#1)(1991-8#1)(2008-11#1)
on cytogenetic##2##2##(1993-10#1)(2007-3#1)
on cytokine and##3##3##(2008-10#1)(2008-11#2)
on cytokine production##2##3##(1994-6#1)(2008-10#1)
on cytokine secretion##2##3##(2008-10#1)(2008-11#1)
on cytokine##10##2##(1993-8#1)(1994-6#1)(2006-10#1)(2008-10#3)(2008-11#3)(2013-7#1)
on cytokines##2##2##(2004-12#1)(2007-11#1)
on cytological##5##2##(1991-4#1)(1993-11#1)(1997-2#1)(2007-7#1)(2008-10#1)
on cytology##2##2##(2009-6#1)(2012-1#1)
on cytomegalovirus##2##2##(2008-1#1)(2008-11#1)
on cytoplasmic and##2##3##(1992-8#1)(1994-8#1)
on cytoplasmic##5##2##(1991-12#1)(1992-8#1)(1993-12#1)(1994-8#1)(2008-5#1)
on cytoskeletal##2##2##(1994-8#1)(2009-9#1)
on cytosolic Ca2+##4##3##(1992-7#1)(1993-3#1)(1994-6#1)(1995-3#1)
on cytosolic free calcium##2##4##(1991-10#1)(1994-10#1)
on cytosolic free##5##3##(1991-10#1)(1992-3#2)(1994-10#1)(2013-1#1)
on cytosolic phospholipase A2 activation in rabbit platelets##2##8##(1995-11#2)
on cytosolic##13##2##(1990-5#1)(1991-10#1)(1992-3#2)(1992-7#1)(1993-3#1)(1994-10#1)(1994-3#1)(1994-6#1)(1995-11#2)(1995-3#1)(2013-1#1)
on cytotoxic activity##2##3##(1993-12#1)(2012-1#1)
on cytotoxic effects##2##3##(1994-5#1)(2007-11#1)
on cytotoxic##6##2##(1993-12#1)(1994-10#1)(1994-5#1)(2007-11#1)(2010-5#1)(2012-1#1)
on cytotoxicity##5##2##(1991-10#1)(1995-3#1)(1996-6#1)(1997-1#1)(2008-5#1)
on d##2##2##(2008-8#2)
on d1##3##2##(1995-10#3)
on daily life##3##3##(1995-2#1)(2006-10#1)(2008-3#1)
on daily mortality##2##3##(1997-1#1)(2007-10#1)
on daily##16##2##(1995-2#1)(1995-3#1)(1997-1#1)(2006-10#1)(2006-11#1)(2007-10#1)(2008-3#1)(2008-8#1)(2009-11#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
on dairy##2##2##(2010-12#1)(2010-4#1)
on damaged##2##2##(1995-2#1)(2008-7#1)
on damping-off##2##2##(2008-10#2)
on dark skin##3##3##(2012-12#3)
on dark##4##2##(2010-8#1)(2012-12#3)
on data analysis##2##3##(2008-4#1)(2008-9#1)
on data collected##8##3##(1994-6#1)(2007-3#1)(2007-6#1)(2008-10#1)(2008-12#2)(2009-5#1)(2013-1#1)
on data for##3##3##(1991-12#1)(1997-2#1)(2007-7#1)
on data from a sample of##2##6##(1997-4#1)(2008-12#1)
on data from a##9##4##(1993-6#1)(1995-10#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-8#1)(2011-1#1)
on data from the##19##4##(1990-11#1)(1991-8#1)(1995-6#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-2#1)(2009-4#1)(2009-7#2)(2010-11#1)(2010-2#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#2)
on data from##49##3##(1990-11#1)(1991-8#1)(1993-1#1)(1993-6#1)(1995-10#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-4#1)(2005-2#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#3)(2010-11#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#3)(2013-1#2)
on data gathered##2##3##(1990-12#1)(2009-9#1)
on data in##2##3##(1990-3#1)(2008-4#1)
on data monitoring##2##3##(2005-11#2)
on data obtained from##3##4##(1996-8#1)(2008-10#1)(2008-11#1)
on data obtained##6##3##(1996-8#1)(2005-11#1)(2008-10#1)(2008-11#2)(2012-3#1)
on data quality##2##3##(2008-3#1)(2010-1#1)
on data##107##2##(1990-11#1)(1990-12#2)(1990-3#1)(1991-12#1)(1991-8#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-6#1)(1995-10#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-4#1)(2005-11#4)(2005-2#1)(2006-11#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-3#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-11#3)(2008-12#4)(2008-3#3)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#3)(2009-9#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#8)
on day 0 to##2##4##(1991-10#2)
on day 0##12##3##(1991-10#3)(1991-8#1)(1996-12#2)(1997-6#1)(1997-7#1)(2008-10#2)(2008-4#1)(2008-7#1)
on day 1 and##3##4##(1991-1#1)(1991-10#1)(1991-5#1)
on day 1 every##2##4##(2008-10#1)(2008-6#1)
on day 1 or days 1 and 2##2##8##(2008-7#2)
on day 1##35##3##(1990-10#1)(1990-2#2)(1991-1#1)(1991-10#2)(1991-4#1)(1991-5#1)(1991-8#1)(1992-11#1)(1995-11#1)(1995-12#1)(2004-1#1)(2006-6#2)(2006-8#1)(2007-10#4)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-7#2)
on day 10 of gestation##2##5##(1993-4#1)(1993-6#1)
on day 10##7##3##(1993-4#1)(1993-6#1)(1993-9#1)(1994-2#1)(2007-2#1)(2008-10#1)(2010-4#1)
on day 11##4##3##(1994-6#1)(1997-6#1)(2009-6#1)(2010-4#1)
on day 12##3##3##(1992-5#1)(1995-12#2)
on day 14 after##2##4##(2006-6#1)(2010-12#1)
on day 14##13##3##(1991-10#1)(1996-12#1)(1996-4#1)(2004-11#1)(2006-6#1)(2007-1#1)(2007-10#2)(2007-11#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-4#1)
on day 16 to##3##4##(1991-2#3)
on day 16##7##3##(1991-2#3)(1993-12#2)(1993-6#2)
on day 17##2##3##(1995-12#1)(2012-2#1)
on day 19##4##3##(1991-2#2)(2006-4#1)(2012-2#1)
on day 2 (p less than 0##2##7##(1991-10#2)
on day 2 after##2##4##(1992-7#1)(1992-8#1)
on day 2 and##3##4##(1991-2#1)(1992-3#1)(1994-8#1)
on day 2##15##3##(1990-12#1)(1991-10#3)(1991-2#1)(1991-4#1)(1992-3#1)(1992-7#1)(1992-8#1)(1994-8#1)(1995-7#1)(2007-10#1)(2008-3#1)(2008-5#1)(2010-7#1)
on day 20 of##3##4##(1993-12#1)(1996-12#1)(2011-1#1)
on day 20##7##3##(1993-12#1)(1995-12#2)(1996-12#1)(2008-10#1)(2010-4#1)(2011-1#1)
on day 21##2##3##(1995-11#1)(2006-6#1)
on day 22##2##3##(1991-2#1)(2013-8#1)
on day 25##2##3##(1991-2#1)(2006-10#1)
on day 28##6##3##(2004-11#2)(2008-7#3)(2012-2#1)
on day 3 was##2##4##(1994-2#1)(1997-7#1)
on day 3##16##3##(1990-9#2)(1994-2#3)(1994-8#1)(1995-2#1)(1997-7#1)(2005-12#1)(2008-11#1)(2008-5#1)(2008-6#2)(2008-9#2)(2010-10#1)
on day 30##2##3##(2006-6#1)(2008-5#1)
on day 4 after##2##4##(2007-11#1)(2010-12#1)
on day 4 and##2##4##(1992-8#1)(1995-7#1)
on day 4 of##2##4##(2008-10#1)(2008-9#1)
on day 4##15##3##(1991-10#2)(1992-8#1)(1994-2#2)(1994-5#2)(1995-11#1)(1995-7#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-9#1)(2009-2#1)(2010-12#1)
on day 40##2##3##(2008-10#1)(2008-7#1)
on day 5 of decidualization##2##5##(1997-6#2)
on day 5 of lactation##2##5##(1992-5#2)
on day 5 of##4##4##(1992-5#2)(1997-6#2)
on day 5##15##3##(1990-7#1)(1992-5#2)(1994-2#3)(1996-10#1)(1997-6#2)(2006-9#1)(2007-10#1)(2007-8#1)(2008-4#1)(2009-10#1)(2013-1#1)
on day 57 after##2##4##(1990-2#1)(2013-8#1)
on day 6 by##2##4##(2008-5#1)(2010-7#1)
on day 6##6##3##(1991-10#1)(1995-2#1)(2008-5#1)(2009-3#1)(2010-7#1)(2012-12#1)
on day 64##3##3##(2008-7#3)
on day 7 after##2##4##(1996-12#1)(2012-1#1)
on day 7 and##2##4##(1995-12#1)(2008-10#1)
on day 7 as##2##4##(1990-9#1)(2008-11#1)
on day 7##14##3##(1990-9#1)(1992-11#1)(1993-4#1)(1994-12#1)(1994-5#1)(1995-12#1)(1996-12#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-1#1)(2012-2#1)
on day 8##8##3##(1991-2#1)(1993-12#1)(2006-9#1)(2007-2#1)(2008-12#1)(2008-8#1)(2011-2#1)(2013-8#1)
on day 9##4##3##(1994-6#2)(2012-1#1)(2012-2#1)
on day of##4##3##(2008-3#1)(2010-12#2)(2012-2#1)
on day##243##2##(1990-10#1)(1990-12#1)(1990-2#4)(1990-5#2)(1990-7#1)(1990-9#3)(1991-1#1)(1991-10#12)(1991-2#9)(1991-4#2)(1991-5#2)(1991-8#2)(1992-11#2)(1992-3#2)(1992-5#3)(1992-7#1)(1992-8#2)(1993-12#4)(1993-4#2)(1993-6#3)(1993-9#1)(1994-12#1)(1994-2#9)(1994-5#3)(1994-6#3)(1994-8#2)(1995-11#4)(1995-12#7)(1995-2#2)(1995-7#2)(1995-9#1)(1996-10#1)(1996-12#5)(1996-2#1)(1996-4#1)(1997-3#1)(1997-5#1)(1997-6#4)(1997-7#2)(2004-1#1)(2004-11#3)(2005-12#1)(2006-10#1)(2006-4#1)(2006-6#5)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#9)(2007-11#2)(2007-2#2)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#4)(2008-7#10)(2008-8#3)(2008-9#6)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#4)(2010-4#4)(2010-7#6)(2011-1#2)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#7)(2013-1#2)(2013-8#9)
on days 0##8##3##(1991-10#1)(1994-6#1)(1995-12#2)(1997-6#1)(2008-10#1)(2008-5#1)(2010-4#1)
on days 1 and 2##2##5##(1992-3#1)(2008-6#1)
on days 1 and 29##2##5##(1990-2#1)(2004-1#1)
on days 1 and 8##3##5##(1994-7#1)(2004-1#1)(2008-10#1)
on days 1 and##9##4##(1990-10#1)(1990-2#1)(1992-3#1)(1994-7#1)(2004-1#2)(2008-10#1)(2008-6#1)(2009-11#1)
on days 1 to 3##3##5##(1991-4#1)(2007-6#1)(2008-6#1)
on days 1 to##4##4##(1991-10#1)(1991-4#1)(2007-6#1)(2008-6#1)
on days 1##32##3##(1990-10#5)(1990-2#2)(1991-10#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-3#1)(1994-2#1)(1994-7#1)(1995-2#1)(1996-1#1)(2004-1#3)(2004-10#1)(2007-10#1)(2007-6#1)(2008-10#2)(2008-4#1)(2008-6#2)(2009-11#1)(2009-12#1)(2012-1#2)(2012-2#1)
on days 1-3##2##3##(1990-2#2)
on days 1-4##2##3##(1991-5#1)(2006-8#1)
on days 1-5##4##3##(1991-10#1)(2007-1#1)(2007-6#1)(2008-10#1)
on days 10-12 at 100 mg/kg##2##6##(1995-2#2)
on days 10-12##3##3##(1993-3#1)(1995-2#2)
on days 13-15##4##3##(1993-3#2)(1995-2#2)
on days 2 and##2##4##(1990-10#1)(2012-1#1)
on days 2##3##3##(1990-10#1)(1992-1#1)(2012-1#1)
on days 20##2##3##(1993-12#2)
on days 4##4##3##(1994-5#1)(2007-7#1)(2010-12#1)(2010-7#1)
on days 5 and 7##3##5##(1997-6#3)
on days 5 and##4##4##(1993-12#1)(1997-6#3)
on days 5##5##3##(1993-12#2)(1997-6#3)
on days 7##3##3##(1997-6#1)(2006-6#1)(2011-2#1)
on days 7-9##7##3##(1991-12#1)(1993-3#3)(1995-2#3)
on days on which##4##4##(2009-7#4)
on days with##2##3##(2008-10#2)
on days##117##2##(1990-10#8)(1990-11#1)(1990-2#4)(1990-8#1)(1991-10#3)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-12#7)(1993-2#2)(1993-3#6)(1994-2#3)(1994-5#1)(1994-6#1)(1994-7#1)(1995-12#3)(1995-2#8)(1995-5#1)(1996-1#1)(1996-10#1)(1997-6#5)(2004-1#4)(2004-10#1)(2004-2#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#3)(2007-6#2)(2007-7#1)(2008-10#9)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-9#1)(2009-11#1)(2009-12#2)(2009-7#5)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#3)(2012-2#1)(2013-1#1)
on daytime##3##2##(2005-11#1)(2008-8#1)(2013-1#1)
on de novo protein##3##4##(1994-3#1)(1995-12#1)(1995-3#1)
on de novo##6##3##(1993-7#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-3#1)(2007-11#1)
on dead##4##2##(2007-2#1)(2008-10#2)(2013-7#1)
on death##8##2##(1994-1#3)(2007-10#2)(2011-1#1)(2011-2#2)
on decaying cephalopod beaks##2##4##(2011-2#2)
on decentralization##3##2##(1992-5#1)(2008-1#1)(2012-3#1)
on deciphering##2##2##(2008-1#1)(2011-1#1)
on decision making##4##3##(1992-3#1)(2004-12#1)(2010-8#1)(2013-7#1)
on decision##5##2##(1992-3#1)(2004-12#1)(2010-8#1)(2013-7#1)(2013-8#1)
on decision-making##3##2##(2006-10#1)(2008-11#1)(2011-1#1)
on decreasing##4##2##(2008-11#1)(2008-2#1)(2012-2#2)
on dedicated##2##2##(2008-3#1)(2008-9#1)
on deep##3##2##(2008-2#1)(2008-8#1)(2009-11#1)
on defense##2##2##(2008-8#1)(2012-1#1)
on defined##6##2##(1990-6#1)(1995-11#1)(2008-11#1)(2008-2#1)(2013-1#2)
on defining the##3##3##(1991-3#1)(2005-7#1)(2005-8#1)
on defining##6##2##(1991-3#1)(1996-3#1)(2005-7#1)(2005-8#1)(2007-11#1)(2012-1#1)
on definite##2##2##(1990-12#1)(2008-9#1)
on degradation##3##2##(1990-8#1)(2004-11#1)(2013-8#1)
on degranulation##2##2##(1990-12#1)(1992-3#1)
on degree of##3##3##(2006-10#1)(2008-5#1)(2011-2#1)
on degree##4##2##(1992-9#1)(2006-10#1)(2008-5#1)(2011-2#1)
on dehydroepiandrosterone##2##2##(1995-12#1)(2005-8#1)
on delayed##5##2##(1992-11#1)(1993-3#1)(2007-12#1)(2008-5#1)(2012-12#1)
on delinquent behavior##2##3##(2009-7#1)(2009-8#1)
on delivery##5##2##(2005-7#1)(2006-10#1)(2008-10#1)(2010-1#1)(2011-2#1)
on demand for##3##3##(2008-10#1)(2008-12#2)
on demand##10##2##(1991-11#1)(1991-12#1)(1994-12#2)(1994-4#1)(2006-7#1)(2008-10#1)(2008-12#2)(2008-7#1)
on demographic and##3##3##(1991-12#1)(2006-7#1)(2012-12#1)
on demographic##11##2##(1991-12#1)(1995-1#1)(1997-1#1)(2006-2#1)(2006-7#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-12#1)
on demographics##5##2##(2006-10#1)(2007-7#1)(2011-2#2)(2013-8#1)
on demonstrating##2##2##(1991-11#1)(2007-8#1)
on denaturation##4##2##(1997-2#2)(1997-7#1)(2006-10#1)
on dendrites of##2##3##(1993-12#1)(1996-5#1)
on dendritic cells##2##3##(2007-1#1)(2008-11#1)
on dendritic##5##2##(1990-7#1)(1996-1#1)(2007-1#1)(2008-10#1)(2008-11#1)
on denervated##2##2##(1994-3#2)
on dengue##2##2##(2006-10#1)(2011-2#1)
on density gradients##2##3##(1991-9#1)(2008-2#1)
on density##6##2##(1991-9#1)(2006-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)
on dental hygiene##2##3##(2006-2#2)
on dental##10##2##(1991-2#1)(2006-2#2)(2008-12#1)(2008-8#1)(2012-12#1)(2012-2#3)(2013-1#1)
on dentin##4##2##(2008-5#1)(2011-2#1)(2013-8#2)
on dephosphorylation##5##2##(1991-12#1)(1991-7#1)(1994-10#1)(2005-11#1)(2008-8#1)
on depolarization##2##2##(2007-9#1)(2008-3#1)
on depression##9##2##(1995-1#1)(1995-2#1)(1995-3#1)(2007-1#1)(2008-4#1)(2008-9#1)(2010-2#2)(2011-2#1)
on depressive symptoms and##2##4##(2009-11#1)(2011-2#1)
on depressive symptoms##4##3##(2009-11#1)(2011-1#1)(2011-2#2)
on derivatization##4##2##(1996-1#1)(2008-10#3)
on describing the##2##3##(2008-2#1)(2008-8#1)
on design of##3##3##(2008-11#2)(2008-3#1)
on design##4##2##(2008-11#2)(2008-3#1)(2010-6#1)
on designing##3##2##(2008-10#1)(2008-3#1)(2009-12#1)
on detached leaflets##2##3##(2008-10#2)
on detached##5##2##(2008-10#4)(2011-2#1)
on detailed analysis of##2##4##(2006-6#1)(2007-4#1)
on detailed##8##2##(1997-3#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-5#1)
on details##2##2##(2005-8#1)(2008-3#1)
on detecting##4##2##(2006-10#1)(2008-10#1)(2008-3#1)(2012-2#1)
on detection of the##6##4##(2004-9#2)(2008-10#1)(2008-8#2)(2011-2#1)
on detection of##16##3##(1990-10#1)(1993-7#1)(1997-6#1)(2004-9#2)(2007-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
on detection##18##2##(1990-10#1)(1993-7#1)(1997-6#1)(2004-9#2)(2007-6#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-8#2)(2008-9#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
on determination of the optical##2##5##(2007-12#1)(2008-2#1)
on determination of the##5##4##(2007-12#1)(2008-2#1)(2008-3#2)(2008-8#1)
on determination of##11##3##(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#3)(2008-8#1)
on determining the##4##3##(1996-8#1)(2008-3#1)(2013-1#2)
on determining##9##2##(1990-12#1)(1996-8#1)(2006-2#1)(2008-3#1)(2008-5#1)(2010-2#1)(2011-1#1)(2013-1#2)
on developing and##2##3##(2005-8#1)(2008-11#1)
on developing countries and##2##4##(2009-4#1)(2011-2#1)
on developing countries##4##3##(2009-4#2)(2011-2#1)(2012-1#1)
on developing rat##2##3##(1991-11#1)(1993-11#1)
on developing##20##2##(1991-11#1)(1993-11#1)(1995-12#1)(2005-8#1)(2006-10#2)(2006-6#1)(2007-12#1)(2008-11#1)(2009-2#1)(2009-4#2)(2009-7#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-1#1)
on development and##5##3##(2005-11#1)(2006-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
on development of a##2##4##(2008-10#1)(2011-2#1)
on development of the##3##4##(1993-1#1)(1995-5#1)(1996-5#1)
on development of##18##3##(1993-1#1)(1995-5#1)(1996-5#1)(2006-10#1)(2008-10#4)(2008-11#1)(2009-2#1)(2010-7#2)(2011-12#1)(2011-2#3)(2012-2#1)(2012-3#1)
on development##33##2##(1993-1#1)(1994-3#1)(1995-5#1)(1996-5#1)(2004-12#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-7#1)(2008-10#4)(2008-11#2)(2008-7#1)(2009-2#1)(2010-12#2)(2010-7#2)(2011-12#2)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)
on developmental and##2##3##(2004-11#1)(2005-7#1)
on developmental##10##2##(2004-11#1)(2005-7#2)(2006-8#2)(2007-6#1)(2010-3#1)(2012-1#1)(2012-12#1)(2013-1#1)
on developments in##3##3##(1992-3#1)(2007-8#1)(2008-3#1)
on devitalised##2##2##(1992-3#1)(2005-7#1)
on dexamethasone##2##2##(1997-1#1)(2010-12#1)
on dextran##2##2##(1990-5#1)(1995-12#1)
on diabetes and##3##3##(2007-1#1)(2008-1#2)
on diabetes control in type 2 diabetic patients##2##8##(2011-2#2)
on diabetes control##3##3##(2011-2#3)
on diabetes mellitus##2##3##(2008-3#1)(2011-2#1)
on diabetes##18##2##(1994-12#1)(2007-1#1)(2008-1#6)(2008-3#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-5#1)(2013-8#2)
on diabetic nephropathy##5##3##(1994-3#3)(2004-11#1)(2008-1#1)
on diabetic##7##2##(1994-3#3)(2004-11#1)(2008-1#2)(2012-2#1)
on diacylglycerol and monoacylglycerol lipase activities##2##6##(1993-2#2)
on diacylglycerol##3##2##(1990-12#1)(1993-2#2)
on diagnosis and management##2##4##(2008-12#1)(2010-12#1)
on diagnosis and treatment of##4##5##(1996-12#1)(2010-12#1)(2013-1#2)
on diagnosis and treatment##5##4##(1996-12#1)(2010-12#1)(2011-2#1)(2013-1#2)
on diagnosis and##11##3##(1990-10#1)(1995-1#2)(1996-12#1)(2008-12#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#2)
on diagnosis##16##2##(1990-10#1)(1995-1#2)(1996-12#1)(2007-7#1)(2008-12#1)(2009-5#1)(2010-12#2)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
on diagnostic and prognostic##2##4##(2010-5#1)(2011-2#1)
on diagnostic and##5##3##(1990-9#1)(2010-2#1)(2010-5#1)(2011-2#1)(2013-1#1)
on diagnostic##17##2##(1990-9#1)(1997-8#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-2#1)(2010-5#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#2)(2013-7#1)
on dialogue##2##2##(1994-4#1)(2005-12#1)
on dialysis and##4##3##(2007-7#2)(2008-1#2)
on dialysis in the##2##4##(2007-7#1)(2011-1#1)
on dialysis in##3##3##(2007-7#1)(2011-1#1)(2012-2#1)
on dialysis treatment##3##3##(1991-6#1)(1996-8#1)(2011-1#1)
on dialysis was##3##3##(2007-8#1)(2008-1#1)(2012-2#1)
on dialysis##45##2##(1991-6#1)(1996-2#1)(1996-8#2)(1997-1#1)(2005-10#1)(2007-7#10)(2007-8#4)(2008-1#11)(2008-10#1)(2008-4#3)(2010-5#1)(2011-1#2)(2011-2#3)(2012-2#4)
on dialyzer##2##2##(2008-1#2)
on diameter##2##2##(1992-8#1)(2011-2#1)
on dielectric##3##2##(2007-11#1)(2008-3#1)(2010-12#1)
on dielectrophoresis##2##2##(2006-2#2)
on diet and cancer##2##4##(1990-8#1)(1993-12#1)
on diet and##4##3##(1990-8#1)(1991-12#1)(1993-12#1)(2006-8#1)
on diet##11##2##(1990-8#1)(1991-12#1)(1993-12#1)(2004-11#1)(2004-2#1)(2006-2#2)(2006-8#1)(2008-9#1)(2009-4#1)(2010-2#1)
on dietary protein and weight reduction##2##6##(2008-3#2)
on dietary##8##2##(1991-12#1)(1996-11#1)(2008-3#2)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
on diets##2##2##(2008-5#1)(2008-6#1)
on difference##6##2##(1991-12#1)(1995-6#1)(2006-12#1)(2006-5#1)(2008-10#1)(2009-8#1)
on differences between the##2##4##(2008-9#1)(2011-1#1)
on differences in the##3##4##(1996-8#1)(2008-10#1)(2008-12#1)
on differences in##11##3##(1992-7#1)(1993-2#1)(1996-8#1)(2008-10#3)(2008-12#1)(2008-3#1)(2009-2#1)(2010-2#1)(2010-5#1)
on differences##14##2##(1992-7#1)(1993-2#1)(1996-8#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-9#1)(2009-2#1)(2010-2#1)(2010-5#1)(2011-1#1)
on different areas of##2##4##(2008-11#1)(2013-1#1)
on different aspects of##4##4##(1990-6#1)(1994-6#1)(2007-12#1)(2012-1#1)
on different chromosomes##3##3##(1995-1#1)(1997-3#1)(2008-2#1)
on different classes of##2##4##(1993-11#1)(2010-3#1)
on different components of the##2##5##(1994-10#1)(2004-12#1)
on different components of##4##4##(1994-10#1)(2004-12#1)(2008-9#1)(2011-1#1)
on different components##5##3##(1994-10#1)(2004-12#1)(2008-10#1)(2008-9#1)(2011-1#1)
on different days of the estrous cycle##2##7##(1993-11#2)
on different days##8##3##(1990-10#1)(1990-12#1)(1993-11#2)(1996-11#1)(2006-4#1)(2008-1#1)(2010-8#1)
on different host##4##3##(2008-10#2)(2008-8#1)(2008-9#1)
on different hosts##2##3##(2008-10#2)
on different length scales##2##4##(2008-2#1)(2011-1#1)
on different levels of##2##4##(2007-9#1)(2010-12#1)
on different levels##3##3##(2007-9#1)(2010-12#1)(2012-2#1)
on different modalities of##2##4##(2007-7#1)(2007-9#1)
on different models##3##3##(2008-2#1)(2009-1#1)(2012-1#1)
on different parameters##2##3##(2008-7#1)(2011-3#1)
on different sites and##2##4##(1996-6#1)(1997-8#1)
on different sites##3##3##(1996-6#1)(1997-8#1)(2008-10#1)
on different skin##2##3##(2008-5#1)(2010-9#1)
on different sources of##2##4##(2008-1#1)(2008-4#1)
on different stages of##2##4##(2007-11#1)(2008-12#1)
on different substrates##3##3##(1992-5#1)(2006-5#1)(2008-3#1)
on different subunit##2##3##(1990-7#1)(2008-8#1)
on different trophic levels##2##4##(2009-2#1)(2013-1#1)
on different types of##5##4##(1996-4#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-5#1)
on different##156##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-11#2)(1991-4#1)(1991-6#1)(1992-5#1)(1992-8#1)(1993-11#3)(1993-6#2)(1994-10#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-4#1)(1996-5#2)(1996-6#1)(1997-3#1)(1997-6#2)(1997-8#3)(2004-12#1)(2005-10#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#6)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#24)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#1)(2008-4#3)(2008-5#7)(2008-7#2)(2008-8#6)(2008-9#3)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-1#3)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#1)
on differential diagnosis##2##3##(2006-6#1)(2011-2#1)
on differential display##2##3##(2008-2#1)(2009-12#1)
on differential hosts##2##3##(2008-10#2)
on differential##18##2##(1991-6#1)(1993-11#1)(2006-6#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-2#4)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-2#1)
on differentiated##4##2##(1992-3#1)(1995-6#1)(1996-11#1)(2009-8#1)
on differentiation of##3##3##(1992-1#1)(2010-3#1)(2013-7#1)
on differentiation##5##2##(1992-1#1)(1994-3#1)(1997-2#1)(2010-3#1)(2013-7#1)
on difficult stretches##2##3##(2008-4#2)
on difficult##3##2##(2008-4#2)(2011-2#1)
on diffraction##3##2##(2006-5#1)(2007-12#2)
on diffuse correlation spectroscopy##2##4##(2011-1#2)
on diffuse##6##2##(1992-1#1)(1995-8#1)(2008-2#1)(2008-3#1)(2011-1#2)
on diffusion##6##2##(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2012-12#1)
on diffusion-weighted magnetic resonance imaging##2##5##(2006-10#1)(2009-11#1)
on diffusion-weighted##4##2##(2006-10#1)(2007-10#2)(2009-11#1)
on digester##2##2##(2008-5#1)(2008-6#1)
on digestible AA##2##3##(2008-12#2)
on digestion##2##2##(1990-12#1)(1990-4#1)
on digestive##3##2##(2007-12#1)(2010-12#2)
on digital##6##2##(2007-12#1)(2008-2#2)(2008-3#2)(2010-8#1)
on dihydropyridine-sensitive Ca2+##2##3##(1993-3#2)
on dihydropyridine-sensitive##3##2##(1993-3#2)(1994-9#1)
on dilute##2##2##(2006-5#1)(2009-5#1)
on dipalmitoylphosphatidylcholine (DPPC)##2##3##(1990-3#1)(1996-1#1)
on direct determination##3##3##(2008-10#3)
on direct observation of##2##4##(1990-8#1)(2008-8#1)
on direct##21##2##(1990-8#1)(1992-2#1)(1994-1#2)(1994-4#1)(2005-7#1)(2007-10#1)(2007-7#1)(2008-10#7)(2008-7#1)(2008-8#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-1#1)
on direction of##2##3##(2009-2#1)(2013-1#1)
on direction##5##2##(2008-2#1)(2008-8#1)(2009-2#1)(2012-12#1)(2013-1#1)
on disability pensions##2##3##(1993-6#2)
on disability##9##2##(1993-6#2)(1997-6#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-7#2)
on disc##2##2##(2007-11#1)(2012-12#1)
on discharge planning and##2##4##(1990-12#1)(1997-3#1)
on discharge planning##3##3##(1990-12#1)(1997-3#1)(2012-11#1)
on discharge##13##2##(1990-12#1)(1991-3#1)(1994-2#1)(1995-3#1)(1997-3#1)(2007-9#1)(2008-3#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#3)
on discoid##2##2##(1994-8#1)(2013-7#1)
on discontinuous##3##2##(1991-7#2)(1995-1#1)
on discrete##3##2##(1996-12#1)(2008-2#1)(2008-9#1)
on discrimination of##2##3##(1992-10#1)(2013-8#1)
on discussion##2##2##(2010-11#1)(2013-1#1)
on disease activity##3##3##(1994-7#2)(2008-10#1)
on disease and##3##3##(2006-10#1)(2007-8#1)(2008-10#1)
on disease control in##2##4##(2008-10#1)(2008-7#1)
on disease development##3##3##(2008-10#3)
on disease incidence##5##3##(2008-10#5)
on disease management##3##3##(1997-4#1)(2008-10#1)(2012-11#1)
on disease progression in##2##4##(2008-10#2)
on disease progression##8##3##(2005-8#1)(2006-2#1)(2007-11#1)(2008-10#4)(2010-6#1)
on disease risk##2##3##(2012-2#1)(2012-3#1)
on disease severity in the##2##5##(2008-10#2)
on disease severity in##3##4##(2007-12#1)(2008-10#2)
on disease severity##6##3##(2007-12#1)(2008-10#5)
on disease suppressiveness of soils##2##5##(2008-10#2)
on disease##65##2##(1990-11#1)(1993-12#1)(1994-7#2)(1995-10#1)(1997-2#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#31)(2008-11#1)(2008-12#1)(2008-7#2)(2009-10#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#1)
on diseased##2##2##(2008-10#2)
on diseases and##2##3##(1990-12#1)(2008-10#1)
on diseases##5##2##(1990-12#1)(1995-9#1)(2007-5#1)(2008-10#1)(2010-8#1)
on dispersal##3##2##(2007-3#2)(2011-12#1)
on dispersed##3##2##(1994-8#2)(2013-1#1)
on dispersion##3##2##(2005-11#1)(2007-12#2)
on dispersion-managed solitons##2##3##(2007-11#1)(2007-12#1)
on dispersion-managed##3##2##(2007-11#2)(2007-12#1)
on dispersive##2##2##(2007-12#1)(2008-10#1)
on disposable screen-printed electrodes##2##4##(2007-8#1)(2008-10#1)
on disposable##3##2##(1996-8#1)(2007-8#1)(2008-10#1)
on disruption of##2##3##(1991-6#1)(2008-4#1)
on dissolution of##3##3##(1991-12#1)(2004-9#1)(2008-5#1)
on dissolution##4##2##(1991-12#1)(2004-9#1)(2007-12#1)(2008-5#1)
on dissolved##2##2##(2005-8#1)(2008-10#1)
on distal##9##2##(1994-8#1)(1996-6#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-9#1)(2010-12#1)(2010-5#1)
on distance##2##2##(1990-10#1)(2008-10#1)
on distinct##9##2##(2008-10#1)(2008-4#2)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
on distribution of##5##3##(1993-4#1)(1995-3#1)(2007-8#1)(2008-10#2)
on distribution##9##2##(1993-4#1)(1994-5#1)(1995-3#1)(2007-8#1)(2008-10#5)
on disturbed##3##2##(1993-11#1)(2006-7#1)(2010-6#1)
on diuretics##5##2##(1993-2#1)(1996-5#1)(1996-9#1)(2007-9#1)(2010-12#1)
on diurnal##2##2##(1992-8#1)(1997-1#1)
on divalent cations##4##3##(1990-4#1)(1992-12#1)(1992-9#1)(1993-8#1)
on divalent##5##2##(1990-4#1)(1991-5#1)(1992-12#1)(1992-9#1)(1993-8#1)
on diverse##4##2##(2007-8#1)(2009-3#2)(2011-3#1)
on documentation and##2##3##(1994-12#1)(1997-6#1)
on documentation##5##2##(1994-12#1)(1997-6#1)(2006-8#1)(2007-9#1)(2010-1#1)
on dofetilide##2##2##(1997-1#2)
on dog##2##2##(1996-12#1)(2007-12#1)
on dogs##2##2##(2011-1#1)(2012-12#1)
on dogwhelk##2##2##(2004-4#2)
on domestic##2##2##(2009-8#1)(2011-1#1)
on dopamine (DA)##2##3##(1991-12#1)(2013-1#1)
on dopamine biosynthesis##2##3##(2008-11#2)
on dopamine release in##2##4##(1995-11#1)(1997-3#1)
on dopamine release##5##3##(1995-11#1)(1996-12#2)(1997-2#1)(1997-3#1)
on dopamine##25##2##(1991-12#1)(1992-1#1)(1993-2#1)(1994-10#2)(1995-11#1)(1995-12#1)(1996-10#2)(1996-12#4)(1996-2#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-5#2)(2009-7#1)(2010-2#1)(2013-1#1)
on dopaminergic nerve terminals##3##4##(1995-12#2)(1996-12#1)
on dopaminergic##11##2##(1991-9#2)(1993-2#1)(1995-12#2)(1995-7#1)(1996-10#1)(1996-12#1)(1997-8#1)(2008-7#1)(2013-1#1)
on dormancy progression in apricot##2##5##(2012-8#2)
on dorsum of##2##3##(2007-8#1)(2008-5#1)
on dose and##2##3##(1997-7#1)(2005-3#1)
on dose##6##2##(1994-8#1)(1997-7#1)(2005-3#1)(2007-10#1)(2008-7#1)(2013-8#1)
on dose-response##3##2##(1990-10#1)(2007-6#1)(2008-7#1)
on double##5##2##(2007-12#2)(2008-3#1)(2008-4#1)(2012-3#1)
on double-stranded DNA##3##3##(1991-7#1)(1994-9#1)(2010-5#1)
on double-stranded##4##2##(1991-7#1)(1994-9#1)(2010-5#1)(2013-1#1)
on downstream##3##2##(1997-7#1)(2008-4#1)(2009-8#1)
on dried##5##2##(2007-11#1)(2008-10#2)(2008-12#2)
on drinking##2##2##(1991-8#1)(2011-1#1)
on driving ability and##2##4##(1993-5#1)(2008-8#1)
on driving behavior##2##3##(2012-12#2)
on driving##9##2##(1993-5#1)(2006-8#1)(2007-12#2)(2008-8#1)(2012-12#4)
on droplet growth in oil-in-water emulsions##2##6##(2005-11#2)
on droplet##4##2##(1995-3#1)(2005-11#2)(2006-12#1)
on drosophila##2##2##(1993-2#1)(2009-5#1)
on drought##2##2##(2012-8#1)(2012-9#1)
on drug concentration##3##3##(1996-3#2)(2007-11#1)
on drug discovery##2##3##(2005-9#1)(2010-2#1)
on drug metabolism##2##3##(1993-1#1)(2005-8#1)
on drug release##2##3##(2011-1#1)(2012-2#1)
on drug resistance##2##3##(2008-11#1)(2008-4#1)
on drug##37##2##(1990-4#1)(1993-1#1)(1993-3#1)(1995-2#2)(1995-9#1)(1996-10#1)(1996-3#3)(1997-7#1)(2005-10#1)(2005-8#2)(2005-9#1)(2006-11#1)(2006-8#1)(2007-11#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
on drug-induced liver##2##3##(1996-11#1)(2006-10#1)
on drug-induced##4##2##(1993-11#1)(1996-11#1)(1997-5#1)(2006-10#1)
on drug-resistance##2##2##(2007-2#1)(2012-2#1)
on drugs with##3##3##(2006-11#1)(2008-7#1)(2008-8#1)
on drugs##13##2##(1990-4#1)(1991-3#1)(1993-3#1)(2005-9#1)(2006-11#1)(2007-11#1)(2007-3#4)(2008-5#1)(2008-7#1)(2008-8#1)
on dry##8##2##(1991-9#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)(2013-8#1)
on dual##4##2##(2007-3#1)(2008-10#2)(2011-3#1)
on duration of##2##3##(1997-8#1)(2011-1#1)
on duration##3##2##(1997-8#1)(2008-7#1)(2011-1#1)
on during##2##2##(1993-5#1)(1995-8#1)
on dust##2##2##(2007-4#1)(2008-3#1)
on duties at work##2##4##(2007-7#2)
on duty##4##2##(1991-6#1)(1992-11#1)(2007-9#1)(2008-8#1)
on dye##4##2##(1996-1#1)(2008-3#2)(2008-9#1)
on dynamic##8##2##(2007-11#1)(2008-2#1)(2008-3#1)(2009-10#1)(2010-10#1)(2011-1#2)(2011-3#1)
on dynamically##2##2##(1997-8#1)(2009-10#1)
on dynamics##2##2##(2010-2#1)(2011-2#1)
on each case##2##3##(1993-10#1)(1996-11#1)
on each cell##2##3##(1990-10#1)(2008-9#1)
on each day##2##3##(1991-12#1)(2008-10#1)
on each dimension##2##3##(2008-12#1)(2011-2#1)
on each explant##3##3##(2008-12#3)
on each host##2##3##(2008-10#1)(2008-9#1)
on each individual##5##3##(1990-5#1)(1994-9#1)(1997-7#1)(2006-10#1)(2013-8#1)
on each item##2##3##(2011-1#1)(2011-2#1)
on each occasion##2##3##(1996-12#1)(2010-2#1)
on each of 4##2##4##(1992-3#1)(1992-6#1)
on each of the##10##4##(1990-12#1)(1991-2#1)(1992-2#1)(1995-2#1)(1996-11#1)(2005-10#1)(2007-9#1)(2008-4#1)(2010-12#1)(2011-1#1)
on each of##16##3##(1990-12#1)(1991-2#1)(1992-2#1)(1992-3#1)(1992-6#1)(1995-2#1)(1995-9#1)(1996-11#1)(1997-4#1)(1997-6#1)(2005-10#1)(2007-5#1)(2007-9#1)(2008-4#1)(2010-12#1)(2011-1#1)
on each other##2##3##(2005-10#1)(2009-8#1)
on each patient##3##3##(2007-9#1)(2009-6#1)(2013-8#1)
on each sampling##2##3##(2007-6#1)(2012-8#1)
on each side of C60##2##5##(2009-2#2)
on each side of the##4##5##(1991-11#1)(1992-11#1)(1995-7#1)(2008-5#1)
on each side of##7##4##(1991-11#1)(1992-11#1)(1995-7#1)(2006-10#1)(2008-5#1)(2009-2#2)
on each side##11##3##(1991-11#1)(1992-11#1)(1995-7#1)(2006-10#1)(2007-12#1)(2008-5#2)(2008-7#1)(2009-2#2)(2013-1#1)
on each side)##2##3##(2006-9#1)(2008-5#1)
on each trial##8##3##(1990-10#1)(1993-12#1)(1995-8#1)(2008-5#2)(2009-11#2)(2009-3#1)
on each##131##2##(1990-10#3)(1990-12#2)(1990-2#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-10#1)(1993-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-7#1)(1995-8#2)(1995-9#1)(1996-11#2)(1996-12#1)(1996-4#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(2004-2#1)(2004-9#1)(2005-10#2)(2006-10#4)(2006-11#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-12#4)(2007-4#2)(2007-5#1)(2007-6#1)(2007-9#2)(2008-10#7)(2008-11#1)(2008-12#4)(2008-2#8)(2008-3#2)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#4)(2012-2#1)(2012-3#2)(2012-8#1)(2013-1#4)(2013-8#2)
on earlier##5##2##(1996-6#1)(1997-7#1)(2006-12#1)(2008-3#1)(2008-8#1)
on early and late##2##4##(1994-9#1)(1997-8#1)
on early and##7##3##(1991-3#1)(1993-11#1)(1994-9#1)(1997-8#1)(2007-2#1)(2007-8#2)
on early diagnosis and##2##4##(2009-1#1)(2012-2#1)
on early diagnosis##3##3##(1991-2#1)(2009-1#1)(2012-2#1)
on early events##2##3##(1995-2#1)(2006-10#1)
on early stage##3##3##(1992-4#1)(2008-11#1)(2010-12#1)
on early##46##2##(1990-12#1)(1991-2#1)(1991-3#1)(1992-4#1)(1993-11#1)(1993-4#1)(1994-1#1)(1994-9#1)(1995-2#1)(1995-6#1)(1997-3#1)(1997-8#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#2)(2009-1#1)(2009-2#1)(2009-9#1)(2010-12#4)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#3)
on earth##9##2##(1994-2#2)(2007-12#1)(2008-11#1)(2008-5#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-8#1)
on easy##2##2##(2008-4#2)
on eating quality##2##3##(2010-4#2)
on eating##8##2##(1995-12#1)(2006-7#1)(2007-12#1)(2007-2#2)(2010-4#2)(2012-1#1)
on echocardiography and##2##3##(2007-8#1)(2011-2#1)
on echocardiography##7##2##(2007-10#2)(2007-7#2)(2007-8#1)(2009-9#1)(2011-2#1)
on ecological and##2##3##(1997-7#1)(2010-12#1)
on ecological communities##2##3##(2008-9#1)(2013-1#1)
on ecological##9##2##(1997-7#1)(2006-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)(2012-2#1)(2013-1#1)
on ecology##2##2##(2008-1#1)(2013-7#1)
on economic##3##2##(1993-3#1)(1994-12#1)(2006-7#1)
on economics##2##2##(1996-1#1)(2006-10#1)
on edema formation in##2##4##(1992-6#1)(2008-2#1)
on edible##4##2##(2007-8#1)(2008-12#2)(2010-7#1)
on educating##2##2##(2008-1#1)(2012-3#1)
on education##6##2##(1992-3#1)(1993-12#1)(2008-9#1)(2011-1#1)(2011-3#1)(2012-2#1)
on educational outcomes##2##3##(2008-11#1)(2010-3#1)
on educational##8##2##(1992-1#1)(2006-3#1)(2006-8#1)(2008-11#1)(2008-9#1)(2009-3#1)(2010-3#1)(2011-2#1)
on effect of##4##3##(1994-6#1)(2007-1#1)(2008-10#1)(2010-12#1)
on effect##6##2##(1994-6#1)(2007-1#1)(2008-10#1)(2010-12#1)(2012-3#1)(2013-8#1)
on effective##14##2##(1995-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#1)(2010-12#1)(2011-2#2)
on effectiveness of##2##3##(2010-4#1)(2010-6#1)
on effectiveness##3##2##(1994-11#1)(2010-4#1)(2010-6#1)
on effects of##4##3##(1994-5#1)(2006-6#1)(2012-2#1)(2013-8#1)
on effects##6##2##(1992-4#1)(1994-5#1)(2006-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
on efficacy and safety##2##4##(2006-10#1)(2008-5#1)
on efficacy and tolerability##2##4##(2007-10#1)(2008-3#1)
on efficacy and##6##3##(2006-10#1)(2007-10#1)(2008-3#1)(2008-5#2)(2010-8#1)
on efficacy of##6##3##(1990-5#1)(1995-10#1)(2008-5#3)(2013-1#1)
on efficacy##19##2##(1990-5#1)(1995-10#1)(2006-10#1)(2007-10#2)(2007-11#2)(2007-6#1)(2008-3#1)(2008-5#7)(2010-8#1)(2012-3#1)(2013-1#1)
on efficient##10##2##(1992-12#1)(1993-2#1)(1994-2#1)(2007-12#3)(2008-9#1)(2011-12#1)(2013-1#2)
on efforts to##3##3##(1990-12#1)(2008-11#1)(2012-3#1)
on efforts##4##2##(1990-12#1)(2008-11#1)(2012-1#1)(2012-3#1)
on egg production but##2##4##(2008-5#2)
on egg production##5##3##(2008-5#4)(2008-7#1)
on egg size##2##3##(1991-5#1)(2008-8#1)
on egg##9##2##(1991-5#1)(2008-5#4)(2008-7#1)(2008-8#1)(2010-2#1)(2010-8#1)
on eggs##3##2##(1990-10#1)(2008-6#1)(2008-8#1)
on eicosanoid##2##2##(1991-5#2)
on eight different##2##3##(2008-10#1)(2012-2#1)
on eight##14##2##(1993-9#1)(2005-7#1)(2007-4#1)(2007-8#1)(2008-10#5)(2008-2#1)(2011-2#2)(2012-2#1)(2013-1#1)
on either a##5##3##(1993-9#1)(1994-6#1)(2008-10#1)(2008-3#1)(2012-3#1)
on either of##2##3##(1992-1#1)(1994-8#1)
on either side of a##2##5##(1995-10#1)(2007-3#1)
on either side of the##17##5##(1990-4#1)(1991-11#1)(1994-9#1)(1995-8#1)(1996-1#1)(1996-2#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-9#1)(2009-6#1)(2013-1#1)(2013-7#1)
on either side of##22##4##(1990-4#1)(1991-11#2)(1991-5#1)(1994-9#1)(1995-10#1)(1995-8#1)(1996-1#1)(1996-2#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-9#1)(2009-6#1)(2013-1#1)(2013-7#1)
on either side##25##3##(1990-4#1)(1991-11#2)(1991-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-8#1)(1996-1#1)(1996-2#1)(2007-11#2)(2007-12#1)(2007-3#2)(2007-5#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-9#1)(2009-6#1)(2013-1#2)(2013-7#1)
on either the##12##3##(1991-9#1)(1992-9#1)(1994-11#1)(1994-2#1)(1995-7#1)(1997-4#1)(2007-10#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-2#1)
on either##84##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-8#1)(1991-11#2)(1991-2#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-6#2)(1992-9#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-6#2)(1995-7#2)(1995-8#3)(1996-1#1)(1996-2#2)(1996-7#1)(1997-1#1)(1997-4#2)(1997-6#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-5#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-3#2)(2007-5#1)(2007-7#1)(2008-10#5)(2008-2#2)(2008-3#5)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#1)(2010-2#1)(2010-4#1)(2010-5#1)(2012-3#1)(2012-9#1)(2013-1#2)(2013-7#1)
on elastic properties of##2##4##(2010-3#1)(2010-8#1)
on elastic##5##2##(2008-11#1)(2008-3#1)(2008-6#1)(2010-3#1)(2010-8#1)
on elderly patients##2##3##(1992-9#1)(1993-9#1)
on elderly##3##2##(1992-9#1)(1993-9#1)(2011-2#1)
on electric hot plate##2##4##(2008-10#2)
on electric##4##2##(2007-12#1)(2008-10#2)(2008-2#1)
on electrical##9##2##(1991-5#1)(1994-5#1)(2007-10#1)(2008-10#1)(2008-2#1)(2009-3#2)(2009-8#1)(2013-8#1)
on electrically induced convulsions##3##4##(1993-3#3)
on electrically induced##4##3##(1993-3#3)(1996-12#1)
on electrically##5##2##(1993-12#1)(1993-3#3)(1996-12#1)
on electro-optic##2##2##(2007-12#1)(2013-8#1)
on electrocardiogram (ECG)##3##3##(2011-2#2)(2012-2#1)
on electrocardiogram##4##2##(2006-9#1)(2011-2#2)(2012-2#1)
on electrochemical reactions##2##3##(2008-10#1)(2010-2#1)
on electrochemical##8##2##(1996-11#1)(2008-10#5)(2010-2#1)(2010-4#1)
on electrochemically##2##2##(2007-12#1)(2007-9#1)
on electrode##3##2##(2008-10#3)
on electrodeposited##2##2##(2008-10#2)
on electrodes modified##2##3##(2008-10#2)
on electrodes##4##2##(2008-10#4)
on electron microscopy##2##3##(1994-10#1)(2008-5#1)
on electron##10##2##(1993-12#1)(1994-10#1)(1995-1#1)(1996-11#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-4#1)
on electronic##5##2##(1997-2#1)(2007-11#1)(2008-11#1)(2008-3#1)(2012-12#1)
on electrophoretic##2##2##(1991-2#1)(2008-10#1)
on electrophysiological##2##2##(1991-5#1)(2012-1#1)
on electrospun##2##2##(2008-5#2)
on electrostatic forces##2##3##(2006-2#1)(2008-10#1)
on electrostatic interaction##3##3##(2008-10#3)
on electrostatic interactions##3##3##(1994-11#1)(2008-10#2)
on electrostatic##8##2##(1994-11#1)(2006-2#1)(2008-10#6)
on elements of##6##3##(1994-6#1)(2006-10#1)(2007-11#1)(2008-8#1)(2013-1#2)
on elements##7##2##(1994-6#1)(2005-10#1)(2006-10#1)(2007-11#1)(2008-8#1)(2013-1#2)
on eliminating##2##2##(2005-4#1)(2009-4#1)
on embedded systems##2##3##(2008-2#2)
on embryo##4##2##(1996-8#1)(2006-5#3)
on embryonic chick##3##3##(1995-12#1)(1995-5#1)(1997-3#1)
on embryonic day 15##2##4##(1993-3#1)(1996-12#1)
on embryonic day##3##3##(1993-3#1)(1995-1#1)(1996-12#1)
on embryonic stem##2##3##(2007-10#1)(2009-4#1)
on embryonic##15##2##(1993-3#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-12#1)(1997-3#1)(2007-10#1)(2008-5#1)(2009-4#1)(2010-7#4)(2012-11#1)
on emergence##4##2##(2008-10#1)(2010-2#1)(2011-2#1)(2012-12#1)
on emergency basis##2##3##(2007-8#1)(2012-3#1)
on emergency department##2##3##(2007-7#1)(2009-4#1)
on emergency medicine##5##3##(2007-3#1)(2007-7#4)
on emergency##12##2##(2007-3#1)(2007-7#5)(2007-8#1)(2008-1#1)(2008-4#1)(2009-4#1)(2011-2#1)(2012-3#1)
on emerging issues##2##3##(1995-1#1)(2012-1#1)
on emerging##5##2##(1995-1#1)(2007-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
on emission##2##2##(2009-4#1)(2013-8#1)
on emotion##3##2##(2007-9#1)(2008-11#1)(2010-12#1)
on emotional##10##2##(1996-6#1)(2007-6#1)(2008-2#2)(2008-5#1)(2008-6#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-8#1)
on empirical data##4##3##(2007-6#1)(2007-9#1)(2008-5#1)(2012-1#1)
on empirical evidence##2##3##(2007-7#1)(2009-8#1)
on empirical##18##2##(1992-1#1)(1992-12#1)(1993-12#1)(2004-3#1)(2006-10#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-1#2)
on employee##2##2##(1991-2#1)(2008-3#1)
on employees##2##2##(1994-2#1)(1997-3#1)
on employer##2##2##(1993-3#1)(2006-5#1)
on employment##2##2##(1996-2#1)(2004-10#1)
on enabling##4##2##(2007-11#1)(2010-8#1)(2012-12#1)(2013-1#1)
on enamel##2##2##(2011-1#1)(2012-12#1)
on end-of-life##2##2##(2007-10#1)(2012-12#1)
on endocrine and##2##3##(2007-2#1)(2012-3#1)
on endocrine##5##2##(1991-2#1)(1996-5#1)(2005-8#1)(2007-2#1)(2012-3#1)
on endogenous hormone##2##3##(1990-9#1)(2013-8#1)
on endogenous##11##2##(1990-9#1)(1991-5#1)(1991-9#1)(1994-2#1)(1996-2#1)(1997-1#1)(2004-2#1)(2009-4#1)(2012-3#1)(2013-7#1)(2013-8#1)
on endometrial##3##2##(2006-10#1)(2008-6#1)(2011-1#1)
on endoscopic examination##3##3##(2008-5#2)(2011-1#1)
on endoscopic retrograde cholangiography##2##4##(2006-10#1)(2010-5#1)
on endoscopic retrograde##3##3##(2006-10#1)(2007-2#1)(2010-5#1)
on endoscopic##12##2##(1995-9#1)(2006-10#2)(2007-2#1)(2007-5#2)(2008-5#2)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)
on endothelial cell proliferation##2##4##(1990-4#1)(1990-7#1)
on endothelial cells##6##3##(1991-2#1)(1991-5#1)(1992-6#1)(1995-8#1)(2010-12#1)(2011-2#1)
on endothelial function##3##3##(1994-7#1)(2008-1#1)(2008-3#1)
on endothelial progenitor cells##2##4##(2009-7#1)(2010-6#1)
on endothelial progenitor##3##3##(2009-7#1)(2010-6#1)(2013-1#1)
on endothelial##16##2##(1990-4#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-6#1)(1994-7#1)(1995-8#1)(2008-1#1)(2008-3#1)(2009-7#1)(2010-12#1)(2010-6#1)(2011-2#2)(2013-1#1)
on endothelium-dependent##3##2##(1990-6#1)(2007-9#1)(2012-12#1)
on energetic##3##2##(1991-2#1)(2008-3#1)(2008-9#1)
on energy acquisition##2##3##(1995-12#2)
on energy metabolism##4##3##(1992-4#1)(1993-12#1)(1993-4#1)(2010-11#1)
on energy##13##2##(1990-8#1)(1991-11#1)(1992-4#1)(1993-12#1)(1993-4#1)(1994-11#1)(1995-12#3)(2008-11#1)(2010-11#1)(2012-12#2)
on enhanced##2##2##(2008-2#1)(2012-1#1)
on enhancement of the##2##4##(2007-12#2)
on enhancement of##4##3##(2007-12#2)(2008-11#1)(2012-2#1)
on enhancing##4##2##(1996-2#1)(2008-12#2)(2012-12#1)
on ensuring##4##2##(2005-5#1)(2007-3#1)(2013-1#2)
on entropy##3##2##(2005-11#1)(2007-12#1)(2008-7#1)
on entry##2##2##(1995-6#1)(2012-2#1)
on environment##2##2##(2008-10#1)(2010-9#1)
on environmental and##4##3##(1990-9#1)(2008-10#1)(2008-8#1)(2011-1#1)
on environmental conditions##4##3##(1991-6#1)(2005-7#1)(2008-10#2)
on environmental surfaces##2##3##(2007-12#2)
on environmental##15##2##(1990-9#1)(1991-6#1)(1992-3#1)(2005-7#1)(2007-12#2)(2008-10#3)(2008-3#1)(2008-4#1)(2008-8#2)(2011-1#1)(2013-8#1)
on enzymatic hydrolysis##3##3##(2008-5#1)(2008-6#2)
on enzymatic##10##2##(1991-10#1)(1995-1#1)(2008-10#1)(2008-5#2)(2008-6#2)(2010-12#1)(2010-4#1)(2011-2#1)
on enzyme activities##2##3##(2009-4#1)(2013-8#1)
on enzyme activity and##2##4##(2006-6#1)(2010-2#1)
on enzyme activity##5##3##(1991-1#1)(1994-6#1)(1995-8#1)(2006-6#1)(2010-2#1)
on enzyme function##3##3##(1991-3#1)(2008-2#1)(2010-2#1)
on enzyme mechanism##2##3##(1990-7#1)(2009-9#1)
on enzyme##21##2##(1990-5#1)(1990-7#1)(1991-1#1)(1991-3#1)(1994-6#1)(1995-5#1)(1995-8#1)(1996-3#1)(2006-6#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-5#1)(2009-4#1)(2009-9#1)(2010-2#2)(2013-8#1)
on enzymes##4##2##(1991-2#1)(1991-5#1)(1994-11#1)(2008-10#1)
on epidemic velocity##2##3##(2008-10#2)
on epidemics of potato late blight in##2##7##(2008-10#2)
on epidemics of##3##3##(2008-10#3)
on epidemics##4##2##(2008-10#3)(2008-12#1)
on epidemiologic##2##2##(1990-10#1)(1996-1#1)
on epidemiological and##2##3##(1997-8#1)(2010-4#1)
on epidemiological data##2##3##(2008-7#1)(2013-1#1)
on epidemiological##9##2##(1997-8#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#1)(2012-1#1)(2013-1#1)
on epidemiology and##2##3##(2006-10#1)(2012-3#1)
on epidemiology##11##2##(2004-11#1)(2006-10#1)(2007-4#1)(2008-10#1)(2009-2#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
on epidermal barrier##2##3##(2006-12#1)(2008-5#1)
on epidermal growth factor##4##4##(1990-12#1)(1994-12#2)(2005-12#1)
on epidermal##6##2##(1990-12#1)(1994-12#2)(2005-12#1)(2006-12#1)(2008-5#1)
on epilepsy##2##2##(2008-12#1)(2012-2#1)
on epileptic##2##2##(2010-8#1)(2012-3#1)
on episodes of##2##3##(2007-12#1)(2012-3#1)
on episodic memory functioning in##2##5##(2008-7#2)
on epithelial cells##7##3##(1990-5#2)(1997-1#1)(1997-7#2)(2005-11#1)(2008-12#1)
on epithelial##9##2##(1990-5#2)(1997-1#1)(1997-7#2)(2005-11#1)(2008-12#1)(2011-1#1)(2012-12#1)
on equal##4##2##(2006-2#2)(2007-8#1)(2010-12#1)
on equilibrium##6##2##(1995-8#1)(1997-2#1)(2007-8#2)(2008-10#1)(2013-8#1)
on equine##3##2##(1992-1#1)(1997-4#1)(2012-1#1)
on equity in##2##3##(1990-12#1)(1996-1#1)
on equity##3##2##(1990-12#1)(1996-1#1)(1997-4#1)
on equivalent##3##2##(2007-12#1)(2008-10#1)(2008-9#1)
on erbium-doped##2##2##(2007-11#1)(2007-12#1)
on error##3##2##(2008-2#1)(2008-9#1)(2013-7#1)
on errors##2##2##(1993-3#1)(2007-4#1)
on erythrocyte##3##2##(1992-6#1)(1994-12#1)(2008-10#1)
on erythrocytes##8##2##(1990-11#1)(1990-12#1)(1993-11#1)(1994-12#1)(1996-12#1)(1996-8#1)(2007-1#1)(2008-11#1)
on erythroid differentiation##2##3##(1991-12#1)(1992-8#1)
on erythroid##4##2##(1990-12#1)(1991-12#1)(1992-8#1)(2008-8#1)
on erythropoiesis in##2##3##(1992-2#1)(2013-1#1)
on erythropoiesis##4##2##(1992-2#1)(2013-1#3)
on esophageal##2##2##(2006-10#1)(2013-8#1)
on essential##2##2##(2008-6#1)(2012-12#1)
on established##12##2##(1994-10#1)(1996-10#1)(2005-6#1)(2007-9#1)(2008-10#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-6#1)(2010-3#1)
on establishing a##2##3##(2007-7#1)(2011-1#1)
on establishing the##2##3##(2007-5#1)(2009-5#1)
on establishing##4##2##(2007-5#1)(2007-7#1)(2009-5#1)(2011-1#1)
on estimated##3##2##(2005-8#2)(2013-1#1)
on estimates of##3##3##(1992-9#1)(1994-11#1)(2008-2#1)
on estimates##4##2##(1992-9#1)(1993-4#1)(1994-11#1)(2008-2#1)
on estimating##2##2##(1996-6#1)(2008-8#1)
on estradiol##2##2##(2008-11#1)(2008-12#1)
on estrogen##4##2##(1995-12#1)(1997-5#1)(2008-10#1)(2008-5#1)
on estrus##4##2##(1992-9#1)(1993-11#1)(2008-12#1)(2008-8#1)
on etanercept therapy##2##3##(2006-10#1)(2012-11#1)
on ethanol##5##2##(1996-12#2)(2005-11#1)(2008-10#1)(2009-12#1)
on ethanol-induced motor incoordination##2##4##(1997-2#2)
on ethical considerations##2##3##(1995-4#1)(2009-4#1)
on ethical issues##3##3##(1996-2#1)(2008-11#1)(2009-4#1)
on ethical##7##2##(1995-4#1)(1996-2#1)(2006-1#1)(2008-11#1)(2008-7#1)(2009-4#2)
on ethics##7##2##(1991-12#1)(1992-1#1)(1992-2#2)(1994-3#1)(1997-6#1)(2009-4#1)
on ethnic differences##2##3##(2008-1#1)(2013-8#1)
on ethnic##3##2##(2008-1#1)(2010-4#1)(2013-8#1)
on ethnicity##2##2##(2006-7#1)(2008-3#1)
on ethylene##4##2##(1994-6#1)(2008-10#1)(2008-3#2)
on etiology##4##2##(1996-7#1)(2006-10#2)(2006-8#1)
on eukaryotic##2##2##(1997-8#1)(2009-2#1)
on evaluating##4##2##(1991-12#1)(2008-3#1)(2013-1#2)
on evaluation of##8##3##(1992-12#1)(2004-2#1)(2006-10#1)(2007-7#1)(2008-10#2)(2010-12#1)(2013-8#1)
on evaluation##9##2##(1992-12#1)(2004-2#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-10#2)(2010-12#1)(2013-8#1)
on events##3##2##(1995-6#1)(2007-11#1)(2007-12#1)
on every dimension##2##3##(2008-10#1)(2010-7#1)
on every##13##2##(1992-6#1)(1994-1#1)(1994-5#1)(1995-8#1)(2004-9#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-7#1)(2011-2#1)(2013-8#1)
on everyday##3##2##(2005-7#1)(2007-4#1)(2007-9#1)
on evidence from##4##3##(2009-12#1)(2010-12#2)(2011-2#1)
on evidence of##5##3##(2004-12#1)(2007-10#1)(2007-11#1)(2008-11#1)(2010-2#1)
on evidence to##2##3##(1993-4#1)(2012-1#1)
on evidence##22##2##(1993-12#1)(1993-4#1)(1994-3#1)(2004-12#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-12#1)(2009-11#1)(2009-12#1)(2010-12#4)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-7#1)
on evoked##3##2##(1990-7#1)(1992-1#1)(2008-2#1)
on evolution of##2##3##(2008-7#1)(2008-8#1)
on evolution##4##2##(2008-7#1)(2008-8#1)(2008-9#1)(2011-12#1)
on evolutionary##10##2##(2007-12#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-4#1)(2010-3#1)(2010-4#1)(2010-7#1)(2013-1#1)
on ex##2##2##(2006-10#1)(2008-3#1)
on examination##8##2##(1993-12#1)(2006-10#1)(2006-8#2)(2007-2#1)(2008-10#1)(2008-3#1)(2010-12#1)
on examining the effects of##2##5##(1993-7#1)(2007-4#1)
on examining the##4##3##(1993-7#1)(2005-10#1)(2007-4#1)(2008-3#1)
on examining##8##2##(1993-7#1)(1994-2#1)(2005-10#1)(2007-4#1)(2008-3#1)(2008-6#1)(2008-7#2)
on examples##3##2##(2007-8#1)(2011-1#1)(2012-1#1)
on exchange##2##2##(2005-11#1)(2008-7#1)
on excised human##2##3##(2008-5#1)(2009-4#1)
on excised##8##2##(1994-2#1)(2008-10#2)(2008-12#2)(2008-5#2)(2009-4#1)
on excitation of the##2##4##(2008-2#1)(2009-6#1)
on excitation##5##2##(2007-12#2)(2008-2#1)(2008-3#1)(2009-6#1)
on excitatory synaptic transmission in the##2##6##(1997-2#2)
on excitatory synaptic##3##3##(1995-7#1)(1997-2#2)
on excitatory##6##2##(1995-7#1)(1996-5#1)(1997-1#1)(1997-2#2)(2012-1#1)
on excited-state##3##2##(2007-11#1)(2008-2#2)
on exercise behaviors##2##3##(2007-10#2)
on exercise tolerance##2##3##(2010-8#1)(2013-7#1)
on exercise##12##2##(1995-3#1)(2007-10#3)(2007-7#1)(2008-12#1)(2009-10#1)(2010-8#1)(2011-12#1)(2011-3#1)(2012-12#1)(2013-7#1)
on exercise-induced##3##2##(1996-2#1)(2010-1#1)(2010-8#1)
on exertion and##5##3##(1991-5#1)(2008-1#1)(2008-10#1)(2012-2#1)(2013-7#1)
on exertion##10##2##(1991-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-8#2)(2012-12#1)(2012-2#1)(2013-7#1)
on existing data##2##3##(2010-11#1)(2011-2#1)
on existing##18##2##(1990-2#1)(1992-12#1)(1996-12#1)(1997-8#1)(2007-10#1)(2007-7#1)(2010-11#1)(2011-1#1)(2011-11#1)(2011-2#1)(2011-9#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#4)
on exogenous##3##2##(1992-6#1)(1995-6#1)(2008-5#1)
on exon##2##2##(1993-12#1)(2006-9#1)
on expanding##2##2##(2008-10#1)(2011-1#1)
on expansion of##2##3##(2008-8#1)(2012-3#1)
on expansion##3##2##(1996-8#1)(2008-8#1)(2012-3#1)
on expectant##3##2##(2007-2#3)
on expectations##2##2##(1996-3#1)(2008-9#1)
on expected##2##2##(1994-2#1)(1996-9#1)
on expenditure##2##2##(1996-3#1)(1997-2#1)
on experience and##2##3##(2009-9#1)(2010-6#1)
on experience in##2##3##(1993-3#1)(1997-3#1)
on experience with##2##3##(1990-4#1)(1992-8#1)
on experience##11##2##(1990-4#1)(1991-10#1)(1992-6#1)(1992-8#1)(1993-3#1)(1997-3#1)(2008-10#1)(2009-9#1)(2010-6#1)(2011-3#2)
on experiences with##2##3##(1996-1#1)(2006-10#1)
on experiences##6##2##(1996-1#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-10#1)
on experimental animals##2##3##(1992-2#1)(2006-8#1)
on experimental data##2##3##(2008-7#2)
on experimental models of##2##4##(1994-12#1)(2008-10#1)
on experimental models##3##3##(1994-12#1)(2008-10#1)(2008-11#1)
on experimental parameters##3##3##(2006-12#1)(2008-10#1)(2010-4#1)
on experimental results##6##3##(1994-2#1)(2005-10#1)(2008-4#1)(2008-7#1)(2010-2#1)(2012-2#1)
on experimental##43##2##(1991-11#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-7#1)(1994-12#1)(1994-2#1)(1994-8#1)(1996-7#1)(2005-10#1)(2006-12#1)(2006-8#2)(2007-10#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-2#2)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
on experimentally induced##5##3##(1990-7#2)(2005-12#1)(2007-6#1)(2008-12#1)
on experimentally##8##2##(1990-7#2)(2005-12#1)(2007-6#1)(2008-10#2)(2008-12#1)(2009-11#1)
on experiments for##2##3##(2007-8#1)(2008-11#1)
on experiments##7##2##(1993-11#1)(1994-3#1)(1994-5#1)(2004-11#1)(2007-8#1)(2008-11#1)(2008-7#1)
on expert opinion##3##3##(2010-6#1)(2011-2#1)(2012-2#1)
on expert##9##2##(1997-3#1)(2006-10#1)(2010-6#1)(2011-10#1)(2011-2#1)(2012-2#1)(2013-1#3)
on expiratory##2##2##(2005-8#1)(2009-3#1)
on explicit##2##2##(1990-12#1)(2012-3#1)
on exploration##2##2##(1993-2#1)(2012-11#1)
on exposed##2##2##(1997-6#1)(2007-7#1)
on exposure time##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
on exposure to a##3##4##(1997-4#1)(2008-10#1)(2008-3#1)
on exposure to##13##3##(1990-2#1)(1991-3#1)(1992-9#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-9#1)
on exposure##17##2##(1990-2#1)(1991-3#1)(1992-9#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-9#1)(2011-2#1)
on expressed##3##2##(1997-8#1)(2005-11#1)(2006-12#1)
on expression and##5##3##(1990-2#1)(1993-4#1)(2010-2#1)(2012-2#2)
on expression of##20##3##(1992-12#1)(1993-12#2)(1994-11#1)(1995-1#1)(1995-6#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-9#2)(2009-2#1)(2010-10#1)(2011-2#2)(2012-3#2)(2013-8#2)
on expression##32##2##(1990-2#1)(1990-4#1)(1991-12#1)(1992-12#1)(1993-12#3)(1993-4#1)(1993-6#1)(1994-11#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-11#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-9#2)(2009-2#1)(2010-10#1)(2010-12#1)(2010-2#2)(2011-2#2)(2012-2#2)(2012-3#2)(2013-8#2)
on extended##2##2##(1996-2#1)(2007-11#1)
on extensive##9##2##(1991-9#1)(1996-3#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2013-1#2)
on external##17##2##(1990-12#1)(1992-8#1)(1994-2#1)(1995-11#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-9#1)(2011-1#2)(2011-2#1)(2013-1#1)
on extinction##5##2##(1997-5#1)(2008-3#1)(2008-8#2)(2008-9#1)
on extracellular Ca2+##3##3##(1991-12#1)(1991-4#1)(1995-12#1)
on extracellular levels of##2##4##(1991-6#1)(1997-5#1)
on extracellular matrix molecules##2##4##(2009-4#2)
on extracellular matrix##4##3##(1990-5#1)(2009-4#3)
on extracellular##25##2##(1990-12#1)(1990-3#2)(1990-5#1)(1991-12#1)(1991-4#1)(1991-6#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1995-11#1)(1995-12#1)(1996-10#1)(1996-5#1)(1996-6#1)(1997-5#2)(1997-7#1)(2008-4#2)(2008-6#1)(2009-4#3)
on extracting##3##2##(2006-5#1)(2008-2#1)(2008-3#1)
on extraction efficiency##3##3##(2008-10#3)
on extraction time##2##3##(2008-10#2)
on extraction##13##2##(2008-10#12)(2012-3#1)
on extrapolations##2##2##(1992-6#1)(2008-8#1)
on extremities##2##2##(2007-11#1)(2009-2#1)
on exudates##3##2##(2006-2#1)(2008-6#2)
on eye##3##2##(1992-3#1)(1997-1#1)(2007-12#1)
on faba bean##2##3##(2008-10#1)(2013-8#1)
on fabricating##2##2##(2010-2#1)(2010-9#1)
on fabrication##2##2##(2007-11#1)(2010-9#1)
on face detection##2##3##(2009-4#2)
on face##10##2##(2007-7#2)(2007-8#1)(2008-11#1)(2009-4#3)(2012-2#1)(2013-1#2)
on facial##3##2##(1996-12#1)(2008-11#1)(2008-9#1)
on factor VIII##2##3##(2007-9#1)(2008-9#1)
on factor##4##2##(1993-11#1)(1994-3#1)(2007-9#1)(2008-9#1)
on factors affecting the##2##4##(1993-9#1)(2008-10#1)
on factors contributing to##2##4##(2006-10#1)(2007-6#1)
on factors such as##4##4##(1996-12#1)(2007-7#1)(2008-10#1)(2011-2#1)
on factors that affect##3##4##(2006-6#1)(2008-10#1)(2013-1#1)
on factors that##7##3##(2006-6#2)(2008-10#1)(2008-9#1)(2009-10#1)(2012-12#1)(2013-1#1)
on factors##25##2##(1990-9#1)(1993-9#1)(1996-12#1)(2005-10#1)(2006-10#1)(2006-6#2)(2007-3#1)(2007-6#1)(2007-7#2)(2008-10#3)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#3)
on faculty##2##2##(2012-1#1)(2012-3#1)
on familial##3##2##(1996-12#1)(2005-8#1)(2006-10#1)
on familiarity##2##2##(2008-8#1)(2013-1#1)
on families of##2##3##(1995-12#1)(2008-10#1)
on families##10##2##(1995-12#1)(2008-10#1)(2008-2#2)(2008-9#1)(2009-9#2)(2010-12#1)(2011-1#1)(2013-8#1)
on family##16##2##(1992-4#1)(1993-5#1)(1996-4#1)(2005-11#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-7#1)(2013-1#4)
on farms in the##2##4##(1991-8#1)(2010-4#1)
on farms in##4##3##(1991-8#1)(2005-7#1)(2010-4#1)(2012-12#1)
on farms##9##2##(1991-8#1)(2005-7#1)(2007-6#1)(2008-12#2)(2010-4#1)(2012-12#1)(2012-3#1)(2013-1#1)
on fasting##3##2##(2010-10#2)(2010-12#1)
on fat##3##2##(1994-9#1)(2005-1#1)(2008-4#1)
on fatigue and##2##3##(2013-1#1)(2013-8#1)
on fatigue##3##2##(2010-7#1)(2013-1#1)(2013-8#1)
on fatty acid composition##2##4##(2008-10#1)(2010-4#1)
on fatty acid##8##3##(1991-2#1)(2007-8#2)(2008-10#3)(2010-4#1)(2013-1#1)
on fatty##10##2##(1991-2#1)(1991-8#1)(1997-3#1)(2007-8#2)(2008-10#3)(2010-4#1)(2013-1#1)
on feather##2##2##(2008-6#2)
on feature##2##2##(2007-12#1)(2008-6#1)
on features##3##2##(2004-12#1)(2008-11#1)(2008-2#1)
on fecundity##3##2##(2008-9#1)(2011-2#2)
on feedback##4##2##(1997-5#1)(2008-12#2)(2008-6#1)
on feeding##10##2##(1992-2#1)(1995-12#1)(2007-12#2)(2007-3#1)(2007-9#1)(2008-11#1)(2008-4#1)(2009-8#1)(2013-7#1)
on feelings of exhaustion##2##4##(1993-12#2)
on feelings##3##2##(1993-12#2)(2013-1#1)
on female fertility]##2##3##(1990-9#1)(2010-12#1)
on female reproductive function##2##4##(2006-1#1)(2010-10#1)
on female reproductive##3##3##(2006-1#1)(2010-10#1)(2011-1#1)
on female##17##2##(1990-9#1)(2006-1#1)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-5#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
on females##3##2##(2008-12#1)(2008-5#1)(2008-8#1)
on femtosecond##2##2##(2007-12#1)(2011-1#1)
on femurs of##4##3##(2013-1#4)
on ferritin##3##2##(1990-5#1)(1995-2#1)(2012-1#1)
on fertility##10##2##(1990-2#1)(1991-12#1)(1991-8#1)(1996-11#1)(1997-6#1)(2005-7#1)(2011-1#1)(2011-2#3)
on ferulic acid##2##3##(2008-10#1)(2013-8#1)
on fetal brain##2##3##(2011-12#1)(2011-2#1)
on fetal development##2##3##(2008-4#1)(2008-9#1)
on fetal loss and under-2-years child mortality##2##7##(2011-1#2)
on fetal##17##2##(1990-11#1)(1990-6#1)(1990-7#1)(1992-1#1)(1995-8#1)(1996-12#1)(2006-9#1)(2008-4#1)(2008-9#1)(2009-11#1)(2010-11#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-3#1)
on few##3##2##(2006-9#1)(2011-2#1)(2012-12#1)
on fiber##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
on fibre##2##2##(2009-7#1)(2010-4#1)
on fibrinogen##4##2##(1990-11#3)(1996-6#1)
on fibrinolysis##3##2##(1994-6#2)(1997-2#1)
on fibroblast and##2##3##(1995-3#1)(1996-4#1)
on fibroblast migration##2##3##(2010-3#1)(2012-12#1)
on fibroblast proliferation in##2##4##(2010-12#1)(2010-3#1)
on fibroblast proliferation##3##3##(2010-12#1)(2010-3#2)
on fibroblast##11##2##(1995-3#1)(1996-4#1)(2007-2#1)(2008-7#1)(2010-12#1)(2010-3#3)(2012-12#1)(2013-1#1)(2013-7#1)
on fibroblasts##3##2##(1995-11#1)(1996-8#1)(2011-1#1)
on fibronectin##8##2##(2008-11#6)(2011-2#1)(2012-2#1)
on fibronectin-coated##2##2##(2008-11#1)(2010-7#1)
on fictive swimming##2##3##(1992-8#2)
on field##11##2##(2008-10#4)(2008-2#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-6#1)(2013-1#1)(2013-7#1)
on field-grown##2##2##(2008-10#2)
on fields##2##2##(2008-3#1)(2008-5#1)
on fifth use##2##3##(2007-6#2)
on fifth##3##2##(2007-6#2)(2013-1#1)
on filamentous bacteriophages##2##3##(1997-4#1)(2008-8#1)
on filamentous##3##2##(1995-5#1)(1997-4#1)(2008-8#1)
on film##4##2##(1997-8#1)(2008-3#2)(2010-3#1)
on filter paper##12##3##(1992-4#1)(1997-1#1)(2008-10#6)(2008-5#1)(2011-2#2)(2012-2#1)
on filter##14##2##(1992-4#1)(1997-1#1)(2008-10#8)(2008-5#1)(2011-2#2)(2012-2#1)
on filters##6##2##(1990-7#1)(2008-10#3)(2008-9#2)
on final##4##2##(2007-11#2)(2008-5#1)(2008-8#1)
on financial##3##2##(1992-12#1)(1996-2#1)(2008-10#1)
on finding a##2##3##(1996-12#1)(2012-3#1)
on finding##8##2##(1996-12#1)(1997-2#1)(2005-7#1)(2007-1#1)(2007-12#1)(2008-2#1)(2008-7#1)(2012-3#1)
on findings from##5##3##(1996-12#1)(2008-1#2)(2010-7#1)(2012-11#1)
on findings of##3##3##(1996-3#1)(2007-8#1)(2008-6#1)
on findings##9##2##(1996-12#1)(1996-3#1)(2007-8#1)(2008-1#2)(2008-6#1)(2010-7#1)(2011-2#1)(2012-11#1)
on fine##3##2##(2008-7#1)(2010-11#1)(2013-1#1)
on finger##3##2##(2006-3#1)(2008-1#1)(2013-8#1)
on finishing##2##2##(2008-12#2)
on fire##2##2##(2012-12#1)(2012-2#1)
on first strand cDNA##2##4##(1994-11#1)(1994-9#1)
on first##17##2##(1992-12#1)(1994-11#1)(1994-4#1)(1994-9#1)(1995-10#1)(2006-6#1)(2007-6#1)(2008-1#2)(2008-10#2)(2009-2#1)(2009-5#1)(2011-1#1)(2011-10#1)(2013-1#2)
on fish growth##3##3##(2009-4#1)(2010-5#1)(2013-7#1)
on fish##14##2##(2008-12#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-5#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#3)
on fishes##3##2##(2010-8#3)
on fitness##5##2##(2008-10#1)(2008-8#1)(2012-3#3)
on fitting##5##2##(2008-10#1)(2008-2#2)(2008-3#1)(2009-7#1)
on five cases##2##3##(1993-10#1)(2010-12#1)
on five continents##2##3##(2008-10#2)
on five different##2##3##(2008-10#2)
on five occasions##2##3##(1990-6#1)(2010-4#1)
on five species of##2##4##(2008-8#1)(2013-1#1)
on five##33##2##(1990-6#1)(1990-9#1)(1993-10#1)(1995-4#1)(1995-6#1)(1997-1#1)(1997-5#1)(1997-7#1)(2004-11#1)(2005-9#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-8#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-9#1)(2013-1#1)(2013-7#1)(2013-8#1)
on fixed chromatin##2##3##(1990-12#2)
on fixed##8##2##(1990-12#2)(1990-5#1)(2008-11#1)(2008-5#1)(2010-8#1)(2011-12#1)(2013-8#1)
on flat##2##2##(2007-12#2)
on flavor##2##2##(2008-5#1)(2010-4#1)
on flax roots##2##3##(2008-10#2)
on flax##3##2##(2008-10#3)
on flexibility##2##2##(1992-1#1)(2009-9#1)
on flexible##3##2##(1991-8#1)(2008-10#1)(2009-11#1)
on flexion and internal rotation##2##5##(2009-3#2)
on floating##2##2##(2008-2#1)(2010-2#1)
on flocculation##2##2##(2008-7#2)
on flow cytometry##2##3##(2008-9#1)(2011-2#1)
on flow injection##3##3##(2008-10#3)
on flow rate##2##3##(1996-2#1)(2008-10#1)
on flow##11##2##(1996-2#1)(2006-6#1)(2008-10#5)(2008-4#1)(2008-9#2)(2011-2#1)
on flower petals##3##3##(2008-10#3)
on flower##4##2##(2008-10#4)
on flowering and##2##3##(2012-11#1)(2012-6#1)
on flowers##3##2##(2008-10#3)
on fluid##5##2##(1994-6#1)(1997-7#1)(2006-11#1)(2007-12#1)(2012-2#1)
on fluorescence enhancement##2##3##(2008-10#1)(2011-1#1)
on fluorescence measurements of##2##4##(1991-3#1)(2008-10#1)
on fluorescence##24##2##(1990-8#1)(1991-3#1)(1991-7#1)(1993-3#1)(1996-12#1)(1997-6#1)(2004-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-3#2)(2008-5#1)(2011-1#1)(2012-12#1)
on fluorescent##4##2##(1990-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
on fluoride removal##3##3##(2005-11#1)(2007-10#2)
on fluoride##5##2##(1993-11#1)(2005-11#1)(2007-10#2)(2011-1#1)
on fluorous##2##2##(2007-11#1)(2009-10#1)
on flux##2##2##(1990-3#1)(2013-1#1)
on focal cerebral##2##3##(2008-7#1)(2010-11#1)
on focal##3##2##(2008-7#1)(2010-11#1)(2011-2#1)
on fodrin##2##2##(2011-1#2)
on foetal##3##2##(2005-7#1)(2006-10#1)(2012-2#1)
on folding##4##2##(1990-2#1)(1996-8#1)(2011-2#2)
on foliage until##2##3##(2008-10#2)
on foliage##10##2##(2008-10#10)
on foliar##3##2##(2008-10#2)(2011-10#1)
on follicular##3##2##(1990-8#1)(2007-11#2)
on follow up at##2##4##(2008-6#1)(2013-1#1)
on follow up##3##3##(1990-8#1)(2008-6#1)(2013-1#1)
on follow-up (r = 0##2##5##(1995-6#2)
on follow-up (r =##3##4##(1995-6#3)
on follow-up MR##3##3##(1996-6#3)
on follow-up##27##2##(1995-5#1)(1995-6#4)(1996-6#3)(1997-8#1)(2006-12#1)(2006-8#3)(2007-11#2)(2007-3#1)(2007-8#1)(2008-3#1)(2008-7#2)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-8#1)
on food and water consumption##2##5##(2005-10#1)(2008-2#1)
on food and water##4##4##(2005-10#1)(2007-2#1)(2008-2#1)(2011-2#1)
on food hoarding##2##3##(1991-1#1)(2008-8#1)
on food intake and##2##4##(1991-6#1)(1996-2#1)
on food intake##8##3##(1991-6#1)(1992-2#2)(1993-7#1)(1995-11#1)(1996-2#2)(2008-6#1)
on food safety##2##3##(2005-5#1)(2012-12#1)
on food##28##2##(1991-1#1)(1991-6#1)(1992-2#2)(1993-7#1)(1994-2#1)(1995-11#1)(1996-2#2)(2005-10#1)(2005-5#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#1)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#3)
on food-motivated behavior##2##3##(1992-9#2)
on foods##3##2##(2007-12#1)(2007-2#1)(2009-9#1)
on foot##3##2##(2010-3#1)(2013-1#2)
on for##25##2##(1990-8#1)(1990-9#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#2)(1992-8#1)(1993-10#2)(2005-8#1)(2006-9#1)(2007-4#1)(2007-8#5)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
on force##4##2##(1995-5#1)(1995-9#1)(2012-1#2)
on forearm##2##2##(2007-7#1)(2008-5#1)
on forensic medicine]##2##3##(1994-4#1)(2011-2#1)
on forensic##3##2##(1994-4#1)(2011-2#2)
on formal##2##2##(1996-3#1)(2010-4#1)
on formalin-fixed##5##2##(1993-11#1)(1993-12#1)(2008-4#1)(2008-9#1)(2013-1#1)
on formate##2##2##(1993-4#1)(2011-2#1)
on formation and##2##3##(1995-5#1)(2008-7#1)
on formation of a##2##4##(2007-12#1)(2008-10#1)
on formation of the##3##4##(2007-11#2)(2008-10#1)
on formation of##15##3##(1993-8#1)(1994-3#1)(1996-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-5#1)(2009-8#1)(2010-2#1)(2010-4#1)(2013-1#1)
on formation##17##2##(1993-8#1)(1994-3#1)(1995-5#1)(1996-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-8#1)(2010-2#1)(2010-4#1)(2013-1#1)
on former##2##2##(1997-8#1)(2008-2#1)
on forty##2##2##(1996-9#1)(2007-1#1)
on four different##3##3##(2007-3#1)(2008-10#2)
on four main##2##3##(2007-12#1)(2008-7#1)
on four##38##2##(1990-8#1)(1992-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1995-9#1)(1996-3#1)(1997-7#1)(2005-12#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-3#1)(2007-4#1)(2008-1#2)(2008-10#4)(2008-7#3)(2009-4#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2012-7#1)(2013-1#1)
on fracture healing##2##3##(2008-8#1)(2009-4#1)
on fracture resistance of##2##4##(2010-6#1)(2013-1#1)
on fracture resistance##3##3##(2010-6#1)(2013-1#2)
on fracture tolerance of the##2##5##(2007-4#2)
on fracture##16##2##(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#2)(2008-11#1)(2008-2#2)(2008-8#1)(2009-4#1)(2009-6#1)(2010-6#1)(2011-2#1)(2013-1#2)(2013-8#1)
on fragile##2##2##(1997-4#1)(2008-10#1)
on fragmentation##2##2##(1991-12#1)(2008-9#1)
on free##9##2##(1991-2#1)(1992-3#1)(1995-9#1)(1996-12#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-12#1)
on free-ranging##2##2##(2007-2#1)(2013-1#1)
on frequency and##3##3##(2007-11#2)(2013-7#1)
on frequency of##3##3##(2006-2#1)(2008-7#1)(2009-2#1)
on frequency##8##2##(2006-2#1)(2006-8#1)(2007-11#2)(2008-3#1)(2008-7#1)(2009-2#1)(2013-7#1)
on fresh##8##2##(2004-11#1)(2006-10#1)(2008-10#1)(2008-5#2)(2008-9#1)(2010-4#2)
on freshly isolated##2##3##(1992-8#1)(2006-10#1)
on freshly##4##2##(1992-8#1)(2006-10#1)(2008-8#1)(2009-3#1)
on friction##2##2##(1990-6#1)(2010-10#1)
on fringe##8##2##(2008-2#4)(2008-3#4)
on frog##2##2##(1990-5#1)(1995-12#1)
on from the##3##3##(2008-11#2)(2013-1#1)
on from##8##2##(2008-1#1)(2008-11#2)(2009-4#1)(2009-5#3)(2013-1#1)
on frontal##3##2##(1994-10#1)(2008-11#1)(2008-9#1)
on frozen section##2##3##(1995-4#2)
on frozen##3##2##(1995-4#2)(1997-7#1)
on fructose##2##2##(1992-3#1)(1994-3#1)
on fruit of##2##3##(2008-10#2)
on fruit##12##2##(2007-6#1)(2008-10#11)
on fruits and vegetables##2##4##(2006-10#1)(2007-12#1)
on fruits and##4##3##(2006-10#1)(2007-12#1)(2008-10#1)(2008-9#1)
on fruits##7##2##(2006-10#1)(2007-12#1)(2008-10#4)(2008-9#1)
on fully##4##2##(1990-2#1)(1997-6#1)(2008-10#2)
on function and##2##3##(2008-2#1)(2009-3#1)
on function##3##2##(2008-2#2)(2009-3#1)
on functional and##2##3##(1995-2#1)(2013-7#1)
on functional magnetic resonance imaging##2##5##(2007-10#1)(2011-1#1)
on functional properties##3##3##(1991-2#1)(2010-4#1)(2012-1#1)
on functional recovery##2##3##(2008-12#1)(2013-1#1)
on functional##28##2##(1991-2#1)(1992-2#1)(1993-1#1)(1995-2#1)(1997-1#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#1)(2013-7#1)
on functionalized##3##2##(2008-10#3)
on functions of##3##3##(1997-6#1)(2004-12#1)(2012-3#1)
on functions##4##2##(1997-6#1)(2004-12#1)(2006-4#1)(2012-3#1)
on fundamental##3##2##(2007-12#1)(2008-1#1)(2008-5#1)
on fundus##2##2##(2007-3#1)(2011-2#1)
on fungal growth##3##3##(2008-10#3)
on fungal##8##2##(2007-10#1)(2007-7#1)(2008-10#5)(2008-7#1)
on fungicide-amended medium##2##3##(2008-10#2)
on fungicide-amended##3##2##(2008-10#3)
on further doping##2##3##(2007-12#2)
on further##12##2##(1991-3#1)(1992-12#1)(1994-11#1)(1995-8#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#3)(2008-3#1)(2008-6#1)
on fusarium head blight and##2##5##(2008-10#2)
on fused-silica substrates##2##3##(2008-3#2)
on fusion of##2##3##(1992-6#1)(1995-8#1)
on fusion##3##2##(1992-6#1)(1995-8#1)(2012-2#1)
on future developments##2##3##(2007-11#1)(2008-1#1)
on future directions##2##3##(2008-3#1)(2009-4#1)
on future trends in##2##4##(1991-5#1)(1994-1#1)
on future##19##2##(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-11#1)(1994-1#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-4#2)
on g-KGM##2##2##(2011-2#2)
on gait and##2##3##(2006-10#1)(2013-1#1)
on gait##10##2##(2006-10#2)(2012-1#5)(2013-1#3)
on gallbladder##6##2##(1990-10#1)(1991-4#1)(1992-6#1)(2008-4#1)(2011-2#1)(2013-1#1)
on gamma-aminobutyric acid##2##3##(1994-12#1)(2008-8#1)
on ganglion cells##2##3##(1991-9#1)(1993-12#1)
on ganglion##3##2##(1991-9#1)(1993-12#1)(1997-3#1)
on garlic and chives##2##4##(2008-10#2)
on garlic and##3##3##(2008-10#3)
on gas##9##2##(1992-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-4#1)(2011-1#1)
on gaseous##3##2##(2008-10#2)(2013-1#1)
on gastric acid secretion and##2##5##(1997-1#1)(2009-5#1)
on gastric acid secretion##4##4##(1997-1#1)(2006-10#1)(2007-1#1)(2009-5#1)
on gastric adenocarcinoma##2##3##(2008-12#1)(2008-9#1)
on gastric carcinogenesis##2##3##(1992-7#1)(2007-11#1)
on gastric contractility##2##3##(1996-9#2)
on gastric emptying##4##3##(1993-7#2)(1997-4#1)(2013-1#1)
on gastric mucosal##3##3##(1993-11#2)(2012-3#1)
on gastric secretion##3##3##(1990-2#1)(1990-5#2)
on gastric##28##2##(1990-2#1)(1990-3#1)(1990-5#2)(1992-6#1)(1992-7#1)(1993-11#2)(1993-7#2)(1994-3#1)(1996-12#1)(1996-9#2)(1997-1#1)(1997-4#1)(1997-5#2)(2006-10#1)(2007-1#1)(2007-11#1)(2008-12#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#1)(2012-3#1)(2013-1#1)
on gastrointestinal##9##2##(1992-6#1)(1995-3#1)(1996-12#1)(2005-10#1)(2005-11#1)(2008-10#1)(2012-2#1)(2012-3#2)
on gel electrophoresis##2##3##(1993-12#1)(1996-2#1)
on gel filtration##2##3##(1991-2#1)(1992-12#1)
on gel##7##2##(1991-2#1)(1992-12#1)(1993-12#1)(1993-8#1)(1996-2#1)(2008-10#1)(2008-8#1)
on gelatin##2##2##(2008-5#1)(2011-2#1)
on gelation##2##2##(1995-11#1)(2006-10#1)
on gels##3##2##(1996-6#2)(2008-9#1)
on gender and##6##3##(2004-11#1)(2009-4#1)(2009-5#1)(2011-1#1)(2012-2#1)(2012-3#1)
on gender##14##2##(2004-11#1)(2006-8#2)(2007-2#1)(2008-4#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
on gene expression and##5##4##(1996-12#1)(2005-7#1)(2006-10#1)(2008-10#1)(2008-11#1)
on gene expression data##3##4##(2006-10#3)
on gene expression in the##2##5##(1996-12#1)(2010-12#1)
on gene expression in##4##4##(1993-4#1)(1996-12#1)(2008-3#1)(2010-12#1)
on gene expression##25##3##(1993-4#1)(1996-12#2)(1996-8#1)(2005-7#1)(2006-10#4)(2007-11#1)(2007-6#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-12#2)(2011-1#1)(2012-2#2)(2013-1#1)
on gene flow##3##3##(2010-10#1)(2012-3#2)
on gene function##3##3##(2008-7#2)(2008-8#1)
on gene regulation##2##3##(1996-4#1)(2008-10#1)
on gene therapy for##2##4##(2005-9#1)(2008-5#1)
on gene therapy##3##3##(2004-1#1)(2005-9#1)(2008-5#1)
on gene##50##2##(1993-4#1)(1993-6#2)(1994-3#1)(1995-2#1)(1996-12#2)(1996-4#1)(1996-8#1)(2004-1#1)(2005-7#1)(2005-9#1)(2006-10#4)(2006-11#1)(2007-11#1)(2007-6#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#7)(2008-8#3)(2009-10#1)(2009-4#1)(2010-10#2)(2010-12#2)(2011-1#1)(2012-2#2)(2012-3#2)(2013-1#1)
on general treatment##2##3##(1996-6#1)(2008-3#1)
on general##22##2##(1990-3#1)(1991-3#1)(1993-12#1)(1995-12#1)(1996-2#1)(1996-6#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-1#2)
on generalized##3##2##(2007-12#1)(2011-1#1)(2013-1#1)
on generation of##4##3##(1993-6#1)(1995-5#1)(2008-10#1)(2008-4#1)
on generation##5##2##(1993-6#1)(1995-1#1)(1995-5#1)(2008-10#1)(2008-4#1)
on genes and##2##3##(2009-5#1)(2010-12#1)
on genes##11##2##(1991-5#1)(1996-2#1)(2006-5#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-3#3)
on genetic and##4##3##(1997-8#1)(2008-9#1)(2009-4#1)(2013-1#1)
on genetic characteristics of##2##4##(2012-1#1)(2013-7#1)
on genetic distances##2##3##(2008-10#1)(2013-1#1)
on genetic engineering##2##3##(2007-8#1)(2012-2#1)
on genetic research##2##3##(2007-3#1)(2008-6#1)
on genetic testing##2##3##(1997-8#1)(2007-12#1)
on genetic variation##2##3##(1995-2#1)(1996-6#1)
on genetic##45##2##(1995-2#1)(1996-6#1)(1997-6#1)(1997-8#2)(2005-11#1)(2006-2#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#2)(2009-4#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
on genetically determined##2##3##(2012-1#1)(2012-3#1)
on genetically##7##2##(2008-8#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)
on genetics of##2##3##(2006-10#1)(2007-10#1)
on genetics##5##2##(2006-10#1)(2007-10#1)(2008-12#1)(2008-7#1)(2012-12#1)
on genome##5##2##(1997-7#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
on genome-wide##3##2##(2009-5#2)(2010-12#1)
on genomic##12##2##(1993-12#1)(1994-11#1)(2005-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-7#1)
on genomics##2##2##(2005-8#1)(2009-5#1)
on genotype##7##2##(1994-5#1)(1997-7#1)(2008-10#1)(2009-11#1)(2012-2#2)(2013-1#1)
on genotypes##3##2##(2008-10#1)(2010-4#1)(2011-2#1)
on genotypic##2##2##(2012-2#1)(2012-3#1)
on geometric##3##2##(2010-2#2)(2012-2#1)
on geometrical##6##2##(1992-9#1)(2007-12#1)(2008-2#1)(2008-3#3)
on geometry and##2##3##(2007-1#1)(2008-3#1)
on geranium plants##2##3##(2008-10#2)
on geranium seedlings##3##3##(2008-10#3)
on geranium##7##2##(2008-10#6)(2008-5#1)
on germinating seeds##2##3##(2006-3#2)
on germination and seedling growth of V##2##7##(2008-12#2)
on germination and seedling growth of Vigna radiata (L##2##9##(2008-12#2)
on germination and seedling growth of Vigna radiata##4##8##(2008-12#4)
on germination and seedling growth of##6##6##(2008-12#6)
on germination and##8##3##(2006-12#1)(2008-12#6)(2011-2#1)
on germination of##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
on germination##13##2##(2006-12#1)(2008-10#2)(2008-12#7)(2011-12#1)(2011-2#2)
on germline##2##2##(2007-12#1)(2009-12#1)
on gestation##2##2##(2008-10#1)(2012-1#1)
on gestational age at booking##2##5##(2009-5#2)
on gestational day##2##3##(1997-1#1)(2006-4#1)
on gestational days##4##3##(1996-5#1)(2005-7#3)
on gestational##8##2##(1996-5#1)(1997-1#1)(2005-7#3)(2006-4#1)(2009-5#2)
on giant unilamellar vesicles##2##4##(2012-2#2)
on giant##3##2##(1990-8#1)(2012-2#2)
on ginseng##3##2##(2008-10#3)
on girls'##2##2##(2011-1#1)(2013-1#1)
on giving##3##2##(1994-12#1)(2004-9#1)(2007-4#1)
on glass by##4##3##(2006-12#1)(2008-10#1)(2008-2#1)(2009-7#1)
on glass fiber filters##3##4##(2008-10#2)(2008-4#1)
on glass fiber##4##3##(2007-5#1)(2008-10#2)(2008-4#1)
on glass slides##7##3##(1991-3#1)(1991-5#1)(1995-5#1)(2006-5#2)(2008-11#1)(2008-8#1)
on glass substrates##7##3##(2007-11#1)(2008-11#1)(2008-2#3)(2010-4#2)
on glass surfaces##3##3##(2005-11#1)(2008-10#2)
on glass##47##2##(1990-4#2)(1991-3#1)(1991-5#2)(1995-5#1)(1995-6#1)(2005-11#2)(2006-12#2)(2006-5#2)(2007-11#2)(2007-12#2)(2007-5#1)(2008-10#12)(2008-11#2)(2008-2#5)(2008-4#1)(2008-5#1)(2008-8#1)(2009-7#3)(2010-4#4)
on glassy carbon (GC) electrode##2##5##(2008-10#2)
on glassy carbon (GC) electrodes##2##5##(2008-10#2)
on glassy carbon (GC)##4##4##(2008-10#4)
on glassy carbon and##2##4##(2008-10#2)
on glassy carbon electrode (GCE)##2##5##(2008-10#2)
on glassy carbon electrode##7##4##(2007-8#1)(2008-10#6)
on glassy carbon electrodes##3##4##(2008-10#2)(2013-1#1)
on glassy carbon##19##3##(2007-8#1)(2008-10#16)(2012-1#1)(2013-1#1)
on glia and neurons##2##4##(2007-11#2)
on glial##3##2##(1993-7#1)(2008-7#1)(2011-1#1)
on global##8##2##(1996-7#1)(2007-11#1)(2007-2#1)(2008-7#2)(2008-8#1)(2010-12#1)(2012-2#1)
on glomerular##2##2##(2005-10#1)(2010-7#1)
on glucagon##3##2##(1994-11#2)(2010-11#1)
on glucocorticoid##3##2##(1995-12#1)(1995-7#1)(2008-8#1)
on glucocorticoid-mediated##2##2##(1994-9#1)(1997-4#1)
on gluconeogenesis##3##2##(1991-1#1)(1994-8#1)(2010-11#1)
on glucose and lipid metabolism##3##5##(1993-8#1)(1994-12#1)(2008-3#1)
on glucose and##9##3##(1993-8#1)(1994-12#1)(1994-6#2)(1994-8#1)(2006-8#1)(2008-1#1)(2008-3#1)(2013-1#1)
on glucose concentration##2##3##(2007-2#1)(2010-2#1)
on glucose control##3##3##(2008-7#1)(2012-12#2)
on glucose metabolism in##2##4##(1994-3#1)(1994-6#1)
on glucose metabolism##3##3##(1994-3#1)(1994-6#1)(2008-7#1)
on glucose output in##2##4##(1994-6#2)
on glucose output##3##3##(1994-6#3)
on glucose transport##4##3##(1992-11#2)(1997-6#1)(2008-3#1)
on glucose##45##2##(1990-3#2)(1990-8#1)(1991-1#1)(1991-2#1)(1992-11#2)(1993-12#1)(1993-8#2)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#6)(1994-8#1)(1996-7#1)(1996-9#1)(1997-6#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#4)(2010-2#1)(2012-12#2)(2013-1#1)
on glutamate release##2##3##(1997-4#2)
on glutamate##6##2##(1990-12#1)(1995-11#1)(1996-12#1)(1997-4#2)(1997-6#1)
on glutamine##2##2##(1994-5#1)(2008-11#1)
on glutathione S-transferase##2##3##(1992-11#1)(1992-4#1)
on glutathione##4##2##(1992-11#1)(1992-4#1)(1992-5#1)(2008-5#1)
on glycaemia and renal function in normal and##2##8##(2007-6#2)
on glycaemia##4##2##(2007-6#3)(2012-3#1)
on glycemic##3##2##(2008-3#1)(2010-10#1)(2012-1#1)
on glycerol##5##2##(1990-5#1)(1995-3#1)(2008-5#1)(2008-6#2)
on glycine##3##2##(1995-7#1)(1996-9#1)(2008-11#1)
on glycogen##2##2##(1991-1#1)(1995-5#1)
on glycolysis##3##2##(1992-3#1)(1992-4#2)
on glycoprotein##2##2##(1991-8#1)(2008-5#1)
on glycoproteins##3##2##(1990-2#1)(1991-12#1)(2008-4#1)
on glycoside##2##2##(1995-11#1)(2006-8#1)
on glycosphingolipid##2##2##(1992-1#2)
on glycosylation##3##2##(1994-11#1)(2009-2#2)
on goat##3##2##(2007-12#1)(2007-7#1)(2010-2#1)
on going from##2##3##(2008-5#1)(2010-5#1)
on going##5##2##(2008-4#2)(2008-5#1)(2010-5#2)
on gold electrode##3##3##(2005-4#2)(2008-10#1)
on gold nanoparticle surfaces##2##4##(2006-12#2)
on gold nanoparticle##3##3##(2006-12#2)(2008-10#1)
on gold nanoparticles##5##3##(2006-12#2)(2007-8#1)(2008-10#1)(2008-11#1)
on gold substrate surfaces##2##4##(2007-8#2)
on gold surfaces##3##3##(2006-12#1)(2008-10#2)
on gold with##2##3##(2007-8#1)(2008-4#1)
on gold##31##2##(2005-11#3)(2005-4#2)(2006-12#6)(2007-11#1)(2007-8#4)(2008-10#9)(2008-11#1)(2008-4#1)(2009-3#1)(2009-7#2)(2013-8#1)
on golf courses in##2##4##(2008-10#2)
on good##13##2##(2005-7#1)(2006-2#1)(2006-8#2)(2007-9#2)(2008-1#1)(2009-10#1)(2009-3#1)(2010-6#2)(2010-8#1)(2013-1#1)
on gout##2##2##(2006-10#1)(2007-5#1)
on gradual##2##2##(2008-10#1)(2008-11#1)
on graduate##2##2##(1991-8#1)(2012-3#1)
on graft survival##2##3##(1991-11#1)(2007-8#1)
on graft##4##2##(1991-11#1)(2007-8#2)(2008-1#1)
on grain yield##2##3##(2008-12#1)(2008-8#1)
on grain##3##2##(2005-11#1)(2008-12#1)(2008-8#1)
on granule##2##2##(1991-6#1)(1997-6#1)
on granulosa##2##2##(2006-5#1)(2008-11#1)
on grape berries##2##3##(2008-10#2)
on grape##5##2##(2008-10#5)
on grapefruit##3##2##(2008-10#3)
on grapevine leaf##2##3##(2008-10#2)
on grapevine##4##2##(2008-10#4)
on graphite##5##2##(1990-4#1)(2007-8#1)(2008-10#3)
on grating##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
on gravity##2##2##(2007-9#1)(2012-10#1)
on greater##2##2##(2008-4#1)(2013-1#1)
on green##4##2##(2008-10#1)(2010-10#1)(2011-2#2)
on greenhouse-grown##2##2##(2008-10#1)(2011-12#1)
on grooming##4##2##(1993-12#2)(1994-8#1)(1996-2#1)
on gross examination##2##3##(2006-9#1)(2010-6#1)
on gross##6##2##(2006-9#1)(2007-2#1)(2008-5#3)(2010-6#1)
on ground and##2##3##(1995-11#1)(1997-7#1)
on ground##5##2##(1995-11#1)(1997-7#1)(2008-3#1)(2008-8#1)(2010-4#1)
on grounds of##2##3##(1991-9#1)(1997-3#1)
on grounds##3##2##(1991-9#1)(1997-3#1)(2008-1#1)
on group##5##2##(1992-1#1)(1996-4#1)(2008-8#2)(2013-1#1)
on groups##2##2##(1997-8#1)(2008-5#1)
on growing tumor cells##2##4##(1992-8#2)
on growing##6##2##(1992-8#2)(2006-4#1)(2007-9#1)(2008-4#1)(2008-5#1)
on growth and DHA production by##3##6##(2005-11#3)
on growth and differentiation##2##4##(1996-5#1)(2008-1#1)
on growth and##21##3##(1992-8#1)(1993-12#2)(1995-3#1)(1996-5#1)(1997-2#1)(2005-11#3)(2006-8#1)(2008-1#1)(2008-12#3)(2008-6#1)(2008-7#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-8#1)
on growth cone##2##3##(1994-11#1)(1994-8#1)
on growth hormone and testosterone##2##5##(2006-9#1)(2008-7#1)
on growth hormone##6##3##(1996-11#1)(2006-9#2)(2007-11#1)(2008-7#1)(2010-5#1)
on growth of##14##3##(1990-11#1)(1993-12#1)(1995-2#1)(2008-10#3)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-1#2)(2011-2#1)
on growth parameters##2##3##(1996-10#1)(2009-4#1)
on growth performance##2##3##(2013-1#2)
on growth rate and##2##4##(2008-11#1)(2010-8#1)
on growth rate##7##3##(1996-7#1)(2007-11#3)(2008-11#1)(2008-12#1)(2010-8#1)
on growth##87##2##(1990-11#1)(1991-7#1)(1991-8#1)(1992-2#1)(1992-8#1)(1993-12#3)(1994-11#2)(1994-3#1)(1994-8#2)(1995-2#2)(1995-3#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#1)(2005-11#3)(2006-12#2)(2006-8#1)(2006-9#2)(2007-11#6)(2008-1#2)(2008-10#4)(2008-11#4)(2008-12#8)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#4)(2012-2#1)(2013-1#3)(2013-8#1)
on guiding##2##2##(2006-9#1)(2011-2#1)
on guinea pig##2##3##(1992-12#1)(2008-3#1)
on guinea-pig##4##2##(1990-7#1)(1995-3#1)(1997-5#1)(2005-11#1)
on gut microbiota and##2##4##(2011-2#1)(2012-1#1)
on gut##3##2##(2011-2#1)(2012-1#1)(2012-2#1)
on hCG were successful##2##4##(1992-12#2)
on hESCs##2##2##(2009-3#1)(2009-4#1)
on habitat selection##2##3##(2008-9#1)(2010-8#1)
on habitat##4##2##(2006-5#1)(2007-9#1)(2008-9#1)(2010-8#1)
on habituation##2##2##(2009-8#1)(2012-2#1)
on haematological parameters in albino Wistar rats##2##7##(2009-5#2)
on haematological parameters of##2##4##(2008-7#2)
on haematological parameters##4##3##(2008-7#2)(2009-5#2)
on haematological##6##2##(1995-3#1)(2008-7#2)(2009-5#3)
on haemodialysis##7##2##(1990-3#1)(1991-11#1)(1992-12#1)(1996-9#1)(2007-7#1)(2013-8#2)
on haemostasis##2##2##(2007-9#2)
on hair growth##3##3##(2008-5#1)(2011-2#2)
on hair##11##2##(1991-9#1)(2007-7#1)(2008-5#6)(2009-5#1)(2011-2#2)
on hand function##2##3##(2006-10#2)
on hand##11##2##(1990-7#1)(2006-10#2)(2006-3#1)(2007-12#3)(2007-7#1)(2008-9#1)(2011-1#1)(2013-1#1)
on handling##4##2##(1993-1#1)(2008-2#1)(2013-1#2)
on hands and##3##3##(2007-10#1)(2012-1#1)(2013-8#1)
on hands##4##2##(2007-10#2)(2012-1#1)(2013-8#1)
on hard##4##2##(2006-5#1)(2007-11#1)(2007-6#1)(2010-6#1)
on hardiness##2##2##(2013-7#2)
on hardness##2##2##(2008-12#1)(2010-10#1)
on hatching##2##2##(2006-5#1)(2008-11#1)
on having##3##2##(1996-2#1)(2007-12#1)(2008-4#1)
on hazard##3##2##(1995-11#1)(1997-4#1)(2011-2#1)
on head and neck##2##4##(2006-4#1)(2012-12#1)
on head movements in##2##4##(1993-12#2)
on head##8##2##(1990-4#1)(1993-12#2)(1995-8#1)(2006-4#1)(2008-11#1)(2012-12#1)(2013-1#1)
on healing of excision wounds##2##5##(2010-12#2)
on healing##4##2##(1996-3#1)(1997-6#1)(2010-12#2)
on health and comfort##2##4##(1992-3#1)(1992-4#1)
on health and safety##2##4##(2007-2#1)(2008-9#1)
on health and social##3##4##(2005-10#2)(2008-2#1)
on health and well-being##2##4##(2008-12#1)(2011-1#1)
on health and##18##3##(1992-3#1)(1992-4#1)(1994-4#1)(2005-10#3)(2006-3#1)(2006-7#1)(2007-2#1)(2007-3#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
on health care costs and##2##5##(1995-2#1)(2008-11#1)
on health care costs##3##4##(1991-12#1)(1995-2#1)(2008-11#1)
on health care for##3##4##(1993-12#1)(1994-3#2)
on health care providers##2##4##(1992-2#1)(2006-2#1)
on health care reform and##2##5##(1993-12#1)(1994-12#1)
on health care reform##6##4##(1993-12#2)(1994-12#2)(1995-2#1)(1996-1#1)
on health care than##2##4##(2007-4#1)(2013-7#1)
on health care use##2##4##(1994-1#1)(1995-12#1)
on health care##42##3##(1990-11#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-2#3)(1992-3#1)(1993-12#3)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#3)(1995-12#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#1)(2005-10#1)(2006-2#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-4#2)(2008-11#1)(2008-4#1)(2010-1#1)(2012-1#1)(2013-7#2)
on health economics##3##3##(1997-8#1)(2008-6#1)(2013-8#1)
on health has##2##3##(1996-8#1)(2011-1#1)
on health human resources##2##4##(2011-2#2)
on health in##3##3##(1996-11#1)(2008-1#1)(2012-1#1)
on health information##2##3##(2006-8#1)(2012-12#1)
on health of##3##3##(2008-7#1)(2011-12#1)(2011-2#1)
on health outcomes##5##3##(2010-3#1)(2010-7#1)(2012-12#2)(2013-1#1)
on health policy##2##3##(1994-12#1)(1995-1#1)
on health promotion##5##3##(1990-10#1)(2007-12#1)(2008-1#1)(2008-12#2)
on health reform##2##3##(1993-3#1)(1994-1#1)
on health research ethics in##2##5##(2011-2#2)
on health research##3##3##(2010-5#1)(2011-2#2)
on health service resources##2##4##(2006-10#1)(2012-3#1)
on health services##4##3##(1991-3#1)(2010-4#1)(2012-12#1)(2012-3#1)
on health status##2##3##(1991-2#1)(2007-6#1)
on health system reform##2##4##(1996-1#2)
on health system##3##3##(1996-1#2)(2008-11#1)
on health##154##2##(1990-10#1)(1990-11#1)(1990-12#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#3)(1992-1#2)(1992-2#3)(1992-3#4)(1992-4#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#2)(1994-1#2)(1994-12#4)(1994-2#1)(1994-3#3)(1994-4#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#2)(1996-1#3)(1996-11#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-8#1)(2005-10#4)(2005-11#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-12#3)(2007-2#2)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#1)(2008-1#4)(2008-10#1)(2008-11#2)(2008-12#3)(2008-2#1)(2008-4#4)(2008-6#1)(2008-7#1)(2008-9#3)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-3#2)(2010-4#3)(2010-5#1)(2010-7#1)(2011-1#4)(2011-12#1)(2011-2#8)(2012-1#3)(2012-12#6)(2012-2#1)(2012-3#3)(2013-1#5)(2013-7#3)(2013-8#2)
on health-care reform##2##3##(1991-8#1)(2009-8#1)
on health-care##3##2##(1991-8#1)(2009-11#1)(2009-8#1)
on health-related quality of life##6##5##(2004-3#1)(2006-2#1)(2008-3#1)(2008-7#1)(2009-5#1)(2012-12#1)
on health-related##10##2##(2004-3#1)(2006-1#1)(2006-2#1)(2008-3#1)(2008-7#1)(2009-5#2)(2011-2#2)(2012-12#1)
on healthcare reform##4##3##(1992-3#2)(1993-12#2)
on healthcare##15##2##(1992-12#1)(1992-3#2)(1993-12#2)(1996-2#1)(1996-3#1)(1997-3#1)(2005-11#1)(2008-3#1)(2009-4#1)(2011-1#3)(2012-12#1)
on healthy and diseased##2##4##(2005-12#1)(2008-10#1)
on healthy plants##2##3##(2008-10#2)
on healthy population##2##3##(2008-1#1)(2008-5#1)
on healthy subjects##2##3##(2010-12#1)(2012-1#1)
on healthy volunteers##2##3##(2008-3#1)(2012-1#1)
on healthy women##2##3##(2008-5#1)(2010-12#1)
on healthy##22##2##(2005-12#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-3#2)(2008-5#3)(2010-12#3)(2012-1#3)(2013-7#1)
on hearing##3##2##(1993-5#1)(2006-3#1)(2009-5#1)
on heart disease##2##3##(1991-3#1)(1997-1#1)
on heart rate and##4##4##(2008-4#1)(2010-5#1)(2012-12#1)(2013-1#1)
on heart rate variability##2##4##(2008-12#1)(2010-12#1)
on heart rate##12##3##(2006-9#1)(2007-9#2)(2008-12#1)(2008-4#1)(2010-12#1)(2010-5#3)(2012-12#2)(2013-1#1)
on heart##20##2##(1990-7#1)(1991-3#1)(1997-1#1)(2006-9#1)(2007-8#1)(2007-9#2)(2008-12#1)(2008-4#1)(2009-10#1)(2010-12#1)(2010-5#3)(2012-12#2)(2013-1#4)
on heat##2##2##(2008-2#1)(2013-1#1)
on heating at##2##3##(1991-12#1)(2006-10#1)
on heating to##2##3##(1991-5#1)(2010-4#1)
on heating##8##2##(1991-12#1)(1991-5#1)(2006-10#3)(2008-2#1)(2008-3#1)(2010-4#1)
on heavy##2##2##(2008-7#1)(2012-3#1)
on helper##2##2##(2008-10#1)(2008-4#1)
on helping##4##2##(1993-1#1)(1994-1#1)(2008-6#1)(2012-12#1)
on hematologic##2##2##(2008-7#2)
on hematological changes in##2##4##(2010-5#2)
on hematopoiesis##2##2##(1990-12#1)(1990-9#1)
on hematopoietic cells##4##3##(1992-8#1)(1994-12#1)(2008-11#1)(2012-2#1)
on hematopoietic##7##2##(1992-8#1)(1994-12#1)(1996-8#1)(2008-11#2)(2012-10#1)(2012-2#1)
on hemimethylated DNA templates##2##4##(1990-11#2)
on hemodialysis (HD) and##2##4##(2008-1#1)(2008-4#1)
on hemodialysis (HD)##6##3##(2007-7#3)(2008-1#1)(2008-4#1)(2011-2#1)
on hemodialysis and##3##3##(1991-8#1)(2008-1#1)(2011-1#1)
on hemodialysis for##2##3##(2013-8#2)
on hemodialysis##36##2##(1991-6#1)(1991-8#1)(1993-6#1)(1995-4#1)(2007-12#2)(2007-7#9)(2007-8#3)(2008-1#5)(2008-4#1)(2009-4#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#5)
on hemodynamic measures##2##3##(2007-10#2)
on hemodynamic##8##2##(1996-2#1)(2006-12#1)(2007-10#2)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
on hemodynamics##3##2##(1990-1#1)(1993-3#1)(2013-8#1)
on hemoglobin##3##2##(2006-10#1)(2013-7#1)(2013-8#1)
on hemopoiesis##2##2##(1991-10#1)(2010-12#1)
on hemopoietic##2##2##(1991-10#1)(2012-1#1)
on hemostasis and sarcoma M-1 growth in##2##7##(2009-2#2)
on hemostasis in##2##3##(2008-1#1)(2008-4#1)
on hemostasis##5##2##(2008-1#1)(2008-4#1)(2009-2#2)(2010-3#1)
on heparin-Sepharose##2##2##(1994-6#1)(1994-8#1)
on hepatic and renal functions##2##5##(1995-9#1)(2011-1#1)
on hepatic and renal##5##4##(1995-9#1)(2009-6#1)(2011-1#1)(2013-1#2)
on hepatic microsomal##5##3##(1994-11#1)(1994-6#1)(1995-3#1)(2008-8#2)
on hepatic regeneration##2##3##(1993-8#1)(2008-3#1)
on hepatic##33##2##(1990-3#1)(1990-4#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-2#1)(1993-8#1)(1994-11#2)(1994-6#1)(1994-8#1)(1995-3#1)(1995-9#1)(1996-12#2)(1997-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-2#1)(2009-3#1)(2009-6#1)(2011-1#1)(2011-2#1)(2013-1#5)
on hepatitis##2##2##(2006-10#1)(2008-10#1)
on hepatocytes were##2##3##(1991-1#1)(2010-12#1)
on hepatocytes##10##2##(1990-12#1)(1991-1#1)(1993-9#1)(2006-10#1)(2007-11#1)(2010-12#1)(2011-12#3)(2012-1#1)
on hepatoma##2##2##(2008-11#2)
on her back##2##3##(2009-2#1)(2012-12#1)
on her face##4##3##(2012-3#1)(2013-1#3)
on her left##3##3##(1996-11#1)(2007-12#1)(2010-8#1)
on her own##2##3##(1992-2#1)(1995-12#1)
on her##26##2##(1991-10#1)(1992-12#1)(1992-2#1)(1993-7#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-6#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-8#1)(2009-2#1)(2010-12#1)(2010-8#1)(2011-12#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
on herbal##3##2##(2005-8#1)(2007-2#1)(2010-5#1)
on herbivore##3##2##(2008-8#3)
on herbivores##2##2##(2008-9#2)
on hereditary##2##2##(1990-12#1)(2006-10#1)
on heroin##2##2##(2008-8#1)(2010-1#1)
on heterologous##2##2##(1995-6#1)(1996-11#1)
on hidden Markov models##4##4##(1991-12#1)(2007-11#1)(2008-2#1)(2008-7#1)
on high K(+)-induced##2##3##(1993-3#1)(1995-11#1)
on high performance liquid chromatography##3##5##(1991-8#1)(1993-12#1)(2008-10#1)
on high resolution##2##3##(2008-10#1)(2012-2#1)
on high standards of##2##4##(1992-9#1)(2009-7#1)
on high##20##2##(1991-1#1)(1991-8#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1995-1#1)(1995-11#2)(2005-11#1)(2007-6#1)(2008-10#3)(2008-2#2)(2009-5#1)(2009-7#1)(2012-2#1)(2013-7#1)
on high-dose##2##2##(1991-6#1)(2006-10#1)
on high-performance liquid chromatography##6##4##(1990-8#1)(1993-2#1)(1997-3#2)(2008-10#2)
on high-quality##2##2##(1993-12#1)(2007-4#1)
on high-resolution computed tomography (HRCT)##2##5##(2005-8#1)(2011-2#1)
on high-resolution computed tomography##3##4##(2005-8#1)(2010-12#1)(2011-2#1)
on high-resolution##12##2##(1991-12#1)(2004-9#1)(2005-5#1)(2005-8#1)(2006-12#1)(2008-3#2)(2010-12#1)(2011-2#1)(2012-2#3)
on higher##4##2##(1992-1#1)(1992-2#1)(2011-1#1)(2013-8#1)
on highly reflective##2##3##(2008-2#1)(2008-3#1)
on highly susceptible##2##3##(2008-10#2)
on highly##17##2##(1996-4#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-2#3)(2008-3#5)(2010-11#1)(2010-9#1)
on him##2##2##(1996-1#1)(2009-6#1)
on hip flexion##2##3##(2007-11#1)(2012-1#1)
on hip##7##2##(2006-11#1)(2007-11#1)(2007-7#1)(2008-12#1)(2010-9#1)(2012-1#1)(2012-12#1)
on hippocampal processing##2##3##(1993-12#2)
on hippocampal##14##2##(1990-2#1)(1992-8#1)(1993-12#2)(1995-12#2)(1996-1#1)(1996-4#1)(1997-5#2)(2008-7#2)(2011-2#1)(2013-1#1)
on his back##3##3##(1996-9#1)(2007-7#1)(2008-5#1)
on his behavioral state##2##4##(2009-8#2)
on his experience##2##3##(1994-12#1)(2008-4#1)
on his left##3##3##(2005-11#1)(2008-12#1)(2008-8#1)
on his or her##2##4##(2008-11#1)(2010-2#1)
on his own##3##3##(2007-11#1)(2008-1#1)(2012-2#1)
on his right arm##2##4##(2007-7#1)(2008-5#1)
on his right##7##3##(1991-6#1)(2007-7#1)(2008-5#1)(2011-2#1)(2012-3#2)(2013-8#1)
on his wrist##2##3##(2012-2#2)
on his##60##2##(1990-12#1)(1991-6#1)(1992-12#1)(1994-1#1)(1994-12#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-9#2)(1997-3#1)(1997-5#1)(1997-6#1)(2004-12#1)(2005-11#2)(2006-3#1)(2006-4#1)(2007-11#1)(2007-7#2)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#2)(2010-2#1)(2010-6#2)(2011-2#2)(2012-11#2)(2012-12#1)(2012-2#4)(2012-3#2)(2013-8#3)
on his/her##4##2##(2008-6#1)(2008-8#1)(2012-1#1)(2012-12#1)
on histamine release##2##3##(1991-12#1)(2008-10#1)
on histamine##4##2##(1991-12#1)(2006-10#1)(2007-1#1)(2008-10#1)
on histidine##2##2##(1992-5#1)(2008-10#1)
on histologic examination##3##3##(1991-6#1)(2006-9#1)(2010-6#1)
on histologic##6##2##(1991-6#1)(1997-8#1)(2006-9#1)(2007-8#1)(2008-9#1)(2010-6#1)
on histological examination##6##3##(2005-1#1)(2006-6#1)(2007-1#1)(2007-8#1)(2008-5#1)(2011-3#1)
on histological##15##2##(1995-9#1)(2005-1#2)(2006-6#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#2)
on histology of the##2##4##(1994-5#1)(2007-4#1)
on histology##10##2##(1990-6#1)(1991-5#1)(1994-5#1)(1997-2#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-6#1)(2012-3#1)(2013-1#1)
on histopathologic examination##3##3##(2007-2#1)(2012-2#1)(2013-8#1)
on histopathological examination##5##3##(2007-1#1)(2007-7#1)(2008-7#1)(2010-4#1)(2012-2#1)
on histopathological##8##2##(2007-1#1)(2007-7#1)(2008-6#1)(2008-7#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
on histopathology was##3##3##(2007-12#1)(2007-8#1)(2009-4#1)
on histopathology##6##2##(2005-7#1)(2007-12#1)(2007-8#1)(2009-4#1)(2012-3#1)(2013-8#1)
on historical and##2##3##(2007-8#1)(2008-3#1)
on historical##9##2##(1996-1#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-6#1)(2013-7#1)
on history and##4##3##(2007-5#1)(2008-12#1)(2012-2#1)(2013-1#1)
on history##7##2##(1996-9#2)(2007-5#1)(2008-12#1)(2012-1#1)(2012-2#1)(2013-1#1)
on holding##2##2##(1995-3#1)(2009-5#1)
on home health##2##3##(1991-12#1)(1992-12#1)
on home##7##2##(1991-12#1)(1992-12#1)(1994-2#1)(1995-3#1)(1997-3#1)(2006-4#1)(2008-1#1)
on homeownership##2##2##(2011-2#2)
on homocysteine##4##2##(2005-10#1)(2007-9#1)(2008-3#1)(2010-5#1)
on homogenates##2##2##(1995-3#1)(2007-11#1)
on homologous recombination##2##3##(1993-11#1)(2008-9#1)
on homologous##5##2##(1993-11#1)(1995-6#1)(1997-3#1)(2008-9#1)(2011-1#1)
on honey##2##2##(2008-6#1)(2011-2#1)
on hope##2##2##(2008-9#1)(2009-8#1)
on hormonal activity##2##3##(1995-12#1)(2012-1#1)
on hormonal##3##2##(1995-12#1)(2008-6#1)(2012-1#1)
on hormone##5##2##(1991-2#1)(1991-6#1)(1993-4#1)(1996-11#1)(2008-11#1)
on hospital admission##4##3##(1994-12#1)(2007-8#1)(2008-7#1)(2010-6#1)
on hospital discharge##3##3##(2006-10#1)(2013-1#2)
on hospital governance##2##3##(1994-1#1)(1995-3#1)
on hospital profitability##2##3##(2008-11#2)
on hospital##31##2##(1990-2#1)(1991-3#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-3#1)(1994-1#1)(1994-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-7#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#5)(2008-7#1)(2010-6#1)(2013-1#2)
on hospitalizations##2##2##(2007-5#1)(2010-9#1)
on hospitals##6##2##(1993-1#1)(1993-2#1)(1996-2#1)(2008-11#2)(2008-12#1)
on host defense##2##3##(2008-10#1)(2009-6#1)
on host growth and yield##2##5##(2008-10#2)
on host plants##3##3##(2008-10#2)(2009-2#1)
on host##30##2##(1994-2#1)(1996-11#1)(1997-7#1)(2006-10#3)(2006-8#1)(2008-10#9)(2008-8#5)(2008-9#2)(2009-10#1)(2009-2#1)(2009-6#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#1)
on host-diversity effects##2##3##(2008-10#2)
on hot##2##2##(2008-5#1)(2008-7#1)
on household##4##2##(1991-1#1)(2008-3#1)(2009-2#1)(2011-2#1)
on how and##2##3##(1994-12#1)(2008-9#1)
on how best to##6##4##(2007-9#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-2#1)(2013-1#1)
on how effectively##2##3##(2007-12#1)(2008-10#1)
on how much of the##2##5##(1995-6#1)(1996-12#1)
on how much##4##3##(1995-6#1)(1996-12#1)(2007-9#1)(2012-3#1)
on how nonprofit##2##3##(1991-12#1)(2008-11#1)
on how our##2##3##(2008-6#1)(2009-5#1)
on how stresses##2##3##(2009-7#2)
on how the##16##3##(1992-12#1)(1994-12#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-3#1)(2006-5#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-10#1)(2009-6#1)(2010-11#1)(2012-3#2)
on how these##7##3##(1993-3#1)(2006-10#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-5#1)(2013-8#1)
on how they may##2##4##(1991-3#1)(2006-10#1)
on how they##9##3##(1991-3#1)(2006-10#1)(2008-1#2)(2008-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
on how this##2##3##(2008-11#1)(2012-12#1)
on how to access##2##4##(2008-4#1)(2009-10#1)
on how to approach##2##4##(2012-3#1)(2013-1#1)
on how to avoid them##2##5##(1995-2#1)(2006-11#1)
on how to avoid##3##4##(1995-2#1)(2006-11#1)(2013-1#1)
on how to deal with##3##5##(2008-11#1)(2012-3#1)(2013-1#1)
on how to develop##2##4##(2007-2#1)(2008-1#1)
on how to grow##2##4##(2008-1#1)(2008-4#1)
on how to handle##3##4##(1994-3#1)(2012-2#2)
on how to improve##4##4##(1990-8#1)(2007-3#1)(2009-7#1)(2011-12#1)
on how to manage##2##4##(2007-4#1)(2008-4#1)
on how to obtain##2##4##(1993-12#1)(1997-2#1)
on how to prepare for##3##5##(2012-2#3)
on how to provide##2##4##(2007-8#1)(2010-11#1)
on how to use##5##4##(1990-2#2)(1996-6#1)(2008-4#2)
on how to##76##3##(1990-2#2)(1990-3#1)(1990-8#1)(1993-12#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-6#2)(1997-2#1)(1997-5#1)(2006-10#2)(2006-11#1)(2006-4#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#4)(2008-12#1)(2008-4#6)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#1)(2009-6#1)(2009-7#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#8)(2013-8#1)
on how we##3##3##(1995-3#1)(1997-3#1)(2008-12#1)
on how well##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
on how##217##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-8#1)(1991-12#2)(1991-3#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-11#1)(1994-12#2)(1994-3#2)(1995-12#1)(1995-2#3)(1995-3#2)(1995-6#2)(1995-9#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-6#2)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#1)(2004-2#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-12#4)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#5)(2008-10#8)(2008-11#11)(2008-12#6)(2008-4#10)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#5)(2009-10#5)(2009-11#1)(2009-12#4)(2009-5#3)(2009-6#4)(2009-7#3)(2009-8#1)(2010-10#1)(2010-11#5)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#3)(2010-9#2)(2011-1#2)(2011-11#1)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#4)(2012-2#11)(2012-3#9)(2013-1#13)(2013-8#7)
on human PBL##2##3##(1997-4#2)
on human and murine##2##4##(1992-1#1)(1995-2#1)
on human and rat##2##4##(2007-8#1)(2008-10#1)
on human and##6##3##(1992-1#1)(1995-1#1)(1995-2#1)(2006-1#1)(2007-8#1)(2008-10#1)
on human arterial##2##3##(1995-8#1)(2010-7#1)
on human beings##3##3##(2006-5#1)(2007-5#1)(2008-1#1)
on human blood coagulation##2##4##(1997-4#2)
on human blood##5##3##(1992-12#1)(1997-4#2)(2007-3#1)(2012-12#1)
on human body##4##3##(2008-7#1)(2011-3#1)(2013-1#1)(2013-7#1)
on human bone##2##3##(2007-7#1)(2008-9#1)
on human bone-derived cells in vitro##2##6##(1991-3#2)
on human brain microvascular endothelial cells##2##6##(1994-2#2)
on human brain##5##3##(1994-2#2)(1995-7#1)(1995-8#1)(2006-8#1)
on human breast cancer cells in##2##6##(1991-10#1)(1994-12#1)
on human breast cancer cells##4##5##(1991-10#1)(1992-5#1)(1993-11#1)(1994-12#1)
on human breast cancer##7##4##(1991-10#2)(1992-5#1)(1992-6#1)(1993-11#1)(1994-12#1)(1997-7#1)
on human breast##8##3##(1991-10#2)(1992-5#1)(1992-6#1)(1993-11#1)(1994-12#1)(1997-5#1)(1997-7#1)
on human cancer cell##2##4##(2008-11#1)(2009-9#1)
on human cells##2##3##(1992-11#1)(2013-1#1)
on human cervical##2##3##(1992-2#1)(2008-8#1)
on human chromosome 1##3##4##(1994-12#1)(2008-7#1)(2008-9#1)
on human chromosome 6##2##4##(1990-5#1)(2008-4#1)
on human chromosome##16##3##(1990-5#1)(1991-9#1)(1994-12#1)(1995-8#2)(1996-10#1)(1996-8#1)(1997-2#1)(1997-4#1)(2007-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2012-3#1)
on human clinical##2##3##(2009-11#1)(2010-9#1)
on human colon##3##3##(1991-8#1)(1994-8#1)(1994-9#1)
on human development and reproduction##3##5##(2005-7#2)(2006-12#1)
on human epidermoid##2##3##(1994-8#2)
on human erythrocytes##3##3##(1994-12#1)(1996-12#1)(2008-11#1)
on human fibroblasts##4##3##(1990-4#1)(1991-7#1)(1992-2#1)(2006-5#1)
on human gastric carcinoma##2##4##(1992-12#1)(1992-4#1)
on human gastric##3##3##(1992-12#1)(1992-4#1)(2008-11#1)
on human health and##3##4##(2010-4#1)(2011-2#1)(2012-2#1)
on human health##19##3##(2007-10#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-8#3)(2010-4#1)(2010-9#3)(2011-2#1)(2012-2#1)(2013-1#1)
on human hepatoma##2##3##(1996-11#1)(2013-8#1)
on human immunodeficiency virus##4##4##(1991-7#1)(1994-5#1)(1996-5#1)(2011-2#1)
on human intestinal cell line Caco-2##2##6##(2008-11#2)
on human intestinal epithelial##2##4##(1995-8#2)
on human intestinal##4##3##(1995-8#2)(2008-11#2)
on human laryngeal epidermoid carcinoma##2##5##(2008-10#2)
on human leukemia##2##3##(1992-8#1)(1996-11#1)
on human liver##2##3##(1991-8#1)(2012-12#1)
on human lung cancer##3##4##(2008-7#1)(2010-5#1)(2013-1#1)
on human lymphocytes##2##3##(1995-3#1)(2008-2#1)
on human melanocytes##3##3##(1995-2#3)
on human myeloid##2##3##(2010-12#2)
on human ovarian cancer##2##4##(2013-1#2)
on human periodontal ligament##2##4##(2013-1#2)
on human peripheral blood lymphocytes##2##5##(2008-11#1)(2008-8#1)
on human peripheral blood mononuclear cells##2##6##(1995-3#1)(2008-4#1)
on human peripheral blood##4##4##(1995-3#1)(2008-11#1)(2008-4#1)(2008-8#1)
on human peripheral nerve fibres##2##5##(1990-7#2)
on human peripheral##7##3##(1990-7#2)(1990-8#1)(1995-3#1)(2008-11#1)(2008-4#1)(2008-8#1)
on human physiology and##2##4##(2006-1#1)(2010-7#1)
on human physiology##4##3##(2006-1#1)(2007-1#2)(2010-7#1)
on human platelet aggregation##2##4##(1995-3#1)(2009-3#1)
on human serum##2##3##(2005-8#1)(2008-10#1)
on human skin##14##3##(1995-3#1)(1996-12#1)(2008-5#10)(2010-5#1)(2013-1#1)
on human small-cell lung carcinoma cells##2##6##(1996-12#2)
on human stratum corneum##2##4##(2008-5#2)
on human subjects##4##3##(1995-2#1)(2005-11#2)(2008-5#1)
on human tumor##2##3##(2008-5#1)(2008-8#1)
on human umbilical vein endothelial cells (HUVECs)##2##7##(1990-8#1)(1994-3#1)
on human umbilical vein endothelial cells##4##6##(1990-8#1)(1994-3#1)(2008-11#1)(2013-7#1)
on human volunteers##2##3##(1994-5#1)(1996-1#1)
on human whole blood##2##4##(2007-8#2)
on human##279##2##(1990-11#1)(1990-2#2)(1990-4#1)(1990-5#2)(1990-7#3)(1990-8#2)(1991-1#1)(1991-10#3)(1991-3#3)(1991-7#3)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#3)(1994-8#3)(1994-9#4)(1995-1#1)(1995-10#2)(1995-12#2)(1995-2#6)(1995-3#4)(1995-5#2)(1995-7#1)(1995-8#6)(1996-1#1)(1996-10#4)(1996-11#2)(1996-12#4)(1996-4#2)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#5)(1997-5#2)(1997-7#1)(2005-10#1)(2005-11#3)(2005-7#2)(2005-8#2)(2006-1#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#2)(2006-5#2)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#4)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#3)(2008-10#12)(2008-11#11)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#18)(2008-6#1)(2008-7#4)(2008-8#11)(2008-9#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#3)(2010-9#4)(2011-11#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#12)(2013-7#2)(2013-8#2)
on humans##10##2##(1992-12#1)(1992-9#1)(1996-12#1)(2007-11#1)(2008-1#1)(2008-8#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
on humoral immunity##3##3##(2008-10#2)(2012-12#1)
on hyaluronic acid##3##3##(2007-7#1)(2008-4#1)(2011-2#1)
on hybrid##7##2##(1996-12#1)(1997-7#1)(2006-5#1)(2007-12#1)(2008-10#2)(2012-3#1)
on hybridization##2##2##(2008-10#2)
on hybridoma cells##2##3##(2008-11#2)
on hybridoma##5##2##(2008-11#5)
on hydrogel##4##2##(2007-11#1)(2007-8#1)(2012-12#1)(2012-3#1)
on hydrogen peroxide##5##3##(1991-9#1)(2005-11#1)(2008-10#3)
on hydrogen production##2##3##(2013-1#2)
on hydrogen##11##2##(1991-9#1)(2005-11#1)(2006-3#1)(2006-8#1)(2008-10#4)(2008-8#1)(2013-1#2)
on hydrolysis##3##2##(1994-11#1)(2008-5#1)(2010-8#1)
on hydrophilic surfaces##2##3##(2008-10#1)(2008-7#1)
on hydrophilic##4##2##(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)
on hydrophobic##7##2##(1993-2#1)(2006-5#1)(2007-9#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-2#1)
on hydrophobicity##2##2##(2009-10#1)(2010-2#1)
on hydrothermal##2##2##(2008-10#2)
on hydroxyapatite##8##2##(1990-8#3)(1992-12#1)(1993-11#1)(1996-3#1)(2008-5#2)
on hydroxychloroquine##4##2##(2013-1#4)
on hydroxyl##2##2##(2008-10#1)(2012-1#1)
on hydroxyl-terminated SAMs##2##3##(2008-10#2)
on hydroxyl-terminated##3##2##(2008-10#3)
on hydroxyurea##2##2##(2007-11#1)(2009-2#1)
on hypercholesterolemia##2##2##(1990-12#1)(2008-6#1)
on hypertension in##2##3##(1996-12#1)(2008-7#1)
on hypertension management##3##3##(2011-2#3)
on hypertension##10##2##(1996-12#1)(2008-1#2)(2008-7#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-2#1)
on hyperthermia-induced seizures in developing rats##2##6##(1996-3#2)
on hyphal growth##2##3##(2008-10#1)(2009-8#1)
on hyphal##4##2##(2008-10#3)(2009-8#1)
on hypothalamic##4##2##(1990-2#1)(1995-12#1)(1995-9#1)(2008-7#1)
on hypoxia and##2##3##(2006-10#1)(2008-10#1)
on hypoxia##3##2##(2006-10#1)(2008-10#1)(2010-11#1)
on ice##7##2##(1990-11#2)(1995-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-4#1)
on identical##2##2##(2006-11#1)(2007-8#1)
on identification and##2##3##(2007-11#1)(2013-8#1)
on identification of##3##3##(1995-1#1)(2008-10#1)(2012-1#1)
on identification##5##2##(1995-1#1)(2007-11#1)(2008-10#1)(2012-1#1)(2013-8#1)
on identified##3##2##(1992-3#1)(2007-2#1)(2008-10#1)
on identifying and##3##3##(2007-12#1)(2011-1#1)(2012-2#1)
on identifying the##4##3##(2006-10#1)(2007-5#1)(2008-7#1)(2009-4#1)
on identifying##21##2##(1994-9#1)(1995-3#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-7#2)(2009-12#1)(2009-4#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-8#2)
on illness##4##2##(1993-10#1)(1994-6#1)(1995-3#1)(1996-2#1)
on image analysis##2##3##(2010-12#1)(2012-1#1)
on image data##2##3##(2007-7#1)(2008-2#1)
on image quality##5##3##(2008-2#3)(2012-1#1)(2013-8#1)
on image##13##2##(2007-12#1)(2007-7#1)(2008-2#6)(2008-3#1)(2010-12#1)(2012-1#2)(2013-8#1)
on images of##2##3##(2008-2#2)
on images##4##2##(1995-6#1)(2008-2#3)
on imaging and##2##3##(2008-3#1)(2009-9#1)
on imaging of the##2##4##(2008-11#1)(2008-2#1)
on imaging studies##2##3##(1996-5#1)(2007-6#1)
on imaging techniques##2##3##(1992-10#1)(2012-1#1)
on imaging##29##2##(1992-10#1)(1993-4#1)(1994-12#1)(1996-5#1)(2005-9#1)(2006-5#1)(2007-12#1)(2007-4#4)(2007-6#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-4#1)(2009-9#2)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-8#1)(2013-1#2)
on imatinib therapy##2##3##(2009-3#2)
on immature development##2##3##(2012-12#2)
on immature fruit was##2##4##(2008-10#2)
on immature fruit##4##3##(2008-10#4)
on immature##9##2##(2005-10#1)(2008-10#6)(2012-12#2)
on immediate##4##2##(1990-2#1)(1995-12#1)(1995-5#1)(2007-10#1)
on immigration##2##2##(1995-3#1)(1996-12#1)
on immobilised##3##2##(1992-7#1)(2008-10#2)
on immobilized metal##2##3##(1996-3#1)(2011-2#1)
on immobilized recombinant##2##3##(1994-6#1)(2008-10#1)
on immobilized##19##2##(1991-2#1)(1992-2#1)(1994-6#1)(1994-9#1)(1996-3#3)(1996-8#1)(1997-6#1)(2007-1#1)(2008-10#8)(2011-2#1)
on immune cell##2##3##(2007-11#1)(2008-4#1)
on immune function is##3##4##(2007-11#1)(2008-9#2)
on immune function##13##3##(1995-12#1)(1995-8#1)(2007-11#3)(2007-2#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#2)(2010-12#1)
on immune response in##2##4##(2008-7#1)(2008-8#1)
on immune response##4##3##(1992-9#2)(2008-7#1)(2008-8#1)
on immune system##2##3##(2007-11#1)(2012-2#1)
on immune##32##2##(1992-9#3)(1993-12#1)(1995-12#1)(1995-8#1)(1996-10#1)(1996-5#1)(2006-10#1)(2006-8#1)(2007-11#6)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#2)(2010-12#1)(2010-3#1)(2012-2#1)(2013-1#1)
on immunisation##2##2##(1997-2#1)(2007-11#1)
on immunity##6##2##(1990-8#1)(2005-9#1)(2007-11#1)(2008-7#1)(2008-8#1)(2013-1#1)
on immunization##12##2##(1990-3#1)(1990-8#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-6#1)(2007-8#1)(2008-11#2)
on immunoblots of##3##3##(1991-9#1)(1995-6#1)(1996-5#1)
on immunoblots with##2##3##(1991-2#1)(1995-6#1)
on immunoblots##10##2##(1990-11#1)(1990-5#1)(1991-2#1)(1991-9#1)(1993-9#1)(1995-6#2)(1996-5#1)(1997-4#1)(2008-4#1)
on immunocompetent##2##2##(2011-2#1)(2012-1#1)
on immunocontraceptives based on sperm##2##5##(2007-11#2)
on immunogenicity##2##2##(1995-11#1)(2010-12#1)
on immunoglobulin##2##2##(2006-2#1)(2008-11#1)
on immunohistochemical##4##2##(1992-6#1)(2009-8#1)(2012-2#1)(2013-8#1)
on immunologic##4##2##(1994-2#1)(1994-9#1)(1997-8#1)(2006-10#1)
on immunological##5##2##(1995-8#1)(1996-9#2)(2011-2#2)
on immunosuppressive drugs##2##3##(2007-7#1)(2013-8#1)
on immunosuppressive##4##2##(1993-11#1)(2007-11#1)(2007-7#1)(2013-8#1)
on impaired##2##2##(2007-8#1)(2011-2#1)
on implant##2##2##(2007-8#1)(2009-4#1)
on implementation of##3##3##(2008-5#1)(2011-2#1)(2013-8#1)
on implementation##7##2##(1997-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#2)(2013-8#1)
on implementing a##3##3##(1993-2#1)(1997-2#1)(2008-3#1)
on implications##2##2##(2012-12#2)
on important##9##2##(1994-3#1)(1994-6#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-3#1)(2009-4#1)(2011-2#1)(2013-8#1)
on imported##2##2##(2007-2#1)(2011-12#1)
on improved##3##2##(2006-10#1)(2010-3#1)(2013-8#1)
on improvement of##4##3##(1991-3#1)(2006-7#1)(2007-8#1)(2011-2#1)
on improvement##5##2##(1991-3#1)(2006-7#2)(2007-8#1)(2011-2#1)
on improving health##2##3##(2010-8#1)(2012-2#1)
on improving quality of life##3##5##(2005-9#1)(2010-7#2)
on improving the##8##3##(1993-3#1)(1996-2#1)(2007-4#1)(2007-8#1)(2008-8#1)(2010-7#1)(2012-2#1)(2013-1#1)
on improving##34##2##(1991-1#1)(1991-6#1)(1993-1#1)(1993-3#1)(1996-2#2)(1996-3#1)(2005-9#1)(2007-2#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-5#2)(2008-8#1)(2010-11#1)(2010-7#5)(2010-8#2)(2010-9#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
on in a##2##3##(2008-5#1)(2010-8#1)
on in silico##2##3##(2008-7#1)(2013-1#1)
on in situ##6##3##(1995-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2012-12#1)
on in the##8##3##(1994-1#1)(2006-6#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
on in this paper##2##4##(2008-12#1)(2008-6#1)
on in this##3##3##(1993-3#1)(2008-12#1)(2008-6#1)
on in vitro development of##2##5##(1996-2#1)(2012-2#1)
on in vitro growth of##2##5##(1992-8#1)(2008-10#1)
on in vitro pollen germination##3##5##(2005-10#1)(2012-2#2)
on in vitro potency##2##4##(1994-9#2)
on in vitro translocation of a model protein into Vibrio alginolyticus inside-out membrane vesicles##2##14##(1997-8#2)
on in vitro##37##3##(1991-3#1)(1992-8#1)(1994-9#3)(1995-8#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-8#2)(2004-12#1)(2005-10#1)(2005-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#5)(2013-1#1)(2013-8#1)
on in vivo and in vitro##2##6##(2007-11#1)(2008-6#1)
on in vivo computing##2##4##(2009-5#2)
on in vivo##15##3##(1990-9#1)(1994-2#1)(1995-12#1)(1997-7#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-5#2)(2010-11#1)(2012-11#2)
on in##84##2##(1990-9#1)(1991-3#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-9#3)(1995-11#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-7#1)(1997-8#2)(2004-12#1)(2005-10#1)(2005-8#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-3#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-11#2)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
on in-depth interviews##2##3##(2006-4#1)(2009-12#1)
on in-depth##4##2##(2006-4#1)(2008-7#1)(2009-12#1)(2009-4#1)
on in-hospital##4##2##(2006-10#1)(2007-8#2)(2011-1#1)
on inactivated##2##2##(1995-5#1)(1996-12#1)
on inactivation of##2##3##(2012-2#1)(2013-8#1)
on incidence and##3##3##(1995-5#1)(2008-10#2)
on incidence at##2##3##(2008-10#2)
on incidence of##4##3##(1993-7#1)(2006-10#1)(2007-12#1)(2012-3#1)
on incidence##16##2##(1993-7#1)(1994-9#1)(1995-5#2)(2006-10#1)(2007-12#1)(2008-10#6)(2009-12#1)(2012-3#1)(2013-1#2)
on incident rain intensity##2##4##(2008-10#2)
on incident##3##2##(1991-2#1)(2008-10#2)
on inclusion of##2##3##(2008-10#1)(2009-9#1)
on inclusion##5##2##(2008-10#2)(2009-9#1)(2012-12#1)(2012-2#1)
on income##3##2##(1996-2#1)(2005-11#1)(2007-7#1)
on incorporating##4##2##(1997-2#1)(2011-12#1)(2013-1#2)
on incorporation of##3##3##(1991-3#1)(1992-2#1)(1995-6#1)
on increase of##3##3##(1990-1#1)(1995-8#1)(2008-5#1)
on increase##4##2##(1990-1#1)(1993-1#1)(1995-8#1)(2008-5#1)
on increased##5##2##(1992-9#1)(1993-12#1)(1995-3#1)(2007-11#1)(2012-12#1)
on increases in##3##3##(1992-3#1)(1994-8#1)(1994-9#1)
on increasing the##5##3##(1990-8#1)(1991-2#1)(1994-6#1)(1997-7#1)(2008-11#1)
on increasing##12##2##(1990-8#1)(1991-2#1)(1991-5#1)(1994-12#1)(1994-6#1)(1995-2#1)(1996-8#1)(1997-7#1)(2006-12#1)(2008-10#2)(2008-11#1)
on incubation period##2##3##(2008-10#2)
on incubation with##2##3##(1990-6#1)(1992-12#1)
on incubation##6##2##(1990-11#1)(1990-6#1)(1992-12#1)(2008-10#2)(2008-8#1)
on independence##2##2##(2005-7#1)(2008-10#1)
on independent component analysis (ICA)##2##5##(2007-8#1)(2008-10#1)
on independent component analysis##4##4##(2007-8#1)(2008-10#2)(2009-11#1)
on independent##12##2##(1993-6#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-8#2)(2009-11#2)(2010-8#1)(2011-1#1)
on index##2##2##(2007-12#1)(2008-2#1)
on indications##3##2##(1993-6#1)(2008-9#1)(2012-2#1)
on indicators of##2##3##(2008-11#1)(2012-12#1)
on indices of##5##3##(1992-3#1)(1995-12#1)(2008-4#1)(2008-5#1)(2013-8#1)
on indices##6##2##(1992-3#1)(1995-12#1)(2006-6#1)(2008-4#1)(2008-5#1)(2013-8#1)
on indirect##5##2##(2005-7#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-9#1)
on indium tin oxide##3##4##(2008-10#1)(2008-12#1)(2010-11#1)
on indium-tin oxide##2##3##(2008-10#1)(2010-4#1)
on individual ADL items##2##4##(2011-2#2)
on individual basis##2##3##(1991-11#1)(2009-4#1)
on individual faults##2##3##(1996-4#2)
on individual or##2##3##(2007-12#1)(2008-10#1)
on individual patient##4##3##(1996-12#1)(2006-10#1)(2008-7#1)(2010-2#1)
on individual##65##2##(1990-1#1)(1990-11#1)(1990-12#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#1)(1993-3#1)(1993-5#1)(1994-3#1)(1995-7#1)(1996-12#2)(1996-3#1)(1996-4#2)(1997-3#1)(1997-5#1)(2004-10#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-6#1)(2007-10#4)(2007-11#2)(2007-12#6)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-2#2)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
on individuals and##3##3##(2006-8#1)(2008-3#1)(2012-2#1)
on individuals of##2##3##(2011-12#1)(2012-12#1)
on individuals##16##2##(1995-5#1)(1997-8#2)(2005-9#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-11#1)(2008-3#1)(2009-10#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-12#2)(2012-2#1)
on individuals'##5##2##(2007-6#1)(2008-2#1)(2008-5#1)(2008-7#1)(2013-1#1)
on indoor##3##2##(1992-4#1)(2008-10#2)
on induced##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
on inducing##2##2##(1992-7#1)(2011-2#1)
on induction and##2##3##(2007-2#1)(2008-8#1)
on induction of microsomal##2##4##(1994-9#1)(2008-4#1)
on induction of##11##3##(1991-1#1)(1993-12#1)(1994-9#1)(1997-7#1)(2007-11#1)(2008-10#3)(2008-4#2)(2012-3#1)
on induction##16##2##(1991-1#1)(1992-5#1)(1993-12#1)(1994-9#1)(1997-7#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-4#2)(2008-8#1)(2012-12#1)(2012-3#1)
on infant outcomes##2##3##(2007-2#2)
on infant##13##2##(1990-12#1)(1994-7#1)(1995-2#1)(2006-11#1)(2006-3#1)(2007-2#3)(2007-6#1)(2007-7#1)(2010-6#1)(2011-1#1)(2011-2#1)
on infantile##2##2##(2007-6#1)(2011-1#1)
on infarct size 48 h after##2##6##(1991-6#2)
on infarct size and##3##4##(1992-5#3)
on infarct size##5##3##(1991-6#2)(1992-5#3)
on infarct##6##2##(1991-6#2)(1992-5#3)(1994-5#1)
on infected plants##4##3##(2008-10#4)
on infected source plants##2##4##(2008-10#2)
on infected##18##2##(2008-10#16)(2008-6#1)(2012-1#1)
on infection control##2##3##(1995-6#1)(2006-8#1)
on infection efficiency##3##3##(2008-10#3)
on infection of##5##3##(1997-4#1)(1997-6#1)(2008-10#3)
on infection##24##2##(1993-6#1)(1995-11#1)(1995-6#1)(1997-4#1)(1997-6#2)(2006-8#3)(2007-9#1)(2008-10#11)(2010-10#2)(2011-2#1)
on infections caused by##2##4##(2007-9#1)(2008-10#1)
on infections##4##2##(2007-9#1)(2008-10#1)(2008-7#1)(2011-2#1)
on infectious##2##2##(1997-6#1)(2013-1#1)
on inference##2##2##(2009-9#1)(2010-2#1)
on inferences##2##2##(1995-2#1)(2008-12#1)
on infested potato seed tubers##2##5##(2008-10#2)
on infested##3##2##(2008-10#3)
on inflammation and##3##3##(1992-6#1)(2013-1#2)
on inflammation##5##2##(1992-6#1)(2006-2#1)(2013-1#2)(2013-7#1)
on inflammatory bowel disease##2##4##(2011-1#1)(2012-11#1)
on inflammatory cells##2##3##(2004-12#1)(2008-5#1)
on inflammatory cytokines##2##3##(2012-12#1)(2013-8#1)
on inflammatory##10##2##(2004-12#1)(2005-3#1)(2006-10#1)(2007-9#1)(2008-5#1)(2010-3#1)(2011-1#1)(2012-11#1)(2012-12#1)(2013-8#1)
on influenza vaccination##3##3##(1995-6#1)(1997-6#2)
on influenza##8##2##(1992-9#1)(1995-6#1)(1997-6#2)(2009-5#2)(2011-2#2)
on influx##3##2##(1991-10#2)(1996-6#1)
on information obtained from a##2##5##(1994-3#1)(2008-12#1)
on information obtained##3##3##(1994-3#1)(2004-12#1)(2008-12#1)
on information of##2##3##(2008-3#1)(2011-2#1)
on information##27##2##(1990-2#1)(1991-3#1)(1993-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-3#1)(2004-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-11#1)(2013-1#2)
on informing##2##2##(2008-4#1)(2013-1#1)
on infrared##9##2##(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2012-2#1)(2013-1#1)(2013-8#1)
on inhaled corticosteroids##2##3##(2005-7#1)(2012-1#1)
on inhaled##5##2##(1991-12#1)(1992-3#1)(2005-7#1)(2008-11#1)(2012-1#1)
on inhibition by##2##3##(1997-3#2)
on inhibition of the##2##4##(1991-12#1)(1992-3#1)
on inhibition of##8##3##(1991-12#1)(1992-3#1)(1993-1#1)(1995-1#1)(1995-3#1)(2008-10#1)(2008-11#1)(2012-2#1)
on inhibition##11##2##(1991-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1995-1#1)(1995-3#1)(1997-3#2)(2008-10#1)(2008-11#1)(2012-2#1)
on inhibitor length##2##3##(1992-8#2)
on inhibitor##3##2##(1992-8#2)(1993-8#1)
on inhibitory##5##2##(1996-12#1)(1996-5#1)(2008-5#1)(2012-2#1)(2013-1#1)
on initial biopsy##2##3##(2006-7#1)(2010-10#1)
on initial presentation##2##3##(2006-10#1)(2010-2#1)
on initial##16##2##(1993-2#1)(1995-11#1)(2006-10#1)(2006-6#1)(2006-7#2)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-11#1)(2009-7#1)(2010-10#1)(2010-2#1)
on initiation of##4##3##(1991-6#1)(2008-10#2)(2008-3#1)
on initiation##5##2##(1991-6#1)(2008-10#2)(2008-3#1)(2010-12#1)
on injection##5##2##(2007-12#2)(2007-7#1)(2008-1#1)(2013-7#1)
on injured##2##2##(1996-5#1)(1997-6#1)
on injuries##2##2##(2006-3#1)(2007-7#1)
on injury and##2##3##(1996-6#1)(2007-4#1)
on injury outcome##4##3##(2006-11#3)(2007-4#1)
on injury risk##2##3##(2007-1#1)(2007-4#1)
on injury##10##2##(1996-6#1)(1997-8#1)(2006-11#3)(2007-1#1)(2007-11#1)(2007-4#3)
on innervation##2##2##(1992-6#1)(1992-8#1)
on innovative##3##2##(1994-1#1)(2007-11#1)(2011-1#1)
on inoculated plants##2##3##(2008-10#2)
on inoculated seedlings##2##3##(2008-10#2)
on inoculated trees and##2##4##(2008-10#2)
on inoculated##13##2##(2008-10#13)
on inoculum##2##2##(2008-10#2)
on inositol phospholipid hydrolysis##2##4##(1995-3#2)
on inositol phospholipids pathway in human thyroid##2##7##(1994-11#1)(1994-6#1)
on inositol##8##2##(1990-12#1)(1990-7#2)(1994-11#1)(1994-12#1)(1994-6#1)(1995-3#2)
on inpatient##5##2##(1992-1#1)(1995-1#1)(2009-6#1)(2010-6#1)(2011-1#1)
on input##5##2##(1992-8#1)(2005-5#1)(2008-3#1)(2009-2#1)(2010-11#1)
on insect abundances##4##3##(2008-8#4)
on insect diversity##2##3##(2008-8#2)
on insect##13##2##(1990-4#1)(2008-8#9)(2011-12#1)(2012-2#1)(2013-7#1)
on insects##3##2##(1990-2#1)(2007-6#2)
on insertion##2##2##(1991-10#1)(2008-10#1)
on insight##2##2##(1996-3#1)(2006-2#1)
on instillation##2##2##(2009-8#1)(2012-10#1)
on institutional##2##2##(2010-10#1)(2013-1#1)
on instrument##2##2##(2008-3#2)
on insufficient##2##2##(2008-6#1)(2008-8#1)
on insulin binding and##2##4##(1990-7#1)(1997-1#1)
on insulin binding##4##3##(1990-7#1)(1995-11#1)(1997-1#2)
on insulin receptors##2##3##(1994-6#1)(2010-11#1)
on insulin resistance and##2##4##(2008-1#1)(2008-3#1)
on insulin resistance##8##3##(2005-1#2)(2005-10#1)(2008-1#1)(2008-3#3)(2009-1#1)
on insulin secretion in##2##4##(1991-6#1)(2007-8#1)
on insulin secretion##6##3##(1991-6#1)(1992-11#1)(1994-8#1)(1995-8#1)(2007-8#1)(2011-1#1)
on insulin sensitivity and some inflammatory indicators in##2##8##(2012-2#2)
on insulin sensitivity and##3##4##(2008-3#1)(2012-2#2)
on insulin sensitivity##8##3##(2008-3#5)(2010-2#1)(2012-2#2)
on insulin signaling##2##3##(1995-3#1)(2010-12#1)
on insulin##37##2##(1990-7#1)(1991-6#1)(1992-11#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-1#1)(1997-1#2)(1997-4#2)(1997-7#1)(2005-1#2)(2005-10#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-3#8)(2009-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-12#2)(2012-2#2)
on insulin-like growth##2##3##(1995-10#2)
on insurance##5##2##(1991-12#1)(1994-2#2)(1996-11#1)(2008-6#1)
on intact cells##6##3##(1990-4#1)(1991-7#1)(1992-8#1)(1994-9#1)(1997-6#1)(2008-4#1)
on intact##22##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#2)(1991-7#1)(1992-5#1)(1992-8#1)(1993-12#1)(1994-9#1)(1995-3#1)(1996-8#1)(1997-2#1)(1997-6#2)(2007-11#1)(2008-10#1)(2008-4#2)(2008-5#2)(2010-12#1)
on intake and##2##3##(2007-8#1)(2012-2#1)
on integrated##8##2##(1994-12#1)(1996-1#1)(2007-12#1)(2008-10#2)(2008-2#1)(2009-4#1)(2011-2#1)
on integrating##4##2##(1996-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
on integration##2##2##(2008-10#1)(2009-6#1)
on integrative painting##2##3##(2007-7#2)
on intensity of##4##3##(2005-10#1)(2007-7#1)(2010-3#1)(2011-2#1)
on intensity##8##2##(2005-10#1)(2007-11#1)(2007-7#1)(2008-2#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#1)
on intensive care##3##3##(2006-10#1)(2007-8#1)(2012-11#1)
on intensive##4##2##(2006-10#1)(2007-10#1)(2007-8#1)(2012-11#1)
on intentions to##3##3##(1994-3#1)(2009-10#1)(2012-1#1)
on interaction of##2##3##(1997-3#1)(2008-5#1)
on interaction with##5##3##(1997-1#1)(2007-2#1)(2008-10#2)(2008-5#1)
on interaction##9##2##(1997-1#1)(1997-3#1)(2006-8#1)(2007-2#1)(2008-10#3)(2008-5#2)
on interactions between##5##3##(1994-9#1)(2005-11#1)(2006-6#1)(2008-2#1)(2009-10#1)
on interactions of##3##3##(1995-10#1)(2006-1#1)(2006-12#1)
on interactions with##2##3##(1995-12#1)(2006-6#1)
on interactions##12##2##(1994-9#1)(1995-10#1)(1995-12#1)(2005-11#1)(2006-1#1)(2006-12#1)(2006-6#2)(2007-12#1)(2008-2#1)(2009-10#1)(2010-11#1)
on interatomic##3##2##(1993-4#1)(2006-5#1)(2007-9#1)
on intercellular##2##2##(1995-8#1)(1996-3#1)
on interdisciplinary##2##2##(2010-1#1)(2012-3#1)
on interface##2##2##(1993-9#1)(2005-11#1)
on interferon production in##2##4##(1994-6#2)
on interferon##3##2##(1994-6#2)(2007-11#1)
on interferon-gamma##2##2##(1992-12#1)(2008-2#1)
on interlaboratory##2##2##(1990-1#1)(2007-8#1)
on interleukin##2##2##(1992-6#1)(1994-5#1)
on interleukin-2##2##2##(1992-8#1)(1994-5#1)
on intermediate##5##2##(1991-9#1)(1996-7#1)(2008-7#2)(2012-12#1)
on intermittent##2##2##(2006-6#1)(2011-2#1)
on intermolecular##3##2##(1993-12#2)(1995-8#1)
on internal carotid##2##3##(2011-3#1)(2012-3#1)
on internal##6##2##(1993-12#1)(1997-3#1)(2007-9#1)(2008-11#1)(2011-3#1)(2012-3#1)
on international development##2##3##(2008-11#1)(2010-9#1)
on international level##2##3##(2007-8#1)(2013-1#1)
on international##11##2##(1993-5#1)(2007-4#1)(2007-8#1)(2008-11#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
on interobserver##5##2##(2008-7#4)(2009-2#1)
on interpersonal##2##2##(2006-9#1)(2009-5#1)
on interpretation of##3##3##(1992-11#1)(2007-11#1)(2009-6#1)
on intervention for##2##3##(2006-10#1)(2008-4#1)
on intervention##7##2##(2006-10#1)(2006-12#1)(2008-4#1)(2010-10#1)(2010-9#1)(2013-1#2)
on interventional pain##3##3##(2006-8#3)
on interventional##4##2##(2006-10#1)(2006-8#3)
on interventions that##2##3##(1992-12#1)(2011-1#1)
on interventions##5##2##(1992-12#1)(2008-3#1)(2011-1#3)
on interviews and##2##3##(2007-3#1)(2011-2#1)
on interviews with##5##3##(1990-12#1)(1995-12#1)(2010-10#1)(2011-1#1)(2013-1#1)
on interviews##7##2##(1990-12#1)(1995-12#1)(2007-3#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
on intestinal##13##2##(1990-3#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-12#1)(1995-8#1)(2005-12#1)(2006-2#1)(2006-4#2)(2007-2#1)(2008-5#1)(2011-12#1)
on intimacy##2##2##(2007-2#1)(2010-5#1)
on intimate##2##2##(2008-11#1)(2012-2#1)
on intracavity##5##2##(2007-11#3)(2007-12#1)(2008-3#1)
on intracellular Ca2+##4##3##(1991-2#1)(1991-6#1)(1993-9#1)(1995-11#1)
on intracellular calcium concentration##2##4##(1993-7#1)(1994-12#1)
on intracellular calcium##8##3##(1991-8#1)(1993-7#1)(1994-10#1)(1994-12#1)(1995-7#1)(1996-2#1)(2007-11#1)(2011-2#1)
on intracellular free##2##3##(1994-6#1)(1996-8#1)
on intracellular##26##2##(1990-3#1)(1991-2#1)(1991-6#1)(1991-8#3)(1993-7#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-6#2)(1995-11#2)(1995-7#1)(1996-2#1)(1996-8#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-7#2)(2009-3#1)(2010-8#1)(2011-2#1)(2012-12#1)
on intracerebral##3##2##(1990-11#1)(1996-12#1)(2013-1#1)
on intracoronary##2##2##(1993-11#1)(2010-5#1)
on intracranial pressure (ICP)##2##4##(1993-1#1)(2008-7#1)
on intracranial pressure##4##3##(1993-1#2)(2008-7#1)(2008-9#1)
on intracranial##5##2##(1993-1#2)(2007-10#1)(2008-7#1)(2008-9#1)
on intramuscular##2##2##(2006-8#1)(2010-4#1)
on intraocular pressure in patients##2##5##(2012-1#1)(2013-8#1)
on intraocular pressure##4##3##(2008-4#1)(2012-1#1)(2013-1#1)(2013-8#1)
on intraoperative##3##2##(2008-7#1)(2010-7#1)(2013-7#1)
on intraoral##2##2##(1993-12#1)(2013-1#1)
on intraperitoneal##2##2##(2010-12#1)(2011-2#1)
on intravenous##7##2##(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#1)(2011-1#1)
on intrinsic##3##2##(2008-1#1)(2008-8#1)(2009-7#1)
on invasion and##2##3##(2008-11#1)(2008-4#1)
on invasion##4##2##(2008-11#3)(2008-4#1)
on invasive##2##2##(1990-12#1)(1997-3#1)
on invertase##2##2##(2008-10#1)(2008-12#1)
on inverted##2##2##(1993-9#1)(2009-4#1)
on investigating##4##2##(1994-9#1)(2007-8#1)(2008-10#1)(2008-6#1)
on investigation##2##2##(1996-5#1)(2007-7#1)
on investigations##3##2##(2005-10#1)(2008-10#1)(2009-6#1)
on investment for##2##3##(2008-7#1)(2010-12#1)
on investment##9##2##(2007-12#1)(2007-9#2)(2008-7#2)(2010-12#1)(2010-8#1)(2013-1#2)
on investments##2##2##(1995-1#1)(1996-1#1)
on ion channels##3##3##(1992-11#1)(2005-12#1)(2008-8#1)
on ion exchange columns by##2##5##(2008-10#2)
on ion exchange##3##3##(2008-10#3)
on ion transport in the##2##5##(2008-1#1)(2008-12#1)
on ion transport in##3##4##(2008-1#2)(2008-12#1)
on ion transport through##2##4##(1992-6#1)(1996-1#1)
on ion transport##6##3##(1992-6#1)(1996-1#1)(2008-1#2)(2008-12#1)(2010-7#1)
on ion##23##2##(1990-5#1)(1990-9#1)(1992-11#1)(1992-6#1)(1996-1#1)(2005-12#1)(2007-8#2)(2008-1#2)(2008-10#8)(2008-12#1)(2008-8#1)(2010-5#1)(2010-7#2)
on ion-selective field-effect##3##3##(2007-9#3)
on ionic strength##7##3##(2008-10#5)(2008-5#1)(2009-4#1)
on ionic##10##2##(1997-5#2)(2006-5#1)(2008-10#5)(2008-5#1)(2009-4#1)
on iris##2##2##(1990-2#1)(2008-10#1)
on iron status##3##3##(2006-10#1)(2012-12#1)(2013-1#1)
on iron##10##2##(1995-6#1)(1996-6#1)(2006-10#2)(2006-8#1)(2008-10#1)(2012-11#1)(2012-12#2)(2013-1#1)
on irradiated##3##2##(1993-9#1)(2006-10#1)(2010-4#1)
on irradiation of##2##3##(1995-6#1)(2010-12#1)
on irradiation with##3##3##(2007-12#1)(2008-3#1)(2008-5#1)
on irradiation##6##2##(1995-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-12#1)
on ischaemic##2##2##(1993-9#1)(2006-10#1)
on ischemia-induced##3##2##(1992-9#2)(1993-3#1)
on ischemia-reperfusion injury##2##3##(1995-12#1)(2008-12#1)
on ischemia-reperfusion##4##2##(1995-12#2)(2008-10#1)(2008-12#1)
on ischemic##4##2##(1991-11#1)(1993-4#1)(1995-8#1)(2005-12#1)
on islands has##2##3##(1996-6#1)(2008-8#1)
on islands##9##2##(1996-6#6)(2008-8#2)(2012-1#1)
on islet##5##2##(2009-4#1)(2010-11#3)(2013-8#1)
on isoelectric focusing gels##2##4##(1992-8#1)(1993-4#1)
on isoelectric focusing##3##3##(1992-11#1)(1992-8#1)(1993-4#1)
on isoforms##2##2##(1995-12#1)(1996-9#1)
on isolated rat liver##2##4##(1994-12#1)(2011-2#1)
on isolated rat##5##3##(1994-12#2)(2007-1#1)(2010-12#1)(2011-2#1)
on isolated uterine##2##3##(2008-4#1)(2010-3#1)
on isolated##21##2##(1991-2#1)(1994-11#1)(1994-12#2)(1995-1#1)(1995-7#1)(1995-8#1)(2006-2#1)(2007-1#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-2#1)
on isolates##2##2##(2008-10#2)
on isolation of##3##3##(1993-5#1)(2008-9#1)(2009-5#1)
on isolation##5##2##(1991-12#1)(1993-5#1)(2006-12#1)(2008-9#1)(2009-5#1)
on issues of##6##3##(1992-2#1)(1997-1#1)(2005-7#1)(2006-10#1)(2007-12#1)(2012-3#1)
on issues relating to##2##4##(1995-5#1)(2008-7#1)
on issues such as##2##4##(2008-1#1)(2008-12#1)
on issues that##2##3##(2007-8#1)(2013-8#1)
on issues##20##2##(1991-2#1)(1992-2#1)(1995-5#1)(1996-2#1)(1997-1#2)(2005-7#1)(2006-10#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-11#1)(2012-2#1)(2012-3#2)(2013-8#1)
on it##19##2##(1993-6#1)(1993-8#1)(1995-12#2)(1995-2#1)(1995-5#1)(2005-11#1)(2006-2#1)(2006-6#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2009-7#1)(2012-3#1)(2013-7#1)
on items##3##2##(2008-11#1)(2011-1#1)(2012-2#1)
on iterative##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
on its ability to##10##4##(1993-9#1)(1994-3#1)(1996-10#1)(1996-5#1)(2005-8#1)(2006-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2013-8#1)
on its activity##3##3##(1991-7#1)(1997-7#1)(2012-2#1)
on its addition##2##3##(1995-1#1)(2008-3#1)
on its adsorption##2##3##(2007-4#1)(2013-1#1)
on its application##3##3##(2005-7#1)(2006-2#1)(2007-2#1)
on its associated##2##3##(2008-10#1)(2011-1#1)
on its binding to##2##4##(1994-8#1)(2008-8#1)
on its binding##3##3##(1994-5#1)(1994-8#1)(2008-8#1)
on its biological activity##2##4##(1992-8#1)(2008-8#1)
on its biological##4##3##(1992-8#1)(2008-10#1)(2008-7#1)(2008-8#1)
on its catalytic##14##3##(1996-2#1)(2008-10#12)(2012-2#1)
on its central##2##3##(1991-5#1)(2008-3#1)
on its clinical##3##3##(2006-10#1)(2008-6#1)(2010-8#1)
on its concentration in##3##4##(1990-3#1)(1991-2#1)(2012-1#1)
on its concentration##5##3##(1990-3#1)(1991-2#1)(2008-10#1)(2010-12#1)(2012-1#1)
on its duration##2##3##(2007-7#1)(2008-2#1)
on its efficacy##2##3##(2008-12#1)(2010-12#1)
on its host##3##3##(1991-1#1)(2008-10#1)(2010-10#1)
on its interaction with##5##4##(1995-3#1)(1996-5#1)(2008-10#3)
on its mechanism of action##2##5##(2007-8#1)(2008-11#1)
on its outcomes##2##3##(2006-5#2)
on its own or in combination with##2##7##(1994-10#1)(2006-2#1)
on its own or##3##4##(1994-10#1)(2006-2#1)(2008-10#1)
on its own##32##3##(1990-10#1)(1990-12#1)(1990-5#2)(1992-3#1)(1993-3#1)(1994-10#1)(1995-12#1)(1995-3#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-12#1)(1997-7#1)(2004-12#1)(2005-10#1)(2005-11#1)(2006-2#2)(2007-2#5)(2007-9#1)(2008-10#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-2#1)
on its physical##2##3##(2008-1#1)(2008-5#1)
on its properties##2##3##(1991-11#1)(2008-5#1)
on its reaction with##6##4##(1995-5#1)(2007-9#1)(2008-10#4)
on its relationship to##2##4##(1993-2#1)(2008-11#1)
on its resonance##2##3##(2008-3#1)(2013-8#1)
on its role in##5##4##(1993-10#1)(2007-10#1)(2008-8#1)(2011-1#1)(2011-2#1)
on its side##2##3##(2006-6#1)(2008-11#1)
on its size##2##3##(2008-10#1)(2008-5#1)
on its specific##3##3##(1990-7#1)(1991-9#1)(1997-2#1)
on its structural##3##3##(1997-8#1)(2009-10#1)(2009-5#1)
on its subsequent##2##3##(2008-4#1)(2009-3#1)
on its surface and##2##4##(2008-3#1)(2008-5#1)
on its surface can be##2##5##(2008-12#1)(2011-1#1)
on its surface##16##3##(1996-12#1)(2005-11#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2009-2#1)(2009-7#1)(2010-4#1)(2011-1#1)
on its use##3##3##(2006-10#1)(2008-11#1)(2011-1#1)
on its vascular pedicle##2##4##(2007-12#1)(2008-6#1)
on its way##3##3##(1994-5#1)(2005-10#1)(2008-5#1)
on its##353##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#3)(1990-7#2)(1990-8#2)(1991-1#1)(1991-11#3)(1991-12#1)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#2)(1992-2#1)(1992-3#1)(1992-8#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#4)(1995-5#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-7#2)(1997-8#1)(2004-12#1)(2005-10#2)(2005-11#3)(2005-12#2)(2005-3#1)(2005-7#2)(2005-8#2)(2006-10#3)(2006-12#1)(2006-2#4)(2006-3#2)(2006-5#4)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-2#7)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#3)(2008-1#4)(2008-10#63)(2008-11#6)(2008-12#3)(2008-2#6)(2008-3#16)(2008-4#7)(2008-5#12)(2008-6#5)(2008-7#3)(2008-8#11)(2008-9#7)(2009-10#3)(2009-2#2)(2009-3#2)(2009-5#1)(2009-7#1)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#3)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#7)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#9)(2012-3#1)(2013-1#7)(2013-7#4)(2013-8#3)
on job##7##2##(1991-12#1)(1991-3#1)(1994-1#1)(1995-1#1)(2006-1#1)(2007-4#1)(2009-7#1)
on joint##7##2##(1990-12#1)(1991-3#1)(2006-10#1)(2007-7#2)(2008-5#1)(2010-9#1)
on judgements of##3##3##(2007-5#1)(2013-7#2)
on jugular venous##2##3##(2008-7#2)
on just##2##2##(2007-12#1)(2008-10#1)
on juvenile growth and##2##4##(2008-11#2)
on juvenile survival and growth##2##5##(2008-11#2)
on juvenile##5##2##(2008-11#4)(2013-1#1)
on kcat##5##2##(1990-5#1)(1992-8#1)(1994-11#1)(1994-5#1)(1995-2#1)
on key##13##2##(1994-3#1)(1996-12#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
on kidney##7##2##(1992-3#1)(2007-8#1)(2009-10#1)(2011-1#1)(2012-2#2)(2013-1#1)
on kidneys of streptozotocin-induced diabetic##2##5##(2011-3#2)
on kindling##3##2##(1993-12#1)(1994-2#1)(2012-12#1)
on kinematic##2##2##(2006-11#1)(2012-3#1)
on kinetic competition between##2##4##(1997-4#1)(2006-10#1)
on kinetic##6##2##(1995-12#1)(1997-4#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#1)
on kinetics and##3##3##(1990-3#1)(1995-1#1)(2008-8#1)
on kinetics##4##2##(1990-3#1)(1995-1#1)(2008-6#1)(2008-8#1)
on knee##6##2##(1993-12#1)(2006-10#1)(2006-11#1)(2006-3#1)(2007-1#1)(2009-6#1)
on knowledge about##2##3##(1997-6#1)(2010-4#1)
on knowledge of the##8##4##(1996-9#1)(1997-5#1)(2004-12#1)(2007-7#1)(2008-3#2)(2008-8#1)(2009-4#1)
on knowledge of##12##3##(1996-9#1)(1997-5#1)(1997-8#1)(2004-12#1)(2005-9#1)(2006-2#1)(2007-7#1)(2008-3#2)(2008-8#1)(2009-4#1)(2012-2#1)
on knowledge##30##2##(1990-6#1)(1990-8#1)(1994-6#1)(1996-9#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-12#1)(2005-9#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#3)
on known##6##2##(1991-7#1)(1997-1#1)(1997-2#1)(1997-6#1)(2008-10#1)(2010-5#1)
on kudzu##3##2##(2008-10#3)
on labeling##3##2##(2008-4#1)(2010-11#1)(2010-7#1)
on labial palps##3##3##(2007-12#3)
on labial##4##2##(1995-6#1)(2007-12#3)
on labor progress##3##3##(2007-2#1)(2013-1#2)
on labor##7##2##(2006-10#1)(2006-7#1)(2007-2#2)(2011-2#1)(2013-1#2)
on laboratory##11##2##(1995-1#2)(2005-7#1)(2008-10#4)(2008-3#1)(2008-9#1)(2011-3#1)(2013-8#1)
on laccase activity##2##3##(2005-11#1)(2008-10#1)
on lactate##4##2##(1991-8#2)(1996-9#1)(2006-5#1)
on lactate/sulfate medium##2##3##(2006-8#2)
on lactation##2##2##(2012-2#2)
on lactic acid bacteria##2##4##(2007-8#1)(2010-4#1)
on lactic acid##3##3##(2007-8#1)(2008-6#1)(2010-4#1)
on lactose##4##2##(1991-9#1)(1997-2#1)(2008-5#2)
on lamb##2##2##(1994-4#2)
on laminin##4##2##(1991-3#3)(1996-12#1)
on language##7##2##(2006-2#1)(2007-1#1)(2007-9#1)(2009-11#1)(2010-4#1)(2012-2#1)(2013-8#1)
on laparoscopic##3##2##(2006-10#1)(2006-6#1)(2009-12#1)
on large populations##2##3##(2006-10#1)(2012-1#1)
on large scale##2##3##(2010-2#1)(2011-3#1)
on large spatial scales##2##4##(2008-9#1)(2013-1#1)
on large##31##2##(1991-11#1)(1991-8#1)(1992-6#1)(1992-8#1)(1996-2#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-12#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#1)(2008-9#2)(2009-1#1)(2009-5#1)(2010-2#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-3#1)(2013-1#3)
on large-scale##5##2##(2007-11#1)(2008-3#2)(2011-1#1)(2013-1#1)
on larger##6##2##(1995-4#1)(2006-5#1)(2008-1#1)(2008-8#1)(2009-2#1)(2013-1#1)
on larvae of Caligo atreus##2##5##(2007-3#2)
on larvae of the##2##4##(2008-5#1)(2013-8#1)
on larvae of##5##3##(2007-3#2)(2008-5#2)(2013-8#1)
on larval##3##2##(2008-8#1)(2011-2#2)
on larvicides##2##2##(1994-6#1)(2013-8#1)
on laryngeal##4##2##(1992-9#1)(1996-12#1)(2006-10#1)(2013-7#1)
on laser fluence##2##3##(2008-2#1)(2008-3#1)
on laser power##2##3##(2007-12#1)(2008-2#1)
on laser##18##2##(2005-4#1)(2007-11#1)(2007-12#5)(2008-10#2)(2008-2#3)(2008-3#3)(2009-5#1)(2011-2#1)(2013-1#1)
on laser-induced breakdown spectroscopy (LIBS)##2##5##(2006-12#1)(2013-8#1)
on laser-induced breakdown spectroscopy##3##4##(2006-12#1)(2013-8#2)
on laser-induced##7##2##(2006-12#1)(2007-12#1)(2008-3#3)(2013-8#2)
on late apoptotic neutrophils##2##4##(2011-1#2)
on late apoptotic##3##3##(2011-1#3)
on late blight##2##3##(2008-10#2)
on late events##2##3##(2007-12#1)(2008-7#1)
on late##11##2##(2005-12#1)(2007-12#1)(2008-10#2)(2008-7#1)(2009-12#1)(2009-2#1)(2011-1#3)(2013-1#1)
on latent##2##2##(2008-10#1)(2010-12#1)
on later conduct problems##2##4##(2006-3#2)
on later##5##2##(2006-3#2)(2009-5#1)(2010-4#1)(2013-1#1)
on later-life appraisals##2##3##(2013-1#2)
on lateral##8##2##(1993-6#1)(2007-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-6#1)(2012-1#1)(2012-12#1)
on latex##2##2##(1994-12#1)(2008-3#1)
on laying performance##3##3##(2010-2#1)(2012-2#2)
on laying##4##2##(2008-5#1)(2010-2#1)(2012-2#2)
on leaching##2##2##(2007-10#1)(2007-8#1)
on lead##5##2##(1996-3#1)(2008-1#1)(2008-10#2)(2011-2#1)
on leading##2##2##(2007-8#1)(2013-1#1)
on leaf disks##3##3##(2008-10#3)
on leaf surfaces##2##3##(2008-10#2)
on leaf tissue##2##3##(2008-10#2)
on leaf##16##2##(2007-1#1)(2008-10#13)(2012-5#2)
on learning abilities##2##3##(1994-8#2)
on learning and memory in##2##5##(1991-10#1)(1993-3#1)
on learning and memory##6##4##(1991-10#1)(1991-5#1)(1993-3#1)(2008-10#1)(2008-5#1)(2013-8#1)
on learning and##7##3##(1991-10#1)(1991-5#1)(1993-3#1)(1994-3#1)(2008-10#1)(2008-5#1)(2013-8#1)
on learning process##3##3##(2013-1#3)
on learning resources##2##3##(2008-11#2)
on learning##26##2##(1991-1#2)(1991-10#1)(1991-5#1)(1993-3#1)(1994-3#1)(1994-8#2)(1996-1#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#1)(2011-1#1)(2012-2#1)(2013-1#5)(2013-8#1)
on leaves and stems##3##4##(2008-10#3)
on leaves and##13##3##(2008-10#12)(2011-12#1)
on leaves of cvs##2##4##(2008-10#2)
on leaves of##8##3##(2004-2#1)(2008-10#7)
on leaves sprayed in##2##4##(2008-10#2)
on leaves sprayed with M##3##5##(2008-10#3)
on leaves sprayed##5##3##(2008-10#5)
on leaves was##2##3##(2007-1#1)(2008-10#1)
on leaves##53##2##(1995-1#1)(2004-2#1)(2007-1#1)(2008-10#48)(2010-3#1)(2011-12#1)
on leek##2##2##(2008-10#2)
on left side of##3##4##(2008-7#1)(2009-6#1)(2011-12#1)
on left ventricular function##4##4##(2006-9#1)(2007-6#1)(2010-11#1)(2013-7#1)
on left ventricular hypertrophy##2##4##(2005-10#1)(2011-1#1)
on left ventricular##10##3##(1995-6#1)(2005-10#1)(2006-9#1)(2007-6#1)(2008-8#1)(2009-10#1)(2010-11#1)(2011-1#1)(2012-2#1)(2013-7#1)
on left##18##2##(1995-6#1)(2005-10#1)(2006-9#1)(2007-6#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-6#1)(2010-11#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
on leg##2##2##(2008-6#2)
on legal##4##2##(1991-1#1)(1991-9#1)(2007-12#1)(2012-12#1)
on legs##2##2##(2006-8#1)(2008-5#1)
on length of stay and##2##5##(1995-12#1)(2012-2#1)
on length of stay##5##4##(1993-12#1)(1993-2#2)(1995-12#1)(2012-2#1)
on length of##7##3##(1993-12#1)(1993-2#2)(1995-12#1)(2006-8#1)(2008-4#1)(2012-2#1)
on length scales##2##3##(2008-7#1)(2012-1#1)
on length##10##2##(1993-12#1)(1993-2#2)(1993-6#1)(1995-12#1)(2006-8#1)(2008-4#1)(2008-7#1)(2012-1#1)(2012-2#1)
on leprosy##2##2##(2007-7#2)
on leptin##2##2##(2008-3#1)(2013-1#1)
on lesbian##2##2##(2008-12#2)
on lesion area##2##3##(1995-8#1)(2012-3#1)
on lesion##13##2##(1994-2#1)(1995-12#1)(1995-8#1)(2006-9#1)(2008-10#7)(2008-4#1)(2012-3#1)
on lesions##2##2##(1997-4#1)(2010-8#1)
on less##3##2##(1995-2#1)(2007-8#1)(2010-12#1)
on lessons##2##2##(2008-1#1)(2008-12#1)
on letter spacing##3##3##(2008-1#3)
on letter##4##2##(2007-3#1)(2008-1#3)
on lettuce##10##2##(2008-10#10)
on leukemia cells##2##3##(2009-12#1)(2011-2#1)
on leukemia##4##2##(1997-8#1)(2005-10#1)(2009-12#1)(2011-2#1)
on leukemic cells##2##3##(1992-6#1)(1993-4#1)
on leukocytes##7##2##(1994-8#1)(1997-2#2)(1997-4#1)(2006-6#2)(2008-5#1)
on level of##5##3##(1995-11#1)(2006-4#1)(2008-10#1)(2008-5#1)(2012-12#1)
on level##6##2##(1995-11#1)(2006-4#1)(2008-10#1)(2008-5#1)(2008-6#1)(2012-12#1)
on levels of##16##3##(1990-5#1)(1992-4#1)(1994-2#1)(1994-3#1)(1995-6#1)(1996-2#1)(1996-9#1)(1997-7#1)(2005-7#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-8#1)(2010-5#1)(2011-2#1)
on levels##18##2##(1990-5#1)(1992-4#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-7#1)(2005-7#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-8#1)(2010-5#1)(2011-2#1)
on lexical##3##2##(2009-2#1)(2013-1#2)
on liability issues##2##3##(1991-1#1)(2008-6#1)
on liability##4##2##(1991-1#1)(1994-3#1)(1996-5#1)(2008-6#1)
on lichen amyloidosis##2##3##(2011-1#2)
on lichen##5##2##(2008-10#2)(2011-1#3)
on lidar##3##2##(2008-2#1)(2008-3#2)
on life span##3##3##(1990-3#1)(1992-12#1)(2006-6#1)
on life##12##2##(1990-3#1)(1992-12#1)(1992-9#1)(1995-1#3)(2006-6#1)(2008-1#1)(2008-7#1)(2010-1#1)(2010-5#1)(2011-1#1)
on life-history traits##2##3##(2008-8#1)(2008-9#1)
on life-history##6##2##(2008-8#3)(2008-9#1)(2010-8#1)(2011-2#1)
on lifespan##4##2##(1995-3#1)(2009-5#1)(2009-9#2)
on lifestyle and##3##3##(2010-7#2)(2011-2#1)
on lifestyle##7##2##(2008-6#1)(2010-12#1)(2010-7#2)(2011-1#2)(2011-2#1)
on lifting##2##2##(1990-12#1)(2009-6#1)
on ligand binding##5##3##(1991-5#1)(1992-9#1)(1996-11#1)(2006-10#1)(2008-10#1)
on ligand##9##2##(1991-5#1)(1992-9#1)(1995-10#1)(1996-11#1)(2006-10#1)(2008-10#4)
on ligands##2##2##(1995-5#1)(2012-3#1)
on light energy transmission through##2##5##(2010-2#2)
on light intensity##3##3##(2006-3#1)(2008-3#2)
on light microscopy##2##3##(1994-2#1)(2012-3#1)
on light##17##2##(1994-2#1)(1996-12#1)(2006-3#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#5)(2010-2#2)(2012-3#1)
on limb##2##2##(2008-1#2)
on limitations##2##2##(1995-2#1)(2009-11#1)
on limited##7##2##(2007-8#1)(2008-10#2)(2008-8#1)(2010-5#1)(2013-1#2)
on limiting##4##2##(2006-10#1)(2008-4#1)(2011-2#1)(2012-1#1)
on line by a##2##4##(1996-6#1)(2008-10#1)
on line preconcentration and##2##4##(2008-10#2)
on line preconcentration##3##3##(2008-10#3)
on line##23##2##(1996-6#1)(2006-2#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-4#2)(2011-1#1)(2012-12#2)(2013-7#2)(2013-8#1)
on line&quot##2##2##(2008-10#1)(2012-12#1)
on linear regression and##2##4##(1995-4#1)(2007-11#1)
on linear sucrose gradients##2##4##(1990-11#1)(1995-11#1)
on linear##13##2##(1990-11#1)(1994-5#1)(1995-11#1)(1995-4#1)(1997-5#1)(2005-11#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-6#1)
on lines##2##2##(2008-10#1)(2008-3#1)
on linguistic##2##2##(2010-5#1)(2013-1#1)
on linkage group##10##3##(2006-12#1)(2008-10#5)(2012-11#3)(2013-8#1)
on linkage##16##2##(1994-2#1)(1995-11#2)(2006-12#1)(2008-10#8)(2012-11#3)(2013-8#1)
on links##2##2##(2008-2#1)(2011-2#1)
on lipase##2##2##(2008-6#1)(2008-7#1)
on lipid and glucose metabolism##2##5##(2008-5#1)(2010-5#1)
on lipid and##3##3##(1996-9#1)(2008-5#1)(2010-5#1)
on lipid composition##2##3##(1994-3#1)(2010-8#1)
on lipid levels##3##3##(1991-6#1)(1994-11#1)(2013-1#1)
on lipid metabolism in##3##4##(1991-2#1)(2008-11#1)(2011-1#1)
on lipid metabolism##6##3##(1991-2#1)(1992-4#1)(1995-3#1)(2007-8#1)(2008-11#1)(2011-1#1)
on lipid oxidation and formation of free cholesterol oxidation products (COPs)##2##11##(2010-4#2)
on lipid oxidation and##3##4##(2010-4#3)
on lipid oxidation##6##3##(2010-4#6)
on lipid peroxidation and##2##4##(2008-4#1)(2008-6#1)
on lipid peroxidation in##2##4##(1990-10#1)(2007-9#1)
on lipid peroxidation##6##3##(1990-10#1)(1995-1#1)(2007-9#2)(2008-4#1)(2008-6#1)
on lipid profile and##2##4##(2012-2#1)(2012-3#1)
on lipid profile##5##3##(2008-10#1)(2008-12#1)(2011-11#1)(2012-2#1)(2012-3#1)
on lipid profiles##2##3##(2007-1#1)(2010-4#1)
on lipid##50##2##(1990-10#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-4#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-3#2)(1994-8#2)(1995-1#1)(1995-3#1)(1996-9#1)(2006-10#2)(2006-6#1)(2007-1#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#2)(2008-6#2)(2010-4#8)(2010-5#1)(2010-8#2)(2011-1#1)(2011-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
on lipid-lowering##2##2##(2006-5#2)
on lipids##2##2##(1993-11#1)(2009-12#1)
on lipolysis in 3T3-L1 adipocytes##2##5##(1990-8#2)
on lipolysis was examined in##2##5##(1991-12#1)(2008-6#1)
on lipolysis##4##2##(1990-8#2)(1991-12#1)(2008-6#1)
on lipoprotein (a)##2##3##(1990-12#2)
on lipoprotein cholesteryl ester metabolism##2##5##(1991-1#2)
on lipoprotein##7##2##(1990-12#2)(1991-1#2)(1991-2#1)(1992-12#1)(2006-10#1)
on lipoproteins##4##2##(1995-1#1)(2009-12#1)(2012-2#1)(2013-7#1)
on liposome coated silica chromatography##2##5##(2008-10#2)
on liposome##4##2##(1990-11#1)(1992-6#1)(2008-10#2)
on liposomes trapping Tb/citrate complex##2##5##(2008-10#2)
on liposomes##4##2##(1997-6#1)(1997-8#1)(2008-10#2)
on lipoxygenase##2##2##(2006-1#1)(2008-3#1)
on liquid##13##2##(1997-3#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-9#1)(2009-8#1)(2010-5#2)(2011-12#1)(2012-12#1)(2013-1#1)
on liquid-liquid extraction##3##3##(2008-10#3)
on listener perceptions of##3##4##(2011-1#3)
on literature and##2##3##(2006-10#1)(2007-11#1)
on literature data##2##3##(2008-8#2)
on literature##6##2##(1990-6#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-8#2)
on lithium##5##2##(2007-7#1)(2009-8#2)(2010-5#1)(2011-2#1)
on litter performance and##2##4##(2010-2#2)
on live algae##2##3##(2012-2#2)
on live cells##2##3##(2008-1#1)(2010-7#1)
on live##7##2##(2007-11#1)(2008-1#2)(2008-12#1)(2010-7#1)(2012-2#2)
on liver and##2##3##(2005-12#1)(2008-10#1)
on liver disease##2##3##(2005-8#1)(2007-2#1)
on liver function##2##3##(2007-12#1)(2012-3#1)
on liver microsomal##2##3##(1993-11#1)(1996-6#1)
on liver of##2##3##(2008-6#1)(2008-7#1)
on liver phase I and##2##5##(2008-7#1)(2009-4#1)
on liver regeneration after##2##4##(1990-11#1)(1997-8#1)
on liver##28##2##(1990-11#2)(1990-3#2)(1992-1#1)(1993-11#1)(1994-3#2)(1995-5#1)(1996-6#1)(1996-9#1)(1997-8#1)(2005-12#1)(2005-8#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-6#1)(2008-7#2)(2009-4#2)(2009-8#1)(2011-12#1)(2011-2#1)(2012-3#1)
on livestock##2##2##(1997-7#1)(2013-8#1)
on living##9##2##(1990-7#1)(2006-11#1)(2007-11#1)(2008-1#1)(2008-10#3)(2010-8#1)(2011-2#1)
on local cerebral glucose##2##4##(1990-2#1)(1996-9#1)
on local cerebral##4##3##(1990-2#1)(1990-7#1)(1993-7#1)(1996-9#1)
on local conditions##4##3##(1993-11#1)(1994-3#1)(2007-12#1)(2008-2#1)
on local control##6##3##(2008-6#4)(2010-3#1)(2013-1#1)
on local##51##2##(1990-2#1)(1990-3#1)(1990-7#1)(1991-2#1)(1992-5#1)(1993-11#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-12#1)(1996-11#1)(1996-9#2)(2005-11#1)(2006-1#1)(2007-12#3)(2007-6#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-6#6)(2008-7#2)(2008-8#2)(2008-9#2)(2009-12#1)(2009-4#1)(2010-1#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#3)
on localized##4##2##(2007-8#1)(2008-2#1)(2009-2#1)(2013-8#1)
on locally##2##2##(1996-3#1)(2011-1#1)
on locating##2##2##(2007-5#1)(2008-2#1)
on location##6##2##(1995-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-2#1)
on locomotion and##2##3##(1994-6#1)(1997-5#1)
on locomotor activity##8##3##(1990-10#1)(1993-12#1)(1993-5#1)(1994-8#1)(1996-5#1)(1997-5#3)
on locomotor##10##2##(1990-10#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-8#1)(1996-5#1)(1997-5#3)(2013-7#1)
on log-transformed##3##2##(1995-4#1)(2013-1#2)
on long term##3##3##(2008-10#1)(2008-6#1)(2010-12#1)
on long##6##2##(2007-11#1)(2007-9#1)(2008-10#2)(2008-6#1)(2010-12#1)
on long-term care##2##3##(1994-12#2)
on long-term dialysis##2##3##(2006-10#1)(2013-1#1)
on long-term effects##2##3##(2009-7#1)(2010-11#1)
on long-term follow up##2##4##(2007-4#1)(2012-12#1)
on long-term outcomes##2##3##(2012-12#1)(2013-1#1)
on long-term potentiation (LTP)##2##4##(1991-3#1)(1997-1#1)
on long-term potentiation##4##3##(1991-12#1)(1991-3#1)(1996-8#1)(1997-1#1)
on long-term survival##5##3##(1991-12#1)(2006-6#1)(2007-8#1)(2008-11#1)(2009-5#1)
on long-term treatment with##2##4##(1995-8#1)(2012-2#1)
on long-term treatment##4##3##(1993-11#1)(1995-8#1)(2008-3#1)(2012-2#1)
on long-term##47##2##(1991-12#2)(1991-3#1)(1993-11#1)(1994-12#2)(1995-12#1)(1995-3#1)(1995-8#1)(1996-8#1)(1996-9#2)(1997-1#1)(2004-11#1)(2005-8#1)(2006-10#2)(2006-6#1)(2006-8#2)(2007-4#1)(2007-8#3)(2008-1#1)(2008-11#2)(2008-3#2)(2008-7#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#2)
on longer##3##2##(2007-9#1)(2008-10#1)(2008-7#1)
on longevity and aging##3##4##(2008-7#3)
on longevity and##4##3##(2008-12#1)(2008-7#3)
on longevity##8##2##(1996-11#1)(2008-11#2)(2008-12#1)(2008-7#3)(2009-4#1)
on longitudinal##2##2##(2008-12#1)(2008-2#1)
on low density lipoprotein metabolism in##2##6##(1993-6#1)(1994-8#1)
on low dose##3##3##(2008-1#1)(2009-5#1)(2013-1#1)
on low frequency##2##3##(1997-8#1)(2012-12#1)
on low molecular weight heparin hemodialysis##4##6##(2013-1#4)
on low##25##2##(1992-8#1)(1993-6#1)(1994-8#1)(1997-8#1)(2005-11#1)(2006-4#1)(2006-5#1)(2008-1#2)(2008-10#3)(2008-12#2)(2008-2#1)(2008-3#1)(2009-5#2)(2012-1#1)(2012-12#1)(2013-1#5)
on low-density lipoprotein##2##3##(1994-11#1)(2011-1#1)
on low-dose##2##2##(2006-6#1)(2012-2#1)
on low-income##2##2##(2009-11#1)(2009-7#1)
on low-level##2##2##(1997-8#1)(2012-2#1)
on low-temperature-grown##2##2##(2008-2#2)
on lower cervical levels##2##4##(2008-4#2)
on lower extremity##3##3##(2008-12#1)(2008-7#1)(2010-11#1)
on lower##15##2##(1991-11#1)(2006-9#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-11#1)(2013-1#1)
on lowering##2##2##(2005-7#1)(2010-4#1)
on lumbar##3##2##(1993-7#1)(2007-8#1)(2008-5#1)
on lung cancer##6##3##(1996-3#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-3#1)
on lung function##2##3##(2007-11#2)
on lung growth##2##3##(1991-2#1)(2005-11#1)
on lung metastasis##2##3##(1992-7#1)(2011-2#1)
on lung##21##2##(1991-1#1)(1991-2#1)(1991-9#1)(1992-7#1)(1993-7#1)(1996-3#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-2#1)(2010-12#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-3#1)(2013-1#1)
on lymph node##2##3##(2007-7#1)(2008-4#1)
on lymph##3##2##(2007-7#1)(2008-4#2)
on lymphocyte##6##2##(1990-9#1)(1991-6#1)(1995-3#2)(2004-12#1)(2008-7#1)
on lymphocytes and##2##3##(1994-9#1)(1995-5#1)
on lymphocytes in##2##3##(1996-3#1)(1997-3#1)
on lymphocytes##11##2##(1990-9#1)(1992-6#1)(1994-9#1)(1995-5#1)(1995-8#2)(1996-3#1)(1997-3#1)(1997-4#1)(2012-2#1)(2013-8#1)
on lymphoid##2##2##(1991-7#1)(1995-2#1)
on lymphoma##2##2##(2008-5#1)(2009-8#1)
on lysosomal##2##2##(1990-5#1)(1995-6#1)
on m-Endo Agar LES##3##4##(2006-10#3)
on mRNA##5##2##(1990-10#1)(1990-3#1)(1995-6#1)(2007-2#1)(2013-1#1)
on macrocyclic##4##2##(2008-10#4)
on macrophage function##4##3##(1994-3#1)(1995-12#2)(2010-5#1)
on macrophage##9##2##(1991-1#1)(1994-3#1)(1994-6#1)(1995-12#2)(1995-8#1)(2008-5#1)(2010-5#1)(2012-12#1)
on macrophages##7##2##(1990-6#1)(1995-12#1)(1997-4#1)(2006-6#1)(2008-4#1)(2008-9#1)(2011-1#1)
on macroporous##2##2##(2008-11#1)(2008-6#1)
on macroscopic##4##2##(2007-3#1)(2008-8#1)(2009-4#1)(2012-12#1)
on magnesium##4##2##(1991-3#1)(2007-8#2)(2010-4#1)
on magnetic beads##3##3##(1996-5#1)(2008-10#2)
on magnetic resonance (MR)##2##4##(2006-8#1)(2007-8#1)
on magnetic resonance imaging (MRI) and##2##6##(2004-11#1)(2007-12#1)
on magnetic resonance imaging (MRI) scans##2##6##(1995-5#1)(1996-3#1)
on magnetic resonance imaging (MRI)##9##5##(1995-5#1)(1996-3#1)(2004-11#1)(2006-9#1)(2007-12#1)(2010-2#1)(2012-2#2)(2012-3#1)
on magnetic resonance imaging of##3##5##(2012-2#2)(2013-1#1)
on magnetic resonance imaging##24##4##(1995-5#1)(1996-3#1)(1996-7#1)(2004-11#1)(2006-12#1)(2006-9#1)(2007-10#2)(2007-12#1)(2008-7#2)(2009-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#2)
on magnetic resonance##27##3##(1995-5#1)(1996-3#1)(1996-5#1)(1996-7#1)(2004-11#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-12#1)(2007-8#1)(2008-7#2)(2009-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#2)
on magnetic##37##2##(1995-5#1)(1995-8#1)(1996-3#1)(1996-5#2)(1996-7#1)(2004-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#2)(2009-11#1)(2009-5#2)(2010-12#1)(2010-2#1)(2010-4#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#2)
on maintaining a##2##3##(1993-3#1)(2010-7#1)
on maintaining##7##2##(1991-5#1)(1993-3#1)(1996-11#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
on maintenance HD##4##3##(2007-7#4)
on maintenance dialysis##2##3##(2007-8#1)(2008-1#1)
on maintenance hemodialysis for##2##4##(2007-2#1)(2008-1#1)
on maintenance hemodialysis in##2##4##(2008-1#2)
on maintenance hemodialysis##14##3##(2007-2#1)(2007-7#5)(2008-1#6)(2009-4#1)(2013-7#1)
on maintenance##28##2##(1990-7#1)(2005-6#1)(2005-8#1)(2007-2#1)(2007-7#10)(2007-8#1)(2008-1#7)(2009-4#1)(2009-8#1)(2011-1#3)(2013-7#1)
on maize leaves##3##3##(2008-10#3)
on maize yield##2##3##(2007-6#1)(2008-12#1)
on maize##12##2##(2007-6#2)(2008-10#8)(2008-12#1)(2008-8#1)
on major##10##2##(1992-4#1)(1993-12#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2010-10#1)(2011-1#2)(2013-1#1)
on making the##2##3##(1997-6#1)(2007-4#1)
on making##7##2##(1995-1#1)(1997-6#1)(2007-4#1)(2008-11#1)(2008-5#1)(2010-7#1)(2012-3#1)
on malaria spreading in rural Venezuela##2##6##(2007-1#2)
on malaria##14##2##(2007-1#2)(2007-2#3)(2008-2#2)(2008-8#3)(2010-3#1)(2010-5#1)(2012-12#1)(2013-8#1)
on male Sprague-Dawley rats##2##4##(2006-9#1)(2008-4#1)
on male Wistar##2##3##(1995-1#1)(1995-12#1)
on male and##2##3##(2008-9#1)(2013-1#1)
on male##19##2##(1991-2#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-6#1)(2006-9#1)(2008-4#1)(2008-5#2)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-6#1)(2009-8#1)(2013-1#1)
on male-male##2##2##(2010-8#1)(2013-8#1)
on males##4##2##(2008-5#1)(2008-8#3)
on malignant##4##2##(1990-10#1)(1993-9#1)(2009-4#1)(2010-11#1)
on mammalian cells##5##3##(1994-2#1)(1994-5#1)(2006-10#1)(2008-9#1)(2011-1#1)
on mammalian##11##2##(1990-8#1)(1994-2#3)(1994-5#1)(2006-10#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-1#1)
on mammals##2##2##(1991-1#1)(2013-1#1)
on mammary epithelial##2##3##(1994-11#2)
on mammary##7##2##(1993-7#1)(1994-11#2)(1995-9#1)(2008-5#1)(2012-12#1)(2013-8#1)
on mammography##8##2##(1996-6#2)(2004-2#1)(2007-6#2)(2011-2#1)(2013-1#2)
on managed care##5##3##(1994-3#1)(1995-3#1)(1996-12#1)(1997-2#1)(2004-11#1)
on managed##8##2##(1994-12#1)(1994-3#2)(1995-1#1)(1995-3#1)(1996-12#1)(1997-2#1)(2004-11#1)
on management of##4##3##(1994-11#1)(2007-2#1)(2008-1#1)(2008-10#1)
on management##14##2##(1994-1#2)(1994-11#1)(1995-1#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#1)(2011-1#1)
on managerial##2##2##(1997-2#1)(2012-3#1)
on managing##7##2##(1991-12#1)(1996-6#1)(2005-7#1)(2006-10#1)(2007-2#1)(2009-5#1)(2009-9#1)
on mandibular endopod segment 1)##2##5##(2007-12#2)
on mandibular##4##2##(2007-12#2)(2007-7#1)(2013-1#1)
on manganese##3##2##(2008-10#3)
on mango##2##2##(2008-10#2)
on manifestations##2##2##(1994-6#1)(2007-2#1)
on mantle##2##2##(1993-2#1)(2007-9#1)
on manual##3##2##(2008-2#1)(2008-9#1)(2013-1#1)
on many aspects of##3##4##(1996-12#1)(2006-10#1)(2007-4#1)
on many different##3##3##(2008-10#1)(2008-4#1)(2010-3#1)
on many factors##8##3##(1993-2#1)(2005-12#1)(2007-11#1)(2007-8#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
on many host##2##3##(2008-10#2)
on many of the##2##4##(2008-10#1)(2008-6#1)
on many##39##2##(1992-11#1)(1993-2#1)(1994-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(2005-12#1)(2006-10#2)(2007-11#2)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-5#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#2)
on maps##2##2##(1997-6#1)(2012-2#1)
on marble##4##2##(2008-10#4)
on marginal##2##2##(2006-10#1)(2013-1#1)
on marital status##3##3##(1991-6#1)(2006-8#1)(2012-12#1)
on marital##4##2##(1991-6#1)(2006-8#1)(2012-1#1)(2012-12#1)
on markers of oxidative stress##2##5##(2008-5#1)(2010-8#1)
on markers of##3##3##(2008-5#1)(2010-8#1)(2012-1#1)
on markers##6##2##(2008-5#1)(2008-9#1)(2010-8#1)(2012-1#2)(2012-12#1)
on market##2##2##(1991-1#1)(1997-3#1)
on marketing##2##2##(1997-3#1)(2006-1#1)
on marriage##2##2##(2004-12#1)(2008-12#1)
on masculinities##2##2##(2006-8#1)(2008-11#1)
on mass##13##2##(1990-8#1)(1996-3#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-7#1)(2010-5#1)(2012-12#1)(2013-1#1)
on mast cells##5##3##(1991-12#1)(1996-5#2)(2008-4#1)(2009-10#1)
on mast##6##2##(1991-12#1)(1996-5#2)(2004-12#1)(2008-4#1)(2009-10#1)
on masticatory muscle reflexes##2##4##(1996-2#2)
on material##10##2##(1997-6#1)(2007-11#3)(2008-3#1)(2009-2#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
on materials##7##2##(1992-2#1)(1994-11#1)(2005-11#1)(2006-4#1)(2007-6#2)(2008-10#1)
on maternal and fetal##2##4##(1992-1#1)(2011-1#1)
on maternal and##4##3##(1992-1#1)(1992-2#1)(2011-1#1)(2012-12#1)
on maternal behavior in##2##4##(1990-12#1)(2008-11#1)
on maternal health##3##3##(2010-7#1)(2011-1#2)
on maternal##31##2##(1990-12#1)(1990-5#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-3#1)(2004-10#1)(2007-10#2)(2007-7#1)(2007-8#2)(2008-11#1)(2008-8#4)(2008-9#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-7#2)(2011-1#4)(2011-2#1)(2012-12#1)
on maternity##2##2##(1994-12#1)(2007-2#1)
on mathematical##4##2##(2007-5#1)(2007-6#1)(2007-9#1)(2012-2#1)
on mating##4##2##(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
on matrix metalloproteinase activity and interferon production##2##7##(2007-2#2)
on matrix metalloproteinase##3##3##(2007-2#2)(2008-5#1)
on matrix##4##2##(2007-2#2)(2008-10#1)(2008-5#1)
on maturation and##2##3##(1990-7#1)(2008-4#1)
on mature leaves##3##3##(2004-2#1)(2008-10#2)
on mature##10##2##(1994-6#1)(1994-9#1)(2004-2#1)(2008-10#6)(2008-11#1)
on maximal##7##2##(1995-12#1)(1995-6#1)(2007-9#1)(2008-10#2)(2008-9#1)(2011-2#1)
on maximum##10##2##(1993-9#1)(1996-3#1)(2006-5#1)(2006-8#1)(2008-10#3)(2008-12#1)(2008-3#1)(2013-8#1)
on mean pressure##2##3##(1991-4#2)
on mean##10##2##(1991-4#2)(1997-5#1)(1997-7#1)(2005-4#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-5#2)
on measles##2##2##(1993-5#1)(2008-9#1)
on measurable parameters##2##3##(2007-8#2)
on measurable##4##2##(2007-8#2)(2008-2#1)(2008-8#1)
on measured##7##2##(2007-11#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)
on measurement of the##4##4##(2006-12#1)(2008-2#1)(2008-3#2)
on measurement of##10##3##(1991-12#1)(2006-12#1)(2008-2#2)(2008-3#3)(2008-8#1)(2010-5#2)
on measurement results##2##3##(2008-10#1)(2008-3#1)
on measurement##15##2##(1991-12#1)(2006-12#1)(2008-10#2)(2008-2#2)(2008-3#4)(2008-8#1)(2010-12#1)(2010-5#2)(2012-2#1)
on measurements of the##8##4##(1991-11#1)(2008-10#1)(2008-2#3)(2008-3#1)(2009-2#1)(2009-9#1)
on measurements of##20##3##(1990-4#1)(1991-11#1)(1995-12#1)(1995-6#1)(1996-12#1)(2005-11#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#4)(2008-9#1)(2009-2#1)(2009-9#1)
on measurements##25##2##(1990-4#1)(1991-11#1)(1995-12#1)(1995-6#1)(1996-12#1)(2005-11#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#8)(2008-9#1)(2009-2#1)(2009-9#1)
on measures of body##2##4##(2006-7#1)(2010-2#1)
on measures of general health##2##5##(1993-12#1)(2009-4#1)
on measures of##25##3##(1991-3#1)(1993-12#1)(1994-8#1)(1996-3#1)(2006-7#4)(2007-11#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-10#1)(2009-4#2)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
on measuring##11##2##(1992-10#1)(2005-11#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-3#1)
on meat and##2##3##(2010-4#1)(2013-1#1)
on meat quality##2##3##(2010-4#2)
on meat##8##2##(2010-4#6)(2013-1#2)
on mechanical properties##2##3##(2009-4#1)(2009-9#1)
on mechanical ventilation##2##3##(2008-6#1)(2012-2#1)
on mechanical##13##2##(1991-11#1)(2005-11#2)(2007-10#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-4#1)(2009-7#1)(2009-9#1)(2011-1#1)(2012-2#1)
on mechanically##2##2##(2008-10#1)(2013-7#1)
on mechanically-induced immediate-early gene expression##3##5##(1997-8#3)
on mechanism of##2##3##(1990-10#1)(2012-3#1)
on mechanism##3##2##(1990-10#1)(2009-2#1)(2012-3#1)
on mechanisms involved in##3##4##(1993-5#1)(1995-11#1)(1996-6#1)
on mechanisms of##6##3##(2006-10#1)(2006-11#1)(2006-2#1)(2007-11#2)(2011-1#1)
on mechanisms##13##2##(1993-5#1)(1994-1#1)(1995-11#1)(1996-6#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-11#2)(2008-10#1)(2008-11#1)(2011-1#1)(2013-8#1)
on media amended with##4##4##(2008-10#4)
on media##9##2##(1995-8#1)(2006-8#1)(2008-10#5)(2008-2#1)(2008-3#1)
on medial##3##2##(1990-10#1)(2006-10#1)(2008-8#1)
on mediated##2##2##(1991-3#1)(2008-10#1)
on medical and##3##3##(1992-12#1)(1994-5#1)(2013-7#1)
on medical education##2##3##(1991-2#1)(2008-7#1)
on medical ethics##5##3##(1993-2#1)(2005-12#2)(2007-4#1)(2009-6#1)
on medical malpractice claims##2##4##(1992-2#1)(1993-1#1)
on medical malpractice##3##3##(1992-2#1)(1993-1#1)(1993-12#1)
on medical practice##3##3##(2012-12#1)(2012-2#1)(2013-1#1)
on medical records##2##3##(1997-3#1)(2010-8#1)
on medical students'##2##3##(2007-4#1)(2012-3#1)
on medical treatment##3##3##(1995-12#1)(2008-11#1)(2008-7#1)
on medical##51##2##(1991-12#1)(1991-2#4)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#2)(1993-12#1)(1993-2#2)(1993-3#2)(1994-5#1)(1995-1#1)(1995-12#1)(1995-5#1)(1997-3#1)(1997-8#1)(2005-12#2)(2005-4#1)(2006-10#1)(2007-4#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2009-3#1)(2009-6#1)(2010-2#2)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
on medication errors in##2##4##(2010-10#1)(2010-8#1)
on medication##9##2##(2004-5#1)(2006-10#1)(2008-11#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2013-1#1)
on medicine and##4##3##(1994-5#1)(2008-11#1)(2008-7#2)
on medicine##5##2##(1994-5#1)(2008-11#1)(2008-7#2)(2011-12#1)
on medium containing##4##3##(1990-3#1)(1991-7#1)(1997-7#1)(2013-1#1)
on medium with##2##3##(2008-9#1)(2013-1#1)
on medium##9##2##(1990-3#1)(1991-7#1)(1997-7#1)(2008-7#2)(2008-9#1)(2013-1#2)(2013-7#1)
on meeting##3##2##(1994-3#1)(1997-2#1)(2009-4#1)
on megakaryocytic differentiation of L8057##2##5##(1991-12#2)
on megakaryocytic differentiation##3##3##(1991-12#3)
on melanogenesis and##2##3##(1991-5#1)(2008-5#1)
on melanogenesis##4##2##(1991-5#1)(2008-5#3)
on melanoma cells##5##3##(1990-5#1)(1993-5#1)(2008-11#1)(2009-10#1)(2009-4#1)
on melanoma skin cancer##2##4##(2012-3#2)
on melanoma##9##2##(1990-5#1)(1993-5#1)(2007-11#1)(2008-11#1)(2008-9#1)(2009-10#1)(2009-4#1)(2012-3#2)
on melt inclusions in Martian##2##5##(2008-10#2)
on members of##2##3##(2010-2#1)(2012-11#1)
on members##3##2##(2008-4#1)(2010-2#1)(2012-11#1)
on membrane fluidity and##3##4##(1990-12#1)(1995-11#2)
on membrane fluidity##4##3##(1990-11#1)(1990-12#1)(1995-11#2)
on membrane potential and##2##4##(1991-1#1)(1992-3#1)
on membrane potential##5##3##(1990-12#1)(1991-1#1)(1992-3#1)(1994-12#1)(2008-4#1)
on membrane structure##2##3##(1994-3#1)(1996-1#1)
on membrane surfaces##4##3##(1992-12#1)(2006-10#3)
on membrane##32##2##(1990-11#1)(1990-12#3)(1990-2#1)(1991-1#2)(1991-10#2)(1992-1#1)(1992-12#1)(1992-3#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-11#2)(1996-1#1)(1997-7#1)(2005-7#1)(2006-10#3)(2006-6#1)(2007-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-5#1)(2013-7#1)
on membranes from##2##3##(1991-12#1)(1993-12#1)
on membranes prepared from##2##4##(2008-11#1)(2010-3#1)
on membranes prepared##3##3##(2008-11#2)(2010-3#1)
on membranes##9##2##(1991-12#1)(1991-9#1)(1993-12#1)(1994-11#1)(1995-9#1)(1996-7#1)(2008-11#2)(2010-3#1)
on memory and##2##3##(1991-8#1)(1993-11#1)
on memory consolidation##2##3##(1990-10#1)(1994-2#1)
on memory processes##4##3##(1992-8#1)(1993-12#1)(2009-4#2)
on memory##27##2##(1990-10#1)(1991-8#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-3#1)(1994-2#2)(1994-6#1)(1994-8#2)(1995-12#1)(1997-2#1)(1997-5#1)(2007-8#1)(2008-1#1)(2008-12#2)(2009-4#2)(2009-6#1)(2009-8#1)(2010-6#1)(2013-7#2)
on men and##2##3##(1991-6#1)(2012-12#1)
on men##7##2##(1991-6#1)(2006-8#1)(2008-1#1)(2010-8#1)(2012-12#3)
on men's##2##2##(2009-5#1)(2012-3#1)
on menstrual##2##2##(1990-9#1)(1997-2#1)
on mental health and##3##4##(2008-12#1)(2010-2#2)
on mental health disorders##2##4##(2007-8#2)
on mental health services offered to##2##6##(2008-2#2)
on mental health services##3##4##(2008-2#2)(2009-11#1)
on mental health##18##3##(1996-10#1)(1996-8#1)(2007-8#2)(2008-12#1)(2008-2#2)(2009-10#2)(2009-11#1)(2010-2#3)(2011-2#1)(2012-3#2)(2013-1#2)
on mental##26##2##(1990-3#1)(1991-4#1)(1991-8#2)(1993-11#1)(1996-10#1)(1996-8#1)(2006-4#2)(2007-8#2)(2008-12#1)(2008-2#2)(2009-10#2)(2009-11#1)(2010-2#3)(2011-2#1)(2012-3#3)(2013-1#2)
on mentoring##2##2##(2009-4#2)
on mercury electrodes##2##3##(2008-10#2)
on mercury##7##2##(1996-7#1)(2004-9#1)(2008-10#5)
on mesalazine##2##2##(2010-11#1)(2010-12#1)
on mesenchymal##3##2##(1990-4#1)(2012-12#2)
on mesoporous silica##3##3##(2008-10#1)(2012-11#2)
on mesoporous##5##2##(2008-10#2)(2010-12#1)(2012-11#2)
on metabolic control##3##3##(1991-2#1)(2006-2#1)(2013-1#1)
on metabolic parameters##3##3##(2010-4#2)(2011-2#1)
on metabolic risk factors in##2##5##(2009-6#2)
on metabolic risk factors##3##4##(2009-6#3)
on metabolic##16##2##(1991-2#1)(1995-1#1)(1996-4#1)(2006-10#1)(2006-2#1)(2008-4#2)(2009-6#3)(2010-4#2)(2010-9#1)(2011-2#1)(2012-11#1)(2013-1#1)
on metabolism and##3##3##(2008-11#1)(2011-1#1)(2012-3#1)
on metabolism##7##2##(1991-6#1)(1992-11#1)(1995-6#1)(1996-7#1)(2008-11#1)(2011-1#1)(2012-3#1)
on metabotropic##2##2##(1996-5#1)(2009-3#1)
on metal ion##2##3##(2008-10#2)
on metal mobility in##2##4##(2004-4#1)(2008-1#1)
on metal surfaces##3##3##(1993-6#1)(2007-12#1)(2008-7#1)
on metal##21##2##(1993-6#1)(2004-4#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-2#1)(2008-5#4)(2008-7#2)(2010-5#1)(2011-1#1)(2012-1#1)
on metallic substrates##2##3##(2006-12#1)(2008-7#1)
on metallic##6##2##(2006-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)
on metaphase chromosomes##3##3##(1993-12#1)(2011-12#1)(2011-2#1)
on metapopulation survival##2##3##(2008-8#2)
on metapopulation##3##2##(2008-8#3)
on metastatic melanoma##2##3##(1994-6#1)(1997-7#1)
on metastatic##4##2##(1994-6#1)(1997-7#1)(2012-1#1)(2013-1#1)
on meteorological and environmental##2##4##(2008-8#2)
on methadone maintenance##2##3##(2011-1#2)
on methadone##4##2##(2005-10#1)(2011-1#2)(2012-12#1)
on methamphetamine-induced##3##2##(1996-12#2)(2008-11#1)
on methane##4##2##(1992-3#1)(2008-2#1)(2008-3#1)(2013-1#1)
on methanogenesis##2##2##(1992-3#1)(2006-5#1)
on methanol##5##2##(1995-9#2)(1996-11#1)(1996-7#1)(1997-6#1)
on methodological##2##2##(1996-2#1)(2010-10#1)
on methodology##2##2##(2008-11#1)(2008-5#1)
on methods for the##2##4##(2008-1#1)(2008-2#1)
on methods for##4##3##(1992-4#1)(2008-1#1)(2008-2#1)(2008-4#1)
on methods that##2##3##(1992-9#1)(2010-12#1)
on methods##11##2##(1992-4#1)(1992-9#1)(1996-2#1)(2006-2#1)(2007-2#1)(2008-1#1)(2008-2#1)(2008-4#1)(2010-12#1)(2010-9#1)(2012-3#1)
on methotrexate##3##2##(1992-8#1)(2009-4#1)(2012-2#1)
on methyl##3##2##(1996-9#1)(2008-10#1)(2010-4#1)
on methylation##2##2##(1993-6#1)(2008-4#1)
on miRNA##3##2##(2011-2#1)(2012-12#2)
on mica##2##2##(1990-4#2)
on mice##8##2##(1991-5#1)(1997-8#1)(2004-11#2)(2008-11#1)(2008-4#2)(2011-2#1)
on micellization in##2##3##(2005-11#2)
on micellization##3##2##(2005-11#3)
on microRNA##3##2##(2011-2#1)(2012-12#1)(2012-2#1)
on microalgae growth and##2##4##(2013-1#2)
on microarray##2##2##(2009-8#1)(2010-2#1)
on microbeads##2##2##(2008-10#1)(2008-2#1)
on microbes##2##2##(2012-1#1)(2012-2#1)
on microbial communities##2##3##(2008-10#2)
on microbial##12##2##(2006-10#1)(2006-7#1)(2007-3#1)(2008-10#6)(2008-11#1)(2008-4#1)(2013-1#1)
on microcarrier##2##2##(2008-11#1)(2008-9#1)
on microcarriers in bioreactors##2##4##(2008-11#2)
on microcarriers in##4##3##(2008-11#4)
on microcarriers##12##2##(2008-11#9)(2012-3#2)(2013-8#1)
on microcirculatory##2##2##(1993-4#1)(2011-2#1)
on microcrystalline naphthalene in the pH range of##2##8##(2008-10#2)
on microcrystalline naphthalene in the pH range##5##7##(2008-10#5)
on microcrystalline naphthalene or by##2##5##(2008-10#2)
on microcrystalline naphthalene or##3##4##(2008-10#3)
on microcrystalline naphthalene##11##3##(2008-10#11)
on microcrystalline##13##2##(1992-3#1)(2008-10#12)
on microfabricated##2##2##(2008-10#1)(2009-6#1)
on microfluidic##2##2##(2008-10#2)
on microglia##4##2##(2008-4#2)(2008-6#2)
on microglial##2##2##(2008-4#1)(2008-7#1)
on microorganisms##3##2##(2006-9#1)(2012-12#1)(2012-3#1)
on micropatterned##2##2##(2010-7#2)
on microscope slides##2##3##(2008-9#2)
on microscope##4##2##(2008-10#1)(2008-2#1)(2008-9#2)
on microscopic examination##4##3##(2006-10#1)(2008-10#1)(2010-4#1)(2010-9#1)
on microscopic##6##2##(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-4#1)(2010-9#1)
on microsomal##2##2##(1991-9#1)(1995-6#1)
on microtiter plates##2##3##(1993-6#1)(2008-10#1)
on microtubule##2##2##(1992-8#1)(2006-10#1)
on microvascular##2##2##(1994-8#1)(2007-1#1)
on mid-infrared##2##2##(2008-3#1)(2010-12#1)
on mid-term memory and swim speed in the##2##8##(2008-12#2)
on mid-term##3##2##(2008-12#2)(2011-2#1)
on midpoint##2##2##(1993-6#1)(1993-9#1)
on migraine##4##2##(2007-10#1)(2007-2#1)(2007-3#1)(2008-9#1)
on migration##7##2##(1993-9#1)(1994-8#1)(2008-10#1)(2008-8#1)(2009-4#1)(2010-2#1)(2012-3#1)
on migratory##2##2##(2008-5#1)(2010-8#1)
on mild##3##2##(1990-3#1)(1991-9#1)(2008-10#1)
on milk production##2##3##(2005-7#1)(2012-2#1)
on milk##6##2##(1996-9#1)(2004-11#1)(2005-7#1)(2007-8#1)(2008-10#1)(2012-2#1)
on mineral##4##2##(2005-11#2)(2008-5#1)(2008-8#1)
on mineralisation##2##2##(2007-8#2)
on minimal##3##2##(2007-11#1)(2008-10#2)
on minimum##2##2##(1995-9#1)(2008-12#1)
on minor##2##2##(2008-10#1)(2008-11#1)
on minority##2##2##(2010-1#1)(2010-8#1)
on mission##2##2##(1991-3#1)(1992-3#1)
on mitochondria##3##2##(1997-6#1)(2008-11#1)(2008-7#1)
on mitochondrial and##3##3##(1995-1#1)(1997-3#1)(2013-8#1)
on mitochondrial bioenergetics##2##3##(2005-8#2)
on mitochondrial gene expression##2##4##(1996-5#1)(1997-7#1)
on mitochondrial respiration##2##3##(1997-8#1)(2004-12#1)
on mitochondrial translation##2##3##(1990-8#1)(1993-12#1)
on mitochondrial##25##2##(1990-3#1)(1990-8#1)(1991-2#1)(1993-12#1)(1994-10#1)(1994-12#1)(1994-6#1)(1995-1#1)(1996-5#2)(1997-3#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-8#2)(2007-8#1)(2008-10#2)(2010-3#2)(2011-2#1)(2013-7#1)(2013-8#2)
on mitogen-activated protein##2##3##(2008-7#1)(2008-8#1)
on mitogen-stimulated lymphocytes##2##3##(1996-7#1)(2008-10#1)
on mitosis##2##2##(1991-1#1)(1994-8#1)
on mitotic##3##2##(1990-11#1)(1992-12#1)(2009-8#1)
on mitoxantrone##2##2##(1991-4#2)
on mixed##3##2##(1992-9#1)(2008-10#2)
on mixing##4##2##(1992-8#1)(2007-11#1)(2008-10#2)
on mixture composition##2##3##(2008-5#2)
on mixture##4##2##(2008-10#1)(2008-12#1)(2008-5#2)
on mixtures of glucose and ethanol##3##6##(1995-4#3)
on mixtures of##5##3##(1995-4#3)(2008-10#1)(2008-7#1)
on mixtures##8##2##(1995-4#3)(1996-1#1)(2008-10#2)(2008-7#2)
on mobile##2##2##(2006-8#1)(2012-3#1)
on mobility##2##2##(1996-4#1)(2007-10#1)
on mode of##3##3##(2010-8#1)(2011-1#2)
on mode##5##2##(2007-12#1)(2008-3#1)(2010-8#1)(2011-1#2)
on model parameters##2##3##(1994-11#1)(2008-10#1)
on model solutions##2##3##(2008-10#2)
on model##15##2##(1994-11#1)(1997-6#1)(1997-7#1)(2007-4#2)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#1)(2013-1#1)(2013-8#2)
on modeling the##2##3##(2007-12#1)(2013-1#1)
on modeling##5##2##(2007-12#1)(2009-9#1)(2011-1#1)(2013-1#1)(2013-7#1)
on models of##3##3##(1992-6#1)(2008-10#2)
on models##7##2##(1992-11#1)(1992-6#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)
on modern##7##2##(2006-12#1)(2008-10#3)(2008-12#1)(2009-12#1)(2011-3#1)
on modes of##3##3##(2008-2#1)(2013-1#2)
on modifiable##2##2##(2008-1#1)(2012-2#1)
on modification of##3##3##(2007-12#2)(2008-6#1)
on modified##10##2##(2005-11#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#2)(2012-12#1)(2012-7#1)(2013-8#1)
on modifying##3##2##(2008-2#1)(2009-11#1)(2012-2#1)
on modulation##3##2##(2005-10#1)(2008-2#1)(2008-3#1)
on molecular dynamics##3##3##(1991-7#1)(1992-1#1)(1995-1#1)
on molecular level##2##3##(2009-2#1)(2010-12#1)
on molecular mechanisms##2##3##(2006-12#1)(2012-2#1)
on molecular sieve chromatography on##2##5##(1990-9#2)
on molecular##39##2##(1990-9#2)(1991-2#1)(1991-7#1)(1992-1#1)(1995-1#1)(1995-3#1)(1996-9#1)(1997-3#2)(1997-7#2)(2005-10#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2009-2#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#2)
on molecularly##2##2##(2012-2#1)(2013-7#1)
on monitoring the##3##3##(2008-10#2)(2010-7#1)
on monitoring##8##2##(1997-2#1)(2007-6#1)(2008-10#2)(2009-7#1)(2010-7#1)(2011-1#1)(2013-8#1)
on monoamine uptake and release##2##5##(1995-6#2)
on monoclonal antibody##3##3##(1996-5#1)(2008-11#2)
on monoclonal##4##2##(1991-10#1)(1996-5#1)(2008-11#2)
on monoculture##2##2##(2007-5#1)(2008-10#1)
on monocyte##4##2##(1992-12#2)(1993-6#1)(2011-1#1)
on monocytes and##2##3##(1994-2#1)(2008-7#1)
on monocytes##5##2##(1990-12#1)(1994-2#1)(1995-6#1)(1996-12#1)(2008-7#1)
on mononuclear cells##2##3##(1990-2#1)(2013-7#1)
on mononuclear##3##2##(1990-2#1)(2008-10#1)(2013-7#1)
on mood and##3##3##(2008-12#1)(2009-10#1)(2013-1#1)
on mood##4##2##(1991-8#1)(2008-12#1)(2009-10#1)(2013-1#1)
on moral##2##2##(2008-11#2)
on morbidity and mortality##7##4##(1993-2#2)(2005-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)
on morbidity##10##2##(1990-1#1)(1993-2#2)(1996-12#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-1#1)
on more recent##2##3##(1996-3#1)(2008-1#1)
on more than 30##2##4##(1992-8#1)(2011-12#1)
on more than one##3##4##(1994-2#1)(2007-12#1)(2008-9#1)
on more than##12##3##(1992-12#1)(1992-3#1)(1992-8#1)(1994-2#1)(2007-1#1)(2007-12#1)(2007-2#1)(2008-9#1)(2009-8#1)(2010-7#1)(2011-12#1)(2012-2#1)
on more##31##2##(1990-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1994-2#1)(1996-3#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-8#2)(2008-1#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-12#1)(2012-12#1)(2012-2#2)(2012-3#1)
on morning##3##2##(1996-1#1)(1996-2#1)(2011-2#1)
on morphine##6##2##(1991-1#1)(1991-6#1)(1992-3#1)(1996-2#1)(1997-2#1)(2008-5#1)
on morphine- and##2##3##(1990-7#2)
on morphologic##4##2##(1991-8#1)(2007-8#1)(2009-8#1)(2013-8#1)
on morphological and##2##3##(2008-8#1)(2010-10#1)
on morphological characteristics and##2##4##(2008-4#1)(2012-1#1)
on morphological characteristics##3##3##(2008-10#1)(2008-4#1)(2012-1#1)
on morphological criteria##3##3##(1994-3#2)(2008-5#1)
on morphological##16##2##(1994-3#2)(1996-8#1)(2005-11#1)(2006-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-1#1)
on morphology and##5##3##(1997-3#1)(2008-10#2)(2008-5#1)(2009-2#1)
on morphology was##3##3##(1996-6#1)(2008-8#1)(2011-2#1)
on morphology##20##2##(1991-2#1)(1996-6#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-2#1)(2009-3#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#2)
on morphometric##3##2##(2007-11#1)(2008-12#1)(2008-7#1)
on mortality and morbidity##3##4##(1992-12#1)(2007-2#1)(2010-9#1)
on mortality and##8##3##(1990-5#1)(1992-12#1)(1995-5#1)(2007-2#1)(2008-6#1)(2008-9#1)(2010-11#1)(2010-9#1)
on mortality from##2##3##(1991-6#1)(1995-2#1)
on mortality in##3##3##(2010-12#1)(2010-7#1)(2011-2#1)
on mortality of##3##3##(1995-3#1)(2012-2#1)(2013-1#1)
on mortality studies##2##3##(1992-2#1)(1995-8#1)
on mortality##37##2##(1990-5#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#1)(1993-3#1)(1994-4#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-3#1)(1996-9#1)(1997-4#2)(2007-10#1)(2007-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-2#2)(2013-1#2)
on mosquitoes##2##2##(2006-12#1)(2008-12#1)
on most sub-scales##2##3##(2006-10#2)
on most##21##2##(1991-7#1)(1995-2#1)(2005-10#1)(2006-10#2)(2007-11#1)(2007-2#1)(2008-1#1)(2008-2#3)(2008-5#1)(2008-9#1)(2009-11#2)(2009-2#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
on mothers'##2##2##(2009-7#1)(2011-1#1)
on motility and##2##3##(2010-7#1)(2013-8#1)
on motility##3##2##(2006-10#1)(2010-7#1)(2013-8#1)
on motoneurones##2##2##(1997-2#2)
on motor function##2##3##(2011-2#2)
on motor neuron##2##3##(1997-5#1)(2012-3#1)
on motor performance##2##3##(2006-10#1)(2008-7#1)
on motor skill##2##3##(2006-10#1)(2013-7#1)
on motor##14##2##(1991-10#1)(1991-11#1)(1994-10#1)(1997-5#2)(2006-10#2)(2007-8#1)(2008-7#2)(2011-2#2)(2012-3#1)(2013-7#1)
on mouse chromosome##3##3##(1992-7#1)(1993-11#1)(1995-2#1)
on mouse skin##4##3##(1990-7#1)(1992-2#1)(1992-9#1)(2006-12#1)
on mouse##28##2##(1990-11#1)(1990-5#1)(1990-7#1)(1992-12#1)(1992-2#1)(1992-7#3)(1992-9#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-6#1)(1995-12#1)(1995-2#2)(1997-2#1)(1997-7#1)(2005-10#1)(2006-12#1)(2006-7#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-11#2)(2010-2#1)(2013-1#1)
on movement coordination##3##3##(2013-1#3)
on movement##7##2##(1990-9#2)(1996-9#1)(2007-2#1)(2013-1#3)
on moving##4##2##(2006-6#1)(2007-8#1)(2008-2#1)(2008-3#1)
on mtDNA##2##2##(2008-12#1)(2008-8#1)
on mu##4##2##(1990-12#1)(1991-1#1)(1995-1#1)(1995-7#1)
on much##3##2##(1994-6#1)(1995-12#1)(1997-6#1)
on mucociliary##2##2##(1991-9#1)(1997-1#1)
on mucosal##5##2##(1993-6#1)(1997-1#1)(2008-10#1)(2008-5#1)(2013-1#1)
on mucus transport##2##3##(1996-1#2)
on mulberry leaves##3##3##(2008-10#3)
on mulberry##4##2##(2008-10#4)
on multidisciplinary##3##2##(1994-1#1)(2007-11#1)(2011-3#1)
on multiple levels##2##3##(1994-3#1)(2012-2#1)
on multiple time scales##2##4##(1994-4#2)
on multiple##47##2##(1990-6#1)(1991-6#1)(1992-1#2)(1993-11#1)(1994-3#1)(1994-4#2)(1994-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-7#3)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
on multiscale##2##2##(2008-2#1)(2011-1#1)
on multivariate analysis##6##3##(2008-6#1)(2011-2#2)(2013-1#3)
on multivariate##12##2##(1995-6#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-6#1)(2011-2#3)(2012-3#1)(2013-1#3)
on murine macrophages##2##3##(1997-6#1)(2007-7#1)
on murine##16##2##(1990-11#1)(1991-3#1)(1992-12#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-9#1)(1995-7#1)(1997-6#1)(2007-7#1)(2008-11#1)(2008-4#2)(2012-2#1)
on muscarinic receptors##2##3##(1995-11#2)
on muscarinic##4##2##(1990-10#1)(1995-11#2)(1996-2#1)
on muscle cells##2##3##(1997-6#1)(2008-11#1)
on muscle contraction##2##3##(1993-6#1)(2009-3#1)
on muscle strength and##2##4##(2007-2#1)(2009-1#1)
on muscle strength##4##3##(2007-11#1)(2007-2#1)(2007-7#1)(2009-1#1)
on muscle tone##2##3##(1993-2#1)(1995-2#1)
on muscle##22##2##(1991-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-2#1)(1996-3#1)(1997-6#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-7#2)(2009-1#1)(2009-3#1)(2012-1#1)
on muscular##4##2##(2008-5#1)(2008-9#1)(2010-12#1)(2012-3#1)
on mutant##3##2##(1994-11#1)(1995-6#1)(2009-10#1)
on mutation##3##2##(1995-1#1)(2008-8#1)(2010-1#1)
on mutations##2##2##(2008-7#1)(2008-8#1)
on mutual##4##2##(1996-3#1)(2008-10#1)(2011-12#2)
on my mind##2##3##(2006-12#1)(2011-2#1)
on my own##2##3##(2006-10#1)(2012-12#1)
on my##5##2##(2006-10#1)(2006-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
on mycelial growth of R##2##5##(2008-10#2)
on mycelial growth##4##3##(2008-10#4)
on mycelial##5##2##(2008-10#5)
on myelination##2##2##(2008-8#1)(2012-12#1)
on myocardial cells##2##3##(1997-6#1)(2013-1#1)
on myocardial function##2##3##(1995-3#1)(2013-8#1)
on myocardial infarction##2##3##(2012-3#1)(2013-1#1)
on myocardial perfusion and##2##4##(2007-8#1)(2008-10#1)
on myocardial##19##2##(1991-2#1)(1993-12#1)(1995-11#1)(1995-3#1)(1996-9#1)(1997-6#1)(2005-10#1)(2007-8#2)(2008-10#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#4)
on nanosized##3##2##(2008-10#3)
on nanostructured##2##2##(2006-5#1)(2008-10#1)
on nanotubes##3##2##(2008-7#2)(2010-2#1)
on naphthalene##2##2##(2008-10#2)
on nasal##2##2##(1992-4#1)(2007-1#1)
on national health##3##3##(1993-12#1)(1994-3#1)(2008-8#1)
on national##10##2##(1993-10#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-6#1)(2005-5#1)(2008-11#1)(2008-8#1)(2011-12#1)(2012-2#1)
on nationwide##2##2##(1992-11#1)(2011-2#1)
on native polyacrylamide gel##2##4##(1995-8#1)(2010-3#1)
on native polyacrylamide##3##3##(1995-8#1)(2008-2#1)(2010-3#1)
on native##17##2##(1990-7#1)(1991-12#1)(1992-12#1)(1992-7#2)(1994-8#1)(1995-3#1)(1995-8#2)(1996-8#1)(1997-7#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-3#1)(2011-12#1)
on natural history##2##3##(1997-3#1)(2006-10#1)
on natural killer cell activity##2##5##(2007-11#1)(2008-10#1)
on natural killer cell##3##4##(2007-11#1)(2008-10#2)
on natural killer##4##3##(2007-11#2)(2008-10#2)
on natural##27##2##(1992-5#1)(1994-3#1)(1995-6#1)(1997-3#1)(2005-7#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2008-10#7)(2008-11#1)(2008-8#4)(2009-10#1)(2009-2#1)(2010-4#1)(2011-1#1)(2013-7#1)
on naturally infected##2##3##(2008-10#1)(2008-7#1)
on near##2##2##(2008-10#1)(2010-8#1)
on near-isogenic##2##2##(2008-10#2)
on nearby##2##2##(2008-5#1)(2009-10#1)
on nearly##3##2##(2007-10#1)(2008-11#1)(2008-4#1)
on necessary##2##2##(1997-3#1)(2011-2#1)
on neck##3##2##(2005-11#1)(2006-11#1)(2013-7#1)
on necrosis##2##2##(1993-2#1)(2008-10#1)
on necrotic##4##2##(2008-10#4)
on need for##2##3##(2005-10#1)(2007-12#1)
on need##3##2##(2005-10#1)(2007-12#1)(2008-6#1)
on needle##2##2##(1996-6#1)(2006-9#1)
on negative symptoms##3##3##(2005-7#1)(2008-6#2)
on negative##9##2##(2005-7#1)(2007-12#1)(2008-2#1)(2008-6#2)(2009-5#1)(2010-7#1)(2011-2#1)(2012-1#1)
on negatively charged##3##3##(1993-2#1)(1993-4#1)(2005-11#1)
on neighboring##4##2##(1996-12#1)(2008-10#2)(2008-7#1)
on nematode##3##2##(2008-10#1)(2009-3#2)
on neocortical high-voltage spindle##2##4##(1992-10#2)
on neocortical##5##2##(1990-3#1)(1991-3#1)(1991-9#1)(1992-10#2)
on neonatal mortality and##3##4##(1992-12#3)
on neonatal rat##3##3##(1992-8#1)(2008-10#1)(2010-12#1)
on neonatal##13##2##(1991-3#1)(1992-12#4)(1992-8#1)(1993-5#2)(2008-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)
on neoplastic cells##2##3##(1990-8#1)(2008-4#1)
on neoplastic##4##2##(1990-8#1)(1992-10#1)(2006-12#1)(2008-4#1)
on nephrology##2##2##(2011-2#2)
on nerve growth factor##3##4##(1996-3#2)(2010-8#1)
on nerve##6##2##(1994-12#1)(1996-3#2)(1996-5#1)(2008-1#1)(2010-8#1)
on network##2##2##(2008-11#1)(2009-9#1)
on networks##4##2##(1997-7#1)(2008-7#2)(2010-10#1)
on neural##15##2##(1990-11#1)(1991-6#1)(1995-7#1)(2005-10#1)(2005-8#1)(2006-11#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-12#1)
on neurite##2##2##(2008-11#1)(2008-4#1)
on neuroAIDS##2##2##(2007-11#2)
on neuroblastoma cells##3##3##(2003-11#2)(2011-2#1)
on neurocognitive function##2##3##(1996-3#1)(2013-1#1)
on neurocognitive##4##2##(1996-3#1)(1996-8#1)(2013-1#2)
on neurodevelopment in the child##2##5##(2012-1#2)
on neurodevelopment##3##2##(2010-12#1)(2012-1#2)
on neuroendocrine##3##2##(1996-12#1)(2008-2#1)(2010-2#1)
on neuroleptics##2##2##(1995-8#1)(2008-9#1)
on neurological##8##2##(1991-11#1)(2006-11#1)(2006-7#1)(2007-11#1)(2007-3#1)(2010-9#1)(2011-2#1)(2013-1#1)
on neuromuscular##3##2##(1996-12#1)(2006-10#1)(2011-2#1)
on neuronal activities##2##3##(1996-12#1)(1997-7#1)
on neuronal activity##4##3##(1990-7#1)(1997-8#1)(2008-7#2)
on neuronal survival##4##3##(1993-3#1)(1997-4#1)(2012-1#2)
on neuronal##28##2##(1990-7#1)(1991-6#1)(1992-4#1)(1993-2#1)(1993-3#1)(1995-5#1)(1996-12#2)(1996-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-11#1)(2007-12#1)(2008-3#1)(2008-7#5)(2008-8#1)(2009-12#1)(2012-1#3)(2013-1#1)
on neurones##2##2##(1996-1#1)(1996-6#1)
on neurons and##3##3##(1994-11#1)(2006-3#1)(2008-7#1)
on neurons in the##3##4##(1993-12#1)(1996-12#1)(2008-4#1)
on neurons in##5##3##(1990-7#1)(1993-12#1)(1996-12#1)(1996-4#1)(2008-4#1)
on neurons of##2##3##(1991-5#1)(2012-1#1)
on neurons##14##2##(1990-3#1)(1990-7#2)(1991-5#1)(1993-12#2)(1994-11#1)(1996-12#1)(1996-4#2)(2006-3#1)(2008-4#1)(2008-7#1)(2012-1#1)
on neuropeptide Y##2##3##(1995-12#1)(2012-3#1)
on neuropeptide##3##2##(1995-12#2)(2012-3#1)
on neuropsychological##4##2##(1996-7#1)(2007-11#1)(2008-4#1)(2011-12#1)
on neuroscience##2##2##(2008-11#1)(2008-2#1)
on neurotensin##2##2##(1994-11#1)(1997-7#1)
on neurotransmission in rat##2##4##(1997-5#2)
on neurotransmission##6##2##(1992-3#1)(1993-12#1)(1997-5#3)(2012-2#1)
on neutral##3##2##(1993-12#1)(2008-10#1)(2010-12#1)
on neutrophil functions##2##3##(1990-8#1)(1993-3#1)
on neutrophil##9##2##(1990-8#1)(1993-1#1)(1993-3#1)(1993-8#1)(1994-8#2)(1996-11#1)(2008-10#1)(2009-6#1)
on neutrophils##2##2##(1994-3#1)(1996-2#1)
on new drugs##2##3##(2008-5#1)(2008-8#1)
on new strategies##2##3##(2005-8#1)(2008-1#1)
on new subjects##2##3##(1996-2#1)(2012-2#1)
on new##47##2##(1990-9#1)(1991-10#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-2#1)(1997-3#1)(1997-5#1)(2004-12#1)(2005-8#2)(2006-10#5)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#1)
on newborn##2##2##(2009-11#1)(2012-2#1)
on newly##5##2##(1994-9#1)(1996-1#1)(2006-10#1)(2008-10#1)(2010-8#1)
on next-generation sequencing##2##3##(2012-3#2)
on nickel##4##2##(1994-5#1)(2008-10#2)(2013-8#1)
on nicotine##3##2##(1996-10#2)(2011-2#1)
on nicotinic##2##2##(1991-5#1)(1995-11#1)
on nigral##2##2##(1994-10#1)(1994-5#1)
on nine##11##2##(1994-6#1)(2005-11#1)(2007-10#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2009-7#1)(2013-7#1)
on nitrate##3##2##(1991-8#1)(2008-10#1)(2011-1#1)
on nitric oxide production##3##4##(1994-5#1)(2013-1#2)
on nitric oxide##8##3##(1992-5#1)(1994-5#1)(2008-9#2)(2011-2#1)(2012-12#1)(2013-1#2)
on nitric##9##2##(1992-5#1)(1994-5#1)(1997-5#1)(2008-9#2)(2011-2#1)(2012-12#1)(2013-1#2)
on nitrocellulose and##2##3##(1995-11#1)(2008-4#1)
on nitrocellulose##3##2##(1991-8#1)(1995-11#1)(2008-4#1)
on nitrogen balance##3##3##(2010-8#1)(2013-8#2)
on nitrogen##12##2##(1990-12#1)(1995-11#1)(1995-3#3)(1996-5#2)(2010-8#1)(2012-1#1)(2013-8#3)
on no account##2##3##(1990-3#1)(2006-10#1)
on no##5##2##(1990-3#1)(2006-10#1)(2007-8#2)(2012-2#1)
on noble##2##2##(2007-9#1)(2010-7#1)
on nociception and##2##3##(1990-7#2)
on nociception##3##2##(1990-7#2)(1997-2#1)
on nociceptive##2##2##(1992-7#1)(1996-12#1)
on nocturnal##2##2##(1990-7#1)(2012-3#1)
on nodulation##2##2##(2008-5#2)
on noise##4##2##(1990-7#1)(2008-2#1)(2008-3#1)(2011-1#1)
on non-denaturing##2##2##(1990-3#1)(1991-7#1)
on non-fermentable carbon sources##3##4##(1992-11#1)(1996-7#1)(2011-1#1)
on non-fermentable##4##2##(1992-11#1)(1994-9#1)(1996-7#1)(2011-1#1)
on non-inoculated##2##2##(2008-10#1)(2010-4#1)
on non-small cell lung##2##4##(2007-4#1)(2011-2#1)
on non-small-cell lung cancer##3##4##(2004-1#1)(2013-1#2)
on nondenaturing##3##2##(1992-2#1)(2008-4#1)(2008-9#1)
on noninvasive##3##2##(2006-10#2)(2007-4#1)
on nonlinear regression##2##3##(2008-10#1)(2008-3#1)
on nonlinear##8##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)
on nonporous##2##2##(2005-11#2)
on nonpreferred resources##2##3##(2008-9#2)
on noradrenaline##3##2##(1990-2#1)(1997-4#1)(2008-6#1)
on noradrenergic##2##2##(1995-7#1)(2008-7#1)
on normal and##6##3##(1995-12#1)(2006-6#1)(2007-11#2)(2008-11#1)(2012-2#1)
on normal human##3##3##(1994-12#1)(2008-11#1)(2008-4#1)
on normal skin##2##3##(1992-8#1)(2010-3#1)
on normal##37##2##(1990-11#1)(1990-12#1)(1991-3#2)(1991-9#1)(1992-12#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-12#1)(1996-2#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-3#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-8#1)
on normative##2##2##(2007-10#1)(2008-9#1)
on northern##2##2##(1995-9#1)(2008-10#1)
on not##2##2##(2008-2#1)(2011-1#1)
on novel hosts##2##3##(2008-8#2)
on novel##13##2##(2005-7#1)(2005-9#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-8#3)(2010-11#1)(2011-1#1)
on nuclear and##2##3##(2008-10#2)
on nuclear##11##2##(1990-12#1)(1990-3#1)(1991-5#1)(1992-4#1)(2006-10#1)(2008-10#2)(2008-9#1)(2009-4#1)(2011-1#1)(2011-2#1)
on nucleotide addition##2##3##(1990-5#2)
on nucleotide##9##2##(1990-5#3)(1994-9#1)(1997-4#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-8#1)
on number of##5##3##(2007-9#1)(2008-10#1)(2013-8#3)
on number##11##2##(2007-9#1)(2008-10#1)(2008-3#3)(2009-1#2)(2009-5#1)(2013-8#3)
on numbers of##3##3##(1991-11#1)(2008-7#1)(2009-3#1)
on numbers##5##2##(1991-11#1)(1997-3#1)(2008-4#1)(2008-7#1)(2009-3#1)
on numerical##5##2##(2006-10#1)(2007-12#1)(2007-2#1)(2008-3#1)(2011-1#1)
on numerous##10##2##(2008-10#2)(2008-7#1)(2010-10#1)(2010-8#1)(2011-2#2)(2013-1#2)(2013-8#1)
on nurse##2##2##(2008-12#1)(2011-1#1)
on nurses##3##2##(1995-3#1)(2004-7#1)(2008-9#1)
on nurses'##8##2##(1993-5#1)(1995-2#1)(2006-1#1)(2008-11#1)(2010-10#1)(2011-1#2)(2013-1#1)
on nursing care##3##3##(1995-1#1)(2009-10#1)(2012-12#1)
on nursing education##3##3##(1990-2#1)(1991-2#1)(1996-3#1)
on nursing home##2##3##(1992-3#1)(1995-2#1)
on nursing practice##2##3##(2008-11#2)
on nursing students'##2##3##(2008-11#2)
on nursing##25##2##(1990-2#1)(1991-2#1)(1992-3#1)(1994-2#2)(1995-1#1)(1995-2#1)(1996-3#1)(1997-3#1)(2007-10#1)(2008-11#4)(2008-12#1)(2008-8#1)(2009-10#1)(2011-1#1)(2012-12#1)(2012-3#4)(2013-1#2)
on nutrient availability##2##3##(2008-5#1)(2013-1#1)
on nutrient intake##3##3##(1994-12#1)(2008-12#1)(2012-2#1)
on nutrient##10##2##(1994-12#1)(2005-10#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-5#1)(2009-2#1)(2012-2#1)(2013-1#1)
on nutrition and##2##3##(2007-12#1)(2008-9#1)
on nutrition##4##2##(2006-4#1)(2006-5#1)(2007-12#1)(2008-9#1)
on nutritional status and##2##4##(2006-7#1)(2008-12#1)
on nutritional status##4##3##(1993-1#1)(1997-4#1)(2006-7#1)(2008-12#1)
on nutritional##9##2##(1993-1#1)(1997-4#1)(2006-6#1)(2006-7#1)(2007-5#1)(2007-8#1)(2008-12#1)(2011-2#1)(2013-1#1)
on nylon filters##3##3##(2008-2#1)(2008-4#1)(2008-9#1)
on nylon membranes##2##3##(2008-10#1)(2008-7#1)
on nylon##7##2##(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)
on nymphs and##2##3##(2013-7#1)(2013-8#1)
on nymphs##3##2##(2013-7#1)(2013-8#2)
on oat and##2##3##(2008-10#2)
on obesity and##3##3##(2006-2#1)(2008-1#1)(2010-3#1)
on obesity##7##2##(2005-8#1)(2006-2#2)(2007-12#1)(2007-2#1)(2008-1#1)(2010-3#1)
on object##3##2##(2008-2#1)(2008-4#1)(2008-7#1)
on objective##4##2##(1990-5#1)(1996-2#1)(2007-12#1)(2009-9#1)
on objects##2##2##(2007-12#1)(2008-6#1)
on observation of##5##3##(1997-4#1)(1997-8#1)(2007-11#1)(2008-11#1)(2008-3#1)
on observations of##6##3##(1992-1#1)(1996-4#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#1)
on observations##11##2##(1992-1#1)(1994-6#1)(1996-4#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)
on observed##9##2##(1990-8#1)(1991-8#1)(1994-12#1)(1995-1#1)(2007-11#1)(2007-12#1)(2008-10#2)(2011-2#1)
on obstetric##3##2##(1994-2#1)(1996-2#1)(2009-9#1)
on obtaining##4##2##(2006-10#1)(2007-2#1)(2008-3#1)(2010-2#1)
on occasion##7##2##(1995-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-5#1)(2008-8#1)(2010-10#1)
on occasions when##2##3##(1990-2#1)(2012-1#1)
on occasions##4##2##(1990-2#1)(1997-4#1)(2007-6#1)(2012-1#1)
on occupational##5##2##(1991-6#1)(2006-1#1)(2008-8#1)(2009-12#1)(2010-12#1)
on occurrence##2##2##(1997-8#1)(2008-5#1)
on oceanic islands##2##3##(1994-3#1)(2008-8#1)
on oceanic##4##2##(1994-3#1)(2008-2#1)(2008-8#1)(2011-2#1)
on octacalcium phosphate##2##3##(2005-11#2)
on octadecyl silica##3##3##(2008-10#3)
on ocular##3##2##(1994-3#1)(2008-4#1)(2009-8#1)
on off-line##2##2##(2008-10#1)(2010-12#1)
on offspring##6##2##(2008-8#1)(2008-9#3)(2009-9#1)(2012-3#1)
on oil##2##2##(2005-11#1)(2006-4#1)
on old##3##2##(1993-7#1)(1994-5#1)(2012-1#1)
on older berries##2##3##(2008-10#2)
on older##11##2##(1995-12#1)(2005-7#1)(2008-10#4)(2009-7#1)(2010-1#1)(2012-11#2)(2012-2#1)
on olfactory##3##2##(1994-8#1)(1995-5#1)(2012-2#1)
on olive plants##2##3##(2008-10#2)
on on##2##2##(1991-12#1)(1995-5#1)
on on-line##3##2##(2007-8#1)(2008-10#2)
on one aspect of##2##4##(1994-1#1)(2007-10#1)
on one face of the##2##5##(1992-12#1)(1992-3#1)
on one face of##3##4##(1992-12#1)(1992-3#1)(1993-11#1)
on one hand and##5##4##(1993-12#1)(2006-6#1)(2008-12#1)(2010-6#1)(2012-2#1)
on one hand##17##3##(1990-12#1)(1990-2#1)(1993-12#1)(2006-10#1)(2006-6#1)(2006-8#1)(2008-12#1)(2008-2#2)(2008-7#1)(2009-2#1)(2010-1#1)(2010-6#1)(2011-12#1)(2012-12#1)(2012-2#2)
on one occasion##2##3##(1990-8#1)(2007-7#1)
on one of the two##2##5##(1994-8#1)(2008-7#1)
on one of the##9##4##(1994-8#1)(1997-2#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-12#1)
on one of##13##3##(1991-9#1)(1993-6#1)(1994-8#1)(1997-2#1)(1997-8#1)(2006-6#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-12#1)
on one or both##2##4##(2008-10#1)(2012-2#1)
on one or more of the##2##6##(1993-11#1)(2007-11#1)
on one or more##5##4##(1993-11#1)(1996-7#1)(2006-10#1)(2007-11#1)(2008-10#1)
on one or##7##3##(1993-11#1)(1996-7#1)(2006-10#1)(2007-11#1)(2008-10#2)(2012-2#1)
on one side and a##2##5##(1996-8#1)(2005-10#1)
on one side and##9##4##(1996-8#1)(2004-9#1)(2005-10#2)(2008-10#1)(2008-11#1)(2011-1#1)(2012-2#2)
on one side of the##2##5##(1992-7#1)(1996-10#1)
on one side of##4##4##(1992-7#1)(1996-10#1)(2007-11#1)(2011-2#1)
on one side were##2##4##(1993-3#1)(2006-9#1)
on one side##26##3##(1990-7#1)(1991-6#1)(1992-7#1)(1993-3#1)(1993-4#1)(1994-2#1)(1996-10#1)(1996-8#1)(2004-9#1)(2005-10#2)(2006-12#2)(2006-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#2)(2012-2#2)
on one single##2##3##(2008-5#1)(2011-1#1)
on one such case##2##4##(2007-7#1)(2008-7#1)
on one##135##2##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-7#2)(1996-8#1)(1997-2#1)(1997-5#2)(1997-8#1)(2003-11#3)(2004-9#1)(2005-10#2)(2006-10#2)(2006-12#2)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-10#10)(2008-11#1)(2008-12#3)(2008-2#7)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#3)(2009-2#1)(2009-4#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-6#1)(2011-1#3)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#7)(2013-1#2)(2013-8#2)
on one's own##2##3##(1992-3#1)(2009-9#1)
on one's##5##2##(1992-3#1)(2007-12#1)(2007-9#1)(2008-10#1)(2009-9#1)
on one-dimensional##2##2##(1993-8#1)(2007-11#1)
on onion##3##2##(2004-11#1)(2008-10#2)
on online end-user##2##3##(1991-3#2)
on only one##11##3##(1990-11#1)(1991-5#1)(1993-9#2)(2006-12#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-6#1)(2011-1#1)(2013-1#1)
on only the##5##3##(1994-6#1)(2008-1#1)(2008-2#1)(2008-4#1)(2010-2#1)
on only##28##2##(1990-11#1)(1991-5#1)(1992-12#1)(1993-7#1)(1993-9#2)(1994-6#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#2)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-4#1)(2008-6#1)(2009-9#1)(2010-2#1)(2011-1#1)(2013-1#1)
on onset##2##2##(1990-10#1)(2011-2#1)
on ontogenically resistant berries##2##4##(2008-10#2)
on oocyst viability##2##3##(2005-12#2)
on oocyte##2##2##(1993-3#1)(1995-2#1)
on open##4##2##(1993-9#2)(1997-2#1)(2007-8#1)
on operational##3##2##(2004-7#1)(2007-2#1)(2008-10#1)
on operative##3##2##(2006-7#1)(2007-11#1)(2009-7#1)
on opiate substitution therapy##2##4##(2012-1#2)
on opiate##3##2##(1991-1#1)(2012-1#2)
on opioid##5##2##(1995-3#1)(1996-12#1)(1997-2#1)(2006-8#2)
on opium poppy##2##3##(2008-10#2)
on opportunistic infections##2##3##(2006-10#1)(2010-11#1)
on opposite sides of##2##4##(2008-1#1)(2008-2#1)
on opposite sides##4##3##(2008-1#1)(2008-2#1)(2008-3#1)(2011-1#1)
on opposite##9##2##(1991-4#1)(1993-11#1)(1996-6#2)(2006-10#1)(2008-1#1)(2008-2#1)(2008-3#1)(2011-1#1)
on optical fiber##2##3##(2005-4#1)(2008-2#1)
on optical image##2##3##(2008-11#1)(2008-3#1)
on optical parametric##4##3##(2007-11#2)(2007-12#2)
on optical performance##2##3##(2008-2#2)
on optical properties##3##3##(2008-2#1)(2008-3#2)
on optical tweezers##2##3##(2006-9#2)
on optical##50##2##(1997-5#1)(2005-4#1)(2005-5#1)(2006-4#1)(2006-9#2)(2007-11#7)(2007-12#11)(2008-1#1)(2008-11#1)(2008-2#10)(2008-3#11)(2008-5#1)(2009-7#1)(2012-2#1)
on optically##3##2##(2007-12#1)(2008-11#1)(2008-3#1)
on optimal##15##2##(1991-7#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#2)
on optimization of the##2##4##(2007-11#1)(2013-1#1)
on optimization of##3##3##(2007-11#1)(2008-10#1)(2013-1#1)
on optimizing##7##2##(2006-6#1)(2007-7#1)(2008-3#2)(2008-6#1)(2012-2#1)(2013-1#1)
on or close to the##2##5##(2008-3#1)(2010-12#1)
on or in the##3##4##(2007-12#1)(2008-10#2)
on or off depending on##2##5##(1994-12#1)(2009-8#1)
on or off##3##3##(1994-12#1)(2007-8#1)(2009-8#1)
on or##15##2##(1990-2#1)(1991-8#1)(1994-12#1)(2005-11#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-4#1)
on oral anticoagulation##2##3##(2010-12#2)
on oral mucosa and##2##4##(2006-8#1)(2012-12#1)
on oral##27##2##(1991-4#1)(1996-11#1)(2005-7#1)(2006-2#1)(2006-8#2)(2006-9#2)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-11#1)(2010-12#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#3)
on orbit##3##2##(2008-3#2)(2012-3#1)
on order##2##2##(2006-10#1)(2008-11#1)
on ordering##2##2##(2007-11#1)(2008-5#1)
on ordinary##2##2##(2005-4#1)(2010-4#1)
on organic hydroperoxides##2##3##(2008-10#2)
on organic matter##3##3##(1996-3#1)(2008-11#2)
on organic##11##2##(1994-5#1)(1995-9#1)(1996-3#1)(2007-9#1)(2008-10#4)(2008-11#2)(2013-1#1)
on organisms##4##2##(2007-5#1)(2008-10#1)(2008-7#1)(2008-8#1)
on organization##4##2##(1990-12#1)(1990-4#1)(1995-8#1)(2011-2#1)
on organizational##7##2##(1990-12#2)(1996-12#1)(2005-9#1)(2008-1#1)(2010-9#1)(2011-2#1)
on orientation##3##2##(1997-8#1)(2010-2#1)(2012-2#1)
on orogastric and systemic candidiasis in immunodeficient mice##2##8##(2008-5#2)
on osmotic##2##2##(1991-7#1)(2009-12#1)
on osteoblast##5##2##(1991-12#1)(1991-8#1)(2008-5#1)(2008-8#1)(2010-8#1)
on osteoblastic differentiation##2##3##(1997-6#2)
on osteoblastic##4##2##(1990-10#1)(1997-6#2)(2006-5#1)
on osteoblasts##2##2##(2008-8#1)(2012-3#1)
on osteocalcin##2##2##(1990-2#1)(1993-3#1)
on osteoclast formation##2##3##(1993-8#1)(2008-5#1)
on osteoclast##4##2##(1993-8#1)(1994-3#1)(1994-6#1)(2008-5#1)
on osteoclasts##2##2##(2010-10#2)
on osteosarcoma##2##2##(2010-3#1)(2013-8#1)
on other cases##2##3##(2006-10#1)(2008-1#1)
on other components##2##3##(2008-10#1)(2009-11#1)
on other host##2##3##(2008-10#2)
on other hosts##4##3##(2008-10#4)
on other indications##2##3##(2006-12#1)(2006-8#1)
on other susceptible##2##3##(2008-10#2)
on other types of##2##4##(2005-1#1)(2005-7#1)
on other##96##2##(1990-9#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-7#3)(1993-12#1)(1993-2#1)(1993-8#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-6#1)(2004-9#1)(2005-1#1)(2005-11#2)(2005-7#1)(2006-10#3)(2006-12#2)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-8#3)(2008-1#2)(2008-10#17)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#2)(2009-6#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#3)(2012-1#1)(2012-2#2)(2013-8#1)
on others for##4##3##(2007-8#1)(2007-9#1)(2012-1#1)(2012-12#1)
on others##12##2##(1993-12#1)(1995-4#1)(1996-3#2)(1997-5#1)(2007-11#1)(2007-8#1)(2007-9#1)(2009-3#1)(2011-2#1)(2012-1#1)(2012-12#1)
on our ability to##2##4##(1994-12#1)(2009-3#1)
on our current##2##3##(2008-11#1)(2009-10#1)
on our data##5##3##(1996-11#1)(2007-12#1)(2007-9#1)(2008-2#1)(2012-3#1)
on our earlier##2##3##(2008-3#1)(2013-8#1)
on our experience with##3##4##(1996-8#1)(2007-6#1)(2008-7#1)
on our experience##10##3##(1996-8#1)(2005-11#1)(2006-6#1)(2007-6#1)(2007-7#2)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
on our findings##7##3##(1996-12#1)(2006-6#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-1#1)
on our observations##3##3##(1995-1#1)(2008-2#1)(2013-1#1)
on our planet##2##3##(2010-5#1)(2012-1#1)
on our previous##4##3##(1991-10#1)(2008-11#1)(2008-9#1)(2010-11#1)
on our recent##4##3##(1992-11#1)(1994-8#1)(2008-7#1)(2009-8#1)
on our study##3##3##(1991-5#1)(2007-2#1)(2008-10#1)
on our understanding of the##2##5##(2008-3#1)(2011-12#1)
on our understanding of##4##4##(1993-3#1)(2007-12#1)(2008-3#1)(2011-12#1)
on our work##2##3##(1990-8#1)(2005-8#1)
on our##126##2##(1990-12#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-1#2)(1995-2#1)(1996-11#1)(1996-12#1)(1996-8#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-2#1)(2006-6#3)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-4#2)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#9)(2008-3#7)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#2)(2009-6#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#2)(2011-1#2)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#3)
on outbreak##2##2##(2006-10#1)(2012-3#1)
on outcome after##3##3##(2006-10#1)(2007-10#1)(2012-3#1)
on outcome following##2##3##(2009-5#1)(2013-8#1)
on outcome in patients##2##4##(2006-10#1)(2011-2#1)
on outcome in##7##3##(1994-8#1)(2006-10#3)(2008-6#1)(2011-2#1)(2012-12#1)
on outcome measures##3##3##(2007-10#1)(2008-7#1)(2011-1#1)
on outcome##28##2##(1991-2#1)(1994-8#1)(2006-10#6)(2006-6#1)(2007-10#3)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
on outcomes after##3##3##(2007-10#2)(2013-8#1)
on outcomes in##3##3##(2007-8#2)(2013-1#1)
on outcomes##17##2##(1991-12#1)(1995-1#1)(1995-2#1)(1996-2#2)(1997-5#1)(2005-9#1)(2006-8#1)(2007-10#2)(2007-8#2)(2010-3#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
on outer##3##2##(1993-6#1)(2006-12#1)(2008-1#1)
on outpatient##2##2##(2006-5#1)(2008-4#1)
on outpatients in##2##3##(2006-8#1)(2008-5#1)
on outputs##2##2##(2005-5#1)(2011-2#1)
on ovarian androgen biosynthesis in##2##5##(2010-10#2)
on ovarian##12##2##(1990-10#1)(1990-5#1)(1996-11#1)(2004-10#1)(2008-12#1)(2008-3#1)(2010-10#2)(2010-12#1)(2012-2#1)(2013-1#2)
on over##4##2##(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)
on overall survival##6##3##(2006-2#1)(2007-4#1)(2008-3#1)(2008-6#2)(2011-2#1)
on overall##18##2##(1990-12#1)(1992-1#1)(1992-4#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#2)(2009-3#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-7#1)
on overcoming##4##2##(2008-10#1)(2008-2#1)(2010-3#1)(2011-2#1)
on overlapping##2##2##(1997-5#1)(2008-8#1)
on overseas##2##2##(1994-4#1)(2004-9#1)
on overweight##2##2##(2007-12#1)(2011-12#1)
on ovine##2##2##(1994-9#1)(2008-12#1)
on ovulation##2##2##(2005-7#1)(2007-1#1)
on oxidation##2##2##(1991-2#1)(2008-10#1)
on oxidative phosphorylation##4##3##(1994-12#1)(1995-7#2)(1996-9#1)
on oxidative stress and##2##4##(2009-6#1)(2010-3#1)
on oxidative stress in the heart and##2##7##(2013-1#2)
on oxidative stress in##3##4##(2009-12#1)(2013-1#2)
on oxidative stress##11##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-6#1)(2010-3#1)(2010-7#1)(2012-12#1)(2013-1#2)
on oxidative##17##2##(1991-9#1)(1994-12#1)(1995-7#2)(1996-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-7#1)(2012-12#1)(2013-1#2)
on oxygen binding to##2##4##(1990-8#1)(1993-6#1)
on oxygen binding##4##3##(1990-8#1)(1991-6#1)(1993-6#1)(2013-8#1)
on oxygen##10##2##(1990-8#1)(1991-6#1)(1993-6#1)(1995-6#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-4#1)(2012-2#1)(2013-8#1)
on ozone##6##2##(1996-1#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#1)(2009-4#1)
on p##39##2##(2005-12#3)(2005-7#1)(2006-3#3)(2007-12#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-7#5)(2009-3#6)(2009-5#2)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
on p-tert-butyl-calix[8]arene-bonded silica gel stationary phase by HPLC##2##8##(2008-10#2)
on p-tert-butyl-calix[8]arene-bonded silica gel stationary phase##3##6##(2008-10#3)
on p21ras##2##2##(1995-11#1)(1995-3#1)
on p34cdc2 kinase##3##3##(1994-9#3)
on p53##2##2##(1995-11#1)(2013-1#1)
on pH and##6##3##(1991-4#1)(1991-7#1)(2005-11#1)(2008-10#2)(2008-6#1)
on pH was##2##3##(1990-3#1)(2008-10#1)
on pH##26##2##(1990-3#1)(1990-7#2)(1990-8#1)(1991-4#1)(1991-7#1)(1991-9#1)(2005-11#1)(2008-10#9)(2008-11#1)(2008-6#2)(2008-8#1)(2009-3#1)(2010-4#2)(2010-5#1)(2011-2#1)
on pH-sensitive##2##2##(2008-10#1)(2013-7#1)
on pacemaker##2##2##(2006-9#1)(2010-12#1)
on paediatric##2##2##(2008-11#1)(2013-1#1)
on page 1754##2##3##(2007-9#2)
on page 970##2##3##(1990-9#2)
on page##20##2##(1990-3#1)(1990-9#3)(1992-2#2)(2007-11#2)(2007-8#1)(2007-9#7)(2012-12#3)(2013-7#1)
on pages##2##2##(1991-11#1)(1996-1#1)
on pain and##4##3##(1995-5#1)(2007-8#1)(2009-7#1)(2012-2#1)
on pain control##2##3##(2006-10#1)(2012-3#1)
on pain intensity##3##3##(2009-12#3)
on pain management and##2##4##(2006-7#1)(2010-8#1)
on pain relief##2##3##(1996-2#1)(2007-2#1)
on pain responses##2##3##(1990-2#2)
on pain##32##2##(1990-2#2)(1995-5#1)(1996-2#2)(2006-10#1)(2006-12#1)(2006-4#1)(2006-7#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#2)(2009-12#3)(2009-7#1)(2010-1#1)(2010-12#1)(2010-8#5)(2011-1#2)(2012-2#3)(2012-3#1)
on paired pulse inhibition##2##4##(1997-5#2)
on paired trials##2##3##(1992-10#2)
on paired##6##2##(1992-10#2)(1997-5#2)(2008-11#1)(2008-7#1)
on palliative##5##2##(1992-10#1)(1996-12#1)(2006-12#1)(2010-7#1)(2011-2#1)
on palpation##3##2##(1996-6#1)(2009-6#1)(2010-3#1)
on pancreatic and##2##3##(1996-6#1)(2006-2#1)
on pancreatic cancer##2##3##(2007-6#1)(2009-4#1)
on pancreatic islet##2##3##(1990-8#1)(2010-10#1)
on pancreatic secretion##2##3##(1992-6#2)
on pancreatic##15##2##(1990-8#1)(1992-2#1)(1992-4#1)(1992-6#2)(1993-6#1)(1996-6#1)(1997-8#1)(2004-12#1)(2006-2#1)(2007-6#1)(2009-4#1)(2010-10#1)(2013-1#2)
on panicle and shoot blight of pistachio##2##7##(2008-10#2)
on panicle and shoot blight##3##5##(2008-10#3)
on pap##2##2##(1990-6#1)(2006-10#1)
on paper and##2##3##(2007-4#1)(2013-7#1)
on paper substrates##2##3##(2012-2#2)
on paper##8##2##(2006-12#1)(2007-4#1)(2008-10#1)(2012-2#2)(2013-7#3)
on paraffin sections##3##3##(1992-9#1)(1995-4#1)(2008-4#1)
on paraffin##5##2##(1991-2#1)(1992-9#1)(1995-4#1)(2008-4#1)(2011-2#1)
on paraffin-embedded##5##2##(1996-1#1)(1996-5#1)(2007-2#1)(2008-6#2)
on parameter estimates##2##3##(1996-12#1)(2013-1#1)
on parameter##5##2##(1996-12#1)(1997-1#1)(2008-2#1)(2008-8#1)(2013-1#1)
on parameters of the##2##4##(2008-3#1)(2011-1#1)
on parameters of##7##3##(1990-8#1)(1994-6#1)(2008-3#2)(2009-6#1)(2011-1#1)(2013-1#1)
on parameters##11##2##(1990-8#1)(1994-6#1)(2008-10#1)(2008-3#2)(2009-6#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#2)
on parasite##4##2##(1990-8#1)(1995-12#1)(1995-9#1)(2006-4#1)
on parasitic##3##2##(1995-9#1)(2006-10#1)(2007-12#1)
on parasitism##2##2##(2008-6#2)
on parental and##2##3##(1994-8#1)(1996-4#1)
on parental##10##2##(1990-10#1)(1994-8#1)(1996-3#1)(1996-4#1)(2006-10#1)(2007-10#1)(2010-2#1)(2010-5#1)(2010-9#1)(2013-8#1)
on parenteral##2##2##(2005-10#2)
on parenting behaviors##2##3##(2007-2#1)(2009-7#1)
on parenting##6##2##(2007-2#1)(2009-7#2)(2009-9#1)(2010-2#1)(2010-9#1)
on parents and##2##3##(1990-2#1)(2012-3#1)
on parents##3##2##(1990-2#1)(2006-8#1)(2012-3#1)
on parents'##4##2##(1991-12#1)(1993-6#1)(2006-2#1)(2011-1#1)
on parietal##6##2##(1990-5#1)(2006-10#5)
on part of##3##3##(2007-3#1)(2008-10#1)(2012-2#1)
on partial##6##2##(1993-8#1)(2008-10#2)(2011-2#2)(2013-8#1)
on partially coherent##2##3##(2007-11#1)(2007-12#1)
on partially##5##2##(1992-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2009-4#1)
on participant##5##2##(2007-7#1)(2008-9#1)(2013-1#2)(2013-8#1)
on participants'##2##2##(2007-10#1)(2008-11#1)
on participating##3##2##(2008-11#1)(2010-7#1)(2010-9#1)
on participation##2##2##(2007-6#1)(2013-1#1)
on particle size##2##3##(1995-3#1)(2005-11#1)
on particle##10##2##(1991-12#1)(1995-3#1)(1996-2#1)(2004-2#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)
on particles##6##2##(2005-11#1)(2006-2#2)(2008-2#2)(2012-1#1)
on particular##7##2##(1996-3#1)(2006-8#1)(2007-11#2)(2008-10#2)(2008-7#1)
on particulate##2##2##(1993-9#1)(2008-10#1)
on partition##2##2##(2008-10#1)(2008-5#1)
on partitioning of##2##3##(1997-3#1)(2008-8#1)
on passage##2##2##(1995-8#1)(2008-5#1)
on passive avoidance behavior in##2##5##(1992-6#1)(1994-10#1)
on passive avoidance##3##3##(1992-10#1)(1992-6#1)(1994-10#1)
on passive##8##2##(1991-9#1)(1992-10#1)(1992-6#1)(1994-10#1)(2007-12#1)(2007-7#1)(2010-12#1)(2010-8#1)
on past##7##2##(1991-1#1)(1991-5#1)(1997-2#1)(2008-7#2)(2012-3#2)
on pasture##2##2##(2010-2#1)(2013-1#1)
on patch##5##2##(1997-2#1)(2008-8#1)(2008-9#2)(2010-2#1)
on patellofemoral##2##2##(2008-12#1)(2012-3#1)
on paternal childbirth fears##2##4##(2010-9#2)
on paternal##3##2##(2008-9#1)(2010-9#2)
on path##4##2##(2008-2#2)(2012-3#2)
on pathogen evolution##2##3##(2008-10#2)
on pathogen populations##2##3##(2008-10#2)
on pathogen##10##2##(2006-5#1)(2008-10#9)
on pathogenesis and##3##3##(1993-9#1)(2006-10#1)(2012-12#1)
on pathogenesis##6##2##(1993-9#1)(2006-10#1)(2009-2#1)(2012-12#1)(2013-1#2)
on pathogenicity##4##2##(1990-3#1)(2008-10#3)
on pathogens##3##2##(2006-10#1)(2009-2#1)(2009-6#1)
on pathological##5##2##(1996-1#1)(2006-10#1)(2008-4#1)(2009-6#1)(2012-2#1)
on pathology##3##2##(2006-8#1)(2012-1#2)
on pathways##4##2##(1997-8#1)(2007-10#1)(2008-5#1)(2012-3#1)
on patient age##2##3##(2007-12#1)(2010-12#1)
on patient and##4##3##(1992-3#1)(2008-11#2)(2011-2#1)
on patient attitudes##2##3##(2011-2#2)
on patient care and##3##4##(2007-2#1)(2013-1#2)
on patient care##11##3##(1995-3#1)(2006-1#1)(2007-2#1)(2007-6#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
on patient compliance##3##3##(1992-8#1)(1995-4#1)(2011-12#1)
on patient demographics##3##3##(2007-10#1)(2011-2#2)
on patient management##7##3##(1996-2#1)(1997-5#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-6#1)(2013-7#1)
on patient outcome##2##3##(2006-10#1)(2013-8#1)
on patient outcomes##7##3##(1994-3#1)(2006-7#1)(2007-12#1)(2007-9#1)(2008-7#1)(2013-1#2)
on patient request##2##3##(2007-8#1)(2011-1#1)
on patient safety##3##3##(2007-4#1)(2008-4#1)(2010-9#1)
on patient satisfaction##4##3##(1996-3#1)(1997-3#1)(2008-3#1)(2010-2#1)
on patient##85##2##(1992-3#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-3#2)(1995-2#1)(1995-3#2)(1995-4#1)(1996-2#2)(1996-3#1)(1997-3#1)(1997-5#1)(2006-1#1)(2006-10#7)(2006-2#1)(2006-7#1)(2007-10#3)(2007-11#1)(2007-12#5)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#2)(2009-12#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#6)(2012-12#2)(2012-3#1)(2013-1#10)(2013-7#1)(2013-8#1)
on patient's daily life##2##4##(2008-7#1)(2009-1#1)
on patient's##13##2##(1992-2#1)(1996-11#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-9#2)(2009-1#2)(2010-8#1)(2011-2#1)(2013-1#1)
on patients and their families##2##5##(2008-11#1)(2011-2#1)
on patients and##10##3##(1990-4#1)(1991-5#1)(2006-11#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-6#1)(2010-5#1)(2010-8#1)(2011-2#1)
on patients at##2##3##(2005-10#1)(2011-2#1)
on patients diagnosed with testicular cancer##2##6##(2006-7#2)
on patients diagnosed with##3##4##(2006-7#2)(2013-8#1)
on patients in##4##3##(1996-1#1)(2009-7#1)(2013-1#2)
on patients receiving##2##3##(2008-7#1)(2008-8#1)
on patients treated##2##3##(1995-4#1)(2007-11#1)
on patients undergoing##3##3##(2007-8#1)(2007-9#1)(2012-12#1)
on patients with acute##2##4##(2006-10#1)(2012-2#1)
on patients with cancer##2##4##(2008-7#1)(2012-3#1)
on patients with coronary artery disease##2##6##(2010-2#1)(2013-1#1)
on patients with coronary heart disease##2##6##(2007-11#2)
on patients with coronary##4##4##(2007-11#2)(2010-2#1)(2013-1#1)
on patients with##28##3##(1990-3#1)(1994-4#1)(1997-8#1)(2005-10#2)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#3)(2007-7#2)(2008-7#1)(2008-8#1)(2009-1#1)(2009-2#1)(2010-2#2)(2010-7#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
on patients##72##2##(1990-3#1)(1990-4#1)(1991-5#1)(1992-10#1)(1994-12#1)(1994-4#1)(1995-4#1)(1996-1#1)(1997-8#1)(2005-10#3)(2006-10#1)(2006-11#1)(2006-2#2)(2006-6#1)(2006-7#2)(2006-8#1)(2007-11#4)(2007-3#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-1#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-2#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-12#1)(2011-2#5)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#4)
on patients' quality of life##3##5##(2007-7#1)(2008-11#1)(2013-1#1)
on patients'##20##2##(1990-10#1)(1991-2#1)(1992-11#1)(1992-8#1)(1994-1#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-2#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
on pattern recognition##4##3##(2009-8#1)(2012-12#1)(2013-1#2)
on pattern##5##2##(2008-2#1)(2009-8#1)(2012-12#1)(2013-1#2)
on patterned##4##2##(1993-2#1)(1994-11#1)(2005-11#1)(2007-8#1)
on patterns and##2##3##(2007-7#1)(2011-12#1)
on patterns of##8##3##(1996-6#1)(2006-11#1)(2007-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)
on patterns##11##2##(1996-6#1)(2006-11#1)(2007-10#2)(2007-7#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2011-12#1)
on pause duration##2##3##(2008-4#2)
on pd 7 and pd 14##2##6##(2008-7#2)
on pd 7##4##3##(2008-7#4)
on pea##5##2##(2008-10#5)
on peach##4##2##(2008-10#2)(2011-12#2)
on peak##6##2##(1990-9#1)(1996-9#1)(2007-10#1)(2007-8#1)(2008-10#2)
on pear and apple trees##2##5##(2008-10#2)
on pear and apple##4##4##(2008-10#4)
on pear leaves##2##3##(2008-10#2)
on pear##16##2##(2008-10#16)
on peas##4##2##(2008-10#4)
on pectin##3##2##(2008-10#3)
on pediatric nutrition##2##3##(2012-2#2)
on pediatric vaccination##2##3##(2009-4#2)
on pediatric##12##2##(1993-12#1)(2006-10#3)(2008-5#1)(2008-8#1)(2009-4#2)(2011-1#2)(2012-2#2)
on peer##2##2##(1996-8#1)(2007-12#1)
on pellet formation##3##3##(2008-5#3)
on pelvic##2##2##(2006-10#1)(2006-7#1)
on pension plans##2##3##(1993-3#2)
on pentobarbital##2##2##(1993-7#1)(1996-4#1)
on penultimate leaf was##2##4##(2008-10#2)
on people with##2##3##(2006-9#1)(2011-2#1)
on people##7##2##(2006-9#1)(2007-1#2)(2010-4#1)(2011-2#1)(2013-1#2)
on people's##2##2##(2008-2#1)(2009-3#1)
on pepper##2##2##(2008-10#2)
on peptic ulcer##2##3##(2006-8#1)(2007-3#1)
on peptide##5##2##(1991-2#1)(1991-7#1)(1995-12#1)(2008-10#2)
on per diem##2##3##(1990-12#1)(1993-12#1)
on per##4##2##(1990-12#1)(1993-12#1)(2006-12#1)(2007-2#1)
on perceived##12##2##(1991-1#1)(2004-11#1)(2009-3#1)(2009-7#1)(2010-5#1)(2013-1#6)(2013-7#1)
on percent##6##2##(2008-10#3)(2008-5#1)(2010-8#1)(2013-8#1)
on percutaneous##3##2##(2006-10#1)(2008-5#1)(2009-11#1)
on perennial ryegrass##2##3##(2008-10#2)
on perennial##3##2##(2008-10#3)
on performance in the##2##4##(2007-12#1)(2008-8#1)
on performance in##8##3##(1990-3#1)(1994-3#1)(2007-12#2)(2007-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
on performance of##9##3##(1993-12#1)(1993-7#1)(1993-9#1)(1995-12#1)(2005-12#1)(2006-10#1)(2008-12#1)(2008-3#1)(2012-3#1)
on performance##26##2##(1990-3#1)(1993-12#2)(1993-3#1)(1993-7#1)(1993-9#1)(1994-3#2)(1995-12#1)(1997-3#1)(2005-12#1)(2006-10#1)(2007-12#2)(2007-7#1)(2008-12#1)(2008-3#1)(2008-8#1)(2011-1#2)(2011-2#1)(2012-3#3)(2013-8#2)
on performing##4##2##(2007-7#1)(2008-7#1)(2008-9#1)(2011-1#1)
on perfusion##3##2##(2006-10#1)(2010-9#1)(2013-1#1)
on peri-operative##3##2##(1991-8#1)(2007-8#1)(2013-7#1)
on perinatal outcome##3##3##(2011-12#1)(2012-3#2)
on perinatal outcomes##2##3##(2008-9#1)(2012-3#1)
on perinatal##7##2##(2007-2#1)(2007-4#1)(2008-9#1)(2011-12#1)(2012-3#3)
on periodic##3##2##(2007-12#2)(2008-2#1)
on periodically poled LiNbO(3)##4##4##(2007-12#4)
on periodically poled##34##3##(2007-11#6)(2007-12#22)(2008-1#2)(2008-3#4)
on periodically##35##2##(2006-12#1)(2007-11#6)(2007-12#22)(2008-1#2)(2008-3#4)
on periodontal##3##2##(2006-2#1)(2008-6#1)(2013-1#1)
on perioperative morbidity##2##3##(2006-10#2)
on perioperative##6##2##(2006-10#4)(2008-3#1)(2008-4#1)
on peripheral blood cells##3##4##(2006-9#1)(2008-4#2)
on peripheral blood lymphocytes and##2##5##(1990-5#1)(1996-3#1)
on peripheral blood lymphocytes##4##4##(1990-5#1)(1996-3#1)(2008-9#2)
on peripheral blood##12##3##(1990-5#1)(1996-3#1)(1997-7#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-4#3)(2008-9#2)(2011-2#1)
on peripheral tissues##3##3##(1990-2#1)(1991-11#1)(2008-10#1)
on peripheral##30##2##(1990-2#2)(1990-5#1)(1991-10#1)(1991-11#1)(1996-12#2)(1996-3#1)(1996-7#2)(1997-7#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-10#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#2)(2010-9#2)(2011-12#1)(2011-2#1)
on periphery of##2##3##(2009-2#1)(2010-7#1)
on periphery##3##2##(2009-2#2)(2010-7#1)
on peritoneal dialysis (PD)##2##4##(2008-1#1)(2008-4#1)
on peritoneal dialysis and##2##4##(2007-12#1)(2008-1#1)
on peritoneal dialysis##8##3##(2007-12#2)(2008-1#2)(2008-4#1)(2008-5#1)(2011-2#1)(2012-12#1)
on peritoneal inflammation in##2##4##(2008-12#2)
on peritoneal macrophages##2##3##(1995-8#1)(2008-10#1)
on peritoneal##19##2##(1995-8#1)(2005-12#1)(2006-6#1)(2007-12#3)(2008-1#3)(2008-10#1)(2008-12#2)(2008-4#1)(2008-5#1)(2010-12#1)(2011-2#3)(2012-12#1)
on peritonitis##2##2##(2008-12#1)(2011-2#1)
on permanent##2##2##(2008-3#1)(2012-3#1)
on persistence of##2##3##(1993-7#1)(2007-3#1)
on persistent##2##2##(2007-12#1)(2010-7#1)
on personal##17##2##(1991-9#1)(1992-1#1)(1993-3#1)(1994-12#1)(1996-2#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-12#1)(2009-7#1)(2010-5#1)(2010-8#2)(2012-1#1)
on personality##2##2##(2004-11#1)(2008-7#1)
on personnel##2##2##(1990-11#1)(2010-8#1)
on persons##2##2##(1993-11#1)(2011-1#1)
on pertussis##2##2##(1993-3#1)(2010-12#1)
on pesticide use##2##3##(2008-12#1)(2009-4#1)
on pesticide##4##2##(2005-10#1)(2008-11#1)(2008-12#1)(2009-4#1)
on petals##2##2##(2008-10#2)
on petioles##2##2##(2008-10#2)
on phage##5##2##(1995-2#1)(1995-3#1)(2008-10#1)(2008-8#1)(2013-1#1)
on phantom##2##2##(2009-12#1)(2011-1#1)
on phantoms##2##2##(2008-3#2)
on pharmaceutical##9##2##(2007-11#1)(2007-8#1)(2008-10#3)(2009-10#1)(2009-3#2)(2011-1#1)
on pharmacokinetic##3##2##(1993-12#1)(1996-11#1)(2012-2#1)
on pharmacokinetics##3##2##(2008-5#1)(2010-6#1)(2012-12#1)
on pharmacologic##2##2##(1990-9#1)(2006-2#1)
on pharmacological##2##2##(2008-7#1)(2010-12#1)
on pharmacotherapy##2##2##(2008-1#1)(2008-9#1)
on pharmacy##3##2##(2008-6#1)(2010-3#2)
on phase modulation##2##3##(2007-11#2)
on phase separation##2##3##(2006-12#1)(2008-10#1)
on phase##12##2##(2006-10#1)(2006-12#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#3)(2013-8#1)
on phase-shifting##3##2##(1996-8#1)(2007-12#1)(2008-2#1)
on phenotype##8##2##(1994-9#2)(2008-10#1)(2010-2#3)(2011-1#1)(2012-3#1)
on phenotypic##3##2##(2008-8#1)(2010-4#1)(2013-7#1)
on philanthropy##2##2##(1995-3#1)(1997-3#1)
on phosphatidylethanolamine lipid polymorphism##2##4##(1990-2#2)
on phosphatidylethanolamine##3##2##(1990-2#2)(1995-2#1)
on phosphatidylinositol (PI)##2##3##(1990-10#1)(2008-4#1)
on phosphatidylinositol##3##2##(1990-10#1)(1990-11#1)(2008-4#1)
on phosphatidylserine##2##2##(1991-4#1)(1991-7#1)
on phosphocellulose##2##2##(1990-3#1)(1992-12#1)
on phosphoinositide hydrolysis and##2##4##(1994-10#1)(1997-1#1)
on phosphoinositide hydrolysis##3##3##(1993-3#1)(1994-10#1)(1997-1#1)
on phosphoinositide metabolism##3##3##(1993-12#2)(1994-12#1)
on phosphoinositide##8##2##(1991-7#1)(1993-12#2)(1993-3#1)(1994-10#1)(1994-12#1)(1994-9#1)(1997-1#1)
on phospholipase A2##3##3##(1990-2#1)(1994-3#1)(1994-8#1)
on phospholipase##6##2##(1990-2#1)(1993-3#1)(1994-3#1)(1994-8#1)(2008-11#1)(2008-8#1)
on phospholipid and##2##3##(1993-6#1)(2008-8#1)
on phospholipid vesicles##2##3##(1995-1#2)
on phospholipid##7##2##(1991-10#1)(1993-6#1)(1994-12#1)(1995-1#2)(2006-8#1)(2008-8#1)
on phosphorus homeostasis##2##3##(2008-4#1)(2009-8#1)
on phosphorus##3##2##(2008-4#2)(2009-8#1)
on phosphorylation of##5##3##(1991-12#1)(1994-9#1)(1996-5#2)(2008-8#1)
on photocatalytic##2##2##(2008-10#2)
on photochemical##2##2##(2008-10#1)(2008-11#1)
on photoinduced##4##2##(2006-10#1)(2007-11#2)(2008-2#1)
on photon migration##4##3##(2007-12#1)(2008-3#3)
on photon##8##2##(2007-12#1)(2008-2#1)(2008-3#5)(2008-7#1)
on photophosphorylation##2##2##(1997-7#1)(2005-10#1)
on photoreceptor##2##2##(1992-6#1)(1996-2#1)
on photosensitization##2##2##(1994-12#1)(1997-1#1)
on photosynthesis##4##2##(1993-12#1)(2008-10#2)(2013-8#1)
on phylogenetic analysis using##2##4##(2008-10#2)
on phylogenetic##6##2##(1990-11#1)(2008-10#3)(2008-8#1)(2010-6#1)
on phylogeny##2##2##(2008-8#1)(2010-6#1)
on physical activity##5##3##(2008-10#1)(2008-12#1)(2008-7#1)(2010-2#1)(2010-8#1)
on physical and mental##2##4##(2009-3#1)(2011-1#1)
on physical and##6##3##(1994-6#1)(2006-4#1)(2007-9#1)(2009-3#1)(2010-6#1)(2011-1#1)
on physical appearance##2##3##(1993-1#1)(2007-12#1)
on physical characteristics of##2##4##(2008-5#2)
on physical examination are##2##4##(2006-5#1)(2009-9#1)
on physical examination##7##3##(2006-10#1)(2006-5#1)(2008-12#1)(2008-6#2)(2009-9#1)(2013-8#1)
on physical fitness##3##3##(2006-10#1)(2010-4#2)
on physical properties##2##3##(2008-4#1)(2012-12#1)
on physical therapy##2##3##(2007-11#1)(2010-7#1)
on physical##46##2##(1990-2#1)(1992-4#1)(1993-1#1)(1994-6#1)(1996-5#1)(1997-7#1)(2006-10#3)(2006-4#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-2#2)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#3)
on physician health##2##3##(1992-12#1)(2007-7#1)
on physician liability##2##3##(1993-2#2)
on physician##19##2##(1991-12#2)(1991-9#1)(1992-12#1)(1993-2#2)(1994-1#1)(1994-2#2)(1996-12#1)(1997-3#1)(2005-9#1)(2006-3#1)(2006-4#1)(2007-7#1)(2007-9#1)(2009-4#1)(2010-5#1)(2013-7#1)
on physicians and##4##3##(1992-3#1)(1996-2#1)(2008-6#1)(2010-5#1)
on physicians in##2##3##(1995-2#1)(2010-11#1)
on physicians##10##2##(1992-2#1)(1992-3#1)(1993-12#2)(1995-2#1)(1996-2#1)(2007-4#1)(2008-6#1)(2010-11#1)(2010-5#1)
on physicians'##3##2##(1991-12#1)(1992-12#1)(2009-3#1)
on physico-chemical##3##2##(2007-6#1)(2008-8#1)(2009-6#1)
on physicochemical and##2##3##(2010-4#2)
on physicochemical properties of##2##4##(1996-1#1)(2010-4#1)
on physicochemical##7##2##(1996-1#1)(2007-1#1)(2010-4#5)
on physiologic##5##2##(1991-1#1)(1996-8#1)(2007-10#1)(2008-4#1)(2012-12#1)
on physiological and##2##3##(2008-10#1)(2013-7#1)
on physiological responses##2##3##(1990-9#1)(2010-8#1)
on physiological##12##2##(1990-9#1)(1996-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-8#2)(2013-1#1)(2013-7#1)
on phytoplankton##3##2##(2009-8#1)(2013-8#2)
on picture##4##2##(1997-8#1)(2004-9#1)(2009-4#1)(2010-2#1)
on pictures 1 and 2##2##5##(2013-1#2)
on pig##5##2##(1992-8#1)(1993-6#1)(1995-11#1)(2010-2#1)(2010-7#1)
on pigeon##2##2##(1991-2#1)(2008-6#1)
on pineal##2##2##(1994-2#2)
on pistachio##2##2##(2008-10#2)
on pituitary##4##2##(1991-2#1)(1996-8#1)(2006-11#1)(2007-7#1)
on pixels##3##2##(2008-3#3)
on place of##2##3##(2005-4#1)(2011-2#1)
on place##4##2##(1992-9#1)(2005-4#1)(2010-3#1)(2011-2#1)
on placebo (P = 0##2##5##(1992-12#2)
on placebo (P##4##3##(1992-12#2)(1992-5#1)(1993-1#1)
on placebo was##2##3##(1990-11#1)(1992-5#1)
on placebo##18##2##(1990-11#1)(1991-3#3)(1992-12#2)(1992-5#2)(1993-1#1)(1994-11#1)(1997-1#1)(2005-9#1)(2008-5#4)(2008-6#2)
on placement##4##2##(2008-11#3)(2008-12#1)
on plain abdominal##2##3##(1991-8#1)(2012-2#1)
on plain radiographs##5##3##(2007-10#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-5#1)
on plain##10##2##(1991-8#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-5#1)(2012-2#1)
on planar substrates##2##3##(2008-2#1)(2012-11#1)
on planar##9##2##(1993-8#1)(1994-2#1)(1997-7#1)(2007-12#1)(2008-2#1)(2008-4#2)(2012-1#1)(2012-11#1)
on plant biomass##2##3##(2008-8#2)
on plant fitness##2##3##(2008-8#2)
on plant growth and##5##4##(2008-10#2)(2009-8#3)
on plant growth##9##3##(2008-10#4)(2008-7#1)(2009-8#3)(2012-7#1)
on plant surfaces##3##3##(2008-10#1)(2008-6#1)(2009-8#1)
on plant##47##2##(2006-12#1)(2006-3#1)(2007-8#1)(2008-10#15)(2008-11#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#9)(2008-9#2)(2009-8#6)(2011-2#1)(2012-5#1)(2012-6#1)(2012-7#1)
on plantar##2##2##(2009-6#1)(2011-2#1)
on plants grown in##3##4##(2008-10#3)
on plants in the##2##4##(2008-10#2)
on plants in##4##3##(2004-11#1)(2008-10#3)
on plants infected with##4##4##(2008-10#3)(2011-12#1)
on plants inoculated with##2##4##(2008-10#2)
on plants of##4##3##(2008-10#4)
on plants##37##2##(1997-3#1)(2004-11#1)(2004-2#1)(2006-10#1)(2007-12#1)(2008-10#27)(2008-8#2)(2008-9#1)(2011-12#1)(2011-2#1)
on plaque##3##2##(1990-10#1)(2011-12#1)(2012-3#1)
on plasma SHBG levels##2##4##(2008-3#2)
on plasma and##3##3##(1990-10#1)(2008-10#1)(2012-12#1)
on plasma calcium##3##3##(1990-6#1)(1994-11#2)
on plasma concentration##2##3##(2012-2#1)(2013-8#1)
on plasma concentrations of##3##4##(2007-8#2)(2012-3#1)
on plasma levels of##3##4##(1992-7#1)(1996-9#1)(1997-5#1)
on plasma lipid##4##3##(2008-7#1)(2011-1#1)(2012-2#2)
on plasma lipids and##2##4##(2008-7#1)(2012-2#1)
on plasma lipids of##2##4##(1992-11#1)(2008-7#1)
on plasma lipids##4##3##(1992-11#1)(2008-7#2)(2012-2#1)
on plasma membrane##4##3##(1991-2#1)(1992-12#1)(1995-6#1)(2011-1#1)
on plasma##60##2##(1990-10#1)(1990-6#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-11#2)(1995-6#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-5#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-8#4)(2007-9#1)(2008-10#3)(2008-12#1)(2008-3#4)(2008-5#1)(2008-7#3)(2011-1#2)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
on plasmid##5##2##(1990-4#1)(1990-9#2)(1992-11#1)(1994-12#1)
on plasmids##3##2##(1991-7#2)(2007-2#1)
on plastic and##3##3##(2008-11#3)
on plastic dishes##2##3##(2008-11#2)
on plastic##20##2##(1990-11#1)(1991-12#1)(1991-7#1)(1996-2#1)(1997-4#1)(2008-11#5)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2009-6#1)(2009-7#1)(2012-1#1)
on plate##3##2##(1994-6#1)(2005-11#1)(2008-8#1)
on plated leaf##2##3##(2008-10#2)
on plated##4##2##(1993-8#1)(1995-11#1)(2008-10#2)
on platelet activation##4##3##(1992-4#1)(2011-2#3)
on platelet aggregation and##2##4##(1990-12#1)(1991-12#1)
on platelet aggregation were##2##4##(1995-12#1)(2005-8#1)
on platelet aggregation##5##3##(1990-12#1)(1991-12#1)(1991-9#1)(1995-12#1)(2005-8#1)
on platelet and##3##3##(1991-9#1)(2008-7#2)
on platelet function##5##3##(1991-11#1)(1991-12#2)(1997-4#1)(2006-6#1)
on platelet##29##2##(1990-10#1)(1990-12#3)(1991-11#1)(1991-12#3)(1991-9#2)(1992-4#1)(1994-8#2)(1995-12#1)(1997-4#1)(2005-8#1)(2006-6#2)(2007-1#1)(2008-11#1)(2008-7#2)(2008-8#1)(2010-12#2)(2011-2#4)
on platelets and##2##3##(2006-6#1)(2008-4#1)
on platelets##5##2##(1992-8#1)(2005-10#1)(2006-6#2)(2008-4#1)
on plates##4##2##(2008-10#2)(2008-4#1)(2010-2#1)
on platinum##4##2##(2007-8#1)(2008-10#3)
on play##2##2##(1991-3#1)(1992-9#1)
on pods##5##2##(2008-10#5)
on point##5##2##(2011-2#5)
on polar auxin transport##2##4##(2009-10#2)
on polar##4##2##(1991-5#1)(2009-10#2)(2010-12#1)
on polarization##7##2##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#1)
on polarized##4##2##(1994-8#1)(2007-11#2)(2009-8#1)
on policies##2##2##(1995-3#1)(2012-2#1)
on policy##4##2##(1991-1#1)(1996-3#1)(2009-11#1)(2012-12#1)
on polished##3##2##(2008-3#1)(2009-4#1)(2013-1#1)
on political##5##2##(1993-6#1)(1996-1#1)(2007-4#1)(2008-1#1)(2008-7#1)
on pollen competitive ability##2##4##(1990-6#1)(2008-8#1)
on pollen##5##2##(1990-6#1)(1992-3#1)(2008-10#2)(2008-8#1)
on pollinator##2##2##(2008-8#2)
on poly(dimethylsiloxane) (PDMS)##2##3##(2006-7#1)(2009-11#1)
on polyacrylamide gel electrophoresis##2##4##(1990-12#1)(1996-7#1)
on polyacrylamide gel##5##3##(1990-12#1)(1992-2#1)(1993-8#1)(1995-6#1)(1996-7#1)
on polyacrylamide gels##2##3##(1993-8#1)(2008-10#1)
on polyacrylamide##9##2##(1990-12#1)(1992-2#1)(1993-8#2)(1995-6#1)(1996-7#1)(2008-10#1)(2008-4#1)(2009-6#1)
on polyamine metabolism and phosphatidylinositol turnover in Ehrlich ascites tumor cells##2##11##(1994-12#2)
on polyamine##3##2##(1994-12#2)(1994-8#1)
on polyaniline##5##2##(1991-6#1)(2005-11#1)(2007-9#1)(2008-10#2)
on polycrystalline##3##2##(1996-2#1)(2005-11#1)(2008-10#1)
on polyelectrolyte multilayer films##2##4##(2008-10#1)(2008-5#1)
on polyelectrolyte surfaces##2##3##(2010-9#2)
on polyelectrolyte##4##2##(2008-10#1)(2008-5#1)(2010-9#2)
on polyester##3##2##(2005-11#2)(2008-10#1)
on polyethylene##2##2##(1997-3#1)(2008-5#1)
on polyethylenimine##2##2##(2006-5#1)(2009-10#1)
on polymer film##2##3##(2008-10#2)
on polymer##5##2##(2008-10#2)(2008-9#1)(2010-11#1)(2013-1#1)
on polymerase chain reaction (PCR)##3##5##(1991-3#1)(1992-8#1)(2005-7#1)
on polymerase chain reaction##5##4##(1991-3#1)(1992-8#1)(1993-4#1)(2005-7#1)(2006-10#1)
on polymers##2##2##(2006-12#1)(2008-2#1)
on polypharmacy##2##2##(2008-3#1)(2011-2#1)
on polyphenols##2##2##(2012-12#1)(2013-1#1)
on polysaccharides##2##2##(2008-5#1)(2008-6#1)
on polysomes##3##2##(1994-9#2)(1997-7#1)
on polysomnography##2##2##(2007-1#1)(2012-12#1)
on polystyrene##2##2##(2008-10#1)(2010-12#1)
on polyurethane##4##2##(2004-9#3)(2008-7#1)
on poor##4##2##(1992-2#1)(2007-10#1)(2008-10#1)(2008-9#1)
on poorly##2##2##(1994-5#1)(2008-2#1)
on population dynamics and##3##4##(2008-8#1)(2011-12#1)(2013-7#1)
on population dynamics of##2##4##(2008-10#2)
on population dynamics##8##3##(1991-2#1)(1994-8#1)(2008-10#3)(2008-8#1)(2011-12#1)(2013-7#1)
on population growth and##2##4##(2008-11#2)
on population health##2##3##(2008-2#1)(2009-4#1)
on population##28##2##(1991-2#1)(1991-6#1)(1994-8#1)(1996-5#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-8#7)(2008-9#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-12#1)(2012-12#1)(2012-2#2)(2013-7#1)
on populations of##2##3##(2007-12#1)(2011-2#1)
on populations##7##2##(1990-8#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
on porcine##3##2##(1990-12#1)(1990-2#1)(1996-5#1)
on pork##2##2##(2010-4#2)
on porous graphitic carbon##2##4##(1990-8#2)
on porous##18##2##(1990-8#2)(1996-8#1)(2005-11#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2009-3#1)(2010-12#1)(2010-4#2)(2013-7#1)
on porphyrin ring##2##3##(2005-4#2)
on porphyrin##4##2##(1991-10#1)(1993-11#1)(2005-4#2)
on porphyrin-heme metabolism##2##3##(1990-3#2)
on position##4##2##(2006-10#1)(2008-10#1)(2008-6#1)(2011-1#1)
on positioning of##2##3##(2006-10#1)(2007-7#1)
on positioning##3##2##(2006-10#1)(2007-7#1)(2008-8#1)
on positive and negative symptoms##2##5##(2008-3#1)(2012-2#1)
on positive##11##2##(1990-11#1)(1993-2#1)(1993-6#1)(1996-11#1)(2007-5#1)(2008-11#1)(2008-3#1)(2009-4#1)(2011-2#2)(2012-2#1)
on possible mechanisms for##2##4##(2006-9#1)(2009-8#1)
on possible mechanisms##4##3##(2006-9#1)(2008-10#2)(2009-8#1)
on possible##19##2##(1992-8#1)(1995-1#1)(2004-9#1)(2006-11#1)(2006-4#1)(2006-9#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-10#1)(2009-4#1)(2009-8#1)(2012-1#1)(2012-2#2)(2013-1#1)
on post operative##2##3##(2007-2#1)(2012-2#1)
on post-20-week abortions##2##3##(1996-6#2)
on post-burn##2##2##(2008-12#1)(2009-6#1)
on post-infection##2##2##(2008-10#1)(2008-11#1)
on post-menopausal women##2##3##(2008-1#1)(2009-4#1)
on post-mortem##2##2##(2008-7#1)(2013-1#1)
on post-operative##2##2##(2006-9#1)(2007-7#1)
on post-traumatic##2##2##(1996-1#1)(1997-7#1)
on posterior gills of the mangrove crab Ucides cordatus##2##9##(2008-7#2)
on posterior##6##2##(1993-5#1)(2006-10#1)(2008-7#2)(2010-6#1)(2011-1#1)
on postinfection##2##2##(2008-10#2)
on postmenopausal##2##2##(2006-10#1)(2008-5#1)
on postnatal day##4##3##(1996-12#1)(1996-3#1)(2009-4#1)(2012-12#1)
on postnatal days##2##3##(1991-4#1)(2012-3#1)
on postnatal##8##2##(1991-4#1)(1996-12#1)(1996-3#1)(2008-10#1)(2009-4#1)(2010-12#1)(2012-12#1)(2012-3#1)
on postoperative complications##2##3##(1997-3#1)(2008-10#1)
on postoperative day##5##3##(2006-9#2)(2010-3#1)(2012-12#1)(2013-8#1)
on postoperative days 2##3##4##(2006-9#1)(2012-2#2)
on postoperative days##6##3##(2006-9#2)(2007-8#1)(2011-2#1)(2012-2#2)
on postoperative nausea and vomiting##2##5##(2006-10#1)(2012-12#1)
on postoperative pain and##4##4##(2010-3#1)(2012-1#1)(2012-12#2)
on postoperative pain in total abdominal hysterectomy##2##7##(2007-2#2)
on postoperative pain##9##3##(1992-8#1)(2006-10#1)(2006-12#1)(2007-2#2)(2010-3#1)(2012-1#1)(2012-12#2)
on postoperative recovery##2##3##(2007-8#2)
on postoperative##42##2##(1992-8#1)(1994-3#1)(1997-3#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-6#1)(2006-9#4)(2007-2#2)(2007-8#5)(2008-10#1)(2008-7#1)(2008-8#1)(2010-3#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
on postpartum##2##2##(2006-2#1)(2006-5#1)
on postprandial##2##2##(1991-10#1)(2004-11#1)
on postsurgical adhesion formation##2##4##(1995-12#2)
on postsynaptic##3##2##(1994-8#1)(1995-5#1)(2006-3#1)
on posture##2##2##(2007-11#1)(2007-7#1)
on potassium##4##2##(1996-1#1)(2005-4#1)(2007-12#1)(2008-2#1)
on potato and tomato##3##4##(2008-10#3)
on potato and##4##3##(2008-10#4)
on potato based ready-to-eat food products##2##6##(2011-2#2)
on potato dextrose agar (PDA)##2##5##(2008-10#2)
on potato dextrose agar##11##4##(2008-10#11)
on potato##31##2##(2005-11#1)(2008-10#28)(2011-2#2)
on potency##2##2##(1995-3#1)(1996-12#1)
on potential##23##2##(1991-4#1)(1993-7#1)(1994-3#1)(1995-2#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#4)(2008-7#1)(2008-9#1)(2010-3#1)(2012-11#2)(2012-12#2)(2013-1#1)(2013-8#1)
on potentially##2##2##(2007-12#1)(2008-2#1)
on poverty##2##2##(2007-7#1)(2008-9#1)
on powdered##2##2##(2005-11#1)(2008-10#1)
on powdery mildew##2##3##(2008-10#2)
on power##2##2##(1996-3#1)(2011-2#1)
on practical##7##2##(1992-3#1)(1995-5#1)(2007-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-2#1)
on practice and##3##3##(2008-11#1)(2013-1#2)
on practice##9##2##(1996-2#1)(2008-11#5)(2009-10#1)(2013-1#2)
on practices##2##2##(2006-8#1)(2008-10#1)
on pre- and##6##3##(1993-8#1)(1994-2#1)(1996-2#1)(2008-1#2)(2012-2#1)
on preclinical##4##2##(2005-7#1)(2005-9#1)(2008-12#1)(2009-3#1)
on predicted##3##2##(1991-12#1)(2009-5#1)(2010-7#1)
on predicting##4##2##(1994-6#1)(2007-11#1)(2008-10#1)(2013-1#1)
on prediction##2##2##(2008-10#1)(2008-4#1)
on predictions of##2##3##(2008-8#1)(2013-8#1)
on predictions##3##2##(2006-12#1)(2008-8#1)(2013-8#1)
on prednisone##2##2##(2007-8#1)(2012-3#1)
on preexisting##3##2##(2007-10#1)(2007-9#1)(2011-12#1)
on preference##2##2##(1992-3#1)(2006-7#1)
on pregnancy and##2##3##(2007-2#1)(2008-9#1)
on pregnancy outcome##3##3##(2004-10#1)(2009-9#1)(2011-2#1)
on pregnancy##16##2##(1991-3#1)(1996-12#1)(1996-3#1)(2004-10#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-9#1)(2009-11#1)(2009-9#1)(2011-12#1)(2011-2#1)(2012-11#1)(2013-1#3)
on pregnant##5##2##(1990-11#1)(2005-7#1)(2007-3#1)(2009-4#1)(2010-12#1)
on preliminary##5##2##(1995-3#1)(2007-9#1)(2008-12#1)(2008-5#1)(2010-2#1)
on premature##5##2##(2007-10#1)(2008-10#1)(2008-5#2)(2012-12#1)
on prenatal maternal stress##2##4##(2008-2#2)
on prenatal##3##2##(1992-9#1)(2008-2#2)
on preoperative##16##2##(1990-8#1)(2006-10#1)(2006-12#2)(2006-9#1)(2007-12#1)(2007-8#2)(2008-12#1)(2008-8#2)(2011-2#1)(2012-2#3)(2013-1#1)
on preparation##3##2##(2006-8#1)(2011-1#1)(2011-2#1)
on preparing##2##2##(2005-12#1)(2008-10#1)
on prescribing patterns##2##3##(2008-11#2)
on prescribing##6##2##(1996-3#2)(2008-11#4)
on prescription##4##2##(1990-2#2)(1991-6#1)(2008-11#1)
on presence of##3##3##(1990-2#1)(2008-10#2)
on present##3##2##(1996-12#1)(2006-10#1)(2008-12#1)
on presentation were##2##3##(2006-11#1)(2006-8#1)
on presentation##6##2##(2006-11#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-10#1)(2010-2#1)
on presenting##3##2##(1991-12#1)(2005-8#1)(2009-2#1)
on preserving the##2##3##(1994-9#1)(2008-2#1)
on pressure##5##2##(1990-9#2)(1992-5#1)(2006-10#1)(2012-2#1)
on prevalence of##2##3##(1993-1#1)(2007-9#1)
on prevalence##6##2##(1993-1#1)(2007-9#1)(2008-1#1)(2008-11#1)(2013-1#2)
on preventing infection##2##3##(2007-2#1)(2008-10#1)
on preventing##7##2##(1993-2#1)(1994-2#1)(2007-2#2)(2008-10#1)(2013-1#2)
on prevention and##6##3##(1994-12#1)(2006-4#1)(2007-7#1)(2010-5#1)(2011-1#1)(2012-2#1)
on prevention of##14##3##(1993-11#1)(2005-10#1)(2005-2#1)(2005-3#1)(2006-12#1)(2006-8#2)(2008-2#1)(2008-7#2)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
on prevention##28##2##(1991-3#1)(1993-11#1)(1994-12#1)(1997-5#1)(2005-10#1)(2005-2#1)(2005-3#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-8#2)(2007-11#1)(2007-7#2)(2008-2#1)(2008-3#1)(2008-7#2)(2010-12#2)(2010-5#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-8#1)
on preventive measures and##2##4##(2007-8#1)(2010-1#1)
on preventive measures##5##3##(2007-7#1)(2007-8#1)(2008-10#1)(2010-1#1)(2011-1#1)
on preventive services##2##3##(1994-2#1)(1995-2#1)
on preventive##8##2##(1994-2#1)(1995-2#1)(1996-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2010-1#1)(2011-1#1)
on previous studies##2##3##(2008-5#1)(2008-7#1)
on previous work##2##3##(2008-7#2)
on previous##28##2##(1991-9#1)(1994-3#1)(1996-11#1)(1996-12#1)(2007-8#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#5)(2008-8#2)(2009-8#1)(2009-9#1)(2010-2#1)(2010-8#1)(2010-9#2)(2011-12#1)(2011-2#2)(2013-1#1)
on previously established##2##3##(2008-10#1)(2008-5#1)
on previously published##2##3##(2007-5#1)(2008-4#1)
on previously##16##2##(1990-8#1)(2004-2#1)(2006-4#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
on prey fitness##2##3##(2008-8#2)
on prey##3##2##(2008-8#3)
on prg##2##2##(2008-10#2)
on primary and secondary##2##4##(2008-10#1)(2012-3#1)
on primary and##3##3##(1997-6#1)(2008-10#1)(2012-3#1)
on primary care##4##3##(1991-1#1)(1993-4#1)(1994-6#1)(2007-4#1)
on primary cultures of##2##4##(1993-3#1)(1996-1#1)
on primary prevention##4##3##(1990-10#1)(1995-11#1)(1996-12#1)(2008-11#1)
on primary##37##2##(1990-10#1)(1991-1#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-6#1)(1995-11#1)(1995-7#1)(1996-1#1)(1996-12#1)(1997-6#1)(2006-3#1)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-11#1)(2012-3#2)(2013-1#1)(2013-8#2)
on principles of##2##3##(1993-7#1)(2010-5#1)
on principles##5##2##(1993-7#1)(2008-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
on prior experience##2##3##(2010-8#2)
on prior knowledge##2##3##(2006-5#1)(2010-2#1)
on prior##7##2##(1990-10#1)(1993-2#1)(2006-5#1)(2008-9#1)(2010-2#1)(2010-8#2)
on prison##2##2##(1991-3#1)(1993-7#1)
on privacy##5##2##(1992-4#1)(1996-5#1)(2006-2#1)(2006-8#1)(2012-12#1)
on private##4##2##(1993-1#1)(1995-3#1)(1996-12#1)(2012-3#1)
on probe##2##2##(1994-5#1)(2009-5#1)
on probing##6##2##(2006-2#2)(2008-12#1)(2012-11#1)(2012-12#1)(2013-1#1)
on problem##3##2##(1994-2#1)(2008-12#1)(2010-10#1)
on problematic##3##2##(2006-11#1)(2009-12#1)(2012-2#1)
on problems of##4##3##(1990-3#1)(1994-3#1)(2007-8#1)(2009-12#1)
on problems##8##2##(1990-3#1)(1994-3#1)(1997-3#1)(2007-8#1)(2008-2#1)(2009-12#1)(2010-8#1)(2011-2#1)
on procedural##2##2##(2006-10#1)(2012-2#1)
on procedure##2##2##(2007-10#1)(2007-4#1)
on processes##5##2##(1993-6#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)
on processing##2##2##(2004-9#2)
on producing##3##2##(2011-1#1)(2013-1#2)
on product##7##2##(1991-11#1)(1992-1#1)(2008-5#1)(2008-7#2)(2009-4#1)(2011-1#1)
on production of##9##3##(1990-4#1)(1990-5#1)(2005-11#1)(2006-6#1)(2006-9#1)(2007-6#1)(2008-11#2)(2008-4#1)
on production##12##2##(1990-4#1)(1990-5#1)(2005-11#1)(2006-6#1)(2006-9#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2013-8#1)
on productivity in##2##3##(2008-7#1)(2008-8#1)
on productivity##6##2##(1991-2#1)(1992-3#1)(2007-9#1)(2008-7#2)(2008-8#1)
on products##2##2##(1997-8#1)(2007-6#1)
on proenzyme cleavage and##2##4##(1995-8#2)
on professional##5##2##(1995-3#1)(2007-4#1)(2008-11#1)(2009-4#1)(2013-1#1)
on progesterone##3##2##(1995-7#1)(1997-8#1)(2012-2#1)
on prognosis and##4##3##(1991-8#1)(2011-1#2)(2013-1#1)
on prognosis##14##2##(1990-1#1)(1990-8#1)(1991-6#1)(1991-8#1)(1992-4#1)(1993-9#1)(2010-11#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#2)
on prognostic factors##3##3##(1995-4#1)(2007-10#1)(2008-7#1)
on program##6##2##(1992-3#1)(1993-3#1)(2008-6#1)(2009-8#1)(2012-3#1)(2013-1#1)
on programmed##2##2##(2006-12#1)(2008-12#1)
on progress in##2##3##(2005-7#1)(2006-6#1)
on progress##3##2##(2005-7#1)(2006-6#1)(2008-12#1)
on progression of chronic##2##4##(1997-7#1)(2008-1#1)
on progression of##7##3##(1990-1#1)(1995-12#1)(1996-3#1)(1997-7#2)(2008-1#1)(2013-1#1)
on progression##9##2##(1990-1#1)(1995-12#1)(1996-3#1)(1997-7#2)(2008-1#1)(2010-5#2)(2013-1#1)
on prolactin (PRL)##4##3##(1995-10#1)(1996-2#1)(2006-1#1)(2008-6#1)
on prolactin##5##2##(1995-10#2)(1996-2#1)(2006-1#1)(2008-6#1)
on proliferating##2##2##(1992-8#1)(1993-11#1)
on proliferation and apoptosis in##2##5##(2011-2#2)
on proliferation and apoptosis of##2##5##(2011-2#1)(2013-1#1)
on proliferation and apoptosis##4##4##(2011-2#3)(2013-1#1)
on proliferation and death of##2##5##(1997-6#2)
on proliferation and##12##3##(1996-8#1)(1997-6#2)(2006-6#1)(2008-11#2)(2011-12#1)(2011-2#3)(2012-12#1)(2013-1#1)
on proliferation of human##2##4##(1993-9#1)(1995-3#1)
on proliferation of murine##2##4##(2006-10#2)
on proliferation of rat##2##4##(1992-2#1)(2011-3#1)
on proliferation of##14##3##(1990-9#1)(1992-2#1)(1993-9#1)(1995-3#1)(1996-3#1)(1997-1#1)(1997-2#1)(2004-12#2)(2006-10#2)(2010-12#2)(2011-3#1)
on proliferation##36##2##(1990-9#1)(1991-5#1)(1992-2#2)(1993-9#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-6#2)(2004-12#2)(2006-10#2)(2006-6#1)(2008-11#3)(2009-8#1)(2010-12#2)(2011-12#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
on prolonged##9##2##(1990-8#1)(1996-12#1)(1996-6#1)(1996-9#1)(2005-11#1)(2007-2#1)(2008-3#1)(2008-5#1)(2013-1#1)
on promoter activity##2##3##(1996-7#1)(2013-1#1)
on promoter##4##2##(1996-4#1)(1996-7#1)(2008-10#1)(2013-1#1)
on promoting cell growth##2##4##(2008-11#2)
on promoting##10##2##(1992-9#1)(1994-3#2)(2008-10#1)(2008-11#4)(2008-9#1)(2009-10#1)
on promotion of##2##3##(1991-12#1)(1992-12#1)
on pronucleus formation in porcine oocytes##2##6##(2006-5#2)
on pronucleus formation##3##3##(2006-5#3)
on propagating##2##2##(1996-4#1)(2009-5#1)
on propagation in free space##2##5##(2008-1#2)
on propagation##4##2##(2007-11#1)(2007-12#1)(2008-1#2)
on proper##8##2##(2005-10#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-4#1)(2010-9#1)(2011-2#1)
on properties of##2##3##(2005-11#1)(2008-10#1)
on properties##5##2##(2005-11#1)(2008-10#1)(2008-11#1)(2009-2#1)(2010-12#1)
on prophenoloxidase activation##2##3##(1990-3#1)(2007-12#1)
on proportional##2##2##(1994-9#1)(2011-1#1)
on proposed##5##2##(2007-12#1)(2008-3#1)(2008-4#1)(2012-3#1)(2013-8#1)
on propranolol##2##2##(1991-2#1)(2008-9#1)
on prospective##4##2##(2005-10#2)(2010-3#1)(2013-7#1)
on prostate and##2##3##(2006-6#1)(2009-5#1)
on prostate cancer##5##3##(2007-3#2)(2008-7#1)(2011-2#1)(2013-1#1)
on prostate##7##2##(2006-6#1)(2007-3#2)(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#1)
on proteases##3##2##(1990-7#1)(2006-10#1)(2008-1#1)
on protection of##2##3##(2005-8#1)(2008-8#1)
on protection##3##2##(2005-8#1)(2007-2#1)(2008-8#1)
on protective##3##2##(2008-12#1)(2008-2#1)(2010-12#1)
on protein concentration##3##3##(1990-10#1)(1991-2#1)(1991-9#1)
on protein function##2##3##(2008-9#1)(2012-3#1)
on protein kinase C activity in##2##6##(1990-8#1)(1993-12#1)
on protein kinase C activity##5##5##(1990-8#1)(1993-12#1)(1993-9#3)
on protein kinase C and##2##5##(1994-5#1)(2008-11#1)
on protein kinase C##15##4##(1990-8#1)(1991-10#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-9#3)(1994-5#1)(1995-12#1)(1995-3#1)(2008-11#1)
on protein kinase##16##3##(1990-8#1)(1991-10#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-6#1)(1993-12#2)(1993-9#3)(1994-5#1)(1995-12#1)(1995-3#1)(2008-11#1)
on protein output##2##3##(1997-5#2)
on protein synthesis in##3##4##(2008-11#3)
on protein synthesis##16##3##(1990-11#1)(1993-9#1)(1994-5#1)(1995-12#1)(1996-4#1)(2008-11#10)(2012-2#1)
on protein##79##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#2)(1992-6#1)(1992-8#1)(1993-12#3)(1993-9#4)(1994-12#1)(1994-5#3)(1994-9#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-11#2)(1996-3#1)(1996-4#2)(1997-2#1)(1997-5#3)(1997-6#1)(1997-8#1)(2005-10#1)(2006-11#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#12)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-4#1)(2012-2#2)(2012-3#1)(2013-8#1)
on protein-coding genes##2##3##(2007-10#1)(2008-7#1)
on proteins##14##2##(1993-3#1)(1997-1#1)(2006-12#1)(2008-10#2)(2008-4#4)(2008-7#1)(2009-5#1)(2010-2#1)(2010-5#1)(2012-1#1)
on proteoglycan##5##2##(1994-12#2)(1997-8#1)(2009-4#1)(2011-1#1)
on proteolytic##2##2##(2008-10#1)(2008-4#1)
on proteomics##2##2##(2006-9#1)(2010-6#1)
on protocols##2##2##(2008-9#1)(2012-2#1)
on proton##3##2##(1991-3#1)(1991-4#1)(2006-8#1)
on provider education##2##3##(1997-2#2)
on provider##4##2##(1994-1#1)(1994-3#1)(1997-2#2)
on providing##10##2##(1997-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-3#1)(2013-1#5)
on provincial and district level##2##5##(2011-12#2)
on proving##2##2##(2007-1#1)(2008-11#1)
on proximal##2##2##(1992-4#1)(2007-7#1)
on psoriasis##2##2##(1993-8#1)(1996-2#1)
on psoriatic##2##2##(2012-1#1)(2012-2#1)
on psychiatric and cognitive##2##4##(2004-3#2)
on psychiatric morbidity##2##3##(2006-9#1)(2012-3#1)
on psychiatric symptoms##4##3##(2012-1#3)(2013-8#1)
on psychiatric##15##2##(1991-1#1)(1991-3#1)(1992-12#1)(1992-3#1)(2004-3#2)(2006-9#1)(2008-6#1)(2009-8#1)(2011-7#1)(2012-1#3)(2012-3#1)(2013-8#1)
on psychiatry##3##2##(1992-6#1)(1993-12#1)(2012-2#1)
on psychoactive drugs##2##3##(2007-9#1)(2008-1#1)
on psychological distress##2##3##(1996-1#1)(2012-3#1)
on psychological##14##2##(1992-1#1)(1993-12#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-1#1)(2007-1#1)(2008-4#2)(2008-8#1)(2009-7#1)(2010-2#1)(2012-3#1)(2013-1#1)
on psychomotor development of##3##4##(2006-10#1)(2013-8#2)
on psychopathology##2##2##(2006-3#1)(2009-11#1)
on psychosis in##2##3##(2011-1#2)
on psychosis##4##2##(2011-1#3)(2012-2#1)
on psychosocial##2##2##(2008-8#1)(2010-2#1)
on public health##17##3##(1990-12#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-3#2)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-7#1)
on public policy##2##3##(1990-12#2)
on public##27##2##(1990-12#4)(1991-5#1)(1992-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#2)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#2)(2013-7#1)
on publications##2##2##(2009-2#1)(2011-2#1)
on publicly##3##2##(1990-12#1)(2008-12#1)(2012-2#1)
on published data##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)
on published##9##2##(1997-1#1)(2007-10#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-8#1)(2010-10#1)
on pulmonary function testing##2##4##(2005-8#1)(2006-10#1)
on pulmonary function##9##3##(1991-12#1)(1993-2#1)(1997-1#1)(2005-8#1)(2006-10#3)(2011-2#1)(2013-1#1)
on pulmonary##17##2##(1991-12#1)(1992-6#2)(1993-2#1)(1996-3#1)(1997-1#1)(1997-4#1)(2005-8#1)(2006-10#3)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
on pulse duration##3##3##(1991-2#1)(2007-11#1)(2008-1#1)
on pulse##6##2##(1991-2#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-1#1)
on pulsed##2##2##(2007-12#1)(2008-2#1)
on pump power##2##3##(2008-3#2)
on pump##6##2##(2007-8#1)(2008-2#1)(2008-3#3)(2010-11#1)
on pure titanium substrates##2##4##(2008-5#1)(2009-9#1)
on pure water absorption##2##4##(2008-3#2)
on pure water and##2##4##(2005-11#2)
on pure water##4##3##(2005-11#2)(2008-3#2)
on pure##10##2##(1994-5#1)(1997-6#1)(2005-11#2)(2006-3#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-9#1)
on purified##8##2##(1990-10#1)(1994-12#1)(1995-1#1)(1995-3#1)(1997-7#1)(2008-10#1)(2008-5#1)(2009-6#1)
on purine##3##2##(1996-5#1)(1997-7#1)(2008-9#1)
on purpose##3##2##(2007-2#1)(2008-10#1)(2012-3#1)
on pyramidal neurons##2##3##(1990-2#1)(1996-5#1)
on pyramidal##3##2##(1990-2#1)(1996-10#1)(1996-5#1)
on pyrocatechol violet and rhodamine##2##5##(2005-4#2)
on pyrolytic graphite (PG) electrodes were##2##6##(2008-10#2)
on pyrolytic graphite (PG) electrodes##3##5##(2008-10#3)
on pyrolytic graphite (PG)##4##4##(2008-10#4)
on pyruvate and##2##3##(1994-11#2)
on pyruvate##3##2##(1991-3#1)(1994-11#2)
on pythium##2##2##(2008-10#2)
on quadrat##3##2##(2008-10#3)
on quadratic##2##2##(2007-11#1)(2007-12#1)
on qualitative##5##2##(2008-10#2)(2008-3#1)(2009-5#1)(2011-1#1)
on quality and cost##2##4##(1994-1#1)(1996-2#1)
on quality and##4##3##(1994-1#1)(1995-2#1)(1996-2#1)(2012-2#1)
on quality assessment##2##3##(1993-2#1)(2007-5#1)
on quality assurance##2##3##(1996-2#1)(2006-2#1)
on quality care##2##3##(2008-1#1)(2008-3#1)
on quality control##2##3##(2008-10#1)(2012-12#1)
on quality of care##4##4##(1992-1#1)(1996-1#1)(1996-12#1)(1997-3#1)
on quality of life (QOL)##4##5##(1995-2#1)(2006-11#1)(2006-12#1)(2011-2#1)
on quality of life and##7##5##(2008-7#1)(2009-5#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-3#1)
on quality of life in patients with##3##7##(2005-6#1)(2006-12#1)(2012-1#1)
on quality of life in##4##5##(2005-6#1)(2006-12#1)(2011-12#1)(2012-1#1)
on quality of life is##2##5##(1996-9#1)(2013-1#1)
on quality of life of##2##5##(2008-4#1)(2012-3#1)
on quality of life##45##4##(1994-6#1)(1995-2#1)(1996-9#1)(2005-6#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#2)(2006-7#1)(2006-9#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-12#3)(2011-2#2)(2012-1#2)(2012-12#4)(2012-3#2)(2013-1#4)(2013-8#3)
on quality of##53##3##(1992-1#1)(1994-6#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-3#1)(2005-6#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#2)(2006-7#1)(2006-9#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-12#3)(2011-2#2)(2012-1#2)(2012-12#5)(2012-3#3)(2013-1#5)(2013-8#3)
on quality##71##2##(1992-1#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-3#1)(1994-6#1)(1995-2#2)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#3)(1996-9#1)(1997-3#1)(2005-6#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#3)(2006-7#1)(2006-9#1)(2007-2#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-12#3)(2011-2#2)(2012-1#2)(2012-12#6)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#3)
on quantitative##17##2##(1990-12#1)(2005-12#1)(2005-5#1)(2006-11#1)(2007-12#2)(2008-10#3)(2008-3#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-2#1)(2011-1#1)(2011-3#1)(2012-3#1)
on quantum dots##2##3##(2008-7#1)(2013-7#1)
on quantum##6##2##(1992-8#1)(2005-11#1)(2007-12#1)(2008-7#1)(2009-6#1)(2013-7#1)
on quartz##8##2##(2005-11#3)(2007-12#1)(2008-10#3)(2008-3#1)
on quasi-phase-matched##5##2##(2007-12#5)
on quercetin-induced##3##2##(1992-4#2)(1992-7#1)
on questions that##3##3##(1992-5#1)(1995-1#1)(2006-10#1)
on questions##6##2##(1992-1#1)(1992-5#1)(1995-1#1)(2006-10#1)(2008-1#1)(2008-11#1)
on quitting intentions in##2##4##(2010-2#2)
on quitting##4##2##(2010-2#2)(2011-2#1)(2012-2#1)
on rRNA##3##2##(2006-12#1)(2011-2#1)(2013-7#1)
on rabbit##4##2##(1991-6#1)(1992-7#1)(2007-11#1)(2008-11#1)
on rabbits##3##2##(2008-8#1)(2012-1#2)
on racial##3##2##(1992-4#1)(2007-2#1)(2009-7#1)
on radial growth of##2##4##(2011-12#2)
on radial##5##2##(1991-2#1)(2008-9#2)(2011-12#2)
on radiance##2##2##(2008-3#2)
on radiation protection##3##3##(1995-1#1)(2010-5#1)(2012-2#1)
on radiation sensitivity##2##3##(1993-4#1)(2008-9#1)
on radiation##9##2##(1993-4#1)(1994-2#1)(1995-1#1)(1996-11#1)(1997-8#1)(2008-7#1)(2008-9#1)(2010-5#1)(2012-2#1)
on radiation-induced##2##2##(1992-9#1)(2008-7#1)
on radio##2##2##(1993-5#1)(2008-10#1)
on radiograms##4##2##(2007-11#2)(2007-8#2)
on radiographic##5##2##(2005-10#1)(2007-11#1)(2008-3#1)(2008-5#1)(2012-12#1)
on radiographs##4##2##(1992-5#1)(2011-2#1)(2013-1#2)
on radiography##3##2##(2006-8#1)(2006-9#1)(2011-1#1)
on radiologic##3##2##(1994-1#1)(1997-6#1)(2012-2#1)
on radiological and##3##3##(1990-11#1)(2009-6#1)(2010-11#1)
on radiological##7##2##(1990-11#1)(2006-10#1)(2007-8#1)(2008-8#1)(2009-6#1)(2010-11#1)(2011-2#1)
on radiologists##3##2##(2007-4#2)(2012-2#1)
on radiology##7##2##(1991-2#1)(1995-1#1)(2007-4#2)(2010-8#1)(2012-2#2)
on radiotherapy##2##2##(1991-9#1)(1994-7#1)
on radish##2##2##(2008-10#1)(2008-12#1)
on raising the free [Mg2+]##2##5##(1990-7#2)
on raising the##3##3##(1990-7#2)(1995-5#1)
on raising##5##2##(1990-7#2)(1995-5#1)(1997-4#1)(2008-12#1)
on random##8##2##(1997-9#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2009-9#1)
on randomized controlled trials (RCTs)##2##5##(2007-7#1)(2010-6#1)
on randomized controlled##3##3##(2006-2#1)(2007-7#1)(2010-6#1)
on randomized##7##2##(2006-10#1)(2006-2#1)(2007-10#1)(2007-7#1)(2008-12#1)(2008-4#1)(2010-6#1)
on range of motion##3##4##(2007-11#1)(2008-8#1)(2009-1#1)
on rapid and##2##3##(1991-2#1)(2008-10#1)
on rapid##6##2##(1991-2#1)(2006-12#1)(2007-7#1)(2008-10#2)(2008-3#1)
on rare variants##3##3##(2012-3#3)
on rare##7##2##(1991-10#1)(2008-10#2)(2012-3#4)
on rare-earth##2##2##(2008-10#1)(2010-7#1)
on rat brain##5##3##(1991-2#1)(1994-12#2)(1995-5#1)(1996-10#1)
on rat hepatic##2##3##(1991-2#1)(1994-11#1)
on rat hippocampal CA1##2##4##(1990-12#1)(1997-5#1)
on rat liver##8##3##(1992-12#1)(1994-8#1)(1994-9#1)(1996-11#1)(2008-10#2)(2011-2#1)(2012-1#1)
on rat pancreatic##2##3##(1993-6#1)(1996-6#1)
on rat prostate testosterone 5α-reductase##2##5##(2012-12#2)
on rat##51##2##(1990-12#2)(1990-2#1)(1990-9#1)(1991-2#3)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#2)(1995-7#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-5#1)(2007-1#1)(2008-10#4)(2008-4#1)(2009-5#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)
on rate constants##2##3##(1991-5#1)(1997-1#1)
on rate##3##2##(1991-5#1)(1997-1#1)(2005-11#1)
on rates of##6##3##(1991-1#1)(1991-6#1)(2008-10#1)(2008-9#1)(2013-1#2)
on rational##6##2##(1992-1#1)(1993-2#1)(2006-7#1)(2008-7#1)(2009-6#1)(2012-2#1)
on rats with##4##3##(2010-12#2)(2012-1#1)(2013-7#1)
on rats##17##2##(1990-2#1)(1993-12#1)(1994-8#1)(1996-6#1)(2008-10#1)(2008-4#1)(2009-11#1)(2010-12#4)(2010-5#1)(2011-1#3)(2012-1#1)(2013-7#1)
on raw data##2##3##(1995-9#1)(2008-8#1)
on raw##3##2##(1995-9#1)(2008-10#1)(2008-8#1)
on reaction kinetics##2##3##(2008-5#1)(2009-12#1)
on reaction temperature##2##3##(2007-10#1)(2013-1#1)
on reaction time##4##3##(1994-2#1)(2009-2#3)
on reaction with##6##3##(2004-12#1)(2008-10#3)(2010-8#1)(2011-1#1)
on reaction##17##2##(1992-3#1)(1994-2#1)(2004-12#1)(2007-10#1)(2008-10#3)(2008-4#1)(2008-5#1)(2009-12#1)(2009-2#4)(2010-8#1)(2011-1#1)(2013-1#1)
on reading##9##2##(2007-9#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2010-12#1)(2010-2#1)(2013-8#1)
on real data##3##3##(2006-10#1)(2009-5#1)(2011-2#1)
on real samples##5##3##(2008-10#5)
on real##24##2##(2006-10#1)(2006-5#1)(2007-8#1)(2008-10#7)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#3)
on real-life##3##2##(2012-1#1)(2013-1#2)
on real-time##6##2##(2008-10#1)(2008-2#3)(2009-2#1)(2011-1#1)
on realistic##2##2##(2007-12#1)(2008-10#1)
on recent advances in the##3##5##(2007-8#1)(2008-7#1)(2009-8#1)
on recent advances in##7##4##(2006-10#2)(2006-9#1)(2007-8#1)(2008-7#1)(2009-8#1)(2012-3#1)
on recent advances##8##3##(2006-10#2)(2006-9#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-8#1)(2012-3#1)
on recent clinical trials##4##4##(2005-8#1)(2008-9#2)(2009-3#1)
on recent clinical##5##3##(2005-8#1)(2008-9#2)(2009-3#1)(2011-1#1)
on recent data##4##3##(2006-2#1)(2007-9#1)(2008-3#1)(2010-3#1)
on recent developments in the##3##5##(1996-3#1)(2006-10#2)
on recent developments##4##3##(1996-3#1)(2006-10#2)(2011-2#1)
on recent evidence##2##3##(2010-12#1)(2012-2#1)
on recent experimental##4##3##(2005-10#1)(2006-10#1)(2006-9#1)(2007-9#1)
on recent findings that##2##4##(2009-12#1)(2009-6#1)
on recent findings##6##3##(1991-3#1)(2008-1#1)(2009-12#1)(2009-6#1)(2011-1#1)(2011-2#1)
on recent insights into the##2##5##(2006-10#1)(2008-1#1)
on recent insights into##3##4##(2006-10#1)(2008-1#1)(2011-2#1)
on recent progress##5##3##(1990-6#1)(2008-1#1)(2009-3#1)(2009-6#1)(2009-7#1)
on recent studies##3##3##(1996-1#1)(2007-10#1)(2013-1#1)
on recent##68##2##(1990-6#1)(1991-3#1)(1993-6#1)(1995-3#1)(1996-1#1)(1996-3#1)(1997-2#1)(2005-10#1)(2005-8#1)(2006-10#7)(2006-2#1)(2006-9#2)(2007-10#1)(2007-2#1)(2007-8#1)(2007-9#2)(2008-1#5)(2008-10#2)(2008-11#3)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#2)(2009-6#2)(2009-7#1)(2009-8#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
on recently dead chestnut wood##2##5##(2008-10#2)
on recently published##2##3##(2006-10#1)(2012-2#1)
on recently##8##2##(2006-10#1)(2007-10#1)(2008-10#2)(2008-5#1)(2010-9#1)(2012-2#2)
on receptor activator of##2##4##(2011-1#1)(2013-1#1)
on receptor##13##2##(1991-12#1)(1993-3#1)(1994-5#1)(1995-2#1)(1996-11#1)(1996-7#1)(1997-5#1)(1997-8#2)(2008-4#1)(2008-5#1)(2011-1#1)(2013-1#1)
on receptor-ligand binding##2##3##(1994-11#1)(2009-2#1)
on receptor-ligand##3##2##(1994-11#1)(1995-11#1)(2009-2#1)
on receptor-stimulated##2##2##(1994-11#1)(1996-5#1)
on recognition memory##2##3##(1997-5#1)(2006-9#1)
on recognition of##2##3##(1992-6#1)(1997-7#1)
on recognition##9##2##(1992-6#1)(1997-5#1)(1997-7#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-6#1)(2009-11#1)(2009-3#1)
on recognized##2##2##(2008-4#1)(2011-2#1)
on recognizing##2##2##(2006-10#1)(2010-12#1)
on recombinant protein expression##2##4##(2008-11#1)(2008-7#1)
on recombinant protein##3##3##(2008-11#2)(2008-7#1)
on recombinant##9##2##(1992-10#1)(1995-11#1)(1995-2#1)(1996-8#1)(2007-11#1)(2008-11#2)(2008-7#1)(2012-2#1)
on recommendation##2##2##(1990-8#1)(2008-8#1)
on recommendations##2##2##(2006-10#1)(2010-8#1)
on reconstituted##2##2##(2006-11#1)(2008-8#1)
on reconstruction##2##2##(2007-12#1)(2008-3#1)
on record##2##2##(2004-11#1)(2011-2#1)
on recording##2##2##(2008-3#2)
on recovery from##6##3##(1990-7#1)(1991-2#1)(1991-6#1)(2010-7#1)(2012-2#1)(2013-8#1)
on recovery of##8##3##(1990-7#2)(1991-2#1)(1992-10#1)(1993-5#1)(2010-10#1)(2010-12#1)(2012-1#1)
on recovery##24##2##(1990-7#3)(1991-2#2)(1991-5#1)(1991-6#1)(1992-10#1)(1993-5#1)(2006-10#1)(2008-10#2)(2008-2#4)(2008-8#1)(2010-10#1)(2010-12#1)(2010-7#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
on recurrent stroke##2##3##(2007-10#2)
on recurrent##6##2##(1993-8#1)(1994-11#1)(2007-10#2)(2008-11#1)(2012-2#1)
on recursive##2##2##(1997-3#1)(2010-12#1)
on red cell##3##3##(1991-5#1)(1993-3#1)(1994-3#1)
on red##10##2##(1991-5#1)(1992-12#1)(1993-3#1)(1994-3#1)(2008-10#3)(2008-5#1)(2008-8#1)(2011-12#1)
on redox##6##2##(1994-8#1)(2008-10#4)(2010-8#1)
on reduced##10##2##(1991-9#1)(1993-11#1)(1996-1#1)(1996-9#1)(1997-2#1)(1997-6#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-2#1)
on reducing both##2##3##(2007-5#1)(2008-3#1)
on reducing the##4##3##(2007-8#1)(2008-1#1)(2008-10#1)(2009-11#1)
on reducing their##3##3##(2008-8#1)(2010-9#1)(2012-3#1)
on reducing##26##2##(1996-7#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-9#1)(2012-1#1)(2012-2#2)(2012-3#3)(2012-6#1)(2013-1#2)(2013-7#2)
on reduction of##5##3##(1992-4#1)(2008-10#1)(2008-3#1)(2009-11#1)(2013-1#1)
on reduction##7##2##(1992-4#1)(2008-10#1)(2008-3#1)(2009-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
on reductive##2##2##(2006-3#1)(2008-10#1)
on reefs##2##2##(2007-5#1)(2011-2#1)
on referral##5##2##(1992-9#1)(2007-4#1)(2007-5#1)(2012-2#1)(2013-1#1)
on referrals##2##2##(1994-1#1)(2012-2#1)
on reflectance data##2##3##(2008-2#2)
on reflectance measurements##3##3##(1992-4#1)(2008-10#1)(2008-3#1)
on reflectance##7##2##(1992-4#1)(2008-10#2)(2008-2#2)(2008-3#2)
on reflection and##2##3##(2008-2#2)
on reflection from the##2##4##(2008-3#2)
on reflection from##6##3##(2007-11#2)(2008-2#2)(2008-3#2)
on reflection of##2##3##(2008-2#2)
on reflection##20##2##(2007-11#4)(2008-11#1)(2008-2#12)(2008-3#3)
on reflex##3##2##(1990-4#1)(1991-1#1)(1991-4#1)
on reflux##2##2##(1992-9#1)(2008-10#1)
on refractive-index##3##2##(2007-12#2)(2008-2#1)
on regional cerebral blood flow##3##5##(1991-9#2)(1992-8#1)
on regional##8##2##(1991-10#1)(1991-9#2)(1992-12#1)(1992-8#1)(2006-10#2)(2013-8#1)
on regions of##2##3##(1995-3#1)(1997-8#1)
on regions##3##2##(1995-3#1)(1997-8#1)(2008-7#1)
on regular follow-up##2##3##(2005-12#1)(2008-3#1)
on regular hemodialysis##5##3##(2007-7#5)
on regular maintenance##2##3##(2007-7#1)(2008-1#1)
on regular##20##2##(1997-3#1)(2005-12#1)(2007-7#8)(2008-1#3)(2008-11#2)(2008-3#1)(2008-8#1)(2011-12#1)(2011-2#1)(2013-1#1)
on regulating##2##2##(1995-1#1)(1997-1#1)
on regulation of##4##3##(1992-11#1)(2008-7#1)(2010-10#1)(2011-12#1)
on regulation##6##2##(1991-12#1)(1992-11#1)(2008-3#1)(2008-7#1)(2010-10#1)(2011-12#1)
on regulatory##3##2##(1995-5#1)(2008-7#1)(2008-8#1)
on rehabilitation outcome##2##3##(2007-11#1)(2007-8#1)
on rehabilitation##7##2##(1995-5#1)(2005-1#1)(2007-11#2)(2007-7#1)(2007-8#1)(2009-8#1)
on related##2##2##(1995-2#1)(2010-10#1)
on relationships##3##2##(2008-11#1)(2010-9#1)(2013-1#1)
on relative abundance##2##3##(2012-6#2)
on relative##11##2##(1994-9#2)(2006-2#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-1#1)(2012-6#2)
on relatively##4##2##(1995-3#1)(2008-10#2)(2008-5#1)
on relaxation##2##2##(1994-8#1)(2008-5#1)
on relearning##2##2##(1992-9#1)(1993-2#1)
on release of##7##3##(1991-8#1)(1995-3#1)(1997-7#1)(2008-11#1)(2008-4#1)(2011-2#2)
on release##11##2##(1991-8#1)(1994-2#1)(1995-3#1)(1997-7#1)(2008-11#1)(2008-4#1)(2010-2#1)(2011-12#1)(2011-2#2)(2013-1#1)
on relevant##11##2##(1992-8#1)(1996-2#1)(1996-3#1)(2006-10#1)(2006-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-8#1)(2010-9#1)(2012-2#1)
on religion and##2##3##(2009-11#1)(2009-7#1)
on religious##2##2##(1997-1#1)(1997-8#1)
on remineralization of##2##3##(2012-2#2)
on remote sensing##2##3##(2008-2#1)(2013-8#1)
on remote##3##2##(2007-7#1)(2008-2#1)(2013-8#1)
on removal of##3##3##(1994-3#1)(2008-3#1)(2011-1#1)
on renal allograft##2##3##(1995-2#2)
on renal biopsy##2##3##(2008-1#1)(2010-4#1)
on renal function and##5##4##(1993-4#1)(2006-10#1)(2007-11#2)(2012-3#1)
on renal function##15##3##(1992-8#1)(1993-4#1)(1995-2#1)(2006-10#2)(2007-11#2)(2007-2#2)(2007-8#1)(2008-1#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-3#1)
on renal gluconeogenesis is##2##4##(1994-8#2)
on renal handling of##2##4##(2006-10#2)
on renal replacement therapy##2##4##(2007-7#1)(2011-2#1)
on renal transplantation##3##3##(2007-12#1)(2008-1#2)
on renal##45##2##(1990-2#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-4#1)(1994-8#2)(1995-2#3)(1997-2#1)(1997-7#1)(2004-11#1)(2005-10#1)(2006-10#4)(2007-11#3)(2007-12#1)(2007-2#4)(2007-7#2)(2007-8#1)(2008-1#7)(2008-12#1)(2010-4#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-3#1)
on repeated##3##2##(1991-9#1)(2006-11#1)(2011-2#1)
on replacement##2##2##(2011-2#2)
on replacing##2##2##(1994-8#1)(2008-7#1)
on replication##2##2##(2008-7#1)(2013-8#1)
on reported##4##2##(1993-9#1)(2007-4#1)(2008-8#1)(2010-11#1)
on reports##2##2##(1992-12#1)(2012-2#1)
on representative##3##2##(2008-10#1)(2008-3#1)(2010-5#1)
on reproducible##2##2##(2006-5#1)(2008-3#1)
on reproduction and development##4##4##(2005-7#2)(2006-12#1)(2010-5#1)
on reproduction##6##2##(2005-7#2)(2006-12#1)(2008-4#1)(2008-8#1)(2010-5#1)
on reproductive health##6##3##(1994-12#1)(2008-1#2)(2008-11#2)(2012-2#1)
on reproductive output##2##3##(2008-8#1)(2011-2#1)
on reproductive performance of##2##4##(2005-7#1)(2010-8#1)
on reproductive performance##3##3##(1996-1#1)(2005-7#1)(2010-8#1)
on reproductive##19##2##(1994-12#1)(1996-1#1)(2005-7#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-8#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#1)
on request##4##2##(1992-11#1)(1996-11#1)(2008-3#1)(2008-7#1)
on research and activities at the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry##3##21##(2007-12#3)
on research and activities at the Centers for Disease Control and Prevention##4##12##(2007-12#4)
on research and##9##3##(1991-9#1)(1995-1#1)(1995-2#1)(2007-12#4)(2007-7#1)(2011-12#1)
on research in##2##3##(2008-3#1)(2010-12#1)
on research with##2##3##(1995-12#1)(2008-4#1)
on research##29##2##(1991-3#1)(1991-9#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1997-4#1)(2005-2#1)(2007-11#2)(2007-12#4)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-12#1)(2013-1#1)
on researchers##3##2##(1991-12#1)(2007-11#1)(2008-6#1)
on residency##2##2##(1994-3#1)(2007-3#1)
on resident##2##2##(2007-4#1)(2007-7#1)
on residential##3##2##(1993-5#1)(2009-6#1)(2013-1#1)
on residents##2##2##(1991-8#1)(2007-7#1)
on residents'##2##2##(2007-5#1)(2008-4#1)
on residual##4##2##(1995-8#1)(2007-11#1)(2009-8#1)(2013-1#1)
on residues##3##2##(2008-10#3)
on resin##3##2##(2008-10#1)(2008-12#1)(2011-1#1)
on resistance of##3##3##(2008-10#1)(2012-3#2)
on resistance to##4##3##(2008-10#3)(2008-8#1)
on resistance##14##2##(2008-10#7)(2008-8#2)(2010-2#1)(2010-4#1)(2012-3#2)(2013-1#1)
on resistant cultivars##2##3##(2008-10#2)
on resistant##11##2##(1993-5#1)(2008-10#7)(2009-3#1)(2010-12#1)(2011-2#1)
on resolution##3##2##(2008-10#2)(2012-3#1)
on resonance##5##2##(2007-12#1)(2008-10#3)(2008-2#1)
on resource allocation##2##3##(2008-11#1)(2008-8#1)
on resource##9##2##(1997-3#1)(2008-11#1)(2008-8#3)(2008-9#1)(2010-8#1)(2013-1#2)
on resources##5##2##(1991-1#1)(1993-7#1)(2006-8#1)(2008-10#1)(2008-12#1)
on respiration and##2##3##(1991-3#1)(2012-2#1)
on respiration##4##2##(1991-3#1)(2008-12#1)(2009-5#1)(2012-2#1)
on respiratory##13##2##(1990-2#1)(1991-6#1)(1994-6#1)(2005-7#1)(2006-8#1)(2008-1#1)(2008-7#1)(2010-12#3)(2010-2#1)(2010-9#1)(2012-1#1)
on responding with conditioned reinforcement##2##5##(1993-6#2)
on response and##3##3##(2004-2#1)(2007-1#1)(2008-7#1)
on response rate##2##3##(1993-6#1)(2012-3#1)
on response to##4##3##(1995-4#1)(1996-9#1)(2010-6#1)(2013-7#1)
on response##16##2##(1990-4#1)(1993-6#1)(1995-4#1)(1996-5#1)(1996-9#1)(2004-2#1)(2006-9#1)(2007-1#1)(2008-10#2)(2008-7#1)(2010-1#1)(2010-12#1)(2010-6#1)(2012-3#1)(2013-7#1)
on responses to##7##3##(1992-12#1)(1993-12#1)(1995-12#1)(1996-3#1)(1997-4#1)(2006-4#1)(2008-2#1)
on responses##10##2##(1992-12#1)(1992-3#1)(1993-12#1)(1995-12#1)(1995-7#2)(1996-3#1)(1997-4#1)(2006-4#1)(2008-2#1)
on resting##6##2##(1993-12#1)(1993-5#1)(1996-5#1)(2008-5#1)(2008-9#1)(2013-8#1)
on restoration of the##2##4##(2008-5#1)(2012-2#1)
on restoration##3##2##(2008-3#1)(2008-5#1)(2012-2#1)
on restricted##2##2##(2008-11#1)(2010-12#1)
on restriction and modification##2##4##(1990-5#2)
on restriction fragment length##2##4##(2008-10#1)(2008-5#1)
on restriction##5##2##(1990-5#2)(1997-6#1)(2008-10#1)(2008-5#1)
on restructuring##3##2##(1992-12#1)(1993-2#1)(1996-12#1)
on results from the##4##4##(1991-6#1)(2006-10#1)(2008-10#1)(2013-8#1)
on results from##7##3##(1991-6#1)(1993-2#1)(2006-10#1)(2007-12#1)(2008-10#1)(2010-10#1)(2013-8#1)
on results obtained##4##3##(2008-10#1)(2009-8#1)(2011-2#2)
on results of##14##3##(1994-2#1)(1997-2#1)(1997-3#1)(2005-12#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-2#2)(2013-1#1)
on results##32##2##(1990-12#1)(1991-6#1)(1993-2#1)(1994-2#1)(1994-6#1)(1996-2#1)(1997-2#1)(1997-3#1)(2005-12#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#5)(2008-2#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-10#2)(2010-8#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#1)
on resuscitation##3##2##(2006-10#2)(2011-2#1)
on retention and selectivity of##2##5##(2008-10#2)
on retention and##5##3##(2005-12#1)(2008-10#2)(2008-5#1)(2012-2#1)
on retention of##3##3##(1993-5#3)
on retention testing##2##3##(1991-2#2)
on retention##21##2##(1990-12#1)(1990-7#1)(1991-2#2)(1992-10#2)(1993-5#3)(1994-5#1)(1996-9#1)(2005-12#1)(2008-10#6)(2008-5#1)(2012-2#1)(2013-8#1)
on retinal##7##2##(1992-3#1)(1994-5#1)(1996-1#1)(2008-3#1)(2013-1#3)
on retrieval and relearning##2##4##(1995-12#2)
on retrievals##3##2##(2008-2#1)(2008-3#2)
on retrieved##3##2##(2008-2#1)(2008-3#2)
on retrograde##2##2##(2008-9#1)(2012-12#1)
on retrospective studies##2##3##(2008-7#1)(2012-3#1)
on retrospective##6##2##(2007-10#1)(2008-10#1)(2008-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
on reverse-phase##2##2##(1995-1#1)(1997-2#1)
on reversed phase##2##3##(1996-9#1)(2010-11#1)
on reversed##3##2##(1994-5#1)(1996-9#1)(2010-11#1)
on reversed-phase##6##2##(1990-5#1)(1991-2#1)(1996-5#2)(1997-8#1)(2008-5#1)
on reversing the##2##3##(2008-11#1)(2008-2#1)
on reversing##3##2##(1993-12#1)(2008-11#1)(2008-2#1)
on review##2##2##(2007-11#1)(2010-4#1)
on revision of##2##3##(2011-12#1)(2013-7#1)
on reward-related brain function##2##4##(2013-8#2)
on reward-related##3##2##(1993-6#1)(2013-8#2)
on rheumatoid arthritis##2##3##(2006-10#1)(2012-12#1)
on rhizosphere colonization##2##3##(2008-10#2)
on rhizosphere##3##2##(2008-10#3)
on rho##2##2##(1992-12#1)(1993-4#1)
on ribonucleotide##2##2##(1994-9#1)(2008-5#1)
on ribosomes##2##2##(1992-3#1)(1995-4#1)
on rice (Oryza##2##3##(1996-12#1)(2008-10#1)
on rice chromosome##3##3##(1996-10#1)(2008-10#1)(2008-8#1)
on rice line##2##3##(2008-10#2)
on rice plants##2##3##(2008-10#1)(2013-8#1)
on rice##18##2##(1996-10#1)(1996-12#1)(2007-8#1)(2008-10#11)(2008-12#1)(2008-8#2)(2013-8#1)
on rich##2##2##(1993-9#1)(2008-9#1)
on right side##2##3##(2011-2#1)(2012-2#1)
on right##8##2##(1995-4#1)(2006-10#2)(2007-7#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)
on rights and##3##3##(2008-11#1)(2009-10#1)(2012-3#1)
on rights##4##2##(2008-11#1)(2009-10#1)(2012-3#2)
on risk factors for##3##4##(2006-2#1)(2011-2#1)(2012-12#1)
on risk factors of##2##4##(2009-10#1)(2011-12#1)
on risk factors##11##3##(1993-12#1)(1996-3#1)(1997-1#1)(2006-10#1)(2006-2#1)(2009-10#2)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
on risk for##2##3##(1993-12#1)(1996-1#1)
on risk of cancer##2##4##(1994-2#1)(2008-11#1)
on risk of##4##3##(1994-2#1)(1997-8#1)(2007-9#1)(2008-11#1)
on risk##30##2##(1992-3#1)(1992-5#1)(1993-12#2)(1994-2#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-6#1)(1997-8#2)(2006-10#1)(2006-2#1)(2007-4#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#3)(2009-4#1)(2009-5#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
on risks##2##2##(2007-2#1)(2008-7#1)
on risky decision-making##2##3##(2009-3#1)(2010-2#1)
on risky##4##2##(2007-12#1)(2009-3#1)(2009-4#1)(2010-2#1)
on river##2##2##(2006-10#1)(2008-5#1)
on robot##2##2##(2012-1#1)(2012-2#1)
on robotic##2##2##(2007-7#1)(2008-11#1)
on rodent##3##2##(1995-1#1)(2008-4#2)
on rodents##2##2##(1991-2#1)(2012-2#1)
on room air and##2##4##(2007-12#1)(2010-7#1)
on room air##5##3##(2007-12#1)(2007-3#1)(2007-8#1)(2010-7#2)
on root##6##2##(2008-10#3)(2008-12#1)(2010-5#1)(2013-7#1)
on roots in##2##3##(2008-10#1)(2009-8#1)
on roots of wheat grown in##2##6##(2008-10#2)
on roots of wheat##4##4##(2008-10#4)
on roots of##7##3##(2008-10#7)
on roots##14##2##(2008-10#12)(2009-8#2)
on rough lemon##2##3##(2008-10#2)
on rough##5##2##(2005-11#1)(2008-10#2)(2008-2#2)
on routine chest##2##3##(2008-4#1)(2008-7#1)
on routine##13##2##(1993-8#1)(1995-2#1)(2006-7#1)(2008-1#1)(2008-4#3)(2008-7#2)(2010-8#1)(2011-12#1)(2011-2#1)(2013-1#1)
on row distances##2##3##(2008-12#2)
on row##3##2##(2008-12#3)
on rural roads##4##3##(2013-1#4)
on rural##10##2##(1990-12#1)(1991-1#1)(1994-2#1)(2009-7#1)(2011-1#1)(2013-1#5)
on rye##3##2##(2008-10#3)
on sGC##2##2##(1997-2#1)(2007-9#1)
on safe##6##2##(1996-6#1)(1997-6#1)(2008-1#1)(2008-12#1)(2013-1#2)
on safer##2##2##(1996-12#1)(2004-8#1)
on safety and##3##3##(2007-10#1)(2010-8#1)(2011-12#1)
on safety##11##2##(1993-3#1)(1994-5#1)(2006-6#1)(2007-10#1)(2008-11#3)(2010-12#1)(2010-6#1)(2010-8#1)(2011-12#1)
on sale##2##2##(2006-2#1)(2012-12#1)
on saline##2##2##(1994-2#1)(2012-11#1)
on saliva##2##2##(2009-4#2)
on salivary gland##2##3##(2008-7#1)(2010-7#1)
on salivary##5##2##(2007-11#1)(2008-7#1)(2010-7#1)(2012-12#1)(2013-1#1)
on salt##3##2##(1991-5#1)(1996-5#1)(2007-11#1)
on sample collection##2##3##(2010-11#1)(2013-1#1)
on sample preparation##2##3##(2008-10#1)(2009-4#1)
on sample size##4##3##(1993-1#1)(1994-6#1)(2009-9#1)(2010-2#1)
on sample##12##2##(1993-1#1)(1994-6#1)(2008-10#4)(2008-9#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-2#1)(2013-1#1)
on samples of##6##3##(2007-11#1)(2007-3#1)(2008-10#1)(2008-2#2)(2012-12#1)
on samples##18##2##(1995-8#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-5#1)(2009-4#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
on sampling##5##2##(2004-11#1)(2008-10#2)(2008-2#1)(2012-3#1)
on sand##3##2##(2007-5#1)(2011-2#1)(2013-1#1)
on saphenous vein##3##3##(1996-2#2)(2007-8#1)
on sapphire##2##2##(2007-12#1)(2008-2#1)
on sarcoidosis##2##2##(2007-10#1)(2008-7#1)
on satellite##2##2##(1993-3#1)(2008-3#1)
on scanning##5##2##(2007-12#1)(2008-10#1)(2008-2#2)(2009-2#1)
on scar##3##2##(2007-11#2)(2008-9#1)
on scats of##2##3##(2008-5#2)
on scattering##2##2##(2008-2#2)
on schedule##3##2##(1997-2#1)(2008-7#1)(2010-8#1)
on schizophrenia##3##2##(1997-5#1)(2006-9#1)(2012-1#1)
on schizophrenic##2##2##(1995-4#1)(2009-9#1)
on school outcomes##2##3##(2009-7#1)(2012-2#1)
on school##5##2##(2007-3#1)(2009-7#1)(2012-2#2)(2013-8#1)
on sciatic##2##2##(1993-11#1)(2008-8#1)
on science##8##2##(2005-10#1)(2007-8#1)(2007-9#1)(2008-8#1)(2011-1#1)(2013-1#3)
on scientific evidence##4##3##(1993-9#1)(2005-10#1)(2008-3#1)(2008-7#1)
on scientific##11##2##(1992-6#1)(1993-9#1)(1994-2#1)(1994-6#1)(2005-10#1)(2006-2#1)(2007-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-12#1)
on sclerotia viability and##2##4##(2008-10#2)
on scoring##2##2##(2008-11#1)(2011-12#1)
on screen-printed carbon##2##3##(2008-10#2)
on screening and##2##3##(2007-4#1)(2008-10#1)
on screening##8##2##(1993-3#1)(2004-2#2)(2007-4#2)(2008-10#1)(2009-11#1)(2011-2#1)
on sea bream Sparus aurata##2##5##(2008-7#1)(2009-4#1)
on sea##3##2##(2008-7#1)(2009-4#1)(2010-8#1)
on search##2##2##(2008-9#1)(2012-3#1)
on second##11##2##(1994-10#1)(2005-11#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-4#1)(2010-10#1)(2011-12#1)
on second-order##4##2##(2007-12#1)(2008-2#3)
on secondary structure##2##3##(1993-6#1)(1995-4#1)
on secondary##10##2##(1991-3#1)(1993-6#1)(1994-2#1)(1995-4#1)(2006-10#2)(2007-11#1)(2008-4#1)(2008-5#1)(2010-1#1)
on secretion##3##2##(1991-4#1)(1993-12#1)(1995-2#1)
on sections from##3##3##(1990-12#1)(1992-6#1)(2008-7#1)
on sections of##3##3##(1990-7#1)(1996-5#1)(1997-7#1)
on sections##6##2##(1990-12#1)(1990-7#1)(1992-6#1)(1996-5#1)(1997-7#1)(2008-7#1)
on seed germination##4##3##(2008-12#2)(2008-7#1)(2008-8#1)
on seed##11##2##(2006-12#2)(2006-9#1)(2008-10#1)(2008-12#3)(2008-5#1)(2008-7#1)(2008-8#2)
on seedling##5##2##(2008-10#4)(2008-5#1)
on seedlings of##3##3##(2008-10#2)(2008-8#1)
on seedlings##6##2##(2008-10#5)(2008-8#1)
on seeds##2##2##(2008-5#1)(2011-1#1)
on seemingly##2##2##(2006-4#1)(2012-2#1)
on segmentation##2##2##(1995-5#1)(2006-5#1)
on segments of##2##3##(2008-10#2)
on seizure threshold in rats##2##5##(2008-4#2)
on seizure##5##2##(1997-3#3)(2008-4#2)
on selected surfaces##2##3##(2013-1#2)
on selected tissues of##2##4##(2008-7#2)
on selected##30##2##(1990-10#1)(1991-12#1)(1991-9#1)(1997-8#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-7#4)(2008-8#1)(2009-10#1)(2010-10#1)(2011-2#2)(2013-1#2)
on selection of the##4##4##(2008-10#1)(2008-2#1)(2008-9#1)(2012-3#1)
on selection of##6##3##(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2012-3#1)
on selection##8##2##(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#1)(2012-2#1)(2012-3#1)
on selective media##3##3##(2008-10#3)
on selective##11##2##(2006-8#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-4#1)
on selectivity of##2##3##(1995-3#1)(2008-10#1)
on selectivity##5##2##(1995-3#1)(2008-10#4)
on selenium (Se)##2##3##(2011-1#1)(2011-2#1)
on selenium##4##2##(2009-10#1)(2011-1#1)(2011-2#2)
on self##2##2##(1990-8#1)(2008-11#1)
on self-assembled monolayers##3##3##(2006-12#1)(2008-10#2)
on self-assembled##8##2##(2006-12#1)(2008-10#6)(2010-4#1)
on self-concept##2##2##(2007-2#1)(2009-7#1)
on self-determination theory##2##3##(2010-2#2)
on self-evaluation##2##2##(2006-6#1)(2007-12#1)
on self-perception##2##2##(2006-6#1)(2011-2#1)
on self-referral##2##2##(2007-4#2)
on self-report of##2##3##(2009-7#1)(2011-1#1)
on self-report##6##2##(2008-12#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-1#1)(2013-1#1)
on self-reported physical activity##2##4##(2008-4#1)(2010-2#1)
on self-reported##13##2##(1991-6#1)(1991-9#1)(1994-2#1)(2006-7#1)(2007-7#1)(2008-4#1)(2009-11#1)(2009-5#1)(2010-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
on self-reports##2##2##(2010-2#1)(2011-2#1)
on semen##2##2##(2005-7#1)(2010-12#1)
on semi-structured interviews##2##3##(2008-1#1)(2009-10#1)
on semiconductors##2##2##(2008-3#1)(2012-2#1)
on seminal and adventitious##2##4##(2008-10#2)
on semithin##2##2##(1992-12#1)(1993-11#1)
on sensing##4##2##(2007-12#1)(2008-10#2)(2008-11#1)
on sensitive##4##2##(1991-2#1)(2006-10#1)(2008-10#2)
on sensitivity and##2##3##(1997-8#1)(2008-10#1)
on sensitivity to##2##3##(1997-7#1)(2008-2#1)
on sensitivity##10##2##(1991-3#1)(1997-7#1)(1997-8#1)(2008-10#4)(2008-2#2)(2009-5#1)
on sensitization to##2##3##(1991-11#1)(2007-11#1)
on sensitization##4##2##(1991-11#1)(1991-5#1)(1996-12#1)(2007-11#1)
on sensitizing potency##2##3##(2008-5#2)
on sensitizing##3##2##(2008-5#3)
on sensor##3##2##(2008-10#3)
on sensors##2##2##(2007-8#1)(2008-10#1)
on sensory and##2##3##(1995-5#1)(2007-12#1)
on sensory neurons##3##3##(1996-3#2)(2007-11#1)
on sensory##16##2##(1991-1#1)(1992-4#1)(1995-5#1)(1996-3#2)(1997-8#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-5#1)(2010-4#1)(2011-2#1)(2012-2#1)
on separate chromosomes##2##3##(2006-10#1)(2008-4#1)
on separate days##3##3##(1996-3#1)(2007-1#1)(2013-1#1)
on separate occasions##2##3##(2006-8#2)
on separate##14##2##(1996-3#1)(2006-10#1)(2006-8#2)(2007-1#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
on separation##9##2##(1990-4#1)(2008-10#8)
on separations of##2##3##(1994-9#2)
on sequence comparisons##2##3##(1990-12#1)(2008-10#1)
on sequence information##2##3##(2008-7#1)(2011-2#1)
on sequence variation in##2##4##(2008-6#1)(2013-8#1)
on sequence##21##2##(1990-12#1)(1990-5#1)(1994-6#1)(1994-8#1)(1995-6#1)(1996-10#1)(1996-7#1)(1997-8#1)(2008-10#6)(2008-6#1)(2008-7#1)(2010-2#1)(2011-2#1)(2013-1#2)(2013-8#1)
on sequences immediately##2##3##(1991-6#1)(1993-2#1)
on sequences##9##2##(1991-6#1)(1992-4#1)(1993-2#1)(2006-12#1)(2007-11#1)(2008-10#3)(2011-2#1)
on sequencing##2##2##(1991-7#1)(1996-6#1)
on sequential##11##2##(2007-12#1)(2007-2#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-2#1)(2010-7#1)
on sera##3##2##(2007-8#1)(2008-4#1)(2008-5#1)
on serial##12##2##(1990-12#1)(1990-6#1)(1991-9#1)(1992-1#1)(1996-6#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-11#1)(2008-2#1)(2013-8#1)
on serine and##2##3##(1991-2#1)(2008-4#1)
on serine residues##4##3##(1991-1#1)(1991-5#1)(1993-8#1)(1996-8#1)
on serine##11##2##(1991-1#1)(1991-2#1)(1991-5#1)(1993-11#1)(1993-6#1)(1993-8#1)(1996-8#1)(2006-8#1)(2008-4#1)(2008-7#1)(2008-8#1)
on serotonin##6##2##(1996-4#1)(1996-5#2)(1997-5#1)(2010-6#1)(2013-8#1)
on serum adiponectin levels in children with vitamin##2##8##(2011-1#2)
on serum cholesterol and##2##4##(1993-12#1)(2007-11#1)
on serum cholesterol##3##3##(1993-12#2)(2007-11#1)
on serum concentrations of##2##4##(1995-2#1)(1996-11#1)
on serum cytokine##3##3##(2007-8#2)(2010-12#1)
on serum levels of##2##4##(2007-2#1)(2010-11#1)
on serum lipid concentrations in##2##5##(2007-8#1)(2008-3#1)
on serum lipid##3##3##(2007-8#1)(2008-10#1)(2008-3#1)
on serum lipids and##3##4##(1992-4#1)(2004-11#1)(2013-1#1)
on serum lipids##4##3##(1992-4#2)(2004-11#1)(2013-1#1)
on serum lipoproteins##2##3##(1992-4#1)(2010-12#1)
on serum total##4##3##(1997-1#1)(2007-8#1)(2008-12#2)
on serum##59##2##(1992-11#1)(1992-4#3)(1992-9#1)(1993-12#2)(1995-2#1)(1995-3#1)(1996-11#3)(1996-9#2)(1997-1#1)(1997-2#1)(1997-8#1)(2004-1#1)(2004-11#1)(2005-10#1)(2006-12#1)(2007-11#1)(2007-2#2)(2007-7#2)(2007-8#5)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#3)(2013-8#1)
on serum-induced mitogenesis in##2##4##(1990-8#1)(1991-9#1)
on service delivery##3##3##(1993-1#1)(1995-3#1)(2008-4#1)
on service quality##2##3##(1994-2#1)(1995-3#1)
on service##9##2##(1991-3#1)(1993-1#1)(1994-2#1)(1995-3#2)(2008-4#1)(2008-8#1)(2010-2#1)(2012-11#1)
on services##2##2##(2005-10#1)(2008-11#1)
on seven##18##2##(1990-12#1)(1994-4#1)(1995-3#1)(1996-11#1)(1996-3#1)(2005-11#1)(2008-10#4)(2008-12#2)(2008-9#2)(2010-10#1)(2013-1#2)(2013-7#1)
on several aspects of##3##4##(1994-3#1)(1997-1#1)(2008-11#1)
on several autosomal##3##3##(1996-5#2)(2012-12#1)
on several components##2##3##(2008-10#1)(2010-6#1)
on several different##3##3##(1996-3#2)(2008-10#1)
on several factors##6##3##(1994-11#1)(1997-5#1)(2006-2#1)(2006-6#1)(2008-5#1)(2009-11#1)
on several important##2##3##(2008-7#1)(2010-7#1)
on several key##2##3##(2008-8#1)(2012-12#1)
on several levels##2##3##(2006-8#1)(2008-10#1)
on several occasions##3##3##(1995-5#1)(2007-2#1)(2010-8#1)
on several other##3##3##(2006-10#1)(2008-10#1)(2008-4#1)
on several tumor##2##3##(1990-11#1)(2009-3#1)
on several types of##2##4##(2008-10#1)(2010-1#1)
on several##89##2##(1990-11#1)(1990-5#1)(1991-12#1)(1991-8#1)(1992-10#1)(1992-5#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-3#1)(1995-10#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-3#2)(1996-5#2)(1997-1#2)(1997-5#1)(2004-10#1)(2006-10#4)(2006-2#1)(2006-6#2)(2006-8#1)(2007-12#2)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#12)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#2)(2009-3#1)(2010-1#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#3)(2013-1#1)
on severe##3##2##(2008-10#1)(2010-12#1)(2010-2#1)
on severity and##3##3##(2007-7#1)(2007-8#1)(2008-10#1)
on severity of the##2##4##(2011-1#1)(2012-12#1)
on severity of##8##3##(1996-1#1)(1996-7#1)(2006-8#1)(2007-7#1)(2008-10#1)(2009-5#1)(2011-1#1)(2012-12#1)
on severity##15##2##(1996-1#1)(1996-7#1)(2006-8#1)(2007-7#2)(2007-8#1)(2008-10#3)(2009-5#1)(2011-1#2)(2011-3#1)(2012-12#1)(2013-1#1)
on sex differences in##3##4##(2008-8#2)(2008-9#1)
on sex differences##4##3##(2008-8#2)(2008-9#1)(2009-1#1)
on sex##12##2##(1991-12#1)(1994-6#2)(1996-10#1)(2006-8#1)(2008-8#2)(2008-9#1)(2009-1#1)(2010-8#1)(2012-3#2)
on sexual and reproductive##2##4##(2009-5#1)(2011-2#1)
on sexual behavior##3##3##(1991-2#1)(2009-8#1)(2012-1#1)
on sexual behaviour##4##3##(1996-6#1)(1997-2#1)(2008-11#1)(2011-1#1)
on sexual differentiation of##2##4##(1991-3#1)(2008-5#1)
on sexual differentiation##3##3##(1991-3#1)(2008-5#2)
on sexual function##2##3##(2009-5#2)
on sexual health##2##3##(1994-4#1)(2011-2#1)
on sexual orientation and##2##4##(1996-5#1)(2008-12#1)
on sexual selection on##2##4##(2008-8#1)(2010-2#1)
on sexual selection##4##3##(2008-8#2)(2010-2#1)(2010-8#1)
on sexual##28##2##(1991-2#1)(1991-3#1)(1992-10#1)(1994-4#1)(1996-5#1)(1996-6#1)(1997-2#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#2)(2009-5#4)(2009-7#1)(2009-8#1)(2010-2#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)
on sexuality##3##2##(1992-10#1)(2013-8#2)
on shape##3##2##(2006-6#1)(2008-6#2)
on shapes##2##2##(1997-8#1)(2009-6#1)
on shared##3##2##(2008-10#1)(2013-1#2)
on shear bond strength##2##4##(2008-12#1)(2013-8#1)
on shear##3##2##(1994-11#1)(2008-12#1)(2013-8#1)
on sheep##2##2##(2006-7#1)(2006-8#1)
on shifting##2##2##(2007-11#1)(2012-2#1)
on ships##2##2##(2008-10#1)(2008-11#1)
on shock##2##2##(2006-9#1)(2009-11#1)
on shoots##2##2##(2008-10#2)
on short length scales##2##4##(2008-7#2)
on short term##2##3##(2009-9#1)(2010-4#1)
on short##10##2##(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#3)(2009-9#1)(2010-4#1)
on short-term##8##2##(1996-2#1)(2005-10#1)(2006-11#2)(2008-1#1)(2008-6#1)(2008-8#1)(2013-1#1)
on shoulder injuries in soccer players##2##6##(2013-1#2)
on shoulder injuries in soccer##3##5##(2013-1#3)
on shoulder##5##2##(1995-3#1)(2013-1#4)
on sialylation of##2##3##(2008-7#2)
on sick leave##3##3##(1990-4#2)(1994-4#1)
on side effects of drugs]##2##5##(1991-6#1)(1993-2#1)
on side effects##6##3##(1991-6#1)(1993-2#2)(1993-3#1)(2005-11#1)(2006-4#1)
on side##9##2##(1991-6#1)(1993-12#1)(1993-2#2)(1993-3#1)(2005-11#1)(2006-4#1)(2007-4#1)(2011-1#1)
on signal transduction in##2##4##(1994-10#1)(1994-12#1)
on signal transduction pathways##3##4##(1996-8#1)(1997-6#1)(2008-7#1)
on signal transduction##9##3##(1994-10#1)(1994-12#1)(1996-8#1)(1997-6#1)(2008-7#3)(2009-8#1)(2010-11#1)
on signal##20##2##(1992-11#1)(1994-10#1)(1994-12#1)(1996-8#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-7#3)(2008-8#1)(2009-8#1)(2010-11#1)(2010-9#2)(2011-2#1)(2013-7#1)
on signaling##2##2##(2008-10#1)(2009-3#1)
on signals of##4##3##(2008-10#1)(2008-8#3)
on signals##5##2##(1993-4#1)(2008-10#1)(2008-8#3)
on significance##2##2##(2008-10#1)(2010-12#1)
on significant##11##2##(1990-8#1)(1991-8#1)(1996-10#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
on signs and symptoms##4##4##(2006-3#1)(2007-10#1)(2008-10#1)(2010-1#1)
on signs##5##2##(2006-3#1)(2007-10#1)(2008-10#1)(2010-1#1)(2010-8#1)
on silencing##2##2##(2010-1#1)(2011-1#1)
on silica gel and##5##4##(1992-2#1)(2007-11#1)(2008-10#2)(2013-8#1)
on silica gel##27##3##(1990-9#1)(1992-2#1)(2007-11#4)(2008-10#17)(2008-11#1)(2008-5#1)(2010-4#1)(2013-8#1)
on silica is##2##3##(2008-10#2)
on silica surface were##2##4##(2008-10#2)
on silica surface##3##3##(2008-10#3)
on silica##60##2##(1990-6#1)(1990-9#1)(1992-2#1)(1996-5#1)(2005-11#5)(2005-12#2)(2007-11#7)(2008-10#31)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2010-4#2)(2013-8#1)
on silicon oxide##3##3##(2006-12#2)(2008-10#1)
on silicon surfaces##2##3##(2008-7#2)
on silicon wafers##5##3##(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-3#1)
on silicon##31##2##(2006-12#3)(2007-11#1)(2007-12#4)(2007-2#2)(2007-8#2)(2007-9#2)(2008-10#5)(2008-2#4)(2008-3#3)(2008-5#1)(2008-7#3)(2009-10#1)
on silicone##4##2##(2004-9#3)(2008-9#1)
on silk fibroin##2##3##(2008-11#2)
on silver wire modified by atom transfer radical##2##8##(2013-8#2)
on silver##10##2##(2008-10#2)(2008-3#1)(2008-8#1)(2010-5#1)(2011-12#1)(2013-1#1)(2013-8#3)
on silver-coated carbon nanotubes##2##4##(2010-7#2)
on similar##9##2##(1994-12#1)(1996-4#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-9#2)(2009-7#1)(2010-5#1)
on similarities in##2##3##(1997-7#1)(2008-1#1)
on similarities##5##2##(1996-10#1)(1997-7#1)(1997-8#1)(2006-12#1)(2008-1#1)
on simple and##3##3##(2008-6#1)(2010-2#1)(2012-1#1)
on simple statistical##2##3##(2008-2#2)
on simple##18##2##(1990-9#1)(1995-12#1)(1996-4#1)(2005-11#1)(2008-10#3)(2008-2#2)(2008-6#1)(2008-8#2)(2009-11#1)(2010-10#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-12#1)
on simulated data##4##3##(1991-12#1)(1993-9#1)(2008-2#1)(2010-2#1)
on simulated##13##2##(1991-12#1)(1993-9#1)(2006-6#1)(2008-2#2)(2008-3#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-3#1)
on simulation##3##2##(2010-12#1)(2010-2#1)(2010-8#1)
on simultaneous##10##2##(1997-7#1)(2007-12#3)(2008-10#3)(2008-2#1)(2008-6#1)(2012-1#1)
on single##17##2##(1990-8#2)(1993-3#1)(1995-12#2)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-12#2)(2009-3#1)(2012-2#1)
on sister chromatid exchanges##2##4##(2008-11#2)
on sister##4##2##(1995-6#1)(1997-6#1)(2008-11#2)
on site A##3##3##(1996-2#3)
on site B##2##3##(1996-2#2)
on site in##2##3##(1993-8#1)(2008-10#1)
on site##17##2##(1993-8#1)(1996-2#5)(2004-4#1)(2006-12#2)(2008-10#5)(2008-11#2)(2013-8#1)
on site-specific recombination##2##3##(1997-2#1)(2008-2#1)
on site-specific##3##2##(1993-6#1)(1997-2#1)(2008-2#1)
on six key##2##3##(1993-12#1)(2007-10#1)
on six patients##2##3##(2010-9#1)(2011-2#1)
on six##16##2##(1993-12#1)(1994-12#1)(1997-1#1)(1997-3#1)(2005-11#1)(2007-10#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-12#1)(2009-2#1)(2009-4#1)(2010-9#1)(2011-2#1)
on size and##5##3##(2007-1#1)(2007-5#1)(2008-3#1)(2010-8#1)(2012-12#1)
on size of##2##3##(2007-12#1)(2008-11#1)
on size##17##2##(1996-8#1)(2007-1#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#1)(2008-8#1)(2010-8#1)(2012-11#1)(2012-12#3)(2012-2#1)
on size-exclusion chromatography##2##3##(1992-9#2)
on skeletal muscle##6##3##(1993-11#1)(2008-5#2)(2010-10#1)(2011-12#1)(2013-1#1)
on skeletal##8##2##(1992-12#1)(1993-11#1)(2008-5#2)(2010-10#1)(2011-12#1)(2013-1#2)
on skilled##2##2##(2005-9#1)(2011-1#1)
on skin and##2##3##(2008-9#1)(2009-2#1)
on skin barrier##2##3##(2008-5#2)
on skin biopsies##2##3##(2008-3#1)(2010-5#1)
on skin carcinogenesis##2##3##(1993-9#2)
on skin penetration##2##3##(2008-3#1)(2013-1#1)
on skin physiology##4##3##(2008-5#3)(2009-8#1)
on skin##47##2##(1992-8#1)(1993-12#1)(1993-9#2)(1996-11#1)(1997-3#3)(2005-8#1)(2006-10#1)(2006-12#1)(2008-3#2)(2008-5#21)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-7#1)
on sky##2##2##(2007-12#1)(2008-3#1)
on sleep and##3##3##(1990-11#1)(1996-1#1)(2006-1#1)
on sleep##17##2##(1990-11#1)(1990-5#1)(1991-1#1)(1995-12#1)(1996-1#2)(1997-3#1)(2006-1#1)(2006-10#1)(2007-6#1)(2010-7#1)(2010-8#1)(2012-12#3)(2012-2#1)(2013-7#1)
on slides##2##2##(1990-12#1)(2008-1#1)
on slowing##2##2##(2008-12#1)(2012-12#1)
on small molecule##2##3##(2008-4#1)(2011-2#1)
on small##32##2##(1990-11#1)(1991-9#1)(1992-8#1)(1993-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(2006-12#2)(2006-2#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#3)(2011-2#1)(2013-1#1)
on smaller##2##2##(2009-3#1)(2011-1#1)
on smoking cessation##4##3##(1994-2#1)(2009-7#1)(2012-1#2)
on smoking for##2##3##(1995-6#2)
on smoking in##2##3##(1991-5#1)(2012-1#1)
on smoking prevention##2##3##(1996-3#2)
on smoking##20##2##(1991-12#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-6#1)(1994-2#1)(1995-6#3)(1996-3#3)(2008-10#2)(2008-8#1)(2009-7#1)(2012-1#4)
on smooth and##2##3##(2006-4#1)(2007-12#1)
on smooth muscle cells##3##4##(1991-2#1)(1995-3#1)(2010-12#1)
on smooth muscle##7##3##(1991-2#1)(1991-5#1)(1991-8#1)(1995-1#1)(1995-3#1)(2009-5#1)(2010-12#1)
on smooth##10##2##(1991-2#1)(1991-5#1)(1991-8#1)(1995-1#1)(1995-3#1)(2006-4#1)(2007-12#1)(2009-5#1)(2010-12#1)(2012-1#1)
on social and economic##2##4##(2006-10#1)(2008-11#1)
on social and##5##3##(1994-6#1)(1995-8#1)(2006-10#1)(2008-11#1)(2008-12#1)
on social influences##2##3##(2008-8#1)(2012-12#1)
on social support and##2##4##(1992-3#1)(2010-3#1)
on social support in##2##4##(1992-3#2)
on social support##5##3##(1992-3#3)(2006-4#1)(2010-3#1)
on social##35##2##(1992-3#3)(1993-2#1)(1994-6#2)(1995-5#1)(1995-8#1)(1996-11#1)(1997-3#1)(2006-10#1)(2006-4#2)(2007-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-4#1)(2010-3#1)(2010-9#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
on society##4##2##(2005-11#1)(2007-10#1)(2008-1#1)(2012-2#1)
on socio-demographic##3##2##(2008-10#1)(2009-7#1)(2013-1#1)
on socio-economic##4##2##(2010-4#1)(2011-2#2)(2012-2#1)
on soda-lime glass##2##3##(2010-1#2)
on soda-lime##4##2##(2008-2#2)(2010-1#2)
on sodium and glucose##2##4##(1994-6#2)
on sodium and##3##3##(1994-6#2)(2005-8#1)
on sodium dodecyl sulfate-polyacrylamide gel electrophoresis##5##6##(1990-10#1)(1990-11#1)(1990-6#1)(1992-12#1)(2006-3#1)
on sodium dodecyl sulfate-polyacrylamide##6##4##(1990-10#1)(1990-11#1)(1990-6#1)(1991-4#1)(1992-12#1)(2006-3#1)
on sodium dodecylsulfate-polyacrylamide gel electrophoresis##2##5##(1993-9#2)
on sodium transport##2##3##(1992-2#1)(1992-6#1)
on sodium##19##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-6#1)(1991-4#1)(1992-12#1)(1992-2#2)(1992-6#1)(1993-9#2)(1994-6#2)(1995-3#1)(1997-4#2)(2005-8#1)(2006-3#1)(2008-4#1)
on soft agar##2##3##(2008-8#2)
on soft substrates for use as##2##6##(2009-11#2)
on soft substrates##3##3##(2009-11#3)
on soft##14##2##(1991-11#1)(1994-5#1)(2004-9#1)(2006-6#1)(2008-10#2)(2008-5#1)(2008-8#2)(2009-11#3)(2009-7#1)(2012-2#1)
on soil chemical properties and##2##5##(2008-10#1)(2013-8#1)
on soil microbial##2##3##(2008-10#2)
on soil pH##2##3##(2008-12#1)(2012-6#1)
on soil texture##2##3##(2008-10#2)
on soil##26##2##(2008-10#12)(2008-12#2)(2008-4#1)(2008-6#1)(2008-9#2)(2010-5#1)(2010-8#1)(2011-12#1)(2012-6#1)(2012-9#1)(2013-8#3)
on soils##2##2##(2009-8#1)(2012-2#1)
on solar elevation##2##3##(2008-2#1)(2008-3#1)
on solar##3##2##(2008-2#2)(2008-3#1)
on solid media##8##3##(1994-6#1)(1997-4#1)(2008-2#1)(2008-9#1)(2010-12#1)(2011-12#2)(2013-7#1)
on solid medium##2##3##(1994-6#1)(2009-6#1)
on solid phase##8##3##(1997-4#1)(2008-10#6)(2008-4#1)
on solid phases##2##3##(1994-6#1)(1994-9#1)
on solid samples##2##3##(2008-10#2)
on solid sorbents##2##3##(2008-10#2)
on solid state##2##3##(1997-2#1)(2008-5#1)
on solid substrates##2##3##(2008-10#1)(2009-6#1)
on solid supports##3##3##(1997-3#1)(2008-10#2)
on solid surfaces##2##3##(2008-4#1)(2009-11#1)
on solid##45##2##(1992-11#1)(1993-8#1)(1994-6#3)(1994-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(2005-10#1)(2006-11#1)(2007-1#1)(2007-11#1)(2008-10#14)(2008-2#2)(2008-4#2)(2008-5#1)(2008-9#2)(2009-11#1)(2009-6#2)(2010-12#1)(2011-1#1)(2011-12#3)(2011-2#1)(2013-7#1)
on solid-phase extraction##6##3##(2008-10#6)
on solid-phase##12##2##(1992-6#1)(2008-10#9)(2008-2#2)
on solid-state##2##2##(2007-8#1)(2008-10#1)
on solution##7##2##(1995-10#1)(2005-11#1)(2008-10#4)(2008-9#1)
on solutions containing##3##3##(2008-10#3)
on solutions##4##2##(1994-3#1)(2008-10#3)
on solvation##2##2##(2008-10#1)(2011-1#1)
on solvent##3##2##(1990-3#1)(2006-10#1)(2008-10#1)
on somatic##8##2##(1992-12#1)(1992-2#1)(1993-9#1)(1997-2#1)(2007-4#2)(2008-12#1)(2010-5#1)
on some agro-physiological traits of##2##5##(2008-12#2)
on some aspects of the##2##5##(2006-10#1)(2012-12#1)
on some aspects of##7##4##(2006-10#2)(2008-12#1)(2009-10#2)(2011-1#1)(2012-12#1)
on some aspects##8##3##(1996-5#1)(2006-10#2)(2008-12#1)(2009-10#2)(2011-1#1)(2012-12#1)
on some basic##3##3##(1991-12#1)(2008-4#1)(2008-8#1)
on some biochemical parameters##5##4##(2007-1#2)(2008-12#1)(2008-4#1)(2008-7#1)
on some biochemical##7##3##(2007-1#2)(2008-12#2)(2008-4#1)(2008-7#2)
on some of the##14##4##(1992-12#1)(1993-12#1)(1993-6#1)(1994-2#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-12#1)(2008-7#2)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
on some parameters of neurobehaviour of Wistar rats##2##8##(2009-5#2)
on some physiological and##2##4##(2008-7#1)(2012-2#1)
on some physiological##3##3##(2008-12#1)(2008-7#1)(2012-2#1)
on some properties of##2##4##(1991-5#1)(1997-7#1)
on some recent##2##3##(1997-3#1)(2011-2#1)
on some trials##2##3##(2011-2#1)(2012-1#1)
on some##106##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-10#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-8#2)(2006-10#3)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#9)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#3)(2009-10#2)(2009-12#1)(2009-4#1)(2009-5#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2011-1#3)(2011-11#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#3)(2013-8#2)
on someone##2##2##(1995-9#1)(2009-6#1)
on sonographic and##2##3##(1990-8#1)(2007-7#1)
on sonography##2##2##(2007-3#1)(2008-10#1)
on sorghum##2##2##(2008-10#2)
on sorption##2##2##(2008-10#2)
on source plants##4##3##(2008-10#4)
on source##7##2##(2008-10#4)(2008-4#1)(2013-8#2)
on sources##2##2##(2009-10#1)(2010-5#1)
on soybean##19##2##(2008-10#17)(2008-8#1)(2012-11#1)
on space##5##2##(2007-9#1)(2008-2#1)(2008-8#3)
on spasticity and volitional control##2##5##(2012-1#2)
on spasticity and##3##3##(2006-8#1)(2012-1#2)
on spatial and temporal##2##4##(2006-7#1)(2008-7#1)
on spatial and##3##3##(1992-3#1)(2006-7#1)(2008-7#1)
on spatial learning in the##3##5##(1993-12#2)(1994-8#1)
on spatial learning##5##3##(1991-7#1)(1993-12#2)(1994-8#1)(2012-2#1)
on spatial navigation##2##3##(1992-3#1)(1994-10#1)
on spatial statistics##2##3##(2008-10#1)(2008-8#1)
on spatial##23##2##(1991-7#1)(1992-3#2)(1993-12#3)(1994-10#1)(1994-8#1)(2006-7#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#2)(2008-7#1)(2008-8#2)(2010-7#1)(2012-2#1)
on spatially##2##2##(2005-11#1)(2007-9#1)
on special##2##2##(1991-11#1)(2007-11#1)
on specialty##4##2##(1994-1#1)(2007-4#1)(2008-4#1)(2013-1#1)
on species diversity##2##3##(2008-9#1)(2009-2#1)
on species richness##3##3##(2008-8#3)
on species##19##2##(1992-11#1)(1994-3#1)(2007-5#4)(2008-8#5)(2008-9#1)(2009-2#1)(2010-2#2)(2012-9#1)(2013-1#1)(2013-7#1)(2013-8#1)
on specific characteristics##2##3##(2007-1#1)(2013-8#1)
on specific genetic##2##3##(2007-8#1)(2012-1#1)
on specific issues##2##3##(2006-10#1)(2013-1#1)
on specific situations##7##3##(2006-7#1)(2006-8#5)(2012-12#1)
on specific stages of##2##4##(2010-12#1)(2012-2#1)
on specific symptoms##2##3##(2008-4#1)(2008-9#1)
on specific##72##2##(1990-12#1)(1993-1#1)(1993-2#1)(1993-4#1)(1995-3#3)(1995-9#3)(1996-1#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-4#2)(1997-8#1)(2005-11#1)(2006-10#2)(2006-4#1)(2006-7#1)(2006-8#5)(2007-1#2)(2007-8#1)(2008-10#2)(2008-11#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-9#2)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#7)(2013-7#1)(2013-8#3)
on specificity##2##2##(1992-3#1)(1993-9#1)
on specimens from##2##3##(2008-5#1)(2009-11#1)
on specimens of##2##3##(2007-5#1)(2008-10#1)
on specimens##6##2##(2007-5#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-11#1)
on spectral analysis##3##3##(2005-7#1)(2007-1#1)(2008-2#1)
on spectral data##2##3##(2007-1#1)(2012-11#1)
on spectral interferometry##2##3##(2007-12#2)
on spectral transmission##2##3##(2008-2#1)(2008-5#1)
on spectral##20##2##(1991-4#1)(1992-2#1)(2005-7#1)(2006-2#1)(2007-1#3)(2007-12#5)(2008-2#3)(2008-3#2)(2008-5#1)(2012-11#1)(2013-8#1)
on spectrin##2##2##(1993-4#2)
on spectrophotometric##5##2##(2008-10#5)
on spectroscopic##6##2##(2007-1#1)(2007-11#1)(2007-12#2)(2008-10#1)(2009-10#1)
on speech perception##4##3##(2008-9#4)
on speech##7##2##(2007-7#1)(2008-2#2)(2008-9#4)
on spending##2##2##(1991-3#1)(1992-3#1)
on sperm motility##2##3##(2007-11#1)(2007-12#1)
on sperm parameters##4##3##(2008-12#2)(2012-2#2)
on sperm viability##2##3##(2010-8#2)
on sperm##21##2##(2007-11#3)(2007-12#2)(2008-12#2)(2008-4#2)(2008-5#3)(2009-6#1)(2010-8#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
on spermatogenesis that##2##3##(2012-2#2)
on spermatogenesis##3##2##(1992-12#1)(2012-2#2)
on spermidine and##2##3##(2009-6#2)
on spherical hydroxyapatite beads##2##4##(1990-8#2)
on spherical##8##2##(1990-8#2)(2005-11#4)(2008-2#1)(2008-3#1)
on spike##2##2##(1990-7#1)(1995-12#1)
on spiked samples##3##3##(2008-10#2)(2011-1#1)
on spiked##8##2##(2007-8#1)(2008-10#5)(2008-12#1)(2011-1#1)
on spinach##2##2##(1991-8#1)(2008-10#1)
on spinal##12##2##(1995-12#1)(1995-7#1)(1997-7#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-3#1)(2011-2#1)
on spine##2##2##(2006-7#1)(2007-7#1)
on splenic##6##2##(1990-3#1)(1992-7#1)(1997-3#1)(2008-10#3)
on splenocytes##2##2##(2007-2#1)(2008-10#1)
on splicing##2##2##(1991-9#1)(2007-12#1)
on spontaneous and##2##3##(1994-6#1)(2006-6#1)
on spontaneous##16##2##(1990-2#2)(1993-11#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-12#1)(1996-10#1)(1996-7#1)(1997-7#1)(2006-6#1)(2007-12#1)(2009-4#2)(2009-6#1)(2011-2#1)
on spore release of Bremia lactucae##2##6##(2008-10#2)
on spore release##4##3##(2008-10#4)
on spore##13##2##(2008-10#11)(2011-2#2)
on sport##4##2##(2009-1#1)(2013-1#1)(2013-7#2)
on sports##2##2##(1993-3#1)(2009-7#1)
on sporulation of Bremia lactucae##2##5##(2008-10#2)
on sporulation##3##2##(2008-10#3)
on spread of##4##3##(2006-7#1)(2008-10#2)(2008-9#1)
on spread##7##2##(1996-5#1)(2006-7#1)(2008-10#4)(2008-9#1)
on spring##3##2##(1990-8#1)(2006-5#1)(2008-10#1)
on stability and##7##3##(1994-2#1)(2007-11#1)(2008-10#1)(2008-5#2)(2012-12#1)(2013-8#1)
on stability of##3##3##(1993-8#1)(2007-11#1)(2008-9#1)
on stability##14##2##(1993-8#1)(1994-2#1)(2006-3#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-5#2)(2008-9#2)(2012-12#1)(2013-8#1)
on stabilization##2##2##(2008-6#1)(2010-2#1)
on stabilizing##2##2##(1993-11#1)(2008-7#1)
on stable##6##2##(1991-4#2)(1996-12#1)(2006-5#1)(2008-6#1)(2008-8#1)
on staff##5##2##(1994-3#1)(2005-5#1)(2008-10#1)(2010-5#1)(2012-1#1)
on staging##3##2##(1995-1#1)(2008-3#2)
on stainless steel##4##3##(2010-4#1)(2011-2#1)(2013-8#2)
on stainless##5##2##(2010-4#1)(2011-2#2)(2013-8#2)
on standard toxicology study##4##4##(1995-2#3)(2008-10#1)
on standard##27##2##(1991-12#1)(1993-9#1)(1995-2#3)(1997-3#1)(2005-7#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#2)
on standardized##6##2##(2007-10#1)(2008-10#1)(2008-3#1)(2010-12#1)(2011-2#1)(2013-1#1)
on standing##3##2##(1995-12#1)(2008-10#1)(2010-10#1)
on starch or maltooligosaccharides##2##4##(2005-11#2)
on starch##7##2##(1991-12#1)(2005-11#2)(2006-11#2)(2008-10#1)(2008-5#1)
on state and local##2##4##(1993-2#1)(2011-9#1)
on state##4##2##(1993-2#1)(1997-1#1)(2007-12#1)(2011-9#1)
on static##2##2##(1993-12#1)(2008-9#1)
on statin therapy##3##3##(2008-3#1)(2010-12#1)(2013-1#1)
on stationary phases of different polarity##2##6##(2008-10#2)
on stationary phases of different##3##5##(2005-12#1)(2008-10#2)
on statistical##10##2##(2006-12#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-3#2)(2009-8#1)
on status and##2##3##(2010-12#1)(2013-7#1)
on steady-state##4##2##(1991-12#1)(1995-12#1)(2008-3#1)(2013-1#1)
on steep slopes##3##3##(2007-5#1)(2011-12#2)
on steep##5##2##(2007-5#2)(2011-12#2)(2013-7#1)
on stem cell biology and##2##5##(2008-11#1)(2010-12#1)
on stem cell##4##3##(2005-11#1)(2008-11#1)(2008-8#1)(2010-12#1)
on stem cells##3##3##(2005-11#1)(2008-8#1)(2009-6#1)
on stem##10##2##(2005-11#2)(2006-12#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-8#2)(2009-6#1)(2010-12#1)
on stems##3##2##(2008-10#2)(2011-12#1)
on sterilized##2##2##(2005-12#1)(2008-10#1)
on steroid##2##2##(2008-10#1)(2008-7#1)
on steroidogenesis in rat##2##4##(1990-2#1)(1996-2#1)
on steroidogenesis##3##2##(1990-2#1)(1991-7#1)(1996-2#1)
on steroids and##4##3##(1995-10#1)(2010-12#1)(2013-1#2)
on steroids##5##2##(1995-10#2)(2010-12#1)(2013-1#2)
on stigmas##2##2##(2005-10#1)(2008-10#1)
on stimulated##4##2##(1991-7#1)(2007-12#3)
on stimulation by##2##3##(1990-11#1)(1994-11#1)
on stimulation##4##2##(1990-11#1)(1990-9#1)(1994-11#1)(2008-11#1)
on stochastic##5##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-1#1)
on stomach##3##2##(1996-12#2)(1997-7#1)
on stomatal guard##2##3##(2008-10#2)
on stomatal##3##2##(2008-10#2)(2008-8#1)
on storage at##3##3##(1993-2#1)(2008-5#2)
on storage##6##2##(1991-12#1)(1993-2#1)(2008-5#2)(2010-12#1)(2010-7#1)
on stored##5##2##(1994-3#1)(2008-10#1)(2008-8#3)
on strain##2##2##(1996-2#1)(2006-11#1)
on strangers##4##2##(2006-10#4)
on strategic management##3##3##(1992-12#1)(1993-12#2)
on strategic##6##2##(1992-12#1)(1993-12#2)(1993-2#1)(1995-2#1)(2010-7#1)
on strategies to##2##3##(1995-11#1)(2008-9#1)
on strategies##5##2##(1993-3#1)(1995-11#1)(1995-12#1)(2008-9#1)(2012-12#1)
on stratospheric and##2##3##(2008-2#1)(2008-3#1)
on stratospheric ozone##2##3##(1996-5#1)(2008-10#1)
on stratospheric##5##2##(1996-5#1)(2008-10#1)(2008-2#2)(2008-3#1)
on stratum corneum function##2##4##(2008-5#1)(2013-1#1)
on stratum corneum##5##3##(2008-10#1)(2008-5#3)(2013-1#1)
on strawberry and##2##3##(2008-10#2)
on strawberry leaves##3##3##(2008-10#3)
on strawberry##14##2##(2008-10#13)(2008-12#1)
on streamlining##2##2##(2007-11#1)(2008-3#1)
on strength and##4##3##(2007-8#1)(2008-3#1)(2012-2#1)(2012-3#1)
on strength##7##2##(2006-3#1)(2007-8#1)(2008-3#1)(2008-5#2)(2012-2#1)(2012-3#1)
on strengthening##3##2##(2010-9#1)(2011-1#1)(2013-1#1)
on stress and##2##3##(2010-2#1)(2013-1#1)
on stress responses##4##3##(2012-1#4)
on stress##10##2##(1994-12#1)(1994-2#1)(2004-9#1)(2006-11#1)(2010-2#1)(2012-1#4)(2013-1#1)
on stress-induced##3##2##(1995-12#1)(1997-4#1)(2008-11#1)
on striatal dopamine release##2##4##(1991-3#2)
on striatal dopamine##3##3##(1991-3#2)(1996-6#1)
on striatal neurones##2##3##(1995-5#2)
on striatal neurons##2##3##(1990-10#2)
on striatal##13##2##(1990-10#2)(1990-2#1)(1991-3#2)(1994-10#1)(1994-8#1)(1995-5#2)(1996-12#1)(1996-6#1)(2007-10#1)(2008-11#1)
on stripe rust##2##3##(2008-10#2)
on stripping##2##2##(2008-10#2)
on stroke risk in the elderly##2##6##(2007-9#2)
on stroke risk##3##3##(2007-9#2)(2013-7#1)
on stroke##9##2##(1991-11#1)(2007-9#4)(2008-8#2)(2013-7#1)(2013-8#1)
on stromal##2##2##(2008-8#1)(2012-12#1)
on strong##5##2##(1995-4#1)(2006-12#1)(2008-10#1)(2008-5#1)(2012-2#1)
on structural and functional##2##4##(2008-4#1)(2012-1#1)
on structural and##4##3##(1991-8#1)(2008-4#1)(2012-1#1)(2013-8#1)
on structural data##3##3##(2008-10#1)(2013-1#2)
on structural##21##2##(1991-8#1)(1994-12#1)(2006-12#1)(2006-3#1)(2008-10#1)(2008-4#3)(2008-7#1)(2009-2#1)(2009-5#1)(2010-2#2)(2010-8#2)(2012-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
on structure and##3##3##(1997-7#1)(2008-10#1)(2010-8#1)
on structure##9##2##(1996-2#1)(1997-7#1)(2006-6#1)(2008-10#1)(2008-4#1)(2008-7#2)(2010-8#1)(2013-8#1)
on structure-function##4##2##(1995-1#1)(2007-3#1)(2008-11#1)(2011-1#1)
on structured##5##2##(2007-12#1)(2009-8#1)(2011-1#1)(2013-1#2)
on structures##4##2##(1992-8#1)(1993-2#1)(2008-5#1)(2008-7#1)
on student learning and##2##4##(1994-2#1)(2009-9#1)
on student##8##2##(1994-2#1)(2006-12#1)(2008-11#2)(2009-9#2)(2013-1#2)
on students##3##2##(2008-12#1)(2009-8#1)(2010-8#1)
on studies in##2##3##(1993-11#1)(2008-10#1)
on studies of the##2##4##(2008-7#1)(2009-7#1)
on studies of##7##3##(2007-11#1)(2008-10#2)(2008-11#2)(2008-7#1)(2009-7#1)
on studies on##2##3##(2007-11#1)(2008-2#1)
on studies with##2##3##(2008-7#1)(2012-12#1)
on studies##21##2##(1993-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-7#2)(2009-2#1)(2009-7#1)(2011-1#1)(2012-12#3)
on study design and##2##4##(2009-4#1)(2011-2#1)
on study##11##2##(1993-1#1)(1995-6#1)(1997-1#1)(2008-10#1)(2008-6#1)(2009-4#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-12#2)
on studying the##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
on studying##5##2##(2008-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
on subarachnoid##2##2##(2006-10#1)(2007-9#1)
on subject##2##2##(2009-3#1)(2013-8#1)
on subjective##11##2##(1991-1#1)(2005-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-11#1)(2011-1#1)(2013-1#2)(2013-7#1)
on subjects##2##2##(2008-11#1)(2008-5#1)
on subsequent days##2##3##(1995-3#1)(2010-2#1)
on subsequent fermentation ability##2##4##(2007-12#2)
on subsequent switch effects##2##4##(2012-3#2)
on subsequent##19##2##(1993-1#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-10#1)(1996-4#1)(1996-7#1)(2006-5#1)(2007-12#2)(2007-2#2)(2008-10#1)(2008-3#1)(2008-9#1)(2010-2#1)(2012-3#2)(2013-1#1)
on subsets of##3##3##(1993-12#1)(2008-4#1)(2008-7#1)
on substance##5##2##(1990-11#1)(1994-3#1)(1994-8#1)(2008-4#1)(2009-7#1)
on substances that##2##3##(1991-12#1)(2007-11#1)
on substances##3##2##(1991-12#1)(2005-4#1)(2007-11#1)
on substantive##2##2##(1996-3#1)(2010-7#1)
on substrate recognition##2##3##(1997-4#1)(2012-3#1)
on substrate specificity of##2##4##(2008-7#1)(2013-8#1)
on substrate specificity##3##3##(1990-7#1)(2008-7#1)(2013-8#1)
on substrate##17##2##(1990-11#1)(1990-7#1)(1990-8#1)(1995-2#1)(1995-4#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-3#1)(2012-3#2)(2013-8#1)
on substrates##6##2##(1991-2#1)(1996-3#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
on subtests of##3##3##(2005-10#3)
on subunit##3##2##(1992-11#1)(1995-11#1)(1997-6#1)
on successful##5##2##(1991-12#1)(2007-12#1)(2010-2#1)(2011-12#1)(2012-12#1)
on successive##6##2##(1992-7#1)(1993-6#1)(2007-12#1)(2007-8#2)(2008-3#1)
on succinate##2##2##(1994-11#1)(1997-7#1)
on such a##3##3##(1994-6#1)(1994-9#1)(2010-6#1)
on such factors as##2##4##(2007-11#1)(2007-6#1)
on such interactions##2##3##(2008-10#2)
on such topics as##2##4##(1994-1#1)(2007-4#1)
on such##34##2##(1990-3#1)(1993-3#1)(1993-4#1)(1994-1#1)(1994-6#1)(1994-9#1)(1995-11#1)(1996-4#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-6#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
on sucrose density gradients##2##4##(1992-12#1)(2008-4#1)
on sucrose gradients##3##3##(1990-4#1)(1993-12#1)(1994-11#1)
on sucrose##11##2##(1990-4#1)(1991-5#1)(1992-12#1)(1993-12#1)(1994-11#1)(1997-6#1)(2004-8#2)(2008-10#1)(2008-4#1)(2009-6#1)
on sugar beet##3##3##(2008-10#3)
on sugar##7##2##(1994-6#1)(1995-9#1)(2006-12#1)(2008-10#3)(2008-6#1)
on suicidal##3##2##(2005-9#1)(2011-2#1)(2013-8#1)
on suicidality##2##2##(2009-7#2)
on suicide##6##2##(1990-3#1)(1996-1#2)(2011-1#1)(2013-1#1)(2013-8#1)
on suitable##2##2##(2008-11#1)(2008-3#1)
on sun exposed##2##3##(2007-11#1)(2007-8#1)
on sun##3##2##(2007-11#1)(2007-8#1)(2010-9#1)
on sun-exposed areas of the##2##5##(2010-6#1)(2010-8#1)
on sun-exposed areas##5##3##(2007-11#1)(2010-6#2)(2010-8#1)(2012-12#1)
on sun-exposed##7##2##(2007-11#2)(2010-6#2)(2010-8#1)(2011-2#1)(2012-12#1)
on sunny days##4##3##(2008-10#4)
on sunny##5##2##(2006-12#1)(2008-10#4)
on sunscreen##2##2##(2008-5#2)
on supercoiled##2##2##(1994-5#1)(1997-5#1)
on supercritical fluid##2##3##(1990-8#1)(2008-10#1)
on supercritical##4##2##(1990-8#1)(2008-10#2)(2010-10#1)
on superficial##2##2##(2007-6#1)(2008-5#1)
on superoxide generation##2##3##(1992-9#1)(1995-1#1)
on superoxide##6##2##(1990-5#1)(1992-6#1)(1992-9#1)(1995-1#1)(1996-2#1)(1997-6#1)
on supplementation##2##2##(2008-7#1)(2012-3#1)
on supply of##2##3##(2008-7#1)(2009-8#1)
on supply##3##2##(1992-1#1)(2008-7#1)(2009-8#1)
on support##5##2##(1991-4#1)(1996-3#2)(2007-8#1)(2011-2#1)
on supported##2##2##(2005-11#2)
on supporting##2##2##(2006-10#2)
on suppression of##3##3##(2008-10#3)
on surface layers produced##2##4##(2004-9#2)
on surface plasmon resonance##7##4##(2008-10#5)(2008-2#1)(2009-5#1)
on surface preparations##2##3##(1993-9#2)
on surface##38##2##(1993-9#2)(2004-9#2)(2005-11#8)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#9)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-5#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-8#1)
on surface-bound##2##2##(1997-2#2)
on surface-enhanced Raman scattering##2##4##(2007-8#1)(2013-8#1)
on surface-modified poly(tert-butyl methacrylate)##2##4##(2008-5#2)
on surface-modified##4##2##(2007-8#1)(2008-5#3)
on surface-plasmon##5##2##(2008-2#1)(2008-3#4)
on surfaces of##5##3##(2008-10#3)(2008-6#1)(2013-8#1)
on surfaces##27##2##(1990-8#1)(1997-3#1)(2005-11#1)(2006-12#1)(2007-11#4)(2007-12#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-7#2)(2009-12#1)(2009-4#1)(2009-6#1)(2010-4#1)(2012-11#2)(2012-5#1)(2013-8#2)
on surfactant##4##2##(1993-9#1)(1997-1#1)(2008-10#1)(2012-2#1)
on surgery##6##2##(1992-11#1)(1997-3#1)(2006-10#1)(2007-11#1)(2008-11#1)(2009-9#1)
on surgical intervention##2##3##(2006-10#2)
on surgical practice in the##2##5##(2006-6#1)(2007-8#1)
on surgical treatment##3##3##(2006-10#2)(2008-11#1)
on surgical##24##2##(1991-4#1)(1993-6#1)(2006-10#4)(2006-6#2)(2006-8#1)(2007-11#2)(2007-5#1)(2007-6#1)(2007-8#3)(2008-1#1)(2008-11#1)(2008-6#2)(2008-8#1)(2009-3#1)(2010-7#1)(2012-3#1)
on surrogate##2##2##(2008-11#1)(2008-2#1)
on surveillance##5##2##(1996-1#1)(2007-12#1)(2008-6#1)(2011-12#1)(2011-2#1)
on survey##2##2##(1991-6#1)(2008-2#1)
on survival after##5##3##(1997-5#1)(2006-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
on survival and fecundity##2##4##(2004-2#1)(2011-2#1)
on survival and##5##3##(1994-5#1)(2004-2#1)(2008-8#1)(2011-2#1)(2013-7#1)
on survival in##5##3##(2004-1#2)(2007-5#1)(2008-7#1)(2010-12#1)
on survival of mice##2##4##(2006-8#1)(2007-12#1)
on survival of patients with##3##5##(1994-4#1)(2004-1#1)(2010-12#1)
on survival of rat##2##4##(1993-11#1)(1994-5#1)
on survival of##18##3##(1993-11#1)(1994-2#1)(1994-4#1)(1994-5#1)(2004-1#1)(2006-8#3)(2007-12#1)(2008-10#5)(2008-7#1)(2010-12#1)(2012-2#1)(2013-8#1)
on survival or##5##3##(1995-2#1)(2004-1#1)(2008-8#1)(2008-9#2)
on survival time##3##3##(1994-2#1)(2007-11#2)
on survival times##2##3##(2008-10#1)(2012-12#1)
on survival##79##2##(1990-12#1)(1990-2#1)(1991-10#2)(1993-11#1)(1993-2#1)(1994-2#2)(1994-4#1)(1994-5#3)(1995-2#2)(1996-11#1)(1997-5#1)(2004-1#5)(2004-10#2)(2004-2#1)(2006-10#3)(2006-6#1)(2006-7#1)(2006-8#4)(2007-11#3)(2007-12#1)(2007-5#2)(2007-8#1)(2008-10#8)(2008-2#1)(2008-5#3)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#1)(2010-10#2)(2010-12#3)(2011-2#6)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
on survivors of##2##3##(1995-11#1)(2008-11#1)
on survivors##3##2##(1995-11#1)(2004-11#1)(2008-11#1)
on survivorship of##2##3##(2008-9#1)(2011-2#1)
on survivorship##4##2##(2004-11#1)(2008-9#1)(2010-8#1)(2011-2#1)
on susceptibility to##4##3##(1996-10#1)(1996-5#1)(2007-2#1)(2008-10#1)
on susceptibility##7##2##(1996-10#1)(1996-5#1)(1997-8#1)(2007-2#1)(2008-10#3)
on susceptible cultivars##3##3##(2008-10#3)
on susceptible##14##2##(2008-10#12)(2008-9#1)(2011-2#1)
on suspended carriers##2##3##(2008-7#2)
on suspended##4##2##(2008-10#1)(2008-2#1)(2008-7#2)
on sustained##4##2##(2008-4#1)(2008-9#1)(2010-11#1)(2011-2#1)
on swards##2##2##(2008-10#2)
on sweet##2##2##(1996-1#1)(2008-10#1)
on swine##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
on sympathetic##5##2##(1990-12#1)(1993-4#1)(1994-2#1)(2006-7#1)(2008-7#1)
on symptom expression##3##3##(2008-10#3)
on symptom severity##3##3##(2006-10#1)(2008-10#2)
on symptom##8##2##(2006-10#1)(2006-7#1)(2008-10#5)(2008-7#1)
on symptomatic##2##2##(2006-8#1)(2007-6#1)
on symptomatology##2##2##(1992-2#1)(2008-10#1)
on symptomless strawberry##2##3##(2008-10#2)
on symptomless##3##2##(2008-10#3)
on symptoms and##2##3##(2005-12#1)(2008-9#1)
on symptoms in##2##3##(2008-10#1)(2010-5#1)
on symptoms of##4##3##(2008-10#1)(2010-12#1)(2013-1#2)
on symptoms##10##2##(2005-12#1)(2007-2#1)(2008-10#3)(2008-9#1)(2010-12#1)(2010-5#1)(2013-1#2)
on synaptic transmission##5##3##(1991-5#2)(1993-12#1)(1996-5#1)(2005-8#1)
on synaptic##9##2##(1991-5#2)(1993-12#1)(1995-7#1)(1996-5#1)(2005-8#1)(2008-3#1)(2008-4#1)(2009-8#1)
on synchronization of##3##3##(2007-11#2)(2008-11#1)
on synthesis##3##2##(1995-2#1)(2008-4#1)(2012-1#1)
on synthesized##5##2##(2006-12#1)(2008-2#1)(2008-3#2)(2009-10#1)
on synthetic and real images##3##5##(2008-2#3)
on synthetic and real##4##4##(2008-2#4)
on synthetic data##3##3##(2006-10#1)(2008-3#1)(2012-12#1)
on synthetic samples prepared with the##2##6##(2008-10#2)
on synthetic samples prepared##4##4##(2008-10#4)
on synthetic samples##5##3##(2008-10#5)
on synthetic##23##2##(1990-3#1)(1990-6#1)(1992-8#1)(2006-10#1)(2006-7#2)(2008-10#6)(2008-2#4)(2008-3#1)(2010-10#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
on system performance##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
on system##6##2##(1990-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-8#1)
on systematic reviews##3##3##(2007-5#1)(2011-2#1)(2013-1#1)
on systematic##9##2##(1996-9#1)(2006-10#1)(2007-11#1)(2007-5#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
on systemic and##2##3##(1992-8#1)(2008-10#1)
on systemic health##2##3##(2007-12#1)(2013-8#1)
on systemic##14##2##(1992-5#1)(1992-8#1)(1994-7#1)(1995-1#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-12#1)(2009-8#1)(2011-12#1)(2013-8#3)
on systems biology##2##3##(2010-12#1)(2013-8#1)
on systems##5##2##(2007-4#1)(2009-12#1)(2010-12#1)(2013-8#2)
on systolic##2##2##(2005-11#1)(2012-12#1)
on tNOX##2##2##(2009-9#2)
on tactile##2##2##(1997-2#1)(2006-8#1)
on tall fescue##4##3##(2008-10#4)
on tall##5##2##(2008-10#4)(2009-2#1)
on tamoxifen##3##2##(1993-11#1)(2008-5#1)(2012-3#1)
on tap##2##2##(2008-1#1)(2008-10#1)
on tapered##2##2##(2007-12#1)(2008-10#1)
on target cells##9##3##(1990-11#1)(1990-8#1)(1991-3#1)(1991-9#1)(1993-3#1)(2008-12#1)(2008-5#1)(2010-4#1)(2011-2#1)
on target genes and##2##4##(2008-4#1)(2011-2#1)
on target##26##2##(1990-11#1)(1990-8#1)(1991-3#1)(1991-9#1)(1992-6#1)(1993-3#2)(1994-11#1)(1994-3#1)(1996-12#1)(1997-6#1)(2005-11#1)(2006-6#2)(2008-1#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-4#1)(2010-5#1)(2011-2#2)
on target-derived##2##2##(1996-3#2)
on targeted##4##2##(1993-9#1)(2006-10#1)(2007-12#1)(2008-9#1)
on targets##4##2##(2008-5#1)(2009-8#1)(2013-1#1)(2013-7#1)
on task##2##2##(1992-8#1)(2009-7#1)
on tasks of##2##3##(2008-9#1)(2012-1#1)
on tasks##7##2##(1992-9#1)(1995-12#1)(2008-11#1)(2008-9#1)(2009-2#1)(2012-1#2)
on tau##2##2##(1997-1#1)(2003-11#1)
on taurine##2##2##(1994-12#1)(1995-1#1)
on taxonomy##2##2##(2006-8#1)(2007-5#1)
on tea consumption##2##3##(1990-6#1)(1990-7#1)
on teaching clinical chemistry##2##4##(1994-12#2)
on teaching##10##2##(1994-12#3)(1995-2#1)(2006-10#1)(2008-10#1)(2008-11#3)(2011-2#1)
on technical##3##2##(1990-11#1)(2007-11#1)(2013-1#1)
on techniques##3##2##(1995-7#1)(2007-12#1)(2009-2#1)
on technological and##3##3##(2008-9#1)(2010-12#1)(2010-4#1)
on technological##4##2##(2008-9#1)(2010-12#1)(2010-4#1)(2010-7#1)
on technology and##2##3##(1992-1#1)(2008-12#1)
on technology##6##2##(1992-1#1)(1994-12#1)(2008-12#1)(2011-1#1)(2013-1#2)
on teicoplanin##4##2##(2008-10#4)
on television##2##2##(2007-10#1)(2010-11#1)
on telomere##2##2##(2008-1#1)(2008-8#1)
on temperature and##5##3##(1992-6#1)(2005-11#1)(2008-10#1)(2008-8#1)(2011-2#1)
on temperature in the##2##4##(2008-10#2)
on temperature was##2##3##(2007-11#1)(2008-10#1)
on temperature##32##2##(1990-3#1)(1991-2#1)(1991-4#1)(1992-6#1)(1993-1#1)(1995-1#1)(1996-2#4)(2005-11#1)(2005-12#1)(2006-10#1)(2007-11#3)(2008-10#7)(2008-3#4)(2008-5#2)(2008-8#1)(2011-2#1)(2013-1#1)
on temporal##9##2##(1993-1#1)(2007-11#1)(2007-5#1)(2008-2#1)(2008-3#1)(2008-8#2)(2009-5#1)(2011-2#1)
on ten##8##2##(2005-7#1)(2006-10#1)(2007-11#1)(2007-6#1)(2008-2#1)(2008-3#1)(2009-10#2)
on tensile##4##2##(2007-4#1)(2008-12#1)(2008-5#1)(2012-2#1)
on term##2##2##(2008-11#1)(2008-3#1)
on termination##3##2##(1992-2#1)(1996-6#1)(2005-7#1)
on terrestrial##2##2##(2006-5#1)(2008-3#1)
on test##8##2##(1996-1#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-3#1)(2009-12#2)(2012-2#1)
on testes##2##2##(2008-12#1)(2008-6#1)
on testicular##5##2##(1995-11#1)(2009-5#3)(2012-2#1)
on testing##2##2##(2008-10#1)(2013-8#1)
on testosterone##2##2##(1990-11#1)(1995-5#1)
on tests of spatial memory##2##5##(1993-12#1)(1993-5#1)
on tests of##6##3##(1993-12#1)(1993-5#1)(1995-11#2)(2007-8#1)(2008-4#1)
on tests##10##2##(1993-12#1)(1993-5#1)(1995-11#2)(1997-8#1)(2007-8#2)(2008-2#1)(2008-4#1)(2011-1#1)
on thalidomide##2##2##(2007-10#1)(2011-2#1)
on thallium##2##2##(1996-2#1)(2008-10#1)
on that of the##2##4##(1991-2#1)(2007-12#1)
on that of##7##3##(1990-9#2)(1991-2#1)(1997-1#1)(2007-12#1)(2008-10#1)(2011-2#1)
on that side##2##3##(2008-10#1)(2009-6#1)
on that##32##2##(1990-9#2)(1991-2#1)(1994-10#1)(1997-1#1)(1997-4#1)(1997-8#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#2)(2008-1#1)(2008-10#9)(2008-3#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
on the &quot##16##3##(1991-4#1)(1992-12#1)(1993-7#1)(1993-9#1)(1994-5#1)(1995-6#1)(1996-1#1)(1996-7#1)(2007-1#1)(2008-10#1)(2008-3#1)(2008-4#2)(2009-7#1)(2010-2#1)(2013-8#1)
on the 1##9##3##(1991-9#1)(1993-11#4)(2005-4#1)(2007-12#1)(2008-10#1)(2012-2#1)
on the 11##3##3##(2008-10#2)(2011-2#1)
on the 11th of##2##4##(2010-12#1)(2012-2#1)
on the 11th##3##3##(1991-6#1)(2010-12#1)(2012-2#1)
on the 12(th) day##2##4##(2009-3#2)
on the 13th##2##3##(2007-12#1)(2010-12#1)
on the 14th##2##3##(1991-4#1)(2007-11#1)
on the 15th##3##3##(1990-11#1)(2004-7#1)(2012-2#1)
on the 16S rRNA##2##4##(2012-2#2)
on the 18th##2##3##(2008-6#1)(2011-1#1)
on the 19 most##2##4##(2008-8#1)(2011-2#1)
on the 1st of September 2007##2##6##(2012-2#2)
on the 1st of##5##4##(2006-8#2)(2012-2#3)
on the 1st##8##3##(1990-12#1)(1991-4#1)(2006-8#2)(2008-10#1)(2012-2#3)
on the 2##2##3##(2007-12#1)(2008-10#1)
on the 2001##2##3##(2008-10#1)(2008-5#1)
on the 21st##2##3##(1990-4#1)(1990-7#1)
on the 23rd##2##3##(2007-8#1)(2010-7#1)
on the 28th day##2##4##(1992-10#1)(1996-12#1)
on the 28th##3##3##(1992-10#1)(1996-12#1)(2010-12#1)
on the 2nd##4##3##(1992-1#1)(1994-6#1)(2008-5#1)(2011-2#1)
on the 3##3##3##(1997-2#1)(2007-10#1)(2008-1#1)
on the 3'##3##3##(1993-12#1)(1993-6#1)(2008-9#1)
on the 30th day of##2##5##(2007-12#1)(2012-3#1)
on the 30th##4##3##(2007-12#1)(2007-4#1)(2008-12#1)(2012-3#1)
on the 3rd##4##3##(2005-8#1)(2007-11#1)(2007-5#1)(2007-8#1)
on the 4##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
on the 40th day after the##2##6##(2007-9#2)
on the 4th day##2##4##(2008-10#2)
on the 4th##5##3##(1991-11#1)(2008-10#2)(2008-5#1)(2010-12#1)
on the 5' end of the##2##6##(2008-10#1)(2008-9#1)
on the 5' side##3##4##(1993-12#1)(1993-6#1)(1995-6#1)
on the 5'##6##3##(1993-12#1)(1993-2#1)(1993-6#1)(1995-6#1)(2008-10#1)(2008-9#1)
on the 5th day##2##4##(2007-10#1)(2008-11#1)
on the 5th##3##3##(2004-10#1)(2007-10#1)(2008-11#1)
on the 6th##2##3##(1993-2#1)(2012-2#1)
on the 70 mM##2##4##(1994-3#2)
on the 7th day##2##4##(2008-10#1)(2013-8#1)
on the 7th##3##3##(2007-2#1)(2008-10#1)(2013-8#1)
on the 8(th)##4##3##(2009-3#2)(2012-12#2)
on the 8th##2##3##(2010-12#1)(2010-5#1)
on the 9##2##3##(2008-7#1)(2010-5#1)
on the 9th day##3##4##(2008-11#1)(2009-8#1)(2013-8#1)
on the 9th##6##3##(1996-8#1)(2008-11#1)(2008-12#1)(2009-8#1)(2013-8#2)
on the A##5##3##(1992-5#1)(1993-6#2)(1995-5#1)(1996-5#1)
on the ACC##2##3##(2005-11#2)
on the AFM##2##3##(2007-12#1)(2008-2#1)
on the AOS##2##3##(1995-11#1)(2006-6#1)
on the ATP hydrolysis##2##4##(1991-10#1)(1992-11#1)
on the Al##3##3##(2008-10#1)(2008-3#1)(2010-4#1)
on the American##5##3##(1991-7#1)(2008-11#1)(2008-4#1)(2010-11#1)(2012-3#1)
on the Atlantic##2##3##(2008-10#1)(2012-12#1)
on the Au surface##4##4##(1996-11#2)(2008-10#2)
on the Au##5##3##(1996-11#2)(2007-8#1)(2008-10#2)
on the Axl promoter##2##4##(2012-12#2)
on the B##8##3##(1990-11#1)(1991-5#1)(1992-9#1)(1995-3#1)(1996-2#1)(1996-5#1)(2007-9#1)(2008-10#1)
on the BMD and bone volume##2##6##(2009-3#2)
on the BMI##2##3##(2007-8#1)(2008-3#1)
on the Basis of##2##4##(2008-2#1)(2008-3#1)
on the Bayley mental##2##4##(2006-12#2)
on the Bayley##3##3##(1991-2#1)(2006-12#2)
on the Beck Depression Inventory##2##5##(2010-12#1)(2012-2#1)
on the Brazilian##3##3##(2007-7#1)(2010-8#1)(2011-1#1)
on the Brief Psychiatric Rating Scale##2##6##(1996-3#1)(1997-2#1)
on the British##2##3##(1992-3#1)(2006-10#1)
on the C##2##3##(2008-5#1)(2013-1#1)
on the C-terminal##4##3##(1990-7#1)(1991-2#1)(1994-5#1)(1995-1#1)
on the CA1 pyramidal##2##4##(1990-5#1)(1993-2#1)
on the CA1##3##3##(1990-5#1)(1991-3#1)(1993-2#1)
on the CALUX##2##3##(2008-10#2)
on the CCD##6##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#3)
on the CL reaction between luminol##2##6##(2008-10#2)
on the CL reaction of##4##5##(2008-10#4)
on the CL reaction##6##4##(2008-10#6)
on the CL##9##3##(2008-10#9)
on the CNS##2##3##(1994-5#1)(2005-9#1)
on the CR lever##2##4##(1993-6#2)
on the CT##2##3##(1996-3#1)(2010-12#1)
on the Ca(2+)-activated##2##3##(1992-6#1)(1997-2#1)
on the Ca2+##2##3##(1990-11#1)(1994-2#1)
on the Calgary##2##3##(2011-2#1)(2012-12#1)
on the Canadian##2##3##(1995-2#1)(2007-12#1)
on the Caribbean##2##3##(2007-5#1)(2010-4#1)
on the Chinese##2##3##(2008-4#1)(2009-6#1)
on the Collins test##2##4##(1994-8#2)
on the DA##2##3##(1996-6#1)(1997-2#1)
on the DICOM##2##3##(1996-2#1)(2010-9#1)
on the DNA synthesis##3##4##(1992-4#1)(1992-7#1)(1993-8#1)
on the DNA##19##3##(1990-5#1)(1991-1#1)(1991-7#1)(1992-4#1)(1992-7#1)(1993-8#1)(1994-8#1)(1995-1#1)(1995-2#1)(1997-7#1)(2006-8#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-5#1)(2012-2#1)
on the DOF##4##3##(2010-8#4)
on the DRC##3##3##(2008-11#3)
on the Department##2##3##(2007-2#1)(2008-9#1)
on the Development of##2##4##(2008-10#2)
on the Dimension clinical chemistry system##2##6##(2008-10#2)
on the Dimension##3##3##(2008-10#3)
on the Dimension((R))##2##3##(2008-10#2)
on the E##2##3##(1991-3#1)(2010-2#1)
on the ECG##2##3##(1990-3#2)
on the EGFR##2##3##(2008-4#1)(2008-5#1)
on the ERP##2##3##(2004-11#1)(2006-5#1)
on the Earth##4##3##(1997-5#2)(2008-2#1)(2011-2#1)
on the Escherichia coli##4##4##(1991-3#1)(1996-4#1)(1997-7#2)
on the European##4##3##(2008-5#1)(2013-1#1)(2013-7#1)(2013-8#1)
on the Faraday effect for measuring ac##2##7##(2008-3#2)
on the Faraday effect##3##4##(2008-2#1)(2008-3#2)
on the Finnish##2##3##(2005-10#1)(2005-11#1)
on the Five Factor Model##2##5##(2008-10#1)(2011-1#1)
on the Five Factor##3##4##(2008-10#1)(2011-1#2)
on the French##4##3##(2008-2#1)(2008-3#1)(2013-1#2)
on the G protein##2##4##(1992-2#1)(1997-3#1)
on the G##3##3##(1992-2#1)(1994-8#1)(1997-3#1)
on the GABA response##2##4##(1995-6#2)
on the GABA##3##3##(1995-6#2)(1997-5#1)
on the GABA(A)##2##3##(1997-5#1)(2007-9#1)
on the GAW17##2##3##(2012-3#2)
on the GCE##2##3##(2008-10#1)(2013-1#1)
on the GH##2##3##(2008-7#1)(2011-1#1)
on the GILDA beamline at the ESRF##2##7##(2006-5#2)
on the GPU##6##3##(2010-2#1)(2011-1#1)(2012-12#3)(2013-8#1)
on the GTPase activity of##2##5##(1992-11#1)(1995-5#1)
on the GTPase activity##3##4##(1990-12#1)(1992-11#1)(1995-5#1)
on the GaAs##2##3##(2009-11#2)
on the Gaussian##2##3##(2008-2#1)(2008-3#1)
on the Genetic Analysis Workshop 17 data##2##7##(2012-3#2)
on the Genetic Analysis Workshop 17##3##6##(2012-3#3)
on the Genetic##4##3##(2008-10#1)(2012-3#3)
on the Geriatric Depression Scale##2##5##(2007-10#1)(2008-7#1)
on the Global##2##3##(2008-12#1)(2008-3#1)
on the HPLC##5##3##(1990-8#2)(2008-10#1)(2008-5#1)(2008-6#1)
on the HSD##2##3##(2006-10#2)
on the Hybrid III##2##4##(2006-11#2)
on the IFN-gamma##2##3##(2006-10#1)(2008-11#1)
on the IL-1##2##3##(1995-2#1)(2007-11#1)
on the IgG##2##3##(1990-11#1)(2008-12#1)
on the Immune System##2##4##(2011-1#1)(2012-12#1)
on the Information##2##3##(2007-12#1)(2007-4#1)
on the International##4##3##(2007-4#1)(2012-2#1)(2013-1#2)
on the Internet for##2##4##(2007-11#1)(2007-2#1)
on the Internet will##2##4##(1996-2#1)(2006-6#1)
on the Internet##30##3##(1995-12#1)(1996-12#4)(1996-2#1)(1996-8#1)(2004-12#1)(2005-10#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-6#3)(2006-7#1)(2007-11#1)(2007-2#3)(2008-11#3)(2008-2#1)(2008-4#1)(2009-5#2)(2010-12#1)(2011-1#1)(2012-2#1)
on the Iowa##2##3##(2008-10#1)(2013-1#1)
on the Iranian oil industry##2##5##(2006-2#2)
on the Jones matrix##2##4##(2008-2#2)
on the Küplüce man made mounds##2##6##(2008-12#2)
on the L-type calcium channels##2##5##(1995-3#2)
on the L-type##4##3##(1995-3#2)(1997-4#1)(1997-5#1)
on the LB films##4##4##(2007-9#1)(2008-11#3)
on the LB membranes##4##4##(2008-11#4)
on the LB##8##3##(2007-9#1)(2008-11#7)
on the LDL oxidation##2##4##(2006-12#2)
on the LPP test##2##4##(1994-8#2)
on the Lambertian##2##3##(2008-2#1)(2008-3#1)
on the Law of##2##4##(1993-5#1)(2007-9#1)
on the Lopez enteral feeding valve##2##6##(2010-6#2)
on the M side of##2##5##(2011-2#2)
on the MIMS response##2##4##(2008-10#2)
on the MMP-1##2##3##(2008-5#1)(2012-3#1)
on the MR##4##3##(1995-4#1)(1996-6#1)(2007-9#2)
on the MX line##2##4##(2008-10#2)
on the Mach-Zehnder##2##3##(2008-3#2)
on the Macintosh computer##2##4##(1996-12#2)
on the Medical Ward##2##4##(1992-12#2)
on the Medicare program and##2##5##(1997-3#1)(2008-10#1)
on the Medicare##4##3##(1995-12#1)(1995-2#1)(1997-3#1)(2008-10#1)
on the Mini Mental State##2##5##(2008-7#1)(2011-2#1)
on the Molecular and##2##4##(1996-8#1)(2008-10#1)
on the Molecular##3##3##(1996-8#1)(2006-3#1)(2008-10#1)
on the Morris water##2##4##(1992-11#1)(2011-2#1)
on the N##2##3##(2008-5#2)
on the N-methyl-D-aspartate##4##3##(1990-7#1)(1991-9#2)(1994-5#1)
on the N-terminal##11##3##(1991-10#1)(1991-5#1)(1991-8#1)(1993-9#1)(1994-12#1)(1995-2#1)(1995-6#1)(2007-12#1)(2008-6#1)(2009-2#1)(2012-2#1)
on the NADase activity##2##4##(1996-5#2)
on the NCLEX-RN##4##3##(2006-12#4)
on the NMDA receptor##3##4##(1990-2#1)(1996-10#1)(1996-8#1)
on the NMDA##6##3##(1990-2#1)(1996-10#1)(1996-12#1)(1996-8#1)(1997-2#1)(2011-1#1)
on the NMR time scale##6##5##(1990-5#2)(1991-2#1)(1995-10#1)(1997-7#1)(2007-11#1)
on the NMR##9##3##(1990-5#2)(1991-2#1)(1995-10#1)(1997-7#1)(2007-11#1)(2008-5#1)(2009-3#1)(2010-6#1)
on the NO-synthase way of##2##5##(2008-8#2)
on the Na+##4##3##(1990-2#2)(1996-10#1)(2008-8#1)
on the National##11##3##(1994-12#1)(1995-11#1)(1996-11#1)(2006-12#1)(2007-1#1)(2007-4#1)(2007-9#1)(2008-3#3)(2012-3#1)
on the Net##2##3##(2004-10#1)(2006-10#1)
on the Norwegian##2##3##(1991-6#1)(1997-6#1)
on the Nottingham##2##3##(2004-10#2)
on the Olympus##3##3##(1992-6#3)
on the P##3##3##(1996-4#1)(2008-10#1)(2010-8#1)
on the PC##2##3##(1996-12#1)(2007-12#1)
on the PCR##2##3##(2008-2#1)(2012-12#1)
on the PET##2##3##(2010-3#1)(2012-12#1)
on the PPI##2##3##(2008-4#1)(2012-2#1)
on the PS sphere surface##2##5##(2010-4#2)
on the PS sphere##3##4##(2010-4#3)
on the PS##5##3##(2007-9#1)(2008-10#1)(2010-4#3)
on the PSC##2##3##(1997-2#1)(2010-10#1)
on the PTFE turnings##2##4##(2007-8#1)(2008-10#1)
on the Pacific coast##2##4##(2007-5#1)(2008-10#1)
on the Pacific##4##3##(1996-4#1)(2007-5#2)(2008-10#1)
on the Poincaré sphere##6##4##(2007-12#3)(2008-3#3)
on the Polish##2##3##(2008-7#1)(2013-8#1)
on the Positive and Negative Syndrome Scale##2##7##(2008-6#1)(2011-1#1)
on the Pt##3##3##(2007-8#1)(2008-10#1)(2008-11#1)
on the R##3##3##(1993-9#1)(1995-3#1)(2008-2#1)
on the RA molecule##2##4##(2008-11#2)
on the RBCs##2##3##(1993-9#1)(1994-12#1)
on the RRE##4##3##(1993-8#4)
on the Raman##3##3##(2007-11#1)(2008-2#1)(2013-8#1)
on the Reproductive##4##3##(2005-7#2)(2006-12#1)(2008-5#1)
on the Role of##3##4##(2010-8#2)(2011-1#1)
on the Royal##2##3##(2005-8#1)(2008-6#1)
on the S column##2##4##(1995-3#2)
on the S##3##3##(1995-3#2)(2008-12#1)
on the SAMs##2##3##(2008-10#2)
on the SM##2##3##(2008-5#2)
on the SNR##2##3##(2004-10#2)
on the SPQ-B##2##3##(2008-1#2)
on the SPR sensor##2##4##(2008-10#1)(2008-4#1)
on the SPR##3##3##(2008-10#2)(2008-4#1)
on the SS##3##3##(2010-4#2)(2012-12#1)
on the San Andreas fault##3##5##(1990-11#1)(1991-3#2)
on the Shroud of Turin##2##5##(2008-2#2)
on the Smooth PDMS##2##4##(2006-4#2)
on the Social Determinants of Health##2##6##(2010-12#1)(2011-1#1)
on the Social##3##3##(2010-12#1)(2011-1#1)(2013-7#1)
on the Stability of##2##4##(2008-5#1)(2009-12#1)
on the Strehl ratio##2##4##(2008-2#2)
on the Stroop##2##3##(2006-4#1)(2007-1#1)
on the Swedish market##2##4##(2007-4#1)(2007-8#1)
on the T##2##3##(1993-9#1)(2008-10#1)
on the T4##2##3##(1990-3#1)(1991-3#1)
on the THOR##2##3##(2006-11#2)
on the TSST-1 molecule##2##4##(1993-3#2)
on the Third##2##3##(2008-11#1)(2011-2#1)
on the U##5##3##(2008-10#1)(2011-1#1)(2012-12#3)
on the US health care system##2##6##(2008-11#2)
on the US##4##3##(2006-2#1)(2008-11#2)(2012-2#1)
on the UV##2##3##(1997-3#1)(2007-8#1)
on the University##2##3##(2007-11#1)(2007-6#1)
on the Upper##2##3##(1993-6#1)(2008-2#1)
on the VAS##5##3##(2007-7#1)(2007-8#1)(2008-1#1)(2008-6#1)(2012-2#1)
on the WCST##4##3##(1995-1#1)(1995-11#1)(1996-3#1)(2006-3#1)
on the Web##16##3##(2006-10#1)(2006-12#5)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-4#5)(2010-3#1)
on the West Fore Reef##3##5##(2007-5#3)
on the Western##2##3##(1995-1#1)(2006-2#1)
on the Wisconsin Card Sorting Test##4##6##(1995-1#1)(1996-3#1)(1996-8#1)(2006-4#1)
on the World Trade Center##2##5##(2007-2#1)(2007-3#1)
on the World Wide Web##10##5##(1996-11#1)(2005-10#1)(2006-9#1)(2008-10#2)(2008-2#2)(2008-4#2)(2009-4#1)
on the World##13##3##(1996-11#1)(2005-10#1)(2006-9#1)(2007-2#1)(2007-3#1)(2008-10#2)(2008-2#2)(2008-4#2)(2009-4#1)(2012-2#1)
on the World-Wide Web##2##4##(1996-12#1)(2008-3#1)
on the X chromosome##8##4##(1990-12#1)(1991-12#1)(1993-10#1)(1996-12#2)(2006-10#1)(2008-9#1)(2010-4#1)
on the X##9##3##(1990-12#1)(1991-12#1)(1993-10#1)(1995-11#1)(1996-12#2)(2006-10#1)(2008-9#1)(2010-4#1)
on the X-ray##4##3##(1993-8#1)(2006-4#1)(2006-5#1)(2008-7#1)
on the Y chromosome##6##4##(1990-11#4)(1992-5#1)(1995-11#1)
on the Y##8##3##(1990-11#4)(1992-5#1)(1995-11#2)(2008-3#1)
on the Y-BOCS##2##3##(2008-3#2)
on the Z chromosome##2##4##(2008-5#2)
on the Zernike polynomials##3##4##(2008-3#3)
on the abaxial##2##3##(2008-10#1)(2008-5#1)
on the abdomen and##2##4##(1997-5#1)(2009-9#1)
on the abdomen##4##3##(1997-5#1)(2006-11#1)(2007-7#1)(2009-9#1)
on the abdominal##4##3##(2006-4#1)(2007-12#1)(2009-8#1)(2011-2#1)
on the ability of a##7##5##(1990-4#2)(1991-12#1)(1995-2#1)(1995-5#1)(1996-3#1)(2013-8#1)
on the ability of the##16##5##(1990-3#1)(1992-2#1)(1993-11#1)(1997-8#2)(2005-9#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-5#1)(2012-12#2)
on the ability of##65##4##(1990-11#2)(1990-3#1)(1990-4#2)(1991-12#1)(1991-3#1)(1992-2#1)(1992-4#1)(1992-7#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-12#1)(1996-3#2)(1996-5#1)(1997-5#1)(1997-6#1)(1997-8#2)(2005-11#1)(2005-9#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-10#6)(2008-11#2)(2008-4#9)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#2)(2013-8#2)
on the ability to isolate##2##5##(2008-10#1)(2009-6#1)
on the ability to##17##4##(1992-9#1)(2006-2#1)(2007-10#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-6#1)(2009-11#1)(2009-6#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-12#2)
on the ability##82##3##(1990-11#2)(1990-3#1)(1990-4#2)(1991-12#1)(1991-3#1)(1992-2#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-12#1)(1996-3#2)(1996-5#1)(1997-5#1)(1997-6#1)(1997-8#2)(2005-11#1)(2005-9#1)(2006-10#1)(2006-2#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-6#2)(2007-9#1)(2008-10#7)(2008-11#4)(2008-3#2)(2008-4#9)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#4)(2013-8#2)
on the above findings and##2##5##(1990-8#1)(2008-10#1)
on the above findings##4##4##(1990-8#1)(1997-8#1)(2008-10#2)
on the above parameters##2##4##(2007-11#1)(2013-1#1)
on the above##18##3##(1990-8#1)(1994-3#1)(1994-9#1)(1995-12#1)(1997-8#1)(2005-11#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2010-12#1)(2012-2#2)(2013-1#1)
on the absolute##7##3##(1993-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)
on the absorbance##5##3##(2008-10#5)
on the absorption of buagafuran in lumen##2##7##(2011-3#2)
on the absorption of buagafuran in##3##6##(2011-3#3)
on the absorption spectra of the complexes of##2##8##(2008-10#2)
on the absorption spectra of##3##5##(2008-10#3)
on the absorption spectrum of##2##5##(2008-2#1)(2008-5#1)
on the absorption spectrum##3##4##(2008-11#1)(2008-2#1)(2008-5#1)
on the absorption##16##3##(1997-3#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2011-3#4)(2013-1#1)
on the abundance##3##3##(2009-5#2)(2013-8#1)
on the academic performance##3##4##(2013-8#3)
on the academic##4##3##(2008-12#1)(2013-8#3)
on the acceleration##2##3##(2008-11#1)(2008-2#1)
on the acceptance##2##3##(2008-10#1)(2012-12#1)
on the accumulation of arsenic in eggs and excreta##2##9##(2013-1#2)
on the accumulation of##11##4##(1992-11#1)(1995-5#1)(1996-9#1)(1997-2#2)(2008-10#3)(2008-5#1)(2013-1#2)
on the accumulation##13##3##(1991-7#1)(1992-11#1)(1994-6#1)(1995-5#1)(1996-9#1)(1997-2#2)(2008-10#3)(2008-5#1)(2013-1#2)
on the accuracy and##4##4##(2008-10#2)(2008-3#2)
on the accuracy of the##10##5##(1993-1#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-3#4)(2009-7#1)(2010-12#1)
on the accuracy of##19##4##(1993-1#1)(1993-9#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#6)(2008-9#1)(2009-7#1)(2010-12#1)(2011-1#1)(2012-2#1)
on the accuracy##27##3##(1993-1#1)(1993-9#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-3#10)(2008-9#1)(2009-7#1)(2010-12#1)(2011-1#1)(2012-2#1)
on the accurate##4##3##(2007-7#1)(2007-8#1)(2008-1#1)(2009-10#1)
on the achievement of##2##4##(2007-7#1)(2008-1#1)
on the acidic##2##3##(2005-11#1)(2008-10#1)
on the acidity of##2##4##(2006-4#1)(2008-10#1)
on the acquired##2##3##(1993-5#1)(2012-3#1)
on the acquisition of a##2##5##(1991-1#1)(2008-10#1)
on the acquisition of two object##2##6##(1991-1#1)(1994-6#1)
on the acquisition of two##3##5##(1990-7#1)(1991-1#1)(1994-6#1)
on the acquisition of##7##4##(1990-7#1)(1991-1#2)(1994-6#1)(2008-10#1)(2008-5#1)(2008-8#1)
on the actin##5##3##(1990-12#1)(1990-7#1)(1996-5#2)(2008-10#1)
on the actin-activated ATPase##2##4##(1990-3#1)(1990-7#1)
on the actin-activated##4##3##(1990-3#1)(1990-7#2)(1993-6#1)
on the action of a##2##5##(1993-3#1)(2007-11#1)
on the action of##11##4##(1990-10#1)(1990-11#1)(1993-12#1)(1993-3#1)(1995-11#2)(1997-2#1)(1997-6#1)(2006-6#1)(2007-1#1)(2007-11#1)
on the action pattern of porcine pancreatic alpha-amylase##2##8##(1990-9#2)
on the action##16##3##(1990-10#1)(1990-11#1)(1990-9#2)(1993-12#1)(1993-3#1)(1995-11#2)(1997-2#1)(1997-6#1)(2005-4#1)(2006-6#1)(2007-1#1)(2007-11#1)(2008-4#2)
on the actions of##3##4##(1996-3#1)(2008-3#1)(2008-4#1)
on the activated##3##3##(1994-8#1)(2008-10#1)(2010-5#1)
on the activation energy##2##4##(1993-12#1)(2008-10#1)
on the activation of the##2##5##(1994-3#1)(2006-10#1)
on the activation of##8##4##(1991-3#1)(1991-8#1)(1994-3#2)(1997-4#1)(2005-11#1)(2006-10#1)(2012-3#1)
on the activation##12##3##(1991-3#1)(1991-8#1)(1992-7#1)(1993-12#1)(1994-3#2)(1996-8#1)(1997-4#1)(2005-11#1)(2006-10#1)(2008-10#1)(2012-3#1)
on the active medium of a neodymium##2##7##(2008-2#2)
on the active site##3##4##(1990-5#1)(1994-8#1)(1997-1#1)
on the active##11##3##(1990-5#1)(1991-6#1)(1993-5#1)(1994-8#1)(1997-1#1)(2008-10#1)(2008-2#2)(2008-6#1)(2008-8#1)(2012-2#1)
on the activities of the##5##5##(1991-1#1)(1991-11#1)(1994-8#1)(1996-8#1)(2008-6#1)
on the activities of##18##4##(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-4#1)(1991-8#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-8#1)(2004-11#1)(2008-10#1)(2008-6#1)(2008-7#1)
on the activities##20##3##(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-4#1)(1991-8#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-8#1)(2004-11#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2013-1#1)
on the activity and##2##4##(1996-5#1)(2008-11#1)
on the activity of antioxidant enzymes##3##6##(1990-4#2)(2011-12#1)
on the activity of antioxidant##4##5##(1990-4#2)(2011-12#1)(2011-2#1)
on the activity of the##13##5##(1991-7#1)(1992-1#2)(1993-9#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-6#1)(2006-11#1)(2008-10#1)(2009-4#1)(2010-9#1)(2013-1#1)
on the activity of three##2##5##(2008-11#1)(2008-5#1)
on the activity of##55##4##(1990-10#1)(1990-11#1)(1990-4#2)(1990-5#2)(1991-4#1)(1991-7#2)(1992-1#2)(1992-11#1)(1993-12#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-2#1)(1995-6#1)(1996-6#1)(1997-6#2)(2005-8#1)(2006-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-12#1)(2011-2#1)(2013-1#1)
on the activity##66##3##(1990-10#1)(1990-11#1)(1990-4#2)(1990-5#2)(1991-4#1)(1991-7#2)(1992-1#2)(1992-11#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-2#1)(1995-6#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-6#2)(1997-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-5#2)(2008-6#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-11#1)(2013-1#1)
on the actual use of##2##5##(2008-11#1)(2008-9#1)
on the actual##12##3##(1993-12#1)(1997-2#1)(2006-6#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2013-8#1)
on the acute##2##3##(1994-12#1)(2012-2#1)
on the acyl##2##3##(1990-4#1)(1991-5#1)
on the adaptation##2##3##(2010-1#1)(2011-1#1)
on the addition of##6##4##(1993-11#1)(1994-11#1)(2007-11#1)(2008-10#1)(2010-12#1)(2012-12#1)
on the additional##2##3##(2010-2#1)(2011-2#1)
on the adhesion##5##3##(2005-11#1)(2008-11#1)(2008-5#1)(2009-8#1)(2012-5#1)
on the adjustment of##2##4##(1994-6#1)(2008-2#1)
on the administration of##2##4##(2010-12#1)(2012-2#1)
on the administration##4##3##(1990-4#1)(2010-12#1)(2012-12#1)(2012-2#1)
on the administrative##2##3##(1994-3#1)(2012-3#1)
on the adoption of##4##4##(1997-7#1)(2010-3#1)(2011-2#1)(2013-1#1)
on the adrenal##2##3##(2011-1#1)(2011-2#1)
on the adrenergic##2##3##(1990-3#1)(1994-2#1)
on the adsorbent##2##3##(2008-10#1)(2008-4#1)
on the adsorption behavior of##2##5##(2005-11#2)
on the adsorption of globular proteins##2##6##(2005-11#2)
on the adsorption of##13##4##(2005-11#7)(2008-10#6)
on the adsorption##21##3##(2005-11#11)(2008-10#9)(2011-2#1)
on the advantages of##3##4##(1996-11#2)(2008-3#1)
on the advantages##4##3##(1996-11#2)(2008-3#1)(2012-2#1)
on the aerosol##2##3##(2008-2#1)(2008-3#1)
on the aesthetic##2##3##(2007-12#1)(2008-5#1)
on the aetiology and##2##4##(2007-11#1)(2007-2#1)
on the aetiology##3##3##(2007-11#1)(2007-2#1)(2008-4#1)
on the affected side during##2##5##(2010-2#2)
on the affected side##3##4##(2010-2#2)(2013-1#1)
on the affected##6##3##(2008-7#1)(2010-2#2)(2010-5#1)(2012-3#1)(2013-1#1)
on the afferent##2##3##(1990-5#1)(1996-9#1)
on the affinities of##2##4##(1991-9#1)(1992-6#1)
on the affinity of the##2##5##(1990-8#1)(1994-5#1)
on the affinity of##3##4##(1990-8#1)(1994-5#2)
on the affinity##4##3##(1990-8#1)(1991-11#1)(1994-5#2)
on the age and##2##4##(1990-8#1)(2004-11#1)
on the age of the##5##5##(1991-9#1)(2004-11#1)(2004-2#1)(2008-9#1)(2011-1#1)
on the age of##9##4##(1991-9#1)(1992-2#1)(2004-11#1)(2004-2#1)(2006-2#1)(2006-7#1)(2008-9#1)(2011-1#1)(2013-1#1)
on the age##13##3##(1990-8#1)(1991-9#1)(1992-2#1)(2004-11#2)(2004-2#1)(2006-2#1)(2006-7#1)(2008-9#1)(2009-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
on the ageing##2##3##(2008-11#1)(2008-5#1)
on the aggregation of##4##4##(1996-2#1)(2005-11#1)(2008-10#2)
on the air##3##3##(1992-4#1)(1995-7#1)(2008-3#1)
on the air/water interface##2##4##(2005-4#2)
on the alert##2##3##(1991-12#1)(2012-2#1)
on the algorithm##2##3##(1994-6#1)(2008-2#1)
on the algorithms##2##3##(2008-2#1)(2008-3#1)
on the alien##3##3##(2008-5#3)
on the alkyl chain##2##4##(2005-11#1)(2008-4#1)
on the alpha 1##2##4##(1995-3#1)(1995-8#1)
on the alpha##7##3##(1992-12#2)(1993-11#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-8#1)
on the alternative##4##3##(1993-8#1)(1994-12#1)(2007-1#1)(2008-8#1)
on the amino acid sequence##5##5##(1990-5#1)(1992-3#1)(1994-6#1)(1996-2#1)(1997-4#1)
on the amino acid##13##4##(1990-5#1)(1992-3#2)(1992-4#1)(1992-8#1)(1994-6#1)(1994-8#1)(1996-2#1)(1997-4#1)(2007-6#1)(2008-10#1)(2008-5#1)(2012-2#1)
on the amino##15##3##(1990-5#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-8#1)(1994-6#1)(1994-8#1)(1996-2#1)(1996-7#1)(1997-4#1)(2007-6#1)(2008-10#1)(2008-5#1)(2012-2#1)
on the aminoacylation of##2##4##(1990-2#2)
on the amount and##4##4##(2007-8#1)(2008-10#1)(2008-5#1)(2009-9#1)
on the amount of an adsorbent##2##6##(2005-11#2)
on the amount of the##2##5##(1990-2#1)(2004-4#1)
on the amount of##36##4##(1990-2#1)(1991-8#1)(1992-4#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-8#1)(1996-5#1)(1996-6#1)(1997-6#1)(2004-4#1)(2005-11#4)(2006-6#1)(2006-9#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-7#1)(2010-8#1)
on the amount##41##3##(1990-2#1)(1991-8#1)(1992-3#1)(1992-4#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-8#1)(1996-5#1)(1996-6#1)(1997-6#1)(2004-4#1)(2005-11#4)(2006-6#1)(2006-9#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#3)(2008-2#2)(2008-4#2)(2008-5#3)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-7#1)(2010-8#1)
on the amounts and##2##4##(1993-9#1)(2008-12#1)
on the amperometric##3##3##(2008-10#3)
on the amplified##2##3##(1995-12#1)(2008-2#1)
on the amplitude and##6##4##(1991-11#1)(1996-3#1)(2007-12#2)(2008-4#1)(2010-3#1)
on the amplitude of##2##4##(1997-4#1)(2009-4#1)
on the amplitude##8##3##(1991-11#1)(1996-3#1)(1997-4#1)(2007-12#2)(2008-4#1)(2009-4#1)(2010-3#1)
on the amplitudes of##3##4##(1997-2#2)(2008-2#1)
on the amygdala##3##3##(1992-8#1)(2008-6#1)(2009-2#1)
on the anaerobic##2##3##(2011-2#1)(2013-1#1)
on the analysis of the##9##5##(1994-9#1)(2005-4#1)(2006-10#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-6#1)(2013-8#1)
on the analysis of##32##4##(1993-2#1)(1993-9#1)(1994-2#1)(1994-9#1)(1996-12#1)(1997-7#1)(2005-11#1)(2005-4#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-1#1)(2013-8#1)
on the analysis##35##3##(1993-2#1)(1993-9#1)(1994-2#1)(1994-9#1)(1996-12#1)(1997-7#1)(2005-11#1)(2005-4#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#9)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-9#1)(2011-1#1)(2012-12#1)(2013-8#1)
on the analyte##4##3##(2007-8#1)(2008-10#3)
on the analytical performance of the##2##6##(2008-10#2)
on the analytical signal##4##4##(2008-10#4)
on the analytical##16##3##(2007-8#1)(2008-10#11)(2008-3#1)(2010-11#1)(2011-2#1)(2013-1#1)
on the analyzed##3##3##(2008-10#1)(2009-10#1)(2012-3#1)
on the anatomical location##2##4##(2008-1#1)(2013-8#1)
on the anatomical##5##3##(1994-12#1)(2008-1#1)(2009-11#1)(2009-2#1)(2013-8#1)
on the angle of incidence##2##5##(2007-2#1)(2008-3#1)
on the angle of##3##4##(2007-2#1)(2008-3#2)
on the angle##6##3##(2007-12#1)(2007-2#1)(2008-1#1)(2008-3#2)(2008-9#1)
on the angular##3##3##(2008-2#2)(2008-3#1)
on the animal##4##3##(2008-4#2)(2008-8#1)(2010-1#1)
on the anion##4##3##(1991-10#1)(2005-12#1)(2008-10#1)(2011-1#1)
on the anisotropy##3##3##(1991-5#1)(2007-11#1)(2008-3#1)
on the antagonistic##2##3##(2008-12#1)(2008-9#1)
on the antenna of##2##4##(2007-12#1)(2008-10#1)
on the antenna##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
on the anterior##7##3##(1996-9#1)(2006-7#1)(2007-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2010-2#1)
on the anterolateral aspect of her right thigh##3##8##(2006-7#3)
on the antiarrhythmic##2##3##(2004-11#2)
on the antibacterial##3##3##(2008-12#2)(2008-5#1)
on the anticoagulant##2##3##(1990-12#1)(2010-7#1)
on the antimicrobial##2##3##(2006-8#1)(2012-12#1)
on the antioxidant activity of##2##5##(2010-8#1)(2012-2#1)
on the antioxidant properties of##2##5##(2008-10#1)(2013-1#1)
on the antioxidant##6##3##(1997-6#1)(2008-10#1)(2010-4#1)(2010-8#1)(2012-2#1)(2013-1#1)
on the antiproliferative##2##3##(2008-5#1)(2010-12#1)
on the antisaccade task##3##4##(1995-1#1)(2006-4#2)
on the antisense strand##2##4##(2006-12#2)
on the antisense##3##3##(2006-12#3)
on the aortic##2##3##(1990-11#1)(2010-8#1)
on the aperture size##2##4##(2007-12#1)(2008-2#1)
on the apical membrane of the##2##6##(2008-3#1)(2008-6#1)
on the apical membrane of##3##5##(2008-3#1)(2008-4#1)(2008-6#1)
on the apical membrane##4##4##(2008-3#1)(2008-4#2)(2008-6#1)
on the apical##7##3##(1994-10#1)(1997-5#1)(2007-12#1)(2008-3#1)(2008-4#2)(2008-6#1)
on the apomorphine (0##2##4##(1995-12#2)
on the apoptosis##2##3##(2006-4#1)(2012-2#1)
on the apoptotic##2##3##(2011-1#2)
on the apparent##2##3##(1996-11#1)(2008-2#1)
on the appearance of##4##4##(2008-11#1)(2008-2#1)(2008-5#1)(2009-5#1)
on the appearance##6##3##(2006-10#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-5#1)
on the applicability of##3##4##(1994-2#1)(1997-4#1)(2007-8#1)
on the application of a##5##5##(2008-10#2)(2008-3#1)(2008-5#1)(2010-4#1)
on the application of the##2##5##(2008-2#1)(2013-1#1)
on the application of these##2##5##(2007-4#1)(2008-9#1)
on the application of##42##4##(1991-6#1)(1993-11#1)(1993-6#1)(1994-2#1)(1996-5#1)(2005-9#1)(2006-10#2)(2007-11#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-8#3)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
on the application##43##3##(1991-6#1)(1993-11#1)(1993-6#1)(1994-2#1)(1996-5#1)(2005-9#1)(2006-10#2)(2007-11#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-8#3)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
on the applications of##2##4##(1990-8#1)(1997-6#1)
on the applications##3##3##(1990-8#1)(1994-1#1)(1997-6#1)
on the applied##11##3##(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2013-1#1)
on the approach to##3##4##(1993-6#1)(2008-10#1)(2008-4#1)
on the approach##5##3##(1993-6#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-10#1)
on the approaches##2##3##(2008-12#1)(2008-5#1)
on the appropriate##8##3##(1991-3#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-2#1)(2013-1#1)
on the appropriateness of##2##4##(2006-10#1)(2010-11#1)
on the aqueous lubrication properties of##2##6##(2010-4#2)
on the aqueous two-phase system##2##5##(2008-10#1)(2008-6#1)
on the aqueous##7##3##(2008-10#2)(2008-5#1)(2008-6#1)(2009-4#1)(2010-4#2)
on the architecture##2##3##(2007-11#1)(2007-12#1)
on the area of##4##4##(2006-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
on the area##7##3##(1991-11#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-2#1)
on the areas##2##3##(2007-1#1)(2010-4#1)
on the argument##2##3##(1996-6#1)(2008-6#1)
on the array##2##3##(2007-8#1)(2008-10#1)
on the arrested heart##5##4##(2006-6#1)(2007-8#4)
on the arrested##7##3##(2006-6#1)(2007-12#1)(2007-8#5)
on the arthropod fauna##2##4##(2008-5#2)
on the arthropod##3##3##(2008-5#2)(2011-2#1)
on the article by##2##4##(1990-8#1)(2006-6#1)
on the article##4##3##(1990-8#1)(2006-6#1)(2012-11#2)
on the aspect of##2##4##(2007-12#1)(2011-2#1)
on the assay##3##3##(1992-9#1)(1993-8#1)(2008-1#1)
on the assembly##3##3##(1994-3#1)(2006-9#1)(2008-10#1)
on the assessment and management of foot ulcers for people with diabetes##2##12##(2010-10#2)
on the assessment of the##2##5##(2006-10#1)(2012-11#1)
on the assessment of##12##4##(1993-10#1)(1997-2#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-1#1)(2010-5#1)(2010-6#1)(2012-11#1)(2013-8#1)
on the assessment##16##3##(1993-10#1)(1997-2#1)(2005-8#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-1#1)(2010-10#2)(2010-5#1)(2010-6#1)(2012-1#1)(2012-11#1)(2013-8#1)
on the associated##3##3##(2008-5#2)(2013-8#1)
on the association between##21##4##(2005-10#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-6#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-10#1)(2010-2#2)(2010-9#1)(2011-1#3)(2012-1#4)(2013-1#2)
on the association of genotypes##2##5##(2008-12#1)(2012-12#1)
on the association of the##3##5##(2008-3#1)(2008-5#1)(2010-12#1)
on the association of##13##4##(1991-4#1)(1993-12#1)(1993-6#1)(2005-10#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-12#1)(2012-12#1)(2012-2#2)
on the association##36##3##(1991-4#1)(1993-12#1)(1993-6#1)(2005-10#2)(2006-12#1)(2006-2#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#2)(2009-5#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-9#1)(2011-1#3)(2012-1#4)(2012-12#1)(2012-2#2)(2013-1#3)
on the associations among##2##4##(2007-6#1)(2012-12#1)
on the associations##3##3##(2007-6#1)(2010-10#1)(2012-12#1)
on the assumption of##8##4##(1994-2#1)(1997-2#1)(1997-6#1)(2005-11#1)(2008-10#2)(2008-3#1)(2009-2#1)
on the assumption that both##2##5##(1992-12#1)(2006-12#1)
on the assumption that the##7##5##(1992-6#1)(2006-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-11#1)(2012-2#1)
on the assumption that##22##4##(1992-12#1)(1992-6#1)(1996-12#1)(1997-1#1)(2006-11#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#2)(2009-5#1)(2009-7#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#2)
on the assumption##30##3##(1992-12#1)(1992-6#1)(1994-2#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-6#1)(2005-11#1)(2006-11#1)(2006-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-9#2)(2009-2#1)(2009-5#1)(2009-7#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#2)
on the assumptions of##2##4##(2008-3#1)(2013-7#1)
on the assumptions##3##3##(2008-2#1)(2008-3#1)(2013-7#1)
on the atmospheric##6##3##(1992-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2013-8#1)
on the atomic##4##3##(1991-11#1)(2007-12#1)(2008-3#1)(2013-1#1)
on the atomization##2##3##(2008-10#2)
on the atrial##3##3##(2007-8#1)(2008-4#1)(2008-5#1)
on the attachment of##2##4##(1991-5#1)(1993-5#1)
on the attachment##3##3##(1991-5#1)(1993-5#1)(1994-5#1)
on the auditory##2##3##(2008-9#1)(2013-1#1)
on the author's own experience##2##5##(2007-11#1)(2008-12#1)
on the author's##4##3##(1991-1#1)(2007-11#1)(2007-4#1)(2008-12#1)
on the authors' experience##2##4##(2005-1#1)(2008-12#1)
on the authors'##4##3##(2005-1#1)(2007-7#1)(2007-8#1)(2008-12#1)
on the autonomic nervous##2##4##(2011-12#1)(2012-2#1)
on the autonomic##3##3##(2007-10#1)(2011-12#1)(2012-2#1)
on the availability of##19##4##(1990-12#1)(1991-1#1)(1991-11#1)(1992-3#1)(1993-11#1)(1994-12#1)(1994-7#1)(2007-1#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-8#1)(2011-2#1)(2013-8#1)
on the available evidence##3##4##(2006-10#1)(2008-12#1)(2008-9#1)
on the available literature##2##4##(2007-4#1)(2008-11#1)
on the available##17##3##(1992-12#1)(2006-10#2)(2007-4#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#1)(2012-2#1)(2013-8#2)
on the average##22##3##(1990-11#1)(1993-12#1)(1994-3#2)(1995-1#1)(1996-4#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#2)
on the axial##2##3##(1990-3#1)(2006-11#1)
on the axillary##2##3##(2008-5#2)
on the axis of##2##4##(2007-5#1)(2008-2#1)
on the axis##3##3##(2007-12#1)(2007-5#1)(2008-2#1)
on the baby##2##3##(2007-2#1)(2008-2#1)
on the baby's##2##3##(2008-11#1)(2008-2#1)
on the back and##2##4##(2008-5#1)(2012-1#1)
on the back of a##2##5##(2008-11#2)
on the back of the hand and##2##7##(2007-11#1)(2008-2#1)
on the back of the##5##5##(1990-6#1)(2007-11#1)(2007-7#1)(2008-2#1)(2012-3#1)
on the back of##8##4##(1990-6#1)(1995-2#1)(2007-11#1)(2007-7#1)(2008-11#2)(2008-2#1)(2012-3#1)
on the back##24##3##(1990-6#1)(1990-8#1)(1995-2#1)(2006-4#1)(2007-11#1)(2007-4#2)(2007-7#1)(2007-8#2)(2008-11#3)(2008-2#3)(2008-3#1)(2008-5#2)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
on the backbone##2##3##(1996-7#1)(2007-3#1)
on the background##6##3##(2006-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2012-2#1)
on the bacterial##5##3##(1997-4#1)(2007-8#1)(2008-10#1)(2010-1#1)(2011-2#1)
on the balance between##4##4##(2007-11#1)(2008-11#1)(2008-7#1)(2013-7#1)
on the balance##6##3##(2005-1#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-7#1)(2013-7#1)
on the bare##2##3##(2008-10#2)
on the barley##2##3##(2008-10#1)(2008-5#1)
on the barrier##2##3##(1994-8#1)(2013-8#1)
on the basal##7##3##(1990-2#1)(1991-7#1)(1995-2#1)(1996-12#1)(2008-12#1)(2008-5#1)(2013-8#1)
on the base of the##5##5##(1991-9#1)(2006-6#1)(2007-1#1)(2007-12#1)(2008-11#1)
on the base of##12##4##(1991-9#1)(2004-10#1)(2005-4#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-7#1)
on the base##16##3##(1991-9#1)(1992-9#1)(1995-5#1)(1995-6#1)(2004-10#1)(2005-4#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-7#1)
on the baseline##2##3##(1992-7#1)(2009-9#1)
on the basement membrane##3##4##(1991-8#1)(2008-5#1)(2009-10#1)
on the bases of their##2##5##(2008-10#1)(2008-5#1)
on the bases of##4##4##(1995-2#1)(2008-10#1)(2008-5#1)(2008-7#1)
on the bases##5##3##(1995-2#1)(2008-10#2)(2008-5#1)(2008-7#1)
on the basic knowledge##2##4##(2008-10#1)(2011-2#1)
on the basic##11##3##(1992-11#1)(1996-3#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-1#1)
on the basis of CT findings##3##6##(1997-8#1)(2008-1#1)(2010-12#1)
on the basis of a comparison of##2##7##(1990-7#1)(2008-3#1)
on the basis of a simple##2##6##(1991-2#1)(1993-6#1)
on the basis of a simplified##2##6##(1991-2#1)(1996-1#1)
on the basis of a single##2##6##(2008-6#1)(2013-1#1)
on the basis of a##52##5##(1990-2#1)(1990-7#1)(1991-2#2)(1991-3#2)(1991-5#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(2005-8#1)(2006-10#1)(2006-6#2)(2007-1#2)(2007-12#1)(2007-6#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
on the basis of abnormal##3##5##(1993-11#2)(2013-1#1)
on the basis of age and##2##6##(2006-12#1)(2007-8#1)
on the basis of age##4##5##(2006-12#1)(2007-8#1)(2008-3#1)(2008-5#1)
on the basis of amino acid sequence##3##7##(1990-5#1)(1990-7#1)(1992-7#1)
on the basis of an original##2##6##(2007-12#1)(2008-3#1)
on the basis of an##11##5##(1992-3#1)(1994-11#1)(1994-6#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-11#1)
on the basis of analytical##3##5##(2008-5#2)(2012-2#1)
on the basis of anatomical##2##5##(1992-7#1)(1993-2#1)
on the basis of bacterial##2##5##(2011-2#1)(2013-1#1)
on the basis of body size##2##6##(2007-8#2)
on the basis of cell##2##5##(1996-4#1)(1997-7#1)
on the basis of chemical and##2##6##(2007-1#2)
on the basis of chemical composition##2##6##(2008-10#1)(2008-3#1)
on the basis of chemical##8##5##(1995-2#1)(2006-12#1)(2007-1#3)(2008-10#1)(2008-3#1)(2010-5#1)
on the basis of clinical and radiological examination##2##8##(2007-8#2)
on the basis of clinical and##5##6##(1990-5#1)(1993-11#1)(2006-6#1)(2007-8#2)
on the basis of clinical symptoms##3##6##(1992-12#1)(2006-6#1)(2011-2#1)
on the basis of clinical##16##5##(1990-5#1)(1990-6#1)(1992-10#1)(1992-12#1)(1993-11#1)(2006-6#3)(2007-8#2)(2008-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
on the basis of conventional##2##5##(1994-11#1)(2007-11#1)
on the basis of data##5##5##(1990-9#1)(2007-7#1)(2007-8#1)(2008-2#1)(2012-2#1)
on the basis of differences##2##5##(2008-10#1)(2013-1#1)
on the basis of differential staining with##3##7##(1997-8#1)(2008-4#1)(2008-9#1)
on the basis of disability##2##5##(1994-1#1)(1996-6#1)
on the basis of disease##2##5##(2006-10#1)(2013-1#1)
on the basis of efficiency##2##5##(1997-1#1)(2008-10#1)
on the basis of electrostatic interactions##2##6##(2005-11#1)(2008-5#1)
on the basis of elemental analysis and##3##7##(2006-9#1)(2008-10#1)(2010-3#1)
on the basis of elemental analysis##5##6##(2006-9#1)(2007-11#1)(2008-10#1)(2008-5#1)(2010-3#1)
on the basis of elemental##6##5##(2006-9#1)(2007-11#1)(2008-10#1)(2008-5#2)(2010-3#1)
on the basis of experimental results##2##6##(2008-2#2)
on the basis of experimental##3##5##(2006-11#1)(2008-2#2)
on the basis of extensive##2##5##(2007-11#1)(2010-6#1)
on the basis of heat stability##2##6##(1990-10#1)(1995-2#1)
on the basis of history##2##5##(2007-7#1)(2008-4#1)
on the basis of host reactions##2##6##(2008-10#2)
on the basis of in vitro##2##6##(1995-4#1)(1997-2#1)
on the basis of in##3##5##(1995-4#1)(1997-2#1)(2012-3#1)
on the basis of individual##3##5##(2007-8#1)(2008-11#1)(2009-7#1)
on the basis of information##2##5##(1994-5#1)(2008-4#1)
on the basis of ionic##2##5##(2006-1#1)(2008-5#1)
on the basis of its##17##5##(1990-10#1)(1990-4#1)(1990-7#1)(1991-8#1)(1992-12#2)(1992-9#1)(1993-11#1)(1993-3#1)(1993-7#1)(1993-8#1)(1997-2#1)(1997-8#1)(2005-11#1)(2008-10#2)(2008-3#1)
on the basis of literature##2##5##(2006-2#1)(2010-3#1)
on the basis of luciferase##2##5##(1996-11#1)(2004-4#1)
on the basis of measurements##2##5##(2008-2#1)(2008-9#1)
on the basis of molecular##2##5##(2008-7#1)(2008-8#1)
on the basis of morphological##2##5##(2008-10#1)(2012-2#1)
on the basis of morphology##2##5##(2007-2#1)(2008-10#1)
on the basis of new##2##5##(2007-1#1)(2008-2#1)
on the basis of objective criteria##2##6##(2005-5#1)(2006-3#1)
on the basis of our##4##5##(1997-2#1)(2007-12#1)(2011-1#1)(2013-8#1)
on the basis of personal experience##2##6##(1990-3#1)(1992-9#1)
on the basis of positive##2##5##(1996-9#1)(2006-12#1)
on the basis of recent##2##5##(1990-10#1)(1990-6#1)
on the basis of recipient##2##5##(1997-5#1)(2007-8#1)
on the basis of scientific##2##5##(2007-9#1)(2010-1#1)
on the basis of sclerotial morphology##2##6##(2008-10#2)
on the basis of sequence homology##2##6##(1992-12#1)(1995-8#1)
on the basis of sequence##4##5##(1992-12#1)(1995-8#1)(1996-6#1)(2008-7#1)
on the basis of sex##2##5##(2008-4#1)(2009-1#1)
on the basis of some##2##5##(1997-5#1)(2008-10#1)
on the basis of spectral data##2##6##(2008-11#1)(2008-6#1)
on the basis of spectral##4##5##(2007-1#1)(2008-11#1)(2008-6#1)(2010-3#1)
on the basis of spectroscopic and chemical##2##7##(1994-3#1)(2008-4#1)
on the basis of spectroscopic##6##5##(1994-3#1)(2007-11#2)(2008-10#1)(2008-4#1)(2013-1#1)
on the basis of studies##2##5##(1995-5#1)(1997-2#1)
on the basis of symptoms##2##5##(1993-9#1)(2007-9#1)
on the basis of test##2##5##(1996-2#1)(2011-2#1)
on the basis of the X-ray##2##6##(1991-7#1)(1995-8#1)
on the basis of the analysis of##2##7##(2007-4#1)(2010-5#1)
on the basis of the available literature##4##7##(1993-5#1)(2007-11#1)(2007-8#1)(2009-4#1)
on the basis of the binding##2##6##(1994-5#1)(1996-11#1)
on the basis of the clinical##4##6##(1990-12#1)(2008-10#1)(2012-12#2)
on the basis of the concept of##3##7##(1994-9#1)(2006-10#1)(2008-2#1)
on the basis of the data obtained from a##2##9##(2008-10#1)(2010-8#1)
on the basis of the data##3##6##(2008-10#1)(2008-9#1)(2010-8#1)
on the basis of the known##2##6##(1992-3#1)(2008-2#1)
on the basis of the literature and##2##7##(1992-8#1)(2007-8#1)
on the basis of the mechanism of the##2##8##(1992-3#1)(2008-10#1)
on the basis of the presence of##2##7##(2006-10#1)(2007-2#1)
on the basis of the presence##3##6##(2006-10#1)(2007-2#1)(2010-8#1)
on the basis of the response of the##2##8##(2008-10#2)
on the basis of the results of##5##7##(1995-8#1)(1996-4#1)(2007-11#1)(2007-12#1)(2008-10#1)
on the basis of the results##6##6##(1995-8#1)(1996-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-6#1)
on the basis of the sequence##2##6##(1996-4#1)(2005-11#1)
on the basis of the##169##5##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-4#2)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-5#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-10#1)(1995-2#2)(1995-3#1)(1995-8#2)(1996-11#1)(1996-3#1)(1996-4#3)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#3)(1997-2#1)(1997-4#1)(1997-8#2)(2004-11#1)(2005-11#6)(2006-10#5)(2006-12#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#6)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#4)(2007-9#3)(2008-10#15)(2008-11#2)(2008-2#10)(2008-3#8)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-9#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-11#1)(2011-12#1)(2012-11#1)(2012-12#5)(2012-2#1)(2013-1#1)(2013-7#1)
on the basis of their past condom use##2##8##(2012-3#2)
on the basis of their physical##3##6##(2008-5#3)
on the basis of their##59##5##(1990-2#1)(1990-4#1)(1990-7#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-5#1)(1995-8#1)(1996-2#1)(1997-8#2)(2005-10#1)(2005-11#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-1#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-3#2)(2010-4#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)
on the basis of theoretical##2##5##(2007-11#1)(2008-2#1)
on the basis of these results##2##6##(1992-8#1)(2013-1#1)
on the basis of these##12##5##(1992-8#1)(1994-4#1)(1995-10#1)(1996-5#1)(1997-1#1)(2007-4#1)(2008-10#3)(2008-5#1)(2009-11#1)(2013-1#1)
on the basis of this##4##5##(1990-6#1)(1994-6#1)(2008-12#1)(2008-2#1)
on the basis of two##2##5##(1990-12#1)(2008-10#1)
on the basis of##764##4##(1990-1#1)(1990-10#5)(1990-11#3)(1990-12#6)(1990-2#6)(1990-3#3)(1990-4#3)(1990-5#6)(1990-6#4)(1990-7#5)(1990-8#2)(1990-9#3)(1991-1#2)(1991-10#1)(1991-12#1)(1991-2#4)(1991-3#3)(1991-4#4)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#3)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#8)(1992-2#2)(1992-3#5)(1992-4#2)(1992-5#3)(1992-6#3)(1992-7#2)(1992-8#3)(1992-9#5)(1993-11#6)(1993-12#4)(1993-2#3)(1993-3#3)(1993-4#2)(1993-5#3)(1993-6#2)(1993-7#1)(1993-8#4)(1993-9#5)(1994-1#1)(1994-10#1)(1994-11#5)(1994-12#1)(1994-2#2)(1994-3#2)(1994-4#1)(1994-5#6)(1994-6#6)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#6)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#5)(1996-2#3)(1996-3#2)(1996-4#4)(1996-5#2)(1996-6#3)(1996-7#3)(1996-8#2)(1996-9#1)(1997-1#9)(1997-2#7)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#10)(2004-11#1)(2004-3#1)(2004-4#2)(2005-10#1)(2005-11#11)(2005-5#1)(2005-8#1)(2006-1#1)(2006-10#17)(2006-11#2)(2006-12#7)(2006-2#4)(2006-3#2)(2006-4#1)(2006-5#4)(2006-6#6)(2006-7#2)(2006-8#1)(2006-9#4)(2007-1#10)(2007-11#20)(2007-12#10)(2007-2#4)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#10)(2007-8#20)(2007-9#7)(2008-1#7)(2008-10#70)(2008-11#12)(2008-12#2)(2008-2#29)(2008-3#24)(2008-4#19)(2008-5#24)(2008-6#6)(2008-7#13)(2008-8#7)(2008-9#11)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#6)(2009-3#1)(2009-4#3)(2009-6#1)(2009-7#5)(2009-9#2)(2010-1#1)(2010-11#4)(2010-12#4)(2010-2#1)(2010-3#7)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#5)(2011-1#6)(2011-11#1)(2011-12#2)(2011-2#10)(2011-3#2)(2012-1#4)(2012-11#1)(2012-12#8)(2012-2#9)(2012-3#5)(2013-1#14)(2013-7#3)(2013-8#7)
on the basis that the##2##5##(1997-8#1)(2010-12#1)
on the basis that##7##4##(1990-4#1)(1997-1#1)(1997-8#1)(2008-5#1)(2010-12#2)(2012-12#1)
on the basis##776##3##(1990-1#1)(1990-10#5)(1990-11#3)(1990-12#6)(1990-2#6)(1990-3#3)(1990-4#4)(1990-5#6)(1990-6#4)(1990-7#5)(1990-8#2)(1990-9#3)(1991-1#2)(1991-10#1)(1991-12#1)(1991-2#4)(1991-3#3)(1991-4#4)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#3)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#8)(1992-2#2)(1992-3#5)(1992-4#2)(1992-5#3)(1992-6#3)(1992-7#2)(1992-8#3)(1992-9#5)(1993-11#6)(1993-12#4)(1993-2#3)(1993-3#3)(1993-4#2)(1993-5#3)(1993-6#2)(1993-7#1)(1993-8#4)(1993-9#5)(1994-1#1)(1994-10#1)(1994-11#5)(1994-12#1)(1994-2#2)(1994-3#2)(1994-4#1)(1994-5#6)(1994-6#6)(1994-7#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#6)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#5)(1996-2#3)(1996-3#2)(1996-4#4)(1996-5#2)(1996-6#3)(1996-7#3)(1996-8#2)(1996-9#1)(1997-1#10)(1997-2#7)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#12)(2004-11#1)(2004-3#1)(2004-4#2)(2005-10#1)(2005-11#11)(2005-5#1)(2005-8#1)(2006-1#1)(2006-10#17)(2006-11#2)(2006-12#7)(2006-2#4)(2006-3#2)(2006-4#1)(2006-5#4)(2006-6#6)(2006-7#2)(2006-8#1)(2006-9#4)(2007-1#10)(2007-11#20)(2007-12#10)(2007-2#4)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#10)(2007-8#20)(2007-9#7)(2008-1#7)(2008-10#70)(2008-11#12)(2008-12#2)(2008-2#30)(2008-3#24)(2008-4#19)(2008-5#25)(2008-6#6)(2008-7#13)(2008-8#7)(2008-9#11)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#6)(2009-3#1)(2009-4#3)(2009-6#1)(2009-7#5)(2009-9#2)(2010-1#1)(2010-11#4)(2010-12#6)(2010-2#1)(2010-3#7)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#5)(2011-1#6)(2011-11#1)(2011-12#2)(2011-2#10)(2011-3#2)(2012-1#5)(2012-11#1)(2012-12#9)(2012-2#9)(2012-3#5)(2013-1#15)(2013-7#3)(2013-8#7)
on the basolateral##2##3##(2007-12#1)(2008-8#1)
on the battery##2##3##(1996-5#1)(2008-10#1)
on the battlefield##2##3##(2010-2#1)(2011-2#1)
on the beads##6##3##(1990-8#2)(1995-6#1)(2008-10#2)(2012-1#1)
on the beam##4##3##(2006-5#1)(2007-12#1)(2008-2#1)(2008-3#1)
on the beating heart##11##4##(2006-6#4)(2007-8#7)
on the behavior and##3##4##(1991-12#1)(2007-4#1)(2009-8#1)
on the behavior of a##2##5##(2005-11#2)
on the behavior of the##4##5##(1990-8#1)(1995-10#1)(2008-10#1)(2011-2#1)
on the behavior of##13##4##(1990-8#1)(1995-10#1)(2005-11#2)(2007-12#1)(2008-10#1)(2008-5#1)(2009-12#1)(2009-9#1)(2010-7#1)(2011-2#2)(2013-7#1)
on the behavior##17##3##(1990-8#1)(1991-12#1)(1995-10#1)(2005-11#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-5#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-7#1)(2011-2#2)(2013-7#1)
on the behavioral and##2##4##(1991-1#1)(1993-5#1)
on the behavioral##3##3##(1991-1#1)(1993-12#1)(1993-5#1)
on the behaviour of the##3##5##(2007-12#1)(2008-10#1)(2008-5#1)
on the behaviour of##8##4##(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#3)
on the behavioural##2##3##(1994-3#1)(2005-7#1)
on the benchmark##3##3##(2009-5#1)(2010-2#1)(2012-3#1)
on the beneficial##2##3##(2008-10#1)(2008-8#1)
on the benefits and##3##4##(2008-6#1)(2010-8#1)(2012-1#1)
on the benefits of##8##4##(1995-12#1)(1995-6#1)(2007-1#1)(2007-2#1)(2008-2#1)(2008-8#1)(2012-2#1)(2013-1#1)
on the benefits##13##3##(1995-12#2)(1995-6#1)(2007-1#1)(2007-2#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#1)
on the benzene ring##2##4##(1990-8#1)(2008-10#1)
on the benzene##3##3##(1990-8#1)(1996-8#1)(2008-10#1)
on the best available evidence##3##5##(2008-9#1)(2012-11#1)(2012-2#1)
on the best available##5##4##(2007-8#1)(2008-9#1)(2012-11#1)(2012-2#2)
on the best##14##3##(1991-3#1)(1991-6#1)(1991-7#1)(1996-2#1)(2006-10#2)(2007-8#1)(2008-11#1)(2008-9#1)(2010-11#1)(2010-12#1)(2012-11#1)(2012-2#2)
on the beta##4##3##(1992-4#1)(1992-6#1)(1997-1#1)(2010-5#1)
on the beta-barrel of##2##4##(1994-11#2)
on the big##2##3##(1997-3#1)(2013-8#1)
on the bilayer##3##3##(1990-2#1)(1996-1#1)(2008-4#1)
on the binding activity##2##4##(1992-2#1)(1997-4#1)
on the binding of the##3##5##(1991-10#1)(1992-4#1)(1997-5#1)
on the binding of##27##4##(1990-10#1)(1990-12#1)(1990-5#1)(1991-10#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-7#1)(1993-9#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#3)(1996-6#1)(1997-2#1)(1997-5#1)(2006-12#1)(2008-3#1)
on the binding to##2##4##(1992-9#1)(1995-6#1)
on the binding##41##3##(1990-10#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-11#2)(1991-2#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-7#1)(1993-9#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#3)(1995-3#1)(1995-6#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-5#1)(2006-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
on the bioadhesion of##2##4##(2004-12#1)(2010-7#1)
on the bioavailability of##3##4##(2008-5#2)(2010-7#1)
on the biochemical origins of##2##5##(2008-5#2)
on the biochemical##8##3##(1991-9#1)(1993-8#2)(1997-8#1)(2008-5#2)(2010-4#1)(2011-2#1)
on the biochemistry and##2##4##(2012-2#1)(2012-3#1)
on the biochemistry##3##3##(2007-12#1)(2012-2#1)(2012-3#1)
on the biodegradation of##2##4##(2006-10#1)(2008-3#1)
on the biodiversity##2##3##(2008-8#1)(2012-2#1)
on the biological activity of##2##5##(1995-2#1)(1997-7#1)
on the biological activity##5##4##(1995-2#1)(1997-4#1)(1997-7#1)(2006-12#1)(2008-5#1)
on the biological and##2##4##(2006-7#1)(2008-10#1)
on the biological behaviour of##2##5##(2008-5#1)(2008-7#1)
on the biological control##2##4##(2008-10#1)(2008-8#1)
on the biological sample##2##4##(2008-10#1)(2008-7#1)
on the biological##22##3##(1991-12#1)(1992-8#1)(1995-2#1)(1995-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-12#1)(2006-7#1)(2008-10#3)(2008-5#2)(2008-7#2)(2008-8#2)(2009-9#1)(2010-10#1)(2011-2#1)(2012-12#1)
on the biology and##2##4##(2008-12#1)(2008-6#1)
on the biology of the##2##5##(2008-1#1)(2008-10#1)
on the biology of##4##4##(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)
on the biology##7##3##(2008-1#1)(2008-10#2)(2008-12#2)(2008-6#2)
on the biomass of##3##4##(2008-10#1)(2008-8#1)(2013-1#1)
on the biomass##7##3##(2007-6#1)(2008-10#4)(2008-8#1)(2013-1#1)
on the biomechanical##2##3##(2008-5#1)(2010-9#1)
on the biosensor##6##3##(2008-10#6)
on the biosynthesis and##2##4##(1997-8#1)(2007-5#1)
on the biosynthesis of##4##4##(1993-8#1)(1993-9#1)(1995-1#1)(2006-12#1)
on the biosynthesis##6##3##(1993-8#1)(1993-9#1)(1995-1#1)(1997-8#1)(2006-12#1)(2007-5#1)
on the bit-error##2##3##(2008-2#2)
on the blood pressure##2##4##(1997-5#1)(2008-7#1)
on the blood##11##3##(1992-4#1)(1993-9#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)
on the blue side of the##2##6##(2007-12#1)(2008-3#1)
on the blue##3##3##(1994-5#1)(2007-12#1)(2008-3#1)
on the body image##2##4##(2006-7#1)(2007-12#1)
on the body surface##2##4##(1995-10#1)(2012-11#1)
on the body##19##3##(1995-10#1)(1995-12#1)(2005-10#2)(2006-10#1)(2006-7#1)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#1)
on the bone##6##3##(2004-2#1)(2008-1#1)(2008-12#1)(2008-8#1)(2010-12#1)(2010-9#1)
on the bottom of the vial##2##6##(2008-3#2)
on the bottom of the##4##5##(2008-10#1)(2008-3#2)(2012-4#1)
on the bottom of##6##4##(2008-10#1)(2008-3#2)(2008-9#1)(2011-2#1)(2012-4#1)
on the bottom##10##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-8#1)(2008-9#1)(2011-2#1)(2012-4#1)
on the boundary##2##3##(2008-2#1)(2009-10#1)
on the bowel##2##3##(2006-5#1)(2007-5#1)
on the brain and##2##4##(1994-11#1)(2013-1#1)
on the brain##21##3##(1991-5#1)(1994-11#1)(1995-1#1)(1995-6#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#2)
on the brains of##3##4##(2007-12#1)(2007-9#1)(2008-7#1)
on the branching pattern of##2##5##(2011-1#2)
on the breast##4##3##(1993-1#2)(2011-1#1)(2012-2#1)
on the breeding##2##3##(2010-8#1)(2013-7#1)
on the bridge##2##3##(1995-4#1)(2008-2#1)
on the brush##2##3##(1992-2#1)(2012-11#1)
on the buccal##2##3##(1991-2#1)(2012-3#1)
on the buffer##3##3##(2006-10#1)(2008-10#1)(2008-5#1)
on the buffering##2##3##(1991-6#1)(2006-10#1)
on the bulk##2##3##(1994-12#1)(2005-11#1)
on the buttocks##2##3##(2006-10#1)(2008-5#1)
on the cAMP##2##3##(1990-10#1)(1991-7#1)
on the calcium##3##3##(1997-7#1)(2008-4#2)
on the calculated##7##3##(1990-4#1)(1996-1#1)(2007-11#1)(2007-7#1)(2008-10#3)
on the calculation of the##2##5##(2008-2#1)(2008-3#1)
on the calculation of##6##4##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)
on the calculation##8##3##(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#2)
on the calibration##2##3##(2008-10#1)(2008-3#1)
on the camera##2##3##(2006-6#1)(2008-2#1)
on the campus of##2##4##(2008-10#1)(2008-5#1)
on the cancer##3##3##(2006-10#1)(2007-12#1)(2011-1#1)
on the cantilever##2##3##(2005-11#1)(2008-10#1)
on the capability of the##2##5##(2006-10#1)(2008-2#1)
on the capability of##3##4##(1992-2#1)(2006-10#1)(2008-2#1)
on the capacity of##7##4##(1990-5#1)(2008-6#1)(2009-9#1)(2012-12#4)
on the capacity to##3##4##(1995-11#1)(2008-11#2)
on the capacity##11##3##(1990-5#1)(1995-11#1)(2008-11#2)(2008-2#1)(2008-6#1)(2009-9#1)(2012-12#4)
on the carbohydrate##2##3##(1994-9#1)(2005-7#1)
on the carbon source##2##4##(1995-6#1)(2006-8#1)
on the carbon surface##4##4##(2005-11#3)(2008-10#1)
on the carbon##12##3##(1992-11#1)(1995-6#1)(2005-11#3)(2006-8#1)(2008-10#4)(2012-2#1)(2013-8#1)
on the carbonyl##3##3##(1995-5#1)(2007-11#1)(2010-5#1)
on the carcinogenicity of asbestos fibers##2##6##(1991-12#2)
on the carcinogenicity of##3##4##(1990-6#1)(1991-12#2)
on the cardiac function##2##4##(1991-3#1)(2012-2#1)
on the cardiac##5##3##(1991-3#1)(1992-7#1)(2007-8#1)(2008-4#1)(2012-2#1)
on the cardiovascular system##11##4##(1991-11#1)(1995-12#1)(1997-5#1)(2005-1#1)(2005-10#1)(2005-8#1)(2006-10#1)(2008-10#2)(2008-7#2)
on the cardiovascular##16##3##(1991-11#1)(1991-2#1)(1995-12#1)(1997-5#2)(2005-1#1)(2005-10#1)(2005-8#1)(2006-10#2)(2008-10#2)(2008-2#1)(2008-7#2)(2009-11#1)
on the care of##4##4##(2008-1#1)(2010-8#1)(2012-11#1)(2013-8#1)
on the care##5##3##(1996-1#1)(2008-1#1)(2010-8#1)(2012-11#1)(2013-8#1)
on the carotid##2##3##(1994-6#1)(2008-5#1)
on the carrier##3##3##(2007-11#1)(2008-10#1)(2008-7#1)
on the carrier-envelope phase##2##4##(2007-11#1)(2007-12#1)
on the cartridge##2##3##(2008-10#2)
on the case of a##3##5##(1992-5#1)(2007-5#2)
on the case of##5##4##(1992-5#1)(2007-5#2)(2008-3#1)(2008-9#1)
on the case##10##3##(1992-5#1)(2007-5#2)(2007-7#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2012-2#1)(2013-1#1)
on the cast films##3##4##(2008-11#3)
on the cast membranes made of##2##6##(2008-11#2)
on the cast membranes was##2##5##(2008-11#2)
on the cast membranes##4##4##(2008-11#4)
on the cast##9##3##(2008-11#8)(2008-5#1)
on the catabolism of##2##4##(2007-12#1)(2011-1#1)
on the catalytic activity of##4##5##(1991-12#1)(1991-2#1)(1994-8#1)(2008-10#1)
on the catalytic activity##7##4##(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1994-8#1)(2008-10#1)(2009-12#1)
on the catalytic##30##3##(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1994-5#2)(1994-8#2)(1994-9#1)(2008-10#17)(2009-12#2)(2010-12#1)(2010-5#1)
on the category of##2##4##(1996-2#1)(2011-1#1)
on the category##3##3##(1996-2#1)(2008-9#1)(2011-1#1)
on the cation##4##3##(2006-2#1)(2008-10#3)
on the causative##2##3##(2007-6#1)(2012-3#1)
on the cause of##2##4##(2006-10#1)(2008-10#1)
on the cause##3##3##(2006-10#2)(2008-10#1)
on the causes of##5##4##(2008-10#2)(2008-11#1)(2012-12#1)(2013-1#1)
on the causes##9##3##(2007-8#1)(2008-10#2)(2008-11#1)(2010-2#2)(2010-8#1)(2012-12#1)(2013-1#1)
on the cavity##2##3##(2007-11#1)(2008-3#1)
on the cell cycle##2##4##(2008-11#1)(2008-3#1)
on the cell growth##3##4##(1994-6#1)(2008-11#1)(2013-1#1)
on the cell line##3##4##(1991-6#1)(1992-2#1)(2008-11#1)
on the cell membrane##7##4##(1991-12#1)(1992-12#1)(1993-9#1)(1994-8#1)(1997-7#1)(2009-12#1)(2009-4#1)
on the cell surface and##5##5##(1992-11#1)(1994-6#1)(1995-2#1)(1996-5#1)(2008-4#1)
on the cell surface even after##2##6##(1990-12#1)(1994-12#1)
on the cell surface of##9##5##(1990-12#1)(1990-7#1)(1991-5#1)(1991-9#1)(1994-8#2)(2008-10#1)(2008-11#1)(2008-4#1)
on the cell surface was##2##5##(1994-12#1)(2008-11#1)
on the cell surface##48##4##(1990-11#1)(1990-12#3)(1990-7#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-6#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-11#3)(1994-12#3)(1994-5#1)(1994-6#2)(1994-8#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-6#1)(2008-10#1)(2008-11#3)(2008-4#4)(2008-6#1)(2009-9#1)(2010-1#1)(2011-1#1)(2011-2#1)(2013-8#1)
on the cell water##2##4##(2008-5#2)
on the cell##91##3##(1990-11#1)(1990-12#3)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#4)(1994-5#1)(1994-6#3)(1994-8#4)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-3#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-11#11)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#2)(2008-9#2)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
on the cells for##2##4##(2007-6#1)(2008-8#1)
on the cells##9##3##(1991-1#1)(1991-7#1)(1992-3#1)(1992-8#1)(1995-1#1)(2007-6#1)(2008-11#1)(2008-8#1)(2011-2#1)
on the cellular functions of##2##5##(2007-12#1)(2008-1#1)
on the cellular##21##3##(1992-12#1)(1992-4#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-8#1)(2006-7#1)(2006-9#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-12#3)(2010-2#1)(2011-1#1)(2011-12#1)
on the cellulose tris(3##2##4##(2008-10#2)
on the cellulose##3##3##(2008-10#2)(2010-4#1)
on the central cholinergic system##2##5##(1991-12#1)(2008-10#1)
on the central coast##2##4##(2008-10#1)(2008-5#1)
on the central nervous system (CNS)##3##6##(1995-5#1)(2011-1#1)(2013-1#1)
on the central nervous system##11##5##(1990-5#1)(1990-9#1)(1993-11#1)(1995-5#1)(1996-1#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-7#1)(2011-1#1)(2013-1#1)
on the central nervous##13##4##(1990-5#1)(1990-9#1)(1993-11#1)(1994-11#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-7#1)(2011-1#1)(2013-1#1)
on the central##28##3##(1990-5#1)(1990-9#1)(1991-12#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-11#1)(1995-12#1)(1995-5#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-2#1)(2011-1#1)(2012-3#1)(2013-1#1)
on the cerebral vasculature##2##4##(2006-11#1)(2007-10#1)
on the cerebral##5##3##(1992-4#1)(1995-1#1)(2006-11#1)(2007-10#1)(2011-2#1)
on the cervical##5##3##(1992-3#1)(1996-12#1)(2006-8#1)(2007-1#1)(2007-5#1)
on the cesium##2##3##(2008-3#2)
on the chain##2##3##(2007-9#1)(2009-3#1)
on the challenges##6##3##(1990-4#1)(1996-2#1)(2008-10#1)(2012-3#1)(2013-1#2)
on the change in the##3##5##(2005-11#1)(2008-2#1)(2008-3#1)
on the change in##4##4##(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
on the change of##3##4##(1993-5#1)(2005-11#1)(2013-8#1)
on the change##7##3##(1993-5#1)(2005-11#2)(2008-10#1)(2008-2#1)(2008-3#1)(2013-8#1)
on the changes in##10##4##(1990-8#1)(1993-3#1)(1995-12#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-4#1)(2012-1#2)
on the changes of the##3##5##(1992-1#1)(2006-10#1)(2010-12#1)
on the changes of##4##4##(1992-1#1)(2006-10#1)(2008-8#1)(2010-12#1)
on the changes##16##3##(1990-8#1)(1992-1#2)(1993-3#1)(1995-12#1)(1996-2#1)(2006-10#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#1)(2012-1#2)
on the changing##2##3##(1997-6#1)(2010-2#1)
on the channel surface##2##4##(2007-8#2)
on the channel walls##2##4##(2007-9#1)(2008-5#1)
on the channel##9##3##(1991-9#1)(1992-11#1)(2007-8#2)(2007-9#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-8#1)
on the chaperonin GroEL##2##4##(1995-3#2)
on the chaperonin##3##3##(1994-5#1)(1995-3#2)
on the character of the##2##5##(1996-5#1)(2005-10#1)
on the character##3##3##(1996-5#1)(2005-10#1)(2006-10#1)
on the characterisation of##2##4##(1995-3#1)(2008-10#1)
on the characteristic##4##3##(2005-7#1)(2008-3#2)(2011-2#1)
on the characteristics of the##16##5##(1997-7#1)(2006-4#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2011-2#2)(2012-12#1)(2012-2#3)
on the characteristics of##22##4##(1993-3#1)(1994-2#1)(1997-7#1)(2006-4#1)(2006-6#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)
on the characteristics##24##3##(1993-3#1)(1994-2#1)(1997-7#1)(2006-4#1)(2006-6#1)(2007-5#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)
on the characterization of the##2##5##(1994-5#1)(1996-2#1)
on the characterization of##4##4##(1994-5#1)(1996-2#1)(2008-8#1)(2010-12#1)
on the characterization##6##3##(1994-5#1)(1996-2#1)(2008-8#1)(2009-2#1)(2010-12#1)(2011-12#1)
on the charge##5##3##(2005-11#1)(2008-10#3)(2012-1#1)
on the cheek than on##3##5##(2008-5#3)
on the cheek##8##3##(2008-5#8)
on the chemical and##2##4##(2008-10#1)(2008-7#1)
on the chemical composition of the##4##6##(1994-12#1)(2007-1#1)(2008-3#1)(2010-4#1)
on the chemical composition of##5##5##(1994-12#1)(2007-1#1)(2008-3#1)(2010-4#1)(2013-1#1)
on the chemical constituents in##2##5##(2011-1#1)(2013-8#1)
on the chemical constituents##7##4##(2011-1#6)(2013-8#1)
on the chemical nature of the##2##6##(2006-10#1)(2008-11#1)
on the chemical structure of the##3##6##(1992-5#1)(2005-3#1)(2009-10#1)
on the chemical structure##4##4##(1992-5#1)(2005-3#1)(2009-10#1)(2012-3#1)
on the chemical##39##3##(1992-5#1)(1992-6#1)(1993-9#1)(1994-12#1)(1994-5#1)(1996-12#1)(2005-11#2)(2005-3#1)(2006-10#1)(2006-8#1)(2007-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-10#1)(2010-4#1)(2011-1#6)(2012-3#1)(2013-1#1)(2013-8#3)
on the chemiluminescence (CL) reaction between##2##6##(2008-10#2)
on the chemiluminescence (CL) reaction##3##5##(2008-10#3)
on the chemiluminescence (CL)##4##4##(2008-10#3)(2010-4#1)
on the chemiluminescence emission##2##4##(2008-10#2)
on the chemiluminescence generated##2##4##(2008-10#2)
on the chemiluminescence of##2##4##(1992-6#1)(2008-10#1)
on the chemiluminescence##17##3##(1992-6#1)(2007-8#1)(2008-10#14)(2010-4#1)
on the chemiluminescent reaction of##2##5##(2008-10#2)
on the chemistry of groundwater samples##2##6##(2013-1#2)
on the chemistry##3##3##(2010-8#1)(2013-1#2)
on the chest and##3##4##(2006-10#1)(2010-6#1)(2012-12#1)
on the chest radiograph##2##4##(2005-11#1)(2013-1#1)
on the chest wall##6##4##(1991-12#1)(2004-1#1)(2009-3#1)(2010-6#1)(2013-1#2)
on the chest##14##3##(1991-12#1)(2004-1#1)(2005-11#1)(2006-10#1)(2007-10#1)(2009-3#1)(2010-6#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#3)
on the child and##2##4##(2007-11#1)(2008-11#1)
on the child##6##3##(1995-5#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-11#1)(2009-7#1)
on the child's##6##3##(2005-10#1)(2005-8#1)(2007-11#1)(2010-3#1)(2011-1#1)(2012-2#1)
on the children's##2##3##(1993-1#1)(2011-2#1)
on the chip##3##3##(2008-10#2)(2010-1#1)
on the chiral##3##3##(2005-12#1)(2008-10#2)
on the chitosan##2##3##(2008-10#1)(2012-12#1)
on the choice of the##3##5##(2006-5#1)(2008-10#1)(2008-2#1)
on the choice of##8##4##(1994-2#1)(2006-5#1)(2007-12#2)(2008-10#1)(2008-2#2)(2009-2#1)
on the choice##9##3##(1994-2#1)(2006-5#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-2#2)(2009-2#1)
on the chopping frequency##2##4##(2007-11#2)
on the chromatogram##3##3##(2008-10#3)
on the chromatographic behavior of##2##5##(2008-10#2)
on the chromatographic##5##3##(2008-10#5)
on the chromosomal##2##3##(2008-11#1)(2008-12#1)
on the chromosome of##4##4##(1990-3#1)(1997-2#2)(2008-10#1)
on the chromosome##12##3##(1990-3#1)(1993-11#1)(1994-5#1)(1996-10#1)(1997-2#2)(1997-4#1)(2006-8#1)(2007-6#1)(2008-10#1)(2008-6#1)(2008-9#1)
on the circadian##5##3##(1991-12#1)(1995-12#1)(2008-3#1)(2008-5#2)
on the circular##2##3##(1994-12#1)(1996-6#1)
on the classical##6##3##(1990-8#1)(1996-7#1)(2007-1#1)(2007-11#1)(2008-11#1)(2009-9#1)
on the classification system##2##4##(1996-11#1)(2011-2#1)
on the classification##5##3##(1996-11#1)(2008-10#1)(2008-5#1)(2009-3#1)(2011-2#1)
on the cleavage##2##3##(1992-7#1)(2013-1#1)
on the climate##2##3##(2008-2#1)(2009-4#1)
on the clinical and##6##4##(1994-5#1)(2007-12#2)(2008-9#1)(2010-6#1)(2012-12#1)
on the clinical applications of##2##5##(2010-11#1)(2012-2#1)
on the clinical condition of##2##5##(2006-6#1)(2008-11#1)
on the clinical course of##2##5##(1990-11#1)(2010-12#1)
on the clinical course##3##4##(1990-11#1)(1990-4#1)(2010-12#1)
on the clinical development of##3##5##(2008-10#1)(2008-3#1)(2009-8#1)
on the clinical features of##2##5##(2005-9#1)(2013-1#1)
on the clinical outcome of##3##5##(1993-11#1)(2010-4#1)(2010-5#1)
on the clinical presentation and##3##5##(1991-12#1)(2007-8#1)(2013-1#1)
on the clinical presentation##4##4##(1991-12#1)(2007-8#1)(2012-2#1)(2013-1#1)
on the clinical status of the##2##6##(2005-11#1)(2009-10#1)
on the clinical trials##2##4##(1994-2#1)(2010-12#1)
on the clinical##55##3##(1990-11#1)(1990-2#1)(1990-4#1)(1990-6#1)(1991-12#1)(1991-4#1)(1992-8#1)(1993-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-6#1)(1997-6#1)(2005-11#1)(2005-6#1)(2005-9#1)(2006-10#3)(2006-2#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#2)(2011-1#1)(2012-12#1)(2012-2#3)(2013-1#2)
on the clinician's##2##3##(2007-12#1)(2008-3#1)
on the cloning and##2##4##(1993-12#1)(1996-9#1)
on the cloud##2##3##(2008-10#1)(2008-3#1)
on the coagulation##3##3##(1994-9#1)(2005-8#1)(2008-10#1)
on the coal surface##2##4##(2005-11#2)
on the coast of Santa Catarina State##2##7##(2011-1#2)
on the coast of##3##4##(2008-5#1)(2011-1#2)
on the coated##2##3##(2008-10#1)(2009-4#1)
on the coating##2##3##(2008-10#1)(2013-1#1)
on the cognitive##6##3##(1994-6#1)(2005-8#2)(2008-1#1)(2008-2#1)(2009-10#1)
on the coherence function##2##4##(2008-3#2)
on the coherence##4##3##(2008-3#3)(2010-7#1)
on the collagen##2##3##(2008-5#1)(2012-12#1)
on the collected##3##3##(1994-8#1)(2010-8#2)
on the collection of##5##4##(1996-3#1)(1997-5#1)(2004-11#1)(2007-11#1)(2010-12#1)
on the collection##8##3##(1996-3#1)(1997-5#1)(2004-11#1)(2007-11#2)(2008-12#1)(2008-4#1)(2010-12#1)
on the collective##2##3##(2008-5#1)(2009-8#1)
on the colloid##3##3##(2008-2#3)
on the colonization of##2##4##(2008-10#2)
on the color of##4##4##(2009-8#3)(2012-11#1)
on the color stability of##2##5##(2010-3#1)(2012-7#1)
on the color##13##3##(2005-4#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-8#3)(2010-3#1)(2012-11#1)(2012-7#1)
on the colour##2##3##(2006-2#1)(2008-10#1)
on the column was##2##4##(2008-10#2)
on the column##15##3##(1990-11#1)(1991-5#1)(1997-8#1)(2008-10#12)
on the columns##2##3##(1990-3#1)(2008-10#1)
on the combination of##15##4##(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#2)(2013-8#2)
on the combined use##2##4##(2006-9#1)(2008-10#1)
on the combined##12##3##(1990-11#1)(1996-7#1)(2006-6#1)(2006-9#1)(2008-10#5)(2008-2#1)(2008-5#1)(2012-3#1)
on the combustion##2##3##(1996-12#1)(2008-10#1)
on the common##8##3##(1996-3#1)(2007-8#1)(2010-10#1)(2010-12#1)(2010-7#1)(2012-3#1)(2013-1#2)
on the communication##4##3##(1990-12#1)(1997-6#1)(2005-7#1)(2008-12#1)
on the community##2##3##(2010-2#1)(2010-3#1)
on the compact##2##3##(2008-1#1)(2008-7#1)
on the comparative##7##3##(2007-1#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-3#2)
on the comparison of the##4##5##(1990-8#1)(2005-11#1)(2008-10#1)(2013-1#1)
on the comparison of##5##4##(1990-8#1)(2005-11#1)(2008-10#2)(2013-1#1)
on the comparison##6##3##(1990-8#1)(1996-3#1)(2005-11#1)(2008-10#2)(2013-1#1)
on the compensation##2##3##(1993-5#1)(1996-2#1)
on the competition##2##3##(1993-6#1)(2007-9#1)
on the competitive intensity between the competing pairs##2##8##(2008-8#2)
on the competitive##8##3##(2005-11#1)(2008-10#5)(2008-8#2)
on the complementary strand##5##4##(1992-9#1)(1994-12#1)(1994-8#2)(1997-3#1)
on the complete##4##3##(1994-12#1)(2008-7#1)(2008-8#1)(2009-5#1)
on the complex formation of##2##5##(2008-10#2)
on the complex formation##3##4##(2008-10#3)
on the complex##13##3##(1993-12#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-3#1)(2009-5#1)
on the complexation of copper(II) by phenolic acids##2##8##(2008-10#2)
on the complexation of##4##4##(2008-10#4)
on the complexation reaction##3##4##(2008-10#3)
on the complexation##11##3##(2007-8#1)(2008-10#10)
on the complexity of the##2##5##(2006-12#1)(2006-6#1)
on the complexity##4##3##(2006-12#1)(2006-4#1)(2006-6#1)(2008-1#1)
on the component##4##3##(2006-11#1)(2008-10#1)(2011-1#1)(2012-1#1)
on the composite's physical properties##2##5##(2006-2#2)
on the composition and##4##4##(2007-12#1)(2008-7#1)(2012-2#1)(2012-3#1)
on the composition of the##7##5##(1991-11#1)(2005-11#1)(2006-10#1)(2007-1#1)(2008-8#2)(2010-12#1)
on the composition of##11##4##(1991-11#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-1#1)(2008-10#2)(2008-8#2)(2010-12#1)(2013-1#1)
on the composition##15##3##(1991-11#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-7#1)(2008-8#2)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
on the comprehension##2##3##(2009-8#1)(2011-1#1)
on the compressive##3##3##(2006-11#2)(2007-9#1)
on the computation of the##2##5##(2008-2#1)(2008-4#1)
on the computation of##3##4##(2008-2#1)(2008-3#1)(2008-4#1)
on the computational##2##3##(2008-2#1)(2010-9#1)
on the computer##5##3##(1992-4#1)(1995-2#1)(1996-9#1)(2007-7#1)(2008-11#1)
on the concentration and lipophilicity of##2##6##(2008-10#2)
on the concentration and##7##4##(1993-12#1)(1997-2#1)(2008-10#5)
on the concentration dependence of##2##5##(1991-8#1)(1995-12#1)
on the concentration of the##5##5##(1991-8#1)(1992-12#1)(2005-11#1)(2008-7#1)(2011-2#1)
on the concentration of##44##4##(1991-1#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-8#2)(1992-12#2)(1992-5#1)(1993-12#1)(1995-1#2)(1996-5#1)(1996-6#1)(1997-4#2)(1997-5#1)(2005-11#1)(2005-4#1)(2006-9#1)(2007-10#1)(2007-12#1)(2008-10#10)(2008-4#1)(2008-5#1)(2008-7#2)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-6#1)(2013-1#1)
on the concentration##61##3##(1991-1#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-8#3)(1992-12#2)(1992-5#1)(1993-11#1)(1993-12#2)(1995-1#2)(1995-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#2)(1997-5#1)(2005-11#2)(2005-4#2)(2006-10#1)(2006-9#1)(2007-10#1)(2007-12#1)(2008-10#16)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-8#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-6#1)(2013-1#1)
on the concentrations of##12##4##(1991-1#1)(1992-11#1)(1993-2#1)(1993-9#2)(2005-12#1)(2006-10#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-1#1)(2013-8#1)
on the concentrations##15##3##(1991-1#1)(1992-11#1)(1993-2#1)(1993-7#1)(1993-9#2)(1995-5#1)(2005-12#1)(2006-10#1)(2008-10#2)(2008-9#1)(2011-1#1)(2012-1#1)(2013-8#1)
on the concept of the##4##5##(1997-6#1)(2008-3#1)(2010-11#1)(2010-12#1)
on the concept of##25##4##(1997-3#1)(1997-6#1)(2006-5#1)(2007-11#1)(2008-10#3)(2008-2#4)(2008-3#4)(2008-4#1)(2009-1#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
on the concept that the##2##5##(2006-12#1)(2008-3#1)
on the concept that##3##4##(1997-4#1)(2006-12#1)(2008-3#1)
on the concept##29##3##(1997-3#1)(1997-4#1)(1997-6#1)(2006-12#1)(2006-5#1)(2007-11#1)(2008-10#3)(2008-2#4)(2008-3#5)(2008-4#1)(2009-1#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
on the conception##2##3##(2009-2#1)(2013-1#1)
on the concepts of##6##4##(1996-1#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2011-2#1)
on the conceptual##2##3##(2008-7#1)(2013-8#1)
on the conclusions##2##3##(2008-8#1)(2013-8#1)
on the concordance##2##3##(2008-10#1)(2013-1#1)
on the condensation of##4##4##(1991-8#1)(2005-11#1)(2008-10#1)(2009-2#1)
on the condensation##7##3##(1991-8#1)(2005-11#2)(2008-10#3)(2009-2#1)
on the condition of the##3##5##(1991-3#1)(2007-12#1)(2008-6#1)
on the condition of##5##4##(1991-3#1)(1997-3#1)(2007-12#1)(2008-6#1)(2008-9#1)
on the condition##6##3##(1991-3#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-9#1)
on the conditions of the##2##5##(1990-8#1)(1992-8#1)
on the conditions of##6##4##(1990-8#1)(1992-8#1)(1994-9#1)(1996-2#1)(2008-10#1)(2008-2#1)
on the conditions##10##3##(1990-8#1)(1991-4#1)(1992-8#1)(1994-9#1)(1996-2#1)(1996-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-8#1)
on the conduct of##3##4##(2006-1#1)(2007-10#1)(2009-4#1)
on the conduct##4##3##(2006-1#1)(2007-10#1)(2009-4#1)(2010-3#1)
on the conductivity and##2##4##(2008-10#1)(2010-4#1)
on the confidence##2##3##(2008-10#2)
on the conformation of the##5##5##(1994-5#1)(2005-11#1)(2008-10#1)(2008-8#1)(2009-9#1)
on the conformation of##10##4##(1992-12#1)(1992-6#1)(1994-5#1)(1996-2#1)(1997-4#1)(2005-11#1)(2008-10#1)(2008-8#2)(2009-9#1)
on the conformation##12##3##(1992-12#1)(1992-6#1)(1994-5#1)(1996-2#1)(1997-4#1)(2005-11#1)(2008-10#1)(2008-8#2)(2009-3#2)(2009-9#1)
on the conformational##3##3##(1990-3#1)(1995-6#1)(2008-10#1)
on the connection between##2##4##(2008-7#1)(2012-2#1)
on the consequences of##4##4##(1990-8#1)(2008-8#1)(2009-4#1)(2011-1#1)
on the construction and##2##4##(2009-8#1)(2010-8#1)
on the construction of an##2##5##(2013-8#2)
on the construction of##6##4##(2008-11#1)(2008-4#2)(2012-12#1)(2013-8#2)
on the construction##8##3##(2008-11#1)(2008-4#2)(2009-8#1)(2010-8#1)(2012-12#1)(2013-8#2)
on the consumption of##2##4##(1994-5#1)(2008-10#1)
on the consumption##3##3##(1994-5#1)(2006-7#1)(2008-10#1)
on the content and##2##4##(1990-5#1)(2012-11#1)
on the content of##3##4##(2005-9#1)(2008-5#1)(2012-12#1)
on the content##6##3##(1990-5#1)(1994-2#1)(2005-9#1)(2008-5#1)(2012-11#1)(2012-12#1)
on the context##3##3##(1993-2#1)(2010-8#1)(2012-2#1)
on the continent##4##3##(1990-6#1)(2005-5#1)(2006-8#1)(2008-10#1)
on the continental shelf##2##4##(2008-5#1)(2010-8#1)
on the continuous##5##3##(1992-11#1)(1997-7#1)(2008-10#2)(2012-2#1)
on the continuum##3##3##(1991-1#1)(2007-6#1)(2008-10#1)
on the contractile responses##2##4##(1993-11#2)
on the contractile##4##3##(1990-8#1)(1993-11#2)(1996-12#1)
on the contralateral side##5##4##(1991-6#2)(1996-9#1)(2004-9#1)(2006-12#1)
on the contralateral##11##3##(1991-6#2)(1991-8#1)(1995-12#1)(1996-5#1)(1996-9#1)(2004-9#1)(2006-12#1)(2008-10#1)(2008-3#1)(2013-1#1)
on the contrary##19##3##(1990-3#1)(1990-6#1)(1991-2#2)(1991-3#1)(1991-9#2)(1993-11#1)(1994-11#1)(1997-1#1)(1997-8#1)(2006-2#1)(2007-3#1)(2008-10#1)(2009-10#1)(2010-8#1)(2011-2#2)(2013-1#1)
on the contrast in the##2##5##(2008-3#2)
on the contrast##3##3##(2007-12#1)(2008-3#2)
on the contribution of the##3##5##(2005-11#1)(2008-3#1)(2008-7#1)
on the contribution of##10##4##(1993-1#1)(2005-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2011-1#2)
on the contributions of##2##4##(2007-11#1)(2012-3#1)
on the control of the##5##5##(1993-6#1)(1994-3#1)(2006-10#1)(2008-5#1)(2010-3#1)
on the control of##16##4##(1993-6#2)(1994-3#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-5#2)(2009-12#1)(2009-2#1)(2009-5#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
on the control##23##3##(1993-6#2)(1994-3#1)(1997-5#1)(2004-4#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-5#3)(2009-12#1)(2009-2#1)(2009-5#2)(2009-9#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
on the controversial##2##3##(2007-12#1)(2011-2#1)
on the conversion efficiency of##2##5##(2007-12#1)(2013-1#1)
on the conversion of the##2##5##(2008-10#1)(2010-4#1)
on the conversion of##5##4##(1991-1#1)(1993-9#1)(2007-12#1)(2008-10#1)(2010-4#1)
on the conversion##8##3##(1991-1#1)(1993-9#1)(2005-10#1)(2007-12#2)(2008-10#1)(2010-4#1)(2013-1#1)
on the convex side##2##4##(2007-8#1)(2012-2#1)
on the convex##3##3##(2007-8#1)(2008-10#1)(2012-2#1)
on the cooperative##3##3##(1990-8#1)(1996-4#1)(2008-4#1)
on the coordination of##2##4##(2008-8#1)(2009-1#1)
on the copper wire##2##4##(2008-10#2)
on the core protein##2##4##(1991-7#2)
on the core##3##3##(1991-7#2)(2008-10#1)
on the cornea##2##3##(2007-1#1)(2008-2#1)
on the corneal graft##3##4##(2011-2#3)
on the corneal##4##3##(2011-2#4)
on the corner of##2##4##(2008-8#2)
on the coronary##5##3##(1994-11#1)(2007-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
on the correct##6##3##(1993-6#1)(2006-10#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)
on the correlation between the##2##5##(1997-6#1)(2012-3#1)
on the correlation between##5##4##(1997-6#1)(2006-10#1)(2007-11#1)(2008-10#1)(2012-3#1)
on the correlation of the##2##5##(2007-12#1)(2013-8#1)
on the correlation of##3##4##(1990-12#1)(2007-12#1)(2013-8#1)
on the correlation##11##3##(1990-12#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2012-3#1)(2013-8#1)
on the corresponding##5##3##(1991-2#1)(1993-4#1)(1997-4#1)(2010-5#1)(2012-2#1)
on the corrosion of##2##4##(2007-11#2)
on the corrosion##3##3##(2007-11#2)(2013-1#1)
on the cortex##2##3##(2008-7#1)(2010-3#1)
on the cost of##4##4##(1992-12#1)(1996-1#1)(2008-9#1)(2010-8#1)
on the cost##6##3##(1990-12#1)(1992-12#1)(1992-2#1)(1996-1#1)(2008-9#1)(2010-8#1)
on the costs of treatment##2##5##(2006-5#1)(2008-5#1)
on the costs of##4##4##(2006-5#1)(2007-4#1)(2008-5#1)(2008-9#1)
on the costs##5##3##(2006-5#1)(2007-4#1)(2008-5#1)(2008-9#1)(2011-1#1)
on the coupling constant##2##4##(2007-12#1)(2009-4#1)
on the coupling of##7##4##(1996-8#1)(2008-10#5)(2010-12#1)
on the coupling##14##3##(1996-8#1)(2005-10#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#1)(2009-4#1)(2010-12#1)
on the course of the##2##5##(2008-3#1)(2009-2#1)
on the course of##11##4##(1990-1#1)(1990-10#1)(1991-9#1)(1996-10#1)(2007-8#2)(2008-3#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-2#1)
on the creation of##3##4##(1994-3#1)(2007-8#1)(2009-5#1)
on the criteria##8##3##(1992-12#1)(2006-10#1)(2006-8#1)(2008-3#2)(2008-5#1)(2011-2#1)(2013-1#1)
on the critical##11##3##(1994-5#1)(1996-5#1)(1997-3#1)(2005-11#3)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2011-2#1)
on the crop##3##3##(2006-4#1)(2007-8#1)(2008-11#1)
on the cross##3##3##(2008-10#1)(2008-3#1)(2012-1#1)
on the crystal##3##3##(2007-12#2)(2012-2#1)
on the crystallization of##3##4##(2004-9#1)(2005-11#2)
on the cued##2##3##(1994-8#1)(2010-5#1)
on the cultural##5##3##(1996-8#1)(2008-4#1)(2008-5#1)(2010-1#1)(2013-8#1)
on the culture of##2##4##(2005-6#1)(2012-1#1)
on the culture##10##3##(2005-6#2)(2008-10#1)(2008-11#2)(2008-9#1)(2009-6#1)(2012-1#1)(2012-3#1)(2013-1#1)
on the cultured##2##3##(1993-3#1)(2008-11#1)
on the cumulative##6##3##(1991-6#1)(1992-12#1)(1996-3#1)(2007-8#1)(2010-10#1)(2012-12#1)
on the current and future##2##5##(2007-4#1)(2008-11#1)
on the current and##4##4##(2007-4#1)(2007-5#1)(2008-11#1)(2009-4#1)
on the current knowledge of##3##5##(2008-10#1)(2011-1#2)
on the current knowledge##4##4##(2008-10#1)(2008-3#1)(2011-1#2)
on the current state of the art##3##7##(2006-8#2)(2007-12#1)
on the current state of##6##5##(2005-8#1)(2006-8#2)(2007-12#1)(2011-2#1)(2012-2#1)
on the current state##7##4##(2005-8#1)(2006-8#2)(2007-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
on the current status of##2##5##(2007-11#1)(2012-12#1)
on the current status##3##4##(2007-11#1)(2011-2#1)(2012-12#1)
on the current understanding of##2##5##(2012-3#2)
on the current##50##3##(1994-1#1)(1994-11#2)(1994-3#1)(1995-7#1)(1995-8#1)(1996-10#1)(2004-10#1)(2005-8#1)(2006-12#1)(2006-8#3)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-4#1)(2007-5#2)(2008-10#2)(2008-11#3)(2008-3#1)(2008-6#1)(2009-11#1)(2009-2#1)(2009-4#3)(2009-5#1)(2010-12#2)(2010-2#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
on the currently available##2##4##(2007-4#1)(2008-7#1)
on the currents##2##3##(1995-5#1)(1997-5#1)
on the cuscore technique##2##4##(1997-6#2)
on the cut-off value##2##4##(1997-3#2)
on the cylinder##2##3##(2008-3#1)(2009-2#1)
on the cytochrome##4##3##(1994-8#2)(1994-9#1)(2005-8#1)
on the cytokine##4##3##(1996-10#1)(2007-11#1)(2008-11#1)(2008-4#1)
on the cytoplasmic free calcium concentration in##2##7##(1992-4#1)(1993-3#1)
on the cytoplasmic free calcium concentration##3##6##(1992-4#2)(1993-3#1)
on the cytoplasmic free##4##4##(1992-4#2)(1993-3#2)
on the cytoplasmic side##2##4##(1992-12#1)(1995-3#1)
on the cytoplasmic##13##3##(1991-1#1)(1991-11#1)(1992-12#2)(1992-4#2)(1993-3#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-3#1)(2008-7#1)
on the cytosolic free##2##4##(1990-8#1)(1992-6#1)
on the cytosolic##3##3##(1990-8#1)(1992-6#1)(1994-6#1)
on the cytotoxic##4##3##(1990-12#1)(1992-9#1)(1994-5#1)(1996-8#1)
on the cytotoxicity of##2##4##(1992-3#1)(2008-8#1)
on the d##2##3##(1996-2#1)(2008-11#1)
on the daily##3##3##(2005-11#1)(2011-1#2)
on the data of the##2##5##(2007-3#1)(2009-8#1)
on the data of##5##4##(2007-3#1)(2008-3#1)(2009-8#2)(2012-2#1)
on the data on##2##4##(1990-3#1)(1990-7#1)
on the data set##2##4##(2008-10#1)(2012-3#1)
on the data##24##3##(1990-3#1)(1990-7#1)(1991-5#1)(1991-9#1)(1995-3#1)(2005-8#2)(2007-12#1)(2007-3#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)(2009-8#2)(2012-1#1)(2012-2#1)(2012-3#1)
on the day after the##2##5##(2006-6#1)(2007-10#1)
on the day after##3##4##(2006-6#1)(2007-10#1)(2010-2#1)
on the day before ovulation##2##5##(1994-7#2)
on the day before##8##4##(1991-3#1)(1992-6#1)(1994-7#2)(2008-8#3)(2012-2#1)
on the day of GK-SRS##2##5##(2012-2#2)
on the day of operation##2##5##(1990-2#1)(2007-8#1)
on the day of recall##2##5##(2004-2#2)
on the day of surgery##7##5##(1992-3#1)(2007-11#1)(2007-8#1)(2008-8#3)(2012-2#1)
on the day of the##4##5##(1996-1#1)(2007-10#1)(2008-10#1)(2012-12#1)
on the day of transplantation##2##5##(1993-1#1)(1995-2#1)
on the day of##34##4##(1990-2#1)(1992-3#1)(1992-7#1)(1993-1#1)(1995-2#2)(1996-1#2)(1996-7#1)(2004-2#2)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#5)(2008-5#1)(2008-8#3)(2009-6#1)(2010-6#1)(2012-12#1)(2012-2#3)
on the day##49##3##(1990-2#1)(1991-3#1)(1992-3#1)(1992-6#1)(1992-7#2)(1993-1#1)(1994-6#1)(1994-7#2)(1995-2#2)(1996-1#2)(1996-7#1)(2004-2#2)(2006-5#1)(2006-6#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#5)(2008-5#2)(2008-8#6)(2009-6#1)(2010-2#1)(2010-6#2)(2012-12#1)(2012-2#4)
on the daytime##2##3##(1992-8#1)(2013-1#1)
on the dead##2##3##(1996-5#1)(2010-10#1)
on the decay##2##3##(2008-3#2)
on the decision to##2##4##(1997-1#1)(2008-9#1)
on the decision##7##3##(1995-9#1)(1997-1#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
on the decisional##2##3##(2008-10#1)(2011-1#1)
on the decline##4##3##(2007-4#2)(2008-4#1)(2008-9#1)
on the decomposition##2##3##(2007-7#1)(2008-3#1)
on the deduced##4##3##(1990-4#1)(1994-2#1)(2008-10#2)
on the deep##3##3##(1995-3#1)(2008-10#1)(2011-2#1)
on the definition of the##2##5##(2006-8#1)(2012-2#1)
on the definition of##5##4##(2006-10#1)(2006-8#1)(2008-3#1)(2011-2#1)(2012-2#1)
on the definition##7##3##(2006-10#1)(2006-8#2)(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
on the deflection##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
on the deformation##3##3##(1996-1#1)(2007-1#1)(2008-3#1)
on the degradation of the##2##5##(1992-11#1)(2008-11#1)
on the degradation of##3##4##(1992-11#1)(1996-9#1)(2008-11#1)
on the degree of the##4##5##(2008-10#3)(2013-1#1)
on the degree of##47##4##(1990-2#1)(1990-9#1)(1991-2#2)(1991-3#1)(1992-4#1)(1992-7#1)(1993-11#1)(1993-6#1)(1994-5#1)(1995-11#1)(1995-8#1)(1996-4#1)(1997-1#1)(2005-11#1)(2006-10#1)(2007-11#3)(2007-12#1)(2007-4#2)(2007-7#2)(2008-10#6)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#2)(2009-8#1)(2011-2#1)(2013-1#3)
on the degree to which##2##5##(2008-8#1)(2008-9#1)
on the degree##50##3##(1990-2#1)(1990-9#1)(1991-2#2)(1991-3#1)(1992-4#1)(1992-7#1)(1993-11#1)(1993-6#1)(1994-5#1)(1995-11#1)(1995-8#1)(1996-4#1)(1997-1#1)(1997-3#1)(2005-11#1)(2006-10#1)(2007-11#3)(2007-12#1)(2007-4#2)(2007-7#2)(2008-10#6)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-5#2)(2009-8#1)(2011-2#1)(2013-1#3)
on the delivery of##4##4##(1995-1#1)(2008-10#1)(2008-5#1)(2011-1#1)
on the delivery##7##3##(1994-12#1)(1995-1#1)(2008-10#1)(2008-5#1)(2010-2#1)(2011-1#1)(2012-2#1)
on the demand for##4##4##(1990-12#1)(1990-2#2)(2006-8#1)
on the demographic##2##3##(2008-4#1)(2008-8#1)
on the denervated side##2##4##(1994-10#2)
on the densities of##2##4##(1994-2#1)(2008-9#1)
on the densities##3##3##(1994-2#1)(2008-10#1)(2008-9#1)
on the density of##3##4##(1993-11#1)(2007-8#1)(2008-12#1)
on the density##4##3##(1993-11#1)(2007-8#1)(2008-12#1)(2008-3#1)
on the dental arch##2##4##(2012-12#2)
on the dental##5##3##(2012-12#2)(2012-2#1)(2013-8#2)
on the dependence of the##4##5##(2008-10#1)(2008-2#2)(2010-8#1)
on the dependence of##5##4##(2008-10#1)(2008-2#2)(2010-8#1)(2012-3#1)
on the dependence##6##3##(2008-10#1)(2008-2#2)(2010-8#2)(2012-3#1)
on the deployment of##2##4##(2008-10#1)(2008-11#1)
on the depression##3##3##(1994-2#1)(2011-1#1)(2013-7#1)
on the depth of##3##4##(1996-9#1)(2008-2#1)(2012-1#1)
on the derivative chromosome 22##2##5##(2007-11#1)(2007-12#1)
on the derivative chromosome##3##4##(2007-11#1)(2007-12#2)
on the derivative##6##3##(2005-4#2)(2007-11#1)(2007-12#2)(2008-10#1)
on the derivatization reaction##3##4##(2008-10#3)
on the derivatization##5##3##(2008-10#5)
on the derived##3##3##(2008-2#3)
on the descending thoracic aorta##2##5##(2007-8#1)(2008-5#1)
on the description of##4##4##(2007-9#1)(2008-1#1)(2008-10#1)(2011-1#1)
on the description##5##3##(2007-9#1)(2008-1#1)(2008-10#1)(2011-1#1)(2013-7#1)
on the design and##6##4##(1992-2#1)(1996-2#1)(2007-12#2)(2008-3#1)(2010-7#1)
on the design of the##2##5##(2007-12#1)(2008-3#1)
on the design of##13##4##(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#2)(2009-2#1)(2012-2#1)(2013-8#1)
on the design##24##3##(1992-2#1)(1996-2#1)(2006-10#1)(2006-12#1)(2007-12#3)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2009-2#1)(2010-7#1)(2010-8#1)(2012-2#2)(2013-8#1)
on the detailed##4##3##(2007-5#1)(2008-3#1)(2008-4#1)(2013-1#1)
on the details of the##3##5##(1997-2#1)(1997-5#1)(2008-1#1)
on the details of##4##4##(1997-2#1)(1997-5#1)(2008-1#1)(2008-3#1)
on the detected##2##3##(2008-3#2)
on the detection and##2##4##(1990-6#1)(2008-4#1)
on the detection of a##4##5##(1992-2#1)(1993-11#1)(2007-8#1)(2008-10#1)
on the detection of##30##4##(1990-12#1)(1991-5#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-11#1)(1994-2#1)(1994-3#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
on the detection##36##3##(1990-12#1)(1990-6#1)(1991-5#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-11#1)(1994-2#1)(1994-3#1)(2006-10#1)(2007-2#1)(2007-8#2)(2008-10#11)(2008-2#1)(2008-3#1)(2008-4#3)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
on the detector##6##3##(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)
on the determinants of##2##4##(2008-9#1)(2011-1#1)
on the determination of bismuth##2##5##(2008-10#2)
on the determination of the##9##5##(1995-12#1)(1997-3#1)(2008-10#2)(2008-2#3)(2008-3#2)
on the determination of these##2##5##(2008-10#2)
on the determination of trace##3##5##(2005-4#1)(2008-10#1)(2013-8#1)
on the determination of##57##4##(1990-8#1)(1991-12#1)(1994-3#1)(1995-12#1)(1996-5#1)(1997-3#1)(2005-4#1)(2008-10#44)(2008-2#3)(2008-3#2)(2013-8#1)
on the determination were##2##4##(2007-8#1)(2008-10#1)
on the determination##60##3##(1990-8#1)(1991-12#1)(1994-3#1)(1995-12#1)(1996-5#1)(1997-3#1)(2005-4#1)(2007-8#1)(2008-10#46)(2008-2#3)(2008-3#2)(2013-8#1)
on the developed##2##3##(2008-10#1)(2013-8#1)
on the developing##9##3##(1990-5#1)(1991-4#1)(1992-7#1)(1995-12#1)(2006-4#1)(2008-10#1)(2010-6#1)(2011-2#1)(2012-12#1)
on the development and course of acute##2##7##(2006-6#2)
on the development and course of##3##6##(2006-6#3)
on the development and progression of##2##6##(1993-9#1)(2012-12#1)
on the development and##13##4##(1991-7#1)(1993-9#1)(1996-2#1)(2006-6#3)(2007-11#1)(2007-5#1)(2008-11#1)(2012-12#2)(2012-2#2)
on the development of a##9##5##(1996-12#1)(2006-2#1)(2006-5#1)(2007-2#1)(2008-2#1)(2008-5#1)(2010-12#1)(2010-4#1)(2012-1#1)
on the development of an##6##5##(2005-8#1)(2006-10#1)(2008-11#2)(2011-2#1)(2012-2#1)
on the development of cognition##2##5##(2009-7#2)
on the development of experimental##2##5##(1991-11#1)(2008-5#1)
on the development of humoral##2##5##(1993-12#2)
on the development of laterality##2##5##(2007-12#1)(2008-1#1)
on the development of new##5##5##(1994-9#1)(2008-5#1)(2010-7#1)(2012-11#1)(2012-12#1)
on the development of novel##2##5##(2008-10#1)(2011-2#1)
on the development of orthopaedic##2##5##(2007-8#2)
on the development of splenic##2##5##(2010-12#2)
on the development of the##18##5##(1993-3#1)(1995-12#2)(1996-12#1)(1996-3#1)(2006-2#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2010-1#1)(2010-4#1)(2012-12#1)
on the development of##138##4##(1990-12#2)(1990-5#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-7#1)(1993-11#3)(1993-12#4)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-12#2)(1996-3#2)(1996-4#1)(2004-11#2)(2004-12#1)(2004-3#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#2)(2006-5#1)(2007-11#3)(2007-12#2)(2007-2#3)(2007-3#3)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#14)(2008-11#6)(2008-12#4)(2008-2#2)(2008-5#6)(2008-6#1)(2008-7#2)(2008-9#2)(2009-2#1)(2009-4#2)(2009-6#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-12#3)(2010-4#3)(2010-6#1)(2010-7#3)(2011-12#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#3)(2013-1#2)(2013-8#2)
on the development##154##3##(1990-12#2)(1990-5#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-7#1)(1993-11#3)(1993-12#4)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(2004-11#2)(2004-12#1)(2004-3#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#2)(2006-5#1)(2006-6#3)(2006-8#1)(2007-11#4)(2007-12#2)(2007-2#3)(2007-3#3)(2007-4#2)(2007-5#2)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#15)(2008-11#7)(2008-12#4)(2008-2#2)(2008-5#6)(2008-6#1)(2008-7#2)(2008-9#2)(2009-2#1)(2009-4#2)(2009-6#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-12#3)(2010-4#3)(2010-6#1)(2010-7#3)(2011-12#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#5)(2013-1#2)(2013-8#2)
on the developmental##6##3##(1991-8#1)(1995-8#1)(2006-11#1)(2007-11#1)(2008-8#1)(2010-12#1)
on the diagnosis and management of##7##6##(2007-7#1)(2010-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
on the diagnosis and treatment of##3##6##(1996-12#1)(2008-2#1)(2013-1#1)
on the diagnosis and##11##4##(1995-9#1)(1996-12#1)(2007-7#1)(2008-2#1)(2010-12#2)(2012-2#1)(2013-1#2)(2013-8#2)
on the diagnosis of##2##4##(2008-10#1)(2010-7#1)
on the diagnosis##16##3##(1995-9#1)(1996-1#1)(1996-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2010-12#2)(2010-7#1)(2011-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
on the diagnostic accuracy of##2##5##(2008-12#1)(2009-4#1)
on the diagnostic utility of##2##5##(2008-12#1)(2012-2#1)
on the diagnostic##15##3##(1990-2#1)(1994-9#1)(2005-5#1)(2006-10#1)(2007-2#1)(2008-11#1)(2008-12#2)(2008-5#1)(2009-4#1)(2010-11#1)(2012-12#1)(2012-2#2)(2013-8#1)
on the diagonal##3##3##(2007-12#1)(2008-4#1)(2008-8#1)
on the diameter of##3##4##(2007-12#1)(2008-3#1)(2008-7#1)
on the dielectric##3##3##(1990-9#1)(2008-3#1)(2011-2#1)
on the diet##3##3##(1991-2#1)(2010-4#1)(2012-2#1)
on the dieting##2##3##(2006-7#2)
on the difference in##3##4##(2008-10#3)
on the difference of the##2##5##(2008-10#1)(2012-3#1)
on the difference##10##3##(1990-12#1)(2008-10#6)(2008-2#1)(2008-5#1)(2012-3#1)
on the differences in##3##4##(2007-2#1)(2008-4#1)(2008-9#1)
on the differences##6##3##(1992-9#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)
on the different##32##3##(1990-8#1)(1991-2#1)(1996-4#1)(1997-2#1)(2005-11#1)(2007-11#1)(2007-6#1)(2008-10#6)(2008-2#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
on the differential diagnosis##3##4##(2008-3#1)(2008-7#1)(2013-1#1)
on the differential##16##3##(1991-11#1)(1993-6#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-7#1)(2012-12#1)(2013-1#1)
on the differentiation of HL-60##2##5##(1991-6#2)
on the differentiation of human##2##5##(2008-11#1)(2013-8#1)
on the differentiation of the##2##5##(1991-9#1)(1996-4#1)
on the differentiation of##11##4##(1990-11#1)(1991-6#2)(1991-9#1)(1994-3#1)(1996-4#1)(2006-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2013-8#1)
on the differentiation##15##3##(1990-11#1)(1991-6#2)(1991-9#1)(1994-3#1)(1996-4#1)(2006-1#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-8#1)
on the difficult##3##3##(2005-8#1)(2008-3#1)(2008-4#1)
on the difficulties##5##3##(1992-5#1)(1993-8#1)(1996-10#1)(2005-7#1)(2007-2#1)
on the diffraction efficiency##2##4##(2008-2#1)(2008-3#1)
on the diffraction##5##3##(2007-12#2)(2008-2#2)(2008-3#1)
on the diffusion of##2##4##(2007-12#1)(2008-10#1)
on the diffusion##7##3##(2005-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)
on the digestive##2##3##(2007-3#1)(2008-12#1)
on the dimension of##2##4##(2009-11#2)
on the dimensions##2##3##(2009-5#1)(2010-3#1)
on the dimeric##2##3##(1995-3#1)(1997-2#1)
on the direct##13##3##(2006-10#1)(2008-10#9)(2008-3#1)(2008-8#1)(2012-11#1)
on the direction of##2##4##(1990-11#1)(2012-12#1)
on the discovery of a##2##5##(2005-7#1)(2011-1#1)
on the discovery of novel##2##5##(2008-10#1)(2013-8#1)
on the discovery of##4##4##(2005-7#1)(2008-10#1)(2011-1#1)(2013-8#1)
on the discovery##5##3##(2005-7#1)(2008-10#2)(2011-1#1)(2013-8#1)
on the discussion of##2##4##(1995-8#1)(2013-1#1)
on the disease burden##2##4##(2006-2#1)(2013-8#1)
on the disease##12##3##(1994-6#1)(2005-3#1)(2006-12#1)(2006-2#1)(2007-6#1)(2008-10#3)(2008-8#1)(2009-9#1)(2012-2#1)(2013-8#1)
on the dislocated##2##3##(2011-2#2)
on the dispersion coefficient of the##2##6##(1996-8#1)(2008-3#1)
on the dispersion of##4##4##(2005-11#1)(2008-10#2)(2008-2#1)
on the dispersion##8##3##(1996-8#1)(2005-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)
on the display##2##3##(1994-2#1)(2008-11#1)
on the dissociation constants##2##4##(2008-10#2)
on the dissociation##5##3##(2008-10#3)(2008-9#1)(2012-12#1)
on the dissolution temperature##3##4##(2005-11#3)
on the dissolution##5##3##(2005-11#3)(2008-10#2)
on the distal aspect of the##3##6##(2007-12#2)(2012-3#1)
on the distal aspect of##4##5##(2007-12#2)(2012-2#1)(2012-3#1)
on the distal part of the##3##6##(2009-8#1)(2012-1#1)(2013-1#1)
on the distal portion of##2##5##(1996-8#1)(2006-6#1)
on the distal##23##3##(1990-4#2)(1991-8#1)(1996-8#1)(2006-3#1)(2006-6#1)(2007-12#8)(2007-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
on the distance between the##5##5##(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-2#1)
on the distance between##6##4##(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-2#1)
on the distance of a##2##5##(1993-7#1)(1994-9#1)
on the distance of##3##4##(1993-7#2)(1994-9#1)
on the distance##12##3##(1993-7#2)(1994-9#2)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-2#1)(2012-12#2)
on the distribution and##4##4##(1994-5#1)(1995-7#1)(1997-8#1)(2008-11#1)
on the distribution of the##5##5##(2006-10#1)(2007-5#1)(2008-10#1)(2011-1#1)(2012-12#1)
on the distribution of##30##4##(1990-12#1)(1991-11#1)(1992-6#1)(1994-12#1)(1995-5#1)(1995-7#1)(1996-5#1)(1996-9#1)(2004-4#1)(2006-10#1)(2007-3#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-7#3)(2008-8#1)(2009-5#1)(2010-7#1)(2011-1#4)(2011-2#1)(2012-12#1)(2013-1#2)
on the distribution##38##3##(1990-12#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-6#1)(1994-12#1)(1994-5#2)(1995-5#1)(1995-7#2)(1996-5#1)(1996-9#1)(1997-8#1)(2004-4#1)(2006-10#1)(2007-3#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-5#1)(2010-7#1)(2011-1#4)(2011-2#1)(2012-12#1)(2013-1#2)
on the diversity of##2##4##(2007-5#1)(2008-10#1)
on the diversity##6##3##(1992-8#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-6#1)(2012-3#1)
on the docking results##2##4##(2010-12#1)(2013-1#1)
on the docking##3##3##(1995-3#1)(2010-12#1)(2013-1#1)
on the doctors'##2##3##(1993-11#1)(2011-2#1)
on the donor##6##3##(1990-5#1)(1996-4#1)(2008-10#2)(2008-11#1)(2011-2#1)
on the dopamine##3##3##(1991-12#1)(1993-11#1)(1995-2#1)
on the dopaminergic##3##3##(1995-5#1)(2008-11#1)(2008-7#1)
on the doping##2##3##(1993-3#1)(2008-10#1)
on the dorsal root ganglion##2##5##(2012-2#2)
on the dorsal side of the##4##6##(1995-8#1)(2007-12#1)(2008-5#1)(2008-7#1)
on the dorsal side of##5##5##(1995-8#1)(2007-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
on the dorsal side##6##4##(1995-8#1)(2007-12#1)(2008-5#2)(2008-7#1)(2011-2#1)
on the dorsal##15##3##(1992-9#1)(1993-2#1)(1995-8#1)(2006-10#1)(2007-12#3)(2008-5#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#2)(2013-7#1)
on the dorsum of the hand##2##6##(2006-3#1)(2008-6#1)
on the dorsum of the tongue##2##6##(2006-2#1)(2006-8#1)
on the dorsum of the##6##5##(2006-2#1)(2006-3#1)(2006-8#1)(2007-7#1)(2008-6#1)(2012-3#1)
on the dorsum of##8##4##(1996-7#1)(2006-2#1)(2006-3#1)(2006-8#1)(2007-7#1)(2008-6#1)(2010-3#1)(2012-3#1)
on the dosage and##2##4##(1994-6#1)(2007-11#1)
on the dosage##4##3##(1992-6#1)(1994-6#1)(2006-4#1)(2007-11#1)
on the dose##4##3##(1993-3#1)(1993-9#1)(1994-8#1)(2008-8#1)
on the double##2##3##(2008-7#1)(2012-2#1)
on the drug for##2##4##(2008-8#1)(2012-3#1)
on the drug or##2##4##(1992-9#1)(2008-10#1)
on the drug##14##3##(1992-3#1)(1992-9#1)(1996-1#1)(2005-11#1)(2005-9#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2012-11#2)(2012-3#2)
on the drugs##3##3##(2006-2#1)(2008-8#1)(2009-6#1)
on the dual##2##3##(2008-10#2)
on the dural sleeve##2##4##(2006-12#2)
on the dural##3##3##(2006-12#2)(2007-8#1)
on the duration and##3##4##(1997-2#1)(1997-7#1)(2012-1#1)
on the duration of the##4##5##(1992-6#1)(1996-5#1)(2008-11#1)(2008-2#1)
on the duration of##13##4##(1990-5#1)(1992-6#1)(1996-5#1)(1997-3#1)(2007-10#1)(2007-2#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-12#1)
on the duration##16##3##(1990-5#1)(1992-6#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-2#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-12#1)(2012-1#1)
on the dye##3##3##(1991-5#1)(1992-11#1)(2008-2#1)
on the dynamic behavior##2##4##(1990-3#1)(2008-10#1)
on the dynamic response##2##4##(2006-11#2)
on the dynamic##15##3##(1990-3#1)(1994-11#1)(1995-1#1)(2005-11#1)(2006-11#2)(2007-1#1)(2007-3#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2013-7#1)
on the dynamical##2##3##(1990-2#1)(1992-1#1)
on the dynamics of disease##2##5##(2008-10#1)(2008-9#1)
on the dynamics of the##5##5##(1994-11#1)(2007-6#1)(2008-10#1)(2008-11#1)(2013-8#1)
on the dynamics of##16##4##(1994-11#1)(1995-9#1)(1996-4#1)(1997-8#1)(2005-11#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-9#2)(2009-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
on the dynamics##20##3##(1992-9#1)(1994-11#1)(1995-9#1)(1996-4#1)(1997-8#1)(2005-11#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-9#2)(2009-8#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
on the ear##2##3##(2007-7#1)(2008-10#1)
on the earliest##3##3##(1995-12#1)(2007-9#1)(2008-10#1)
on the early detection of##3##5##(1992-10#1)(2007-11#1)(2008-3#1)
on the early steps##2##4##(1997-5#1)(2007-12#1)
on the early##15##3##(1992-10#1)(1997-5#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-2#1)(2013-1#1)
on the ears##2##3##(1994-2#2)
on the earth's surface##2##4##(2008-10#1)(2010-5#1)
on the ease of##4##4##(1990-10#1)(2008-10#1)(2010-5#1)(2012-3#1)
on the east coast of##2##5##(2007-10#1)(2010-8#1)
on the east coast##3##4##(1991-6#1)(2007-10#1)(2010-8#1)
on the east##4##3##(1991-6#1)(2007-10#1)(2007-9#1)(2010-8#1)
on the eastern##3##3##(1996-9#1)(2010-8#1)(2012-12#1)
on the eating quality of pork##2##6##(2010-4#2)
on the ecological##10##3##(1995-11#1)(2007-7#1)(2008-11#2)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#2)(2013-8#1)
on the ecology and##2##4##(1996-3#1)(2007-10#1)
on the ecology of##2##4##(2006-8#1)(2007-5#1)
on the ecology##4##3##(1996-3#1)(2006-8#1)(2007-10#1)(2007-5#1)
on the economic##4##3##(1995-5#1)(2007-6#1)(2009-10#1)(2010-12#1)
on the economics of##2##4##(2006-10#1)(2007-11#1)
on the edge of##4##4##(1996-3#1)(2007-10#1)(2007-12#1)(2008-9#1)
on the edge##6##3##(1996-3#1)(2007-10#1)(2007-12#1)(2008-2#1)(2008-9#1)(2013-1#1)
on the edges##2##3##(2007-3#1)(2010-7#1)
on the educational##2##3##(2008-12#1)(2012-12#1)
on the effect of different##2##5##(2008-10#1)(2012-8#1)
on the effect of the##5##5##(2006-8#1)(2007-8#1)(2008-11#1)(2011-2#1)(2012-11#1)
on the effect of this##2##5##(1996-1#1)(2008-3#1)
on the effect of##55##4##(1990-12#1)(1990-8#1)(1991-11#1)(1991-2#1)(1992-4#1)(1992-9#1)(1993-4#1)(1993-9#1)(1994-6#2)(1995-1#1)(1995-9#1)(1996-1#2)(1997-7#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#1)(2009-8#2)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-3#3)(2012-8#1)
on the effect that##2##4##(2008-10#1)(2008-8#1)
on the effect##59##3##(1990-12#1)(1990-8#1)(1991-11#1)(1991-2#1)(1992-4#1)(1992-9#1)(1993-4#1)(1993-9#1)(1994-2#1)(1994-6#2)(1995-1#1)(1995-9#1)(1996-1#2)(1997-7#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#2)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-3#3)(2012-8#1)
on the effective##9##3##(1990-11#1)(1992-9#1)(2006-12#1)(2007-12#2)(2008-10#2)(2008-3#1)(2013-8#1)
on the effectiveness of the##4##5##(2008-10#1)(2012-2#1)(2013-1#2)
on the effectiveness of##20##4##(1992-12#1)(1994-6#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#2)(2012-10#1)(2012-2#4)(2013-1#5)
on the effectiveness##21##3##(1992-12#1)(1994-6#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#2)(2012-10#1)(2012-12#1)(2012-2#4)(2013-1#5)
on the effector##2##3##(1995-2#1)(2011-2#1)
on the effects and##3##4##(1996-3#1)(2007-12#1)(2008-1#1)
on the effects of a##2##5##(2008-11#1)(2013-1#1)
on the effects of adding##2##5##(2007-1#1)(2010-4#1)
on the effects of combined##2##5##(2007-2#1)(2008-8#1)
on the effects of different##2##5##(2007-6#1)(2012-1#1)
on the effects of prenatal##2##5##(2011-2#1)(2012-2#1)
on the effects of the##3##5##(2010-2#1)(2012-12#1)(2013-1#1)
on the effects of various##2##5##(1991-2#1)(1992-6#1)
on the effects of withdrawal on immune function##2##8##(2007-11#2)
on the effects of##79##4##(1990-2#1)(1990-3#1)(1991-1#1)(1991-2#3)(1991-6#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-9#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-8#1)(2007-1#1)(2007-11#3)(2007-2#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#2)(2009-11#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#2)
on the effects that##2##4##(2008-10#1)(2010-4#1)
on the effects##85##3##(1990-2#1)(1990-3#1)(1991-1#1)(1991-2#3)(1991-6#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-3#1)(1996-9#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#2)(2009-11#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#2)
on the efficacy and safety of the##2##7##(2009-4#1)(2013-1#1)
on the efficacy and safety of##5##6##(2006-10#1)(2008-6#1)(2009-4#1)(2013-1#1)(2013-8#1)
on the efficacy and##8##4##(2006-10#1)(2007-11#1)(2008-6#1)(2009-4#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
on the efficacy of##28##4##(1990-12#1)(1990-3#1)(1993-5#1)(1994-4#1)(1996-3#1)(2006-10#3)(2006-8#1)(2007-11#2)(2007-3#1)(2008-10#1)(2008-11#1)(2008-5#4)(2008-6#1)(2009-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#2)
on the efficacy##42##3##(1990-12#1)(1990-3#1)(1993-5#1)(1994-4#1)(1996-3#1)(2006-10#4)(2006-6#1)(2006-8#1)(2007-11#3)(2007-3#1)(2007-6#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#5)(2008-6#2)(2009-10#1)(2009-4#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
on the efficiency and##2##4##(2008-2#1)(2008-8#1)
on the efficiency of a##2##5##(2008-2#2)
on the efficiency of the##3##5##(2008-10#1)(2008-6#1)(2010-3#1)
on the efficiency of this##2##5##(2008-10#1)(2009-10#1)
on the efficiency of##22##4##(1990-8#1)(1992-12#1)(1995-2#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#4)(2008-6#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-3#1)(2013-1#1)
on the efficiency##24##3##(1990-8#1)(1992-12#1)(1995-2#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#5)(2008-6#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-3#1)(2013-1#1)
on the egg##2##3##(1995-6#1)(2008-8#1)
on the eighth day of##2##5##(2007-12#1)(2010-7#1)
on the eighth day##4##4##(1994-3#1)(2007-12#1)(2010-7#1)(2011-2#1)
on the eighth##5##3##(1994-3#1)(2007-12#1)(2010-7#1)(2011-2#2)
on the elastic##2##3##(2004-9#1)(2008-3#1)
on the elderly##2##3##(2008-10#1)(2011-2#1)
on the electric field##2##4##(2006-2#1)(2007-12#1)
on the electric##5##3##(1993-8#1)(2006-2#1)(2007-12#1)(2010-6#1)(2013-1#1)
on the electrical##6##3##(1990-11#1)(1990-5#1)(1992-3#1)(1997-7#1)(2005-11#1)(2006-10#1)
on the electrically stimulated##2##4##(1993-2#1)(1997-5#1)
on the electrically##3##3##(1993-2#2)(1997-5#1)
on the electrocardiogram##4##3##(1990-5#1)(1995-6#1)(2012-2#1)(2013-1#1)
on the electrochemical##11##3##(1991-2#1)(1997-8#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-8#2)(2010-4#1)(2010-5#1)(2010-6#1)
on the electrochemistry of##4##4##(2005-11#2)(2007-8#1)(2008-10#1)
on the electrode and##2##4##(1990-5#1)(2008-10#1)
on the electrode response##2##4##(2008-10#2)
on the electrode surface and##2##5##(2008-10#2)
on the electrode surface via##2##5##(2008-10#2)
on the electrode surface##22##4##(2008-10#21)(2008-11#1)
on the electrode with##2##4##(1997-1#1)(2008-10#1)
on the electrode##41##3##(1990-5#1)(1997-1#1)(2008-10#37)(2008-11#1)(2010-11#1)
on the electrodes##2##3##(2008-10#1)(2008-9#1)
on the electrokinetic##2##3##(2005-11#1)(2008-10#1)
on the electrolyte##3##3##(1990-3#1)(2005-11#2)
on the electron transfer##2##4##(2005-11#1)(2006-10#1)
on the electronic##3##3##(1994-2#1)(2008-10#2)
on the electropolymerization##2##3##(2007-8#1)(2008-10#1)
on the electrospun##3##3##(2008-5#2)(2010-9#1)
on the electrostatic interaction between##2##5##(2012-6#1)(2013-1#1)
on the electrostatic##5##3##(2005-11#1)(2008-10#1)(2010-7#1)(2012-6#1)(2013-1#1)
on the elements of##2##4##(2007-12#1)(2007-8#1)
on the elements##3##3##(2005-4#1)(2007-12#1)(2007-8#1)
on the elevated##2##3##(2011-2#1)(2013-1#1)
on the elevation of##2##4##(2007-8#1)(2008-8#1)
on the elevation##3##3##(2007-8#1)(2008-3#1)(2008-8#1)
on the embryo##2##3##(2008-11#1)(2010-7#1)
on the emergence##3##3##(2011-2#2)(2012-2#1)
on the emergency##5##3##(1995-9#1)(2006-10#1)(2007-3#1)(2013-1#2)
on the emerging##2##3##(2006-6#1)(2012-12#1)
on the emission of rubidium##2##5##(2008-10#2)
on the emission of##3##4##(2008-10#3)
on the emission spectra##2##4##(2007-12#2)
on the emission##7##3##(1997-1#1)(2007-12#2)(2008-10#4)
on the empirical##3##3##(1995-1#1)(2007-4#1)(2008-10#1)
on the employment##5##3##(2008-10#4)(2009-3#1)
on the end of##4##4##(2008-12#1)(2008-2#1)(2008-3#1)(2009-9#1)
on the end##7##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-9#1)
on the endemic diet##2##4##(1994-3#2)
on the endocrine##2##3##(1991-3#1)(2008-11#1)
on the endogenous##3##3##(1990-11#1)(2012-12#1)(2013-8#1)
on the endometrium##2##3##(1994-9#1)(2011-2#1)
on the endoplasmic reticulum membrane##2##5##(1995-6#2)
on the endoplasmic reticulum##3##4##(1995-6#2)(2008-11#1)
on the endoscopic##3##3##(1994-3#1)(2007-9#1)(2011-12#1)
on the endothelial cell surface##3##5##(1995-2#1)(1996-8#1)(2008-1#1)
on the endothelial##5##3##(1995-2#1)(1996-8#1)(2008-1#1)(2008-4#1)(2010-7#1)
on the endothelium##2##3##(1996-9#1)(2008-3#1)
on the ends of##2##4##(2006-10#1)(2007-11#1)
on the energetic##2##3##(2008-8#1)(2012-12#1)
on the energy metabolism##2##4##(2008-11#2)
on the energy##7##3##(1993-8#1)(2008-10#1)(2008-11#2)(2008-2#2)(2009-8#1)
on the engineering of##2##4##(1995-3#1)(2008-1#1)
on the enhanced##3##3##(1992-9#1)(1994-12#1)(2008-10#1)
on the enhancement of##6##4##(2007-8#1)(2008-10#4)(2009-5#1)
on the enhancing effect of##2##5##(2008-10#2)
on the enhancing effect##3##4##(2008-10#3)
on the enrichment##2##3##(2011-2#2)
on the enthalpy of##2##4##(1996-11#1)(2005-11#1)
on the entire##9##3##(1996-12#1)(1997-3#1)(2005-1#1)(2007-11#1)(2008-10#1)(2009-2#1)(2010-2#1)(2012-12#1)(2013-7#1)
on the entrance##3##3##(2008-2#1)(2008-3#1)(2010-9#1)
on the entry##2##3##(1994-4#1)(1994-6#1)
on the environment in##2##4##(1991-12#1)(2009-10#1)
on the environment##11##3##(1991-12#1)(1991-6#1)(1995-8#1)(1997-4#1)(2008-10#4)(2008-5#1)(2009-10#1)(2010-10#1)
on the enzymatic activity of##3##5##(1995-1#1)(1996-5#1)(2008-8#1)
on the enzymatic##10##3##(1995-1#1)(1995-3#1)(1996-5#2)(1997-7#1)(2008-10#2)(2008-12#1)(2008-8#1)(2013-1#1)
on the enzyme activity##4##4##(1990-5#1)(1993-3#1)(1996-6#1)(2009-12#1)
on the enzyme##24##3##(1990-5#2)(1990-8#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-3#2)(1994-11#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-6#1)(2008-10#2)(2008-7#1)(2009-12#1)(2012-12#1)
on the enzymes##2##3##(1993-9#1)(2007-11#1)
on the epidemiology and management of##2##6##(2007-12#1)(2008-10#1)
on the epidemiology and##4##4##(2007-12#1)(2008-10#2)(2008-4#1)
on the epidemiology of the##2##5##(2008-10#1)(2008-9#1)
on the epidemiology of##11##4##(1990-12#1)(1990-7#1)(1995-12#1)(2004-9#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-9#1)
on the epidemiology##18##3##(1990-12#1)(1990-7#1)(1995-12#1)(2004-9#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-4#1)(2013-1#1)
on the epidermis##4##3##(1993-5#1)(2007-12#1)(2008-5#2)
on the epithelial cells##2##4##(1997-2#1)(1997-6#1)
on the epithelial##3##3##(1997-2#1)(1997-6#2)
on the equilibrium##10##3##(1990-8#1)(1995-4#1)(1995-5#1)(2004-9#1)(2005-11#2)(2008-10#3)(2009-10#1)
on the equipment##2##3##(2007-8#1)(2013-1#1)
on the ergometer##2##3##(2007-7#1)(2008-9#1)
on the error##2##3##(1997-8#1)(2008-2#1)
on the erythrocyte membrane##2##4##(1993-4#1)(1995-8#1)
on the erythrocyte##4##3##(1993-4#1)(1995-8#1)(2013-8#2)
on the essential##2##3##(2008-1#1)(2012-1#1)
on the establishment and##2##4##(1997-2#1)(2008-5#1)
on the establishment of a##3##5##(1996-2#1)(2011-1#1)(2013-1#1)
on the establishment of##9##4##(1996-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
on the establishment##11##3##(1996-2#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
on the estimated##5##3##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
on the estimates of the##2##5##(1994-8#1)(1995-8#1)
on the estimates##3##3##(1994-8#1)(1995-8#1)(2008-3#1)
on the estimation of the##3##5##(2007-11#1)(2008-10#1)(2008-3#1)
on the estimation of##9##4##(1992-9#1)(2005-11#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)
on the ethical##2##3##(2012-2#1)(2013-8#1)
on the ethics##2##3##(1993-1#1)(2008-10#1)
on the etiological##6##3##(1996-2#1)(2010-4#5)
on the etiology and##6##4##(1994-8#1)(2005-10#1)(2005-8#1)(2007-7#1)(2009-9#1)(2013-8#1)
on the etiology of the##4##5##(1996-11#1)(2010-11#1)(2012-1#1)(2012-11#1)
on the etiology of##7##4##(1992-8#1)(1996-11#1)(2006-8#1)(2007-10#1)(2010-11#1)(2012-1#1)(2012-11#1)
on the etiology##16##3##(1990-9#1)(1992-8#1)(1994-8#1)(1996-11#1)(2005-10#1)(2005-8#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2009-9#1)(2010-11#1)(2012-1#1)(2012-11#1)(2013-8#1)
on the evaluation of the##4##5##(1991-5#1)(2008-10#1)(2008-4#1)(2008-8#1)
on the evaluation of##12##4##(1991-5#1)(1993-6#1)(1995-2#1)(1996-11#1)(2005-10#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)
on the evaluation##14##3##(1991-5#1)(1993-6#1)(1995-2#1)(1996-11#1)(1996-2#1)(2005-10#1)(2006-8#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)
on the eve of the##2##5##(2009-7#1)(2012-11#1)
on the events##3##3##(2009-11#1)(2009-9#1)(2010-9#1)
on the evidence for##2##4##(2008-11#1)(2011-2#1)
on the evidence##10##3##(1993-12#1)(1994-11#1)(2007-12#1)(2008-11#1)(2008-8#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
on the evolution of life-history##2##5##(2008-8#2)
on the evolution of the##15##5##(1991-6#1)(1993-3#1)(1995-11#1)(1997-5#1)(1997-8#1)(1997-9#1)(2006-6#1)(2007-12#3)(2008-10#2)(2008-8#1)(2012-12#1)(2013-1#1)
on the evolution of##38##4##(1990-11#1)(1991-5#1)(1991-6#1)(1992-11#1)(1993-3#1)(1995-11#2)(1995-5#1)(1997-5#1)(1997-8#1)(1997-9#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-12#3)(2007-9#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-8#6)(2008-9#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
on the evolution##40##3##(1990-11#1)(1991-5#1)(1991-6#1)(1992-11#1)(1993-2#1)(1993-3#1)(1995-11#2)(1995-5#1)(1997-5#1)(1997-8#1)(1997-9#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-12#3)(2007-9#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-8#6)(2008-9#2)(2010-10#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
on the evolutionary process##2##4##(1994-3#1)(2012-3#1)
on the evolutionary relations among##2##5##(2008-7#1)(2008-8#1)
on the evolutionary##8##3##(1994-3#1)(2006-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-3#2)
on the evolving role of these##2##6##(2005-8#1)(2009-5#1)
on the evolving role of##3##5##(2005-8#1)(2006-10#1)(2009-5#1)
on the evolving##4##3##(2005-8#1)(2006-10#1)(2007-12#1)(2009-5#1)
on the exact##7##3##(1995-11#1)(2007-12#2)(2007-2#1)(2008-3#1)(2008-9#2)
on the examination##2##3##(2008-12#1)(2012-3#1)
on the example of the##2##5##(2006-12#1)(2012-2#1)
on the example of##6##4##(1994-2#1)(2006-12#1)(2008-10#1)(2012-2#1)(2013-7#2)
on the excess##2##3##(1995-2#1)(2008-10#1)
on the exchange##2##3##(2008-10#1)(2008-11#1)
on the excitation and emission##2##5##(2007-11#1)(2008-10#1)
on the excitation##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
on the excitation-beam##2##3##(2008-3#2)
on the excretion##3##3##(1990-5#1)(1994-5#1)(1996-8#1)
on the exercise##2##3##(1991-3#1)(2008-11#1)
on the existence and##2##4##(2007-9#1)(2008-8#1)
on the existence of two##2##5##(2007-9#1)(2008-3#1)
on the existence of##9##4##(1994-2#2)(1997-7#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)(2010-8#1)
on the existence##11##3##(1994-2#2)(1997-7#1)(2007-9#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#1)(2010-8#1)
on the existing##8##3##(1992-1#1)(2006-8#1)(2008-6#1)(2008-7#1)(2012-3#1)(2013-1#3)
on the exit site of long term central##2##8##(2007-7#2)
on the exit##5##3##(2007-7#2)(2008-2#2)(2008-3#1)
on the expansion of teaching##2##5##(2010-7#2)
on the expansion##3##3##(1996-8#1)(2010-7#2)
on the expected##4##3##(1993-1#1)(2008-10#1)(2010-6#1)(2011-2#1)
on the experience of the##5##5##(1992-3#1)(2007-3#1)(2007-7#1)(2008-6#1)(2012-12#1)
on the experience of##16##4##(1992-3#1)(1994-1#1)(2004-12#1)(2005-5#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-12#2)(2008-6#1)(2008-7#2)(2012-12#2)
on the experience##17##3##(1992-3#1)(1994-1#1)(1995-12#1)(2004-12#1)(2005-5#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-12#2)(2008-6#1)(2008-7#2)(2012-12#2)
on the experiences of##3##4##(1997-1#1)(2008-12#1)(2009-7#1)
on the experiences##5##3##(1995-5#1)(1997-1#1)(2008-10#1)(2008-12#1)(2009-7#1)
on the experimental conditions##4##4##(1995-1#1)(1996-6#1)(2006-10#1)(2010-11#1)
on the experimental parameters##2##4##(1997-3#1)(2010-4#1)
on the experimental results##5##4##(2005-11#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-8#1)
on the experimental##30##3##(1990-8#1)(1995-1#1)(1995-3#1)(1996-6#1)(1997-3#1)(2005-11#1)(2006-10#2)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#4)(2008-7#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-2#1)
on the exposed##6##3##(2006-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2010-4#1)
on the exposure of##2##4##(1993-8#1)(2008-8#1)
on the exposure##5##3##(1992-11#1)(1993-8#1)(2008-10#1)(2008-8#1)(2013-1#1)
on the expressed##2##3##(1997-6#1)(2008-4#1)
on the expression and secretion##2##5##(1991-9#1)(1997-2#1)
on the expression and##6##4##(1990-2#1)(1991-9#1)(1994-5#1)(1997-2#1)(2007-12#1)(2013-8#1)
on the expression level of##3##5##(2006-4#1)(2008-10#1)(2013-7#1)
on the expression level##4##4##(2006-4#1)(2008-10#1)(2010-5#1)(2013-7#1)
on the expression of a##2##5##(1990-11#1)(2008-6#1)
on the expression of heat shock proteins##2##7##(1992-6#1)(2010-4#1)
on the expression of heat shock##3##6##(1992-6#1)(1994-8#1)(2010-4#1)
on the expression of human##2##5##(2005-10#1)(2010-2#1)
on the expression of immediate early genes##2##7##(1993-6#1)(1997-8#1)
on the expression of intercellular adhesion molecule-1##2##7##(1995-5#1)(2010-1#1)
on the expression of resistance##2##5##(2008-10#2)
on the expression of the aggrecan##2##6##(1992-1#2)
on the expression of the##12##5##(1990-2#1)(1991-10#1)(1991-12#1)(1992-1#2)(1993-5#1)(1994-11#1)(1995-11#1)(1996-2#1)(1997-3#1)(2008-5#1)(2012-12#1)
on the expression of various##2##5##(1994-2#1)(2011-2#1)
on the expression of##89##4##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-1#2)(1992-3#1)(1992-6#2)(1992-8#3)(1993-12#1)(1993-2#1)(1993-5#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#4)(1995-2#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-12#3)(1996-2#2)(1997-3#1)(1997-7#1)(1997-8#3)(2005-10#1)(2005-9#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#2)
on the expression##104##3##(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-9#2)(1992-1#2)(1992-3#1)(1992-6#2)(1992-8#3)(1993-12#1)(1993-2#1)(1993-5#2)(1993-6#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#4)(1995-2#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-12#3)(1996-2#2)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#3)(2005-10#1)(2005-9#1)(2006-4#1)(2007-12#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#3)
on the extension##2##3##(1991-8#1)(1997-2#1)
on the extent and##4##4##(1993-11#1)(2006-10#1)(2009-6#1)(2012-1#1)
on the extent of the##6##5##(1996-8#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-7#1)
on the extent of##23##4##(1992-9#1)(1993-12#1)(1994-12#1)(1994-3#1)(1996-8#1)(1997-1#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#1)(2011-12#1)(2012-2#1)(2013-8#1)
on the extent to which the##2##6##(1995-3#1)(2007-10#1)
on the extent to which##5##5##(1993-8#1)(1995-3#1)(2007-10#1)(2009-5#2)
on the extent##33##3##(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-8#1)(1997-1#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-11#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-5#2)(2009-6#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-8#1)
on the external surface of the##2##6##(2006-10#1)(2008-10#1)
on the external surface of##4##5##(1994-11#2)(2006-10#1)(2008-10#1)
on the external surface##6##4##(1994-11#2)(2006-10#1)(2008-10#3)
on the external##16##3##(1990-2#1)(1993-12#1)(1994-11#2)(1996-9#2)(1997-1#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#4)(2013-1#1)
on the extracellular surface##2##4##(1991-11#1)(1992-12#1)
on the extracellular##5##3##(1990-11#1)(1990-5#2)(1991-11#1)(1992-12#1)
on the extract##4##3##(2008-10#1)(2009-6#1)(2010-12#1)(2013-1#1)
on the extraction and##3##4##(2008-10#2)(2008-11#1)
on the extraction efficiency of##2##5##(2008-10#2)
on the extraction of the##3##5##(1990-1#1)(2008-10#2)
on the extraction of##9##4##(1990-1#1)(2008-10#7)(2012-1#1)
on the extraction##24##3##(1990-1#1)(1992-12#1)(2008-10#19)(2008-11#1)(2011-1#1)(2012-1#1)
on the extraction-ability and -selectivity##2##5##(2008-10#2)
on the extrapolation of##2##4##(1997-8#1)(2013-1#1)
on the extremities##2##3##(2007-8#1)(2009-2#1)
on the extremity##2##3##(2007-11#1)(2008-6#1)
on the eye##2##3##(1992-9#1)(2012-2#1)
on the eyelid##2##3##(1992-7#1)(2013-8#1)
on the fabrication and##6##4##(2007-12#4)(2008-2#1)(2008-3#1)
on the fabrication of##4##4##(2008-1#1)(2008-2#2)(2008-3#1)
on the fabrication##13##3##(2007-12#4)(2007-9#1)(2008-1#1)(2008-2#4)(2008-3#3)
on the face and##2##4##(2010-6#1)(2011-2#1)
on the face of a##3##5##(2005-11#1)(2007-8#1)(2008-2#1)
on the face##15##3##(1993-1#1)(2005-11#1)(2006-12#1)(2007-7#2)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-5#1)(2010-6#1)(2011-2#2)
on the facial##2##3##(1996-2#1)(2008-12#1)
on the fact that the##9##5##(1991-12#1)(1992-9#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)
on the fact that there##3##5##(2008-10#1)(2008-4#2)
on the fact that##30##4##(1990-10#1)(1990-11#1)(1991-12#1)(1992-9#1)(1993-9#1)(1994-3#1)(1995-6#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#9)(2008-2#1)(2008-3#2)(2008-4#3)(2010-4#1)
on the fact##31##3##(1990-10#1)(1990-11#1)(1991-12#1)(1992-9#1)(1993-9#1)(1994-3#1)(1995-6#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#9)(2008-2#2)(2008-3#2)(2008-4#3)(2010-4#1)
on the factor##2##3##(2004-11#1)(2009-8#1)
on the factors that##5##4##(1991-2#1)(1995-12#1)(2007-8#1)(2013-1#2)
on the factors##10##3##(1991-2#1)(1992-2#1)(1995-12#1)(1996-3#1)(2007-8#1)(2008-3#1)(2009-6#1)(2010-2#1)(2013-1#2)
on the familiar##2##3##(2008-3#1)(2012-3#1)
on the family of##2##4##(2008-5#1)(2011-2#1)
on the family##11##3##(1996-1#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-12#1)(2011-2#2)(2012-1#1)
on the far field##2##4##(2007-12#2)
on the farm##7##3##(1993-2#1)(2007-7#2)(2008-10#1)(2008-4#1)(2008-5#1)(2010-4#1)
on the fate of##3##4##(1990-7#2)(2008-7#1)
on the fate##4##3##(1990-7#2)(2006-10#1)(2008-7#1)
on the fatigue##3##3##(2008-7#1)(2009-7#2)
on the fatty acid composition of##2##6##(1991-7#1)(2010-4#1)
on the fatty acid##3##4##(1991-7#1)(2006-6#1)(2010-4#1)
on the fault##4##3##(1996-4#3)(2008-3#1)
on the feasibility of##2##4##(2010-3#1)(2013-7#1)
on the feasibility##4##3##(2010-3#1)(2010-8#1)(2012-1#1)(2013-7#1)
on the features of##2##4##(2007-12#1)(2010-8#1)
on the features##3##3##(2007-12#1)(2009-7#1)(2010-8#1)
on the federal##3##3##(1993-10#1)(2008-11#1)(2009-7#1)
on the feeding##2##3##(2005-7#1)(2011-2#1)
on the feet##2##3##(1990-5#1)(2007-2#1)
on the female##5##3##(1994-5#1)(1995-6#2)(2004-2#2)
on the femoral##2##3##(2008-6#1)(2009-3#1)
on the femtosecond time scale##2##5##(2006-5#1)(2007-12#1)
on the femtosecond##3##3##(2006-4#1)(2006-5#1)(2007-12#1)
on the fiber##9##3##(2005-11#1)(2007-12#4)(2008-2#2)(2009-11#1)(2012-11#1)
on the fibers##2##3##(2004-9#1)(2008-2#1)
on the fibre##3##3##(2008-10#2)(2008-5#1)
on the field##7##3##(1993-2#1)(1994-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2011-2#2)
on the fifth day of##2##5##(1993-12#1)(2008-12#1)
on the fifth day##3##4##(1993-12#1)(2007-11#1)(2008-12#1)
on the fifth postoperative day##2##5##(2007-4#1)(2011-1#1)
on the fifth##5##3##(1993-12#1)(2007-11#1)(2007-4#1)(2008-12#1)(2011-1#1)
on the film and the##2##5##(2008-10#1)(2008-3#1)
on the film and##3##4##(2008-10#2)(2008-3#1)
on the film##8##3##(2005-11#2)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)
on the films##4##3##(1992-11#1)(1992-8#1)(2008-11#1)(2008-3#1)
on the filter were##2##4##(2008-10#2)
on the filter##8##3##(2008-10#5)(2008-3#2)(2010-8#1)
on the final height##2##4##(2007-11#2)
on the final outcome of##2##5##(2007-11#1)(2009-5#1)
on the final outcome##3##4##(1991-6#1)(2007-11#1)(2009-5#1)
on the final product##2##4##(2008-6#1)(2008-7#1)
on the final##17##3##(1991-6#1)(1996-12#1)(2005-11#2)(2007-11#4)(2008-5#2)(2008-6#1)(2008-7#1)(2009-5#1)(2009-8#2)(2010-12#1)(2011-2#1)
on the financial##2##3##(1994-12#1)(2008-10#1)
on the financing##3##3##(1992-1#1)(1993-3#1)(2012-1#1)
on the finding of##4##4##(1990-11#1)(1990-9#1)(1996-11#1)(2008-1#1)
on the finding##8##3##(1990-11#1)(1990-9#1)(1995-6#1)(1996-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-10#1)
on the findings of a##3##5##(1995-2#1)(1996-3#1)(2007-2#1)
on the findings of the##6##5##(2007-1#1)(2007-2#1)(2008-1#1)(2010-3#1)(2011-1#1)(2012-3#1)
on the findings of##15##4##(1990-7#1)(1995-2#1)(1996-3#1)(2007-1#1)(2007-2#2)(2008-1#1)(2008-11#1)(2008-7#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
on the findings##30##3##(1990-7#1)(1991-12#1)(1995-2#1)(1996-3#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
on the finest##3##3##(2008-2#2)(2008-4#1)
on the finger##2##3##(2006-3#1)(2010-6#1)
on the firing##2##3##(1993-7#1)(1996-8#1)
on the first and##2##4##(1997-7#1)(2008-3#1)
on the first day after##4##5##(1990-12#2)(1996-2#1)(2007-8#1)
on the first day of life##2##6##(1990-12#1)(1993-12#1)
on the first day of##7##5##(1990-12#2)(1993-12#2)(2005-11#1)(2012-12#1)(2013-1#1)
on the first day##14##4##(1990-12#5)(1993-12#2)(1996-2#1)(2005-11#1)(2007-8#1)(2008-5#1)(2010-8#1)(2012-12#1)(2013-1#1)
on the first few##2##4##(1990-9#1)(2008-11#1)
on the first or##2##4##(2006-5#1)(2008-3#1)
on the first phase##2##4##(1995-12#1)(2008-12#1)
on the first place##2##4##(2008-1#1)(2008-9#1)
on the first post-operative day##2##5##(2007-2#1)(2008-1#1)
on the first postoperative day##5##5##(1990-2#1)(2007-1#1)(2007-10#1)(2008-8#1)(2011-1#1)
on the first postoperative##6##4##(1990-2#1)(1993-5#1)(2007-1#1)(2007-10#1)(2008-8#1)(2011-1#1)
on the first upper true leaves at 14##2##8##(2008-10#2)
on the first##66##3##(1990-12#5)(1990-2#1)(1990-9#1)(1991-2#1)(1992-7#1)(1993-12#2)(1993-3#1)(1993-5#2)(1994-12#1)(1994-7#1)(1995-12#2)(1995-2#1)(1995-7#1)(1996-2#1)(1997-3#1)(1997-7#1)(2005-11#2)(2006-10#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#3)(2008-8#1)(2008-9#1)(2009-10#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
on the fitness of##2##4##(2006-3#1)(2008-8#1)
on the five##2##3##(1997-5#1)(2008-10#1)
on the flagellum##3##3##(2007-12#3)
on the flat##2##3##(2005-11#1)(2008-3#1)
on the flexural strength##3##4##(2008-12#2)(2009-7#1)
on the flexural##4##3##(2008-12#2)(2009-7#1)(2011-2#1)
on the floor of the##3##5##(1990-4#1)(1996-5#1)(2007-7#1)
on the floor##7##3##(1990-4#1)(1996-5#1)(1997-2#1)(2007-7#1)(2008-11#1)(2008-6#2)
on the flow rate##3##4##(2008-10#3)
on the flow##6##3##(2007-9#2)(2008-10#4)
on the fluorescence characteristics of the##2##6##(2008-10#1)(2008-3#1)
on the fluorescence emission of##3##5##(2008-10#2)(2008-3#1)
on the fluorescence emission##4##4##(1997-4#1)(2008-10#2)(2008-3#1)
on the fluorescence enhancement of##4##5##(2007-8#1)(2008-10#3)
on the fluorescence intensity##2##4##(2008-10#1)(2008-2#1)
on the fluorescence of##4##4##(2007-8#1)(2008-10#2)(2008-9#1)
on the fluorescence##33##3##(1996-2#1)(1996-6#1)(1997-1#1)(1997-4#1)(2005-11#1)(2005-4#1)(2006-10#1)(2007-8#2)(2008-10#17)(2008-2#2)(2008-3#3)(2008-9#1)(2009-2#1)
on the fluorescent##3##3##(2005-4#1)(2008-10#2)
on the flux##3##3##(1990-11#1)(1990-12#1)(2008-2#1)
on the fly##4##3##(2008-1#2)(2008-3#1)(2008-6#1)
on the focal plane##2##4##(2008-3#2)
on the focal##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
on the folding and##2##4##(1991-6#1)(1993-3#1)
on the folding##3##3##(1991-6#1)(1992-6#1)(1993-3#1)
on the follow-up##2##3##(2006-2#1)(2008-9#1)
on the following aspects##2##4##(1994-6#1)(2008-4#1)
on the following day##4##4##(2008-3#2)(2008-7#1)(2011-1#1)
on the following##32##3##(1990-9#1)(1991-6#1)(1994-6#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-4#1)(2004-10#1)(2005-5#1)(2008-1#1)(2008-10#5)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-1#1)(2013-1#1)
on the food##3##3##(1997-1#1)(2007-12#1)(2011-12#1)
on the force##2##3##(1990-2#1)(2010-4#1)
on the forearm##4##3##(2006-9#1)(2008-5#3)
on the forehead##4##3##(2008-5#3)(2010-6#1)
on the foreign##2##3##(1993-6#1)(2009-11#1)
on the form of the##2##5##(2006-10#1)(2008-3#1)
on the form of##3##4##(1996-8#1)(2006-10#1)(2008-3#1)
on the formal##2##3##(2005-12#1)(2008-10#1)
on the formation and##7##4##(1990-2#1)(2007-11#1)(2008-10#2)(2010-12#1)(2010-4#1)(2011-1#1)
on the formation of NO##2##5##(1992-5#1)(1994-2#1)
on the formation of a##12##5##(2008-10#11)(2011-1#1)
on the formation of an##3##5##(2008-10#3)
on the formation of the complex##2##6##(2008-10#2)
on the formation of the##13##5##(1991-3#1)(1992-1#1)(1993-3#1)(2006-8#1)(2008-10#7)(2010-2#1)(2011-2#1)
on the formation of##58##4##(1990-7#1)(1990-9#1)(1991-11#1)(1991-3#1)(1992-1#1)(1992-5#1)(1992-8#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#35)(2008-5#1)(2009-2#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)
on the formation##68##3##(1990-2#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-3#1)(1992-1#1)(1992-5#1)(1992-8#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-8#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-12#1)(2008-10#39)(2008-5#1)(2009-2#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)
on the former##4##3##(1996-8#1)(2006-6#1)(2007-5#1)(2011-2#1)
on the formulation of##2##4##(2008-5#1)(2013-8#1)
on the formulation##5##3##(1995-12#1)(2008-5#2)(2012-12#1)(2013-8#1)
on the found##2##3##(2008-10#2)
on the foundation of##3##4##(2008-1#1)(2011-1#1)(2012-12#1)
on the four##3##3##(1993-2#1)(1997-8#1)(2007-2#1)
on the fourth day of admission##2##6##(2009-12#1)(2010-12#1)
on the fourth day##5##4##(1993-7#1)(2008-5#1)(2009-12#1)(2010-12#1)(2012-2#1)
on the fourth##7##3##(1993-7#1)(2006-6#1)(2008-5#2)(2009-12#1)(2010-12#1)(2012-2#1)
on the fraction of the##2##5##(2007-12#1)(2011-3#1)
on the fraction of##5##4##(1994-5#1)(2007-12#1)(2008-10#2)(2011-3#1)
on the fracture##2##3##(2004-9#1)(2013-8#1)
on the free energy of##2##5##(1992-6#1)(2010-2#1)
on the free energy##3##4##(1992-6#1)(2010-2#1)(2010-7#1)
on the free##10##3##(1990-7#1)(1991-3#1)(1992-6#1)(1993-4#1)(1994-3#1)(1994-6#1)(1997-4#1)(2010-2#1)(2010-7#1)(2012-2#1)
on the frequency and##5##4##(1993-11#1)(1993-12#1)(2007-11#1)(2008-1#1)(2008-2#1)
on the frequency of##16##4##(1990-8#1)(1990-9#1)(1991-6#1)(1992-11#1)(1993-1#1)(1993-12#1)(1997-1#2)(1997-3#1)(2004-12#1)(2007-12#2)(2008-1#1)(2008-5#1)(2012-2#1)(2013-1#1)
on the frequency response##2##4##(2008-10#1)(2008-2#1)
on the frequency##27##3##(1990-8#1)(1990-9#1)(1991-6#1)(1992-11#1)(1993-1#1)(1993-11#1)(1993-12#2)(1996-2#1)(1997-1#2)(1997-3#1)(2004-12#1)(2007-11#3)(2007-12#2)(2008-1#2)(2008-10#1)(2008-2#2)(2008-5#1)(2012-1#1)(2012-2#1)(2013-1#1)
on the fringe of##2##4##(2008-9#2)
on the fringe##6##3##(2008-2#2)(2008-3#2)(2008-9#2)
on the front line##2##4##(2007-12#1)(2009-12#1)
on the front surface and##2##5##(2008-2#1)(2008-3#1)
on the front##11##3##(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#3)(2009-12#1)(2010-5#3)
on the frontal##3##3##(1997-8#1)(2006-11#1)(2011-2#1)
on the fruit fly##2##4##(2010-5#1)(2013-8#1)
on the fruit##3##3##(2008-10#1)(2010-5#1)(2013-8#1)
on the full##7##3##(2006-10#1)(2006-11#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-2#1)(2012-2#1)
on the function and##6##4##(1992-9#1)(1994-5#1)(1994-6#1)(2008-11#1)(2008-5#1)(2013-8#1)
on the function of the##5##5##(1990-11#1)(1994-12#1)(1994-6#1)(1995-8#1)(1997-7#1)
on the function of these##2##5##(2006-10#1)(2008-11#1)
on the function of##19##4##(1990-11#1)(1991-12#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-7#1)(2006-10#2)(2007-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-11#1)
on the function##25##3##(1990-11#1)(1991-12#1)(1992-9#1)(1994-12#1)(1994-5#2)(1994-6#2)(1995-6#1)(1995-8#1)(1996-2#1)(1997-7#1)(2006-10#2)(2007-10#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-9#1)(2012-11#1)(2013-8#1)
on the functional capacity of patients in the early period following intracranial aneurysm surgery##2##14##(2007-7#2)
on the functional capacity of##3##5##(1991-10#1)(2007-7#2)
on the functional properties of##4##5##(1990-8#1)(1994-3#1)(1995-12#2)
on the functional role of##2##5##(2008-1#1)(2009-2#1)
on the functional##25##3##(1990-7#1)(1990-8#1)(1991-10#1)(1994-3#1)(1994-8#1)(1995-12#3)(1997-5#1)(2006-6#1)(2007-11#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-9#1)
on the functionality of##2##4##(2007-2#1)(2007-3#1)
on the functions of##3##4##(2007-12#1)(2007-2#1)(2013-1#1)
on the functions##4##3##(2007-12#1)(2007-2#1)(2008-9#1)(2013-1#1)
on the fundamental##2##3##(2006-12#1)(2008-7#1)
on the further development of##2##5##(2006-10#1)(2009-2#1)
on the fusion##3##3##(2008-11#1)(2008-5#2)
on the future of health##2##5##(1991-12#1)(1997-2#1)
on the future of the##3##5##(2007-9#1)(2011-1#1)(2012-12#1)
on the future of##9##4##(1991-12#1)(1997-2#1)(2005-2#1)(2007-9#1)(2008-11#1)(2008-8#1)(2011-1#2)(2012-12#1)
on the future prospects##2##4##(2008-8#1)(2009-3#1)
on the future##20##3##(1991-12#1)(1997-2#1)(2005-2#1)(2005-7#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-8#2)(2009-3#1)(2010-11#1)(2010-3#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
on the gain margin##2##4##(2008-3#2)
on the gait##4##3##(2012-1#4)
on the gap##2##3##(2008-1#1)(2013-8#1)
on the gas##2##3##(2004-4#1)(2008-3#1)
on the gastric##4##3##(1990-9#1)(1995-11#2)(2008-1#1)
on the gastrointestinal tract##5##4##(1993-10#1)(1997-4#1)(2008-3#1)(2008-4#1)(2008-7#1)
on the gastrointestinal##8##3##(1993-10#1)(1997-4#1)(2006-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2012-2#1)
on the gate##2##3##(1991-5#1)(2006-8#1)
on the gating##2##3##(1990-11#1)(2008-8#1)
on the gel##5##3##(1992-1#1)(1992-12#1)(1993-8#1)(2007-8#1)(2008-10#1)
on the gene expression of RXR alpha##2##7##(1993-3#2)
on the gene expression of##3##5##(1992-6#1)(1993-3#2)
on the gene expression##4##4##(1992-6#1)(1993-3#2)(1993-9#1)
on the gene level##2##4##(1995-7#1)(2012-3#1)
on the gene##10##3##(1992-3#1)(1992-6#1)(1993-3#2)(1993-9#1)(1995-7#1)(1996-6#1)(2008-7#1)(2010-6#1)(2012-3#1)
on the general##10##3##(1993-12#1)(1993-2#1)(2006-11#1)(2006-2#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-6#1)(2012-2#1)(2012-3#1)
on the generalizability of##2##4##(1993-3#1)(2013-8#1)
on the generalizability##4##3##(1993-3#1)(2013-1#2)(2013-8#1)
on the generalization##3##3##(2008-2#2)(2008-9#1)
on the generated##2##3##(2007-12#1)(2008-3#1)
on the generation of a##2##5##(2006-10#1)(2007-11#1)
on the generation of inositol##2##5##(1991-2#2)
on the generation of##22##4##(1991-12#1)(1991-2#2)(1991-5#1)(1994-3#2)(1995-5#2)(1996-10#1)(1996-2#1)(2005-8#1)(2006-10#2)(2007-11#3)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#2)
on the generation##23##3##(1991-12#1)(1991-2#2)(1991-5#1)(1992-3#1)(1994-3#2)(1995-5#2)(1996-10#1)(1996-2#1)(2005-8#1)(2006-10#2)(2007-11#3)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#2)
on the generic##2##3##(1996-3#1)(2008-6#1)
on the genes##4##3##(1996-6#1)(2008-8#1)(2008-9#1)(2011-2#1)
on the genesis##2##3##(1990-11#1)(2013-8#1)
on the genetic and##3##4##(2005-7#1)(2008-11#1)(2008-7#1)
on the genetic background##2##4##(1996-5#1)(2012-3#1)
on the genetic diversity##2##4##(1995-8#1)(2008-10#1)
on the genetic map of##4##5##(1996-12#2)(1997-4#1)(2008-10#1)
on the genetic map##9##4##(1992-4#1)(1996-10#1)(1996-12#2)(1996-6#1)(1997-4#2)(2008-10#1)(2008-5#1)
on the genetic structure of natural populations of##2##8##(2007-12#1)(2012-3#1)
on the genetic structure of##4##5##(2007-12#1)(2008-8#1)(2012-3#1)(2013-8#1)
on the genetic##37##3##(1992-4#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-12#2)(1996-5#1)(1996-6#1)(1997-4#2)(1997-6#1)(2005-7#1)(2006-6#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#1)(2010-4#1)(2010-5#1)(2012-3#2)(2013-1#1)(2013-8#1)
on the genetically##2##3##(2006-10#1)(2008-5#1)
on the genetics and##3##4##(2008-10#1)(2008-8#1)(2013-1#1)
on the genetics of resistance in##2##6##(2008-10#1)(2011-10#1)
on the genetics of##5##4##(2007-10#1)(2007-9#1)(2008-10#2)(2011-10#1)
on the genetics##9##3##(2007-10#1)(2007-9#1)(2008-10#3)(2008-4#1)(2008-8#1)(2011-10#1)(2013-1#1)
on the genome of Synechocystis sp##4##6##(1996-8#1)(1997-2#1)(1997-6#2)
on the genome of the##2##5##(1990-4#1)(1995-6#1)
on the genome of##8##4##(1990-4#1)(1993-11#1)(1995-6#1)(1996-8#1)(1997-2#1)(1997-6#2)(2009-5#1)
on the genome sequence of##2##5##(1996-8#1)(2013-1#1)
on the genome##16##3##(1990-4#1)(1993-11#1)(1995-6#1)(1996-6#1)(1996-8#3)(1997-2#1)(1997-4#1)(1997-6#2)(2008-6#1)(2009-5#1)(2012-3#2)(2013-1#1)
on the genomic##5##3##(1991-11#1)(1994-12#1)(1997-3#1)(2008-10#1)(2013-8#1)
on the geometric##5##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
on the geometrical##3##3##(2005-11#1)(2006-5#1)(2013-8#1)
on the geometry##3##3##(2007-12#1)(2008-9#1)(2009-12#1)
on the germination of seeds of Kwao Kreu Kao (Pueraria candollei Grah##2##12##(2008-12#2)
on the germination of##4##4##(2008-12#2)(2008-5#1)(2012-2#1)
on the germination##5##3##(2006-12#1)(2008-12#2)(2008-5#1)(2012-2#1)
on the gestational age##2##4##(2009-5#1)(2012-2#1)
on the giant##3##3##(2008-7#1)(2013-7#2)
on the gingiva##4##3##(1993-1#2)(2012-12#1)(2012-3#1)
on the gingival##2##3##(2012-12#1)(2012-3#1)
on the glass surface##2##4##(1991-5#1)(2013-1#1)
on the glass##9##3##(1991-5#1)(2005-4#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2013-1#1)
on the glassy carbon electrode (GCE)##2##6##(2008-10#2)
on the glassy carbon electrode##3##5##(2008-10#3)
on the glassy carbon##4##4##(2008-10#4)
on the global##2##3##(2008-9#1)(2011-2#1)
on the glucose##6##3##(1995-3#1)(2008-10#3)(2012-11#1)(2012-12#1)
on the glutamate-induced rise in##2##5##(1995-12#2)
on the glycoprotein##3##3##(1991-11#1)(1991-12#1)(2005-7#1)
on the glycosylation##2##3##(2006-12#1)(2012-3#1)
on the goals and##2##4##(1994-3#1)(1996-1#1)
on the goals##3##3##(1994-1#1)(1994-3#1)(1996-1#1)
on the gold electrode surface##2##5##(2008-10#2)
on the gold electrode##3##4##(2008-10#3)
on the gold##5##3##(2008-10#4)(2008-2#1)
on the government's##2##3##(1996-5#1)(2008-11#1)
on the gradient##2##3##(2008-7#1)(2011-1#1)
on the graphite electrode surface##2##5##(2008-10#2)
on the graphite##5##3##(2007-10#1)(2008-10#4)
on the grating length##2##4##(2007-12#1)(2008-3#1)
on the grating plane##2##4##(2008-3#2)
on the grating##15##3##(2007-11#2)(2007-12#3)(2008-2#3)(2008-3#7)
on the green##3##3##(2004-2#1)(2008-1#1)(2008-7#1)
on the ground and##2##4##(2006-12#1)(2008-10#1)
on the ground of the##3##5##(2008-8#1)(2009-6#1)(2013-7#1)
on the ground of##5##4##(2007-9#1)(2008-3#1)(2008-8#1)(2009-6#1)(2013-7#1)
on the ground##18##3##(1990-8#1)(2005-11#1)(2006-12#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2012-2#2)(2012-3#1)(2013-7#1)
on the ground-state##2##3##(2006-3#1)(2010-5#1)
on the grounds of##4##4##(1990-11#1)(1996-6#1)(2007-7#1)(2011-1#1)
on the grounds that it##4##5##(1995-12#1)(1996-6#1)(1997-4#1)(2006-7#1)
on the grounds that##9##4##(1991-12#1)(1991-7#1)(1995-12#1)(1996-6#1)(1997-4#1)(2006-7#1)(2007-11#1)(2011-2#1)(2012-11#1)
on the grounds##13##3##(1990-11#1)(1991-12#1)(1991-7#1)(1995-12#1)(1996-6#2)(1997-4#1)(2006-7#1)(2007-11#1)(2007-7#1)(2011-1#1)(2011-2#1)(2012-11#1)
on the groundwater##2##3##(2007-10#1)(2011-1#1)
on the group##5##3##(2008-1#1)(2008-2#1)(2009-10#1)(2010-6#1)(2013-8#1)
on the grove floor##3##4##(2008-10#3)
on the growing##2##3##(2007-4#1)(2008-5#1)
on the growth and development of##4##6##(2007-12#1)(2008-12#2)(2010-2#1)
on the growth and metabolism of##2##6##(2008-11#2)
on the growth and survival of##2##6##(1994-12#1)(2008-1#1)
on the growth and##22##4##(1994-12#1)(1994-8#1)(2004-4#1)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-8#1)(2008-9#1)(2010-2#1)(2010-6#1)(2010-8#1)(2012-12#1)(2012-2#1)
on the growth of human##5##5##(1990-7#1)(1992-1#1)(1993-9#1)(1994-8#1)(2008-11#1)
on the growth of the human##2##6##(1991-8#1)(1992-8#1)
on the growth of the##4##5##(1991-8#1)(1992-8#2)(2008-12#1)
on the growth of transplanted##2##5##(2010-12#1)(2011-2#1)
on the growth of##56##4##(1990-11#1)(1990-7#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-8#3)(1993-3#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-8#2)(1996-12#1)(1997-1#1)(2005-6#1)(2006-10#1)(2006-8#2)(2007-11#1)(2007-3#1)(2007-7#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-4#2)(2008-5#3)(2008-7#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#2)
on the growth performance##5##4##(2010-2#4)(2012-2#1)
on the growth rate of the##4##6##(2005-11#1)(2007-9#1)(2008-10#1)(2008-7#1)
on the growth rate of##5##5##(2005-11#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-7#1)
on the growth rate##6##4##(2005-11#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-7#1)
on the growth##100##3##(1990-11#1)(1990-7#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-8#3)(1993-3#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-8#3)(1996-12#1)(1996-9#1)(1997-1#1)(2004-4#1)(2005-11#1)(2005-6#1)(2006-10#2)(2006-8#2)(2007-11#1)(2007-12#2)(2007-3#3)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#10)(2008-12#5)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#6)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-8#2)
on the guidelines##2##3##(1992-8#1)(2008-5#1)
on the guiding##2##3##(2007-12#1)(2008-7#1)
on the guinea pig##2##4##(1992-12#1)(1992-6#1)
on the gut##2##3##(2008-3#1)(2010-7#1)
on the hair cycle##2##4##(2008-5#2)
on the hair##7##3##(1996-7#1)(2006-12#1)(2008-5#4)(2008-8#1)
on the half-life of##2##4##(1993-1#1)(2007-6#1)
on the hamster##2##3##(1993-3#1)(1995-12#1)
on the handling##2##3##(2006-10#1)(2009-4#1)
on the hands of##2##4##(2007-12#1)(2008-10#1)
on the hands##3##3##(2007-12#1)(2008-10#1)(2013-1#1)
on the hanging mercury drop electrode##2##6##(2008-10#2)
on the hanging mercury##3##4##(2005-11#1)(2008-10#2)
on the haplotype##2##3##(1996-11#1)(2010-2#1)
on the head and neck##2##5##(2006-12#1)(2007-9#1)
on the head and##4##4##(2006-12#1)(2007-2#1)(2007-9#1)(2008-5#1)
on the head##15##3##(1990-6#1)(1993-11#1)(1996-4#1)(2006-12#1)(2007-12#2)(2007-2#1)(2007-4#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-3#1)
on the healing of##2##4##(2005-11#1)(2009-3#1)
on the health and##6##4##(1991-3#1)(2005-7#1)(2008-3#1)(2009-5#1)(2012-1#1)(2012-11#1)
on the health care industry##2##5##(1990-12#1)(1991-12#1)
on the health care system##4##5##(1994-12#1)(1995-4#1)(2008-1#1)(2012-12#1)
on the health care##16##4##(1990-12#1)(1991-12#1)(1992-1#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#2)(1995-4#1)(1996-1#1)(1997-3#2)(2008-1#1)(2012-12#1)(2013-1#2)
on the health effects of##3##5##(1994-6#1)(2008-4#1)(2013-1#1)
on the health of individuals##2##5##(2010-4#2)
on the health of the##3##5##(2010-12#1)(2012-12#1)(2012-2#1)
on the health of##13##4##(1993-1#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-12#1)(2010-12#1)(2010-4#2)(2010-8#1)(2012-12#2)(2012-2#1)(2013-8#1)
on the health##49##3##(1990-12#1)(1991-12#1)(1991-3#2)(1992-1#1)(1992-3#1)(1993-1#1)(1993-10#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#2)(1994-6#2)(1995-12#1)(1995-4#1)(1995-6#1)(1996-1#1)(1997-3#2)(2005-7#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-4#2)(2010-8#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#1)(2013-1#3)(2013-8#2)
on the healthcare system##3##4##(2006-5#1)(2010-12#1)(2011-7#1)
on the healthy##3##3##(2009-6#1)(2012-3#1)(2013-7#1)
on the heart muscle##2##4##(2008-4#2)
on the heart were##2##4##(2006-6#1)(2008-7#1)
on the heart##16##3##(1990-1#1)(1991-4#1)(1991-8#1)(1994-6#1)(2006-6#1)(2007-9#1)(2008-1#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-5#1)(2011-1#1)(2011-2#1)
on the hearts of adult rats##2##6##(2013-7#2)
on the hearts of rats##2##5##(2013-7#2)
on the hearts of##4##4##(2013-7#4)
on the heat tolerance of##2##5##(2010-4#2)
on the heat##4##3##(1994-2#1)(2008-3#1)(2010-4#2)
on the height of##2##4##(1993-7#1)(2008-10#1)
on the height##3##3##(1993-7#1)(2008-10#1)(2008-12#1)
on the heme##2##3##(1994-8#1)(2007-11#1)
on the hepatic##4##3##(1991-7#1)(1992-8#1)(1995-9#1)(1997-2#1)
on the heterogeneity of the test##2##6##(2008-10#2)
on the heterogeneity of##3##4##(2007-6#1)(2008-10#2)
on the hexagonal column##2##4##(2008-3#2)
on the high affinity of##2##5##(2008-4#1)(2008-9#1)
on the high affinity##3##4##(1996-9#1)(2008-4#1)(2008-9#1)
on the high risk##2##4##(1994-11#1)(2008-5#1)
on the high seas##2##4##(2007-5#1)(2008-10#1)
on the high##18##3##(1991-10#1)(1992-2#1)(1992-8#1)(1993-6#1)(1994-11#1)(1996-12#1)(1996-9#1)(1997-7#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-4#1)(2010-5#1)(2010-8#1)
on the high-fat##2##3##(1991-2#2)
on the high-level##2##3##(1992-5#1)(2013-8#1)
on the high-resolution##2##3##(1997-4#1)(2010-2#1)
on the higher##5##3##(1990-6#1)(1993-8#1)(2008-10#2)(2011-2#1)
on the highly##7##3##(1992-9#2)(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-1#1)
on the hippocampus##2##3##(2008-4#1)(2008-7#1)
on the hiring##2##3##(1992-9#1)(1994-1#1)
on the histidine##2##3##(1992-5#1)(1992-8#1)
on the histogenesis##2##3##(1996-6#1)(2007-2#1)
on the histological##2##3##(1990-7#1)(1993-11#1)
on the historical##3##3##(2011-1#1)(2013-1#1)(2013-8#1)
on the history of the##2##5##(1993-5#1)(2008-6#1)
on the history of##7##4##(1993-5#1)(2008-6#1)(2009-2#1)(2011-1#1)(2011-8#1)(2012-3#1)(2013-8#1)
on the history##8##3##(1993-5#1)(2008-6#1)(2009-2#1)(2011-1#1)(2011-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
on the holographic##4##3##(2008-2#1)(2008-3#3)
on the horizon for##3##4##(2006-10#1)(2006-9#1)(2011-2#1)
on the horizon##9##3##(2006-10#3)(2006-9#1)(2007-11#1)(2008-1#1)(2008-9#1)(2011-12#1)(2011-2#1)
on the horizontal##2##3##(2008-3#1)(2008-8#1)
on the hormonal status of patients with JRA##2##8##(2007-11#2)
on the hormonal##4##3##(2007-11#2)(2008-10#1)(2012-2#1)
on the hospital##5##3##(1992-3#1)(1993-1#1)(1993-3#1)(2008-4#1)(2013-8#1)
on the hospital's##2##3##(1993-12#1)(2007-11#1)
on the host and##2##4##(2008-10#2)
on the host cell##4##4##(1992-5#1)(2006-4#1)(2008-11#1)(2010-1#1)
on the host from which##2##5##(2008-10#2)
on the host surface##2##4##(2008-10#1)(2010-10#1)
on the host##22##3##(1991-5#1)(1992-5#1)(1994-12#1)(1997-1#1)(2006-4#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-7#1)
on the host's##3##3##(2006-10#1)(2008-2#1)(2010-3#1)
on the hot plate test##2##5##(1994-2#1)(1996-2#1)
on the hsp70##2##3##(2013-1#2)
on the human body##2##4##(2008-10#1)(2013-7#1)
on the human erythrocyte membrane##2##5##(1990-12#1)(2008-11#1)
on the human gait##2##4##(2012-1#2)
on the human genome##2##4##(1997-2#1)(2011-1#1)
on the human health##2##4##(2008-1#1)(2008-10#1)
on the human hearts##2##4##(2005-10#2)
on the human##34##3##(1990-12#1)(1991-1#2)(1991-2#1)(1992-6#1)(1993-4#1)(1994-10#1)(1994-6#2)(1995-5#1)(1997-2#1)(1997-6#1)(2005-10#2)(2006-11#1)(2006-12#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#3)(2011-1#1)(2012-1#4)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
on the humoral immune response##2##5##(2006-10#1)(2008-11#1)
on the humoral immune responses of##2##6##(2006-12#1)(2008-11#1)
on the humoral immune##4##4##(2006-10#1)(2006-12#1)(2008-11#2)
on the hybrid##5##3##(1995-8#1)(2008-10#2)(2008-3#1)(2008-8#1)
on the hydration of##2##4##(2006-10#2)
on the hydration##5##3##(2006-10#2)(2006-5#1)(2008-10#1)(2008-5#1)
on the hydrocarbon##2##3##(1993-3#1)(2007-1#1)
on the hydrogen bonding##2##4##(1996-8#1)(2009-2#1)
on the hydrogen##5##3##(1992-12#1)(1995-2#1)(1996-8#1)(2008-8#1)(2009-2#1)
on the hydrolysis of##7##4##(1990-7#1)(1991-2#1)(1994-3#1)(1994-5#2)(2008-10#1)(2013-1#1)
on the hydrolysis##9##3##(1990-11#1)(1990-7#1)(1991-2#1)(1994-3#1)(1994-5#2)(1996-6#1)(2008-10#1)(2013-1#1)
on the hydrophilic##6##3##(1990-11#1)(1990-2#1)(1991-2#1)(1991-3#1)(2008-3#1)(2009-12#1)
on the hydrophobic##6##3##(1990-5#1)(1994-12#1)(2005-11#1)(2008-10#1)(2010-2#1)(2011-1#1)
on the hydrophobicity of the##2##5##(1993-4#1)(2008-10#1)
on the hypothalamic##2##3##(1994-10#1)(2007-8#1)
on the hypothalamic-pituitary-adrenal axis##2##4##(1994-11#1)(1995-12#1)
on the hypothalamic-pituitary-adrenal##3##3##(1994-11#1)(1995-12#1)(1996-12#1)
on the hypothalamo-pituitary-adrenal axis##2##4##(1990-2#2)
on the hypothesis that##6##4##(2004-9#1)(2008-11#1)(2009-6#1)(2009-8#1)(2010-8#1)(2013-1#1)
on the hypoxia-inducible factor##2##4##(2009-3#2)
on the idea of the##2##5##(2007-12#2)
on the idea of##9##4##(1990-12#1)(2007-12#3)(2008-2#1)(2008-3#1)(2009-12#1)(2012-2#1)(2012-3#1)
on the idea##12##3##(1990-12#1)(2007-12#3)(2007-9#1)(2008-2#1)(2008-3#1)(2009-12#1)(2009-5#1)(2012-1#1)(2012-2#1)(2012-3#1)
on the ideal##3##3##(2007-4#1)(2007-8#1)(2013-1#1)
on the identification and##2##4##(1994-3#1)(2010-12#1)
on the identification of a##2##5##(1991-12#1)(2009-8#1)
on the identification of##20##4##(1990-7#1)(1991-12#2)(1991-5#1)(1996-12#1)(1997-4#1)(2004-2#1)(2006-10#2)(2008-12#1)(2008-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#2)(2013-8#1)
on the identification##22##3##(1990-7#1)(1991-12#2)(1991-5#1)(1994-3#1)(1996-12#1)(1997-4#1)(2004-2#1)(2006-10#2)(2008-12#1)(2008-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2011-1#2)(2013-8#1)
on the identified patient##2##4##(1993-12#1)(2007-7#1)
on the identified##3##3##(1993-12#1)(2007-7#1)(2008-12#1)
on the identity of the dispersing detergent##2##7##(1991-7#2)
on the identity of the##8##5##(1991-7#2)(1993-11#1)(1994-12#1)(1996-8#1)(2005-11#1)(2008-5#1)(2008-8#1)
on the identity of##9##4##(1991-6#1)(1991-7#2)(1993-11#1)(1994-12#1)(1996-8#1)(2005-11#1)(2008-5#1)(2008-8#1)
on the identity##10##3##(1990-10#1)(1991-6#1)(1991-7#2)(1993-11#1)(1994-12#1)(1996-8#1)(2005-11#1)(2008-5#1)(2008-8#1)
on the idler pulses##2##4##(2007-11#1)(2007-12#1)
on the iliac artery##2##4##(2008-3#1)(2012-1#1)
on the illumination##3##3##(2008-2#1)(2008-3#2)
on the image formation of##2##5##(2008-2#1)(2008-3#1)
on the image formation##4##4##(2008-2#2)(2008-3#2)
on the image##11##3##(2006-2#1)(2007-12#1)(2008-2#6)(2008-3#3)
on the images of##2##4##(2010-8#1)(2011-1#1)
on the imaging of##3##4##(2006-6#1)(2007-12#1)(2008-8#1)
on the imaging##9##3##(2006-6#2)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-8#1)(2013-8#1)
on the immediate##3##3##(2008-7#1)(2009-5#1)(2012-1#1)
on the immobilization of##3##4##(2008-10#3)
on the immobilization##4##3##(2008-10#4)
on the immobilized##2##3##(2008-10#2)
on the immune response in the##2##6##(2007-7#1)(2010-12#1)
on the immune response of##2##5##(1992-9#1)(2006-10#1)
on the immune response to##3##5##(1993-8#1)(1997-4#1)(2012-2#1)
on the immune response##10##4##(1992-9#1)(1993-8#1)(1997-4#1)(2004-12#2)(2006-10#1)(2006-8#1)(2007-7#1)(2010-12#1)(2012-2#1)
on the immune responses##2##4##(1995-5#1)(1997-4#1)
on the immune status of the##2##6##(2007-2#1)(2008-5#1)
on the immune system and##4##5##(1990-11#1)(2007-11#2)(2013-1#1)
on the immune system of##3##5##(1993-12#1)(2008-10#2)
on the immune system were evaluated##2##6##(2008-10#2)
on the immune system were##4##5##(1993-12#1)(2008-10#2)(2008-4#1)
on the immune system##33##4##(1990-11#1)(1991-1#1)(1993-12#3)(1995-12#2)(2006-1#2)(2006-10#3)(2006-6#1)(2007-11#6)(2008-10#8)(2008-4#2)(2008-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
on the immune##52##3##(1990-11#1)(1991-1#1)(1992-9#1)(1993-12#3)(1993-8#1)(1995-12#3)(1995-5#1)(1997-4#2)(2004-12#2)(2005-11#1)(2006-1#2)(2006-10#4)(2006-6#1)(2006-8#1)(2007-11#6)(2007-2#2)(2007-7#1)(2008-10#9)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
on the immunity of##2##4##(2008-2#1)(2008-7#1)
on the immunology of##4##4##(1993-12#1)(2006-10#3)
on the impact of the##3##5##(1994-1#2)(2012-2#1)
on the impact of##23##4##(1990-1#1)(1994-1#2)(1995-6#1)(1997-6#1)(2007-1#1)(2007-11#3)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-8#1)(2010-6#1)(2012-2#2)
on the impact on##3##4##(2006-10#1)(2008-8#1)(2012-3#1)
on the impact##28##3##(1990-1#1)(1994-1#2)(1995-6#1)(1997-6#1)(2006-10#1)(2007-1#2)(2007-11#3)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-8#2)(2010-6#1)(2012-2#2)(2012-3#1)
on the implant##4##3##(2004-9#1)(2008-9#1)(2009-7#1)(2010-12#1)
on the implementation of the##2##5##(1995-3#1)(2006-6#1)
on the implementation of##7##4##(1995-3#1)(2006-6#1)(2007-8#1)(2008-3#2)(2009-4#1)(2011-1#1)
on the implementation strategies adopted for the instruments##2##8##(2013-1#2)
on the implementation##13##3##(1995-3#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-4#1)(2011-1#1)(2013-1#4)
on the implications of using##2##5##(1994-1#1)(2006-10#1)
on the implications of##6##4##(1994-1#1)(2005-9#1)(2006-10#1)(2008-10#1)(2008-7#2)
on the importance of the##5##5##(1991-3#1)(1996-3#1)(2005-8#1)(2008-7#1)(2010-12#1)
on the importance of these##2##5##(1995-4#1)(2010-12#1)
on the importance of##39##4##(1990-3#2)(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#1)(1993-6#1)(1994-4#1)(1995-4#1)(1996-1#1)(1996-3#1)(2005-8#2)(2006-10#2)(2006-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-10#1)(2010-12#2)(2010-3#1)(2011-2#3)(2012-11#1)(2012-12#1)(2013-1#2)
on the importance##40##3##(1990-3#2)(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#1)(1993-6#1)(1994-4#1)(1995-2#1)(1995-4#1)(1996-1#1)(1996-3#1)(2005-8#2)(2006-10#2)(2006-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-10#1)(2010-12#2)(2010-3#1)(2011-2#3)(2012-11#1)(2012-12#1)(2013-1#2)
on the important##2##3##(2006-10#1)(2010-11#1)
on the improved##2##3##(2007-7#1)(2008-10#1)
on the improvement of##2##4##(2008-6#1)(2010-6#1)
on the improvement##4##3##(1996-12#1)(2008-6#1)(2010-11#1)(2010-6#1)
on the in vitro metabolism of##2##6##(1993-11#1)(1996-4#1)
on the in vitro phosphorylation of##2##6##(1990-11#1)(1997-2#1)
on the in vitro##22##4##(1990-11#1)(1990-2#1)(1992-8#1)(1993-11#1)(1993-7#1)(1994-10#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-2#1)(2010-3#3)
on the in vivo performance##2##5##(2008-5#1)(2012-2#1)
on the in vivo##8##4##(1990-9#1)(1994-2#1)(1995-5#1)(1996-12#1)(2005-6#1)(2006-10#1)(2008-5#1)(2012-2#1)
on the in##32##3##(1990-11#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-6#1)(1992-8#1)(1993-11#1)(1993-7#1)(1994-10#1)(1994-2#1)(1995-5#1)(1996-12#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-6#1)(2006-10#2)(2007-11#1)(2008-10#3)(2008-11#1)(2008-5#2)(2010-2#1)(2010-3#3)(2012-2#1)
on the inactivation##2##3##(1995-8#1)(2007-6#1)
on the incidence and severity of##2##6##(2007-8#1)(2008-10#1)
on the incidence and##4##4##(2007-8#1)(2008-10#2)(2011-1#1)
on the incidence of cancers and miscarriages##2##7##(2009-6#2)
on the incidence of coronary##2##5##(1993-12#1)(1997-7#1)
on the incidence of##34##4##(1990-12#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-3#1)(1991-9#1)(1992-10#1)(1993-12#1)(1993-9#1)(1996-4#1)(1997-7#1)(2006-10#4)(2007-7#1)(2007-9#4)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-2#1)(2009-6#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
on the incidence##40##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-3#1)(1991-9#1)(1992-10#1)(1993-12#1)(1993-9#1)(1996-4#1)(1997-7#1)(2006-10#4)(2007-11#2)(2007-7#1)(2007-8#1)(2007-9#4)(2008-1#1)(2008-10#5)(2008-5#1)(2008-7#1)(2009-2#1)(2009-6#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
on the incident##2##3##(2007-12#1)(2008-2#1)
on the inclusion of##4##4##(1990-2#1)(1992-2#1)(2011-1#1)(2011-2#1)
on the inclusion##6##3##(1990-2#1)(1992-2#1)(2008-10#1)(2009-6#1)(2011-1#1)(2011-2#1)
on the incorporation of [3H]-thymidine into DNA of the rat thyroid lobes##2##12##(1991-12#1)(1991-7#1)
on the incorporation of##16##4##(1991-12#2)(1991-2#1)(1991-7#1)(1992-4#1)(1993-12#1)(2006-3#1)(2006-4#1)(2007-11#2)(2008-10#1)(2008-11#1)(2010-2#1)(2010-7#1)(2012-1#1)(2012-2#1)
on the increase in##5##4##(1992-8#1)(1996-10#1)(2006-8#1)(2008-1#2)
on the increase of##4##4##(1992-11#1)(2008-10#1)(2008-5#1)(2012-2#1)
on the increase##15##3##(1992-11#1)(1992-8#2)(1995-11#1)(1996-10#1)(2006-10#1)(2006-8#1)(2008-1#4)(2008-10#1)(2008-5#1)(2012-12#1)(2012-2#1)
on the increasing##3##3##(2008-10#1)(2011-12#1)(2012-12#1)
on the incubation##3##3##(1992-9#1)(2008-10#1)(2010-12#1)
on the index##2##3##(2007-11#1)(2008-2#1)
on the indication##3##3##(1992-6#1)(1996-12#1)(2006-10#1)
on the indications for##2##4##(2008-5#1)(2011-2#1)
on the indications##6##3##(1996-12#1)(2006-3#1)(2007-11#1)(2008-5#1)(2010-12#1)(2011-2#1)
on the individual patient's##3##4##(2005-10#1)(2007-5#1)(2008-9#1)
on the individual##17##3##(1990-3#1)(1993-3#1)(1995-2#1)(1996-5#1)(1996-8#1)(2005-10#1)(2005-7#1)(2006-12#1)(2006-3#1)(2006-7#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-9#1)(2013-1#2)
on the indole##2##3##(1991-2#1)(1995-10#1)
on the induced##4##3##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)
on the induction and##2##4##(1991-12#1)(1992-4#1)
on the induction of DNA damage##3##6##(1997-1#1)(1997-4#1)(2003-11#1)
on the induction of DNA##4##5##(1991-12#1)(1997-1#1)(1997-4#1)(2003-11#1)
on the induction of IFN-gamma##2##5##(1996-10#1)(2008-4#1)
on the induction of c-fos##2##5##(1996-3#2)
on the induction of##26##4##(1990-2#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-5#1)(1992-7#1)(1993-11#1)(1994-10#1)(1994-6#1)(1994-8#1)(1996-10#1)(1996-3#2)(1996-9#1)(1997-1#1)(1997-4#2)(2003-11#1)(2006-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2013-1#1)
on the induction##30##3##(1990-2#1)(1990-9#1)(1991-12#2)(1991-4#1)(1991-6#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-11#1)(1994-10#1)(1994-6#1)(1994-8#1)(1996-10#1)(1996-3#2)(1996-9#1)(1997-1#2)(1997-4#2)(2003-11#1)(2006-10#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2013-1#1)
on the infection of peach##2##5##(2008-10#2)
on the infection of##4##4##(2008-10#2)(2008-8#1)(2012-12#1)
on the infection##9##3##(1996-2#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-8#1)(2012-12#1)
on the inflammation##2##3##(2007-11#1)(2011-1#1)
on the inflammatory process##2##4##(2008-10#1)(2008-3#1)
on the inflammatory response##3##4##(1994-5#1)(2006-10#1)(2010-2#1)
on the inflammatory##6##3##(1994-5#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-2#1)
on the influence of a##2##5##(2008-5#1)(2013-7#1)
on the influence of the##3##5##(2007-3#1)(2012-12#2)
on the influence of these##2##5##(2007-2#1)(2008-10#1)
on the influence of##24##4##(1996-3#1)(1996-8#1)(2005-10#1)(2006-6#1)(2007-2#1)(2007-3#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#2)(2009-2#1)(2009-4#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-7#2)
on the influence##25##3##(1996-3#1)(1996-8#1)(2005-10#1)(2006-6#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#2)(2009-2#1)(2009-4#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-7#2)
on the influx##2##3##(1993-2#1)(1996-8#1)
on the information##12##3##(1991-6#1)(1993-1#1)(1994-12#1)(1994-2#1)(1995-1#1)(1996-2#1)(2006-10#1)(2008-12#1)(2009-10#1)(2009-5#1)(2011-1#1)(2012-12#1)
on the infrared##2##3##(1990-2#1)(2005-4#1)
on the inhibition effect of##4##5##(2008-10#3)(2010-12#1)
on the inhibition of gastric##2##5##(2008-11#1)(2013-1#1)
on the inhibition of##18##4##(1990-11#1)(1990-4#1)(1990-8#1)(1990-9#1)(1992-7#1)(1996-5#1)(1997-8#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#3)(2009-2#1)(2009-9#1)(2013-1#1)
on the inhibition##24##3##(1990-11#1)(1990-4#1)(1990-8#1)(1990-9#1)(1992-7#1)(1993-3#1)(1995-3#1)(1996-5#1)(1997-8#1)(2006-12#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#3)(2009-2#1)(2009-9#1)(2010-12#1)(2013-1#1)
on the inhibitory potency##2##4##(1992-3#1)(2010-11#1)
on the inhibitory##11##3##(1990-12#1)(1992-3#1)(1992-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1996-2#1)(2006-12#1)(2008-10#2)(2010-11#1)
on the initial MR##2##4##(1996-6#1)(2007-10#1)
on the initial##22##3##(1991-7#1)(1992-6#1)(1996-6#1)(1997-4#2)(2004-11#1)(2005-11#2)(2007-10#1)(2007-12#3)(2007-7#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-2#1)
on the initiation##2##3##(2007-11#1)(2012-2#1)
on the injection##6##3##(2007-12#1)(2008-10#3)(2008-12#1)(2010-1#1)
on the injured side##2##4##(1996-12#1)(2009-10#1)
on the injured##3##3##(1996-12#1)(2007-9#1)(2009-10#1)
on the injury rate##2##4##(2008-11#2)
on the injury##3##3##(2006-11#1)(2008-11#2)
on the innate##3##3##(2006-10#1)(2008-10#1)(2013-1#1)
on the inner acrosomal##2##4##(2006-5#2)
on the inner side of the##2##6##(1995-6#1)(2008-10#1)
on the inner surface of the##3##6##(2008-10#2)(2008-2#1)
on the inner surface of##4##5##(2008-10#2)(2008-2#2)
on the inner surface##5##4##(2007-12#1)(2008-10#2)(2008-2#2)
on the inner wall of the##2##6##(2007-8#1)(2011-2#1)
on the inner wall of##3##5##(2007-8#1)(2008-10#1)(2011-2#1)
on the inner##17##3##(1990-11#1)(1990-2#1)(1995-6#1)(2006-5#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-2#2)(2010-9#1)(2011-2#1)
on the innovative##2##3##(2010-3#1)(2011-2#1)
on the input light##2##4##(2007-12#2)
on the input plane##2##4##(2008-3#2)
on the input##13##3##(2007-11#3)(2007-12#4)(2008-2#2)(2008-3#3)(2008-9#1)
on the insertion##2##3##(2008-2#1)(2010-2#1)
on the inside of##3##4##(1994-6#1)(2008-10#1)(2008-2#1)
on the inside##6##3##(1994-6#1)(1995-1#1)(2008-10#2)(2008-2#1)(2011-2#1)
on the instrument##4##3##(2006-10#1)(2008-10#2)(2008-3#1)
on the insulin receptor##2##4##(1990-8#1)(1993-12#1)
on the insulin##4##3##(1990-8#1)(1993-12#1)(2008-11#1)(2008-9#1)
on the intact side##2##4##(1996-2#2)
on the intact##5##3##(1990-2#1)(1990-7#1)(1996-2#2)(2008-10#1)
on the integrated platform of##3##5##(2008-10#3)
on the integrated##5##3##(2007-11#1)(2008-10#3)(2012-1#1)
on the integration of##9##4##(1995-1#1)(2008-10#3)(2008-2#1)(2009-5#1)(2012-3#1)(2013-1#2)
on the integration##10##3##(1995-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-5#1)(2012-3#1)(2013-1#2)
on the integrity of##9##4##(1990-5#2)(1990-8#1)(1995-2#1)(1997-5#1)(2008-2#1)(2008-5#1)(2009-2#1)(2009-9#1)
on the integument##3##3##(1991-2#1)(2004-2#1)(2007-12#1)
on the intelligentsia##2##3##(2008-12#2)
on the intensity of the##3##5##(1991-3#1)(2008-1#1)(2009-5#1)
on the intensity of##8##4##(1991-3#1)(1995-12#2)(2005-1#1)(2008-1#1)(2008-9#1)(2009-5#1)(2012-3#1)
on the intensity##13##3##(1991-3#1)(1995-12#2)(2005-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-5#1)(2009-9#1)(2012-3#1)
on the intensive##2##3##(1992-5#1)(2006-10#1)
on the interaction between the##2##5##(2008-10#1)(2010-7#1)
on the interaction between##14##4##(1990-3#1)(2006-10#1)(2008-1#1)(2008-10#6)(2008-3#1)(2009-5#1)(2010-2#1)(2010-7#1)(2012-12#1)
on the interaction of a##3##5##(1990-6#1)(2008-10#1)(2008-2#1)
on the interaction of the##4##5##(1992-12#1)(1993-11#1)(1995-5#1)(2008-5#1)
on the interaction of##32##4##(1990-6#1)(1991-10#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-2#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-7#1)(2005-11#2)(2007-8#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)
on the interaction with##3##4##(1991-1#1)(2008-10#1)(2009-8#1)
on the interaction##51##3##(1990-3#1)(1990-6#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-2#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-7#1)(2005-11#2)(2006-10#2)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-7#1)(2012-12#1)(2012-2#1)
on the interactions between##5##4##(1995-1#1)(2008-11#1)(2008-8#2)(2012-2#1)
on the interactions of the##2##5##(1993-6#1)(2010-4#1)
on the interactions of##6##4##(1991-7#1)(1993-6#1)(2008-3#1)(2010-12#1)(2010-4#2)
on the interactions##12##3##(1991-7#1)(1992-6#1)(1993-6#1)(1995-1#1)(2008-11#1)(2008-3#1)(2008-8#2)(2010-12#1)(2010-4#2)(2012-2#1)
on the interactive effects##2##4##(1996-8#1)(2012-12#1)
on the interactive##3##3##(1996-8#1)(2011-1#1)(2012-12#1)
on the interest##2##3##(1992-6#1)(2006-5#1)
on the interface of the##2##5##(2007-12#1)(2012-3#1)
on the interface##4##3##(2007-12#1)(2010-8#1)(2012-1#1)(2012-3#1)
on the interfacial properties##2##4##(1990-2#1)(2006-7#1)
on the interfacial##7##3##(1990-2#1)(1993-6#1)(1995-10#1)(2004-12#1)(2005-11#2)(2006-7#1)
on the interference##5##3##(2007-12#2)(2008-2#2)(2008-3#1)
on the interferometer##2##3##(2007-12#1)(2008-2#1)
on the internal##6##3##(1990-2#1)(1993-4#1)(2006-1#1)(2008-10#1)(2008-2#2)
on the international##3##3##(1991-11#1)(2006-1#1)(2010-12#1)
on the internet and in the##2##6##(2007-11#2)
on the internet##17##3##(1994-6#1)(2006-10#1)(2007-11#3)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-2#1)(2008-4#1)(2009-5#1)(2010-3#1)(2011-2#1)(2013-1#2)
on the interplay##2##3##(2008-5#1)(2011-1#1)
on the interpretation of the##2##5##(2008-7#1)(2009-6#1)
on the interpretation of##7##4##(1993-1#1)(1994-11#1)(1994-3#1)(2005-11#1)(2008-12#1)(2008-7#1)(2009-6#1)
on the interpretation##8##3##(1993-1#1)(1994-11#1)(1994-3#1)(2005-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-6#1)
on the interval of the##2##5##(2008-5#2)
on the interval##3##3##(2007-11#1)(2008-5#2)
on the intervening##2##3##(1991-4#1)(2010-2#1)
on the intestinal epithelium##2##4##(2006-10#1)(2010-4#1)
on the intestinal##10##3##(1995-11#1)(2005-10#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-11#3)(2010-4#1)(2012-12#1)
on the intestine##2##3##(2006-8#1)(2010-12#1)
on the intracellular nucleotide##2##4##(2008-11#2)
on the intracellular##17##3##(1991-12#1)(1991-5#1)(1991-9#1)(1993-3#2)(1994-12#1)(1994-2#1)(1995-8#1)(1997-4#1)(2007-10#1)(2008-11#3)(2008-4#1)(2009-7#1)(2011-1#1)(2012-1#1)
on the intracranial##2##3##(1995-11#1)(1997-6#1)
on the intraocular pressure##2##4##(2012-12#1)(2013-1#1)
on the intricate##2##3##(1995-12#1)(2005-11#1)
on the intrinsic##9##3##(1993-11#1)(1994-12#1)(1995-1#2)(2004-10#1)(2008-10#1)(2010-12#1)(2010-9#2)
on the introduction of the##2##5##(2007-6#1)(2008-7#1)
on the introduction of##5##4##(1997-2#1)(2005-9#1)(2007-6#1)(2008-7#1)(2009-4#1)
on the introduction##6##3##(1997-2#1)(2005-9#1)(2007-2#1)(2007-6#1)(2008-7#1)(2009-4#1)
on the invasion of##4##4##(2008-11#3)(2008-4#1)
on the invasion##7##3##(2008-10#1)(2008-11#4)(2008-4#1)(2013-8#1)
on the inverse##4##3##(2007-11#1)(2008-10#1)(2008-2#2)
on the inversion##5##3##(2008-3#2)(2012-1#1)(2013-1#1)(2013-8#1)
on the investigation of##2##4##(1995-11#1)(2013-1#1)
on the investigation##4##3##(1995-11#1)(2007-12#2)(2013-1#1)
on the involved##3##3##(2007-4#1)(2008-12#1)(2011-1#1)
on the involvement of the##2##5##(2007-12#1)(2012-1#1)
on the involvement of##6##4##(1993-3#1)(2007-12#1)(2008-4#1)(2009-8#1)(2012-1#1)(2013-1#1)
on the ion##6##3##(2006-10#1)(2008-10#3)(2010-2#1)(2010-6#1)
on the ion-exchange##3##3##(1996-8#1)(2007-8#1)(2008-10#1)
on the ion-pairing principle using##2##5##(2008-10#2)
on the ionic strength and##2##5##(1990-12#1)(1990-2#1)
on the ionic strength of the medium##2##7##(1991-2#1)(1992-6#1)
on the ionic strength##6##4##(1990-12#1)(1990-2#1)(1991-2#2)(1992-6#1)(2008-10#1)
on the ionization of##2##4##(2008-10#2)
on the ionization state of##2##5##(1991-7#1)(2006-10#1)
on the ionization##4##3##(1991-7#1)(2006-10#1)(2008-10#2)
on the ipsilateral side##3##4##(1996-1#1)(1996-2#1)(1996-5#1)
on the ipsilateral##6##3##(1991-8#1)(1991-9#1)(1996-1#1)(1996-2#1)(1996-5#1)(2008-3#1)
on the iron##2##3##(1992-8#1)(2010-5#1)
on the irreversible##2##3##(1991-2#1)(2008-1#1)
on the island of Krk##2##5##(2011-1#2)
on the island of##9##4##(1995-6#1)(2008-10#2)(2008-5#1)(2011-1#2)(2011-2#2)(2013-8#1)
on the island##16##3##(1995-6#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-5#1)(2011-1#3)(2011-2#3)(2013-8#2)
on the isolate##2##3##(2008-10#1)(2011-2#1)
on the isolated gamma subunit is at##2##7##(2008-8#2)
on the isolated##6##3##(1991-5#1)(1994-9#1)(1996-9#1)(1997-8#1)(2008-8#2)
on the isolation of a##2##5##(1991-2#1)(2008-11#1)
on the isolation##5##3##(1991-2#1)(1991-7#1)(1992-12#1)(2008-10#1)(2008-11#1)
on the isomer##2##3##(2008-5#1)(2009-9#1)
on the isothermal characteristics of##2##5##(1997-2#2)
on the isothermal##3##3##(1997-2#3)
on the issue of##9##4##(1992-2#1)(1993-5#1)(2008-2#2)(2008-9#1)(2009-10#2)(2009-4#1)(2013-7#1)
on the issue##16##3##(1992-2#1)(1993-5#1)(1994-1#2)(1994-3#1)(2008-2#3)(2008-7#1)(2008-9#1)(2009-10#2)(2009-4#1)(2011-1#1)(2012-12#1)(2013-7#1)
on the issues of##4##4##(1991-3#1)(1993-2#1)(2008-2#1)(2012-2#1)
on the issues##8##3##(1991-3#1)(1993-2#1)(1994-12#1)(2006-9#1)(2008-2#1)(2009-4#1)(2012-2#1)(2012-3#1)
on the job in##2##4##(1993-2#2)
on the job##12##3##(1993-2#3)(1994-2#1)(1994-3#1)(1995-12#1)(1996-2#1)(1996-6#1)(1996-7#1)(2004-3#1)(2004-8#1)(2007-10#1)
on the job&quot##2##3##(2013-1#2)
on the joint##5##3##(1994-3#1)(2007-11#2)(2007-12#1)(2012-3#1)
on the key role##2##4##(1991-7#1)(2011-2#1)
on the key##8##3##(1991-7#1)(1992-9#1)(2008-1#1)(2008-11#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
on the kidney##3##3##(1991-12#1)(1996-12#1)(2010-12#1)
on the kidneys of two##2##5##(2007-5#2)
on the kidneys##6##3##(1997-7#1)(2006-10#1)(2006-6#1)(2007-5#2)(2008-5#1)
on the kinase##2##3##(1993-8#1)(2012-3#1)
on the kind of##5##4##(1994-8#1)(2008-10#2)(2008-11#1)(2008-12#1)
on the kind##6##3##(1994-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)
on the kinetic constants##2##4##(1994-9#1)(1996-2#1)
on the kinetic##10##3##(1991-4#1)(1993-8#1)(1994-9#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-8#1)(2005-10#1)(2008-10#2)
on the kinetics and the##2##5##(1995-1#1)(2007-11#1)
on the kinetics and uptake##2##5##(2008-5#2)
on the kinetics and##6##4##(1995-1#1)(2005-11#1)(2007-11#1)(2008-5#3)
on the kinetics of the##3##5##(1992-1#1)(1994-8#2)
on the kinetics of##17##4##(1990-10#1)(1992-1#1)(1994-2#1)(1994-5#1)(1994-8#2)(1997-7#1)(2004-11#2)(2008-1#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-4#1)(2010-2#1)
on the kinetics##25##3##(1990-10#1)(1992-1#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-12#1)(1997-7#1)(2004-11#2)(2005-11#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-5#4)(2008-7#1)(2008-8#1)(2009-4#1)(2010-2#1)
on the knee##8##3##(2007-1#1)(2007-11#1)(2007-7#2)(2009-10#1)(2009-5#1)(2009-9#1)(2012-1#1)
on the knowledge of##7##4##(1990-5#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)
on the knowledge##12##3##(1990-5#1)(2006-10#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
on the known effects of##2##5##(2008-4#1)(2008-5#1)
on the known##6##3##(1992-12#1)(1996-12#1)(2008-4#1)(2008-5#1)(2009-5#1)(2013-1#1)
on the labeling pattern of the##2##6##(2008-7#2)
on the laboratory diagnosis of##2##5##(2005-7#1)(2008-1#1)
on the laboratory##4##3##(2005-7#1)(2008-1#1)(2008-5#1)(2008-6#1)
on the lack of##7##4##(1993-12#1)(2006-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-8#1)(2013-1#1)
on the lagging strand##3##4##(1990-12#1)(1994-9#2)
on the land##3##3##(1992-8#1)(2013-8#2)
on the large##5##3##(1996-4#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-12#1)
on the largest##2##3##(1996-9#1)(2006-6#1)
on the larvae##2##3##(2012-12#1)(2013-8#1)
on the laser##9##3##(2007-12#4)(2008-2#2)(2008-3#2)(2011-1#1)
on the last##8##3##(1992-8#1)(2004-11#1)(2005-10#1)(2006-12#1)(2008-1#1)(2008-10#1)(2009-4#1)(2011-3#1)
on the late control##2##4##(2013-1#2)
on the late##5##3##(1994-2#1)(2006-10#1)(2008-9#1)(2013-1#2)
on the lateral side of the##2##6##(2007-12#1)(2007-9#1)
on the lateral##8##3##(2006-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2010-12#1)(2011-2#1)(2012-1#1)
on the latest##11##3##(2004-12#1)(2005-8#1)(2008-2#1)(2008-4#3)(2008-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
on the latter##7##3##(1997-1#1)(2004-9#1)(2006-12#1)(2008-10#2)(2008-4#2)
on the layered##2##3##(2007-12#1)(2008-2#1)
on the leaching##2##3##(1993-9#1)(1997-4#1)
on the leading strand of the replication fork##2##8##(1994-9#2)
on the leading##4##3##(1994-9#2)(2005-10#1)(2013-8#1)
on the leaf surface##3##4##(2008-10#2)(2009-8#1)
on the leaf##10##3##(2008-10#8)(2009-8#1)(2013-8#1)
on the learning##2##3##(2008-11#1)(2010-2#1)
on the leaves of##2##4##(2008-10#1)(2011-3#1)
on the leaves##5##3##(2008-10#4)(2011-3#1)
on the left and right##2##5##(2005-10#1)(2006-11#1)
on the left and##3##4##(2005-10#1)(2006-11#1)(2007-10#1)
on the left anterior##2##4##(2007-8#2)
on the left arm of chromosome IX##2##7##(1995-6#1)(1995-9#1)
on the left arm of chromosome VII##2##7##(1995-9#1)(1996-9#1)
on the left arm of chromosome##8##6##(1993-9#1)(1995-6#1)(1995-9#2)(1996-3#2)(1996-6#1)(1996-9#1)
on the left arm of##10##5##(1993-9#1)(1995-6#1)(1995-9#3)(1996-3#2)(1996-6#2)(1996-9#1)
on the left arm##11##4##(1993-9#1)(1995-11#1)(1995-6#1)(1995-9#3)(1996-3#2)(1996-6#2)(1996-9#1)
on the left coronary artery##2##5##(1994-11#1)(1997-1#1)
on the left coronary##3##4##(1994-11#1)(1997-1#1)(2005-12#1)
on the left eye##4##4##(2011-2#4)
on the left forearm##2##4##(2010-6#1)(2012-3#1)
on the left main stem##2##5##(1990-9#2)
on the left side and##2##5##(2008-5#1)(2012-2#1)
on the left side in##2##5##(1995-12#1)(2008-7#1)
on the left side of the face and##2##8##(2005-5#1)(2011-1#1)
on the left side of the heart##2##7##(1991-6#1)(1993-6#1)
on the left side of the##12##6##(1991-6#1)(1993-6#1)(2005-5#1)(2006-7#1)(2007-7#2)(2008-12#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-12#1)(2013-8#1)
on the left side of##13##5##(1991-6#1)(1993-6#1)(2005-5#1)(2006-7#1)(2007-7#2)(2008-12#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-12#1)(2013-8#1)
on the left side##33##4##(1991-6#1)(1993-6#1)(1995-12#1)(2005-5#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-7#4)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#2)
on the left thumb##2##4##(2010-6#2)
on the left##86##3##(1990-4#1)(1990-9#2)(1991-11#1)(1991-6#1)(1992-7#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-9#3)(1996-3#2)(1996-6#2)(1996-9#1)(1997-1#1)(2005-10#1)(2005-12#1)(2005-5#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-7#5)(2007-8#4)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#3)(2008-7#2)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#5)(2011-1#1)(2011-12#1)(2011-2#9)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
on the legal and##2##4##(2004-12#1)(2006-7#1)
on the legal##5##3##(1992-2#1)(2004-12#1)(2005-11#1)(2006-7#1)(2013-1#1)
on the legs##6##3##(1992-8#1)(1994-8#1)(1997-5#1)(2008-4#1)(2012-2#1)(2012-3#1)
on the length and the##2##5##(1996-8#1)(2008-9#1)
on the length of the##4##5##(1992-2#1)(1996-7#1)(2005-11#1)(2008-10#1)
on the length of##9##4##(1992-2#1)(1996-12#1)(1996-7#1)(2005-11#2)(2007-8#1)(2008-10#1)(2010-9#1)(2012-2#1)
on the length##13##3##(1992-2#1)(1996-12#1)(1996-7#1)(1996-8#1)(2005-11#2)(2006-10#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-3#1)(2010-9#1)(2012-2#1)
on the lensing signal##2##4##(2008-2#2)
on the lensing##3##3##(2008-2#3)
on the lesioned side##2##4##(1996-5#1)(1997-2#1)
on the lesions##4##3##(1994-7#1)(2008-4#1)(2012-2#1)(2012-3#1)
on the lessons learned##2##4##(2006-10#1)(2007-4#1)
on the leukemia cell##2##4##(2007-4#1)(2008-9#1)
on the level 0##2##4##(2013-1#2)
on the level of individuals##2##5##(2008-10#1)(2008-7#1)
on the level of knowledge##2##5##(2008-8#1)(2010-8#1)
on the level of membrane fatty acid composition##2##8##(2011-1#2)
on the level of the##7##5##(1991-12#1)(1991-8#1)(1994-5#1)(1995-8#1)(2006-4#1)(2008-5#1)(2011-2#1)
on the level of##51##4##(1990-2#1)(1991-12#1)(1991-8#2)(1992-5#1)(1993-12#1)(1994-2#3)(1994-5#1)(1995-1#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-5#1)(2006-12#2)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-3#1)(2010-12#1)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#4)(2013-1#3)
on the level##55##3##(1990-2#1)(1991-12#1)(1991-8#2)(1992-5#1)(1993-12#1)(1994-2#3)(1994-5#1)(1995-1#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-5#1)(2006-12#2)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-3#1)(2010-12#1)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#4)(2013-1#5)
on the levels of NADPH-dependent cytosolic 3##2##7##(1991-5#2)
on the levels of the##2##5##(1992-8#1)(1995-7#1)
on the levels of##19##4##(1990-7#1)(1991-5#2)(1992-8#1)(1994-11#1)(1994-2#1)(1995-10#1)(1995-11#1)(1995-7#2)(2006-4#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-8#1)(2009-4#2)
on the levels##20##3##(1990-7#1)(1991-5#2)(1992-8#1)(1994-11#1)(1994-2#1)(1995-10#1)(1995-11#1)(1995-7#2)(2006-4#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-8#1)(2009-4#2)(2013-8#1)
on the lidar##5##3##(2008-2#3)(2008-3#2)
on the life##8##3##(1995-12#1)(2004-11#1)(2008-11#2)(2008-2#1)(2008-9#1)(2010-10#1)(2013-1#1)
on the lifetime of##2##4##(2007-12#1)(2009-9#1)
on the lifetime##3##3##(2007-12#1)(2008-3#1)(2009-9#1)
on the ligand##2##3##(1994-3#1)(2007-3#1)
on the ligand-binding##2##3##(1995-5#1)(2008-4#1)
on the light##12##3##(1990-8#1)(1992-6#1)(1996-3#1)(2007-9#1)(2008-10#1)(2008-2#3)(2008-3#3)(2012-2#1)
on the likelihood of##4##4##(1995-12#1)(2008-10#1)(2008-4#1)(2010-10#1)
on the likelihood##5##3##(1995-12#1)(1995-4#1)(2008-10#1)(2008-4#1)(2010-10#1)
on the limb##3##3##(2007-7#1)(2007-8#2)
on the limitations of##3##4##(1993-9#1)(2008-11#1)(2012-12#1)
on the limited##2##3##(2008-9#1)(2010-2#1)
on the limits##2##3##(2008-10#1)(2008-2#1)
on the line##3##3##(2008-2#1)(2008-3#2)
on the lineage##3##3##(1995-11#1)(2008-8#1)(2011-2#1)
on the linear relationship between the changes in the##2##9##(2008-10#2)
on the linear relationship between the##3##6##(2008-10#3)
on the linear##8##3##(1994-8#1)(1995-9#1)(2005-11#1)(2006-8#1)(2007-11#1)(2008-10#3)
on the link between oxidative status and normal anxiety##2##9##(2010-4#2)
on the link between##8##4##(2008-11#2)(2010-1#2)(2010-4#2)(2012-12#2)
on the link##9##3##(2008-11#2)(2010-1#2)(2010-12#1)(2010-4#2)(2012-12#2)
on the linkage map##9##4##(1996-12#4)(1996-6#2)(1997-4#2)(2008-8#1)
on the linkage##11##3##(1996-12#4)(1996-6#2)(1997-4#2)(2008-8#1)(2009-4#1)(2012-3#1)
on the lip##3##3##(2011-2#2)(2012-12#1)
on the lipid composition of rat##3##6##(1990-7#2)(1994-6#1)
on the lipid composition of##4##5##(1990-7#2)(1994-2#1)(1994-6#1)
on the lipid composition##5##4##(1990-7#2)(1994-2#1)(1994-6#1)(2008-5#1)
on the lipid metabolism##2##4##(1992-11#1)(2008-11#1)
on the lipid##20##3##(1990-2#2)(1990-7#2)(1991-5#1)(1992-11#1)(1993-12#1)(1994-2#1)(1994-6#1)(1997-1#2)(2006-10#1)(2006-12#1)(2008-1#1)(2008-11#1)(2008-5#2)(2009-8#1)(2010-4#1)(2010-5#1)
on the liposome surface##3##4##(1990-5#1)(2008-10#2)
on the liposome##4##3##(1990-5#1)(1994-9#1)(2008-10#2)
on the liquid-liquid extraction of##2##5##(2008-10#2)
on the liquid-solid##2##3##(2008-3#1)(2008-5#1)
on the list of##2##4##(1995-6#1)(2011-2#1)
on the list##3##3##(1995-6#1)(1995-7#1)(2011-2#1)
on the literature and##4##4##(2007-11#3)(2008-5#1)
on the literature to date##2##5##(1993-4#1)(2008-11#1)
on the literature##18##3##(1993-4#1)(1996-12#1)(1997-3#1)(2006-10#2)(2007-11#4)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
on the liver and##4##4##(2005-12#1)(2006-10#1)(2007-2#1)(2010-11#1)
on the liver##16##3##(1991-7#1)(1994-9#1)(1995-6#1)(1996-5#1)(2005-12#1)(2006-10#2)(2007-2#1)(2008-4#1)(2010-11#1)(2010-12#1)(2010-5#1)(2013-8#4)
on the lives of##4##4##(1997-2#1)(2007-11#1)(2008-11#1)(2008-2#1)
on the load##3##3##(2005-10#1)(2006-11#1)(2008-5#1)
on the loading##4##3##(2006-11#1)(2008-10#1)(2009-7#1)(2010-2#1)
on the local market##3##4##(2007-2#3)
on the local##20##3##(1990-4#1)(1993-6#1)(1995-11#1)(1995-12#1)(2007-2#3)(2007-3#1)(2007-4#1)(2008-1#1)(2008-2#1)(2008-3#3)(2008-8#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
on the localization##2##3##(2008-9#1)(2012-3#1)
on the location and nature of##2##6##(2007-11#1)(2013-1#1)
on the location and##7##4##(2006-9#1)(2007-11#1)(2007-5#1)(2008-3#1)(2008-4#1)(2012-12#1)(2013-1#1)
on the location of the##7##5##(1991-4#1)(1992-8#1)(1995-1#1)(2006-10#1)(2007-11#1)(2008-3#1)(2012-1#1)
on the location of##9##4##(1991-4#1)(1992-8#1)(1995-1#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-3#1)(2012-1#1)
on the location##18##3##(1991-4#1)(1992-8#1)(1995-1#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-11#2)(2007-5#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-9#1)(2012-1#1)(2012-12#1)(2013-1#2)
on the locations of##2##4##(2008-10#1)(2008-11#1)
on the locomotor activity##2##4##(1997-7#1)(2008-5#1)
on the locomotor rhythm##2##4##(2008-5#1)(2008-6#1)
on the locomotor##4##3##(1997-7#1)(2008-5#2)(2008-6#1)
on the log##2##3##(1997-8#1)(2008-10#1)
on the logarithm of##2##4##(1990-10#1)(2008-10#1)
on the logarithm##3##3##(1990-10#1)(2008-10#1)(2009-12#1)
on the logarithmic##2##3##(1997-8#1)(2005-11#1)
on the long arm of chromosome 7##2##7##(2006-10#1)(2010-3#1)
on the long arm of chromosome##11##6##(1993-10#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-7#1)(2008-9#1)(2010-3#1)(2012-12#1)
on the long arm of wheat##2##6##(2008-10#2)
on the long arm of##15##5##(1993-10#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-7#1)(2008-9#1)(2010-3#1)(2012-12#1)
on the long arm##16##4##(1993-10#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2012-12#1)
on the long run##2##4##(2008-3#1)(2013-1#1)
on the long term##2##4##(2007-12#1)(2008-7#1)
on the long##22##3##(1993-10#1)(1994-9#1)(1997-2#1)(1997-8#1)(2006-10#1)(2007-12#2)(2008-10#6)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-3#1)(2012-12#1)(2013-1#1)
on the long-term effects of##2##5##(1995-11#1)(2008-10#1)
on the long-term##14##3##(1995-11#1)(2006-12#1)(2006-4#1)(2006-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-4#1)(2009-7#1)(2012-12#1)(2013-1#1)(2013-8#2)
on the longevity##2##3##(1993-11#1)(2009-5#1)
on the longitudinal##2##3##(1997-5#1)(2008-3#1)
on the loss of##2##4##(1993-11#1)(2008-2#1)
on the low##5##3##(1991-4#1)(1993-6#1)(1995-3#1)(2008-7#1)(2009-8#1)
on the lower bole##2##4##(2008-10#2)
on the lower extremities##4##4##(2005-10#1)(2006-12#1)(2006-4#1)(2011-1#1)
on the lower limbs##5##4##(1996-4#1)(2007-8#1)(2013-1#3)
on the lower rim##2##4##(1996-5#2)
on the lower##17##3##(1996-4#1)(1996-5#2)(2005-10#1)(2006-12#1)(2006-4#1)(2007-8#1)(2008-10#3)(2008-2#1)(2011-1#2)(2011-2#1)(2013-1#3)
on the lowered side and a decrease on the lifted side##2##11##(2008-5#2)
on the lumbar spine##2##4##(2006-8#1)(2007-6#1)
on the lumbar##6##3##(1992-1#1)(2006-7#1)(2006-8#1)(2007-6#1)(2007-7#1)(2008-6#1)
on the lumbosacral area##2##4##(2010-6#2)
on the luminescence##2##3##(2008-10#2)
on the lung##4##3##(1991-1#1)(1997-4#1)(2007-2#1)(2012-11#1)
on the lymphocyte##4##3##(1990-8#1)(1991-1#1)(1991-10#1)(1995-12#1)
on the lymphoid tissues##2##4##(1996-12#2)
on the lymphoid##4##3##(1993-7#1)(1996-12#3)
on the mRNA##3##3##(1995-11#1)(1996-6#1)(2012-2#1)
on the mRNAs##2##3##(1993-5#1)(1997-7#1)
on the macroion surface##2##4##(2005-11#2)
on the macromolecular##2##3##(1994-8#1)(1996-2#1)
on the magnetic beads##2##4##(2008-10#2)
on the magnetic resonance imaging##2##5##(2007-11#1)(2008-8#1)
on the magnetic##6##3##(2007-11#1)(2008-10#3)(2008-8#1)(2010-5#1)
on the magnitude of the##6##5##(1997-8#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)
on the magnitude of##11##4##(1994-5#1)(1997-8#1)(2005-1#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#1)(2011-1#1)
on the magnitude##12##3##(1994-5#1)(1997-8#1)(2005-1#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#2)(2011-1#1)
on the main##19##3##(1991-4#1)(1993-2#1)(1994-12#1)(1994-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-5#3)(2010-4#1)(2011-12#1)(2011-2#1)(2012-3#1)
on the mainland##2##3##(1996-6#1)(2007-2#1)
on the maintenance of##3##4##(2008-7#1)(2012-2#1)(2013-8#1)
on the major##15##3##(1991-12#1)(1991-2#1)(1993-11#1)(1994-10#1)(1994-3#2)(1997-3#1)(2005-5#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
on the male##3##3##(1995-5#1)(2004-2#1)(2007-10#1)
on the mammalian##3##3##(1995-11#2)(2013-7#1)
on the man made mounds in the##3##7##(2008-12#3)
on the management of patients with##3##6##(2010-12#1)(2012-1#1)(2012-12#1)
on the management of patients##4##5##(2010-12#2)(2012-1#1)(2012-12#1)
on the management of##27##4##(1996-4#1)(2005-7#1)(2005-8#2)(2006-10#3)(2006-8#1)(2007-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-8#2)(2010-12#2)(2010-3#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)
on the management##29##3##(1993-1#1)(1996-4#1)(2005-7#1)(2005-8#2)(2006-10#3)(2006-8#1)(2007-12#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-8#2)(2010-12#2)(2010-3#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)
on the mandible and##2##4##(2010-2#2)
on the manipulation of##3##4##(1991-12#1)(2008-4#1)(2008-7#1)
on the manipulation##4##3##(1991-12#1)(2007-12#1)(2008-4#1)(2008-7#1)
on the manner in which the##2##6##(1992-1#1)(2005-11#1)
on the manner##3##3##(1992-1#1)(2005-11#1)(2008-10#1)
on the manure##2##3##(2004-11#1)(2011-12#1)
on the map##2##3##(1996-2#1)(2012-3#1)
on the mapping of##2##4##(2008-10#1)(2008-11#1)
on the mapping##3##3##(2008-10#1)(2008-11#1)(2010-9#1)
on the margins##2##3##(1997-8#1)(2008-9#1)
on the marine environment##3##4##(2008-11#3)
on the marker##2##3##(2008-10#2)
on the market for##6##4##(1990-6#1)(1992-3#2)(1994-2#1)(2007-8#1)(2010-1#1)
on the market##34##3##(1990-6#1)(1991-2#1)(1992-3#2)(1993-5#1)(1994-2#1)(1994-5#1)(1996-5#1)(2005-5#2)(2005-9#1)(2006-10#1)(2006-6#2)(2006-8#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-5#1)(2009-6#2)(2010-1#1)(2011-1#1)(2012-12#3)(2013-8#1)
on the mass and##2##4##(2007-8#1)(2013-8#1)
on the mass of##3##4##(1995-7#1)(1997-5#1)(2008-9#1)
on the mass##7##3##(1995-7#1)(1997-5#1)(2005-12#1)(2007-8#1)(2008-9#1)(2010-4#1)(2013-8#1)
on the material##5##3##(2004-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)
on the materials##4##3##(2007-9#1)(2008-10#1)(2012-11#2)
on the maternal##4##3##(1994-9#1)(1995-8#1)(2005-10#1)(2013-1#1)
on the mathematical##2##3##(1992-4#1)(2012-12#1)
on the matrix side of the##3##6##(1997-1#2)(2005-8#1)
on the matrix side of##4##5##(1997-1#3)(2005-8#1)
on the matrix##6##3##(1997-1#3)(2005-8#1)(2008-10#1)(2008-5#1)
on the matter##2##3##(2007-7#1)(2008-1#1)
on the maturation of##3##4##(1993-7#2)(1995-6#1)
on the maturation##4##3##(1993-7#2)(1995-6#1)(2007-3#1)
on the mature##5##3##(1990-12#1)(1995-12#1)(2006-6#1)(2008-9#2)
on the maxillary##2##3##(2007-12#1)(2010-11#1)
on the maximization of the##2##5##(2007-9#2)
on the maximum wave-front##2##4##(2007-12#2)
on the maximum##7##3##(2007-12#3)(2008-1#1)(2008-6#2)(2012-3#1)
on the mean value##2##4##(1994-10#1)(2008-2#1)
on the mean##9##3##(1994-10#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2012-2#1)(2013-7#1)
on the meaning of##5##4##(1993-2#1)(1994-9#1)(2009-4#1)(2011-3#1)(2012-2#1)
on the meaning##6##3##(1993-2#1)(1994-9#1)(2009-4#1)(2009-6#1)(2011-3#1)(2012-2#1)
on the means##2##3##(1992-6#1)(2006-7#1)
on the measure##2##3##(2007-3#1)(2011-1#1)
on the measured##20##3##(1992-4#1)(1994-12#1)(1995-11#1)(1995-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#5)(2009-5#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
on the measurement accuracy##2##4##(2008-3#2)
on the measurement of optical properties##2##6##(2008-3#2)
on the measurement of the##12##5##(2006-11#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2013-8#1)
on the measurement of##31##4##(1992-2#1)(1997-4#2)(2004-9#1)(2006-11#1)(2008-10#11)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#1)(2008-9#3)(2013-1#1)(2013-8#1)
on the measurement##42##3##(1992-2#1)(1997-4#2)(2004-9#1)(2005-11#1)(2006-11#1)(2008-10#12)(2008-2#5)(2008-3#10)(2008-4#1)(2008-5#1)(2008-9#3)(2012-3#1)(2013-1#1)(2013-8#2)
on the measurements of##4##4##(2008-10#2)(2008-3#1)(2009-12#1)
on the measurements##5##3##(1993-11#1)(2008-10#2)(2008-3#1)(2009-12#1)
on the mechanical function of##2##5##(2007-11#1)(2008-3#1)
on the mechanical properties and##3##5##(2010-4#1)(2012-2#1)(2013-8#1)
on the mechanical properties of the##4##6##(2004-9#1)(2005-11#1)(2008-6#1)(2011-2#1)
on the mechanical properties of##15##5##(2004-9#2)(2005-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-5#2)(2009-7#2)(2010-4#1)(2011-2#2)
on the mechanical properties##22##4##(2004-9#3)(2005-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-5#2)(2009-7#3)(2010-4#2)(2011-2#2)(2012-2#1)(2013-8#1)
on the mechanical##33##3##(2004-9#3)(2005-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#2)(2009-7#4)(2010-12#1)(2010-4#2)(2011-2#3)(2012-2#2)(2013-8#1)
on the mechanism and##2##4##(2007-11#1)(2008-10#1)
on the mechanism of action of##4##6##(1993-9#1)(1997-2#1)(2008-10#1)(2009-6#1)
on the mechanism of action##7##5##(1993-12#1)(1993-9#1)(1997-2#1)(2008-10#1)(2008-5#1)(2009-6#1)(2010-11#1)
on the mechanism of the##3##5##(1997-1#1)(2008-10#1)(2008-2#1)
on the mechanism of##29##4##(1990-11#1)(1990-2#1)(1990-7#1)(1992-11#1)(1993-12#1)(1993-9#1)(1996-6#2)(1997-1#1)(1997-2#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-11#1)(2012-1#1)(2013-1#2)
on the mechanism##35##3##(1990-11#1)(1990-2#1)(1990-7#1)(1992-11#1)(1993-12#1)(1993-9#1)(1995-2#1)(1996-6#2)(1997-1#1)(1997-2#1)(2006-10#1)(2006-6#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2012-1#1)(2013-1#2)
on the mechanism(s)##2##3##(1995-1#1)(2008-10#1)
on the mechanisms by which##4##5##(1993-9#1)(2006-10#1)(2010-1#1)(2013-1#1)
on the mechanisms of##14##4##(1995-2#1)(1996-9#1)(2005-10#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-12#2)(2008-4#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
on the mechanisms that##2##4##(2009-8#1)(2010-12#1)
on the mechanisms##25##3##(1993-6#1)(1993-9#1)(1995-2#1)(1996-9#1)(2005-10#1)(2005-11#1)(2006-10#3)(2008-10#4)(2008-12#2)(2008-4#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
on the media##2##3##(2008-10#1)(2012-2#1)
on the medial surface of##2##5##(2007-12#1)(2008-5#1)
on the medial##7##3##(2007-12#2)(2007-4#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-1#1)
on the median##6##3##(1990-1#1)(1996-12#2)(2004-3#1)(2008-10#1)(2013-8#1)
on the medical staff##2##4##(1992-2#1)(2007-5#1)
on the medical##12##3##(1992-2#1)(1994-2#1)(2007-11#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2012-3#2)
on the medium##10##3##(1990-12#1)(1992-12#1)(1997-6#1)(2005-11#1)(2006-12#1)(2008-10#2)(2008-6#1)(2008-8#1)(2011-12#1)
on the membrane by##3##4##(2007-2#1)(2008-10#1)(2010-5#1)
on the membrane fluidity of tumor cells##2##7##(1992-8#2)
on the membrane of the##2##5##(1993-6#1)(2008-8#1)
on the membrane potential and##2##5##(1990-8#1)(1994-8#1)
on the membrane potential##7##4##(1990-3#1)(1990-5#1)(1990-8#1)(1993-11#1)(1994-8#1)(1997-1#1)(1997-7#1)
on the membrane surface##5##4##(1990-11#1)(1994-11#1)(1994-2#1)(2008-5#1)(2010-4#1)
on the membrane##34##3##(1990-11#1)(1990-3#1)(1990-5#1)(1990-8#1)(1992-2#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-7#1)(2007-2#1)(2008-10#5)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-5#2)
on the membranes during##2##4##(1992-6#1)(2007-9#1)
on the membranes##4##3##(1990-2#1)(1992-6#2)(2007-9#1)
on the mental health##2##4##(2008-12#1)(2011-2#1)
on the mental##3##3##(2006-10#1)(2008-12#1)(2011-2#1)
on the mercury electrode##4##4##(2005-11#1)(2008-10#3)
on the mercury##7##3##(2005-11#1)(2008-10#6)
on the mesenteric##2##3##(2010-12#1)(2012-2#1)
on the metabolic pathways##2##4##(1995-1#1)(2010-12#1)
on the metabolic##16##3##(1990-5#1)(1991-1#1)(1991-10#1)(1991-12#1)(1992-1#1)(1995-1#1)(1996-1#1)(1996-3#1)(2008-10#1)(2010-10#1)(2010-12#1)(2012-11#1)(2012-2#2)(2013-1#2)
on the metabolism and##2##4##(1994-6#1)(2013-8#1)
on the metabolism of##15##4##(1991-2#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-7#1)(1997-2#1)(1997-3#1)(2006-12#1)(2008-11#2)(2010-7#1)(2011-2#1)
on the metabolism##17##3##(1991-2#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-7#1)(1997-2#1)(1997-3#1)(2006-12#1)(2008-11#2)(2010-7#1)(2011-2#1)(2013-8#1)
on the metal and##2##4##(2006-12#1)(2008-10#1)
on the metal ion##3##4##(1996-2#1)(2008-10#2)
on the metal surface##5##4##(2004-9#1)(2007-12#2)(2008-5#1)(2010-4#1)
on the metal##19##3##(1991-7#1)(1994-5#1)(1996-2#2)(2004-9#1)(2006-12#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-3#1)(2008-5#1)(2010-11#1)(2010-4#2)
on the metallic##2##3##(2008-10#1)(2008-3#1)
on the metallocenes##2##3##(2007-11#2)
on the metastasis of##2##4##(1991-9#1)(2005-10#1)
on the method of##8##4##(1994-9#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)
on the method used for##3##5##(2005-11#1)(2008-10#1)(2011-2#1)
on the method used##5##4##(2005-11#1)(2007-11#1)(2008-10#2)(2011-2#1)
on the method##16##3##(1992-11#1)(1994-9#1)(2005-11#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2011-2#1)
on the methods##5##3##(2008-3#1)(2008-4#1)(2008-5#1)(2013-1#2)
on the methylation of the##2##5##(1995-2#1)(1997-4#1)
on the microarray##2##3##(2007-8#1)(2008-4#1)
on the microbial##3##3##(2008-10#1)(2012-12#1)(2013-8#1)
on the microbiology of##2##4##(1997-5#1)(2012-2#1)
on the microcarrier##2##3##(2008-11#1)(2008-9#1)
on the microchip##4##3##(2007-8#2)(2008-10#2)
on the microelectrode##2##3##(2008-10#2)
on the micrometer##2##3##(2005-11#1)(2012-2#1)
on the microscale##2##3##(2006-6#1)(2010-10#1)
on the microscopic##2##3##(1995-3#1)(2005-12#1)
on the microsecond time scale##3##5##(1990-8#1)(1995-2#1)(1996-2#1)
on the microsecond##5##3##(1990-8#1)(1995-2#1)(1996-2#1)(1997-5#1)(2008-2#1)
on the microshear bond strength of##3##6##(2013-1#3)
on the microstructure and##2##4##(2006-2#1)(2008-5#1)
on the microstructure of##2##4##(2008-5#2)
on the microstructure##5##3##(2006-2#1)(2008-5#3)(2010-4#1)
on the microtubule##2##3##(1994-2#1)(2006-10#1)
on the micturition reflex in anesthetized rats##2##7##(1990-5#2)
on the micturition reflex##3##4##(1990-5#2)(1992-3#1)
on the middle##2##3##(2007-8#1)(2008-10#1)
on the migration and invasion##2##5##(1993-7#1)(2012-3#1)
on the migration of##3##4##(2008-1#1)(2008-10#1)(2010-7#1)
on the migration##7##3##(1993-2#1)(1993-7#1)(2008-1#1)(2008-10#2)(2010-7#1)(2012-3#1)
on the mineral##2##3##(2008-10#1)(2008-8#1)
on the minimum number of##2##5##(2006-10#2)
on the minimum##5##3##(2006-10#2)(2007-11#1)(2008-2#1)(2011-1#1)
on the mitochondrial##4##3##(1994-6#1)(2005-8#1)(2010-4#1)(2011-2#1)
on the mitral echogram##2##4##(1995-6#2)
on the mitral valve##2##4##(2006-10#1)(2009-8#1)
on the mitral##4##3##(1995-6#2)(2006-10#1)(2009-8#1)
on the mixed##2##3##(2008-10#2)
on the mixing##3##3##(1997-3#1)(2010-5#1)(2011-12#1)
on the mixture##3##3##(2007-5#1)(2008-10#1)(2008-6#1)
on the mode of action##3##5##(2006-10#1)(2006-12#1)(2009-7#1)
on the mode of##8##4##(1997-2#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-12#1)(2008-2#1)(2009-7#1)(2010-4#1)
on the mode##11##3##(1997-2#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-5#1)(2008-1#1)(2008-2#2)(2009-7#1)(2010-4#1)
on the model of##11##4##(2006-12#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#3)
on the model##26##3##(1996-12#1)(1996-2#1)(2005-8#1)(2006-12#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-2#4)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#3)
on the modeling of##3##4##(2007-12#1)(2008-3#1)(2010-8#1)
on the modification of##6##4##(1993-9#1)(1996-1#1)(2008-10#2)(2008-7#1)(2009-12#1)
on the modified electrode##3##4##(2008-10#3)
on the modified protein##2##4##(2009-10#2)
on the modified##14##3##(2005-11#2)(2007-7#1)(2008-10#7)(2008-3#2)(2009-10#2)
on the modulation of##5##4##(1991-9#1)(1993-6#1)(2007-11#1)(2008-1#1)(2009-8#1)
on the modulation##8##3##(1991-9#1)(1993-6#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#2)(2009-8#1)
on the moiré fringes in Talbot interferometry##2##7##(2008-3#2)
on the moiré fringes in##3##5##(2008-3#3)
on the moiré fringes##4##4##(2008-3#4)
on the moiré##5##3##(2008-2#1)(2008-3#4)
on the molar absorptivity##2##4##(2008-10#2)
on the molar##4##3##(2005-4#1)(2008-10#3)
on the mole fraction scale##2##5##(1990-8#2)
on the molecular and cellular##2##5##(2006-10#1)(2009-8#1)
on the molecular and##4##4##(2006-10#1)(2007-10#1)(2008-4#1)(2009-8#1)
on the molecular basis of the##2##6##(1990-8#1)(2006-10#1)
on the molecular basis of##5##5##(1990-8#1)(1994-5#1)(2006-10#1)(2008-8#1)(2009-8#1)
on the molecular basis##7##4##(1990-8#1)(1994-5#1)(2005-9#1)(2006-10#1)(2008-8#1)(2009-8#1)(2012-12#1)
on the molecular level##7##4##(1994-11#1)(2007-11#3)(2008-10#1)(2008-7#1)(2011-1#1)
on the molecular mechanism of##2##5##(2011-3#1)(2012-1#1)
on the molecular mechanisms of##4##5##(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)
on the molecular mechanisms underlying##2##5##(2004-11#1)(2009-5#1)
on the molecular mechanisms##9##4##(2004-11#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
on the molecular structure of the##2##6##(1994-5#1)(2006-12#1)
on the molecular structure##3##4##(1994-5#1)(2006-12#1)(2006-6#1)
on the molecular##51##3##(1990-5#1)(1990-8#1)(1994-11#1)(1994-5#2)(1997-2#1)(2004-11#1)(2005-4#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#2)(2009-8#2)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#2)(2013-8#1)
on the molecule##5##3##(1990-5#1)(1995-1#2)(2009-10#1)(2013-7#1)
on the monitor##4##3##(2008-5#1)(2011-12#1)(2012-12#2)
on the monitoring of##2##4##(2008-10#2)
on the monitoring##3##3##(2007-8#1)(2008-10#2)
on the monolayer##2##3##(1996-1#1)(2007-8#1)
on the moon##2##3##(2007-9#1)(2013-8#1)
on the morbidity and mortality of the##2##7##(2012-3#1)(2013-8#1)
on the morbidity and mortality of##3##6##(2008-8#1)(2012-3#1)(2013-8#1)
on the morbidity and mortality##4##5##(2006-10#1)(2008-8#1)(2012-3#1)(2013-8#1)
on the morbidity##5##3##(2006-10#1)(2008-5#1)(2008-8#1)(2012-3#1)(2013-8#1)
on the more common##2##4##(1992-12#1)(2007-12#1)
on the more##10##3##(1992-12#1)(1997-4#1)(2005-9#1)(2006-10#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#1)
on the morning of##2##4##(1996-8#1)(2005-7#1)
on the morphologic##2##3##(2009-7#1)(2010-12#1)
on the morphological##7##3##(1990-7#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-5#2)(2009-8#1)
on the morphology and function of##2##6##(2008-10#1)(2012-1#1)
on the morphology and##9##4##(1996-5#1)(1997-5#1)(2005-11#1)(2007-11#1)(2008-10#2)(2008-4#1)(2011-2#1)(2012-1#1)
on the morphology of the##3##5##(2005-11#1)(2007-12#1)(2007-3#1)
on the morphology of##9##4##(1993-9#1)(2004-12#1)(2005-11#2)(2007-12#1)(2007-3#1)(2008-10#1)(2008-6#1)(2013-1#1)
on the morphology##19##3##(1993-9#1)(1996-5#1)(1997-5#1)(2004-12#1)(2005-11#3)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#4)(2008-4#1)(2008-6#1)(2011-2#1)(2012-1#1)(2013-1#1)
on the mortality and##3##4##(1992-12#1)(2007-7#1)(2008-11#1)
on the mortality of##2##4##(2008-1#1)(2008-10#1)
on the mortality rate##2##4##(2007-12#1)(2008-7#1)
on the mortality##11##3##(1990-4#1)(1992-12#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2013-1#2)
on the most common##2##4##(2005-10#1)(2006-10#1)
on the most effective##2##4##(2008-1#1)(2009-5#1)
on the most recent advances in##3##6##(2006-10#2)(2008-5#1)
on the most recent##7##4##(2006-10#4)(2008-5#1)(2009-6#1)(2013-1#1)
on the most severe##2##4##(2007-2#1)(2009-5#1)
on the most##27##3##(1990-4#1)(1993-2#1)(1996-1#1)(1997-2#1)(2005-10#1)(2006-10#6)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#2)(2009-6#1)(2010-11#1)(2011-1#1)(2013-1#1)
on the mother plant##2##4##(2008-12#1)(2011-12#1)
on the mother##4##3##(1992-12#1)(2008-12#1)(2008-8#1)(2011-12#1)
on the mother's##5##3##(1992-4#2)(1996-9#1)(2005-10#1)(2008-11#1)
on the motility of##2##4##(1996-12#2)
on the motion##2##3##(1996-12#1)(2008-3#1)
on the motor##5##3##(1991-2#1)(1993-10#1)(1996-10#1)(1997-8#1)(2008-7#1)
on the mouse X chromosome##2##5##(1991-5#1)(1996-10#1)
on the mouse##4##3##(1991-5#1)(1996-10#1)(1997-7#1)(2008-4#1)
on the mouth##2##3##(2009-4#2)
on the move##2##3##(2011-12#1)(2013-8#1)
on the mucosa##2##3##(1995-4#1)(2010-12#1)
on the mucosal side##2##4##(1994-3#1)(2008-5#1)
on the mucosal##3##3##(1994-3#1)(2008-4#1)(2008-5#1)
on the multiple##6##3##(1996-3#1)(1997-8#1)(2008-7#1)(2009-2#1)(2009-4#1)(2012-3#1)
on the multiplicity##2##3##(1997-3#1)(2008-4#1)
on the multivariate##2##3##(1992-6#1)(2009-12#1)
on the murine##2##3##(2008-4#1)(2008-5#1)
on the muscle##4##3##(1995-3#1)(1996-3#1)(2009-3#1)(2009-9#1)
on the muscular stress##2##4##(2008-6#2)
on the muscular##3##3##(2008-5#1)(2008-6#2)
on the mutant##2##3##(1992-4#1)(2006-12#1)
on the mutual##3##3##(2005-4#1)(2007-11#1)(2008-10#1)
on the myocardium##2##3##(1996-6#1)(2007-9#1)
on the nanometer scale##2##4##(2007-12#1)(2008-2#1)
on the nanoscale##3##3##(2008-7#1)(2009-4#1)(2010-4#1)
on the nanosecond time scale##2##5##(1990-8#1)(1994-9#1)
on the nanosecond##3##3##(1990-8#1)(1992-7#1)(1994-9#1)
on the nasolabial fold and chin##2##6##(2008-5#2)
on the nasolabial fold##3##4##(2008-5#3)
on the national level##2##4##(1995-2#1)(2008-1#1)
on the national##6##3##(1995-1#1)(1995-2#1)(2006-3#1)(2007-2#1)(2008-1#2)
on the native fluorescence##2##4##(2008-10#2)
on the native##10##3##(1994-8#1)(1995-3#1)(1996-6#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2011-3#1)
on the natural course##2##4##(1992-9#1)(1995-6#1)
on the natural history of the disease##2##7##(1991-6#1)(2010-10#1)
on the natural history of##7##5##(1991-6#1)(2005-10#1)(2005-11#1)(2006-10#1)(2008-10#1)(2010-10#1)(2011-3#1)
on the natural history##8##4##(1991-6#1)(2005-10#1)(2005-11#1)(2006-10#1)(2008-10#1)(2009-8#1)(2010-10#1)(2011-3#1)
on the natural##20##3##(1991-6#1)(1992-9#1)(1994-8#1)(1995-6#1)(2004-7#1)(2005-10#1)(2005-11#1)(2006-10#2)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-3#1)
on the nature and extent of##2##6##(2008-1#1)(2008-10#1)
on the nature and the##2##5##(2008-5#2)
on the nature and##12##4##(1996-2#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-5#2)(2010-11#1)(2012-12#2)
on the nature of the disease##2##6##(2008-4#1)(2013-1#1)
on the nature of the substrate and##2##7##(2007-10#1)(2013-7#1)
on the nature of the##33##5##(1990-5#1)(1990-8#1)(1993-11#1)(1993-2#1)(1994-11#2)(1994-5#1)(1997-3#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
on the nature of their##2##5##(2006-10#1)(2010-12#1)
on the nature of##50##4##(1990-5#1)(1990-8#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-11#2)(1994-5#1)(1995-2#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#2)(2008-8#1)(2009-9#1)(2010-12#1)(2012-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
on the nature##63##3##(1990-5#1)(1990-8#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-11#2)(1994-5#1)(1995-2#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-7#1)(2005-11#1)(2006-10#3)(2006-11#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#4)(2008-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2012-1#1)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#1)
on the near##2##3##(2006-10#1)(2007-12#1)
on the necessity of##2##4##(2008-10#1)(2011-1#1)
on the necessity##3##3##(2008-10#1)(2011-1#1)(2012-2#1)
on the neck##7##3##(1992-12#1)(1995-8#2)(1997-6#1)(2007-4#1)(2008-7#1)(2010-12#1)
on the need for##9##4##(1990-10#1)(1993-1#1)(2008-10#1)(2008-5#2)(2008-8#1)(2009-9#1)(2010-9#1)(2011-2#1)
on the need to##4##4##(1990-5#1)(1995-6#1)(2007-12#1)(2013-1#1)
on the need##14##3##(1990-10#1)(1990-5#1)(1993-1#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-5#2)(2008-8#1)(2009-9#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
on the needs of the##3##5##(1993-1#2)(1996-1#1)
on the needs of##7##4##(1993-1#2)(1993-12#1)(1996-1#1)(2008-7#1)(2010-6#1)(2013-8#1)
on the needs##8##3##(1991-6#1)(1993-1#2)(1993-12#1)(1996-1#1)(2008-7#1)(2010-6#1)(2013-8#1)
on the negative##7##3##(1994-2#1)(1996-2#1)(2007-8#1)(2008-8#2)(2009-2#1)(2011-2#1)
on the negatively charged##2##4##(2008-10#1)(2010-7#1)
on the nerve##4##3##(2006-12#1)(2010-1#1)(2011-1#2)
on the nervous system##3##4##(1997-3#1)(2004-11#1)(2007-11#1)
on the nervous tissue##2##4##(1990-3#1)(2006-12#1)
on the nervous##5##3##(1990-3#1)(1997-3#1)(2004-11#1)(2006-12#1)(2007-11#1)
on the net##4##3##(1991-9#1)(1995-9#1)(2006-10#1)(2008-12#1)
on the network##7##3##(1997-3#3)(2004-9#1)(2006-10#1)(2007-12#1)(2012-3#1)
on the neural network##2##4##(2008-2#1)(2010-4#1)
on the neural##8##3##(2006-8#1)(2008-2#1)(2008-9#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#1)
on the neuromuscular junction##3##4##(1992-8#2)(1996-8#1)
on the neuromuscular##4##3##(1992-8#2)(1996-8#1)(2008-12#1)
on the neuronal voltage-dependent sodium channel##2##6##(1994-9#2)
on the neuronal##5##3##(1994-10#1)(1994-9#2)(2008-12#1)(2012-12#1)
on the neurons##2##3##(1993-5#1)(2009-2#1)
on the neutrophil##2##3##(1990-9#2)
on the new data##2##4##(1994-8#1)(2007-12#1)
on the new##20##3##(1992-1#2)(1994-8#1)(1995-7#1)(2005-4#2)(2006-2#1)(2007-12#1)(2008-10#6)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#1)(2010-7#1)(2012-1#1)
on the newer##3##3##(2010-5#1)(2012-2#1)(2013-1#1)
on the next##2##3##(2007-8#1)(2012-1#1)
on the night side of##2##5##(1991-5#2)
on the night##4##3##(1991-5#2)(2008-10#1)(2008-2#1)
on the nitric##2##3##(1996-9#1)(2009-4#1)
on the nitrosation##3##3##(1992-8#2)(2008-10#1)
on the noise##2##3##(2008-3#1)(2013-7#1)
on the nomenclature for the##2##5##(1990-12#2)
on the nonlinear optical##2##4##(2007-12#1)(2008-2#1)
on the nonlinear##8##3##(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#1)
on the nontranscribed strand##2##4##(1994-8#1)(1996-7#1)
on the normal development of##3##5##(1992-7#1)(2008-1#1)(2008-8#1)
on the normal##16##3##(1992-7#1)(1993-11#1)(1993-3#1)(1993-5#1)(1996-8#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-4#1)(2008-8#2)(2008-9#1)(2012-3#1)(2013-8#1)
on the north coast##2##4##(2007-5#2)
on the nose##6##3##(1991-11#1)(2007-2#1)(2007-8#1)(2008-5#3)
on the notion of##2##4##(2009-3#1)(2009-7#1)
on the novel##5##3##(2008-5#2)(2008-6#1)(2011-1#1)(2013-7#1)
on the nuclear##4##3##(1995-2#1)(2008-10#1)(2012-12#2)
on the nucleic acid##2##4##(1991-4#1)(1995-11#1)
on the nucleobase##2##3##(2008-4#2)
on the nucleophilic##2##3##(1992-4#1)(1997-8#1)
on the nucleotide sequence##2##4##(2008-10#1)(2010-7#1)
on the nucleotide##7##3##(1992-7#1)(1993-12#1)(1997-4#1)(2007-6#1)(2008-10#2)(2010-7#1)
on the number and##5##4##(1992-4#1)(1994-6#2)(2007-3#1)(2008-10#1)
on the number of individuals##2##5##(2009-5#1)(2010-4#1)
on the number of patients##3##5##(1993-1#1)(2006-8#1)(2012-2#1)
on the number of people##2##5##(1994-2#1)(1995-12#1)
on the number of##51##4##(1990-10#1)(1990-12#1)(1991-12#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-12#2)(1994-2#1)(1995-12#2)(1995-3#2)(1996-1#1)(2004-11#1)(2004-9#1)(2005-11#2)(2006-11#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-4#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
on the number##59##3##(1990-10#1)(1990-12#1)(1991-12#1)(1992-4#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-12#2)(1994-2#1)(1994-6#2)(1995-12#2)(1995-3#2)(1996-1#1)(2004-11#1)(2004-9#1)(2005-11#2)(2006-11#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-6#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-4#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)
on the numbers of##3##4##(1991-11#1)(2008-9#2)
on the numbers##4##3##(1991-11#1)(2008-8#1)(2008-9#2)
on the numerical aperture##2##4##(2007-11#1)(2007-12#1)
on the numerical##7##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)(2008-6#1)
on the nurse's##2##3##(1990-2#1)(2009-4#1)
on the nutrient##2##3##(2008-10#1)(2013-8#1)
on the nutrition##2##3##(2005-7#1)(2006-10#1)
on the nutritional status of##2##5##(2006-6#1)(2013-1#1)
on the nutritional##3##3##(2006-6#1)(2012-1#1)(2013-1#1)
on the object surface##2##4##(2008-2#1)(2008-3#1)
on the object##6##3##(2007-12#1)(2008-2#3)(2008-3#2)
on the observation of##7##4##(1994-10#1)(1994-3#1)(2005-7#1)(2007-11#2)(2007-7#1)(2007-8#1)
on the observation that the##3##5##(2007-9#1)(2008-6#1)(2012-3#1)
on the observation that##10##4##(1994-11#1)(1994-5#1)(1997-6#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2012-3#1)
on the observation##18##3##(1994-10#1)(1994-11#1)(1994-3#1)(1994-5#1)(1997-6#1)(2005-7#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2012-3#1)
on the observations of##2##4##(1995-3#1)(2009-4#1)
on the observations##5##3##(1995-3#1)(2008-2#1)(2008-3#1)(2009-4#1)(2013-8#1)
on the observed##17##3##(1994-5#1)(1995-12#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-7#1)(2012-2#1)(2013-8#1)
on the obtained##9##3##(1994-10#1)(2008-10#4)(2010-4#1)(2011-2#1)(2013-8#2)
on the occasion of his##2##5##(1990-8#1)(1992-5#1)
on the occasion of the##3##5##(1994-3#1)(1997-3#1)(2010-6#1)
on the occasion of##8##4##(1990-8#1)(1992-5#1)(1994-3#1)(1997-3#1)(2007-7#1)(2008-11#1)(2010-6#1)(2013-1#1)
on the occipital scalp##2##4##(2010-6#2)
on the occipital##3##3##(2008-7#1)(2010-6#2)
on the occluded##2##3##(1997-7#1)(2008-5#1)
on the occurrence and##2##4##(2008-10#1)(2008-8#1)
on the occurrence of malignant##2##5##(2008-9#1)(2010-9#1)
on the occurrence of##22##4##(1992-11#1)(1993-5#1)(1993-8#1)(1994-5#1)(1995-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#3)(2009-8#1)(2010-9#1)(2011-2#3)(2013-8#2)
on the occurrence##24##3##(1992-11#1)(1993-5#1)(1993-8#1)(1994-5#1)(1995-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-8#1)(2010-9#1)(2011-2#3)(2013-8#2)
on the ocular surface##5##4##(2006-11#1)(2007-1#3)(2009-8#1)
on the ocular##6##3##(2006-11#1)(2007-1#3)(2009-8#1)(2013-1#1)
on the odds##2##3##(1994-9#1)(2008-12#1)
on the olfactory epithelium##2##4##(2008-5#1)(2008-6#1)
on the olfactory identification task##2##5##(1997-8#2)
on the olfactory##8##3##(1994-5#1)(1995-5#1)(1997-8#3)(2006-12#1)(2008-5#1)(2008-6#1)
on the one hand and on##3##6##(1994-2#1)(2006-8#1)(2007-10#1)
on the one hand and the##2##6##(1991-7#1)(1994-6#1)
on the one hand and##12##5##(1990-9#1)(1991-6#1)(1991-7#1)(1994-2#1)(1994-6#1)(2006-8#1)(2007-10#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#2)
on the one hand the##2##5##(1991-11#1)(2008-3#1)
on the one hand##48##4##(1990-5#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#3)(2009-10#1)(2009-2#2)(2009-9#1)(2011-1#1)(2012-12#1)(2013-1#4)
on the one side##3##4##(1996-8#1)(2008-11#2)
on the one##53##3##(1990-5#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#3)(2009-10#1)(2009-2#2)(2009-9#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#4)
on the ongoing##3##3##(1994-12#1)(2011-1#1)(2012-1#1)
on the onset of Type 1 diabetes in##2##8##(2007-6#2)
on the onset of cervical##2##5##(2007-2#2)
on the onset of##8##4##(1990-11#1)(1991-12#1)(2007-2#2)(2007-6#2)(2009-8#1)(2012-2#1)
on the onset##10##3##(1990-11#1)(1991-12#1)(2007-2#2)(2007-6#2)(2008-6#1)(2009-8#1)(2012-2#1)(2013-8#1)
on the open##4##3##(1995-12#1)(1995-3#1)(2006-10#1)(2008-9#1)
on the opening##2##3##(2008-12#1)(2013-1#1)
on the operated side##4##4##(2007-9#1)(2008-3#1)(2008-5#1)(2011-1#1)
on the operated##5##3##(2007-8#1)(2007-9#1)(2008-3#1)(2008-5#1)(2011-1#1)
on the operating table##3##4##(2007-12#1)(2007-8#1)(2008-2#1)
on the operating##9##3##(1991-8#1)(1997-2#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)
on the operation of##2##4##(2006-10#1)(2008-2#1)
on the operation##3##3##(2006-10#1)(2008-10#1)(2008-2#1)
on the operative##3##3##(2007-11#1)(2007-8#1)(2012-12#1)
on the operator##2##3##(2007-11#1)(2008-1#1)
on the opposite side##8##4##(1993-4#1)(2007-7#1)(2008-3#1)(2008-5#1)(2009-6#2)(2011-1#1)(2013-7#1)
on the opposite strand##4##4##(1990-5#1)(1992-12#1)(1995-8#1)(2008-11#1)
on the opposite##14##3##(1990-5#1)(1992-12#1)(1993-4#1)(1995-8#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-6#2)(2011-1#1)(2012-4#1)(2013-7#1)
on the optical and##3##4##(2005-11#1)(2008-10#1)(2008-3#1)
on the optical axis##4##4##(2007-12#1)(2008-3#3)
on the optical biosensor##2##4##(1997-2#2)
on the optical properties of the##2##6##(2008-3#2)
on the optical properties of##7##5##(2007-11#2)(2008-2#2)(2008-3#2)(2011-1#1)
on the optical properties##8##4##(2007-11#2)(2008-2#2)(2008-3#2)(2010-9#1)(2011-1#1)
on the optical thickness of the##2##6##(2007-11#1)(2008-3#1)
on the optical##39##3##(1997-2#2)(2005-11#1)(2007-11#5)(2007-12#3)(2008-10#1)(2008-2#7)(2008-3#18)(2010-9#1)(2011-1#1)
on the optimal##7##3##(2007-11#1)(2008-10#1)(2008-2#2)(2008-5#1)(2009-8#1)(2011-2#1)
on the optimization of##3##4##(2008-10#1)(2008-2#2)
on the optimum##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2012-12#1)
on the oral health##2##4##(2007-2#1)(2008-9#1)
on the oral##8##3##(1993-1#1)(2007-2#1)(2007-9#1)(2008-9#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-8#1)
on the orange-spotted grouper##2##4##(2010-5#2)
on the orchard floor and##2##5##(2008-10#2)
on the orchard floor##5##4##(2008-10#5)
on the orchard##6##3##(2008-10#6)
on the order of 0##2##5##(2007-12#1)(2008-10#1)
on the order of 1##3##5##(2008-8#1)(2008-9#1)(2009-7#1)
on the order of 10##4##5##(1995-6#1)(2008-7#1)(2009-12#1)(2010-7#1)
on the order of 100##2##5##(2006-4#1)(2007-5#1)
on the order of a##2##5##(2009-11#1)(2009-5#1)
on the order of##35##4##(1992-2#1)(1992-9#3)(1993-11#1)(1993-7#1)(1995-6#1)(1996-5#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#1)(2010-4#2)(2010-7#1)(2011-2#1)
on the order##36##3##(1992-2#1)(1992-9#3)(1993-11#1)(1993-7#1)(1995-6#1)(1996-5#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#1)(2010-4#2)(2010-7#1)(2011-2#1)
on the organic##2##3##(2006-3#1)(2008-10#1)
on the organization of##4##4##(1991-9#1)(1994-5#1)(1995-11#1)(2008-3#1)
on the organization##5##3##(1991-9#1)(1994-5#1)(1995-11#1)(1995-12#1)(2008-3#1)
on the organizational##2##3##(2005-9#1)(2007-3#1)
on the orientation of the##5##5##(2006-4#1)(2008-2#1)(2008-3#3)
on the orientation of##6##4##(1996-1#1)(2006-4#1)(2008-2#1)(2008-3#3)
on the orientation##8##3##(1996-1#1)(2006-4#1)(2008-10#1)(2008-2#2)(2008-3#3)
on the origin and##3##4##(1995-8#1)(2012-3#2)
on the origin of life##3##5##(2008-10#2)(2010-7#1)
on the origin of##9##4##(1990-8#2)(2008-10#3)(2010-1#1)(2010-7#1)(2011-2#1)(2013-1#1)
on the origin##12##3##(1990-8#2)(1995-8#1)(2008-10#3)(2010-1#1)(2010-7#1)(2011-2#1)(2012-3#2)(2013-1#1)
on the original article##3##4##(2013-1#3)
on the original data##2##4##(2008-10#1)(2008-8#1)
on the original##19##3##(1990-10#1)(1990-3#1)(1994-12#1)(1996-12#1)(1997-8#1)(2007-11#1)(2007-5#2)(2008-10#2)(2008-3#1)(2008-8#1)(2009-2#1)(2010-9#1)(2011-2#1)(2013-1#3)(2013-8#1)
on the oscillating##3##3##(2008-10#3)
on the oscillatory##2##3##(1992-7#1)(2006-10#1)
on the osmotic##4##3##(1990-2#1)(1994-2#1)(2005-11#1)(2009-12#1)
on the other hand is##3##5##(1992-6#1)(2007-11#1)(2008-5#1)
on the other hand there is##2##6##(2009-5#1)(2013-8#1)
on the other hand was##2##5##(1997-2#1)(2009-5#1)
on the other hand##133##4##(1990-10#3)(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-10#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-6#1)(1995-8#2)(1996-11#2)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-8#1)(2004-9#1)(2005-11#3)(2006-10#1)(2006-6#3)(2006-7#1)(2007-1#3)(2007-11#2)(2007-7#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-2#1)(2009-5#3)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-12#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#5)
on the other side of the##2##6##(1993-7#1)(2008-10#1)
on the other side##9##4##(1993-7#1)(2006-9#2)(2008-10#1)(2008-11#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#1)
on the other##193##3##(1990-10#3)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#2)(1993-12#2)(1993-2#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-1#2)(1994-10#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-4#1)(1995-6#1)(1995-7#2)(1995-8#2)(1996-11#2)(1996-12#2)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-10#2)(2005-11#3)(2006-10#1)(2006-12#1)(2006-3#1)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#3)(2007-10#1)(2007-11#3)(2007-5#1)(2007-7#2)(2008-10#8)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#6)(2009-10#1)(2009-2#3)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#4)(2011-12#2)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#5)
on the outcome of patients with##4##6##(1994-4#2)(2006-10#1)(2010-9#1)
on the outcome of pregnancy##3##5##(1997-4#1)(2008-3#1)(2013-8#1)
on the outcome of rehabilitation##2##5##(2007-11#1)(2007-8#1)
on the outcome of the##6##5##(2007-8#1)(2008-5#1)(2009-12#1)(2009-4#2)(2011-2#1)
on the outcome of##27##4##(1990-9#1)(1993-1#1)(1994-4#2)(1997-4#1)(1997-8#1)(2006-10#2)(2007-11#1)(2007-8#3)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-2#2)(2009-4#2)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
on the outcome##35##3##(1990-9#1)(1993-1#1)(1994-4#2)(1997-4#1)(1997-8#1)(2006-10#2)(2007-11#1)(2007-7#1)(2007-8#4)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#2)(2009-4#2)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
on the outcomes of##2##4##(1996-3#1)(2008-4#1)
on the outcomes##7##3##(1991-12#1)(1994-11#1)(1996-3#1)(2006-5#1)(2008-4#1)(2009-7#1)(2013-1#1)
on the outer coast##2##4##(1990-11#2)
on the outer surface##2##4##(2007-11#1)(2008-5#1)
on the outer##14##3##(1990-11#2)(1991-1#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-6#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-8#1)
on the outermost##2##3##(2008-10#1)(2008-5#1)
on the outpatient##2##3##(1992-12#1)(2006-6#1)
on the output plane##3##4##(2008-3#3)
on the output surface##2##4##(2007-12#1)(2008-3#1)
on the output##10##3##(2007-12#2)(2008-2#2)(2008-3#5)(2010-8#1)
on the outside of the cell##2##6##(2005-10#1)(2011-1#1)
on the outside of the##5##5##(2005-10#1)(2008-10#1)(2011-1#1)(2012-2#2)
on the outside##7##3##(1996-12#1)(2005-10#1)(2008-10#1)(2009-3#1)(2011-1#1)(2012-2#2)
on the overall performance##2##4##(2008-12#1)(2008-2#1)
on the overall##23##3##(1990-10#1)(1991-2#1)(1991-4#1)(1993-5#1)(1993-6#2)(1994-12#1)(1996-3#1)(1996-9#1)(2006-8#1)(2008-11#2)(2008-12#1)(2008-2#3)(2008-5#3)(2010-1#1)(2011-2#2)(2012-2#1)
on the own##2##3##(2012-12#1)(2013-1#1)
on the oxidant and antioxidant status##2##6##(2008-12#2)
on the oxidation of N##3##5##(2008-10#2)(2008-3#1)
on the oxidation of methylene blue (MB)##2##7##(2008-10#2)
on the oxidation of##40##4##(2008-10#39)(2008-3#1)
on the oxidation reaction of##5##5##(2008-10#5)
on the oxidation##47##3##(2008-10#46)(2008-3#1)
on the oxidative coupling of 3-methyl-2-benzothiazolinone hydrazone##2##7##(2008-10#2)
on the oxidative coupling of##4##5##(2008-10#4)
on the oxidative coupling##5##4##(2008-10#5)
on the oxidative metabolism##3##4##(1993-4#2)(1995-7#1)
on the oxidative##9##3##(1993-4#2)(1995-7#1)(2006-2#1)(2008-10#5)
on the oxide surface##2##4##(2009-11#2)
on the oxygen binding##2##4##(1991-5#1)(1993-9#1)
on the oxygen##6##3##(1991-5#1)(1993-8#1)(1993-9#1)(1997-8#1)(2007-8#1)(2013-8#1)
on the ozone##3##3##(1996-1#1)(2008-2#1)(2008-3#1)
on the pH and ionic strength##2##6##(1990-12#1)(2008-10#1)
on the pH and##4##4##(1990-12#1)(2008-10#2)(2008-3#1)
on the pH of the medium and the##2##8##(1994-8#1)(2008-10#1)
on the pH of the solution##2##6##(1990-11#1)(2008-5#1)
on the pH of the##7##5##(1990-11#1)(1991-5#1)(1994-8#1)(1995-6#1)(2008-10#2)(2008-5#1)
on the pH of##8##4##(1990-11#1)(1991-5#1)(1994-8#1)(1995-6#1)(2007-8#1)(2008-10#2)(2008-5#1)
on the pH value##3##4##(1997-7#1)(2005-11#1)(2008-10#1)
on the pH##23##3##(1990-11#1)(1990-12#1)(1991-2#1)(1991-5#1)(1992-7#1)(1993-8#1)(1994-8#1)(1995-6#1)(1997-7#1)(2005-11#2)(2007-8#1)(2008-10#9)(2008-3#1)(2008-5#1)
on the pKa of the leaving group##3##7##(1991-7#1)(1993-8#2)
on the pad##3##3##(2008-5#3)
on the pain##4##3##(2006-10#1)(2009-10#1)(2010-12#1)(2012-1#1)
on the palm##2##3##(2007-12#1)(2010-12#1)
on the pancreatic##2##3##(1996-12#1)(1996-6#1)
on the panel##3##3##(2008-2#1)(2009-9#2)
on the paper##2##3##(2008-2#1)(2008-3#1)
on the parameters of the##5##5##(1993-3#1)(2008-10#2)(2009-10#1)(2011-2#1)
on the parameters of##8##4##(1993-3#1)(2005-10#1)(2006-4#1)(2008-10#2)(2009-10#1)(2011-2#1)(2013-8#1)
on the parameters##13##3##(1990-10#1)(1990-11#1)(1993-3#1)(1995-9#1)(2005-10#1)(2006-4#1)(2008-10#2)(2009-10#2)(2009-5#1)(2011-2#1)(2013-8#1)
on the parasite##3##3##(1997-7#1)(2006-10#1)(2012-2#1)
on the parasites of##2##4##(2013-1#2)
on the parents##3##3##(1992-4#1)(1993-7#1)(2013-1#1)
on the parhelic circle##3##4##(2008-3#3)
on the parietal cells##2##4##(1992-6#1)(1993-6#1)
on the parietal##3##3##(1992-6#1)(1993-6#1)(2008-10#1)
on the part of the##17##5##(1990-11#1)(1990-12#1)(1993-10#1)(1995-2#1)(1995-5#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-5#1)(2012-12#1)
on the part of##36##4##(1990-11#1)(1990-12#1)(1992-1#2)(1992-3#1)(1993-10#1)(1994-1#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-5#2)(1996-12#1)(1997-3#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
on the part##37##3##(1990-11#1)(1990-12#1)(1991-4#1)(1992-1#2)(1992-3#1)(1993-10#1)(1994-1#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-5#2)(1996-12#1)(1997-3#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
on the partial##2##3##(1990-2#1)(2008-10#1)
on the partially##3##3##(1990-5#1)(1995-9#1)(2008-5#1)
on the particle size##6##4##(1997-2#1)(2005-11#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-8#1)
on the particle surface##3##4##(2005-11#1)(2007-8#1)(2008-10#1)
on the particle##13##3##(1992-2#1)(1997-2#1)(2005-11#2)(2007-8#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-4#1)(2011-2#1)(2013-8#1)
on the particles##3##3##(1997-2#1)(2008-10#2)
on the particular##9##3##(1996-6#1)(2004-4#1)(2005-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)
on the partition of##2##4##(1992-7#1)(2008-11#1)
on the partition##3##3##(1992-7#1)(2008-11#1)(2008-6#1)
on the partitioning##2##3##(2008-10#2)
on the passage##2##3##(1995-2#1)(2008-9#1)
on the passive electrical properties of isolated guinea pig ventricular myocytes##2##11##(1991-2#2)
on the passive##3##3##(1991-2#2)(2010-12#1)
on the past##4##3##(2006-4#1)(2008-12#1)(2008-4#1)(2012-12#1)
on the patella##2##3##(2006-11#2)
on the path to##3##4##(1990-9#1)(1996-3#1)(2011-2#1)
on the path##5##3##(1990-9#1)(1996-3#1)(2008-3#2)(2011-2#1)
on the pathogen in##2##4##(2008-10#2)
on the pathogen##6##3##(2008-10#5)(2008-9#1)
on the pathogenesis of the##2##5##(1996-12#1)(2008-8#1)
on the pathogenesis of##19##4##(1991-7#1)(1994-7#1)(1996-11#1)(1996-12#1)(1996-6#1)(2006-12#1)(2006-2#1)(2006-6#1)(2008-1#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
on the pathogenesis##20##3##(1991-7#1)(1994-7#1)(1996-11#1)(1996-12#1)(1996-6#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2008-1#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
on the pathogenic##3##3##(1991-7#1)(2008-4#1)(2011-1#1)
on the pathogenicity##2##3##(2008-10#1)(2008-11#1)
on the pathological##5##3##(1997-3#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-6#1)
on the pathology and##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
on the pathomechanics##2##3##(2007-7#1)(2007-8#1)
on the pathophysiological##2##3##(1997-3#1)(2008-7#1)
on the pathophysiology and##2##4##(2006-10#1)(2008-9#1)
on the pathophysiology of the##2##5##(2006-6#1)(2009-4#1)
on the pathophysiology of##8##4##(1993-9#1)(2006-10#1)(2006-6#1)(2007-6#1)(2008-4#1)(2009-4#1)(2010-12#1)(2013-8#1)
on the pathophysiology##13##3##(1993-9#1)(2006-10#2)(2006-6#1)(2007-6#1)(2008-4#2)(2008-9#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
on the patient and##2##4##(1996-6#1)(2006-7#1)
on the patient##19##3##(1990-11#1)(1993-2#1)(1994-2#1)(1995-2#1)(1996-6#1)(2006-12#2)(2006-6#1)(2006-7#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-2#1)(2010-5#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#1)
on the patient's symptoms and the##2##6##(1991-6#1)(2007-12#1)
on the patient's##31##3##(1990-8#1)(1991-6#1)(1992-4#1)(1994-3#1)(1995-4#1)(1996-9#1)(1997-1#1)(2005-10#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
on the patients with##2##4##(2008-5#1)(2011-2#1)
on the patients##7##3##(1990-2#1)(2005-12#1)(2006-10#1)(2008-5#1)(2009-10#1)(2011-2#1)(2012-1#1)
on the patients'##4##3##(1991-2#1)(2007-11#1)(2009-1#1)(2011-2#1)
on the pattern of the##2##5##(1995-7#1)(2012-1#1)
on the pattern of##8##4##(1991-12#1)(1995-7#1)(2007-7#1)(2008-1#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-1#1)
on the pattern##11##3##(1991-12#1)(1991-8#1)(1995-7#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-1#1)
on the patterns##2##3##(2008-2#1)(2012-2#1)
on the peak shape##2##4##(1996-8#1)(2008-10#1)
on the peak##6##3##(1996-8#1)(2007-10#1)(2008-10#4)
on the pelvis##3##3##(2012-1#2)(2013-1#1)
on the penetration##2##3##(2008-3#1)(2008-8#1)
on the penis and##2##4##(2005-7#1)(2007-7#1)
on the peptide##4##3##(1991-5#1)(1993-5#1)(1995-3#1)(1996-5#1)
on the perceived usefulness##4##4##(2013-1#4)
on the perceived##11##3##(2004-11#1)(2008-2#1)(2008-8#1)(2011-2#1)(2013-1#5)(2013-7#2)
on the percent##3##3##(2008-10#3)
on the percentage of##12##4##(1995-5#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-4#1)(2010-4#2)(2011-2#2)
on the perception of##4##4##(2010-2#1)(2012-3#1)(2013-8#2)
on the perception##6##3##(1991-2#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-8#2)
on the percutaneous##3##3##(1990-4#1)(2011-3#2)
on the performance of a heavily##2##6##(2007-12#2)
on the performance of a##8##5##(2007-12#2)(2008-2#1)(2008-3#4)(2009-11#1)
on the performance of an optical##2##6##(2008-10#1)(2008-2#1)
on the performance of the##8##5##(1991-2#1)(1992-12#1)(1992-2#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-6#1)
on the performance of their##2##5##(2008-5#2)
on the performance of##48##4##(1991-2#1)(1992-11#2)(1992-12#1)(1992-2#1)(1994-1#2)(1994-10#1)(1996-5#1)(2007-11#2)(2007-12#4)(2007-6#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-2#8)(2008-3#9)(2008-5#2)(2008-6#1)(2009-11#2)(2011-2#1)(2013-1#1)
on the performance##49##3##(1991-2#1)(1992-11#2)(1992-12#1)(1992-2#1)(1994-1#2)(1994-10#1)(1996-5#1)(2007-11#2)(2007-12#4)(2007-6#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#9)(2008-5#2)(2008-6#1)(2009-11#2)(2011-2#1)(2013-1#1)
on the performances of the##2##5##(2008-10#2)
on the perineum##2##3##(2008-7#2)
on the period of##4##4##(2008-10#1)(2008-2#1)(2013-1#2)
on the period##7##3##(2008-10#1)(2008-2#2)(2010-6#1)(2013-1#3)
on the periodontal##3##3##(1996-2#1)(2008-1#1)(2012-3#1)
on the peripheral##4##3##(2007-11#1)(2008-10#1)(2011-2#1)(2012-3#1)
on the periphery of the##2##5##(1994-3#1)(2008-9#1)
on the periphery of##4##4##(1994-3#1)(2007-12#1)(2008-5#1)(2008-9#1)
on the periphery##6##3##(1994-3#1)(2007-12#1)(2008-12#1)(2008-5#1)(2008-9#1)(2013-7#1)
on the permeability##4##3##(1990-11#1)(1992-11#1)(1992-7#1)(2006-10#1)
on the permeation profile of flavonoids##2##6##(2008-5#2)
on the permeation##3##3##(2008-10#1)(2008-5#2)
on the peroxidase##2##3##(2008-10#2)
on the persistence##2##3##(2008-8#1)(2013-8#1)
on the personal##4##3##(1992-10#1)(2008-11#1)(2008-2#1)(2009-7#1)
on the perspective of##3##4##(2008-1#1)(2008-12#1)(2010-10#1)
on the phagocytosis of##3##4##(1992-5#1)(1992-6#1)(1994-3#1)
on the pharmacokinetic##2##3##(2011-2#1)(2013-8#1)
on the pharmacokinetics of YH439 and its metabolites in rats##2##10##(2008-11#2)
on the pharmacokinetics of##9##4##(1990-3#1)(1991-12#2)(1994-3#1)(2008-11#2)(2008-8#1)(2010-12#1)(2011-2#1)
on the pharmacokinetics##16##3##(1990-1#1)(1990-3#3)(1991-12#2)(1994-3#1)(2007-9#1)(2008-11#2)(2008-8#2)(2009-2#1)(2010-12#1)(2011-2#1)(2012-3#1)
on the pharmacological##5##3##(2005-8#1)(2007-11#1)(2008-5#1)(2012-12#2)
on the pharmacology and##2##4##(1991-2#1)(2006-10#1)
on the pharmacology##3##3##(1991-2#1)(2005-7#1)(2006-10#1)
on the phase behavior of##3##5##(1990-2#1)(2005-11#1)(2010-4#1)
on the phase behavior##5##4##(1990-2#1)(2005-11#2)(2008-12#1)(2010-4#1)
on the phase of##2##4##(2008-12#1)(2010-12#1)
on the phase##15##3##(1990-2#1)(1992-6#1)(2005-11#2)(2005-7#1)(2007-12#2)(2007-8#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-4#1)
on the phenomenology of##3##4##(2005-7#1)(2008-11#1)(2010-6#1)
on the phenomenon of##2##4##(2008-2#1)(2008-9#1)
on the phenomenon##4##3##(1993-6#1)(2008-10#1)(2008-2#1)(2008-9#1)
on the phenotype of##3##4##(1995-2#1)(1995-8#1)(2012-2#1)
on the phenotype##5##3##(1995-2#1)(1995-8#1)(2008-6#1)(2012-2#2)
on the phenotypes of##2##4##(1991-7#1)(2008-4#1)
on the phenotypes##3##3##(1991-7#1)(2008-4#1)(2008-8#1)
on the phenyl ring##3##4##(1993-4#1)(2007-10#1)(2008-10#1)
on the phosphatase activity##2##4##(1997-2#1)(2008-9#1)
on the phosphate##2##3##(2008-10#1)(2010-10#1)
on the phospholipid composition in##3##5##(1992-1#2)(1992-3#1)
on the phospholipid##5##3##(1992-1#2)(1992-3#2)(2008-10#1)
on the phosphorylation of##4##4##(1990-8#1)(1994-12#1)(1997-6#2)
on the phosphorylation state of##5##5##(1994-6#1)(1994-9#2)(1997-2#1)(1997-6#1)
on the phosphorylation##11##3##(1990-8#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#2)(1995-1#1)(1997-2#1)(1997-6#3)
on the phosphotyrosine##2##3##(1994-9#1)(1996-9#1)
on the photochemical##2##3##(2008-10#1)(2008-11#1)
on the photodetector##2##3##(2008-2#1)(2008-3#1)
on the photodynamics of bacteriorhodopsin##2##5##(1990-2#2)
on the photorefractive##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
on the photosynthetic##2##3##(2008-10#2)
on the physical and##2##4##(1991-2#1)(1997-1#1)
on the physical characteristics of the##3##6##(1990-9#1)(1992-2#1)(1996-3#1)
on the physical characteristics of##4##5##(1990-9#1)(1992-2#1)(1996-3#1)(2008-7#1)
on the physical map of##3##5##(1995-6#1)(1997-6#1)(1997-8#1)
on the physical map##4##4##(1995-6#1)(1997-6#1)(1997-8#1)(1997-9#1)
on the physical properties of the##3##6##(2008-2#1)(2008-5#1)(2013-1#1)
on the physical properties of##6##5##(1991-1#1)(1993-11#1)(2008-2#1)(2008-5#1)(2013-1#1)(2013-7#1)
on the physical stability of##2##5##(2007-5#1)(2013-7#1)
on the physical state##2##4##(1991-7#1)(2008-5#1)
on the physical##31##3##(1990-5#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-7#1)(1992-2#1)(1993-11#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-6#1)(1997-8#1)(1997-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-5#1)(2007-9#1)(2008-12#1)(2008-2#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-4#1)(2012-2#2)(2013-1#1)(2013-7#2)
on the physician##3##3##(1995-9#1)(2009-6#1)(2012-2#1)
on the physico-chemical properties of the##2##6##(1992-6#1)(2008-5#1)
on the physico-chemical properties of##3##5##(1992-6#1)(2004-9#1)(2008-5#1)
on the physico-chemical##4##3##(1992-6#1)(2004-9#1)(2008-10#1)(2008-5#1)
on the physiological mechanisms##2##4##(2008-1#1)(2008-11#1)
on the physiological##11##3##(1992-1#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-11#2)(2008-7#2)(2009-8#1)(2012-3#1)(2013-1#1)
on the physiology and##2##4##(2007-1#1)(2009-8#1)
on the physiology of the##2##5##(1993-2#1)(2011-1#1)
on the physiology of##4##4##(1993-2#1)(2007-11#1)(2009-3#1)(2011-1#1)
on the physiology##7##3##(1993-2#1)(2007-1#1)(2007-11#1)(2008-10#1)(2009-3#1)(2009-8#1)(2011-1#1)
on the picosecond time scale##3##5##(1995-1#2)(2006-3#1)
on the pineal gland##2##4##(1994-2#1)(1995-3#1)
on the pituitary##2##3##(2006-1#1)(2011-1#1)
on the place of##2##4##(2008-2#1)(2008-6#1)
on the place##3##3##(2008-2#2)(2008-6#1)
on the plain film##2##4##(2007-11#2)
on the planet##2##3##(1995-9#1)(2012-12#1)
on the planning and##2##4##(1993-12#1)(1996-2#1)
on the planning##3##3##(1993-12#1)(1996-2#1)(2011-2#1)
on the plant leaf##3##4##(2013-8#3)
on the plant species##2##4##(2008-10#1)(2008-6#1)
on the plant surface##3##4##(2008-10#1)(2008-8#1)(2009-8#1)
on the plant##16##3##(1991-3#1)(1992-3#1)(2007-12#1)(2008-10#4)(2008-6#1)(2008-8#2)(2009-8#3)(2013-8#3)
on the plasma concentration of##3##5##(2006-7#1)(2013-8#2)
on the plasma membrane and##2##5##(1997-4#1)(2005-8#1)
on the plasma membrane of the##4##6##(1994-11#1)(1994-8#1)(2008-8#2)
on the plasma membrane of##9##5##(1990-7#1)(1993-3#1)(1994-11#1)(1994-8#1)(1997-1#1)(1997-4#1)(2008-8#2)(2010-7#1)
on the plasma membrane##19##4##(1990-7#1)(1992-4#1)(1993-3#2)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-6#1)(1995-7#1)(1997-1#2)(1997-4#2)(2005-8#1)(2008-4#1)(2008-8#2)(2010-7#1)
on the plasma##29##3##(1990-7#1)(1991-12#1)(1992-4#1)(1992-9#1)(1993-3#2)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-6#1)(1995-7#1)(1996-12#1)(1997-1#2)(1997-4#2)(2005-8#1)(2006-7#1)(2008-10#2)(2008-4#1)(2008-8#2)(2010-4#1)(2010-7#1)(2012-2#1)(2013-8#2)
on the plasmid##3##3##(1996-4#1)(1996-7#1)(2008-9#1)
on the plastic##2##3##(2005-11#1)(2013-1#1)
on the plate##5##3##(2005-10#1)(2007-8#1)(2008-10#2)(2012-3#1)
on the plateau##2##3##(1996-3#1)(2005-11#1)
on the platelet surface and##2##5##(1990-5#1)(2006-6#1)
on the platelet surface##4##4##(1990-5#1)(1994-12#1)(1996-7#1)(2006-6#1)
on the platelet##6##3##(1990-5#1)(1993-6#1)(1994-12#1)(1996-7#1)(2006-6#1)(2007-11#1)
on the plates##2##3##(2008-10#1)(2008-11#1)
on the point-spread function##3##4##(2008-2#1)(2008-3#2)
on the polar##2##3##(1994-5#1)(2008-11#1)
on the polarity of##2##4##(2008-5#1)(2012-12#1)
on the polarization direction of##2##5##(2008-3#2)
on the polarization of the incident##2##6##(2007-11#1)(2008-3#1)
on the polarization of##4##4##(2007-11#1)(2008-3#3)
on the polarization state of the incident##2##7##(2008-2#1)(2008-3#1)
on the polarization state of##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
on the polarization##14##3##(2007-11#2)(2007-12#3)(2008-2#3)(2008-3#6)
on the polarized##2##3##(2008-2#1)(2008-3#1)
on the poling##2##3##(2007-12#2)
on the polymer surface##2##4##(2008-10#1)(2008-5#1)
on the polymer##10##3##(2005-11#3)(2008-10#4)(2008-5#1)(2013-1#2)
on the polymerase##8##3##(1991-12#1)(1991-2#1)(1993-10#1)(1993-5#1)(1993-7#1)(1993-8#1)(2008-10#2)
on the polymerization##2##3##(2005-11#1)(2008-5#1)
on the population density##2##4##(2007-2#1)(2008-10#1)
on the population dynamics of##3##5##(1994-8#1)(2008-11#1)(2010-12#1)
on the population dynamics##5##4##(1994-8#1)(2008-11#1)(2008-8#1)(2010-12#1)(2013-8#1)
on the population level##3##4##(2010-12#1)(2011-1#1)(2012-2#1)
on the population of##3##4##(1992-7#1)(2008-10#1)(2008-5#1)
on the population structure and##2##5##(2008-10#1)(2008-5#1)
on the population structure of##2##5##(2008-10#1)(2013-8#1)
on the population structure##4##4##(2008-10#2)(2008-5#1)(2013-8#1)
on the population##29##3##(1991-6#1)(1992-7#1)(1994-8#1)(2005-11#1)(2007-2#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-6#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
on the position of the desired image##2##7##(2008-3#2)
on the position of the##9##5##(1991-10#1)(1997-1#1)(2007-11#2)(2008-2#2)(2008-3#2)(2009-5#1)
on the position of##10##4##(1991-10#1)(1997-1#1)(2007-11#2)(2008-2#2)(2008-3#2)(2009-5#1)(2010-2#1)
on the position##11##3##(1991-10#1)(1997-1#1)(2005-10#1)(2007-11#2)(2008-2#2)(2008-3#2)(2009-5#1)(2010-2#1)
on the positions##2##3##(1997-4#1)(2008-3#1)
on the positive and negative##2##5##(2007-8#2)
on the positive and##3##4##(1990-10#1)(2007-8#2)
on the positive inotropic##3##4##(1993-11#1)(1997-7#2)
on the positive##13##3##(1990-10#1)(1993-1#1)(1993-11#1)(1997-7#2)(1997-8#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-4#1)(2008-8#1)(2012-12#1)
on the possibilities of##2##4##(1991-2#1)(2008-6#1)
on the possibilities##5##3##(1991-2#1)(2007-11#1)(2008-11#1)(2008-6#1)(2012-2#1)
on the possibility of##4##4##(2007-3#2)(2007-8#1)(2008-11#1)
on the possibility that##3##4##(2008-1#1)(2008-4#1)(2011-1#1)
on the possibility##7##3##(2007-3#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2011-1#1)
on the possible role of##3##5##(2007-7#1)(2008-1#1)(2013-7#1)
on the possible##22##3##(1990-6#1)(1991-5#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-6#1)(2005-8#1)(2006-10#2)(2006-8#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-11#1)(2010-3#1)(2012-2#1)(2013-7#1)(2013-8#2)
on the posterior##11##3##(1991-6#1)(1993-1#1)(1994-11#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-7#1)(2007-8#1)(2009-9#1)(2010-5#1)(2013-1#1)
on the postnatal##3##3##(1991-4#1)(1993-12#1)(2012-2#1)
on the postoperative##3##3##(2011-2#1)(2013-1#2)
on the postsynaptic membrane of##2##5##(1996-8#1)(1997-5#1)
on the postsynaptic##3##3##(1996-8#1)(1997-5#1)(1997-7#1)
on the potency##2##3##(1996-8#1)(2006-5#1)
on the potential energy surface for##2##6##(2006-3#2)
on the potential for##2##4##(2005-8#1)(2008-11#1)
on the potential health##2##4##(2007-11#1)(2007-8#1)
on the potential impact of##2##5##(2013-8#2)
on the potential impact##3##4##(2012-3#1)(2013-8#2)
on the potential of##5##4##(2006-11#1)(2007-9#1)(2008-11#1)(2011-1#1)(2012-12#1)
on the potential response of the##2##6##(2008-10#2)
on the potential response of##3##5##(2008-10#3)
on the potential role of##4##5##(2006-10#1)(2008-1#1)(2008-5#1)(2012-12#1)
on the potential##38##3##(1990-5#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#4)(2008-5#1)(2008-8#1)(2010-3#1)(2011-1#1)(2011-3#1)(2012-12#2)(2012-3#1)(2013-7#1)(2013-8#2)
on the potentiometric selectivity##2##4##(2008-10#2)
on the potentiometric##4##3##(2007-8#1)(2008-10#2)(2010-5#1)
on the powder##2##3##(2004-9#2)
on the power of##4##4##(1996-2#1)(2007-12#1)(2008-11#1)(2008-2#1)
on the power##9##3##(1992-6#1)(1996-2#1)(2007-12#1)(2008-11#1)(2008-2#3)(2008-8#1)(2010-10#1)
on the powerful##3##3##(2008-3#1)(2008-4#1)(2011-2#1)
on the practical aspects of##2##5##(2008-11#1)(2010-3#1)
on the practical implications of using##2##6##(2008-11#1)(2008-4#1)
on the practical##5##3##(2007-11#1)(2008-11#2)(2008-4#1)(2010-3#1)
on the practice of medicine##2##5##(1991-2#1)(2007-4#1)
on the practice of##6##4##(1991-2#1)(1991-6#1)(2007-4#1)(2007-7#1)(2008-11#2)
on the practice##7##3##(1991-2#1)(1991-6#1)(2007-4#1)(2007-7#1)(2008-11#3)
on the pre-column##2##3##(1997-3#1)(2008-10#1)
on the precipitation##3##3##(2008-10#2)(2008-7#1)
on the precise##3##3##(1994-10#1)(2012-12#2)
on the precision of##2##4##(2008-10#1)(2012-11#1)
on the precision##4##3##(2008-10#3)(2012-11#1)
on the preclinical##3##3##(2007-5#1)(2008-10#1)(2008-5#1)
on the preconcentration of##2##4##(2008-10#2)
on the preconcentration##4##3##(2008-10#4)
on the precursor##2##3##(2005-11#1)(2008-9#1)
on the predicted##6##3##(1995-3#1)(1995-5#1)(2005-11#1)(2006-11#2)(2010-7#1)
on the prediction of##2##4##(1993-12#1)(1993-5#1)
on the prediction##5##3##(1993-12#1)(1993-5#1)(2008-10#2)(2012-2#1)
on the predictive##2##3##(1992-2#1)(2008-10#1)
on the predictors##2##3##(1993-1#1)(2012-2#1)
on the preferential localization of##2##5##(1994-2#1)(1995-12#1)
on the preliminary##2##3##(2006-2#1)(2008-11#1)
on the premise that##9##4##(1992-3#1)(2006-3#1)(2006-8#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-8#1)(2013-1#1)
on the preoperative##4##3##(2009-3#1)(2011-2#1)(2012-12#2)
on the preparation of##4##4##(2006-12#1)(2008-2#1)(2008-5#1)(2012-3#1)
on the preparation##5##3##(2006-12#1)(2007-9#1)(2008-2#1)(2008-5#1)(2012-3#1)
on the prescribed##2##3##(2007-4#1)(2008-10#1)
on the presence and##3##4##(1991-1#1)(1997-8#1)(2008-10#1)
on the presence in##2##4##(1990-5#1)(1993-8#1)
on the presence of a##5##5##(1991-9#1)(1993-9#1)(1997-1#1)(2005-8#1)(2007-12#1)
on the presence of both##2##5##(1993-2#1)(1994-12#1)
on the presence of bound##2##5##(1992-8#1)(1995-8#1)
on the presence of extracellular Ca2+##2##6##(1991-5#1)(1994-6#1)
on the presence of extracellular calcium##2##6##(1991-5#1)(1993-12#1)
on the presence of extracellular##5##5##(1991-5#2)(1992-3#1)(1993-12#1)(1994-6#1)
on the presence of healthy##2##5##(2008-10#1)(2011-2#1)
on the presence of the##9##5##(1990-11#1)(1990-8#1)(1991-3#1)(1994-12#1)(1995-2#1)(1996-4#1)(2006-12#1)(2008-4#1)(2009-2#1)
on the presence of##112##4##(1990-1#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-8#2)(1991-2#3)(1991-3#3)(1991-5#3)(1991-8#2)(1991-9#3)(1992-1#2)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-2#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#2)(2013-8#1)
on the presence or absence of##8##6##(1992-7#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-8#1)(2010-7#1)
on the presence or##9##4##(1992-7#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-8#1)(2010-7#1)
on the presence##126##3##(1990-1#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-8#2)(1991-1#1)(1991-2#3)(1991-3#3)(1991-5#3)(1991-8#2)(1991-9#3)(1992-1#2)(1992-11#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#2)(2005-12#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#10)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#1)(2009-2#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#2)(2013-8#1)
on the present evidence##2##4##(1994-2#1)(2006-8#1)
on the present situation##2##4##(2006-6#1)(2008-1#1)
on the present##12##3##(1994-2#1)(1997-2#1)(2006-6#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-11#2)(2009-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
on the presentation of##3##4##(1992-9#1)(1996-2#1)(2008-8#1)
on the pressor response to big##2##6##(1991-6#1)(1995-1#1)
on the pressor response to##3##5##(1991-6#1)(1992-8#1)(1995-1#1)
on the pressor response##4##4##(1991-6#1)(1992-8#2)(1995-1#1)
on the pressor##5##3##(1991-6#1)(1992-8#2)(1995-1#1)(1997-2#1)
on the pressure##5##3##(1991-2#1)(2006-12#1)(2008-2#1)(2010-2#1)(2010-9#1)
on the prevalence and##7##4##(2007-6#1)(2007-7#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#2)
on the prevalence of metabolic syndrome##2##6##(2008-3#2)
on the prevalence of obesity##2##5##(2012-2#1)(2013-1#1)
on the prevalence of the##2##5##(2008-1#1)(2008-3#1)
on the prevalence of##32##4##(1991-11#1)(1991-4#1)(1996-7#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#3)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#3)
on the prevalence##39##3##(1991-11#1)(1991-4#1)(1996-7#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#4)(2008-5#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#4)(2013-1#1)(2013-8#3)
on the prevention and management of##3##6##(1996-1#1)(2008-7#1)(2009-4#1)
on the prevention and##5##4##(1996-1#1)(2008-7#1)(2009-4#1)(2010-5#1)(2013-1#1)
on the prevention of cervical cancer##2##6##(2011-1#2)
on the prevention of##15##4##(1994-8#1)(2004-2#1)(2006-10#3)(2007-2#1)(2007-7#1)(2008-4#1)(2009-3#1)(2011-1#3)(2011-12#1)(2012-12#1)(2013-8#1)
on the prevention##20##3##(1994-8#1)(1996-1#1)(2004-2#1)(2006-10#3)(2007-2#1)(2007-7#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-4#1)(2010-5#1)(2011-1#3)(2011-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
on the previous##6##3##(1992-3#1)(2005-4#1)(2005-8#1)(2007-11#1)(2010-5#1)(2012-2#1)
on the prey##2##3##(2008-9#1)(2012-3#1)
on the primary and##3##4##(1992-6#1)(2008-10#1)(2008-2#1)
on the primary##15##3##(1990-12#1)(1990-4#1)(1992-6#1)(2006-5#1)(2007-5#1)(2007-6#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-8#1)(2009-11#1)
on the principal##3##3##(2008-10#1)(2010-11#1)(2012-1#1)
on the principle of##13##4##(1996-1#2)(2005-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-7#1)(2011-1#1)(2012-12#1)
on the principle that##5##4##(1994-2#1)(1994-9#1)(2008-4#2)(2012-10#1)
on the principle##19##3##(1994-2#1)(1994-9#1)(1996-1#2)(2005-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#2)(2008-7#1)(2011-1#1)(2012-10#1)(2012-12#1)
on the principles of##9##4##(1991-2#1)(1992-12#1)(1996-12#1)(2006-6#1)(2007-5#1)(2008-10#1)(2012-1#2)(2013-1#1)
on the principles##12##3##(1991-2#1)(1992-12#1)(1996-12#1)(2006-6#1)(2007-5#1)(2008-10#1)(2009-3#1)(2010-6#1)(2011-1#1)(2012-1#2)(2013-1#1)
on the prior##2##3##(1997-2#1)(2008-8#1)
on the pro-R oxygen##2##4##(1996-7#2)
on the probability of##6##4##(1993-8#1)(1994-6#1)(1996-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
on the probability##7##3##(1993-8#1)(1994-6#1)(1996-7#1)(2008-8#1)(2011-2#1)(2013-1#2)
on the probable##3##3##(2007-5#1)(2008-3#1)(2009-6#1)
on the problem of##9##4##(1994-2#1)(1995-5#1)(1996-3#1)(2007-2#1)(2008-11#1)(2009-2#1)(2009-5#1)(2010-4#1)(2012-1#1)
on the problem##11##3##(1994-2#1)(1995-5#1)(1996-3#1)(2006-2#1)(2007-2#2)(2008-11#1)(2009-2#1)(2009-5#1)(2010-4#1)(2012-1#1)
on the problems of##2##4##(1993-9#1)(2006-10#1)
on the problems##6##3##(1990-2#1)(1993-9#1)(2005-8#1)(2006-10#1)(2008-4#1)(2008-8#1)
on the procedure of##2##4##(1996-8#1)(2008-7#1)
on the procedure##3##3##(1996-8#1)(2008-10#1)(2008-7#1)
on the process by##2##4##(2006-10#1)(2007-4#1)
on the process of care##3##5##(1996-3#1)(1997-1#1)(2008-3#1)
on the process of##17##4##(1990-3#1)(1991-5#1)(1996-3#1)(1997-1#1)(2006-10#1)(2006-3#1)(2006-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2011-2#1)
on the process##23##3##(1990-3#1)(1991-5#1)(1994-12#1)(1995-3#1)(1996-3#1)(1997-1#1)(2006-10#2)(2006-3#1)(2006-5#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2011-2#1)(2013-8#1)
on the processes of##3##4##(2008-10#1)(2012-2#1)(2012-3#1)
on the processes##8##3##(1992-12#1)(1993-7#1)(2006-10#1)(2008-10#1)(2012-2#1)(2012-3#2)(2013-1#1)
on the processing of##4##4##(1991-6#1)(1996-6#2)(2008-9#1)
on the processing##5##3##(1991-6#1)(1996-6#2)(2008-9#1)(2010-4#1)
on the product##5##3##(1991-5#1)(1997-3#1)(2008-11#1)(2008-2#1)(2012-12#1)
on the production and##6##4##(1991-1#1)(2008-10#2)(2010-12#1)(2012-3#1)(2013-1#1)
on the production of osteocalcin##2##5##(1990-2#1)(1991-3#1)
on the production of recombinant##2##5##(2008-11#2)
on the production of##28##4##(1990-11#1)(1990-2#1)(1991-3#1)(1993-2#1)(1994-2#1)(1994-3#2)(1995-10#1)(1997-4#1)(2006-8#1)(2006-9#1)(2008-10#2)(2008-11#3)(2008-12#3)(2008-5#5)(2008-6#1)(2010-6#1)(2011-2#2)
on the production##37##3##(1990-11#1)(1990-2#1)(1991-1#1)(1991-3#1)(1993-2#1)(1994-2#1)(1994-3#2)(1995-10#1)(1997-4#1)(2006-8#1)(2006-9#1)(2008-10#4)(2008-11#3)(2008-12#3)(2008-5#6)(2008-6#1)(2008-7#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
on the professional##3##3##(1990-10#1)(1993-3#1)(2010-12#1)
on the profile of##3##4##(1994-9#1)(2008-3#1)(2010-3#1)
on the prognosis of##4##4##(1996-3#1)(2007-10#1)(2007-11#1)(2007-4#1)
on the progress of##3##4##(2007-11#1)(2008-12#1)(2010-8#1)
on the progress##5##3##(2005-7#1)(2007-11#1)(2008-12#1)(2010-8#1)(2012-3#1)
on the progression of the##2##5##(1993-11#1)(2007-11#1)
on the progression of##5##4##(1993-11#1)(1994-3#1)(2007-11#1)(2008-5#1)(2008-7#1)
on the progressive##2##3##(1997-5#1)(2010-8#1)
on the project##3##3##(2007-5#1)(2007-9#1)(2008-11#1)
on the proliferation and differentiation of##2##6##(1995-10#1)(2012-12#1)
on the proliferation and differentiation##3##5##(1995-10#1)(1995-2#1)(2012-12#1)
on the proliferation and invasion of hepatoma cells in culture##2##10##(2008-11#2)
on the proliferation and invasion of##5##6##(2008-11#5)
on the proliferation and##10##4##(1995-10#1)(1995-2#1)(2008-11#5)(2011-2#1)(2012-12#2)
on the proliferation of esophageal cancer##2##6##(2012-2#2)
on the proliferation of human##5##5##(1991-9#1)(1994-3#1)(2008-11#1)(2008-5#1)(2008-8#1)
on the proliferation of osteoblastic MC3T3-E1 cells##2##7##(1991-12#2)
on the proliferation of osteoblastic##3##5##(1991-12#2)(1991-8#1)
on the proliferation of the##3##5##(2008-11#2)(2008-3#1)
on the proliferation of three human breast cancer cell lines that differed in their estrogen receptor contents##2##17##(2008-11#2)
on the proliferation of##30##4##(1990-12#2)(1990-7#1)(1991-12#2)(1991-8#1)(1991-9#1)(1994-11#1)(1994-3#2)(1995-1#1)(1995-5#1)(2005-9#1)(2008-11#6)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-1#1)(2011-2#1)(2012-2#3)(2013-8#1)
on the proliferation##42##3##(1990-12#2)(1990-7#1)(1991-12#2)(1991-8#1)(1991-9#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#2)(1995-1#1)(1995-10#1)(1995-2#1)(1995-5#1)(2005-9#1)(2008-11#11)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-1#1)(2011-2#2)(2012-12#2)(2012-2#3)(2013-8#1)
on the proliferative##2##3##(1994-12#1)(1994-8#1)
on the promoter region of##2##5##(2009-4#1)(2009-8#1)
on the promoter##6##3##(1993-12#2)(1995-3#1)(1995-6#1)(2009-4#1)(2009-8#1)
on the promotion of##5##4##(2007-3#1)(2007-8#1)(2008-9#1)(2010-10#1)(2012-12#1)
on the propagation of intense##2##5##(2007-12#2)
on the propagation of##4##4##(2005-11#1)(2007-12#3)
on the propagation##8##3##(2005-11#1)(2007-12#3)(2008-2#2)(2008-3#2)
on the propensity##2##3##(1997-4#1)(2006-1#1)
on the proper use of##2##5##(2007-4#1)(2010-9#1)
on the proper##7##3##(1991-3#1)(2007-11#1)(2007-12#1)(2007-4#1)(2010-9#1)(2012-2#1)(2012-3#1)
on the properties of a##2##5##(2008-5#1)(2013-8#1)
on the properties of the##6##5##(1997-3#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-5#1)
on the properties of##26##4##(1990-5#1)(1990-8#1)(1991-4#1)(1991-5#1)(1993-12#1)(1993-9#1)(1994-2#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-3#1)(2005-11#2)(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)(2008-5#3)(2009-5#1)(2012-3#1)(2013-8#1)
on the properties##28##3##(1990-5#1)(1990-8#1)(1991-4#1)(1991-5#1)(1993-12#1)(1993-9#1)(1994-2#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-3#1)(2005-11#3)(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)(2008-5#3)(2008-8#1)(2009-5#1)(2012-3#1)(2013-8#1)
on the prophylactic##2##3##(1992-11#1)(2008-5#1)
on the proportion of similar responses##2##6##(1996-7#2)
on the proportion of##8##4##(1996-1#1)(1996-7#2)(2007-7#1)(2008-10#3)(2012-2#1)
on the proportion##9##3##(1996-1#1)(1996-7#2)(2007-7#1)(2008-10#4)(2012-2#1)
on the proposed##8##3##(1993-8#1)(1996-1#1)(2008-10#2)(2008-3#1)(2010-8#1)(2012-1#1)(2012-2#1)
on the protease activity##2##4##(1996-9#1)(2011-2#1)
on the proteasome##3##3##(1996-2#1)(2008-1#1)(2009-7#1)
on the protection and##3##4##(1997-1#1)(2010-9#2)
on the protection of workers from the risks related to exposure to asbestos at work##2##15##(2010-9#2)
on the protection of##6##4##(1990-2#1)(1991-10#1)(2007-10#1)(2009-4#1)(2010-9#2)
on the protection##9##3##(1990-2#1)(1991-10#1)(1997-1#1)(2007-10#1)(2009-4#1)(2010-9#4)
on the protein concentration##2##4##(2008-4#1)(2010-12#1)
on the protein expression of##2##5##(2008-12#1)(2013-8#1)
on the protein kinase C (PKC)##2##6##(1995-8#1)(1996-5#1)
on the protein kinase##3##4##(1995-8#1)(1996-5#1)(1997-2#1)
on the protein level##2##4##(2008-4#1)(2008-7#1)
on the protein surface##5##4##(1991-7#1)(1993-3#1)(1997-4#1)(2006-10#1)(2008-8#1)
on the protein tyrosine kinases##2##5##(1991-7#1)(1994-3#1)
on the protein tyrosine##3##4##(1991-7#1)(1992-8#1)(1994-3#1)
on the protein##33##3##(1990-2#1)(1991-7#3)(1991-8#2)(1992-8#1)(1993-3#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-8#2)(1996-5#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#4)(2008-7#2)(2008-8#1)(2010-12#1)(2010-4#1)(2013-8#1)
on the proteins##3##3##(2006-10#2)(2012-2#1)
on the proteome##2##3##(2008-4#1)(2011-3#1)
on the protonation##2##3##(2008-10#2)
on the provision of##6##4##(1994-2#1)(1995-2#1)(1996-5#1)(2007-10#1)(2008-11#1)(2011-1#1)
on the proximal##7##3##(1994-5#1)(1996-2#1)(2005-7#1)(2007-8#1)(2009-5#1)(2013-8#2)
on the psychological and##3##4##(1993-12#1)(2007-9#1)(2008-2#1)
on the psychological##9##3##(1990-8#1)(1993-12#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-7#1)(2012-2#1)
on the psychometric properties of the##2##6##(2009-9#1)(2011-2#1)
on the psychometric##5##3##(1990-3#1)(2006-9#1)(2009-9#1)(2011-2#2)
on the psychophysiological responses to imagined exercise##2##7##(1992-12#2)
on the psychosocial##2##3##(2006-2#1)(2008-1#1)
on the public health system##2##5##(1995-12#1)(2007-11#1)
on the public health##6##4##(1991-3#1)(1995-12#1)(2007-11#1)(2010-8#1)(2011-1#1)(2013-1#1)
on the public##7##3##(1991-3#1)(1995-12#1)(2004-9#1)(2007-11#1)(2010-8#1)(2011-1#1)(2013-1#1)
on the published##2##3##(2008-12#1)(2008-7#1)
on the pulse##8##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#1)(2012-2#1)
on the pump power##2##4##(2007-11#1)(2007-12#1)
on the pump##6##3##(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#1)
on the purification of##2##4##(1994-8#1)(2008-1#1)
on the purified##2##3##(1990-3#1)(1991-7#1)
on the purpose of##2##4##(1996-2#1)(2011-2#1)
on the purpose##3##3##(1996-2#1)(2008-9#1)(2011-2#1)
on the push-pull tracking-error signal##2##5##(2008-3#2)
on the push-pull##4##3##(2008-2#1)(2008-3#3)
on the putative##3##3##(1993-11#2)(2013-1#1)
on the qualitative##2##3##(2008-10#1)(2011-2#1)
on the quality and##4##4##(1992-2#1)(1993-12#1)(1997-1#1)(2012-2#1)
on the quality of care in##2##6##(1994-12#1)(2012-3#1)
on the quality of care##6##5##(1994-12#1)(2006-10#1)(2008-3#1)(2010-5#1)(2012-2#1)(2012-3#1)
on the quality of life and##4##6##(1991-12#1)(1992-1#1)(2007-7#1)(2011-2#1)
on the quality of life for##2##6##(2006-2#1)(2010-8#1)
on the quality of life of patients##2##7##(2007-11#1)(2008-11#1)
on the quality of life of##6##6##(1990-10#1)(2007-11#2)(2008-11#1)(2010-11#1)(2012-3#1)
on the quality of life##18##5##(1990-1#1)(1990-10#1)(1991-12#1)(1992-1#1)(1996-7#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-7#1)(2008-11#1)(2009-11#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
on the quality of non conventional poultry patties##2##8##(2010-4#2)
on the quality of patient##4##5##(2012-11#2)(2013-1#2)
on the quality of the interaction##2##6##(2008-10#1)(2009-7#1)
on the quality of the##17##5##(1990-3#1)(2006-6#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-3#2)(2009-2#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
on the quality of##63##4##(1990-1#1)(1990-10#1)(1990-3#1)(1991-11#1)(1991-12#1)(1992-1#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-7#1)(2006-10#2)(2006-2#2)(2006-6#1)(2007-11#4)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#5)(2009-11#1)(2009-2#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-4#3)(2010-5#1)(2010-8#1)(2011-2#2)(2012-11#2)(2012-2#3)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#2)
on the quality##70##3##(1990-1#1)(1990-10#1)(1990-3#1)(1991-11#1)(1991-12#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-7#1)(1997-1#1)(2006-10#2)(2006-2#2)(2006-6#1)(2007-11#4)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#5)(2009-11#1)(2009-2#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-4#3)(2010-5#1)(2010-8#1)(2011-2#2)(2012-11#2)(2012-2#4)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#2)
on the quantification of##2##4##(2008-10#1)(2008-3#1)
on the quantitative##8##3##(2007-9#1)(2008-10#1)(2009-12#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
on the quantity and##3##4##(2008-4#1)(2008-5#1)(2008-9#1)
on the quantity##4##3##(2008-4#1)(2008-5#1)(2008-9#1)(2009-9#1)
on the quartz##2##3##(2008-10#1)(2008-5#1)
on the quenching##4##3##(2008-10#3)(2013-8#1)
on the question of the##2##5##(1990-3#1)(1997-6#1)
on the question of##8##4##(1990-2#1)(1990-3#1)(1991-12#1)(1991-3#1)(1997-6#1)(2008-12#1)(2008-7#1)(2012-2#1)
on the question##9##3##(1990-2#1)(1990-3#1)(1991-12#1)(1991-3#1)(1997-6#1)(2008-12#1)(2008-7#1)(2011-12#1)(2012-2#1)
on the questionnaire in##2##4##(2008-11#1)(2008-9#1)
on the radial##3##3##(1993-2#1)(2008-2#1)(2011-12#1)
on the radiation##4##3##(1994-7#1)(2008-12#1)(2008-9#1)(2013-8#1)
on the radical##4##3##(2008-10#1)(2008-3#1)(2010-4#1)(2010-5#1)
on the radiology##2##3##(2007-4#1)(2012-2#1)
on the random##4##3##(1995-2#1)(1995-7#1)(2008-3#1)(2008-8#1)
on the range of motion##2##5##(2009-1#1)(2012-1#1)
on the range of##5##4##(2007-8#1)(2008-10#1)(2008-2#1)(2009-1#1)(2012-1#1)
on the rapid##5##3##(2008-10#4)(2008-7#1)
on the rare##2##3##(2007-8#1)(2008-10#1)
on the rat##9##3##(1990-5#1)(1992-12#1)(1992-3#1)(1993-6#1)(1994-2#1)(1996-10#1)(1997-2#1)(2005-10#1)(2008-4#1)
on the rate at which the##2##6##(1991-2#1)(2010-8#1)
on the rate at which##5##5##(1991-2#1)(1995-6#1)(2007-9#1)(2008-10#1)(2010-8#1)
on the rate of iodide oxidation by##2##7##(2007-8#1)(2008-10#1)
on the rate of transport##2##5##(2008-10#2)
on the rate of##32##4##(1991-12#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-9#1)(1995-1#1)(1995-3#3)(1997-7#1)(2004-11#1)(2005-11#1)(2005-9#1)(2006-3#1)(2007-3#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-6#1)(2009-5#1)(2009-8#2)(2010-8#1)(2011-1#1)
on the rate##42##3##(1991-12#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-9#1)(1994-12#2)(1995-1#1)(1995-2#1)(1995-3#3)(1995-6#1)(1997-7#1)(2004-11#1)(2005-11#1)(2005-9#1)(2006-3#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-6#1)(2009-5#1)(2009-8#2)(2010-8#2)(2011-1#1)
on the ratio between the##2##5##(2007-12#1)(2008-3#1)
on the ratio of the##4##5##(2007-12#2)(2008-10#1)(2008-3#1)
on the ratio of##12##4##(1995-1#1)(1996-4#1)(1997-6#1)(2005-12#1)(2007-12#3)(2008-10#3)(2008-3#1)(2008-5#1)
on the ratio##14##3##(1995-1#1)(1996-4#1)(1997-6#1)(2005-12#1)(2007-12#4)(2008-10#3)(2008-3#2)(2008-5#1)
on the rationale that the##3##5##(1992-5#1)(1993-7#1)(2008-2#1)
on the rationale##7##3##(1992-5#1)(1993-7#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-9#1)(2011-2#1)
on the raw##4##3##(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)
on the reaction between##14##4##(2004-9#1)(2008-10#13)
on the reaction conditions##3##4##(1992-12#1)(1996-2#1)(2008-10#1)
on the reaction kinetics##2##4##(1994-2#1)(2008-10#1)
on the reaction of the##2##5##(2008-1#1)(2008-10#1)
on the reaction of##34##4##(1993-11#1)(1994-5#1)(1995-10#1)(2004-9#1)(2005-11#1)(2008-1#1)(2008-10#27)(2008-8#1)
on the reaction rate##3##4##(2008-10#2)(2008-7#1)
on the reaction with##3##4##(2008-10#2)(2008-5#1)
on the reaction##71##3##(1992-12#1)(1993-11#1)(1993-4#1)(1994-2#1)(1994-5#1)(1995-10#1)(1995-2#1)(1996-2#1)(1996-5#2)(2004-9#2)(2005-11#1)(2008-1#1)(2008-10#50)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#2)(2012-3#1)
on the reactions of the##2##5##(2008-10#2)
on the reactivity of##2##4##(1990-5#1)(1996-2#1)
on the reactivity##3##3##(1990-5#1)(1995-8#1)(1996-2#1)
on the reading##2##3##(2004-10#1)(2011-2#1)
on the real##2##3##(2008-10#1)(2009-12#1)
on the recent advances##4##4##(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
on the recent literature##3##4##(2006-3#1)(2012-2#1)(2013-1#1)
on the recent##25##3##(1992-12#1)(1994-12#1)(1994-6#1)(1996-4#1)(2005-8#2)(2006-10#2)(2006-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
on the recently##5##3##(2007-12#1)(2007-5#1)(2008-5#1)(2009-10#1)(2013-8#1)
on the receptor##2##3##(1991-4#1)(2005-8#1)
on the reciprocal of##2##4##(1990-11#1)(2008-10#1)
on the recognition of the##4##5##(1995-9#1)(2007-11#1)(2008-6#1)(2012-3#1)
on the recognition of##6##4##(1994-12#1)(1995-9#1)(2007-11#1)(2007-7#1)(2008-6#1)(2012-3#1)
on the recognition##9##3##(1994-12#1)(1995-9#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-6#1)(2009-12#1)(2012-3#1)
on the recombinant protein production##2##5##(2008-11#2)
on the recombinant##3##3##(2006-11#1)(2008-11#2)
on the recommended##3##3##(2013-1#2)(2013-8#1)
on the reconfigurable array of processors with wider bus networks##2##10##(2008-2#2)
on the reconstitution of##2##4##(1990-8#1)(1992-11#1)
on the reconstitution##4##3##(1990-8#1)(1992-11#1)(1995-8#2)
on the reconstruction##2##3##(2008-2#1)(2008-3#1)
on the recorded##2##3##(1996-1#1)(2008-7#1)
on the recovery of the analyte##4##6##(2008-10#4)
on the recovery of the##8##5##(2008-10#7)(2008-3#1)
on the recovery of##21##4##(1992-7#1)(2006-10#1)(2008-10#15)(2008-3#1)(2012-1#1)(2012-3#1)(2013-1#1)
on the recovery process##3##4##(2006-10#1)(2013-1#2)
on the recovery##26##3##(1992-7#1)(2006-10#2)(2008-10#16)(2008-3#1)(2008-5#1)(2012-1#1)(2012-3#1)(2013-1#3)
on the recurrence of##2##4##(1995-2#1)(2009-6#1)
on the red blood cells##2##5##(1994-12#1)(1995-3#1)
on the red blood##3##4##(1994-12#1)(1994-6#1)(1995-3#1)
on the red##7##3##(1994-12#1)(1994-5#1)(1994-6#1)(1995-3#1)(2007-8#1)(2008-11#1)(2008-3#1)
on the red-ox state of the substrate##2##7##(1991-1#2)
on the redox reaction between##4##5##(2008-10#4)
on the redox reaction of##2##5##(2008-10#2)
on the redox reaction##6##4##(2008-10#6)
on the redox##11##3##(1991-2#1)(1994-8#1)(1995-5#1)(2007-11#1)(2008-10#7)
on the reduction of nitrate to##2##6##(2008-10#2)
on the reduction of the##6##5##(2007-1#1)(2008-10#3)(2012-12#1)(2012-2#1)
on the reduction of##21##4##(1991-3#2)(1992-8#1)(1993-12#1)(2005-11#2)(2007-1#1)(2008-10#11)(2012-12#1)(2012-2#2)
on the reduction##24##3##(1991-3#2)(1992-8#1)(1993-12#1)(1997-7#1)(2005-11#2)(2007-1#1)(2008-10#12)(2008-3#1)(2012-12#1)(2012-2#2)
on the reference##2##3##(2008-2#1)(2011-2#1)
on the reflectance##3##3##(2008-10#1)(2008-2#2)
on the reflected##2##3##(2007-12#1)(2008-3#1)
on the reflectivity##2##3##(2008-2#1)(2008-3#1)
on the refractive index of the##2##6##(2007-12#1)(2008-2#1)
on the refractive index##3##4##(2007-12#1)(2008-2#2)
on the refractive##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
on the regenerated A##3##4##(2008-5#3)
on the region of the##3##5##(2004-9#1)(2008-2#1)(2008-5#1)
on the region of##5##4##(2004-9#1)(2008-2#1)(2008-5#1)(2012-3#1)(2013-1#1)
on the region##7##3##(1991-3#1)(2004-9#1)(2008-2#1)(2008-5#1)(2009-9#1)(2012-3#1)(2013-1#1)
on the regional##2##3##(1996-12#1)(2008-10#1)
on the regions##2##3##(2008-11#1)(2008-2#1)
on the regression parameters##2##4##(1992-9#1)(2008-7#1)
on the regression##7##3##(1992-9#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-7#1)(2011-2#1)
on the regular##2##3##(2008-10#1)(2013-8#1)
on the regulation of PEPCK gene expression##2##7##(1995-6#2)
on the regulation of PEPCK gene##3##6##(1995-6#2)(1996-2#1)
on the regulation of the##2##5##(1994-6#1)(2009-5#1)
on the regulation of##20##4##(1990-10#1)(1990-9#1)(1991-1#1)(1994-6#1)(1995-6#3)(1996-2#1)(2006-1#1)(2008-1#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
on the regulation##21##3##(1990-10#1)(1990-9#1)(1991-1#1)(1994-6#1)(1995-6#3)(1996-2#1)(2006-1#1)(2008-1#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#2)(2011-2#1)(2013-1#1)
on the regulatory mechanisms##2##4##(2010-11#1)(2011-2#1)
on the regulatory##8##3##(1993-3#1)(1994-5#1)(1996-2#1)(1997-2#1)(2009-3#1)(2010-11#1)(2011-2#1)(2013-8#1)
on the rehabilitation process##2##4##(1996-3#1)(2007-7#1)
on the rehabilitation##3##3##(1996-3#1)(2007-7#1)(2008-2#1)
on the relation between##6##4##(1990-8#1)(1991-6#1)(2008-3#1)(2010-12#1)(2010-4#1)(2011-1#1)
on the relations between##3##4##(1996-1#1)(2011-1#1)(2013-8#1)
on the relationship among##2##4##(2009-7#1)(2013-1#1)
on the relationship between burnout##2##5##(1997-1#1)(2008-11#1)
on the relationship between exercise and BMD in##2##8##(2006-8#2)
on the relationship between the##9##5##(1994-2#1)(1995-11#1)(2004-7#1)(2008-1#2)(2008-12#1)(2008-3#1)(2008-9#1)(2013-1#1)
on the relationship between##48##4##(1991-2#1)(1991-3#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-1#1)(1995-11#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-6#1)(2004-7#1)(2005-11#1)(2006-1#1)(2006-2#1)(2006-5#1)(2006-8#2)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#3)(2013-1#5)(2013-8#1)
on the relationship of##4##4##(2006-10#1)(2007-10#1)(2008-10#1)(2011-2#1)
on the relationship##57##3##(1991-2#1)(1991-3#1)(1991-6#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-1#1)(1995-11#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-6#1)(2004-7#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#4)(2013-1#6)(2013-8#1)
on the relationships among##2##4##(2008-2#1)(2012-2#1)
on the relationships between##4##4##(2007-8#1)(2008-1#1)(2008-9#1)(2010-3#1)
on the relationships##8##3##(1993-11#1)(1995-6#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-9#1)(2010-3#1)(2012-2#1)
on the relative conformational##2##4##(1992-12#1)(1992-2#1)
on the relative importance##2##4##(2007-2#1)(2010-1#1)
on the relative##34##3##(1990-2#1)(1990-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-9#2)(1993-6#1)(1994-3#1)(2005-11#1)(2006-10#2)(2007-2#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#3)(2009-9#1)(2010-1#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-7#1)
on the relaxation##4##3##(1994-11#1)(1994-5#1)(1996-10#1)(2009-5#1)
on the release of atrial natriuretic peptide##2##7##(1990-3#2)
on the release of dopamine##3##5##(1991-9#2)(1992-7#1)
on the release of endogenous##2##5##(1990-2#1)(1995-12#1)
on the release of##27##4##(1990-12#2)(1990-2#3)(1990-3#2)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-7#1)(1994-2#1)(1994-3#1)(1995-11#2)(1995-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(2004-1#1)(2006-6#1)(2006-9#1)(2007-8#1)(2008-6#1)(2009-11#1)
on the release##34##3##(1990-12#2)(1990-2#3)(1990-3#2)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-7#1)(1994-2#1)(1994-3#1)(1995-11#2)(1995-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(2004-1#1)(2006-1#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-11#1)(2009-4#1)
on the relevance of the##2##5##(2010-3#1)(2011-1#1)
on the relevance of##5##4##(1993-3#1)(2006-10#1)(2008-10#1)(2010-3#1)(2011-1#1)
on the relevance##6##3##(1993-3#1)(1997-3#1)(2006-10#1)(2008-10#1)(2010-3#1)(2011-1#1)
on the relevant##3##3##(1996-4#1)(2004-9#1)(2011-2#1)
on the reliability and validity of##2##6##(1992-3#1)(2009-9#1)
on the reliability of##4##4##(1990-5#1)(2008-10#2)(2010-2#1)
on the reliability##6##3##(1990-5#1)(1992-3#1)(2008-10#2)(2009-9#1)(2010-2#1)
on the remaining##3##3##(2005-8#1)(2008-10#1)(2012-1#1)
on the removal of##4##4##(1995-6#1)(2008-10#1)(2008-5#1)(2011-2#1)
on the renal##5##3##(1991-9#1)(1992-8#1)(1997-2#1)(2007-10#1)(2010-4#1)
on the repair of wounded##2##5##(1997-2#2)
on the repair of##3##4##(1997-1#1)(1997-2#2)
on the replication of Bombyx mori nucleopolyhedrovirus##2##7##(2008-11#2)
on the replication of##5##4##(1991-10#1)(1995-2#1)(2008-11#2)(2008-5#1)
on the replication##6##3##(1991-10#1)(1995-2#1)(2008-11#2)(2008-5#1)(2013-1#1)
on the reproducibility##4##3##(1994-4#2)(2008-1#1)(2008-10#1)
on the reproduction of##2##4##(2008-5#1)(2009-4#1)
on the reproduction##3##3##(2008-5#1)(2009-4#1)(2012-2#1)
on the reproductive health##2##4##(2008-11#1)(2011-1#1)
on the reproductive performance of##3##5##(2005-7#1)(2006-5#1)(2008-10#1)
on the reproductive tract and on uterine##2##7##(2006-5#2)
on the reproductive##11##3##(2005-7#1)(2006-2#1)(2006-5#3)(2008-10#2)(2008-11#1)(2009-4#1)(2011-1#1)(2011-2#1)
on the required##5##3##(1992-9#1)(1993-1#1)(2008-1#1)(2008-11#1)(2010-8#1)
on the requirement for##2##4##(1995-3#1)(1997-5#1)
on the requirement##3##3##(1995-3#1)(1997-5#1)(2006-10#1)
on the requirements of##4##4##(2006-7#1)(2007-7#1)(2008-1#1)(2008-3#1)
on the requirements##5##3##(2006-7#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)
on the research of##3##4##(2008-2#1)(2008-3#1)(2009-5#1)
on the research##9##3##(1992-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#2)
on the resin were##2##4##(2008-10#2)
on the resin##8##3##(2008-10#7)(2008-4#1)
on the resistance of##3##4##(1997-5#1)(2005-11#1)(2010-4#1)
on the resistance##5##3##(1997-5#1)(2005-11#1)(2009-6#1)(2010-4#1)(2013-8#1)
on the resistant##2##3##(2008-10#2)
on the resolution of the##2##5##(1997-2#1)(1997-8#1)
on the resolution of##3##4##(1997-2#1)(1997-8#1)(2009-2#1)
on the resolution were##3##4##(2008-10#3)
on the resolution##6##3##(1997-2#1)(1997-8#1)(2008-10#3)(2009-2#1)
on the resonance modes##2##4##(2008-1#1)(2008-2#1)
on the resonance##6##3##(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-9#1)
on the resonator##2##3##(2007-12#1)(2008-1#1)
on the respective##2##3##(1995-1#1)(2008-3#1)
on the respiratory activity of##2##5##(2008-10#1)(2008-5#1)
on the respiratory system##2##4##(2006-11#1)(2012-1#1)
on the respiratory tract##2##4##(1992-3#1)(1994-6#1)
on the respiratory##10##3##(1990-6#1)(1992-3#1)(1994-6#1)(1997-1#1)(2006-10#1)(2006-11#1)(2007-1#1)(2008-10#1)(2008-5#1)(2012-1#1)
on the response of the##8##5##(1992-3#1)(2007-1#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-7#1)
on the response of##16##4##(1992-3#1)(1995-7#1)(1996-5#1)(2007-1#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-7#1)(2009-10#1)
on the response properties of the##2##6##(2008-10#2)
on the response to##7##4##(1990-2#1)(1995-12#1)(2006-5#1)(2007-10#1)(2008-10#1)(2008-2#1)(2013-7#1)
on the response##32##3##(1990-2#1)(1992-3#1)(1995-12#1)(1995-7#1)(1996-5#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-2#1)(2008-7#1)(2009-10#1)(2013-7#1)
on the responses of##6##4##(1990-7#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-7#1)
on the responses to##3##4##(1990-10#1)(1992-2#1)(1997-5#1)
on the responses##9##3##(1990-10#1)(1990-7#1)(1992-2#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-7#1)
on the restenosis##2##3##(1991-3#1)(1996-8#1)
on the restorative role of##2##5##(2008-12#2)
on the restriction##2##3##(1991-12#1)(2008-10#1)
on the result of##3##4##(2008-2#1)(2008-7#1)(2013-7#1)
on the result##5##3##(2008-2#1)(2008-7#1)(2011-2#1)(2013-7#1)(2013-8#1)
on the resulting##10##3##(1997-3#1)(2005-11#1)(2007-7#1)(2008-2#1)(2008-3#2)(2008-4#1)(2010-2#1)(2010-8#1)(2012-2#1)
on the results obtained by the##2##6##(2006-4#1)(2007-12#1)
on the results obtained by##3##5##(2006-4#1)(2007-12#1)(2008-3#1)
on the results obtained##11##4##(1995-2#1)(2006-11#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2010-3#1)(2010-5#1)(2011-2#1)
on the results of a survey of##2##7##(2008-1#1)(2009-4#1)
on the results of a##8##5##(1992-3#1)(1996-1#1)(2005-8#1)(2007-6#1)(2008-1#1)(2009-10#1)(2009-4#1)(2011-1#1)
on the results of clinical##2##5##(1995-1#1)(2007-10#1)
on the results of hysteroscopic endometrial##2##6##(1996-2#2)
on the results of our##3##5##(2008-5#1)(2008-8#1)(2011-2#1)
on the results of the##9##5##(1994-2#1)(1995-12#1)(2005-11#1)(2006-11#1)(2006-12#1)(2006-4#1)(2008-10#2)(2008-7#1)
on the results of these##2##5##(2008-10#1)(2008-7#1)
on the results of this study##6##6##(1990-6#1)(1995-1#1)(2007-1#1)(2008-10#2)(2008-5#1)
on the results of this##10##5##(1990-6#1)(1995-1#1)(2007-1#1)(2008-10#5)(2008-5#1)(2011-2#1)
on the results of##65##4##(1990-6#1)(1990-8#1)(1991-10#1)(1992-1#1)(1992-3#1)(1993-2#1)(1994-2#2)(1995-1#2)(1995-12#1)(1996-1#1)(1996-2#2)(1996-9#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
on the results was##2##4##(2005-11#1)(2008-3#1)
on the results##89##3##(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#1)(1992-1#1)(1992-3#1)(1993-2#1)(1994-2#2)(1995-1#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-9#2)(1997-8#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-11#2)(2006-12#1)(2006-4#2)(2006-5#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#16)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#2)
on the retention and enantioselectivity##2##5##(2008-10#2)
on the retention behavior##3##4##(2008-10#3)
on the retention of the##2##5##(2008-10#2)
on the retention of##12##4##(1990-8#1)(1994-1#1)(1996-5#2)(2005-12#1)(2008-10#5)(2008-11#1)(2009-4#1)
on the retention##20##3##(1990-8#1)(1992-6#1)(1994-1#1)(1996-5#3)(2005-12#1)(2008-10#10)(2008-11#2)(2009-4#1)
on the retinal##2##3##(1990-3#1)(1996-5#1)
on the retrieval of##6##4##(2008-2#4)(2008-3#2)
on the retrieval##7##3##(2008-2#5)(2008-3#2)
on the retrieved##2##3##(2008-2#1)(2008-3#1)
on the reverse##4##3##(1990-11#1)(2008-10#1)(2008-7#1)(2009-9#1)
on the reversible inhibition of the##2##6##(1990-3#1)(2008-10#1)
on the reversible##3##3##(1990-3#1)(2008-10#2)
on the review of the literature##2##6##(2007-11#1)(2013-1#1)
on the review of##6##4##(2006-2#1)(2007-11#1)(2008-11#1)(2008-4#1)(2009-4#1)(2013-1#1)
on the revised##2##3##(1993-6#1)(2009-6#1)
on the rheological##3##3##(2008-5#2)(2011-2#1)
on the rheology of hair shampoo containing##2##7##(2008-5#2)
on the rheology##3##3##(2008-5#3)
on the ribosome##3##3##(1992-2#1)(1994-12#1)(2006-11#1)
on the ribosomes##3##3##(1995-4#3)
on the ribs##2##3##(2006-11#1)(2010-12#1)
on the right and##2##4##(2011-2#2)
on the right arm of chromosome VII##3##7##(1995-6#2)(1996-9#1)
on the right arm of chromosome XI##2##7##(1996-6#2)
on the right arm of chromosome##9##6##(1990-12#1)(1995-6#3)(1995-9#1)(1996-6#3)(1996-9#1)
on the right arm of##12##5##(1990-12#1)(1993-5#1)(1995-6#3)(1995-9#1)(1996-6#3)(1996-9#1)(1997-3#2)
on the right arm##13##4##(1990-12#1)(1993-5#1)(1995-6#3)(1995-9#1)(1996-6#4)(1996-9#1)(1997-3#2)
on the right lower##3##4##(2010-12#1)(2010-3#1)(2010-6#1)
on the right side and##4##5##(2007-7#1)(2008-7#2)(2012-2#1)
on the right side in##2##5##(1995-12#1)(2008-6#1)
on the right side of the pelvis##3##7##(2011-2#3)
on the right side of the##6##6##(2010-4#1)(2011-1#1)(2011-2#4)
on the right side of##8##5##(2007-10#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-12#1)
on the right side##30##4##(1991-6#1)(1995-12#1)(2006-7#1)(2007-10#2)(2007-7#2)(2008-1#2)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-6#2)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
on the right thigh##2##4##(2007-7#1)(2012-3#1)
on the right track for##2##5##(1995-12#1)(2008-10#1)
on the right track##3##4##(1995-12#1)(1996-2#1)(2008-10#1)
on the right##98##3##(1990-12#1)(1990-2#1)(1990-4#1)(1991-11#2)(1991-6#1)(1993-3#1)(1993-5#1)(1993-9#1)(1995-12#2)(1995-4#1)(1995-6#3)(1995-9#1)(1996-2#1)(1996-3#2)(1996-6#4)(1996-9#1)(1997-3#2)(1997-6#1)(1997-7#1)(2005-11#2)(2006-2#1)(2006-3#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#3)(2009-4#1)(2009-5#1)(2009-6#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#5)(2010-7#2)(2011-1#1)(2011-2#11)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#3)
on the ring##2##3##(2006-8#1)(2011-1#1)
on the rise for##2##4##(2008-5#1)(2009-4#1)
on the rise in the##2##5##(2010-9#1)(2011-1#1)
on the rise in##4##4##(1992-2#1)(2010-8#1)(2010-9#1)(2011-1#1)
on the rise##25##3##(1992-2#1)(1993-5#1)(1994-1#1)(1995-12#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-7#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#2)
on the risk factors and##2##5##(2006-10#1)(2008-8#1)
on the risk factors##8##4##(1996-2#1)(2006-10#1)(2007-11#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
on the risk for##4##4##(1993-8#1)(2008-10#1)(2009-10#1)(2009-8#1)
on the risk of##23##4##(1991-8#1)(1992-9#1)(1994-3#1)(1996-3#1)(2006-12#1)(2007-10#1)(2007-2#2)(2007-4#1)(2008-4#1)(2010-12#1)(2010-4#1)(2011-12#2)(2011-2#1)(2011-3#1)(2012-11#2)(2012-12#1)(2013-1#2)(2013-7#2)
on the risk##39##3##(1991-8#1)(1992-9#1)(1993-8#1)(1994-3#1)(1995-11#1)(1996-2#1)(1996-3#1)(2006-10#1)(2006-12#1)(2007-10#2)(2007-11#1)(2007-2#2)(2007-4#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-12#2)(2011-2#3)(2011-3#1)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
on the risks involved##2##4##(2005-12#1)(2009-6#1)
on the risks##3##3##(2005-12#1)(2007-2#1)(2009-6#1)
on the road to##3##4##(2009-12#1)(2012-12#1)(2013-8#1)
on the road##7##3##(1996-11#1)(1996-3#1)(2006-11#1)(2008-8#1)(2009-12#1)(2012-12#1)(2013-8#1)
on the rod##2##3##(1997-2#2)
on the role of genetic factors##2##6##(1997-8#1)(2007-2#1)
on the role of genetic##3##5##(1997-8#1)(2007-2#1)(2012-2#1)
on the role of social##2##5##(1991-1#1)(2012-12#1)
on the role of the##20##5##(1992-9#1)(1996-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)
on the role of this##3##5##(1991-12#1)(1997-7#1)(2009-12#1)
on the role of vitamin##2##5##(2010-12#1)(2012-12#1)
on the role of##109##4##(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-9#1)(1994-5#1)(1994-9#1)(1996-11#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#3)(2009-10#3)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-9#1)(2011-1#5)(2011-2#5)(2012-1#3)(2012-12#7)(2012-2#4)(2012-3#3)(2013-1#4)(2013-8#3)
on the role##116##3##(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-9#1)(1994-5#1)(1994-9#1)(1996-11#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#3)(2009-10#3)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#5)(2011-2#5)(2012-1#3)(2012-12#8)(2012-2#4)(2012-3#4)(2013-1#4)(2013-8#3)
on the roles of##12##4##(1990-2#1)(1994-1#1)(2008-1#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)
on the roles##13##3##(1990-2#1)(1994-1#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)
on the roof of the##2##5##(2007-9#1)(2010-5#1)
on the roof of##3##4##(2007-9#1)(2008-5#1)(2010-5#1)
on the roof##4##3##(2007-9#1)(2008-5#1)(2010-5#1)(2013-8#1)
on the root and##2##4##(2008-10#2)
on the root surface##4##4##(2008-10#2)(2013-8#2)
on the root##8##3##(2008-10#5)(2010-3#1)(2013-8#2)
on the roots of the##2##5##(2007-9#1)(2012-6#1)
on the roots of##3##4##(2007-1#1)(2007-9#1)(2012-6#1)
on the roots##4##3##(2007-1#1)(2007-9#1)(2008-10#1)(2012-6#1)
on the roughness##2##3##(2008-3#1)(2011-2#1)
on the route##2##3##(1996-2#1)(2013-1#1)
on the routine##2##3##(2006-9#1)(2008-7#1)
on the safety and security of##2##6##(1992-2#1)(1996-12#1)
on the safety and##4##4##(1992-2#1)(1996-12#1)(2010-1#1)(2012-12#1)
on the safety of##6##4##(2006-10#1)(2006-4#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
on the safety##13##3##(1992-2#1)(1993-12#1)(1994-6#1)(1996-12#1)(2006-10#1)(2006-4#1)(2008-10#1)(2008-8#1)(2010-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
on the sagittal plane##2##4##(2007-11#1)(2007-7#1)
on the salivary glands and neuroendocrine organs of unfed##2##9##(2004-11#2)
on the salivary##3##3##(1995-8#1)(2004-11#2)
on the same cell##2##4##(2007-2#1)(2008-9#1)
on the same cells##2##4##(1990-7#1)(1994-3#1)
on the same chip##2##4##(2007-8#1)(2008-3#1)
on the same data##3##4##(1996-12#1)(2007-11#1)(2012-2#1)
on the same day as##2##5##(2007-1#1)(2008-7#1)
on the same day##11##4##(1995-5#1)(1995-7#1)(1997-3#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-8#1)
on the same filament##2##4##(2008-10#2)
on the same gel##3##4##(2008-2#1)(2008-4#1)(2010-3#1)
on the same host##3##4##(2008-10#3)
on the same individual##2##4##(1996-3#1)(2008-10#1)
on the same leaf##2##4##(2008-10#2)
on the same level##5##4##(1990-12#1)(1991-11#1)(1992-5#1)(2008-1#1)(2008-2#1)
on the same mechanism##2##4##(1993-9#1)(1994-8#1)
on the same patient##4##4##(1996-3#2)(2013-1#2)
on the same plane##2##4##(2008-3#1)(2009-8#1)
on the same plasmid##5##4##(1990-10#1)(1994-12#1)(1994-9#1)(2005-8#1)(2007-2#1)
on the same protein##4##4##(1990-11#1)(1991-11#1)(1991-2#1)(2012-2#1)
on the same sample##2##4##(1990-12#1)(2008-3#1)
on the same side as the##2##6##(2011-2#1)(2013-1#1)
on the same side of the##5##6##(1990-5#1)(1991-9#1)(1996-8#1)(2007-12#1)(2008-10#1)
on the same side of##6##5##(1990-5#1)(1991-9#1)(1995-11#1)(1996-8#1)(2007-12#1)(2008-10#1)
on the same side##10##4##(1990-5#1)(1991-9#1)(1995-11#1)(1996-8#1)(2006-9#1)(2007-12#1)(2008-10#1)(2011-2#2)(2013-1#1)
on the same test##3##4##(2008-9#1)(2013-1#2)
on the same time scale##2##5##(1995-8#1)(1996-7#1)
on the same##153##3##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-10#1)(1992-5#1)(1993-12#1)(1993-9#4)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-12#3)(1996-3#3)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-8#1)(2005-11#2)(2005-8#1)(2006-1#1)(2006-5#1)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#28)(2008-11#3)(2008-2#5)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-4#1)(2009-5#2)(2009-8#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
on the sample surface##2##4##(1994-9#1)(2008-3#1)
on the sample width##2##4##(2008-3#2)
on the sample##26##3##(1994-9#1)(1995-6#1)(2006-5#2)(2007-5#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#6)(2009-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
on the sample)##2##3##(2008-5#1)(2009-4#1)
on the samples##3##3##(2005-7#1)(2008-7#1)(2010-8#1)
on the sampling##4##3##(1997-8#1)(2008-10#2)(2011-2#1)
on the saturated##2##3##(1994-2#1)(2010-4#1)
on the scaffolds##3##3##(2008-5#3)
on the scale of##6##4##(1990-7#1)(1992-1#1)(2006-8#1)(2007-2#1)(2008-7#1)(2012-1#1)
on the scale##11##3##(1990-7#1)(1992-1#1)(1993-1#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-7#1)(2012-1#1)
on the scales##2##3##(2006-10#1)(2008-6#1)
on the scalp##8##3##(2007-8#2)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#2)(2012-12#1)
on the scattering of##2##4##(2008-2#1)(2009-10#1)
on the scattering properties of##2##5##(2007-11#1)(2008-3#1)
on the scattering properties##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
on the scattering##9##3##(2007-11#1)(2008-2#4)(2008-3#3)(2009-10#1)
on the school##3##3##(2006-7#1)(2008-7#1)(2009-7#1)
on the science of##4##4##(2006-11#1)(2010-12#1)(2013-1#2)
on the scientific##8##3##(1991-11#1)(1995-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2011-2#1)(2013-1#1)
on the score##2##3##(2008-10#1)(2010-12#1)
on the screen##7##3##(1992-10#1)(2006-6#1)(2008-10#1)(2008-2#4)
on the seagrass##2##3##(2007-5#1)(2011-2#1)
on the search for new##2##5##(2008-1#1)(2008-10#1)
on the search for##4##4##(2006-10#2)(2008-1#1)(2008-10#1)
on the search terms##2##4##(1996-9#1)(2013-8#1)
on the search##6##3##(1996-9#1)(2006-10#2)(2008-1#1)(2008-10#1)(2013-8#1)
on the season##3##3##(2007-8#1)(2008-10#1)(2011-2#1)
on the seasonal##2##3##(2008-7#1)(2010-8#1)
on the second allele##2##4##(1995-1#1)(2013-1#1)
on the second and##3##4##(2007-10#1)(2007-12#2)
on the second day of life##2##6##(2008-4#1)(2011-1#1)
on the second day of shifted training##2##7##(1993-12#2)
on the second day of##6##5##(1993-12#2)(2005-8#1)(2008-4#2)(2011-1#1)
on the second day##11##4##(1993-12#3)(1995-5#1)(1997-3#1)(2005-8#1)(2008-4#2)(2011-1#1)(2012-12#2)
on the second postoperative day##3##5##(2007-3#1)(2009-3#1)(2013-7#1)
on the second step##2##4##(2006-10#1)(2009-8#1)
on the second##41##3##(1990-7#1)(1993-12#3)(1993-6#1)(1994-9#1)(1995-1#2)(1995-5#1)(1996-10#1)(1996-3#1)(1997-3#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-12#4)(2007-3#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-4#2)(2009-2#1)(2009-3#1)(2009-8#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#2)(2013-1#1)(2013-7#1)
on the secondary effect of##2##5##(1990-8#1)(2008-9#1)
on the secondary structure of##2##5##(1990-10#1)(1994-3#1)
on the secondary structure##3##4##(1990-10#1)(1992-6#1)(1994-3#1)
on the secondary##11##3##(1990-10#1)(1990-8#1)(1991-5#1)(1992-6#1)(1994-3#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-1#1)
on the secretion of##9##4##(1990-5#1)(1994-3#1)(1995-1#1)(1996-4#1)(1996-9#1)(2006-11#1)(2010-2#1)(2011-2#1)(2013-1#1)
on the secretion##12##3##(1990-5#1)(1993-5#1)(1994-3#1)(1995-1#1)(1995-8#1)(1996-4#1)(1996-9#1)(2006-11#1)(2008-7#1)(2010-2#1)(2011-2#1)(2013-1#1)
on the secretory##4##3##(1992-6#1)(1994-6#1)(1997-5#1)(2008-4#1)
on the sedimentation##3##3##(1990-11#1)(1990-7#1)(1991-4#1)
on the selected##7##3##(1991-12#1)(2005-8#1)(2006-6#1)(2008-10#1)(2010-12#1)(2010-3#1)(2010-7#1)
on the selection of##6##4##(1995-9#1)(2008-10#1)(2010-4#1)(2011-2#3)
on the selection##7##3##(1995-9#1)(2006-10#1)(2008-10#1)(2010-4#1)(2011-2#3)
on the selective##6##3##(1990-12#1)(1991-9#1)(1994-10#1)(2008-10#3)
on the selectivity of ISEs##2##5##(2008-10#2)
on the selectivity of the##2##5##(1996-2#1)(2006-12#1)
on the selectivity of##4##4##(1996-2#1)(2006-12#1)(2008-10#2)
on the selectivity##9##3##(1996-2#1)(2006-12#1)(2008-10#7)
on the self##2##3##(2007-7#1)(2012-12#1)
on the sense strand##2##4##(2006-12#1)(2009-3#1)
on the sense##5##3##(2006-12#2)(2009-3#1)(2009-9#2)
on the sensing surface of##2##5##(2007-8#1)(2008-4#1)
on the sensitive##2##3##(2008-10#1)(2013-8#1)
on the sensitivity and selectivity##2##5##(2007-8#1)(2008-10#1)
on the sensitivity of the##4##5##(2008-10#3)(2008-4#1)
on the sensitivity of##12##4##(1990-5#1)(1994-6#1)(2006-10#1)(2008-10#4)(2008-2#1)(2008-4#1)(2010-11#1)(2011-2#1)(2012-3#1)
on the sensitivity##17##3##(1990-5#1)(1994-6#1)(2006-10#1)(2007-8#2)(2008-10#7)(2008-2#1)(2008-4#1)(2010-11#1)(2011-2#1)(2012-3#1)
on the sensitizing effect of##3##5##(2008-10#3)
on the sensor chip##8##4##(2007-8#4)(2008-10#4)
on the sensor response##3##4##(2007-8#1)(2008-10#2)
on the sensor surface##5##4##(1997-2#1)(2008-10#4)
on the sensor##18##3##(1997-2#1)(2007-8#5)(2008-10#12)
on the sensory organ##2##4##(1993-12#2)
on the sensory##3##3##(1993-12#2)(2010-4#1)
on the separation and##3##4##(2008-10#3)
on the separation of the##4##5##(2005-12#1)(2008-10#2)(2012-12#1)
on the separation of##12##4##(1990-9#1)(2005-12#1)(2008-1#1)(2008-10#8)(2012-12#1)
on the separation##17##3##(1990-9#1)(1991-3#1)(2005-12#1)(2007-12#1)(2008-1#1)(2008-10#11)(2012-12#1)
on the sequence analysis of##2##5##(2008-10#1)(2008-8#1)
on the sequence##17##3##(1991-11#1)(1991-6#1)(1991-9#1)(1992-9#1)(1995-8#1)(2007-6#1)(2008-10#5)(2008-4#2)(2008-8#1)(2010-4#1)(2013-8#2)
on the sequence-specific##2##3##(2008-10#1)(2008-7#1)
on the sequential injection##4##4##(2007-8#1)(2008-10#3)
on the sequential##6##3##(2007-8#1)(2008-10#4)(2008-12#1)
on the serum and##2##4##(2008-3#1)(2011-1#1)
on the serum lipid profile##2##5##(2006-10#1)(2007-1#1)
on the serum##12##3##(1990-3#1)(2006-10#1)(2007-1#1)(2007-9#2)(2008-1#1)(2008-3#1)(2010-2#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
on the services##3##3##(1991-3#1)(1993-12#1)(1995-1#1)
on the sets technique##2##4##(1997-6#2)
on the setting time##3##4##(2004-9#2)(2008-5#1)
on the setting##4##3##(2004-9#2)(2008-5#1)(2012-3#1)
on the seventh day of##3##5##(2007-8#1)(2008-5#1)(2010-8#1)
on the seventh##4##3##(2007-10#1)(2007-8#1)(2008-5#1)(2010-8#1)
on the severity and##4##4##(2008-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
on the severity of##15##4##(1990-9#1)(1997-5#1)(2005-11#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-12#1)(2009-2#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
on the severity##19##3##(1990-9#1)(1997-5#1)(2005-11#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-2#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-1#1)(2013-1#2)(2013-7#1)
on the sex and age of##2##6##(1994-6#1)(2007-6#1)
on the sex##5##3##(1994-6#1)(1997-6#1)(2007-6#1)(2013-1#2)
on the sexual##6##3##(1991-2#2)(2006-10#1)(2007-7#1)(2008-11#1)(2010-12#1)
on the shape and##2##4##(2008-10#1)(2008-7#1)
on the shape of the dose response##2##7##(2008-7#2)
on the shape of the##8##5##(2005-11#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)
on the shape of##15##4##(1996-11#1)(1997-7#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-6#1)(2010-8#1)
on the shape##18##3##(1996-11#1)(1997-7#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#3)(2009-6#1)(2010-8#1)
on the shapes of##2##4##(1997-7#1)(2008-1#1)
on the shaping of##2##4##(2006-11#1)(2007-10#1)
on the shear##3##3##(1994-11#1)(2011-1#1)(2013-1#1)
on the shelf are##2##4##(2010-8#2)
on the shelf##3##3##(2010-8#3)
on the shooting hand##2##4##(1995-11#2)
on the short arm of barley chromosome##2##7##(2008-10#2)
on the short arm of chromosome 6##2##7##(2008-10#1)(2008-4#1)
on the short arm of chromosome##7##6##(2008-10#5)(2008-4#1)(2012-3#1)
on the short arm of##12##5##(1996-2#1)(2008-10#9)(2008-4#1)(2012-3#1)
on the short arm##14##4##(1996-2#1)(2008-10#10)(2008-4#1)(2008-5#1)(2012-3#1)
on the short support surface##3##5##(1991-4#3)
on the short##18##3##(1991-4#3)(1996-2#1)(2007-11#1)(2008-10#10)(2008-4#1)(2008-5#1)(2012-3#1)
on the short- and long-term##2##5##(1994-2#1)(2006-9#1)
on the short- and##3##4##(1994-2#1)(2006-9#1)(2008-3#1)
on the short-term##4##3##(1992-4#1)(2007-8#1)(2008-6#1)(2008-8#1)
on the shoulder##5##3##(2006-12#1)(2007-7#1)(2008-12#1)(2009-1#2)
on the side chain of##2##5##(1994-11#1)(1996-6#1)
on the side chain##3##4##(1994-11#1)(1996-6#1)(2007-11#1)
on the side contralateral to##2##5##(2007-7#1)(2008-7#1)
on the side ipsilateral to the rhizotomy##2##7##(1995-7#2)
on the side ipsilateral to the sciatic nerve lesion##2##9##(1991-6#2)
on the side ipsilateral to the##6##6##(1991-6#2)(1992-10#1)(1995-7#2)(1996-5#1)
on the side of the##5##5##(1995-7#1)(2007-5#1)(2008-10#1)(2009-6#2)
on the side of##7##4##(1995-7#1)(2007-5#1)(2008-10#1)(2009-3#1)(2009-6#2)(2012-1#1)
on the side opposite##2##4##(1992-5#1)(2011-1#1)
on the side##23##3##(1991-6#2)(1992-10#1)(1992-11#1)(1992-5#1)(1994-11#1)(1995-7#3)(1996-5#1)(1996-6#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-3#1)(2009-6#2)(2011-1#2)(2012-1#1)
on the sides of##3##4##(1992-9#1)(2007-9#1)(2008-10#1)
on the sides##4##3##(1992-9#1)(2007-5#1)(2007-9#1)(2008-10#1)
on the sidewalls of##2##4##(2008-10#1)(2008-4#1)
on the sign of the##3##5##(2008-3#1)(2009-7#1)(2009-8#1)
on the sign of##4##4##(2007-8#1)(2008-3#1)(2009-7#1)(2009-8#1)
on the sign##5##3##(2007-8#1)(2008-3#1)(2008-8#1)(2009-7#1)(2009-8#1)
on the signal transduction##2##4##(1992-6#1)(2008-4#1)
on the signal##12##3##(1992-6#1)(1994-2#1)(1995-6#1)(2007-12#1)(2008-10#5)(2008-2#2)(2008-4#1)
on the signal-to-noise ratio##5##4##(2008-10#2)(2008-2#2)(2008-3#1)
on the significance of##7##4##(1991-2#1)(1993-10#1)(1995-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2013-8#1)
on the silica gel##2##4##(2005-12#1)(2008-10#1)
on the silica surface##3##4##(2005-11#1)(2008-10#2)
on the silica##7##3##(1995-3#1)(2005-11#1)(2005-12#1)(2008-10#3)(2010-4#1)
on the silicon##3##3##(2008-10#2)(2008-5#1)
on the silver surface##2##4##(2005-4#1)(2008-10#1)
on the similarity##4##3##(1994-8#1)(1994-9#1)(2008-10#1)(2012-2#1)
on the simplifying assumption that the##2##6##(2008-2#1)(2008-8#1)
on the simultaneous##9##3##(1995-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-4#1)(2010-5#1)
on the single##10##3##(1995-4#1)(1996-12#2)(1996-9#1)(2007-12#2)(2008-10#2)(2008-2#1)(2011-2#1)
on the sintered##2##3##(2004-9#2)
on the site and##2##4##(1990-8#1)(2012-2#1)
on the site of the##2##5##(2007-12#1)(2008-5#1)
on the site of##7##4##(1994-2#1)(1994-3#1)(2007-12#2)(2008-5#2)(2008-6#1)
on the site##10##3##(1990-8#1)(1994-2#1)(1994-3#1)(2007-12#2)(2008-5#3)(2008-6#1)(2012-2#1)
on the situation in##2##4##(2008-1#1)(2011-2#1)
on the situation##5##3##(1993-10#1)(1993-3#1)(2008-1#1)(2011-2#2)
on the six##3##3##(1996-12#1)(2007-9#1)(2013-7#1)
on the sixth##2##3##(1991-12#1)(2011-2#1)
on the size and shape of##3##6##(1995-5#1)(2008-1#1)(2013-8#1)
on the size and the##3##5##(1995-11#1)(2008-10#1)(2008-3#1)
on the size and##12##4##(1993-2#1)(1995-11#1)(1995-5#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-2#1)(2010-2#1)(2012-2#1)(2013-8#1)
on the size distribution##2##4##(2008-2#1)(2008-9#1)
on the size of particles##2##5##(2006-2#1)(2008-2#1)
on the size of the##17##5##(1990-10#1)(1991-10#1)(1993-5#1)(1993-8#1)(1996-3#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-1#1)(2010-8#1)
on the size of##28##4##(1990-10#1)(1991-10#1)(1993-5#1)(1993-8#1)(1996-3#1)(2006-2#1)(2007-12#4)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-2#1)
on the size##45##3##(1990-10#1)(1991-10#1)(1993-2#1)(1993-5#1)(1993-8#1)(1995-11#1)(1995-5#1)(1996-3#1)(1997-7#1)(2005-11#1)(2006-2#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
on the skeleton##5##3##(1993-11#1)(1996-5#1)(2008-5#1)(2012-3#1)(2013-1#1)
on the skills and##3##4##(2007-5#1)(2008-11#1)(2008-12#1)
on the skills##5##3##(2007-4#1)(2007-5#1)(2008-11#1)(2008-12#2)
on the skin and##5##4##(2008-12#1)(2008-5#3)(2012-2#1)
on the skin in##2##4##(2007-8#1)(2011-3#1)
on the skin of female##2##5##(1990-7#1)(1992-2#1)
on the skin of the##2##5##(2006-8#1)(2008-5#1)
on the skin of##5##4##(1990-7#1)(1992-2#1)(2006-8#1)(2008-5#1)(2011-12#1)
on the skin surface##3##4##(2008-5#3)
on the skin##41##3##(1990-7#1)(1991-6#1)(1992-2#1)(1994-11#1)(1996-2#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-12#2)(2008-5#22)(2008-6#1)(2011-1#1)(2011-12#1)(2011-3#1)(2012-12#3)(2012-2#1)(2013-7#1)
on the skull##3##3##(1995-6#1)(1996-3#1)(2012-12#1)
on the sleep##2##3##(1994-11#1)(2012-12#1)
on the slider##2##3##(2008-3#2)
on the slides##2##3##(2006-10#1)(2008-10#1)
on the slope of the##2##5##(1995-3#1)(2008-2#1)
on the slope##4##3##(1995-3#1)(2008-10#1)(2008-2#1)(2008-3#1)
on the slopes of##2##4##(2007-11#1)(2008-8#1)
on the slow##2##3##(2006-1#1)(2008-10#1)
on the small##4##3##(2005-7#1)(2006-10#1)(2007-9#1)(2009-5#1)
on the smallest##2##3##(1996-9#1)(2008-10#1)
on the smooth muscle cells##2##5##(1993-11#1)(1996-12#1)
on the smooth muscle##3##4##(1993-11#1)(1996-12#1)(2012-3#1)
on the smooth##8##3##(1993-11#1)(1993-6#1)(1996-12#1)(2005-11#1)(2006-6#1)(2007-4#1)(2008-2#1)(2012-3#1)
on the snout##2##3##(1992-9#1)(2010-8#1)
on the so-called##3##3##(2009-11#1)(2012-1#1)(2012-2#1)
on the social and economic##2##5##(1995-4#1)(2010-2#1)
on the social and##5##4##(1995-4#1)(1995-5#1)(2006-2#1)(2009-10#1)(2010-2#1)
on the social##16##3##(1991-6#1)(1993-3#1)(1995-4#1)(1995-5#1)(1996-1#1)(2006-2#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-8#1)(2013-8#1)
on the society##2##3##(2007-10#1)(2008-3#1)
on the socio-demographic characteristics of##2##5##(2008-8#1)(2010-12#1)
on the socio-economic##2##3##(2007-6#1)(2008-3#1)
on the sodium##4##3##(1991-12#1)(1993-4#1)(2008-10#1)(2008-3#1)
on the sodium-proton-antiport##2##3##(1991-12#1)(1992-12#1)
on the soft##2##3##(1990-6#1)(2010-3#1)
on the soil surface and##2##5##(2008-10#1)(2010-5#1)
on the soil surface##9##4##(2008-10#6)(2008-11#1)(2010-5#2)
on the soil##19##3##(2008-10#10)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-5#2)(2013-8#3)
on the solid phase extraction of##3##6##(2008-10#3)
on the solid phase##10##4##(1991-5#1)(1994-9#1)(1997-3#1)(2006-12#1)(2008-10#6)
on the solid support of glass slides##2##7##(2008-10#2)
on the solid support##5##4##(2006-5#1)(2008-10#4)
on the solid##23##3##(1991-5#1)(1994-9#1)(1997-3#1)(2005-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2008-10#14)(2008-3#1)(2011-1#1)
on the solubility of##5##4##(2008-10#3)(2008-5#1)(2010-5#1)
on the solubility##10##3##(2006-10#1)(2008-10#5)(2008-5#1)(2010-5#1)(2013-1#2)
on the soluble##2##3##(2004-4#1)(2007-11#1)
on the solution##9##3##(1991-2#1)(1997-2#1)(2008-10#1)(2008-2#3)(2008-4#1)(2008-5#1)(2009-3#1)
on the solvent##5##3##(1992-1#2)(2005-11#1)(2008-10#2)
on the somatic##3##3##(2008-4#1)(2010-12#1)(2012-2#1)
on the soot##2##3##(2008-3#2)
on the sorbent##4##3##(2008-10#4)
on the sorption of##6##4##(2008-10#6)
on the sorption##9##3##(2008-10#9)
on the sound##3##3##(2008-2#2)(2008-8#1)
on the source of##3##4##(1996-11#1)(2010-7#1)(2012-1#1)
on the source##4##3##(1996-11#1)(2010-7#1)(2012-1#1)(2012-2#1)
on the southern##2##3##(1996-4#1)(2007-5#1)
on the soybean stems and leaves##2##6##(2011-2#2)
on the soybean##4##3##(2008-10#1)(2011-2#2)(2012-11#1)
on the space##3##3##(2005-11#1)(2008-8#1)(2008-9#1)
on the spatial arrangement of##2##5##(2008-10#1)(2008-5#1)
on the spatial coherence##2##4##(2007-12#1)(2008-2#1)
on the spatial conformation of the##2##6##(1990-4#1)(2008-8#1)
on the spatial distribution of##3##5##(2006-10#1)(2013-7#2)
on the spatial distribution##6##4##(2006-10#1)(2007-12#1)(2008-8#1)(2013-7#2)(2013-8#1)
on the spatial light modulator##2##5##(2008-1#1)(2008-3#1)
on the spatial memory##2##4##(1993-5#1)(2011-2#1)
on the spatial pattern of##2##5##(1994-5#1)(2008-10#1)
on the spatial##30##3##(1990-4#1)(1993-5#1)(1994-5#1)(1994-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#5)(2009-9#1)(2011-2#1)(2013-7#2)(2013-8#2)
on the special diet##2##4##(1990-5#2)
on the special##3##3##(1990-5#2)(2012-2#1)
on the species##8##3##(1997-4#1)(2007-9#1)(2008-10#1)(2008-5#3)(2009-8#1)(2013-8#1)
on the specific roles of##2##5##(2006-2#1)(2009-9#1)
on the specific##40##3##(1991-12#1)(1992-2#1)(1993-1#1)(1993-10#1)(1994-10#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-9#1)(2004-11#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#2)(2009-4#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-3#1)(2013-1#1)
on the specificity of the##2##5##(1995-3#1)(2008-5#1)
on the specificity of##5##4##(1991-7#1)(1993-4#1)(1995-3#1)(2007-10#1)(2008-5#1)
on the specificity##6##3##(1991-7#1)(1993-4#1)(1995-3#1)(2007-10#1)(2008-5#1)(2013-1#1)
on the specimen##3##3##(1991-6#1)(2008-3#1)(2009-7#1)
on the spectra##3##3##(2007-8#2)(2008-10#1)
on the spectral and##3##4##(2007-12#1)(2008-3#1)(2008-4#1)
on the spectral characteristics of##2##5##(2008-2#2)
on the spectral frequency##2##4##(2007-11#1)(2008-2#1)
on the spectral##20##3##(1992-12#1)(1997-3#1)(2006-2#1)(2007-11#3)(2007-12#5)(2008-2#3)(2008-3#5)(2008-4#1)
on the spectrophotometric determination of##2##5##(2008-10#2)
on the spectroscopic properties of the##2##6##(2008-10#1)(2009-10#1)
on the spectroscopic##4##3##(2008-10#3)(2009-10#1)
on the spectroscopy of##2##4##(2008-3#1)(2011-1#1)
on the spectroscopy##3##3##(2008-3#1)(2008-7#1)(2011-1#1)
on the spectrum are##2##4##(2007-11#1)(2008-3#1)
on the spectrum##5##3##(1997-7#1)(2007-11#2)(2008-10#1)(2008-3#1)
on the speech##2##3##(2008-9#1)(2009-10#1)
on the speed of##3##4##(1994-8#1)(2007-9#1)(2009-7#1)
on the sperm acrosome##2##4##(1992-8#1)(2008-8#1)
on the sperm viability##2##4##(2010-8#2)
on the sperm##4##3##(1992-8#1)(2008-8#1)(2010-8#2)
on the spherical##2##3##(2008-7#1)(2011-2#1)
on the spinal##4##3##(1994-10#1)(2008-7#1)(2011-2#1)(2013-8#1)
on the spine##4##3##(1990-6#1)(2006-8#1)(2007-6#1)(2007-7#1)
on the spontaneous##7##3##(1990-11#1)(1993-9#1)(1995-12#1)(1995-3#1)(2006-10#1)(2009-5#1)(2011-2#1)
on the sporulation##4##3##(2008-10#4)
on the spread of##4##4##(1992-5#1)(1993-7#1)(1994-6#1)(2008-10#1)
on the spread##5##3##(1992-5#1)(1993-7#1)(1994-6#1)(2008-10#2)
on the stability and##6##4##(1995-5#1)(2006-10#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-11#1)
on the stability of a##3##5##(2005-11#1)(2008-5#1)(2008-9#1)
on the stability of the liquid crystalline##2##7##(2005-11#2)
on the stability of the##11##5##(1990-2#1)(1991-11#1)(1995-1#1)(1995-8#1)(1996-2#1)(1996-5#1)(2005-11#3)(2006-12#1)(2007-11#1)
on the stability of##34##4##(1990-2#1)(1991-11#1)(1992-1#1)(1993-12#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-8#1)(1996-1#3)(1996-2#1)(1996-5#1)(1996-6#1)(2005-11#6)(2006-12#2)(2007-11#1)(2008-10#3)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)
on the stability##40##3##(1990-2#1)(1991-11#1)(1992-1#1)(1993-12#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-1#3)(1996-2#1)(1996-5#1)(1996-6#1)(2005-11#6)(2006-10#1)(2006-12#2)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#2)(2012-11#1)
on the stable##2##3##(1991-4#1)(1997-5#1)
on the stage of the disease##2##6##(1991-6#1)(2007-7#1)
on the stage of the##3##5##(1991-6#1)(2007-7#1)(2012-1#1)
on the stage of##10##4##(1991-6#1)(1993-2#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2012-1#1)
on the stage##11##3##(1991-6#1)(1993-2#1)(2006-11#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2012-1#1)
on the standard deviation##2##4##(2008-10#1)(2008-3#1)
on the standard##12##3##(1991-11#1)(1991-2#1)(1993-11#1)(1993-12#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-3#1)
on the starting##2##3##(2008-5#1)(2010-4#1)
on the state of polarization##2##5##(2007-12#1)(2008-3#1)
on the state of the##4##5##(1990-2#1)(1991-1#1)(2008-4#1)(2008-8#1)
on the state of##14##4##(1990-2#2)(1991-1#1)(1991-7#1)(1993-5#1)(1994-5#1)(1994-9#1)(2005-11#1)(2007-12#1)(2007-5#1)(2008-3#1)(2008-4#1)(2008-8#2)
on the stationary phase was##2##5##(2008-10#2)
on the stationary phase##6##4##(2008-10#6)
on the statistical properties of##2##5##(2007-11#1)(2007-12#1)
on the statistical##10##3##(1994-2#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-2#2)(2010-9#1)(2011-1#1)
on the statistics##3##3##(2008-2#2)(2008-3#1)
on the status of these##2##5##(1994-1#1)(2007-3#1)
on the status of##6##4##(1993-3#1)(1994-1#1)(2005-6#1)(2007-3#1)(2007-5#1)(2010-8#1)
on the steady state##2##4##(1994-8#1)(2008-5#1)
on the stem##4##3##(2008-10#4)
on the stereochemical##2##3##(1994-8#1)(2008-7#1)
on the sternum##2##3##(2006-11#1)(2007-8#1)
on the steroid##2##3##(1993-11#2)
on the stiffness##2##3##(2009-7#1)(2012-2#1)
on the stimulated##2##3##(1990-7#1)(2008-5#1)
on the stimulation of##2##4##(1992-3#1)(1995-3#1)
on the stimulus##2##3##(1994-3#1)(2007-9#1)
on the stoichiometric##2##3##(1997-2#1)(2005-11#1)
on the stoichiometry of##2##4##(2008-10#1)(2008-7#1)
on the stoichiometry##3##3##(1996-11#1)(2008-10#1)(2008-7#1)
on the storage##2##3##(2008-10#1)(2012-1#1)
on the strain and##2##4##(2008-11#1)(2008-5#1)
on the strain##6##3##(1997-5#1)(2008-11#1)(2008-2#1)(2008-5#3)
on the strains##2##3##(2008-10#2)
on the strand##2##3##(1993-12#1)(1994-9#1)
on the strategy##3##3##(1994-3#1)(1994-4#1)(2008-6#1)
on the streets##2##3##(1992-5#1)(2012-2#1)
on the strength of the expression vector##2##7##(1997-8#2)
on the strength of the##5##5##(1997-8#2)(2007-11#1)(2008-11#1)(2010-2#1)
on the strength of##10##4##(1997-1#1)(1997-8#2)(2007-11#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-10#1)(2010-2#1)
on the strength##11##3##(1994-8#1)(1997-1#1)(1997-8#2)(2007-11#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-10#1)(2010-2#1)
on the strengths and##3##4##(2008-10#1)(2008-11#1)(2008-12#1)
on the strengths of##3##4##(2008-1#1)(2008-8#1)(2012-2#1)
on the strengths##6##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2012-2#1)
on the stress of##2##4##(1994-12#1)(2012-1#1)
on the stress response##2##4##(2010-12#2)
on the stress##7##3##(1994-12#1)(2006-9#1)(2008-5#1)(2009-4#1)(2010-12#2)(2012-1#1)
on the striatal dopamine##2##4##(1993-4#1)(1996-2#1)
on the striatal dopaminergic##2##4##(1996-10#1)(2008-7#1)
on the striatal##5##3##(1993-4#1)(1996-10#1)(1996-2#1)(2008-11#1)(2008-7#1)
on the strong##4##3##(2006-3#1)(2008-10#2)(2008-2#1)
on the structural and##3##4##(1995-12#1)(2006-3#1)(2008-3#1)
on the structural dynamics of##2##5##(2008-10#2)
on the structural organization##2##4##(2006-10#1)(2008-5#1)
on the structural##21##3##(1990-4#1)(1993-12#1)(1995-12#1)(1995-8#2)(1997-1#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#2)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
on the structure and dynamics of##2##6##(2004-4#1)(2006-10#1)
on the structure and function of the##2##7##(2007-1#1)(2009-10#1)
on the structure and function of##7##6##(1992-11#1)(1992-3#1)(2007-1#1)(2008-1#1)(2008-11#1)(2009-10#1)(2010-5#1)
on the structure and stability of##3##6##(1993-3#1)(2007-11#1)(2008-1#1)
on the structure and##16##4##(1990-5#1)(1992-11#1)(1992-3#1)(1993-3#1)(2004-4#1)(2004-9#1)(2006-10#2)(2007-1#1)(2007-11#1)(2008-1#2)(2008-11#1)(2009-10#1)(2009-2#1)(2010-5#1)
on the structure in##2##4##(1994-7#1)(2008-5#1)
on the structure of maize##2##5##(2013-8#2)
on the structure of the peptide and##2##7##(1990-3#1)(2006-12#1)
on the structure of the peptide##4##6##(1990-3#1)(1991-3#1)(1994-2#1)(2006-12#1)
on the structure of the##18##5##(1990-3#1)(1990-4#1)(1991-3#1)(1992-11#1)(1992-6#1)(1994-2#1)(1994-5#1)(1995-7#1)(1996-7#1)(1996-8#1)(1997-7#1)(2005-11#2)(2005-12#1)(2006-12#1)(2006-2#1)(2008-8#1)(2010-7#1)
on the structure of two##2##5##(1992-4#1)(2006-12#1)
on the structure of##34##4##(1990-3#1)(1990-4#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-4#1)(1992-6#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-7#1)(1996-7#1)(1996-8#1)(1997-7#1)(2005-11#2)(2005-12#1)(2005-4#1)(2005-8#1)(2006-12#2)(2006-2#2)(2008-10#2)(2008-8#1)(2008-9#1)(2010-1#1)(2010-4#1)(2010-7#1)(2013-1#1)(2013-8#2)
on the structure##57##3##(1990-3#1)(1990-4#1)(1990-5#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-11#2)(1992-3#1)(1992-4#1)(1992-6#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-7#1)(1996-7#1)(1996-8#1)(1997-7#1)(2004-4#1)(2004-9#1)(2005-11#2)(2005-12#1)(2005-4#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-2#2)(2007-1#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2010-1#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#1)(2013-1#1)(2013-8#2)
on the structure-function relationship of##2##5##(1993-10#1)(2008-9#1)
on the structure-function##3##3##(1993-10#1)(1994-3#1)(2008-9#1)
on the structure-property relationships of##2##5##(2010-4#2)
on the structures and emulsifying properties of caseins##2##8##(2013-8#2)
on the structures and##3##4##(2008-3#1)(2013-8#2)
on the structures of##2##4##(2005-4#1)(2008-10#1)
on the structures##5##3##(2005-4#1)(2008-10#1)(2008-3#1)(2013-8#2)
on the students'##4##3##(2008-11#2)(2008-12#1)(2009-8#1)
on the studied##6##3##(1990-3#1)(1995-2#1)(2008-10#2)(2008-4#1)(2012-3#1)
on the study design and##2##5##(1996-11#1)(2007-7#1)
on the study design##3##4##(1994-5#1)(1996-11#1)(2007-7#1)
on the study of the##5##5##(2006-2#1)(2007-9#1)(2010-11#1)(2011-1#1)(2012-2#1)
on the study of##17##4##(1993-6#1)(2006-2#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#2)(2009-10#1)(2009-7#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)
on the study##22##3##(1992-11#1)(1992-3#1)(1993-6#1)(1994-5#1)(1996-11#1)(2006-2#1)(2007-7#2)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#2)(2009-10#1)(2009-7#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)
on the subcellular##2##3##(1994-12#1)(2012-12#1)
on the subject and##6##4##(1993-10#1)(1997-2#1)(2007-6#1)(2007-8#2)(2008-11#1)
on the subject of##7##4##(2005-7#1)(2006-10#2)(2008-2#1)(2008-7#1)(2009-4#1)(2013-1#1)
on the subject##47##3##(1990-5#1)(1992-8#1)(1993-10#1)(1993-7#1)(1994-1#1)(1994-11#1)(1995-12#1)(1996-11#1)(1997-2#1)(2005-10#1)(2005-7#1)(2005-9#1)(2006-10#4)(2007-1#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-11#2)(2008-2#2)(2008-4#1)(2008-7#2)(2008-9#2)(2009-1#1)(2009-4#1)(2009-6#2)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)
on the subjective and objective##2##5##(2009-9#2)
on the subjective##3##3##(1996-12#1)(2009-9#2)
on the subjects##2##3##(2008-7#1)(2012-3#1)
on the subsequent development of##2##5##(1997-6#1)(2008-10#1)
on the subsequent##13##3##(1990-6#1)(1992-3#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-10#1)(1996-11#1)(1997-6#1)(2006-6#1)(2007-2#1)(2008-10#3)
on the substituents of##2##4##(2007-11#1)(2008-5#1)
on the substrate and##2##4##(1994-5#1)(2010-4#1)
on the substrate##20##3##(1990-9#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-3#1)(1994-5#1)(1995-1#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2009-4#1)(2009-7#1)(2010-4#1)
on the subunit composition of##2##5##(1991-10#1)(1991-5#1)
on the subunit##4##3##(1991-10#1)(1991-5#1)(1991-7#1)(2008-8#1)
on the success of##8##4##(1994-4#2)(2006-9#1)(2007-2#1)(2008-8#1)(2013-1#2)(2013-8#1)
on the success##9##3##(1994-4#2)(2006-9#1)(2007-2#1)(2008-8#1)(2012-1#1)(2013-1#2)(2013-8#1)
on the successful##5##3##(1995-11#1)(1996-5#1)(1997-3#1)(2007-8#1)(2008-8#1)
on the sugar##2##3##(1993-4#1)(2007-3#1)
on the suicide##2##3##(1991-5#1)(2013-1#1)
on the suitability of##3##4##(1995-2#1)(2007-11#1)(2011-12#1)
on the sun##4##3##(1992-7#1)(2007-9#1)(2008-5#1)(2013-1#1)
on the supply of a neurotrophic factor##2##7##(1991-3#1)(1996-3#1)
on the supply of##5##4##(1991-3#1)(1992-3#1)(1994-3#1)(1996-3#1)(2010-1#1)
on the supply##6##3##(1991-3#1)(1992-3#1)(1994-3#1)(1996-3#1)(2006-4#1)(2010-1#1)
on the support##5##3##(1997-6#1)(2008-11#1)(2008-5#1)(2008-7#1)(2013-1#1)
on the supposition that##2##4##(1990-8#1)(2008-9#1)
on the suppression of##2##4##(1993-12#1)(1996-4#1)
on the supramolecular system##2##4##(2008-10#2)
on the supramolecular##4##3##(2008-10#4)
on the surface activity##3##4##(1990-11#1)(2004-12#1)(2005-11#1)
on the surface and##7##4##(2006-6#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-12#1)(2009-3#1)
on the surface charge##2##4##(2005-11#1)(2009-8#1)
on the surface chemistry##2##4##(2005-11#1)(2010-4#1)
on the surface in##2##4##(1994-5#1)(2008-3#1)
on the surface of B cells##2##6##(1995-3#1)(1995-6#1)
on the surface of T cells##2##6##(1990-11#1)(1991-2#1)
on the surface of a glassy carbon electrode by##2##9##(2008-10#2)
on the surface of a glassy carbon electrode##4##8##(1990-12#1)(2008-10#3)
on the surface of a##22##5##(1990-12#1)(1995-4#1)(1996-5#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-2#1)(2010-7#1)
on the surface of activated charcoal##3##6##(2005-11#3)
on the surface of activated##4##5##(1995-3#1)(2005-11#3)
on the surface of an##6##5##(2006-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2010-5#1)
on the surface of bacteriophage##2##5##(1995-2#1)(2008-8#1)
on the surface of cancer cells and##2##7##(1996-3#1)(1997-4#1)
on the surface of electrode##2##5##(2008-10#2)
on the surface of endothelial cells##4##6##(1992-9#1)(1995-8#1)(1996-3#1)(1996-5#1)
on the surface of human PMNs##2##6##(1996-2#2)
on the surface of human##6##5##(1994-11#1)(1994-8#1)(1996-2#2)(1997-6#1)(2007-11#1)
on the surface of infected cells##2##6##(1990-3#1)(1991-7#1)
on the surface of infected##4##5##(1990-3#1)(1991-7#1)(2008-10#2)
on the surface of silica gel##3##6##(2008-10#2)(2013-8#1)
on the surface of silica##4##5##(2005-11#1)(2008-10#2)(2013-8#1)
on the surface of target cells##2##6##(2006-10#1)(2010-10#1)
on the surface of the electrode##4##6##(2008-10#4)
on the surface of the filamentous bacteriophage##2##7##(2008-10#1)(2008-8#1)
on the surface of the glassy carbon electrode##2##8##(2008-10#2)
on the surface of the host##2##6##(2008-10#2)
on the surface of the membrane##2##6##(2008-10#2)
on the surface of the sample##2##6##(2008-10#2)
on the surface of the sensor##2##6##(2007-8#1)(2008-10#1)
on the surface of the##90##5##(1990-8#1)(1991-12#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-9#1)(1995-10#1)(1996-8#1)(1997-1#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-12#2)(2007-8#3)(2008-1#1)(2008-10#33)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2009-11#1)(2009-12#2)(2009-7#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-8#3)
on the surface of##272##4##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-2#4)(1995-3#3)(1995-4#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#3)(1996-8#2)(1996-9#2)(1997-1#3)(1997-4#2)(1997-6#1)(2004-9#1)(2005-10#1)(2005-11#7)(2005-8#1)(2006-10#5)(2006-12#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#5)(2007-12#5)(2007-2#1)(2007-6#1)(2007-8#7)(2007-9#1)(2008-1#2)(2008-10#73)(2008-11#10)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#10)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#2)(2009-11#2)(2009-12#3)(2009-2#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#3)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-8#5)
on the surface structure##2##4##(1997-6#1)(2013-1#1)
on the surface tension of molten silicon##2##7##(2005-11#2)
on the surface tension##3##4##(2005-11#2)(2008-10#1)
on the surface was##5##4##(1991-5#1)(2005-11#1)(2008-10#2)(2008-3#1)
on the surface were##2##4##(2005-11#1)(2008-11#1)
on the surface which##2##4##(2008-5#2)
on the surface##360##3##(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-12#2)(1995-2#4)(1995-3#3)(1995-4#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#5)(1996-8#2)(1996-9#2)(1997-1#4)(1997-4#2)(1997-6#2)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#24)(2005-4#1)(2005-8#2)(2006-10#6)(2006-12#1)(2006-6#2)(2006-9#1)(2007-1#1)(2007-11#5)(2007-12#5)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#8)(2007-9#2)(2008-1#3)(2008-10#85)(2008-11#12)(2008-12#1)(2008-2#3)(2008-3#14)(2008-4#5)(2008-5#13)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#3)(2009-11#2)(2009-12#4)(2009-2#2)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#3)(2010-9#1)(2011-1#1)(2011-12#3)(2011-2#3)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#5)(2013-1#3)(2013-8#7)
on the surface-plasmon##2##3##(2008-2#1)(2008-3#1)
on the surfaces of the##4##5##(2005-11#2)(2008-10#2)
on the surfaces of##15##4##(1994-11#1)(1994-12#1)(2005-11#3)(2005-12#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2010-4#1)(2010-7#1)
on the surfaces##22##3##(1994-11#1)(1994-12#1)(1994-6#1)(2005-11#3)(2005-12#1)(2006-12#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2010-4#1)(2010-7#1)
on the surfactant chain length and##2##6##(2005-11#1)(2010-2#1)
on the surfactant##3##3##(2005-11#2)(2010-2#1)
on the surgeon's##4##3##(2006-5#1)(2006-6#2)(2007-11#1)
on the surgical treatment of##3##5##(2006-2#1)(2008-10#1)(2008-9#1)
on the surgical treatment##4##4##(2006-2#1)(2008-10#1)(2008-9#1)(2010-7#1)
on the surgical##9##3##(2006-2#1)(2006-6#1)(2007-4#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-7#1)(2012-3#1)
on the surrounding community##2##4##(2010-2#2)
on the surrounding##5##3##(2008-7#1)(2008-9#1)(2009-3#1)(2010-2#2)
on the survey##5##3##(2006-2#1)(2010-3#1)(2012-1#1)(2012-2#1)(2013-8#1)
on the survival and##5##4##(1990-10#1)(2008-5#1)(2009-10#1)(2010-2#1)(2010-8#1)
on the survival of fish##2##5##(2010-8#2)
on the survival of patients with##2##6##(2008-11#1)(2008-2#1)
on the survival of the##2##5##(2008-10#1)(2013-1#1)
on the survival of##17##4##(1995-2#1)(1996-12#1)(2004-2#1)(2004-4#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
on the survival##25##3##(1990-10#1)(1995-2#2)(1996-12#1)(2004-2#1)(2004-4#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2009-10#1)(2010-2#1)(2010-8#3)(2011-2#1)(2012-2#1)(2013-1#1)
on the susceptibility of##4##4##(1993-11#1)(1994-5#1)(2006-8#1)(2011-2#1)
on the susceptible cultivar##2##4##(2008-10#2)
on the susceptible cv##3##4##(2008-10#3)
on the susceptible##9##3##(2008-10#9)
on the suspension##2##3##(1997-1#2)
on the swelling##3##3##(2004-12#1)(2005-11#1)(2007-10#1)
on the switched off plate##2##5##(1994-2#2)
on the symptomatology##2##3##(1997-8#1)(2011-2#1)
on the symptoms of##2##4##(2007-6#1)(2008-10#1)
on the symptoms##4##3##(1993-8#1)(2007-6#1)(2008-10#2)
on the synthesis and release of##2##6##(1991-10#1)(1994-2#1)
on the synthesis and##6##4##(1990-4#1)(1991-10#1)(1992-6#1)(1994-2#1)(2007-11#1)(2009-3#1)
on the synthesis of##14##4##(1990-7#2)(1990-8#1)(1991-1#1)(1991-5#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-4#1)(1994-10#1)(1995-3#1)(1996-11#1)(1997-4#1)(2011-2#1)
on the synthesis##21##3##(1990-4#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-4#1)(1994-10#1)(1994-2#1)(1995-3#1)(1996-11#1)(1997-4#1)(2007-11#1)(2008-11#1)(2009-3#1)(2011-2#1)
on the synthetic##3##3##(1991-1#1)(1991-6#1)(2010-2#1)
on the system##10##3##(1996-12#1)(2005-11#2)(2006-10#1)(2007-5#1)(2008-10#3)(2008-2#1)(2010-4#1)
on the system's ability to##2##5##(2007-9#1)(2008-2#1)
on the systematic##2##3##(1991-3#1)(1994-12#1)
on the systemic##3##3##(2008-10#1)(2010-3#1)(2010-6#1)
on the table##2##3##(1995-2#1)(2008-7#1)
on the tail##3##3##(2008-3#2)(2011-12#1)
on the target cell##2##4##(1993-12#1)(1993-6#1)
on the target cells##3##4##(1990-7#1)(1993-12#1)(2008-11#1)
on the target##15##3##(1990-7#1)(1993-12#2)(1993-6#1)(1997-4#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#2)(2010-8#1)(2011-1#1)(2012-1#1)
on the taxonomy##2##3##(2008-10#1)(2010-8#1)
on the teaching##2##3##(2008-11#1)(2009-2#1)
on the technical##3##3##(2007-5#1)(2007-8#1)(2012-12#1)
on the technique##5##3##(1996-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)
on the techniques for##2##4##(2008-2#1)(2008-9#1)
on the techniques##4##3##(2006-10#1)(2008-10#1)(2008-2#1)(2008-9#1)
on the telomeric##2##3##(1994-11#1)(2008-12#1)
on the temperature dependence of the##2##6##(2008-2#2)
on the temperature of the##2##5##(1996-2#1)(2008-4#1)
on the temperature of##3##4##(1994-6#1)(1996-2#1)(2008-4#1)
on the temperature##14##3##(1994-5#1)(1994-6#1)(1996-2#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-10#2)(2008-2#3)(2008-4#1)(2008-8#1)(2012-5#1)
on the template##2##3##(2008-9#1)(2012-3#1)
on the temporal and spatial##2##5##(2007-12#1)(2008-10#1)
on the temporal and##3##4##(1990-8#1)(2007-12#1)(2008-10#1)
on the temporal dynamics of##2##5##(2008-10#2)
on the temporal dynamics##3##4##(1995-12#1)(2008-10#2)
on the temporal##17##3##(1990-5#1)(1990-8#1)(1993-11#1)(1995-12#1)(2006-10#1)(2007-11#2)(2007-12#4)(2008-10#4)(2009-1#1)(2012-2#1)
on the tensile##3##3##(2007-4#1)(2008-12#1)(2009-7#1)
on the tension##2##3##(2007-10#1)(2012-3#1)
on the terminal##4##3##(1994-9#1)(1996-8#1)(2008-11#1)(2012-3#1)
on the ternary complex##2##4##(2005-4#1)(2008-10#1)
on the ternary##3##3##(1992-9#1)(2005-4#1)(2008-10#1)
on the tertiary structure of the##2##6##(1996-5#1)(1996-7#1)
on the test##6##3##(1990-10#1)(1992-1#1)(1993-6#1)(1997-5#1)(2009-4#1)(2013-8#1)
on the testes of##2##4##(2008-5#2)
on the testicular##2##3##(2009-5#1)(2013-8#1)
on the testosterone displacement equilibrium from its##2##7##(2008-10#2)
on the tests##2##3##(2006-11#1)(2008-3#1)
on the theoretical##7##3##(1996-2#1)(2008-3#1)(2008-6#2)(2011-2#1)(2012-12#1)(2013-7#1)
on the theory of##11##4##(1992-8#1)(1993-9#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2012-3#1)(2013-8#2)
on the theory##15##3##(1992-8#1)(1993-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-4#1)(2012-12#1)(2012-3#2)(2013-8#2)
on the therapeutic##7##3##(1992-5#1)(1997-4#1)(2006-10#2)(2008-4#1)(2010-12#1)(2012-2#1)
on the therapy##3##3##(1990-8#1)(1995-9#1)(2009-8#1)
on the thermal denaturation of##2##5##(1991-2#2)
on the thermal inactivation##2##4##(1991-2#2)
on the thermal##12##3##(1991-2#4)(1994-3#1)(2004-9#1)(2005-11#2)(2009-6#1)(2010-4#2)(2010-7#1)
on the thermodynamic##2##3##(1993-3#1)(2008-10#1)
on the thermodynamics of the##2##5##(1991-8#1)(1995-4#1)
on the thermodynamics##3##3##(1991-8#1)(1992-9#1)(1995-4#1)
on the thermosensitivity of##2##4##(1994-8#1)(1995-8#1)
on the thickness and the##2##5##(2008-3#2)
on the thickness of the outer layer##2##7##(2008-3#2)
on the thickness of the##6##5##(2007-11#1)(2008-2#1)(2008-3#2)(2009-5#1)(2012-12#1)
on the thickness##8##3##(2007-11#1)(2008-2#1)(2008-3#4)(2009-5#1)(2012-12#1)
on the third chromosome##2##4##(1992-12#1)(1996-5#1)
on the third day of##4##5##(1990-10#1)(2005-8#1)(2007-9#1)(2011-12#1)
on the third day##6##4##(1990-10#1)(1990-11#1)(1993-12#1)(2005-8#1)(2007-9#1)(2011-12#1)
on the third postoperative day##6##5##(1993-1#1)(2010-6#3)(2012-12#2)
on the third postoperative##7##4##(1993-1#1)(2006-12#1)(2010-6#3)(2012-12#2)
on the third##23##3##(1990-10#1)(1990-11#1)(1990-7#1)(1992-12#1)(1993-1#1)(1993-12#1)(1995-3#1)(1995-6#1)(1996-5#1)(2005-8#1)(2006-12#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-2#1)(2010-6#3)(2011-1#1)(2011-12#1)(2012-12#2)(2013-8#1)
on the thoracic##2##3##(2007-8#1)(2011-2#1)
on the three different##2##4##(1993-9#1)(2011-2#1)
on the three types of##2##5##(2007-1#1)(2008-10#1)
on the three##15##3##(1991-2#1)(1993-2#1)(1993-9#1)(1996-5#1)(2006-5#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-9#1)(2010-3#1)(2011-2#2)(2012-3#1)
on the three-dimensional##5##3##(1995-2#1)(1996-7#1)(1997-5#1)(2008-11#1)(2008-2#1)
on the threshold current##2##4##(2008-3#2)
on the threshold of##3##4##(2006-10#2)(2008-7#1)
on the threshold##6##3##(2006-10#2)(2008-3#3)(2008-7#1)
on the throughput##2##3##(2008-2#1)(2008-3#1)
on the thyroid gland##3##4##(1990-4#1)(1993-5#1)(2013-1#1)
on the thyroid##10##3##(1990-4#1)(1990-6#1)(1991-7#1)(1992-8#1)(1993-5#1)(2006-10#2)(2006-11#1)(2008-7#1)(2013-1#1)
on the tilt of the##2##5##(1994-5#1)(2008-2#1)
on the tilt##3##3##(1994-5#1)(2008-2#2)
on the time after##3##4##(1991-1#1)(1994-10#1)(2006-5#1)
on the time course of##6##5##(1990-5#1)(1992-8#1)(1996-8#1)(2004-12#1)(2009-11#1)(2012-1#1)
on the time elapsed since##2##5##(1990-3#1)(2009-9#1)
on the time of##4##4##(2007-8#1)(2009-8#2)(2012-2#1)
on the time period##2##4##(1996-5#1)(2011-2#1)
on the time required for##2##5##(2008-10#1)(2008-5#1)
on the time scale of##6##5##(1994-12#1)(1994-8#1)(2005-11#1)(2006-10#1)(2007-11#1)(2011-2#1)
on the time scale##7##4##(1994-12#1)(1994-8#1)(1996-7#1)(2005-11#1)(2006-10#1)(2007-11#1)(2011-2#1)
on the time##35##3##(1990-3#1)(1990-5#1)(1991-1#1)(1992-8#1)(1994-10#1)(1994-12#1)(1994-8#1)(1995-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-8#1)(2004-12#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-11#1)(2009-8#2)(2009-9#1)(2011-2#3)(2012-1#1)(2012-2#1)
on the time-dependent##2##3##(1995-7#1)(2008-11#1)
on the time-domain##2##3##(2007-12#1)(2008-3#1)
on the times##2##3##(1995-8#1)(1997-4#1)
on the timing of the##2##5##(1997-6#1)(2005-8#1)
on the timing of##10##4##(1992-12#1)(1993-5#1)(1994-2#1)(1997-2#2)(1997-6#1)(2005-8#1)(2008-10#1)(2008-7#1)(2009-5#1)
on the timing##13##3##(1990-5#1)(1992-12#1)(1993-5#1)(1994-2#1)(1997-2#2)(1997-6#1)(2005-8#1)(2008-10#1)(2008-7#1)(2009-5#1)(2009-9#1)(2010-5#1)
on the tip of the##5##5##(1990-8#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-10#1)
on the tip of##6##4##(1990-8#1)(1997-5#1)(2007-12#2)(2007-8#1)(2008-10#1)
on the tip##7##3##(1990-8#1)(1997-5#1)(2006-6#1)(2007-12#2)(2007-8#1)(2008-10#1)
on the tissue surface##3##4##(2009-11#1)(2011-1#1)(2013-1#1)
on the tissue##11##3##(1995-11#1)(2007-5#1)(2008-11#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-10#1)(2011-1#1)(2012-2#2)(2013-1#1)
on the tissues##4##3##(1995-5#1)(2007-8#1)(2010-8#2)
on the tolerability##2##3##(1990-7#1)(1991-7#1)
on the tolerance of the##2##5##(2006-11#2)
on the tongue and##4##4##(1993-1#2)(2007-2#1)(2007-3#1)
on the tongue##9##3##(1993-1#3)(2006-2#1)(2007-2#1)(2007-3#2)(2009-12#1)(2013-1#1)
on the top of the##4##5##(2007-10#1)(2007-7#1)(2008-10#1)(2008-2#1)
on the top##7##3##(2007-10#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#2)
on the topic of##7##4##(2006-10#1)(2006-11#1)(2008-11#1)(2008-6#1)(2009-4#1)(2012-2#1)(2013-7#1)
on the topic##24##3##(1991-10#1)(1991-9#1)(1994-2#2)(1996-2#1)(1996-4#1)(2006-10#3)(2006-11#1)(2007-8#3)(2008-1#1)(2008-11#2)(2008-6#1)(2009-4#2)(2009-6#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
on the topics##3##3##(1995-2#1)(2011-2#1)(2012-3#1)
on the total number of##4##5##(1990-12#1)(2008-3#1)(2009-3#1)(2011-3#1)
on the total##25##3##(1990-12#1)(1991-9#1)(1992-2#1)(1994-8#1)(1997-2#1)(2005-11#1)(2006-12#1)(2006-7#1)(2007-12#1)(2007-9#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)(2009-3#1)(2010-10#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-7#1)
on the total-internal-reflection effect##2##4##(2008-2#1)(2008-3#1)
on the toxic##3##3##(2008-10#1)(2013-1#2)
on the toxicity of##5##4##(1995-3#1)(1996-12#1)(1997-3#1)(2008-5#1)(2011-2#1)
on the toxicological##2##3##(1996-12#1)(1996-8#1)
on the toxicology##8##3##(2008-7#2)(2008-8#1)(2008-9#3)(2013-1#2)
on the toxin##2##3##(2008-8#1)(2010-10#1)
on the traditional##5##3##(2004-10#1)(2008-10#1)(2009-5#1)(2011-2#1)(2012-2#1)
on the training set##2##4##(2008-10#1)(2008-2#1)
on the training##5##3##(2008-10#1)(2008-12#1)(2008-2#2)(2011-1#1)
on the trait##5##3##(2007-12#1)(2008-8#3)(2012-3#1)
on the transcribed strand of the##2##6##(1994-8#1)(1996-11#1)
on the transcription of##4##4##(1990-7#1)(1992-9#1)(1997-1#1)(2008-11#1)
on the transcription##8##3##(1990-7#2)(1992-9#1)(1994-11#1)(1997-1#2)(2008-11#1)(2008-4#1)
on the transducer##2##3##(2008-10#2)
on the transfer##3##3##(1992-9#1)(2008-10#1)(2011-2#1)
on the transformation of##3##4##(1992-5#1)(1995-6#1)(2008-2#1)
on the transformation##5##3##(1992-5#1)(1995-6#1)(1996-4#1)(1996-7#1)(2008-2#1)
on the transient##5##3##(1996-12#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)
on the transients##2##3##(2008-2#1)(2008-3#1)
on the translational##2##3##(1990-3#1)(1994-8#1)
on the translocation##3##3##(1995-3#1)(1997-8#1)(2008-6#1)
on the transmembrane##2##3##(1994-3#1)(2012-2#1)
on the transmission of##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
on the transmission properties##2##4##(2007-12#1)(2008-3#1)
on the transmission##8##3##(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#2)
on the transport of Hct##3##5##(2011-3#3)
on the transport of hydrochlorothiazide##2##5##(2011-3#2)
on the transport of##11##4##(1990-12#1)(1990-8#1)(1994-3#1)(1997-8#1)(2009-10#1)(2011-2#1)(2011-3#5)
on the transverse##2##3##(1993-12#1)(2007-11#1)
on the trapping##2##3##(1993-9#1)(2007-11#1)
on the treated##2##3##(1996-7#1)(2005-11#1)
on the treatment and##2##4##(1990-3#1)(2007-11#1)
on the treatment of a##2##5##(1991-2#1)(1992-6#1)
on the treatment of patients with##4##6##(1992-1#1)(1996-7#1)(2008-9#1)(2012-3#1)
on the treatment of the##3##5##(2007-11#1)(2008-10#1)(2009-9#1)
on the treatment of##44##4##(1990-5#1)(1990-9#1)(1991-2#1)(1992-1#1)(1992-6#2)(1993-3#1)(1993-4#1)(1993-9#1)(1994-9#1)(1995-4#1)(1995-9#1)(1996-11#1)(1996-7#1)(1997-3#1)(2004-3#1)(2005-6#1)(2006-10#2)(2006-9#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-9#2)(2010-10#1)(2010-12#2)(2010-4#1)(2011-12#1)(2011-2#4)(2012-3#1)(2013-7#2)(2013-8#3)
on the treatment results##2##4##(2011-2#2)
on the treatment##57##3##(1990-3#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-6#2)(1993-3#1)(1993-4#1)(1993-9#1)(1994-9#1)(1995-4#1)(1995-9#1)(1996-11#1)(1996-7#1)(1996-8#1)(1997-3#1)(2004-3#1)(2005-6#1)(2006-10#2)(2006-9#1)(2007-11#2)(2007-7#2)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-9#2)(2010-10#1)(2010-12#3)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#8)(2012-3#1)(2013-7#2)(2013-8#3)
on the trend##2##3##(1991-11#1)(1993-2#1)
on the trial##2##3##(2005-8#2)
on the trunk and##3##4##(2006-4#1)(2007-11#1)(2010-6#1)
on the trunk of##2##4##(2008-5#1)(2008-9#1)
on the trunk##7##3##(2006-4#1)(2007-11#2)(2007-7#1)(2008-5#1)(2008-9#1)(2010-6#1)
on the tumor cell##2##4##(2006-12#1)(2008-11#1)
on the tumor type##2##4##(2010-2#1)(2012-12#1)
on the tumor##12##3##(1995-4#1)(2006-11#1)(2006-12#1)(2006-7#1)(2008-11#2)(2008-12#1)(2010-2#1)(2010-6#1)(2012-12#1)(2013-1#1)(2013-8#1)
on the tumour##2##3##(2008-9#1)(2012-12#1)
on the twin##2##3##(2006-10#1)(2008-10#1)
on the two different##2##4##(1996-2#1)(2008-3#1)
on the two surfaces##2##4##(2008-12#1)(2010-10#1)
on the two##26##3##(1991-6#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-5#2)(1994-8#1)(1996-2#1)(1997-8#1)(2005-11#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-5#1)(2011-2#1)(2013-7#1)
on the two-dimensional##2##3##(2008-3#2)
on the two-photon fluorescence spectroscopy of##2##6##(2008-3#2)
on the two-photon##3##3##(2007-11#1)(2008-3#2)
on the type II enzyme##2##5##(1995-3#2)
on the type and stage of##2##6##(2007-11#1)(2008-8#1)
on the type and##6##4##(1992-8#1)(2007-11#1)(2008-2#1)(2008-8#1)(2009-7#1)(2013-1#1)
on the type of interaction##2##5##(1997-2#1)(2008-7#1)
on the type of the##4##5##(2007-11#1)(2007-5#1)(2007-9#1)(2008-11#1)
on the type of##59##4##(1990-6#1)(1991-11#1)(1991-12#1)(1991-3#2)(1992-10#1)(1992-2#1)(1993-10#1)(1993-9#1)(1994-10#1)(1994-7#1)(1995-5#1)(1996-4#1)(1996-9#1)(1997-2#3)(1997-4#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-8#1)(2007-11#3)(2007-5#1)(2007-7#2)(2007-9#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#1)
on the type##70##3##(1990-6#1)(1991-11#1)(1991-12#1)(1991-3#2)(1992-10#1)(1992-2#1)(1992-8#1)(1993-10#1)(1993-9#1)(1994-10#1)(1994-7#1)(1995-3#2)(1995-5#1)(1996-4#1)(1996-9#1)(1997-2#3)(1997-4#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-8#1)(2007-11#4)(2007-5#1)(2007-7#2)(2007-9#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#1)(2013-1#2)
on the types and##2##4##(2007-7#1)(2008-2#1)
on the types of##6##4##(1991-10#1)(1992-1#1)(1994-5#1)(2004-9#1)(2008-12#1)(2011-2#1)
on the types##8##3##(1991-10#1)(1992-1#1)(1994-5#1)(2004-9#1)(2007-7#1)(2008-12#1)(2008-2#1)(2011-2#1)
on the typical##7##3##(2007-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-2#1)(2012-2#1)(2012-3#1)
on the ultimate##3##3##(2008-11#1)(2008-4#1)(2010-8#1)
on the ultrastructural##4##3##(1992-6#1)(1995-11#1)(2011-2#2)
on the ultrastructure and##2##4##(2008-5#1)(2012-2#1)
on the ultrastructure of##6##4##(1995-7#1)(2007-5#2)(2007-9#1)(2008-10#1)(2008-7#1)
on the ultrastructure##8##3##(1995-7#1)(2007-5#2)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)
on the umbilical##2##3##(1992-1#1)(2009-8#1)
on the umbilicus##2##3##(2010-6#2)
on the underlying cause##2##4##(2005-11#1)(2010-2#1)
on the underlying##24##3##(1990-2#1)(1993-12#1)(1993-3#1)(1995-11#1)(1995-9#1)(1996-3#1)(1997-4#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-11#2)(2006-3#1)(2006-8#1)(2008-10#1)(2008-3#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#1)
on the understanding of the##3##5##(2006-4#1)(2008-1#1)(2009-8#1)
on the understanding of##9##4##(2006-4#1)(2006-6#1)(2008-1#1)(2008-10#2)(2009-8#1)(2010-12#1)(2010-2#1)(2012-3#1)
on the unique##10##3##(1991-12#1)(1996-5#1)(1997-7#1)(2004-9#1)(2005-8#1)(2006-3#1)(2007-11#1)(2008-7#1)(2008-8#1)(2010-1#1)
on the unit for##2##4##(2010-2#1)(2010-3#1)
on the unit##4##3##(1990-9#1)(2007-3#1)(2010-2#1)(2010-3#1)
on the unlesioned side##2##4##(1994-10#2)
on the untransformed##2##3##(1991-7#1)(2009-12#1)
on the untreated##2##3##(2008-11#1)(2008-5#1)
on the upper arm##2##4##(2007-12#1)(2008-5#1)
on the upper body##2##4##(2004-11#2)
on the upper labial mucosa##2##5##(2013-8#2)
on the upper limb##2##4##(2008-9#1)(2012-1#1)
on the upper lip##2##4##(1995-12#1)(2013-7#1)
on the upper or lower##2##5##(2007-8#1)(2008-10#1)
on the upper##22##3##(1993-12#1)(1993-9#1)(1995-12#1)(2004-11#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-9#2)(2009-4#1)(2012-1#1)(2013-7#2)(2013-8#3)
on the uptake of##10##4##(1991-1#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-6#2)(1994-8#1)(1996-2#1)(1996-6#1)(2008-10#1)
on the uptake##13##3##(1990-11#1)(1991-1#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-6#2)(1994-8#1)(1996-2#1)(1996-6#1)(2005-4#1)(2008-10#1)
on the urban##2##3##(1991-12#1)(2008-10#1)
on the uric acid##2##4##(1990-11#1)(2008-10#1)
on the urinary mutagenicity##2##4##(1993-9#2)
on the urinary##6##3##(1993-8#1)(1993-9#2)(2009-1#1)(2010-12#1)(2012-12#1)
on the usage of##2##4##(2006-2#1)(2011-2#1)
on the use and##2##4##(1996-9#1)(2006-8#1)
on the use of 15##2##5##(1996-11#1)(2007-3#1)
on the use of IVIG in##2##6##(2005-11#2)
on the use of a polymerase chain reaction##2##8##(2008-5#2)
on the use of a##29##5##(1990-5#1)(1996-5#1)(1996-8#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#6)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#2)(2009-8#1)(2013-8#1)
on the use of an##4##5##(2008-2#1)(2008-3#1)(2011-1#1)(2013-1#1)
on the use of animal##2##5##(2008-7#1)(2013-1#1)
on the use of animals in##2##6##(2007-3#1)(2012-2#1)
on the use of conventional##2##5##(2008-11#1)(2008-7#1)
on the use of different##2##5##(2008-10#1)(2011-2#1)
on the use of either##2##5##(2007-12#1)(2008-10#1)
on the use of light##2##5##(2007-11#1)(2008-3#1)
on the use of pediatric medicines and their##2##8##(2008-9#2)
on the use of polyclonal##3##5##(2008-3#2)(2008-4#1)
on the use of the##29##5##(1991-2#1)(1992-12#1)(1994-10#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-5#1)(1997-4#1)(2005-10#1)(2006-7#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2009-9#1)(2010-1#1)(2010-2#1)(2010-5#1)(2011-1#1)
on the use of these agents##3##6##(2006-10#1)(2008-1#1)(2008-3#1)
on the use of these##7##5##(1996-2#1)(1997-4#1)(2006-10#1)(2008-1#1)(2008-3#1)(2008-9#1)(2013-1#1)
on the use of this##2##5##(2007-7#1)(2012-2#1)
on the use of two##2##5##(1990-12#1)(1991-3#1)
on the use of##270##4##(1990-12#3)(1990-5#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-2#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-6#3)(1994-9#1)(1995-1#2)(1995-12#3)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-2#2)(1996-5#2)(1996-8#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(2004-4#1)(2005-10#1)(2005-11#5)(2005-7#1)(2005-8#1)(2006-10#9)(2006-11#1)(2006-12#2)(2006-4#2)(2006-6#2)(2006-7#3)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#8)(2007-12#8)(2007-3#2)(2007-5#2)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#3)(2008-10#49)(2008-11#7)(2008-12#1)(2008-2#8)(2008-3#21)(2008-4#9)(2008-5#6)(2008-7#6)(2008-8#2)(2008-9#4)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#5)(2011-7#1)(2012-1#2)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#10)(2013-8#4)
on the use##273##3##(1990-12#3)(1990-5#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-2#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-6#3)(1994-9#1)(1995-1#2)(1995-12#3)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-2#2)(1996-5#2)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(2004-4#1)(2005-10#1)(2005-11#5)(2005-7#1)(2005-8#1)(2006-10#9)(2006-11#1)(2006-12#2)(2006-4#2)(2006-6#2)(2006-7#3)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#8)(2007-12#8)(2007-3#2)(2007-5#2)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#3)(2008-10#49)(2008-11#7)(2008-12#1)(2008-2#8)(2008-3#21)(2008-4#9)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#4)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#5)(2011-7#1)(2012-1#2)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#10)(2013-8#4)
on the usefulness of##5##4##(1991-3#1)(1991-6#1)(2005-1#1)(2008-4#1)(2009-4#1)
on the usefulness##6##3##(1991-3#1)(1991-6#1)(2005-1#1)(2008-4#1)(2009-4#1)(2013-1#1)
on the uses of##2##4##(1991-12#1)(2010-5#1)
on the utilisation of##2##4##(2008-10#2)
on the utility of##3##4##(2005-8#1)(2008-9#1)(2010-9#1)
on the utility##5##3##(2005-8#1)(2008-9#1)(2010-9#1)(2013-1#2)
on the utilization of##7##4##(1996-2#1)(2005-7#1)(2008-10#2)(2008-4#1)(2008-6#1)(2010-8#1)
on the vaccine##2##3##(1995-5#2)
on the validity of##3##4##(1995-2#1)(2004-9#1)(2007-2#1)
on the validity##4##3##(1995-2#1)(2004-9#1)(2007-2#1)(2011-2#1)
on the value of the##3##5##(1996-2#1)(2006-4#1)(2008-2#1)
on the value of##14##4##(1990-5#1)(1990-6#1)(1994-3#1)(1996-2#1)(2006-10#1)(2006-4#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2009-6#1)(2010-4#1)
on the value##15##3##(1990-5#1)(1990-6#1)(1994-3#1)(1996-2#1)(2006-10#1)(2006-4#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2009-6#1)(2010-4#1)(2012-3#1)
on the values of##2##4##(1990-7#1)(2005-11#1)
on the values##4##3##(1990-7#1)(2005-11#1)(2007-2#1)(2011-2#1)
on the variable##3##3##(2007-11#2)(2012-12#1)
on the variance of the##3##5##(2008-2#2)(2012-3#1)
on the variance##6##3##(1997-2#1)(2008-10#1)(2008-2#2)(2008-8#1)(2012-3#1)
on the variation of##2##4##(2011-1#1)(2013-8#1)
on the variation##3##3##(2008-3#1)(2011-1#1)(2013-8#1)
on the variety of##2##4##(2007-9#1)(2013-1#1)
on the various##17##3##(1990-12#1)(1990-5#1)(1992-3#1)(1993-5#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)
on the varying##3##3##(2007-4#1)(2007-8#1)(2008-3#1)
on the vascular endothelial cell##2##5##(2009-7#1)(2013-1#1)
on the vascular smooth muscle##2##5##(1995-12#1)(2008-7#1)
on the vascular##8##3##(1990-5#1)(1994-2#1)(1995-12#1)(2007-10#1)(2008-7#1)(2009-5#1)(2009-7#1)(2013-1#1)
on the vector##2##3##(1990-3#1)(2008-2#1)
on the vegetation##2##3##(2004-11#1)(2013-8#1)
on the velocity of##3##4##(2008-11#1)(2009-8#1)(2011-2#1)
on the ventral side of the##2##6##(2007-12#1)(2008-5#1)
on the ventral##7##3##(1992-8#1)(1993-12#1)(2007-12#1)(2008-5#3)(2008-9#1)
on the verge of##6##4##(1992-10#1)(1997-6#1)(2007-9#1)(2008-11#1)(2008-4#1)(2012-12#1)
on the vertex of##2##4##(2008-9#1)(2013-8#1)
on the vertex##3##3##(2008-5#1)(2008-9#1)(2013-8#1)
on the vertical##2##3##(2008-3#1)(2011-12#1)
on the vessel##7##3##(1990-8#1)(2006-10#1)(2007-5#1)(2008-6#1)(2009-10#1)(2009-8#1)(2010-6#1)
on the viability and##3##4##(1990-6#1)(2008-5#1)(2008-7#1)
on the viability of cells##3##5##(2006-12#1)(2009-12#1)(2013-1#1)
on the viability of##10##4##(1995-9#1)(2006-12#1)(2008-10#3)(2008-7#2)(2009-12#1)(2011-2#1)(2013-1#1)
on the viability##16##3##(1990-6#1)(1995-7#1)(1995-9#1)(2006-12#1)(2008-10#4)(2008-5#1)(2008-7#3)(2008-8#1)(2009-12#1)(2011-2#1)(2013-1#1)
on the vibrational##2##3##(1992-9#1)(2008-8#1)
on the video##2##3##(1992-12#1)(2013-1#1)
on the view of##2##4##(1995-2#1)(2008-11#1)
on the view##3##3##(1995-2#1)(2008-11#2)
on the viral complementary strand##3##5##(2008-10#3)
on the viral##9##3##(1990-10#1)(2008-10#4)(2008-4#1)(2008-5#1)(2009-8#1)(2012-2#1)
on the virus##3##3##(1997-1#1)(2004-11#1)(2008-10#1)
on the virus-infected##2##3##(1990-3#1)(2008-10#1)
on the viscosity of the##3##5##(1990-2#1)(1991-7#2)
on the viscosity of##5##4##(1990-2#1)(1991-7#2)(1994-11#2)
on the viscosity##7##3##(1990-2#1)(1991-7#2)(1994-11#2)(2005-11#1)(2008-5#1)
on the visible and near-ultraviolet##2##5##(2008-3#2)
on the visual abilities of macaques##3##6##(1992-11#1)(1992-9#1)(1993-2#1)
on the visual system##2##4##(2008-8#1)(2009-12#1)
on the visual##8##3##(1991-2#1)(1992-11#1)(1992-9#1)(1993-2#1)(2007-7#1)(2008-1#1)(2008-8#1)(2009-12#1)
on the vitamin##2##3##(1990-4#1)(1992-1#1)
on the volar surface of the forearm##2##7##(1996-7#1)(2008-10#1)
on the volar##4##3##(1996-7#1)(2008-10#1)(2008-5#1)(2013-7#1)
on the volatile##2##3##(2006-12#1)(2012-3#1)
on the voltammetric response##2##4##(2008-10#2)
on the voltammetric##4##3##(2008-10#4)
on the volume of##5##4##(1993-12#1)(2005-11#1)(2007-9#1)(2008-4#1)(2009-9#1)
on the volume##7##3##(1993-12#1)(1997-5#1)(2005-11#1)(2007-9#1)(2008-4#1)(2009-9#1)(2013-1#1)
on the vulva##2##3##(1993-8#1)(2007-7#1)
on the wafer scale##2##4##(2008-7#1)(2010-4#1)
on the waiting list##5##4##(1991-11#1)(1991-4#1)(2007-8#2)(2011-2#1)
on the waiting##6##3##(1991-11#1)(1991-4#1)(2007-8#2)(2008-9#1)(2011-2#1)
on the wall##3##3##(1990-9#1)(2006-12#1)(2008-11#1)
on the walls of blood vessels##2##6##(2005-10#1)(2011-2#1)
on the walls of the##2##5##(2008-10#2)
on the walls of##9##4##(2005-10#1)(2007-8#1)(2008-10#5)(2011-2#1)(2012-2#1)
on the walls##10##3##(2005-10#1)(2007-10#1)(2007-8#1)(2008-10#5)(2011-2#1)(2012-2#1)
on the water quality##2##4##(2007-3#1)(2012-2#1)
on the water##9##3##(1992-9#1)(1993-2#1)(1996-9#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#1)
on the waveguide surface##2##4##(2008-3#2)
on the waveguide##3##3##(2008-2#1)(2008-3#2)
on the wavelength##7##3##(2007-11#2)(2008-2#1)(2008-3#4)
on the way they##2##4##(2008-1#1)(2008-8#1)
on the way to##2##4##(2007-6#1)(2011-1#1)
on the way we##3##4##(2007-12#1)(2007-8#1)(2011-2#1)
on the wear##2##3##(2004-9#1)(2009-3#1)
on the web##9##3##(2006-10#4)(2007-4#1)(2008-12#1)(2008-7#1)(2013-1#2)
on the weight of the##2##5##(2006-2#1)(2008-8#1)
on the weight-bearing##2##3##(2005-7#1)(2008-3#1)
on the welfare##2##3##(1996-9#1)(2008-3#1)
on the west##2##3##(2007-5#2)
on the western##2##3##(1992-8#1)(2007-5#1)
on the wheat##2##3##(2008-10#2)
on the whole genome##2##4##(2008-10#1)(2009-8#1)
on the whole##15##3##(1994-9#1)(2004-11#1)(2006-12#1)(2006-8#1)(2006-9#1)(2008-10#2)(2008-2#2)(2008-5#1)(2008-7#1)(2009-8#2)(2010-11#1)(2010-6#1)
on the width of the##3##5##(2008-1#1)(2008-10#1)(2008-3#1)
on the width##4##3##(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)
on the willingness of##2##4##(2007-10#1)(2007-7#1)
on the willingness##3##3##(2007-10#1)(2007-7#1)(2012-12#1)
on the wings of the##2##5##(2006-7#1)(2008-3#1)
on the wire##2##3##(2009-2#1)(2012-1#1)
on the work of##2##4##(2008-11#2)
on the work##3##3##(1997-8#1)(2008-11#2)
on the working electrode##4##4##(1990-11#1)(2008-10#3)
on the working##7##3##(1990-11#1)(1991-1#1)(2007-8#1)(2008-10#3)(2009-2#1)
on the world##2##3##(2008-11#2)
on the wound##3##3##(1996-8#1)(2008-11#1)(2011-1#1)
on the writing##2##3##(2008-1#1)(2008-4#1)
on the x-ray##2##3##(1991-6#1)(2012-2#1)
on the year of##2##4##(1991-3#1)(2008-10#1)
on the year##4##3##(1991-3#1)(2007-2#1)(2008-10#2)
on the yield of##3##4##(2008-10#1)(2008-5#1)(2008-8#1)
on the yield##5##3##(2008-10#2)(2008-5#1)(2008-8#1)(2011-1#1)
on the zinc##5##3##(1990-8#1)(1994-10#1)(2008-10#2)(2013-7#1)
on the##22187##2##(1990-1#12)(1990-10#45)(1990-11#74)(1990-12#88)(1990-2#96)(1990-3#64)(1990-4#42)(1990-5#98)(1990-6#32)(1990-7#64)(1990-8#84)(1990-9#45)(1991-1#45)(1991-10#33)(1991-11#48)(1991-12#96)(1991-2#113)(1991-3#72)(1991-4#45)(1991-5#61)(1991-6#68)(1991-7#62)(1991-8#43)(1991-9#55)(1992-1#53)(1992-10#15)(1992-11#47)(1992-12#86)(1992-2#57)(1992-3#61)(1992-4#39)(1992-5#44)(1992-6#85)(1992-7#39)(1992-8#68)(1992-9#64)(1993-1#40)(1993-10#17)(1993-11#78)(1993-12#103)(1993-2#60)(1993-3#77)(1993-4#30)(1993-5#43)(1993-6#68)(1993-7#28)(1993-8#56)(1993-9#73)(1994-1#25)(1994-10#32)(1994-11#77)(1994-12#90)(1994-2#106)(1994-3#103)(1994-4#11)(1994-5#103)(1994-6#89)(1994-7#12)(1994-8#93)(1994-9#82)(1995-1#68)(1995-10#25)(1995-11#83)(1995-12#101)(1995-2#91)(1995-3#74)(1995-4#26)(1995-5#64)(1995-6#84)(1995-7#38)(1995-8#62)(1995-9#30)(1996-1#53)(1996-10#23)(1996-11#46)(1996-12#109)(1996-2#105)(1996-3#72)(1996-4#52)(1996-5#100)(1996-6#62)(1996-7#48)(1996-8#70)(1996-9#53)(1997-1#81)(1997-2#120)(1997-3#67)(1997-4#92)(1997-5#61)(1997-6#81)(1997-7#68)(1997-8#86)(1997-9#2)(2003-11#1)(2004-1#2)(2004-10#13)(2004-11#35)(2004-12#17)(2004-2#14)(2004-3#5)(2004-4#13)(2004-7#3)(2004-8#2)(2004-9#45)(2005-1#9)(2005-10#65)(2005-11#332)(2005-12#21)(2005-2#1)(2005-3#4)(2005-4#37)(2005-5#12)(2005-6#10)(2005-7#46)(2005-8#66)(2005-9#21)(2006-1#19)(2006-10#383)(2006-11#77)(2006-12#136)(2006-2#64)(2006-3#38)(2006-4#52)(2006-5#65)(2006-6#94)(2006-7#58)(2006-8#92)(2006-9#40)(2007-1#81)(2007-10#93)(2007-11#410)(2007-12#487)(2007-2#93)(2007-3#60)(2007-4#72)(2007-5#94)(2007-6#59)(2007-7#171)(2007-8#331)(2007-9#145)(2008-1#219)(2008-10#2848)(2008-11#504)(2008-12#200)(2008-2#694)(2008-3#857)(2008-4#334)(2008-5#664)(2008-6#179)(2008-7#364)(2008-8#351)(2008-9#261)(2009-1#14)(2009-10#84)(2009-11#39)(2009-12#52)(2009-2#89)(2009-3#80)(2009-4#100)(2009-5#98)(2009-6#62)(2009-7#70)(2009-8#103)(2009-9#81)(2010-1#33)(2010-10#52)(2010-11#46)(2010-12#212)(2010-2#114)(2010-3#73)(2010-4#156)(2010-5#94)(2010-6#73)(2010-7#80)(2010-8#131)(2010-9#49)(2011-1#273)(2011-10#2)(2011-11#2)(2011-12#56)(2011-2#493)(2011-3#30)(2011-7#4)(2011-8#1)(2012-1#147)(2012-10#2)(2012-11#54)(2012-12#288)(2012-2#356)(2012-3#235)(2012-4#2)(2012-5#3)(2012-6#3)(2012-7#1)(2012-8#1)(2012-9#2)(2013-1#497)(2013-7#106)(2013-8#345)
on their ability to##13##4##(1992-9#1)(1995-2#1)(2005-11#1)(2005-8#1)(2007-11#1)(2008-1#1)(2008-3#1)(2009-10#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2013-1#1)
on their activity##2##3##(1994-6#1)(2008-10#1)
on their anatomical##2##3##(2007-11#1)(2011-2#1)
on their behalf##3##3##(2007-2#1)(2009-5#2)
on their biological##4##3##(1995-8#1)(2008-3#1)(2008-5#2)
on their capability to##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
on their cell##2##3##(1994-12#1)(2008-11#1)
on their chemical##3##3##(2008-10#2)(2010-7#1)
on their clinical##4##3##(2007-11#1)(2007-12#1)(2008-5#1)(2012-1#1)
on their composition##3##3##(2007-11#1)(2008-4#1)(2011-2#1)
on their concentration##3##3##(2007-8#1)(2008-10#1)(2009-4#1)
on their current##2##3##(1993-12#1)(2009-4#1)
on their degree of##4##4##(1990-11#1)(1994-8#1)(2004-12#1)(2007-12#1)
on their development##2##3##(1992-9#1)(2008-10#1)
on their different##4##3##(1993-2#1)(2008-10#2)(2009-5#1)
on their disease and##2##4##(2007-8#1)(2011-12#1)
on their disease##3##3##(2007-7#1)(2007-8#1)(2011-12#1)
on their distribution##4##3##(2006-12#1)(2012-2#1)(2013-1#2)
on their efficacy and##2##4##(2008-5#1)(2012-2#1)
on their efficacy##3##3##(2008-5#1)(2012-2#1)(2013-1#1)
on their energy##2##3##(2008-7#1)(2011-2#1)
on their environmental##2##3##(1990-12#1)(2008-5#1)
on their experience##6##3##(1990-10#1)(1990-5#1)(1995-1#1)(2006-12#1)(2007-7#2)
on their experiences##2##3##(2009-5#1)(2010-8#1)
on their family##2##3##(2008-7#1)(2009-12#1)
on their feeding##2##3##(2010-8#1)(2011-2#1)
on their feelings##2##3##(2007-3#1)(2008-1#1)
on their first##4##3##(1991-2#1)(2008-12#3)
on their function and##2##4##(2007-12#1)(2010-11#1)
on their health##2##3##(1991-6#1)(2013-1#1)
on their high##4##3##(2008-1#1)(2008-11#1)(2009-8#1)(2013-8#1)
on their host of origin##2##5##(2008-10#2)
on their host##3##3##(2008-10#2)(2013-1#1)
on their hosts##2##3##(2004-11#1)(2008-10#1)
on their impact on##2##4##(2006-10#1)(2012-12#1)
on their incorporation into##2##4##(2006-10#1)(2008-2#1)
on their knowledge and attitudes##2##5##(2011-2#2)
on their knowledge##4##3##(2008-2#1)(2011-2#2)(2013-1#1)
on their level of##3##4##(2006-10#1)(2007-10#1)(2008-12#1)
on their life##2##3##(2011-2#2)
on their lives##8##3##(1992-1#1)(2004-12#1)(2007-8#5)(2008-7#1)
on their location##3##3##(2005-2#1)(2008-10#1)(2008-7#1)
on their medication##2##3##(2008-11#2)
on their membrane##2##3##(1991-9#1)(1992-6#1)
on their milk##2##3##(2012-2#2)
on their molecular##2##3##(2006-10#1)(2008-4#1)
on their own accord##2##4##(2006-8#1)(2011-1#1)
on their own experience and##2##5##(1991-11#1)(2007-11#1)
on their own experience##3##4##(1991-11#1)(2007-11#1)(2007-7#1)
on their own experiences##2##4##(2007-11#1)(2008-11#1)
on their own initiative##2##4##(1996-9#1)(2011-12#1)
on their own or##3##4##(2004-2#1)(2007-10#1)(2009-12#1)
on their own to##2##4##(1992-11#1)(1997-3#1)
on their own##36##3##(1990-8#1)(1991-11#1)(1992-11#1)(1992-3#1)(1993-3#2)(1995-1#1)(1995-11#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-6#1)(2004-2#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-6#1)(2007-7#1)(2008-11#4)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-12#1)(2012-3#1)
on their performance##2##3##(1992-11#1)(2008-3#1)
on their personal and##2##4##(2008-11#1)(2008-2#1)
on their personal##3##3##(2008-11#1)(2008-2#1)(2010-3#1)
on their physico-chemical properties##3##4##(2006-1#1)(2008-5#2)
on their physicochemical properties##2##4##(2008-5#1)(2010-5#1)
on their physiological##2##3##(2009-9#1)(2012-2#1)
on their poor##2##3##(1996-12#1)(2007-2#1)
on their position##2##3##(2007-11#1)(2007-12#1)
on their possible##3##3##(1993-1#1)(2005-8#1)(2010-6#1)
on their potential##4##3##(2005-11#1)(2005-7#1)(2010-8#1)(2011-2#1)
on their properties##2##3##(2005-12#1)(2008-8#1)
on their putative##3##3##(2008-3#1)(2009-12#1)(2009-8#1)
on their quality of life##3##5##(2011-2#2)(2013-8#1)
on their relevance##2##3##(2011-1#1)(2013-1#1)
on their research##2##3##(2009-8#1)(2013-1#1)
on their respective##3##3##(2007-2#1)(2008-7#2)
on their response to##3##4##(1990-11#1)(1992-7#1)(2013-8#1)
on their response##4##3##(1990-11#1)(1992-7#1)(2009-12#1)(2013-8#1)
on their responses to##2##4##(1997-7#1)(2008-5#1)
on their results##2##3##(1993-2#1)(2006-3#1)
on their role in##4##4##(1990-12#1)(2006-9#1)(2008-1#1)(2010-1#1)
on their school performance##2##4##(2007-12#1)(2009-7#1)
on their school##3##3##(2007-12#1)(2008-11#1)(2009-7#1)
on their sensitivity##2##3##(1995-12#1)(2008-2#1)
on their size##2##3##(1990-6#1)(2008-10#1)
on their smoking habits##2##4##(1993-10#1)(2011-2#1)
on their solubility in##2##4##(1993-8#1)(2005-11#1)
on their structural##2##3##(2006-12#1)(2012-12#1)
on their surface##15##3##(1990-9#1)(1991-6#1)(1994-2#1)(1996-4#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-4#2)(2008-5#1)(2010-4#2)(2012-12#1)(2012-3#1)(2013-1#1)
on their survival##2##3##(1997-2#1)(2013-7#1)
on their target##3##3##(2006-1#1)(2011-2#1)(2013-1#1)
on their treatment##2##3##(1991-2#1)(2010-2#1)
on their unique##2##3##(2008-1#1)(2013-1#1)
on their use in##2##4##(2007-11#1)(2009-5#1)
on their use##7##3##(1996-1#1)(2007-11#1)(2007-8#1)(2009-5#1)(2010-8#1)(2012-1#1)(2013-1#1)
on their way to##2##4##(1991-1#1)(1993-6#1)
on their way##3##3##(1991-1#1)(1993-6#1)(2009-4#1)
on their work##5##3##(1995-6#1)(2006-10#1)(2008-2#1)(2011-1#1)(2012-12#1)
on their##606##2##(1990-10#1)(1990-11#2)(1990-12#7)(1990-2#1)(1990-5#1)(1990-6#3)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#2)(1991-2#5)(1991-3#1)(1991-5#1)(1991-6#3)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#3)(1993-1#4)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#2)(1993-6#2)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#4)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#1)(1995-1#3)(1995-11#5)(1995-12#1)(1995-2#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#5)(1996-4#1)(1996-5#2)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-6#3)(1997-7#4)(1997-8#3)(2004-10#1)(2004-11#2)(2004-12#2)(2004-2#1)(2004-3#2)(2004-9#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-2#1)(2005-7#2)(2005-8#2)(2006-1#2)(2006-10#8)(2006-12#5)(2006-2#2)(2006-3#2)(2006-4#1)(2006-6#1)(2006-7#4)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#14)(2007-12#12)(2007-2#5)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#12)(2007-9#5)(2008-1#14)(2008-10#52)(2008-11#27)(2008-12#9)(2008-2#11)(2008-3#12)(2008-4#12)(2008-5#19)(2008-6#2)(2008-7#14)(2008-8#9)(2008-9#7)(2009-10#3)(2009-11#2)(2009-12#5)(2009-3#1)(2009-4#4)(2009-5#6)(2009-6#2)(2009-7#4)(2009-8#4)(2009-9#4)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#7)(2010-2#3)(2010-3#2)(2010-4#5)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#4)(2011-1#11)(2011-12#3)(2011-2#26)(2012-1#4)(2012-11#5)(2012-12#7)(2012-2#10)(2012-3#4)(2013-1#24)(2013-7#2)(2013-8#9)
on them in##2##3##(1995-12#1)(2010-9#1)
on them##21##2##(1990-5#1)(1995-12#1)(1996-12#1)(1997-6#1)(2005-11#1)(2006-12#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-9#2)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
on themselves##4##2##(1993-8#1)(2008-11#2)(2009-6#1)
on theoretical considerations##3##3##(1994-6#1)(2008-10#1)(2010-12#1)
on theoretical##8##2##(1994-6#1)(1996-3#1)(1997-1#1)(2008-10#2)(2010-12#1)(2010-6#1)(2013-8#1)
on theories##3##2##(2006-5#1)(2010-1#1)(2012-12#1)
on theory of mind##3##4##(2006-2#2)(2013-1#1)
on theory##6##2##(1993-7#1)(1994-12#1)(2006-2#2)(2013-1#1)(2013-7#1)
on therapeutic approaches##2##3##(1991-7#1)(2007-11#1)
on therapeutic##21##2##(1991-7#1)(1993-8#1)(2005-7#1)(2005-8#1)(2006-11#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-11#2)(2008-8#1)(2011-1#2)(2012-12#3)(2012-3#1)(2013-1#1)(2013-7#1)
on therapy for##2##3##(2008-5#1)(2011-3#1)
on therapy with##2##3##(2010-12#1)(2012-12#1)
on therapy##14##2##(1990-5#1)(1996-11#1)(2006-10#2)(2006-2#1)(2007-7#1)(2008-1#1)(2008-5#2)(2009-11#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#1)
on thermal and##2##3##(2007-4#1)(2008-10#1)
on thermal lens##2##3##(2008-10#1)(2008-3#1)
on thermal##11##2##(1993-12#1)(1995-12#1)(1996-12#1)(1997-6#1)(2005-11#1)(2007-4#1)(2008-10#4)(2008-3#1)
on thermally##3##2##(2007-12#1)(2009-5#1)(2011-1#1)
on thermodynamic considerations##2##3##(2006-10#1)(2008-10#1)
on thermodynamic##5##2##(1995-5#1)(2006-10#1)(2006-12#1)(2008-10#1)(2013-1#1)
on these and other##5##4##(1991-11#1)(1992-2#1)(1992-9#1)(2011-12#1)(2012-2#1)
on these and##6##3##(1991-11#1)(1992-2#1)(1992-9#1)(1996-3#1)(2011-12#1)(2012-2#1)
on these cells was##2##4##(2008-5#1)(2008-8#1)
on these cells##18##3##(1990-2#2)(1990-7#1)(1991-2#1)(1993-5#1)(1993-7#1)(1997-2#1)(1997-5#1)(1997-7#2)(2006-10#1)(2006-12#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-12#1)(2012-1#1)(2013-1#1)
on these changes##2##3##(1996-6#1)(2010-9#1)
on these components##2##3##(2007-7#1)(2008-10#1)
on these compounds##3##3##(2007-12#1)(2008-10#1)(2012-2#1)
on these conditions##4##3##(1993-3#1)(1996-2#1)(1997-1#1)(2012-2#1)
on these criteria##2##3##(2006-5#1)(2008-1#1)
on these data##12##3##(1994-6#1)(1994-8#1)(1996-3#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-2#1)(2011-1#1)
on these disorders##3##3##(2008-7#1)(2010-4#1)(2012-3#1)
on these effects##2##3##(2006-2#1)(2008-10#1)
on these enzymes##2##3##(1990-8#1)(2007-7#1)
on these estimates##3##3##(2006-10#1)(2006-7#1)(2008-7#1)
on these findings##35##3##(1991-5#1)(1993-12#1)(1993-2#1)(1994-2#1)(1996-7#1)(2004-8#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-10#3)(2008-4#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-3#1)(2011-2#2)(2012-1#2)(2012-2#3)(2013-8#4)
on these four##4##3##(1994-6#1)(1996-1#1)(2011-1#1)(2012-3#1)
on these indicators##2##3##(2005-11#1)(2006-2#1)
on these issues##4##3##(1993-3#1)(2008-11#1)(2009-12#1)(2011-2#1)
on these leaves##2##3##(2008-10#2)
on these measurements##3##3##(2005-9#1)(2006-11#1)(2007-12#1)
on these mechanisms##2##3##(1996-6#1)(2012-2#1)
on these media##2##3##(2008-10#1)(2010-6#1)
on these observations##11##3##(1990-4#1)(1991-6#1)(1992-11#1)(1993-3#1)(1995-5#1)(2005-8#1)(2007-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2011-2#1)
on these parameters##8##3##(1991-5#1)(2005-10#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-2#1)(2013-1#1)(2013-8#1)
on these patients##5##3##(2006-11#1)(2006-8#1)(2007-8#1)(2008-7#1)(2008-8#1)
on these peptides##2##3##(1993-11#1)(1994-12#1)
on these plasmids##2##3##(1990-5#1)(1995-8#1)
on these properties##3##3##(1996-2#1)(2006-10#1)(2010-9#1)
on these relationships##2##3##(2007-1#1)(2011-2#1)
on these residues##2##3##(1996-5#2)
on these results##48##3##(1990-12#1)(1990-2#1)(1990-3#1)(1991-3#1)(1992-1#1)(1993-12#1)(1993-9#1)(1994-7#1)(1994-9#1)(1995-4#1)(1997-3#1)(1997-8#2)(2006-10#1)(2006-12#2)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2011-1#1)(2012-12#1)(2012-2#1)
on these seven##2##3##(2008-10#2)
on these sites##2##3##(1995-3#1)(2004-12#1)
on these studies##6##3##(2004-1#1)(2007-11#1)(2009-6#1)(2009-8#1)(2010-3#1)(2011-2#1)
on these substrates##5##3##(1994-11#1)(2006-5#1)(2006-8#1)(2007-12#1)(2008-11#1)
on these surfaces##2##3##(2007-12#1)(2008-5#1)
on these three##5##3##(1996-1#1)(1996-9#1)(2008-1#1)(2008-10#1)(2013-1#1)
on these topics##4##3##(2005-9#1)(2012-3#1)(2013-1#2)
on these traits##2##3##(2008-10#1)(2012-3#1)
on these transitions##2##3##(2007-12#1)(2009-5#1)
on these two##10##3##(1991-9#1)(1993-2#1)(1994-11#1)(2007-1#1)(2008-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#1)
on these variables##9##3##(1991-4#1)(1992-5#1)(2006-12#1)(2007-12#1)(2008-8#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-7#1)
on these##423##2##(1990-10#1)(1990-12#1)(1990-2#4)(1990-3#2)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#2)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#3)(1993-4#1)(1993-5#1)(1993-7#2)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#1)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-12#2)(1996-2#3)(1996-3#3)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#4)(1997-8#3)(2004-1#1)(2004-11#1)(2004-12#1)(2004-8#2)(2005-10#1)(2005-11#4)(2005-2#1)(2005-7#1)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#10)(2006-11#2)(2006-12#4)(2006-2#2)(2006-3#1)(2006-5#3)(2006-6#1)(2006-7#2)(2006-8#6)(2007-1#3)(2007-10#1)(2007-11#4)(2007-12#9)(2007-2#2)(2007-3#3)(2007-4#3)(2007-6#2)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#47)(2008-11#6)(2008-12#3)(2008-2#4)(2008-3#6)(2008-4#3)(2008-5#17)(2008-6#1)(2008-7#11)(2008-8#7)(2008-9#4)(2009-10#3)(2009-12#5)(2009-2#3)(2009-3#2)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#3)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#4)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#4)(2011-1#4)(2011-12#1)(2011-2#11)(2012-1#6)(2012-11#1)(2012-12#2)(2012-2#9)(2012-3#6)(2013-1#10)(2013-7#4)(2013-8#7)
on thesurface of##2##3##(2008-11#2)
on theta-values##2##2##(2009-8#2)
on thick##2##2##(2008-2#1)(2008-3#1)
on thin##15##2##(1996-5#1)(2004-9#1)(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#5)(2008-4#1)
on thin-layer chromatograms##2##3##(1991-3#1)(2008-10#1)
on thin-layer chromatography (TLC) plates##2##5##(1996-2#1)(2008-10#1)
on thin-layer chromatography##3##3##(1993-9#1)(1996-2#1)(2008-10#1)
on thin-layer plates##2##3##(2008-10#1)(2008-5#1)
on thin-layer##8##2##(1991-3#1)(1993-9#1)(1996-2#1)(2008-10#4)(2008-5#1)
on thioredoxin##3##2##(1991-2#1)(2009-10#1)(2009-9#1)
on third##2##2##(2007-6#1)(2008-5#1)
on thirty##2##2##(2007-2#1)(2013-8#1)
on this approach##4##3##(2008-2#2)(2009-2#1)(2010-5#1)
on this assumption##2##3##(2005-7#1)(2008-9#1)
on this basis##4##3##(2008-10#1)(2008-2#1)(2008-8#1)(2013-1#1)
on this beamline##2##3##(2006-4#2)
on this behavior##3##3##(1992-9#1)(1993-12#1)(2007-10#1)
on this case report##3##4##(1990-2#1)(2006-10#1)(2011-2#1)
on this case##4##3##(1990-2#1)(2006-10#1)(2010-6#1)(2011-2#1)
on this cell line##2##4##(1997-5#1)(2008-11#1)
on this cell##3##3##(1997-5#1)(2008-11#1)(2011-2#1)
on this chart##2##3##(1995-9#2)
on this chromosome##4##3##(1995-12#1)(2006-10#1)(2008-10#1)(2008-7#1)
on this complex##4##3##(1995-1#1)(1997-7#1)(2008-4#1)(2009-10#1)
on this concept##6##3##(2006-10#1)(2007-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-5#1)
on this debate##2##3##(2010-11#1)(2012-2#1)
on this device##2##3##(2012-1#2)
on this effect##2##3##(1995-2#1)(2008-10#1)
on this electrode##2##3##(2008-10#2)
on this enzyme##3##3##(1996-6#1)(2008-7#2)
on this field##4##3##(1990-9#1)(2006-10#1)(2007-6#1)(2013-1#1)
on this fragment##2##3##(1990-9#1)(1997-3#1)
on this group of parasites##2##5##(2007-3#2)
on this group of##4##4##(1990-3#1)(2007-3#2)(2011-2#1)
on this host##2##3##(2008-10#2)
on this important##2##3##(1997-4#1)(2006-10#1)
on this information##4##3##(1991-11#1)(1992-4#1)(2011-1#1)(2013-7#1)
on this issue##15##3##(1991-3#1)(1991-7#1)(1992-12#1)(2004-12#1)(2005-10#1)(2006-10#3)(2007-10#1)(2007-8#1)(2008-1#1)(2008-11#2)(2011-2#1)(2013-8#1)
on this matter##6##3##(1993-8#1)(1997-8#1)(2007-1#1)(2007-5#1)(2008-7#1)(2008-9#1)
on this medium##2##3##(2008-10#1)(2008-5#1)
on this method##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2012-3#1)
on this model##3##3##(1990-7#1)(1997-2#1)(2007-9#1)
on this new##2##3##(2008-10#1)(2008-2#1)
on this newly##2##3##(2008-10#1)(2008-7#1)
on this particular##2##3##(2006-2#1)(2008-11#1)
on this pathway##2##3##(1996-8#1)(2011-3#1)
on this patient##2##3##(2008-4#1)(2008-5#1)
on this patient's##2##3##(1995-9#1)(2007-5#1)
on this peptide##2##3##(1991-1#1)(1993-3#1)
on this phenomenon##4##3##(2007-11#1)(2008-10#2)(2009-9#1)
on this plant##2##3##(2008-10#1)(2013-7#1)
on this problem##6##3##(1992-8#1)(2007-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)
on this process##3##3##(1991-1#1)(2008-10#1)(2008-11#1)
on this rare disease##2##4##(2007-7#1)(2010-3#1)
on this rare##4##3##(2007-7#1)(2008-12#1)(2010-3#1)(2010-8#1)
on this receptor##2##3##(1994-12#1)(2008-4#1)
on this schedule##2##3##(1997-1#1)(2008-6#1)
on this situation##3##3##(2011-2#1)(2013-1#2)
on this species##2##3##(2008-10#1)(2008-12#1)
on this specific issue##2##4##(2008-11#1)(2008-9#1)
on this specific##3##3##(2007-3#1)(2008-11#1)(2008-9#1)
on this study##6##3##(1997-4#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-8#1)(2013-8#1)
on this subject and##2##4##(2007-3#1)(2009-7#1)
on this subject is##2##4##(1993-10#1)(2010-11#1)
on this subject##25##3##(1991-10#1)(1992-1#1)(1992-12#1)(1993-10#1)(1994-9#1)(1996-8#1)(2006-10#1)(2006-2#3)(2006-9#1)(2007-3#1)(2007-7#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-11#1)(2011-12#1)(2011-2#1)
on this substrate##2##3##(2007-8#1)(2008-11#1)
on this system##2##3##(2008-10#1)(2008-11#1)
on this task##7##3##(1992-9#1)(1993-3#2)(1994-3#2)(1997-8#1)(2012-3#1)
on this technique##2##3##(2008-10#1)(2008-2#1)
on this theme##2##3##(2008-11#1)(2011-2#1)
on this theory##2##3##(1995-4#1)(2008-10#1)
on this topic and##2##4##(2008-10#1)(2011-1#1)
on this topic are##2##4##(2006-10#1)(2008-1#1)
on this topic is##5##4##(1992-4#1)(2007-6#1)(2008-10#1)(2008-8#1)(2011-2#1)
on this topic to##3##4##(2007-2#2)(2008-11#1)
on this topic were##2##4##(2008-8#1)(2010-3#1)
on this topic##43##3##(1990-11#1)(1992-10#1)(1992-4#1)(1993-6#1)(1997-1#1)(2004-10#1)(2005-8#1)(2006-10#3)(2007-10#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#7)(2008-1#2)(2008-10#2)(2008-11#1)(2008-8#3)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
on this type of##4##4##(1990-2#1)(1992-3#1)(2008-7#1)(2011-3#1)
on this##470##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#3)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-3#1)(1992-4#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-12#3)(1993-3#5)(1993-6#2)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#5)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-9#3)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-8#3)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#2)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#5)(2004-10#1)(2004-11#1)(2004-12#1)(2005-10#1)(2005-11#4)(2005-7#1)(2005-8#1)(2006-10#17)(2006-12#5)(2006-2#5)(2006-4#2)(2006-5#3)(2006-6#2)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#5)(2007-2#3)(2007-3#7)(2007-4#4)(2007-5#2)(2007-6#2)(2007-7#4)(2007-8#14)(2007-9#2)(2008-1#5)(2008-10#51)(2008-11#17)(2008-12#3)(2008-2#12)(2008-3#8)(2008-4#8)(2008-5#12)(2008-6#5)(2008-7#16)(2008-8#11)(2008-9#6)(2009-10#3)(2009-11#1)(2009-2#2)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#5)(2011-1#6)(2011-12#2)(2011-2#14)(2011-3#2)(2011-7#1)(2012-1#4)(2012-11#2)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#12)(2013-7#4)(2013-8#4)
on thoracic and##2##3##(1996-12#1)(2010-9#1)
on thoracic##3##2##(1996-12#1)(2007-4#1)(2010-9#1)
on those of##2##3##(1995-11#1)(1995-6#1)
on those that##5##3##(1994-12#1)(2006-1#1)(2006-10#1)(2008-10#1)(2008-8#1)
on those used##3##3##(1994-8#1)(2008-11#1)(2008-3#1)
on those who##2##3##(1992-3#1)(2004-9#1)
on those##50##2##(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(2004-9#1)(2006-1#1)(2006-10#4)(2006-2#2)(2006-6#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2010-2#1)(2010-3#1)(2010-4#1)(2011-12#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
on three consecutive days##2##4##(2008-1#1)(2010-12#1)
on three different media##2##4##(2005-11#2)
on three different##9##3##(2005-11#3)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)
on three factors##2##3##(2008-11#1)(2010-12#1)
on three independent##2##3##(1996-7#1)(1997-6#1)
on three issues##2##3##(2008-1#1)(2009-4#1)
on three occasions during##2##4##(2007-12#1)(2007-8#1)
on three occasions##4##3##(1993-1#1)(1994-12#1)(2007-12#1)(2007-8#1)
on three of the##2##4##(2008-5#1)(2009-4#1)
on three of##5##3##(2006-7#2)(2008-5#1)(2008-9#1)(2009-4#1)
on three parameters##3##3##(2008-10#2)(2013-8#1)
on three patients with##2##4##(2007-8#1)(2011-2#1)
on three patients##3##3##(2007-3#1)(2007-8#1)(2011-2#1)
on three separate occasions##2##4##(1991-3#1)(2011-1#1)
on three times##2##3##(2007-7#1)(2008-10#1)
on three types of##2##4##(1992-7#1)(2008-2#1)
on three##103##2##(1990-3#1)(1991-1#1)(1991-3#1)(1992-11#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-6#1)(1996-11#2)(1996-12#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-6#1)(2005-10#1)(2005-11#3)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-7#2)(2007-10#1)(2007-12#5)(2007-3#1)(2007-7#3)(2007-8#4)(2008-1#4)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#3)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2012-6#1)(2013-8#2)
on three-dimensional##9##2##(1993-2#1)(1994-8#1)(2007-1#1)(2008-2#2)(2008-3#2)(2010-9#1)(2013-1#1)
on thrombin##2##2##(1990-11#1)(1997-5#1)
on thromboembolic##2##2##(2008-7#2)
on through a##2##3##(2008-10#1)(2008-7#1)
on through##3##2##(2008-10#1)(2008-7#1)(2010-4#1)
on thymine radical anion##2##4##(2006-10#2)
on thymine##3##2##(1997-6#1)(2006-10#2)
on thyroid function and##2##4##(2006-11#1)(2012-2#1)
on thyroid function tests was##2##5##(2006-10#2)
on thyroid function##8##3##(1994-6#1)(2006-10#2)(2006-11#2)(2007-9#1)(2008-7#1)(2012-2#1)
on thyroid hormone##2##3##(1996-5#1)(2007-1#1)
on thyroid hormones##2##3##(2007-1#1)(2007-9#1)
on thyroid##20##2##(1991-8#1)(1992-8#1)(1994-6#1)(1996-5#1)(2006-10#2)(2006-11#3)(2007-1#2)(2007-9#2)(2008-5#1)(2008-7#3)(2009-2#1)(2012-2#1)(2013-1#1)
on thyrotropin##2##2##(1992-2#1)(1994-9#1)
on tick##2##2##(2004-11#1)(2008-8#1)
on tight##2##2##(1995-3#1)(2008-8#1)
on time and on##2##4##(1991-1#1)(2008-10#1)
on time and##3##3##(1991-1#1)(1996-11#1)(2008-10#1)
on time scales from##2##4##(1990-3#1)(1995-1#1)
on time scales of##2##4##(1996-4#1)(2009-2#1)
on time scales##7##3##(1990-3#1)(1994-9#1)(1995-1#1)(1996-4#1)(2008-10#1)(2008-4#1)(2009-2#1)
on time to##2##3##(2008-10#1)(2012-12#1)
on time##33##2##(1990-3#1)(1990-5#1)(1991-1#1)(1991-8#1)(1993-2#1)(1994-9#1)(1995-1#1)(1996-11#1)(1996-4#1)(1997-3#1)(2004-3#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-8#1)(2009-2#1)(2009-4#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)
on time-dependent##4##2##(1996-12#1)(1996-7#1)(2008-2#1)(2008-6#1)
on timing of##2##3##(2008-10#1)(2012-3#1)
on timing##4##2##(2007-12#1)(2008-10#1)(2009-7#1)(2012-3#1)
on tissue and##2##3##(2006-12#1)(2007-8#1)
on tissue factor##2##3##(1992-10#1)(1994-11#1)
on tissue sections of##3##4##(1996-3#1)(2010-7#1)(2012-2#1)
on tissue##28##2##(1991-11#1)(1992-10#1)(1992-12#1)(1992-4#1)(1993-4#1)(1994-11#1)(1994-3#1)(1996-3#1)(1997-1#1)(2005-8#1)(2006-12#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-3#2)(2009-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
on tissues##4##2##(2005-10#1)(2009-4#1)(2012-2#1)(2013-1#1)
on titanium foil##2##3##(2009-11#2)
on titanium salts##2##3##(2008-10#1)(2008-5#1)
on titanium##12##2##(2007-5#1)(2008-10#4)(2008-5#2)(2009-11#2)(2009-7#1)(2012-11#2)
on titration with polyclonal antibody##2##5##(1996-11#2)
on titration##4##2##(1996-11#2)(1997-2#1)(2008-10#1)
on to a hanging mercury drop electrode##2##7##(2008-10#2)
on to a##8##3##(1997-8#1)(2006-2#1)(2006-3#1)(2008-10#2)(2008-9#1)(2010-2#1)(2013-1#1)
on to an##2##3##(2006-1#1)(2007-4#1)
on to develop##3##3##(1993-12#1)(2007-7#1)(2012-3#1)
on to explore##2##3##(1993-2#1)(1994-1#1)
on to have##3##3##(2008-10#1)(2009-10#1)(2010-12#1)
on to the surface##2##4##(2008-10#1)(2008-5#1)
on to the##13##3##(1990-12#1)(1997-5#1)(1997-8#1)(2004-8#1)(2004-9#1)(2007-7#1)(2008-10#4)(2008-5#1)(2009-1#1)(2012-3#1)
on to##74##2##(1990-12#1)(1990-8#1)(1992-1#1)(1992-12#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-3#1)(1995-1#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-5#1)(1997-8#2)(2004-3#1)(2004-8#1)(2004-9#1)(2005-11#1)(2005-6#1)(2005-7#3)(2006-1#1)(2006-10#1)(2006-2#1)(2006-3#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#2)(2008-10#12)(2008-11#1)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-9#1)(2012-1#1)(2012-3#3)(2013-1#3)(2013-7#2)
on tobacco and##4##3##(2008-10#4)
on tobacco control##2##3##(2009-12#2)
on tobacco##19##2##(1991-6#1)(1996-1#1)(1996-8#1)(2008-10#8)(2008-7#1)(2009-12#2)(2009-6#1)(2010-9#1)(2011-12#1)(2012-1#1)(2013-1#1)
on today's##3##2##(1991-3#1)(2006-5#1)(2007-4#1)
on tolerance##4##2##(2005-8#1)(2008-12#1)(2010-7#1)(2012-11#1)
on toluene##6##2##(1995-10#1)(2008-10#1)(2008-7#4)
on tomato and potato##2##4##(2008-10#2)
on tomato and##4##3##(2008-10#4)
on tomato plants grown in##2##5##(2008-10#2)
on tomato plants##5##3##(2008-10#4)(2011-12#1)
on tomato roots##2##3##(2008-10#2)
on tomato than##2##3##(2008-8#2)
on tomato##29##2##(2008-10#21)(2008-8#3)(2011-12#4)(2012-2#1)
on tooth##3##2##(2005-11#1)(2013-1#2)
on top of a waveguide##2##5##(2008-2#1)(2008-3#1)
on top of a##5##4##(1995-5#1)(2007-8#1)(2008-2#1)(2008-3#2)
on top of an##2##4##(2008-10#1)(2008-3#1)
on top of it##3##4##(2007-12#1)(2008-4#1)(2008-7#1)
on top of the##9##4##(1994-11#1)(2006-12#2)(2008-10#2)(2008-11#3)(2008-3#1)
on top of##33##3##(1994-11#1)(1995-5#1)(2006-12#3)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#4)(2008-2#2)(2008-3#6)(2008-4#1)(2008-7#1)(2010-4#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#2)
on top##36##2##(1994-11#1)(1995-5#1)(2006-12#3)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#4)(2008-2#3)(2008-3#6)(2008-4#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#2)
on top-down##2##2##(1997-8#1)(2013-8#1)
on topical##5##2##(1997-8#1)(2005-8#1)(2007-7#2)(2013-8#1)
on topics ranging from##2##4##(2005-8#1)(2006-10#1)
on topics##7##2##(1993-1#1)(1993-3#1)(1994-3#1)(1995-9#1)(1997-2#1)(2005-8#1)(2006-10#1)
on topoisomerase II##2##3##(1991-2#1)(1993-3#1)
on topoisomerase##4##2##(1991-2#2)(1993-3#1)(1995-7#1)
on total and##3##3##(2006-8#1)(2008-10#1)(2008-12#1)
on total internal reflection##3##4##(2008-2#2)(2008-3#1)
on total internal##4##3##(2008-2#3)(2008-3#1)
on total parenteral nutrition##3##4##(2006-10#1)(2006-7#1)(2011-2#1)
on total protein##2##3##(2006-12#1)(2012-2#1)
on total serum cholesterol in##2##5##(1996-3#1)(2010-3#1)
on total##36##2##(1990-11#3)(1990-8#1)(1992-3#1)(1992-8#1)(1993-9#1)(1994-2#1)(1994-6#1)(1996-3#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-12#3)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-4#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#2)(2013-1#1)
on touch##4##2##(1995-8#1)(2007-2#2)(2013-8#1)
on toughness##2##2##(2012-2#1)(2013-1#1)
on toxicity##4##2##(1992-8#1)(2008-5#1)(2012-2#1)(2013-8#1)
on trace metal##2##3##(2004-4#1)(2008-10#1)
on tracheal mucous velocity##2##4##(1991-9#2)
on tracheal##3##2##(1990-4#1)(1991-9#2)
on track##2##2##(1995-12#1)(2007-9#1)
on traditional Chinese medicine##2##4##(2013-1#2)
on traditional medicine##2##3##(2007-3#1)(2008-10#1)
on traditional##23##2##(1991-3#1)(1993-9#1)(1995-1#1)(2005-10#2)(2005-12#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-3#1)(2008-10#3)(2008-3#1)(2008-9#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-7#1)(2012-3#2)(2013-1#2)
on traffic##7##2##(1993-5#1)(1996-11#1)(2006-11#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
on training and##2##3##(1993-8#1)(2006-10#1)
on training##13##2##(1990-11#1)(1991-2#3)(1993-8#1)(1996-12#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-8#1)
on trait self-objectification##3##3##(2007-12#3)
on trait##4##2##(2007-12#3)(2012-3#1)
on trajectories##2##2##(2006-11#1)(2011-2#1)
on transcript##3##2##(1991-11#2)(2008-7#1)
on transcription of the ada gene##2##6##(1991-9#2)
on transcription of the##6##4##(1991-9#2)(1995-2#1)(1995-6#1)(1996-4#1)(1996-5#1)
on transcription##23##2##(1990-11#1)(1991-1#2)(1991-5#1)(1991-9#3)(1992-3#1)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-2#1)(2008-10#1)(2008-7#1)(2012-12#1)(2013-1#1)
on transcriptional activation##2##3##(1994-11#1)(2009-8#1)
on transcriptional and post-transcriptional##2##4##(1990-3#1)(2009-8#1)
on transcriptional regulation##2##3##(1996-7#1)(1997-6#1)
on transcriptional##7##2##(1990-3#1)(1994-11#1)(1996-7#1)(1997-6#1)(2008-8#1)(2009-8#2)
on transesophageal echocardiography##3##3##(1996-6#1)(2006-12#1)(2007-2#1)
on transferrin##2##2##(1994-10#1)(1995-5#1)
on transformation##4##2##(1990-4#1)(1994-2#1)(1997-3#1)(2008-10#1)
on transformed##3##2##(1991-3#1)(1992-9#1)(1995-2#1)
on transfusion##2##2##(1990-11#1)(2005-12#1)
on transgenic##5##2##(1990-5#1)(2006-12#1)(2010-9#1)(2011-2#1)(2013-1#1)
on transient##6##2##(1992-9#1)(1996-5#1)(1996-6#1)(2005-11#1)(2006-12#1)(2010-12#1)
on transiently transfected##2##3##(1994-6#1)(2008-7#1)
on translation initiation##2##3##(2005-10#2)
on translation##7##2##(1992-2#1)(1995-3#1)(1995-5#1)(2005-10#2)(2008-9#1)(2013-8#1)
on translational activity##2##3##(1990-2#2)
on translational##3##2##(1990-2#2)(2010-5#1)
on translocation of##2##3##(1995-11#1)(2008-10#1)
on transmission of##3##3##(1991-10#1)(2006-8#1)(2013-8#1)
on transmission##8##2##(1991-10#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-5#1)(2013-8#1)
on transmittance##2##2##(2008-3#2)
on transmitter release from##2##4##(1992-8#1)(1995-11#1)
on transmitter##3##2##(1992-8#1)(1993-12#1)(1995-11#1)
on transparent substrates##2##3##(2008-2#2)
on transparent##5##2##(2007-11#1)(2007-12#1)(2008-2#3)
on transplant##3##2##(2008-1#1)(2008-4#1)(2008-8#1)
on transplantation of##3##3##(1991-12#1)(2005-11#1)(2010-2#1)
on transplantation##5##2##(1991-12#1)(2005-11#1)(2007-8#1)(2010-2#1)(2011-2#1)
on transport of##2##3##(1997-7#1)(2012-2#1)
on transport##9##2##(1990-12#1)(1997-6#1)(1997-7#1)(2005-11#2)(2008-11#1)(2010-2#1)(2011-2#1)(2012-2#1)
on transthoracic echocardiography##2##3##(2007-8#1)(2008-11#1)
on transverse##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
on trap trees##3##3##(2011-2#3)
on trap##5##2##(2008-10#1)(2008-2#1)(2011-2#3)
on trauma##2##2##(2007-4#1)(2008-6#1)
on traumatic##2##2##(2006-10#1)(2007-11#1)
on travel health##2##3##(2007-2#2)
on travel##6##2##(2007-2#4)(2009-7#1)(2011-2#1)
on treated##8##2##(1991-12#1)(1996-12#1)(2008-10#2)(2008-5#3)(2010-11#1)
on treating the underlying##2##4##(1991-12#1)(2008-3#1)
on treating the##4##3##(1991-12#1)(2008-3#1)(2010-12#1)(2011-1#1)
on treating##9##2##(1991-12#1)(1991-5#1)(2006-6#1)(2008-3#2)(2009-4#1)(2010-12#1)(2011-1#1)(2013-1#1)
on treatment and##6##3##(2004-4#2)(2006-10#1)(2008-3#1)(2008-5#1)(2010-4#1)
on treatment benefits##2##3##(2013-7#2)
on treatment efficacy##2##3##(2005-6#1)(2008-4#1)
on treatment for##2##3##(2007-10#1)(2008-9#1)
on treatment of##13##3##(1991-7#1)(1992-6#1)(1997-8#1)(2005-10#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-8#2)(2012-2#1)(2012-3#1)(2013-8#1)
on treatment outcome##4##3##(2007-8#3)(2010-5#1)
on treatment with##9##3##(1992-4#1)(1996-5#1)(1997-6#1)(2004-3#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-3#1)(2011-1#1)
on treatment##70##2##(1990-12#1)(1991-7#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-3#1)(1994-2#1)(1994-8#2)(1995-3#1)(1995-9#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-6#1)(1997-8#1)(2004-3#1)(2004-4#2)(2005-10#1)(2005-6#1)(2006-10#3)(2006-11#1)(2006-6#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#2)(2007-7#3)(2007-8#3)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
on tree##5##2##(2007-6#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-8#1)
on trees and##2##3##(2008-10#2)
on trees with##2##3##(2011-12#2)
on trees##6##2##(2008-10#3)(2008-5#1)(2011-12#2)
on trends in##2##3##(1991-3#2)
on trends##4##2##(1991-3#2)(1996-3#1)(2011-2#1)
on triacylglycerol##3##2##(1991-10#1)(1991-2#2)
on trial##9##2##(1990-5#1)(1992-2#1)(1994-3#1)(1994-4#1)(1995-8#1)(2006-6#1)(2008-3#1)(2012-3#2)
on trials in##2##3##(2006-12#1)(2009-4#1)
on trials##7##2##(1994-3#1)(2006-12#1)(2008-3#1)(2009-3#1)(2009-4#1)(2012-2#1)(2013-1#1)
on tricyclic##2##2##(1995-3#1)(2006-10#1)
on trigeminal##3##2##(1992-1#1)(1995-5#1)(1997-2#1)
on triglyceride##3##2##(1997-2#2)(2007-8#1)
on triple##4##2##(2007-7#1)(2008-1#2)(2008-10#1)
on trophoblast##3##2##(1994-9#1)(1996-12#1)(2013-1#1)
on tropical##2##2##(2008-5#1)(2012-2#1)
on troponin##2##2##(1996-5#2)
on true##2##2##(2008-10#1)(2013-1#1)
on trunk and##2##3##(2007-7#2)
on trypsin##2##2##(1991-7#1)(1993-5#1)
on tryptophan##2##2##(2008-10#1)(2009-10#1)
on tubal##2##2##(1994-12#1)(1996-3#1)
on tuberculosis##3##2##(2005-9#1)(2010-8#1)(2011-1#1)
on tubulin##4##2##(1991-7#2)(1995-5#1)(1997-4#1)
on tumor cell lines##2##4##(1992-2#1)(2011-1#1)
on tumor cell##4##3##(1992-2#1)(1997-5#1)(2008-9#1)(2011-1#1)
on tumor cells and##3##4##(1990-12#1)(1992-8#1)(2010-11#1)
on tumor cells##11##3##(1990-11#1)(1990-12#1)(1991-9#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-2#1)(2008-4#1)(2009-2#1)(2010-11#1)(2013-8#1)
on tumor development##2##3##(1990-5#1)(2013-1#1)
on tumor growth##8##3##(1994-12#1)(1994-6#2)(1996-6#1)(2008-9#1)(2010-12#1)(2013-1#1)(2013-7#1)
on tumor size##3##3##(1996-6#1)(2010-2#1)(2011-2#1)
on tumor##49##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-9#1)(1992-2#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-7#1)(1994-12#2)(1994-2#1)(1994-6#2)(1995-2#1)(1995-4#1)(1996-6#3)(1997-2#1)(1997-5#1)(1997-7#1)(2005-9#1)(2006-6#2)(2008-11#1)(2008-4#1)(2008-9#4)(2009-2#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
on tumour##6##2##(1995-5#1)(2009-10#1)(2009-9#1)(2010-4#1)(2011-2#1)(2013-8#1)
on twelve##2##2##(2008-3#1)(2008-5#1)
on twenty##2##2##(2008-5#1)(2013-1#1)
on two adjacent##2##3##(1996-5#1)(2008-10#1)
on two approaches##2##3##(2008-11#1)(2008-4#1)
on two aspects of##2##4##(1996-7#1)(2012-12#1)
on two cases##3##3##(2008-1#1)(2010-12#1)(2011-1#1)
on two closely related##2##4##(2008-8#1)(2012-3#1)
on two competing##2##3##(1991-3#1)(1994-3#1)
on two consecutive##2##3##(1996-2#1)(2007-8#1)
on two different##9##3##(1990-11#1)(1995-8#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-1#1)
on two factors##2##3##(1992-3#1)(2009-6#1)
on two farms##3##3##(1994-7#1)(2008-5#1)(2013-8#1)
on two fronts##2##3##(1992-6#1)(1993-3#1)
on two genetic##2##3##(2006-10#1)(2010-2#1)
on two groups of##2##4##(1991-9#1)(1996-2#1)
on two groups##5##3##(1991-9#1)(1996-2#1)(2007-9#1)(2008-12#1)(2013-1#1)
on two host##2##3##(2007-6#1)(2008-9#1)
on two important##2##3##(1995-5#1)(2008-10#1)
on two key##2##3##(2008-9#1)(2009-11#1)
on two new##4##3##(1993-12#1)(2008-10#1)(2008-11#1)(2010-7#1)
on two objective##2##3##(1993-6#1)(2008-9#1)
on two occasions##7##3##(1991-8#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-9#1)
on two or more##2##4##(2006-8#1)(2011-1#1)
on two parameters##5##3##(1995-12#1)(2008-2#2)(2008-3#1)(2010-8#1)
on two patients##4##3##(1990-11#1)(2008-10#1)(2010-5#1)(2011-1#1)
on two separate days##2##4##(1997-5#1)(2008-12#1)
on two separate occasions##4##4##(1996-5#1)(2006-5#1)(2006-8#1)(2010-2#1)
on two separate##8##3##(1996-5#1)(1997-5#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-2#1)(2008-12#1)(2010-2#1)
on two successive days##2##4##(1991-12#1)(1995-11#1)
on two types of##6##4##(1991-7#1)(1992-8#1)(1993-9#1)(2008-3#1)(2010-10#1)(2013-1#1)
on two##221##2##(1990-11#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#2)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#2)(1994-3#3)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#3)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-4#1)(2005-10#1)(2005-11#2)(2006-10#2)(2006-12#3)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#22)(2008-11#8)(2008-12#5)(2008-2#11)(2008-3#10)(2008-4#5)(2008-5#8)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#6)(2009-1#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#4)(2012-3#2)(2012-6#1)(2012-9#1)(2013-1#5)(2013-7#2)(2013-8#3)
on two-dimensional polyacrylamide##2##3##(1994-9#1)(1997-2#1)
on two-dimensional##12##2##(1990-7#1)(1991-8#1)(1992-9#1)(1993-11#1)(1994-9#1)(1997-2#1)(2006-10#1)(2007-12#2)(2008-2#1)(2008-3#1)(2011-1#1)
on two-photon fluorescence##4##3##(2007-11#2)(2008-2#1)(2008-3#1)
on two-photon##9##2##(1992-8#1)(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#1)(2009-4#1)
on type 2##3##3##(1990-7#1)(2006-2#1)(2013-1#1)
on type II##4##3##(1994-2#2)(1997-1#2)
on type IV and##3##4##(2007-7#2)(2007-8#1)
on type and##3##3##(2010-12#1)(2010-5#1)(2013-8#1)
on type of##3##3##(2008-10#1)(2008-12#1)(2008-8#1)
on type##19##2##(1990-7#1)(1994-2#2)(1994-9#1)(1997-1#2)(2006-2#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-12#1)(2010-5#1)(2013-1#3)(2013-8#1)
on types of##3##3##(1997-1#1)(2009-7#1)(2013-1#1)
on tyrosinase##3##2##(2007-8#1)(2008-10#1)(2008-5#1)
on tyrosine and an##2##4##(1990-11#1)(1993-9#1)
on tyrosine and##5##3##(1990-11#1)(1993-9#1)(1995-3#1)(1996-2#1)(1996-5#1)
on tyrosine hydroxylase##2##3##(1995-11#1)(1995-12#1)
on tyrosine phosphorylation##2##3##(1994-9#1)(1996-5#1)
on tyrosine residues in vivo##2##5##(1991-12#1)(1995-12#1)
on tyrosine residues in##5##4##(1991-12#1)(1992-8#1)(1993-6#1)(1995-12#1)(1995-8#1)
on tyrosine residues##11##3##(1991-12#1)(1991-5#1)(1992-3#1)(1992-8#2)(1993-6#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)
on tyrosine##28##2##(1990-11#1)(1990-3#2)(1991-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-7#1)(1992-8#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-5#3)(2005-4#1)(2012-12#1)
on tyrosines##2##2##(1993-6#2)
on ultrafast##2##2##(2007-12#2)
on ultrasonic extraction##3##3##(1997-1#1)(2008-10#1)(2013-8#1)
on ultrasonic##4##2##(1997-1#1)(2008-10#1)(2009-10#1)(2013-8#1)
on ultrasonography in##2##3##(2007-3#1)(2011-2#1)
on ultrasonography##4##2##(2007-3#2)(2008-5#1)(2011-2#1)
on ultrasound##17##2##(1994-6#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-4#1)(2011-2#3)(2012-2#3)(2012-3#1)
on ultrastructural##2##2##(1996-9#1)(2008-6#1)
on ultrathin sections##2##3##(2007-12#1)(2008-1#1)
on ultraviolet##5##2##(1990-5#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
on umbilical vein##2##3##(1994-2#1)(1994-8#1)
on umbilical##3##2##(1994-2#1)(1994-8#1)(1995-9#1)
on unconventional##2##2##(1992-10#1)(2007-3#1)
on uncovering##3##2##(2006-10#1)(2008-5#1)(2011-12#1)
on undergraduate##3##2##(2008-11#2)(2013-1#1)
on underlying mechanisms##3##3##(2007-10#1)(2008-11#2)
on underlying##7##2##(1994-9#1)(2007-10#1)(2008-11#2)(2008-6#1)(2010-12#1)(2011-2#1)
on understanding of##2##3##(2009-7#1)(2010-12#1)
on understanding the mechanisms##2##4##(2009-8#1)(2011-1#1)
on understanding the##10##3##(2006-8#1)(2007-11#1)(2007-3#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-12#1)
on understanding##15##2##(1996-2#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-7#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-12#1)
on undifferentiated##3##2##(1990-11#1)(1991-9#1)(2013-8#1)
on unfolding##2##2##(1994-2#1)(1997-2#1)
on uniform##2##2##(2008-10#1)(2009-4#1)
on uninjured##2##2##(1997-6#2)
on univariate analysis##2##3##(1990-8#1)(2007-8#1)
on universal processes##2##3##(2012-2#2)
on university##3##2##(1994-12#1)(2008-11#1)(2011-2#1)
on unmodified##2##2##(2005-11#1)(2011-2#1)
on unrelated##2##2##(2011-12#1)(2012-3#1)
on untreated##10##2##(1994-3#1)(1994-9#1)(1996-12#1)(2008-10#2)(2008-11#2)(2008-5#2)(2011-2#1)
on unusual##2##2##(1990-6#1)(2007-7#1)
on upper extremity##2##3##(2006-3#1)(2008-8#1)
on upper##7##2##(1991-5#1)(2006-10#1)(2006-3#1)(2008-10#1)(2008-12#1)(2008-8#1)(2012-3#1)
on uptake##4##2##(1995-1#1)(1995-11#2)(2011-12#1)
on urban and##2##3##(2010-5#1)(2011-1#1)
on urban##4##2##(1992-12#1)(2008-11#1)(2010-5#1)(2011-1#1)
on uredinial##2##2##(2008-10#2)
on urediniospore germination##2##3##(2008-10#2)
on uric acid##2##3##(2006-10#1)(2008-10#1)
on urinary tract##3##3##(1991-5#1)(2008-10#1)(2010-2#1)
on urinary##12##2##(1990-12#1)(1991-5#1)(1992-3#1)(1992-8#1)(1995-6#2)(2007-10#1)(2008-10#1)(2008-12#1)(2010-2#1)(2011-2#1)(2012-2#1)
on urine##6##2##(1990-10#1)(1993-5#1)(1997-8#1)(2007-4#1)(2008-10#1)(2008-3#1)
on urology##3##2##(2006-9#3)
on use of##12##3##(1995-12#1)(1996-1#1)(1996-3#1)(2004-8#1)(2007-10#1)(2007-9#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-6#1)
on use##16##2##(1995-1#1)(1995-12#1)(1996-1#1)(1996-3#1)(2004-8#1)(2006-10#1)(2007-10#1)(2007-9#1)(2008-11#2)(2008-3#3)(2008-4#1)(2008-6#1)(2012-12#1)
on user##2##2##(2011-2#2)
on using a##4##3##(1992-1#1)(2008-3#1)(2008-9#1)(2012-2#1)
on using the##6##3##(1992-12#1)(2005-11#1)(2007-12#1)(2008-2#2)(2008-9#1)
on using##29##2##(1992-1#1)(1992-12#1)(1996-12#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-8#2)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-9#4)(2009-9#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
on uterine epithelial cells##2##4##(2008-6#2)
on uterine##8##2##(1990-8#1)(1995-10#1)(2006-5#2)(2008-4#1)(2008-6#2)(2010-3#1)
on utilization and##3##3##(2011-2#1)(2012-12#2)
on utilization of prenatal care and##2##6##(2005-10#2)
on utilization of##3##3##(1997-4#1)(2005-10#2)
on utilization##9##2##(1994-3#1)(1997-4#1)(2005-10#2)(2011-2#1)(2012-12#3)(2013-8#1)
on v##2##2##(2008-2#1)(2008-5#1)
on vaccine##2##2##(2007-11#1)(2008-12#1)
on vagal##2##2##(1992-9#2)
on vaginal##3##2##(1995-1#2)(2012-3#1)
on valid##2##2##(2008-2#2)
on validation##2##2##(1990-12#1)(1997-1#1)
on value##5##2##(1990-12#1)(1994-2#1)(1995-1#1)(2006-2#1)(2007-11#1)
on values##2##2##(2006-10#1)(2008-9#1)
on vanadium##2##2##(2004-4#1)(2011-2#1)
on vancomycin and##2##3##(2007-6#1)(2008-10#1)
on vancomycin##3##2##(2007-6#1)(2008-10#1)(2013-1#1)
on variability##2##2##(1996-11#1)(2008-7#1)
on variable##3##2##(1993-1#1)(2013-8#2)
on variables such as##2##4##(1993-1#1)(2011-1#1)
on variables##5##2##(1993-1#1)(1994-2#1)(2006-3#1)(2008-3#1)(2011-1#1)
on variance in##2##3##(2008-8#1)(2010-8#1)
on variance##3##2##(2008-3#1)(2008-8#1)(2010-8#1)
on variation##2##2##(2008-10#1)(2008-3#1)
on variations of##3##3##(1990-9#1)(2008-4#1)(2009-3#1)
on variations##4##2##(1990-9#1)(2007-12#1)(2008-4#1)(2009-3#1)
on various aspects of##7##4##(1995-12#1)(2005-7#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2010-10#1)
on various aspects##9##3##(1995-12#1)(2005-7#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#2)(2010-10#1)(2010-2#1)
on various cells##2##3##(1992-11#1)(2007-2#1)
on various immune##2##3##(2007-11#1)(2008-10#1)
on various media##2##3##(2008-3#1)(2011-2#1)
on various substrates##2##3##(2004-9#1)(2008-6#1)
on various system parameters##2##4##(2007-11#1)(2008-2#1)
on various types of##4##4##(1991-11#1)(2008-1#1)(2008-10#1)(2008-2#1)
on various##95##2##(1990-2#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-11#2)(1992-7#2)(1993-3#1)(1993-9#1)(1994-3#1)(1995-12#3)(1995-3#3)(1996-1#1)(1996-3#1)(1997-2#1)(2004-9#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#2)(2006-12#2)(2006-8#1)(2007-11#2)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#5)(2008-11#5)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#4)(2009-11#1)(2009-4#1)(2009-8#1)(2010-10#3)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#4)(2013-8#1)
on vascular endothelial cells##2##4##(1991-5#1)(1994-5#1)
on vascular endothelial##3##3##(1991-5#1)(1994-5#1)(2011-2#1)
on vascular grafts in##2##4##(1990-11#1)(1994-7#1)
on vascular prostacyclin production##2##4##(1991-5#1)(1994-5#1)
on vascular prostacyclin##3##3##(1991-5#2)(1994-5#1)
on vascular risk##2##3##(2005-10#2)
on vascular smooth muscle cells##2##5##(1992-2#1)(1995-12#1)
on vascular smooth muscle##3##4##(1990-4#1)(1992-2#1)(1995-12#1)
on vascular smooth##4##3##(1990-4#1)(1992-2#1)(1995-12#1)(2013-1#1)
on vascular##32##2##(1990-11#1)(1990-4#2)(1991-10#1)(1991-5#3)(1991-7#2)(1992-2#1)(1993-9#1)(1994-5#2)(1994-7#1)(1995-12#1)(1996-10#2)(1996-12#1)(1997-6#2)(2005-10#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
on vasopressin##3##2##(1990-5#1)(1994-2#2)
on vector##3##2##(2007-6#1)(2008-10#1)(2008-6#1)
on vectors##2##2##(1994-6#1)(2010-1#1)
on vegetable##2##2##(2008-10#1)(2008-5#1)
on vegetative##3##2##(2008-10#2)(2012-8#1)
on ventilators##3##2##(2010-8#3)
on ventricular##4##2##(1996-7#1)(2006-9#1)(2008-7#1)(2009-10#1)
on verb##3##2##(2007-8#1)(2012-1#1)(2012-11#1)
on verbal working memory##2##4##(1995-12#1)(2012-3#1)
on verbal##7##2##(1990-3#1)(1995-12#1)(2007-8#1)(2008-4#1)(2012-1#1)(2012-11#1)(2012-3#1)
on vertical##2##2##(2008-2#1)(2008-3#1)
on very##4##2##(1994-3#1)(2007-9#1)(2008-2#1)(2011-1#1)
on vesicle##2##2##(1994-6#1)(2008-11#1)
on vesicular##2##2##(1994-2#1)(1995-2#1)
on vessel##2##2##(1995-2#1)(2008-11#1)
on vestibular##2##2##(2006-11#1)(2013-1#1)
on viability and##2##3##(1991-10#1)(2008-5#1)
on viability of##3##3##(1990-6#1)(2010-5#1)(2013-1#1)
on viability##9##2##(1990-6#1)(1991-10#1)(2006-5#1)(2006-8#1)(2008-11#2)(2008-5#1)(2010-5#1)(2013-1#1)
on viable cell##2##3##(2008-11#2)
on victimization##2##2##(2012-12#2)
on victims and##2##3##(2008-4#1)(2013-8#1)
on video##2##2##(2008-11#2)
on vimentin##2##2##(1991-3#2)
on violence in##2##3##(1995-2#1)(2008-11#1)
on violence##5##2##(1995-2#1)(2007-2#1)(2008-11#1)(2008-7#1)(2013-1#1)
on viral load##2##3##(1995-9#1)(1996-2#1)
on viral replication##3##3##(2008-11#1)(2009-9#1)(2012-3#1)
on viral##12##2##(1992-8#1)(1995-9#1)(1996-2#1)(1997-1#1)(1997-4#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-9#1)(2010-6#1)(2012-3#1)(2013-8#1)
on virulence##7##2##(1997-2#1)(2008-10#5)(2009-3#1)
on virus accumulation in##2##4##(2008-10#2)
on virus accumulation##3##3##(2008-10#3)
on virus##11##2##(2007-12#1)(2008-10#6)(2008-11#1)(2008-9#1)(2013-8#2)
on virus-infected plants##2##3##(2008-10#2)
on visceral##2##2##(2008-3#1)(2008-5#1)
on viscosity##3##2##(2008-5#3)
on visible##4##2##(1992-9#1)(1993-8#1)(2011-12#1)(2013-8#1)
on vision##2##2##(1995-3#1)(2006-10#1)
on visual analog scales##2##4##(2006-10#1)(2008-10#1)
on visual attention##2##3##(1997-2#1)(2007-4#1)
on visual cues##3##3##(1991-2#1)(2008-8#1)(2008-9#1)
on visual field##3##3##(1992-7#1)(2011-2#2)
on visual##34##2##(1990-10#1)(1991-2#1)(1992-7#1)(1994-11#1)(1997-2#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
on vital##2##2##(2012-2#1)(2013-1#1)
on vitamin A##4##3##(2006-10#2)(2008-8#1)(2011-2#1)
on vitamin D##2##3##(1992-6#1)(2012-2#1)
on vitamin##12##2##(1992-6#1)(1992-9#3)(1995-8#1)(2006-10#2)(2008-10#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
on vocational rehabilitation##2##3##(2006-8#1)(2010-12#1)
on volatile##2##2##(2008-5#1)(2011-10#1)
on voltage##3##2##(1991-9#1)(1993-9#1)(2006-2#1)
on voltage-activated##3##2##(1993-12#1)(1994-3#1)(1994-8#1)
on voltage-dependent gating of a cloned mammalian neuronal##2##8##(1997-2#2)
on voltage-dependent ion currents in##2##5##(1997-7#2)
on voltage-dependent ion currents##3##4##(1997-7#3)
on voltage-dependent##8##2##(1990-7#1)(1991-9#1)(1997-2#2)(1997-7#3)(2007-9#1)
on volume and##2##3##(1991-2#1)(2008-5#1)
on volume##6##2##(1991-2#1)(2007-12#1)(2008-3#1)(2008-5#2)(2010-12#1)
on voluntary##4##2##(1996-10#1)(2009-6#1)(2012-3#1)(2013-1#1)
on volunteers##4##2##(1994-6#1)(2008-2#1)(2008-5#1)(2009-5#1)
on vulnerable Medicare beneficiaries##2##4##(2007-2#2)
on vulnerable##4##2##(2007-1#1)(2007-2#3)
on vulvar##2##2##(1993-9#1)(2006-10#1)
on waist-to-hip ratio##2##3##(1990-9#1)(1991-10#1)
on waiting lists##4##3##(1991-11#1)(2006-10#1)(2006-8#1)(2011-3#1)
on waiting##6##2##(1991-11#1)(2006-10#1)(2006-8#1)(2011-3#3)
on walking##3##2##(2007-10#1)(2010-3#1)(2012-11#1)
on walls##2##2##(2008-10#1)(2008-5#1)
on warfarin##5##2##(2006-8#2)(2008-5#1)(2011-1#1)(2012-1#1)
on waste##2##2##(1994-2#1)(1996-1#1)
on wastewater##2##2##(2008-10#1)(2009-6#1)
on water agar##4##3##(2008-10#4)
on water and soil##2##4##(2007-10#1)(2008-5#1)
on water and##4##3##(2005-11#1)(2006-8#1)(2007-10#1)(2008-5#1)
on water binding##2##3##(2010-4#2)
on water quality##2##3##(2007-3#1)(2007-5#1)
on water toxicity##2##3##(2008-10#2)
on water##37##2##(1991-5#1)(1992-7#1)(1993-4#1)(1996-12#1)(2004-2#1)(2005-11#2)(2006-8#1)(2007-10#1)(2007-3#1)(2007-5#1)(2007-9#1)(2008-10#8)(2008-3#4)(2008-5#1)(2008-8#1)(2009-10#2)(2009-2#1)(2009-8#1)(2010-4#3)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)
on wave##2##2##(1990-3#1)(2008-2#1)
on waveguide##4##2##(2008-2#4)
on wavelength and##3##3##(2007-11#1)(2008-2#2)
on wavelength##12##2##(1995-3#1)(2007-11#1)(2008-2#8)(2008-3#2)
on ways in which##2##4##(2006-7#1)(2009-12#1)
on ways to##3##3##(1994-2#1)(2007-11#1)(2008-10#1)
on ways##5##2##(1994-2#1)(2006-7#1)(2007-11#1)(2008-10#1)(2009-12#1)
on weather##2##2##(1992-3#1)(2008-10#1)
on weed##3##2##(2008-12#3)
on week 2##2##3##(2013-1#2)
on weekdays##4##2##(2006-8#1)(2010-6#2)(2012-2#1)
on weight and##4##3##(2006-8#1)(2008-12#2)(2008-3#1)
on weight gain##4##3##(1991-2#1)(2006-8#1)(2007-2#1)(2007-8#1)
on weight loss##3##3##(2006-10#1)(2007-5#1)(2008-9#1)
on weight##21##2##(1990-9#1)(1991-2#1)(1996-9#2)(2006-10#1)(2006-8#4)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-12#2)(2008-3#2)(2008-9#1)(2011-2#1)(2012-3#1)
on welfare##4##2##(1994-3#2)(1996-11#1)(2007-12#1)
on well characterized##2##3##(1992-7#1)(2008-4#1)
on well##3##2##(1992-7#1)(2008-4#1)(2011-1#1)
on well-being##2##2##(2008-3#1)(2011-1#1)
on well-characterized##3##2##(2005-11#1)(2008-11#1)(2008-9#1)
on well-established##2##2##(2008-3#1)(2008-4#1)
on wellness rather than##2##4##(2011-2#1)(2013-8#1)
on wells##2##2##(1994-9#1)(2007-8#1)
on western blots##3##3##(1991-9#1)(1997-7#1)(2009-9#1)
on wetting##2##2##(1990-7#1)(2012-1#1)
on what constitutes an##2##4##(2008-12#1)(2013-1#1)
on what constitutes##5##3##(1995-2#1)(1995-3#1)(2008-12#1)(2010-10#1)(2013-1#1)
on what is known##2##4##(2009-8#1)(2012-12#1)
on what is##10##3##(2007-11#2)(2007-12#3)(2008-6#1)(2009-8#1)(2010-10#1)(2012-12#1)(2013-1#1)
on what it##2##3##(1993-12#1)(2008-1#1)
on what the##3##3##(1993-2#1)(2008-10#1)(2008-8#1)
on what to##2##3##(1996-2#1)(1997-2#1)
on what we do##2##4##(2006-8#1)(2007-7#1)
on what we##6##3##(1991-7#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-3#2)
on what##53##2##(1991-2#1)(1991-7#1)(1993-12#1)(1993-2#1)(1994-10#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-2#2)(1997-2#2)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#5)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#4)(2010-7#2)(2011-1#1)(2012-11#1)(2012-12#3)(2012-3#1)(2013-1#2)(2013-7#1)
on wheat and##2##3##(2008-10#1)(2008-8#1)
on wheat chromosome##3##3##(2008-10#2)(2008-5#1)
on wheat crops##2##3##(2008-10#2)
on wheat germ##4##3##(1990-12#1)(1990-8#1)(1991-12#1)(1993-8#1)
on wheat spikes##2##3##(2008-10#2)
on wheat yield##2##3##(2008-12#1)(2008-8#1)
on wheat##44##2##(1990-12#1)(1990-8#1)(1991-12#1)(1993-3#1)(1993-8#1)(2006-12#1)(2008-10#33)(2008-12#1)(2008-5#1)(2008-8#2)(2011-1#1)
on when it##2##3##(1995-5#1)(2006-8#1)
on when they are##2##4##(1994-5#1)(2010-2#1)
on when##9##2##(1994-5#1)(1995-1#1)(1995-5#1)(2006-8#1)(2007-7#1)(2010-2#1)(2010-8#1)(2011-2#2)
on where##4##2##(1992-9#1)(2007-9#1)(2009-11#1)(2011-2#1)
on whether or not##6##4##(1992-9#1)(1996-9#1)(2006-8#1)(2008-1#1)(2008-7#1)(2012-2#1)
on whether the##20##3##(1990-8#1)(1991-12#1)(1994-6#1)(1995-5#1)(1996-10#1)(1996-5#1)(1996-8#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-6#1)(2012-2#1)
on whether there is##2##4##(2006-7#1)(2012-3#1)
on whether they##6##3##(1997-3#1)(2007-6#1)(2008-3#1)(2008-5#1)(2011-2#2)
on whether this##2##3##(1991-4#1)(2007-8#1)
on whether to##2##3##(1996-2#1)(2007-9#1)
on whether##70##2##(1990-8#1)(1991-12#1)(1991-4#1)(1992-9#1)(1993-12#1)(1994-3#1)(1994-6#1)(1995-5#1)(1996-10#1)(1996-2#2)(1996-5#1)(1996-8#2)(1996-9#1)(1997-3#2)(2005-7#2)(2006-10#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#2)(2007-6#2)(2007-8#1)(2007-9#3)(2008-1#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-2#1)(2009-7#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#4)(2012-2#4)(2012-3#2)(2013-1#2)
on which a##4##3##(2008-11#1)(2008-3#1)(2008-5#1)(2012-3#1)
on which any##2##3##(2006-12#1)(2012-12#1)
on which classification##2##3##(2006-8#1)(2010-2#1)
on which it has##2##4##(2007-6#1)(2008-3#1)
on which it is##2##4##(1997-8#1)(2008-11#1)
on which it##6##3##(1991-3#1)(1997-8#1)(2007-6#1)(2007-9#1)(2008-11#1)(2008-3#1)
on which of##3##3##(2006-10#1)(2008-2#1)(2008-4#1)
on which one##2##3##(1994-3#1)(2009-8#1)
on which the##20##3##(1990-3#1)(1991-4#1)(1996-5#1)(1997-7#2)(1997-8#1)(2005-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2009-3#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-12#1)
on which these##2##3##(2007-8#1)(2008-12#1)
on which they are based##3##5##(2006-11#1)(2007-11#1)(2008-8#1)
on which they##8##3##(1995-11#1)(1995-5#1)(1996-4#1)(2006-10#1)(2006-11#1)(2007-11#1)(2008-8#1)(2009-4#1)
on which this##2##3##(1994-3#1)(2010-11#1)
on which to base##8##4##(1992-12#1)(1997-1#1)(2006-10#2)(2006-7#1)(2008-1#1)(2008-11#1)(2008-7#1)
on which to develop##2##4##(2006-11#1)(2008-11#1)
on which to##19##3##(1992-1#1)(1992-12#1)(1996-1#1)(1997-1#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-7#1)(2010-12#1)(2011-8#1)(2012-12#1)
on which viruliferous##2##3##(2008-10#2)
on which we##4##3##(2008-2#1)(2010-2#2)(2011-2#1)
on which##147##2##(1990-11#1)(1990-3#1)(1991-11#1)(1991-3#1)(1991-4#1)(1992-1#1)(1992-12#2)(1992-7#2)(1993-12#1)(1994-11#1)(1994-2#3)(1994-3#3)(1994-5#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-7#2)(1997-8#3)(2004-8#1)(2005-11#2)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#5)(2006-11#2)(2006-12#2)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#14)(2008-11#6)(2008-12#2)(2008-2#6)(2008-3#3)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-2#1)(2009-3#2)(2009-4#2)(2009-7#4)(2009-8#1)(2010-11#1)(2010-12#4)(2010-2#3)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#2)(2011-8#1)(2012-11#1)(2012-12#4)(2012-3#2)(2013-8#1)
on white fir at Teakettle##2##5##(2008-10#2)
on white fir in Lake Tahoe##2##6##(2008-10#2)
on white fir in##3##4##(2008-10#3)
on white fir##6##3##(2008-10#6)
on white##10##2##(2005-6#1)(2007-11#1)(2008-10#6)(2008-9#1)(2011-12#1)
on who##4##2##(1994-6#2)(2013-7#1)(2013-8#1)
on whole bacterial##2##3##(2008-7#2)
on whole blood##3##3##(1991-1#1)(2008-2#1)(2008-4#1)
on whole body sweat rate and##2##6##(2008-5#2)
on whole body##4##3##(2004-11#1)(2008-5#2)(2010-8#1)
on whole plants##2##3##(2008-10#2)
on whole##16##2##(1991-1#1)(2004-11#1)(2006-11#1)(2006-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#3)(2010-1#2)(2010-8#1)
on whole-cell##3##2##(1992-11#1)(1993-7#1)(1995-8#1)
on whom##11##2##(1991-8#1)(1992-12#1)(1993-11#1)(1994-2#1)(2006-6#1)(2007-3#1)(2007-7#1)(2007-8#1)(2009-7#2)(2011-12#1)
on why##3##2##(1995-2#1)(2008-11#1)(2008-8#1)
on wide##4##2##(1991-9#1)(1996-12#1)(2007-3#1)(2010-11#1)
on wild and##2##3##(2008-10#1)(2012-2#1)
on wild type##2##3##(2006-2#1)(2013-8#1)
on wild##8##2##(2006-2#1)(2008-10#3)(2012-2#2)(2013-8#2)
on wild-type##4##2##(1990-12#1)(1991-5#1)(1994-11#1)(2008-5#1)
on wildlife##2##2##(2013-1#1)(2013-8#1)
on winter wheat in##2##4##(2008-10#1)(2012-2#1)
on winter wheat##8##3##(2008-10#7)(2012-2#1)
on winter##10##2##(2008-10#8)(2009-9#1)(2012-2#1)
on with##7##2##(1991-5#1)(1991-9#1)(1992-10#1)(2007-7#1)(2007-8#2)(2008-10#1)
on withdrawal##2##2##(2006-10#1)(2012-11#1)
on women and##4##3##(1995-9#1)(1996-12#1)(2007-2#1)(2010-8#1)
on women who##2##3##(1994-12#1)(2007-3#1)
on women with##3##3##(2008-9#1)(2010-12#2)
on women##17##2##(1992-2#1)(1994-12#1)(1994-5#1)(1995-9#1)(1996-12#1)(2007-2#1)(2007-3#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
on women's body image##2##4##(2007-12#2)
on women's body##3##3##(2007-12#3)
on women's health##2##3##(2009-11#1)(2011-1#1)
on women's##16##2##(1994-3#1)(1996-8#1)(2007-12#4)(2007-7#1)(2008-11#1)(2009-11#1)(2009-3#2)(2010-11#1)(2010-2#1)(2010-3#2)(2011-1#1)
on wood##6##2##(2007-6#1)(2010-4#3)(2012-5#1)(2013-1#1)
on word##3##2##(2009-11#2)(2011-2#1)
on word-problem##2##2##(2009-11#2)
on work##6##2##(1991-11#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#2)
on workers##5##2##(1994-6#2)(2007-7#1)(2013-7#2)
on workers'##2##2##(1996-2#1)(2011-2#1)
on working memory##4##3##(1993-12#1)(1993-3#1)(2012-3#2)
on working##14##2##(1990-8#2)(1992-2#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-6#1)(2007-2#1)(2008-12#1)(2008-5#1)(2012-12#1)(2012-3#2)(2013-8#1)
on wound healing##5##3##(2007-12#1)(2008-4#1)(2011-12#1)(2012-12#1)(2013-8#1)
on wound##6##2##(1990-3#1)(2007-12#1)(2008-4#1)(2011-12#1)(2012-12#1)(2013-8#1)
on wounded apples##2##3##(2008-10#2)
on wounded##3##2##(2008-10#3)
on x-rays##2##2##(2007-11#1)(2007-9#1)
on xylose fermentation by Neurospora##2##5##(2005-11#2)
on xylose fermentation by##3##4##(2005-11#2)(2008-5#1)
on xylose##6##2##(1995-8#1)(2005-11#2)(2008-5#1)(2008-6#1)(2012-3#1)
on year##2##2##(2006-2#1)(2013-1#1)
on yeast##9##2##(1990-10#1)(1993-2#1)(1995-4#1)(1995-6#1)(1995-9#1)(2007-12#1)(2008-5#1)(2008-6#1)(2010-7#1)
on yield were##2##3##(2008-10#2)
on yield##10##2##(2007-6#1)(2008-10#5)(2008-12#1)(2009-7#1)(2011-12#2)
on young adult outcomes##2##4##(2010-7#2)
on young adult##6##3##(2010-7#6)
on young adults##3##3##(1993-12#1)(2011-12#1)(2013-1#1)
on young##21##2##(1993-12#2)(2007-12#3)(2007-8#1)(2008-5#1)(2008-7#1)(2010-7#7)(2011-12#1)(2012-1#1)(2012-3#1)(2013-1#3)
on younger patients##2##3##(2012-12#1)(2013-1#1)
on younger##6##2##(1990-5#1)(2008-10#1)(2012-12#3)(2013-1#1)
on your##3##2##(1995-12#1)(2007-1#1)(2007-4#1)
on youth##3##2##(2008-9#1)(2009-7#1)(2011-2#1)
on zinc##5##2##(1990-9#1)(1993-8#1)(2005-11#1)(2008-10#1)(2010-2#1)
on zircon##3##2##(2005-11#3)
on α-glucosidase activity in##2##4##(2010-11#2)
on β##2##2##(2011-1#1)(2013-1#1)
on γ-PGA-Bn##4##2##(2012-11#4)
on##67622##1##(1990-1#27)(1990-10#144)(1990-11#214)(1990-12#285)(1990-2#254)(1990-3#184)(1990-4#118)(1990-5#212)(1990-6#103)(1990-7#186)(1990-8#235)(1990-9#134)(1991-1#168)(1991-10#127)(1991-11#155)(1991-12#287)(1991-2#295)(1991-3#218)(1991-4#122)(1991-5#215)(1991-6#173)(1991-7#160)(1991-8#154)(1991-9#207)(1992-1#158)(1992-10#74)(1992-11#136)(1992-12#260)(1992-2#186)(1992-3#251)(1992-4#116)(1992-5#114)(1992-6#195)(1992-7#133)(1992-8#200)(1992-9#201)(1993-1#113)(1993-10#37)(1993-11#199)(1993-12#370)(1993-2#194)(1993-3#254)(1993-4#97)(1993-5#112)(1993-6#206)(1993-7#93)(1993-8#135)(1993-9#204)(1994-1#79)(1994-10#88)(1994-11#216)(1994-12#284)(1994-2#340)(1994-3#314)(1994-4#44)(1994-5#213)(1994-6#283)(1994-7#37)(1994-8#271)(1994-9#239)(1995-1#224)(1995-10#81)(1995-11#241)(1995-12#344)(1995-2#306)(1995-3#257)(1995-4#74)(1995-5#193)(1995-6#239)(1995-7#114)(1995-8#196)(1995-9#107)(1996-1#178)(1996-10#95)(1996-11#169)(1996-12#360)(1996-2#317)(1996-3#276)(1996-4#134)(1996-5#275)(1996-6#196)(1996-7#127)(1996-8#175)(1996-9#155)(1997-1#227)(1997-2#349)(1997-3#240)(1997-4#221)(1997-5#229)(1997-6#237)(1997-7#242)(1997-8#287)(1997-9#5)(2003-11#8)(2004-1#23)(2004-10#38)(2004-11#104)(2004-12#77)(2004-2#51)(2004-3#20)(2004-4#33)(2004-5#1)(2004-7#6)(2004-8#12)(2004-9#111)(2005-1#23)(2005-10#208)(2005-11#731)(2005-12#90)(2005-2#6)(2005-3#16)(2005-4#75)(2005-5#33)(2005-6#26)(2005-7#173)(2005-8#185)(2005-9#55)(2006-1#54)(2006-10#1073)(2006-11#200)(2006-12#384)(2006-2#234)(2006-3#117)(2006-4#159)(2006-5#237)(2006-6#257)(2006-7#193)(2006-8#374)(2006-9#161)(2007-1#232)(2007-10#347)(2007-11#1159)(2007-12#1488)(2007-2#373)(2007-3#201)(2007-4#264)(2007-5#239)(2007-6#192)(2007-7#581)(2007-8#949)(2007-9#437)(2008-1#728)(2008-10#8258)(2008-11#1497)(2008-12#681)(2008-2#1747)(2008-3#2161)(2008-4#1012)(2008-5#1735)(2008-6#586)(2008-7#1301)(2008-8#1176)(2008-9#846)(2009-1#48)(2009-10#255)(2009-11#170)(2009-12#193)(2009-2#226)(2009-3#257)(2009-4#366)(2009-5#281)(2009-6#218)(2009-7#238)(2009-8#311)(2009-9#242)(2010-1#111)(2010-10#188)(2010-11#169)(2010-12#650)(2010-2#393)(2010-3#217)(2010-4#444)(2010-5#281)(2010-6#177)(2010-7#249)(2010-8#412)(2010-9#192)(2011-1#928)(2011-10#7)(2011-11#9)(2011-12#277)(2011-2#1607)(2011-3#102)(2011-4#1)(2011-7#11)(2011-8#2)(2011-9#3)(2012-1#536)(2012-10#5)(2012-11#215)(2012-12#878)(2012-2#1226)(2012-3#845)(2012-4#9)(2012-5#16)(2012-6#18)(2012-7#8)(2012-8#9)(2012-9#8)(2013-1#1835)(2013-4#1)(2013-7#386)(2013-8#961)
on&quot##13##1##(1990-8#1)(1997-2#1)(2008-7#6)(2008-8#4)(2011-1#1)
on'##2##1##(2006-10#1)(2008-11#1)
on)##11##1##(1995-5#1)(1995-8#1)(2006-2#2)(2007-2#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)
on- and off-rates##2##3##(1992-4#1)(1992-9#1)
on- and##6##2##(1992-4#1)(1992-9#1)(2007-8#1)(2008-2#1)(2008-7#1)(2008-8#1)
on-##11##1##(1991-3#3)(1992-4#1)(1992-9#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2012-12#1)
on-PVDF washing##2##2##(2007-8#2)
on-axis aberration##2##2##(2008-3#2)
on-axis current##2##2##(2007-12#2)
on-axis digital##2##2##(2007-12#2)
on-axis intensity##2##2##(2007-12#1)(2008-2#1)
on-axis##33##1##(2007-11#2)(2007-12#5)(2008-2#12)(2008-3#14)
on-bead##2##1##(2008-2#1)(2013-1#1)
on-bipolar cell##4##2##(1993-8#4)
on-board##7##1##(2008-10#3)(2008-11#1)(2008-2#1)(2009-10#1)(2012-1#1)
on-call physician##2##2##(2010-11#2)
on-call##5##1##(1996-2#1)(2007-4#1)(2010-11#2)(2011-2#1)
on-campus##3##1##(2008-11#2)(2010-11#1)
on-capillary##5##1##(1997-3#1)(2007-8#3)(2008-10#1)
on-chip capillary electrophoresis##2##3##(2008-10#2)
on-chip sample##2##2##(2007-8#1)(2008-10#1)
on-chip separation##2##2##(2008-10#2)
on-chip##24##1##(2007-8#1)(2008-10#9)(2008-2#3)(2008-3#2)(2009-12#2)(2009-5#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-11#2)
on-column UV##2##2##(2008-10#2)
on-column##15##1##(1992-2#2)(1993-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(2008-10#8)(2013-1#1)
on-demand##5##1##(2008-5#2)(2008-7#1)(2008-8#1)(2010-10#1)
on-farm measures##2##2##(2011-2#2)
on-farm safety##2##2##(2008-12#2)
on-farm##8##1##(2005-5#1)(2007-1#1)(2008-12#4)(2011-2#2)
on-fiber##2##1##(2007-12#1)(2008-10#1)
on-flow##2##1##(2007-1#2)
on-going research##2##2##(2008-3#1)(2013-1#1)
on-going##25##1##(1991-12#1)(1995-2#1)(1997-1#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
on-lattice##5##1##(2005-11#5)
on-line UV##5##2##(1996-5#1)(2005-12#1)(2008-10#3)
on-line adsorption preconcentration##2##3##(2008-10#2)
on-line analysis of##3##3##(1990-11#1)(2008-10#2)
on-line analysis##5##2##(1990-11#1)(2007-8#1)(2008-10#2)(2013-8#1)
on-line and off-line##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
on-line and##5##2##(2008-10#2)(2008-11#2)(2008-3#1)
on-line atomic absorption##2##3##(2008-10#2)
on-line atomic##3##2##(2008-10#3)
on-line automated##4##2##(2008-10#4)
on-line by flame atomic absorption spectrometry##2##6##(2008-10#2)
on-line by##8##2##(1992-2#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)
on-line column enrichment##2##3##(2008-10#2)
on-line column preconcentration and separation systems##2##6##(2007-8#1)(2008-10#1)
on-line column preconcentration##3##3##(2007-8#1)(2008-10#2)
on-line column##8##2##(1992-11#1)(2007-8#1)(2008-10#6)
on-line concentration##2##2##(2008-10#2)
on-line control##2##2##(2007-11#1)(2008-7#1)
on-line coupled continuous flow liquid membrane extraction##2##7##(2008-10#2)
on-line coupled##5##2##(1996-11#1)(2008-10#4)
on-line coupling of##3##3##(1997-2#1)(2008-10#2)
on-line coupling##6##2##(1997-2#1)(2007-1#1)(2008-10#4)
on-line data##2##2##(2006-5#1)(2007-10#1)
on-line derivatization##7##2##(2008-10#7)
on-line detection of the##2##4##(2008-10#1)(2008-4#1)
on-line detection of##3##3##(2008-10#1)(2008-4#1)(2010-11#1)
on-line detection##10##2##(1997-3#1)(2008-10#6)(2008-11#1)(2008-4#1)(2010-11#1)
on-line determination of##12##3##(2006-12#1)(2008-10#10)(2010-5#1)
on-line determination##14##2##(2006-12#1)(2008-10#12)(2010-5#1)
on-line determined##2##2##(2008-10#2)
on-line dilution of the##2##4##(2008-10#2)
on-line dilution of##3##3##(2007-10#1)(2008-10#2)
on-line dilution##9##2##(2007-10#2)(2008-10#7)
on-line during##2##2##(1997-2#1)(2008-7#1)
on-line electrogenerated##5##2##(2008-10#5)
on-line enrichment##3##2##(2005-4#1)(2007-8#1)(2008-10#1)
on-line extraction and##2##3##(1990-8#1)(2008-10#1)
on-line extraction##5##2##(1990-8#1)(2005-4#1)(2008-10#3)
on-line flow injection##4##3##(2008-10#4)
on-line flow##6##2##(2008-10#5)(2008-11#1)
on-line flow-injection microwave-assisted mineralization and##2##5##(2008-10#2)
on-line formed##3##2##(2007-8#1)(2008-10#2)
on-line high performance liquid chromatography##2##5##(2007-8#1)(2010-5#1)
on-line hydride generation atomic absorption spectrometry##2##6##(2007-8#2)
on-line hydrolysis##3##2##(2008-10#3)
on-line identification of##3##3##(2007-1#1)(2008-10#1)(2008-11#1)
on-line in a##2##3##(1990-8#1)(2008-10#1)
on-line in the##2##3##(2008-10#2)
on-line in##6##2##(1990-8#1)(2008-10#4)(2008-7#1)
on-line instrumentation##3##2##(2008-10#3)
on-line into##3##2##(2007-8#1)(2008-10#2)
on-line learning##3##2##(2008-12#1)(2008-2#1)(2008-8#1)
on-line liquid-liquid extraction##3##3##(2008-10#3)
on-line liquid-liquid##5##2##(2008-10#5)
on-line measurement of the##2##4##(2008-2#1)(2008-3#1)
on-line measurement of##5##3##(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
on-line measurement##6##2##(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
on-line measurements are##2##3##(2008-10#1)(2008-3#1)
on-line measurements##5##2##(2008-10#4)(2008-3#1)
on-line method was##3##3##(2008-10#2)(2008-7#1)
on-line method##8##2##(2007-8#1)(2008-10#5)(2008-3#1)(2008-7#1)
on-line methods##2##2##(2008-1#1)(2008-10#1)
on-line microdialysis sampling##2##3##(2008-10#2)
on-line microdialysis##3##2##(2008-10#3)
on-line mixing and##2##3##(2008-10#2)
on-line mixing##3##2##(2008-10#3)
on-line monitoring and##3##3##(2007-8#2)(2008-10#1)
on-line monitoring of##8##3##(2006-3#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)
on-line monitoring system##2##3##(2007-12#1)(2008-10#1)
on-line monitoring##16##2##(1996-8#1)(2006-3#1)(2007-12#1)(2007-8#3)(2008-10#6)(2008-11#1)(2008-2#1)(2008-7#2)
on-line multiplexed sorption preconcentration##2##4##(2008-10#2)
on-line of##2##2##(2008-10#2)
on-line oxidation##3##2##(2008-10#3)
on-line portal##2##2##(1994-9#1)(2006-2#1)
on-line pre-concentration and##2##3##(2008-10#1)(2008-3#1)
on-line pre-concentration##4##2##(2007-8#1)(2008-10#1)(2008-3#2)
on-line pre-reduction##3##2##(2008-10#1)(2009-6#2)
on-line precipitation##4##2##(2008-10#4)
on-line preconcentration and##11##3##(2007-8#2)(2008-10#8)(2008-3#1)
on-line preconcentration of cobalt##2##4##(2008-10#2)
on-line preconcentration of##7##3##(2008-10#7)
on-line preconcentration system for zinc determination in##2##7##(2008-10#2)
on-line preconcentration system for##7##4##(2008-10#7)
on-line preconcentration system##10##3##(2008-10#10)
on-line preconcentration technique was##2##4##(2007-8#1)(2008-10#1)
on-line preconcentration with a##2##4##(2008-10#2)
on-line preconcentration with##4##3##(2008-10#4)
on-line preconcentration##40##2##(2007-8#4)(2008-10#35)(2008-3#1)
on-line preconcentration/separation and determination##2##4##(2008-10#2)
on-line reaction##3##2##(2008-10#3)
on-line retention of##2##3##(2008-10#2)
on-line sample cleanup##2##3##(2008-10#2)
on-line sample concentration##2##3##(2008-10#2)
on-line sample pretreatment##4##3##(2008-10#4)
on-line sample purification##2##3##(1992-2#1)(2008-10#1)
on-line sample##17##2##(1992-2#2)(1997-3#1)(2008-10#13)(2010-7#1)
on-line scanning##3##2##(1992-2#1)(2008-1#1)(2008-11#1)
on-line separation and##3##3##(2008-10#3)
on-line separation##6##2##(2008-10#6)
on-line sequential injection##3##3##(2008-10#3)
on-line sequential##4##2##(2008-10#4)
on-line solid phase extraction##4##4##(2007-8#2)(2008-10#2)
on-line solid phase##5##3##(2007-8#2)(2008-10#3)
on-line solid-phase extraction and##3##4##(1997-3#2)(2008-10#1)
on-line solid-phase extraction##12##3##(1990-6#1)(1997-2#1)(1997-3#2)(2007-8#1)(2008-10#7)
on-line sorbent##2##2##(2008-10#2)
on-line sorption##2##2##(2008-10#2)
on-line spectrophotometric##2##2##(2008-10#2)
on-line standard addition##4##3##(2008-10#4)
on-line system for##3##3##(2008-10#3)
on-line system with##3##3##(2008-10#3)
on-line system##12##2##(2007-8#1)(2008-10#11)
on-line systems##2##2##(2008-10#1)(2008-3#1)
on-line the##2##2##(2008-10#2)
on-line to an##2##3##(2008-10#2)
on-line to##8##2##(1994-11#1)(2007-8#1)(2008-10#5)(2008-7#1)
on-line urea##2##2##(2008-1#2)
on-line using a##2##3##(1996-8#1)(2008-10#1)
on-line wavelet transform##5##3##(2008-10#5)
on-line with the##3##3##(2008-10#3)
on-line with##17##2##(1992-1#1)(2007-8#1)(2008-10#15)
on-line##578##1##(1990-11#1)(1990-6#1)(1990-8#3)(1991-2#1)(1991-5#2)(1991-8#1)(1992-1#1)(1992-11#2)(1992-2#4)(1992-5#1)(1993-12#2)(1993-2#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#1)(1996-8#3)(1997-2#3)(1997-3#5)(1997-8#1)(2004-10#2)(2004-11#1)(2004-8#1)(2005-12#1)(2005-4#3)(2006-12#1)(2006-2#2)(2006-3#1)(2006-5#3)(2006-7#1)(2007-1#2)(2007-10#3)(2007-11#2)(2007-12#2)(2007-8#34)(2008-1#5)(2008-10#399)(2008-11#19)(2008-12#1)(2008-2#9)(2008-3#12)(2008-4#3)(2008-7#12)(2008-8#1)(2009-6#2)(2010-11#2)(2010-4#2)(2010-5#4)(2010-7#2)(2012-3#1)(2013-1#1)(2013-8#1)
on-off contrast##2##2##(2007-11#1)(2007-12#1)
on-off control##3##2##(2004-8#2)(2013-8#1)
on-off keying##2##2##(2007-11#2)
on-off switch##2##2##(1991-11#1)(2005-11#1)
on-off use of##2##3##(2009-8#1)(2013-8#1)
on-off##25##1##(1991-11#1)(1992-10#1)(1994-10#2)(1994-5#1)(1995-6#1)(2004-8#2)(2005-11#1)(2007-11#4)(2007-12#7)(2008-11#1)(2008-2#1)(2009-8#1)(2013-8#2)
on-plate##2##1##(2009-7#2)
on-pump Maze procedures through a mid-sternotomy approach##2##7##(2011-2#2)
on-pump Maze procedures##3##3##(2011-2#3)
on-pump coronary artery bypass grafting##3##5##(2007-8#1)(2013-1#2)
on-pump coronary artery bypass##4##4##(2007-8#2)(2013-1#2)
on-pump coronary##5##2##(2007-8#3)(2013-1#2)
on-pump patients##2##2##(2007-8#2)
on-pump to off-pump##2##3##(2007-8#2)
on-pump##19##1##(2007-8#12)(2008-10#1)(2008-6#1)(2011-2#3)(2013-1#2)
on-rate##3##1##(1995-11#1)(2008-1#1)(2008-8#1)
on-rates##2##1##(1995-2#1)(1997-7#1)
on-scene resuscitation##2##2##(2005-2#1)(2006-10#1)
on-set##2##1##(2004-9#2)
on-site cancellations##2##2##(1995-1#2)
on-site environmental analysis of explosives##2##5##(2008-10#2)
on-site environmental##4##2##(2008-10#4)
on-site monitoring of##3##3##(2007-8#1)(2008-10#2)
on-site monitoring##4##2##(2007-8#1)(2008-10#2)(2010-4#1)
on-site or##2##2##(2010-5#1)(2013-8#1)
on-site##51##1##(1993-3#1)(1995-1#2)(1995-12#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-8#1)(2006-8#1)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#15)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2009-4#1)(2009-9#1)(2010-1#1)(2010-4#2)(2010-5#1)(2011-1#1)(2012-2#3)(2012-3#1)(2013-8#3)
on-spot characterization##2##2##(2010-5#2)
on-spot##3##1##(2010-5#3)
on-target##7##1##(2007-11#2)(2008-3#2)(2012-2#3)
on-the-job training##3##2##(1993-2#1)(1996-3#1)(2007-3#1)
on-the-job##4##1##(1993-2#1)(1996-11#1)(1996-3#1)(2007-3#1)
on-treatment HBsAg##2##2##(2013-1#2)
on-treatment##8##1##(2009-8#4)(2011-2#1)(2013-1#2)(2013-7#1)
on/off##9##1##(1990-6#1)(1995-11#1)(2007-12#1)(2007-5#1)(2008-4#1)(2008-6#1)(2008-7#2)(2012-1#1)
on?##5##1##(1995-6#1)(2004-5#1)(2006-7#1)(2007-2#1)(2008-11#1)
onboard a satellite##2##3##(2008-3#2)
onboard the##5##2##(2008-2#2)(2008-3#3)
onboard##19##1##(2007-11#1)(2008-2#6)(2008-3#9)(2010-2#3)
once a day and##2##4##(2008-3#1)(2008-5#1)
once a day for##3##4##(1994-6#1)(2007-7#1)(2008-5#1)
once a day##20##3##(1990-4#1)(1990-5#1)(1991-7#2)(1991-9#2)(1993-11#1)(1994-6#1)(1995-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2012-12#1)
once a day)##3##3##(1995-5#1)(2007-2#1)(2008-5#1)
once a month##6##3##(1991-9#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-5#1)
once a week for##5##4##(1991-6#1)(2007-7#1)(2008-10#1)(2008-8#1)(2011-2#1)
once a week##15##3##(1991-5#1)(1991-6#1)(1992-2#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-3#1)(2010-11#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)
once a year##5##3##(1990-8#1)(1996-12#1)(2007-3#1)(2007-8#1)(2012-1#1)
once a##59##2##(1990-11#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#3)(1992-2#1)(1993-11#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-12#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-5#6)(2008-7#3)(2008-8#2)(2009-3#1)(2010-11#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)
once admitted##2##2##(2007-8#2)
once after##6##2##(1995-1#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-5#1)(2009-9#1)
once again that##2##3##(1994-10#1)(2006-7#1)
once again to##2##3##(2010-8#1)(2012-12#1)
once again##21##2##(1991-5#1)(1991-7#1)(1992-6#1)(1993-5#1)(1994-10#1)(1995-1#1)(1995-2#1)(1997-1#1)(2005-7#1)(2006-7#1)(2008-10#1)(2008-11#2)(2008-6#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
once age##2##2##(2007-2#1)(2009-4#1)
once an##3##2##(2006-2#1)(2008-2#1)(2008-7#1)
once and##5##2##(1996-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)
once at##3##2##(1994-3#1)(2008-2#1)(2013-1#1)
once before the##3##3##(2007-11#1)(2007-5#1)(2007-7#1)
once before##5##2##(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2012-12#1)
once but##2##2##(2007-12#1)(2011-1#1)
once by##4##2##(1996-1#1)(2008-10#1)(2008-5#1)(2008-6#1)
once considered a##2##3##(2008-6#1)(2012-12#1)
once daily and##3##3##(2005-8#1)(2007-8#1)(2010-8#1)
once daily dosage##2##3##(2007-11#1)(2010-5#1)
once daily dosing and##2##4##(2008-5#1)(2013-7#1)
once daily for 14##2##4##(1995-12#1)(1996-10#1)
once daily for##12##3##(1991-8#1)(1993-12#1)(1995-12#1)(1996-10#2)(2007-7#1)(2008-10#1)(2008-3#1)(2009-5#1)(2013-1#2)(2013-8#1)
once daily in the morning##2##5##(2007-11#2)
once daily in##5##3##(1992-8#1)(2007-11#3)(2012-1#1)
once daily subcutaneous sermorelin 30 microg/kg bodyweight##3##7##(2007-11#3)
once daily subcutaneous##5##3##(2007-11#5)
once daily##50##2##(1990-11#1)(1991-11#1)(1991-8#1)(1992-2#1)(1992-4#1)(1992-8#2)(1993-12#1)(1995-12#1)(1996-10#2)(1997-4#1)(2005-7#1)(2005-8#1)(2007-10#1)(2007-11#11)(2007-7#2)(2007-8#1)(2008-10#2)(2008-3#3)(2008-5#1)(2008-6#2)(2009-3#1)(2009-5#1)(2010-2#1)(2010-5#3)(2010-8#1)(2012-1#1)(2013-1#2)(2013-7#1)(2013-8#2)
once daily)##5##2##(2004-1#1)(2008-5#1)(2009-10#2)(2012-11#1)
once during##5##2##(1995-1#1)(1995-11#1)(2006-10#1)(2008-12#1)(2011-2#1)
once each##4##2##(1992-8#1)(2008-10#1)(2010-2#1)(2011-2#1)
once every##7##2##(1990-8#1)(1991-12#1)(1993-12#1)(1997-8#1)(2008-1#1)(2008-10#2)
once expressed##3##2##(1994-12#1)(2005-7#1)(2010-1#1)
once for##4##2##(1991-11#2)(1996-12#1)(2007-12#1)
once formed##2##2##(2007-12#1)(2009-7#1)
once from##4##2##(2007-12#2)(2007-7#1)(2008-10#1)
once had##2##2##(2010-8#1)(2010-9#1)
once having##2##2##(1990-3#1)(2011-2#1)
once in a lifetime##2##4##(2009-3#1)(2011-1#1)
once in a##3##3##(2009-3#1)(2011-1#1)(2013-1#1)
once in both##2##3##(2006-12#1)(2008-2#1)
once in every##3##3##(1995-2#1)(2007-7#1)(2010-8#1)
once in four##2##3##(2007-8#1)(2009-6#1)
once in the literature##2##4##(2005-12#1)(2008-9#1)
once in the##8##3##(1990-11#1)(1997-7#1)(2005-12#1)(2008-10#1)(2008-9#1)(2009-12#1)(2012-11#1)(2013-7#1)
once in##25##2##(1990-11#1)(1995-2#1)(1997-7#1)(2005-12#1)(2006-12#1)(2007-7#1)(2007-8#2)(2007-9#4)(2008-10#2)(2008-2#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-6#1)(2010-8#1)(2011-1#1)(2012-11#1)(2013-1#2)(2013-7#1)
once infected##2##2##(1995-2#1)(2008-10#1)
once it has been##2##4##(1994-9#1)(2012-2#1)
once it has##3##3##(1994-9#1)(1996-6#1)(2012-2#1)
once it is##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
once it##11##2##(1993-3#1)(1994-9#1)(1996-6#1)(2005-3#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2012-2#2)
once more##3##2##(1991-11#1)(2008-10#1)(2008-12#1)
once or twice a week##2##5##(1990-3#1)(2013-1#1)
once or twice daily##3##4##(1997-4#1)(2007-1#1)(2010-8#1)
once or twice##9##3##(1990-3#1)(1992-8#1)(1997-2#1)(1997-4#1)(2007-1#1)(2010-8#1)(2012-6#1)(2013-1#2)
once or##11##2##(1990-3#1)(1990-4#1)(1992-8#1)(1994-5#1)(1997-2#1)(1997-4#1)(2007-1#1)(2010-8#1)(2012-6#1)(2013-1#2)
once per day##3##3##(2008-5#1)(2008-7#1)(2008-8#1)
once per week for##3##4##(2006-6#1)(2008-12#1)(2009-8#1)
once per week##6##3##(1991-12#1)(2006-6#1)(2008-12#1)(2009-8#1)(2013-1#2)
once per year##3##3##(1997-3#2)(2008-2#1)
once per##16##2##(1991-12#1)(1997-3#2)(2006-6#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#2)(2013-1#2)
once released##2##2##(1997-4#1)(2010-8#1)
once said##2##2##(1994-1#1)(2011-2#1)
once started##2##2##(1990-3#1)(2013-7#1)
once the diagnosis##3##3##(1994-2#1)(2006-7#1)(2011-2#1)
once the##47##2##(1991-2#1)(1992-11#2)(1992-3#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-12#1)(1997-6#1)(2005-11#1)(2005-7#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-7#1)(2007-9#2)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-5#1)(2010-12#2)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
once there is##2##3##(2005-7#1)(2013-1#1)
once there##3##2##(2005-7#1)(2008-10#1)(2013-1#1)
once they are##2##3##(2007-12#1)(2011-12#1)
once they had##2##3##(1995-9#1)(2008-8#1)
once they have##5##3##(1996-2#1)(1997-2#1)(2004-9#1)(2007-2#1)(2010-8#1)
once they were##2##3##(1995-8#1)(2008-10#1)
once they##15##2##(1990-11#1)(1991-3#1)(1992-3#1)(1995-8#1)(1995-9#1)(1996-2#1)(1997-2#1)(2004-9#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-8#1)(2011-12#1)
once thought to be##2##4##(2008-5#1)(2010-7#1)
once thought##5##2##(1992-8#1)(1997-4#1)(2007-9#1)(2008-5#1)(2010-7#1)
once used##2##2##(2005-8#1)(2010-11#1)
once weekly for 2##2##4##(1992-3#1)(2007-11#1)
once weekly for##4##3##(1991-9#1)(1992-3#1)(2007-11#1)(2007-12#1)
once weekly##21##2##(1991-9#1)(1992-12#1)(1992-3#1)(1993-7#1)(2006-10#1)(2007-11#4)(2007-12#2)(2008-3#1)(2008-7#9)
once widely##3##2##(1994-2#1)(2008-5#1)(2011-2#1)
once with a##2##3##(1995-9#1)(2008-5#1)
once with##3##2##(1995-9#1)(2008-5#1)(2010-7#1)
once##522##1##(1990-10#1)(1990-11#5)(1990-2#1)(1990-3#3)(1990-4#3)(1990-5#2)(1990-7#2)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#5)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#1)(1991-7#4)(1991-8#4)(1991-9#4)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#5)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#2)(1993-5#2)(1993-7#1)(1994-1#2)(1994-10#1)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#1)(1994-7#2)(1994-9#2)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#6)(1995-3#1)(1995-5#2)(1995-8#2)(1995-9#2)(1996-1#2)(1996-10#2)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#3)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-1#1)(2004-2#1)(2004-9#1)(2005-11#3)(2005-12#1)(2005-3#1)(2005-7#6)(2005-8#2)(2006-1#1)(2006-10#8)(2006-12#3)(2006-2#1)(2006-5#4)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#26)(2007-12#17)(2007-2#3)(2007-3#4)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#11)(2007-8#10)(2007-9#10)(2008-1#3)(2008-10#40)(2008-11#8)(2008-12#3)(2008-2#8)(2008-3#13)(2008-4#4)(2008-5#20)(2008-6#7)(2008-7#18)(2008-8#9)(2008-9#3)(2009-10#2)(2009-12#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#3)(2010-10#1)(2010-11#3)(2010-12#4)(2010-2#3)(2010-4#2)(2010-5#4)(2010-7#2)(2010-8#11)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#13)(2012-1#5)(2012-11#4)(2012-12#8)(2012-2#6)(2012-3#2)(2012-6#1)(2013-1#15)(2013-7#4)(2013-8#5)
once)##3##1##(1992-12#1)(2010-4#2)
once- or twice-daily##2##3##(2008-5#1)(2010-8#1)
once-a-day##7##1##(1995-2#5)(2010-11#1)(2010-12#1)
once-a-month##2##1##(1990-12#2)
once-daily amlodipine##3##2##(2008-3#3)
once-daily dosing##4##2##(1992-8#1)(2005-7#1)(2008-5#1)(2013-1#1)
once-daily oral##2##2##(2005-9#2)
once-daily treatment##2##2##(2008-3#1)(2010-8#1)
once-daily##38##1##(1991-12#1)(1992-4#2)(1992-8#4)(1996-9#1)(2005-10#3)(2005-7#1)(2005-8#1)(2005-9#2)(2007-1#2)(2007-8#1)(2008-1#1)(2008-3#7)(2008-5#4)(2009-8#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#1)(2013-1#2)
once-monthly oral##2##2##(2008-3#2)
once-weekly##4##1##(2007-11#1)(2008-5#1)(2008-7#1)(2010-11#1)
onchocerciasis are##2##2##(1991-12#2)
onchocerciasis control##3##2##(1990-6#1)(2006-10#1)(2011-2#1)
onchocerciasis in##2##2##(1990-6#1)(2010-8#1)
onchocerciasis##16##1##(1990-6#4)(1991-12#3)(1991-3#1)(1991-9#2)(2006-10#3)(2007-7#1)(2010-8#1)(2011-2#1)
oncidii##2##1##(2012-11#2)
onco-antigens##4##1##(2013-1#4)
oncocytoma is##2##2##(1990-5#1)(1992-5#1)
oncocytoma##11##1##(1990-5#2)(1992-5#2)(1992-8#1)(2010-2#2)(2013-7#4)
oncofetal##4##1##(1992-7#1)(1994-9#2)(1996-12#1)
oncogene activated##2##2##(2008-11#2)
oncogene activation##3##2##(1990-8#1)(1994-9#1)(2006-2#1)
oncogene amplification##2##2##(1990-6#1)(1994-6#1)
oncogene and tumour##2##3##(1993-7#1)(2007-11#1)
oncogene and##8##2##(1990-7#1)(1991-4#1)(1993-7#1)(1995-8#1)(2007-11#1)(2008-11#2)(2010-3#1)
oncogene encodes a##2##3##(1990-9#1)(1991-9#1)
oncogene expression in human##2##4##(1991-9#1)(1996-4#1)
oncogene expression in##4##3##(1991-9#1)(1992-3#1)(1995-8#1)(1996-4#1)
oncogene expression##7##2##(1991-5#1)(1991-9#3)(1992-3#1)(1995-8#1)(1996-4#1)
oncogene family##3##2##(1993-6#1)(1994-10#2)
oncogene has been##3##3##(1991-7#1)(1994-6#1)(1996-12#1)
oncogene in##4##2##(1992-8#1)(1994-8#1)(1996-12#1)(1996-4#1)
oncogene is##7##2##(1990-6#1)(1991-10#1)(1991-9#2)(1994-8#1)(1995-2#1)(2012-2#1)
oncogene of the##2##3##(1994-12#1)(2008-9#1)
oncogene of##4##2##(1994-12#1)(2008-11#2)(2008-9#1)
oncogene on##2##2##(1994-10#1)(2010-3#1)
oncogene or##3##2##(1990-9#1)(1993-2#1)(2011-2#1)
oncogene product##11##2##(1990-12#1)(1990-9#1)(1991-11#2)(1991-9#1)(1993-11#2)(1994-8#1)(1995-2#1)(1996-5#2)
oncogene products##5##2##(1990-9#1)(1992-11#1)(1995-2#1)(2008-11#1)(2008-4#1)
oncogene transfection##3##2##(2008-11#3)
oncogene##122##1##(1990-11#2)(1990-12#1)(1990-6#3)(1990-7#1)(1990-8#1)(1990-9#4)(1991-10#1)(1991-11#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#3)(1991-9#8)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#5)(1993-2#1)(1993-5#1)(1993-6#3)(1993-7#1)(1993-9#1)(1994-10#3)(1994-12#1)(1994-6#2)(1994-8#4)(1994-9#1)(1995-2#4)(1995-6#1)(1995-8#3)(1996-12#5)(1996-4#2)(1996-5#3)(1997-7#2)(2004-1#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#1)(2008-11#16)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#4)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)
oncogene-transfected##4##1##(1990-11#1)(1994-8#1)(1995-9#1)(2008-11#1)
oncogene-transformed##2##1##(1993-7#1)(2011-2#1)
oncogenes and tumor suppressor genes##3##5##(1995-6#1)(2008-7#1)(2009-5#1)
oncogenes and tumor##4##3##(1995-6#1)(2008-7#1)(2009-12#1)(2009-5#1)
oncogenes and tumour suppressor genes##2##5##(1995-2#1)(2010-12#1)
oncogenes and##11##2##(1990-12#1)(1992-2#1)(1995-2#1)(1995-6#1)(2005-11#1)(2007-11#1)(2008-7#1)(2009-12#2)(2009-5#1)(2010-12#1)
oncogenes as##2##2##(1996-12#1)(2008-11#1)
oncogenes in##8##2##(1991-5#1)(1996-7#1)(2008-11#3)(2008-3#1)(2008-6#1)(2012-2#1)
oncogenes may##2##2##(1991-12#1)(1997-7#1)
oncogenes on##2##2##(1994-4#1)(2008-11#1)
oncogenes or##7##2##(1990-11#1)(2007-10#1)(2007-3#1)(2008-1#1)(2009-12#1)(2011-2#2)
oncogenes such as##3##3##(2004-1#1)(2008-11#2)
oncogenes##87##1##(1990-11#5)(1990-12#1)(1990-7#2)(1990-8#3)(1991-1#2)(1991-10#1)(1991-12#1)(1991-4#2)(1991-5#3)(1991-7#2)(1991-9#1)(1992-2#1)(1993-4#1)(1994-4#1)(1994-6#1)(1995-2#9)(1995-3#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-7#1)(1997-3#1)(1997-7#3)(2004-1#1)(2005-11#1)(2007-10#2)(2007-11#2)(2007-3#1)(2008-1#1)(2008-11#15)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-12#3)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#1)(2011-2#4)(2012-2#2)
oncogenesis and##2##2##(2008-6#1)(2013-1#1)
oncogenesis is##2##2##(1992-8#1)(2006-12#1)
oncogenesis of##3##2##(1991-10#1)(1992-4#1)(2011-2#1)
oncogenesis##27##1##(1991-10#1)(1992-2#1)(1992-4#1)(1992-8#1)(1992-9#2)(1993-6#2)(1994-10#1)(2003-11#1)(2006-10#1)(2006-12#2)(2006-2#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-12#4)(2013-1#1)(2013-8#1)
oncogenetic##2##1##(2004-1#1)(2008-4#1)
oncogenic HPV types##3##3##(1992-9#1)(1994-1#1)(2011-2#1)
oncogenic Ras##2##2##(1995-2#1)(1996-4#1)
oncogenic activity##2##2##(2012-12#2)
oncogenic effects##5##2##(1991-12#1)(2006-10#2)(2008-4#1)(2013-8#1)
oncogenic events##2##2##(2009-12#1)(2012-2#1)
oncogenic forms of##2##3##(1994-10#1)(2008-5#1)
oncogenic human##2##2##(1996-8#1)(2006-10#1)
oncogenic mechanism##2##2##(1991-4#1)(2009-12#1)
oncogenic mutation##2##2##(1995-2#1)(1995-3#1)
oncogenic osteomalacia##4##2##(1996-11#3)(2008-6#1)
oncogenic pathways##3##2##(2008-5#1)(2008-7#1)(2013-8#1)
oncogenic potential##3##2##(1995-2#1)(1995-3#1)(1996-1#1)
oncogenic properties##2##2##(2009-9#1)(2011-2#1)
oncogenic protein##3##2##(1991-11#1)(1994-8#1)(1997-4#1)
oncogenic transformation##5##2##(1994-11#1)(1994-8#2)(1995-2#1)(2012-12#1)
oncogenic type##2##2##(1994-1#1)(2011-2#1)
oncogenic types##2##2##(2012-2#1)(2013-1#1)
oncogenic##95##1##(1991-11#1)(1991-12#3)(1991-4#1)(1991-6#1)(1991-7#3)(1992-11#2)(1992-2#1)(1992-9#1)(1994-1#2)(1994-10#1)(1994-11#1)(1994-8#5)(1995-2#5)(1995-3#2)(1995-6#2)(1996-1#1)(1996-11#3)(1996-4#2)(1996-5#1)(1996-8#1)(1997-3#1)(1997-4#1)(2006-10#5)(2007-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2009-12#3)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#10)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#6)
oncogenically transformed cells##2##3##(1995-2#1)(2007-9#1)
oncogenicity of##2##2##(1992-9#1)(2013-8#1)
oncogenicity##6##1##(1992-9#1)(1995-12#1)(2013-8#4)
oncologic and functional outcome##2##4##(2008-6#2)
oncologic and functional outcomes##2##4##(2007-7#1)(2010-3#1)
oncologic and functional##5##3##(2007-7#1)(2008-6#3)(2010-3#1)
oncologic and##8##2##(1997-8#1)(2007-11#2)(2007-7#1)(2008-6#3)(2010-3#1)
oncologic outcome##3##2##(2011-2#3)
oncologic patients##6##2##(1995-9#1)(2006-6#1)(2011-1#3)(2013-1#1)
oncologic resection##2##2##(2012-2#2)
oncologic resections##2##2##(2012-2#2)
oncologic##50##1##(1990-4#1)(1991-12#1)(1991-2#1)(1991-3#1)(1995-9#1)(1997-8#1)(2005-8#1)(2006-6#1)(2007-11#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-6#6)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-1#5)(2011-2#9)(2012-2#5)(2012-3#1)(2013-1#2)
oncological centers##2##2##(2011-2#2)
oncological diseases##6##2##(1996-4#1)(2007-10#1)(2007-5#1)(2008-10#1)(2011-2#1)(2013-1#1)
oncological hyperthermia##2##2##(2007-11#2)
oncological or chronic disease##2##4##(2013-8#2)
oncological patients]##2##2##(2006-6#2)
oncological treatment##8##2##(2005-1#1)(2007-11#1)(2008-5#1)(2010-4#1)(2012-12#3)(2012-3#1)
oncological treatments##2##2##(2011-2#1)(2012-12#1)
oncological##72##1##(1990-4#1)(1991-12#1)(1991-3#1)(1992-5#1)(1993-10#2)(1993-11#1)(1995-5#1)(1996-3#2)(1996-4#1)(1997-3#1)(2004-2#1)(2005-1#2)(2006-6#6)(2007-10#1)(2007-11#7)(2007-5#3)(2007-6#1)(2007-7#1)(2008-10#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2009-9#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#2)(2012-1#1)(2012-12#6)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#3)
oncologist and##4##2##(1992-5#1)(2007-11#1)(2008-10#1)(2013-1#1)
oncologist is##2##2##(2007-11#1)(2008-6#1)
oncologist with##2##2##(2007-11#1)(2009-11#1)
oncologist##23##1##(1992-5#1)(2007-11#3)(2007-4#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#3)(2008-7#1)(2009-11#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
oncologists and other##2##3##(2011-2#1)(2012-3#1)
oncologists and##11##2##(1991-2#1)(2007-2#1)(2007-4#1)(2007-5#1)(2008-10#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
oncologists are##2##2##(2007-11#1)(2012-12#1)
oncologists have##2##2##(2012-11#1)(2012-3#1)
oncologists in##2##2##(2011-3#1)(2013-1#1)
oncologists to plan##2##3##(2008-6#1)(2013-8#1)
oncologists to##3##2##(2008-6#1)(2012-3#1)(2013-8#1)
oncologists who##2##2##(1992-1#1)(2012-12#1)
oncologists##51##1##(1991-2#3)(1992-1#1)(1992-12#1)(1993-3#1)(1994-7#1)(1996-6#1)(2005-10#1)(2005-8#1)(2007-11#1)(2007-2#2)(2007-4#5)(2007-5#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#3)(2009-2#2)(2009-3#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#7)(2013-8#1)
oncology agents##2##2##(2008-6#2)
oncology and in##3##3##(1991-3#1)(2011-12#1)(2011-3#1)
oncology and palliative care##2##4##(2008-7#1)(2012-3#1)
oncology and##17##2##(1991-3#2)(1991-4#1)(1993-2#1)(1995-10#1)(1997-1#1)(1997-8#1)(2007-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-7#1)(2011-12#1)(2011-3#1)(2012-3#1)
oncology as##2##2##(2007-4#1)(2008-5#1)
oncology care##3##2##(2011-2#1)(2013-1#2)
oncology centers##4##2##(2008-10#1)(2008-7#2)(2010-7#1)
oncology clinical##2##2##(2012-3#1)(2013-1#1)
oncology community##3##2##(2007-4#1)(2008-6#2)
oncology department##2##2##(2012-2#1)(2012-3#1)
oncology departments##2##2##(2007-4#2)
oncology in Poland in years##2##5##(2008-9#2)
oncology in Poland##3##3##(2008-9#3)
oncology in the United States##2##5##(2010-3#2)
oncology in the##3##3##(1991-8#1)(2010-3#2)
oncology in##10##2##(1991-8#1)(1996-12#1)(2008-6#1)(2008-9#3)(2009-4#1)(2010-3#2)(2010-9#1)
oncology is##5##2##(2007-4#2)(2010-5#1)(2011-1#1)(2011-2#1)
oncology nurses##2##2##(2007-12#2)
oncology nursing##2##2##(1994-10#1)(2013-1#1)
oncology patients undergoing chemotherapy##2##4##(1991-11#1)(2007-7#1)
oncology patients undergoing##3##3##(1991-11#1)(1994-12#1)(2007-7#1)
oncology patients##17##2##(1991-11#1)(1992-12#2)(1994-12#2)(1995-12#1)(1995-6#1)(1996-6#1)(2006-12#1)(2007-12#1)(2007-7#4)(2008-10#1)(2008-7#1)(2009-10#1)
oncology practice##3##2##(2011-2#1)(2012-3#1)(2013-1#1)
oncology practices##3##2##(2010-9#2)(2012-3#1)
oncology procedures##2##2##(1994-3#1)(2006-10#1)
oncology research##4##2##(2009-6#1)(2010-5#2)(2011-1#1)
oncology setting##4##2##(2008-11#1)(2012-2#1)(2012-3#2)
oncology staff##2##2##(2012-1#2)
oncology team##2##2##(2008-7#1)(2010-3#1)
oncology treatment##2##2##(2007-11#1)(2007-4#1)
oncology trials##2##2##(2012-2#2)
oncology where##2##2##(2008-6#1)(2012-2#1)
oncology##242##1##(1990-12#1)(1991-10#1)(1991-11#2)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-8#2)(1992-12#2)(1993-2#1)(1994-10#1)(1994-12#2)(1994-3#4)(1994-5#1)(1994-6#1)(1994-7#1)(1995-10#1)(1995-12#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-8#1)(2004-1#1)(2006-10#6)(2006-12#2)(2006-9#1)(2007-11#3)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#19)(2007-5#2)(2007-6#1)(2007-7#8)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-2#3)(2008-5#3)(2008-6#10)(2008-7#16)(2008-8#5)(2008-9#6)(2009-10#1)(2009-12#3)(2009-3#2)(2009-4#2)(2009-6#1)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#4)(2010-3#5)(2010-5#4)(2010-7#4)(2010-8#1)(2010-9#4)(2011-1#6)(2011-12#1)(2011-2#12)(2011-3#2)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#13)(2012-3#10)(2013-1#8)(2013-7#3)
oncology?##2##1##(1994-2#1)(2007-4#1)
oncology]##5##1##(1990-3#1)(1991-2#1)(2005-10#1)(2007-3#1)(2010-12#1)
oncolytic activity##4##2##(2009-4#1)(2013-1#3)
oncolytic viral##2##2##(2012-3#1)(2013-1#1)
oncolytic viruses and a##2##4##(1995-2#1)(2013-8#1)
oncolytic viruses##10##2##(1995-2#1)(2007-11#1)(2012-2#1)(2013-1#2)(2013-8#5)
oncolytic##30##1##(1995-2#2)(2007-11#1)(2008-1#1)(2009-4#5)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#7)(2013-8#5)
oncomiR##2##1##(2011-2#2)
oncomodulin##8##1##(1990-6#6)(1991-7#2)
oncophora##3##1##(1996-12#3)
oncoprotein expression##2##2##(1993-9#1)(1996-4#1)
oncoprotein is##3##2##(1996-5#1)(2008-1#1)(2011-2#1)
oncoprotein##28##1##(1990-10#2)(1990-7#1)(1991-5#1)(1993-11#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-6#1)(1996-4#1)(1996-5#4)(1997-4#4)(2005-7#1)(2008-1#1)(2008-11#1)(2011-2#2)(2012-2#2)
oncoproteins in##2##2##(2007-11#1)(2008-11#1)
oncoproteins of##2##2##(1994-3#1)(1994-9#1)
oncoproteins##13##1##(1991-10#1)(1993-6#1)(1994-3#1)(1994-6#1)(1994-9#1)(1996-5#1)(2007-11#1)(2008-11#1)(2010-2#1)(2011-2#1)(2012-12#2)(2012-2#1)
oncopterin##6##1##(1997-3#6)
oncoretroviral vectors##2##2##(2008-2#2)
oncosis##3##1##(2008-8#3)
oncostatin M##10##2##(1991-10#2)(1994-11#5)(1995-12#1)(1996-2#1)(1996-5#1)
oncotic pressure##4##2##(1996-9#4)
oncotypes##2##1##(1990-2#1)(1990-4#1)
ondansetron (0##2##2##(1996-8#2)
ondansetron (8##4##2##(2008-7#1)(2011-12#3)
ondansetron and##4##2##(1994-4#1)(1996-3#1)(1996-8#1)(2008-7#1)
ondansetron for the prevention of nausea and vomiting during high-dose myeloablative chemotherapy##2##12##(2008-7#2)
ondansetron for##3##2##(1995-9#1)(2008-7#2)
ondansetron in acute##2##3##(2008-7#1)(2011-12#1)
ondansetron in##4##2##(2008-7#2)(2010-7#1)(2011-12#1)
ondansetron pretreatment##3##2##(1996-8#3)
ondansetron##45##1##(1991-1#1)(1992-3#1)(1994-4#1)(1995-9#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-8#9)(2006-10#1)(2008-5#2)(2008-6#1)(2008-7#15)(2010-3#1)(2010-7#1)(2011-12#5)(2012-12#1)
ondansetron]##2##1##(1993-8#1)(2005-11#1)
one (0##3##2##(2007-8#1)(2008-1#1)(2008-9#1)
one (1##3##2##(2007-7#1)(2007-8#1)(2008-7#1)
one (12%)##3##2##(2007-7#1)(2011-2#1)(2013-8#1)
one (3%)##2##2##(2005-10#1)(2008-6#1)
one (4##5##2##(2004-2#1)(2007-7#1)(2013-1#3)
one (Mr##2##2##(1990-5#1)(1997-7#1)
one (P##2##2##(1995-6#1)(2008-2#1)
one 1##4##2##(2008-11#1)(2008-9#3)
one 12##2##2##(2008-9#1)(2010-12#1)
one 4##2##2##(1991-8#1)(2009-3#1)
one 50##2##2##(1994-2#1)(2008-9#1)
one British##2##2##(1992-4#1)(1994-12#1)
one Ca2+##3##2##(1990-11#2)(1995-6#1)
one Cu2+##2##2##(1993-11#1)(1994-2#1)
one Cys##2##2##(1991-11#1)(1993-11#1)
one DNA fingerprint##3##3##(2008-10#3)
one DNA##7##2##(1990-4#1)(1990-5#1)(1996-6#1)(2008-10#4)
one FAD##2##2##(1990-3#1)(1995-10#1)
one Fusarium##2##2##(2008-10#1)(2010-10#1)
one MCG##2##2##(2008-10#2)
one P##2##2##(2007-5#1)(2008-10#1)
one PCR##2##2##(2007-3#1)(2008-12#1)
one QTL affected##2##3##(2008-10#2)
one QTL for##2##3##(2008-8#2)
one QTL##4##2##(2008-10#2)(2008-8#2)
one RAPD##2##2##(2008-10#2)
one SNP##3##2##(2006-12#1)(2009-4#1)(2012-3#1)
one SSRI##2##2##(2011-2#1)(2013-8#1)
one School of##2##3##(2008-11#1)(2008-12#1)
one State##2##2##(1991-2#1)(1997-2#1)
one UL9 dimer##2##3##(1995-3#2)
one UL9##3##2##(1995-3#3)
one V lambda##4##3##(1996-11#4)
one V##5##2##(1995-5#1)(1996-11#4)
one Zn2+##3##2##(1997-4#3)
one [4Fe-4S]##2##2##(1990-7#1)(1990-8#1)
one a##7##2##(1993-10#1)(1993-8#1)(1996-3#1)(1997-3#1)(2006-12#1)(2008-10#2)
one abnormal##3##2##(2008-1#2)(2011-2#1)
one acidic##2##2##(1991-2#1)(1996-8#1)
one active##3##2##(1995-1#1)(1997-2#1)(2008-10#1)
one acute##2##2##(2008-11#1)(2008-4#1)
one additional case##2##3##(2005-10#1)(2008-10#1)
one additional##18##2##(1993-8#1)(1994-11#1)(1994-5#1)(1995-2#1)(1997-2#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)
one adult female##2##3##(1992-8#1)(2004-11#1)
one adult##6##2##(1992-8#1)(1993-2#1)(1996-12#1)(1997-6#1)(2004-11#1)(2008-8#1)
one adverse##2##2##(2006-10#1)(2008-6#1)
one aeroallergen##2##2##(2007-2#2)
one affected##5##2##(1995-11#1)(1997-1#1)(2007-2#1)(2008-1#1)(2008-7#1)
one after the##2##3##(2007-11#1)(2008-10#1)
one after##8##2##(1991-10#1)(1996-6#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2012-2#1)
one aimed##2##2##(1993-2#1)(2008-10#1)
one allele and##2##3##(1994-8#1)(1995-1#1)
one allele of##2##3##(1990-6#1)(2007-10#1)
one allele##10##2##(1990-11#1)(1990-6#2)(1994-8#1)(1995-1#1)(1995-11#1)(1996-5#1)(2007-10#1)(2008-9#1)(2012-12#1)
one alpha##3##2##(1991-12#1)(1996-4#1)(2012-12#1)
one alpha-helix##3##2##(1995-1#1)(1995-3#1)(2008-9#1)
one also had##3##3##(1996-3#1)(2007-11#1)(2007-12#1)
one also##4##2##(1993-3#1)(1996-3#1)(2007-11#1)(2007-12#1)
one alternative##2##2##(2008-10#1)(2008-9#1)
one amino acid##12##3##(1991-12#1)(1991-2#1)(1992-11#1)(1992-2#1)(1994-11#1)(1994-9#1)(1996-6#1)(1997-4#1)(1997-7#1)(1997-8#1)(2012-12#2)
one among the##3##3##(1994-7#1)(2011-2#1)(2012-11#1)
one among##5##2##(1994-7#1)(2008-5#1)(2011-2#1)(2012-11#1)(2012-3#1)
one ampoule of##2##3##(1994-3#2)
one an##2##2##(2008-10#1)(2008-4#1)
one analysis##3##2##(1994-6#1)(2008-10#2)
one analyte##2##2##(2008-10#2)
one and a half year##2##5##(2007-7#1)(2008-12#1)
one and a half years##4##5##(1995-7#1)(2006-10#1)(2008-10#1)(2008-12#1)
one and a half##15##4##(1991-9#2)(1993-2#1)(1995-7#1)(1996-6#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-12#2)(2009-3#1)(2010-12#1)(2010-6#1)(2011-1#1)
one and a half-year##2##4##(2007-7#1)(2008-10#1)
one and a##19##3##(1991-9#2)(1992-6#1)(1993-2#1)(1995-7#1)(1996-6#1)(2006-10#1)(2007-7#2)(2008-10#3)(2008-12#2)(2008-9#1)(2009-3#1)(2010-12#1)(2010-6#1)(2011-1#1)
one and four##4##3##(1997-8#1)(2008-12#1)(2010-3#1)(2013-8#1)
one and half years##2##4##(2007-7#1)(2010-11#1)
one and half##3##3##(2007-7#1)(2007-8#1)(2010-11#1)
one and only##3##3##(1995-5#1)(2008-1#1)(2009-2#1)
one and six##2##3##(1993-3#1)(2005-11#1)
one and the same##3##4##(1995-6#1)(1997-2#1)(2008-6#1)
one and the##5##3##(1994-2#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-6#1)
one and three years##2##4##(1992-2#1)(2008-1#1)
one and three##5##3##(1992-2#1)(1993-12#1)(2008-1#1)(2008-10#1)(2013-1#1)
one and two dimensions##2##4##(1997-6#1)(2008-2#1)
one and two years##2##4##(2006-8#1)(2010-10#1)
one and two##13##3##(1990-10#1)(1993-11#1)(1997-6#1)(2006-8#1)(2007-6#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-10#1)
one and##94##2##(1990-10#1)(1990-2#1)(1991-4#1)(1991-9#2)(1992-2#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-2#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#13)(2008-11#1)(2008-12#4)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-6#1)(2011-1#2)(2012-1#2)(2012-11#1)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#2)
one angle of##2##3##(2008-3#1)(2009-11#1)
one angle##4##2##(2008-3#2)(2009-11#1)(2010-3#1)
one animal##4##2##(1990-5#1)(2006-5#1)(2008-4#1)(2010-3#1)
one another (e##2##3##(1997-4#1)(2008-8#1)
one another and##9##3##(1993-9#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-5#1)(2012-11#1)(2012-3#1)
one another at##2##3##(2006-12#1)(2007-9#1)
one another by##3##3##(2008-2#1)(2008-9#1)(2010-12#1)
one another during##2##3##(1996-5#1)(2008-8#1)
one another in##9##3##(1992-2#1)(1992-3#1)(1993-12#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#1)
one another to##2##3##(2007-12#1)(2011-1#1)
one another##102##2##(1990-11#1)(1990-8#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-9#2)(1993-12#1)(1993-7#1)(1993-9#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-7#1)(1997-8#2)(2006-12#2)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#3)(2013-1#3)(2013-8#2)
one another's##3##2##(1996-1#1)(2008-11#1)(2013-8#1)
one anterior##2##2##(2006-12#1)(2006-8#1)
one aperture##3##2##(2007-11#2)(2008-3#1)
one application of the##2##4##(2007-12#1)(2008-5#1)
one application##9##2##(1990-8#1)(1991-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-8#1)(2013-7#1)
one approach to##6##3##(1990-12#1)(1993-3#1)(1996-12#1)(2005-7#1)(2008-11#1)(2013-1#1)
one approach##11##2##(1990-12#1)(1993-3#1)(1996-1#1)(1996-12#1)(2005-7#1)(2006-6#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
one arbitrary##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
one are##3##2##(2008-11#1)(2008-4#1)(2010-11#1)
one area of##4##3##(1991-12#1)(2008-4#1)(2008-9#1)(2012-12#1)
one area##10##2##(1991-12#1)(1995-12#1)(2005-11#1)(2006-2#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-12#1)
one arm of the##4##4##(1995-3#1)(2007-12#1)(2008-2#1)(2008-3#1)
one arm of##5##3##(1995-3#1)(2007-12#2)(2008-2#1)(2008-3#1)
one arm##7##2##(1995-3#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
one article##2##2##(2004-12#1)(2012-3#1)
one as a##2##3##(1994-10#1)(2008-10#1)
one as##5##2##(1994-10#1)(2008-10#1)(2008-5#1)(2009-3#1)(2009-5#1)
one aspect of a##3##4##(2007-10#1)(2013-1#2)
one aspect of the##6##4##(1994-1#1)(1994-9#1)(2006-5#1)(2007-3#1)(2007-9#1)(2008-12#1)
one aspect of##14##3##(1994-1#1)(1994-9#1)(1997-3#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-3#1)(2007-9#1)(2008-12#1)(2008-9#1)(2012-1#2)(2013-1#2)
one aspect##15##2##(1993-2#1)(1994-1#1)(1994-9#1)(1997-3#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-3#1)(2007-9#1)(2008-12#1)(2008-9#1)(2012-1#2)(2013-1#2)
one associated##4##2##(1996-3#1)(2006-7#1)(2008-10#1)(2009-11#1)
one at a concentration##2##4##(1990-8#1)(2008-5#1)
one at a time##7##4##(1990-2#1)(1994-11#1)(2008-10#2)(2008-7#1)(2012-3#1)(2013-1#1)
one at a##9##3##(1990-2#1)(1990-8#1)(1994-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#1)
one at the sentence level and the other at the word level##2##12##(2013-1#2)
one at the##7##3##(1990-8#1)(1991-12#1)(2004-3#1)(2008-10#1)(2008-5#1)(2013-1#2)
one at##29##2##(1990-2#1)(1990-8#2)(1991-12#1)(1991-9#1)(1994-11#2)(1995-1#1)(1995-12#1)(1997-6#1)(2004-3#1)(2006-10#1)(2006-8#1)(2008-10#6)(2008-4#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-3#2)(2013-1#3)
one autoimmune##2##2##(2006-10#2)
one axial##2##2##(1997-7#1)(2009-3#1)
one axis##2##2##(2008-2#2)
one band##7##2##(1993-3#1)(1994-3#1)(1996-7#1)(1997-2#1)(2008-10#3)
one base##6##2##(1992-4#1)(1996-6#1)(2007-5#1)(2008-10#2)(2008-4#1)
one based on the##5##4##(1995-2#1)(2006-4#1)(2007-12#1)(2007-9#1)(2013-1#1)
one based on##12##3##(1990-10#1)(1993-11#1)(1995-2#1)(2006-4#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-6#1)(2013-1#1)
one beam is##2##3##(2008-2#1)(2008-3#1)
one beam##3##2##(2008-2#1)(2008-3#2)
one because of##3##3##(2007-7#2)(2008-8#1)
one because##5##2##(1991-3#1)(2007-7#2)(2008-8#1)(2013-1#1)
one before##4##2##(1990-12#1)(1996-6#1)(2004-11#1)(2008-1#1)
one being##13##2##(1991-9#1)(1993-12#1)(1994-3#1)(1995-8#1)(1996-7#1)(2006-9#1)(2007-12#1)(2008-7#2)(2008-8#1)(2010-2#1)(2012-2#1)(2013-1#1)
one belonging to the##3##4##(2005-11#1)(2011-1#2)
one best##3##2##(1996-1#1)(1996-2#1)(2006-12#1)
one between the##2##3##(1996-2#1)(2008-7#1)
one between##5##2##(1990-8#1)(1996-2#1)(2006-5#1)(2008-12#1)(2008-7#1)
one billion atoms##2##3##(2006-4#2)
one billion##3##2##(2006-2#1)(2006-4#2)
one bite##2##2##(1996-11#1)(2008-4#1)
one brand of##2##3##(1995-2#1)(1996-3#1)
one but##3##2##(1992-5#1)(2008-10#1)(2008-4#1)
one by one##5##3##(2008-10#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#1)
one by##19##2##(1990-7#1)(1992-2#1)(1993-10#1)(1993-3#1)(1993-8#1)(1994-11#1)(2007-3#1)(2008-10#3)(2008-2#2)(2008-4#2)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#2)
one cDNA clone##4##3##(1990-7#1)(2008-8#3)
one cDNA##6##2##(1990-7#1)(1993-6#1)(2008-8#4)
one calendar year##2##3##(1995-7#1)(2013-1#1)
one calibration line##2##3##(2007-12#1)(2008-10#1)
one calibration##3##2##(1996-7#1)(2007-12#1)(2008-10#1)
one can achieve##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
one can assess##2##3##(1995-9#1)(2010-2#1)
one can avoid the##2##4##(2008-3#2)
one can be##4##3##(1997-4#1)(2008-2#1)(2008-3#1)(2009-8#1)
one can come##2##3##(2006-10#1)(2012-2#1)
one can conclude that##2##4##(2008-2#1)(2009-12#1)
one can deduce##2##3##(1993-11#1)(2008-3#1)
one can determine the##6##4##(2007-12#2)(2008-10#1)(2008-2#3)
one can determine##9##3##(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#2)
one can easily##4##3##(1991-3#1)(2007-12#1)(2008-3#1)(2009-4#1)
one can eliminate##2##3##(2008-3#2)
one can estimate##2##3##(1993-1#1)(2008-2#1)
one can evaluate the##2##4##(2008-2#1)(2008-3#1)
one can find##2##3##(2008-1#1)(2008-10#1)
one can generate##2##3##(2008-2#1)(2008-3#1)
one can go##2##3##(2008-2#1)(2009-10#1)
one can identify##2##3##(1993-1#1)(1996-10#1)
one can make##2##3##(1996-7#1)(2008-7#1)
one can measure##2##3##(2007-12#1)(2008-2#1)
one can obtain a##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
one can obtain##8##3##(1992-6#1)(2007-12#1)(2008-2#3)(2008-3#3)
one can often##2##3##(2008-2#1)(2012-3#1)
one can predict the##2##4##(2008-10#1)(2008-11#1)
one can reduce the##2##4##(2008-3#1)(2010-2#1)
one can show that##2##4##(1992-9#1)(2007-12#1)
one can tune##3##3##(2007-12#2)(2008-1#1)
one can use the##2##4##(2008-2#1)(2008-9#1)
one can use##6##3##(1994-11#1)(2008-2#3)(2008-3#1)(2008-9#1)
one can##141##2##(1990-7#1)(1991-3#1)(1992-2#1)(1992-6#2)(1992-9#1)(1993-1#2)(1993-11#2)(1994-11#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-9#1)(1996-10#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-11#8)(2007-12#25)(2007-5#1)(2007-9#1)(2008-1#5)(2008-10#6)(2008-11#2)(2008-2#28)(2008-3#23)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
one cannot##8##2##(1991-12#1)(1995-6#1)(1995-9#1)(1996-7#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-2#1)
one capsule##2##2##(1997-2#1)(2011-2#1)
one carbon##2##2##(2006-8#1)(2007-1#1)
one carboxyl##2##2##(1991-7#1)(2005-12#1)
one carotid##2##2##(1995-3#1)(2007-9#1)
one carrying##2##2##(1993-6#1)(2012-2#1)
one case and##7##3##(1992-4#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-5#1)(2008-7#1)
one case each of##3##4##(1996-11#1)(2008-5#1)(2008-9#1)
one case each##4##3##(1996-11#1)(2006-8#1)(2008-5#1)(2008-9#1)
one case had##2##3##(2006-3#1)(2007-7#1)
one case in##4##3##(1991-4#1)(1996-5#1)(2008-4#1)(2013-7#1)
one case of acute##2##4##(2008-5#1)(2012-12#1)
one case of meningitis##2##4##(2006-5#1)(2011-2#1)
one case of pseudoarthrosis and one case of##2##8##(2008-4#2)
one case of##49##3##(1990-9#1)(1991-5#2)(1992-6#1)(1993-10#1)(1993-5#1)(1993-9#1)(1997-3#2)(2005-12#1)(2006-12#1)(2006-5#1)(2006-8#3)(2007-11#1)(2007-2#3)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-12#1)(2008-4#5)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#2)
one case the##8##3##(1990-8#1)(1991-2#1)(1992-8#1)(1994-9#1)(1996-8#1)(2007-11#1)(2007-6#1)(2007-8#1)
one case was characterized by##2##5##(2006-10#1)(2012-2#1)
one case was##7##3##(1993-3#1)(2005-10#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-7#1)(2012-2#1)
one case with both##2##4##(1994-6#2)
one case with##6##3##(1991-12#1)(1994-6#2)(2006-12#1)(2007-7#1)(2007-8#1)
one case##180##2##(1990-12#1)(1990-3#2)(1990-4#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#2)(1991-8#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#2)(1993-3#3)(1993-5#1)(1993-8#2)(1993-9#2)(1994-6#3)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-11#3)(1996-5#1)(1996-8#2)(1997-3#2)(1997-4#1)(1997-8#2)(2004-12#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-8#5)(2006-10#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#6)(2007-11#9)(2007-12#2)(2007-2#3)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#11)(2007-8#11)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#7)(2008-5#4)(2008-6#3)(2008-7#11)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-5#1)(2010-6#1)(2010-7#2)(2011-1#3)(2011-12#1)(2011-2#2)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#1)(2013-7#1)
one catalytic##3##2##(1992-3#1)(1992-4#1)(1992-6#1)
one catalytically##3##2##(1991-6#2)(1994-11#1)
one causing##2##2##(1990-7#1)(2012-11#1)
one cavity##2##2##(2007-11#1)(2008-10#1)
one cell line##6##3##(1992-11#1)(1992-12#1)(1992-3#1)(1997-2#1)(2008-11#1)(2008-6#1)
one cell type##2##3##(1996-11#1)(2008-8#1)
one cell##26##2##(1992-11#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-2#1)(1994-3#1)(1995-11#1)(1996-11#1)(1997-2#1)(1997-3#2)(1997-8#1)(2007-10#1)(2007-12#1)(2008-11#2)(2008-2#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-2#1)(2012-12#3)(2013-1#1)
one cellular##2##2##(1996-10#1)(2009-8#1)
one center were##2##3##(2007-2#1)(2010-4#1)
one center##4##2##(2007-2#1)(2008-1#1)(2010-4#2)
one centered at##2##3##(1991-3#1)(2008-1#1)
one central##3##2##(2007-12#1)(2008-5#1)(2008-7#1)
one centre##2##2##(2008-9#1)(2012-2#1)
one century##3##2##(1996-6#1)(2009-12#1)(2012-2#1)
one change##2##2##(1993-8#1)(2012-3#1)
one character##3##2##(2008-11#2)(2008-8#1)
one characteristic of##2##3##(2006-5#1)(2007-3#1)
one characterized by##3##3##(1996-11#2)(2006-10#1)
one chicken##2##2##(2007-6#1)(2008-5#1)
one child was##2##3##(1993-2#1)(2008-7#1)
one child with##3##3##(1992-1#1)(2008-9#1)(2012-2#1)
one child##18##2##(1990-8#1)(1992-1#1)(1993-2#1)(1994-5#1)(1996-12#1)(1997-5#2)(2006-10#1)(2007-3#1)(2008-7#1)(2008-9#2)(2011-2#1)(2012-12#3)(2012-2#2)
one chooses##2##2##(1991-4#1)(1994-12#1)
one chromatographic##2##2##(1992-1#1)(2008-10#1)
one chromosome##3##2##(1993-9#1)(2008-10#1)(2008-12#1)
one cigarette##3##2##(1991-9#1)(2007-8#1)(2013-1#1)
one class of binding sites##2##5##(1990-8#1)(1992-12#1)
one class of##5##3##(1990-8#1)(1992-12#1)(1993-1#1)(1993-12#1)(2008-10#1)
one class##12##2##(1990-8#1)(1992-12#1)(1992-4#1)(1993-1#2)(1993-12#1)(1993-2#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#2)
one climatic area##2##3##(2008-10#2)
one climatic##3##2##(2008-10#2)(2013-1#1)
one clinical##3##2##(2007-12#1)(2009-2#1)(2010-12#1)
one clone##5##2##(1994-12#1)(1994-6#1)(1995-2#1)(2008-4#1)(2008-9#1)
one cluster of##2##3##(1990-2#1)(2008-10#1)
one cluster##5##2##(1990-2#1)(2008-10#2)(2008-6#1)(2009-5#1)
one cohort study##2##3##(1990-5#2)
one cohort##3##2##(1990-5#2)(2008-11#1)
one colony##2##2##(2008-5#2)
one column##2##2##(1990-11#1)(2008-11#1)
one commercial##2##2##(2005-11#1)(2007-6#1)
one common##9##2##(1991-5#1)(1992-12#1)(1992-6#1)(1993-12#1)(2007-12#1)(2008-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
one commonly##3##2##(2005-12#1)(2006-6#1)(2010-2#1)
one community hospital##3##3##(1994-3#1)(1995-3#1)(2009-2#1)
one community##4##2##(1994-3#1)(1995-3#1)(2009-2#1)(2011-2#1)
one company##2##2##(1997-3#1)(2013-8#1)
one compartment##5##2##(1994-3#1)(2006-10#1)(2008-11#2)(2011-2#1)
one complete##8##2##(1990-6#1)(2005-11#1)(2006-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2012-2#1)
one complication##2##2##(2008-4#1)(2012-12#1)
one component of a##3##4##(2008-12#1)(2010-7#1)(2013-8#1)
one component of the##7##4##(1992-9#1)(1994-3#1)(2006-10#1)(2008-11#1)(2008-3#1)(2009-2#1)(2009-4#1)
one component of this##2##4##(1993-9#1)(2008-10#1)
one component of##18##3##(1990-11#1)(1992-9#2)(1993-9#1)(1994-3#1)(1994-5#1)(1997-4#1)(2005-8#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2009-2#1)(2009-4#1)(2010-7#1)(2013-8#1)
one component##24##2##(1990-11#1)(1992-9#2)(1993-3#1)(1993-9#1)(1994-3#1)(1994-5#1)(1996-2#1)(1997-4#1)(2005-8#1)(2006-10#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2009-2#1)(2009-4#1)(2010-7#1)(2012-12#1)(2013-8#1)
one composed of##2##3##(1990-2#1)(2010-4#1)
one compound##5##2##(1991-10#1)(1996-2#1)(2004-8#1)(2007-6#1)(2008-7#1)
one comprising##2##2##(2008-10#1)(2008-5#1)
one concept##2##2##(2005-10#1)(2006-12#1)
one condition and##2##3##(1991-2#1)(2007-2#1)
one condition##5##2##(1991-2#1)(2007-2#1)(2012-12#1)(2013-1#2)
one consequence of##2##3##(1991-1#1)(1991-9#1)
one conservative##2##2##(1994-9#1)(2012-2#1)
one considers that##2##3##(2007-11#1)(2008-2#1)
one considers##3##2##(2005-5#1)(2007-11#1)(2008-2#1)
one consisting of##6##3##(2008-10#2)(2008-5#1)(2008-7#1)(2009-2#1)(2011-2#1)
one contained the##2##3##(2008-10#2)
one contained##4##2##(1990-11#1)(1997-7#1)(2008-10#2)
one containing the##4##3##(1990-7#1)(1991-12#1)(1991-2#2)
one containing##8##2##(1990-7#1)(1991-12#1)(1991-2#2)(1996-8#1)(2005-11#1)(2007-12#1)(2008-10#1)
one continuous##2##2##(2008-10#1)(2008-2#1)
one contributor to##2##3##(2010-12#1)(2010-2#1)
one control and##2##3##(2011-2#1)(2013-1#1)
one control##8##2##(1991-9#1)(1997-6#1)(2006-10#1)(2008-10#2)(2011-2#1)(2013-1#1)(2013-8#1)
one controlled##2##2##(2006-6#1)(2011-1#1)
one conventional##3##2##(2007-12#1)(2012-12#1)(2013-1#1)
one copy of the##3##4##(1992-5#1)(2008-8#1)(2012-3#1)
one copy of##12##3##(1990-5#1)(1992-5#1)(1994-9#1)(1997-2#1)(1997-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-2#1)(2012-3#2)
one copy##17##2##(1990-5#1)(1992-5#1)(1994-9#2)(1997-2#2)(1997-6#1)(2007-11#2)(2007-2#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-2#1)(2012-3#2)
one correlator##3##2##(2008-2#2)(2008-3#1)
one corresponding to##2##3##(1990-3#1)(2011-2#1)
one could##9##2##(2004-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-1#1)(2012-12#1)
one county##2##2##(1992-3#1)(2013-1#1)
one critical##3##2##(2007-7#1)(2008-1#1)(2013-1#1)
one cross##3##2##(2008-10#1)(2008-2#1)(2010-4#1)
one cultivar##4##2##(2008-10#4)
one current##2##2##(1994-3#1)(1995-1#1)
one cycle of##6##3##(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2010-4#1)
one cycle##8##2##(1990-10#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2010-4#1)
one cysteine##3##2##(1990-2#1)(1992-11#1)(1994-8#1)
one cytoplasmic##3##2##(1991-2#1)(1996-5#1)(1997-7#1)
one dataset##2##2##(2008-11#1)(2009-8#1)
one daughter##2##2##(2009-12#1)(2009-2#1)
one day after##5##3##(1992-7#1)(1995-12#1)(2004-9#1)(2006-8#1)(2010-4#1)
one day before operation was##2##5##(1990-8#2)
one day before operation##4##4##(1990-8#4)
one day before##5##3##(1990-8#4)(2009-12#1)
one day in##2##3##(1997-7#1)(2008-5#1)
one day later##3##3##(1991-9#1)(2009-7#2)
one day of##5##3##(1997-6#1)(1997-7#1)(2005-12#1)(2007-12#1)(2011-2#1)
one day to##2##3##(1991-3#1)(2008-3#1)
one day##51##2##(1990-8#6)(1991-3#1)(1991-9#1)(1992-7#1)(1992-8#1)(1993-2#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-12#1)(1997-6#1)(1997-7#3)(2004-9#1)(2005-10#1)(2005-12#2)(2006-1#1)(2006-11#1)(2006-4#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-9#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-7#2)(2010-4#2)(2011-2#3)(2012-2#1)(2012-8#1)
one day's##2##2##(1990-4#1)(2013-8#1)
one death##9##2##(1991-3#1)(1997-8#1)(2006-7#1)(2007-7#2)(2007-8#1)(2008-6#1)(2008-7#1)(2013-8#1)
one decade##2##2##(2007-10#1)(2007-8#1)
one degree##2##2##(1995-8#1)(2007-5#1)
one derived from##2##3##(1992-2#1)(1994-12#1)
one derived##3##2##(1992-2#1)(1994-12#1)(2005-11#1)
one designated##4##2##(1994-8#2)(2006-8#1)(2008-10#1)
one designed##2##2##(2008-10#1)(2008-5#1)
one developed##3##2##(1996-9#1)(1997-3#1)(2006-12#1)
one diagnostic##2##2##(2007-2#1)(2008-5#1)
one did not show any change##2##6##(2007-7#2)
one did not##4##3##(2007-7#2)(2008-4#1)(2012-11#1)
one died of##4##3##(1997-3#1)(2007-8#1)(2008-4#1)(2009-10#1)
one died##7##2##(1997-3#1)(2007-8#2)(2008-4#2)(2009-10#1)(2012-12#1)
one diffraction##2##2##(2008-3#2)
one dimension##17##2##(1991-11#1)(1991-6#1)(1995-8#1)(2007-11#1)(2007-12#4)(2007-8#1)(2007-9#2)(2008-10#1)(2008-2#2)(2008-3#2)(2009-12#1)
one dimensional##2##2##(2008-2#1)(2010-7#1)
one direction##7##2##(1995-5#1)(1996-8#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)
one disease##4##2##(1994-2#1)(2006-10#1)(2010-1#1)(2010-2#1)
one documented##2##2##(2010-1#1)(2010-9#1)
one dog##4##2##(1993-7#1)(2008-6#3)
one domain##3##2##(1991-2#1)(1991-7#1)(2008-7#1)
one dominant gene and one recessive gene##2##7##(2008-10#2)
one dominant gene##3##3##(2008-10#3)
one dominant##7##2##(1993-9#1)(2008-10#4)(2009-11#1)(2009-6#1)
one dose of##5##3##(1990-2#1)(1993-7#1)(1994-7#2)(2012-2#1)
one dose##9##2##(1990-2#1)(1993-7#1)(1994-7#2)(2004-12#1)(2007-11#1)(2007-12#1)(2008-7#1)(2012-2#1)
one double##2##2##(1991-10#1)(1995-4#1)
one drop of##3##3##(1993-3#2)(2008-10#1)
one drop##4##2##(1993-3#2)(1994-2#1)(2008-10#1)
one drug##8##2##(1991-1#1)(2006-10#1)(2006-12#1)(2007-10#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-7#1)
one dual-rail optical##2##3##(2008-3#2)
one due to##4##3##(2008-10#1)(2008-6#2)(2013-1#1)
one during the##2##3##(2007-8#1)(2009-10#1)
one each from##2##3##(2008-10#2)
one each had##2##3##(1995-12#1)(2008-1#1)
one each of the##2##4##(2006-5#1)(2012-2#1)
one each of##4##3##(2006-5#1)(2007-7#1)(2008-1#1)(2012-2#1)
one each##9##2##(1995-12#1)(2006-5#1)(2007-7#1)(2008-1#2)(2008-10#2)(2009-6#1)(2012-2#1)
one effect of##2##3##(2008-11#1)(2013-7#1)
one effect##3##2##(2005-11#1)(2008-11#1)(2013-7#1)
one electrode##2##2##(2008-10#1)(2008-2#1)
one electron reduced##2##3##(1997-4#1)(2008-4#1)
one electron##7##2##(1994-11#1)(1997-4#2)(2008-10#2)(2008-4#1)(2009-9#1)
one element of the##3##4##(1997-2#1)(1997-3#1)(2007-12#1)
one element of##5##3##(1997-2#1)(1997-3#1)(2007-1#1)(2007-12#1)(2008-11#1)
one element##7##2##(1997-2#1)(1997-3#1)(1997-5#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#1)
one empirical##2##2##(1994-5#1)(2007-6#1)
one empirically##2##2##(1995-3#1)(2004-9#1)
one encoding##2##2##(1991-9#1)(2008-11#1)
one end and##3##3##(2008-10#1)(2008-5#1)(2008-6#1)
one end of a##6##4##(1990-9#1)(1993-11#1)(1994-11#1)(2006-11#1)(2007-11#1)(2008-10#1)
one end of the##7##4##(1990-10#1)(1995-1#1)(1996-10#1)(1996-6#1)(1996-7#1)(2007-12#1)(2012-12#1)
one end of##14##3##(1990-10#1)(1990-9#1)(1993-11#1)(1994-11#1)(1995-1#1)(1995-2#1)(1996-10#1)(1996-6#1)(1996-7#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2012-12#1)
one end to##3##3##(1996-2#1)(2008-10#1)(2008-7#1)
one end##27##2##(1990-10#1)(1990-9#1)(1993-11#1)(1994-11#1)(1995-1#1)(1995-2#1)(1996-10#1)(1996-2#1)(1996-6#1)(1996-7#1)(2006-11#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2012-1#1)(2012-12#1)(2012-3#1)
one endometrial##2##2##(1993-3#1)(2007-3#1)
one enzyme##11##2##(1990-2#1)(1991-5#1)(1991-9#1)(1992-6#1)(1992-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-3#1)(2012-2#1)
one episode of##7##3##(1991-11#1)(1994-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-6#2)
one episode##12##2##(1991-11#1)(1994-6#1)(1994-8#1)(1996-7#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-6#2)(2010-12#1)
one equivalent of##3##3##(1995-4#1)(2009-2#1)(2010-2#1)
one essential##4##2##(2004-9#1)(2006-10#1)(2008-4#1)(2010-5#1)
one establishment every##2##3##(2008-10#2)
one ethical##2##2##(2005-7#1)(2011-2#1)
one event##2##2##(1996-4#1)(2008-2#1)
one ewe to##2##3##(2009-4#2)
one example of the##4##4##(1995-12#1)(2006-4#1)(2008-4#1)(2010-9#1)
one example of##7##3##(1995-12#1)(2006-4#1)(2008-10#1)(2008-4#2)(2008-9#1)(2010-9#1)
one example##9##2##(1995-12#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-9#1)(2010-9#1)
one exception##10##2##(1991-8#1)(1994-2#1)(1995-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-4#1)
one existing##2##2##(2008-2#1)(2008-9#1)
one exon##3##2##(1990-5#1)(1994-12#1)(1994-2#1)
one expects##2##2##(2010-12#1)(2012-3#1)
one experiment##14##2##(1991-8#1)(1992-10#1)(1994-6#1)(2006-3#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-8#1)(2009-3#2)(2010-8#1)
one experimental##2##2##(2005-11#1)(2008-10#1)
one explanation for the##3##4##(1991-12#1)(1997-1#1)(2011-1#1)
one explanation for##4##3##(1991-12#1)(1997-1#1)(2010-2#1)(2011-1#1)
one explanation##5##2##(1991-12#1)(1997-1#1)(2010-2#1)(2010-8#1)(2011-1#1)
one exposure##5##2##(1992-1#1)(1997-8#2)(2007-11#1)(2008-10#1)
one extreme##2##2##(2006-10#1)(2007-6#1)
one eye##14##2##(1994-3#1)(1994-6#1)(1994-8#1)(1996-7#1)(1997-3#1)(2005-11#1)(2007-8#1)(2008-2#1)(2008-7#1)(2009-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
one face of the##3##4##(1992-12#1)(1992-3#1)(1994-9#1)
one face of##4##3##(1992-12#1)(1992-3#1)(1993-11#1)(1994-9#1)
one face##5##2##(1992-12#1)(1992-3#1)(1993-11#1)(1994-9#1)(2008-7#1)
one facility##7##2##(1991-3#2)(1996-11#1)(2008-11#1)(2008-9#1)(2013-1#2)
one factor in##2##3##(2007-11#1)(2008-11#1)
one factor that##2##3##(2008-9#1)(2012-11#1)
one factor##10##2##(1992-7#1)(1993-11#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-12#1)(2012-11#1)
one faculty##3##2##(1993-2#1)(2008-1#1)(2008-12#1)
one false positive##2##3##(1994-9#1)(2008-1#1)
one family##8##2##(1991-12#1)(1993-10#1)(1994-8#1)(1995-11#1)(2006-10#1)(2007-2#1)(2007-3#1)(2008-10#1)
one farm##2##2##(1994-7#1)(1997-5#1)
one feature of a##2##4##(1996-9#1)(2012-3#1)
one female##6##2##(1991-8#1)(2004-4#1)(2007-4#1)(2008-5#1)(2008-9#1)(2009-4#1)
one fetus##2##2##(1993-12#1)(2012-3#1)
one fiber##2##2##(2008-10#1)(2008-3#1)
one field isolate##2##3##(2007-6#1)(2008-5#1)
one field##13##2##(2007-6#1)(2008-10#9)(2008-5#1)(2009-3#1)(2011-2#1)
one fifth of patients##2##4##(2009-3#1)(2012-3#1)
one fifth of##7##3##(1990-11#1)(1992-1#1)(2006-10#1)(2007-2#1)(2008-8#1)(2009-3#1)(2012-3#1)
one fifth##9##2##(1990-11#1)(1992-1#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-7#1)(2008-8#1)(2009-3#1)(2012-3#1)
one finds##2##2##(2007-12#1)(2010-4#1)
one first##3##2##(1993-5#1)(2006-10#1)(2008-11#1)
one fish##2##2##(1997-2#1)(2010-8#1)
one fixed##2##2##(2008-2#1)(2011-1#1)
one fluorescent##2##2##(1993-3#1)(2008-1#1)
one fluorophore##2##2##(1997-2#1)(2008-4#1)
one focus##2##2##(2008-10#1)(2008-2#1)
one focuses on##3##3##(2008-8#2)(2010-2#1)
one focuses##4##2##(2008-2#1)(2008-8#2)(2010-2#1)
one followed by##2##3##(2008-10#1)(2008-3#1)
one for 1##2##3##(2008-10#1)(2008-9#1)
one for a##2##3##(2007-8#1)(2008-3#1)
one for amplification##2##3##(2008-10#1)(2008-3#1)
one for each##5##3##(1990-12#1)(1994-8#1)(2006-12#1)(2007-11#1)(2008-2#1)
one for the upwelling radiance##2##5##(2008-2#2)
one for the##18##3##(1992-6#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-4#1)(2008-5#1)(2008-6#1)(2011-1#1)
one for##86##2##(1990-11#1)(1990-12#1)(1990-4#1)(1991-10#1)(1991-9#1)(1992-6#2)(1993-10#1)(1993-6#1)(1993-8#1)(1994-8#3)(1995-9#1)(1997-7#1)(1997-8#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-12#1)(2006-8#2)(2007-11#2)(2007-12#3)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#4)(2008-4#7)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#5)(2009-3#2)(2010-1#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
one form of the##3##4##(1990-2#1)(1992-3#1)(2007-1#1)
one form of##15##3##(1990-12#1)(1990-2#1)(1991-8#1)(1992-3#1)(1993-2#1)(1993-6#1)(2006-5#1)(2007-1#1)(2008-1#1)(2008-10#3)(2008-9#1)(2009-5#1)(2012-2#1)
one form##24##2##(1990-12#1)(1990-2#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-2#1)(1993-6#1)(1995-3#1)(1995-8#1)(2006-5#1)(2006-8#1)(2007-1#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-9#1)(2009-5#1)(2010-2#1)(2012-2#2)(2013-1#2)
one format##3##2##(2008-10#1)(2008-4#1)(2010-10#1)
one found in##2##3##(1996-8#1)(2008-2#1)
one found solely in##2##4##(2008-10#2)
one found##6##2##(1990-2#1)(1996-8#1)(1996-9#1)(2008-10#2)(2008-2#1)
one fourth of patients##3##4##(2007-10#1)(2007-9#1)(2010-4#1)
one fourth of the##2##4##(1990-12#2)
one fourth of##6##3##(1990-12#2)(2007-10#1)(2007-9#1)(2010-12#1)(2010-4#1)
one fourth##9##2##(1990-12#2)(1993-9#1)(1996-2#1)(2007-10#1)(2007-9#1)(2008-8#1)(2010-12#1)(2010-4#1)
one fraction##2##2##(1992-11#1)(2008-10#1)
one fracture##2##2##(2008-6#1)(2009-4#1)
one free##3##2##(2006-5#2)(2008-10#1)
one from a##3##3##(1992-12#1)(2005-9#1)(2008-5#1)
one from chrysanthemum and##2##4##(2008-10#2)
one from each##4##3##(1990-11#1)(1992-8#1)(2008-1#1)(2011-2#1)
one from meningitis and one from severe sepsis##2##8##(2007-3#2)
one from the##13##3##(2005-9#1)(2006-6#1)(2007-1#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#2)(2010-11#1)(2010-8#1)(2011-2#1)
one from##48##2##(1990-11#1)(1990-12#1)(1990-3#1)(1992-12#1)(1992-8#1)(1992-9#3)(1996-6#1)(1997-4#1)(2005-9#3)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-3#4)(2008-1#3)(2008-10#10)(2008-2#2)(2008-3#2)(2008-5#2)(2008-9#2)(2009-2#1)(2009-9#1)(2010-11#1)(2010-8#1)(2011-2#2)
one full##2##2##(2007-2#1)(2012-11#1)
one function of##6##3##(1990-8#1)(1994-3#1)(1995-10#1)(1995-8#1)(2005-11#1)(2008-9#1)
one function##8##2##(1990-8#1)(1993-4#1)(1994-3#1)(1995-10#1)(1995-8#1)(2005-11#1)(2008-12#1)(2008-9#1)
one functional type##2##3##(2008-11#1)(2013-7#1)
one functional##8##2##(1991-5#1)(1992-3#1)(1994-6#1)(1997-1#1)(2006-3#1)(2008-11#1)(2010-8#1)(2013-7#1)
one fungicide##2##2##(2008-10#1)(2008-7#1)
one fusion##2##2##(1991-11#1)(2013-1#1)
one gene for##3##3##(1997-2#1)(2008-10#1)(2008-4#1)
one gene##21##2##(1990-11#1)(1990-6#1)(1990-8#1)(1991-5#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-8#1)(1994-9#1)(1997-2#1)(2007-11#1)(2008-10#4)(2008-4#1)(2009-3#1)(2009-5#2)(2013-8#1)
one generation##6##2##(1991-10#1)(2006-12#1)(2009-9#1)(2011-2#2)(2013-1#1)
one generic##2##2##(2011-1#1)(2013-7#1)
one genetic##2##2##(2008-2#1)(2013-1#1)
one genotype##7##2##(2008-10#6)(2013-8#1)
one genus##2##2##(2008-3#1)(2008-7#1)
one germ##2##2##(2006-8#1)(2012-2#1)
one given##2##2##(2008-10#2)
one gold##2##2##(2008-5#1)(2013-8#1)
one grating##3##2##(2005-4#1)(2007-11#1)(2008-3#1)
one greenhouse strain##2##3##(2011-2#2)
one greenhouse##3##2##(2008-10#1)(2011-2#2)
one group and##2##3##(2008-10#1)(2011-2#1)
one group could##2##3##(1991-11#1)(2010-4#1)
one group of rats##4##4##(1994-2#1)(1994-8#1)(1996-12#1)(2009-11#1)
one group of##12##3##(1990-11#1)(1990-2#1)(1990-4#1)(1991-9#1)(1994-2#1)(1994-8#1)(1996-12#1)(2006-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-11#1)
one group was treated with##2##5##(2008-12#2)
one group was##3##3##(2008-12#3)
one group with##2##3##(1995-7#1)(1996-9#1)
one group##40##2##(1990-11#1)(1990-2#1)(1990-4#1)(1991-11#2)(1991-9#1)(1993-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-9#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-10#9)(2008-12#3)(2008-7#1)(2008-9#1)(2009-11#1)(2010-4#2)(2011-2#1)(2013-1#1)(2013-8#2)
one group's##2##2##(1995-3#1)(2007-4#1)
one had PCL mid substance rupture##2##6##(2007-1#2)
one had a##7##3##(1992-6#1)(1995-1#1)(2007-1#2)(2007-8#2)(2008-6#1)
one had an##2##3##(1991-2#1)(2007-1#1)
one had increased##2##3##(1992-3#1)(1992-7#1)
one had the##2##3##(2008-9#1)(2013-1#1)
one had##47##2##(1990-3#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-6#4)(1992-7#1)(1995-1#1)(1995-2#1)(1996-9#1)(1997-5#1)(2004-2#1)(2005-12#1)(2007-1#6)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#3)(2007-8#3)(2008-1#2)(2008-11#1)(2008-4#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2009-9#1)(2012-3#1)(2013-1#2)
one half liter##2##3##(1993-11#2)
one half of the##13##4##(1990-8#1)(1991-10#1)(1991-4#1)(1992-9#1)(1993-12#1)(1995-3#1)(2007-12#1)(2008-2#2)(2008-9#2)(2009-5#1)(2012-3#1)
one half of##20##3##(1990-8#1)(1991-10#1)(1991-4#1)(1992-12#1)(1992-9#1)(1993-12#1)(1995-3#1)(1997-2#1)(2005-10#1)(2006-10#1)(2007-12#1)(2008-2#3)(2008-9#2)(2009-5#2)(2011-2#1)(2012-3#1)
one half##31##2##(1990-8#1)(1991-10#1)(1991-4#2)(1991-6#1)(1992-12#1)(1992-9#1)(1993-11#2)(1993-12#1)(1995-3#1)(1996-8#1)(1997-2#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-2#3)(2008-3#1)(2008-9#2)(2009-5#2)(2011-2#2)(2012-3#1)
one hand and the capacity##2##5##(1991-7#1)(2008-12#1)
one hand and the##3##4##(1991-7#1)(1994-6#1)(2008-12#1)
one hand and##17##3##(1990-9#1)(1991-6#1)(1991-7#1)(1993-12#1)(1994-2#1)(1994-6#1)(2006-6#1)(2006-8#1)(2007-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#2)
one hand##98##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-8#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-7#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-6#3)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#4)(2009-10#1)(2009-2#4)(2009-5#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#4)(2012-2#2)(2013-1#5)(2013-8#1)
one haplotype##4##2##(1993-9#1)(2008-10#2)(2008-11#1)
one has a##5##3##(2008-10#3)(2010-10#2)
one has been##4##3##(2007-8#1)(2008-10#1)(2008-2#1)(2009-8#1)
one has image##2##3##(2008-2#2)
one has the##2##3##(1990-6#1)(2008-10#1)
one has to select##2##4##(2007-12#1)(2008-1#1)
one has to##7##3##(2005-11#1)(2006-10#1)(2007-12#2)(2008-1#1)(2009-5#1)(2013-8#1)
one has##29##2##(1990-6#1)(1991-11#1)(1993-8#1)(1995-3#1)(1995-6#1)(1995-9#1)(2005-11#1)(2006-10#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-2#3)(2008-4#1)(2009-5#1)(2009-8#1)(2010-10#2)(2013-8#1)
one have##2##2##(2010-4#1)(2011-2#1)
one having##2##2##(1991-12#1)(2008-10#1)
one health care##3##3##(1992-2#1)(1995-2#1)(2008-1#1)
one health##5##2##(1992-2#1)(1992-9#1)(1995-2#1)(2008-1#1)(2008-7#1)
one heart##2##2##(1995-2#1)(2007-8#1)
one heavy atom##2##3##(1992-4#1)(1993-3#1)
one hemisphere##2##2##(1997-3#1)(2007-10#1)
one herd##3##2##(1992-2#1)(1994-4#2)
one heterozygous individual##2##3##(2006-10#2)
one hidden layer##3##3##(1994-9#1)(2008-6#1)(2010-8#1)
one high##2##2##(1992-7#1)(1996-2#1)
one histidine##4##2##(1990-9#1)(1991-4#1)(1994-8#1)(1995-3#1)
one homozygous##3##2##(1997-8#1)(2006-10#1)(2006-12#1)
one hospital and##2##3##(1993-12#1)(2007-2#1)
one hospital##12##2##(1990-9#1)(1991-4#1)(1991-9#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-9#1)(2006-8#1)(2007-2#2)(2007-8#1)
one hospital's##5##2##(1992-1#1)(1992-2#1)(1994-3#1)(1996-12#1)(2006-1#1)
one host species##2##3##(2008-10#1)(2008-9#1)
one host##5##2##(2008-10#3)(2008-9#2)
one hour after surgery##2##4##(2007-8#1)(2012-2#1)
one hour after##5##3##(1994-8#2)(1995-9#1)(2007-8#1)(2012-2#1)
one hour before decapitation##2##4##(1995-12#2)
one hour before##5##3##(1990-8#2)(1995-12#2)(2008-8#1)
one hour is##2##3##(1990-8#1)(2008-3#1)
one hour later##3##3##(2008-4#1)(2008-5#1)(2012-2#1)
one hour of exposure##2##4##(1994-9#1)(2013-1#1)
one hour of##8##3##(1992-2#1)(1992-6#1)(1993-12#1)(1994-9#1)(1996-11#1)(2007-2#1)(2010-8#1)(2013-1#1)
one hour per##3##3##(2006-10#2)(2008-9#1)
one hour post dialysis##3##4##(2008-4#3)
one hour prior to##2##4##(2008-6#1)(2011-2#1)
one hour prior##3##3##(2008-6#1)(2011-2#1)(2012-2#1)
one hour##58##2##(1990-12#2)(1990-4#1)(1990-5#1)(1990-8#3)(1991-8#1)(1992-12#1)(1992-2#2)(1992-6#2)(1993-12#1)(1994-8#2)(1994-9#1)(1995-12#3)(1995-9#1)(1996-11#1)(2006-10#2)(2007-1#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#2)
one human##2##2##(1991-9#1)(1994-8#1)
one hundred and twenty##2##4##(2006-10#1)(2009-5#1)
one hundred and##8##3##(1995-10#1)(2006-10#1)(2007-10#1)(2007-3#2)(2007-6#1)(2009-5#1)(2012-2#1)
one hundred patients##3##3##(1995-4#1)(2007-7#2)
one hundred years##3##3##(2009-10#1)(2011-12#1)(2011-2#1)
one hundred##27##2##(1991-12#1)(1991-9#1)(1992-10#1)(1992-11#1)(1995-10#1)(1995-4#1)(2006-10#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)
one hybridization##2##2##(1997-3#1)(2008-10#1)
one hydrogen bond##3##3##(1992-6#1)(1997-4#1)(2012-3#1)
one hydrophilic##2##2##(2008-5#1)(2010-5#1)
one hydrophobic##3##2##(1990-5#1)(2004-8#1)(2012-3#1)
one hypothesis is##2##3##(2006-5#1)(2008-10#1)
one hypothesis##3##2##(2006-5#1)(2008-10#1)(2008-8#1)
one image at a time##2##5##(2008-3#1)(2013-1#1)
one image##4##2##(2007-1#1)(2008-2#1)(2008-3#1)(2013-1#1)
one imaging##2##2##(1997-8#1)(2008-12#1)
one immediately##2##2##(1992-12#1)(2007-9#1)
one implant##2##2##(2013-1#2)
one important##10##2##(1991-9#1)(1992-8#1)(1996-5#1)(1997-3#1)(2006-10#1)(2006-11#1)(2006-7#2)(2007-8#1)(2010-3#1)
one in a million##2##4##(2008-3#1)(2010-2#1)
one in a##8##3##(1991-7#1)(2007-2#1)(2008-10#1)(2008-3#2)(2009-7#1)(2010-2#1)(2013-1#1)
one in each of the##2##5##(2007-8#1)(2008-10#1)
one in each##4##3##(1992-5#1)(1996-2#1)(2007-8#1)(2008-10#1)
one in favour of##2##4##(2007-8#2)
one in five##8##3##(1992-2#1)(2008-1#1)(2008-4#2)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
one in group##2##3##(1996-3#1)(2007-7#1)
one in response to##2##4##(1997-2#2)
one in terms of##2##4##(1991-3#1)(2010-10#1)
one in the distal##2##4##(1997-4#1)(2008-1#1)
one in the former##2##4##(1992-1#2)
one in the outer##2##4##(1994-8#1)(2006-1#1)
one in the placebo group##2##5##(1993-11#1)(2005-7#1)
one in the proximal##2##4##(1997-4#1)(2008-1#1)
one in the##35##3##(1990-10#1)(1990-11#1)(1991-9#1)(1992-1#2)(1992-12#1)(1993-11#1)(1994-8#2)(1994-9#1)(1995-5#2)(1996-4#1)(1996-5#1)(1996-6#1)(1997-4#3)(2005-7#1)(2006-1#1)(2006-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-12#1)(2008-5#1)(2009-2#1)(2010-8#2)(2011-2#2)(2012-2#1)
one in three##3##3##(2006-8#1)(2007-2#1)(2012-12#1)
one in which the##8##4##(1994-8#1)(1995-11#1)(2005-11#1)(2009-7#1)(2011-2#3)(2012-12#1)
one in which##16##3##(1991-2#1)(1991-9#1)(1994-8#1)(1995-11#1)(1995-8#1)(2005-11#1)(2008-2#1)(2008-8#2)(2009-7#1)(2010-2#1)(2010-7#1)(2011-2#3)(2012-12#1)
one in##136##2##(1990-10#1)(1990-11#2)(1990-5#1)(1990-8#1)(1991-2#2)(1991-3#1)(1991-7#1)(1991-9#3)(1992-1#2)(1992-12#1)(1992-2#1)(1992-5#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-8#2)(1993-9#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-5#2)(1995-8#2)(1996-11#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-4#3)(1997-8#2)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-5#1)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#4)(2008-10#8)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#4)(2008-8#4)(2008-9#1)(2009-2#1)(2009-7#2)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-2#8)(2012-11#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)
one in-hospital##2##2##(2007-8#1)(2011-2#1)
one includes##2##2##(2007-11#2)
one including##4##2##(1991-1#1)(1993-8#1)(2008-10#1)(2009-10#1)
one index##3##2##(1996-6#1)(2008-3#1)(2009-8#1)
one indicator##3##2##(1995-12#1)(2007-8#1)(2013-8#1)
one individual##8##2##(1991-2#1)(2005-10#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-4#1)(2010-10#1)(2010-8#1)
one induced by##2##3##(1990-9#1)(1995-3#1)
one infected##2##2##(2010-6#2)
one infection##2##2##(2008-4#1)(2008-6#1)
one infectious##2##2##(1993-3#1)(2008-10#1)
one inhibitor of type##2##4##(1995-6#2)
one inhibitor##4##2##(1992-11#1)(1992-3#1)(1995-6#2)
one inhibitory##3##2##(1992-5#1)(1996-9#1)(2007-12#1)
one injection##3##2##(1995-5#1)(2008-4#1)(2012-12#1)
one inland##2##2##(2008-2#1)(2012-12#1)
one instance of##3##3##(1996-12#1)(2007-8#1)(2008-5#1)
one instance##11##2##(1991-7#1)(1992-1#1)(1992-12#1)(1996-12#1)(2004-9#1)(2005-1#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-1#1)(2010-4#1)
one institution##5##2##(1994-6#1)(1996-3#1)(2007-8#1)(2013-1#2)
one institution's experience##3##3##(1994-3#1)(2007-8#1)(2009-11#1)
one instrument##3##2##(1996-2#1)(1997-8#1)(2008-3#1)
one instrumental##2##2##(2008-10#1)(2008-2#1)
one international##2##2##(2008-8#1)(2012-3#1)
one intramuscular injection of##2##4##(1992-11#2)
one inverted##2##2##(1996-7#1)(2008-2#1)
one investigator##2##2##(1995-2#1)(2008-4#1)
one involved in##2##3##(1996-5#1)(2010-3#1)
one involved##3##2##(1996-5#1)(2007-12#1)(2010-3#1)
one involving##2##2##(1994-12#1)(2008-2#1)
one irreversible##3##2##(2006-10#1)(2008-10#2)
one is a##6##3##(2007-2#1)(2008-10#1)(2008-3#1)(2009-3#1)(2012-3#1)(2013-1#1)
one is able to##2##4##(2007-12#1)(2008-8#1)
one is an##2##3##(1990-7#1)(2008-8#1)
one is based on##3##4##(2008-3#1)(2009-9#1)(2012-3#1)
one is dealing with##5##4##(1994-3#1)(2007-11#1)(2007-12#1)(2008-3#2)
one is located in##2##4##(1990-11#1)(2008-9#1)
one is of##2##3##(2007-8#1)(2008-1#1)
one is protein##2##3##(1996-8#1)(2010-2#1)
one is still alive##2##4##(1993-3#1)(2008-7#1)
one is still##3##3##(1993-3#1)(2008-7#1)(2011-12#1)
one is that##3##3##(2005-11#1)(2008-11#1)(2008-6#1)
one is the##9##3##(1991-7#1)(1994-5#1)(2006-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-2#1)
one is used##2##3##(2006-5#1)(2008-10#1)
one is viewing##2##3##(2008-4#1)(2013-7#1)
one is##91##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-7#1)(1992-12#1)(1992-6#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-5#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-8#1)(2005-11#2)(2006-10#2)(2006-12#1)(2006-2#2)(2006-5#2)(2006-6#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-4#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#4)(2008-3#6)(2008-4#3)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#2)(2009-3#1)(2009-9#3)(2010-12#1)(2010-2#4)(2011-1#1)(2011-12#1)(2012-11#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#2)
one island##2##2##(2010-10#1)(2010-8#1)
one isolate from##3##3##(2008-10#2)(2008-5#1)
one isolate of##7##3##(2007-6#1)(2008-10#6)
one isolate was##2##3##(2007-7#1)(2008-10#1)
one isolate##23##2##(2004-11#1)(2005-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#14)(2008-5#2)(2012-12#1)(2012-2#1)
one issue##2##2##(1993-12#1)(2008-12#1)
one it was##2##3##(2008-10#1)(2012-2#1)
one item##3##2##(2010-4#1)(2011-1#1)(2012-2#1)
one iteration##2##2##(2008-3#2)
one kidney##4##2##(2006-7#1)(2008-10#1)(2011-1#1)(2011-2#1)
one kind of##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
one knee joint##2##3##(2007-8#2)
one knee##4##2##(2007-8#2)(2013-1#2)
one knot with the proximal apex stay suture the right wall of the inferior vena cava and the donor s##2##20##(2008-11#2)
one known##5##2##(1994-9#1)(2007-1#2)(2008-4#1)(2010-12#1)
one laboratory##2##2##(2008-5#2)
one large Brazilian kindred##2##4##(1994-8#2)
one large open reading frame##2##5##(2008-10#2)
one large##18##2##(1993-2#1)(1994-8#2)(1997-5#1)(2006-10#2)(2007-4#2)(2008-10#4)(2008-5#1)(2008-8#2)(2010-10#1)(2010-8#1)(2012-3#1)
one laser beam##2##3##(2007-11#1)(2008-2#1)
one laser##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
one late##3##2##(1996-8#1)(2007-7#1)(2007-8#1)
one latent period##2##3##(2008-10#2)
one latent##4##2##(1994-2#1)(1997-2#1)(2008-10#2)
one lateral##3##2##(1993-3#1)(2007-12#1)(2008-3#1)
one layer of##9##3##(2008-10#1)(2008-2#3)(2008-3#1)(2008-9#1)(2011-2#1)(2013-1#2)
one layer##14##2##(1990-2#1)(2008-10#1)(2008-2#4)(2008-3#3)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#2)
one leading to the##2##4##(1991-4#1)(2007-11#1)
one led to##2##3##(1993-4#1)(1995-1#1)
one leg##4##2##(1992-5#1)(1994-12#1)(1997-4#1)(2012-1#1)
one lesion per leaf was expected following##2##7##(2008-10#2)
one lesion was##2##3##(2006-7#1)(2008-6#1)
one lesion##6##2##(1997-8#1)(2006-2#1)(2006-7#1)(2008-10#2)(2008-6#1)
one less##3##2##(1992-1#2)(2009-9#1)
one level##4##2##(2004-4#1)(2007-11#1)(2007-8#1)(2008-1#1)
one library##2##2##(1997-6#1)(2010-4#1)
one lifetime##2##2##(1994-9#1)(2012-3#1)
one liganded subunit of intermediate (alpha##2##6##(1994-8#2)
one liganded##3##2##(1992-6#1)(1994-8#2)
one limb##2##2##(1993-7#1)(2013-8#1)
one line containing the PinII##2##5##(2008-10#2)
one line##9##2##(1990-5#1)(1993-3#1)(1993-7#1)(2006-11#1)(2008-10#4)(2008-2#1)
one lineage##4##2##(1994-3#1)(2008-10#3)
one linkage##2##2##(2008-10#1)(2012-3#1)
one live##2##2##(2009-6#1)(2010-12#1)
one local##2##2##(1992-6#1)(2008-10#1)
one located##3##2##(1991-4#1)(2008-8#1)(2013-8#1)
one location##8##2##(1994-12#1)(2006-3#1)(2008-10#4)(2008-11#1)(2011-12#1)
one locus with##2##3##(1995-5#1)(2008-10#1)
one locus##7##2##(1995-5#1)(2008-10#3)(2008-12#2)(2008-9#1)
one long open reading frame encoding a##2##7##(1990-5#1)(2008-10#1)
one long##3##2##(1990-5#1)(1991-6#1)(2008-10#1)
one looks##2##2##(2006-10#1)(2008-7#1)
one lost##2##2##(2007-3#1)(2008-7#1)
one louse##2##2##(1996-12#2)
one lung ventilation##2##3##(2007-9#1)(2010-7#1)
one lung##6##2##(1993-3#1)(2005-8#1)(2007-9#1)(2008-10#1)(2010-7#1)(2011-2#1)
one made##2##2##(2008-2#1)(2008-5#1)
one main##7##2##(2006-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#2)(2013-8#1)
one major and##3##3##(1990-4#1)(1990-7#1)(1997-8#1)
one major cluster##3##3##(2008-10#1)(2008-5#1)(2012-12#1)
one major mRNA##2##3##(1995-6#1)(1996-7#1)
one major obstacle to##2##4##(1994-12#1)(2006-7#1)
one major##37##2##(1990-11#1)(1990-4#1)(1990-6#2)(1990-7#2)(1992-12#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-4#1)(1994-1#1)(1994-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-7#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#2)
one makes##2##2##(1996-3#1)(2006-8#1)
one male patient##2##3##(2005-12#1)(2007-7#1)
one male##7##2##(1995-1#1)(2005-12#1)(2007-7#1)(2008-12#1)(2008-8#1)(2008-9#1)(2013-8#1)
one man##4##2##(1995-12#1)(2007-11#1)(2007-9#1)(2011-2#1)
one manifestation of##2##3##(1996-11#1)(1996-12#1)
one matched##2##2##(2007-11#1)(2008-7#1)
one mating type##2##3##(2008-10#2)
one mating##3##2##(2008-10#2)(2008-8#1)
one may##16##2##(1991-5#1)(1993-4#1)(2007-12#1)(2008-11#1)(2008-2#5)(2008-5#2)(2008-8#1)(2009-10#1)(2009-8#1)(2011-2#1)(2013-1#1)
one means of##2##3##(2008-11#1)(2008-12#1)
one measure##2##2##(2006-6#1)(2008-9#1)
one measurement##3##2##(2008-1#1)(2008-2#1)(2012-1#1)
one measures##2##2##(1992-6#1)(2008-2#1)
one mechanical##2##2##(1990-11#1)(1991-12#1)
one mechanism by which##4##4##(1992-3#1)(1993-11#1)(1995-8#1)(2008-8#1)
one mechanism for##3##3##(1993-6#1)(1995-2#1)(1995-5#1)
one mechanism of##3##3##(1990-2#1)(2006-10#1)(2008-10#1)
one mechanism##15##2##(1990-2#1)(1992-3#1)(1993-11#1)(1993-6#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-2#1)(2005-10#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-1#1)
one medical center had 873 order sets available to clinicians##2##10##(2013-1#2)
one medical center##3##3##(1990-10#1)(2013-1#2)
one medical##5##2##(1990-10#1)(1994-11#1)(2008-11#1)(2013-1#2)
one medium##2##2##(1994-6#1)(2008-11#1)
one megabase##3##2##(1995-12#2)(2012-2#1)
one member of the##3##4##(1993-12#1)(1997-4#1)(2011-2#1)
one member of##5##3##(1990-12#1)(1993-12#1)(1997-4#1)(2011-2#2)
one member##7##2##(1990-12#1)(1993-12#1)(1995-3#1)(1997-4#1)(2006-4#1)(2011-2#2)
one meta-analysis##2##2##(1994-6#1)(2006-10#1)
one metal ion##2##3##(1991-4#1)(2008-5#1)
one metastatic site and##2##4##(2008-8#2)
one metastatic site##6##3##(2008-8#6)
one metastatic##7##2##(2008-8#6)(2010-2#1)
one method for##2##3##(1990-12#1)(2013-7#1)
one method that has##2##4##(2008-11#1)(2009-7#1)
one method to##2##3##(1996-12#1)(2008-9#1)
one method##12##2##(1990-12#1)(1992-1#1)(1993-10#1)(1996-12#1)(2006-6#1)(2008-10#1)(2008-11#3)(2008-9#1)(2009-7#1)(2013-7#1)
one might expect##5##3##(1992-6#1)(2007-12#1)(2008-12#1)(2009-10#1)(2012-2#1)
one might think##2##3##(2007-9#1)(2012-2#1)
one might##16##2##(1992-2#1)(1992-6#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-9#1)(2006-12#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-12#2)(2009-10#1)(2012-2#2)(2012-8#1)
one milk replacer##2##3##(2010-2#2)
one million people##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
one million##17##2##(1990-3#1)(1992-6#1)(1994-3#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-3#1)
one minute endoscopy room test##2##5##(2008-5#2)
one minute##8##2##(1990-8#1)(2008-11#1)(2008-5#3)(2008-6#1)(2009-6#1)(2012-3#1)
one missing row##2##3##(2007-11#1)(2007-12#1)
one mode of##2##3##(1997-1#1)(1997-2#1)
one mode##4##2##(1997-1#1)(1997-2#1)(2008-3#1)(2009-6#1)
one model##5##2##(1993-1#1)(1996-2#1)(2008-10#1)(2008-11#1)(2010-9#1)
one module##2##2##(2011-12#1)(2011-2#1)
one mole of##4##3##(1991-7#1)(1994-12#1)(2007-11#2)
one molecule at a##2##4##(1995-11#1)(2008-3#1)
one molecule in##2##3##(1994-9#1)(1995-3#1)
one molecule of##9##3##(1990-10#1)(1990-9#2)(1991-2#1)(1992-3#1)(1994-5#2)(1995-3#1)(2011-1#1)
one molecule with##2##3##(2007-12#1)(2008-8#1)
one molecule##20##2##(1990-10#1)(1990-9#2)(1991-2#1)(1992-1#1)(1992-3#1)(1994-5#2)(1994-9#2)(1995-11#1)(1995-3#2)(2006-11#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)
one monkey##3##2##(2005-11#3)
one monoclonal antibody##3##3##(1990-12#1)(2007-8#1)(2008-4#1)
one monolayer##2##2##(2008-3#2)
one monomer##2##2##(1991-8#1)(1994-8#1)
one month after discharge##3##4##(2005-1#1)(2007-10#2)
one month after the##7##4##(1990-9#1)(1992-11#1)(1996-9#1)(2007-7#2)(2008-5#1)(2013-8#1)
one month after##21##3##(1990-9#1)(1991-2#1)(1991-3#1)(1992-11#1)(1996-9#1)(1997-3#1)(1997-5#1)(2005-1#1)(2006-4#2)(2007-10#3)(2007-2#2)(2007-7#2)(2008-5#1)(2008-8#2)(2013-8#1)
one month and##6##3##(1992-11#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-4#1)(2009-6#1)
one month before##3##3##(2006-8#1)(2012-2#1)(2013-1#1)
one month following##3##3##(1990-2#1)(1991-3#1)(1996-3#1)
one month in##7##3##(1990-2#1)(1994-6#1)(1996-8#1)(2007-1#1)(2008-1#1)(2008-11#1)(2010-8#1)
one month later##2##3##(2008-11#1)(2008-5#1)
one month of age##3##4##(2012-2#3)
one month of therapy##2##4##(1992-4#1)(2011-1#1)
one month of##12##3##(1990-4#1)(1992-4#1)(1993-11#1)(2006-9#1)(2007-7#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#1)
one month or##2##3##(2007-2#1)(2008-9#1)
one month to##3##3##(1991-9#1)(2006-8#1)(2007-7#1)
one month##110##2##(1990-2#3)(1990-3#1)(1990-4#1)(1990-9#1)(1991-2#1)(1991-3#2)(1991-9#1)(1992-11#4)(1992-3#1)(1992-4#1)(1992-8#2)(1993-11#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-6#1)(1996-3#2)(1996-8#1)(1996-9#2)(1997-3#1)(1997-5#1)(1997-8#1)(2005-1#2)(2006-4#2)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#1)(2007-2#5)(2007-7#7)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#4)(2008-4#1)(2008-5#8)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#2)(2012-2#4)(2013-1#6)(2013-8#4)
one month's##2##2##(1991-4#1)(2006-8#1)
one month)##3##2##(2005-1#1)(2007-12#2)
one more##18##2##(1991-3#1)(1993-3#1)(1994-3#1)(1995-12#1)(1996-12#1)(2004-12#1)(2006-10#1)(2006-9#1)(2007-5#1)(2008-10#1)(2008-2#2)(2008-5#3)(2008-7#1)(2010-12#1)(2011-2#1)
one most##4##2##(2008-3#1)(2010-5#1)(2010-6#1)(2012-2#1)
one mostly##2##2##(2006-2#2)
one mouse##4##2##(1995-12#1)(2008-10#1)(2008-8#2)
one muscle group##2##3##(2010-7#2)
one must be aware of##3##5##(2006-9#1)(2007-11#1)(2013-8#1)
one must be##5##3##(2006-9#1)(2007-11#1)(2007-4#1)(2010-9#1)(2013-8#1)
one must consider the##2##4##(2006-10#1)(2009-5#1)
one must consider##4##3##(1994-11#1)(2006-10#1)(2008-4#1)(2009-5#1)
one must know the##2##4##(1993-10#1)(2008-3#1)
one must take##4##3##(1996-7#1)(2008-2#1)(2008-3#2)
one must##33##2##(1993-10#1)(1994-11#2)(1994-9#2)(1996-4#1)(1996-7#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#1)(2009-5#3)(2010-9#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
one mutant##5##2##(1994-3#1)(1995-8#1)(1997-2#1)(2008-10#1)(2008-8#1)
one mutation##4##2##(1993-6#1)(1994-3#1)(1996-2#1)(2006-10#1)
one need##3##2##(1995-6#1)(1997-6#1)(2012-2#1)
one needed##2##2##(2007-9#1)(2008-10#1)
one needs a##2##3##(1991-4#1)(2008-3#1)
one needs to develop##3##4##(2008-2#1)(2008-3#1)(2008-7#1)
one needs to##11##3##(1997-7#2)(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#2)(2009-6#1)(2012-11#1)
one needs##14##2##(1991-4#1)(1997-7#2)(2007-6#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-7#2)(2009-6#1)(2012-11#1)
one neurite##2##2##(1996-9#2)
one neuron##4##2##(1990-4#1)(1990-5#1)(1993-12#1)(1997-3#1)
one new##3##2##(1997-8#1)(2007-10#1)(2007-11#1)
one newborn##2##2##(1990-7#1)(1997-1#1)
one nitrogen atom##3##3##(1992-1#2)(1992-8#1)
one normal##2##2##(1991-9#1)(2012-1#1)
one not##3##2##(2007-5#1)(2008-9#1)(2011-1#1)
one novel##5##2##(1990-7#1)(1994-12#1)(2007-12#1)(2008-12#1)(2008-4#1)
one nucleotide##7##2##(1990-2#1)(1990-3#1)(1991-2#1)(1995-3#1)(1996-6#1)(1996-7#1)(2008-9#1)
one nucleus##2##2##(2008-10#1)(2008-5#1)
one nursing##2##2##(1994-3#1)(2008-12#1)
one object##4##2##(1993-7#1)(2007-12#1)(2008-2#1)(2008-4#1)
one obtained##3##2##(1995-3#1)(1996-2#1)(2005-8#1)
one obtains a##2##3##(1996-3#1)(2008-3#1)
one obtains an estimate of the##2##6##(1997-3#2)
one obtains an##3##3##(1997-3#2)(2007-7#1)
one obtains##7##2##(1996-3#1)(1997-2#1)(1997-3#2)(2007-7#1)(2008-2#1)(2008-3#1)
one occasion##5##2##(1990-8#1)(1994-2#1)(2007-5#1)(2007-7#1)(2008-4#1)
one occurred##2##2##(1996-3#1)(2008-10#1)
one ochre mutation##2##3##(2008-9#2)
one octamer##2##2##(1991-12#2)
one of 1##2##3##(2008-10#1)(2012-2#1)
one of 18##2##3##(1992-12#1)(2008-9#1)
one of 2##2##3##(2007-11#1)(2008-3#1)
one of 3##2##3##(1994-7#1)(1996-2#1)
one of a group of##3##5##(1990-2#1)(1990-7#1)(2006-10#1)
one of a number of##7##5##(1992-5#1)(2008-11#2)(2008-3#1)(2011-2#1)(2012-1#1)(2012-2#1)
one of a small##2##4##(1995-5#1)(2010-12#1)
one of a variety of##2##5##(1996-1#1)(2006-5#1)
one of a##26##3##(1990-2#1)(1990-6#1)(1990-7#1)(1992-5#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-9#1)(1997-3#2)(2006-10#2)(2006-5#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-11#2)(2008-3#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
one of eight##2##3##(1992-7#1)(2008-2#1)
one of five Hairy/Enhancer of Split (HES) homologs in C##2##10##(2012-12#2)
one of five locations##2##4##(1992-11#1)(2008-4#1)
one of five##14##3##(1991-2#1)(1991-8#1)(1992-11#1)(1996-2#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-12#1)(2012-12#2)
one of four main##2##4##(2008-6#1)(2008-9#1)
one of four types of##2##5##(2009-8#1)(2012-2#1)
one of four##31##3##(1991-3#1)(1992-1#1)(1994-9#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-4#1)(1997-3#1)(1997-8#1)(2006-9#1)(2007-12#2)(2008-10#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-8#1)(2010-4#2)(2011-2#2)(2012-2#4)(2012-9#1)(2013-8#1)
one of her##5##3##(1995-10#1)(1996-3#2)(2007-2#1)(2008-5#1)
one of his##4##3##(1993-12#1)(1995-6#1)(2010-10#1)(2011-12#1)
one of its components##3##4##(2007-12#1)(2008-5#1)(2008-6#1)
one of its##28##3##(1991-3#1)(1992-12#1)(1992-8#1)(1994-12#2)(1994-2#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-5#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-2#1)(2009-8#1)(2010-9#1)(2012-3#1)
one of major##5##3##(1993-9#1)(2005-3#1)(2006-6#1)(2007-8#1)(2009-8#1)
one of many##8##3##(1990-5#1)(1991-7#1)(2006-10#1)(2006-12#1)(2007-7#1)(2009-12#1)(2010-12#1)(2012-11#1)
one of mechanisms##2##3##(2009-9#1)(2013-1#1)
one of most common##2##4##(2010-12#1)(2011-2#1)
one of most##3##3##(2006-10#1)(2010-12#1)(2011-2#1)
one of multiple##2##3##(1994-9#1)(1997-5#1)
one of nine##4##3##(1993-2#1)(2006-10#1)(2008-10#1)(2011-2#1)
one of our patients##3##4##(1991-3#1)(2007-7#1)(2008-7#1)
one of our##7##3##(1990-12#1)(1991-3#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2013-8#1)
one of providing##2##3##(1990-12#1)(2007-10#1)
one of rare##2##3##(2008-1#1)(2010-2#1)
one of seven##7##3##(1993-1#1)(1994-3#1)(1995-12#1)(2007-2#1)(2008-10#1)(2012-11#1)(2012-2#1)
one of several##27##3##(1990-10#1)(1990-2#1)(1992-12#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-1#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#1)
one of six##9##3##(2006-10#1)(2006-5#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-12#1)(2009-7#1)
one of the &quot##3##4##(2007-6#1)(2009-4#1)(2010-7#1)
one of the 25##2##4##(2008-10#1)(2010-1#1)
one of the 3##2##4##(2008-9#1)(2013-7#1)
one of the 4##2##4##(1992-9#1)(2011-1#1)
one of the 5##2##4##(2008-8#1)(2012-12#1)
one of the 7##2##4##(2007-8#1)(2013-1#1)
one of the above##2##4##(1997-3#1)(2004-9#1)
one of the active##3##4##(1992-2#1)(2007-12#1)(2012-2#1)
one of the alternative##3##4##(1996-12#1)(2008-4#1)(2012-2#1)
one of the amino acids##2##5##(2006-10#1)(2008-11#1)
one of the antagonists##2##4##(1995-11#1)(2008-8#1)
one of the authors##3##4##(2007-5#1)(2008-11#2)
one of the basic##7##4##(1994-3#1)(2007-10#2)(2007-11#1)(2008-4#1)(2009-5#1)(2010-12#1)
one of the best characterized##2##5##(1995-8#1)(2008-10#1)
one of the best predictors of##3##6##(2008-10#1)(2008-6#1)(2010-12#1)
one of the best sources of##2##6##(2008-7#1)(2012-3#1)
one of the best understood##2##5##(2008-1#1)(2011-1#1)
one of the best##26##4##(1990-12#1)(1991-6#1)(1993-12#1)(1993-8#1)(1995-12#1)(1995-8#1)(1997-8#1)(2004-2#1)(2005-7#1)(2007-5#1)(2008-1#2)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-8#1)
one of the biggest##3##4##(2008-7#1)(2010-11#1)(2012-2#1)
one of the brain##2##4##(1992-9#1)(2007-1#1)
one of the cases##2##4##(2007-8#1)(2008-8#1)
one of the causes of##11##5##(1990-10#1)(1994-6#1)(1996-6#1)(1997-1#1)(2005-1#1)(2007-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2013-1#1)(2013-8#1)
one of the causes##12##4##(1990-10#1)(1994-6#1)(1996-6#1)(1997-1#1)(2005-1#1)(2007-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
one of the cell##2##4##(2008-10#1)(2008-11#1)
one of the cellular##3##4##(1993-2#1)(1995-6#1)(2008-2#1)
one of the central##2##4##(2005-11#1)(2005-7#1)
one of the characteristic##2##4##(2008-10#1)(2010-12#1)
one of the characteristics##2##4##(2008-6#2)
one of the children##2##4##(1994-12#1)(2008-9#1)
one of the classical##2##4##(1991-9#1)(2010-2#1)
one of the clinical##5##4##(2005-9#1)(2006-10#1)(2011-2#1)(2012-1#1)(2012-12#1)
one of the common causes of##2##6##(2007-8#1)(2012-12#1)
one of the common##11##4##(2006-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
one of the commonest##9##4##(2006-4#1)(2007-6#1)(2007-7#2)(2008-5#1)(2008-7#1)(2009-6#1)(2011-1#1)(2012-3#1)
one of the complications of##2##5##(2005-11#1)(2008-4#1)
one of the complications##3##4##(1990-6#1)(2005-11#1)(2008-4#1)
one of the components of the##3##6##(1991-2#1)(2008-10#2)
one of the components of##4##5##(1991-2#1)(2006-12#1)(2008-10#2)
one of the components##5##4##(1991-2#1)(2006-12#1)(2008-10#3)
one of the compounds##3##4##(1992-3#1)(2008-10#1)(2012-11#1)
one of the control##2##4##(1990-11#1)(1996-1#1)
one of the critical##3##4##(2008-11#1)(2008-2#1)(2013-1#1)
one of the crucial##3##4##(1995-8#1)(2005-1#1)(2006-6#1)
one of the differential diagnosis of##2##6##(2011-1#1)(2012-2#1)
one of the differential##3##4##(2008-7#1)(2011-1#1)(2012-2#1)
one of the earliest##6##4##(1997-6#1)(2008-1#2)(2008-11#1)(2010-3#1)(2011-2#1)
one of the effective##2##4##(2006-8#1)(2011-2#1)
one of the eight##3##4##(2008-10#1)(2008-5#1)(2010-12#1)
one of the elements##3##4##(1991-5#1)(2008-10#1)(2013-1#1)
one of the enzymes involved in##2##6##(1994-9#1)(2007-10#1)
one of the enzymes##4##4##(1990-5#1)(1994-9#1)(2007-10#1)(2010-2#1)
one of the excitatory##2##4##(2005-10#1)(2007-1#1)
one of the factors contributing to##2##6##(1991-1#1)(2007-3#1)
one of the factors in##2##5##(1997-8#1)(2009-5#1)
one of the factors responsible for##4##6##(1992-12#1)(1995-12#1)(2008-12#1)(2013-8#1)
one of the factors that##3##5##(1997-2#1)(2009-8#1)(2012-10#1)
one of the factors##19##4##(1991-1#1)(1991-9#1)(1992-12#1)(1994-6#1)(1995-12#1)(1997-2#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-8#1)(2012-10#1)(2013-8#1)
one of the few##15##4##(1990-3#1)(1993-11#1)(1993-12#1)(1994-5#1)(1994-6#1)(1995-10#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-6#1)(2009-9#1)(2010-2#1)(2013-7#1)
one of the first signs of##2##6##(2008-5#1)(2011-2#1)
one of the first steps##2##5##(1997-2#1)(2008-1#1)
one of the first to##2##5##(2008-11#1)(2012-3#1)
one of the first##30##4##(1992-3#1)(1993-12#1)(1994-9#1)(1995-2#1)(1996-12#1)(1996-3#2)(1996-4#1)(1997-1#1)(1997-2#1)(2005-7#1)(2007-11#1)(2007-5#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2009-12#1)(2009-4#1)(2009-7#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#2)
one of the five##6##4##(1992-1#1)(1994-11#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-3#1)
one of the following##20##4##(1990-8#1)(1991-2#1)(1992-8#2)(1993-1#1)(1995-2#1)(1997-4#1)(2005-10#1)(2005-11#1)(2006-12#1)(2007-2#1)(2007-5#1)(2008-10#3)(2008-3#1)(2008-8#1)(2008-9#1)(2010-2#1)(2012-2#1)
one of the foremost##2##4##(2008-7#1)(2008-9#1)
one of the forms##2##4##(1992-9#1)(2008-6#1)
one of the founding##2##4##(2008-10#1)(2008-8#1)
one of the four##19##4##(1990-5#1)(1990-6#2)(1992-2#1)(1994-8#1)(1994-9#1)(1996-2#1)(1997-6#1)(2004-4#1)(2006-8#1)(2007-2#1)(2007-5#1)(2008-10#2)(2008-7#1)(2009-3#1)(2010-12#1)(2011-1#1)(2012-12#1)
one of the free-living strains##2##5##(2006-3#2)
one of the fundamental problems##2##5##(2008-8#1)(2012-3#1)
one of the fundamental##8##4##(1993-3#1)(1995-8#1)(2007-1#1)(2008-8#2)(2010-7#1)(2012-3#1)(2013-8#1)
one of the genes##2##4##(1991-8#1)(2008-9#1)
one of the global##2##4##(1991-9#1)(2012-2#1)
one of the goals of##2##5##(2007-7#1)(2009-5#1)
one of the goals##3##4##(2007-7#1)(2009-5#1)(2012-3#1)
one of the great##4##4##(2006-10#1)(2007-4#1)(2008-9#1)(2011-2#1)
one of the greatest challenges##2##5##(2007-11#1)(2008-8#1)
one of the greatest##11##4##(2004-2#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-9#1)(2012-11#1)
one of the highest in##3##5##(2008-11#1)(2010-10#1)(2011-1#1)
one of the highest rates of##2##6##(2007-9#1)(2008-5#1)
one of the highest##16##4##(1994-12#1)(2006-1#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-11#3)(2008-5#2)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
one of the important##24##4##(1992-12#1)(1993-3#1)(1994-8#1)(1994-9#1)(1997-7#1)(2005-3#1)(2006-12#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#2)
one of the initial##2##4##(2008-10#1)(2013-7#1)
one of the key enzymes of##2##6##(1994-12#1)(1997-2#1)
one of the key enzymes##6##5##(1992-1#1)(1994-12#1)(1996-10#1)(1997-2#1)(2008-9#2)
one of the key##26##4##(1990-2#1)(1992-1#1)(1994-12#1)(1996-1#1)(1996-10#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
one of the known##3##4##(1996-10#1)(1996-4#1)(2009-2#1)
one of the largest and most##2##6##(2007-12#1)(2008-10#1)
one of the largest and##3##5##(2007-12#1)(2008-10#1)(2013-8#1)
one of the largest groups of##2##6##(2004-4#1)(2012-2#1)
one of the largest##14##4##(1991-2#1)(1995-6#1)(2004-4#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#2)(2013-7#1)(2013-8#1)
one of the last##2##4##(1993-6#1)(2010-5#1)
one of the leading causes of##16##6##(2005-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-3#1)(2010-10#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-8#1)
one of the leading##22##4##(2005-10#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-11#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-8#1)(2011-2#4)(2012-12#2)(2013-8#2)
one of the least##3##4##(1991-8#1)(2012-12#1)(2013-1#1)
one of the less##2##4##(2008-4#1)(2008-6#1)
one of the ligands##3##4##(1990-8#1)(1997-4#1)(2008-5#1)
one of the lower##2##4##(1991-7#1)(2008-7#1)
one of the lowest##2##4##(2006-1#1)(2008-12#1)
one of the main causes of##6##6##(1997-3#1)(2006-11#1)(2008-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
one of the main causes##7##5##(1997-3#1)(2006-11#1)(2008-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
one of the main factors in##2##6##(1994-12#1)(2011-1#1)
one of the main factors##4##5##(1992-1#1)(1994-12#1)(2010-12#1)(2011-1#1)
one of the main objectives##2##5##(2006-10#1)(2011-2#1)
one of the main players##2##5##(2005-7#1)(2010-3#1)
one of the main problems of##2##6##(1996-10#1)(2008-5#1)
one of the main problems##4##5##(1996-10#1)(2008-5#1)(2009-2#2)
one of the main reasons of##2##6##(2011-2#1)(2013-8#1)
one of the main reasons##4##5##(1992-9#1)(2008-10#1)(2011-2#1)(2013-8#1)
one of the main sources of##3##6##(2007-5#1)(2008-10#1)(2013-1#1)
one of the main##59##4##(1991-6#1)(1992-1#1)(1992-12#2)(1992-9#1)(1993-12#1)(1994-12#1)(1996-10#1)(1997-3#1)(1997-4#1)(2003-11#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#2)(2006-8#1)(2007-3#1)(2007-5#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-2#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#3)
one of the mainstays##2##4##(1996-2#1)(2006-5#1)
one of the major causes of##10##6##(2006-10#1)(2007-11#1)(2008-11#3)(2009-12#1)(2009-4#1)(2013-7#2)(2013-8#1)
one of the major causes##11##5##(2006-10#1)(2007-11#1)(2008-11#3)(2008-8#1)(2009-12#1)(2009-4#1)(2013-7#2)(2013-8#1)
one of the major challenges##3##5##(1995-4#1)(2009-7#1)(2011-2#1)
one of the major complications of##2##6##(2008-1#1)(2011-2#1)
one of the major complications##7##5##(2007-12#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#2)
one of the major factors in##2##6##(1997-6#1)(2008-10#1)
one of the major factors##5##5##(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2012-2#1)
one of the major obstacles to##2##6##(1996-5#1)(2008-12#1)
one of the major obstacles##4##5##(1996-5#1)(2007-6#1)(2008-12#1)(2008-5#1)
one of the major risk factors##2##6##(2008-11#1)(2011-1#1)
one of the major##90##4##(1990-12#1)(1990-3#1)(1991-5#1)(1992-3#1)(1992-5#1)(1994-10#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-5#2)(1997-2#1)(1997-6#1)(2004-10#1)(2006-10#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#9)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#2)
one of the many factors##2##5##(1995-11#1)(2008-11#1)
one of the many##11##4##(1990-2#1)(1995-11#1)(1996-3#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)
one of the means##2##4##(2008-7#1)(2010-4#1)
one of the mechanisms of##2##5##(2008-10#1)(2008-3#1)
one of the mechanisms responsible for##2##6##(2008-10#1)(2008-11#1)
one of the mechanisms that##2##5##(1997-4#1)(2009-8#1)
one of the mechanisms##16##4##(1990-12#1)(1993-9#1)(1996-5#1)(1997-4#2)(1997-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2009-12#1)(2009-8#1)(2012-12#1)(2012-3#1)
one of the members of##3##5##(2005-11#1)(2007-7#1)(2008-9#1)
one of the more common##2##5##(1996-9#1)(2008-4#1)
one of the more##13##4##(1994-12#1)(1994-5#1)(1996-10#2)(1996-9#1)(2004-11#1)(2008-10#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)
one of the most abundant and##2##6##(2010-11#1)(2012-2#1)
one of the most abundant##9##5##(1993-12#1)(1995-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
one of the most accurate##2##5##(2007-12#1)(2009-4#1)
one of the most active##3##5##(1995-3#1)(2005-11#1)(2008-6#1)
one of the most challenging problems##2##6##(2012-12#1)(2012-2#1)
one of the most challenging##8##5##(1991-12#1)(2007-11#1)(2008-3#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)
one of the most clinically significant##2##6##(2006-2#1)(2007-9#1)
one of the most common and##3##6##(2008-11#1)(2008-3#1)(2008-8#1)
one of the most common autosomal dominant##2##7##(1992-8#1)(2008-7#1)
one of the most common autosomal##3##6##(1992-8#1)(2008-7#1)(2012-12#1)
one of the most common cause of##2##7##(2008-10#1)(2013-1#1)
one of the most common causes of##6##7##(2006-10#2)(2008-7#1)(2009-5#1)(2011-2#1)(2013-8#1)
one of the most common childhood##2##6##(2008-9#1)(2011-2#1)
one of the most common chronic diseases##2##7##(1991-2#1)(2013-7#1)
one of the most common chronic##4##6##(1991-2#1)(2007-9#1)(2008-1#1)(2013-7#1)
one of the most common complaints##2##6##(2011-1#1)(2011-2#1)
one of the most common conditions##2##6##(2006-9#1)(2012-12#1)
one of the most common congenital##2##6##(1993-8#1)(2010-9#1)
one of the most common infectious diseases##2##7##(1997-8#2)
one of the most common psychiatric##2##6##(2006-9#1)(2013-1#1)
one of the most common reasons for##3##7##(2007-7#1)(2009-5#1)(2011-2#1)
one of the most common reasons##4##6##(2007-7#1)(2009-5#1)(2011-2#2)
one of the most common sexually transmitted##2##7##(2007-7#1)(2011-2#1)
one of the most common types of##3##7##(2008-6#1)(2008-7#1)(2011-1#1)
one of the most common##104##5##(1990-8#1)(1990-9#1)(1991-2#1)(1991-7#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-3#2)(1996-12#1)(1997-7#1)(1997-8#2)(2005-11#1)(2005-12#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-8#1)(2006-9#2)(2007-11#2)(2007-12#2)(2007-2#3)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-5#3)(2009-8#1)(2010-12#3)(2010-2#3)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#6)(2012-12#4)(2012-2#1)(2013-1#8)(2013-7#3)(2013-8#4)
one of the most commonly performed##3##6##(2005-10#1)(2011-2#2)
one of the most commonly used##3##6##(1994-6#1)(2008-11#1)(2008-8#1)
one of the most commonly##10##5##(1994-6#1)(2005-10#1)(2006-6#1)(2007-7#1)(2008-11#1)(2008-8#1)(2009-5#1)(2011-2#2)(2012-1#1)
one of the most comprehensive##3##5##(1991-8#1)(1997-3#1)(2005-7#1)
one of the most conserved##2##5##(1991-9#1)(1996-5#1)
one of the most crucial##2##5##(2008-7#1)(2010-12#1)
one of the most devastating diseases of##3##7##(1997-7#1)(2008-10#1)(2011-2#1)
one of the most devastating##7##5##(1997-7#1)(2005-7#1)(2007-11#1)(2008-10#2)(2011-2#1)(2012-3#1)
one of the most difficult challenges##3##6##(2007-12#1)(2007-7#1)(2009-3#1)
one of the most difficult##12##5##(1995-1#1)(2005-11#1)(2007-12#1)(2007-7#2)(2009-3#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
one of the most diverse and##2##6##(2007-11#1)(2011-2#1)
one of the most effective methods##2##6##(2006-10#1)(2011-1#1)
one of the most effective##12##5##(1994-7#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2009-11#1)(2009-3#1)(2009-6#1)(2011-1#1)(2011-12#1)(2013-8#1)
one of the most efficient##2##5##(2010-4#1)(2011-2#1)
one of the most exciting##4##5##(2006-6#1)(2007-12#1)(2007-5#1)(2008-9#1)
one of the most extensively##2##5##(2009-4#1)(2012-3#1)
one of the most fascinating##3##5##(2008-11#1)(2008-12#1)(2010-4#1)
one of the most frequent causes of##2##7##(2007-8#1)(2013-1#1)
one of the most frequent complications##2##6##(2007-7#1)(2008-1#1)
one of the most frequent##17##5##(1992-8#1)(2006-2#2)(2006-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2009-2#1)(2009-9#1)(2010-12#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
one of the most frequently performed##2##6##(2007-8#1)(2010-9#1)
one of the most frequently used##3##6##(2006-9#1)(2008-4#1)(2012-12#1)
one of the most frequently##6##5##(2006-9#1)(2007-8#1)(2008-4#1)(2010-4#1)(2010-9#1)(2012-12#1)
one of the most fundamental##3##5##(2010-12#1)(2012-12#1)(2012-2#1)
one of the most important aspects of##3##7##(2008-7#1)(2013-1#2)
one of the most important causes of##2##7##(2011-2#1)(2013-1#1)
one of the most important challenges of##2##7##(2008-10#1)(2011-2#1)
one of the most important challenges##3##6##(2008-10#1)(2008-7#1)(2011-2#1)
one of the most important classes of##2##7##(2006-12#1)(2008-9#1)
one of the most important diseases##5##6##(2006-10#1)(2008-10#3)(2011-10#1)
one of the most important factors##6##6##(2007-2#1)(2007-7#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#1)
one of the most important foliar diseases of##2##8##(2008-10#2)
one of the most important issues##2##6##(1995-1#1)(2008-7#1)
one of the most important neurotransmitters##2##6##(1990-3#1)(2007-2#1)
one of the most important public health##2##7##(2007-11#1)(2012-1#1)
one of the most important risk factors##2##7##(2008-10#1)(2013-7#1)
one of the most important##108##5##(1990-12#1)(1990-3#1)(1990-5#1)(1993-6#1)(1994-1#1)(1995-1#1)(1995-4#1)(1995-7#1)(1996-7#1)(1997-6#1)(2005-1#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-6#1)(2006-7#1)(2007-11#3)(2007-2#4)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#2)(2009-11#1)(2009-8#2)(2010-10#1)(2010-5#2)(2010-7#2)(2010-9#1)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#9)(2012-1#1)(2012-11#3)(2012-12#3)(2012-2#3)(2013-1#5)(2013-7#2)(2013-8#2)
one of the most interesting##4##5##(2006-10#1)(2008-2#1)(2008-5#1)(2009-8#1)
one of the most intractable##2##5##(2007-8#1)(2013-1#1)
one of the most intriguing##2##5##(2008-5#1)(2011-2#1)
one of the most popular##8##5##(1997-2#1)(2005-9#1)(2006-4#1)(2007-11#1)(2008-5#1)(2009-8#1)(2011-1#1)(2013-7#1)
one of the most potent toxins known##2##7##(2008-10#1)(2009-6#1)
one of the most potent##10##5##(1994-12#1)(1995-5#1)(2008-10#1)(2008-4#1)(2009-3#1)(2009-6#1)(2010-4#1)(2010-8#1)(2012-12#2)
one of the most powerful tools##2##6##(1997-5#1)(2008-9#1)
one of the most powerful##9##5##(1993-7#1)(1994-9#1)(1995-3#1)(1997-5#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)
one of the most predominantly##2##5##(1991-9#1)(2009-9#1)
one of the most pressing##2##5##(2009-4#1)(2010-4#1)
one of the most prevalent diseases##2##6##(2008-10#1)(2012-3#1)
one of the most prevalent##9##5##(1991-9#1)(2004-11#1)(2008-10#1)(2008-7#2)(2009-5#2)(2010-3#1)(2012-3#1)
one of the most productive##2##5##(2007-6#1)(2012-2#1)
one of the most prominent##5##5##(1995-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)
one of the most promising##6##5##(2006-5#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-7#1)
one of the most rapidly##5##5##(1995-2#1)(2008-12#1)(2010-7#1)(2011-10#1)(2013-1#1)
one of the most reliable##3##5##(2008-10#1)(2011-2#1)(2012-12#1)
one of the most sensitive indicators##2##6##(2010-5#1)(2010-9#1)
one of the most sensitive##6##5##(2008-10#3)(2008-7#1)(2010-5#1)(2010-9#1)
one of the most significant##6##5##(2007-11#1)(2008-1#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
one of the most studied##4##5##(2005-8#1)(2006-2#1)(2011-2#1)(2012-12#1)
one of the most successful##2##5##(2011-1#1)(2012-2#1)
one of the most useful##4##5##(1996-6#1)(2007-11#1)(2009-5#1)(2011-2#1)
one of the most valuable##3##5##(1992-9#1)(2013-1#2)
one of the most versatile##2##5##(1990-12#1)(2008-2#1)
one of the most widely used##11##6##(2005-11#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
one of the most widely##16##5##(2005-11#1)(2006-10#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
one of the most##528##4##(1990-12#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#4)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-12#2)(1994-2#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#5)(1995-4#1)(1995-5#2)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-11#1)(2005-1#1)(2005-10#2)(2005-11#5)(2005-12#1)(2005-7#2)(2005-8#3)(2005-9#1)(2006-10#12)(2006-11#1)(2006-12#5)(2006-2#4)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#6)(2006-7#1)(2006-8#1)(2006-9#3)(2007-11#14)(2007-12#5)(2007-2#8)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#9)(2007-8#8)(2007-9#3)(2008-1#10)(2008-10#44)(2008-11#6)(2008-12#7)(2008-2#4)(2008-3#5)(2008-4#9)(2008-5#11)(2008-6#3)(2008-7#19)(2008-8#8)(2008-9#10)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#4)(2009-4#3)(2009-5#8)(2009-6#3)(2009-7#3)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#11)(2010-2#4)(2010-3#1)(2010-4#7)(2010-5#3)(2010-7#4)(2010-8#4)(2010-9#5)(2011-1#12)(2011-10#2)(2011-12#4)(2011-2#33)(2011-3#2)(2012-1#2)(2012-11#6)(2012-12#20)(2012-2#16)(2012-3#4)(2013-1#27)(2013-7#9)(2013-8#7)
one of the municipalities##2##4##(1991-6#1)(1992-2#1)
one of the mutants##2##4##(1992-9#1)(1994-12#1)
one of the naturally occurring##2##5##(2008-5#2)
one of the new##2##4##(2007-7#1)(2007-8#1)
one of the oldest and##2##5##(2010-12#1)(2011-1#1)
one of the oldest##15##4##(2006-10#1)(2006-6#1)(2006-9#1)(2007-7#1)(2008-1#1)(2008-10#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2013-1#2)(2013-7#1)
one of the other##2##4##(1991-5#1)(1991-9#1)
one of the parents##3##4##(2008-10#1)(2008-5#1)(2013-1#1)
one of the pathological features of##2##6##(1995-3#1)(2007-2#1)
one of the patients##5##4##(1992-4#1)(1996-6#1)(2007-11#1)(2008-5#1)(2012-11#1)
one of the peptides##2##4##(1990-5#1)(1992-4#1)
one of the poorest##2##4##(2008-7#1)(2012-2#1)
one of the positive##2##4##(2008-8#1)(2011-3#1)
one of the possibilities##2##4##(1990-12#1)(2012-1#1)
one of the possible##4##4##(1992-7#1)(2008-12#1)(2008-9#1)(2012-12#1)
one of the potential##2##4##(1996-1#1)(2013-8#1)
one of the predictors##2##4##(2008-11#1)(2011-2#1)
one of the primary factors##2##5##(2008-10#1)(2008-5#1)
one of the primary##12##4##(1991-1#1)(1993-1#1)(1994-5#1)(1996-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-8#1)(2011-12#1)(2013-8#1)
one of the principal##3##4##(2007-9#1)(2008-7#1)(2011-2#1)
one of the products##2##4##(1991-4#1)(1996-8#1)
one of the proteins##3##4##(1995-10#1)(1995-6#1)(2005-11#1)
one of the proximal##2##4##(2008-1#1)(2011-2#1)
one of the public health##2##5##(2008-1#1)(2011-1#1)
one of the rare##6##4##(1992-11#1)(1997-5#1)(2009-4#1)(2010-5#1)(2012-12#1)(2012-2#1)
one of the rarest forms of##2##6##(2010-3#1)(2010-8#1)
one of the rarest##3##4##(1997-7#1)(2010-3#1)(2010-8#1)
one of the reasons for##3##5##(2008-10#2)(2008-8#1)
one of the reasons##5##4##(1993-11#1)(2006-6#1)(2008-10#2)(2008-8#1)
one of the recombinant##2##4##(2008-10#1)(2012-3#1)
one of the regulatory##4##4##(1990-10#1)(1993-8#1)(1993-9#1)(1995-9#1)
one of the responsible##2##4##(1995-5#1)(1997-7#1)
one of the risk factors##3##5##(1990-9#1)(1993-12#1)(2011-1#1)
one of the samples##2##4##(2006-5#1)(2008-10#1)
one of the serious complications##2##5##(2010-7#1)(2012-12#1)
one of the serious##3##4##(2007-8#1)(2010-7#1)(2012-12#1)
one of the seven##2##4##(2008-10#1)(2008-12#1)
one of the several##2##4##(2012-3#1)(2013-8#1)
one of the side effects##2##5##(2007-2#1)(2008-11#1)
one of the significant##2##4##(2008-1#1)(2008-10#1)
one of the simplest##5##4##(1995-2#1)(1995-3#1)(2008-10#2)(2008-2#1)
one of the sites##3##4##(1996-7#1)(2007-9#1)(2013-1#1)
one of the six##4##4##(1994-8#1)(2006-9#1)(2008-10#1)(2012-12#1)
one of the smallest##3##4##(1991-7#1)(1992-7#1)(2007-3#1)
one of the strategies##2##4##(2007-10#1)(2008-5#1)
one of the strongest known##2##5##(1990-8#1)(2012-12#1)
one of the strongest##3##4##(1990-8#1)(2012-12#1)(2013-1#1)
one of the surgical treatment##2##5##(2007-11#1)(2009-2#1)
one of the surgical##3##4##(2007-11#1)(2007-7#1)(2009-2#1)
one of the targets for##2##5##(1994-9#1)(1995-8#1)
one of the therapeutic##2##4##(2010-12#1)(2011-2#1)
one of the three conditions##2##5##(2006-7#1)(2008-11#1)
one of the three groups##4##5##(2007-6#1)(2008-12#1)(2011-12#1)(2013-8#1)
one of the three most##2##5##(1990-12#1)(2011-2#1)
one of the three##22##4##(1990-12#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-9#1)(1995-10#1)(1997-6#1)(2006-11#1)(2006-7#1)(2007-12#2)(2007-6#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-4#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
one of the tools##3##4##(1996-3#1)(2008-9#1)(2009-10#1)
one of the two arms##3##5##(2007-12#1)(2008-2#2)
one of the two species##3##5##(2008-10#1)(2008-5#2)
one of the two substrates##2##5##(1997-2#1)(2008-7#1)
one of the two##73##4##(1990-1#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-3#1)(1991-9#1)(1992-3#3)(1992-9#1)(1993-11#2)(1993-8#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#2)(2004-10#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#3)(2008-5#4)(2008-7#4)(2008-8#2)(2009-10#1)(2009-6#1)(2010-4#1)(2010-5#2)(2011-2#1)(2012-12#1)(2013-1#1)
one of the very##3##4##(2005-1#1)(2009-6#1)(2009-7#1)
one of the world's##2##4##(1993-7#1)(1996-12#1)
one of the worst##2##4##(2008-1#1)(2011-2#1)
one of the##1893##3##(1990-1#1)(1990-10#3)(1990-11#4)(1990-12#9)(1990-2#5)(1990-3#4)(1990-4#2)(1990-5#7)(1990-6#3)(1990-7#6)(1990-8#7)(1990-9#4)(1991-1#2)(1991-10#1)(1991-12#6)(1991-2#4)(1991-3#4)(1991-4#6)(1991-5#5)(1991-6#4)(1991-7#6)(1991-8#6)(1991-9#9)(1992-1#4)(1992-10#1)(1992-11#2)(1992-12#7)(1992-2#6)(1992-3#6)(1992-4#3)(1992-5#4)(1992-6#3)(1992-7#2)(1992-8#6)(1992-9#8)(1993-1#2)(1993-11#5)(1993-12#7)(1993-2#3)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#6)(1993-7#3)(1993-8#5)(1993-9#3)(1994-1#3)(1994-10#1)(1994-11#1)(1994-12#14)(1994-2#7)(1994-3#7)(1994-5#4)(1994-6#4)(1994-7#1)(1994-8#8)(1994-9#11)(1995-1#5)(1995-10#5)(1995-11#2)(1995-12#4)(1995-2#7)(1995-3#10)(1995-4#4)(1995-5#5)(1995-6#8)(1995-7#1)(1995-8#9)(1995-9#2)(1996-1#3)(1996-10#7)(1996-11#4)(1996-12#7)(1996-2#9)(1996-3#6)(1996-4#3)(1996-5#9)(1996-6#5)(1996-7#4)(1996-8#2)(1996-9#2)(1997-1#3)(1997-2#14)(1997-3#8)(1997-4#11)(1997-5#6)(1997-6#11)(1997-7#7)(1997-8#6)(2003-11#1)(2004-10#2)(2004-11#2)(2004-2#2)(2004-4#2)(2004-8#1)(2004-9#2)(2005-1#5)(2005-10#6)(2005-11#14)(2005-12#2)(2005-3#1)(2005-4#2)(2005-7#8)(2005-8#6)(2005-9#3)(2006-1#2)(2006-10#27)(2006-11#5)(2006-12#19)(2006-2#6)(2006-3#3)(2006-4#7)(2006-5#4)(2006-6#13)(2006-7#3)(2006-8#6)(2006-9#6)(2007-1#6)(2007-10#5)(2007-11#35)(2007-12#37)(2007-2#18)(2007-3#7)(2007-4#4)(2007-5#9)(2007-6#8)(2007-7#26)(2007-8#24)(2007-9#10)(2008-1#32)(2008-10#153)(2008-11#40)(2008-12#21)(2008-2#30)(2008-3#37)(2008-4#27)(2008-5#58)(2008-6#13)(2008-7#46)(2008-8#45)(2008-9#27)(2009-1#1)(2009-10#4)(2009-11#4)(2009-12#5)(2009-2#7)(2009-3#5)(2009-4#11)(2009-5#14)(2009-6#11)(2009-7#6)(2009-8#15)(2009-9#4)(2010-1#3)(2010-10#7)(2010-11#7)(2010-12#22)(2010-2#12)(2010-3#6)(2010-4#17)(2010-5#8)(2010-6#1)(2010-7#10)(2010-8#11)(2010-9#7)(2011-1#38)(2011-10#2)(2011-12#9)(2011-2#65)(2011-3#5)(2012-1#9)(2012-10#1)(2012-11#12)(2012-12#50)(2012-2#38)(2012-3#20)(2013-1#61)(2013-7#21)(2013-8#36)
one of their most##2##4##(2008-4#1)(2011-2#1)
one of their##10##3##(1990-11#1)(2006-12#1)(2006-7#1)(2007-8#1)(2008-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
one of them also##2##4##(1991-12#1)(1997-2#1)
one of them is##2##4##(2005-10#1)(2009-2#1)
one of them the##3##4##(1990-10#1)(2008-10#2)
one of them was##8##4##(1993-5#1)(1994-6#1)(1995-3#1)(1995-6#1)(1997-5#1)(2007-7#1)(2008-10#2)
one of them##57##3##(1990-10#2)(1990-12#3)(1990-6#1)(1990-7#2)(1991-10#1)(1991-12#1)(1991-2#2)(1991-8#1)(1992-1#1)(1992-4#2)(1993-5#1)(1993-7#1)(1994-3#1)(1994-6#2)(1995-3#1)(1995-6#1)(1997-1#1)(1997-2#2)(1997-5#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#11)(2008-2#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#3)(2013-8#1)
one of these cases##2##4##(2006-11#1)(2012-2#1)
one of these compounds##2##4##(1995-10#1)(2008-8#1)
one of these conditions##2##4##(2007-2#1)(2011-12#1)
one of these drugs##2##4##(1991-8#1)(2012-2#1)
one of these factors##2##4##(1991-5#1)(2008-10#1)
one of these filters##2##4##(2008-2#1)(2008-3#1)
one of these genes##4##4##(1990-8#1)(1992-5#1)(1992-9#1)(1997-2#1)
one of these mechanisms##2##4##(1997-4#1)(2008-1#1)
one of these patients##6##4##(2006-10#1)(2006-9#1)(2008-2#1)(2008-6#1)(2011-1#1)(2012-2#1)
one of these proteins##2##4##(1994-12#1)(2008-10#1)
one of these sites##2##4##(1994-6#1)(2013-7#1)
one of these systems##2##4##(2005-9#1)(2008-2#1)
one of these three##2##4##(1994-9#1)(2008-10#1)
one of these two##3##4##(1993-4#1)(1994-9#1)(2008-2#1)
one of these was##2##4##(1990-12#1)(2012-12#1)
one of these##114##3##(1990-10#1)(1990-12#1)(1990-3#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-10#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-2#1)(1993-4#1)(1993-8#3)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-10#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#1)(2005-10#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-7#2)(2006-9#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#5)(2008-2#6)(2008-3#5)(2008-4#3)(2008-5#6)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-7#1)(2013-8#1)
one of this##5##3##(1995-1#1)(2005-7#1)(2008-1#1)(2008-2#1)(2013-1#1)
one of those##8##3##(1992-3#1)(1996-5#1)(1996-8#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-7#1)
one of three different##2##4##(2008-2#1)(2012-1#1)
one of three doses of##3##5##(1992-9#1)(1996-1#1)(2011-2#1)
one of three groups##6##4##(1991-1#1)(2006-9#1)(2008-10#2)(2008-4#1)(2009-5#1)
one of three medications##2##4##(2010-11#1)(2011-1#1)
one of three surgical##2##4##(1993-5#1)(1994-3#1)
one of three##49##3##(1991-1#2)(1992-2#1)(1992-9#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-11#1)(1997-4#1)(2004-11#1)(2006-11#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-2#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2009-10#1)(2009-5#1)(2010-11#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
one of transient##2##3##(2006-5#2)
one of two broad##2##4##(2008-12#1)(2009-12#1)
one of two complexes that act as master regulators of the body plan of the fly##2##16##(1995-8#2)
one of two different##3##4##(1990-12#1)(2008-10#1)(2009-8#1)
one of two groups##3##4##(1996-8#1)(2010-4#1)(2013-7#1)
one of two nuclear##2##4##(1996-5#1)(2004-1#1)
one of two or##3##4##(1994-5#1)(1995-11#1)(2011-2#1)
one of two specific##2##4##(1994-11#1)(2008-5#1)
one of two strains of M##2##6##(1997-3#2)
one of two ways##2##4##(2008-10#1)(2008-3#1)
one of two##69##3##(1990-12#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-6#1)(1992-11#1)(1992-9#1)(1993-6#1)(1993-7#1)(1994-11#2)(1994-5#2)(1995-10#1)(1995-11#1)(1995-3#1)(1995-8#3)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#4)(1997-4#1)(1997-7#1)(2004-1#1)(2005-11#1)(2005-8#1)(2006-7#1)(2007-12#1)(2007-2#1)(2008-10#5)(2008-12#1)(2008-3#3)(2008-5#3)(2008-7#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
one of us##2##3##(2007-9#1)(2008-2#1)
one of ventricular##2##3##(1993-8#2)
one of which also##2##4##(2008-10#2)
one of which encodes##2##4##(1993-3#1)(1994-12#1)
one of which had##5##4##(1994-2#1)(1997-2#1)(2006-9#1)(2008-7#1)(2009-9#1)
one of which includes##2##4##(2008-10#1)(2010-12#1)
one of which is a##2##5##(1992-8#1)(2009-8#1)
one of which is located##2##5##(1993-5#1)(1996-7#1)
one of which is##25##4##(1990-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-8#1)(1993-2#2)(1993-5#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-7#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-8#2)
one of which was##12##4##(1990-4#1)(1992-5#1)(1992-9#1)(1994-3#1)(1994-6#1)(1996-7#1)(2006-8#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-10#1)(2011-2#1)
one of which##71##3##(1990-1#1)(1990-11#2)(1990-2#1)(1990-4#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-12#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-2#3)(1993-3#2)(1993-5#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-3#1)(1996-7#2)(1997-2#1)(2006-8#1)(2006-9#1)(2007-12#2)(2008-10#8)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-4#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2011-2#1)
one of whom had##2##4##(2006-8#1)(2011-2#1)
one of whom##6##3##(1996-1#1)(2006-8#1)(2008-7#1)(2010-2#1)(2011-2#1)(2013-8#1)
one of##2624##2##(1990-1#2)(1990-10#7)(1990-11#7)(1990-12#18)(1990-2#9)(1990-3#5)(1990-4#3)(1990-5#9)(1990-6#5)(1990-7#9)(1990-8#9)(1990-9#5)(1991-1#4)(1991-10#3)(1991-12#11)(1991-2#10)(1991-3#10)(1991-4#6)(1991-5#7)(1991-6#8)(1991-7#7)(1991-8#9)(1991-9#11)(1992-1#6)(1992-10#3)(1992-11#5)(1992-12#12)(1992-2#8)(1992-3#7)(1992-4#6)(1992-5#8)(1992-6#3)(1992-7#3)(1992-8#12)(1992-9#12)(1993-1#3)(1993-11#5)(1993-12#9)(1993-2#9)(1993-3#8)(1993-4#2)(1993-5#4)(1993-6#9)(1993-7#6)(1993-8#11)(1993-9#5)(1994-1#3)(1994-10#1)(1994-11#6)(1994-12#24)(1994-2#11)(1994-3#13)(1994-5#9)(1994-6#8)(1994-7#3)(1994-8#10)(1994-9#17)(1995-1#7)(1995-10#9)(1995-11#5)(1995-12#8)(1995-2#10)(1995-3#17)(1995-4#4)(1995-5#7)(1995-6#11)(1995-7#1)(1995-8#14)(1995-9#3)(1996-1#9)(1996-10#7)(1996-11#7)(1996-12#8)(1996-2#12)(1996-3#13)(1996-4#5)(1996-5#12)(1996-6#7)(1996-7#7)(1996-8#4)(1996-9#3)(1997-1#8)(1997-2#19)(1997-3#17)(1997-4#14)(1997-5#8)(1997-6#15)(1997-7#9)(1997-8#9)(2003-11#1)(2004-1#1)(2004-10#2)(2004-11#3)(2004-2#3)(2004-4#2)(2004-8#1)(2004-9#2)(2005-1#5)(2005-10#8)(2005-11#16)(2005-12#2)(2005-3#2)(2005-4#2)(2005-7#12)(2005-8#7)(2005-9#4)(2006-1#2)(2006-10#39)(2006-11#7)(2006-12#25)(2006-2#7)(2006-3#3)(2006-4#7)(2006-5#9)(2006-6#16)(2006-7#8)(2006-8#10)(2006-9#10)(2007-1#6)(2007-10#6)(2007-11#37)(2007-12#47)(2007-2#28)(2007-3#8)(2007-4#5)(2007-5#10)(2007-6#9)(2007-7#34)(2007-8#29)(2007-9#18)(2008-1#37)(2008-10#215)(2008-11#58)(2008-12#28)(2008-2#43)(2008-3#53)(2008-4#41)(2008-5#77)(2008-6#21)(2008-7#61)(2008-8#53)(2008-9#39)(2009-1#1)(2009-10#7)(2009-11#5)(2009-12#8)(2009-2#12)(2009-3#6)(2009-4#14)(2009-5#16)(2009-6#11)(2009-7#7)(2009-8#25)(2009-9#10)(2010-1#3)(2010-10#9)(2010-11#8)(2010-12#29)(2010-2#14)(2010-3#9)(2010-4#22)(2010-5#9)(2010-6#1)(2010-7#12)(2010-8#14)(2010-9#9)(2011-1#42)(2011-10#2)(2011-12#11)(2011-2#89)(2011-3#5)(2012-1#13)(2012-10#1)(2012-11#14)(2012-12#58)(2012-2#56)(2012-3#25)(2012-9#1)(2013-1#73)(2013-7#26)(2013-8#44)
one often wishes to##2##4##(1997-2#1)(2010-10#1)
one on his##2##3##(2008-5#2)
one on one##2##3##(1991-3#1)(2008-8#1)
one on the##5##3##(1994-8#1)(2006-12#1)(2008-2#1)(2008-5#1)(2013-7#1)
one on##26##2##(1990-10#1)(1991-3#1)(1994-8#1)(1996-3#1)(1997-5#2)(2006-12#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#6)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2013-7#1)
one onion##2##2##(2008-10#2)
one online##2##2##(2007-12#2)
one opal mutation##2##3##(2008-9#2)
one open reading frame##3##4##(1991-9#1)(1995-8#1)(2005-11#1)
one operation##2##2##(1996-1#1)(2008-3#1)
one option##4##2##(1995-3#1)(1996-5#1)(2006-12#1)(2009-6#1)
one or a few##7##4##(1990-4#2)(1990-8#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)
one or a##11##3##(1990-4#2)(1990-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-4#1)(2011-2#1)
one or both glycosylation sites##2##5##(1992-3#2)
one or both of the hydrogen##2##6##(1992-6#1)(2005-11#1)
one or both of the##5##5##(1991-7#1)(1992-6#1)(1994-8#1)(2005-11#1)(2008-10#1)
one or both of their##2##5##(2008-2#1)(2008-4#1)
one or both of these##5##5##(1991-12#1)(1991-3#1)(1994-6#1)(1995-11#1)(2008-10#1)
one or both of##13##4##(1991-12#1)(1991-3#1)(1991-7#1)(1992-6#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-11#1)(2005-11#1)(2008-10#2)(2008-2#1)(2008-4#1)
one or both##46##3##(1990-9#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-3#2)(1992-6#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1997-8#1)(2005-10#1)(2005-11#2)(2006-10#1)(2007-2#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
one or more R genes##2##5##(2008-10#2)
one or more chronic diseases##2##5##(1992-4#1)(1994-6#1)
one or more chronic##3##4##(1992-4#1)(1993-3#1)(1994-6#1)
one or more copies of the##2##6##(1993-7#1)(2006-10#1)
one or more mechanisms##2##4##(2008-1#1)(2008-10#1)
one or more members of the##2##6##(1995-2#1)(1995-8#1)
one or more of 12##2##5##(2008-10#1)(2008-11#1)
one or more of the cell##2##6##(1997-4#1)(2010-12#1)
one or more of the following##7##6##(1991-9#1)(1992-5#1)(1996-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2009-6#1)
one or more of the##26##5##(1990-8#1)(1991-9#1)(1992-5#1)(1992-6#1)(1993-11#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-2#1)(1997-4#2)(2005-11#1)(2006-10#2)(2007-1#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-2#1)(2009-6#2)(2010-12#1)(2010-2#1)
one or more of these##11##5##(1994-6#2)(2004-4#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)
one or more of##41##4##(1990-8#1)(1991-9#1)(1992-5#1)(1992-6#1)(1993-11#1)(1994-6#2)(1995-2#1)(1995-5#1)(1996-10#1)(1996-12#1)(1996-2#1)(1997-4#3)(2004-4#1)(2005-11#1)(2006-10#3)(2007-1#1)(2007-11#2)(2008-1#2)(2008-10#5)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-6#2)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#1)
one or more positive##2##4##(1993-3#1)(2007-7#1)
one or more proteins##3##4##(1994-11#1)(2008-10#1)(2008-4#1)
one or more specific##3##4##(2008-1#1)(2008-4#1)(2009-5#1)
one or more##230##3##(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#4)(1991-1#1)(1991-11#1)(1991-4#3)(1991-7#2)(1991-9#3)(1992-11#1)(1992-12#3)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#1)(1993-11#1)(1993-2#3)(1993-3#3)(1993-4#1)(1993-5#1)(1993-7#1)(1994-11#2)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#3)(1994-9#4)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#4)(1995-3#2)(1995-5#6)(1995-8#3)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#1)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#3)(1997-4#3)(1997-8#1)(2004-4#1)(2005-11#1)(2006-10#6)(2006-12#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#9)(2008-10#21)(2008-11#6)(2008-2#5)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#3)(2009-4#1)(2009-5#2)(2009-6#3)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#4)
one or multiple##2##3##(2011-2#1)(2012-3#1)
one or one and a half mg##2##7##(1991-9#2)
one or one##3##3##(1991-9#2)(2013-8#1)
one or other of the##2##5##(1993-2#1)(1996-12#1)
one or other of these##3##5##(1991-3#1)(1993-2#1)(2007-6#1)
one or other of##5##4##(1991-3#1)(1993-2#2)(1996-12#1)(2007-6#1)
one or other##8##3##(1991-3#1)(1991-8#1)(1993-2#2)(1996-12#1)(2006-2#1)(2007-6#1)(2008-11#1)
one or several##16##3##(1990-5#1)(1991-6#1)(1991-9#1)(1992-8#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-5#1)(2007-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2009-2#1)(2009-5#1)(2010-12#1)
one or the other##13##4##(1990-5#1)(1991-9#1)(1994-11#1)(1995-2#1)(1996-9#1)(1997-7#1)(2006-10#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2013-7#1)
one or two genotypes##2##4##(2008-10#2)
one or two of the##3##5##(1990-4#1)(1993-3#1)(2006-7#1)
one or two of##4##4##(1990-4#1)(1993-3#1)(2006-7#1)(2007-10#1)
one or two pairs##2##4##(1993-12#1)(2007-12#1)
one or two selected##2##4##(2006-5#1)(2008-10#1)
one or two small##2##4##(1992-10#1)(1995-3#1)
one or two years##3##4##(1994-6#1)(2011-2#1)(2013-1#1)
one or two##78##3##(1990-11#1)(1990-4#1)(1991-2#1)(1991-5#1)(1992-10#2)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-5#2)(2004-2#1)(2005-11#1)(2005-8#2)(2006-11#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#3)(2008-8#4)(2008-9#3)(2009-2#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)
one or##417##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#3)(1990-5#3)(1990-7#1)(1990-8#5)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#3)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#7)(1992-10#2)(1992-11#1)(1992-12#3)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#7)(1993-3#5)(1993-4#2)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#5)(1994-8#1)(1994-9#6)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#3)(1995-5#8)(1995-6#1)(1995-8#4)(1996-10#1)(1996-11#3)(1996-12#4)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#4)(1996-7#2)(1996-8#1)(1996-9#4)(1997-1#3)(1997-4#3)(1997-7#1)(1997-8#2)(2004-2#1)(2004-4#1)(2005-10#1)(2005-11#4)(2005-8#2)(2006-10#8)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#8)(2007-12#9)(2007-2#4)(2007-3#1)(2007-6#1)(2007-7#5)(2007-8#5)(2007-9#2)(2008-1#11)(2008-10#39)(2008-11#9)(2008-12#1)(2008-2#8)(2008-3#8)(2008-4#10)(2008-5#10)(2008-6#2)(2008-7#6)(2008-8#8)(2008-9#9)(2009-12#1)(2009-2#2)(2009-4#2)(2009-5#4)(2009-6#3)(2009-9#2)(2010-11#1)(2010-12#3)(2010-2#3)(2010-4#1)(2010-5#3)(2010-8#1)(2010-9#1)(2011-1#4)(2011-11#1)(2011-2#10)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#12)(2013-7#3)(2013-8#5)
one order of magnitude for##3##5##(1991-5#1)(1995-5#1)(2007-12#1)
one order of magnitude in##2##5##(2007-12#1)(2007-3#1)
one order of magnitude lower than##3##6##(1996-12#1)(1997-2#1)(2007-8#1)
one order of magnitude##16##4##(1990-12#1)(1991-5#1)(1994-11#1)(1995-5#1)(1996-12#1)(1997-2#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-10#4)(2012-3#1)(2013-8#1)
one organ##3##2##(1990-10#1)(2006-10#1)(2008-7#1)
one organic##2##2##(2008-7#1)(2010-4#1)
one organism can##2##3##(1993-2#1)(1996-5#1)
one organism##4##2##(1993-2#1)(1995-8#1)(1996-5#1)(2011-2#1)
one orientation##3##2##(1991-11#1)(1995-10#1)(1995-3#1)
one oscillation period##2##3##(2008-2#2)
one other case of##3##4##(1990-5#1)(2008-12#1)(2012-2#1)
one other enzyme##2##3##(1990-12#1)(1995-12#1)
one other##23##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-10#1)(1991-8#1)(1992-10#1)(1993-11#1)(1994-6#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#1)(2006-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
one out of 2##2##4##(1990-10#2)
one out of 9##2##4##(2007-7#1)(2011-12#1)
one out of four##3##4##(1990-4#2)(1992-5#1)
one out of the##2##4##(1991-8#1)(1995-6#1)
one out of##19##3##(1990-10#2)(1990-11#1)(1990-4#3)(1991-8#1)(1991-9#2)(1992-5#2)(1992-6#1)(1995-6#1)(1996-2#1)(2007-7#1)(2008-7#1)(2010-12#1)(2011-12#1)(2013-1#1)
one out##24##2##(1990-10#2)(1990-11#1)(1990-4#3)(1991-8#1)(1991-9#2)(1992-5#2)(1992-6#1)(1995-6#1)(1996-2#1)(2006-1#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-12#1)(2013-1#3)
one output##3##2##(1995-9#1)(2006-5#1)(2008-3#1)
one ovary was##2##3##(1992-3#2)
one over the##2##3##(1996-9#1)(2008-5#1)
one over##5##2##(1996-9#1)(2008-3#1)(2008-5#2)(2009-5#1)
one oxygen atom##3##3##(1995-10#1)(2008-3#1)(2008-4#1)
one oxygen##5##2##(1995-10#1)(2008-3#2)(2008-4#1)(2009-12#1)
one pH unit##3##3##(1991-2#1)(1997-5#1)(2005-11#1)
one page##2##2##(2009-10#1)(2010-2#1)
one pair of##9##3##(1992-9#1)(2007-12#3)(2008-10#1)(2008-12#1)(2008-3#1)(2010-7#1)(2012-3#1)
one pair##10##2##(1992-9#1)(2007-12#3)(2008-10#2)(2008-12#1)(2008-3#1)(2010-7#1)(2012-3#1)
one paper##3##2##(2007-8#1)(2008-11#1)(2012-3#1)
one parameter##7##2##(1990-12#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)
one parasitoid species##3##3##(2010-2#3)
one parent##7##2##(1997-1#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-4#1)
one part of the##2##4##(2007-12#1)(2007-9#1)
one part of##8##3##(1996-2#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-5#1)(2008-9#1)(2009-6#1)
one part##10##2##(1996-2#1)(2007-10#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-6#1)
one partial##2##2##(2008-6#1)(2008-9#1)
one participant##2##2##(2010-8#1)(2010-9#1)
one particular##11##2##(1991-11#1)(1991-2#1)(1996-12#1)(2006-5#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-11#1)(2012-12#1)(2012-2#1)
one partner##6##2##(1992-9#1)(1995-11#1)(1996-1#1)(1997-6#1)(2007-4#1)(2011-1#1)
one passage##2##2##(1994-3#1)(2008-11#1)
one pathogen##3##2##(2008-10#2)(2008-2#1)
one pathway##8##2##(1990-11#1)(1994-6#1)(2007-12#1)(2008-1#1)(2008-4#2)(2010-3#1)(2013-1#1)
one patient (6##2##3##(2008-1#1)(2008-10#1)
one patient a##4##3##(2006-11#1)(2007-8#1)(2008-3#1)(2008-6#1)
one patient an##2##3##(1997-8#1)(2006-6#1)
one patient and from##2##4##(1995-9#1)(2011-1#1)
one patient and##13##3##(1994-11#1)(1994-2#1)(1995-9#1)(1997-5#1)(2006-12#1)(2007-7#1)(2008-1#2)(2008-6#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-8#1)
one patient developed##6##3##(2005-5#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-6#2)
one patient did not##2##4##(1990-7#1)(2008-5#1)
one patient died##10##3##(1991-8#1)(1993-6#1)(1996-9#1)(2006-11#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-6#2)(2008-7#1)
one patient experienced mild##2##4##(2008-9#1)(2012-3#1)
one patient had a##6##4##(1994-11#1)(1996-6#1)(2006-11#1)(2006-12#1)(2008-6#1)(2009-10#1)
one patient had total##2##4##(2006-10#1)(2007-7#1)
one patient had##17##3##(1990-4#1)(1992-11#1)(1992-4#1)(1994-11#1)(1996-6#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-7#3)(2007-8#1)(2008-6#3)(2009-10#1)(2011-2#1)
one patient in the##2##4##(1990-12#1)(2008-5#1)
one patient in##6##3##(1990-12#1)(1996-8#1)(1997-7#1)(2006-12#1)(2008-1#1)(2008-5#1)
one patient of##2##3##(2007-7#1)(2008-5#1)
one patient reported##4##3##(2006-10#1)(2007-7#2)(2007-8#1)
one patient required##3##3##(2006-6#1)(2006-7#1)(2007-11#1)
one patient showed a##3##4##(1994-6#1)(2009-4#1)(2010-12#1)
one patient showed##4##3##(1994-6#1)(2007-3#1)(2009-4#1)(2010-12#1)
one patient suffered##2##3##(1992-9#1)(2006-11#1)
one patient the##4##3##(1990-10#1)(1992-10#1)(1996-9#1)(2006-12#1)
one patient underwent##4##3##(1995-7#1)(2006-12#1)(2007-7#2)
one patient was found to##2##5##(2008-7#1)(2011-1#1)
one patient was lost##2##4##(1994-11#1)(2008-3#1)
one patient was##12##3##(1990-10#1)(1990-3#1)(1992-11#1)(1994-11#1)(1995-4#1)(2005-5#1)(2006-4#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)
one patient who was reoperated##2##5##(2007-8#2)
one patient who was##4##4##(1993-6#1)(2004-9#1)(2007-8#2)
one patient who##7##3##(1993-6#1)(1997-6#1)(2004-9#1)(2006-11#1)(2007-8#3)
one patient with a##5##4##(1996-9#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-1#1)
one patient with metastatic##2##4##(1990-12#1)(2006-8#1)
one patient with##24##3##(1990-10#1)(1990-12#2)(1991-4#2)(1991-5#1)(1993-5#1)(1994-12#1)(1994-9#1)(1996-9#1)(2004-11#2)(2006-10#1)(2006-12#3)(2006-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-12#1)
one patient##254##2##(1990-10#3)(1990-11#1)(1990-12#3)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-4#2)(1991-5#1)(1991-8#1)(1992-10#1)(1992-11#2)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-10#1)(1993-2#1)(1993-5#1)(1993-6#3)(1993-7#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-4#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-6#1)(1996-8#3)(1996-9#5)(1997-1#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#2)(2004-11#2)(2004-9#1)(2005-5#2)(2006-10#6)(2006-11#5)(2006-12#17)(2006-4#1)(2006-6#7)(2006-7#2)(2006-8#7)(2007-1#1)(2007-11#4)(2007-2#2)(2007-3#4)(2007-7#24)(2007-8#13)(2008-1#9)(2008-10#6)(2008-11#2)(2008-3#6)(2008-4#1)(2008-5#5)(2008-6#13)(2008-7#10)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#2)(2009-4#3)(2010-12#6)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#8)(2011-3#1)(2012-1#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
one patients with##4##3##(2006-6#1)(2011-1#1)(2013-8#2)
one patients##12##2##(2006-6#2)(2007-11#2)(2007-3#1)(2008-4#1)(2011-1#1)(2012-2#1)(2013-8#4)
one peak at##2##3##(2008-10#1)(2009-9#1)
one peak of##3##3##(1992-1#2)(1993-9#1)
one peak##7##2##(1990-2#1)(1992-1#2)(1993-9#1)(2008-10#1)(2008-3#1)(2009-9#1)
one pediatric##3##2##(2010-2#1)(2011-2#1)(2012-2#1)
one peptide named##2##3##(2008-10#1)(2012-12#1)
one peptide##8##2##(1993-6#1)(1995-1#1)(1995-3#1)(2005-11#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-12#1)
one per##9##2##(1990-9#1)(1992-2#1)(1996-2#1)(2006-10#2)(2007-3#1)(2008-10#2)(2012-2#1)
one percent of##3##3##(1996-3#1)(2009-9#1)(2013-1#1)
one percent##5##2##(1996-3#1)(2004-2#1)(2009-9#1)(2013-1#2)
one period of##4##3##(2007-8#1)(2008-3#1)(2011-12#1)(2011-2#1)
one period##6##2##(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2011-12#1)(2011-2#1)
one permanent##3##2##(1991-10#1)(1997-3#1)(2008-10#1)
one person##9##2##(1991-4#1)(1992-4#1)(1995-11#1)(2006-10#1)(2008-3#1)(2010-5#1)(2013-1#3)
one pharmacy##2##2##(1990-9#1)(2008-10#1)
one phase of##2##3##(1997-1#1)(2005-11#1)
one phase##5##2##(1997-1#1)(2005-11#2)(2008-3#1)(2009-3#1)
one photon##2##2##(2007-11#1)(2007-12#1)
one phototype##2##2##(2008-5#2)
one physician##4##2##(1997-2#1)(2006-8#1)(2007-6#1)(2011-2#1)
one plane##2##2##(2008-3#1)(2008-8#1)
one plant species##3##3##(2008-10#2)(2008-8#1)
one plant##9##2##(1994-7#1)(2006-12#1)(2008-10#3)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)
one point in the##2##4##(2006-10#1)(2008-5#1)
one point of##2##3##(2006-4#1)(2008-12#1)
one point##8##2##(2005-11#1)(2006-10#1)(2006-4#1)(2008-12#2)(2008-5#1)(2008-6#1)(2010-12#1)
one polarization##4##2##(2008-2#1)(2008-3#2)(2008-7#1)
one pole##3##2##(1994-8#1)(2006-10#1)(2007-12#1)
one policy##2##2##(1993-3#1)(1996-3#1)
one polypeptide##4##2##(1991-12#1)(1992-8#1)(1993-2#1)(2008-8#1)
one pool of##2##3##(1995-11#1)(2008-5#1)
one poorly##2##2##(1990-2#1)(2012-12#1)
one population of##3##3##(2006-2#1)(2007-8#1)(2008-10#1)
one population##8##2##(2006-2#1)(2007-8#1)(2008-10#4)(2008-8#1)(2012-3#1)
one portion##2##2##(1996-11#1)(2007-8#1)
one position##3##2##(1997-7#2)(2007-8#1)
one positive clone##3##3##(1994-12#1)(1997-6#1)(2008-9#1)
one positive##8##2##(1992-5#1)(1993-8#1)(1994-12#2)(1997-6#1)(2008-9#1)(2011-2#2)
one possible mechanism by which##2##5##(1995-3#1)(2011-1#1)
one possible mechanism##6##3##(1993-6#1)(1995-3#1)(2007-7#2)(2011-1#1)(2012-3#1)
one possible##20##2##(1993-6#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-5#1)(2005-4#1)(2007-11#1)(2007-7#2)(2008-3#3)(2009-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
one pot##2##2##(1996-5#1)(2009-10#1)
one potential mechanism##2##3##(2006-10#1)(2007-8#1)
one potential well##2##3##(1996-2#2)
one potential##9##2##(1996-2#2)(1997-2#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-10#1)(2010-12#1)(2012-12#1)
one potentially##2##2##(2006-10#1)(2011-2#1)
one pregnancy##7##2##(1994-8#1)(2008-10#1)(2008-4#1)(2010-8#1)(2012-12#3)
one presented##3##2##(2007-8#1)(2008-3#1)(2008-8#1)
one presenting with##2##3##(1991-10#1)(2008-7#1)
one presenting##3##2##(1991-10#1)(2008-11#1)(2008-7#1)
one previous##4##2##(1992-7#1)(2006-10#1)(2008-10#1)(2012-12#1)
one previously published##2##3##(2008-10#1)(2008-9#1)
one previously##4##2##(2008-10#2)(2008-9#1)(2013-1#1)
one prey##2##2##(2007-9#1)(2008-2#1)
one primary##3##2##(1990-5#1)(1996-7#1)(1997-7#1)
one primer##3##2##(2008-10#1)(2008-2#2)
one private##2##2##(1993-12#1)(2006-8#1)
one problem##7##2##(2006-2#1)(2006-4#1)(2006-7#1)(2007-1#1)(2008-12#1)(2008-2#1)(2008-3#1)
one procedure##4##2##(1991-2#1)(2007-2#2)(2008-10#1)
one process##5##2##(1991-9#1)(1992-10#1)(1995-3#1)(1996-2#1)(2008-3#1)
one produced by##2##3##(1993-2#1)(1994-2#1)
one produced##4##2##(1993-2#1)(1994-2#1)(1997-6#1)(2008-8#1)
one product##2##2##(1994-8#1)(2008-10#1)
one program##2##2##(2008-2#1)(2008-5#1)
one promising##2##2##(1996-8#1)(2010-8#1)
one proposed##3##2##(1991-12#1)(2008-2#2)
one prospective##2##2##(2010-10#1)(2012-12#1)
one protein of##2##3##(2008-10#1)(2008-4#1)
one protein##17##2##(1990-5#1)(1991-10#1)(1991-2#1)(1991-9#1)(2006-10#1)(2007-6#1)(2008-10#2)(2008-4#3)(2008-9#3)(2009-9#1)(2010-12#1)(2012-2#1)
one proton##5##2##(1993-6#1)(1995-10#1)(1996-2#1)(2006-10#1)(2008-10#1)
one psychiatric hospital##2##3##(1993-12#1)(1997-8#1)
one pump##3##2##(2007-12#2)(2008-10#1)
one putative##4##2##(1990-11#1)(1993-3#1)(1993-6#1)(2008-3#1)
one quadrant##2##2##(2011-12#1)(2013-1#1)
one quarter of the##6##4##(1991-3#2)(1993-12#1)(2008-11#1)(2008-2#1)(2012-2#1)
one quarter##10##2##(1991-3#4)(1993-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-12#1)(2012-2#1)
one race of P##2##4##(2008-10#2)
one race of##4##3##(2008-10#4)
one race##5##2##(2008-10#5)
one random##2##2##(1991-11#1)(2008-9#1)
one reason for##3##3##(1991-11#1)(2006-10#1)(2008-11#1)
one reason why##4##3##(2008-10#1)(2008-9#1)(2010-2#1)(2013-8#1)
one reason##8##2##(1991-11#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-2#1)(2013-8#1)
one recent##2##2##(2006-10#1)(2008-3#1)
one receptor##3##2##(1990-8#2)(1996-12#1)
one recessive gene was detected in BBA 809##2##8##(2008-10#2)
one recessive gene was detected in BBA##3##7##(2008-10#3)
one recessive gene was detected in##4##6##(2008-10#4)
one recessive gene##8##3##(2008-10#7)(2008-9#1)
one recurrence##2##2##(1995-3#1)(2007-11#1)
one reference electrode##2##3##(2008-10#2)
one reference##4##2##(1993-5#1)(2008-10#2)(2008-11#1)
one region of##2##3##(1994-8#1)(2004-9#1)
one region##9##2##(1991-2#1)(1994-8#1)(1996-4#1)(2004-9#1)(2006-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
one related to##4##3##(1990-2#1)(1996-12#1)(2007-8#1)(2008-7#1)
one renal##2##2##(2008-4#1)(2011-2#1)
one repetitive##2##2##(1995-4#1)(2008-10#1)
one report##6##2##(2006-10#1)(2007-5#1)(2007-9#1)(2008-12#1)(2009-3#1)(2013-8#1)
one reported##8##2##(1991-7#1)(1992-3#1)(1994-6#1)(2007-1#1)(2007-7#2)(2007-9#1)(2011-2#1)
one representation##2##2##(2008-4#1)(2010-2#1)
one representative##3##2##(2008-10#2)(2012-12#1)
one represented##2##2##(1996-5#1)(2008-10#1)
one required##2##2##(1997-3#1)(2006-10#1)
one requires##2##2##(1995-4#1)(2008-2#1)
one residue##6##2##(1990-8#1)(1991-10#1)(1992-12#1)(1996-7#1)(2008-11#1)(2009-3#1)
one responded##2##2##(2008-4#1)(2008-5#1)
one response##2##2##(1994-12#1)(2004-12#1)
one result of##2##3##(2008-12#1)(2008-7#1)
one review##2##2##(2012-12#1)(2013-8#1)
one rice##2##2##(2008-10#1)(2009-10#1)
one risk factor##5##3##(1990-9#1)(2006-2#1)(2006-8#2)(2012-1#1)
one risk##7##2##(1990-9#1)(2006-2#1)(2006-8#2)(2009-9#1)(2010-12#1)(2012-1#1)
one rodent species##2##3##(1990-9#1)(1995-10#1)
one role##2##2##(2006-10#1)(2007-12#1)
one root##4##2##(2008-3#2)(2013-1#2)
one rotation##2##2##(1992-7#1)(2008-2#1)
one round of##3##3##(1990-5#1)(2008-7#1)(2008-9#1)
one rural##3##2##(1995-3#1)(2010-3#1)(2013-1#1)
one sample in##2##3##(2008-10#1)(2008-5#1)
one sample of##3##3##(2008-10#2)(2008-3#1)
one sample to##2##3##(1994-2#1)(2008-10#1)
one sample was##3##3##(1996-7#1)(2008-10#2)
one sample##24##2##(1991-8#1)(1994-2#1)(1994-6#1)(1996-7#1)(2006-3#1)(2007-12#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
one samples##2##2##(1992-2#2)
one sampling##2##2##(2007-12#1)(2013-1#1)
one season##5##2##(2008-10#3)(2008-8#1)(2011-2#1)
one second##5##2##(2007-2#2)(2007-8#1)(2012-12#1)(2012-3#1)
one secondary##2##2##(1995-10#1)(2005-11#1)
one section##2##2##(2006-3#1)(2013-1#1)
one segment##4##2##(2007-7#1)(2008-10#3)
one sensitive to##2##3##(1991-3#1)(1992-3#1)
one sensor##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
one sensory##2##2##(1990-4#1)(2012-1#1)
one sequence##4##2##(1997-4#1)(1997-6#1)(2008-4#1)(2011-2#1)
one series##3##2##(2008-11#1)(2008-4#1)(2010-3#1)
one serious##3##2##(2006-10#2)(2012-12#1)
one serum##4##2##(2005-10#1)(2006-10#1)(2008-11#2)
one service##2##2##(1996-2#1)(2008-11#1)
one session##5##2##(2006-6#1)(2008-5#2)(2010-12#1)(2010-8#1)
one set of##13##3##(1994-11#1)(1995-12#1)(2006-10#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#2)(2010-2#1)
one set##17##2##(1990-2#1)(1994-11#1)(1995-12#1)(2005-12#1)(2006-10#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#2)(2010-2#1)
one setting##2##2##(2007-8#1)(2013-8#1)
one should apply##2##3##(2008-2#1)(2009-3#1)
one should be able to##2##5##(1994-3#1)(2005-11#1)
one should be aware that##2##5##(2006-5#1)(2012-2#1)
one should be aware##3##4##(2006-5#1)(2012-2#2)
one should be cautious##2##4##(2008-5#1)(2008-7#1)
one should be##8##3##(1994-3#1)(2005-11#1)(2006-5#1)(2008-5#2)(2008-7#1)(2012-2#2)
one should consider##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
one should not##3##3##(1992-6#1)(1997-6#1)(2012-2#1)
one should preferably##2##3##(2008-8#2)
one should##30##2##(1992-6#1)(1994-3#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#2)(2009-3#2)(2011-12#1)(2012-2#4)
one showed##5##2##(1994-6#1)(2007-6#1)(2007-8#1)(2008-7#1)(2012-1#1)
one showing##4##2##(1993-3#1)(2007-11#1)(2008-4#1)(2008-5#1)
one shows##3##2##(1990-7#1)(1990-9#1)(2008-3#1)
one sibling##3##2##(2004-11#1)(2008-11#1)(2010-2#1)
one side and the##2##4##(2008-10#1)(2008-2#1)
one side and with##2##4##(2008-11#1)(2008-5#1)
one side and##11##3##(1996-8#1)(2004-9#1)(2005-10#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2011-1#1)(2012-2#2)
one side of a##2##4##(1991-1#1)(2007-11#1)
one side of each##2##4##(2006-11#1)(2008-3#1)
one side of the##12##4##(1990-11#1)(1991-5#1)(1992-7#1)(1993-3#1)(1996-10#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)
one side of##19##3##(1990-11#1)(1991-1#1)(1991-5#1)(1992-7#1)(1993-3#1)(1995-12#1)(1996-10#1)(1997-4#1)(2006-11#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2011-2#1)(2012-1#1)
one side or##2##3##(1991-5#1)(1994-7#1)
one side##49##2##(1990-11#1)(1990-7#1)(1991-1#1)(1991-5#2)(1991-6#1)(1992-7#1)(1993-3#2)(1993-4#1)(1994-2#1)(1994-7#1)(1995-12#1)(1996-10#1)(1996-8#2)(1997-4#1)(2004-9#1)(2005-10#2)(2006-11#1)(2006-12#2)(2006-9#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-2#4)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)
one significant##5##2##(1990-5#1)(2007-7#1)(2010-2#1)(2011-2#1)(2013-1#1)
one similar##2##2##(1990-7#1)(1991-4#1)
one simulation##2##2##(2008-2#1)(2008-8#1)
one single dose##2##3##(2008-7#1)(2008-8#1)
one single molecule##2##3##(2008-5#1)(2010-6#1)
one single##35##2##(1990-11#1)(1991-4#1)(1992-11#1)(1993-6#1)(1995-6#1)(2007-3#1)(2007-8#3)(2008-1#1)(2008-10#4)(2008-11#3)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#1)(2009-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
one site##18##2##(1990-11#1)(1990-5#1)(1990-8#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-3#1)(1994-11#1)(1994-5#1)(1996-7#1)(1997-4#1)(2006-10#1)(2007-3#1)(2008-10#2)(2008-6#1)(2008-8#1)(2011-2#1)
one sitting##3##2##(1992-10#1)(2009-4#1)(2009-6#1)
one sixth##2##2##(1990-2#1)(2011-2#1)
one size fits all##3##4##(2012-12#1)(2013-1#2)
one size##6##2##(1994-3#1)(2012-12#1)(2013-1#3)(2013-8#1)
one small step##2##3##(2006-2#1)(2008-5#1)
one small##6##2##(2006-2#1)(2007-8#1)(2008-4#1)(2008-5#1)(2012-12#2)
one soil##2##2##(2005-10#1)(2008-6#1)
one solution##2##2##(2005-11#1)(2007-12#1)
one source of##3##3##(2007-8#1)(2010-6#1)(2010-9#1)
one source##4##2##(2007-8#1)(2008-8#1)(2010-6#1)(2010-9#1)
one space##2##2##(2008-2#1)(2011-2#1)
one spatial##2##2##(2007-9#1)(2008-7#1)
one speaker##2##2##(2008-2#1)(2011-1#1)
one species are##2##3##(2008-4#1)(2008-5#1)
one species is##3##3##(2007-3#1)(2008-10#1)(2008-5#1)
one species of##9##3##(1990-12#2)(1991-8#1)(1992-12#1)(1992-8#1)(2007-9#1)(2008-12#1)(2008-5#2)
one species to##5##3##(1992-11#1)(2007-9#1)(2008-8#1)(2012-2#2)
one species##39##2##(1990-12#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-12#1)(1994-3#1)(1996-8#1)(2007-12#1)(2007-3#2)(2007-9#2)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#5)(2008-8#4)(2008-9#2)(2009-8#1)(2011-12#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
one specific##20##2##(1991-3#1)(1992-5#1)(1992-6#1)(1993-6#1)(1995-1#1)(1995-4#1)(1996-2#1)(2007-1#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2010-4#1)(2011-1#1)(2013-8#1)
one specimen##4##2##(2007-12#1)(2007-8#1)(2008-5#2)
one spouse##2##2##(2010-8#1)(2012-11#1)
one spray##2##2##(2008-10#2)
one stage##8##2##(1992-2#1)(1992-8#1)(1994-8#1)(1997-7#2)(2008-1#1)(2008-5#1)(2013-1#1)
one standard deviation##4##3##(2006-11#2)(2008-2#1)(2008-3#1)
one standard drink##2##3##(2009-7#2)
one standard solution##3##3##(2008-10#3)
one standard##9##2##(2006-11#2)(2008-10#3)(2008-2#1)(2008-3#1)(2009-7#2)
one state##2##2##(1996-8#1)(2008-2#1)
one step closer to##3##4##(2007-9#2)(2008-6#1)
one step further##4##3##(2008-11#1)(2008-9#1)(2009-9#1)(2012-2#1)
one step in##5##3##(1992-4#1)(1995-1#1)(1996-5#1)(2006-10#1)(2013-1#1)
one step of##2##3##(1990-4#1)(2009-11#1)
one step procedure##4##3##(1991-10#1)(1994-3#2)(2010-11#1)
one step##54##2##(1990-4#1)(1990-6#1)(1991-10#1)(1992-4#1)(1992-8#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-1#1)(1996-2#2)(1996-5#1)(2006-10#1)(2007-12#2)(2007-8#1)(2007-9#2)(2008-10#7)(2008-11#2)(2008-2#5)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-12#1)(2012-12#2)(2012-2#3)(2013-1#1)
one still##3##2##(2006-8#1)(2008-3#1)(2012-2#1)
one stone##2##2##(2011-2#1)(2012-3#1)
one strain of##5##3##(1995-2#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-8#1)
one strain##15##2##(1995-2#1)(1996-12#1)(2005-11#1)(2006-8#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-8#1)
one strand of the##2##4##(1997-9#1)(2008-2#1)
one strand of##3##3##(1992-11#1)(1997-9#1)(2008-2#1)
one strand##11##2##(1992-11#1)(1992-12#1)(1995-1#1)(1995-10#1)(1995-4#1)(1995-6#1)(1997-9#1)(2005-11#1)(2008-2#2)(2008-4#1)
one strategy##2##2##(1991-1#1)(2007-8#1)
one stretch##3##2##(1993-9#2)(1996-4#1)
one structural##2##2##(1993-9#1)(1995-4#1)
one student##2##2##(1992-3#1)(2008-11#1)
one study has##3##3##(1994-11#1)(2006-3#1)(2012-2#1)
one study showed##4##3##(2007-11#1)(2011-2#2)(2013-1#1)
one study##31##2##(1990-7#1)(1991-1#1)(1991-12#1)(1992-3#1)(1994-11#1)(1995-2#1)(1996-8#1)(2006-10#2)(2006-2#2)(2006-3#1)(2006-4#1)(2007-11#3)(2007-12#1)(2007-8#2)(2008-5#2)(2009-11#1)(2010-10#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
one subject##5##2##(1993-2#1)(1993-9#1)(1994-6#1)(2007-12#1)(2012-1#1)
one subpopulation##3##2##(2008-10#2)(2012-3#1)
one substituent##2##2##(2008-10#1)(2010-5#1)
one substitution##3##2##(1991-7#1)(1997-4#1)(2008-10#1)
one subunit in##2##3##(1993-9#1)(1995-3#1)
one subunit of the##4##4##(1991-1#1)(1994-9#1)(2006-8#1)(2009-7#1)
one subunit of##5##3##(1991-1#1)(1994-9#1)(1996-11#1)(2006-8#1)(2009-7#1)
one subunit##16##2##(1990-8#1)(1991-1#2)(1991-12#1)(1991-6#1)(1992-3#1)(1993-11#1)(1993-9#1)(1994-9#2)(1995-3#1)(1995-8#1)(1996-11#1)(1996-8#1)(2006-8#1)(2009-7#1)
one successful##4##2##(1992-12#1)(2007-7#1)(2008-2#1)(2008-8#1)
one such case in which##2##5##(2007-12#1)(2008-7#1)
one such case in##3##4##(2007-12#1)(2008-7#1)(2011-1#1)
one such case##11##3##(2007-12#1)(2007-7#3)(2008-7#2)(2009-10#1)(2009-9#1)(2010-2#1)(2011-1#1)(2012-12#1)
one such device##2##3##(1993-5#1)(2008-7#1)
one such method##2##3##(2008-4#1)(2008-5#1)
one such model that##2##4##(1997-3#1)(2008-1#1)
one such model##3##3##(1997-3#1)(2008-1#1)(2008-9#1)
one such technique##2##3##(2007-12#1)(2009-11#1)
one such##66##2##(1990-6#1)(1991-1#1)(1991-12#1)(1991-7#1)(1992-10#1)(1992-7#1)(1993-5#1)(1994-11#1)(1995-1#1)(1995-5#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-3#1)(2005-10#1)(2005-11#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-7#3)(2011-1#3)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)
one sulfate##2##2##(1995-4#1)(1997-1#1)
one superficial##2##2##(2006-8#1)(2010-11#1)
one surgeon's##2##2##(2007-3#1)(2007-8#1)
one survey##3##2##(1994-4#1)(2008-10#1)(2012-2#1)
one suspected##2##2##(2007-3#1)(2008-12#1)
one synapse##2##2##(1996-2#1)(2013-8#1)
one syncytial##2##2##(2013-1#2)
one system of##2##3##(1994-2#1)(2005-8#1)
one system##6##2##(1994-12#1)(1994-2#1)(2005-8#1)(2008-1#1)(2008-10#1)(2008-2#1)
one tablet##2##2##(2006-7#1)(2007-11#1)
one target for##2##3##(1993-9#1)(1997-4#1)
one target##5##2##(1993-9#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#1)
one task##2##2##(1997-8#1)(2008-11#1)
one taxon##2##2##(2008-5#1)(2008-8#1)
one teaching##2##2##(1993-2#1)(2008-12#1)
one temperature##3##2##(2008-10#1)(2008-8#2)
one tenth of the##3##4##(1994-11#1)(2008-10#1)(2008-2#1)
one tenth of##5##3##(1993-4#1)(1994-11#1)(2007-2#1)(2008-10#1)(2008-2#1)
one tenth that of##2##4##(2007-12#1)(2010-6#1)
one tenth##8##2##(1993-4#1)(1994-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-2#1)(2010-6#1)
one terminal##2##2##(1996-10#1)(2008-8#1)
one test##11##2##(1996-9#2)(2007-3#1)(2007-4#2)(2008-11#1)(2008-3#1)(2008-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
one that allows for##2##4##(2008-2#1)(2013-1#1)
one that allows##3##3##(1992-3#1)(2008-2#1)(2013-1#1)
one that can##3##3##(2008-3#1)(2008-7#1)(2008-8#1)
one that involves##2##3##(2008-11#1)(2008-9#1)
one that is not##3##4##(1995-1#1)(2006-10#1)(2008-3#1)
one that is##15##3##(1992-2#1)(1995-1#2)(1995-5#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-4#1)(2008-10#1)(2008-3#3)(2008-9#1)(2009-3#1)(2013-8#1)
one that primarily blocks IL-12/IL-12R beta##2##6##(1996-10#2)
one that provides##3##3##(2007-4#1)(2008-4#1)(2008-9#1)
one that regulates##2##3##(1990-8#2)
one that uses##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
one that was##4##3##(2005-5#1)(2007-12#1)(2007-4#1)(2010-1#1)
one that##79##2##(1990-12#1)(1990-8#2)(1992-11#1)(1992-2#3)(1992-3#1)(1992-9#1)(1993-2#1)(1995-1#2)(1995-3#1)(1995-4#1)(1995-5#1)(1996-10#2)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(2005-5#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-6#3)(2007-12#5)(2007-4#3)(2008-1#3)(2008-10#3)(2008-11#3)(2008-2#4)(2008-3#6)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#4)(2009-3#1)(2009-5#1)(2010-1#1)(2012-1#2)(2012-2#2)(2013-1#1)(2013-8#1)
one the most##2##3##(2011-2#1)(2013-8#1)
one the##11##2##(1990-9#1)(1995-2#1)(1995-8#1)(1996-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-3#1)(2011-2#1)(2013-8#1)
one theoretical##3##2##(1994-5#1)(2010-3#1)(2012-2#1)
one therapeutic##2##2##(2005-7#1)(2006-5#1)
one thiocyanate##2##2##(1995-11#1)(2008-10#1)
one third and##3##3##(1990-8#1)(2006-1#1)(2007-12#1)
one third of all helices##2##5##(1991-10#2)
one third of all##8##4##(1991-10#2)(1997-5#1)(2005-10#1)(2007-4#1)(2008-12#1)(2008-8#1)(2011-1#1)
one third of our##2##4##(2007-10#1)(2008-8#1)
one third of patients##4##4##(2008-5#1)(2009-11#1)(2011-2#1)(2013-1#1)
one third of the cases##2##5##(1990-3#1)(2007-12#1)
one third of the##24##4##(1990-12#1)(1990-3#1)(1990-8#1)(1991-7#1)(1992-3#1)(1993-10#1)(1995-9#1)(1997-4#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-12#2)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#1)(2009-3#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
one third of them##2##4##(2007-7#1)(2009-3#1)
one third of##61##3##(1990-12#1)(1990-3#1)(1990-8#1)(1991-10#2)(1991-7#1)(1992-3#1)(1993-10#1)(1993-6#1)(1994-2#1)(1995-9#1)(1996-11#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(2005-10#1)(2005-11#2)(2006-1#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#4)(2008-1#2)(2008-10#2)(2008-12#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#2)(2010-11#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-3#2)(2013-1#4)
one third the##2##3##(2008-2#1)(2011-2#1)
one third to one half of##2##6##(1991-4#1)(2005-10#1)
one third to##3##3##(1991-4#1)(2005-10#1)(2008-2#1)
one third##82##2##(1990-12#1)(1990-3#1)(1990-8#2)(1990-9#1)(1991-10#2)(1991-4#1)(1991-7#1)(1992-3#1)(1993-10#1)(1993-6#1)(1994-2#1)(1995-9#1)(1996-11#1)(1996-8#1)(1997-2#1)(1997-4#3)(1997-5#1)(2005-10#2)(2005-11#2)(2006-1#2)(2006-10#2)(2006-12#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#4)(2008-1#2)(2008-10#3)(2008-12#2)(2008-2#3)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-3#2)(2010-11#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-3#2)(2013-1#4)
one thousand##7##2##(2007-7#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#2)(2012-2#1)
one through##2##2##(1992-10#1)(1997-5#1)
one tight##2##2##(1992-6#1)(1994-8#1)
one time per day for 3 days)##3##7##(1993-3#3)
one time##20##2##(1990-10#1)(1993-3#3)(1993-9#1)(1994-4#1)(1995-10#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)
one to calculate the##2##4##(2007-12#1)(2008-3#1)
one to conclude that##2##4##(1995-3#1)(2013-7#1)
one to conclude##4##3##(1995-3#1)(2008-10#1)(2008-11#1)(2013-7#1)
one to consider##2##3##(2006-10#1)(2008-2#1)
one to control##3##3##(2007-12#1)(2008-2#1)(2008-4#1)
one to derive##2##3##(2008-3#1)(2008-6#1)
one to detect##2##3##(2008-10#1)(2008-9#1)
one to determine the##2##4##(2008-10#1)(2008-9#1)
one to determine##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)
one to differentiate##2##3##(1997-2#1)(2013-1#1)
one to distinguish##3##3##(2007-12#1)(2008-4#1)(2008-9#1)
one to effectively##2##3##(2008-11#1)(2008-4#1)
one to estimate the##3##4##(2007-8#1)(2008-3#1)(2009-8#1)
one to estimate##4##3##(2007-8#1)(2008-2#1)(2008-3#1)(2009-8#1)
one to evaluate##2##3##(2008-10#2)
one to five years##2##4##(1995-7#1)(2012-12#1)
one to five##6##3##(1995-7#1)(2007-10#1)(2008-10#3)(2012-12#1)
one to four##6##3##(2006-4#1)(2008-10#3)(2008-9#1)(2012-12#1)
one to measure the##4##4##(2007-11#2)(2008-2#1)(2010-7#1)
one to measure##6##3##(2007-11#2)(2007-12#1)(2008-2#2)(2010-7#1)
one to monitor##3##3##(2008-1#1)(2008-2#1)(2008-9#1)
one to obtain a##2##4##(2008-2#1)(2008-3#1)
one to obtain##5##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
one to one##2##3##(1994-9#1)(2010-5#1)
one to overcome the##2##4##(2007-12#1)(2008-3#1)
one to perform##2##3##(2008-10#1)(2008-11#1)
one to phenotype##2##3##(2008-10#2)
one to reduce the##2##4##(2008-10#1)(2008-2#1)
one to resolve##2##3##(2008-2#1)(2008-3#1)
one to retrieve##3##3##(2008-3#3)
one to six##3##3##(2005-10#1)(2008-10#2)
one to solve##2##3##(2008-3#1)(2008-7#1)
one to study##2##3##(2008-2#1)(2012-3#1)
one to the##3##3##(2007-12#1)(2009-1#1)(2011-1#1)
one to three months##2##4##(2011-1#1)(2012-2#1)
one to three years earlier##2##5##(2006-10#2)
one to three years##4##4##(1990-12#1)(2006-10#2)(2007-7#1)
one to three##19##3##(1990-12#1)(1991-4#1)(1995-12#1)(1997-8#1)(2004-11#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-7#3)(2008-1#1)(2008-10#2)(2008-4#2)(2011-1#1)(2012-2#1)
one to two years##4##4##(1992-11#1)(2005-9#1)(2006-10#1)(2007-1#1)
one to two##12##3##(1992-11#1)(1993-12#1)(1995-1#1)(1995-11#1)(1996-2#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-2#1)(2007-1#1)(2008-11#1)(2008-8#1)
one to use a##2##4##(2006-10#1)(2008-3#1)
one to use##3##3##(2006-10#1)(2008-3#1)(2013-1#1)
one to##216##2##(1990-11#1)(1990-12#2)(1991-4#1)(1991-5#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#2)(1995-7#1)(1995-8#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#3)(1997-2#1)(1997-4#3)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-4#3)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#19)(2007-7#7)(2007-8#2)(2007-9#2)(2008-1#7)(2008-10#29)(2008-11#5)(2008-12#1)(2008-2#20)(2008-3#23)(2008-4#9)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#7)(2009-1#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
one told##2##2##(2009-10#1)(2011-2#1)
one tomato##2##2##(2008-10#1)(2013-8#1)
one tool in the##2##4##(2008-10#1)(2010-11#1)
one tool in##3##3##(1995-12#1)(2008-10#1)(2010-11#1)
one training##2##2##(1996-3#1)(2009-4#1)
one trait##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
one transgenic##2##2##(1990-11#1)(2011-2#1)
one transient##2##2##(1990-11#1)(2006-11#1)
one transverse##4##2##(2007-11#2)(2007-12#2)
one treatment modality##2##3##(2007-12#1)(2008-3#1)
one treatment##10##2##(1992-5#1)(1993-5#1)(1995-2#1)(2006-6#1)(2007-12#2)(2008-3#1)(2008-7#1)(2012-12#2)
one trial learning##2##3##(1991-1#1)(1994-8#1)
one trial per day##2##4##(1990-7#1)(1994-6#1)
one trial##10##2##(1990-1#1)(1990-7#1)(1991-1#1)(1994-6#1)(1994-8#1)(2004-1#1)(2008-10#1)(2008-5#1)(2009-6#1)(2013-8#1)
one tumor##3##2##(1990-2#1)(1995-1#1)(1995-5#1)
one twentieth of##2##3##(1990-2#1)(1993-6#1)
one twin##3##2##(1992-12#1)(2008-9#1)(2012-2#1)
one type of effect##2##4##(1991-1#2)
one type of##27##3##(1990-5#1)(1991-1#2)(1991-9#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-3#2)(1993-9#1)(2005-9#1)(2007-12#3)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#2)(2008-7#1)(2010-5#1)(2012-12#1)(2013-7#1)(2013-8#1)
one type##31##2##(1990-5#1)(1991-1#2)(1991-9#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-8#1)(2005-9#1)(2007-12#4)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#2)(2008-7#1)(2010-5#1)(2012-12#1)(2013-7#1)(2013-8#1)
one typical##3##2##(1996-12#1)(2008-5#1)(2011-1#1)
one tyrosine##3##2##(1991-12#1)(1991-4#1)(1995-3#1)
one under the##2##3##(2007-3#1)(2008-7#1)
one underwent##2##2##(2007-8#1)(2008-9#1)
one unique##4##2##(1994-12#1)(1994-5#1)(2008-4#1)(2008-9#1)
one unit##2##2##(1993-3#1)(2007-9#1)
one university in##2##3##(2008-11#1)(2008-12#1)
one university##4##2##(2008-11#2)(2008-12#2)
one ureter##2##2##(1996-3#1)(2008-10#1)
one used##5##2##(1990-8#1)(1992-1#1)(2009-12#1)(2010-2#1)(2013-7#1)
one uses##6##2##(2008-2#4)(2008-3#2)
one using the##2##3##(2007-8#1)(2008-9#1)
one using##8##2##(1990-2#1)(1993-9#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-9#1)(2010-1#1)
one vector##2##2##(1993-12#1)(2007-12#1)
one versus##2##2##(2009-3#1)(2013-1#1)
one very##2##2##(2012-12#1)(2013-1#1)
one vessel##3##2##(1994-11#1)(2006-11#1)(2007-8#1)
one via##2##2##(2008-5#1)(2011-1#1)
one view##2##2##(1990-12#1)(2004-2#1)
one vineyard##3##2##(2008-10#3)
one virulence##2##2##(2013-8#2)
one virus##3##2##(2008-10#3)
one was a##3##3##(1991-10#1)(2006-10#1)(2008-5#1)
one was associated with##2##4##(2008-10#1)(2008-11#1)
one was due to##2##4##(2007-8#2)
one was managed##2##3##(2007-3#1)(2008-3#1)
one was not##3##3##(2006-10#1)(2007-8#1)(2008-4#1)
one was treated with##2##4##(1997-6#1)(2006-4#1)
one was##70##2##(1990-3#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-4#1)(1992-11#2)(1992-12#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-12#1)(1995-8#1)(1996-10#1)(1997-3#1)(1997-4#1)(1997-6#1)(2004-11#1)(2005-12#1)(2006-10#3)(2006-4#1)(2006-6#2)(2007-1#2)(2007-2#4)(2007-3#1)(2007-8#4)(2008-1#2)(2008-10#4)(2008-11#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-7#1)(2013-8#2)
one water ligand##2##3##(2006-3#2)
one water##4##2##(2006-3#2)(2008-5#1)(2011-2#1)
one wavelength are##2##3##(2008-2#1)(2008-3#1)
one wavelength##8##2##(2007-12#1)(2008-2#2)(2008-3#5)
one way ANOVA##2##3##(2010-3#1)(2013-8#1)
one way in which##3##4##(2005-5#1)(2007-2#1)(2011-1#1)
one way of##6##3##(2006-2#1)(2007-12#1)(2008-2#1)(2009-4#1)(2010-10#1)(2012-3#1)
one way to##11##3##(1994-12#1)(1994-2#1)(1997-2#1)(2005-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2007-11#1)(2009-11#1)(2013-1#2)
one way##30##2##(1992-2#1)(1992-5#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1997-2#1)(2005-11#1)(2005-5#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-2#1)(2009-11#1)(2009-4#1)(2010-10#1)(2010-3#1)(2011-1#2)(2012-3#1)(2013-1#2)(2013-8#1)
one we##2##2##(2007-11#1)(2008-2#1)
one week after the operation##3##5##(2011-2#1)(2013-1#2)
one week after the##6##4##(1992-2#1)(2008-4#1)(2011-1#1)(2011-2#1)(2013-1#2)
one week after##16##3##(1991-2#1)(1992-2#1)(1994-2#1)(1996-9#1)(2006-2#1)(2007-10#1)(2007-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#2)(2013-1#3)
one week and##2##3##(1991-9#1)(2007-10#1)
one week before##7##3##(1996-9#1)(2007-3#1)(2008-5#1)(2008-8#1)(2010-12#2)(2011-2#1)
one week later##3##3##(1993-3#1)(2007-6#1)(2013-1#1)
one week of##7##3##(1992-4#1)(1994-12#1)(2007-10#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-1#1)
one week period##2##3##(2008-7#1)(2011-1#1)
one week##73##2##(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-2#1)(1992-4#1)(1993-10#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-2#2)(1996-3#1)(1996-9#3)(1997-6#2)(2004-9#2)(2005-3#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-10#4)(2007-12#1)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2010-10#1)(2010-12#3)(2010-5#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-2#1)(2013-1#6)(2013-8#2)
one well-defined##3##2##(2008-10#3)
one were##5##2##(1996-2#1)(1996-8#1)(2007-2#1)(2008-1#1)(2008-10#1)
one where##6##2##(1997-4#1)(1997-7#1)(2006-1#1)(2008-12#1)(2008-7#1)(2010-10#1)
one which can##4##3##(1991-11#1)(1996-7#1)(1997-7#1)(2008-7#1)
one which inhibits##2##3##(1995-6#2)
one which is##4##3##(1991-3#1)(1991-7#1)(1992-1#1)(2008-11#1)
one which##27##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-7#2)(1992-1#1)(1993-1#1)(1994-10#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-6#3)(1996-7#1)(1997-2#1)(1997-7#1)(2005-7#1)(2007-11#1)(2008-11#1)(2008-7#2)(2011-2#1)(2013-1#1)
one who underwent##2##3##(2006-11#1)(2006-12#1)
one who##11##2##(1994-1#1)(1996-2#1)(2006-11#1)(2006-12#1)(2007-2#1)(2007-3#2)(2008-6#1)(2009-6#1)(2011-1#1)(2011-2#1)
one will##2##2##(1994-12#1)(2009-10#1)
one window##2##2##(2008-4#1)(2012-2#1)
one wishes to##2##3##(1997-2#1)(2012-3#1)
one wishes##3##2##(1997-2#1)(2006-8#1)(2012-3#1)
one with a wide##2##4##(1990-12#1)(2008-10#1)
one with a##18##3##(1990-12#1)(1991-4#1)(1992-1#1)(1992-5#1)(1996-12#1)(2006-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#2)(2011-2#1)(2012-1#2)(2013-1#2)
one with acute##2##3##(2008-5#1)(2008-7#1)
one with an##3##3##(1990-5#1)(1997-8#1)(2006-10#1)
one with high##2##3##(1990-3#1)(2008-4#1)
one with respect to##2##4##(1996-8#1)(2008-3#1)
one with simple##2##3##(1993-8#1)(1996-2#1)
one with the##11##3##(1990-3#1)(1993-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-7#2)(2013-8#1)
one with##99##2##(1990-12#1)(1990-3#2)(1990-5#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-4#1)(1992-1#1)(1992-5#1)(1993-11#1)(1993-8#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-12#2)(1996-2#1)(1996-8#1)(1997-6#1)(1997-8#1)(2006-10#7)(2006-12#1)(2006-2#1)(2006-3#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#4)(2008-7#5)(2008-9#4)(2009-10#1)(2009-6#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#1)
one without any##2##3##(1990-3#1)(1993-12#1)
one without##8##2##(1990-3#1)(1993-12#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2013-7#1)
one woman##6##2##(1990-6#1)(1994-4#1)(1995-1#1)(2007-2#1)(2009-5#1)(2013-8#1)
one working##2##2##(2008-2#1)(2009-10#1)
one would expect##4##3##(1990-4#1)(1995-12#1)(1997-8#1)(2008-11#1)
one would##7##2##(1990-4#1)(1992-2#1)(1995-12#1)(1995-2#1)(1997-8#1)(2007-4#1)(2008-11#1)
one year after a##3##4##(2007-10#2)(2012-12#1)
one year after the operation##3##5##(1993-2#1)(2007-7#1)(2007-8#1)
one year after the##17##4##(1993-2#1)(1993-9#1)(1995-4#1)(1996-6#1)(2006-1#1)(2006-2#1)(2006-4#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-5#1)(2008-9#1)(2013-1#3)
one year after##41##3##(1990-10#1)(1991-8#1)(1992-10#1)(1992-4#1)(1993-2#1)(1993-9#1)(1995-10#1)(1995-2#1)(1995-4#1)(1996-6#1)(1996-8#1)(1997-6#1)(2004-1#2)(2006-1#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-7#2)(2007-8#2)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#4)
one year ago##3##3##(1993-3#1)(2007-7#1)(2007-8#1)
one year and##15##3##(1990-12#1)(1990-9#1)(1993-9#1)(1994-7#1)(2006-7#1)(2008-1#2)(2008-8#1)(2009-12#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
one year apart##2##3##(2008-3#1)(2008-7#1)
one year at##4##3##(1997-6#1)(2006-8#1)(2007-8#1)(2008-1#1)
one year by##2##3##(1992-3#1)(1995-11#1)
one year follow up##6##4##(1991-2#1)(2006-8#1)(2007-2#1)(2007-8#1)(2013-1#2)
one year follow-up##4##3##(2009-7#1)(2013-1#1)(2013-8#2)
one year from the##2##4##(1990-7#1)(2007-11#1)
one year from##5##3##(1990-7#1)(1993-5#1)(2007-11#1)(2007-3#1)(2013-8#1)
one year in a##2##4##(2007-10#1)(2008-3#1)
one year in the##2##4##(1993-12#1)(1994-7#1)
one year in##9##3##(1991-11#1)(1993-12#1)(1994-12#1)(1994-7#1)(1997-5#1)(2007-10#1)(2007-4#1)(2008-10#1)(2008-3#1)
one year later##10##3##(1993-7#1)(2006-7#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2012-12#1)
one year of age##5##4##(1991-11#1)(1991-6#2)(1993-5#1)(2009-4#1)
one year of follow-up##2##4##(2008-8#1)(2013-1#1)
one year of##21##3##(1991-11#2)(1991-2#1)(1991-6#2)(1993-5#1)(1993-9#1)(1996-1#1)(2004-9#1)(2006-6#1)(2006-8#2)(2007-7#1)(2008-8#1)(2009-4#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
one year old##2##3##(2013-8#2)
one year on##3##3##(2005-10#1)(2009-5#1)(2009-7#1)
one year or more##2##4##(2007-11#1)(2008-9#1)
one year or##3##3##(1994-3#1)(2007-11#1)(2008-9#1)
one year period##9##3##(1996-2#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-12#1)(2009-10#1)(2010-7#1)(2011-2#1)(2012-2#1)
one year quality of life improvement##2##6##(2006-8#2)
one year since##2##3##(2006-8#1)(2011-2#1)
one year six##2##3##(2006-10#2)
one year the##3##3##(1991-4#1)(2008-6#1)(2012-12#1)
one year was##7##3##(1994-5#1)(1996-6#1)(2007-2#1)(2008-10#1)(2008-2#1)(2010-8#2)
one year were##6##3##(1990-11#1)(1994-8#1)(2007-12#1)(2008-1#1)(2008-11#1)(2012-12#1)
one year with##3##3##(1994-2#1)(1994-3#1)(2011-1#1)
one year##283##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#4)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#4)(1991-8#1)(1991-9#2)(1992-10#1)(1992-3#1)(1992-4#1)(1992-5#2)(1993-1#1)(1993-12#1)(1993-2#5)(1993-3#1)(1993-5#3)(1993-7#1)(1993-8#2)(1993-9#3)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#1)(1994-7#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-4#1)(1996-1#2)(1996-2#1)(1996-6#2)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#2)(2004-1#2)(2004-9#1)(2005-10#1)(2005-12#1)(2006-1#1)(2006-10#5)(2006-2#1)(2006-4#2)(2006-6#2)(2006-7#3)(2006-8#10)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#3)(2007-2#3)(2007-3#4)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#11)(2007-8#9)(2008-1#6)(2008-10#6)(2008-11#6)(2008-12#4)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#5)(2008-7#3)(2008-8#3)(2008-9#4)(2009-10#5)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#2)(2010-8#7)(2011-1#4)(2011-12#1)(2011-2#7)(2012-12#9)(2012-2#3)(2012-3#6)(2013-1#21)(2013-8#11)
one year's experience##2##3##(1990-11#1)(1996-6#1)
one year's treatment##4##3##(1995-3#2)(2006-6#2)
one year's##6##2##(1990-11#1)(1995-3#2)(1996-6#1)(2006-6#2)
one year]##2##2##(1991-11#1)(1993-5#1)
one young##2##2##(1992-12#1)(2011-1#1)
one##11379##1##(1990-1#3)(1990-10#27)(1990-11#47)(1990-12#63)(1990-2#41)(1990-3#32)(1990-4#29)(1990-5#48)(1990-6#24)(1990-7#38)(1990-8#60)(1990-9#29)(1991-1#21)(1991-10#19)(1991-11#25)(1991-12#43)(1991-2#48)(1991-3#38)(1991-4#38)(1991-5#27)(1991-6#27)(1991-7#29)(1991-8#36)(1991-9#56)(1992-1#34)(1992-10#27)(1992-11#31)(1992-12#47)(1992-2#42)(1992-3#43)(1992-4#20)(1992-5#30)(1992-6#47)(1992-7#15)(1992-8#44)(1992-9#37)(1993-1#12)(1993-10#13)(1993-11#37)(1993-12#47)(1993-2#49)(1993-3#60)(1993-4#11)(1993-5#21)(1993-6#43)(1993-7#18)(1993-8#40)(1993-9#36)(1994-1#8)(1994-10#5)(1994-11#47)(1994-12#62)(1994-2#48)(1994-3#63)(1994-4#8)(1994-5#27)(1994-6#47)(1994-7#13)(1994-8#57)(1994-9#66)(1995-1#39)(1995-10#24)(1995-11#30)(1995-12#42)(1995-2#50)(1995-3#72)(1995-4#20)(1995-5#39)(1995-6#41)(1995-7#7)(1995-8#46)(1995-9#16)(1996-1#23)(1996-10#25)(1996-11#34)(1996-12#52)(1996-2#57)(1996-3#49)(1996-4#23)(1996-5#39)(1996-6#35)(1996-7#38)(1996-8#40)(1996-9#36)(1997-1#30)(1997-2#71)(1997-3#56)(1997-4#64)(1997-5#28)(1997-6#47)(1997-7#46)(1997-8#50)(1997-9#2)(2003-11#4)(2004-1#6)(2004-10#5)(2004-11#14)(2004-12#7)(2004-2#10)(2004-3#2)(2004-4#6)(2004-8#4)(2004-9#14)(2005-1#10)(2005-10#30)(2005-11#73)(2005-12#18)(2005-3#3)(2005-4#4)(2005-5#5)(2005-6#1)(2005-7#21)(2005-8#25)(2005-9#11)(2006-1#13)(2006-10#170)(2006-11#35)(2006-12#103)(2006-2#31)(2006-3#17)(2006-4#30)(2006-5#34)(2006-6#59)(2006-7#41)(2006-8#91)(2006-9#23)(2007-1#33)(2007-10#48)(2007-11#172)(2007-12#285)(2007-2#97)(2007-3#61)(2007-4#31)(2007-5#41)(2007-6#35)(2007-7#184)(2007-8#196)(2007-9#76)(2008-1#175)(2008-10#1005)(2008-11#239)(2008-12#120)(2008-2#317)(2008-3#315)(2008-4#201)(2008-5#288)(2008-6#121)(2008-7#243)(2008-8#214)(2008-9#203)(2009-1#5)(2009-10#44)(2009-11#18)(2009-12#23)(2009-2#43)(2009-3#36)(2009-4#46)(2009-5#44)(2009-6#33)(2009-7#23)(2009-8#47)(2009-9#35)(2010-1#14)(2010-10#33)(2010-11#28)(2010-12#83)(2010-2#62)(2010-3#26)(2010-4#52)(2010-5#32)(2010-6#15)(2010-7#36)(2010-8#56)(2010-9#26)(2011-1#130)(2011-10#3)(2011-11#1)(2011-12#36)(2011-2#289)(2011-3#8)(2012-1#53)(2012-10#1)(2012-11#29)(2012-12#165)(2012-2#170)(2012-3#114)(2012-8#2)(2012-9#1)(2013-1#287)(2013-7#64)(2013-8#172)
one&quot##2##1##(2007-5#1)(2012-3#1)
one's ability to##3##3##(1990-8#1)(2009-4#1)(2012-1#1)
one's appearance##2##2##(2006-7#1)(2007-12#1)
one's body##2##2##(2006-2#1)(2007-12#1)
one's current##3##2##(2007-7#1)(2008-5#1)(2010-8#1)
one's health##2##2##(2009-5#2)
one's life##3##2##(2006-2#1)(2008-7#1)(2013-1#1)
one's own body##2##3##(2006-2#1)(2013-1#1)
one's own institution##2##3##(2009-4#2)
one's own##26##2##(1992-11#1)(1992-3#2)(1993-12#1)(1995-5#1)(1997-8#1)(2005-11#1)(2005-12#1)(2006-2#1)(2006-7#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#2)(2009-4#3)(2009-9#1)(2010-10#1)(2010-2#1)(2013-1#2)
one's professional career##2##3##(2007-4#1)(2008-12#1)
one's professional##3##2##(2007-2#1)(2007-4#1)(2008-12#1)
one's##103##1##(1990-8#1)(1990-9#1)(1991-2#2)(1992-11#1)(1992-3#2)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-5#1)(1995-9#2)(1996-5#1)(1997-8#1)(2005-11#1)(2005-12#1)(2006-2#3)(2006-7#2)(2007-11#1)(2007-12#4)(2007-2#5)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-4#4)(2009-5#3)(2009-6#1)(2009-9#2)(2010-10#1)(2010-2#3)(2010-6#1)(2010-8#3)(2010-9#2)(2011-2#1)(2012-1#2)(2012-2#3)(2012-3#2)(2013-1#4)
one) and##2##2##(2006-7#1)(2012-2#1)
one) were##2##2##(1993-11#1)(1995-11#1)
one)##22##1##(1990-2#1)(1990-8#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-7#1)(1995-11#1)(2006-7#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-2#1)(2008-5#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
one- and two-dimensional 1H NMR##2##5##(1995-2#1)(1995-3#1)
one- and two-dimensional 1H##3##4##(1995-11#1)(1995-2#1)(1995-3#1)
one- and two-dimensional gel electrophoresis##2##5##(1995-11#2)
one- and two-dimensional##17##3##(1990-7#1)(1991-2#1)(1995-11#3)(1995-2#1)(1995-3#1)(2006-12#2)(2007-1#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#1)
one- and two-photon excitation##3##4##(1996-11#3)
one- and two-photon##4##3##(1996-11#4)
one- and two-stage##2##3##(2006-2#1)(2010-4#1)
one- and two-year##2##3##(2007-11#1)(2012-1#1)
one- and##29##2##(1990-7#1)(1991-2#1)(1995-11#3)(1995-2#1)(1995-3#1)(1995-5#1)(1996-11#4)(1996-8#1)(2006-12#2)(2006-2#1)(2007-1#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)(2010-4#1)(2012-1#1)
one- or two-dimensional gel electrophoresis##2##5##(1993-8#1)(2008-9#1)
one- or two-dimensional##6##3##(1993-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)
one- or##8##2##(1993-8#1)(1996-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
one-##39##1##(1990-7#1)(1991-2#1)(1993-8#1)(1995-11#3)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#4)(1996-8#1)(2006-12#2)(2006-2#1)(2007-1#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#4)(2008-4#2)(2008-8#1)(2008-9#1)(2010-4#1)(2012-1#1)(2012-2#1)
one-arm##3##1##(1991-5#2)(2007-11#1)
one-base deletions##2##2##(1993-3#2)
one-base##3##1##(1993-2#1)(1993-3#2)
one-beam cross-correlation##3##2##(2008-2#1)(2008-3#2)
one-beam interferometer with##2##3##(2007-12#2)
one-beam pumping##2##2##(2007-12#2)
one-beam##10##1##(2007-12#6)(2008-2#1)(2008-3#3)
one-body##3##1##(2012-1#3)
one-bottle dentine bonding systems##2##4##(2006-8#2)
one-carbon donor##2##2##(1992-10#2)
one-carbon##8##1##(1992-10#2)(2006-8#1)(2007-11#1)(2009-12#1)(2011-2#2)(2012-2#1)
one-channel##4##1##(2008-3#1)(2008-9#3)
one-color laser##2##2##(2008-3#2)
one-color##5##1##(2007-12#1)(2008-2#1)(2008-3#3)
one-day##14##1##(1991-10#1)(1994-7#1)(1994-9#1)(2004-12#1)(2005-8#1)(2007-2#3)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2012-12#1)
one-day-old##4##1##(1994-5#1)(2008-5#2)(2013-8#1)
one-dimensional (1-D)##4##2##(2008-2#1)(2008-3#3)
one-dimensional (1D)##3##2##(1996-2#1)(2006-12#1)(2008-7#1)
one-dimensional Fourier##2##2##(2007-12#1)(2008-2#1)
one-dimensional and two-dimensional##4##3##(2008-1#3)(2010-11#1)
one-dimensional coherent imaging through##2##4##(2008-1#2)
one-dimensional gratings##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
one-dimensional model with##2##3##(1993-6#1)(1996-4#1)
one-dimensional model##5##2##(1993-6#1)(1996-4#1)(2008-3#3)
one-dimensional nanostructures##2##2##(2006-12#1)(2010-4#1)
one-dimensional objects is presented##2##4##(2007-12#1)(2008-2#1)
one-dimensional objects##3##2##(2007-12#1)(2008-2#1)(2008-6#1)
one-dimensional optical##3##2##(1993-8#1)(2007-12#1)(2011-2#1)
one-dimensional photonic bandgap##4##3##(2007-11#1)(2007-12#3)
one-dimensional photonic crystal##3##3##(2007-12#3)
one-dimensional photonic##9##2##(2007-11#2)(2007-12#6)(2008-3#1)
one-dimensional profilometer##2##2##(2008-3#2)
one-dimensional quadratic solitons##2##3##(2008-1#2)
one-dimensional radiative transfer##2##3##(2008-3#2)
one-dimensional random##2##2##(2007-12#2)
one-dimensional rough perfectly reflecting##2##4##(2007-12#2)
one-dimensional sample##3##2##(2007-12#3)
one-dimensional space##2##2##(2007-12#1)(2013-8#1)
one-dimensional spatial##3##2##(2007-12#2)(2008-3#1)
one-dimensional thin-layer##2##2##(1990-11#1)(2008-4#1)
one-dimensional wavelet##3##2##(2008-10#2)(2008-2#1)
one-dimensional##201##1##(1990-11#2)(1990-4#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#2)(1993-5#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-7#1)(1996-2#1)(1996-4#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-12#2)(2006-5#1)(2007-11#10)(2007-12#51)(2007-3#1)(2007-9#1)(2008-1#8)(2008-10#7)(2008-11#2)(2008-2#30)(2008-3#44)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#1)(2010-11#1)(2010-12#2)(2010-4#3)(2010-5#2)(2010-7#1)(2011-2#1)(2013-8#1)
one-dimensionally##2##1##(2007-12#1)(2008-10#1)
one-disulfide bond species##2##3##(1992-6#2)
one-disulfide bond##3##2##(1992-6#3)
one-electron oxidation of##2##3##(1990-2#1)(2006-3#1)
one-electron oxidation##7##2##(1990-2#1)(1996-5#1)(2006-3#5)
one-electron reduced to the##2##4##(2008-10#2)
one-electron reduction in##2##3##(1995-6#2)
one-electron reduction of##4##3##(1994-8#2)(1994-9#1)(1997-4#1)
one-electron reduction##9##2##(1994-5#1)(1994-8#2)(1994-9#1)(1995-6#3)(1997-4#1)(1997-8#1)
one-electron transfer##2##2##(2006-10#2)
one-electron##27##1##(1990-2#2)(1993-8#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-6#3)(1996-5#1)(1996-6#1)(1997-4#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-3#6)(2008-10#3)
one-fifth of the##5##3##(1992-1#1)(1994-3#1)(2007-11#1)(2008-3#1)(2008-7#1)
one-fifth of##11##2##(1990-2#1)(1992-1#1)(1993-1#1)(1994-11#1)(1994-3#1)(1996-11#1)(2007-11#1)(2008-3#2)(2008-7#1)(2010-2#1)
one-fifth##17##1##(1990-2#1)(1990-3#1)(1992-1#1)(1992-12#1)(1993-1#1)(1994-11#1)(1994-3#1)(1996-11#1)(2005-10#2)(2007-11#1)(2008-3#2)(2008-7#1)(2010-2#1)(2011-12#1)(2012-1#1)
one-fourth of the##4##3##(1997-1#1)(2008-10#1)(2008-3#1)(2008-8#1)
one-fourth of##8##2##(1990-5#1)(1997-1#1)(2006-6#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-12#1)
one-fourth##11##1##(1990-3#1)(1990-5#1)(1994-9#1)(1997-1#1)(1997-4#1)(2006-6#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-12#1)
one-frequency##2##1##(2008-10#2)
one-group##2##1##(1996-3#1)(2011-1#1)
one-half and one-third##2##3##(1997-7#1)(2009-10#1)
one-half hour##2##2##(1991-12#1)(2011-12#1)
one-half of all##2##3##(2009-7#1)(2010-8#1)
one-half of the##11##3##(1990-12#1)(1991-1#1)(1994-12#1)(1994-9#1)(1995-3#1)(2007-2#1)(2008-10#1)(2008-8#1)(2012-2#1)(2013-1#2)
one-half of##21##2##(1990-12#1)(1991-1#2)(1991-2#1)(1992-1#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-3#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#2)
one-half the##5##2##(1990-8#1)(1992-5#1)(1994-11#1)(1994-5#1)(1995-5#1)
one-half##43##1##(1990-12#1)(1990-8#1)(1991-1#2)(1991-12#1)(1991-2#1)(1992-1#2)(1992-5#1)(1993-3#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-1#1)(1997-7#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-12#1)(2012-2#2)(2013-1#2)
one-hour##3##1##(2008-10#1)(2008-12#1)(2012-1#1)
one-hybrid##7##1##(1997-4#1)(2008-2#2)(2008-8#1)(2008-9#3)
one-layer SIS##2##2##(2008-5#2)
one-layer##7##1##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#3)
one-level##3##1##(2007-11#2)(2010-4#1)
one-lung ventilation##9##2##(2006-10#7)(2011-2#2)
one-memory-matrix fuzzy associative memory##2##4##(2007-12#2)
one-month postpartum##2##2##(2007-10#2)
one-month##11##1##(2006-6#1)(2007-10#2)(2007-8#1)(2008-3#1)(2008-5#1)(2011-3#1)(2013-1#3)(2013-8#1)
one-month-old infant with##2##3##(2008-11#1)(2011-1#1)
one-night##2##1##(2005-11#1)(2006-7#1)
one-on-one##2##1##(1997-2#1)(2008-2#1)
one-page##2##1##(2006-10#1)(2007-12#1)
one-phase##2##1##(1990-2#1)(2005-11#1)
one-photon and two-photon excitation##2##4##(1996-11#1)(2008-3#1)
one-photon and two-photon##3##3##(1996-11#1)(2008-3#2)
one-photon excitation##2##2##(1996-11#1)(2011-1#1)
one-photon##14##1##(1996-11#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#6)(2011-1#1)
one-point##2##1##(2008-10#1)(2008-2#1)
one-pot reaction##4##2##(2007-11#4)
one-pot synthesis of##6##3##(1991-12#1)(1997-2#1)(2005-8#1)(2007-11#2)(2012-2#1)
one-pot synthesis##8##2##(1991-12#1)(1997-2#1)(1997-3#1)(2005-8#1)(2007-11#2)(2012-2#1)(2012-3#1)
one-pot tandem##2##2##(2009-12#1)(2012-3#1)
one-pot##32##1##(1991-12#1)(1996-5#2)(1997-2#1)(1997-3#2)(2005-8#1)(2007-11#8)(2008-10#3)(2008-11#2)(2008-3#1)(2009-12#1)(2009-2#1)(2009-3#1)(2010-2#1)(2010-5#1)(2011-3#1)(2012-2#1)(2012-3#4)
one-quarter of the##4##3##(1996-1#1)(2007-11#1)(2008-9#1)(2010-12#1)
one-quarter of##10##2##(1995-11#1)(1996-1#1)(1997-8#1)(2007-11#1)(2008-5#1)(2008-9#1)(2010-12#2)(2010-3#1)(2010-9#1)
one-quarter##12##1##(1994-8#1)(1995-11#1)(1996-1#1)(1997-8#1)(2007-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-12#2)(2010-3#1)(2010-9#1)
one-shot cases##3##2##(1993-1#3)
one-shot sensor##4##2##(2008-10#4)
one-shot##9##1##(1993-1#3)(2007-8#1)(2008-10#5)
one-sided equivalence##2##2##(1995-8#2)
one-sided test##2##2##(1992-6#1)(1995-4#1)
one-sided##22##1##(1992-6#1)(1993-6#1)(1995-4#6)(1995-6#1)(1995-8#2)(1996-8#1)(1997-1#1)(2006-12#2)(2008-4#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
one-site##3##1##(1995-11#1)(2009-8#1)(2013-8#1)
one-sixth##3##1##(2004-9#2)(2013-1#1)
one-stage approach##2##2##(2008-3#1)(2009-5#1)
one-stage model##2##2##(2010-2#2)
one-stage reconstruction##2##2##(2007-8#1)(2008-1#1)
one-stage repair##2##2##(2009-5#2)
one-stage##22##1##(1994-3#1)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-5#4)(2010-2#2)(2012-1#1)(2013-8#1)
one-step RT-PCR##5##2##(2008-9#1)(2013-8#4)
one-step liquid-liquid extraction##2##3##(1990-11#1)(1996-5#1)
one-step method##4##2##(1990-11#1)(1997-2#1)(2008-3#2)
one-step nonphotolithographic fabrication technique##2##4##(2007-12#1)(2008-2#1)
one-step procedure##7##2##(1991-11#1)(1994-3#1)(1995-2#1)(2006-5#1)(2007-8#2)(2008-10#1)
one-step process##5##2##(1995-5#1)(2008-3#2)(2009-11#1)(2013-1#1)
one-step protein##2##2##(2008-4#1)(2011-2#1)
one-step purification##2##2##(1992-11#1)(1993-6#1)
one-step sandwich enzyme immunoassay (EIA)##4##5##(1993-11#1)(1995-1#1)(1996-1#2)
one-step sandwich enzyme immunoassay##7##4##(1993-11#2)(1995-1#1)(1996-1#4)
one-step sandwich##8##2##(1991-10#1)(1993-11#2)(1995-1#1)(1996-1#4)
one-step##98##1##(1990-11#2)(1990-12#1)(1991-10#1)(1991-11#1)(1991-2#1)(1992-11#1)(1993-11#2)(1993-6#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#2)(1995-5#1)(1996-1#4)(1996-12#1)(1996-5#1)(1997-2#2)(2004-9#1)(2005-11#2)(2005-8#2)(2006-10#2)(2006-5#4)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#2)(2007-9#1)(2008-10#8)(2008-11#1)(2008-2#7)(2008-3#12)(2008-4#5)(2008-5#2)(2008-7#1)(2008-9#2)(2009-11#1)(2009-3#1)(2009-7#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#5)
one-stop shopping##4##2##(1990-12#1)(1996-1#1)(1997-3#2)
one-stop##5##1##(1990-12#1)(1996-1#1)(1997-3#3)
one-tailed##3##1##(1995-9#1)(2012-2#1)(2013-8#1)
one-tenth of##4##2##(1990-3#1)(1997-3#1)(2008-5#1)(2010-6#1)
one-tenth the##3##2##(1993-5#1)(2008-10#1)(2008-6#1)
one-tenth##7##1##(1990-3#1)(1993-5#1)(1997-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-6#1)
one-third and##2##2##(2008-6#1)(2009-10#1)
one-third of all patients##2##4##(2007-5#1)(2008-11#1)
one-third of all##3##3##(1995-1#1)(2007-5#1)(2008-11#1)
one-third of cases of##2##4##(2007-12#1)(2008-5#1)
one-third of cases##3##3##(2007-12#1)(2008-5#1)(2012-2#1)
one-third of patients with##2##4##(2006-12#1)(2009-9#1)
one-third of patients##6##3##(2006-12#1)(2009-6#2)(2009-9#1)(2010-12#1)(2012-12#1)
one-third of the total##2##4##(1992-3#1)(2008-12#1)
one-third of the##25##3##(1992-3#1)(1992-5#1)(1992-9#1)(1993-8#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-8#2)(2006-4#2)(2006-7#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-5#1)
one-third of##59##2##(1991-1#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-4#1)(1995-6#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#2)(2006-12#2)(2006-4#2)(2006-7#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-12#1)(2011-1#2)(2012-12#1)(2012-2#5)(2013-7#1)
one-third the##4##2##(1990-8#1)(2008-2#1)(2008-9#1)(2011-2#1)
one-third to one-half of##3##4##(2007-2#1)(2008-4#1)(2010-11#1)
one-third to##4##2##(1994-3#1)(2007-2#1)(2008-4#1)(2010-11#1)
one-third with##2##2##(2010-12#2)
one-third##95##1##(1990-11#1)(1990-2#1)(1990-8#1)(1991-1#1)(1992-3#1)(1992-5#2)(1992-9#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-4#1)(1995-6#1)(1996-2#1)(1996-4#2)(1996-9#2)(1997-2#2)(1997-4#2)(1997-7#2)(1997-8#2)(2004-10#1)(2005-10#1)(2005-12#1)(2006-12#2)(2006-4#2)(2006-5#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-2#3)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#2)(2009-4#2)(2009-5#1)(2009-6#2)(2009-9#1)(2010-11#1)(2010-12#3)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#5)(2013-7#1)
one-time##11##1##(1990-8#1)(1991-2#1)(2006-4#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#2)(2010-1#1)(2013-1#2)
one-to-one mappings##2##2##(2010-10#2)
one-to-one relationship##2##2##(1994-2#1)(2008-10#1)
one-to-one##12##1##(1994-2#1)(1996-12#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#3)(2008-3#1)(2010-10#2)
one-trial passive avoidance task##2##4##(1993-12#1)(2008-6#1)
one-trial passive avoidance##3##3##(1993-12#1)(2008-6#2)
one-trial##9##1##(1990-10#1)(1990-11#1)(1991-1#1)(1992-10#1)(1993-12#1)(1994-3#1)(2008-6#2)(2008-7#1)
one-tube##3##1##(1991-7#1)(2008-10#1)(2008-9#1)
one-twentieth of the##2##3##(1990-11#1)(2008-7#1)
one-twentieth##3##1##(1990-11#1)(1990-3#1)(2008-7#1)
one-way ANOVA##7##2##(2008-10#1)(2008-12#2)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
one-way analysis of variance##5##4##(1993-2#1)(1997-5#1)(2008-10#1)(2011-2#1)(2012-12#1)
one-way avoidance##4##2##(1996-10#4)
one-way##32##1##(1993-2#2)(1996-10#4)(1997-1#1)(1997-5#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#4)(2008-7#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#2)
one-week##6##1##(1997-7#1)(2008-11#1)(2008-2#1)(2009-5#1)(2011-3#2)
one-year follow up##2##3##(2007-7#1)(2010-8#1)
one-year follow-up##6##2##(1991-6#1)(2007-7#2)(2010-4#1)(2012-1#1)(2013-8#1)
one-year mortality##2##2##(2006-8#2)
one-year period##9##2##(1993-12#1)(1995-3#1)(1997-1#1)(2006-7#1)(2007-2#1)(2007-3#1)(2007-7#1)(2012-2#1)(2013-1#1)
one-year survival rate##2##3##(2007-11#2)
one-year survival##4##2##(1995-2#1)(2007-11#2)(2008-10#1)
one-year##47##1##(1990-11#1)(1990-2#1)(1991-6#1)(1993-12#1)(1993-7#2)(1995-2#1)(1995-3#1)(1995-9#1)(1996-9#1)(1997-1#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#4)(2007-8#1)(2008-10#2)(2008-4#3)(2010-12#2)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
one-year-old##10##1##(1991-8#1)(1993-1#2)(2006-11#1)(2007-4#1)(2008-8#1)(2009-2#3)(2009-8#1)
one?##4##1##(1990-10#1)(2006-5#1)(2008-3#1)(2013-8#1)
oneidensis Mr -1##2##3##(2011-1#2)
oneidensis##3##1##(2011-1#3)
onemacr##12##1##(1996-2#10)(1997-7#2)
onerous##4##1##(1994-2#1)(1996-5#1)(2007-8#1)(2007-9#1)
ones (e##2##2##(1993-3#1)(2012-12#1)
ones a##2##2##(2008-10#2)
ones and the##2##3##(1995-6#1)(2008-8#1)
ones and##12##2##(1995-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-1#1)(2013-1#1)
ones are##12##2##(1990-10#1)(1990-3#1)(1991-4#1)(1991-6#1)(1994-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-4#1)(2013-1#2)
ones being##3##2##(2006-10#1)(2007-7#1)(2008-12#1)
ones by##6##2##(1991-2#1)(1993-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2013-7#1)
ones could##2##2##(2007-11#1)(2008-5#1)
ones do##2##2##(1997-2#1)(2010-12#1)
ones for##2##2##(2008-10#1)(2008-2#1)
ones from the##4##3##(2005-11#1)(2006-10#1)(2008-10#2)
ones from##8##2##(1991-10#1)(2005-11#1)(2006-10#1)(2008-10#3)(2011-1#2)
ones had##2##2##(2008-3#1)(2012-2#1)
ones in the##5##3##(1996-6#1)(2006-2#1)(2008-12#1)(2009-1#2)
ones in##15##2##(1992-6#1)(1995-10#1)(1995-5#1)(1996-2#1)(1996-6#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-6#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-1#2)(2013-1#1)
ones is##3##2##(1991-4#1)(2008-10#1)(2008-3#1)
ones may be##2##3##(2008-10#1)(2008-9#1)
ones measured##2##2##(1997-2#1)(2008-3#1)
ones of the##3##3##(2008-1#1)(2008-3#1)(2009-2#1)
ones of##6##2##(2007-11#1)(2008-1#1)(2008-3#1)(2009-2#1)(2011-1#1)(2012-2#1)
ones reported##2##2##(2008-1#1)(2008-3#1)
ones should be##2##3##(1997-2#1)(2007-8#1)
ones such as##6##3##(1990-9#1)(1997-1#1)(2006-11#1)(2008-12#1)(2009-9#1)(2013-8#1)
ones that are##4##3##(1990-2#1)(1996-1#1)(2008-1#1)(2008-11#1)
ones that do not##2##4##(2008-11#1)(2010-6#1)
ones that##20##2##(1990-11#1)(1990-2#1)(1996-1#1)(2008-1#1)(2008-11#5)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-4#1)(2010-6#1)(2011-12#1)
ones to##3##2##(2006-6#1)(2007-7#1)(2013-7#1)
ones used##4##2##(1997-4#1)(2006-11#1)(2008-10#1)(2010-8#1)
ones were##11##2##(1990-8#1)(1991-2#4)(2007-1#1)(2007-11#1)(2007-8#1)(2010-12#1)(2011-1#1)(2013-8#1)
ones who##5##2##(1992-3#2)(2008-4#1)(2011-1#1)(2013-1#1)
ones will be##2##3##(1991-12#1)(1995-6#1)
ones with##10##2##(1990-2#1)(1994-8#1)(1995-11#1)(2008-10#2)(2008-4#1)(2009-5#1)(2012-2#1)(2012-3#1)(2013-7#1)
ones within the##2##3##(2008-10#1)(2009-5#1)
ones##519##1##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#3)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#7)(1991-3#2)(1991-4#8)(1991-5#1)(1991-6#3)(1991-7#1)(1991-9#4)(1992-12#2)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#3)(1994-8#4)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#1)(1995-5#3)(1995-6#3)(1996-1#1)(1996-12#1)(1996-2#4)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#5)(1997-7#2)(2004-4#1)(2005-11#3)(2005-4#1)(2005-7#1)(2005-9#2)(2006-10#5)(2006-11#2)(2006-12#3)(2006-2#2)(2006-4#2)(2006-5#1)(2006-6#4)(2006-7#1)(2006-8#3)(2007-1#3)(2007-11#8)(2007-12#7)(2007-3#6)(2007-4#1)(2007-5#1)(2007-7#6)(2007-8#5)(2007-9#3)(2008-1#6)(2008-10#55)(2008-11#13)(2008-12#9)(2008-2#15)(2008-3#16)(2008-4#9)(2008-5#20)(2008-6#7)(2008-7#12)(2008-8#7)(2008-9#8)(2009-1#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#3)(2009-4#2)(2009-5#5)(2009-6#3)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#6)(2010-2#3)(2010-4#5)(2010-5#1)(2010-6#2)(2010-8#5)(2010-9#1)(2011-1#12)(2011-12#1)(2011-2#13)(2011-3#1)(2012-1#3)(2012-12#4)(2012-2#8)(2012-3#6)(2013-1#17)(2013-7#6)(2013-8#9)
ones)##7##1##(1996-6#1)(1997-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-6#1)(2010-9#1)
oneself as##3##2##(1990-9#1)(2012-2#2)
oneself in##2##2##(2006-5#1)(2011-2#1)
oneself##11##1##(1990-9#1)(1995-7#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-5#1)(2008-2#1)(2009-10#1)(2011-2#1)(2012-2#2)
onfFN expression##3##2##(1994-9#3)
onfFN##6##1##(1994-9#6)
ongoing HIV##2##2##(2007-6#1)(2012-3#1)
ongoing Phase##2##2##(2007-9#1)(2010-11#1)
ongoing acute##2##2##(1997-8#1)(2007-11#1)
ongoing and future##2##3##(2006-6#1)(2009-12#1)
ongoing and##8##2##(2005-8#1)(2006-6#1)(2007-1#1)(2007-11#1)(2008-3#1)(2009-12#1)(2010-2#1)(2011-1#1)
ongoing assessment and##2##3##(1996-2#1)(2005-10#1)
ongoing assessment of##2##3##(2007-2#1)(2012-3#1)
ongoing assessment##5##2##(1996-2#1)(2005-10#1)(2007-2#1)(2011-1#1)(2012-3#1)
ongoing at##2##2##(2005-11#1)(2007-2#1)
ongoing biological##2##2##(2006-4#1)(2008-7#1)
ongoing care##2##2##(1993-1#1)(2006-8#1)
ongoing challenge##5##2##(1996-3#1)(2006-5#1)(2007-11#1)(2008-7#1)(2011-2#1)
ongoing clinical and##2##3##(2008-8#1)(2009-6#1)
ongoing clinical trials are##3##4##(2005-10#1)(2008-3#1)(2008-7#1)
ongoing clinical trials in##2##4##(2005-11#1)(2010-5#1)
ongoing clinical trials##13##3##(2005-10#1)(2005-11#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-5#1)(2010-6#1)(2011-7#1)(2013-1#2)
ongoing clinical##21##2##(1995-1#1)(2005-10#1)(2005-11#1)(2007-4#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2009-11#1)(2009-6#1)(2010-5#1)(2010-6#1)(2011-7#1)(2013-1#2)
ongoing communication with##2##3##(2007-12#1)(2012-12#1)
ongoing concern##2##2##(2009-4#1)(2010-5#1)
ongoing data collection##2##3##(2008-4#1)(2010-8#1)
ongoing debate about##2##3##(2007-7#1)(2012-3#1)
ongoing debate on the##3##4##(2007-7#1)(2009-10#1)(2011-2#1)
ongoing debate on##4##3##(1991-1#1)(2007-7#1)(2009-10#1)(2011-2#1)
ongoing debate regarding the##2##4##(2006-10#1)(2007-11#1)
ongoing debate##14##2##(1991-1#1)(2006-10#2)(2007-11#1)(2007-7#2)(2008-11#1)(2008-2#1)(2008-7#1)(2009-10#1)(2011-2#2)(2012-2#1)(2012-3#1)
ongoing destruction of the##2##4##(1993-3#1)(1997-5#1)
ongoing destruction##3##2##(1993-3#1)(1997-5#2)
ongoing development of##4##3##(1994-12#1)(2007-5#1)(2008-11#1)(2009-11#1)
ongoing development##5##2##(1994-12#1)(2006-8#1)(2007-5#1)(2008-11#1)(2009-11#1)
ongoing dialogue##2##2##(2006-4#1)(2008-12#1)
ongoing discussion##2##2##(1993-11#1)(2010-9#1)
ongoing education##5##2##(1996-7#1)(2005-8#1)(2005-9#1)(2010-6#1)(2013-8#1)
ongoing effort##2##2##(1996-2#1)(2009-11#1)
ongoing efforts to##5##3##(2008-11#1)(2009-6#1)(2012-12#1)(2013-1#2)
ongoing efforts##6##2##(2008-11#1)(2009-4#1)(2009-6#1)(2012-12#1)(2013-1#2)
ongoing engagement in##2##3##(2013-1#2)
ongoing evaluation of##2##3##(1996-2#1)(2010-6#1)
ongoing evaluation##3##2##(1996-2#1)(2008-12#1)(2010-6#1)
ongoing feedback to##2##3##(1996-1#1)(2008-3#1)
ongoing feedback##3##2##(1996-1#1)(1996-3#1)(2008-3#1)
ongoing for##2##2##(2008-1#1)(2012-3#1)
ongoing improvement in user-interface design##2##5##(2013-1#2)
ongoing improvement##3##2##(2008-4#1)(2013-1#2)
ongoing in the##2##3##(2005-11#1)(2006-10#1)
ongoing in##9##2##(2005-11#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#1)
ongoing infection##2##2##(2008-6#1)(2008-7#1)
ongoing investigation of##2##3##(2006-10#1)(2013-1#1)
ongoing investigation##5##2##(1996-3#1)(1997-1#1)(2006-10#1)(2006-7#1)(2013-1#1)
ongoing large-scale##3##2##(2009-11#1)(2011-8#1)(2012-3#1)
ongoing management##4##2##(1993-12#1)(2005-5#1)(2008-3#1)(2013-8#1)
ongoing monitoring##2##2##(1997-1#1)(2005-10#1)
ongoing phase III##2##3##(2008-5#1)(2008-7#1)
ongoing phase##4##2##(2005-7#1)(2008-5#2)(2008-7#1)
ongoing population-based##2##2##(2008-6#1)(2010-2#1)
ongoing process##4##2##(1997-2#1)(2007-4#1)(2008-7#1)(2013-1#1)
ongoing professional development##2##3##(2007-9#1)(2008-11#1)
ongoing professional##3##2##(1992-3#1)(2007-9#1)(2008-11#1)
ongoing prospective##2##2##(1994-2#1)(2009-11#1)
ongoing quality##2##2##(1993-2#1)(2010-6#1)
ongoing randomized clinical trials##2##4##(2008-11#1)(2008-8#1)
ongoing randomized##4##2##(1996-1#1)(2008-11#1)(2008-8#1)(2009-10#1)
ongoing research and##2##3##(1997-1#1)(2006-10#1)
ongoing research in##3##3##(2006-10#1)(2006-12#1)(2007-12#1)
ongoing research on##2##3##(2008-5#1)(2013-7#1)
ongoing research##17##2##(1992-1#1)(1997-1#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#1)(2011-3#1)(2013-7#1)
ongoing review##2##2##(1996-3#1)(2008-7#1)
ongoing social##2##2##(2008-11#1)(2012-3#1)
ongoing studies##5##2##(2005-7#1)(2005-9#1)(2008-10#1)(2008-8#1)(2012-3#1)
ongoing study of##5##3##(1992-5#1)(1992-8#1)(1993-6#1)(1997-5#1)(2004-10#1)
ongoing study to##2##3##(2008-10#1)(2008-5#1)
ongoing study##11##2##(1992-5#1)(1992-8#1)(1993-6#1)(1997-5#1)(2004-10#1)(2007-11#2)(2007-5#1)(2008-10#1)(2008-2#1)(2008-5#1)
ongoing support##3##2##(2004-3#1)(2008-12#1)(2013-1#1)
ongoing symptoms##2##2##(2005-7#1)(2008-3#1)
ongoing terror##2##2##(2009-7#2)
ongoing to determine##3##3##(2006-4#1)(2008-1#1)(2011-2#1)
ongoing to##9##2##(2004-1#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-9#1)(2008-1#1)(2008-7#1)(2011-2#1)(2012-2#1)
ongoing training##3##2##(1993-12#1)(1994-1#1)(2005-5#1)
ongoing treatment##3##2##(2005-11#1)(2007-8#2)
ongoing trial##3##2##(1996-6#1)(2011-2#1)(2012-2#1)
ongoing trials of##2##3##(1992-10#1)(2005-10#1)
ongoing trials##9##2##(1992-10#1)(2005-10#1)(2005-8#1)(2008-3#2)(2008-5#1)(2010-12#1)(2013-8#2)
ongoing with##2##2##(2006-6#1)(2009-8#1)
ongoing work##2##2##(2010-12#1)(2012-12#1)
ongoing##456##1##(1991-1#1)(1991-10#1)(1991-12#2)(1991-6#1)(1992-1#1)(1992-10#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-7#1)(1992-8#2)(1993-1#2)(1993-11#1)(1993-12#6)(1993-2#1)(1993-3#2)(1993-5#2)(1993-6#2)(1993-8#1)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#5)(1996-12#1)(1996-2#4)(1996-3#6)(1996-4#1)(1996-6#2)(1996-7#2)(1996-8#1)(1997-1#4)(1997-2#3)(1997-4#1)(1997-5#4)(1997-6#1)(1997-8#3)(2004-1#1)(2004-10#3)(2004-12#1)(2004-3#1)(2005-10#4)(2005-11#5)(2005-5#2)(2005-6#2)(2005-7#5)(2005-8#7)(2005-9#2)(2006-10#16)(2006-12#4)(2006-2#3)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#6)(2006-7#2)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#10)(2007-12#9)(2007-2#5)(2007-3#1)(2007-4#3)(2007-5#5)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#8)(2008-1#9)(2008-10#10)(2008-11#15)(2008-12#5)(2008-2#2)(2008-3#12)(2008-4#2)(2008-5#12)(2008-6#7)(2008-7#19)(2008-8#11)(2008-9#3)(2009-10#2)(2009-11#7)(2009-12#1)(2009-4#4)(2009-6#3)(2009-7#3)(2009-8#5)(2009-9#5)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#4)(2010-3#2)(2010-4#1)(2010-5#4)(2010-6#5)(2010-7#1)(2010-8#1)(2010-9#4)(2011-1#5)(2011-2#9)(2011-3#1)(2011-4#1)(2011-7#1)(2011-8#2)(2012-1#2)(2012-11#2)(2012-12#11)(2012-2#9)(2012-3#9)(2012-6#1)(2013-1#21)(2013-7#1)(2013-8#6)
onion and garlic##2##3##(1992-8#2)
onion and##5##2##(1992-8#2)(2004-11#1)(2006-10#1)(2008-10#1)
onion cultivars##8##2##(2008-10#3)(2013-8#5)
onion in##2##2##(2008-10#2)
onion is##2##2##(2008-10#2)
onion plants##3##2##(2008-10#3)
onion strains of Xanthomonas and##2##5##(2008-10#2)
onion yellow##2##2##(2008-10#2)
onion yellows##4##2##(2008-10#4)
onion##61##1##(1992-8#2)(1993-12#1)(2004-11#3)(2005-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#42)(2008-12#1)(2013-8#8)
onion-like##2##1##(2006-12#2)
onions##10##1##(1993-12#2)(1993-9#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2011-2#3)
onium salt##5##2##(2008-10#5)
onium##6##1##(1994-8#1)(2008-10#5)
onlay bone grafts##2##3##(1992-4#1)(2004-9#1)
onlay##9##1##(1992-4#1)(2004-9#3)(2008-10#1)(2008-7#2)(2011-1#1)(2013-8#1)
online CME courses##2##3##(2006-6#2)
online CME##3##2##(2006-6#3)
online and offline##3##3##(2010-4#2)(2012-12#1)
online and##7##2##(2008-12#1)(2008-7#1)(2009-2#1)(2010-4#2)(2012-12#2)
online clinical##3##2##(2008-7#1)(2013-1#2)
online communication##2##2##(1991-11#1)(2010-12#1)
online content##2##2##(2010-12#2)
online course##5##2##(2007-12#1)(2007-7#1)(2008-12#1)(2012-12#2)
online courses##2##2##(2007-12#1)(2008-12#1)
online database##4##2##(1994-1#2)(2006-12#1)(2009-10#1)
online databases##3##2##(2007-11#1)(2011-2#1)(2013-1#1)
online file##2##2##(1991-3#1)(2012-2#1)
online format##2##2##(2005-7#1)(2008-11#1)
online health communities##6##3##(2011-2#6)
online health information about##2##4##(2008-7#1)(2010-4#1)
online health information##3##3##(2007-12#1)(2008-7#1)(2010-4#1)
online health##11##2##(2007-12#1)(2008-7#1)(2010-10#2)(2010-4#1)(2011-2#6)
online information##5##2##(1996-6#2)(2005-7#1)(2006-2#1)(2011-2#1)
online journals##2##2##(1997-3#1)(2007-2#1)
online learning##4##2##(2006-1#1)(2006-6#1)(2008-12#2)
online monitoring of##2##3##(2008-11#1)(2011-2#1)
online on##2##2##(2005-7#1)(2013-1#1)
online options##2##2##(2008-12#2)
online preconcentration and separation##2##4##(2008-10#2)
online preconcentration and##3##3##(2008-10#3)
online preconcentration##4##2##(2008-10#4)
online publication##155##2##(2010-12#8)(2011-1#53)(2011-12#4)(2011-2#12)(2012-1#72)(2013-7#5)(2013-8#1)
online questionnaire to##2##3##(2008-4#1)(2013-1#1)
online questionnaire##5##2##(2008-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
online resources##5##2##(1994-12#1)(2008-11#2)(2008-9#1)(2009-8#1)
online searching##2##2##(1991-3#1)(1995-3#1)
online sources##2##2##(1997-3#1)(2010-12#1)
online survey##8##2##(2007-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
online system##4##2##(1991-2#1)(1992-12#1)(1995-11#1)(2008-2#1)
online to##2##2##(2007-12#1)(2010-11#1)
online users##3##2##(2010-10#2)(2010-12#1)
online version of##28##3##(2010-1#2)(2010-12#6)(2011-1#3)(2011-2#3)(2012-1#3)(2012-11#2)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#1)
online version##29##2##(2005-7#1)(2010-1#2)(2010-12#6)(2011-1#3)(2011-2#3)(2012-1#3)(2012-11#2)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#1)
online versions##2##2##(2007-4#2)
online with##2##2##(2008-10#1)(2010-12#1)
online##406##1##(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#4)(1992-1#1)(1992-12#1)(1993-2#2)(1994-1#2)(1994-12#1)(1995-11#1)(1995-3#2)(1996-12#1)(1996-3#1)(1996-6#2)(1997-3#3)(2005-7#8)(2006-1#2)(2006-12#1)(2006-2#2)(2006-6#5)(2007-10#2)(2007-11#1)(2007-12#9)(2007-2#1)(2007-4#4)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#17)(2008-11#7)(2008-12#10)(2008-2#5)(2008-3#1)(2008-4#6)(2008-5#1)(2008-7#6)(2008-9#4)(2009-10#3)(2009-2#3)(2009-8#2)(2010-1#2)(2010-10#9)(2010-11#1)(2010-12#27)(2010-3#1)(2010-4#5)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#59)(2011-12#4)(2011-2#31)(2012-1#77)(2012-11#3)(2012-12#7)(2012-2#10)(2012-3#7)(2013-1#13)(2013-7#7)(2013-8#5)
online?##2##1##(2007-12#1)(2007-9#1)
only (i##2##2##(2010-4#1)(2012-1#1)
only 0##52##2##(1990-10#2)(1990-6#1)(1990-8#1)(1991-5#1)(1992-11#1)(1993-8#1)(1994-10#1)(1994-3#1)(1994-6#2)(1994-7#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-5#1)(2004-4#1)(2005-8#1)(2006-7#1)(2007-10#2)(2007-12#5)(2008-10#7)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2010-4#1)(2011-2#1)(2011-7#1)(2012-12#2)(2013-1#1)(2013-7#1)
only 1 case of##2##4##(1995-10#1)(2010-6#1)
only 1 case##9##3##(1990-12#1)(1991-4#1)(1995-10#1)(1996-6#1)(2006-12#1)(2007-7#1)(2007-9#1)(2010-6#1)(2012-3#1)
only 1 mol%##2##3##(2010-2#1)(2010-5#1)
only 1 of the##2##4##(1994-2#1)(2010-6#1)
only 1 of##6##3##(1994-2#1)(1997-2#1)(2007-10#1)(2008-10#1)(2010-6#1)(2012-2#1)
only 1 patient##4##3##(1990-6#1)(1991-3#1)(1993-2#1)(1996-1#1)
only 1 to 3##2##4##(2009-2#1)(2009-5#1)
only 1 to##4##3##(2005-8#1)(2008-1#1)(2009-2#1)(2009-5#1)
only 1##76##2##(1990-10#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-6#2)(1990-9#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-10#1)(1992-4#1)(1992-8#2)(1993-2#1)(1993-7#1)(1993-8#2)(1994-12#1)(1994-2#2)(1995-10#1)(1995-11#1)(1995-8#1)(1996-1#2)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-6#1)(2009-2#2)(2009-5#1)(2010-2#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
only 1% of##3##3##(2006-8#1)(2008-4#1)(2008-7#1)
only 1% were##2##3##(2008-5#1)(2013-1#1)
only 1%##9##2##(1992-5#1)(2006-8#1)(2007-9#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-12#1)(2013-1#1)
only 1-2##2##2##(2007-10#1)(2012-1#1)
only 1-2% of##3##3##(1990-6#1)(1995-10#1)(2013-8#1)
only 1-5%##2##2##(1992-3#1)(2009-8#1)
only 10 cases##2##3##(2008-7#1)(2010-12#1)
only 10 of##2##3##(1991-4#1)(2007-8#1)
only 10##21##2##(1990-4#1)(1991-3#1)(1991-4#1)(1995-1#1)(1995-12#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2013-8#1)
only 10% had##2##3##(1995-5#1)(2010-12#1)
only 10% of the##9##4##(1995-2#1)(1996-11#1)(1997-4#1)(2006-4#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-9#1)
only 10% of##13##3##(1992-9#1)(1995-2#1)(1996-11#1)(1997-4#1)(2006-4#1)(2006-8#1)(2007-12#2)(2007-3#1)(2007-7#2)(2008-10#1)(2008-9#1)
only 10% reported##2##3##(1991-8#1)(2006-2#1)
only 10%##27##2##(1990-2#1)(1991-8#1)(1992-9#1)(1993-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-11#2)(1997-4#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-12#2)(2007-3#2)(2007-7#2)(2007-8#1)(2008-10#2)(2008-3#2)(2008-9#1)(2010-12#1)(2013-1#1)
only 10(-5)##2##2##(1995-8#1)(2008-11#1)
only 10-20% of##2##3##(1995-12#1)(2007-4#1)
only 100##2##2##(1995-6#1)(2007-7#1)
only 104##2##2##(2007-8#1)(2008-11#1)
only 10min##2##2##(2008-10#2)
only 10ml##2##2##(2008-10#2)
only 11 cases##2##3##(1990-8#1)(2006-8#1)
only 11##8##2##(1990-8#1)(1990-9#1)(1995-5#1)(2006-8#1)(2008-10#2)(2008-8#1)(2013-8#1)
only 11% of##2##3##(1990-12#1)(2006-2#1)
only 11%##4##2##(1990-12#1)(2006-2#1)(2008-3#1)(2013-1#1)
only 12##8##2##(1991-10#1)(2007-2#1)(2007-8#1)(2008-10#2)(2011-1#2)(2012-2#1)
only 12% of the##3##4##(2006-8#1)(2007-7#1)(2013-7#1)
only 12% of##5##3##(2004-10#1)(2006-8#1)(2007-7#1)(2012-3#1)(2013-7#1)
only 12%##9##2##(1996-9#1)(2004-10#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-9#1)(2012-3#1)(2013-7#1)(2013-8#1)
only 123##2##2##(2006-8#1)(2008-11#1)
only 13 to##2##3##(2007-8#1)(2008-10#1)
only 13##14##2##(1990-4#1)(1992-2#1)(1994-2#1)(1997-4#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2012-2#1)
only 13% of##3##3##(1995-3#1)(2006-8#1)(2008-10#1)
only 14 articles##2##3##(2006-12#1)(2012-3#1)
only 14 cases##2##3##(1990-6#1)(2012-2#1)
only 14 of##2##3##(1990-9#1)(2008-7#1)
only 14##12##2##(1990-6#1)(1990-9#1)(1992-9#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-2#2)(2012-3#1)
only 14% of##3##3##(2004-11#1)(2008-1#1)(2008-5#1)
only 14%##7##2##(1990-6#1)(2004-11#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-7#1)
only 15##14##2##(1992-4#1)(1995-12#1)(2006-4#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-4#1)(2013-1#2)
only 15% of the##2##4##(1992-6#1)(2011-2#1)
only 15% of##4##3##(1992-6#1)(1996-2#1)(2006-8#1)(2011-2#1)
only 15%##8##2##(1992-6#1)(1993-3#1)(1994-12#1)(1996-2#1)(2006-8#1)(2008-7#1)(2011-2#1)(2013-8#1)
only 16 to##2##3##(2008-10#1)(2008-11#1)
only 16##14##2##(1990-6#1)(1991-12#1)(1991-5#1)(1994-9#1)(1997-3#1)(2004-10#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-3#1)(2013-1#1)
only 16%##4##2##(1993-9#1)(1994-8#1)(1995-6#1)(2009-4#1)
only 17##4##2##(1990-8#1)(1991-4#1)(2008-12#1)(2009-3#1)
only 17% of##4##3##(1993-2#1)(2008-10#1)(2008-5#2)
only 17%##7##2##(1993-2#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-5#2)(2009-4#1)
only 18##6##2##(1990-6#1)(1992-12#1)(2008-5#1)(2008-9#1)(2011-12#1)(2011-2#1)
only 18% of the##2##4##(1990-12#1)(1995-3#1)
only 18%##4##2##(1990-12#1)(1990-6#1)(1995-3#1)(2008-10#1)
only 19##4##2##(1996-2#1)(2007-6#1)(2008-10#1)(2010-12#1)
only 19%##2##2##(2006-10#1)(2008-4#1)
only 2 cases##3##3##(1993-10#1)(1993-2#1)(2012-2#1)
only 2 of##3##3##(1990-3#1)(1994-7#1)(2008-10#1)
only 2 patients##4##3##(1990-12#1)(1991-6#1)(2007-9#1)(2011-2#1)
only 2##50##2##(1990-12#2)(1990-3#2)(1990-5#1)(1991-6#1)(1991-8#1)(1993-10#2)(1993-2#2)(1993-6#1)(1994-10#1)(1994-7#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-9#1)(1997-8#1)(2007-8#2)(2007-9#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-5#2)(2011-2#1)(2012-2#1)(2012-3#1)
only 2% of the##2##4##(2006-3#1)(2010-5#1)
only 2% of##6##3##(1992-8#1)(1995-4#1)(1997-2#1)(2006-3#1)(2010-5#1)(2012-3#1)
only 2%##10##2##(1990-8#1)(1992-8#1)(1994-11#1)(1995-4#1)(1997-2#1)(2006-3#1)(2008-7#1)(2008-9#1)(2010-5#1)(2012-3#1)
only 2-fold##3##2##(1992-7#1)(1993-12#1)(1995-11#1)
only 20 min##2##3##(2011-2#1)(2013-8#1)
only 20 patients##2##3##(2008-11#1)(2008-9#1)
only 20##11##2##(1993-2#1)(1996-11#1)(2005-7#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
only 20% of the##2##4##(1992-5#1)(2011-2#1)
only 20% of##8##3##(1990-12#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-5#1)(1995-5#1)(2008-10#1)(2011-2#1)
only 20%##16##2##(1990-12#1)(1990-8#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-5#1)(1994-2#1)(1994-5#1)(1995-5#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#2)(2012-2#1)
only 200##4##2##(2007-11#1)(2007-12#1)(2008-1#1)(2012-2#1)
only 22##2##2##(2007-8#1)(2008-10#1)
only 23##2##2##(2008-8#1)(2013-1#1)
only 23% of the##2##4##(2007-3#1)(2009-3#1)
only 23% of##4##3##(2007-3#1)(2008-1#1)(2009-3#1)(2012-3#1)
only 23%##8##2##(1990-7#1)(1993-9#1)(1995-2#1)(1996-3#1)(2007-3#1)(2008-1#1)(2009-3#1)(2012-3#1)
only 24##8##2##(1990-4#1)(1994-12#1)(1996-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2011-1#1)
only 25 cases##2##3##(2008-6#1)(2010-6#1)
only 25##9##2##(1991-12#1)(2006-8#1)(2007-7#1)(2008-2#1)(2008-6#1)(2010-6#1)(2011-2#1)(2013-1#2)
only 25% of the##3##4##(1990-8#1)(1992-2#1)(2007-7#1)
only 25% of##4##3##(1990-8#1)(1992-11#1)(1992-2#1)(2007-7#1)
only 25%##6##2##(1990-8#1)(1992-11#1)(1992-2#1)(1996-5#1)(2007-7#1)(2008-3#1)
only 26##2##2##(2004-10#1)(2011-2#1)
only 26%##5##2##(1992-5#1)(1993-8#1)(2006-4#1)(2008-4#1)(2010-8#1)
only 27 reported cases##2##4##(2007-8#2)
only 28##2##2##(1992-2#1)(2013-8#1)
only 28% of##2##3##(1993-11#1)(1994-12#1)
only 28%##4##2##(1993-11#1)(1993-3#1)(1994-12#1)(2006-8#1)
only 29##2##2##(2007-9#1)(2012-2#1)
only 29% of the patients##2##5##(2006-8#1)(2008-1#1)
only 29% of the##3##4##(2006-8#1)(2008-1#1)(2008-4#1)
only 29%##4##2##(2006-8#1)(2008-1#1)(2008-11#1)(2008-4#1)
only 3 cases of PTC metastatic to the##2##8##(2009-5#2)
only 3 cases of##4##4##(1992-2#1)(1993-8#1)(2009-5#2)
only 3 cases##6##3##(1992-2#1)(1993-8#1)(2008-6#2)(2009-5#2)
only 3 of the##2##4##(1996-7#1)(2008-4#1)
only 3 of##3##3##(1996-7#1)(2008-10#1)(2008-4#1)
only 3##47##2##(1991-8#1)(1991-9#1)(1992-2#1)(1992-5#1)(1993-10#1)(1993-8#1)(1994-7#1)(1995-10#1)(1996-5#1)(1996-7#1)(1997-7#1)(2004-1#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-5#2)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
only 3% of the total##2##5##(2008-10#1)(2013-1#1)
only 3% of the##4##4##(2008-10#2)(2008-3#1)(2013-1#1)
only 3% of##6##3##(1995-5#1)(2007-11#1)(2008-10#2)(2008-3#1)(2013-1#1)
only 3%##8##2##(1995-5#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-3#1)(2011-2#1)(2013-1#1)
only 30 min##2##3##(1990-4#1)(2009-2#1)
only 30##7##2##(1990-4#1)(1995-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2009-2#1)(2011-1#1)
only 30% had##2##3##(2007-7#1)(2008-3#1)
only 30% of the##2##4##(2009-12#1)(2009-5#1)
only 30% of##6##3##(2004-3#1)(2007-2#1)(2008-5#1)(2009-12#1)(2009-5#1)(2010-12#1)
only 30%##13##2##(1990-5#1)(1995-6#1)(1996-9#1)(2004-3#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-12#1)(2009-5#1)(2010-12#1)(2011-2#1)
only 30-40% of##3##3##(1990-11#1)(1993-2#1)(1997-5#1)
only 30-40%##4##2##(1990-11#2)(1993-2#1)(1997-5#1)
only 31%##2##2##(1993-9#1)(2005-12#1)
only 32%##3##2##(1991-2#1)(2008-1#1)(2009-9#1)
only 33%##6##2##(1994-12#1)(2010-6#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-7#1)
only 34% of##2##3##(1994-12#1)(2011-1#1)
only 34%##3##2##(1994-12#1)(2008-10#1)(2011-1#1)
only 35##5##2##(1995-9#1)(1997-2#1)(1997-8#1)(2008-10#2)
only 35% of the##2##4##(1990-5#1)(2011-2#1)
only 35% of##4##3##(1990-5#1)(2007-11#1)(2008-11#1)(2011-2#1)
only 35%##5##2##(1990-5#1)(1996-12#1)(2007-11#1)(2008-11#1)(2011-2#1)
only 36##3##2##(1992-10#1)(2006-8#1)(2007-3#1)
only 37%##2##2##(1995-2#1)(1995-9#1)
only 38##4##2##(2007-3#1)(2008-7#1)(2009-7#1)(2013-8#1)
only 39##6##2##(2007-7#2)(2008-5#1)(2011-2#2)(2012-1#1)
only 39%##2##2##(2007-8#1)(2009-4#1)
only 4 cases##2##3##(1991-11#1)(2009-3#1)
only 4 of##2##3##(2007-8#1)(2008-10#1)
only 4##28##2##(1990-11#1)(1991-11#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-5#2)(2008-7#2)(2009-3#1)(2010-7#1)(2012-2#1)
only 4% of the##2##4##(1995-9#1)(1996-1#1)
only 4% of##3##3##(1995-9#1)(1996-1#1)(2012-12#1)
only 4%##9##2##(1992-3#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-1#1)(2006-10#1)(2012-1#1)(2012-12#1)(2013-1#1)
only 40##3##2##(2007-8#1)(2008-10#1)(2008-3#1)
only 40% of the##2##4##(1991-5#1)(1996-10#1)
only 40% of##8##3##(1991-5#1)(1996-10#1)(2008-3#1)(2008-4#2)(2011-2#2)(2012-3#1)
only 40%##10##2##(1991-5#1)(1991-9#1)(1995-12#1)(1996-10#1)(2008-3#1)(2008-4#2)(2011-2#2)(2012-3#1)
only 41##2##2##(1994-3#1)(2012-2#1)
only 42##2##2##(1994-5#1)(2005-5#1)
only 42% of##4##3##(1994-2#1)(2007-10#1)(2008-5#1)(2011-2#1)
only 42%##6##2##(1993-9#1)(1994-2#1)(2007-10#1)(2008-5#1)(2011-2#1)(2012-3#1)
only 43##3##2##(2008-4#1)(2008-5#1)(2011-2#1)
only 44##2##2##(2008-10#1)(2011-2#1)
only 44% of##2##3##(1992-10#1)(2008-10#1)
only 45##3##2##(2006-8#1)(2008-12#1)(2010-6#1)
only 47% of##2##3##(1990-6#1)(2010-11#1)
only 47%##3##2##(1990-6#1)(2006-8#1)(2010-11#1)
only 48##2##2##(2008-1#1)(2011-2#1)
only 48% of##2##3##(2006-8#1)(2008-10#1)
only 5 of the##2##4##(1994-2#1)(1995-6#1)
only 5 of##3##3##(1994-2#1)(1995-6#1)(2006-8#1)
only 5 to##2##3##(1990-6#1)(1996-12#1)
only 5##24##2##(1990-6#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-6#1)(1996-12#1)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-7#1)(2011-2#2)(2012-12#1)(2013-1#3)
only 5% of all##2##4##(2008-11#1)(2011-2#1)
only 5% of the##4##4##(1992-12#1)(1996-8#1)(2006-3#1)(2008-4#1)
only 5% of##10##3##(1992-12#1)(1993-8#1)(1996-8#1)(2006-10#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-4#2)(2011-2#1)
only 5% the##2##3##(1994-9#1)(1995-11#1)
only 5%##17##2##(1992-12#1)(1992-2#1)(1993-8#1)(1994-9#1)(1995-11#1)(1996-8#1)(2006-10#1)(2006-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
only 5-10%##3##2##(1990-2#1)(2009-8#1)(2012-3#1)
only 50##2##2##(2008-10#1)(2009-7#1)
only 50% of the##5##4##(1990-4#1)(1995-10#1)(1996-5#1)(1996-8#1)(2008-10#1)
only 50% of##7##3##(1990-4#1)(1995-10#1)(1996-5#1)(1996-8#1)(2008-10#1)(2008-2#1)(2012-2#1)
only 50%##12##2##(1990-4#1)(1993-9#1)(1994-9#1)(1995-10#1)(1996-5#1)(1996-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
only 51% of##2##3##(2007-3#1)(2007-7#1)
only 51%##3##2##(1991-8#1)(2007-3#1)(2007-7#1)
only 52% of##2##3##(1991-10#1)(2010-5#1)
only 52%##4##2##(1991-10#1)(1992-3#1)(2010-5#1)(2011-2#1)
only 53%##4##2##(1991-2#1)(1991-6#1)(1993-8#1)(2008-7#1)
only 54%##4##2##(2007-10#1)(2008-10#1)(2008-5#1)(2008-7#1)
only 55##2##2##(2009-2#1)(2011-1#1)
only 56%##2##2##(2012-3#1)(2013-1#1)
only 59##2##2##(1993-7#1)(2008-7#1)
only 6 +/-##2##3##(1996-1#1)(1996-5#1)
only 6 of##3##3##(2008-10#1)(2008-2#1)(2012-2#1)
only 6 patients##3##3##(1992-4#1)(1992-6#1)(2011-2#1)
only 6##21##2##(1991-5#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-6#1)(1996-1#1)(1996-5#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-4#1)(2010-12#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-7#1)
only 6% of the##3##4##(1993-8#1)(1994-2#1)(2008-6#1)
only 6% of##7##3##(1991-3#1)(1993-2#1)(1993-8#1)(1994-2#1)(1995-1#1)(2008-10#1)(2008-6#1)
only 6%##11##2##(1991-3#1)(1992-2#1)(1993-2#1)(1993-8#1)(1994-2#1)(1995-1#1)(1996-6#1)(2006-10#1)(2008-10#2)(2008-6#1)
only 60%##4##2##(1992-7#1)(2005-10#1)(2008-10#1)(2008-7#1)
only 64##2##2##(1992-2#1)(2007-2#1)
only 65##2##2##(1991-3#1)(1992-2#1)
only 65% of##2##3##(1991-2#1)(2008-10#1)
only 65%##3##2##(1991-2#1)(2008-10#2)
only 69% of##2##3##(2006-10#1)(2008-3#1)
only 69%##3##2##(2006-10#1)(2007-7#1)(2008-3#1)
only 7 days##3##3##(1994-8#1)(1995-3#1)(2008-10#1)
only 7 of##3##3##(2008-10#2)(2011-2#1)
only 7##22##2##(1990-10#1)(1991-4#1)(1992-4#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-11#1)(1996-9#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-9#1)(2010-4#1)(2011-2#2)
only 7% of##2##3##(1993-3#1)(1995-7#1)
only 7%##4##2##(1993-3#1)(1993-4#1)(1995-7#1)(2008-9#1)
only 72##2##2##(1995-9#1)(2008-10#1)
only 8 cases##2##3##(2013-1#2)
only 8##17##2##(1991-4#1)(1992-11#1)(1996-5#1)(1997-7#1)(2006-10#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-8#1)(2010-12#1)(2010-7#1)(2013-1#3)
only 8% of##2##3##(1997-3#1)(2008-4#1)
only 8%##6##2##(1992-5#1)(1992-6#1)(1997-3#1)(2008-4#1)(2010-8#1)(2012-1#1)
only 80##2##2##(2008-10#2)
only 80%##5##2##(1994-10#1)(1994-7#1)(2007-10#1)(2008-10#1)(2008-6#1)
only 9##8##2##(1996-3#1)(2007-4#1)(2007-6#1)(2008-10#2)(2008-7#1)(2011-2#1)(2013-1#1)
only 9%##3##2##(1992-4#1)(1992-9#1)(2008-9#1)
only A##2##2##(1990-7#1)(2008-9#1)
only B##2##2##(2008-10#2)
only EDTA##2##2##(1992-12#1)(2009-8#1)
only Fe(II)##2##2##(2008-10#2)
only MaYMFV##2##2##(2008-10#2)
only Mg2+##2##2##(1990-7#1)(2005-9#1)
only N##2##2##(1997-7#2)
only NO##2##2##(1996-5#1)(1996-6#1)
only O##3##2##(2008-5#1)(2012-12#2)
only PKC##3##2##(1994-5#1)(1995-2#1)(1996-8#1)
only PP1alpha was##2##3##(1996-2#2)
only Type 1 Cu sites##2##5##(1992-9#2)
only X##3##2##(1994-3#1)(2008-10#2)
only a 2##2##3##(1991-7#1)(2008-5#1)
only a decade ago##2##4##(2007-7#1)(2011-12#1)
only a factor of##3##4##(1996-4#1)(1997-8#1)(2008-10#1)
only a few cases have been reported in##2##8##(1997-8#1)(2013-7#1)
only a few cases have been reported##3##7##(1997-8#1)(2004-4#1)(2013-7#1)
only a few cases of##5##5##(1992-11#1)(1994-3#1)(2006-10#1)(2008-12#1)(2013-8#1)
only a few cases##12##4##(1992-11#1)(1994-3#1)(1997-8#1)(2004-10#1)(2004-4#1)(2005-11#1)(2006-10#2)(2008-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
only a few countries##2##4##(2006-10#1)(2007-2#1)
only a few glomeruli##2##4##(2007-12#1)(2010-12#1)
only a few have##2##4##(2007-11#1)(2008-6#1)
only a few hours##2##4##(2007-9#1)(2008-12#1)
only a few minutes##3##4##(2007-12#1)(2008-2#1)(2008-4#1)
only a few molecules##2##4##(2007-9#1)(2008-2#1)
only a few of the##3##5##(1990-12#1)(1992-8#1)(2007-2#1)
only a few of these##3##5##(1990-2#1)(1995-11#1)(2008-8#1)
only a few of##7##4##(1990-12#1)(1990-2#1)(1992-3#1)(1992-8#1)(1995-11#1)(2007-2#1)(2008-8#1)
only a few patients##4##4##(2006-10#1)(2007-10#1)(2008-6#1)(2013-1#1)
only a few percent##5##4##(1992-4#1)(1997-7#1)(2007-12#1)(2008-2#1)(2008-3#1)
only a few published##3##4##(2006-10#1)(2008-11#1)(2013-1#1)
only a few reports##4##4##(2006-12#1)(2006-4#1)(2007-6#1)(2009-5#1)
only a few scattered##2##4##(1996-4#1)(2010-6#1)
only a few studies on##3##5##(2006-10#1)(2008-1#1)(2009-4#1)
only a few studies##10##4##(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-4#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
only a few were##2##4##(1990-8#1)(2006-4#1)
only a few years ago##2##5##(1990-12#1)(2006-4#1)
only a few years##3##4##(1990-12#1)(2006-4#1)(2007-8#1)
only a few##159##3##(1990-12#3)(1990-2#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-6#1)(1993-7#1)(1994-10#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-7#1)(1997-8#4)(2004-10#1)(2004-4#1)(2005-11#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-4#3)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#12)(2007-2#2)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#13)(2008-11#3)(2008-12#4)(2008-2#6)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-10#2)(2010-12#1)(2010-2#3)(2010-3#1)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-4#1)(2013-1#8)(2013-7#2)(2013-8#2)
only a fraction of the##7##5##(1990-5#1)(1992-5#1)(1996-4#1)(1997-2#1)(2005-11#1)(2007-6#1)(2008-6#1)
only a fraction of##11##4##(1990-5#1)(1992-5#1)(1996-4#1)(1997-2#1)(1997-5#1)(2005-11#1)(2006-2#1)(2007-4#1)(2007-6#1)(2008-2#1)(2008-6#1)
only a fraction##12##3##(1990-5#1)(1992-5#1)(1994-9#1)(1996-4#1)(1997-2#1)(1997-5#1)(2005-11#1)(2006-2#1)(2007-4#1)(2007-6#1)(2008-2#1)(2008-6#1)
only a handful of##4##4##(2005-7#1)(2007-10#1)(2011-1#1)(2013-1#1)
only a handful##5##3##(2005-7#1)(2007-10#1)(2008-7#1)(2011-1#1)(2013-1#1)
only a limited amount of##2##5##(2008-7#1)(2009-12#1)
only a limited and##2##4##(1994-2#1)(2006-5#1)
only a limited number of studies have##3##7##(2006-8#1)(2007-11#1)(2012-12#1)
only a limited number of##11##5##(2005-11#1)(2005-6#1)(2006-12#2)(2006-8#1)(2007-11#1)(2007-12#1)(2008-6#2)(2009-10#1)(2012-12#1)
only a limited##24##3##(1990-6#1)(1994-2#1)(1995-11#1)(1997-1#1)(2005-11#1)(2005-6#1)(2006-12#2)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-12#1)(2010-11#1)(2012-12#2)
only a little##5##3##(1991-2#1)(1993-6#1)(2004-2#1)(2008-4#1)(2008-9#1)
only a low##4##3##(1990-11#1)(1994-6#1)(1994-8#2)
only a marginal role in the##2##6##(2008-6#1)(2012-1#1)
only a marginal##5##3##(1990-2#1)(1990-6#1)(1991-1#1)(2008-6#1)(2012-1#1)
only a matter of##2##4##(2007-2#1)(2007-4#1)
only a mild##4##3##(1993-8#1)(2008-1#1)(2008-10#1)(2009-8#1)
only a minimal##7##3##(1992-2#1)(1992-7#2)(1994-9#1)(1996-10#1)(2008-1#1)(2009-9#1)
only a minor decrease##2##4##(1990-11#1)(2009-9#1)
only a minor effect##3##4##(1993-9#1)(1995-2#1)(2008-10#1)
only a minor role in##3##5##(1997-4#1)(2008-10#1)(2008-9#1)
only a minor role##6##4##(1997-4#1)(2006-10#1)(2008-10#1)(2008-5#2)(2008-9#1)
only a minor##26##3##(1990-11#1)(1990-3#1)(1993-9#1)(1995-11#2)(1995-2#1)(1996-5#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-12#1)(2007-9#1)(2008-10#5)(2008-4#1)(2008-5#3)(2008-9#1)(2009-9#1)(2011-2#1)(2013-8#1)
only a minority of patients##5##5##(1993-5#1)(2006-6#2)(2008-8#1)(2010-12#1)
only a minority of##11##4##(1993-5#1)(2006-10#1)(2006-6#2)(2006-8#1)(2008-8#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
only a minority##16##3##(1992-3#1)(1993-5#1)(2006-10#2)(2006-6#2)(2006-8#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
only a moderate##6##3##(1997-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-6#1)
only a modest index contrast##2##5##(2007-12#2)
only a modest##10##3##(1991-1#1)(1991-12#1)(1991-3#1)(1994-5#1)(1996-5#1)(1997-7#1)(2007-12#2)(2008-2#1)(2009-10#1)
only a narrow##2##3##(1997-4#1)(2008-10#1)
only a necessary##2##3##(1990-3#1)(2006-7#1)
only a negligible##2##3##(1995-1#1)(1997-2#1)
only a part of the##4##5##(1991-12#1)(1996-5#1)(2006-2#1)(2008-8#1)
only a part of##7##4##(1991-12#1)(1996-5#1)(2006-2#1)(2007-7#1)(2007-8#1)(2008-8#1)(2011-1#1)
only a partial##9##3##(1990-7#1)(1995-2#1)(1995-6#1)(1997-4#1)(1997-7#2)(2008-1#1)(2008-10#1)(2008-2#1)
only a portion of the##4##5##(1992-3#1)(1993-4#1)(2008-10#1)(2011-1#1)
only a portion of##5##4##(1992-3#1)(1993-4#1)(1994-4#1)(2008-10#1)(2011-1#1)
only a proportion of##2##4##(1991-3#1)(2004-11#1)
only a relationship##2##3##(2008-1#1)(2008-11#1)
only a relatively low##2##4##(1995-3#1)(1997-8#1)
only a relatively##4##3##(1995-3#1)(1997-8#1)(2008-10#1)(2009-9#1)
only a rudimentary##2##3##(1992-7#1)(2007-12#1)
only a short time##4##4##(1993-7#1)(1994-12#1)(1996-1#1)(2007-9#1)
only a short##10##3##(1993-7#1)(1994-12#1)(1995-5#1)(1995-6#1)(1996-1#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-6#1)(2007-9#1)
only a simple##2##3##(2008-10#1)(2008-5#1)
only a single class##2##4##(1990-7#1)(1992-7#1)
only a single detector##2##4##(2008-3#2)
only a single gene##2##4##(1991-2#1)(1993-8#1)
only a single haploid##2##4##(2008-10#1)(2009-12#1)
only a single measurement##2##4##(2008-1#1)(2008-2#1)
only a single particle##2##4##(1990-12#1)(2008-5#1)
only a single##63##3##(1990-12#2)(1990-2#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-7#1)(1993-8#1)(1994-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-7#1)(1997-1#1)(1997-6#1)(2005-7#1)(2006-12#1)(2007-12#4)(2007-2#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#6)(2008-3#8)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-5#1)(2013-1#1)
only a slight effect##2##4##(1991-2#1)(1995-1#1)
only a slight increase in the##2##6##(1991-7#1)(1992-12#1)
only a slight increase in##5##5##(1991-7#1)(1992-12#1)(1994-10#1)(1994-3#1)(2008-12#1)
only a slight increase##6##4##(1991-7#1)(1992-12#1)(1994-10#1)(1994-3#1)(2006-4#1)(2008-12#1)
only a slight##18##3##(1990-2#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-12#1)(1993-3#1)(1994-10#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#1)(2006-4#1)(2007-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2011-2#1)
only a slightly##2##3##(1991-2#1)(1991-5#1)
only a small amount of##6##5##(1990-11#1)(1996-12#1)(2008-10#1)(2008-4#1)(2013-1#1)(2013-7#1)
only a small decrease in##2##5##(2007-12#1)(2008-10#1)
only a small decrease##3##4##(2006-5#1)(2007-12#1)(2008-10#1)
only a small effect on##2##5##(1990-2#1)(1995-3#1)
only a small fraction of the##2##6##(2008-7#1)(2010-11#1)
only a small fraction of##5##5##(2008-10#1)(2008-7#1)(2010-11#2)(2010-5#1)
only a small fraction##7##4##(1992-12#1)(2008-10#1)(2008-7#1)(2010-11#2)(2010-5#1)(2012-2#1)
only a small impact##2##4##(1991-3#1)(1996-11#1)
only a small improvement in##2##5##(2008-7#1)(2012-1#1)
only a small increase in##6##5##(1990-12#1)(1993-6#1)(1995-1#1)(1996-5#1)(2008-7#1)(2012-1#1)
only a small minority##2##4##(1995-11#1)(2006-10#1)
only a small number of patients##2##6##(1991-9#1)(2006-8#1)
only a small number of##13##5##(1990-9#1)(1991-9#1)(1994-9#1)(2006-8#1)(2007-11#3)(2008-2#1)(2008-4#1)(2008-7#1)(2009-5#1)(2011-1#1)(2013-8#1)
only a small number##15##4##(1990-9#1)(1991-9#1)(1994-9#1)(2006-8#1)(2007-11#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-3#1)(2011-1#1)(2013-8#1)
only a small part of the##4##6##(1993-6#1)(1994-12#1)(1996-6#1)(2008-3#1)
only a small percentage of patients##2##6##(2006-6#1)(2011-2#1)
only a small percentage of##7##5##(1991-3#1)(2006-6#1)(2007-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
only a small percentage##8##4##(1991-3#1)(2006-6#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
only a small portion of the##4##6##(1991-10#1)(1991-6#1)(2008-3#1)(2009-5#1)
only a small portion of##5##5##(1991-10#1)(1991-6#1)(2007-10#1)(2008-3#1)(2009-5#1)
only a small proportion of patients##2##6##(1991-4#1)(2009-11#1)
only a small proportion of the##6##6##(1994-8#1)(1995-12#1)(2007-12#1)(2008-11#1)(2010-3#1)(2011-2#1)
only a small proportion of##12##5##(1991-11#1)(1991-4#1)(1994-8#1)(1995-12#1)(1996-5#1)(1997-1#1)(2007-12#1)(2008-11#1)(2009-11#1)(2010-3#1)(2011-2#1)(2013-1#1)
only a small##106##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-3#2)(1991-4#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-5#2)(1996-6#1)(1997-1#1)(1997-5#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#1)(2009-10#1)(2009-11#1)(2009-5#2)(2010-11#2)(2010-3#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
only a subpopulation of##2##4##(1994-2#1)(2007-11#1)
only a subset of the##3##5##(1992-9#1)(2008-8#1)(2012-2#1)
only a subset of##5##4##(1991-7#1)(1992-7#1)(1992-9#1)(2008-8#1)(2012-2#1)
only a suitable##2##3##(2008-11#1)(2009-4#1)
only a thin##2##3##(2007-8#1)(2012-2#1)
only a trace amount of##2##5##(1991-5#1)(2008-8#1)
only a transient increase in##2##5##(1997-3#1)(2008-8#1)
only a transient##6##3##(1994-2#2)(1996-4#1)(1996-5#1)(1997-3#1)(2008-8#1)
only a very limited##2##4##(2008-10#1)(2008-11#1)
only a very low level of##2##6##(1996-7#1)(2008-10#1)
only a very small##5##4##(1992-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-5#1)
only a very##10##3##(1992-10#1)(1996-7#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#1)(2009-4#1)(2010-5#1)
only a wavelength##2##3##(2007-11#1)(2008-3#1)
only a weak effect on##2##5##(2008-3#1)(2008-6#1)
only a weak effect##3##4##(2008-3#1)(2008-6#1)(2012-2#1)
only a weak##7##3##(1991-12#1)(1991-7#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2012-2#1)
only a##688##2##(1990-11#4)(1990-12#7)(1990-2#6)(1990-3#2)(1990-5#1)(1990-6#3)(1990-7#2)(1990-8#5)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#5)(1991-2#5)(1991-3#4)(1991-4#2)(1991-5#3)(1991-6#3)(1991-7#5)(1991-9#3)(1992-10#2)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#4)(1992-4#2)(1992-5#2)(1992-6#1)(1992-7#6)(1992-8#1)(1992-9#2)(1993-1#1)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#5)(1993-7#2)(1993-8#2)(1993-9#2)(1994-1#1)(1994-10#2)(1994-11#1)(1994-12#3)(1994-2#6)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#4)(1994-9#6)(1995-1#3)(1995-11#7)(1995-12#4)(1995-2#6)(1995-3#3)(1995-5#4)(1995-6#3)(1995-7#1)(1996-1#2)(1996-10#2)(1996-11#2)(1996-12#5)(1996-2#1)(1996-4#4)(1996-5#10)(1996-6#1)(1996-7#2)(1997-1#4)(1997-2#2)(1997-3#3)(1997-4#5)(1997-5#2)(1997-6#2)(1997-7#6)(1997-8#6)(2004-10#1)(2004-11#1)(2004-2#1)(2004-4#1)(2005-10#1)(2005-11#6)(2005-6#1)(2005-7#2)(2006-1#1)(2006-10#12)(2006-11#2)(2006-12#7)(2006-2#5)(2006-4#4)(2006-5#3)(2006-6#6)(2006-7#1)(2006-8#5)(2006-9#1)(2007-1#2)(2007-10#4)(2007-11#15)(2007-12#28)(2007-2#5)(2007-3#1)(2007-4#2)(2007-6#3)(2007-7#5)(2007-8#9)(2007-9#5)(2008-1#10)(2008-10#50)(2008-11#12)(2008-12#5)(2008-2#23)(2008-3#28)(2008-4#13)(2008-5#15)(2008-6#11)(2008-7#16)(2008-8#11)(2008-9#6)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#4)(2009-5#4)(2009-6#1)(2009-8#1)(2009-9#3)(2010-10#2)(2010-11#4)(2010-12#2)(2010-2#4)(2010-3#4)(2010-4#1)(2010-5#5)(2010-6#6)(2010-7#1)(2010-8#1)(2011-1#8)(2011-12#1)(2011-2#11)(2012-1#4)(2012-12#4)(2012-2#9)(2012-3#1)(2012-4#1)(2013-1#16)(2013-7#3)(2013-8#6)
only able to##7##3##(1991-1#1)(1996-5#1)(2007-11#1)(2008-5#1)(2008-8#1)(2011-3#1)(2012-2#1)
only about 1##3##3##(1993-12#1)(1996-3#1)(2008-10#1)
only about 1% of all##3##5##(1996-12#1)(2008-4#1)(2012-3#1)
only about 1%##4##3##(1996-12#1)(2008-4#1)(2010-1#1)(2012-3#1)
only about 10% of the##2##5##(1992-3#1)(2010-12#1)
only about 20% of##2##4##(1992-2#1)(2011-3#1)
only about 50%##3##3##(1990-2#1)(1996-11#1)(2008-11#1)
only about a##2##3##(1994-3#1)(2013-1#1)
only about half of##2##4##(2008-2#1)(2011-2#1)
only about one##2##3##(1990-11#1)(2010-4#1)
only about##44##2##(1990-11#1)(1990-2#2)(1991-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-3#1)(1996-11#2)(1996-12#1)(1996-3#1)(2005-10#1)(2006-11#1)(2006-2#1)(2006-4#1)(2006-7#1)(2007-5#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2009-11#1)(2009-6#1)(2010-1#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#1)
only accepted##2##2##(2005-7#1)(2013-1#1)
only accessible to##2##3##(1997-8#1)(2012-2#1)
only according to##2##3##(2008-11#1)(2008-4#1)
only accounted for 15##2##4##(2013-1#2)
only accounted for##3##3##(1991-10#1)(2013-1#2)
only accumulated##2##2##(1997-6#1)(2008-10#1)
only achievable##2##2##(2007-7#1)(2010-7#1)
only achieved when##3##3##(2009-5#1)(2013-1#2)
only achieved##6##2##(2008-10#1)(2008-11#1)(2009-5#1)(2012-2#1)(2013-1#2)
only activates##2##2##(1997-2#1)(1997-7#1)
only active against##2##3##(2008-5#2)
only active in##3##3##(1997-6#1)(2008-9#1)(2012-12#1)
only active##11##2##(1991-4#1)(1996-5#1)(1996-7#1)(1997-6#1)(2008-10#3)(2008-5#2)(2008-9#1)(2012-12#1)
only actively##2##2##(2007-10#1)(2008-10#1)
only acute##3##2##(2007-10#1)(2007-8#1)(2012-2#1)
only additive##2##2##(2008-10#1)(2008-11#1)
only adequate##2##2##(2007-5#1)(2008-10#1)
only adult##2##2##(1994-2#1)(2011-2#1)
only adverse##3##2##(2007-11#1)(2008-3#1)(2009-11#1)
only affected by the##2##4##(2008-11#1)(2008-8#1)
only affected by##3##3##(2007-12#1)(2008-11#1)(2008-8#1)
only affected##6##2##(2004-9#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-8#1)(2013-1#1)
only affects the##4##3##(1992-6#1)(2008-11#1)(2008-2#1)(2010-12#1)
only affects##7##2##(1991-9#1)(1992-6#1)(2008-11#1)(2008-2#1)(2010-12#1)(2012-2#1)(2012-3#1)
only after 2##2##3##(1997-4#1)(1997-6#1)
only after a##7##3##(1992-12#1)(1994-12#1)(1995-6#1)(1997-4#1)(2008-1#1)(2008-10#1)(2011-2#1)
only after it##2##3##(1996-6#1)(2008-10#1)
only after many##2##3##(2008-3#1)(2009-4#1)
only after the##14##3##(1991-7#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-4#1)(1997-5#1)(2005-8#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2009-12#1)(2013-1#1)
only after##89##2##(1990-11#1)(1990-2#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-4#2)(1997-5#2)(1997-6#1)(2005-11#1)(2005-8#2)(2006-12#1)(2006-2#3)(2006-3#2)(2007-11#1)(2007-12#2)(2007-6#1)(2007-9#2)(2008-1#2)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#5)(2009-12#1)(2009-4#2)(2009-6#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
only against PMA-induced arachidonate release##2##5##(2008-11#2)
only against the##3##3##(1992-8#1)(2007-11#1)(2008-11#1)
only against##8##2##(1992-8#1)(1995-12#1)(2007-11#1)(2008-11#3)(2008-4#1)(2008-7#1)
only age##5##2##(1991-3#1)(2008-10#1)(2008-7#2)(2011-2#1)
only allow##3##2##(1994-9#1)(2006-6#1)(2008-2#1)
only allowed##2##2##(2009-8#1)(2012-3#1)
only allows##6##2##(2004-9#1)(2007-11#1)(2008-2#2)(2008-3#1)(2010-12#1)
only along the##2##3##(2008-3#2)
only along##3##2##(1992-7#1)(2008-3#2)
only amenable##2##2##(2008-9#1)(2010-8#1)
only among##9##2##(2007-12#1)(2008-11#1)(2009-10#1)(2011-2#3)(2012-1#2)(2013-8#1)
only an early##2##3##(2007-7#1)(2011-2#1)
only an##28##2##(1991-12#1)(1993-8#1)(1994-2#1)(1995-11#1)(1995-12#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#3)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-7#1)
only and##17##2##(1990-10#1)(1992-4#1)(1992-7#1)(1993-8#1)(2005-11#1)(2006-7#1)(2008-10#1)(2008-2#1)(2008-6#2)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)
only animal##2##2##(1991-12#1)(2005-7#1)
only animals##2##2##(1991-2#1)(1992-1#1)
only antihypertensive##2##2##(1993-2#1)(2007-2#1)
only apparent##3##2##(1991-12#1)(2005-11#1)(2008-10#1)
only applicable##2##2##(2008-4#1)(2012-2#1)
only applies to##2##3##(2008-10#1)(2008-8#1)
only approved##3##2##(2006-12#1)(2007-10#1)(2012-3#1)
only approx##2##2##(1994-11#1)(2008-6#1)
only approximately 1##2##3##(1993-11#1)(2008-11#1)
only approximately 30##2##3##(2008-10#1)(2008-3#1)
only approximately##20##2##(1993-11#1)(1994-8#1)(1997-9#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#1)(2009-5#1)(2009-9#1)(2010-4#1)(2011-2#1)
only are the##2##3##(2008-7#2)
only are##12##2##(1994-1#1)(2006-8#1)(2007-8#2)(2008-1#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-3#1)(2012-1#1)
only arises##2##2##(2008-6#1)(2009-10#1)
only around##3##2##(2008-4#1)(2008-8#1)(2012-1#1)
only as a control##3##4##(2008-5#1)(2013-1#2)
only as a##22##3##(1990-3#1)(1992-12#1)(1994-2#1)(1996-4#1)(2003-11#1)(2007-10#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-10#1)(2010-4#1)(2012-2#2)(2012-3#1)(2013-1#2)
only as an energy##2##4##(2008-1#1)(2008-4#1)
only as an##14##3##(1990-12#1)(1990-6#1)(1991-8#1)(1992-11#1)(1994-12#1)(1995-12#1)(2008-1#1)(2008-2#1)(2008-4#1)(2010-3#1)(2013-8#4)
only as good as##3##4##(2009-11#1)(2010-2#1)(2012-3#1)
only as well as##2##4##(1994-12#1)(2007-4#1)
only as##62##2##(1990-12#1)(1990-3#1)(1990-6#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1994-12#2)(1994-2#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-4#1)(2003-11#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#4)
only associated with##10##3##(1992-6#1)(1996-2#1)(1996-9#1)(2007-7#1)(2008-5#1)(2008-8#1)(2009-8#1)(2011-1#1)(2012-1#1)(2013-1#1)
only at 0##2##3##(2006-3#1)(2008-12#1)
only at 1##2##3##(1992-4#1)(1994-10#1)
only at 30##2##3##(1994-3#1)(2006-12#1)
only at a##8##3##(1991-6#1)(1994-3#1)(2008-10#3)(2008-8#1)(2008-9#1)(2010-9#1)
only at concentrations##5##3##(1990-11#1)(1990-2#1)(1994-11#1)(1994-8#1)(2008-9#1)
only at high concentrations##5##4##(1990-7#1)(1991-8#1)(1993-4#1)(1996-8#1)(2009-9#1)
only at high doses##2##4##(2006-12#1)(2007-12#1)
only at high##10##3##(1990-7#1)(1991-8#1)(1993-4#1)(1993-9#1)(1995-3#1)(1996-8#1)(2006-12#1)(2007-12#1)(2008-10#1)(2009-9#1)
only at higher doses##2##4##(1993-8#1)(2012-12#1)
only at higher##6##3##(1991-9#1)(1993-8#1)(1994-11#1)(1994-5#1)(2005-11#1)(2012-12#1)
only at low##5##3##(1992-12#1)(2004-12#1)(2007-6#1)(2008-2#1)(2013-8#1)
only at most##2##3##(2012-3#2)
only at much higher concentrations##2##5##(1994-9#1)(1997-8#1)
only at pH##3##3##(1997-4#1)(2008-10#2)
only at the higher inoculum density##2##6##(2008-10#2)
only at the highest##2##4##(1997-2#1)(2012-12#1)
only at the level of##3##5##(1992-11#1)(1994-8#1)(2012-3#1)
only at the site of##2##5##(1992-8#1)(2004-12#1)
only at the site##3##4##(1992-8#1)(2004-12#1)(2008-10#1)
only at the##33##3##(1990-2#1)(1991-11#2)(1991-12#1)(1992-11#1)(1992-8#1)(1993-12#1)(1994-8#1)(1995-2#1)(1996-8#1)(1997-2#1)(1997-8#1)(2004-12#1)(2006-4#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-8#1)(2009-3#1)(2010-12#3)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
only at very high##4##4##(1991-1#1)(1992-6#1)(1996-12#1)(1997-6#1)
only at very low temperatures##2##5##(1991-2#1)(2008-9#1)
only at very##6##3##(1991-1#1)(1991-2#1)(1992-6#1)(1996-12#1)(1997-6#1)(2008-9#1)
only at##133##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-7#3)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#2)(1994-3#2)(1994-5#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-10#1)(1996-12#2)(1996-2#2)(1996-6#1)(1996-8#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#2)(2004-12#2)(2005-11#1)(2006-12#3)(2006-3#1)(2006-4#2)(2006-8#2)(2007-12#4)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#5)(2009-2#2)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-7#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
only attracted##2##2##(2007-11#1)(2012-2#1)
only available in##3##3##(1996-1#1)(2008-1#1)(2008-11#1)
only available##17##2##(1993-11#1)(1996-1#1)(1997-6#1)(2004-11#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-2#1)
only bacteria##2##2##(2008-5#1)(2010-4#1)
only basal##2##2##(1991-12#1)(1997-1#1)
only based on##3##3##(2010-8#1)(2011-2#1)(2012-3#1)
only be achieved by##8##4##(1993-10#1)(1997-6#1)(2006-10#1)(2008-5#1)(2008-7#1)(2010-2#1)(2012-2#2)
only be achieved if##2##4##(1992-3#1)(1997-7#1)
only be achieved##15##3##(1992-3#1)(1993-10#1)(1994-12#1)(1997-6#1)(1997-7#1)(2004-7#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-2#2)
only be applied##5##3##(2008-10#2)(2008-7#1)(2008-8#1)(2013-1#1)
only be carried out in##2##5##(1993-8#1)(2007-8#1)
only be carried out##5##4##(1993-8#1)(2006-6#1)(2007-7#1)(2007-8#1)(2011-1#1)
only be demonstrated##2##3##(1992-8#1)(1997-6#1)
only be detected##7##3##(1994-2#1)(1995-2#1)(1996-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2011-1#1)
only be established##3##3##(1992-3#1)(2007-7#1)(2008-9#1)
only be explained by the##2##5##(1994-8#1)(2008-10#1)
only be explained by##4##4##(1994-8#1)(2006-10#1)(2008-10#1)(2010-7#1)
only be explained##5##3##(1994-8#1)(2006-10#1)(2008-1#1)(2008-10#1)(2010-7#1)
only be imaged##2##3##(2008-1#1)(2008-12#1)
only be obtained by##4##4##(1995-2#1)(1996-9#1)(2009-2#1)(2010-7#1)
only be obtained through##2##4##(2008-9#1)(2009-3#1)
only be obtained##8##3##(1995-2#1)(1996-9#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-7#1)
only be offered##2##3##(1993-3#1)(1995-5#1)
only be performed in##3##4##(2006-10#1)(2006-6#1)(2008-8#1)
only be realized##4##3##(1997-3#1)(2008-8#1)(2011-2#1)(2012-2#1)
only be reduced##2##3##(2010-2#1)(2010-5#1)
only be removed##3##3##(1993-11#1)(1995-5#1)(2007-8#1)
only be seen##2##3##(1993-12#1)(2009-3#1)
only be stimulated##2##3##(1992-12#1)(2009-3#1)
only be studied##2##3##(1993-8#1)(2010-2#1)
only be treated##4##3##(2007-11#2)(2008-4#1)(2010-12#1)
only be used in##3##4##(2008-2#1)(2012-12#1)(2013-7#1)
only be used when##2##4##(2008-10#2)
only be used with##3##4##(1994-8#1)(2008-5#1)(2008-9#1)
only be used##14##3##(1993-8#1)(1994-8#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-9#2)(2012-12#1)(2012-2#2)(2013-7#1)
only be##183##2##(1990-10#2)(1990-3#2)(1990-5#1)(1990-7#1)(1991-1#1)(1991-11#3)(1991-2#1)(1991-3#1)(1991-7#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#4)(1994-12#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-2#2)(1995-5#2)(1995-6#4)(1995-7#1)(1996-1#1)(1996-3#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-3#3)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-7#1)(2005-11#2)(2006-10#6)(2006-2#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#5)(2007-8#4)(2008-1#3)(2008-10#8)(2008-11#3)(2008-12#3)(2008-2#4)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#6)(2008-9#7)(2009-12#1)(2009-2#3)(2009-3#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2011-1#3)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#6)(2013-1#3)(2013-7#1)(2013-8#1)
only because of##7##3##(1995-2#1)(1996-12#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-6#1)(2008-5#1)
only because they##3##3##(1993-3#1)(1997-1#1)(2012-11#1)
only because##14##2##(1993-3#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-9#1)(1997-1#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-6#1)(2008-5#1)(2008-8#1)(2012-11#1)(2012-2#1)
only become apparent##2##3##(1994-11#1)(2008-1#1)
only become##5##2##(1990-11#1)(1994-11#1)(2008-1#1)(2008-5#1)(2011-3#1)
only been reported##6##3##(1995-10#1)(2006-10#1)(2008-9#1)(2011-12#1)(2012-1#1)(2013-1#1)
only been##44##2##(1990-11#1)(1991-11#1)(1992-6#1)(1992-9#1)(1993-5#1)(1994-10#1)(1995-10#1)(1995-8#1)(1996-2#1)(1997-4#1)(1997-6#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#2)(2007-11#2)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-12#2)(2011-2#2)(2012-1#1)(2013-1#3)
only beginning to be##4##4##(2006-1#1)(2006-10#1)(2007-12#2)
only beginning to##6##3##(2006-1#1)(2006-10#1)(2007-12#2)(2008-4#1)(2011-2#1)
only being##4##2##(2007-4#1)(2008-10#1)(2012-2#2)
only below##2##2##(1997-7#1)(2008-8#1)
only benefit##3##2##(2012-3#1)(2013-1#2)
only between the##4##3##(1994-8#1)(1996-12#1)(2009-2#1)(2013-8#1)
only between##13##2##(1990-9#1)(1994-8#1)(1996-12#1)(1997-2#2)(2007-11#1)(2008-10#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
only binary##2##2##(1993-9#1)(1994-8#1)
only body##4##2##(1990-11#1)(2007-12#1)(2008-4#1)(2012-2#1)
only bound##2##2##(1992-12#1)(1994-11#1)
only brain##2##2##(1996-1#1)(2007-11#1)
only briefly##3##2##(1994-4#1)(2009-9#1)(2011-1#1)
only by a##10##3##(1991-1#1)(1991-5#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-1#1)(2005-12#1)(2007-12#1)(2012-1#1)
only by being##2##3##(2007-9#1)(2008-11#1)
only by following##2##3##(2006-12#1)(2013-1#1)
only by irradiation##2##3##(2007-1#1)(2011-2#1)
only by specialists##2##3##(1993-6#1)(2012-11#1)
only by the application of##2##5##(1991-7#1)(2013-8#1)
only by the shape##2##4##(2012-3#2)
only by the##50##3##(1990-11#1)(1990-3#1)(1990-4#1)(1991-11#1)(1991-12#1)(1991-7#1)(1992-4#1)(1992-8#1)(1993-12#3)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1997-4#1)(2005-10#1)(2006-2#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-12#6)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#4)(2008-7#2)(2008-9#2)(2009-11#1)(2009-12#1)(2012-3#2)(2013-8#1)
only by their##3##3##(2008-3#1)(2009-5#1)(2011-2#1)
only by using##2##3##(1990-1#1)(1997-7#1)
only by##181##2##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-8#4)(1992-9#1)(1993-12#3)(1993-2#1)(1993-6#4)(1993-8#1)(1994-11#1)(1994-12#5)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#3)(1995-3#2)(1996-1#1)(1996-2#1)(1996-5#2)(1996-8#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-8#1)(2004-9#1)(2005-10#2)(2005-12#2)(2006-10#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#5)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#9)(2007-5#1)(2007-9#1)(2008-1#3)(2008-10#16)(2008-11#4)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#2)(2009-9#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#3)(2013-8#1)
only can be##3##3##(2008-3#1)(2009-10#1)(2013-1#1)
only can##8##2##(1997-4#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2013-1#2)
only capable of##2##3##(2005-10#1)(2006-6#1)
only case##4##2##(1991-11#1)(2007-9#1)(2008-5#1)(2009-2#1)
only cause##3##2##(2007-12#1)(2008-5#2)
only causes a##3##3##(1996-11#1)(2008-3#1)(2010-10#1)
only causes##5##2##(1995-6#1)(1996-11#1)(2007-11#1)(2008-3#1)(2010-10#1)
only cell##4##2##(1991-1#1)(1995-3#1)(2007-12#1)(2008-11#1)
only cells##3##2##(1991-7#1)(1994-12#1)(2007-1#1)
only certain##4##2##(1993-6#1)(2006-7#1)(2008-8#1)(2010-1#1)
only change##2##2##(1997-8#1)(2011-1#1)
only changes##2##2##(1990-12#1)(2008-1#1)
only chemotaxis but##2##3##(1991-2#2)
only clinical##5##2##(1993-11#1)(2006-12#1)(2007-7#1)(2008-7#1)(2013-1#1)
only collagen##2##2##(1990-12#1)(2008-5#1)
only common##4##2##(2008-4#1)(2011-1#1)(2012-3#2)
only comparable to##2##3##(2007-12#1)(2012-3#1)
only complete##2##2##(1997-7#1)(2008-1#1)
only completely##2##2##(2008-8#2)
only complication##6##2##(1990-4#1)(1997-8#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#1)
only composed of##2##3##(2008-10#1)(2008-11#1)
only compound##6##2##(1995-12#1)(2005-8#2)(2008-8#1)(2009-8#1)(2013-1#1)
only compounds##4##2##(1992-9#1)(1993-6#1)(2007-10#1)(2011-3#1)
only consider##3##2##(2008-2#2)(2010-6#1)
only considered##4##2##(1993-3#1)(2006-9#1)(2008-5#1)(2012-1#1)
only considers##2##2##(2011-2#2)
only consistent findings##2##3##(1990-10#1)(2012-1#1)
only consistent##3##2##(1990-10#1)(1993-5#1)(2012-1#1)
only contained##2##2##(1997-2#1)(2008-6#1)
only conventional##3##2##(2007-9#1)(2008-10#1)(2008-11#1)
only correlated with##2##3##(2013-1#1)(2013-7#1)
only correlated##3##2##(2008-12#1)(2013-1#1)(2013-7#1)
only critical##3##2##(1996-5#1)(2011-1#1)(2012-12#1)
only cue##2##2##(1995-1#1)(2012-3#1)
only curative therapy##2##3##(2010-12#1)(2010-7#1)
only curative treatment##2##3##(1995-5#1)(2008-6#1)
only curative##6##2##(1992-8#1)(1995-5#1)(2008-3#1)(2008-6#1)(2010-12#1)(2010-7#1)
only currently##3##2##(2007-9#1)(2008-10#1)(2009-3#1)
only data##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
only decrease##2##2##(2008-2#1)(2010-4#1)
only decreases##5##2##(1995-12#1)(2007-11#1)(2008-3#1)(2012-12#2)
only demonstrated in##2##3##(1997-3#1)(2006-8#1)
only demonstrated##5##2##(1997-3#1)(1997-6#1)(2006-10#1)(2006-8#1)(2008-1#1)
only dependent on##2##3##(1991-8#1)(2008-5#1)
only describe the##2##3##(2007-10#1)(2008-11#1)
only describes##2##2##(2010-5#1)(2013-1#1)
only detectable##7##2##(1990-11#1)(1990-3#1)(1991-8#1)(1993-12#1)(1995-4#1)(2008-5#1)(2011-2#1)
only detected in the##5##4##(1990-11#1)(1990-8#1)(2008-10#2)(2008-3#1)
only detected in##13##3##(1990-11#2)(1990-8#1)(1991-5#2)(1992-7#1)(1993-12#1)(1994-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#1)
only detected##17##2##(1990-11#2)(1990-8#1)(1991-5#2)(1992-7#1)(1993-12#1)(1994-12#1)(2004-4#1)(2008-10#4)(2008-11#1)(2008-3#1)(2010-10#1)(2011-2#1)
only determination of##3##3##(2008-10#2)(2009-8#1)
only diagnosed##2##2##(2007-6#1)(2012-1#1)
only diagnostic##3##2##(1990-6#1)(2007-10#1)(2007-8#1)
only did##3##2##(1992-6#1)(1993-6#1)(1996-1#1)
only differed##3##2##(2008-10#1)(2008-7#1)(2010-1#1)
only difference##6##2##(1990-12#1)(1990-7#1)(1996-12#1)(1996-7#1)(2008-10#1)(2012-3#1)
only different##2##2##(1992-3#1)(2013-1#1)
only direct##5##2##(1991-12#1)(1993-8#1)(2006-12#1)(2008-4#1)(2009-9#1)
only directly##2##2##(1991-12#1)(2008-5#1)
only discrete##2##2##(1991-12#1)(2008-6#1)
only dissolution of##2##3##(2008-10#1)(2009-10#1)
only distantly related to##3##4##(2008-10#2)(2008-4#1)
only distinct##2##2##(1995-5#1)(2008-10#1)
only do##5##2##(1994-9#1)(1996-12#1)(1997-2#1)(2007-12#1)(2012-12#1)
only documented##2##2##(2008-4#1)(2008-9#1)
only does the##4##3##(1995-5#1)(2008-5#1)(2008-6#1)(2009-3#1)
only does##7##2##(1995-5#1)(1996-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-3#1)(2012-2#1)
only drawback##2##2##(2007-12#1)(2013-8#1)
only due to##3##3##(1993-6#1)(1996-12#1)(2011-2#1)
only during the first##2##4##(2008-10#1)(2008-3#1)
only during the last few years##2##6##(1990-3#1)(2006-12#1)
only during the last few##3##5##(1990-3#1)(2006-12#1)(2013-1#1)
only during the last##4##4##(1990-3#1)(1995-1#1)(2006-12#1)(2013-1#1)
only during the##14##3##(1990-3#1)(1991-12#1)(1992-9#1)(1995-1#2)(1995-7#2)(2006-12#1)(2008-10#3)(2008-3#1)(2008-7#1)(2013-1#1)
only during##27##2##(1990-12#1)(1990-3#1)(1991-12#1)(1992-8#1)(1992-9#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-7#2)(2004-3#1)(2006-12#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
only early##3##2##(2008-10#1)(2008-5#1)(2008-6#1)
only effective in##3##3##(1990-7#1)(1994-10#1)(2006-5#1)
only effective##25##2##(1990-7#1)(1992-6#1)(1994-10#1)(1995-2#1)(1996-11#1)(1997-1#1)(2004-11#2)(2006-10#6)(2006-5#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#1)(2008-6#1)(2009-11#1)(2009-8#1)(2010-6#1)
only efficient##2##2##(1997-7#1)(2009-11#1)
only eight of the##2##4##(1990-4#1)(2008-7#1)
only eight of##3##3##(1990-4#1)(2008-7#2)
only eight##10##2##(1990-4#1)(1990-5#1)(1994-8#1)(1996-7#1)(2006-10#2)(2007-12#1)(2008-1#1)(2008-7#2)
only emerged##2##2##(2008-10#1)(2010-1#1)
only enhance##2##2##(1993-3#1)(2012-12#1)
only essential##2##2##(1990-12#1)(1995-3#1)
only estimates of##2##3##(1990-8#1)(1996-9#1)
only evident in##2##3##(1994-3#1)(2011-2#1)
only evident##3##2##(1994-3#1)(1995-11#1)(2011-2#1)
only examined##2##2##(1993-9#1)(2011-2#1)
only exception is##2##3##(1991-10#1)(2007-6#1)
only exception##8##2##(1990-2#1)(1991-10#1)(1995-7#1)(1996-11#1)(1996-5#1)(2007-6#1)(2007-8#1)(2013-1#1)
only expands##2##2##(2008-2#1)(2009-12#1)
only experimental##2##2##(1990-9#1)(2013-1#1)
only explain##2##2##(1994-3#1)(2009-9#1)
only exposure##2##2##(1992-3#1)(1997-2#1)
only express##2##2##(2008-9#1)(2009-3#1)
only expressed in the##3##4##(2006-12#1)(2007-12#1)(2012-3#1)
only expressed in##15##3##(1990-3#1)(1992-12#1)(1993-6#1)(1994-12#1)(1996-2#3)(1997-5#1)(1997-7#1)(2006-12#1)(2007-12#1)(2008-11#1)(2008-8#1)(2012-12#1)(2012-3#1)
only expressed##18##2##(1990-3#1)(1992-12#1)(1993-6#1)(1993-9#1)(1994-12#1)(1996-2#3)(1997-5#1)(1997-7#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-8#1)(2012-12#1)(2012-3#1)
only extracted##2##2##(2008-10#1)(2012-1#1)
only extreme##2##2##(1997-7#1)(2010-4#1)
only extremely##3##2##(1991-5#1)(1997-2#1)(2007-8#1)
only factor significantly associated with##2##5##(2012-2#2)
only factor##13##2##(1990-10#1)(1991-2#1)(1994-4#1)(2005-8#1)(2006-9#1)(2007-10#1)(2007-7#1)(2008-4#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
only faintly##2##2##(1991-5#1)(2003-11#1)
only feature##2##2##(1996-11#1)(2007-9#1)
only female##2##2##(1997-5#1)(2008-5#1)
only few cases published##2##4##(2013-1#1)(2013-8#1)
only few cases##5##3##(1991-8#1)(2007-7#1)(2009-5#1)(2013-1#1)(2013-8#1)
only few reports##4##3##(2007-4#1)(2008-10#2)(2008-4#1)
only few studies have##3##4##(2006-8#1)(2008-9#1)(2011-2#1)
only few studies##5##3##(2006-8#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
only few##36##2##(1991-8#1)(1991-9#1)(1992-1#1)(1995-2#1)(1996-12#1)(1997-2#1)(1997-4#1)(2006-2#3)(2006-8#1)(2007-4#1)(2007-7#3)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-5#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
only five and##2##3##(1990-3#1)(2008-3#1)
only five of the##2##4##(1993-9#1)(1995-1#1)
only five of##3##3##(1993-9#1)(1995-1#1)(2008-10#1)
only five patients##3##3##(1991-7#1)(2013-1#1)(2013-8#1)
only five##27##2##(1990-3#2)(1991-2#1)(1991-7#1)(1993-9#1)(1994-2#1)(1995-1#2)(1996-10#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
only focal##2##2##(2008-6#2)
only focus on##2##3##(2007-8#1)(2008-7#1)
only following##3##2##(1993-12#1)(1995-11#1)(2008-10#1)
only for 1##2##3##(1997-1#1)(2010-5#1)
only for a few##3##4##(1997-4#1)(2008-8#2)
only for a short time##2##5##(1990-7#1)(2008-5#1)
only for a small##3##4##(2007-9#1)(2008-11#1)(2010-9#1)
only for a##12##3##(1990-7#1)(1992-11#1)(1997-4#1)(2007-10#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-8#2)(2009-2#1)(2010-9#1)(2012-1#1)
only for girls##2##3##(2006-10#1)(2009-7#1)
only for high##2##3##(2006-12#1)(2011-12#1)
only for mothers##3##3##(2012-12#1)(2013-1#2)
only for patients##2##3##(2008-1#1)(2012-1#1)
only for the first 24 h##2##6##(2008-5#2)
only for the first##5##4##(1993-5#1)(2008-5#2)(2012-12#2)
only for the##38##3##(1990-12#1)(1991-5#1)(1992-3#1)(1993-5#1)(1993-9#1)(1994-2#2)(1994-9#1)(1996-11#1)(1997-4#1)(1997-7#2)(2004-3#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-2#1)(2008-10#4)(2008-2#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
only for those##2##3##(1990-3#1)(2004-1#1)
only for##184##2##(1990-12#4)(1990-3#2)(1990-7#1)(1990-8#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-9#2)(1995-10#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-9#1)(1996-11#2)(1996-12#1)(1996-5#2)(1997-1#1)(1997-4#2)(1997-7#2)(1997-8#1)(2004-1#1)(2004-11#1)(2004-3#1)(2005-10#2)(2005-11#2)(2005-8#2)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-3#2)(2007-4#2)(2007-6#1)(2007-9#1)(2008-1#3)(2008-10#11)(2008-11#5)(2008-2#3)(2008-3#10)(2008-4#4)(2008-5#7)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#2)(2009-3#2)(2009-7#1)(2009-8#2)(2010-12#2)(2010-5#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#3)(2011-10#1)(2011-12#3)(2011-2#8)(2012-1#4)(2012-12#8)(2012-2#4)(2012-3#3)(2013-1#3)(2013-8#3)
only form##6##2##(1994-12#1)(1995-12#1)(2006-10#2)(2007-11#1)(2007-9#1)
only found for##2##3##(1993-9#1)(2009-7#1)
only found in the##4##4##(2005-9#1)(2006-8#1)(2007-12#1)(2007-5#1)
only found in##14##3##(1993-9#1)(1995-12#1)(1997-6#1)(2005-9#1)(2006-8#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-2#1)(2012-3#1)
only found on##2##3##(1991-7#1)(2008-10#1)
only found##20##2##(1991-7#1)(1993-9#2)(1995-12#1)(1997-6#1)(2005-9#1)(2006-8#2)(2007-12#1)(2007-5#1)(2007-6#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
only four cases of##3##4##(2007-7#1)(2007-8#1)(2009-5#1)
only four cases##4##3##(2007-7#1)(2007-8#1)(2009-5#1)(2012-3#1)
only four of the##2##4##(1990-5#1)(2010-4#1)
only four of these had##2##5##(1991-7#1)(1994-2#1)
only four of##5##3##(1990-5#1)(1991-7#1)(1994-2#1)(2008-6#1)(2010-4#1)
only four patients##2##3##(1990-3#1)(2010-3#1)
only four##36##2##(1990-3#1)(1990-5#1)(1991-7#2)(1993-9#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)
only free##6##2##(1993-6#1)(1994-9#1)(1995-5#1)(1997-2#1)(2008-10#1)(2008-2#1)
only from a##4##3##(1995-5#1)(2007-11#1)(2008-1#1)(2011-2#1)
only from lung##2##3##(1992-6#1)(2008-5#1)
only from the##17##3##(1991-5#1)(1992-6#2)(1993-12#1)(1995-11#1)(1996-12#1)(1997-3#1)(2005-1#1)(2005-5#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2012-1#1)
only from##66##2##(1990-10#1)(1990-11#1)(1991-5#1)(1992-3#1)(1992-6#4)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-3#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-6#1)(1997-3#1)(2004-3#1)(2005-1#1)(2005-5#1)(2006-10#2)(2006-12#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-6#1)(2008-1#2)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-2#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-2#1)
only gene##2##2##(2008-10#1)(2012-2#1)
only genes##4##2##(1992-8#1)(1995-11#1)(1995-3#1)(2008-7#1)
only gradually##2##2##(2008-2#2)
only group##6##2##(1996-8#1)(2007-1#1)(2008-10#2)(2010-7#1)(2013-1#1)
only had a##2##3##(2006-7#1)(2010-4#1)
only had##7##2##(1993-10#1)(1996-12#1)(2006-7#2)(2007-11#2)(2010-4#1)
only half (50##2##3##(2012-2#2)
only half of the##4##4##(1991-11#1)(2007-12#1)(2007-8#1)(2010-8#1)
only half of##6##3##(1991-11#1)(1992-6#1)(2007-12#1)(2007-8#1)(2010-8#1)(2011-12#1)
only half##12##2##(1990-11#1)(1991-11#1)(1992-6#2)(2007-12#1)(2007-8#1)(2008-7#1)(2009-10#1)(2010-8#1)(2011-12#1)(2012-2#2)
only has to##2##3##(1990-12#1)(1997-6#1)
only has##9##2##(1990-12#1)(1993-7#1)(1997-6#1)(2008-10#1)(2008-2#1)(2009-5#1)(2009-6#1)(2011-2#1)(2013-8#1)
only have a##5##3##(2005-5#1)(2008-11#1)(2008-8#1)(2011-1#1)(2011-2#1)
only have to##2##3##(2006-10#1)(2011-2#1)
only have##12##2##(1991-11#1)(2005-5#1)(2006-10#1)(2007-12#1)(2008-11#2)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-3#1)
only healthy##2##2##(2005-5#1)(2007-11#1)
only helps##6##2##(2007-8#1)(2010-12#1)(2013-1#2)(2013-8#2)
only high##2##2##(1994-5#1)(2012-1#1)
only highly##2##2##(2008-10#1)(2010-5#1)
only histidine##2##2##(1994-10#1)(1995-3#1)
only human##4##2##(2007-4#1)(2008-11#1)(2012-1#1)(2012-2#1)
only identifiable##3##2##(1991-12#1)(2008-6#2)
only identified##2##2##(1993-6#1)(2006-2#1)
only if all##2##3##(2007-2#1)(2008-3#1)
only if it is##2##4##(1992-10#1)(2008-11#1)
only if it##4##3##(1992-10#1)(2008-10#1)(2008-11#1)(2008-4#1)
only if the##27##3##(1990-2#1)(1993-3#1)(1995-3#1)(1995-6#1)(1996-1#1)(2005-11#2)(2006-10#2)(2006-5#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#2)(2008-6#1)(2008-8#3)(2009-3#1)(2012-3#1)
only if they are##3##4##(2007-9#1)(2009-8#1)(2010-10#1)
only if they have##2##4##(2012-11#1)(2013-8#1)
only if they##7##3##(1995-6#1)(2006-2#1)(2007-9#1)(2009-8#1)(2010-10#1)(2012-11#1)(2013-8#1)
only if##77##2##(1990-2#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-7#1)(1992-10#1)(1993-3#1)(1994-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-1#1)(2005-11#2)(2006-10#2)(2006-12#2)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-9#2)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
only important##10##2##(1992-8#1)(1993-10#1)(2005-11#1)(2006-12#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-4#1)(2012-11#1)(2013-1#1)
only improve the##3##3##(2006-4#1)(2010-9#1)(2013-8#1)
only improve##6##2##(1995-2#1)(2006-4#1)(2010-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
only improved##6##2##(1992-9#1)(2006-10#1)(2008-5#1)(2011-1#1)(2013-1#2)
only in 0##2##3##(1992-1#1)(2006-12#1)
only in 1 case##2##4##(1992-8#1)(1994-1#1)
only in 1##4##3##(1990-6#1)(1992-8#1)(1994-1#1)(2008-11#1)
only in 14##2##3##(2007-10#1)(2012-3#1)
only in 17##2##3##(1990-12#1)(2007-7#1)
only in 2##2##3##(1992-6#1)(2007-10#1)
only in 4 patients##2##4##(1996-12#1)(2007-10#1)
only in 5##2##3##(1993-10#1)(2007-11#1)
only in AQP2 transfected cells##2##5##(2012-12#2)
only in M##2##3##(2008-10#1)(2008-5#1)
only in a few cases##2##5##(2008-11#1)(2009-10#1)
only in a few##6##4##(2006-2#1)(2007-2#1)(2007-8#1)(2008-11#1)(2009-10#1)(2013-1#1)
only in a limited number of##2##6##(2008-3#1)(2008-5#1)
only in a minority of##3##5##(1990-6#1)(2007-11#1)(2012-12#1)
only in a region##2##4##(2008-2#2)
only in a small##2##4##(2012-12#1)(2012-2#1)
only in a very##2##4##(1993-12#1)(2008-10#1)
only in a##31##3##(1990-2#1)(1990-6#1)(1991-3#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-3#1)(1997-6#1)(1997-7#1)(2006-2#1)(2006-7#1)(2007-11#2)(2007-2#2)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-10#1)(2010-4#1)(2010-8#1)(2011-12#1)(2012-12#2)(2012-2#1)(2013-1#1)
only in aged##2##3##(1994-5#1)(2008-7#1)
only in an##3##3##(1992-3#1)(1996-7#1)(2007-4#1)
only in association with##2##4##(2008-7#2)
only in brain##2##3##(1993-4#1)(1996-12#1)
only in case of##2##4##(2010-12#1)(2012-2#1)
only in case##3##3##(2009-2#1)(2010-12#1)(2012-2#1)
only in cases where##3##4##(1992-6#1)(1995-7#1)(2008-11#1)
only in cases##4##3##(1992-6#1)(1995-7#1)(2007-11#1)(2008-11#1)
only in cells##6##3##(1991-4#1)(1993-12#1)(1995-8#1)(1997-2#1)(1997-7#1)(2008-10#1)
only in certain##4##3##(1991-2#1)(1993-12#1)(2004-12#1)(2010-12#1)
only in endemic areas##2##4##(1996-11#1)(2008-4#1)
only in having##2##3##(2007-12#1)(2011-1#1)
only in human##3##3##(1991-12#1)(2008-9#1)(2010-11#1)
only in identifying##2##3##(2008-7#1)(2011-2#1)
only in liver and##3##4##(1990-8#1)(1994-11#1)(2008-10#1)
only in liver##4##3##(1990-8#1)(1994-11#1)(1995-3#1)(2008-10#1)
only in men##2##3##(2007-9#1)(2012-1#1)
only in mice##2##3##(1991-2#1)(1997-8#1)
only in normal experiment by comparison with normal control##2##9##(2007-6#2)
only in normal experiment by comparison with##3##7##(2007-6#3)
only in normal##4##3##(1990-5#1)(2007-6#3)
only in one case##2##4##(1991-11#1)(2012-12#1)
only in one patient##2##4##(1992-8#1)(2008-7#1)
only in one##11##3##(1990-12#1)(1991-11#1)(1991-9#1)(1992-8#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
only in part related to##2##5##(1996-7#1)(2012-3#1)
only in part##4##3##(1996-7#1)(1997-7#1)(2007-12#1)(2012-3#1)
only in patients with a##2##5##(1996-1#1)(2011-1#1)
only in patients with high##2##5##(2007-8#1)(2008-7#1)
only in patients with##17##4##(1991-12#1)(1992-12#1)(1992-5#1)(1995-3#1)(1996-1#1)(1996-6#1)(2006-10#1)(2007-10#2)(2007-8#2)(2008-4#3)(2008-7#1)(2011-1#1)(2012-12#1)
only in patients##18##3##(1991-12#2)(1992-12#1)(1992-5#1)(1995-3#1)(1996-1#1)(1996-6#1)(2006-10#1)(2007-10#2)(2007-8#2)(2008-4#3)(2008-7#1)(2011-1#1)(2012-12#1)
only in pharmacies##2##3##(1997-7#1)(2012-12#1)
only in plants##2##3##(1994-11#1)(2008-10#1)
only in proliferating##2##3##(1991-8#1)(1993-4#1)
only in rat##4##3##(1991-10#1)(1991-12#1)(1992-1#1)(1995-6#1)
only in regions##2##3##(2008-3#2)
only in relation##2##3##(2009-5#1)(2010-1#1)
only in response to##5##4##(1990-12#1)(1993-6#1)(2008-4#1)(2008-8#1)(2011-2#1)
only in selected cases##3##4##(2007-7#2)(2007-9#1)
only in severe##2##3##(2006-8#1)(2013-7#1)
only in small series##2##4##(2007-8#1)(2012-12#1)
only in small##4##3##(1992-12#1)(2007-8#1)(2010-3#1)(2012-12#1)
only in some##4##3##(1990-1#1)(1992-8#1)(1993-9#1)(2008-10#1)
only in spermatogonia##2##3##(2008-5#1)(2010-5#1)
only in the absence of the##2##6##(1991-6#1)(2007-11#1)
only in the absence of##4##5##(1991-6#1)(1992-3#1)(1996-8#1)(2007-11#1)
only in the anterior##2##4##(2008-5#1)(2012-12#1)
only in the basic##2##4##(1996-6#1)(2008-3#1)
only in the blue##2##4##(2008-2#1)(2008-3#1)
only in the brain##2##4##(1993-4#1)(2008-9#1)
only in the case of##4##5##(1991-2#1)(1993-8#1)(2008-10#1)(2008-11#1)
only in the cellular##2##4##(1994-12#1)(1997-3#1)
only in the choroid##3##4##(1994-10#1)(1996-2#1)(2009-4#1)
only in the cytosol##2##4##(1997-6#1)(2008-11#1)
only in the first##5##4##(2007-7#2)(2007-8#1)(2008-10#1)(2008-7#1)
only in the formation of##2##5##(1996-5#1)(2007-1#1)
only in the hippocampus##2##4##(1994-12#1)(2011-2#1)
only in the hospital##2##4##(1997-1#1)(2007-2#1)
only in the kidney##3##4##(1992-9#1)(2008-11#1)(2008-7#1)
only in the last##2##4##(2005-8#1)(2013-1#1)
only in the left##2##4##(2008-4#1)(2008-9#1)
only in the liver##3##4##(1990-11#2)(1997-2#1)
only in the older DS and##2##6##(1991-1#2)
only in the presence of an##2##6##(1990-7#1)(1991-5#1)
only in the presence of the##6##6##(1993-6#1)(1994-11#2)(1994-12#1)(1994-2#1)(1996-7#1)
only in the presence of##31##5##(1990-6#1)(1990-7#1)(1991-5#1)(1992-4#2)(1992-7#1)(1993-6#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-7#1)(1997-3#1)(1997-5#1)(2005-11#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-3#1)(2012-3#1)(2013-1#2)
only in the salivary glands of##2##6##(2008-10#1)(2013-1#1)
only in the study##2##4##(2009-10#1)(2013-1#1)
only in the third##2##4##(2006-2#1)(2007-7#1)
only in the triradiate lumen##2##5##(2008-10#2)
only in the##255##3##(1990-10#1)(1990-11#5)(1990-12#2)(1990-4#3)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#3)(1992-3#2)(1992-4#2)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#3)(1993-8#1)(1994-10#1)(1994-11#4)(1994-12#4)(1994-2#4)(1994-5#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#1)(1996-10#3)(1996-12#2)(1996-2#2)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-2#1)(2005-10#1)(2005-11#2)(2005-4#1)(2005-8#2)(2006-10#2)(2006-11#2)(2006-12#2)(2006-2#3)(2006-6#2)(2006-7#1)(2006-8#2)(2007-1#3)(2007-11#6)(2007-12#4)(2007-2#1)(2007-7#4)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#19)(2008-11#10)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#15)(2008-6#6)(2008-7#5)(2008-8#1)(2008-9#7)(2009-10#2)(2009-2#1)(2009-3#3)(2009-4#2)(2009-7#1)(2009-8#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#10)(2013-7#1)
only in their##8##3##(1992-9#1)(1994-9#1)(1997-7#1)(2006-10#1)(2006-2#1)(2008-3#1)(2008-4#1)(2008-7#1)
only in this##3##3##(1993-5#1)(1994-9#1)(1997-6#1)
only in those cases##3##4##(1992-12#1)(1993-10#1)(2006-8#1)
only in those##10##3##(1990-12#1)(1990-9#1)(1991-5#1)(1992-10#1)(1992-12#1)(1993-10#1)(1994-8#1)(2006-8#1)(2008-7#1)(2010-12#1)
only in tissues##2##3##(1990-8#1)(2008-10#1)
only in trace##2##3##(1996-4#1)(2004-4#1)
only in two cases##2##4##(2009-12#1)(2012-12#1)
only in two##6##3##(1991-2#1)(1996-12#1)(1997-3#1)(2008-8#1)(2009-12#1)(2012-12#1)
only in women##2##3##(2006-9#1)(2012-1#1)
only in young##2##3##(2008-7#2)
only in##759##2##(1990-1#1)(1990-10#2)(1990-11#5)(1990-12#9)(1990-2#2)(1990-3#4)(1990-4#4)(1990-5#2)(1990-6#4)(1990-7#1)(1990-8#4)(1990-9#3)(1991-1#3)(1991-10#2)(1991-11#4)(1991-12#4)(1991-2#5)(1991-3#2)(1991-4#4)(1991-5#3)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#8)(1992-1#4)(1992-10#1)(1992-11#1)(1992-12#5)(1992-2#1)(1992-3#3)(1992-4#4)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#5)(1992-9#3)(1993-1#1)(1993-10#2)(1993-11#3)(1993-12#6)(1993-2#3)(1993-3#2)(1993-4#5)(1993-5#2)(1993-6#5)(1993-7#1)(1993-8#4)(1993-9#2)(1994-1#1)(1994-10#2)(1994-11#7)(1994-12#8)(1994-2#7)(1994-3#2)(1994-5#7)(1994-6#1)(1994-7#1)(1994-8#5)(1994-9#5)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#7)(1995-4#1)(1995-5#4)(1995-6#4)(1995-7#2)(1995-8#3)(1995-9#2)(1996-1#1)(1996-10#3)(1996-11#2)(1996-12#7)(1996-2#3)(1996-4#1)(1996-5#3)(1996-6#4)(1996-7#4)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#4)(1997-4#3)(1997-5#1)(1997-6#5)(1997-7#12)(1997-8#7)(2004-1#1)(2004-12#1)(2004-2#1)(2004-4#2)(2004-9#1)(2005-10#3)(2005-11#4)(2005-4#1)(2005-8#3)(2005-9#1)(2006-10#6)(2006-11#3)(2006-12#5)(2006-2#8)(2006-4#3)(2006-6#3)(2006-7#3)(2006-8#4)(2006-9#2)(2007-1#4)(2007-10#5)(2007-11#18)(2007-12#13)(2007-2#4)(2007-3#1)(2007-4#2)(2007-5#5)(2007-6#5)(2007-7#8)(2007-8#7)(2007-9#5)(2008-1#1)(2008-10#58)(2008-11#20)(2008-12#1)(2008-2#5)(2008-3#14)(2008-4#14)(2008-5#30)(2008-6#10)(2008-7#24)(2008-8#5)(2008-9#10)(2009-10#4)(2009-12#1)(2009-2#5)(2009-3#5)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#5)(2010-1#1)(2010-11#1)(2010-12#8)(2010-2#2)(2010-3#3)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#3)(2011-1#5)(2011-12#2)(2011-2#18)(2012-1#5)(2012-11#1)(2012-12#16)(2012-2#6)(2012-3#6)(2012-4#1)(2012-8#1)(2013-1#16)(2013-7#3)(2013-8#3)
only included##2##2##(2005-10#1)(2007-10#1)
only includes##3##2##(2007-12#1)(2007-8#1)(2008-10#1)
only incompletely##2##2##(1996-9#1)(2005-10#1)
only increase##10##2##(1990-1#1)(1993-2#1)(1995-1#1)(1996-4#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-11#1)(2012-3#1)
only increased the##2##3##(1993-2#1)(2008-10#1)
only increased with##2##3##(1991-2#1)(2008-5#1)
only increased##8##2##(1991-2#1)(1993-2#1)(2007-12#1)(2008-10#3)(2008-5#1)(2012-2#1)
only increases the##5##3##(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-9#1)
only increases##7##2##(1996-12#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-9#1)
only indicated##4##2##(1990-12#1)(1993-10#1)(2008-12#1)(2010-4#1)
only individual##3##2##(1996-2#1)(2008-6#1)(2008-7#1)
only induced an##2##3##(1997-5#1)(2008-8#1)
only induced##8##2##(1993-3#1)(1995-3#1)(1997-5#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
only inherited##2##2##(1993-10#1)(2008-10#1)
only inhibited the##2##3##(1996-5#1)(2008-10#1)
only inhibited##4##2##(1996-5#2)(2008-10#2)
only inhibitory##2##2##(2005-7#1)(2008-11#1)
only inhibits##4##2##(1994-12#1)(1996-8#1)(1997-6#1)(2012-2#1)
only initial##2##2##(2008-3#1)(2013-7#1)
only injection##2##2##(1991-3#1)(2008-10#1)
only inorganic##3##2##(2008-10#2)(2008-6#1)
only into##4##2##(1991-1#1)(2007-12#1)(2008-11#1)(2008-9#1)
only intravenous##2##2##(2008-1#1)(2010-12#1)
only involving##2##2##(2008-10#2)
only is it##2##3##(2008-10#1)(2008-3#1)
only is not##2##3##(2007-12#1)(2008-1#1)
only is the##7##3##(1991-8#1)(1995-4#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
only is##16##2##(1991-12#1)(1991-5#1)(1991-8#1)(1995-4#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2010-5#1)(2012-12#1)(2013-1#1)
only isolated##5##2##(1997-2#1)(2008-10#1)(2008-5#1)(2009-2#1)(2013-8#1)
only isolates of##2##3##(2008-10#2)
only isolates##5##2##(2008-10#5)
only its##9##2##(1990-7#1)(1991-4#1)(1992-3#1)(1992-6#1)(1994-11#1)(2007-8#1)(2008-1#1)(2008-9#1)(2010-6#1)
only just##5##2##(1993-3#1)(2006-5#1)(2007-4#1)(2009-8#1)(2012-2#1)
only know##2##2##(1992-9#1)(2010-12#1)
only known from##3##3##(2007-3#1)(2008-10#1)(2012-11#1)
only known##22##2##(1991-12#1)(1991-5#1)(1991-7#1)(1995-12#1)(1995-3#1)(1996-11#1)(1997-1#1)(2007-1#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-5#1)(2009-12#2)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)
only large##2##2##(2004-2#1)(2007-8#1)
only larvae and pupae##3##4##(2007-11#3)
only larvae##4##2##(1995-2#1)(2007-11#3)
only later##3##2##(1995-3#1)(2008-10#2)
only leads to##2##3##(1990-3#1)(2013-8#1)
only led to##2##3##(2006-2#1)(2011-1#1)
only less than##2##3##(1996-5#1)(2008-10#1)
only less##4##2##(1996-5#1)(2008-10#2)(2008-5#1)
only light staining##2##3##(1995-8#1)(2008-7#1)
only lightly##2##2##(1995-12#1)(1996-5#1)
only limited amounts of##2##4##(1992-6#1)(2008-12#1)
only limited data##2##3##(2005-10#1)(2006-9#1)
only limited information is available##2##5##(2006-5#1)(2006-8#1)
only limited information##3##3##(2006-5#1)(2006-8#1)(2012-12#1)
only limited success##4##3##(1995-2#1)(2006-6#1)(2007-11#1)(2008-3#1)
only limited##31##2##(1990-2#2)(1990-7#1)(1991-12#1)(1991-3#1)(1992-6#1)(1992-7#1)(1995-2#1)(1995-3#1)(2005-10#2)(2006-11#2)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-8#1)(2011-2#1)(2012-12#3)(2012-3#2)
only little##8##2##(1995-11#1)(1995-3#1)(1996-10#1)(2007-5#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-1#1)
only local information##2##3##(1992-9#1)(2008-6#1)
only local##9##2##(1992-9#1)(1993-1#1)(1995-9#1)(1996-10#1)(2006-10#1)(2007-11#1)(2008-2#1)(2008-6#1)(2008-8#1)
only locally##3##2##(1991-10#1)(2006-12#1)(2008-3#1)
only located in##2##3##(1991-9#1)(2013-7#1)
only located##3##2##(1991-9#1)(2008-9#1)(2013-7#1)
only logical##2##2##(2007-11#1)(2008-5#1)
only loosely##3##2##(1993-8#1)(1995-5#1)(1997-1#1)
only low levels##2##3##(1995-2#2)
only low##17##2##(1991-9#1)(1992-4#1)(1993-5#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-2#2)(1995-5#1)(1997-4#1)(2006-7#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-11#1)(2011-2#1)
only major##6##2##(1994-8#1)(2005-12#1)(2006-12#1)(2008-7#1)(2009-10#1)(2011-12#1)
only males##2##2##(1991-1#1)(1991-10#1)
only manifestation of##4##3##(2007-7#1)(2007-8#1)(2009-10#1)(2013-8#1)
only marginal##9##2##(1991-5#1)(1992-10#1)(1995-6#1)(1996-12#1)(2006-6#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-3#1)
only marginally affected by the##2##5##(1990-9#1)(1996-11#1)
only marginally affected by##5##4##(1990-9#1)(1992-4#1)(1993-7#1)(1996-11#1)(2008-3#1)
only marginally affected the##2##4##(1995-6#1)(1997-1#1)
only marginally affected##8##3##(1990-9#1)(1992-4#1)(1993-7#1)(1995-6#1)(1996-11#1)(1997-1#1)(2008-3#1)(2010-11#1)
only marginally more##2##3##(1990-7#1)(2008-10#1)
only marginally##25##2##(1990-5#1)(1990-7#1)(1990-9#2)(1991-4#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-7#1)(1994-2#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#1)(1997-1#1)(2006-12#2)(2008-10#3)(2008-3#2)(2009-6#1)(2010-11#1)(2013-8#1)
only measured##2##2##(1995-11#1)(2008-10#1)
only measurements##2##2##(2008-3#2)
only medical school##2##3##(2010-5#1)(2013-8#1)
only medical##4##2##(2007-11#1)(2009-3#1)(2010-5#1)(2013-8#1)
only mild##17##2##(1990-11#1)(1991-1#1)(1991-11#1)(1994-6#1)(2005-7#1)(2006-3#1)(2006-7#1)(2007-10#1)(2007-8#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-6#1)(2011-1#1)
only mildly affected in##2##4##(1994-12#1)(2011-1#1)
only mildly##8##2##(1993-2#1)(1994-12#1)(1995-4#1)(1996-6#1)(2007-5#1)(2010-2#1)(2011-1#1)(2012-3#1)
only minimal changes in##2##4##(2008-8#1)(2013-8#1)
only minimal changes##3##3##(1991-8#1)(2008-8#1)(2013-8#1)
only minimal##14##2##(1990-11#1)(1991-8#1)(1992-4#1)(1993-11#1)(1993-5#1)(1996-3#1)(2005-11#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2013-8#1)
only minimally##9##2##(1992-6#1)(1995-5#1)(1996-8#1)(2006-6#1)(2007-7#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
only minor changes##3##3##(1990-10#1)(1990-2#1)(2008-11#1)
only minor differences##3##3##(1990-3#1)(1991-4#1)(2006-11#1)
only minor influence on##2##4##(1995-5#1)(2008-10#1)
only minor modifications##2##3##(2008-2#1)(2008-4#1)
only minor symptoms##4##3##(1995-6#1)(2006-10#1)(2006-12#1)(2007-11#1)
only minor##34##2##(1990-10#1)(1990-2#2)(1990-3#1)(1991-4#1)(1992-3#1)(1993-8#1)(1994-11#1)(1995-5#2)(1995-6#1)(1996-4#1)(1996-5#1)(1997-3#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-11#2)(2007-5#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-4#1)(2013-1#1)
only moderate##16##2##(1991-4#1)(1994-5#1)(1995-8#1)(1996-10#1)(1996-4#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2010-5#1)(2011-1#1)(2012-3#1)
only moderately elevated##2##3##(1991-2#1)(1997-1#1)
only moderately reduced##2##3##(1992-8#1)(2008-11#1)
only moderately##18##2##(1990-11#1)(1990-8#1)(1991-10#2)(1991-2#1)(1992-2#1)(1992-8#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-5#1)(1997-1#1)(2008-10#1)(2008-11#1)(2010-4#1)(2010-6#1)(2011-2#1)(2013-1#1)
only modest##20##2##(1990-12#2)(1991-2#1)(1992-3#1)(1993-4#1)(1995-2#2)(1996-5#1)(1997-2#1)(1997-7#1)(2005-12#1)(2006-10#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-1#1)
only modestly##6##2##(1991-12#1)(1997-2#1)(2008-7#1)(2010-3#1)(2012-1#1)(2013-1#1)
only molecular##3##2##(2006-8#1)(2008-2#1)(2008-6#1)
only natural##3##2##(1990-12#1)(1995-11#1)(2008-7#1)
only necessary##3##2##(1992-11#1)(2006-6#1)(2009-5#1)
only needed##2##2##(1996-12#1)(2012-12#1)
only needs to##2##3##(2008-10#1)(2009-2#1)
only needs##3##2##(2008-10#1)(2009-2#1)(2012-1#1)
only negligible amounts of##2##4##(1991-12#1)(1996-12#1)
only negligible##3##2##(1991-12#1)(1996-12#1)(2008-2#1)
only neurons##4##2##(1994-8#1)(1996-8#1)(2007-12#1)(2008-7#1)
only new##3##2##(2010-12#1)(2010-3#1)(2010-4#1)
only nine##7##2##(1990-4#1)(1991-2#1)(1992-5#1)(1995-4#1)(2006-10#2)(2012-3#1)
only nitrogen##2##2##(1994-11#1)(1996-6#1)
only now beginning to##3##4##(1993-6#1)(2012-11#2)
only now being##3##3##(2007-7#1)(2008-9#1)(2012-2#1)
only now##11##2##(1990-5#1)(1993-6#1)(2007-7#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-5#2)(2012-11#2)(2012-2#1)
only nucleotides##2##2##(1990-3#1)(1991-7#1)
only objective##2##2##(1991-3#1)(2006-10#1)
only observed after##2##3##(1991-3#1)(1994-6#1)
only observed at##3##3##(1993-7#1)(2008-10#1)(2008-7#1)
only observed for##5##3##(1990-3#1)(1991-5#1)(1997-1#1)(2009-7#1)(2012-2#1)
only observed if##2##3##(1993-6#1)(2008-11#1)
only observed in the##3##4##(1997-1#1)(2009-4#1)(2011-2#1)
only observed in##13##3##(1993-6#1)(1994-6#1)(1996-6#2)(1996-8#1)(1997-1#1)(2005-11#1)(2007-3#1)(2008-10#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-5#1)
only observed under##2##3##(1992-3#1)(2008-7#1)
only observed when##3##3##(1991-3#1)(1993-3#1)(1994-11#1)
only observed##35##2##(1990-3#1)(1990-4#1)(1991-3#2)(1991-5#1)(1992-3#1)(1993-3#1)(1993-6#2)(1993-7#1)(1994-11#1)(1994-6#2)(1996-6#2)(1996-8#1)(1997-1#2)(2005-11#2)(2007-3#1)(2008-10#3)(2008-11#1)(2008-7#2)(2009-4#1)(2009-7#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-5#1)(2013-1#1)
only obtained##2##2##(2008-10#1)(2013-8#1)
only obvious##2##2##(1991-11#1)(2008-9#1)
only occasional##4##2##(1990-2#1)(1993-11#1)(2007-4#1)(2008-12#1)
only occasionally after##2##3##(2008-5#1)(2008-6#1)
only occasionally##13##2##(1992-1#1)(1992-4#1)(1994-5#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2011-2#1)
only occur in the##3##4##(1995-8#1)(2010-12#1)(2010-5#1)
only occur once##2##3##(2005-7#2)
only occur when the##2##4##(1994-3#1)(2005-8#1)
only occur##12##2##(1993-2#1)(1994-3#2)(1995-8#1)(2005-7#2)(2005-8#1)(2007-1#1)(2008-7#1)(2010-12#1)(2010-5#1)(2011-2#1)
only occurred after##2##3##(1994-5#1)(1996-9#1)
only occurred in##4##3##(2008-10#1)(2010-12#1)(2012-12#1)(2013-8#1)
only occurred when P was##2##5##(1993-2#1)(2012-3#1)
only occurred when##3##3##(1993-2#1)(2011-2#1)(2012-3#1)
only occurred##12##2##(1993-2#1)(1994-2#1)(1994-5#1)(1996-9#1)(2008-10#2)(2008-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
only occurs in the##2##4##(2008-8#1)(2013-8#1)
only occurs in##4##3##(1995-6#1)(2008-8#1)(2010-10#1)(2013-8#1)
only occurs when##2##3##(1990-5#1)(2006-12#1)
only occurs##8##2##(1990-5#1)(1995-6#1)(2006-12#1)(2007-1#1)(2008-4#1)(2008-8#1)(2010-10#1)(2013-8#1)
only of a##2##3##(1990-8#1)(1991-4#1)
only of limited##2##3##(1992-12#1)(2006-2#1)
only of the##8##3##(1993-6#1)(2005-11#1)(2008-11#2)(2008-2#2)(2008-3#2)
only of##43##2##(1990-3#1)(1990-8#1)(1991-11#1)(1991-4#1)(1992-10#1)(1992-12#1)(1993-6#2)(1993-8#1)(1994-2#1)(1996-2#1)(1997-6#1)(1997-8#1)(2005-1#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#1)(2008-9#1)(2010-7#2)(2012-12#1)
only on a##2##3##(1991-3#1)(1996-2#1)
only on an##2##3##(2007-11#1)(2008-1#1)
only on its##3##3##(1997-7#1)(2008-4#1)(2013-1#1)
only on measurable##2##3##(2007-8#1)(2008-8#1)
only on one##2##3##(2009-4#1)(2011-1#1)
only on strawberry##2##3##(2008-10#2)
only on the basis of clinical##2##6##(1992-10#1)(1992-12#1)
only on the basis of##6##5##(1991-3#1)(1992-10#1)(1992-12#1)(1997-1#1)(1997-7#1)(2008-2#1)
only on the distance##2##4##(1993-7#1)(2008-10#1)
only on the first##2##4##(1993-5#1)(2007-12#1)
only on the health##2##4##(1991-3#1)(2010-12#1)
only on the left side##2##5##(2008-1#1)(2008-5#1)
only on the presence of##3##5##(1991-2#2)(1997-1#1)
only on the presence##4##4##(1991-2#2)(1997-1#1)(2008-4#1)
only on the##71##3##(1990-2#1)(1991-2#3)(1991-3#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-5#1)(1993-7#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-5#1)(1996-8#1)(1997-1#2)(1997-7#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#8)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-2#6)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)
only on their##3##3##(1995-11#1)(1997-8#1)(2007-7#1)
only on##167##2##(1990-2#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#4)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-5#1)(1993-7#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-5#1)(1996-2#1)(1996-8#1)(1997-1#2)(1997-6#1)(1997-7#2)(1997-8#1)(2004-10#1)(2005-1#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-2#1)(2007-1#1)(2007-11#2)(2007-12#9)(2007-2#1)(2007-6#1)(2007-7#4)(2007-8#3)(2008-1#5)(2008-10#24)(2008-11#2)(2008-2#7)(2008-3#3)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#4)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#1)
only once in##3##3##(2005-12#1)(2006-12#1)(2012-11#1)
only once under Ca2(+)-free conditions##2##5##(1990-7#2)
only once##23##2##(1990-5#1)(1990-7#2)(1991-7#1)(1992-12#1)(1996-12#1)(1996-2#1)(1997-6#1)(2005-12#1)(2006-12#1)(2006-5#2)(2007-12#3)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-6#1)(2011-1#1)(2012-11#1)
only one CO molecule##2##4##(1990-3#2)
only one amino acid##3##4##(1991-12#1)(1994-9#1)(1997-8#1)
only one aspect of##4##4##(2006-5#1)(2008-9#1)(2013-1#2)
only one calibration##2##3##(1996-7#1)(2007-12#1)
only one case in##2##4##(1991-4#1)(1996-5#1)
only one case of##6##4##(1990-9#1)(1991-5#1)(2008-4#1)(2010-6#1)(2012-3#2)
only one case##19##3##(1990-9#2)(1991-4#1)(1991-5#1)(1991-8#1)(1996-5#1)(1997-8#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-4#1)(2008-6#1)(2008-9#1)(2010-6#1)(2012-3#2)(2013-1#1)
only one cell##2##3##(1992-3#1)(1996-11#1)
only one child##2##3##(1990-8#1)(1996-12#1)
only one color##2##3##(2007-12#1)(2008-2#1)
only one copy of##2##4##(2008-9#1)(2012-3#1)
only one day##2##3##(1991-3#1)(2006-8#1)
only one enzyme##2##3##(1992-8#1)(2008-5#1)
only one episode##2##3##(2007-7#1)(2010-12#1)
only one form##2##3##(1995-8#1)(2012-2#1)
only one gene##3##3##(1997-2#1)(2009-5#2)
only one group##2##3##(1990-11#1)(2008-10#1)
only one had##3##3##(1992-3#1)(2007-1#1)(2008-9#1)
only one hospital##2##3##(1995-9#1)(2007-2#1)
only one in##3##3##(1996-11#1)(2011-2#2)
only one instance##2##3##(1996-12#1)(2009-1#1)
only one is##2##3##(1990-11#1)(2006-12#1)
only one isolate##2##3##(2008-10#1)(2012-2#1)
only one major##5##3##(1990-6#1)(1992-12#1)(1992-7#1)(1995-2#1)(2008-7#1)
only one mating##2##3##(2008-10#1)(2008-8#1)
only one of four##3##4##(2007-12#1)(2008-10#1)(2008-7#1)
only one of many##2##4##(1990-5#1)(2006-12#1)
only one of several##4##4##(1990-2#1)(1994-2#1)(2008-11#1)(2009-8#1)
only one of the four##4##5##(1997-6#1)(2007-5#1)(2008-10#1)(2009-3#1)
only one of the many##4##5##(1990-2#1)(1995-11#1)(1996-3#1)(2011-1#1)
only one of the populations##2##5##(2008-8#1)(2008-9#1)
only one of the two##11##5##(1993-11#1)(1993-8#1)(1997-1#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-7#2)(2010-5#2)(2011-2#1)
only one of the##42##4##(1990-2#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-5#1)(1993-11#2)(1993-2#1)(1993-8#1)(1994-12#1)(1995-11#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#6)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-3#1)
only one of them##4##4##(1991-2#2)(1992-1#1)(2013-8#1)
only one of these##5##4##(1995-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2012-12#1)
only one of which is##3##5##(1993-5#1)(1995-1#1)(1995-2#1)
only one of which was##3##5##(1992-9#1)(1994-6#1)(1996-7#1)
only one of which##7##4##(1992-9#1)(1993-5#1)(1994-6#1)(1995-1#1)(1995-2#1)(1996-7#1)(2009-4#1)
only one of##74##3##(1990-11#1)(1990-2#2)(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-8#1)(1991-9#1)(1992-1#2)(1992-5#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#2)(1996-3#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#2)(2009-8#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
only one or two lesions##2##5##(2007-2#1)(2012-12#1)
only one or two##7##4##(1993-9#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-8#1)(2012-12#1)
only one or##9##3##(1991-9#1)(1993-9#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-8#1)(2012-12#1)
only one other##3##3##(1991-8#1)(1995-12#1)(2008-12#1)
only one out of##3##4##(1990-4#1)(1991-9#1)(2010-12#1)
only one oxygen##2##3##(1995-10#1)(2008-3#1)
only one pair of##2##4##(1992-9#1)(2007-12#1)
only one parameter##5##3##(2006-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)
only one patient developed##2##4##(2008-1#1)(2008-6#1)
only one patient had##2##4##(1992-11#1)(1996-6#1)
only one patient was##2##4##(1992-11#1)(2008-10#1)
only one patient##15##3##(1992-11#2)(1992-8#1)(1993-10#1)(1993-2#1)(1996-6#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-6#1)(2011-2#1)(2012-3#1)
only one plant##2##3##(2008-5#1)(2012-2#1)
only one previous report of##2##5##(2006-10#1)(2012-12#1)
only one process##2##3##(1992-10#1)(1996-2#1)
only one protein##2##3##(2008-10#1)(2008-9#1)
only one report of##2##4##(2007-9#1)(2008-12#1)
only one report##3##3##(2007-9#1)(2008-12#1)(2013-8#1)
only one side of the##3##5##(1990-11#1)(1991-5#1)(1997-4#1)
only one single##4##3##(1990-11#1)(2007-3#1)(2008-11#1)(2013-1#1)
only one species##4##3##(1992-12#1)(2007-12#1)(2008-8#1)(2011-2#1)
only one specific##2##3##(2008-11#2)
only one standard solution##2##4##(2008-10#2)
only one step in##2##4##(2006-10#1)(2013-1#1)
only one step##4##3##(1990-4#1)(2006-10#1)(2008-10#1)(2013-1#1)
only one strain##2##3##(1996-12#1)(2008-11#1)
only one study has##2##4##(1994-11#1)(2012-2#1)
only one study showed##2##4##(2011-2#2)
only one study##5##3##(1994-11#1)(2011-2#2)(2012-12#1)(2012-2#1)
only one third of the##3##5##(1992-3#1)(2006-8#1)(2010-11#1)
only one third of##4##4##(1992-3#1)(2006-8#1)(2007-10#1)(2010-11#1)
only one to##5##3##(1991-5#1)(1995-8#1)(2006-2#1)(2008-10#1)(2008-12#1)
only one type of##8##4##(1991-9#1)(1993-3#1)(2005-9#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-7#1)(2010-5#1)
only one with##2##3##(1990-5#1)(2008-10#1)
only one year##2##3##(2006-4#1)(2008-4#1)
only one##489##2##(1990-11#7)(1990-12#1)(1990-2#2)(1990-3#3)(1990-4#3)(1990-5#6)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#3)(1991-3#3)(1991-4#2)(1991-5#3)(1991-7#2)(1991-8#3)(1991-9#5)(1992-1#3)(1992-10#3)(1992-11#3)(1992-12#2)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#2)(1993-10#1)(1993-11#3)(1993-12#1)(1993-2#3)(1993-3#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#3)(1993-9#3)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#2)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-11#3)(1996-12#4)(1996-2#1)(1996-3#3)(1996-5#1)(1996-6#1)(1996-7#3)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#5)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#5)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-4#1)(2005-7#1)(2005-9#1)(2006-10#8)(2006-11#1)(2006-12#7)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#5)(2007-12#18)(2007-2#2)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#6)(2007-9#5)(2008-1#6)(2008-10#48)(2008-11#8)(2008-12#5)(2008-2#12)(2008-3#12)(2008-4#5)(2008-5#10)(2008-6#5)(2008-7#12)(2008-8#12)(2008-9#14)(2009-1#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#5)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#11)(2012-11#1)(2012-12#5)(2012-2#6)(2012-3#8)(2013-1#8)(2013-7#3)(2013-8#6)
only one)##2##2##(2007-12#1)(2011-1#1)
only one-fourth##2##2##(1997-4#1)(2008-8#1)
only one-third##3##2##(1992-9#1)(2008-10#1)(2009-4#1)
only open##2##2##(1994-12#1)(2007-9#1)
only optimal##2##2##(1994-5#1)(2006-4#1)
only option##5##2##(1992-3#1)(1994-12#1)(2004-11#1)(2008-7#1)(2008-9#1)
only or##8##2##(1996-11#1)(2006-11#1)(2007-10#1)(2008-3#1)(2008-6#1)(2010-11#1)(2012-2#1)(2013-1#1)
only other##6##2##(1993-6#1)(1995-6#1)(1997-4#1)(2008-10#1)(2008-4#1)(2009-12#1)
only over a##2##3##(2008-10#1)(2008-3#1)
only over##6##2##(1993-6#1)(2008-10#3)(2008-3#1)(2011-12#1)
only parameters##2##2##(2007-7#1)(2013-1#1)
only part of a##2##4##(2008-11#1)(2008-6#1)
only part of the##10##4##(1991-4#1)(1993-12#1)(1996-5#1)(1997-5#1)(2006-10#1)(2008-1#2)(2008-3#1)(2008-7#1)(2012-1#1)
only part of##13##3##(1991-4#1)(1993-12#1)(1996-5#1)(1997-5#1)(2006-10#1)(2008-1#2)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2012-1#1)
only part##14##2##(1991-4#1)(1993-12#1)(1996-5#1)(1996-9#1)(1997-5#1)(2006-10#1)(2008-1#2)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2012-1#1)
only partial compensation is attainable##2##5##(2007-12#1)(2008-2#1)
only partial compensation##3##3##(2007-12#1)(2008-2#2)
only partial##25##2##(1990-2#1)(1990-8#1)(1991-10#1)(1992-7#3)(1994-9#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-6#2)(2005-9#1)(2006-12#2)(2006-5#1)(2007-12#1)(2008-2#3)(2008-5#1)(2008-9#2)(2011-1#1)(2011-2#1)
only partially blocked by##3##4##(1991-6#1)(1996-7#1)(2008-4#1)
only partially blocked##4##3##(1990-9#1)(1991-6#1)(1996-7#1)(2008-4#1)
only partially by##2##3##(1990-3#1)(1995-10#1)
only partially effective##4##3##(2007-1#1)(2008-10#1)(2008-9#1)(2012-2#1)
only partially explained by##2##4##(1991-8#1)(2008-10#1)
only partially inhibited by##2##4##(1990-3#1)(1993-3#1)
only partially inhibited##6##3##(1990-3#1)(1993-3#1)(1993-6#1)(1995-10#1)(1996-8#1)(2009-2#1)
only partially modified##3##3##(1990-9#1)(2012-11#2)
only partially or not##2##4##(2008-6#1)(2008-7#1)
only partially reversed##2##3##(1991-9#1)(1997-5#1)
only partially to##2##3##(1994-8#1)(2008-10#1)
only partially understood##3##3##(2006-10#1)(2008-8#1)(2009-8#1)
only partially##76##2##(1990-10#1)(1990-3#2)(1990-5#2)(1990-7#1)(1990-9#2)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-7#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-5#1)(1994-6#2)(1994-8#2)(1995-10#3)(1995-12#1)(1995-2#1)(1996-10#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-5#1)(1997-8#1)(2005-11#1)(2006-10#3)(2006-7#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#2)(2012-12#3)(2012-2#1)(2013-8#1)
only partly by##2##3##(1991-9#1)(2005-11#1)
only partly understood##2##3##(1997-6#1)(2006-10#1)
only partly##10##2##(1991-4#1)(1991-9#1)(1992-12#2)(1994-12#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-8#1)
only pathological##2##2##(2007-11#1)(2010-11#1)
only patients who##2##3##(1990-8#1)(2004-3#1)
only patients with##5##3##(1991-6#1)(1992-6#1)(2007-8#1)(2008-3#1)(2008-8#1)
only patients##9##2##(1990-8#1)(1991-2#1)(1991-6#1)(1992-6#1)(2004-3#1)(2006-6#1)(2007-8#1)(2008-3#1)(2008-8#1)
only peptidase activity##2##3##(1990-3#2)
only percent##2##2##(2006-7#1)(2008-4#1)
only performed##3##2##(2006-8#1)(2009-9#1)(2012-12#1)
only phosphatidylcholine##2##2##(1990-5#1)(1990-9#1)
only physician##2##2##(1995-9#1)(1997-1#1)
only pixels##2##2##(2008-2#1)(2008-3#1)
only plasma##2##2##(1991-10#1)(1997-5#1)
only poor##3##2##(2007-11#1)(2008-1#1)(2008-10#1)
only poorly##6##2##(1991-8#1)(1994-3#1)(1995-5#1)(1997-4#1)(2008-7#1)(2013-1#1)
only positive##4##2##(2008-5#1)(2009-5#1)(2011-2#1)(2012-1#1)
only positively charged##2##3##(1997-7#1)(2008-10#1)
only possible by##2##3##(1996-6#1)(2007-11#1)
only possible in##3##3##(2008-10#1)(2008-4#1)(2012-12#1)
only possible when##2##3##(2008-1#1)(2008-10#1)
only possible##18##2##(1991-12#1)(1992-5#1)(1993-10#1)(1994-12#1)(1996-6#1)(1996-7#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-4#2)(2008-6#1)(2012-12#1)(2012-2#1)(2013-8#1)
only potentially##3##2##(2008-3#1)(2011-2#1)(2013-1#1)
only potentiated##2##2##(1995-7#1)(2008-11#1)
only preliminary##4##2##(1995-7#1)(2009-5#1)(2010-12#1)(2011-2#1)
only present during##2##3##(2007-12#1)(2008-10#1)
only present in the##4##4##(1991-9#1)(1993-12#1)(2009-2#1)(2012-12#1)
only present in##10##3##(1991-11#1)(1991-9#1)(1993-12#1)(1996-2#1)(1996-5#1)(2008-10#1)(2008-5#1)(2009-2#1)(2011-1#1)(2012-12#1)
only present##16##2##(1991-11#1)(1991-9#1)(1993-12#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-5#1)(2004-2#1)(2007-12#1)(2008-10#2)(2008-5#2)(2009-2#1)(2011-1#1)(2012-12#1)
only produce##4##2##(2008-10#1)(2008-2#1)(2009-2#1)(2013-1#1)
only produced a##2##3##(1994-6#1)(1995-3#1)
only produced by##2##3##(1997-5#1)(2008-10#1)
only produced##7##2##(1994-6#1)(1995-3#1)(1997-5#1)(2006-8#1)(2008-10#2)(2011-1#1)
only produces##3##2##(1990-2#1)(1991-5#1)(2004-11#1)
only products##2##2##(2006-8#1)(2011-2#1)
only propylene##2##2##(2007-11#1)(2008-5#1)
only protein##4##2##(1991-7#1)(1994-2#1)(1994-8#1)(2007-12#1)
only provide##7##2##(1994-11#1)(1994-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-1#1)(2013-1#1)
only provided physiotherapy##2##3##(2012-12#2)
only provided the##2##3##(2008-11#1)(2008-8#1)
only provided##10##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
only provides a##2##3##(2008-1#1)(2008-11#1)
only provides##9##2##(1992-6#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-7#1)(2012-3#1)
only quantitative##3##2##(1994-3#1)(2008-10#1)(2012-1#1)
only rare variants##2##3##(2012-3#2)
only rare##5##2##(2009-4#1)(2012-12#2)(2012-3#2)
only rarely been##5##3##(1991-3#1)(1992-5#1)(2006-10#1)(2011-2#1)(2012-2#1)
only rarely in the##2##4##(2008-10#2)
only rarely were##2##3##(1993-3#1)(2008-10#1)
only rarely##23##2##(1991-10#1)(1991-12#1)(1991-3#1)(1991-6#2)(1991-8#1)(1992-2#1)(1992-5#1)(1993-3#1)(1997-2#1)(2006-10#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
only reached##3##2##(1997-2#1)(2006-10#1)(2012-2#1)
only reacted##2##2##(1993-5#1)(2008-10#1)
only readily available##2##3##(2007-12#1)(2008-3#1)
only readily##3##2##(1996-4#1)(2007-12#1)(2008-3#1)
only received##3##2##(2006-10#1)(2011-2#1)(2013-1#1)
only recently been##13##3##(1991-6#1)(1994-8#1)(1995-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2011-1#1)
only recently described##3##3##(1992-10#1)(2011-2#1)(2012-11#1)
only recently have##4##3##(2008-1#1)(2008-3#1)(2010-3#1)(2013-8#1)
only recently that##5##3##(2006-12#1)(2006-8#1)(2007-11#1)(2009-6#1)(2013-1#1)
only recently##49##2##(1991-6#1)(1992-1#1)(1992-10#1)(1992-8#2)(1993-1#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#1)(1997-1#1)(2006-12#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#2)
only recognize the##2##3##(1991-9#1)(1993-11#1)
only recognize##3##2##(1991-9#1)(1993-11#1)(1995-3#1)
only reduced by##2##3##(1990-3#1)(1995-7#1)
only reduced##8##2##(1990-3#1)(1993-8#1)(1995-1#1)(1995-4#1)(1995-7#1)(2008-10#1)(2009-10#1)(2011-2#1)
only reflects##2##2##(2008-8#1)(2012-12#1)
only regulate##2##2##(2006-10#1)(2008-8#1)
only related to the##2##4##(2007-5#1)(2008-10#1)
only related to##3##3##(2007-5#1)(2008-10#1)(2012-12#1)
only relatively few of these cell-based approaches have entered the clinic##2##11##(2012-12#2)
only relatively small##2##3##(1994-12#1)(1997-3#1)
only relatively##5##2##(1994-12#1)(1997-3#1)(1997-5#1)(2012-12#2)
only relevant##3##2##(2006-9#1)(2008-10#1)(2012-2#1)
only reliable##7##2##(1993-7#1)(1994-6#1)(1996-12#1)(1997-8#1)(2007-7#1)(2008-1#1)(2012-1#1)
only remotely##3##2##(1990-6#1)(1995-2#1)(1996-6#1)
only reported##4##2##(2007-8#1)(2008-1#1)(2012-12#1)(2012-2#1)
only require##2##2##(1996-12#1)(2012-3#1)
only requires the##2##3##(2008-5#1)(2012-11#1)
only requires##7##2##(1997-8#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-2#1)(2011-2#1)(2012-11#1)
only requiring##2##2##(1997-4#1)(2011-2#1)
only responsible##3##2##(2007-10#1)(2008-1#1)(2010-6#1)
only resulted in a##2##4##(2010-7#1)(2012-1#1)
only resulted in the##2##4##(2007-8#1)(2008-5#1)
only resulted in##6##3##(2007-8#1)(2008-5#2)(2010-7#2)(2012-1#1)
only results in##5##3##(1993-3#1)(1995-1#1)(2008-10#1)(2008-8#1)(2011-2#1)
only results##6##2##(1990-7#1)(1993-3#1)(1995-1#1)(2008-10#1)(2008-8#1)(2011-2#1)
only retain##2##2##(1994-5#1)(2008-2#1)
only revealed##4##2##(2009-4#1)(2009-8#1)(2013-1#1)(2013-8#1)
only sample##2##2##(1994-9#1)(2008-10#1)
only samples##3##2##(1992-7#1)(1997-7#1)(2007-7#1)
only scanty##3##2##(1995-10#1)(2007-3#1)(2007-9#1)
only scarcely##2##2##(1996-4#1)(2009-9#1)
only seen in the##2##4##(1993-4#2)
only seen in##3##3##(1990-5#1)(1993-4#2)
only seen##5##2##(1990-5#1)(1993-3#1)(1993-4#2)(1995-2#1)
only selected##3##2##(1991-2#1)(1993-5#1)(2011-1#1)
only sensitive##2##2##(2008-10#1)(2013-1#1)
only serine##2##2##(1990-2#1)(1993-8#1)
only serum##2##2##(2008-1#1)(2008-10#1)
only serve to##2##3##(2008-11#1)(2012-2#1)
only seven of##2##3##(2008-10#1)(2008-4#1)
only seven##12##2##(1993-12#1)(2007-12#1)(2007-3#1)(2007-8#2)(2008-10#2)(2008-3#1)(2008-4#1)(2012-3#1)(2013-1#2)
only several##2##2##(1996-2#1)(2008-10#1)
only severe##2##2##(2012-12#1)(2012-3#1)
only short term##2##3##(2007-11#1)(2012-2#1)
only short##4##2##(1993-9#1)(1997-4#1)(2007-11#1)(2012-2#1)
only showed##8##2##(1990-5#1)(1991-3#1)(2005-9#1)(2008-10#1)(2008-5#1)(2010-12#1)(2013-7#2)
only shown##2##2##(2006-6#1)(2008-7#1)
only side##3##2##(1990-5#1)(1990-9#1)(2005-7#1)
only sign of##3##3##(1992-12#1)(2011-1#1)(2013-1#1)
only significant difference##4##3##(1992-8#1)(1994-2#1)(1995-1#1)(2013-1#1)
only significant effect of##2##4##(1990-9#1)(2007-6#1)
only significant##29##2##(1990-4#2)(1990-9#1)(1991-11#1)(1992-8#1)(1993-1#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-12#1)(1996-3#1)(1997-1#1)(2007-10#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
only significantly##5##2##(1993-12#1)(1996-1#1)(2006-9#1)(2008-10#1)(2009-4#1)
only simple##2##2##(1993-6#1)(2008-7#1)
only single genotypic##2##3##(2008-12#2)
only single##10##2##(1993-6#1)(1994-8#1)(1995-7#1)(2008-10#2)(2008-12#2)(2008-8#1)(2011-1#1)(2012-2#1)
only site##3##2##(1990-5#1)(2006-6#1)(2013-1#1)
only sites##2##2##(1995-11#1)(1996-9#1)
only six##14##2##(1990-5#1)(1992-11#1)(1994-6#1)(1995-1#1)(1995-3#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2010-4#1)(2011-2#1)
only skin##2##2##(2006-10#1)(2008-8#1)
only slight changes in##2##4##(1991-7#1)(2006-12#1)
only slight changes##3##3##(1991-7#1)(2006-12#1)(2009-6#1)
only slight differences##2##3##(1996-2#1)(2011-12#1)
only slight increases##2##3##(1990-12#1)(2008-10#1)
only slight##21##2##(1990-12#2)(1991-12#1)(1991-7#1)(1992-4#1)(1993-8#1)(1994-2#1)(1996-2#1)(1996-5#1)(1997-6#1)(2003-11#1)(2006-12#1)(2007-11#1)(2008-10#2)(2009-10#1)(2009-6#1)(2011-1#1)(2011-12#2)(2013-7#1)
only slightly affected##4##3##(1995-7#1)(1995-8#1)(1996-5#1)(2005-11#1)
only slightly by##2##3##(1995-7#1)(1997-6#1)
only slightly elevated in##2##4##(1990-2#1)(1993-11#1)
only slightly enhanced##2##3##(1995-11#1)(2008-5#1)
only slightly in##2##3##(1992-6#1)(2007-7#1)
only slightly induced##2##3##(1990-12#1)(2010-3#1)
only slightly influenced by##3##4##(1990-2#1)(1993-8#1)(2008-2#1)
only slightly inhibited##5##3##(1990-11#1)(1995-11#1)(1996-2#1)(2008-6#1)(2008-8#1)
only slightly less##2##3##(1995-3#1)(2008-5#1)
only slightly lower##4##3##(1996-3#2)(2005-7#1)(2010-7#1)
only slightly modified##3##3##(1993-11#1)(1994-6#1)(2008-8#1)
only slightly more##3##3##(1991-11#1)(2008-10#1)(2009-9#1)
only slightly on##2##3##(2007-12#1)(2008-3#1)
only slightly reduced##3##3##(1994-5#1)(1995-2#1)(1995-5#1)
only slightly the##2##3##(1990-8#1)(1996-2#1)
only slightly to##2##3##(1990-7#1)(1991-9#1)
only slightly##86##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-4#1)(1991-9#2)(1992-1#2)(1992-11#1)(1992-6#1)(1993-1#1)(1993-11#3)(1993-12#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#3)(1995-2#3)(1995-3#2)(1995-5#2)(1995-7#3)(1995-8#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-5#1)(1996-7#1)(1997-6#1)(2005-11#2)(2005-7#1)(2006-8#1)(2007-11#4)(2007-12#3)(2007-7#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#2)(2009-10#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-3#2)(2010-7#1)(2012-1#2)(2012-2#1)
only small amounts of##5##4##(1993-7#1)(1996-5#1)(2008-10#1)(2008-11#1)(2010-12#1)
only small and##2##3##(1997-3#1)(1997-4#1)
only small numbers of##2##4##(2007-11#1)(2008-12#1)
only small quantities of##2##4##(1994-3#1)(2008-9#1)
only small##34##2##(1990-2#1)(1990-7#1)(1991-12#1)(1991-4#1)(1993-6#1)(1993-7#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-4#2)(1997-6#1)(2006-3#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-12#1)(2010-2#1)(2011-2#3)(2012-11#1)(2012-12#1)(2013-8#1)
only some of the##4##4##(1990-11#1)(1996-12#1)(1997-2#1)(2008-11#1)
only some of them##3##4##(1996-3#1)(2013-1#2)
only some of##9##3##(1990-11#1)(1996-12#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2013-1#2)(2013-8#1)
only some##18##2##(1990-11#2)(1990-4#1)(1991-9#1)(1995-10#1)(1996-12#1)(1996-3#1)(1997-2#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2013-1#2)(2013-8#2)
only species in##3##3##(2008-10#1)(2011-2#1)(2013-7#1)
only species of the##2##4##(2011-2#2)
only species of##5##3##(2006-2#1)(2007-5#1)(2010-8#1)(2011-2#2)
only species present in##2##4##(1990-2#1)(2008-10#1)
only species##11##2##(1990-2#1)(2006-2#1)(2007-5#1)(2008-10#2)(2009-8#1)(2010-8#1)(2011-2#3)(2013-7#1)
only specific##4##2##(1993-4#1)(2008-10#1)(2008-3#1)(2010-12#1)
only sporadic##2##2##(2007-10#2)
only sporadically##2##2##(2008-7#2)
only stable##2##2##(1990-3#1)(2007-7#1)
only starting to##2##3##(2011-1#1)(2013-8#1)
only starting##4##2##(2009-2#1)(2010-4#1)(2011-1#1)(2013-8#1)
only statistically significant##4##3##(1996-5#1)(2008-9#1)(2010-12#1)(2013-8#1)
only stimulated##2##2##(1995-8#1)(2008-3#1)
only stimulates##3##2##(1992-9#1)(1996-11#1)(2007-5#1)
only strains##2##2##(2008-10#2)
only study##2##2##(2008-7#1)(2011-2#1)
only subject##2##2##(2011-2#1)(2013-8#1)
only subjective##2##2##(2006-10#1)(2011-2#1)
only substantially##2##2##(1990-10#1)(1991-7#1)
only substrate##3##2##(2006-10#1)(2012-3#1)(2013-1#1)
only successful##2##2##(1997-8#1)(2008-5#1)
only such##3##2##(2007-7#1)(2008-7#1)(2012-1#1)
only suffer##2##2##(2008-5#1)(2013-8#1)
only suggest a role for##2##5##(2007-7#1)(2011-1#1)
only surface##2##2##(2008-2#1)(2010-2#1)
only sustained##3##2##(1991-1#1)(1995-12#1)(1997-6#1)
only symptom##4##2##(1993-5#1)(1993-8#1)(2006-2#1)(2008-7#1)
only symptomatic##2##2##(1990-5#1)(1996-11#1)
only takes##2##2##(2008-10#1)(2008-11#1)
only technique##2##2##(2008-11#2)
only temporary##4##2##(2006-1#1)(2007-1#1)(2007-11#1)(2008-10#1)
only that the##5##3##(1995-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)
only that##9##2##(1991-6#1)(1992-12#1)(1995-8#1)(1996-3#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-12#1)
only the &quot##2##3##(2006-8#1)(2013-1#1)
only the DNA##2##3##(1990-2#1)(2008-2#1)
only the active##2##3##(1992-12#1)(2013-1#1)
only the amount of##2##4##(2008-3#1)(2009-10#1)
only the best##2##3##(1991-6#1)(2008-10#1)
only the combination##2##3##(2008-9#1)(2011-2#1)
only the constitutive##2##3##(1990-3#1)(1997-8#1)
only the core##2##3##(1995-8#1)(2009-8#1)
only the correlation of the##2##5##(2007-10#2)
only the current##3##3##(1991-12#1)(2008-2#2)
only the distal##2##3##(1992-9#1)(2012-2#1)
only the enzyme##2##3##(2008-6#2)
only the extent of##2##4##(1997-2#1)(2010-2#1)
only the first step##2##4##(1991-2#1)(1994-3#1)
only the first three##2##4##(1996-6#1)(2008-10#1)
only the first##17##3##(1990-4#1)(1991-2#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-6#1)(2006-5#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-5#1)(2010-6#1)(2011-2#2)(2012-2#1)
only the following##2##3##(2007-3#1)(2008-1#1)
only the former##3##3##(1990-2#1)(1993-12#1)(1994-6#1)
only the highest##2##3##(2005-7#1)(2007-8#1)
only the influence of##2##4##(2008-2#1)(2008-5#1)
only the latter is##2##4##(1996-5#1)(2008-8#1)
only the latter##8##3##(1990-12#1)(1996-10#1)(1996-5#2)(2006-10#1)(2008-10#1)(2008-8#1)(2013-1#1)
only the levels of##2##4##(1991-2#2)
only the magnitude##2##3##(2007-12#1)(2008-2#1)
only the most common##2##4##(2008-4#1)(2013-7#1)
only the most##8##3##(1992-6#1)(2006-7#1)(2008-10#2)(2008-4#1)(2013-1#2)(2013-7#1)
only the number of##4##4##(1992-4#1)(2008-11#1)(2008-3#1)(2012-4#1)
only the patients##2##3##(2006-8#1)(2011-2#1)
only the peptide##2##3##(1994-5#1)(2008-5#1)
only the phosphorylated##2##3##(2007-8#1)(2008-1#1)
only the possible##2##3##(2006-12#1)(2007-3#1)
only the posterior##2##3##(1996-7#1)(2006-11#1)
only the primary tumor##2##4##(1992-6#1)(2007-3#1)
only the primary##3##3##(1992-6#1)(2007-3#1)(2008-11#1)
only the region##2##3##(1997-2#1)(2008-1#1)
only the right##2##3##(2008-2#1)(2013-8#1)
only the same##3##3##(1991-12#1)(2004-2#1)(2007-12#1)
only the second report##3##4##(2006-10#1)(2007-2#1)(2012-3#1)
only the second##17##3##(1991-2#1)(1993-8#1)(1996-1#1)(2005-12#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)
only the small##3##3##(2008-4#2)(2011-3#1)
only the third##8##3##(1994-3#1)(1996-1#1)(2007-12#1)(2010-8#1)(2011-2#4)
only the two##3##3##(1993-11#1)(1993-12#1)(2008-7#1)
only the##532##2##(1990-10#3)(1990-11#1)(1990-12#4)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#5)(1990-8#2)(1990-9#2)(1991-1#1)(1991-12#4)(1991-2#6)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-10#2)(1992-11#5)(1992-12#5)(1992-2#3)(1992-3#4)(1992-4#2)(1992-5#3)(1992-6#6)(1992-7#2)(1992-8#2)(1992-9#5)(1993-1#1)(1993-11#2)(1993-12#5)(1993-2#2)(1993-5#1)(1993-6#2)(1993-8#3)(1993-9#6)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#6)(1994-3#4)(1994-5#3)(1994-6#2)(1994-8#4)(1994-9#5)(1995-1#4)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#5)(1995-6#2)(1995-7#1)(1995-8#5)(1996-1#3)(1996-10#2)(1996-11#2)(1996-12#2)(1996-2#3)(1996-4#1)(1996-5#6)(1996-6#3)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#4)(1997-8#1)(2003-11#1)(2004-12#1)(2004-2#1)(2004-4#1)(2005-11#2)(2005-12#1)(2005-3#2)(2005-7#3)(2006-1#1)(2006-10#8)(2006-11#2)(2006-12#6)(2006-2#2)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#3)(2006-9#1)(2007-10#4)(2007-11#5)(2007-12#14)(2007-2#2)(2007-3#3)(2007-4#5)(2007-5#2)(2007-7#3)(2007-8#7)(2007-9#1)(2008-1#8)(2008-10#47)(2008-11#11)(2008-12#4)(2008-2#20)(2008-3#23)(2008-4#7)(2008-5#12)(2008-6#3)(2008-7#8)(2008-8#8)(2008-9#5)(2009-10#3)(2009-11#1)(2009-2#2)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#4)(2010-6#2)(2010-8#2)(2011-1#4)(2011-2#17)(2011-3#1)(2012-1#8)(2012-11#1)(2012-12#2)(2012-2#8)(2012-3#3)(2012-4#1)(2012-6#1)(2013-1#11)(2013-7#4)(2013-8#3)
only their##4##2##(2008-1#2)(2008-5#1)(2012-1#1)
only therapy##2##2##(2006-10#1)(2011-2#1)
only these##2##2##(2007-11#1)(2009-7#1)
only this##7##2##(1990-11#1)(1990-2#1)(1991-3#1)(1993-6#1)(1995-2#1)(2007-12#1)(2008-10#1)
only those cases##2##3##(2006-7#1)(2007-6#1)
only those cells##2##3##(1990-4#1)(1997-4#1)
only those##30##2##(1990-2#2)(1990-4#1)(1990-6#1)(1990-7#1)(1991-3#1)(1992-3#1)(1992-7#1)(1993-5#1)(1995-12#1)(1995-3#2)(1995-6#1)(1997-4#1)(2005-8#1)(2006-2#2)(2006-7#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-6#1)(2010-8#1)(2012-7#1)
only three cases##3##3##(2006-4#1)(2007-2#1)(2008-10#1)
only three of them##4##4##(1996-7#1)(2008-7#1)(2011-2#1)(2013-1#1)
only three of##7##3##(1995-4#1)(1996-4#1)(1996-7#1)(2007-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
only three or four##2##4##(2010-4#1)(2011-1#1)
only three patients##4##3##(1990-9#1)(1993-1#1)(1994-7#1)(2011-2#1)
only three##46##2##(1990-11#1)(1990-2#1)(1990-9#1)(1991-6#1)(1993-1#1)(1993-5#1)(1994-7#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-5#1)(2006-10#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-5#1)(2008-7#1)(2008-9#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
only through the##8##3##(1990-7#1)(1991-11#1)(1991-3#1)(1992-3#1)(1994-3#1)(1997-3#1)(2008-2#1)(2009-7#1)
only through##18##2##(1990-2#1)(1990-7#1)(1991-11#1)(1991-3#1)(1992-3#1)(1992-6#1)(1994-10#1)(1994-3#2)(1997-3#1)(2008-1#1)(2008-2#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)
only tiny amounts of##2##4##(2008-4#1)(2008-7#1)
only to a limited extent##2##5##(2007-11#1)(2013-7#1)
only to a limited##3##4##(2007-11#1)(2011-2#1)(2013-7#1)
only to a##15##3##(1990-5#1)(1991-6#1)(1991-9#1)(1995-11#1)(1996-1#1)(1997-8#2)(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#2)(2013-7#1)
only to an##3##3##(1990-8#1)(1994-8#1)(2008-10#1)
only to atmospheric##2##3##(2008-1#1)(2008-2#1)
only to be##5##3##(1995-7#1)(2008-10#1)(2009-10#1)(2009-7#1)(2012-12#1)
only to increase##2##3##(2005-3#1)(2008-3#1)
only to one or##2##4##(2007-10#1)(2008-5#1)
only to one##3##3##(2007-10#1)(2008-5#2)
only to reduce the##3##4##(2006-10#1)(2008-10#2)
only to reduce##4##3##(2006-10#1)(2008-10#2)(2009-11#1)
only to return##2##3##(1991-10#1)(2006-10#1)
only to that of##2##4##(2007-11#1)(2008-12#1)
only to the extent##4##4##(1991-2#1)(1991-7#1)(2006-1#1)(2009-7#1)
only to the##38##3##(1991-2#2)(1991-3#2)(1991-5#1)(1991-7#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-6#1)(1994-1#1)(1994-9#1)(1995-11#2)(1996-5#1)(1996-9#1)(1997-4#1)(2006-1#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-7#2)(2010-2#1)(2012-12#1)
only to##231##2##(1990-11#3)(1990-2#1)(1990-5#3)(1990-7#1)(1990-8#2)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#1)(1993-10#1)(1993-12#2)(1993-6#1)(1994-1#1)(1994-11#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#4)(1995-2#2)(1995-7#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#4)(2004-1#1)(2004-12#1)(2005-3#1)(2005-7#1)(2006-1#1)(2006-10#10)(2006-12#2)(2006-2#2)(2006-4#1)(2006-6#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#4)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#3)(2008-1#3)(2008-10#17)(2008-11#4)(2008-12#2)(2008-2#5)(2008-3#4)(2008-4#3)(2008-5#9)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#5)(2009-10#2)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#3)(2009-8#1)(2010-11#1)(2010-2#1)(2010-3#4)(2011-1#2)(2011-2#10)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#3)(2013-8#3)
only took##2##2##(1991-10#1)(2009-6#1)
only towards##2##2##(1993-2#1)(2008-3#1)
only trace amounts of##2##4##(1993-12#1)(2008-11#1)
only trace amounts##4##3##(1991-9#1)(1993-12#1)(1995-3#1)(2008-11#1)
only trace levels of##2##4##(1995-2#1)(2008-10#1)
only trace##6##2##(1991-9#1)(1993-12#1)(1995-2#1)(1995-3#1)(2008-10#1)(2008-11#1)
only traces of##4##3##(1990-11#1)(1990-5#1)(1991-2#1)(2008-10#1)
only transient##3##2##(1995-5#1)(2006-11#1)(2010-1#1)
only transiently##8##2##(1992-10#2)(1992-2#1)(1993-2#1)(1993-4#1)(1995-2#1)(2005-8#1)(2007-11#1)
only treated##4##2##(1990-4#1)(1993-10#1)(2006-11#1)(2010-1#1)
only treatment##19##2##(1991-6#1)(1996-11#1)(2006-8#1)(2007-7#1)(2007-8#2)(2008-10#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#4)
only triethylamine acetate##2##3##(1997-3#2)
only true##3##2##(1991-7#1)(1993-12#1)(1995-5#1)
only tumor##3##2##(1995-2#1)(2008-4#1)(2008-6#1)
only twenty##3##2##(2005-8#1)(2008-3#1)(2011-2#1)
only two active##2##3##(1994-12#1)(1994-2#1)
only two cases have been##2##5##(1990-12#1)(2009-6#1)
only two cases of this##2##5##(1996-3#1)(1996-9#1)
only two cases of##4##4##(1996-3#1)(1996-9#1)(2008-2#1)(2009-8#1)
only two cases##8##3##(1990-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-3#1)(2008-2#1)(2009-6#1)(2009-8#1)
only two conventional##2##3##(2008-2#2)
only two copies of##2##4##(1993-6#1)(1996-6#1)
only two of the##4##4##(1993-8#1)(2007-1#1)(2008-10#1)(2008-2#1)
only two of them##4##4##(2007-7#1)(2008-10#1)(2008-5#1)(2009-2#1)
only two of these##2##4##(1996-11#1)(1996-3#1)
only two of##12##3##(1992-8#1)(1993-8#1)(1996-11#1)(1996-3#1)(2007-1#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-5#1)(2009-2#1)
only two patients##4##3##(1993-1#1)(1994-2#1)(2011-1#1)(2013-1#1)
only two prior##2##3##(2008-6#1)(2008-7#1)
only two sites##2##3##(2008-10#2)
only two##124##2##(1990-10#1)(1990-12#2)(1990-4#1)(1990-5#1)(1991-12#3)(1991-6#2)(1991-7#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#3)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#2)(1995-6#1)(1995-8#2)(1996-11#2)(1996-3#2)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-7#1)(2005-11#2)(2006-12#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#11)(2008-2#13)(2008-3#5)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
only type##3##2##(1991-7#1)(1992-8#1)(2006-2#1)
only under conditions of##2##4##(2011-1#2)
only under illumination##2##3##(1992-8#1)(1994-8#1)
only under reducing conditions##2##4##(1990-5#1)(1997-8#1)
only under specific##3##3##(1996-2#1)(1996-5#1)(2008-7#1)
only under the##6##3##(1990-8#1)(1993-8#1)(2005-11#1)(2008-9#1)(2010-2#2)
only under very##2##3##(1995-4#1)(1996-11#1)
only under##28##2##(1990-3#1)(1990-5#1)(1990-8#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-4#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-8#1)(2004-4#1)(2005-11#2)(2006-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-2#2)(2011-1#2)(2013-1#1)
only up to##6##3##(1991-3#1)(1993-8#1)(1994-2#1)(1996-9#1)(2007-12#1)(2010-5#1)
only upon##7##2##(1993-4#1)(1993-7#1)(1995-3#2)(1997-1#1)(2008-7#1)(2010-2#1)
only use##2##2##(2005-4#1)(2009-8#1)
only used in##2##3##(2008-4#1)(2011-2#1)
only used##5##2##(1997-3#1)(2007-2#1)(2008-10#1)(2008-4#1)(2011-2#1)
only useful##2##2##(1991-2#1)(2010-8#1)
only vaccine##2##2##(2004-12#1)(2012-12#1)
only valid##2##2##(1991-8#1)(2006-4#1)
only variable##4##2##(1990-8#1)(2008-10#1)(2008-2#1)(2013-1#1)
only variables##2##2##(1995-5#1)(2007-2#1)
only variants##2##2##(2012-3#2)
only venous##2##2##(2006-5#1)(2008-9#1)
only very few##2##3##(2008-11#2)
only very limited##4##3##(1990-5#1)(1997-8#1)(2008-7#1)(2010-12#1)
only very slowly##2##3##(1993-5#1)(2005-10#1)
only very small##2##3##(1993-3#1)(2008-10#1)
only very##19##2##(1990-11#1)(1990-5#1)(1991-5#1)(1992-9#1)(1993-3#1)(1993-5#1)(1997-2#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-12#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-12#1)
only via the phosphate group##2##5##(2008-5#2)
only via the##4##3##(1990-7#1)(2005-8#1)(2008-5#2)
only via##10##2##(1990-1#1)(1990-5#1)(1990-7#1)(1991-2#1)(2005-8#1)(2007-8#1)(2008-11#1)(2008-5#2)(2011-2#1)
only viable##2##2##(1990-4#1)(2011-12#1)
only viral##4##2##(1990-9#1)(1995-2#1)(2008-11#1)(2012-2#1)
only viruses##2##2##(2010-4#1)(2012-12#1)
only visualized##2##2##(2008-10#2)
only was##12##2##(1990-11#1)(1991-4#1)(1992-9#1)(1997-6#1)(2004-2#1)(2006-7#1)(2007-11#1)(2008-10#3)(2008-11#1)(2010-11#1)
only water and##2##3##(2009-6#1)(2010-6#1)
only water##5##2##(2007-3#1)(2008-10#1)(2008-7#1)(2009-6#1)(2010-6#1)
only way to##13##3##(1991-11#1)(1994-9#1)(1997-5#1)(1997-6#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-5#1)(2012-2#1)
only way##22##2##(1990-3#1)(1991-11#1)(1994-9#2)(1995-1#1)(1996-6#1)(1997-5#1)(1997-6#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-5#1)(2010-6#1)(2010-7#1)(2012-2#1)
only weak activity##2##3##(1990-6#1)(1993-4#1)
only weak evidence##2##3##(1996-5#2)
only weak##18##2##(1990-6#1)(1991-2#1)(1992-5#1)(1992-6#1)(1993-4#1)(1993-9#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-5#2)(1996-9#1)(2007-1#1)(2007-11#1)(2008-10#3)(2010-4#1)
only weakly inhibits##2##3##(1993-11#1)(1994-9#1)
only weakly on the##2##4##(2008-2#1)(2009-5#1)
only weakly on##3##3##(2007-11#1)(2008-2#1)(2009-5#1)
only weakly with##3##3##(1991-7#1)(1992-11#1)(2007-1#1)
only weakly##28##2##(1990-8#1)(1991-5#1)(1991-7#2)(1992-11#1)(1992-12#2)(1993-11#1)(1994-11#1)(1994-9#2)(1995-1#1)(1995-10#1)(1996-12#1)(1996-9#1)(1997-5#1)(2007-1#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#3)(2009-5#1)
only were excluded##2##3##(1991-2#1)(2012-12#1)
only were##6##2##(1990-5#1)(1991-2#1)(2007-7#1)(2008-10#1)(2009-4#1)(2012-12#1)
only when a##7##3##(1990-2#1)(1990-8#1)(1991-7#1)(1995-6#1)(2007-12#1)(2011-2#2)
only when cells##2##3##(1992-11#1)(1994-9#1)
only when it is##2##4##(1990-2#1)(1995-6#1)
only when it##4##3##(1990-2#1)(1995-6#1)(1997-3#1)(2007-9#1)
only when no##2##3##(1992-8#1)(2008-2#1)
only when one##2##3##(2006-12#1)(2009-3#1)
only when the cells were##2##5##(1992-9#1)(2008-11#1)
only when the organism##2##4##(2005-12#1)(2006-8#1)
only when the##44##3##(1990-11#1)(1990-12#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-3#1)(1993-9#1)(1995-10#1)(1995-11#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-11#2)(2005-12#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-12#3)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#2)(2009-2#1)(2010-2#2)(2010-7#1)(2012-3#1)
only when there##2##3##(1990-2#1)(2008-2#1)
only when they are##2##4##(1996-11#1)(2008-11#1)
only when they have##2##4##(2006-7#1)(2010-4#1)
only when they##7##3##(1991-12#1)(1995-6#1)(1996-11#1)(2006-7#1)(2008-11#1)(2010-4#1)(2010-6#1)
only when we##2##3##(2006-12#1)(2006-3#1)
only when##133##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-8#2)(1992-9#3)(1993-12#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-6#3)(1995-8#2)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2004-11#1)(2005-11#2)(2005-12#2)(2006-12#3)(2006-3#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#5)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#6)(2008-2#6)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-3#1)(2009-6#2)(2010-12#1)(2010-2#3)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#1)
only where##2##2##(2008-3#1)(2008-6#1)
only while##3##2##(1992-8#1)(2005-10#1)(2007-1#1)
only with a##6##3##(1990-3#1)(1991-7#1)(1994-3#1)(1996-11#1)(2008-2#2)
only with an##2##3##(1994-8#1)(2008-2#1)
only with antiestrogen##2##3##(1992-5#2)
only with one##2##3##(1992-10#1)(2008-4#1)
only with the development of##2##5##(1990-6#1)(2013-8#1)
only with the##30##3##(1990-2#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-4#1)(1991-6#2)(1992-1#1)(1992-11#1)(1992-9#3)(1994-9#1)(1995-3#1)(1996-2#1)(2006-12#1)(2006-8#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
only with##118##2##(1990-2#1)(1990-3#2)(1990-4#1)(1990-6#1)(1990-7#2)(1991-2#1)(1991-4#1)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-5#3)(1992-8#1)(1992-9#4)(1993-11#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-2#3)(1997-3#1)(2005-4#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-12#2)(2012-3#3)(2013-1#2)(2013-8#1)
only within a single##2##4##(2008-10#1)(2010-2#1)
only within a##3##3##(2008-1#1)(2008-10#1)(2010-2#1)
only within the##3##3##(1996-6#1)(2007-12#1)(2009-7#1)
only within##12##2##(1992-2#1)(1994-12#1)(1996-6#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-4#1)
only women##2##2##(1995-5#1)(2009-3#1)
only worked##2##2##(2004-11#1)(2012-2#1)
only ~1##2##2##(2007-12#1)(2012-2#1)
only ~10%##2##2##(2007-11#1)(2008-2#1)
only##10005##1##(1990-1#5)(1990-10#24)(1990-11#55)(1990-12#64)(1990-2#61)(1990-3#51)(1990-4#36)(1990-5#51)(1990-6#30)(1990-7#44)(1990-8#40)(1990-9#32)(1991-1#22)(1991-10#23)(1991-11#34)(1991-12#58)(1991-2#60)(1991-3#48)(1991-4#34)(1991-5#37)(1991-6#33)(1991-7#39)(1991-8#36)(1991-9#42)(1992-1#20)(1992-10#22)(1992-11#27)(1992-12#54)(1992-2#34)(1992-3#52)(1992-4#27)(1992-5#31)(1992-6#43)(1992-7#29)(1992-8#44)(1992-9#46)(1993-1#13)(1993-10#17)(1993-11#36)(1993-12#53)(1993-2#37)(1993-3#35)(1993-4#23)(1993-5#19)(1993-6#53)(1993-7#19)(1993-8#47)(1993-9#41)(1994-1#6)(1994-10#15)(1994-11#35)(1994-12#65)(1994-2#65)(1994-3#48)(1994-4#3)(1994-5#36)(1994-6#24)(1994-7#10)(1994-8#61)(1994-9#61)(1995-1#40)(1995-10#21)(1995-11#46)(1995-12#46)(1995-2#61)(1995-3#60)(1995-4#14)(1995-5#46)(1995-6#45)(1995-7#18)(1995-8#35)(1995-9#17)(1996-1#26)(1996-10#19)(1996-11#44)(1996-12#59)(1996-2#47)(1996-3#27)(1996-4#19)(1996-5#69)(1996-6#37)(1996-7#28)(1996-8#32)(1996-9#28)(1997-1#38)(1997-2#53)(1997-3#44)(1997-4#44)(1997-5#36)(1997-6#50)(1997-7#60)(1997-8#55)(1997-9#1)(2003-11#4)(2004-1#8)(2004-10#5)(2004-11#16)(2004-12#8)(2004-2#7)(2004-3#5)(2004-4#9)(2004-7#1)(2004-8#1)(2004-9#9)(2005-1#3)(2005-10#24)(2005-11#51)(2005-12#17)(2005-3#3)(2005-4#6)(2005-5#6)(2005-6#1)(2005-7#24)(2005-8#20)(2005-9#11)(2006-1#7)(2006-10#147)(2006-11#18)(2006-12#84)(2006-2#58)(2006-3#15)(2006-4#30)(2006-5#24)(2006-6#38)(2006-7#38)(2006-8#91)(2006-9#16)(2007-1#39)(2007-10#57)(2007-11#163)(2007-12#228)(2007-2#44)(2007-3#36)(2007-4#32)(2007-5#28)(2007-6#28)(2007-7#113)(2007-8#131)(2007-9#55)(2008-1#117)(2008-10#857)(2008-11#205)(2008-12#60)(2008-2#210)(2008-3#255)(2008-4#135)(2008-5#254)(2008-6#115)(2008-7#214)(2008-8#161)(2008-9#127)(2009-1#2)(2009-10#38)(2009-11#14)(2009-12#20)(2009-2#45)(2009-3#39)(2009-4#34)(2009-5#33)(2009-6#27)(2009-7#26)(2009-8#46)(2009-9#25)(2010-1#16)(2010-10#20)(2010-11#22)(2010-12#76)(2010-2#40)(2010-3#28)(2010-4#51)(2010-5#45)(2010-6#30)(2010-7#35)(2010-8#36)(2010-9#10)(2011-1#118)(2011-10#1)(2011-11#1)(2011-12#26)(2011-2#267)(2011-3#8)(2011-7#1)(2011-9#1)(2012-1#88)(2012-11#27)(2012-12#133)(2012-2#169)(2012-3#109)(2012-4#3)(2012-5#2)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#196)(2013-7#44)(2013-8#106)
only&quot##2##1##(1995-9#1)(2012-1#1)
only'##2##1##(1997-7#1)(2008-11#1)
only) and##4##2##(1995-1#1)(1997-8#1)(2011-2#1)(2013-1#1)
only) in##3##2##(1997-8#1)(2005-11#1)(2008-9#1)
only) were##2##2##(1990-5#1)(2007-11#1)
only)##36##1##(1990-5#1)(1992-11#1)(1992-4#2)(1994-6#1)(1995-1#1)(1997-3#1)(1997-8#3)(2005-11#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-6#1)(2008-9#2)(2009-3#1)(2009-7#2)(2009-9#1)(2010-1#1)(2011-1#1)(2011-2#2)(2012-11#1)(2013-1#3)(2013-8#2)
only--in##2##1##(2008-4#2)
onset (34%##2##2##(2006-10#2)
onset (n =##2##3##(1994-5#2)
onset AD##4##2##(1995-12#1)(1996-1#1)(1997-1#2)
onset Alzheimer's disease (AD)##4##4##(1993-11#1)(1995-12#1)(1996-1#1)(1997-1#1)
onset Alzheimer's disease##6##3##(1993-11#1)(1995-12#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-3#1)
onset JRA in##2##3##(2006-10#2)
onset JRA##3##2##(2006-10#3)
onset Still's disease##7##3##(1992-3#1)(1995-11#1)(2006-10#5)
onset Still's##8##2##(1990-9#1)(1992-3#1)(1995-11#1)(2006-10#5)
onset after the birth of their##2##6##(2004-3#1)(2010-2#1)
onset after the##3##3##(2004-3#1)(2010-2#1)(2011-2#1)
onset after##7##2##(1996-7#1)(2004-12#1)(2004-3#1)(2007-10#1)(2008-7#1)(2010-2#1)(2011-2#1)
onset age of##3##3##(1992-1#1)(2007-2#2)
onset age##6##2##(1992-1#1)(2007-2#2)(2009-7#3)
onset and clinical##3##3##(2006-2#1)(2008-7#1)(2013-8#1)
onset and course of##2##4##(2009-6#1)(2010-12#1)
onset and course##3##3##(2009-6#1)(2010-12#1)(2013-7#1)
onset and death##2##3##(1997-3#1)(2007-10#1)
onset and duration of alopecia areata was not significantly related to the presence of atopy##2##15##(2007-7#1)(2007-8#1)
onset and duration of##4##4##(1991-8#1)(2007-7#1)(2007-8#1)(2008-4#1)
onset and higher##2##3##(1996-8#1)(2006-10#1)
onset and progression of##12##4##(1993-9#1)(1996-4#2)(2007-11#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-8#1)
onset and recovery##2##3##(1991-7#1)(1991-8#1)
onset and the##5##3##(2007-11#1)(2007-7#1)(2008-10#1)(2011-2#1)(2013-1#1)
onset and##93##2##(1990-10#1)(1991-11#1)(1991-7#1)(1991-8#2)(1992-10#1)(1992-12#1)(1992-7#1)(1993-2#3)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-2#1)(1996-10#1)(1996-4#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-8#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#4)(2007-8#3)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#3)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#3)
onset as well as##2##4##(2007-6#1)(2008-1#1)
onset at##8##2##(1996-6#1)(2007-7#2)(2007-8#1)(2008-3#1)(2008-7#1)(2011-1#1)(2013-8#1)
onset before##5##2##(1992-8#1)(1994-9#1)(1997-7#1)(2007-8#1)(2011-2#1)
onset but##3##2##(1990-2#1)(2008-10#1)(2012-3#1)
onset depression##2##2##(2011-2#2)
onset diabetes##3##2##(1997-6#1)(2008-1#2)
onset during##2##2##(1993-6#1)(2007-7#1)
onset for##2##2##(1996-9#1)(2006-2#1)
onset group##2##2##(2006-10#1)(2006-2#1)
onset has##2##2##(1994-11#1)(2011-2#1)
onset in a patient##2##4##(2006-2#1)(2009-4#1)
onset in the##2##3##(1992-8#1)(2008-7#1)
onset in##20##2##(1990-5#1)(1992-8#1)(1995-11#2)(1997-2#1)(2006-12#1)(2006-2#2)(2006-6#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-7#2)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2013-8#1)
onset infection##2##2##(1996-6#1)(2006-8#1)
onset is##10##2##(1996-9#1)(2006-10#1)(2006-12#1)(2007-10#2)(2007-4#1)(2008-4#1)(2008-7#1)(2009-7#1)(2012-3#1)
onset latency of##2##3##(1991-6#1)(1993-9#1)
onset latency##4##2##(1991-6#1)(1993-9#2)(2010-7#1)
onset may##3##2##(2006-2#1)(2007-11#1)(2008-8#1)
onset neonatal##2##2##(2006-8#1)(2013-8#1)
onset obesity##4##2##(2006-8#1)(2011-2#3)
onset of Alzheimer's disease##4##4##(1996-1#1)(1996-5#1)(2008-7#2)
onset of Alzheimer's##5##3##(1996-1#1)(1996-5#1)(2008-7#2)(2008-8#1)
onset of DNA synthesis##4##4##(1994-5#2)(2008-7#2)
onset of DNA##6##3##(1994-3#1)(1994-5#2)(1995-2#1)(2008-7#2)
onset of DmRP140 transcription##2##4##(1997-2#2)
onset of HIV-related disease##2##4##(1992-6#1)(1993-7#1)
onset of S-phase##2##3##(1993-11#1)(1993-9#1)
onset of Type 1 diabetes##3##5##(2007-6#3)
onset of a##10##3##(1990-9#2)(1995-3#1)(2006-5#1)(2008-1#2)(2008-4#1)(2008-5#1)(2010-6#1)(2011-2#1)
onset of abdominal pain##2##4##(2008-10#1)(2012-12#1)
onset of action and##2##4##(2007-2#1)(2010-1#1)
onset of action than the##2##5##(2008-7#2)
onset of action than##3##4##(2006-9#1)(2008-7#2)
onset of action##15##3##(1993-1#1)(1997-5#1)(2005-9#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-3#2)(2008-7#2)(2009-9#1)(2010-1#1)(2012-2#2)
onset of age-related diseases##2##4##(2008-7#1)(2012-2#1)
onset of alcohol dependence##2##4##(1994-2#2)
onset of an##4##3##(2007-10#1)(2007-7#1)(2007-9#1)(2008-8#1)
onset of any##2##3##(1991-12#1)(2013-7#1)
onset of apoptosis##3##3##(1994-3#1)(1996-7#1)(2008-5#1)
onset of cancer##2##3##(1992-12#1)(2013-7#1)
onset of cell death##3##4##(1994-12#1)(1996-12#1)(1996-9#1)
onset of chest pain##3##4##(2006-10#1)(2013-1#2)
onset of clinical disease##2##4##(1997-4#1)(2008-11#1)
onset of clinical##6##3##(1990-3#1)(1997-4#1)(2008-11#2)(2012-1#1)(2012-2#1)
onset of clonic convulsions##2##4##(1993-11#1)(2010-12#1)
onset of coma##4##3##(2008-11#1)(2008-7#3)
onset of convulsions##4##3##(1993-11#1)(1993-12#2)(2004-10#1)
onset of darkness##2##3##(1990-5#1)(1997-5#1)
onset of delirium##2##3##(2005-7#2)
onset of depressive##2##3##(1995-1#1)(2010-4#1)
onset of diabetes##6##3##(1991-8#1)(1994-12#1)(1996-10#1)(2009-5#1)(2010-10#2)
onset of disease##15##3##(1992-10#1)(1993-11#1)(1994-11#1)(1994-5#1)(1997-3#1)(2005-7#1)(2006-10#2)(2007-2#1)(2007-9#1)(2008-10#2)(2010-12#1)(2011-2#1)(2013-1#1)
onset of disease)##2##3##(2005-10#2)
onset of diseases##2##3##(2011-1#1)(2012-12#1)
onset of estrus##4##3##(2006-5#1)(2013-1#3)
onset of expression##3##3##(1994-10#1)(1997-7#1)(2008-5#1)
onset of fatigue##3##3##(1991-6#1)(2008-5#1)(2010-8#1)
onset of fever##5##3##(2007-12#2)(2008-11#1)(2008-5#1)(2013-8#1)
onset of first##3##3##(2010-3#1)(2010-8#1)(2011-2#1)
onset of florid##2##3##(2007-7#1)(2008-1#1)
onset of heatstroke##2##3##(1995-12#2)
onset of her##2##3##(2008-1#1)(2012-11#1)
onset of hypertension##3##3##(1993-8#1)(2008-1#1)(2008-4#1)
onset of illness##3##3##(1995-11#1)(1995-4#1)(2008-5#1)
onset of infection##2##3##(1994-11#1)(2013-1#1)
onset of intestinal##2##3##(1993-10#1)(2006-2#1)
onset of labour is##2##4##(1994-8#2)
onset of low##2##3##(1995-6#1)(2007-6#1)
onset of mitosis##4##3##(1991-6#2)(1994-3#1)(2008-8#1)
onset of motor##2##3##(1997-5#1)(2012-12#1)
onset of obsessive-compulsive disorder (OCD)##2##5##(2007-6#2)
onset of obsessive-compulsive disorder##3##4##(2007-6#3)
onset of osteoarthritis##3##3##(2008-4#1)(2009-7#1)(2012-1#1)
onset of painless##2##3##(2006-10#1)(2008-4#1)
onset of paralysis##2##3##(1991-1#1)(2007-3#1)
onset of phase separation during polymerization##2##6##(2004-9#2)
onset of pseudothecia maturity and seasonal ascospore showers in relation to blackleg##2##12##(2008-10#2)
onset of pseudothecia maturity##5##4##(2008-10#5)
onset of puberty in the female offspring##3##7##(2009-5#3)
onset of puberty in the##4##5##(2009-5#4)
onset of puberty in##5##4##(2009-5#5)
onset of puberty##10##3##(1991-1#1)(2006-10#1)(2008-4#1)(2009-5#6)(2013-8#1)
onset of renal##3##3##(2008-1#1)(2013-1#2)
onset of severe##5##3##(1995-12#1)(2006-10#1)(2008-7#1)(2012-12#1)(2012-2#1)
onset of significant##2##3##(2007-11#1)(2008-5#1)
onset of skin metastases##2##4##(1991-6#1)(2008-6#1)
onset of skin##6##3##(1991-6#1)(2008-5#1)(2008-6#1)(2010-8#1)(2011-1#1)(2013-1#1)
onset of stroke symptoms##3##4##(2007-10#1)(2007-9#1)(2010-10#1)
onset of stroke##16##3##(1995-5#1)(1995-9#1)(2007-10#5)(2007-11#2)(2007-9#3)(2008-5#1)(2008-7#1)(2009-11#1)(2010-10#1)
onset of symptoms and##11##4##(1996-1#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-7#1)(2012-12#5)
onset of symptoms was##2##4##(2007-7#1)(2008-7#1)
onset of symptoms##49##3##(1990-4#1)(1992-8#1)(1993-12#2)(1995-9#1)(1996-1#1)(1996-6#1)(2004-11#1)(2006-10#1)(2006-4#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2007-9#6)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-8#1)(2009-9#1)(2010-10#1)(2012-12#9)(2012-2#1)(2013-1#1)
onset of the disease in##2##5##(1991-12#1)(2008-10#1)
onset of the disease##20##4##(1991-12#1)(1991-8#1)(1993-9#1)(1994-11#1)(1995-6#1)(2006-10#1)(2007-11#2)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#1)(2009-3#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-8#3)
onset of the illness##3##4##(1996-11#1)(2010-8#1)(2011-2#1)
onset of the increase in##2##5##(1997-1#1)(1997-5#1)
onset of the##78##3##(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-8#1)(1992-1#2)(1992-7#1)(1993-2#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-5#2)(1997-1#1)(1997-5#1)(2006-10#3)(2006-5#1)(2006-6#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-2#1)(2009-3#2)(2009-8#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#3)
onset of their##5##3##(1996-8#1)(2006-10#1)(2006-7#1)(2010-2#1)(2012-1#1)
onset of these##5##3##(1993-10#1)(2008-11#1)(2012-11#2)(2012-12#1)
onset of this disease##2##4##(2008-10#1)(2008-5#1)
onset of this##6##3##(1990-8#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
onset of treatment##3##3##(1992-5#1)(1997-1#1)(2007-8#1)
onset of tremor##2##3##(2008-7#2)
onset of type 2 diabetes mellitus##2##6##(2008-1#1)(2008-10#1)
onset of type 2 diabetes##4##5##(2008-1#1)(2008-10#1)(2008-7#1)(2009-12#1)
onset of type##5##3##(2008-1#1)(2008-10#1)(2008-7#1)(2009-12#1)(2011-2#1)
onset of weakness##2##3##(2009-2#1)(2010-8#1)
onset of##726##2##(1990-11#1)(1990-12#4)(1990-3#3)(1990-4#3)(1990-5#3)(1990-7#2)(1990-8#3)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#5)(1991-12#5)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#5)(1991-7#1)(1991-8#4)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-5#2)(1992-6#1)(1992-7#3)(1992-8#2)(1993-1#1)(1993-10#4)(1993-11#6)(1993-12#6)(1993-2#1)(1993-4#1)(1993-7#4)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#5)(1994-12#3)(1994-2#5)(1994-3#6)(1994-4#1)(1994-5#5)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#3)(1995-12#4)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#4)(1995-7#3)(1995-8#1)(1995-9#2)(1996-1#4)(1996-10#2)(1996-11#2)(1996-12#4)(1996-2#2)(1996-3#1)(1996-4#3)(1996-5#6)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#5)(1997-1#3)(1997-2#5)(1997-3#4)(1997-4#4)(1997-5#4)(1997-7#2)(1997-8#2)(2004-10#1)(2004-11#2)(2004-3#2)(2004-9#3)(2005-1#2)(2005-10#2)(2005-11#2)(2005-7#6)(2005-8#3)(2005-9#1)(2006-10#20)(2006-12#2)(2006-2#2)(2006-4#4)(2006-5#5)(2006-6#1)(2006-7#2)(2006-8#5)(2006-9#2)(2007-10#12)(2007-11#19)(2007-12#10)(2007-2#8)(2007-3#2)(2007-5#1)(2007-6#11)(2007-7#9)(2007-8#10)(2007-9#16)(2008-1#17)(2008-10#33)(2008-11#11)(2008-12#3)(2008-2#3)(2008-3#11)(2008-4#9)(2008-5#22)(2008-6#5)(2008-7#32)(2008-8#5)(2008-9#5)(2009-10#2)(2009-11#2)(2009-12#3)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#8)(2009-6#1)(2009-7#4)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#6)(2010-12#4)(2010-2#4)(2010-3#2)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#9)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#23)(2011-7#1)(2012-1#5)(2012-11#6)(2012-12#23)(2012-2#24)(2012-3#5)(2012-5#1)(2013-1#22)(2013-7#2)(2013-8#7)
onset on##3##2##(1990-3#1)(1992-11#1)(2007-8#1)
onset or##13##2##(1993-8#1)(2007-7#1)(2008-1#3)(2008-4#2)(2008-7#1)(2009-3#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
onset rate##2##2##(2006-11#1)(2007-4#1)
onset schizophrenia##4##2##(1997-2#2)(1997-8#2)
onset sepsis##2##2##(2011-2#2)
onset strabismus##2##2##(1992-7#2)
onset stroke severity##2##3##(2007-10#2)
onset than##5##2##(1991-2#1)(1993-7#1)(1995-8#1)(2008-1#1)(2008-11#1)
onset time in##2##3##(1990-5#1)(1996-7#1)
onset time of##3##3##(2006-10#1)(2008-5#1)(2012-2#1)
onset time##12##2##(1990-5#2)(1996-7#2)(2006-10#3)(2008-10#1)(2008-5#1)(2009-6#1)(2012-2#1)(2013-1#1)
onset times##3##2##(1992-9#1)(1993-3#1)(2009-10#1)
onset to##4##2##(2007-7#1)(2008-3#1)(2012-2#1)(2012-3#1)
onset was also##2##3##(1996-5#1)(1996-6#1)
onset was delayed##2##3##(2008-10#2)
onset was##21##2##(1996-1#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(2004-3#1)(2007-3#2)(2007-7#1)(2007-8#2)(2008-10#4)(2008-8#1)(2010-3#1)(2011-1#1)(2012-12#1)(2013-8#2)
onset were evaluated##2##3##(2007-9#1)(2012-12#1)
onset were##10##2##(1994-12#1)(1997-5#1)(2007-10#2)(2007-9#1)(2008-3#1)(2012-12#1)(2013-1#3)
onset with##4##2##(2007-11#1)(2008-10#2)(2012-12#1)
onset##1361##1##(1990-10#2)(1990-11#2)(1990-12#5)(1990-2#2)(1990-3#4)(1990-4#3)(1990-5#8)(1990-7#3)(1990-8#3)(1990-9#3)(1991-1#2)(1991-10#1)(1991-11#6)(1991-12#5)(1991-2#3)(1991-3#3)(1991-4#3)(1991-5#3)(1991-6#8)(1991-7#2)(1991-8#7)(1991-9#4)(1992-1#3)(1992-10#2)(1992-11#3)(1992-12#4)(1992-3#1)(1992-5#2)(1992-6#2)(1992-7#7)(1992-8#8)(1992-9#2)(1993-1#1)(1993-10#4)(1993-11#10)(1993-12#7)(1993-2#4)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#5)(1993-8#2)(1993-9#9)(1994-10#1)(1994-11#7)(1994-12#5)(1994-2#9)(1994-3#7)(1994-4#1)(1994-5#7)(1994-6#1)(1994-8#6)(1994-9#4)(1995-1#3)(1995-10#3)(1995-11#7)(1995-12#7)(1995-2#2)(1995-3#8)(1995-4#2)(1995-5#3)(1995-6#4)(1995-7#4)(1995-8#2)(1995-9#3)(1996-1#7)(1996-10#7)(1996-11#2)(1996-12#4)(1996-2#6)(1996-3#2)(1996-4#5)(1996-5#9)(1996-6#10)(1996-7#8)(1996-8#2)(1996-9#11)(1997-1#7)(1997-2#9)(1997-3#8)(1997-4#5)(1997-5#10)(1997-6#5)(1997-7#3)(1997-8#6)(2004-10#2)(2004-11#3)(2004-12#1)(2004-3#6)(2004-9#3)(2005-1#2)(2005-10#2)(2005-11#3)(2005-4#1)(2005-7#6)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#50)(2006-11#1)(2006-12#8)(2006-2#9)(2006-3#5)(2006-4#5)(2006-5#5)(2006-6#2)(2006-7#5)(2006-8#11)(2006-9#2)(2007-10#37)(2007-11#27)(2007-12#15)(2007-2#12)(2007-3#4)(2007-4#2)(2007-5#5)(2007-6#18)(2007-7#29)(2007-8#22)(2007-9#28)(2008-1#32)(2008-10#63)(2008-11#18)(2008-12#5)(2008-2#7)(2008-3#20)(2008-4#17)(2008-5#31)(2008-6#7)(2008-7#58)(2008-8#9)(2008-9#7)(2009-10#6)(2009-11#2)(2009-12#5)(2009-2#3)(2009-3#6)(2009-4#3)(2009-5#11)(2009-6#4)(2009-7#11)(2009-8#5)(2009-9#3)(2010-1#1)(2010-10#7)(2010-11#3)(2010-12#11)(2010-2#8)(2010-3#5)(2010-4#8)(2010-6#2)(2010-7#2)(2010-8#14)(2010-9#1)(2011-1#19)(2011-12#3)(2011-2#48)(2011-7#1)(2012-1#8)(2012-11#7)(2012-12#37)(2012-2#36)(2012-3#8)(2012-5#1)(2013-1#41)(2013-7#8)(2013-8#26)
onset)##5##1##(1996-7#1)(2006-5#2)(2008-8#2)
onsets of illness##2##3##(1996-3#2)
onsets##3##1##(1996-3#2)(2010-2#1)
onshore##4##1##(1991-6#3)(2007-5#1)
onsite determination of pirimicarb in##2##5##(2007-8#2)
onsite##5##1##(2007-8#2)(2008-3#2)(2009-9#1)
onslaught of##3##2##(1993-2#1)(2006-8#1)(2012-12#1)
ont été##7##2##(2011-2#1)(2012-2#2)(2013-1#4)
ont##11##1##(2008-5#1)(2011-2#2)(2012-2#3)(2013-1#5)
ontario##9##1##(2010-11#3)(2010-5#2)(2010-9#2)(2011-2#1)(2012-2#1)
onthe##2##1##(2008-11#2)
onto 5##2##2##(2008-10#2)
onto DNA##2##2##(1994-12#1)(2008-10#1)
onto PUFs##2##2##(2008-10#2)
onto TiO2##2##2##(2005-11#1)(2010-4#1)
onto a C18##2##3##(2007-8#2)
onto a CCD camera##3##4##(2007-12#2)(2008-3#1)
onto a CCD##5##3##(2007-12#2)(2008-2#2)(2008-3#1)
onto a flat##2##3##(2007-3#1)(2008-3#1)
onto a glass##4##3##(2005-11#1)(2007-12#2)(2008-7#1)
onto a glassy carbon electrode##2##5##(2008-10#2)
onto a glassy carbon##3##4##(2008-10#3)
onto a glassy##4##3##(2008-10#4)
onto a mini-column packed with##2##5##(2008-10#2)
onto a mini-column##3##3##(2008-10#2)(2008-3#1)
onto a minicolumn packed with##2##5##(2008-10#2)
onto a minicolumn##3##3##(2008-10#3)
onto a nylon##2##3##(1995-6#1)(2008-4#1)
onto a phase-only##2##3##(2008-3#2)
onto a piece of wood##2##5##(2013-1#2)
onto a porous##2##3##(2005-11#1)(2010-4#1)
onto a set of##2##4##(2006-4#1)(2008-10#1)
onto a silica##2##3##(1997-8#1)(2007-12#1)
onto a single##7##3##(2006-4#2)(2007-8#2)(2008-2#1)(2008-3#1)(2008-4#1)
onto a small##2##3##(2008-11#1)(2009-5#1)
onto a solid##4##3##(1994-6#1)(2008-10#1)(2008-11#1)(2009-4#1)
onto a three-dimensional##2##3##(1996-8#1)(2006-10#1)
onto a two-dimensional##2##3##(2008-2#1)(2010-6#1)
onto a##171##2##(1990-6#1)(1990-7#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-7#1)(1992-8#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-2#2)(1995-6#1)(1996-12#1)(1996-8#2)(1997-4#1)(1997-7#1)(1997-8#3)(2004-4#1)(2004-9#1)(2005-11#5)(2006-10#1)(2006-4#4)(2006-5#1)(2006-6#2)(2007-11#5)(2007-12#8)(2007-3#2)(2007-8#6)(2008-1#2)(2008-10#48)(2008-11#5)(2008-2#8)(2008-3#10)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#3)(2010-4#4)(2010-5#1)(2010-6#1)(2011-1#4)(2011-2#1)(2011-7#1)(2012-1#1)(2012-11#2)(2012-2#2)(2012-3#1)(2013-1#3)
onto agar##2##2##(2008-10#1)(2008-8#1)
onto an aluminum##2##3##(1991-12#1)(2008-10#1)
onto an inert##2##3##(1990-8#1)(2008-10#1)
onto an object surface##2##4##(2008-3#2)
onto an##23##2##(1990-8#1)(1991-12#1)(1992-12#1)(1996-12#1)(1996-8#1)(2005-11#1)(2005-12#1)(2006-8#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#6)(2008-4#1)(2009-9#1)
onto carbon##2##2##(2007-12#1)(2008-10#1)
onto cell##3##2##(2007-12#1)(2008-11#1)(2008-9#1)
onto cultured##2##2##(2008-5#1)(2011-2#1)
onto detached##2##2##(2008-10#1)(2008-4#1)
onto each##3##2##(2005-11#1)(2008-11#1)(2008-2#1)
onto either##3##2##(1994-12#1)(2008-10#1)(2008-5#1)
onto glass slides##2##3##(2008-4#1)(2013-8#1)
onto glass substrates##2##3##(2008-10#1)(2008-3#1)
onto glass##7##2##(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-12#1)(2013-8#1)
onto glassy carbon electrode##2##4##(2008-10#2)
onto glassy carbon##6##3##(2008-10#6)
onto glycidoxypropyl-modified Fractosil 1000)##3##4##(1997-2#3)
onto goethite and kaolinite##2##4##(2005-11#2)
onto gold electrode##2##3##(2008-10#2)
onto gold surfaces##2##3##(1996-11#1)(2005-11#1)
onto gold##11##2##(1996-11#2)(2005-11#1)(2008-10#4)(2009-7#1)(2010-4#1)(2012-11#2)
onto hydrophobic surfaces##2##3##(2006-5#2)
onto loaded silica gel##2##4##(2008-10#2)
onto loaded##3##2##(2008-10#3)
onto metal##2##2##(2008-10#1)(2009-2#1)
onto microcrystalline naphthalene or##2##4##(2008-10#2)
onto modified##2##2##(2007-7#1)(2008-10#1)
onto nitrocellulose##2##2##(1992-7#1)(1997-3#1)
onto normal##2##2##(1995-11#1)(2008-5#1)
onto one end##2##3##(2007-11#1)(2008-2#1)
onto one of the##2##4##(2008-10#1)(2008-2#1)
onto one of##3##3##(2008-10#1)(2008-2#2)
onto one##5##2##(2007-11#1)(2008-10#1)(2008-2#3)
onto optical##2##2##(2008-3#2)
onto oriented##2##2##(2007-11#2)
onto pentafluorophenyl methacrylate (PFM)-modified surfaces obtained by PFM grafting affter Ar plasma treatment##2##13##(2012-11#2)
onto phase-only##2##2##(2008-3#2)
onto planar and##2##3##(2008-3#2)
onto plant surfaces##2##3##(1992-6#1)(2008-10#1)
onto plastic##2##2##(1990-12#1)(2008-4#1)
onto polyurethane foam##5##3##(2008-10#5)
onto polyurethane##6##2##(2008-10#6)
onto predesigned##2##2##(2006-12#2)
onto replicating DNA##2##3##(1995-6#2)
onto silica gel was##3##4##(2008-10#3)
onto silica gel##4##3##(2008-10#4)
onto silica##8##2##(2005-11#2)(2008-10#5)(2008-11#1)
onto silicone tubing##2##3##(2008-10#2)
onto silicone##3##2##(2008-10#2)(2008-11#1)
onto single amygdaloid##2##3##(1992-7#2)
onto single##4##2##(1992-7#2)(2007-10#1)(2012-11#1)
onto single-stranded DNA##3##3##(1994-12#3)
onto small##2##2##(2008-10#1)(2010-8#1)
onto solid##5##2##(2005-11#1)(2008-5#1)(2011-1#1)(2013-8#2)
onto the HPLC column##2##4##(1993-2#1)(1997-3#1)
onto the HPLC##4##3##(1993-2#1)(1996-8#1)(1997-3#1)(1997-8#1)
onto the SC##2##3##(2008-5#2)
onto the SPE column##3##4##(2007-8#2)(2008-10#1)
onto the SPE##4##3##(2007-8#2)(2008-10#2)
onto the analytical column##2##4##(1992-2#1)(1993-2#1)
onto the analytical##4##3##(1992-2#1)(1993-2#1)(1997-3#1)(2008-10#1)
onto the cationic##3##3##(2008-10#1)(2010-4#2)
onto the cells##7##3##(1990-11#1)(2008-1#2)(2008-2#2)(2008-4#2)
onto the column##3##3##(2008-10#2)(2012-12#1)
onto the detector##2##3##(2008-2#2)
onto the electrode surface##4##4##(2007-8#1)(2008-10#3)
onto the electrode##5##3##(2007-8#1)(2008-10#4)
onto the fiber##2##3##(2005-11#2)
onto the glassy carbon electrode surface##2##6##(2008-10#2)
onto the gold surface##3##4##(2007-8#1)(2008-10#2)
onto the gold##5##3##(2007-8#1)(2008-10#3)(2010-5#1)
onto the hanging mercury drop electrode for##2##7##(2008-10#2)
onto the inner##4##3##(2005-11#1)(2008-10#1)(2008-2#1)(2012-12#1)
onto the membrane##4##3##(1997-1#1)(2008-1#1)(2008-11#1)(2008-5#1)
onto the object##5##3##(2007-12#1)(2008-1#1)(2008-3#3)
onto the polymer##2##3##(2005-11#1)(2008-2#1)
onto the resin##3##3##(2008-10#3)
onto the sample surface##2##4##(2008-10#1)(2008-2#1)
onto the spinal cord##3##4##(1991-5#1)(1995-7#1)(1996-12#1)
onto the stamp##2##3##(2009-2#2)
onto the substrate##4##3##(2007-8#2)(2008-11#1)(2008-3#1)
onto the surface of a##5##5##(2007-8#2)(2008-10#3)
onto the surface of the CNTs##2##6##(2010-7#2)
onto the surface of the##11##5##(1997-7#1)(2005-11#1)(2006-5#1)(2008-10#3)(2008-2#1)(2008-5#1)(2009-3#1)(2010-7#2)
onto the surface of##24##4##(1997-7#1)(2004-9#1)(2005-11#2)(2006-5#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-2#1)(2008-5#1)(2009-11#1)(2009-3#1)(2010-7#2)(2013-1#1)
onto the surface##27##3##(1997-7#1)(2004-9#1)(2005-11#4)(2006-5#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-2#2)(2008-5#1)(2009-11#1)(2009-3#1)(2010-7#2)(2013-1#1)
onto the surfaces of##2##4##(2009-3#1)(2013-1#1)
onto the underlying##2##3##(2008-11#1)(2008-7#1)
onto the viral capsid##2##4##(1995-2#2)
onto the wells of##2##4##(1990-12#1)(1994-8#1)
onto the##297##2##(1990-11#2)(1990-12#3)(1990-7#1)(1990-8#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-2#2)(1993-4#1)(1994-12#1)(1994-2#3)(1994-8#1)(1994-9#2)(1995-11#2)(1995-2#4)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-3#3)(1997-7#2)(1997-8#3)(2004-11#1)(2004-12#1)(2004-4#1)(2004-9#1)(2005-11#18)(2006-10#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-12#6)(2007-2#1)(2007-4#1)(2007-8#18)(2007-9#1)(2008-1#5)(2008-10#63)(2008-11#9)(2008-2#20)(2008-3#15)(2008-4#5)(2008-5#7)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#2)(2009-10#2)(2009-11#2)(2009-2#2)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#3)(2010-8#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-10#1)(2012-12#3)(2012-3#1)(2012-8#1)(2013-1#5)(2013-7#2)(2013-8#4)
onto their##4##2##(1995-11#1)(2006-12#1)(2007-10#1)(2011-2#1)
onto these##3##2##(2005-8#2)(2008-2#1)
onto this##3##2##(1990-8#1)(2008-6#1)(2011-2#1)
onto three##2##2##(2008-10#1)(2008-3#1)
onto various##3##2##(1996-5#1)(1996-8#1)(2008-10#1)
onto which##2##2##(2005-11#2)
onto##880##1##(1990-11#2)(1990-12#5)(1990-3#1)(1990-6#1)(1990-7#2)(1990-8#4)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#7)(1991-6#1)(1992-1#1)(1992-11#3)(1992-12#4)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#5)(1992-8#3)(1993-12#1)(1993-2#2)(1993-4#2)(1993-6#2)(1994-12#9)(1994-2#4)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#5)(1995-2#6)(1995-5#2)(1995-6#5)(1995-7#1)(1995-8#1)(1996-11#3)(1996-12#4)(1996-2#1)(1996-4#1)(1996-5#4)(1996-8#6)(1997-1#1)(1997-2#7)(1997-3#5)(1997-4#2)(1997-5#1)(1997-7#3)(1997-8#6)(2004-11#1)(2004-12#2)(2004-4#2)(2004-9#2)(2005-11#54)(2005-12#2)(2005-7#1)(2005-8#2)(2006-10#4)(2006-11#2)(2006-12#6)(2006-3#1)(2006-4#5)(2006-5#5)(2006-6#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#16)(2007-12#21)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#1)(2007-8#27)(2007-9#2)(2008-1#9)(2008-10#229)(2008-11#27)(2008-2#40)(2008-3#56)(2008-4#18)(2008-5#25)(2008-6#5)(2008-7#18)(2008-8#9)(2008-9#6)(2009-10#3)(2009-11#5)(2009-12#1)(2009-2#4)(2009-3#2)(2009-4#2)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-1#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#13)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#9)(2011-12#1)(2011-2#8)(2011-7#1)(2012-1#4)(2012-10#1)(2012-11#8)(2012-12#5)(2012-2#7)(2012-3#3)(2012-4#1)(2012-8#1)(2013-1#12)(2013-7#2)(2013-8#8)
ontogenesis in##4##2##(1991-12#2)(1993-12#1)(2008-12#1)
ontogenesis of##4##2##(1992-12#1)(1995-7#1)(2007-3#1)(2010-8#1)
ontogenesis##18##1##(1990-2#1)(1990-7#1)(1991-12#3)(1992-12#1)(1993-12#2)(1995-7#1)(2007-11#1)(2007-3#1)(2008-12#1)(2008-8#1)(2009-2#2)(2009-8#1)(2010-8#1)(2011-2#1)
ontogenesis]##2##1##(2009-2#2)
ontogenetic data##2##2##(1994-5#1)(2007-12#1)
ontogenetic##19##1##(1991-4#1)(1992-3#1)(1993-9#1)(1994-5#2)(2007-12#3)(2007-3#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-2#1)(2010-8#3)(2011-2#1)
ontogenic resistance is##2##3##(2008-10#2)
ontogenic resistance to##3##3##(2008-10#3)
ontogenic resistance##15##2##(2008-10#15)
ontogenic##23##1##(1995-3#1)(1996-3#1)(2008-10#17)(2008-11#1)(2008-7#1)(2009-8#1)(2012-2#1)
ontogenically##3##1##(1997-5#1)(2008-10#2)
ontogeny and##10##2##(1991-5#1)(1992-6#1)(1993-3#1)(1994-10#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-11#1)(2012-1#1)(2013-7#1)
ontogeny have been##2##3##(2007-12#2)
ontogeny in##3##2##(1991-4#1)(2008-4#1)(2009-6#1)
ontogeny induced##2##2##(2008-4#1)(2010-12#1)
ontogeny is##2##2##(1991-9#1)(1996-3#1)
ontogeny of the##4##3##(1994-11#1)(2007-12#1)(2008-5#1)(2010-3#1)
ontogeny of##25##2##(1991-2#1)(1991-9#1)(1992-12#1)(1993-12#1)(1993-5#2)(1993-7#1)(1994-11#1)(1994-3#1)(1996-3#2)(1996-4#2)(2007-12#4)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)
ontogeny was##3##2##(1991-4#1)(2010-8#2)
ontogeny which##2##2##(1995-5#1)(2005-9#1)
ontogeny##77##1##(1991-12#2)(1991-2#1)(1991-4#2)(1991-5#1)(1991-9#2)(1992-12#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-5#2)(1993-7#1)(1994-10#1)(1994-11#2)(1994-3#2)(1995-3#1)(1995-5#1)(1996-3#5)(1996-4#3)(1997-5#1)(1997-7#1)(1997-9#1)(2005-9#1)(2007-11#1)(2007-12#11)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#2)(2009-10#3)(2009-12#2)(2009-6#1)(2009-8#1)(2010-12#6)(2010-3#1)(2010-8#4)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
ontological engineering##2##2##(2008-7#2)
ontological##16##1##(2006-3#1)(2008-11#1)(2008-7#4)(2008-8#1)(2010-5#1)(2012-2#3)(2013-1#5)
ontologies and##9##2##(2008-7#5)(2008-9#1)(2010-8#3)
ontologies are##3##2##(2008-7#1)(2013-1#2)
ontologies for##6##2##(2008-7#6)
ontologies in##4##2##(2007-6#1)(2008-7#3)
ontologies is##5##2##(2008-7#1)(2013-1#4)
ontologies to integrate##3##3##(2008-7#2)(2010-5#1)
ontologies##74##1##(2007-6#3)(2008-11#1)(2008-7#41)(2008-9#1)(2009-10#1)(2009-5#3)(2010-5#1)(2010-8#3)(2013-1#20)
ontology and##2##2##(2007-6#1)(2008-7#1)
ontology design patterns##6##3##(2013-1#6)
ontology design##8##2##(2013-1#8)
ontology development##3##2##(2007-10#1)(2013-1#2)
ontology for the##2##3##(2008-7#2)
ontology for##8##2##(2008-7#4)(2013-1#4)
ontology is##2##2##(2008-7#2)
ontology of##5##2##(2008-7#2)(2012-2#1)(2013-1#2)
ontology terms in##4##3##(2013-1#4)
ontology terms##6##2##(2008-8#1)(2012-11#1)(2013-1#4)
ontology to##3##2##(2007-10#1)(2007-6#1)(2008-7#1)
ontology will##3##2##(2008-7#3)
ontology##94##1##(2007-10#2)(2007-6#2)(2008-11#1)(2008-12#1)(2008-7#44)(2008-8#2)(2009-9#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#36)
ontology-based data##3##2##(2008-7#1)(2013-1#2)
ontology-based##6##1##(2008-7#2)(2013-1#4)
onward for##2##2##(2008-5#2)
onward transmission##2##2##(2007-12#1)(2012-2#1)
onward##15##1##(1990-11#1)(1995-11#2)(1995-9#2)(1996-7#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-5#3)(2012-2#1)(2013-8#1)
onwards in##3##2##(1990-12#1)(1996-12#1)(1996-3#1)
onwards##29##1##(1990-12#2)(1991-8#1)(1993-11#1)(1994-12#1)(1994-4#1)(1994-6#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-3#1)(2005-11#1)(2005-7#1)(2007-6#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-2#1)(2011-1#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
onycholysis##2##1##(2007-7#1)(2008-9#1)
onychomycoses##4##1##(1993-3#1)(1993-4#1)(1996-1#1)(2008-5#1)
onychomycosis and##2##2##(2006-12#1)(2011-2#1)
onychomycosis by##2##2##(2008-5#2)
onychomycosis caused by##2##3##(2009-2#1)(2011-2#1)
onychomycosis in##2##2##(2008-3#1)(2009-2#1)
onychomycosis of##2##2##(2005-11#1)(2009-2#1)
onychomycosis##28##1##(2005-11#3)(2006-12#2)(2007-12#1)(2007-7#7)(2008-3#3)(2008-5#6)(2009-2#3)(2011-2#3)
onychophoran cephalic##2##2##(2007-12#2)
onychophoran eyes##3##2##(2007-12#3)
onychophoran##11##1##(2007-12#11)
oocyst count##2##2##(2008-5#2)
oocyst counts##2##2##(2008-5#1)(2012-2#1)
oocyst per##2##2##(1996-12#1)(2004-11#1)
oocyst##17##1##(1996-12#3)(2004-11#1)(2005-12#2)(2006-10#1)(2008-5#6)(2011-1#2)(2012-2#2)
oocysts and##3##2##(2007-2#2)(2011-1#1)
oocysts from##2##2##(2007-12#1)(2011-1#1)
oocysts in the##3##3##(2005-7#1)(2008-5#2)
oocysts in##7##2##(1993-7#1)(1996-12#1)(2005-12#2)(2005-7#1)(2008-5#2)
oocysts of##4##2##(1996-12#1)(2008-5#1)(2011-1#1)(2012-2#1)
oocysts were detected##2##3##(1996-12#2)
oocysts were##4##2##(1996-12#2)(2005-12#1)(2011-1#1)
oocysts##38##1##(1993-7#1)(1996-12#9)(2004-11#1)(2005-12#6)(2005-7#1)(2007-12#1)(2007-2#3)(2007-8#1)(2008-10#1)(2008-5#6)(2011-1#6)(2012-2#2)
oocyte G alpha subunits##3##4##(1992-11#3)
oocyte G alpha##4##3##(1992-11#4)
oocyte Pf##2##2##(1991-2#1)(1993-3#1)
oocyte and##6##2##(1991-11#1)(1993-6#1)(1995-8#1)(2007-12#1)(2008-12#1)(2008-7#1)
oocyte cell##2##2##(1992-11#1)(2012-12#1)
oocyte chromosomes##2##2##(2006-5#1)(2007-12#1)
oocyte development##4##2##(2008-5#2)(2009-4#1)(2012-3#1)
oocyte differentiation##3##2##(1991-11#2)(2007-8#1)
oocyte donation##4##2##(2007-2#2)(2010-12#1)(2011-2#1)
oocyte expression system##4##3##(1992-6#1)(1995-2#1)(1997-2#2)
oocyte expression##5##2##(1992-6#1)(1994-9#1)(1995-2#1)(1997-2#2)
oocyte extracts##3##2##(1991-9#1)(1994-12#1)(1997-2#1)
oocyte growth##2##2##(2008-5#1)(2010-5#1)
oocyte maturation##16##2##(1991-12#2)(1992-9#1)(1994-12#1)(1995-2#2)(1996-5#1)(1996-7#2)(2006-5#2)(2008-5#1)(2008-9#2)(2012-3#1)(2013-1#1)
oocyte meiotic maturation and##2##4##(2007-12#1)(2012-3#1)
oocyte meiotic maturation##3##3##(2007-12#2)(2012-3#1)
oocyte membrane##2##2##(1995-2#1)(1995-8#1)
oocyte nuclear##2##2##(1992-11#1)(2013-1#1)
oocyte nuclei##2##2##(2007-12#2)
oocyte nucleus and##3##3##(1994-11#1)(2007-12#2)
oocyte nucleus##8##2##(1994-11#1)(2007-12#7)
oocyte plasma membrane##2##3##(1994-12#2)
oocyte plasma##3##2##(1994-12#3)
oocyte preparation##2##2##(1990-2#1)(2007-12#1)
oocyte program##2##2##(1994-9#2)
oocyte recipients##3##2##(1994-9#3)
oocyte retrieval##7##2##(2007-2#4)(2009-6#1)(2010-7#1)(2012-12#1)
oocyte stage##2##2##(1992-11#1)(2010-8#1)
oocyte to##3##2##(2012-12#2)(2012-2#1)
oocyte unite##2##2##(2012-12#1)(2012-2#1)
oocyte##176##1##(1990-2#1)(1991-11#5)(1991-12#5)(1991-2#1)(1991-5#1)(1991-9#1)(1992-11#11)(1992-6#1)(1992-9#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#7)(1994-2#1)(1994-3#2)(1994-9#12)(1995-2#4)(1995-6#1)(1995-8#3)(1996-2#1)(1996-5#1)(1996-7#2)(1996-9#1)(1997-2#3)(1997-4#1)(2006-12#2)(2006-5#3)(2007-12#24)(2007-2#6)(2007-3#1)(2007-8#2)(2008-10#3)(2008-12#4)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#2)(2009-4#2)(2009-5#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#18)(2012-2#3)(2012-3#3)(2013-1#7)
oocyte-specific##2##1##(1991-11#1)(1994-9#1)
oocytes (phase##4##2##(2008-8#4)
oocytes after##5##2##(1994-8#1)(2006-5#1)(2008-8#1)(2012-2#1)(2013-1#1)
oocytes and in the##2##4##(1996-11#1)(2007-12#1)
oocytes and in##3##3##(1994-11#1)(1996-11#1)(2007-12#1)
oocytes and the##3##3##(2007-12#1)(2008-9#1)(2010-2#1)
oocytes and##27##2##(1990-7#1)(1991-12#1)(1992-11#1)(1992-9#1)(1994-11#2)(1994-12#2)(1994-9#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-7#1)(1996-8#2)(2006-5#1)(2007-12#4)(2008-12#1)(2008-8#1)(2008-9#2)(2010-2#1)(2011-2#1)(2012-2#1)
oocytes are##7##2##(1990-10#2)(1994-9#1)(1995-8#1)(2007-12#1)(2009-6#1)(2012-2#1)
oocytes at##3##2##(2008-12#1)(2008-9#1)(2013-1#1)
oocytes by##7##2##(1992-11#1)(1995-1#1)(1995-6#2)(1997-2#1)(2013-1#2)
oocytes can be##2##3##(1991-12#1)(2006-5#1)
oocytes can##3##2##(1991-12#1)(1995-8#1)(2006-5#1)
oocytes caused##2##2##(1993-6#1)(1994-3#1)
oocytes collected##3##2##(2006-5#1)(2010-12#2)
oocytes could be##2##3##(1991-10#1)(2006-5#1)
oocytes could##3##2##(1991-10#1)(1992-6#1)(2006-5#1)
oocytes cultured##2##2##(2006-5#1)(2008-9#1)
oocytes expressing the alpha 3 beta##2##6##(1995-11#2)
oocytes expressing the##7##3##(1995-11#3)(1997-2#2)(2008-4#2)
oocytes expressing##14##2##(1990-8#1)(1994-3#1)(1994-9#2)(1995-11#4)(1997-2#3)(2008-4#3)
oocytes following##3##2##(1993-6#2)(2006-5#1)
oocytes for##4##2##(1993-3#1)(2006-5#1)(2007-12#1)(2007-3#1)
oocytes from##3##2##(1995-12#1)(2008-12#1)(2008-8#1)
oocytes in the##3##3##(1995-2#1)(2008-5#2)
oocytes in##13##2##(1990-7#1)(1991-12#1)(1992-2#1)(1995-2#1)(2006-5#4)(2008-5#3)(2008-7#1)(2012-12#1)
oocytes injected with##14##3##(1990-7#3)(1991-5#1)(1992-6#1)(1993-8#2)(1994-3#1)(1995-2#1)(1996-8#1)(1997-2#1)(2008-8#3)
oocytes matured in vitro were##2##5##(2006-5#1)(2008-9#1)
oocytes matured in vitro##4##4##(2006-5#3)(2008-9#1)
oocytes matured in##5##3##(2006-5#4)(2008-9#1)
oocytes matured##6##2##(2006-5#5)(2008-9#1)
oocytes of Xenopus laevis##2##4##(1991-9#1)(1997-2#1)
oocytes of a common cellar spider##2##6##(2007-12#2)
oocytes of##13##2##(1991-9#1)(1993-9#1)(1995-2#1)(1997-2#1)(2007-12#5)(2008-7#2)(2008-8#1)(2009-7#1)
oocytes or##2##2##(1994-11#1)(2006-5#1)
oocytes penetrated##2##2##(2006-5#2)
oocytes per##2##2##(2006-5#1)(2007-11#1)
oocytes revealed that##2##3##(1992-3#1)(1997-4#1)
oocytes that are##2##3##(1990-8#1)(2006-5#1)
oocytes that##5##2##(1990-8#1)(1995-6#1)(2006-5#1)(2007-12#1)(2013-1#1)
oocytes to##6##2##(1990-7#2)(1991-10#1)(1996-11#1)(2006-5#1)(2010-8#1)
oocytes treated with##3##3##(1990-7#1)(1994-9#1)(2006-5#1)
oocytes was##6##2##(1994-8#2)(1996-1#1)(2006-5#2)(2012-3#1)
oocytes were cultured##2##3##(2006-5#2)
oocytes were injected with##2##4##(1990-7#1)(2008-8#1)
oocytes were inseminated with##2##4##(2006-5#1)(2012-2#1)
oocytes were##17##2##(1990-7#1)(1994-12#1)(1995-7#1)(1996-7#1)(1996-8#1)(2006-5#7)(2008-8#3)(2008-9#1)(2012-2#1)
oocytes with##4##2##(2006-5#2)(2008-9#2)
oocytes##361##1##(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#1)(1990-7#13)(1990-8#2)(1991-10#5)(1991-11#1)(1991-12#7)(1991-2#3)(1991-5#3)(1991-9#5)(1992-11#8)(1992-2#1)(1992-3#1)(1992-6#3)(1992-9#1)(1993-12#1)(1993-3#2)(1993-6#5)(1993-8#2)(1993-9#1)(1994-11#5)(1994-12#7)(1994-2#1)(1994-3#7)(1994-8#7)(1994-9#14)(1995-1#3)(1995-11#12)(1995-12#2)(1995-2#9)(1995-3#2)(1995-5#1)(1995-6#4)(1995-7#1)(1995-8#5)(1996-1#2)(1996-10#4)(1996-11#5)(1996-2#1)(1996-4#2)(1996-5#2)(1996-7#4)(1996-8#5)(1996-9#1)(1997-2#6)(1997-3#2)(1997-4#1)(1997-7#1)(2006-5#47)(2007-11#1)(2007-12#22)(2007-3#1)(2007-8#1)(2008-1#3)(2008-11#1)(2008-12#6)(2008-4#6)(2008-5#6)(2008-7#3)(2008-8#17)(2008-9#17)(2009-6#2)(2009-7#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#7)(2012-2#6)(2012-3#2)(2013-1#16)
oocytes)##4##1##(2008-8#4)
oocytic uptake##2##2##(1994-9#2)
oocytic##3##1##(1994-9#3)
oogenesis and spermatogenesis##2##3##(2009-7#1)(2010-5#1)
oogenesis and##8##2##(1992-11#2)(1995-2#1)(2007-12#1)(2008-11#1)(2009-3#1)(2009-7#1)(2010-5#1)
oogenesis in##3##2##(2007-12#3)
oogenesis##40##1##(1991-12#1)(1992-11#3)(1992-12#1)(1994-12#1)(1994-3#3)(1995-11#1)(1995-2#1)(1996-7#1)(2004-11#1)(2007-12#9)(2007-3#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#3)(2009-7#1)(2010-12#1)(2010-5#2)(2012-12#2)(2012-3#1)
oogonia and##2##2##(1992-11#1)(2010-5#1)
oogonia##6##1##(1992-11#1)(2008-10#3)(2010-3#1)(2010-5#1)
ookinete##2##1##(2006-10#2)
oolemma and##2##2##(1990-12#1)(1991-10#1)
oolemma##4##1##(1990-12#3)(1991-10#1)
oolong and black teas##2##4##(2008-11#2)
oolong and black##3##3##(2008-11#3)
oolong tea##2##2##(2008-10#1)(2008-5#1)
oolong##6##1##(2008-10#1)(2008-11#4)(2008-5#1)
oomycete and fungal##2##3##(2008-10#2)
oomycete pathogens##2##2##(2008-10#2)
oomycete that causes##4##3##(2008-10#4)
oomycete##16##1##(1997-2#1)(2008-10#14)(2009-8#1)
oomycetes##11##1##(2008-10#11)
oophorectomized##7##1##(1994-3#2)(1994-6#5)
oophorectomy##19##1##(1990-5#2)(1991-4#1)(1992-12#2)(1993-12#1)(1993-3#1)(1993-9#1)(1996-3#2)(2004-2#3)(2013-1#6)
oophoritis##2##1##(2008-4#1)(2013-8#1)
ooplasm during##2##2##(2008-7#1)(2008-9#1)
ooplasm##10##1##(1994-9#1)(2006-5#1)(2007-12#2)(2008-7#1)(2008-9#5)
ooplasmic##2##1##(1994-9#1)(2007-12#1)
ooplax##2##1##(2008-5#2)
oospore formation##4##2##(2008-10#4)
oospore production in##2##3##(2008-10#2)
oospore production##5##2##(2008-10#5)
oospore progeny##2##2##(2008-10#2)
oospore##12##1##(2008-10#12)
oospores exposed to##2##3##(2008-10#2)
oospores in the##5##3##(2008-10#5)
oospores in##15##2##(2008-10#15)
oospores of##4##2##(2008-10#4)
oospores per leaflet##3##3##(2008-10#3)
oospores per##5##2##(2008-10#5)
oospores were formed on media amended with##2##7##(2008-10#2)
oospores were recorded in##2##4##(2008-10#2)
oospores were##11##2##(2008-10#11)
oospores##67##1##(2008-10#66)(2010-3#1)
oozing type##2##2##(2007-8#2)
oozing##4##1##(1992-10#1)(1995-1#1)(2007-8#2)
op genotype and gender##2##4##(1995-8#2)
op genotype##3##2##(1995-8#3)
op##13##1##(1990-5#4)(1995-8#3)(1996-8#1)(2006-7#1)(2007-8#1)(2008-10#1)(2012-12#1)(2012-2#1)
op/op fibroblasts##2##2##(1990-5#2)
op/op mice##3##2##(1990-5#3)
op/op##9##1##(1990-5#5)(1991-5#4)
opacification and neovascularization##2##3##(2009-8#2)
opacification and##4##2##(2006-8#1)(2008-10#1)(2009-8#2)
opacification in##3##2##(2006-8#2)(2008-5#1)
opacification of the##5##3##(1997-8#1)(2007-12#1)(2010-2#1)(2011-2#1)(2013-7#1)
opacification of##6##2##(1997-8#1)(2007-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-7#1)
opacification##32##1##(1996-6#1)(1997-8#1)(2006-8#10)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-10#2)(2009-8#3)(2010-2#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-7#1)
opacities and##3##2##(2008-12#2)(2010-12#1)
opacities in##3##2##(1991-12#1)(2007-7#1)(2013-1#1)
opacities were##2##2##(2007-8#1)(2012-2#1)
opacities##19##1##(1991-12#2)(2005-8#3)(2007-1#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-7#1)(2010-12#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
opacity and##4##2##(1993-5#1)(2008-4#1)(2011-7#1)(2012-2#1)
opacity and/or##2##2##(1993-5#1)(2007-3#1)
opacity in the##4##3##(2008-1#1)(2008-7#1)(2012-1#1)(2012-2#1)
opacity of##3##2##(1992-7#1)(2008-2#1)(2010-12#1)
opacity with##3##2##(2008-1#1)(2008-7#1)(2010-10#1)
opacity##43##1##(1991-12#1)(1992-7#1)(1993-5#2)(1993-6#1)(1994-9#1)(1996-5#1)(1997-1#1)(2005-8#1)(2007-2#1)(2007-3#2)(2007-8#2)(2008-1#2)(2008-2#4)(2008-3#4)(2008-4#2)(2008-7#2)(2009-3#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-9#1)(2011-1#2)(2011-7#1)(2012-1#1)(2012-2#4)(2013-7#1)
opal and##2##2##(2008-9#1)(2010-5#1)
opal##7##1##(1993-11#2)(2008-9#3)(2010-5#1)(2013-7#1)
opalescent##3##1##(2007-8#1)(2008-3#2)
opaque materials##2##2##(2008-2#1)(2008-3#1)
opaque object##2##2##(2007-12#1)(2008-3#1)
opaque##52##1##(1990-3#1)(1993-10#1)(1993-6#1)(1994-6#1)(2003-11#1)(2005-11#1)(2005-7#1)(2006-3#1)(2007-12#5)(2008-10#2)(2008-11#1)(2008-2#8)(2008-3#13)(2008-5#2)(2008-7#2)(2009-5#1)(2009-9#2)(2010-1#1)(2010-8#1)(2012-2#4)(2012-3#1)(2013-1#1)
open a new##5##3##(1997-4#1)(2008-10#1)(2008-6#1)(2008-9#1)(2010-7#1)
open a##11##2##(1991-11#1)(1996-4#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-7#1)
open abdominal##4##2##(2008-3#1)(2008-5#1)(2011-2#2)
open access to primary##2##4##(1997-3#1)(2012-3#1)
open access to the##3##4##(2007-4#1)(2008-9#1)(2012-3#1)
open access to##11##3##(1996-6#1)(1997-3#1)(2006-7#1)(2007-4#2)(2008-9#1)(2012-3#4)(2013-8#1)
open access##19##2##(1992-2#1)(1996-6#1)(1997-3#1)(2006-10#1)(2006-7#1)(2007-4#4)(2008-9#1)(2010-5#2)(2011-2#1)(2012-12#1)(2012-3#4)(2013-8#1)
open against##2##2##(2008-11#1)(2008-9#1)
open air##5##2##(2007-6#2)(2008-2#2)(2008-3#1)
open and arthroscopic##2##3##(2007-11#1)(2008-8#1)
open and closed forms##2##4##(2007-12#1)(2009-9#1)
open and closed states##2##4##(1995-6#1)(2008-8#1)
open and closed time distributions##2##5##(1996-2#2)
open and closed##10##3##(1991-12#1)(1995-6#1)(1996-2#2)(2007-12#1)(2008-8#1)(2009-9#2)(2010-9#1)(2012-12#1)
open and endovascular repair##2##4##(2012-12#2)
open and free##2##3##(1996-11#1)(2007-8#1)
open and##37##2##(1990-11#1)(1991-12#1)(1992-9#1)(1995-11#1)(1995-6#2)(1996-11#1)(1996-2#2)(1996-3#1)(1997-6#1)(2005-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-9#2)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)
open angle glaucoma and ocular hypertension##2##6##(2009-8#1)(2013-8#1)
open angle glaucoma##12##3##(2009-8#1)(2010-3#1)(2011-2#3)(2012-2#3)(2013-1#1)(2013-8#3)
open angle##15##2##(2009-8#1)(2010-3#1)(2011-2#5)(2012-2#3)(2013-1#1)(2013-8#4)
open apices##2##2##(2012-2#1)(2013-1#1)
open approach##6##2##(2009-6#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
open areas##3##2##(1994-3#1)(2007-3#1)(2010-3#1)
open arms##4##2##(1993-9#2)(1995-12#1)(2011-2#1)
open arthrotomy##2##2##(2007-12#1)(2009-3#1)
open at##4##2##(1991-2#1)(1992-8#1)(2007-9#1)(2008-10#1)
open biopsy was##2##3##(1993-10#1)(2013-8#1)
open biopsy##7##2##(1993-10#1)(2008-12#2)(2008-6#1)(2009-3#1)(2013-8#2)
open bite##4##2##(2008-5#1)(2011-2#1)(2012-2#2)
open chain polyammonium cations##3##4##(2008-10#3)
open chain polyammonium##4##3##(2008-10#4)
open channel block##2##3##(1996-10#1)(1996-9#1)
open channel##4##2##(1991-4#1)(1996-10#1)(1996-9#1)(2008-7#1)
open channels##2##2##(1993-8#1)(1994-2#1)
open chromatin##2##2##(1992-5#2)
open circuit potential##2##3##(2008-10#2)
open circuit##12##2##(2008-10#11)(2010-12#1)
open circular##2##2##(2008-10#1)(2013-1#1)
open clinical trial##4##3##(1991-8#1)(1996-1#1)(2007-7#2)
open clinical##5##2##(1991-8#1)(1996-1#1)(2007-7#3)
open configuration##3##2##(1990-11#1)(1997-1#1)(2006-12#1)
open conformation##4##2##(1992-9#1)(1995-6#2)(1996-11#1)
open conventional##2##2##(2006-10#1)(2011-2#1)
open cranial##2##2##(1990-5#1)(2007-12#1)
open craniotomy##3##2##(1995-11#1)(2006-5#2)
open discussion##3##2##(2007-11#1)(2011-2#1)(2012-3#1)
open doors##2##2##(2007-6#1)(2011-1#1)
open end##3##2##(2006-6#1)(2008-8#2)
open ended questions##2##3##(2012-12#2)
open environment##4##2##(2010-7#1)(2011-1#1)(2013-8#2)
open exchange of##2##3##(1996-1#1)(2010-11#1)
open field activity##2##3##(1990-5#1)(1991-10#1)
open field and##8##3##(1990-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-2#1)(1994-3#1)(1996-2#1)
open field behavior##3##3##(1993-5#1)(1994-10#1)(1994-3#1)
open field test##3##3##(1995-11#1)(2012-1#1)(2013-1#1)
open field##47##2##(1990-10#3)(1990-5#1)(1991-10#2)(1992-12#2)(1992-3#1)(1993-12#4)(1993-2#2)(1993-3#5)(1993-5#2)(1993-7#3)(1994-10#1)(1994-2#2)(1994-3#2)(1995-10#2)(1995-11#2)(1996-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2009-4#1)(2009-5#1)(2009-6#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
open focused microwave##2##3##(2008-10#2)
open focused##3##2##(2008-10#3)
open for##6##2##(1993-7#1)(1994-12#1)(2006-4#1)(2006-9#1)(2008-10#1)(2011-2#1)
open format interviews##2##3##(2006-5#2)
open forms##2##2##(1996-11#1)(2012-2#1)
open forum##4##2##(2006-5#3)(2012-3#1)
open fracture##4##2##(2008-11#1)(2009-9#1)(2010-12#1)(2010-3#1)
open fractures involving##2##3##(1991-6#1)(2010-11#1)
open fractures of the tibia##2##5##(2013-8#2)
open fractures of the tibial shaft##2##6##(2009-9#2)
open fractures of the##6##4##(2008-9#1)(2009-9#3)(2013-8#2)
open fractures of##9##3##(2007-8#1)(2008-9#2)(2009-9#3)(2013-8#3)
open fractures##21##2##(1991-6#1)(2007-11#1)(2007-8#2)(2008-9#2)(2009-9#7)(2010-11#1)(2010-12#1)(2013-1#1)(2013-8#5)
open gastrectomy##2##2##(2006-6#1)(2010-12#1)
open group##7##2##(2006-6#1)(2007-8#5)(2009-6#1)
open habitats##2##2##(2008-5#1)(2008-8#1)
open heart surgery and##3##4##(1993-10#1)(2007-8#2)
open heart surgery in##2##4##(1997-8#1)(2007-8#1)
open heart surgery is there##2##5##(2007-8#2)
open heart surgery is##3##4##(2007-8#3)
open heart surgery##24##3##(1990-2#2)(1992-10#1)(1992-5#1)(1993-10#2)(1996-5#2)(1996-9#2)(1997-8#1)(2007-8#9)(2007-9#2)(2009-4#1)(2012-2#1)
open heart##31##2##(1990-2#3)(1992-10#1)(1992-5#1)(1993-10#2)(1996-5#3)(1996-9#2)(1997-8#1)(2007-8#12)(2007-9#2)(2008-5#1)(2009-4#1)(2012-1#1)(2012-2#1)
open in response to##2##4##(2007-9#1)(2009-10#1)
open in the##4##3##(1992-11#1)(1992-2#1)(2007-12#2)
open in##12##2##(1992-11#1)(1992-2#1)(1992-5#1)(2007-12#2)(2007-9#1)(2008-3#2)(2008-5#1)(2009-10#1)(2011-12#2)
open incision##2##2##(2006-3#1)(2006-4#1)
open inguinal hernia##2##3##(2005-8#1)(2012-2#1)
open into the##2##3##(2007-12#1)(2008-7#1)
open into##4##2##(2007-12#1)(2008-4#1)(2008-7#2)
open isomer##2##2##(2008-3#2)
open label study##3##3##(2008-6#1)(2008-8#1)(2013-1#1)
open label##9##2##(2006-4#1)(2007-7#1)(2008-6#1)(2008-8#1)(2009-8#1)(2012-2#3)(2013-1#1)
open letter to##4##3##(2006-12#1)(2008-6#1)(2008-7#1)(2009-3#1)
open letter##7##2##(1996-3#1)(2006-12#1)(2006-4#1)(2008-6#1)(2008-7#2)(2009-3#1)
open loop##5##2##(1997-2#1)(2007-11#1)(2008-8#2)(2010-12#1)
open lung biopsy##6##3##(1994-6#1)(1996-9#1)(2005-11#1)(2006-10#2)(2007-8#1)
open lung##8##2##(1994-6#2)(1996-9#1)(2005-11#1)(2006-10#2)(2007-8#2)
open markets##2##2##(2007-12#1)(2007-2#1)
open method##3##2##(2007-11#1)(2007-7#1)(2011-2#1)
open multicenter##2##2##(1994-6#1)(2008-6#1)
open new avenues##2##3##(1994-3#1)(2009-5#1)
open new possibilities for##2##4##(2007-12#2)
open new possibilities in##2##4##(2005-11#1)(2008-4#1)
open new possibilities##4##3##(2005-11#1)(2007-12#2)(2008-4#1)
open new therapeutic##2##3##(2008-7#1)(2010-11#1)
open new##15##2##(1994-3#1)(2005-11#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-11#1)(2013-1#2)
open ocean water##3##3##(2008-2#1)(2008-3#2)
open ocean##8##2##(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#3)(2012-2#1)
open of##3##2##(1991-3#1)(2008-5#2)
open one##4##2##(1994-9#1)(2008-5#1)(2011-2#2)
open operation##6##2##(1995-9#1)(1997-8#2)(2006-5#1)(2008-3#2)
open or closed##2##3##(1991-6#1)(2008-10#1)
open or##10##2##(1991-6#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-12#1)(2011-2#1)(2012-12#3)
open oral challenge##3##3##(2012-3#3)
open phase##2##2##(1997-3#1)(2008-5#1)
open pilot study was##2##4##(2004-2#1)(2005-5#1)
open pilot study##3##3##(1991-1#1)(2004-2#1)(2005-5#1)
open possibilities##2##2##(2007-12#1)(2012-1#1)
open probability of the##2##4##(1994-2#1)(1994-3#1)
open probability of these channels increased##2##6##(1994-11#1)(1995-8#1)
open probability of##5##3##(1994-11#1)(1994-2#1)(1994-3#1)(1995-5#1)(1995-8#1)
open probability##9##2##(1994-11#1)(1994-2#1)(1994-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(2008-4#1)(2008-8#2)
open problem##6##2##(2005-1#1)(2006-2#2)(2010-3#2)(2013-8#1)
open problems in bioinformatics##2##4##(2010-7#1)(2012-3#1)
open problems##3##2##(2010-7#2)(2012-3#1)
open procedure##5##2##(2007-8#1)(2008-10#1)(2010-3#1)(2011-2#1)(2013-8#1)
open procedures##8##2##(1992-12#1)(2007-11#2)(2007-5#1)(2008-3#3)(2009-5#1)
open prospective##2##2##(1991-2#1)(2009-5#1)
open prostatectomy##2##2##(2007-7#1)(2011-12#1)
open pyeloplasty##6##2##(2007-10#1)(2008-10#2)(2009-6#3)
open question##6##2##(1993-11#1)(1996-11#1)(1996-4#1)(2006-10#1)(2006-12#1)(2006-5#1)
open questions and##4##3##(1992-12#1)(2011-1#1)(2011-12#1)(2013-8#1)
open questions are##3##3##(2008-8#1)(2009-3#1)(2012-2#1)
open questions in##2##3##(2008-8#1)(2012-12#1)
open questions##17##2##(1992-12#1)(1995-11#1)(1995-8#1)(1996-2#1)(1997-3#1)(2008-8#4)(2009-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
open randomized##2##2##(2008-4#1)(2011-1#1)
open reading frame (ORF) and##3##5##(1993-9#1)(1994-12#1)(1997-4#1)
open reading frame (ORF) encodes##2##5##(1990-1#1)(1996-10#1)
open reading frame (ORF) encoding a protein##3##7##(1994-11#1)(1995-6#1)(1997-5#1)
open reading frame (ORF) encoding a##5##6##(1993-12#1)(1994-11#1)(1995-6#1)(1997-5#1)(1997-7#1)
open reading frame (ORF) encoding##7##5##(1993-12#1)(1993-6#1)(1994-11#1)(1995-6#1)(1997-1#1)(1997-5#1)(1997-7#1)
open reading frame (ORF) of the##3##6##(1990-3#1)(1995-8#1)(1997-5#1)
open reading frame (ORF) of##12##5##(1990-11#1)(1990-3#1)(1991-9#1)(1993-12#1)(1995-8#2)(1997-2#1)(1997-5#1)(2008-10#1)(2008-7#1)(2008-9#1)(2013-1#1)
open reading frame (ORF) was found##2##6##(1990-11#2)
open reading frame (ORF) was##3##5##(1990-11#2)(1995-8#1)
open reading frame (ORF) which encodes a protein##2##8##(1990-11#1)(2008-8#1)
open reading frame (ORF) with##2##5##(1995-2#1)(2008-10#1)
open reading frame (ORF)##57##4##(1990-1#1)(1990-11#4)(1990-3#1)(1990-9#1)(1991-9#1)(1993-11#1)(1993-12#4)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#6)(1995-2#3)(1995-6#1)(1995-8#5)(1996-10#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#2)(1997-7#2)(2008-10#4)(2008-7#3)(2008-8#3)(2008-9#1)(2013-1#1)
open reading frame and##4##4##(1990-11#1)(1991-2#1)(1993-12#1)(1994-12#1)
open reading frame coding for a##6##6##(1990-4#1)(1990-9#1)(1991-10#1)(1991-9#1)(1993-12#1)(1994-9#1)
open reading frame coding for##8##5##(1990-2#1)(1990-4#1)(1990-9#2)(1991-10#1)(1991-9#1)(1993-12#1)(1994-9#1)
open reading frame encodes a##5##5##(1991-2#1)(1991-7#1)(1994-8#1)(1997-5#1)(2008-8#1)
open reading frame encoding a polypeptide of##5##7##(1990-5#1)(1991-10#1)(1992-7#1)(1997-3#1)(2008-8#1)
open reading frame encoding a polypeptide##6##6##(1990-5#1)(1991-10#1)(1992-7#1)(1996-11#1)(1997-3#1)(2008-8#1)
open reading frame encoding a protein of##7##7##(1990-11#1)(1991-2#1)(1991-5#1)(1993-3#1)(1994-9#1)(2006-8#1)(2009-5#1)
open reading frame encoding a protein##9##6##(1990-11#1)(1991-2#1)(1991-5#1)(1993-3#1)(1994-9#1)(2006-8#1)(2008-10#1)(2008-8#1)(2009-5#1)
open reading frame encoding a putative##2##6##(1992-12#1)(1995-6#1)
open reading frame encoding a##28##5##(1990-11#1)(1990-5#2)(1991-10#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-8#1)(2008-10#3)(2008-8#2)(2009-5#1)
open reading frame encoding the##3##5##(1997-3#1)(2008-10#1)(2009-5#1)
open reading frame encoding##43##4##(1990-11#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-3#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-11#1)(1996-7#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-6#1)(2006-8#1)(2008-10#5)(2008-5#1)(2008-8#2)(2009-5#2)(2012-3#1)(2013-1#1)
open reading frame for##3##4##(1991-9#1)(1997-2#2)
open reading frame found##3##4##(1994-8#1)(1995-2#1)(1995-8#1)
open reading frame from##6##4##(1991-12#1)(1991-5#1)(1991-6#1)(1992-2#1)(1995-2#1)(2008-8#1)
open reading frame in the##3##5##(1993-4#1)(1994-11#1)(1997-7#1)
open reading frame in##4##4##(1993-4#1)(1994-11#1)(1997-7#1)(2005-11#1)
open reading frame is not##2##5##(1995-8#1)(2008-2#1)
open reading frame is##8##4##(1990-3#1)(1990-7#1)(1993-5#1)(1993-6#1)(1995-8#1)(1996-10#1)(1996-2#1)(2008-2#1)
open reading frame of 375##2##5##(1995-10#1)(1995-8#1)
open reading frame of human##2##5##(1990-5#1)(1994-5#1)
open reading frame of the mouse mammary tumor virus long terminal repeat##2##12##(1992-8#2)
open reading frame of the##8##5##(1992-6#1)(1992-8#2)(1993-12#1)(1993-6#1)(1994-12#1)(1995-12#1)(2008-10#1)
open reading frame of unknown function##2##6##(1992-9#1)(1994-6#1)
open reading frame of##80##4##(1990-11#1)(1990-12#1)(1990-4#4)(1990-5#4)(1990-9#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#3)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#2)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-10#2)(1996-12#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-6#2)(1997-7#1)(1997-9#1)(2005-6#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)
open reading frame that encodes a##2##6##(1996-5#1)(2006-5#1)
open reading frame that##7##4##(1990-7#1)(1992-10#1)(1996-5#1)(1997-2#1)(2006-5#1)(2008-10#1)(2008-9#1)
open reading frame was cloned and##2##6##(1994-8#1)(2008-10#1)
open reading frame was identified##2##5##(1993-3#1)(1997-6#1)
open reading frame was##7##4##(1990-12#1)(1993-3#2)(1994-8#1)(1997-6#2)(2008-10#1)
open reading frame were##2##4##(1991-7#1)(2008-10#1)
open reading frame which encodes a protein of##2##8##(1994-11#1)(1994-12#1)
open reading frame which##3##4##(1990-11#1)(1994-11#1)(1994-12#1)
open reading frame with a##2##5##(1993-11#1)(2008-10#1)
open reading frame with##6##4##(1990-9#1)(1993-11#2)(1994-2#1)(2008-10#1)(2009-5#1)
open reading frame##311##3##(1990-1#1)(1990-11#8)(1990-12#2)(1990-2#1)(1990-3#3)(1990-4#8)(1990-5#7)(1990-7#3)(1990-9#8)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#5)(1991-2#4)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#1)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#5)(1992-9#2)(1993-11#4)(1993-12#9)(1993-2#2)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#5)(1993-7#1)(1993-8#2)(1993-9#2)(1994-11#5)(1994-12#13)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#4)(1994-8#6)(1994-9#9)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#8)(1995-3#1)(1995-6#5)(1995-8#14)(1995-9#1)(1996-10#6)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-7#4)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#9)(1997-3#4)(1997-4#4)(1997-5#4)(1997-6#6)(1997-7#5)(1997-9#1)(2005-11#1)(2005-6#1)(2006-5#1)(2006-8#1)(2008-10#22)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#10)(2008-9#4)(2009-5#3)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
open reading frame-beta-galactosidase fusion protein##2##5##(1992-8#2)
open reading frames (ORF) were##2##5##(1997-1#1)(2008-10#1)
open reading frames (ORF)##5##4##(1992-3#1)(1997-1#2)(2008-10#1)(2008-5#1)
open reading frames (ORFs) and##2##5##(1996-3#1)(2008-10#1)
open reading frames (ORFs) in##3##5##(1995-4#1)(2008-10#1)(2012-2#1)
open reading frames (ORFs) longer##2##5##(1995-9#1)(1996-3#1)
open reading frames (ORFs) of at least 100 amino acids##2##10##(1995-6#1)(1997-3#1)
open reading frames (ORFs) of unknown function##2##7##(1996-6#1)(1997-3#1)
open reading frames (ORFs) of##7##5##(1993-12#1)(1995-6#2)(1996-6#1)(1997-3#2)(2008-10#1)
open reading frames (ORFs) were found##3##6##(1990-9#1)(1991-7#1)(1991-9#1)
open reading frames (ORFs) were identified##2##6##(1995-9#1)(1997-4#1)
open reading frames (ORFs) were##6##5##(1990-9#1)(1991-7#1)(1991-9#1)(1995-9#1)(1997-4#1)(2008-10#1)
open reading frames (ORFs) with##2##5##(1997-3#1)(2008-7#1)
open reading frames (ORFs)##45##4##(1990-9#1)(1991-7#1)(1991-9#1)(1993-12#1)(1993-9#1)(1994-12#2)(1995-12#1)(1995-4#2)(1995-6#2)(1995-9#3)(1996-3#5)(1996-6#4)(1997-2#1)(1997-3#6)(1997-4#2)(1997-6#1)(2008-10#9)(2008-7#1)(2012-2#1)
open reading frames and##3##4##(1996-3#1)(1997-3#2)
open reading frames coding for##2##5##(2008-10#2)
open reading frames encoding the##2##5##(2008-10#2)
open reading frames encoding##4##4##(2008-10#3)(2008-9#1)
open reading frames from the##2##5##(1995-3#1)(1997-7#1)
open reading frames in##4##4##(1996-3#1)(1996-7#1)(2008-10#1)(2008-7#1)
open reading frames including##4##4##(1995-6#2)(1995-9#1)(1996-6#1)
open reading frames of the##2##5##(1991-7#1)(2008-10#1)
open reading frames of##6##4##(1990-1#1)(1990-7#1)(1991-7#1)(1993-9#1)(1994-11#1)(2008-10#1)
open reading frames that##2##4##(1997-1#1)(2005-11#1)
open reading frames were identified##2##5##(1996-10#1)(2005-11#1)
open reading frames were##4##4##(1996-10#1)(1996-7#1)(1997-3#1)(2005-11#1)
open reading frames##131##3##(1990-1#1)(1990-11#2)(1990-3#2)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-7#4)(1991-9#2)(1992-3#1)(1992-6#1)(1993-12#2)(1993-9#2)(1994-11#2)(1994-12#2)(1994-3#1)(1994-9#1)(1995-12#2)(1995-3#2)(1995-4#4)(1995-6#4)(1995-8#2)(1995-9#6)(1996-10#1)(1996-12#2)(1996-3#8)(1996-4#1)(1996-6#8)(1996-7#2)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#12)(1997-4#3)(1997-6#1)(1997-7#1)(2005-11#2)(2006-12#1)(2008-10#22)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2011-1#2)(2012-2#1)(2013-8#2)
open reading##449##2##(1990-1#2)(1990-11#10)(1990-12#2)(1990-2#1)(1990-3#5)(1990-4#8)(1990-5#9)(1990-7#5)(1990-8#1)(1990-9#9)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#5)(1991-2#4)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#7)(1991-8#1)(1991-9#6)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#7)(1992-9#2)(1993-11#4)(1993-12#11)(1993-2#2)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#5)(1993-7#1)(1993-8#2)(1993-9#4)(1994-11#8)(1994-12#15)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#4)(1994-8#6)(1994-9#10)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#8)(1995-3#3)(1995-4#4)(1995-6#9)(1995-8#16)(1995-9#7)(1996-10#7)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#9)(1996-4#1)(1996-5#1)(1996-6#10)(1996-7#6)(1996-8#1)(1996-9#2)(1997-1#7)(1997-2#11)(1997-3#16)(1997-4#7)(1997-5#4)(1997-6#7)(1997-7#6)(1997-9#1)(2005-11#4)(2005-6#1)(2006-12#1)(2006-5#1)(2006-8#1)(2008-10#45)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#11)(2008-9#6)(2009-5#3)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
open reduction and internal fixation of##3##6##(2008-12#1)(2009-9#1)(2011-2#1)
open reduction and internal fixation with##2##6##(2009-3#1)(2012-2#1)
open reduction and internal fixation##10##5##(2008-12#1)(2008-7#1)(2008-8#1)(2009-3#2)(2009-9#1)(2011-2#1)(2012-2#2)(2013-1#1)
open reduction and##11##3##(2008-12#1)(2008-7#1)(2008-8#1)(2009-3#2)(2009-9#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
open reduction internal fixation##4##4##(2007-12#1)(2008-8#1)(2009-4#1)(2013-1#1)
open reduction of##2##3##(2007-12#1)(2008-4#1)
open reduction##22##2##(1990-10#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-3#2)(2009-4#1)(2009-9#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#1)
open repair with##3##3##(2010-8#2)(2012-1#1)
open repair##8##2##(2010-12#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
open resection##3##2##(2008-10#1)(2011-2#2)
open source software##2##3##(2010-2#1)(2011-1#1)
open source##13##2##(2008-11#1)(2008-7#2)(2009-12#2)(2010-2#1)(2010-8#1)(2011-1#1)(2013-1#5)
open state and##2##3##(1990-11#1)(1990-2#1)
open state was calculated##2##4##(1992-9#2)
open state##6##2##(1990-11#1)(1990-2#1)(1992-9#2)(1996-12#1)(2007-9#1)
open states##2##2##(1990-11#1)(1992-9#1)
open structure##2##2##(1991-4#1)(1997-2#1)
open studies##4##2##(1992-10#1)(1997-8#1)(2006-10#1)(2006-12#1)
open study with##2##3##(1991-3#1)(1991-4#1)
open study##13##2##(1990-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1992-11#3)(1997-5#1)(2007-7#1)(2008-3#3)
open surgery and##3##3##(2011-2#1)(2012-12#2)
open surgery for##3##3##(1994-5#1)(2013-1#1)(2013-7#1)
open surgery in##3##3##(1995-8#1)(2006-6#1)(2009-3#1)
open surgery or##2##3##(1997-4#1)(2008-10#1)
open surgery##39##2##(1994-5#1)(1995-8#1)(1996-3#1)(1997-4#1)(1997-8#1)(2006-6#8)(2006-9#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2009-3#1)(2010-11#1)(2010-12#1)(2011-2#5)(2012-12#3)(2013-1#1)(2013-7#1)
open surgical approaches##2##3##(2006-6#1)(2011-2#1)
open surgical biopsy##2##3##(1994-7#1)(2008-6#1)
open surgical procedures##3##3##(2006-11#1)(2008-8#1)(2012-2#1)
open surgical repair##2##3##(2006-1#1)(2011-2#1)
open surgical##24##2##(1994-7#1)(1995-5#1)(2006-1#1)(2006-11#1)(2006-6#4)(2007-1#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#3)(2012-2#1)(2013-8#4)
open system##5##2##(2006-10#1)(2008-10#2)(2010-12#1)(2010-7#1)
open technique##6##2##(2007-7#1)(2007-8#2)(2008-12#1)(2008-3#1)(2011-2#1)
open techniques##3##2##(2006-3#1)(2006-8#1)(2007-12#1)
open the door to##5##4##(2006-12#1)(2007-8#1)(2007-9#2)(2008-4#1)
open the possibility for##2##4##(1996-6#1)(2009-3#1)
open the possibility of##4##4##(2007-11#1)(2008-4#2)(2012-2#1)
open the possibility to##3##4##(2005-11#1)(2008-10#1)(2013-8#1)
open the possibility##9##3##(1996-6#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-4#2)(2009-3#1)(2012-2#1)(2013-8#1)
open the question of the##2##5##(2005-7#1)(2007-11#1)
open the question of##3##4##(2005-7#1)(2007-11#1)(2012-3#1)
open the way for a##3##5##(1992-1#1)(1994-11#1)(2010-2#1)
open the way##4##3##(1992-1#1)(1994-11#1)(2007-8#1)(2010-2#1)
open the##28##2##(1992-1#1)(1994-11#1)(1996-6#1)(2005-11#2)(2005-7#1)(2006-12#1)(2007-11#2)(2007-8#4)(2007-9#4)(2008-10#1)(2008-11#1)(2008-4#3)(2009-3#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
open thoracotomy and##2##3##(2007-6#1)(2012-12#1)
open thoracotomy##8##2##(2006-10#2)(2006-7#1)(2007-6#1)(2007-8#1)(2012-12#2)(2013-7#1)
open tibial fractures##3##3##(2007-8#1)(2009-9#2)
open tibial shaft##3##3##(2009-3#1)(2009-9#2)
open tibial##7##2##(2007-8#1)(2009-3#1)(2009-9#5)
open time and##2##3##(1996-12#2)
open time of the##2##4##(1996-7#1)(2008-8#1)
open time of##3##3##(1994-2#1)(1996-7#1)(2008-8#1)
open time##8##2##(1994-12#2)(1994-2#1)(1995-6#1)(1996-12#2)(1996-7#1)(2008-8#1)
open times##4##2##(1990-11#1)(1992-9#3)
open to all##3##3##(1994-1#1)(2008-12#1)(2013-1#1)
open to investigation##2##3##(2006-9#1)(2008-7#1)
open to new##2##3##(1995-2#1)(2008-8#1)
open to question##5##3##(1991-12#1)(1996-5#1)(2005-10#1)(2008-4#1)(2009-5#1)
open to the atmosphere##2##4##(2008-3#2)
open to the public##3##4##(1992-9#1)(2007-10#1)(2008-7#1)
open to the##11##3##(1992-9#1)(1995-3#1)(1997-1#2)(2007-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2012-11#1)
open to##49##2##(1991-12#1)(1991-4#1)(1992-11#1)(1992-6#2)(1992-9#1)(1994-1#2)(1994-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-5#1)(1997-1#2)(2005-10#1)(2005-7#1)(2006-7#1)(2006-9#1)(2007-10#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-3#6)(2013-1#3)
open treatment##2##2##(2004-3#1)(2009-3#1)
open trial in##3##3##(1990-5#1)(2006-10#1)(2013-7#1)
open trial##7##2##(1990-5#1)(2006-10#1)(2007-7#2)(2008-11#1)(2008-5#1)(2013-7#1)
open trials##3##2##(1993-1#1)(2006-10#1)(2008-4#1)
open tubular capillary##2##3##(2008-10#2)
open tubular##6##2##(2007-8#2)(2008-10#4)
open up a new##2##4##(1995-3#1)(2011-12#1)
open up a##4##3##(1995-3#1)(2006-3#1)(2008-4#1)(2011-12#1)
open up new avenues for##2##5##(2007-10#1)(2011-2#1)
open up new opportunities for##2##5##(2008-5#1)(2012-2#1)
open up new##5##3##(2007-10#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
open up the##5##3##(1991-9#1)(1995-4#1)(1996-2#1)(2010-8#1)(2012-11#1)
open up##18##2##(1991-9#1)(1995-3#1)(1995-4#1)(1996-2#1)(2006-3#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#1)
open urban##3##2##(2008-10#1)(2008-11#2)
open vessel##5##2##(2008-10#5)
open while##2##2##(1996-12#1)(2007-4#1)
open wounds##4##2##(1993-8#1)(2006-2#1)(2008-10#1)(2012-3#1)
open##1557##1##(1990-1#2)(1990-10#5)(1990-11#15)(1990-12#4)(1990-2#7)(1990-3#5)(1990-4#8)(1990-5#14)(1990-7#5)(1990-8#1)(1990-9#10)(1991-1#2)(1991-10#6)(1991-11#4)(1991-12#8)(1991-2#10)(1991-3#3)(1991-4#5)(1991-5#3)(1991-6#5)(1991-7#8)(1991-8#3)(1991-9#7)(1992-1#2)(1992-10#3)(1992-11#7)(1992-12#8)(1992-2#3)(1992-3#5)(1992-4#2)(1992-5#6)(1992-6#9)(1992-7#1)(1992-8#9)(1992-9#12)(1993-1#2)(1993-10#3)(1993-11#5)(1993-12#16)(1993-2#7)(1993-3#10)(1993-4#2)(1993-5#4)(1993-6#6)(1993-7#7)(1993-8#4)(1993-9#6)(1994-1#2)(1994-10#1)(1994-11#12)(1994-12#19)(1994-2#7)(1994-3#9)(1994-5#4)(1994-6#8)(1994-7#1)(1994-8#8)(1994-9#13)(1995-1#1)(1995-10#3)(1995-11#6)(1995-12#6)(1995-2#9)(1995-3#6)(1995-4#5)(1995-5#3)(1995-6#15)(1995-7#1)(1995-8#19)(1995-9#9)(1996-1#2)(1996-10#8)(1996-11#9)(1996-12#10)(1996-2#6)(1996-3#12)(1996-4#3)(1996-5#6)(1996-6#13)(1996-7#7)(1996-8#2)(1996-9#7)(1997-1#12)(1997-2#17)(1997-3#19)(1997-4#10)(1997-5#6)(1997-6#8)(1997-7#7)(1997-8#6)(1997-9#1)(2004-2#1)(2004-3#1)(2005-1#1)(2005-10#1)(2005-11#9)(2005-5#1)(2005-6#1)(2005-7#3)(2005-8#2)(2006-1#1)(2006-10#19)(2006-11#2)(2006-12#9)(2006-2#6)(2006-3#4)(2006-4#6)(2006-5#18)(2006-6#17)(2006-7#6)(2006-8#5)(2006-9#3)(2007-1#4)(2007-10#9)(2007-11#17)(2007-12#22)(2007-2#6)(2007-3#3)(2007-4#6)(2007-5#3)(2007-6#4)(2007-7#14)(2007-8#51)(2007-9#16)(2008-1#3)(2008-10#115)(2008-11#17)(2008-12#10)(2008-2#9)(2008-3#29)(2008-4#17)(2008-5#25)(2008-6#9)(2008-7#32)(2008-8#40)(2008-9#19)(2009-10#4)(2009-12#4)(2009-3#13)(2009-4#5)(2009-5#8)(2009-6#7)(2009-7#2)(2009-8#3)(2009-9#17)(2010-1#1)(2010-11#4)(2010-12#13)(2010-2#2)(2010-3#10)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#10)(2010-8#6)(2010-9#2)(2011-1#15)(2011-12#7)(2011-2#48)(2012-1#5)(2012-11#2)(2012-12#25)(2012-2#25)(2012-3#20)(2013-1#38)(2013-7#9)(2013-8#33)
open- and closed-loop##2##3##(2007-12#1)(2012-2#1)
open- and##5##2##(1990-9#1)(2007-12#1)(2008-10#1)(2008-5#1)(2012-2#1)
open-access system##2##2##(2007-4#2)
open-access##8##1##(2007-4#4)(2010-12#3)(2012-2#1)
open-angle glaucoma (POAG)##2##3##(2011-12#2)
open-angle glaucoma and##2##3##(2006-6#1)(2008-3#1)
open-angle glaucoma##10##2##(2006-6#1)(2008-3#1)(2009-8#2)(2011-1#1)(2011-12#2)(2011-2#2)(2012-12#1)
open-angle##13##1##(2006-6#1)(2008-3#1)(2009-8#2)(2011-1#1)(2011-12#2)(2011-2#5)(2012-12#1)
open-bite##2##1##(2009-11#1)(2012-12#1)
open-chain##5##1##(2008-10#1)(2008-11#2)(2010-2#2)
open-channel##5##1##(1996-10#1)(1996-8#1)(1997-1#1)(2008-10#2)
open-chest##2##1##(1992-10#1)(2007-8#1)
open-circuit##3##1##(2008-10#2)(2010-4#1)
open-complex formation##2##2##(1995-2#1)(1996-11#1)
open-ended interviews##2##2##(1997-6#1)(2009-5#1)
open-ended question##2##2##(2010-10#1)(2013-7#1)
open-ended questionnaire##3##2##(1993-3#1)(2006-8#1)(2007-11#1)
open-ended questions were##2##3##(2013-1#1)(2013-8#1)
open-ended questions##16##2##(1995-12#1)(1996-1#1)(2007-3#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-5#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
open-ended##40##1##(1992-12#1)(1992-9#1)(1993-3#1)(1995-12#4)(1996-1#1)(1997-6#1)(1997-8#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-9#4)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2009-5#3)(2010-10#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#3)(2013-7#1)(2013-8#1)
open-field test##2##2##(1991-11#2)
open-field##12##1##(1991-1#1)(1991-11#3)(1992-10#1)(1993-12#1)(1994-3#2)(1994-6#2)(1996-12#1)(2012-2#1)
open-fringe##2##1##(2008-3#2)
open-heart surgery in##5##3##(1995-3#1)(1996-6#1)(2012-2#3)
open-heart surgery##20##2##(1993-6#1)(1995-3#1)(1996-12#1)(1996-6#1)(2007-8#3)(2007-9#2)(2008-11#1)(2010-7#2)(2012-2#7)(2013-1#1)
open-heart##22##1##(1993-6#1)(1995-3#1)(1996-12#1)(1996-6#1)(2007-8#3)(2007-9#2)(2008-11#1)(2010-7#2)(2012-2#9)(2013-1#1)
open-label filgrastim##2##2##(2008-7#2)
open-label phase##3##2##(2008-5#1)(2008-6#1)(2013-8#1)
open-label pilot study##3##3##(2008-5#1)(2008-7#1)(2012-1#1)
open-label portion of##2##3##(2004-3#1)(2012-2#1)
open-label portion##3##2##(2004-3#1)(2012-2#2)
open-label prospective study##2##3##(2006-12#1)(2008-7#1)
open-label studies##3##2##(2008-12#1)(2008-3#1)(2008-8#1)
open-label study##10##2##(1993-12#1)(1996-8#1)(2004-12#1)(2008-2#1)(2008-7#3)(2009-11#1)(2010-8#1)(2013-7#1)
open-label trial of fluvoxamine##2##4##(2004-3#2)
open-label trial of##4##3##(2004-3#2)(2007-8#1)(2008-5#1)
open-label trial##7##2##(2004-3#2)(2007-12#1)(2007-8#2)(2008-5#1)(2010-11#1)
open-label##58##1##(1992-11#1)(1993-12#1)(1996-8#1)(2004-12#1)(2004-3#4)(2006-10#1)(2006-12#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#3)(2008-6#2)(2008-7#11)(2008-8#2)(2009-10#1)(2009-11#1)(2009-9#1)(2010-11#2)(2010-4#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
open-labeled##2##1##(2008-3#1)(2011-2#1)
open-loop##8##1##(2007-12#1)(2008-1#2)(2008-2#2)(2008-4#2)(2013-1#1)
open-mesh##3##1##(1997-6#1)(2011-2#2)
open-mouth##2##1##(2007-1#1)(2010-2#1)
open-path eddy covariance system and##2##5##(2013-8#2)
open-path instrument##2##2##(2008-2#1)(2008-3#1)
open-path##8##1##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2013-8#2)
open-pollinated##3##1##(2006-12#1)(2008-10#2)
open-reading##3##1##(1991-12#1)(1991-5#1)(2010-5#1)
open-set speech perception##2##3##(2008-9#2)
open-set speech recognition##3##3##(2008-9#3)
open-set speech##6##2##(2008-9#6)
open-set##11##1##(2008-9#11)
open-source software in##2##3##(2007-4#1)(2011-1#1)
open-source software##5##2##(2007-4#2)(2008-4#1)(2011-1#2)
open-source##14##1##(2007-4#2)(2008-10#1)(2008-4#3)(2008-5#1)(2008-7#2)(2011-1#3)(2013-1#2)
open-state probability##2##2##(1990-11#1)(1996-12#1)
open-state##3##1##(1990-11#1)(1996-12#1)(2008-8#1)
open-time##2##1##(1990-11#1)(1991-12#1)
open-tubular capillary column##2##3##(2008-10#2)
open/closed FIA##2##2##(2008-10#2)
openable##2##1##(2008-2#2)
opened a new era##2##4##(1991-8#1)(2006-12#1)
opened a new##3##3##(1991-8#1)(2006-12#1)(2010-12#1)
opened a##5##2##(1991-8#1)(1993-8#1)(2006-12#1)(2010-12#1)(2012-2#1)
opened and closed##2##3##(1994-12#1)(2008-12#1)
opened and semi-closed abdomen techniques were employed for IPHP using cisplatin plus mitomycin-C##2##13##(2006-6#2)
opened and the##2##3##(2006-6#2)
opened and##11##2##(1990-12#1)(1992-6#1)(1994-12#1)(2006-12#1)(2006-6#4)(2008-12#1)(2009-2#1)(2011-2#1)
opened at##2##2##(1993-1#1)(2008-9#1)
opened by the##4##3##(1997-8#1)(2007-11#1)(2008-10#1)(2008-5#1)
opened by##7##2##(1994-10#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#2)
opened for##2##2##(2007-8#1)(2011-2#1)
opened in##6##2##(1995-1#1)(1996-6#1)(2007-7#1)(2008-10#1)(2008-8#1)(2011-2#1)
opened its##3##2##(2008-10#1)(2008-5#1)(2009-10#1)
opened new##5##2##(2006-10#1)(2008-1#1)(2008-7#1)(2008-8#1)(2011-2#1)
opened the way##2##3##(1993-11#1)(2011-2#1)
opened the##11##2##(1993-11#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-5#2)(2010-12#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
opened their##2##2##(1996-1#1)(2011-11#1)
opened to##2##2##(1993-2#1)(1996-2#1)
opened up a##2##3##(2006-11#1)(2006-5#1)
opened up new possibilities##2##4##(1993-8#1)(2007-8#1)
opened up new##3##3##(1993-8#1)(2006-6#1)(2007-8#1)
opened up the possibility of##2##5##(2008-7#1)(2009-2#1)
opened up the##3##3##(2008-12#1)(2008-7#1)(2009-2#1)
opened up##16##2##(1993-8#1)(1994-8#1)(1995-6#1)(2006-11#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-4#1)(2011-2#1)(2013-1#1)
opened##106##1##(1990-12#2)(1991-3#1)(1991-8#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-8#2)(1994-10#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-6#2)(1997-8#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-5#1)(2006-6#5)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#5)(2008-7#7)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#2)(2010-12#2)(2010-4#2)(2010-7#4)(2011-11#1)(2011-12#1)(2011-2#9)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
opener and##2##2##(2007-12#2)
opener pinacidil##2##2##(1994-3#1)(2008-8#1)
opener##13##1##(1992-8#1)(1992-9#1)(1993-11#2)(1994-3#1)(1997-1#1)(2007-12#3)(2008-5#1)(2008-8#1)(2011-1#2)
openers##10##1##(1991-1#2)(1993-11#1)(1996-12#3)(2008-12#1)(2008-5#1)(2013-1#2)
opening (approximately##2##2##(1994-3#1)(1995-11#1)
opening a##5##2##(2007-6#1)(2008-10#1)(2009-3#1)(2012-1#1)(2013-8#1)
opening and closing of the##4##5##(2006-6#1)(2007-8#1)(2010-11#1)(2010-2#1)
opening and closing of##5##4##(2006-6#1)(2007-8#1)(2010-11#1)(2010-2#2)
opening and closing##7##3##(1997-2#1)(1997-6#1)(2006-6#1)(2007-8#1)(2010-11#1)(2010-2#2)
opening and##23##2##(1995-1#1)(1996-2#1)(1997-2#1)(1997-6#1)(2006-6#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-2#2)(2012-1#1)(2012-2#3)(2013-7#4)
opening angle of the##2##4##(2008-10#1)(2008-9#1)
opening angle of##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
opening can##2##2##(2008-1#1)(2008-5#1)
opening ceremony##3##2##(2005-8#1)(2007-8#1)(2008-5#1)
opening during##2##2##(1996-9#1)(2012-3#1)
opening frequency##2##2##(1990-7#1)(1992-7#1)
opening hours##3##2##(1991-5#1)(1992-2#1)(1997-8#1)
opening in the##4##3##(1990-6#1)(1994-5#1)(2008-5#1)(2013-7#1)
opening in##11##2##(1990-3#1)(1990-6#1)(1992-2#1)(1994-3#1)(1994-5#1)(2005-10#1)(2008-5#1)(2010-8#1)(2012-3#2)(2013-7#1)
opening is##3##2##(1994-3#1)(2008-10#1)(2008-12#1)
opening new##4##2##(2008-10#1)(2008-7#1)(2010-4#1)(2012-12#1)
opening of a new##2##4##(1992-2#1)(2012-2#1)
opening of a##3##3##(1992-2#1)(2005-8#1)(2012-2#1)
opening of the blood-brain barrier in##2##6##(1990-5#1)(1995-12#1)
opening of the mitochondrial##2##4##(2005-8#1)(2010-3#1)
opening of the vas deferens into Müllerian duct cysts##2##9##(2008-10#2)
opening of the vas deferens into##3##6##(2008-10#3)
opening of the##24##3##(1990-5#1)(1995-12#1)(1995-2#1)(1995-4#1)(1996-3#1)(2005-8#3)(2006-12#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2010-3#1)(2011-1#1)(2012-2#1)
opening of voltage-dependent##2##3##(1992-7#1)(2009-8#1)
opening of##53##2##(1990-5#1)(1991-8#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-12#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-4#1)(1996-3#1)(1996-9#1)(2005-8#4)(2006-12#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-2#1)(2010-3#1)(2011-1#2)(2012-2#3)(2013-1#1)
opening on the##2##3##(1993-8#1)(2010-8#1)
opening pressure of##2##3##(2006-8#1)(2011-2#1)
opening pressure was##2##3##(2006-8#2)
opening pressure##4##2##(2006-8#3)(2011-2#1)
opening probability##2##2##(1992-6#1)(2008-8#1)
opening ratio##2##2##(2008-2#2)
opening session##2##2##(1994-3#1)(2005-8#1)
opening signal##2##2##(1995-2#2)
opening the semicircular canal##2##4##(2006-12#2)
opening the way to##2##4##(2007-11#1)(2007-8#1)
opening the##19##2##(1995-3#1)(1995-4#1)(2005-9#1)(2006-12#2)(2006-6#1)(2007-11#1)(2007-8#2)(2008-1#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#1)(2011-1#1)(2011-2#1)
opening to##3##2##(2007-12#1)(2008-10#1)(2012-12#1)
opening up new##5##3##(2008-4#1)(2009-10#1)(2009-6#1)(2011-3#1)(2012-2#1)
opening up##10##2##(1996-3#1)(2006-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-3#1)(2009-6#1)(2011-3#1)(2012-2#1)
opening wedge##8##2##(2008-8#5)(2008-9#1)(2010-2#1)(2011-2#1)
opening with##2##2##(1995-2#1)(1996-5#1)
opening##265##1##(1990-10#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-2#3)(1991-4#2)(1991-5#1)(1991-8#1)(1992-2#3)(1992-6#1)(1992-7#2)(1992-9#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#5)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#3)(1995-11#3)(1995-12#1)(1995-2#5)(1995-3#1)(1995-4#2)(1996-12#2)(1996-2#3)(1996-3#2)(1996-5#1)(1996-9#2)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#7)(2005-9#1)(2006-10#1)(2006-12#6)(2006-6#2)(2006-8#3)(2007-10#4)(2007-11#7)(2007-12#10)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#5)(2008-10#15)(2008-11#8)(2008-12#5)(2008-2#5)(2008-3#3)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#6)(2008-8#12)(2008-9#7)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-2#4)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#4)(2011-11#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#7)(2012-3#3)(2012-6#1)(2013-1#6)(2013-7#9)(2013-8#2)
openings and shuttings##2##3##(1992-9#2)
openings and##3##2##(1992-9#2)(2007-12#1)
openings are##3##2##(2005-10#1)(2007-12#1)(2008-7#1)
openings as##2##2##(1994-3#1)(1996-12#1)
openings in the##3##3##(1995-1#1)(2008-1#1)(2008-7#1)
openings in##4##2##(1995-1#1)(2005-10#1)(2008-1#1)(2008-7#1)
openings of##3##2##(1990-2#2)(1994-2#1)
openings##35##1##(1990-2#3)(1990-7#1)(1992-9#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#3)(1996-12#1)(1997-1#1)(1997-5#1)(2005-10#3)(2006-4#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#2)(2011-2#1)(2013-1#1)
openly about##2##2##(2012-3#2)
openly available##2##2##(2008-4#1)(2012-3#1)
openly discussed##2##2##(2006-7#1)(2008-1#1)
openly##14##1##(1992-12#1)(1995-5#1)(1996-11#1)(2005-7#1)(2006-7#2)(2007-11#1)(2007-9#1)(2008-1#1)(2008-4#1)(2009-12#1)(2012-3#3)
openness and transparency##3##3##(2008-7#1)(2013-8#2)
openness and##5##2##(2008-7#1)(2012-3#2)(2013-8#2)
openness of##2##2##(2008-7#2)
openness to##3##2##(2008-12#1)(2008-3#1)(2012-12#1)
openness##22##1##(1990-8#1)(1997-5#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#3)(2009-8#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-3#2)(2013-8#3)
opens a new approach##2##4##(2007-11#1)(2012-2#1)
opens a new##5##3##(2007-11#2)(2008-11#1)(2010-7#1)(2012-2#1)
opens a##11##2##(1991-5#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2010-7#1)(2011-1#1)(2012-2#3)
opens an##2##2##(2006-10#1)(2008-7#1)
opens attractive##2##2##(2007-12#1)(2008-10#1)
opens avenues for##2##3##(1995-1#1)(2012-12#1)
opens new avenues##2##3##(2009-6#1)(2012-2#1)
opens new perspectives for##2##4##(2007-12#1)(2008-3#1)
opens new perspectives##4##3##(1993-8#1)(2007-12#2)(2008-3#1)
opens new possibilities##3##3##(1990-2#1)(1990-6#1)(1994-12#1)
opens new##12##2##(1990-2#1)(1990-6#1)(1993-8#1)(1994-12#1)(2007-12#2)(2008-11#1)(2008-3#1)(2008-5#1)(2009-6#1)(2012-12#1)(2012-2#1)
opens possibilities for##2##3##(2007-12#1)(2012-11#1)
opens the door##2##3##(2007-11#1)(2008-9#1)
opens the possibility for##2##4##(2006-10#1)(2011-2#1)
opens the possibility of##5##4##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)
opens the possibility to##2##4##(2008-10#1)(2008-3#1)
opens the possibility##9##3##(2006-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
opens the prospect##2##3##(2008-7#1)(2010-12#1)
opens the way for##4##4##(1992-8#1)(2009-8#1)(2009-9#1)(2011-1#1)
opens the way to a##2##5##(1991-1#1)(2005-11#1)
opens the way to##9##4##(1991-1#1)(1995-1#1)(2005-11#1)(2007-12#1)(2008-2#2)(2009-3#1)(2010-7#1)(2011-2#1)
opens the way##13##3##(1991-1#1)(1992-8#1)(1995-1#1)(2005-11#1)(2007-12#1)(2008-2#2)(2009-3#1)(2009-8#1)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#1)
opens the##31##2##(1991-1#1)(1991-3#1)(1992-8#1)(1995-1#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#1)
opens up a##4##3##(1990-6#1)(2010-2#1)(2010-7#1)(2010-8#1)
opens up new possibilities for##2##5##(2004-4#1)(2008-3#1)
opens up new possibilities##3##4##(2004-4#1)(2008-3#1)(2008-8#1)
opens up new##6##3##(1993-2#1)(2004-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)
opens up the possibility of##5##5##(1990-5#1)(2008-11#1)(2008-7#3)
opens up the possibility##6##4##(1990-5#1)(2008-11#1)(2008-7#3)(2009-5#1)
opens up##19##2##(1990-5#1)(1990-6#1)(1993-2#1)(1997-6#1)(2004-4#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-5#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#1)
opens with detailed discussions on the latest principles of sterile technique and preparation of culture media##4##16##(2008-2#1)(2008-4#2)(2008-9#1)
opens with##7##2##(2008-2#1)(2008-4#5)(2008-9#1)
opens##110##1##(1990-2#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-8#1)(1993-10#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-1#2)(1996-2#1)(1997-6#1)(2004-4#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-11#5)(2007-12#9)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#4)(2008-3#5)(2008-4#5)(2008-5#2)(2008-7#6)(2008-8#2)(2008-9#2)(2009-3#2)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-7#3)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#6)
operability of##2##2##(1990-9#1)(2008-11#1)
operability##5##1##(1990-9#1)(2004-2#1)(2006-10#1)(2008-11#1)(2008-5#1)
operable breast cancer##15##3##(1991-12#1)(1991-8#2)(1992-10#1)(1992-12#2)(1993-11#2)(1994-6#1)(1996-4#2)(2004-1#2)(2007-11#1)(2007-5#1)
operable breast##17##2##(1991-12#1)(1991-8#2)(1992-10#1)(1992-12#2)(1993-11#3)(1994-12#1)(1994-6#1)(1996-4#2)(2004-1#2)(2007-11#1)(2007-5#1)
operable gastric cancer##2##3##(2012-12#2)
operable lung##2##2##(1996-9#1)(2007-8#1)
operable##37##1##(1991-12#1)(1991-4#1)(1991-8#2)(1992-10#1)(1992-12#2)(1992-3#1)(1993-11#3)(1993-5#1)(1994-12#1)(1994-4#1)(1994-6#1)(1994-8#1)(1996-1#1)(1996-11#1)(1996-4#2)(1996-9#1)(1997-2#1)(1997-8#2)(2004-1#2)(2005-10#1)(2007-11#2)(2007-5#1)(2007-8#3)(2008-3#1)(2008-5#1)(2012-12#2)
operand##2##1##(2008-2#1)(2008-3#1)
operant behavior##3##2##(1993-6#1)(1997-6#2)
operant conditioning procedure##2##3##(1992-10#1)(2008-4#1)
operant conditioning##8##2##(1992-10#1)(1994-2#1)(2007-2#1)(2008-4#2)(2010-2#2)(2013-1#1)
operant feeding##2##2##(1993-6#1)(2012-1#1)
operant learning##2##2##(2008-8#1)(2010-2#1)
operant responding##4##2##(1992-9#1)(1993-6#2)(2008-4#1)
operant response##3##2##(1997-6#1)(2008-4#2)
operant##37##1##(1990-12#1)(1990-7#2)(1992-10#1)(1992-9#1)(1993-6#4)(1994-2#1)(1994-3#1)(1997-6#5)(2007-2#1)(2007-8#1)(2008-10#2)(2008-4#7)(2008-8#2)(2009-11#1)(2009-8#1)(2010-2#3)(2011-2#1)(2012-1#1)(2013-1#1)
operants##2##1##(2011-2#2)
operate a##5##2##(1995-1#1)(1996-4#1)(2007-4#1)(2007-9#1)(2008-3#1)
operate and##8##2##(1993-10#1)(1994-12#1)(1996-2#1)(2007-12#1)(2008-10#3)(2008-11#1)
operate as##4##2##(1990-2#1)(1995-8#1)(1996-5#1)(2010-2#1)
operate at a##2##3##(2007-12#1)(2008-3#1)
operate at the level of##2##5##(1991-12#1)(2009-11#1)
operate at the##8##3##(1991-12#1)(1994-12#1)(2006-4#1)(2008-10#1)(2008-3#1)(2009-11#1)(2009-12#1)(2012-2#1)
operate at##23##2##(1991-12#1)(1994-12#1)(2004-4#1)(2006-11#1)(2006-4#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2012-2#1)
operate during##2##2##(2008-4#1)(2008-9#1)
operate efficiently##2##2##(2007-12#2)
operate for##2##2##(1995-1#1)(2011-12#1)
operate in a##8##3##(1990-10#1)(1992-12#1)(1997-1#1)(1997-8#1)(2007-8#1)(2008-2#1)(2010-7#1)(2012-2#1)
operate in all eukaryotes##2##4##(1991-11#1)(2010-4#1)
operate in all##3##3##(1991-11#1)(2010-4#1)(2012-3#1)
operate in an##2##3##(2008-12#1)(2008-3#1)
operate in different##2##3##(2010-4#1)(2012-2#1)
operate in the##10##3##(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-4#1)(2008-9#1)(2012-2#1)
operate in their##2##3##(2008-11#1)(2008-2#1)
operate in these##3##3##(1991-9#1)(2005-8#1)(2006-7#1)
operate in##52##2##(1990-10#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1996-10#1)(1996-9#1)(1997-1#1)(1997-8#1)(2005-8#1)(2006-7#2)(2007-1#1)(2007-11#1)(2007-12#5)(2007-8#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#1)(2008-4#2)(2008-5#2)(2008-9#3)(2009-5#1)(2010-12#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-8#1)
operate more##2##2##(1994-2#1)(2007-12#1)
operate on##5##2##(1997-8#1)(2007-7#1)(2008-7#1)(2009-5#1)(2013-1#1)
operate the##5##2##(2007-12#1)(2008-3#4)
operate their##2##2##(2007-4#1)(2012-2#1)
operate through a##3##3##(1991-6#1)(2007-12#1)(2011-2#1)
operate through##7##2##(1991-6#1)(1994-5#1)(2007-12#1)(2008-5#1)(2010-12#1)(2010-9#1)(2011-2#1)
operate to##4##2##(1994-3#1)(2007-2#1)(2008-10#1)(2009-10#1)
operate under##6##2##(1994-12#1)(1994-3#1)(2005-8#1)(2008-1#1)(2008-11#1)(2008-3#1)
operate using##2##2##(2008-2#1)(2008-4#1)
operate with the##2##3##(2008-2#2)
operate with##10##2##(1993-9#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-2#3)(2008-3#3)
operate within the##2##3##(1991-11#1)(2008-2#1)
operate##218##1##(1990-10#1)(1990-2#1)(1990-4#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-10#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1995-1#2)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#2)(2004-4#1)(2005-10#1)(2005-8#2)(2006-11#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#2)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#15)(2007-2#1)(2007-4#3)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#16)(2008-11#10)(2008-12#2)(2008-2#17)(2008-3#14)(2008-4#4)(2008-5#4)(2008-7#7)(2008-8#3)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#3)(2009-7#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#5)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#1)(2013-8#2)
operated and##6##2##(1993-5#1)(2005-5#1)(2006-3#1)(2007-1#1)(2007-11#1)(2011-1#1)
operated as an##2##3##(2007-12#1)(2008-10#1)
operated as##7##2##(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
operated at 1##2##3##(2008-2#2)
operated at a##10##3##(2008-10#2)(2008-2#1)(2008-3#2)(2008-6#1)(2009-10#1)(2010-6#1)(2013-1#2)
operated at our##2##3##(2007-7#1)(2008-8#1)
operated at the##4##3##(1991-9#1)(2007-11#1)(2008-3#1)(2013-1#1)
operated at##41##2##(1991-4#1)(1991-5#1)(1991-9#1)(1995-9#2)(1996-6#1)(1997-2#1)(2006-12#1)(2006-5#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-4#1)(2010-6#1)(2012-12#1)(2013-1#4)
operated between 1997 and##2##4##(2007-11#1)(2007-7#1)
operated between##7##2##(1993-9#1)(2007-11#1)(2007-7#3)(2009-2#1)(2010-11#1)
operated by the##5##3##(1991-4#1)(2006-6#1)(2007-7#2)(2007-8#1)
operated by##17##2##(1991-4#1)(1992-2#1)(1993-11#1)(1993-8#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-3#2)(2008-9#1)(2011-1#1)(2012-2#1)
operated cases]##2##2##(1990-9#1)(1991-10#1)
operated control animals treated##2##4##(1992-9#2)
operated control##3##2##(1992-9#2)(1994-3#1)
operated during the##2##3##(1991-6#1)(1996-11#1)
operated during##4##2##(1990-2#1)(1991-6#1)(1996-11#1)(2008-2#1)
operated for a period of##2##5##(2008-6#2)
operated for a##5##3##(2005-11#1)(2007-8#1)(2008-6#2)(2008-9#1)
operated for colorectal##2##3##(1992-5#1)(2009-2#1)
operated for ventral hernia##2##4##(1996-12#2)
operated for##31##2##(1990-5#1)(1991-5#1)(1992-5#1)(1992-9#1)(1993-5#1)(1993-9#1)(1996-12#2)(2005-11#1)(2006-8#1)(2007-11#1)(2007-7#4)(2007-8#4)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-8#2)
operated from##5##2##(2007-8#3)(2008-3#2)
operated gastric##2##2##(1990-10#1)(2011-2#1)
operated in a##3##3##(2007-12#1)(2008-10#1)(2010-6#1)
operated in single mode and##2##5##(2008-2#2)
operated in the##21##3##(1991-9#1)(1992-6#1)(1993-9#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#1)(2011-3#2)(2012-3#1)
operated in##44##2##(1991-3#2)(1991-9#1)(1992-6#1)(1993-9#1)(2006-10#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-7#3)(2007-8#3)(2008-1#2)(2008-10#7)(2008-2#6)(2008-3#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-1#1)(2011-3#2)(2012-12#1)(2012-3#1)
operated knees##2##2##(2007-11#1)(2007-7#1)
operated on CPB between##2##4##(2007-8#2)
operated on a##3##3##(2008-10#3)
operated on and##2##3##(1993-3#1)(2013-1#1)
operated on at the##2##4##(1992-8#1)(2007-8#1)
operated on before the##2##4##(2006-7#1)(2007-8#1)
operated on between##4##3##(1991-6#1)(1992-9#1)(2006-7#1)(2007-8#1)
operated on both##2##3##(2008-10#1)(2010-8#1)
operated on by##5##3##(1991-4#1)(2006-12#1)(2008-10#1)(2012-2#1)(2013-1#1)
operated on for aneurysm of the##2##6##(1991-9#1)(1993-10#1)
operated on for##20##3##(1990-8#1)(1990-9#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-8#1)(1993-10#2)(2006-9#1)(2007-4#1)(2007-8#5)(2008-10#1)(2008-4#1)(2011-2#1)
operated on in##4##3##(1993-8#1)(2006-6#1)(2006-8#1)(2008-6#1)
operated on the##3##3##(1990-6#1)(2008-10#1)(2013-1#1)
operated on using##3##3##(1992-1#1)(2007-8#1)(2013-1#1)
operated on without##2##3##(2007-8#1)(2010-12#1)
operated on##92##2##(1990-4#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#3)(1991-2#1)(1991-4#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-10#3)(1993-2#1)(1993-3#1)(1993-5#2)(1993-7#1)(1993-8#2)(1996-1#1)(1996-12#1)(1996-2#2)(1997-6#1)(2006-12#1)(2006-6#3)(2006-7#3)(2006-8#2)(2006-9#1)(2007-11#2)(2007-4#1)(2007-8#17)(2008-10#7)(2008-4#1)(2008-6#1)(2008-7#3)(2010-12#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)
operated over##3##2##(2007-7#1)(2008-3#2)
operated patients##11##2##(1990-3#1)(1992-6#1)(1992-9#1)(2007-11#2)(2007-7#1)(2008-9#2)(2011-2#2)(2013-1#1)
operated to##2##2##(2006-7#1)(2009-7#1)
operated under##8##2##(2006-7#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-7#1)(2013-1#1)
operated upon by##2##3##(1991-11#1)(2009-2#1)
operated upon for##4##3##(2006-12#1)(2008-10#1)(2008-7#1)(2012-2#1)
operated upon##17##2##(1990-11#1)(1990-3#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-5#1)(1992-6#1)(1997-3#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-2#1)(2010-2#1)(2012-2#1)
operated using##7##2##(1993-11#1)(2007-11#2)(2007-7#2)(2007-8#1)(2013-1#1)
operated with a##6##3##(1995-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
operated with the##3##3##(2007-7#2)(2008-2#1)
operated with this##2##3##(1990-9#1)(2013-8#1)
operated with##21##2##(1990-9#2)(1993-8#1)(1994-2#1)(1995-3#1)(2006-6#1)(2007-12#1)(2007-7#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2009-6#1)(2011-1#1)(2013-8#1)
operated##461##1##(1990-10#3)(1990-11#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#2)(1990-9#5)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#3)(1991-4#4)(1991-5#3)(1991-6#3)(1991-8#1)(1991-9#4)(1992-1#3)(1992-10#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#4)(1992-8#3)(1992-9#5)(1993-10#3)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#3)(1993-5#4)(1993-7#1)(1993-8#5)(1993-9#3)(1994-12#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#3)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-6#1)(2004-1#1)(2004-9#1)(2005-11#1)(2005-5#1)(2006-10#2)(2006-12#4)(2006-3#1)(2006-5#2)(2006-6#6)(2006-7#5)(2006-8#6)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#29)(2007-12#10)(2007-2#1)(2007-4#2)(2007-6#1)(2007-7#31)(2007-8#47)(2007-9#2)(2008-1#6)(2008-10#32)(2008-11#5)(2008-12#2)(2008-2#18)(2008-3#16)(2008-4#2)(2008-5#9)(2008-6#5)(2008-7#12)(2008-8#5)(2008-9#6)(2009-1#1)(2009-10#1)(2009-2#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#9)(2011-12#1)(2011-2#7)(2011-3#3)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#13)(2013-7#1)(2013-8#4)
operates and##3##2##(2006-11#1)(2008-1#1)(2008-8#1)
operates as a##5##3##(1993-3#1)(2007-12#2)(2008-4#1)(2008-9#1)
operates as##8##2##(1993-3#1)(2007-12#3)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)
operates at a##5##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2012-2#1)
operates at the##3##3##(2006-11#1)(2008-2#1)(2010-5#1)
operates at##18##2##(1995-1#1)(1997-2#1)(2006-11#1)(2006-4#1)(2007-11#3)(2007-12#1)(2008-1#2)(2008-2#3)(2008-3#3)(2010-5#1)(2012-2#1)
operates by##6##2##(1994-3#1)(1996-12#1)(2007-12#2)(2008-3#1)(2008-7#1)
operates demonstrated##4##2##(1992-9#3)(1993-9#1)
operates from##2##2##(2008-1#1)(2008-3#1)
operates in a##8##3##(1995-6#2)(2006-4#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)
operates in the##8##3##(1993-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-1#1)
operates in##28##2##(1993-12#1)(1994-12#1)(1995-2#1)(1995-6#2)(1996-10#1)(2006-4#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#2)
operates on the##3##3##(1994-8#1)(2007-4#1)(2008-7#1)
operates on##6##2##(1994-8#2)(2007-4#1)(2008-2#1)(2008-4#1)(2008-7#1)
operates through a##2##3##(2008-11#1)(2008-8#1)
operates through##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
operates today##2##2##(2010-12#1)(2012-3#1)
operates under##4##2##(2007-12#1)(2008-2#1)(2010-3#1)(2012-2#1)
operates via##2##2##(1995-11#1)(2008-4#1)
operates were significantly##2##3##(1993-9#1)(1994-3#1)
operates with a##5##3##(2007-12#4)(2008-3#1)
operates with##9##2##(1993-9#2)(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#1)
operates##126##1##(1992-2#1)(1992-9#5)(1993-12#1)(1993-3#1)(1993-7#1)(1993-9#6)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#3)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(2005-5#1)(2006-11#2)(2006-4#2)(2007-11#7)(2007-12#13)(2007-3#1)(2007-4#1)(2007-9#1)(2008-1#5)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#10)(2008-3#14)(2008-4#4)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
operating a##7##2##(1991-12#1)(2006-7#1)(2007-4#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)
operating and##4##2##(1995-1#1)(1996-3#1)(2008-1#1)(2009-12#1)
operating as efficiently##2##3##(1995-12#1)(2008-12#1)
operating as##3##2##(1995-12#1)(2008-12#1)(2010-12#1)
operating at 1##7##3##(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)
operating at 13##2##3##(2010-10#1)(2010-12#1)
operating at 3##2##3##(1993-9#1)(2011-1#1)
operating at a 10-Hz repetition rate##2##6##(2007-12#2)
operating at a repetition rate of##2##6##(2007-12#1)(2008-3#1)
operating at a wavelength of##3##5##(2007-11#1)(2007-12#1)(2008-3#1)
operating at a##16##3##(2005-9#1)(2006-8#1)(2007-11#2)(2007-12#8)(2008-2#2)(2008-3#2)
operating at ambient##2##3##(2008-10#2)
operating at an##2##3##(2007-12#1)(2008-3#1)
operating at approximately##2##3##(2008-3#1)(2008-7#1)
operating at high##2##3##(1994-12#1)(2008-10#1)
operating at lambda =##2##4##(2008-2#2)
operating at room temperature##2##4##(2006-12#1)(2008-3#1)
operating at the##9##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#3)
operating at wavelengths of##2##4##(2007-12#1)(2008-2#1)
operating at##79##2##(1992-7#1)(1993-9#1)(1994-12#1)(2005-9#1)(2006-12#1)(2006-8#1)(2007-11#8)(2007-12#20)(2007-8#1)(2008-1#1)(2008-10#7)(2008-2#17)(2008-3#13)(2008-7#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#2)
operating between##5##2##(1994-5#1)(1995-3#1)(2008-2#2)(2008-3#1)
operating budget##3##2##(1991-12#1)(1995-3#1)(1997-8#1)
operating channel##2##2##(1996-1#1)(2007-8#1)
operating characteristic (ROC) analysis##3##4##(2010-9#1)(2011-1#1)(2012-3#1)
operating characteristic (ROC)##10##3##(1995-10#1)(1996-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-2#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-3#1)
operating characteristic curve##13##3##(1990-12#1)(2006-6#1)(2007-8#1)(2008-10#3)(2008-3#2)(2010-2#2)(2011-1#1)(2012-2#2)
operating characteristic curves##3##3##(1996-9#1)(2007-8#1)(2013-7#1)
operating characteristic##32##2##(1990-12#1)(1995-10#1)(1996-7#1)(1996-9#1)(2006-6#1)(2007-8#4)(2008-10#5)(2008-2#1)(2008-3#2)(2010-1#1)(2010-2#3)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-7#2)
operating characteristics of a##2##4##(2007-12#1)(2008-3#1)
operating characteristics of the##5##4##(1997-2#1)(2007-12#1)(2009-5#1)(2012-2#1)(2012-3#1)
operating characteristics of##11##3##(1997-2#1)(2007-12#2)(2008-2#2)(2008-3#1)(2009-10#1)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
operating characteristics##18##2##(1997-2#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-2#2)(2008-3#2)(2009-10#1)(2009-5#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
operating conditions and##6##3##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)
operating conditions are##3##3##(1995-12#1)(1996-9#1)(2008-10#1)
operating conditions for##3##3##(2008-10#1)(2008-2#1)(2009-11#1)
operating conditions of the##4##4##(1997-3#1)(2007-8#1)(2008-10#1)(2011-12#1)
operating conditions of##6##3##(1997-3#1)(2007-8#1)(2008-10#2)(2008-6#1)(2011-12#1)
operating conditions##54##2##(1995-12#1)(1996-9#1)(1997-3#2)(2006-10#1)(2006-4#1)(2007-11#1)(2007-8#2)(2008-10#12)(2008-2#5)(2008-3#5)(2008-5#3)(2008-6#1)(2008-7#10)(2009-11#1)(2010-4#2)(2011-1#1)(2011-12#2)(2011-2#2)(2012-3#1)
operating cost##3##2##(1991-4#1)(2007-4#1)(2013-1#1)
operating costs##5##2##(1991-12#1)(1994-1#1)(1996-2#1)(2007-9#1)(2008-2#1)
operating curve##7##2##(2008-2#4)(2008-3#1)(2012-3#1)(2013-1#1)
operating cycle##2##2##(2007-10#1)(2008-10#1)
operating during##2##2##(2007-7#1)(2008-5#1)
operating expenses##6##2##(1992-2#1)(1995-1#1)(1996-12#1)(2008-11#2)(2011-2#1)
operating fiberoptic hysteroscope##2##3##(1991-2#2)
operating frequency##2##2##(2007-2#1)(2008-3#1)
operating in a##14##3##(2007-11#2)(2007-12#4)(2008-10#3)(2008-11#2)(2008-3#1)(2013-1#2)
operating in an##2##3##(1991-12#1)(2007-12#1)
operating in parallel##2##3##(2008-2#1)(2008-5#1)
operating in the visible##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
operating in the##41##3##(1990-10#1)(1990-5#1)(1991-3#1)(1995-12#1)(1995-8#1)(2007-11#3)(2007-12#7)(2007-4#1)(2008-1#1)(2008-10#2)(2008-2#9)(2008-3#8)(2008-7#3)(2011-2#1)(2012-2#1)
operating in##85##2##(1990-10#2)(1990-12#1)(1990-5#1)(1991-12#2)(1991-3#1)(1992-10#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-8#1)(2005-6#1)(2006-10#1)(2007-11#5)(2007-12#16)(2007-4#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#15)(2008-3#10)(2008-5#1)(2008-7#3)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
operating mechanisms##3##2##(1992-9#1)(2008-10#1)(2013-8#1)
operating method##2##2##(2007-11#1)(2008-3#1)
operating microscope is##2##3##(2006-9#1)(2008-5#1)
operating microscope##11##2##(2006-12#1)(2006-5#1)(2006-9#2)(2007-1#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
operating mode##6##2##(2008-11#5)(2008-9#1)
operating near 1##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
operating near 2##5##3##(2007-12#1)(2008-3#4)
operating near real time##2##4##(2008-3#2)
operating near the##2##3##(2007-11#1)(2007-12#1)
operating near##20##2##(2007-11#1)(2007-12#6)(2007-8#1)(2008-2#2)(2008-3#10)
operating on a##4##3##(1995-3#1)(2007-11#1)(2008-2#1)(2008-9#1)
operating on the##7##3##(2007-12#2)(2007-5#1)(2008-2#1)(2008-3#1)(2009-7#1)(2013-1#1)
operating on##23##2##(1995-3#1)(1997-8#1)(2007-11#1)(2007-12#4)(2007-5#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-8#1)(2008-9#3)(2009-7#1)(2011-12#1)(2013-1#2)
operating parameters for##2##3##(2008-10#2)
operating parameters of the##2##4##(2008-10#1)(2008-2#1)
operating parameters of##4##3##(2008-10#1)(2008-2#1)(2008-9#1)(2012-3#1)
operating parameters on the##2##4##(2008-10#2)
operating parameters were##2##3##(2005-12#1)(2008-10#1)
operating parameters##16##2##(2005-12#1)(2008-10#8)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-3#1)
operating patients with##2##3##(2007-11#1)(2013-8#1)
operating performance##2##2##(1991-1#1)(2008-11#1)
operating plans##2##2##(1990-12#1)(1996-12#1)
operating plants##2##2##(2009-12#2)
operating point is##2##3##(1997-2#1)(2007-11#1)
operating point##4##2##(1997-2#1)(2007-11#1)(2008-2#1)(2008-3#1)
operating potential of##3##3##(2007-2#1)(2008-10#2)
operating potential##6##2##(2007-2#2)(2008-10#4)
operating pressure##4##2##(1991-8#1)(2008-7#1)(2009-7#1)(2012-3#1)
operating principle##4##2##(2007-9#1)(2008-3#1)(2010-4#1)(2013-7#1)
operating principles##5##2##(1997-8#1)(2008-10#1)(2008-3#2)(2008-9#1)
operating procedure for##2##3##(2011-2#2)
operating procedures##8##2##(1990-6#1)(2005-12#1)(2007-7#1)(2008-3#1)(2010-11#1)(2010-3#2)(2011-2#1)
operating range##5##2##(2007-11#1)(2008-2#2)(2008-5#1)(2009-9#1)
operating ratio##3##2##(2008-11#3)
operating regime in##2##3##(2008-3#2)
operating requirements##2##2##(2005-11#1)(2007-11#1)
operating revenue##2##2##(1994-2#2)
operating room (OR)##4##3##(2006-6#2)(2013-1#2)
operating room environment##4##3##(1991-1#1)(2007-5#2)(2008-8#1)
operating room for##3##3##(2006-10#2)(2013-8#1)
operating room is##2##3##(2006-10#1)(2012-3#1)
operating room time##3##3##(2006-6#1)(2006-8#1)(2012-2#1)
operating room under##2##3##(2007-7#1)(2011-2#1)
operating room##93##2##(1990-8#2)(1991-1#3)(1991-2#2)(1992-12#1)(1996-1#1)(1996-3#1)(2006-10#21)(2006-2#1)(2006-6#8)(2006-8#2)(2006-9#2)(2007-10#1)(2007-12#1)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-4#2)(2008-6#2)(2008-8#3)(2008-9#2)(2009-3#1)(2009-6#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-5#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-12#6)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
operating rooms##12##2##(1991-6#1)(1991-7#2)(2006-5#1)(2006-6#6)(2011-2#2)
operating strategy##4##2##(1994-1#1)(1997-2#1)(2006-2#1)(2008-11#1)
operating system##3##2##(2006-5#1)(2007-6#1)(2008-4#1)
operating systems##6##2##(1991-8#1)(2007-11#1)(2008-1#2)(2008-10#1)(2012-2#1)
operating table##6##2##(2007-12#1)(2007-8#1)(2008-2#1)(2008-8#1)(2011-2#2)
operating team##3##2##(2006-6#1)(2007-11#1)(2008-1#1)
operating temperature is##2##3##(2007-12#1)(2008-2#1)
operating temperature of##2##3##(2007-12#1)(2008-3#1)
operating temperature range##2##3##(2008-10#2)
operating temperature##11##2##(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#1)(2013-1#1)(2013-8#1)
operating temperatures##2##2##(2008-2#1)(2011-2#1)
operating the##5##2##(1996-12#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
operating theatre and##2##3##(2006-10#1)(2008-10#1)
operating theatre##19##2##(1991-7#1)(1992-3#1)(1995-4#1)(1996-1#4)(1996-9#1)(2006-10#2)(2006-6#2)(2007-7#1)(2008-10#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
operating theatres##2##2##(2006-10#1)(2006-6#1)
operating through##2##2##(1997-7#2)
operating time for the##2##4##(2006-6#1)(2008-10#1)
operating time for##5##3##(1996-3#1)(2006-6#1)(2008-10#1)(2008-5#1)(2008-6#1)
operating time was##7##3##(1991-1#1)(1995-3#1)(1996-1#1)(2007-7#1)(2008-1#1)(2011-2#1)(2012-12#1)
operating time##21##2##(1991-1#1)(1995-3#1)(1996-1#2)(1996-2#1)(1996-3#1)(2006-12#2)(2006-6#2)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
operating to##2##2##(1995-1#1)(2009-5#1)
operating under##8##2##(1994-12#1)(1995-3#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
operating variables##2##2##(2008-10#1)(2008-5#1)
operating very##2##2##(1991-1#1)(1993-3#1)
operating voltage of##2##3##(2007-12#2)
operating voltage##4##2##(1995-3#1)(2007-12#3)
operating wavelength##5##2##(2007-11#1)(2007-12#4)
operating with a##2##3##(2007-12#2)
operating with an##2##3##(2007-12#1)(2008-3#1)
operating with net##2##3##(2007-11#1)(2007-12#1)
operating with##10##2##(1994-2#1)(2007-11#1)(2007-12#4)(2007-6#1)(2008-2#1)(2008-3#2)
operating within the##3##3##(2007-12#1)(2008-2#1)(2009-5#1)
operating within##5##2##(2007-12#1)(2008-2#1)(2009-5#1)(2010-9#1)(2012-1#1)
operating##783##1##(1990-10#2)(1990-12#3)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#2)(1991-1#7)(1991-12#5)(1991-2#4)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#3)(1991-8#3)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-9#2)(1994-1#2)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#2)(1995-1#5)(1995-10#1)(1995-12#3)(1995-3#7)(1995-4#1)(1995-6#1)(1995-8#2)(1996-1#8)(1996-12#5)(1996-2#3)(1996-3#5)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#3)(1997-2#3)(1997-3#2)(1997-7#2)(1997-8#4)(2005-11#1)(2005-12#2)(2005-6#1)(2005-9#1)(2006-10#26)(2006-12#4)(2006-2#2)(2006-4#2)(2006-5#5)(2006-6#25)(2006-7#1)(2006-8#5)(2006-9#4)(2007-1#2)(2007-10#2)(2007-11#34)(2007-12#70)(2007-2#3)(2007-3#1)(2007-4#5)(2007-5#5)(2007-6#2)(2007-7#7)(2007-8#17)(2007-9#5)(2008-1#7)(2008-10#65)(2008-11#17)(2008-12#2)(2008-2#68)(2008-3#65)(2008-4#4)(2008-5#12)(2008-6#6)(2008-7#21)(2008-8#7)(2008-9#11)(2009-10#2)(2009-11#1)(2009-12#3)(2009-3#1)(2009-5#5)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#5)(2010-3#3)(2010-4#4)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#7)(2011-12#4)(2011-2#26)(2012-1#3)(2012-12#9)(2012-2#12)(2012-3#13)(2013-1#14)(2013-7#5)(2013-8#6)
operation &quot##3##2##(1993-9#1)(2008-11#2)
operation (P##3##2##(1990-8#1)(2007-10#2)
operation a##4##2##(1995-9#1)(2007-11#1)(2007-12#1)(2008-8#1)
operation allows##2##2##(2007-7#1)(2008-2#1)
operation and a##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
operation and control##3##3##(1992-11#1)(2007-8#1)(2008-10#1)
operation and died##2##3##(1996-9#1)(2012-2#1)
operation and postoperative##4##3##(1990-12#1)(1992-9#1)(2006-1#1)(2012-12#1)
operation and reached##3##3##(1991-5#1)(2007-10#1)(2007-7#1)
operation and stability##2##3##(2008-10#1)(2008-2#1)
operation and the##8##3##(1992-9#1)(1996-2#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#2)
operation and##75##2##(1990-12#1)(1990-2#3)(1990-3#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-6#1)(1992-9#2)(1993-2#2)(1994-12#1)(1994-3#2)(1995-9#1)(1996-2#2)(1996-9#1)(1997-2#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#5)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#8)(2008-7#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)
operation are discussed##2##3##(1990-9#1)(2008-3#1)
operation are##11##2##(1990-9#1)(1991-5#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#2)(2009-2#1)
operation as##3##2##(2007-8#1)(2008-10#1)(2008-2#1)
operation at 1##2##3##(2008-3#2)
operation at a##4##3##(1992-11#1)(1992-3#1)(2007-12#2)
operation at the##4##3##(1993-4#1)(1995-9#1)(1997-2#1)(2006-5#1)
operation at##24##2##(1992-11#1)(1992-3#1)(1993-10#1)(1993-4#1)(1995-9#1)(1997-2#1)(2006-5#1)(2007-11#1)(2007-12#6)(2008-1#1)(2008-2#2)(2008-3#5)(2010-1#1)(2010-4#1)
operation by##10##2##(1990-2#1)(1993-9#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-10#1)(2010-8#1)(2011-2#1)
operation can be obtained##2##4##(2008-2#2)
operation can be performed in##2##5##(1997-2#1)(2008-3#1)
operation can be##5##3##(1997-2#1)(2008-2#2)(2008-3#2)
operation can##7##2##(1997-2#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)
operation combined with##4##3##(1992-3#1)(2007-3#1)(2007-8#1)(2008-12#1)
operation conditions##5##2##(2005-11#1)(2008-10#3)(2008-2#1)
operation could be##2##3##(2007-8#1)(2008-7#1)
operation died##2##2##(1994-6#1)(1997-8#1)
operation due to##5##3##(1991-6#1)(1994-5#1)(2007-11#1)(2008-7#2)
operation during##2##2##(2008-4#1)(2012-12#1)
operation field##3##2##(2007-8#2)(2013-8#1)
operation for a##3##3##(2008-3#2)(2008-9#1)
operation for the##4##3##(1996-6#1)(2008-3#1)(2008-8#1)(2011-2#1)
operation for##44##2##(1990-3#1)(1990-6#1)(1991-5#1)(1993-2#1)(1995-9#1)(1996-6#1)(1997-3#1)(1997-8#1)(2005-12#2)(2006-11#1)(2007-10#1)(2007-12#2)(2007-8#3)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-2#1)(2009-4#1)(2010-12#2)(2010-6#1)(2011-2#1)(2013-1#1)
operation from##3##2##(2007-12#2)(2012-2#1)
operation gives##2##2##(2008-10#1)(2008-11#1)
operation group##2##2##(2008-5#1)(2011-2#1)
operation has been##4##3##(2007-12#1)(2007-8#2)(2008-3#1)
operation in Poland##2##3##(2007-11#2)
operation in a##9##3##(2007-12#5)(2007-8#3)(2012-2#1)
operation in both##3##3##(2007-12#1)(2007-8#1)(2013-7#1)
operation in order to##2##4##(1994-9#1)(2008-10#1)
operation in patients with##2##4##(2007-8#2)
operation in terms of##2##4##(1991-12#1)(2010-10#1)
operation in the field##2##4##(2008-2#1)(2008-3#1)
operation in the##19##3##(1990-3#1)(2004-10#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-11#2)(2008-2#2)(2008-3#6)
operation in##65##2##(1990-3#1)(1991-12#1)(1993-5#1)(1994-9#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-8#1)(2004-10#1)(2004-4#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-11#4)(2007-12#10)(2007-7#1)(2007-8#7)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#6)(2008-3#8)(2010-10#1)(2010-8#2)(2011-1#1)(2012-1#1)(2012-2#1)(2013-7#1)
operation inside##2##2##(2006-2#1)(2007-9#1)
operation into##2##2##(2008-2#1)(2013-1#1)
operation is achieved by use of##2##6##(2007-12#2)
operation is based on##3##4##(2007-11#1)(2008-10#2)
operation is indicated##2##3##(1996-12#1)(2006-6#1)
operation is obtained##2##3##(2008-2#2)
operation is shown to##2##4##(2007-12#1)(2008-2#1)
operation is the##5##3##(1991-9#1)(2007-11#2)(2008-11#1)(2013-8#1)
operation is very##2##3##(2005-4#1)(2011-2#1)
operation is##62##2##(1990-3#1)(1990-4#1)(1991-3#1)(1991-5#1)(1991-9#1)(1993-6#1)(1996-12#1)(2005-4#1)(2006-10#1)(2006-3#1)(2006-6#3)(2006-7#1)(2007-11#6)(2007-12#7)(2007-8#5)(2008-10#5)(2008-11#2)(2008-2#7)(2008-3#8)(2008-4#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#3)(2013-8#1)
operation it##2##2##(2008-10#1)(2012-2#1)
operation may be##4##3##(2007-12#1)(2007-8#1)(2012-2#1)(2013-1#1)
operation may##6##2##(2006-10#1)(2007-12#1)(2007-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
operation methods##2##2##(2006-8#1)(2007-11#1)
operation mode##6##2##(2008-2#1)(2010-5#1)(2012-2#1)(2013-1#3)
operation modes##3##2##(2007-12#1)(2008-2#1)(2012-3#1)
operation of a Nd##2##4##(2007-12#1)(2008-3#1)
operation of a continuous##2##4##(2004-8#2)
operation of a continuous-wave##2##4##(2008-2#2)
operation of a cw##2##4##(2008-1#1)(2008-3#1)
operation of a diode-pumped Nd##4##5##(2007-12#1)(2008-2#1)(2008-3#2)
operation of a diode-pumped##11##4##(2007-12#4)(2008-1#2)(2008-2#2)(2008-3#3)
operation of a laboratory##2##4##(2008-7#1)(2013-1#1)
operation of a motor vehicle##3##5##(1996-11#2)(2008-8#1)
operation of a pulsed##2##4##(2008-3#2)
operation of a##69##3##(1996-11#2)(2004-8#2)(2007-11#2)(2007-12#20)(2008-1#4)(2008-10#1)(2008-11#1)(2008-2#13)(2008-3#14)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#2)(2010-12#1)(2012-12#1)(2013-1#1)
operation of an all-optical##2##4##(2007-12#2)
operation of an##13##3##(1996-1#1)(1996-12#1)(1997-3#1)(2007-12#5)(2007-8#1)(2008-2#2)(2008-3#1)(2011-1#1)
operation of any health##2##4##(1991-12#1)(2008-12#1)
operation of optical##2##3##(2007-12#1)(2008-2#1)
operation of such##3##3##(2007-12#3)
operation of the hospital##2##4##(1995-12#1)(2006-8#1)
operation of the laser##3##4##(2007-12#3)
operation of the system##4##4##(2007-12#2)(2008-2#2)
operation of the##65##3##(1990-12#1)(1990-3#1)(1992-6#1)(1993-10#1)(1995-12#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-10#3)(2007-11#2)(2007-12#11)(2007-5#1)(2007-9#1)(2008-10#4)(2008-2#15)(2008-3#7)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-9#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#1)
operation of these devices##2##4##(2007-11#1)(2007-9#1)
operation of these##5##3##(2006-12#1)(2007-11#1)(2007-9#1)(2008-3#2)
operation of this laser##3##4##(2008-1#1)(2008-2#1)(2008-3#1)
operation of this##6##3##(1991-3#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-2#1)(2008-3#1)
operation of##221##2##(1990-12#1)(1990-3#1)(1990-6#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-6#1)(1993-10#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-1#2)(1995-12#1)(1995-6#1)(1996-1#1)(1996-11#2)(1996-12#1)(1997-3#3)(2004-8#2)(2004-9#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-5#1)(2006-8#2)(2007-10#3)(2007-11#10)(2007-12#49)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#2)(2008-1#8)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#36)(2008-3#28)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
operation on the##5##3##(1991-11#1)(2004-1#1)(2007-7#1)(2008-5#1)(2011-2#1)
operation on##12##2##(1991-11#1)(2004-1#1)(2006-9#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-6#1)(2010-12#1)(2010-8#1)(2011-2#1)
operation or##7##2##(1996-9#1)(2006-8#1)(2007-8#2)(2008-10#1)(2008-12#1)(2009-5#1)
operation over a##2##3##(2007-11#1)(2010-4#1)
operation over the##2##3##(2008-2#1)(2008-3#1)
operation over##5##2##(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-4#1)
operation parameters##4##2##(2008-10#1)(2008-2#1)(2008-7#1)(2011-1#1)
operation performed##3##2##(1990-3#1)(1992-10#1)(2007-7#1)
operation period##2##2##(2007-12#1)(2008-7#1)
operation periods##3##2##(2007-8#1)(2008-10#1)(2008-7#1)
operation potential##2##2##(2008-10#2)
operation principle is##2##3##(2007-12#1)(2008-2#1)
operation results##2##2##(2008-10#1)(2008-2#1)
operation she##2##2##(1996-6#2)
operation should be done##2##4##(1996-11#1)(2008-8#1)
operation should be performed##2##4##(1994-9#1)(2008-3#1)
operation should be##6##3##(1994-9#1)(1996-11#1)(2007-8#1)(2008-3#1)(2008-8#1)(2009-2#1)
operation should##7##2##(1994-9#1)(1996-11#1)(2006-10#1)(2007-8#1)(2008-3#1)(2008-8#1)(2009-2#1)
operation showed##4##2##(1994-7#1)(2006-12#1)(2007-2#1)(2008-9#1)
operation since##3##2##(2006-10#1)(2008-10#1)(2008-3#1)
operation site##2##2##(2007-5#1)(2009-6#1)
operation speed##2##2##(2007-12#1)(2008-2#1)
operation that##5##2##(1993-11#1)(2008-3#1)(2008-9#2)(2011-2#1)
operation the patient##2##3##(2008-6#1)(2010-12#1)
operation the##8##2##(1992-2#1)(1992-6#1)(1993-6#1)(2007-10#1)(2008-2#1)(2008-6#2)(2010-12#1)
operation theatre##3##2##(2007-11#1)(2012-3#1)(2013-8#1)
operation time##13##2##(2006-6#1)(2007-11#1)(2007-8#4)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-12#1)(2013-1#2)
operation to a##2##3##(2006-8#1)(2007-11#1)
operation to be##3##3##(1993-5#1)(2008-1#1)(2008-10#1)
operation to##12##2##(1991-3#1)(1993-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2010-11#1)(2013-1#1)(2013-7#1)
operation under##5##2##(1997-2#1)(2007-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
operation using##4##2##(2007-7#1)(2007-8#1)(2010-11#1)(2013-1#1)
operation voltage##2##2##(2007-12#2)
operation was achieved##2##3##(2007-11#1)(2007-12#1)
operation was observed##2##3##(2007-12#1)(2008-7#1)
operation was obtained##4##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)
operation was performed in##2##4##(1994-11#1)(1994-3#1)
operation was performed##4##3##(1994-11#1)(1994-3#1)(2006-12#1)(2008-5#1)
operation was##55##2##(1990-8#2)(1990-9#1)(1991-6#1)(1992-8#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-3#1)(1996-2#1)(1996-3#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#5)(2007-3#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#4)(2008-3#2)(2008-5#2)(2008-7#2)(2009-2#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-7#1)
operation were obtained##2##3##(2007-12#1)(2008-3#1)
operation were##13##2##(1993-2#1)(1994-3#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-12#2)(2008-10#1)(2008-3#1)(2008-7#1)(2010-7#1)(2011-2#1)
operation will##3##2##(2006-6#2)(2010-5#1)
operation with a##4##3##(1990-3#1)(2007-4#1)(2008-3#2)
operation with an##3##3##(2006-1#1)(2008-10#1)(2008-2#1)
operation with the##2##3##(2008-2#1)(2008-3#1)
operation with##24##2##(1990-3#1)(1993-2#1)(2006-1#1)(2006-6#1)(2007-12#4)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-2#4)(2008-3#6)
operation without##6##2##(1994-9#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-8#1)(2013-1#1)
operation##1407##1##(1990-12#3)(1990-2#5)(1990-3#10)(1990-4#3)(1990-5#1)(1990-6#5)(1990-8#13)(1990-9#7)(1991-1#1)(1991-10#1)(1991-11#4)(1991-12#3)(1991-3#7)(1991-4#2)(1991-5#4)(1991-6#6)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#4)(1992-8#1)(1992-9#2)(1993-1#3)(1993-10#4)(1993-11#2)(1993-2#9)(1993-3#4)(1993-4#1)(1993-5#6)(1993-6#2)(1993-8#2)(1993-9#6)(1994-11#4)(1994-12#5)(1994-2#4)(1994-3#8)(1994-5#2)(1994-6#3)(1994-7#1)(1994-9#4)(1995-1#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#2)(1995-6#3)(1995-9#5)(1996-1#2)(1996-11#4)(1996-12#6)(1996-2#8)(1996-3#4)(1996-5#2)(1996-6#4)(1996-8#1)(1996-9#4)(1997-1#1)(1997-2#5)(1997-3#6)(1997-5#4)(1997-6#2)(1997-8#8)(2004-1#1)(2004-10#3)(2004-12#2)(2004-4#1)(2004-8#2)(2004-9#3)(2005-11#8)(2005-12#2)(2005-4#2)(2005-5#1)(2005-9#1)(2006-1#2)(2006-10#13)(2006-11#1)(2006-12#8)(2006-2#7)(2006-3#1)(2006-4#5)(2006-5#10)(2006-6#20)(2006-7#6)(2006-8#14)(2006-9#4)(2007-1#2)(2007-10#20)(2007-11#65)(2007-12#131)(2007-2#7)(2007-3#6)(2007-4#5)(2007-5#5)(2007-6#2)(2007-7#23)(2007-8#92)(2007-9#6)(2008-1#17)(2008-10#97)(2008-11#25)(2008-12#11)(2008-2#120)(2008-3#128)(2008-4#9)(2008-5#13)(2008-6#13)(2008-7#36)(2008-8#6)(2008-9#18)(2009-10#2)(2009-12#2)(2009-2#6)(2009-4#2)(2009-5#2)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#4)(2010-12#9)(2010-4#2)(2010-5#7)(2010-6#2)(2010-7#6)(2010-8#12)(2011-1#10)(2011-2#32)(2012-1#6)(2012-11#1)(2012-12#11)(2012-2#17)(2012-3#8)(2012-8#1)(2013-1#23)(2013-7#6)(2013-8#6)
operation) and##2##2##(2007-9#1)(2013-1#1)
operation)##12##1##(1993-10#1)(1994-3#1)(2006-8#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-3#1)(2013-1#1)
operation]##5##1##(1991-10#1)(1997-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
operational amplifier to##2##3##(2008-10#1)(2010-8#1)
operational amplifier##5##2##(2008-10#3)(2010-8#1)(2013-7#1)
operational and clinical##2##3##(1994-12#1)(2007-4#1)
operational and financial##2##3##(1996-1#1)(2007-4#1)
operational and organizational##2##3##(1994-1#1)(1997-1#1)
operational and storage stability##6##4##(2008-10#6)
operational and temporal factors##4##4##(2013-1#4)
operational and##20##2##(1994-1#1)(1994-12#1)(1994-3#1)(1995-1#1)(1996-1#1)(1997-1#1)(2007-4#2)(2008-10#7)(2012-2#1)(2013-1#4)
operational approach##2##2##(1991-9#1)(2013-7#1)
operational aspects##3##2##(1993-6#1)(2011-2#1)(2013-8#1)
operational availability##3##2##(2013-1#3)
operational change##2##2##(1994-1#1)(2005-10#1)
operational changes##2##2##(1994-12#1)(1996-3#1)
operational characteristics##7##2##(1995-1#1)(2007-12#1)(2008-10#2)(2008-2#3)
operational conditions were##2##3##(2008-10#2)
operational conditions##12##2##(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2010-4#1)(2010-5#1)
operational costs and##2##3##(2004-9#1)(2010-9#1)
operational costs##4##2##(2004-4#1)(2004-9#2)(2010-9#1)
operational criteria for##3##3##(1995-1#1)(2008-11#1)(2012-1#1)
operational criteria##6##2##(1995-1#1)(1997-8#1)(2006-9#1)(2007-2#1)(2008-11#1)(2012-1#1)
operational data##4##2##(1997-3#1)(2010-8#1)(2013-1#2)
operational definition of##4##3##(1997-8#1)(2008-10#1)(2013-1#2)
operational definition##8##2##(1997-8#1)(2008-10#1)(2013-1#6)
operational definitions##3##2##(1996-7#1)(2004-10#1)(2013-1#1)
operational environment##3##2##(1994-12#1)(2008-2#1)(2012-3#1)
operational feasibility##3##2##(1992-2#1)(2005-9#1)(2007-7#1)
operational in the##2##3##(2007-12#1)(2008-5#1)
operational in##4##2##(2006-4#1)(2007-12#1)(2008-2#1)(2008-5#1)
operational issues##6##2##(1992-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-11#1)
operational lifetime of 8 weeks##2##5##(2008-10#2)
operational lifetime of##3##3##(2008-10#3)
operational lifetime##4##2##(2008-10#4)
operational model that##2##3##(2008-3#2)
operational model##4##2##(1997-3#1)(2008-3#3)
operational pH##2##2##(2008-10#2)
operational parameters had been investigated##2##5##(2008-10#2)
operational parameters have been selected for the drug##2##8##(2008-10#2)
operational parameters have been##3##4##(2008-10#3)
operational parameters##11##2##(2008-10#9)(2009-4#1)(2011-1#1)
operational performance##2##2##(1996-3#1)(2006-4#1)
operational principles##3##2##(2007-12#1)(2008-10#1)(2013-8#1)
operational processes##2##2##(1993-2#1)(2010-9#1)
operational range##2##2##(2008-10#2)
operational research##7##2##(2007-12#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-2#2)
operational results##2##2##(2008-2#1)(2009-5#1)
operational simplicity##2##2##(1990-5#1)(2011-2#1)
operational stability and##2##3##(2008-10#2)
operational stability of the##3##4##(2008-10#3)
operational stability of##4##3##(2008-10#4)
operational stability##10##2##(2008-10#9)(2012-11#1)
operational systems##2##2##(1996-2#1)(2007-11#1)
operational taxonomic units##2##3##(2005-11#1)(2012-2#1)
operational understanding##2##2##(1997-2#1)(2009-5#1)
operational use of##2##3##(2008-8#1)(2011-2#1)
operational##276##1##(1990-5#1)(1991-1#2)(1991-12#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#2)(1993-2#3)(1993-3#2)(1993-6#1)(1994-1#2)(1994-12#3)(1994-2#1)(1994-3#2)(1995-1#4)(1995-2#2)(1995-3#1)(1995-6#1)(1996-1#2)(1996-2#3)(1996-3#5)(1996-6#1)(1996-7#1)(1997-1#3)(1997-2#2)(1997-3#3)(1997-8#2)(2004-10#1)(2004-11#1)(2004-4#1)(2004-7#2)(2004-9#2)(2005-10#1)(2005-11#1)(2005-5#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-4#4)(2006-6#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#8)(2007-2#1)(2007-4#5)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#54)(2008-11#4)(2008-12#1)(2008-2#18)(2008-3#16)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#4)(2009-10#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#6)(2012-1#2)(2012-11#1)(2012-2#6)(2012-3#3)(2013-1#21)(2013-7#4)(2013-8#2)
operationalising##4##1##(2008-12#2)(2012-3#2)
operationalization of##2##2##(2010-2#1)(2011-12#1)
operationalization##5##1##(1992-1#1)(2008-1#1)(2010-2#1)(2011-12#1)(2012-12#1)
operationalizations of##3##2##(1997-1#2)(2008-12#1)
operationalizations##4##1##(1997-1#3)(2008-12#1)
operationalize##4##1##(1991-12#1)(1996-1#1)(2008-1#1)(2011-2#1)
operationalized##4##1##(2007-12#2)(2009-12#2)
operationally defined as##2##3##(1995-2#1)(1996-12#1)
operationally defined by the factor scores for the first principal components on##2##12##(2010-12#2)
operationally defined##6##2##(1995-2#1)(1996-12#1)(2007-8#1)(2008-10#1)(2010-12#2)
operationally##16##1##(1991-2#1)(1995-2#1)(1996-12#1)(2007-2#1)(2007-8#2)(2008-10#2)(2008-3#2)(2008-7#1)(2010-12#2)(2012-12#2)(2013-1#1)
operations and the##2##3##(1995-2#1)(2008-9#1)
operations and##23##2##(1991-11#1)(1991-5#1)(1991-8#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-8#3)(2005-8#1)(2006-11#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-2#1)(2009-8#1)(2011-2#1)
operations are done##2##3##(2008-2#1)(2010-8#1)
operations are performed##2##3##(2007-8#1)(2013-1#1)
operations are##18##2##(1990-3#1)(1997-1#1)(2006-10#1)(2007-5#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2010-8#1)(2013-1#1)
operations as##2##2##(1990-3#1)(2008-10#1)
operations at##7##2##(1991-3#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-9#1)(2013-1#2)
operations can be implemented##2##4##(2006-4#1)(2008-2#1)
operations can be##6##3##(1992-6#1)(1995-9#1)(2006-4#1)(2008-10#1)(2008-2#1)(2008-7#1)
operations can##8##2##(1992-6#1)(1995-9#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-7#1)
operations during##2##2##(1990-8#1)(1995-3#1)
operations for colonic##2##3##(1993-5#1)(2011-2#1)
operations for##18##2##(1990-5#1)(1990-9#2)(1991-10#1)(1992-11#1)(1993-3#2)(1993-5#1)(1996-12#1)(1997-8#2)(2006-7#2)(2007-11#1)(2007-7#1)(2008-9#1)(2010-8#1)(2011-2#1)
operations from##3##2##(2008-10#1)(2008-3#1)(2012-12#1)
operations has been##2##3##(2006-10#1)(2012-12#1)
operations has##3##2##(2006-10#1)(2006-8#1)(2012-12#1)
operations have been proposed##2##4##(2008-9#1)(2013-1#1)
operations have been##5##3##(1993-5#1)(2008-10#1)(2008-3#1)(2008-9#1)(2013-1#1)
operations have##9##2##(1990-5#1)(1993-5#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2013-1#1)
operations in a##3##3##(2005-9#1)(2008-3#1)(2010-8#1)
operations in patients with##3##4##(2007-8#2)(2012-3#1)
operations in the##7##3##(1990-8#1)(2006-6#1)(2007-8#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-2#1)
operations in two##2##3##(2007-8#1)(2009-1#1)
operations in##33##2##(1990-3#1)(1990-4#1)(1990-8#1)(1992-3#1)(1993-5#1)(1994-11#1)(1994-9#1)(1996-3#1)(1997-8#2)(2005-9#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-8#5)(2008-10#1)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-1#1)(2010-8#1)(2011-2#1)(2012-2#3)(2012-3#1)
operations included##2##2##(2006-8#1)(2008-10#1)
operations involve##2##2##(2006-8#1)(2008-2#1)
operations involving##3##2##(2005-11#1)(2007-8#1)(2008-9#1)
operations is##3##2##(1996-1#1)(2008-3#1)(2010-2#1)
operations may be##2##3##(2007-8#1)(2013-1#1)
operations may##3##2##(1992-1#1)(2007-8#1)(2013-1#1)
operations of public health##2##4##(1996-1#1)(2011-1#1)
operations of the##6##3##(2006-6#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)
operations of##24##2##(1992-3#1)(1993-9#1)(1996-1#1)(1996-12#1)(1996-3#2)(2006-6#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-4#1)(2009-10#1)(2010-1#1)(2010-8#1)(2011-1#1)(2013-1#1)
operations on the##4##3##(1996-4#1)(2007-12#1)(2008-2#1)(2009-2#1)
operations on##9##2##(1992-12#1)(1992-2#1)(1992-9#1)(1996-4#1)(2007-12#1)(2008-2#1)(2008-6#1)(2009-2#1)(2010-12#1)
operations or##2##2##(2006-12#1)(2007-8#1)
operations per event##2##3##(2011-1#2)
operations per##3##2##(2006-8#1)(2011-1#2)
operations performed by##3##3##(1990-12#1)(1996-9#1)(2007-11#1)
operations performed##8##2##(1990-12#1)(1994-2#1)(1996-9#1)(2007-11#1)(2008-6#1)(2008-9#1)(2013-1#2)
operations required##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
operations should be##2##3##(2006-7#1)(2007-11#1)
operations such as##5##3##(1993-11#1)(1994-6#1)(2006-6#1)(2008-3#2)
operations that##6##2##(1996-1#1)(2004-12#1)(2008-10#1)(2008-2#1)(2009-7#1)(2012-11#1)
operations to##9##2##(1997-1#2)(2007-11#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-3#1)(2010-6#1)(2011-2#1)
operations using##3##2##(1994-6#1)(2007-11#1)(2007-7#1)
operations was##2##2##(2008-10#1)(2013-1#1)
operations were carried out##2##4##(1990-4#1)(2006-5#1)
operations were carried##3##3##(1990-4#1)(1993-10#1)(2006-5#1)
operations were performed in##4##4##(1990-8#1)(1993-5#1)(2007-7#1)(2008-8#1)
operations were performed##12##3##(1990-8#2)(1993-3#1)(1993-5#1)(1996-1#1)(2006-6#1)(2006-7#1)(2007-7#1)(2007-8#2)(2008-8#1)(2009-3#1)
operations were successful##2##3##(1990-8#1)(2008-6#1)
operations were##33##2##(1990-4#1)(1990-8#3)(1993-10#1)(1993-3#1)(1993-5#2)(1993-6#1)(1993-9#1)(1994-2#1)(1995-3#1)(1996-1#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)
operations with##3##2##(2006-4#1)(2007-9#1)(2008-12#1)
operations without##2##2##(2004-2#1)(2011-2#1)
operations##490##1##(1990-12#5)(1990-2#1)(1990-3#3)(1990-4#3)(1990-5#3)(1990-8#5)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#4)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#4)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#3)(1992-5#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#2)(1993-2#2)(1993-3#6)(1993-5#8)(1993-6#1)(1993-9#3)(1994-1#2)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#5)(1994-5#2)(1994-6#4)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#1)(1995-9#3)(1996-1#6)(1996-12#2)(1996-2#1)(1996-3#7)(1996-4#2)(1996-6#1)(1996-9#2)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#8)(2004-10#1)(2004-12#1)(2004-2#2)(2004-9#2)(2005-10#1)(2005-11#2)(2005-5#1)(2005-8#1)(2005-9#1)(2006-10#6)(2006-11#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#2)(2006-6#13)(2006-7#6)(2006-8#6)(2007-1#3)(2007-11#10)(2007-12#10)(2007-2#3)(2007-3#1)(2007-4#7)(2007-5#6)(2007-6#3)(2007-7#4)(2007-8#23)(2007-9#5)(2008-10#29)(2008-11#10)(2008-12#2)(2008-2#14)(2008-3#39)(2008-4#7)(2008-5#3)(2008-6#5)(2008-7#7)(2008-8#5)(2008-9#9)(2009-1#2)(2009-10#2)(2009-2#4)(2009-3#2)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-6#2)(2010-8#6)(2011-1#4)(2011-2#9)(2012-11#2)(2012-12#4)(2012-2#7)(2012-3#7)(2013-1#18)(2013-7#2)(2013-8#3)
operations)##5##1##(1992-6#1)(2007-7#2)(2007-9#1)(2009-2#1)
operative and postoperative##3##3##(2010-7#1)(2011-2#1)(2013-1#1)
operative and##9##2##(2006-2#1)(2007-8#2)(2009-2#1)(2009-5#1)(2010-7#1)(2011-2#2)(2013-1#1)
operative approach is##3##3##(2008-9#2)(2010-11#1)
operative approach##12##2##(1996-1#1)(2006-10#2)(2006-7#1)(2007-8#1)(2008-1#1)(2008-7#1)(2008-9#4)(2010-11#1)
operative approaches##3##2##(2005-5#1)(2006-11#1)(2007-12#1)
operative arthroscopy##2##2##(1995-8#1)(2007-8#1)
operative atrial fibrillation##2##3##(2007-8#1)(2010-12#1)
operative blood loss##6##3##(1993-12#2)(2005-8#1)(2008-10#1)(2009-5#1)(2009-7#1)
operative blood##7##2##(1993-12#2)(2005-8#1)(2008-10#1)(2009-5#1)(2009-7#1)(2010-7#1)
operative care##3##2##(1996-6#1)(2009-5#1)(2010-2#1)
operative complication##3##2##(2006-1#1)(2010-12#1)(2011-2#1)
operative complications##5##2##(1991-2#1)(2006-10#1)(2006-12#1)(2007-7#1)(2010-12#1)
operative conditions##3##2##(2008-10#1)(2008-2#1)(2012-3#1)
operative day##3##2##(2007-8#1)(2012-2#2)
operative delivery##3##2##(2006-10#2)(2007-3#1)
operative drainage##2##2##(2008-10#1)(2009-4#1)
operative exposure and##2##3##(2007-8#2)
operative exposure##3##2##(2006-6#1)(2007-8#2)
operative field##12##2##(1995-1#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-5#1)(2008-7#1)(2010-12#1)(2010-8#2)
operative findings##6##2##(1995-3#1)(1997-8#1)(2005-12#1)(2008-9#2)(2012-2#1)
operative hysteroscopy##2##2##(1990-12#1)(2007-8#1)
operative imaging##2##2##(2007-2#1)(2012-2#1)
operative in the##2##3##(1990-4#1)(1995-12#1)
operative in##13##2##(1990-4#1)(1992-2#1)(1993-7#1)(1993-9#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-5#1)(2006-10#1)(2006-12#1)(2007-1#1)(2008-10#2)
operative intervention in##3##3##(1997-8#1)(2008-4#1)(2010-8#1)
operative intervention##13##2##(1996-2#1)(1997-8#1)(2005-12#2)(2006-10#1)(2006-9#1)(2007-7#1)(2008-10#1)(2008-4#2)(2010-12#1)(2010-8#1)(2011-2#1)
operative interventions##4##2##(1991-6#1)(2007-8#1)(2009-5#1)(2011-2#1)
operative laparoscopy during the##2##4##(1993-12#2)
operative laparoscopy for##2##3##(1994-3#1)(1996-3#1)
operative laparoscopy has##2##3##(1994-9#1)(1995-2#1)
operative laparoscopy##16##2##(1992-12#1)(1993-12#6)(1993-3#2)(1994-3#1)(1994-9#1)(1995-2#3)(1996-2#1)(1996-3#1)
operative management of##4##3##(2007-9#1)(2008-12#1)(2011-2#1)(2013-8#1)
operative management##8##2##(2006-7#1)(2007-8#1)(2007-9#1)(2008-12#1)(2009-3#1)(2011-2#2)(2013-8#1)
operative method##3##2##(2008-10#1)(2008-8#1)(2010-5#1)
operative methods are##2##3##(1996-12#1)(2007-7#1)
operative methods##3##2##(1991-5#1)(1996-12#1)(2007-7#1)
operative mode##2##2##(2006-5#1)(2010-6#1)
operative mortality and morbidity##2##4##(2008-7#1)(2012-12#1)
operative mortality and##6##3##(2006-2#1)(2007-8#2)(2008-10#1)(2008-7#1)(2012-12#1)
operative mortality in##3##3##(1990-8#1)(2006-8#1)(2007-8#1)
operative mortality rate##2##3##(1990-3#1)(1993-5#1)
operative mortality was##2##3##(1991-10#1)(2007-8#1)
operative mortality##22##2##(1990-3#1)(1990-8#2)(1991-10#1)(1991-8#1)(1993-5#2)(1994-11#1)(2006-2#1)(2006-8#1)(2007-8#7)(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#1)(2013-1#1)
operative notes##10##2##(2006-5#1)(2007-8#1)(2013-1#8)
operative or##2##2##(1992-2#1)(2008-3#1)
operative patients##3##2##(2008-9#1)(2011-2#1)(2012-2#1)
operative planning##2##2##(2007-9#1)(2009-5#1)
operative procedure are##2##3##(1991-6#1)(2010-2#1)
operative procedure is##2##3##(2007-1#1)(2007-11#1)
operative procedure##17##2##(1990-10#1)(1991-3#1)(1991-6#1)(1992-9#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-11#3)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-7#1)(2010-2#1)
operative procedures##11##2##(1990-9#1)(1993-3#1)(1995-5#1)(2006-8#2)(2007-8#2)(2008-3#1)(2008-7#1)(2009-5#1)(2010-2#1)
operative repair of##2##3##(2009-3#1)(2009-5#1)
operative repair##3##2##(2009-3#2)(2009-5#1)
operative report##5##2##(2006-8#2)(2012-12#1)(2013-1#2)
operative resection##2##2##(2007-8#1)(2009-3#1)
operative response mechanism##2##3##(2007-8#2)
operative results##3##2##(2006-10#1)(2006-11#1)(2006-6#1)
operative risk and##2##3##(1990-8#1)(2006-7#1)
operative risk##8##2##(1990-8#1)(1992-2#1)(2006-7#1)(2007-8#3)(2008-8#1)(2013-1#1)
operative setting##3##2##(2010-11#1)(2013-1#2)
operative site##6##2##(2004-9#1)(2006-6#2)(2008-7#1)(2011-11#2)
operative stages##2##2##(1993-6#1)(2007-11#1)
operative steps##3##2##(2007-8#1)(2009-3#2)
operative strategy and##2##3##(1990-8#1)(2006-8#1)
operative strategy##4##2##(1990-8#1)(2006-8#1)(2007-8#1)(2010-8#1)
operative survivors##2##2##(2007-9#1)(2011-2#1)
operative technique can be##2##4##(2006-3#1)(2007-8#1)
operative technique for##2##3##(2007-8#1)(2008-10#1)
operative technique is##2##3##(1990-12#1)(1992-8#1)
operative technique##19##2##(1990-12#1)(1992-8#1)(1993-9#1)(2006-3#2)(2006-7#2)(2007-11#1)(2007-7#1)(2007-8#3)(2008-10#3)(2008-4#1)(2008-7#1)(2013-8#2)
operative techniques and the##2##4##(2006-3#1)(2013-8#1)
operative techniques and##3##3##(2006-3#1)(2006-7#1)(2013-8#1)
operative techniques##9##2##(2006-3#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#2)(2008-8#1)(2013-1#1)(2013-8#1)
operative time and the##2##4##(2006-6#2)
operative time and##6##3##(1994-12#1)(1995-1#1)(2006-6#2)(2008-10#1)(2009-6#1)
operative time was##9##3##(1996-1#1)(1996-2#1)(2007-8#2)(2008-10#3)(2009-3#1)(2013-1#1)
operative time with##2##3##(2009-6#1)(2012-2#1)
operative time##35##2##(1994-1#1)(1994-12#1)(1995-1#1)(1996-1#1)(1996-2#3)(2005-12#1)(2006-6#4)(2006-7#1)(2007-8#3)(2008-10#4)(2008-8#1)(2008-9#1)(2009-3#3)(2009-6#3)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
operative times##9##2##(2006-5#1)(2007-8#1)(2009-3#2)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
operative trauma##7##2##(2006-7#1)(2007-8#1)(2008-3#1)(2012-12#3)(2013-8#1)
operative treatment in##3##3##(2007-11#2)(2007-7#1)
operative treatment is##4##3##(1993-8#1)(1996-12#1)(2008-3#1)(2012-12#1)
operative treatment of bone metastases to##3##6##(2007-11#3)
operative treatment of the##3##4##(2007-11#1)(2007-8#1)(2008-9#1)
operative treatment of##23##3##(1991-6#1)(1992-2#2)(1992-3#1)(1992-8#1)(1994-3#1)(1994-5#1)(2007-11#7)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#2)(2013-1#2)
operative treatment were##2##3##(2007-11#1)(2007-7#1)
operative treatment##53##2##(1991-6#1)(1992-2#2)(1992-3#2)(1992-8#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-7#1)(1996-12#1)(2007-11#17)(2007-7#5)(2007-8#3)(2008-10#2)(2008-3#3)(2008-8#2)(2008-9#2)(2009-2#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
operative video##2##2##(2006-12#1)(2007-8#1)
operative##517##1##(1990-10#1)(1990-12#5)(1990-3#3)(1990-4#1)(1990-6#2)(1990-8#4)(1990-9#1)(1991-10#1)(1991-2#1)(1991-3#3)(1991-4#2)(1991-5#1)(1991-6#3)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#5)(1992-3#3)(1992-8#4)(1992-9#1)(1993-1#1)(1993-12#8)(1993-3#4)(1993-5#3)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#3)(1994-1#1)(1994-11#1)(1994-12#3)(1994-3#3)(1994-5#1)(1994-7#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#5)(1995-3#1)(1995-5#2)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#5)(1996-3#1)(1996-6#3)(1997-4#1)(1997-8#2)(2004-2#1)(2004-9#1)(2005-10#1)(2005-12#6)(2005-5#2)(2005-8#1)(2006-1#1)(2006-10#9)(2006-11#2)(2006-12#5)(2006-2#3)(2006-3#4)(2006-4#2)(2006-5#4)(2006-6#12)(2006-7#9)(2006-8#8)(2006-9#2)(2007-1#8)(2007-11#27)(2007-12#4)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#12)(2007-8#57)(2007-9#5)(2008-1#2)(2008-10#26)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#3)(2008-5#1)(2008-7#8)(2008-8#7)(2008-9#11)(2009-2#6)(2009-3#11)(2009-4#2)(2009-5#8)(2009-6#5)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#6)(2010-2#6)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#4)(2010-8#5)(2010-9#1)(2011-1#1)(2011-11#2)(2011-2#16)(2012-12#7)(2012-2#15)(2012-3#6)(2013-1#31)(2013-7#1)(2013-8#6)
operative-technical special features of the##2##5##(2008-10#2)
operative-technical special features##3##3##(2008-10#3)
operatively treated##4##2##(2007-11#1)(2009-2#1)(2011-2#1)(2013-1#1)
operatively##31##1##(1990-4#1)(1992-8#1)(2007-11#6)(2007-7#8)(2007-8#3)(2008-3#1)(2009-10#1)(2009-2#2)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
operator DNA##2##2##(1994-9#1)(1995-1#1)
operator and##8##2##(1990-4#1)(1990-5#2)(1996-2#1)(2007-7#1)(2007-9#1)(2008-5#2)
operator binding##2##2##(1994-3#1)(1995-1#1)
operator in##4##2##(1991-2#1)(1995-8#1)(2008-9#2)
operator intervention##2##2##(2008-10#1)(2008-11#1)
operator is##8##2##(1991-6#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-7#1)(2012-1#1)
operator on##2##2##(2009-10#1)(2013-1#1)
operator performance in teleradiology applications##2##5##(2004-9#2)
operator region##2##2##(1994-3#1)(1997-6#1)
operator sequence##6##2##(1990-9#2)(1991-12#1)(1992-6#2)(2008-11#1)
operator sequences##6##2##(1990-4#2)(1992-6#3)(2008-11#1)
operator sites OL1 and OR3##2##5##(1991-6#2)
operator sites##3##2##(1991-6#2)(2008-8#1)
operator that##2##2##(1997-4#1)(2008-2#1)
operator to##7##2##(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)
operator##134##1##(1990-4#8)(1990-5#6)(1990-9#2)(1991-12#3)(1991-2#1)(1991-6#4)(1992-12#2)(1992-4#4)(1992-6#11)(1993-10#1)(1994-3#2)(1994-9#1)(1995-1#3)(1995-10#1)(1995-8#3)(1996-11#3)(1996-2#1)(1997-4#1)(1997-6#1)(2004-9#2)(2006-10#1)(2006-6#2)(2007-11#2)(2007-3#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#5)(2008-2#12)(2008-3#6)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2011-2#1)(2012-1#1)(2012-10#1)(2012-12#1)(2012-3#6)(2013-1#4)
operator's##5##1##(1991-8#1)(2008-10#1)(2008-3#1)(2009-10#1)(2011-2#1)
operators and##5##2##(2008-11#1)(2008-2#1)(2008-5#1)(2010-2#1)(2011-2#1)
operators are##4##2##(2008-2#1)(2009-10#1)(2010-12#1)(2011-2#1)
operators for##2##2##(2007-12#1)(2010-2#1)
operators have##3##2##(1994-6#1)(2010-8#1)(2012-2#1)
operators in the##2##3##(2008-2#1)(2011-2#1)
operators in##7##2##(1990-1#1)(2007-7#1)(2008-10#1)(2008-2#1)(2011-2#2)(2012-2#1)
operators of##2##2##(1990-1#1)(2011-2#1)
operators that##2##2##(2008-2#1)(2008-3#1)
operators to##4##2##(1995-3#1)(2008-2#2)(2008-3#1)
operators were##2##2##(1992-10#1)(2007-4#1)
operators##77##1##(1990-1#2)(1990-11#1)(1990-5#1)(1991-6#1)(1991-8#1)(1992-10#3)(1992-6#1)(1994-6#1)(1995-3#2)(2005-11#1)(2007-1#2)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#12)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#3)(2010-12#1)(2010-2#3)(2010-7#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-2#3)(2013-7#1)(2013-8#1)
operators'##6##1##(2007-8#1)(2009-10#1)(2011-2#1)(2012-2#3)
opercular bones readings##2##3##(2008-5#2)
opercular##4##1##(2008-5#4)
opercularis##3##1##(2010-2#3)
operculofrontal AVM##2##2##(2008-7#2)
operculum##6##1##(1996-5#1)(2007-12#3)(2008-11#1)(2012-12#1)
operon and##8##2##(1991-12#1)(1991-7#2)(1992-12#1)(1992-2#1)(1994-12#1)(1997-4#1)(2011-1#1)
operon consisting of##3##3##(1993-12#1)(1995-8#1)(1997-2#1)
operon encodes a##2##3##(1990-4#1)(1992-12#1)
operon encoding##2##2##(1990-3#1)(1996-10#1)
operon from##4##2##(1993-2#2)(1994-12#1)(2008-10#1)
operon fusions##3##2##(1990-9#2)(1995-1#1)
operon in##4##2##(1991-12#1)(1993-9#1)(1997-1#1)(2008-11#1)
operon is##8##2##(1990-11#1)(1993-11#2)(1995-6#2)(1995-8#1)(1997-2#1)(2008-9#1)
operon of Escherichia coli##2##4##(1990-10#1)(1994-12#1)
operon of##9##2##(1990-10#1)(1990-5#1)(1991-9#1)(1993-11#1)(1994-12#1)(1996-10#1)(1996-11#1)(1997-1#1)(2011-1#1)
operon specifies##2##2##(1993-11#1)(1995-8#1)
operon that##3##2##(1990-11#1)(1995-3#1)(2008-10#1)
operon was cloned##2##3##(1994-12#1)(1996-9#1)
operon was##5##2##(1994-12#1)(1996-9#1)(1997-4#3)
operon with##3##2##(1995-2#1)(1996-12#1)(1997-2#1)
operon##118##1##(1990-10#1)(1990-11#4)(1990-3#3)(1990-4#7)(1990-5#2)(1990-9#6)(1991-12#2)(1991-7#5)(1991-9#2)(1992-11#1)(1992-12#3)(1992-2#1)(1993-11#8)(1993-12#3)(1993-2#2)(1993-9#1)(1994-12#7)(1994-2#1)(1994-5#1)(1994-6#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#5)(1995-8#7)(1996-10#3)(1996-11#1)(1996-12#3)(1996-2#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#6)(1997-4#7)(1997-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2011-1#2)(2011-2#2)
operons across##2##2##(2008-8#2)
operons are##3##2##(1990-5#1)(1993-11#1)(2008-8#1)
operons by##2##2##(1994-5#1)(1997-1#1)
operons contain##2##2##(2007-12#2)
operons encoding##2##2##(2011-1#1)(2011-2#1)
operons in##7##2##(1990-5#1)(1993-11#1)(1996-2#3)(1997-1#1)(2008-8#1)
operons were##3##2##(1993-11#1)(1997-1#1)(2008-8#1)
operons##45##1##(1990-3#1)(1990-4#1)(1990-5#3)(1992-2#2)(1993-11#5)(1994-5#1)(1995-12#2)(1995-8#1)(1996-2#4)(1997-1#5)(1997-4#1)(2007-12#4)(2008-11#2)(2008-7#1)(2008-8#8)(2011-1#2)(2011-2#2)
ophionines##2##1##(2008-5#2)
ophiuroid##3##1##(2013-8#3)
ophiuroids##4##1##(2007-5#4)
ophtalmopathy##2##1##(2007-8#1)(2011-2#1)
ophthalmic arteries##2##2##(2006-12#1)(2011-2#1)
ophthalmic artery##10##2##(1992-6#1)(1996-9#1)(2005-5#1)(2006-12#1)(2008-7#2)(2009-8#1)(2012-3#2)(2013-1#1)
ophthalmic delivery of##2##3##(2011-3#1)(2013-7#1)
ophthalmic drugs and##2##3##(2004-8#1)(2007-8#1)
ophthalmic examination##2##2##(2007-3#1)(2010-2#1)
ophthalmic formulation##3##2##(2005-7#2)(2013-7#1)
ophthalmic imaging##4##2##(2007-11#1)(2011-1#1)(2011-7#2)
ophthalmic lens##2##2##(2008-2#1)(2008-3#1)
ophthalmic products##3##2##(2006-11#2)(2008-5#1)
ophthalmic segment##5##2##(2005-5#2)(2012-3#3)
ophthalmic solution##7##2##(2009-8#6)(2013-8#1)
ophthalmic solutions##4##2##(1997-8#1)(2008-10#2)(2009-8#1)
ophthalmic suspension##2##2##(2009-8#2)
ophthalmic##90##1##(1990-4#1)(1991-7#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-8#1)(1995-9#1)(1996-9#2)(1997-3#1)(1997-8#2)(2004-8#1)(2005-5#3)(2005-7#2)(2006-10#1)(2006-11#3)(2006-12#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#3)(2009-2#1)(2009-8#11)(2010-10#1)(2010-2#1)(2011-1#6)(2011-2#3)(2011-3#1)(2011-7#2)(2012-12#3)(2012-3#7)(2013-1#7)(2013-7#3)(2013-8#2)
ophthalmologic clinics]##2##2##(2007-3#2)
ophthalmologic evaluation##4##2##(1996-10#1)(2006-12#1)(2007-3#1)(2013-1#1)
ophthalmologic examination##3##2##(2007-3#2)(2007-7#1)
ophthalmologic studies##2##2##(1996-7#1)(1997-2#1)
ophthalmologic##21##1##(1994-5#1)(1996-10#1)(1996-3#1)(1996-7#1)(1997-2#1)(2006-10#2)(2006-12#1)(2007-3#8)(2007-7#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#1)
ophthalmological examination##3##2##(1992-7#1)(2009-2#1)(2011-12#1)
ophthalmological##15##1##(1990-7#1)(1992-7#1)(1995-6#1)(2008-5#1)(2008-7#1)(2009-2#5)(2011-12#1)(2011-2#1)(2012-12#3)
ophthalmologist and##4##2##(2007-3#1)(2009-4#1)(2013-1#1)(2013-7#1)
ophthalmologist##13##1##(1993-11#1)(2006-12#1)(2007-3#2)(2009-4#1)(2010-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
ophthalmologists and##7##2##(2006-10#1)(2006-7#1)(2007-11#1)(2007-2#1)(2008-4#1)(2010-10#1)(2011-1#1)
ophthalmologists##14##1##(1995-9#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-2#1)(2008-2#1)(2008-4#1)(2009-2#2)(2010-10#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
ophthalmology##37##1##(1991-11#1)(1991-2#1)(1991-9#1)(1992-5#1)(1995-9#1)(1997-2#2)(2006-10#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-2#3)(2010-10#3)(2010-12#1)(2010-8#2)(2011-1#2)(2011-2#2)(2011-7#2)(2012-11#4)(2012-3#1)(2013-1#2)(2013-8#3)
ophthalmomyiasis##2##1##(2010-10#2)
ophthalmopathy##12##1##(2006-1#2)(2006-11#5)(2007-7#1)(2009-2#3)(2009-8#1)
ophthalmopathy]##2##1##(2009-2#1)(2013-7#1)
ophthalmoplegia##14##1##(1990-12#1)(1993-12#1)(1993-8#1)(2006-12#2)(2008-4#2)(2008-7#3)(2010-10#2)(2013-1#1)(2013-7#1)
ophthalmoscope##10##1##(2007-11#1)(2008-2#2)(2008-3#2)(2010-5#1)(2011-1#3)(2013-1#1)
ophthalmoscopy##10##1##(1994-12#1)(1996-6#1)(2007-11#1)(2007-12#1)(2007-6#1)(2011-1#2)(2011-7#3)
opiate abusers##2##2##(2007-11#2)
opiate addicts##2##2##(1991-1#1)(2007-2#1)
opiate agonists##2##2##(1990-2#1)(1991-1#1)
opiate antagonist##5##2##(1990-7#2)(1991-1#1)(1991-2#1)(1991-3#1)
opiate antagonists##2##2##(1991-1#1)(2007-8#1)
opiate dependence and withdrawal##2##4##(1991-1#1)(2007-11#1)
opiate dependence##6##2##(1990-8#1)(1991-1#2)(2007-11#2)(2011-1#1)
opiate detoxification##3##2##(2007-2#2)(2008-11#1)
opiate exposure##2##2##(2007-11#1)(2010-11#1)
opiate morphine##2##2##(1993-12#1)(2007-11#1)
opiate or##2##2##(1991-2#1)(2010-9#1)
opiate receptor density##3##3##(1992-5#3)
opiate receptor##10##2##(1991-3#1)(1991-5#2)(1992-5#3)(1992-8#1)(1996-8#2)(2005-7#1)
opiate receptors in##2##3##(1992-5#1)(1997-4#1)
opiate receptors##16##2##(1990-7#1)(1991-1#5)(1991-3#2)(1991-5#1)(1992-5#1)(1994-2#1)(1995-12#1)(1995-7#1)(1996-8#1)(1997-4#1)(2013-8#1)
opiate tolerance and dependence##2##4##(1996-10#2)
opiate use##3##2##(1991-1#1)(2010-11#1)(2011-2#1)
opiate withdrawal##5##2##(1991-1#1)(1996-5#1)(1997-5#1)(2007-11#1)(2008-11#1)
opiate##93##1##(1990-2#1)(1990-7#5)(1990-8#2)(1991-1#15)(1991-2#3)(1991-3#5)(1991-5#3)(1992-5#5)(1992-8#1)(1993-12#2)(1994-2#1)(1994-8#3)(1995-12#3)(1995-7#2)(1996-1#2)(1996-10#2)(1996-5#2)(1996-8#4)(1997-4#1)(1997-5#1)(2005-7#1)(2006-7#2)(2007-11#8)(2007-2#3)(2007-8#1)(2008-10#1)(2008-11#2)(2009-6#1)(2010-11#4)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2013-8#1)
opiate-HIV-1 interactions##2##2##(2007-11#2)
opiate-dependent individuals##3##2##(2013-1#3)
opiate-dependent##4##1##(2007-2#1)(2013-1#3)
opiate-induced muscle rigidity in the rat##2##6##(1991-3#2)
opiate-induced##5##1##(1991-1#1)(1991-3#3)(2008-9#1)
opiates and##5##2##(1991-1#1)(1992-2#1)(2006-12#1)(2010-12#1)(2010-4#1)
opiates in##10##2##(1991-1#1)(1995-12#1)(1995-7#1)(1997-2#1)(2005-8#1)(2008-3#1)(2012-3#4)
opiates on##3##2##(1991-1#1)(1995-7#2)
opiates##41##1##(1990-7#1)(1991-1#5)(1992-2#1)(1993-3#1)(1994-8#1)(1995-12#2)(1995-7#7)(1996-5#1)(1997-2#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-12#1)(2010-4#1)(2012-3#7)(2013-1#1)
opiates]##2##1##(1995-6#1)(2007-11#1)
opinion about the##2##3##(1992-2#1)(2007-8#1)
opinion about##9##2##(1990-5#1)(1992-2#2)(1993-1#1)(1994-4#1)(1997-8#1)(2007-8#1)(2013-1#2)
opinion and controversies##2##3##(2007-9#1)(2008-1#1)
opinion and the##2##3##(1995-2#1)(2011-12#1)
opinion and##16##2##(1995-2#2)(1996-1#1)(1996-6#1)(2005-10#1)(2006-11#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-12#1)(2009-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
opinion as##2##2##(1994-3#1)(2005-9#1)
opinion in##3##2##(1993-12#1)(2006-10#1)(2008-4#1)
opinion is that the##2##4##(2008-1#1)(2013-8#1)
opinion is that##5##3##(1990-6#1)(1992-8#1)(1993-11#1)(2008-1#1)(2013-8#1)
opinion is the##2##3##(2008-11#1)(2010-7#1)
opinion is##11##2##(1990-6#1)(1992-8#1)(1993-11#1)(1994-7#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-7#1)(2011-12#1)(2013-8#1)
opinion it##2##2##(1990-11#1)(1996-1#1)
opinion leaders##5##2##(2005-12#1)(2008-11#1)(2008-6#1)(2010-11#1)(2012-1#1)
opinion of surgical##2##3##(1990-5#1)(1996-11#1)
opinion of the##13##3##(1990-2#2)(1991-3#1)(1993-5#1)(1993-8#1)(1995-6#1)(1995-9#1)(1996-12#1)(1997-3#1)(2006-10#1)(2006-8#1)(2008-1#1)(2012-3#1)
opinion of##31##2##(1990-2#2)(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1993-12#2)(1993-5#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-9#1)(2009-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
opinion on the##4##3##(2006-10#1)(2007-2#1)(2007-8#1)(2008-2#1)
opinion on##24##2##(1993-1#1)(1993-2#1)(1997-8#1)(2006-10#2)(2006-7#1)(2006-8#6)(2007-10#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-4#1)(2010-8#1)(2011-12#1)(2011-2#1)(2013-7#2)
opinion paper##2##2##(1996-2#1)(2007-12#1)
opinion survey##4##2##(2006-7#1)(2008-8#1)(2013-1#2)
opinion that the##5##3##(2007-1#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-7#1)
opinion that these##2##3##(1995-5#1)(2006-11#1)
opinion that##19##2##(1990-4#1)(1994-12#1)(1995-2#1)(1995-5#1)(2004-10#1)(2006-11#1)(2007-1#1)(2007-3#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-7#2)(2008-8#1)(2009-11#1)(2010-9#1)(2011-2#2)
opinion the most##2##3##(1991-11#1)(1994-2#1)
opinion the##7##2##(1991-11#1)(1994-2#1)(1996-11#1)(2007-11#1)(2007-8#2)(2009-12#1)
opinion there##2##2##(1990-6#1)(1992-8#1)
opinion was##4##2##(2008-5#1)(2009-10#2)(2012-12#1)
opinion when##3##2##(1993-12#2)(1996-9#1)
opinion##244##1##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#2)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-2#2)(1992-3#1)(1992-8#2)(1993-1#2)(1993-11#1)(1993-12#5)(1993-2#1)(1993-5#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-4#1)(1994-5#1)(1994-7#1)(1995-2#3)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#3)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#2)(1996-6#2)(1996-9#1)(1997-3#1)(1997-6#1)(1997-8#3)(2004-10#1)(2005-10#1)(2005-12#2)(2005-8#1)(2005-9#1)(2006-10#8)(2006-11#2)(2006-12#1)(2006-2#1)(2006-3#2)(2006-5#1)(2006-7#2)(2006-8#7)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#7)(2007-6#1)(2007-7#6)(2007-8#7)(2007-9#4)(2008-1#4)(2008-11#6)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#6)(2011-2#9)(2012-1#2)(2012-11#3)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#10)(2013-7#4)(2013-8#5)
opinion)##2##1##(2008-9#1)(2011-2#1)
opinionating in##2##2##(2009-4#1)(2010-9#1)
opinionating##8##1##(2009-4#5)(2010-9#3)
opinions about a web-based distance##2##5##(2010-10#2)
opinions about a##3##3##(2005-7#1)(2010-10#2)
opinions about the##2##3##(1995-1#1)(2010-10#1)
opinions about##17##2##(1991-3#2)(1991-9#1)(1995-1#2)(2005-7#1)(2006-7#1)(2008-11#1)(2009-12#1)(2009-4#1)(2010-10#3)(2010-12#2)(2012-2#1)(2013-1#1)
opinions and##9##2##(1991-9#1)(1994-12#1)(2007-2#1)(2008-1#1)(2008-2#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
opinions as to the##2##4##(2008-3#1)(2008-5#1)
opinions as to##3##3##(1990-12#1)(2008-3#1)(2008-5#1)
opinions between##2##2##(1996-11#1)(2012-2#1)
opinions concerning##3##2##(2009-4#1)(2010-11#1)(2012-3#1)
opinions for##2##2##(2009-4#1)(2011-12#1)
opinions from##3##2##(2007-2#1)(2013-1#2)
opinions in##5##2##(1991-12#1)(2007-2#1)(2008-5#1)(2009-4#1)(2010-12#1)
opinions of the##6##3##(1990-11#1)(1991-2#1)(1991-6#1)(1996-3#1)(2007-9#1)(2010-2#1)
opinions of##25##2##(1990-11#1)(1991-2#1)(1991-6#1)(1993-4#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-8#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-9#2)(2008-12#3)(2008-2#1)(2008-6#1)(2009-6#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
opinions on the##5##3##(1996-1#1)(2007-11#1)(2008-10#1)(2013-1#2)
opinions on##13##2##(1992-3#1)(1994-10#1)(1994-3#1)(1996-1#1)(2006-6#1)(2007-11#2)(2008-10#1)(2008-12#1)(2013-1#2)(2013-7#2)
opinions regarding the##3##3##(2007-4#1)(2008-7#1)(2013-8#1)
opinions regarding##6##2##(2006-3#1)(2007-4#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
opinions to##3##2##(2008-5#1)(2013-1#2)
opinions##138##1##(1990-11#1)(1990-12#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-9#3)(1992-3#1)(1993-1#1)(1993-4#1)(1993-5#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#2)(1995-5#2)(1996-1#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-3#2)(1997-8#2)(2005-10#1)(2005-7#2)(2006-3#1)(2006-6#2)(2006-7#1)(2006-8#3)(2007-10#1)(2007-11#2)(2007-2#6)(2007-4#1)(2007-7#2)(2007-9#4)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#4)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2009-12#1)(2009-4#6)(2009-6#1)(2010-10#3)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-12#8)(2011-2#9)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#10)(2013-7#3)(2013-8#1)
opinions]##2##1##(1993-5#1)(2011-12#1)
opioid abuse##6##2##(2006-7#1)(2007-2#1)(2008-6#1)(2009-7#1)(2012-2#2)
opioid activity##3##2##(1991-1#1)(1992-4#1)(1995-3#1)
opioid addiction##3##2##(2006-8#1)(2007-2#1)(2008-6#1)
opioid administration##3##2##(2007-11#1)(2007-2#1)(2012-12#1)
opioid agonist and##2##3##(2008-5#1)(2010-6#1)
opioid agonist##7##2##(1995-12#2)(2008-5#2)(2008-7#1)(2010-2#1)(2010-6#1)
opioid agonists##9##2##(1991-1#1)(1991-5#1)(1994-10#2)(1995-12#1)(1995-7#1)(1997-5#1)(1997-8#1)(2006-10#1)
opioid analgesia and##2##3##(1990-7#1)(1997-1#1)
opioid analgesia##12##2##(1990-7#1)(1994-10#1)(1995-5#1)(1997-1#1)(2005-8#1)(2006-10#3)(2007-2#1)(2007-3#1)(2008-3#1)(2013-1#1)
opioid analgesic##4##2##(1995-9#1)(1996-7#1)(2006-10#1)(2010-5#1)
opioid analgesics##4##2##(2006-10#1)(2007-7#1)(2008-3#1)(2013-1#1)
opioid and non-opioid##2##3##(2006-10#2)
opioid and##9##2##(1990-2#1)(1992-12#1)(1996-7#1)(2006-10#2)(2008-10#1)(2008-8#1)(2011-2#1)(2012-2#1)
opioid antagonist naloxone##3##3##(1995-6#1)(1996-7#1)(1997-1#1)
opioid antagonist##7##2##(1991-5#1)(1993-6#1)(1995-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(2010-2#1)
opioid antagonists##7##2##(1991-1#1)(1997-8#3)(2008-2#2)(2008-7#1)
opioid binding affinity##2##3##(1995-3#2)
opioid binding sites in rat##2##5##(1991-5#2)
opioid binding sites in##3##4##(1991-5#3)
opioid binding sites##7##3##(1991-5#3)(1995-7#4)
opioid binding##18##2##(1991-1#1)(1991-5#4)(1993-7#2)(1995-3#3)(1995-7#8)
opioid compounds##3##2##(1991-1#2)(2005-7#1)
opioid dependence##7##2##(2007-2#3)(2008-6#2)(2009-4#1)(2010-2#1)
opioid dependency##3##2##(2007-2#1)(2008-11#1)(2009-9#1)
opioid detoxification and##2##3##(2007-2#1)(2012-2#1)
opioid detoxification##4##2##(2007-2#3)(2012-2#1)
opioid dosing##3##2##(2008-7#3)
opioid drugs##5##2##(1995-3#1)(1995-6#1)(2006-10#2)(2010-7#1)
opioid equivalence table##2##3##(2007-2#2)
opioid genes##2##2##(1996-12#2)
opioid ligands##3##2##(1993-8#2)(1995-12#1)
opioid loading##2##2##(1993-4#2)
opioid maintenance##2##2##(2006-12#1)(2010-4#1)
opioid management##3##2##(2006-12#3)
opioid mechanisms##3##2##(1995-12#1)(2008-3#1)(2012-1#1)
opioid of choice for##2##4##(2006-10#1)(2008-3#1)
opioid of##3##2##(2006-10#1)(2008-3#1)(2012-1#1)
opioid or##2##2##(1991-2#1)(1996-2#1)
opioid peptide levels##2##3##(1995-5#2)
opioid peptide##13##2##(1992-12#2)(1992-3#1)(1992-4#1)(1993-11#1)(1995-5#3)(1996-2#1)(2007-11#1)(2008-3#2)(2009-12#1)
opioid peptides and##4##3##(1997-2#1)(2006-10#1)(2007-11#2)
opioid peptides in the##2##4##(1991-1#1)(1993-2#1)
opioid peptides in##4##3##(1991-1#2)(1993-2#1)(1994-2#1)
opioid peptides##27##2##(1991-1#2)(1992-11#3)(1993-2#1)(1994-2#2)(1994-9#2)(1995-12#1)(1995-3#1)(1995-6#2)(1996-12#2)(1996-2#1)(1997-2#1)(2006-10#1)(2007-11#3)(2008-3#3)(2009-12#1)(2009-7#1)
opioid pharmacotherapy##3##2##(2008-4#2)(2008-7#1)
opioid potency##3##2##(1992-11#1)(1995-3#2)
opioid prescribing##2##2##(2006-11#1)(2006-12#1)
opioid receptor affinity##2##3##(1997-2#2)
opioid receptor agonist##3##3##(1995-12#2)(1997-2#1)
opioid receptor agonists and##2##4##(2009-7#1)(2010-6#1)
opioid receptor agonists##4##3##(1995-12#2)(2009-7#1)(2010-6#1)
opioid receptor and##2##3##(1992-3#1)(2008-11#1)
opioid receptor antagonist##5##3##(1991-6#2)(1993-11#1)(1993-12#1)(1993-3#1)
opioid receptor antagonists such as##2##5##(1995-12#1)(2009-7#1)
opioid receptor antagonists##4##3##(1993-12#1)(1995-11#1)(1995-12#1)(2009-7#1)
opioid receptor binding##2##3##(1993-12#1)(1997-2#1)
opioid receptor cDNA##2##3##(1995-6#2)
opioid receptor densities##2##3##(1990-2#1)(2008-11#1)
opioid receptor expression##2##3##(1997-2#1)(2008-3#1)
opioid receptor gene##4##3##(1995-6#2)(1997-7#2)
opioid receptor homologue##2##3##(1996-12#2)
opioid receptor levels##2##3##(1993-12#2)
opioid receptor radioligand displacement assays##2##5##(1997-2#2)
opioid receptor##63##2##(1990-2#2)(1991-1#2)(1991-3#1)(1991-5#1)(1991-6#2)(1992-12#2)(1992-3#1)(1993-11#1)(1993-12#6)(1993-3#1)(1994-9#2)(1995-11#1)(1995-12#5)(1995-6#5)(1996-12#2)(1996-5#1)(1997-2#11)(1997-7#2)(1997-8#1)(2007-11#2)(2008-11#6)(2008-3#1)(2009-7#2)(2010-12#1)(2010-6#1)(2012-12#1)
opioid receptor-like (ORL1)##2##3##(1996-2#2)
opioid receptor-like##3##2##(1996-2#2)(2008-11#1)
opioid receptors and##4##3##(1991-1#1)(2007-11#1)(2008-11#1)(2009-7#1)
opioid receptors have been##2##4##(2006-10#1)(2007-11#1)
opioid receptors in Xenopus oocytes##2##5##(1993-6#2)
opioid receptors in the##6##4##(1993-12#1)(1995-7#1)(1996-12#1)(1997-7#1)(2008-11#2)
opioid receptors in##15##3##(1993-12#1)(1993-6#2)(1995-7#1)(1996-12#1)(1997-7#1)(2005-8#1)(2008-11#3)(2008-3#1)(2009-7#4)
opioid receptors were##2##3##(1990-2#1)(1993-6#1)
opioid receptors with##2##3##(1996-10#1)(1996-7#1)
opioid receptors##71##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-1#2)(1991-5#2)(1993-10#1)(1993-12#4)(1993-6#5)(1995-11#1)(1995-12#3)(1995-6#3)(1995-7#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-2#6)(1997-7#1)(1997-8#2)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#8)(2008-11#5)(2008-3#2)(2008-7#1)(2009-12#4)(2009-7#7)(2010-12#2)
opioid rotation##2##2##(2006-10#1)(2008-7#1)
opioid side effects##2##3##(1996-2#1)(2007-11#1)
opioid sites##6##2##(1991-5#3)(1995-7#3)
opioid system##7##2##(1991-1#1)(1996-12#3)(2008-7#1)(2009-7#1)(2012-1#1)
opioid systems in##2##3##(1991-5#1)(2008-11#1)
opioid systems##5##2##(1991-1#1)(1991-5#2)(2006-10#1)(2008-11#1)
opioid therapy##5##2##(2007-2#5)
opioid titration order sheet##3##4##(2007-2#3)
opioid titration##5##2##(2007-12#1)(2007-2#4)
opioid tolerance and##4##3##(1991-1#1)(2006-10#1)(2007-10#1)(2007-11#1)
opioid tolerance##7##2##(1991-1#1)(2006-10#1)(2007-10#1)(2007-11#2)(2009-7#2)
opioid toxicity##2##2##(2006-10#1)(2007-2#1)
opioid treatment##5##2##(2006-12#1)(2008-6#3)(2012-1#1)
opioid use##5##2##(2005-8#1)(2006-7#1)(2007-2#1)(2009-2#1)(2013-1#1)
opioid with##2##2##(2008-11#1)(2008-3#1)
opioid withdrawal##3##2##(2007-2#2)(2008-6#1)
opioid##456##1##(1990-10#1)(1990-2#4)(1990-3#1)(1990-7#2)(1991-1#20)(1991-2#1)(1991-3#1)(1991-5#15)(1991-6#2)(1992-11#4)(1992-12#8)(1992-3#2)(1992-4#2)(1993-10#2)(1993-11#2)(1993-12#10)(1993-2#1)(1993-3#1)(1993-4#2)(1993-6#6)(1993-7#2)(1993-8#2)(1993-9#1)(1994-10#6)(1994-2#2)(1994-9#5)(1995-11#2)(1995-12#14)(1995-3#9)(1995-5#4)(1995-6#12)(1995-7#17)(1995-9#1)(1996-10#1)(1996-12#12)(1996-2#7)(1996-5#1)(1996-7#4)(1997-1#4)(1997-2#20)(1997-3#1)(1997-5#3)(1997-7#3)(1997-8#7)(2005-7#1)(2005-8#3)(2006-10#23)(2006-11#1)(2006-12#8)(2006-7#4)(2006-8#4)(2007-10#1)(2007-11#22)(2007-12#3)(2007-2#34)(2007-3#1)(2007-7#2)(2008-10#1)(2008-11#15)(2008-2#3)(2008-3#17)(2008-4#2)(2008-5#2)(2008-6#9)(2008-7#11)(2008-8#1)(2008-9#1)(2009-12#7)(2009-2#1)(2009-4#1)(2009-7#14)(2009-9#3)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2011-2#1)(2012-1#5)(2012-11#2)(2012-12#2)(2012-2#5)(2013-1#7)
opioid-induced##7##1##(1991-1#2)(2006-10#3)(2007-11#1)(2011-1#1)
opioid-mediated##3##1##(1990-7#1)(1991-3#1)(2008-10#1)
opioid-receptor##2##1##(1996-2#1)(1997-5#1)
opioidergic##6##1##(1994-6#1)(1996-12#1)(1997-7#1)(2008-2#1)(2009-7#1)(2010-12#1)
opioids (morphine##2##2##(2009-5#1)(2010-9#1)
opioids and amphetamines##2##3##(2010-9#2)
opioids and other##3##3##(2010-2#1)(2010-4#1)(2011-2#1)
opioids and##14##2##(1990-4#1)(1996-12#1)(1997-5#1)(2006-10#3)(2007-2#2)(2008-7#1)(2010-2#1)(2010-4#1)(2010-9#2)(2011-2#1)
opioids are the##2##3##(2008-3#1)(2008-7#1)
opioids are used##2##3##(2006-12#1)(2007-2#1)
opioids are##9##2##(2006-10#2)(2006-12#1)(2007-2#2)(2008-3#2)(2008-7#2)
opioids can##2##2##(1993-12#1)(2005-8#1)
opioids for the##2##3##(2010-2#1)(2010-7#1)
opioids for##4##2##(2006-10#1)(2006-7#1)(2010-2#1)(2010-7#1)
opioids have##4##2##(1992-12#1)(1994-9#1)(2006-10#1)(2008-3#1)
opioids in chronic##2##3##(2006-10#2)
opioids in##16##2##(1991-1#2)(1995-12#1)(1996-5#1)(2006-10#3)(2006-12#1)(2007-2#1)(2008-3#1)(2010-8#1)(2011-2#4)(2012-3#1)
opioids like morphine##2##3##(2008-7#1)(2009-7#1)
opioids like##3##2##(2008-7#1)(2009-7#2)
opioids may##4##2##(1995-6#1)(2007-9#1)(2008-3#2)
opioids on the##2##3##(1991-2#1)(2006-10#1)
opioids on##5##2##(1991-2#1)(1993-7#2)(1995-12#1)(2006-10#1)
opioids such as##2##3##(1995-5#1)(2008-7#1)
opioids to##3##2##(1993-6#1)(2006-10#1)(2008-7#1)
opioids which##3##2##(2005-8#1)(2006-7#2)
opioids##151##1##(1990-2#3)(1990-4#4)(1991-1#6)(1991-2#1)(1992-12#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-7#2)(1993-9#1)(1994-9#5)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-5#1)(1996-7#1)(1997-5#2)(1997-6#2)(2005-8#4)(2006-10#27)(2006-12#5)(2006-6#1)(2006-7#4)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#6)(2007-9#2)(2008-3#7)(2008-5#1)(2008-6#1)(2008-7#9)(2008-9#1)(2009-5#2)(2009-7#4)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#3)(2010-8#1)(2010-9#3)(2011-2#7)(2012-1#1)(2012-3#2)(2013-1#5)(2013-8#3)
opisthosomal##2##1##(2007-12#2)
opium poppy (Papaver somniferum)##2##4##(2008-10#2)
opium poppy from##2##3##(2008-10#2)
opium poppy plant##2##3##(2008-10#2)
opium poppy##13##2##(2008-10#13)
opium##19##1##(2007-10#1)(2007-7#1)(2008-10#14)(2008-3#2)(2008-8#1)
opossum kidney cells##4##3##(1991-8#1)(1991-9#1)(1992-1#1)(1996-11#1)
opossum kidney##5##2##(1991-3#1)(1991-8#1)(1991-9#1)(1992-1#1)(1996-11#1)
opossum##13##1##(1990-5#1)(1991-3#1)(1991-8#2)(1991-9#1)(1992-1#1)(1996-11#1)(1996-5#2)(2006-11#1)(2008-5#2)(2008-8#1)
opponens##4##1##(2006-3#1)(2012-12#3)
opponensplasty##4##1##(2006-3#4)
opponent's##6##1##(2007-9#2)(2008-11#4)
opponents of##5##2##(1994-1#1)(1994-10#1)(2006-5#1)(2008-11#1)(2008-9#1)
opponents##20##1##(1994-1#1)(1994-10#1)(1994-6#2)(2006-5#1)(2006-6#1)(2006-7#2)(2007-4#1)(2007-8#1)(2008-11#3)(2008-8#1)(2008-9#3)(2009-9#1)(2010-12#1)(2010-8#1)
opportune and##2##2##(2008-10#2)
opportune##4##1##(1992-5#1)(2008-10#2)(2013-1#1)
opportunely##2##1##(2008-5#1)(2013-7#1)
opportunism##2##1##(2006-7#1)(2012-3#1)
opportunist##6##1##(2006-10#1)(2007-3#1)(2007-7#1)(2008-8#2)(2013-1#1)
opportunistic agents##2##2##(1994-7#1)(2009-9#1)
opportunistic and##5##2##(2007-2#1)(2008-1#1)(2008-5#1)(2010-5#1)(2012-3#1)
opportunistic bacteria##4##2##(2006-8#1)(2010-4#1)(2013-1#2)
opportunistic disease##2##2##(2006-10#1)(2009-9#1)
opportunistic fungi##3##2##(2009-6#1)(2010-12#1)(2011-2#1)
opportunistic infection among##2##3##(1993-6#1)(2007-8#1)
opportunistic infection and##3##3##(1993-12#1)(2007-2#1)(2007-7#1)
opportunistic infection associated with##2##4##(1993-8#1)(2007-7#1)
opportunistic infection in HIV-infected##2##4##(2007-11#1)(2008-5#1)
opportunistic infection in patients with##2##5##(2006-10#1)(2011-2#1)
opportunistic infection in patients##3##4##(2006-10#1)(2007-4#1)(2011-2#1)
opportunistic infection in##8##3##(1993-5#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
opportunistic infection of the##2##4##(2007-12#1)(2008-5#1)
opportunistic infection##26##2##(1991-6#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-8#1)(1996-3#1)(2006-10#4)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-5#3)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
opportunistic infections and##4##3##(1993-8#1)(2007-11#1)(2007-2#1)(2010-12#1)
opportunistic infections in##6##3##(2006-10#1)(2006-8#1)(2007-12#1)(2008-12#1)(2010-11#1)(2010-12#1)
opportunistic infections or##3##3##(1990-3#1)(1993-1#1)(2012-2#1)
opportunistic infections##33##2##(1990-3#1)(1993-1#1)(1993-8#1)(1994-5#1)(1997-4#1)(2006-10#4)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)
opportunistic microorganisms##3##2##(2005-8#1)(2010-5#1)(2013-1#1)
opportunistic mycoses##2##2##(2007-7#1)(2011-2#1)
opportunistic parasitic infections##2##3##(2006-10#1)(2007-7#1)
opportunistic parasitic##3##2##(2006-10#1)(2007-7#1)(2009-7#1)
opportunistic pathogen in##2##3##(2007-7#1)(2010-9#1)
opportunistic pathogen of humans##2##4##(1991-9#1)(2008-10#1)
opportunistic pathogen##13##2##(1991-9#1)(1993-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
opportunistic pathogens##7##2##(1996-11#1)(1996-6#1)(2006-6#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-5#1)
opportunistic screening##2##2##(1991-6#1)(1996-6#1)
opportunistic##137##1##(1990-3#1)(1991-3#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-8#2)(1994-5#1)(1994-7#1)(1995-11#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#2)(1997-4#1)(1997-5#1)(2005-8#3)(2006-10#12)(2006-6#1)(2006-8#3)(2007-10#2)(2007-11#3)(2007-12#10)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#5)(2007-8#3)(2008-1#3)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#9)(2008-7#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#2)(2010-10#3)(2010-11#1)(2010-12#4)(2010-4#1)(2010-5#4)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#1)
opportunistically##4##1##(1991-11#1)(2008-1#1)(2008-5#1)(2010-8#1)
opportunities and challenges for##2##4##(2008-7#1)(2009-9#1)
opportunities and challenges##9##3##(1990-12#1)(2007-4#1)(2008-10#1)(2008-7#2)(2009-9#1)(2010-3#1)(2013-1#2)
opportunities and limitations##4##3##(1997-1#1)(2007-2#1)(2008-5#1)(2010-11#1)
opportunities and obstacles##2##3##(1994-2#1)(2008-9#1)
opportunities and resources##2##3##(2008-11#1)(2008-7#1)
opportunities and threats##2##3##(2005-11#2)
opportunities and##37##2##(1990-12#1)(1992-3#1)(1993-1#1)(1993-9#1)(1994-2#1)(1997-1#1)(2005-11#2)(2006-1#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-4#3)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-9#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
opportunities are being##2##3##(2011-2#1)(2012-12#1)
opportunities are##6##2##(1992-12#1)(1995-2#1)(2006-10#1)(2008-8#1)(2011-2#1)(2012-12#1)
opportunities as##2##2##(1996-3#1)(2008-12#1)
opportunities exist##2##2##(1996-1#1)(2013-1#1)
opportunities for a##2##3##(2008-11#1)(2012-3#1)
opportunities for advancing##2##3##(2008-9#1)(2010-2#1)
opportunities for biomedical material research##2##5##(2008-5#2)
opportunities for both##2##3##(1992-3#1)(2008-11#1)
opportunities for change##2##3##(2007-3#2)
opportunities for developing##2##3##(2008-1#1)(2012-1#1)
opportunities for dietitians##2##3##(1993-12#2)
opportunities for direct reproduction##2##4##(2010-2#2)
opportunities for direct##3##3##(1996-5#1)(2010-2#2)
opportunities for enhancing##2##3##(2008-1#1)(2010-4#1)
opportunities for further improvement##2##4##(1995-3#1)(1996-3#1)
opportunities for further##6##3##(1995-3#1)(1996-11#1)(1996-3#1)(2009-5#1)(2010-2#1)(2011-12#1)
opportunities for improvement in##2##4##(1997-1#1)(2008-5#1)
opportunities for improvement##3##3##(1994-2#1)(1997-1#1)(2008-5#1)
opportunities for learning and##2##4##(2011-1#1)(2012-2#1)
opportunities for learning##3##3##(2011-1#1)(2012-2#1)(2013-8#1)
opportunities for medical##2##3##(1993-6#1)(1993-8#1)
opportunities for nurses in##2##4##(1992-11#1)(2008-11#1)
opportunities for nurses##3##3##(1992-11#1)(2005-7#1)(2008-11#1)
opportunities for personal##2##3##(1995-1#1)(1997-1#1)
opportunities for postgraduate##2##3##(1993-11#1)(1993-6#1)
opportunities for psychologists##2##3##(2008-12#2)
opportunities for the development of##4##5##(2006-10#1)(2008-6#1)(2010-5#1)(2012-12#1)
opportunities for the##18##3##(1995-1#1)(1997-3#1)(2006-10#3)(2006-2#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-2#1)(2010-5#2)(2012-12#1)(2012-2#1)(2013-1#1)
opportunities for therapeutic##2##3##(2006-1#1)(2011-2#1)
opportunities for training and development##2##5##(2011-1#2)
opportunities for##184##2##(1991-12#1)(1992-11#1)(1992-2#3)(1992-3#1)(1993-11#1)(1993-12#2)(1993-6#2)(1993-8#1)(1994-12#1)(1994-2#1)(1995-1#3)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#5)(1996-5#1)(1997-1#3)(1997-2#2)(1997-3#3)(2004-10#1)(2005-11#1)(2005-7#3)(2006-1#1)(2006-10#5)(2006-12#1)(2006-2#4)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#6)(2008-11#8)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-7#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-2#9)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#2)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#2)
opportunities have##2##2##(1996-12#1)(2010-2#1)
opportunities in the##6##3##(1992-3#1)(1994-3#1)(2005-6#1)(2007-4#1)(2008-7#1)(2010-2#1)
opportunities in##20##2##(1992-3#1)(1994-2#1)(1994-3#1)(1994-6#1)(1996-3#1)(2005-6#1)(2006-2#2)(2007-4#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-2#1)(2011-12#1)(2013-1#1)(2013-8#1)
opportunities may##2##2##(2008-3#1)(2010-8#1)
opportunities not##2##2##(2007-1#1)(2010-2#1)
opportunities of##4##2##(2008-2#1)(2013-1#2)(2013-8#1)
opportunities offered by##2##3##(2008-9#1)(2012-12#1)
opportunities offered##3##2##(2008-7#1)(2008-9#1)(2012-12#1)
opportunities on the##2##3##(2006-10#1)(2010-8#1)
opportunities that are##2##3##(2008-1#1)(2008-11#1)
opportunities that##8##2##(1993-1#1)(1994-3#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-2#1)(2010-3#1)(2013-1#1)
opportunities to become##2##3##(2006-9#1)(2008-11#1)
opportunities to develop##6##3##(1992-7#1)(2008-5#1)(2009-12#1)(2010-11#1)(2011-2#1)(2012-2#1)
opportunities to examine##2##3##(2006-3#1)(2007-12#1)
opportunities to explore##3##3##(1996-7#1)(2009-11#1)(2010-3#1)
opportunities to further##2##3##(1995-3#1)(2008-11#1)
opportunities to implement##2##3##(2008-11#1)(2013-1#1)
opportunities to improve the##4##4##(1995-3#1)(1997-3#1)(2008-7#1)(2012-12#1)
opportunities to improve##10##3##(1995-3#1)(1997-3#1)(2007-10#1)(2007-4#1)(2007-8#1)(2008-7#1)(2010-7#1)(2010-8#1)(2012-12#1)(2013-8#1)
opportunities to increase the##2##4##(2009-4#1)(2010-4#1)
opportunities to increase##3##3##(2008-7#1)(2009-4#1)(2010-4#1)
opportunities to influence##2##3##(2008-11#1)(2011-1#1)
opportunities to learn##3##3##(1993-2#1)(2011-1#1)(2012-12#1)
opportunities to obtain##2##3##(2008-10#1)(2012-1#1)
opportunities to prevent##2##3##(2009-10#1)(2012-2#1)
opportunities to provide##2##3##(2008-7#1)(2012-2#1)
opportunities to study##2##3##(1992-9#1)(2010-3#1)
opportunities to##75##2##(1992-7#1)(1992-9#2)(1993-2#3)(1993-3#1)(1993-6#1)(1995-1#1)(1995-3#2)(1996-2#1)(1996-7#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-3#1)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#5)(2013-1#5)(2013-8#1)
opportunities will##2##2##(2008-11#1)(2012-1#1)
opportunities with##2##2##(2007-9#1)(2008-11#1)
opportunities##478##1##(1990-12#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#3)(1992-7#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#4)(1993-6#3)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#3)(1994-3#3)(1994-6#1)(1995-1#6)(1995-12#3)(1995-2#4)(1995-3#4)(1995-5#1)(1996-1#2)(1996-11#1)(1996-12#10)(1996-2#3)(1996-3#10)(1996-5#1)(1996-7#1)(1997-1#7)(1997-2#2)(1997-3#4)(1997-5#1)(1997-8#2)(2004-10#2)(2005-11#4)(2005-6#1)(2005-7#3)(2005-8#3)(2005-9#2)(2006-1#2)(2006-10#15)(2006-11#1)(2006-12#1)(2006-2#6)(2006-3#2)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#2)(2007-1#5)(2007-10#6)(2007-11#2)(2007-12#6)(2007-2#4)(2007-3#2)(2007-4#7)(2007-5#1)(2007-7#4)(2007-8#4)(2007-9#6)(2008-1#6)(2008-10#16)(2008-11#19)(2008-12#12)(2008-2#4)(2008-3#5)(2008-4#6)(2008-5#12)(2008-6#6)(2008-7#15)(2008-8#6)(2008-9#9)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#4)(2009-3#2)(2009-4#4)(2009-5#2)(2009-7#3)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#15)(2010-3#4)(2010-4#3)(2010-5#4)(2010-6#1)(2010-7#4)(2010-8#6)(2011-1#8)(2011-12#3)(2011-2#13)(2012-1#6)(2012-11#1)(2012-12#9)(2012-2#11)(2012-3#6)(2013-1#23)(2013-7#1)(2013-8#7)
opportunity and##3##2##(2007-9#1)(2008-11#1)(2008-5#1)
opportunity cost for##5##3##(2011-2#5)
opportunity cost of##3##3##(1991-2#1)(2011-2#1)(2013-8#1)
opportunity cost##9##2##(1991-2#1)(2011-2#7)(2013-8#1)
opportunity exists##3##2##(2007-2#1)(2009-12#1)(2012-2#1)
opportunity for blood##2##3##(2008-1#1)(2013-8#1)
opportunity for career development##2##4##(1994-3#2)
opportunity for career##3##3##(1994-1#1)(1994-3#2)
opportunity for cure##2##3##(2006-9#1)(2010-11#1)
opportunity for intervention##2##3##(2005-7#1)(2008-12#1)
opportunity for meaningful##2##3##(1996-12#1)(2011-2#1)
opportunity for participants to##2##4##(2010-11#1)(2012-12#1)
opportunity for prophylaxis##2##3##(1995-7#2)
opportunity for research##2##3##(2005-9#1)(2010-7#1)
opportunity for sexual selection##4##4##(2008-8#4)
opportunity for the##15##3##(1996-12#1)(1996-3#1)(2004-7#1)(2007-11#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
opportunity for vertical transmission##2##4##(2008-9#2)
opportunity for##119##2##(1990-4#1)(1991-2#1)(1991-3#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-3#1)(1995-7#2)(1996-12#3)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-5#1)(2004-7#1)(2005-7#3)(2005-9#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-8#1)(2006-9#2)(2007-11#5)(2007-12#1)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#3)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#8)(2008-9#4)(2009-10#3)(2009-2#2)(2009-4#1)(2009-9#1)(2010-11#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#3)(2012-12#3)(2012-2#5)(2013-1#6)(2013-8#3)
opportunity in##4##2##(2007-11#1)(2007-4#1)(2008-6#1)(2011-2#1)
opportunity is limited##2##3##(2008-8#1)(2012-1#1)
opportunity is##3##2##(1992-4#1)(2008-8#1)(2012-1#1)
opportunity of##9##2##(1991-2#1)(1992-9#1)(1994-9#1)(1995-1#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-1#1)(2012-3#1)
opportunity that##5##2##(2006-7#1)(2007-10#1)(2008-11#2)(2013-1#1)
opportunity to access##2##3##(2008-4#1)(2012-11#1)
opportunity to achieve##2##3##(2007-11#1)(2008-12#1)
opportunity to assess the##3##4##(1993-12#1)(2006-10#1)(2012-3#1)
opportunity to assess##4##3##(1993-12#1)(2006-10#1)(2008-10#1)(2012-3#1)
opportunity to become##2##3##(1990-3#1)(2008-11#1)
opportunity to classify##2##3##(1993-4#1)(2012-2#1)
opportunity to compare##2##3##(1994-3#1)(1997-8#1)
opportunity to demonstrate##2##3##(2006-9#1)(2008-12#1)
opportunity to determine##2##3##(2004-11#1)(2007-12#1)
opportunity to develop##4##3##(2007-3#1)(2007-8#1)(2008-11#1)(2010-11#1)
opportunity to discuss##4##3##(1994-8#1)(2007-2#1)(2008-1#1)(2010-11#1)
opportunity to engage##2##3##(2008-7#1)(2012-1#1)
opportunity to enhance the##3##4##(1995-12#1)(2004-12#1)(2008-3#1)
opportunity to examine the##4##4##(1992-8#1)(2006-10#1)(2006-4#1)(2008-4#1)
opportunity to examine##10##3##(1992-1#1)(1992-10#1)(1992-8#1)(2006-10#1)(2006-4#1)(2008-10#1)(2008-4#1)(2009-10#1)(2010-9#1)(2011-1#1)
opportunity to explore the##3##4##(1993-9#1)(2008-4#1)(2012-11#1)
opportunity to explore##5##3##(1993-11#1)(1993-9#1)(2008-12#1)(2008-4#1)(2012-11#1)
opportunity to identify##4##3##(1991-6#1)(2006-10#1)(2012-11#1)(2012-3#1)
opportunity to improve##7##3##(2005-11#1)(2006-7#1)(2007-7#1)(2008-10#1)(2009-11#1)(2011-2#1)(2013-1#1)
opportunity to investigate the##2##4##(1991-8#1)(2007-12#1)
opportunity to measure##2##3##(2008-2#2)
opportunity to meet##3##3##(1991-6#1)(2005-7#1)(2007-8#1)
opportunity to observe##2##3##(1991-8#1)(2009-4#1)
opportunity to obtain##2##3##(2008-5#1)(2012-2#1)
opportunity to perform##3##3##(2010-3#1)(2011-12#1)(2012-12#1)
opportunity to practice##2##3##(2009-4#1)(2013-1#1)
opportunity to prevent the##2##4##(2006-12#1)(2012-1#1)
opportunity to prevent##3##3##(2006-12#1)(2008-3#1)(2012-1#1)
opportunity to reduce the##2##4##(2008-7#1)(2009-4#1)
opportunity to reduce##4##3##(2007-4#1)(2008-7#1)(2009-4#1)(2013-1#1)
opportunity to reflect##2##3##(2011-1#1)(2012-3#1)
opportunity to respond to##4##4##(1991-3#1)(2008-10#3)
opportunity to review##4##3##(2005-8#1)(2007-2#1)(2008-4#1)(2010-3#1)
opportunity to study the effects of##2##6##(2008-2#2)
opportunity to study the##6##4##(2007-12#1)(2007-8#2)(2008-11#1)(2008-2#2)
opportunity to study##11##3##(1993-11#1)(1995-10#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-11#1)(2008-2#3)(2009-8#1)
opportunity to test the##2##4##(2008-1#1)(2013-1#1)
opportunity to test this hypothesis##2##5##(2006-7#1)(2012-3#1)
opportunity to test this##3##4##(2006-7#1)(2008-12#1)(2012-3#1)
opportunity to test##7##3##(1994-8#1)(2006-7#1)(2008-1#1)(2008-12#1)(2010-3#1)(2012-3#1)(2013-1#1)
opportunity to understand##2##3##(2010-2#1)(2012-2#1)
opportunity to use##5##3##(1994-6#1)(2008-2#1)(2008-7#1)(2009-9#1)(2010-5#1)
opportunity to##228##2##(1990-3#1)(1991-3#1)(1991-6#3)(1991-8#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-4#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-4#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-12#2)(1995-4#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-8#1)(2004-11#1)(2004-12#2)(2005-11#2)(2005-7#1)(2005-8#2)(2006-10#4)(2006-11#1)(2006-12#1)(2006-4#1)(2006-7#3)(2006-9#1)(2007-11#3)(2007-12#5)(2007-2#3)(2007-3#1)(2007-4#4)(2007-5#2)(2007-7#2)(2007-8#5)(2008-1#6)(2008-10#11)(2008-11#9)(2008-12#5)(2008-2#7)(2008-3#5)(2008-4#8)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#3)(2009-10#2)(2009-11#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#2)(2010-2#3)(2010-3#3)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#3)(2012-11#3)(2012-12#1)(2012-2#5)(2012-3#8)(2013-1#8)(2013-7#1)(2013-8#6)
opportunity##430##1##(1990-3#1)(1990-4#1)(1991-2#3)(1991-3#2)(1991-6#3)(1991-8#2)(1992-1#2)(1992-10#1)(1992-11#2)(1992-3#1)(1992-4#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#1)(1993-4#1)(1993-9#1)(1994-1#5)(1994-12#3)(1994-2#3)(1994-3#5)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-7#2)(1995-9#1)(1996-12#5)(1996-3#2)(1996-5#1)(1996-8#1)(1997-1#3)(1997-2#3)(1997-3#3)(1997-5#2)(1997-8#1)(2004-11#1)(2004-12#2)(2004-7#1)(2005-11#2)(2005-7#4)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-7#4)(2006-8#1)(2006-9#4)(2007-10#1)(2007-11#11)(2007-12#6)(2007-2#7)(2007-3#2)(2007-4#6)(2007-5#4)(2007-7#3)(2007-8#7)(2007-9#3)(2008-1#10)(2008-10#20)(2008-11#18)(2008-12#9)(2008-2#8)(2008-3#9)(2008-4#10)(2008-5#6)(2008-6#4)(2008-7#10)(2008-8#15)(2008-9#7)(2009-10#5)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#5)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-11#4)(2010-12#2)(2010-2#3)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#5)(2011-12#1)(2011-2#17)(2012-1#5)(2012-11#4)(2012-12#4)(2012-2#11)(2012-3#10)(2013-1#16)(2013-7#1)(2013-8#10)
oppose each other##2##3##(2009-4#1)(2012-3#1)
oppose the##3##2##(2008-8#1)(2011-2#1)(2013-7#1)
oppose##15##1##(1993-3#1)(1996-6#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-3#2)(2013-7#1)
opposed by##6##2##(1994-11#1)(1996-11#1)(1997-2#2)(1997-7#1)(2006-12#1)
opposed fields##3##2##(1990-8#1)(2007-2#1)(2008-6#1)
opposed lateral##3##2##(1990-12#1)(1993-9#2)
opposed this##2##2##(2008-9#1)(2011-1#1)
opposed to a##9##3##(1992-8#1)(1997-3#1)(2007-12#1)(2008-7#1)(2010-11#1)(2011-12#1)(2011-2#1)(2013-1#2)
opposed to that##2##3##(2008-11#1)(2008-12#1)
opposed to the traditional##2##4##(2008-10#1)(2011-2#1)
opposed to the##23##3##(1990-2#1)(1990-3#1)(1992-6#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-6#1)(2005-9#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-7#1)(2009-10#1)(2009-11#1)(2011-2#1)(2012-3#1)
opposed to##120##2##(1990-2#2)(1990-3#2)(1990-8#1)(1991-1#1)(1991-5#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-12#1)(1995-6#2)(1995-9#2)(1996-2#1)(1996-3#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#2)(2004-3#1)(2005-8#2)(2005-9#1)(2006-10#3)(2006-11#3)(2006-3#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#8)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
opposed##145##1##(1990-12#1)(1990-2#2)(1990-3#2)(1990-8#2)(1991-1#1)(1991-5#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#2)(1995-9#2)(1996-11#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#3)(2004-3#1)(2005-8#2)(2005-9#1)(2006-10#3)(2006-11#3)(2006-12#2)(2006-3#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#8)(2012-1#3)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
opposed-phase images##2##2##(1997-8#2)
opposed-phase imaging##3##2##(1997-8#3)
opposed-phase pulse sequence##3##3##(1997-8#3)
opposed-phase##12##1##(1997-8#12)
opposes the##2##2##(1993-6#1)(2008-9#1)
opposes##6##1##(1993-6#1)(1994-8#1)(1996-11#1)(2008-3#1)(2008-9#1)(2013-1#1)
opposing actions on##2##3##(1996-12#1)(2008-4#1)
opposing directions##2##2##(2006-12#1)(2012-12#1)
opposing effects of##2##3##(2008-4#1)(2008-8#1)
opposing effects on##7##3##(1990-5#1)(1993-9#1)(1994-8#1)(1997-7#1)(1997-8#1)(2005-10#1)(2008-8#1)
opposing effects##9##2##(1990-5#1)(1993-9#1)(1994-8#1)(1997-7#1)(1997-8#1)(2005-10#1)(2008-4#1)(2008-8#2)
opposing responses##2##2##(1997-3#2)
opposing roles##3##2##(1995-8#1)(1996-12#1)(2013-8#1)
opposing the##3##2##(1993-9#1)(2009-10#1)(2012-2#1)
opposing##62##1##(1990-5#2)(1993-2#1)(1993-3#1)(1993-9#2)(1994-12#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#1)(1997-3#2)(1997-7#2)(1997-8#1)(2005-10#2)(2006-12#2)(2006-2#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-9#1)(2013-1#3)(2013-7#1)(2013-8#1)
opposita##3##1##(2005-11#2)(2008-5#1)
opposite 8-oxoGua##5##2##(1996-7#5)
opposite C##2##2##(1993-3#1)(1995-1#1)
opposite DNA##2##2##(1993-11#1)(2009-10#1)
opposite Gs##2##2##(1993-3#2)
opposite a##6##2##(1993-3#1)(1994-8#1)(1995-1#1)(1996-12#1)(1996-7#1)(2009-8#1)
opposite action##2##2##(1991-10#1)(1996-11#1)
opposite associations##2##2##(2008-8#1)(2010-1#1)
opposite case##2##2##(2007-12#1)(2008-9#1)
opposite changes##3##2##(1996-5#1)(2007-12#1)(2008-8#1)
opposite charge##3##2##(2005-11#2)(2008-7#1)
opposite dC in##3##3##(1996-7#3)
opposite dT in##2##3##(1995-1#2)
opposite dT##5##2##(1995-1#5)
opposite direction in##2##3##(1996-2#1)(2010-12#1)
opposite direction of##4##3##(1996-2#1)(2008-2#1)(2009-7#1)(2012-2#1)
opposite direction##20##2##(1991-5#1)(1993-2#1)(1994-3#1)(1996-2#2)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#1)(2005-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-7#2)(2010-12#1)(2012-2#1)
opposite directions##16##2##(1990-4#1)(1991-2#1)(1991-5#1)(1991-7#1)(1994-11#1)(1996-7#2)(1997-3#2)(2007-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-3#1)
opposite effect on the##2##4##(2008-10#1)(2008-5#1)
opposite effect on##4##3##(1990-12#1)(2004-12#1)(2008-10#1)(2008-5#1)
opposite effect was observed##2##4##(1990-2#1)(1993-12#1)
opposite effect was##3##3##(1990-2#1)(1993-12#1)(2008-11#1)
opposite effect##18##2##(1990-12#1)(1990-2#1)(1993-12#1)(1995-12#1)(1996-2#1)(1997-7#1)(2004-12#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
opposite effects of##2##3##(1993-3#1)(2012-12#1)
opposite effects on the##4##4##(1992-11#1)(1994-5#1)(1994-9#1)(2006-1#1)
opposite effects on##11##3##(1991-2#1)(1992-11#1)(1994-11#1)(1994-5#1)(1994-9#1)(1996-2#2)(1997-5#1)(2006-1#1)(2007-8#1)(2010-3#1)
opposite effects##17##2##(1990-2#1)(1991-2#1)(1991-9#1)(1992-11#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-2#2)(1997-5#1)(2006-1#1)(2007-8#1)(2010-3#1)(2012-12#1)
opposite enantiomer##2##2##(2006-12#1)(2008-5#1)
opposite end##5##2##(2007-12#1)(2007-8#1)(2008-10#1)(2011-12#1)(2011-2#1)
opposite ends of the##2##4##(1994-8#1)(2012-2#1)
opposite from the##2##3##(1994-12#2)
opposite in##3##2##(1994-5#1)(1995-3#1)(2008-8#1)
opposite mating##2##2##(1994-12#1)(2008-10#1)
opposite of##7##2##(1990-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#2)
opposite pattern was observed##2##4##(1994-6#1)(2010-8#1)
opposite response##2##2##(1991-11#1)(1995-8#1)
opposite result was obtained##2##4##(2008-3#1)(2008-6#1)
opposite sex##12##2##(1990-8#1)(1995-12#1)(2007-12#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-2#2)
opposite sides of the##3##4##(2008-1#1)(2008-11#1)(2012-4#1)
opposite sides of##5##3##(2008-1#1)(2008-11#1)(2008-2#1)(2009-12#1)(2012-4#1)
opposite sides##8##2##(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-12#1)(2011-1#1)(2012-4#1)
opposite signs of##2##3##(1990-3#1)(2008-3#1)
opposite signs##4##2##(1990-3#1)(2007-11#1)(2008-3#1)(2009-11#1)
opposite specificities toward##2##3##(1992-11#2)
opposite strand##5##2##(1990-5#1)(1992-12#2)(1995-8#1)(2008-11#1)
opposite that##4##2##(1993-11#1)(2007-11#1)(2008-3#2)
opposite the modified##2##3##(1995-1#1)(1996-11#1)
opposite the##18##2##(1992-9#2)(1993-1#1)(1995-1#2)(1995-5#1)(1996-11#1)(1996-6#1)(2007-12#1)(2008-10#4)(2008-2#2)(2010-3#1)(2011-1#1)(2013-8#1)
opposite to each other##2##4##(1990-12#1)(2008-2#1)
opposite to that of the##2##5##(2007-11#1)(2012-1#1)
opposite to that of##5##4##(1991-5#2)(2007-11#1)(2012-1#1)(2013-7#1)
opposite to that##8##3##(1990-11#1)(1991-5#2)(1992-5#1)(2004-4#1)(2007-11#1)(2012-1#1)(2013-7#1)
opposite to the direction##2##4##(1996-6#1)(2007-8#1)
opposite to the##13##3##(1990-8#1)(1994-7#1)(1996-11#1)(1996-5#1)(1996-6#2)(2005-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-12#1)(2011-2#1)
opposite to##25##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-5#2)(1992-11#1)(1992-5#1)(1992-9#1)(1994-7#1)(1996-11#1)(1996-5#1)(1996-6#2)(2004-4#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-12#1)(2011-2#1)(2012-1#1)(2013-7#1)
opposite trend was##2##3##(2009-1#1)(2012-1#1)
opposite trend##6##2##(2006-10#1)(2008-5#1)(2009-1#1)(2009-10#1)(2009-2#1)(2012-1#1)
opposite was found##2##3##(1993-12#1)(1994-3#1)
opposite was observed##2##3##(2008-7#1)(2011-1#1)
opposite was true for##3##4##(2010-11#1)(2010-8#1)(2012-2#1)
opposite was##8##2##(1990-7#1)(1993-12#1)(1994-3#1)(2008-7#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-2#1)
opposite##379##1##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#4)(1991-1#2)(1991-10#3)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#6)(1991-6#1)(1991-7#1)(1991-9#2)(1992-11#4)(1992-12#3)(1992-5#1)(1992-9#4)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#9)(1993-4#2)(1993-8#1)(1994-11#2)(1994-12#3)(1994-3#2)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#10)(1995-10#3)(1995-12#4)(1995-2#3)(1995-3#1)(1995-5#4)(1995-6#2)(1995-8#2)(1996-11#4)(1996-12#3)(1996-2#6)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#6)(1996-7#13)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#4)(1997-5#3)(1997-7#3)(2004-12#1)(2004-4#1)(2005-10#1)(2005-11#4)(2006-1#1)(2006-10#5)(2006-12#2)(2006-3#1)(2006-8#1)(2007-11#9)(2007-12#16)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#5)(2008-12#1)(2008-2#11)(2008-3#15)(2008-4#3)(2008-5#10)(2008-6#2)(2008-7#6)(2008-8#8)(2008-9#8)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#2)(2009-2#1)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-3#3)(2010-7#1)(2010-8#2)(2011-1#8)(2011-12#1)(2011-2#5)(2012-1#5)(2012-11#1)(2012-12#5)(2012-2#4)(2012-3#3)(2012-4#1)(2013-1#5)(2013-7#2)(2013-8#2)
opposite-sex##5##1##(2007-12#3)(2010-2#2)
oppositely charged##16##2##(1995-5#1)(2005-11#2)(2006-10#4)(2008-10#2)(2008-5#1)(2008-7#1)(2009-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-9#1)
oppositely##17##1##(1995-5#1)(1997-6#1)(2005-11#2)(2006-10#4)(2008-10#2)(2008-5#1)(2008-7#1)(2009-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-9#1)
opposites##2##1##(2008-12#1)(2009-10#1)
opposition from##4##2##(2008-12#1)(2009-10#1)(2012-1#1)(2013-8#1)
opposition of##2##2##(2006-2#1)(2010-2#1)
opposition to the##2##3##(1995-6#1)(2007-4#1)
opposition to##13##2##(1991-3#1)(1994-4#1)(1995-6#1)(1996-6#1)(2006-7#1)(2007-4#1)(2007-9#1)(2008-7#1)(2009-2#2)(2010-12#1)(2012-11#1)(2012-2#1)
opposition##36##1##(1990-2#1)(1990-3#1)(1991-3#1)(1992-5#1)(1994-4#1)(1995-1#1)(1995-6#1)(1996-5#1)(1996-6#1)(2006-2#2)(2006-7#1)(2007-4#1)(2007-9#1)(2008-11#4)(2008-12#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-2#2)(2010-12#2)(2010-2#1)(2010-6#1)(2012-1#2)(2012-11#1)(2012-2#2)(2012-3#1)(2013-8#2)
oppositional defiant disorder##5##3##(1996-5#1)(2006-10#1)(2008-2#1)(2009-9#1)(2010-2#1)
oppositional defiant##7##2##(1996-5#3)(2006-10#1)(2008-2#1)(2009-9#1)(2010-2#1)
oppositional##10##1##(1994-4#1)(1996-5#3)(2005-10#1)(2006-10#1)(2008-2#1)(2009-9#1)(2010-2#1)(2012-12#1)
oppressed##2##1##(2008-11#1)(2008-7#1)
oppression##4##1##(1990-6#1)(1991-6#1)(2004-12#2)
oppressive##3##1##(2004-12#1)(2010-9#1)(2012-12#1)
opsin gene##3##2##(1994-3#3)
opsin##12##1##(1991-9#1)(1994-3#5)(1995-1#1)(1996-2#1)(1996-5#1)(1997-7#1)(2013-1#2)
opsin-specific##2##1##(1994-3#1)(2007-5#1)
opsoclonus##3##1##(1995-8#1)(2013-1#2)
opsoclonus-myoclonus syndrome##2##2##(2010-12#1)(2011-2#1)
opsoclonus-myoclonus##3##1##(1996-1#1)(2010-12#1)(2011-2#1)
opsonic activity##4##2##(1992-6#3)(1995-5#1)
opsonic defect##3##2##(1991-6#3)
opsonic##10##1##(1991-6#3)(1992-6#5)(1993-3#1)(1995-5#1)
opsonin##2##1##(1993-3#1)(2008-4#1)
opsonin-independent##2##1##(2008-6#2)
opsonins are##2##2##(1992-6#2)
opsonins##4##1##(1992-6#3)(2008-9#1)
opsonisation and##2##2##(1996-12#1)(2005-11#1)
opsonisation##3##1##(1996-12#2)(2005-11#1)
opsonised zymosan and##2##3##(1990-4#2)
opsonised zymosan##4##2##(1990-4#4)
opsonised##6##1##(1990-4#4)(1991-12#1)(1996-12#1)
opsonised-zymosan-induced stimulation of apoE##2##4##(1990-4#2)
opsonised-zymosan-stimulated##2##1##(1990-4#2)
opsonization##3##1##(1991-4#2)(1997-2#1)
opsonized or not with##2##4##(2008-10#2)
opsonized zymosan##4##2##(1991-2#1)(1991-9#1)(1992-8#1)(1994-11#1)
opsonized##12##1##(1990-12#1)(1990-9#1)(1991-2#2)(1991-6#2)(1991-9#1)(1992-8#1)(1994-11#1)(2008-10#3)
opt for a##2##3##(2008-10#1)(2010-12#1)
opt for##7##2##(2006-10#1)(2008-10#1)(2009-7#1)(2010-12#1)(2012-2#1)(2013-1#2)
opt out##2##2##(2007-8#1)(2010-8#1)
opt to##2##2##(1995-10#1)(2012-2#1)
opt##12##1##(1995-10#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-10#1)(2009-7#1)(2010-12#1)(2010-8#1)(2012-2#2)(2013-1#2)
opt-out HIV testing##2##3##(2008-10#1)(2010-12#1)
opt-out##4##1##(2008-10#1)(2010-12#2)(2012-12#1)
opted for##5##2##(2007-10#1)(2007-6#1)(2008-7#1)(2010-12#1)(2012-12#1)
opted to##2##2##(2009-3#1)(2013-8#1)
opted##7##1##(2007-10#1)(2007-6#1)(2008-7#1)(2009-3#1)(2010-12#1)(2012-12#1)(2013-8#1)
optic and##2##2##(2005-11#1)(2006-11#1)
optic atrophy##6##2##(2007-1#1)(2011-12#1)(2012-2#2)(2013-1#2)
optic axis##8##2##(2008-2#5)(2008-3#3)
optic chiasm##3##2##(1997-8#1)(2008-7#1)(2012-12#1)
optic chiasma##2##2##(1997-3#1)(2008-5#1)
optic disc and retinal nerve fiber layer##8##7##(2007-6#8)
optic disc size##2##3##(2012-2#2)
optic disc##19##2##(1993-1#1)(2007-1#1)(2007-6#8)(2009-8#2)(2010-9#1)(2011-2#1)(2012-2#4)(2013-7#1)
optic fiber probe##2##3##(2007-8#2)
optic fiber##3##2##(1991-2#1)(2007-8#2)
optic flow##7##2##(1994-6#1)(2008-11#1)(2008-2#2)(2008-9#3)
optic glioma##3##2##(2005-9#3)
optic lobe##8##2##(1996-6#1)(2007-12#4)(2008-3#1)(2008-5#2)
optic lobes##5##2##(1994-3#1)(1995-5#2)(2007-12#1)(2008-11#1)
optic nerve and##3##3##(2011-1#1)(2011-2#1)(2012-12#1)
optic nerve compression##2##3##(2008-7#1)(2011-1#1)
optic nerve decompression##3##3##(2006-12#2)(2009-8#1)
optic nerve head and retinal nerve fiber layer##2##8##(2007-6#2)
optic nerve head topography##2##4##(2008-5#1)(2011-1#1)
optic nerve head##13##3##(1995-9#1)(2007-11#1)(2007-6#2)(2008-5#5)(2009-2#1)(2011-1#1)(2012-12#1)(2012-2#1)
optic nerve hypoplasia##2##3##(1997-3#1)(2011-1#1)
optic nerve injury##2##3##(2011-7#1)(2013-8#1)
optic nerve sheath##5##3##(1996-2#1)(2009-8#3)(2010-5#1)
optic nerve was##2##3##(1996-2#1)(2008-10#1)
optic nerve##78##2##(1990-5#1)(1990-7#2)(1991-10#1)(1991-3#1)(1992-2#3)(1993-12#4)(1994-2#3)(1995-11#1)(1995-9#1)(1996-2#2)(1996-3#3)(1997-3#1)(2005-5#1)(2005-9#1)(2006-12#4)(2007-11#1)(2007-2#1)(2007-6#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#7)(2008-7#3)(2009-2#2)(2009-8#5)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#5)(2011-2#7)(2011-7#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-8#1)
optic nerves from##2##3##(1993-12#1)(2008-5#1)
optic nerves##9##2##(1993-12#3)(1994-2#1)(1997-3#1)(2008-5#2)(2009-8#1)(2013-8#1)
optic neuritis and##2##3##(2007-11#1)(2011-7#1)
optic neuritis##15##2##(1992-3#1)(1995-12#2)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2011-1#3)(2011-7#1)(2012-1#1)(2012-12#2)(2012-3#1)
optic neuropathy in Graves' eye disease##3##6##(2008-7#3)
optic neuropathy in##5##3##(2008-7#4)(2011-1#1)
optic neuropathy is##2##3##(2006-12#1)(2012-12#1)
optic neuropathy##30##2##(1991-12#3)(1992-9#3)(1996-5#3)(1997-7#1)(2004-8#1)(2005-11#2)(2006-12#1)(2008-7#5)(2009-2#2)(2010-1#1)(2011-1#1)(2012-12#4)(2013-1#2)(2013-7#1)
optic or##2##2##(1990-12#1)(2008-2#1)
optic pathway##3##2##(1992-7#1)(1995-7#1)(2006-12#1)
optic probe##4##2##(2008-10#3)(2009-5#1)
optic sensor##11##2##(1992-4#1)(2008-10#10)
optic sensors##5##2##(2008-10#5)
optic system##4##2##(1995-11#1)(2008-10#2)(2008-2#1)
optic tectum##8##2##(1990-5#1)(1990-7#1)(1993-12#2)(1995-5#1)(1997-3#1)(2008-6#2)
optic to##2##2##(2008-11#1)(2008-3#1)
optic tract and##3##3##(2007-10#1)(2007-12#1)(2008-7#1)
optic tract##9##2##(1992-7#1)(1992-9#1)(1996-5#3)(2007-10#1)(2007-12#1)(2008-7#2)
optic##326##1##(1990-12#1)(1990-5#2)(1990-7#4)(1990-8#6)(1991-10#1)(1991-12#3)(1991-2#2)(1991-3#2)(1992-2#3)(1992-3#1)(1992-4#2)(1992-7#2)(1992-9#4)(1993-1#1)(1993-12#9)(1994-2#4)(1994-3#1)(1994-6#1)(1995-11#3)(1995-12#3)(1995-3#1)(1995-5#3)(1995-7#1)(1995-9#1)(1996-1#1)(1996-2#2)(1996-3#3)(1996-5#6)(1996-6#1)(1997-3#4)(1997-7#1)(1997-8#1)(2004-8#1)(2005-11#4)(2005-5#1)(2005-9#4)(2006-10#1)(2006-11#1)(2006-12#8)(2006-4#1)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#8)(2007-2#1)(2007-3#1)(2007-6#10)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#34)(2008-11#7)(2008-2#21)(2008-3#21)(2008-4#4)(2008-5#13)(2008-6#2)(2008-7#12)(2008-9#3)(2009-2#4)(2009-4#1)(2009-5#1)(2009-8#10)(2010-1#1)(2010-5#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#10)(2011-12#1)(2011-2#10)(2011-7#2)(2012-1#1)(2012-12#10)(2012-2#9)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#2)
optic-lobe##2##1##(1994-3#2)
optica (NMO)##3##2##(2010-12#1)(2012-3#1)(2013-8#1)
optica##15##1##(2010-12#1)(2011-1#2)(2012-12#4)(2012-3#3)(2013-8#5)
optical CO(2) sensor based on##2##5##(2008-10#2)
optical Clos##2##2##(2008-2#2)
optical Doppler tomography##2##3##(2007-11#2)
optical Doppler velocimetry##2##3##(2008-1#1)(2008-3#1)
optical Doppler##6##2##(2007-11#2)(2007-12#1)(2008-1#1)(2008-3#2)
optical Fourier processor##2##3##(2008-3#2)
optical Fourier transformation##2##3##(2007-11#1)(2008-2#1)
optical Fourier##6##2##(2007-11#2)(2008-2#1)(2008-3#2)(2011-1#1)
optical I/O##4##2##(2008-3#4)
optical Kerr effect##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
optical Kerr##10##2##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#4)
optical aberrations##4##2##(2007-12#2)(2008-3#2)
optical absorbance##3##2##(2005-11#1)(2008-10#1)(2008-7#1)
optical absorption and fluorescence properties##2##5##(2010-4#2)
optical absorption and scattering##2##4##(1997-6#1)(2007-8#1)
optical absorption and##5##3##(1997-6#1)(2007-8#1)(2008-3#1)(2010-4#2)
optical absorption coefficient of##4##4##(2006-12#1)(2008-2#1)(2008-3#2)
optical absorption coefficient##7##3##(2006-12#2)(2008-2#1)(2008-3#4)
optical absorption in the##2##4##(1992-9#1)(2011-7#1)
optical absorption in##4##3##(1992-9#1)(2008-10#1)(2008-2#1)(2011-7#1)
optical absorption of the##2##4##(2008-10#1)(2008-3#1)
optical absorption of##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
optical absorption spectroscopy##8##3##(1995-8#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#4)
optical absorption##46##2##(1990-8#1)(1992-9#1)(1994-5#1)(1995-2#2)(1995-8#1)(1997-6#1)(2006-12#3)(2007-11#1)(2007-12#4)(2007-8#2)(2008-10#3)(2008-2#7)(2008-3#12)(2008-4#1)(2010-4#3)(2011-1#1)(2011-7#1)(2013-1#1)
optical access##3##2##(2008-2#2)(2008-3#1)
optical activity of the##2##4##(2008-7#1)(2009-5#1)
optical activity of##3##3##(2008-7#1)(2009-5#2)
optical activity##8##2##(1991-2#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-5#3)
optical addressing##2##2##(2007-12#2)
optical alignment##9##2##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-9#1)
optical amplification and##2##3##(2007-12#2)
optical amplification##4##2##(2007-12#4)
optical amplifier was##2##3##(2007-12#2)
optical amplifier##25##2##(2007-11#2)(2007-12#20)(2008-1#2)(2008-3#1)
optical amplifiers and##4##3##(2007-12#2)(2008-3#2)
optical amplifiers##15##2##(2007-11#2)(2007-12#4)(2008-1#5)(2008-2#2)(2008-3#2)
optical analog-to-digital##2##2##(2008-2#1)(2008-3#1)
optical analysis##2##2##(2008-2#1)(2008-3#1)
optical and electrical##5##3##(2008-1#1)(2008-2#3)(2013-8#1)
optical and electron microscopy##2##4##(2004-9#1)(2009-7#1)
optical and electronic microscopy##2##4##(2008-10#1)(2009-7#1)
optical and electronic##6##3##(2007-12#1)(2008-10#1)(2008-3#2)(2009-7#1)(2013-1#1)
optical and magnetic properties##2##4##(2009-7#1)(2010-6#1)
optical and magnetic##3##3##(2009-7#1)(2010-6#2)
optical and mechanical properties##4##4##(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
optical and mechanical##6##3##(2007-12#1)(2008-2#2)(2008-3#2)(2008-7#1)
optical and physiological##2##3##(1997-6#1)(2009-5#1)
optical and scanning electron microscopy##2##5##(2009-7#1)(2010-4#1)
optical and scanning electron##3##4##(2008-10#1)(2009-7#1)(2010-4#1)
optical and structural properties of##3##5##(2008-2#2)(2010-5#1)
optical and thermal properties##2##4##(2008-3#2)
optical and##56##2##(1992-9#2)(1994-12#1)(1997-6#1)(2004-9#1)(2005-11#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#6)(2008-2#10)(2008-3#8)(2008-5#2)(2008-7#1)(2009-2#1)(2009-5#1)(2009-7#4)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#2)(2012-12#1)(2013-1#2)(2013-8#1)
optical anisotropy##7##2##(1991-7#1)(2007-11#2)(2008-3#4)
optical antipodes##2##2##(1994-8#1)(1994-9#1)
optical aperture##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
optical applications##4##2##(2006-2#1)(2007-11#1)(2008-2#1)(2008-3#1)
optical architecture##2##2##(2007-12#1)(2008-2#1)
optical architectures##2##2##(2008-3#2)
optical arrangement for##3##3##(2007-12#1)(2008-2#2)
optical arrangement is##2##3##(2007-12#1)(2008-10#1)
optical arrangement##16##2##(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#6)(2008-3#4)
optical array##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
optical attenuation in##2##3##(1997-6#1)(2008-2#1)
optical attenuation##7##2##(1997-6#2)(2008-2#3)(2008-3#2)
optical axes##2##2##(2008-2#1)(2008-6#1)
optical axis of the system##3##5##(2008-2#2)(2008-3#1)
optical axis of the##6##4##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#2)
optical axis of##7##3##(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#2)
optical axis##35##2##(2007-11#4)(2007-12#3)(2008-10#1)(2008-2#8)(2008-3#19)
optical background##2##2##(2008-3#1)(2008-9#1)
optical backplane demonstrator##3##3##(2008-2#3)
optical backplane##7##2##(2008-2#7)
optical band gap is##2##4##(2013-1#2)
optical band##3##2##(2006-10#1)(2013-1#2)
optical bandpass filter##2##3##(2007-11#1)(2008-3#1)
optical bandwidth##4##2##(2007-12#1)(2008-3#3)
optical beam in##2##3##(2008-3#2)
optical beam##25##2##(2007-11#5)(2007-12#5)(2008-2#7)(2008-3#8)
optical beams by##3##3##(2007-12#3)
optical beams from##2##3##(2008-2#2)
optical beams in##4##3##(2007-12#2)(2008-1#1)(2008-3#1)
optical beams##19##2##(2007-11#2)(2007-12#8)(2008-1#2)(2008-2#5)(2008-3#2)
optical beat##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
optical behavior of##3##3##(2008-10#1)(2008-3#2)
optical behavior##4##2##(2008-10#1)(2008-3#3)
optical binary##2##2##(2008-2#2)
optical bio-sniffer was applied to##2##5##(2007-8#2)
optical bio-sniffer##4##2##(2007-8#4)
optical biopsy##6##2##(2007-12#1)(2008-3#1)(2012-2#2)(2013-1#2)
optical biosensor based on the resonant mirror##2##7##(1997-2#1)(2008-10#1)
optical biosensor based on##3##4##(1997-2#1)(2008-10#2)
optical biosensor for##3##3##(2007-12#1)(2008-10#2)
optical biosensor is##2##3##(2007-12#1)(2008-10#1)
optical biosensor##18##2##(1995-12#1)(1997-2#4)(2005-8#1)(2007-12#2)(2008-10#10)
optical biosensors##3##2##(2006-2#1)(2008-1#2)
optical birefringence##2##2##(1996-4#1)(2007-12#1)
optical bistability##5##2##(2007-12#3)(2008-1#1)(2008-3#1)
optical bit##2##2##(2007-12#1)(2008-1#1)
optical bottle beam##2##3##(2007-12#2)
optical breakdown##8##2##(2007-12#1)(2008-2#4)(2008-3#3)
optical bus##2##2##(2008-2#1)(2008-3#1)
optical carrier##6##2##(2007-11#1)(2007-12#3)(2008-2#2)
optical cavities##12##2##(2007-11#2)(2007-12#3)(2008-3#7)
optical cavity and##3##3##(2008-2#1)(2008-3#2)
optical cavity used##2##3##(2007-12#1)(2008-2#1)
optical cavity##23##2##(2007-11#4)(2007-12#8)(2008-2#4)(2008-3#5)(2008-7#1)(2009-2#1)
optical cell##4##2##(2007-8#1)(2008-2#1)(2008-3#2)
optical cells##2##2##(2007-8#2)
optical change##2##2##(1990-8#1)(2007-12#1)
optical channel waveguides##2##3##(2008-2#2)
optical channel##3##2##(2008-2#2)(2008-3#1)
optical channels##3##2##(2008-2#1)(2008-3#2)
optical characteristics of the##4##4##(2008-2#2)(2008-3#2)
optical characteristics of##11##3##(2008-2#7)(2008-3#4)
optical characteristics##15##2##(2007-12#1)(2008-2#7)(2008-3#7)
optical characterization of scattering media by##2##6##(2008-3#2)
optical characterization of the##2##4##(2008-2#2)
optical characterization of##11##3##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#5)(2009-2#1)
optical characterization##13##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#6)(2009-2#1)
optical characterizations##2##2##(2007-11#1)(2008-2#1)
optical chemical sensor based on##3##5##(2007-12#1)(2008-10#2)
optical chemical sensor##7##3##(2007-12#1)(2008-10#6)
optical chemical sensors and##2##4##(2008-3#1)(2010-5#1)
optical chemical##10##2##(2007-12#2)(2008-10#6)(2008-3#1)(2010-5#1)
optical chromatography##2##2##(2008-10#2)
optical circuit##5##2##(2008-1#1)(2008-2#2)(2008-3#2)
optical clock stream##2##3##(2007-12#1)(2008-3#1)
optical clock##3##2##(2007-12#1)(2008-3#2)
optical coatings on##2##3##(2008-3#2)
optical coatings with##2##3##(2008-3#2)
optical coatings##12##2##(2007-12#1)(2008-2#4)(2008-3#7)
optical code division multiple-access##2##4##(2008-3#2)
optical coefficient##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2013-1#1)
optical coefficients of the##3##4##(2008-2#3)
optical coefficients of##4##3##(2008-2#3)(2008-3#1)
optical coefficients##11##2##(2007-12#1)(2008-1#1)(2008-2#7)(2008-3#2)
optical coherence microscopy##3##3##(2007-11#1)(2007-12#2)
optical coherence tomograph##2##3##(2008-3#2)
optical coherence tomographic##2##3##(2007-12#1)(2008-3#1)
optical coherence tomography (OCT) and##4##5##(2008-5#1)(2011-1#1)(2012-2#2)
optical coherence tomography (OCT) images##2##5##(2008-3#1)(2010-2#1)
optical coherence tomography (OCT) imaging##2##5##(2007-12#2)
optical coherence tomography (OCT) in##2##5##(2007-11#1)(2011-7#1)
optical coherence tomography (OCT) is##2##5##(2007-12#1)(2011-1#1)
optical coherence tomography (OCT) system##8##5##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#2)(2013-1#1)
optical coherence tomography (OCT)##37##4##(1997-4#1)(2007-11#3)(2007-12#9)(2008-1#2)(2008-2#1)(2008-3#4)(2008-5#2)(2010-12#1)(2010-2#1)(2011-1#3)(2011-7#4)(2012-12#1)(2012-2#2)(2013-1#3)
optical coherence tomography (PS-OCT)##2##4##(2007-11#1)(2007-12#1)
optical coherence tomography (SD-OCT) has##2##5##(2011-7#2)
optical coherence tomography (SOCT)##2##4##(2007-12#1)(2011-1#1)
optical coherence tomography and##5##4##(2007-11#2)(2009-5#1)(2011-1#1)(2013-1#1)
optical coherence tomography by optimal synthesis of##2##7##(2007-11#2)
optical coherence tomography for imaging##3##5##(2007-12#2)(2011-7#1)
optical coherence tomography for##9##4##(2007-11#1)(2007-12#4)(2009-3#1)(2011-1#1)(2011-7#1)(2012-2#1)
optical coherence tomography in##3##4##(2007-3#1)(2008-3#1)(2011-7#1)
optical coherence tomography of##3##4##(2007-12#3)
optical coherence tomography study##3##4##(2007-3#1)(2009-9#1)(2012-2#1)
optical coherence tomography system##7##4##(2007-11#3)(2008-2#1)(2008-3#3)
optical coherence tomography that##2##4##(2007-11#1)(2008-1#1)
optical coherence tomography with##3##4##(2007-11#1)(2007-12#2)
optical coherence tomography##171##3##(1997-4#2)(2006-10#2)(2007-11#35)(2007-12#51)(2007-3#4)(2007-6#1)(2008-1#7)(2008-10#1)(2008-2#3)(2008-3#15)(2008-5#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#12)(2011-7#13)(2012-12#5)(2012-2#4)(2013-1#6)(2013-7#1)
optical coherence tomography]##2##3##(2013-1#1)(2013-7#1)
optical coherence##188##2##(1997-4#2)(2006-10#2)(2007-11#36)(2007-12#58)(2007-3#4)(2007-6#1)(2008-1#9)(2008-10#1)(2008-2#3)(2008-3#20)(2008-5#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#12)(2011-7#13)(2012-12#5)(2012-2#4)(2013-1#7)(2013-7#2)
optical coherent transient true-time delay##2##5##(2007-12#2)
optical coherent transient true-time##3##4##(2007-12#3)
optical coherent transient##8##3##(2007-12#8)
optical coherent##9##2##(2007-12#8)(2008-6#1)
optical communication between##3##3##(2008-2#2)(2008-3#1)
optical communication by##2##3##(2007-12#1)(2008-2#1)
optical communication links##2##3##(2008-2#2)
optical communication systems##2##3##(2007-11#1)(2008-1#1)
optical communication##19##2##(2007-11#2)(2007-12#5)(2008-1#1)(2008-2#9)(2008-3#2)
optical communications and##3##3##(2007-12#1)(2008-3#2)
optical communications##16##2##(2007-11#2)(2007-12#6)(2008-2#2)(2008-3#6)
optical component##8##2##(2007-12#2)(2008-2#3)(2008-3#3)
optical components and##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
optical components for##2##3##(2008-2#1)(2008-3#1)
optical components such as##2##4##(2008-2#1)(2008-3#1)
optical components with##3##3##(2007-12#1)(2008-3#2)
optical components##33##2##(2006-5#1)(2007-11#4)(2007-12#3)(2008-1#3)(2008-2#13)(2008-3#8)(2008-9#1)
optical computing##14##2##(2007-12#1)(2008-2#6)(2008-3#7)
optical configuration is##5##3##(2007-11#1)(2008-2#4)
optical configuration of##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
optical configuration##22##2##(2007-11#1)(2007-12#1)(2008-2#9)(2008-3#10)(2010-4#1)
optical configurations##4##2##(2008-2#3)(2008-3#1)
optical confinement##2##2##(2007-11#1)(2008-3#1)
optical constant##3##2##(2008-3#3)
optical constants and##7##3##(2008-2#3)(2008-3#4)
optical constants are##4##3##(2008-2#1)(2008-3#3)
optical constants in the##4##4##(2008-2#2)(2008-3#2)
optical constants in##5##3##(2008-2#3)(2008-3#2)
optical constants is##2##3##(2008-2#2)
optical constants n and k of##2##6##(2008-2#2)
optical constants n and k##3##5##(2008-2#3)
optical constants n##4##3##(2008-2#3)(2008-3#1)
optical constants of a##4##4##(2008-2#3)(2008-3#1)
optical constants of solids##2##4##(2007-12#1)(2008-2#1)
optical constants of thin films##3##5##(2008-2#1)(2008-3#2)
optical constants of thin##6##4##(2008-2#3)(2008-3#3)
optical constants of water ice##2##5##(2008-3#2)
optical constants of##30##3##(2007-11#1)(2007-12#2)(2008-2#14)(2008-3#13)
optical constants were##4##3##(2008-2#3)(2008-3#1)
optical constants##80##2##(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#40)(2008-3#35)
optical contact##2##2##(2006-12#1)(2008-3#1)
optical content-addressable parallel processor##2##4##(2008-3#2)
optical contrast##6##2##(2007-11#1)(2008-2#3)(2008-3#1)(2009-7#1)
optical contrasts##2##2##(2008-3#1)(2011-1#1)
optical control##6##2##(2007-12#2)(2008-2#1)(2008-3#3)
optical controller##3##2##(2008-2#1)(2008-3#2)
optical conversion efficiency##3##3##(2007-12#2)(2008-2#1)
optical conversion##5##2##(2007-12#3)(2008-2#2)
optical correction##2##2##(1992-7#1)(2008-6#1)
optical correlation with##3##3##(2008-3#3)
optical correlation##22##2##(1994-11#1)(2007-12#5)(2008-1#1)(2008-2#8)(2008-3#7)
optical correlation-based##2##2##(2007-11#1)(2008-3#1)
optical correlations##2##2##(2007-12#1)(2008-3#1)
optical correlator for##2##3##(2007-12#1)(2008-3#1)
optical correlator with##3##3##(2008-3#3)
optical correlator##15##2##(2007-12#5)(2008-2#2)(2008-3#8)
optical correlators##9##2##(2008-2#3)(2008-3#6)
optical coupler##2##2##(2007-12#1)(2013-1#1)
optical coupling scheme##2##3##(2008-2#1)(2008-3#1)
optical coupling##11##2##(2007-11#2)(2007-12#2)(2008-2#5)(2008-3#2)
optical cross sections##3##3##(2008-2#1)(2008-3#2)
optical cross talk between##2##4##(2008-3#2)
optical cross talk##5##3##(2007-12#1)(2008-3#4)
optical cross##9##2##(2007-12#2)(2008-2#1)(2008-3#6)
optical cross-connect##3##2##(2007-12#2)(2008-3#1)
optical crystals##5##2##(2007-12#1)(2008-10#1)(2008-2#3)
optical cycle##2##2##(2007-12#2)
optical cycles##4##2##(2007-12#4)
optical damage##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
optical data and##2##3##(2008-2#2)
optical data by use of##2##5##(2007-12#1)(2008-3#1)
optical data communications##2##3##(2008-3#2)
optical data for##2##3##(2005-11#1)(2008-3#1)
optical data in##2##3##(2008-2#1)(2008-3#1)
optical data links##4##3##(2008-3#4)
optical data on##2##3##(2007-12#1)(2008-3#1)
optical data routing##2##3##(2007-12#2)
optical data storage by##5##4##(2007-12#2)(2008-1#2)(2008-2#1)
optical data storage in a##2##5##(2007-12#1)(2008-3#1)
optical data storage in##3##4##(2007-12#2)(2008-3#1)
optical data storage systems##3##4##(2008-2#2)(2008-3#1)
optical data storage##30##3##(2007-12#6)(2008-1#3)(2008-2#8)(2008-3#13)
optical data##60##2##(2005-11#1)(2007-11#1)(2007-12#14)(2008-1#3)(2008-2#13)(2008-3#28)
optical data-storage media##4##3##(2008-3#4)
optical data-storage##9##2##(2007-12#2)(2008-2#2)(2008-3#5)
optical decryption of##2##3##(2008-3#2)
optical degradation##4##2##(2008-2#1)(2008-3#3)
optical delay line is##2##4##(2007-11#1)(2008-3#1)
optical delay line that##2##4##(2008-1#1)(2008-2#1)
optical delay line##10##3##(2007-11#3)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#3)
optical delay##15##2##(2007-11#4)(2007-12#1)(2008-1#2)(2008-2#4)(2008-3#4)
optical densities##9##2##(1992-8#1)(1994-11#1)(1994-5#1)(1996-12#1)(1997-3#1)(2007-11#1)(2008-2#2)(2008-3#1)
optical density and##3##3##(2008-12#1)(2008-2#1)(2012-3#1)
optical density of the bacterial cultures##2##6##(2006-11#1)(2013-1#1)
optical density of the##6##4##(2006-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-8#1)(2013-1#1)
optical density of##9##3##(2006-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#1)(2013-1#1)
optical density readings##3##3##(1994-11#2)(2010-3#1)
optical density values##2##3##(1992-7#1)(1997-4#1)
optical density##38##2##(1992-7#1)(1994-11#2)(1994-2#1)(1997-3#1)(1997-4#2)(2006-11#1)(2008-10#4)(2008-12#2)(2008-2#5)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#1)(2009-8#4)(2010-12#2)(2010-3#2)(2012-3#2)(2013-1#1)
optical depth and##2##3##(2008-2#2)
optical depth for##2##3##(2008-2#1)(2008-3#1)
optical depth is##2##3##(2008-2#2)
optical depth of the##2##4##(2008-2#1)(2008-3#1)
optical depth of##3##3##(2008-2#2)(2008-3#1)
optical depth##28##2##(2008-2#18)(2008-3#10)
optical depths##5##2##(2008-2#3)(2008-3#2)
optical derotator##2##2##(2008-3#2)
optical design and the##2##4##(2006-4#1)(2008-3#1)
optical design and##6##3##(2006-4#1)(2008-2#1)(2008-3#4)
optical design for##2##3##(2008-3#2)
optical design of a##2##4##(2008-2#1)(2008-3#1)
optical design of##3##3##(2008-2#1)(2008-3#2)
optical design##18##2##(2006-4#1)(2008-2#5)(2008-3#11)(2013-8#1)
optical designer to##2##3##(2008-2#1)(2008-3#1)
optical designs for##2##3##(2008-2#1)(2008-3#1)
optical designs##3##2##(2008-2#1)(2008-3#1)(2008-4#1)
optical detection of magnetic resonance##3##5##(1990-2#1)(1993-11#2)
optical detection of##7##3##(1990-2#1)(1993-11#2)(1997-2#1)(1997-7#1)(2008-2#1)(2008-3#1)
optical detection##17##2##(1990-2#1)(1993-11#2)(1997-2#1)(1997-7#1)(2006-2#2)(2006-9#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#5)(2011-1#1)
optical detector fibers##2##3##(2007-12#1)(2008-3#1)
optical detector##8##2##(2007-12#4)(2008-10#1)(2008-2#1)(2008-3#2)
optical device capable of##2##4##(2008-2#1)(2008-3#1)
optical device that##2##3##(2007-11#1)(2007-12#1)
optical device##9##2##(2005-11#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#1)
optical devices in##2##3##(2008-2#2)
optical devices such as##2##4##(2008-1#1)(2008-2#1)
optical devices##22##2##(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#1)(2008-2#9)(2008-3#4)(2008-9#1)(2012-2#1)
optical diagnostic##3##2##(2008-2#2)(2008-5#1)
optical diagnostics of##2##3##(2008-3#2)
optical diagnostics##3##2##(2008-2#1)(2008-3#2)
optical diffraction##6##2##(2007-11#1)(2008-2#4)(2008-3#1)
optical diffusion imaging##3##3##(2007-12#3)
optical diffusion tomography is##2##4##(2008-2#1)(2008-3#1)
optical diffusion tomography##3##3##(2008-2#1)(2008-3#2)
optical diffusion##8##2##(2007-12#3)(2008-2#3)(2008-3#2)
optical diode##4##2##(2007-11#2)(2008-2#1)(2008-3#1)
optical dipole trap##2##3##(2007-12#2)
optical disc##2##2##(2008-2#1)(2008-3#1)
optical disk data storage##4##4##(2008-2#3)(2008-3#1)
optical disk is##2##3##(2008-2#1)(2008-3#1)
optical disk readout##5##3##(2008-2#2)(2008-3#3)
optical disk system##2##3##(2008-2#1)(2008-3#1)
optical disk systems##3##3##(2008-2#1)(2008-3#2)
optical disk with a##2##4##(2007-11#1)(2008-3#1)
optical disk with##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
optical disk##40##2##(2007-11#2)(2008-2#19)(2008-3#19)
optical disks##17##2##(2008-2#11)(2008-3#6)
optical displacement sensor##3##3##(2008-2#2)(2008-3#1)
optical distortion##2##2##(2007-11#2)
optical effect in##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
optical effect##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
optical effects in##3##3##(1990-8#1)(2008-2#1)(2008-3#1)
optical effects##9##2##(1990-8#1)(2007-12#1)(2008-2#4)(2008-3#3)
optical efficiency and##2##3##(2007-12#1)(2008-2#1)
optical efficiency of the##2##4##(2008-3#2)
optical efficiency of##6##3##(2007-11#2)(2008-2#1)(2008-3#3)
optical efficiency##16##2##(1990-12#1)(2007-11#2)(2007-12#2)(2008-2#5)(2008-3#6)
optical electric##2##2##(2007-12#2)
optical element and##2##3##(2008-3#2)
optical element design##2##3##(2008-2#1)(2008-3#1)
optical element for##2##3##(2007-12#1)(2008-3#1)
optical element in##2##3##(2006-4#1)(2008-3#1)
optical element that##5##3##(2007-11#2)(2008-3#3)
optical element to##2##3##(2007-12#1)(2008-3#1)
optical element with##3##3##(2007-11#1)(2008-3#2)
optical element##56##2##(2006-4#1)(2007-11#4)(2007-12#11)(2008-2#11)(2008-3#29)
optical elements and##5##3##(2008-2#1)(2008-3#4)
optical elements are##6##3##(2007-11#2)(2008-1#1)(2008-2#1)(2008-3#2)
optical elements by##2##3##(2008-2#2)
optical elements can be##2##4##(2008-2#1)(2008-3#1)
optical elements in the##2##4##(2007-12#1)(2008-3#1)
optical elements in##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
optical elements is##6##3##(2007-12#1)(2008-2#2)(2008-3#3)
optical elements such##2##3##(2008-2#1)(2008-3#1)
optical elements that##2##3##(2007-12#1)(2008-2#1)
optical elements with the##2##4##(2008-3#2)
optical elements with##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
optical elements##114##2##(2006-5#2)(2007-11#7)(2007-12#10)(2008-1#2)(2008-2#39)(2008-3#53)(2012-2#1)
optical elements)##2##2##(2008-2#1)(2008-3#1)
optical emission spectrometry (ICP-OES)##12##4##(2008-10#12)
optical emission spectrometry##30##3##(2007-8#1)(2008-10#28)(2012-12#1)
optical emission spectroscopy##7##3##(2008-10#2)(2008-2#1)(2010-11#1)(2010-4#1)(2011-2#2)
optical emission##43##2##(2006-12#1)(2007-12#2)(2007-8#1)(2008-10#31)(2008-2#1)(2008-3#1)(2010-11#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-8#1)
optical encoder is##2##3##(2008-3#2)
optical encoder##4##2##(2008-1#1)(2008-3#3)
optical encryption system##2##3##(2008-2#1)(2008-3#1)
optical encryption##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
optical energy##4##2##(2007-12#1)(2008-3#1)(2011-1#1)(2012-2#1)
optical engineers##2##2##(2008-2#2)
optical equipment##2##2##(2007-11#1)(2008-2#1)
optical erasure##2##2##(2008-2#1)(2008-3#1)
optical excitation of##3##3##(1992-12#1)(2007-12#2)
optical excitation##9##2##(1992-12#1)(2006-5#1)(2007-11#2)(2007-12#5)
optical excitations in##2##3##(2008-7#2)
optical experiment##2##2##(2008-2#1)(2008-3#1)
optical experimental##3##2##(2008-2#2)(2008-3#1)
optical experiments##4##2##(2008-1#1)(2008-2#1)(2008-3#2)
optical exposure##2##2##(2008-1#1)(2008-3#1)
optical extinction##2##2##(2008-2#1)(2008-3#1)
optical features##2##2##(2007-12#1)(2008-3#1)
optical feedback and##5##3##(2007-12#4)(2008-3#1)
optical feedback from an external##2##5##(2007-12#1)(2008-3#1)
optical feedback from##5##3##(2007-12#3)(2008-3#2)
optical feedback interferometer##2##3##(2008-2#1)(2008-3#1)
optical feedback is##2##3##(2007-12#1)(2008-3#1)
optical feedback tomography##2##3##(2007-12#2)
optical feedback##49##2##(2007-11#7)(2007-12#24)(2008-2#3)(2008-3#15)
optical fiber Bragg gratings##2##4##(2007-11#1)(2008-3#1)
optical fiber Bragg##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
optical fiber and a##2##4##(2008-1#1)(2008-10#1)
optical fiber and the##3##4##(2007-11#1)(2008-3#2)
optical fiber and##12##3##(2005-4#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-3#5)
optical fiber are##2##3##(2007-12#2)
optical fiber assembly##2##3##(2008-10#2)
optical fiber based on##2##4##(2007-12#1)(2008-2#1)
optical fiber based##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
optical fiber bundle##3##3##(2007-11#1)(2007-8#1)(2008-7#1)
optical fiber by use of a##2##6##(2007-12#1)(2008-1#1)
optical fiber by##8##3##(2007-12#4)(2008-1#1)(2008-2#2)(2008-3#1)
optical fiber communications##2##3##(2007-12#2)
optical fiber coupler##3##3##(2007-11#1)(2007-12#2)
optical fiber current sensor##2##4##(2008-3#2)
optical fiber fabricated from##2##4##(2007-12#1)(2010-4#1)
optical fiber for##5##3##(2007-11#1)(2007-12#1)(2008-2#3)
optical fiber gas sensors##2##4##(2008-3#2)
optical fiber grating##2##3##(2008-3#2)
optical fiber has been##5##4##(2007-11#3)(2007-12#1)(2008-3#1)
optical fiber in##2##3##(2008-3#2)
optical fiber is demonstrated##2##4##(2007-12#2)
optical fiber is##11##3##(2007-11#3)(2007-12#5)(2008-2#1)(2008-3#2)
optical fiber laser##2##3##(2007-12#2)
optical fiber modulator##2##3##(2008-2#2)
optical fiber refractometer based on a path-matching differential interferometer##2##9##(2008-3#2)
optical fiber refractometer based on a##3##6##(2008-3#3)
optical fiber refractometer##4##3##(2008-3#4)
optical fiber sensor for##4##4##(2008-10#4)
optical fiber sensor##11##3##(2007-11#2)(2007-12#1)(2008-10#5)(2008-2#3)
optical fiber systems##4##3##(2007-11#2)(2007-12#1)(2008-2#1)
optical fiber that##5##3##(2007-12#3)(2008-3#2)
optical fiber tip##2##3##(2008-2#1)(2008-3#1)
optical fiber was##2##3##(2008-10#1)(2008-3#1)
optical fiber with a##2##4##(2007-12#2)
optical fiber with##15##3##(2007-11#2)(2007-12#6)(2008-1#1)(2008-10#1)(2008-2#5)
optical fiber##259##2##(2005-4#4)(2007-11#45)(2007-12#83)(2007-8#3)(2008-1#3)(2008-10#21)(2008-2#43)(2008-3#49)(2008-5#1)(2008-7#1)(2009-12#1)(2009-2#1)(2010-4#2)(2013-1#1)(2013-8#1)
optical fibers and##12##3##(2006-4#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#4)
optical fibers are##4##3##(2008-1#1)(2008-2#1)(2008-3#2)
optical fibers by use of a##2##6##(2007-11#1)(2008-3#1)
optical fibers by##10##3##(2007-11#4)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#2)
optical fibers consisting of##2##4##(2007-11#1)(2007-12#1)
optical fibers for##2##3##(1991-1#1)(2008-3#1)
optical fibers immersed in##2##4##(2007-11#1)(2008-3#1)
optical fibers into ultrahigh vacuum systems##2##6##(2008-2#2)
optical fibers is##5##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
optical fibers of##2##3##(2007-11#1)(2008-3#1)
optical fibers that##2##3##(2007-12#1)(2008-3#1)
optical fibers to##6##3##(2007-11#3)(2007-12#1)(2008-3#2)
optical fibers was##2##3##(2008-2#1)(2008-3#1)
optical fibers were##3##3##(2007-11#2)(2008-9#1)
optical fibers with zero##2##4##(2007-12#2)
optical fibers with##6##3##(2007-11#2)(2007-12#3)(2008-3#1)
optical fibers##150##2##(1991-1#1)(1995-10#1)(1995-4#1)(2006-4#1)(2007-11#39)(2007-12#38)(2008-1#6)(2008-10#2)(2008-2#25)(2008-3#35)(2008-9#1)
optical fibre##3##2##(2006-6#2)(2008-10#1)
optical field and##2##3##(2007-12#2)
optical field in##2##3##(2007-11#1)(2008-3#1)
optical field is##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
optical field##24##2##(2007-11#5)(2007-12#8)(2008-2#3)(2008-3#6)(2008-7#1)(2009-5#1)
optical fields in##2##3##(2008-3#2)
optical fields that##2##3##(2007-11#1)(2007-12#1)
optical fields##15##2##(1993-5#1)(2007-11#5)(2007-12#4)(2008-2#1)(2008-3#4)
optical filter that##2##3##(2007-11#1)(2008-2#1)
optical filter with a Michelson-Gires-Tournois interferometer##2##6##(2007-12#2)
optical filter with a##3##4##(2007-12#2)(2008-2#1)
optical filter##21##2##(2007-11#6)(2007-12#5)(2008-1#1)(2008-2#3)(2008-3#5)(2008-9#1)
optical filtering##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#1)
optical filters##17##2##(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#6)(2008-6#1)(2008-9#2)
optical flow cell##2##3##(2008-10#2)
optical flow technique##2##3##(2010-8#2)
optical flow##11##2##(1992-9#4)(2008-10#2)(2008-2#2)(2008-6#1)(2010-8#2)
optical fluctuations##2##2##(2008-3#2)
optical fluorescence##3##2##(2006-12#1)(2008-3#1)(2010-12#1)
optical force##2##2##(2007-8#1)(2009-5#1)
optical forces##2##2##(2007-12#1)(2009-5#1)
optical frequencies of the idler##2##5##(2007-12#2)
optical frequencies of##3##3##(2007-12#3)
optical frequencies##8##2##(2007-12#7)(2008-3#1)
optical frequency comb generation##2##4##(2007-12#2)
optical frequency comb generator##4##4##(2007-12#3)(2008-3#1)
optical frequency comb##13##3##(2007-11#1)(2007-12#10)(2008-3#2)
optical frequency conversion##2##3##(2007-11#1)(2007-12#1)
optical frequency domain imaging (OFDI)##2##5##(2011-1#1)(2013-1#1)
optical frequency interval divider##2##4##(2007-12#2)
optical frequency modulation##2##3##(2007-12#1)(2008-2#1)
optical frequency standard##3##3##(2007-12#2)(2008-2#1)
optical frequency standards##3##3##(2007-11#1)(2007-12#2)
optical frequency was##2##3##(2007-12#1)(2008-2#1)
optical frequency##44##2##(2007-11#5)(2007-12#28)(2008-2#5)(2008-3#4)(2011-1#1)(2013-1#1)
optical frequency-domain##5##2##(2007-12#2)(2008-3#3)
optical front end##2##3##(2008-3#2)
optical function##3##2##(2005-8#2)(2007-11#1)
optical functions of##6##3##(2008-1#3)(2008-2#2)(2008-3#1)
optical functions##9##2##(2007-12#1)(2008-1#4)(2008-2#3)(2008-3#1)
optical gain##7##2##(2007-12#1)(2008-2#1)(2008-3#2)(2008-7#2)(2009-6#1)
optical gating (FROG)##9##3##(2007-11#1)(2007-12#7)(2008-3#1)
optical gating and##2##3##(2007-11#1)(2007-12#1)
optical gating is##3##3##(2007-11#1)(2007-12#2)
optical gating measurements##2##3##(2007-12#2)
optical gating##51##2##(2007-11#8)(2007-12#38)(2008-1#1)(2008-2#1)(2008-3#3)
optical generation and detection of##2##5##(2007-11#2)
optical generation and##3##3##(2007-11#2)(2008-3#1)
optical geometry of the##2##4##(2008-10#1)(2008-3#1)
optical geometry##6##2##(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)
optical glass waveguide gratings##2##4##(2008-3#2)
optical glass##8##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#4)
optical glasses##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
optical guidance of##2##3##(2007-12#1)(2008-1#1)
optical guiding##2##2##(2007-11#1)(2008-2#1)
optical head##6##2##(2008-3#6)
optical heterodyne detection##2##3##(2008-2#1)(2008-3#1)
optical heterodyne polarimeter##2##3##(2008-2#2)
optical heterodyne profilometer##2##3##(2008-2#2)
optical heterodyne signal##2##3##(2007-12#1)(2008-2#1)
optical heterodyne##15##2##(2007-12#3)(2008-2#10)(2008-3#2)
optical heterodyning##2##2##(2008-2#1)(2008-3#1)
optical holographic##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
optical homogeneity##2##2##(2008-2#1)(2013-1#1)
optical image processing##5##3##(2008-2#4)(2008-3#1)
optical image reconstruction##2##3##(2007-12#1)(2008-3#1)
optical image##15##2##(2007-12#2)(2008-11#1)(2008-2#4)(2008-3#5)(2008-9#1)(2010-8#1)(2011-1#1)
optical images is##2##3##(2007-12#1)(2010-8#1)
optical images with##3##3##(2007-12#1)(2008-1#1)(2011-1#1)
optical images##14##2##(2007-12#3)(2008-1#1)(2008-2#2)(2009-5#2)(2010-8#5)(2011-1#1)
optical imaging agents##4##3##(2013-1#4)
optical imaging modalities##3##3##(2011-1#2)(2013-1#1)
optical imaging of intrinsic signals##2##5##(1995-12#1)(2009-5#1)
optical imaging of##7##3##(1995-12#1)(1997-5#1)(1997-6#2)(2007-12#1)(2008-2#1)(2009-5#1)
optical imaging reveals##2##3##(2008-11#2)
optical imaging system##5##3##(1997-6#1)(2008-3#2)(2009-4#1)(2011-1#1)
optical imaging systems##2##3##(2008-3#1)(2011-1#1)
optical imaging technique##3##3##(2007-12#2)(2008-2#1)
optical imaging through##2##3##(2008-3#2)
optical imaging##53##2##(1995-12#1)(1997-5#2)(1997-6#4)(2007-11#1)(2007-12#4)(2007-6#2)(2008-1#1)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#7)(2009-4#1)(2009-5#1)(2010-2#1)(2010-5#1)(2011-1#9)(2012-12#1)(2013-1#6)(2013-7#1)
optical immunosensor##2##2##(2008-10#2)
optical implementation of the fractional##2##5##(2008-3#2)
optical implementation of the##7##4##(2008-2#2)(2008-3#5)
optical implementation of##16##3##(2007-12#3)(2008-2#4)(2008-3#9)
optical implementation##29##2##(2007-12#4)(2008-2#11)(2008-3#14)
optical implementations are##2##3##(2008-2#1)(2008-3#1)
optical implementations of the##3##4##(2007-12#1)(2008-2#2)
optical implementations##7##2##(2007-12#1)(2008-2#4)(2008-3#2)
optical information processing##4##3##(2007-12#1)(2008-3#3)
optical information##8##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#3)
optical injection##5##2##(2007-11#2)(2007-12#2)(2011-1#1)
optical input and output##2##4##(2008-2#1)(2008-3#1)
optical input field##2##3##(2007-12#2)
optical input##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
optical input-output##3##2##(2008-2#1)(2008-3#2)
optical inputs and outputs##2##4##(2006-4#1)(2008-2#1)
optical inputs and##3##3##(2006-4#2)(2008-2#1)
optical inspection##2##2##(2006-12#1)(2009-9#1)
optical instrument##4##2##(2008-3#1)(2011-12#3)
optical instruments and##2##3##(2006-10#1)(2008-2#1)
optical instruments##3##2##(2006-10#1)(2008-2#1)(2008-3#1)
optical integrated circuits##3##3##(2007-11#1)(2007-12#1)(2012-2#1)
optical intensity##9##2##(2007-11#1)(2007-12#5)(2008-3#3)
optical interactions##3##2##(2007-12#3)
optical interconnect consisting of##2##4##(2008-2#1)(2008-3#1)
optical interconnect for##2##3##(2008-2#2)
optical interconnect networks for massively parallel processing##2##7##(2008-2#2)
optical interconnect system##5##3##(2008-2#3)(2008-3#2)
optical interconnect systems is##2##4##(2008-2#1)(2008-3#1)
optical interconnect systems##3##3##(2008-2#1)(2008-3#2)
optical interconnect##26##2##(2007-12#1)(2008-2#15)(2008-3#10)
optical interconnection applications##2##3##(2007-12#1)(2008-2#1)
optical interconnection module##2##3##(2008-3#2)
optical interconnection modules##2##3##(2008-2#2)
optical interconnection network##2##3##(2008-2#1)(2008-3#1)
optical interconnection system##3##3##(2008-2#1)(2008-3#2)
optical interconnection##22##2##(2007-12#1)(2008-2#10)(2008-3#11)
optical interconnections##14##2##(2007-11#1)(2007-12#1)(2008-2#7)(2008-3#5)
optical interconnects based on##3##4##(2008-2#1)(2008-3#2)
optical interconnects##28##2##(2007-12#2)(2008-2#8)(2008-3#18)
optical interference##6##2##(2007-12#1)(2008-3#3)(2013-8#2)
optical interferometer##9##2##(2006-4#1)(2007-11#1)(2008-2#3)(2008-3#3)(2011-1#1)
optical interferometers##4##2##(2007-11#2)(2008-2#2)
optical interferometry##3##2##(2005-11#1)(2008-2#1)(2008-3#1)
optical irradiation##2##2##(1992-4#1)(2007-12#1)
optical isolation of the sampling volume##2##6##(2008-3#2)
optical isolation##3##2##(2008-3#3)
optical isolator by##3##3##(2007-12#1)(2008-3#2)
optical isolator##4##2##(2007-12#1)(2008-3#3)
optical isolators##2##2##(2007-12#1)(2008-3#1)
optical isomers of##2##3##(1996-5#1)(2008-10#1)
optical isomers##4##2##(1992-9#1)(1996-5#1)(2008-10#1)(2008-7#1)
optical kicked##2##2##(2007-11#2)
optical laser##5##2##(2007-12#1)(2008-2#3)(2008-5#1)
optical layouts##2##2##(2008-3#2)
optical length##3##2##(2007-11#1)(2007-12#1)(2008-1#1)
optical light##2##2##(2008-2#1)(2011-1#1)
optical limiter##5##2##(2007-12#4)(2008-3#1)
optical limiters##2##2##(2008-2#2)
optical limiting behavior##4##3##(2007-11#3)(2008-3#1)
optical limiting devices##2##3##(2007-9#1)(2008-2#1)
optical limiting of nanosecond##2##4##(2008-1#1)(2008-3#1)
optical limiting performance of a##2##5##(2007-11#2)
optical limiting##23##2##(2007-11#8)(2007-12#3)(2007-9#1)(2008-1#4)(2008-2#2)(2008-3#5)
optical line shapes##2##3##(1991-7#2)
optical line##6##2##(1991-7#2)(2008-2#1)(2008-3#3)
optical link##5##2##(2007-12#1)(2008-2#3)(2008-3#1)
optical links##3##2##(2007-12#1)(2008-2#2)
optical lithographic##3##2##(2006-12#1)(2008-2#1)(2008-3#1)
optical lithography system##2##3##(2008-2#2)
optical lithography##7##2##(2007-12#2)(2007-8#1)(2008-2#3)(2008-3#1)
optical lock-in##2##2##(2008-2#2)
optical logic##2##2##(2007-12#1)(2008-3#1)
optical loop configuration##2##3##(2007-12#2)
optical loop##21##2##(2007-11#6)(2007-12#13)(2008-3#2)
optical loss did not significantly change##2##6##(2008-2#2)
optical loss of##4##3##(2007-12#2)(2008-2#2)
optical loss##20##2##(2007-11#3)(2007-12#4)(2008-2#11)(2008-3#2)
optical losses##2##2##(2007-12#1)(2008-2#1)
optical low-coherence reflectometry##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
optical low-coherence##5##2##(2007-11#1)(2007-12#3)(2008-3#1)
optical magnetic-field##2##2##(2008-3#2)
optical magnification##2##2##(2008-3#1)(2008-5#1)
optical mammograms##2##2##(2008-3#2)
optical mammography##5##2##(2008-2#3)(2008-3#2)
optical material##5##2##(2007-11#1)(2007-12#1)(2008-3#3)
optical materials##11##2##(2007-11#1)(2007-12#2)(2008-2#5)(2008-3#3)
optical matrix##2##2##(2008-2#1)(2008-3#1)
optical means is##2##3##(2008-2#2)
optical means##7##2##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#1)
optical measurement method##2##3##(2008-3#1)(2011-1#1)
optical measurement##7##2##(2007-12#2)(2008-2#3)(2008-3#1)(2011-1#1)
optical measurements are##2##3##(2007-12#1)(2008-3#1)
optical measurements of##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
optical measurements##14##2##(1991-4#1)(2006-12#1)(2007-12#2)(2008-2#5)(2008-3#4)(2008-9#1)
optical media##4##2##(2008-2#1)(2008-3#2)(2009-5#1)
optical memories##4##2##(2007-12#2)(2008-2#2)
optical memory in##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
optical memory system using##2##4##(2007-12#2)
optical memory system##3##3##(2007-12#2)(2008-3#1)
optical memory with urethane-urea copolymers##2##5##(2008-3#2)
optical memory##22##2##(2007-12#12)(2007-9#1)(2008-2#2)(2008-3#7)
optical method for real-time##2##4##(2007-12#2)
optical method for##7##3##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#2)
optical method of##3##3##(2007-12#1)(2009-4#1)(2011-1#1)
optical method##19##2##(1992-9#1)(1996-5#1)(1997-6#1)(2005-4#1)(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#4)(2008-4#1)(2009-4#1)(2009-5#1)(2011-1#1)(2013-8#1)
optical methods for##3##3##(1997-8#1)(2008-2#1)(2008-3#1)
optical methods##14##2##(1995-8#1)(1997-5#1)(1997-8#1)(2007-12#1)(2007-5#1)(2008-2#3)(2008-3#5)(2011-1#1)
optical metrology##8##2##(2007-12#3)(2008-2#1)(2008-3#4)
optical microcavities##2##2##(2007-11#2)
optical microcavity##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
optical micrographs##2##2##(2008-3#2)
optical microlithography##2##2##(2008-3#2)
optical microscope by##2##3##(2007-12#1)(2009-10#1)
optical microscope is##2##3##(2007-12#1)(2008-9#1)
optical microscope with a##2##4##(2008-1#1)(2013-1#1)
optical microscope with an##2##4##(2007-12#1)(2008-1#1)
optical microscope with##5##3##(2007-12#1)(2008-1#3)(2013-1#1)
optical microscope##38##2##(2007-11#2)(2007-12#9)(2008-1#4)(2008-10#1)(2008-2#8)(2008-3#7)(2008-5#3)(2008-9#1)(2009-10#1)(2011-1#1)(2013-1#1)
optical microscopes##6##2##(2008-10#1)(2008-3#3)(2009-5#1)(2013-1#1)
optical microscopy (OM)##2##3##(2008-10#1)(2009-11#1)
optical microscopy and##7##3##(1997-5#1)(2007-12#1)(2008-10#1)(2008-3#2)(2009-7#1)(2011-2#1)
optical microscopy has been##2##4##(2007-12#1)(2008-2#1)
optical microscopy is##2##3##(2008-2#1)(2009-5#1)
optical microscopy of##5##3##(2007-12#2)(2008-2#1)(2008-5#1)(2012-2#1)
optical microscopy to##2##3##(2008-3#1)(2009-4#1)
optical microscopy##57##2##(1995-10#1)(1997-5#1)(2005-11#2)(2007-11#2)(2007-12#11)(2008-10#5)(2008-11#1)(2008-2#7)(2008-3#11)(2008-5#3)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#3)(2009-7#2)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#1)
optical misalignment##3##2##(2008-3#3)
optical mode##2##2##(2007-12#2)
optical model##6##2##(2008-2#4)(2008-3#2)
optical modes were##2##3##(2007-11#2)
optical modes##8##2##(2007-11#3)(2007-12#3)(2008-3#1)(2009-5#1)
optical modulation of the##2##4##(2007-11#1)(2008-3#1)
optical modulation##6##2##(2007-11#1)(2007-12#2)(2008-3#3)
optical modulator##9##2##(2007-11#1)(2008-2#6)(2008-3#2)
optical modulators##2##2##(2007-11#1)(2008-3#1)
optical module##2##2##(2008-10#2)
optical modules##2##2##(2008-2#1)(2008-3#1)
optical multichannel analyzer##2##3##(2005-4#1)(2007-11#1)
optical multilayer##4##2##(2007-12#1)(2008-3#3)
optical multipass cell##2##3##(2008-3#2)
optical multiplication##2##2##(2007-12#1)(2008-2#1)
optical multistage##2##2##(2008-2#2)
optical near field##4##3##(2007-11#2)(2007-12#1)(2008-2#1)
optical near##6##2##(2007-11#2)(2007-12#3)(2008-2#1)
optical near-field##2##2##(2007-12#2)
optical network unit##3##3##(2008-2#3)
optical network units##2##3##(2008-2#2)
optical network##12##2##(2007-12#1)(2008-2#7)(2008-3#4)
optical networks##2##2##(2006-4#1)(2007-12#1)
optical neuron##2##2##(2008-3#2)
optical noise##2##2##(2007-11#1)(2008-2#1)
optical nonlinear##3##2##(2006-12#1)(2007-9#1)(2008-1#1)
optical nonlinearities##5##2##(2007-11#1)(2007-12#1)(2008-10#2)(2011-1#1)
optical nonlinearity in##3##3##(2007-12#2)(2008-3#1)
optical nonlinearity of the##2##4##(2007-11#1)(2007-12#1)
optical nonlinearity of##7##3##(2007-11#1)(2007-12#5)(2008-1#1)
optical nonlinearity##17##2##(2006-12#1)(2007-11#3)(2007-12#11)(2008-1#1)(2008-3#1)
optical one-shot sensor##2##3##(2008-10#2)
optical or##2##2##(2005-5#1)(2008-10#1)
optical orthogonal signature patterns##2##4##(2008-2#2)
optical orthogonal signature##3##3##(2008-2#3)
optical oscillation##2##2##(2007-12#1)(2008-1#1)
optical oscillator##3##2##(2007-12#2)(2008-1#1)
optical output##2##2##(2008-2#1)(2008-3#1)
optical oxygen##2##2##(2008-10#1)(2010-5#1)
optical parallel architecture for##2##4##(2008-2#2)
optical parallel##3##2##(2008-2#3)
optical parameter##6##2##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)
optical parameters and##2##3##(2006-2#1)(2008-2#1)
optical parameters for##2##3##(2008-2#1)(2008-3#1)
optical parameters from##2##3##(2008-3#2)
optical parameters of the##5##4##(1991-4#1)(2008-3#3)(2011-2#1)
optical parameters of##10##3##(1991-4#1)(2007-12#1)(2008-2#1)(2008-3#5)(2011-2#1)(2013-8#1)
optical parameters that##3##3##(1990-8#1)(2008-3#2)
optical parameters##43##2##(1990-8#3)(1991-4#1)(1994-3#1)(2006-2#1)(2007-12#3)(2008-2#8)(2008-3#21)(2010-4#1)(2011-2#2)(2013-8#2)
optical parametric amplification and##2##4##(2007-11#2)
optical parametric amplification in##3##4##(2007-11#2)(2007-12#1)
optical parametric amplification##9##3##(2007-11#5)(2007-12#4)
optical parametric amplifier (OPA)##3##4##(2007-12#1)(2008-2#2)
optical parametric amplifier based on##2##5##(2007-11#2)
optical parametric amplifier in the visible##5##6##(2007-12#5)
optical parametric amplifier in##6##4##(2007-11#1)(2007-12#5)
optical parametric amplifier is##2##4##(2007-12#2)
optical parametric amplifier pumped by a##2##6##(2007-11#1)(2008-1#1)
optical parametric amplifier##32##3##(2007-11#8)(2007-12#15)(2008-1#4)(2008-2#4)(2008-3#1)
optical parametric chirped pulse amplification##4##5##(2007-11#3)(2008-3#1)
optical parametric generation in##4##4##(2007-12#3)(2008-1#1)
optical parametric generator based on##2##5##(2007-12#2)
optical parametric generator pumped at##2##5##(2007-12#2)
optical parametric generator##12##3##(2007-12#11)(2008-2#1)
optical parametric generator-optical parametric amplifier##2##5##(2007-12#2)
optical parametric oscillation in##3##4##(2007-12#1)(2008-3#2)
optical parametric oscillation with periodically poled LiNbO3##2##7##(2008-3#2)
optical parametric oscillation with periodically poled##3##6##(2007-12#1)(2008-3#2)
optical parametric oscillation##10##3##(2007-11#2)(2007-12#3)(2008-3#5)
optical parametric oscillator (OPO) based on a##3##7##(2007-11#1)(2007-12#2)
optical parametric oscillator (OPO) based on periodically poled##4##8##(2007-12#2)(2008-3#2)
optical parametric oscillator (OPO) based on##9##6##(2007-11#1)(2007-12#6)(2008-3#2)
optical parametric oscillator (OPO) driven##2##5##(2007-12#1)(2008-3#1)
optical parametric oscillator (OPO) pumped by a##4##7##(2007-12#2)(2008-2#1)(2008-3#1)
optical parametric oscillator (OPO) pumped by##5##6##(2007-12#2)(2008-2#2)(2008-3#1)
optical parametric oscillator (OPO) pumped##7##5##(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#2)
optical parametric oscillator (OPO) that is##2##6##(2007-11#1)(2007-12#1)
optical parametric oscillator (OPO) that##3##5##(2007-11#1)(2007-12#1)(2008-1#1)
optical parametric oscillator (OPO) with##4##5##(2007-11#2)(2007-12#2)
optical parametric oscillator (OPO)##48##4##(2007-11#6)(2007-12#25)(2008-1#3)(2008-10#1)(2008-2#5)(2008-3#7)(2008-5#1)
optical parametric oscillator (SRO)##5##4##(2007-12#4)(2008-1#1)
optical parametric oscillator as##2##4##(2007-11#1)(2008-3#1)
optical parametric oscillator based on a##2##6##(2007-12#2)
optical parametric oscillator based on periodically poled RbTiOAsO(4)##5##8##(2007-12#3)(2008-1#2)
optical parametric oscillator based on periodically poled lithium niobate##7##9##(2007-11#4)(2007-12#3)
optical parametric oscillator based on periodically poled lithium##8##8##(2007-11#4)(2007-12#4)
optical parametric oscillator based on periodically poled##16##7##(2007-11#4)(2007-12#10)(2008-1#2)
optical parametric oscillator based on##21##5##(2007-11#4)(2007-12#15)(2008-1#2)
optical parametric oscillator by##2##4##(2007-12#2)
optical parametric oscillator for##3##4##(2007-11#2)(2007-12#1)
optical parametric oscillator in##2##4##(2007-12#1)(2008-2#1)
optical parametric oscillator including an alpha-cut##2##6##(2007-12#2)
optical parametric oscillator pumped by a Ti##2##7##(2007-12#1)(2008-3#1)
optical parametric oscillator pumped by a##7##6##(2007-12#4)(2008-2#1)(2008-3#2)
optical parametric oscillator pumped by##8##5##(2007-12#5)(2008-2#1)(2008-3#2)
optical parametric oscillator pumped##9##4##(2007-12#6)(2008-2#1)(2008-3#2)
optical parametric oscillator that uses##2##5##(2007-11#1)(2007-12#1)
optical parametric oscillator that##6##4##(2007-11#3)(2007-12#3)
optical parametric oscillator through##2##4##(2007-11#1)(2008-3#1)
optical parametric oscillator using##2##4##(2008-1#2)
optical parametric oscillator with a##2##5##(2007-12#1)(2008-3#1)
optical parametric oscillator with##8##4##(2007-12#6)(2008-1#1)(2008-3#1)
optical parametric oscillator##176##3##(2007-11#31)(2007-12#102)(2008-1#12)(2008-10#1)(2008-2#8)(2008-3#21)(2008-5#1)
optical parametric oscillators (OPO's) based on##2##6##(2007-12#1)(2008-3#1)
optical parametric oscillators (OPO's)##4##4##(2007-12#3)(2008-3#1)
optical parametric oscillators and generators##3##5##(2007-12#3)
optical parametric oscillators based on##2##5##(2007-11#1)(2007-12#1)
optical parametric oscillators##29##3##(2007-11#6)(2007-12#19)(2008-1#1)(2008-2#1)(2008-3#2)
optical parametric process##4##3##(2007-12#4)
optical parametric processes##2##3##(2007-12#2)
optical parametric##292##2##(2007-11#60)(2007-12#167)(2008-1#18)(2008-10#1)(2008-2#15)(2008-3#30)(2008-5#1)
optical part of the##2##4##(2008-2#1)(2011-2#1)
optical particle##2##2##(2008-3#2)
optical passive##2##2##(2008-2#1)(2008-3#1)
optical path adhesive##2##3##(2008-3#2)
optical path and##2##3##(2008-2#1)(2011-1#1)
optical path difference (OPD)##3##4##(2008-2#1)(2008-3#2)
optical path difference between the two beams##2##7##(2008-2#2)
optical path difference between the##4##5##(2008-2#3)(2008-3#1)
optical path difference between##5##4##(2008-2#4)(2008-3#1)
optical path difference deviation##2##4##(2013-8#2)
optical path difference is##2##4##(2007-12#1)(2008-2#1)
optical path difference##30##3##(2007-12#4)(2008-2#11)(2008-3#9)(2013-8#6)
optical path differences##3##3##(2007-11#2)(2008-3#1)
optical path length of##2##4##(2008-2#1)(2008-3#1)
optical path length##18##3##(1997-6#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#5)(2008-3#5)(2010-2#1)
optical path lengths##9##3##(2007-12#3)(2008-2#1)(2008-3#5)
optical path##90##2##(1997-6#1)(2007-11#3)(2007-12#15)(2008-10#7)(2008-2#25)(2008-3#29)(2010-2#1)(2011-1#1)(2013-8#8)
optical path-length spectroscopy##3##3##(2007-12#1)(2008-3#2)
optical path-length##7##2##(2007-12#2)(2008-2#1)(2008-3#4)
optical pathlength##5##2##(2008-10#3)(2011-1#2)
optical paths##9##2##(2007-11#1)(2008-2#2)(2008-3#6)
optical pattern recognition##8##3##(2008-2#1)(2008-3#7)
optical pattern##9##2##(2007-12#1)(2008-2#1)(2008-3#7)
optical patterns##2##2##(2007-12#2)
optical penetration##2##2##(2008-3#1)(2011-1#1)
optical performance and##2##3##(2008-3#2)
optical performance is##2##3##(2008-2#2)
optical performance of##6##3##(2007-12#1)(2008-2#3)(2008-3#2)
optical performance##24##2##(2007-12#2)(2008-2#9)(2008-3#12)(2008-9#1)
optical performances##2##2##(2008-3#2)
optical phase and##2##3##(2007-12#2)
optical phase conjugation in a type II##2##7##(2007-12#2)
optical phase conjugation##4##3##(2007-12#2)(2008-1#1)(2008-2#1)
optical phase modulation##2##3##(2008-2#1)(2008-3#1)
optical phase noise##2##3##(2007-12#2)
optical phase of the##2##4##(2008-2#1)(2008-3#1)
optical phase of##3##3##(2008-2#1)(2008-3#2)
optical phase shifter-modulator##2##3##(2007-11#2)
optical phase##38##2##(1993-8#1)(2007-11#3)(2007-12#15)(2008-1#3)(2008-2#8)(2008-3#8)
optical phase-locked loop##3##3##(2007-11#1)(2007-12#2)
optical phases##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
optical phenomena##7##2##(2008-2#4)(2008-3#2)(2008-7#1)
optical phenomenon of##2##3##(2007-12#1)(2008-4#1)
optical phenomenon##3##2##(2007-12#2)(2008-4#1)
optical phonons in##2##3##(1992-11#1)(2012-2#1)
optical phonons##3##2##(1992-11#1)(2012-2#2)
optical pickup##6##2##(2007-12#1)(2008-3#5)
optical pickups##2##2##(2007-12#1)(2008-3#1)
optical polarization splitter##2##3##(2008-2#2)
optical polarization##6##2##(2008-2#3)(2008-3#3)
optical polarizing films##3##3##(2008-3#3)
optical polarizing##4##2##(2008-3#3)(2008-5#1)
optical poling##5##2##(2007-11#3)(2007-12#2)
optical polymer##2##2##(2008-2#1)(2008-3#1)
optical power and##2##3##(2007-12#1)(2008-3#1)
optical power density##2##3##(2007-12#1)(2008-2#1)
optical power into##2##3##(2008-2#2)
optical power of##3##3##(2008-3#3)
optical power supply spot-array generator for a##2##7##(2008-2#2)
optical power supply##4##3##(2008-2#4)
optical power transfer to whispering-gallery modes##2##6##(2007-12#2)
optical power##39##2##(2007-11#2)(2007-12#12)(2008-1#1)(2008-2#16)(2008-3#8)
optical powers##5##2##(2007-11#1)(2007-12#3)(2008-3#1)
optical pressure##2##2##(2008-2#2)
optical probe##5##2##(2008-2#3)(2008-3#1)(2011-1#1)
optical probes##7##2##(1997-6#1)(2007-12#2)(2008-12#2)(2008-2#1)(2009-7#1)
optical process##2##2##(2007-12#1)(2010-7#1)
optical processes##3##2##(2007-12#2)(2008-3#1)
optical processing system is##2##4##(2007-12#1)(2008-2#1)
optical processing##10##2##(2007-11#3)(2007-12#3)(2008-2#3)(2008-3#1)
optical processor is##2##3##(2008-3#2)
optical processor##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
optical processors##5##2##(2007-12#2)(2008-2#3)
optical profilometry##5##2##(2006-12#1)(2008-2#1)(2008-3#2)(2010-4#1)
optical programming pulses to a##2##5##(2007-12#2)
optical projection tomography##3##3##(2006-11#1)(2011-1#2)
optical propagation##5##2##(2007-12#2)(2008-1#1)(2008-3#2)
optical properties and size##2##4##(2008-2#1)(2008-3#1)
optical properties and the##2##4##(2008-2#1)(2008-3#1)
optical properties and##14##3##(2007-6#1)(2008-2#3)(2008-3#7)(2009-2#2)(2010-9#1)
optical properties are##4##3##(2007-12#2)(2008-3#1)(2011-1#1)
optical properties as well as##2##5##(2009-2#1)(2010-1#1)
optical properties as##3##3##(2008-3#1)(2009-2#1)(2010-1#1)
optical properties at##3##3##(2008-3#2)(2011-1#1)
optical properties by##3##3##(2008-2#2)(2008-3#1)
optical properties for the##2##4##(2008-2#1)(2008-3#1)
optical properties for##4##3##(2008-2#2)(2008-3#1)(2011-1#1)
optical properties from integrating sphere measurements##2##6##(2008-3#2)
optical properties from##9##3##(2008-2#3)(2008-3#5)(2011-1#1)
optical properties have been##2##4##(2008-3#1)(2010-2#1)
optical properties in the##5##4##(2007-11#2)(2008-2#2)(2008-3#1)
optical properties in turbid media##3##5##(2008-3#3)
optical properties in##11##3##(2007-11#2)(2008-2#5)(2008-3#4)
optical properties is##5##3##(2008-2#4)(2011-1#1)
optical properties obtained##2##3##(2008-2#2)
optical properties of a##7##4##(2007-11#1)(2008-2#3)(2008-3#3)
optical properties of carbon nanotubes##2##5##(2007-9#1)(2008-10#1)
optical properties of clouds and aerosols##2##6##(2008-3#2)
optical properties of seawater##3##4##(2008-2#2)(2008-3#1)
optical properties of the water##2##5##(2008-2#1)(2008-3#1)
optical properties of the##32##4##(2006-11#1)(2006-2#1)(2006-7#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#8)(2008-3#14)(2009-2#1)(2010-4#1)
optical properties of thermally##2##4##(2007-12#1)(2008-2#1)
optical properties of tissues##2##4##(2008-2#1)(2008-3#1)
optical properties of two-layer##3##4##(2008-3#3)
optical properties of##131##3##(1991-12#1)(1997-6#1)(2005-11#1)(2006-11#1)(2006-2#1)(2006-7#1)(2007-11#14)(2007-12#8)(2007-9#2)(2008-10#3)(2008-2#39)(2008-3#51)(2008-7#2)(2009-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2013-8#2)
optical properties on##3##3##(2008-2#2)(2008-3#1)
optical properties that##3##3##(2007-12#1)(2008-3#1)(2008-7#1)
optical properties to##2##3##(2008-2#2)
optical properties typical of##2##4##(2008-3#2)
optical properties using##2##3##(1997-6#1)(2008-2#1)
optical properties were calculated##2##4##(2008-2#1)(2008-3#1)
optical properties were##4##3##(2008-2#3)(2008-3#1)
optical properties##286##2##(1991-11#1)(1991-12#1)(1997-6#2)(2005-11#1)(2006-11#1)(2006-2#1)(2006-7#1)(2007-11#19)(2007-12#17)(2007-6#1)(2007-9#2)(2008-10#6)(2008-2#96)(2008-3#105)(2008-7#6)(2009-11#2)(2009-2#4)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#2)(2010-9#1)(2011-1#9)(2013-8#2)
optical property of##2##3##(2007-11#1)(2008-3#1)
optical property##14##2##(2007-11#2)(2007-12#2)(2008-2#3)(2008-3#7)
optical pulse compression##2##3##(2008-1#2)
optical pulse in##3##3##(2007-11#1)(2007-12#2)
optical pulse is##4##3##(2007-11#2)(2007-12#2)
optical pulse propagation##3##3##(2007-12#3)
optical pulse sequences##2##3##(2007-11#1)(2007-12#1)
optical pulse train at##2##4##(2007-12#2)
optical pulse train generated##2##4##(2007-12#2)
optical pulse train in##2##4##(2007-11#1)(2007-12#1)
optical pulse train##9##3##(2007-11#1)(2007-12#8)
optical pulse trains by##2##4##(2007-12#1)(2008-1#1)
optical pulse trains##3##3##(2007-12#2)(2008-1#1)
optical pulse##50##2##(2007-11#9)(2007-12#30)(2008-1#5)(2008-2#2)(2008-3#3)(2012-2#1)
optical pulses and##7##3##(2007-11#4)(2007-12#2)(2008-3#1)
optical pulses at a##3##4##(2007-12#2)(2008-1#1)
optical pulses at##4##3##(2007-12#3)(2008-1#1)
optical pulses by##4##3##(2007-12#4)
optical pulses in a##4##4##(2007-11#2)(2007-12#2)
optical pulses in##10##3##(2007-11#4)(2007-12#6)
optical pulses that are##2##4##(2007-11#1)(2007-12#1)
optical pulses that##3##3##(2007-11#1)(2007-12#2)
optical pulses with##3##3##(2007-12#3)
optical pulses##57##2##(2007-11#15)(2007-12#32)(2008-1#2)(2008-2#6)(2008-3#2)
optical pump##2##2##(2007-12#1)(2012-2#1)
optical pumping in##3##3##(2007-12#3)
optical pumping##12##2##(2006-1#1)(2007-12#9)(2008-3#2)
optical purity##7##2##(1990-8#1)(1997-2#1)(2007-10#1)(2008-6#2)(2011-1#1)(2013-1#1)
optical qualities##2##2##(2008-3#1)(2011-1#1)
optical quality and##2##3##(2005-8#1)(2007-12#1)
optical quality of the##3##4##(2008-3#3)
optical quality of##5##3##(2008-3#5)
optical quality##16##2##(2005-8#1)(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#10)
optical radiation##7##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)
optical range##3##2##(1992-2#1)(2007-12#1)(2008-2#1)
optical ranging##4##2##(2008-1#3)(2008-2#1)
optical ray tracing##2##3##(2008-2#2)
optical read head##2##3##(2008-2#2)
optical readout##4##2##(2008-3#4)
optical receiver##3##2##(2008-2#2)(2008-3#1)
optical receivers##4##2##(2007-12#1)(2008-3#3)
optical recognition of##2##3##(2008-3#2)
optical recognition##3##2##(2007-12#1)(2008-3#2)
optical reconstruction##3##2##(2008-3#1)(2011-1#2)
optical recording and##2##3##(1996-12#1)(2008-3#1)
optical recording media##3##3##(2008-2#1)(2008-3#2)
optical recording with##3##3##(1996-12#1)(2008-2#1)(2008-3#1)
optical recording##18##2##(1996-12#2)(1996-5#1)(2007-11#2)(2007-12#1)(2008-2#4)(2008-3#7)(2008-4#1)
optical rectification and the electro-optic effect##2##6##(2007-12#2)
optical rectification and the##3##4##(2007-12#3)
optical rectification and##4##3##(2007-11#1)(2007-12#3)
optical rectification##14##2##(2007-11#6)(2007-12#8)
optical reflectance##2##2##(2007-12#1)(2008-10#1)
optical regeneration##3##2##(2007-12#3)
optical relay##2##2##(2008-2#1)(2008-3#1)
optical remote-sensing##2##2##(2008-2#1)(2008-3#1)
optical resolution of the##2##4##(1997-2#1)(2009-12#1)
optical resolution of##5##3##(1997-2#1)(2005-11#1)(2007-12#2)(2009-12#1)
optical resolution##9##2##(1997-2#1)(2005-11#1)(2007-12#3)(2008-3#1)(2008-9#1)(2009-12#1)(2012-2#1)
optical resonance##2##2##(2008-2#1)(2008-7#1)
optical resonator based on##2##4##(2007-11#1)(2008-3#1)
optical resonator##12##2##(2007-11#2)(2007-12#4)(2008-3#6)
optical resonators##5##2##(2007-11#2)(2007-12#1)(2008-3#2)
optical response functions##2##3##(2007-12#2)
optical response of##8##3##(1995-2#1)(1995-6#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#1)
optical response that##2##3##(2007-11#1)(2011-1#1)
optical response##19##2##(1990-8#2)(1995-2#1)(1995-6#1)(2007-11#3)(2007-12#5)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2011-1#2)
optical responses##2##2##(2008-10#2)
optical ring can##2##3##(2008-3#2)
optical ring##9##2##(2007-11#1)(2007-12#1)(2008-3#7)
optical rotation##6##2##(1990-3#1)(2006-12#2)(2008-2#1)(2008-3#1)(2009-5#1)
optical samples and##2##3##(2008-3#2)
optical sampling##4##2##(2007-11#2)(2008-2#1)(2008-3#1)
optical scanners##3##2##(2008-3#3)
optical scanning holography##5##3##(2007-12#2)(2008-1#1)(2008-3#2)
optical scanning microscopy##3##3##(2008-2#1)(2008-3#2)
optical scanning##10##2##(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#5)
optical scatter##2##2##(2007-12#1)(2008-3#1)
optical scattering##13##2##(2007-12#4)(2008-2#3)(2008-3#2)(2008-7#1)(2011-1#3)
optical scatterometry##3##2##(2008-3#3)
optical scheme##4##2##(2008-1#1)(2008-2#1)(2008-3#2)
optical scintillation##3##2##(2008-3#3)
optical second-harmonic generation##3##3##(2007-12#3)
optical sectioning##8##2##(2007-11#1)(2007-12#2)(2008-1#2)(2008-3#2)(2009-4#1)
optical sections##3##2##(2008-2#2)(2008-9#1)
optical security##2##2##(2008-3#2)
optical sensing##11##2##(2007-8#2)(2008-10#5)(2008-3#1)(2008-5#2)(2008-7#1)
optical sensor based on##3##4##(2007-11#1)(2007-8#1)(2008-3#1)
optical sensor for##7##3##(1996-5#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#1)
optical sensor system for##2##4##(2008-3#2)
optical sensor system##3##3##(2008-2#1)(2008-3#2)
optical sensor##30##2##(1992-4#1)(1996-5#1)(2007-11#3)(2007-12#2)(2007-8#3)(2008-10#10)(2008-2#2)(2008-3#6)(2010-5#2)
optical sensors for##3##3##(2008-10#3)
optical sensors##12##2##(2007-12#2)(2008-10#5)(2008-2#1)(2008-3#4)
optical setup is##6##3##(2007-12#1)(2008-2#2)(2008-3#3)
optical setup##23##2##(2007-11#3)(2007-12#1)(2008-2#7)(2008-3#11)(2011-1#1)
optical setups##2##2##(2007-12#1)(2008-3#1)
optical signal at the##2##4##(2006-12#1)(2007-12#1)
optical signal is##2##3##(2007-12#1)(2008-3#1)
optical signal transmission system##2##4##(2007-11#2)
optical signal transmission##3##3##(2007-11#2)(2007-12#1)
optical signal##36##2##(1997-8#1)(2006-12#2)(2007-11#5)(2007-12#6)(2008-1#1)(2008-10#1)(2008-2#9)(2008-3#7)(2008-9#2)(2011-1#1)(2013-7#1)
optical signal-to-noise ratio##2##3##(2007-12#2)
optical signal-to-noise##3##2##(2007-12#2)(2008-2#1)
optical signals are##4##3##(2008-2#2)(2008-3#2)
optical signals by##2##3##(2006-4#1)(2007-12#1)
optical signals in##2##3##(2008-12#1)(2008-3#1)
optical signals to##2##3##(2008-3#2)
optical signals with optical signals##2##5##(2006-4#2)
optical signals##31##2##(1996-12#2)(2006-4#7)(2007-11#2)(2007-12#5)(2008-12#1)(2008-2#3)(2008-3#10)(2012-2#1)
optical slope efficiency##4##3##(2007-12#1)(2008-2#3)
optical soliton##3##2##(1992-11#1)(2007-12#2)
optical solitons in##6##3##(2007-11#1)(2007-12#3)(2008-2#2)
optical solitons##15##2##(2007-11#3)(2007-12#10)(2008-2#2)
optical source and##2##3##(2007-12#1)(2008-2#1)
optical source##11##2##(2007-11#1)(2007-12#5)(2008-2#3)(2008-3#1)(2012-11#1)
optical sources in##2##3##(2007-9#1)(2008-3#1)
optical sources##8##2##(2007-9#1)(2008-2#4)(2008-3#3)
optical space##3##2##(2008-2#3)
optical spatial solitons##4##3##(2007-12#3)(2008-3#1)
optical spatial##7##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#2)
optical specifications##2##2##(2008-2#1)(2008-3#1)
optical speckle##2##2##(2008-2#1)(2008-3#1)
optical spectra of##3##3##(2005-11#1)(2007-11#1)(2009-9#1)
optical spectra##6##2##(1991-4#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-12#1)(2009-9#1)
optical spectral##3##2##(1990-7#1)(2007-12#1)(2008-2#1)
optical spectroscopic##2##2##(1992-9#1)(1993-3#1)
optical spectroscopy and##3##3##(1997-7#1)(2006-7#1)(2007-11#1)
optical spectroscopy techniques##2##3##(2008-10#1)(2010-12#1)
optical spectroscopy##13##2##(1992-9#1)(1997-5#1)(1997-7#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-9#1)(2009-9#2)(2010-12#2)(2011-1#1)(2012-1#1)
optical spectrum analysis##2##3##(2007-11#1)(2008-3#1)
optical spectrum analyzer##2##3##(2007-11#1)(2008-3#1)
optical spectrum of##2##3##(2007-11#1)(2008-1#1)
optical spectrum##19##2##(1990-3#1)(1990-5#1)(1990-7#1)(2005-4#1)(2007-11#4)(2007-12#2)(2008-1#1)(2008-3#4)(2011-2#1)(2013-8#3)
optical storage with##4##3##(2008-3#4)
optical storage##19##2##(1994-3#2)(2007-12#3)(2008-2#1)(2008-3#13)
optical streak camera##2##3##(2007-12#2)
optical structures##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
optical study of##2##3##(2007-12#1)(2008-1#1)
optical study##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
optical substrate##2##2##(2008-10#1)(2008-3#1)
optical superlattice##7##2##(2007-11#4)(2007-12#3)
optical surface plasmon resonance##2##4##(2008-10#1)(2008-3#1)
optical surface##5##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
optical surfaces for the##2##4##(2008-3#2)
optical surfaces is presented##2##4##(2008-2#1)(2008-3#1)
optical surfaces##18##2##(2007-12#2)(2008-2#5)(2008-3#10)(2011-2#1)
optical susceptibility in##2##3##(2007-11#1)(2007-12#1)
optical susceptibility##5##2##(2007-11#2)(2007-12#3)
optical switch for##2##3##(2008-2#1)(2008-3#1)
optical switch##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
optical switches##2##2##(2007-12#2)
optical switching##9##2##(1995-6#1)(2007-12#2)(2008-2#2)(2008-3#4)
optical symmetry##2##2##(2008-2#1)(2008-3#1)
optical system and##6##3##(2008-2#3)(2008-3#3)
optical system are##2##3##(2007-12#1)(2008-2#1)
optical system based on##2##4##(2008-2#1)(2008-3#1)
optical system consisting of##2##4##(2008-3#2)
optical system design##3##3##(2008-2#1)(2008-3#2)
optical system for##14##3##(2006-6#2)(2007-12#3)(2008-1#1)(2008-2#5)(2008-3#2)(2009-2#1)
optical system is##6##3##(2008-2#2)(2008-3#4)
optical system that##8##3##(2007-12#1)(2008-3#7)
optical system to##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
optical system was##2##3##(2008-2#1)(2008-3#1)
optical system with a##4##4##(2008-2#2)(2008-3#2)
optical system with##10##3##(2007-12#3)(2008-2#2)(2008-3#5)
optical system##126##2##(2006-5#1)(2006-6#2)(2007-11#2)(2007-12#15)(2008-1#1)(2008-10#1)(2008-2#35)(2008-3#67)(2008-4#1)(2009-2#1)
optical systems and##4##3##(2008-3#4)
optical systems are##3##3##(2008-2#1)(2008-3#2)
optical systems at##2##3##(2008-2#2)
optical systems based on##2##4##(2008-2#1)(2008-3#1)
optical systems for##4##3##(2008-2#2)(2008-3#2)
optical systems is##4##3##(2007-12#1)(2008-3#2)(2013-8#1)
optical systems that##3##3##(2008-2#2)(2008-3#1)
optical systems where##2##3##(2008-2#1)(2008-3#1)
optical systems with##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
optical systems##68##2##(2007-12#5)(2008-2#22)(2008-3#40)(2013-8#1)
optical technique for measuring##2##4##(2008-2#1)(2008-3#1)
optical technique for##7##3##(2007-12#2)(2008-2#1)(2008-3#3)(2009-5#1)
optical technique that has##2##4##(2008-2#1)(2008-4#1)
optical technique that##3##3##(2008-2#2)(2008-4#1)
optical technique to##2##3##(2007-11#1)(2008-3#1)
optical technique##15##2##(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#5)(2008-4#1)(2009-5#1)(2011-1#1)
optical techniques and##2##3##(2007-11#1)(2008-3#1)
optical techniques to##2##3##(2008-3#1)(2008-4#1)
optical techniques##12##2##(1997-6#1)(2007-11#2)(2007-12#2)(2008-3#4)(2008-4#1)(2009-9#1)(2011-1#1)
optical technologies##3##2##(2007-8#1)(2008-3#1)(2011-9#1)
optical technology##2##2##(2007-12#1)(2008-3#1)
optical testing##2##2##(2007-12#1)(2008-3#1)
optical tests##2##2##(2008-2#1)(2008-3#1)
optical thickness at##2##3##(2008-2#1)(2008-3#1)
optical thickness for##2##3##(2008-2#1)(2008-3#1)
optical thickness of the##5##4##(2007-11#1)(2008-3#4)
optical thickness##33##2##(2007-11#2)(2008-2#17)(2008-3#14)
optical thicknesses##13##2##(2008-2#9)(2008-3#4)
optical thin films##3##3##(2008-2#2)(2008-3#1)
optical thin-film coatings is##2##4##(2008-2#1)(2008-3#1)
optical thin-film##3##2##(2008-2#1)(2008-3#2)
optical throughput##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
optical time domain-reflectometry##2##3##(2007-12#2)
optical time##4##2##(2007-12#4)
optical time-division multiplexed##4##3##(2007-11#3)(2008-3#1)
optical time-division##6##2##(2007-11#5)(2008-3#1)
optical time-domain reflectometry##5##3##(2007-12#1)(2008-2#3)(2008-3#1)
optical time-domain##7##2##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#1)
optical tomographic imaging##2##3##(2008-2#1)(2008-3#1)
optical tomographic##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
optical tomography and##2##3##(2008-2#1)(2011-1#1)
optical tomography in biological tissue##3##5##(2007-12#1)(2008-3#2)
optical tomography is##3##3##(2007-11#1)(2007-12#2)
optical tomography of##2##3##(2007-12#1)(2008-2#1)
optical tomography using##2##3##(2008-3#1)(2011-1#1)
optical tomography##58##2##(1997-6#4)(2006-2#1)(2007-11#5)(2007-12#14)(2008-1#1)(2008-2#6)(2008-3#13)(2011-1#12)(2012-12#1)(2013-1#1)
optical transducer##2##2##(2008-10#1)(2008-2#1)
optical transduction##2##2##(2007-8#1)(2008-3#1)
optical transfection system##3##3##(2011-1#3)
optical transfection##9##2##(2009-5#3)(2011-1#6)
optical transfer function of##2##4##(2007-12#1)(2008-2#1)
optical transfer function##10##3##(2007-11#1)(2007-12#1)(2008-2#7)(2008-3#1)
optical transfer##12##2##(2007-11#1)(2007-12#3)(2008-2#7)(2008-3#1)
optical transition##4##2##(2007-12#3)(2008-3#1)
optical transitions##2##2##(1990-8#1)(2008-2#1)
optical transmission efficiency##2##3##(2008-2#1)(2008-3#1)
optical transmission in##2##3##(1997-6#2)
optical transmission spectra##3##3##(2007-11#1)(2008-3#2)
optical transmission system##3##3##(2007-12#1)(2008-1#1)(2008-2#1)
optical transmission systems##4##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)
optical transmission through##2##3##(2007-12#2)
optical transmission##31##2##(1997-6#2)(2005-11#1)(2007-11#5)(2007-12#4)(2008-1#2)(2008-2#6)(2008-3#9)(2008-7#2)
optical transmissions##2##2##(2007-11#1)(2008-2#1)
optical transmittance##2##2##(2008-2#2)
optical transmitter##2##2##(2007-12#1)(2008-3#1)
optical transparency and##3##3##(2008-7#1)(2010-4#2)
optical transparency##7##2##(2008-7#2)(2010-2#1)(2010-4#4)
optical trap##11##2##(1997-4#1)(2005-11#3)(2007-11#1)(2008-2#2)(2008-3#3)(2012-2#1)
optical trapping and##3##3##(2007-11#2)(2008-10#1)
optical trapping of##4##3##(2007-12#4)
optical trapping##16##2##(2006-10#1)(2006-9#1)(2007-11#2)(2007-12#5)(2008-10#2)(2008-3#3)(2008-7#1)(2009-5#1)
optical traps##2##2##(2006-9#1)(2008-2#1)
optical triangular profilometry##2##3##(2008-3#2)
optical tunnel##2##2##(2008-3#2)
optical tunneling##5##2##(2007-12#3)(2008-3#2)
optical turbulence##3##2##(2008-2#1)(2008-3#2)
optical tweezers by##2##3##(2007-11#1)(2009-12#1)
optical tweezers to##2##3##(2007-11#1)(2012-2#1)
optical tweezers##22##2##(1991-11#1)(1994-6#1)(2006-9#4)(2007-11#10)(2007-12#1)(2008-10#1)(2008-3#2)(2009-12#1)(2012-2#1)
optical two-dimensional##4##2##(2008-2#4)
optical vector-matrix multiplier##2##3##(2008-2#1)(2008-3#1)
optical velocimetry##2##2##(2008-2#1)(2011-2#1)
optical video##3##2##(2005-11#1)(2008-10#1)(2008-2#1)
optical vortex##7##2##(2007-11#3)(2007-12#2)(2009-5#2)
optical vortices##7##2##(2007-11#2)(2007-12#3)(2008-2#2)
optical wave##5##2##(2007-11#2)(2007-12#1)(2008-2#2)
optical wave-front##4##2##(2008-1#1)(2008-2#1)(2008-3#2)
optical waveforms##4##2##(2007-12#4)
optical waveguide lightmode spectroscopy##2##4##(2007-8#2)
optical waveguide spectroscopy##4##3##(2007-11#1)(2008-10#3)
optical waveguide was##2##3##(2007-12#1)(2008-10#1)
optical waveguide##56##2##(2007-11#10)(2007-12#15)(2007-8#3)(2008-10#14)(2008-2#4)(2008-3#9)(2010-8#1)
optical waveguides and##2##3##(2007-11#1)(2008-2#1)
optical waveguides can be##2##4##(2007-12#1)(2008-3#1)
optical waveguides for##2##3##(2008-10#1)(2009-2#1)
optical waveguides have been##2##4##(2008-2#2)
optical waveguides in##2##3##(2007-12#1)(2008-3#1)
optical waveguides is##3##3##(2008-2#1)(2008-3#2)
optical waveguides were fabricated from fluorinated polyimides##2##7##(2008-2#2)
optical waveguides##40##2##(2006-2#1)(2007-11#5)(2007-12#9)(2008-10#2)(2008-2#15)(2008-3#6)(2009-2#1)(2010-8#1)
optical waveguiding##4##2##(2007-11#2)(2008-2#1)(2008-7#1)
optical wavelength interchange with a##2##5##(2007-12#2)
optical wavelength interchange##4##3##(2007-12#4)
optical wavelength##10##2##(2007-11#2)(2007-12#5)(2008-2#1)(2008-3#2)
optical wavelengths##2##2##(2007-12#1)(2008-3#1)
optical wavelet##2##2##(2008-2#1)(2008-3#1)
optical waves##6##2##(2007-12#2)(2008-3#4)
optical wedge##2##2##(2008-3#2)
optical workshop##2##2##(2008-3#2)
optical workstation##2##2##(2008-7#2)
optical##6120##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#3)(1990-8#10)(1991-1#1)(1991-11#4)(1991-12#2)(1991-2#1)(1991-4#3)(1991-7#4)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#12)(1993-11#2)(1993-3#2)(1993-5#1)(1993-8#2)(1994-11#5)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#3)(1994-8#1)(1994-9#1)(1995-10#2)(1995-12#2)(1995-2#4)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-12#5)(1996-2#1)(1996-4#1)(1996-5#4)(1997-2#7)(1997-3#2)(1997-4#5)(1997-5#7)(1997-6#22)(1997-7#3)(1997-8#2)(2004-9#1)(2005-11#16)(2005-4#8)(2005-5#1)(2005-8#4)(2006-1#1)(2006-10#5)(2006-11#4)(2006-12#17)(2006-2#11)(2006-4#15)(2006-5#6)(2006-6#6)(2006-7#2)(2006-9#8)(2007-10#1)(2007-11#584)(2007-12#1368)(2007-3#4)(2007-4#2)(2007-5#1)(2007-6#4)(2007-8#29)(2007-9#7)(2008-1#140)(2008-10#217)(2008-11#6)(2008-12#8)(2008-2#1294)(2008-3#1708)(2008-4#9)(2008-5#23)(2008-6#8)(2008-7#36)(2008-9#18)(2009-10#1)(2009-11#4)(2009-12#3)(2009-2#15)(2009-3#1)(2009-4#7)(2009-5#28)(2009-6#1)(2009-7#11)(2009-8#4)(2009-9#6)(2010-1#3)(2010-11#1)(2010-12#8)(2010-2#5)(2010-3#2)(2010-4#22)(2010-5#11)(2010-6#2)(2010-7#4)(2010-8#12)(2010-9#2)(2011-1#94)(2011-12#3)(2011-2#14)(2011-7#14)(2011-9#1)(2012-1#5)(2012-11#3)(2012-12#11)(2012-2#27)(2012-3#2)(2013-1#37)(2013-7#4)(2013-8#24)
optical)##3##1##(2007-12#1)(2008-3#1)(2013-7#1)
optical-CT gel dosimetry##2##3##(2007-1#2)
optical-CT##5##1##(2007-1#5)
optical-beam-induced current##2##2##(2007-12#2)
optical-correlation##2##1##(2008-3#2)
optical-digital systems##2##2##(2008-2#1)(2008-3#1)
optical-digital##10##1##(2008-2#3)(2008-3#7)
optical-fiber displacement sensor##3##3##(2008-2#2)(2008-3#1)
optical-fiber nanoprobes##2##2##(2008-2#2)
optical-fiber probe##3##2##(2007-12#2)(2008-2#1)
optical-fiber probes##3##2##(2008-2#3)
optical-fiber##27##1##(2007-12#3)(2008-2#10)(2008-3#14)
optical-frequency##4##1##(2007-12#4)
optical-limiting##2##1##(2008-2#1)(2008-3#1)
optical-optical conversion efficiency of##3##4##(2007-11#2)(2008-2#1)
optical-optical double resonance##3##3##(2005-4#3)
optical-optical##7##1##(2005-4#3)(2007-11#2)(2007-12#1)(2008-2#1)
optical-pulse trains by phase locking of three##2##7##(2007-11#1)(2007-12#1)
optical-pulse trains##4##2##(2007-11#2)(2007-12#2)
optical-sectioning##3##1##(2007-12#2)(2008-2#1)
optical-thickness##2##1##(2008-2#1)(2008-3#1)
optical-to-optical conversion efficiency of##4##4##(2007-11#2)(2007-12#2)
optical-to-optical conversion efficiency##8##3##(2007-11#2)(2007-12#3)(2008-2#3)
optical-to-optical efficiency of##5##3##(2007-12#3)(2008-2#2)
optical-to-optical efficiency was##2##3##(2007-12#1)(2008-3#1)
optical-to-optical efficiency##8##2##(2007-12#5)(2008-2#2)(2008-3#1)
optical-to-optical##18##1##(2007-11#2)(2007-12#8)(2008-2#7)(2008-3#1)
optically absorbing##2##2##(2008-3#2)
optically active 3-methyl macrolides##2##4##(2006-12#2)
optically active viologens##2##3##(1997-7#2)
optically active##32##2##(1990-4#2)(1995-3#1)(1996-2#2)(1996-5#4)(1997-7#2)(2006-12#2)(2007-12#4)(2008-10#2)(2008-2#5)(2008-3#2)(2008-5#2)(2008-7#3)(2009-10#1)
optically addressed liquid-crystal spatial light modulator##3##6##(2007-12#2)(2008-3#1)
optically addressed liquid-crystal##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
optically addressed spatial light modulator##3##5##(2008-2#1)(2008-3#2)
optically addressed spatial light##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
optically addressed##17##2##(2007-11#2)(2007-12#9)(2008-2#1)(2008-3#5)
optically amplified time-division-multiplexed polarization-insensitive fiber-optic##2##5##(2008-2#2)
optically amplified time-division-multiplexed##3##3##(2008-2#3)
optically amplified##5##2##(2007-12#2)(2008-2#3)
optically and then##2##3##(2007-11#1)(2008-1#1)
optically and##4##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)
optically anisotropic##2##2##(2007-8#1)(2008-2#1)
optically as a##2##3##(1991-7#1)(2008-2#1)
optically by use of##2##4##(2008-2#1)(2008-3#1)
optically by##6##2##(1996-5#1)(2007-12#1)(2008-2#2)(2008-3#2)
optically controlled##3##2##(2007-12#2)(2008-3#1)
optically coupled##2##2##(2007-12#1)(2008-2#1)
optically dense sprays##2##3##(2008-3#2)
optically dense##6##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
optically diffuse##3##2##(2008-3#3)
optically encoded##2##2##(2008-2#1)(2008-9#1)
optically evaluated##2##2##(2007-12#1)(2008-3#1)
optically excited##2##2##(2007-12#2)
optically flat##3##2##(2007-12#1)(2008-2#1)(2008-7#1)
optically generated##2##2##(2005-11#1)(2007-12#1)
optically in##5##2##(1990-4#1)(2007-12#1)(2008-2#2)(2008-3#1)
optically induced electrokinetic##2##3##(2010-7#2)
optically induced thermal##2##3##(2007-12#1)(2008-3#1)
optically induced##9##2##(2006-12#1)(2007-11#1)(2007-12#3)(2008-3#2)(2010-7#2)
optically modulated##2##2##(2008-2#1)(2008-3#1)
optically poled##2##2##(2007-11#1)(2008-1#1)
optically preamplified##2##2##(2007-12#2)
optically pumped lasing in single conjugated polymer nanowires##2##8##(2008-7#2)
optically pumped##12##2##(1993-6#1)(1994-2#1)(2007-12#6)(2008-3#2)(2008-7#2)
optically pure amino##2##3##(1992-11#1)(1995-3#1)
optically pure##18##2##(1990-9#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-3#1)(1994-3#1)(1995-3#3)(1996-9#1)(1997-2#1)(2005-8#1)(2008-5#3)(2008-6#3)
optically reconstructed##3##2##(2008-2#1)(2008-3#2)
optically rectified##2##2##(2007-11#1)(2008-3#1)
optically resolved##2##2##(1994-9#1)(2008-3#1)
optically sectioned##2##2##(2007-12#1)(2008-1#1)
optically sensitive##3##2##(2007-12#2)(2008-3#1)
optically thick media##2##3##(2008-10#1)(2008-2#1)
optically thick scattering##3##3##(2008-3#3)
optically thick##21##2##(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#7)(2008-3#9)
optically thin##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
optically transparent##8##2##(2007-11#2)(2007-12#1)(2008-11#2)(2008-7#1)(2010-1#1)(2012-2#1)
optically trapped##8##2##(2007-11#3)(2008-1#1)(2008-3#3)(2012-2#1)
optically turbid##2##2##(1997-6#1)(2008-3#1)
optically with##2##2##(2008-10#1)(2008-2#1)
optically##281##1##(1990-4#3)(1990-8#1)(1990-9#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-3#4)(1996-2#2)(1996-5#5)(1996-9#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#2)(2005-11#1)(2005-8#1)(2006-12#4)(2006-4#1)(2007-11#19)(2007-12#63)(2007-8#2)(2008-1#6)(2008-10#8)(2008-11#2)(2008-2#43)(2008-3#68)(2008-5#5)(2008-6#3)(2008-7#9)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-1#1)(2010-5#1)(2010-7#2)(2011-1#4)(2012-2#3)
optics and micro-optics##3##3##(2008-3#3)
optics and photonics##2##3##(2007-12#1)(2008-7#1)
optics and the##5##3##(2006-5#1)(2008-2#1)(2008-3#3)
optics and##32##2##(2006-5#2)(2007-12#2)(2008-1#3)(2008-10#1)(2008-2#11)(2008-3#9)(2008-4#1)(2008-7#3)
optics applications##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
optics approach##2##2##(2008-2#1)(2008-3#1)
optics approximation##5##2##(2008-2#3)(2008-3#2)
optics are discussed##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
optics are used to##2##4##(2006-12#1)(2008-3#1)
optics are##11##2##(2006-12#1)(2007-11#1)(2007-12#5)(2008-2#2)(2008-3#2)
optics as well as##2##4##(2008-2#1)(2008-3#1)
optics as##4##2##(2008-2#1)(2008-3#3)
optics at the##2##3##(2007-12#1)(2008-3#1)
optics at##4##2##(2007-12#2)(2008-3#2)
optics be##3##2##(2006-10#1)(2008-2#2)
optics by##4##2##(2007-11#1)(2007-12#1)(2008-2#2)
optics calculation of##2##3##(2008-2#1)(2008-3#1)
optics calculations##2##2##(2007-11#1)(2008-2#1)
optics can##2##2##(2008-2#1)(2008-3#1)
optics for improving##2##3##(2007-11#1)(2008-3#1)
optics for the##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
optics for##14##2##(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#7)
optics have been##2##3##(2006-4#1)(2008-3#1)
optics in the##7##3##(2007-11#1)(2007-12#2)(2008-3#4)
optics in which##2##3##(2007-11#1)(2008-2#1)
optics in##19##2##(1994-10#1)(2007-11#3)(2007-12#5)(2008-2#2)(2008-3#8)
optics into##2##2##(2007-12#1)(2008-2#1)
optics is presented##2##3##(2008-2#1)(2008-3#1)
optics is##14##2##(2007-11#2)(2007-12#1)(2008-1#2)(2008-2#2)(2008-3#6)(2013-1#1)
optics may##2##2##(1990-8#1)(2008-2#1)
optics module##2##2##(2008-2#1)(2008-3#1)
optics must be##2##3##(2008-2#1)(2008-3#1)
optics of the##4##3##(2008-2#2)(2008-3#2)
optics of##11##2##(2006-5#1)(2007-12#3)(2008-2#2)(2008-3#5)
optics results##2##2##(2007-12#1)(2008-3#1)
optics system##18##2##(2007-11#1)(2007-12#1)(2008-2#14)(2008-3#2)
optics systems##12##2##(2007-12#2)(2008-2#6)(2008-3#4)
optics that##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
optics to##6##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)
optics used##3##2##(2007-12#1)(2008-3#2)
optics when##2##2##(2008-3#2)
optics with a##3##3##(2008-2#2)(2008-3#1)
optics with##10##2##(2007-11#1)(2007-12#1)(2008-2#7)(2008-3#1)
optics##432##1##(1990-8#1)(1991-9#1)(1994-10#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-4#2)(2006-5#5)(2007-11#28)(2007-12#65)(2007-8#3)(2008-1#10)(2008-10#6)(2008-2#138)(2008-3#150)(2008-4#3)(2008-5#1)(2008-7#3)(2008-9#2)(2010-5#1)(2011-1#6)(2012-2#1)(2012-3#1)(2013-1#1)
optics) and##2##2##(2008-2#2)
optics) is##2##2##(2008-3#2)
optics)##6##1##(2008-2#3)(2008-3#3)
optima##16##1##(1991-11#1)(1991-12#2)(1991-5#1)(1996-7#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-8#1)(2010-3#1)(2011-2#2)
optimal SBP##2##2##(2007-12#2)
optimal action##2##2##(2008-10#1)(2008-2#1)
optimal activation##2##2##(1996-2#1)(1996-9#1)
optimal activity at##2##3##(1992-11#1)(2008-10#1)
optimal activity was##2##3##(1992-9#1)(1997-2#1)
optimal activity##10##2##(1990-12#1)(1992-11#1)(1992-9#1)(1994-8#2)(1996-9#1)(1997-2#1)(2006-8#1)(2008-10#1)(2008-5#1)
optimal algorithm for##2##3##(2008-2#1)(2008-5#1)
optimal algorithm##3##2##(2008-2#1)(2008-3#1)(2008-5#1)
optimal amount of##2##3##(2008-2#1)(2008-3#1)
optimal amounts of##2##3##(1991-8#1)(2008-12#1)
optimal analytical conditions##3##3##(2008-10#3)
optimal analytical##4##2##(2008-10#4)
optimal and##5##2##(1996-8#1)(2006-12#1)(2007-11#1)(2008-11#1)(2011-2#1)
optimal anesthetic##2##2##(2012-12#1)(2013-7#1)
optimal anti-inflammatory##2##2##(2007-11#1)(2012-12#1)
optimal approach##6##2##(2006-10#1)(2007-11#1)(2008-8#1)(2009-3#1)(2009-8#1)(2011-2#1)
optimal approximate##2##2##(1996-2#2)
optimal approximation##2##2##(2008-6#2)
optimal at a##2##3##(2008-3#1)(2009-8#1)
optimal at##12##2##(1990-9#1)(1992-8#1)(1994-3#1)(1995-11#1)(2006-2#1)(2008-10#4)(2008-11#1)(2008-3#1)(2009-8#1)
optimal beam##2##2##(2008-2#1)(2008-3#1)
optimal benefit##2##2##(2008-6#2)
optimal binary phase-only filters##2##4##(2008-2#2)
optimal binary##3##2##(2008-2#3)
optimal binding site##2##3##(1996-7#1)(1996-8#1)
optimal binding##3##2##(1993-4#1)(1996-7#1)(1996-8#1)
optimal cardiovascular health##2##3##(2010-3#2)
optimal care and##2##3##(2006-10#1)(2008-1#1)
optimal care can be##2##4##(2008-11#1)(2011-2#1)
optimal care for##2##3##(2011-1#1)(2013-1#1)
optimal care##8##2##(2006-1#1)(2006-10#1)(2008-1#1)(2008-11#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
optimal cell##2##2##(2006-10#1)(2011-2#1)
optimal choice of##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2011-2#1)
optimal choice##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2011-2#1)(2012-3#1)
optimal combinations##2##2##(2008-8#1)(2010-4#1)
optimal composition##2##2##(2010-12#1)(2010-4#1)
optimal concentration of gastrodin##2##4##(2012-3#2)
optimal concentration of##7##3##(1992-8#1)(1994-11#1)(1995-9#1)(2008-4#2)(2012-3#2)
optimal concentration##10##2##(1992-8#1)(1994-11#1)(1995-9#1)(2005-11#1)(2008-4#2)(2008-8#2)(2012-3#2)
optimal concentrations of##7##3##(1990-8#1)(1994-3#1)(2004-12#1)(2008-10#2)(2008-11#2)
optimal concentrations##10##2##(1990-8#1)(1994-3#1)(1994-8#1)(2004-12#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#2)
optimal condition for##2##3##(2006-12#1)(2013-1#1)
optimal condition##3##2##(2006-12#1)(2008-10#1)(2013-1#1)
optimal conditions for a##2##4##(1992-8#1)(2012-1#1)
optimal conditions for the##9##4##(1992-3#1)(2007-11#1)(2008-10#6)(2013-8#1)
optimal conditions for##31##3##(1990-12#1)(1990-9#1)(1991-5#1)(1992-3#1)(1992-8#1)(1994-6#1)(1995-5#1)(1996-3#1)(2007-11#2)(2007-12#1)(2008-10#14)(2008-11#2)(2008-7#2)(2012-1#1)(2013-8#1)
optimal conditions in##3##3##(1995-8#1)(2008-5#1)(2009-7#1)
optimal conditions of##5##3##(2008-10#3)(2008-6#1)(2013-1#1)
optimal conditions was##3##3##(2008-10#2)(2008-6#1)
optimal conditions##109##2##(1990-12#1)(1990-9#1)(1991-5#2)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#1)(1994-6#1)(1995-5#1)(1995-8#1)(1996-3#1)(1997-4#1)(2006-12#2)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#65)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2009-2#1)(2009-7#2)(2010-7#1)(2011-2#1)(2012-1#1)(2013-1#4)(2013-8#2)
optimal control problem##2##3##(2007-8#1)(2013-8#1)
optimal control##11##2##(1996-7#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-6#2)(2009-5#4)(2013-8#1)
optimal correction##2##2##(1993-11#1)(2008-2#1)
optimal culture##2##2##(2008-5#1)(2008-9#1)
optimal cutoff##2##2##(1995-3#1)(2011-1#1)
optimal decision threshold##2##3##(2008-10#2)
optimal decision##5##2##(1991-12#1)(1992-3#1)(2008-10#2)(2012-3#1)
optimal degree##2##2##(1990-12#1)(2010-5#1)
optimal design of a##2##4##(2008-3#2)
optimal design of##7##3##(1995-4#2)(2008-3#2)(2008-5#1)(2013-1#2)
optimal design##11##2##(1994-5#1)(1995-4#4)(2008-3#2)(2008-5#1)(2010-2#1)(2013-1#2)
optimal designs##4##2##(2008-1#1)(2009-9#3)
optimal detection##2##2##(2008-10#1)(2008-2#1)
optimal diagnostic##2##2##(2005-8#1)(2006-8#1)
optimal discriminant analysis##2##3##(1994-5#2)
optimal discriminant##4##2##(1994-5#2)(2009-11#2)
optimal distance##2##2##(1995-2#1)(2008-3#1)
optimal dosage and administration of##2##5##(2013-1#2)
optimal dosage and##3##3##(1992-9#1)(2013-1#2)
optimal dosage in##2##3##(1994-6#1)(2008-8#1)
optimal dosage##10##2##(1992-9#1)(1994-6#1)(2007-11#2)(2008-4#1)(2008-8#1)(2012-12#2)(2013-1#2)
optimal dose##12##2##(1994-6#2)(1997-6#1)(2004-10#1)(2006-10#2)(2007-8#2)(2008-3#1)(2008-7#1)(2008-8#1)(2012-12#1)
optimal doses##3##2##(1997-3#1)(2007-8#1)(2009-3#1)
optimal dosing##2##2##(2008-5#2)
optimal drug##3##2##(1996-2#1)(2010-4#1)(2011-2#1)
optimal duration of##4##3##(2007-11#1)(2008-6#1)(2012-2#2)
optimal duration##5##2##(2007-11#1)(2008-6#1)(2012-2#2)(2013-8#1)
optimal effect##2##2##(2011-1#1)(2011-3#1)
optimal efficacy##4##2##(1995-5#1)(2010-12#1)(2012-12#2)
optimal estimation formalism can be used##2##6##(2008-3#2)
optimal experimental conditions##6##3##(2008-10#6)
optimal experimental##7##2##(2007-8#1)(2008-10#6)
optimal extraction conditions##3##3##(2007-8#1)(2008-10#1)(2011-12#1)
optimal extraction##6##2##(1997-7#1)(2007-8#1)(2008-10#3)(2011-12#1)
optimal feed##2##2##(2008-7#2)
optimal filter##5##2##(2006-10#1)(2007-12#1)(2008-1#1)(2008-2#2)
optimal filters for##2##3##(2008-2#2)
optimal filters is##4##3##(2008-2#2)(2008-6#2)
optimal filters##6##2##(2008-2#4)(2008-6#2)
optimal fluid##2##2##(2006-8#1)(2007-8#1)
optimal focusing##3##2##(2007-12#2)(2008-1#1)
optimal for a##2##3##(1994-2#1)(2007-12#1)
optimal for survival##2##3##(1997-6#1)(2013-8#1)
optimal for the##5##3##(1996-5#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-2#1)
optimal for##37##2##(1990-7#1)(1991-10#1)(1992-12#1)(1992-2#1)(1993-4#1)(1994-11#1)(1994-2#1)(1995-2#1)(1996-12#1)(1996-5#2)(1996-8#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-12#2)(2006-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-2#1)(2009-5#1)(2013-8#1)
optimal foraging theory##2##3##(2008-8#1)(2008-9#1)
optimal foraging##6##2##(2008-8#3)(2008-9#3)
optimal formulations##2##2##(2004-12#2)
optimal frequency##2##2##(1990-11#1)(2007-12#1)
optimal function##2##2##(1993-3#1)(1993-4#1)
optimal growth conditions##3##3##(2007-12#1)(2008-11#1)(2009-10#1)
optimal growth##11##2##(1994-11#1)(1997-1#1)(2005-8#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-9#1)(2009-10#1)(2012-2#1)
optimal harvest time##5##3##(2008-11#4)(2008-7#1)
optimal health##6##2##(1996-3#1)(2006-12#1)(2008-5#1)(2009-7#1)(2010-7#1)(2013-1#1)
optimal in the presence of##2##5##(1990-2#1)(2007-12#1)
optimal in the##4##3##(1990-2#1)(2007-12#2)(2008-2#1)
optimal in##12##2##(1990-2#1)(1991-11#1)(2007-12#2)(2007-9#1)(2008-2#3)(2009-2#1)(2010-6#1)(2011-2#1)(2012-12#1)
optimal induction##2##2##(1994-9#1)(2007-8#1)
optimal information##2##2##(1997-7#1)(2008-1#1)
optimal initial##2##2##(2008-3#2)
optimal injection##2##2##(2008-10#1)(2008-7#1)
optimal integration of##2##3##(1994-11#1)(2012-2#1)
optimal investment in##3##3##(2008-8#2)(2012-3#1)
optimal laboratory##2##2##(1996-2#1)(2007-12#1)
optimal launch points##2##3##(2007-12#2)
optimal level of##8##3##(1991-8#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-8#3)(2013-1#1)
optimal level##10##2##(1991-8#1)(1996-3#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-8#3)(2009-7#1)(2013-1#1)
optimal levels##5##2##(1992-2#1)(2008-10#1)(2008-11#1)(2011-12#1)(2013-8#1)
optimal management for##3##3##(2008-2#1)(2008-5#1)(2012-11#1)
optimal management of the##3##4##(2007-12#1)(2008-3#1)(2011-3#1)
optimal management of##14##3##(1996-6#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-10#1)(2011-3#1)(2012-11#1)
optimal management##26##2##(1996-6#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-10#2)(2010-2#1)(2011-2#2)(2011-3#1)(2012-11#2)(2012-2#1)
optimal measurement##2##2##(2008-10#1)(2008-3#1)
optimal media for##2##3##(2006-5#1)(2008-2#1)
optimal medical therapy and##2##4##(2006-9#1)(2010-6#1)
optimal medical therapy##3##3##(2006-9#1)(2010-6#1)(2011-3#1)
optimal medical treatment##3##3##(2007-8#1)(2008-3#1)(2008-8#1)
optimal medical##7##2##(2006-9#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-8#1)(2010-6#1)(2011-3#1)
optimal medium##6##2##(2005-11#1)(2008-11#1)(2008-7#1)(2011-2#2)(2013-1#1)
optimal membrane##2##2##(2008-10#1)(2008-5#1)
optimal method for##4##3##(2006-4#1)(2007-11#1)(2008-5#1)(2009-5#1)
optimal method of##3##3##(2008-1#1)(2008-11#1)(2013-1#1)
optimal method##9##2##(2006-4#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-5#1)(2011-2#1)(2013-1#1)
optimal methods of##2##3##(2008-4#1)(2010-12#1)
optimal mode##3##2##(1993-11#1)(2008-2#1)(2013-8#1)
optimal monitoring##2##2##(2009-8#1)(2011-2#1)
optimal mutation schedule##2##3##(1995-8#2)
optimal mutation##3##2##(1995-8#3)
optimal neurocontrollers##2##2##(2008-2#2)
optimal number of##3##3##(2007-12#1)(2008-5#1)(2012-3#1)
optimal operation##2##2##(2007-7#1)(2011-1#1)
optimal orientation##4##2##(1995-11#1)(1997-8#1)(2007-8#1)(2008-3#1)
optimal outcome##5##2##(1992-3#1)(2008-1#1)(2008-7#1)(2010-8#1)(2012-2#1)
optimal outcomes in##2##3##(1994-1#1)(2009-2#1)
optimal outcomes##3##2##(1994-1#1)(2008-3#1)(2009-2#1)
optimal oxygen##3##2##(1996-3#2)(2008-6#1)
optimal pH and temperature for##2##5##(1994-11#1)(2008-10#1)
optimal pH and##3##3##(1994-11#1)(1996-7#1)(2008-10#1)
optimal pH of##3##3##(1993-3#1)(2008-10#2)
optimal pH range##2##3##(1995-2#1)(2008-10#1)
optimal pH value##2##3##(1993-3#1)(2011-2#1)
optimal pH was##2##3##(1994-10#1)(2005-11#1)
optimal pH##24##2##(1990-2#2)(1991-5#2)(1991-7#1)(1993-3#2)(1994-10#1)(1994-11#2)(1995-2#1)(1996-7#1)(1997-2#1)(2004-11#1)(2005-11#2)(2006-3#1)(2006-8#1)(2008-10#4)(2009-3#1)(2011-2#1)
optimal pain management in older adults on acute medical units##2##10##(2010-7#2)
optimal pain##3##2##(2009-5#1)(2010-7#2)
optimal patient##3##2##(2008-10#1)(2009-5#1)(2010-12#1)
optimal performance in##2##3##(1994-12#1)(1996-2#1)
optimal performance##9##2##(1994-12#1)(1996-2#1)(2004-9#2)(2007-4#1)(2008-2#1)(2009-10#1)(2013-1#2)
optimal period prevalence##2##3##(2011-1#2)
optimal period##4##2##(2007-10#1)(2009-2#1)(2011-1#2)
optimal phase##3##2##(2008-2#1)(2008-3#2)
optimal physical##2##2##(2007-12#1)(2011-2#1)
optimal physician inquiry starting time##2##5##(2010-8#2)
optimal postoperative##2##2##(2010-11#1)(2013-1#1)
optimal power##2##2##(2008-2#1)(2008-3#1)
optimal production##2##2##(1997-4#1)(2008-5#1)
optimal propagule size is larger##2##5##(2008-8#2)
optimal protection##3##2##(1995-5#1)(2006-12#1)(2008-5#1)
optimal quality##2##2##(2007-4#1)(2012-12#1)
optimal radiological##3##2##(1990-12#1)(1993-5#1)(2008-6#1)
optimal range##4##2##(1992-9#1)(1995-1#1)(2008-11#1)(2008-5#1)
optimal ratio##3##2##(2008-3#1)(2008-5#1)(2012-11#1)
optimal reaction conditions##3##3##(2008-10#2)(2008-8#1)
optimal reaction norms##2##3##(2008-8#2)
optimal reaction##8##2##(2008-10#4)(2008-5#1)(2008-8#3)
optimal recovery##2##2##(2008-12#1)(2008-2#1)
optimal region##4##2##(2008-10#1)(2008-5#2)(2008-6#1)
optimal rehabilitation##2##2##(2008-1#1)(2012-1#1)
optimal response##2##2##(2008-10#1)(2012-4#1)
optimal result##2##2##(2013-1#1)(2013-8#1)
optimal results##5##2##(1992-12#1)(2005-12#1)(2006-12#1)(2008-4#1)(2011-2#1)
optimal role##2##2##(2004-1#1)(2008-5#1)
optimal route##2##2##(2007-11#1)(2012-12#1)
optimal sample##2##2##(2008-5#1)(2010-2#1)
optimal sampling##2##2##(2008-10#1)(2013-7#1)
optimal screening##2##2##(2007-8#1)(2010-10#1)
optimal selection of##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
optimal sensitivity##2##2##(1990-12#1)(2008-10#1)
optimal separation##4##2##(2008-10#3)(2008-4#1)
optimal setting##2##2##(2008-3#1)(2008-7#1)
optimal settings##2##2##(2008-11#1)(2011-2#1)
optimal size of##2##3##(2008-2#2)
optimal size##4##2##(1996-2#1)(2008-2#2)(2008-8#1)
optimal solution for##2##3##(2008-2#2)
optimal solution##13##2##(2007-8#1)(2007-9#1)(2008-2#7)(2008-3#1)(2009-3#1)(2009-7#1)(2012-3#1)
optimal solutions##2##2##(2008-2#1)(2012-1#1)
optimal spatial frequency##2##3##(2008-8#2)
optimal spatial##7##2##(2008-2#1)(2008-3#1)(2008-8#2)(2010-2#1)(2013-8#2)
optimal stability##3##2##(1994-12#1)(2007-12#1)(2008-5#1)
optimal staining##2##2##(1997-2#1)(2011-2#1)
optimal strategies##2##2##(2007-9#1)(2010-7#1)
optimal strategy for##7##3##(1991-11#1)(2005-8#1)(2006-10#2)(2006-9#1)(2008-2#1)(2012-2#1)
optimal strategy##12##2##(1991-11#1)(2005-8#1)(2006-10#2)(2006-9#1)(2008-2#1)(2008-3#1)(2008-7#3)(2012-2#1)(2013-1#1)
optimal subset of anions##2##4##(2011-1#2)
optimal superposition##2##2##(2008-7#2)
optimal surface##3##2##(2008-2#3)
optimal surgery##2##2##(1991-2#1)(2012-12#1)
optimal surgical management##2##3##(1992-10#1)(2006-1#1)
optimal surgical methods##2##3##(2006-6#2)
optimal surgical##13##2##(1992-10#1)(1994-12#1)(2006-1#1)(2006-10#1)(2006-4#1)(2006-6#2)(2007-7#1)(2008-12#1)(2009-2#1)(2010-5#1)(2012-12#1)(2013-1#1)
optimal synthesis of several##2##4##(2007-11#2)
optimal synthesis of##3##3##(2007-11#3)
optimal synthesis##4##2##(1997-4#1)(2007-11#3)
optimal system to##2##3##(2007-12#1)(2011-2#1)
optimal system##5##2##(1990-8#1)(2007-12#1)(2008-2#2)(2011-2#1)
optimal target##4##2##(1992-9#1)(1996-7#1)(2006-5#1)(2010-3#1)
optimal technique##3##2##(2006-6#1)(2007-7#1)(2011-1#1)
optimal temperature##7##2##(1992-2#1)(1997-2#1)(1997-4#1)(2005-11#1)(2008-10#1)(2008-12#1)(2008-6#1)
optimal temperatures##2##2##(2008-10#2)
optimal therapeutic regimen##2##3##(2009-9#1)(2010-10#1)
optimal therapeutic##12##2##(2005-9#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-4#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#1)
optimal therapy for##3##3##(1995-2#1)(2009-8#1)(2011-2#1)
optimal therapy##11##2##(1995-2#1)(2005-12#2)(2007-4#1)(2008-1#1)(2009-5#1)(2009-8#1)(2010-5#1)(2010-9#1)(2011-2#1)(2013-8#1)
optimal time##3##2##(2007-12#1)(2008-11#1)(2011-2#1)
optimal timing##13##2##(1996-4#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-12#1)(2013-1#2)
optimal tissue##2##2##(2006-10#1)(2012-12#1)
optimal to achieve##2##3##(1993-1#1)(2008-7#1)
optimal trade-off##3##2##(2008-2#1)(2008-3#2)
optimal training##3##2##(2006-10#1)(2008-10#1)(2008-5#1)
optimal treatment for##8##3##(1995-6#1)(1997-8#1)(2006-6#1)(2006-9#1)(2007-8#1)(2008-6#1)(2008-7#2)
optimal treatment of patients with##3##5##(2006-10#1)(2006-9#1)(2010-9#1)
optimal treatment of patients##4##4##(2006-10#1)(2006-9#1)(2008-7#1)(2010-9#1)
optimal treatment of##9##3##(1995-5#1)(1996-9#1)(2006-10#1)(2006-9#1)(2008-4#1)(2008-7#1)(2010-5#1)(2010-9#1)(2012-12#1)
optimal treatment options##3##3##(2008-1#1)(2012-12#2)
optimal treatment strategies##2##3##(2009-11#1)(2012-3#1)
optimal treatment strategy##2##3##(2011-2#1)(2013-1#1)
optimal treatment##39##2##(1992-8#1)(1995-5#1)(1995-6#1)(1996-9#1)(1997-1#1)(1997-8#1)(2006-10#1)(2006-6#1)(2006-9#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-1#1)(2009-11#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#3)(2012-12#3)(2012-3#2)(2013-1#2)
optimal use of the##5##4##(1991-2#1)(2005-7#1)(2007-7#1)(2008-10#1)(2008-3#1)
optimal use of##15##3##(1991-2#1)(1996-12#1)(2005-7#1)(2007-11#5)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2011-1#1)
optimal use##16##2##(1991-2#1)(1996-12#1)(2005-7#1)(2007-11#6)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2011-1#1)
optimal utilization of##3##3##(1993-11#1)(1997-2#1)(2007-7#1)
optimal value of##6##3##(1994-9#1)(1996-8#1)(2008-10#2)(2008-2#1)(2008-8#1)
optimal value##11##2##(1991-5#1)(1994-9#1)(1996-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-8#1)
optimal values for the##2##4##(2008-10#1)(2009-10#1)
optimal values for##3##3##(2008-10#1)(2008-7#1)(2009-10#1)
optimal values##8##2##(2008-10#3)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2013-1#1)
optimal vascular##3##2##(2007-10#1)(2007-7#1)(2010-4#1)
optimal water##2##2##(2008-12#1)(2013-1#1)
optimal wavelength##2##2##(2008-2#1)(2008-7#1)
optimal when##4##2##(2006-10#1)(2007-12#1)(2008-5#1)(2012-3#1)
optimal working conditions##3##3##(2007-12#1)(2008-10#2)
optimal working##6##2##(2006-2#1)(2007-12#1)(2008-10#2)(2008-2#1)(2010-10#1)
optimal##1390##1##(1990-11#1)(1990-12#5)(1990-2#3)(1990-7#3)(1990-8#2)(1990-9#5)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#6)(1991-7#1)(1991-8#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#5)(1992-3#4)(1992-6#2)(1992-7#2)(1992-8#5)(1992-9#5)(1993-1#1)(1993-11#3)(1993-3#4)(1993-4#3)(1993-5#1)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#11)(1994-12#5)(1994-2#2)(1994-3#3)(1994-4#1)(1994-5#3)(1994-6#4)(1994-8#4)(1994-9#3)(1995-1#3)(1995-11#4)(1995-12#1)(1995-2#6)(1995-3#3)(1995-4#4)(1995-5#4)(1995-6#1)(1995-7#2)(1995-8#10)(1995-9#3)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#9)(1996-3#6)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#6)(1996-8#6)(1996-9#5)(1997-1#2)(1997-2#7)(1997-3#3)(1997-4#6)(1997-5#1)(1997-6#5)(1997-7#3)(1997-8#3)(2004-1#2)(2004-10#1)(2004-11#1)(2004-12#3)(2004-9#2)(2005-1#1)(2005-10#2)(2005-11#12)(2005-12#3)(2005-3#1)(2005-5#1)(2005-7#1)(2005-8#5)(2005-9#1)(2006-1#2)(2006-10#32)(2006-12#11)(2006-2#4)(2006-3#1)(2006-4#2)(2006-5#5)(2006-6#10)(2006-7#1)(2006-8#5)(2006-9#7)(2007-10#6)(2007-11#32)(2007-12#38)(2007-2#3)(2007-4#4)(2007-5#2)(2007-7#11)(2007-8#33)(2007-9#9)(2008-1#19)(2008-10#163)(2008-11#35)(2008-12#12)(2008-2#87)(2008-3#61)(2008-4#20)(2008-5#47)(2008-6#27)(2008-7#39)(2008-8#47)(2008-9#16)(2009-1#2)(2009-10#7)(2009-11#6)(2009-12#1)(2009-2#8)(2009-3#4)(2009-4#4)(2009-5#12)(2009-7#7)(2009-8#6)(2009-9#6)(2010-1#1)(2010-10#7)(2010-11#2)(2010-12#10)(2010-2#11)(2010-3#4)(2010-4#9)(2010-5#6)(2010-6#2)(2010-7#8)(2010-8#6)(2010-9#2)(2011-1#14)(2011-12#3)(2011-2#38)(2011-3#5)(2011-7#1)(2012-1#7)(2012-11#3)(2012-12#22)(2012-2#20)(2012-3#20)(2012-4#1)(2013-1#46)(2013-7#2)(2013-8#17)
optimal-rotation-angle method##2##2##(2008-2#2)
optimal-rotation-angle##3##1##(2008-2#3)
optimality criteria##2##2##(2006-5#1)(2009-9#1)
optimality model##4##2##(2006-5#2)(2008-8#2)
optimality models##3##2##(2008-8#2)(2008-9#1)
optimality of##2##2##(2008-2#1)(2008-7#1)
optimality##23##1##(1996-2#1)(1996-6#1)(1997-8#1)(2006-5#3)(2007-9#1)(2008-2#4)(2008-7#1)(2008-8#4)(2008-9#3)(2009-9#1)(2010-1#1)(2013-1#2)
optimally at##5##2##(1995-5#1)(2006-8#2)(2008-10#1)(2011-2#1)
optimally designed to##2##3##(2008-3#2)
optimally foraging##3##2##(2008-8#1)(2008-9#2)
optimally in##2##2##(2008-9#1)(2013-8#1)
optimally shaped##2##2##(2007-12#2)
optimally suited##2##2##(1995-5#1)(2012-2#1)
optimally to##2##2##(2008-2#1)(2008-3#1)
optimally treat##2##2##(2005-12#1)(2012-2#1)
optimally##69##1##(1990-12#1)(1991-12#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#3)(1993-12#1)(1994-2#2)(1995-5#2)(1996-5#1)(1997-6#1)(2005-12#1)(2006-1#1)(2006-10#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-12#2)(2007-4#2)(2007-5#1)(2007-8#3)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-2#2)(2011-2#3)(2012-1#1)(2012-2#6)(2013-1#1)(2013-8#1)
optimisation and validation of##3##4##(2008-10#2)(2008-3#1)
optimisation and##8##2##(2008-10#5)(2008-11#1)(2008-3#1)(2010-5#1)
optimisation in the frequency domain##2##5##(2007-1#2)
optimisation is##2##2##(2008-11#1)(2010-11#1)
optimisation of a##2##3##(2008-10#2)
optimisation of an on-line preconcentration##2##5##(2008-10#2)
optimisation of the experimental conditions##2##5##(2008-10#2)
optimisation of the experimental##3##4##(2008-10#3)
optimisation of the variables##2##4##(2008-10#2)
optimisation of the##16##3##(1996-8#1)(2008-10#13)(2008-11#2)
optimisation of##34##2##(1990-2#1)(1996-6#1)(1996-8#1)(2007-11#2)(2007-12#1)(2008-10#22)(2008-11#4)(2010-5#2)
optimisation process##4##2##(2008-10#3)(2010-5#1)
optimisation##73##1##(1990-2#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-6#1)(2007-1#2)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#42)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2010-11#1)(2010-5#4)(2012-2#1)
optimise the##12##2##(1993-2#1)(1996-12#1)(2006-6#1)(2007-11#1)(2008-10#6)(2008-3#1)(2012-11#1)
optimise##29##1##(1990-3#1)(1993-2#1)(1996-12#1)(2006-6#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-10#10)(2008-11#3)(2008-3#2)(2008-7#1)(2010-10#1)(2012-11#2)(2012-12#1)
optimised and applied##2##3##(2008-10#1)(2011-1#1)
optimised and##10##2##(2008-10#9)(2011-1#1)
optimised by a##2##3##(2008-10#2)
optimised by using##2##3##(2008-10#2)
optimised by##13##2##(2008-10#12)(2012-2#1)
optimised conditions the##3##3##(2008-10#3)
optimised conditions were##2##3##(2008-10#2)
optimised conditions##15##2##(2008-10#14)(2008-8#1)
optimised for the##3##3##(2008-10#2)(2012-3#1)
optimised for##12##2##(1990-9#1)(2008-10#9)(2008-8#1)(2012-3#1)
optimised in order to##4##4##(2008-10#4)
optimised in##6##2##(2007-8#1)(2008-10#4)(2013-1#1)
optimised method##3##2##(2007-8#3)
optimised methods##2##2##(1996-12#1)(2008-10#1)
optimised reverse transcriptase-polymerase chain reaction##2##5##(1996-12#2)
optimised the##2##2##(1992-8#1)(2007-11#1)
optimised to##7##2##(2008-10#6)(2008-7#1)
optimised using##5##2##(1996-8#1)(2007-8#1)(2008-10#3)
optimised with##2##2##(2007-8#1)(2008-10#1)
optimised##140##1##(1990-9#1)(1992-8#1)(1994-10#1)(1995-3#1)(1996-12#3)(1996-8#2)(1997-7#1)(2005-7#1)(2006-1#1)(2007-11#1)(2007-8#9)(2008-10#104)(2008-5#1)(2008-7#1)(2008-8#2)(2009-6#3)(2010-5#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
optimising all##2##2##(2008-10#1)(2010-12#1)
optimising the##5##2##(1996-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-5#1)
optimising##13##1##(1991-3#2)(1996-4#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#1)(2009-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
optimism about##2##2##(2006-10#1)(2009-9#1)
optimism and##7##2##(1991-5#1)(2007-3#1)(2008-6#1)(2009-10#1)(2009-3#1)(2010-2#1)(2013-7#1)
optimism bias##4##2##(2010-7#4)
optimism for##2##2##(2006-10#1)(2008-2#1)
optimism in##2##2##(2008-7#1)(2009-3#1)
optimism##34##1##(1990-5#1)(1991-5#1)(1992-12#1)(1992-5#1)(1994-3#1)(1995-12#1)(2004-9#1)(2006-10#3)(2007-12#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-7#4)(2012-2#2)(2013-7#1)
optimism/pessimism##2##1##(2009-3#2)
optimistic about##3##2##(1996-3#1)(1996-4#1)(2007-6#1)
optimistic that##2##2##(1995-1#1)(2007-6#1)
optimistic##25##1##(1990-10#1)(1992-12#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-5#1)(1996-3#1)(1996-4#1)(1997-6#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-6#2)(2007-8#2)(2007-9#1)(2008-12#1)(2008-2#1)(2010-10#3)(2011-2#2)(2013-8#1)
optimization algorithm for##3##3##(2007-12#1)(2008-2#2)
optimization algorithm is##2##3##(2007-11#1)(2008-3#1)
optimization algorithm##18##2##(2007-11#1)(2007-12#3)(2008-2#6)(2008-3#8)
optimization algorithms to the design of diffractive##2##7##(2007-12#2)
optimization algorithms to##3##3##(2007-12#2)(2010-2#1)
optimization algorithms##6##2##(2007-12#2)(2008-10#1)(2008-2#1)(2008-7#1)(2010-2#1)
optimization and characterization##2##3##(2008-10#2)
optimization and validation of##2##4##(2008-10#1)(2010-12#1)
optimization and##25##2##(1991-11#1)(1997-4#1)(2006-5#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#4)(2008-3#1)(2008-8#1)(2009-2#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-12#2)
optimization approach for##2##3##(2007-12#1)(2013-1#1)
optimization approach##6##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-1#1)(2013-1#1)
optimization approaches##3##2##(2004-8#1)(2008-2#1)(2008-3#1)
optimization are##2##2##(2008-12#1)(2008-3#1)
optimization as##3##2##(2008-3#1)(2013-1#2)
optimization based on##2##3##(2008-10#1)(2013-7#1)
optimization by the##2##3##(2008-10#1)(2008-3#1)
optimization by##7##2##(1995-8#1)(2007-5#1)(2008-10#3)(2008-3#1)(2012-3#1)
optimization can##2##2##(2007-12#1)(2008-2#1)
optimization conditions##3##2##(2008-10#1)(2008-2#1)(2008-9#1)
optimization criteria##2##2##(1996-2#1)(2008-2#1)
optimization design of diffractive optical elements##2##6##(2008-3#2)
optimization design of##3##3##(2008-3#3)
optimization design##4##2##(2008-3#4)
optimization for the##3##3##(2006-6#1)(2008-10#1)(2008-6#1)
optimization for##15##2##(2005-8#1)(2006-6#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-6#1)(2011-1#2)(2012-1#1)(2013-7#1)
optimization framework for##3##3##(2008-11#1)(2009-10#1)(2012-1#1)
optimization has been##3##3##(2006-5#1)(2008-10#1)(2008-3#1)
optimization in the##2##3##(2008-11#1)(2008-2#1)
optimization in##5##2##(2006-5#1)(2008-10#1)(2008-11#2)(2008-2#1)
optimization increased##2##2##(2013-1#1)(2013-8#1)
optimization is carried out##2##4##(2008-2#1)(2013-8#1)
optimization is the##2##3##(2008-6#1)(2012-12#1)
optimization is##10##2##(2006-6#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)(2010-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
optimization method##9##2##(2007-12#1)(2008-10#2)(2008-2#3)(2008-7#1)(2012-1#2)
optimization methods##3##2##(1996-8#1)(2008-2#1)(2010-11#1)
optimization models##3##2##(1995-2#1)(2008-2#1)(2008-8#1)
optimization of a novel##2##4##(2008-10#1)(2012-2#1)
optimization of a##28##3##(1991-11#1)(1992-6#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-11#2)(2008-2#3)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#2)(2011-2#2)(2012-2#1)
optimization of an on-line##2##4##(2008-10#2)
optimization of an##6##3##(2008-10#4)(2008-2#2)
optimization of analytical##2##3##(2008-10#2)
optimization of any##2##3##(1995-10#1)(2008-3#1)
optimization of carrier features is necessary to effectively deliver the targeting agents to tumor sites##2##15##(2012-11#2)
optimization of crystallization conditions is##2##5##(2008-4#2)
optimization of crystallization conditions##3##4##(2008-4#3)
optimization of culture##2##3##(2005-11#1)(2008-9#1)
optimization of experimental##3##3##(2008-10#3)
optimization of in##2##3##(2008-2#1)(2009-5#1)
optimization of optical##4##3##(2008-2#2)(2008-3#2)
optimization of oxygen##2##3##(2008-6#1)(2011-2#1)
optimization of preconcentration procedure for##2##5##(2008-10#2)
optimization of protein##2##3##(2007-8#1)(2009-11#1)
optimization of single-mode##2##3##(2008-2#2)
optimization of the cavity design##2##5##(2008-3#2)
optimization of the design of##3##5##(2008-2#1)(2012-11#2)
optimization of the design##4##4##(2007-11#1)(2008-2#1)(2012-11#2)
optimization of the experimental conditions##2##5##(2008-10#2)
optimization of the experimental parameters##2##5##(2008-10#2)
optimization of the experimental##4##4##(2008-10#4)
optimization of the extraction##3##4##(2008-10#3)
optimization of the fermentation process##2##5##(2008-10#1)(2011-2#1)
optimization of the method##4##4##(2008-10#2)(2008-2#1)(2011-1#1)
optimization of the reaction##2##4##(1996-2#1)(2011-1#1)
optimization of the signal-to-noise ratio##2##5##(2007-12#1)(2008-3#1)
optimization of the system##4##4##(2007-8#1)(2008-10#2)(2008-2#1)
optimization of the##84##3##(1996-11#1)(1996-2#1)(1996-8#1)(1997-2#2)(1997-8#1)(2005-11#1)(2006-5#1)(2007-11#3)(2007-12#5)(2007-8#3)(2008-10#26)(2008-11#1)(2008-2#10)(2008-3#9)(2008-4#1)(2008-7#2)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-11#2)(2013-1#2)
optimization of these##7##3##(2007-12#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-7#1)
optimization of this##2##3##(2008-2#1)(2010-7#1)
optimization of various parameters##2##4##(2008-10#1)(2008-2#1)
optimization of##300##2##(1991-11#1)(1991-12#1)(1992-6#1)(1993-11#1)(1993-4#2)(1994-9#1)(1995-10#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-8#1)(2005-11#4)(2005-4#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#1)(2007-11#9)(2007-12#17)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#7)(2008-1#1)(2008-10#76)(2008-11#7)(2008-2#39)(2008-3#25)(2008-4#7)(2008-5#5)(2008-6#2)(2008-7#13)(2008-8#2)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-4#1)(2010-5#2)(2010-7#2)(2011-1#4)(2011-2#6)(2011-3#2)(2012-1#2)(2012-11#4)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#4)
optimization parameter##2##2##(2008-3#1)(2008-7#1)
optimization point##2##2##(2009-2#2)
optimization points for##2##3##(2009-2#2)
optimization points##8##2##(2009-2#8)
optimization problem##15##2##(1992-12#1)(2006-4#1)(2007-9#1)(2008-2#6)(2008-3#1)(2009-3#2)(2012-1#1)(2012-3#1)(2013-1#1)
optimization problems are##2##3##(2008-7#1)(2009-3#1)
optimization problems##11##2##(2007-9#2)(2008-2#5)(2008-3#1)(2008-7#1)(2009-3#1)(2013-7#1)
optimization procedure for##2##3##(2008-10#1)(2008-2#1)
optimization procedure that##2##3##(2007-12#1)(2008-2#1)
optimization procedure##11##2##(2004-12#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)
optimization procedures##2##2##(2008-10#1)(2008-6#1)
optimization process is##2##3##(2007-12#1)(2008-2#1)
optimization process##15##2##(1990-12#1)(2006-4#1)(2007-12#2)(2008-10#8)(2008-2#1)(2010-4#1)(2012-2#1)
optimization results##4##2##(2007-8#1)(2008-2#1)(2008-7#1)(2012-1#1)
optimization routines##2##2##(2008-3#1)(2009-2#1)
optimization scheme##2##2##(2008-3#1)(2011-1#1)
optimization software##3##2##(2008-2#1)(2013-1#2)
optimization strategies##2##2##(1993-4#1)(2011-1#1)
optimization studies##5##2##(2007-12#1)(2008-10#3)(2008-2#1)
optimization study##7##2##(2008-10#4)(2008-2#1)(2010-12#1)(2011-2#1)
optimization technique is##2##3##(2008-3#1)(2010-7#1)
optimization technique##7##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-7#2)
optimization techniques for##3##3##(2008-2#1)(2013-1#2)
optimization techniques to##2##3##(2008-2#1)(2010-7#1)
optimization techniques##11##2##(2004-8#1)(2007-11#1)(2008-11#1)(2008-2#3)(2008-5#1)(2010-7#1)(2011-1#1)(2013-1#2)
optimization to##4##2##(1995-12#1)(2007-9#1)(2008-2#1)(2008-5#1)
optimization using simulated annealing##2##4##(2008-2#1)(2008-3#1)
optimization using##6##2##(2008-2#3)(2008-3#2)(2012-12#1)
optimization was performed##2##3##(2008-10#2)
optimization was##4##2##(1997-3#1)(1997-6#1)(2008-10#2)
optimization with##6##2##(1992-8#1)(2006-6#1)(2007-9#1)(2008-11#1)(2009-4#1)(2012-12#1)
optimization##693##1##(1990-12#1)(1991-11#3)(1991-12#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-4#3)(1993-6#3)(1994-12#1)(1994-9#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#2)(1996-11#1)(1996-2#2)(1996-5#1)(1996-8#3)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#3)(1997-8#1)(2004-12#1)(2004-8#2)(2005-11#4)(2005-4#2)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-4#2)(2006-5#6)(2006-6#4)(2007-1#1)(2007-11#12)(2007-12#35)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#12)(2007-9#7)(2008-1#2)(2008-10#153)(2008-11#18)(2008-12#2)(2008-2#110)(2008-3#58)(2008-4#11)(2008-5#9)(2008-6#6)(2008-7#22)(2008-8#6)(2008-9#7)(2009-1#1)(2009-10#2)(2009-11#2)(2009-2#16)(2009-3#4)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#7)(2011-1#9)(2011-12#2)(2011-2#8)(2011-3#2)(2012-1#11)(2012-11#4)(2012-12#7)(2012-2#10)(2012-3#5)(2013-1#23)(2013-7#5)(2013-8#8)
optimization-based##3##1##(2008-3#1)(2013-1#2)
optimizations in##2##2##(2008-3#1)(2009-2#1)
optimizations were##2##2##(2008-10#1)(2008-2#1)
optimizations##11##1##(1997-2#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-2#2)
optimize a##6##2##(2004-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)
optimize and accelerate##2##3##(2005-9#1)(2008-10#1)
optimize and##3##2##(2005-9#1)(2008-10#1)(2009-1#1)
optimize both the##2##3##(2006-10#1)(2008-2#1)
optimize both##3##2##(2006-10#1)(2008-2#1)(2008-5#1)
optimize functional##2##2##(2008-7#1)(2011-2#1)
optimize lung##2##2##(2008-6#2)
optimize outcomes##2##2##(2007-2#1)(2009-12#1)
optimize parameters##2##2##(1997-4#1)(2008-10#1)
optimize product quantity##2##3##(2008-10#2)
optimize the clinical##2##3##(2007-8#1)(2008-10#1)
optimize the performance of the##2##5##(2008-2#1)(2008-3#1)
optimize the performance of##3##4##(1994-2#1)(2008-2#1)(2008-3#1)
optimize the treatment##2##3##(2008-5#1)(2009-3#1)
optimize the use of##3##4##(2006-10#1)(2007-3#1)(2011-2#1)
optimize the##141##2##(1991-11#1)(1992-2#1)(1992-5#1)(1993-11#1)(1993-5#1)(1994-2#1)(1994-8#1)(1995-1#1)(1996-5#1)(1997-2#3)(1997-4#1)(2004-11#1)(2004-8#1)(2005-10#1)(2005-11#2)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-10#2)(2007-11#3)(2007-12#5)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#34)(2008-11#2)(2008-2#9)(2008-3#12)(2008-4#4)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#4)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#2)(2012-2#1)(2013-1#6)(2013-7#2)
optimize their use of##3##4##(2007-4#1)(2013-1#2)
optimize their##10##2##(1990-7#1)(1992-10#1)(1993-5#1)(2007-4#1)(2008-11#1)(2008-8#1)(2013-1#4)
optimize these##3##2##(2008-1#1)(2008-5#1)(2013-7#1)
optimize this##4##2##(2007-8#1)(2008-5#1)(2012-12#1)(2012-2#1)
optimize treatment##5##2##(2006-10#1)(2007-12#1)(2008-5#2)(2010-5#1)
optimize##327##1##(1990-3#1)(1990-7#1)(1991-11#2)(1992-10#1)(1992-2#1)(1992-5#1)(1993-11#1)(1993-5#2)(1994-2#1)(1994-8#1)(1995-1#2)(1995-2#1)(1995-3#1)(1996-10#1)(1996-5#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-7#1)(1997-8#1)(2004-11#1)(2004-12#1)(2004-8#1)(2005-10#2)(2005-11#3)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#4)(2007-11#4)(2007-12#16)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#2)(2007-8#3)(2008-1#3)(2008-10#53)(2008-11#9)(2008-12#2)(2008-2#20)(2008-3#21)(2008-4#6)(2008-5#17)(2008-6#5)(2008-7#6)(2008-8#2)(2008-9#5)(2009-1#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#4)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#2)(2010-10#3)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#3)(2010-4#2)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#11)(2012-12#4)(2012-2#11)(2012-3#3)(2013-1#18)(2013-7#3)(2013-8#3)
optimized Rowland##2##2##(2008-2#1)(2008-3#1)
optimized a new##2##3##(2008-10#1)(2008-11#1)
optimized a##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
optimized after##4##2##(2006-5#1)(2008-10#1)(2008-3#1)(2013-1#1)
optimized and a##4##3##(2008-10#3)(2008-4#1)
optimized and applied to the determination of##3##7##(2008-10#2)(2009-8#1)
optimized and applied to the##4##5##(1995-3#1)(2008-10#2)(2009-8#1)
optimized and the##13##3##(1990-9#1)(1992-2#1)(1996-6#1)(2008-10#9)(2008-3#1)
optimized and then##2##3##(2008-11#1)(2008-8#1)
optimized and validated##2##3##(1997-8#1)(2008-10#1)
optimized and##45##2##(1990-9#1)(1992-2#1)(1995-3#1)(1996-3#1)(1996-6#1)(1997-8#1)(2008-10#27)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-8#1)
optimized at a##2##3##(2010-5#1)(2012-2#1)
optimized at the##2##3##(2007-12#1)(2009-2#1)
optimized at##5##2##(1997-1#1)(2007-12#1)(2009-2#1)(2010-5#1)(2012-2#1)
optimized between##2##2##(2008-10#1)(2010-1#1)
optimized both##2##2##(2005-11#1)(2012-2#1)
optimized by a##4##3##(2008-10#3)(2008-5#1)
optimized by both static and dynamic methods##4##7##(2008-10#4)
optimized by means of##3##4##(2008-1#1)(2008-10#2)
optimized by selecting##2##3##(2008-10#1)(2008-7#1)
optimized by the##4##3##(2008-10#2)(2008-3#1)(2011-1#1)
optimized by##40##2##(1994-12#1)(1994-9#1)(1995-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#22)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-11#1)(2010-12#1)(2011-1#1)(2012-2#1)
optimized combination was##2##3##(2010-5#1)(2012-2#1)
optimized condition##6##2##(2008-10#6)
optimized conditions for##3##3##(2007-8#1)(2008-10#2)
optimized conditions of##5##3##(1996-7#1)(2008-10#3)(2011-1#1)
optimized conditions were##6##3##(2008-10#5)(2012-1#1)
optimized conditions##78##2##(1996-7#3)(1997-5#1)(2004-12#1)(2005-12#1)(2006-12#1)(2007-12#1)(2007-8#6)(2008-10#51)(2008-12#1)(2008-4#1)(2008-5#2)(2009-6#1)(2011-1#4)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
optimized culture##2##2##(2008-5#1)(2008-6#1)
optimized design##2##2##(2008-2#1)(2011-1#1)
optimized dose distributions for vaginal cylinders##2##6##(2009-2#2)
optimized dose distributions##3##3##(2009-2#3)
optimized experimental conditions##8##3##(1994-2#1)(2007-8#2)(2008-10#3)(2009-12#1)(2013-8#1)
optimized experimental##9##2##(1994-2#1)(2007-8#2)(2008-10#4)(2009-12#1)(2013-8#1)
optimized extraction##4##2##(2007-8#1)(2008-10#2)(2008-4#1)
optimized flow##2##2##(2007-8#1)(2013-1#1)
optimized for a##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
optimized for both##2##3##(2008-2#1)(2008-3#1)
optimized for each##3##3##(2008-11#1)(2008-3#1)(2013-1#1)
optimized for low##2##3##(2007-12#1)(2008-3#1)
optimized for the analysis of##2##5##(2008-10#1)(2008-11#1)
optimized for the determination of##4##5##(2008-10#4)
optimized for the##19##3##(2007-12#1)(2007-8#2)(2008-10#11)(2008-11#2)(2008-2#1)(2010-12#1)(2012-3#1)
optimized for use in##2##4##(2006-4#1)(2009-8#1)
optimized for use##3##3##(2006-4#1)(2008-2#1)(2009-8#1)
optimized for##81##2##(1990-9#1)(1991-11#1)(1994-11#1)(2005-12#1)(2006-4#1)(2006-5#1)(2007-12#4)(2007-8#2)(2008-1#1)(2008-10#23)(2008-11#6)(2008-2#9)(2008-3#11)(2008-4#3)(2008-6#1)(2008-9#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-5#2)(2011-1#2)(2012-11#1)(2012-3#2)(2013-1#1)
optimized formulation##9##2##(2010-12#2)(2010-2#2)(2010-3#1)(2011-1#1)(2012-12#3)
optimized from##2##2##(2008-10#1)(2008-3#1)
optimized in order to obtain##2##5##(2007-8#1)(2008-10#1)
optimized in terms of##3##4##(2008-10#1)(2008-5#1)(2011-3#1)
optimized in the##2##3##(2008-10#2)
optimized in##11##2##(2006-12#1)(2007-8#1)(2008-10#6)(2008-5#2)(2011-3#1)
optimized integral##2##2##(2007-12#1)(2009-2#1)
optimized medium composition##2##3##(2008-6#1)(2013-7#1)
optimized medium##7##2##(2008-11#1)(2008-6#2)(2013-7#4)
optimized method was##4##3##(2008-10#3)(2013-7#1)
optimized method##9##2##(2007-8#2)(2008-10#5)(2008-5#1)(2013-7#1)
optimized microwindows for##2##3##(2008-2#1)(2008-3#1)
optimized model##3##2##(2008-10#1)(2012-3#1)(2013-8#1)
optimized on##4##2##(2008-10#3)(2012-12#1)
optimized operating conditions##2##3##(2008-10#1)(2008-3#1)
optimized operational conditions##2##3##(2008-10#2)
optimized optical##2##2##(2008-10#1)(2008-3#1)
optimized parameters##4##2##(2008-10#3)(2008-2#1)
optimized procedure was##2##3##(2008-10#2)
optimized procedure##4##2##(2008-10#4)
optimized process##2##2##(2008-2#1)(2008-5#1)
optimized production of##2##3##(2008-2#1)(2008-5#1)
optimized protocol##4##2##(1997-2#1)(2008-10#1)(2008-12#1)(2013-1#1)
optimized reaction conditions##3##3##(2008-10#1)(2008-5#2)
optimized reaction##4##2##(2008-10#1)(2008-5#2)(2013-8#1)
optimized sample preparation##2##3##(2008-10#1)(2013-1#1)
optimized sample##4##2##(1996-8#1)(2008-10#1)(2008-9#1)(2013-1#1)
optimized sampling##2##2##(2007-12#1)(2008-10#1)
optimized separation conditions##2##3##(2008-10#2)
optimized spatial frequency##2##3##(2008-2#2)
optimized structures##2##2##(2007-11#1)(2012-2#1)
optimized system was##2##3##(2008-10#2)
optimized system##9##2##(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#3)
optimized the##14##2##(1994-11#1)(1995-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-9#2)(2010-12#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-8#1)
optimized through##2##2##(1994-9#1)(2008-10#1)
optimized to achieve##2##3##(1991-5#1)(2008-2#1)
optimized to allow##2##3##(2008-10#1)(2008-4#1)
optimized to deliver##2##3##(2007-12#1)(2008-5#1)
optimized to give##2##3##(2006-5#1)(2008-10#1)
optimized to improve the##2##4##(2008-10#1)(2013-8#1)
optimized to match##2##3##(2007-12#1)(2008-3#1)
optimized to maximize the##4##4##(2007-12#1)(2008-10#2)(2009-9#1)
optimized to obtain##5##3##(1993-2#1)(2008-10#3)(2008-2#1)
optimized to yield a##2##4##(2008-10#2)
optimized to yield##3##3##(2007-12#1)(2008-10#2)
optimized to##48##2##(1991-5#1)(1993-2#1)(1996-8#1)(2004-11#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-12#4)(2007-8#1)(2008-10#14)(2008-2#6)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#1)(2009-3#1)(2009-5#1)(2009-9#2)(2011-2#1)(2012-1#1)(2013-8#2)
optimized using a##7##3##(2007-8#2)(2008-10#3)(2008-7#1)(2010-12#1)
optimized using different##2##3##(1996-3#1)(2008-10#1)
optimized using experimental design methodology##2##5##(2008-10#2)
optimized using the##3##3##(2008-10#3)
optimized using##21##2##(1996-3#1)(2007-8#2)(2008-10#11)(2008-5#2)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
optimized with a##2##3##(1997-3#1)(2008-2#1)
optimized with respect to the##4##5##(1991-5#1)(1994-12#1)(2007-12#1)(2008-10#1)
optimized with respect to##10##4##(1991-5#1)(1994-12#1)(2007-12#3)(2008-10#3)(2008-2#1)(2008-7#1)
optimized with##14##2##(1991-5#1)(1994-12#1)(1997-3#1)(2007-12#3)(2008-10#3)(2008-2#2)(2008-3#1)(2008-7#1)(2011-1#1)
optimized##829##1##(1990-7#1)(1990-8#1)(1990-9#2)(1991-11#2)(1991-5#2)(1991-8#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-8#2)(1994-11#3)(1994-12#2)(1994-2#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-3#3)(1996-5#2)(1996-6#1)(1996-7#3)(1996-8#2)(1997-1#3)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#1)(2004-12#2)(2005-11#4)(2005-12#3)(2006-10#3)(2006-11#2)(2006-12#3)(2006-4#1)(2006-5#4)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#4)(2007-12#26)(2007-4#1)(2007-5#2)(2007-8#28)(2008-1#4)(2008-10#345)(2008-11#16)(2008-12#2)(2008-2#42)(2008-3#57)(2008-4#12)(2008-5#19)(2008-6#6)(2008-7#10)(2008-8#2)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#8)(2009-3#3)(2009-5#1)(2009-6#2)(2009-8#3)(2009-9#5)(2010-1#2)(2010-10#3)(2010-12#7)(2010-2#3)(2010-3#1)(2010-4#5)(2010-5#7)(2010-7#2)(2010-8#1)(2011-1#24)(2011-2#10)(2011-3#1)(2012-1#6)(2012-11#2)(2012-12#12)(2012-2#11)(2012-3#8)(2013-1#14)(2013-7#9)(2013-8#14)
optimizer##4##1##(2008-3#4)
optimizes the##8##2##(1995-8#1)(1996-12#1)(1996-8#1)(1997-1#1)(2007-11#1)(2008-11#1)(2008-5#1)(2011-2#1)
optimizes##23##1##(1991-4#1)(1995-8#1)(1996-12#1)(1996-8#2)(1997-1#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-5#1)(2011-2#2)(2012-2#1)
optimizing a##3##2##(2008-10#1)(2008-3#1)(2008-4#1)
optimizing cell##2##2##(2008-11#1)(2009-10#1)
optimizing clinical##3##2##(2005-9#1)(2008-6#1)(2011-1#1)
optimizing patient##2##2##(2008-3#2)
optimizing perfusion##2##2##(2006-10#1)(2008-11#1)
optimizing protein##2##2##(2008-2#1)(2008-5#1)
optimizing standard##2##2##(2009-10#1)(2010-12#1)
optimizing the culture##2##3##(1995-1#1)(2008-11#1)
optimizing the design of##2##4##(2008-3#1)(2012-1#1)
optimizing the design##3##3##(2008-2#1)(2008-3#1)(2012-1#1)
optimizing the efficiency of##2##4##(1991-7#1)(2008-3#1)
optimizing the extent of##2##4##(2008-2#1)(2011-12#1)
optimizing the management of##2##4##(2008-7#1)(2013-1#1)
optimizing the use of##2##4##(2011-2#1)(2013-1#1)
optimizing the##52##2##(1991-11#1)(1991-7#1)(1993-4#1)(1995-1#1)(1995-2#1)(1995-7#1)(1996-12#1)(1996-6#2)(1997-2#1)(2006-1#1)(2006-6#1)(2007-11#1)(2007-12#4)(2008-10#8)(2008-11#2)(2008-2#5)(2008-3#6)(2008-5#1)(2008-6#2)(2008-7#1)(2009-6#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#2)(2013-1#2)(2013-8#1)
optimizing their##3##2##(1996-1#1)(2009-8#1)(2013-1#1)
optimizing therapeutic##3##2##(2006-10#1)(2006-2#1)(2012-2#1)
optimizing this##3##2##(2006-6#1)(2008-4#2)
optimizing tumor##2##2##(2008-3#1)(2008-6#1)
optimizing##151##1##(1991-11#1)(1991-7#2)(1992-8#1)(1993-3#1)(1993-4#1)(1995-1#1)(1995-2#1)(1995-7#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-6#2)(1997-1#2)(1997-2#1)(2004-9#1)(2005-9#2)(2006-1#1)(2006-10#5)(2006-2#2)(2006-5#1)(2006-6#2)(2007-11#2)(2007-12#6)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#13)(2008-11#4)(2008-2#10)(2008-3#18)(2008-4#6)(2008-5#7)(2008-6#5)(2008-7#4)(2008-9#1)(2009-10#3)(2009-12#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-12#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#3)
optimum AV interval for the individual##2##6##(1992-5#2)
optimum SFE conditions##2##3##(2008-10#2)
optimum SFE##3##2##(2008-10#3)
optimum acid phosphatase##4##3##(1993-4#1)(1993-8#1)(1994-8#2)
optimum activity at pH 7##2##5##(1992-5#1)(2008-8#1)
optimum activity at##3##3##(1992-5#1)(2008-8#1)(2013-1#1)
optimum activity was at pH##2##5##(1991-2#2)
optimum activity##5##2##(1991-2#2)(1992-5#1)(2008-8#1)(2013-1#1)
optimum amount of##3##3##(1996-9#1)(2007-12#1)(2008-10#1)
optimum amounts of##2##3##(2008-12#1)(2010-12#1)
optimum amounts##3##2##(2008-12#2)(2010-12#1)
optimum analytical conditions##4##3##(2008-10#4)
optimum analytical##6##2##(2008-10#6)
optimum and##5##2##(1992-7#1)(1995-2#1)(2008-10#2)(2008-8#1)
optimum antihypertensive##2##2##(1992-8#2)
optimum at pH 7##3##4##(1990-3#1)(1992-12#1)(1994-3#1)
optimum at pH##6##3##(1990-3#1)(1990-6#1)(1991-2#1)(1992-12#1)(1994-3#1)(2006-6#1)
optimum at##19##2##(1990-2#1)(1990-3#1)(1990-6#1)(1991-10#1)(1991-2#1)(1992-12#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-9#1)(2006-6#1)(2008-10#6)
optimum beam##4##2##(2008-2#1)(2008-3#3)
optimum binding##2##2##(1996-8#1)(2008-10#1)
optimum choice##2##2##(1991-3#1)(2008-3#1)
optimum closed-loop bandwidth##2##3##(2008-2#2)
optimum coacervation occurred##2##3##(2010-5#2)
optimum composition of the##3##4##(2007-8#1)(2008-10#1)(2009-2#1)
optimum concentration of##4##3##(1996-12#1)(2008-10#2)(2008-8#1)
optimum concentration ranges were 0##2##5##(2008-10#2)
optimum concentration ranges##3##3##(2008-10#3)
optimum concentration was##2##3##(2008-5#1)(2013-1#1)
optimum concentration##11##2##(1996-12#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-8#1)(2013-1#1)
optimum concentrations of##4##3##(1990-12#1)(1991-9#1)(2006-12#1)(2008-5#1)
optimum condition for the##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
optimum condition for##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
optimum condition##17##2##(2007-10#1)(2007-12#2)(2008-10#11)(2008-12#1)(2008-2#1)(2008-3#1)
optimum conditions established##2##3##(2008-10#2)
optimum conditions for separation##2##4##(2008-10#2)
optimum conditions for the extraction of the##2##7##(1992-2#1)(2008-10#1)
optimum conditions for the##17##4##(1992-2#1)(2005-11#1)(2005-4#1)(2008-10#13)(2008-3#1)
optimum conditions for##35##3##(1992-2#1)(1994-3#1)(1996-3#1)(2005-11#1)(2005-4#1)(2007-12#2)(2008-10#21)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2010-5#1)
optimum conditions obtained by the##2##5##(2008-10#2)
optimum conditions obtained##3##3##(2008-10#3)
optimum conditions of##4##3##(2007-8#1)(2008-10#3)
optimum conditions that##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
optimum conditions the##2##3##(2008-10#1)(2008-3#1)
optimum conditions were found to##2##5##(2008-10#2)
optimum conditions were found##3##4##(2008-10#2)(2008-3#1)
optimum conditions were##11##3##(2008-10#9)(2008-3#1)(2012-12#1)
optimum conditions##147##2##(1992-2#1)(1994-3#1)(1996-3#1)(1997-3#1)(2005-11#1)(2005-4#1)(2007-10#1)(2007-12#5)(2007-8#3)(2008-10#115)(2008-11#2)(2008-12#1)(2008-3#6)(2008-5#2)(2010-5#1)(2012-12#2)(2012-3#1)(2013-1#2)
optimum control##2##2##(2008-10#1)(2008-3#1)
optimum coupling##2##2##(2007-12#1)(2008-2#1)
optimum design##3##2##(2008-2#1)(2008-3#2)
optimum dosage##2##2##(2007-8#1)(2008-5#1)
optimum dose of##4##3##(1993-6#1)(2008-10#1)(2013-1#2)
optimum dose##7##2##(1993-6#1)(2008-10#2)(2008-4#1)(2013-1#2)(2013-8#1)
optimum experimental conditions for##3##4##(2008-10#3)
optimum experimental conditions were investigated##3##5##(2008-10#3)
optimum experimental conditions were##5##4##(2008-10#5)
optimum experimental conditions##15##3##(2007-8#1)(2008-10#14)
optimum flow rate of##3##4##(2008-10#3)
optimum flow rate##4##3##(2008-10#4)
optimum for the enzyme##2##4##(1992-2#1)(1993-3#1)
optimum for the##3##3##(1990-3#1)(1992-2#1)(1993-3#1)
optimum for##7##2##(1990-3#1)(1992-2#1)(1993-3#1)(1997-3#1)(2008-10#2)(2008-5#1)
optimum growth##3##2##(1991-8#1)(1994-2#1)(2008-11#1)
optimum in##3##2##(1997-4#2)(2008-9#1)
optimum level##4##2##(1997-2#1)(2005-10#1)(2008-6#1)(2012-2#1)
optimum levels##3##2##(1994-3#1)(2008-10#1)(2009-4#1)
optimum management of##3##3##(2006-5#1)(2007-11#1)(2008-10#1)
optimum medium##2##2##(2005-11#1)(2008-11#1)
optimum model##2##2##(2007-10#2)
optimum models##2##2##(2009-4#2)
optimum number of factors##2##4##(2008-10#2)
optimum number of##3##3##(2005-5#1)(2008-10#2)
optimum of##20##2##(1990-12#3)(1990-2#2)(1991-11#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-4#1)(1993-11#1)(1994-5#1)(1995-8#1)(1996-1#1)(1996-5#1)(2004-8#2)(2008-10#1)(2008-2#1)(2008-8#1)
optimum operating conditions##6##3##(2008-10#3)(2008-3#1)(2011-12#2)
optimum operating##7##2##(2008-10#3)(2008-3#2)(2011-12#2)
optimum operation##2##2##(2007-12#1)(2008-10#1)
optimum outcome##2##2##(1993-5#1)(2010-3#1)
optimum pH and temperature##4##4##(1991-12#1)(1992-11#1)(2008-10#1)(2008-5#1)
optimum pH and##5##3##(1991-12#1)(1992-11#1)(2008-10#2)(2008-5#1)
optimum pH for the##5##4##(1990-7#2)(2008-10#2)(2008-3#1)
optimum pH for##10##3##(1990-2#1)(1990-7#2)(1996-5#1)(2004-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2012-2#1)
optimum pH in##2##3##(1990-7#1)(2007-9#1)
optimum pH of##4##3##(1990-12#1)(1990-4#1)(1994-9#1)(2008-9#1)
optimum pH range was##2##4##(2008-10#2)
optimum pH range##5##3##(2008-10#5)
optimum pH value##3##3##(1995-3#1)(2008-10#2)
optimum pH values##3##3##(2006-10#1)(2008-10#2)
optimum pH##52##2##(1990-12#2)(1990-2#1)(1990-4#1)(1990-6#1)(1990-7#5)(1991-12#1)(1992-11#1)(1992-2#3)(1994-8#1)(1994-9#1)(1995-3#1)(1996-5#1)(1997-2#1)(2004-11#1)(2005-6#1)(2006-10#1)(2007-9#1)(2008-10#23)(2008-3#1)(2008-5#2)(2008-9#1)(2012-2#1)
optimum parameters for##3##3##(2008-10#1)(2008-2#1)(2013-1#1)
optimum parameters##6##2##(2008-10#2)(2008-12#1)(2008-2#1)(2012-12#1)(2013-1#1)
optimum performance is##2##3##(2008-3#2)
optimum performance of##3##3##(2007-10#1)(2008-10#1)(2010-2#1)
optimum performance##7##2##(2007-10#1)(2008-10#2)(2008-3#3)(2010-2#1)
optimum polarization orientation of the##2##5##(2008-3#2)
optimum polarization##4##2##(2008-3#4)
optimum position##2##2##(2008-4#1)(2011-1#1)
optimum procedures##2##2##(2008-10#2)
optimum protein##2##2##(2009-4#2)
optimum pyrolysis and atomization temperatures of##3##6##(2008-10#3)
optimum pyrolysis and atomization temperatures##4##5##(2008-10#4)
optimum range##4##2##(2006-8#1)(2008-10#3)
optimum ratio##3##2##(2007-12#1)(2010-5#1)(2012-2#1)
optimum reaction conditions were##8##4##(2008-10#6)(2008-3#1)(2012-3#1)
optimum reaction conditions##15##3##(2005-7#1)(2008-10#11)(2008-3#1)(2012-3#1)(2013-1#1)
optimum resolution##3##2##(2005-4#1)(2008-10#1)(2008-3#1)
optimum response##3##2##(2008-10#2)(2008-6#1)
optimum results for##2##3##(2008-5#1)(2010-5#1)
optimum results##4##2##(2008-3#1)(2008-5#1)(2009-2#1)(2010-5#1)
optimum sample size##2##3##(2007-7#1)(2008-10#1)
optimum sampling depth##2##3##(2008-10#2)
optimum sampling##3##2##(2008-10#2)(2013-7#1)
optimum sensitivity##3##2##(1991-2#1)(2008-10#1)(2009-12#1)
optimum separation conditions##2##3##(2008-10#2)
optimum separation##5##2##(2008-10#5)
optimum set of##3##3##(2008-2#2)(2008-7#1)
optimum signal-to-noise ratio##2##3##(2008-2#1)(2008-3#1)
optimum specific##2##2##(1994-3#1)(2009-11#1)
optimum surface roughness##2##3##(2007-2#2)
optimum surface##4##2##(2007-2#2)(2008-2#2)
optimum temperature and##4##3##(1990-4#1)(1994-2#1)(2005-11#1)(2008-10#1)
optimum temperature for##6##3##(2008-10#4)(2008-11#1)(2008-6#1)
optimum temperature of 25##2##4##(2008-10#1)(2008-5#1)
optimum temperature range##2##3##(2008-10#2)
optimum temperature was##2##3##(1997-2#1)(2008-5#1)
optimum temperature##22##2##(1990-4#1)(1994-2#1)(1997-2#1)(2005-11#1)(2007-11#1)(2008-10#11)(2008-11#1)(2008-5#2)(2008-6#2)(2012-2#1)
optimum temperatures##3##2##(2008-10#3)
optimum therapy##2##2##(2007-11#1)(2007-7#1)
optimum thickness of the##2##4##(2008-2#2)
optimum thickness##3##2##(2007-11#1)(2008-2#2)
optimum time##2##2##(1994-8#1)(1997-3#1)
optimum transitions for##2##3##(2008-2#1)(2008-3#1)
optimum treatment##6##2##(2006-7#1)(2007-10#1)(2007-11#1)(2008-5#1)(2009-5#1)(2012-2#1)
optimum use of##4##3##(2007-11#2)(2009-5#1)(2010-5#1)
optimum use##5##2##(2007-11#3)(2009-5#1)(2010-5#1)
optimum value##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
optimum values of the##4##4##(1997-6#1)(2008-10#2)(2008-3#1)
optimum values of##7##3##(1997-6#1)(2008-10#4)(2008-12#1)(2008-3#1)
optimum values##12##2##(1997-6#1)(2005-4#1)(2007-11#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#1)
optimum was between##2##3##(1990-5#1)(1996-5#1)
optimum was##8##2##(1990-5#2)(1996-5#1)(1996-7#1)(1996-9#1)(2008-10#2)(2008-6#1)
optimum wavelength##2##2##(2008-10#1)(2008-2#1)
optimum working##6##2##(1992-4#1)(2008-10#5)
optimum##838##1##(1990-10#1)(1990-12#7)(1990-2#5)(1990-3#3)(1990-4#2)(1990-5#2)(1990-6#2)(1990-7#6)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#4)(1992-2#9)(1992-4#2)(1992-5#3)(1992-7#1)(1992-8#2)(1993-11#1)(1993-3#3)(1993-4#3)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-3#3)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#2)(1997-2#3)(1997-3#6)(1997-4#2)(1997-6#1)(1997-8#1)(2004-1#1)(2004-11#1)(2004-2#1)(2004-8#2)(2005-10#1)(2005-11#7)(2005-12#1)(2005-4#6)(2005-5#1)(2005-6#1)(2005-7#2)(2006-10#5)(2006-12#2)(2006-2#1)(2006-5#2)(2006-6#5)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#9)(2007-11#17)(2007-12#24)(2007-2#2)(2007-7#7)(2007-8#9)(2007-9#3)(2008-1#1)(2008-10#330)(2008-11#8)(2008-12#12)(2008-2#42)(2008-3#67)(2008-4#7)(2008-5#15)(2008-6#8)(2008-7#5)(2008-8#10)(2008-9#2)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#2)(2009-4#8)(2009-5#5)(2010-10#1)(2010-12#2)(2010-2#2)(2010-3#3)(2010-4#2)(2010-5#7)(2010-6#1)(2010-8#2)(2011-1#3)(2011-12#3)(2011-2#3)(2012-1#1)(2012-12#6)(2012-2#9)(2012-3#2)(2013-1#12)(2013-7#2)(2013-8#3)
optimum-design method##2##2##(2013-8#2)
opting for a##2##3##(2007-7#1)(2010-12#1)
opting for##3##2##(2007-7#1)(2010-12#2)
option and##9##2##(1992-2#1)(1993-8#1)(1997-4#1)(2004-3#1)(2007-8#1)(2008-4#1)(2008-6#1)(2011-2#1)(2013-1#1)
option as##4##2##(2005-5#1)(2010-3#1)(2011-1#1)(2013-1#1)
option available##2##2##(1992-3#1)(2008-4#1)
option but##4##2##(2008-1#2)(2008-11#1)(2012-12#1)
option by##2##2##(2006-9#1)(2011-12#1)
option for a##2##3##(2010-12#1)(2011-3#1)
option for acute##3##3##(2008-7#1)(2011-1#2)
option for certain##2##3##(2008-1#1)(2010-5#1)
option for children##2##3##(2006-10#1)(2008-4#1)
option for managing##2##3##(2007-12#1)(2008-10#1)
option for many##3##3##(2004-11#1)(2008-11#1)(2008-6#1)
option for patients failing##3##4##(2005-8#1)(2006-10#1)(2010-12#1)
option for patients who are not##2##6##(2007-7#1)(2008-6#1)
option for patients with end-stage##2##5##(2007-8#1)(2013-8#1)
option for patients with##15##4##(1994-12#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-8#3)(2008-4#1)(2009-8#2)(2010-11#1)(2012-11#1)(2013-8#1)
option for patients##21##3##(1994-12#1)(1997-3#1)(2005-8#1)(2006-10#3)(2006-8#1)(2007-11#2)(2007-7#1)(2007-8#3)(2008-4#1)(2008-6#1)(2009-8#2)(2010-11#1)(2010-12#1)(2012-11#1)(2013-8#1)
option for reducing##2##3##(2006-5#1)(2009-11#1)
option for select patients with##2##5##(2007-7#1)(2012-2#1)
option for selected##2##3##(1991-2#1)(2007-11#1)
option for the control of##3##5##(2007-6#2)(2008-10#1)
option for the correction of##2##5##(2007-12#1)(2009-10#1)
option for the management of##2##5##(2007-12#1)(2013-8#1)
option for the treatment of infections##2##6##(2008-3#1)(2013-8#1)
option for the treatment of##14##5##(2006-10#1)(2008-3#5)(2008-5#1)(2009-5#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
option for the##32##3##(2006-10#1)(2006-2#1)(2006-3#1)(2007-12#2)(2007-6#2)(2008-10#3)(2008-12#1)(2008-3#5)(2008-5#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#3)
option for these##3##3##(2008-3#1)(2011-2#1)(2012-1#1)
option for this##2##3##(2008-4#1)(2011-2#1)
option for treating##2##3##(2007-8#1)(2009-6#1)
option for treatment##2##3##(2008-5#1)(2009-3#1)
option for women##2##3##(1996-8#1)(2011-1#1)
option for##169##2##(1990-12#1)(1991-10#1)(1991-2#1)(1993-12#2)(1994-12#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#1)(2004-11#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#8)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#4)(2007-12#3)(2007-3#1)(2007-6#3)(2007-7#5)(2007-8#7)(2008-1#3)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#9)(2008-4#3)(2008-5#4)(2008-6#4)(2008-7#2)(2008-9#1)(2009-10#2)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#1)(2010-11#2)(2010-12#4)(2010-4#3)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#8)(2011-3#2)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#9)(2012-3#2)(2012-8#1)(2013-1#5)(2013-7#1)(2013-8#6)
option has##4##2##(1995-12#1)(2006-2#1)(2010-2#1)(2011-2#1)
option if##2##2##(1996-8#1)(2013-1#1)
option in a##2##3##(1993-11#1)(2011-1#1)
option in cases##2##3##(2006-10#1)(2007-8#1)
option in patients with##3##4##(2007-12#1)(2007-7#1)(2013-1#1)
option in patients##7##3##(2007-12#1)(2007-7#1)(2008-5#1)(2010-12#2)(2011-2#1)(2013-1#1)
option in selected##2##3##(2006-3#1)(2011-2#1)
option in severe##2##3##(2007-9#1)(2012-1#1)
option in the management of##2##5##(2004-10#1)(2011-3#1)
option in the treatment of##8##5##(2005-7#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-1#1)(2007-7#1)
option in the##17##3##(2004-10#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2010-12#1)(2011-3#1)(2012-3#1)
option in these##2##3##(2007-9#1)(2012-2#1)
option in this##2##3##(2007-8#1)(2012-2#1)
option in treating##2##3##(2008-10#1)(2008-5#1)
option in##67##2##(1992-10#1)(1993-11#1)(1995-10#1)(1996-8#1)(1997-6#1)(2004-10#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-12#2)(2006-3#1)(2006-6#1)(2007-1#1)(2007-11#6)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#3)(2008-3#2)(2008-5#2)(2010-12#5)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)
option is available for##2##4##(2006-8#1)(2012-2#1)
option is available##3##3##(2006-8#1)(2007-8#1)(2012-2#1)
option is##15##2##(1993-3#1)(1994-2#1)(1996-12#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-5#2)(2008-7#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
option may##3##2##(2007-7#1)(2008-1#1)(2008-10#1)
option of combination##2##3##(2006-10#1)(2007-8#1)
option of treatment##3##3##(2007-10#1)(2007-7#1)(2011-2#1)
option of##25##2##(1994-12#1)(1996-5#1)(1997-3#1)(2004-9#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#1)
option on##3##2##(1991-1#1)(2006-12#1)(2010-12#1)
option should##2##2##(2012-11#1)(2013-8#1)
option that is##2##3##(2008-6#1)(2011-2#1)
option that##4##2##(2008-6#1)(2009-5#1)(2011-2#1)(2012-12#1)
option to optimize##2##3##(2008-3#1)(2011-2#1)
option to reduce##2##3##(2008-7#1)(2013-8#1)
option to treat##2##3##(2007-1#1)(2012-12#1)
option to##27##2##(1993-3#1)(1993-4#1)(1993-6#1)(1994-12#1)(1995-12#1)(1996-4#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
option under##2##2##(1992-2#1)(1997-3#1)
option was##4##2##(2007-8#1)(2008-11#1)(2008-9#1)(2010-2#1)
option when##3##2##(2008-9#1)(2010-12#1)(2011-1#1)
option with##3##2##(2005-7#1)(2006-12#1)(2012-12#1)
option##456##1##(1990-12#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1992-10#1)(1992-2#3)(1992-3#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-3#3)(1993-4#1)(1993-6#1)(1993-8#2)(1994-1#1)(1994-12#4)(1994-2#1)(1994-3#1)(1995-10#1)(1995-12#2)(1995-3#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-8#4)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#2)(2004-10#1)(2004-11#2)(2004-3#1)(2004-4#1)(2004-9#1)(2005-5#2)(2005-6#1)(2005-7#4)(2005-8#2)(2005-9#1)(2006-1#2)(2006-10#19)(2006-11#1)(2006-12#8)(2006-2#3)(2006-3#2)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#12)(2007-12#7)(2007-2#2)(2007-3#2)(2007-4#1)(2007-6#3)(2007-7#15)(2007-8#19)(2007-9#3)(2008-1#11)(2008-10#18)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#14)(2008-4#5)(2008-5#11)(2008-6#9)(2008-7#7)(2008-8#3)(2008-9#6)(2009-10#3)(2009-11#2)(2009-3#1)(2009-4#1)(2009-5#6)(2009-6#3)(2009-7#1)(2009-8#6)(2009-9#3)(2010-11#3)(2010-12#18)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#4)(2010-8#4)(2010-9#1)(2011-1#12)(2011-12#2)(2011-2#27)(2011-3#4)(2012-1#7)(2012-11#3)(2012-12#14)(2012-2#18)(2012-3#8)(2012-8#1)(2013-1#11)(2013-7#1)(2013-8#16)
option?##4##1##(2006-6#1)(2007-11#1)(2009-5#1)(2013-8#1)
option]##2##1##(1991-3#1)(2011-2#1)
optional unit##2##2##(2008-10#2)
optional##28##1##(1992-11#1)(1993-11#1)(1993-8#1)(1994-1#1)(1995-11#1)(1996-5#1)(1997-2#1)(2006-10#1)(2006-6#1)(2007-7#2)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#1)(2009-10#1)(2010-9#1)(2011-2#2)(2013-1#1)
optionally##10##1##(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-10#1)(2013-1#1)
options and alternatives##2##3##(2008-8#1)(2011-2#1)
options and prognosis##3##3##(2006-12#1)(2008-3#1)(2010-2#1)
options and the##2##3##(2011-2#1)(2012-3#1)
options and their##3##3##(2006-10#1)(2008-11#1)(2009-5#1)
options and##33##2##(1992-1#1)(1993-2#1)(1994-1#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-9#1)(2005-12#1)(2006-10#1)(2006-12#2)(2006-7#1)(2006-9#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-3#1)
options are available for##2##4##(2008-1#1)(2010-8#1)
options are available##6##3##(2005-11#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-6#1)(2010-8#1)
options are discussed##5##3##(2005-12#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-12#1)
options are limited##5##3##(2006-10#2)(2011-2#1)(2012-12#1)(2013-8#1)
options are reviewed##3##3##(2006-4#1)(2007-8#1)(2012-3#1)
options are##36##2##(1990-4#1)(2005-11#1)(2005-12#1)(2006-10#4)(2006-12#1)(2006-4#1)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-5#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
options as##3##2##(2006-2#1)(2007-11#2)
options at##3##2##(1991-1#1)(2006-10#1)(2010-2#1)
options available for management of##2##5##(2008-8#1)(2010-8#1)
options available for the##4##4##(2005-6#1)(2005-7#1)(2007-9#1)(2008-11#1)
options available for##13##3##(1997-3#1)(2005-5#1)(2005-6#1)(2005-7#1)(2006-12#1)(2006-8#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-8#1)
options available to clinicians##2##4##(2007-11#1)(2009-5#1)
options available to the##2##4##(2007-7#1)(2009-9#1)
options available to##13##3##(1991-3#1)(1993-11#1)(1995-12#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-9#1)(2009-5#1)(2009-9#1)(2011-2#2)(2012-2#1)(2012-3#1)
options available##39##2##(1991-3#1)(1992-12#1)(1993-11#1)(1995-12#1)(1997-3#1)(2005-5#1)(2005-6#1)(2005-7#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#2)(2009-9#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)
options because of##2##3##(1994-2#1)(2008-10#1)
options before##2##2##(1996-2#1)(2007-6#1)
options can be##2##3##(2008-6#1)(2009-8#1)
options exist##5##2##(1995-5#1)(2006-3#1)(2006-7#1)(2010-11#1)(2011-2#1)
options for future##2##3##(2006-10#1)(2008-12#1)
options for level##2##3##(2011-2#2)
options for management of##2##4##(2008-3#1)(2008-9#1)
options for managing##2##3##(2010-8#1)(2013-1#1)
options for new##2##3##(2008-3#1)(2010-11#1)
options for nonalcoholic##2##3##(2010-12#1)(2013-1#1)
options for patients with##8##4##(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-5#1)(2009-3#1)(2010-4#1)
options for patients##11##3##(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-5#1)(2009-3#1)(2010-4#1)(2011-2#2)(2012-12#1)
options for refractory##3##3##(1996-12#1)(2006-4#1)(2008-7#1)
options for surgical##2##3##(2008-12#1)(2013-1#1)
options for the management of##3##5##(2005-7#1)(2010-8#1)(2013-8#1)
options for the treatment of##6##5##(2007-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-8#1)(2013-1#1)
options for the treatment##7##4##(2007-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-5#1)(2010-8#1)(2013-1#1)
options for the##16##3##(2005-7#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-5#1)(2010-7#1)(2010-8#2)(2012-2#2)(2013-1#1)(2013-8#1)
options for these##2##3##(2006-10#1)(2006-12#1)
options for treatment of##2##4##(2007-11#1)(2012-12#1)
options for treatment##3##3##(2006-8#1)(2007-11#1)(2012-12#1)
options for##161##2##(1990-12#1)(1991-2#1)(1991-3#1)(1992-3#1)(1993-12#1)(1995-1#1)(1995-3#1)(1996-12#1)(1996-2#2)(2005-10#1)(2005-11#1)(2005-6#1)(2005-7#1)(2006-10#5)(2006-11#2)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#5)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#4)(2007-12#5)(2007-2#4)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#8)(2008-5#3)(2008-6#5)(2008-7#3)(2008-8#1)(2008-9#5)(2009-10#1)(2009-11#1)(2009-3#2)(2009-5#1)(2009-8#2)(2010-10#1)(2010-11#3)(2010-12#3)(2010-2#3)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#5)(2011-1#2)(2011-2#12)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#9)(2013-7#4)(2013-8#2)
options from##2##2##(2007-2#1)(2008-10#1)
options has##2##2##(2011-1#1)(2011-2#1)
options have been##4##3##(2006-10#1)(2007-8#1)(2008-1#1)(2013-1#1)
options have##14##2##(2006-10#2)(2006-2#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-2#1)(2010-12#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
options in chronic##2##3##(2006-6#1)(2010-8#1)
options in detail##2##3##(2008-1#1)(2008-2#1)
options in recurrent##2##3##(2007-10#1)(2009-5#1)
options in the management of##3##5##(2008-5#1)(2009-8#2)
options in the treatment of##4##5##(1993-8#1)(2006-10#1)(2007-6#1)(2008-1#1)
options in the##13##3##(1993-8#1)(2006-10#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-8#2)(2012-2#1)
options in##45##2##(1993-10#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-12#1)(1996-1#1)(1997-1#2)(2005-11#1)(2005-8#1)(2006-10#3)(2006-6#1)(2006-9#1)(2007-10#1)(2007-6#1)(2007-7#1)(2008-1#4)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#2)(2009-2#1)(2009-5#1)(2009-8#3)(2010-12#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)
options include observation##2##3##(2007-3#1)(2008-6#1)
options include##14##2##(1996-2#1)(1996-7#1)(2006-5#1)(2007-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-2#2)(2010-5#1)(2011-2#1)(2013-1#1)
options including##6##2##(2005-9#1)(2007-6#1)(2007-8#1)(2008-9#1)(2012-3#1)(2013-8#1)
options is##5##2##(2008-10#2)(2008-11#1)(2008-5#1)(2009-6#1)
options may be##2##3##(2007-8#1)(2012-2#1)
options may##3##2##(2006-10#1)(2007-8#1)(2012-2#1)
options now available for the##2##5##(2008-4#1)(2009-5#1)
options now available for##3##4##(2008-4#1)(2009-5#1)(2009-8#1)
options of the##3##3##(1992-12#1)(1993-5#1)(2011-2#1)
options of##17##2##(1992-12#1)(1993-5#1)(2006-10#1)(2006-5#2)(2007-11#1)(2008-1#1)(2008-7#1)(2009-2#1)(2009-4#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
options or##3##2##(2008-7#1)(2010-5#1)(2012-2#1)
options range from##2##3##(2006-9#1)(2007-10#1)
options remain##2##2##(2006-10#1)(2006-9#1)
options such as##6##3##(1990-9#1)(2005-6#1)(2007-11#1)(2007-8#1)(2008-12#1)(2009-5#1)
options that may##2##3##(2008-3#1)(2008-6#1)
options that##8##2##(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-8#1)
options to improve##2##3##(2008-10#1)(2011-2#1)
options to restore##2##3##(2008-8#1)(2012-2#1)
options to the##3##3##(2005-8#1)(2008-8#1)(2013-8#1)
options to##23##2##(1992-12#1)(1996-1#1)(2005-8#1)(2006-10#1)(2006-7#3)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-8#3)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
options vary##2##2##(1991-6#1)(1993-5#1)
options was##2##2##(2008-10#2)
options were##7##2##(1997-4#1)(2007-7#1)(2008-10#1)(2012-12#1)(2013-1#3)
options when##2##2##(2006-11#1)(2011-2#1)
options will be discussed##2##4##(2006-11#1)(2008-8#1)
options will be##4##3##(2006-11#1)(2008-6#1)(2008-8#1)(2009-5#1)
options will##8##2##(2006-11#1)(2006-9#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-11#1)(2012-3#1)
options with##5##2##(2007-7#1)(2007-8#1)(2008-10#1)(2008-8#1)(2012-12#1)
options##728##1##(1990-12#2)(1990-4#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-3#3)(1991-6#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-10#2)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#2)(1993-8#2)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#2)(1995-5#1)(1996-1#5)(1996-12#3)(1996-2#5)(1996-3#4)(1996-7#1)(1996-9#1)(1997-1#4)(1997-3#3)(1997-4#2)(1997-7#1)(1997-8#1)(2004-1#1)(2004-11#1)(2004-12#1)(2004-5#1)(2004-7#1)(2005-10#3)(2005-11#7)(2005-12#2)(2005-5#1)(2005-6#3)(2005-7#5)(2005-8#8)(2005-9#1)(2006-10#24)(2006-11#4)(2006-12#10)(2006-2#8)(2006-3#4)(2006-4#7)(2006-5#5)(2006-6#3)(2006-7#6)(2006-8#3)(2006-9#10)(2007-1#2)(2007-10#10)(2007-11#14)(2007-12#9)(2007-2#10)(2007-3#1)(2007-4#3)(2007-5#2)(2007-6#4)(2007-7#11)(2007-8#16)(2007-9#1)(2008-1#20)(2008-10#22)(2008-11#13)(2008-12#12)(2008-2#4)(2008-3#16)(2008-4#12)(2008-5#15)(2008-6#16)(2008-7#18)(2008-8#12)(2008-9#15)(2009-10#3)(2009-11#3)(2009-12#2)(2009-2#4)(2009-3#6)(2009-4#4)(2009-5#15)(2009-6#4)(2009-7#1)(2009-8#10)(2009-9#2)(2010-10#1)(2010-11#8)(2010-12#13)(2010-2#11)(2010-3#2)(2010-4#4)(2010-5#4)(2010-6#5)(2010-7#3)(2010-8#13)(2011-1#11)(2011-12#2)(2011-2#37)(2011-3#3)(2012-1#3)(2012-11#1)(2012-12#15)(2012-2#22)(2012-3#9)(2013-1#31)(2013-7#5)(2013-8#12)
options?##2##1##(1997-1#1)(2006-4#1)
options]##7##1##(1994-8#1)(2006-8#1)(2008-4#1)(2009-2#1)(2009-9#1)(2012-2#1)(2013-7#1)
opto-electronic##5##1##(2006-6#1)(2008-7#2)(2009-2#1)(2010-5#1)
optoacoustic##4##1##(2008-3#2)(2009-4#1)(2012-12#1)
optochemical absorbance##2##2##(2007-12#2)
optochemical##3##1##(2007-12#2)(2007-8#1)
optode is##4##2##(2008-10#4)
optode membrane for##3##3##(2008-10#3)
optode membrane##10##2##(2008-10#10)
optode with##2##2##(2008-10#2)
optode##26##1##(2007-8#1)(2008-10#25)
optodes##5##1##(2007-12#1)(2008-10#4)
optoelectric##2##1##(2006-12#1)(2013-8#1)
optoelectronic PH##2##2##(2008-3#2)
optoelectronic VLSI##2##2##(2008-2#1)(2008-3#1)
optoelectronic and##4##2##(2007-9#1)(2008-2#2)(2008-3#1)
optoelectronic chips##3##2##(2008-2#3)
optoelectronic circuits##2##2##(2008-3#2)
optoelectronic device##5##2##(2008-3#4)(2009-8#1)
optoelectronic devices##14##2##(2007-12#3)(2007-9#1)(2008-2#4)(2008-3#3)(2008-7#1)(2009-2#1)(2010-4#1)
optoelectronic feedback##3##2##(2007-12#3)
optoelectronic harmonic mixing##2##3##(2007-11#2)
optoelectronic imaging##3##2##(2008-3#3)
optoelectronic implementation of##2##3##(2008-2#1)(2008-3#1)
optoelectronic implementation##7##2##(2008-2#5)(2008-3#2)
optoelectronic integrated circuits##3##3##(2008-2#2)(2008-3#1)
optoelectronic integrated##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
optoelectronic interconnects##3##2##(2008-3#3)
optoelectronic oscillator##2##2##(2007-11#1)(2008-1#1)
optoelectronic processor that##2##3##(2007-12#1)(2008-3#1)
optoelectronic system design##2##3##(2008-2#2)
optoelectronic system##6##2##(2008-2#4)(2008-3#1)(2008-7#1)
optoelectronic systems##4##2##(2008-2#3)(2008-3#1)
optoelectronic technology##2##2##(2008-3#2)
optoelectronic##136##1##(2006-4#1)(2007-11#5)(2007-12#13)(2007-8#1)(2007-9#2)(2008-1#3)(2008-2#46)(2008-3#54)(2008-7#3)(2009-2#2)(2009-5#2)(2009-8#1)(2009-9#1)(2010-4#2)
optoelectronics##5##1##(2007-12#2)(2008-2#1)(2008-7#1)(2009-2#1)
optofluidic waveguide##2##2##(2010-8#2)
optofluidic##3##1##(2010-8#2)(2011-1#1)
optogenetic##3##1##(2013-1#3)
optogeometrical parameters of the##2##4##(2007-12#1)(2008-3#1)
optogeometrical parameters of##3##3##(2007-12#1)(2008-3#2)
optokinetic afternystagmus ct##2##3##(2008-4#2)
optokinetic afternystagmus##8##2##(2008-4#8)
optokinetic nystagmus (OKN)##2##3##(1992-3#1)(1992-7#1)
optokinetic nystagmus gain##2##3##(2008-4#2)
optokinetic nystagmus##11##2##(1991-10#1)(1992-3#1)(1992-7#3)(2008-4#5)(2011-2#1)
optokinetic##23##1##(1991-10#2)(1991-5#1)(1992-3#1)(1992-7#4)(2008-4#13)(2008-8#1)(2011-2#1)
optomechanical##7##1##(2008-2#2)(2008-3#3)(2012-2#2)
optomechanics##5##1##(2008-2#5)
optometric##3##1##(2009-10#3)
optometrists##2##1##(2009-10#2)
optomotor##4##1##(1992-9#1)(2007-12#2)(2008-8#1)
optomotor-blind##2##1##(1992-7#2)
optosensing method##2##2##(2008-10#2)
optosensing properties of##2##3##(2008-10#2)
optosensing##11##1##(2008-10#11)
optosensor for##3##2##(2008-10#3)
optosensor##7##1##(2008-10#7)
optotypes on##2##2##(1992-7#2)
optotypes##3##1##(1992-7#2)(2005-11#1)
optrode is##2##2##(2008-10#2)
optrode system##2##2##(2008-10#2)
optrode##8##1##(2008-10#8)
optronic##2##1##(2007-12#1)(2008-3#1)
opulus##4##1##(2008-6#4)
opuntiarum##3##1##(2008-10#3)
opératoire##2##1##(2012-2#2)
opératoires##5##1##(2011-2#2)(2012-2#1)(2013-1#2)
opérée##2##1##(2012-2#2)
or &gt##14##2##(1997-1#1)(2006-5#2)(2006-7#1)(2007-2#1)(2008-10#5)(2008-12#1)(2008-7#1)(2011-1#1)(2013-1#1)
or &lt##10##2##(1995-11#3)(1996-2#1)(2004-11#1)(2009-1#1)(2010-9#1)(2013-1#3)
or &quot##118##2##(1990-11#1)(1990-3#1)(1990-9#2)(1991-12#3)(1991-2#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#2)(1993-10#1)(1993-2#2)(1994-1#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-12#1)(2004-3#1)(2005-12#1)(2006-10#3)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-4#5)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#4)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#4)(2008-4#5)(2008-5#1)(2008-8#2)(2008-9#2)(2009-3#2)(2009-4#1)(2009-7#2)(2009-9#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-12#1)(2011-2#7)(2012-11#3)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#10)(2013-7#2)(2013-8#1)
or 'Rely'##2##2##(2008-10#2)
or 'not##2##2##(1994-6#1)(2008-10#1)
or (2)##7##2##(1990-11#1)(1997-4#1)(2008-2#1)(2008-6#1)(2008-9#2)(2013-7#1)
or (3) the##2##3##(1997-7#1)(2006-12#1)
or (3)##12##2##(1992-12#1)(1993-12#1)(1993-9#1)(1997-7#1)(2004-11#1)(2006-12#1)(2007-12#2)(2008-10#1)(2008-4#1)(2012-1#1)(2013-7#1)
or (4)##7##2##(1992-1#1)(2004-4#1)(2008-7#1)(2009-11#1)(2010-9#1)(2011-2#1)(2013-1#1)
or (5)##2##2##(1995-5#1)(2010-9#1)
or (DOMBT##2##2##(2008-10#2)
or (b)##3##2##(2008-3#1)(2008-5#1)(2013-8#1)
or (c)##2##2##(1995-8#1)(2008-10#1)
or (d)##2##2##(2008-2#1)(2012-2#1)
or (ii) an##2##3##(1992-8#1)(2010-5#1)
or (ii)##7##2##(1992-8#1)(1992-9#1)(1995-6#1)(1996-4#1)(1997-4#1)(2008-10#1)(2010-5#1)
or (iii)##4##2##(1994-6#1)(2008-10#1)(2008-11#1)(2009-7#1)
or -##5##2##(2006-6#1)(2007-8#1)(2008-5#2)(2010-6#1)
or -10 kPa##2##3##(2008-10#2)
or -10##3##2##(2008-10#2)(2012-2#1)
or -2##3##2##(1995-5#2)(1996-9#1)
or -3##2##2##(1990-2#1)(1991-10#1)
or -4##2##2##(1995-2#1)(1996-5#1)
or -deficient##6##2##(1997-4#6)
or 0##70##2##(1990-2#2)(1990-6#2)(1990-9#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-4#4)(1994-12#1)(1994-5#3)(1994-8#1)(1994-9#2)(1995-12#2)(1995-2#2)(1995-3#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-5#1)(1997-8#1)(2004-12#1)(2004-9#1)(2005-4#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#10)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-2#1)
or 1 mM##5##3##(1992-8#1)(1993-6#1)(1995-3#1)(1996-5#1)(2008-4#1)
or 1 mg/kg##2##3##(1996-10#1)(1997-4#1)
or 1 microM##3##3##(1992-8#1)(1995-11#1)(1995-12#1)
or 1##92##2##(1990-6#1)(1991-4#1)(1991-5#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-8#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-2#2)(1994-3#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-3#1)(1996-10#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-11#1)(2006-10#1)(2006-5#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#21)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#4)(2008-7#2)(2008-8#2)(2010-2#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-7#1)(2013-1#1)(2013-8#1)
or 1%##6##2##(1992-3#1)(2006-8#1)(2008-10#1)(2008-5#2)(2013-1#1)
or 1/4##2##2##(2008-11#1)(2008-3#1)
or 10 days##3##3##(1990-12#1)(1991-11#1)(2008-10#1)
or 10 degrees##2##3##(2005-11#1)(2008-10#1)
or 10 mM##4##3##(1991-2#1)(1995-8#1)(2006-8#2)
or 10 mg of##2##4##(1995-5#1)(2008-5#1)
or 10 mg##4##3##(1992-2#1)(1995-5#1)(2008-5#2)
or 10 mg/kg##5##3##(1991-6#1)(1995-7#1)(1996-10#1)(1996-12#1)(1997-2#1)
or 10 microM##4##3##(1995-5#1)(1996-10#1)(1997-1#1)(2006-8#1)
or 10 min##4##3##(1990-2#1)(1991-5#1)(1994-12#1)(1997-1#1)
or 10 ml##2##3##(1993-4#1)(1993-7#1)
or 10##62##2##(1990-10#1)(1990-12#2)(1990-2#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-2#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-12#1)(1994-3#1)(1994-5#2)(1995-5#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#2)(1996-12#2)(1996-5#2)(1996-6#1)(1997-1#2)(1997-2#1)(1997-7#1)(2004-11#1)(2005-11#1)(2006-5#1)(2006-8#3)(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#5)(2008-6#1)(2009-5#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
or 10%##11##2##(1990-8#1)(1993-12#1)(1995-11#1)(1995-5#1)(1996-11#1)(2004-9#1)(2005-12#1)(2007-12#1)(2008-10#2)(2011-2#1)
or 10(-4)##2##2##(1993-11#1)(2008-10#1)
or 10(-5)##2##2##(1994-2#1)(1997-4#1)
or 10(8)##2##2##(1991-11#1)(2008-10#1)
or 100 mg bromodichloromethane/kg body weight in corn oil by gavage##2##11##(2008-9#2)
or 100 mg##3##3##(2008-10#1)(2008-9#2)
or 100 mg/kg i##2##4##(1990-5#1)(1997-7#1)
or 100 mg/kg in corn oil by gavage##2##8##(2008-9#2)
or 100 mg/kg##9##3##(1990-4#1)(1990-5#1)(1995-2#1)(1997-7#1)(2007-2#1)(2008-9#4)
or 100 microM)##3##3##(1990-7#1)(1995-7#1)(1997-3#1)
or 100 nM##3##3##(1991-5#1)(1994-11#1)(1995-11#1)
or 100 ng/ml##2##3##(1995-6#1)(2008-12#1)
or 100##33##2##(1990-4#1)(1990-5#1)(1990-7#1)(1991-5#1)(1994-10#2)(1994-11#2)(1995-11#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-7#1)(1996-12#3)(1997-3#1)(1997-7#1)(2004-1#1)(2007-2#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#6)
or 100%##4##2##(2007-10#1)(2008-10#2)(2009-8#1)
or 1000##6##2##(1995-11#1)(1995-3#2)(1996-8#1)(2008-3#1)(2010-2#1)
or 10mg##2##2##(2008-3#1)(2010-4#1)
or 11##8##2##(1991-4#1)(1994-1#1)(1995-11#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-11#1)(2008-6#1)
or 12 mg dicyclohexylcarbodiimide/kg body weight in ethanol##3##8##(2008-9#3)
or 12 mg pentaerythritol triacrylate/kg body weight in acetone 5 days per week for 14 weeks##2##16##(2008-9#2)
or 12 mg pentaerythritol##3##4##(2008-9#3)
or 12 mg trimethylolpropane triacrylate/kg body weight in acetone 5 days per week for 14 weeks##2##16##(2008-9#2)
or 12 mg trimethylolpropane triacrylate/kg body weight in acetone 5 days per week for##3##14##(2008-9#3)
or 12 mg##9##3##(2008-9#9)
or 12 mg/kg##2##3##(2008-9#2)
or 12 months##2##3##(1996-11#1)(2006-8#1)
or 12 weeks##4##3##(2004-9#1)(2008-10#2)(2008-9#1)
or 12##35##2##(1990-9#1)(1992-1#1)(1992-11#1)(1993-4#1)(1994-6#1)(1995-1#1)(1996-11#1)(1996-9#2)(1997-5#1)(2004-9#1)(2005-7#1)(2006-5#2)(2006-8#1)(2007-11#2)(2007-7#1)(2008-10#2)(2008-9#13)(2010-8#1)(2013-1#1)
or 12)##2##2##(1995-2#1)(2008-10#1)
or 120 min##3##3##(1995-11#1)(2007-8#1)(2009-2#1)
or 120##6##2##(1992-11#1)(1995-11#1)(2007-4#1)(2007-8#1)(2008-5#1)(2009-2#1)
or 13##7##2##(1990-5#1)(1994-9#1)(1995-5#1)(1996-5#1)(1996-8#1)(2008-1#1)(2008-9#1)
or 13% of##2##3##(2007-10#1)(2008-8#1)
or 13-15##2##2##(1993-3#2)
or 131I##2##2##(1990-8#1)(1991-2#1)
or 14 days##4##3##(1993-12#1)(1995-3#1)(2007-2#1)(2013-8#1)
or 14##8##2##(1991-6#1)(1993-12#1)(1993-4#1)(1995-3#1)(2007-2#1)(2007-8#1)(2008-12#1)(2013-8#1)
or 15 mg##2##3##(2008-9#1)(2011-1#1)
or 15##15##2##(1992-3#1)(1993-7#1)(1994-8#1)(1997-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-9#2)(2010-2#1)(2011-1#1)
or 150##6##2##(1992-4#1)(1992-9#1)(1994-6#1)(2006-5#1)(2008-10#1)(2010-5#1)
or 16 h##3##3##(1994-12#1)(2010-8#1)(2011-2#1)
or 16##12##2##(1990-3#1)(1992-7#1)(1994-12#1)(1996-12#1)(2004-9#1)(2008-10#3)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)
or 17##4##2##(1992-5#1)(1993-4#1)(2008-5#2)
or 18##10##2##(1990-5#1)(1991-2#1)(1995-10#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
or 182##2##2##(1993-6#2)
or 19##6##2##(1996-12#1)(2005-10#1)(2006-10#1)(2008-5#1)(2008-9#1)(2009-3#1)
or 2 and##2##3##(2008-5#2)
or 2 micrograms/kg##2##3##(1993-1#1)(1995-5#1)
or 2##95##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-4#1)(1991-5#1)(1991-8#2)(1992-10#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-3#2)(1996-6#2)(1996-9#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#1)(2004-12#1)(2004-3#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-5#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#14)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#9)(2008-9#3)(2009-11#1)(2009-3#1)(2009-8#1)(2010-4#2)(2011-2#1)(2012-2#1)(2013-1#4)
or 2%##2##2##(2005-4#1)(2011-2#1)
or 2'-deoxyguanosine##2##2##(1992-4#2)
or 2) and##4##3##(1990-12#1)(1992-4#1)(2008-10#1)(2008-5#1)
or 2)##9##2##(1990-12#1)(1992-4#1)(1995-3#1)(2007-3#1)(2008-10#2)(2008-5#2)(2013-1#1)
or 20 degrees C##2##4##(2008-10#2)
or 20 mg/kg##2##3##(1996-10#1)(2007-7#1)
or 20 mumol Cu(II)(2) (3##2##5##(2008-5#2)
or 20 mumol##3##3##(2008-5#3)
or 20 or 40 mg twice a day##2##8##(1991-7#2)
or 20##18##2##(1990-6#1)(1991-7#2)(1994-2#1)(1995-10#1)(1996-10#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#4)(2009-10#1)(2010-2#1)(2011-2#1)
or 20%##6##2##(1993-11#1)(1996-11#1)(2007-11#1)(2008-4#1)(2009-3#2)
or 200 mg pentaerythritol triacrylate/kg body weight in acetone 5 days per week for 17 days##2##16##(2008-9#2)
or 200 mg trimethylolpropane triacrylate/kg body weight in acetone 5 days per week for 16 days##2##16##(2008-9#2)
or 200 mg##7##3##(2008-10#1)(2008-9#6)
or 200 mg/kg##2##3##(1995-3#1)(2008-9#1)
or 200##17##2##(1995-3#1)(1996-4#1)(1997-3#1)(2004-1#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#7)(2009-12#1)
or 21 days##3##3##(1994-3#1)(1996-12#1)(2008-10#1)
or 21##4##2##(1992-3#1)(1994-3#1)(1996-12#1)(2008-10#1)
or 23S RNA##2##3##(1996-9#2)
or 24 h of##2##4##(1994-10#1)(1995-12#1)
or 24 h##11##3##(1990-12#1)(1992-6#1)(1993-9#1)(1994-10#1)(1994-5#1)(1995-12#1)(1996-12#1)(2004-9#1)(2008-10#1)(2008-7#1)(2013-1#1)
or 24 hours##2##3##(2007-10#1)(2011-1#1)
or 24 hr##2##3##(2006-4#1)(2008-11#1)
or 24##23##2##(1990-11#2)(1990-12#1)(1992-6#1)(1993-9#1)(1994-10#1)(1994-5#1)(1995-12#1)(1996-12#1)(2004-9#2)(2006-4#1)(2007-10#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#1)
or 240##3##2##(1993-3#1)(2005-11#1)(2008-5#1)
or 25 degrees C##4##4##(1994-3#1)(2008-10#3)
or 25 mg##2##3##(2008-10#1)(2011-2#1)
or 25##14##2##(1992-11#1)(1992-8#1)(1994-3#2)(1997-5#1)(2008-10#5)(2008-5#1)(2009-8#1)(2010-12#1)(2011-2#1)
or 25%##2##2##(1994-10#1)(2008-10#1)
or 25-hydroxycholesterol##2##2##(1993-9#2)
or 250 muM##2##3##(2008-5#1)(2008-6#1)
or 256 mg sodium bromate/kg body weight##2##7##(2008-9#2)
or 256 mg##3##3##(2008-9#3)
or 27##5##2##(1992-8#2)(2008-10#1)(2008-9#2)
or 28 days##4##3##(1996-12#1)(2008-10#1)(2008-5#1)(2010-6#1)
or 28##12##2##(1996-12#1)(1996-6#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-6#1)(2011-1#1)(2013-1#1)
or 280##3##2##(1992-12#1)(2008-10#2)
or 29##4##2##(1992-11#1)(2007-8#1)(2008-10#1)(2008-7#1)
or 3 days##2##3##(1990-12#1)(1995-12#1)
or 3 h##4##3##(1990-3#1)(1991-6#1)(1992-5#1)(1995-3#1)
or 3 mg/kg)##2##3##(1993-12#1)(1996-10#1)
or 3 month##2##3##(1994-3#1)(2007-10#1)
or 3 months##3##3##(1991-12#1)(2008-9#2)
or 3##60##2##(1990-12#2)(1990-3#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-6#2)(1996-10#1)(1997-3#2)(2006-10#2)(2006-12#1)(2007-10#2)(2007-11#3)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-5#6)(2008-9#2)(2010-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-7#1)(2013-1#3)
or 3% acesulfame potassium (equivalent to average daily doses of approximately##2##11##(2008-9#2)
or 3%##4##2##(2008-9#3)(2011-2#1)
or 3'##3##2##(1993-6#1)(1994-3#1)(1995-1#1)
or 3)##4##2##(1993-4#1)(1994-5#1)(2008-10#1)(2012-1#1)
or 3-amino-1##2##2##(1997-4#1)(2009-2#1)
or 3-vessel disease##2##3##(1997-2#1)(2008-7#1)
or 30 days##2##3##(1992-12#1)(2012-12#1)
or 30 degrees C at pH##2##6##(2008-10#2)
or 30 degrees C##5##4##(2008-10#5)
or 30 mg/kg##4##3##(1991-6#2)(1994-2#1)(2008-10#1)
or 30 microM)##2##3##(1996-10#1)(2008-10#1)
or 30##34##2##(1991-2#2)(1991-5#1)(1991-6#2)(1992-12#1)(1993-11#2)(1993-12#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1996-1#1)(1996-10#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-5#1)(2008-10#12)(2008-6#1)(2012-12#1)(2013-1#1)
or 300##4##2##(1992-3#1)(2008-10#1)(2008-2#1)(2008-5#1)
or 32##3##2##(1993-3#1)(1997-5#1)(2007-2#1)
or 35##3##2##(2006-10#1)(2008-10#1)(2012-2#1)
or 36 degrees C##2##4##(2008-10#2)
or 36##4##2##(1994-10#1)(2008-10#2)(2008-5#1)
or 360 sec)##2##3##(2008-5#2)
or 360##3##2##(1994-5#1)(2008-5#2)
or 37 degrees C##6##4##(1990-11#1)(1990-8#1)(1991-3#1)(1992-6#1)(2006-9#1)(2007-6#1)
or 37##7##2##(1990-11#1)(1990-8#1)(1991-3#1)(1992-6#1)(2006-9#1)(2007-6#1)(2013-8#1)
or 3D##3##2##(2008-6#2)(2010-4#1)
or 4 consecutive days##2##4##(2008-7#2)
or 4 days##2##3##(1996-10#1)(1997-8#1)
or 4 degrees C##2##4##(2006-5#1)(2008-10#1)
or 4 weeks##4##3##(2008-7#1)(2013-1#2)(2013-8#1)
or 4 were##3##3##(1993-1#1)(2006-3#1)(2007-8#1)
or 4##54##2##(1990-6#1)(1990-7#1)(1991-8#1)(1991-9#1)(1993-1#1)(1993-12#1)(1993-4#1)(1994-12#2)(1994-3#1)(1994-9#1)(1996-10#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-3#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-8#3)(2008-10#8)(2008-2#1)(2008-6#2)(2008-7#4)(2008-9#3)(2009-3#1)(2009-4#1)(2011-2#2)(2013-1#3)(2013-8#1)
or 4% of##2##3##(2008-1#1)(2012-2#1)
or 4%##3##2##(2008-1#1)(2012-2#2)
or 4'##2##2##(1993-11#1)(2010-2#1)
or 4)##4##2##(1997-7#1)(2008-10#3)
or 40 mumol##3##3##(2008-5#3)
or 40##16##2##(1991-5#1)(1991-7#4)(1991-8#1)(1993-2#1)(1997-3#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#1)
or 40%##2##2##(2004-9#1)(2007-8#1)
or 400##5##2##(1991-9#1)(2008-1#1)(2008-5#1)(2008-9#1)(2010-2#1)
or 4000 U/kg##2##3##(2010-2#2)
or 41 weeks##6##3##(2008-9#6)
or 41##7##2##(2005-10#1)(2008-9#6)
or 42##5##2##(2008-10#1)(2008-9#2)(2009-7#1)(2011-2#1)
or 45 degrees##2##3##(1992-10#1)(2008-10#1)
or 45##4##2##(1992-10#1)(2008-10#1)(2008-7#1)(2008-9#1)
or 48 h after##2##4##(1992-3#1)(2010-12#1)
or 48 h##7##3##(1991-2#1)(1992-3#1)(2008-10#3)(2009-8#1)(2010-12#1)
or 48##10##2##(1991-2#1)(1992-3#1)(1996-10#1)(2005-10#1)(2008-10#3)(2008-9#1)(2009-8#1)(2010-12#1)
or 48-h##2##2##(1991-6#1)(1997-8#1)
or 4h##2##2##(2010-4#2)
or 5 days##5##3##(1996-10#1)(1997-8#1)(2008-10#1)(2008-5#2)
or 5 h##2##3##(1991-6#1)(1997-2#1)
or 5 mM##2##3##(1996-11#1)(2008-11#1)
or 5 mg##2##3##(2007-10#1)(2010-4#1)
or 5 microM##2##3##(1990-7#1)(1997-8#1)
or 5##42##2##(1990-11#1)(1990-12#2)(1990-7#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-5#1)(1992-8#1)(1994-11#1)(1995-12#1)(1995-6#1)(1995-9#2)(1996-10#1)(1996-11#3)(1996-3#1)(1996-5#3)(1996-6#1)(1997-2#1)(1997-8#2)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-9#2)(2010-4#1)(2012-2#1)(2013-1#2)
or 5%##7##2##(1997-2#1)(2007-12#1)(2008-10#1)(2008-4#1)(2010-4#1)(2012-12#2)
or 5'##4##2##(1994-8#1)(2008-10#1)(2008-7#2)
or 5')##2##2##(1990-4#1)(1991-3#1)
or 5'-GC##2##2##(2008-11#2)
or 5'-N-ethylcarboxamido-adenosine##2##2##(1995-8#2)
or 5-HT##3##2##(1990-4#1)(1993-4#1)(1994-2#1)
or 5-lipoxygenase##2##2##(1993-6#1)(2007-11#1)
or 50 degrees C##2##4##(1997-6#1)(2008-10#1)
or 50 mM##3##3##(1991-5#1)(1995-3#1)(1995-8#1)
or 50 mg##2##3##(2005-7#1)(2011-12#1)
or 50 mg/kg body##2##4##(1993-4#1)(1996-6#1)
or 50 mg/kg##3##3##(1993-4#1)(1994-12#1)(1996-6#1)
or 50 microM##3##3##(1990-7#1)(1995-5#1)(1996-12#1)
or 50 ppm Cd as CdCl(2)##2##6##(1997-4#2)
or 50 ppm Cd as##3##5##(1997-4#3)
or 50 ppm##4##3##(1997-4#3)(2008-5#1)
or 50##35##2##(1990-5#1)(1990-7#1)(1991-5#1)(1992-12#1)(1992-6#1)(1993-4#1)(1993-7#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-12#1)(1996-6#1)(1997-4#3)(1997-6#1)(1997-8#1)(2005-7#1)(2008-10#7)(2008-5#1)(2008-8#5)(2011-12#1)
or 50%##5##2##(1994-12#1)(2007-10#1)(2011-2#1)(2013-8#2)
or 500 mL of pond water##2##6##(2012-3#2)
or 500##9##2##(1993-12#1)(1995-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#2)(2012-3#2)
or 52##2##2##(1993-6#1)(2008-10#1)
or 56%##2##2##(1996-12#1)(2009-12#1)
or 5th##2##2##(1991-11#1)(2008-11#1)
or 6 days##3##3##(2009-10#3)
or 6 h##4##3##(1993-4#1)(1995-12#1)(2008-7#1)(2010-8#1)
or 6 weeks##3##3##(1991-2#1)(1997-3#1)(2008-5#1)
or 6##31##2##(1990-11#1)(1991-2#2)(1991-6#1)(1991-7#1)(1991-8#1)(1993-4#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#3)(2010-8#1)(2012-1#1)
or 60 min##7##3##(1991-5#1)(1992-10#1)(1992-11#2)(1995-12#1)(2008-5#2)
or 60##10##2##(1991-3#1)(1991-5#1)(1992-10#1)(1992-11#2)(1995-12#1)(2008-12#1)(2008-5#2)(2010-4#1)
or 60%##3##2##(1995-12#1)(1995-3#1)(2004-11#1)
or 61##4##2##(1991-5#2)(2005-10#1)(2008-9#1)
or 65##2##2##(2006-2#1)(2008-9#1)
or 66%##2##2##(2006-10#1)(2007-3#1)
or 7 days after##3##4##(1994-5#1)(1995-9#1)(2008-2#1)
or 7 days##5##3##(1994-5#1)(1995-9#1)(1997-4#1)(2008-2#2)
or 7##24##2##(1990-2#2)(1990-3#1)(1990-9#1)(1991-8#1)(1994-5#1)(1995-9#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-7#1)(2006-8#1)(2008-10#1)(2008-2#2)(2008-5#2)(2008-8#2)(2011-2#1)(2012-11#1)(2012-9#1)
or 7%##2##2##(1993-8#1)(1996-11#1)
or 7)##2##2##(2004-3#2)
or 70 mg/kg in ethanol##2##5##(2008-9#2)
or 70 mg/kg##3##3##(2008-9#3)
or 70##7##2##(1991-8#1)(2006-8#1)(2008-9#4)(2009-3#1)
or 700 mg/L bromodichloromethane for 26 weeks (equivalent to average daily doses of approximately##2##14##(2008-9#2)
or 700 mg/L bromodichloromethane for##3##5##(2008-9#3)
or 700 mg/L##6##3##(2008-9#6)
or 72 h of##2##4##(1995-11#1)(2008-7#1)
or 72 h##4##3##(1995-11#1)(1996-12#1)(2008-5#1)(2008-7#1)
or 72##5##2##(1995-11#1)(1996-12#1)(2008-5#1)(2008-7#1)(2011-12#1)
or 75##4##2##(2004-12#1)(2008-10#1)(2008-5#1)(2010-9#1)
or 78##2##2##(1992-2#1)(2011-1#1)
or 78%##2##2##(2006-7#1)(2006-8#1)
or 8 h##2##3##(1990-5#1)(1996-2#1)
or 8 weeks of##2##4##(1990-4#1)(2013-1#1)
or 8 weeks##4##3##(1990-4#1)(1992-3#1)(2012-2#1)(2013-1#1)
or 8##20##2##(1990-4#1)(1990-5#1)(1992-1#1)(1992-3#1)(1994-2#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-2#1)(2006-11#1)(2006-2#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2012-2#1)(2013-1#1)
or 8-position##2##2##(1997-3#1)(2008-4#1)
or 80 mg/kg##2##3##(1996-10#1)(1997-3#1)
or 80##6##2##(1992-2#1)(1996-10#1)(1997-3#1)(2005-11#1)(2006-10#1)(2008-3#1)
or 80%##2##2##(1992-11#1)(2008-8#1)
or 800 mg/L sodium bromate for 27 weeks (equivalent to average daily doses of approximately##2##15##(2008-9#2)
or 800 mg/L sodium bromate for 43 weeks (equivalent to average daily doses of approximately##2##15##(2008-9#2)
or 800 mg/L sodium bromate for##4##6##(2008-9#4)
or 800 mg/L##5##3##(2008-9#5)
or 800##6##2##(2008-9#6)
or 87##2##2##(1994-3#1)(2008-4#1)
or 9##10##2##(1990-8#1)(1992-9#1)(1993-11#1)(1993-9#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-8#2)
or 90 min##2##3##(1995-12#1)(1997-2#1)
or 90 ppm##5##3##(1996-11#5)
or 90##14##2##(1995-12#1)(1995-2#2)(1996-11#5)(1997-2#1)(2006-8#1)(2007-12#1)(2008-5#2)(2009-5#1)
or 900##2##2##(1990-5#1)(2012-3#1)
or 91 amino##2##3##(1991-2#2)
or 96 h##3##3##(1994-6#1)(1996-12#1)(2008-10#1)
or 96##5##2##(1994-6#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)
or 99%##2##2##(2008-10#2)
or = 0##42##3##(1992-11#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-4#1)(1996-11#1)(1996-2#2)(1996-3#3)(1996-9#1)(1997-1#1)(2005-12#1)(2005-7#2)(2005-9#2)(2006-9#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#3)(2009-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#4)
or = 1 nM)##3##4##(1993-11#3)
or = 1##25##3##(1993-11#4)(1993-9#1)(1994-6#1)(1994-9#2)(1995-10#2)(1996-11#1)(1996-5#1)(1996-7#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-12#1)(2008-3#2)(2008-5#1)(2011-2#3)(2012-2#1)
or = 1)##2##3##(1992-6#1)(2007-4#1)
or = 10 microM)##2##4##(1994-2#1)(1994-3#1)
or = 10 mm##2##4##(1994-9#1)(1997-5#1)
or = 10##14##3##(1993-11#2)(1994-2#1)(1994-3#1)(1994-9#1)(1996-6#1)(1997-1#1)(1997-5#2)(2006-2#1)(2006-6#3)(2013-8#1)
or = 10(4)##2##3##(1997-3#1)(2007-12#1)
or = 10(7)##2##3##(1993-12#1)(1997-5#1)
or = 10)##2##3##(1996-8#1)(2005-11#1)
or = 100##4##3##(1994-8#1)(1995-5#1)(2007-8#1)(2008-3#1)
or = 12##2##3##(2007-8#1)(2008-10#1)
or = 14)##2##3##(2008-7#2)
or = 15##4##3##(1994-12#1)(1995-3#1)(2007-4#2)
or = 1500 g##2##4##(1993-5#1)(1994-6#1)
or = 180 microm##2##4##(2008-5#2)
or = 2##16##3##(1992-10#2)(1992-9#1)(1993-9#1)(1995-2#1)(1995-5#4)(1996-12#2)(2005-4#1)(2006-12#1)(2007-10#1)(2008-5#1)(2012-2#1)
or = 2-fold##2##3##(1995-1#1)(2007-11#1)
or = 20 microM##2##4##(1995-8#2)
or = 20##10##3##(1995-8#4)(1997-1#1)(1997-5#1)(1997-8#1)(2007-3#1)(2008-10#1)(2008-3#1)
or = 20%)##2##3##(2008-8#2)
or = 200##3##3##(1993-11#1)(2007-8#1)(2012-2#1)
or = 240 mg/dL##2##4##(2012-2#2)
or = 240##3##3##(1997-3#1)(2012-2#2)
or = 25##5##3##(1994-6#1)(1995-11#1)(1995-6#1)(2005-8#1)(2012-2#1)
or = 25% restenosis##2##4##(2005-10#2)
or = 25)##2##3##(1997-8#1)(2008-7#1)
or = 250##2##3##(1997-4#1)(2009-3#1)
or = 3 mg/kg) produced##2##5##(1993-11#2)
or = 3##8##3##(1993-11#3)(1995-6#1)(1996-2#1)(1996-4#1)(2005-1#1)(2007-8#1)
or = 30 kg/m2##2##4##(2007-8#1)(2011-2#1)
or = 30##9##3##(1994-12#1)(1994-8#1)(2006-10#1)(2007-10#2)(2007-8#1)(2008-3#1)(2011-2#2)
or = 32##3##3##(1994-6#1)(1995-6#1)(2008-12#1)
or = 35 yrs)##2##4##(2012-3#2)
or = 35##5##3##(1992-12#1)(1997-1#1)(1997-2#1)(2012-3#2)
or = 37##3##3##(1994-3#1)(2006-4#1)(2008-7#1)
or = 4##10##3##(1996-1#1)(1996-12#2)(1996-5#1)(1997-1#1)(1997-8#1)(2005-10#1)(2008-5#1)(2012-2#2)
or = 40##5##3##(1994-12#1)(1994-9#2)(1995-12#1)(2013-1#1)
or = 400##2##3##(2008-3#1)(2011-2#1)
or = 4g/dl##2##3##(1996-12#2)
or = 5##16##3##(1992-12#1)(1993-8#4)(1994-12#2)(1994-3#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-6#1)(1997-5#1)(1997-8#1)(2005-8#1)(2007-3#1)
or = 50 years##2##4##(1995-5#1)(2012-12#1)
or = 50##6##3##(1995-5#1)(1997-1#1)(1997-5#1)(2004-1#1)(2007-8#1)(2012-12#1)
or = 50% restenosis##2##4##(2005-10#2)
or = 50%##5##3##(1995-12#1)(2005-10#2)(2007-10#1)(2008-8#1)
or = 500/mm3)##2##3##(1996-8#1)(2012-12#1)
or = 55##2##3##(1993-9#1)(1995-9#1)
or = 6 and 40 healthy controls were collected by sterile curette##2##12##(2008-12#2)
or = 6##7##3##(1995-3#1)(1995-9#1)(1996-3#1)(2006-8#1)(2007-8#1)(2008-12#2)
or = 6)##4##3##(2007-3#3)(2008-8#1)
or = 60 years##2##4##(2007-10#1)(2012-12#1)
or = 60##4##3##(1997-8#1)(2007-10#2)(2012-12#1)
or = 65##2##3##(1992-12#1)(2011-2#1)
or = 7##4##3##(1993-1#1)(1993-6#2)(1997-5#1)
or = 70##3##3##(1996-3#1)(2008-1#1)(2008-3#1)
or = 70% restenosis##2##4##(2005-10#2)
or = 70%##3##3##(2005-10#2)(2007-8#1)
or = 75 microm##2##4##(2008-5#2)
or = 75##3##3##(2007-8#1)(2008-5#2)
or = 8##2##3##(1992-9#1)(2008-7#1)
or = 90##2##3##(1995-6#1)(1997-3#1)
or = 90% for the##2##5##(2006-8#1)(2012-12#1)
or = 90%##4##3##(2006-7#1)(2006-8#1)(2012-12#2)
or = 90%)##2##3##(1993-9#1)(2012-12#1)
or = 98%##2##3##(1994-6#1)(2013-8#1)
or = T##2##3##(1997-6#1)(2010-7#1)
or =##373##2##(1992-10#2)(1992-11#2)(1992-12#4)(1992-6#1)(1992-9#3)(1993-1#1)(1993-11#12)(1993-12#4)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#4)(1993-9#5)(1994-12#11)(1994-2#2)(1994-3#4)(1994-5#2)(1994-6#5)(1994-8#4)(1994-9#6)(1995-1#3)(1995-10#3)(1995-11#3)(1995-12#2)(1995-2#5)(1995-3#3)(1995-4#1)(1995-5#8)(1995-6#5)(1995-8#5)(1995-9#2)(1996-1#1)(1996-11#2)(1996-12#9)(1996-2#4)(1996-3#5)(1996-4#1)(1996-5#3)(1996-6#3)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#9)(1997-2#7)(1997-3#4)(1997-4#4)(1997-5#12)(1997-6#4)(1997-8#11)(2004-1#1)(2005-1#1)(2005-10#9)(2005-11#3)(2005-12#1)(2005-4#1)(2005-7#2)(2005-8#3)(2005-9#4)(2006-10#4)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#4)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#6)(2007-11#3)(2007-12#2)(2007-2#2)(2007-3#6)(2007-4#3)(2007-8#12)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#4)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#12)(2008-7#9)(2008-8#4)(2009-2#1)(2009-3#1)(2009-5#7)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#10)(2012-12#8)(2012-2#13)(2012-3#2)(2013-1#1)(2013-8#2)
or =0##10##2##(1996-6#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-4#1)(2009-2#1)(2009-4#1)
or =1##5##2##(2006-10#1)(2008-10#2)(2008-4#1)(2011-2#1)
or =10##5##2##(2005-11#2)(2007-3#1)(2008-10#1)(2010-3#1)
or =150 ms in the ischaemic group##2##7##(2008-10#2)
or =150 ms##3##3##(2008-10#3)
or =2##4##2##(2006-8#1)(2008-10#1)(2008-3#1)(2011-2#1)
or =20##3##2##(2008-11#1)(2008-5#1)(2011-1#1)
or =25 Kg/m2)##2##3##(2008-10#2)
or =25##5##2##(2008-10#3)(2011-2#2)
or =256 microg/mL)##2##3##(2006-5#2)
or =3##4##2##(2006-12#1)(2007-12#1)(2008-10#2)
or =30##3##2##(2008-3#2)(2008-7#1)
or =30%##2##2##(2009-4#2)
or =4##3##2##(1997-5#1)(2008-10#1)(2011-2#1)
or =40##2##2##(2005-11#1)(2006-10#1)
or =5 x 10(-2))##2##4##(2005-11#2)
or =5##3##2##(2005-11#2)(2013-8#1)
or =50%##2##2##(2007-9#1)(2011-2#1)
or =6##3##2##(2008-10#3)
or =60 years##2##3##(2007-12#1)(2008-3#1)
or =60##5##2##(2007-12#1)(2007-9#1)(2008-3#1)(2008-7#2)
or =65##2##2##(2007-8#2)
or =75 years##2##3##(2007-8#2)
or =75##3##2##(2007-8#2)(2013-8#1)
or =90##2##2##(2007-9#1)(2008-3#1)
or A beta##4##3##(1994-3#1)(1995-3#2)(1996-6#1)
or A##7##2##(1994-3#1)(1995-3#2)(1996-6#1)(2004-11#1)(2007-2#1)(2008-10#1)
or A23187##5##2##(1991-5#1)(1994-3#1)(1997-2#1)(2004-12#1)(2008-11#1)
or AC##2##2##(1990-3#1)(1995-3#1)
or ACBP##2##2##(1994-8#2)
or ADP##12##2##(1990-3#1)(1992-3#4)(1992-6#1)(1993-8#1)(1994-10#2)(1994-11#1)(1994-9#1)(1997-7#1)
or AIDS##8##2##(1991-6#1)(1992-1#1)(1992-2#1)(1995-6#2)(2007-1#1)(2008-5#2)
or AMP##3##2##(1990-11#1)(1991-1#1)(1992-6#1)
or APLP2 mRNA##2##3##(1996-12#2)
or AS##2##2##(1994-6#1)(1996-3#1)
or ATP##13##2##(1990-7#1)(1990-9#1)(1991-7#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-3#1)(1996-7#1)(1996-9#1)(1997-4#1)(2007-10#2)
or ATP)##2##2##(1993-4#1)(1995-6#1)
or Al##2##2##(2007-9#1)(2008-10#1)
or Ala##4##2##(1990-11#1)(1992-4#1)(1992-9#1)(1995-2#1)
or Alzheimer's disease##2##3##(1997-7#1)(2005-11#1)
or Alzheimer's##3##2##(1993-12#1)(1997-7#1)(2005-11#1)
or Ar atoms##3##3##(2010-4#3)
or Ar##5##2##(2010-4#5)
or Arab##2##2##(2007-2#1)(2008-10#1)
or Arg##3##2##(1992-4#1)(1994-8#1)(1996-5#1)
or Asia##2##2##(2007-4#1)(2008-10#1)
or Asian##3##2##(2008-12#1)(2010-11#1)(2010-8#1)
or Asn##2##2##(1997-3#1)(1997-4#1)
or Asp##2##2##(1990-7#1)(1993-3#1)
or B##32##2##(1990-8#1)(1991-6#1)(1993-11#1)(1993-4#1)(1995-3#1)(1995-9#3)(1996-8#1)(1997-5#4)(1997-6#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#1)(2008-10#3)(2008-9#1)(2009-3#1)(2010-6#1)(2012-2#1)(2013-8#3)
or BHA##2##2##(2007-3#2)
or BMD##2##2##(2006-8#1)(2009-5#1)
or BMI##2##2##(1996-9#1)(2008-3#1)
or BSA##3##2##(2006-5#3)
or Beta-blockers##2##2##(2007-9#2)
or Bradford##2##2##(1994-8#1)(2008-9#1)
or BuONa##2##2##(1993-8#2)
or C and##4##3##(1993-3#1)(2005-10#1)(2009-8#1)(2012-2#1)
or C##29##2##(1991-6#1)(1992-6#1)(1993-3#3)(1997-2#1)(2005-10#1)(2007-11#4)(2007-12#3)(2007-9#1)(2008-10#6)(2008-2#1)(2008-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
or C-terminal##8##2##(1990-10#1)(1992-5#1)(1992-9#2)(1996-12#1)(1996-6#1)(2008-9#1)(2011-2#1)
or C18)##2##2##(2005-11#1)(2005-3#1)
or C57BL/6 mice##2##3##(1995-10#1)(2013-1#1)
or C6##2##2##(1992-6#1)(2012-2#1)
or C8##2##2##(1992-11#1)(1995-8#1)
or CA##2##2##(1995-10#1)(1997-3#1)
or CAT##2##2##(1993-10#1)(2008-10#1)
or CCK-8##2##2##(1995-11#1)(1995-12#1)
or CCK-8-induced [14C]aminopyrine accumulation##2##4##(1995-12#2)
or CD##2##2##(2007-2#1)(2008-7#1)
or CD14##2##2##(2012-12#1)(2012-3#1)
or CD8##2##2##(1992-4#1)(2007-2#1)
or CD8+##2##2##(1996-3#1)(1997-7#1)
or CFA##2##2##(1995-3#2)
or CHO-CHO##2##2##(2013-1#2)
or CI##3##2##(2008-9#1)(2012-2#1)(2013-1#1)
or CNP##2##2##(1990-7#1)(1992-11#1)
or CO##2##2##(1991-9#1)(1992-3#1)
or COS-7 cells##2##3##(1991-12#1)(1996-5#1)
or CRS##2##2##(2012-11#2)
or CS from the patient perspective is needed##2##8##(2013-1#2)
or CS##3##2##(2008-10#1)(2013-1#2)
or CSF##2##2##(1994-8#1)(2010-12#1)
or CT in##2##3##(2005-10#1)(2007-11#1)
or CT##13##2##(1995-7#1)(2005-10#1)(2006-6#1)(2006-9#1)(2007-11#2)(2007-6#1)(2007-8#1)(2008-10#1)(2008-4#2)(2009-7#1)(2013-1#1)
or Ca(2+) channel##2##3##(2008-8#1)(2012-2#1)
or Ca(2+)##4##2##(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#1)
or Ca(2+)-free##3##2##(1991-9#1)(1993-12#1)(2008-4#1)
or Ca(II)##2##2##(2005-11#1)(2008-10#1)
or Ca2+##10##2##(1990-5#1)(1991-12#1)(1991-9#1)(1992-5#1)(1992-8#1)(1993-3#1)(1994-3#1)(1994-6#1)(1995-5#1)(2007-12#1)
or CaCl(2)##2##2##(2008-10#2)
or Candida##2##2##(2005-8#1)(2008-5#1)
or Cd2+##2##2##(1995-1#1)(1995-12#1)
or CdCl2##2##2##(1991-4#1)(2007-9#1)
or Cl##3##2##(1997-7#3)
or Co(2+)##2##2##(2008-11#1)(2008-8#1)
or Crohn's disease##3##3##(1991-8#1)(1994-2#1)(2009-12#1)
or Cu##3##2##(1997-4#1)(2008-7#1)(2010-5#1)
or Cu(II) ions##2##3##(2005-11#1)(2011-1#1)
or Cu(II)##3##2##(2005-11#1)(2008-10#1)(2011-1#1)
or Cys##5##2##(1990-8#1)(1996-5#2)(1997-4#1)(2011-2#1)
or Cys486##2##2##(1994-11#2)
or Cys511##2##2##(1994-11#2)
or D##11##2##(1991-7#1)(1992-5#1)(1994-2#1)(1995-11#1)(1995-8#1)(2007-7#1)(2008-10#1)(2009-8#1)(2010-7#3)
or D2##3##2##(1993-6#1)(1994-10#1)(1995-2#1)
or DA##3##2##(1996-11#1)(2008-5#1)(2013-7#1)
or DMSO##4##2##(1990-7#1)(1996-9#1)(2008-1#1)(2008-2#1)
or DNA constituents##2##3##(2008-10#2)
or DNA from##2##3##(2008-4#1)(2013-8#1)
or DNA sequence##3##3##(2008-10#1)(2008-9#1)(2009-2#1)
or DNA##38##2##(1990-11#1)(1991-2#2)(1991-5#1)(1992-3#1)(1994-3#1)(1994-6#1)(1994-8#1)(1996-2#1)(1997-4#1)(1997-6#2)(1997-8#1)(2005-4#1)(2006-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-4#5)(2008-9#3)(2009-2#1)(2010-12#1)(2010-2#1)(2010-4#1)(2013-8#1)
or DOS##2##2##(2008-10#1)(2010-2#1)
or DSM-IV##2##2##(2008-1#1)(2009-7#1)
or DTT##6##2##(1992-3#5)(1994-12#1)
or Drosophila##3##2##(1990-6#1)(1994-8#1)(2007-12#1)
or Dynastab stabilizers##2##3##(2007-8#2)
or E##14##2##(1992-9#1)(1994-2#1)(1996-12#1)(1997-3#1)(1997-6#1)(2005-10#1)(2008-1#1)(2008-10#5)(2008-5#1)(2008-8#1)
or E-selectin##2##2##(1995-12#1)(1996-3#1)
or E12R1+E12R2##2##2##(1997-2#2)
or E64-d##2##2##(1994-12#2)
or EC##2##2##(1993-6#1)(1994-2#1)
or EGF##3##2##(1990-8#1)(1995-8#1)(1996-5#1)
or EGTA##4##2##(1991-8#1)(1993-6#1)(1994-3#1)(1995-6#1)
or English##2##2##(2008-11#1)(2009-10#1)
or Escherichia coli##2##3##(2008-10#1)(2008-7#1)
or Europe##3##2##(2007-3#1)(2008-7#1)(2012-3#1)
or European##3##2##(2005-7#1)(2007-7#1)(2008-10#1)
or F##11##2##(1990-10#1)(1990-4#1)(1992-6#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-10#3)
or F2##2##2##(1990-2#1)(2013-8#1)
or Fab##2##2##(1990-12#1)(2008-4#1)
or Fisher exact tests##2##4##(2006-12#1)(2007-9#1)
or Fourier##2##2##(2006-10#1)(2008-10#1)
or G x##3##3##(2009-2#3)
or G##10##2##(1990-12#1)(1992-3#2)(1993-9#1)(2008-10#2)(2009-2#3)(2013-8#1)
or G) were##2##3##(1992-9#1)(2008-8#1)
or G-CSF in##2##3##(2008-7#2)
or G-rich##2##2##(1996-4#1)(2008-1#1)
or G2/M##2##2##(1994-9#1)(2008-11#1)
or G8 showed##2##3##(2009-3#2)
or GABA##3##2##(1995-6#1)(1996-9#2)
or GDP##6##2##(1990-5#1)(1990-8#1)(1993-8#2)(1994-3#1)(1995-5#1)
or GH##2##2##(2010-8#1)(2013-7#1)
or GHR##2##2##(1995-3#1)(2008-1#1)
or GM-CSF##6##2##(1990-11#1)(1993-6#2)(1995-6#1)(1997-4#1)(2009-12#1)
or GO terms##2##3##(2008-7#1)(2010-4#1)
or GSSG##2##2##(1995-5#1)(1997-8#1)
or GTP gamma S##4##4##(1991-6#1)(1992-7#2)(1992-8#1)
or GTP##7##2##(1990-7#2)(1991-6#1)(1992-7#2)(1992-8#1)(1995-3#1)
or German##2##2##(2007-9#1)(2011-2#1)
or Glu##3##2##(1990-5#1)(1992-6#1)(1996-7#1)
or Group##2##2##(2006-8#1)(2007-9#1)
or H##7##2##(1993-3#1)(1995-5#1)(1997-2#1)(2006-2#1)(2008-10#1)(2011-12#1)(2011-2#1)
or H2##6##2##(1993-11#1)(1995-10#2)(2006-8#1)(2008-10#1)(2008-4#1)
or HAP##3##2##(2008-9#3)
or HDL##3##2##(1996-5#1)(1997-7#1)(2005-10#1)
or HEM##2##2##(1995-12#2)
or HIV infection##3##3##(1990-12#1)(1997-5#1)(2008-10#1)
or HIV##9##2##(1990-12#1)(1997-3#1)(1997-5#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-12#1)(2009-5#1)(2012-2#1)
or HIV-1 infection##2##3##(1993-7#1)(1995-12#1)
or HIV-1##3##2##(1991-4#1)(1993-7#1)(1995-12#1)
or HLA##3##2##(2008-4#1)(2011-2#1)(2013-8#1)
or HNO(3)##6##2##(2008-10#6)
or Hb##2##2##(2008-7#2)
or HindIII##2##2##(1992-4#1)(1993-11#1)
or I##4##2##(1997-1#1)(2008-10#1)(2008-12#1)(2011-2#1)
or IB##2##2##(2013-8#2)
or ICSI##2##2##(2010-12#1)(2013-7#1)
or IGF##2##2##(1993-9#1)(2008-4#1)
or IGF-I##6##2##(1991-12#1)(1992-3#2)(1992-6#1)(1995-12#2)
or II##24##2##(1990-10#1)(1992-8#2)(1995-7#1)(1996-6#1)(1997-6#2)(2005-7#1)(2006-10#2)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-8#1)(2009-6#1)(2010-7#1)(2012-3#1)(2013-1#1)
or III##11##2##(1995-12#1)(2005-8#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-12#1)(2013-7#1)
or IL-1##5##2##(1993-12#1)(1995-6#1)(1996-12#1)(2007-11#2)
or IL-10##2##2##(1996-12#2)
or IL-12##2##2##(1996-10#2)
or IL-4##2##2##(1995-12#1)(1995-8#1)
or IL-6##4##2##(1996-11#1)(1996-12#1)(2007-11#1)(2008-4#1)
or IPRO##3##2##(2008-10#3)
or IV##12##2##(1992-9#1)(1997-6#1)(2004-1#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-4#2)(2008-5#1)(2009-3#1)(2011-2#1)(2012-2#1)
or IgM##2##2##(1991-11#1)(1996-12#1)
or Ile##2##2##(1992-8#1)(1994-9#1)
or JAK2##2##2##(1995-3#1)(2005-8#1)
or K+##5##2##(1990-12#1)(1990-8#1)(1993-11#1)(1993-3#1)(1995-12#1)
or KCl##4##2##(1992-6#1)(1996-2#1)(2009-5#2)
or KN-62##2##2##(1997-8#2)
or KT##3##2##(2008-9#3)
or L##3##2##(1990-12#1)(2006-5#1)(2008-5#1)
or L-type voltage-gated##2##3##(1997-7#1)(2008-8#1)
or L-tyrosine##2##2##(2008-5#2)
or LDL cholesterol##2##3##(1993-12#1)(2005-10#1)
or LIM##2##2##(1990-7#1)(2008-1#1)
or LPS##7##2##(1990-12#1)(1995-12#2)(1997-7#1)(2006-8#1)(2007-2#1)(2008-11#1)
or LS-CMV##2##2##(2008-10#2)
or LTP##3##2##(1995-2#1)(1996-2#1)(1997-1#1)
or LY294002##2##2##(1995-3#1)(2007-3#1)
or Lys##3##2##(1990-8#1)(1993-3#1)(1995-5#1)
or M##12##2##(1990-3#2)(2007-11#1)(2008-10#7)(2008-3#1)(2008-5#1)
or MAP##5##2##(1996-10#3)(1996-3#1)(2009-12#1)
or MDL 72222 (0##2##4##(1990-2#2)
or ME##2##2##(1993-2#1)(2008-10#1)
or MG##2##2##(2007-12#1)(2008-10#1)
or MR##3##2##(1995-3#1)(2006-8#1)(2012-12#1)
or MRI is##2##3##(2008-1#2)
or MRI##11##2##(2007-11#2)(2007-5#1)(2007-8#1)(2008-1#3)(2008-7#1)(2010-12#1)(2010-5#1)(2012-12#1)
or MRP##2##2##(2008-11#2)
or MY(2-)) species are##2##4##(2008-10#2)
or Mab##2##2##(1990-5#2)
or Medicaid##2##2##(1992-1#1)(1995-12#1)
or Met)##2##2##(1991-9#1)(1994-8#1)
or Mg2+##11##2##(1990-10#1)(1990-7#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1994-12#1)(1995-5#1)(1995-6#1)(1997-1#1)(1997-3#1)
or Mg2+)##2##2##(1990-4#1)(1995-6#1)
or Middle##2##2##(2008-10#2)
or Mn2+##7##2##(1991-7#1)(1993-4#3)(1995-2#1)(1996-6#1)(1996-7#1)
or Monte Carlo##3##3##(2007-11#1)(2008-2#1)(2008-4#1)
or Mycoplasma##2##2##(1997-3#1)(2013-8#1)
or N##6##2##(1990-10#1)(1992-3#1)(1995-8#1)(2008-10#2)(2008-7#1)
or NADH##2##2##(1990-8#1)(1992-6#1)
or NADPH##4##2##(1991-2#1)(1994-2#1)(2008-10#1)(2009-10#1)
or NAS##2##2##(1992-10#1)(2011-2#1)
or NE##3##2##(1993-2#1)(1994-6#1)(1994-8#1)
or NG corn##3##3##(2009-4#3)
or NMDA##5##2##(1993-2#1)(1994-9#1)(1995-12#1)(1996-6#2)
or NMR##4##2##(2008-4#3)(2011-1#1)
or NPY##3##2##(1991-6#1)(1995-11#1)(1997-5#1)
or NSAIDs##2##2##(1991-2#1)(2006-10#1)
or Na+##2##2##(1995-5#1)(1997-1#1)
or NaCl##2##2##(1996-5#1)(2008-10#1)
or NaOH##2##2##(1992-3#1)(2008-10#1)
or Naphtylazoxine 6S and Cd(2+)##2##5##(2008-10#2)
or Newcastle disease##2##3##(2013-8#2)
or Ni(II)##3##2##(2008-10#1)(2008-5#2)
or Northern blot##2##3##(1996-10#1)(2008-1#1)
or Not to##2##3##(2012-11#1)(2012-3#1)
or Nucleus##3##2##(2008-9#1)(2012-2#2)
or O3##3##2##(1992-9#2)(1995-3#1)
or P &lt##4##3##(2008-10#2)(2011-3#2)
or P##13##2##(1993-2#1)(1995-11#1)(2008-10#6)(2008-2#1)(2011-3#2)(2012-12#1)(2012-2#1)
or PA performance##2##3##(1992-3#2)
or PA##3##2##(1992-3#2)(2013-8#1)
or PB-induced##2##2##(1994-8#2)
or PBS##6##2##(1994-8#1)(2005-10#4)(2010-2#1)
or PCR##4##2##(1994-1#1)(2008-1#1)(2008-10#1)(2008-4#1)
or PDGF##4##2##(1990-7#1)(1991-12#2)(1995-3#1)
or PG##3##2##(1996-7#1)(2007-8#2)
or PGE2##2##2##(1990-11#1)(1993-12#1)
or PKC##7##2##(1991-12#1)(1991-7#1)(1992-3#2)(1994-8#1)(1994-9#1)(1995-3#1)
or PMA##5##2##(1990-7#1)(1991-9#1)(1993-6#1)(1994-2#1)(1994-6#1)
or PS##2##2##(1993-11#1)(2008-10#1)
or PSY##3##2##(2004-11#3)
or PTH##2##2##(1993-8#1)(1994-12#1)
or Phe##2##2##(1993-4#1)(2008-4#1)
or Phe)##2##2##(1993-4#1)(1994-12#1)
or Pi##2##2##(1991-9#1)(1992-3#1)
or Picea##2##2##(2008-7#1)(2010-12#1)
or Predictive FactorsCurrent General Therapy Standards##2##6##(2009-4#2)
or Predictive FactorsCurrent General Therapy##3##5##(2009-4#3)
or Predictive FactorsCurrent##5##3##(2009-4#5)
or Predictive##6##2##(2009-4#6)
or Pseudomonas##2##2##(1993-3#1)(2008-10#1)
or Pt##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
or Pyricularia grisea##2##3##(2008-10#1)(2008-9#1)
or R##2##2##(1990-8#1)(2008-10#1)
or R1##2##2##(2008-10#1)(2011-2#1)
or RNA probes##5##3##(2008-2#1)(2008-4#4)
or RNA##16##2##(1991-7#1)(2006-12#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-4#6)(2008-7#1)(2008-9#1)(2009-3#1)(2012-2#1)
or RNAi##2##2##(2008-9#1)(2012-2#1)
or RT-PCR##2##2##(1997-3#1)(2008-6#1)
or RU##2##2##(1991-6#1)(1994-5#1)
or RX 77368##2##3##(1996-9#2)
or S##5##2##(2006-9#1)(2008-10#3)(2009-2#1)
or SA##3##2##(2008-10#2)(2011-2#1)
or SAT##2##2##(1994-12#1)(2013-1#1)
or SR##2##2##(1995-5#1)(2008-10#1)
or Se-deficient##2##2##(1991-12#1)(2008-10#1)
or Ser##3##2##(1991-2#1)(1996-5#1)(1997-8#1)
or SigmaFe##2##2##(2008-10#2)
or Sitisi##2##2##(2008-1#2)
or Southern##2##2##(1997-2#1)(2008-2#1)
or Staphylococcus aureus##2##3##(1991-2#1)(2008-4#1)
or Staphylococcus##3##2##(1991-2#1)(2008-4#1)(2009-3#1)
or Streptococcus##3##2##(2005-8#1)(2006-8#1)(2008-4#1)
or Swingle citrumelo##2##3##(2008-10#2)
or T beta##2##3##(1994-11#1)(1995-3#1)
or T cell##3##3##(2008-4#2)(2008-5#1)
or T##18##2##(1992-6#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-3#1)(1995-5#1)(1996-12#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-4#3)(2008-5#1)(2008-7#1)
or T)##2##2##(1996-11#2)
or T1##2##2##(2010-2#1)(2013-1#1)
or T3##3##2##(1993-8#1)(1994-11#1)(2008-10#1)
or T4##8##2##(1991-5#3)(1992-5#1)(1997-3#1)(2006-9#2)(2008-10#1)
or TA1535##2##2##(2008-8#1)(2008-9#1)
or TGF-beta##4##2##(1991-10#1)(1991-4#1)(1992-9#1)(2008-6#1)
or TGFbeta##2##2##(1994-10#1)(2007-11#1)
or TH##2##2##(1996-5#1)(1997-2#1)
or TIA##5##2##(1994-6#1)(2007-10#4)
or TNF##2##2##(1992-11#1)(1992-5#1)
or TNF-alpha##4##2##(1993-3#1)(1994-9#2)(1996-9#1)
or TNF-beta##2##2##(1993-3#1)(1995-5#1)
or TR##2##2##(1994-3#1)(1996-2#1)
or Tat-BH4##3##2##(2008-2#3)
or TiO(2)##2##2##(2008-10#1)(2010-6#1)
or Total##2##2##(2008-1#1)(2011-12#1)
or Trauma##2##2##(1991-7#1)(2005-5#1)
or Tris##4##2##(2008-10#3)(2008-5#1)
or Triton X-100##3##3##(1990-7#1)(2006-8#1)(2010-4#1)
or Two##2##2##(2008-9#1)(2013-1#1)
or Type##2##2##(2008-3#1)(2008-8#1)
or U##10##2##(1993-3#8)(2007-5#1)(2007-8#1)
or U-69##3##2##(1996-10#3)
or U0126##2##2##(2008-11#1)(2008-4#1)
or US##2##2##(1996-7#1)(2004-2#1)
or UTP##2##2##(1995-1#1)(2008-4#1)
or UTR (for##2##3##(2008-10#2)
or UV irradiation##2##3##(2008-5#2)
or UV##3##2##(1994-8#1)(2008-5#2)
or V##6##2##(1992-12#1)(2008-1#2)(2008-10#1)(2009-6#1)(2012-3#1)
or W##3##2##(2008-10#2)(2010-5#1)
or WT##2##2##(1997-4#2)
or X##4##2##(1994-5#1)(1997-4#1)(1997-7#1)(2008-10#1)
or X-ray##3##2##(1994-5#1)(2008-4#1)(2011-2#1)
or Y##2##2##(1992-11#1)(2009-9#1)
or Zn(2+)##5##2##(2008-10#2)(2008-3#1)(2008-4#1)(2012-12#1)
or Zn(II)##2##2##(2008-5#2)
or Zn2+##3##2##(1993-6#1)(1994-5#1)(1995-6#1)
or Zr)##3##2##(2007-11#2)(2008-3#1)
or a &quot##2##3##(2009-4#1)(2011-1#1)
or a 1##3##3##(1990-4#1)(1992-4#1)(1994-2#1)
or a causal##2##3##(1991-12#1)(2005-10#1)
or a change in the##2##5##(2005-10#1)(2008-1#1)
or a circular##2##3##(2008-2#1)(2008-3#1)
or a cluster of##2##4##(2009-4#1)(2009-6#1)
or a combination of 4 microg each of##2##8##(2009-5#2)
or a combination of both##7##5##(1996-11#1)(2008-1#1)(2009-7#1)(2010-7#1)(2011-1#2)(2012-3#1)
or a combination of the##3##5##(2007-11#1)(2008-3#1)(2008-8#1)
or a combination of these treatments##2##6##(2006-2#1)(2010-1#1)
or a combination of these##7##5##(1995-9#1)(2004-1#1)(2006-2#1)(2006-9#1)(2008-8#1)(2009-3#1)(2010-1#1)
or a combination of##37##4##(1990-12#1)(1990-2#1)(1992-3#1)(1994-11#1)(1994-8#1)(1995-9#1)(1996-11#1)(2004-1#1)(2006-10#2)(2006-2#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-5#2)(2009-7#1)(2010-1#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2012-9#1)(2013-1#2)
or a combination##40##3##(1990-12#1)(1990-2#1)(1992-3#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-9#1)(1996-11#1)(2004-1#1)(2004-3#1)(2006-10#2)(2006-2#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-5#2)(2009-7#1)(2010-1#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2012-9#1)(2013-1#2)
or a component of##2##4##(2006-5#1)(2008-10#1)
or a conformational change##2##4##(1995-11#1)(1996-7#1)
or a consequence of##2##4##(1990-6#1)(2008-7#1)
or a continuous##2##3##(1993-7#1)(1997-4#1)
or a control group##4##4##(2007-11#1)(2007-12#1)(2008-12#1)(2009-12#1)
or a control##11##3##(1991-11#1)(1995-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-8#1)(2012-3#1)
or a conventional##4##3##(2007-11#1)(2008-10#2)(2010-4#1)
or a daily##2##3##(2008-7#1)(2008-9#1)
or a decline in##2##4##(1990-11#1)(2010-4#1)
or a decreased##2##3##(2010-10#1)(2011-1#1)
or a derivative##2##3##(1992-3#1)(2009-5#1)
or a different##5##3##(1992-6#1)(2008-3#1)(2008-4#1)(2009-4#1)(2011-2#1)
or a direct##2##3##(2008-10#1)(2008-3#1)
or a distinct##3##3##(2009-3#1)(2010-7#2)
or a few##9##3##(1990-4#2)(1990-8#1)(2006-7#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-4#1)(2008-7#1)
or a fluorescent##2##3##(1994-12#1)(2008-4#1)
or a flux##2##3##(1997-8#1)(2008-7#1)
or a granulomatous##2##3##(1993-5#1)(2007-7#1)
or a group##4##3##(1996-8#1)(2007-11#1)(2010-5#2)
or a hard##2##3##(2008-8#1)(2010-12#1)
or a high##5##3##(1993-2#1)(2008-10#1)(2012-12#1)(2012-2#2)
or a higher##3##3##(1990-2#1)(1991-1#1)(2005-12#1)
or a history of##3##4##(1996-3#1)(2007-7#1)(2010-10#1)
or a laboratory##2##3##(1994-6#1)(2008-3#1)
or a lack of##2##4##(2008-1#1)(2008-10#1)
or a large##7##3##(1990-2#1)(1993-5#1)(2007-12#1)(2007-8#1)(2008-7#1)(2008-9#1)(2013-8#1)
or a larger##2##3##(1996-8#1)(2008-10#1)
or a light##2##3##(2007-9#1)(2008-2#1)
or a long##3##3##(1994-3#2)(2007-12#1)
or a low##3##3##(1997-6#1)(2009-3#1)(2012-2#1)
or a lower##3##3##(2008-3#1)(2008-7#1)(2012-3#1)
or a malignancy##2##3##(2009-1#1)(2010-7#1)
or a mass##2##3##(2009-2#1)(2010-5#1)
or a mechanical##2##3##(2008-7#1)(2008-8#1)
or a minor##2##3##(1992-12#1)(2012-2#1)
or a mixture of##6##4##(1991-8#1)(1996-2#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-12#1)
or a more##3##3##(1992-6#1)(1995-1#1)(2008-2#1)
or a multivariate##2##3##(2006-5#1)(2008-10#1)
or a mutant##2##3##(1990-3#1)(2012-12#1)
or a new##8##3##(1990-10#1)(1996-11#1)(2007-10#2)(2007-12#1)(2008-2#1)(2008-5#1)(2012-2#1)
or a nuclear##2##3##(1995-2#1)(2008-10#1)
or a number of##2##4##(1997-4#1)(2008-3#1)
or a pair of##2##4##(2007-12#1)(2010-4#1)
or a part of the##4##5##(1991-12#1)(2008-10#1)(2008-7#1)(2012-3#1)
or a part of##5##4##(1991-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-3#1)
or a partial##3##3##(1991-9#1)(2004-4#1)(2009-9#1)
or a particular##2##3##(1991-11#1)(2012-12#1)
or a personal##2##3##(2005-10#1)(2007-10#1)
or a placebo (n =##2##5##(1993-11#1)(2006-10#1)
or a placebo##6##3##(1993-11#1)(2006-10#1)(2008-5#3)(2010-8#1)
or a plane##2##3##(2008-3#1)(2008-6#1)
or a polyclonal##2##3##(1994-9#1)(2007-11#1)
or a portion of it##2##5##(2006-7#1)(2008-2#1)
or a product of##2##4##(1990-8#1)(1996-5#1)
or a protein##3##3##(1993-12#1)(1994-3#1)(2005-8#1)
or a purified##2##3##(1991-2#1)(2008-4#1)
or a reduction of##2##4##(1991-5#1)(2008-5#1)
or a reduction##3##3##(1991-5#1)(2008-3#1)(2008-5#1)
or a regulatory##2##3##(1991-1#1)(1995-2#1)
or a related##4##3##(1992-1#1)(1994-12#1)(2009-10#1)(2010-12#1)
or a research##2##3##(1992-4#1)(2008-11#1)
or a right##2##3##(2007-8#1)(2008-4#1)
or a second##3##3##(1990-4#1)(2007-12#1)(2008-7#1)
or a separate##3##3##(1995-6#1)(1996-3#1)(2013-7#1)
or a series of##3##4##(2007-12#1)(2008-10#1)(2008-4#1)
or a set of##2##4##(2008-4#1)(2011-2#1)
or a shift##4##3##(1992-7#1)(2008-2#2)(2008-9#1)
or a similar##3##3##(1991-12#1)(1993-6#1)(1996-5#1)
or a single##5##3##(1995-6#1)(1997-7#1)(2006-10#1)(2008-10#1)(2011-1#1)
or a small##2##3##(1995-12#1)(2008-10#1)
or a specific##4##3##(1991-9#1)(1994-3#1)(2006-1#1)(2008-4#1)
or a stable##2##3##(2006-8#1)(2008-10#1)
or a stroke##2##3##(1996-11#1)(2012-1#1)
or a surgical##3##3##(2005-11#1)(2005-12#1)(2006-6#1)
or a surrogate##2##3##(1992-3#1)(2005-7#1)
or a synthetic##2##3##(2004-11#1)(2007-12#1)
or a transient##2##3##(1992-5#1)(2006-8#1)
or a treatment##2##3##(2008-1#1)(2010-12#1)
or a variable##2##3##(1990-10#2)
or a variety of##2##4##(1996-7#1)(2008-11#1)
or a very##3##3##(1990-2#1)(2010-12#1)(2011-2#1)
or a wait-list control group##2##5##(2010-6#1)(2013-8#1)
or a weighted##2##3##(2012-3#2)
or a##774##2##(1990-10#3)(1990-11#3)(1990-12#4)(1990-2#5)(1990-3#2)(1990-4#5)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#2)(1991-1#3)(1991-10#1)(1991-11#3)(1991-12#6)(1991-2#7)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#2)(1992-12#2)(1992-3#8)(1992-4#3)(1992-5#3)(1992-6#3)(1992-7#2)(1992-8#2)(1993-1#2)(1993-10#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#3)(1993-4#2)(1993-5#5)(1993-6#1)(1993-7#3)(1993-8#3)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#5)(1994-2#3)(1994-3#9)(1994-5#1)(1994-6#6)(1994-8#5)(1994-9#2)(1995-1#3)(1995-11#4)(1995-12#3)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#1)(1995-9#4)(1996-1#3)(1996-10#1)(1996-11#3)(1996-12#3)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#8)(1996-6#2)(1996-7#4)(1996-8#3)(1996-9#3)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#4)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#2)(2004-1#1)(2004-10#1)(2004-11#1)(2004-12#1)(2004-2#2)(2004-3#1)(2004-4#1)(2004-9#1)(2005-10#6)(2005-11#13)(2005-12#5)(2005-7#3)(2005-8#5)(2005-9#1)(2006-1#1)(2006-10#13)(2006-11#1)(2006-12#8)(2006-2#3)(2006-4#1)(2006-5#3)(2006-6#3)(2006-7#4)(2006-8#5)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#9)(2007-12#24)(2007-2#3)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#6)(2007-8#17)(2007-9#4)(2008-1#10)(2008-10#47)(2008-11#10)(2008-12#1)(2008-2#35)(2008-3#27)(2008-4#18)(2008-5#16)(2008-6#7)(2008-7#20)(2008-8#11)(2008-9#13)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#3)(2009-2#3)(2009-3#4)(2009-4#5)(2009-5#7)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#6)(2010-1#1)(2010-10#4)(2010-11#5)(2010-12#7)(2010-3#1)(2010-4#5)(2010-5#7)(2010-6#3)(2010-7#5)(2010-8#4)(2011-1#7)(2011-2#14)(2012-1#3)(2012-12#8)(2012-2#13)(2012-3#9)(2012-9#1)(2013-1#15)(2013-7#3)(2013-8#15)
or abdominal##10##2##(1990-5#1)(1997-8#1)(2006-12#1)(2007-12#1)(2007-8#1)(2009-8#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-2#1)
or abiotic##4##2##(2008-10#1)(2008-8#1)(2009-8#1)(2012-1#1)
or ablation##2##2##(2006-10#1)(2012-2#1)
or ablative##2##2##(2007-12#1)(2011-1#1)
or abnormal##12##2##(1992-1#1)(1994-5#1)(1995-3#1)(1996-12#2)(2008-1#1)(2008-7#2)(2009-10#1)(2010-9#1)(2012-2#1)(2012-3#1)
or abnormality##3##2##(2010-6#1)(2013-1#2)
or abolished##4##2##(1990-11#1)(1991-6#1)(1992-9#1)(1996-11#1)
or abolition of##2##3##(2006-8#1)(2011-2#1)
or abortion##3##2##(1994-2#1)(2005-7#1)(2007-10#1)
or abortive##2##2##(2008-9#1)(2013-1#1)
or about##3##2##(1997-7#1)(2006-8#1)(2011-12#1)
or above 70##2##3##(1996-12#1)(2008-5#1)
or above a##3##3##(1996-12#2)(2008-10#1)
or above the##4##3##(1991-7#1)(1995-10#1)(2005-10#1)(2008-10#1)
or above##26##2##(1990-4#1)(1990-9#1)(1991-7#1)(1992-1#1)(1995-10#1)(1996-12#3)(1996-5#2)(1997-7#1)(2005-10#1)(2005-11#1)(2005-3#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#1)(2011-1#2)(2013-1#1)(2013-7#1)
or absence of a##16##4##(1990-7#1)(1991-8#1)(1991-9#1)(1994-3#1)(1996-12#1)(1996-4#1)(2005-8#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#2)(2011-2#1)(2012-12#1)
or absence of the##21##4##(1991-5#2)(1994-6#1)(1995-11#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-7#1)(1996-9#1)(2006-12#1)(2008-10#6)(2008-5#1)(2008-6#1)(2008-7#1)(2010-9#1)(2013-8#1)
or absence of##162##3##(1990-11#1)(1990-3#2)(1990-5#1)(1990-7#2)(1990-9#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#3)(1991-8#1)(1991-9#3)(1992-1#2)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#3)(1993-8#1)(1994-11#1)(1994-3#1)(1994-6#2)(1995-11#2)(1995-3#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-4#2)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-5#3)(1997-7#1)(1997-8#1)(2005-11#1)(2005-12#2)(2005-8#3)(2006-12#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#5)(2007-7#2)(2007-9#3)(2008-10#29)(2008-11#1)(2008-12#4)(2008-2#3)(2008-4#5)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#4)(2009-11#1)(2009-2#1)(2009-5#1)(2010-10#2)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#3)(2013-8#1)
or absence##177##2##(1990-11#1)(1990-3#3)(1990-5#1)(1990-7#2)(1990-9#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#3)(1991-8#2)(1991-9#3)(1992-1#2)(1992-12#2)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#3)(1993-8#1)(1994-11#1)(1994-3#1)(1994-6#2)(1995-11#2)(1995-3#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-4#2)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-4#2)(1997-5#3)(1997-7#1)(1997-8#1)(2005-11#1)(2005-12#2)(2005-4#2)(2005-8#3)(2006-12#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#5)(2007-7#2)(2007-9#3)(2008-1#1)(2008-10#29)(2008-11#3)(2008-12#4)(2008-2#3)(2008-3#1)(2008-4#5)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#4)(2009-11#1)(2009-2#1)(2009-5#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#3)(2013-8#1)
or absent in the##2##4##(1995-6#1)(2008-3#1)
or absent in##4##3##(1993-11#1)(1995-6#1)(2007-12#1)(2008-3#1)
or absent##28##2##(1991-11#1)(1992-11#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-9#1)(1995-3#1)(1995-5#2)(1995-6#1)(1997-7#1)(2006-3#1)(2006-5#1)(2007-12#3)(2007-2#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
or absolute##2##2##(2008-8#1)(2013-8#1)
or absolutely##2##2##(2005-11#1)(2008-4#1)
or absorbing##6##2##(2008-2#3)(2008-3#2)(2011-2#1)
or absorption##5##2##(1995-3#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
or abstinence for##2##3##(2006-10#1)(2007-11#1)
or academic##5##2##(1990-12#1)(1994-3#1)(2006-12#1)(2006-7#1)(2007-4#1)
or accelerate##2##2##(1995-2#1)(2006-10#1)
or accelerates##2##2##(1993-11#1)(2009-2#1)
or acceleration##2##2##(2008-10#1)(2013-1#1)
or acceptors##2##2##(1990-7#1)(1994-5#1)
or access##2##2##(2006-10#1)(2011-2#1)
or accessibility of##2##3##(2012-3#1)(2013-8#1)
or accessory##4##2##(1991-12#1)(2008-10#1)(2013-1#2)
or accidental##5##2##(1994-3#1)(2007-11#2)(2008-10#1)(2010-3#1)
or accompanied by##2##3##(1996-12#1)(2013-7#1)
or accumulation of##2##3##(2008-11#1)(2008-5#1)
or accumulation##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
or accuracy##3##2##(1997-8#1)(2008-10#1)(2008-7#1)
or acetate##2##2##(1991-1#1)(2008-7#1)
or acetone##7##2##(1990-10#3)(1995-11#1)(1995-3#2)(2008-10#1)
or acetonitrile##3##2##(1995-6#1)(2007-10#1)(2008-10#1)
or acetylcholine##2##2##(1991-12#1)(1991-2#1)
or acid digested##2##3##(2008-10#2)
or acid##8##2##(2006-2#1)(2007-11#1)(2008-10#3)(2008-5#1)(2008-9#1)(2013-1#1)
or acid-base##2##2##(1997-7#1)(2008-10#1)
or acidic##5##2##(1990-12#1)(1991-3#1)(1993-3#1)(1997-6#1)(2012-9#1)
or acidified##2##2##(1993-4#1)(1996-7#1)
or acquire##2##2##(2006-10#1)(2008-9#1)
or acquired resistance##2##3##(2008-11#1)(2008-5#1)
or acquired##18##2##(1990-11#1)(1990-6#2)(1991-6#1)(1995-1#1)(1996-12#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-11#1)(2008-4#1)(2008-5#1)(2012-12#1)(2013-1#1)(2013-7#1)
or acquired)##3##2##(2007-3#1)(2008-11#1)(2011-2#1)
or acquiring##2##2##(1997-3#1)(2008-11#1)
or acquisition of##2##3##(2006-10#1)(2008-9#1)
or acquisition##3##2##(1991-7#1)(2006-10#1)(2008-9#1)
or across the##2##3##(1993-11#1)(2009-10#1)
or across##5##2##(1993-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-10#1)
or act##3##2##(1997-2#1)(2008-10#1)(2008-8#1)
or acting##2##2##(1995-3#1)(2012-12#1)
or actinomycin D##4##3##(1994-11#1)(1994-8#1)(1996-5#1)(1997-7#1)
or action##3##2##(1996-2#1)(1997-8#1)(2010-11#1)
or activated##13##2##(1990-12#1)(1991-5#1)(1991-9#1)(1992-12#1)(1994-11#1)(1996-4#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-9#1)(2011-1#1)
or activation of the##3##4##(1996-6#1)(2008-10#1)(2012-2#1)
or activation of##9##3##(1996-6#1)(1997-2#2)(2007-11#1)(2008-10#1)(2008-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
or activation##13##2##(1994-2#1)(1995-1#1)(1996-6#1)(1997-2#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#2)(2012-12#1)(2012-2#1)(2012-3#1)
or active roles (OR##2##4##(2008-7#2)
or active##18##2##(1991-1#1)(1993-2#1)(1994-8#1)(2006-12#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#5)(2010-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
or activities##2##2##(2005-11#1)(2008-3#1)
or activity##10##2##(1991-3#1)(1993-8#1)(1994-5#1)(1994-9#1)(1995-3#2)(1996-8#1)(2008-1#1)(2012-2#1)(2013-7#1)
or actual##4##2##(1996-8#1)(2006-10#1)(2008-12#1)(2008-5#1)
or actually##2##2##(2006-9#1)(2010-11#1)
or acupuncture##2##2##(2006-10#1)(2012-3#1)
or acute hepatitis##2##3##(1990-8#1)(2006-2#1)
or acute myocardial infarction##3##4##(2007-10#1)(2008-5#1)(2012-11#1)
or acute##24##2##(1990-7#1)(1990-8#1)(1992-3#1)(1992-9#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-3#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#2)
or acyl##2##2##(1994-3#1)(1996-10#1)
or ad libitum##2##3##(1992-1#1)(2005-9#1)
or adapt##2##2##(1997-8#1)(2008-11#1)
or adaptation##2##2##(1991-2#1)(1995-2#1)
or adaptive##2##2##(2008-7#1)(2012-1#1)
or add##2##2##(2007-8#1)(2008-2#1)
or added##5##2##(1992-11#1)(1995-11#1)(2006-3#1)(2008-12#1)(2008-2#1)
or addiction##3##2##(1996-7#1)(1997-6#1)(2007-11#1)
or adding the##2##3##(1991-6#1)(2008-10#1)
or addition of##7##3##(1992-3#1)(1992-6#1)(1996-1#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-12#1)
or additional##8##2##(1990-4#1)(2008-10#2)(2008-2#2)(2008-5#1)(2008-8#1)(2012-2#1)
or additive##4##2##(1991-7#1)(2007-11#1)(2012-3#2)
or address##2##2##(1991-7#1)(2010-8#1)
or adenosine##4##2##(1990-7#1)(1993-9#1)(1994-6#1)(2010-4#1)
or adherent##6##2##(1990-3#1)(2008-4#5)
or adhesion##3##2##(1997-5#1)(2008-1#1)(2012-12#1)
or adipose##3##2##(1995-11#1)(2009-10#1)(2012-5#1)
or adjacent to the##4##4##(1990-10#1)(1997-3#1)(2008-4#1)(2008-7#1)
or adjacent to##5##3##(1990-10#1)(1997-3#1)(2008-4#1)(2008-7#1)(2009-12#1)
or adjacent##7##2##(1990-10#1)(1994-6#1)(1997-3#1)(2006-7#1)(2008-4#1)(2008-7#1)(2009-12#1)
or adjunctive##3##2##(1992-12#1)(2004-1#1)(2011-2#1)
or adjusted##2##2##(2006-2#1)(2008-10#1)
or adjusting##2##2##(1993-12#1)(2006-4#1)
or adjuvant therapy##4##3##(1994-12#1)(2011-1#3)
or adjuvant##6##2##(1994-12#1)(2007-11#1)(2011-1#3)(2013-1#1)
or administered##3##2##(1994-11#1)(2006-10#1)(2008-1#1)
or administration of##4##3##(1995-11#1)(2008-4#3)
or administration##5##2##(1995-11#1)(2007-11#1)(2008-4#3)
or administrative##3##2##(2006-8#1)(2007-10#1)(2008-1#1)
or admitted to##2##3##(1995-2#1)(2008-11#1)
or adolescence stages##2##3##(2010-12#2)
or adolescence with##2##3##(2005-12#1)(2007-7#1)
or adolescence##11##2##(2005-12#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2010-12#2)(2012-12#1)(2012-2#1)(2013-1#1)
or adolescent##2##2##(2006-10#1)(2006-9#1)
or adolescents##4##2##(2008-10#1)(2008-6#1)(2008-9#1)(2013-1#1)
or adoptive##3##2##(1995-5#1)(2008-4#2)
or adsorption of##2##3##(1992-4#1)(2009-3#1)
or adsorption##3##2##(1992-4#1)(2007-8#1)(2009-3#1)
or adult##13##2##(1991-2#1)(1997-3#2)(1997-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
or adults##4##2##(1992-8#1)(2008-10#2)(2008-4#1)
or advanced##6##2##(2005-8#1)(2006-9#1)(2008-5#2)(2010-11#1)(2012-2#1)
or adverse effects##4##3##(1996-2#1)(2010-5#1)(2013-1#1)(2013-8#1)
or adverse##9##2##(1996-2#1)(2007-12#1)(2008-11#1)(2009-10#1)(2010-5#1)(2011-2#2)(2013-1#1)(2013-8#1)
or aerobic##2##2##(2008-5#1)(2013-1#1)
or aerosol##3##2##(2008-2#2)(2008-3#1)
or affect##7##2##(1995-8#1)(2007-5#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-2#1)(2010-3#1)
or affected##3##2##(1995-1#1)(2006-10#1)(2013-1#1)
or affective disorder##3##3##(1995-11#2)(1996-8#1)
or affective##5##2##(1994-2#1)(1995-11#2)(1996-8#1)(2008-9#1)
or affinity##8##2##(1992-9#1)(1994-6#1)(1995-8#1)(1997-5#1)(2008-4#1)(2008-6#1)(2008-7#2)
or after a##9##3##(1994-12#1)(1994-3#1)(1994-8#1)(1997-2#1)(1997-4#1)(2007-9#1)(2010-12#1)(2012-12#2)
or after being##2##3##(2008-10#1)(2008-5#1)
or after hysterectomy##2##3##(2007-2#1)(2010-3#1)
or after induction##2##3##(1995-12#1)(1995-6#1)
or after one##2##3##(2007-11#1)(2010-8#1)
or after stimulation with##2##4##(1991-2#1)(1994-2#1)
or after storage##2##3##(1992-2#1)(1994-12#1)
or after surgery##2##3##(2006-10#1)(2007-11#1)
or after the##10##3##(1991-3#1)(1992-10#1)(1993-12#1)(1994-9#1)(2004-12#1)(2008-10#1)(2008-5#2)(2011-2#1)(2013-1#1)
or after their##2##3##(2008-2#1)(2010-3#1)
or after treatment##3##3##(1992-3#1)(2010-8#1)(2012-12#1)
or after##122##2##(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-10#1)(1992-11#2)(1992-2#1)(1992-3#2)(1992-5#4)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-4#1)(1993-5#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-6#3)(1996-11#1)(1996-12#1)(1996-8#3)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2004-12#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-2#2)(2006-5#2)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-12#2)(2010-3#2)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-12#5)(2012-3#1)(2013-1#4)(2013-8#2)
or against##7##2##(1993-11#1)(1995-4#1)(2006-2#1)(2008-10#1)(2008-9#1)(2012-3#1)(2013-7#1)
or age at##2##3##(1993-9#1)(2012-1#1)
or age of the##2##4##(1991-2#1)(2004-12#1)
or age of##3##3##(1991-2#1)(2004-12#1)(2006-11#1)
or age##21##2##(1991-2#1)(1993-9#1)(1995-2#1)(1995-6#1)(1996-1#1)(2004-12#1)(2006-11#1)(2006-12#1)(2006-8#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#2)
or age-related##5##2##(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-12#1)
or agenesis##2##2##(2008-9#1)(2009-9#1)
or agents##2##2##(2005-8#1)(2010-12#1)
or aggregate##3##2##(2008-10#2)(2012-12#1)
or aggregates##3##2##(2008-10#2)(2008-11#1)
or aggregation##2##2##(1995-12#1)(2008-11#1)
or aggressive##4##2##(1995-2#1)(2006-3#1)(2010-12#1)(2011-10#1)
or aging##5##2##(1995-12#2)(1996-12#1)(2008-4#1)(2011-2#1)
or agitated##2##2##(2009-6#1)(2011-2#1)
or agonist-induced##2##2##(1997-3#1)(1997-5#1)
or air##2##2##(1991-12#1)(1992-11#1)
or alanine##5##2##(1991-7#1)(1992-9#1)(1993-6#1)(1994-9#1)(2008-10#1)
or alcohol##12##2##(1992-12#1)(1993-8#2)(1994-2#1)(1995-10#1)(1997-4#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-7#1)(2011-2#1)
or alcoholism##4##2##(1991-12#1)(1993-12#1)(1993-2#1)(2006-10#1)
or aldehyde##4##2##(1994-8#1)(2010-7#3)
or aldosterone##3##2##(1994-2#1)(1995-10#1)(2007-8#1)
or alendronate##3##2##(2009-3#2)(2013-8#1)
or alfalfa##2##2##(2008-10#1)(2009-4#1)
or algal##2##2##(2007-5#1)(2012-1#1)
or algorithms##2##2##(2006-1#1)(2007-12#1)
or alkali##2##2##(1993-9#1)(2010-5#1)
or alkaline phosphatase (AP)##2##4##(1994-2#1)(1994-5#1)
or alkaline phosphatase##7##3##(1994-2#1)(1994-5#1)(2008-10#1)(2008-2#1)(2008-4#3)
or alkaline##15##2##(1991-12#1)(1994-2#1)(1994-5#2)(1995-10#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#3)
or alkaline-earth##2##2##(2008-10#1)(2010-5#1)
or alkyl##2##2##(2008-5#1)(2010-4#1)
or alkylation##2##2##(1994-8#1)(2008-6#1)
or all of the##6##4##(1991-8#1)(1992-12#1)(1992-3#1)(1993-2#1)(1995-1#1)(2008-10#1)
or all of##12##3##(1990-12#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-2#1)(1993-3#1)(1995-1#1)(1996-5#1)(2006-12#1)(2007-12#1)(2008-10#2)
or all three##3##3##(1992-3#1)(1997-3#1)(2008-10#1)
or all##29##2##(1990-12#3)(1991-11#1)(1991-8#1)(1992-12#1)(1992-3#2)(1993-2#1)(1993-3#1)(1993-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-5#2)(1997-3#1)(2006-12#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#1)
or all-cause mortality##2##3##(2010-1#1)(2010-2#1)
or all-trans##2##2##(1994-12#1)(2005-10#1)
or allelic##2##2##(2008-10#1)(2013-1#1)
or allergic##6##2##(2006-10#1)(2006-12#1)(2008-7#1)(2010-6#1)(2013-1#2)
or allergy##2##2##(1990-10#1)(2006-10#1)
or alleviate##2##2##(2008-1#1)(2008-11#1)
or allogeneic##10##2##(1993-4#1)(1993-9#2)(1995-2#1)(1997-4#1)(2008-1#2)(2008-4#1)(2009-9#1)(2010-4#1)
or allograft##2##2##(2008-5#1)(2010-7#1)
or allopatry##2##2##(2010-8#2)
or alloplastic##2##2##(2007-12#2)
or allowed##2##2##(1992-8#1)(2008-5#1)
or allyl##2##2##(1997-3#1)(2005-10#1)
or almost##5##2##(1990-10#1)(2005-12#1)(2009-1#1)(2010-8#1)(2011-2#1)
or along the##2##3##(2007-8#1)(2008-9#1)
or along with##2##3##(1995-8#1)(2007-7#1)
or along##5##2##(1995-8#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-9#1)
or alpha 3##2##3##(1991-9#1)(1997-7#1)
or alpha##18##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-3#1)(1991-9#3)(1992-11#1)(1994-3#2)(1995-11#1)(1996-11#1)(1997-2#2)(1997-7#1)(2008-4#1)(2008-7#1)(2010-7#1)
or alter##7##2##(1992-8#1)(1993-7#1)(2006-11#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-5#1)
or alteration of##2##3##(1992-9#1)(2007-9#1)
or alteration##3##2##(1992-9#1)(1993-4#1)(2007-9#1)
or alterations in##3##3##(2007-11#1)(2008-5#1)(2009-4#1)
or alterations##4##2##(2006-12#1)(2007-11#1)(2008-5#1)(2009-4#1)
or altered##10##2##(1992-5#1)(1992-9#1)(1993-6#1)(1994-3#1)(1995-3#1)(2005-8#1)(2006-8#1)(2008-4#1)(2012-3#1)(2013-1#1)
or altering##2##2##(2008-11#1)(2008-7#1)
or alternative##9##2##(1992-12#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#2)
or alternatively by streaking or spreading a plate##2##8##(2008-2#1)(2008-9#1)
or alternatively by##3##3##(1992-3#1)(2008-2#1)(2008-9#1)
or alternatively##13##2##(1992-3#1)(2003-11#1)(2006-4#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#2)(2010-7#1)(2011-2#1)(2012-12#1)
or aluminum fluoride##2##3##(1995-7#1)(1997-4#1)
or ambiguous##2##2##(2008-7#1)(2011-2#1)
or ameliorating##2##2##(2005-7#1)(2008-11#1)
or amino acid##4##3##(1991-9#1)(1992-5#1)(2007-12#1)(2008-9#1)
or amino acids##4##3##(2007-12#1)(2008-5#1)(2008-7#1)(2013-1#1)
or amino##10##2##(1991-9#1)(1992-5#1)(1996-2#1)(2007-11#1)(2007-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
or ammonia##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
or ammonium##3##2##(1992-1#1)(1997-6#1)(2008-6#1)
or among##6##2##(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2013-1#1)
or amount of##2##3##(2007-9#1)(2010-12#1)
or amperometric##3##2##(2008-10#3)
or amphetamine (1##2##3##(1994-2#2)
or amphetamine##5##2##(1994-2#2)(1996-10#1)(1997-7#1)(1997-8#1)
or amphipathic##2##2##(1995-3#1)(2006-12#1)
or amplified##2##2##(1994-12#1)(2008-10#1)
or amputation##5##2##(1990-3#1)(1995-12#1)(2006-10#1)(2008-6#1)(2009-9#1)
or amygdala##8##2##(1991-3#1)(1992-9#2)(1993-6#5)
or amygdaloid##2##2##(1995-12#1)(1997-3#1)
or an abnormal##2##3##(1994-3#1)(2010-8#1)
or an active##2##3##(1994-10#1)(2008-7#1)
or an additional##3##3##(1996-5#1)(1996-8#2)
or an adjacent##2##3##(1990-5#1)(1997-7#1)
or an alkaline##2##3##(2008-10#1)(2008-7#1)
or an increase in##4##4##(2005-7#1)(2008-7#1)(2009-12#1)(2012-3#1)
or an increase of##2##4##(2011-2#1)(2012-5#1)
or an increase##6##3##(2005-7#1)(2008-7#1)(2009-12#1)(2011-2#1)(2012-3#1)(2012-5#1)
or an increased##3##3##(1996-5#1)(2006-10#1)(2010-3#1)
or an independent##2##3##(1993-1#1)(2006-10#1)
or an individual##2##3##(1994-3#1)(2007-10#1)
or an inflammatory##3##3##(1992-2#1)(2006-8#1)(2008-3#1)
or an inhibitor of##3##4##(1995-12#1)(2006-5#1)(2007-2#1)
or an integrated##2##3##(1996-1#1)(2008-12#1)
or an isolated##2##3##(1997-7#1)(2009-2#1)
or an object##3##3##(1997-8#1)(2011-1#1)(2013-8#1)
or an##166##2##(1990-3#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-11#3)(1994-3#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#3)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2005-10#1)(2005-11#1)(2005-7#2)(2006-10#3)(2006-12#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#8)(2007-10#1)(2007-11#2)(2007-2#2)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#6)(2009-12#1)(2009-2#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#2)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#4)(2011-11#1)(2011-2#6)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#4)(2013-7#1)(2013-8#2)
or anal##3##2##(1996-8#1)(2005-8#1)(2010-7#1)
or analysis of##4##3##(1992-9#1)(2008-4#3)
or analysis##5##2##(1992-9#1)(2008-4#4)
or analytical##3##2##(1993-7#1)(2008-3#1)(2013-1#1)
or analyzed##2##2##(2012-2#1)(2013-1#1)
or anatomical##2##2##(1994-11#1)(2007-10#1)
or ancient##3##2##(2008-4#1)(2013-1#2)
or androgen##2##2##(1996-5#1)(2008-11#1)
or anesthesia##3##2##(1991-2#1)(2006-10#2)
or aneurysm##3##2##(1993-10#1)(2008-4#1)(2008-7#1)
or aneurysmal##2##2##(2008-4#1)(2011-3#1)
or angina##2##2##(2007-8#1)(2008-3#1)
or angiography##3##2##(2006-2#1)(2007-10#1)(2011-2#1)
or angioplasty##2##2##(2005-7#1)(2011-2#1)
or angiotensin II##4##3##(1995-12#1)(1996-2#1)(1996-6#1)(2008-11#1)
or angiotensin receptor##2##3##(2007-10#1)(2013-1#1)
or angiotensin##6##2##(1995-12#1)(1996-2#1)(1996-6#1)(2007-10#1)(2008-11#1)(2013-1#1)
or angle##2##2##(2008-3#1)(2011-2#1)
or animal proteins##2##3##(1997-4#1)(2007-11#1)
or animal##9##2##(1994-3#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-11#2)(2008-2#1)(2009-5#1)(2010-4#1)
or animals##6##2##(1990-5#1)(2006-7#1)(2007-12#1)(2008-9#1)(2012-1#1)(2013-7#1)
or animals)##2##2##(1997-8#1)(2010-4#1)
or anionic##5##2##(1992-2#1)(1994-11#1)(2007-8#1)(2008-8#1)(2008-9#1)
or anorexia##2##2##(2006-2#1)(2009-12#1)
or another##13##2##(1991-1#1)(1993-9#1)(1995-8#1)(1997-2#1)(2006-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-2#1)
or antagonist##7##2##(1991-5#1)(1991-6#1)(1992-3#1)(1996-8#1)(1997-4#1)(1997-5#1)(2008-9#1)
or antagonistic effects##2##3##(2008-10#2)
or antagonistic##5##2##(1993-4#2)(2008-10#3)
or antagonists##5##2##(1994-2#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-4#1)
or anterior##3##2##(2006-8#1)(2007-7#1)(2011-2#1)
or anti##2##2##(1991-11#1)(2011-2#1)
or anti-inflammatory##5##2##(2005-12#1)(2007-11#1)(2008-3#1)(2008-5#1)(2012-1#1)
or anti-microbial##2##2##(1992-7#1)(2010-7#1)
or anti-triadin##2##2##(1994-12#2)
or antibodies to##3##3##(1996-2#1)(1997-6#1)(2007-2#1)
or antibodies##8##2##(1994-3#1)(1996-2#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-2#1)(2008-10#1)(2010-5#1)
or antibody##5##2##(1994-6#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-9#1)
or anticoagulation##2##2##(2008-8#2)
or antidromic##2##2##(1991-2#1)(1996-12#1)
or antigen##9##2##(1990-8#1)(1991-12#1)(1992-8#1)(1997-7#1)(2004-12#1)(2008-11#1)(2011-2#2)(2012-2#1)
or antigen-induced##2##2##(1992-11#1)(2008-4#1)
or antigens##3##2##(2006-10#1)(2008-4#1)(2008-9#1)
or antiplatelet##2##2##(2006-11#1)(2007-10#1)
or antisense##3##2##(2006-12#1)(2008-10#1)(2008-6#1)
or antithrombotic##2##2##(1994-12#1)(2005-12#1)
or anxiety disorders##2##3##(1992-8#1)(2004-3#1)
or anxiety##5##2##(1992-8#1)(2004-3#1)(2008-2#1)(2010-3#1)(2013-8#1)
or anxious##3##2##(1992-2#1)(2008-4#2)
or any combination of##2##4##(1991-8#1)(1992-12#1)
or any of the other##2##5##(1991-7#1)(1997-4#1)
or any of the##4##4##(1991-7#1)(1996-10#1)(1997-4#1)(2008-11#1)
or any other place##2##4##(2007-4#1)(2011-2#1)
or any other##23##3##(1990-7#1)(1993-4#1)(1995-12#1)(1996-4#1)(1996-6#1)(1996-8#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-10#1)(2010-6#1)(2011-12#1)(2011-2#1)(2013-1#1)
or any##50##2##(1990-7#2)(1991-7#1)(1991-8#1)(1992-12#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-12#1)(1995-12#1)(1996-10#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-4#1)(2004-2#1)(2005-8#1)(2006-10#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-5#1)(2010-10#1)(2010-6#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
or aortic##2##2##(1992-10#1)(2007-8#1)
or apoptosis of##2##3##(2008-5#1)(2012-1#1)
or apoptosis##14##2##(1995-2#2)(1996-10#2)(2003-11#1)(2005-12#2)(2006-2#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-1#1)(2013-8#1)
or apoptotic##2##2##(2008-10#1)(2008-11#1)
or apparent##5##2##(1990-5#1)(1991-3#1)(1992-2#1)(2012-2#1)(2012-3#1)
or appear as##2##3##(2008-7#1)(2013-1#1)
or appearance of##2##3##(1994-5#1)(2007-12#1)
or appearance##3##2##(1994-5#1)(2007-12#2)
or apple##4##2##(2006-5#1)(2008-10#3)
or application##2##2##(2010-12#1)(2010-4#1)
or applied##6##2##(2007-8#1)(2008-10#2)(2008-12#2)(2012-12#1)
or approaches##4##2##(2006-10#1)(2008-10#1)(2008-3#1)(2010-12#1)
or appropriate##2##2##(2006-10#1)(2008-1#1)
or approximately##6##2##(1994-9#1)(1996-3#1)(2008-10#1)(2008-3#2)(2012-11#1)
or aqueous##6##2##(2008-10#5)(2008-5#1)
or arachidonic acid##3##3##(1992-8#1)(1997-6#1)(2009-12#1)
or arachidonic##4##2##(1992-8#1)(1994-2#1)(1997-6#1)(2009-12#1)
or are caused by##3##4##(2008-10#1)(2013-7#2)
or are considered##2##3##(1990-4#1)(2006-10#1)
or are currently in##2##4##(2006-10#2)
or are currently##6##3##(2006-10#2)(2006-11#1)(2008-11#1)(2008-6#1)(2010-12#1)
or are in##2##3##(1995-5#1)(2008-11#1)
or are not##5##3##(1992-9#1)(2005-1#1)(2007-12#1)(2008-4#1)(2008-8#1)
or are ongoing##2##3##(2006-10#1)(2007-12#1)
or are still##2##3##(2006-6#1)(2008-4#1)
or are used##2##3##(1997-6#1)(2008-1#1)
or are##77##2##(1990-4#1)(1991-1#3)(1991-12#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-9#1)(1994-8#1)(1995-5#1)(1996-12#2)(1996-5#1)(1996-8#1)(1997-6#1)(2005-1#1)(2005-9#1)(2006-10#8)(2006-11#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#2)(2009-5#1)(2010-10#1)(2010-12#2)(2010-5#2)(2011-12#1)(2011-2#3)(2012-1#2)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#1)
or area of##2##3##(2008-3#1)(2012-2#1)
or area##8##2##(1994-9#1)(1995-5#1)(1996-9#1)(1997-5#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-2#1)
or areas##2##2##(2010-8#1)(2012-12#1)
or arginine##5##2##(1991-3#1)(1994-12#1)(1996-2#1)(2012-1#1)(2013-7#1)
or argon##2##2##(2005-11#1)(2008-10#1)
or arising##2##2##(2010-2#1)(2012-12#1)
or arm##2##2##(2005-10#1)(2007-11#1)
or armed##2##2##(2006-12#1)(2012-12#1)
or aromatic##2##2##(1995-3#1)(2007-11#1)
or around the##8##3##(1992-12#1)(2006-12#1)(2006-7#1)(2007-8#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-1#1)
or around##11##2##(1992-12#2)(1996-8#1)(1997-7#1)(2006-12#1)(2006-7#1)(2007-8#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-1#1)
or arranged in##2##3##(2005-11#1)(2008-7#1)
or arrays of##2##3##(2007-3#1)(2008-2#1)
or arrays##4##2##(2007-11#1)(2007-3#1)(2008-2#2)
or arrhythmia##2##2##(2008-7#2)
or arterial##7##2##(1996-3#1)(1997-3#1)(2006-10#1)(2007-12#1)(2008-10#1)(2012-12#1)(2013-8#1)
or artery##4##2##(1996-3#1)(2008-4#2)(2008-7#1)
or arthritis##2##2##(2006-7#1)(2008-9#1)
or arthrodesis##3##2##(2008-4#1)(2008-8#1)(2011-2#1)
or artificial##13##2##(1993-1#1)(1993-12#1)(1994-2#1)(1997-6#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2011-2#1)
or as &quot##2##3##(2006-9#1)(2008-9#1)
or as a result of##4##5##(1991-3#1)(2005-1#1)(2006-10#1)(2013-8#1)
or as a source for tissues##2##6##(2008-4#2)
or as a##55##3##(1990-6#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-3#1)(1991-9#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-4#1)(1997-2#1)(1997-8#1)(2005-1#1)(2006-1#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#1)(2006-8#2)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#1)(2013-8#1)
or as an adjunct##2##4##(2006-5#1)(2011-2#1)
or as an integrated##2##4##(1997-4#1)(2010-12#1)
or as an##17##3##(1996-11#1)(1996-12#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-5#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-8#1)
or as direct##2##3##(2007-3#1)(2008-11#1)
or as isolated##2##3##(1996-1#1)(2008-8#1)
or as part of a##4##5##(1996-4#1)(2006-10#1)(2008-4#1)(2013-1#1)
or as part of the##2##5##(2008-10#1)(2013-7#1)
or as part of##9##4##(1996-4#1)(2006-10#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
or as permanent##2##3##(2007-7#1)(2008-10#1)
or as result of the degradation associated with chronic internal disc disruption##2##12##(2006-11#1)(2006-12#1)
or as result of##4##4##(1997-8#1)(2006-11#1)(2006-12#1)(2008-7#1)
or as the##5##3##(2005-12#1)(2006-4#1)(2007-11#1)(2007-6#1)(2013-1#1)
or as##176##2##(1990-12#2)(1990-6#2)(1990-8#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-8#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#4)(1996-11#1)(1996-12#1)(1996-4#2)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#2)(2004-7#1)(2005-1#1)(2005-11#1)(2005-12#1)(2006-1#1)(2006-10#7)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-3#3)(2007-5#2)(2007-6#2)(2007-7#4)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#14)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#9)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#4)
or ascites##2##2##(1994-12#1)(2013-8#1)
or ascorbate##3##2##(1991-10#1)(1992-6#1)(1997-8#1)
or ascorbic acid##2##3##(2008-10#1)(2009-10#1)
or asexual##2##2##(2008-10#1)(2013-7#1)
or aspartic acid##2##3##(1993-6#1)(1994-3#1)
or aspartic##3##2##(1990-12#1)(1993-6#1)(1994-3#1)
or aspheric##2##2##(2005-11#1)(2008-2#1)
or aspiration##3##2##(1996-9#1)(2007-5#1)(2009-8#1)
or assessment##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
or assistance##2##2##(2006-7#1)(2006-8#1)
or assistant##2##2##(1992-3#1)(2010-3#1)
or assisted##7##2##(1991-8#6)(2007-12#1)
or associated with other##4##4##(1993-6#1)(2007-11#1)(2009-3#1)(2011-2#1)
or associated with##8##3##(1993-6#1)(1994-6#1)(2007-11#1)(2008-5#1)(2008-9#1)(2009-3#1)(2011-2#2)
or associated##18##2##(1990-2#1)(1991-12#1)(1993-6#1)(1994-6#1)(1996-12#1)(1996-6#1)(1997-4#1)(2006-8#1)(2007-11#1)(2007-5#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-2#1)
or association##3##2##(1995-11#1)(2008-4#1)(2012-2#1)
or associations##5##2##(1993-12#1)(1997-5#1)(2007-7#2)(2008-4#1)
or asthma##2##2##(2005-7#1)(2010-12#1)
or asymmetric##3##2##(1997-4#1)(2007-12#1)(2008-3#1)
or asymptomatic##4##2##(2007-12#1)(2007-7#1)(2008-12#1)(2009-8#1)
or asystole##2##2##(1992-5#1)(2010-1#1)
or at 1##2##3##(2006-7#1)(2007-6#1)
or at 4##2##3##(1990-4#1)(2008-10#1)
or at 45 degrees##3##4##(2008-2#1)(2008-5#2)
or at a##10##3##(1990-9#1)(1993-9#1)(1994-6#1)(1995-12#1)(1996-6#2)(1997-2#1)(2008-10#1)(2008-3#1)(2009-9#1)
or at an##2##3##(1996-11#1)(2008-7#1)
or at any##2##3##(1991-3#1)(1994-8#1)
or at high##2##3##(1994-2#1)(2008-10#1)
or at home##2##3##(2008-11#1)(2010-2#1)
or at least be##2##4##(1997-1#1)(2009-4#1)
or at least to##3##4##(1996-3#1)(2008-10#1)(2008-3#1)
or at least##32##3##(1991-7#1)(1993-3#2)(1993-6#1)(1995-12#1)(1996-1#1)(1996-3#1)(1997-1#1)(2006-12#1)(2006-2#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-9#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-7#2)(2009-2#1)(2009-4#1)(2010-11#1)(2012-1#1)(2012-12#1)(2012-5#1)
or at most##2##3##(2008-11#1)(2008-5#1)
or at other##2##3##(1995-2#1)(2007-12#1)
or at risk for malignant melanoma##2##6##(2007-12#2)
or at risk for##4##4##(2007-12#2)(2008-11#1)(2012-12#1)
or at risk of##3##4##(2007-7#1)(2008-6#1)(2010-9#1)
or at risk##7##3##(2007-12#2)(2007-7#1)(2008-11#1)(2008-6#1)(2010-9#1)(2012-12#1)
or at the end of##2##5##(2006-8#1)(2008-11#1)
or at the same##2##4##(2003-11#1)(2008-10#1)
or at the time of##4##5##(1994-6#1)(1996-2#1)(2007-12#1)(2013-1#1)
or at the##23##3##(1991-1#1)(1992-11#1)(1994-6#1)(1995-5#1)(1996-2#1)(1996-8#1)(2003-11#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-12#2)(2007-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-4#1)(2010-4#1)(2013-1#2)(2013-8#1)
or at worst##2##3##(2008-11#1)(2011-2#1)
or at##135##2##(1990-4#1)(1990-9#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-2#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-5#1)(1994-6#2)(1994-8#2)(1995-12#2)(1995-2#1)(1995-5#1)(1996-1#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(2003-11#1)(2005-11#1)(2006-10#2)(2006-12#2)(2006-2#2)(2006-7#3)(2006-8#4)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#5)(2007-2#1)(2007-3#1)(2007-6#2)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#14)(2008-11#5)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-11#1)(2010-2#2)(2010-4#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-5#1)(2013-1#3)(2013-8#1)
or atelectasis##2##2##(1997-4#1)(2012-1#1)
or atomic##3##2##(2008-10#3)
or atopic##3##2##(1990-3#1)(2007-1#1)(2009-8#1)
or atopy##2##2##(2010-6#2)
or atrial septal defect##2##4##(2006-8#1)(2012-3#1)
or atrial##6##2##(1993-10#1)(2006-8#1)(2006-9#1)(2009-10#1)(2010-12#1)(2012-3#1)
or atrophic##2##2##(1995-3#1)(2007-12#1)
or atrophy##2##2##(2008-10#1)(2012-2#1)
or attachment##2##2##(2007-12#1)(2009-12#1)
or attention##2##2##(1993-12#1)(2007-10#1)
or atypical##7##2##(1992-9#1)(1996-11#1)(2007-11#1)(2008-11#1)(2010-12#1)(2011-12#1)(2012-1#1)
or auditory##2##2##(2006-10#1)(2008-6#1)
or augment##2##2##(1993-8#1)(1997-2#1)
or autoimmune diseases##2##3##(1991-11#1)(2010-12#1)
or autoimmune##5##2##(1991-11#1)(2008-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
or autoimmunity##2##2##(2008-10#1)(2012-12#1)
or autologous##6##2##(1995-9#1)(2007-7#1)(2007-9#1)(2008-4#1)(2011-2#1)(2013-1#1)
or automatic##5##2##(2005-12#1)(2006-6#1)(2008-11#1)(2008-8#1)(2010-12#1)
or autopsy##4##2##(1990-5#1)(2006-10#1)(2006-8#1)(2013-7#1)
or auxiliary##2##2##(2004-8#1)(2008-7#1)
or available##2##2##(1991-2#1)(2008-5#1)
or avascular##2##2##(2006-8#1)(2008-4#1)
or average##5##2##(2008-10#1)(2008-2#2)(2008-8#1)(2012-2#1)
or avian##3##2##(1993-4#1)(2008-10#1)(2008-5#1)
or avirulent##2##2##(2008-10#2)
or avoid##5##2##(2006-2#1)(2010-12#1)(2011-2#1)(2013-1#2)
or avoidance of##3##3##(2007-11#1)(2008-10#1)(2010-2#1)
or avoidance##6##2##(1993-3#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2010-2#1)
or awareness of##2##3##(2007-12#1)(2012-1#1)
or axial##4##2##(2006-7#1)(2007-12#1)(2008-2#1)(2008-8#1)
or axonal##2##2##(2009-10#1)(2011-1#1)
or azide##2##2##(1992-8#1)(1997-7#1)
or bFGF##4##2##(1991-12#2)(1996-5#1)(2008-7#1)
or back##2##2##(1995-3#1)(2012-1#1)
or background##3##2##(2008-9#1)(2010-3#1)(2010-4#1)
or bacteria##3##2##(2006-8#1)(2008-2#1)(2013-8#1)
or bacterial cells##2##3##(1995-12#1)(2008-9#1)
or bacterial infection##3##3##(1992-8#1)(2008-9#1)(2012-12#1)
or bacterial##14##2##(1990-11#1)(1991-9#1)(1992-8#1)(1995-12#1)(1995-2#1)(2005-11#1)(2007-11#1)(2007-7#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-4#1)(2012-12#1)
or bad##2##2##(1997-4#1)(2008-11#1)
or balloons##3##2##(2007-8#1)(2008-4#1)(2009-10#1)
or band##2##2##(1992-8#1)(2013-1#1)
or banding##2##2##(2007-5#1)(2012-1#1)
or bandpass##2##2##(2007-12#1)(2008-2#1)
or barbiturates##2##2##(1996-1#1)(2005-7#1)
or barium##2##2##(1993-6#1)(2008-2#1)
or basal##4##2##(1997-3#1)(2008-5#1)(2013-1#1)(2013-7#1)
or base##4##2##(1994-2#1)(1995-8#2)(2008-3#1)
or based on##2##3##(2008-9#1)(2011-2#1)
or baseline##2##2##(2010-12#1)(2013-8#1)
or basic fibroblast growth factor##2##5##(1995-2#1)(1996-5#1)
or basic##7##2##(1991-12#1)(1995-2#1)(1996-5#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-3#1)
or basilar##3##2##(2007-9#2)(2008-11#1)
or basolateral##4##2##(1995-11#2)(1996-1#1)(2008-1#1)
or batch##2##2##(2008-10#1)(2008-4#1)
or be a##3##3##(2007-12#1)(2008-9#1)(2009-5#1)
or be associated with##2##4##(2008-5#1)(2011-1#1)
or be##20##2##(1993-6#1)(2005-8#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-1#2)
or beam##3##2##(2007-12#1)(2008-3#1)(2011-1#1)
or became##2##2##(1992-5#1)(2007-10#1)
or because of##2##3##(2004-12#1)(2007-3#1)
or because they are##3##4##(2008-2#1)(2008-4#1)(2013-7#1)
or because they have##2##4##(1995-2#1)(2008-11#1)
or because they##9##3##(1995-2#1)(2006-5#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-7#1)(2013-7#1)
or because##14##2##(1995-2#1)(2004-12#1)(2006-5#1)(2007-3#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-7#1)(2012-11#1)(2013-7#1)
or become##5##2##(1997-7#1)(2009-10#1)(2010-2#1)(2012-12#1)(2013-1#1)
or becoming##4##2##(2006-7#1)(2007-12#1)(2008-9#1)(2012-12#1)
or before##11##2##(1991-11#1)(1997-2#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-3#2)(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#1)
or behavior##2##2##(2011-1#1)(2013-8#1)
or behavioral phenotyping of transgenic and knockout mice for genes expressed in specific brain regions##2##15##(2008-4#2)
or behavioral##9##2##(1993-4#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-6#1)(2009-10#1)
or behaviors##3##2##(1996-9#1)(2012-2#1)(2013-1#1)
or behaviour##3##2##(1991-8#1)(1994-2#1)(1995-2#1)
or behavioural##3##2##(1995-6#1)(2008-1#1)(2008-9#1)
or being##10##2##(1991-8#1)(1997-8#1)(2006-2#1)(2008-7#2)(2010-3#1)(2011-2#1)(2012-12#2)(2012-2#1)
or below the##9##3##(1995-6#1)(1996-12#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-3#2)(2010-12#1)
or below##20##2##(1990-12#1)(1991-9#1)(1992-10#1)(1995-6#1)(1996-12#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-3#2)(2010-12#1)
or beneath##2##2##(1990-9#1)(2008-11#1)
or beneficial##5##2##(2006-12#1)(2008-10#1)(2008-7#1)(2009-3#1)(2012-3#1)
or benefit##4##2##(1993-6#1)(2008-7#2)(2008-9#1)
or benefits##2##2##(1993-9#1)(2010-4#1)
or benign disease##2##3##(1992-2#1)(2006-10#1)
or benign##8##2##(1990-3#1)(1990-6#1)(1990-8#1)(1992-2#1)(1993-1#1)(1994-6#1)(2004-2#1)(2006-10#1)
or benzodiazepine##2##2##(1990-3#1)(1991-2#1)
or beta 2##5##3##(1991-3#2)(1994-3#1)(1994-9#1)(2008-11#1)
or beta 3##3##3##(1992-11#2)(1994-3#1)
or beta##23##2##(1990-12#1)(1990-7#3)(1990-9#1)(1991-1#1)(1991-3#2)(1992-11#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-8#1)(1994-3#3)(1994-9#1)(1997-7#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)
or beta-carotene##2##2##(1995-3#1)(2008-8#1)
or beta-endorphin##2##2##(1990-2#1)(2008-6#1)
or betamethasone##2##2##(1992-2#1)(2012-3#1)
or better in##3##3##(2005-5#1)(2007-2#1)(2008-11#1)
or better than that of##2##5##(2007-11#1)(2011-2#1)
or better than that##3##4##(2007-11#1)(2008-5#1)(2011-2#1)
or better than the##5##4##(1994-9#1)(1997-8#1)(2008-2#1)(2008-3#1)(2008-9#1)
or better than those##3##4##(2007-11#1)(2008-10#2)
or better than##19##3##(1991-2#1)(1994-9#1)(1996-3#1)(1997-8#1)(2006-10#1)(2006-9#1)(2007-11#2)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#2)(2008-9#2)(2011-2#1)
or better##46##2##(1991-2#1)(1991-3#1)(1994-9#1)(1996-3#1)(1996-6#1)(1997-4#1)(1997-8#1)(2005-5#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#3)(2007-12#2)(2007-2#1)(2008-10#8)(2008-11#1)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#3)(2009-3#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-7#1)
or between groups##2##3##(1997-9#1)(2008-7#1)
or between the##10##3##(1990-5#1)(1991-8#1)(1993-3#1)(1994-6#1)(1996-1#1)(2004-4#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-10#1)
or between two##2##3##(1990-4#1)(2008-10#1)
or between##46##2##(1990-12#1)(1990-4#1)(1990-5#1)(1991-8#2)(1992-4#1)(1993-3#1)(1994-6#1)(1995-10#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-9#1)(2004-4#1)(2005-7#2)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-5#1)(2009-6#1)(2009-7#1)(2011-1#2)(2011-12#1)(2012-11#1)(2012-2#2)(2013-7#1)
or big##2##2##(2007-3#1)(2009-4#1)
or bilateral##30##2##(1990-5#1)(1992-1#1)(1992-11#1)(1992-9#1)(1993-1#1)(1994-7#1)(1995-12#1)(1995-8#1)(1996-9#1)(1997-1#1)(2006-12#1)(2006-9#1)(2007-7#1)(2007-9#3)(2008-10#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-4#2)(2009-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
or bile acid##2##3##(1990-4#1)(2005-7#1)
or bile##3##2##(1990-4#1)(2005-7#1)(2011-1#1)
or biliary colic##2##3##(2006-2#1)(2008-10#1)
or biliary##6##2##(2006-10#1)(2006-2#2)(2006-6#1)(2008-10#1)(2008-3#1)
or binary##2##2##(1993-9#1)(1997-2#1)
or binding##6##2##(1993-6#1)(1997-2#1)(2008-11#1)(2008-3#1)(2008-4#1)(2011-1#1)
or biochemical##8##2##(1990-3#1)(1990-6#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-8#1)
or biologic agents##2##3##(2006-10#2)
or biologic##4##2##(1991-4#1)(2006-10#2)(2008-4#1)
or biological fluids##2##3##(2008-4#1)(2008-7#1)
or biological##19##2##(1990-9#1)(1997-2#1)(2006-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-12#2)(2010-7#1)
or biologically##2##2##(1993-9#1)(2008-9#1)
or biopsy##8##2##(2006-10#1)(2006-12#1)(2008-3#1)(2009-2#1)(2011-1#1)(2012-2#1)(2013-1#2)
or biotin##2##2##(1997-2#1)(2008-4#1)
or biotinylated##2##2##(1995-11#1)(2008-11#1)
or bipolar##2##2##(2007-8#1)(2011-2#1)
or bisexual##3##2##(1992-2#1)(2008-12#1)(2010-8#1)
or black##5##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
or bladder##5##2##(1991-11#1)(1992-3#1)(2008-10#1)(2008-4#1)(2010-8#1)
or bleeding##5##2##(1990-11#1)(1990-12#1)(2006-6#1)(2008-7#1)(2013-8#1)
or block the##2##3##(1990-5#1)(1994-11#1)
or block##4##2##(1990-5#1)(1994-11#1)(1996-10#1)(2008-12#1)
or blockade of##5##3##(1991-10#1)(1996-12#1)(2008-3#1)(2008-5#1)(2010-12#1)
or blocked##3##2##(1992-3#1)(1993-2#1)(2008-2#1)
or blocking the##2##3##(1996-1#1)(2006-2#1)
or blocking##4##2##(1992-5#1)(1996-1#1)(2006-2#1)(2011-2#1)
or blocks##2##2##(2004-9#1)(2008-4#1)
or blood glucose##3##3##(2007-9#2)(2008-3#1)
or blood pressure##4##3##(1990-12#1)(1992-4#1)(2005-8#2)
or blood products##5##3##(1992-6#1)(2007-11#1)(2009-5#1)(2011-3#1)(2013-1#1)
or blood##27##2##(1990-11#1)(1990-12#2)(1991-3#1)(1992-12#1)(1992-4#1)(1992-6#1)(1994-9#1)(1997-3#1)(1997-6#1)(2005-1#1)(2005-8#2)(2006-4#1)(2007-11#1)(2007-9#2)(2008-1#1)(2008-11#2)(2008-3#1)(2009-5#1)(2010-12#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
or blue fluorescent##2##3##(1990-5#1)(2008-11#1)
or blue##4##2##(1990-12#1)(1990-5#1)(2008-11#1)(2008-3#1)
or body fat##3##3##(1991-10#1)(2007-12#1)(2008-5#1)
or body mass##2##3##(1990-3#1)(1991-7#1)
or body##12##2##(1990-3#1)(1991-10#1)(1991-11#1)(1991-7#1)(1995-6#1)(1997-1#1)(2006-7#1)(2007-10#1)(2007-12#1)(2008-5#1)(2012-2#2)
or boiled##3##2##(1991-10#1)(2008-10#1)(2012-10#1)
or bolus##2##2##(2008-10#1)(2009-2#1)
or bone graft##2##3##(2006-3#1)(2007-12#1)
or bone grafts##2##3##(2007-7#1)(2009-3#1)
or bone marrow cells##2##4##(1990-3#1)(2008-4#1)
or bone marrow##12##3##(1990-3#1)(1991-10#1)(2006-10#3)(2007-10#1)(2008-1#1)(2008-4#2)(2008-9#1)(2012-12#2)
or bone##28##2##(1990-3#1)(1991-10#1)(1993-9#1)(1994-6#1)(2006-10#3)(2006-12#1)(2006-3#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-4#2)(2008-9#1)(2009-3#2)(2009-9#1)(2010-6#1)(2011-2#1)(2012-12#2)(2013-8#2)
or bony##3##2##(2008-6#1)(2012-2#1)(2013-1#1)
or borderline##2##2##(1996-3#1)(2013-1#1)
or born##2##2##(1996-11#1)(2006-2#1)
or both and##2##3##(2008-10#2)
or both copies##2##3##(2007-11#1)(2010-2#1)
or both fungicides##2##3##(2008-10#2)
or both in the##2##4##(2008-10#1)(2010-3#1)
or both in##7##3##(2007-10#1)(2007-3#1)(2008-10#2)(2010-3#1)(2011-12#1)(2011-2#1)
or both of the##9##4##(1990-4#1)(1991-7#1)(1991-8#1)(1992-6#1)(1994-8#1)(1997-2#1)(2005-11#1)(2007-1#1)(2008-10#1)
or both of these##6##4##(1991-12#1)(1991-3#1)(1994-6#1)(1995-11#1)(2008-10#1)(2008-8#1)
or both of##18##3##(1990-4#1)(1991-12#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-6#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-11#1)(1997-2#1)(2005-11#1)(2007-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)
or both parents##2##3##(2007-7#1)(2011-1#1)
or both the##5##3##(1991-5#1)(1993-4#1)(1996-10#1)(2010-8#1)(2013-8#1)
or both to##2##3##(2007-12#1)(2007-5#1)
or both were##3##3##(1990-7#1)(2007-9#1)(2008-10#1)
or both##190##2##(1990-11#1)(1990-12#1)(1990-4#2)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#2)(1992-7#2)(1992-8#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#2)(1993-5#1)(1993-7#1)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-11#2)(1995-2#1)(1995-5#3)(1995-8#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-4#3)(1997-2#3)(1997-3#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-12#1)(2005-10#1)(2005-11#3)(2006-1#2)(2006-10#5)(2006-12#4)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#27)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#5)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-12#2)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#6)(2013-7#2)(2013-8#3)
or both)##2##2##(1991-4#1)(1994-12#1)
or both?##8##2##(1992-4#1)(1995-8#1)(2006-4#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
or bottom-up##2##2##(2009-8#1)(2010-3#1)
or bound##8##2##(1992-12#1)(1997-4#1)(1997-7#1)(2008-10#4)(2008-5#1)
or boundaries##2##2##(2008-10#2)
or bovine serum albumin##5##4##(1992-7#1)(1994-12#1)(1995-6#1)(1996-2#1)(2008-7#1)
or bovine serum##6##3##(1992-7#1)(1994-12#1)(1995-6#1)(1996-2#1)(2006-5#1)(2008-7#1)
or bovine##11##2##(1992-12#1)(1992-7#1)(1994-12#1)(1995-6#1)(1996-2#1)(2006-5#1)(2008-11#2)(2008-7#1)(2010-4#1)(2010-8#1)
or bowel##2##2##(1993-1#1)(2012-1#1)
or brachial plexus##2##3##(2006-8#1)(2013-1#1)
or brain tumors##2##3##(2010-2#1)(2011-2#1)
or brain##13##2##(1990-11#1)(1993-1#1)(1995-5#2)(1997-9#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-2#1)(2011-2#1)
or brainstem##2##2##(1991-5#1)(2007-10#1)
or branches##2##2##(2007-3#1)(2008-5#1)
or breakage of the##2##4##(2007-7#1)(2008-7#1)
or breaking##2##2##(1995-2#1)(2008-10#1)
or breast cancer##5##3##(1996-1#1)(2006-7#1)(2007-6#1)(2008-7#2)
or breast##9##2##(1990-4#1)(1996-1#1)(2005-11#1)(2006-2#1)(2006-7#1)(2007-6#1)(2008-7#2)(2010-12#1)
or breathing##2##2##(1991-12#1)(2008-1#1)
or breeding##2##2##(2008-8#2)
or bright##2##2##(2007-12#1)(2010-1#1)
or bronchial##4##2##(1991-11#1)(2006-10#1)(2008-10#1)(2011-3#1)
or bronchoalveolar lavage##2##3##(2005-11#1)(2011-2#1)
or bronchoalveolar##3##2##(1996-9#1)(2005-11#1)(2011-2#1)
or buffer##3##2##(1992-11#1)(2009-8#1)(2012-12#1)
or bulbous nose##2##3##(1990-9#1)(1997-3#1)
or bulbous##3##2##(1990-9#1)(1995-11#1)(1997-3#1)
or bulk##2##2##(2007-8#1)(2010-2#1)
or bumetanide##2##2##(1992-8#1)(1994-3#1)
or buried##3##2##(1990-5#1)(2008-10#2)
or buspirone##2##2##(1994-2#1)(2008-6#1)
or by a mixture of##2##5##(1995-6#1)(2008-9#1)
or by a##23##3##(1990-12#1)(1992-10#1)(1992-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-5#1)(1996-9#1)(2006-11#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-3#1)(2008-4#2)(2008-7#2)(2008-9#1)(2010-4#1)
or by adding an##2##4##(2006-9#1)(2008-10#1)
or by adding##5##3##(1991-3#1)(2006-9#1)(2008-10#1)(2008-5#2)
or by addition of##2##4##(1990-11#1)(1995-5#1)
or by adoptive transfer of##2##5##(2008-4#2)
or by adoptive##3##3##(2008-4#2)(2010-7#1)
or by an##8##3##(1992-11#1)(1992-12#1)(1994-1#1)(1994-2#1)(2005-7#1)(2007-11#2)(2008-7#1)
or by both##2##3##(2007-7#1)(2008-9#1)
or by changes in##3##4##(1996-7#1)(2008-7#1)(2008-9#1)
or by combining##2##3##(2006-6#1)(2007-10#1)
or by continuous##2##3##(2005-11#2)
or by culture##2##3##(2008-11#1)(2008-5#1)
or by direct##4##3##(1991-10#1)(1995-2#1)(2005-11#1)(2008-10#1)
or by exposure to##3##4##(1995-11#1)(1997-2#1)(2008-4#1)
or by flame-atomic absorption##2##4##(2008-10#2)
or by gavage for 26 or 41 weeks##2##8##(2008-9#2)
or by generating##2##3##(2006-4#1)(2008-11#1)
or by genetic##2##3##(1997-4#1)(2010-7#1)
or by high##2##3##(1993-11#1)(2005-8#1)
or by increasing##2##3##(1995-12#1)(2008-10#1)
or by manipulating##2##3##(2008-11#1)(2009-12#1)
or by measuring##3##3##(1993-11#1)(1996-1#1)(2010-4#1)
or by mild##2##3##(1995-3#1)(2009-3#1)
or by other##5##3##(1990-11#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
or by peptides##2##3##(1994-8#1)(2008-5#1)
or by phorbol##2##3##(1992-12#1)(1994-3#1)
or by positive##2##3##(2007-11#1)(2008-4#1)
or by replacing##2##3##(1991-8#1)(1992-5#1)
or by the use of##2##5##(1992-9#1)(1996-8#1)
or by the##45##3##(1990-1#1)(1990-7#1)(1990-8#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-9#1)(1993-9#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-7#1)(1996-12#1)(1996-3#1)(1996-8#1)(2005-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#2)(2011-2#1)(2012-3#1)
or by treatment with##2##4##(2008-9#1)(2012-2#1)
or by treatment##4##3##(1996-5#1)(1997-6#1)(2008-9#1)(2012-2#1)
or by use of##2##4##(2008-10#1)(2008-3#1)
or by using a##2##4##(1993-4#1)(2005-12#1)
or by using the##3##4##(1992-9#1)(2008-10#1)(2008-4#1)
or by using##8##3##(1991-10#1)(1992-9#1)(1993-4#1)(2005-12#1)(2008-10#1)(2008-4#1)(2010-4#1)(2012-1#1)
or by##422##2##(1990-1#1)(1990-10#3)(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#3)(1990-7#2)(1990-8#2)(1991-10#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#3)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#1)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#3)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#4)(1992-9#3)(1993-1#1)(1993-11#4)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#3)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#4)(1994-1#1)(1994-10#1)(1994-11#2)(1994-2#4)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#6)(1994-9#4)(1995-1#4)(1995-11#4)(1995-12#2)(1995-2#4)(1995-3#3)(1995-5#1)(1995-6#3)(1995-7#2)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#6)(1996-3#2)(1996-5#6)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#4)(1997-8#1)(2003-11#2)(2004-9#1)(2005-11#5)(2005-12#2)(2005-7#3)(2005-8#2)(2006-1#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#3)(2006-5#3)(2006-6#3)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#10)(2007-12#7)(2007-2#2)(2007-3#4)(2007-4#1)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#40)(2008-11#11)(2008-12#2)(2008-2#10)(2008-3#3)(2008-4#21)(2008-5#15)(2008-6#3)(2008-7#6)(2008-8#2)(2008-9#9)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#4)(2010-8#1)(2011-1#5)(2011-2#9)(2012-1#2)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#3)
or cAMP##3##2##(1990-3#1)(1992-3#1)(1995-11#1)
or cadmium##4##2##(1994-6#1)(1996-3#1)(2008-10#2)
or caffeine##3##2##(1992-2#1)(1992-7#1)(2007-10#1)
or calcitonin gene-related##2##3##(1990-7#1)(2010-10#1)
or calcium ionophore##3##3##(1990-12#1)(1993-8#1)(2008-11#1)
or calcium##10##2##(1990-12#1)(1993-8#1)(1993-9#1)(1994-12#1)(1997-4#1)(2007-1#1)(2008-10#1)(2008-11#1)(2010-12#1)(2013-7#1)
or calcium-channel blockers##2##3##(2009-6#2)
or calculated##6##2##(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2011-1#1)
or calf##2##2##(1992-11#1)(1994-9#1)
or calmodulin##3##2##(1991-2#1)(1995-2#1)(1995-3#1)
or calmodulin-dependent protein kinase##2##4##(1991-7#1)(1994-5#1)
or calvaria##2##2##(2008-11#2)
or can be##10##3##(1993-12#1)(1993-5#1)(2006-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2012-1#1)
or can##20##2##(1993-12#1)(1993-5#1)(1993-7#1)(1995-1#1)(1996-10#1)(2006-10#1)(2006-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-8#1)(2010-12#1)(2012-1#1)(2012-12#1)
or cancer##11##2##(1990-8#1)(1993-9#1)(1996-1#1)(2008-10#1)(2009-12#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
or cancers##2##2##(2009-12#1)(2012-2#1)
or cannot##2##2##(1993-3#1)(2008-8#1)
or capsaicin##2##2##(1993-4#1)(2008-8#1)
or captopril##2##2##(1992-11#1)(1996-2#1)
or capture##2##2##(1990-8#1)(2008-10#1)
or carbachol##6##2##(1990-2#1)(1992-4#1)(1992-6#1)(2007-1#3)
or carbachol-stimulated##2##2##(1995-2#1)(2007-1#1)
or carbamazepine##3##2##(1992-8#1)(1997-5#2)
or carbohydrates##2##2##(1996-12#1)(2008-7#1)
or carbon dioxide##4##3##(1990-11#1)(2006-6#2)(2011-2#1)
or carbon##7##2##(1990-11#1)(1995-1#1)(2006-6#2)(2007-8#1)(2008-10#1)(2011-2#1)
or carboplatin##3##2##(1990-6#1)(2012-2#1)(2013-8#1)
or carboxyl##7##2##(1994-9#1)(1995-3#2)(1996-5#1)(2007-8#1)(2008-2#1)(2008-4#1)
or carboxylic##3##2##(2007-12#1)(2008-10#1)(2010-2#1)
or carcinomas##3##2##(1993-7#1)(1994-6#1)(2012-3#1)
or cardiac##15##2##(1992-5#1)(1994-3#1)(1995-3#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-4#1)(2010-11#1)(2010-6#1)(2010-8#1)
or cardiolipin##2##2##(1994-12#1)(1994-5#1)
or cardiovascular complications##2##3##(2007-11#1)(2008-5#1)
or cardiovascular##10##2##(1993-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-2#1)(2012-2#1)
or care##4##2##(1994-2#1)(1995-3#2)(2006-8#1)
or caregiver##2##2##(2010-4#1)(2012-12#1)
or cartilage##3##2##(1991-12#1)(2007-11#1)(2012-2#1)
or case##4##2##(2004-12#1)(2006-1#1)(2007-10#1)(2007-11#1)
or casein##5##2##(1990-11#1)(1990-8#1)(2008-4#3)
or catabolic##2##2##(2008-5#1)(2012-2#1)
or catalase##6##2##(1990-2#1)(1994-9#1)(1995-3#1)(1995-8#1)(2008-2#1)(2012-3#1)
or catalyst##2##2##(2008-10#2)
or catalytic##2##2##(2008-11#1)(2010-6#1)
or categories##2##2##(2008-7#2)
or catheter##2##2##(2006-10#1)(2007-7#1)
or cationic##2##2##(2005-11#1)(2008-10#1)
or caudal##2##2##(1993-7#1)(2006-10#1)
or caudate nucleus##3##3##(1994-8#1)(1995-5#2)
or causal##2##2##(2005-11#1)(2011-1#1)
or cause##8##2##(1991-5#1)(1996-6#1)(2007-6#1)(2008-11#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-1#1)
or caused by##6##3##(1992-10#1)(2005-5#1)(2008-2#1)(2009-3#1)(2009-6#1)(2010-6#1)
or caused##7##2##(1992-10#1)(1996-10#1)(2005-5#1)(2008-2#1)(2009-3#1)(2009-6#1)(2010-6#1)
or ceftriaxone##2##2##(2006-8#1)(2011-2#1)
or cell cultures with##2##4##(2008-10#1)(2008-9#1)
or cell death##3##3##(1993-4#1)(2007-11#1)(2008-11#1)
or cell growth##2##3##(1990-12#1)(1994-2#1)
or cell surface##4##3##(1995-2#1)(2007-11#1)(2008-1#1)(2008-9#1)
or cell type##3##3##(1996-8#1)(2008-7#1)(2008-9#1)
or cell wall##2##3##(2006-8#1)(2008-10#1)
or cell##32##2##(1990-12#2)(1990-8#1)(1993-4#1)(1994-2#1)(1994-6#1)(1995-2#1)(1996-12#1)(1996-8#1)(1997-2#1)(2006-8#1)(2007-11#2)(2008-1#2)(2008-10#4)(2008-11#2)(2008-4#1)(2008-7#2)(2008-9#4)(2011-1#1)(2011-2#1)(2012-12#2)
or cell-cell##2##2##(2005-11#1)(2008-7#1)
or cell-specific##3##2##(1992-9#1)(2006-10#1)(2008-7#1)
or cells from##3##3##(2008-4#2)(2013-8#1)
or cells##15##2##(1990-2#1)(1991-12#1)(1993-6#2)(2007-11#1)(2008-1#1)(2008-11#3)(2008-4#3)(2008-7#1)(2010-3#1)(2013-8#1)
or cellular##9##2##(1994-3#1)(1997-7#1)(2007-1#1)(2007-2#1)(2008-4#2)(2009-7#1)(2010-8#1)(2011-2#1)
or cement##2##2##(2010-3#1)(2012-2#1)
or censoring##2##2##(2011-2#1)(2012-2#1)
or central nervous system##5##4##(1993-9#1)(2005-8#1)(2010-8#2)(2011-2#1)
or central nervous##6##3##(1993-9#1)(2005-8#1)(2008-9#1)(2010-8#2)(2011-2#1)
or central venous##2##3##(1990-6#1)(2007-8#1)
or central##19##2##(1990-6#1)(1991-5#1)(1992-11#1)(1993-6#1)(1993-9#1)(2005-8#1)(2006-9#1)(2007-10#2)(2007-8#1)(2008-10#1)(2008-6#1)(2008-9#2)(2010-5#1)(2010-8#2)(2011-2#1)(2012-2#1)
or centrally##3##2##(1990-3#1)(1991-6#1)(1996-7#1)
or centrifugation##2##2##(1997-3#1)(2008-6#1)
or cerebellar##2##2##(1994-10#1)(1996-12#1)
or cerebellopontine angle##2##3##(1994-9#1)(2008-7#1)
or cerebellum##4##2##(1992-10#1)(1993-12#1)(1994-6#1)(1995-9#1)
or cerebral##12##2##(1991-5#1)(1993-11#1)(1994-2#1)(1995-5#1)(1996-12#1)(1996-8#1)(1997-5#1)(2005-8#1)(2008-12#1)(2008-4#1)(2008-7#1)(2012-12#1)
or cerebral)##2##2##(2007-12#2)
or cerebrospinal fluid (CSF)##3##4##(1991-6#1)(1993-4#1)(2011-2#1)
or cerebrospinal fluid##5##3##(1991-6#1)(1993-4#1)(2006-8#1)(2008-10#1)(2011-2#1)
or cerebrovascular##3##2##(2007-7#1)(2008-3#1)(2010-12#1)
or certain##5##2##(1991-11#1)(1994-1#1)(2012-2#2)(2013-1#1)
or cervical##4##2##(2007-10#1)(2008-12#1)(2009-2#1)(2013-8#1)
or cervicitis##2##2##(2011-2#2)
or cesarean##2##2##(2007-2#1)(2008-9#1)
or challenge##2##2##(2008-4#1)(2012-11#1)
or change in##5##3##(1992-6#1)(2007-6#1)(2008-8#1)(2010-11#1)(2010-2#1)
or change the##2##3##(2007-12#1)(2013-8#1)
or change##16##2##(1992-6#1)(1997-1#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-12#1)(2008-6#2)(2008-8#1)(2010-11#1)(2010-2#1)(2011-1#1)(2013-8#2)
or changed##4##2##(2007-9#1)(2008-11#1)(2008-8#1)(2012-3#1)
or changes in the##2##4##(2008-2#1)(2008-5#1)
or changes in##9##3##(1991-10#1)(1995-8#1)(1996-3#1)(2008-2#1)(2008-5#2)(2010-4#1)(2011-2#1)(2012-12#1)
or changes##11##2##(1991-10#1)(1994-12#1)(1995-8#1)(1996-3#1)(1997-6#1)(2008-2#1)(2008-5#2)(2010-4#1)(2011-2#1)(2012-12#1)
or changing the##2##3##(2006-12#1)(2008-9#1)
or changing##4##2##(1997-7#1)(2006-10#1)(2006-12#1)(2008-9#1)
or channel##2##2##(1994-12#1)(1994-3#1)
or chaos##2##2##(2006-10#1)(2007-9#1)
or character##2##2##(1991-12#1)(2011-2#1)
or characterised##2##2##(1996-12#1)(2012-12#1)
or characteristics of##2##3##(1991-6#1)(1997-7#1)
or characteristics##3##2##(1991-6#1)(1997-7#1)(2009-7#1)
or characterized##2##2##(1991-8#1)(2008-10#1)
or charge##2##2##(1991-5#1)(2010-8#1)
or charybdotoxin##2##2##(2008-8#1)(2010-12#1)
or chelerythrine##2##2##(1995-5#1)(1996-9#1)
or chemical modification of##2##4##(1992-9#1)(2009-2#1)
or chemical modification##3##3##(1990-5#1)(1992-9#1)(2009-2#1)
or chemical##28##2##(1990-2#1)(1990-5#1)(1992-7#2)(1992-9#1)(1993-8#1)(1994-11#1)(1994-8#1)(1996-12#1)(1996-2#1)(1997-5#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-5#2)(2008-6#1)(2008-7#1)(2009-12#2)(2009-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
or chemical)##2##2##(1993-4#1)(2006-5#1)
or chemically irritated lumbar nerve root##2##6##(2006-11#1)(2006-12#1)
or chemically modified##2##3##(1991-5#1)(2011-1#1)
or chemically##4##2##(1991-5#1)(2006-11#1)(2006-12#1)(2011-1#1)
or chemicals##3##2##(1994-3#1)(2005-12#1)(2008-11#1)
or chemiluminescent##2##2##(2008-10#1)(2011-12#1)
or chemoradiation##2##2##(2004-1#1)(2010-12#1)
or chemostat##2##2##(2008-11#1)(2008-9#1)
or chemotherapeutic##2##2##(2008-10#1)(2011-1#1)
or chemotherapy in##4##3##(1990-5#1)(2008-6#1)(2012-2#2)
or chemotherapy##16##2##(1990-5#1)(1993-9#1)(2006-10#1)(2006-2#1)(2007-6#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#1)(2012-12#1)(2012-2#2)
or chemotherapy-induced##2##2##(2008-4#1)(2010-10#1)
or chest pain##2##3##(2007-7#1)(2012-2#1)
or chest wall##4##3##(1991-12#1)(1997-4#1)(2007-8#2)
or chest##8##2##(1991-12#1)(1997-4#1)(2005-8#1)(2007-7#2)(2007-8#2)(2012-2#1)
or chewing##2##2##(1994-7#1)(2011-12#1)
or chick##2##2##(1990-7#1)(1996-12#1)
or chicken##2##2##(1991-6#1)(2008-10#1)
or child##5##2##(1992-3#1)(1997-6#1)(2008-11#1)(2010-7#1)(2013-8#1)
or children with##2##3##(1995-6#1)(2009-5#1)
or children##4##2##(1995-6#1)(2008-6#1)(2009-5#1)(2012-12#1)
or chloramphenicol##2##2##(1995-8#2)
or chlorides##2##2##(2007-11#1)(2008-10#1)
or chloroethylclonidine##2##2##(1995-12#2)
or chloroform##2##2##(2007-8#1)(2008-10#1)
or chlorpromazine##3##2##(1990-5#1)(1991-4#2)
or chlortetracycline##3##2##(2008-10#3)
or chlorthalidone##2##2##(1996-9#2)
or choice of##2##3##(1994-11#1)(2007-3#1)
or cholecystokinin##3##2##(1991-1#2)(1995-2#1)
or cholera##2##2##(1990-7#1)(2008-4#1)
or cholesterol content##2##3##(1991-7#1)(1997-2#1)
or cholesterol crystals##2##3##(1994-9#2)
or cholesterol##10##2##(1990-3#1)(1991-5#1)(1991-7#1)(1992-9#1)(1993-9#1)(1994-9#2)(1997-2#1)(2008-10#2)
or choline##3##2##(1990-11#1)(1995-10#2)
or chondrogenic##2##2##(2008-1#1)(2008-11#1)
or chromatin##2##2##(2007-11#1)(2008-8#1)
or chromatographic##2##2##(2008-10#2)
or chromogenic##2##2##(2007-11#1)(2008-10#1)
or chromosomal##2##2##(1991-11#1)(2010-12#1)
or chronic active##3##3##(2006-10#1)(2008-9#2)
or chronic hepatitis##2##3##(2008-4#1)(2012-2#1)
or chronic inflammatory##2##3##(2008-7#1)(2010-6#1)
or chronic low back pain##3##5##(2006-7#1)(2006-8#2)
or chronic obstructive pulmonary disease##3##5##(1991-4#1)(2010-12#1)(2010-2#1)
or chronic obstructive pulmonary##4##4##(1991-4#1)(2010-11#1)(2010-12#1)(2010-2#1)
or chronic pancreatitis##3##3##(1994-7#1)(2007-5#1)(2008-10#1)
or chronic##84##2##(1990-7#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1992-11#1)(1992-5#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-7#1)(1995-1#1)(1995-12#2)(1995-4#1)(1995-8#1)(1996-1#1)(1996-12#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-7#1)(2006-8#3)(2007-11#3)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#2)(2009-3#3)(2009-6#2)(2010-1#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#6)(2013-7#1)(2013-8#2)
or chronically##6##2##(1992-9#1)(1994-12#1)(1994-6#1)(1996-1#1)(1996-12#1)(2011-2#1)
or ciprofloxacin plus metronidazole##2##4##(2006-8#2)
or circularly polarized light##2##4##(2008-2#1)(2008-3#1)
or circumflex artery##2##3##(2007-8#1)(2013-7#1)
or cirrhosis##2##2##(2006-2#1)(2013-1#1)
or cisplatin and##3##3##(1991-7#1)(2004-1#1)(2006-6#1)
or cisplatin##5##2##(1991-7#2)(2004-1#2)(2006-6#1)
or citric acid##2##3##(2008-5#2)
or class I##5##3##(1992-4#1)(1995-5#1)(1997-2#1)(2007-11#1)(2008-5#1)
or class of##2##3##(2007-11#1)(2008-10#1)
or class##9##2##(1991-12#1)(1992-4#1)(1995-5#1)(1997-2#1)(2007-11#3)(2008-10#1)(2008-5#1)
or classic##4##2##(1990-3#1)(1997-6#1)(2008-8#1)(2010-2#1)
or classification##2##2##(2008-10#1)(2013-1#1)
or clear##3##2##(2008-11#1)(2008-4#1)(2008-5#1)
or clearance of##2##3##(1991-2#1)(1996-6#1)
or clinic##6##2##(1992-4#1)(2007-11#1)(2008-7#1)(2009-5#2)(2011-2#1)
or clinical study##2##3##(2007-9#1)(2010-11#1)
or clinical##40##2##(1990-5#1)(1991-1#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#2)(1997-2#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-5#5)(2008-6#2)(2008-8#1)(2009-11#1)(2009-4#1)(2010-11#1)(2011-2#1)(2012-12#2)(2013-8#1)
or clinically relevant##2##3##(2004-1#1)(2011-2#1)
or clinically##4##2##(2004-1#1)(2008-7#1)(2011-2#2)
or cloned##3##2##(1997-7#2)(2008-4#1)
or clonidine##3##2##(1996-10#1)(2007-2#1)(2008-7#1)
or clopidogrel alone##2##3##(2008-11#1)(2008-8#1)
or clopidogrel##6##2##(2007-10#1)(2008-11#1)(2008-8#1)(2009-5#2)(2010-9#1)
or close to the edge##2##5##(2008-3#1)(2008-6#1)
or close to the##8##4##(1990-12#1)(1992-12#1)(1996-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-12#1)
or close to zero##2##4##(2008-2#1)(2012-3#1)
or close to##13##3##(1990-12#1)(1992-12#1)(1992-6#1)(1995-6#1)(1996-8#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-12#1)(2012-3#1)
or close##20##2##(1990-12#1)(1992-12#1)(1992-6#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-8#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
or closed circuit anaesthesia##2##4##(2011-2#2)
or closed##8##2##(1991-3#1)(1991-6#1)(2008-10#1)(2008-2#2)(2010-12#1)(2011-2#2)
or closely linked to##2##4##(1997-4#1)(2008-10#1)
or closely linked##5##3##(1994-3#1)(1997-4#1)(2008-10#3)
or closely related##3##3##(1991-9#1)(1992-2#1)(2008-4#1)
or closely##8##2##(1991-9#1)(1992-2#1)(1994-3#1)(1997-4#1)(2008-10#3)(2008-4#1)
or clump##2##2##(2008-6#1)(2010-2#1)
or cluster##4##2##(2007-12#1)(2008-10#2)(2009-11#1)
or clustering##4##2##(2008-1#1)(2008-10#1)(2008-2#1)(2012-3#1)
or clusters of##3##3##(1991-3#1)(2005-11#1)(2013-1#1)
or clusters##4##2##(1991-3#1)(2005-11#1)(2008-2#1)(2013-1#1)
or coated with##3##3##(2005-11#1)(2007-12#1)(2012-11#1)
or cobalt##3##2##(1994-6#1)(2005-11#1)(2008-5#1)
or cobalt(II)##2##2##(2008-10#2)
or cocaine##5##2##(1996-10#1)(2007-6#1)(2008-10#1)(2013-7#1)(2013-8#1)
or coding region##2##3##(2005-8#1)(2013-1#1)
or coding##3##2##(2005-8#1)(2011-2#1)(2013-1#1)
or codominant##2##2##(2008-4#1)(2008-5#1)
or cofactor##3##2##(1993-11#1)(1994-12#1)(2008-4#1)
or cognitive deficits##2##3##(2008-6#1)(2008-7#1)
or cognitive impairment##3##3##(2007-9#1)(2008-6#1)(2013-1#1)
or cognitive##10##2##(2006-12#1)(2007-9#1)(2008-1#1)(2008-4#2)(2008-6#2)(2008-7#1)(2012-3#1)(2013-1#1)
or cohabiting##8##2##(1990-4#1)(2008-6#1)(2012-3#5)(2013-7#1)
or coil##2##2##(2008-7#1)(2013-7#1)
or cold##3##2##(2008-1#1)(2012-12#2)
or collagen I##2##3##(1994-9#1)(2007-11#1)
or collagen##5##2##(1991-8#1)(1994-9#1)(1995-1#1)(2007-11#1)(2012-3#1)
or collection##2##2##(1991-6#1)(1995-1#1)
or colon cancer##2##3##(2007-3#1)(2009-4#1)
or colon##5##2##(1992-10#2)(2007-3#1)(2008-1#1)(2009-4#1)
or colonic##3##2##(1990-6#1)(1992-10#1)(2012-2#1)
or column##3##2##(2008-10#1)(2008-4#2)
or comatose##2##2##(2005-7#1)(2008-7#1)
or combination chemotherapy##3##3##(1992-10#1)(1993-5#1)(2011-2#1)
or combination of##5##3##(1992-3#1)(2007-4#1)(2008-3#1)(2009-4#1)(2011-2#1)
or combination therapy##2##3##(2010-4#1)(2013-1#1)
or combination##13##2##(1992-10#1)(1992-3#1)(1993-5#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-3#1)(2009-4#1)(2009-8#1)(2010-4#1)(2011-2#2)(2013-1#1)
or combinations of these##2##4##(1991-5#1)(2010-4#1)
or combinations of##13##3##(1991-5#1)(1994-7#1)(2005-7#1)(2007-10#1)(2008-1#1)(2008-4#1)(2008-5#2)(2010-4#3)(2012-12#1)(2013-8#1)
or combinations##18##2##(1991-5#1)(1994-7#1)(2005-7#1)(2007-10#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2009-3#1)(2010-4#4)(2012-12#2)(2013-8#1)
or combinations)##2##2##(2008-5#2)
or combined with##11##3##(1993-12#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-5#1)(2011-2#2)(2012-2#1)(2013-8#1)
or combined##31##2##(1990-6#1)(1991-8#1)(1992-3#1)(1993-12#1)(1993-8#1)(1995-11#1)(1995-5#1)(1996-4#1)(2006-8#1)(2007-1#1)(2007-11#5)(2007-5#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-2#1)(2011-2#4)(2012-2#2)(2013-1#2)(2013-8#1)
or comet##2##2##(1997-4#2)
or commercial##5##2##(1995-9#1)(2008-10#1)(2010-8#1)(2012-12#1)(2013-7#1)
or common factors##2##3##(2012-2#2)
or common##7##2##(1990-7#1)(1994-3#1)(2008-10#1)(2012-2#3)(2013-8#1)
or communication##2##2##(2005-5#1)(2008-11#1)
or community##5##2##(1991-1#1)(1994-3#1)(2007-5#1)(2008-2#1)(2008-3#1)
or comparable to##2##3##(1993-12#1)(2006-10#1)
or comparable with##3##3##(2007-12#1)(2008-3#1)(2012-1#1)
or comparable##5##2##(1993-12#1)(2006-10#1)(2007-12#1)(2008-3#1)(2012-1#1)
or compare##4##2##(2008-8#2)(2009-5#1)(2012-2#1)
or comparing##3##2##(2008-4#1)(2010-11#1)(2012-12#1)
or comparison##3##2##(1994-12#1)(2008-12#1)(2013-8#1)
or compatible##2##2##(1991-5#1)(2008-10#1)
or competitive##2##2##(1995-2#1)(2011-2#1)
or complement##3##2##(2008-5#1)(2010-7#1)(2011-1#1)
or complementary##3##2##(2007-11#1)(2008-2#1)(2008-4#1)
or complete absence of the##2##5##(2006-11#1)(2013-1#1)
or complete absence of##3##4##(2006-11#1)(2011-1#1)(2013-1#1)
or complete loss##2##3##(1995-5#1)(2008-9#1)
or complete##30##2##(1990-6#1)(1990-9#1)(1991-2#1)(1991-9#1)(1993-2#1)(1993-7#1)(1995-1#1)(1995-5#1)(1996-2#1)(2006-11#1)(2006-12#2)(2006-4#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#2)(2011-1#1)(2011-2#1)(2011-7#1)(2013-1#3)
or completed##2##2##(2007-10#1)(2008-10#1)
or completely abolished##3##3##(1991-5#2)(2008-7#1)
or completely replacing##2##3##(1993-8#1)(2008-4#1)
or completely##18##2##(1990-7#1)(1991-12#1)(1991-5#2)(1993-8#1)(1995-3#1)(1995-6#1)(1997-6#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-4#2)(2008-5#1)(2008-7#1)(2012-2#1)(2012-3#1)
or complex##10##2##(1996-4#1)(2006-10#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2010-7#1)(2011-1#1)
or complexes##2##2##(1994-11#1)(2008-10#1)
or complicated##3##2##(2008-10#1)(2008-3#2)
or complication##4##2##(1995-1#1)(2005-7#1)(2007-8#1)(2013-1#1)
or complications of immobility##2##4##(2007-9#2)
or complications of##4##3##(2006-11#1)(2007-8#1)(2007-9#2)
or complications##11##2##(1992-10#1)(1995-8#1)(2006-11#1)(2006-12#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-7#2)(2012-2#1)
or composite##3##2##(1991-4#1)(2008-10#1)(2009-3#1)
or composition##2##2##(2008-9#1)(2012-3#1)
or compound##3##2##(2007-9#1)(2008-10#1)(2008-4#1)
or compounds##2##2##(1991-4#1)(2008-10#1)
or compressed##3##2##(1991-12#1)(2007-12#1)(2008-1#1)
or compression##4##2##(1991-5#1)(2007-4#1)(2008-2#1)(2013-1#1)
or compressive##2##2##(2007-4#1)(2008-3#1)
or computational##2##2##(2008-11#1)(2009-5#1)
or computed tomography (CT)##2##4##(2005-8#1)(2013-1#1)
or computed tomography scans##2##4##(2007-10#1)(2008-7#1)
or computed tomography##8##3##(1991-8#1)(2005-8#1)(2007-10#1)(2007-8#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#1)
or computed##9##2##(1991-8#1)(1996-12#1)(2005-8#1)(2007-10#1)(2007-8#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#1)
or computer##4##2##(2006-10#1)(2007-11#1)(2013-1#2)
or computerized##2##2##(1996-12#1)(2006-8#1)
or concentrate##2##2##(2008-4#1)(2012-2#1)
or concentrated##4##2##(2008-3#1)(2008-4#1)(2012-12#2)
or concentration##4##2##(2006-10#1)(2007-11#2)(2008-1#1)
or conceptual##2##2##(1993-12#1)(2012-12#1)
or concomitant##6##2##(1990-6#1)(1997-7#1)(2005-11#1)(2007-3#1)(2008-7#1)(2012-2#1)
or concomitantly##2##2##(2011-2#1)(2012-2#1)
or concurrent use of##3##4##(1991-12#1)(2006-10#1)(2007-11#1)
or concurrent##6##2##(1991-12#1)(1996-12#1)(2006-10#1)(2007-11#1)(2010-2#1)(2013-8#1)
or condition##5##2##(1993-8#1)(1995-9#1)(1997-2#1)(1997-4#1)(2008-4#1)
or conditional##4##2##(1993-4#1)(1996-7#1)(2008-7#1)(2008-8#1)
or conditioned##2##2##(1993-11#1)(1995-11#1)
or conditions##9##2##(1994-12#1)(1994-6#1)(1995-9#1)(2004-12#1)(2005-9#1)(2008-3#1)(2009-6#1)(2009-7#1)(2013-8#1)
or conduct disorder##2##3##(2008-2#1)(2008-9#1)
or conformational changes##2##3##(2013-1#1)(2013-8#1)
or conformational##3##2##(2008-4#1)(2013-1#1)(2013-8#1)
or confounding##2##2##(1990-8#1)(2008-7#1)
or confusing##3##2##(2006-12#1)(2013-1#2)
or congenital heart disease##3##4##(2005-11#1)(2006-6#1)(2009-4#1)
or congenital##11##2##(1993-5#1)(1996-5#1)(2005-11#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-7#1)(2009-3#1)(2009-4#1)
or connected to##2##3##(2006-6#1)(2007-8#1)
or consensus##2##2##(2008-10#1)(2011-2#1)
or consequence of##4##3##(1996-1#1)(1996-4#1)(2008-7#1)(2012-1#1)
or conservative surgery##2##3##(1995-5#1)(2004-1#1)
or conservative##9##2##(1993-4#1)(1993-6#1)(1995-5#1)(2004-1#1)(2006-10#1)(2008-3#1)(2008-7#1)(2010-3#1)(2013-1#1)
or consideration of##2##3##(1992-9#1)(2004-3#1)
or consideration##3##2##(1992-9#1)(1993-1#1)(2004-3#1)
or considering##2##2##(1994-5#1)(2008-10#1)
or consistent##4##2##(1990-12#1)(1993-9#1)(2012-12#1)(2012-3#1)
or consonantal##2##2##(2012-1#2)
or construct##2##2##(2008-6#1)(2013-1#1)
or consumption##2##2##(1994-3#1)(2005-12#1)
or contact lens##2##3##(2005-11#1)(2007-11#1)
or contact##5##2##(1992-8#1)(2005-10#2)(2005-11#1)(2007-11#1)
or contain##2##2##(2007-12#1)(2013-1#1)
or contained##2##2##(1996-11#1)(2009-8#1)
or contaminated##3##2##(1993-1#1)(2008-2#1)(2008-5#1)
or content of##3##3##(1996-2#1)(2009-4#1)(2009-7#1)
or content##5##2##(1996-2#1)(2008-2#1)(2008-9#1)(2009-4#1)(2009-7#1)
or continuation of##3##3##(1993-12#1)(2011-1#2)
or continue to##2##3##(2006-3#1)(2007-4#1)
or continue##3##2##(2006-3#1)(2007-4#1)(2008-8#1)
or continued##2##2##(2006-10#1)(2006-7#1)
or continuing##3##2##(1992-2#1)(1993-12#1)(2011-1#1)
or continuous##16##2##(1990-3#1)(1990-9#1)(1992-4#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-3#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-3#1)(2011-1#1)(2013-1#2)
or continuously##2##2##(1993-11#1)(2006-1#1)
or contracted##3##2##(1990-5#1)(1994-12#1)(2008-11#1)
or contraindicated##2##2##(2006-6#1)(2013-1#1)
or contrast-enhanced##2##2##(2006-12#1)(2010-12#1)
or contribute to the##3##4##(2007-6#1)(2008-10#2)
or control animals in##2##4##(1992-1#2)
or control animals##3##3##(1992-1#2)(1996-9#1)
or control diets##2##3##(1993-12#1)(2009-3#1)
or control group##4##3##(2006-8#1)(2007-11#1)(2008-11#1)(2013-7#1)
or control the##3##3##(2008-1#1)(2013-1#2)
or control##39##2##(1990-4#1)(1992-1#2)(1992-7#1)(1993-1#1)(1993-12#1)(1994-8#1)(1996-10#1)(1996-9#1)(1997-1#1)(2005-5#1)(2005-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#2)(2013-7#1)
or controlled##3##2##(2008-10#2)(2010-12#1)
or controlling##2##2##(2005-5#1)(2011-2#1)
or controls##3##2##(1990-12#1)(1996-8#1)(2007-3#1)
or convective##2##2##(1994-9#1)(2008-1#1)
or conventional heating##2##3##(2007-11#1)(2008-5#1)
or conventional##10##2##(1992-5#1)(1993-12#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)
or conventionally##2##2##(2007-11#1)(2013-1#1)
or conversely##3##2##(2003-11#1)(2008-5#1)(2008-6#1)
or conversion##4##2##(2006-10#1)(2007-11#1)(2008-11#2)
or converted##2##2##(1994-3#1)(2008-6#1)
or cooking##2##2##(1997-4#1)(2008-4#1)
or cooperative##2##2##(1994-12#1)(1997-2#1)
or copper##5##2##(1992-4#3)(2008-10#1)(2011-2#1)
or cord blood##4##3##(1995-12#1)(2005-8#1)(2008-10#1)(2008-4#1)
or core##4##2##(1993-9#1)(1994-2#1)(2004-1#1)(2004-2#1)
or corn oil##2##3##(2006-5#1)(2008-3#1)
or corn##3##2##(1995-5#1)(2006-5#1)(2008-3#1)
or corn-oil##4##2##(2006-8#4)
or coronary artery disease##2##4##(2008-11#1)(2013-1#1)
or coronary artery##5##3##(2006-10#1)(2008-11#1)(2008-3#2)(2013-1#1)
or coronary##8##2##(1991-10#1)(1996-11#1)(2005-9#1)(2006-10#1)(2008-11#1)(2008-3#2)(2013-1#1)
or correct the##2##3##(2007-12#1)(2010-1#1)
or correct##4##2##(2006-10#1)(2007-12#1)(2008-1#1)(2010-1#1)
or corrected##2##2##(1992-7#1)(2008-10#1)
or correcting##3##2##(1993-8#1)(2006-10#1)(2008-10#1)
or correction of##2##3##(2006-10#1)(2007-3#1)
or correlated##2##2##(1995-11#1)(2009-9#1)
or cortex##2##2##(2007-9#1)(2008-10#1)
or cortical##6##2##(1991-10#1)(1994-6#1)(1996-12#1)(2006-11#1)(2008-1#1)(2008-10#1)
or corticosteroid##2##2##(2007-11#1)(2007-2#1)
or corticosteroids##2##2##(2006-10#2)
or corticosterone##2##2##(2008-4#1)(2008-5#1)
or cortisol##5##2##(1990-11#1)(2006-1#1)(2008-5#1)(2008-6#1)(2013-1#1)
or cosmetic##3##2##(1997-5#1)(2008-5#2)
or cost##6##2##(1992-12#2)(1994-3#1)(2005-10#1)(2006-12#1)(2008-3#1)
or cot##2##2##(2007-1#1)(2011-1#1)
or cotton##3##2##(2007-11#1)(2008-10#1)(2011-2#1)
or could be##2##3##(1995-7#1)(2008-10#1)
or could not be##2##4##(2004-10#1)(2008-7#1)
or could not##3##3##(1994-1#1)(2004-10#1)(2008-7#1)
or could##8##2##(1991-12#1)(1994-1#1)(1995-7#1)(2004-10#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-3#1)
or coumarin##2##2##(1992-11#1)(2009-2#1)
or coupled##2##2##(2008-10#1)(2008-4#1)
or covalent grafting##2##3##(2008-10#2)
or covalent##3##2##(1994-6#1)(2008-10#2)
or covalently##2##2##(1997-1#1)(2008-5#1)
or create##2##2##(1990-2#1)(2008-12#1)
or creating##2##2##(2010-9#1)(2013-1#1)
or creatinine##3##2##(1990-10#1)(2006-8#1)(2007-12#1)
or creation of a##3##4##(2007-1#1)(2008-10#1)(2010-8#1)
or creation of##4##3##(2007-1#1)(2008-10#2)(2010-8#1)
or crisis##3##2##(1994-2#1)(1996-9#1)(2011-2#1)
or criteria##3##2##(1990-9#1)(2009-2#1)(2012-3#1)
or critical##4##2##(2008-10#1)(2008-3#1)(2008-5#1)(2010-11#1)
or critically##2##2##(2008-11#1)(2013-8#1)
or crop##2##2##(2008-10#1)(2008-7#1)
or crossing##2##2##(2006-10#1)(2008-12#1)
or crude##3##2##(1992-8#1)(2008-10#1)(2008-12#1)
or cryotherapy##2##2##(2006-12#1)(2011-2#1)
or cryptic##2##2##(1990-11#1)(2007-7#1)
or cultivars##2##2##(2008-10#2)
or culture##4##2##(1994-11#1)(2007-7#1)(2008-10#2)
or cultured##2##2##(1993-12#1)(1997-1#1)
or curative##2##2##(2008-5#1)(2010-12#1)
or cure of##2##3##(1993-11#1)(2007-7#1)
or cure##5##2##(1993-11#1)(2005-7#1)(2007-7#1)(2008-7#1)(2009-6#1)
or current disease##2##3##(2007-12#1)(2012-2#1)
or current##5##2##(1993-6#1)(2007-12#2)(2007-8#1)(2012-2#1)
or custom-made##2##2##(2007-11#1)(2008-4#1)
or cutaneous##4##2##(2007-2#3)(2008-5#1)
or cuts##2##2##(2008-12#1)(2009-4#1)
or cw##3##2##(2007-12#2)(2008-3#1)
or cyclic AMP##3##3##(1990-5#1)(1991-7#1)(1997-8#1)
or cyclic##10##2##(1990-5#1)(1991-7#1)(1992-12#1)(1995-10#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-8#1)(2008-10#1)(2010-4#1)
or cycloheximide##3##2##(1992-5#1)(1992-8#1)(1996-11#1)
or cyclophosphamide##2##2##(2006-9#1)(2007-7#1)
or cyclosporin##2##2##(1995-3#1)(2007-11#1)
or cylindrical##3##2##(2007-9#1)(2008-10#1)(2008-2#1)
or cysteine##6##2##(1990-10#1)(1990-3#1)(1991-9#1)(1994-5#1)(1995-3#1)(1997-6#1)
or cystic##3##2##(2006-10#1)(2008-1#1)(2008-3#1)
or cytochrome P-450##2##3##(1991-2#1)(2008-9#1)
or cytochrome c on##2##4##(1995-5#2)
or cytochrome c##3##3##(1991-9#1)(1995-5#2)
or cytochrome##7##2##(1991-2#1)(1991-9#1)(1994-3#1)(1994-8#1)(1995-5#2)(2008-9#1)
or cytokine##3##2##(1994-5#1)(1995-2#1)(1996-10#1)
or cytokines such as##2##4##(1995-5#1)(2008-1#1)
or cytokines##4##2##(1995-5#1)(2008-1#1)(2009-5#1)(2010-12#1)
or cytoplasmic##4##2##(1992-7#1)(1995-8#1)(2008-2#1)(2010-3#1)
or cytosine##3##2##(2007-8#1)(2008-5#2)
or cytosol##2##2##(1992-7#1)(2008-4#1)
or cytosolic##4##2##(1991-1#1)(1994-3#1)(1995-5#1)(1995-8#1)
or cytotoxic T lymphocytes##2##4##(1995-5#1)(2008-4#1)
or cytotoxic T##3##3##(1991-9#1)(1995-5#1)(2008-4#1)
or cytotoxic drugs##2##3##(1997-4#1)(2008-1#1)
or cytotoxic therapy##2##3##(1992-10#1)(2008-6#1)
or cytotoxic##9##2##(1990-12#1)(1991-9#1)(1992-10#1)(1995-5#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-6#1)
or daily##2##2##(2008-10#1)(2013-8#1)
or dairy##2##2##(2013-1#2)
or damage the##2##3##(1997-8#2)
or damage to the##4##4##(2004-11#1)(2006-3#1)(2007-7#1)(2011-1#1)
or damage to##6##3##(1992-11#1)(2004-11#1)(2006-3#1)(2007-7#2)(2011-1#1)
or damage##11##2##(1992-11#1)(1997-8#2)(2004-11#1)(2006-3#1)(2007-7#2)(2008-4#1)(2010-9#1)(2011-1#1)(2012-12#1)
or damaged##6##2##(1992-9#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-8#1)(2010-2#1)
or data##5##2##(1990-11#1)(2008-5#1)(2008-7#1)(2010-2#1)(2011-2#1)
or days##5##2##(1991-6#1)(1995-2#1)(1997-3#1)(2008-7#2)
or daytime##2##2##(1992-8#1)(2010-7#1)
or de novo##4##3##(1993-12#1)(2007-8#1)(2008-4#1)(2011-1#1)
or dead##4##2##(2007-10#1)(2008-1#1)(2010-3#1)(2012-2#1)
or death after##2##3##(2007-10#2)
or death in patients with##2##5##(1991-11#1)(2011-2#1)
or death in##3##3##(1991-11#1)(2009-6#1)(2011-2#1)
or death of the##2##4##(2005-12#1)(2013-1#1)
or death of##3##3##(2005-12#1)(2008-8#1)(2013-1#1)
or death were##2##3##(2007-8#1)(2013-7#1)
or death##41##2##(1991-10#1)(1991-11#2)(1991-12#1)(1993-7#1)(1995-12#1)(1995-2#1)(2005-12#1)(2006-10#1)(2006-8#1)(2007-10#4)(2007-8#3)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-6#3)(2010-1#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#4)(2013-7#2)(2013-8#2)
or deaths##3##2##(2006-11#1)(2007-8#1)(2008-3#1)
or decision-making##2##2##(1993-12#1)(2012-12#1)
or decompensated##4##2##(1991-10#1)(1997-4#1)(2007-9#1)(2013-8#1)
or decrease in the##4##4##(1997-5#1)(2007-11#1)(2008-12#1)(2012-2#1)
or decrease in##9##3##(1990-5#1)(1992-8#1)(1994-6#1)(1997-5#1)(2007-11#1)(2008-10#1)(2008-12#1)(2012-12#1)(2012-2#1)
or decrease of##4##3##(1990-9#1)(2007-12#1)(2007-9#1)(2011-2#1)
or decrease the##6##3##(1991-6#1)(1992-7#1)(1995-4#1)(1995-6#1)(2008-3#1)(2010-4#1)
or decrease their##2##3##(2008-10#1)(2010-12#1)
or decrease##32##2##(1990-5#1)(1990-9#1)(1991-6#1)(1992-7#1)(1992-8#1)(1993-9#1)(1994-6#1)(1995-4#1)(1995-6#1)(1996-2#1)(1997-1#1)(1997-5#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-3#3)(2008-7#1)(2009-10#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-12#2)(2012-2#1)
or decreased by##3##3##(1993-11#1)(2005-11#1)(2007-10#1)
or decreased in##2##3##(1997-7#1)(2008-11#1)
or decreased with##2##3##(2007-8#1)(2008-10#1)
or decreased##27##2##(1990-11#1)(1990-7#1)(1991-9#1)(1993-11#1)(1993-3#1)(1993-7#1)(1994-3#1)(1994-8#1)(1996-12#1)(1997-1#1)(1997-7#1)(2005-11#1)(2007-10#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-7#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)
or decreases##6##2##(1992-6#1)(1996-10#1)(2010-11#1)(2010-5#2)(2012-3#1)
or decreasing the##4##3##(2008-1#1)(2008-8#1)(2009-10#1)(2009-12#1)
or decreasing##10##2##(1993-12#1)(1994-11#1)(1995-3#1)(1996-4#1)(2008-1#1)(2008-8#2)(2009-10#1)(2009-12#1)(2011-2#1)
or deduced amino##2##3##(1997-4#1)(2008-8#1)
or deep infections##2##3##(2006-10#1)(2007-8#1)
or deep##7##2##(2006-10#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-8#1)(2013-8#1)
or defective##3##2##(2005-11#1)(2007-7#1)(2010-8#1)
or defects##4##2##(2007-11#2)(2008-1#1)(2010-3#1)
or deficiency of##2##3##(1991-4#1)(2007-12#1)
or deficient##5##2##(1991-2#1)(1994-5#1)(1995-12#1)(2008-9#1)(2012-2#1)
or deficits in##2##3##(2010-3#1)(2011-1#1)
or define##2##2##(1994-8#1)(1995-1#1)
or defined##3##2##(1991-11#1)(1994-9#1)(2008-4#1)
or definitely##2##2##(1992-10#1)(1997-8#1)
or definitive##7##2##(1993-5#1)(2007-11#1)(2007-7#2)(2008-4#1)(2010-7#1)(2013-1#1)
or deformation##2##2##(2004-9#1)(2008-2#1)
or degenerative changes##3##3##(2006-1#1)(2007-11#1)(2008-12#1)
or degenerative diseases##2##3##(2009-3#1)(2012-2#1)
or degenerative##11##2##(1991-4#1)(2006-1#1)(2007-11#2)(2007-7#1)(2008-12#1)(2009-3#1)(2010-4#1)(2012-2#1)(2013-1#2)
or degradation of mitochondrial ATP synthase##2##6##(1997-6#2)
or degradation of##5##3##(1993-11#1)(1997-6#2)(2012-12#2)
or degradation##6##2##(1993-11#1)(1997-6#2)(2008-5#1)(2012-12#2)
or degree of##4##3##(2008-10#1)(2010-5#1)(2010-7#1)(2011-2#1)
or degrees of freedom##2##4##(2008-3#2)
or dehydration##2##2##(2008-10#1)(2010-7#1)
or delay the development of##2##5##(1991-9#1)(2007-11#1)
or delay the##5##3##(1991-9#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-1#1)
or delay##20##2##(1991-9#1)(2005-11#2)(2006-10#3)(2006-9#1)(2007-11#1)(2008-1#3)(2008-2#1)(2008-5#1)(2009-11#1)(2010-10#2)(2010-12#2)(2011-1#1)(2013-7#1)
or delayed changes at the##2##5##(1991-8#2)
or delayed complications##2##3##(2007-8#1)(2011-12#1)
or delayed##12##2##(1991-8#2)(1992-7#1)(1993-3#1)(1996-9#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-12#1)
or delaying disease##2##3##(2008-10#2)
or delaying the##4##3##(2005-11#1)(2007-11#1)(2010-6#1)(2011-2#1)
or delaying##7##2##(2005-11#1)(2007-11#1)(2007-4#1)(2008-10#2)(2010-6#1)(2011-2#1)
or delays##2##2##(2008-7#2)
or deleted in##3##3##(1990-4#1)(1997-7#1)(2011-2#1)
or deleted##6##2##(1990-4#1)(1991-11#1)(1997-7#1)(2007-11#1)(2008-10#1)(2011-2#1)
or deleterious##3##2##(1997-4#1)(2007-11#1)(2008-8#1)
or deleting##4##2##(2008-11#1)(2009-7#3)
or deletion of the##2##4##(1997-3#1)(2008-9#1)
or deletion of##7##3##(1995-6#1)(1996-12#1)(1997-3#2)(2007-11#1)(2008-9#1)(2011-1#1)
or deletion##9##2##(1995-6#1)(1996-12#1)(1997-3#2)(2007-11#1)(2008-10#1)(2008-9#2)(2011-1#1)
or deletions of##3##3##(2005-8#1)(2008-4#1)(2008-9#1)
or deletions##6##2##(1991-11#1)(1992-6#1)(2005-8#1)(2008-4#1)(2008-9#1)(2012-12#1)
or deliberate##3##2##(1992-3#1)(2007-12#1)(2008-7#1)
or deliberately##2##2##(2008-10#1)(2009-4#1)
or delipidated##2##2##(1990-5#1)(1994-5#1)
or delivery##4##2##(1995-3#1)(1995-6#1)(2008-5#1)(2009-5#1)
or delta##5##2##(1994-5#1)(1994-9#2)(1995-10#1)(2008-11#1)
or demonstration##2##2##(2008-11#1)(2012-2#1)
or denatured##3##2##(1994-5#1)(1995-3#1)(2008-4#1)
or dendrites##3##2##(1995-7#2)(1996-3#1)
or dendritic##3##2##(1995-7#1)(1996-4#1)(2007-11#1)
or density##7##2##(1993-6#1)(1995-5#1)(2008-4#2)(2008-5#1)(2008-9#1)(2010-4#1)
or dental##5##2##(2007-12#1)(2007-8#1)(2008-5#1)(2011-2#1)(2012-2#1)
or deny##3##2##(2006-9#1)(2010-9#1)(2012-1#1)
or deoxyribonuclease##2##2##(1991-9#1)(1994-2#1)
or dependency##2##2##(2007-10#2)
or dependent##2##2##(2008-10#1)(2013-7#1)
or dephosphorylated##2##2##(1996-6#1)(1997-2#1)
or depigmentation##2##2##(2007-7#1)(2012-12#1)
or depletion of##2##3##(1997-7#1)(2009-8#1)
or depletion##3##2##(1997-7#1)(2009-11#1)(2009-8#1)
or depressed##4##2##(2008-12#1)(2009-7#2)(2013-1#1)
or depression of##2##3##(2008-11#1)(2008-5#1)
or depression##15##2##(1990-5#1)(1992-8#1)(1994-2#1)(1996-2#1)(2005-7#1)(2006-12#1)(2006-8#1)(2008-11#2)(2008-5#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
or depth##2##2##(2008-2#1)(2013-8#1)
or derivatization##2##2##(2008-10#2)
or descending##3##2##(1993-11#1)(2011-2#2)
or descriptive##4##2##(2006-8#1)(2008-11#1)(2010-9#1)(2012-12#1)
or descriptors##2##2##(2008-1#1)(2011-3#1)
or desferrioxamine##2##2##(1990-9#1)(1993-2#1)
or desiccation##3##2##(2008-10#1)(2008-8#1)(2013-7#1)
or desipramine##3##2##(1990-5#1)(1995-12#1)(1996-12#1)
or destroy##2##2##(1992-10#1)(1997-4#1)
or destroyed##2##2##(2006-12#1)(2009-9#1)
or destruction of##2##3##(2008-1#1)(2009-8#1)
or destruction through##3##3##(2005-10#1)(2008-10#2)
or destruction##5##2##(2005-10#1)(2008-1#1)(2008-10#2)(2009-8#1)
or detect##3##2##(2008-10#1)(2008-5#1)(2011-1#1)
or detectable##4##2##(2005-1#1)(2008-9#1)(2011-1#2)
or detection of##3##3##(2008-11#1)(2009-2#1)(2012-2#1)
or detection##5##2##(2008-11#1)(2008-9#1)(2009-2#1)(2010-12#1)(2012-2#1)
or detergent##3##2##(1996-9#1)(2006-10#1)(2008-4#1)
or detergents##2##2##(1993-8#1)(1996-9#1)
or deteriorating##3##2##(2006-5#1)(2010-12#1)(2012-3#1)
or deterioration##4##2##(1990-10#1)(1991-9#1)(1995-11#1)(2007-10#1)
or determine##3##2##(1996-6#1)(2008-4#1)(2008-7#1)
or determining the##2##3##(2007-12#1)(2010-12#1)
or detoxification of##2##3##(1995-3#1)(2010-2#1)
or detoxification##3##2##(1995-3#1)(1996-3#1)(2010-2#1)
or develop##4##2##(2006-10#1)(2008-12#1)(2009-7#1)(2013-1#1)
or developed##2##2##(2009-6#1)(2012-1#1)
or developing##5##2##(1997-2#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-6#1)
or development of##5##3##(2005-10#1)(2008-5#1)(2008-7#2)(2009-12#1)
or development##7##2##(2005-10#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-12#1)
or developmental toxicity##2##3##(2005-7#2)
or developmental##5##2##(2005-12#1)(2005-7#2)(2008-1#2)
or device failures##2##3##(2011-1#1)(2011-2#1)
or device##5##2##(1997-2#1)(2010-9#2)(2011-1#1)(2011-2#1)
or devices##2##2##(2006-10#1)(2013-7#1)
or dew##2##2##(2008-10#2)
or dexamethasone##6##2##(1990-7#2)(1993-2#1)(1995-7#1)(2008-10#2)
or dexamethasone-induced##2##2##(1992-9#1)(1993-4#1)
or diabetes##15##2##(1992-7#1)(2005-11#1)(2007-10#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#2)
or diabetic nephropathy##2##3##(2008-1#1)(2008-8#1)
or diabetic##4##2##(2008-1#1)(2008-8#1)(2011-1#1)(2013-1#1)
or diagnosis of##2##3##(2006-10#1)(2012-2#1)
or diagnosis##4##2##(2006-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
or diagnostic##8##2##(1995-4#1)(1997-5#1)(1997-8#1)(2006-3#1)(2007-8#1)(2007-9#1)(2010-2#1)(2010-6#1)
or diazepam##2##2##(1994-5#2)
or dibutyryl cAMP was##2##4##(1990-8#1)(1991-3#1)
or dibutyryl cyclic##2##3##(1995-11#1)(1997-8#1)
or dibutyryl##4##2##(1990-8#1)(1991-3#1)(1995-11#1)(1997-8#1)
or dichloromethane##2##2##(2008-10#2)
or did not respond##4##4##(1997-5#1)(2007-11#2)(2012-12#1)
or did not##17##3##(1992-12#1)(1997-5#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
or die##4##2##(2006-2#1)(2006-6#1)(2007-12#1)(2008-11#1)
or died##5##2##(1993-2#1)(2007-10#1)(2008-7#1)(2009-3#1)(2012-2#1)
or dielectric##2##2##(2007-11#1)(2008-10#1)
or diet and##2##3##(1991-7#1)(2011-2#1)
or diet##6##2##(1991-7#1)(1995-2#1)(2009-3#1)(2011-2#1)(2013-1#2)
or dietary supplements##4##3##(2006-8#3)(2008-8#1)
or dietary##7##2##(2006-8#3)(2008-7#1)(2008-8#1)(2010-2#1)(2010-8#1)
or differ##2##2##(1990-1#1)(2011-1#1)
or differences in the##2##4##(1996-12#1)(1996-3#1)
or differences in##4##3##(1990-5#1)(1991-12#1)(1996-12#1)(1996-3#1)
or differences##5##2##(1990-5#1)(1991-12#1)(1992-12#1)(1996-12#1)(1996-3#1)
or different from##2##3##(1992-9#1)(2007-3#1)
or different##23##2##(1992-9#1)(1994-2#1)(1996-10#1)(1996-5#1)(2005-11#1)(2005-12#1)(2005-8#1)(2007-12#2)(2007-3#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-4#1)(2012-12#1)(2012-3#1)(2012-6#1)
or differential##8##2##(2008-2#2)(2008-3#1)(2008-7#2)(2010-12#3)
or differentiation##7##2##(1990-11#1)(1994-12#1)(1997-7#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-12#1)
or difficult to##4##3##(1991-12#1)(2008-2#1)(2010-11#1)(2012-2#1)
or difficult##5##2##(1991-12#1)(2006-12#1)(2008-2#1)(2010-11#1)(2012-2#1)
or difficulties##2##2##(2008-5#1)(2012-2#1)
or difficulty##3##2##(1993-10#1)(2005-6#1)(2012-3#1)
or diffuse##8##2##(1990-4#1)(2008-10#1)(2008-12#1)(2009-2#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)
or diffusion##2##2##(1996-3#1)(2007-11#1)
or digestion##2##2##(1994-11#1)(2008-10#1)
or digital##2##2##(2007-11#1)(2008-2#1)
or digoxigenin##2##2##(2008-10#2)
or dihydrolipoate##2##2##(1992-9#1)(1994-8#1)
or dilated##4##2##(1990-7#2)(2009-5#1)(2013-7#1)
or diluted##4##2##(2008-10#3)(2013-1#1)
or dimethyl sulfoxide (DMSO)##3##4##(1996-9#1)(2008-4#1)(2013-7#1)
or dimethyl sulfoxide##4##3##(1996-9#1)(2008-4#1)(2013-7#2)
or diminish##2##2##(1990-11#1)(1992-12#1)
or diminished##2##2##(1995-11#1)(1996-12#1)
or dipyridamole##2##2##(1994-5#1)(2007-9#1)
or direct exposure##2##3##(1996-11#1)(2008-11#1)
or direct##18##2##(1990-12#1)(1990-9#1)(1994-12#1)(1996-11#1)(1996-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
or direction of##2##3##(1991-2#1)(1992-9#1)
or direction##5##2##(1991-2#1)(1992-9#1)(1994-2#1)(2008-8#2)
or directly by##4##3##(1990-3#1)(1994-12#1)(2008-4#1)(2011-2#1)
or directly from the##2##4##(2008-1#1)(2008-3#1)
or directly in the##2##4##(2009-10#1)(2012-2#1)
or directly through##2##3##(2007-11#1)(2008-10#1)
or directly##13##2##(1990-3#1)(1994-12#1)(1994-9#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-10#1)(2010-6#1)(2011-2#1)(2012-2#1)
or disability pension##2##3##(1991-11#1)(1993-9#1)
or disability##7##2##(1991-11#1)(1992-2#1)(1993-9#1)(1995-1#1)(2006-12#1)(2011-2#1)(2012-3#1)
or disabling conditions##2##3##(1997-2#2)
or disabling##3##2##(1991-11#1)(1997-2#2)
or disadvantages##2##2##(2006-10#1)(2008-5#1)
or disappear##3##2##(2007-8#1)(2008-10#1)(2008-7#1)
or disappearance of##2##3##(1990-5#1)(2007-8#1)
or disaster##2##2##(2008-2#1)(2010-12#1)
or disc##2##2##(2006-7#1)(2010-2#1)
or discharge##3##2##(1991-6#1)(1995-1#1)(2007-10#1)
or discontinuation of##2##3##(2007-11#1)(2008-3#1)
or discontinuation##3##2##(2007-11#1)(2008-3#1)(2011-1#1)
or discontinuing##2##2##(2008-7#1)(2011-1#1)
or discontinuous##2##2##(2008-1#1)(2008-3#1)
or discordant##2##2##(2008-9#1)(2010-12#1)
or disease of##2##3##(2008-7#1)(2008-9#1)
or disease progression##2##3##(1997-5#1)(2007-11#1)
or disease severity##2##3##(2008-10#1)(2008-7#1)
or disease##26##2##(1993-2#1)(1996-7#1)(1997-5#1)(2007-1#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-11#1)
or diseased##5##2##(2006-12#1)(2007-9#1)(2008-10#1)(2009-4#1)(2010-6#1)
or diseases##6##2##(1992-5#1)(1996-3#1)(2006-2#1)(2008-10#1)(2010-9#1)(2011-2#1)
or dislocation in the##3##4##(2006-4#1)(2007-7#2)
or dislocation##5##2##(2006-4#1)(2007-7#2)(2008-12#1)(2012-2#1)
or disorder##2##2##(2006-10#1)(2008-9#1)
or disordered##2##2##(2006-10#1)(2008-12#1)
or disparage##2##2##(2008-7#1)(2009-11#1)
or dispersed##2##2##(1991-12#1)(2008-7#1)
or displacement of##2##3##(1997-1#1)(2006-10#1)
or displacement##3##2##(1997-1#1)(2006-10#1)(2008-2#1)
or disrupting##2##2##(2008-1#2)
or dissection of the##4##4##(1992-5#2)(2006-12#1)(2008-4#1)
or dissection##6##2##(1992-5#2)(2006-12#1)(2007-8#1)(2008-4#1)(2011-2#1)
or disseminated##2##2##(1993-5#1)(2007-8#1)
or dissociated##3##2##(1990-8#1)(2008-2#1)(2009-4#1)
or dissociation constant##2##3##(1992-6#1)(1997-5#1)
or dissociative##3##2##(2012-12#1)(2013-1#2)
or dissolved##4##2##(2007-9#1)(2011-2#3)
or distal to the##2##4##(1991-8#1)(2007-8#1)
or distal##8##2##(1991-8#1)(1991-9#1)(1992-5#1)(1992-9#1)(2006-11#1)(2007-8#2)(2008-3#1)
or distant disease##2##3##(1993-1#1)(2006-12#1)
or distant metastases##7##3##(1990-6#1)(1991-9#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2012-12#1)
or distant##14##2##(1990-6#2)(1991-9#1)(1993-1#1)(1997-8#1)(2006-12#1)(2006-6#1)(2007-6#1)(2008-10#2)(2008-2#1)(2008-8#1)(2012-12#2)
or distilled water##3##3##(2007-3#1)(2013-1#2)
or distilled##4##2##(1994-9#1)(2007-3#1)(2013-1#2)
or distortion of##4##3##(2005-11#1)(2008-11#1)(2010-10#1)(2012-2#1)
or distortion##6##2##(1991-1#1)(1991-4#1)(2005-11#1)(2008-11#1)(2010-10#1)(2012-2#1)
or distribution of##2##3##(1991-12#1)(1994-5#1)
or distribution##3##2##(1991-12#1)(1994-5#1)(2009-5#1)
or disturbed##2##2##(2006-9#1)(2007-2#1)
or dithionite##2##2##(1990-8#1)(1991-4#1)
or dithiothreitol##2##2##(1991-10#1)(1994-12#1)
or diuretic##2##2##(1990-4#1)(2010-9#1)
or divalent##2##2##(1992-6#1)(1997-1#1)
or divergent##2##2##(2010-12#1)(2010-2#1)
or divorced##2##2##(2006-8#1)(2011-1#1)
or do not##7##3##(1996-5#1)(2006-12#1)(2007-8#1)(2008-11#1)(2010-11#2)(2012-2#1)
or do they##2##3##(2006-7#1)(2007-11#1)
or do##11##2##(1996-5#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-9#1)(2010-11#2)(2011-2#1)(2012-2#1)
or dodecyl##2##2##(1990-11#1)(1992-6#1)
or does not##4##3##(1991-2#1)(2008-10#1)(2010-10#1)(2011-12#1)
or does##5##2##(1991-2#1)(2007-7#1)(2008-10#1)(2010-10#1)(2011-12#1)
or domain##2##2##(2008-4#1)(2010-12#1)
or domains##2##2##(1993-11#1)(1995-1#1)
or domestic##2##2##(2010-12#1)(2012-3#1)
or dominant##2##2##(1996-6#1)(2008-5#1)
or donor##4##2##(1991-11#1)(1993-6#1)(1994-9#1)(2008-11#1)
or dopamine##3##2##(1993-12#1)(1996-12#1)(2012-2#1)
or dorsal caudate-putamen##2##3##(1993-6#2)
or dorsal##4##2##(1992-9#1)(1993-6#2)(2008-9#1)
or dose##3##2##(2008-7#1)(2009-11#1)(2009-4#1)
or dot##5##2##(2006-12#1)(2008-2#1)(2008-4#3)
or double##9##2##(1992-12#1)(1993-11#1)(1997-6#1)(2006-10#1)(2007-8#1)(2007-9#2)(2009-9#1)(2013-7#1)
or double-stranded##3##2##(2008-2#1)(2008-4#1)(2012-2#1)
or doubly##2##2##(2006-7#1)(2007-12#1)
or down regulation of##2##4##(2006-10#1)(2008-3#1)
or down##3##2##(2006-10#1)(2008-2#1)(2008-3#1)
or down-regulated by##2##3##(1996-2#1)(2008-5#1)
or down-regulated in##2##3##(2009-5#1)(2012-2#1)
or down-regulated##7##2##(1996-2#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-4#2)(2012-2#1)
or down-regulation##2##2##(2006-12#1)(2008-7#1)
or downregulation of##2##3##(2008-2#1)(2008-5#1)
or downstream of##2##3##(1992-3#1)(1996-12#1)
or downstream##7##2##(1990-4#1)(1992-3#1)(1993-3#1)(1996-12#1)(2005-8#1)(2008-8#1)(2012-2#1)
or doxorubicin##4##2##(1994-11#1)(1997-4#1)(2007-11#1)(2013-8#1)
or dramatic##2##2##(2008-10#2)
or dramatically##2##2##(1996-3#1)(2006-9#1)
or dried##3##2##(1992-4#1)(2007-1#1)(2008-10#1)
or drinking##3##2##(1993-6#1)(1997-3#1)(2008-10#1)
or droplet aerosols##2##3##(1992-3#1)(2011-1#1)
or drug therapy##3##3##(2006-10#1)(2006-12#1)(2013-8#1)
or drug##25##2##(1990-9#1)(1992-12#1)(1994-2#1)(1995-12#2)(1997-3#1)(1997-5#2)(1997-6#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-4#2)(2009-5#2)(2009-6#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-8#1)
or drug-induced##4##2##(1992-2#1)(1992-9#1)(2005-11#1)(2008-9#1)
or drugs##12##2##(1992-9#2)(1993-10#1)(1995-10#1)(2005-7#1)(2006-2#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-4#1)(2011-1#1)(2013-8#1)
or dry##5##2##(2007-11#1)(2008-10#1)(2008-6#2)(2012-2#1)
or dual##5##2##(2007-10#1)(2008-1#1)(2008-3#1)(2011-1#1)(2013-8#1)
or due to the##3##4##(2008-1#1)(2008-4#1)(2008-7#1)
or due to##18##3##(1994-3#1)(2005-12#1)(2007-6#2)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
or duodenal##3##2##(1992-9#1)(2008-10#1)(2008-8#1)
or duration of##5##3##(1994-6#1)(2007-2#2)(2008-7#1)(2013-1#1)
or duration##6##2##(1990-3#1)(1994-6#1)(2007-2#2)(2008-7#1)(2013-1#1)
or durations of##3##3##(2007-11#1)(2008-10#1)(2010-6#1)
or during periods##2##3##(2008-10#2)
or during the##6##3##(1992-3#1)(1993-11#1)(1994-3#1)(2006-8#1)(2008-10#1)(2008-7#1)
or during##35##2##(1990-8#2)(1991-10#1)(1992-3#1)(1992-9#1)(1993-11#2)(1993-3#1)(1994-3#1)(1995-1#1)(1995-5#1)(2006-1#1)(2006-8#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#2)(2011-2#2)(2012-1#2)(2012-2#2)(2013-7#1)
or dying##3##2##(2006-10#1)(2008-1#1)(2008-12#1)
or dynamic##4##2##(1994-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
or dysfunction in##2##3##(2008-5#1)(2012-2#1)
or dysfunction of the##4##4##(2007-6#1)(2008-9#2)(2011-12#1)
or dysfunction##11##2##(2007-10#1)(2007-6#1)(2007-7#1)(2008-5#1)(2008-9#2)(2010-10#1)(2010-3#1)(2011-12#1)(2012-12#1)(2012-2#1)
or dysfunctional##3##2##(1994-12#1)(2007-1#1)(2007-10#1)
or dyspnea##3##2##(2007-2#1)(2010-6#1)(2011-2#1)
or each##2##2##(2008-10#1)(2008-8#1)
or earlier##3##2##(1990-6#1)(2005-11#1)(2008-10#1)
or early childhood##6##3##(1996-12#1)(2007-10#1)(2008-11#1)(2008-6#1)(2011-1#1)(2011-2#1)
or early##28##2##(1992-2#1)(1992-5#1)(1993-2#1)(1994-2#1)(1995-2#1)(1996-12#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2013-1#1)
or easily##3##2##(2007-12#1)(2009-4#1)(2010-11#1)
or eat##2##2##(1992-12#1)(1993-12#1)
or eaten##2##2##(1991-11#1)(2008-2#1)
or eating disorders##2##3##(1993-12#1)(2007-12#1)
or eating##3##2##(1993-12#1)(2006-6#1)(2007-12#1)
or ecological##2##2##(2008-9#1)(2012-3#1)
or economic##9##2##(1997-1#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-7#1)
or ectopically##2##2##(1993-2#1)(2008-4#1)
or education##4##2##(1990-12#1)(2005-10#1)(2006-8#1)(2009-5#1)
or educational##3##2##(2007-11#1)(2007-4#1)(2008-4#1)
or effect of##2##3##(2006-4#1)(2011-1#1)
or effect##7##2##(1992-6#1)(2006-10#1)(2006-4#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-3#1)
or effector##2##2##(2005-11#1)(2013-1#1)
or efficacy##4##2##(1994-12#1)(1995-5#1)(1996-12#1)(2004-1#1)
or egg##6##2##(1996-1#1)(2008-10#1)(2008-11#2)(2009-3#1)(2012-3#1)
or eggs##2##2##(1991-5#1)(2009-3#1)
or either##4##2##(1992-3#1)(1994-12#1)(1995-11#1)(2008-11#1)
or elective##4##2##(1992-5#1)(2006-2#1)(2008-3#1)(2012-1#1)
or electric field##3##3##(1990-9#1)(2005-11#2)
or electric##4##2##(1990-9#1)(2005-11#2)(2007-9#1)
or electrical stimulation##3##3##(1993-12#2)(1996-6#1)
or electrical##8##2##(1992-3#1)(1993-12#2)(1996-6#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-9#1)
or electroconvulsive##2##2##(1992-8#1)(1995-12#1)
or electrode##2##2##(2008-10#1)(2012-2#1)
or electron withdrawing##2##3##(2009-9#1)(2010-5#1)
or electron##6##2##(1997-3#1)(2007-12#1)(2009-10#1)(2009-9#1)(2010-5#2)
or electronic##2##2##(2008-10#1)(2008-3#1)
or electronically##2##2##(2008-4#1)(2008-9#1)
or electrophoretic##2##2##(1996-11#1)(2007-8#1)
or electroporation##3##2##(1991-8#1)(1993-4#1)(2011-2#1)
or electrospray ionization##2##3##(2007-1#1)(2010-7#1)
or electrospray##3##2##(1997-8#1)(2007-1#1)(2010-7#1)
or electrothermal##2##2##(2008-10#2)
or elevated##12##2##(1991-9#2)(1993-8#1)(1995-10#1)(1995-3#1)(1996-6#1)(2006-1#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-5#1)
or eliminate the##3##3##(1992-2#1)(2006-2#1)(2010-7#1)
or eliminate these##2##3##(1997-7#1)(2007-12#1)
or eliminate##11##2##(1991-12#1)(1991-6#1)(1992-2#1)(1994-3#1)(1997-7#1)(2006-2#1)(2006-3#1)(2007-11#1)(2007-12#1)(2008-2#1)(2010-7#1)
or eliminated##10##2##(1991-4#1)(1993-12#1)(1993-3#1)(1995-1#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-8#1)
or eliminating the##4##3##(1990-3#1)(1997-3#1)(2006-3#1)(2010-12#1)
or eliminating##6##2##(1990-3#1)(1997-3#1)(2006-3#1)(2008-11#1)(2008-2#1)(2010-12#1)
or elimination of##4##3##(1992-5#1)(1997-3#1)(2008-5#1)(2013-1#1)
or elimination##5##2##(1991-9#1)(1992-5#1)(1997-3#1)(2008-5#1)(2013-1#1)
or elongation##4##2##(1990-5#1)(1994-8#1)(1996-7#1)(2005-12#1)
or else##3##2##(1992-11#1)(1997-7#1)(2007-2#1)
or elsewhere in the##2##4##(1996-5#1)(2008-3#1)
or elsewhere##6##2##(1996-5#1)(2006-6#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-12#1)
or emergency##6##2##(1992-5#1)(2007-2#1)(2007-7#1)(2008-8#1)(2010-12#1)(2013-1#1)
or emergent##5##2##(2006-10#1)(2007-8#1)(2010-12#1)(2010-2#1)(2010-6#1)
or emotional##8##2##(1990-11#1)(1993-11#1)(1993-5#1)(2009-6#2)(2011-1#1)(2012-12#1)(2012-2#1)
or empirical##2##2##(2004-12#1)(2006-10#1)
or employing##2##2##(2007-11#1)(2008-10#1)
or employment##4##2##(2008-11#1)(2010-7#1)(2011-2#1)(2012-12#1)
or emulsion##2##2##(2008-11#1)(2008-2#1)
or enalapril##2##2##(2008-1#1)(2008-5#1)
or encapsulated##2##2##(2005-7#1)(2008-5#1)
or encephalitis##2##2##(2007-11#1)(2009-10#1)
or endocrine##4##2##(1997-7#1)(2005-10#1)(2008-10#1)(2008-11#1)
or endogenous##2##2##(2007-11#1)(2008-1#1)
or endoscopic##8##2##(2006-10#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-5#1)(2007-9#1)(2008-4#1)(2011-2#1)
or endothelial cells##4##3##(1992-3#1)(1995-1#1)(2008-11#1)(2012-12#1)
or endothelial##5##2##(1992-3#1)(1995-1#1)(2008-11#1)(2008-9#1)(2012-12#1)
or endovascular##7##2##(1995-11#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-7#1)(2011-2#1)(2011-3#1)
or energy##5##2##(2007-11#1)(2007-2#1)(2008-1#1)(2008-9#1)(2013-1#1)
or engineered##2##2##(1996-4#1)(2010-11#1)
or enhance##14##2##(1993-3#1)(1996-12#1)(2006-10#9)(2008-10#1)(2008-4#1)(2011-2#1)
or enhanced##8##2##(1991-5#1)(1997-3#1)(2007-12#1)(2008-11#2)(2008-3#1)(2009-5#1)(2009-7#1)
or enhancing##4##2##(1994-5#1)(2005-8#1)(2007-2#1)(2008-11#1)
or enlarged##2##2##(1996-12#1)(2008-10#1)
or enlargement##2##2##(2006-5#1)(2013-7#1)
or enriched##2##2##(2010-8#1)(2012-3#1)
or entire##2##2##(1994-3#1)(2008-4#1)
or entirely##3##2##(1993-11#1)(1993-6#1)(2012-12#1)
or environmental conditions##3##3##(2007-1#1)(2009-2#1)(2010-8#1)
or environmental factors##3##3##(1993-1#1)(2006-10#1)(2006-11#1)
or environmental risk##2##3##(1992-12#1)(2008-11#1)
or environmental##20##2##(1992-12#1)(1993-1#1)(1996-5#2)(2006-10#1)(2006-11#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#1)
or environmental?##2##2##(2007-2#1)(2008-3#1)
or environments##2##2##(2008-11#1)(2010-4#1)
or enzymatic##6##2##(2008-10#1)(2008-9#2)(2009-12#1)(2010-12#1)(2010-7#1)
or enzyme##7##2##(1990-8#1)(1992-6#1)(1994-12#1)(1995-11#1)(2008-10#2)(2008-5#1)
or epi##2##2##(2008-6#2)
or epidemic##2##2##(2007-12#1)(2007-2#1)
or epidemiological##2##2##(1995-6#1)(2008-5#1)
or epidermal growth factor##3##4##(1993-1#1)(1995-8#1)(1996-5#1)
or epidural##2##2##(1993-4#1)(2012-2#1)
or epilepsy##2##2##(1996-3#1)(2005-10#1)
or epinephrine##2##2##(1992-8#1)(1994-6#1)
or epirubicin##2##2##(2009-4#2)
or epithelial##2##2##(1990-11#1)(2012-2#1)
or equal to 10##4##4##(1991-8#1)(1992-2#1)(1992-4#1)(2012-3#1)
or equal to 5##4##4##(1990-10#1)(1990-4#1)(1992-5#1)(2012-3#1)
or equal to that of##2##5##(1994-11#1)(2008-10#1)
or equal to##135##3##(1990-10#3)(1990-11#3)(1990-12#4)(1990-2#11)(1990-3#6)(1990-4#4)(1990-5#4)(1990-6#3)(1991-1#1)(1991-10#2)(1991-11#2)(1991-2#4)(1991-4#3)(1991-5#2)(1991-6#2)(1991-7#8)(1991-8#13)(1991-9#2)(1992-2#4)(1992-3#2)(1992-4#4)(1992-5#4)(1992-6#2)(1992-7#5)(1992-8#2)(1992-9#2)(1993-2#1)(1994-11#1)(1996-9#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#3)(2008-5#4)(2008-7#1)(2008-9#1)(2011-2#7)(2012-2#1)(2012-3#2)(2013-8#1)
or equally##3##2##(1995-11#1)(1997-5#1)(2008-2#1)
or equipment##2##2##(1995-3#1)(2011-2#1)
or equivalence##2##2##(1990-8#1)(2012-11#1)
or equivalently##2##2##(2005-11#1)(2008-2#1)
or equivocal##2##2##(1992-2#1)(2006-10#1)
or erosion##2##2##(2005-3#1)(2011-2#1)
or erratic##2##2##(1993-9#1)(2006-4#1)
or errors in##2##3##(1993-2#1)(2013-7#1)
or errors##3##2##(1993-2#1)(2010-12#1)(2013-7#1)
or erythema##2##2##(2006-2#1)(2008-5#1)
or erythromycin##2##2##(2010-4#1)(2010-6#1)
or esophageal##4##2##(1996-6#1)(1997-7#1)(2006-10#2)
or ester linkage to##2##4##(2008-10#2)
or ester##3##2##(1991-12#1)(2008-10#2)
or estimated##3##2##(1997-4#1)(2008-10#1)(2008-2#1)
or estradiol plus RU 39##3##5##(1992-5#3)
or estradiol##5##2##(1992-5#3)(1995-1#1)(2013-1#1)
or estrogen##2##2##(1994-8#1)(1996-8#1)
or etching##2##2##(2008-12#1)(2008-2#1)
or ethanol precipitation##2##3##(1994-12#1)(1995-10#1)
or ethanol##8##2##(1991-9#1)(1993-8#1)(1994-12#1)(1995-10#1)(1996-10#1)(2008-12#2)(2008-5#1)
or ethanol)##3##2##(1995-2#1)(1995-6#1)(2008-5#1)
or ethnic group##2##3##(2011-2#1)(2013-1#1)
or ethnic##5##2##(2006-10#1)(2007-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
or ethyl##5##2##(2005-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
or ethylene glycol##3##3##(2008-3#1)(2012-12#2)
or etoposide##2##2##(1991-11#1)(1993-9#1)
or eukaryotic##3##2##(1990-11#1)(1994-5#1)(2008-1#1)
or evaluating##2##2##(2011-2#1)(2013-1#1)
or evaluation##2##2##(2005-10#1)(2008-7#1)
or evanescent##2##2##(2007-12#1)(2008-1#1)
or even a single##2##4##(2008-7#1)(2012-12#1)
or even a##8##3##(1996-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-2#1)(2012-12#1)(2013-8#1)
or even additional##2##3##(1993-3#1)(2012-2#1)
or even an##3##3##(1991-10#1)(1996-10#1)(2008-12#1)
or even better##2##3##(1990-5#1)(2008-10#1)
or even between##2##3##(1996-1#1)(2008-7#1)
or even by##2##3##(1992-5#1)(2008-3#1)
or even completely##2##3##(1997-7#1)(2009-5#1)
or even harmful##2##3##(2009-11#1)(2013-1#1)
or even higher##3##3##(1993-4#1)(2008-10#1)(2012-3#1)
or even in##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
or even increased##3##3##(1996-12#1)(2012-1#2)
or even less##2##3##(2006-4#1)(2008-10#1)
or even more##2##3##(2007-4#1)(2011-2#1)
or even no##3##3##(1993-9#1)(1995-5#1)(2007-2#1)
or even prevent##2##3##(2008-1#1)(2009-12#1)
or even preventing##3##3##(2007-5#2)(2008-8#1)
or even slightly##2##3##(2008-1#1)(2008-10#1)
or even sudden##2##3##(2007-11#1)(2008-4#1)
or even superior##2##3##(2007-10#1)(2007-8#1)
or even the##9##3##(1993-9#1)(2007-11#1)(2008-10#1)(2008-2#1)(2011-2#2)(2012-3#1)(2013-1#2)
or even to implement specific precautions##2##6##(2012-11#2)
or even to##8##3##(1994-3#1)(2005-7#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-11#2)(2013-7#1)
or even whole genome##2##4##(2009-10#1)(2012-1#1)
or even whole##3##3##(2008-11#1)(2009-10#1)(2012-1#1)
or even years##3##3##(2007-9#1)(2008-7#1)(2011-2#1)
or even##212##2##(1990-10#1)(1990-5#2)(1990-8#2)(1991-10#1)(1991-12#2)(1991-8#1)(1992-4#1)(1992-5#2)(1992-6#1)(1993-3#1)(1993-4#1)(1993-9#2)(1994-12#1)(1994-3#3)(1995-1#1)(1995-5#1)(1995-7#1)(1996-1#1)(1996-10#2)(1996-12#3)(1996-2#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-3#1)(1997-4#2)(1997-7#1)(2004-11#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-7#2)(2006-1#1)(2006-10#9)(2006-12#3)(2006-3#1)(2006-4#2)(2006-6#1)(2007-1#1)(2007-10#2)(2007-11#8)(2007-12#7)(2007-2#5)(2007-4#1)(2007-5#3)(2007-6#1)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#16)(2008-11#8)(2008-12#3)(2008-2#4)(2008-3#1)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-6#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#5)(2012-1#6)(2012-11#2)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#3)(2013-8#3)
or evening##2##2##(1993-10#1)(2008-3#1)
or event##2##2##(1994-2#1)(2006-2#1)
or events##2##2##(1997-4#1)(2010-7#1)
or every##4##2##(1991-8#1)(1991-9#1)(1996-12#1)(2008-7#1)
or evidence of##2##3##(1994-8#1)(2005-10#1)
or evidence##4##2##(1994-8#1)(2005-10#1)(2006-8#1)(2012-2#1)
or evoked##3##2##(1995-7#1)(2010-12#1)(2011-2#1)
or evolution##2##2##(1996-4#1)(2008-4#1)
or evolutionary##3##2##(2007-9#1)(2011-1#1)(2012-3#1)
or ex##2##2##(2004-4#1)(2006-6#1)
or exacerbate##2##2##(2005-10#1)(2013-7#1)
or exaggerated##4##2##(1996-11#1)(2008-3#1)(2008-4#1)(2008-9#1)
or exceed the##4##3##(1995-1#1)(1997-6#1)(2008-6#1)(2011-1#1)
or exceed##6##2##(1994-1#1)(1995-1#1)(1997-6#1)(2008-6#1)(2010-2#1)(2011-1#1)
or exceeded the##2##3##(2008-6#1)(2013-8#1)
or exceeded##7##2##(1991-12#1)(1993-12#1)(1997-2#1)(2006-10#1)(2008-10#1)(2008-6#1)(2013-8#1)
or exceeding##2##2##(2007-4#1)(2008-7#1)
or exceeds##2##2##(1995-4#1)(2007-11#1)
or excellent outcomes##3##3##(2006-7#1)(2007-11#1)(2007-9#1)
or excellent results were##2##4##(2006-8#1)(2009-3#1)
or excellent##16##2##(1990-10#1)(1990-6#1)(1992-2#4)(1993-8#1)(1996-1#1)(2004-12#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-7#1)(2007-9#1)(2009-3#1)
or excess##6##2##(1997-3#1)(2005-10#1)(2008-9#1)(2009-11#1)(2012-1#1)(2012-2#1)
or excessive##8##2##(1992-4#1)(1997-2#1)(2008-10#2)(2008-7#1)(2009-4#1)(2010-12#1)(2013-1#1)
or excised##2##2##(2008-10#1)(2008-11#1)
or excising##2##2##(1994-3#1)(2007-10#1)
or excisional biopsy##2##3##(2010-2#1)(2013-1#1)
or exclude a##2##3##(2008-1#1)(2008-6#1)
or exclude##10##2##(1990-2#1)(1996-12#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-12#2)(2010-2#1)(2012-2#1)
or excluded##5##2##(1991-11#1)(1993-10#1)(2005-11#1)(2007-5#1)(2008-7#1)
or exclusion of##5##3##(1990-3#1)(1993-2#1)(2006-10#1)(2012-12#1)(2012-2#1)
or exclusively##4##2##(1996-1#1)(1997-3#1)(2005-8#1)(2008-10#1)
or excreted##2##2##(2007-2#1)(2008-4#1)
or exhibit##2##2##(1993-11#1)(2008-1#1)
or exhibiting##2##2##(1996-12#1)(2009-3#1)
or existing##3##2##(2006-5#1)(2007-7#1)(2009-8#1)
or exocytosis##2##2##(2008-10#1)(2009-6#1)
or exogenous##9##2##(1991-12#1)(1991-7#1)(1991-9#1)(1992-5#1)(1995-6#1)(1996-9#1)(2008-3#1)(2010-11#1)(2011-1#1)
or exon##2##2##(1995-8#1)(1996-2#1)
or expanded##2##2##(2008-10#1)(2010-2#1)
or expanding##3##2##(1992-5#1)(2007-8#1)(2008-10#1)
or expansion of##4##3##(2007-12#2)(2009-11#1)(2010-2#1)
or expected##2##2##(2007-4#1)(2013-1#1)
or expecting##2##2##(2007-10#1)(2007-9#1)
or expensive##3##2##(1992-12#1)(1992-2#1)(2008-7#1)
or experience##5##2##(1994-1#1)(2005-8#1)(2007-11#1)(2007-2#1)(2008-4#1)
or experimental##9##2##(1996-11#1)(2006-4#1)(2006-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-5#1)(2013-1#1)(2013-8#1)
or explain##2##2##(2007-6#1)(2010-5#1)
or exploit##2##2##(1994-10#1)(2008-3#1)
or exponential##2##2##(2008-10#1)(2008-5#1)
or exposed to the##2##4##(2008-10#1)(2009-9#1)
or exposed to##6##3##(2005-9#1)(2007-12#1)(2008-10#2)(2008-5#1)(2009-9#1)
or exposed##7##2##(2005-9#1)(2007-12#1)(2008-10#2)(2008-5#1)(2009-9#1)(2010-11#1)
or exposure to##5##3##(1993-2#1)(1996-5#1)(1997-5#1)(2008-9#1)(2010-12#1)
or exposure##12##2##(1993-2#1)(1995-5#1)(1996-5#1)(1997-5#1)(2008-10#1)(2008-9#1)(2010-12#6)
or express##2##2##(1993-2#1)(1994-11#1)
or expression in##2##3##(2009-10#1)(2009-9#1)
or expression levels##2##3##(1997-6#1)(2008-10#1)
or expression of the##5##4##(1992-9#1)(1993-6#1)(1996-4#1)(2008-4#1)(2012-12#1)
or expression of##10##3##(1991-7#1)(1992-9#1)(1993-6#1)(1995-11#1)(1995-3#1)(1996-4#1)(2006-12#1)(2008-4#2)(2012-12#1)
or expression##17##2##(1990-11#1)(1991-7#1)(1992-9#1)(1993-6#1)(1993-9#1)(1995-11#1)(1995-3#1)(1996-3#1)(1996-4#1)(1997-6#1)(2006-12#1)(2008-10#1)(2008-4#2)(2009-10#1)(2009-9#1)(2012-12#1)
or extended##4##2##(1994-3#1)(1996-9#1)(2008-5#1)(2008-7#1)
or extensive##6##2##(1990-12#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-5#1)(2012-12#1)
or extent of##3##3##(1991-3#1)(1994-9#1)(2008-1#1)
or external##19##2##(1990-2#4)(1992-3#1)(1993-4#1)(1994-7#1)(2005-10#1)(2006-1#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-7#2)(2009-10#1)(2010-5#1)(2011-2#1)(2012-11#1)
or extinction##4##2##(1992-12#1)(2008-8#1)(2008-9#1)(2013-8#1)
or extracellular matrix##2##3##(1996-11#1)(2008-4#1)
or extracellular##6##2##(1994-3#1)(1996-11#1)(2005-12#1)(2008-4#1)(2011-2#1)(2013-8#1)
or extracorporeal##2##2##(1991-3#1)(2011-2#1)
or extract##2##2##(2008-11#1)(2008-4#1)
or extracted##3##2##(2006-5#1)(2007-11#1)(2008-10#1)
or extraction##2##2##(2008-10#1)(2012-12#1)
or extraintestinal##2##2##(1990-6#1)(2013-1#1)
or extramedullary##3##2##(2008-9#1)(2012-12#1)(2012-3#1)
or extravasation of##2##3##(1993-7#1)(2009-2#1)
or extreme##5##2##(1991-7#1)(1993-8#1)(2006-8#1)(2007-6#2)
or extremely##2##2##(2007-6#1)(2008-8#1)
or extremities##2##2##(2010-6#1)(2012-3#1)
or extrinsic##4##2##(1990-5#1)(2008-1#1)(2009-6#1)(2011-2#1)
or exudates##3##2##(1997-8#1)(2008-10#1)(2008-5#1)
or eye##2##2##(1997-3#1)(2007-9#1)
or face##7##2##(1991-5#1)(1995-4#1)(2007-11#1)(2007-12#2)(2010-7#1)(2012-1#1)
or faces##2##2##(1993-6#1)(2009-4#1)
or facilitate##2##2##(2008-2#1)(2012-2#1)
or facilitative##2##2##(2008-8#1)(2009-4#1)
or factor##7##2##(1990-11#1)(1993-10#1)(1997-5#1)(2005-10#4)
or factors that##2##3##(2008-8#1)(2011-1#1)
or factors##11##2##(1996-12#1)(2007-7#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-11#1)(2010-3#1)(2011-1#1)(2013-1#2)
or faculty##2##2##(2008-12#1)(2012-1#1)
or fail##3##2##(2007-8#1)(2010-11#1)(2011-1#1)
or failed to##3##3##(1994-9#1)(1997-6#1)(2008-11#1)
or failed##6##2##(1994-9#1)(1997-6#1)(2008-1#1)(2008-11#1)(2008-6#1)(2012-2#1)
or failure of the##3##4##(1996-2#1)(2008-12#1)(2011-2#1)
or failure of##10##3##(1996-2#1)(2005-8#2)(2006-10#1)(2008-10#2)(2008-12#1)(2008-4#1)(2011-2#1)(2012-2#1)
or failure to##3##3##(2007-4#1)(2008-11#1)(2009-4#1)
or failure##16##2##(1996-2#1)(2005-8#2)(2006-10#2)(2007-4#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2009-4#1)(2009-9#1)(2011-2#1)(2012-2#1)
or faint##3##2##(1996-3#1)(1997-7#1)(2012-3#1)
or fall##4##2##(1996-2#1)(2009-10#1)(2010-9#1)(2011-2#1)
or false##4##2##(1994-7#1)(1997-6#1)(2007-12#1)(2008-7#1)
or familial##5##2##(1990-2#1)(1991-2#1)(2005-11#1)(2007-2#1)(2009-6#1)
or family history of##5##4##(1990-9#1)(1996-3#1)(2007-10#1)(2009-9#1)(2010-6#1)
or family history##7##3##(1990-9#1)(1996-3#1)(1996-8#1)(2004-12#1)(2007-10#1)(2009-9#1)(2010-6#1)
or family##16##2##(1990-9#1)(1993-12#1)(1993-9#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-8#1)(2004-12#1)(2006-7#1)(2007-10#1)(2007-12#1)(2008-7#1)(2009-9#2)(2010-6#1)(2013-1#1)
or fasted##2##2##(1991-1#1)(2008-7#1)
or faster##2##2##(1995-8#1)(2008-10#1)
or fasting##2##2##(2008-1#1)(2008-3#1)
or fat mass##2##3##(2006-9#1)(2008-5#1)
or fat##6##2##(1992-1#1)(2006-9#1)(2008-4#1)(2008-5#1)(2012-12#1)(2013-1#1)
or fatty##3##2##(1990-3#2)(1997-2#1)
or features##2##2##(2007-8#1)(2010-11#1)
or fecal##3##2##(1997-3#1)(2008-10#1)(2012-3#1)
or feces##4##2##(1994-6#1)(1996-12#1)(2008-10#1)(2009-6#1)
or feed##2##2##(2008-10#1)(2008-7#1)
or feet##2##2##(2007-2#1)(2008-6#1)
or female##28##2##(1990-11#1)(1994-7#1)(1995-2#1)(2006-7#4)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#12)(2009-9#1)(2012-11#1)(2012-12#1)
or female)##2##2##(2009-7#1)(2010-8#1)
or females##4##2##(1992-12#1)(1996-10#1)(2010-8#1)(2012-12#1)
or femoral##3##2##(2007-8#2)(2007-9#1)
or fetal growth##2##3##(2006-10#1)(2009-11#1)
or fetal##7##2##(1996-12#1)(2004-9#1)(2006-10#1)(2008-10#1)(2008-4#1)(2009-11#1)(2013-1#1)
or fewer##6##2##(1993-3#1)(1994-8#1)(2006-6#1)(2008-3#1)(2008-7#1)(2009-5#1)
or fiber##2##2##(2008-3#1)(2011-2#1)
or fibers##2##2##(2008-3#1)(2008-5#1)
or fibrates##2##2##(2005-9#1)(2012-6#1)
or fibrillar##2##2##(2007-12#1)(2008-10#1)
or fibrin##2##2##(1990-12#1)(2012-1#1)
or fibroblast growth factor##2##4##(1997-2#1)(2006-2#1)
or fibroblast##3##2##(1996-7#1)(1997-2#1)(2006-2#1)
or fibroblasts##4##2##(1990-6#1)(1995-12#1)(1997-1#1)(1997-2#1)
or fibronectin##2##2##(2004-9#1)(2011-2#1)
or fibrosis##6##2##(1993-10#1)(2006-10#1)(2006-7#1)(2007-8#1)(2010-12#1)(2012-12#1)
or fibrous##3##2##(2008-5#1)(2010-3#1)(2011-2#1)
or fiction?##4##2##(2006-10#1)(2008-3#1)(2009-4#1)(2012-2#1)
or field##6##2##(2008-1#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-10#1)(2011-2#1)
or filgrastim##2##2##(2008-7#2)
or filled teeth##2##3##(2008-1#1)(2008-9#1)
or filtration##2##2##(1997-8#1)(2008-10#1)
or final##2##2##(1996-12#1)(2010-2#1)
or financial##3##2##(1991-1#1)(1996-12#1)(2007-4#1)
or find##2##2##(1996-5#1)(2010-12#1)
or findings##2##2##(2010-3#1)(2012-3#1)
or fine##2##2##(1990-10#1)(2008-4#1)
or finger##2##2##(1990-8#1)(1995-11#1)
or fire##3##2##(1991-3#1)(2004-9#2)
or first and second##2##4##(1991-10#1)(2008-6#1)
or first##8##2##(1990-6#1)(1991-10#1)(2006-3#1)(2007-2#1)(2008-1#1)(2008-3#1)(2008-6#1)(2009-3#1)
or fish oil##5##3##(1991-2#1)(1993-9#2)(1997-1#2)
or fish##8##2##(1991-2#1)(1993-8#1)(1993-9#2)(1997-1#2)(2008-6#1)(2008-7#1)
or fistula##2##2##(2011-2#2)
or fitness##2##2##(2008-10#1)(2009-3#1)
or five##11##2##(1991-3#1)(1992-3#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-5#1)(2011-2#1)
or fixation##3##2##(2008-3#1)(2013-1#2)
or fixed##4##2##(1996-7#1)(2008-10#1)(2008-2#1)(2008-4#1)
or flat##2##2##(2006-8#1)(2012-2#1)
or flattened##3##2##(2008-5#1)(2009-9#1)(2011-2#1)
or flexible##2##2##(2007-12#1)(2008-7#1)
or floor##2##2##(2008-3#1)(2011-1#1)
or flow##5##2##(2007-8#2)(2008-10#1)(2008-4#1)(2010-4#1)
or fluctuating##2##2##(2007-12#1)(2008-10#1)
or fluids##3##2##(2008-4#3)
or fluorescence detection##3##3##(1990-6#1)(1991-5#1)(2008-4#1)
or fluorescence##4##2##(1990-6#1)(1990-9#1)(1991-5#1)(2008-4#1)
or fluorescent##7##2##(1997-3#1)(2006-5#1)(2008-10#1)(2008-4#3)(2008-9#1)
or focal cerebral##2##3##(1993-4#1)(2007-7#1)
or focal##9##2##(1993-4#1)(1996-5#1)(2005-8#1)(2007-7#1)(2008-7#1)(2009-2#1)(2010-2#1)(2012-2#1)(2013-1#1)
or foes?##2##2##(2008-4#1)(2009-3#1)
or folate##2##2##(1991-5#1)(1992-9#1)
or fold##4##2##(2008-7#3)(2012-2#1)
or folic acid##2##3##(1992-9#1)(2008-10#1)
or follow-up##2##2##(2007-12#1)(2010-8#1)
or following##18##2##(1992-8#1)(1994-5#1)(1996-12#1)(1996-3#1)(1997-2#1)(2005-11#1)(2005-8#1)(2006-8#1)(2007-1#1)(2008-10#3)(2008-11#1)(2008-5#2)(2009-5#1)(2010-8#1)(2012-2#1)
or food consumption##2##3##(1991-3#1)(2007-8#1)
or food samples##2##3##(2008-10#1)(2008-11#1)
or food##16##2##(1991-3#1)(1992-7#1)(1993-10#1)(1993-12#2)(1994-3#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2009-7#1)(2011-1#1)(2012-2#1)
or foods##2##2##(2008-1#1)(2009-3#1)
or foot##4##2##(2005-7#1)(2008-6#3)
or for &quot##2##3##(1995-12#1)(2011-2#1)
or for a##5##3##(1995-6#1)(1996-2#1)(2005-10#1)(2011-2#1)(2012-1#1)
or for patients##2##3##(2010-12#1)(2011-1#1)
or for recombinant proteins that have been engineered to bind with high affinity to a molecule that can be coupled to a solid-phase matrix##2##24##(2008-2#1)(2008-4#1)
or for recombinant proteins that##3##5##(2008-2#1)(2008-4#2)
or for the##12##3##(1990-12#1)(1996-2#1)(1997-2#1)(1997-6#1)(2005-12#1)(2007-12#1)(2008-10#4)(2008-2#1)(2011-2#1)
or for their##2##3##(1990-6#1)(2008-10#1)
or for those with##2##4##(2006-10#1)(2007-11#1)
or for those##6##3##(2006-10#1)(2007-11#1)(2008-10#3)(2008-6#1)
or for three##2##3##(1990-9#1)(2007-2#1)
or for transient expression##2##4##(2008-1#1)(2008-2#1)
or for whom##5##3##(1992-3#1)(2007-1#1)(2007-11#1)(2012-12#1)(2012-3#1)
or for##131##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-10#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#2)(1996-4#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-5#2)(2005-8#1)(2006-10#1)(2006-12#3)(2006-5#1)(2006-6#1)(2007-1#2)(2007-11#5)(2007-12#1)(2007-2#2)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#17)(2008-11#4)(2008-2#3)(2008-3#2)(2008-4#10)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#2)(2010-12#2)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)
or foraminal##2##2##(2006-6#1)(2006-8#1)
or forced##4##2##(1994-7#1)(2006-12#1)(2007-9#1)(2010-11#1)
or foreign body##2##3##(2006-10#1)(2008-5#1)
or foreign##4##2##(2006-10#1)(2007-5#1)(2008-4#1)(2008-5#1)
or forensic##2##2##(1991-11#1)(2007-8#1)
or form of##2##3##(1997-1#1)(2008-3#1)
or form##5##2##(1997-1#1)(1997-8#1)(2007-12#1)(2008-3#1)(2011-1#1)
or formalin-fixed##2##2##(1990-2#1)(2008-11#1)
or formed##2##2##(2006-10#1)(2008-4#1)
or forskolin##7##2##(1992-8#1)(1994-12#1)(1995-8#1)(1997-1#1)(1997-2#3)
or four##22##2##(1990-12#1)(1993-12#1)(1993-5#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-8#1)(2005-7#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-7#1)
or fractionated##2##2##(1992-1#1)(2008-7#1)
or fractions##2##2##(2008-11#1)(2010-12#1)
or fracture##3##2##(2004-9#1)(2008-8#1)(2013-1#1)
or fragmentation##2##2##(2006-10#1)(2008-9#1)
or fragments##5##2##(1991-12#1)(1993-2#1)(1993-9#1)(1995-11#1)(1997-5#1)
or free radicals##2##3##(1993-6#1)(2008-1#1)
or free##10##2##(1993-6#1)(1994-9#1)(1995-5#1)(1997-1#1)(2006-3#1)(2007-5#1)(2008-1#1)(2008-3#1)(2011-2#1)(2013-7#1)
or frequency of##4##3##(1991-6#1)(2007-12#1)(2008-10#1)(2010-12#1)
or frequency##7##2##(1991-6#2)(2007-12#3)(2008-10#1)(2010-12#1)
or frequent##3##2##(1993-3#1)(2007-2#1)(2008-9#1)
or fresh semen##4##3##(2006-5#4)
or freshly##2##2##(2008-4#1)(2010-12#1)
or friend##2##2##(2006-4#1)(2007-2#1)
or friends##3##2##(2011-1#1)(2011-2#2)
or from a composite##2##4##(2008-10#1)(2012-1#1)
or from a##16##3##(1991-1#2)(1991-11#1)(1992-12#1)(1994-3#1)(1995-10#1)(1995-11#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2009-11#1)(2012-1#1)(2013-7#1)
or from an##2##3##(1991-12#1)(2007-12#1)
or from both sources##2##4##(1994-5#2)
or from construction##2##3##(1992-2#1)(1994-3#1)
or from direct##2##3##(1990-5#1)(2008-10#1)
or from either##2##3##(1995-5#1)(2008-10#1)
or from other##2##3##(1993-7#1)(2008-10#1)
or from that of##2##4##(1992-2#1)(2008-11#1)
or from the##14##3##(1992-8#1)(1993-3#1)(2006-11#1)(2006-3#1)(2006-6#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-3#1)(2009-5#1)(2011-1#1)
or from##112##2##(1990-10#1)(1990-5#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-7#1)(1992-12#3)(1992-2#3)(1992-8#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-3#4)(1994-5#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#2)(1995-5#2)(1995-6#1)(1997-2#1)(1997-6#1)(2005-5#1)(2005-8#1)(2006-10#10)(2006-11#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#14)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2009-3#2)(2009-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-7#1)
or frontal##2##2##(1993-6#1)(2006-3#1)
or frontotemporal dementia (FTD)##2##4##(2008-7#1)(2011-2#1)
or frozen##4##2##(2006-5#1)(2008-2#1)(2008-8#1)(2008-9#1)
or frozen-thawed##4##2##(2006-5#4)
or fructose 1##2##3##(1991-2#1)(1992-1#1)
or fructose##4##2##(1991-2#1)(1992-1#1)(1992-12#1)(1994-8#1)
or frustrates##2##2##(1991-9#1)(2006-10#1)
or full##6##2##(1991-1#1)(1995-2#1)(1995-5#1)(2006-10#1)(2006-12#1)(2008-5#1)
or full-length##4##2##(1994-11#1)(1995-2#1)(2008-7#1)(2008-8#1)
or fully##8##2##(1992-12#1)(1992-9#1)(1995-9#1)(2008-10#2)(2009-11#1)(2011-3#1)(2012-12#1)
or function as##3##3##(1992-6#1)(2008-4#1)(2012-2#1)
or function in##2##3##(1990-8#1)(2012-12#1)
or function of the##3##4##(1994-11#1)(2008-4#2)
or function of##8##3##(1994-11#1)(1995-2#1)(1996-8#1)(2007-12#1)(2008-4#2)(2010-11#1)(2012-12#1)
or function##25##2##(1990-8#1)(1991-5#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-8#1)(1997-3#1)(1997-6#1)(2007-12#2)(2008-4#3)(2010-11#1)(2012-12#3)(2012-2#2)(2013-1#1)
or functional studies##2##3##(2006-2#1)(2008-4#1)
or functional##28##2##(1990-11#2)(1992-2#1)(1992-5#1)(1992-8#1)(1994-9#1)(1995-7#1)(2006-12#1)(2006-2#2)(2007-1#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-4#3)(2009-3#1)(2009-5#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
or functionally##3##2##(1997-4#1)(1997-6#1)(2011-2#1)
or functions##2##2##(2007-8#1)(2008-10#1)
or fungal##3##2##(2007-2#1)(2008-10#2)
or fungi##2##2##(2006-10#1)(2006-6#1)
or further##6##2##(1995-10#1)(2008-10#1)(2008-4#1)(2008-9#2)(2010-1#1)
or fused##3##2##(1995-5#1)(1996-12#1)(2008-8#1)
or fused-silica##2##2##(2008-2#1)(2008-3#1)
or fusiform##3##2##(1997-3#1)(2013-8#2)
or future##6##2##(1997-7#1)(2006-3#1)(2008-12#1)(2009-6#2)(2010-4#1)
or gadolinium##3##2##(1991-7#1)(2013-1#2)
or gain of function##2##4##(2008-4#1)(2013-1#1)
or gain of##6##3##(2007-11#1)(2008-10#1)(2008-4#1)(2010-12#1)(2010-6#1)(2013-1#1)
or gain##7##2##(2005-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2010-12#1)(2010-6#1)(2013-1#1)
or gained##2##2##(1996-11#1)(2010-8#1)
or gamma##10##2##(1990-5#1)(1990-7#1)(1990-9#1)(1991-2#1)(1995-11#2)(1995-2#2)(1996-2#1)(1997-1#1)
or gamma-aminobutyric acid##2##3##(1997-5#1)(2008-4#1)
or gas##7##2##(1990-8#1)(1992-2#1)(2005-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-6#1)
or gaseous##2##2##(1993-9#1)(2007-10#1)
or gastric cancer##2##3##(1990-8#1)(1997-3#1)
or gastric##10##2##(1990-8#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-11#2)(1997-3#1)(2008-11#2)(2010-12#1)
or gastrointestinal##7##2##(1992-8#1)(1996-6#1)(2006-10#1)(2007-2#1)(2008-3#1)(2008-5#1)(2009-8#1)
or gel##3##2##(1991-5#1)(2006-12#1)(2008-10#1)
or gelatin##4##2##(1996-5#1)(2007-11#1)(2009-7#1)(2010-8#1)
or gender##10##2##(1993-2#1)(1997-5#1)(2006-8#1)(2007-10#1)(2007-12#2)(2008-11#1)(2008-7#1)(2010-11#1)(2012-12#1)
or gene expression##2##3##(2008-4#1)(2012-12#1)
or gene therapy##2##3##(2008-1#1)(2008-11#1)
or gene##20##2##(1993-11#1)(1996-11#2)(1996-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-4#2)(2008-5#1)(2010-12#1)(2012-12#1)(2012-3#4)
or general anaesthesia is##2##4##(1992-11#1)(2006-10#1)
or general anaesthesia##3##3##(1992-11#1)(2006-10#1)(2013-1#1)
or general anesthesia##4##3##(1993-1#1)(2007-12#1)(2007-5#1)(2008-4#1)
or general markers##2##3##(2008-5#1)(2011-2#1)
or general##23##2##(1991-3#1)(1992-11#1)(1993-1#1)(1995-8#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
or generalized##4##2##(2004-3#1)(2008-11#1)(2009-7#1)(2012-12#1)
or generally##2##2##(2007-11#1)(2013-1#1)
or generate##3##2##(2008-5#1)(2008-7#1)(2012-3#1)
or generated from##2##3##(1991-12#1)(2008-4#1)
or generated##4##2##(1991-12#1)(1992-5#1)(2008-4#1)(2012-12#1)
or generic##2##2##(2008-5#1)(2013-1#1)
or genes##14##2##(1991-5#1)(1995-6#1)(1997-3#1)(2006-8#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)
or genetic##14##2##(2004-12#1)(2006-10#1)(2006-5#1)(2006-8#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
or genetically engineered##3##3##(2004-4#1)(2009-5#1)(2012-2#1)
or genetically##6##2##(2004-4#1)(2008-10#2)(2009-5#1)(2012-2#1)(2012-3#1)
or genital##2##2##(1992-5#1)(2007-8#1)
or genomic DNA##5##3##(1991-1#1)(1991-7#1)(2008-1#1)(2008-2#1)(2008-4#1)
or genomic##7##2##(1991-1#1)(1991-7#1)(2008-1#1)(2008-2#1)(2008-4#2)(2012-1#1)
or genotoxic##3##2##(1996-10#1)(2004-4#1)(2011-2#1)
or genotype##2##2##(2009-4#2)
or genotypic##3##2##(1995-11#1)(2008-10#1)(2010-3#1)
or geographic##2##2##(2008-10#2)
or geographical##3##2##(1997-6#1)(2006-10#1)(2008-10#1)
or germinating##3##2##(1993-6#1)(2008-10#2)
or gestational##5##2##(1993-11#1)(2007-8#1)(2011-1#3)
or giant condyloma acuminatum##2##4##(2007-11#1)(2010-5#1)
or giant##4##2##(1994-6#1)(1996-3#1)(2007-11#1)(2010-5#1)
or gingival##2##2##(2006-2#1)(2007-11#1)
or given##2##2##(1997-1#1)(2008-4#1)
or glass##3##2##(2004-9#1)(2006-10#1)(2010-9#1)
or glassy##2##2##(2006-10#1)(2008-10#1)
or glaucoma##2##2##(2007-11#1)(2011-2#1)
or glia##2##2##(1997-4#1)(2010-12#1)
or gliosis##2##2##(1995-5#1)(2006-5#1)
or global##7##2##(1993-9#2)(2007-7#1)(2008-2#2)(2009-3#1)(2010-6#1)
or glucagon##4##2##(1991-12#1)(1991-6#1)(1994-11#1)(1997-2#1)
or glucocorticoid##2##2##(1994-5#1)(1996-5#1)
or glucose metabolism##2##3##(1992-4#1)(2008-3#1)
or glucose##16##2##(1990-3#1)(1990-8#2)(1991-3#1)(1992-4#1)(1993-12#1)(1995-5#1)(1997-2#2)(2007-11#1)(2008-10#1)(2008-3#2)(2008-9#1)(2010-11#2)
or glutamate##4##2##(1996-1#1)(1996-6#1)(1997-6#1)(2011-2#1)
or glutamate-induced##2##2##(1991-4#1)(1997-5#1)
or glutamic acid##2##3##(1994-9#1)(1997-6#1)
or glutamine##6##2##(1994-11#1)(1996-11#1)(1996-8#1)(2008-11#2)(2008-7#1)
or glutathione peroxidase##2##3##(1994-3#1)(2005-7#1)
or glutathione##5##2##(1994-3#1)(1995-3#1)(2005-7#1)(2008-10#2)
or glycerol##6##2##(1990-8#1)(1994-8#1)(1995-4#1)(1997-6#1)(2007-12#1)(2008-5#1)
or glycine##7##2##(1992-1#1)(1993-3#1)(1993-6#1)(1994-5#1)(1995-3#1)(1996-5#1)(2008-5#1)
or glycolipid##2##2##(1994-10#1)(1995-3#1)
or glycoproteins##2##2##(2008-4#1)(2009-6#1)
or glyoxal##2##2##(1995-8#1)(2008-5#1)
or gold##3##2##(2008-10#2)(2009-7#1)
or good in##3##3##(1991-3#1)(1993-11#1)(2008-3#1)
or good results##4##3##(1991-12#1)(2007-11#2)(2012-12#1)
or good##25##2##(1991-10#1)(1991-12#1)(1991-3#1)(1991-8#1)(1993-11#1)(1997-6#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#6)(2007-7#5)(2008-3#1)(2009-3#1)(2012-1#1)(2012-12#1)(2012-3#1)
or government##2##2##(1992-3#1)(2010-12#1)
or grade##5##2##(2004-1#1)(2008-12#1)(2008-7#1)(2010-6#1)(2011-2#1)
or graft##14##2##(1994-11#1)(1997-1#1)(2007-1#1)(2007-11#2)(2007-7#5)(2011-1#1)(2011-2#2)(2012-1#1)
or grammatical##2##2##(2008-11#1)(2013-1#1)
or granulocytes##2##2##(1996-8#1)(2009-6#1)
or graphene##2##2##(2009-2#1)(2012-1#1)
or graphite##2##2##(2007-5#1)(2010-4#1)
or grass##3##2##(2008-10#3)
or grating##2##2##(2008-3#2)
or greater increases##2##3##(1992-10#1)(2008-10#1)
or greater reactions##2##3##(1993-12#2)
or greater reduction in##2##4##(1994-3#1)(2006-12#1)
or greater reduction##3##3##(1994-3#1)(2006-12#2)
or greater than##18##3##(1990-11#1)(1990-12#1)(1990-5#1)(1991-12#1)(1991-2#1)(1995-12#1)(1996-8#1)(1997-4#3)(1997-6#1)(2006-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#2)
or greater were##5##3##(2006-5#1)(2006-8#1)(2008-9#3)
or greater##98##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1991-12#2)(1991-2#1)(1992-10#1)(1993-12#4)(1993-6#1)(1994-10#1)(1994-3#1)(1994-5#2)(1995-12#1)(1996-1#1)(1996-2#1)(1996-6#3)(1996-8#2)(1997-4#4)(1997-5#1)(1997-6#1)(2004-3#1)(2006-11#1)(2006-12#2)(2006-3#1)(2006-5#1)(2006-8#6)(2007-12#1)(2007-5#1)(2007-9#3)(2008-10#8)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#20)(2009-10#2)(2011-2#2)(2012-1#2)(2012-3#1)(2013-1#4)
or greater)##3##2##(2006-10#1)(2007-11#1)(2008-3#1)
or green light##2##3##(1992-12#1)(2008-3#1)
or green##8##2##(1992-12#1)(2006-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)(2013-8#1)
or greenhouse##2##2##(2008-10#2)
or gross##6##2##(2006-5#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-2#1)
or ground##4##2##(2004-11#1)(2006-10#1)(2007-2#1)(2009-6#1)
or group differences##2##3##(2007-12#1)(2009-3#1)
or group of##3##3##(1993-5#1)(1995-12#1)(2005-8#1)
or group##12##2##(1993-5#1)(1995-12#1)(2005-7#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#2)(2009-3#1)(2010-12#1)(2010-4#1)
or groups of##8##3##(1990-4#1)(1990-5#1)(1993-4#1)(2006-5#1)(2008-2#1)(2008-9#1)(2010-3#1)(2011-2#1)
or groups##12##2##(1990-4#1)(1990-5#1)(1991-4#1)(1993-4#1)(2006-5#1)(2008-2#1)(2008-5#2)(2008-9#1)(2010-3#1)(2011-2#1)(2013-1#1)
or growing##2##2##(2006-10#1)(2008-10#1)
or growth factor##2##3##(1996-4#1)(2008-11#1)
or growth factors##4##3##(1991-10#1)(1993-8#1)(2004-9#1)(2008-11#1)
or growth##19##2##(1991-10#1)(1992-7#1)(1992-9#2)(1993-6#1)(1993-8#1)(1995-3#1)(1996-4#1)(2004-9#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-7#2)(2010-8#1)(2011-12#1)(2011-2#1)
or guanidine##2##2##(1992-3#1)(1995-5#1)
or guarantee##2##2##(1997-1#1)(2006-10#1)
or guardians##5##2##(1994-3#1)(2005-7#2)(2008-11#1)(2011-1#1)
or guidelines##2##2##(2006-12#1)(2013-1#1)
or guinea##2##2##(1992-9#1)(2008-4#1)
or hROM-K3##2##2##(1994-9#2)
or had a##5##3##(2006-6#1)(2007-12#1)(2008-11#1)(2011-1#1)(2012-3#1)
or had an##2##3##(1993-9#1)(2006-10#1)
or had been##4##3##(1991-7#1)(1995-4#1)(2007-2#1)(2008-10#1)
or had not##2##3##(2006-7#1)(2010-12#1)
or had the##2##3##(1992-11#1)(2008-3#1)
or had to##2##3##(2011-3#1)(2013-1#1)
or had##35##2##(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-9#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-12#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-3#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#4)
or haematocrit##2##2##(1995-5#1)(2007-11#1)
or hair##3##2##(2008-10#2)(2008-7#1)
or hamster##5##2##(1996-5#1)(2008-4#2)(2008-9#2)
or hamstring tendon##2##3##(2009-6#1)(2009-9#1)
or hamstring##3##2##(2009-6#1)(2009-9#2)
or harassed##2##2##(2005-9#1)(2011-2#1)
or hard##5##2##(2007-7#1)(2009-2#1)(2011-12#1)(2011-2#2)
or harm##4##2##(2009-7#2)(2011-2#1)(2012-2#1)
or harmful##6##2##(1990-3#1)(1993-11#1)(2006-7#1)(2008-1#1)(2009-11#1)(2011-2#1)
or has been##2##3##(1994-10#1)(2006-10#1)
or has previously##2##3##(2010-12#1)(2011-2#1)
or has##10##2##(1994-10#1)(2006-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-8#1)(2011-2#2)(2013-8#1)
or hatching##2##2##(2009-3#1)(2010-8#1)
or have a##5##3##(1994-2#1)(2008-10#2)(2008-12#1)(2012-2#1)
or have been##5##3##(1991-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2012-2#1)
or have evidence of##2##4##(1995-3#1)(2006-5#1)
or have no##2##3##(2008-5#1)(2009-9#1)
or have only##2##3##(2010-11#1)(2011-2#1)
or have recently##2##3##(1990-12#1)(2012-2#1)
or have undergone##2##3##(1993-11#1)(1995-11#1)
or have##41##2##(1990-12#1)(1991-12#1)(1993-11#1)(1993-9#1)(1994-2#1)(1994-4#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-3#1)(2006-5#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-12#2)(2008-3#2)(2008-5#2)(2008-7#2)(2009-9#1)(2010-11#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#1)
or having##11##2##(1991-12#1)(1995-6#1)(2006-10#1)(2007-11#1)(2008-5#1)(2009-7#1)(2010-12#2)(2010-3#1)(2010-8#1)(2013-1#1)
or hazardous##2##2##(1992-1#1)(2008-10#1)
or head##3##2##(2006-10#1)(2008-11#2)
or headache##2##2##(2010-12#1)(2010-5#1)
or healing##4##2##(1997-6#1)(2011-2#1)(2012-10#1)(2013-1#1)
or health##14##2##(1990-10#1)(1992-5#1)(1994-3#1)(1996-2#2)(2006-2#1)(2007-12#1)(2007-2#1)(2007-3#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)
or healthy##9##2##(1994-11#1)(1994-9#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-6#1)(2013-1#3)
or heard##2##2##(1997-4#1)(2013-1#1)
or heart disease##2##3##(1997-2#1)(2008-1#1)
or heart failure##3##3##(2006-9#1)(2008-1#1)(2013-1#1)
or heart##12##2##(1990-11#1)(1991-2#1)(1993-1#1)(1997-2#1)(2006-9#1)(2007-11#2)(2008-1#2)(2008-11#2)(2013-1#1)
or heat shock protein##2##4##(1993-8#1)(1995-6#1)
or heat##5##2##(1993-8#1)(1995-12#1)(1995-6#1)(2006-5#1)(2008-4#1)
or heating##3##2##(1992-8#1)(1996-11#1)(2005-11#1)
or heavily##2##2##(2008-5#1)(2013-7#1)
or heavy##2##2##(2008-5#1)(2011-2#1)
or height##2##2##(2007-12#1)(2008-10#1)
or held##3##2##(2008-7#1)(2010-8#1)(2013-8#1)
or helical##4##2##(2007-3#1)(2009-8#3)
or helium##2##2##(1997-1#1)(2007-9#1)
or help##2##2##(2011-1#1)(2013-1#1)
or hemagglutination##2##2##(1993-3#1)(2008-9#1)
or hematopoietic##2##2##(2008-7#1)(2010-2#1)
or hemoglobin##3##2##(1990-8#1)(1994-9#1)(1995-2#1)
or hemorrhage of the##2##4##(1995-3#1)(2010-2#1)
or hemorrhage##5##2##(1995-1#1)(1995-3#1)(2007-8#1)(2010-2#1)(2011-2#1)
or heparin##5##2##(1993-12#1)(1997-5#1)(1997-6#1)(2005-7#1)(2008-4#1)
or hepatic impairment##2##3##(2007-11#1)(2008-3#1)
or hepatic##12##2##(1990-3#1)(1995-11#1)(2005-7#1)(2006-12#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-3#1)(2008-9#1)(2012-3#1)
or hepatitis B virus##2##4##(1991-6#1)(2009-4#1)
or hepatitis B##5##3##(1991-6#1)(2007-11#1)(2007-2#1)(2009-4#1)(2012-2#1)
or hepatitis##7##2##(1991-6#1)(1997-7#1)(2007-11#1)(2007-2#1)(2008-6#1)(2009-4#1)(2012-2#1)
or hepatocellular carcinoma##3##3##(2006-2#1)(2007-12#1)(2009-10#1)
or her##62##2##(1992-12#1)(1992-2#1)(1992-4#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-9#1)(1997-8#1)(2004-10#1)(2004-12#1)(2004-3#1)(2005-12#1)(2006-10#9)(2006-11#1)(2006-12#1)(2006-4#1)(2006-7#2)(2007-10#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-10#2)(2009-2#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-5#2)(2010-8#2)(2010-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
or herbal##2##2##(2009-3#1)(2012-2#1)
or hereditary##3##2##(1997-4#1)(2008-7#1)(2009-10#1)
or herpes simplex##2##3##(1997-2#1)(2013-7#1)
or herself to##2##3##(2008-1#1)(2008-7#1)
or heterodimers##4##2##(1996-2#1)(2006-11#1)(2007-6#1)(2008-11#1)
or heterogeneous##3##2##(2008-10#1)(2009-10#1)(2012-1#1)
or heterologous##6##2##(1993-5#1)(1994-8#1)(2006-11#1)(2008-10#1)(2008-4#2)
or heterosexual##2##2##(1990-5#1)(2007-12#1)
or hidden##2##2##(2006-12#1)(2008-10#1)
or high K+##3##3##(1995-5#2)(1997-5#1)
or high concentrations of##2##4##(2006-3#1)(2008-4#1)
or high density##4##3##(1993-9#1)(1997-8#1)(2008-10#1)(2010-8#1)
or high dose heparin##2##4##(1990-11#2)
or high dose##6##3##(1990-11#2)(1990-12#1)(2005-7#1)(2006-10#1)(2008-11#1)
or high doses##3##3##(1995-10#1)(2008-5#1)(2008-7#1)
or high insertion##2##3##(2013-1#2)
or high levels of##2##4##(1996-12#1)(2006-8#1)
or high levels##3##3##(1996-12#1)(2006-8#1)(2013-1#1)
or high performance liquid##2##4##(1996-9#1)(2008-10#1)
or high risk##4##3##(2006-10#1)(2007-2#1)(2010-9#1)(2011-12#1)
or high temperatures##2##3##(2008-8#1)(2008-9#1)
or high##86##2##(1990-11#2)(1990-12#1)(1990-7#1)(1991-4#1)(1992-1#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-9#1)(1994-5#1)(1995-10#2)(1995-5#3)(1995-6#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-5#1)(1997-8#1)(2004-11#2)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#2)(2006-8#1)(2007-2#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-8#2)(2010-9#1)(2011-12#1)(2012-12#1)(2012-2#3)(2012-3#3)(2012-9#2)(2013-1#7)(2013-8#1)
or high-dose##2##2##(2006-11#1)(2012-3#1)
or high-fat##4##2##(1995-2#2)(1995-8#1)(2009-5#1)
or high-grade##2##2##(2005-10#1)(2006-10#1)
or high-risk##4##2##(2007-12#2)(2007-8#1)(2010-11#1)
or higher in##3##3##(1990-11#1)(2008-10#1)(2008-2#1)
or higher of##2##3##(1994-2#1)(2009-6#1)
or higher than that##2##4##(1995-6#1)(2006-12#1)
or higher than##12##3##(1992-9#1)(1995-6#1)(2005-8#1)(2006-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2013-1#1)
or higher was##3##3##(2005-11#1)(2006-5#1)(2012-11#1)
or higher##58##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-7#2)(1992-12#1)(1992-9#1)(1993-9#1)(1994-2#2)(1994-5#1)(1994-8#2)(1995-6#1)(1996-2#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-12#2)(2011-1#4)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#3)(2013-8#1)
or higher)##3##2##(2008-5#1)(2009-2#1)(2012-2#1)
or highly resistant to##2##4##(2008-10#1)(2011-2#1)
or highly##11##2##(1996-6#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)
or hip subluxation after developmental##2##5##(2007-7#2)
or hip##7##2##(2006-10#2)(2007-10#1)(2007-7#2)(2007-8#1)(2013-1#1)
or hippocampal##3##2##(1991-9#1)(1993-3#1)(1995-11#1)
or hippocampus of##2##3##(1996-12#1)(2012-2#1)
or hippocampus##5##2##(1990-2#1)(1991-9#1)(1996-1#1)(1996-12#1)(2012-2#1)
or his##3##2##(1991-7#1)(2006-2#1)(2008-8#1)
or histamine##4##2##(1990-7#2)(1993-6#1)(2008-1#1)
or histidine##3##2##(1995-2#1)(1996-11#1)(1996-9#1)
or histologic##2##2##(1990-10#1)(1993-12#1)
or histone##4##2##(1995-7#1)(2008-5#1)(2010-12#1)(2011-2#1)
or histopathologic##4##2##(1991-12#1)(2007-2#1)(2013-1#2)
or histopathology##2##2##(2007-10#2)
or history of##3##3##(1993-10#1)(1993-2#1)(2012-2#1)
or home care##2##3##(2005-8#1)(2011-2#1)
or home##6##2##(2005-8#1)(2007-12#1)(2007-8#1)(2008-5#1)(2010-2#1)(2011-2#1)
or horizontal##2##2##(2008-7#2)
or hormonal##5##2##(1997-3#1)(2005-11#1)(2007-11#1)(2007-6#1)(2008-1#1)
or hormone therapy##2##3##(1990-12#1)(2012-2#1)
or hospital##12##2##(1990-3#1)(1991-3#1)(1992-2#1)(1995-12#2)(2005-11#1)(2007-10#1)(2008-1#1)(2008-11#3)(2009-5#1)
or hospitalization##7##2##(1992-3#1)(1993-5#1)(1995-2#1)(2008-11#1)(2008-3#1)(2012-12#1)(2013-1#1)
or hospitalized##2##2##(2009-5#1)(2013-8#1)
or hospitals##4##2##(2007-9#1)(2008-7#1)(2009-10#1)(2011-1#1)
or host origin##2##3##(2006-10#1)(2008-10#1)
or host##10##2##(1990-11#1)(1994-5#1)(2006-10#1)(2008-10#5)(2008-5#1)(2009-6#1)
or hot##2##2##(2008-10#1)(2013-7#1)
or house##3##2##(1991-3#1)(2007-11#1)(2011-2#1)
or household##2##2##(2007-11#1)(2010-12#1)
or how to##4##3##(2006-11#1)(2007-8#1)(2010-12#1)(2011-2#1)
or how##12##2##(2006-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-9#2)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
or human immunodeficiency##2##3##(1996-5#1)(2009-8#1)
or human serum albumin##3##4##(1994-9#1)(2005-12#1)(2008-10#1)
or human serum##4##3##(1994-9#1)(1995-12#1)(2005-12#1)(2008-10#1)
or human##45##2##(1990-2#1)(1991-2#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-11#1)(1996-5#1)(2005-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#2)(2008-8#1)(2009-8#2)(2010-11#2)(2010-8#1)(2012-12#2)(2013-1#2)(2013-7#1)
or humans##4##2##(1991-12#1)(1995-2#1)(2008-7#1)(2010-3#1)
or hybrid##3##2##(2006-12#1)(2008-3#1)(2009-10#1)
or hydration##3##2##(1991-9#1)(2006-1#1)(2008-5#1)
or hydrazones##3##2##(2007-11#3)
or hydrogen bond##2##3##(1992-8#1)(1993-4#1)
or hydrogen peroxide##5##3##(1992-12#1)(1993-7#1)(1997-3#1)(2008-10#1)(2008-5#1)
or hydrogen##8##2##(1992-12#1)(1992-8#1)(1993-4#1)(1993-7#1)(1995-11#1)(1997-3#1)(2008-10#1)(2008-5#1)
or hydrophobic interactions##3##3##(1990-5#1)(1996-12#1)(2012-2#1)
or hydrophobic##9##2##(1990-5#1)(1990-8#1)(1995-1#1)(1996-12#1)(2005-11#1)(2008-10#2)(2012-2#1)(2013-1#1)
or hydrophobicity##2##2##(1993-4#1)(2008-10#1)
or hydroxyl##4##2##(1994-2#1)(1994-5#1)(2008-10#1)(2011-2#1)
or hydroxylamine##2##2##(1994-3#1)(1995-3#1)
or hydroxyurea##2##2##(2008-11#1)(2011-2#1)
or hyperplasia of##2##3##(2009-1#1)(2011-12#1)
or hypersensitivity##2##2##(1995-12#1)(2005-8#1)
or hypertension##7##2##(1995-12#1)(2006-10#2)(2007-7#1)(2008-10#1)(2010-12#1)(2013-1#1)
or hyperthermia##2##2##(1994-5#1)(2006-6#1)
or hypoglycemia##2##2##(1993-11#1)(1995-1#1)
or hypoplasia of##3##3##(1993-6#1)(2009-6#1)(2011-1#1)
or hypoplasia##4##2##(1993-6#1)(2008-1#1)(2009-6#1)(2011-1#1)
or hypothalamic abnormalities##2##3##(2007-6#2)
or hypothyroid##2##2##(2006-11#1)(2009-9#1)
or hypothyroidism##2##2##(2006-11#1)(2011-1#1)
or hypoxia##4##2##(1991-2#1)(1992-3#2)(1997-5#1)
or i##5##2##(1992-12#1)(1992-3#1)(1993-1#1)(1995-5#1)(1996-12#1)
or i-propanol##2##2##(2008-10#2)
or iatrogenic##3##2##(2010-5#1)(2011-2#1)(2013-1#1)
or ice##4##2##(2007-9#1)(2008-2#2)(2008-3#1)
or identical##4##2##(1990-6#1)(1991-8#1)(1992-4#1)(1994-5#1)
or identification##2##2##(1992-3#1)(2005-12#1)
or identify##4##2##(2008-10#1)(2008-11#1)(2010-11#1)(2011-1#1)
or idiopathic##5##2##(1994-10#1)(2009-4#1)(2009-5#1)(2010-12#1)(2013-8#1)
or if a##2##3##(2006-10#1)(2010-11#1)
or if all##2##3##(2008-9#2)
or if it##3##3##(2008-2#1)(2008-4#1)(2012-12#1)
or if the##7##3##(1990-12#1)(1994-9#1)(2005-8#1)(2006-10#1)(2006-9#1)(2008-10#1)(2013-1#1)
or if there is##2##4##(1997-2#1)(2006-9#1)
or if there##4##3##(1997-2#1)(2006-9#1)(2011-2#1)(2013-1#1)
or if they##3##3##(1992-3#1)(2009-4#1)(2011-12#1)
or if##39##2##(1990-12#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-3#1)(1993-2#1)(1994-9#1)(1995-8#1)(1997-2#1)(2005-8#1)(2006-10#2)(2006-6#1)(2006-9#2)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-11#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
or ifosfamide##2##2##(1991-11#1)(2008-6#1)
or ignored##6##2##(1992-6#1)(1996-12#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#1)
or ill##2##2##(1995-11#1)(2007-8#1)
or illness##2##2##(2009-11#1)(2011-2#1)
or illumination##2##2##(2008-3#1)(2009-6#1)
or image##4##2##(1995-2#1)(2007-11#1)(2008-2#1)(2008-6#1)
or imaging##5##2##(2008-2#1)(2008-3#1)(2008-7#1)(2012-12#1)(2012-3#1)
or imbalances##2##2##(2005-10#2)
or imidazole##4##2##(1992-6#1)(2009-11#1)(2010-5#1)(2012-12#1)
or imipenem##3##2##(2006-8#1)(2012-2#2)
or immature##3##2##(2006-10#1)(2008-10#1)(2009-9#1)
or immediately after##3##3##(1993-1#1)(2012-2#1)(2013-7#1)
or immediately##4##2##(1993-1#1)(2011-12#1)(2012-2#1)(2013-7#1)
or immigration##2##2##(2008-10#2)
or imminent##3##2##(2007-3#1)(2007-7#1)(2008-1#1)
or immobilized##4##2##(2008-10#2)(2008-11#1)(2008-6#1)
or immune##7##2##(1991-1#1)(1993-11#1)(1995-5#1)(2007-11#1)(2008-4#1)(2009-2#1)(2011-2#1)
or immunodeficiency##2##2##(2009-8#1)(2011-1#1)
or immunoglobulin##2##2##(1992-8#1)(2008-4#1)
or immunohistochemistry##2##2##(2008-1#1)(2008-11#1)
or immunological##5##2##(1994-3#1)(1996-3#1)(2007-11#1)(2008-10#1)(2011-2#1)
or immunoprecipitates)##2##2##(2008-2#1)(2008-4#1)
or immunosuppressive agents##2##3##(1997-2#1)(2005-8#1)
or immunosuppressive drugs##2##3##(2008-3#1)(2011-2#1)
or immunosuppressive##6##2##(1997-2#1)(2005-8#1)(2006-10#1)(2008-1#1)(2008-3#1)(2011-2#1)
or impaired##12##2##(1991-4#1)(1996-6#1)(2005-7#1)(2006-9#1)(2008-7#2)(2009-2#1)(2009-8#2)(2010-12#1)(2013-8#2)
or impairment of##2##3##(1995-2#1)(2008-1#1)
or impairment##3##2##(1995-2#1)(2008-1#1)(2012-12#1)
or impede##2##2##(1992-7#1)(2008-1#1)
or implantable##3##2##(2009-5#1)(2010-10#1)(2012-2#1)
or implantation##2##2##(1990-4#1)(2007-8#1)
or implement##2##2##(2007-5#1)(2008-11#1)
or implicitly##2##2##(1995-4#1)(2007-6#1)
or impossible to##8##3##(1997-3#1)(1997-8#1)(2005-8#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)
or impossible##10##2##(1993-7#1)(1996-2#1)(1997-3#1)(1997-8#1)(2005-8#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)
or improve the##2##3##(2006-10#1)(2010-5#1)
or improve##8##2##(1995-3#2)(2006-10#1)(2006-6#1)(2007-9#1)(2008-11#1)(2009-3#1)(2010-5#1)
or improved in##4##3##(1994-9#1)(2008-10#1)(2012-3#1)(2013-1#1)
or improved##16##2##(1994-9#2)(1995-5#1)(1997-6#1)(2005-10#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)(2013-1#3)
or improvement in##4##3##(2007-11#1)(2007-12#1)(2008-8#1)(2011-2#1)
or improvement of the##2##4##(1996-11#1)(2013-1#1)
or improvement of##6##3##(1996-11#1)(2004-4#1)(2006-7#1)(2007-7#1)(2011-1#1)(2013-1#1)
or improvement##10##2##(1996-11#1)(2004-4#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
or improves##2##2##(1990-4#1)(2007-12#1)
or improving the##3##3##(1991-7#1)(2008-10#1)(2010-2#1)
or improving##5##2##(1991-7#1)(1995-12#1)(2007-11#1)(2008-10#1)(2010-2#1)
or impurities##3##2##(2008-10#2)(2012-2#1)
or in a different##2##4##(2007-11#1)(2008-2#1)
or in a mixture##2##4##(2008-10#2)
or in a##34##3##(1990-10#1)(1990-8#1)(1991-3#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-4#1)(1994-12#1)(1994-9#1)(1995-10#2)(1995-5#1)(1996-11#1)(1996-5#1)(1997-6#2)(2005-11#2)(2006-8#1)(2007-11#1)(2007-2#2)(2007-8#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#2)(2008-8#1)(2013-1#1)
or in addition to##4##4##(1995-8#2)(1997-2#1)(2006-10#1)
or in adult##2##3##(1993-5#1)(1996-11#1)
or in animals##2##3##(1995-7#1)(2008-4#1)
or in any combination##2##4##(1995-4#1)(1996-1#1)
or in any other##2##4##(1996-1#1)(2008-10#1)
or in any##6##3##(1995-4#1)(1996-1#2)(2008-1#1)(2008-10#1)(2013-8#1)
or in association with##11##4##(1990-2#2)(1997-4#1)(2006-10#2)(2010-11#1)(2010-3#1)(2011-2#1)(2013-1#3)
or in association##13##3##(1990-2#2)(1990-9#1)(1997-4#1)(2006-10#2)(2008-7#1)(2010-11#1)(2010-3#1)(2011-2#1)(2013-1#3)
or in biological fluids##2##4##(2008-10#1)(2010-7#1)
or in both##2##3##(1994-8#1)(2008-10#1)
or in case of##4##4##(1990-8#1)(1996-12#1)(2009-3#1)(2013-8#1)
or in cases with##3##4##(2007-8#1)(2008-10#1)(2008-11#1)
or in cases##4##3##(2007-8#1)(2008-10#1)(2008-11#1)(2012-2#1)
or in children at risk for malnutrition##2##7##(2010-7#2)
or in children unable to maintain an adequate nutritional status with oral intake##2##13##(2010-7#2)
or in children##5##3##(2005-8#1)(2010-7#4)
or in clinical##3##3##(2008-5#2)(2011-1#1)
or in close##3##3##(1990-6#1)(1996-12#1)(2010-7#1)
or in combination have##2##4##(2008-5#1)(2011-12#1)
or in combination in##2##4##(2008-12#1)(2012-12#1)
or in combination to##2##4##(2008-10#1)(2009-4#1)
or in combination with a##5##5##(1994-10#1)(2006-10#1)(2008-10#1)(2008-4#1)(2012-12#1)
or in combination with cytotoxic chemotherapy##2##6##(1993-12#1)(2008-5#1)
or in combination with other antihypertensive drugs##2##7##(2008-3#2)
or in combination with other antihypertensive##3##6##(1990-1#1)(2008-3#2)
or in combination with other##19##5##(1990-1#1)(1992-3#1)(1994-4#1)(1995-2#1)(2004-1#1)(2006-11#1)(2006-12#1)(2007-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-4#1)(2009-6#1)(2010-8#1)(2011-2#1)(2013-1#1)
or in combination with standard##2##5##(2005-11#1)(2010-4#1)
or in combination with the##3##5##(2004-2#1)(2008-8#1)(2009-3#1)
or in combination with##91##4##(1990-1#1)(1990-2#1)(1990-4#2)(1990-5#1)(1990-6#1)(1992-3#2)(1992-5#1)(1993-12#2)(1993-5#1)(1993-7#1)(1994-10#1)(1994-4#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-12#2)(1997-5#1)(1997-6#1)(2004-1#2)(2004-2#1)(2005-1#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#3)(2007-3#4)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#3)(2013-7#1)
or in combination##124##3##(1990-1#1)(1990-2#1)(1990-4#2)(1990-5#1)(1990-6#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-12#2)(1993-5#1)(1993-6#1)(1993-7#1)(1994-10#1)(1994-4#1)(1994-6#1)(1994-8#2)(1995-2#1)(1995-3#1)(1996-12#2)(1997-5#1)(1997-6#1)(2004-1#2)(2004-2#1)(2004-4#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-5#1)(2006-8#2)(2006-9#1)(2007-10#3)(2007-11#4)(2007-3#5)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#2)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#2)(2011-1#2)(2011-12#2)(2011-2#3)(2012-1#2)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)
or in combination)##2##3##(2008-1#1)(2011-2#1)
or in combinations##2##3##(1993-3#2)
or in concert with##3##4##(2008-10#1)(2008-11#1)(2008-4#1)
or in conjunction with##6##4##(2007-12#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2010-4#1)
or in determining##2##3##(2005-5#1)(2013-1#1)
or in different##3##3##(2006-10#1)(2008-10#1)(2008-6#1)
or in extracellular matrices##2##4##(1995-2#1)(2008-8#1)
or in fixed##2##3##(1994-5#1)(2006-6#1)
or in hospital##3##3##(2008-3#1)(2011-2#2)
or in its##2##3##(1990-11#1)(1997-2#1)
or in liquid##2##3##(2008-4#1)(2008-9#1)
or in mixtures##2##3##(2008-10#1)(2012-7#1)
or in pairs##3##3##(1997-3#1)(2006-8#1)(2008-8#1)
or in patients who have##2##5##(2007-7#1)(2008-5#1)
or in patients who##3##4##(2007-7#1)(2008-5#1)(2013-1#1)
or in patients with##4##4##(1990-6#1)(1997-8#1)(2009-9#1)(2013-8#1)
or in patients##7##3##(1990-6#1)(1997-8#1)(2007-7#1)(2008-5#1)(2009-9#1)(2013-1#1)(2013-8#1)
or in presence of##4##4##(1990-5#1)(1994-3#1)(1997-4#1)(2012-2#1)
or in response to##6##4##(1997-7#1)(2005-7#1)(2006-5#1)(2007-11#1)(2008-8#1)(2009-10#1)
or in response##7##3##(1991-11#1)(1997-7#1)(2005-7#1)(2006-5#1)(2007-11#1)(2008-8#1)(2009-10#1)
or in selected##2##3##(1991-2#1)(1993-10#1)
or in situ##5##3##(1994-3#1)(2005-11#1)(2008-10#2)(2011-2#1)
or in small groups##3##4##(1991-11#1)(1996-5#1)(2008-5#1)
or in small##4##3##(1991-11#1)(1996-5#1)(2007-4#1)(2008-5#1)
or in soil##2##3##(2006-12#1)(2008-10#1)
or in some cases##3##4##(1992-3#1)(2008-10#1)(2009-6#1)
or in terms of##2##4##(2008-10#1)(2008-7#1)
or in the absence of extracellular##2##6##(1990-6#1)(1992-4#1)
or in the absence of##4##5##(1990-6#1)(1992-4#1)(1996-5#1)(2008-1#1)
or in the blood##2##4##(1996-12#1)(2008-5#1)
or in the brain##2##4##(2008-5#1)(2008-9#1)
or in the case of##3##5##(1994-2#1)(2006-10#1)(2006-6#1)
or in the combination##2##4##(2011-2#1)(2013-1#1)
or in the early##3##4##(1992-3#1)(1994-3#1)(2006-7#1)
or in the environment##2##4##(1996-5#1)(2010-9#1)
or in the form of a##2##6##(1997-4#1)(2008-8#1)
or in the form of##3##5##(1997-4#1)(2008-8#1)(2013-1#1)
or in the group##3##4##(1992-8#1)(1996-7#1)(2008-3#1)
or in the nucleus##2##4##(1997-1#1)(2008-9#1)
or in the number of##2##5##(1996-7#1)(2006-5#1)
or in the presence of the##3##6##(2008-5#1)(2008-8#1)(2011-2#1)
or in the presence of##21##5##(1990-2#1)(1993-11#1)(1993-8#2)(1994-3#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-4#1)(2006-5#1)(2007-10#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2011-2#1)
or in the##145##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#2)(1992-8#1)(1993-11#2)(1993-12#1)(1993-4#1)(1993-7#1)(1993-8#2)(1994-2#1)(1994-3#4)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-8#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#2)(1996-7#2)(1997-1#2)(1997-3#1)(1997-4#2)(1997-6#1)(2004-10#1)(2005-7#1)(2006-10#4)(2006-5#3)(2006-6#1)(2006-7#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#4)(2009-3#1)(2009-5#1)(2010-5#1)(2010-9#1)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
or in their##4##3##(1991-7#1)(1993-6#1)(2008-7#1)(2011-2#1)
or in those treated with##2##5##(1993-2#1)(2010-6#1)
or in those##11##3##(1993-2#1)(1995-12#1)(1995-2#1)(1995-5#1)(2006-12#1)(2007-11#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-6#1)(2011-2#1)
or in very##2##3##(2008-8#1)(2011-1#1)
or in vitro##23##3##(1990-11#1)(1990-12#1)(1990-4#1)(1991-5#1)(1992-5#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-1#2)(1997-4#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#4)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
or in vivo##12##3##(1992-6#1)(1992-9#1)(1994-9#1)(1997-4#2)(1997-5#1)(2006-12#2)(2006-5#1)(2008-11#1)(2008-5#1)(2012-12#1)
or in water##2##3##(2007-11#1)(2008-10#1)
or in which a##2##4##(1997-2#1)(2006-8#1)
or in which##5##3##(1994-8#1)(1997-2#1)(2006-8#1)(2008-3#1)(2011-2#1)
or in##690##2##(1990-1#1)(1990-10#2)(1990-11#8)(1990-12#1)(1990-2#8)(1990-3#2)(1990-4#3)(1990-5#3)(1990-6#5)(1990-8#3)(1990-9#1)(1991-1#2)(1991-11#3)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#5)(1991-6#1)(1991-7#2)(1991-8#2)(1992-10#1)(1992-12#4)(1992-2#1)(1992-3#8)(1992-4#2)(1992-5#4)(1992-6#4)(1992-8#1)(1992-9#4)(1993-10#1)(1993-11#5)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#2)(1993-5#2)(1993-6#3)(1993-7#2)(1993-8#4)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#7)(1994-4#1)(1994-5#1)(1994-6#4)(1994-7#1)(1994-8#9)(1994-9#3)(1995-1#2)(1995-10#2)(1995-11#2)(1995-12#4)(1995-2#5)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#5)(1995-9#1)(1996-1#3)(1996-10#3)(1996-11#2)(1996-12#8)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#3)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#4)(1997-2#5)(1997-3#2)(1997-4#7)(1997-5#3)(1997-6#4)(1997-7#4)(1997-8#2)(2004-1#2)(2004-10#1)(2004-2#1)(2004-4#1)(2005-1#1)(2005-10#2)(2005-11#4)(2005-5#1)(2005-7#2)(2005-8#5)(2005-9#1)(2006-10#13)(2006-11#1)(2006-12#6)(2006-2#2)(2006-3#1)(2006-5#9)(2006-6#3)(2006-7#1)(2006-8#7)(2006-9#1)(2007-10#6)(2007-11#14)(2007-12#7)(2007-2#6)(2007-3#7)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#4)(2007-8#8)(2007-9#2)(2008-1#10)(2008-10#53)(2008-11#13)(2008-12#3)(2008-2#3)(2008-3#22)(2008-4#25)(2008-5#24)(2008-6#4)(2008-7#14)(2008-8#14)(2008-9#9)(2009-10#5)(2009-11#1)(2009-3#3)(2009-4#3)(2009-5#4)(2009-6#3)(2009-8#2)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#3)(2010-6#1)(2010-7#8)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#17)(2012-1#4)(2012-11#1)(2012-12#13)(2012-2#12)(2012-3#3)(2012-7#1)(2013-1#18)(2013-7#2)(2013-8#6)
or in-hospital##2##2##(1992-6#1)(2007-8#1)
or inaccurate##3##2##(1993-11#1)(1993-12#1)(2013-1#1)
or inactivate##3##2##(2004-1#1)(2008-10#1)(2009-11#1)
or inactivated##2##2##(2005-7#1)(2009-8#1)
or inactivating##2##2##(2006-8#1)(2008-6#1)
or inactivation of 5-HT##2##4##(2006-10#2)
or inactivation of##3##3##(1996-8#1)(2006-10#2)
or inactivation##4##2##(1993-11#1)(1996-8#1)(2006-10#2)
or inadequate##6##2##(1991-12#1)(1994-9#1)(2005-1#1)(2010-8#1)(2010-9#1)(2013-1#1)
or inappropriate##10##2##(1991-10#1)(1997-1#1)(2007-2#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)
or inappropriately treated##2##3##(2008-6#1)(2011-2#1)
or inappropriately##3##2##(2007-4#1)(2008-6#1)(2011-2#1)
or incentives##2##2##(2010-10#1)(2012-2#1)
or incidence##6##2##(1994-3#1)(2008-10#2)(2009-12#1)(2010-8#1)(2012-3#1)
or included##2##2##(2004-9#1)(2010-1#1)
or inclusion##2##2##(2008-11#1)(2008-8#1)
or incomplete##9##2##(1990-5#1)(1993-1#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-4#1)(2012-12#1)
or incompletely##2##2##(2008-7#1)(2012-3#1)
or inconclusive##5##2##(1997-8#1)(2006-10#1)(2006-8#2)(2013-8#1)
or inconsistent##2##2##(2011-1#1)(2013-1#1)
or incorporated into##2##3##(1993-3#1)(1994-3#1)
or incorporated##3##2##(1993-3#1)(1994-3#1)(2010-9#1)
or incorrect##4##2##(1991-6#1)(2008-11#1)(2009-5#1)(2012-2#1)
or incorrectly##3##2##(2007-12#2)(2007-8#1)
or increase in##3##3##(1994-12#1)(2008-5#1)(2008-8#1)
or increase the##3##3##(1996-11#1)(2008-5#1)(2010-11#1)
or increase##16##2##(1993-1#1)(1993-11#1)(1993-2#1)(1994-12#1)(1996-1#1)(1996-11#1)(1996-12#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-8#1)(2010-11#1)(2010-8#1)(2012-12#1)
or increased by##2##3##(2006-10#1)(2008-7#1)
or increased risk##2##3##(1990-11#1)(2005-7#1)
or increased##34##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1991-1#1)(1992-11#1)(1992-8#1)(1994-10#1)(1994-6#1)(1995-12#1)(1997-1#1)(1997-6#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-4#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
or increases##3##2##(1992-9#1)(2004-11#1)(2007-4#1)
or increasing the##6##3##(2005-12#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)
or increasing##13##2##(1991-12#1)(1993-12#1)(1996-11#1)(2005-12#1)(2006-10#2)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)
or incubation##3##2##(1991-8#1)(1995-3#1)(1997-6#1)
or independent of##2##3##(2006-12#1)(2007-5#1)
or independent##10##2##(1993-1#1)(1993-12#1)(1993-2#1)(1996-10#1)(2005-10#1)(2006-12#1)(2007-5#1)(2009-3#1)(2012-3#1)(2013-1#1)
or indirect##21##2##(1992-9#1)(1994-9#1)(1996-8#1)(1997-5#1)(1997-6#1)(2005-11#1)(2006-1#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#2)(2009-3#1)(2009-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
or indirectly by##5##3##(1990-3#1)(1991-12#1)(1997-4#1)(2006-10#1)(2010-5#1)
or indirectly in##2##3##(1991-9#1)(2007-5#1)
or indirectly through##3##3##(1991-6#1)(1994-5#1)(2008-3#1)
or indirectly##48##2##(1990-3#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1994-11#1)(1994-5#2)(1996-2#1)(1996-3#2)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#1)(2005-10#1)(2005-7#1)(2006-10#1)(2007-11#3)(2007-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-5#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
or individual gene##2##3##(2007-3#1)(2012-2#1)
or individual##18##2##(1990-1#1)(1993-1#1)(1997-8#1)(2005-5#1)(2007-3#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
or individually##3##2##(1991-1#1)(1995-8#1)(2012-3#1)
or individuals##4##2##(2006-7#1)(2008-2#1)(2008-9#1)(2013-1#1)
or indomethacin##2##2##(2005-11#1)(2007-11#1)
or induce apoptosis##2##3##(2008-10#1)(2009-3#1)
or induce##8##2##(1990-4#1)(1991-5#1)(1996-8#1)(2006-10#2)(2007-10#1)(2008-10#1)(2009-3#1)
or induced by##3##3##(1991-8#1)(2009-6#1)(2010-4#1)
or induced##20##2##(1990-3#1)(1990-9#1)(1991-4#1)(1991-7#3)(1991-8#1)(1992-1#1)(1996-11#1)(2005-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2012-1#1)
or inducible##3##2##(1993-9#1)(2010-2#1)(2012-12#1)
or inducing##3##2##(1996-12#1)(2007-12#1)(2008-10#1)
or induction of##5##3##(1995-3#1)(2007-11#2)(2008-4#1)(2013-1#1)
or induction##6##2##(1995-3#1)(2007-11#2)(2008-4#1)(2008-7#1)(2013-1#1)
or industrial##2##2##(1996-8#1)(2008-10#1)
or industry##2##2##(1991-6#1)(1993-11#1)
or ineffective##4##2##(1994-2#1)(2005-12#1)(2006-5#1)(2012-2#1)
or infant##4##2##(2007-12#1)(2008-11#1)(2010-1#1)(2013-1#1)
or infants##2##2##(2006-10#1)(2007-11#1)
or infarction##2##2##(1996-9#1)(2007-5#1)
or infected with##3##3##(1993-1#1)(1994-3#1)(2007-12#1)
or infected##12##2##(1992-7#1)(1993-1#1)(1994-3#1)(1994-7#1)(1996-12#1)(2005-10#1)(2005-11#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-10#2)
or infection is##2##3##(2008-4#1)(2011-2#1)
or infection of##2##3##(2008-10#1)(2013-1#1)
or infection##27##2##(1991-5#1)(1994-8#1)(1996-3#1)(1997-3#1)(2005-5#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#2)(2009-3#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)
or infections##4##2##(1995-9#1)(2007-11#2)(2008-10#1)
or infectious agents##2##3##(1997-7#1)(2012-2#1)
or infectious diseases##2##3##(2010-12#1)(2011-1#1)
or infectious##6##2##(1997-7#1)(2005-8#2)(2010-12#1)(2011-1#1)(2012-2#1)
or inferior##3##2##(2006-7#1)(2011-2#1)(2012-12#1)
or infiltrating##2##2##(1992-8#1)(1995-4#1)
or infiltration by##2##3##(1990-3#1)(2006-6#1)
or infiltration##3##2##(1990-3#1)(1992-12#1)(2006-6#1)
or inflammation##5##2##(1991-10#1)(2006-10#1)(2008-10#1)(2008-7#1)(2010-12#1)
or inflammatory bowel##2##3##(2010-2#1)(2012-12#1)
or inflammatory response##2##3##(2008-12#1)(2011-2#1)
or inflammatory##20##2##(1993-2#1)(1994-3#1)(1995-12#2)(1997-1#1)(2006-12#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2009-10#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
or influence##3##2##(1994-6#1)(1995-1#1)(2008-10#1)
or information##5##2##(2006-4#1)(2007-12#1)(2008-2#1)(2012-12#1)(2012-3#1)
or infra-red illumination##2##3##(1991-2#2)
or infusion##2##2##(1996-11#1)(2012-2#1)
or ingest##2##2##(2008-5#1)(2009-4#1)
or ingested##2##2##(1991-5#1)(2008-2#1)
or ingestion of food##3##4##(1991-5#2)(2012-12#1)
or ingestion of##4##3##(1991-5#2)(1996-8#1)(2012-12#1)
or inhalation of##4##3##(1992-8#1)(2007-12#1)(2008-10#1)(2011-2#1)
or inhalation##5##2##(1992-8#1)(2007-12#1)(2008-10#1)(2010-2#1)(2011-2#1)
or inhibit the##4##3##(1990-5#1)(2004-12#1)(2008-5#1)(2013-1#1)
or inhibit##19##2##(1990-11#1)(1990-5#1)(1992-7#1)(1994-8#1)(1995-6#2)(1997-1#1)(2004-12#1)(2006-10#1)(2008-1#1)(2008-5#1)(2008-9#1)(2009-5#1)(2009-8#2)(2011-1#1)(2012-12#2)(2013-1#1)
or inhibited by the##2##4##(1991-5#1)(1996-8#1)
or inhibited by##3##3##(1991-5#1)(1996-5#1)(1996-8#1)
or inhibited##5##2##(1991-5#1)(1996-5#1)(1996-8#1)(2012-2#2)
or inhibiting##3##2##(1990-11#1)(2009-3#1)(2013-7#1)
or inhibition of##13##3##(1990-11#1)(1991-10#1)(1991-7#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#1)(1996-12#1)(1997-4#1)(2006-3#1)(2007-11#2)(2009-5#1)
or inhibition##17##2##(1990-11#1)(1991-10#1)(1991-7#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#1)(1996-12#1)(1997-4#1)(2006-3#1)(2007-11#2)(2008-7#1)(2008-8#2)(2009-3#1)(2009-5#1)
or inhibitor##2##2##(1995-7#1)(2008-6#1)
or inhibitors##6##2##(1992-8#1)(2008-10#1)(2008-9#1)(2009-2#1)(2009-9#1)(2012-3#1)
or inhibitory effects##2##3##(2008-7#1)(2013-1#1)
or inhibitory##11##2##(1992-11#1)(1995-11#1)(1996-2#1)(1997-3#1)(1997-7#1)(2006-6#1)(2008-7#2)(2009-4#1)(2013-1#2)
or inhibits##2##2##(1996-4#1)(2008-12#1)
or inhomogeneous##3##2##(1990-9#2)(2008-3#1)
or initial##4##2##(1994-7#1)(1997-3#1)(2008-10#1)(2008-3#1)
or injected with##2##3##(1993-12#1)(2008-10#1)
or injected##4##2##(1992-11#1)(1993-12#1)(2006-5#1)(2008-10#1)
or injection of##3##3##(1990-5#1)(1991-11#1)(2008-12#1)
or injection##6##2##(1990-5#1)(1991-11#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)
or injections##3##2##(1993-12#1)(2006-10#2)
or injured##2##2##(2005-8#1)(2008-7#1)
or injuries##3##2##(2005-10#1)(2005-8#1)(2013-7#1)
or injury##12##2##(1990-10#1)(1995-7#1)(1997-2#1)(2006-8#1)(2007-12#1)(2008-1#2)(2009-2#1)(2010-5#1)(2012-1#1)(2012-12#1)(2013-8#1)
or inorganic##3##2##(1991-3#1)(2008-10#1)(2008-9#1)
or inositol 1##2##3##(1995-3#1)(1997-4#1)
or inositol##4##2##(1995-3#1)(1996-5#1)(1997-4#1)(2008-4#1)
or inpatient##2##2##(2010-2#1)(2011-1#1)
or insect##4##2##(1993-3#1)(2007-11#1)(2008-10#1)(2009-6#1)
or insertion##4##2##(1995-7#1)(1995-8#1)(2008-11#1)(2013-8#1)
or insertions##2##2##(1993-3#1)(2012-3#1)
or inside the##2##3##(1991-9#1)(1995-9#1)
or inside##3##2##(1991-9#1)(1995-9#1)(2006-6#1)
or insignificant##2##2##(1992-3#1)(2008-11#1)
or insufficient##3##2##(1990-9#1)(1997-4#1)(2008-3#1)
or insulin induced##2##3##(1990-3#1)(1990-8#1)
or insulin resistance##4##3##(1997-2#1)(1997-7#1)(2005-10#1)(2011-2#1)
or insulin##23##2##(1990-11#4)(1990-3#1)(1990-8#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-6#1)(1994-4#1)(1994-8#1)(1995-3#1)(1996-1#2)(1996-11#1)(1997-2#1)(1997-7#2)(2005-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
or insurance companies##2##3##(1993-9#1)(1994-3#1)
or insurance##4##2##(1993-9#1)(1994-3#1)(1996-2#1)(2009-9#1)
or intact##7##2##(1992-3#1)(1995-7#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)
or integrated##5##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#2)
or integration##3##2##(2006-9#1)(2008-2#1)(2008-4#1)
or intelligence##2##2##(2008-11#1)(2009-9#1)
or intense##2##2##(2006-4#1)(2013-8#1)
or intensity of##2##3##(1991-12#1)(2006-8#1)
or intensity##6##2##(1991-12#1)(1991-6#1)(2006-4#1)(2006-8#1)(2009-1#1)(2012-12#1)
or interact##2##2##(1994-9#1)(2008-1#1)
or interaction##4##2##(1991-12#1)(1993-11#1)(2008-2#1)(2009-3#1)
or interactions between##3##3##(1990-6#1)(1995-2#1)(2011-2#1)
or interactions with##2##3##(1994-9#1)(2011-2#1)
or interactions##6##2##(1990-6#1)(1994-9#1)(1995-2#1)(2008-4#1)(2011-2#2)
or interactive##3##2##(2008-9#1)(2009-4#1)(2013-8#1)
or interest##3##2##(1992-3#1)(2006-10#1)(2008-12#1)
or interesting##2##2##(1990-10#1)(2008-2#1)
or interfaces##2##2##(2008-2#1)(2010-8#1)
or interfere with##6##3##(1993-6#1)(1995-6#1)(1996-4#1)(2010-3#1)(2010-7#1)(2012-1#1)
or interference with##3##3##(2008-11#2)(2013-7#1)
or interim##2##2##(1990-1#1)(2010-3#1)
or interleukin##2##2##(1991-10#1)(2008-4#1)
or interleukin-1##3##2##(1995-3#2)(1995-7#1)
or interleukin-6##2##2##(1992-5#1)(1992-8#1)
or intermediate levels of the defense##2##6##(2008-9#2)
or intermediate##11##2##(1991-2#1)(1996-12#1)(2006-10#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-8#1)(2013-1#2)
or intermediate-risk##2##2##(2010-4#1)(2011-2#1)
or intermittent##5##2##(2006-10#1)(2007-11#1)(2008-11#1)(2008-8#1)(2012-4#1)
or intermolecular##2##2##(1990-11#1)(1996-8#1)
or internal jugular##2##3##(2006-6#1)(2008-1#1)
or internal##15##2##(1990-11#1)(1994-12#1)(1995-5#1)(1996-12#1)(1996-9#1)(1997-7#1)(2005-12#1)(2006-12#1)(2006-6#1)(2008-1#1)(2010-4#2)(2013-8#3)
or internalization##3##2##(1991-11#1)(1991-5#1)(2008-9#1)
or internalized##2##2##(1995-10#1)(2009-11#1)
or international##2##2##(2006-12#1)(2011-2#1)
or interphase##2##2##(1997-3#1)(2008-1#1)
or interpreting##2##2##(2012-12#1)(2012-3#1)
or interrupted##2##2##(1993-2#1)(2007-8#1)
or interstitial##2##2##(2005-12#1)(2012-1#1)
or intervention##4##2##(2006-6#1)(2006-7#1)(2008-3#1)(2010-12#1)
or interventional##5##2##(2006-1#1)(2006-7#1)(2008-3#1)(2008-8#1)(2011-1#1)
or interventions##2##2##(2007-10#1)(2013-1#1)
or intestinal##7##2##(1994-2#1)(1995-1#1)(2006-2#2)(2008-11#1)(2008-9#1)(2010-9#1)
or into the lateral##2##4##(1991-6#1)(1995-7#1)
or into the##6##3##(1991-6#2)(1992-1#1)(1993-6#1)(1995-7#1)(2013-8#1)
or into##13##2##(1991-6#2)(1992-1#1)(1992-12#1)(1993-6#1)(1994-9#1)(1995-7#1)(1996-4#1)(2006-2#1)(2008-1#1)(2008-3#1)(2008-4#1)(2013-8#1)
or intolerable##2##2##(2008-10#1)(2008-3#1)
or intolerance to##3##3##(2008-3#1)(2010-11#1)(2012-3#1)
or intraabdominal##2##2##(1995-12#1)(2012-2#1)
or intraarterial##3##2##(1993-4#2)(1995-4#1)
or intracardiac##2##2##(2007-11#1)(2009-3#1)
or intracellular calcium##2##3##(1991-11#1)(1994-11#1)
or intracellular##11##2##(1991-11#1)(1992-9#1)(1993-2#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-6#1)(2006-8#1)(2008-9#2)
or intracellularly##2##2##(1992-8#1)(1995-11#1)
or intracranial##3##2##(2009-7#1)(2011-2#1)(2012-1#1)
or intractable##2##2##(1996-3#1)(2008-2#1)
or intramedullary##3##2##(2007-7#1)(2007-8#1)(2013-1#1)
or intramuscular routes##2##3##(1997-4#1)(1997-6#1)
or intramuscular##5##2##(1990-2#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-6#1)
or intranasal##4##2##(2007-11#2)(2008-5#2)
or intraoperative##5##2##(1991-3#1)(2005-5#1)(2006-12#1)(2008-5#1)(2011-2#1)
or intraperitoneal##4##2##(1992-2#1)(1996-12#1)(2008-10#1)(2012-2#1)
or intraperitoneally##2##2##(1995-12#1)(1996-6#1)
or intrathecal (i##2##3##(1992-8#1)(1996-7#1)
or intrauterine growth retardation##2##4##(1990-6#1)(2008-3#1)
or intrauterine##3##2##(1990-6#1)(1990-8#1)(2008-3#1)
or intravenous##16##2##(1990-8#1)(1991-9#1)(1992-7#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-9#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-7#1)(2010-7#1)(2013-1#1)(2013-7#1)
or intravenously##4##2##(1990-8#1)(1996-6#1)(1996-8#1)(2007-11#1)
or intraventricular##2##2##(1994-10#1)(2008-7#1)
or intrinsic##5##2##(1995-12#1)(1995-6#1)(2007-2#1)(2008-11#1)(2011-2#1)
or introducing a##2##3##(2008-2#1)(2012-2#1)
or invasion##3##2##(2008-10#1)(2009-5#1)(2013-8#1)
or invasive carcinoma##2##3##(2007-6#1)(2008-5#1)
or invasive procedures##2##3##(2008-10#1)(2008-7#1)
or invasive##10##2##(1992-9#1)(2004-1#1)(2006-12#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-5#3)(2008-7#1)
or inverse##7##2##(2008-5#1)(2008-6#1)(2009-7#1)(2010-2#1)(2011-2#3)
or inversely##2##2##(2008-3#1)(2010-7#1)
or inverted##2##2##(2011-2#1)(2012-2#1)
or involuntary##2##2##(1996-6#1)(2009-12#1)
or involve##2##2##(1995-6#1)(2008-1#1)
or iodine##2##2##(2007-8#1)(2010-10#1)
or ion chromatography##2##3##(2008-10#2)
or ion##3##2##(2006-10#1)(2008-10#2)
or ionic##3##2##(1991-5#1)(2005-11#1)(2009-8#1)
or ionizing radiation##2##3##(1995-3#1)(2007-10#1)
or ionomycin##5##2##(1990-6#1)(1994-3#1)(1995-8#1)(1997-3#1)(2008-11#1)
or iontophoresis##2##2##(1997-5#1)(2006-10#1)
or iron##6##2##(1992-4#1)(1994-12#1)(1994-8#1)(2006-4#1)(2008-10#1)(2012-2#1)
or irregular##2##2##(1994-9#1)(2008-6#1)
or irrelevant##2##2##(1994-9#1)(2007-12#1)
or irreversible##6##2##(1990-5#1)(1996-3#1)(2005-8#1)(2009-10#1)(2009-6#1)(2011-2#1)
or irritability##2##2##(1996-3#1)(2005-10#1)
or irritable##2##2##(2007-7#1)(2013-1#1)
or is a##2##3##(2007-8#1)(2008-1#1)
or is even##2##3##(1996-7#1)(2008-10#1)
or is it##7##3##(1991-2#1)(1994-11#1)(1997-3#1)(2007-12#1)(2007-6#1)(2007-8#1)(2009-5#1)
or is not##3##3##(1994-3#1)(2010-5#1)(2011-12#1)
or is##43##2##(1991-2#1)(1991-5#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#1)(1994-11#1)(1994-3#2)(1995-5#1)(1996-12#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-12#1)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#2)(2010-5#2)(2010-8#1)(2011-12#1)(2011-2#1)
or ischaemia##2##2##(1997-1#1)(2008-3#1)
or ischemic brain##3##3##(1991-9#1)(2007-9#1)(2008-4#1)
or ischemic stroke##2##3##(2008-8#2)
or ischemic##14##2##(1991-9#1)(1994-11#1)(1995-12#2)(1997-3#1)(2007-8#1)(2007-9#1)(2008-4#1)(2008-7#2)(2008-8#2)(2010-4#1)(2010-8#1)
or isolate##2##2##(2008-10#2)
or isolated from##2##3##(1994-5#1)(2012-2#1)
or isolated##12##2##(1994-5#1)(2006-10#1)(2006-9#1)(2007-7#1)(2008-4#1)(2008-9#2)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
or isolates##2##2##(2008-10#1)(2008-9#1)
or isolation##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
or isometric##2##2##(2007-11#1)(2012-1#1)
or isozyme##2##2##(2008-10#1)(2012-2#1)
or it can be##3##4##(2006-5#1)(2008-10#1)(2008-7#1)
or it can##5##3##(1994-3#1)(2006-5#1)(2007-9#1)(2008-10#1)(2008-7#1)
or it could##2##3##(1994-2#1)(1996-7#1)
or it is##3##3##(2007-3#1)(2008-7#1)(2011-12#1)
or it may be##2##4##(2007-1#1)(2008-3#1)
or it may##3##3##(2007-1#1)(2008-3#1)(2010-6#1)
or it##19##2##(1992-3#1)(1994-2#1)(1994-3#1)(1996-7#1)(2006-5#1)(2007-1#1)(2007-3#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#2)(2009-10#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-12#1)
or itraconazole##4##2##(2006-8#1)(2007-12#1)(2008-5#2)
or its activity is##2##4##(1997-4#1)(2008-11#1)
or its analog##2##3##(1996-5#1)(1997-2#1)
or its antibody##2##3##(1991-9#2)
or its combination with##2##4##(2012-2#1)(2012-7#1)
or its derivative##2##3##(1997-6#1)(2008-5#1)
or its derivatives##4##3##(1990-10#1)(1990-6#1)(1995-8#1)(2008-5#1)
or its equivalent##3##3##(1991-3#1)(1991-4#1)(2008-2#1)
or its length##2##3##(2008-3#1)(2008-7#1)
or its major##2##3##(1992-1#1)(2007-10#1)
or its metabolite##3##3##(1995-3#1)(2008-10#1)(2012-12#1)
or its metabolites##3##3##(1993-6#1)(2005-1#1)(2005-11#1)
or its primary##2##3##(1996-10#1)(2013-8#1)
or its receptors##2##3##(1990-7#1)(2010-10#1)
or its synthetic##2##3##(1995-9#1)(1997-7#1)
or its##124##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-9#2)(1992-1#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#2)(1996-2#1)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#3)(2005-1#1)(2005-11#1)(2005-3#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-11#3)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-10#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-7#1)(2013-1#1)(2013-7#1)(2013-8#4)
or jaw##2##2##(2010-3#1)(2010-6#1)
or joining##2##2##(1995-9#1)(2007-4#1)
or joint##4##2##(2006-10#1)(2006-11#1)(2006-12#1)(2008-9#1)
or just another##2##3##(1996-12#1)(2006-4#1)
or just##11##2##(1993-3#1)(1996-12#1)(2006-1#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-8#1)(2008-4#1)(2009-10#1)(2011-1#1)
or juvenile##2##2##(2008-10#1)(2012-2#1)
or kainic acid (50 ng/0##2##5##(1995-12#2)
or kainic acid##3##3##(1995-12#3)
or kappa opioid receptors##2##4##(2007-11#2)
or kidney involvement##2##3##(2006-10#1)(2009-5#1)
or kidney transplant##2##3##(2007-11#1)(2011-2#1)
or kidney##17##2##(1991-12#1)(1991-5#1)(1992-4#1)(1992-7#3)(1995-10#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-5#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
or kill##2##2##(1995-2#1)(2008-6#1)
or killed##2##2##(2008-11#1)(2008-4#1)
or kinase##3##2##(1996-5#1)(1997-6#1)(2011-2#1)
or kinetic##7##2##(1995-8#1)(1997-2#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)
or knee##9##2##(1990-6#1)(1993-11#1)(2006-8#1)(2009-3#1)(2010-9#2)(2011-2#1)(2013-1#2)
or knowledge##4##2##(1994-12#1)(1994-4#1)(2008-9#1)(2012-2#1)
or known##10##2##(1990-4#1)(1994-9#1)(1996-6#1)(1997-3#1)(2006-10#2)(2006-12#1)(2008-3#1)(2008-9#1)(2010-7#1)
or labeled##2##2##(1995-1#1)(2008-1#1)
or laboratory evidence of##2##4##(1992-2#1)(2007-12#1)
or laboratory findings##2##3##(2009-4#1)(2011-2#1)
or laboratory tests##2##3##(1994-6#1)(2008-5#1)
or laboratory##23##2##(1992-2#1)(1992-8#1)(1994-12#2)(1994-6#1)(1995-9#3)(1996-2#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-5#1)(2008-9#1)(2009-4#1)(2011-2#2)(2012-2#1)(2013-8#1)
or lack of##22##3##(1991-8#1)(1993-3#1)(1993-8#1)(1995-10#1)(1996-9#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2009-12#1)(2009-5#1)(2011-1#1)(2011-12#1)(2012-12#1)
or lack thereof##3##3##(1995-6#1)(2012-2#1)(2012-3#1)
or lack##27##2##(1991-3#1)(1991-8#1)(1993-3#1)(1993-6#1)(1993-8#1)(1995-10#1)(1995-6#1)(1996-9#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2009-12#1)(2009-5#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
or lacked##2##2##(1995-11#1)(2008-1#1)
or lacking##4##2##(1994-3#1)(1996-11#1)(2007-8#1)(2012-2#1)
or lacrimal##2##2##(2011-1#2)
or lactate##3##2##(1991-8#1)(1996-2#1)(2008-7#1)
or lameness##2##2##(1997-3#1)(2005-7#1)
or lamotrigine##2##2##(2008-8#1)(2010-12#1)
or language##4##2##(1997-7#1)(2006-12#1)(2007-10#1)(2013-1#1)
or laparoscopic##4##2##(1993-3#1)(2009-12#1)(2011-2#2)
or large##23##2##(1990-2#1)(1991-2#2)(1992-11#1)(1993-6#1)(1994-11#1)(1995-10#1)(2005-10#1)(2005-11#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-9#1)(2011-2#1)(2012-3#1)
or larger by##2##3##(1991-2#1)(1996-1#1)
or larger oligosaccharides having##2##4##(1994-5#2)
or larger than a##2##4##(1995-9#1)(2005-11#1)
or larger than the##2##4##(2007-11#1)(2007-12#1)
or larger than##7##3##(1995-9#1)(2005-11#1)(2007-11#1)(2007-12#3)(2008-8#1)
or larger##26##2##(1991-2#1)(1992-5#2)(1993-1#1)(1993-9#1)(1994-5#2)(1995-9#1)(1996-1#1)(1996-6#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-10#1)(2010-8#1)
or larval##2##2##(1995-8#1)(2008-8#1)
or laryngeal##2##2##(2007-8#1)(2008-2#1)
or laser##12##2##(1992-3#2)(1993-2#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2013-1#1)
or laser-scanning##2##2##(2008-4#2)
or last##3##2##(1993-11#1)(2007-7#1)(2008-2#1)
or late complications such as##2##5##(1991-4#1)(2011-3#1)
or late##19##2##(1990-10#1)(1991-4#1)(1993-9#1)(1995-9#1)(1996-3#2)(2006-10#1)(2006-5#1)(2007-7#1)(2008-12#1)(2008-8#1)(2009-11#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-1#2)(2013-1#1)(2013-8#1)
or latent##3##2##(1990-6#1)(2006-10#1)(2008-12#1)
or later on##2##3##(2008-9#1)(2012-12#1)
or later##10##2##(1990-12#1)(1990-2#1)(1990-5#1)(1993-5#1)(1995-11#1)(2008-9#1)(2010-6#1)(2010-9#1)(2012-12#1)(2013-1#1)
or lateral position##2##3##(1992-4#1)(2013-7#1)
or lateral##16##2##(1990-3#1)(1991-2#1)(1991-4#1)(1992-4#1)(2005-5#3)(2006-5#1)(2007-12#1)(2007-5#1)(2008-3#1)(2008-7#1)(2009-8#1)(2013-1#2)(2013-7#1)
or lead cation##2##3##(2008-10#2)
or lead to##2##3##(1994-5#1)(2008-9#1)
or lead##8##2##(1994-5#1)(2008-10#3)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
or leaf##10##2##(2008-10#6)(2008-12#1)(2012-1#1)(2012-2#1)(2012-9#1)
or leaking##2##2##(1991-5#1)(1993-2#1)
or learning##2##2##(1997-3#1)(2006-8#1)
or leave##3##2##(1996-3#1)(2008-10#1)(2008-4#1)
or leave-one-out##2##2##(1994-5#1)(2010-8#1)
or leaves##4##2##(2008-10#3)(2008-9#1)
or leaving##2##2##(1997-7#1)(2011-2#1)
or lectin##2##2##(2005-7#1)(2008-4#1)
or left main##2##3##(2007-8#1)(2008-11#1)
or left untreated##3##3##(2008-10#1)(2010-12#1)(2010-4#1)
or left ventricular##3##3##(1992-5#1)(1995-6#1)(2013-8#1)
or left##24##2##(1991-3#1)(1992-5#1)(1995-11#2)(1995-6#1)(1996-6#1)(2004-9#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2013-8#1)
or leg##3##2##(1990-12#1)(2007-10#1)(2011-1#1)
or legal aspects##2##3##(2008-12#1)(2011-2#1)
or legal##6##2##(2007-12#1)(2008-12#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-7#1)
or legislation##2##2##(1996-8#1)(2008-7#1)
or length of hospital stay##2##5##(2007-8#1)(2008-3#1)
or length of##5##3##(1991-12#1)(1996-2#1)(2006-7#1)(2007-8#1)(2008-3#1)
or length##7##2##(1991-12#1)(1993-7#1)(1996-2#1)(2006-7#1)(2007-8#1)(2008-3#1)(2008-5#1)
or lengthening of##2##3##(2006-3#1)(2007-11#1)
or lengthening##3##2##(1997-4#1)(2006-3#1)(2007-11#1)
or lenses##2##2##(2008-3#2)
or lesion size##2##3##(2008-10#1)(2008-2#1)
or lesion##4##2##(1997-8#1)(2008-10#1)(2008-2#1)(2012-3#1)
or lesions##2##2##(2008-10#1)(2008-5#1)
or less active##2##3##(1995-12#1)(1997-2#1)
or less and##2##3##(1996-1#1)(2007-1#1)
or less at birth##2##4##(1991-6#1)(2012-12#1)
or less at##3##3##(1991-6#1)(2008-10#1)(2012-12#1)
or less did not##3##4##(1997-3#1)(2006-2#1)(2010-4#1)
or less efficient##2##3##(1995-5#1)(2008-11#1)
or less frequently##2##3##(2008-10#1)(2009-3#1)
or less from the##2##4##(2004-9#1)(2007-10#1)
or less in the##4##4##(2006-11#2)(2006-2#1)(2008-10#1)
or less in##11##3##(1990-8#1)(1995-8#1)(2006-11#2)(2006-2#1)(2006-9#1)(2008-10#2)(2008-5#1)(2008-9#2)
or less is##3##3##(1993-12#2)(2007-10#1)
or less of the##3##4##(1996-8#1)(2007-8#1)(2008-10#1)
or less of##4##3##(1996-8#1)(2007-8#1)(2008-10#1)(2008-5#1)
or less per##2##3##(2010-8#1)(2012-11#1)
or less severe##3##3##(2008-10#1)(2008-12#1)(2011-1#1)
or less specific##2##3##(1991-2#1)(2012-2#1)
or less successful##2##3##(1993-2#1)(2012-12#1)
or less than that used for prostratin##2##7##(1992-5#2)
or less than that##3##4##(1992-5#2)(1993-6#1)
or less than the##2##4##(2008-2#2)
or less than##18##3##(1992-5#2)(1993-6#1)(1995-1#1)(2006-11#1)(2007-2#1)(2008-10#1)(2008-2#2)(2008-5#2)(2008-6#2)(2009-2#1)(2011-2#2)(2013-8#2)
or less were##3##3##(1990-8#1)(2006-2#1)(2008-10#1)
or less##191##2##(1990-12#2)(1990-2#1)(1990-5#4)(1990-8#2)(1991-12#1)(1991-2#2)(1991-4#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-6#1)(1996-8#2)(1997-2#2)(1997-3#2)(1997-7#1)(1997-8#1)(2004-11#1)(2004-4#1)(2004-9#1)(2005-10#3)(2005-11#1)(2006-10#2)(2006-11#3)(2006-12#3)(2006-2#4)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#3)(2007-12#6)(2007-2#2)(2007-6#1)(2007-8#3)(2007-9#2)(2008-10#21)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#1)(2008-5#6)(2008-6#3)(2008-8#3)(2008-9#8)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-11#1)(2011-2#7)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#5)
or less) in##2##3##(2005-8#1)(2011-12#1)
or less)##10##2##(1991-8#1)(1996-11#1)(2005-8#1)(2006-7#1)(2008-10#1)(2008-2#1)(2008-7#2)(2011-12#1)(2013-8#1)
or lethality##2##2##(1996-12#1)(2009-10#1)
or leucine##3##2##(1992-3#1)(1993-6#1)(1996-6#1)
or level of##3##3##(2005-10#1)(2008-10#1)(2010-6#1)
or levels of##4##3##(1993-12#1)(2006-11#1)(2007-5#1)(2010-3#1)
or levobupivacaine 0##3##3##(2012-12#1)(2013-7#2)
or lidocaine##2##2##(1996-10#1)(2006-12#1)
or life##2##2##(2006-7#1)(2007-3#1)
or life-threatening##3##2##(1996-9#1)(2010-8#1)(2010-9#1)
or lifestyle##2##2##(2009-11#1)(2010-12#1)
or ligand##2##2##(1995-3#1)(2008-4#1)
or ligands##4##2##(1995-11#1)(2007-6#1)(2008-4#2)
or ligation##3##2##(2007-9#1)(2008-11#1)(2009-7#1)
or light##9##2##(1990-12#1)(1993-5#1)(1995-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#2)(2009-10#1)
or lightly##4##2##(1992-7#3)(2008-5#1)
or limb##3##2##(1993-2#1)(2008-8#1)(2009-9#1)
or limit the##3##3##(1997-3#1)(2006-10#1)(2011-2#1)
or limit their##2##3##(1991-12#1)(2008-9#1)
or limit##9##2##(1991-12#1)(1997-3#1)(2005-1#1)(2006-10#2)(2006-9#1)(2008-9#1)(2009-1#1)(2011-2#1)
or limitations##3##2##(1995-1#1)(2008-12#1)(2013-8#1)
or limited##7##2##(1997-2#1)(2004-3#1)(2005-9#1)(2008-10#3)(2008-4#1)
or limiting##3##2##(2005-7#1)(2007-2#1)(2009-11#1)
or linear##6##2##(1991-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-12#1)
or linked to a##2##4##(1997-3#1)(2008-8#1)
or linked to##3##3##(1992-7#1)(1997-3#1)(2008-8#1)
or linked##7##2##(1991-2#1)(1992-7#1)(1997-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)
or linseed oils##2##3##(2008-7#2)
or lip##2##2##(1991-6#1)(2012-3#1)
or lipid metabolism##2##3##(2008-7#1)(2010-5#1)
or lipid##9##2##(1991-11#1)(1992-11#1)(1992-3#1)(1992-9#1)(1995-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-5#1)
or lipids##3##2##(1990-6#1)(1994-11#1)(2009-12#1)
or lipopolysaccharide (LPS)##3##3##(1990-3#1)(2007-11#1)(2008-10#1)
or lipopolysaccharide##5##2##(1990-3#1)(1993-8#1)(2007-11#1)(2008-10#1)(2013-1#1)
or lipoprotein##4##2##(1990-8#2)(1995-6#1)(1997-4#1)
or lipoprotein(a)##2##2##(1997-2#1)(2008-3#1)
or liposomal##2##2##(2005-8#1)(2007-11#1)
or liquid media##5##3##(1991-11#1)(2008-10#3)(2011-12#1)
or liquid##12##2##(1990-8#1)(1991-11#1)(1992-3#2)(2008-10#6)(2008-7#1)(2011-12#1)
or liquor##2##2##(2005-10#1)(2013-1#1)
or litter##3##2##(1994-6#2)(1994-8#1)
or little##6##2##(1994-8#1)(1995-11#1)(2008-10#2)(2008-11#1)(2012-3#1)
or live##5##2##(1995-5#1)(2006-8#1)(2007-9#1)(2008-4#1)(2013-7#1)
or lived##2##2##(1994-6#1)(1997-4#1)
or liver disease##2##3##(1997-2#1)(2011-2#1)
or liver transplantation##3##3##(2004-11#1)(2007-11#1)(2010-12#1)
or liver##23##2##(1990-11#1)(1990-2#2)(1990-4#1)(1991-4#1)(1992-11#1)(1992-5#1)(1993-12#1)(1994-3#1)(1996-12#1)(1996-2#1)(1997-2#1)(2004-11#1)(2007-11#2)(2008-1#1)(2008-4#1)(2008-8#1)(2010-12#2)(2010-9#1)(2011-2#1)(2013-1#1)
or living in##2##3##(2008-5#2)
or living tissue##2##3##(2008-2#1)(2010-3#1)
or living##7##2##(1991-12#1)(2005-8#1)(2007-11#1)(2008-2#1)(2008-5#2)(2010-3#1)
or loaded##2##2##(2006-12#1)(2010-9#1)
or local anesthesia##2##3##(1991-11#1)(1996-12#1)
or local application of##2##4##(1995-7#1)(1996-3#1)
or local##29##2##(1990-9#1)(1991-11#1)(1993-2#1)(1993-3#1)(1995-2#1)(1995-7#1)(1996-1#1)(1996-12#2)(1996-3#1)(2004-4#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2009-5#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-9#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
or localization##2##2##(2007-12#1)(2009-6#1)
or localized##3##2##(1993-10#1)(2008-10#1)(2008-7#1)
or locally##5##2##(1992-9#1)(1996-3#1)(2004-4#1)(2008-6#2)
or location of##2##3##(2007-3#1)(2008-10#1)
or location##4##2##(1992-10#1)(2007-3#1)(2008-10#1)(2011-2#1)
or locations##3##2##(2008-10#3)
or locoregional##2##2##(1993-11#1)(2006-6#1)
or log##2##2##(1996-5#1)(2008-7#1)
or long term##5##3##(1992-3#1)(1997-4#1)(2007-4#1)(2007-7#1)(2008-5#1)
or long##12##2##(1992-3#1)(1997-4#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-2#1)(2009-3#1)(2009-5#1)(2013-7#1)
or long-term##13##2##(1991-9#1)(1992-3#1)(1992-9#1)(1993-10#1)(1994-4#1)(1996-3#1)(2005-10#1)(2006-8#1)(2007-10#1)(2007-8#1)(2011-2#1)(2012-5#1)(2013-1#1)
or longer at##2##3##(2008-5#1)(2009-12#1)
or longer than##2##3##(1997-6#1)(2008-10#1)
or longer##26##2##(1990-5#1)(1991-3#1)(1991-5#1)(1992-1#1)(1993-8#1)(1994-8#1)(1996-6#1)(1996-9#1)(1997-6#1)(2004-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-2#1)(2011-12#1)(2011-2#1)
or longitudinal##2##2##(2008-2#1)(2010-3#1)
or loops##2##2##(2006-8#1)(2012-2#1)
or lose##3##2##(2006-4#1)(2006-5#1)(2007-10#1)
or loss of##16##3##(1990-3#1)(1990-5#1)(1991-12#1)(1994-12#2)(1995-11#1)(1997-2#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-12#1)(2013-8#1)
or loss##22##2##(1990-3#1)(1990-5#1)(1991-12#1)(1993-2#1)(1994-12#2)(1995-11#1)(1996-12#1)(1997-2#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-11#1)(2010-12#1)(2011-1#1)(2013-8#1)
or losses##6##2##(2008-10#4)(2009-8#1)(2010-3#1)
or lost##5##2##(1994-11#1)(2008-1#2)(2011-3#1)(2012-1#1)
or lover##2##2##(2005-8#1)(2008-1#1)
or low doses##3##3##(2008-7#2)(2008-8#1)
or low levels of##4##4##(1996-12#1)(2004-2#1)(2007-6#1)(2010-2#1)
or low molecular weight##2##4##(1990-7#1)(2008-1#1)
or low standards are##2##4##(2004-12#2)
or low##63##2##(1990-10#1)(1990-5#1)(1990-7#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-12#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-7#1)(1996-12#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-12#2)(2004-2#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-4#1)(2007-6#2)(2007-7#3)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#5)(2008-9#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-8#1)(2012-2#3)(2012-7#1)
or low-birth-weight##2##2##(2013-1#2)
or low-density##2##2##(1992-9#1)(2008-6#1)
or low-grade##2##2##(1997-7#1)(2010-7#1)
or low-pH buffer##2##3##(2008-4#2)
or lower extremities##2##3##(1997-4#1)(2008-9#1)
or lower in##2##3##(1996-7#1)(2008-10#1)
or lower limb##2##3##(2012-2#1)(2013-8#1)
or lower than##9##3##(1995-12#1)(1997-8#1)(2007-8#2)(2008-10#2)(2008-7#1)(2011-2#1)(2012-2#1)
or lower##47##2##(1992-8#1)(1994-8#2)(1995-12#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-8#2)(2005-11#1)(2007-10#1)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#13)(2008-12#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-7#1)(2010-5#1)(2011-2#2)(2012-11#1)(2012-2#3)(2013-8#1)
or lowered##3##2##(2007-9#1)(2008-5#1)(2008-7#1)
or lowering##2##2##(2006-8#1)(2008-11#1)
or lumbar spine##3##3##(2006-8#1)(2007-7#1)(2011-12#1)
or lumbar##6##2##(1997-4#1)(2006-8#1)(2007-7#2)(2008-7#1)(2011-12#1)
or luminescent substrates##3##3##(2008-2#1)(2008-4#2)
or lung##9##2##(1991-2#1)(1992-9#1)(2008-8#1)(2010-12#1)(2012-1#3)(2012-12#2)
or lymph node##6##3##(1992-7#1)(1992-8#1)(1996-3#1)(2005-11#1)(2011-2#1)(2013-1#1)
or lymph nodes##3##3##(1992-8#1)(2006-10#2)
or lymph##11##2##(1992-7#1)(1992-8#2)(1996-3#1)(2005-11#1)(2006-10#2)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
or lymphatic##2##2##(2008-5#1)(2013-1#1)
or lymphoma##3##2##(1990-9#1)(2006-11#1)(2009-1#1)
or lyophilized##2##2##(1994-6#1)(2008-10#1)
or lysine at##2##3##(1990-7#1)(1994-3#1)
or lysine##3##2##(1990-7#1)(1991-1#1)(1994-3#1)
or lytic##2##2##(1994-6#1)(2008-11#1)
or mRNA##6##2##(1993-6#1)(1994-3#1)(1997-4#1)(2008-11#1)(2008-9#1)(2009-9#1)
or macular##3##2##(2011-1#1)(2013-1#2)
or magnesium##4##2##(1990-7#1)(1993-8#1)(2008-10#1)(2008-5#1)
or magnetic resonance imaging##11##4##(1990-5#1)(1994-7#1)(1996-5#1)(1997-8#1)(2007-4#1)(2008-1#1)(2009-6#1)(2010-12#1)(2010-7#1)(2013-1#2)
or magnetic resonance##15##3##(1990-5#1)(1994-7#1)(1996-5#1)(1997-8#1)(2006-6#1)(2007-4#1)(2007-9#1)(2008-1#1)(2009-6#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
or magnetic##19##2##(1990-5#1)(1992-11#1)(1994-7#1)(1996-5#1)(1997-8#1)(2006-12#1)(2006-6#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
or magneto-optic##2##2##(2007-12#1)(2008-2#1)
or main##3##2##(1992-12#1)(2008-5#1)(2012-3#1)
or maintain a##3##3##(2007-7#1)(2008-10#1)(2010-11#1)
or maintain##6##2##(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2010-11#1)(2010-2#1)
or maintained##4##2##(2007-11#1)(2007-4#1)(2008-10#1)(2008-8#1)
or maintaining the##2##3##(1990-5#1)(2008-12#1)
or maintaining##5##2##(1990-5#1)(2006-10#1)(2007-12#1)(2008-12#1)(2008-7#1)
or maintenance of##6##3##(1997-2#1)(2005-8#1)(2006-10#1)(2010-12#1)(2011-1#1)(2011-2#1)
or maintenance##9##2##(1997-2#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-12#1)(2010-12#1)(2011-1#1)(2011-2#1)
or major depression##2##3##(1995-5#1)(2007-10#1)
or major##18##2##(1990-6#1)(1991-2#1)(1993-11#1)(1994-6#1)(1995-5#1)(1996-1#1)(1997-5#1)(2006-12#1)(2007-10#1)(2008-1#2)(2008-11#1)(2009-10#1)(2009-4#1)(2009-5#2)(2011-2#1)(2012-2#1)
or make##3##2##(1995-3#1)(2010-8#1)(2013-8#1)
or maladaptive##3##2##(2009-11#1)(2012-12#2)
or malaria##3##2##(2007-1#1)(2008-2#2)
or malate##3##2##(1993-12#1)(2008-10#2)
or male##3##2##(1991-9#1)(1992-11#1)(2013-1#1)
or malformation##2##2##(2008-4#1)(2008-7#1)
or malignancies##4##2##(2005-7#1)(2006-6#1)(2007-11#2)
or malignancy##6##2##(2006-10#1)(2006-8#1)(2007-12#1)(2010-2#1)(2010-3#1)(2011-2#1)
or malignant##18##2##(1990-2#1)(1990-4#1)(1991-2#1)(1992-9#1)(1993-6#1)(1996-3#1)(2006-10#2)(2007-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-5#1)(2010-2#1)(2012-1#1)
or malnutrition##2##2##(2008-3#1)(2008-7#1)
or maltose##2##2##(1993-12#1)(1996-12#1)
or mammalian##4##2##(1991-1#2)(1996-9#1)(2008-1#1)
or manage##4##2##(2005-8#1)(2008-11#1)(2008-2#1)(2010-9#1)
or managed##3##2##(2008-7#2)(2013-1#1)
or management or that demonstrate new and important knowledge in the area of colposcopy or pathology##6##16##(2006-10#6)
or management##13##2##(1994-2#1)(1997-2#1)(2006-10#9)(2007-12#1)(2008-12#1)
or manganese##3##2##(1995-3#1)(2008-10#2)
or manual##3##2##(2008-11#1)(2008-6#1)(2010-5#1)
or many##3##2##(2008-9#2)(2012-12#1)
or marginal excision and##2##4##(2008-6#2)
or marginal##5##2##(1995-9#1)(2008-6#4)
or marital status##2##3##(2006-4#1)(2007-2#1)
or marked##2##2##(1990-12#1)(2010-7#1)
or markedly decreased##2##3##(1991-2#1)(1994-3#1)
or markedly##6##2##(1991-2#1)(1992-6#1)(1993-12#1)(1994-3#1)(1996-7#1)(2007-11#1)
or mass##8##2##(1990-12#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-7#1)(2011-1#1)
or mastectomy##3##2##(1990-12#1)(1991-4#1)(2005-12#1)
or matched##5##2##(1990-12#1)(1992-6#1)(2007-11#1)(2007-12#1)(2010-3#1)
or material##2##2##(2008-3#1)(2011-2#1)
or materials##3##2##(2008-4#1)(2010-4#1)(2012-2#1)
or maternal##5##2##(1992-2#1)(1993-4#1)(2004-10#1)(2010-3#1)(2010-6#1)
or matrix##2##2##(2007-12#1)(2008-7#1)
or maturation##2##2##(2008-5#1)(2008-9#1)
or mature##7##2##(1990-7#1)(1992-8#1)(1994-12#1)(2006-5#2)(2008-1#1)(2008-10#1)
or maxillofacial##2##2##(2004-9#1)(2007-3#1)
or maximum##3##2##(1992-6#1)(2008-11#1)(2008-7#1)
or may act##2##3##(1996-9#1)(1997-2#1)
or may be a##2##4##(1991-12#1)(2006-10#1)
or may be associated with##2##5##(2006-8#1)(2007-3#1)
or may be the##2##4##(2006-11#1)(2007-7#1)
or may be##16##3##(1991-12#1)(2005-11#1)(2006-10#3)(2006-11#1)(2006-8#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2012-2#1)
or may develop##2##3##(1992-3#1)(2011-2#1)
or may not##29##3##(1990-12#1)(1992-12#1)(1993-9#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-5#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-4#1)(2007-8#1)(2008-7#2)(2008-8#2)(2009-8#2)(2010-1#1)(2010-10#1)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
or may result in##2##4##(1996-4#1)(2008-6#1)
or may##67##2##(1990-12#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-9#1)(1994-2#3)(1994-3#1)(1995-1#1)(1995-5#1)(1996-4#1)(1996-5#1)(1996-9#2)(1997-2#1)(1997-3#1)(2005-11#2)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#2)(2008-10#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
or meal##2##2##(2006-5#2)
or mean arterial##2##3##(2010-7#1)(2013-1#1)
or mean##10##2##(1990-9#1)(1997-2#1)(2007-6#1)(2008-1#2)(2008-8#1)(2008-9#2)(2010-7#1)(2013-1#1)
or measurement of##3##3##(1992-2#1)(2007-8#1)(2008-10#1)
or measurement##4##2##(1992-2#1)(1994-6#1)(2007-8#1)(2008-10#1)
or measurements##2##2##(1992-3#1)(2007-11#1)
or mechanical##15##2##(2005-11#2)(2007-9#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-12#1)(2013-1#1)(2013-8#1)
or mechanically##2##2##(2007-11#1)(2008-10#1)
or mechanism of##2##3##(2010-11#1)(2011-1#1)
or mechanism##4##2##(1997-2#1)(2008-8#1)(2010-11#1)(2011-1#1)
or mechanisms##2##2##(2006-10#1)(2007-4#1)
or media##4##2##(1992-5#1)(1995-12#1)(2008-11#1)(2009-7#1)
or medial##6##2##(1992-9#1)(1993-11#1)(1996-12#1)(1997-2#1)(2007-9#1)(2011-2#1)
or median##6##2##(1992-2#2)(1995-12#1)(1997-6#1)(2006-9#1)(2007-7#1)
or mediastinal##2##2##(2009-4#1)(2010-3#1)
or medical condition##2##3##(1996-8#1)(2009-9#1)
or medical therapy##2##3##(1990-10#1)(2006-1#1)
or medical treatment##2##3##(2008-12#1)(2011-2#1)
or medical##25##2##(1990-10#1)(1990-12#1)(1994-12#1)(1994-3#1)(1996-8#1)(1997-6#2)(1997-8#1)(2006-1#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-5#1)(2009-3#1)(2009-4#1)(2009-9#2)(2011-2#5)(2012-1#1)(2012-3#1)(2013-1#1)
or medications##3##2##(2006-10#2)(2010-11#1)
or medium##10##2##(1992-11#1)(1992-6#1)(1994-11#1)(1996-9#1)(2004-2#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-8#1)
or melon##2##2##(2008-10#2)
or membrane##5##2##(1991-10#1)(1992-3#1)(1993-11#1)(2006-5#1)(2008-5#1)
or membrane-associated##3##2##(1990-4#1)(1992-12#1)(1997-4#1)
or membranes##2##2##(1996-4#1)(2008-10#1)
or memory of##2##3##(2007-12#1)(2008-4#1)
or men##2##2##(1993-11#1)(2012-12#1)
or meningitis##2##2##(2005-7#1)(2008-10#1)
or mental##2##2##(1997-6#1)(2008-8#1)
or mercapto##2##2##(1997-1#1)(2008-10#1)
or merely##3##2##(1993-3#1)(1994-12#1)(1995-1#1)
or merge##3##2##(1996-1#1)(2007-12#1)(2008-4#1)
or mesh##3##2##(2006-8#1)(2008-9#2)
or metabolic syndrome##5##3##(2008-7#1)(2009-11#3)(2013-1#1)
or metabolic##14##2##(1990-8#1)(1994-3#1)(1996-11#1)(1997-4#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#3)(2009-3#1)(2012-12#1)(2013-1#2)
or metabolism##2##2##(1992-11#1)(1993-12#1)
or metabolite##2##2##(2008-11#1)(2013-1#1)
or metabolites##4##2##(2007-8#1)(2008-8#1)(2010-11#1)(2011-12#1)
or metal##5##2##(1992-3#1)(1997-4#1)(2008-10#1)(2008-9#1)(2010-4#1)
or metastases##2##2##(1990-9#1)(1993-2#1)
or metastasis of##2##3##(2008-6#1)(2008-7#1)
or metastasis##6##2##(1992-6#1)(1993-11#1)(2006-10#1)(2008-6#1)(2008-7#1)(2011-2#1)
or metastatic disease##6##3##(2007-11#1)(2007-7#1)(2008-6#4)
or metastatic soft tissue sarcomas##2##5##(2008-6#2)
or metastatic tumors##3##3##(1994-2#1)(2006-6#1)(2013-7#1)
or metastatic##33##2##(1991-10#1)(1993-8#2)(1994-2#1)(2006-6#2)(2006-7#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-6#13)(2009-9#2)(2010-12#2)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
or metham sodium##2##3##(2008-10#2)
or methanol##7##2##(1996-7#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)
or methionine##5##2##(1991-9#1)(2006-12#1)(2008-10#1)(2008-11#2)
or method##3##2##(2007-11#1)(2008-10#1)(2013-7#1)
or methods##2##2##(2008-2#1)(2011-1#1)
or methyl##8##2##(1991-1#1)(1995-3#1)(1996-10#1)(1996-4#1)(1997-3#1)(2005-11#1)(2008-10#2)
or methylamine##2##2##(1995-9#2)
or methylated##2##2##(1992-9#1)(1996-2#1)
or methylation-specific##2##2##(1996-5#1)(2008-7#1)
or methylene##3##2##(1993-8#2)(2008-10#1)
or metronidazole##2##2##(1996-6#1)(2006-8#1)
or mianserin##2##2##(1991-5#2)
or mice##3##2##(1994-5#1)(1996-4#1)(2008-4#1)
or micelle##2##2##(2005-11#1)(2008-10#1)
or micelles##3##2##(1994-3#1)(1994-5#1)(2007-8#1)
or microarray##2##2##(2008-4#1)(2009-12#1)
or microbial##3##2##(1994-3#1)(2008-4#1)(2011-2#1)
or microfibrillar collagen##2##3##(2009-3#2)
or microinjection##2##2##(1993-12#1)(2008-11#1)
or microporous polysaccharide hemospheres##2##4##(2009-3#2)
or microsatellite DNA##2##3##(1995-2#1)(2008-5#1)
or microscopic##4##2##(1991-12#1)(2007-8#1)(2008-10#1)(2011-2#1)
or mid##2##2##(2012-12#1)(2013-1#1)
or midazolam##2##2##(2006-10#1)(2013-8#1)
or might be##3##3##(1996-2#1)(2007-12#1)(2007-6#1)
or might##6##2##(1990-6#1)(1994-6#1)(1996-2#1)(2007-12#1)(2007-6#1)(2011-2#1)
or migration of the##2##4##(2006-8#1)(2008-11#1)
or migration##6##2##(2006-8#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-4#1)
or mild hypothermia##2##3##(1995-11#1)(2011-2#1)
or mild##13##2##(1993-8#1)(1995-11#1)(1996-5#1)(1997-8#1)(2006-10#1)(2007-2#1)(2008-3#1)(2008-5#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
or mildly##2##2##(2008-8#1)(2013-1#1)
or milk##7##2##(1992-2#1)(1994-5#1)(2007-5#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#1)
or mimic##2##2##(2007-6#1)(2008-10#1)
or mineral##2##2##(2005-10#1)(2008-10#1)
or minimal##11##2##(1993-5#1)(1995-6#1)(2004-2#1)(2005-1#1)(2008-10#2)(2008-2#1)(2008-9#1)(2009-9#1)(2010-1#1)(2013-1#1)
or minimally invasive##5##3##(2007-12#1)(2007-5#1)(2009-11#1)(2010-9#1)(2012-2#1)
or minimally##7##2##(2006-2#1)(2007-11#1)(2007-12#1)(2007-5#1)(2009-11#1)(2010-9#1)(2012-2#1)
or minimise##2##2##(1991-2#1)(2007-11#1)
or minimize##7##2##(1994-12#1)(2008-10#1)(2008-4#2)(2010-2#1)(2011-2#1)(2012-3#1)
or minimized##3##2##(2005-8#1)(2007-8#1)(2008-2#1)
or minimizing##2##2##(1993-1#1)(2009-4#1)
or minimum##4##2##(2006-10#1)(2008-3#1)(2008-7#1)(2009-9#1)
or minor stroke##4##3##(1991-11#1)(2008-8#3)
or minor##12##2##(1990-12#1)(1991-10#1)(1991-11#1)(2006-11#1)(2007-10#1)(2008-8#4)(2012-11#1)(2013-1#1)(2013-8#1)
or mirror##4##2##(1996-2#2)(2011-2#2)
or misdiagnosed##2##2##(2010-12#1)(2013-8#1)
or misleading##2##2##(2006-10#1)(2007-12#1)
or missed##4##2##(1993-6#1)(2008-1#1)(2010-10#1)(2013-8#1)
or missing##7##2##(1991-7#1)(2005-5#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-8#1)(2011-1#1)
or mitochondrial DNA##2##3##(2008-12#1)(2008-5#1)
or mitochondrial##4##2##(1992-6#1)(1993-6#1)(2008-12#1)(2008-5#1)
or mitogen##2##2##(1991-12#1)(2008-4#1)
or mitotic##2##2##(2008-10#1)(2008-4#1)
or mitral valve##2##3##(1990-12#1)(2011-2#1)
or mitral##3##2##(1990-12#1)(1995-3#1)(2011-2#1)
or mix##2##2##(1997-3#1)(2008-4#1)
or mixed##29##2##(1990-11#1)(1992-10#1)(1993-7#1)(1994-5#1)(1995-11#1)(1996-3#1)(2004-11#1)(2004-12#1)(2004-2#1)(2005-11#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)
or mixtures of##2##3##(2006-12#1)(2008-10#1)
or mobile##4##2##(1994-12#1)(2008-12#1)(2008-9#1)(2013-1#1)
or model##2##2##(2008-2#1)(2011-1#1)
or modeling##2##2##(2006-2#1)(2008-4#1)
or models##2##2##(2008-11#1)(2012-1#1)
or moderate levels of##2##4##(1991-12#1)(2008-2#1)
or moderate##33##2##(1991-12#3)(1991-2#1)(1991-9#1)(1993-3#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-8#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#2)(2007-10#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-12#2)
or moderately##4##2##(2006-6#1)(2008-10#2)(2008-8#1)
or modest##3##2##(1991-9#1)(1993-3#1)(2007-11#1)
or modification of a##2##4##(2006-6#1)(2011-12#1)
or modification of##7##3##(1992-11#1)(1995-10#1)(1995-3#1)(2006-6#1)(2007-8#1)(2008-8#1)(2011-12#1)
or modification##10##2##(1992-11#1)(1995-10#1)(1995-3#2)(2006-12#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-8#1)(2011-12#1)
or modified##8##2##(1995-1#1)(1995-3#1)(2005-5#1)(2007-8#1)(2008-11#1)(2008-9#1)(2009-9#1)(2011-1#1)
or modify the##3##3##(2006-9#1)(2009-2#1)(2010-3#1)
or modify##9##2##(1994-1#1)(1994-10#1)(2006-9#1)(2007-7#1)(2008-10#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-3#1)
or modulate the##3##3##(1996-5#1)(2007-5#1)(2012-1#1)
or modulated##2##2##(2007-12#1)(2008-7#1)
or modulating the##2##3##(2008-4#1)(2011-2#1)
or modulation of##3##3##(1996-3#1)(1997-4#1)(1997-7#1)
or moist##2##2##(2006-11#1)(2011-2#1)
or molecular level##2##3##(2008-11#1)(2010-1#1)
or molecular techniques##2##3##(2007-12#1)(2008-10#1)
or molecular##13##2##(1990-6#1)(1992-8#1)(1993-12#1)(1995-7#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-1#1)(2011-1#1)
or molecules##2##2##(1997-4#1)(2009-10#1)
or monitoring of##2##3##(2008-10#1)(2012-12#1)
or monitoring##5##2##(2008-10#1)(2009-2#1)(2010-10#1)(2010-12#1)(2012-12#1)
or mono(2-ethylhexyl)phthalate##2##2##(1992-11#1)(1992-4#1)
or monobasic##2##2##(1992-2#1)(1994-11#1)
or monoclonal antibodies##4##3##(2008-2#1)(2008-4#3)
or monoclonal##6##2##(1991-6#1)(1996-6#1)(2008-2#1)(2008-4#3)
or monocytes##4##2##(1990-12#1)(1991-2#1)(1997-7#1)(2011-2#1)
or monthly##2##2##(2008-5#1)(2011-2#1)
or months##4##2##(1992-7#1)(2007-10#1)(2008-5#1)(2008-7#1)
or mood##3##2##(2006-9#1)(2007-11#1)(2008-1#1)
or moral##3##2##(1996-2#1)(2008-12#1)(2011-2#1)
or morbidity##5##2##(1995-8#1)(2007-11#1)(2008-7#3)
or more DNA##2##3##(1997-2#1)(2008-10#1)
or more above the##2##4##(1990-2#1)(2013-1#1)
or more acute organ failures##2##5##(2006-4#1)(2011-1#1)
or more after##7##3##(1992-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2013-1#1)
or more and##5##3##(1993-12#1)(2005-7#1)(2006-10#1)(2010-4#1)(2012-3#1)
or more antibiotics##2##3##(2008-10#1)(2013-8#1)
or more at##2##3##(2006-8#1)(2012-12#1)
or more cell##2##3##(1995-6#1)(2008-11#1)
or more children##4##3##(1990-6#1)(1997-2#2)(2010-8#1)
or more clinical##3##3##(2007-11#1)(2008-11#1)(2008-3#1)
or more commonly##5##3##(1990-12#1)(2006-6#1)(2008-5#1)(2008-7#1)(2009-11#1)
or more communication related impairments##2##5##(2011-1#2)
or more complications##2##3##(2007-9#1)(2013-1#1)
or more conveniently##2##3##(1990-11#1)(2012-12#1)
or more days##4##3##(1990-8#2)(2007-11#1)(2008-9#1)
or more different##3##3##(1991-1#1)(1992-7#1)(2010-12#1)
or more drugs##3##3##(1997-2#1)(2008-10#1)(2011-2#1)
or more episodes of##2##4##(1996-12#1)(2005-8#1)
or more episodes##3##3##(1996-12#1)(2005-8#1)(2013-8#1)
or more for##2##3##(1994-2#1)(2008-3#1)
or more from the##3##4##(1990-11#1)(2008-3#1)(2008-9#1)
or more from##4##3##(1990-11#1)(2008-3#1)(2008-5#1)(2008-9#1)
or more genes##2##3##(1993-11#1)(2008-10#1)
or more hours##3##3##(1991-9#1)(1995-3#1)(2008-10#1)
or more in the##2##4##(2006-10#1)(2012-12#1)
or more in##13##3##(1990-8#1)(1991-4#1)(1992-2#1)(1996-4#1)(1997-6#1)(2004-2#1)(2006-10#1)(2007-8#3)(2011-1#1)(2012-12#2)
or more institutions##3##3##(1996-9#1)(2013-1#2)
or more intensity measurements##2##4##(2007-12#2)
or more large##2##3##(1994-3#1)(1996-4#1)
or more medications##2##3##(2006-7#1)(2011-2#1)
or more members##4##3##(1995-2#1)(1995-8#1)(1996-5#1)(2011-2#1)
or more minutes##2##3##(2008-7#1)(2010-9#1)
or more negative##2##3##(1993-3#1)(1997-7#1)
or more of the following criteria##2##6##(1992-5#1)(2006-10#1)
or more of the following##11##5##(1991-9#1)(1992-5#1)(1996-10#1)(1996-6#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-6#1)(2011-2#1)
or more of the six##2##5##(1996-2#1)(2010-6#1)
or more of the##44##4##(1990-8#2)(1991-9#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-2#1)(1996-6#1)(1997-4#2)(2005-11#1)(2006-10#3)(2006-11#1)(2006-12#1)(2007-1#1)(2007-11#3)(2007-2#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-6#2)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#2)
or more of their##2##4##(1996-3#1)(1997-7#1)
or more of these##16##4##(1994-6#2)(2004-4#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-5#2)(2008-7#1)(2011-2#1)(2012-1#1)
or more of##74##3##(1990-8#2)(1991-3#1)(1991-9#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-3#1)(1994-6#2)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-4#3)(1997-7#1)(2004-3#1)(2004-4#1)(2005-11#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-2#1)(2009-6#2)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#1)
or more particles##2##3##(2008-5#2)
or more per##2##3##(1993-9#1)(2006-5#1)
or more positive axillary nodes##2##5##(1997-7#1)(2004-1#1)
or more positive##5##3##(1993-3#1)(1997-7#1)(2004-1#1)(2007-7#2)
or more potent than##2##4##(1994-9#2)
or more rarely##2##3##(1990-8#1)(2008-7#1)
or more recent##2##3##(2009-2#2)
or more resistant to##2##4##(1994-5#1)(2008-10#1)
or more risk factors##3##4##(2008-3#1)(2009-5#2)
or more sensitive##2##3##(2008-10#2)
or more servings of##3##4##(1997-1#1)(2011-1#2)
or more severe cytology##3##4##(2011-1#3)
or more severe lesions##4##4##(1992-10#2)(1992-6#2)
or more severe than##2##4##(2007-11#1)(2007-4#1)
or more severe##16##3##(1992-10#2)(1992-6#2)(2007-11#2)(2007-12#1)(2007-4#1)(2011-1#8)
or more sophisticated##2##3##(1996-7#1)(2007-12#1)
or more species##2##3##(1990-3#1)(2008-10#1)
or more susceptible##2##3##(1994-5#1)(2008-1#1)
or more than one of##2##5##(1990-7#1)(1997-6#1)
or more than one##3##4##(1990-12#1)(1990-7#1)(1997-6#1)
or more than##12##3##(1990-12#1)(1990-7#1)(1995-8#1)(1997-6#1)(2006-11#1)(2007-10#1)(2007-3#1)(2008-10#2)(2008-9#1)(2011-2#2)
or more times##2##3##(1993-9#1)(2008-11#1)
or more to the##2##4##(1991-4#1)(1994-12#1)
or more to##4##3##(1991-4#1)(1994-12#1)(2008-10#1)(2010-2#1)
or more variables from the history##2##6##(2007-7#2)
or more virulence factors##2##4##(2007-8#1)(2008-10#1)
or more weeks##4##3##(1992-1#1)(2008-1#1)(2008-9#1)(2011-1#1)
or more were##2##3##(1991-12#1)(2007-8#1)
or more while##2##3##(1993-4#1)(2007-11#1)
or more who##2##3##(1993-6#1)(2012-12#1)
or more years of##2##4##(2008-12#1)(2012-12#1)
or more years##8##3##(1991-12#3)(1992-10#1)(2008-12#1)(2009-2#1)(2012-12#1)(2013-1#1)
or more##684##2##(1990-11#2)(1990-12#5)(1990-2#4)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#8)(1990-9#1)(1991-1#2)(1991-11#3)(1991-12#7)(1991-2#1)(1991-3#2)(1991-4#5)(1991-7#3)(1991-8#2)(1991-9#4)(1992-1#3)(1992-10#6)(1992-11#1)(1992-12#5)(1992-2#2)(1992-3#2)(1992-4#2)(1992-5#4)(1992-6#4)(1992-7#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#4)(1993-12#1)(1993-2#5)(1993-3#4)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#5)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#4)(1994-4#1)(1994-5#5)(1994-6#3)(1994-7#1)(1994-9#7)(1995-1#3)(1995-10#3)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#4)(1995-4#2)(1995-5#8)(1995-6#2)(1995-8#4)(1995-9#1)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#3)(1996-4#5)(1996-5#3)(1996-6#3)(1996-7#4)(1996-8#1)(1996-9#4)(1997-1#4)(1997-2#9)(1997-4#5)(1997-5#1)(1997-6#6)(1997-7#4)(1997-8#2)(2004-1#1)(2004-2#1)(2004-3#1)(2004-4#1)(2004-9#1)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#17)(2006-11#2)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#4)(2006-5#4)(2006-6#1)(2006-7#3)(2006-8#6)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#17)(2007-12#9)(2007-2#4)(2007-3#2)(2007-4#1)(2007-6#3)(2007-7#9)(2007-8#10)(2007-9#2)(2008-1#15)(2008-10#56)(2008-11#14)(2008-12#3)(2008-2#8)(2008-3#16)(2008-4#7)(2008-5#11)(2008-6#4)(2008-7#10)(2008-8#6)(2008-9#17)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#4)(2009-4#2)(2009-5#9)(2009-6#4)(2009-9#3)(2010-1#1)(2010-11#2)(2010-12#4)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#21)(2011-2#24)(2011-3#1)(2012-1#4)(2012-12#12)(2012-2#6)(2012-3#7)(2013-1#17)(2013-7#1)(2013-8#14)
or more) of##2##3##(1997-3#1)(2006-2#1)
or more)##17##2##(1991-8#1)(1992-1#1)(1993-6#1)(1994-9#1)(1997-3#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)
or morphine##3##2##(1996-1#1)(1996-2#1)(1997-2#1)
or morphological##2##2##(2006-7#1)(2010-8#1)
or morphology of##2##3##(1995-2#1)(2007-1#1)
or morphology##6##2##(1994-5#1)(1995-2#1)(1995-6#2)(1996-7#1)(2007-1#1)
or mortality between##2##3##(1994-2#1)(2012-3#1)
or mortality##20##2##(1993-11#1)(1994-2#1)(1996-9#1)(2004-2#1)(2006-10#2)(2006-6#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
or mosaic##2##2##(2008-10#1)(2008-3#1)
or most##12##2##(1990-5#1)(1996-10#1)(1996-3#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-1#1)(2013-1#1)
or mostly##2##2##(2008-10#2)
or motor block recorded in both groups##2##7##(2013-7#2)
or motor cortex##2##3##(2006-10#2)
or motor##15##2##(1991-5#1)(1991-6#1)(1997-3#1)(1997-6#1)(2006-10#2)(2007-12#1)(2008-3#1)(2008-7#1)(2010-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#2)
or mouse##15##2##(1992-7#1)(1992-8#1)(1993-12#2)(1993-8#1)(1994-8#1)(1997-4#2)(2008-11#1)(2008-4#5)(2011-2#1)
or mouth##2##2##(2008-11#1)(2008-6#1)
or movable##2##2##(2008-3#1)(2012-1#1)
or movement##8##2##(2005-7#1)(2007-6#1)(2008-10#1)(2011-2#2)(2012-12#2)(2013-8#1)
or moving##4##2##(2008-3#1)(2012-2#2)(2012-3#1)
or much less##2##3##(1992-2#1)(2007-11#1)
or much##4##2##(1992-2#1)(1994-9#1)(1997-2#1)(2007-11#1)
or mucosal##3##2##(1990-6#1)(2007-7#1)(2008-8#1)
or mucus##2##2##(2009-4#1)(2011-1#1)
or multilamellar##2##2##(1993-9#1)(1996-7#1)
or multiple spinal##2##3##(2006-7#2)
or multiple##52##2##(1992-11#1)(1992-6#1)(1992-7#1)(1993-11#1)(1994-12#1)(1994-2#3)(1994-9#1)(1995-4#1)(1995-8#1)(1997-1#2)(1997-5#1)(2006-10#1)(2006-7#2)(2007-10#2)(2007-11#2)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-9#2)(2010-3#2)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)
or multisource data aggregation##2##4##(2013-1#2)
or multivesicular##2##2##(2008-4#1)(2008-6#1)
or murine##12##2##(1991-5#1)(1992-7#1)(1994-11#1)(1995-7#1)(1996-10#1)(2008-4#5)(2010-7#1)(2011-2#1)
or muscarinic##3##2##(1992-3#1)(2004-12#1)(2010-12#1)
or muscle##10##2##(1993-11#1)(1994-11#1)(1996-12#1)(1997-5#1)(2006-3#1)(2008-4#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
or muscles##4##2##(2008-10#1)(2008-6#1)(2009-11#1)(2009-3#1)
or mutant cyanases##2##3##(1994-11#2)
or mutant##14##2##(1990-12#1)(1994-11#2)(1994-12#2)(1994-9#1)(1995-6#1)(1996-10#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-11#1)(2012-2#1)
or mutants##2##2##(2008-10#1)(2008-9#1)
or mutated##3##2##(1995-6#1)(1997-3#1)(2009-10#1)
or mutation of##2##3##(1994-2#1)(1994-8#1)
or mutation##3##2##(1994-2#1)(1994-8#1)(2008-4#1)
or mutations in the##2##4##(2008-4#1)(2011-1#1)
or mutations of the##2##4##(1991-9#1)(2006-9#1)
or mutations of##3##3##(1991-9#1)(2006-9#1)(2012-2#1)
or mutations##5##2##(1991-9#1)(2006-9#1)(2008-4#1)(2011-1#1)(2012-2#1)
or mutually exclusive##2##3##(1996-6#1)(2006-7#1)
or myc##2##2##(1991-10#1)(1991-9#1)
or mycobacterial##2##2##(2012-2#1)(2013-8#1)
or mycophenolate mofetil##2##3##(2008-1#2)
or mycophenolate##3##2##(2007-11#1)(2008-1#2)
or myelin##2##2##(1993-9#1)(2010-2#1)
or myelodysplastic syndrome##4##3##(1992-10#1)(2010-11#1)(2011-2#2)
or myelodysplastic##5##2##(1990-8#1)(1992-10#1)(2010-11#1)(2011-2#2)
or myeloid##2##2##(1990-12#1)(1992-6#1)
or myocardial##4##2##(1991-11#1)(2008-4#1)(2011-12#1)(2012-2#1)
or myosin light chain##2##4##(1992-11#1)(1992-5#1)
or myosin##3##2##(1992-11#1)(1992-5#1)(1995-8#1)
or naloxone##2##2##(1991-2#1)(1995-12#1)
or narrow##2##2##(2008-11#1)(2008-3#1)
or nasal##3##2##(1993-11#1)(1995-9#1)(2011-1#1)
or native##6##2##(1990-12#1)(1991-7#1)(1994-11#1)(2008-4#1)(2008-8#1)(2009-10#1)
or natural##10##2##(2008-10#3)(2009-4#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-7#1)(2013-7#1)
or naturally##2##2##(1995-9#1)(2008-1#1)
or near its##2##3##(1993-3#1)(2007-12#1)
or near the##34##3##(1990-11#2)(1990-2#2)(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#2)(1995-3#1)(1995-5#1)(1995-8#4)(1996-7#3)(1996-8#1)(2005-10#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-5#1)
or near##58##2##(1990-10#1)(1990-11#2)(1990-2#2)(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-5#1)(1993-11#1)(1993-3#2)(1993-9#1)(1994-11#2)(1994-12#2)(1994-3#1)(1995-3#2)(1995-5#1)(1995-8#5)(1996-7#4)(1996-8#3)(2005-10#1)(2006-9#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#5)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-9#1)(2012-2#1)
or near-infrared##3##2##(2008-3#1)(2008-7#1)(2010-12#1)
or nearly complete##2##3##(2010-8#1)(2012-12#1)
or nearly identical##4##3##(1997-4#1)(2008-10#2)(2012-2#1)
or nearly so##2##3##(1995-11#1)(2012-3#1)
or nearly total glossectomy and##2##5##(2011-12#2)
or nearly##13##2##(1995-11#1)(1997-4#1)(2006-10#1)(2007-1#1)(2008-10#2)(2008-9#1)(2010-8#1)(2011-12#2)(2012-12#1)(2012-2#1)(2012-3#1)
or necessarily##2##2##(1992-3#1)(2008-6#1)
or neck##6##2##(1995-8#1)(2006-4#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
or necrosis was##2##3##(2010-12#1)(2010-3#1)
or necrosis##9##2##(2005-10#1)(2005-7#2)(2006-11#1)(2007-1#1)(2008-7#1)(2010-12#1)(2010-2#1)(2010-3#1)
or necrotic changes##2##3##(1997-8#1)(2013-7#1)
or necrotic##8##2##(1997-8#1)(2006-4#1)(2008-10#2)(2008-5#2)(2008-6#1)(2013-7#1)
or necrotizing##2##2##(2007-9#1)(2008-1#1)
or needle##2##2##(2007-11#1)(2011-2#1)
or needles in##2##3##(2012-12#2)
or needles##6##2##(2008-11#1)(2010-4#1)(2012-12#4)
or negative control##3##3##(1997-6#1)(2008-7#1)(2008-8#1)
or negative selection##3##3##(1990-8#1)(2008-11#1)(2012-1#1)
or negative##57##2##(1990-10#1)(1990-5#1)(1990-6#1)(1990-8#3)(1991-12#1)(1991-2#1)(1991-8#1)(1993-5#1)(1994-7#1)(1995-11#2)(1995-12#1)(1995-8#1)(1996-1#1)(1996-10#1)(1997-6#1)(2004-1#1)(2005-11#1)(2006-6#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-11#1)(2009-7#1)(2010-4#2)(2010-6#1)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
or negative)##3##2##(1995-11#1)(1995-6#1)(2005-7#1)
or negatively##11##2##(1994-2#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-8#1)(2010-9#1)
or neglect##2##2##(1996-5#1)(2007-12#1)
or neglected##2##2##(2008-4#1)(2011-2#1)
or negligible##2##2##(1995-12#1)(2005-11#1)
or neighboring##2##2##(1992-4#1)(1994-12#1)
or neither##7##2##(1991-8#1)(1997-2#1)(1997-5#1)(2005-10#1)(2008-10#1)(2008-2#1)(2008-5#1)
or neoadjuvant##2##2##(1993-11#1)(2007-7#1)
or neocortex##2##2##(1994-3#1)(1996-5#1)
or neonatal death##2##3##(2007-2#1)(2008-12#1)
or neonatal##11##2##(1990-6#1)(1992-12#1)(1994-9#2)(1995-11#1)(2006-10#1)(2007-2#1)(2008-11#1)(2008-12#1)(2010-9#1)(2013-1#1)
or neoplastic##7##2##(1991-7#1)(2005-11#1)(2007-2#1)(2008-10#1)(2008-4#1)(2009-3#1)(2011-2#1)
or nerve##5##2##(1997-3#1)(2007-11#1)(2008-1#2)(2008-9#1)
or neural##4##2##(1995-3#1)(2006-10#1)(2008-4#1)(2008-6#1)
or neurodegenerative##2##2##(2007-11#1)(2008-6#1)
or neurologic##3##2##(1996-12#1)(2008-7#1)(2008-8#1)
or neurological##10##2##(1992-10#1)(2006-10#1)(2007-11#1)(2007-9#2)(2008-11#1)(2008-6#1)(2008-7#1)(2009-11#1)(2013-1#1)
or neuromuscular##3##2##(2005-11#1)(2006-10#1)(2008-4#1)
or neuropathic##2##2##(2007-11#1)(2008-8#1)
or neurotization (nerve transfer)##2##4##(2008-9#2)
or neurotransmitters##2##2##(1993-9#1)(2007-11#1)
or neutral target##2##3##(2009-3#1)(2010-7#1)
or neutral##20##2##(1991-3#1)(1992-6#1)(1993-2#1)(1994-1#1)(1996-9#2)(2006-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-12#1)(2009-3#2)(2009-4#1)(2010-10#1)(2010-7#1)(2012-2#2)(2012-3#1)
or never##4##2##(1993-6#1)(2007-12#1)(2007-4#1)(2009-6#1)
or new##15##2##(1994-12#1)(1996-12#1)(1997-3#1)(2005-8#1)(2006-4#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-11#1)(2010-11#1)(2012-12#1)(2013-1#2)
or newborn##2##2##(1991-9#1)(2010-9#1)
or newer##2##2##(2006-10#1)(2008-5#1)
or newly##2##2##(2008-10#1)(2008-7#1)
or niche##2##2##(2008-8#1)(2009-12#1)
or nickel##4##2##(1991-7#1)(1997-2#1)(2008-10#1)(2013-8#1)
or nicotinamide##2##2##(1995-7#1)(2010-4#1)
or nifedipine##4##2##(1990-10#1)(1992-4#1)(1994-11#2)
or night blindness##2##3##(1991-8#2)
or night##4##2##(1991-8#2)(2010-10#1)(2012-12#1)
or nine##2##2##(1995-6#1)(2008-5#1)
or ninhydrin##2##2##(2008-10#1)(2013-7#1)
or nitrate##3##2##(1991-7#1)(2008-10#2)
or nitric oxide##3##3##(1992-6#1)(1996-1#1)(2011-2#1)
or nitrocellulose membrane##2##3##(2008-4#2)
or nitrogen##3##2##(1991-6#1)(2007-12#1)(2008-10#1)
or no activity##2##3##(1992-5#1)(2012-12#1)
or no change in the##2##5##(1994-11#1)(2008-10#1)
or no change in##5##4##(1991-3#1)(1994-11#1)(2007-11#1)(2008-10#2)
or no change##9##3##(1990-3#1)(1991-3#1)(1993-7#1)(1994-11#1)(1995-10#1)(2005-6#1)(2007-11#1)(2008-10#2)
or no damage to##2##4##(2008-10#1)(2009-12#1)
or no damage##3##3##(1994-8#1)(2008-10#1)(2009-12#1)
or no effect on the##6##5##(1991-7#1)(1994-9#1)(1995-7#1)(1997-6#1)(2008-10#2)
or no effect on##15##4##(1991-7#1)(1992-12#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-7#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-6#1)(2007-9#1)(2008-10#3)
or no effect##19##3##(1991-7#1)(1992-12#1)(1992-8#1)(1994-12#1)(1994-3#1)(1994-6#3)(1994-9#1)(1995-7#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-6#1)(2004-2#1)(2007-9#1)(2008-10#3)
or no effects##2##3##(2006-11#1)(2008-8#1)
or no expression of##2##4##(1991-12#1)(2006-7#1)
or no expression##3##3##(1991-12#1)(1995-5#1)(2006-7#1)
or no germination occurred##2##4##(2008-10#2)
or no impact on the##2##5##(1991-4#1)(1995-5#1)
or no impact on##4##4##(1991-4#1)(1991-6#1)(1995-5#1)(2007-11#1)
or no impact##7##3##(1991-10#1)(1991-4#1)(1991-6#1)(1993-6#1)(1995-5#1)(2007-11#1)(2012-3#1)
or no information##2##3##(1993-2#2)
or no interaction##2##3##(2008-10#1)(2011-2#1)
or no intervention##2##3##(2007-10#1)(2013-1#1)
or no response to##2##4##(2005-11#1)(2008-6#1)
or no response##4##3##(1996-5#1)(2005-11#1)(2008-6#1)(2013-1#1)
or no significant##2##3##(1997-2#1)(2007-12#1)
or no symptoms##2##3##(1994-4#1)(2008-10#1)
or no treatment##4##3##(1993-1#1)(2005-10#1)(2007-11#1)(2011-2#1)
or no virus##2##3##(1994-3#1)(2008-10#1)
or no voltage is applied to##2##6##(2008-2#1)(2008-3#1)
or no##234##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#1)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#3)(1991-9#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#2)(1993-1#1)(1993-10#1)(1993-11#2)(1993-2#3)(1993-6#1)(1993-7#2)(1993-8#2)(1994-11#4)(1994-12#2)(1994-2#3)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#4)(1994-8#3)(1994-9#1)(1995-1#2)(1995-10#2)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#2)(1995-7#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-3#1)(1996-5#2)(1996-7#1)(1996-8#2)(1996-9#2)(1997-2#4)(1997-3#1)(1997-5#2)(1997-6#1)(2004-11#1)(2004-2#1)(2004-3#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#2)(2006-12#1)(2006-2#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#4)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#4)(2008-10#22)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#6)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#3)(2009-12#2)(2009-6#1)(2009-8#2)(2010-1#2)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#2)(2011-1#1)(2011-11#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#6)(2013-8#2)
or nodules##3##2##(1994-6#1)(2007-11#1)(2009-6#1)
or non##9##2##(2007-11#2)(2007-5#1)(2008-2#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
or non-NMDA receptors (KA and AMPA)##2##6##(1993-7#2)
or non-NMDA##3##2##(1992-8#1)(1993-7#2)
or non-neoplastic proliferation of abnormal mixture of tissue's##2##8##(2007-7#2)
or non-nucleoside##2##2##(2005-7#2)
or non-specific##4##2##(1990-12#1)(1992-11#1)(2006-10#1)(2010-6#1)
or non-steroidal anti-inflammatory drugs##2##4##(2006-10#2)
or non-steroidal anti-inflammatory##3##3##(1997-1#1)(2006-10#2)
or nonadherent##2##2##(2008-4#2)
or none of##4##3##(1990-12#1)(1991-2#1)(2005-9#1)(2012-3#1)
or none##8##2##(1990-12#1)(1991-2#1)(1995-6#1)(2005-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-3#1)
or none)##2##2##(2008-10#1)(2011-2#1)
or noninoculated##2##2##(2008-10#2)
or nonlinear##4##2##(1990-7#1)(2007-11#1)(2008-3#1)(2009-12#1)
or nonneoplastic##9##2##(2008-8#2)(2008-9#6)(2011-2#1)
or nonpharmacological##2##2##(2006-11#1)(2010-12#1)
or nonsense mutations##2##3##(2008-1#1)(2012-12#1)
or noradrenaline##3##2##(1991-8#1)(1996-1#1)(1997-5#1)
or norepinephrine##3##2##(1991-8#1)(1992-6#1)(1993-7#1)
or normal subjects##2##3##(1995-11#1)(1997-8#1)
or normal##21##2##(1990-9#1)(1992-8#1)(1993-11#1)(1994-6#1)(1994-8#1)(1995-11#1)(1997-8#1)(2007-10#1)(2007-3#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-10#1)(2010-12#1)(2011-1#1)(2013-8#1)
or normalized to plasma lipids##2##5##(1997-2#2)
or not a##9##3##(1991-1#1)(1992-9#1)(1996-5#1)(2006-9#1)(2007-11#1)(2007-2#1)(2008-11#2)(2008-5#1)
or not and##3##3##(2006-2#1)(2008-8#1)(2011-2#1)
or not at all from##2##5##(1996-8#1)(2008-6#1)
or not at all##17##4##(1991-2#1)(1991-9#1)(1992-10#1)(1992-6#1)(1993-6#1)(1994-8#1)(1995-4#2)(1996-7#1)(1996-8#1)(1997-1#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#1)
or not available##3##3##(2008-10#1)(2008-12#1)(2012-12#1)
or not by##4##3##(2006-3#1)(2008-10#1)(2008-5#1)(2011-12#1)
or not exposed to bulls (Group##2##6##(2006-5#2)
or not for##3##3##(2008-10#1)(2008-8#1)(2012-12#1)
or not in##4##3##(2006-10#1)(2008-5#1)(2010-2#1)(2013-1#1)
or not induced##2##3##(2007-10#1)(2009-9#1)
or not of##7##3##(1993-2#1)(1993-5#1)(2006-10#1)(2008-2#1)(2009-9#1)(2011-1#1)(2013-8#1)
or not the##35##3##(1990-1#1)(1990-7#1)(1991-7#2)(1991-9#1)(1992-11#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-8#1)(1996-4#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-2#2)(2007-7#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-4#1)(2009-7#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
or not to know the##2##5##(2013-1#2)
or not to pilot##2##4##(1994-3#2)
or not to the##2##4##(2008-2#1)(2012-12#1)
or not to##46##3##(1991-2#1)(1991-3#1)(1992-12#1)(1993-3#1)(1994-3#3)(1994-4#1)(1995-4#2)(1995-5#1)(1995-6#1)(1996-1#2)(1997-3#1)(2005-8#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-5#1)(2008-8#3)(2010-2#1)(2011-2#2)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
or not was##2##3##(1993-3#1)(2008-8#1)
or not with##10##3##(1990-8#1)(1991-2#1)(1991-4#1)(1997-1#1)(2006-6#1)(2008-10#4)(2009-3#1)
or not##367##2##(1990-1#1)(1990-11#2)(1990-3#1)(1990-4#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-4#1)(1991-6#2)(1991-7#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-12#1)(1993-2#2)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#5)(1994-3#4)(1994-4#2)(1994-5#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#4)(1995-5#3)(1995-6#1)(1995-8#1)(1996-1#3)(1996-10#2)(1996-12#1)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#4)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#2)(2005-4#1)(2005-7#1)(2005-8#2)(2005-9#2)(2006-10#9)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#2)(2006-5#3)(2006-6#1)(2006-7#3)(2006-8#7)(2006-9#3)(2007-1#1)(2007-10#5)(2007-11#3)(2007-12#7)(2007-2#5)(2007-4#1)(2007-5#1)(2007-6#4)(2007-7#4)(2007-8#6)(2007-9#2)(2008-1#2)(2008-10#31)(2008-11#18)(2008-12#4)(2008-2#6)(2008-3#1)(2008-4#2)(2008-5#13)(2008-6#6)(2008-7#9)(2008-8#6)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#4)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#3)(2010-5#1)(2010-8#2)(2011-1#3)(2011-12#3)(2011-2#13)(2012-1#1)(2012-11#1)(2012-12#9)(2012-2#7)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#4)
or not) and##3##3##(2007-11#1)(2008-5#1)(2009-11#1)
or not)##8##2##(2007-11#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-9#1)(2010-6#1)(2011-2#1)(2012-3#1)
or not?##8##2##(1994-12#1)(1997-8#1)(2007-11#1)(2008-11#2)(2010-4#1)(2011-2#2)
or noted that HIE improved their access to complete information##2##10##(2013-1#2)
or notification##2##2##(1994-2#1)(2008-5#1)
or novel##5##2##(1993-4#1)(1993-6#1)(2011-3#1)(2012-1#2)
or nuclear magnetic resonance##2##4##(1994-9#1)(2009-10#1)
or nuclear medicine##2##3##(1992-2#1)(1997-6#1)
or nuclear##13##2##(1992-2#1)(1993-6#1)(1994-9#1)(1997-6#1)(2005-8#1)(2007-9#1)(2008-7#2)(2009-10#1)(2009-6#2)(2012-3#1)(2013-1#1)
or nucleotide##3##2##(1993-9#1)(1997-4#1)(2009-5#1)
or nucleus##3##2##(1990-5#1)(1996-10#1)(2010-10#1)
or null##5##2##(2007-9#3)(2008-12#1)(2010-2#1)
or number of##7##3##(1997-4#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-10#2)
or number##10##2##(1997-4#1)(2005-11#1)(2006-6#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-10#3)
or numbness##3##2##(2006-7#1)(2007-5#1)(2008-4#1)
or numerical##3##2##(2008-2#2)(2011-2#1)
or numerous##2##2##(1995-6#1)(2007-8#1)
or nurse##2##2##(1996-1#1)(2008-11#1)
or nurses##2##2##(1991-3#1)(1991-7#1)
or nursing home##2##3##(2007-12#1)(2009-2#1)
or nursing##6##2##(1991-12#1)(2005-6#1)(2007-10#1)(2007-12#1)(2008-1#1)(2009-2#1)
or nutrient##6##2##(1994-3#1)(1997-4#2)(2004-11#1)(2008-10#1)(2008-5#1)
or nutritional##3##2##(2004-2#1)(2007-12#1)(2013-7#1)
or nutritive properties##2##3##(2010-7#2)
or nylon##2##2##(2008-4#1)(2010-5#1)
or obese##25##2##(1996-12#1)(2006-8#2)(2007-3#1)(2008-1#2)(2008-10#2)(2008-3#5)(2010-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#7)
or obesity##8##2##(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#2)(2010-2#1)(2011-2#1)(2012-12#1)
or object##2##2##(2009-10#1)(2009-2#1)
or objects##2##2##(2011-2#2)
or oblique##2##2##(1995-6#1)(2008-3#1)
or observational##4##2##(1991-9#1)(1994-6#1)(2006-8#1)(2010-12#1)
or observed##2##2##(1991-12#1)(1996-2#1)
or obstetrical##2##2##(1991-7#1)(2011-1#1)
or obstruction##2##2##(2010-2#1)(2010-5#1)
or obtain##3##2##(2006-5#1)(2006-7#1)(2012-12#1)
or obtained##3##2##(1994-12#1)(1996-2#1)(1996-6#1)
or obtaining##3##2##(1995-6#1)(2006-7#1)(2008-10#1)
or obvious##2##2##(1994-2#1)(2011-1#1)
or occasionally##2##2##(1993-1#1)(2013-8#1)
or occipital##3##2##(1994-3#1)(2006-11#1)(2010-6#1)
or occlusion##6##2##(1996-2#2)(2007-11#1)(2007-7#1)(2008-8#1)(2010-12#1)
or occlusions##2##2##(2007-9#1)(2011-2#1)
or occupational##7##2##(1991-12#1)(1991-4#1)(1996-6#1)(2006-2#1)(2008-4#3)
or occur##2##2##(1993-6#1)(2012-1#1)
or occurred##2##2##(1994-12#1)(1994-5#1)
or occurs##2##2##(2008-10#1)(2009-9#1)
or octreotide##2##2##(1995-5#1)(1997-4#1)
or octyl##2##2##(1990-12#1)(2008-5#1)
or ocular hypertension##3##3##(2009-8#2)(2011-2#1)
or ocular##5##2##(2007-3#1)(2009-8#2)(2011-2#2)
or odd-number##2##2##(2008-11#2)
or of a##5##3##(1991-3#1)(1992-5#1)(1993-9#1)(2007-11#1)(2011-2#1)
or of an##5##3##(1992-7#1)(1994-6#1)(1995-1#1)(1996-9#1)(2006-8#1)
or of the##20##3##(1990-5#1)(1990-7#2)(1990-8#1)(1991-5#2)(1992-2#1)(1995-11#1)(1996-4#1)(1997-7#1)(2006-6#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
or of their##2##3##(2008-10#1)(2008-4#1)
or of transformed##2##3##(1993-5#1)(1996-12#1)
or of tumor##2##3##(1994-5#1)(1997-4#1)
or of##99##2##(1990-3#3)(1990-5#1)(1990-7#2)(1990-8#2)(1991-10#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-5#3)(1991-7#1)(1991-8#1)(1992-2#2)(1992-5#2)(1992-7#1)(1992-9#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-4#2)(1997-7#2)(2005-7#1)(2005-8#1)(2006-10#1)(2006-6#2)(2006-8#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#5)(2008-5#2)(2008-8#2)(2008-9#1)(2009-12#2)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
or offspring##3##2##(2008-8#1)(2008-9#1)(2013-1#1)
or oil##3##2##(2008-10#1)(2008-2#1)(2010-9#1)
or oils##2##2##(1995-5#1)(2008-10#1)
or okadaic acid##2##3##(1994-2#1)(1994-8#1)
or old##3##2##(2008-7#2)(2011-1#1)
or older and##3##3##(1990-5#1)(1992-6#1)(2011-2#1)
or older increased##2##3##(2006-10#1)(2011-1#1)
or older##50##2##(1990-5#1)(1991-11#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-5#1)(1992-6#1)(1992-9#3)(1993-2#1)(1993-3#1)(1993-8#1)(1995-9#1)(1996-3#1)(1997-6#1)(2004-10#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-10#6)(2007-12#1)(2008-11#2)(2008-3#1)(2009-5#1)(2009-8#1)(2010-10#2)(2010-8#1)(2011-1#5)(2011-11#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#3)
or older)##3##2##(1995-9#1)(2007-7#1)(2009-7#1)
or oleic##2##2##(2008-10#1)(2009-11#1)
or oligandrin##3##2##(2008-10#3)
or oligoarthritis##3##2##(1992-11#1)(2006-10#1)(2007-11#1)
or oligosaccharides##2##2##(1994-11#1)(1997-2#1)
or olive##3##2##(1994-2#1)(2008-10#1)(2012-2#1)
or omental##2##2##(1990-2#1)(2012-2#1)
or omission##3##2##(1990-12#1)(1992-7#1)(2005-7#1)
or on a##3##3##(2006-10#1)(2007-11#1)(2008-4#1)
or on both##2##3##(1992-3#1)(2011-2#1)
or on data##2##3##(2008-11#1)(2012-12#1)
or on leaves##2##3##(2008-10#2)
or on the extent of##2##5##(1992-9#1)(2007-7#1)
or on the spatial##2##4##(1990-4#1)(1994-6#1)
or on the##30##3##(1990-3#1)(1990-4#2)(1991-2#1)(1991-7#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-6#1)(1996-11#1)(1996-4#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-9#2)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)
or on##109##2##(1990-3#3)(1990-4#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-7#1)(1991-8#1)(1992-12#2)(1992-3#1)(1992-5#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-4#1)(1997-3#1)(1997-6#1)(2004-9#1)(2005-5#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#12)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-2#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#3)(2010-7#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
or on-line##4##2##(1992-11#1)(2008-10#2)(2013-8#1)
or once##3##2##(2006-1#1)(2008-5#1)(2008-6#1)
or ondansetron##3##2##(1996-8#1)(2008-7#1)(2011-12#1)
or one of its##2##4##(1994-12#1)(2006-10#1)
or one of three##2##4##(1995-11#1)(1996-1#1)
or one of two##2##4##(1997-3#1)(2013-8#1)
or one of##8##3##(1994-12#1)(1995-11#1)(1996-1#1)(1997-3#1)(2006-10#1)(2008-4#1)(2011-2#1)(2013-8#1)
or one with##2##3##(2008-1#1)(2008-4#1)
or one##31##2##(1991-4#1)(1991-9#2)(1992-11#1)(1993-11#1)(1993-12#1)(1994-12#1)(1995-11#1)(1996-1#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-8#3)
or ongoing##3##2##(1995-12#1)(1997-8#1)(2008-7#1)
or only a small##2##4##(1992-12#1)(2013-7#1)
or only a##4##3##(1992-12#1)(2005-10#1)(2011-1#1)(2013-7#1)
or only minimal##2##3##(1993-5#1)(2008-8#1)
or only one##3##3##(1997-4#1)(2006-10#2)
or only rarely##2##3##(1997-2#1)(2008-7#1)
or only slightly##3##3##(1990-2#1)(1995-3#1)(2008-8#1)
or only the##3##3##(1997-6#1)(2007-2#1)(2013-1#1)
or only with##2##3##(1992-5#1)(2011-3#1)
or only##41##2##(1990-10#1)(1990-2#1)(1991-11#1)(1992-12#1)(1992-5#1)(1993-5#1)(1993-7#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-6#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-8#1)(2011-1#1)(2011-3#1)(2013-1#1)(2013-7#1)
or onset of##4##3##(2007-11#1)(2008-7#1)(2009-7#1)(2012-11#1)
or onset##6##2##(2007-11#1)(2007-7#1)(2007-8#1)(2008-7#1)(2009-7#1)(2012-11#1)
or onto##5##2##(1997-2#1)(1997-3#1)(2005-11#1)(2008-10#1)(2008-4#1)
or open surgical##3##3##(1995-5#1)(2006-6#1)(2008-6#1)
or open##11##2##(1995-11#1)(1995-5#1)(1996-9#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-3#1)(2008-6#1)(2009-3#1)(2011-2#1)(2013-8#1)
or opposition##2##2##(2008-11#1)(2009-2#1)
or optical##8##2##(1995-10#1)(2006-4#1)(2007-12#3)(2007-9#1)(2008-2#1)(2008-3#1)
or optimal##3##2##(1996-2#1)(2006-6#1)(2010-3#1)
or oral contraceptive use##2##4##(1993-9#1)(2011-1#1)
or oral gavage##2##3##(1997-2#1)(2007-11#1)
or oral##17##2##(1991-10#1)(1991-9#1)(1993-7#1)(1993-9#1)(1996-11#1)(1997-1#1)(1997-2#1)(2004-1#1)(2006-2#1)(2007-11#2)(2009-4#1)(2010-5#1)(2010-6#2)(2011-1#1)(2013-1#1)
or orally##4##2##(2007-11#2)(2008-8#1)(2013-7#1)
or orbital##2##2##(2011-1#1)(2013-1#1)
or ordered##2##2##(1991-9#1)(2007-11#1)
or ordinal##3##2##(1997-8#1)(2008-12#1)(2008-5#1)
or organ##11##2##(1994-11#1)(2006-10#1)(2007-3#1)(2007-4#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#2)(2012-2#1)
or organelle##2##2##(2005-11#1)(2007-12#1)
or organelles##2##2##(2007-10#1)(2009-8#1)
or organic solvents##2##3##(1990-12#1)(2008-10#1)
or organic##7##2##(1990-12#1)(1995-10#1)(2008-10#5)
or organism##2##2##(2008-7#1)(2008-9#1)
or organization##2##2##(1995-2#1)(1996-2#1)
or organs##11##2##(2007-4#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2009-12#1)(2010-8#1)(2010-9#1)(2011-1#1)
or orientation##3##2##(1991-9#1)(1992-9#1)(1997-8#1)
or originate from a##2##4##(2008-1#1)(2011-12#1)
or oro-tracheal tube##2##3##(2008-2#2)
or orthopaedic##2##2##(1991-5#1)(2006-10#1)
or oscillating##2##2##(1990-5#1)(2007-12#1)
or osteonecrosis of the##2##4##(2007-6#1)(2012-3#1)
or osteoporosis##5##2##(2006-10#3)(2012-12#1)(2013-1#1)
or other adverse effects##3##4##(2007-9#1)(2013-1#2)
or other adverse##4##3##(1997-1#1)(2007-9#1)(2013-1#2)
or other agents##4##3##(1997-5#1)(2007-8#1)(2008-1#1)(2012-2#1)
or other aspects of##2##4##(1990-4#1)(2007-11#1)
or other biological##2##3##(1995-12#1)(2010-11#1)
or other causes##3##3##(2007-11#1)(2008-12#1)(2011-2#1)
or other cellular##2##3##(1991-4#1)(2007-11#1)
or other changes in##2##4##(2006-10#1)(2011-2#1)
or other changes##4##3##(2005-10#1)(2006-10#1)(2010-8#1)(2011-2#1)
or other clinical##2##3##(2007-7#1)(2012-3#1)
or other cofactors##2##3##(1995-6#1)(1996-8#1)
or other common##2##3##(2005-8#1)(2008-10#1)
or other complications##3##3##(2007-7#1)(2010-6#1)(2011-1#1)
or other conditions##2##3##(2010-7#1)(2013-7#1)
or other considerations##2##3##(1992-12#1)(2005-9#1)
or other downstream##2##3##(2008-4#1)(2009-3#1)
or other drugs##4##3##(1995-9#1)(2009-9#1)(2010-4#1)(2012-3#1)
or other environmental##2##3##(2008-11#1)(2008-8#1)
or other factors##3##3##(2006-8#1)(2008-12#1)(2011-2#1)
or other forms of##3##4##(1991-11#1)(2008-1#1)(2009-9#1)
or other gastrointestinal##2##3##(2007-8#2)
or other health care##2##4##(1993-12#1)(2009-5#1)
or other health##3##3##(1993-12#1)(1995-2#1)(2009-5#1)
or other human##2##3##(2007-12#1)(2011-2#1)
or other of these##4##4##(1991-3#1)(1991-8#1)(1993-2#1)(2007-6#1)
or other of##6##3##(1991-3#1)(1991-8#1)(1993-2#2)(1996-12#1)(2007-6#1)
or other organs##2##3##(2008-11#1)(2008-5#1)
or other parts of##2##4##(2007-12#1)(2012-12#1)
or other phenomena##2##3##(1993-9#1)(2012-3#1)
or other proteins##3##3##(1994-9#1)(1995-6#1)(2008-8#1)
or other reasons##3##3##(1990-4#1)(1994-3#1)(2010-8#1)
or other tissues##2##3##(1996-8#1)(2008-4#1)
or other treatment##2##3##(2007-11#1)(2010-12#1)
or other type of##2##4##(2008-11#1)(2008-4#1)
or other##323##2##(1990-10#2)(1990-2#2)(1990-4#2)(1990-6#1)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-3#2)(1991-4#2)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#3)(1993-3#2)(1993-4#1)(1993-7#2)(1993-8#2)(1993-9#1)(1994-3#3)(1994-6#1)(1994-9#1)(1995-11#3)(1995-12#2)(1995-2#2)(1995-3#3)(1995-5#2)(1995-6#7)(1995-8#1)(1995-9#1)(1996-1#4)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#2)(1996-7#2)(1996-8#3)(1997-1#3)(1997-2#1)(1997-4#1)(1997-5#3)(1997-7#1)(2004-11#1)(2004-3#1)(2005-10#2)(2005-11#2)(2005-7#3)(2005-8#2)(2005-9#1)(2006-10#3)(2006-12#1)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#4)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#7)(2007-2#2)(2007-4#1)(2007-6#2)(2007-7#3)(2007-8#5)(2007-9#2)(2008-1#8)(2008-10#18)(2008-11#6)(2008-12#4)(2008-2#6)(2008-3#5)(2008-4#15)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#7)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#3)(2009-5#3)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#8)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#5)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#14)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#7)(2013-1#4)(2013-7#2)(2013-8#2)
or others to receive##2##4##(2013-1#2)
or others##10##2##(1990-2#1)(1991-12#1)(1997-5#1)(1997-7#1)(2005-6#1)(2007-2#1)(2008-3#1)(2013-1#2)(2013-8#1)
or otherwise of##2##3##(1990-10#1)(2008-4#1)
or otherwise##16##2##(1990-10#1)(1993-1#2)(1993-5#1)(1995-9#1)(2007-11#1)(2008-11#1)(2008-4#2)(2008-8#1)(2010-8#1)(2012-12#1)(2013-8#4)
or out of the##2##4##(2009-11#1)(2012-3#1)
or out of##4##3##(2008-9#2)(2009-11#1)(2012-3#1)
or outbreaks##3##2##(2007-12#1)(2010-12#2)
or outcome of##2##3##(2009-4#1)(2011-2#1)
or outcome##7##2##(1995-12#1)(2006-11#1)(2008-11#1)(2008-7#1)(2009-4#1)(2011-2#2)
or outcomes##3##2##(2006-10#1)(2007-7#1)(2012-1#1)
or outpatient##5##2##(1994-2#1)(2007-1#1)(2011-1#1)(2011-2#1)(2012-3#1)
or outside the##4##3##(1991-6#1)(1995-8#1)(2005-10#1)(2006-9#1)
or outside##10##2##(1991-6#1)(1991-9#1)(1995-8#1)(1996-1#1)(1996-3#1)(2005-10#1)(2006-9#1)(2008-8#1)(2012-12#1)(2012-3#1)
or oval##3##2##(1997-3#1)(2007-9#1)(2012-2#1)
or ovarian##2##2##(2004-2#1)(2010-12#1)
or over##21##2##(1991-12#1)(1991-3#1)(1992-1#1)(1992-9#1)(1993-1#1)(1994-6#2)(1997-8#2)(2005-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#1)
or overall##6##2##(1994-12#1)(1994-9#1)(1997-8#1)(2008-6#1)(2008-8#1)(2010-2#1)
or overcome##2##2##(1991-9#1)(2008-10#1)
or overexpressed##2##2##(2005-12#1)(2011-2#1)
or overexpression of##2##3##(2008-9#1)(2011-2#1)
or overexpression##3##2##(2008-9#2)(2011-2#1)
or overhead##2##2##(2007-10#1)(2008-10#1)
or overlap##2##2##(2008-4#1)(2008-7#1)
or overlooked##2##2##(2007-4#1)(2009-5#1)
or overt diabetes##2##3##(1994-12#1)(2007-7#1)
or overt##6##2##(1994-12#1)(2005-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-5#1)
or overuse##4##2##(2007-7#3)(2008-7#1)
or overweight##4##2##(2006-9#1)(2007-12#2)(2008-4#1)
or oxaliplatin##3##2##(2008-4#1)(2008-5#1)(2009-4#1)
or oxidation of##2##3##(1996-8#1)(2004-4#1)
or oxidation##4##2##(1996-8#1)(2004-4#1)(2008-10#1)(2013-1#1)
or oxidative stress##2##3##(2007-8#1)(2008-10#1)
or oxidative##5##2##(1990-2#1)(2005-8#1)(2007-8#1)(2008-10#1)(2008-8#1)
or oxygen##6##2##(2007-1#1)(2007-8#3)(2008-1#1)(2008-3#1)
or ozone##3##2##(2008-2#2)(2008-3#1)
or p##3##2##(1993-11#2)(1997-6#1)
or p53##3##2##(1995-6#1)(2008-9#1)(2010-12#1)
or p53175P##2##2##(2008-7#2)
or pH##12##2##(1991-4#1)(1992-8#2)(1995-2#1)(1996-3#1)(2006-8#1)(2008-10#4)(2008-8#1)(2010-1#1)
or packed##2##2##(2008-11#2)
or paediatric)##2##2##(2007-5#1)(2008-11#1)
or pain##12##2##(1990-11#1)(1995-4#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-7#1)(2009-12#1)(2009-3#1)(2010-6#1)(2010-8#1)
or painful##4##2##(1990-12#1)(1996-1#1)(2007-11#1)(2008-10#1)
or paint##2##2##(2008-3#2)
or paired##2##2##(1996-12#1)(1996-9#1)
or palatable##2##2##(1997-8#2)
or palliative##6##2##(1991-8#1)(2008-11#1)(2008-7#1)(2009-8#1)(2012-2#1)(2012-3#1)
or palpable nodules##2##3##(1991-4#1)(2007-10#1)
or palpable##3##2##(1991-4#1)(1993-10#1)(2007-10#1)
or pancreas##3##2##(2006-10#1)(2008-7#1)(2010-12#1)
or pancreatic##3##2##(1991-2#1)(1995-7#1)(1996-2#1)
or pantoprazole 20 mg od##2##5##(2008-5#2)
or pantoprazole##3##2##(2008-5#3)
or papilla##2##2##(2008-10#1)(2008-5#1)
or papillary##3##2##(1993-2#1)(2010-6#1)(2011-12#1)
or para##2##2##(1990-12#1)(2008-10#1)
or paracetamol##2##2##(1990-2#1)(1991-9#1)
or paradoxical##2##2##(2010-8#1)(2013-1#1)
or paraffin-embedded##2##2##(1997-3#1)(2008-9#1)
or parallel##4##2##(1990-12#1)(1996-10#1)(2007-12#1)(2008-3#1)
or paralyzed arm##2##3##(2007-10#2)
or paraneoplastic##3##2##(2008-11#1)(2010-2#1)(2013-1#1)
or parasitic##4##2##(2007-7#1)(2008-4#1)(2008-8#1)(2013-1#1)
or parathyroid hormone (PTH)##2##4##(1990-11#1)(2005-3#1)
or parathyroid hormone##3##3##(1990-11#1)(2005-3#1)(2006-10#1)
or parathyroid##4##2##(1990-11#1)(2005-3#1)(2006-10#1)(2007-8#1)
or paraxial##2##2##(2008-10#1)(2008-3#1)
or parent##3##2##(2006-10#1)(2007-9#1)(2013-8#1)
or parental##2##2##(1994-2#1)(2010-9#1)
or parenteral##4##2##(2006-2#1)(2006-7#1)(2007-11#1)(2013-1#1)
or parents##3##2##(2006-7#1)(2010-2#1)(2012-1#1)
or parietal cortex##2##3##(2008-7#1)(2013-7#1)
or parietal##3##2##(1996-9#1)(2008-7#1)(2013-7#1)
or part of a##2##4##(1991-11#1)(2007-7#1)
or part of the##2##4##(2008-6#1)(2010-5#1)
or part of##7##3##(1991-11#1)(2007-11#1)(2007-7#2)(2008-6#1)(2008-7#1)(2010-5#1)
or partial response##2##3##(2007-11#1)(2007-8#1)
or partial sterility##2##3##(2008-8#1)(2010-3#1)
or partial##39##2##(1990-10#1)(1990-11#1)(1991-10#1)(1991-6#1)(1991-9#1)(1992-4#1)(1993-5#1)(1993-6#1)(1993-9#1)(1995-2#1)(1996-11#1)(1997-3#2)(2004-1#1)(2005-11#1)(2006-10#2)(2007-10#1)(2007-11#3)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-12#1)(2013-1#1)
or partially purified##4##3##(1991-4#1)(1995-2#1)(2008-1#1)(2008-2#1)
or partially##28##2##(1990-8#1)(1991-4#1)(1994-10#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-3#1)(2005-11#1)(2006-5#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-3#1)(2013-8#1)
or participation##2##2##(1990-10#1)(1996-2#1)
or particle##4##2##(1995-8#1)(2008-10#1)(2008-7#1)(2008-9#1)
or partly##2##2##(1995-8#1)(2008-11#1)
or partner##2##2##(2005-7#1)(2007-7#1)
or partners##2##2##(2011-2#1)(2012-3#1)
or parts of the##3##4##(1994-3#1)(1995-3#1)(2008-12#1)
or parts of##4##3##(1994-3#1)(1995-3#1)(2008-12#1)(2012-12#1)
or parts##6##2##(1994-3#1)(1995-3#1)(2008-10#2)(2008-12#1)(2012-12#1)
or pass##2##2##(1990-5#1)(2008-10#1)
or passive##9##2##(1995-5#1)(1996-12#1)(2008-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#2)(2013-7#1)
or passively##2##2##(1994-12#1)(2008-10#1)
or past##6##2##(1990-12#1)(1992-2#1)(1994-6#1)(2006-6#1)(2008-11#1)(2010-9#1)
or pathogen##6##2##(2008-10#5)(2010-9#1)
or pathologic##8##2##(1990-6#1)(2006-9#2)(2009-12#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#1)
or pathological##13##2##(1993-2#1)(1993-3#1)(1996-6#1)(2006-9#1)(2007-9#1)(2008-5#1)(2008-7#2)(2010-3#1)(2012-2#2)(2013-1#2)
or pathology##12##2##(1993-5#1)(2006-10#10)(2007-12#1)
or pathways##3##2##(2008-4#1)(2011-2#1)(2012-2#1)
or patient age##2##3##(1991-6#1)(2011-2#1)
or patient##10##2##(1991-12#1)(1991-6#1)(1995-3#1)(1996-1#1)(1997-2#1)(1997-5#1)(2006-5#1)(2010-9#1)(2011-2#2)
or patient-specified categories##2##3##(2013-1#2)
or patients with##5##3##(1990-1#1)(1994-11#1)(1994-3#1)(1995-3#1)(1996-1#1)
or patients##21##2##(1990-1#1)(1990-3#1)(1994-1#1)(1994-11#1)(1994-3#1)(1995-3#1)(1996-1#1)(1997-1#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#2)
or pattern of##2##3##(1992-3#1)(2009-6#1)
or pattern##3##2##(1992-3#1)(2008-11#1)(2009-6#1)
or patterns of##2##3##(2007-12#1)(2008-11#1)
or patterns##3##2##(1993-9#1)(2007-12#1)(2008-11#1)
or pay##3##2##(1996-3#1)(2007-4#1)(2012-11#1)
or peak##4##2##(1993-5#1)(2006-5#1)(2007-2#1)(2008-9#1)
or peat##2##2##(2008-10#2)
or pediatric##3##2##(2006-10#1)(2008-5#1)(2010-2#1)
or pedicled##2##2##(1990-4#1)(2009-9#1)
or pelvic##7##2##(1990-6#1)(1992-2#1)(1994-12#1)(2006-8#1)(2006-9#1)(2007-2#2)
or penetrating##3##2##(2008-9#1)(2010-12#1)(2012-2#1)
or people##2##2##(1993-2#1)(2009-2#1)
or peptidase##2##2##(1995-6#1)(2008-4#1)
or peptide##5##2##(1994-12#1)(1995-5#1)(2006-6#1)(2008-11#1)(2008-9#1)
or peptides##9##2##(1995-5#1)(1997-7#1)(2008-11#1)(2008-4#3)(2008-5#2)(2008-8#1)
or per os##2##3##(1993-12#1)(2006-6#1)
or per##7##2##(1992-11#1)(1993-12#1)(1994-8#2)(2006-6#1)(2008-4#1)(2013-8#1)
or perceived##2##2##(1995-9#1)(2007-1#1)
or percent##2##2##(2007-7#1)(2008-10#1)
or percentage of##2##3##(1996-11#1)(2007-8#1)
or perceptions of##3##3##(2008-9#1)(2013-1#2)
or percutaneous##9##2##(1996-9#2)(2006-2#1)(2007-8#1)(2009-12#1)(2013-8#4)
or perennial##3##2##(2007-11#1)(2008-8#1)(2013-8#1)
or performance##2##2##(2004-3#1)(2012-2#1)
or performing##3##2##(1994-1#1)(2006-6#1)(2008-4#1)
or perfused##2##2##(1991-2#1)(2006-10#1)
or perfusion bioreactors##2##3##(2008-11#2)
or perfusion##5##2##(1994-12#1)(2008-11#3)(2010-12#1)
or perhaps a##2##3##(1994-11#1)(2007-2#1)
or perhaps##10##2##(1992-12#1)(1994-11#1)(2007-11#2)(2007-2#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-8#1)(2012-2#1)
or periarticular##2##2##(2006-10#2)
or perimenopausal##2##2##(1993-11#1)(2004-3#1)
or perinatal##2##2##(1995-6#1)(2009-9#1)
or perinatally##2##2##(1992-6#1)(1993-5#1)
or periods of##2##3##(1990-4#1)(2012-12#1)
or peripheral arterial##3##3##(2007-10#1)(2007-8#1)(2012-2#1)
or peripheral blood stem##3##4##(2005-12#1)(2005-8#1)(2008-11#1)
or peripheral blood##8##3##(1995-2#1)(2005-12#1)(2005-8#2)(2008-11#2)(2008-4#2)
or peripheral embolism##2##3##(2007-11#1)(2008-8#1)
or peripheral##29##2##(1990-2#1)(1991-6#1)(1992-2#1)(1992-8#1)(1993-11#1)(1994-11#1)(1995-2#1)(1997-1#1)(2005-12#1)(2005-8#2)(2006-10#1)(2007-10#1)(2007-11#2)(2007-8#2)(2008-10#1)(2008-11#2)(2008-4#2)(2008-7#2)(2008-8#1)(2010-4#1)(2010-7#2)(2012-2#1)
or peripheral-blood##2##2##(1992-9#1)(2008-1#1)
or peritoneal dialysis##3##3##(2006-5#1)(2007-7#1)(2008-4#1)
or peritoneal##6##2##(1990-6#1)(2006-5#1)(2007-7#1)(2008-4#1)(2012-2#1)(2012-3#1)
or peritonitis##2##2##(1993-4#1)(2013-1#1)
or permanent##24##2##(1990-9#1)(1991-10#1)(1993-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(2004-9#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-9#2)(2008-5#1)(2009-3#2)(2010-4#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
or permanently##3##2##(1991-7#1)(1993-12#1)(2013-8#1)
or permeabilized##2##2##(1994-9#1)(2008-4#1)
or permit##2##2##(2008-9#2)
or peroxidase##2##2##(1991-8#1)(1992-6#1)
or perpendicular##3##2##(2007-4#1)(2008-2#1)(2011-2#1)
or persistence of##3##3##(2007-10#1)(2008-4#2)
or persistence##5##2##(2006-10#1)(2007-10#1)(2008-4#2)(2010-4#1)
or persistent pain##2##3##(1992-6#1)(2006-8#1)
or persistent##10##2##(1992-6#1)(1994-6#1)(2005-1#1)(2006-10#1)(2006-8#1)(2007-10#1)(2009-2#1)(2010-12#1)(2010-6#1)(2011-1#1)
or personal##3##2##(2006-3#1)(2008-10#1)(2010-2#1)
or personality disorders##3##3##(1991-9#1)(1995-4#1)(2013-8#1)
or personality##4##2##(1991-9#1)(1995-4#1)(2013-7#1)(2013-8#1)
or personnel##2##2##(1995-3#1)(1996-12#1)
or persons##4##2##(1994-11#1)(2005-10#1)(2011-2#1)(2013-7#1)
or pharmaceutical##6##2##(1990-9#1)(1996-5#1)(2008-4#2)(2008-5#2)
or pharmacologic activation##2##3##(1995-6#2)
or pharmacologic##3##2##(1995-6#2)(2011-2#1)
or pharmacological##12##2##(1996-10#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-6#1)(2011-1#2)(2012-2#1)
or phase unwrapping##2##3##(2007-12#1)(2008-3#1)
or phase##7##2##(1992-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)
or phases##2##2##(2005-5#1)(2006-5#1)
or phenol##2##2##(1995-6#1)(2005-7#1)
or phenylalanine##3##2##(1991-11#1)(1995-1#1)(2008-4#1)
or phenylephrine (10##2##3##(1995-12#1)(1997-7#1)
or phenylephrine##4##2##(1991-3#1)(1994-12#1)(1995-12#1)(1997-7#1)
or phorbol 12-myristate 13-acetate (PMA)##3##5##(1995-2#1)(1995-6#1)(1996-2#1)
or phorbol 12-myristate 13-acetate##4##4##(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)
or phorbol ester##5##3##(1990-5#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-5#1)
or phorbol esters##3##3##(1991-12#1)(1995-6#2)
or phorbol##17##2##(1990-5#1)(1990-6#1)(1991-12#1)(1991-9#2)(1994-11#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-6#4)(1996-2#1)(1996-5#1)
or phosphate buffer##3##3##(1993-12#1)(2008-10#1)(2008-6#1)
or phosphate##8##2##(1990-2#1)(1993-12#1)(1995-8#1)(1997-1#1)(2008-10#2)(2008-6#1)(2010-5#1)
or phosphatidylinositol##3##2##(1991-4#1)(1992-12#1)(2008-11#1)
or phosphatidylserine##4##2##(1990-6#2)(1991-9#1)(1994-5#1)
or phosphodiesterase##3##2##(1994-8#1)(2007-8#1)(2009-2#1)
or phospholipase##2##2##(1994-9#1)(2005-7#1)
or phospholipids##2##2##(1996-4#1)(2011-1#1)
or phosphomolybdic acid##2##3##(2008-10#2)
or phosphoramidon##3##2##(1990-9#1)(1991-1#1)(1995-6#1)
or phosphotyrosine##2##2##(1996-8#1)(2008-4#1)
or photochemically##2##2##(1997-3#1)(2008-11#1)
or phylogenetic##2##2##(2008-4#1)(2009-6#1)
or physical examination findings##2##4##(2006-8#1)(2010-11#1)
or physical examination##4##3##(1992-2#1)(2006-8#1)(2008-7#1)(2010-11#1)
or physical##22##2##(1992-2#1)(1995-6#2)(1996-6#1)(1997-7#1)(1997-8#1)(2006-12#2)(2006-3#1)(2006-8#2)(2007-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-2#1)(2010-11#1)(2012-11#1)(2012-2#1)
or physically##5##2##(1991-1#1)(2007-11#1)(2008-7#1)(2010-3#1)(2013-7#1)
or physiological##11##2##(1995-3#1)(1996-10#1)(2004-12#1)(2008-11#1)(2008-8#3)(2009-9#1)(2010-2#1)(2010-4#1)(2012-1#1)
or phytohemagglutinin##2##2##(1995-2#1)(1995-3#1)
or piecewise##2##2##(2008-10#1)(2008-2#1)
or pigmentation##4##2##(1997-6#1)(2008-10#1)(2009-4#1)(2012-11#1)
or pituitary##6##2##(1994-3#1)(1995-12#1)(2006-12#1)(2006-9#1)(2008-4#1)(2012-3#1)
or placebo (n =##3##4##(1997-1#1)(2006-10#1)(2013-1#1)
or placebo at##2##3##(1990-12#1)(2012-2#1)
or placebo for 6 weeks##2##5##(2008-5#1)(2013-1#1)
or placebo for 8 weeks##3##5##(2008-10#2)(2012-1#1)
or placebo for##13##3##(1992-10#1)(1992-8#1)(2004-12#1)(2005-8#1)(2008-10#2)(2008-3#1)(2008-5#3)(2012-1#1)(2012-2#1)(2013-1#1)
or placebo in##3##3##(2012-2#1)(2013-1#2)
or placebo were##2##3##(1990-5#1)(2008-10#1)
or placebo##61##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-10#1)(1992-8#1)(1993-12#1)(1995-1#1)(1995-12#1)(1997-1#1)(1997-6#1)(2004-12#1)(2005-8#2)(2006-10#2)(2006-9#1)(2007-10#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-3#3)(2008-5#8)(2008-7#1)(2010-4#2)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#5)(2013-7#2)(2013-8#1)
or placement##3##2##(2005-12#1)(2006-5#1)(2010-12#1)
or placing##2##2##(2008-10#1)(2008-7#1)
or planar##4##2##(2008-2#2)(2008-3#1)(2012-2#1)
or planned##4##2##(1992-1#1)(1997-2#1)(2008-5#1)(2008-7#1)
or planning##2##2##(2006-10#1)(2013-1#1)
or plant##9##2##(1990-12#1)(2004-4#1)(2008-1#1)(2008-10#3)(2008-8#1)(2009-8#1)(2011-2#1)
or plasma##24##2##(1990-2#1)(1990-4#3)(1990-8#2)(1991-2#1)(1994-2#3)(1994-6#1)(1995-5#1)(1996-12#1)(1997-3#1)(1997-8#1)(2006-5#1)(2006-9#1)(2007-2#1)(2008-3#1)(2008-4#2)(2009-6#1)(2010-5#1)(2011-2#1)
or plasmid##2##2##(1991-12#1)(2008-4#1)
or plasminogen##2##2##(1995-2#1)(1997-2#1)
or plastic##6##2##(1991-12#1)(1992-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-12#1)
or plate and##2##3##(2007-8#1)(2011-2#1)
or plate##3##2##(2007-11#1)(2007-8#1)(2011-2#1)
or platelet derived growth factor##2##5##(1991-12#1)(2013-1#1)
or platelet##4##2##(1991-12#1)(2008-7#1)(2013-1#2)
or plates with##2##3##(2008-10#1)(2011-2#1)
or plates##4##2##(2007-12#1)(2007-8#1)(2008-10#1)(2011-2#1)
or playing##3##2##(2005-7#1)(2012-12#2)
or pleural##3##2##(2007-8#1)(2010-9#2)
or plexus##3##2##(2008-4#2)(2009-5#1)
or pneumonectomy##2##2##(2007-8#1)(2008-5#1)
or point##2##2##(1995-3#1)(2008-4#1)
or point-to-point data transmission##2##4##(2013-1#2)
or pointed##2##2##(1995-2#1)(2008-1#1)
or points##3##2##(1991-12#1)(2008-2#2)
or policy##4##2##(2012-1#1)(2013-1#2)(2013-8#1)
or political##4##2##(1995-4#1)(2009-10#1)(2009-6#1)(2012-3#1)
or poly-L-lysine##3##2##(1994-8#1)(2006-12#1)(2008-8#1)
or poly-aspartic##2##2##(2008-11#2)
or polyamines##2##2##(1993-8#1)(1996-12#1)
or polyclonal antibodies##5##3##(1990-12#1)(1991-5#1)(1991-8#1)(1996-6#1)(2008-9#1)
or polyclonal##9##2##(1990-12#1)(1991-5#1)(1991-8#1)(1996-6#1)(2007-11#2)(2008-5#1)(2008-9#1)(2012-2#1)
or polymer##5##2##(2006-9#1)(2008-10#2)(2008-12#1)(2009-7#1)
or polymerase##2##2##(2012-2#1)(2012-3#1)
or polymers##2##2##(1994-3#1)(2008-7#1)
or polystyrene##5##2##(1993-12#1)(2005-11#1)(2008-11#3)
or polyunsaturated fatty acids##2##4##(1993-9#1)(2012-2#1)
or polyunsaturated fatty##3##3##(1993-9#1)(1996-9#1)(2012-2#1)
or polyurethane##2##2##(2008-10#1)(2008-2#1)
or poor##13##2##(1992-5#1)(1997-2#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-7#1)(2012-3#1)(2013-1#2)
or poorly understood##2##3##(2007-12#1)(2013-7#1)
or poorly##6##2##(1994-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-12#1)(2013-7#1)
or population##7##2##(1993-6#1)(1997-8#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
or populations##4##2##(2008-10#4)
or porcelain-based materials##2##3##(2008-7#1)(2013-1#1)
or porcine##2##2##(1995-1#1)(2008-10#1)
or positive for##2##3##(2006-7#1)(2011-2#1)
or positive##12##2##(1990-8#1)(2005-10#2)(2006-7#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)(2011-2#3)
or possible##6##2##(1996-11#1)(1997-6#1)(2008-10#1)(2008-4#2)(2008-7#1)
or possibly##9##2##(1990-10#1)(1990-8#1)(1994-2#1)(1997-1#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-9#1)(2011-2#1)
or post##2##2##(1996-9#1)(2006-8#1)
or post-QQc cells##3##3##(2012-12#3)
or post-surgical##2##2##(1993-9#1)(2011-1#1)
or post-translational levels##2##3##(1992-8#1)(1995-3#1)
or post-translational modifications##3##3##(1994-2#1)(1994-8#1)(2008-4#1)
or post-translational processes##2##3##(1993-11#1)(2012-2#1)
or post-translational##8##2##(1992-8#1)(1993-11#1)(1994-2#1)(1994-8#1)(1995-3#1)(2008-4#1)(2008-5#1)(2012-2#1)
or posterior interbody fusion##2##4##(2007-8#2)
or posterior##15##2##(1990-11#1)(1991-2#1)(1994-3#1)(2006-12#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-8#2)(2007-9#2)(2008-3#1)(2008-9#1)
or postnatal##5##2##(1996-1#1)(2007-12#1)(2008-11#1)(2008-4#1)(2011-1#1)
or postoperative complications##4##3##(1992-2#1)(2012-12#3)
or postoperative##9##2##(1992-2#1)(1993-4#1)(2006-11#1)(2007-11#2)(2008-3#1)(2012-12#3)
or postpone##2##2##(1990-11#1)(2009-5#1)
or postsynaptic##2##2##(1997-2#1)(2008-4#1)
or potassium##6##2##(2006-4#1)(2007-11#2)(2008-10#2)(2008-7#1)
or potential risks##2##3##(2008-11#1)(2013-1#1)
or potential##18##2##(1991-11#1)(1996-7#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-11#2)(2008-4#2)(2008-7#1)(2009-12#1)(2009-9#1)(2012-12#1)(2012-2#1)(2013-1#4)
or potentially##3##2##(1995-2#1)(2008-10#1)(2010-4#1)
or potentiate##2##2##(1996-12#1)(2006-6#1)
or powders##2##2##(2008-10#1)(2008-3#1)
or power##2##2##(1992-12#1)(2008-2#1)
or practical##3##2##(1993-9#1)(1995-12#1)(2008-3#1)
or practice##3##2##(1996-12#1)(2009-1#1)(2010-10#1)
or practices##2##2##(2007-12#1)(2012-3#1)
or pre-existing##3##2##(2007-8#1)(2007-9#1)(2010-6#1)
or preceded##2##2##(1993-9#1)(2013-7#1)
or precise##3##2##(1994-9#1)(2010-12#2)
or predict##3##2##(2007-4#1)(2010-10#1)(2010-5#1)
or prediction##2##2##(1991-6#1)(2008-8#1)
or predictive##3##2##(2004-2#1)(2008-10#1)(2009-11#1)
or predisposing##2##2##(1990-11#1)(2009-4#1)
or predominant##2##2##(1994-8#1)(2007-10#1)
or pregnancy##4##2##(1990-8#1)(1991-3#2)(1994-12#1)
or premature##4##2##(2008-11#1)(2010-10#1)(2010-3#1)(2011-1#1)
or preoperative##4##2##(1996-12#1)(2004-12#1)(2006-12#1)(2012-3#1)
or presence of the##4##4##(1990-7#1)(1992-9#1)(1995-5#1)(1997-7#1)
or presence of##30##3##(1990-7#2)(1990-9#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-9#1)(1993-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2006-12#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#3)(2013-7#1)
or presence##33##2##(1990-7#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2006-12#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#3)(2013-7#1)
or present in##9##3##(1992-7#1)(1993-12#1)(1993-9#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-4#1)(2010-6#1)
or present##14##2##(1992-7#1)(1993-12#1)(1993-9#1)(1994-9#1)(1997-4#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-4#1)(2009-4#1)(2010-6#1)(2010-9#1)(2013-8#1)
or presented##4##2##(2008-11#1)(2013-1#1)(2013-7#2)
or pressure##9##2##(1990-4#1)(1993-12#1)(1995-4#1)(2004-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-11#1)
or presumed##2##2##(1991-4#1)(2007-11#1)
or preterm##2##2##(1995-8#1)(2010-12#1)
or pretreatment##2##2##(1990-3#1)(1994-12#1)
or prevalence##2##2##(1991-10#1)(1997-3#1)
or prevent the##2##3##(1996-11#1)(2007-11#1)
or prevent this##2##3##(2004-11#1)(2006-10#1)
or prevent##20##2##(1993-2#1)(1996-11#1)(2004-11#1)(2006-10#3)(2006-11#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#1)(2009-11#1)(2010-1#1)(2010-5#1)(2011-2#1)(2013-8#1)
or prevented by##2##3##(1992-2#1)(2006-11#1)
or prevented##4##2##(1992-2#1)(1994-3#1)(2006-11#1)(2010-1#1)
or preventing##3##2##(2007-11#1)(2010-11#1)(2012-3#1)
or prevention of the##2##4##(2008-3#1)(2009-5#1)
or prevention of##7##3##(1990-5#1)(2006-2#1)(2008-3#1)(2009-5#1)(2010-12#1)(2011-2#2)
or prevention##10##2##(1990-5#1)(1996-11#1)(2005-10#1)(2006-2#1)(2007-12#1)(2008-3#1)(2009-5#1)(2010-12#1)(2011-2#2)
or prevents##2##2##(1991-9#1)(2010-7#1)
or previous##7##2##(1990-6#1)(2007-1#1)(2007-2#1)(2008-1#2)(2008-6#1)(2008-9#1)
or previously##2##2##(1991-4#1)(2012-2#1)
or primary care##3##3##(1993-1#1)(1995-2#1)(2011-2#1)
or primary cells##2##3##(2008-11#1)(2009-4#1)
or primary##19##2##(1993-1#1)(1995-11#1)(1995-2#1)(1995-5#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-2#1)
or primers##2##2##(1997-7#1)(2006-3#1)
or priming##2##2##(1993-2#1)(2008-10#1)
or primitive##2##2##(2008-1#1)(2011-1#1)
or principal##3##2##(1994-3#1)(2010-2#2)
or prion##2##2##(2008-11#1)(2010-11#1)
or prior to##4##3##(2007-11#1)(2008-5#1)(2013-7#2)
or prior##8##2##(1995-3#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-5#1)(2012-12#1)(2013-7#2)
or private##4##2##(1994-12#1)(2005-5#1)(2010-1#1)(2012-3#1)
or problem##3##2##(2004-12#1)(2007-12#1)(2008-12#1)
or problematic##2##2##(2008-11#1)(2012-12#1)
or problems##3##2##(1995-1#1)(2009-7#1)(2012-2#1)
or procedure##2##2##(1993-3#1)(2007-2#1)
or procedures##4##2##(1993-12#1)(2005-7#1)(2009-5#1)(2010-11#1)
or processes##2##2##(2008-10#1)(2009-8#1)
or processing##4##2##(1990-2#1)(1994-11#1)(1995-6#1)(2008-1#1)
or produce##4##2##(2005-10#1)(2007-12#1)(2008-10#1)(2008-12#1)
or produced##4##2##(2005-10#1)(2005-12#1)(2005-6#1)(2008-11#1)
or producing##2##2##(2007-4#1)(2008-10#1)
or product##9##2##(1995-5#1)(1996-12#2)(2005-5#1)(2006-12#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)
or production of##3##3##(1994-3#1)(2008-11#1)(2010-11#1)
or production##6##2##(1993-3#1)(1994-3#1)(2008-1#1)(2008-11#2)(2010-11#1)
or productivity##2##2##(1993-2#1)(2008-9#1)
or products##6##2##(1991-9#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-5#1)
or professional##6##2##(1990-5#1)(1992-1#1)(2004-12#1)(2008-1#1)(2008-11#1)(2008-9#1)
or profiles##2##2##(2007-10#1)(2011-1#1)
or profound##3##2##(1990-9#1)(2007-10#1)(2012-1#1)
or profoundly hypothermic CPB##2##4##(2007-9#2)
or progenitor##3##2##(2009-6#2)(2009-8#1)
or progesterone##3##2##(1995-10#1)(2005-6#1)(2008-6#1)
or prognosis##4##2##(1992-2#1)(1993-7#1)(1996-4#1)(2007-12#1)
or prognostic##3##2##(1990-2#1)(1991-8#1)(2010-12#1)
or programmed cell death##3##4##(2008-11#1)(2008-4#1)(2011-2#1)
or programs##2##2##(1996-3#1)(2007-2#1)
or progression of disease##2##4##(1990-8#1)(2013-1#1)
or progression of the##2##4##(2010-12#1)(2011-2#1)
or progression of##8##3##(1990-8#1)(2006-10#1)(2006-6#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-7#1)
or progression to##2##3##(2008-1#1)(2012-2#1)
or progression##18##2##(1990-8#1)(1991-8#1)(1996-7#1)(2006-10#3)(2006-6#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-4#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
or progressive disease##3##3##(1994-8#1)(2005-5#1)(2009-3#1)
or progressive##7##2##(1994-8#1)(2005-5#1)(2006-8#1)(2008-5#1)(2008-6#1)(2009-3#1)(2009-8#1)
or progressively##2##2##(1992-9#1)(1996-4#1)
or proinflammatory##3##2##(1995-1#1)(2007-3#1)(2008-4#1)
or proliferation##6##2##(1992-9#1)(1996-10#1)(1997-4#1)(1997-7#1)(2008-10#1)(2012-2#1)
or proliferative##2##2##(1994-5#1)(2009-3#1)
or proline##2##2##(1991-5#1)(1991-7#1)
or prolonged##11##2##(1991-11#1)(1992-5#1)(1995-12#1)(1995-2#1)(1996-12#1)(2004-10#1)(2006-10#1)(2008-10#1)(2008-8#1)(2010-12#1)(2010-4#1)
or promote the##3##3##(1996-4#1)(2008-2#1)(2012-12#1)
or prone##2##2##(1993-4#1)(2008-5#1)
or proof of##2##3##(2007-1#1)(2008-8#1)
or prophylactic##2##2##(1993-10#1)(2011-2#1)
or propofol##4##2##(1995-12#1)(2013-1#1)(2013-7#2)
or proportion of##2##3##(2011-2#1)(2012-3#1)
or propranolol##4##2##(1990-5#1)(1994-9#2)(1995-3#1)
or propyl##2##2##(1996-8#1)(2008-7#1)
or prostaglandin E2##4##3##(1991-3#1)(1991-7#1)(1992-6#1)(1994-10#1)
or prostaglandin##8##2##(1991-3#1)(1991-7#1)(1992-6#1)(1992-8#1)(1993-5#1)(1994-10#1)(1996-10#1)(2006-5#1)
or prostate cancer##5##3##(2007-2#1)(2008-7#2)(2013-8#2)
or prostate##6##2##(1991-12#1)(2007-2#1)(2008-7#2)(2013-8#2)
or prosthetic##3##2##(2008-3#1)(2010-3#1)(2011-2#1)
or protease##4##2##(1991-12#1)(1994-5#1)(1995-6#1)(2011-3#1)
or protect against##4##3##(2005-10#1)(2006-10#1)(2008-1#1)(2010-8#1)
or protect##7##2##(1996-6#1)(2005-10#1)(2006-10#1)(2008-1#1)(2010-8#1)(2010-9#1)(2013-1#1)
or protecting##2##2##(2007-7#1)(2008-10#1)
or protection##6##2##(1991-10#2)(2013-7#4)
or protective effects##3##3##(1996-2#1)(2008-10#1)(2008-7#1)
or protective##5##2##(1995-5#1)(1996-2#1)(2008-10#2)(2008-7#1)
or protein G in##2##4##(1992-7#2)
or protein G##3##3##(1992-7#2)(2005-8#1)
or protein complex##3##3##(1991-11#1)(1994-12#1)(2008-4#1)
or protein degradation##2##3##(1992-4#1)(2007-3#1)
or protein domains##2##3##(1995-2#1)(2008-4#1)
or protein kinase C##3##4##(1994-2#2)(1995-2#1)
or protein synthesis inhibitors##2##4##(1991-5#1)(1997-2#1)
or protein synthesis##3##3##(1990-2#1)(1991-5#1)(1997-2#1)
or protein##44##2##(1990-2#1)(1990-3#1)(1991-11#1)(1991-3#1)(1991-5#1)(1992-4#1)(1992-7#2)(1993-4#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-4#2)(1995-6#1)(1995-8#1)(1997-2#1)(1997-4#2)(1997-7#1)(2005-8#1)(2006-5#1)(2007-12#1)(2007-3#1)(2008-11#1)(2008-2#1)(2008-4#4)(2008-5#1)(2008-8#1)(2008-9#2)(2010-4#1)(2011-2#2)(2012-2#1)
or proteinase##2##2##(1991-1#1)(2007-8#1)
or proteins##16##2##(1992-4#1)(1992-5#1)(1995-2#2)(1995-7#1)(1995-9#1)(2005-11#1)(2006-10#1)(2006-5#1)(2008-10#2)(2008-4#2)(2008-7#1)(2009-12#1)(2011-2#1)
or proteinuria##5##2##(2006-8#1)(2007-10#1)(2008-1#1)(2008-8#1)(2011-2#1)
or prototypes##2##2##(1997-8#1)(2008-5#1)
or protruding##3##2##(2008-5#3)
or provide##9##2##(1990-12#1)(1996-9#1)(1997-1#1)(2007-10#1)(2008-1#1)(2008-2#1)(2008-4#1)(2010-12#1)(2010-5#1)
or providing##4##2##(1994-3#1)(1996-2#1)(2008-1#1)(2013-8#1)
or provocative##2##2##(1997-6#1)(2013-1#1)
or proximal##6##2##(2006-11#1)(2007-7#1)(2010-12#1)(2012-12#2)(2012-3#1)
or pseudocysts)##2##2##(2013-1#2)
or psoriasis##2##2##(2008-3#2)
or psychiatric disorders##5##3##(1995-1#1)(2007-10#1)(2008-1#1)(2008-9#2)
or psychiatric##12##2##(1995-1#1)(2007-10#1)(2007-2#2)(2007-6#1)(2008-1#1)(2008-6#1)(2008-9#4)(2013-1#1)
or psychological##5##2##(2006-10#2)(2007-9#1)(2008-7#1)(2013-1#1)
or psychosocial stress##2##3##(2008-11#1)(2008-4#1)
or psychosocial##3##2##(2006-2#1)(2008-11#1)(2008-4#1)
or psychotherapeutic##2##2##(2006-8#1)(2008-2#1)
or public health##2##3##(2009-11#1)(2013-8#1)
or public##8##2##(1991-3#1)(2007-8#1)(2008-11#1)(2009-11#1)(2013-1#3)(2013-8#1)
or publication##2##2##(2008-7#2)
or published##7##2##(1990-1#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#1)
or pulmonary artery##2##3##(1991-6#1)(1994-8#1)
or pulmonary##13##2##(1990-2#1)(1991-6#1)(1994-8#1)(1996-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
or pulse##3##2##(2007-11#2)(2011-2#1)
or pulsed##2##2##(2008-2#1)(2011-2#1)
or purchase##2##2##(1990-12#1)(1996-2#1)
or pure##3##2##(1994-9#1)(2008-10#2)
or purification of##2##3##(1997-3#1)(2008-4#1)
or purification##3##2##(1996-9#1)(1997-3#1)(2008-4#1)
or purified##11##2##(1990-11#1)(1991-1#1)(1991-5#1)(1992-12#1)(1992-4#1)(1993-11#1)(1993-8#1)(1996-12#1)(1997-6#1)(2008-4#1)(2010-12#1)
or purple##3##2##(2008-10#1)(2010-12#1)(2011-2#1)
or putative##5##2##(1993-8#1)(1994-10#1)(1997-3#1)(2008-10#1)(2008-8#1)
or pyridine##2##2##(1997-2#1)(2007-11#1)
or pyrophosphate##2##2##(2008-4#2)
or quadratic##2##2##(2007-11#1)(2008-8#1)
or qualitative##4##2##(2006-12#1)(2006-6#1)(2008-9#1)(2009-9#1)
or quality assurance##2##3##(1995-1#1)(2009-4#1)
or quality of life##6##4##(1997-8#1)(2006-10#2)(2006-12#1)(2007-11#1)(2008-7#1)
or quality of##10##3##(1992-2#1)(1992-3#1)(1995-2#1)(1997-8#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-8#1)(2008-7#1)
or quality##14##2##(1992-2#1)(1992-3#1)(1995-1#1)(1995-2#1)(1997-8#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-4#1)
or quantification of##3##3##(1993-2#1)(2008-10#1)(2010-2#1)
or quantified##2##2##(2008-9#1)(2011-2#1)
or quantitative##9##2##(2007-11#1)(2008-10#3)(2008-6#1)(2011-1#1)(2012-11#1)(2012-2#1)(2012-3#1)
or quartz##4##2##(2008-10#3)(2008-3#1)
or quasi-RCTs##2##2##(2008-10#2)
or quaternary##3##2##(1990-11#1)(2008-4#2)
or quinone##2##2##(2008-10#1)(2012-1#1)
or rabbit##8##2##(1992-6#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-6#1)(2008-4#2)
or radiation therapy##4##3##(2007-7#1)(2008-6#1)(2008-7#1)(2012-2#1)
or radiation##12##2##(2004-1#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-6#1)(2008-7#2)(2012-2#1)(2013-1#1)
or radiation-induced##4##2##(2006-11#2)(2008-7#2)
or radio##4##2##(1992-1#1)(1996-5#1)(2007-7#1)(2008-2#1)
or radiographic evidence of##3##4##(2010-2#1)(2011-2#1)(2013-1#1)
or radiographic outcomes##2##3##(2013-1#2)
or radiographic##8##2##(2005-8#1)(2010-2#1)(2011-2#2)(2013-1#4)
or radiological signs of##2##4##(2006-9#1)(2007-7#1)
or radiological##5##2##(2006-9#1)(2007-7#1)(2009-3#1)(2013-1#2)
or radiosurgical##2##2##(1996-3#1)(2007-12#1)
or radiotherapy for##2##3##(2007-10#1)(2011-12#1)
or radiotherapy##16##2##(1996-6#1)(1996-9#2)(2005-11#1)(2007-10#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-6#1)(2009-3#1)(2011-12#1)(2012-3#1)(2013-8#1)
or raise##2##2##(2005-8#1)(2006-10#1)
or random##8##2##(1990-6#1)(1995-7#1)(1996-3#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)
or randomized##2##2##(2006-12#1)(2012-2#1)
or randomly##5##2##(1993-2#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-5#1)
or ranitidine##2##2##(2008-11#1)(2013-8#1)
or rapid##3##2##(2010-2#1)(2011-2#2)
or rapidly progressive##2##3##(2006-10#1)(2007-7#1)
or rapidly##4##2##(2006-10#2)(2007-7#1)(2007-9#1)
or rare##2##2##(1992-11#1)(2011-2#1)
or rarely##6##2##(2006-9#1)(2007-11#1)(2008-10#2)(2008-4#1)(2012-12#1)
or rat liver##2##3##(1993-8#1)(2008-9#1)
or rat##14##2##(1991-5#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-6#1)(1997-2#1)(2006-9#1)(2008-4#1)(2008-9#1)
or rate##2##2##(2007-4#1)(2008-10#1)
or rats##3##2##(1993-3#1)(2008-4#1)(2009-11#1)
or reacted##2##2##(1991-7#1)(1994-3#1)
or reaction##2##2##(2008-10#1)(2010-3#1)
or reactivation##2##2##(2008-10#1)(2011-2#1)
or reactive##2##2##(1990-3#1)(2008-10#1)
or reagents##2##2##(2008-10#1)(2009-6#1)
or reality?##6##2##(1991-1#1)(1991-8#1)(2006-3#1)(2006-9#1)(2008-11#1)(2009-7#1)
or reason for##2##3##(2008-7#1)(2010-3#1)
or reasonably##2##2##(2008-4#1)(2008-7#1)
or recN##2##2##(1991-10#2)
or received##7##2##(1995-11#1)(2007-12#1)(2008-2#1)(2009-11#1)(2010-10#1)(2010-6#1)(2011-1#1)
or receiving##2##2##(2011-2#2)
or recent##5##2##(1991-7#1)(2007-11#1)(2007-12#1)(2010-8#1)(2011-2#1)
or receptor##7##2##(1991-3#1)(1991-7#1)(1994-8#1)(1996-12#1)(1997-1#1)(2008-7#1)(2013-8#1)
or receptors##2##2##(1997-2#1)(2006-10#1)
or recombinant##8##2##(1990-12#1)(1990-5#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-4#2)(2012-12#1)
or recombination##3##2##(1992-6#1)(1994-8#1)(2008-10#1)
or reconstructed##2##2##(1996-12#1)(2007-1#1)
or reconstructive##2##2##(2008-9#1)(2012-2#1)
or recover##2##2##(2007-1#1)(2013-1#1)
or recovery##3##2##(2005-9#1)(2008-10#1)(2013-8#1)
or recruitment##3##2##(1995-12#1)(1997-4#1)(2011-12#1)
or rectal##3##2##(1991-7#1)(1993-7#1)(2007-2#1)
or rectum##3##2##(1991-10#1)(1996-12#1)(2008-5#1)
or recurrence after##2##3##(2004-1#1)(2008-7#1)
or recurrence of the disease##2##5##(2006-11#1)(2013-8#1)
or recurrence of the##3##4##(2006-11#1)(2010-5#1)(2013-8#1)
or recurrence of##6##3##(2006-11#1)(2008-1#1)(2008-6#1)(2010-5#1)(2012-12#1)(2013-8#1)
or recurrence##15##2##(1992-3#1)(2004-1#1)(2004-10#1)(2005-5#1)(2006-11#1)(2006-9#1)(2008-1#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
or recurrent disease##4##3##(2006-9#2)(2008-6#1)(2009-11#1)
or recurrent gastric cancer##2##4##(2008-4#1)(2009-8#1)
or recurrent pain##2##3##(2009-12#1)(2010-3#1)
or recurrent##46##2##(1990-5#1)(1990-9#1)(1991-10#1)(1991-2#1)(1993-6#1)(1995-10#1)(1995-8#1)(1997-5#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#1)(2006-9#2)(2007-11#4)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)
or red blood cells##2##4##(2012-2#1)(2013-1#1)
or red cell##2##3##(1992-12#1)(2006-10#1)
or red##10##2##(1990-8#1)(1992-12#1)(1997-7#1)(2006-10#1)(2006-12#1)(2008-3#1)(2009-6#1)(2010-7#1)(2012-2#1)(2013-1#1)
or redox##3##2##(1990-8#1)(1994-8#1)(2008-10#1)
or reduce the##5##3##(1994-4#1)(1996-12#1)(1997-2#1)(2008-5#1)(2010-11#1)
or reduce##12##2##(1994-4#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-2#1)(2008-11#1)(2008-5#1)(2009-7#1)(2010-11#1)(2010-7#1)(2012-1#1)(2012-2#1)
or reduced to##2##3##(1994-8#1)(2008-11#1)
or reduced##22##2##(1990-1#1)(1990-10#1)(1990-12#1)(1990-2#1)(1991-1#1)(1991-2#1)(1991-6#1)(1992-8#1)(1993-4#1)(1994-5#1)(1994-8#1)(1995-1#1)(1996-11#1)(1996-2#1)(2004-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-1#1)
or reducing the##6##3##(1990-10#1)(1992-11#1)(1992-3#1)(2007-3#1)(2011-1#1)(2012-12#1)
or reducing##13##2##(1990-10#1)(1990-5#2)(1992-11#1)(1992-3#1)(1996-8#1)(1996-9#1)(2007-3#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
or reduction of##5##3##(1990-3#1)(2008-10#1)(2010-10#1)(2010-9#1)(2013-8#1)
or reduction##8##2##(1990-3#2)(1990-8#1)(1996-2#1)(2008-10#1)(2010-10#1)(2010-9#1)(2013-8#1)
or reference##4##2##(1992-10#1)(2008-10#2)(2008-12#1)
or referred##2##2##(2006-8#1)(2008-12#1)
or reflected##2##2##(2006-1#1)(2008-3#1)
or reflective##2##2##(2008-11#2)
or reflex##2##2##(2008-4#1)(2011-2#1)
or refractory##9##2##(1995-12#1)(2005-7#1)(2007-11#4)(2008-5#1)(2008-6#1)(2011-2#1)
or refuse consent to##2##4##(1993-5#1)(2008-11#1)
or refuse##3##2##(1993-5#1)(2006-10#1)(2008-11#1)
or refute##5##2##(1996-3#1)(1997-8#1)(2007-6#2)(2012-12#1)
or regain##2##2##(2010-10#1)(2011-1#1)
or regenerating##2##2##(1994-3#1)(2008-1#1)
or regimens##2##2##(2007-5#1)(2007-9#1)
or region##2##2##(2006-6#1)(2013-1#1)
or regional flaps##2##3##(2006-12#1)(2007-12#1)
or regional variation in##2##4##(2008-10#1)(2012-1#1)
or regional##19##2##(1990-11#1)(1992-2#1)(2006-10#4)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)
or regions##4##2##(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)
or regression of##4##3##(2004-3#1)(2007-6#1)(2008-8#1)(2013-8#1)
or regression##7##2##(2004-3#1)(2006-10#1)(2007-6#1)(2008-8#2)(2012-12#1)(2013-8#1)
or regulating##2##2##(2010-11#1)(2011-2#1)
or regulation##3##2##(1990-7#1)(1994-3#1)(2012-2#1)
or regulatory##4##2##(1994-1#1)(1994-5#1)(1996-12#1)(2007-10#1)
or rehabilitation##2##2##(1990-5#1)(2008-8#1)
or reinfection##2##2##(1991-2#1)(2006-10#1)
or reinforce##2##2##(2006-10#1)(2013-7#1)
or reject the##2##3##(2006-5#1)(2010-11#1)
or reject##5##2##(1997-4#1)(2006-5#1)(2008-3#1)(2010-11#1)(2012-11#1)
or rejection of the null hypothesis##2##6##(2008-3#1)(2008-7#1)
or rejection of the##3##4##(2008-3#1)(2008-7#1)(2012-2#1)
or rejection of##7##3##(2007-10#1)(2008-3#1)(2008-7#1)(2012-2#1)(2012-3#2)(2013-7#1)
or rejection##10##2##(2006-10#1)(2007-10#1)(2007-8#1)(2008-3#1)(2008-7#1)(2012-2#1)(2012-3#2)(2013-7#2)
or relapse after##2##3##(2005-12#1)(2009-11#1)
or relapse##6##2##(1996-2#1)(2005-12#1)(2008-6#1)(2009-11#1)(2009-3#1)(2011-2#1)
or relapsed##7##2##(2007-10#4)(2007-11#1)(2008-1#1)(2010-4#1)
or relapsing##2##2##(1993-3#1)(2006-6#1)
or related to##5##3##(1995-3#1)(2006-10#1)(2007-7#1)(2008-6#1)(2011-12#1)
or related##23##2##(1992-12#1)(1993-4#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-5#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-10#1)(2010-12#1)(2010-5#1)(2011-12#1)(2011-2#1)(2013-1#1)
or relative##5##2##(1996-4#1)(2006-2#1)(2010-11#1)(2010-5#1)(2012-1#1)
or relatively##3##2##(2008-9#1)(2011-2#1)(2012-1#1)
or relatives##7##2##(1993-11#1)(1996-6#1)(1997-6#1)(2008-12#1)(2008-7#1)(2009-6#1)(2011-2#1)
or release of##2##3##(1994-2#1)(2006-8#1)
or release##6##2##(1991-11#1)(1991-2#1)(1994-10#1)(1994-2#1)(1996-12#1)(2006-8#1)
or released##2##2##(2007-3#1)(2011-12#1)
or releasing##2##2##(2008-12#1)(2008-9#1)
or reliability##2##2##(1997-8#1)(2008-1#1)
or relieve##3##2##(1993-1#1)(2008-9#1)(2010-9#1)
or remain at##2##3##(2008-8#2)
or remain in##2##3##(2006-2#1)(2007-2#1)
or remain##7##2##(2006-2#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-8#2)(2013-1#1)
or remained##3##2##(2008-10#3)
or remains##2##2##(1991-5#1)(2006-10#1)
or remote##2##2##(1995-12#1)(2005-10#1)
or remotely##2##2##(2007-4#1)(2008-3#1)
or removal of the##2##4##(1990-2#1)(1993-2#1)
or removal of##9##3##(1990-2#1)(1990-7#1)(1993-2#1)(1994-12#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-11#1)
or removal##11##2##(1990-2#1)(1990-7#1)(1993-2#1)(1994-12#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#1)
or remove##4##2##(2004-10#1)(2005-11#1)(2005-7#1)(2009-3#1)
or removed##2##2##(1991-11#1)(2008-8#1)
or removing##2##2##(2008-3#1)(2012-11#1)
or renal function##2##3##(1991-11#1)(2006-4#1)
or renal involvement##2##3##(2011-1#1)(2011-2#1)
or renal##14##2##(1991-11#1)(1993-12#1)(2006-10#1)(2006-4#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
or rendered##2##2##(2005-11#1)(2011-2#1)
or repair and##2##3##(1990-4#1)(2007-10#1)
or repair the##2##3##(2008-5#2)
or repair##13##2##(1990-4#1)(1992-12#1)(1992-9#1)(1996-11#1)(2007-10#1)(2007-8#2)(2008-5#2)(2008-9#1)(2012-2#1)(2013-8#2)
or repeated##12##2##(1990-12#1)(1990-4#1)(1990-7#1)(1993-12#1)(2006-5#1)(2008-11#1)(2008-5#1)(2010-1#1)(2010-2#2)(2012-12#1)(2012-2#1)
or replace it##2##3##(2007-8#1)(2011-2#1)
or replace##7##2##(2006-10#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-4#1)(2009-9#1)(2011-2#1)
or replacement of##4##3##(1993-3#1)(1994-3#1)(2008-4#1)(2008-5#1)
or replacement with##2##3##(1995-8#1)(2008-10#1)
or replacement##12##2##(1993-3#1)(1994-3#1)(1995-8#1)(1997-3#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-9#1)(2011-2#1)(2012-3#1)
or replacing##2##2##(1991-1#1)(2008-11#1)
or replication##3##2##(1994-8#1)(1997-3#1)(2010-2#1)
or reported##4##2##(2006-2#1)(2008-2#1)(2009-4#1)(2010-7#1)
or reporting##2##2##(2008-9#1)(2011-1#1)
or represent##3##2##(2006-5#1)(2011-1#1)(2013-8#1)
or repress##3##2##(1993-2#1)(2008-4#2)
or repression##2##2##(2008-10#1)(2008-9#1)
or reproductive##5##2##(1992-3#2)(2004-2#1)(2008-3#1)(2008-9#1)
or require##4##2##(2005-2#1)(2007-12#1)(2008-4#1)(2011-2#1)
or required##4##2##(1994-4#1)(2005-11#1)(2008-5#1)(2010-12#1)
or requires##2##2##(1990-7#1)(2010-4#1)
or research##6##2##(1996-2#1)(2004-11#1)(2008-11#1)(2008-7#1)(2010-9#1)(2012-2#1)
or resection of##2##3##(1990-3#1)(2011-2#1)
or reserve##2##2##(2008-11#1)(2011-2#1)
or residence##2##2##(1991-10#1)(2010-9#1)
or residual##7##2##(1992-9#1)(2007-9#1)(2008-1#1)(2009-10#1)(2009-11#1)(2010-5#1)(2013-1#1)
or residue##2##2##(1994-9#1)(2008-10#1)
or residues##2##2##(2007-6#1)(2010-5#1)
or resistance to##8##3##(1996-10#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#2)
or resistance##17##2##(1993-3#1)(1993-8#1)(1996-10#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#3)(2012-12#1)(2013-1#1)
or resistant to imatinib##2##4##(2009-3#1)(2012-12#1)
or resistant to##11##3##(1992-11#1)(1992-7#1)(1996-9#1)(1997-4#1)(2008-10#3)(2008-2#1)(2008-5#1)(2009-3#1)(2012-12#1)
or resistant##20##2##(1992-11#1)(1992-7#1)(1996-12#1)(1996-9#1)(1997-3#1)(1997-4#1)(2008-10#7)(2008-2#1)(2008-5#1)(2009-3#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-7#1)
or resolution of##5##3##(1991-2#1)(1997-2#1)(2006-8#1)(2007-8#1)(2008-7#1)
or resources##2##2##(1993-12#1)(1997-8#1)
or respiratory depression##2##3##(2007-2#1)(2010-7#1)
or respiratory insufficiency##2##3##(1991-9#1)(2010-9#1)
or respiratory##8##2##(1991-6#1)(1991-9#1)(2005-8#1)(2007-2#1)(2008-10#1)(2010-1#1)(2010-7#1)(2010-9#1)
or response to##3##3##(1991-7#1)(2006-12#1)(2008-9#1)
or response##7##2##(1991-7#1)(1993-1#1)(2006-12#2)(2008-9#1)(2012-3#2)
or resting##2##2##(1994-3#1)(1997-8#1)
or restoration of##2##3##(2008-9#1)(2012-2#1)
or restoration##4##2##(2008-10#2)(2008-9#1)(2012-2#1)
or restore the##2##3##(2006-7#1)(2008-7#1)
or restore##4##2##(2005-8#1)(2006-7#1)(2007-11#1)(2008-7#1)
or restrict##2##2##(1995-9#1)(2008-10#1)
or restricted##3##2##(2008-10#1)(2010-1#1)(2013-8#1)
or restriction fragment length polymorphism analysis##2##6##(2008-10#2)
or restriction of##2##3##(2009-2#1)(2011-2#1)
or restriction##6##2##(1992-5#1)(1994-6#1)(2008-10#2)(2009-2#1)(2011-2#1)
or restrictive##3##2##(2010-6#1)(2011-2#1)(2012-12#1)
or result from##2##3##(2008-9#1)(2013-1#1)
or result##3##2##(2008-3#1)(2008-9#1)(2013-1#1)
or resultant##2##2##(2008-7#1)(2009-4#1)
or resulting from##2##3##(2007-11#1)(2013-8#1)
or resulting##3##2##(1991-4#1)(2007-11#1)(2013-8#1)
or results##2##2##(1997-3#1)(2006-10#1)
or retention of##2##3##(1994-3#1)(2008-4#1)
or reticulated##2##2##(2006-6#1)(2008-10#1)
or retinal##3##2##(1991-7#1)(2007-9#1)(2010-10#1)
or retinoic acid or##3##4##(1991-12#2)(2008-5#1)
or retinoic acid##6##3##(1991-12#3)(1994-9#1)(2007-12#1)(2008-5#1)
or retinoic##7##2##(1991-12#3)(1994-9#1)(1995-3#1)(2007-12#1)(2008-5#1)
or retired##3##2##(1992-1#1)(2006-8#1)(2008-11#1)
or retrieval##2##2##(2004-9#1)(2008-1#1)
or retrograde cerebral perfusion##2##4##(2007-8#2)
or retrograde##3##2##(2007-8#2)(2010-12#1)
or retroperitoneal##3##2##(1992-8#1)(2008-6#1)(2013-1#1)
or retrospective##3##2##(2010-12#1)(2012-12#1)(2013-1#1)
or return##3##2##(1996-2#1)(2009-10#1)(2013-8#1)
or revascularization##2##2##(1997-3#1)(2008-7#1)
or reversal of##2##3##(1991-9#1)(1996-10#1)
or reversal##4##2##(1991-9#1)(1993-6#1)(1996-10#1)(2006-8#1)
or reverse the##11##3##(1992-9#1)(1994-2#1)(1994-5#1)(2004-11#1)(2005-7#1)(2006-2#1)(2008-11#2)(2008-5#1)(2011-1#1)(2013-1#1)
or reverse##26##2##(1990-8#1)(1991-9#1)(1992-9#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-6#1)(1997-5#1)(2004-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-12#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2009-10#1)(2009-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
or reversed by##2##3##(2008-7#1)(2010-4#1)
or reversed##4##2##(1996-4#1)(2008-7#1)(2009-9#1)(2010-4#1)
or reversing##2##2##(1995-5#1)(2008-3#1)
or revision##5##2##(2008-1#1)(2008-8#1)(2008-9#1)(2009-3#1)(2013-1#1)
or rheumatoid arthritis##3##3##(2007-11#1)(2008-8#1)(2009-3#1)
or rheumatoid##4##2##(2007-11#1)(2007-8#1)(2008-8#1)(2009-3#1)
or riboflavin##2##2##(1992-3#1)(2005-10#1)
or ribosomal proteins##2##3##(1990-3#1)(2009-8#1)
or rice##5##2##(1991-5#1)(2006-12#1)(2008-10#1)(2008-5#2)
or right hemisphere##2##3##(1993-12#1)(1997-8#1)
or right##16##2##(1990-10#2)(1993-11#1)(1993-12#1)(1997-2#1)(1997-8#1)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-7#1)(2008-8#1)(2009-10#1)
or ring##2##2##(1996-5#1)(2006-3#1)
or risk factors for##4##4##(2007-10#1)(2011-2#3)
or risk factors##8##3##(1995-12#1)(2007-10#1)(2008-7#2)(2011-2#3)(2012-2#1)
or risk for##2##3##(1992-2#1)(2008-5#1)
or risk##21##2##(1991-7#1)(1991-8#1)(1992-2#1)(1994-9#1)(1995-12#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-7#5)(2009-9#1)(2010-6#1)(2011-2#4)(2011-3#1)(2012-2#1)
or risking##2##2##(2008-11#1)(2012-2#1)
or risky##2##2##(1992-1#1)(2008-11#1)
or river##2##2##(2007-5#1)(2008-10#1)
or rodent##3##2##(2008-4#2)(2008-7#1)
or role##3##2##(1992-2#1)(1997-7#1)(2005-8#1)
or root##2##2##(2006-10#1)(2008-10#1)
or roots##2##2##(2008-10#2)
or rotation##3##2##(2008-9#1)(2010-8#1)(2011-12#1)
or round##2##2##(2008-6#1)(2008-9#1)
or rubella##2##2##(2007-11#1)(2008-4#1)
or rule out##5##3##(2007-10#2)(2008-1#1)(2008-5#1)(2012-12#1)
or running##2##2##(2008-10#2)
or rupture##7##2##(2007-1#1)(2007-8#1)(2008-4#1)(2009-10#1)(2012-1#1)(2012-2#2)
or rural areas##2##3##(2006-10#1)(2011-2#1)
or rural##6##2##(1991-3#1)(2006-10#1)(2007-7#1)(2009-4#1)(2011-2#1)(2012-12#1)
or s##2##2##(1993-6#1)(2008-3#1)
or safe##2##2##(1991-9#1)(2008-9#1)
or safety##5##2##(1993-12#1)(1996-3#1)(1996-8#1)(1996-9#1)(2008-7#1)
or saline and##2##3##(1997-7#1)(2007-10#1)
or saline at##2##3##(1995-12#1)(2010-7#1)
or saline for 14 days##2##5##(1996-10#2)
or saline for##4##3##(1992-11#1)(1996-10#2)(1997-5#1)
or saline solution##2##3##(2006-9#1)(2007-10#1)
or saline##37##2##(1990-4#1)(1990-7#1)(1991-11#1)(1991-3#2)(1991-8#1)(1992-11#1)(1993-12#1)(1993-2#1)(1994-8#3)(1995-11#1)(1995-12#1)(1996-10#3)(1996-12#1)(1996-9#1)(1997-2#1)(1997-5#2)(1997-7#1)(1997-8#1)(2006-5#2)(2006-9#1)(2007-10#2)(2010-3#1)(2010-6#2)(2010-7#1)(2011-12#1)(2011-2#1)(2012-3#1)(2012-5#1)
or saliva##4##2##(1992-2#1)(1995-11#1)(2012-12#1)(2013-7#1)
or salivary##2##2##(1993-5#1)(2008-10#1)
or salt##4##2##(2007-11#1)(2008-10#1)(2008-4#2)
or salvage##2##2##(2006-5#1)(2009-9#1)
or sample registration##2##3##(2012-12#2)
or sample sizes##2##3##(2008-10#1)(2011-2#1)
or sample solution was##3##4##(2008-10#3)
or sample types (P = 0##2##6##(2013-8#2)
or sample##16##2##(2008-10#10)(2011-2#1)(2012-12#2)(2013-7#1)(2013-8#2)
or samples##3##2##(2007-2#1)(2008-10#1)(2008-2#1)
or sampling##2##2##(1997-5#1)(2008-11#1)
or sand##2##2##(2007-5#1)(2011-2#1)
or saralasin##2##2##(1994-8#1)(1994-9#1)
or sarcoidosis##3##2##(1993-9#1)(2007-7#1)(2012-12#1)
or sarcoma##3##2##(2007-2#1)(2010-3#1)(2012-12#1)
or satellite##3##2##(2007-5#1)(2008-3#2)
or saturation##3##2##(1994-12#1)(2006-6#1)(2008-10#1)
or scab##2##2##(2008-10#2)
or scattered##2##2##(2007-12#1)(2008-5#1)
or schizoaffective disorder##4##3##(1995-1#1)(1996-3#1)(2008-3#1)(2009-9#1)
or schizoaffective##8##2##(1991-9#1)(1995-1#1)(1996-3#1)(1996-7#1)(1997-5#1)(2004-3#1)(2008-3#1)(2009-9#1)
or school##2##2##(2011-12#2)
or scientific##3##2##(2008-4#1)(2012-3#1)(2013-8#1)
or sclerosing##3##2##(2006-2#1)(2009-7#1)(2011-2#1)
or screening##2##2##(1997-1#1)(1997-8#1)
or screw##2##2##(2007-7#1)(2011-12#1)
or second line##2##3##(1993-2#1)(2011-1#1)
or second##16##2##(1992-7#1)(1993-2#1)(1994-6#1)(1996-2#1)(2006-5#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-7#2)(2009-10#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
or secondarily##2##2##(1991-9#1)(1992-8#1)
or secondary to a##2##4##(2007-3#1)(2011-2#1)
or secondary to##12##3##(1991-12#1)(2004-3#1)(2007-1#1)(2007-3#1)(2007-7#1)(2008-1#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-2#2)
or secondary##53##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#1)(1993-5#1)(1993-6#1)(1994-2#1)(1995-10#1)(1996-11#1)(1996-12#1)(1996-9#1)(2004-3#1)(2005-9#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-2#3)(2012-3#1)(2013-8#1)
or sections##3##2##(1995-2#1)(2008-11#1)(2008-3#1)
or sedentary##3##2##(2008-3#1)(2008-5#1)(2012-2#1)
or sediment##2##2##(2008-10#1)(2008-5#1)
or sedimentation##2##2##(1990-12#1)(1996-7#1)
or seed##5##2##(2008-10#1)(2008-2#1)(2008-9#1)(2010-4#1)(2013-8#1)
or segmental##4##2##(1990-2#1)(1995-5#1)(2008-5#1)(2009-12#1)
or seizure##3##2##(1990-5#1)(1992-12#2)
or seizures##2##2##(2006-10#1)(2012-2#1)
or select##3##2##(2008-2#1)(2011-1#2)
or selected##4##2##(1991-2#1)(1992-9#1)(1993-1#1)(2008-10#1)
or selection of##3##3##(2006-10#1)(2008-1#1)(2010-4#1)
or selection##4##2##(1990-9#1)(2006-10#1)(2008-1#1)(2010-4#1)
or selective determination of##2##4##(2008-10#2)
or selective##8##2##(1990-2#1)(1996-7#1)(2006-8#1)(2008-10#4)(2013-1#1)
or selling##2##2##(2008-12#1)(2009-10#1)
or semantic##3##2##(2008-4#1)(2008-5#1)(2012-2#1)
or semen##2##2##(2007-11#1)(2007-12#1)
or semiconducting##2##2##(2008-2#1)(2008-7#1)
or seminal##3##2##(1991-2#1)(1994-6#1)(1995-3#1)
or senescence##2##2##(2008-8#1)(2012-3#1)
or sensitive##3##2##(1990-9#1)(1997-1#1)(2008-8#1)
or sensitivity##3##2##(2008-10#2)(2010-8#1)
or sensitization##2##2##(1995-12#1)(2009-7#1)
or sensory##6##2##(1996-1#1)(1996-3#1)(1997-4#1)(2005-10#1)(2008-10#1)(2012-2#1)
or separate##2##2##(2007-8#1)(2008-4#1)
or separated##2##2##(2012-12#1)(2013-1#1)
or separately##2##2##(2008-3#1)(2008-6#1)
or separation of##3##3##(1990-7#1)(2008-10#2)
or separation##6##2##(1990-7#1)(1996-5#1)(2008-10#4)
or sepsis##5##2##(1994-6#1)(2006-10#1)(2007-10#1)(2008-5#1)(2010-12#1)
or septic shock##3##3##(2008-4#1)(2011-2#2)
or septic##5##2##(2007-11#1)(2008-4#1)(2010-4#1)(2011-2#2)
or sequence##6##2##(1993-4#1)(1997-8#1)(2008-4#1)(2010-8#1)(2011-2#1)(2012-3#1)
or sequences##2##2##(1991-7#1)(1993-2#1)
or sequential chemotherapy##2##3##(2007-5#1)(2012-3#1)
or sequential##10##2##(2005-8#1)(2006-6#1)(2007-5#1)(2008-10#4)(2008-4#1)(2012-2#1)(2012-3#1)
or sequentially##7##2##(1992-5#1)(1992-6#1)(1996-3#1)(2005-11#1)(2008-10#1)(2008-7#1)(2009-2#1)
or series of##2##3##(2004-12#1)(2013-1#1)
or serine##2##2##(1994-11#1)(1995-8#1)
or serious##3##2##(1990-12#1)(2007-7#1)(2011-2#1)
or serological##2##2##(2008-10#1)(2008-4#1)
or serotonin##5##2##(1991-5#1)(1996-10#1)(1996-5#1)(1997-6#1)(2008-4#1)
or serum cholesterol##2##3##(1994-11#1)(2009-4#1)
or serum##31##2##(1990-12#1)(1990-6#1)(1991-2#1)(1991-7#1)(1992-8#1)(1994-11#2)(1994-12#1)(1995-12#1)(1996-3#1)(1996-8#2)(1997-8#2)(2005-8#2)(2007-11#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2009-4#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-2#2)
or serum-free##3##2##(1996-5#1)(2008-11#2)
or serve as##3##3##(1991-1#1)(2008-9#1)(2012-2#1)
or serve##4##2##(1991-1#1)(2008-9#1)(2012-2#2)
or service##7##2##(1994-3#1)(1997-3#1)(2006-8#2)(2008-9#1)(2011-1#1)(2011-2#1)
or services##5##2##(1994-3#1)(1995-12#1)(1995-3#1)(2008-12#1)(2008-6#1)
or sessile##2##2##(2008-10#1)(2013-8#1)
or sets of##3##3##(2008-8#1)(2013-1#2)
or setting##2##2##(2008-11#1)(2008-12#1)
or seven##5##2##(1990-5#1)(1992-10#1)(1996-8#1)(2006-12#1)(2008-7#1)
or several##26##2##(1990-5#1)(1991-6#1)(1991-9#1)(1992-8#1)(1994-5#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-5#1)(1996-9#1)(2006-3#1)(2006-4#1)(2007-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-7#1)
or severe infections##2##3##(2007-2#2)
or severe##48##2##(1990-12#1)(1990-3#1)(1991-11#1)(1991-2#1)(1991-8#1)(1991-9#1)(1994-11#1)(1994-6#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-4#1)(2004-11#1)(2004-2#1)(2004-3#1)(2006-1#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#5)(2012-2#1)(2013-8#1)
or severely affected##2##3##(2007-10#1)(2008-10#1)
or severely##4##2##(1993-2#1)(2007-10#1)(2008-10#1)(2010-3#1)
or severity of##9##3##(1994-3#1)(1997-1#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-1#1)(2013-1#1)
or severity##13##2##(1994-3#1)(1997-1#1)(1997-5#1)(2005-8#1)(2006-10#1)(2007-10#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2012-1#1)(2013-1#1)
or sex differentiation##2##3##(2010-5#2)
or sex##12##2##(1991-6#1)(1991-9#1)(1992-2#1)(1992-9#1)(1997-4#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-5#2)
or sexual##7##2##(1991-2#1)(2006-12#1)(2008-10#1)(2008-9#2)(2012-12#2)
or sexually##2##2##(1995-12#1)(2013-1#1)
or sham lesions of the##2##5##(1994-2#1)(2004-11#1)
or sham operation##3##3##(1991-1#1)(1997-5#1)(2008-7#1)
or sham##10##2##(1991-1#1)(1993-12#1)(1994-2#1)(1994-5#1)(1997-5#1)(2004-11#1)(2006-10#1)(2008-7#1)(2009-10#1)(2009-3#1)
or sham-operated##4##2##(1996-10#1)(1997-4#3)
or shape of the##2##4##(2008-3#1)(2013-1#1)
or shape##5##2##(1997-1#1)(2007-12#1)(2008-3#2)(2013-1#1)
or shared##3##2##(2007-12#1)(2008-10#1)(2008-8#1)
or sharp##2##2##(1995-3#1)(2008-9#1)
or shave excision##2##3##(2006-12#2)
or shear##2##2##(2006-11#1)(2011-2#1)
or shell##2##2##(2008-5#1)(2010-1#1)
or shift##2##2##(1994-1#1)(2008-11#1)
or shock##4##2##(1995-2#1)(2008-3#1)(2008-4#1)(2011-2#1)
or short term##2##3##(2007-11#1)(2012-2#1)
or short##8##2##(1996-11#1)(2007-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-8#1)
or short-rod##2##2##(2005-11#2)
or short-term##3##2##(1992-4#1)(1993-12#1)(1994-4#1)
or shortly after##6##3##(1995-12#1)(2008-3#1)(2008-8#2)(2009-7#1)(2013-7#1)
or shortly##9##2##(1993-7#1)(1995-12#1)(2007-6#1)(2008-3#1)(2008-8#2)(2009-7#1)(2010-12#1)(2013-7#1)
or should be##3##3##(1997-8#1)(2006-10#1)(2010-2#1)
or should##9##2##(1990-11#1)(1991-12#1)(1992-8#1)(1997-8#2)(2006-10#2)(2008-9#1)(2010-2#1)
or shoulder##4##2##(1995-3#1)(2004-1#1)(2010-4#1)(2011-2#1)
or showed##3##2##(1991-3#1)(2008-7#1)(2011-1#1)
or shunt##2##2##(2006-8#1)(2009-6#1)
or sibling##3##2##(1995-2#1)(2008-10#1)(2012-3#1)
or siblings##2##2##(2007-7#1)(2011-2#1)
or side effects##3##3##(2007-11#1)(2008-10#1)(2012-12#1)
or side##5##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-6#1)(2012-12#1)
or sigma##2##2##(1991-2#1)(1997-7#1)
or sign##5##2##(1991-8#2)(1993-5#1)(2006-8#1)(2008-9#1)
or signal##4##2##(1992-2#1)(2008-4#1)(2008-9#1)(2010-2#1)
or significant reduction##2##3##(2007-8#2)
or significant##12##2##(1995-12#1)(1996-3#1)(2006-5#1)(2006-8#1)(2007-2#1)(2007-5#1)(2007-8#2)(2008-3#1)(2012-12#2)(2012-3#1)
or significantly affect##2##3##(1991-1#1)(2008-11#1)
or significantly reduced the##2##4##(1992-6#1)(2008-8#1)
or significantly reduced##5##3##(1990-2#1)(1990-9#1)(1992-6#1)(1996-12#1)(2008-8#1)
or significantly##15##2##(1990-2#1)(1990-9#1)(1991-1#1)(1992-6#1)(1992-7#1)(1996-12#1)(2006-10#1)(2008-11#1)(2008-8#1)(2011-1#1)(2012-12#2)(2013-1#3)
or signs of##7##3##(1991-8#1)(1996-11#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-3#1)(2012-2#1)
or signs##10##2##(1991-4#1)(1991-8#1)(1996-11#1)(1997-6#1)(2006-10#1)(2007-7#2)(2007-8#1)(2008-3#1)(2012-2#1)
or silenced##2##2##(2008-8#1)(2010-12#1)
or silent##2##2##(2008-11#1)(2012-2#1)
or silica gel##2##3##(2007-11#1)(2009-6#1)
or silica##3##2##(2007-11#1)(2008-10#1)(2009-6#1)
or silicon##2##2##(2008-10#1)(2008-4#1)
or silver##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
or similar risk##2##3##(2008-3#2)
or similar to##5##3##(1990-7#1)(1996-12#2)(1996-6#1)(1997-4#1)
or similar##17##2##(1990-7#1)(1991-2#1)(1993-11#1)(1996-12#2)(1996-6#1)(1997-4#1)(2005-11#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-8#1)(2011-1#1)(2012-3#1)
or simple sequence repeat##2##4##(2010-10#1)(2011-12#1)
or simple##13##2##(1992-12#1)(1993-8#1)(2006-5#1)(2006-7#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-10#1)(2011-12#1)
or simply not##2##3##(2007-2#1)(2008-2#1)
or simply##11##2##(2006-10#2)(2007-2#1)(2007-4#1)(2008-2#1)(2009-10#1)(2010-10#1)(2010-12#2)(2011-2#2)
or simulate fractures##2##3##(2006-1#2)
or simulated##2##2##(2008-10#1)(2008-2#1)
or simultaneous##5##2##(2008-1#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-2#1)
or simultaneously##8##2##(1991-10#1)(1995-5#1)(1997-1#1)(2007-11#1)(2009-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
or single##12##2##(1994-6#2)(1995-7#1)(1997-3#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-11#1)(2010-5#1)
or single-stranded##2##2##(1995-3#1)(2011-1#1)
or site##3##2##(1991-6#1)(2008-10#1)(2008-8#1)
or sites of##2##3##(1995-2#1)(1995-3#1)
or sites##5##2##(1993-6#1)(1995-2#1)(1995-3#1)(2008-10#2)
or sitting positions##2##3##(1993-10#1)(2011-2#1)
or six##7##2##(1991-6#1)(1992-2#1)(1995-11#1)(2008-8#1)(2010-2#1)(2011-2#1)(2013-7#1)
or size of##2##3##(2008-5#1)(2012-12#1)
or size##9##2##(1996-11#1)(1996-2#1)(2007-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-12#1)(2013-8#1)
or skeletal muscle##5##3##(1990-5#1)(1991-8#1)(1994-11#1)(1996-9#1)(2009-5#1)
or skeletal##6##2##(1990-5#1)(1991-8#1)(1994-11#1)(1996-9#1)(2009-5#1)(2012-12#1)
or skin is from the primary tumor situated in the head and neck region in nearly 85% cases##2##18##(2013-1#2)
or skin##14##2##(1994-11#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#4)(2008-9#1)(2011-2#1)(2013-1#2)
or sleep##6##2##(1994-8#1)(1997-6#2)(2005-9#1)(2008-8#1)(2012-2#1)
or sleepiness##2##2##(2010-7#1)(2012-12#1)
or slight##4##2##(1991-12#1)(2007-11#1)(2007-8#1)(2008-10#1)
or slightly greater##2##3##(1994-9#1)(2008-10#1)
or slightly increased##2##3##(1995-1#1)(1995-11#1)
or slightly less##2##3##(1995-1#1)(1995-2#1)
or slightly lower##2##3##(1997-8#1)(2012-12#1)
or slightly##20##2##(1990-12#1)(1993-2#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-2#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#2)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
or slope##3##2##(1992-8#1)(2008-10#1)(2009-4#1)
or slow down the##4##4##(2007-3#1)(2008-5#1)(2008-9#1)(2009-5#1)
or slow##9##2##(1995-8#1)(1996-3#1)(2007-12#1)(2007-3#1)(2008-5#1)(2008-9#1)(2009-5#1)(2011-1#1)(2013-8#1)
or slowly##3##2##(1996-6#1)(2008-2#1)(2011-2#1)
or sludge##2##2##(1993-5#1)(2008-9#1)
or small group##2##3##(2008-10#1)(2013-8#1)
or small groups##2##3##(2008-12#1)(2008-5#1)
or small unilamellar vesicles##2##4##(1990-2#1)(2008-10#1)
or small##31##2##(1990-2#2)(1996-12#1)(2005-11#1)(2007-10#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
or smaller than the##2##4##(2007-11#1)(2010-8#1)
or smaller than##5##3##(1995-5#1)(2005-11#1)(2007-11#1)(2008-2#1)(2010-8#1)
or smaller##12##2##(1991-5#1)(1994-8#1)(1995-5#1)(2005-11#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-2#2)(2009-11#1)(2010-8#1)(2013-1#1)
or smoking##2##2##(1997-2#1)(2011-2#1)
or smooth muscle##3##3##(1991-2#1)(2005-7#1)(2007-11#1)
or so called##3##3##(2008-10#2)(2008-4#1)
or so##16##2##(1995-12#1)(1997-7#1)(1997-8#1)(2007-2#1)(2007-6#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#1)(2011-2#1)
or so-called##3##2##(2008-10#2)(2008-7#1)
or social##18##2##(1990-2#1)(1995-8#1)(1996-1#1)(1996-9#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-7#1)(2007-9#1)(2008-12#2)(2009-4#1)(2009-6#1)(2009-7#1)(2012-3#1)(2013-1#2)
or sodium hydrosulfide##2##3##(2008-5#2)
or sodium nitroprusside##2##3##(1993-3#1)(2008-11#1)
or sodium##17##2##(1990-11#1)(1991-7#1)(1991-9#1)(1992-2#1)(1993-3#2)(1994-9#1)(1997-6#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-9#1)(2011-2#1)
or soft tissue##5##3##(2008-6#2)(2009-3#1)(2011-2#1)(2013-8#1)
or soft##7##2##(2007-12#1)(2008-6#2)(2009-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
or soil##8##2##(2008-10#5)(2008-4#1)(2009-8#1)(2011-1#1)
or sold##2##2##(2007-3#1)(2009-10#1)
or solid##2##2##(2008-3#1)(2012-3#1)
or solid-liquid extraction##2##3##(2008-10#2)
or solid-phase##2##2##(1997-8#1)(2008-4#1)
or solitary##2##2##(1993-10#1)(2012-12#1)
or solubility##2##2##(1997-2#1)(2005-11#1)
or soluble factors##2##3##(2008-4#1)(2012-12#1)
or soluble##6##2##(2006-8#1)(2008-10#1)(2008-4#2)(2012-12#1)(2012-9#1)
or solution##5##2##(2007-9#1)(2008-10#2)(2008-4#2)
or solvent##4##2##(1996-4#1)(2006-10#1)(2008-10#2)
or somatic##3##2##(1990-2#1)(1997-2#1)(2009-9#1)
or some combination of##3##4##(2008-6#2)(2010-2#1)
or some of##2##3##(2010-6#1)(2013-8#1)
or some other##6##3##(1992-9#1)(1996-12#1)(2008-4#1)(2009-9#1)(2010-10#1)(2010-2#1)
or some##23##2##(1990-8#1)(1991-3#1)(1992-9#2)(1996-12#1)(2005-11#1)(2006-10#2)(2006-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-6#1)(2013-8#1)
or something##2##2##(1993-10#1)(2005-9#1)
or sometimes##4##2##(2007-11#1)(2007-12#1)(2008-7#1)(2013-1#1)
or soon##2##2##(1992-2#1)(2011-1#1)
or sound##2##2##(2008-2#1)(2011-1#1)
or sources##2##2##(2008-2#1)(2012-3#1)
or southern##2##2##(1997-8#1)(2008-10#1)
or soy##2##2##(1991-10#1)(2013-1#1)
or soybean##2##2##(1995-11#1)(2008-10#1)
or spatial coordinate of the point along##2##7##(2008-10#2)
or spatial##13##2##(1994-8#1)(1995-6#1)(2007-12#2)(2008-10#2)(2008-2#3)(2008-7#1)(2008-8#1)(2009-10#1)(2010-2#1)
or special##4##2##(2007-2#1)(2008-11#1)(2010-11#2)
or specialist##2##2##(2009-4#1)(2010-8#1)
or specialized##2##2##(2007-2#1)(2008-9#1)
or species##7##2##(1991-10#1)(2006-4#1)(2007-4#1)(2008-10#1)(2010-2#1)(2012-9#2)
or specific diagnostic##2##3##(2008-12#1)(2009-7#1)
or specific for##2##3##(1997-1#1)(2006-8#1)
or specific##30##2##(1990-11#1)(1990-5#1)(1994-8#1)(1995-12#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-8#2)(2006-10#1)(2006-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-10#1)(2009-7#1)(2010-1#1)(2010-7#1)(2011-1#2)(2011-2#1)
or spectral##3##2##(1996-12#1)(2008-3#1)(2010-6#1)
or sperm##3##2##(1995-11#1)(2006-5#1)(2008-6#1)
or spheroids##2##2##(2008-11#2)
or sphingomyelin##2##2##(1993-3#1)(2008-10#1)
or sphingosine##3##2##(1994-3#1)(1996-3#1)(2010-7#1)
or spiked with##2##3##(2004-4#1)(2008-10#1)
or spin##2##2##(2008-10#1)(2008-9#1)
or spinal cord compression##2##4##(2007-11#1)(2007-7#1)
or spinal cord##6##3##(2006-10#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-12#1)(2008-4#1)
or spinal##13##2##(1993-11#1)(1993-4#1)(1996-12#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-12#1)(2008-4#1)
or spiral##2##2##(1995-8#1)(2007-8#1)
or spiritual##2##2##(1995-7#1)(2008-12#1)
or spleen##6##2##(1992-8#1)(2008-4#4)(2013-8#1)
or split##3##2##(2007-11#1)(2008-12#1)(2008-5#1)
or spontaneous##5##2##(1991-7#1)(1993-7#1)(1996-3#1)(1996-9#1)(1997-4#1)
or sporadic##6##2##(2006-2#1)(2007-7#2)(2008-11#1)(2011-1#1)(2012-12#1)
or spore germination##2##3##(2008-10#2)
or spore##3##2##(2008-10#3)
or sporting##2##2##(1991-3#1)(2005-10#1)
or sports##2##2##(2008-5#1)(2013-7#1)
or spray##3##2##(1992-2#1)(2005-11#1)(2010-4#1)
or spray-dried##2##2##(2007-1#2)
or spread of##3##3##(2008-10#2)(2010-4#1)
or spreading##3##2##(1990-7#1)(2008-2#1)(2008-9#1)
or squamous cell carcinoma##2##4##(2007-12#1)(2007-8#1)
or squamous cell carcinomas##2##4##(1994-4#1)(2013-8#1)
or squamous cell##4##3##(1994-4#1)(2007-12#1)(2007-8#1)(2013-8#1)
or squamous##6##2##(1990-6#1)(1994-4#1)(2007-12#1)(2007-8#1)(2008-5#1)(2013-8#1)
or square##2##2##(1995-1#1)(2008-2#1)
or stability of##3##3##(1994-12#1)(1996-5#1)(2008-4#1)
or stability##6##2##(1993-3#1)(1994-12#1)(1996-5#1)(2008-10#1)(2008-4#1)(2012-2#1)
or stabilization of the##3##4##(2008-4#1)(2010-12#1)(2012-12#1)
or stabilization of##5##3##(1996-1#1)(2007-1#1)(2008-4#1)(2010-12#1)(2012-12#1)
or stabilization##6##2##(1996-1#1)(2007-1#1)(2008-4#1)(2010-12#1)(2012-12#1)(2013-8#1)
or stabilize##4##2##(1996-2#1)(2004-12#1)(2008-5#1)(2011-3#1)
or stabilizing##3##2##(2008-1#1)(2008-4#1)(2008-9#1)
or stable disease##3##3##(1993-8#1)(1994-8#1)(2007-11#1)
or stable##7##2##(1992-9#1)(1993-8#1)(1994-8#2)(1995-6#1)(2007-11#1)(2010-2#1)
or staff##2##2##(2005-7#1)(2008-1#1)
or stage##7##2##(1990-8#1)(1992-12#1)(1996-9#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
or stages##2##2##(2010-9#1)(2012-12#1)
or standard##16##2##(1990-12#1)(1991-1#1)(1992-11#1)(1994-2#1)(1996-9#1)(2007-8#1)(2008-10#4)(2008-3#2)(2008-7#1)(2010-8#2)(2013-8#1)
or standardized##4##2##(2008-11#1)(2008-4#1)(2009-4#1)(2012-3#1)
or standards##5##2##(1996-12#1)(2006-5#1)(2007-10#2)(2007-12#1)
or state of##2##3##(1992-3#1)(1996-8#1)
or state##8##2##(1992-3#1)(1993-2#1)(1995-2#1)(1996-8#1)(2007-4#2)(2008-8#1)(2013-1#1)
or states##2##2##(1997-8#1)(2008-10#1)
or static##3##2##(2006-8#1)(2008-9#1)(2010-10#1)
or statistical##3##2##(2008-4#2)(2009-9#1)
or staurosporine##2##2##(1990-11#1)(1993-3#1)
or stem cell##3##3##(1995-2#1)(2011-2#2)
or stem cells##3##3##(2008-1#1)(2008-4#1)(2011-2#1)
or stem##9##2##(1995-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2011-2#3)(2012-2#1)(2013-1#1)
or stenosis##2##2##(1990-4#1)(1997-8#1)
or stent##2##2##(2008-5#1)(2010-4#1)
or stepped##2##2##(1997-5#1)(2008-3#1)
or steroid##2##2##(2008-1#2)
or sticking##2##2##(2009-7#1)(2012-12#1)
or stiffness##2##2##(2008-5#1)(2008-9#1)
or stimulated##2##2##(1991-5#1)(1992-2#1)
or stimulating##3##2##(2006-2#1)(2007-11#1)(2008-11#1)
or stimulation of##5##3##(1994-2#1)(1996-1#1)(2008-11#3)
or stimulatory##4##2##(1990-11#1)(1992-9#1)(1996-11#1)(2008-10#1)
or stochastic##3##2##(1996-6#1)(2006-5#1)(2008-2#1)
or stones##2##2##(1990-12#1)(1993-5#1)
or stop##4##2##(2005-10#1)(2007-7#1)(2009-8#1)(2010-9#1)
or stopped##2##2##(2007-4#1)(2008-3#1)
or stopping##3##2##(2007-1#1)(2008-1#1)(2008-7#1)
or stops##2##2##(1991-7#1)(2007-2#1)
or storage##5##2##(2005-11#1)(2008-1#1)(2008-4#1)(2008-5#1)(2010-8#1)
or stored for##2##3##(2006-5#1)(2008-9#1)
or stored##5##2##(2006-5#2)(2008-1#1)(2008-10#1)(2008-9#1)
or strain##6##2##(2006-4#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-9#1)
or strains##2##2##(2008-10#1)(2008-2#1)
or strategies##2##2##(2008-11#1)(2012-3#1)
or strength##2##2##(1993-12#1)(2009-6#1)
or strengthening##2##2##(1994-12#1)(2008-5#1)
or streptavidin##2##2##(1990-12#1)(2008-4#1)
or stress##11##2##(2006-12#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-10#3)(2009-7#1)(2009-9#1)(2012-2#1)
or strip##2##2##(2008-10#2)
or stroke dementia##2##3##(1990-3#2)
or stroke subtype##2##3##(2007-10#1)(2007-9#1)
or stroke##13##2##(1990-3#2)(2005-10#1)(2007-10#1)(2007-8#1)(2007-9#2)(2008-8#2)(2010-5#1)(2011-2#1)(2012-12#1)(2013-7#1)
or strong##7##2##(2005-11#1)(2006-10#1)(2007-8#2)(2008-10#2)(2008-3#1)
or stronger##3##2##(1991-6#1)(1994-3#1)(1997-1#1)
or strongly##4##2##(2007-12#1)(2008-11#1)(2008-2#2)
or structural equation##2##3##(2005-10#1)(2007-11#1)
or structural##13##2##(1990-9#1)(1995-4#1)(2005-10#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-12#1)
or structure of##2##3##(1995-1#1)(2007-12#1)
or structure##4##2##(1995-1#1)(1995-10#1)(2007-12#1)(2008-9#1)
or structures##2##2##(1994-9#1)(2012-2#1)
or study##4##2##(2007-9#2)(2008-7#1)(2013-1#1)
or subarachnoid##3##2##(2007-10#1)(2008-7#1)(2009-6#1)
or subcellular fractions##3##3##(1990-9#1)(1992-4#1)(2008-1#1)
or subcellular##6##2##(1990-9#1)(1992-4#1)(2008-1#1)(2008-4#1)(2009-2#1)(2010-12#1)
or subchronic##2##2##(1996-10#2)
or subclavian##3##2##(2007-7#2)(2008-7#1)
or subclinical##3##2##(2005-7#1)(2007-7#1)(2011-1#1)
or subcortical##2##2##(2006-10#1)(2006-9#1)
or subcutaneous tissue##2##3##(2008-5#1)(2011-2#1)
or subcutaneous##7##2##(1991-3#1)(2006-10#1)(2008-4#1)(2008-5#1)(2010-4#1)(2011-2#1)(2012-1#1)
or subcutaneously##3##2##(2008-4#1)(2008-7#1)(2008-9#1)
or subgroups##2##2##(1997-4#1)(2007-12#1)
or subject##2##2##(1991-12#1)(2012-1#1)
or subjected to##2##3##(1996-11#1)(2013-8#1)
or subluxations##3##2##(2007-11#3)
or submucosal##3##2##(1993-5#1)(2006-10#1)(2007-8#1)
or subpopulations##2##2##(1992-10#1)(2008-4#1)
or subsequent to the##2##4##(1994-4#1)(2006-10#1)
or subsequent##6##2##(1992-6#2)(1994-4#1)(1995-2#1)(2004-10#1)(2006-10#1)
or subsequently##2##2##(2008-2#1)(2012-2#1)
or substance##5##2##(1994-2#1)(1995-1#1)(2011-12#3)
or substances##2##2##(1993-2#1)(2008-2#1)
or substantially##4##2##(1993-9#1)(2008-11#1)(2008-8#1)(2012-3#1)
or substituting##2##2##(1994-9#1)(2012-1#1)
or substitution of##3##3##(1990-6#1)(2007-3#1)(2008-10#1)
or substitution##5##2##(1990-6#1)(1994-5#1)(2006-10#1)(2007-3#1)(2008-10#1)
or substrate##3##2##(1991-9#1)(2008-10#1)(2010-2#1)
or substrates##3##2##(2008-10#1)(2008-2#1)(2008-4#1)
or subtle##2##2##(1994-9#1)(2008-4#1)
or subtype##2##2##(1992-10#1)(1996-6#1)
or subunit##3##2##(1993-9#1)(2008-4#1)(2010-10#1)
or succinate##2##2##(1990-8#1)(2004-12#1)
or sucrose##2##2##(2008-10#1)(2009-8#1)
or sudden cardiac death##3##4##(2005-10#1)(2007-11#1)(2009-9#1)
or sudden death##2##3##(2007-8#1)(2012-12#1)
or sudden##7##2##(2005-10#1)(2007-11#1)(2007-8#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-12#1)
or suffer##2##2##(2008-2#1)(2009-10#1)
or sugar##4##2##(1996-8#1)(2006-12#1)(2008-6#1)(2009-9#1)
or suggest##2##2##(1990-3#1)(2012-1#1)
or suicidal##2##2##(1997-8#1)(2006-7#1)
or suicide##3##2##(1993-9#1)(2005-8#1)(2010-6#1)
or sulfasalazine##3##2##(2007-11#3)
or sulfite##4##2##(1993-3#4)
or sulfur##2##2##(2008-10#1)(2008-7#1)
or sulglicotide##2##2##(1991-4#2)
or sunflower oil##2##3##(2004-11#1)(2010-4#1)
or sunflower##3##2##(1991-2#1)(2004-11#1)(2010-4#1)
or superficial##5##2##(1992-2#1)(2007-7#1)(2008-6#1)(2010-7#1)(2011-1#1)
or superior to those##3##4##(2007-9#1)(2011-1#1)(2013-8#1)
or superior to##8##3##(1992-1#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2009-10#1)(2011-1#1)(2013-8#1)
or superior##16##2##(1992-1#1)(1995-5#1)(1997-1#1)(2005-7#1)(2006-10#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-10#1)(2010-8#1)(2011-1#1)(2013-8#1)
or superoxide dismutase##3##3##(1993-6#1)(1994-10#1)(1997-5#1)
or supplement to##4##3##(1993-10#1)(1996-3#1)(2008-10#1)(2010-8#1)
or supplementation##3##2##(2008-4#1)(2013-1#2)
or supplemented##2##2##(2008-2#1)(2008-4#1)
or supplements##3##2##(2006-12#1)(2008-10#1)(2012-2#1)
or supplied##2##2##(1994-11#1)(1997-3#1)
or support##4##2##(2008-10#1)(2008-5#1)(2010-4#1)(2012-2#1)
or supported##2##2##(2008-4#1)(2012-1#1)
or supporting##2##2##(2008-3#1)(2013-8#1)
or supportive##3##2##(2005-7#1)(2010-7#1)(2013-1#1)
or suppress##5##2##(1991-9#1)(1997-4#1)(2007-8#1)(2009-8#1)(2011-2#1)
or suppressed by##2##3##(1992-5#1)(2008-2#1)
or suppressed##6##2##(1992-5#1)(1994-5#1)(1996-2#1)(2008-2#1)(2009-8#1)(2010-9#1)
or suppressing##2##2##(1993-7#2)
or suppression in##2##3##(1996-4#1)(2013-7#1)
or suppression of##6##3##(1991-11#1)(1993-7#1)(2008-11#1)(2008-9#1)(2011-1#1)(2013-7#1)
or suppression##12##2##(1991-11#1)(1993-7#1)(1996-4#1)(1997-7#1)(2008-11#1)(2008-9#2)(2011-1#1)(2012-3#2)(2013-7#2)
or suppressor##2##2##(1991-12#1)(2011-1#1)
or suprapubic##2##2##(1992-12#1)(2008-7#1)
or surface##13##2##(1992-5#1)(1993-9#1)(1995-5#1)(2005-11#1)(2005-12#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2010-4#1)
or surfactant##2##2##(1994-5#1)(2008-5#1)
or surgery##18##2##(1990-12#1)(1991-2#1)(1992-12#1)(1993-2#1)(2006-10#2)(2006-12#1)(2006-3#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-7#4)(2010-12#1)(2012-1#1)(2013-1#1)
or surgery?##2##2##(2007-11#1)(2008-12#1)
or surgical complications##3##3##(2011-2#2)(2013-1#1)
or surgical intervention##5##3##(1990-6#1)(2007-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
or surgical procedures##2##3##(2008-1#1)(2012-12#1)
or surgical therapy##2##3##(2010-12#1)(2013-1#1)
or surgical treatment##4##3##(1990-8#1)(1996-6#1)(2010-6#1)(2012-3#1)
or surgical##48##2##(1990-5#1)(1990-6#2)(1990-8#1)(1991-5#1)(1992-6#1)(1996-6#1)(2004-1#1)(2005-1#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-7#2)(2009-4#2)(2009-5#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
or surgically##10##2##(1993-12#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-7#3)(2007-8#1)(2010-2#1)(2013-1#1)
or surpassed the##2##3##(1994-12#1)(2008-10#1)
or surrounding##2##2##(2008-10#1)(2011-1#1)
or survival of the##2##4##(1993-3#1)(2013-8#1)
or survival of##3##3##(1993-3#1)(2008-10#1)(2013-8#1)
or survival##10##2##(1993-3#1)(1995-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-6#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
or survive##2##2##(2008-10#1)(2008-9#1)
or surviving##2##2##(1997-5#1)(2008-8#1)
or susceptibility to##3##3##(2006-10#1)(2008-10#1)(2008-5#1)
or susceptibility##5##2##(2006-10#1)(2008-10#2)(2008-5#2)
or susceptible##7##2##(2008-10#6)(2010-10#1)
or suspected##10##2##(1991-12#1)(1995-6#1)(2004-11#1)(2006-10#1)(2007-6#1)(2008-1#1)(2008-4#1)(2010-6#1)(2012-2#1)(2013-8#1)
or suspended##3##2##(1993-5#1)(2007-6#1)(2012-12#1)
or suspension in##2##3##(1993-12#1)(2008-10#1)
or suspension##6##2##(1993-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)
or suspensions to##2##3##(1994-2#2)
or suspensions##3##2##(1994-2#2)(2008-10#1)
or suspicion of##2##3##(1991-2#1)(2013-1#1)
or sustained##4##2##(1995-2#1)(1996-12#1)(1997-8#1)(2008-2#1)
or sutured##2##2##(2013-1#2)
or sweet##2##2##(2008-10#2)
or swelling##4##2##(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)
or swim speed##5##3##(1992-9#1)(1993-12#4)
or swine manure##2##3##(2008-10#2)
or symbiotic relationships##2##3##(2008-1#1)(2008-10#1)
or sympathetic##3##2##(1994-10#1)(1996-12#1)(2006-12#1)
or symptom##3##2##(2006-12#1)(2008-7#1)(2010-1#1)
or symptomatic##8##2##(1990-8#1)(1996-6#2)(2006-8#1)(2007-12#2)(2008-10#1)(2012-3#1)
or symptoms of##8##3##(1991-8#1)(1995-2#1)(2006-8#1)(2007-8#1)(2008-7#2)(2010-8#1)(2012-11#1)
or symptoms##16##2##(1991-8#1)(1992-12#1)(1995-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#2)(2010-8#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
or synchronized##2##2##(2008-4#1)(2009-9#1)
or syndrome##3##2##(2006-12#1)(2008-1#1)(2010-12#1)
or syndromes##2##2##(2006-3#1)(2007-5#1)
or synergistic effects##4##3##(2007-11#1)(2007-9#1)(2008-10#1)(2013-8#1)
or synergistic##10##2##(1991-8#1)(1996-9#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-11#1)(2010-8#1)(2013-8#1)
or synergize with##2##3##(1995-8#1)(2009-12#1)
or synthetic chemical##2##3##(2008-1#1)(2009-11#1)
or synthetic materials##2##3##(1991-3#1)(2006-10#1)
or synthetic##22##2##(1990-3#1)(1991-3#1)(1994-2#1)(1994-5#1)(2006-10#1)(2006-12#1)(2006-2#1)(2008-1#3)(2008-10#3)(2008-5#1)(2008-6#1)(2009-11#1)(2009-3#1)(2010-8#1)(2012-1#1)(2012-12#3)
or system##3##2##(2008-10#1)(2008-2#1)(2013-1#1)
or systematic##4##2##(1993-2#1)(1993-6#1)(2008-4#1)(2009-8#1)
or systemic disease##3##3##(1991-2#1)(1992-9#1)(2011-1#1)
or systemic diseases##2##3##(1994-6#1)(2009-8#1)
or systemic##27##2##(1991-2#1)(1992-4#2)(1992-9#1)(1994-6#1)(1996-5#1)(2006-11#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-9#2)(2009-4#1)(2009-8#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
or systems##3##2##(2008-5#1)(2009-5#1)(2013-1#1)
or tacrolimus##5##2##(2006-5#3)(2007-11#2)
or tacrolimus)##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
or tags##2##2##(1992-11#1)(2008-4#1)
or take##3##2##(1990-12#1)(2007-9#1)(2011-2#1)
or taken##3##2##(2004-9#1)(2009-8#1)(2011-2#1)
or taking##3##2##(1997-3#1)(2006-7#1)(2009-7#1)
or tap water##2##3##(1992-7#1)(2008-5#1)
or target cells##2##3##(1991-9#1)(1995-2#1)
or target##9##2##(1991-9#1)(1994-11#1)(1995-2#1)(1996-3#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)
or targeting##4##2##(2007-11#1)(2007-12#1)(2010-7#1)(2012-12#1)
or task##3##2##(1992-1#1)(1995-2#1)(2008-11#1)
or taurine##2##2##(2009-10#1)(2011-2#1)
or tearing##2##2##(2011-12#1)(2011-2#1)
or technical##9##2##(2005-11#1)(2007-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-3#1)(2010-7#1)(2010-8#1)(2013-1#1)
or technique##2##2##(2006-10#1)(2007-12#1)
or techniques##2##2##(2007-2#1)(2008-10#1)
or technological##4##2##(2008-11#1)(2008-2#1)(2010-2#1)(2011-1#1)
or tegaserod##3##2##(2010-6#3)
or telephone interviews##2##3##(2008-11#2)
or temperature##9##2##(1990-5#1)(1992-5#1)(1995-11#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2013-8#1)
or temporal##7##2##(1992-8#1)(1996-6#1)(2005-5#1)(2008-10#1)(2008-9#1)(2009-10#1)(2009-5#1)
or temporally##2##2##(2008-10#1)(2008-8#1)
or temporary##2##2##(1990-6#1)(2006-10#1)
or tender##2##2##(2008-9#1)(2013-8#1)
or terminally ill##3##3##(1993-12#1)(2008-12#2)
or terminate##3##2##(1993-3#1)(1996-11#1)(1997-5#1)
or termination##4##2##(1993-6#1)(1997-5#2)(2012-11#1)
or territory##3##2##(2006-5#1)(2008-11#1)(2009-10#1)
or terrorist##4##2##(2007-12#1)(2007-8#1)(2008-12#1)(2008-7#1)
or tertiary##6##2##(2007-11#1)(2007-6#1)(2008-10#1)(2008-4#2)(2011-2#1)
or test##2##2##(1996-3#1)(2008-5#1)
or testing##2##2##(2008-6#1)(2011-8#1)
or testosterone##5##2##(1990-11#1)(1991-4#1)(1994-6#1)(1996-5#1)(2012-2#1)
or tethered##2##2##(1996-1#1)(2009-12#1)
or tethering##2##2##(1996-5#1)(2012-12#1)
or tetracaine##3##2##(1995-3#2)(2008-10#1)
or tetraethylammonium##3##2##(1993-9#1)(1997-2#1)(2008-8#1)
or than##2##2##(2007-3#1)(2008-10#1)
or that a##4##3##(2006-2#1)(2007-9#1)(2008-10#2)
or that are##5##3##(1992-9#1)(1993-1#1)(2007-9#1)(2008-2#1)(2008-4#1)
or that demonstrate new and important knowledge in the area of colposcopy or pathology##8##14##(2006-10#8)
or that it##3##3##(1997-6#1)(2007-4#1)(2008-10#1)
or that may##2##3##(1995-6#1)(2007-10#1)
or that of##3##3##(1995-6#1)(2008-10#1)(2010-1#1)
or that the##9##3##(1990-5#1)(1992-1#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-9#1)(2007-11#1)(2007-4#1)(2012-2#1)
or that there##3##3##(1990-8#1)(1991-7#1)(2008-10#1)
or that this##2##3##(2009-12#1)(2010-12#1)
or that##80##2##(1990-5#1)(1990-8#1)(1991-3#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-5#1)(1995-6#2)(1997-5#1)(1997-6#1)(2004-12#1)(2005-8#1)(2006-10#9)(2006-2#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#2)(2007-9#2)(2008-10#6)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
or the &quot##4##3##(2006-7#1)(2008-11#1)(2008-3#1)(2009-12#1)
or the 3'##2##3##(1990-11#1)(1991-6#1)
or the B##3##3##(1994-12#1)(1994-5#1)(2008-10#1)
or the Ca2+ ionophore##2##4##(1992-12#1)(1994-6#1)
or the Ca2+##3##3##(1992-12#1)(1992-6#1)(1994-6#1)
or the Escherichia coli##2##4##(1990-5#1)(2006-12#1)
or the S##2##3##(1990-3#1)(1992-6#1)
or the T##2##3##(2008-10#1)(2008-4#1)
or the ability of##2##4##(1993-3#1)(2008-11#1)
or the absence of##5##4##(1991-2#1)(1994-12#1)(1995-5#1)(2008-7#1)(2011-2#1)
or the absence##6##3##(1991-2#1)(1991-9#1)(1994-12#1)(1995-5#1)(2008-7#1)(2011-2#1)
or the action of##2##4##(1990-11#1)(2006-10#1)
or the activity of##3##4##(1991-8#1)(1994-5#1)(1995-11#1)
or the addition of##6##4##(1995-11#1)(1997-7#1)(2007-11#2)(2008-10#1)(2008-11#1)
or the adjacent##3##3##(1993-12#1)(1994-3#1)(2008-10#1)
or the amount of##3##4##(2008-1#1)(2008-10#1)(2008-9#1)
or the amplitude##2##3##(1991-5#2)
or the anterior##2##3##(2006-9#1)(2008-10#1)
or the antioxidant##2##3##(1992-5#1)(1995-6#1)
or the appearance of##2##4##(1995-10#1)(2013-1#1)
or the application of##2##4##(2007-7#1)(2010-12#1)
or the association##2##3##(1993-11#1)(2007-4#1)
or the bacterial##2##3##(2008-5#1)(2010-7#1)
or the basis##2##3##(2005-10#1)(2008-4#1)
or the benefits##2##3##(2007-8#1)(2008-8#1)
or the beta-adrenergic##2##3##(1993-4#1)(2007-9#1)
or the binding##3##3##(1990-8#1)(1995-1#1)(2011-2#1)
or the calcium##2##3##(1991-8#1)(1995-12#1)
or the cells##2##3##(2008-4#1)(2009-2#1)
or the cellular##2##3##(1991-12#1)(2011-2#1)
or the combination of##10##4##(1990-12#1)(1991-8#1)(1994-11#1)(1995-5#1)(1996-12#1)(2004-4#1)(2006-10#1)(2007-3#1)(2009-11#1)(2011-1#1)
or the complete##2##3##(2007-12#1)(2008-10#1)
or the constant##2##3##(2005-11#1)(2007-11#1)
or the control##3##3##(1992-11#1)(1997-7#1)(2010-12#1)
or the controls##2##3##(1992-2#1)(1994-2#1)
or the core##3##3##(1997-3#1)(2008-2#1)(2008-3#1)
or the cyclooxygenase##2##3##(1994-2#1)(1995-12#1)
or the degree of##2##4##(1995-4#1)(2007-8#1)
or the delta##2##3##(1994-11#1)(1994-12#1)
or the development of##3##4##(1992-4#1)(2005-7#1)(2008-3#1)
or the dielectric constant##2##4##(2008-3#1)(2010-4#1)
or the distal##2##3##(1990-9#1)(2006-11#1)
or the dose##3##3##(1991-11#1)(2013-1#2)
or the downstream##2##3##(1997-2#1)(2012-12#1)
or the duration##2##3##(1992-3#1)(2011-2#1)
or the early##2##3##(2008-10#1)(2008-6#1)
or the effects of##2##4##(1993-8#1)(2006-10#1)
or the effects##3##3##(1993-8#1)(2006-10#1)(2008-5#1)
or the entire##4##3##(1991-12#1)(2007-11#1)(2008-10#1)(2009-2#1)
or the equivalent of##2##4##(2008-10#1)(2009-12#1)
or the estimating equation approach of##2##6##(1994-5#2)
or the exposure##2##3##(1996-7#1)(2010-6#1)
or the expression of##3##4##(1990-3#1)(1993-11#1)(2010-12#1)
or the expression##5##3##(1990-3#1)(1993-11#1)(1997-4#1)(2009-6#1)(2010-12#1)
or the extent of the##2##5##(1990-11#1)(2011-2#1)
or the first##4##3##(2008-2#1)(2012-12#3)
or the full labeled rate##2##5##(2008-10#2)
or the heart##2##3##(1993-11#1)(2008-8#1)
or the human##3##3##(1993-9#1)(1997-5#1)(2004-4#1)
or the immune##2##3##(2008-11#1)(2008-5#1)
or the inability to##2##4##(1994-11#1)(1995-1#1)
or the inactive##2##3##(1993-12#1)(1996-4#1)
or the incidence of##2##4##(1990-11#1)(1993-4#1)
or the indirect##2##3##(2005-8#1)(2008-8#1)
or the inducible##2##3##(1990-10#1)(1995-8#1)
or the induction##2##3##(2007-11#1)(2008-11#1)
or the inhibition##2##3##(1991-9#1)(2008-9#1)
or the initial##2##3##(1992-4#1)(2005-4#1)
or the intake of##2##4##(1994-12#1)(2012-12#1)
or the intensity##2##3##(1992-11#1)(2008-2#1)
or the interest##2##3##(2007-8#1)(2010-2#1)
or the internet##2##3##(2007-8#1)(2011-2#1)
or the involvement of##2##4##(2007-10#1)(2011-2#1)
or the kidney##2##3##(2006-4#1)(2007-11#1)
or the lack of##2##4##(1991-9#1)(2013-8#1)
or the lateral##5##3##(1995-11#1)(2007-12#1)(2007-9#1)(2008-3#2)
or the low##2##3##(1993-9#1)(2007-5#1)
or the lung##2##3##(2008-11#1)(2008-7#1)
or the main##2##3##(1990-4#1)(2008-7#1)
or the maintenance##3##3##(1995-1#1)(2007-11#1)(2007-4#1)
or the mean##2##3##(1990-12#1)(2013-7#1)
or the medial##2##3##(1993-5#1)(1996-9#1)
or the mixture of##3##4##(2007-6#1)(2008-10#2)
or the more##2##3##(2006-10#1)(2008-11#1)
or the mother##3##3##(2006-10#1)(2006-7#1)(2008-3#1)
or the multiple##2##3##(2006-12#1)(2013-7#1)
or the murine##4##3##(1990-5#1)(1995-11#1)(2008-11#2)
or the need for##3##4##(1994-11#1)(2008-4#1)(2011-2#1)
or the nuclear##2##3##(1997-6#1)(2009-8#1)
or the nucleus accumbens (NAS)##2##5##(1992-10#1)(1993-12#1)
or the nucleus accumbens##3##4##(1992-10#1)(1993-12#1)(1997-8#1)
or the nucleus##4##3##(1992-10#1)(1993-12#1)(1997-8#1)(2005-8#1)
or the number of##6##4##(1991-2#1)(1991-8#1)(2008-10#1)(2012-12#1)(2013-1#2)
or the occurrence of##2##4##(2008-10#2)
or the operation##3##3##(2005-5#1)(2007-12#1)(2008-10#1)
or the optical##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
or the other##23##3##(1990-5#1)(1991-9#1)(1992-2#1)(1994-11#1)(1995-2#1)(1996-9#1)(1997-7#1)(2006-10#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
or the overall##2##3##(1994-9#1)(2008-6#1)
or the patient##2##3##(1991-12#1)(1992-1#1)
or the patient's##3##3##(1995-3#1)(1996-2#1)(2007-8#1)
or the phosphodiesterase inhibitor##2##4##(1994-6#1)(1995-12#1)
or the posterior##2##3##(2006-12#1)(2008-8#1)
or the precision##2##3##(1991-3#1)(2007-12#1)
or the presence of a##2##5##(1997-7#1)(2006-10#1)
or the presence of##26##4##(1990-10#1)(1990-6#1)(1991-2#1)(1991-4#2)(1991-8#1)(1991-9#1)(1993-11#1)(1994-8#1)(1995-11#1)(1995-8#1)(1997-7#2)(2005-8#2)(2006-10#2)(2006-6#1)(2007-3#2)(2007-8#1)(2008-10#2)(2008-5#1)(2010-12#1)(2011-2#1)
or the proportion of##2##4##(2008-11#1)(2010-2#1)
or the pulse##2##3##(2007-12#1)(2008-3#1)
or the rate of##2##4##(1991-12#1)(2008-10#1)
or the rate##3##3##(1991-12#1)(2008-10#1)(2008-8#1)
or the ratio between the##2##5##(2008-10#2)
or the ratio##3##3##(1991-12#1)(2008-10#2)
or the related##3##3##(1990-8#1)(1991-10#1)(2007-12#1)
or the removal of##2##4##(1995-2#1)(2006-10#1)
or the result of##3##4##(1993-11#1)(1997-2#1)(2013-8#1)
or the right##5##3##(1994-2#1)(1996-1#1)(2008-10#1)(2008-4#1)(2008-7#1)
or the risk of##2##4##(2006-4#1)(2009-12#1)
or the risk##3##3##(1995-9#1)(2006-4#1)(2009-12#1)
or the same##4##3##(2007-12#1)(2008-10#1)(2008-4#1)(2009-12#1)
or the saphenous nerve##2##4##(1997-3#2)
or the side##2##3##(1993-12#1)(1994-11#1)
or the single##2##3##(1994-11#1)(1995-3#1)
or the skin##2##3##(2008-11#1)(2008-5#1)
or the so-called##2##3##(2008-7#1)(2009-11#1)
or the social##2##3##(1992-3#1)(2008-9#1)
or the solution##2##3##(1995-3#1)(2008-10#1)
or the specific##3##3##(2008-11#2)(2010-2#1)
or the spinal##2##3##(1996-5#1)(2008-7#1)
or the standard of care##2##5##(2007-10#1)(2008-7#1)
or the standard##4##3##(2007-10#1)(2007-8#1)(2008-10#1)(2008-7#1)
or the stimulation of##2##4##(1990-2#1)(1997-1#1)
or the subsequent##2##3##(1993-5#1)(2007-5#1)
or the synthetic##2##3##(1994-5#1)(2006-10#1)
or the target##2##3##(2009-9#1)(2010-2#1)
or the time##5##3##(1993-5#1)(2008-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
or the total##2##3##(1995-6#1)(2008-3#1)
or the transfer of##2##4##(1995-2#1)(2006-8#1)
or the treatment of##2##4##(2007-3#1)(2009-8#1)
or the type of##3##4##(2007-11#1)(2007-7#1)(2008-10#1)
or the use of##4##4##(2008-3#1)(2008-9#1)(2013-7#1)(2013-8#1)
or the ventral tegmental area##2##5##(1993-12#2)
or the##1051##2##(1990-1#1)(1990-10#2)(1990-11#4)(1990-12#9)(1990-2#3)(1990-3#3)(1990-4#1)(1990-5#5)(1990-6#3)(1990-7#2)(1990-8#4)(1990-9#3)(1991-10#1)(1991-11#2)(1991-12#8)(1991-2#5)(1991-3#5)(1991-4#2)(1991-5#3)(1991-6#4)(1991-7#1)(1991-8#14)(1991-9#9)(1992-1#3)(1992-10#2)(1992-11#4)(1992-12#4)(1992-2#2)(1992-3#4)(1992-4#5)(1992-5#3)(1992-6#5)(1992-7#2)(1992-8#5)(1992-9#3)(1993-1#1)(1993-10#2)(1993-11#6)(1993-12#10)(1993-2#5)(1993-3#7)(1993-4#5)(1993-5#4)(1993-7#2)(1993-8#3)(1993-9#3)(1994-1#1)(1994-11#12)(1994-12#5)(1994-2#4)(1994-3#4)(1994-4#1)(1994-5#10)(1994-6#7)(1994-8#5)(1994-9#4)(1995-1#5)(1995-10#5)(1995-11#14)(1995-12#9)(1995-2#7)(1995-3#9)(1995-4#2)(1995-5#10)(1995-6#5)(1995-7#2)(1995-8#8)(1995-9#2)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#4)(1996-3#4)(1996-4#2)(1996-5#5)(1996-7#2)(1996-8#3)(1996-9#3)(1997-1#4)(1997-2#7)(1997-3#9)(1997-4#4)(1997-5#4)(1997-6#5)(1997-7#10)(1997-8#9)(2004-1#1)(2004-10#1)(2004-11#1)(2004-12#3)(2004-3#1)(2004-4#2)(2005-10#3)(2005-11#5)(2005-4#2)(2005-5#3)(2005-7#2)(2005-8#5)(2006-10#23)(2006-11#3)(2006-12#12)(2006-2#3)(2006-3#3)(2006-4#3)(2006-5#4)(2006-6#3)(2006-7#3)(2006-8#6)(2006-9#1)(2007-10#5)(2007-11#20)(2007-12#24)(2007-2#1)(2007-3#6)(2007-4#5)(2007-5#3)(2007-6#1)(2007-7#6)(2007-8#18)(2007-9#3)(2008-1#6)(2008-10#89)(2008-11#27)(2008-12#3)(2008-2#27)(2008-3#42)(2008-4#15)(2008-5#26)(2008-6#6)(2008-7#24)(2008-8#18)(2008-9#11)(2009-1#1)(2009-10#5)(2009-11#3)(2009-12#5)(2009-2#3)(2009-3#4)(2009-4#2)(2009-5#3)(2009-6#3)(2009-7#5)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#10)(2010-2#8)(2010-3#3)(2010-4#4)(2010-5#4)(2010-6#4)(2010-7#4)(2010-8#5)(2010-9#2)(2011-1#8)(2011-2#18)(2011-7#1)(2012-12#14)(2012-2#11)(2012-3#5)(2012-5#1)(2013-1#15)(2013-7#5)(2013-8#10)
or their combination##5##3##(1992-4#1)(2005-1#1)(2008-9#1)(2011-11#1)(2012-12#1)
or their components##2##3##(2007-12#1)(2008-1#1)
or their families##4##3##(1991-2#1)(2012-1#1)(2013-1#2)
or their products##2##3##(1997-5#1)(2006-10#1)
or their treatment##2##3##(2006-10#1)(2007-2#1)
or their##76##2##(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-3#2)(1992-4#1)(1992-8#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-5#1)(1997-1#1)(1997-5#1)(1997-8#1)(2005-1#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#2)(2008-9#3)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-11#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#6)(2013-8#1)
or theophylline##3##2##(1992-6#1)(2007-8#1)(2011-2#1)
or theoretical##2##2##(2008-12#1)(2012-3#1)
or theory##2##2##(1996-1#1)(2008-10#1)
or therapeutic purposes##3##3##(2006-9#1)(2007-7#1)(2008-11#1)
or therapeutic##23##2##(1990-12#1)(1991-9#1)(1994-2#1)(1996-3#1)(2006-10#3)(2006-9#2)(2007-7#2)(2008-1#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
or therapy##8##2##(1993-6#1)(2006-5#1)(2007-10#1)(2008-11#1)(2008-7#1)(2009-9#1)(2010-12#1)(2012-3#1)
or therapy-induced##2##2##(2007-11#1)(2008-1#1)
or there is a##2##4##(1996-9#1)(2008-10#1)
or there is##4##3##(1990-3#1)(1996-9#1)(2008-1#1)(2008-10#1)
or there##7##2##(1990-3#1)(1991-11#1)(1995-11#1)(1996-9#1)(2007-11#1)(2008-1#1)(2008-10#1)
or thermal##5##2##(2006-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
or these##4##2##(1990-12#1)(1991-7#1)(1992-8#1)(1996-6#1)
or theta##2##2##(1996-3#1)(2007-12#1)
or they are##2##3##(2006-10#1)(2008-2#1)
or they can##2##3##(2005-11#1)(2008-2#1)
or they could##2##3##(2010-8#1)(2011-12#1)
or they may be##3##4##(1995-11#1)(2008-5#1)(2010-12#1)
or they may##5##3##(1995-11#1)(2008-5#1)(2009-10#1)(2010-12#1)(2012-1#1)
or they##18##2##(1994-2#1)(1995-11#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-2#3)(2008-5#1)(2009-10#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)
or thiazolidinediones##2##2##(2007-9#1)(2008-1#1)
or thin##3##2##(1995-7#1)(1996-9#1)(2008-3#1)
or thin-film##2##2##(2006-12#1)(2008-7#1)
or thiols##2##2##(1991-9#1)(2006-12#1)
or thiosulfate##2##2##(1993-3#1)(1997-1#1)
or thoracic spine##2##3##(2007-8#1)(2012-12#1)
or thoracic##8##2##(1996-12#1)(2005-8#1)(2006-10#2)(2006-7#1)(2007-8#1)(2012-12#1)(2012-2#1)
or those born##2##3##(2008-11#1)(2011-1#1)
or those that##2##3##(2006-6#1)(2012-12#1)
or those who are##2##4##(2006-10#1)(2011-2#1)
or those who have##2##4##(2008-11#1)(2008-8#1)
or those who##6##3##(1990-8#1)(2006-10#1)(2007-6#1)(2008-11#1)(2008-8#1)(2011-2#1)
or those with##7##3##(1993-3#1)(1996-9#1)(2006-11#1)(2007-11#1)(2008-1#1)(2008-2#1)(2013-8#1)
or those##38##2##(1990-8#1)(1992-6#1)(1993-3#1)(1994-3#1)(1995-6#1)(1996-9#1)(2004-1#1)(2004-2#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#2)
or three copies of##2##4##(1991-10#1)(1994-11#1)
or three times##5##3##(1992-2#1)(1994-1#1)(2007-7#1)(2008-10#1)(2008-5#1)
or three weeks##2##3##(2005-3#1)(2010-12#1)
or three##55##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#2)(1991-10#2)(1991-7#1)(1992-2#1)(1992-8#1)(1994-1#1)(1994-11#2)(1994-3#2)(1995-1#1)(1995-6#2)(1996-12#1)(1996-3#1)(1996-6#1)(1997-4#2)(1997-6#1)(2005-10#1)(2005-3#1)(2005-7#1)(2006-11#1)(2006-8#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-10#1)(2010-12#1)(2012-2#1)
or three)##2##2##(2007-12#1)(2012-12#1)
or three-dimensional##3##2##(1991-5#1)(2007-11#1)(2008-3#1)
or threonine##5##2##(1991-12#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-8#1)
or threshold##2##2##(2006-4#1)(2008-7#1)
or thrombin##5##2##(1991-10#1)(1993-11#1)(1997-6#1)(1997-7#2)
or thrombocytopenia##2##2##(2008-8#1)(2011-1#1)
or thrombosed##2##2##(1995-11#1)(2007-7#1)
or thrombosis##3##2##(2007-11#1)(2008-3#1)(2011-2#1)
or thrombotic##2##2##(1995-5#1)(2011-1#1)
or through a##2##3##(1990-5#1)(2013-8#1)
or through altering the##2##4##(1993-8#1)(1994-5#1)
or through an##2##3##(2005-8#1)(2006-3#1)
or through the use of##3##5##(1997-7#1)(2008-4#2)
or through the##11##3##(1996-8#1)(1997-7#1)(2005-11#1)(2007-4#1)(2008-10#1)(2008-4#2)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
or through##47##2##(1990-5#2)(1990-7#1)(1992-7#1)(1993-2#1)(1993-8#1)(1994-5#1)(1996-1#1)(1996-10#1)(1996-5#2)(1996-8#1)(1997-7#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-10#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
or thymus##4##2##(1990-11#1)(2008-10#1)(2008-4#2)
or thyroid##8##2##(1991-5#1)(1991-7#2)(1992-12#1)(2012-12#1)(2012-2#1)(2013-1#2)
or time of##2##3##(2004-11#1)(2008-10#1)
or time to##2##3##(1995-1#1)(2008-7#1)
or time##11##2##(1991-9#1)(1995-1#2)(2004-11#1)(2004-9#1)(2006-7#1)(2008-10#2)(2008-7#1)(2008-8#1)(2012-3#1)
or tissue damage##2##3##(2008-10#1)(2012-1#1)
or tissue##21##2##(1990-12#1)(1992-9#1)(1993-4#1)(1996-10#1)(2004-11#1)(2006-10#2)(2007-2#1)(2008-10#1)(2008-2#1)(2008-4#5)(2008-7#1)(2008-8#2)(2010-6#1)(2011-2#1)(2012-1#1)
or tissue-specific##4##2##(1995-8#1)(1996-2#1)(1997-4#1)(2007-11#1)
or tissues of##2##3##(1996-11#1)(1996-12#1)
or tissues##18##2##(1994-2#1)(1994-6#1)(1995-2#1)(1996-11#1)(1996-12#1)(1997-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2010-10#2)(2010-12#1)
or titanium##2##2##(2007-11#2)
or to a control group##3##5##(1990-5#1)(2012-2#1)(2013-1#1)
or to a##31##3##(1990-3#1)(1990-5#1)(1990-7#1)(1992-12#2)(1992-3#1)(1994-11#1)(1994-9#1)(1996-3#1)(2004-1#1)(2006-5#1)(2006-8#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-3#4)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#2)(2012-2#2)(2013-1#2)
or to achieve##2##3##(1995-2#1)(1997-8#1)
or to address##2##3##(2009-5#1)(2012-12#1)
or to age##2##3##(1991-9#1)(2006-8#1)
or to an##6##3##(1992-12#1)(1992-6#1)(1995-9#1)(2008-3#1)(2008-4#1)(2010-2#1)
or to any##2##3##(1995-2#1)(2008-3#1)
or to assess##2##3##(2005-8#1)(2008-10#1)
or to be##4##3##(1990-5#1)(1993-3#1)(1995-3#1)(2012-12#1)
or to both##2##3##(1997-5#1)(2008-11#1)
or to continue##3##3##(1993-11#1)(1995-12#1)(2005-8#1)
or to control##2##3##(2009-9#1)(2010-10#1)
or to determine the##2##4##(2006-4#1)(2008-4#1)
or to differences in the##2##5##(1992-9#1)(2011-2#1)
or to direct##2##3##(1995-8#1)(2008-1#1)
or to establish##2##3##(2007-4#1)(2011-2#1)
or to estimate the##2##4##(2008-8#1)(2013-7#1)
or to estimate##3##3##(2008-10#1)(2008-8#1)(2013-7#1)
or to evaluate##4##3##(1991-1#1)(1991-7#1)(2008-9#1)(2010-6#1)
or to have##3##3##(1990-8#1)(1994-7#1)(2007-4#1)
or to improve##2##3##(1993-4#1)(2006-10#1)
or to induce##2##3##(1994-9#1)(2009-5#1)
or to inhibit##2##3##(2008-1#1)(2008-8#1)
or to isolate##2##3##(1995-7#1)(2008-10#1)
or to limit##2##3##(2008-8#1)(2009-8#1)
or to make##2##3##(2009-5#1)(2011-2#1)
or to other##4##3##(1990-3#1)(1995-1#1)(1997-3#1)(2010-8#1)
or to preserve##2##3##(1996-8#1)(2008-2#1)
or to prevent##3##3##(1994-11#1)(2007-6#1)(2011-2#1)
or to propose##2##3##(2013-1#1)(2013-7#1)
or to provide##3##3##(1995-2#1)(2006-7#1)(2013-7#1)
or to receive##3##3##(2008-4#1)(2010-3#2)
or to reduce##4##3##(1993-10#1)(1993-11#1)(2008-9#1)(2012-1#1)
or to start##2##3##(2007-11#1)(2010-9#1)
or to support##2##3##(1996-3#1)(2008-11#1)
or to test the##2##4##(2008-4#2)
or to test##3##3##(2008-10#1)(2008-4#2)
or to the control##2##4##(1993-12#1)(2013-8#1)
or to the##46##3##(1990-1#1)(1990-7#1)(1990-8#2)(1991-4#3)(1991-5#1)(1991-9#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-4#2)(1997-6#1)(1997-8#1)(2005-11#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#2)(2009-3#1)(2011-12#1)(2011-2#1)(2012-11#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
or to use##3##3##(2008-8#1)(2008-9#1)(2011-12#1)
or to##348##2##(1990-1#1)(1990-3#2)(1990-5#5)(1990-6#1)(1990-7#3)(1990-8#3)(1990-9#1)(1991-1#1)(1991-3#1)(1991-4#4)(1991-5#2)(1991-7#3)(1991-9#6)(1992-1#1)(1992-12#5)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#3)(1993-10#2)(1993-11#2)(1993-12#1)(1993-3#2)(1993-4#1)(1993-6#2)(1993-7#2)(1993-9#2)(1994-11#4)(1994-12#1)(1994-3#3)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#5)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#3)(1995-7#1)(1995-8#4)(1995-9#2)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#4)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-3#2)(1997-4#3)(1997-5#3)(1997-6#2)(1997-7#2)(1997-8#2)(2003-11#1)(2004-1#1)(2005-10#2)(2005-11#1)(2005-8#3)(2006-10#7)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#2)(2007-11#4)(2007-12#3)(2007-3#1)(2007-4#3)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#16)(2008-11#7)(2008-12#2)(2008-2#5)(2008-3#9)(2008-4#19)(2008-5#3)(2008-7#3)(2008-8#9)(2008-9#7)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#4)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#4)(2011-12#3)(2011-2#10)(2011-3#1)(2012-1#2)(2012-11#4)(2012-12#3)(2012-2#9)(2012-3#5)(2013-1#8)(2013-7#6)(2013-8#4)
or tobacco##3##2##(1996-9#1)(2008-10#1)(2011-2#1)
or together with##4##3##(1996-6#1)(2006-8#1)(2009-8#1)(2011-1#1)
or tolerance to##2##3##(1997-8#1)(2011-10#1)
or tolerance##6##2##(1995-12#1)(1997-8#1)(2005-10#1)(2008-10#2)(2011-10#1)
or tolerance)##2##2##(2008-5#1)(2009-2#1)
or tolerated##2##2##(2008-11#1)(2012-2#1)
or too##5##2##(1993-2#1)(1995-6#1)(2008-8#1)(2009-3#1)(2013-1#1)
or topical application of##2##4##(1992-9#2)
or topical##3##2##(1992-9#2)(2006-9#1)
or total hip replacement##2##4##(2007-11#1)(2013-7#1)
or total hip##3##3##(2007-11#1)(2009-3#1)(2013-7#1)
or total knee arthroplasty (TKA)##3##5##(1994-3#1)(2011-2#1)(2013-7#1)
or total knee##5##3##(1994-3#1)(2007-10#1)(2011-2#1)(2013-1#1)(2013-7#1)
or total pancreatectomy##2##3##(1990-9#1)(2010-12#1)
or total##55##2##(1990-10#1)(1990-12#3)(1990-9#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-4#1)(1994-11#1)(1994-3#1)(1994-8#1)(1997-1#1)(1997-6#2)(1997-8#1)(2004-11#1)(2005-10#1)(2005-7#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-8#3)(2008-9#5)(2009-3#1)(2009-7#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#2)
or totally##2##2##(2008-5#1)(2008-7#1)
or towards##3##2##(2006-8#1)(2008-11#1)(2012-12#1)
or toxic effects##2##3##(2008-5#1)(2008-7#1)
or toxic##9##2##(1991-9#1)(2006-9#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#3)
or toxicity##5##2##(1996-3#1)(1997-1#1)(2007-2#2)(2010-11#1)
or toxicological##2##2##(2005-8#1)(2010-4#1)
or toxins##2##2##(2007-11#1)(2008-3#1)
or trabecular##2##2##(2008-1#1)(2012-3#1)
or trace##3##2##(2008-10#2)(2013-8#1)
or tracer##2##2##(1994-2#1)(2008-2#1)
or tracheostomy##2##2##(1996-9#1)(2009-2#1)
or track patients with diabetes##2##5##(2013-8#2)
or traditional##4##2##(1993-2#1)(2008-10#1)(2008-5#1)(2013-1#1)
or trailer##2##2##(2008-7#1)(2008-8#1)
or trailing##3##2##(2011-12#2)(2011-2#1)
or training in the##2##4##(2008-2#1)(2013-1#1)
or training##5##2##(2008-2#1)(2008-5#1)(2010-3#1)(2012-1#1)(2013-1#1)
or transcription##4##2##(1990-10#1)(1994-7#1)(1995-5#1)(2008-4#1)
or transfected##2##2##(1993-8#1)(1996-8#1)
or transfer of##2##3##(1995-8#1)(1997-6#1)
or transfer##7##2##(1995-8#3)(1997-6#1)(2007-7#1)(2008-3#2)
or transferred##2##2##(1996-8#1)(2012-3#1)
or transformed cells##4##3##(1992-2#1)(1995-6#1)(2006-10#1)(2013-8#1)
or transformed##6##2##(1992-2#1)(1995-6#1)(1996-2#1)(2006-10#1)(2007-11#1)(2013-8#1)
or transforming growth factor##4##4##(1990-9#1)(1992-9#1)(1993-7#1)(2011-2#1)
or transforming##6##2##(1990-9#1)(1992-9#1)(1993-7#1)(2007-8#1)(2011-2#2)
or transgenic##5##2##(1993-9#1)(2007-11#1)(2008-4#2)(2011-2#1)
or transient##20##2##(1993-11#1)(1994-6#1)(2005-12#1)(2006-2#1)(2007-10#6)(2007-7#1)(2007-9#1)(2008-11#2)(2008-4#1)(2008-8#1)(2010-12#2)(2011-1#1)(2013-8#1)
or transiently##2##2##(1996-5#1)(2008-4#1)
or transition metals##2##3##(1991-4#1)(1995-8#1)
or transition##3##2##(1991-4#1)(1994-8#1)(1995-8#1)
or translation##3##2##(1992-3#1)(2008-3#1)(2012-1#1)
or translational##6##2##(1993-12#1)(1994-8#1)(1997-4#1)(2005-12#1)(2006-12#1)(2010-10#1)
or transmission##5##2##(2008-1#1)(2008-2#1)(2008-3#2)(2011-12#1)
or transmitted through##2##3##(2007-4#1)(2009-5#1)
or transparency##3##2##(2007-8#1)(2008-11#1)(2008-2#1)
or transplant##3##2##(2007-7#1)(2008-9#1)(2009-10#1)
or transplantation##2##2##(2007-7#1)(2010-11#1)
or transport##4##2##(1994-11#1)(1997-4#1)(2007-5#1)(2007-8#1)
or transportation##2##2##(1995-5#1)(2010-8#1)
or trauma and##2##3##(2007-9#1)(2012-1#1)
or trauma to the##2##4##(2007-2#1)(2008-1#1)
or trauma##16##2##(1997-5#1)(2005-5#1)(2005-7#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-3#1)(2009-6#1)(2012-1#1)(2012-8#1)(2013-8#1)
or traumatic or##2##3##(2005-8#1)(2007-12#1)
or traumatic##8##2##(1990-4#1)(1993-10#1)(2005-8#1)(2007-12#1)(2008-9#1)(2012-1#2)(2012-2#1)
or treat##8##2##(1993-11#1)(2006-10#1)(2006-11#1)(2007-11#1)(2008-10#2)(2008-7#1)(2013-8#1)
or treatable##2##2##(2007-2#1)(2008-11#1)
or treated with##4##3##(1997-2#1)(2008-10#1)(2008-12#1)(2008-8#1)
or treated##14##2##(1990-11#1)(1997-2#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-9#1)(2012-12#1)(2013-1#1)
or treating##4##2##(1997-4#1)(2006-4#1)(2013-1#2)
or treatment delivery##2##3##(1995-2#1)(2008-2#1)
or treatment of the##2##4##(1996-5#1)(2007-7#1)
or treatment of##10##3##(1993-2#1)(1996-5#1)(2004-10#1)(2006-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-7#1)(2010-2#1)(2013-1#1)
or treatment with##6##3##(1992-8#1)(1995-12#1)(1995-3#1)(1996-11#1)(2008-1#1)(2008-6#1)
or treatment##36##2##(1990-9#1)(1992-8#1)(1993-11#1)(1993-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-5#1)(1997-8#1)(2004-10#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
or treatments##5##2##(1991-3#1)(1993-12#1)(2008-10#1)(2008-2#1)(2013-1#1)
or trehalose##2##2##(2008-5#1)(2012-3#1)
or trends in##2##3##(2008-8#1)(2013-7#1)
or trigger##2##2##(2005-11#1)(2008-11#1)
or triglycerides##4##2##(1992-4#1)(1993-12#1)(2008-8#1)(2010-4#1)
or trimming##2##2##(2008-2#1)(2009-9#1)
or triple mutations##2##3##(1996-5#1)(2008-10#1)
or triple##10##2##(1990-5#1)(1994-9#1)(1995-11#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-10#2)(2010-12#1)(2012-3#1)
or true##3##2##(2008-8#2)(2009-7#1)
or truncated##6##2##(1990-2#1)(1997-3#1)(1997-7#1)(2008-3#1)(2012-12#2)
or trypsin##2##2##(1992-11#1)(1994-8#1)
or tryptophan methyl ester hydrochloride##2##5##(2008-10#2)
or tuberculosis##2##2##(2007-8#1)(2010-12#1)
or tubular##3##2##(2008-10#1)(2012-1#1)(2013-8#1)
or tumor necrosis factor alpha##2##5##(1991-9#1)(1993-12#1)
or tumor necrosis factor-alpha##2##4##(1991-10#1)(1992-7#1)
or tumor necrosis##4##3##(1991-10#1)(1991-9#1)(1992-7#1)(1993-12#1)
or tumor##17##2##(1991-10#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-7#1)(1993-12#1)(1994-10#1)(1994-6#1)(1994-9#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-12#1)(2010-10#1)(2012-2#1)(2013-1#1)
or tumoral##2##2##(1992-5#1)(2007-9#1)
or tumors##4##2##(1994-3#1)(2007-1#1)(2010-12#1)(2012-12#1)
or tumour##5##2##(2007-11#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-4#1)
or tumours##2##2##(2008-3#1)(2008-5#1)
or tungsten##3##2##(1994-3#1)(2008-10#2)
or turmeric treated groups##2##4##(1994-8#2)
or turmeric##6##2##(1994-8#6)
or turnover##2##2##(1990-11#1)(1994-10#1)
or twice daily##7##3##(1997-4#1)(1997-8#1)(2007-1#1)(2010-8#3)(2011-12#1)
or twice weekly##2##3##(2007-12#1)(2012-6#1)
or twice##15##2##(1990-3#1)(1992-8#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-5#1)(2007-1#1)(2007-12#1)(2010-8#3)(2011-12#1)(2012-6#1)(2013-1#2)
or twice-daily##4##2##(2008-5#2)(2010-8#2)
or two long##2##3##(2008-11#1)(2012-2#1)
or two or##2##3##(1990-6#1)(1991-11#1)
or two other##3##3##(1991-7#1)(1997-4#1)(2008-4#1)
or two weeks##3##3##(2011-2#1)(2012-2#1)(2013-1#1)
or two##114##2##(1990-11#2)(1990-4#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-10#2)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-3#1)(1994-6#2)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#2)(1997-4#1)(1997-7#1)(2004-2#1)(2005-11#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#5)(2008-5#3)(2008-7#1)(2008-8#5)(2008-9#4)(2009-2#2)(2009-3#1)(2009-4#1)(2010-5#2)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
or two-dimensional##7##2##(1993-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)
or two-sided##2##2##(1996-1#1)(2011-1#1)
or two-stage##2##2##(2008-8#1)(2009-5#1)
or two?##2##2##(1993-9#1)(2008-12#1)
or type 1##3##3##(2007-12#1)(2007-5#1)(2013-1#1)
or type 2 diabetes##5##4##(2008-1#1)(2008-3#4)
or type 2##7##3##(2007-12#1)(2008-1#1)(2008-3#5)
or type II##3##3##(1994-3#1)(1994-8#1)(2008-3#1)
or type of##13##3##(1991-6#1)(1994-5#1)(1995-1#1)(2006-8#1)(2007-10#1)(2007-9#2)(2008-10#2)(2008-8#1)(2011-2#1)(2013-1#2)
or type##31##2##(1991-10#1)(1991-6#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1996-2#1)(2005-10#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-5#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-3#6)(2008-8#1)(2011-2#1)(2013-1#3)
or types of##2##3##(2008-4#1)(2009-5#1)
or tyrosine residues##2##3##(2008-4#2)
or tyrosine##9##2##(1992-6#1)(1993-4#1)(1994-3#1)(1995-11#1)(1995-6#1)(1996-5#1)(2008-4#3)
or ulcerative colitis tissues##2##4##(1990-9#2)
or ulcerative colitis##3##3##(1990-9#2)(2008-5#1)
or ulnar nerve##2##3##(2007-7#1)(2013-8#1)
or ulnar##3##2##(2007-7#1)(2008-9#1)(2013-8#1)
or ultrafiltration##2##2##(1990-10#1)(2007-11#1)
or ultrasonic##3##2##(1990-12#1)(1996-2#1)(2006-10#1)
or ultrasound##7##2##(1993-9#1)(2007-11#1)(2007-7#1)(2008-10#1)(2010-12#1)(2010-8#1)(2013-1#1)
or ultraviolet light##2##3##(1990-5#1)(2007-12#1)
or ultraviolet##5##2##(1990-5#1)(1996-5#1)(1996-8#1)(2007-12#1)(2008-2#1)
or umbilical##2##2##(1992-2#1)(1995-1#1)
or unable to##2##3##(2006-10#1)(2008-7#1)
or unacceptable##3##2##(2007-4#1)(2008-10#1)(2009-8#1)
or unbalanced##2##2##(1996-1#1)(2010-12#1)
or unchanged##6##2##(1994-5#1)(1995-1#1)(1997-1#1)(2006-11#1)(2010-7#1)(2012-1#1)
or under conditions##2##3##(1991-5#1)(1991-8#1)
or under development##3##3##(2007-7#1)(2011-1#2)
or under##22##2##(1990-11#1)(1990-12#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-7#1)(1993-5#1)(2004-4#1)(2004-9#1)(2007-7#1)(2008-10#5)(2008-4#2)(2008-6#1)(2011-1#2)
or underestimated##2##2##(2012-1#1)(2012-12#1)
or undergo apoptosis##2##3##(1994-10#1)(2010-12#1)
or undergo##4##2##(1994-10#1)(2007-11#1)(2010-12#1)(2012-1#1)
or underinsured##3##2##(2007-11#1)(2008-11#2)
or underlying##4##2##(2007-10#1)(2007-3#1)(2008-3#1)(2012-2#1)
or undermine##2##2##(2008-11#1)(2009-11#1)
or undertreated##3##2##(2007-12#1)(2008-9#1)(2011-2#1)
or underweight##2##2##(2007-12#1)(2010-6#1)
or underwent##2##2##(1993-4#1)(2013-1#1)
or undesirable##2##2##(2007-8#1)(2008-2#1)
or undetectable##7##2##(1991-4#1)(1994-8#1)(1997-1#1)(2007-11#1)(2008-10#1)(2012-2#1)(2013-8#1)
or undifferentiated##3##2##(2006-10#2)(2008-5#1)
or unexpected##3##2##(2006-10#1)(2007-11#1)(2008-4#1)
or unfavorable##4##2##(1994-3#2)(2007-12#1)(2011-1#1)
or unfolded##3##2##(1993-11#1)(1995-5#1)(2008-4#1)
or unfractionated##2##2##(1991-2#1)(2007-10#1)
or unidentified##2##2##(2008-1#1)(2008-10#1)
or unilateral##6##2##(1992-7#1)(1993-7#1)(2006-2#1)(2007-2#1)(2008-12#1)(2010-12#1)
or university##2##2##(1990-6#1)(1992-3#1)
or unknown factors##2##3##(2007-9#1)(2008-4#1)
or unknown##15##2##(1992-11#1)(1992-3#1)(2007-12#1)(2007-9#2)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-5#1)(2011-2#1)
or unlabeled##2##2##(1994-2#1)(2006-7#1)
or unrecognized##3##2##(1992-4#1)(2007-12#1)(2009-9#1)
or unresectable##3##2##(2006-12#1)(2006-6#1)(2008-6#1)
or unstable##6##2##(1992-7#1)(1992-9#1)(1993-4#1)(2008-5#1)(2009-10#1)(2009-12#1)
or unsuitable##4##2##(2005-10#1)(2008-9#1)(2010-12#1)(2013-7#1)
or unsuspected##2##2##(2008-7#1)(2008-9#1)
or until##4##2##(1996-3#1)(2006-7#1)(2008-3#1)(2013-8#1)
or untreated##8##2##(1996-12#1)(2005-7#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-11#1)(2012-12#1)
or unusual##2##2##(1991-11#1)(2007-2#1)
or unwanted##4##2##(1996-3#1)(2008-6#1)(2012-1#1)(2012-2#1)
or up to##4##3##(1994-5#1)(2006-5#1)(2008-10#2)
or upon##2##2##(1993-11#1)(1997-7#1)
or upper##6##2##(1990-3#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-7#1)
or upregulated##2##2##(2008-10#1)(2012-2#1)
or urea##5##2##(1990-12#1)(1995-1#1)(1997-6#1)(2008-8#1)(2009-4#1)
or urinary##5##2##(1990-5#1)(2007-8#1)(2008-7#1)(2012-3#1)(2013-1#1)
or urine##12##2##(1990-2#2)(1990-6#1)(1992-7#1)(1993-12#2)(1993-2#1)(1996-1#1)(1997-3#1)(2008-1#1)(2009-5#1)(2012-3#1)
or urokinase##2##2##(1990-11#1)(1993-8#1)
or use of##14##3##(1991-8#1)(1993-12#1)(1996-11#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-8#1)(2011-2#1)
or use##19##2##(1991-8#1)(1993-12#1)(1995-3#1)(1996-11#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2009-8#1)(2011-2#1)
or used as##2##3##(2008-2#1)(2013-8#1)
or used for##2##3##(2005-12#1)(2008-10#1)
or used in##3##3##(2007-10#1)(2008-10#2)
or used to##3##3##(2008-8#1)(2008-9#1)(2009-4#1)
or used with##2##3##(1996-3#1)(2011-1#1)
or used##16##2##(1991-1#1)(1996-3#1)(2005-12#1)(2007-10#1)(2007-3#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2011-1#1)(2013-8#1)
or using a##2##3##(2007-11#1)(2012-12#1)
or using the##3##3##(1993-3#1)(2008-10#1)(2008-4#1)
or using##27##2##(1993-2#1)(1993-3#1)(1994-2#1)(1996-5#1)(1997-1#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-12#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2011-1#1)(2012-12#2)
or usual care##2##3##(2010-4#1)(2010-5#1)
or uterus##2##2##(1993-8#1)(1995-11#1)
or utilization##2##2##(1994-12#1)(2011-1#1)
or utilized##2##2##(2008-11#1)(2008-8#1)
or vaccination##4##2##(1996-10#1)(2006-11#1)(2008-11#1)(2009-6#1)
or vaccines##2##2##(2008-11#1)(2010-12#1)
or vacuum##2##2##(1995-8#1)(2008-3#1)
or vaginal##3##2##(2007-5#1)(2011-2#1)(2013-1#1)
or validate##2##2##(2012-2#1)(2012-3#1)
or validoxylamine##2##2##(2008-10#2)
or valine##2##2##(1990-4#1)(1996-4#1)
or valproate##4##2##(1990-5#1)(1992-8#3)
or value of##2##3##(1993-6#1)(2006-8#1)
or value##3##2##(1993-6#1)(2006-8#1)(2007-5#1)
or values##3##2##(2005-7#1)(2008-3#1)(2011-1#1)
or vancomycin##2##2##(2010-4#1)(2011-2#1)
or variable##4##2##(1996-2#1)(2008-10#1)(2008-8#1)(2012-1#1)
or variants##2##2##(1993-6#1)(2009-2#1)
or variation##2##2##(1993-11#1)(1993-2#1)
or variations in the##2##4##(2006-8#1)(2008-4#1)
or variations in##3##3##(2006-8#1)(2008-2#1)(2008-4#1)
or various##7##2##(1990-6#1)(1994-9#1)(2005-8#1)(2008-10#2)(2010-6#1)(2012-2#1)
or varying##3##2##(2006-9#1)(2008-3#1)(2012-4#1)
or vascular endothelial growth factor##2##5##(1994-12#1)(2008-5#1)
or vascular##12##2##(1993-9#2)(1994-12#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-3#1)(2013-8#1)
or vasopressin##7##2##(1990-9#1)(1991-5#1)(1995-12#1)(1996-10#2)(1997-4#2)
or vector##3##2##(1995-2#1)(2008-8#2)
or vegetables##4##2##(1994-2#1)(2010-8#1)(2011-1#1)(2012-2#1)
or vehicle (n =##2##4##(1993-2#1)(1995-3#1)
or vehicle (sesame oil##2##4##(1993-4#1)(1997-2#1)
or vehicle in##2##3##(1991-8#1)(1994-8#1)
or vehicle once##2##3##(1991-8#1)(1993-11#1)
or vehicle only##2##3##(1994-9#1)(2008-10#1)
or vehicle##30##2##(1990-7#1)(1991-12#1)(1991-8#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#2)(1994-5#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-2#2)(2006-10#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-8#1)(2012-11#1)(2012-2#1)
or vein##2##2##(2006-8#1)(2011-3#1)
or vena cava##3##3##(2008-4#2)(2008-8#1)
or venous##10##2##(1990-12#1)(1993-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-9#1)(2008-3#1)(2008-7#1)(2012-12#1)
or ventral##2##2##(1996-2#1)(2007-10#1)
or ventricles##2##2##(1992-9#1)(2007-8#1)
or ventricular##6##2##(1993-10#2)(2006-10#1)(2007-9#1)(2009-6#1)(2010-5#1)
or verbal##2##2##(2007-2#1)(2011-1#1)
or vertebral##3##2##(1996-9#1)(2007-10#1)(2007-11#1)
or vertical##2##2##(1994-2#1)(2006-10#1)
or very close to##2##4##(1990-7#1)(1996-2#1)
or very early in##2##4##(1990-9#1)(2012-12#1)
or very good in##3##4##(1990-6#1)(2005-10#1)(2007-7#1)
or very good##6##3##(1990-6#1)(1990-7#1)(1993-2#1)(2005-10#1)(2006-10#1)(2007-7#1)
or very low##9##3##(2007-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
or very satisfied with the##2##5##(1992-5#1)(2008-9#1)
or very##47##2##(1990-6#1)(1990-7#2)(1990-9#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-2#1)(1995-1#1)(1996-2#1)(1997-6#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-7#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#3)(2013-8#3)
or vesicles##4##2##(1991-8#1)(1994-11#1)(1995-7#2)
or vessels##2##2##(1993-10#1)(2006-12#1)
or veterinary##2##2##(1997-3#1)(2010-7#1)
or via glass beads extraction##2##5##(2008-2#1)(2008-4#1)
or via the##6##3##(1991-11#1)(1995-3#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-7#1)
or via##22##2##(1991-11#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-5#1)(1997-4#1)(2004-3#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)
or viable##3##2##(2011-2#1)(2013-7#2)
or vibrational##2##2##(1994-11#1)(2007-11#1)
or vice versa##7##3##(1992-6#1)(1996-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-6#1)(2011-12#1)
or video##2##2##(2006-6#1)(2008-9#1)
or vincristine##3##2##(1997-5#1)(2008-6#1)(2012-1#1)
or violate##2##2##(1991-7#1)(2010-3#1)
or violated##2##2##(2008-5#1)(2010-10#1)
or violence##2##2##(1994-4#1)(2010-9#1)
or violent##3##2##(1993-4#1)(2008-8#1)(2012-11#1)
or viral transduction##2##3##(2008-4#1)(2012-12#1)
or viral##14##2##(1991-9#1)(1994-8#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
or viral-based##2##2##(2010-5#1)(2012-2#1)
or virulence of##2##3##(2008-10#2)
or virulence##4##2##(2008-10#3)(2008-7#1)
or virus##10##2##(1990-5#3)(1996-2#1)(2008-10#4)(2008-11#1)(2008-4#1)
or viruses##2##2##(2008-4#1)(2008-9#1)
or visceral##2##2##(2008-8#1)(2009-3#1)
or visible##5##2##(1992-10#1)(2006-12#1)(2008-10#2)(2008-5#1)
or visual##12##2##(1990-7#1)(1996-6#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-1#1)
or vitamin C##3##3##(1995-5#1)(2011-12#1)(2011-2#1)
or vitamin D receptor##2##4##(2008-4#1)(2013-1#1)
or vitamin##7##2##(1995-5#1)(2006-5#1)(2008-4#1)(2011-12#2)(2011-2#1)(2013-1#1)
or vocal##2##2##(2009-2#1)(2011-12#1)
or voiding##2##2##(2007-8#1)(2012-11#1)
or volume##4##2##(2007-5#1)(2010-2#1)(2012-12#2)
or voluntary##3##2##(2009-12#1)(2010-10#1)(2012-12#1)
or vomiting##7##2##(1991-9#1)(2008-10#1)(2008-7#5)
or war##2##2##(2008-7#1)(2012-11#1)
or ward##2##2##(1997-3#1)(2005-8#1)
or warfarin therapy##2##3##(2006-9#1)(2007-10#1)
or warfarin##3##2##(2006-9#1)(2007-10#1)(2008-3#1)
or was not##5##3##(1990-4#1)(1990-6#1)(2008-11#1)(2013-1#2)
or was##22##2##(1990-11#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-5#1)(1992-1#1)(1992-9#1)(1993-3#1)(1995-2#1)(1997-1#1)(1997-2#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-12#2)(2013-1#2)
or washing##2##2##(2007-10#1)(2008-5#1)
or water##21##2##(1990-5#1)(1990-8#1)(1991-5#1)(1994-10#1)(1994-8#1)(1996-12#1)(2005-9#1)(2006-10#1)(2006-11#1)(2007-2#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2010-4#1)
or wave-front deformation##3##3##(2008-3#3)
or wavy##2##2##(2006-10#1)(2010-6#1)
or we##2##2##(1990-10#1)(2006-1#1)
or weak##10##2##(1992-1#1)(1992-4#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
or weakly##9##2##(1990-2#1)(1991-5#1)(1995-1#1)(1995-2#1)(2006-8#2)(2006-9#1)(2007-12#1)(2008-11#1)
or weakness##3##2##(1991-8#1)(2009-5#1)(2011-2#1)
or weekly##3##2##(2007-11#1)(2008-5#1)(2009-9#1)
or weight gain##2##3##(2008-6#1)(2013-8#1)
or weight loss##3##3##(2009-6#1)(2012-3#2)
or weight##10##2##(2006-10#1)(2006-7#1)(2007-1#2)(2007-5#1)(2008-6#1)(2009-6#1)(2012-3#2)(2013-8#1)
or well##3##2##(2008-3#1)(2009-10#1)(2011-2#1)
or well-being##2##2##(2009-11#1)(2010-8#1)
or were exposed to##2##4##(1995-8#1)(2008-8#1)
or were not##5##3##(1991-10#1)(1994-2#1)(1994-3#1)(2008-10#1)(2012-2#1)
or were##63##2##(1990-4#1)(1991-10#1)(1991-12#1)(1992-8#1)(1993-10#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-4#1)(1995-11#1)(1995-12#2)(1995-8#3)(1996-11#1)(1996-12#1)(1996-6#1)(1997-4#1)(1997-6#1)(2004-4#1)(2005-5#1)(2005-7#1)(2006-10#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#5)(2009-6#1)(2011-2#3)(2012-2#1)
or western##2##2##(1996-12#1)(2010-12#1)
or wet##3##2##(1997-4#1)(2008-3#1)(2013-1#1)
or what##11##2##(1990-2#1)(1992-1#1)(2004-1#1)(2004-12#1)(2006-10#1)(2007-3#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-1#1)
or wheat germ##2##3##(1991-12#1)(2008-1#1)
or wheat##3##2##(1991-12#1)(2008-1#1)(2008-10#1)
or wheezing##3##2##(2007-2#1)(2008-3#1)(2012-3#1)
or when a##3##3##(1990-8#1)(1994-8#1)(2010-11#1)
or when both##2##3##(2008-10#1)(2008-8#1)
or when it is##2##4##(1991-1#1)(2008-4#1)
or when one##2##3##(2008-10#1)(2012-2#1)
or when the ligand is weakly soluble in solvents required for phosphoramidite- or H-phosphonate-mediated oligonucleotide synthesis##2##16##(2008-4#2)
or when the patient##2##4##(1993-2#1)(1997-6#1)
or when the##20##3##(1990-1#1)(1991-4#1)(1991-6#1)(1992-6#1)(1993-2#1)(1995-8#1)(1996-11#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-9#1)
or when there is a##3##5##(2008-10#1)(2008-3#2)
or when there is##4##4##(2008-10#1)(2008-3#2)(2010-3#1)
or when there##5##3##(1995-6#1)(2008-10#1)(2008-3#2)(2010-3#1)
or when they##5##3##(1992-5#1)(1995-8#1)(2007-9#1)(2008-4#1)(2009-3#1)
or when##76##2##(1990-1#1)(1990-11#2)(1990-8#2)(1991-1#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-3#1)(1995-6#1)(1995-8#3)(1996-11#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#4)(2008-3#3)(2008-4#4)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-10#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
or where a##2##3##(2008-4#1)(2012-12#1)
or where the##6##3##(1990-5#2)(2007-7#1)(2008-8#2)(2011-2#1)
or where there##2##3##(1994-3#1)(1997-5#1)
or where##12##2##(1990-5#2)(1994-3#1)(1997-5#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-8#2)(2011-2#1)(2012-12#1)(2012-2#1)
or whether it is##3##4##(1994-5#1)(2008-11#1)(2008-5#1)
or whether it##6##3##(1994-5#1)(2008-11#1)(2008-4#1)(2008-5#2)(2009-5#1)
or whether or not##2##4##(1991-6#1)(2008-7#1)
or whether the##7##3##(1992-4#2)(1994-6#1)(1996-8#1)(2005-10#1)(2006-10#1)(2008-7#1)
or whether there##3##3##(1990-12#1)(2013-1#2)
or whether they##4##3##(2007-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
or whether##32##2##(1990-12#1)(1991-6#1)(1992-4#2)(1994-10#1)(1994-5#1)(1994-6#1)(1996-12#1)(1996-8#1)(1997-4#1)(2005-10#1)(2006-10#2)(2006-8#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#2)(2009-5#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
or which##8##2##(1990-11#1)(1992-2#1)(1995-7#1)(1996-12#1)(2008-11#1)(2008-9#1)(2011-12#1)(2012-2#1)
or white##5##2##(1992-11#1)(2007-7#1)(2008-5#2)(2010-11#1)
or who are##4##3##(2008-11#1)(2008-6#1)(2009-3#1)(2010-12#1)
or who have##4##3##(1993-6#1)(2008-5#1)(2009-3#1)(2012-12#1)
or who were##4##3##(1994-1#1)(2005-10#1)(2008-6#1)(2012-3#1)
or who##22##2##(1991-4#1)(1991-9#1)(1992-6#1)(1993-6#1)(1994-1#2)(1996-1#1)(2005-10#1)(2005-7#2)(2006-9#1)(2008-11#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-3#2)(2010-12#1)(2010-5#1)(2012-12#1)(2012-3#1)
or whole blood##4##3##(1990-12#2)(2008-4#1)(2008-5#1)
or whole genome re-sequence data from the 50K##2##8##(2012-1#2)
or whole##16##2##(1990-12#2)(1990-5#1)(2006-10#1)(2007-10#1)(2008-4#2)(2008-5#1)(2009-4#1)(2009-5#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#1)
or whose##6##2##(1993-4#1)(2006-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)
or wide excision##2##3##(2004-1#1)(2007-11#1)
or wide##7##2##(1990-10#1)(2004-1#1)(2006-4#1)(2007-11#1)(2008-3#1)(2008-6#1)(2013-1#1)
or widely##2##2##(2008-5#1)(2010-5#1)
or widespread##3##2##(1992-1#2)(2008-4#1)
or wild type##4##3##(1997-4#1)(2006-12#2)(2009-4#1)
or will be##4##3##(2005-5#1)(2006-8#1)(2008-6#1)(2009-6#1)
or will soon##2##3##(2007-6#2)
or will##9##2##(1991-1#1)(2005-5#1)(2006-8#1)(2007-6#2)(2008-10#1)(2008-6#1)(2009-4#1)(2009-6#1)
or window)##2##2##(2006-9#2)
or with 0##2##3##(1991-7#1)(2011-2#1)
or with 1##2##3##(1992-6#1)(2008-5#1)
or with a combination of##2##5##(1993-8#1)(2008-2#1)
or with a##19##3##(1991-12#1)(1992-11#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-9#1)(1995-11#1)(1995-6#1)(2004-12#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#2)(2010-12#1)(2011-2#1)(2013-8#1)
or with an##5##3##(1994-8#1)(2008-3#1)(2008-5#1)(2011-3#1)(2012-3#1)
or with both##2##3##(2008-10#1)(2008-3#1)
or with complications##2##3##(1996-11#1)(2011-1#1)
or with conservative##2##3##(2008-7#1)(2011-1#1)
or with diamorphine##2##3##(1993-7#2)
or with internal##2##3##(2005-11#1)(2008-7#1)
or with isolated##2##3##(1995-10#1)(2009-5#1)
or with other##8##3##(1994-6#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-11#1)(2012-12#1)
or with primary##2##3##(1991-2#1)(2006-10#1)
or with the same##2##4##(1996-4#1)(2008-3#1)
or with the##25##3##(1990-1#1)(1990-7#1)(1991-11#1)(1991-3#1)(1991-5#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-6#2)(1996-4#1)(1997-4#3)(2004-12#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2010-12#1)(2012-3#1)
or with##245##2##(1990-1#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#2)(1991-9#1)(1992-10#1)(1992-11#2)(1992-2#1)(1992-6#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#3)(1993-6#1)(1993-7#3)(1993-8#2)(1993-9#5)(1994-10#2)(1994-11#2)(1994-12#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#3)(1995-4#1)(1995-6#3)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-4#3)(1997-8#1)(2004-12#2)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#5)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#2)(2006-9#3)(2007-10#4)(2007-11#8)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#33)(2008-11#8)(2008-12#1)(2008-2#5)(2008-3#7)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#3)(2009-10#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-5#1)(2011-1#8)(2011-2#5)(2011-3#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
or withdraw##2##2##(2006-10#1)(2010-5#1)
or withdrawal of##4##3##(1994-12#1)(1997-8#1)(2007-2#1)(2012-2#1)
or withdrawal##6##2##(1994-12#1)(1997-8#1)(2007-2#1)(2008-8#1)(2012-2#2)
or withdrawing##2##2##(2009-7#1)(2010-5#1)
or withdrawn##2##2##(2006-10#1)(2013-8#1)
or withhold a##2##3##(2008-10#1)(2010-12#1)
or within 5##2##3##(2007-8#1)(2013-8#1)
or within the##7##3##(1994-5#1)(1996-7#1)(1997-3#1)(2006-2#1)(2007-11#1)(2008-7#1)(2011-1#1)
or within##21##2##(1994-5#1)(1996-7#1)(1997-3#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#1)(2013-8#1)
or without a##16##3##(1993-9#2)(1996-7#1)(2006-10#2)(2006-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-2#1)
or without cardiopulmonary bypass##2##4##(2006-12#1)(2007-8#1)
or without cardiopulmonary##3##3##(2006-10#1)(2006-12#1)(2007-8#1)
or without home health##2##4##(1995-3#2)
or without pain##3##3##(2006-8#1)(2008-1#1)(2011-1#1)
or without the##21##3##(1990-4#1)(1991-10#1)(1995-8#1)(1996-9#1)(2004-9#2)(2005-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2009-1#1)(2009-6#2)(2012-2#1)(2013-8#1)
or without##414##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-1#2)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#2)(1991-5#2)(1991-6#2)(1991-8#3)(1992-11#1)(1992-12#4)(1992-2#3)(1992-3#3)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-4#2)(1993-5#1)(1993-7#2)(1993-8#2)(1993-9#6)(1994-11#1)(1994-12#1)(1994-2#4)(1994-6#4)(1994-7#2)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#1)(1995-8#3)(1996-1#1)(1996-11#3)(1996-2#3)(1996-3#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-8#3)(2004-12#1)(2004-2#1)(2004-9#2)(2005-10#1)(2005-11#2)(2005-12#1)(2005-8#2)(2006-10#13)(2006-11#3)(2006-12#3)(2006-3#1)(2006-5#3)(2006-6#4)(2006-7#2)(2006-8#19)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#8)(2007-12#3)(2007-2#4)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#7)(2007-9#5)(2008-1#10)(2008-10#23)(2008-11#7)(2008-12#4)(2008-2#2)(2008-3#9)(2008-4#9)(2008-5#14)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#10)(2009-1#1)(2009-10#2)(2009-3#5)(2009-4#4)(2009-5#1)(2009-6#6)(2009-8#4)(2009-9#1)(2010-11#1)(2010-12#10)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#6)(2011-11#1)(2011-12#1)(2011-2#10)(2012-1#1)(2012-12#7)(2012-2#9)(2012-3#5)(2012-4#1)(2013-1#7)(2013-7#2)(2013-8#11)
or women with##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
or women##8##2##(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-2#1)(2012-12#1)
or word##2##2##(2007-12#1)(2008-11#1)
or work##4##2##(1995-2#1)(1996-1#1)(2006-2#1)(2009-7#1)
or working##2##2##(2008-1#1)(2013-7#1)
or worse##5##2##(1994-2#3)(2008-5#1)(2008-7#1)
or worsen##2##2##(1995-2#1)(2007-12#1)
or worsening of##2##3##(2004-3#1)(2011-1#1)
or worsening##5##2##(2004-3#1)(2007-7#1)(2008-4#1)(2010-6#1)(2011-1#1)
or would##3##2##(1993-8#2)(2010-2#1)
or wrist##2##2##(2008-9#1)(2013-1#1)
or wrong##4##2##(1991-3#1)(1994-1#2)(2007-12#1)
or xylose##3##2##(2006-8#1)(2008-10#1)(2011-2#1)
or years in the United States##2##6##(1997-2#2)
or years of##3##3##(1996-8#1)(2010-6#1)(2011-2#1)
or years##8##2##(1996-8#1)(1997-2#2)(2008-7#1)(2009-11#1)(2010-6#1)(2011-1#1)(2011-2#1)
or yeast##8##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-2#1)(1992-5#1)(2007-11#1)(2008-6#1)
or yield##4##2##(2007-11#1)(2008-10#3)
or yohimbine##3##2##(1990-5#1)(1993-4#2)
or young##10##2##(1993-5#1)(2006-9#1)(2007-3#2)(2008-10#2)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#1)
or younger##12##2##(1995-8#1)(2004-11#1)(2006-12#2)(2008-10#1)(2008-3#1)(2008-5#2)(2009-4#1)(2009-5#1)(2010-3#1)(2011-2#1)
or zero##5##2##(1993-3#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-8#1)
or zinc##5##2##(1991-9#1)(2006-8#1)(2008-10#1)(2013-8#2)
or zinc(II)##2##2##(1991-5#1)(2008-10#1)
or zymosan##2##2##(1991-12#1)(1994-6#1)
or##38684##1##(1990-1#16)(1990-10#85)(1990-11#151)(1990-12#199)(1990-2#142)(1990-3#119)(1990-4#92)(1990-5#176)(1990-6#106)(1990-7#115)(1990-8#147)(1990-9#90)(1991-1#80)(1991-10#82)(1991-11#115)(1991-12#186)(1991-2#217)(1991-3#107)(1991-4#95)(1991-5#149)(1991-6#116)(1991-7#144)(1991-8#160)(1991-9#174)(1992-1#76)(1992-10#63)(1992-11#112)(1992-12#144)(1992-2#134)(1992-3#185)(1992-4#77)(1992-5#133)(1992-6#150)(1992-7#93)(1992-8#170)(1992-9#171)(1993-1#69)(1993-10#53)(1993-11#184)(1993-12#203)(1993-2#135)(1993-3#162)(1993-4#114)(1993-5#81)(1993-6#140)(1993-7#77)(1993-8#118)(1993-9#157)(1994-1#29)(1994-10#48)(1994-11#158)(1994-12#211)(1994-2#193)(1994-3#256)(1994-4#21)(1994-5#145)(1994-6#167)(1994-7#21)(1994-8#206)(1994-9#202)(1995-1#138)(1995-10#71)(1995-11#197)(1995-12#209)(1995-2#218)(1995-3#220)(1995-4#48)(1995-5#208)(1995-6#176)(1995-7#64)(1995-8#174)(1995-9#65)(1996-1#126)(1996-10#110)(1996-11#124)(1996-12#264)(1996-2#150)(1996-3#156)(1996-4#84)(1996-5#192)(1996-6#129)(1996-7#79)(1996-8#126)(1996-9#132)(1997-1#152)(1997-2#224)(1997-3#186)(1997-4#225)(1997-5#150)(1997-6#158)(1997-7#194)(1997-8#185)(1997-9#2)(2003-11#8)(2004-1#35)(2004-10#16)(2004-11#45)(2004-12#58)(2004-2#30)(2004-3#27)(2004-4#24)(2004-7#1)(2004-8#2)(2004-9#44)(2005-1#18)(2005-10#166)(2005-11#232)(2005-12#66)(2005-2#2)(2005-3#11)(2005-4#17)(2005-5#35)(2005-6#10)(2005-7#129)(2005-8#161)(2005-9#39)(2006-1#32)(2006-10#776)(2006-11#98)(2006-12#305)(2006-2#143)(2006-3#65)(2006-4#91)(2006-5#185)(2006-6#150)(2006-7#131)(2006-8#334)(2006-9#108)(2007-1#88)(2007-10#296)(2007-11#780)(2007-12#589)(2007-2#242)(2007-3#143)(2007-4#132)(2007-5#106)(2007-6#99)(2007-7#324)(2007-8#547)(2007-9#260)(2008-1#502)(2008-10#3120)(2008-11#827)(2008-12#247)(2008-2#607)(2008-3#733)(2008-4#1092)(2008-5#947)(2008-6#338)(2008-7#857)(2008-8#589)(2008-9#731)(2009-1#14)(2009-10#150)(2009-11#88)(2009-12#96)(2009-2#116)(2009-3#174)(2009-4#160)(2009-5#173)(2009-6#123)(2009-7#91)(2009-8#151)(2009-9#139)(2010-1#51)(2010-10#87)(2010-11#124)(2010-12#368)(2010-2#188)(2010-3#117)(2010-4#184)(2010-5#143)(2010-6#119)(2010-7#132)(2010-8#203)(2010-9#86)(2011-1#436)(2011-10#7)(2011-11#6)(2011-12#114)(2011-2#1001)(2011-3#23)(2011-7#2)(2011-8#1)(2011-9#1)(2012-1#218)(2012-10#3)(2012-11#76)(2012-12#533)(2012-2#621)(2012-3#363)(2012-4#5)(2012-5#7)(2012-6#4)(2012-7#7)(2012-8#2)(2012-9#9)(2013-1#860)(2013-7#193)(2013-8#468)
or/and##14##1##(1993-5#1)(2006-10#3)(2007-11#1)(2007-8#1)(2008-10#3)(2008-7#1)(2009-12#1)(2010-3#1)(2013-7#1)(2013-8#1)
or= 0##7##2##(2008-2#2)(2008-3#4)(2010-4#1)
or= 1##3##2##(2004-1#1)(2006-7#1)(2008-3#1)
or= 70##2##2##(2004-1#1)(2008-3#1)
or= Ea##2##2##(2008-11#2)
or= r &lt##2##3##(2010-9#2)
or= r##3##2##(2010-9#3)
or=##36##1##(2004-1#2)(2006-7#2)(2008-11#4)(2008-2#4)(2008-3#19)(2010-4#1)(2010-6#1)(2010-9#3)
or=3##2##1##(2007-11#1)(2008-3#1)
or=40 years##3##2##(2007-11#1)(2007-8#1)(2009-8#1)
or=50##2##1##(2007-8#2)
or=50%##2##1##(2007-8#2)
or=6##2##1##(2007-11#1)(2009-5#1)
ora##2##1##(2005-11#1)(2007-11#1)
oracle##5##1##(1991-11#1)(2008-2#1)(2010-1#2)(2012-1#1)
oral Candida carriage in##2##4##(2012-2#2)
oral Candida##8##2##(2007-7#1)(2008-5#2)(2010-8#1)(2012-2#4)
oral Crohn's disease is##2##4##(2012-2#2)
oral Crohn's disease##3##3##(2012-2#3)
oral FSA##2##2##(2012-1#2)
oral HIV##3##2##(2006-8#3)
oral Zn(++) administration##2##3##(2008-5#2)
oral absorption and##2##3##(1991-12#1)(2008-5#1)
oral absorption of##3##3##(2007-8#1)(2008-9#1)(2010-1#1)
oral absorption##6##2##(1991-12#1)(2007-8#1)(2008-5#1)(2008-9#1)(2010-1#1)(2012-3#1)
oral aciclovir##2##2##(2006-12#2)
oral activity in##3##3##(1993-4#1)(1994-9#2)
oral activity of##2##3##(1993-10#1)(2005-8#1)
oral activity##7##2##(1993-10#1)(1993-4#1)(1994-9#2)(1996-8#2)(2005-8#1)
oral administration and##3##3##(1992-2#1)(1997-1#1)(2008-4#1)
oral administration at##2##3##(2009-1#1)(2010-12#1)
oral administration in##6##3##(1996-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-6#1)(2011-1#1)
oral administration of 0##3##4##(1995-4#1)(2008-10#1)(2008-5#1)
oral administration of BIM##2##4##(2008-11#2)
oral administration of YH439##2##4##(2008-11#2)
oral administration of a##8##4##(1991-12#1)(1993-10#1)(1993-11#1)(1994-6#1)(2008-10#2)(2008-11#1)(2008-5#1)
oral administration of an##2##4##(1990-6#1)(1993-11#1)
oral administration of hyperimmune##2##4##(2008-8#2)
oral administration of potassium##2##4##(1992-9#1)(2007-8#1)
oral administration of racemic tramadol##2##5##(1993-2#2)
oral administration of the##5##4##(1992-8#1)(1996-5#1)(2005-12#1)(2008-10#2)
oral administration of this##2##4##(2008-3#1)(2009-8#1)
oral administration of##85##3##(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1991-12#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#4)(1993-2#2)(1993-9#2)(1994-12#1)(1994-6#1)(1995-12#1)(1995-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-12#1)(2005-12#2)(2006-2#1)(2006-4#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#11)(2008-11#10)(2008-3#1)(2008-4#2)(2008-5#3)(2008-8#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-8#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
oral administration with##2##3##(1995-3#1)(2007-10#1)
oral administration##129##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1991-12#2)(1992-2#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#4)(1993-2#2)(1993-9#2)(1994-12#1)(1994-6#3)(1994-9#1)(1995-12#1)(1995-3#2)(1995-4#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-12#2)(2005-7#3)(2006-2#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-6#1)(2007-7#2)(2007-8#2)(2008-10#12)(2008-11#13)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#8)(2008-6#1)(2008-8#2)(2009-1#1)(2009-5#1)(2009-8#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#4)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
oral agent##3##2##(1993-12#1)(2007-3#1)(2007-7#1)
oral agents##13##2##(2006-2#1)(2007-12#1)(2007-3#1)(2008-1#2)(2009-11#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#2)(2011-2#2)
oral aluminum##3##2##(1992-11#3)
oral ampicillin##2##2##(2006-10#2)
oral anaerobic##2##2##(2008-9#2)
oral and gastrointestinal mucositis##2##4##(2008-7#2)
oral and gastrointestinal##3##3##(2008-7#2)(2011-2#1)
oral and genital##3##3##(1997-8#1)(2007-11#1)(2013-1#1)
oral and intravenous administration##6##4##(1992-2#1)(1997-1#1)(2008-3#1)(2011-1#3)
oral and intravenous formulations##2##4##(2008-12#2)
oral and intravenous##17##3##(1991-12#1)(1992-2#1)(1994-12#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-12#2)(2008-3#1)(2008-7#1)(2011-1#3)(2011-2#2)(2013-7#1)
oral and maxillofacial surgeon##7##4##(2007-12#6)(2008-7#1)
oral and maxillofacial surgeons are##2##5##(2007-12#2)
oral and maxillofacial surgeons in##2##5##(2007-12#2)
oral and maxillofacial surgeons##12##4##(2007-12#12)
oral and maxillofacial surgery patients##5##5##(2007-12#5)
oral and maxillofacial surgery##26##4##(1993-1#2)(2007-12#20)(2008-7#4)
oral and maxillofacial##51##3##(1993-1#2)(2007-12#40)(2008-7#6)(2011-12#1)(2012-12#1)(2012-2#1)
oral and poster presentations##3##4##(2005-8#1)(2005-9#1)(2006-12#1)
oral and poster##4##3##(2005-8#2)(2005-9#1)(2006-12#1)
oral and rectal##2##3##(2008-4#1)(2009-10#1)
oral and systemic health##2##4##(2010-3#1)(2012-3#1)
oral and systemic##3##3##(2010-3#2)(2012-3#1)
oral and topical##5##3##(1992-6#1)(2006-10#1)(2007-7#1)(2008-5#1)(2012-12#1)
oral and written##2##3##(1991-2#1)(2007-9#1)
oral and##114##2##(1990-12#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-2#1)(1992-6#1)(1993-1#2)(1994-12#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-8#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-9#1)(2007-11#3)(2007-12#40)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#9)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-9#1)(2010-10#1)(2010-3#2)(2010-7#2)(2011-1#4)(2011-12#1)(2011-2#3)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)
oral anti-inflammatory##2##2##(2006-8#1)(2007-1#1)
oral antibiotic treatment##2##3##(2009-5#1)(2011-2#1)
oral antibiotic##3##2##(2009-5#1)(2010-12#1)(2011-2#1)
oral antibiotics##16##2##(1994-8#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-10#2)(2007-7#1)(2008-1#1)(2010-8#1)(2011-1#5)(2012-12#1)(2013-8#1)
oral anticoagulant therapy##3##3##(1993-6#1)(1997-2#1)(2007-8#1)
oral anticoagulant##7##2##(1993-6#1)(1993-7#1)(1994-5#1)(1997-2#1)(2007-10#1)(2007-8#1)(2013-8#1)
oral anticoagulants for##2##3##(1993-7#1)(1996-6#1)
oral anticoagulants in##3##3##(1993-7#1)(2007-10#1)(2012-12#1)
oral anticoagulants##16##2##(1990-12#1)(1993-7#7)(1994-3#1)(1995-10#1)(1996-6#1)(2004-12#1)(2007-10#1)(2011-12#1)(2012-12#1)(2013-1#1)
oral anticoagulation (OAC)##2##3##(1994-4#1)(2010-12#1)
oral anticoagulation for##3##3##(1995-11#2)(2007-8#1)
oral anticoagulation is##2##3##(1994-4#2)
oral anticoagulation therapy##4##3##(2011-2#2)(2013-1#2)
oral anticoagulation##23##2##(1994-4#3)(1995-11#2)(1995-5#1)(1996-2#1)(1997-5#1)(2007-3#1)(2007-8#4)(2008-3#1)(2008-8#1)(2009-5#2)(2010-12#2)(2011-2#2)(2013-1#2)
oral antidiabetic##3##2##(1996-11#1)(2008-11#1)(2009-9#1)
oral antidiabetics##2##2##(1992-3#1)(1994-4#1)
oral antifungal##3##2##(2007-8#1)(2008-3#2)
oral antifungals##2##2##(2008-5#1)(2012-12#1)
oral antiviral##2##2##(2009-11#1)(2009-8#1)
oral application##2##2##(1994-11#1)(2005-8#1)
oral assessment##2##2##(2008-7#1)(2013-8#1)
oral attenuated candidate vaccines against##2##5##(2007-10#2)
oral baclofen##2##2##(1996-2#1)(2008-10#1)
oral bacteria##2##2##(2008-5#1)(2013-8#1)
oral bacterial##3##2##(1991-3#1)(1992-11#1)(2008-5#1)
oral bacteriotherapy##5##2##(2007-11#5)
oral bacterium##3##2##(1990-12#1)(1991-1#1)(1993-9#1)
oral beta-lactam antibiotics##2##3##(1994-12#1)(1996-9#1)
oral bexarotene##2##2##(2004-1#2)
oral bioavailability and a##2##4##(2004-12#1)(2005-8#1)
oral bioavailability and##4##3##(1997-1#1)(2004-12#1)(2005-8#1)(2007-11#1)
oral bioavailability in##3##3##(1994-9#1)(1996-8#1)(2005-8#1)
oral bioavailability of Drug X in male##2##7##(2009-4#2)
oral bioavailability of Drug X in##3##6##(2009-4#3)
oral bioavailability of Drug X##4##5##(2009-4#4)
oral bioavailability of drugs##2##4##(2009-4#1)(2012-2#1)
oral bioavailability of##9##3##(2005-7#1)(2008-5#1)(2009-4#5)(2012-12#1)(2012-2#1)
oral bioavailability##34##2##(1994-9#1)(1996-8#1)(1997-1#3)(2004-12#1)(2005-7#2)(2005-8#2)(2005-9#1)(2007-11#2)(2007-8#2)(2008-3#3)(2008-5#2)(2008-8#1)(2009-4#7)(2010-1#1)(2010-12#1)(2012-12#2)(2012-2#2)
oral biofilms##3##2##(1995-12#1)(2008-9#2)
oral biopsies##2##2##(2012-2#1)(2013-8#1)
oral bisphosphonates##3##2##(2008-11#1)(2008-3#1)(2008-5#1)
oral bone##2##2##(2010-10#1)(2013-8#1)
oral breathing##2##2##(2008-11#1)(2009-11#1)
oral calcium##5##2##(2005-3#1)(2005-7#2)(2007-11#1)(2013-8#1)
oral cancer cells##3##3##(2010-2#1)(2013-1#2)
oral cancer in##5##3##(1993-4#1)(2007-2#1)(2008-4#1)(2011-2#1)(2013-1#1)
oral cancer is##2##3##(2008-1#1)(2010-12#1)
oral cancer patients##3##3##(1991-5#3)
oral cancer##53##2##(1991-5#4)(1991-6#1)(1992-9#1)(1993-12#1)(1993-4#1)(1994-6#2)(2007-12#7)(2007-2#1)(2007-7#1)(2007-9#4)(2008-1#1)(2008-4#2)(2010-12#2)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-12#1)(2012-2#1)(2013-1#10)(2013-8#2)
oral cancers in##2##3##(2005-11#1)(2012-2#1)
oral cancers##10##2##(1992-8#2)(2005-11#2)(2007-6#2)(2011-1#3)(2012-2#1)
oral candidiasis and##2##3##(2006-8#1)(2008-5#1)
oral candidiasis##10##2##(2006-8#4)(2007-2#4)(2008-5#1)(2012-2#1)
oral candidosis##5##2##(2007-7#1)(2008-5#3)(2013-1#1)
oral capecitabine##2##2##(2008-7#1)(2011-1#1)
oral carcinomas##2##2##(1991-5#1)(2008-1#1)
oral care products##2##3##(1997-4#1)(2008-5#1)
oral care program##2##3##(2006-10#1)(2008-7#1)
oral care##14##2##(1997-4#1)(2005-11#1)(2006-10#1)(2006-2#5)(2007-2#1)(2008-5#1)(2008-7#2)(2011-1#1)(2012-2#1)
oral cavity and pharynx##7##4##(1991-5#2)(1995-5#2)(2009-10#1)(2013-1#2)
oral cavity and##12##3##(1991-5#2)(1993-12#1)(1995-5#2)(2008-12#1)(2009-10#1)(2011-1#2)(2012-3#1)(2013-1#2)
oral cavity by##2##3##(2008-2#1)(2010-9#1)
oral cavity cancers##2##3##(2008-1#1)(2013-1#1)
oral cavity fluids##5##3##(2010-2#5)
oral cavity is a##2##4##(2008-7#1)(2012-3#1)
oral cavity is rare##2##4##(2013-1#1)(2013-7#1)
oral cavity is##8##3##(2005-11#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
oral cavity of children##2##4##(2008-12#1)(2012-12#1)
oral cavity of##10##3##(1995-9#1)(2007-7#1)(2008-12#2)(2008-5#1)(2012-12#1)(2013-1#4)
oral cavity##113##2##(1990-1#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-10#2)(1991-4#1)(1991-5#3)(1991-6#1)(1992-8#1)(1993-12#1)(1994-2#1)(1995-5#2)(1995-8#2)(1995-9#1)(1996-8#2)(1997-4#1)(2005-11#2)(2006-1#1)(2006-2#2)(2006-4#1)(2006-6#1)(2007-12#5)(2007-7#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#4)(2008-2#2)(2008-4#1)(2008-5#4)(2008-7#2)(2008-9#1)(2009-10#4)(2009-5#1)(2010-12#1)(2010-2#6)(2010-4#1)(2010-7#2)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#4)(2011-7#1)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#15)(2013-7#2)(2013-8#1)
oral cephalosporin##3##2##(1992-1#1)(1994-11#2)
oral challenge##5##2##(2008-5#2)(2012-3#3)
oral ciprofloxacin##2##2##(1991-4#1)(1993-1#1)
oral clearance##2##2##(1991-12#1)(1996-2#1)
oral clonidine##4##2##(2006-12#3)(2012-1#1)
oral coadministration##2##2##(2010-12#2)
oral combination##2##2##(1990-8#1)(2012-2#1)
oral communication##3##2##(2008-12#1)(2008-9#1)(2012-2#1)
oral complications##3##2##(2007-12#1)(2008-11#1)(2008-7#1)
oral conditions##4##2##(2006-2#1)(2007-2#1)(2009-7#1)(2012-2#1)
oral contraception##5##2##(1991-4#1)(1994-5#1)(2009-12#1)(2010-12#1)(2013-8#1)
oral contraceptive in##2##3##(2008-5#1)(2011-2#1)
oral contraceptive pill##3##3##(2007-12#1)(2010-1#1)(2012-3#1)
oral contraceptive pills##3##3##(2011-2#2)(2013-1#1)
oral contraceptive use and##2##4##(1993-9#2)
oral contraceptive use##8##3##(1990-6#1)(1991-9#2)(1993-9#2)(2010-12#1)(2011-1#1)(2013-7#1)
oral contraceptive##21##2##(1990-6#1)(1991-4#1)(1991-9#2)(1993-9#2)(1994-5#1)(2007-12#1)(2008-5#1)(2008-7#2)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
oral contraceptives (OC)##3##3##(1990-11#1)(2006-9#1)(2008-11#1)
oral contraceptives (OCs)##3##3##(1990-11#1)(1994-5#1)(1996-11#1)
oral contraceptives are##2##3##(2010-12#2)
oral contraceptives##48##2##(1990-10#2)(1990-11#4)(1990-2#1)(1990-6#3)(1990-9#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-4#1)(1992-9#1)(1993-9#1)(1994-5#2)(1996-11#1)(1996-2#1)(2004-3#1)(2006-9#1)(2007-10#2)(2007-12#1)(2007-2#2)(2007-8#3)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-8#1)(2010-12#5)(2011-2#1)
oral contrast##3##2##(2011-12#1)(2012-2#1)(2013-8#1)
oral controlled-release##2##2##(1991-12#1)(1992-8#1)
oral corticosteroid therapy##3##3##(2008-1#1)(2008-11#1)(2011-12#1)
oral corticosteroid use##2##3##(2008-11#2)
oral corticosteroid##8##2##(2006-10#1)(2008-1#1)(2008-11#5)(2011-12#1)
oral corticosteroids or##2##3##(2005-11#1)(2007-7#1)
oral corticosteroids was##2##3##(2006-4#1)(2007-7#1)
oral corticosteroids##13##2##(2004-3#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-7#3)(2007-8#1)(2008-11#4)(2012-2#1)
oral daily##3##2##(1994-6#2)(2006-9#1)
oral delivery of insulin##4##4##(2008-5#1)(2011-1#3)
oral delivery of##11##3##(2006-11#1)(2007-8#2)(2008-5#1)(2008-8#1)(2009-8#1)(2010-1#1)(2011-1#3)(2012-3#1)
oral delivery system##2##3##(2012-3#2)
oral delivery##18##2##(1995-12#1)(2006-11#2)(2007-11#1)(2007-8#2)(2008-5#1)(2008-8#1)(2009-8#1)(2010-1#2)(2011-1#3)(2012-12#1)(2012-3#3)
oral deposition##2##2##(2008-11#1)(2008-8#1)
oral diet##2##2##(2007-8#1)(2011-2#1)
oral direct thrombin inhibitor##2##4##(2007-10#1)(2012-12#1)
oral disease##9##2##(2006-8#1)(2012-12#1)(2012-2#5)(2013-8#2)
oral diseases and##3##3##(1991-6#1)(2010-3#2)
oral diseases##11##2##(1991-5#1)(1991-6#2)(2006-10#1)(2006-2#1)(2008-1#2)(2010-3#2)(2012-2#1)(2013-8#1)
oral disodium cromoglycate##2##3##(1997-6#2)
oral dissolution##2##2##(1991-12#1)(1991-3#1)
oral dosage form of##2##4##(2011-1#1)(2012-2#1)
oral dosage##6##2##(1994-11#1)(2005-9#2)(2010-1#1)(2011-1#1)(2012-2#1)
oral dose of 1##4##4##(1992-2#1)(1993-4#1)(1993-7#1)(1996-5#1)
oral dose of the##4##4##(2005-10#1)(2005-12#1)(2008-3#1)(2013-1#1)
oral dose of##31##3##(1990-3#3)(1992-2#2)(1992-5#1)(1993-4#1)(1993-7#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-5#1)(1996-8#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-12#1)(2005-9#1)(2006-6#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-4#2)(2012-2#1)(2013-1#3)
oral dose with##3##3##(1990-3#1)(2007-8#1)(2008-7#1)
oral dose##40##2##(1990-3#4)(1992-2#2)(1992-5#1)(1993-4#1)(1993-7#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-5#1)(1996-8#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-12#1)(2005-9#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-11#1)(2009-4#2)(2012-2#1)(2013-1#3)
oral doses of##7##3##(1993-1#1)(1995-3#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-5#1)(2011-1#1)
oral doses##9##2##(1993-1#1)(1995-3#1)(2005-7#1)(2006-6#1)(2007-11#2)(2008-10#1)(2008-5#1)(2011-1#1)
oral dosing##4##2##(1995-12#1)(2005-8#1)(2008-11#2)
oral drug##3##2##(2008-11#1)(2008-5#1)(2013-8#1)
oral drugs in##2##3##(2012-1#1)(2012-2#1)
oral dryness##2##2##(2007-10#1)(2008-7#1)
oral dyskinesia##5##2##(1991-8#5)
oral efficacy##2##2##(1995-3#1)(1996-8#1)
oral environment##4##2##(2007-12#1)(2008-11#1)(2012-3#1)(2013-1#1)
oral epidermoid carcinoma##3##3##(1991-10#1)(2006-12#1)(2007-7#1)
oral epithelial cells##2##3##(2013-1#1)(2013-8#1)
oral epithelium##2##2##(2008-7#1)(2013-1#1)
oral estrogen##2##2##(1993-11#1)(2009-2#1)
oral etoposide in##2##3##(1993-12#1)(1996-10#1)
oral etoposide##4##2##(1993-12#1)(1996-10#1)(1996-8#1)(2007-7#1)
oral exam##2##2##(2011-2#2)
oral examination##2##2##(2008-1#1)(2011-2#1)
oral examinations and##2##3##(2006-10#1)(2006-8#1)
oral examinations##4##2##(1994-12#1)(2006-10#2)(2006-8#1)
oral feeding##3##2##(2008-10#1)(2009-8#1)(2012-2#1)
oral feeds##2##2##(2010-7#2)
oral flora##2##2##(2006-10#1)(2007-7#1)
oral fluconazole and##2##3##(1991-3#1)(2010-11#1)
oral fluconazole##3##2##(1991-3#1)(1996-8#1)(2010-11#1)
oral fludarabine##3##2##(2009-12#3)
oral fluid##2##2##(2009-4#1)(2010-4#1)
oral fluids##2##2##(1993-6#1)(2010-2#1)
oral food challenge##3##3##(2012-2#1)(2012-3#2)
oral form##4##2##(2005-8#1)(2008-11#1)(2009-1#1)(2012-3#1)
oral forms##2##2##(2005-6#1)(2012-12#1)
oral formulation of##2##3##(2005-8#1)(2007-8#1)
oral formulation##11##2##(2005-8#2)(2005-9#1)(2007-8#1)(2008-3#1)(2008-5#4)(2008-7#1)(2010-11#1)
oral formulations for##2##3##(2005-7#1)(2008-1#1)
oral formulations##8##2##(2005-7#1)(2005-8#2)(2008-1#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-12#1)
oral function in##2##3##(2013-8#2)
oral function##6##2##(2008-3#1)(2011-2#2)(2013-8#3)
oral gallium bioavailability##2##3##(2008-5#2)
oral gavage##10##2##(1996-10#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-10#4)(2008-6#1)(2011-2#1)
oral glucocorticoids##3##2##(2006-10#1)(2006-11#1)(2009-6#1)
oral glucose challenge##2##3##(1997-7#1)(2008-3#1)
oral glucose load (OGTT)##2##4##(2007-7#1)(2008-5#1)
oral glucose tolerance test (OGTT)##10##5##(1994-12#1)(2007-8#1)(2009-3#1)(2011-1#3)(2011-2#2)(2012-3#1)(2012-7#1)
oral glucose tolerance test was##2##5##(2007-8#1)(2008-4#1)
oral glucose tolerance test##25##4##(1990-8#1)(1992-8#1)(1994-12#1)(1997-3#1)(2005-8#2)(2006-6#1)(2006-9#1)(2007-8#3)(2008-1#1)(2008-3#2)(2008-4#1)(2009-3#1)(2009-6#1)(2011-1#3)(2011-2#2)(2012-3#1)(2012-7#2)
oral glucose tolerance##27##3##(1990-8#1)(1992-8#1)(1994-12#1)(1997-3#1)(2005-8#2)(2006-6#1)(2006-9#1)(2007-11#1)(2007-8#3)(2008-1#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-3#1)(2009-6#1)(2011-1#3)(2011-2#2)(2012-3#1)(2012-7#2)
oral glucose##36##2##(1990-8#1)(1992-8#1)(1994-12#1)(1995-1#1)(1995-11#1)(1996-3#1)(1997-3#1)(1997-7#1)(2005-8#2)(2006-6#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-6#1)(2010-11#1)(2011-1#3)(2011-2#2)(2012-3#1)(2012-7#2)
oral granisetron##6##2##(2010-12#6)
oral hairy leukoplakia##2##3##(2006-8#1)(2007-1#1)
oral health and##11##3##(2006-2#5)(2008-1#1)(2008-5#1)(2008-7#1)(2012-1#1)(2012-12#1)(2013-8#1)
oral health are##2##3##(2008-9#1)(2010-7#1)
oral health care in##2##4##(2006-8#2)
oral health care professionals##2##4##(2006-2#1)(2008-1#1)
oral health care providers##5##4##(2008-1#3)(2012-3#2)
oral health care##19##3##(2006-10#1)(2006-2#3)(2006-8#3)(2008-1#5)(2008-4#1)(2010-7#1)(2012-2#1)(2012-3#3)(2013-7#1)
oral health conditions##2##3##(2007-12#1)(2008-9#1)
oral health education##2##3##(2008-9#1)(2013-8#1)
oral health examination##2##3##(2008-12#1)(2011-1#1)
oral health in this##2##4##(1995-12#1)(2006-2#1)
oral health in##9##3##(1991-6#1)(1995-12#1)(2006-2#2)(2006-8#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
oral health into##2##3##(1991-6#1)(2005-11#1)
oral health is##2##3##(2005-11#1)(2006-2#1)
oral health of##6##3##(2006-2#1)(2008-9#1)(2009-4#1)(2010-4#1)(2012-3#1)(2013-1#1)
oral health program##2##3##(2008-5#2)
oral health promotion programs##2##4##(2012-2#2)
oral health promotion##4##3##(2010-7#1)(2012-1#1)(2012-2#2)
oral health services for##2##4##(2012-2#2)
oral health services##5##3##(2005-11#1)(2012-2#4)
oral health status and##2##4##(2008-1#2)
oral health status of##3##4##(2007-2#1)(2008-1#1)(2008-5#1)
oral health status##10##3##(2006-2#1)(2007-2#2)(2008-1#3)(2008-5#3)(2008-9#1)
oral health survey##2##3##(2008-1#2)
oral health##125##2##(1991-6#3)(1995-12#4)(2005-11#7)(2005-9#1)(2006-10#3)(2006-2#22)(2006-8#4)(2007-12#1)(2007-2#2)(2008-1#13)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#6)(2008-7#1)(2008-9#11)(2009-4#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#5)(2011-1#3)(2012-1#2)(2012-12#2)(2012-2#9)(2012-3#5)(2013-1#8)(2013-7#2)(2013-8#3)
oral health-related quality of life##2##5##(2011-7#1)(2013-1#1)
oral health-related quality of##3##4##(2011-2#1)(2011-7#1)(2013-1#1)
oral health-related##4##2##(2011-2#1)(2011-7#1)(2012-12#1)(2013-1#1)
oral hygiene index##2##3##(2012-12#1)(2013-8#1)
oral hygiene products##2##3##(2006-10#1)(2013-1#1)
oral hygiene status##3##3##(2009-7#1)(2010-12#2)
oral hygiene##35##2##(2006-10#1)(2006-2#9)(2006-8#1)(2007-12#3)(2008-9#2)(2009-7#1)(2010-12#4)(2010-7#1)(2011-1#4)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
oral hygienists##2##2##(2006-8#2)
oral hyperkeratosis and##3##3##(2012-3#3)
oral hyperkeratosis##4##2##(2012-3#4)
oral hypoglycaemic agents##2##3##(1990-11#1)(1993-12#1)
oral hypoglycaemic##3##2##(1990-11#1)(1993-12#1)(1995-6#1)
oral hypoglycemic agents##2##3##(2008-1#1)(2009-3#1)
oral hypoglycemic##4##2##(1990-11#1)(2008-1#1)(2009-3#1)(2011-1#1)
oral hypoglycemics##4##2##(1991-12#4)
oral ibandronate##3##2##(2008-3#3)
oral ibuprofen in##2##3##(2012-12#2)
oral ibuprofen##5##2##(2008-10#1)(2012-12#4)
oral immunization##3##2##(2006-12#1)(2008-4#2)
oral infections and##2##3##(2013-8#2)
oral ingestion of##2##3##(1995-11#1)(2012-2#1)
oral ingestion##3##2##(1995-11#2)(2012-2#1)
oral injury in a##2##4##(2007-12#1)(2008-5#1)
oral insulin drug##2##3##(2011-1#2)
oral insulin in##3##3##(2007-5#3)
oral insulin##6##2##(2007-5#3)(2008-5#1)(2011-1#2)
oral intake and##2##3##(1990-9#1)(2012-2#1)
oral intake of##5##3##(1995-7#1)(2008-11#1)(2012-3#3)
oral intake##14##2##(1990-9#2)(1995-7#1)(2008-11#1)(2008-6#1)(2010-7#2)(2011-2#1)(2012-2#3)(2012-3#3)
oral interviews##2##2##(2007-7#1)(2008-7#1)
oral intubation##6##2##(1993-9#2)(2006-10#1)(2008-11#3)
oral isotretinoin##3##2##(2013-1#2)(2013-8#1)
oral itraconazole##2##2##(2009-8#1)(2013-8#1)
oral language and##3##3##(2008-12#2)(2012-3#1)
oral language##5##2##(2007-9#1)(2008-12#2)(2011-12#1)(2012-3#1)
oral lesions and##2##3##(2012-2#1)(2013-7#1)
oral lesions are##4##3##(2006-8#2)(2013-1#1)(2013-7#1)
oral lesions by##2##3##(2008-5#1)(2013-1#1)
oral lesions##20##2##(2006-10#1)(2006-2#1)(2006-8#4)(2007-12#1)(2007-2#1)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#2)
oral leukoplakia##2##2##(1993-12#1)(2010-10#1)
oral lichen planus##16##3##(1991-3#1)(2005-10#3)(2005-12#1)(2006-2#1)(2008-4#5)(2009-6#1)(2012-2#1)(2013-1#3)
oral lichen##17##2##(1991-3#1)(2005-10#3)(2005-12#1)(2006-2#1)(2008-4#6)(2009-6#1)(2012-2#1)(2013-1#3)
oral linezolid and rifampin##2##4##(2007-12#2)
oral liquid##2##2##(2013-7#1)(2013-8#1)
oral live##2##2##(2006-10#1)(2007-2#1)
oral lymphoma treated with##2##4##(2012-1#2)
oral lymphoma##4##2##(2012-1#4)
oral magnesium##3##2##(1990-9#3)
oral malformation##2##2##(2013-1#2)
oral malignancies##5##2##(1991-5#3)(2008-2#1)(2011-1#1)
oral malodor##5##2##(2006-8#2)(2008-6#1)(2011-1#2)
oral malodour##7##2##(2006-2#4)(2008-10#2)(2013-7#1)
oral manifestations and##3##3##(2008-5#1)(2010-3#2)
oral manifestations in##3##3##(2006-2#1)(2006-8#1)(2012-2#1)
oral manifestations of##5##3##(2006-2#1)(2007-12#1)(2007-7#1)(2012-2#1)(2013-7#1)
oral manifestations##17##2##(2006-2#4)(2006-8#4)(2007-12#1)(2007-7#1)(2008-5#1)(2010-3#2)(2012-2#2)(2013-1#1)(2013-7#1)
oral medication##4##2##(1992-5#1)(2006-11#1)(2006-9#1)(2008-4#1)
oral medications##6##2##(2008-8#1)(2009-6#1)(2010-11#2)(2010-2#1)(2010-7#1)
oral medicine##2##2##(1991-6#1)(1995-6#1)
oral metronidazole##5##2##(1996-3#1)(2006-10#4)
oral midazolam##3##2##(2006-10#1)(2009-4#1)(2012-2#1)
oral mini-pulse therapy##2##3##(2007-7#1)(2007-8#1)
oral mode of##2##3##(2008-8#1)(2008-9#1)
oral morphine##2##2##(2007-2#2)
oral motor responses##2##3##(1993-12#2)
oral motor##6##2##(1993-12#4)(2006-8#1)(2008-10#1)
oral mucosa and##3##3##(1991-12#1)(2006-8#1)(2012-12#1)
oral mucosa were##2##3##(2013-1#1)(2013-8#1)
oral mucosa##24##2##(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-8#1)(1993-1#3)(1994-6#1)(1996-11#1)(2006-8#1)(2007-7#1)(2007-9#1)(2008-3#2)(2009-5#1)(2010-12#1)(2010-4#1)(2011-1#2)(2012-12#2)(2013-1#1)(2013-8#1)
oral mucosal##6##2##(1991-5#1)(2007-12#1)(2007-7#1)(2009-5#1)(2013-8#2)
oral mucositis##8##2##(2007-11#1)(2008-3#2)(2008-7#2)(2010-7#3)
oral myiasis##2##2##(2013-1#2)
oral naltrexone##4##2##(2007-2#4)
oral nutrition##2##2##(2005-10#1)(2009-2#1)
oral opening##2##2##(1991-2#1)(2013-1#1)
oral or intravenous##3##3##(2007-11#1)(2008-1#1)(2013-7#1)
oral or##11##2##(1990-6#1)(1992-2#1)(1995-5#1)(2007-11#2)(2008-1#1)(2008-9#1)(2010-12#1)(2010-5#1)(2013-1#1)(2013-7#1)
oral pathogens##2##2##(2008-12#2)
oral pathologies##3##2##(2007-2#2)(2012-2#1)
oral pathology##3##2##(1990-12#1)(2008-12#1)(2010-8#1)
oral phenytoin##2##2##(2007-7#1)(2007-8#1)
oral polio vaccine (OPV)##3##4##(1994-9#1)(2008-4#1)(2008-8#1)
oral polio vaccine##6##3##(1994-9#2)(2007-10#2)(2008-4#1)(2008-8#1)
oral polio##8##2##(1994-9#2)(2007-10#3)(2007-2#1)(2008-4#1)(2008-8#1)
oral poliovirus vaccine (OPV)##2##4##(1995-3#1)(1997-1#1)
oral poliovirus vaccine##5##3##(1995-3#2)(1997-1#1)(2006-10#1)(2007-11#1)
oral poliovirus##9##2##(1990-3#1)(1995-3#3)(1995-5#1)(1997-1#1)(2006-10#1)(2007-11#1)(2008-11#1)
oral potassium##3##2##(1991-10#1)(1997-8#1)(2007-7#1)
oral prednisolone was##2##3##(2007-7#2)
oral prednisolone##9##2##(2006-4#2)(2006-9#1)(2007-7#4)(2013-7#1)(2013-8#1)
oral prednisone##9##2##(2004-1#2)(2006-10#3)(2007-7#1)(2010-5#1)(2010-6#1)(2013-8#1)
oral preparation##2##2##(2008-3#2)
oral presentation and##2##3##(2005-10#1)(2005-8#1)
oral presentations and more than##2##5##(2008-5#1)(2010-11#1)
oral presentations and##5##3##(2005-8#1)(2008-5#2)(2008-7#1)(2010-11#1)
oral presentations##7##2##(2005-8#3)(2008-5#2)(2008-7#1)(2010-11#1)
oral problems##3##2##(2006-2#1)(2008-7#1)(2012-2#1)
oral provocation test##2##3##(2007-7#1)(2013-1#1)
oral provocation##3##2##(2007-7#1)(2013-1#2)
oral radiology##2##2##(2007-4#1)(2012-1#1)
oral reading fluency##7##3##(2004-10#1)(2007-3#2)(2008-12#4)
oral reading##10##2##(2004-10#1)(2007-3#2)(2007-9#1)(2008-12#4)(2008-4#2)
oral rehabilitation of##2##3##(2008-7#1)(2011-2#1)
oral rehabilitation##4##2##(2005-11#1)(2008-7#1)(2011-2#2)
oral rehydration solution##2##3##(1991-9#2)
oral rehydration##6##2##(1991-9#2)(1992-5#1)(2007-2#1)(2010-12#1)(2012-3#1)
oral retinoids##2##2##(1992-6#1)(2007-8#1)
oral route is##2##3##(2010-6#1)(2012-12#1)
oral route##22##2##(1991-10#1)(1991-11#1)(1992-11#1)(2004-12#1)(2005-1#2)(2007-1#2)(2008-4#4)(2008-5#3)(2009-4#1)(2009-5#2)(2010-12#1)(2010-6#1)(2012-12#1)(2012-2#1)
oral saline##2##2##(2008-5#1)(2010-7#1)
oral samples of##3##3##(2006-2#1)(2008-5#1)(2010-4#1)
oral samples##4##2##(2006-2#1)(2008-5#1)(2010-4#1)(2013-1#1)
oral secretions##2##2##(1990-11#2)
oral sessions##2##2##(2005-8#1)(2008-5#1)
oral sex##3##2##(1996-5#2)(2009-7#1)
oral solution##6##2##(2008-8#1)(2009-6#2)(2013-1#1)(2013-7#2)
oral squamous cell carcinoma (OSCC)##2##5##(2011-1#1)(2013-1#1)
oral squamous cell carcinoma##12##4##(2007-11#1)(2007-12#1)(2007-3#1)(2010-12#2)(2011-1#2)(2012-12#1)(2013-1#4)
oral squamous cell##15##3##(2007-11#1)(2007-12#1)(2007-3#1)(2010-12#2)(2010-7#2)(2010-8#1)(2011-1#2)(2012-12#1)(2013-1#4)
oral squamous##18##2##(1991-2#1)(2007-11#1)(2007-12#1)(2007-3#3)(2010-12#2)(2010-7#2)(2010-8#1)(2011-1#2)(2012-12#1)(2013-1#4)
oral squamous-cell carcinomas##2##3##(1991-5#2)
oral stereotypy in##2##3##(2009-4#2)
oral steroids and##2##3##(2007-7#1)(2007-8#1)
oral steroids##7##2##(1997-2#1)(2007-7#1)(2007-8#2)(2010-5#1)(2011-1#1)(2012-3#1)
oral streptococci##5##2##(1990-10#1)(2006-6#1)(2011-1#3)
oral submucous fibrosis and##3##4##(2013-1#2)(2013-8#1)
oral submucous fibrosis##11##3##(1991-5#1)(1996-6#1)(2013-1#8)(2013-8#1)
oral sumatriptan##2##2##(2005-7#2)
oral supplementation##4##2##(2007-11#1)(2007-5#1)(2008-5#1)(2010-8#1)
oral surfaces with water##2##4##(2008-7#2)
oral surgery with##3##3##(1993-1#3)
oral surgery##10##2##(1990-10#1)(1990-2#1)(1993-1#7)(2007-12#1)
oral surgical patients##3##3##(2007-12#3)
oral surgical##4##2##(2007-12#4)
oral sustained release##4##3##(2008-11#3)(2012-2#1)
oral symptoms##2##2##(2006-10#1)(2006-11#1)
oral tablets##3##2##(1990-2#1)(2010-1#1)(2010-4#1)
oral temperature##3##2##(1990-2#3)
oral temperatures##3##2##(1990-2#3)
oral therapy##6##2##(1996-2#1)(2005-11#1)(2006-10#1)(2008-11#1)(2008-5#1)(2009-8#1)
oral tissue##4##2##(2007-9#1)(2008-3#1)(2011-1#1)(2011-12#1)
oral tissues##5##2##(1994-6#1)(2007-9#2)(2008-7#2)
oral tolerance and##2##3##(2006-10#2)
oral tolerance induction##3##3##(2006-11#1)(2008-11#2)
oral tolerance was##2##3##(1990-5#1)(2008-11#1)
oral tolerance##20##2##(1990-5#2)(2006-10#8)(2006-11#1)(2008-11#7)(2008-5#2)
oral tongue##2##2##(1993-4#1)(2013-1#1)
oral toxicity##8##2##(1995-3#2)(2005-10#1)(2008-5#3)(2011-3#1)(2013-1#1)
oral transmucosal##2##2##(2007-2#1)(2011-2#1)
oral treatment of rats with 10% Comfrey##2##7##(2008-10#2)
oral treatment of##4##3##(1993-12#1)(2005-7#1)(2008-10#2)
oral treatment with##4##3##(1990-11#1)(1991-3#1)(2012-2#1)(2013-7#1)
oral treatment##11##2##(1990-11#1)(1991-3#1)(1992-11#1)(1993-12#1)(2005-7#1)(2008-1#1)(2008-10#2)(2009-6#1)(2012-2#1)(2013-7#1)
oral ulceration##2##2##(2009-9#1)(2012-2#1)
oral ulcers and##2##3##(2006-8#1)(2007-10#1)
oral ulcers##5##2##(2006-8#1)(2007-10#1)(2007-2#2)(2007-7#1)
oral uptake##2##2##(2005-11#1)(2007-8#1)
oral uridine##3##2##(1996-6#3)
oral vaccination##4##2##(1992-5#1)(1995-5#1)(2008-5#1)(2010-6#1)
oral vaccine against##2##3##(1997-4#1)(2012-3#1)
oral vaccine##7##2##(1996-10#1)(1997-4#1)(2005-11#2)(2008-5#1)(2008-9#1)(2012-3#1)
oral vaccines##4##2##(2006-12#1)(2007-11#1)(2008-8#1)(2010-7#1)
oral vancomycin##2##2##(1996-3#1)(2009-8#1)
oral##2175##1##(1990-1#1)(1990-10#6)(1990-11#9)(1990-12#5)(1990-2#12)(1990-3#9)(1990-4#1)(1990-5#4)(1990-6#6)(1990-7#3)(1990-8#3)(1990-9#8)(1991-1#2)(1991-10#6)(1991-11#2)(1991-12#13)(1991-2#7)(1991-3#7)(1991-4#5)(1991-5#20)(1991-6#10)(1991-8#7)(1991-9#7)(1992-1#1)(1992-10#1)(1992-11#10)(1992-2#7)(1992-3#2)(1992-4#2)(1992-5#5)(1992-6#2)(1992-7#1)(1992-8#7)(1992-9#5)(1993-1#15)(1993-10#2)(1993-11#6)(1993-12#11)(1993-2#4)(1993-3#2)(1993-4#5)(1993-6#2)(1993-7#10)(1993-8#2)(1993-9#10)(1994-11#4)(1994-12#5)(1994-2#1)(1994-3#1)(1994-4#4)(1994-5#5)(1994-6#9)(1994-8#2)(1994-9#9)(1995-1#2)(1995-10#1)(1995-11#7)(1995-12#8)(1995-2#2)(1995-3#12)(1995-4#2)(1995-5#7)(1995-6#3)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#3)(1996-11#4)(1996-12#3)(1996-2#6)(1996-3#4)(1996-4#1)(1996-5#6)(1996-6#8)(1996-8#16)(1996-9#1)(1997-1#8)(1997-2#3)(1997-3#7)(1997-4#6)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#5)(2004-1#4)(2004-10#1)(2004-12#6)(2004-3#2)(2005-1#3)(2005-10#9)(2005-11#24)(2005-12#5)(2005-3#1)(2005-6#1)(2005-7#18)(2005-8#23)(2005-9#12)(2006-1#3)(2006-10#42)(2006-11#6)(2006-12#10)(2006-2#61)(2006-4#5)(2006-5#1)(2006-6#7)(2006-7#2)(2006-8#35)(2006-9#7)(2007-1#4)(2007-10#16)(2007-11#40)(2007-12#85)(2007-2#35)(2007-3#9)(2007-4#1)(2007-5#5)(2007-6#6)(2007-7#42)(2007-8#37)(2007-9#16)(2008-1#37)(2008-10#29)(2008-11#58)(2008-12#22)(2008-2#4)(2008-3#34)(2008-4#28)(2008-5#101)(2008-6#8)(2008-7#42)(2008-8#21)(2008-9#31)(2009-1#2)(2009-10#11)(2009-11#6)(2009-12#5)(2009-2#6)(2009-3#4)(2009-4#21)(2009-5#10)(2009-6#8)(2009-7#4)(2009-8#11)(2009-9#5)(2010-1#11)(2010-10#5)(2010-11#7)(2010-12#50)(2010-2#10)(2010-3#7)(2010-4#6)(2010-5#9)(2010-6#8)(2010-7#28)(2010-8#8)(2010-9#2)(2011-1#58)(2011-12#8)(2011-2#59)(2011-3#1)(2011-7#3)(2012-1#20)(2012-12#42)(2012-2#78)(2012-3#46)(2012-7#3)(2013-1#100)(2013-7#20)(2013-8#52)
oral-facial-digital##2##1##(1997-3#2)
oral-rd##6##1##(1990-10#5)(1990-2#1)
oralis##7##1##(1990-4#3)(2006-6#1)(2007-3#1)(2011-1#1)(2012-2#1)
orally absorbed drugs##2##3##(2007-11#2)
orally active agents##2##3##(1993-11#1)(2007-11#1)
orally active##20##2##(1990-11#1)(1993-11#1)(1994-11#1)(1994-9#2)(1995-12#1)(1997-1#1)(2004-12#1)(2005-11#1)(2005-7#2)(2005-8#1)(2005-9#3)(2007-11#1)(2008-3#1)(2008-4#1)(2008-5#2)
orally administered HET may##2##4##(2008-10#2)
orally administered to##6##3##(1990-3#1)(2006-2#1)(2008-10#1)(2008-8#1)(2012-2#1)(2013-8#1)
orally administered##33##2##(1990-2#1)(1990-3#1)(1992-8#1)(1993-3#1)(1994-8#1)(1995-5#1)(1996-10#2)(1996-12#2)(1996-8#1)(2004-11#1)(2005-7#2)(2006-2#1)(2007-11#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#3)(2008-8#1)(2009-3#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
orally administrated##2##2##(2008-10#1)(2012-12#1)
orally and##6##2##(1994-6#1)(1997-3#1)(2007-10#1)(2007-8#1)(2008-8#1)(2012-12#1)
orally at a##3##3##(1993-7#1)(1994-6#1)(2013-1#1)
orally at doses of##2##4##(2008-5#1)(2012-2#1)
orally at##13##2##(1992-12#1)(1993-7#1)(1994-6#2)(1995-12#1)(2007-6#1)(2008-5#2)(2009-5#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
orally available##2##2##(2005-7#2)
orally bioavailable##7##2##(1996-8#1)(1997-1#1)(1997-2#1)(2005-7#1)(2008-4#1)(2009-8#1)(2012-3#1)
orally by##2##2##(2008-10#1)(2012-11#1)
orally effective iron##2##3##(2008-3#2)
orally effective##6##2##(1996-8#2)(2007-8#1)(2008-1#1)(2008-3#2)
orally fed##3##2##(1997-3#1)(2008-11#2)
orally for 3 months##2##4##(2006-10#1)(2007-8#1)
orally for 4##3##3##(1996-3#1)(2007-8#1)(2008-3#1)
orally for 5##2##3##(1995-2#1)(1996-7#1)
orally for 7 consecutive days##2##5##(2008-10#1)(2008-11#1)
orally for 7##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
orally for 8 weeks##2##4##(2008-5#2)
orally for##17##2##(1993-7#1)(1995-2#2)(1996-3#1)(1996-7#1)(2006-10#1)(2007-8#4)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2012-2#2)
orally given##4##2##(1992-12#1)(2008-11#2)(2011-2#1)
orally in##8##2##(1990-2#1)(2005-9#1)(2007-7#1)(2008-3#1)(2008-5#2)(2011-2#1)(2012-2#1)
orally ingested##2##2##(1997-5#1)(2010-2#1)
orally once##2##2##(2004-1#1)(2009-5#1)
orally or by##2##3##(2006-6#1)(2006-8#1)
orally or parenterally##2##3##(1996-5#1)(2008-5#1)
orally or##8##2##(1992-12#1)(1995-12#1)(1996-5#1)(2006-6#1)(2006-8#1)(2008-1#2)(2008-5#1)
orally three times##2##3##(1995-12#1)(1996-5#1)
orally to mice##3##3##(2007-11#1)(2008-4#1)(2013-1#1)
orally to##13##2##(1991-5#1)(1992-7#1)(1994-3#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2010-12#1)(2012-2#1)(2013-1#2)
orally twice daily for##2##4##(2007-8#1)(2009-5#1)
orally twice daily##3##3##(1991-12#1)(2007-8#1)(2009-5#1)
orally twice##4##2##(1990-2#1)(1991-12#1)(2007-8#1)(2009-5#1)
orally with##7##2##(1990-12#1)(1993-12#1)(1996-10#1)(1996-4#1)(1996-6#1)(2007-2#1)(2008-5#1)
orally##227##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#1)(1990-6#1)(1991-12#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-12#3)(1992-5#2)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#3)(1993-3#1)(1993-7#2)(1993-8#1)(1994-11#1)(1994-3#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-12#5)(1995-2#2)(1995-3#1)(1995-5#1)(1996-10#4)(1996-12#3)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#4)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#1)(2004-1#1)(2004-11#2)(2004-12#1)(2005-10#1)(2005-11#2)(2005-7#7)(2005-8#1)(2005-9#4)(2006-10#2)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#4)(2007-11#6)(2007-2#2)(2007-6#2)(2007-7#3)(2007-8#10)(2008-1#3)(2008-10#11)(2008-11#12)(2008-12#3)(2008-3#8)(2008-4#3)(2008-5#16)(2008-6#1)(2008-7#1)(2008-8#4)(2009-3#1)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#2)(2011-2#4)(2012-11#2)(2012-12#4)(2012-2#7)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#3)
orally) for 7##2##3##(2011-2#2)
orally)##6##1##(1993-10#1)(1993-5#1)(2007-9#1)(2011-2#3)
orally-active##5##1##(2005-7#3)(2008-5#2)
orally-administered##4##1##(2005-8#1)(2007-11#1)(2008-3#1)(2008-5#1)
orange (AO)##6##2##(2008-10#3)(2008-12#2)(2008-9#1)
orange (Citrus sinensis)##3##3##(2008-10#2)(2012-12#1)
orange (Citrus##4##2##(2008-10#3)(2012-12#1)
orange (XO)##3##2##(2008-10#3)
orange and##8##2##(1995-4#1)(2008-10#5)(2008-11#1)(2008-7#1)
orange as##2##2##(1993-11#1)(2008-10#1)
orange direct count technique##2##4##(1997-4#2)
orange for##2##2##(1991-11#1)(2008-10#1)
orange juice and##4##3##(1997-3#1)(2006-1#2)(2008-10#1)
orange juice##24##2##(1997-3#2)(1997-4#1)(2006-1#2)(2007-8#10)(2008-10#5)(2008-8#1)(2010-5#3)
orange or##2##2##(1992-3#1)(2008-10#1)
orange than##2##2##(2008-10#2)
orange to##3##2##(2008-10#1)(2012-2#2)
orange with##2##2##(2008-10#2)
orange##134##1##(1990-6#3)(1990-7#1)(1990-8#1)(1991-11#1)(1992-3#1)(1993-11#2)(1995-2#1)(1995-4#1)(1997-3#2)(1997-4#3)(2005-4#1)(2006-1#2)(2006-12#1)(2007-1#1)(2007-12#1)(2007-8#13)(2008-10#70)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#5)(2009-11#1)(2009-7#2)(2010-5#3)(2012-12#1)(2012-2#2)(2013-8#1)
orange)##2##1##(2006-6#1)(2008-10#1)
orange-flavored##2##1##(2006-10#1)(2007-11#1)
orange-spotted grouper##4##2##(2010-5#4)
oranges##6##1##(1992-10#1)(2007-8#3)(2008-10#1)(2008-12#1)
oranges?##2##1##(1996-3#1)(2008-8#1)
orangutan##8##1##(1991-12#2)(1995-11#1)(1997-6#1)(2007-2#2)(2009-10#2)
orbiculare from##2##2##(2008-10#2)
orbiculare##13##1##(2008-10#13)
orbicularis oris inferior and mentalis##2##5##(1991-11#2)
orbicularis oris##5##2##(1991-11#2)(2008-10#1)(2012-12#2)
orbicularis##6##1##(1991-11#2)(2008-10#1)(2010-11#1)(2012-12#2)
orbignyanus##3##1##(2007-9#3)
orbit and##8##2##(2006-12#1)(2008-6#1)(2008-7#1)(2010-11#1)(2011-2#3)(2013-1#1)
orbit are##2##2##(2008-2#1)(2011-2#1)
orbit in##3##2##(2008-3#1)(2013-1#1)(2013-8#1)
orbit showed##2##2##(2008-4#1)(2011-1#1)
orbit##63##1##(1992-1#1)(1995-2#1)(1996-6#1)(2005-4#1)(2006-12#3)(2006-5#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-8#1)(2007-9#3)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#7)(2008-4#1)(2008-6#4)(2008-7#3)(2008-9#1)(2009-10#1)(2009-2#3)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#1)(2011-1#3)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
orbital analysis##3##2##(2010-12#1)(2010-5#1)(2013-1#1)
orbital and##4##2##(2005-4#1)(2006-12#1)(2008-10#1)(2011-2#1)
orbital angular momentum is##2##4##(2007-11#2)
orbital angular momentum##6##3##(2007-11#3)(2007-12#3)
orbital apex syndrome##2##3##(2008-4#1)(2013-7#1)
orbital cavity##3##2##(1990-4#1)(2008-8#1)(2013-1#1)
orbital complication of##2##3##(2011-1#2)
orbital complication##3##2##(2011-1#3)
orbital complications##3##2##(2011-1#1)(2013-1#2)
orbital cortex##5##2##(1992-8#1)(1994-3#3)(1995-5#1)
orbital decompression for##3##3##(2008-7#2)(2013-7#1)
orbital decompression##10##2##(2006-11#1)(2008-7#6)(2013-1#2)(2013-7#1)
orbital energies##2##2##(1996-5#1)(2012-2#1)
orbital exenteration##5##2##(2007-11#4)(2008-8#1)
orbital fat##2##2##(2009-2#1)(2010-12#1)
orbital infarction and retinal detachment##2##5##(2013-8#2)
orbital infarction##4##2##(2013-8#4)
orbital interaction##2##2##(2006-12#1)(2010-5#1)
orbital metastases##2##2##(1992-2#1)(2009-2#1)
orbital radiotherapy and##2##3##(2006-11#1)(2013-1#1)
orbital radiotherapy##4##2##(2006-11#2)(2013-1#2)
orbital reconstruction##2##2##(2006-12#1)(2008-8#1)
orbital rhabdomyosarcoma with##3##3##(2010-11#2)(2011-1#1)
orbital rhabdomyosarcoma##4##2##(2010-11#2)(2011-1#2)
orbital rim osteotomy##3##3##(2006-12#3)
orbital rim##7##2##(2006-12#5)(2010-12#2)
orbital roof##4##2##(2006-12#2)(2008-8#1)(2009-2#1)
orbital splitting##2##2##(1997-7#2)
orbital variations##2##2##(2007-9#2)
orbital wall##4##2##(2008-10#1)(2009-2#1)(2010-10#1)(2013-1#1)
orbital##172##1##(1990-4#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#2)(1992-7#1)(1992-8#1)(1993-4#1)(1993-8#2)(1994-3#3)(1994-5#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-2#6)(1996-5#2)(1997-3#1)(1997-7#2)(2005-1#1)(2005-4#1)(2006-1#2)(2006-10#1)(2006-11#3)(2006-12#12)(2007-10#1)(2007-11#11)(2007-12#5)(2007-9#5)(2008-10#3)(2008-11#1)(2008-4#5)(2008-7#8)(2008-8#4)(2009-2#5)(2010-10#1)(2010-11#3)(2010-12#6)(2010-2#1)(2010-4#2)(2010-5#6)(2011-1#13)(2011-2#8)(2012-12#7)(2012-2#3)(2013-1#18)(2013-7#3)(2013-8#4)
orbitals of the##2##3##(1997-7#1)(2010-5#1)
orbitals of##3##2##(1997-7#1)(2010-5#2)
orbitals provided by the heteroatom or the role of steric factors in the pi-electron conjugation##2##15##(2007-11#2)
orbitals with the##2##3##(1997-7#2)
orbitals with##3##2##(1997-7#2)(2007-11#1)
orbitals##24##1##(1997-7#7)(2007-11#4)(2009-2#1)(2010-2#1)(2010-5#8)(2010-7#2)(2013-1#1)
orbiting the##2##2##(1991-8#1)(2006-7#1)
orbiting##11##1##(1991-8#1)(2006-7#1)(2007-12#2)(2007-9#2)(2008-3#2)(2011-2#3)
orbitofacial trauma##2##2##(2011-1#2)
orbitofrontal and inferiorfrontal cortices##2##4##(2012-12#2)
orbitofrontal and##7##2##(2008-1#1)(2009-10#1)(2011-2#1)(2012-12#3)(2013-1#1)
orbitofrontal cortex and##5##3##(1996-5#1)(2008-11#1)(2009-10#2)(2011-1#1)
orbitofrontal cortex##16##2##(1996-5#2)(2006-9#1)(2007-8#1)(2008-11#3)(2008-12#1)(2009-10#4)(2009-2#1)(2011-1#1)(2012-12#2)
orbitofrontal fibrous dysplasia##2##3##(2006-12#2)
orbitofrontal##30##1##(1996-5#2)(2006-12#3)(2006-9#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-7#1)(2009-10#5)(2009-2#1)(2011-1#1)(2011-2#2)(2012-12#5)(2013-1#1)
orbitopterional approach##4##2##(2011-2#4)
orbitotomy##6##1##(2006-12#4)(2008-7#2)
orbitozygomatic approach##2##2##(2006-12#2)
orbitozygomatic craniotomy##3##2##(2006-12#3)
orbitozygomatic##6##1##(2006-12#5)(2008-7#1)
orbits and##2##2##(1992-8#1)(2007-9#1)
orbits in##2##2##(1993-6#1)(1995-5#1)
orbits##14##1##(1991-6#1)(1991-8#1)(1992-8#1)(1993-6#1)(1995-2#1)(1995-5#1)(1995-9#1)(2006-10#1)(2007-12#1)(2007-9#2)(2011-2#2)(2013-8#1)
orbona##4##1##(2008-10#4)
orchard and##6##2##(2008-10#6)
orchard block##5##2##(2008-10#5)
orchard blocks##3##2##(2008-10#3)
orchard experiments##3##2##(2008-10#3)
orchard floor##7##2##(2008-10#7)
orchard in##2##2##(2008-10#2)
orchard observations##2##2##(2008-10#2)
orchard sites##2##2##(2008-10#2)
orchard soil##5##2##(2008-10#5)
orchard soils were##2##3##(2008-10#2)
orchard soils##11##2##(2008-10#11)
orchard that had##2##3##(2008-10#2)
orchard were##2##2##(2008-10#2)
orchard##98##1##(2008-10#97)(2009-12#1)
orchard)##2##1##(2008-10#2)
orchards and the##2##3##(2005-12#1)(2008-10#1)
orchards and##6##2##(2005-12#1)(2008-10#4)(2008-12#1)
orchards are##2##2##(2008-10#2)
orchards at##3##2##(2008-10#3)
orchards during##4##2##(2008-10#4)
orchards in California##3##3##(2008-10#3)
orchards in northern##2##3##(2008-10#2)
orchards in the##3##3##(2008-10#3)
orchards in##19##2##(2005-12#1)(2008-10#16)(2008-6#1)(2009-6#1)
orchards located in##2##3##(2008-10#2)
orchards over##3##2##(2008-10#3)
orchards were##3##2##(2008-10#3)
orchards with##5##2##(2008-10#5)
orchards##101##1##(2005-12#2)(2008-10#91)(2008-12#1)(2008-6#4)(2009-12#1)(2009-6#1)(2011-12#1)
orchestra##3##1##(2007-8#1)(2011-1#2)
orchestrate the##2##2##(2008-9#1)(2012-3#1)
orchestrate##14##1##(1995-5#1)(2007-12#1)(2008-1#3)(2008-9#2)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
orchestrated to##2##2##(2008-10#1)(2008-3#1)
orchestrated##10##1##(2008-10#1)(2008-3#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
orchestrates the##2##2##(1996-4#1)(2012-3#1)
orchestrates##3##1##(1996-4#1)(2012-3#1)(2013-7#1)
orchestrating##5##1##(2008-1#1)(2009-9#1)(2012-2#1)(2013-1#2)
orchid bee abundance##2##3##(2008-5#2)
orchid bees##2##2##(2008-5#1)(2008-6#1)
orchid species##2##2##(2007-3#1)(2012-2#1)
orchid viruses##4##2##(2008-10#4)
orchid##26##1##(1997-4#5)(2007-3#2)(2008-10#10)(2008-5#3)(2008-6#1)(2012-2#3)(2013-8#2)
orchidectomy was##4##2##(2006-10#1)(2008-6#1)(2012-12#1)(2012-2#1)
orchidectomy##12##1##(2006-10#1)(2007-6#1)(2007-8#1)(2008-6#4)(2012-12#2)(2012-2#2)(2013-7#1)
orchidopexy was##2##2##(2006-2#1)(2011-2#1)
orchidopexy##7##1##(2006-2#1)(2008-10#2)(2009-7#1)(2011-2#3)
orchids##13##1##(1997-4#7)(2006-4#1)(2008-10#1)(2012-2#4)
orchiectomized##2##1##(1996-2#2)
orchiectomy (n =##2##3##(1992-4#2)
orchiectomy and testosterone replacement##2##4##(1992-4#2)
orchiectomy and##6##2##(1992-4#2)(2007-5#1)(2008-10#1)(2012-2#2)
orchiectomy for##2##2##(2007-3#1)(2008-6#1)
orchiectomy in##2##2##(2008-10#1)(2009-7#1)
orchiectomy was performed##2##3##(1992-4#1)(1997-3#1)
orchiectomy##25##1##(1990-3#1)(1991-9#2)(1992-4#6)(1995-12#1)(1995-2#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-3#1)(2007-5#1)(2008-10#4)(2008-6#1)(2009-7#1)(2011-1#1)(2012-2#2)
orchiopexies##2##1##(2012-2#2)
orchiopexy##4##1##(2008-10#2)(2012-2#2)
orchitis##9##1##(1990-9#1)(1997-8#2)(2006-10#1)(2008-10#1)(2010-11#1)(2010-12#1)(2011-2#2)
ord##3##1##(2013-8#3)
ordained##2##1##(1996-1#1)(2008-7#1)
order 1##4##2##(1995-5#1)(2005-11#1)(2008-10#1)(2008-8#1)
order 2##2##2##(1995-5#1)(2008-10#1)
order I##3##2##(2013-8#3)
order along the##2##3##(2011-1#2)
order along##3##2##(1993-4#1)(2011-1#2)
order alpha##2##2##(1990-4#1)(1995-8#1)
order and orientation##2##3##(2008-10#1)(2008-7#1)
order and the##2##3##(2007-12#1)(2012-12#1)
order and##38##2##(1992-11#1)(1992-12#1)(1992-5#1)(1993-3#1)(1994-11#1)(1995-10#1)(1997-2#1)(2004-1#1)(2004-11#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#6)(2008-3#4)(2008-7#1)(2008-9#2)(2009-10#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-12#2)
order are##3##2##(2007-11#2)(2008-2#1)
order as a##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
order as##13##2##(1990-12#1)(1991-11#1)(1992-11#1)(1993-2#1)(1994-6#1)(1995-10#1)(2006-4#1)(2007-12#2)(2008-2#1)(2008-3#2)(2008-8#1)
order between##3##2##(1993-8#1)(1995-3#1)(2008-10#1)
order by##7##2##(1992-3#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-3#3)
order can be##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
order can##7##2##(1992-1#1)(2007-11#1)(2008-2#1)(2008-3#4)
order dependence##2##2##(2007-10#2)
order derivative##5##2##(2005-4#1)(2008-10#3)(2010-5#1)
order entry and on-line results viewing##2##6##(2004-10#2)
order entry and##5##3##(1995-2#1)(2004-10#3)(2010-8#1)
order entry system##2##3##(2013-1#2)
order entry##19##2##(1995-2#3)(2004-10#3)(2007-1#1)(2010-8#1)(2013-1#11)
order for the##12##3##(1991-9#1)(1993-1#1)(1994-11#1)(1996-11#1)(2006-10#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-4#1)(2010-5#1)(2011-2#1)
order for##41##2##(1990-5#1)(1991-8#1)(1991-9#1)(1992-3#2)(1993-1#1)(1993-3#1)(1994-11#1)(1994-3#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(2006-10#3)(2006-11#1)(2006-4#2)(2007-2#1)(2007-3#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-11#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)
order from the##4##3##(1991-10#1)(1995-3#1)(2007-9#1)(2008-6#1)
order from##6##2##(1991-10#1)(1991-7#1)(1995-3#1)(2007-9#1)(2008-10#1)(2008-6#1)
order in a##6##3##(1992-1#1)(2006-7#1)(2007-11#1)(2008-2#1)(2008-3#1)(2010-6#1)
order in both##2##3##(2006-10#1)(2006-3#1)
order in the##15##3##(1996-4#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2010-3#1)(2013-8#1)
order in##52##2##(1990-4#2)(1992-1#3)(1992-3#1)(1993-3#1)(1993-6#1)(1996-2#1)(1996-4#1)(2006-10#1)(2006-11#2)(2006-3#2)(2006-5#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#6)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2010-3#1)(2010-6#1)(2012-2#2)(2013-8#1)
order information##2##2##(1992-11#1)(2013-7#1)
order is##18##2##(1990-4#1)(1991-2#1)(1992-1#1)(1996-2#1)(1997-6#1)(2006-1#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#5)(2010-10#1)
order kinetics##8##2##(1990-11#1)(1990-2#1)(1991-5#1)(1992-3#1)(1994-3#1)(2008-10#2)(2008-11#1)
order linguistic##2##2##(2013-1#2)
order m##2##2##(1996-5#1)(2013-1#1)
order may##3##2##(1991-12#1)(2006-10#1)(2009-11#1)
order model##2##2##(2008-10#1)(2008-5#1)
order modes##2##2##(2012-11#2)
order near##4##2##(2008-3#4)
order of a##9##3##(2007-12#1)(2008-2#2)(2008-3#4)(2009-11#1)(2009-5#1)
order of abundance##3##3##(1992-12#1)(2004-11#1)(2012-12#1)
order of activity##3##3##(1991-5#1)(1993-8#1)(1997-2#1)
order of affinities##2##3##(1995-12#1)(2008-11#1)
order of agonist potency##2##4##(1995-12#1)(1997-5#1)
order of approximation##3##3##(2008-2#2)(2008-3#1)
order of cytotoxicity##2##3##(1997-2#1)(2008-5#1)
order of decreasing##8##3##(1991-11#1)(1993-4#1)(1993-9#2)(1994-9#1)(2006-12#1)(2008-4#1)(2008-9#1)
order of efficacy##2##3##(1995-8#1)(2007-1#1)
order of elution##2##3##(1990-8#1)(2008-10#1)
order of events in##2##4##(1992-11#1)(2013-7#1)
order of frequency were##2##4##(2007-7#2)
order of frequency##13##3##(1990-10#1)(1991-2#1)(1992-8#1)(1997-5#1)(2007-7#3)(2007-8#1)(2008-10#1)(2010-11#1)(2010-7#1)(2012-12#1)(2012-3#1)
order of genes##4##3##(1993-12#1)(1994-3#1)(2008-4#1)(2009-5#1)
order of importance##6##3##(1994-1#1)(2005-11#1)(2007-10#1)(2008-3#1)(2010-4#1)(2011-12#1)
order of increasing##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
order of inhibitory##2##3##(1991-8#1)(1995-6#1)
order of magnitude and##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
order of magnitude change in##2##5##(2008-10#2)
order of magnitude faster##2##4##(1994-11#1)(2010-6#1)
order of magnitude higher than##4##5##(1991-5#1)(1994-11#1)(2008-10#1)(2008-7#1)
order of magnitude higher##7##4##(1991-5#1)(1994-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-1#1)
order of magnitude larger than that##4##6##(2008-3#2)(2010-8#1)(2013-8#1)
order of magnitude larger than##8##5##(2007-11#2)(2007-12#1)(2008-3#2)(2009-9#1)(2010-8#1)(2013-8#1)
order of magnitude larger##9##4##(1996-11#1)(2007-11#2)(2007-12#1)(2008-3#2)(2009-9#1)(2010-8#1)(2013-8#1)
order of magnitude less than##3##5##(2008-2#1)(2008-3#1)(2009-6#1)
order of magnitude less##5##4##(1995-12#1)(1997-2#1)(2008-2#1)(2008-3#1)(2009-6#1)
order of magnitude lower than that of##2##7##(1996-12#1)(2007-11#1)
order of magnitude lower than##7##5##(1990-7#1)(1995-8#1)(1996-12#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#1)
order of magnitude lower##10##4##(1990-2#1)(1990-7#1)(1990-8#1)(1995-8#1)(1996-12#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2009-11#1)
order of magnitude more##5##4##(1992-3#1)(2007-12#2)(2008-10#1)(2008-2#1)
order of magnitude of the##6##5##(1997-8#1)(2005-11#1)(2007-12#1)(2008-3#2)(2012-3#1)
order of magnitude of##9##4##(1993-3#1)(1995-8#1)(1997-8#1)(2005-11#1)(2007-12#1)(2008-3#3)(2012-3#1)
order of magnitude smaller than##2##5##(2007-12#1)(2010-9#1)
order of magnitude than that##2##5##(2007-12#1)(2008-10#1)
order of magnitude##120##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-5#3)(1992-3#1)(1992-6#2)(1993-3#2)(1993-8#1)(1994-11#3)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-8#1)(2004-11#1)(2005-11#4)(2006-4#1)(2007-11#7)(2007-12#11)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#9)(2008-3#13)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#2)
order of potency for##6##4##(1991-2#1)(1994-3#1)(1995-12#2)(1995-6#1)(1996-12#1)
order of potency of the##3##5##(1991-2#1)(1995-12#1)(1996-12#1)
order of potency of##5##4##(1990-2#1)(1991-12#1)(1991-2#1)(1995-12#1)(1996-12#1)
order of potency was##3##4##(1993-3#1)(1994-12#1)(1996-10#1)
order of potency##28##3##(1990-2#2)(1991-12#1)(1991-2#2)(1991-5#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#3)(1995-1#2)(1995-12#4)(1995-6#1)(1995-7#1)(1996-10#1)(1996-12#2)(2009-12#1)(2010-12#1)
order of reactivity of the##2##5##(1996-2#1)(1997-7#1)
order of reactivity##4##3##(1995-11#1)(1996-2#1)(1997-7#1)(1997-8#1)
order of relative##3##3##(1995-12#1)(2008-10#1)(2008-11#1)
order of sensitivity##2##3##(1992-7#1)(2008-10#1)
order of susceptibility##2##3##(1991-7#1)(2008-10#1)
order of testing##2##3##(2006-12#1)(2009-12#1)
order of the genes##2##4##(1990-5#1)(2011-12#1)
order of the surface##2##4##(1996-5#2)
order of the##67##3##(1990-2#1)(1990-4#1)(1990-5#1)(1991-2#1)(1991-3#1)(1992-1#2)(1992-2#1)(1992-6#1)(1992-9#2)(1994-9#1)(1995-11#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#5)(1996-6#1)(1997-1#1)(1997-2#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-9#1)(2008-10#8)(2008-2#6)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2009-2#1)(2010-1#1)(2010-4#2)(2011-1#2)(2011-12#2)(2012-1#1)(2013-8#2)
order of their##5##3##(1990-11#1)(1991-6#1)(2008-10#1)(2008-5#1)(2010-3#1)
order of these##2##3##(2008-10#1)(2008-7#1)
order of##619##2##(1990-10#1)(1990-11#5)(1990-12#3)(1990-2#6)(1990-3#2)(1990-4#4)(1990-5#1)(1990-7#1)(1990-8#4)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#1)(1991-2#9)(1991-3#1)(1991-5#5)(1991-6#1)(1991-7#1)(1991-8#4)(1992-1#4)(1992-11#4)(1992-12#1)(1992-2#2)(1992-3#3)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#2)(1992-9#6)(1993-11#1)(1993-12#4)(1993-3#5)(1993-4#1)(1993-6#1)(1993-7#2)(1993-8#4)(1993-9#2)(1994-1#1)(1994-11#5)(1994-12#2)(1994-2#1)(1994-3#8)(1994-6#3)(1994-8#3)(1994-9#2)(1995-1#2)(1995-11#4)(1995-12#10)(1995-2#3)(1995-3#2)(1995-5#4)(1995-6#6)(1995-7#1)(1995-8#4)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#5)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#8)(1996-6#2)(1996-7#2)(1996-8#1)(1997-1#2)(1997-2#6)(1997-4#2)(1997-5#3)(1997-6#2)(1997-7#1)(1997-8#2)(2004-11#3)(2005-11#13)(2005-4#2)(2005-7#1)(2006-10#2)(2006-12#3)(2006-2#1)(2006-4#3)(2006-5#2)(2006-6#1)(2007-1#1)(2007-10#4)(2007-11#15)(2007-12#42)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#65)(2008-11#6)(2008-12#2)(2008-2#43)(2008-3#62)(2008-4#9)(2008-5#14)(2008-6#4)(2008-7#5)(2008-8#7)(2008-9#5)(2009-11#3)(2009-12#4)(2009-2#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#6)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#4)(2011-1#5)(2011-12#4)(2011-2#5)(2012-1#4)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#7)
order on the##3##3##(2004-11#1)(2008-10#2)
order on##7##2##(2004-11#2)(2008-10#3)(2008-12#1)(2009-3#1)
order or##5##2##(1991-5#1)(1994-3#1)(2008-2#1)(2008-4#1)(2013-8#1)
order out of##2##3##(2005-8#1)(2006-10#1)
order parameter for##2##3##(1992-1#1)(2008-9#1)
order parameter in##2##3##(1990-12#1)(1995-11#1)
order parameter##19##2##(1990-12#1)(1990-2#1)(1991-2#1)(1991-7#1)(1992-1#1)(1992-9#2)(1993-3#2)(1994-10#1)(1994-5#1)(1995-11#1)(1995-5#1)(1995-7#1)(1995-8#1)(1997-1#1)(2006-10#1)(2008-9#1)(2009-10#1)
order parameters calculated##2##3##(1990-3#1)(1995-8#1)
order parameters in##2##3##(1990-12#1)(1992-1#1)
order parameters##14##2##(1990-12#1)(1990-3#2)(1992-1#2)(1992-9#2)(1994-9#1)(1995-8#2)(1996-7#2)(2008-11#1)(2010-2#1)
order patterns##3##2##(2008-11#3)
order polarization##2##2##(1994-7#1)(2008-3#1)
order process with##2##3##(1990-11#1)(2010-7#1)
order process##3##2##(1990-11#1)(2009-7#1)(2010-7#1)
order rate##3##2##(1996-9#1)(2008-1#1)(2013-1#1)
order reaction##6##2##(1992-6#1)(1996-7#1)(2008-10#3)(2008-5#1)
order residue##3##2##(2012-2#3)
order set usage##4##3##(2013-1#4)
order set##7##2##(2008-3#1)(2013-1#6)
order sets##30##2##(1996-12#2)(2008-3#4)(2013-1#24)
order sheet##5##2##(2007-2#4)(2008-3#1)
order statistic##2##2##(2008-3#2)
order statistics##4##2##(2008-11#1)(2011-1#3)
order substrate binding##2##3##(1995-6#2)
order that##17##2##(1990-11#1)(1995-3#1)(1997-1#1)(2006-10#1)(2006-6#2)(2007-8#1)(2007-9#1)(2008-11#2)(2008-12#2)(2008-2#2)(2008-5#1)(2012-3#1)(2013-1#1)
order to accelerate##3##3##(2008-5#1)(2009-8#1)(2012-3#1)
order to accomplish the##2##4##(2007-9#1)(2008-2#1)
order to accomplish##4##3##(2007-9#1)(2008-2#1)(2008-5#1)(2010-8#1)
order to achieve a##13##4##(1991-9#1)(1992-4#1)(1992-9#1)(1993-12#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-4#1)(2010-4#1)(2011-2#1)
order to achieve better##2##4##(2009-10#1)(2013-8#1)
order to achieve high##3##4##(1990-12#1)(2008-10#2)
order to achieve the##11##4##(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2009-3#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-1#1)
order to achieve##59##3##(1990-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-3#2)(1992-4#1)(1992-9#1)(1993-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1997-3#2)(2005-9#1)(2006-12#1)(2007-12#1)(2007-4#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-8#1)
order to acquire##2##3##(2007-7#1)(2008-10#1)
order to adapt##4##3##(1997-4#1)(2007-8#1)(2008-10#1)(2011-1#1)
order to add##2##3##(2008-12#1)(2009-9#1)
order to address the##7##4##(1994-5#1)(1996-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-3#1)(2012-12#1)
order to address these##2##4##(1997-2#1)(2008-1#1)
order to address##14##3##(1992-6#1)(1994-5#1)(1996-7#1)(1997-2#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-1#1)(2012-12#1)(2012-3#1)
order to aid the##2##4##(2008-1#1)(2012-2#1)
order to aid##3##3##(2008-1#1)(2008-5#1)(2012-2#1)
order to allow the##8##4##(1992-1#1)(2008-10#4)(2013-1#3)
order to allow##13##3##(1992-1#1)(1994-3#2)(2008-10#4)(2009-4#1)(2011-1#1)(2012-1#1)(2013-1#3)
order to amplify##2##3##(1994-11#1)(2007-8#1)
order to analyze the##9##4##(1997-7#1)(2007-10#1)(2007-5#1)(2008-10#1)(2008-6#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
order to analyze##17##3##(1992-5#1)(1994-12#1)(1994-6#1)(1997-7#1)(2007-10#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-9#2)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
order to answer##4##3##(2004-9#1)(2007-2#1)(2008-11#1)(2010-2#1)
order to apply##3##3##(2008-10#2)(2008-4#1)
order to approach##2##3##(2006-11#1)(2008-2#1)
order to arrive at##2##4##(1995-4#1)(2008-12#1)
order to ascertain whether##2##4##(2008-11#1)(2010-8#1)
order to ascertain##7##3##(1991-10#1)(2006-1#1)(2006-7#1)(2007-2#1)(2008-10#1)(2008-11#1)(2010-8#1)
order to assess changes in##2##5##(1995-9#1)(1996-2#1)
order to assess the influence of##3##6##(1990-4#1)(1993-12#1)(2008-11#1)
order to assess the##46##4##(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#2)(1991-5#1)(1991-8#1)(1992-9#1)(1993-12#1)(1993-9#2)(1995-1#1)(1995-5#1)(1995-6#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-5#1)(1997-6#1)(2004-11#1)(2006-6#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#4)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#3)(2009-3#1)(2013-1#2)
order to assess their##4##4##(1992-8#1)(2007-9#1)(2008-4#1)(2012-3#1)
order to assess whether##5##4##(1994-5#1)(1997-8#1)(2008-2#1)(2008-7#1)(2012-2#1)
order to assess##73##3##(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#2)(1991-5#1)(1991-8#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-9#2)(1994-5#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-11#1)(2006-6#2)(2007-10#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-10#7)(2008-11#1)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#7)(2009-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
order to assist##5##3##(2005-10#1)(2007-4#1)(2012-1#1)(2013-1#2)
order to attain##5##3##(1997-8#1)(2008-1#1)(2008-10#1)(2010-9#1)(2011-2#1)
order to avoid complications##3##4##(1995-8#1)(2006-10#1)(2011-2#1)
order to avoid the##15##4##(1991-8#1)(1994-11#1)(2006-7#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-4#2)(2009-5#1)(2010-9#1)(2013-1#2)
order to avoid##55##3##(1990-11#1)(1991-11#1)(1991-12#1)(1991-8#1)(1992-12#1)(1993-3#1)(1994-11#1)(1995-5#1)(1995-8#2)(1996-2#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#1)(2004-9#1)(2005-12#1)(2005-5#2)(2006-10#3)(2006-7#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#3)(2008-6#1)(2008-7#1)(2009-2#2)(2009-5#1)(2010-9#1)(2011-2#2)(2012-2#2)(2013-1#3)(2013-7#1)
order to be able to##11##5##(1990-12#1)(1990-6#1)(1991-11#1)(1991-3#1)(1992-12#1)(1993-12#1)(1995-7#1)(2006-12#1)(2008-10#1)(2012-1#1)(2012-12#1)
order to be able##12##4##(1990-12#1)(1990-6#1)(1991-11#1)(1991-3#1)(1992-12#1)(1993-12#1)(1995-7#1)(2006-12#1)(2008-10#1)(2008-11#1)(2012-1#1)(2012-12#1)
order to be consistent with the##2##6##(1992-3#1)(1995-8#1)
order to be##39##3##(1990-12#1)(1990-6#1)(1991-11#1)(1991-3#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-3#2)(1994-6#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-5#1)(1997-1#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#2)
order to become##4##3##(2005-8#1)(2008-11#2)(2011-2#1)
order to begin to##2##4##(1990-10#1)(1994-6#1)
order to better understand the##8##5##(1993-6#1)(1993-8#1)(1995-3#1)(1997-7#1)(2007-9#1)(2008-10#1)(2008-3#1)(2009-11#1)
order to better understand##11##4##(1993-12#1)(1993-6#1)(1993-8#1)(1995-3#1)(1997-7#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-11#1)(2013-1#1)
order to better##18##3##(1993-12#1)(1993-6#1)(1993-8#1)(1995-3#1)(1997-7#1)(2006-11#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-12#2)(2013-1#1)
order to both##4##3##(1991-7#1)(2006-2#1)(2012-1#1)(2013-7#1)
order to bring about##2##4##(2007-8#1)(2010-4#1)
order to bring##4##3##(2006-1#1)(2007-8#1)(2008-1#1)(2010-4#1)
order to build##5##3##(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2011-2#1)
order to calculate the##5##4##(1996-1#1)(2008-10#1)(2008-2#1)(2009-4#1)(2011-2#1)
order to calculate##8##3##(1996-1#1)(1997-6#1)(2008-10#2)(2008-2#2)(2009-4#1)(2011-2#1)
order to carry out##2##4##(1997-6#1)(2007-1#1)
order to carry##3##3##(1997-6#1)(2007-1#1)(2008-10#1)
order to characterise the##4##4##(1990-11#1)(1991-9#1)(1994-12#1)(2012-12#1)
order to characterize the##21##4##(1990-10#1)(1991-5#1)(1992-2#2)(1992-8#1)(1994-3#1)(1994-9#1)(1995-12#1)(2005-11#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-7#1)(2009-8#1)(2010-11#1)(2012-12#1)
order to characterize##28##3##(1990-10#1)(1991-5#1)(1992-2#2)(1992-8#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-4#1)(2005-11#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#3)(2009-8#1)(2010-11#1)(2012-12#1)
order to check the##4##4##(1993-11#1)(2008-12#1)(2008-5#1)(2010-8#1)
order to check##11##3##(1992-5#1)(1993-11#1)(1997-4#1)(2006-5#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-8#1)(2012-7#1)
order to clarify the role of##2##6##(1991-12#1)(1991-2#1)
order to clarify the##14##4##(1991-12#2)(1991-2#1)(1991-8#1)(1992-12#1)(1992-3#1)(1995-6#2)(1995-8#1)(2004-11#3)(2008-2#1)(2011-2#1)
order to clarify##19##3##(1991-12#2)(1991-2#1)(1991-8#1)(1992-12#1)(1992-3#1)(1995-6#2)(1995-8#1)(2004-11#3)(2007-10#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2011-2#1)(2013-8#1)
order to classify##5##3##(1994-6#1)(2008-2#1)(2010-5#1)(2012-1#2)
order to compare the##13##4##(1990-8#1)(1992-3#1)(1993-4#1)(1994-3#2)(1995-8#1)(1996-8#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
order to compare##22##3##(1990-11#1)(1990-8#1)(1991-7#1)(1992-3#1)(1993-4#1)(1994-3#2)(1994-5#1)(1995-8#1)(1996-8#1)(2008-10#5)(2008-5#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)
order to confirm the##10##4##(1991-7#1)(1992-12#1)(1994-2#1)(1996-5#1)(2007-11#1)(2008-10#1)(2008-5#2)(2008-7#1)(2013-8#1)
order to confirm##18##3##(1990-2#1)(1990-5#1)(1991-7#1)(1992-12#1)(1992-2#1)(1994-2#1)(1996-5#1)(1997-8#1)(2006-4#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2012-3#1)(2013-8#1)
order to construct a##3##4##(2008-10#1)(2008-11#1)(2013-1#1)
order to continue##2##3##(2008-8#1)(2010-3#1)
order to contribute to##7##4##(1994-6#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)
order to control the##6##4##(2004-11#1)(2007-8#1)(2008-10#3)(2012-1#1)
order to control##10##3##(1992-3#1)(2004-11#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-11#1)(2012-1#1)(2013-8#1)
order to correct##3##3##(2007-3#1)(2008-11#1)(2013-8#1)
order to correctly##4##3##(2006-2#1)(2008-1#1)(2012-2#1)(2013-8#1)
order to correlate the##2##4##(1990-8#1)(2012-9#1)
order to correlate##5##3##(1990-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2012-9#1)
order to cover the##2##4##(1996-12#1)(2005-8#1)
order to cover##3##3##(1996-12#1)(1996-6#1)(2005-8#1)
order to create##3##3##(2006-12#1)(2010-10#1)(2010-11#1)
order to decide##6##3##(1996-6#1)(2007-10#1)(2007-2#1)(2010-12#1)(2011-2#1)(2013-8#1)
order to decrease the##5##4##(1996-8#1)(2006-10#1)(2008-12#1)(2009-10#1)(2011-2#1)
order to decrease##6##3##(1996-8#1)(2006-10#1)(2008-12#1)(2009-10#1)(2011-2#1)(2012-2#1)
order to define a##3##4##(2011-2#1)(2012-2#1)(2013-1#1)
order to define more accurately##2##5##(2005-10#1)(2012-2#1)
order to define the role of##2##6##(1993-11#1)(1995-5#1)
order to define the##6##4##(1993-11#1)(1995-5#1)(1996-11#1)(2010-11#1)(2010-2#1)(2011-1#1)
order to define##16##3##(1990-4#1)(1993-11#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-6#1)(2005-10#1)(2008-11#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
order to demonstrate the##6##4##(2008-10#3)(2008-7#1)(2013-1#2)
order to demonstrate whether##2##4##(2008-10#1)(2010-4#1)
order to demonstrate##16##3##(1996-9#1)(1997-7#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-7#1)(2010-4#1)(2013-1#2)
order to derive a##3##4##(1992-3#1)(2008-10#2)
order to derive##4##3##(1992-3#1)(2008-10#2)(2008-7#1)
order to describe the##4##4##(2007-9#1)(2008-11#1)(2008-6#1)(2012-2#1)
order to describe##7##3##(1996-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-4#1)(2012-2#1)
order to design##5##3##(1994-10#1)(2005-8#1)(2006-11#1)(2007-7#1)(2010-9#1)
order to determine if the##2##5##(1990-2#1)(2008-4#1)
order to determine if##7##4##(1990-12#1)(1990-2#1)(1993-6#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-4#1)
order to determine the clinical##2##5##(1992-10#1)(2007-2#1)
order to determine the effect of##4##6##(1992-10#1)(1995-3#1)(2011-2#1)(2013-1#1)
order to determine the effect##5##5##(1992-10#1)(1995-3#1)(2011-2#1)(2013-1#1)(2013-7#1)
order to determine the frequency of##2##6##(2007-2#2)
order to determine the minimal##2##5##(1990-11#1)(2011-2#1)
order to determine the prevalence##2##5##(2007-2#1)(2007-3#1)
order to determine the role of##3##6##(1994-11#1)(1994-8#1)(1995-2#1)
order to determine the##73##4##(1990-10#1)(1990-11#1)(1990-3#1)(1992-10#2)(1993-11#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-7#1)(1996-8#1)(1997-4#1)(2005-12#1)(2005-8#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-2#7)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#4)(2012-12#1)(2013-1#1)(2013-7#1)
order to determine their##4##4##(2005-11#1)(2007-12#1)(2008-10#1)(2011-1#1)
order to determine whether the##4##5##(1991-9#1)(1993-12#1)(1995-3#1)(2010-8#1)
order to determine whether this is##2##6##(1991-5#1)(1996-4#1)
order to determine whether this##4##5##(1991-12#1)(1991-5#1)(1991-9#1)(1996-4#1)
order to determine whether##21##4##(1990-6#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-4#1)(1992-5#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-12#1)(1996-4#2)(1997-3#1)(2007-6#1)(2010-8#1)(2013-8#1)
order to determine which##5##4##(1992-7#1)(1994-2#1)(2008-10#1)(2011-2#1)(2013-8#1)
order to determine##146##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-9#2)(1992-10#2)(1992-4#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-7#1)(1996-10#1)(1996-12#1)(1996-4#2)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-12#4)(2007-2#8)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#23)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#5)(2012-12#1)(2013-1#2)(2013-7#2)(2013-8#2)
order to develop a better##2##5##(2007-11#1)(2008-7#1)
order to develop a##13##4##(1990-5#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-7#1)(2010-7#1)
order to develop an##5##4##(1990-12#1)(1994-12#1)(1994-2#1)(2007-8#1)(2010-5#1)
order to develop new##2##4##(2006-5#1)(2012-12#1)
order to develop the##4##4##(1994-2#1)(1995-5#1)(2008-11#1)(2008-9#1)
order to develop##44##3##(1990-12#1)(1990-5#1)(1993-6#1)(1994-12#1)(1994-2#2)(1995-5#1)(1997-6#1)(2005-11#1)(2006-11#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-5#2)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#1)
order to diagnose##2##3##(2009-5#1)(2013-1#1)
order to differentiate##5##3##(1997-2#1)(2007-10#1)(2008-10#3)
order to discover the##3##4##(1990-4#1)(1993-7#1)(2012-3#1)
order to discover##4##3##(1990-4#1)(1993-7#1)(1994-12#1)(2012-3#1)
order to distinguish between##3##4##(1996-1#1)(2008-10#2)
order to distinguish##10##3##(1996-1#1)(1997-3#1)(2007-1#2)(2008-10#5)(2012-2#1)
order to effect a##4##4##(1991-4#1)(2004-1#1)(2008-4#2)
order to effect##5##3##(1991-4#1)(2004-1#1)(2008-4#2)(2008-7#1)
order to effectively##3##3##(2008-2#1)(2008-6#1)(2012-3#1)
order to efficiently##3##3##(1996-12#1)(2007-8#1)(2010-3#1)
order to eliminate the##4##4##(1997-4#1)(2008-10#1)(2010-11#1)(2011-1#1)
order to eliminate##11##3##(1992-9#1)(1996-3#1)(1997-1#1)(1997-4#1)(2007-11#2)(2008-10#1)(2008-2#1)(2010-11#1)(2011-1#1)(2012-3#1)
order to elucidate the role of##3##6##(1992-6#1)(2008-10#1)(2009-10#1)
order to elucidate the underlying##2##5##(1995-12#1)(2008-5#1)
order to elucidate the##22##4##(1990-7#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1995-12#1)(1995-3#1)(1995-7#1)(2005-8#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-5#2)(2009-10#1)(2010-4#1)(2011-3#1)(2012-2#1)
order to elucidate##27##3##(1990-7#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-8#1)(1995-12#1)(1995-3#2)(1995-7#1)(1996-9#1)(2005-8#2)(2007-12#1)(2007-8#2)(2008-10#3)(2008-5#2)(2008-7#1)(2009-10#1)(2010-4#1)(2011-3#1)(2012-2#1)
order to enhance the##6##4##(2007-8#1)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#2)
order to enhance##15##3##(2006-1#1)(2006-10#1)(2007-8#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#1)
order to ensure a##7##4##(1997-2#1)(2006-9#1)(2009-5#1)(2009-6#1)(2010-7#1)(2011-2#1)(2012-3#1)
order to ensure that##5##4##(1995-4#1)(1997-8#1)(2006-7#1)(2008-11#1)(2013-1#1)
order to ensure##37##3##(1990-5#1)(1995-1#1)(1995-4#1)(1997-1#1)(1997-2#1)(1997-8#1)(2006-7#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
order to eradicate the##2##4##(1994-9#1)(2008-1#1)
order to eradicate##3##3##(1994-9#2)(2008-1#1)
order to establish a##4##4##(2007-3#1)(2008-11#1)(2008-7#1)(2011-1#1)
order to establish the##16##4##(1991-12#1)(1991-6#1)(1997-2#1)(1997-5#1)(1997-6#1)(2005-12#1)(2006-12#1)(2008-10#3)(2008-12#1)(2008-8#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)
order to establish##40##3##(1991-12#1)(1991-5#1)(1991-6#1)(1994-2#1)(1995-5#1)(1996-11#1)(1997-2#1)(1997-5#1)(1997-6#1)(2004-2#1)(2005-12#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-6#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-2#1)
order to estimate the##11##4##(1995-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2012-12#1)(2013-7#1)(2013-8#1)
order to estimate##15##3##(1993-3#1)(1995-5#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-7#1)(2012-12#1)(2013-7#1)(2013-8#1)
order to evaluate possible##2##4##(1992-11#1)(2008-10#1)
order to evaluate the effect of a##2##7##(1995-11#1)(1997-4#1)
order to evaluate the effect of##7##6##(1995-11#1)(1997-4#1)(2008-10#1)(2008-5#3)(2008-7#1)
order to evaluate the effect##8##5##(1995-11#1)(1997-4#1)(2008-10#1)(2008-5#4)(2008-7#1)
order to evaluate the effectiveness of##2##6##(1994-6#1)(2007-11#1)
order to evaluate the effects of##5##6##(1995-2#1)(2007-11#1)(2008-10#2)(2008-12#1)
order to evaluate the potential##3##5##(1991-7#1)(1992-9#1)(2006-6#1)
order to evaluate the role of##6##6##(1990-10#2)(1990-5#1)(1994-6#1)(1996-2#1)(2008-5#1)
order to evaluate the##70##4##(1990-10#2)(1990-2#1)(1990-5#1)(1991-7#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-6#3)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-9#2)(1996-2#1)(1996-3#1)(1996-8#1)(1997-4#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#11)(2008-12#1)(2008-3#1)(2008-5#8)(2008-7#2)(2009-7#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-11#2)(2013-7#1)(2013-8#2)
order to evaluate whether##3##4##(1994-12#1)(2008-10#1)(2008-12#1)
order to evaluate##105##3##(1990-10#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-3#1)(1994-11#1)(1994-12#2)(1994-6#3)(1994-7#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-9#2)(1996-2#1)(1996-3#1)(1996-8#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-1#2)(2007-11#2)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#15)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#13)(2008-7#3)(2009-7#1)(2010-12#3)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-3#2)(2013-7#1)(2013-8#2)
order to examine how##2##4##(1994-12#1)(2005-11#1)
order to examine if##3##4##(1996-3#1)(2004-12#1)(2008-11#1)
order to examine the effect of the##2##7##(1990-2#1)(2009-4#1)
order to examine the effect of##3##6##(1990-2#1)(2008-12#1)(2009-4#1)
order to examine the effects of##2##6##(1997-4#1)(2005-11#1)
order to examine the##19##4##(1990-2#1)(1990-8#1)(1993-2#1)(1994-12#1)(1997-4#1)(2005-11#1)(2006-9#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#1)(2013-1#2)
order to examine##35##3##(1990-2#1)(1990-4#1)(1990-8#1)(1992-6#1)(1993-2#1)(1993-5#1)(1994-12#2)(1996-3#2)(1997-2#1)(1997-4#1)(1997-8#1)(2004-12#1)(2005-11#2)(2006-8#1)(2006-9#1)(2007-7#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-9#1)(2010-8#1)(2013-1#2)
order to expand the##3##4##(2008-10#2)(2012-11#1)
order to explain the##5##4##(1994-5#1)(1997-1#1)(2007-2#1)(2008-10#2)
order to explain##10##3##(1990-12#1)(1993-12#2)(1994-5#1)(1997-1#1)(2007-2#1)(2008-10#2)(2011-2#1)(2012-2#1)
order to explore the effects of##2##6##(1991-1#1)(2008-9#1)
order to explore the mechanism of##2##6##(1994-6#1)(2010-11#1)
order to explore the##12##4##(1991-1#1)(1993-9#1)(1994-6#1)(1995-12#1)(1996-5#1)(1997-1#1)(2007-3#1)(2008-10#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-5#1)
order to explore##18##3##(1991-1#1)(1993-9#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-1#2)(2007-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-5#1)(2012-3#1)
order to express##2##3##(1994-5#1)(1995-2#1)
order to extend##2##3##(2008-10#1)(2010-2#1)
order to facilitate the implementation of##2##6##(1993-3#1)(2005-5#1)
order to facilitate the implementation##3##5##(1993-3#1)(2005-5#1)(2008-2#1)
order to facilitate the##10##4##(1990-12#1)(1990-7#1)(1993-3#1)(1996-10#1)(1996-12#1)(2005-5#1)(2006-10#1)(2008-10#1)(2008-2#1)(2012-11#1)
order to facilitate##31##3##(1990-12#1)(1990-7#1)(1993-3#1)(1993-8#1)(1994-3#1)(1996-10#1)(1996-12#1)(1996-3#1)(1997-3#1)(2005-5#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#2)(2009-11#1)(2009-4#1)(2010-8#1)(2012-11#1)(2012-3#1)(2013-1#1)
order to fight##2##3##(2007-7#1)(2008-5#1)
order to find out##8##4##(1991-11#1)(1997-2#1)(2008-1#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
order to find the##9##4##(2007-1#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)(2011-1#1)
order to find##33##3##(1990-5#1)(1991-11#1)(1993-3#1)(1993-8#1)(1996-5#1)(1997-2#1)(1997-6#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2010-2#2)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
order to follow the##2##4##(1992-12#1)(1994-5#1)
order to form##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
order to fulfil##3##3##(1997-6#1)(2006-2#1)(2007-3#1)
order to fulfill##2##3##(2007-1#1)(2007-10#1)
order to fully##4##3##(2007-2#1)(2007-4#1)(2008-2#1)(2009-7#1)
order to further understand##3##4##(2006-5#1)(2008-10#1)(2011-1#1)
order to further##18##3##(1990-11#1)(1992-8#1)(1994-1#1)(1995-11#1)(1996-10#1)(1996-12#1)(1996-7#1)(1997-5#1)(2006-5#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2009-8#1)(2011-1#1)
order to gain a##3##4##(1994-11#1)(1997-5#1)(2010-10#1)
order to gain insight into the##2##6##(1992-6#1)(1995-8#1)
order to gain insight into##4##5##(1992-6#1)(1993-6#1)(1995-8#1)(2008-7#1)
order to gain##16##3##(1992-6#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-8#1)(1997-5#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#2)(2010-10#1)(2010-6#1)
order to generate##5##3##(1991-11#1)(2005-7#1)(2007-11#1)(2008-10#1)(2008-8#1)
order to get a##4##4##(2008-10#3)(2013-8#1)
order to get an insight into the##2##7##(2008-11#1)(2008-7#1)
order to get an insight into##3##6##(2008-11#1)(2008-7#1)(2009-12#1)
order to get insight##2##4##(2008-10#1)(2009-9#1)
order to get##21##3##(1994-3#1)(1995-9#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-9#1)(2011-1#1)(2013-8#1)
order to give a##4##4##(2006-11#1)(2008-11#1)(2008-7#1)(2012-2#1)
order to give##9##3##(1992-10#1)(1993-1#1)(2006-11#1)(2007-2#1)(2008-11#2)(2008-6#1)(2008-7#1)(2012-2#1)
order to guarantee##4##3##(2005-5#1)(2007-11#1)(2007-8#1)(2011-2#1)
order to have a##2##4##(2008-10#1)(2008-12#1)
order to have##7##3##(1992-3#1)(1993-11#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-7#1)
order to help the##5##4##(1991-5#1)(1992-2#1)(1994-8#1)(2007-9#1)(2008-6#1)
order to help##21##3##(1991-5#1)(1992-2#1)(1994-6#1)(1994-8#1)(2004-10#1)(2005-3#1)(2006-8#1)(2007-2#1)(2007-9#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2009-4#1)(2010-8#1)(2012-12#2)(2013-1#1)
order to identify a##3##4##(1992-3#1)(2009-4#1)(2012-12#1)
order to identify and##3##4##(1997-2#1)(2008-10#1)(2012-2#1)
order to identify diagnostic##2##4##(1994-6#1)(1996-12#1)
order to identify factors##3##4##(1995-10#1)(2007-10#1)(2011-1#1)
order to identify new targets##2##5##(2010-3#2)
order to identify new##3##4##(2010-3#2)(2012-1#1)
order to identify such##2##4##(2005-9#1)(2008-7#1)
order to identify the##20##4##(1991-7#1)(1992-9#1)(1993-12#1)(1993-6#2)(1994-6#1)(1994-9#1)(2004-9#1)(2006-10#1)(2006-6#1)(2007-2#1)(2007-3#1)(2008-10#3)(2008-7#1)(2010-5#1)(2010-6#1)(2012-2#1)(2013-1#1)
order to identify##88##3##(1990-10#1)(1991-12#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-9#2)(1993-12#1)(1993-6#2)(1994-5#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-12#3)(1996-2#1)(1996-5#1)(1997-2#2)(1997-5#1)(2004-9#1)(2005-9#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#8)(2008-11#2)(2008-2#1)(2008-4#3)(2008-6#1)(2008-7#5)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#3)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#2)(2013-7#2)(2013-8#1)
order to illuminate##2##3##(1997-3#1)(2005-7#1)
order to illustrate the##3##4##(1990-8#1)(2007-11#1)(2008-10#1)
order to illustrate##5##3##(1990-8#1)(2007-11#1)(2008-10#3)
order to implement##2##3##(1994-9#1)(2008-10#1)
order to improve the selectivity and##2##6##(2005-12#1)(2008-10#1)
order to improve the sensitivity##3##5##(1993-2#1)(2008-10#1)(2012-12#1)
order to improve the##46##4##(1991-6#1)(1993-2#1)(1996-2#1)(1996-9#1)(2004-9#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-11#1)(2007-2#1)(2007-8#1)(2008-10#12)(2008-11#3)(2008-2#2)(2008-6#1)(2008-7#1)(2009-4#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
order to improve##81##3##(1991-3#1)(1991-6#1)(1993-2#2)(1994-11#1)(1996-12#1)(1996-2#1)(1996-9#1)(2004-9#2)(2005-11#1)(2005-12#1)(2006-10#4)(2006-11#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-2#2)(2007-8#1)(2008-10#17)(2008-11#4)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#2)
order to increase sensitivity##2##4##(2008-10#2)
order to increase the understanding of the##2##7##(1995-1#1)(1997-4#1)
order to increase the##16##4##(1995-1#1)(1997-3#1)(1997-4#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
order to increase##33##3##(1995-1#1)(1995-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-1#3)(2008-10#8)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-7#1)(2012-2#1)(2013-8#1)
order to interpret the##2##4##(1990-8#1)(1997-1#1)
order to investigate if the##2##5##(1997-2#1)(2008-10#1)
order to investigate if##4##4##(1990-5#1)(1997-2#1)(1997-5#1)(2008-10#1)
order to investigate its##2##4##(2007-9#1)(2008-5#1)
order to investigate the contribution of##2##6##(1995-12#1)(2012-3#1)
order to investigate the mechanism of this##2##7##(1990-9#1)(1994-8#1)
order to investigate the mechanism##4##5##(1990-9#1)(1991-11#1)(1994-8#1)(2008-3#1)
order to investigate the molecular##3##5##(1990-8#1)(2010-12#1)(2012-1#1)
order to investigate the potential##2##5##(1992-9#1)(2004-9#1)
order to investigate the relationship between the##4##7##(2005-11#1)(2008-10#1)(2008-9#1)(2011-2#1)
order to investigate the relationship between##7##6##(1991-9#1)(1994-3#2)(2005-11#1)(2008-10#1)(2008-9#1)(2011-2#1)
order to investigate the##55##4##(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-8#2)(1994-9#1)(1995-12#1)(1995-6#1)(1996-12#2)(2004-9#1)(2005-11#3)(2005-8#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-3#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#3)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)
order to investigate their##9##4##(1990-12#1)(1997-5#1)(1997-6#1)(2005-10#1)(2007-9#1)(2008-11#1)(2008-9#1)(2009-12#1)(2013-1#1)
order to investigate whether the##3##5##(1991-9#1)(1995-3#1)(2011-1#1)
order to investigate whether this##2##5##(1994-12#1)(1997-8#1)
order to investigate whether##9##4##(1991-9#1)(1992-8#1)(1994-12#1)(1995-3#1)(1997-8#1)(2007-10#1)(2011-1#1)(2012-5#1)(2013-8#1)
order to investigate##92##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-9#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-8#3)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#2)(1996-5#1)(1996-7#1)(1997-2#1)(1997-5#2)(1997-6#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#3)(2005-8#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-9#2)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#3)(2008-8#1)(2008-9#5)(2009-12#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#1)
order to isolate##5##3##(1992-8#1)(1992-9#1)(1997-2#1)(2004-11#1)(2011-2#1)
order to keep the##2##4##(1992-1#1)(2006-4#1)
order to keep##5##3##(1990-3#1)(1992-1#1)(1993-11#1)(2006-4#1)(2012-2#1)
order to know the##10##4##(1991-9#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
order to know##11##3##(1991-9#1)(1992-7#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
order to learn more about the##2##6##(2009-4#1)(2010-11#1)
order to learn more about##3##5##(1995-3#1)(2009-4#1)(2010-11#1)
order to learn##6##3##(1995-3#1)(1996-12#1)(2008-5#1)(2009-4#1)(2010-11#1)(2011-2#1)
order to localize##4##3##(1990-7#1)(1991-9#1)(1997-6#1)(2009-5#1)
order to locate the##4##4##(1990-7#1)(1992-11#1)(2006-10#1)(2006-4#1)
order to locate##5##3##(1990-7#1)(1992-11#1)(2006-10#1)(2006-4#1)(2008-4#1)
order to maintain the##7##4##(1990-11#1)(2005-10#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)
order to maintain##16##3##(1990-11#1)(2005-10#1)(2006-7#1)(2006-8#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#2)(2011-1#1)(2011-2#1)(2013-8#1)
order to make a##3##4##(1997-2#1)(2010-1#1)(2012-12#1)
order to make it##2##4##(1993-9#1)(2005-11#1)
order to make the##8##4##(2006-11#1)(2008-10#1)(2009-10#1)(2010-4#2)(2011-2#1)(2013-1#2)
order to make this##2##4##(1997-8#1)(2006-6#1)
order to make##36##3##(1990-3#1)(1991-2#1)(1993-5#1)(1993-9#1)(1994-1#1)(1996-3#1)(1997-2#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-10#5)(2008-12#1)(2008-4#1)(2009-10#1)(2009-8#1)(2010-1#1)(2010-4#2)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
order to manage##4##3##(2006-4#1)(2009-3#1)(2010-11#1)(2013-1#1)
order to map##2##3##(1991-8#1)(2008-12#1)
order to maximize the##8##4##(1995-11#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)
order to maximize##16##3##(1995-11#1)(1996-7#1)(2004-1#1)(2006-10#1)(2006-6#1)(2007-3#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#2)(2008-9#1)(2011-2#1)
order to measure##10##3##(1994-9#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2011-2#2)(2012-12#1)(2013-8#1)
order to meet the##9##4##(1994-2#1)(2006-6#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-7#1)(2011-2#1)
order to meet##11##3##(1994-2#1)(2006-6#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
order to mimic the##3##4##(1996-2#1)(2009-2#1)(2009-7#1)
order to mimic##4##3##(1996-2#1)(2008-10#1)(2009-2#1)(2009-7#1)
order to minimise the##4##4##(1996-8#1)(2008-12#1)(2010-12#1)(2011-2#1)
order to minimise##6##3##(1996-8#1)(2005-11#1)(2007-6#1)(2008-12#1)(2010-12#1)(2011-2#1)
order to minimize the risk of##4##6##(1995-8#1)(1996-3#1)(2007-8#1)(2011-11#1)
order to minimize the##11##4##(1995-8#1)(1996-3#1)(1997-6#1)(2005-7#1)(2007-4#1)(2007-8#2)(2008-10#3)(2011-11#1)
order to minimize##20##3##(1993-8#1)(1995-8#1)(1996-3#1)(1997-6#1)(2005-7#1)(2006-8#1)(2007-4#1)(2007-8#3)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#2)(2009-3#1)(2011-11#1)(2012-1#1)
order to monitor the##3##4##(1991-12#1)(1993-6#1)(2005-11#1)
order to monitor##6##3##(1991-12#1)(1993-6#1)(1995-9#1)(2005-11#1)(2010-8#1)(2011-1#1)
order to more##5##3##(2006-9#1)(2008-2#1)(2009-4#1)(2010-4#1)(2011-2#1)
order to observe##6##3##(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-10#1)
order to obtain a complete##2##5##(2007-11#1)(2008-7#1)
order to obtain a##28##4##(1990-4#1)(1995-9#1)(2006-6#1)(2007-11#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2010-5#1)(2010-6#1)(2011-1#2)(2012-2#1)(2013-1#2)
order to obtain an effective##2##5##(2008-5#1)(2013-1#1)
order to obtain an##6##4##(2008-10#2)(2008-5#1)(2009-7#1)(2010-9#1)(2013-1#1)
order to obtain better##3##4##(2008-10#2)(2008-7#1)
order to obtain good##3##4##(1990-5#1)(2008-10#1)(2008-9#1)
order to obtain information##3##4##(1993-12#1)(1994-11#1)(2007-12#1)
order to obtain more##4##4##(1995-5#1)(1996-2#1)(2009-4#1)(2010-1#1)
order to obtain reliable##2##4##(1996-6#1)(2006-12#1)
order to obtain the##16##4##(1994-12#1)(2005-11#1)(2005-6#1)(2008-10#9)(2008-5#1)(2008-7#1)(2008-9#1)(2010-9#1)
order to obtain##100##3##(1990-4#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-7#1)(1993-12#1)(1994-11#1)(1994-12#1)(1995-5#1)(1995-9#1)(1996-2#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-4#1)(1997-6#1)(2004-9#1)(2005-11#2)(2005-6#1)(2006-1#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#29)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-9#2)(2009-1#1)(2009-12#1)(2009-4#1)(2009-7#2)(2010-1#1)(2010-12#1)(2010-5#3)(2010-6#1)(2010-9#2)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#4)
order to optimize the extraction##2##5##(2008-10#2)
order to optimize the##13##4##(1996-5#1)(1997-4#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2010-4#1)(2013-1#1)
order to optimize##20##3##(1996-5#1)(1997-4#1)(1997-7#1)(2007-10#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2010-4#1)(2011-1#1)(2013-1#1)
order to overcome the current##2##5##(2007-11#1)(2013-1#1)
order to overcome the##9##4##(1992-5#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
order to overcome##21##3##(1990-12#1)(1992-5#1)(2006-12#2)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-11#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
order to perform a##2##4##(2008-10#1)(2008-7#1)
order to perform the##2##4##(2008-10#2)
order to perform##9##3##(2008-10#5)(2008-2#1)(2008-7#1)(2010-11#1)(2010-7#1)
order to permit##4##3##(1991-8#1)(1992-6#1)(1996-12#1)(2012-1#1)
order to pinpoint the##2##4##(1990-12#1)(2008-10#1)
order to predict the##6##4##(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2013-1#2)
order to predict##7##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2013-1#2)
order to present##3##3##(1991-4#1)(2009-11#1)(2013-1#1)
order to preserve the##5##4##(1993-7#1)(2006-10#1)(2007-7#1)(2008-10#1)(2010-8#1)
order to preserve##8##3##(1993-7#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-8#1)(2012-11#1)
order to prevent postoperative##2##4##(1992-3#1)(2005-12#1)
order to prevent the##11##4##(1991-10#1)(1993-8#1)(1994-9#1)(1997-6#1)(2006-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-3#1)
order to prevent this##2##4##(1993-11#1)(2013-1#1)
order to prevent##45##3##(1991-10#1)(1991-4#1)(1991-6#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-5#1)(1993-8#1)(1994-9#1)(1995-2#1)(1996-11#1)(1997-2#1)(1997-6#1)(2005-12#2)(2006-4#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-1#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#1)
order to probe the structural##2##5##(1994-5#1)(1994-9#1)
order to probe the##5##4##(1992-6#1)(1994-5#1)(1994-9#1)(1995-5#1)(1997-2#1)
order to probe##6##3##(1992-6#1)(1994-5#1)(1994-9#1)(1995-5#1)(1997-2#1)(2008-8#1)
order to produce a##2##4##(1994-9#1)(2006-12#1)
order to produce##7##3##(1990-5#1)(1991-12#1)(1994-9#1)(1996-9#1)(2006-12#1)(2008-12#1)(2008-5#1)
order to protect##6##3##(1992-5#1)(1996-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2012-2#1)
order to prove##5##3##(2008-10#2)(2008-5#1)(2008-8#1)(2009-8#1)
order to provide a##9##4##(1991-4#1)(1992-6#1)(2006-12#1)(2008-11#1)(2008-4#2)(2009-9#1)(2011-2#1)(2012-1#1)
order to provide##45##3##(1990-2#1)(1991-1#1)(1991-2#1)(1991-4#1)(1992-2#1)(1992-6#1)(1995-1#1)(1995-5#1)(1996-8#1)(1997-1#1)(2004-9#1)(2005-11#2)(2006-12#2)(2006-2#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2009-9#2)(2010-4#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)
order to quantify the##7##4##(1995-3#1)(1997-6#1)(2008-10#2)(2013-1#3)
order to quantify##11##3##(1995-3#1)(1997-6#1)(2008-10#4)(2009-7#1)(2012-2#1)(2013-1#3)
order to quantitate##2##3##(1992-6#1)(2008-4#1)
order to raise awareness##2##4##(2007-10#1)(2007-3#1)
order to raise the##2##4##(2008-8#1)(2011-2#1)
order to raise##5##3##(2007-10#1)(2007-3#1)(2008-8#1)(2011-2#2)
order to rapidly##2##3##(2008-11#1)(2008-7#1)
order to reach##6##3##(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)
order to realize##6##3##(2008-10#1)(2009-4#1)(2010-11#1)(2010-8#1)(2012-3#2)
order to recommend##2##3##(2007-8#1)(2012-1#1)
order to reconcile##2##3##(2006-2#1)(2008-11#1)
order to recruit##2##3##(1993-6#1)(2012-2#1)
order to reduce the risk of##8##6##(1990-2#1)(1996-2#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2013-8#2)
order to reduce the##27##4##(1990-2#1)(1993-10#1)(1996-2#1)(2006-11#2)(2006-3#1)(2006-8#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#2)
order to reduce##47##3##(1990-2#1)(1991-6#1)(1992-11#1)(1992-9#1)(1993-10#1)(1993-5#1)(1996-2#1)(2006-11#3)(2006-3#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-8#2)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#6)(2013-8#4)
order to regenerate##2##3##(1992-1#1)(2008-11#1)
order to relate##2##3##(1996-5#1)(2008-9#1)
order to remove the##7##4##(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#4)
order to remove##10##3##(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-6#1)(2011-2#1)(2013-1#1)
order to resolve##3##3##(1994-2#1)(1996-9#1)(2013-8#1)
order to respond to the##2##5##(2011-2#1)(2012-12#1)
order to respond to##3##4##(1992-9#1)(2011-2#1)(2012-12#1)
order to respond##4##3##(1992-9#1)(2011-2#1)(2012-1#1)(2012-12#1)
order to satisfy##4##3##(1994-3#1)(2006-12#1)(2008-10#1)(2008-9#1)
order to see##3##3##(1995-5#1)(2008-2#1)(2013-1#1)
order to select the best##2##5##(2006-10#1)(2008-10#1)
order to select the##4##4##(1996-6#1)(2006-10#1)(2008-10#1)(2011-1#1)
order to select##10##3##(1996-6#1)(2005-11#1)(2005-8#1)(2006-10#1)(2008-10#3)(2008-5#1)(2011-1#1)(2012-1#1)
order to separate##5##3##(1990-8#1)(2005-12#1)(2008-10#2)(2010-2#1)
order to shed light on this##2##6##(1997-2#1)(2013-1#1)
order to shed light on##3##5##(1997-2#1)(2007-12#1)(2013-1#1)
order to shed##4##3##(1997-2#1)(2007-12#1)(2008-11#1)(2013-1#1)
order to show how the##2##5##(2007-8#1)(2008-10#1)
order to show##5##3##(1990-10#1)(1994-3#1)(2007-8#1)(2008-10#2)
order to simplify the##3##4##(1997-4#1)(2010-8#1)(2013-1#1)
order to simulate##7##3##(1995-3#1)(2006-6#1)(2007-4#2)(2008-10#2)(2009-7#1)
order to stabilize the##2##4##(1996-9#1)(2006-10#1)
order to stabilize##4##3##(1996-9#1)(2006-10#1)(2008-10#1)(2010-4#1)
order to study the effect of##5##6##(1991-6#1)(1991-7#1)(1996-1#1)(2008-12#1)(2008-2#1)
order to study the effects of##3##6##(1993-11#1)(1993-3#1)(2009-8#1)
order to study the influence of##4##6##(1992-6#1)(1994-8#1)(2005-11#1)(2013-8#1)
order to study the##42##4##(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-12#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-5#2)(1996-1#1)(1997-1#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-12#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-8#1)(2010-12#1)(2011-2#2)(2013-8#1)
order to study##63##3##(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#3)(1994-2#2)(1994-5#1)(1994-6#2)(1994-8#2)(1995-12#1)(1995-5#2)(1996-1#1)(1997-1#1)(1997-4#2)(1997-6#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-8#1)
order to successfully##2##3##(2008-7#1)(2009-4#1)
order to suggest##2##3##(2008-5#1)(2013-7#1)
order to support##10##3##(1994-3#1)(1996-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-11#1)(2010-2#1)(2010-6#1)(2010-8#1)(2012-3#1)
order to suppress the##2##4##(2008-10#1)(2008-2#1)
order to suppress##3##3##(2008-10#2)(2008-2#1)
order to take account of##2##5##(2008-7#1)(2012-1#1)
order to take into account the##3##6##(2008-10#2)(2010-2#1)
order to take##7##3##(2008-10#3)(2008-7#1)(2010-2#1)(2010-5#1)(2012-1#1)
order to target##4##3##(1990-12#1)(1997-2#1)(2008-4#1)(2008-7#1)
order to test for##4##4##(1994-2#1)(1996-2#1)(2006-8#1)(2009-4#1)
order to test the effects of##2##6##(1990-10#1)(2012-2#1)
order to test the hypothesis that##3##6##(1995-4#1)(2008-5#1)(2009-5#1)
order to test the##15##4##(1990-10#1)(1990-12#1)(1991-5#1)(1991-6#1)(1992-6#1)(1992-8#1)(1995-4#1)(1996-11#1)(2005-11#1)(2008-10#2)(2008-5#1)(2009-5#1)(2009-9#1)(2012-2#1)
order to test this##4##4##(1995-5#1)(1996-3#1)(1997-7#1)(2008-7#1)
order to test whether the##2##5##(1994-3#1)(2009-10#1)
order to test whether##6##4##(1992-8#1)(1994-3#1)(1996-7#1)(2008-10#1)(2008-8#1)(2009-10#1)
order to test##36##3##(1990-10#1)(1990-12#1)(1991-5#2)(1991-6#1)(1992-6#1)(1992-8#2)(1993-4#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-4#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-8#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-9#1)(2012-1#1)(2012-2#1)
order to the##2##3##(2007-4#1)(2008-2#1)
order to treat the##2##4##(1993-12#1)(2007-11#1)
order to treat##6##3##(1993-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-10#1)
order to understand the role of##3##6##(1997-2#1)(2008-6#1)(2012-3#1)
order to understand the##32##4##(1990-10#1)(1993-6#1)(1994-10#1)(1994-5#1)(1995-5#1)(1996-11#1)(1997-2#2)(1997-4#1)(1997-8#1)(2006-5#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#5)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
order to understand##46##3##(1990-10#1)(1993-6#1)(1994-10#1)(1994-5#1)(1995-3#1)(1995-5#1)(1996-11#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-1#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
order to unify##2##3##(2007-11#2)
order to use the##3##4##(2004-9#1)(2007-12#1)(2008-10#1)
order to use##5##3##(2004-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)
order to utilize the##2##4##(2008-11#1)(2009-5#1)
order to utilize##5##3##(1990-3#1)(2007-12#1)(2008-11#2)(2009-5#1)
order to validate the##7##4##(1997-2#1)(2008-10#3)(2008-5#1)(2010-12#1)(2011-2#1)
order to validate##10##3##(1995-5#1)(1997-2#1)(2007-10#1)(2008-10#4)(2008-5#1)(2010-12#1)(2011-2#1)
order to verify the##9##4##(1991-6#1)(1996-8#1)(1997-2#1)(2007-7#2)(2008-10#2)(2008-3#1)(2008-9#1)
order to verify##12##3##(1991-6#1)(1996-12#1)(1996-8#1)(1997-2#1)(2007-7#2)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2013-7#1)
order to work##2##3##(1997-5#1)(2008-7#1)
order to##2862##2##(1990-10#9)(1990-11#7)(1990-12#15)(1990-2#9)(1990-3#6)(1990-4#7)(1990-5#13)(1990-6#5)(1990-7#6)(1990-8#13)(1990-9#2)(1991-1#5)(1991-10#3)(1991-11#8)(1991-12#10)(1991-2#6)(1991-3#6)(1991-4#4)(1991-5#9)(1991-6#7)(1991-7#7)(1991-8#7)(1991-9#10)(1992-1#3)(1992-10#3)(1992-11#4)(1992-12#8)(1992-2#7)(1992-3#13)(1992-4#3)(1992-5#8)(1992-6#11)(1992-7#3)(1992-8#9)(1992-9#13)(1993-1#2)(1993-10#2)(1993-11#8)(1993-12#16)(1993-2#7)(1993-3#13)(1993-4#4)(1993-5#5)(1993-6#12)(1993-7#2)(1993-8#7)(1993-9#9)(1994-1#5)(1994-10#3)(1994-11#12)(1994-12#16)(1994-2#12)(1994-3#18)(1994-5#14)(1994-6#16)(1994-7#1)(1994-8#12)(1994-9#10)(1995-1#7)(1995-10#1)(1995-11#5)(1995-12#9)(1995-2#8)(1995-3#13)(1995-4#4)(1995-5#18)(1995-6#9)(1995-7#3)(1995-8#7)(1995-9#8)(1996-1#4)(1996-10#3)(1996-11#10)(1996-12#19)(1996-2#11)(1996-3#11)(1996-4#4)(1996-5#13)(1996-6#5)(1996-7#9)(1996-8#8)(1996-9#8)(1997-1#17)(1997-2#26)(1997-3#11)(1997-4#16)(1997-5#9)(1997-6#20)(1997-7#8)(1997-8#8)(2004-1#2)(2004-10#1)(2004-11#6)(2004-12#1)(2004-2#1)(2004-3#1)(2004-9#10)(2005-10#6)(2005-11#24)(2005-12#7)(2005-3#1)(2005-5#4)(2005-6#1)(2005-7#3)(2005-8#12)(2005-9#2)(2006-1#6)(2006-10#26)(2006-11#15)(2006-12#15)(2006-2#10)(2006-3#3)(2006-4#8)(2006-5#7)(2006-6#18)(2006-7#8)(2006-8#15)(2006-9#5)(2007-1#10)(2007-10#19)(2007-11#37)(2007-12#21)(2007-2#27)(2007-3#15)(2007-4#16)(2007-5#11)(2007-6#9)(2007-7#22)(2007-8#48)(2007-9#21)(2008-1#44)(2008-10#375)(2008-11#105)(2008-12#43)(2008-2#53)(2008-3#16)(2008-4#40)(2008-5#85)(2008-6#21)(2008-7#80)(2008-8#32)(2008-9#40)(2009-1#2)(2009-10#9)(2009-11#6)(2009-12#6)(2009-2#9)(2009-3#9)(2009-4#19)(2009-5#10)(2009-6#11)(2009-7#11)(2009-8#9)(2009-9#7)(2010-1#9)(2010-10#7)(2010-11#16)(2010-12#18)(2010-2#13)(2010-3#11)(2010-4#17)(2010-5#15)(2010-6#8)(2010-7#8)(2010-8#21)(2010-9#12)(2011-1#46)(2011-11#1)(2011-12#2)(2011-2#77)(2011-3#2)(2011-7#1)(2012-1#29)(2012-11#6)(2012-12#31)(2012-2#51)(2012-3#28)(2012-5#1)(2012-7#1)(2012-9#1)(2013-1#86)(2013-7#16)(2013-8#35)
order transformation rates##2##3##(2012-12#2)
order under##2##2##(2007-12#1)(2008-3#1)
order was found##2##3##(2005-12#1)(2008-10#1)
order was used##2##3##(2007-12#1)(2009-8#1)
order was##16##2##(1990-11#1)(1992-12#1)(1993-12#1)(1996-11#1)(1996-4#1)(2005-12#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-2#3)(2009-8#1)(2011-1#2)
order were##6##2##(1995-1#1)(2006-10#1)(2007-2#1)(2007-7#2)(2011-1#1)
order which##3##2##(1991-3#1)(2013-1#2)
order with##4##2##(1990-11#1)(2007-11#1)(2008-10#1)(2009-9#1)
order within the##2##3##(1990-5#1)(2006-4#1)
order within##4##2##(1990-5#1)(2006-4#1)(2008-11#1)(2010-8#1)
order##4369##1##(1990-1#1)(1990-10#12)(1990-11#17)(1990-12#23)(1990-2#18)(1990-3#12)(1990-4#16)(1990-5#18)(1990-6#5)(1990-7#8)(1990-8#17)(1990-9#4)(1991-1#8)(1991-10#5)(1991-11#14)(1991-12#12)(1991-2#19)(1991-3#9)(1991-4#5)(1991-5#16)(1991-6#8)(1991-7#12)(1991-8#13)(1991-9#13)(1992-1#17)(1992-10#4)(1992-11#13)(1992-12#19)(1992-2#11)(1992-3#23)(1992-4#3)(1992-5#10)(1992-6#17)(1992-7#4)(1992-8#12)(1992-9#27)(1993-1#3)(1993-10#2)(1993-11#10)(1993-12#25)(1993-2#10)(1993-3#24)(1993-4#6)(1993-5#5)(1993-6#14)(1993-7#7)(1993-8#13)(1993-9#12)(1994-1#6)(1994-10#6)(1994-11#20)(1994-12#22)(1994-2#15)(1994-3#31)(1994-5#18)(1994-6#22)(1994-7#4)(1994-8#16)(1994-9#18)(1995-1#11)(1995-10#3)(1995-11#13)(1995-12#23)(1995-2#15)(1995-3#20)(1995-4#4)(1995-5#30)(1995-6#21)(1995-7#7)(1995-8#17)(1995-9#9)(1996-1#5)(1996-10#5)(1996-11#17)(1996-12#29)(1996-2#18)(1996-3#14)(1996-4#13)(1996-5#27)(1996-6#9)(1996-7#14)(1996-8#9)(1996-9#10)(1997-1#23)(1997-2#36)(1997-3#12)(1997-4#19)(1997-5#14)(1997-6#26)(1997-7#11)(1997-8#11)(2004-1#3)(2004-10#4)(2004-11#13)(2004-12#1)(2004-2#1)(2004-3#1)(2004-4#1)(2004-9#11)(2005-10#6)(2005-11#44)(2005-12#9)(2005-3#1)(2005-4#3)(2005-5#5)(2005-6#1)(2005-7#4)(2005-8#17)(2005-9#2)(2006-1#8)(2006-10#44)(2006-11#18)(2006-12#22)(2006-2#13)(2006-3#5)(2006-4#15)(2006-5#12)(2006-6#21)(2006-7#11)(2006-8#16)(2006-9#5)(2007-1#15)(2007-10#26)(2007-11#68)(2007-12#90)(2007-2#34)(2007-3#19)(2007-4#18)(2007-5#13)(2007-6#11)(2007-7#31)(2007-8#57)(2007-9#25)(2008-1#56)(2008-10#512)(2008-11#137)(2008-12#49)(2008-2#151)(2008-3#140)(2008-4#56)(2008-5#116)(2008-6#31)(2008-7#95)(2008-8#47)(2008-9#51)(2009-1#2)(2009-10#13)(2009-11#10)(2009-12#10)(2009-2#12)(2009-3#10)(2009-4#23)(2009-5#15)(2009-6#13)(2009-7#14)(2009-8#11)(2009-9#12)(2010-1#10)(2010-10#8)(2010-11#18)(2010-12#19)(2010-2#16)(2010-3#17)(2010-4#28)(2010-5#23)(2010-6#10)(2010-7#14)(2010-8#25)(2010-9#18)(2011-1#69)(2011-11#1)(2011-12#8)(2011-2#99)(2011-3#2)(2011-7#1)(2012-1#38)(2012-11#8)(2012-12#39)(2012-2#72)(2012-3#33)(2012-5#1)(2012-7#1)(2012-9#1)(2013-1#151)(2013-7#22)(2013-8#58)
order)##10##1##(1993-12#2)(2006-12#1)(2008-10#2)(2008-2#1)(2008-6#1)(2009-6#1)(2011-1#1)(2011-2#1)
order-disorder transitions##2##2##(1992-8#1)(2005-11#1)
order-disorder##3##1##(1992-8#1)(2005-11#1)(2008-10#1)
order-of-magnitude##6##1##(2007-11#1)(2007-12#3)(2008-2#1)(2008-8#1)
order-parameter##2##1##(2008-8#2)
ordered a##3##2##(1996-6#1)(1997-5#1)(2007-9#1)
ordered and##3##2##(1990-11#1)(1997-1#1)(2007-11#1)
ordered array of##3##3##(2005-11#1)(2008-3#1)(2008-7#1)
ordered array##6##2##(1996-6#1)(2005-11#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)
ordered arrays of##4##3##(2008-7#3)(2010-4#1)
ordered as##2##2##(2004-12#1)(2008-12#1)
ordered assembly of##2##3##(1997-4#1)(2007-9#1)
ordered assembly##3##2##(1994-3#1)(1997-4#1)(2007-9#1)
ordered binding##2##2##(1990-7#1)(1992-12#1)
ordered by their##3##3##(1995-2#1)(1996-1#1)(2010-5#1)
ordered by##4##2##(1993-2#1)(1995-2#1)(1996-1#1)(2010-5#1)
ordered categorical data##6##3##(1995-6#3)(1996-7#2)(1997-2#1)
ordered categorical##9##2##(1995-6#3)(1996-7#3)(1997-2#1)(1997-4#2)
ordered for a##2##3##(1994-9#1)(1997-5#1)
ordered for##5##2##(1994-9#1)(1997-4#1)(1997-5#1)(2005-10#1)(2007-8#1)
ordered helix is##2##3##(1993-6#2)
ordered helix##4##2##(1993-6#4)
ordered him to##2##3##(1996-11#1)(1996-6#1)
ordered in the##2##3##(1996-5#1)(2009-11#1)
ordered in##4##2##(1990-8#1)(1996-5#1)(2007-9#1)(2009-11#1)
ordered mechanism##2##2##(1991-4#1)(1995-2#1)
ordered mesoporous carbon##2##3##(2010-12#2)
ordered mesoporous##3##2##(2010-12#3)
ordered phase##3##2##(2006-10#3)
ordered population##2##2##(1996-2#2)
ordered secondary structure##2##3##(1994-12#1)(1994-9#1)
ordered set of##2##3##(2008-11#1)(2008-2#1)
ordered set##3##2##(2006-10#1)(2008-11#1)(2008-2#1)
ordered single##2##2##(1991-7#1)(1992-8#1)
ordered structure of##2##3##(1990-5#1)(1997-5#1)
ordered structure##4##2##(1990-5#1)(1993-3#1)(1997-5#1)(2008-11#1)
ordered structures##2##2##(1992-3#1)(2008-8#1)
ordered to##3##2##(1990-12#1)(1995-6#1)(1996-5#1)
ordered water molecules##2##3##(1990-7#1)(1997-5#1)
ordered water##3##2##(1990-2#1)(1990-7#1)(1997-5#1)
ordered##191##1##(1990-11#3)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#3)(1990-8#1)(1991-12#4)(1991-4#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-2#1)(1993-3#4)(1993-6#5)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#3)(1995-10#2)(1995-12#1)(1995-2#4)(1995-4#1)(1995-5#1)(1995-6#5)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#2)(1996-6#4)(1996-7#3)(1997-1#1)(1997-2#1)(1997-4#5)(1997-5#4)(1997-7#3)(2004-12#1)(2005-10#1)(2005-11#3)(2006-10#5)(2006-12#1)(2006-5#2)(2007-11#3)(2007-12#4)(2007-8#2)(2007-9#3)(2008-10#6)(2008-11#5)(2008-12#3)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#8)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-4#5)(2010-5#2)(2011-1#3)(2011-2#1)(2011-7#1)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
ordering a##2##2##(2006-8#1)(2007-11#1)
ordering and electronic coupling in bilayer nanoscale InAs/GaAs quantum dots separated by a thin##2##14##(2009-11#2)
ordering and##10##2##(1992-3#1)(1997-7#1)(2007-9#1)(2008-3#1)(2008-7#1)(2009-11#2)(2013-1#3)
ordering effect of##2##3##(2005-11#2)
ordering effect##3##2##(2005-11#3)
ordering in the##2##3##(2005-11#1)(2008-3#1)
ordering in##8##2##(1990-4#1)(1991-2#1)(2005-11#1)(2007-11#1)(2008-3#1)(2008-8#1)(2009-11#1)(2012-2#1)
ordering of InGaAs##2##3##(2009-11#2)
ordering of the##10##3##(1993-11#1)(1996-1#1)(1996-10#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-3#1)(2012-12#1)
ordering of##24##2##(1992-9#2)(1993-11#1)(1995-2#1)(1996-1#1)(1996-10#1)(1996-2#2)(1996-3#1)(1997-5#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-11#3)(2010-3#1)(2012-1#1)(2012-12#1)(2013-1#1)
ordering processes##3##2##(2013-1#3)
ordering theory##2##2##(2008-6#2)
ordering these##2##2##(1996-12#1)(2005-10#1)
ordering with##2##2##(1992-6#1)(2008-10#1)
ordering##98##1##(1990-12#1)(1990-4#1)(1991-2#1)(1992-1#2)(1992-3#2)(1992-6#3)(1992-9#2)(1993-11#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#3)(1996-3#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-3#1)(2005-10#1)(2005-11#4)(2006-12#1)(2006-8#1)(2007-11#3)(2007-9#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#2)(2008-8#1)(2009-11#7)(2009-5#1)(2010-3#2)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#20)
orderly and##3##2##(2008-5#1)(2013-1#2)
orderly##17##1##(1990-12#1)(1991-3#1)(1996-2#1)(2007-12#1)(2008-11#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-5#1)(2009-6#1)(2009-7#1)(2012-2#1)(2013-1#2)(2013-8#1)
orders and##11##2##(2007-12#1)(2007-3#1)(2007-8#1)(2008-2#1)(2008-3#2)(2011-1#1)(2011-2#2)(2013-1#2)
orders are##7##2##(1993-6#1)(1994-3#1)(1995-2#1)(2007-12#1)(2008-2#1)(2008-3#2)
orders as##3##2##(1993-6#1)(2007-10#1)(2007-12#1)
orders at##3##2##(2008-3#1)(2013-1#2)
orders be##2##2##(2005-5#1)(2006-10#1)
orders can be##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
orders can##4##2##(1995-2#1)(2008-2#1)(2008-3#1)(2013-1#1)
orders for##7##2##(1997-7#1)(2006-1#1)(2008-10#2)(2010-2#1)(2013-1#2)
orders in a pediatric environment with a preliminary investigation of methods to automate the creation and modification of order sets using historical ordering data##2##24##(2013-1#2)
orders in animal societies##2##4##(2007-9#2)
orders in the##5##3##(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#2)
orders in##13##2##(1996-3#1)(2006-10#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-3#2)(2013-1#4)(2013-8#1)
orders into##3##2##(2008-10#1)(2013-1#2)
orders is##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2011-2#1)
orders m##2##2##(2007-12#1)(2008-3#1)
orders of diffraction##2##3##(2008-1#1)(2008-2#1)
orders of magnitude (i##2##4##(2008-10#2)
orders of magnitude and the limits of detection##2##8##(1997-1#1)(2008-10#1)
orders of magnitude and the##4##5##(1997-1#1)(2008-10#3)
orders of magnitude and##8##4##(1997-1#1)(2007-12#2)(2008-10#4)(2008-3#1)
orders of magnitude as##2##4##(1992-6#1)(2007-11#1)
orders of magnitude below the##2##5##(1990-11#1)(2007-11#1)
orders of magnitude below##3##4##(1990-11#1)(2007-11#1)(2008-2#1)
orders of magnitude by##4##4##(2008-3#1)(2008-9#1)(2009-11#1)(2010-5#1)
orders of magnitude compared##2##4##(2008-2#1)(2008-5#1)
orders of magnitude depending on the##2##6##(1997-4#2)
orders of magnitude faster than##3##5##(1995-10#1)(1995-2#1)(2007-9#1)
orders of magnitude faster##5##4##(1995-10#1)(1995-2#1)(2007-12#1)(2007-9#1)(2008-3#1)
orders of magnitude for##3##4##(2007-12#2)(2008-10#1)
orders of magnitude from##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
orders of magnitude greater than that of##2##7##(1995-6#1)(2010-9#1)
orders of magnitude greater than##3##5##(1995-6#1)(2008-3#1)(2010-9#1)
orders of magnitude higher than for##2##6##(1995-8#1)(2007-12#1)
orders of magnitude higher than in##2##6##(1992-4#1)(2007-12#1)
orders of magnitude higher than that of the##3##8##(2007-12#2)(2008-10#1)
orders of magnitude higher than that of##5##7##(1992-8#1)(2007-12#3)(2008-10#1)
orders of magnitude higher than those##3##6##(1990-7#1)(2008-10#1)(2012-2#1)
orders of magnitude higher than##17##5##(1990-7#1)(1992-4#1)(1992-8#1)(1995-11#1)(1995-8#1)(1996-5#1)(2006-4#1)(2007-11#1)(2007-12#5)(2008-10#3)(2012-2#1)
orders of magnitude higher##20##4##(1990-7#1)(1992-4#1)(1992-8#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-5#1)(1997-6#1)(2006-4#1)(2007-11#1)(2007-12#6)(2008-10#3)(2012-2#1)
orders of magnitude in the##3##5##(1990-12#1)(2008-2#1)(2008-3#1)
orders of magnitude in##9##4##(1990-12#1)(1990-5#1)(1997-8#1)(2008-2#2)(2008-3#2)(2009-11#1)(2010-8#1)
orders of magnitude larger than the##2##6##(2008-2#1)(2011-1#1)
orders of magnitude larger than##6##5##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#1)
orders of magnitude less than##2##5##(1997-4#1)(2008-11#1)
orders of magnitude less##6##4##(1997-2#1)(1997-4#2)(2008-11#1)(2008-3#1)(2012-1#1)
orders of magnitude lower than that of##2##7##(1990-11#1)(2010-2#1)
orders of magnitude lower than that##3##6##(1990-11#1)(1996-5#1)(2010-2#1)
orders of magnitude lower than those##2##6##(2008-10#1)(2009-3#1)
orders of magnitude lower than with##2##6##(1991-7#1)(2008-3#1)
orders of magnitude lower than##11##5##(1990-11#1)(1991-7#2)(1995-8#1)(1996-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-3#1)(2010-2#1)
orders of magnitude lower##12##4##(1990-11#1)(1991-7#2)(1995-8#1)(1996-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-3#1)(2010-2#1)
orders of magnitude more efficient##2##5##(1995-8#1)(2010-12#1)
orders of magnitude more sensitive than##3##6##(2006-3#1)(2007-12#1)(2008-11#1)
orders of magnitude more sensitive##4##5##(2006-3#1)(2007-12#1)(2008-11#1)(2008-8#1)
orders of magnitude more##8##4##(1990-7#1)(1991-4#1)(1995-8#1)(2006-3#1)(2007-12#1)(2008-11#1)(2008-8#1)(2010-12#1)
orders of magnitude of##3##4##(2006-1#1)(2008-10#2)
orders of magnitude relative to##2##5##(1994-5#1)(1995-2#1)
orders of magnitude smaller than##3##5##(2008-10#1)(2008-2#1)(2008-7#1)
orders of magnitude smaller##4##4##(2008-10#1)(2008-2#1)(2008-7#1)(2013-1#1)
orders of magnitude than##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
orders of magnitude that##2##4##(1994-9#1)(2008-3#1)
orders of magnitude using##2##4##(1997-2#1)(2010-12#1)
orders of magnitude were achieved##2##5##(2007-12#1)(2013-8#1)
orders of magnitude when##2##4##(2008-10#2)
orders of magnitude with detection limits##2##6##(2008-10#2)
orders of magnitude with respect to##2##6##(2008-1#1)(2009-11#1)
orders of magnitude with##7##4##(2008-1#1)(2008-10#4)(2009-11#1)(2009-2#1)
orders of magnitude##208##3##(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#2)(1991-10#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#2)(1992-4#1)(1992-6#1)(1992-8#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#3)(1994-9#1)(1995-10#1)(1995-11#2)(1995-2#2)(1995-6#1)(1995-8#3)(1996-11#1)(1996-5#2)(1996-7#1)(1997-1#2)(1997-2#2)(1997-4#6)(1997-6#2)(1997-8#1)(2005-11#2)(2005-12#1)(2006-1#1)(2006-10#1)(2006-3#1)(2006-4#2)(2007-11#9)(2007-12#25)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#46)(2008-11#2)(2008-2#10)(2008-3#18)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
orders of magnitude)##4##3##(1995-2#1)(2007-11#1)(2008-10#2)
orders of scattering##2##3##(2008-3#2)
orders of the##6##3##(1996-1#1)(2006-12#1)(2008-2#1)(2008-3#3)
orders of##248##2##(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#2)(1991-10#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-6#2)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#3)(1994-9#1)(1995-10#1)(1995-11#2)(1995-2#3)(1995-6#1)(1995-7#1)(1995-8#3)(1996-1#1)(1996-11#1)(1996-5#3)(1996-7#1)(1997-1#2)(1997-2#2)(1997-4#6)(1997-6#2)(1997-8#1)(2005-11#2)(2005-12#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-7#1)(2007-11#13)(2007-12#29)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#49)(2008-11#2)(2008-2#12)(2008-3#27)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
orders that##2##2##(2007-12#1)(2008-3#1)
orders the##2##2##(1990-2#1)(2008-10#1)
orders to##6##2##(2008-2#1)(2008-3#1)(2013-1#4)
orders were##6##2##(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2011-2#1)
orders when##3##2##(2008-10#1)(2013-1#2)
orders with an##2##3##(2007-12#2)
orders with##6##2##(2007-12#4)(2008-10#1)(2008-2#1)
orders##445##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#2)(1991-10#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#2)(1992-12#3)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-6#4)(1994-11#1)(1994-2#1)(1994-3#3)(1994-5#4)(1994-9#1)(1995-10#1)(1995-11#2)(1995-2#6)(1995-6#1)(1995-7#2)(1995-8#3)(1996-1#1)(1996-11#1)(1996-3#1)(1996-5#3)(1996-7#2)(1997-1#2)(1997-2#2)(1997-4#6)(1997-6#2)(1997-7#1)(1997-8#1)(2004-10#1)(2004-11#1)(2005-11#2)(2005-12#1)(2005-5#2)(2006-1#2)(2006-10#6)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#1)(2006-7#3)(2007-10#2)(2007-11#16)(2007-12#48)(2007-2#2)(2007-3#4)(2007-5#8)(2007-7#1)(2007-8#3)(2007-9#3)(2008-1#7)(2008-10#62)(2008-11#3)(2008-12#1)(2008-2#29)(2008-3#51)(2008-4#2)(2008-5#7)(2008-6#4)(2008-7#7)(2008-8#3)(2008-9#3)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#1)(2010-10#1)(2010-12#4)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#8)(2012-1#1)(2012-2#4)(2012-3#2)(2012-7#1)(2013-1#26)(2013-7#2)(2013-8#3)
ordinal data##8##2##(1995-9#1)(1996-3#1)(1997-2#1)(2008-10#4)(2008-12#1)
ordinal logistic regression##2##3##(1994-8#1)(2011-2#1)
ordinal logistic##4##2##(1994-8#2)(2008-4#1)(2011-2#1)
ordinal outcomes##3##2##(1996-12#1)(1997-2#1)(1997-4#1)
ordinal rating##2##2##(1997-8#1)(2008-10#1)
ordinal regression##2##2##(1996-8#1)(2008-9#1)
ordinal responses##4##2##(1993-11#1)(1995-9#1)(1996-2#1)(1996-3#1)
ordinal scale##5##2##(1995-9#1)(1996-2#1)(2008-10#1)(2008-5#1)(2012-1#1)
ordinal##43##1##(1992-12#1)(1993-11#1)(1993-6#1)(1994-8#2)(1995-9#4)(1996-12#1)(1996-2#3)(1996-3#2)(1996-8#1)(1997-2#2)(1997-4#2)(1997-8#2)(2008-10#7)(2008-12#2)(2008-4#1)(2008-5#2)(2008-9#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-8#2)
ordinances##3##1##(1996-1#2)(2013-1#1)
ordinarily used##2##2##(2008-3#1)(2012-3#1)
ordinarily##17##1##(1990-5#1)(1991-12#1)(1992-6#1)(1993-4#1)(1994-2#1)(1996-3#1)(2005-11#1)(2006-2#1)(2007-12#3)(2008-3#2)(2008-9#1)(2009-9#1)(2010-3#1)(2012-3#1)
ordinary UV##2##2##(2008-10#2)
ordinary and extraordinary##3##3##(2008-2#2)(2008-3#1)
ordinary and the extraordinary##2##4##(2008-2#1)(2008-3#1)
ordinary and##7##2##(2008-10#1)(2008-2#4)(2008-3#2)
ordinary chondrites##2##2##(2007-9#2)
ordinary differential equation##2##3##(2007-2#1)(2009-12#1)
ordinary differential equations##8##3##(2005-10#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-6#1)(2010-10#1)(2013-8#1)
ordinary differential##11##2##(2005-10#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-9#2)(2008-10#1)(2008-6#1)(2009-12#1)(2010-10#1)(2013-8#1)
ordinary health care##2##3##(1993-3#1)(2005-8#1)
ordinary hospital wards##2##3##(1992-6#2)
ordinary kriging##2##2##(2008-8#1)(2012-2#1)
ordinary least squares regression##4##4##(1993-12#1)(2007-4#1)(2008-11#1)(2011-2#1)
ordinary least squares##7##3##(1992-6#1)(1993-12#1)(1995-2#1)(2007-4#1)(2008-10#1)(2008-11#1)(2011-2#1)
ordinary logit models##3##3##(2009-11#3)
ordinary mean estimator and##2##4##(2008-10#2)
ordinary menu##2##2##(1997-7#2)
ordinary physical##2##2##(2007-11#1)(2012-2#1)
ordinary runs##2##2##(2008-10#2)
ordinary serous and##2##3##(2008-7#2)
ordinary serous##3##2##(2008-7#3)
ordinary strain##2##2##(2008-10#2)
ordinary subjects##2##2##(1991-5#2)
ordinary wards##2##2##(1992-6#2)
ordinary##155##1##(1990-11#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-5#2)(1991-6#3)(1992-5#1)(1992-6#5)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-4#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-7#3)(1997-8#1)(2005-10#1)(2005-11#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-11#3)(2007-12#12)(2007-2#1)(2007-4#2)(2007-8#1)(2007-9#4)(2008-1#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#11)(2008-3#9)(2008-5#2)(2008-6#3)(2008-7#6)(2008-8#2)(2008-9#2)(2009-11#3)(2009-12#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#3)
ordinate and##2##2##(2008-3#1)(2010-8#1)
ordinate##4##1##(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#1)
ordination##2##1##(2007-5#1)(2008-5#1)
ore and##3##2##(2005-4#1)(2008-10#2)
ore body rock sample##2##4##(2013-8#2)
ore body rock##6##3##(2013-8#6)
ore body rock--&gt##2##3##(2013-8#2)
ore body##8##2##(2013-8#8)
ore or##2##2##(2008-10#2)
ore samples##10##2##(2007-12#1)(2008-10#9)
ore##40##1##(1990-12#1)(2005-4#2)(2007-12#2)(2007-8#1)(2008-10#22)(2013-1#2)(2013-8#10)
orebody##2##1##(1996-3#2)
ores and##5##2##(2005-4#1)(2008-10#4)
ores by##2##2##(2005-4#1)(2008-10#1)
ores##19##1##(2005-4#2)(2008-10#15)(2008-12#1)(2008-9#1)
orexigenic##7##1##(1993-7#1)(1996-12#1)(2004-12#1)(2006-1#3)(2013-8#1)
orexin neurons##6##2##(2010-10#6)
orexin##7##1##(2010-10#6)(2013-1#1)
orf##6##1##(1992-8#1)(2007-3#1)(2012-2#1)(2013-8#3)
orf17 is##2##2##(1994-12#2)
orf17 may be##2##3##(1994-12#2)
orf17##6##1##(1994-12#6)
orfA and##2##2##(1997-4#2)
orfs##6##1##(1997-1#3)(1997-7#2)(2007-12#1)
org Web-assisted tobacco intervention using smokers (N=204) recruited via Google advertisements##2##11##(2013-1#2)
org for six months and we tracked their usage and assessed their six months cessation using a rigorous follow-up##2##19##(2013-1#2)
org##29##1##(2005-7#1)(2007-10#1)(2007-2#1)(2007-6#2)(2007-8#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-11#2)(2012-2#1)(2013-1#4)
org) is a##2##3##(2008-4#1)(2008-7#1)
org) is##3##2##(2006-9#1)(2008-4#1)(2008-7#1)
org)##18##1##(2006-9#1)(2008-11#1)(2008-12#3)(2008-4#1)(2008-7#4)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-7#1)
org/##3##1##(2007-6#2)(2011-2#1)
org/)##3##1##(2008-4#1)(2008-7#1)(2011-1#1)
org/10##5##1##(2013-8#5)
org/100 m(3)##2##2##(2012-2#2)
org/catalog/pubdates##148##1##(2010-12#8)(2011-1#53)(2011-12#4)(2011-2#11)(2012-1#72)
organ allocation and##2##3##(2006-10#1)(2008-9#1)
organ allocation##5##2##(2006-10#2)(2007-2#1)(2008-9#1)(2010-6#1)
organ allograft##3##2##(1995-2#1)(2007-11#1)(2008-5#1)
organ allografts##2##2##(1991-12#1)(2007-11#1)
organ and the##3##3##(1994-11#1)(1994-5#1)(2011-2#1)
organ and tissue##4##3##(1990-12#1)(2009-4#1)(2010-9#1)(2013-1#1)
organ and to##4##3##(1990-4#1)(1995-12#1)(2005-11#1)(2008-11#1)
organ and##19##2##(1990-12#1)(1990-3#1)(1990-4#1)(1993-12#1)(1994-11#1)(1994-5#1)(1995-12#1)(1997-5#1)(2005-11#1)(2006-10#2)(2008-11#1)(2009-4#1)(2009-6#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
organ and/or##3##2##(1991-6#1)(1992-3#1)(1992-5#1)
organ at risk##2##3##(2008-2#1)(2008-6#1)
organ bath containing Tyrode solution##2##5##(2008-12#1)(2011-1#1)
organ bath containing##3##3##(2008-12#1)(2008-4#1)(2011-1#1)
organ bath experiments##2##3##(1997-4#1)(2009-5#1)
organ bath##9##2##(1991-5#1)(1993-8#1)(1997-4#1)(2008-12#1)(2008-4#2)(2009-5#1)(2011-1#1)(2011-2#1)
organ baths containing##3##3##(2009-5#1)(2010-12#1)(2010-3#1)
organ baths##5##2##(1994-5#1)(2007-10#1)(2009-5#1)(2010-12#1)(2010-3#1)
organ blood flow##2##3##(1991-2#1)(2008-10#1)
organ chamber##2##2##(1995-12#1)(2011-2#1)
organ culture##12##2##(1992-7#1)(1993-12#1)(1994-2#1)(1995-3#2)(1995-8#2)(2007-3#1)(2008-11#1)(2008-4#1)(2012-3#2)
organ cultures from##2##3##(1991-12#1)(2008-5#1)
organ cultures of##4##3##(1990-7#1)(1993-8#1)(1997-3#1)(2007-1#1)
organ cultures##10##2##(1990-7#1)(1991-12#1)(1993-8#1)(1997-3#1)(2007-1#1)(2008-11#2)(2008-4#1)(2008-5#2)
organ damage and##3##3##(2007-11#1)(2007-2#1)(2007-9#1)
organ damage in##5##3##(1992-6#1)(2006-10#1)(2007-9#1)(2008-1#1)(2009-1#1)
organ damage##24##2##(1991-9#1)(1992-3#1)(1992-6#1)(1994-6#1)(1995-12#1)(1995-8#1)(2006-10#1)(2007-11#1)(2007-2#2)(2007-8#2)(2007-9#2)(2008-1#2)(2009-1#4)(2011-2#1)(2012-12#2)(2012-2#1)
organ development##3##2##(2007-12#2)(2008-9#1)
organ disease##2##2##(2007-11#1)(2013-1#1)
organ diseases##2##2##(2007-11#1)(2012-12#1)
organ distribution of##4##3##(1992-12#2)(1992-9#1)(2006-10#1)
organ distribution##7##2##(1991-5#1)(1992-12#2)(1992-9#1)(1997-7#2)(2006-10#1)
organ donation##21##2##(1991-3#1)(1992-1#1)(1993-10#2)(1993-2#1)(1994-4#1)(1994-5#1)(1995-5#1)(1996-9#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-10#1)(2008-1#1)(2008-12#3)(2008-4#2)(2011-2#1)(2012-2#1)
organ donations##2##2##(1993-2#1)(1994-7#1)
organ donor##3##2##(2005-7#1)(2007-7#1)(2008-3#1)
organ donors and##3##3##(1991-3#1)(2008-1#1)(2012-2#1)
organ donors##17##2##(1991-3#1)(1991-4#1)(1993-10#2)(2005-7#1)(2006-10#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#2)(2010-11#2)(2010-12#1)(2012-2#1)
organ during##2##2##(1994-6#1)(2012-2#1)
organ dysfunction syndrome (MODS)##3##4##(2008-5#1)(2011-2#1)(2012-12#1)
organ dysfunction syndrome##4##3##(1997-5#1)(2008-5#1)(2011-2#1)(2012-12#1)
organ dysfunction##27##2##(1996-9#1)(1997-5#1)(2005-12#1)(2006-10#3)(2006-6#2)(2007-11#1)(2007-9#3)(2008-4#1)(2008-5#2)(2009-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#5)
organ failure and##5##3##(2007-11#1)(2009-6#1)(2013-1#3)
organ failure in##4##3##(2006-6#1)(2007-9#1)(2009-4#1)(2010-12#1)
organ failure##37##2##(1990-8#1)(1996-3#1)(1997-1#1)(1997-2#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-4#2)(2006-6#1)(2007-11#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#7)
organ failures##4##2##(2006-10#1)(2006-4#1)(2007-5#1)(2011-1#1)
organ for the##2##3##(1996-5#1)(2008-11#1)
organ for##8##2##(1992-12#1)(1994-11#1)(1996-5#1)(2007-12#2)(2008-11#1)(2011-1#1)(2012-2#1)
organ formation##2##2##(2007-8#1)(2008-7#1)
organ function in##2##3##(1993-10#1)(2008-5#1)
organ function##11##2##(1992-3#1)(1993-10#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-9#1)(2012-11#1)(2013-1#1)
organ functions##6##2##(2006-10#2)(2009-6#1)(2010-1#1)(2010-11#1)(2013-1#1)
organ growth rates##3##3##(2008-8#3)
organ growth##4##2##(2008-8#3)(2009-8#1)
organ has##2##2##(1997-1#1)(2007-12#1)
organ in the##4##3##(1997-5#1)(2006-12#1)(2007-12#1)(2008-7#1)
organ in which##2##3##(1991-5#1)(1993-10#1)
organ in##14##2##(1991-5#1)(1993-10#1)(1995-3#1)(1995-8#1)(1997-5#1)(2006-10#1)(2006-12#1)(2007-12#2)(2008-7#2)(2008-9#1)(2010-12#1)(2010-2#1)
organ injuries##4##2##(2006-11#2)(2007-8#1)(2012-12#1)
organ injury##8##2##(1997-4#1)(2006-6#1)(2007-1#1)(2008-12#2)(2012-12#1)(2012-3#1)(2013-1#1)
organ involvement and##2##3##(1997-8#1)(2005-8#1)
organ involvement##15##2##(1995-11#1)(1996-1#1)(1997-8#1)(2005-11#1)(2005-8#1)(2007-11#1)(2007-3#2)(2007-5#1)(2007-7#1)(2008-5#1)(2010-12#3)(2013-1#1)
organ is##6##2##(1992-3#1)(1997-3#1)(2007-12#1)(2008-11#1)(2008-9#1)(2010-3#1)
organ ischemia##2##2##(1996-9#1)(2006-10#1)
organ itself##2##2##(1993-12#1)(1994-5#1)
organ manifestations##2##2##(1995-1#1)(2010-10#1)
organ of Corti of the adult##2##6##(1993-9#1)(1996-1#1)
organ of Corti##8##3##(1993-9#2)(1994-6#2)(1996-1#1)(1996-3#2)(2008-1#1)
organ of the##8##3##(1994-10#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-5#1)(2011-1#1)(2012-12#2)
organ of vision##2##3##(2009-2#1)(2011-2#1)
organ of##36##2##(1990-5#1)(1991-3#1)(1991-5#1)(1992-6#2)(1992-9#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#2)(1996-1#1)(1996-3#2)(1997-8#2)(2007-12#3)(2007-8#1)(2008-1#2)(2008-11#1)(2008-5#3)(2008-6#1)(2009-2#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#2)
organ or##3##2##(1990-2#1)(2006-10#1)(2011-2#1)
organ pathologies##2##2##(1995-12#2)
organ perfusion##3##2##(2006-10#1)(2008-12#1)(2011-3#1)
organ preservation and##2##3##(2011-1#1)(2013-1#1)
organ preservation##7##2##(1997-2#1)(2006-2#1)(2007-8#1)(2011-1#2)(2011-3#1)(2013-1#1)
organ procurement##2##2##(1990-12#1)(2011-2#1)
organ prolapse##8##2##(2007-4#1)(2007-8#4)(2008-12#3)
organ protection##2##2##(2006-10#1)(2007-8#1)
organ rejection##2##2##(2008-10#1)(2011-1#1)
organ samples##3##2##(2008-10#1)(2008-5#2)
organ shortage##3##2##(1995-2#1)(2007-2#1)(2007-7#1)
organ sites##3##2##(2008-6#1)(2009-10#1)(2012-1#1)
organ specialists##2##2##(1990-10#2)
organ specific##4##2##(1990-2#1)(2008-10#1)(2008-8#1)(2009-3#1)
organ specificity##2##2##(1992-11#1)(2007-3#1)
organ system##8##2##(1990-10#1)(1990-11#1)(1996-12#1)(1996-6#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-7#1)
organ systems and##3##3##(2005-7#1)(2008-3#1)(2011-2#1)
organ systems including the##2##4##(1993-10#1)(2008-8#1)
organ systems may##2##3##(1995-8#1)(1996-12#1)
organ systems##39##2##(1990-11#1)(1990-8#1)(1991-4#1)(1992-8#1)(1993-10#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-7#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-1#1)(2005-7#1)(2006-10#4)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
organ that plays a##2##4##(2006-10#1)(2008-3#1)
organ that##9##2##(1995-8#1)(2006-10#1)(2008-3#1)(2008-7#2)(2009-6#1)(2010-5#1)(2010-7#1)(2010-9#1)
organ tissues##5##2##(1994-12#1)(2007-2#1)(2008-5#1)(2010-4#2)
organ to##6##2##(1990-11#1)(1994-11#1)(2007-4#1)(2010-5#1)(2010-9#1)(2013-1#1)
organ toxicity##3##2##(2008-6#1)(2008-8#1)(2011-2#1)
organ transplant patients##3##3##(2007-11#1)(2008-8#1)(2013-1#1)
organ transplant recipients##22##3##(1991-11#1)(1995-2#1)(1997-2#1)(2006-10#1)(2007-11#8)(2007-12#4)(2008-10#1)(2008-6#2)(2010-12#1)(2012-12#1)(2013-1#1)
organ transplant rejection##4##3##(2005-8#1)(2005-9#1)(2008-11#1)(2008-8#1)
organ transplant##31##2##(1991-11#1)(1995-2#1)(1997-2#1)(2005-8#1)(2005-9#1)(2006-10#1)(2007-11#9)(2007-12#5)(2008-10#1)(2008-11#1)(2008-6#2)(2008-8#2)(2010-12#1)(2012-12#1)(2013-1#2)(2013-8#1)
organ transplantation in##3##3##(1997-5#1)(2006-10#1)(2007-2#1)
organ transplantation or##2##3##(2005-1#1)(2007-7#1)
organ transplantation##44##2##(1994-8#1)(1995-2#2)(1996-11#1)(1996-2#1)(1997-5#2)(1997-8#1)(2005-1#1)(2005-8#1)(2006-10#5)(2007-11#16)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#2)(2008-1#2)(2008-12#1)(2008-6#1)(2009-3#1)(2009-9#1)(2011-3#1)(2012-3#1)
organ transplants##8##2##(1991-12#1)(1991-7#1)(2005-7#1)(2007-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-8#1)
organ types##2##2##(2007-12#1)(2008-8#1)
organ utilization##2##2##(2009-2#2)
organ weights and##2##3##(2008-4#1)(2008-9#1)
organ weights##15##2##(1994-3#1)(1995-2#1)(2005-10#1)(2008-10#5)(2008-4#2)(2008-5#1)(2008-9#2)(2010-7#1)(2013-8#1)
organ were##4##2##(1991-2#1)(1995-5#1)(2008-5#2)
organ with##3##2##(1990-9#1)(1996-11#1)(2008-5#1)
organ without##2##2##(2006-10#1)(2007-12#1)
organ##821##1##(1990-10#5)(1990-11#4)(1990-12#3)(1990-2#3)(1990-3#2)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-11#2)(1991-12#3)(1991-2#2)(1991-3#4)(1991-4#3)(1991-5#4)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-3#5)(1992-5#1)(1992-6#6)(1992-7#1)(1992-8#2)(1992-9#3)(1993-10#7)(1993-12#6)(1993-2#6)(1993-3#1)(1993-6#2)(1993-7#1)(1993-8#4)(1993-9#2)(1994-10#2)(1994-11#4)(1994-12#1)(1994-2#4)(1994-3#2)(1994-4#1)(1994-5#14)(1994-6#4)(1994-7#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#5)(1995-2#7)(1995-3#3)(1995-5#3)(1995-6#5)(1995-7#3)(1995-8#7)(1996-1#2)(1996-11#2)(1996-12#5)(1996-2#2)(1996-3#4)(1996-5#1)(1996-6#1)(1996-9#4)(1997-1#3)(1997-2#4)(1997-3#3)(1997-4#4)(1997-5#6)(1997-6#1)(1997-7#2)(1997-8#6)(2005-1#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-7#7)(2005-8#5)(2005-9#1)(2006-10#40)(2006-11#2)(2006-12#1)(2006-2#3)(2006-4#3)(2006-5#1)(2006-6#7)(2006-8#2)(2007-1#3)(2007-10#4)(2007-11#39)(2007-12#29)(2007-2#8)(2007-3#5)(2007-4#6)(2007-5#3)(2007-7#8)(2007-8#17)(2007-9#6)(2008-1#16)(2008-10#19)(2008-11#11)(2008-12#17)(2008-2#5)(2008-3#5)(2008-4#14)(2008-5#32)(2008-6#7)(2008-7#20)(2008-8#15)(2008-9#18)(2009-1#4)(2009-10#1)(2009-2#6)(2009-3#3)(2009-4#4)(2009-5#6)(2009-6#7)(2009-8#6)(2009-9#3)(2010-1#2)(2010-10#2)(2010-11#5)(2010-12#13)(2010-2#3)(2010-3#5)(2010-4#3)(2010-5#4)(2010-6#1)(2010-7#4)(2010-8#4)(2010-9#8)(2011-1#12)(2011-2#19)(2011-3#5)(2012-1#4)(2012-11#2)(2012-12#18)(2012-2#11)(2012-3#12)(2013-1#32)(2013-8#6)
organ)##3##1##(2008-10#1)(2008-3#1)(2008-6#1)
organ-dependent##2##1##(1997-7#1)(2010-12#1)
organ-derived##2##1##(1992-9#2)
organ-related##2##1##(1995-4#1)(2012-2#1)
organ-specific antigens##2##2##(1996-6#1)(2008-4#1)
organ-specific autoimmune diseases##4##3##(1990-5#1)(1991-12#1)(2008-10#1)(2008-4#1)
organ-specific autoimmune##6##2##(1990-5#1)(1991-12#1)(2008-10#1)(2008-4#1)(2011-1#1)(2011-2#1)
organ-specific autoimmunity##3##2##(1991-11#1)(2012-1#2)
organ-specific colonization##2##2##(1991-5#1)(1992-9#1)
organ-specific##31##1##(1990-10#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-9#3)(1993-8#1)(1994-5#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-6#2)(2006-10#1)(2006-12#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2011-1#1)(2011-2#2)(2012-1#3)(2012-12#1)
organ-tropism##2##1##(1997-4#2)
organellar##6##1##(1990-12#1)(1995-2#1)(2008-8#1)(2009-8#1)(2010-4#1)(2012-3#1)
organelle and##2##2##(1994-8#1)(2008-10#1)
organelle function##2##2##(2008-1#1)(2008-9#1)
organelle##56##1##(1990-3#1)(1990-8#1)(1991-8#1)(1992-5#1)(1994-6#1)(1994-8#1)(1996-5#1)(1996-9#2)(1997-6#3)(2005-11#2)(2007-10#2)(2007-12#3)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#5)(2008-7#4)(2008-9#2)(2009-10#2)(2009-5#2)(2010-12#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)
organelle-specific##3##1##(1994-9#1)(1996-4#1)(2008-9#1)
organelles and cytoskeletal network##2##4##(2009-8#2)
organelles and##15##2##(1990-4#1)(1991-1#1)(1991-9#1)(2006-10#1)(2007-9#1)(2008-3#1)(2008-4#2)(2008-7#2)(2009-8#2)(2010-4#1)(2011-12#1)(2012-1#1)
organelles are##3##2##(1991-5#1)(2008-2#1)(2008-5#1)
organelles by##3##2##(2007-8#1)(2008-4#1)(2008-9#1)
organelles from##4##2##(1990-12#2)(2008-4#2)
organelles in a##2##3##(1996-5#1)(1997-4#1)
organelles in the##4##3##(2007-2#1)(2008-11#1)(2008-8#1)(2009-10#1)
organelles in##10##2##(1996-5#1)(1997-4#1)(1997-6#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)(2011-1#1)
organelles is##2##2##(1992-1#1)(2011-2#1)
organelles of the##3##3##(1990-3#1)(2008-10#1)(2009-3#1)
organelles of##6##2##(1990-12#1)(1990-3#1)(1993-9#1)(2005-7#1)(2008-10#1)(2009-3#1)
organelles or##4##2##(1993-11#1)(2004-11#1)(2008-4#1)(2008-7#1)
organelles such as mitochondria##3##4##(2008-11#1)(2009-8#2)
organelles such as##4##3##(1994-11#1)(2008-11#1)(2009-8#2)
organelles that are##2##3##(1993-9#1)(2008-1#1)
organelles that##6##2##(1993-9#1)(1994-8#1)(2008-1#3)(2009-10#1)
organelles which##2##2##(2007-10#1)(2008-7#1)
organelles##146##1##(1990-11#2)(1990-12#5)(1990-3#1)(1990-4#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-9#4)(1994-11#1)(1994-5#1)(1994-6#2)(1994-8#2)(1995-11#2)(1995-6#1)(1995-9#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-6#4)(2004-11#2)(2005-7#1)(2006-10#1)(2007-10#4)(2007-12#7)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#7)(2008-10#4)(2008-11#5)(2008-2#2)(2008-3#1)(2008-4#12)(2008-5#2)(2008-7#9)(2008-8#2)(2008-9#4)(2009-10#4)(2009-3#1)(2009-5#2)(2009-8#8)(2010-12#2)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#2)(2011-12#2)(2011-2#3)(2012-1#2)(2012-2#2)(2012-3#2)
organgenesis and##2##2##(2008-8#1)(2008-9#1)
organgenesis##3##1##(2008-8#2)(2008-9#1)
organic C (TOC)##2##3##(2007-7#1)(2013-8#1)
organic C##6##2##(2007-7#2)(2013-8#4)
organic Ca2+ antagonists##2##3##(1993-4#2)
organic Ca2+ channel blockers##2##4##(1990-7#1)(1996-2#1)
organic Ca2+##4##2##(1990-7#1)(1993-4#2)(1996-2#1)
organic acid anhydrides##4##3##(1995-11#2)(1997-3#2)
organic acid production##2##3##(2008-5#2)
organic acid##16##2##(1992-1#1)(1994-9#1)(1995-11#2)(1997-3#2)(2007-8#1)(2008-10#5)(2008-5#2)(2008-7#1)(2010-4#1)
organic acids and##8##3##(2006-12#1)(2008-10#5)(2009-5#1)(2009-9#1)
organic acids from##2##3##(2004-8#1)(2013-1#1)
organic acids in##13##3##(1990-8#1)(1994-9#3)(2008-10#5)(2008-4#1)(2008-5#2)(2013-8#1)
organic acids like##3##3##(2008-10#1)(2008-7#2)
organic acids##59##2##(1990-8#1)(1992-3#2)(1993-12#1)(1993-9#1)(1994-9#5)(1995-5#1)(1996-12#1)(1996-6#1)(2004-8#2)(2005-11#2)(2006-1#1)(2006-12#2)(2008-10#21)(2008-2#1)(2008-4#3)(2008-5#3)(2008-7#4)(2009-5#1)(2009-9#1)(2010-4#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
organic additives and##2##3##(1994-9#1)(2012-12#1)
organic additives##5##2##(1994-9#2)(2008-10#2)(2012-12#1)
organic amendment##3##2##(2008-10#3)
organic amendments##6##2##(2008-10#6)
organic amine##4##2##(2008-10#4)
organic amines##3##2##(2008-10#3)
organic and aqueous##4##3##(2005-11#1)(2008-10#3)
organic and biological##3##3##(2008-10#2)(2012-2#1)
organic and elemental##2##3##(2008-10#2)
organic and inorganic anions in the##2##6##(2005-12#1)(2008-10#1)
organic and inorganic anions in##3##5##(2005-12#1)(2008-10#2)
organic and inorganic anions##5##4##(2005-12#1)(2008-10#4)
organic and inorganic nitrogen##2##4##(2008-10#1)(2008-5#1)
organic and inorganic semiconductors##2##4##(2008-7#2)
organic and inorganic species##2##4##(2007-8#1)(2008-10#1)
organic and inorganic##31##3##(1997-3#1)(2004-8#1)(2005-12#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#13)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-7#1)(2010-4#1)(2013-8#3)
organic and##51##2##(1997-3#1)(1997-4#1)(2004-8#1)(2005-11#1)(2005-12#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#3)(2008-10#23)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-7#1)(2010-2#1)(2010-4#1)(2011-12#1)(2012-2#1)(2013-7#1)(2013-8#3)
organic anions on surface charge##2##5##(2005-11#2)
organic anions##8##2##(1992-3#1)(2005-11#3)(2008-10#2)(2008-11#2)
organic arsenic##4##2##(2008-10#4)
organic azides##2##2##(2006-12#2)
organic bases##3##2##(2006-3#1)(2008-10#2)
organic brain syndrome##2##3##(1990-8#1)(2007-9#1)
organic brain##4##2##(1990-8#1)(2004-11#1)(2007-9#1)(2008-6#1)
organic by-products##2##2##(2005-11#2)
organic carbon (TOC)##4##3##(2007-8#1)(2008-10#2)(2011-1#1)
organic carbon and##9##3##(2007-10#2)(2008-10#1)(2008-12#1)(2008-5#3)(2013-8#2)
organic carbon content in##2##4##(2008-5#1)(2013-8#1)
organic carbon content##9##3##(2005-11#4)(2008-10#1)(2008-5#1)(2013-8#3)
organic carbon to##4##3##(2008-10#1)(2008-5#1)(2013-8#2)
organic carbon##53##2##(1996-3#2)(2005-11#4)(2006-3#1)(2007-10#3)(2007-8#1)(2008-1#1)(2008-10#13)(2008-12#6)(2008-5#8)(2011-1#1)(2011-12#2)(2013-8#11)
organic cations##3##2##(2005-11#2)(2008-10#1)
organic causes of sleep##2##4##(2006-10#2)
organic causes of##3##3##(2006-10#2)(2006-11#1)
organic causes##8##2##(1993-2#1)(1996-2#1)(1997-2#1)(2006-10#2)(2006-11#1)(2008-3#1)(2011-2#1)
organic chemicals##7##2##(2008-10#3)(2008-11#1)(2009-8#1)(2013-1#2)
organic chemist##2##2##(2007-7#1)(2010-6#1)
organic chemistry##9##2##(1997-4#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2010-6#2)(2012-2#1)(2013-1#1)
organic chromophore##3##2##(2008-3#1)(2008-5#2)
organic chromophores##2##2##(2007-12#1)(2010-4#1)
organic coffee farms##2##3##(2008-5#2)
organic coffee##4##2##(2008-5#2)(2008-6#2)
organic complex##2##2##(2007-8#1)(2008-10#1)
organic complexes##3##2##(2006-3#1)(2006-6#1)(2008-10#1)
organic components##4##2##(2007-3#1)(2008-10#1)(2010-12#1)(2010-7#1)
organic compound##8##2##(1992-4#1)(1993-8#1)(2004-8#1)(2008-3#1)(2010-5#1)(2011-1#1)(2012-8#1)(2013-8#1)
organic compounds (VOCs)##10##3##(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#6)(2011-1#1)
organic compounds and##4##3##(2008-10#3)(2008-7#1)
organic compounds are##3##3##(2008-10#3)
organic compounds at##2##3##(2008-10#2)
organic compounds from##5##3##(2008-10#5)
organic compounds has been##2##4##(2005-11#1)(2007-8#1)
organic compounds in##9##3##(1992-4#1)(2008-10#4)(2008-11#1)(2011-1#1)(2013-1#2)
organic compounds of##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
organic compounds were##2##3##(2008-10#2)
organic compounds with##2##3##(2006-12#1)(2008-10#1)
organic compounds##109##2##(1992-4#1)(1992-5#1)(1992-7#1)(1993-4#1)(1995-6#1)(2005-11#1)(2005-4#1)(2006-12#2)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-8#3)(2008-10#68)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#2)(2009-8#1)(2010-4#1)(2011-1#4)(2011-2#1)(2012-12#1)(2012-8#1)(2013-1#3)(2013-8#1)
organic constituents##4##2##(2008-10#3)(2008-7#1)
organic contaminants in the##2##4##(2008-10#2)
organic contaminants in##5##3##(1994-3#1)(2004-4#1)(2008-10#3)
organic contaminants##7##2##(1994-3#2)(2004-4#1)(2007-9#1)(2008-10#3)
organic content and##2##3##(1995-3#1)(2008-12#1)
organic content##5##2##(1995-3#1)(1996-3#1)(2008-10#2)(2008-12#1)
organic cosolvent##2##2##(2008-10#1)(2010-2#1)
organic crystal##7##2##(2007-12#7)
organic damage##2##2##(1995-9#1)(2007-11#1)
organic derivatives##3##2##(2008-3#3)
organic disease in##2##3##(2006-10#1)(2007-6#1)
organic disease##7##2##(1992-11#1)(1993-8#2)(2006-10#1)(2007-6#1)(2008-10#1)(2008-4#1)
organic disorders##2##2##(2007-7#1)(2007-8#1)
organic disulfides##2##2##(2008-5#2)
organic dust##5##2##(1995-11#3)(1995-8#1)(2008-10#1)
organic dusts##3##2##(2005-8#1)(2008-10#1)(2008-11#1)
organic dye##7##2##(2007-8#2)(2008-10#4)(2008-2#1)
organic dye-doped##3##2##(2007-12#3)
organic dyes have##2##3##(1990-8#1)(2008-10#1)
organic dyes in##5##3##(2007-11#1)(2008-10#2)(2008-11#1)(2010-4#1)
organic dyes##16##2##(1990-8#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-3#2)(2009-10#1)(2010-4#3)
organic electro-optic##2##2##(2007-12#2)
organic energetic materials##3##3##(2008-10#1)(2010-4#2)
organic energetic##4##2##(2008-10#1)(2010-4#2)(2013-7#1)
organic extract was##4##3##(1990-9#1)(1993-2#1)(1997-3#1)(2008-10#1)
organic extractant##2##2##(1990-9#1)(2008-10#1)
organic extracts##2##2##(2011-1#1)(2011-2#1)
organic farm##2##2##(2008-5#2)
organic ferromagnet##2##2##(1995-2#1)(2007-11#1)
organic fields##2##2##(2008-10#2)
organic film##2##2##(2008-2#2)
organic fraction of##5##3##(2008-10#4)(2008-5#1)
organic fraction##7##2##(2004-9#1)(2008-10#5)(2008-5#1)
organic fragments##2##2##(1995-1#1)(2008-3#1)
organic frameworks##2##2##(2010-12#2)
organic geochemistry##2##2##(2008-11#2)
organic group##3##2##(1996-5#1)(2008-10#2)
organic halogens##3##2##(2004-4#1)(2008-10#2)
organic heart##3##2##(1990-3#2)(2006-2#1)
organic hydroperoxide##3##2##(1990-4#2)(1991-2#1)
organic impurities##2##2##(2008-3#2)
organic ion##5##2##(1994-5#1)(1997-2#2)(2008-10#2)
organic ionic salt##3##3##(2007-12#3)
organic ions##4##2##(1990-3#1)(1997-2#2)(2008-10#1)
organic laser##3##2##(2007-9#1)(2008-3#2)
organic lesions##2##2##(1992-6#1)(2005-12#1)
organic ligand##4##2##(2007-10#1)(2008-10#3)
organic ligands in##3##3##(2007-10#1)(2008-10#1)(2010-4#1)
organic ligands##12##2##(2007-10#1)(2007-8#1)(2008-10#8)(2008-5#1)(2010-4#1)
organic light emitting##3##3##(2007-9#2)(2010-11#1)
organic light-emitting##2##2##(2008-7#1)(2010-11#1)
organic liquid##5##2##(2005-11#2)(2008-10#3)
organic loading rate (OLR)##2##4##(2006-8#1)(2013-1#1)
organic loading rate##5##3##(2006-8#1)(2007-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
organic loading rates##3##3##(2008-1#1)(2008-6#1)(2013-1#1)
organic loading##8##2##(2006-8#1)(2007-12#1)(2008-1#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#2)
organic material and##2##3##(2008-10#1)(2008-5#1)
organic material##9##2##(1991-11#1)(1997-4#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)
organic materials and##2##3##(1997-2#1)(2008-7#1)
organic materials are##2##3##(2008-3#1)(2008-7#1)
organic materials from##2##3##(1997-2#1)(2008-10#1)
organic materials##15##2##(1991-7#1)(1995-3#1)(1997-2#2)(2005-11#1)(2007-11#1)(2007-12#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#2)
organic matrices##2##2##(2008-10#2)
organic matrix in##2##3##(2011-2#1)(2013-8#1)
organic matrix of##4##3##(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)
organic matrix##10##2##(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-7#2)(2009-7#1)(2011-2#1)(2013-8#1)
organic matter (DOM)##8##3##(2005-11#1)(2005-12#1)(2007-8#1)(2008-10#4)(2008-11#1)
organic matter and##9##3##(2008-10#2)(2008-12#2)(2008-2#1)(2008-5#1)(2011-2#1)(2013-8#2)
organic matter are##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
organic matter by##2##3##(2008-11#1)(2008-3#1)
organic matter content and##2##4##(2008-10#2)
organic matter content##8##3##(2008-10#6)(2008-5#1)(2009-3#1)
organic matter contents##3##3##(2007-3#1)(2008-10#1)(2011-12#1)
organic matter decomposition##2##3##(2008-11#2)
organic matter from##3##3##(2008-10#1)(2009-8#1)(2013-8#1)
organic matter in the##3##4##(2004-4#1)(2007-7#1)(2007-8#1)
organic matter in##6##3##(2004-4#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-5#1)
organic matter on the##2##4##(2007-8#1)(2008-10#1)
organic matter on##4##3##(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)
organic matter that##2##3##(1993-9#1)(2007-8#1)
organic matter was##3##3##(2008-10#3)
organic matter were##4##3##(2008-10#2)(2008-5#1)(2008-6#1)
organic matter##118##2##(1992-5#2)(1993-9#1)(1996-3#1)(2004-4#3)(2005-11#1)(2005-12#2)(2006-10#1)(2006-12#1)(2006-3#1)(2007-12#1)(2007-3#2)(2007-5#1)(2007-7#2)(2007-8#5)(2008-10#41)(2008-11#11)(2008-12#5)(2008-2#6)(2008-3#4)(2008-5#8)(2008-6#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#2)(2010-5#2)(2011-12#2)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#6)
organic matter)##2##2##(2011-2#1)(2012-2#1)
organic matters##4##2##(2005-4#2)(2008-10#1)(2008-12#1)
organic media##9##2##(2006-12#2)(2007-8#1)(2008-7#5)(2009-7#1)
organic mercury species##2##3##(2008-10#2)
organic mercury##10##2##(1993-6#1)(2006-12#1)(2008-10#8)
organic microdrop##2##2##(2008-10#2)
organic modifier and##6##3##(1990-6#1)(2008-10#5)
organic modifier was##2##3##(1997-3#1)(2008-10#1)
organic modifier##23##2##(1990-6#4)(1990-8#1)(1991-3#1)(1994-9#1)(1996-5#1)(1996-8#1)(1997-3#1)(2007-8#1)(2008-10#12)
organic modifiers##4##2##(1990-6#1)(1991-8#1)(1994-9#1)(1997-8#1)
organic moieties##3##2##(1997-2#1)(2008-10#1)(2008-3#1)
organic molecular semiconductors##2##3##(2007-9#2)
organic molecular##5##2##(2007-9#2)(2008-3#2)(2009-11#1)
organic molecules such as##3##4##(1996-5#1)(2005-7#1)(2008-10#1)
organic molecules to##2##3##(2008-11#1)(2013-8#1)
organic molecules##33##2##(1991-9#1)(1992-2#1)(1992-8#1)(1994-2#1)(1995-7#1)(1996-5#1)(1997-6#2)(2005-11#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-11#4)(2007-12#1)(2008-10#3)(2008-11#1)(2008-9#3)(2009-11#2)(2010-11#2)(2010-2#1)(2010-7#2)(2013-8#1)
organic monolayers##4##2##(1992-8#1)(1993-3#1)(1994-9#1)(2007-9#1)
organic nanocolloids##2##2##(2011-2#2)
organic nitrates##7##2##(1991-9#3)(1992-6#2)(1994-2#1)(2005-1#1)
organic nitrogen sources##2##3##(1995-9#2)
organic nitrogen##5##2##(1995-9#2)(2008-10#1)(2008-5#1)(2011-2#1)
organic optical##2##2##(2007-12#1)(2008-3#1)
organic or##2##2##(2006-2#1)(2008-10#1)
organic osmolytes##2##2##(2008-7#1)(2013-1#1)
organic pathology##4##2##(1991-4#1)(2006-2#1)(2006-8#1)(2007-6#1)
organic peroxides##4##2##(2008-10#2)(2008-5#1)(2008-7#1)
organic phase containing##2##3##(2008-10#2)
organic phase in the##4##4##(2005-11#2)(2008-10#2)
organic phase of##2##3##(2008-10#1)(2013-1#1)
organic phase through##2##3##(2008-7#1)(2010-4#1)
organic phase was##6##3##(1992-10#1)(1993-2#1)(2005-11#1)(2008-10#3)
organic phase with 1##2##4##(2008-10#2)
organic phase with##5##3##(2008-10#5)
organic phase##69##2##(1992-10#1)(1993-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1996-8#1)(2005-11#5)(2007-6#1)(2007-8#1)(2008-10#47)(2008-5#1)(2008-7#1)(2010-4#3)(2010-5#3)(2013-1#1)
organic phases were##3##3##(1994-3#1)(2007-6#1)(2008-10#1)
organic phases##11##2##(1994-3#1)(2007-6#2)(2008-10#6)(2010-4#2)
organic phosphate##4##2##(1990-8#1)(1992-3#1)(2008-10#2)
organic phosphate-solubilizing##2##2##(2013-8#2)
organic phosphates##3##2##(1990-8#1)(1994-3#1)(2008-10#1)
organic phosphorus compounds##2##3##(1993-4#1)(2008-10#1)
organic phosphorus##16##2##(1993-4#1)(1995-11#1)(2008-10#14)
organic phthalates##2##2##(2008-11#2)
organic pollutants (POPs)##2##3##(2008-10#1)(2008-7#1)
organic pollutants and##2##3##(1997-4#1)(2008-5#1)
organic pollutants at##2##3##(2004-4#1)(2008-10#1)
organic pollutants in##3##3##(2004-4#1)(2008-10#2)
organic pollutants with##2##3##(2004-4#1)(2008-10#1)
organic pollutants##21##2##(1997-4#1)(2004-4#3)(2005-11#1)(2008-10#7)(2008-11#2)(2008-5#1)(2008-7#2)(2010-5#1)(2010-9#1)(2011-12#1)(2012-12#1)
organic pollution in##2##3##(2004-4#1)(2008-11#1)
organic pollution##3##2##(2004-4#1)(2008-11#1)(2013-8#1)
organic polyanions##2##2##(2008-10#2)
organic polymer##4##2##(2008-10#3)(2008-3#1)
organic polymers##2##2##(2008-10#1)(2008-2#1)
organic potato##2##2##(2008-10#2)
organic precursors##2##2##(2010-4#1)(2012-2#1)
organic psychosis##2##2##(1993-5#1)(2012-3#1)
organic radical##2##2##(1994-12#1)(2008-10#1)
organic radicals##2##2##(2007-11#1)(2008-3#1)
organic reactions##5##2##(2007-11#1)(2008-5#1)(2009-10#2)(2012-2#1)
organic residue##2##2##(2008-11#1)(2008-3#1)
organic residues##2##2##(2007-11#1)(2008-3#1)
organic scaffolds##3##2##(2008-9#1)(2010-12#1)(2012-3#1)
organic selenium##2##2##(1990-10#1)(2005-4#1)
organic silicon sol##4##3##(2008-10#4)
organic silicon##5##2##(2008-10#5)
organic small molecules##4##3##(2008-10#4)
organic soil##3##2##(2005-11#1)(2008-10#1)(2008-5#1)
organic solutions using##2##3##(2005-11#1)(2008-10#1)
organic solutions##4##2##(2004-12#1)(2005-11#1)(2008-10#2)
organic solvent and##9##3##(1990-12#1)(1996-5#1)(2008-10#6)(2008-8#1)
organic solvent as##2##3##(2008-10#2)
organic solvent consumption##2##3##(2008-10#2)
organic solvent extraction##3##3##(1990-1#1)(2008-10#1)(2008-9#1)
organic solvent has been##2##4##(2008-10#1)(2010-11#1)
organic solvent in##2##3##(2008-10#2)
organic solvent is##3##3##(2008-10#3)
organic solvent modifier##2##3##(2008-10#2)
organic solvent stable proteases##2##4##(2013-1#2)
organic solvent vapor##2##3##(2005-11#1)(2008-7#1)
organic solvent was##6##3##(1990-4#1)(1996-9#1)(2008-10#4)
organic solvent##91##2##(1990-1#1)(1990-12#1)(1990-4#2)(1990-5#3)(1992-3#2)(1993-9#1)(1994-12#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-8#1)(2004-12#1)(2005-11#1)(2007-8#1)(2008-10#56)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-11#1)(2012-12#1)(2013-1#4)
organic solvents and##5##3##(1992-12#1)(1997-8#1)(2007-8#1)(2008-10#1)(2010-2#1)
organic solvents as the extractants##2##5##(2008-10#2)
organic solvents as##4##3##(2008-10#4)
organic solvents for##2##3##(2008-5#1)(2013-1#1)
organic solvents in##5##3##(1996-5#1)(2008-10#2)(2012-12#2)
organic solvents is##2##3##(2005-11#1)(2008-10#1)
organic solvents may##2##3##(1990-4#1)(2013-1#1)
organic solvents on##2##3##(2008-10#1)(2011-1#1)
organic solvents or##2##3##(2008-4#1)(2012-2#1)
organic solvents to##3##3##(1995-3#1)(2008-10#2)
organic solvents were##5##3##(1996-2#1)(2007-6#1)(2007-8#1)(2008-10#2)
organic solvents with##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
organic solvents##108##2##(1990-12#1)(1990-4#2)(1990-5#1)(1990-8#2)(1991-2#1)(1992-12#1)(1994-2#1)(1994-8#4)(1994-9#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-2#1)(1996-5#2)(1997-8#3)(2005-11#2)(2005-12#1)(2005-4#1)(2006-6#1)(2007-11#1)(2007-6#3)(2007-8#2)(2008-1#1)(2008-10#42)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2010-2#1)(2010-4#1)(2010-7#2)(2011-1#2)(2011-2#1)(2012-12#5)(2012-2#1)(2013-1#5)
organic species in##2##3##(2007-8#1)(2008-10#1)
organic species##6##2##(2006-6#1)(2007-8#1)(2008-10#4)
organic substances##5##2##(1996-7#1)(2005-4#1)(2008-10#3)
organic substrate##3##2##(2008-10#3)
organic substrates and##2##3##(2008-10#1)(2009-4#1)
organic substrates in##2##3##(1990-9#1)(2008-7#1)
organic substrates##6##2##(1990-9#1)(2006-2#1)(2008-10#2)(2008-7#1)(2009-4#1)
organic sulfur compounds##3##3##(2008-10#1)(2008-3#2)
organic sulfur##5##2##(2008-10#2)(2008-3#2)(2008-6#1)
organic synthesis##14##2##(1992-11#1)(1992-5#1)(1997-4#4)(2005-8#1)(2006-12#1)(2008-10#2)(2008-4#1)(2009-12#1)(2010-12#1)(2012-2#1)
organic thin film##3##3##(2007-11#3)
organic thin films##4##3##(2008-3#4)
organic thin##7##2##(2007-11#3)(2008-3#4)
organic tin##3##2##(1993-4#1)(2005-4#1)(2008-10#1)
organic transformations##2##2##(2009-10#1)(2010-7#1)
organic vapors investigated##3##3##(2008-10#3)
organic vapors##9##2##(2005-11#4)(2008-10#5)
organic wastes##2##2##(2008-12#1)(2008-6#1)
organic xenobiotics in##2##3##(2008-11#2)
organic##1557##1##(1990-1#1)(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#4)(1990-4#7)(1990-5#4)(1990-6#5)(1990-7#2)(1990-8#8)(1990-9#4)(1991-11#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#7)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#6)(1992-4#2)(1992-5#7)(1992-6#3)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-4#5)(1993-5#1)(1993-6#1)(1993-8#3)(1993-9#5)(1994-12#3)(1994-2#3)(1994-3#7)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#7)(1994-9#13)(1995-1#3)(1995-10#1)(1995-11#6)(1995-12#1)(1995-2#2)(1995-3#6)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#1)(1995-9#3)(1996-1#1)(1996-12#3)(1996-2#3)(1996-3#4)(1996-5#8)(1996-6#3)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#9)(1997-3#5)(1997-4#9)(1997-6#2)(1997-7#2)(1997-8#5)(2004-11#1)(2004-12#3)(2004-3#2)(2004-4#10)(2004-8#4)(2004-9#1)(2005-1#1)(2005-11#41)(2005-12#6)(2005-4#10)(2005-7#1)(2005-8#4)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#15)(2006-2#5)(2006-3#7)(2006-4#2)(2006-5#2)(2006-6#6)(2006-8#6)(2007-10#10)(2007-11#25)(2007-12#33)(2007-3#3)(2007-5#2)(2007-6#9)(2007-7#8)(2007-8#30)(2007-9#11)(2008-1#3)(2008-10#589)(2008-11#40)(2008-12#17)(2008-2#15)(2008-3#44)(2008-4#9)(2008-5#53)(2008-6#11)(2008-7#45)(2008-8#3)(2008-9#8)(2009-10#6)(2009-11#4)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#3)(2009-8#5)(2009-9#2)(2010-11#6)(2010-12#8)(2010-2#4)(2010-4#30)(2010-5#10)(2010-6#4)(2010-7#8)(2010-9#1)(2011-1#9)(2011-12#7)(2011-2#18)(2012-11#3)(2012-12#11)(2012-2#10)(2012-3#3)(2012-8#3)(2013-1#21)(2013-7#4)(2013-8#36)
organic)##3##1##(2008-10#1)(2008-7#1)(2010-4#1)
organic-aqueous##3##1##(2010-4#2)(2013-1#1)
organic-inorganic hybrid multilayers##2##3##(2008-10#2)
organic-inorganic hybrid##3##2##(2008-10#2)(2010-4#1)
organic-inorganic##11##1##(2006-5#1)(2008-10#3)(2008-5#3)(2008-7#1)(2010-4#3)
organic-phase##2##1##(2008-10#1)(2008-6#1)
organic/inorganic##5##1##(2005-11#2)(2008-7#2)(2009-7#1)
organically managed##2##2##(2008-10#2)
organically modified silane##2##3##(2007-12#1)(2008-3#1)
organically modified silicate (ORMOSIL)##2##4##(2008-10#1)(2010-5#1)
organically modified silicate##4##3##(2005-11#1)(2008-10#2)(2010-5#1)
organically modified sol-gel glass##3##4##(2007-11#1)(2008-10#2)
organically modified##13##2##(2005-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-3#1)(2010-5#1)(2011-1#1)
organically##20##1##(1994-8#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-3#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-5#1)(2011-1#1)
organics in the environment##2##4##(2011-1#2)
organics in##4##2##(2005-4#1)(2008-10#1)(2011-1#2)
organics##12##1##(1992-6#1)(2005-4#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-6#1)(2010-4#1)(2011-1#3)
organisation and##14##2##(1990-6#1)(1990-7#1)(1991-6#1)(1993-7#1)(1994-12#1)(2005-11#1)(2005-5#2)(2007-12#1)(2007-6#1)(2008-1#1)(2008-7#1)(2011-1#1)(2012-3#1)
organisation for animal health)##5##4##(2005-5#5)
organisation in##7##2##(1991-7#1)(1992-2#1)(2007-8#1)(2008-7#3)(2010-10#1)
organisation is##4##2##(1995-11#1)(2008-6#1)(2009-6#1)(2010-10#1)
organisation of Veterinary Services##2##4##(2005-5#2)
organisation of the##11##3##(1990-11#1)(1994-12#1)(1995-6#1)(2005-5#3)(2005-7#1)(2007-10#1)(2008-6#1)(2008-8#1)(2009-7#1)
organisation of these##2##3##(1990-5#1)(1991-7#1)
organisation of##34##2##(1990-11#1)(1990-5#1)(1991-7#1)(1993-6#1)(1994-12#1)(1995-6#1)(1996-12#1)(1996-8#1)(2005-5#6)(2005-7#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-7#2)(2010-10#1)(2012-1#1)(2012-2#1)
organisation##102##1##(1990-11#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-6#1)(1991-7#2)(1992-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-12#3)(1994-6#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-7#1)(2005-11#1)(2005-12#1)(2005-5#16)(2005-7#1)(2006-11#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#4)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#6)(2008-2#2)(2008-6#3)(2008-7#9)(2008-8#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#2)(2010-10#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)
organisational and##6##2##(2004-7#1)(2005-11#1)(2005-5#1)(2008-11#3)
organisational problems in##2##3##(1990-12#1)(2007-7#1)
organisational publications on the processes##2##5##(2012-3#2)
organisational##34##1##(1990-12#1)(1993-1#2)(1993-3#1)(1994-3#1)(2004-7#1)(2005-11#1)(2005-5#4)(2006-10#1)(2006-2#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-11#7)(2008-12#2)(2008-2#1)(2008-7#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-3#2)
organisations (NGOs)##5##2##(2007-2#2)(2012-3#3)
organisations and the##2##3##(1997-7#1)(2010-3#1)
organisations and##7##2##(1997-7#1)(2006-2#1)(2008-11#1)(2010-3#2)(2011-2#1)(2012-12#1)
organisations are##2##2##(2008-1#1)(2013-1#1)
organisations as##2##2##(2012-2#1)(2013-1#1)
organisations can##4##2##(1996-1#1)(2006-2#1)(2008-11#1)(2008-6#1)
organisations have##2##2##(2005-7#1)(2007-9#1)
organisations in##7##2##(1990-12#1)(1997-3#1)(2007-7#2)(2008-12#1)(2013-1#2)
organisations such as the##2##4##(1994-4#1)(2008-5#1)
organisations will##2##2##(2008-7#1)(2010-8#1)
organisations##68##1##(1990-12#1)(1994-4#1)(1996-1#1)(1996-4#1)(1997-3#1)(1997-7#2)(2005-5#2)(2005-7#1)(2006-1#1)(2006-2#5)(2007-2#8)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#5)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2009-5#1)(2010-10#1)(2010-3#4)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
organise##5##1##(2008-11#1)(2008-6#1)(2012-11#2)(2012-2#1)
organised a##2##2##(1993-12#1)(2007-7#1)
organised by the European Commission and Ecoles des Mines d'Alès##2##10##(2008-10#2)
organised by the European##3##4##(2008-10#3)
organised by the##5##3##(1995-5#1)(2008-10#3)(2010-12#1)
organised by##6##2##(1995-5#1)(2008-10#3)(2008-5#1)(2010-12#1)
organised cervical##3##2##(2011-1#3)
organised in an##2##3##(1994-12#1)(2011-1#1)
organised in##4##2##(1994-12#1)(2006-11#1)(2007-11#1)(2011-1#1)
organised into##3##2##(1994-3#1)(2007-8#1)(2010-2#1)
organised programmes##2##2##(2011-1#2)
organised screening programmes##3##3##(2011-1#3)
organised##38##1##(1993-12#1)(1994-12#1)(1994-3#1)(1995-5#2)(1995-6#1)(1996-12#2)(2005-5#1)(2006-10#1)(2006-11#2)(2006-2#2)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#5)(2008-5#1)(2010-12#1)(2010-2#1)(2011-1#10)(2011-2#1)(2012-12#1)
organiser##3##1##(1996-8#1)(2012-12#2)
organising pneumonia##2##2##(2010-12#1)(2011-2#1)
organising##13##1##(1995-2#1)(2005-8#4)(2006-10#3)(2008-10#1)(2008-11#1)(2010-12#1)(2011-2#1)(2012-2#1)
organism Rhodopirellula baltica##2##3##(2011-1#2)
organism against##3##2##(1995-5#1)(2008-11#1)(2008-7#1)
organism and in##2##3##(2011-2#1)(2013-1#1)
organism and the##4##3##(1990-6#1)(1996-9#1)(2009-12#1)(2013-1#1)
organism and##28##2##(1990-2#1)(1990-6#1)(1990-8#2)(1994-3#1)(1994-5#1)(1995-2#1)(1996-9#1)(2005-1#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-12#2)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
organism are##11##2##(1991-6#1)(1997-6#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-4#1)(2011-1#1)(2012-3#1)
organism as well as##2##4##(2008-7#2)
organism as##5##2##(1992-4#1)(2007-8#1)(2008-11#1)(2008-7#2)
organism before##2##2##(1991-9#1)(2008-7#1)
organism by##4##2##(1990-2#1)(2008-5#1)(2008-7#1)(2011-2#1)
organism can##4##2##(1993-2#1)(1995-8#1)(1996-5#1)(2008-9#1)
organism could##2##2##(2006-10#1)(2008-1#1)
organism for##13##2##(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#3)(2009-12#1)(2011-2#3)(2012-2#1)
organism from the##2##3##(1994-11#1)(2008-5#1)
organism from##6##2##(1991-6#1)(1994-11#1)(2005-7#1)(2006-7#1)(2008-5#1)(2009-2#1)
organism has been##2##3##(1997-1#1)(2008-4#1)
organism has##7##2##(1997-1#1)(2004-9#1)(2006-5#1)(2007-8#1)(2008-1#1)(2008-4#1)(2012-3#1)
organism have##3##2##(2005-8#1)(2007-7#1)(2009-9#1)
organism in a##2##3##(2006-10#1)(2011-2#1)
organism in the##2##3##(1996-11#1)(1996-8#1)
organism in##17##2##(1991-11#1)(1993-9#1)(1996-11#1)(1996-8#1)(1997-1#1)(2004-4#1)(2006-10#1)(2007-12#1)(2008-12#1)(2009-5#1)(2011-2#4)(2012-2#1)(2013-1#2)
organism is##29##2##(1990-2#1)(1993-7#1)(1995-12#1)(1996-9#1)(1997-3#1)(1997-7#1)(2005-12#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-10#1)(2010-6#1)(2011-2#3)
organism isolated in##2##3##(2007-7#1)(2009-6#1)
organism isolated##3##2##(2007-7#1)(2009-6#1)(2010-6#1)
organism may##2##2##(2007-12#1)(2008-10#1)
organism of interest##2##3##(2008-10#1)(2008-9#1)
organism of##9##2##(2006-10#1)(2006-7#1)(2007-12#1)(2008-10#4)(2008-5#1)(2008-9#1)
organism that causes##2##3##(2005-8#1)(2010-12#1)
organism that##10##2##(1995-8#1)(1996-6#1)(1996-8#1)(2005-8#2)(2006-8#1)(2008-5#1)(2010-12#1)(2011-2#2)
organism to study##3##3##(2008-11#2)(2013-8#1)
organism to##23##2##(1990-8#1)(1995-12#1)(1996-11#2)(1996-2#1)(1997-6#1)(2006-5#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-2#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
organism under##2##2##(2009-2#1)(2011-1#1)
organism was identified##2##3##(2006-8#1)(2008-5#1)
organism was isolated##2##3##(2007-8#1)(2012-12#1)
organism was##19##2##(1990-2#1)(1992-5#1)(1996-8#1)(2006-10#1)(2006-5#1)(2006-8#2)(2007-12#1)(2007-7#4)(2007-8#1)(2008-5#3)(2011-2#2)(2012-12#1)
organism with a##3##3##(1995-12#1)(2009-4#1)(2011-2#1)
organism with##7##2##(1995-12#1)(2008-10#3)(2009-4#1)(2011-2#1)(2012-1#1)
organism##480##1##(1990-12#1)(1990-2#4)(1990-3#1)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#2)(1991-11#3)(1991-5#1)(1991-6#3)(1991-8#1)(1991-9#4)(1992-10#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1993-11#1)(1993-2#3)(1993-6#1)(1993-7#2)(1993-9#2)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-12#4)(1995-2#2)(1995-5#3)(1995-8#5)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#4)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#3)(1996-9#4)(1997-1#3)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#2)(2004-4#1)(2004-9#1)(2005-1#3)(2005-12#4)(2005-7#3)(2005-8#6)(2006-10#20)(2006-11#1)(2006-12#4)(2006-2#2)(2006-5#4)(2006-7#4)(2006-8#5)(2007-11#2)(2007-12#18)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#12)(2007-8#6)(2007-9#2)(2008-1#9)(2008-10#28)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#11)(2008-5#16)(2008-7#27)(2008-8#17)(2008-9#17)(2009-10#2)(2009-12#3)(2009-2#3)(2009-3#4)(2009-4#1)(2009-5#4)(2009-6#3)(2009-8#4)(2009-9#3)(2010-1#1)(2010-11#4)(2010-12#3)(2010-2#2)(2010-3#3)(2010-4#5)(2010-6#2)(2010-8#1)(2010-9#2)(2011-1#7)(2011-2#52)(2012-1#2)(2012-12#9)(2012-2#7)(2012-3#8)(2013-1#8)(2013-7#2)(2013-8#4)
organism's ability to##5##3##(2008-4#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-1#1)
organism's genetic##2##2##(1994-11#1)(2012-2#1)
organism's##22##1##(1994-11#1)(1994-8#1)(1995-12#1)(2004-4#1)(2006-11#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#2)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-8#1)
organism-level##2##1##(2008-9#1)(2009-12#1)
organismal level##2##2##(2006-11#1)(2009-5#1)
organismal##11##1##(1995-11#1)(2006-11#1)(2007-12#2)(2008-8#2)(2009-5#1)(2010-5#1)(2012-12#2)(2012-3#1)
organismic##2##1##(1997-2#1)(2008-11#1)
organisms against##2##2##(2008-10#1)(2013-8#1)
organisms and cell##2##3##(2008-11#1)(2008-6#1)
organisms and other##2##3##(2008-8#1)(2012-2#1)
organisms and the##2##3##(1994-3#1)(1995-12#1)
organisms and their##2##3##(2008-7#1)(2011-1#1)
organisms and to##2##3##(2007-7#1)(2013-7#1)
organisms and##46##2##(1990-11#1)(1990-7#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-9#1)(1996-7#1)(2004-1#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-5#2)(2007-7#3)(2007-8#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2009-4#1)(2009-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#2)
organisms are more##2##3##(1993-6#1)(2012-2#1)
organisms are resistant##2##3##(1991-12#1)(2008-11#1)
organisms are##19##2##(1991-12#1)(1991-9#1)(1993-6#1)(1994-6#1)(2006-10#1)(2006-12#1)(2007-5#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#2)
organisms as##5##2##(2006-10#1)(2008-10#1)(2009-5#1)(2012-2#1)(2013-8#1)
organisms at##2##2##(2008-9#1)(2012-12#1)
organisms by##6##2##(1992-2#1)(2006-12#1)(2007-7#1)(2008-5#1)(2008-7#1)(2012-2#1)
organisms can be used##2##4##(2008-10#1)(2008-2#1)
organisms can be##5##3##(2008-10#1)(2008-2#1)(2008-9#2)(2012-3#1)
organisms can##9##2##(1990-2#1)(1991-7#1)(1994-6#1)(2008-10#1)(2008-2#1)(2008-9#3)(2012-3#1)
organisms causing serious infections in the hospital##2##7##(2008-7#2)
organisms causing serious infections in##3##5##(2008-7#3)
organisms causing##7##2##(1997-7#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-7#3)
organisms contain##2##2##(1991-9#1)(2008-5#1)
organisms could##2##2##(2008-8#1)(2009-6#1)
organisms exhibit##2##2##(1990-8#1)(2007-7#1)
organisms exposed##2##2##(2008-11#2)
organisms fed##2##2##(2012-2#2)
organisms for##14##2##(1995-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-5#2)(2008-8#1)(2011-1#1)(2011-2#1)
organisms from middle ear in children with##2##7##(2007-9#2)
organisms from the##3##3##(1992-4#1)(2008-10#1)(2008-7#1)
organisms from##13##2##(1992-4#1)(2006-8#2)(2007-9#2)(2008-10#2)(2008-4#1)(2008-7#1)(2009-10#2)(2010-11#1)(2012-2#1)
organisms has been##2##3##(2008-11#1)(2008-4#1)
organisms has##6##2##(2006-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#2)
organisms have been##4##3##(2006-10#1)(2008-4#1)(2008-7#1)(2008-8#1)
organisms have##12##2##(1995-2#1)(2006-10#2)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-5#1)
organisms in a##7##3##(1994-11#1)(1997-3#1)(1997-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)
organisms in the oceans##2##4##(2007-5#1)(2011-1#1)
organisms in the##13##3##(1992-5#1)(1997-7#1)(2007-12#1)(2007-5#1)(2008-10#3)(2010-9#1)(2011-1#2)(2011-2#2)(2013-8#1)
organisms in##39##2##(1990-6#1)(1992-5#1)(1994-11#1)(1995-9#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-4#1)(2005-8#1)(2006-11#2)(2006-8#1)(2007-12#2)(2007-3#2)(2007-5#1)(2008-10#3)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#2)(2011-2#3)(2013-8#1)
organisms including##4##2##(1994-2#1)(2008-11#1)(2008-9#1)(2012-2#1)
organisms into##2##2##(2008-11#1)(2008-8#1)
organisms involved in##2##3##(2007-12#1)(2008-7#1)
organisms involved##3##2##(2007-12#1)(2008-5#1)(2008-7#1)
organisms is provided##2##3##(2008-5#1)(2009-10#1)
organisms is##14##2##(1991-10#1)(1992-5#1)(2006-8#1)(2007-12#2)(2007-7#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-9#1)(2013-7#1)
organisms isolated from##2##3##(2007-7#1)(2008-7#1)
organisms isolated were##2##3##(2007-2#1)(2007-8#1)
organisms isolated##4##2##(2007-2#1)(2007-7#1)(2007-8#1)(2008-7#1)
organisms like bacteria##2##3##(1990-10#1)(2009-2#1)
organisms like##5##2##(1990-10#1)(2006-8#1)(2009-2#2)(2010-12#1)
organisms may##6##2##(1997-5#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)
organisms obtained##2##2##(2007-2#1)(2008-5#1)
organisms of the##2##3##(2007-3#1)(2007-7#1)
organisms of##9##2##(2006-12#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-7#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-2#1)
organisms on##5##2##(2006-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-4#1)
organisms or##3##2##(2008-5#1)(2012-12#1)(2013-1#1)
organisms produce##3##2##(2006-10#1)(2008-10#1)(2008-8#1)
organisms ranging from insects to humans##2##6##(1992-5#1)(2009-8#1)
organisms ranging from##4##3##(1992-5#1)(1994-12#1)(2008-8#1)(2009-8#1)
organisms ranging##5##2##(1992-5#1)(1994-12#1)(2008-8#1)(2009-8#1)(2010-10#1)
organisms recovered from##2##3##(2008-4#1)(2008-7#1)
organisms respond to##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
organisms responsible for##2##3##(2004-4#1)(2011-2#1)
organisms should be##2##3##(2008-5#1)(2009-2#1)
organisms should##3##2##(2008-5#1)(2008-8#1)(2009-2#1)
organisms show##2##2##(1994-11#1)(1997-7#1)
organisms such as diatoms##2##4##(2008-7#1)(2012-2#1)
organisms such as##12##3##(1991-8#1)(2006-10#1)(2007-7#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2012-12#2)(2012-2#1)(2013-8#1)
organisms tested##4##2##(1996-12#1)(2006-5#1)(2008-5#1)(2013-1#1)
organisms that are##3##3##(2008-10#1)(2008-8#2)
organisms that can##3##3##(2006-5#1)(2009-2#1)(2011-2#1)
organisms that lack the conventional CysRS##2##6##(2006-12#2)
organisms that lack##3##3##(2006-12#3)
organisms that##25##2##(1992-5#1)(2006-10#1)(2006-12#3)(2006-5#2)(2006-7#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-2#1)(2009-4#1)(2011-2#2)(2012-12#1)(2013-7#1)
organisms the##3##2##(2008-7#1)(2012-12#2)
organisms to be##2##3##(2008-10#1)(2008-11#1)
organisms to detect##2##3##(1991-6#1)(2009-3#1)
organisms to survive##2##3##(2008-7#2)
organisms to##25##2##(1991-6#1)(1995-12#1)(1995-8#1)(2004-4#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-3#2)(2011-1#2)(2011-12#2)(2012-2#2)
organisms under##3##2##(2008-11#3)
organisms was##5##2##(1996-11#1)(2007-6#1)(2008-5#1)(2010-1#1)(2011-1#1)
organisms were Escherichia coli##2##4##(2007-7#1)(2008-7#1)
organisms were collected from##2##4##(2008-5#2)
organisms were found in##2##4##(1993-2#1)(2006-10#1)
organisms were isolated##3##3##(1994-12#1)(1997-3#1)(2006-8#1)
organisms were##28##2##(1990-6#1)(1990-9#1)(1993-2#1)(1994-12#1)(1996-12#1)(1997-3#1)(1997-4#1)(2005-7#1)(2006-10#2)(2006-8#1)(2007-7#3)(2008-10#2)(2008-11#1)(2008-5#4)(2008-7#2)(2008-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)
organisms when##3##2##(1992-6#1)(1994-11#1)(2011-2#1)
organisms which##3##2##(2005-9#1)(2006-8#1)(2010-4#1)
organisms will##4##2##(1991-8#1)(1997-7#1)(2006-10#1)(2008-2#1)
organisms with a##3##3##(2006-10#1)(2008-8#2)
organisms with high##2##3##(1995-11#1)(2011-2#1)
organisms with##14##2##(1990-7#1)(1995-11#1)(1997-7#1)(2005-12#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-12#1)(2011-2#1)(2012-3#1)
organisms##824##1##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#1)(1990-6#3)(1990-7#2)(1990-8#2)(1990-9#2)(1991-10#3)(1991-11#1)(1991-12#2)(1991-3#1)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#3)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#4)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-2#4)(1993-6#3)(1993-9#3)(1994-11#4)(1994-12#6)(1994-2#4)(1994-3#1)(1994-6#3)(1994-9#1)(1995-1#3)(1995-11#2)(1995-12#3)(1995-2#5)(1995-4#1)(1995-6#1)(1995-8#5)(1995-9#2)(1996-11#3)(1996-12#3)(1996-3#2)(1996-4#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#4)(1997-3#4)(1997-4#5)(1997-5#2)(1997-6#1)(1997-7#7)(2004-1#1)(2004-12#2)(2004-4#4)(2005-1#1)(2005-11#2)(2005-12#1)(2005-7#3)(2005-8#3)(2005-9#1)(2006-10#24)(2006-11#2)(2006-12#13)(2006-2#1)(2006-5#11)(2006-7#2)(2006-8#15)(2006-9#1)(2007-10#1)(2007-11#7)(2007-12#18)(2007-2#3)(2007-3#8)(2007-5#6)(2007-6#3)(2007-7#17)(2007-8#6)(2007-9#4)(2008-1#4)(2008-10#51)(2008-11#21)(2008-12#3)(2008-2#8)(2008-3#9)(2008-4#27)(2008-5#42)(2008-6#6)(2008-7#53)(2008-8#46)(2008-9#38)(2009-10#10)(2009-12#2)(2009-2#7)(2009-3#6)(2009-4#3)(2009-5#9)(2009-6#4)(2009-8#7)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#5)(2010-2#6)(2010-3#3)(2010-4#4)(2010-5#1)(2010-6#5)(2010-7#2)(2010-9#5)(2011-1#18)(2011-12#4)(2011-2#30)(2012-1#1)(2012-11#1)(2012-12#15)(2012-2#23)(2012-3#10)(2013-1#11)(2013-7#8)(2013-8#10)
organisms'##2##1##(2004-4#1)(2012-2#1)
organisms)##3##1##(2006-10#2)(2008-10#1)
organisms?##3##1##(2006-5#1)(2009-12#1)(2010-9#1)
organization &quot##2##2##(1994-1#1)(1996-2#1)
organization and a##2##3##(1992-2#1)(2008-10#1)
organization and cell##3##3##(1994-8#1)(2009-5#1)(2013-1#1)
organization and chromatin structure##2##4##(1992-5#1)(2007-12#1)
organization and distribution##2##3##(1996-12#1)(2009-8#1)
organization and evolution of the##2##5##(1994-11#1)(2010-2#1)
organization and evolution of##3##4##(1994-11#1)(2010-2#1)(2012-1#1)
organization and evolution##4##3##(1994-11#1)(2008-8#1)(2010-2#1)(2012-1#1)
organization and fee-for-service##2##3##(1991-3#1)(1993-12#1)
organization and implementation of##2##4##(1996-2#1)(2008-12#1)
organization and its##2##3##(2007-4#1)(2012-2#1)
organization and nucleotide##2##3##(1993-6#1)(1994-12#1)
organization and the##10##3##(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#1)(1992-7#1)(1994-1#1)(2007-2#1)(2012-2#1)(2013-1#2)
organization and##110##2##(1990-2#2)(1990-3#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-7#2)(1992-9#1)(1993-12#3)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-7#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#3)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1997-1#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-12#7)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#5)(2009-3#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#4)(2013-1#3)(2013-8#1)
organization are##10##2##(1990-5#1)(1991-6#1)(1992-2#1)(1994-5#1)(1995-1#1)(1995-3#2)(1997-2#1)(2007-12#1)(2012-3#1)
organization as well as the##3##5##(1993-12#1)(1993-3#1)(2009-8#1)
organization as well as##4##4##(1993-12#1)(1993-3#1)(1995-2#1)(2009-8#1)
organization as##8##2##(1993-12#1)(1993-3#1)(1994-11#1)(1995-2#1)(1996-2#1)(2005-11#1)(2008-1#1)(2009-8#1)
organization at the##2##3##(2008-12#1)(2011-1#1)
organization at##3##2##(2008-12#1)(2008-9#1)(2011-1#1)
organization between##2##2##(1995-11#1)(2008-8#1)
organization by##5##2##(1992-2#1)(1994-10#1)(2008-7#1)(2009-10#1)(2012-2#1)
organization can##4##2##(1995-3#1)(2008-1#1)(2009-6#1)(2013-8#1)
organization developed##2##2##(1996-3#1)(2008-7#1)
organization during the##3##3##(2008-11#1)(2010-4#1)(2011-2#1)
organization during##6##2##(1992-1#1)(1995-12#1)(2008-11#2)(2010-4#1)(2011-2#1)
organization factors##2##2##(2007-10#2)
organization for the##3##3##(1990-4#1)(1994-12#1)(2010-12#1)
organization for##8##2##(1990-12#1)(1990-4#1)(1990-6#1)(1993-12#1)(1994-12#1)(2007-4#1)(2007-9#1)(2010-12#1)
organization has been##2##3##(1994-12#1)(1997-2#1)
organization has##3##2##(1994-12#1)(1997-2#1)(2008-8#1)
organization have##2##2##(1991-9#1)(2007-7#1)
organization in a##2##3##(2006-4#1)(2008-9#1)
organization in the##17##3##(1991-11#1)(1991-8#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-2#1)(1997-4#1)(2007-5#1)(2007-8#1)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#1)(2012-2#1)
organization in##43##2##(1990-5#1)(1990-9#1)(1991-11#2)(1991-5#2)(1991-8#1)(1993-12#1)(1994-12#1)(1994-2#2)(1995-12#1)(1995-2#1)(1996-2#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-4#1)(2006-5#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-3#1)(2011-2#2)(2012-2#2)
organization into the##2##3##(1997-1#1)(2010-9#1)
organization into##3##2##(1997-1#1)(2008-3#1)(2010-9#1)
organization is a##3##3##(1994-12#1)(1996-7#1)(2008-12#1)
organization is important##2##3##(1991-12#1)(2011-2#1)
organization is not##2##3##(1992-9#1)(2009-9#1)
organization is to##2##3##(1994-2#1)(2008-7#1)
organization is##28##2##(1991-12#1)(1991-2#1)(1992-2#1)(1992-9#1)(1993-1#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-7#1)(1994-9#1)(1995-8#1)(1996-1#2)(1996-7#1)(1997-4#1)(2006-5#1)(2007-10#1)(2007-4#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#2)
organization may##5##2##(1991-2#1)(1994-1#1)(1996-2#1)(2007-1#1)(2008-5#1)
organization members##2##2##(1993-12#1)(1996-2#1)
organization might be##2##3##(1992-11#1)(2008-11#1)
organization might##3##2##(1992-11#1)(2008-11#1)(2008-7#1)
organization model##2##2##(1992-12#1)(2013-7#1)
organization must be##2##3##(1994-2#1)(1994-3#1)
organization must##5##2##(1992-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)
organization needs to##2##3##(1995-1#1)(1995-12#1)
organization of a##5##3##(1993-3#1)(1995-11#1)(1996-10#1)(1997-6#1)(2006-10#1)
organization of actin filaments##3##4##(1990-9#1)(2008-1#1)(2009-9#1)
organization of actin##4##3##(1990-9#1)(1994-8#1)(2008-1#1)(2009-9#1)
organization of an##3##3##(2007-12#2)(2008-5#1)
organization of bacterial##2##3##(2011-11#1)(2013-1#1)
organization of behavior##2##3##(1992-11#1)(2008-11#1)
organization of care of diabetics##2##5##(1990-11#2)
organization of care##3##3##(1990-11#2)(2008-2#1)
organization of functional##2##3##(1994-8#1)(2013-7#1)
organization of health services##2##4##(1991-9#1)(1993-3#1)
organization of health##3##3##(1991-9#1)(1993-3#1)(1997-8#1)
organization of mental health services##3##5##(2008-2#1)(2013-1#2)
organization of normal and##2##4##(1994-8#1)(2010-8#1)
organization of rDNA##2##3##(2008-5#2)
organization of services##8##3##(2008-2#7)(2012-12#1)
organization of stroke services##2##4##(2008-8#2)
organization of the actin##2##4##(1997-4#1)(2008-11#1)
organization of the brain##2##4##(2007-12#1)(2007-9#1)
organization of the future##2##4##(1994-12#1)(2011-2#1)
organization of the gene##5##4##(1992-11#1)(1994-11#1)(1996-4#1)(1997-2#1)(2010-4#1)
organization of the genes##2##4##(1992-3#1)(1993-3#1)
organization of the human##12##4##(1990-5#1)(1991-6#1)(1993-4#2)(1996-12#1)(1996-2#3)(1996-4#1)(1997-2#1)(1997-6#1)(2010-12#1)
organization of the medical##2##4##(1996-2#1)(2006-10#1)
organization of the olfactory##2##4##(2007-12#2)
organization of the primate##2##4##(1995-5#2)
organization of the rat##2##4##(1990-8#1)(1992-3#1)
organization of the stratum corneum##2##5##(2008-10#1)(2008-5#1)
organization of the##141##3##(1990-1#1)(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#4)(1991-9#1)(1992-10#2)(1992-11#2)(1992-12#1)(1992-3#3)(1992-9#2)(1993-12#1)(1993-3#1)(1993-4#2)(1993-6#3)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#5)(1995-6#2)(1995-7#1)(1996-10#1)(1996-12#1)(1996-2#5)(1996-4#3)(1996-6#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-7#1)(2007-12#13)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#4)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-4#1)(2011-2#2)(2012-1#2)(2013-1#1)(2013-8#3)
organization of their##4##3##(1995-2#1)(2007-12#1)(2008-12#1)(2012-2#1)
organization of these##5##3##(2006-12#1)(2008-2#1)(2008-7#1)(2009-8#1)(2012-2#1)
organization of this##4##3##(1992-3#1)(1993-6#1)(2006-8#1)(2009-8#1)
organization of##337##2##(1990-1#1)(1990-10#1)(1990-11#4)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#3)(1991-12#1)(1991-2#4)(1991-3#2)(1991-5#2)(1991-6#4)(1991-9#3)(1992-1#2)(1992-10#2)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#4)(1992-5#1)(1992-7#1)(1992-9#2)(1993-12#1)(1993-2#3)(1993-3#5)(1993-4#2)(1993-6#5)(1993-7#2)(1993-8#1)(1993-9#6)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#6)(1995-1#2)(1995-11#3)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#8)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#2)(1996-10#2)(1996-12#2)(1996-2#5)(1996-3#2)(1996-4#4)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#2)(2005-10#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#19)(2007-7#1)(2007-8#5)(2007-9#3)(2008-1#3)(2008-10#10)(2008-11#10)(2008-12#2)(2008-2#12)(2008-3#1)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#11)(2008-8#12)(2008-9#4)(2009-10#5)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#4)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-11#2)(2011-12#1)(2011-2#3)(2012-1#3)(2012-12#2)(2012-2#5)(2013-1#5)(2013-7#2)(2013-8#5)
organization on##6##2##(1994-1#1)(1995-12#1)(2007-4#1)(2008-12#1)(2010-9#1)(2011-1#1)
organization or##2##2##(1990-4#1)(1992-2#1)
organization patterns##2##2##(1991-11#1)(2008-9#1)
organization represents##2##2##(1995-3#1)(1997-1#1)
organization structure##3##2##(1994-12#1)(1996-1#1)(1996-2#1)
organization structures##3##2##(1996-2#1)(1996-3#1)(2010-10#1)
organization that does not##2##4##(1993-1#1)(1996-3#1)
organization that is##2##3##(2008-4#1)(2008-7#1)
organization that##15##2##(1992-12#1)(1992-8#1)(1993-1#1)(1995-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2006-3#1)(2006-5#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-3#1)(2013-1#1)
organization through##5##2##(1993-12#1)(1995-12#2)(1997-3#1)(2007-4#1)
organization to a##2##3##(1997-2#2)
organization to##14##2##(1992-3#1)(1992-6#1)(1995-3#3)(1996-10#1)(1996-3#1)(1997-2#2)(2008-10#1)(2008-2#1)(2008-8#2)(2009-8#1)
organization was observed##2##3##(1997-3#1)(2008-11#1)
organization was typical of##2##4##(2008-10#2)
organization was typical##3##3##(2005-11#1)(2008-10#2)
organization was##12##2##(1991-12#1)(1991-2#1)(1991-6#1)(1997-3#1)(2005-11#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2011-12#1)
organization were##4##2##(2007-5#1)(2008-12#1)(2009-4#1)(2013-1#1)
organization which##2##2##(2007-12#2)
organization will##2##2##(1996-3#1)(1997-1#1)
organization with a##2##3##(1996-1#1)(2012-3#1)
organization with the##2##3##(1993-12#1)(1994-3#1)
organization with##11##2##(1993-12#1)(1994-1#1)(1994-3#1)(1996-1#1)(1997-7#1)(2007-9#1)(2009-10#1)(2012-3#1)(2013-1#2)(2013-7#1)
organization within the##2##3##(1991-2#1)(1991-6#1)
organization within##3##2##(1991-2#1)(1991-6#1)(2008-11#1)
organization would##2##2##(1995-11#1)(2008-10#1)
organization##1041##1##(1990-1#1)(1990-10#1)(1990-11#4)(1990-12#5)(1990-2#5)(1990-3#2)(1990-4#3)(1990-5#6)(1990-6#3)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#9)(1991-12#4)(1991-2#12)(1991-3#6)(1991-5#7)(1991-6#11)(1991-8#1)(1991-9#8)(1992-1#6)(1992-10#3)(1992-11#4)(1992-12#7)(1992-2#8)(1992-3#8)(1992-5#4)(1992-6#1)(1992-7#3)(1992-8#2)(1992-9#6)(1993-1#6)(1993-12#14)(1993-2#7)(1993-3#8)(1993-4#2)(1993-6#9)(1993-7#3)(1993-8#3)(1993-9#8)(1994-1#17)(1994-10#1)(1994-11#5)(1994-12#20)(1994-2#12)(1994-3#14)(1994-5#2)(1994-6#1)(1994-7#2)(1994-8#8)(1994-9#2)(1995-1#11)(1995-11#5)(1995-12#18)(1995-2#14)(1995-3#21)(1995-5#8)(1995-6#4)(1995-7#1)(1995-8#3)(1996-1#16)(1996-10#3)(1996-12#8)(1996-2#20)(1996-3#14)(1996-4#5)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#11)(1997-2#13)(1997-3#14)(1997-4#9)(1997-5#3)(1997-6#4)(1997-7#4)(1997-8#3)(2004-12#1)(2005-10#2)(2005-11#2)(2006-1#1)(2006-10#7)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#9)(2006-6#1)(2006-7#3)(2006-8#4)(2007-1#4)(2007-10#10)(2007-12#31)(2007-2#5)(2007-3#1)(2007-4#10)(2007-5#3)(2007-7#6)(2007-8#9)(2007-9#9)(2008-1#14)(2008-10#32)(2008-11#25)(2008-12#15)(2008-2#19)(2008-3#3)(2008-4#9)(2008-5#15)(2008-6#3)(2008-7#26)(2008-8#27)(2008-9#17)(2009-10#13)(2009-11#2)(2009-12#2)(2009-2#4)(2009-3#4)(2009-4#5)(2009-5#6)(2009-6#1)(2009-7#1)(2009-8#13)(2009-9#2)(2010-1#2)(2010-10#5)(2010-11#2)(2010-12#6)(2010-2#4)(2010-3#4)(2010-4#5)(2010-5#5)(2010-6#2)(2010-7#2)(2010-8#5)(2010-9#4)(2011-1#11)(2011-11#2)(2011-12#2)(2011-2#13)(2011-3#1)(2011-7#1)(2012-1#9)(2012-12#6)(2012-2#19)(2012-3#4)(2012-7#1)(2013-1#18)(2013-7#4)(2013-8#12)
organization'##2##1##(1993-2#1)(2007-4#1)
organization's ability to##2##3##(1995-1#1)(1995-3#1)
organization's professional liability##2##3##(1993-1#2)
organization's##34##1##(1990-12#3)(1991-1#1)(1992-12#1)(1993-1#4)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-1#1)(2006-5#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#3)(2009-10#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-7#1)
organization)##3##1##(2008-11#2)(2012-3#1)
organization-wide##7##1##(1993-3#1)(1994-1#1)(1995-3#1)(1996-2#3)(2010-8#1)
organization?##3##1##(1995-12#1)(1996-2#1)(2005-8#1)
organizational and clinical##2##3##(1995-12#1)(2006-10#1)
organizational and economic##2##3##(2011-2#1)(2012-12#1)
organizational and environmental##2##3##(1992-12#2)
organizational and management##4##3##(1991-4#1)(1992-1#1)(1992-2#1)(2005-9#1)
organizational and market characteristics##2##4##(2008-11#2)
organizational and staffing##2##3##(1996-3#1)(2007-10#1)
organizational and##26##2##(1990-12#1)(1991-1#1)(1991-4#1)(1992-1#1)(1992-12#2)(1992-2#2)(1993-2#1)(1994-12#1)(1995-1#1)(1995-12#1)(1996-3#1)(1996-6#1)(2004-10#1)(2005-9#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#3)(2009-5#1)(2011-2#1)(2012-12#1)
organizational aspects are##2##3##(1990-11#1)(2008-2#1)
organizational aspects of##2##3##(1996-9#1)(2007-12#1)
organizational aspects##7##2##(1990-11#1)(1992-12#1)(1996-9#1)(2007-12#1)(2008-2#1)(2010-9#1)(2012-12#1)
organizational behavior##6##2##(1996-3#1)(2007-4#1)(2008-1#1)(2009-4#1)(2013-1#2)
organizational behaviour##3##2##(1994-2#1)(1994-3#2)
organizational boundaries##2##2##(1990-12#1)(1997-3#1)
organizational categories##3##2##(2006-3#3)
organizational change and##2##3##(1996-1#1)(2008-12#1)
organizational change in##2##3##(1993-2#1)(2007-5#1)
organizational change##10##2##(1992-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1996-1#1)(1997-2#1)(2007-5#1)(2008-12#1)(2008-6#1)(2009-11#1)
organizational changes to##2##3##(2006-10#1)(2012-3#1)
organizational changes##10##2##(1991-12#1)(1996-1#1)(2006-10#1)(2007-6#1)(2007-9#2)(2009-10#3)(2012-3#1)
organizational characteristics##8##2##(1992-12#1)(2004-12#1)(2006-10#2)(2007-10#1)(2008-11#1)(2010-8#2)
organizational climate##3##2##(1993-2#1)(2008-11#1)(2012-11#1)
organizational commitment##10##2##(1993-2#2)(1995-12#1)(1996-1#6)(2007-5#1)
organizational concern##2##2##(2008-12#2)
organizational conditions##3##2##(2008-10#1)(2013-1#2)
organizational context##3##2##(2010-7#1)(2010-8#1)(2012-3#1)
organizational contexts##2##2##(1993-2#1)(2008-7#1)
organizational culture and performance indexes in teaching hospitals##2##8##(2011-2#2)
organizational culture and performance indexes in##3##6##(2011-2#3)
organizational culture gap analysis in 6 New Zealand community pharmacies##2##10##(2011-1#2)
organizational culture##15##2##(1993-1#1)(1993-2#1)(1994-2#1)(2009-8#1)(2011-1#5)(2011-2#6)
organizational design##2##2##(1994-3#1)(1996-2#1)
organizational development##5##2##(1990-10#1)(1992-12#1)(1993-12#1)(1994-12#1)(2007-5#1)
organizational dynamics##2##2##(1996-2#2)
organizational effectiveness##3##2##(1992-12#1)(1994-12#1)(1995-1#1)
organizational environment##4##2##(1992-12#3)(2008-11#1)
organizational factors##5##2##(1996-12#1)(2007-10#1)(2010-8#1)(2013-1#2)
organizational feature##2##2##(1991-11#1)(2008-11#1)
organizational forms##2##2##(1992-1#1)(2008-7#1)
organizational framework##3##2##(1994-3#1)(2013-1#2)
organizational goals and##2##3##(1993-1#1)(1996-1#1)
organizational goals##3##2##(1993-1#1)(1996-1#1)(1996-3#1)
organizational growth##3##2##(1993-12#1)(1995-12#1)(1997-1#1)
organizational implications of##3##3##(1990-12#1)(1996-2#1)(2008-12#1)
organizational integration##3##2##(2008-2#3)
organizational intelligence##2##2##(2008-1#2)
organizational issues##3##2##(1996-2#1)(2005-9#1)(2007-12#1)
organizational leadership##2##2##(1994-12#1)(2013-1#1)
organizational level##4##2##(1994-12#1)(1996-3#1)(2007-10#1)(2008-2#1)
organizational model for##2##3##(1994-12#1)(1996-1#1)
organizational model##3##2##(1994-12#1)(1995-1#1)(1996-1#1)
organizational models to##3##3##(2005-8#1)(2006-10#1)(2009-4#1)
organizational models##5##2##(2005-8#1)(2006-10#1)(2008-2#1)(2009-4#1)(2010-8#1)
organizational needs and##2##3##(1993-1#1)(2006-8#1)
organizational needs##3##2##(1993-1#1)(1994-2#1)(2006-8#1)
organizational objectives##2##2##(1992-2#1)(1994-2#1)
organizational performance##3##2##(1995-1#1)(1995-12#1)(1995-2#1)
organizational perspective##3##2##(1994-12#1)(1996-2#1)(2010-5#1)
organizational plan##3##2##(1990-12#2)(2008-3#1)
organizational practices##3##2##(1992-5#1)(2013-1#2)
organizational principles##3##2##(2008-7#1)(2012-2#2)
organizational processes##3##2##(1992-12#1)(1993-12#1)(2008-8#1)
organizational purpose##2##2##(1993-1#2)
organizational religion and##2##3##(2010-2#2)
organizational renewal##3##2##(1995-1#3)
organizational restructuring##2##2##(1992-1#1)(1997-2#1)
organizational routines##4##2##(2013-1#4)
organizational skills##2##2##(1995-3#1)(2012-3#1)
organizational strategies##3##2##(2005-11#1)(2013-1#2)
organizational structure and##3##3##(1991-3#1)(1997-2#1)(2009-10#1)
organizational structure based on##2##4##(1992-5#1)(1993-2#1)
organizational structure of medical record departments in##2##7##(2007-12#2)
organizational structure of##3##3##(1995-3#1)(2007-12#2)
organizational structure to##2##3##(1996-1#1)(2010-3#1)
organizational structure##27##2##(1990-12#1)(1991-1#1)(1991-3#1)(1992-5#2)(1993-2#3)(1994-2#2)(1995-1#1)(1995-3#1)(1995-8#1)(1996-1#2)(1997-2#1)(2007-1#1)(2007-12#2)(2007-4#1)(2008-10#2)(2008-11#2)(2009-10#1)(2010-3#1)(2013-8#1)
organizational structures and##3##3##(1992-2#1)(1993-12#1)(1993-3#1)
organizational structures##10##2##(1991-2#1)(1991-3#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-1#1)(1995-1#1)(1996-12#1)(2008-11#1)(2010-8#1)
organizational support##2##2##(1993-1#1)(2008-9#1)
organizational tenure##2##2##(2010-6#2)
organizational##340##1##(1990-10#1)(1990-11#3)(1990-12#7)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-6#1)(1992-1#4)(1992-12#14)(1992-2#4)(1992-4#1)(1992-5#3)(1993-1#6)(1993-10#1)(1993-12#5)(1993-2#14)(1993-3#1)(1994-1#4)(1994-12#11)(1994-2#10)(1994-3#4)(1995-1#11)(1995-12#4)(1995-2#1)(1995-3#5)(1995-5#1)(1995-8#1)(1996-1#13)(1996-12#4)(1996-2#7)(1996-3#6)(1996-6#1)(1996-9#1)(1997-1#5)(1997-2#3)(1997-3#1)(2004-10#1)(2004-12#1)(2005-11#1)(2005-8#1)(2005-9#2)(2006-10#6)(2006-3#3)(2006-8#2)(2007-1#1)(2007-10#6)(2007-12#5)(2007-3#1)(2007-4#4)(2007-5#3)(2007-6#1)(2007-9#3)(2008-1#4)(2008-10#7)(2008-11#16)(2008-12#8)(2008-2#7)(2008-3#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#4)(2009-11#1)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#2)(2010-3#2)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#6)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#10)(2012-1#2)(2012-11#3)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#20)(2013-8#2)
organizational-level##3##1##(2007-10#1)(2013-1#2)
organizationally##3##1##(1996-2#1)(1997-3#1)(2012-1#1)
organizations across##2##2##(1992-2#1)(1994-2#1)
organizations active in##2##3##(2008-4#1)(2011-12#1)
organizations agree that##2##3##(2007-3#1)(2009-5#1)
organizations and individuals##3##3##(2007-2#2)(2010-8#1)
organizations and institutions##2##3##(2008-7#1)(2012-3#1)
organizations and may##2##3##(1993-3#1)(2008-11#1)
organizations and other##2##3##(1991-3#1)(1997-2#1)
organizations and the##6##3##(1991-3#2)(1993-10#1)(2008-12#1)(2008-2#1)(2013-1#1)
organizations and##52##2##(1990-6#1)(1991-3#3)(1992-2#1)(1993-1#1)(1993-10#1)(1993-3#3)(1994-12#1)(1994-3#2)(1995-2#3)(1996-1#2)(1996-2#2)(1997-1#1)(1997-2#1)(1997-3#1)(2006-7#1)(2007-2#2)(2007-4#1)(2007-5#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#5)
organizations are increasingly##2##3##(1993-3#1)(2008-12#1)
organizations are now##2##3##(1991-3#1)(1993-1#1)
organizations are presented##2##3##(1994-12#1)(1996-1#1)
organizations are##34##2##(1991-3#1)(1993-1#2)(1993-12#1)(1993-2#2)(1993-3#2)(1994-12#4)(1994-2#2)(1995-1#2)(1995-12#3)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#2)(1997-3#2)(2007-4#1)(2008-12#2)(2008-7#1)(2008-9#1)(2013-1#2)
organizations as##8##2##(1992-12#1)(2005-7#4)(2007-1#1)(2008-1#1)(2008-12#1)
organizations can##13##2##(1992-3#1)(1993-12#3)(1993-2#1)(1994-10#1)(1996-12#1)(1996-3#1)(2008-1#1)(2008-12#1)(2008-6#1)(2010-8#1)(2011-12#1)
organizations could##2##2##(1995-12#1)(2012-3#1)
organizations dealing with##2##3##(2011-12#1)(2012-1#1)
organizations develop##2##2##(1992-6#1)(1996-2#1)
organizations for##4##2##(1990-12#1)(2006-5#1)(2013-1#2)
organizations from##2##2##(1995-2#1)(2008-8#1)
organizations has##2##2##(2006-5#1)(2013-1#1)
organizations have##12##2##(1991-1#1)(1991-3#1)(1993-11#1)(1993-12#1)(1994-1#1)(1994-2#1)(1995-12#1)(1995-3#1)(2007-12#1)(2007-7#1)(2010-2#1)(2010-8#1)
organizations in a##2##3##(1991-3#1)(1995-3#1)
organizations in children##2##3##(2006-3#2)
organizations in the health##2##4##(1995-2#1)(1995-3#1)
organizations in the##6##3##(1995-2#2)(1995-3#1)(1996-1#1)(1996-2#1)(2008-12#1)
organizations in##21##2##(1991-3#1)(1992-6#1)(1994-12#2)(1995-2#3)(1995-3#3)(1996-1#1)(1996-2#1)(1997-2#1)(1997-3#1)(2005-5#1)(2006-3#2)(2006-5#1)(2008-12#1)(2008-7#1)(2013-8#1)
organizations involved in##4##3##(1995-5#1)(2007-5#1)(2008-11#1)(2012-2#1)
organizations involved##6##2##(1994-12#1)(1995-5#1)(1996-4#1)(2007-5#1)(2008-11#1)(2012-2#1)
organizations is not##2##3##(1991-12#1)(2008-2#1)
organizations is##8##2##(1990-10#1)(1991-12#1)(1993-1#1)(1993-12#2)(1994-12#1)(1996-3#1)(2008-2#1)
organizations may##4##2##(1994-12#1)(1995-2#1)(2008-7#1)(2009-11#1)
organizations might##2##2##(2008-6#1)(2009-10#1)
organizations must##6##2##(1993-12#1)(1994-12#1)(1995-12#1)(1997-1#1)(1997-2#1)(1997-3#1)
organizations need to##4##3##(1993-3#1)(2007-1#1)(2007-9#1)(2010-7#1)
organizations need##5##2##(1993-3#1)(1995-2#1)(2007-1#1)(2007-9#1)(2010-7#1)
organizations of the##5##3##(1996-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)
organizations often##2##2##(1991-3#1)(2008-2#1)
organizations should##3##2##(1992-3#1)(1996-1#1)(1997-1#1)
organizations such as the##4##4##(1990-12#1)(1995-12#1)(2008-10#1)(2010-1#1)
organizations that are##5##3##(1993-12#1)(1994-1#1)(1995-3#1)(1996-2#1)(1996-3#1)
organizations that have##5##3##(1991-3#1)(1996-2#1)(2009-3#1)(2010-5#1)(2010-8#1)
organizations that##21##2##(1991-3#1)(1993-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-2#3)(1996-3#1)(1997-2#1)(2008-12#2)(2008-9#1)(2009-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
organizations themselves##2##2##(1992-6#1)(1994-12#1)
organizations to##21##2##(1992-1#1)(1992-3#1)(1993-2#1)(1994-12#2)(1994-2#1)(1995-3#1)(1996-2#2)(1997-1#1)(1997-2#2)(2007-12#1)(2007-5#1)(2007-9#1)(2008-3#1)(2008-7#2)(2011-2#1)(2013-1#1)(2013-8#1)
organizations use##3##2##(1994-3#1)(1996-12#1)(1997-6#1)
organizations were##7##2##(1995-1#1)(1995-6#1)(1996-3#1)(2005-8#1)(2008-11#1)(2008-7#1)(2009-5#1)
organizations will##3##2##(1994-1#1)(1995-2#1)(1996-3#1)
organizations with##7##2##(1990-12#1)(1991-12#1)(1995-1#1)(1996-2#1)(2008-7#3)
organizations within##2##2##(2008-1#1)(2008-6#1)
organizations working##2##2##(1996-4#1)(2008-6#1)
organizations##581##1##(1990-10#1)(1990-12#6)(1990-5#1)(1990-6#1)(1991-1#4)(1991-12#8)(1991-2#2)(1991-3#16)(1991-4#1)(1992-1#7)(1992-11#1)(1992-12#2)(1992-2#5)(1992-3#6)(1992-6#4)(1992-9#1)(1993-1#12)(1993-10#1)(1993-11#1)(1993-12#19)(1993-2#7)(1993-3#9)(1993-9#1)(1994-1#9)(1994-10#1)(1994-12#29)(1994-2#15)(1994-3#7)(1994-7#2)(1995-1#12)(1995-12#15)(1995-2#14)(1995-3#10)(1995-4#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#15)(1996-12#7)(1996-2#19)(1996-3#16)(1996-4#3)(1996-6#1)(1997-1#15)(1997-2#13)(1997-3#15)(1997-5#1)(1997-6#1)(2005-5#1)(2005-7#4)(2005-8#4)(2006-10#2)(2006-12#1)(2006-3#2)(2006-5#5)(2006-7#1)(2006-8#3)(2007-1#4)(2007-12#4)(2007-2#6)(2007-3#3)(2007-4#6)(2007-5#3)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#6)(2008-10#3)(2008-11#10)(2008-12#13)(2008-2#11)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#6)(2008-7#18)(2008-8#6)(2008-9#3)(2009-10#2)(2009-11#4)(2009-3#2)(2009-4#7)(2009-5#4)(2009-6#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-2#3)(2010-5#5)(2010-7#1)(2010-8#6)(2011-1#3)(2011-12#5)(2011-2#9)(2011-7#1)(2012-1#3)(2012-2#9)(2012-3#5)(2013-1#20)(2013-8#7)
organizations'##4##1##(1992-1#1)(1992-12#1)(1996-3#1)(2008-11#1)
organizations?##3##1##(2005-8#1)(2008-6#1)(2008-7#1)
organize a##4##2##(1992-1#1)(2011-12#1)(2013-7#1)(2013-8#1)
organize and integrate##3##3##(2009-9#1)(2013-1#2)
organize and##7##2##(1990-12#1)(1991-5#1)(1996-2#1)(2009-9#2)(2013-1#2)
organize information##2##2##(1997-2#1)(2009-8#1)
organize organ donation##2##3##(2008-4#2)
organize the##14##2##(1992-2#1)(1995-2#1)(1997-7#1)(1997-8#2)(2008-1#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
organize their##3##2##(1991-3#1)(1997-4#1)(2009-4#1)
organize##57##1##(1990-12#1)(1990-2#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-2#2)(1993-12#1)(1994-1#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#3)(2005-8#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#2)(2009-3#1)(2009-4#2)(2009-8#1)(2009-9#3)(2010-11#1)(2010-12#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#2)
organized a one-day##2##3##(1994-7#1)(2004-12#1)
organized a workshop##2##3##(1992-12#1)(2008-7#1)
organized a##5##2##(1992-12#1)(1994-7#1)(1996-4#1)(2004-12#1)(2008-7#1)
organized and##14##2##(1992-3#1)(1993-12#1)(1997-3#1)(1997-8#1)(2005-8#2)(2006-12#1)(2006-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
organized around##4##2##(1996-1#1)(2006-10#1)(2008-11#1)(2008-2#1)
organized as a##7##3##(1995-2#1)(2005-8#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-8#1)(2013-1#1)
organized as##12##2##(1993-12#1)(1994-5#1)(1995-2#1)(1996-7#1)(2005-8#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#2)
organized by a##2##3##(1990-5#1)(2007-12#1)
organized by the American##3##4##(2008-5#2)(2013-1#1)
organized by the European##2##4##(2008-5#1)(2013-1#1)
organized by the International Society of##2##6##(2008-5#1)(2008-8#1)
organized by the##19##3##(1990-5#1)(1990-6#1)(2005-8#1)(2006-1#1)(2006-8#3)(2007-11#1)(2008-10#2)(2008-5#5)(2008-8#1)(2009-10#1)(2013-1#2)
organized by##43##2##(1990-5#2)(1990-6#1)(1995-11#1)(1996-7#1)(2005-7#1)(2005-8#3)(2005-9#1)(2006-1#1)(2006-8#3)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#10)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#1)(2010-5#1)(2011-2#2)(2013-1#3)(2013-8#1)
organized care systems##2##3##(1995-1#1)(2008-1#1)
organized in a##10##3##(1990-11#1)(1990-4#1)(1991-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-2#1)(1996-7#1)(2008-7#1)(2009-12#1)
organized in the same way##2##5##(1996-7#1)(2007-11#1)
organized in the##5##3##(1993-2#1)(1996-7#1)(1997-2#1)(2007-11#1)(2007-12#1)
organized in three##2##3##(2008-10#1)(2012-12#1)
organized in##39##2##(1990-11#1)(1990-4#1)(1991-1#1)(1991-2#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-2#1)(1995-6#1)(1996-7#2)(1997-2#2)(2005-6#1)(2005-9#1)(2006-1#1)(2006-7#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2011-12#1)(2011-2#3)(2012-12#1)
organized into a##6##3##(1993-12#1)(1994-10#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-9#1)
organized into six##2##3##(1996-3#1)(2007-8#1)
organized into##32##2##(1990-11#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#2)(1994-10#1)(1996-1#1)(1996-3#1)(2005-8#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2011-2#1)(2012-1#2)
organized medical##2##2##(1992-1#1)(1992-3#1)
organized medicine##3##2##(2007-4#1)(2008-4#1)(2008-6#1)
organized network of##2##3##(2011-2#1)(2013-8#1)
organized parallel##2##2##(2007-12#1)(2008-5#1)
organized protests##2##2##(1991-10#2)
organized similarly to##2##3##(2008-10#2)
organized structure##3##2##(1990-12#1)(1996-1#1)(1996-11#1)
organized structures##2##2##(1994-5#1)(2008-7#1)
organized systems of care##2##4##(1994-2#1)(1996-1#1)
organized systems of##3##3##(1994-2#1)(1996-1#1)(2008-12#1)
organized systems##4##2##(1994-2#1)(1996-1#1)(2008-12#1)(2012-2#1)
organized the First Tongan##2##4##(2008-1#2)
organized the##5##2##(1996-11#1)(1996-3#1)(2008-1#2)(2010-1#1)
organized to##3##2##(2008-12#1)(2011-2#1)(2013-1#1)
organized##282##1##(1990-11#2)(1990-12#1)(1990-4#4)(1990-5#2)(1990-6#4)(1990-8#1)(1991-1#2)(1991-10#2)(1991-2#2)(1991-3#2)(1992-1#1)(1992-11#1)(1992-12#3)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#3)(1993-10#1)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#3)(1994-10#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-7#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#2)(1996-1#7)(1996-11#2)(1996-12#2)(1996-3#3)(1996-4#2)(1996-7#4)(1997-1#2)(1997-2#2)(1997-3#2)(1997-8#1)(2004-12#1)(2005-6#1)(2005-7#1)(2005-8#8)(2005-9#2)(2006-1#2)(2006-10#3)(2006-11#1)(2006-12#3)(2006-4#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#11)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#7)(2008-10#14)(2008-11#8)(2008-12#2)(2008-2#4)(2008-4#4)(2008-5#19)(2008-6#4)(2008-7#9)(2008-8#7)(2008-9#3)(2009-10#4)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-12#1)(2011-2#11)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#9)(2013-8#4)
organizer and active defender in response to mechanical stimulation##2##9##(2009-8#2)
organizer and##3##2##(2008-11#1)(2009-8#2)
organizer of the##2##3##(2006-5#1)(2011-4#1)
organizer of##3##2##(2006-5#1)(2011-2#1)(2011-4#1)
organizer region (NOR)##4##3##(2008-12#1)(2008-5#2)(2011-12#1)
organizer regions (NORs)##2##3##(1993-12#1)(2008-12#1)
organizer regions##4##2##(1993-12#1)(2007-11#1)(2008-12#1)(2011-12#1)
organizer##17##1##(1993-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#2)(2008-5#2)(2009-8#2)(2010-5#1)(2011-12#2)(2011-2#1)(2011-4#1)(2013-1#1)
organizers of##2##2##(1997-8#1)(2008-12#1)
organizers##8##1##(1994-3#1)(1997-8#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-5#1)
organizes the##3##2##(1990-11#1)(2007-12#1)(2012-2#1)
organizes##8##1##(1990-11#1)(1994-12#1)(1995-3#1)(2006-12#1)(2007-12#2)(2008-4#1)(2012-2#1)
organizing and standardizing knowledge and related measures around alerts##2##9##(2013-1#2)
organizing and##11##2##(1992-3#1)(1997-1#1)(2007-1#1)(2008-12#1)(2009-12#1)(2010-5#1)(2013-1#5)
organizing centers##4##2##(1991-5#1)(1995-9#2)(2012-12#1)
organizing diffuse alveolar damage##2##4##(2005-8#1)(2006-10#1)
organizing pneumonia (OP)##2##3##(2005-8#1)(2010-12#1)
organizing pneumonia and eosinophilic pneumonia##2##5##(2005-8#2)
organizing pneumonia##12##2##(2005-8#6)(2006-10#2)(2008-1#2)(2010-12#2)
organizing principles##2##2##(2008-11#1)(2012-1#1)
organizing region##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
organizing the##3##2##(1992-9#1)(2007-7#1)(2012-12#1)
organizing##77##1##(1991-11#1)(1991-5#2)(1992-3#1)(1992-9#1)(1993-3#1)(1994-3#1)(1995-9#2)(1996-12#1)(1996-3#1)(1997-1#1)(2005-8#7)(2006-10#3)(2006-8#1)(2007-1#1)(2007-12#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#3)(2008-11#1)(2008-12#4)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-12#2)(2009-2#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-5#2)(2010-8#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#1)(2013-1#7)(2013-8#1)
organo-iron##2##1##(2008-5#2)
organoarsenic##2##1##(1993-6#1)(2010-2#1)
organoarsenical##3##1##(2008-10#1)(2010-11#1)(2010-2#1)
organocatalysts##2##1##(2007-10#1)(2011-2#1)
organocatalytic##4##1##(2008-7#1)(2010-12#1)(2011-2#2)
organochlorine and##2##2##(2008-10#1)(2008-5#1)
organochlorine compounds in##2##3##(2008-10#1)(2008-8#1)
organochlorine compounds##6##2##(1991-8#2)(2008-10#3)(2008-8#1)
organochlorine pesticide##4##2##(1993-9#2)(1997-3#1)(2007-10#1)
organochlorine pesticides (OCPs)##2##3##(2008-10#2)
organochlorine pesticides are##2##3##(2008-10#1)(2008-7#1)
organochlorine pesticides from##4##3##(2007-7#1)(2007-8#1)(2008-10#2)
organochlorine pesticides in soil##2##4##(2007-8#1)(2008-10#1)
organochlorine pesticides in##4##3##(2005-11#2)(2007-8#1)(2008-10#1)
organochlorine pesticides##17##2##(1997-4#1)(2004-4#1)(2005-11#2)(2007-7#2)(2007-8#2)(2008-10#8)(2008-7#1)
organochlorine residuals##3##2##(2008-8#3)
organochlorine##40##1##(1990-4#1)(1991-3#1)(1991-8#2)(1993-9#4)(1997-3#1)(1997-4#1)(2004-4#1)(2005-11#2)(2007-10#1)(2007-7#3)(2007-8#2)(2008-10#15)(2008-5#1)(2008-7#1)(2008-8#4)
organochlorines##3##1##(2008-10#1)(2008-8#1)(2011-2#1)
organoclays##2##1##(2005-11#2)
organofunctional##4##1##(2007-8#1)(2009-7#3)
organofunctionalized##3##1##(2008-10#3)
organogel##2##1##(2005-11#1)(2010-2#1)
organogelator##2##1##(2005-11#2)
organogels##7##1##(1991-6#2)(2005-11#2)(2010-2#3)
organogenesis and##5##2##(1995-8#1)(2005-7#1)(2008-6#1)(2010-8#1)(2011-12#1)
organogenesis in##4##2##(1993-7#1)(2007-3#1)(2008-12#1)(2011-2#1)
organogenesis of##3##2##(2008-12#2)(2011-2#1)
organogenesis##31##1##(1993-7#1)(1995-8#1)(1996-1#1)(2005-10#1)(2005-7#1)(2007-12#1)(2007-3#2)(2007-8#1)(2008-1#2)(2008-12#4)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#2)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#2)
organogermanium##2##1##(2008-5#2)
organohalides##2##1##(2004-4#1)(2008-10#1)
organoid##3##1##(1992-4#1)(1996-3#1)(1997-1#1)
organoids and##2##2##(1990-3#2)
organolead compounds##2##2##(2008-10#2)
organoleptic characteristics##4##2##(2008-5#1)(2008-7#1)(2010-4#1)(2011-12#1)
organoleptic properties##4##2##(2006-12#2)(2012-12#2)
organoleptic qualities##2##2##(1997-4#1)(2008-5#1)
organoleptic##13##1##(1997-4#1)(2006-12#2)(2008-10#1)(2008-5#2)(2008-7#1)(2010-4#2)(2011-12#1)(2012-12#2)(2013-8#1)
organolithium compound##2##2##(1996-5#2)
organolithium##4##1##(1996-5#4)
organomegaly##2##1##(2005-1#1)(2010-6#1)
organomercurial##3##1##(1990-9#1)(1994-5#1)(2008-5#1)
organomercurials##5##1##(1992-2#1)(2008-10#3)(2008-5#1)
organomercury##5##1##(1990-12#1)(2008-10#2)(2008-3#2)
organometallic reagents and##2##3##(2010-6#1)(2012-3#1)
organometallic##16##1##(2006-12#2)(2007-11#2)(2007-12#1)(2008-10#2)(2008-5#1)(2009-10#1)(2009-2#2)(2009-9#1)(2010-12#2)(2010-6#1)(2012-3#1)
organophilic##3##1##(1992-3#1)(2008-10#2)
organophosphate (OP)##2##2##(1997-3#1)(2010-2#1)
organophosphate insecticide##3##2##(2008-6#1)(2009-3#1)(2013-1#1)
organophosphate pesticide##2##2##(2008-10#1)(2009-6#1)
organophosphate pesticides##3##2##(1997-6#1)(2005-11#1)(2008-10#1)
organophosphate poisoning##5##2##(2006-4#1)(2009-6#1)(2012-1#1)(2012-2#2)
organophosphate##35##1##(1990-9#1)(1992-10#1)(1993-11#1)(1994-11#1)(1995-1#3)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-4#1)(2007-10#1)(2008-10#3)(2008-5#1)(2008-6#2)(2009-12#1)(2009-3#1)(2009-6#2)(2010-2#1)(2012-1#4)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
organophosphates##10##1##(1994-5#2)(1994-6#1)(2005-11#2)(2008-10#2)(2008-6#1)(2009-3#1)(2010-2#1)
organophosphorous hydrolase##2##2##(2008-10#2)
organophosphorous##12##1##(1994-5#1)(1995-3#1)(2008-10#6)(2010-5#2)(2013-1#2)
organophosphorus compound##2##2##(1997-4#1)(2008-10#1)
organophosphorus compounds##5##2##(1992-2#1)(1996-12#1)(2007-11#1)(2007-8#2)
organophosphorus derivatives containing##2##3##(2008-5#2)
organophosphorus insecticides##4##2##(1992-11#1)(1996-4#1)(2007-8#1)(2008-5#1)
organophosphorus pesticide##4##2##(2008-10#4)
organophosphorus pesticides (OPPs)##2##3##(2008-10#2)
organophosphorus pesticides (OPs)##2##3##(2008-10#2)
organophosphorus pesticides in water##6##4##(1991-8#1)(2008-10#5)
organophosphorus pesticides such as##2##4##(2008-10#2)
organophosphorus pesticides##18##2##(1991-8#2)(2008-10#14)(2008-11#1)(2010-4#1)
organophosphorus##50##1##(1991-8#2)(1992-11#1)(1992-2#2)(1996-12#1)(1996-4#1)(1997-4#1)(2007-11#1)(2007-8#6)(2008-10#26)(2008-11#1)(2008-4#1)(2008-5#3)(2010-12#1)(2010-4#1)(2011-1#1)(2012-12#1)
organosilane##4##1##(1997-2#1)(2006-12#1)(2008-10#1)(2010-4#1)
organosilanes##4##1##(2010-4#3)(2012-11#1)
organosilica##2##1##(2010-11#1)(2010-7#1)
organosilicon and##2##2##(2008-5#2)
organosilicon##3##1##(2006-12#1)(2008-5#2)
organosiloxane##2##1##(2008-5#1)(2010-7#1)
organosolv ethanol##2##2##(2008-5#2)
organosolv##4##1##(2008-5#4)
organosulfur compounds##4##2##(1992-5#1)(2008-1#2)(2009-11#1)
organosulfur##6##1##(1992-5#1)(2008-1#4)(2009-11#1)
organotin anti-tumor##2##2##(2008-5#2)
organotin complexes##2##2##(2008-10#2)
organotin compounds in##3##3##(2008-10#1)(2008-3#2)
organotin compounds##8##2##(2008-10#5)(2008-3#3)
organotin derivatives##3##2##(2008-5#3)
organotin was##2##2##(2005-4#2)
organotin with##2##2##(2008-10#1)(2008-5#1)
organotin##33##1##(2005-4#4)(2007-11#1)(2008-10#14)(2008-3#3)(2008-5#9)(2010-5#1)(2012-2#1)
organotin(IV) complexes##3##2##(2008-10#2)(2008-3#1)
organotin(IV)##5##1##(2008-10#2)(2008-3#1)(2008-5#1)(2012-2#1)
organotins in##3##2##(2008-10#2)(2012-2#1)
organotins##8##1##(2008-10#5)(2012-2#3)
organotypic brain##2##2##(2006-11#1)(2008-4#1)
organotypic culture##3##2##(1996-3#2)(2010-12#1)
organotypic cultures of##2##3##(1996-3#1)(2008-4#1)
organotypic cultures##5##2##(1996-3#1)(2008-11#1)(2008-4#3)
organotypic hippocampal##4##2##(1995-7#1)(1996-6#1)(2006-11#1)(2008-7#1)
organotypic models##2##2##(2007-11#1)(2013-1#1)
organotypic neocortical##2##2##(1990-2#1)(1991-9#1)
organotypic slice cultures from##2##4##(2008-11#2)
organotypic slice cultures##5##3##(1995-9#1)(1996-1#1)(2008-11#3)
organotypic slice##6##2##(1995-9#2)(1996-1#1)(2008-11#3)
organotypic##38##1##(1990-2#1)(1991-9#2)(1995-5#1)(1995-7#1)(1995-9#2)(1996-1#1)(1996-3#4)(1996-6#2)(2006-11#2)(2007-11#1)(2008-11#5)(2008-4#7)(2008-7#1)(2008-9#1)(2009-4#1)(2009-9#3)(2010-12#1)(2010-5#1)(2013-1#1)
organotypical in vitro model##2##4##(2008-11#2)
organs (kidney##2##2##(2009-8#1)(2012-1#1)
organs (liver##3##2##(1991-5#1)(1994-11#1)(2010-4#1)
organs affected##2##2##(1997-6#1)(2007-10#1)
organs and are##2##3##(2008-4#1)(2013-8#1)
organs and brain regions##2##4##(1994-5#2)
organs and cells##2##3##(1994-3#1)(2008-4#1)
organs and in the##2##4##(2008-10#1)(2008-9#1)
organs and in##3##3##(1997-7#1)(2008-10#1)(2008-9#1)
organs and systems##5##3##(2007-11#1)(2008-1#1)(2008-10#1)(2008-9#1)(2012-3#1)
organs and the##2##3##(1996-12#1)(2013-7#1)
organs and their##2##3##(2007-12#1)(2009-2#1)
organs and tissues of##2##4##(1996-2#1)(2005-11#1)
organs and tissues##28##3##(1990-8#2)(1991-3#2)(1992-1#1)(1994-3#1)(1995-12#1)(1996-2#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-11#2)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#1)(2009-4#1)(2010-10#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
organs and##75##2##(1990-8#2)(1991-2#2)(1991-3#2)(1992-1#1)(1993-4#1)(1993-8#1)(1993-9#2)(1994-3#2)(1994-5#2)(1995-12#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-7#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#3)(2006-11#2)(2006-8#1)(2007-11#2)(2007-12#3)(2007-5#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-2#1)(2011-1#3)(2011-2#3)(2012-2#1)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#1)
organs are##13##2##(1991-11#1)(1993-3#1)(1994-6#1)(1995-2#2)(2006-11#1)(2006-7#1)(2007-12#1)(2008-5#2)(2008-7#1)(2011-12#1)(2013-1#1)
organs as well as##4##4##(1992-6#1)(2007-4#1)(2008-10#1)(2008-5#1)
organs as well##5##3##(1992-6#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-5#1)
organs as##6##2##(1992-6#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-5#1)
organs at risk (OAR)##2##4##(2008-6#1)(2011-2#1)
organs at risk##8##3##(2008-2#2)(2008-6#2)(2009-5#2)(2011-2#1)(2013-1#1)
organs at##13##2##(1991-11#1)(2008-10#2)(2008-2#2)(2008-6#2)(2009-5#2)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
organs between##2##2##(2008-5#1)(2008-8#1)
organs both##2##2##(1991-2#1)(2008-12#1)
organs by##3##2##(1992-4#1)(1992-7#1)(2008-10#1)
organs can##3##2##(1996-6#1)(1996-9#1)(2011-2#1)
organs could##2##2##(1993-8#1)(2009-12#1)
organs during##8##2##(1991-11#1)(1992-3#1)(2006-6#1)(2012-12#5)
organs examined##2##2##(2004-11#1)(2008-10#1)
organs following##2##2##(1996-6#1)(2008-1#1)
organs for transplantation##4##3##(1991-11#1)(1991-3#1)(1994-1#1)(2006-10#1)
organs for##14##2##(1991-11#1)(1991-3#1)(1992-8#1)(1994-1#1)(2006-10#2)(2007-11#2)(2007-12#2)(2007-7#1)(2008-1#1)(2008-4#1)(2008-5#1)
organs from##9##2##(1992-4#1)(1993-2#1)(1996-2#1)(1997-4#1)(2006-6#1)(2008-2#1)(2008-5#1)(2009-2#1)(2011-2#1)
organs has##2##2##(2008-1#1)(2008-12#1)
organs have been##4##3##(2008-5#3)(2011-2#1)
organs have the##2##3##(1990-8#1)(2010-10#1)
organs have##7##2##(1990-8#1)(2008-12#1)(2008-5#3)(2010-10#1)(2011-2#1)
organs in the##11##3##(1990-3#1)(1996-12#1)(1996-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
organs in##27##2##(1990-3#2)(1991-8#1)(1995-12#1)(1996-12#1)(1996-6#1)(2006-10#2)(2007-12#3)(2007-4#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
organs including the##3##3##(2007-10#1)(2008-10#1)(2008-7#1)
organs including##4##2##(2007-10#1)(2008-10#1)(2008-7#1)(2010-11#1)
organs into##2##2##(2007-12#1)(2012-1#1)
organs involved in##3##3##(2008-10#1)(2010-11#1)(2012-2#1)
organs involved##7##2##(1991-5#1)(2008-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2012-2#1)
organs is an##2##3##(1993-11#1)(2008-2#1)
organs is##12##2##(1991-5#1)(1993-11#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#2)(2009-6#1)(2012-12#1)(2012-3#1)
organs like the##2##3##(2008-1#1)(2009-4#1)
organs may##3##2##(1990-7#1)(1992-7#1)(2007-12#1)
organs of the body##3##4##(1994-5#1)(2006-10#1)(2012-2#1)
organs of the##15##3##(1992-6#1)(1993-7#1)(1994-5#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#1)(1997-8#1)(2004-2#1)(2006-10#1)(2006-11#1)(2008-10#1)(2008-12#1)(2009-2#1)(2012-2#1)
organs of##54##2##(1990-8#1)(1991-5#1)(1991-8#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#2)(1996-3#1)(1997-3#1)(1997-8#1)(2004-11#2)(2004-2#1)(2006-10#2)(2006-11#1)(2007-12#4)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-1#2)(2012-2#1)(2013-8#2)
organs on the##2##3##(1997-5#1)(2007-12#1)
organs or systems##2##3##(2008-5#1)(2013-1#1)
organs or tissues##4##3##(1994-6#1)(1995-2#1)(1996-12#1)(2008-10#1)
organs or##14##2##(1994-6#1)(1995-2#1)(1996-12#1)(1997-6#1)(2007-10#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
organs such as the spleen##2##5##(2004-2#1)(2013-8#1)
organs such as the##4##4##(2004-2#1)(2009-2#1)(2010-11#1)(2013-8#1)
organs such as##6##3##(1993-5#1)(2004-2#1)(2009-2#1)(2010-11#1)(2012-12#1)(2013-8#1)
organs such##7##2##(1993-5#1)(2004-2#1)(2006-1#1)(2009-2#1)(2010-11#1)(2012-12#1)(2013-8#1)
organs support the##2##3##(1994-9#1)(2007-12#1)
organs tested##2##2##(1991-9#1)(2008-10#1)
organs that##6##2##(2006-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-4#1)(2012-1#1)
organs through##2##2##(2006-7#1)(2007-12#1)
organs to the##3##3##(1990-7#1)(2006-10#1)(2008-12#1)
organs to##9##2##(1990-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#2)(2008-8#1)(2010-12#1)
organs under##3##2##(1997-4#1)(2004-11#1)(2007-10#1)
organs using##2##2##(2008-7#1)(2008-8#1)
organs was assessed in##2##4##(1990-12#1)(1996-12#1)
organs was##8##2##(1990-12#2)(1993-6#1)(1996-12#1)(2006-11#2)(2008-11#1)(2008-5#1)
organs were collected##2##3##(2008-5#1)(2013-1#1)
organs were normal##2##3##(2005-7#1)(2006-10#1)
organs were##17##2##(1990-7#1)(1991-11#1)(1991-5#1)(1992-1#1)(1993-3#1)(1997-3#2)(2005-7#1)(2006-10#2)(2007-12#2)(2008-11#1)(2008-5#2)(2008-7#1)(2013-1#1)
organs where##3##2##(1994-11#1)(2008-3#1)(2008-4#1)
organs with a##2##3##(1992-12#1)(2009-9#1)
organs with##3##2##(1992-12#1)(1994-11#1)(2009-9#1)
organs##728##1##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#3)(1990-3#4)(1990-4#3)(1990-5#1)(1990-7#4)(1990-8#6)(1991-11#5)(1991-12#3)(1991-2#5)(1991-3#3)(1991-5#8)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#2)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#3)(1992-5#2)(1992-6#3)(1992-7#4)(1992-8#2)(1992-9#4)(1993-10#2)(1993-11#2)(1993-2#3)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#4)(1994-1#2)(1994-10#1)(1994-11#8)(1994-2#1)(1994-3#4)(1994-4#1)(1994-5#5)(1994-6#3)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#8)(1995-2#5)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#7)(1996-2#5)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#5)(1996-7#3)(1996-8#1)(1996-9#3)(1997-2#1)(1997-3#7)(1997-4#4)(1997-5#4)(1997-6#3)(1997-7#1)(1997-8#2)(2004-11#4)(2004-2#3)(2005-10#2)(2005-11#2)(2005-12#1)(2005-7#3)(2005-8#2)(2006-1#1)(2006-10#21)(2006-11#11)(2006-12#1)(2006-2#1)(2006-6#4)(2006-7#3)(2006-8#2)(2006-9#1)(2007-10#5)(2007-11#8)(2007-12#36)(2007-2#1)(2007-3#2)(2007-4#5)(2007-5#3)(2007-6#4)(2007-7#3)(2007-8#11)(2007-9#4)(2008-1#13)(2008-10#38)(2008-11#12)(2008-12#12)(2008-2#5)(2008-3#4)(2008-4#21)(2008-5#36)(2008-6#6)(2008-7#22)(2008-8#13)(2008-9#11)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#8)(2009-3#2)(2009-4#5)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#4)(2010-12#9)(2010-2#2)(2010-4#5)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#6)(2011-1#11)(2011-12#2)(2011-2#18)(2011-3#1)(2012-1#9)(2012-11#2)(2012-12#18)(2012-2#15)(2012-3#11)(2013-1#13)(2013-7#3)(2013-8#13)
organs)##3##1##(2007-12#1)(2011-1#1)(2012-2#1)
organs/systems involved##2##2##(2008-1#1)(2011-2#1)
organs/tissues##3##1##(2005-7#1)(2008-10#1)(2010-11#1)
organs]##6##1##(1990-6#1)(1992-3#1)(1995-11#1)(2006-6#1)(2012-3#2)
organum vasculosum of the lamina terminalis##2##6##(1991-8#1)(2008-4#1)
organum vasculosum of##3##3##(1991-8#1)(1993-2#1)(2008-4#1)
organum vasculosum##4##2##(1991-8#1)(1993-2#1)(1993-7#1)(2008-4#1)
orgasmic##3##1##(2010-9#1)(2012-3#1)(2013-7#1)
ori lambda##7##2##(1994-11#4)(1995-2#3)
ori##14##1##(1994-11#4)(1994-12#3)(1995-2#3)(1995-8#2)(1996-6#1)(1996-7#1)
oriC site##2##2##(1995-1#2)
oriC##11##1##(1990-11#2)(1991-8#1)(1995-1#3)(1995-2#2)(1997-4#2)(2006-10#1)
oriC-deleted mutants of Bacillus subtilis##2##5##(1997-4#2)
oriC-deleted##3##1##(1997-4#3)
oriLyt replication##3##2##(1997-3#3)
oriLyt##11##1##(1997-3#11)
oriP elements##2##2##(2008-11#2)
oriP##6##1##(1994-3#2)(2008-11#4)
oriP-binding proteins##2##2##(1994-3#2)
oriantha##2##1##(2008-3#2)
oribatid##2##1##(2007-3#1)(2008-4#1)
oriens##3##1##(1990-4#1)(1991-6#1)(1997-7#1)
orient in the##2##3##(2009-8#1)(2010-12#1)
orient in##3##2##(2009-8#2)(2010-12#1)
orient the##7##2##(1990-7#1)(1991-1#1)(1993-3#1)(1995-10#1)(2008-11#1)(2008-3#1)(2011-1#1)
orient to##3##2##(2008-10#1)(2011-2#2)
orient##19##1##(1990-7#1)(1991-1#1)(1993-3#1)(1994-9#1)(1995-10#1)(1996-8#1)(2006-5#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-4#1)(2009-8#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)
oriental melon##4##2##(2008-10#4)
oriental##18##1##(1997-1#1)(1997-8#3)(2006-10#2)(2008-10#8)(2008-3#1)(2008-6#1)(2011-12#1)(2011-2#1)
orientale##4##1##(2012-3#4)
orientalis##9##1##(1990-10#2)(2004-4#2)(2007-1#2)(2008-5#1)(2008-8#2)
orientated in##2##2##(1996-7#1)(2008-10#1)
orientated vector moment##2##3##(2004-11#2)
orientated##16##1##(1996-7#1)(1997-3#1)(2004-11#2)(2006-12#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2011-2#3)(2012-12#1)(2012-2#1)
orientating the##2##2##(1992-6#1)(2012-1#1)
orientating##4##1##(1992-6#1)(1996-4#1)(2008-9#1)(2012-1#1)
orientation about##2##2##(1997-7#1)(2008-11#1)
orientation and angular distribution of##2##5##(2008-10#2)
orientation and chemicals) of the laboratory in which Professor Chiranjeevi worked##2##11##(2008-10#2)
orientation and chemicals) of the laboratory in which##3##8##(2008-10#3)
orientation and for##2##3##(2008-3#1)(2009-8#1)
orientation and sexual behavior##2##4##(2008-12#2)
orientation and size of##3##4##(1996-1#1)(1996-2#2)
orientation and the##4##3##(1996-1#1)(1997-8#1)(2008-8#2)
orientation and with##2##3##(1990-9#1)(2008-7#1)
orientation and##80##2##(1990-12#1)(1990-9#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-7#1)(1994-12#1)(1994-8#1)(1995-12#2)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#1)(1997-7#1)(1997-8#2)(2004-11#1)(2004-9#1)(2005-11#2)(2006-2#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-12#4)(2008-2#4)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#4)(2009-4#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-3#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#1)
orientation angle of##3##3##(2008-10#2)(2008-2#1)
orientation angle was##2##3##(2008-10#1)(2008-6#1)
orientation angle##8##2##(2008-10#6)(2008-2#1)(2008-6#1)
orientation angles##4##2##(2007-12#3)(2008-2#1)
orientation are##4##2##(1992-9#1)(1994-3#1)(2006-11#1)(2013-7#1)
orientation as a##3##3##(2008-12#1)(2009-7#2)
orientation as##8##2##(1991-9#1)(1994-3#1)(1995-8#1)(2007-1#1)(2008-12#1)(2009-7#2)(2010-3#1)
orientation at the##3##3##(1995-3#1)(1997-3#1)(2008-10#1)
orientation at##6##2##(1995-3#2)(1997-3#1)(2007-12#1)(2008-10#1)(2008-7#1)
orientation averaging##2##2##(2008-3#2)
orientation behavior##4##2##(1993-9#1)(2007-11#1)(2008-8#1)(2011-12#1)
orientation between the##2##3##(1991-4#1)(1994-3#1)
orientation between##4##2##(1991-4#1)(1994-3#1)(1995-8#1)(2012-2#1)
orientation by##3##2##(1991-3#1)(1996-8#1)(2008-3#1)
orientation can be##5##3##(1997-3#1)(1997-7#1)(2007-11#1)(2008-12#1)(2008-3#1)
orientation can##6##2##(1992-7#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-12#1)(2008-3#1)
orientation changes##3##2##(2007-12#1)(2010-3#1)(2013-1#1)
orientation columns##4##2##(2013-7#4)
orientation distribution##2##2##(2008-3#1)(2012-1#1)
orientation does##2##2##(2008-12#1)(2012-2#1)
orientation during##2##2##(2006-6#1)(2008-9#1)
orientation effects in##2##3##(1992-3#1)(2007-12#1)
orientation estimation##2##2##(2008-2#2)
orientation field##3##2##(2008-2#3)
orientation for the##2##3##(2007-8#1)(2008-10#1)
orientation for##8##2##(1995-3#1)(2007-8#1)(2007-9#1)(2008-10#2)(2012-12#1)(2013-1#2)
orientation from the##2##3##(1993-8#1)(2008-8#1)
orientation from##4##2##(1993-8#1)(1995-12#1)(1996-2#1)(2008-8#1)
orientation groups##2##2##(2010-11#2)
orientation has##4##2##(1991-8#1)(2007-4#1)(2008-3#1)(2010-3#1)
orientation in the##11##3##(1991-11#1)(1991-2#1)(1991-3#1)(1992-1#1)(1997-4#1)(2004-9#1)(2008-7#1)(2008-8#2)(2010-4#1)(2012-12#1)
orientation in their##2##3##(2010-4#1)(2013-7#1)
orientation in##27##2##(1990-11#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-1#1)(1993-5#1)(1997-4#1)(2004-9#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-7#1)(2008-8#2)(2010-2#1)(2010-3#1)(2010-4#2)(2012-1#1)(2012-12#1)(2013-7#1)
orientation index##2##2##(2008-8#1)(2008-9#1)
orientation is a##3##3##(1991-3#1)(1993-12#1)(1997-3#1)
orientation is the##2##3##(1990-10#1)(1994-11#1)
orientation is##16##2##(1990-10#1)(1991-2#1)(1991-3#1)(1992-1#1)(1993-12#1)(1993-2#1)(1994-11#1)(1995-3#1)(1996-12#1)(1997-3#1)(1997-4#1)(2007-12#2)(2008-2#3)
orientation located##2##2##(2007-12#1)(2013-7#1)
orientation map##3##2##(2008-11#1)(2008-2#1)(2010-2#1)
orientation maps##3##2##(2008-11#1)(2010-2#2)
orientation neurons##2##2##(2013-7#2)
orientation of CaD*##2##3##(1994-5#2)
orientation of a##9##3##(1990-10#1)(1993-5#1)(2006-12#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-2#2)(2010-4#1)
orientation of bubbles##2##3##(2005-11#2)
orientation of human##2##3##(2009-5#1)(2011-1#1)
orientation of the particles##3##4##(2008-3#3)
orientation of the third strand##2##5##(1995-3#2)
orientation of the##97##3##(1990-7#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-9#3)(1992-6#1)(1992-9#3)(1993-11#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-3#2)(1995-4#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-4#1)(1996-6#1)(1996-7#2)(1997-2#1)(1997-7#2)(2005-11#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#6)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#8)(2008-3#15)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-12#2)(2009-5#1)(2010-5#3)(2010-7#1)(2013-7#1)(2013-8#1)
orientation of these##2##3##(1996-7#1)(2013-1#1)
orientation of this##2##3##(1991-4#1)(1994-9#1)
orientation of##188##2##(1990-10#1)(1990-11#1)(1990-4#1)(1990-7#1)(1991-10#2)(1991-2#1)(1991-4#2)(1991-7#2)(1991-9#3)(1992-12#1)(1992-6#1)(1992-7#1)(1992-9#4)(1993-11#2)(1993-3#2)(1993-5#1)(1994-12#1)(1994-2#2)(1994-5#5)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-3#3)(1995-4#1)(1995-6#2)(1995-8#1)(1996-1#2)(1996-11#1)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#3)(1996-8#2)(1997-2#1)(1997-6#1)(1997-7#2)(2005-11#6)(2005-4#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#12)(2007-12#9)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#4)(2008-10#8)(2008-11#3)(2008-2#11)(2008-3#23)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-12#2)(2009-3#1)(2009-5#3)(2009-7#1)(2010-4#1)(2010-5#4)(2010-7#1)(2011-1#2)(2011-3#1)(2012-12#3)(2013-1#1)(2013-7#1)(2013-8#1)
orientation on a##2##3##(2009-9#1)(2010-2#1)
orientation on the##7##3##(1991-11#1)(1992-6#1)(1994-9#1)(1995-5#1)(2008-10#1)(2008-3#1)(2009-5#1)
orientation on##11##2##(1991-11#1)(1992-6#1)(1994-9#1)(1995-5#1)(1996-3#1)(2008-10#1)(2008-3#1)(2009-5#1)(2009-9#1)(2010-2#1)(2011-3#1)
orientation or direction##2##3##(2008-8#2)
orientation or##8##2##(1996-2#2)(2006-5#1)(2008-11#1)(2008-8#3)(2009-7#1)
orientation preference##2##2##(2012-2#2)
orientation process##2##2##(1996-1#1)(2007-11#1)
orientation program##3##2##(1991-1#1)(1996-1#2)
orientation relative to##3##3##(1991-12#1)(1993-3#1)(2008-4#1)
orientation selectivity in##2##3##(2008-11#1)(2008-8#1)
orientation selectivity##7##2##(1994-3#1)(2008-11#1)(2008-8#4)(2012-2#1)
orientation than##2##2##(1990-11#1)(2007-11#1)
orientation to the##2##3##(1995-3#1)(2012-12#1)
orientation to##12##2##(1993-2#1)(1995-3#1)(1997-1#1)(1997-3#1)(2004-8#1)(2006-12#1)(2006-2#1)(2007-12#1)(2008-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
orientation toward##5##2##(2008-11#2)(2008-8#1)(2012-2#1)(2013-1#1)
orientation towards##2##2##(1993-3#1)(2008-8#1)
orientation tuning##5##2##(2008-11#3)(2013-7#2)
orientation was##7##2##(1991-12#1)(1993-11#1)(2004-11#1)(2008-8#1)(2009-5#2)(2009-7#1)
orientation were##6##2##(2008-10#1)(2008-8#2)(2009-7#1)(2009-8#1)(2012-2#1)
orientation with respect to the##4##5##(1990-11#1)(1994-11#1)(1995-10#1)(1997-9#1)
orientation with respect to##7##4##(1990-11#1)(1994-11#1)(1995-10#1)(1995-2#1)(1997-9#1)(2005-11#1)(2008-11#1)
orientation with the##2##3##(1990-11#1)(1994-11#1)
orientation with##10##2##(1990-11#2)(1994-11#2)(1995-10#1)(1995-2#1)(1997-9#1)(2005-11#1)(2008-11#1)(2008-7#1)
orientation within their##2##3##(1995-11#1)(2012-2#1)
orientation within##4##2##(1995-11#1)(1996-3#1)(2008-10#1)(2012-2#1)
orientation##754##1##(1990-1#1)(1990-10#2)(1990-11#7)(1990-12#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#4)(1991-11#3)(1991-12#4)(1991-2#3)(1991-3#4)(1991-4#3)(1991-5#1)(1991-6#2)(1991-7#4)(1991-8#2)(1991-9#7)(1992-1#5)(1992-12#2)(1992-2#1)(1992-3#3)(1992-6#3)(1992-7#7)(1992-9#5)(1993-11#4)(1993-12#2)(1993-2#3)(1993-3#4)(1993-5#2)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#7)(1994-12#7)(1994-2#2)(1994-3#5)(1994-5#5)(1994-7#1)(1994-8#2)(1994-9#4)(1995-1#1)(1995-10#4)(1995-11#5)(1995-12#6)(1995-2#1)(1995-3#17)(1995-4#2)(1995-5#3)(1995-6#2)(1995-8#4)(1996-1#9)(1996-11#3)(1996-12#3)(1996-2#6)(1996-3#5)(1996-4#3)(1996-5#3)(1996-6#2)(1996-7#4)(1996-8#3)(1997-1#3)(1997-2#1)(1997-3#5)(1997-4#3)(1997-6#3)(1997-7#5)(1997-8#5)(1997-9#1)(2004-11#2)(2004-8#1)(2004-9#4)(2005-10#1)(2005-11#11)(2005-4#2)(2005-5#1)(2006-11#3)(2006-12#4)(2006-2#3)(2006-4#1)(2006-5#2)(2006-6#6)(2006-7#2)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#31)(2007-12#34)(2007-4#3)(2007-5#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#7)(2008-10#31)(2008-11#20)(2008-12#14)(2008-2#44)(2008-3#51)(2008-4#5)(2008-5#4)(2008-6#8)(2008-7#11)(2008-8#24)(2008-9#8)(2009-10#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#11)(2009-6#1)(2009-7#11)(2009-8#7)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-2#6)(2010-3#8)(2010-4#6)(2010-5#4)(2010-7#1)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#5)(2011-3#2)(2012-1#6)(2012-12#8)(2012-2#15)(2012-3#1)(2013-1#21)(2013-7#15)(2013-8#2)
orientation)##3##1##(2008-10#1)(2008-2#2)
orientation-##2##1##(1992-7#1)(2007-11#1)
orientation-conserved transfer##2##2##(1993-11#2)
orientation-contrast-sensitive modules##2##2##(1995-12#2)
orientation-dependent##4##1##(1995-1#1)(1995-11#1)(1995-4#1)(2008-8#1)
orientation-independent##2##1##(1995-3#1)(2008-8#1)
orientation-patterned GaAs##2##2##(2007-11#2)
orientation-patterned##3##1##(2007-11#3)
orientation-sensitive mechanisms##2##2##(1992-7#2)
orientational birefringence##2##2##(2008-3#2)
orientational changes##2##2##(1994-11#2)
orientational constraints##2##2##(1995-10#2)
orientational disorder##3##2##(1991-11#1)(1991-2#1)(1994-5#1)
orientational distribution of##3##3##(1994-11#1)(2006-10#2)
orientational distribution##4##2##(1994-11#1)(2006-10#2)(2008-3#1)
orientational order in##2##3##(1996-2#1)(1996-4#1)
orientational order##8##2##(1990-2#2)(1992-1#1)(1995-7#1)(1996-2#1)(1996-4#3)
orientational##45##1##(1990-2#2)(1991-11#1)(1991-2#1)(1991-5#1)(1992-1#2)(1992-12#1)(1992-9#1)(1994-11#6)(1994-5#1)(1994-8#1)(1995-10#2)(1995-11#1)(1995-7#1)(1996-2#1)(1996-4#3)(1996-8#1)(2006-10#3)(2006-12#2)(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#2)(2008-3#4)(2008-8#1)(2011-2#1)
orientations (i##2##2##(2007-12#1)(2010-7#1)
orientations and##8##2##(1995-5#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-7#1)(2010-7#2)
orientations are##4##2##(1994-8#1)(2007-12#1)(2008-3#1)(2008-6#1)
orientations for the##4##3##(1994-9#1)(1995-8#1)(2008-3#2)
orientations for##7##2##(1991-5#1)(1994-9#1)(1995-8#1)(1997-4#1)(2008-3#3)
orientations in the##2##3##(1997-8#1)(2011-2#1)
orientations in##4##2##(1997-8#1)(2005-11#1)(2007-9#1)(2011-2#1)
orientations of the optical##2##4##(2008-3#2)
orientations of the##17##3##(1991-3#1)(1991-9#1)(1992-6#2)(1995-3#1)(1996-10#1)(1996-11#1)(1997-4#1)(2006-11#1)(2007-11#1)(2008-2#2)(2008-3#3)(2010-5#1)(2012-2#1)
orientations of##29##2##(1991-3#1)(1991-9#1)(1992-6#2)(1993-8#2)(1995-11#1)(1995-3#1)(1996-10#1)(1996-11#1)(1997-4#1)(1997-7#1)(2006-11#1)(2007-11#2)(2007-12#1)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-7#1)(2010-5#1)(2012-2#1)(2013-1#1)
orientations relative to the##2##4##(2008-2#1)(2013-1#1)
orientations were##4##2##(2007-4#1)(2010-3#1)(2011-2#2)
orientations with respect to the##2##5##(1995-10#1)(2008-11#1)
orientations##120##1##(1990-11#3)(1991-2#1)(1991-3#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-12#1)(1993-8#2)(1994-5#2)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-4#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2004-7#1)(2005-11#2)(2006-11#1)(2007-11#2)(2007-12#5)(2007-4#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#17)(2008-3#15)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-3#2)(2010-5#1)(2010-7#4)(2011-2#6)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)
oriented along the##2##3##(2007-12#1)(2008-5#1)
oriented along##4##2##(2006-11#2)(2007-12#1)(2008-5#1)
oriented and##7##2##(1991-3#2)(1995-10#1)(2008-10#1)(2009-9#1)(2010-4#1)(2010-8#1)
oriented anisotropic##2##2##(2007-11#1)(2008-2#1)
oriented at 45 degrees##2##4##(1992-7#1)(2007-11#1)
oriented at the##3##3##(1995-10#1)(2007-12#1)(2009-9#1)
oriented at##10##2##(1992-7#1)(1995-10#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-6#1)(2009-7#1)(2009-9#1)(2011-12#1)
oriented away from the##3##4##(1995-1#1)(2008-3#1)(2009-12#1)
oriented fibers##2##2##(2008-2#1)(2008-5#1)
oriented films##2##2##(2007-11#1)(2007-12#1)
oriented from##2##2##(2008-10#1)(2009-11#1)
oriented ice crystals##2##3##(2008-3#2)
oriented ice##3##2##(2008-2#1)(2008-3#2)
oriented in a##6##3##(1997-4#1)(2006-11#1)(2006-5#1)(2008-11#1)(2008-3#1)(2012-2#1)
oriented in the same direction as the##2##7##(1994-12#1)(2007-12#1)
oriented in the same direction##3##5##(1991-7#1)(1994-12#1)(2007-12#1)
oriented in the##13##3##(1991-10#1)(1991-7#1)(1991-9#1)(1994-12#1)(2006-11#1)(2006-6#1)(2007-12#1)(2008-3#2)(2008-8#1)(2009-11#1)(2009-7#1)(2010-12#1)
oriented in##24##2##(1991-10#1)(1991-2#1)(1991-7#1)(1991-9#1)(1993-11#1)(1994-12#1)(1996-7#1)(1997-4#1)(2006-11#2)(2006-5#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-8#1)(2009-11#1)(2009-7#1)(2010-12#1)(2012-2#1)
oriented line-elements##2##2##(1995-12#2)
oriented molecules in##2##3##(2008-1#1)(2008-3#1)
oriented molecules##3##2##(2008-1#2)(2008-3#1)
oriented opposite to the##2##4##(2008-5#1)(2008-6#1)
oriented parallel to the##6##4##(1993-9#1)(1996-4#1)(2007-11#1)(2008-11#1)(2009-10#1)(2010-4#1)
oriented particles##2##2##(2008-3#2)
oriented perpendicular to the##5##4##(1994-12#1)(1995-5#1)(2007-11#1)(2007-12#1)(2010-4#1)
oriented poly(tetrafluoroethylene)##2##2##(2007-11#1)(2008-3#1)
oriented research##2##2##(1993-3#1)(2007-8#1)
oriented samples##2##2##(1991-2#1)(1995-10#1)
oriented than##2##2##(2007-12#1)(2011-1#1)
oriented to the##3##3##(1993-2#1)(2008-4#1)(2013-8#1)
oriented to##7##2##(1993-2#1)(1995-2#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-5#1)(2013-8#1)
oriented toward the##5##3##(1990-2#1)(1991-12#1)(1994-3#1)(1995-1#1)(2010-5#1)
oriented toward##9##2##(1990-2#1)(1991-12#1)(1992-1#1)(1994-3#1)(1995-1#1)(2009-5#1)(2010-5#1)(2011-2#2)
oriented towards the##4##3##(1995-3#1)(2008-3#1)(2008-5#1)(2011-1#1)
oriented towards##7##2##(1995-3#1)(1995-8#1)(2006-5#1)(2007-11#1)(2008-3#1)(2008-5#1)(2011-1#1)
oriented treatment##3##2##(1990-5#1)(2009-7#1)(2011-1#1)
oriented with##5##2##(1993-11#1)(1993-7#1)(2007-12#1)(2008-2#1)(2009-5#1)
oriented##244##1##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#3)(1991-4#1)(1991-7#2)(1991-9#1)(1992-1#2)(1992-7#2)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#2)(1993-7#2)(1993-9#1)(1994-11#2)(1994-12#4)(1994-3#1)(1994-9#2)(1995-1#2)(1995-10#4)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#2)(1996-4#2)(1996-5#1)(1996-7#1)(1997-1#3)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-9#2)(2005-11#4)(2005-8#1)(2006-10#2)(2006-11#4)(2006-12#2)(2006-5#2)(2006-6#1)(2007-10#3)(2007-11#9)(2007-12#10)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#8)(2008-11#5)(2008-2#19)(2008-3#25)(2008-4#4)(2008-5#6)(2008-6#7)(2008-7#1)(2008-8#4)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#4)(2009-12#1)(2009-5#2)(2009-7#4)(2009-9#2)(2010-11#1)(2010-12#1)(2010-4#5)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#8)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-8#1)(2013-1#4)(2013-8#1)
orienting reflex##3##2##(1992-4#1)(2012-1#1)(2013-8#1)
orienting tasks##2##2##(2007-4#1)(2008-11#1)
orienting the##7##2##(1991-2#1)(1994-8#2)(1996-1#1)(1997-2#1)(1997-4#1)(2009-4#1)
orienting themselves on##2##3##(1994-8#2)
orienting toward##2##2##(1994-1#1)(2009-2#1)
orienting##23##1##(1991-2#1)(1992-4#1)(1992-7#1)(1993-11#1)(1994-1#1)(1994-8#4)(1995-3#1)(1996-1#1)(1997-2#1)(1997-4#1)(2007-4#2)(2008-11#1)(2008-4#1)(2009-2#1)(2009-4#1)(2011-1#1)(2012-1#1)(2013-8#2)
orifice and##3##2##(2007-8#1)(2011-1#1)(2011-2#1)
orifice in the##3##3##(2013-1#1)(2013-8#2)
orifice in##4##2##(2009-10#1)(2013-1#1)(2013-8#2)
orifice surgery##3##2##(2010-12#2)(2010-6#1)
orifice transluminal endoscopic##2##3##(2009-2#1)(2010-12#1)
orifice##31##1##(1995-11#1)(1997-3#1)(2007-3#1)(2007-8#6)(2008-10#2)(2008-5#6)(2008-9#1)(2009-10#1)(2009-2#1)(2010-12#3)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
orifices##7##1##(1991-6#1)(2006-10#2)(2007-8#1)(2008-10#2)(2012-12#1)
origin (fragment##2##2##(1997-6#2)
origin and a##3##3##(1990-3#1)(1992-12#1)(2011-1#1)
origin and are##2##3##(2007-6#1)(2007-8#1)
origin and development##2##3##(1992-11#1)(2006-5#1)
origin and distribution of##2##4##(1992-12#1)(1997-1#1)
origin and evolution of the##3##5##(2008-5#1)(2008-7#1)(2012-2#1)
origin and evolution of##6##4##(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
origin and fate of##2##4##(2008-7#1)(2011-1#1)
origin and function##2##3##(1991-12#1)(1997-6#1)
origin and functional##2##3##(1997-1#1)(2006-10#1)
origin and host##2##3##(2005-11#1)(2008-10#1)
origin and in##2##3##(1991-9#1)(1996-4#1)
origin and may##2##3##(1994-3#1)(1995-3#1)
origin and possible##2##3##(1995-12#1)(1997-5#1)
origin and spread##2##3##(2007-12#1)(2008-9#1)
origin and that##2##3##(1994-9#1)(2007-12#1)
origin and the##11##3##(1993-12#1)(1993-6#1)(1995-9#1)(2008-10#3)(2008-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
origin and to##2##3##(1990-3#1)(1992-5#1)
origin and was##2##3##(1994-8#1)(2007-5#1)
origin and##122##2##(1990-3#3)(1991-12#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-5#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-8#1)(1995-9#1)(1996-12#2)(1996-4#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-11#2)(2005-8#1)(2006-10#4)(2006-5#2)(2006-7#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-7#6)(2008-8#3)(2008-9#3)(2009-2#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#7)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-7#1)(2013-8#1)
origin are##7##2##(1991-10#1)(1991-6#1)(1991-9#1)(2008-11#1)(2008-4#1)(2010-12#1)(2011-2#1)
origin as well as##2##4##(2009-4#1)(2011-2#1)
origin as well##3##3##(2009-4#1)(2011-2#1)(2012-3#1)
origin as##8##2##(1992-12#1)(2004-4#1)(2008-10#1)(2009-4#1)(2011-12#1)(2011-2#2)(2012-3#1)
origin at##3##2##(1992-1#1)(2005-5#1)(2012-12#1)
origin based on##2##3##(2011-1#1)(2013-1#1)
origin binding protein##2##3##(1994-3#1)(1995-3#1)
origin by##5##2##(1991-10#1)(1996-5#1)(1996-8#1)(2008-12#1)(2012-2#1)
origin can be##3##3##(1992-5#1)(2007-12#1)(2008-5#1)
origin can##5##2##(1992-5#1)(1994-9#1)(2007-12#1)(2008-5#1)(2011-2#1)
origin for modern humans##3##4##(1994-3#2)(1996-4#1)
origin for the##5##3##(1991-12#1)(1992-11#1)(2008-10#1)(2009-6#1)(2011-1#1)
origin for these##4##3##(1990-5#1)(1997-4#1)(2006-12#1)(2008-4#1)
origin for##24##2##(1990-5#1)(1991-12#1)(1992-11#1)(1994-12#1)(1994-3#3)(1995-11#1)(1996-4#1)(1997-3#1)(1997-4#1)(1997-5#1)(2006-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-7#1)(2009-6#1)(2011-1#1)(2013-1#2)
origin from a##2##3##(2008-6#1)(2008-7#1)
origin from an##2##3##(1997-1#1)(2007-12#1)
origin from the##8##3##(1990-11#1)(1992-2#1)(1993-12#1)(1997-2#1)(2007-8#1)(2008-12#1)(2010-12#1)(2011-2#1)
origin from##19##2##(1990-11#1)(1992-2#1)(1993-12#1)(1997-1#1)(1997-2#1)(2006-10#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-12#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-1#2)
origin has been##2##3##(1991-12#1)(2008-1#1)
origin has##3##2##(1991-12#1)(2006-10#1)(2008-1#1)
origin have been reported##2##4##(2006-10#1)(2013-1#1)
origin have##3##2##(2006-10#2)(2013-1#1)
origin in a##2##3##(2008-11#1)(2008-7#1)
origin in an##2##3##(1993-10#1)(1993-8#1)
origin in the##16##3##(1990-2#1)(1992-12#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#2)(2008-7#1)(2009-2#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
origin in##40##2##(1990-2#1)(1992-12#1)(1993-1#1)(1993-10#1)(1993-2#1)(1993-8#1)(1995-2#1)(1995-5#1)(1996-6#1)(2007-11#1)(2008-10#6)(2008-11#3)(2008-2#2)(2008-5#2)(2008-7#2)(2008-8#2)(2009-2#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#4)
origin is also##2##3##(2008-10#1)(2008-5#1)
origin is the##2##3##(2006-10#1)(2006-11#1)
origin is##17##2##(1990-4#1)(1992-3#1)(1993-8#1)(1996-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2008-10#2)(2008-2#1)(2008-5#2)(2009-8#1)(2010-6#1)(2012-2#1)(2013-7#1)
origin may be##2##3##(2008-10#1)(2009-9#1)
origin may##3##2##(2006-8#1)(2008-10#1)(2009-9#1)
origin of DNA replication##3##4##(1990-11#1)(1990-3#1)(1994-12#1)
origin of DNA##4##3##(1990-11#1)(1990-3#1)(1994-12#1)(2008-12#1)
origin of F##2##3##(2008-10#2)
origin of Heliosperma##2##3##(2010-6#2)
origin of a##9##3##(1992-8#1)(1997-6#1)(2006-11#1)(2008-12#1)(2008-5#1)(2009-2#1)(2010-12#1)(2012-11#1)(2012-2#1)
origin of an##2##3##(2008-4#1)(2008-5#1)
origin of bidirectional replication (ori beta)##2##6##(1994-12#2)
origin of both##2##3##(2007-11#1)(2008-10#1)
origin of bronchial##2##3##(1990-8#1)(2006-6#1)
origin of differences##2##3##(1997-2#1)(2008-8#1)
origin of human##2##3##(2011-1#1)(2013-1#1)
origin of humans##4##3##(1996-11#4)
origin of inversions##2##3##(2013-1#2)
origin of most##2##3##(2011-2#1)(2012-12#1)
origin of organic##2##3##(2007-8#1)(2008-10#1)
origin of ovarian cancer##2##4##(2013-8#2)
origin of plasmid DNA replication##2##5##(1994-3#2)
origin of primary##4##3##(1990-7#1)(2008-10#1)(2008-6#1)(2009-12#1)
origin of radial##2##3##(2007-7#1)(2008-7#1)
origin of replication of the##3##5##(1990-11#1)(1992-12#1)(1995-8#1)
origin of replication##23##3##(1990-11#1)(1990-5#1)(1992-12#4)(1993-11#1)(1993-12#1)(1994-11#1)(1994-12#1)(1995-1#2)(1995-2#2)(1995-3#3)(1995-8#1)(1996-10#1)(2006-10#1)(2008-10#2)(2011-2#1)
origin of some##3##3##(2008-10#1)(2012-12#2)
origin of the brain##2##4##(2007-12#2)
origin of the cells##2##4##(1994-12#1)(2010-12#1)
origin of the contamination##2##4##(2006-8#1)(2008-10#1)
origin of the disease##3##4##(1993-1#1)(1995-11#1)(2009-3#1)
origin of the left##6##4##(2006-6#1)(2007-7#1)(2008-12#1)(2008-4#2)(2013-8#1)
origin of the maize genome##2##5##(2008-7#2)
origin of the observed##3##4##(2006-10#1)(2007-11#1)(2008-3#1)
origin of the pathogen##2##4##(2008-10#1)(2012-2#1)
origin of the poor##2##4##(2006-10#1)(2008-10#1)
origin of the right coronary artery from##2##7##(2007-8#1)(2009-8#1)
origin of the right coronary##3##5##(2007-8#2)(2009-8#1)
origin of the right##4##4##(2006-2#1)(2007-8#2)(2009-8#1)
origin of the term &quot##2##5##(2006-9#1)(2008-9#1)
origin of the##156##3##(1990-5#2)(1990-7#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-9#2)(1995-11#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-4#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-8#1)(2004-2#1)(2004-3#2)(2005-10#1)(2005-12#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-3#2)(2006-6#4)(2006-8#2)(2006-9#1)(2007-11#6)(2007-12#10)(2007-5#3)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#14)(2008-11#2)(2008-12#2)(2008-2#8)(2008-3#4)(2008-4#3)(2008-5#3)(2008-7#7)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#2)(2010-12#2)(2010-2#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-12#6)(2012-2#3)(2012-3#1)(2013-8#1)
origin of these species##3##4##(1996-6#1)(2008-9#1)(2010-3#1)
origin of these##13##3##(1990-1#1)(1992-10#1)(1995-1#1)(1996-6#1)(2006-10#2)(2006-9#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-3#1)
origin of this##20##3##(1990-2#1)(1991-10#1)(1994-11#1)(1995-8#1)(1996-2#1)(1996-9#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
origin of##419##2##(1990-1#1)(1990-11#2)(1990-2#1)(1990-3#3)(1990-5#3)(1990-7#4)(1990-8#2)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#1)(1991-9#4)(1992-10#1)(1992-12#7)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-8#1)(1994-11#2)(1994-12#6)(1994-3#4)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#3)(1995-11#6)(1995-2#5)(1995-3#5)(1995-5#2)(1995-6#1)(1995-8#3)(1996-10#1)(1996-11#5)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#3)(1996-5#3)(1996-6#1)(1996-7#1)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#4)(1997-6#3)(1997-8#3)(2004-2#1)(2004-3#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-4#1)(2006-10#11)(2006-11#2)(2006-12#6)(2006-2#1)(2006-3#2)(2006-5#3)(2006-6#5)(2006-7#1)(2006-8#2)(2006-9#2)(2007-11#8)(2007-12#17)(2007-5#3)(2007-6#2)(2007-7#2)(2007-8#6)(2007-9#3)(2008-1#2)(2008-10#43)(2008-11#6)(2008-12#5)(2008-2#8)(2008-3#8)(2008-4#9)(2008-5#8)(2008-6#3)(2008-7#13)(2008-8#8)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#2)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#4)(2010-7#2)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#13)(2012-1#3)(2012-11#1)(2012-12#13)(2012-2#6)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#5)
origin on the##2##3##(1994-12#1)(2012-3#1)
origin or##8##2##(1993-9#1)(2006-10#1)(2008-10#2)(2008-9#1)(2011-1#1)(2011-2#2)
origin related##2##2##(2007-11#1)(2008-10#1)
origin should##2##2##(1996-11#1)(2008-8#1)
origin that are##2##3##(2008-10#1)(2008-11#1)
origin that##11##2##(1992-8#1)(1995-2#1)(1996-3#1)(2006-7#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-11#2)(2011-2#1)(2012-3#1)
origin theory##3##2##(2008-8#2)(2013-8#1)
origin to the##2##3##(2007-11#1)(2008-1#1)
origin to##10##2##(1992-5#1)(1994-10#1)(1996-4#1)(2007-11#1)(2007-5#1)(2008-1#2)(2008-11#1)(2009-5#1)(2013-1#1)
origin using##3##2##(1994-5#1)(2008-12#1)(2011-2#1)
origin was determined by##2##4##(1991-9#1)(2010-8#1)
origin was##9##2##(1991-9#1)(1997-6#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-7#2)(2010-8#1)(2013-1#1)
origin we##2##2##(1994-8#1)(2008-11#1)
origin were identified##2##3##(2006-6#1)(2007-2#1)
origin were##11##2##(1991-11#1)(1993-1#1)(1997-4#1)(2005-11#1)(2006-6#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-5#1)(2008-8#1)
origin which##5##2##(1993-10#1)(1995-2#1)(2009-10#1)(2009-4#1)(2012-2#1)
origin who##2##2##(1996-7#1)(2012-2#1)
origin with the##2##3##(1992-3#1)(2012-2#1)
origin with##5##2##(1992-3#1)(1994-3#1)(2008-10#1)(2010-12#1)(2012-2#1)
origin##1326##1##(1990-1#2)(1990-11#5)(1990-12#3)(1990-2#7)(1990-3#9)(1990-4#4)(1990-5#6)(1990-6#1)(1990-7#4)(1990-8#3)(1990-9#7)(1991-1#1)(1991-10#6)(1991-11#7)(1991-12#9)(1991-2#2)(1991-3#4)(1991-5#6)(1991-6#4)(1991-8#3)(1991-9#12)(1992-1#2)(1992-10#2)(1992-11#6)(1992-12#15)(1992-2#2)(1992-3#7)(1992-4#1)(1992-5#5)(1992-7#1)(1992-8#3)(1992-9#3)(1993-1#3)(1993-10#2)(1993-11#4)(1993-12#6)(1993-2#4)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#2)(1993-8#6)(1993-9#2)(1994-10#2)(1994-11#3)(1994-12#14)(1994-2#2)(1994-3#15)(1994-4#1)(1994-5#5)(1994-6#6)(1994-7#2)(1994-8#6)(1994-9#4)(1995-1#4)(1995-10#1)(1995-11#9)(1995-12#4)(1995-2#10)(1995-3#13)(1995-5#5)(1995-6#2)(1995-8#8)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#7)(1996-12#4)(1996-2#4)(1996-3#5)(1996-4#7)(1996-5#6)(1996-6#2)(1996-7#5)(1996-8#3)(1996-9#6)(1997-1#6)(1997-2#5)(1997-3#8)(1997-4#12)(1997-5#3)(1997-6#8)(1997-7#4)(1997-8#9)(2004-10#1)(2004-2#1)(2004-3#2)(2004-4#1)(2004-9#1)(2005-10#5)(2005-11#7)(2005-12#2)(2005-4#1)(2005-5#3)(2005-7#1)(2005-8#2)(2006-10#43)(2006-11#5)(2006-12#13)(2006-2#2)(2006-3#3)(2006-4#1)(2006-5#6)(2006-6#7)(2006-7#5)(2006-8#8)(2006-9#6)(2007-1#3)(2007-10#3)(2007-11#17)(2007-12#29)(2007-2#5)(2007-3#3)(2007-5#6)(2007-6#3)(2007-7#14)(2007-8#24)(2007-9#6)(2008-1#8)(2008-10#144)(2008-11#29)(2008-12#11)(2008-2#16)(2008-3#10)(2008-4#17)(2008-5#36)(2008-6#5)(2008-7#34)(2008-8#24)(2008-9#12)(2009-1#2)(2009-10#2)(2009-12#2)(2009-2#6)(2009-3#1)(2009-4#7)(2009-5#8)(2009-6#4)(2009-7#2)(2009-8#12)(2009-9#5)(2010-1#4)(2010-10#4)(2010-11#1)(2010-12#13)(2010-2#4)(2010-3#8)(2010-4#5)(2010-5#1)(2010-6#7)(2010-7#7)(2010-8#10)(2010-9#2)(2011-1#21)(2011-12#5)(2011-2#44)(2011-3#1)(2012-1#7)(2012-11#6)(2012-12#25)(2012-2#26)(2012-3#16)(2012-7#1)(2012-9#1)(2013-1#36)(2013-7#4)(2013-8#21)
origin&quot##2##1##(2007-8#1)(2009-2#1)
origin(s) of##3##2##(1997-9#1)(2009-2#2)
origin)##6##1##(1994-8#1)(1995-12#1)(1997-3#1)(2007-12#1)(2007-9#1)(2012-2#1)
origin]##6##1##(1992-10#1)(1994-4#1)(1995-9#1)(2005-11#1)(2006-8#1)(2008-10#1)
original DNA##3##2##(1995-3#1)(2008-10#1)(2008-8#1)
original ICH Score##2##3##(2012-3#2)
original activity after##3##3##(2007-8#1)(2008-10#2)
original activity##7##2##(1997-7#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-5#2)
original analytical##2##2##(2007-8#1)(2008-3#1)
original and##16##2##(1990-3#1)(1996-12#1)(1996-8#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2009-4#1)(2011-3#1)
original application##4##2##(1995-6#1)(2007-8#1)(2008-2#1)(2008-5#1)
original approach to##2##3##(2007-11#1)(2009-2#1)
original article##5##2##(2009-3#1)(2009-4#1)(2013-1#3)
original articles##4##2##(2007-2#1)(2008-7#1)(2011-1#1)(2013-1#1)
original brand medicines##2##3##(2011-1#2)
original brand##3##2##(2011-1#3)
original clinical##3##2##(1990-9#1)(1993-12#1)(2006-10#1)
original color and##2##3##(2008-10#1)(2008-3#1)
original color##3##2##(2008-10#1)(2008-3#1)(2010-4#1)
original compound##3##2##(2007-11#2)(2008-9#1)
original concept of##4##3##(2007-3#1)(2008-10#1)(2010-12#1)(2012-12#1)
original contributions##2##2##(2006-6#1)(2010-7#1)
original culture##2##2##(2008-8#2)
original data was##3##3##(2008-10#2)(2010-8#1)
original data##21##2##(1995-5#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-8#2)(2008-10#9)(2008-3#2)(2008-8#2)(2010-8#1)(2012-1#1)
original definition##2##2##(1990-10#1)(2006-6#1)
original design##2##2##(1992-2#1)(2006-5#1)
original diagnosis##2##2##(1992-8#1)(2010-10#1)
original equipment manufacturers (OEMs)##2##4##(1996-2#1)(2008-7#1)
original expectations##2##2##(1997-2#1)(2008-3#1)
original extract##2##2##(2008-10#1)(2008-5#1)
original features##2##2##(2008-6#2)
original finding##2##2##(1990-8#1)(1991-8#1)
original form##3##2##(2006-10#1)(2007-5#1)(2008-10#1)
original fructosamine assay##2##3##(1992-4#2)
original host##4##2##(2008-10#3)(2008-8#1)
original in##2##2##(2006-3#1)(2008-3#1)
original infection##2##2##(1990-6#1)(2008-10#1)
original information is##2##3##(2008-3#2)
original information##3##2##(2008-3#3)
original level##7##2##(1990-2#1)(1992-1#1)(1992-9#1)(1994-5#1)(1996-7#1)(2006-3#1)(2008-11#1)
original location##3##2##(2008-10#1)(2009-4#1)(2012-12#1)
original material##2##2##(2008-10#1)(2011-2#1)
original method for##2##3##(1995-6#1)(2008-2#1)
original method of##3##3##(2008-2#1)(2008-6#1)(2012-3#1)
original method##11##2##(1992-4#1)(1992-9#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-6#1)(2012-3#1)
original methods##3##2##(2006-4#1)(2007-8#1)(2009-4#1)
original model##8##2##(1995-1#1)(2006-10#2)(2007-1#1)(2008-2#2)(2013-7#1)(2013-8#1)
original operation##2##2##(1990-6#1)(2008-9#1)
original papers##3##2##(2009-4#1)(2010-12#1)(2013-1#1)
original procedure##3##2##(1990-12#1)(2007-8#1)(2008-5#1)
original publication in##2##3##(2008-4#1)(2010-5#1)
original publication##3##2##(2008-11#1)(2008-4#1)(2010-5#1)
original publications##2##2##(1990-9#1)(2005-8#1)
original renal disease##2##3##(2008-1#2)
original research##4##2##(2007-11#1)(2007-2#1)(2008-2#1)(2009-10#1)
original samples##3##2##(2008-10#2)(2008-7#1)
original scale##2##2##(1995-4#1)(2012-2#1)
original schedule##2##2##(1990-2#2)
original sequence##3##2##(1994-12#1)(2008-3#1)(2008-8#1)
original set##3##2##(2013-1#3)
original signal##6##2##(2007-11#2)(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#1)
original spatial##3##2##(1997-8#1)(2007-12#1)(2008-3#1)
original substrate##2##2##(2008-5#1)(2011-2#1)
original technique of##4##3##(1995-9#1)(2007-8#1)(2008-3#1)(2009-2#1)
original technique##9##2##(1995-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-3#2)(2008-4#1)(2009-2#1)(2009-5#1)
original validation##2##2##(2007-12#1)(2009-11#1)
original value##5##2##(1990-11#1)(1992-10#1)(1992-6#1)(2008-5#1)(2008-8#1)
original version of the##2##4##(1994-2#1)(2008-1#1)
original version##8##2##(1994-2#1)(2007-8#1)(2008-1#1)(2008-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
original video-assisted technique of##2##4##(2007-8#2)
original weight##2##2##(1990-11#1)(1992-8#1)
original##755##1##(1990-10#4)(1990-11#3)(1990-12#1)(1990-2#6)(1990-3#3)(1990-4#1)(1990-5#2)(1990-6#4)(1990-7#2)(1990-8#1)(1990-9#3)(1991-1#2)(1991-12#3)(1991-2#2)(1991-5#3)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#2)(1992-2#2)(1992-4#3)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#5)(1993-11#1)(1993-12#2)(1993-3#2)(1993-4#1)(1993-5#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-10#3)(1994-11#1)(1994-12#10)(1994-2#6)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-4#2)(1995-5#5)(1995-6#4)(1995-9#2)(1996-1#1)(1996-10#1)(1996-12#5)(1996-2#3)(1996-4#2)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#2)(1997-4#3)(1997-6#1)(1997-7#3)(1997-8#3)(2004-1#1)(2004-2#2)(2004-9#2)(2005-10#1)(2005-11#6)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#10)(2006-11#2)(2006-12#3)(2006-2#1)(2006-3#3)(2006-4#3)(2006-5#2)(2006-6#6)(2006-8#2)(2007-1#4)(2007-10#3)(2007-11#20)(2007-12#20)(2007-2#4)(2007-3#2)(2007-4#4)(2007-5#3)(2007-6#2)(2007-7#1)(2007-8#20)(2007-9#2)(2008-1#10)(2008-10#82)(2008-11#18)(2008-12#6)(2008-2#42)(2008-3#49)(2008-4#10)(2008-5#31)(2008-6#11)(2008-7#13)(2008-8#14)(2008-9#11)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#9)(2009-3#3)(2009-4#6)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#7)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#4)(2010-9#2)(2011-1#11)(2011-12#1)(2011-2#12)(2011-3#2)(2012-1#6)(2012-11#4)(2012-12#8)(2012-2#9)(2012-3#10)(2013-1#26)(2013-7#2)(2013-8#11)
originality and##2##2##(2010-7#1)(2011-1#1)
originality of##4##2##(1992-10#1)(1992-6#1)(1997-2#1)(2013-7#1)
originality##9##1##(1992-10#1)(1992-6#1)(1997-2#1)(1997-5#1)(2008-8#1)(2010-7#1)(2011-1#1)(2013-7#2)
originally assigned##2##2##(2006-2#1)(2008-10#1)
originally based on##4##3##(2007-11#1)(2007-8#1)(2009-10#1)(2012-12#1)
originally characterized##2##2##(2008-7#1)(2012-2#1)
originally conceived##2##2##(2008-11#1)(2012-2#1)
originally derived by##2##3##(2008-2#1)(2008-3#1)
originally derived from a##2##4##(2005-9#1)(2007-12#1)
originally derived from##4##3##(1997-6#1)(2005-9#1)(2007-12#1)(2008-2#1)
originally derived##6##2##(1997-6#1)(2005-9#1)(2007-12#1)(2008-2#2)(2008-3#1)
originally described as an##2##4##(1994-12#1)(2006-10#1)
originally described as##5##3##(1993-9#1)(1994-12#1)(2006-10#1)(2008-5#1)(2011-1#1)
originally described by##7##3##(1997-1#1)(1997-8#1)(2008-2#1)(2008-4#1)(2010-12#1)(2012-12#1)(2012-3#1)
originally described in the##2##4##(2006-10#1)(2008-10#1)
originally described##17##2##(1993-9#1)(1994-12#1)(1997-1#1)(1997-8#1)(2006-10#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)
originally designed as##2##3##(1992-12#1)(2008-10#1)
originally designed for##4##3##(2008-10#2)(2008-4#1)(2008-5#1)
originally designed to##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
originally designed##9##2##(1992-12#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#1)(2013-1#1)
originally detected in##2##3##(1992-9#1)(2010-4#1)
originally detected##4##2##(1992-9#1)(1993-6#1)(1995-10#1)(2010-4#1)
originally developed as##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
originally developed at##2##3##(2008-2#1)(2008-5#1)
originally developed by##4##3##(1990-8#1)(2008-3#2)(2008-5#1)
originally developed for##10##3##(2008-10#2)(2008-2#2)(2008-4#3)(2008-7#1)(2008-9#1)(2012-3#1)
originally developed questionnaire##2##3##(2009-11#1)(2009-7#1)
originally developed##25##2##(1990-8#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2012-3#1)
originally disclosed in##2##3##(2005-8#2)
originally discovered as##2##3##(2008-1#1)(2012-12#1)
originally discovered in##2##3##(1991-8#1)(2007-8#1)
originally discovered##5##2##(1991-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2012-12#1)
originally emerged##2##2##(2008-4#1)(2013-1#1)
originally for##2##2##(1997-6#1)(2007-8#1)
originally formed##2##2##(2008-10#1)(2013-1#1)
originally found in##3##3##(1992-10#1)(1993-8#1)(2008-10#1)
originally found##4##2##(1992-10#1)(1993-8#1)(1997-7#1)(2008-10#1)
originally identified as a##2##4##(1997-4#1)(2012-12#1)
originally identified as the##2##4##(1991-6#1)(2010-8#1)
originally identified as##8##3##(1990-5#1)(1991-6#1)(1993-6#1)(1997-4#1)(2008-10#1)(2010-6#1)(2010-8#1)(2012-12#1)
originally identified in a##2##4##(1990-11#1)(2012-12#1)
originally identified in##4##3##(1990-11#1)(1995-12#1)(2008-1#1)(2012-12#1)
originally identified##13##2##(1990-11#1)(1990-5#1)(1991-12#1)(1991-6#1)(1993-6#1)(1995-12#1)(1997-4#1)(2008-1#1)(2008-10#1)(2010-6#1)(2010-8#1)(2012-12#2)
originally intended##5##2##(1993-5#1)(1996-3#1)(2005-7#1)(2007-10#1)(2010-8#1)
originally introduced to##2##3##(2006-3#1)(2007-12#1)
originally introduced##3##2##(2006-3#1)(2007-12#1)(2008-5#1)
originally isolated from a##2##4##(2008-10#1)(2011-2#1)
originally isolated from human##2##4##(1994-11#1)(2005-8#1)
originally isolated from the##3##4##(2009-3#1)(2010-3#1)(2011-2#1)
originally isolated from##15##3##(1994-11#1)(1996-2#1)(2005-8#1)(2005-9#1)(2008-10#2)(2009-3#1)(2010-3#1)(2011-2#6)(2012-2#1)
originally isolated##17##2##(1994-11#1)(1996-2#1)(2005-8#1)(2005-9#1)(2008-10#4)(2009-3#1)(2010-3#1)(2011-2#6)(2012-2#1)
originally planned##2##2##(2007-2#1)(2013-8#1)
originally present##3##2##(1990-3#1)(2008-10#2)
originally produced##2##2##(2008-11#2)
originally proposed by##7##3##(1990-5#1)(1990-7#1)(1997-2#1)(2006-10#1)(2008-2#1)(2011-1#1)(2012-3#1)
originally proposed to##2##3##(1995-6#1)(2008-3#1)
originally proposed##12##2##(1990-5#1)(1990-7#1)(1995-6#1)(1996-10#1)(1997-2#1)(2005-8#1)(2006-10#1)(2008-2#1)(2008-3#2)(2011-1#1)(2012-3#1)
originally purified from##2##3##(1990-12#1)(1991-8#1)
originally reported##2##2##(1993-4#1)(2008-9#1)
originally scheduled##2##2##(1997-2#1)(2008-5#1)
originally tested##2##2##(1992-6#1)(2009-12#1)
originally thought to have##2##4##(1997-1#1)(2012-2#1)
originally thought to##3##3##(1997-1#1)(2008-4#1)(2012-2#1)
originally thought##7##2##(1997-1#1)(1997-7#1)(2006-10#1)(2007-8#1)(2008-4#1)(2010-12#1)(2012-2#1)
originally transferred##2##2##(1993-8#1)(2012-2#1)
originally used in##2##3##(2007-8#1)(2010-7#1)
originally used##5##2##(2006-4#1)(2007-8#1)(2010-7#1)(2013-1#2)
originally using##2##2##(2008-7#1)(2009-11#1)
originally##241##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#3)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-4#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#1)(2003-11#1)(2005-7#2)(2005-8#5)(2005-9#2)(2006-10#7)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#5)(2008-1#5)(2008-10#26)(2008-11#10)(2008-12#1)(2008-2#10)(2008-3#8)(2008-4#11)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-7#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#9)(2012-1#2)(2012-12#6)(2012-2#8)(2012-3#5)(2013-1#6)(2013-8#2)
originals##2##1##(2007-11#1)(2008-3#1)
originate by##2##2##(1993-3#1)(1996-7#1)
originate from a common##2##4##(1990-5#1)(1996-10#1)
originate from a##9##3##(1990-5#1)(1994-5#1)(1995-1#1)(1996-10#1)(1997-8#1)(2007-12#1)(2008-1#1)(2011-1#1)(2011-12#1)
originate from bone marrow##2##4##(2007-11#1)(2008-1#1)
originate from different##2##3##(1996-9#1)(2012-12#1)
originate from the##20##3##(1990-4#1)(1992-10#1)(1995-3#1)(1997-1#1)(1997-3#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)
originate from##80##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-11#2)(1992-10#1)(1992-12#1)(1992-3#2)(1993-4#3)(1993-6#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-3#1)(1996-10#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#5)(2007-12#8)(2007-2#2)(2007-5#1)(2007-8#1)(2008-1#4)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-1#1)(2009-2#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#3)
originate in the##11##3##(1993-12#1)(1997-4#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2011-12#1)(2011-2#1)
originate in##20##2##(1990-2#1)(1990-6#1)(1993-12#1)(1995-3#1)(1996-5#1)(1997-3#1)(1997-4#1)(2007-12#2)(2007-9#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#1)
originate##113##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#2)(1992-10#1)(1992-12#1)(1992-3#3)(1993-12#1)(1993-3#1)(1993-4#3)(1993-6#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-3#2)(1996-10#1)(1996-5#1)(1996-7#1)(1996-9#2)(1997-1#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#5)(2007-12#11)(2007-2#3)(2007-5#2)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#1)(2009-1#1)(2009-2#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)
originated as##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
originated at the##3##3##(2008-10#1)(2009-12#1)(2009-7#1)
originated by##7##2##(1993-11#1)(1994-12#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#2)
originated from a##6##3##(1993-11#1)(1993-3#1)(1996-2#1)(2006-11#1)(2008-10#1)(2013-7#1)
originated from the right coronary##2##5##(1991-3#1)(2007-8#1)
originated from the##22##3##(1991-3#1)(1995-2#1)(1995-9#1)(1996-9#1)(1997-4#1)(2004-9#1)(2005-11#1)(2006-8#1)(2007-1#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
originated from##76##2##(1991-10#1)(1991-3#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-4#1)(1993-7#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-6#2)(2004-4#1)(2004-9#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-8#2)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#18)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
originated in the##14##3##(1993-12#1)(1994-7#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-4#1)(2009-4#1)(2010-12#1)(2011-2#2)
originated in##25##2##(1993-12#1)(1993-4#1)(1994-7#1)(2004-3#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#1)(2009-2#1)(2009-4#1)(2010-12#1)(2011-2#2)(2012-11#1)
originated the##2##2##(2007-4#1)(2013-1#1)
originated##138##1##(1991-10#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-6#1)(1993-11#2)(1993-12#3)(1993-3#2)(1993-4#2)(1993-7#1)(1994-12#1)(1994-7#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#3)(1997-7#1)(2004-3#1)(2004-4#1)(2004-9#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-12#3)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#28)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-12#1)(2009-2#3)(2009-4#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
originates from a##6##3##(1990-8#1)(2007-11#1)(2008-10#2)(2010-11#1)(2010-6#1)
originates from the right##3##4##(1996-3#1)(2007-8#2)
originates from the##21##3##(1992-12#1)(1992-7#1)(1993-11#1)(1994-2#1)(1996-12#1)(1996-3#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-6#1)(2012-12#1)(2012-2#1)(2012-3#1)
originates from##43##2##(1990-10#1)(1990-8#1)(1992-12#1)(1992-7#1)(1993-11#1)(1994-2#1)(1995-10#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-6#1)(2011-12#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
originates in the##3##3##(2006-10#1)(2008-3#1)(2013-8#1)
originates not only from##2##4##(2008-7#2)
originates##55##1##(1990-10#1)(1990-8#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-11#2)(1994-2#1)(1995-10#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-6#1)(2006-10#2)(2006-12#1)(2007-11#2)(2007-12#2)(2007-8#3)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#4)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-6#1)(2011-12#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#2)
originating from a single##2##4##(2007-12#1)(2008-3#1)
originating from a##12##3##(1995-8#1)(1996-2#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#2)(2009-6#1)(2011-1#1)(2013-1#1)
originating from aromatic##2##3##(1991-4#1)(1997-4#1)
originating from different sources##2##4##(2007-9#1)(2008-10#1)
originating from different##5##3##(2007-12#1)(2007-9#1)(2008-10#2)(2009-8#1)
originating from either##2##3##(1991-2#1)(2007-5#1)
originating from four##2##3##(2010-10#1)(2011-1#1)
originating from or having travelled to##2##6##(2010-12#2)
originating from samples##2##3##(2008-11#1)(2010-9#1)
originating from the central##2##4##(1993-12#1)(1996-8#1)
originating from the cervical spine##2##5##(2006-8#1)(2007-7#1)
originating from the right##2##4##(2007-9#1)(2013-8#1)
originating from the same##2##4##(2007-12#1)(2008-10#1)
originating from the superior cervical##2##5##(1993-5#1)(1994-5#1)
originating from the##61##3##(1991-12#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-5#2)(1995-5#1)(1996-8#1)(1997-6#1)(2004-4#1)(2005-11#2)(2006-12#1)(2006-8#2)(2007-11#2)(2007-12#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#2)
originating from##184##2##(1990-11#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-4#1)(1992-12#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-5#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-4#1)(2005-11#2)(2005-8#1)(2006-12#2)(2006-8#3)(2007-1#2)(2007-11#4)(2007-12#5)(2007-2#1)(2007-3#1)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#4)(2007-9#4)(2008-10#37)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#2)(2009-5#2)(2009-6#3)(2009-8#2)(2010-10#2)(2010-12#5)(2010-4#2)(2010-5#2)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#3)(2012-12#6)(2012-2#2)(2012-3#1)(2012-9#1)(2013-1#7)(2013-8#2)
originating in lateral recess of the fourth ventricle##2##8##(2013-1#2)
originating in the##14##3##(1992-6#1)(1992-8#1)(1994-3#1)(1994-5#1)(1995-5#2)(2006-10#1)(2007-2#1)(2008-10#2)(2008-7#2)(2010-11#1)(2013-1#1)
originating in##23##2##(1992-6#1)(1992-8#1)(1994-3#1)(1994-5#1)(1995-5#2)(1997-3#1)(2006-10#1)(2006-6#1)(2007-2#2)(2007-8#1)(2008-10#4)(2008-7#2)(2010-11#1)(2012-2#1)(2013-1#3)
originating##221##1##(1990-11#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-4#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-2#1)(1994-3#1)(1994-5#3)(1995-5#3)(1995-8#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#1)(2004-3#1)(2004-4#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-12#2)(2006-5#1)(2006-6#1)(2006-8#3)(2007-1#2)(2007-11#4)(2007-12#5)(2007-2#3)(2007-3#1)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#5)(2007-9#4)(2008-10#43)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#6)(2008-4#4)(2008-5#4)(2008-6#3)(2008-7#4)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#2)(2009-5#2)(2009-6#3)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#5)(2010-4#2)(2010-5#2)(2010-7#2)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#3)(2012-12#6)(2012-2#4)(2012-3#1)(2012-9#1)(2013-1#10)(2013-8#3)
origination##5##1##(1991-6#1)(2008-2#1)(2009-10#3)
origins and the##3##3##(2007-12#1)(2008-10#1)(2013-1#1)
origins and##22##2##(1991-5#1)(1993-11#1)(1995-11#1)(1997-2#2)(1997-7#2)(2006-11#2)(2006-12#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#2)(2010-6#1)(2013-1#2)
origins are##2##2##(2006-12#1)(2008-7#1)
origins for##6##2##(1997-6#1)(2006-12#1)(2008-7#1)(2010-4#1)(2010-8#1)(2012-12#1)
origins from##2##2##(2008-7#1)(2008-8#1)
origins in##5##2##(2008-10#1)(2008-11#2)(2008-5#1)(2011-1#1)
origins including##2##2##(2008-5#1)(2009-9#1)
origins of DNA replication##3##4##(1990-10#1)(1995-1#1)(2008-7#1)
origins of adult##4##3##(2012-2#2)(2013-1#2)
origins of health##2##3##(1993-2#1)(2012-2#1)
origins of language##2##3##(2006-3#2)
origins of life##3##3##(2006-12#1)(2007-8#1)(2012-2#1)
origins of replication##3##3##(1994-12#1)(1995-2#1)(2010-3#1)
origins of resistance##2##3##(1997-6#1)(2013-1#1)
origins of the##17##3##(1992-9#1)(1994-8#1)(1995-1#1)(2005-10#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-4#1)(2010-7#1)(2012-1#1)(2013-7#1)
origins of these##8##3##(1994-8#1)(1995-2#1)(1996-4#1)(1997-2#1)(2008-11#1)(2009-11#1)(2010-6#1)(2011-1#1)
origins of this##3##3##(1992-8#1)(1996-8#1)(2013-7#1)
origins of unidentified cadavers##2##4##(2008-12#2)
origins of##115##2##(1990-10#2)(1990-7#3)(1991-6#1)(1992-5#2)(1992-8#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-5#1)(1994-12#1)(1994-8#2)(1995-1#3)(1995-2#2)(1996-4#1)(1996-8#1)(1997-2#1)(1997-6#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-12#2)(2006-3#2)(2006-7#3)(2006-8#2)(2007-12#4)(2007-3#1)(2007-8#5)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#2)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#8)(2013-1#6)(2013-7#2)(2013-8#2)
origins to##5##2##(2008-10#1)(2008-11#1)(2009-2#1)(2011-1#1)(2012-12#1)
origins were##3##2##(2008-10#2)(2011-1#1)
origins##248##1##(1990-10#3)(1990-7#3)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-5#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#3)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#2)(1996-8#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#2)(2005-10#2)(2005-11#3)(2005-4#1)(2005-8#1)(2005-9#1)(2006-11#3)(2006-12#5)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#3)(2007-12#8)(2007-2#1)(2007-3#1)(2007-8#5)(2008-1#1)(2008-10#27)(2008-11#10)(2008-12#3)(2008-2#2)(2008-3#3)(2008-5#7)(2008-6#1)(2008-7#14)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#4)(2009-4#2)(2009-6#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-2#1)(2010-3#4)(2010-4#2)(2010-6#3)(2010-7#2)(2010-8#2)(2011-1#5)(2011-2#4)(2012-1#2)(2012-11#3)(2012-12#5)(2012-2#13)(2012-5#1)(2013-1#10)(2013-7#2)(2013-8#3)
orinocense##3##1##(2008-5#3)
oris##6##1##(1991-11#2)(2008-10#1)(2012-12#3)
orlistat therapy##4##2##(2007-8#3)(2008-5#1)
orlistat##14##1##(2006-10#2)(2006-2#1)(2007-8#4)(2008-3#1)(2008-5#6)
orlon fabric##2##2##(2008-10#2)
orlon##3##1##(2008-10#3)
ormosil-modified electrodes##3##2##(2008-10#3)
ornament##2##1##(2008-8#2)
ornamental crops##3##2##(2008-10#3)
ornamental fish##6##2##(2007-5#3)(2008-5#1)(2012-2#1)(2013-7#1)
ornamental fisheries##2##2##(2007-5#2)
ornamental plant##3##2##(2007-3#1)(2008-12#1)(2011-2#1)
ornamental plants##4##2##(2008-10#3)(2009-2#1)
ornamental##45##1##(2007-3#2)(2007-5#8)(2008-10#18)(2008-12#1)(2008-5#1)(2008-8#3)(2008-9#3)(2009-2#1)(2011-2#6)(2012-2#1)(2013-7#1)
ornamentals##5##1##(2007-5#2)(2008-10#3)
ornamentation in##2##2##(2008-8#1)(2008-9#1)
ornamentation of##2##2##(2008-9#1)(2010-3#1)
ornamentation##10##1##(2007-2#1)(2008-8#4)(2008-9#2)(2009-6#2)(2010-3#1)
ornamented males##2##2##(2008-8#2)
ornamented##6##1##(2008-10#1)(2008-5#1)(2008-8#3)(2010-10#1)
ornaments##10##1##(2008-8#9)(2009-2#1)
ornidazole in##3##2##(2006-6#1)(2010-5#2)
ornidazole##5##1##(2006-6#2)(2010-5#3)
ornidazole)##3##1##(2010-5#3)
ornithine 5-aminotransferase##4##2##(1996-7#4)
ornithine aminotransferase (OAT)##2##3##(1990-5#1)(1993-3#1)
ornithine aminotransferase activity##3##3##(1994-12#3)
ornithine aminotransferase##9##2##(1990-5#2)(1991-2#2)(1993-3#2)(1994-12#3)
ornithine and##3##2##(1992-7#1)(2006-8#1)(2007-7#1)
ornithine carbamoyl transferase##3##3##(1992-7#1)(2008-7#2)
ornithine carrier##4##2##(1994-12#3)(1997-6#1)
ornithine decarboxylase (ODC) activity##2##4##(1990-10#1)(1993-8#1)
ornithine decarboxylase (ODC) was##2##4##(1994-12#2)
ornithine decarboxylase (ODC)##10##3##(1990-10#1)(1991-11#1)(1991-3#1)(1992-2#1)(1993-8#1)(1994-12#2)(1994-8#1)(1995-8#1)(2008-10#1)
ornithine decarboxylase activity in##4##4##(1992-8#1)(1994-6#1)(1997-8#1)(2010-9#1)
ornithine decarboxylase activity##10##3##(1992-8#2)(1992-9#2)(1994-6#2)(1997-8#2)(2008-10#1)(2010-9#1)
ornithine decarboxylase and the##2##4##(1992-9#1)(1994-11#1)
ornithine decarboxylase and##3##3##(1992-9#1)(1994-11#1)(1995-8#1)
ornithine decarboxylase gene expression in##2##5##(1991-2#1)(1991-3#1)
ornithine decarboxylase gene##5##3##(1991-2#2)(1991-3#1)(1992-8#2)
ornithine decarboxylase in##4##3##(1990-10#1)(1991-11#1)(1991-2#1)(1994-12#1)
ornithine decarboxylase protein##2##3##(1991-2#2)
ornithine decarboxylase##44##2##(1990-10#3)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#6)(1991-3#2)(1992-2#1)(1992-5#1)(1992-8#5)(1992-9#4)(1993-8#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-6#3)(1994-8#1)(1995-8#2)(1997-8#2)(2008-10#2)(2010-9#1)
ornithine transcarbamylase deficiency##3##3##(2009-8#1)(2010-11#2)
ornithine transcarbamylase##5##2##(1991-6#1)(1992-4#1)(2009-8#1)(2010-11#2)
ornithine##94##1##(1990-10#3)(1990-2#1)(1990-4#2)(1990-5#3)(1990-9#3)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#8)(1991-3#3)(1991-6#1)(1992-2#1)(1992-4#1)(1992-5#2)(1992-7#2)(1992-8#5)(1992-9#4)(1993-3#2)(1993-8#1)(1994-11#1)(1994-12#10)(1994-3#1)(1994-6#3)(1994-8#1)(1995-8#2)(1996-7#7)(1996-9#1)(1997-6#3)(1997-8#2)(2006-7#1)(2006-8#1)(2007-7#1)(2008-10#3)(2008-7#4)(2009-8#1)(2010-11#2)(2010-12#1)(2010-9#1)(2011-2#1)
ornithine/ornithine##2##1##(1994-12#2)
orntide##4##1##(2008-5#4)
oro-dental##2##1##(2010-3#2)
oro-pharyngeal diseases##2##2##(2008-5#2)
oro-pharyngeal##5##1##(2008-5#4)(2010-7#1)
oro-tracheal tube##3##2##(2008-2#3)
oro-tracheal##4##1##(2008-2#4)
orodental infections##2##2##(2007-7#2)
orodental##3##1##(2007-7#2)(2008-5#1)
orodispersible tablets of pheniramine maleate##2##5##(2010-3#2)
orofacial clefting##2##2##(2009-6#2)
orofacial clefts##8##2##(2009-10#6)(2012-12#2)
orofacial dyskinesia##3##2##(2012-2#3)
orofacial features##2##2##(2007-12#1)(2009-11#1)
orofacial granulomatosis##5##2##(2009-2#1)(2012-12#2)(2012-2#2)
orofacial myofunctional therapy and an occlusal splint##2##7##(2008-10#2)
orofacial myofunctional therapy##4##3##(2008-10#4)
orofacial myofunctional##6##2##(2008-10#6)
orofacial pain##3##2##(2006-12#1)(2008-5#1)(2012-3#1)
orofacial region##3##2##(1996-8#1)(2007-12#1)(2012-2#1)
orofacial##43##1##(1995-1#1)(1996-8#1)(2006-12#1)(2007-12#2)(2007-2#1)(2007-3#1)(2008-10#7)(2008-12#1)(2008-5#1)(2008-6#1)(2009-10#7)(2009-11#1)(2009-2#1)(2009-6#2)(2011-2#1)(2012-12#5)(2012-2#7)(2012-3#1)(2013-1#1)
orogastric and##3##2##(2008-5#3)
orogastric##6##1##(2008-5#4)(2010-7#2)
orogenital ulceration##2##2##(2006-10#1)(2010-9#1)
orogenital##3##1##(2006-10#2)(2010-9#1)
oromotor behaviors##2##2##(1993-12#1)(2009-12#1)
oromotor dysfunction##4##2##(2010-7#4)
oromotor##8##1##(1993-12#2)(2009-12#2)(2010-7#4)
oropharyngeal SCC##2##2##(2010-7#2)
oropharyngeal adverse events##3##3##(2008-8#3)
oropharyngeal and esophageal candidiasis are##2##5##(2005-8#1)(2008-5#1)
oropharyngeal and esophageal candidiasis##3##4##(2005-8#1)(2008-5#2)
oropharyngeal and##6##2##(2005-8#1)(2007-8#1)(2008-5#4)
oropharyngeal candidiasis (OPC)##2##3##(2008-5#2)
oropharyngeal candidiasis##5##2##(2005-8#1)(2007-12#1)(2008-5#3)
oropharyngeal carcinoma##2##2##(2009-10#1)(2011-2#1)
oropharyngeal clearance##4##2##(1996-2#4)
oropharyngeal deposition##2##2##(1997-1#1)(2008-3#1)
oropharyngeal examination is normal##2##4##(2012-12#2)
oropharyngeal examination##4##2##(2012-12#4)
oropharyngeal infections##2##2##(2006-4#1)(2010-2#1)
oropharyngeal samples##2##2##(1997-6#2)
oropharyngeal squamous cell##2##3##(2010-7#1)(2011-2#1)
oropharyngeal ulceration##2##2##(1990-9#1)(2010-9#1)
oropharyngeal##62##1##(1990-9#1)(1995-6#1)(1996-2#5)(1996-3#1)(1997-1#1)(1997-3#1)(1997-6#2)(2005-8#2)(2006-10#3)(2006-2#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-5#8)(2008-8#4)(2009-10#5)(2009-9#1)(2010-2#3)(2010-7#5)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#4)(2012-3#1)(2013-1#2)
oropharynx and##4##2##(2006-6#1)(2008-8#1)(2011-2#1)(2012-2#1)
oropharynx##18##1##(1990-6#1)(1991-5#2)(2005-11#1)(2006-10#1)(2006-6#2)(2007-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#2)(2010-7#3)(2011-2#1)(2012-2#1)
oroscopy##3##1##(2013-1#3)
orosomucoid##6##1##(1990-1#1)(1992-9#1)(1996-3#1)(1997-8#2)(2010-12#1)
orotate and alpha-D-5-phosphoribosyl-1-pyrophosphate##2##3##(1995-8#2)
orotate complexes##2##2##(1995-8#2)
orotate phosphoribosyltransferase##6##2##(1995-8#6)
orotate##18##1##(1992-7#1)(1994-8#4)(1995-4#1)(1995-8#12)
orotic acid##10##2##(1993-7#1)(1993-9#3)(1994-6#3)(1995-8#1)(2008-10#2)
orotic##11##1##(1993-7#1)(1993-9#4)(1994-6#3)(1995-8#1)(2008-10#2)
orotidine 5'-monophosphate (OMP)##3##3##(1994-8#1)(1995-8#2)
orotidine 5'-monophosphate decarboxylase##2##3##(1995-8#1)(2006-4#1)
orotidine 5'-monophosphate##5##2##(1994-8#1)(1995-8#3)(2006-4#1)
orotidine##6##1##(1994-8#1)(1995-8#3)(2006-4#1)(2008-10#1)
orotracheal intubation##2##2##(2010-7#1)(2012-12#1)
orotracheal##3##1##(2010-7#1)(2011-1#1)(2012-12#1)
orphan drug##3##2##(2005-8#1)(2005-9#1)(2008-7#1)
orphan genes##4##2##(2008-7#4)
orphan human##2##2##(1994-12#1)(2012-2#1)
orphan metabolites##2##2##(2012-3#2)
orphan nuclear receptors##2##3##(2005-7#1)(2008-4#1)
orphan nuclear##5##2##(1995-11#1)(1996-5#1)(2005-7#1)(2008-4#1)(2012-12#1)
orphan receptor RDC1##2##3##(1992-3#1)(1994-5#1)
orphan receptor mRNAs##3##3##(1996-11#3)
orphan receptor##20##2##(1992-3#1)(1994-12#2)(1994-5#3)(1995-12#1)(1995-3#1)(1996-11#3)(1996-5#1)(1997-1#2)(1997-4#1)(1997-7#1)(2006-11#2)(2008-4#1)(2012-12#1)
orphan receptors##4##2##(1994-8#1)(1995-12#1)(1996-5#1)(2008-4#1)
orphan##55##1##(1992-3#1)(1994-12#4)(1994-5#3)(1994-8#2)(1995-11#1)(1995-12#2)(1995-3#1)(1996-11#3)(1996-5#6)(1997-1#2)(1997-4#1)(1997-7#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-11#2)(2007-7#1)(2008-4#4)(2008-7#5)(2010-12#2)(2011-7#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#3)
orphan&quot##2##1##(2012-2#1)(2013-1#1)
orphanage##3##1##(1991-6#3)
orphaned##6##1##(1994-12#1)(1997-6#2)(2008-11#1)(2011-1#1)(2012-2#1)
orphanin FQ##2##2##(1996-12#1)(1996-5#1)
orphanin##4##1##(1996-12#1)(1996-5#3)
orphans in##2##2##(1997-6#2)
orphans were significantly more likely##2##5##(2011-1#2)
orphans##13##1##(1990-12#1)(1997-6#3)(2006-10#1)(2008-11#1)(2009-11#1)(2011-1#6)
ortho catechol##2##2##(2008-11#2)
ortho ester##2##2##(2007-11#2)
ortho esters##2##2##(1992-3#1)(2007-11#1)
ortho position##2##2##(1996-8#1)(2010-5#1)
ortho##15##1##(1990-12#1)(1992-3#1)(1995-6#1)(1996-8#1)(2007-11#3)(2008-10#3)(2008-11#3)(2010-5#1)(2010-8#1)
ortho- and##2##2##(1997-8#1)(2008-10#1)
ortho-##3##1##(1997-8#1)(2008-10#2)
ortho-amino substituent of##2##3##(1996-2#2)
ortho-amino substituent##4##2##(1996-2#4)
ortho-amino substituents##2##2##(1996-2#2)
ortho-amino##6##1##(1996-2#6)
ortho-nitrophenyl##2##1##(2008-10#1)(2013-8#1)
ortho-periodic acid as the oxidant##4##5##(2007-11#4)
ortho-phosphate##3##1##(2008-10#2)(2011-1#1)
ortho-phosphates##2##1##(2013-1#2)
ortho-substituted##3##1##(1994-10#1)(1996-12#1)(2008-10#1)
orthodontic brackets##4##2##(2011-1#1)(2011-12#1)(2013-1#2)
orthodontic displacement##2##2##(2010-3#2)
orthodontic force##2##2##(2008-11#1)(2013-1#1)
orthodontic management##3##2##(2007-12#3)
orthodontic pain##2##2##(2013-8#2)
orthodontic tooth movement##4##3##(2004-3#3)(2011-1#1)
orthodontic treatment is##4##3##(2010-2#1)(2010-3#1)(2011-1#1)(2012-12#1)
orthodontic treatment need indices##2##4##(2012-12#2)
orthodontic treatment need##3##3##(2012-12#2)(2013-7#1)
orthodontic treatment##32##2##(2007-12#2)(2009-7#2)(2010-2#2)(2010-3#2)(2011-1#4)(2012-12#10)(2012-2#1)(2012-3#4)(2013-1#1)(2013-7#2)(2013-8#2)
orthodontic##80##1##(1990-10#2)(1991-5#1)(2004-3#3)(2005-9#1)(2007-12#7)(2007-2#1)(2008-11#1)(2008-12#1)(2008-7#2)(2009-7#3)(2010-12#1)(2010-2#3)(2010-3#6)(2011-1#7)(2011-12#2)(2012-12#12)(2012-2#3)(2012-3#5)(2013-1#8)(2013-7#2)(2013-8#9)
orthodontically##3##1##(2007-12#1)(2009-3#1)(2013-8#1)
orthodontics##10##1##(1993-11#1)(2007-10#1)(2007-12#2)(2010-3#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
orthodontist##4##1##(2007-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
orthodontists##3##1##(2012-12#2)(2013-1#1)
orthodox##11##1##(1997-4#1)(1997-6#1)(2006-12#1)(2008-11#4)(2008-2#1)(2011-2#1)(2013-1#1)(2013-7#1)
orthodoxy##3##1##(1991-12#1)(2007-10#1)(2010-4#1)
orthodromic stimulation of the##2##4##(1995-3#1)(1997-5#1)
orthodromic##7##1##(1991-5#1)(1992-7#1)(1993-12#1)(1995-3#1)(1997-2#1)(1997-5#1)(2008-11#1)
orthodromically##2##1##(1991-3#1)(1993-12#1)
orthognathic surgery##7##2##(2007-12#6)(2011-2#1)
orthognathic##9##1##(2007-12#7)(2011-2#1)(2012-2#1)
orthogonal array design##3##3##(2008-10#3)
orthogonal array##4##2##(2008-10#4)
orthogonal axes##3##2##(1997-7#1)(2008-3#2)
orthogonal components of##2##3##(1990-5#1)(2007-12#1)
orthogonal dashpot system##2##3##(2008-7#2)
orthogonal design##2##2##(2008-10#1)(2013-7#1)
orthogonal directions##5##2##(2007-4#1)(2008-2#2)(2008-3#2)
orthogonal experimental design##4##3##(2008-10#3)(2008-11#1)
orthogonal functions##2##2##(2007-12#2)
orthogonal independent##2##2##(1996-5#1)(1997-8#1)
orthogonal linear polarization##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
orthogonal moments##2##2##(2008-2#2)
orthogonal polarization components##2##3##(2007-12#1)(2008-2#1)
orthogonal polarization states##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
orthogonal polarization##17##2##(2007-11#3)(2007-12#4)(2008-2#6)(2008-3#4)
orthogonal polarizations##7##2##(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)
orthogonal pump beams##2##3##(2008-1#2)
orthogonal signal correction##2##3##(2007-8#1)(2008-10#1)
orthogonal signal correction-partial least squares##2##5##(2007-8#1)(2008-10#1)
orthogonal signal##5##2##(2007-8#2)(2008-10#2)(2011-1#1)
orthogonal spatial channels##2##3##(2007-12#1)(2008-3#1)
orthogonal spatial##3##2##(2007-12#1)(2008-3#1)(2010-1#1)
orthogonal to the##9##3##(1990-7#1)(1995-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-4#1)(2011-1#1)
orthogonal to##13##2##(1990-7#1)(1995-10#2)(1996-4#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2009-4#1)(2011-1#1)
orthogonal##150##1##(1990-5#1)(1990-7#1)(1992-12#1)(1995-10#2)(1996-4#1)(1996-5#1)(1997-7#1)(1997-8#2)(2005-11#1)(2005-4#2)(2006-12#2)(2006-4#1)(2007-11#7)(2007-12#25)(2007-4#1)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#20)(2008-11#2)(2008-2#27)(2008-3#23)(2008-6#1)(2008-7#2)(2009-11#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#2)(2013-7#1)
orthogonal-polarization##2##1##(2007-12#1)(2008-1#1)
orthogonality as a##2##3##(2008-3#1)(2009-3#1)
orthogonality of##3##2##(2008-2#1)(2008-3#2)
orthogonality##13##1##(2005-4#1)(2007-9#1)(2008-10#1)(2008-2#3)(2008-3#4)(2009-3#3)
orthogonally and##2##2##(2008-10#1)(2008-3#1)
orthogonally funtionalised##2##2##(2007-11#2)
orthogonally polarized beams##4##3##(2007-12#2)(2008-3#2)
orthogonally polarized components of a##2##5##(2007-11#1)(2008-1#1)
orthogonally polarized components##3##3##(2007-11#1)(2008-1#1)(2008-3#1)
orthogonally polarized##15##2##(2007-11#1)(2007-12#6)(2008-1#1)(2008-3#7)
orthogonally to the##2##3##(1993-5#1)(2007-12#1)
orthogonally##27##1##(1993-5#1)(1995-11#1)(1997-8#1)(2006-12#1)(2007-11#3)(2007-12#8)(2008-1#1)(2008-10#1)(2008-3#8)(2008-6#1)(2009-2#1)
orthograde##2##1##(1996-3#1)(2008-7#1)
orthographic depth##2##2##(2008-4#2)
orthographic pattern recognition##3##3##(2007-9#3)
orthographic##17##1##(1991-2#2)(2007-9#4)(2008-12#1)(2008-4#6)(2008-6#1)(2009-9#1)(2012-1#1)(2013-8#1)
orthographically##3##1##(2008-4#2)(2009-9#1)
orthography##5##1##(2007-5#1)(2008-4#2)(2008-9#1)(2013-8#1)
orthokeratinized##2##1##(2013-1#2)
ortholoci for##2##2##(2008-10#2)
ortholog of eukaryotic NudC domain proteins##2##6##(2012-12#2)
ortholog of##10##2##(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-12#2)(2012-3#1)
ortholog##21##1##(1990-12#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#2)
orthologous genes in##2##3##(2008-8#1)(2010-10#1)
orthologous genes##9##2##(1997-4#1)(2008-7#3)(2008-8#1)(2010-10#2)(2010-6#1)(2011-1#1)
orthologous species and##2##3##(2008-7#2)
orthologous to the##2##3##(2010-3#2)
orthologous to##3##2##(2008-7#1)(2010-3#2)
orthologous##32##1##(1993-12#1)(1993-9#1)(1994-6#2)(1994-8#1)(1996-4#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-4#2)(2008-5#1)(2008-7#10)(2008-8#2)(2010-10#2)(2010-2#1)(2010-3#3)(2010-6#1)(2011-1#1)
orthologs of##5##2##(2007-11#2)(2008-7#1)(2008-8#1)(2012-11#1)
orthologs##9##1##(2007-11#2)(2008-7#1)(2008-8#2)(2009-10#2)(2012-11#1)(2013-1#1)
orthologue of##2##2##(1997-7#1)(2006-12#1)
orthologue##6##1##(1995-3#1)(1997-7#1)(2006-12#1)(2008-10#1)(2008-7#1)(2010-2#1)
orthologues are##2##2##(2005-7#1)(2011-10#1)
orthologues in##4##2##(2008-11#1)(2008-7#3)
orthologues of known##2##3##(2008-7#1)(2010-3#1)
orthologues of##4##2##(2008-7#2)(2010-3#1)(2011-2#1)
orthologues##20##1##(2005-7#1)(2008-11#1)(2008-7#15)(2010-3#1)(2011-10#1)(2011-2#1)
orthology analysis##6##2##(2010-6#6)
orthology predictions##3##2##(2010-6#3)
orthology probabilities##2##2##(2010-6#2)
orthology##15##1##(2008-1#1)(2010-6#14)
orthonormal##3##1##(2008-1#1)(2008-2#2)
orthopaedic and##5##2##(2006-10#1)(2006-4#1)(2006-6#1)(2009-9#1)(2012-4#1)
orthopaedic applications##4##2##(2004-9#2)(2008-12#1)(2008-5#1)
orthopaedic biomaterials##2##2##(2004-9#2)
orthopaedic braces##2##2##(2007-8#2)
orthopaedic departments##3##2##(1990-9#1)(1993-8#1)(2007-11#1)
orthopaedic hospital##2##2##(1997-7#1)(2008-8#1)
orthopaedic implant##2##2##(2006-10#1)(2006-6#1)
orthopaedic implants##2##2##(2004-9#1)(2012-2#1)
orthopaedic infections##3##2##(2007-11#3)
orthopaedic interventions##2##2##(2006-6#1)(2012-2#1)
orthopaedic manual therapy##2##3##(2008-12#1)(2010-9#1)
orthopaedic oncology##2##2##(2008-6#1)(2010-3#1)
orthopaedic patients##4##2##(1992-5#1)(2007-10#3)
orthopaedic practice##2##2##(2008-9#1)(2013-7#1)
orthopaedic surgeon##5##2##(1996-3#1)(2007-11#1)(2008-5#1)(2008-6#1)(2008-8#1)
orthopaedic surgeons##8##2##(1991-6#1)(2007-11#1)(2007-5#2)(2007-8#1)(2009-3#1)(2013-1#2)
orthopaedic surgery##14##2##(1990-2#1)(1990-9#1)(2006-10#2)(2006-4#1)(2006-6#2)(2007-5#2)(2008-10#1)(2008-11#1)(2011-2#1)(2013-7#2)
orthopaedic surgical##2##2##(2007-10#1)(2007-5#1)
orthopaedic##100##1##(1990-2#1)(1990-9#3)(1991-5#1)(1991-6#1)(1992-5#1)(1993-8#1)(1994-2#1)(1994-3#1)(1996-3#2)(1997-7#1)(2004-9#8)(2006-10#5)(2006-2#1)(2006-4#2)(2006-6#5)(2007-10#5)(2007-11#8)(2007-5#5)(2007-8#8)(2008-10#1)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#2)(2008-9#1)(2009-3#2)(2009-7#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#3)(2012-12#4)(2012-2#3)(2012-4#1)(2013-1#4)(2013-7#3)(2013-8#1)
orthopaedics and traumatology##2##3##(2007-8#2)
orthopaedics and##3##2##(2007-8#2)(2013-1#1)
orthopaedics from##2##2##(2007-8#2)
orthopaedics in the##2##3##(2007-8#2)
orthopaedics in##3##2##(2007-11#1)(2007-8#2)
orthopaedics##20##1##(2006-6#1)(2007-11#3)(2007-5#1)(2007-8#10)(2008-12#2)(2011-1#1)(2012-2#1)(2013-1#1)
orthopaedists##3##1##(1995-8#1)(2007-8#2)
orthopedic and trauma##2##3##(2009-4#1)(2013-8#1)
orthopedic and##9##2##(2006-10#2)(2007-7#2)(2008-8#1)(2009-3#1)(2009-4#1)(2012-1#1)(2013-8#1)
orthopedic appliance##2##2##(2013-1#2)
orthopedic applications##5##2##(2007-8#2)(2009-4#1)(2010-3#1)(2012-3#1)
orthopedic centers##2##2##(2007-7#1)(2007-8#1)
orthopedic conditions##2##2##(2007-8#1)(2008-7#1)
orthopedic devices##5##2##(2007-11#4)(2009-4#1)
orthopedic hospital in##2##3##(2007-8#1)(2008-8#1)
orthopedic hospital##3##2##(2007-8#2)(2008-8#1)
orthopedic implant##2##2##(2007-8#1)(2011-1#1)
orthopedic implants##3##2##(2006-10#1)(2008-8#1)(2011-1#1)
orthopedic oncology##4##2##(2007-8#1)(2009-3#2)(2010-3#1)
orthopedic patients##8##2##(2006-12#1)(2007-8#2)(2010-6#3)(2011-2#1)(2012-2#1)
orthopedic practice##2##2##(2007-8#1)(2011-2#1)
orthopedic problem##3##2##(2007-11#1)(2007-8#2)
orthopedic procedures##3##2##(2007-7#1)(2008-5#1)(2008-8#1)
orthopedic surgeon##15##2##(2007-11#2)(2007-7#1)(2008-7#1)(2008-8#1)(2009-3#4)(2009-4#2)(2009-8#1)(2009-9#2)(2012-12#1)
orthopedic surgeons for##2##3##(2009-3#1)(2009-9#1)
orthopedic surgeons##17##2##(2006-2#1)(2006-8#1)(2007-11#2)(2007-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-9#3)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
orthopedic surgery for##3##3##(2005-10#1)(2011-2#2)
orthopedic surgery in spinal anesthesia##2##5##(2011-2#2)
orthopedic surgery##35##2##(1990-7#1)(2005-10#1)(2006-10#4)(2007-11#2)(2007-3#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-4#2)(2010-6#1)(2011-2#12)(2012-3#1)(2013-1#2)
orthopedic surgical##2##2##(2006-10#1)(2012-3#1)
orthopedic trauma##2##2##(2013-8#2)
orthopedic treatment##2##2##(2007-8#1)(2009-4#1)
orthopedic##184##1##(1990-7#1)(1991-6#1)(1994-3#2)(1996-9#1)(2005-10#1)(2006-10#9)(2006-12#1)(2006-2#1)(2006-3#1)(2006-8#2)(2007-11#16)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#12)(2007-8#20)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#11)(2009-2#2)(2009-3#13)(2009-4#9)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#5)(2010-3#2)(2010-6#4)(2011-1#3)(2011-12#1)(2011-2#18)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#9)(2013-8#6)
orthopedics have##2##2##(1997-6#1)(2007-11#1)
orthopedics in##2##2##(2007-11#1)(2013-1#1)
orthopedics##25##1##(1997-6#2)(2006-10#1)(2006-7#1)(2007-11#7)(2007-4#1)(2007-7#1)(2007-8#5)(2008-8#2)(2012-12#1)(2012-2#3)(2013-1#1)
orthopedist##7##1##(1991-3#1)(2007-7#2)(2009-3#1)(2009-4#1)(2013-7#1)(2013-8#1)
orthopedists in##2##2##(1993-3#1)(2007-8#1)
orthopedists##6##1##(1993-3#1)(2007-8#4)(2009-3#1)
orthophosphate and total inorganic phosphates in##3##6##(2008-10#3)
orthophosphate and total##5##3##(2008-10#5)
orthophosphate and##7##2##(2008-10#7)
orthophosphate dikinase##2##2##(2006-12#1)(2009-10#1)
orthophosphate in seawater##3##3##(2007-8#2)(2008-10#1)
orthophosphate in##6##2##(2007-8#2)(2008-10#4)
orthophosphate ions##2##2##(2008-10#1)(2010-2#1)
orthophosphate##42##1##(1990-6#2)(1993-12#1)(1996-9#1)(2006-12#1)(2007-8#4)(2008-10#31)(2009-10#1)(2010-2#1)
orthophosphoric acid##3##2##(1996-5#1)(2010-7#1)(2013-7#1)
orthophosphoric acid)##4##2##(1996-5#1)(2008-10#1)(2008-5#1)(2010-3#1)
orthophosphoric##7##1##(1996-5#2)(2008-10#1)(2008-5#1)(2010-3#1)(2010-7#1)(2013-7#1)
orthoptic##2##1##(1992-7#1)(1996-12#1)
orthoquinones##2##1##(2007-1#2)
orthorhombic crystal form##4##3##(1993-8#1)(2008-8#3)
orthorhombic space group##8##3##(1992-8#1)(1994-9#1)(1996-2#4)(1997-6#1)(2007-11#1)
orthorhombic##31##1##(1991-9#1)(1992-12#1)(1992-8#1)(1993-8#1)(1994-9#1)(1995-4#1)(1996-2#6)(1997-6#1)(1997-7#5)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#2)(2008-10#1)(2008-5#3)(2008-8#3)(2013-8#1)
orthoses in the##2##3##(2006-7#1)(2007-8#1)
orthoses on##2##2##(2006-10#1)(2010-3#1)
orthoses##18##1##(1993-9#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-7#1)(2007-11#3)(2007-7#1)(2007-8#5)(2010-3#1)(2012-1#3)
orthosilicate##6##1##(2005-11#2)(2007-8#1)(2008-10#1)(2008-6#1)(2010-3#1)
orthosis and##3##2##(1993-9#1)(2012-1#2)
orthosis for##4##2##(1993-9#1)(2009-3#1)(2012-1#2)
orthosis that##2##2##(2006-8#1)(2012-1#1)
orthosis was##2##2##(2006-7#1)(2010-3#1)
orthosis##26##1##(1993-9#2)(2006-7#1)(2006-8#1)(2007-11#2)(2007-8#1)(2009-3#1)(2010-3#2)(2012-1#16)
orthostatic headache##3##2##(2009-6#3)
orthostatic hypotension##2##2##(1991-7#1)(2007-5#1)
orthostatic##11##1##(1991-7#1)(1994-3#1)(2007-10#1)(2007-5#1)(2009-6#4)(2010-12#1)(2011-1#1)(2012-12#1)
orthotic devices##2##2##(1993-3#1)(2006-10#1)
orthotic immobilization##2##2##(2005-2#2)
orthotic intervention##2##2##(2009-10#2)
orthotic management of##2##3##(2007-11#2)
orthotic management##4##2##(2007-11#2)(2007-8#1)(2008-11#1)
orthotic use##3##2##(2007-11#1)(2007-6#1)(2007-8#1)
orthotic##23##1##(1990-6#1)(1993-3#1)(2005-2#2)(2006-10#1)(2006-7#2)(2007-11#3)(2007-6#2)(2007-7#1)(2007-8#2)(2008-11#1)(2009-10#5)(2010-3#1)(2012-1#1)
orthotics##5##1##(2007-11#1)(2009-10#2)(2012-1#2)
orthotopic heart##3##2##(2007-8#2)(2013-1#1)
orthotopic liver transplantation (OLT)##4##4##(1993-3#1)(1995-2#1)(2007-11#1)(2011-2#1)
orthotopic liver transplantation for##3##4##(1991-11#1)(1992-8#1)(2007-8#1)
orthotopic liver transplantation in a##2##5##(2005-10#1)(2010-11#1)
orthotopic liver transplantation in##3##4##(2005-10#1)(2005-12#1)(2010-11#1)
orthotopic liver transplantation##27##3##(1991-11#2)(1992-12#2)(1992-8#1)(1993-2#1)(1993-3#2)(1995-2#2)(1995-7#1)(2004-11#4)(2005-10#1)(2005-12#3)(2006-10#2)(2006-4#1)(2007-11#1)(2007-8#1)(2010-11#1)(2011-2#1)(2013-8#1)
orthotopic liver##29##2##(1991-11#2)(1992-12#2)(1992-8#1)(1993-2#1)(1993-3#2)(1995-2#2)(1995-7#1)(2004-11#4)(2005-10#1)(2005-12#3)(2005-9#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-8#1)(2008-3#1)(2010-11#1)(2011-2#1)(2013-8#1)
orthotopic##42##1##(1991-11#2)(1992-12#2)(1992-8#1)(1993-2#1)(1993-3#2)(1995-2#2)(1995-7#1)(2004-11#4)(2005-10#1)(2005-12#3)(2005-9#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-8#4)(2008-11#1)(2008-3#2)(2008-5#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
orthotopically implanted##2##2##(2013-1#1)(2013-8#1)
orthotopically##4##1##(1991-3#1)(2006-9#1)(2013-1#1)(2013-8#1)
orthotropic liver##2##2##(2012-3#1)(2013-7#1)
orthotropic##4##1##(2009-7#2)(2012-3#1)(2013-7#1)
orthovanadate and##2##2##(1996-2#1)(1997-7#1)
orthovanadate or##2##2##(1995-5#1)(1997-7#1)
orthovanadate##15##1##(1991-11#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-7#4)(2008-10#2)
orthovanadate-induced##2##1##(1997-7#2)
oryzacystatin I (OC-I)##2##3##(2006-12#1)(2008-10#1)
oryzacystatin##3##1##(2006-12#1)(2008-10#2)
oryzae Alt 505(T)##2##3##(2012-2#2)
oryzae NRRL 395##4##3##(2008-5#1)(2008-6#3)
oryzae Strains##2##2##(2008-10#2)
oryzae and##6##2##(2008-10#4)(2009-10#1)(2012-2#1)
oryzae by##2##2##(2012-2#2)
oryzae for##2##2##(2008-5#2)
oryzae in Arabidopsis##2##3##(2012-2#2)
oryzae in Nepal##2##3##(2008-10#2)
oryzae in##10##2##(2008-10#5)(2008-6#1)(2012-2#3)(2013-8#1)
oryzae is##3##2##(2008-10#2)(2012-2#1)
oryzae isolates##2##2##(2008-10#2)
oryzae pv##35##2##(1993-9#1)(2008-10#32)(2008-9#1)(2009-10#1)
oryzae to##3##2##(2008-10#2)(2008-5#1)
oryzae was##2##2##(2008-10#1)(2009-2#1)
oryzae were##2##2##(2008-10#1)(2008-6#1)
oryzae with##2##2##(2008-10#1)(2012-2#1)
oryzae##142##1##(1992-11#1)(1993-3#3)(1993-9#3)(1996-7#1)(2006-9#2)(2008-10#90)(2008-5#8)(2008-6#5)(2008-9#2)(2009-10#2)(2009-2#2)(2009-6#2)(2011-2#1)(2012-2#19)(2013-8#1)
oryzae)##2##1##(1990-3#1)(2008-10#1)
oryzae-sativae##5##1##(2007-7#2)(2008-10#3)
oryzalin in##4##2##(1997-8#4)
oryzalin with##2##2##(1997-8#2)
oryzalin##10##1##(1997-8#10)
oryzicola##2##1##(2008-10#2)
oryzophilus##6##1##(2013-8#6)
os calcis##6##2##(2008-4#3)(2008-6#2)(2009-5#1)
os odontoideum##5##2##(2006-9#4)(2008-5#1)
os##33##1##(1991-3#1)(1992-2#1)(1993-12#1)(1996-6#1)(1997-6#1)(2005-9#1)(2006-10#3)(2006-2#2)(2006-6#1)(2006-9#4)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#3)(2008-5#2)(2008-6#2)(2009-2#3)(2009-5#1)(2009-8#1)(2011-2#1)
oscillate between##3##2##(2008-3#1)(2008-9#1)(2009-8#1)
oscillate##12##1##(1990-2#1)(1994-12#1)(1996-6#1)(2005-11#1)(2007-12#3)(2008-2#2)(2008-3#1)(2008-9#1)(2009-8#1)
oscillated between##3##2##(2008-5#1)(2009-2#1)(2011-2#1)
oscillated##6##1##(1996-6#1)(2005-4#1)(2008-10#1)(2008-5#1)(2009-2#1)(2011-2#1)
oscillates in##2##2##(2007-9#1)(2008-2#1)
oscillates##7##1##(1991-7#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-2#1)(2008-3#1)
oscillating biochemical systems##2##3##(2006-10#2)
oscillating bubble##4##2##(2005-11#2)(2008-10#1)(2008-11#1)
oscillating chemical reaction##4##3##(2007-8#1)(2008-10#3)
oscillating chemical system involving the##2##5##(2008-10#2)
oscillating chemical system##4##3##(2008-10#4)
oscillating chemical##8##2##(2007-8#1)(2008-10#7)
oscillating current##2##2##(2008-7#2)
oscillating heat##2##2##(2010-6#2)
oscillating in##2##2##(2005-11#1)(2008-1#1)
oscillating period##2##2##(2007-8#1)(2008-10#1)
oscillating reaction is##2##3##(2008-10#2)
oscillating reaction##6##2##(2006-12#1)(2007-8#1)(2008-10#4)
oscillating system##3##2##(1997-1#1)(2008-10#2)
oscillating tails##3##2##(2007-12#3)
oscillating wavelengths##2##2##(2007-12#2)
oscillating##81##1##(1990-5#1)(1991-2#1)(1992-7#1)(1997-1#2)(1997-6#1)(2005-11#7)(2005-4#2)(2006-10#2)(2006-12#3)(2007-11#2)(2007-12#12)(2007-8#4)(2008-1#2)(2008-10#17)(2008-11#3)(2008-2#3)(2008-3#5)(2008-4#2)(2008-7#3)(2009-9#1)(2010-6#2)(2011-2#4)(2013-1#1)
oscillation amplitude and##3##3##(2005-11#1)(2008-10#1)(2012-2#1)
oscillation amplitude##10##2##(2005-11#3)(2008-10#5)(2012-2#2)
oscillation amplitudes of##2##3##(2008-2#2)
oscillation and##5##2##(2005-11#1)(2006-4#1)(2008-1#1)(2008-10#1)(2012-3#1)
oscillation are##5##2##(1996-5#1)(2007-12#2)(2008-1#1)(2008-3#1)
oscillation at 3 and 2 mum with a##2##8##(2007-12#2)
oscillation at##5##2##(2005-11#1)(2007-11#1)(2007-12#3)
oscillation by use of##2##4##(2007-12#1)(2008-3#1)
oscillation frequencies##2##2##(1992-7#1)(1996-5#1)
oscillation frequency##10##2##(1997-1#1)(2007-11#5)(2007-12#2)(2008-2#2)
oscillation in the##2##3##(1996-9#1)(2007-12#1)
oscillation in##17##2##(1991-4#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-9#1)(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-6#1)
oscillation induced##2##2##(1991-4#1)(1993-4#1)
oscillation is##10##2##(1996-11#1)(2007-11#2)(2007-12#4)(2008-2#2)(2009-5#1)
oscillation of a##2##3##(2008-3#2)
oscillation of the##6##3##(2006-4#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2009-6#1)
oscillation of##17##2##(1993-5#1)(1994-7#1)(2006-10#1)(2006-4#1)(2007-12#5)(2008-1#1)(2008-2#1)(2008-3#4)(2009-6#2)
oscillation patterns##3##2##(2005-11#2)(2008-10#1)
oscillation period of the##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
oscillation period to##2##3##(2007-12#1)(2010-10#1)
oscillation period##12##2##(1996-5#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#3)(2010-10#3)
oscillation periods##2##2##(1996-5#1)(2009-7#1)
oscillation profile##3##2##(2009-12#3)
oscillation threshold##6##2##(2007-12#5)(2008-3#1)
oscillation was##8##2##(1991-4#1)(1991-7#1)(1995-11#1)(1996-2#1)(2007-12#1)(2008-2#3)
oscillation were##2##2##(2005-11#1)(2008-7#1)
oscillation with##6##2##(2006-10#1)(2007-12#2)(2008-2#1)(2008-3#2)
oscillation##210##1##(1990-8#1)(1991-4#4)(1991-7#2)(1992-7#1)(1993-4#1)(1993-5#1)(1994-6#6)(1994-7#1)(1995-11#2)(1995-2#1)(1996-11#1)(1996-2#3)(1996-5#7)(1996-7#1)(1996-9#1)(1997-1#1)(2005-11#11)(2005-8#2)(2006-10#3)(2006-2#1)(2006-4#5)(2007-11#20)(2007-12#45)(2008-1#5)(2008-10#14)(2008-11#7)(2008-2#21)(2008-3#17)(2008-5#1)(2008-7#4)(2008-9#1)(2009-12#3)(2009-5#3)(2009-6#3)(2009-7#1)(2010-10#3)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
oscillations (birhythmicity)##2##2##(2006-10#1)(2007-9#1)
oscillations after##2##2##(1991-10#1)(2007-12#1)
oscillations and complex dynamics in##2##5##(2006-10#2)
oscillations and complex dynamics##3##4##(2006-10#3)
oscillations and produce##2##3##(2005-8#1)(2008-2#1)
oscillations and the##4##3##(1992-11#1)(1995-7#1)(2006-10#1)(2008-1#1)
oscillations and##18##2##(1992-11#1)(1995-7#1)(1995-8#1)(1997-1#2)(2005-8#1)(2006-10#6)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)
oscillations are characterized by##2##4##(2007-9#1)(2008-10#1)
oscillations are##16##2##(1990-11#1)(1990-5#1)(1992-5#1)(1995-11#1)(1996-11#1)(1996-7#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-10#1)(2013-8#1)
oscillations arise##2##2##(1997-1#1)(2007-9#1)
oscillations between##2##2##(2006-12#1)(2007-12#1)
oscillations by##4##2##(1990-5#1)(1990-8#1)(1992-5#1)(1994-11#1)
oscillations can be##3##3##(2006-10#1)(2007-12#1)(2008-3#1)
oscillations can##5##2##(1997-1#1)(2006-10#1)(2007-12#2)(2008-3#1)
oscillations could be##2##3##(1994-11#1)(2013-8#1)
oscillations could##4##2##(1994-11#1)(2011-2#1)(2013-8#2)
oscillations from##2##2##(1995-11#2)
oscillations in Saccharomyces cerevisiae##2##4##(1996-11#1)(2005-8#1)
oscillations in a##7##3##(1990-7#1)(1993-5#1)(2006-10#2)(2007-12#2)(2008-11#1)
oscillations in glycolysis##2##3##(2006-10#2)
oscillations in ras-transformed##2##3##(1991-7#1)(1992-5#1)
oscillations in the##21##3##(1990-5#1)(1991-7#1)(1992-8#1)(1992-9#2)(1994-2#1)(1995-11#2)(1997-7#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#2)(2012-1#1)(2013-7#1)(2013-8#1)
oscillations in##67##2##(1990-5#3)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-7#2)(1992-5#1)(1992-8#1)(1992-9#2)(1993-5#2)(1994-11#3)(1994-2#2)(1994-5#2)(1995-11#3)(1996-11#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-7#1)(2005-8#1)(2006-10#9)(2007-11#1)(2007-12#5)(2007-2#1)(2007-9#3)(2008-1#2)(2008-10#1)(2008-11#3)(2008-2#2)(2008-7#2)(2008-9#1)(2010-10#1)(2012-1#1)(2013-7#1)(2013-8#3)
oscillations interact##2##2##(2008-7#1)(2009-8#1)
oscillations is##7##2##(1997-1#1)(2006-10#1)(2007-12#2)(2008-2#1)(2008-3#2)
oscillations observed##2##2##(2008-11#1)(2008-3#1)
oscillations of intracellular##2##3##(1990-8#1)(1992-12#1)
oscillations of the##11##3##(1996-5#1)(1997-1#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-3#3)(2009-2#1)(2009-8#1)
oscillations of##27##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-5#1)(1992-12#1)(1992-8#1)(1994-11#1)(1994-5#1)(1996-5#2)(1997-1#1)(2006-10#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-3#3)(2008-7#1)(2009-2#1)(2009-8#1)(2010-10#2)(2012-2#1)
oscillations on different transitions##3##4##(2007-12#3)
oscillations on##5##2##(2007-12#3)(2008-10#1)(2008-2#1)
oscillations that are observed##2##4##(1993-9#1)(2008-3#1)
oscillations that are##3##3##(1993-9#1)(2008-1#1)(2008-3#1)
oscillations to##2##2##(2008-3#1)(2009-6#1)
oscillations was##4##2##(1992-5#1)(1992-7#1)(1996-11#1)(1997-1#1)
oscillations were found##2##3##(2008-7#1)(2011-2#1)
oscillations were##7##2##(1991-10#1)(1992-5#1)(1994-6#1)(1995-11#1)(1996-11#1)(2008-7#1)(2011-2#1)
oscillations which##2##2##(2007-9#1)(2011-1#1)
oscillations with##4##2##(1992-6#1)(1994-11#1)(2007-12#1)(2008-7#1)
oscillations##288##1##(1990-11#2)(1990-2#1)(1990-5#6)(1990-7#2)(1990-8#9)(1991-1#4)(1991-10#3)(1991-5#4)(1991-7#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#6)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-4#1)(1993-5#2)(1993-9#1)(1994-11#9)(1994-2#2)(1994-5#4)(1994-6#4)(1995-11#7)(1995-5#1)(1995-7#1)(1995-8#2)(1996-11#5)(1996-2#1)(1996-5#3)(1996-6#3)(1996-7#5)(1997-1#12)(1997-7#1)(2005-11#2)(2005-8#3)(2006-10#31)(2006-12#1)(2006-7#1)(2007-11#4)(2007-12#22)(2007-2#1)(2007-9#11)(2008-1#9)(2008-10#5)(2008-11#9)(2008-2#18)(2008-3#11)(2008-7#13)(2008-8#2)(2008-9#3)(2009-2#1)(2009-6#1)(2009-8#3)(2010-10#5)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#2)(2013-1#1)(2013-7#2)(2013-8#9)
oscillator amplifier system##3##3##(2007-12#3)
oscillator amplifier##4##2##(2007-12#3)(2008-3#1)
oscillator and a##4##3##(2007-11#2)(2007-12#2)
oscillator and##12##2##(1994-5#1)(2007-11#3)(2007-12#2)(2008-2#3)(2008-3#3)
oscillator are##2##2##(2008-1#1)(2008-2#1)
oscillator as the##2##3##(2007-12#1)(2008-3#1)
oscillator as##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
oscillator by use of an##2##5##(2007-12#2)
oscillator by use of##4##4##(2007-11#1)(2007-12#3)
oscillator by##5##2##(2007-11#1)(2007-12#4)
oscillator directly pumped by##2##4##(2007-12#2)
oscillator for##8##2##(2007-11#2)(2007-12#1)(2008-1#2)(2008-2#1)(2008-3#2)
oscillator has been##2##3##(2007-11#1)(2008-2#1)
oscillator in a##2##3##(2007-12#1)(2008-2#1)
oscillator in the##2##3##(2007-12#1)(2008-7#1)
oscillator in##6##2##(2007-12#4)(2008-2#1)(2008-7#1)
oscillator is demonstrated##2##3##(2008-1#1)(2008-3#1)
oscillator is pumped by##2##4##(2007-12#1)(2008-1#1)
oscillator is##9##2##(1994-5#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-3#3)
oscillator model##4##2##(2007-11#1)(2008-2#2)(2009-10#1)
oscillator pulses##2##2##(2007-12#2)
oscillator strengths##4##2##(2005-4#2)(2008-3#1)(2008-7#1)
oscillator that##8##2##(2007-11#4)(2007-12#3)(2009-12#1)
oscillator to the##2##3##(2007-12#1)(2009-8#1)
oscillator to##6##2##(2007-12#4)(2008-1#1)(2009-8#1)
oscillator was##3##2##(2008-2#1)(2008-3#2)
oscillator with a##6##3##(2007-11#1)(2007-12#4)(2008-3#1)
oscillator with an##2##3##(2007-12#2)
oscillator with##20##2##(1990-12#1)(2007-11#3)(2007-12#14)(2008-1#1)(2008-3#1)
oscillator##333##1##(1990-12#1)(1990-5#1)(1990-8#1)(1991-9#1)(1992-12#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-5#2)(1995-6#1)(1996-9#1)(2005-11#1)(2005-4#2)(2006-10#1)(2007-11#52)(2007-12#156)(2008-1#22)(2008-10#1)(2008-2#32)(2008-3#39)(2008-5#1)(2008-7#2)(2009-10#2)(2009-12#2)(2009-6#1)(2009-8#1)(2010-7#2)(2011-1#2)(2012-1#1)
oscillator-amplifier system is##2##3##(2008-2#1)(2008-3#1)
oscillator-amplifier system##6##2##(2007-12#2)(2008-2#1)(2008-3#3)
oscillator-amplifier##10##1##(2007-12#4)(2008-2#1)(2008-3#5)
oscillators and##6##2##(1994-5#2)(2007-12#3)(2008-2#1)
oscillators as##2##2##(2007-11#1)(2008-2#1)
oscillators by##2##2##(2007-12#1)(2008-3#1)
oscillators can##2##2##(2007-12#1)(2008-2#1)
oscillators for##3##2##(2008-2#2)(2008-3#1)
oscillators in the sinusoidal and relaxation##2##6##(2008-2#2)
oscillators in the##4##3##(2008-2#4)
oscillators in##6##2##(2008-1#1)(2008-2#5)
oscillators that##2##2##(1990-8#1)(2008-3#1)
oscillators with##3##2##(2005-11#1)(2007-11#1)(2008-2#1)
oscillators##87##1##(1990-5#1)(1990-8#1)(1994-5#3)(1995-2#1)(2005-11#2)(2006-10#1)(2007-11#11)(2007-12#23)(2008-1#2)(2008-2#23)(2008-3#10)(2009-8#3)(2010-2#2)(2010-7#1)(2012-2#3)
oscillatory Ca(2+)##2##2##(2008-4#2)
oscillatory activity in the##2##4##(2008-11#1)(2012-2#1)
oscillatory activity in##3##3##(2008-11#2)(2012-2#1)
oscillatory activity##6##2##(2008-11#2)(2012-2#2)(2013-1#1)(2013-8#1)
oscillatory behavior in##3##3##(2008-7#3)
oscillatory behavior##10##2##(1990-8#1)(1992-7#1)(2005-11#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-7#4)
oscillatory behaviors##2##2##(1993-9#1)(2008-11#1)
oscillatory fields and##2##3##(1990-6#2)
oscillatory fields##3##2##(1990-6#3)
oscillatory networks##3##2##(2008-2#1)(2009-8#1)(2011-2#1)
oscillatory pattern of##2##3##(1997-6#1)(2009-9#1)
oscillatory patterns##3##2##(2008-2#1)(2008-7#1)(2009-8#1)
oscillatory peroxidase-oxidase reaction##2##3##(1992-7#1)(2006-10#1)
oscillatory phenomena##2##2##(2007-9#1)(2013-8#1)
oscillatory reactions##3##2##(1997-1#3)
oscillatory tails##2##2##(2007-12#2)
oscillatory ventilation has been##2##4##(2006-10#2)
oscillatory ventilation has##3##3##(2006-10#3)
oscillatory ventilation##8##2##(2005-11#1)(2006-10#5)(2006-4#1)(2012-2#1)
oscillatory##110##1##(1990-6#3)(1990-8#1)(1991-4#1)(1991-7#1)(1992-7#2)(1993-9#2)(1994-10#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-3#1)(1997-1#4)(1997-6#2)(2005-11#2)(2005-8#1)(2006-10#16)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#6)(2007-4#3)(2007-9#2)(2008-1#2)(2008-11#9)(2008-12#3)(2008-2#6)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#4)(2009-9#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#4)(2013-1#1)(2013-8#4)
oscillometric##2##1##(1990-8#2)
oscilloscope##2##1##(2007-12#1)(2008-2#1)
osculatum##2##1##(2012-2#2)
oseltamivir was##2##2##(2011-2#1)(2013-1#1)
oseltamivir##4##1##(2005-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
osidic bonds##2##2##(1995-3#1)(2006-10#1)
osk##3##1##(1994-12#1)(2012-12#2)
oskar##5##1##(1994-12#1)(2012-12#4)
osm-3##6##1##(1995-3#6)
osmeteria##2##1##(2007-12#2)
osmiophilic material##6##2##(2008-10#6)
osmiophilic##11##1##(1997-2#1)(2007-3#1)(2008-10#8)(2009-8#1)
osmium tetroxide##9##2##(1991-7#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-4#1)(2008-7#2)
osmium##32##1##(1991-7#1)(1992-2#2)(1993-7#1)(1996-2#2)(1996-5#1)(2007-12#1)(2007-9#1)(2008-10#14)(2008-4#1)(2008-7#2)(2010-11#3)(2010-6#2)(2010-7#1)
osmium(IV) in##2##2##(2008-10#2)
osmium(IV)##3##1##(2008-10#3)
osmolalities##6##1##(1997-7#1)(2007-9#1)(2008-11#3)(2008-7#1)
osmolality and##5##2##(1996-9#1)(2008-5#2)(2009-12#1)(2013-1#1)
osmolality compensation##2##2##(2008-11#2)
osmolality of##5##2##(1990-3#1)(1992-5#1)(2008-11#2)(2012-2#1)
osmolality##38##1##(1990-3#2)(1992-5#1)(1995-10#1)(1996-9#3)(1997-7#1)(2006-4#1)(2007-8#1)(2008-11#17)(2008-5#4)(2009-12#1)(2012-2#1)(2013-1#2)(2013-8#3)
osmolar##3##1##(1990-10#1)(1993-3#1)(1996-9#1)
osmolarities##3##1##(1995-1#1)(2009-12#2)
osmolarity and##3##2##(1991-5#1)(2008-11#2)
osmolarity for##2##2##(2006-11#1)(2008-11#1)
osmolarity from##2##2##(1991-11#1)(1997-1#1)
osmolarity medium##2##2##(2008-11#2)
osmolarity of the##9##3##(1991-11#3)(1993-3#1)(1994-12#2)(1995-1#1)(2005-11#1)(2006-5#1)
osmolarity of##12##2##(1991-11#5)(1993-3#1)(1994-12#2)(1995-1#1)(2005-11#1)(2006-5#1)(2009-12#1)
osmolarity on##4##2##(1990-3#2)(2008-11#1)(2009-12#1)
osmolarity##61##1##(1990-10#1)(1990-3#3)(1991-1#4)(1991-11#15)(1991-5#1)(1993-3#1)(1994-12#5)(1995-1#1)(1996-12#1)(1997-1#1)(2005-11#1)(2006-11#2)(2006-5#1)(2008-1#1)(2008-11#13)(2008-5#1)(2008-8#1)(2009-12#4)(2009-6#1)(2010-12#1)(2011-2#1)(2012-1#1)
osmolyte##3##1##(1990-7#1)(1997-6#1)(1997-7#1)
osmolytes in cells##2##3##(1991-11#1)(1997-6#1)
osmolytes in##3##2##(1991-11#1)(1997-6#1)(2013-1#1)
osmolytes##10##1##(1991-11#2)(1997-6#1)(1997-7#1)(2005-12#2)(2008-11#1)(2008-7#1)(2008-8#1)(2013-1#1)
osmopriming##2##1##(2008-12#2)
osmoregulation##5##1##(2007-12#1)(2008-12#1)(2008-5#1)(2010-12#1)(2011-2#1)
osmoregulatory##9##1##(1993-3#2)(2005-12#1)(2008-7#6)
osmosensor histidine kinase##2##3##(2008-10#2)
osmotic adjustment##3##2##(2008-11#1)(2012-7#2)
osmotic and fungicide##2##3##(2008-10#2)
osmotic and##4##2##(1996-9#1)(2004-4#1)(2008-10#2)
osmotic challenge##2##2##(1990-3#2)
osmotic coefficients##3##2##(1991-11#3)
osmotic conditions##2##2##(1991-1#1)(1991-11#1)
osmotic effect##2##2##(2008-12#1)(2008-5#1)
osmotic fragility of##2##3##(1991-7#2)
osmotic fragility##5##2##(1991-7#3)(2008-9#2)
osmotic hemolysis##2##2##(1996-1#1)(2005-11#1)
osmotic induction##2##2##(2013-7#2)
osmotic lysis##3##2##(1994-9#2)(2005-11#1)
osmotic minipumps##4##2##(1992-10#1)(1994-8#1)(1995-12#1)(1995-5#1)
osmotic potential##7##2##(1994-12#1)(2008-10#1)(2008-9#3)(2009-6#1)(2012-7#1)
osmotic pressure of the##2##4##(2005-11#1)(2010-7#1)
osmotic pressure of##3##3##(2005-11#1)(2008-11#1)(2010-7#1)
osmotic pressure was maintained at the same level as control tadpoles by a significant increase (P&lt##2##16##(2012-12#2)
osmotic pressure was##3##3##(2008-11#1)(2012-12#2)
osmotic pressure##25##2##(1993-12#1)(2005-11#1)(2006-10#2)(2006-6#1)(2007-2#1)(2008-11#11)(2008-12#1)(2008-5#1)(2009-12#1)(2009-8#1)(2010-7#1)(2012-12#2)(2013-8#1)
osmotic properties of##2##3##(2008-5#1)(2011-1#1)
osmotic properties##3##2##(2008-5#1)(2009-12#1)(2011-1#1)
osmotic pump##3##2##(1996-5#1)(2012-3#2)
osmotic sensitivity##2##2##(2008-10#2)
osmotic shock##15##2##(1990-11#1)(1991-8#1)(1993-3#2)(1994-11#1)(1994-2#1)(1997-7#1)(2007-1#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2011-12#1)(2012-2#1)
osmotic stimulation of the hypothalamic paraventricular nucleus##2##7##(1994-8#2)
osmotic stimulation of the##4##4##(1994-8#3)(1996-8#1)
osmotic stimulation##8##2##(1991-3#2)(1994-8#3)(1996-8#3)
osmotic stress and##4##3##(1992-8#1)(1996-4#1)(2009-8#2)
osmotic stress on##2##3##(1991-8#1)(1994-12#1)
osmotic stress##30##2##(1991-8#1)(1992-7#1)(1992-8#1)(1993-12#2)(1994-12#1)(1995-7#1)(1996-4#2)(1997-8#1)(2006-10#1)(2006-5#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#3)(2009-8#3)(2010-12#2)(2013-1#1)(2013-7#1)
osmotic swelling##5##2##(1990-2#2)(1991-5#1)(1994-2#1)(1996-1#1)
osmotic water permeability (Pf)##2##4##(1991-2#1)(1993-3#1)
osmotic water permeability##4##3##(1990-2#1)(1991-2#1)(1993-3#1)(2010-11#1)
osmotic##175##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#2)(1991-1#1)(1991-11#4)(1991-2#1)(1991-3#2)(1991-5#1)(1991-7#4)(1991-8#2)(1992-10#1)(1992-7#2)(1992-8#1)(1993-12#3)(1993-3#3)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#1)(1994-8#4)(1994-9#2)(1995-12#3)(1995-5#1)(1995-7#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-8#4)(1996-9#2)(1997-1#2)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-4#1)(2005-11#5)(2006-10#3)(2006-5#1)(2006-6#1)(2007-1#1)(2007-2#2)(2008-10#7)(2008-11#16)(2008-12#2)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#8)(2009-12#4)(2009-2#1)(2009-6#2)(2009-8#6)(2010-11#1)(2010-12#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#2)(2012-7#4)(2013-1#1)(2013-7#3)(2013-8#1)
osmotic-remedial##2##1##(1994-11#1)(1995-8#1)
osmotically controlled##3##2##(1994-12#2)(1996-4#1)
osmotically stimulated##2##2##(1991-3#1)(1996-8#1)
osmotically##15##1##(1991-3#1)(1992-6#1)(1993-3#1)(1994-12#2)(1994-8#1)(1995-12#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-1#1)(2008-10#1)(2008-5#2)(2008-7#1)
osmotin and thaumatin-like protein##2##4##(2008-10#2)
osmotin promoter##2##2##(2008-8#2)
osmotin##6##1##(2008-10#2)(2008-8#4)
osseointegrate##3##1##(2007-11#1)(2009-3#1)(2013-1#1)
osseointegrated##4##1##(2007-3#1)(2008-5#1)(2009-3#1)(2012-2#1)
osseointegration of the##3##3##(2004-9#1)(2007-11#1)(2012-12#1)
osseointegration##7##1##(2004-9#1)(2007-11#3)(2009-3#2)(2012-12#1)
osseous and##2##2##(2011-2#1)(2012-12#1)
osseous changes##2##2##(2007-11#1)(2007-8#1)
osseous compression##3##2##(2008-5#3)
osseous defect##2##2##(2013-7#2)
osseous involvement##2##2##(2008-1#1)(2010-6#1)
osseous lesions##2##2##(2006-1#1)(2008-7#1)
osseous metaplasia##5##2##(1992-2#2)(2010-12#1)(2011-1#2)
osseous metastases##4##2##(2006-10#1)(2007-11#2)(2008-7#1)
osseous tissue in##2##3##(2007-7#2)
osseous tissue organic base##2##4##(2006-6#2)
osseous tissue##11##2##(1991-11#1)(2005-1#1)(2006-6#3)(2007-7#4)(2011-2#1)(2012-3#1)
osseous##60##1##(1991-1#2)(1991-11#2)(1992-2#2)(1992-6#1)(1994-7#1)(2004-3#1)(2005-1#1)(2006-1#1)(2006-10#2)(2006-3#1)(2006-6#3)(2007-11#4)(2007-12#2)(2007-3#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-5#4)(2008-7#2)(2009-3#3)(2010-12#1)(2010-3#1)(2010-5#2)(2010-6#3)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#4)
ossicle was##3##2##(2008-9#3)
ossicle##9##1##(2006-9#1)(2007-12#1)(2008-12#2)(2008-9#5)
ossicles and sesamoid bones of the ankle and foot##2##9##(2006-1#2)
ossicles and sesamoid bones##3##4##(2006-1#3)
ossicles are##5##2##(2007-12#4)(2007-2#1)
ossicles##20##1##(1993-8#1)(1996-6#1)(2006-1#3)(2007-12#10)(2007-2#1)(2008-12#2)(2008-9#2)
ossificans progressiva##5##2##(1997-6#1)(2007-2#2)(2007-7#2)
ossificans##20##1##(1992-2#3)(1997-6#1)(2007-2#2)(2007-7#5)(2008-9#1)(2009-3#5)(2013-1#1)(2013-8#2)
ossification (HO)##2##2##(1994-8#1)(2007-11#1)
ossification after##4##2##(2005-3#1)(2007-11#2)(2007-12#1)
ossification and##5##2##(1996-12#1)(2007-12#1)(2007-7#2)(2012-12#1)
ossification centers##3##2##(1993-12#1)(2012-12#2)
ossification in##2##2##(1996-12#1)(2005-3#1)
ossification nucleus in the epiphysis and##2##6##(2009-2#2)
ossification nucleus in the##3##4##(2009-2#3)
ossification nucleus##4##2##(2009-2#4)
ossification of the##6##3##(2005-9#1)(2006-11#1)(2007-12#1)(2008-12#1)(2013-1#2)
ossification of##8##2##(2005-9#1)(2006-11#1)(2007-12#1)(2008-12#1)(2008-9#1)(2012-3#1)(2013-1#2)
ossification##52##1##(1991-2#1)(1993-12#1)(1994-8#2)(1996-12#3)(1996-6#1)(1996-8#1)(2005-12#1)(2005-3#3)(2005-7#1)(2005-9#1)(2006-11#2)(2007-11#3)(2007-12#5)(2007-7#2)(2008-12#2)(2008-5#1)(2008-9#4)(2009-2#4)(2009-3#1)(2012-12#9)(2012-2#1)(2012-3#1)(2013-1#2)
ossifications after##2##2##(2007-12#1)(2010-9#1)
ossifications##6##1##(1991-11#1)(2007-12#1)(2010-9#1)(2011-1#1)(2012-2#2)
ossified cochlea##5##2##(2008-9#5)
ossified##13##1##(1996-3#1)(2008-9#8)(2010-8#1)(2012-12#1)(2013-1#2)
ossify##2##1##(1992-4#1)(2010-8#1)
ossifying fibroma##7##2##(2012-12#2)(2013-1#2)(2013-7#3)
ossifying fibroma&quot##4##2##(2013-7#4)
ossifying##17##1##(1992-2#2)(2007-12#1)(2008-10#3)(2012-12#2)(2013-1#2)(2013-7#7)
osteitis pubis##7##2##(2006-10#7)
osteitis##18##1##(1997-3#1)(2006-10#8)(2006-8#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-2#1)(2009-3#2)
osteitis)##2##1##(1996-12#1)(2006-10#1)
ostensibly##5##1##(1996-6#1)(2008-2#1)(2008-7#1)(2008-9#1)(2012-2#1)
osteo and chondrogenic potential##2##4##(2008-1#2)
osteo##3##1##(2008-1#3)
osteo-articular diseases##2##2##(1990-6#1)(1991-9#1)
osteo-articular##5##1##(1990-5#2)(1990-6#2)(1991-9#1)
osteoarthritic##13##1##(1992-3#1)(1993-12#1)(1996-1#1)(2006-10#1)(2006-12#1)(2006-5#2)(2008-10#1)(2008-11#1)(2009-12#1)(2010-11#1)(2011-1#2)
osteoarthritis (OA)##15##2##(1992-3#1)(2005-8#1)(2006-10#3)(2006-5#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
osteoarthritis after##2##2##(2011-2#1)(2013-1#1)
osteoarthritis and the##3##3##(1993-11#1)(2007-11#2)
osteoarthritis and##10##2##(1991-1#1)(1993-11#1)(1996-1#1)(2006-10#1)(2007-11#2)(2007-7#1)(2008-9#1)(2010-5#1)(2011-2#1)
osteoarthritis are discussed##2##3##(1993-11#1)(2007-11#1)
osteoarthritis are##4##2##(1993-11#1)(2006-10#1)(2007-11#2)
osteoarthritis following ligament injury##2##4##(2007-8#2)
osteoarthritis following ligament##3##3##(2007-8#3)
osteoarthritis following##4##2##(2007-8#4)
osteoarthritis in##11##2##(1993-11#1)(2006-11#1)(2006-3#1)(2007-8#2)(2009-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
osteoarthritis is##6##2##(2007-7#1)(2007-8#1)(2008-1#1)(2011-1#2)(2012-2#1)
osteoarthritis of knee##3##3##(2008-5#2)(2011-2#1)
osteoarthritis of the hip##6##4##(1993-11#4)(2007-7#1)(2008-5#1)
osteoarthritis of the knee##18##4##(1997-1#1)(2006-10#5)(2007-11#2)(2008-5#1)(2010-12#3)(2011-2#3)(2013-1#3)
osteoarthritis of the##30##3##(1993-11#5)(1997-1#1)(2006-10#9)(2007-11#2)(2007-7#1)(2008-5#2)(2010-12#3)(2011-2#3)(2012-2#1)(2013-1#3)
osteoarthritis of##35##2##(1993-11#5)(1997-1#1)(2006-10#10)(2007-11#3)(2007-7#1)(2008-5#4)(2010-12#3)(2011-2#4)(2012-2#1)(2013-1#3)
osteoarthritis##202##1##(1990-7#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-5#1)(1992-3#3)(1993-11#9)(1995-9#1)(1996-1#1)(1996-3#1)(1997-1#2)(2005-8#3)(2006-10#30)(2006-11#1)(2006-3#1)(2006-5#1)(2006-7#1)(2007-11#21)(2007-12#1)(2007-5#1)(2007-7#5)(2007-8#11)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#3)(2008-9#3)(2009-3#2)(2009-4#2)(2009-5#3)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-9#1)(2011-1#14)(2011-12#2)(2011-2#12)(2012-1#3)(2012-2#8)(2012-3#1)(2013-1#20)(2013-8#2)
osteoarthrosis and##2##2##(1995-9#1)(2011-2#1)
osteoarthrosis of the##2##3##(1997-7#1)(2006-6#1)
osteoarthrosis##20##1##(1993-2#1)(1995-9#1)(1997-7#1)(2006-6#1)(2007-11#4)(2007-8#2)(2008-3#2)(2010-10#1)(2010-3#1)(2011-2#5)(2013-1#1)
osteoarticular allograft reconstruction##3##3##(2008-6#3)
osteoarticular pain##2##2##(2011-2#2)
osteoarticular##16##1##(1993-11#2)(1996-6#1)(2007-8#1)(2008-1#1)(2008-6#3)(2008-9#1)(2010-12#1)(2011-2#5)(2012-3#1)
osteoblast and osteoclast activity##2##4##(2011-2#2)
osteoblast and osteoclast##3##3##(1996-8#1)(2011-2#2)
osteoblast and##4##2##(1996-8#1)(2007-8#1)(2011-2#2)
osteoblast behaviour##2##2##(2008-5#2)
osteoblast cell##3##2##(1992-6#1)(2008-5#2)
osteoblast differentiation and##4##3##(2005-7#1)(2006-10#1)(2009-4#1)(2013-1#1)
osteoblast differentiation##7##2##(2005-7#1)(2006-10#1)(2008-8#2)(2009-4#2)(2013-1#1)
osteoblast functions##2##2##(1991-12#1)(2008-11#1)
osteoblast membranes##2##2##(2009-8#2)
osteoblast metabolism##3##2##(2008-11#3)
osteoblast mitogenesis##3##2##(1990-11#1)(1993-8#2)
osteoblast number##2##2##(2007-8#1)(2008-11#1)
osteoblast phenotype##2##2##(1991-3#1)(1996-11#1)
osteoblast proliferation##12##2##(1990-11#1)(1991-12#3)(1991-5#3)(1991-8#4)(2008-11#1)
osteoblast specific##2##2##(1990-11#1)(1990-9#1)
osteoblast viability##2##2##(2008-11#1)(2010-8#1)
osteoblast##62##1##(1990-11#3)(1990-9#1)(1991-11#1)(1991-12#5)(1991-3#1)(1991-4#1)(1991-5#3)(1991-8#4)(1992-6#1)(1993-8#3)(1996-11#1)(1996-8#2)(2004-9#1)(2005-7#1)(2006-10#1)(2007-8#3)(2008-11#10)(2008-5#5)(2008-8#3)(2009-4#2)(2009-8#3)(2010-12#1)(2010-8#2)(2011-2#2)(2012-3#1)(2013-1#1)
osteoblast-derived##3##1##(1993-8#1)(1993-9#1)(2010-10#1)
osteoblast-like cell line##2##3##(1991-3#1)(1994-6#1)
osteoblast-like cell##4##2##(1991-3#1)(1993-3#1)(1994-6#1)(2008-11#1)
osteoblast-like cells (MC3T3-E1)##2##3##(1991-3#1)(2008-5#1)
osteoblast-like cells by##2##3##(2008-11#2)
osteoblast-like cells in vitro##3##4##(1990-9#1)(1994-2#1)(2008-11#1)
osteoblast-like cells in##6##3##(1990-2#3)(1990-9#1)(1994-2#1)(2008-11#1)
osteoblast-like cells was##2##3##(1990-12#1)(1992-12#1)
osteoblast-like cells##33##2##(1990-12#3)(1990-2#3)(1990-7#1)(1990-9#2)(1991-3#3)(1992-12#2)(1992-4#3)(1993-3#1)(1993-8#2)(1994-11#1)(1994-2#3)(1994-3#2)(1994-6#1)(1997-7#1)(2008-11#4)(2008-5#1)
osteoblast-like##43##1##(1990-12#3)(1990-2#3)(1990-7#1)(1990-9#3)(1991-3#4)(1992-12#2)(1992-4#3)(1992-8#2)(1993-3#2)(1993-8#2)(1994-11#1)(1994-2#4)(1994-3#2)(1994-6#2)(1997-7#1)(2008-11#5)(2008-5#1)(2012-1#1)(2012-2#1)
osteoblast]##2##1##(2005-9#1)(2011-2#1)
osteoblastic MC3T3-E1 cells##6##3##(1991-12#2)(1992-9#1)(1997-1#3)
osteoblastic activity##3##2##(2006-5#1)(2008-7#1)(2011-1#1)
osteoblastic cell lines##2##3##(1990-10#1)(2008-11#1)
osteoblastic cell##3##2##(1990-10#1)(1990-11#1)(2008-11#1)
osteoblastic cells induced by alpha-thrombin##2##5##(1993-8#2)
osteoblastic cells##21##2##(1990-10#1)(1991-10#2)(1991-8#2)(1992-9#1)(1993-12#1)(1993-8#5)(1994-11#1)(1994-12#3)(2008-11#4)(2011-1#1)
osteoblastic differentiation##5##2##(1994-2#1)(1997-6#3)(2006-4#1)
osteoblastic metastases##4##2##(1990-12#1)(1991-8#2)(2007-11#1)
osteoblastic osteosarcoma cells (UMR-106)##2##4##(1991-8#1)(1994-2#1)
osteoblastic osteosarcoma cells##3##3##(1991-5#1)(1991-8#1)(1994-2#1)
osteoblastic osteosarcoma##4##2##(1991-5#1)(1991-8#1)(1992-8#1)(1994-2#1)
osteoblastic phenotype##3##2##(1990-10#1)(2006-4#1)(2010-3#1)
osteoblastic##67##1##(1990-10#3)(1990-11#3)(1990-12#1)(1991-10#2)(1991-12#2)(1991-5#1)(1991-8#5)(1992-12#1)(1992-8#1)(1992-9#2)(1993-10#1)(1993-12#2)(1993-8#5)(1994-11#1)(1994-12#3)(1994-2#5)(1994-6#2)(1997-1#3)(1997-6#3)(2006-4#2)(2006-5#1)(2007-11#2)(2008-11#9)(2008-6#1)(2008-7#1)(2010-3#2)(2011-1#2)(2013-1#1)
osteoblastic-osteolytic bone metastases##2##3##(2007-11#2)
osteoblastic-osteolytic##3##1##(2007-11#3)
osteoblastoma##3##1##(2007-12#1)(2010-5#2)
osteoblasts and adipocytes##2##3##(2012-2#2)
osteoblasts and cementoblasts##2##3##(2008-11#2)
osteoblasts and osteoclasts##2##3##(2007-7#1)(2009-4#1)
osteoblasts and##18##2##(1990-11#1)(1992-12#2)(1997-1#1)(1997-7#1)(2007-7#1)(2008-11#3)(2008-5#1)(2008-8#1)(2009-4#1)(2010-3#1)(2011-1#1)(2012-12#2)(2012-2#2)
osteoblasts can##2##2##(2004-9#1)(2005-11#1)
osteoblasts cultured##2##2##(2008-11#2)
osteoblasts in vitro##4##3##(2008-5#4)
osteoblasts in##6##2##(2008-5#5)(2012-4#1)
osteoblasts is##2##2##(2008-11#2)
osteoblasts to##4##2##(1993-6#1)(2007-11#1)(2008-11#1)(2010-2#1)
osteoblasts was##2##2##(2008-5#1)(2011-2#1)
osteoblasts were##4##2##(2008-11#1)(2008-5#3)
osteoblasts##103##1##(1990-11#3)(1992-12#2)(1993-12#1)(1993-3#2)(1993-6#2)(1993-8#1)(1994-12#1)(1994-2#3)(1997-1#3)(1997-6#1)(1997-7#3)(2004-9#1)(2005-1#1)(2005-11#1)(2006-5#4)(2007-11#1)(2007-7#3)(2008-1#1)(2008-11#15)(2008-5#18)(2008-8#1)(2008-9#2)(2009-3#5)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#5)(2010-2#1)(2010-3#1)(2010-9#3)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#2)(2012-3#1)(2012-4#2)(2013-1#3)
osteocalcin (BGP)##2##2##(1990-12#1)(1992-1#1)
osteocalcin (OC)##3##2##(1996-9#1)(2006-6#1)(2013-8#1)
osteocalcin and osteopontin##3##3##(2008-11#2)(2010-2#1)
osteocalcin and##9##2##(1991-11#2)(1995-2#1)(2006-10#1)(2008-11#2)(2010-12#1)(2010-2#1)(2012-12#1)
osteocalcin fractions##4##2##(1996-12#4)
osteocalcin gene expression in##2##4##(1993-3#1)(1994-11#1)
osteocalcin gene expression##5##3##(1993-3#2)(1994-11#1)(2012-11#2)
osteocalcin gene##8##2##(1993-3#3)(1994-11#2)(1997-6#1)(2012-11#2)
osteocalcin in##7##2##(1990-12#2)(1991-11#1)(2010-2#3)(2011-2#1)
osteocalcin is##2##2##(1990-2#1)(1996-12#1)
osteocalcin levels##3##2##(1990-12#1)(1992-1#1)(2012-4#1)
osteocalcin production##2##2##(1990-2#1)(2012-4#1)
osteocalcin was##2##2##(1990-12#1)(2010-2#1)
osteocalcin were##2##2##(1996-12#1)(2008-11#1)
osteocalcin##73##1##(1990-12#5)(1990-2#8)(1991-11#3)(1991-3#1)(1992-1#2)(1992-12#2)(1992-6#1)(1993-3#4)(1994-11#3)(1994-2#1)(1995-2#1)(1996-12#10)(1996-9#1)(1997-6#1)(2006-10#2)(2006-6#1)(2008-11#3)(2008-5#3)(2008-7#1)(2008-8#2)(2009-3#2)(2010-12#1)(2010-2#7)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-4#2)(2013-8#1)
osteochondral allograft##4##2##(2008-6#2)(2012-3#2)
osteochondral allografts##3##2##(2008-6#1)(2012-3#2)
osteochondral defects##2##2##(2012-3#1)(2013-1#1)
osteochondral fracture##4##2##(2008-12#1)(2008-8#2)(2013-1#1)
osteochondral fractures##3##2##(2006-11#1)(2007-1#1)(2008-12#1)
osteochondral fragment##2##2##(2008-3#1)(2011-2#1)
osteochondral transfer##2##2##(2009-3#2)
osteochondral transplantation##2##2##(2011-2#2)
osteochondral##37##1##(2006-11#2)(2007-1#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-6#3)(2008-8#2)(2009-1#1)(2009-3#2)(2011-2#8)(2012-12#2)(2012-3#6)(2013-1#2)
osteochondritis dissecans##4##2##(1992-4#1)(2008-3#1)(2008-8#2)
osteochondritis##5##1##(1992-4#1)(2007-9#1)(2008-3#1)(2008-8#2)
osteochondrodysplasia##3##1##(1996-8#1)(1997-1#2)
osteochondroma##4##1##(1997-8#1)(2008-8#2)(2010-3#1)
osteochondromatosis of the##2##3##(2010-5#1)(2010-7#1)
osteochondromatosis##6##1##(2007-7#1)(2010-5#3)(2010-7#2)
osteochondrosis and##2##2##(2007-11#2)
osteochondrosis##8##1##(2005-7#1)(2007-11#5)(2008-7#2)
osteoclast activation##3##2##(1993-8#1)(1994-3#1)(2013-1#1)
osteoclast activity in##2##3##(1994-3#1)(2011-2#1)
osteoclast activity##5##2##(1994-3#1)(1996-8#1)(2011-2#3)
osteoclast and##4##2##(1991-12#1)(1991-5#1)(1993-11#1)(2007-8#1)
osteoclast apoptosis##5##2##(2008-11#4)(2009-3#1)
osteoclast differentiation and##2##3##(2009-4#1)(2011-2#1)
osteoclast differentiation from##2##3##(2007-8#1)(2010-10#1)
osteoclast differentiation##12##2##(1991-5#1)(1993-8#1)(1994-12#3)(2005-3#1)(2007-8#1)(2008-11#1)(2009-4#2)(2010-10#1)(2011-2#1)
osteoclast formation and##2##3##(1993-9#1)(2010-10#1)
osteoclast formation##10##2##(1990-9#1)(1991-5#2)(1992-9#1)(1993-8#1)(1993-9#1)(2008-4#1)(2008-5#1)(2010-10#1)(2012-3#1)
osteoclast function##5##2##(1990-2#1)(1991-12#1)(1994-3#1)(2008-4#1)(2008-7#1)
osteoclast growth and##2##3##(1994-6#1)(2013-1#1)
osteoclast number##2##2##(2009-3#1)(2012-1#1)
osteoclast precursors##2##2##(1994-12#2)
osteoclast##68##1##(1990-2#3)(1990-9#1)(1991-11#2)(1991-12#2)(1991-5#4)(1992-3#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-8#3)(1993-9#5)(1994-12#5)(1994-3#4)(1994-6#3)(1996-8#2)(2005-3#2)(2007-8#2)(2008-11#5)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#2)(2009-4#2)(2010-10#2)(2011-2#5)(2012-1#1)(2012-3#1)(2013-1#2)
osteoclast-like cell formation in##2##4##(1990-9#1)(1993-8#1)
osteoclast-like cells in vitro##2##4##(1990-9#2)
osteoclast-like giant cells##7##3##(2012-1#1)(2012-3#6)
osteoclast-like multinucleated giant cells##3##4##(2007-12#1)(2013-1#2)
osteoclast-like##15##1##(1990-9#3)(1993-8#1)(2007-12#1)(2008-11#1)(2012-1#1)(2012-3#6)(2013-1#2)
osteoclast-mediated bone resorption##2##3##(1993-11#1)(2006-6#1)
osteoclast-poor phase##2##2##(2006-10#2)
osteoclast-rich##2##1##(2006-10#2)
osteoclastic activity##6##2##(2008-11#1)(2008-5#1)(2009-3#3)(2013-8#1)
osteoclastic bone resorption and##3##4##(1992-3#1)(2005-3#1)(2008-11#1)
osteoclastic bone resorption by##2##4##(1992-3#1)(1993-9#1)
osteoclastic bone resorption in##2##4##(1992-3#1)(1993-9#1)
osteoclastic bone resorption##17##3##(1990-2#1)(1992-3#4)(1992-7#1)(1993-6#1)(1993-9#3)(1994-3#2)(1995-3#1)(2005-3#1)(2008-11#2)(2008-3#1)
osteoclastic differentiation##3##2##(1991-5#2)(2009-3#1)
osteoclastic resorption##5##2##(1992-10#1)(2005-3#1)(2008-5#2)(2008-8#1)
osteoclastic trepanation##2##2##(1991-11#2)
osteoclastic##37##1##(1990-2#1)(1991-11#3)(1991-5#2)(1991-8#1)(1992-10#1)(1992-3#4)(1992-7#1)(1993-6#1)(1993-9#3)(1994-3#2)(1995-3#1)(2005-3#2)(2007-3#1)(2008-11#4)(2008-3#1)(2008-5#3)(2008-8#1)(2009-3#4)(2013-8#1)
osteoclastic-rich phase##2##2##(2006-10#2)
osteoclastogenesis##7##1##(1994-6#1)(2011-1#4)(2013-1#2)
osteoclasts and in##2##3##(1992-7#1)(2005-1#1)
osteoclasts and##10##2##(1992-7#4)(1997-6#2)(2005-1#1)(2007-11#1)(2010-10#1)(2011-2#1)
osteoclasts from##2##2##(1990-9#1)(1992-7#1)
osteoclasts in##5##2##(1990-9#1)(1993-9#1)(1994-12#1)(2006-4#1)(2010-10#1)
osteoclasts to##3##2##(1991-8#1)(1992-3#1)(2005-3#1)
osteoclasts##91##1##(1990-5#1)(1990-6#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-5#1)(1991-8#8)(1992-11#1)(1992-3#2)(1992-7#12)(1993-11#1)(1993-8#1)(1993-9#8)(1994-12#2)(1994-6#1)(1996-8#2)(1997-6#6)(1997-7#2)(2005-1#1)(2005-3#1)(2006-4#1)(2007-11#2)(2007-7#2)(2008-11#12)(2008-4#2)(2008-7#1)(2008-8#3)(2009-3#1)(2009-4#1)(2010-10#4)(2011-12#1)(2011-2#3)(2012-2#1)(2012-3#2)
osteocondensation##2##1##(1991-11#1)(2010-12#1)
osteoconductive agent##3##2##(2006-7#3)
osteoconductive##8##1##(2004-9#1)(2006-6#1)(2006-7#3)(2008-5#2)(2012-3#1)
osteocyte##3##1##(2007-8#1)(2010-9#1)(2013-1#1)
osteocytes##11##1##(2008-11#1)(2008-5#2)(2010-9#5)(2012-12#1)(2013-7#2)
osteodystrophy##15##1##(1990-9#1)(1997-6#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-4#2)(2008-7#1)(2010-6#2)(2011-1#1)(2011-2#2)
osteofibrous dysplasia##3##2##(2008-6#2)(2010-3#1)
osteoforming##2##1##(1991-11#1)(2005-1#1)
osteogenesis and##5##2##(1996-5#1)(2009-3#1)(2009-8#1)(2010-2#1)(2012-11#1)
osteogenesis for##4##2##(2006-7#1)(2007-12#1)(2009-3#1)(2011-2#1)
osteogenesis has##3##2##(2007-12#2)(2007-8#1)
osteogenesis imperfecta##10##2##(2006-10#2)(2007-8#4)(2008-7#1)(2013-1#3)
osteogenesis in##7##2##(2007-12#5)(2007-8#1)(2008-11#1)
osteogenesis is##3##2##(2007-12#3)
osteogenesis##57##1##(1991-5#1)(1993-9#1)(1996-5#1)(2005-7#1)(2006-10#2)(2006-7#1)(2007-12#17)(2007-7#1)(2007-8#12)(2008-1#1)(2008-11#3)(2008-5#3)(2008-7#1)(2008-8#1)(2009-3#2)(2009-8#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-11#1)(2013-1#3)
osteogenetic##2##1##(2007-11#2)
osteogenic and chondrogenic differentiation potentials of hMSCs##2##7##(2008-11#2)
osteogenic and chondrogenic differentiation potentials of##3##6##(2008-11#3)
osteogenic and chondrogenic differentiation##5##4##(2008-11#4)(2012-12#1)
osteogenic and##6##2##(2008-11#4)(2012-12#1)(2013-1#1)
osteogenic cell compartment##2##3##(2013-8#2)
osteogenic cells##6##2##(1995-3#1)(2006-6#1)(2008-11#1)(2008-5#1)(2010-2#1)(2010-8#1)
osteogenic differentiation of MSC##2##4##(2008-5#2)
osteogenic differentiation of human##4##4##(2008-5#2)(2012-1#2)
osteogenic differentiation of##11##3##(2008-5#7)(2012-1#3)(2012-6#1)
osteogenic differentiation was observed##3##4##(2008-11#2)(2012-12#1)
osteogenic differentiation##24##2##(2008-11#8)(2008-5#8)(2009-4#2)(2012-1#3)(2012-12#1)(2012-4#1)(2012-6#1)
osteogenic lineage##4##2##(1994-2#1)(2008-11#1)(2012-11#2)
osteogenic medium##5##2##(2008-11#3)(2008-5#1)(2012-4#1)
osteogenic or##2##2##(2008-1#1)(2008-11#1)
osteogenic potential##4##2##(2008-11#4)
osteogenic protein-1##2##2##(1993-12#1)(1994-6#1)
osteogenic sarcoma of the##6##4##(1992-2#2)(1996-6#1)(2008-6#2)(2011-2#1)
osteogenic sarcoma of##7##3##(1992-2#2)(1996-6#1)(2008-6#3)(2011-2#1)
osteogenic sarcoma##16##2##(1992-12#2)(1992-2#2)(1994-2#1)(1996-3#1)(1996-6#1)(2007-8#2)(2008-6#5)(2011-1#1)(2011-2#1)
osteogenic##94##1##(1992-12#3)(1992-2#2)(1993-11#1)(1993-12#1)(1993-9#2)(1994-2#2)(1994-6#2)(1995-3#1)(1996-3#1)(1996-6#1)(2006-6#2)(2007-8#2)(2008-1#1)(2008-11#25)(2008-5#15)(2008-6#5)(2009-4#2)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-11#4)(2012-12#4)(2012-2#1)(2012-4#2)(2012-6#2)(2013-1#1)(2013-7#1)(2013-8#2)
osteoid and##3##2##(2006-10#1)(2008-6#1)(2010-3#1)
osteoid osteoma in children##2##4##(2007-11#2)
osteoid osteoma in##3##3##(2007-11#2)(2010-9#1)
osteoid osteoma of the##3##4##(2008-8#1)(2013-1#2)
osteoid osteoma##18##2##(1990-9#1)(2007-11#2)(2008-8#2)(2010-12#2)(2010-9#1)(2012-12#1)(2012-2#3)(2013-1#6)
osteoid osteomas##4##2##(2013-1#4)
osteoid##32##1##(1990-9#1)(2006-10#1)(2007-11#3)(2007-7#1)(2008-6#1)(2008-8#2)(2009-8#3)(2010-12#2)(2010-3#2)(2010-9#2)(2012-12#1)(2012-2#3)(2013-1#10)
osteoinductive growth factors##3##3##(2008-5#1)(2008-8#2)
osteoinductive##7##1##(2006-6#1)(2008-5#2)(2008-7#1)(2008-8#2)(2010-8#1)
osteointegration##4##1##(2007-8#4)
osteolitic##3##1##(2007-11#3)
osteological##2##1##(1992-1#1)(2012-12#1)
osteology##2##1##(1996-6#1)(2012-12#1)
osteolysis and##3##2##(2004-9#1)(2009-3#1)(2013-1#1)
osteolysis is##2##2##(2007-11#1)(2008-8#1)
osteolysis of the##3##3##(1995-9#1)(2007-11#1)(2007-7#1)
osteolysis of##5##2##(1995-9#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-6#1)
osteolysis##29##1##(1993-10#1)(1995-9#1)(2004-9#1)(2006-10#1)(2007-11#2)(2007-7#1)(2008-11#1)(2008-4#1)(2008-6#2)(2008-8#8)(2008-9#1)(2009-3#5)(2013-1#4)
osteolytic bone lesions##2##3##(1992-10#2)
osteolytic bone##3##2##(1992-10#2)(2008-7#1)
osteolytic lesion##6##2##(2007-11#2)(2008-12#2)(2010-9#1)(2012-12#1)
osteolytic lesions in the##2##4##(2008-12#1)(2012-12#1)
osteolytic lesions##5##2##(2007-7#2)(2008-12#1)(2012-12#1)(2013-1#1)
osteolytic metastases##3##2##(1991-8#1)(1997-6#1)(2008-7#1)
osteolytic tumours of bone##2##4##(2008-6#2)
osteolytic##28##1##(1991-5#1)(1991-8#1)(1992-10#2)(1995-9#1)(1997-5#1)(1997-6#1)(2005-3#1)(2007-11#2)(2007-12#1)(2007-7#2)(2008-1#1)(2008-12#3)(2008-6#3)(2008-7#2)(2010-12#2)(2010-9#1)(2012-12#2)(2013-1#1)
osteoma cutis is characterized by##2##5##(2005-11#1)(2010-6#1)
osteoma cutis##4##2##(2005-11#1)(2010-6#3)
osteoma in the##3##3##(2010-9#1)(2012-12#2)
osteoma in##6##2##(2007-11#2)(2008-5#1)(2010-9#1)(2012-12#2)
osteoma is##3##2##(2012-12#1)(2013-1#2)
osteoma of the##7##3##(2008-5#1)(2008-8#1)(2010-5#2)(2011-2#1)(2013-1#2)
osteoma##40##1##(1990-9#2)(2005-11#2)(2007-11#2)(2007-3#1)(2008-5#2)(2008-8#2)(2009-2#1)(2010-12#2)(2010-5#2)(2010-6#3)(2010-9#1)(2011-2#3)(2012-12#8)(2012-2#3)(2013-1#6)
osteomalacia and##3##2##(1996-8#1)(1997-4#1)(2006-10#1)
osteomalacia in##4##2##(1991-11#1)(1997-4#1)(2008-4#2)
osteomalacia or##2##2##(2005-1#1)(2012-12#1)
osteomalacia that##2##2##(2006-10#1)(2008-6#1)
osteomalacia##33##1##(1991-11#1)(1996-11#4)(1996-8#4)(1997-4#2)(1997-6#3)(2005-1#1)(2006-10#7)(2008-4#2)(2008-6#4)(2008-7#1)(2010-12#1)(2010-3#1)(2012-12#1)(2013-1#1)
osteomas##12##1##(2005-11#2)(2011-2#6)(2013-1#4)
osteomyelitis and##10##2##(1990-9#1)(1993-10#1)(2006-10#1)(2007-2#1)(2007-8#2)(2008-4#1)(2010-6#1)(2012-2#1)(2013-8#1)
osteomyelitis due to##2##3##(2006-12#1)(2007-7#1)
osteomyelitis has##2##2##(2010-6#1)(2012-2#1)
osteomyelitis in a##3##3##(1995-9#1)(2005-9#1)(2013-8#1)
osteomyelitis in children and adolescents##2##5##(1993-10#1)(2008-7#1)
osteomyelitis in##13##2##(1993-10#1)(1995-9#1)(2005-9#3)(2008-7#1)(2008-9#1)(2009-4#1)(2010-6#2)(2012-2#2)(2013-8#1)
osteomyelitis is a##2##3##(2010-6#1)(2012-11#1)
osteomyelitis is##5##2##(2008-9#1)(2010-6#2)(2012-11#1)(2012-2#1)
osteomyelitis may##2##2##(2005-10#1)(2010-6#1)
osteomyelitis of the lower##2##4##(2009-4#1)(2011-2#1)
osteomyelitis of the##12##3##(1991-1#1)(1992-3#1)(1996-8#1)(2007-12#1)(2007-8#3)(2009-4#1)(2009-6#1)(2010-6#1)(2011-2#1)(2012-8#1)
osteomyelitis of##16##2##(1991-1#1)(1992-3#1)(1996-8#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-9#1)(2009-4#1)(2009-6#1)(2010-6#2)(2011-2#2)(2012-8#1)
osteomyelitis or##4##2##(2007-8#1)(2008-7#1)(2008-9#1)(2010-3#1)
osteomyelitis with##2##2##(2008-9#1)(2013-8#1)
osteomyelitis##134##1##(1990-7#1)(1990-9#1)(1991-1#2)(1991-10#1)(1992-3#1)(1992-6#1)(1993-10#3)(1995-9#1)(1996-8#1)(2005-10#1)(2005-7#1)(2005-9#4)(2006-10#2)(2006-12#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#6)(2007-2#4)(2007-7#4)(2007-8#6)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-9#6)(2009-2#3)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#2)(2010-12#1)(2010-3#2)(2010-6#40)(2011-2#2)(2012-11#2)(2012-12#1)(2012-2#10)(2012-8#1)(2013-8#4)
osteomyelitis]##2##1##(1992-6#1)(2011-2#1)
osteon##2##1##(2009-7#1)(2010-2#1)
osteonal cortical bone is##2##4##(2009-7#2)
osteonal cortical bone##3##3##(2009-7#3)
osteonal##4##1##(2008-6#1)(2009-7#3)
osteonecrosis and##3##2##(1994-7#2)(2009-3#1)
osteonecrosis of the femoral head associated with pregnancy##2##8##(2009-3#2)
osteonecrosis of the femoral head in##2##6##(2007-6#1)(2009-10#1)
osteonecrosis of the femoral head##7##5##(2007-6#1)(2009-10#1)(2009-3#5)
osteonecrosis of the jaw (BRONJ)##2##5##(2012-12#1)(2013-8#1)
osteonecrosis of the jaw##6##4##(2008-1#1)(2008-7#2)(2012-12#2)(2013-8#1)
osteonecrosis of the jaws##3##4##(2012-12#2)(2013-7#1)
osteonecrosis of the##17##3##(2007-6#1)(2008-1#1)(2008-7#2)(2009-10#1)(2009-3#5)(2012-12#4)(2012-3#1)(2013-7#1)(2013-8#1)
osteonecrosis##38##1##(1994-7#5)(1995-2#1)(2006-10#1)(2006-8#4)(2007-12#1)(2007-6#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-7#2)(2009-10#1)(2009-3#8)(2012-12#5)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
osteonecrotic group##2##2##(1994-7#2)
osteonecrotic##3##1##(1994-7#2)(2007-9#1)
osteonectin##2##1##(2008-1#1)(2010-2#1)
osteonectin/SPARC##2##1##(2007-12#1)(2009-3#1)
osteons##4##1##(2004-9#3)(2009-2#1)
osteopathic literature##2##2##(1991-12#1)(2007-11#1)
osteopathic manipulative treatment##3##3##(2007-12#1)(2008-3#1)(2013-1#1)
osteopathic medicine##3##2##(1991-12#1)(1991-8#1)(2007-12#1)
osteopathic research##5##2##(2007-11#1)(2008-3#4)
osteopathic##23##1##(1991-12#3)(1991-8#1)(2006-8#1)(2007-11#7)(2007-12#2)(2008-12#1)(2008-3#6)(2010-1#1)(2013-1#1)
osteopaths##8##1##(2007-11#8)
osteopathy and##2##2##(2008-12#1)(2010-12#1)
osteopathy##8##1##(1991-11#1)(2007-11#2)(2008-12#1)(2010-12#4)
osteopenia and osteoporosis##6##3##(2006-10#2)(2007-8#1)(2008-1#1)(2008-7#1)(2011-2#1)
osteopenia and##9##2##(2006-10#3)(2007-8#2)(2008-1#1)(2008-7#1)(2011-2#1)(2012-2#1)
osteopenia or osteoporosis compared with##2##5##(2006-10#2)
osteopenia or osteoporosis##3##3##(2006-10#3)
osteopenia##35##1##(1997-7#1)(2004-11#1)(2005-3#5)(2006-10#7)(2006-7#1)(2006-8#1)(2007-3#2)(2007-8#2)(2008-1#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-7#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
osteopetrosis is##3##2##(1990-5#1)(2008-11#1)(2012-2#1)
osteopetrosis##13##1##(1990-5#2)(1994-3#1)(2006-10#1)(2007-8#1)(2008-11#2)(2008-7#1)(2010-10#2)(2012-2#3)
osteopetrotic##2##1##(1995-8#1)(2009-1#1)
osteophyte##3##1##(2008-8#1)(2011-2#2)
osteophytes around fissure margin of lumbar spondylolysis##2##7##(2007-7#2)
osteophytes##6##1##(1994-11#1)(2007-11#3)(2007-7#2)
osteophytic##3##1##(2011-2#3)
osteopontin (OPN)##2##2##(1995-10#1)(2012-2#1)
osteopontin and bone sialoprotein II##2##5##(1990-11#2)
osteopontin and osteocalcin##2##3##(2008-5#1)(2010-2#1)
osteopontin and##6##2##(1990-11#2)(2008-5#1)(2010-2#2)(2012-2#1)
osteopontin from##2##2##(1992-7#1)(2006-5#1)
osteopontin in##4##2##(1992-7#1)(2008-7#1)(2010-11#1)(2010-2#1)
osteopontin##40##1##(1990-11#2)(1992-1#2)(1992-4#3)(1992-7#3)(1995-10#1)(1995-8#1)(2006-5#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#6)(2009-3#2)(2009-7#1)(2009-9#2)(2010-11#1)(2010-2#6)(2012-1#1)(2012-12#1)(2012-2#2)
osteoporosis and bone##3##3##(2006-10#2)(2012-12#1)
osteoporosis and fracture##2##3##(2007-11#1)(2012-12#1)
osteoporosis and its##3##3##(1992-2#2)(2012-2#1)
osteoporosis and the##2##3##(1997-6#1)(2013-1#1)
osteoporosis and to##2##3##(1994-9#1)(2010-3#1)
osteoporosis and##42##2##(1991-12#1)(1992-2#3)(1992-6#1)(1993-11#1)(1993-5#1)(1994-7#1)(1994-9#1)(1996-6#1)(1996-8#1)(1997-6#1)(2005-1#1)(2005-3#2)(2005-8#1)(2006-10#2)(2006-12#1)(2006-8#2)(2007-11#2)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-3#1)(2010-10#1)(2010-3#2)(2010-4#1)(2011-1#1)(2012-12#2)(2012-2#3)(2013-1#2)
osteoporosis are##2##2##(1993-11#1)(2007-11#1)
osteoporosis around##2##2##(2005-3#2)
osteoporosis as compared with##3##4##(2005-1#1)(2013-1#2)
osteoporosis as compared##4##3##(2005-1#1)(2012-2#1)(2013-1#2)
osteoporosis as##7##2##(2005-1#1)(2006-10#1)(2007-11#1)(2008-4#1)(2012-2#1)(2013-1#2)
osteoporosis at##2##2##(2005-3#1)(2012-2#1)
osteoporosis by##3##2##(2010-9#1)(2012-2#2)
osteoporosis can be##3##3##(1992-1#1)(1993-11#1)(1996-6#1)
osteoporosis development##2##2##(2008-4#2)
osteoporosis from the##2##3##(1992-2#1)(2005-3#1)
osteoporosis from##3##2##(1992-2#1)(2005-3#1)(2006-10#1)
osteoporosis have##2##2##(2007-11#1)(2012-2#1)
osteoporosis in the##6##3##(1991-11#1)(1996-6#1)(2006-10#1)(2007-7#1)(2008-8#1)(2010-3#1)
osteoporosis in##36##2##(1991-11#1)(1993-11#1)(1995-9#1)(1996-6#1)(2005-3#2)(2005-7#1)(2006-10#2)(2006-6#1)(2007-1#1)(2007-11#3)(2007-7#3)(2008-12#1)(2008-4#1)(2008-7#4)(2008-8#2)(2010-3#3)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#4)
osteoporosis is discussed##2##3##(2007-11#2)
osteoporosis is to##3##3##(2005-3#1)(2007-11#1)(2007-8#1)
osteoporosis is##20##2##(1991-11#1)(2005-3#3)(2006-10#1)(2006-8#1)(2007-11#3)(2007-8#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-10#1)(2010-3#2)(2010-9#1)(2011-1#1)(2013-1#1)
osteoporosis of the femoral head##2##5##(2009-3#2)
osteoporosis of the##3##3##(2006-10#1)(2009-3#2)
osteoporosis of##4##2##(2006-10#2)(2009-3#2)
osteoporosis or##7##2##(2006-12#1)(2006-8#1)(2008-1#1)(2008-4#1)(2008-8#1)(2012-12#1)(2012-2#1)
osteoporosis patients##2##2##(2005-3#1)(2008-11#1)
osteoporosis prevention##2##2##(1993-11#1)(2008-11#1)
osteoporosis should##2##2##(1993-11#1)(2005-3#1)
osteoporosis than##2##2##(1996-6#2)
osteoporosis treated with##2##3##(1991-11#1)(2007-11#1)
osteoporosis was##3##2##(1991-11#1)(1993-7#1)(2013-8#1)
osteoporosis with##10##2##(1991-11#1)(1992-1#1)(1993-11#2)(2005-1#1)(2006-6#1)(2007-11#1)(2008-3#1)(2008-8#1)(2013-1#1)
osteoporosis##428##1##(1990-11#1)(1990-12#1)(1990-9#1)(1991-11#12)(1991-12#2)(1991-3#1)(1991-6#1)(1992-1#3)(1992-2#5)(1992-3#1)(1992-6#2)(1992-8#1)(1993-11#30)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-7#2)(1994-9#1)(1995-11#2)(1995-4#2)(1995-9#2)(1996-1#1)(1996-11#2)(1996-6#6)(1996-8#1)(1997-6#8)(1997-7#2)(1997-8#1)(2004-11#1)(2004-3#1)(2005-1#9)(2005-12#1)(2005-3#26)(2005-7#2)(2005-8#1)(2006-10#24)(2006-12#3)(2006-3#1)(2006-6#3)(2006-8#8)(2006-9#1)(2007-1#1)(2007-11#34)(2007-7#7)(2007-8#15)(2007-9#2)(2008-1#5)(2008-11#6)(2008-12#1)(2008-3#13)(2008-4#13)(2008-5#3)(2008-6#5)(2008-7#14)(2008-8#20)(2008-9#3)(2009-12#2)(2009-3#6)(2009-5#1)(2009-6#1)(2010-10#2)(2010-2#1)(2010-3#19)(2010-4#1)(2010-6#1)(2010-9#3)(2011-1#5)(2011-12#3)(2011-2#3)(2011-3#1)(2012-12#12)(2012-2#21)(2013-1#21)(2013-8#7)
osteoporosis?]##2##1##(2005-3#1)(2005-7#1)
osteoporosis]##11##1##(1991-11#2)(1991-3#1)(1992-1#1)(1993-7#1)(1994-12#1)(1995-11#1)(1997-6#1)(2005-3#2)(2006-5#1)
osteoporotic bone##6##2##(1992-6#1)(2006-3#3)(2007-8#1)(2011-2#1)
osteoporotic compression fractures##5##3##(2006-8#2)(2007-8#1)(2008-7#1)(2012-2#1)
osteoporotic fracture##3##2##(2007-9#1)(2008-8#1)(2013-1#1)
osteoporotic fractures of the proximal##2##5##(2007-11#2)
osteoporotic fractures of the##4##4##(2007-11#3)(2007-8#1)
osteoporotic fractures##18##2##(1991-11#1)(1993-10#1)(1993-11#1)(1996-8#2)(1997-6#1)(2006-10#2)(2007-11#4)(2007-8#4)(2007-9#1)(2008-3#1)
osteoporotic patients##6##2##(1997-7#1)(2005-3#2)(2007-11#1)(2008-6#1)(2013-8#1)
osteoporotic postmenopausal women##3##3##(1993-7#1)(2007-9#2)
osteoporotic postmenopausal##4##2##(1993-7#1)(2007-9#3)
osteoporotic vertebral compression fracture##2##4##(2006-8#1)(2008-12#1)
osteoporotic vertebral compression fractures##3##4##(2007-8#1)(2008-7#1)(2010-9#1)
osteoporotic vertebral compression##5##3##(2006-8#1)(2007-8#1)(2008-12#1)(2008-7#1)(2010-9#1)
osteoporotic vertebral fracture##2##3##(2006-10#1)(2007-11#1)
osteoporotic vertebral##12##2##(1991-11#2)(2006-10#1)(2006-8#2)(2007-11#1)(2007-8#3)(2008-12#1)(2008-7#1)(2010-9#1)
osteoporotic women##9##2##(1993-7#1)(2007-11#1)(2007-9#1)(2008-11#1)(2012-3#1)(2013-7#4)
osteoporotic##82##1##(1991-11#5)(1992-6#2)(1993-10#1)(1993-11#1)(1993-7#2)(1996-8#2)(1997-6#1)(1997-7#1)(2005-3#3)(2006-10#4)(2006-3#4)(2006-8#4)(2007-11#9)(2007-8#11)(2007-9#6)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#4)(2013-8#1)
osteoporotics##2##1##(2005-3#2)
osteoprogenitor cells##4##2##(1992-1#1)(1996-11#2)(2012-4#1)
osteoprogenitor##5##1##(1992-1#1)(1993-9#1)(1996-11#2)(2012-4#1)
osteoprotegerin (OPG) gene##2##3##(2013-1#2)
osteoprotegerin (OPG)##11##2##(2007-8#1)(2008-12#2)(2010-10#3)(2011-1#2)(2013-1#2)(2013-8#1)
osteoprotegerin and##2##2##(2011-12#1)(2012-12#1)
osteoprotegerin production in##3##3##(2011-12#3)
osteoprotegerin production##4##2##(2011-12#4)
osteoprotegerin##25##1##(2005-3#1)(2007-8#3)(2008-11#1)(2008-12#2)(2008-7#1)(2010-10#3)(2011-1#2)(2011-12#6)(2012-12#1)(2013-1#4)(2013-8#1)
osteoprotic##3##1##(1997-7#3)
osteoradionecrosis of the cervical spine##2##5##(2011-2#2)
osteoradionecrosis##5##1##(2007-12#1)(2011-2#3)(2013-1#1)
osteosarcoma 29 years after radiation therapy##2##6##(2013-8#2)
osteosarcoma and Ewing sarcoma##2##4##(2008-7#2)
osteosarcoma and##10##2##(1990-9#1)(2008-6#2)(2008-7#2)(2010-3#5)
osteosarcoma are##5##2##(2008-6#1)(2010-3#4)
osteosarcoma around the knee joint##4##5##(2008-1#4)
osteosarcoma at##2##2##(2008-6#2)
osteosarcoma by##2##2##(2008-6#1)(2010-3#1)
osteosarcoma cases were##2##3##(2008-6#2)
osteosarcoma cell line##3##3##(1990-11#1)(1993-12#1)(2008-6#1)
osteosarcoma cell lines with##2##4##(1994-2#1)(2010-3#1)
osteosarcoma cell lines##9##3##(1992-8#1)(1993-11#2)(1994-2#1)(1997-7#2)(2008-6#1)(2010-3#2)
osteosarcoma cell##17##2##(1990-11#2)(1991-4#1)(1992-8#3)(1993-11#2)(1993-12#1)(1994-2#1)(1997-7#2)(2008-6#2)(2010-3#2)(2011-2#1)
osteosarcoma cells##21##2##(1990-9#1)(1991-5#1)(1991-8#1)(1993-11#2)(1994-2#2)(1994-6#2)(1994-9#1)(1995-3#1)(1995-5#3)(1995-8#1)(1996-11#1)(1997-7#2)(2010-3#2)(2013-8#1)
osteosarcoma has##6##2##(2008-6#1)(2010-3#4)(2013-1#1)
osteosarcoma have##3##2##(2010-3#3)
osteosarcoma in the##6##3##(2008-6#2)(2009-3#1)(2010-3#1)(2013-1#2)
osteosarcoma in##12##2##(2008-6#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
osteosarcoma is##8##2##(2008-6#2)(2010-3#6)
osteosarcoma of the extremities##5##4##(1992-6#4)(2010-3#1)
osteosarcoma of the extremity##3##4##(2010-3#3)
osteosarcoma of the orbit##2##4##(2008-6#2)
osteosarcoma of the right##2##4##(1991-11#1)(2008-6#1)
osteosarcoma of the##15##3##(1991-11#1)(1992-6#4)(1993-10#1)(2008-6#5)(2010-3#4)
osteosarcoma patients prior to##2##4##(2010-3#2)
osteosarcoma patients##7##2##(2010-3#7)
osteosarcoma survivors##2##2##(2010-3#2)
osteosarcoma were treated##2##3##(2008-6#1)(2010-3#1)
osteosarcoma were##3##2##(2008-6#2)(2010-3#1)
osteosarcoma with##5##2##(2008-6#1)(2010-3#3)(2012-1#1)
osteosarcoma##246##1##(1990-11#2)(1990-12#1)(1990-9#2)(1991-11#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-6#4)(1992-8#4)(1993-10#2)(1993-11#4)(1993-12#2)(1994-2#3)(1994-6#3)(1994-9#1)(1995-3#1)(1995-5#3)(1995-8#1)(1996-11#1)(1996-6#1)(1997-7#6)(2007-5#1)(2008-1#4)(2008-2#1)(2008-5#1)(2008-6#47)(2008-7#3)(2008-8#4)(2009-3#1)(2010-12#1)(2010-3#116)(2011-2#2)(2012-1#2)(2012-12#1)(2013-1#4)(2013-7#4)(2013-8#5)
osteosarcoma)##2##1##(1992-5#1)(1992-6#1)
osteosarcomas are uncommon##2##3##(2008-6#2)
osteosarcomas are##4##2##(2008-6#3)(2013-1#1)
osteosarcomas of the skull##2##4##(1993-10#2)
osteosarcomas of the##3##3##(1993-10#2)(2010-3#1)
osteosarcomas##13##1##(1993-10#2)(2008-6#7)(2010-3#3)(2013-1#1)
osteosarcomatous##2##1##(1992-8#1)(2007-8#1)
osteosclerosis##4##1##(1996-8#1)(2008-4#1)(2008-7#1)(2012-12#1)
osteosclerotic##2##1##(2011-2#2)
osteoseptocutaneous fibular transplant##2##3##(2006-3#2)
osteosynthesis and##4##2##(2007-11#3)(2011-2#1)
osteosynthesis for##3##2##(2009-2#2)(2013-8#1)
osteosynthesis in##3##2##(2007-11#1)(2009-2#1)(2013-8#1)
osteosynthesis of the##2##3##(2006-6#1)(2008-6#1)
osteosynthesis of##6##2##(2006-6#1)(2007-11#1)(2008-6#1)(2009-2#1)(2010-2#1)(2013-1#1)
osteosynthesis was##3##2##(2007-11#1)(2007-8#1)(2008-9#1)
osteosynthesis##51##1##(1993-8#1)(1995-3#1)(2004-9#1)(2006-6#1)(2007-11#17)(2007-7#4)(2007-8#4)(2008-4#4)(2008-6#1)(2008-9#1)(2009-2#6)(2009-3#2)(2010-2#1)(2011-2#1)(2013-1#1)(2013-8#5)
osteosynthesis)##2##1##(2007-8#1)(2011-2#1)
osteotomied##2##1##(2007-8#2)
osteotomies of the##4##3##(1996-6#1)(2007-5#2)(2008-9#1)
osteotomies##22##1##(1996-6#1)(2006-7#1)(2007-5#3)(2007-7#4)(2007-8#2)(2008-4#1)(2008-8#4)(2008-9#1)(2010-3#1)(2012-2#3)(2013-1#1)
osteotomy and denervation##2##3##(2007-8#2)
osteotomy and##9##2##(2007-8#4)(2008-10#1)(2010-7#2)(2011-2#1)(2013-1#1)
osteotomy angle##2##2##(2007-7#2)
osteotomy are##2##2##(2010-11#1)(2012-2#1)
osteotomy fixed with##5##3##(2008-9#1)(2013-1#4)
osteotomy for##9##2##(2006-3#1)(2006-4#1)(2007-12#1)(2007-7#1)(2008-4#1)(2008-9#1)(2009-5#1)(2009-9#1)(2012-2#1)
osteotomy gap##4##2##(2006-3#2)(2008-9#1)(2011-2#1)
osteotomy has been##2##3##(2012-2#2)
osteotomy in adolescents##2##3##(2007-7#1)(2009-3#1)
osteotomy in the treatment of developmental##2##6##(2007-7#1)(2007-8#1)
osteotomy in the treatment of##4##5##(2006-12#1)(2007-7#1)(2007-8#1)(2010-11#1)
osteotomy in the##6##3##(2006-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2010-11#1)
osteotomy in##15##2##(2006-12#1)(2007-7#5)(2007-8#1)(2008-10#2)(2009-3#2)(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#1)
osteotomy is a##3##3##(2008-8#1)(2009-3#1)(2010-3#1)
osteotomy is##15##2##(1997-4#1)(2006-3#3)(2007-7#2)(2008-8#4)(2009-3#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-2#1)
osteotomy of the distal radius##2##5##(2006-3#1)(2008-9#1)
osteotomy of the distal##3##4##(2006-3#1)(2008-9#1)(2011-2#1)
osteotomy of the proximal femur##5##5##(2007-5#1)(2007-7#4)
osteotomy of the proximal##6##4##(2007-5#1)(2007-7#4)(2010-3#1)
osteotomy of the##12##3##(2006-3#1)(2006-4#1)(2007-5#1)(2007-7#4)(2008-9#1)(2009-3#2)(2010-3#1)(2011-2#1)
osteotomy of##13##2##(2006-3#1)(2006-4#1)(2007-2#1)(2007-5#1)(2007-7#4)(2008-9#1)(2009-3#2)(2010-3#1)(2011-2#1)
osteotomy or##2##2##(2007-12#1)(2012-2#1)
osteotomy performed##2##2##(1990-6#1)(2009-3#1)
osteotomy stabilized with##2##3##(2009-10#1)(2012-12#1)
osteotomy techniques##2##2##(2005-7#2)
osteotomy to##4##2##(2007-2#1)(2009-3#1)(2013-1#2)
osteotomy was performed##4##3##(2007-7#3)(2011-2#1)
osteotomy was##6##2##(2006-12#1)(2007-7#3)(2009-3#1)(2011-2#1)
osteotomy with a##3##3##(2006-3#1)(2008-8#1)(2010-3#1)
osteotomy with##6##2##(2006-3#1)(2007-8#1)(2008-8#1)(2010-3#1)(2012-2#1)(2013-1#1)
osteotomy##165##1##(1990-6#3)(1997-4#2)(1997-6#1)(2005-7#2)(2005-9#2)(2006-12#3)(2006-3#10)(2006-4#5)(2007-11#1)(2007-12#5)(2007-2#2)(2007-5#2)(2007-7#29)(2007-8#13)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#5)(2008-8#14)(2008-9#4)(2009-10#1)(2009-3#10)(2009-5#1)(2009-9#1)(2010-11#3)(2010-3#3)(2010-5#1)(2010-7#2)(2011-2#10)(2012-12#5)(2012-2#8)(2012-3#3)(2013-1#8)(2013-8#1)
osterix##2##1##(2009-3#1)(2012-1#1)
ostertagi##2##1##(1996-12#2)
osthol##6##1##(2009-3#6)
ostia##6##1##(1990-3#1)(2007-12#1)(2008-5#2)(2011-2#2)
ostial lesions##2##2##(1994-9#2)
ostial##7##1##(1994-9#2)(2007-8#2)(2008-11#1)(2008-12#1)(2010-12#1)
ostium of the##2##3##(2007-8#1)(2009-10#1)
ostium of##3##2##(2007-8#1)(2008-7#1)(2009-10#1)
ostium stenosis##2##2##(2007-8#2)
ostium##15##1##(2007-12#1)(2007-8#7)(2008-7#2)(2009-10#2)(2009-11#1)(2010-12#1)(2013-1#1)
ostomy##2##1##(2011-2#1)(2012-12#1)
ostracod##2##1##(2008-5#1)(2012-2#1)
ostracod-maxillopodan##2##1##(2007-12#2)
ostracods and##2##2##(2008-5#1)(2013-7#1)
ostracods##4##1##(2007-5#2)(2008-5#1)(2013-7#1)
ostreatus in##3##2##(2008-10#2)(2008-5#1)
ostreatus##12##1##(1990-4#1)(2008-10#3)(2008-5#2)(2011-1#6)
ostrich##4##1##(1996-8#1)(1997-6#1)(2007-4#1)(2008-5#1)
ostriches (Struthio camelus)##6##3##(1996-8#1)(1997-6#1)(2008-5#3)(2013-1#1)
ostriches and chickens##2##3##(2008-5#2)
ostriches and##3##2##(2008-5#3)
ostriches in##3##2##(2008-5#3)
ostriches were##2##2##(1996-8#1)(2008-5#1)
ostriches##23##1##(1996-8#2)(1997-6#3)(2008-5#17)(2013-1#1)
ot##7##1##(1994-12#1)(2006-2#1)(2006-8#1)(2007-11#1)(2008-11#1)(2009-10#1)(2010-7#1)
otalgia##3##1##(2008-9#1)(2012-12#2)
other &quot##5##2##(2008-4#1)(2008-5#2)(2008-9#1)(2013-8#1)
other (i##2##2##(2008-11#2)
other (the##2##2##(1992-7#1)(2013-8#1)
other 10##5##2##(1990-2#1)(1992-2#1)(2008-12#1)(2008-3#1)(2008-5#1)
other 12 patients##2##3##(2008-4#1)(2008-9#1)
other 12##4##2##(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)
other 13##2##2##(2010-12#1)(2011-1#1)
other 14##2##2##(1997-3#1)(2008-6#1)
other 15##4##2##(1991-5#1)(2008-10#1)(2008-5#1)(2008-9#1)
other 16##3##2##(2008-1#1)(2008-9#1)(2013-1#1)
other 17##2##2##(2008-8#1)(2011-2#1)
other 19##2##2##(1990-12#2)
other 2##12##2##(1992-8#1)(1993-8#1)(1994-7#1)(1995-12#1)(1997-5#1)(2004-9#1)(2006-5#2)(2007-10#2)(2007-8#1)(2013-1#1)
other 3##10##2##(1990-7#1)(1993-7#1)(1995-12#1)(1996-5#1)(2006-8#1)(2008-12#1)(2010-10#1)(2011-2#1)(2013-1#2)
other 4##7##2##(1994-7#1)(2005-11#1)(2006-7#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-8#1)
other 5##3##2##(1993-12#1)(1993-9#1)(2008-5#1)
other 8 patients##2##3##(2007-8#1)(2010-3#1)
other 8##4##2##(1991-8#1)(1995-11#1)(2007-8#1)(2010-3#1)
other ACE inhibitors##2##3##(1993-12#2)
other AD##2##2##(1995-8#1)(2008-3#1)
other AGs of R##3##4##(2008-10#3)
other AGs##4##2##(2008-10#4)
other American##2##2##(2004-12#1)(2012-2#1)
other Arab countries##2##3##(2007-7#1)(2008-1#1)
other Arthropoda##2##2##(2007-12#2)
other Asian countries##2##3##(2005-10#1)(2010-12#1)
other Asian##8##2##(1997-4#1)(2005-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2010-12#1)(2010-3#1)(2011-2#1)
other Axis I disorder are##2##5##(1995-11#2)
other B cell##2##3##(1997-7#2)
other B##5##2##(1997-7#2)(2007-12#1)(2008-10#2)
other Bacillus##2##2##(1996-5#1)(2008-10#1)
other CEA##2##2##(1991-7#1)(1994-2#1)
other CNS##2##2##(1995-7#1)(2008-12#1)
other Ca2+##3##2##(1993-3#1)(1994-6#1)(2008-8#1)
other Canadian organizations##2##3##(1993-1#2)
other Canadian##3##2##(1993-1#2)(2008-10#1)
other Caribbean##2##2##(2008-5#2)
other Chinese##2##2##(2007-1#1)(2008-10#1)
other DNA polymerases##2##3##(1997-1#1)(1997-6#1)
other DNA##10##2##(1995-11#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)
other DNA-binding proteins##4##3##(1990-2#1)(1991-7#1)(2008-2#1)(2008-8#1)
other DNA-binding##6##2##(1990-2#1)(1991-6#1)(1991-7#1)(1994-8#1)(2008-2#1)(2008-8#1)
other E##4##2##(1990-10#1)(1995-6#1)(1997-2#1)(2008-9#1)
other EDRF inhibitors##2##3##(1991-9#2)
other European countries##8##3##(2005-7#1)(2006-10#3)(2007-8#1)(2008-10#1)(2008-7#1)(2012-12#1)
other European##10##2##(2005-7#1)(2006-10#3)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#1)
other F##2##2##(1996-7#1)(2008-10#1)
other Fusarium##4##2##(1997-6#1)(2008-10#3)
other G protein-coupled receptors##3##4##(1991-5#1)(1993-6#1)(2008-4#1)
other G protein-coupled##4##3##(1991-5#1)(1992-11#1)(1993-6#1)(2008-4#1)
other G##7##2##(1991-5#1)(1992-11#1)(1993-11#1)(1993-6#1)(2008-4#2)(2010-3#1)
other GABA##3##2##(1990-10#1)(1991-5#1)(2007-12#1)
other GPCRs##2##2##(1996-2#1)(2012-2#1)
other GTP-binding proteins##3##3##(1995-3#1)(1996-5#2)
other Gram-positive##4##2##(1990-9#1)(1994-3#1)(2007-12#1)(2009-6#1)
other Gryllus species##2##3##(2008-9#2)
other H-iridoid products##2##3##(2008-10#2)
other HIV incidence parameters##2##4##(1996-8#2)
other HIV##3##2##(1996-8#2)(2007-7#1)
other Hrs##2##2##(1991-10#2)
other IEMAs##2##2##(1993-8#2)
other Japanese##5##2##(2008-10#4)(2008-3#1)
other LED##2##2##(2008-10#1)(2008-11#1)
other LNAAs##4##2##(1995-3#4)
other Latin American##2##3##(2012-1#1)(2013-1#1)
other Lys##2##2##(1992-9#1)(1996-10#1)
other MAbs##3##2##(1993-9#1)(1996-8#1)(2008-10#1)
other Medicaid##2##2##(1990-12#1)(1992-2#1)
other Medicare heart failures##2##4##(1995-3#2)
other Medicare##4##2##(1993-12#1)(1995-3#3)
other Mediterranean##2##2##(1993-9#1)(2011-12#1)
other Meloidogyne##2##2##(2008-10#2)
other NCDs##4##2##(2013-8#4)
other NK-1##2##2##(1991-4#1)(2008-7#1)
other NSAIDs##3##2##(2005-8#1)(2008-11#1)(2013-1#1)
other Na+##2##2##(1993-3#1)(1997-1#1)
other New World##2##3##(2008-10#2)
other New##3##2##(2008-1#1)(2008-10#2)
other OECD countries##4##3##(1993-2#1)(1996-3#2)(2012-1#1)
other ORFs##4##2##(1990-1#1)(1995-9#1)(1996-3#1)(1997-3#1)
other P##3##2##(2008-10#3)
other P450##2##2##(2009-9#2)
other P450s##2##2##(1994-8#2)
other PH##2##2##(1993-2#1)(1995-1#1)
other PKC##2##2##(1990-6#1)(1996-7#1)
other PTMs##2##2##(2012-3#2)
other Pacific##2##2##(2008-1#2)
other Pg genes##3##3##(2008-10#3)
other Phytophthora spp##3##3##(2008-10#3)
other Phytophthora##5##2##(2008-10#5)
other Polish populations##2##3##(2008-12#2)
other QTL##2##2##(2008-10#1)(2013-8#1)
other RNA##3##2##(1991-11#1)(1997-1#1)(2008-7#1)
other RNAs##2##2##(1991-11#1)(1997-5#1)
other S##3##2##(1995-1#1)(1996-3#2)
other SIV strains##2##3##(1997-3#2)
other States##2##2##(1991-2#1)(1996-1#1)
other T cells##2##3##(2006-10#1)(2011-2#1)
other T##3##2##(1994-3#1)(2006-10#1)(2011-2#1)
other TNF##2##2##(1996-5#1)(2008-3#1)
other U##2##2##(2008-10#2)
other V##2##2##(2008-10#2)
other VACTERL malformations##4##3##(1996-6#4)
other VACTERL##5##2##(1996-6#5)
other Venturia##2##2##(2008-10#2)
other Western countries##2##3##(1990-6#1)(2009-3#1)
other Western##6##2##(1990-6#1)(1996-6#1)(2006-10#1)(2006-8#1)(2008-10#1)(2009-3#1)
other X##5##2##(2008-10#5)
other Xanthomonas##3##2##(2008-10#3)
other a##14##2##(1991-3#1)(1991-9#1)(1992-8#1)(1995-8#1)(1996-8#1)(2007-2#1)(2008-10#2)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)
other abdominal diseases##2##3##(1992-12#1)(2008-9#1)
other abdominal##7##2##(1992-12#1)(1993-5#1)(2007-12#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#1)
other abnormalities and##2##3##(2006-2#1)(2012-3#1)
other abnormalities of##3##3##(1997-8#1)(2006-9#1)(2007-2#1)
other abnormalities##14##2##(1990-6#1)(1991-10#1)(1991-3#1)(1992-12#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-2#1)(2008-1#1)(2010-12#1)(2010-8#1)(2012-3#1)
other accessory##2##2##(1990-8#1)(2011-1#1)
other actin-binding proteins##2##3##(1993-8#1)(2012-2#1)
other actions of##2##3##(2007-6#1)(2008-11#1)
other actions##3##2##(1995-12#1)(2007-6#1)(2008-11#1)
other activators##3##2##(1995-3#1)(1997-4#1)(2008-9#1)
other active##8##2##(1991-4#1)(1994-6#1)(2007-11#1)(2008-10#3)(2011-2#1)(2012-2#1)
other activities##5##2##(1991-5#1)(2006-6#1)(2007-3#1)(2008-9#1)(2013-1#1)
other activity##2##2##(1991-9#1)(2008-7#1)
other additional##4##2##(2008-10#1)(2010-12#1)(2010-7#1)(2013-1#1)
other adults##5##2##(1991-8#1)(1993-9#1)(1996-12#1)(2008-9#2)
other advances that##2##3##(2006-10#1)(2008-7#1)
other advances##3##2##(2006-10#1)(2008-7#1)(2010-9#1)
other advantages of##2##3##(2006-5#1)(2008-10#1)
other advantages##4##2##(2006-5#1)(2008-10#2)(2011-2#1)
other adverse effects were##2##4##(1997-7#1)(2007-8#1)
other adverse effects##6##3##(1995-3#1)(1997-7#1)(2007-8#1)(2007-9#1)(2013-1#2)
other adverse events##3##3##(2008-8#1)(2011-2#1)(2012-12#1)
other adverse##16##2##(1994-6#1)(1995-3#1)(1997-1#1)(1997-7#1)(2007-8#1)(2007-9#1)(2008-7#2)(2008-8#2)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
other affective##2##2##(2004-3#1)(2008-2#1)
other after##2##2##(2006-8#1)(2013-8#1)
other age groups##6##3##(1990-3#1)(1991-8#1)(1996-5#1)(2008-12#1)(2011-2#2)
other age##8##2##(1990-3#1)(1991-8#1)(1996-11#1)(1996-5#1)(2008-12#1)(2011-2#2)(2012-3#1)
other age-related##3##2##(1996-1#2)(2008-7#1)
other agencies##8##2##(1993-2#1)(1994-2#1)(1996-2#1)(1996-3#1)(1997-2#1)(2006-10#1)(2007-2#2)
other agency##2##2##(1995-6#1)(1996-11#1)
other agents have##2##3##(2007-10#1)(2008-4#1)
other agents such as##2##4##(2007-7#1)(2008-7#1)
other agents that##2##3##(1991-12#1)(2009-8#1)
other agents##37##2##(1991-12#2)(1991-9#1)(1994-8#1)(1995-12#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-5#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-7#1)(2007-8#1)(2008-1#2)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2012-2#1)
other ages##3##2##(1996-12#1)(2012-2#1)(2013-1#1)
other agonists##2##2##(1994-5#1)(1995-12#1)
other agricultural workers##2##3##(2008-12#2)
other agricultural##3##2##(2008-12#2)(2013-8#1)
other airway##2##2##(1996-1#1)(2010-12#1)
other alcoholic beverages##4##3##(1995-3#1)(1996-3#3)
other alcoholic##5##2##(1991-9#1)(1995-3#1)(1996-3#3)
other alcohols##2##2##(1992-7#1)(2008-10#1)
other algorithms##3##2##(2008-10#1)(2008-2#1)(2009-3#1)
other alignment##2##2##(2012-2#1)(2013-1#1)
other alkali##5##2##(2008-10#5)
other alkyl##2##2##(2006-10#1)(2009-8#1)
other allergic##4##2##(2008-5#1)(2010-6#1)(2011-1#1)(2013-8#1)
other alpha-amylases##2##2##(1997-4#2)
other alphaherpesviruses##2##2##(2013-8#2)
other alternate##3##2##(2006-12#1)(2008-4#1)(2009-3#1)
other alternative##5##2##(2006-10#2)(2006-2#1)(2007-4#1)(2008-8#1)
other alternatives##3##2##(2007-3#1)(2008-10#1)(2008-2#1)
other amines##2##2##(2008-10#2)
other amino acid##7##3##(1991-5#1)(1991-7#1)(1992-1#1)(1992-2#1)(1995-11#1)(1995-6#1)(2013-8#1)
other amino acids and##2##4##(2008-10#2)
other amino acids did not##2##5##(1992-8#1)(1994-9#1)
other amino acids that##2##4##(1997-5#1)(2008-5#1)
other amino acids to##2##4##(1990-5#1)(1993-3#1)
other amino acids##22##3##(1990-5#1)(1991-9#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-9#1)(1996-8#1)(1997-5#2)(1997-6#1)(2006-12#1)(2008-10#5)(2008-5#1)(2009-8#2)(2010-5#1)(2013-1#1)
other amino##30##2##(1990-5#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-6#1)(1996-8#1)(1997-5#2)(1997-6#1)(2006-12#1)(2008-10#6)(2008-5#1)(2009-8#2)(2010-5#1)(2013-1#1)(2013-8#1)
other amyloid##2##2##(1991-3#1)(1993-4#1)
other anaerobic##2##2##(2006-5#1)(2010-12#1)
other anaesthetic##2##2##(2006-10#1)(2010-7#1)
other analgesics##2##2##(2011-2#1)(2013-1#1)
other analogs##3##2##(1993-6#1)(1994-12#1)(2008-4#1)
other analogues##6##2##(1993-4#1)(1997-3#1)(1997-4#1)(2005-11#1)(2008-10#1)(2008-6#1)
other analyses##3##2##(1990-5#1)(1995-1#1)(2008-10#1)
other analytes##8##2##(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#1)
other analytical parameters##2##3##(2008-10#2)
other analytical##4##2##(2008-1#1)(2008-10#2)(2008-5#1)
other analyzed##2##2##(2008-10#1)(2008-5#1)
other anatomic##4##2##(1994-6#1)(2008-6#2)(2011-2#1)
other ancient##2##2##(1992-6#1)(1997-4#1)
other ancillary##2##2##(2010-8#1)(2011-2#1)
other and to the##7##4##(1991-5#1)(1997-6#1)(2008-10#1)(2009-4#1)(2012-12#2)(2013-1#1)
other and to##12##3##(1990-7#1)(1991-5#1)(1996-4#1)(1996-7#1)(1997-6#1)(2008-10#1)(2009-4#1)(2012-12#2)(2012-3#1)(2013-1#2)
other and##91##2##(1990-2#1)(1990-4#2)(1990-7#1)(1991-5#2)(1992-1#1)(1992-4#1)(1993-11#2)(1993-3#2)(1994-1#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(2005-11#1)(2005-8#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#4)(2009-4#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-12#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
other animal##5##2##(1994-6#1)(1996-10#1)(1997-8#1)(2007-12#1)(2012-2#1)
other animals and##2##3##(1993-2#1)(1994-9#1)
other animals in the population##2##5##(2008-8#2)
other animals##19##2##(1991-8#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-9#1)(1995-2#2)(2006-8#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-4#2)(2008-8#3)(2009-3#1)(2010-4#1)(2012-1#1)
other anionic##2##2##(1992-6#1)(1994-5#1)
other anions and can be used in##2##7##(2008-10#2)
other anions and##3##3##(2008-10#3)
other anions##8##2##(1990-5#1)(2008-10#7)
other anomalies##8##2##(1996-12#2)(2006-8#1)(2007-11#1)(2011-1#1)(2012-2#1)(2013-1#2)
other antagonists##4##2##(1993-3#1)(2005-8#1)(2008-10#2)
other anti-anginal drugs##3##3##(2005-7#1)(2005-8#2)
other antibiotics##10##2##(1991-4#1)(1994-6#1)(2005-7#2)(2007-4#3)(2008-5#1)(2011-2#1)(2012-12#1)
other antibodies##4##2##(1995-2#1)(1997-7#1)(2008-4#2)
other antiepileptic drugs##6##3##(1996-8#1)(2008-3#2)(2008-7#1)(2008-8#1)(2013-7#1)
other antifungal##2##2##(2008-10#1)(2010-11#1)
other antigenic##2##2##(1996-11#1)(2012-2#1)
other antigens##7##2##(1995-2#1)(1995-5#1)(2007-2#1)(2008-4#2)(2012-12#1)(2012-2#1)
other antihypertensive agents##3##3##(1990-1#1)(1992-6#1)(2005-8#1)
other antihypertensive drugs in##2##4##(2008-3#2)
other antihypertensive drugs##5##3##(1995-11#1)(2008-3#3)(2008-8#1)
other antihypertensive##10##2##(1990-1#1)(1992-6#1)(1995-11#1)(2005-10#1)(2005-8#1)(2008-3#3)(2008-8#1)(2012-3#1)
other antihypertensives##2##2##(2010-12#2)
other antimalarials##4##2##(2007-2#2)(2009-6#2)
other antimicrobial agents##3##3##(2005-8#1)(2006-8#1)(2012-2#1)
other antimicrobial##4##2##(2005-8#1)(2006-8#1)(2007-1#1)(2012-2#1)
other antioxidants##4##2##(1990-4#1)(1996-5#1)(2008-10#1)(2013-8#1)
other antirheumatic##2##2##(2006-10#1)(2007-11#1)
other antirheumatics##3##2##(2007-11#3)
other anxiety disorders##4##3##(2008-4#1)(2008-6#1)(2011-2#2)
other apparent##2##2##(1992-9#1)(2008-2#1)
other applications in##2##3##(2007-12#1)(2010-7#1)
other applications of##3##3##(2007-11#1)(2008-2#1)(2012-12#1)
other applications such as##2##4##(2008-2#1)(2008-6#1)
other applications that##2##3##(2007-12#1)(2012-2#1)
other applications##33##2##(1990-12#1)(1991-7#1)(1992-10#1)(1997-7#1)(2005-7#1)(2005-8#1)(2007-11#3)(2007-12#3)(2007-4#1)(2008-10#1)(2008-11#2)(2008-2#5)(2008-3#1)(2008-4#4)(2008-6#1)(2008-9#1)(2009-11#1)(2010-2#1)(2010-7#1)(2012-12#1)(2012-2#1)
other approach##5##2##(1996-6#2)(2008-2#1)(2009-6#1)(2013-7#1)
other approaches that##2##3##(2006-7#1)(2008-1#1)
other approaches##18##2##(1995-1#1)(1996-12#1)(2004-4#1)(2006-10#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#1)
other appropriate##3##2##(1992-9#1)(2008-1#1)(2008-3#1)
other are##4##2##(2006-8#2)(2008-9#1)(2010-12#1)
other area##5##2##(2008-10#1)(2008-9#1)(2009-4#1)(2010-6#1)(2011-2#1)
other areas in##2##3##(2006-4#1)(2011-1#1)
other areas of the##13##4##(1991-9#1)(1992-8#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#2)(2009-4#1)(2010-11#1)(2012-2#1)
other areas of##34##3##(1990-12#1)(1991-2#1)(1991-9#1)(1992-8#2)(1996-3#1)(2006-10#4)(2006-6#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-4#1)(2009-9#1)(2010-11#1)(2012-2#1)(2013-1#2)
other areas##59##2##(1990-12#1)(1990-6#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-8#2)(1994-6#1)(1996-3#1)(1996-7#1)(2005-3#1)(2005-6#1)(2005-9#1)(2006-10#4)(2006-11#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-9#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
other aromatic##4##2##(1996-5#1)(2008-10#2)(2010-7#1)
other arrhythmias##2##2##(2006-10#2)
other arsenic species##2##3##(2008-10#2)
other arsenic##3##2##(2008-10#3)
other arterial##3##2##(2005-12#2)(2006-6#1)
other arthropods##3##2##(2007-12#2)(2008-6#1)
other articles in this##2##4##(2006-2#1)(2009-4#1)
other articles##3##2##(2006-2#1)(2008-11#1)(2009-4#1)
other as##13##2##(1992-5#1)(1993-8#1)(1994-8#1)(1995-6#1)(1997-6#1)(2006-10#1)(2008-10#4)(2010-3#1)(2010-9#1)(2011-2#1)
other aspects of the##4##4##(1992-5#1)(1992-8#1)(2007-11#1)(2011-12#1)
other aspects of##27##3##(1990-4#1)(1990-9#1)(1991-11#1)(1991-5#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-2#1)(1996-11#1)(1996-12#1)(2004-7#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-7#1)(2011-12#1)(2012-2#2)(2012-3#1)(2013-7#1)
other aspects##34##2##(1990-4#1)(1990-9#1)(1991-11#1)(1991-5#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-2#1)(1996-11#1)(1996-12#1)(2004-7#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-7#1)(2011-12#1)(2012-2#2)(2012-3#1)(2013-7#1)
other assays in that##2##4##(1995-3#1)(2008-4#1)
other assays##4##2##(1992-12#1)(1995-3#1)(2008-4#1)(2008-8#1)
other associated anomalies##2##3##(2008-9#1)(2009-6#1)
other associated syndromes##2##3##(2009-7#1)(2010-7#1)
other associated##9##2##(2007-7#1)(2007-8#1)(2008-1#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-7#1)
other associations##2##2##(1997-8#1)(2006-10#1)
other at about##2##3##(1990-7#1)(2008-7#1)
other at the##4##3##(1994-9#1)(2008-2#1)(2013-1#2)
other at##13##2##(1990-7#1)(1991-3#1)(1994-9#1)(1995-12#1)(1997-6#1)(2006-8#1)(2008-2#2)(2008-7#1)(2010-7#1)(2013-1#3)
other atmospheric##2##2##(2008-3#2)
other attributes##3##2##(1990-12#1)(1995-5#1)(2008-5#1)
other authors and##3##3##(2011-2#1)(2012-12#1)(2013-8#1)
other authors have##2##3##(1992-10#1)(1994-2#1)
other authors##31##2##(1990-10#1)(1990-2#1)(1990-4#1)(1990-9#1)(1991-2#1)(1992-1#1)(1992-10#1)(1993-9#1)(1994-2#1)(1994-3#1)(1996-4#2)(2005-1#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
other autoantibodies##3##2##(2006-10#2)(2010-6#1)
other autoimmune diseases##8##3##(2005-8#1)(2007-11#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-8#2)
other autoimmune disorders##2##3##(1990-5#1)(2010-6#1)
other autoimmune##16##2##(1990-5#1)(1991-8#1)(2005-1#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-11#2)(2008-10#1)(2008-7#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#2)
other available##12##2##(1990-8#1)(1991-12#1)(2006-11#1)(2006-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
other avian##3##2##(1990-12#1)(1993-6#1)(2013-8#1)
other bacteria##15##2##(1990-1#1)(1990-9#1)(1991-7#1)(1993-9#1)(1995-8#1)(2006-10#2)(2006-8#1)(2008-10#3)(2008-5#2)(2008-9#1)(2011-1#1)
other bacterial PLPCs##2##3##(2006-5#2)
other bacterial species##3##3##(1994-12#1)(2007-5#1)(2008-5#1)
other bacterial##13##2##(1990-4#1)(1994-12#2)(1994-8#1)(2006-5#2)(2007-5#1)(2007-7#1)(2008-10#2)(2008-5#1)(2009-6#1)(2011-2#1)
other barriers to##2##3##(1997-5#1)(2012-2#1)
other barriers##4##2##(1997-5#1)(2008-5#1)(2012-2#1)(2012-3#1)
other basal##4##2##(1994-2#1)(1994-3#1)(1997-6#1)(2008-11#1)
other based on the##2##4##(1993-11#1)(2006-8#1)
other based on##5##3##(1993-11#1)(2006-8#1)(2007-12#1)(2008-2#1)(2009-5#1)
other basic##5##2##(1997-2#1)(1997-4#1)(2008-1#1)(2011-12#1)(2012-2#1)
other begomoviruses##5##2##(2008-10#5)
other behavioral risk factors for##3##5##(2008-3#1)(2011-1#2)
other behavioral##5##2##(2008-3#1)(2008-8#1)(2009-8#1)(2011-1#2)
other behaviors during##2##3##(2008-11#1)(2011-12#1)
other behaviors##4##2##(1995-12#1)(1996-5#1)(2008-11#1)(2011-12#1)
other behavioural##5##2##(1994-6#1)(1995-11#1)(2006-10#1)(2008-10#1)(2010-2#1)
other beneficial##3##2##(2008-7#1)(2010-10#1)(2011-12#1)
other benefits##8##2##(1991-12#1)(1991-3#1)(1993-3#1)(2006-6#1)(2007-4#2)(2008-1#1)(2008-8#1)
other benign##5##2##(2006-10#1)(2006-12#1)(2009-3#1)(2010-12#1)(2013-7#1)
other benzodiazepines##2##2##(1993-5#1)(2008-1#1)
other binding sites##2##3##(1991-2#1)(1997-5#1)
other binding##5##2##(1991-2#1)(1997-5#1)(2008-10#1)(2008-3#1)(2008-5#1)
other biochemical##8##2##(1990-2#1)(1992-5#1)(1992-8#1)(1996-6#1)(2008-10#1)(2008-4#2)(2009-8#1)
other bioinformatics##3##2##(2008-4#2)(2012-2#1)
other biologic##2##2##(2006-10#1)(2008-4#1)
other biological fluids##4##3##(1993-4#1)(2005-8#1)(2008-4#2)
other biological parameters##2##3##(2008-9#1)(2010-3#1)
other biological processes##2##3##(2008-7#1)(2010-9#1)
other biological systems##3##3##(2008-9#2)(2010-2#1)
other biological##26##2##(1992-8#1)(1992-9#1)(1993-4#1)(1994-6#1)(1995-12#1)(1996-11#1)(2005-8#2)(2006-10#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-9#3)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-9#1)
other biophysical##2##2##(1996-11#1)(2006-10#1)
other biosynthetic##2##2##(1994-8#1)(2010-10#1)
other birds##2##2##(2005-9#2)
other birth##2##2##(2008-3#1)(2010-1#1)
other bisphosphonates##4##2##(2007-11#1)(2008-3#1)(2008-7#1)(2009-6#1)
other blinding##2##2##(2008-7#1)(2010-10#1)
other blood##5##2##(1994-8#1)(2005-11#1)(2007-2#1)(2008-4#1)(2013-1#1)
other body fluids##5##3##(1995-1#1)(2007-12#1)(2008-9#1)(2011-2#2)
other body organs##3##3##(2008-7#2)(2012-1#1)
other body##13##2##(1992-9#1)(1995-1#1)(1996-3#1)(2006-11#1)(2007-12#1)(2007-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#2)(2012-1#1)
other bones##3##2##(2010-3#1)(2010-6#1)(2012-2#1)
other books##4##2##(1991-11#1)(1991-3#1)(2008-10#1)(2010-5#1)
other bovine##2##2##(1992-2#1)(1997-2#1)
other brain areas##2##3##(1994-12#1)(1997-5#1)
other brain regions##5##3##(1995-12#1)(1996-3#1)(1997-2#1)(1997-7#1)(2010-2#1)
other brain structures##2##3##(1996-12#1)(2008-1#1)
other brain##16##2##(1994-12#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-5#1)(1997-7#1)(2004-12#1)(2007-12#1)(2008-1#1)(2008-4#2)(2009-4#1)(2009-5#1)(2010-2#1)(2012-1#1)
other branches of science##2##4##(2008-3#1)(2012-2#1)
other branches of##3##3##(2008-3#1)(2008-5#1)(2012-2#1)
other breeds##2##2##(2010-4#1)(2012-1#1)
other bronchodilators##2##2##(1990-5#2)
other broods##2##2##(2008-9#2)
other but##5##2##(1995-2#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#1)
other by a##3##3##(1996-2#1)(2005-8#1)(2008-10#1)
other by one##2##3##(1996-10#1)(1997-7#1)
other by two##2##3##(1996-5#1)(2008-4#1)
other by##30##2##(1990-9#1)(1991-8#1)(1992-11#1)(1992-6#1)(1992-7#1)(1994-11#1)(1995-3#1)(1996-10#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-7#1)(2005-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2010-2#1)(2010-7#1)(2010-8#1)
other cDNA##2##2##(1990-7#1)(1994-12#1)
other calcium channel blockers##2##4##(1993-3#1)(2013-7#1)
other calcium##5##2##(1991-9#1)(1993-3#1)(1994-9#1)(2009-12#1)(2013-7#1)
other can be##2##3##(2008-11#1)(2008-3#1)
other cancer sites##2##3##(1993-10#1)(1993-9#1)
other cancer types##2##3##(2005-8#1)(2012-2#1)
other cancer##7##2##(1990-12#1)(1993-10#2)(1993-9#1)(2005-8#1)(2012-2#2)
other cancers in##3##3##(1992-5#1)(2008-11#1)(2010-2#1)
other cancers were##3##3##(1991-3#1)(1993-2#1)(2008-7#1)
other cancers##18##2##(1991-3#1)(1992-5#1)(1993-1#1)(1993-10#1)(1993-2#1)(2006-2#1)(2007-4#1)(2008-11#2)(2008-7#2)(2009-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
other candidate##3##2##(1996-6#1)(2006-10#1)(2007-12#1)
other carboxylic acids with##2##4##(2007-10#2)
other cardiac lesions##3##3##(1993-12#1)(2007-3#2)
other cardiac##16##2##(1993-12#1)(1997-4#1)(2006-6#1)(2007-3#2)(2007-8#2)(2008-12#1)(2008-4#1)(2008-7#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)
other cardiovascular diseases##3##3##(1995-8#1)(2008-4#1)(2009-9#1)
other cardiovascular risk factors in a hypertensive population##2##8##(2010-4#2)
other cardiovascular risk factors##6##4##(1991-4#1)(1996-8#1)(2008-5#1)(2010-4#2)(2013-4#1)
other cardiovascular##13##2##(1991-4#1)(1995-8#1)(1996-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-9#1)(2010-11#1)(2010-4#2)(2011-2#1)(2013-4#1)
other care practices##2##3##(2006-2#1)(2011-1#1)
other care##3##2##(2006-2#1)(2011-1#1)(2012-1#1)
other caregivers and##2##3##(2006-12#1)(2012-2#1)
other caregivers##3##2##(2006-12#1)(2010-12#1)(2012-2#1)
other carotenoids##2##2##(1992-9#1)(2011-12#1)
other carriers##2##2##(1994-5#1)(2013-1#1)
other case of##4##3##(1990-5#1)(2008-12#1)(2009-2#1)(2012-2#1)
other case##8##2##(1990-5#1)(1992-4#1)(1996-5#1)(2006-11#1)(2008-12#1)(2008-7#1)(2009-2#1)(2012-2#1)
other cases and##3##3##(1993-10#1)(1996-9#1)(2008-1#1)
other cases in##2##3##(1990-3#1)(2006-10#1)
other cases it##2##3##(1990-5#1)(2013-7#1)
other cases of##10##3##(1993-10#1)(1996-6#1)(2006-12#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#1)
other cases##41##2##(1990-3#1)(1990-5#1)(1991-4#1)(1993-10#2)(1996-10#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#2)(2011-1#2)(2011-2#1)(2012-11#1)(2013-7#1)
other caspases##2##2##(2006-2#1)(2008-11#1)
other catecholamines##2##2##(1997-3#1)(2008-10#1)
other categories of##6##3##(1990-11#1)(1992-1#1)(1992-6#1)(1992-8#1)(1994-1#1)(2008-1#1)
other categories##7##2##(1990-11#1)(1992-1#1)(1992-6#1)(1992-8#1)(1994-1#1)(1996-9#1)(2008-1#1)
other cationic##2##2##(1990-12#1)(2012-12#1)
other cations and##2##3##(2008-10#1)(2010-7#1)
other cations including##3##3##(1997-2#1)(2008-10#2)
other cations##17##2##(1993-6#1)(1997-2#1)(1997-4#1)(2008-10#13)(2010-7#1)
other causative##2##2##(2006-4#1)(2008-5#1)
other cause##6##2##(1990-11#1)(1991-4#1)(1993-8#1)(1996-6#1)(2012-3#1)(2013-1#1)
other causes for##2##3##(1991-11#1)(2008-10#1)
other causes of a##2##4##(2004-1#1)(2007-9#1)
other causes of acute GI hemorrhage##2##6##(1996-11#2)
other causes of overutilization##2##4##(2007-4#2)
other causes of##27##3##(1993-5#1)(1993-6#1)(1995-9#2)(1996-11#2)(2004-1#1)(2006-10#4)(2006-8#1)(2007-4#2)(2007-9#1)(2008-1#1)(2008-12#1)(2008-8#2)(2009-8#1)(2011-1#4)(2012-2#1)(2013-1#2)
other causes##54##2##(1991-11#1)(1992-10#1)(1993-5#1)(1993-6#2)(1993-9#1)(1995-4#1)(1995-9#2)(1996-11#2)(1997-1#1)(2004-1#1)(2005-11#1)(2006-10#5)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-12#2)(2008-6#1)(2008-8#3)(2009-8#1)(2011-1#5)(2011-2#1)(2012-2#2)(2013-1#3)
other cell cultures##4##3##(1994-3#1)(1996-4#1)(1997-3#1)(2008-11#1)
other cell cycle genes##3##4##(2008-10#3)
other cell cycle##4##3##(1996-4#1)(2008-10#3)
other cell lineages##2##3##(1995-12#1)(2008-11#1)
other cell lines##12##3##(1990-12#1)(1991-7#1)(1992-5#1)(1992-7#1)(1995-3#1)(2007-10#1)(2008-11#3)(2008-4#1)(2010-12#1)(2011-12#1)
other cell types and##2##4##(1995-3#1)(2008-11#1)
other cell types for##2##4##(1993-2#1)(2012-3#1)
other cell types in##3##4##(2008-4#2)(2008-7#1)
other cell types such as##3##5##(2008-1#1)(2008-11#1)(2009-9#1)
other cell types which##2##4##(1994-3#1)(2006-5#1)
other cell types##35##3##(1990-5#1)(1992-10#1)(1992-4#1)(1993-2#1)(1993-7#1)(1994-3#1)(1995-3#2)(1996-5#1)(1997-6#1)(2004-11#1)(2006-5#1)(2006-7#1)(2008-1#1)(2008-11#6)(2008-4#6)(2008-7#2)(2008-8#1)(2009-9#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
other cell##73##2##(1990-12#1)(1990-4#1)(1990-5#1)(1991-10#2)(1991-7#1)(1991-8#1)(1992-10#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-2#1)(1993-6#1)(1993-7#2)(1994-12#1)(1994-3#2)(1995-12#1)(1995-3#4)(1996-4#2)(1996-5#1)(1997-3#1)(1997-6#1)(2004-11#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-1#2)(2008-10#3)(2008-11#15)(2008-4#7)(2008-5#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
other cells in##2##3##(1995-3#1)(2008-7#1)
other cells of the##2##4##(2008-4#1)(2008-5#1)
other cells such as##2##4##(1997-2#1)(2008-11#1)
other cells##32##2##(1990-7#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1994-12#1)(1994-2#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-5#1)(2006-10#1)(2006-4#1)(2006-6#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#2)(2009-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
other cellular and##3##3##(2008-4#1)(2008-7#1)(2008-8#1)
other cellular changes##2##3##(1991-3#1)(2008-7#1)
other cellular macromolecules##2##3##(2008-4#1)(2009-3#1)
other cellular parameters##2##3##(1993-12#1)(2008-9#1)
other cellular processes##2##3##(1994-5#1)(2008-5#1)
other cellular proteins##4##3##(1991-2#1)(1994-9#1)(2006-12#1)(2009-8#1)
other cellular##27##2##(1991-2#2)(1991-3#1)(1991-4#1)(1993-12#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-3#1)(1996-12#1)(1996-4#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-2#1)
other centers##3##2##(2007-10#1)(2007-3#1)(2008-1#1)
other central nervous system##3##4##(2007-9#1)(2009-12#1)(2009-7#1)
other central##4##2##(1990-8#1)(2007-9#1)(2009-12#1)(2009-7#1)
other centrally acting##2##3##(1992-6#1)(1994-2#1)
other centres##8##2##(1991-4#1)(2006-4#1)(2006-8#2)(2007-11#1)(2007-6#1)(2008-6#1)(2008-8#1)
other cereals##4##2##(1991-12#1)(2006-11#1)(2008-12#1)(2009-10#1)
other challenges##4##2##(1996-3#1)(2007-4#1)(2008-8#1)(2013-8#1)
other changes in the##2##4##(1991-6#1)(2008-3#1)
other changes in##4##3##(1991-6#1)(2006-10#1)(2008-3#1)(2011-2#1)
other changes##12##2##(1991-6#1)(1992-3#1)(1996-1#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-3#1)(2010-12#1)(2010-8#1)(2011-2#1)
other channel##2##2##(1990-4#1)(1990-5#1)
other channels##2##2##(2008-4#2)
other characteristics of##2##3##(2008-10#1)(2008-8#1)
other characteristics##9##2##(1992-6#1)(2005-11#1)(2006-4#1)(2007-8#1)(2008-10#3)(2008-8#1)(2010-8#1)
other characterized##2##2##(1995-8#1)(2008-10#1)
other charged##2##2##(1992-1#1)(1994-9#1)
other charged-surface microcarriers##2##3##(2008-11#2)
other charged-surface##3##2##(2008-11#3)
other chemical##9##2##(1993-9#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#3)
other chemicals##2##2##(2010-8#1)(2010-9#1)
other chemotherapeutic agents##3##3##(2008-1#1)(2008-3#1)(2009-12#1)
other chemotherapeutic##4##2##(2008-1#1)(2008-3#1)(2009-12#1)(2009-8#1)
other child##2##2##(1990-12#1)(2010-6#1)
other children##5##2##(1993-2#1)(1994-6#1)(2006-10#1)(2008-4#1)(2012-12#1)
other chiral dihydropyridine calcium entry blockers##2##6##(1990-6#2)
other chromosomal abnormalities##3##3##(1994-4#2)(1995-8#1)
other chromosomal##5##2##(1994-4#2)(1995-2#1)(1995-8#1)(1997-9#1)
other chromosome##2##2##(2008-12#1)(2010-12#1)
other chronic conditions##2##3##(2007-6#1)(2012-3#1)
other chronic disease##3##3##(1994-6#1)(2006-2#1)(2010-1#1)
other chronic##24##2##(1991-5#1)(1994-12#1)(1994-3#1)(1994-6#1)(2005-8#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-6#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#2)
other chronically##2##2##(1996-1#1)(2009-7#1)
other cities##2##2##(2009-12#1)(2012-12#1)
other class##3##2##(1993-1#1)(1997-4#1)(2008-8#1)
other classes of drugs##2##4##(2008-10#1)(2010-12#1)
other classes of##9##3##(1993-2#1)(1994-2#1)(2005-7#1)(2007-7#1)(2008-10#2)(2008-7#1)(2010-12#1)(2012-3#1)
other classes##11##2##(1993-2#1)(1994-2#1)(2005-7#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-7#1)(2010-12#2)(2012-3#1)
other clinical and##2##3##(1992-2#1)(2006-5#1)
other clinical or##3##3##(1995-6#1)(2006-12#1)(2010-12#1)
other clinical parameters##3##3##(2007-12#1)(2008-7#1)(2012-3#1)
other clinical syndromes##2##3##(1997-1#1)(2009-4#1)
other clinical variables##2##3##(1994-2#1)(1996-5#1)
other clinical##39##2##(1991-5#1)(1992-2#1)(1993-11#1)(1994-2#1)(1995-6#1)(1996-1#1)(1996-5#1)(1997-1#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-7#2)(2009-4#1)(2010-12#4)(2010-3#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
other clinically important##2##3##(1995-5#1)(2007-2#1)
other clinically##5##2##(1991-2#1)(1995-5#1)(2007-2#1)(2011-2#2)
other clinicians##3##2##(2005-12#1)(2010-8#1)(2012-2#1)
other cloned##2##2##(1995-8#1)(2008-11#1)
other clones##3##2##(1990-3#1)(1991-2#1)(2008-10#1)
other close##3##2##(1994-10#1)(1997-3#1)(2007-7#1)
other closely related species##2##4##(2007-2#1)(2007-3#1)
other closely related##7##3##(1992-3#1)(2006-10#1)(2007-2#1)(2007-3#1)(2008-4#1)(2008-9#1)(2010-5#1)
other closely##8##2##(1992-3#1)(2006-10#1)(2007-2#1)(2007-3#1)(2008-4#1)(2008-9#1)(2009-2#1)(2010-5#1)
other closteroviruses##4##2##(2008-10#4)
other clubs##2##2##(2009-8#2)
other co-morbidities##3##2##(2007-10#1)(2008-2#1)(2011-2#1)
other coexisting##6##2##(2007-8#1)(2008-10#2)(2012-3#1)(2013-1#2)
other cofactors##4##2##(1990-5#1)(1995-6#1)(1996-8#1)(2011-2#1)
other cognitive processes##2##3##(2009-10#1)(2009-11#1)
other cognitive##8##2##(1990-8#1)(1993-11#1)(2006-10#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-8#1)
other colleagues##2##2##(2004-9#1)(2012-12#1)
other color##2##2##(2008-2#1)(2011-12#1)
other combinations of A2 and T2##2##6##(1996-2#2)
other combinations of##5##3##(1996-2#2)(2006-8#1)(2007-9#1)(2012-2#1)
other combinations##6##2##(1996-2#2)(2006-8#1)(2007-9#1)(2008-12#1)(2012-2#1)
other common##14##2##(1990-6#1)(2005-11#1)(2005-8#1)(2006-8#1)(2008-1#1)(2008-10#6)(2009-9#1)(2011-1#1)(2012-3#1)
other commonly used##6##3##(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-2#1)(2012-3#1)
other commonly##10##2##(1995-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-2#1)(2012-3#3)
other communities##3##2##(2007-10#1)(2008-2#1)(2009-4#1)
other community##5##2##(1996-1#1)(1996-12#1)(2008-9#1)(2009-4#1)(2012-2#1)
other comorbidities##3##2##(2009-6#1)(2011-2#1)(2012-12#1)
other companies##3##2##(1993-9#1)(1996-5#1)(1997-3#1)
other compared##2##2##(2008-10#1)(2008-9#1)
other competing##3##2##(2008-1#1)(2009-11#1)(2010-2#1)
other competitive##2##2##(1990-12#1)(1996-12#1)
other complementary##4##2##(1996-5#1)(2006-10#2)(2008-8#1)
other complex##7##2##(1991-9#1)(2005-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-8#1)(2011-2#1)
other complexes##8##2##(1991-6#1)(1993-11#1)(1993-8#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-5#2)
other complicating##2##2##(1992-7#1)(1997-2#1)
other complications may be##2##4##(2007-7#1)(2008-7#1)
other complications of##4##3##(1990-5#1)(1992-2#1)(2006-10#1)(2008-11#1)
other complications##20##2##(1990-2#1)(1990-5#1)(1992-2#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-10#1)(2007-7#6)(2008-11#2)(2008-12#1)(2008-7#1)(2010-6#1)(2011-1#1)
other components in##4##3##(2008-10#1)(2008-5#1)(2009-8#1)(2012-12#1)
other components of the##14##4##(1991-3#1)(1992-11#1)(1995-5#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#2)(2008-8#1)(2012-3#1)
other components of##23##3##(1991-3#2)(1992-1#1)(1992-11#1)(1995-5#1)(1996-7#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-3#4)(2008-4#2)(2008-8#1)(2010-7#1)(2012-3#1)
other components were##2##3##(2006-12#1)(2012-1#1)
other components##45##2##(1991-3#2)(1992-1#1)(1992-11#1)(1995-5#1)(1996-7#1)(1997-6#1)(2005-9#1)(2006-12#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#4)(2008-4#3)(2008-5#3)(2008-8#1)(2009-11#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
other compounds in##2##3##(1995-3#1)(2007-11#1)
other compounds to##2##3##(1994-3#1)(2007-1#1)
other compounds with##2##3##(1996-8#1)(2008-10#1)
other compounds##27##2##(1990-2#1)(1991-5#1)(1991-9#1)(1993-3#1)(1993-9#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-3#2)(1995-4#1)(1996-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-11#1)(2008-10#6)(2008-3#1)(2013-7#1)
other computer##2##2##(1993-2#1)(2006-6#1)
other concomitant##2##2##(1991-7#1)(2012-12#1)
other concurrent##2##2##(2008-7#1)(2010-6#1)
other condition##2##2##(1991-2#1)(1997-3#1)
other conditions are##2##3##(1992-2#1)(2008-5#1)
other conditions such as##6##4##(1991-8#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-3#1)(2009-10#1)
other conditions that##3##3##(2007-5#1)(2011-2#1)(2013-7#1)
other conditions##49##2##(1991-2#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-9#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-8#1)(1997-3#1)(1997-4#1)(2006-10#2)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#3)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-7#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)
other congenital malformations##2##3##(2010-8#1)(2011-12#1)
other congenital##4##2##(2007-8#1)(2010-8#1)(2011-12#1)(2013-1#1)
other connective tissue diseases##2##4##(2005-7#1)(2008-8#1)
other connective tissue##4##3##(1994-5#1)(2005-7#1)(2008-8#1)(2011-2#1)
other connective##5##2##(1994-5#1)(2005-7#1)(2008-8#1)(2009-6#1)(2011-2#1)
other conservative methods##2##3##(1995-4#1)(2007-7#1)
other conservative##5##2##(1995-4#1)(2006-8#1)(2007-7#1)(2008-10#1)(2012-12#1)
other conserved residues##2##3##(1992-3#1)(2011-2#1)
other conserved##3##2##(1992-3#1)(2008-9#1)(2011-2#1)
other considerations##5##2##(1992-12#1)(1992-2#1)(1993-1#1)(1996-1#1)(2005-9#1)
other constituents of##2##3##(1991-2#1)(2007-1#1)
other constituents##5##2##(1991-2#1)(1996-9#1)(2007-1#1)(2007-11#1)(2012-12#1)
other constructs##2##2##(1993-12#1)(2005-10#1)
other contained##2##2##(1990-12#1)(2008-5#1)
other contaminant##2##2##(2008-9#1)(2010-12#1)
other contaminants to##2##3##(1994-3#1)(2008-10#1)
other contaminants##5##2##(1994-3#1)(2007-5#1)(2008-10#2)(2011-2#1)
other contextual##4##2##(2007-7#1)(2008-7#1)(2008-8#1)(2010-11#1)
other continents##4##2##(2008-10#2)(2008-8#1)(2010-5#1)
other contraceptive##2##2##(1992-7#1)(2012-11#1)
other contraceptives##3##2##(2012-11#2)(2012-2#1)
other control##4##2##(1993-2#1)(1996-4#1)(2008-10#1)(2013-8#1)
other conventional methods##2##3##(2007-12#1)(2012-3#1)
other conventional##10##2##(1993-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-3#1)
other copies##2##2##(1996-10#2)
other copper##2##2##(1994-3#1)(2008-10#1)
other cortical areas##3##3##(1995-11#1)(1996-8#1)(2009-6#1)
other cortical##5##2##(1995-11#1)(1996-8#1)(2005-10#1)(2008-11#1)(2009-6#1)
other corticosteroids##2##2##(2007-11#2)
other corynebacterial##2##2##(1993-11#2)
other countries are##2##3##(1991-9#1)(1993-6#1)
other countries as##2##3##(1990-6#1)(2008-5#1)
other countries have##2##3##(1990-9#1)(1992-3#1)
other countries in the region##3##5##(2007-7#1)(2008-8#1)(2012-2#1)
other countries in the##5##4##(2007-7#1)(2008-12#1)(2008-8#1)(2012-12#1)(2012-2#1)
other countries in##7##3##(2007-7#1)(2007-9#1)(2008-12#1)(2008-8#1)(2010-8#1)(2012-12#1)(2012-2#1)
other countries is##4##3##(1993-2#1)(2006-10#2)(2008-12#1)
other countries such as##3##4##(2008-7#1)(2008-8#1)(2010-12#1)
other countries to##2##3##(2009-4#1)(2009-6#1)
other countries with##2##3##(2010-11#1)(2011-1#1)
other countries##109##2##(1990-11#1)(1990-6#2)(1990-9#2)(1991-12#2)(1991-9#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-2#2)(1993-6#2)(1994-2#1)(1994-4#1)(1994-6#1)(1995-1#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(2005-11#1)(2005-12#1)(2006-1#1)(2006-10#8)(2006-2#1)(2006-8#3)(2007-11#2)(2007-12#2)(2007-2#2)(2007-4#2)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#5)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#1)(2009-6#3)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#4)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#3)(2013-8#2)
other countries]##3##2##(1996-3#1)(2010-9#1)(2011-3#1)
other country in the world##2##5##(2008-8#1)(2010-8#1)
other country##6##2##(1991-6#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-8#1)
other courses##2##2##(2005-10#1)(2007-12#1)
other covariates##4##2##(2007-8#1)(2011-2#2)(2012-3#1)
other criteria##2##2##(2008-10#1)(2011-2#1)
other critical##7##2##(1996-12#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-8#1)(2010-11#1)
other crops##3##2##(2008-10#2)(2013-1#1)
other crystalline##2##2##(2007-12#1)(2008-3#1)
other cultivars##4##2##(2007-1#1)(2008-10#3)
other cultures##5##2##(2008-11#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-3#1)
other current##4##2##(2006-6#1)(2007-1#1)(2008-5#1)(2012-12#1)
other currently available##2##3##(1991-8#1)(2008-11#1)
other currently##5##2##(1991-8#1)(1995-2#1)(2008-10#2)(2008-11#1)
other cyanobacterial##2##2##(1992-3#1)(1995-6#1)
other cymbidium##2##2##(1997-2#2)
other cystic##2##2##(2007-10#1)(2008-7#1)
other cytokine##3##2##(1990-12#1)(1996-9#1)(2007-11#1)
other cytokines are##2##3##(2008-4#1)(2010-12#1)
other cytokines in##2##3##(1994-9#1)(2008-4#1)
other cytokines including##2##3##(1996-11#1)(2008-4#1)
other cytokines present in##2##4##(2008-4#2)
other cytokines such as##2##4##(1992-8#1)(1994-9#1)
other cytokines##29##2##(1991-5#1)(1992-12#1)(1992-8#2)(1993-6#1)(1994-5#1)(1994-9#2)(1996-10#1)(1996-11#1)(1996-2#2)(1997-7#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-4#9)(2008-7#1)(2010-12#1)(2010-2#1)
other cytoplasmic##2##2##(1991-12#1)(2007-3#1)
other cytotoxic agents##2##3##(2008-8#1)(2013-8#1)
other daily##2##2##(2008-12#1)(2010-9#1)
other dairy##2##2##(1990-8#1)(1995-8#1)
other dangerous##2##2##(1996-1#1)(2008-5#1)
other data in the literature##3##5##(1994-3#1)(2008-3#1)(2008-9#1)
other data obtained##2##3##(1991-5#1)(1997-8#1)
other data were##3##3##(1990-12#1)(1991-1#1)(2011-2#1)
other data##24##2##(1990-10#2)(1990-12#1)(1991-1#1)(1991-12#1)(1991-5#1)(1994-12#2)(1994-3#1)(1995-8#2)(1997-2#1)(1997-4#1)(1997-8#1)(2005-10#1)(2007-4#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-3#2)(2011-2#1)
other databases##3##2##(1991-3#1)(2008-4#1)(2008-8#1)
other decisions##2##2##(2004-12#1)(2006-8#1)
other defects##3##2##(1996-12#1)(1996-6#1)(1997-4#1)
other degenerative diseases##3##3##(2008-9#1)(2009-3#1)(2011-2#1)
other degenerative##4##2##(1995-12#1)(2008-9#1)(2009-3#1)(2011-2#1)
other deleterious##2##2##(2006-8#1)(2008-11#1)
other delivery systems##3##3##(2008-5#1)(2008-7#1)(2011-2#1)
other demographic or##2##3##(1994-12#1)(2007-10#1)
other demographic##7##2##(1992-8#1)(1993-2#1)(1994-12#1)(2007-10#1)(2008-11#1)(2008-12#1)(2013-7#1)
other departments##3##2##(1992-1#1)(2005-12#1)(2010-8#1)
other derivatives of##2##3##(1990-7#1)(2008-10#1)
other derivatives were##2##3##(2010-1#1)(2011-2#1)
other derivatives##6##2##(1990-7#1)(2007-10#1)(2008-10#1)(2008-11#1)(2010-1#1)(2011-2#1)
other described##2##2##(2008-10#2)
other detection##2##2##(2008-10#1)(2010-6#1)
other detergents##2##2##(1990-5#1)(1992-6#1)
other determinants of##2##3##(2005-10#1)(2012-1#1)
other determinants##3##2##(1996-4#1)(2005-10#1)(2012-1#1)
other developed countries##4##3##(2007-8#1)(2009-11#1)(2011-2#1)(2012-1#1)
other developed##5##2##(1992-2#1)(2007-8#1)(2009-11#1)(2011-2#1)(2012-1#1)
other developing countries##9##3##(2007-10#1)(2007-7#1)(2008-11#1)(2008-4#1)(2009-2#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
other developmental##9##2##(1997-1#1)(2005-7#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-11#1)(2009-4#1)(2009-8#1)(2010-10#1)
other devices##5##2##(1991-3#2)(1991-4#1)(2007-11#1)(2010-10#1)
other diagnoses##9##2##(1990-6#1)(1995-4#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-12#1)(2008-4#1)(2008-7#1)(2012-2#1)
other diagnosis##2##2##(2007-2#1)(2010-12#1)
other diagnostic techniques##2##3##(2007-7#1)(2012-2#1)
other diagnostic##10##2##(1993-10#1)(1995-1#1)(1996-2#1)(1996-4#1)(2006-6#1)(2006-9#1)(2007-5#1)(2007-7#1)(2009-4#1)(2012-2#1)
other diets##4##2##(2008-12#2)(2008-3#1)(2012-2#1)
other differences in##2##3##(1996-3#1)(2009-5#1)
other differences were##2##3##(1995-5#1)(2012-1#1)
other differences##6##2##(1995-11#1)(1995-5#1)(1996-3#1)(2009-2#1)(2009-5#1)(2012-1#1)
other different##2##2##(2007-10#1)(2010-12#1)
other difficulties##2##2##(1996-3#1)(2007-11#1)
other dimensions of##3##3##(1992-12#1)(2009-4#1)(2011-2#1)
other dimensions##6##2##(1992-12#1)(2007-12#1)(2008-11#1)(2008-9#1)(2009-4#1)(2011-2#1)
other direct##6##2##(1992-9#1)(1996-2#1)(2007-11#1)(2007-9#1)(2008-10#1)(2011-12#1)
other direction##2##2##(2008-3#1)(2008-7#1)
other directions##5##2##(1992-10#2)(2008-1#1)(2008-10#1)(2008-6#1)
other disasters##2##2##(2008-2#1)(2013-1#1)
other disciplines could##2##3##(2008-12#1)(2008-5#1)
other disciplines of##3##3##(1991-2#1)(1994-12#1)(2008-10#1)
other disciplines##16##2##(1990-3#1)(1990-6#2)(1991-2#1)(1994-12#1)(2005-10#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-5#2)(2010-2#1)(2011-2#1)(2013-1#1)
other discovery##2##2##(2008-10#1)(2013-1#1)
other disease processes##2##3##(2006-10#1)(2009-2#1)
other disease##15##2##(1993-11#1)(1997-7#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-2#2)(2012-12#1)
other diseases can##3##3##(1990-6#1)(1992-6#1)(2010-8#1)
other diseases including##2##3##(2010-12#1)(2012-3#1)
other diseases of the##2##4##(1995-4#1)(1995-5#1)
other diseases of##5##3##(1995-4#1)(1995-5#1)(1997-5#1)(2006-8#1)(2008-10#1)
other diseases or##2##3##(2005-9#1)(2008-4#1)
other diseases such as##3##4##(1991-8#1)(2010-8#1)(2011-12#1)
other diseases that##3##3##(2007-11#1)(2010-11#1)(2010-12#1)
other diseases##74##2##(1990-3#1)(1990-5#2)(1990-6#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-6#2)(1993-12#3)(1993-8#1)(1994-5#3)(1995-4#1)(1995-5#1)(1995-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#2)(2005-10#1)(2005-9#1)(2006-10#5)(2006-2#1)(2006-7#1)(2006-8#2)(2007-11#3)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
other disorders and##2##3##(2010-1#1)(2012-3#1)
other disorders including##2##3##(2008-3#1)(2008-7#1)
other disorders of##2##3##(2010-3#1)(2012-12#1)
other disorders##17##2##(1992-4#1)(1997-2#1)(2004-3#1)(2006-10#1)(2007-7#1)(2008-1#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-1#1)(2010-3#1)(2012-12#1)(2012-3#2)
other distortions in the##2##4##(1997-5#1)(2008-2#1)
other distortions##3##2##(1997-5#1)(2006-12#1)(2008-2#1)
other dithiocarbamates##2##2##(2008-10#2)
other divalent cations##5##3##(1990-5#1)(1991-2#2)(1993-6#1)(1996-1#1)
other divalent##6##2##(1990-5#1)(1991-2#2)(1993-6#1)(1996-1#1)(2008-10#1)
other diverse##3##2##(2008-10#1)(2009-10#1)(2009-4#1)
other doctors##3##2##(2007-4#1)(2007-9#2)
other domains##9##2##(1996-7#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-8#1)(2009-9#1)(2011-2#1)(2013-1#2)
other domestic##2##2##(1990-12#1)(2013-8#1)
other downstream##3##2##(2007-11#1)(2008-4#1)(2009-3#1)
other drug abuse and/or dependence##3##5##(1997-5#3)
other drug therapies##2##3##(2005-7#1)(2007-11#1)
other drug use behaviors##3##4##(1996-1#3)
other drug use##6##3##(1996-1#3)(2005-10#1)(2009-11#1)(2009-7#1)
other drug##14##2##(1996-1#3)(1997-5#3)(2005-10#1)(2005-7#1)(2007-11#1)(2009-11#1)(2009-7#1)(2010-12#1)(2010-4#1)(2012-12#1)
other drugs and##5##3##(1993-11#1)(2005-10#1)(2009-9#1)(2010-12#1)(2012-3#1)
other drugs have been##2##4##(2008-4#1)(2008-8#1)
other drugs in##5##3##(1995-1#1)(1997-2#1)(2007-11#1)(2008-3#1)(2010-12#1)
other drugs of abuse##3##4##(1991-1#1)(1995-12#1)(2009-7#1)
other drugs of##4##3##(1991-1#1)(1995-12#1)(2008-10#1)(2009-7#1)
other drugs used##2##3##(1996-3#1)(2006-10#1)
other drugs##59##2##(1990-12#1)(1990-2#2)(1990-7#1)(1990-9#1)(1991-1#3)(1991-4#1)(1991-8#1)(1993-11#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-3#1)(1996-8#1)(1997-2#2)(2005-10#2)(2005-7#1)(2006-10#3)(2006-8#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#1)(2008-8#4)(2009-11#1)(2009-7#1)(2009-9#2)(2010-12#3)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#2)(2012-3#2)
other drugs)##2##2##(2008-5#1)(2013-1#1)
other drugs]##2##2##(1991-8#1)(1992-12#1)
other during the##2##3##(1991-12#1)(1997-6#1)
other early##2##2##(2006-7#1)(2008-10#1)
other ecological##3##2##(2008-10#2)(2008-8#1)
other ecosystems##2##2##(2006-12#2)
other ectodermal##2##2##(2007-7#2)
other eczema##2##2##(2013-1#2)
other educational##3##2##(1994-2#1)(2006-12#1)(2006-5#1)
other effectors##2##2##(2008-8#1)(2010-2#1)
other effects of the##2##4##(1990-12#1)(1991-2#1)
other effects on the##2##4##(1990-9#1)(2012-11#1)
other effects on##3##3##(1990-12#1)(1990-9#1)(2012-11#1)
other effects##12##2##(1990-12#2)(1990-9#1)(1991-2#1)(1994-5#1)(1994-6#1)(2005-4#1)(2008-5#1)(2010-7#1)(2010-8#1)(2012-11#1)(2013-7#1)
other efforts##2##2##(1994-10#1)(2010-8#1)
other eicosanoids##2##2##(1993-9#1)(2008-4#1)
other eight##5##2##(1991-4#1)(2006-12#1)(2008-10#3)
other electroactive##2##2##(2007-8#1)(2008-10#1)
other electron##2##2##(2006-10#1)(2006-8#1)
other elements in##3##3##(2004-4#1)(2005-4#1)(2006-2#1)
other elements of the##2##4##(1995-8#1)(2008-3#1)
other elements of##4##3##(1995-8#1)(1996-1#1)(2008-3#1)(2012-12#1)
other elements##16##2##(1994-6#1)(1995-8#1)(1996-1#1)(2004-4#1)(2005-4#2)(2006-2#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-4#1)(2012-12#1)
other emerging##7##2##(2005-8#2)(2007-8#1)(2010-2#1)(2010-7#1)(2011-2#1)(2013-1#1)
other emission##2##2##(1992-3#1)(2008-2#1)
other empirical##2##2##(2006-9#1)(2010-6#1)
other employed##2##2##(2005-12#1)(2008-7#1)
other endogenous##3##2##(1991-9#1)(2006-12#1)(2008-10#1)
other enteric pathogens##2##3##(2008-10#1)(2011-1#1)
other entities##2##2##(1991-3#1)(1993-2#1)
other environmental and##2##3##(2008-10#1)(2009-12#1)
other environmental stressors##2##3##(2008-7#1)(2008-8#1)
other environmental##23##2##(1990-10#1)(1991-12#1)(1996-12#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-5#1)(2012-2#1)(2013-7#1)
other enzymatic##3##2##(1990-12#1)(1992-6#1)(1996-12#1)
other enzyme##4##2##(1990-11#1)(1990-12#1)(1995-12#1)(2011-2#1)
other enzymes in the##2##4##(1993-12#1)(1994-6#1)
other enzymes##20##2##(1990-5#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-4#1)(1992-8#2)(1993-12#1)(1993-6#1)(1994-3#1)(1994-6#1)(1995-6#1)(1997-4#1)(1997-5#1)(2005-7#1)(2008-4#1)(2008-7#1)(2011-1#1)(2011-12#1)
other errors##2##2##(2008-2#1)(2008-3#1)
other essential##4##2##(1991-6#1)(1995-2#1)(2008-10#1)(2008-7#1)
other established methods##2##3##(2008-3#1)(2008-9#1)
other established##6##2##(2008-10#1)(2008-3#1)(2008-9#1)(2011-1#1)(2012-1#2)
other estimates##2##2##(1995-6#1)(2011-3#1)
other ethnic groups in Hawaii##2##5##(2008-1#2)
other ethnic groups##9##3##(1991-10#1)(2006-10#1)(2007-2#1)(2008-1#2)(2008-3#1)(2009-5#1)(2010-7#1)(2010-8#1)
other ethnic populations##5##3##(2007-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
other ethnic##15##2##(1991-10#1)(1996-9#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-1#2)(2008-3#1)(2009-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)
other etiologies of##5##3##(2013-1#4)(2013-8#1)
other etiologies##11##2##(1990-9#1)(2005-8#1)(2007-8#1)(2008-1#2)(2013-1#4)(2013-8#2)
other eukaryotes##9##2##(1991-6#1)(1992-5#1)(1992-8#1)(1994-12#1)(1994-5#2)(1996-10#1)(1996-3#1)(2012-2#1)
other eukaryotic##7##2##(1992-4#1)(1993-4#1)(1994-2#1)(1995-11#1)(1997-6#1)(2008-4#1)(2008-9#1)
other events##3##2##(2008-4#1)(2008-9#1)(2010-1#1)
other evidence of systemic##2##4##(1992-3#1)(2008-7#1)
other evidence of##4##3##(1992-3#1)(2006-10#1)(2008-7#1)(2011-2#1)
other evidence that##2##3##(1990-6#1)(2007-9#1)
other evidence##10##2##(1990-6#1)(1992-3#1)(1993-12#1)(1994-8#1)(2006-10#1)(2007-9#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#1)
other examinations##4##2##(1990-5#1)(1997-4#1)(2007-11#1)(2010-12#1)
other examined##3##2##(2007-11#1)(2008-6#1)(2008-8#1)
other examples are##2##3##(2008-5#1)(2012-2#1)
other examples of##2##3##(1996-8#1)(2010-2#1)
other examples##6##2##(1996-8#1)(2007-11#1)(2008-4#1)(2008-5#1)(2010-2#1)(2012-2#1)
other excipients##2##2##(2008-5#1)(2012-12#1)
other exercise##3##2##(2006-8#2)(2008-3#1)
other exercises##3##2##(2006-8#1)(2013-1#2)
other existing methods##3##3##(2008-2#1)(2008-6#1)(2012-3#1)
other existing##14##2##(2006-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2009-12#1)(2009-4#1)(2010-12#1)(2012-3#1)(2013-1#3)
other exogenous##2##2##(1991-3#1)(2012-2#1)
other expenses##3##2##(2006-2#1)(2008-12#1)(2009-10#1)
other experiment##2##2##(1990-10#1)(2008-8#1)
other experimental paradigms##2##3##(1996-12#1)(2008-4#1)
other experimental results##2##3##(1997-2#1)(2008-3#1)
other experimental##18##2##(1994-8#1)(1996-12#1)(1997-2#1)(2005-11#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2010-7#1)(2012-11#1)
other experiments##11##2##(1990-4#1)(1993-6#1)(1994-2#1)(1996-10#1)(2006-6#1)(2008-10#4)(2008-3#1)(2008-9#1)
other explanations are##2##3##(1996-3#1)(2007-7#1)
other explanations##3##2##(1995-11#1)(1996-3#1)(2007-7#1)
other explanatory variables##2##3##(2007-6#1)(2007-7#1)
other exposure##2##2##(1995-3#1)(2011-1#1)
other exposures##2##2##(1996-8#1)(2007-7#1)
other external##4##2##(2007-1#1)(2008-2#1)(2008-7#2)
other extracellular matrix##2##3##(1991-3#1)(2006-2#1)
other extracellular##5##2##(1991-3#1)(2006-2#1)(2008-4#2)(2008-7#1)
other extraction##3##2##(2008-10#3)
other extrinsic##2##2##(1996-11#1)(2008-11#1)
other eye##2##2##(2007-9#1)(2013-7#1)
other face##2##2##(2009-4#2)
other facial##3##2##(2006-12#1)(2008-5#1)(2008-9#1)
other facilities##3##2##(1994-3#1)(1995-6#1)(2008-10#1)
other factors (e##2##3##(1990-12#1)(2008-2#1)
other factors also##3##3##(1994-11#1)(2008-9#1)(2009-10#1)
other factors are involved in the##2##6##(2006-5#1)(2006-8#1)
other factors are involved##3##4##(2006-5#1)(2006-8#1)(2008-1#1)
other factors are##8##3##(1996-3#1)(2006-5#1)(2006-8#1)(2008-1#1)(2009-7#1)(2010-10#1)(2012-3#1)(2013-1#1)
other factors associated with##2##4##(2008-12#1)(2011-2#1)
other factors can##2##3##(2012-1#1)(2012-12#1)
other factors in the##5##4##(2004-11#1)(2008-2#1)(2010-11#1)(2010-8#1)(2013-8#1)
other factors in##6##3##(1995-12#1)(2004-11#1)(2008-2#1)(2010-11#1)(2010-8#1)(2013-8#1)
other factors including##3##3##(2006-10#1)(2007-5#1)(2010-2#1)
other factors influencing##2##3##(1995-3#1)(2008-12#1)
other factors like##2##3##(2008-11#1)(2008-4#1)
other factors may be##4##4##(1990-6#1)(2008-10#1)(2012-2#1)(2013-1#1)
other factors may##5##3##(1990-6#1)(2006-12#1)(2008-10#1)(2012-2#1)(2013-1#1)
other factors on the##3##4##(1990-12#1)(1996-9#1)(2005-4#1)
other factors on##4##3##(1990-12#1)(1996-9#1)(2005-4#1)(2013-1#1)
other factors should be##2##4##(2008-11#1)(2008-9#1)
other factors such as the##2##5##(2006-12#1)(2008-5#1)
other factors such as##8##4##(1994-11#1)(1997-8#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-7#1)
other factors that affect the##2##5##(2008-4#1)(2008-6#1)
other factors that influence##2##4##(1994-12#1)(2008-2#1)
other factors that##8##3##(1994-12#1)(2005-7#1)(2006-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2010-8#1)(2012-11#1)
other factors to##2##3##(1992-5#1)(1993-2#1)
other factors were##3##3##(2009-7#1)(2011-1#1)(2012-12#1)
other factors##140##2##(1990-11#1)(1990-12#3)(1990-3#1)(1990-6#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-2#3)(1993-5#1)(1994-11#2)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#3)(1995-3#1)(1996-3#3)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-10#2)(2005-4#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#3)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#3)(2008-1#6)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-2#2)(2009-4#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#4)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#5)(2012-3#2)(2012-6#2)(2013-1#3)(2013-7#1)(2013-8#1)
other faculty##2##2##(1993-1#1)(1993-2#1)
other false##2##2##(2007-12#1)(2012-3#1)
other families##7##2##(1993-3#1)(2008-7#2)(2008-8#2)(2008-9#1)(2013-8#1)
other family members##9##3##(1992-6#1)(1994-12#1)(1996-10#1)(1996-5#2)(2006-8#1)(2008-1#1)(2011-2#1)(2012-12#1)
other family##14##2##(1992-6#1)(1993-10#1)(1994-12#1)(1996-10#1)(1996-5#2)(2005-11#1)(2006-8#1)(2007-2#1)(2008-1#1)(2009-11#1)(2009-9#1)(2011-2#1)(2012-12#1)
other farmers##3##2##(1996-3#3)
other fast fractal algorithms##2##4##(2008-2#2)
other fatty acids##2##3##(1995-3#1)(2004-11#1)
other feature##3##2##(1992-9#1)(2008-2#1)(2008-3#1)
other features of the metabolic syndrome##2##6##(2008-3#2)
other features of the##3##4##(1995-6#1)(2008-3#2)
other features of##7##3##(1991-6#1)(1995-6#1)(2008-1#1)(2008-3#2)(2009-7#1)(2010-11#1)
other features##13##2##(1990-8#1)(1991-6#1)(1995-6#1)(2008-1#1)(2008-3#3)(2008-4#1)(2008-9#1)(2009-7#1)(2010-11#1)(2013-1#1)(2013-8#1)
other fern families##2##3##(2008-5#2)
other fetal##2##2##(1994-4#1)(2009-3#1)
other field##5##2##(1996-1#1)(2008-10#1)(2008-5#2)(2010-2#1)
other fields of##3##3##(2008-11#1)(2011-3#1)(2013-8#1)
other fields##12##2##(1990-3#1)(2006-5#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-5#1)(2011-1#1)(2011-3#1)(2013-8#1)
other filamentous fungi##3##3##(2005-11#1)(2008-10#1)(2012-3#1)
other findings##8##2##(1990-5#1)(1996-12#1)(1997-3#1)(2006-10#1)(2007-2#1)(2009-11#1)(2011-2#1)(2012-3#1)
other fish species##6##3##(2008-10#1)(2008-11#1)(2008-7#3)(2010-5#1)
other fish##10##2##(1991-5#1)(2008-10#2)(2008-11#1)(2008-7#3)(2009-9#1)(2010-5#1)(2012-2#1)
other five##17##2##(1990-2#1)(1990-3#1)(1994-9#1)(1996-5#1)(1997-1#1)(1997-4#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#3)(2009-4#1)(2012-1#1)(2013-8#1)
other flow##3##2##(2008-10#3)
other flu-like diseases##2##3##(2007-7#2)
other fluid##2##2##(1995-6#1)(1995-8#1)
other fluorescent##2##2##(1997-8#1)(2008-12#1)
other focal##2##2##(1990-3#1)(2010-12#1)
other focusing##2##2##(2006-2#1)(2008-2#1)
other food sources##2##3##(2007-8#1)(2013-8#1)
other food##9##2##(1997-4#1)(2007-11#4)(2007-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
other foods and##2##3##(2008-12#1)(2012-2#1)
other foods##7##2##(1990-2#1)(1994-7#1)(2007-8#1)(2008-12#1)(2011-1#1)(2012-2#2)
other for##22##2##(1991-3#1)(1992-8#1)(1994-8#1)(1995-4#1)(1995-6#1)(1997-7#1)(2005-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2011-1#1)(2011-2#1)
other forearm##3##2##(2008-5#2)(2008-9#1)
other forebrain##3##2##(1993-12#2)(1993-6#1)
other form##7##2##(1993-11#1)(1997-6#1)(2008-10#1)(2008-4#1)(2009-4#1)(2010-5#1)(2010-6#1)
other forms of health##2##4##(1997-2#1)(2007-7#1)
other forms of repetitive thinking##2##5##(2010-8#2)
other forms of treatment##2##4##(1993-9#1)(2012-3#1)
other forms of##65##3##(1991-1#1)(1991-11#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-9#2)(1995-2#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-2#2)(2005-6#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-3#1)(2006-9#1)(2007-11#3)(2007-12#3)(2007-4#1)(2007-7#2)(2008-1#4)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-9#1)(2010-12#3)(2010-6#1)(2010-7#1)(2010-8#3)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
other forms##67##2##(1991-1#1)(1991-11#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-9#2)(1995-2#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-2#2)(2005-11#1)(2005-6#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-3#1)(2006-9#1)(2007-11#3)(2007-12#3)(2007-4#1)(2007-7#2)(2008-1#4)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-9#1)(2010-12#3)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
other formulations##4##2##(2008-10#2)(2008-5#1)(2012-2#1)
other four cases##4##3##(1994-6#1)(2006-12#1)(2007-1#1)(2007-8#1)
other four##24##2##(1990-8#1)(1994-3#1)(1994-6#1)(1995-9#1)(1996-12#1)(1997-6#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-5#2)(2008-9#1)(2012-2#1)(2012-3#1)
other fractions##2##2##(2008-10#1)(2008-11#1)
other fragments##3##2##(1993-11#1)(1995-11#1)(1996-12#1)
other from the##3##3##(1992-6#1)(2008-3#1)(2010-8#1)
other from##13##2##(1990-5#1)(1991-9#1)(1992-2#1)(1992-6#1)(1996-8#1)(2006-6#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-8#1)
other fullerenes##2##2##(2008-2#2)
other functional groups##2##3##(1997-2#1)(2008-4#1)
other functional##6##2##(1997-2#1)(2005-11#1)(2008-4#2)(2009-6#1)(2013-1#1)
other functions for##2##3##(1992-7#1)(2007-10#1)
other functions of##3##3##(1997-8#1)(2006-2#1)(2009-10#1)
other functions such as##2##4##(2008-6#1)(2010-8#1)
other functions##11##2##(1992-7#1)(1992-9#1)(1997-8#1)(2006-2#1)(2007-10#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-10#1)(2010-8#1)
other fungal pathogens##3##3##(2008-10#2)(2011-1#1)
other fungal peroxidases##2##3##(1994-12#2)
other fungal##11##2##(1993-3#1)(1994-12#2)(1997-2#2)(1997-6#1)(2007-7#2)(2008-10#2)(2011-1#1)
other fungi##16##2##(1994-3#1)(1995-3#1)(2005-8#1)(2008-10#10)(2008-5#1)(2010-7#1)(2011-12#1)
other fungicides##2##2##(2008-10#2)
other future##2##2##(1997-8#1)(2008-3#1)
other gangliosides##4##2##(1990-4#1)(1994-10#2)(2008-7#1)
other gaseous##2##2##(2008-2#1)(2010-12#1)
other gases##5##2##(1991-5#1)(1996-12#1)(2008-10#1)(2008-2#2)
other gastrointestinal diseases##2##3##(2006-10#2)
other gastrointestinal##6##2##(2006-10#3)(2007-8#2)(2013-1#1)
other geminiviruses##2##2##(2008-10#1)(2008-8#1)
other gene##15##2##(1990-11#1)(1990-8#1)(1994-12#1)(1994-2#1)(1995-6#1)(1996-12#2)(1996-5#1)(1996-6#1)(1997-2#1)(2006-11#1)(2006-4#1)(2008-10#1)(2008-5#1)(2008-9#1)
other gene-finding programs##2##3##(1996-12#1)(2008-4#1)
other genera of##2##3##(2007-12#1)(2010-9#1)
other genera##3##2##(2007-12#1)(2008-12#1)(2010-9#1)
other general##2##2##(1991-12#1)(1992-2#1)
other generating##2##2##(2007-8#1)(2008-7#1)
other genes in the##2##4##(2009-4#1)(2012-11#1)
other genes in##5##3##(2008-10#1)(2008-6#1)(2008-7#1)(2009-4#1)(2012-11#1)
other genes involved in##2##4##(1995-11#1)(2008-10#1)
other genes##44##2##(1990-11#1)(1990-5#1)(1990-7#1)(1992-10#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-2#1)(1994-3#2)(1995-11#1)(1995-2#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-4#1)(2007-12#1)(2007-2#1)(2008-10#5)(2008-11#1)(2008-4#4)(2008-6#1)(2008-7#5)(2009-10#1)(2009-4#2)(2009-8#1)(2010-3#1)(2012-11#1)(2012-12#1)(2012-3#2)
other genetic diseases##2##3##(2008-8#1)(2012-12#1)
other genetic factors##3##3##(2006-8#1)(2008-7#1)(2013-1#1)
other genetic markers##2##3##(1994-12#1)(2013-7#1)
other genetic##15##2##(1993-9#1)(1994-12#1)(2005-1#1)(2006-8#2)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
other genome##2##2##(1997-4#1)(2008-4#1)
other genomes##5##2##(1996-7#1)(2008-2#1)(2008-7#1)(2008-8#1)(2012-2#1)
other genomic##4##2##(1993-8#2)(2008-10#1)(2010-3#1)
other genotypes (A##2##3##(2008-10#2)
other genotypes##11##2##(1994-3#1)(2006-10#1)(2008-10#4)(2008-5#1)(2008-8#1)(2010-12#1)(2010-4#1)(2012-2#1)
other geographic areas##2##3##(2008-10#1)(2010-8#1)
other geographic##3##2##(1992-8#1)(2008-10#1)(2010-8#1)
other geographical locations##2##3##(1991-11#1)(2007-12#1)
other geographical##3##2##(1991-11#1)(2007-12#1)(2013-7#1)
other geometrical##2##2##(1990-2#1)(2006-12#1)
other governmental##3##2##(1996-1#1)(2008-11#2)
other gram-negative bacteria##3##3##(2007-2#1)(2008-10#1)(2013-1#1)
other gram-negative##4##2##(1996-10#1)(2007-2#1)(2008-10#1)(2013-1#1)
other gram-positive##2##2##(2006-9#1)(2012-2#1)
other grape##2##2##(2008-10#2)
other grasses##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
other group did not##2##4##(1995-1#1)(1996-2#1)
other group members##3##3##(2008-9#3)
other group of##5##3##(1990-4#1)(1996-9#1)(2006-4#1)(2007-11#1)(2008-5#1)
other group##35##2##(1990-4#1)(1991-2#3)(1991-6#1)(1992-12#1)(1992-8#1)(1994-6#1)(1995-1#1)(1995-8#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-2#2)(2006-12#1)(2006-4#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-9#3)(2009-11#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-11#1)(2013-8#1)
other groups are##2##3##(1993-11#1)(1997-6#1)
other groups of##13##3##(1990-12#1)(1991-2#1)(1992-1#1)(1992-11#1)(1994-11#1)(1995-12#1)(2006-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2011-1#1)(2012-1#1)(2013-7#1)
other groups were##3##3##(2008-12#1)(2008-7#1)(2012-11#1)
other groups##86##2##(1990-12#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-2#2)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#2)(1993-5#1)(1993-7#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-8#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(2004-2#1)(2006-12#1)(2006-3#1)(2006-5#2)(2006-8#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-2#4)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#4)(2013-7#2)(2013-8#2)
other growth factor##2##3##(1992-9#1)(2006-1#1)
other growth factors##5##3##(1990-5#1)(1991-10#1)(1993-6#1)(2008-11#1)(2011-2#1)
other growth##8##2##(1990-5#1)(1991-10#1)(1992-9#1)(1993-6#1)(1995-11#1)(2006-1#1)(2008-11#1)(2011-2#1)
other half of the##2##4##(1990-7#1)(1996-8#1)
other half##16##2##(1990-7#1)(1994-9#1)(1995-3#1)(1996-1#1)(1996-8#1)(2005-10#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-2#3)(2009-7#1)(2010-8#1)(2011-2#1)(2012-1#1)
other harmful##2##2##(2004-4#1)(2008-10#1)
other has been##2##3##(2007-8#1)(2008-3#1)
other health and social welfare##2##5##(1990-4#1)(1990-5#1)
other health and social##3##4##(1990-4#1)(1990-5#1)(2008-12#1)
other health care organizations##2##4##(2008-11#1)(2009-11#1)
other health care professionals to##2##5##(2009-12#1)(2010-8#1)
other health care professionals##13##4##(1994-3#1)(2006-10#1)(2007-2#1)(2007-6#1)(2008-11#1)(2008-4#1)(2009-12#1)(2009-5#1)(2010-8#1)(2010-9#2)(2012-11#1)(2012-12#1)
other health care providers##7##4##(1992-2#1)(1993-1#1)(1994-12#1)(1997-3#1)(2007-12#1)(2007-2#1)(2009-10#1)
other health care settings##2##4##(1996-12#1)(2010-8#1)
other health care##33##3##(1992-2#1)(1993-1#2)(1993-12#1)(1994-12#1)(1994-3#1)(1995-2#2)(1996-12#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-12#2)(2007-2#2)(2007-6#1)(2008-11#4)(2008-4#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2010-8#2)(2010-9#2)(2012-11#1)(2012-12#1)
other health problems and##2##4##(2005-7#1)(2013-7#1)
other health problems in##2##4##(2008-9#1)(2011-11#1)
other health problems##5##3##(2005-7#1)(2008-1#1)(2008-9#1)(2011-11#1)(2013-7#1)
other health professionals##4##3##(1994-6#1)(2007-11#1)(2008-11#1)(2010-4#1)
other health professions were##2##4##(1991-6#2)
other health professions##5##3##(1991-6#2)(1997-3#1)(2007-6#1)(2010-3#1)
other health services##2##3##(1994-3#1)(2012-3#1)
other health systems##2##3##(1996-12#1)(2010-8#1)
other health##73##2##(1990-4#1)(1990-5#1)(1991-10#1)(1991-3#1)(1991-6#2)(1992-2#1)(1993-1#2)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-2#3)(1996-12#2)(1997-3#2)(1997-5#1)(2005-10#3)(2005-7#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-2#3)(2007-6#2)(2007-7#1)(2008-1#2)(2008-11#6)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#4)(2010-9#2)(2011-11#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-7#1)
other health-care##2##2##(2006-8#1)(2007-2#1)
other healthcare professionals##4##3##(1996-7#1)(2008-2#1)(2008-5#1)(2012-1#1)
other healthcare##10##2##(1996-7#1)(1997-2#1)(2007-11#1)(2008-2#1)(2008-5#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-1#1)
other heart diseases##2##3##(1990-3#1)(1993-2#1)
other heart##3##2##(1990-3#1)(1992-9#1)(1993-2#1)
other heavy metals and##2##4##(1995-3#1)(2008-10#1)
other heavy metals##3##3##(1995-3#2)(2008-10#1)
other heavy##5##2##(1995-2#1)(1995-3#2)(2008-10#2)
other helioseismic##2##2##(1996-5#2)
other hematological##3##2##(1993-3#1)(2008-7#1)(2010-11#1)
other hematopoietic##3##2##(2008-4#2)(2012-12#1)
other heme##2##2##(1994-3#1)(1994-8#1)
other hemodynamic##2##2##(2007-10#1)(2007-8#1)
other hemoglobins##3##2##(1990-8#1)(1993-6#2)
other hepatic##4##2##(1991-8#1)(1992-2#1)(2008-5#1)(2012-12#1)
other herpesviruses##4##2##(1993-11#1)(1994-8#1)(2007-6#1)(2013-8#1)
other high##2##2##(1990-9#1)(2011-2#1)
other high-risk##4##2##(2008-5#1)(2008-6#1)(2009-5#1)(2011-1#1)
other higher##5##2##(1993-6#1)(1994-5#1)(2007-12#1)(2008-12#1)(2008-3#1)
other highly##3##2##(1997-2#1)(2008-1#1)(2008-7#1)
other histologic types##2##3##(1991-9#1)(2009-5#1)
other histone##4##2##(1990-5#1)(1992-7#2)(1993-9#1)
other homologous##3##2##(1994-5#1)(1994-8#1)(1997-6#1)
other hormonal##2##2##(1995-12#1)(2007-8#1)
other hormones##6##2##(1990-11#1)(1990-6#1)(1995-12#1)(1997-2#1)(2004-10#1)(2005-3#1)
other hospital##11##2##(1990-12#1)(1990-2#1)(1990-9#1)(1993-3#1)(1995-12#1)(2007-12#3)(2010-8#1)(2013-1#2)
other hospitals##8##2##(1990-12#1)(1990-9#1)(1991-11#1)(1992-12#1)(1992-2#2)(2006-10#1)(2008-11#1)
other host cells##2##3##(2008-10#1)(2012-12#1)
other host plants##3##3##(2008-10#3)
other host species##6##3##(1994-3#1)(2008-10#3)(2012-12#2)
other host##16##2##(1994-3#1)(2006-10#1)(2008-10#10)(2011-2#1)(2012-12#3)
other hosts##21##2##(2008-10#18)(2011-2#2)(2012-12#1)
other human diseases##2##3##(1992-8#1)(2013-1#1)
other human pathogens##2##3##(2010-4#1)(2013-8#1)
other human##20##2##(1991-7#1)(1992-1#1)(1992-8#1)(1993-6#1)(1994-8#1)(1996-5#1)(1997-2#1)(1997-6#1)(2006-6#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
other hybrid##2##2##(2008-10#1)(2013-1#1)
other hydrocarbons##2##2##(2006-10#1)(2008-10#1)
other hypothalamic##2##2##(1993-12#1)(1995-12#1)
other hypotheses##2##2##(2008-8#1)(2009-9#1)
other identifiable##3##2##(2006-7#1)(2007-7#1)(2008-10#1)
other identified##5##2##(1994-6#1)(2007-12#2)(2008-10#1)(2013-8#1)
other ill##2##2##(2007-5#1)(2008-1#1)
other illegal drugs##2##3##(1991-2#1)(1996-1#1)
other illicit drugs##2##3##(2006-3#1)(2006-9#1)
other illnesses##2##2##(2007-8#1)(2011-2#1)
other image##3##2##(1992-2#1)(2008-2#1)(2012-1#1)
other imaging modalities##2##3##(2008-8#1)(2010-11#1)
other imaging techniques to##2##4##(2006-7#1)(2012-2#1)
other imaging techniques##4##3##(2006-7#1)(2010-6#1)(2011-2#1)(2012-2#1)
other imaging##14##2##(1991-2#1)(1992-11#1)(2006-7#1)(2007-5#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-2#2)(2013-7#1)
other immune cell##2##3##(1992-2#1)(2010-5#1)
other immune cells##2##3##(2008-4#1)(2010-12#1)
other immune##10##2##(1991-12#1)(1992-2#1)(2006-10#1)(2008-4#2)(2010-12#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
other immunological tests were##2##4##(2007-2#2)
other immunological##3##2##(2007-2#2)(2008-10#1)
other immunosuppressive agents##5##3##(2006-10#1)(2007-11#2)(2012-2#1)(2013-7#1)
other immunosuppressive##7##2##(2006-10#1)(2007-11#2)(2007-8#1)(2012-2#1)(2013-7#1)(2013-8#1)
other important analytical##3##3##(2008-10#2)(2008-2#1)
other important factors##2##3##(2008-7#1)(2011-1#1)
other important##26##2##(1991-3#1)(1992-2#1)(1992-3#2)(1996-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#1)(2009-5#1)(2009-7#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-4#1)(2013-7#1)(2013-8#1)
other in a##10##3##(1991-12#1)(1995-2#1)(2005-10#1)(2008-10#1)(2009-5#1)(2010-2#1)(2012-12#2)(2013-1#1)(2013-7#1)
other in an##2##3##(1994-4#1)(2008-10#1)
other in the##19##3##(1992-4#1)(1992-8#2)(1996-2#1)(1996-5#1)(2005-8#1)(2006-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2012-2#1)(2013-1#1)
other in their##2##3##(1997-7#1)(2008-3#1)
other in vivo##3##3##(1991-9#1)(2008-10#1)(2008-7#1)
other in##69##2##(1990-11#1)(1990-12#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-8#2)(1994-4#2)(1994-9#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-7#1)(2004-10#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-11#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2009-5#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-5#1)(2012-12#4)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#1)
other inbred strains##2##3##(1994-5#1)(2008-4#1)
other incentives##2##2##(2007-4#1)(2008-5#1)
other independent##3##2##(1992-2#1)(2006-12#1)(2008-7#1)
other indications in##2##3##(1995-5#1)(2007-11#1)
other indications##12##2##(1993-3#1)(1995-5#1)(1995-9#1)(2005-7#2)(2006-12#1)(2006-8#2)(2007-11#1)(2008-3#1)(2010-3#1)(2011-12#1)
other indicators of##5##3##(1990-12#1)(1997-1#1)(2006-10#1)(2008-1#1)(2012-1#1)
other indicators##7##2##(1990-12#1)(1997-1#1)(2006-10#1)(2007-7#1)(2008-1#1)(2011-1#1)(2012-1#1)
other indigenous##3##2##(1994-3#1)(2008-10#1)(2013-1#1)
other individual##2##2##(2007-3#1)(2010-2#1)
other individuals##9##2##(1992-2#1)(1995-9#1)(2006-5#1)(2008-1#1)(2008-3#1)(2010-2#1)(2010-5#1)(2012-1#1)(2012-12#1)
other indolent lymphomas##2##3##(2010-12#2)
other industrialized countries##3##3##(1990-2#1)(2007-9#1)(2011-2#1)
other industrialized##4##2##(1990-2#1)(1995-3#1)(2007-9#1)(2011-2#1)
other industries##9##2##(1993-12#2)(1993-3#1)(1995-12#2)(2007-12#2)(2009-11#1)(2010-12#1)
other infection-related##2##2##(2008-7#1)(2009-8#1)
other infections##8##2##(1995-5#1)(1995-9#1)(2006-8#1)(2007-4#1)(2008-8#1)(2010-5#1)(2011-2#1)(2013-1#1)
other infectious disease##2##3##(1995-11#1)(2010-2#1)
other infectious diseases in##2##4##(1993-7#1)(2005-8#1)
other infectious diseases##8##3##(1993-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2007-7#1)(2008-8#1)(2012-11#1)
other infectious##11##2##(1993-7#1)(1995-11#1)(2005-8#1)(2006-10#2)(2006-2#1)(2007-7#1)(2008-5#1)(2008-8#1)(2010-2#1)(2012-11#1)
other inflammatory cells##3##3##(1995-12#1)(2005-11#1)(2008-7#1)
other inflammatory processes##2##3##(2008-9#1)(2012-12#1)
other inflammatory##16##2##(1994-3#1)(1994-9#1)(1995-12#1)(1995-7#1)(2005-11#1)(2006-10#2)(2007-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-7#2)
other information##7##2##(1996-11#1)(1997-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-10#1)(2010-12#1)
other ingredients in##2##3##(2008-10#2)
other ingredients##3##2##(2008-10#2)(2010-12#1)
other inhaled##2##2##(2006-10#1)(2008-3#1)
other inhibitors of##6##3##(1994-11#1)(1994-4#1)(1995-1#1)(1995-3#1)(1997-6#1)(2007-11#1)
other inhibitors##8##2##(1994-11#1)(1994-4#1)(1995-1#1)(1995-3#2)(1997-3#1)(1997-6#1)(2007-11#1)
other initiatives##2##2##(1995-12#1)(2008-3#1)
other injected##2##2##(1992-2#1)(2010-4#1)
other injection##2##2##(2007-4#1)(2008-11#1)
other injuries##5##2##(1991-6#1)(1992-3#1)(2007-7#1)(2010-11#1)(2011-1#1)
other inocula##2##2##(2008-10#2)
other inorganic anions##2##3##(2008-10#2)
other inorganic species##2##3##(2008-10#2)
other inorganic##7##2##(1991-2#1)(2008-10#5)(2010-12#1)
other insect species##3##3##(2004-4#1)(2007-12#1)(2008-7#1)
other insect##4##2##(2004-4#1)(2007-12#1)(2008-11#1)(2008-7#1)
other insects##7##2##(1993-6#1)(1997-2#1)(2007-12#1)(2008-5#1)(2008-7#1)(2009-12#1)(2013-7#1)
other instances##6##2##(1990-4#1)(1997-5#1)(2008-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
other institutions as##2##3##(1994-3#1)(1995-1#1)
other institutions##14##2##(1991-3#1)(1993-10#1)(1994-3#1)(1995-1#1)(1996-1#2)(1997-1#1)(2006-6#1)(2007-2#1)(2007-4#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-3#1)
other interesting##4##2##(2006-12#1)(2007-8#1)(2008-11#1)(2008-4#1)
other interferents##2##2##(2008-10#2)
other interfering##3##2##(2008-10#3)
other interferons##3##2##(2007-11#3)
other intermediates##2##2##(1994-3#1)(1994-8#1)
other international##3##2##(2013-1#3)
other interventions##5##2##(2006-10#1)(2006-5#1)(2007-6#1)(2010-10#1)(2012-2#1)
other intracellular##5##2##(1990-6#1)(1992-12#1)(1997-1#1)(2008-10#1)(2008-3#1)
other intrusions##2##2##(2005-11#1)(2005-8#1)
other invasive##7##2##(1990-12#1)(1990-2#1)(1992-6#1)(2006-10#2)(2011-2#1)(2012-12#1)
other invertebrate##5##2##(1990-5#1)(1991-5#1)(1996-7#1)(2008-7#1)(2008-8#1)
other investigated##2##2##(1990-6#1)(2008-8#1)
other investigations##4##2##(2007-11#1)(2007-3#1)(2007-8#1)(2008-3#1)
other investigators##12##2##(1990-3#1)(1991-11#1)(1992-8#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-8#1)(2008-10#1)(2008-4#2)(2008-8#1)(2009-8#1)
other involved##2##2##(1995-5#1)(2008-12#1)
other ion##2##2##(2005-4#1)(2008-8#1)
other ions##17##2##(1990-4#1)(1996-5#1)(1997-5#1)(2007-8#1)(2008-10#10)(2008-2#1)(2008-6#1)(2010-11#1)
other is a##9##3##(1993-3#1)(2005-11#2)(2008-3#4)(2008-4#1)(2010-8#1)
other is an##2##3##(1992-5#1)(2008-9#1)
other is based on##2##4##(2008-10#1)(2008-2#1)
other is the##3##3##(2008-11#1)(2008-2#2)
other is##43##2##(1990-12#1)(1991-1#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-3#2)(1994-11#1)(1995-1#1)(1995-2#1)(1995-3#1)(2005-11#2)(2006-12#1)(2006-2#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#6)(2008-3#6)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-8#1)(2013-1#1)
other islands##2##2##(1994-3#1)(1994-9#1)
other isoflavones##2##2##(1996-4#1)(2008-10#1)
other isoforms of##2##3##(1992-3#1)(2008-9#1)
other isoforms##7##2##(1992-3#1)(1994-9#1)(1996-5#1)(1997-4#2)(2008-9#1)(2010-12#1)
other isolates of##2##3##(2008-10#2)
other isolates were##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
other isolates##13##2##(2008-10#9)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
other issues of concern##2##4##(1997-1#1)(2013-1#1)
other issues##14##2##(1995-12#1)(1995-5#1)(1996-2#1)(1997-1#2)(1997-5#1)(2005-11#1)(2005-8#1)(2008-12#1)(2008-7#1)(2010-12#1)(2010-5#1)(2011-12#1)(2013-1#1)
other items##2##2##(1991-11#1)(2013-1#1)
other joint##3##2##(2007-11#1)(2007-8#1)(2013-1#1)
other joints##5##2##(1997-3#1)(2006-10#1)(2006-8#1)(2007-11#1)(2012-1#1)
other jurisdictions##3##2##(1994-1#1)(2008-7#1)(2010-12#1)
other key enzymes##2##3##(2009-5#1)(2009-8#1)
other key##14##2##(1994-1#1)(1994-11#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-2#2)(2009-11#1)(2009-5#1)(2009-8#1)(2010-7#1)(2012-2#2)(2012-3#1)
other kinds of##11##3##(1990-3#1)(1991-3#1)(1993-12#1)(1995-5#1)(1995-6#1)(1996-5#1)(2005-8#1)(2007-12#1)(2008-3#1)(2008-6#1)(2012-12#1)
other known annexins##2##3##(1991-2#1)(1993-8#1)
other known compounds##2##3##(2006-12#1)(2012-2#1)
other known genes##5##3##(1996-12#2)(1996-6#1)(1997-4#1)(1997-6#1)
other known serine proteases##2##4##(1991-2#2)
other known##72##2##(1990-10#2)(1990-11#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#5)(1991-5#2)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-11#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-8#2)(1995-1#1)(1995-2#6)(1995-3#1)(1995-4#1)(1995-8#2)(1996-12#2)(1996-2#1)(1996-6#1)(1997-2#2)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-6#1)(2006-12#2)(2006-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
other laboratories##13##2##(1990-8#1)(1994-8#1)(1996-4#1)(1997-8#1)(2008-11#2)(2008-2#2)(2008-4#3)(2008-8#1)(2012-12#1)
other laboratory tests##2##3##(2008-1#1)(2009-3#1)
other laboratory##3##2##(2008-1#1)(2009-3#1)(2012-3#1)
other languages and##2##3##(2008-10#1)(2008-2#1)
other languages##3##2##(2008-10#1)(2008-2#1)(2012-3#1)
other laparoscopic##2##2##(1995-1#1)(2006-6#1)
other large##5##2##(2008-4#1)(2008-6#1)(2008-7#1)(2012-12#1)(2012-2#1)
other large-scale##3##2##(2007-12#1)(2008-7#1)(2009-5#1)
other laser##4##2##(1995-2#1)(2007-12#1)(2008-3#2)
other layered##2##2##(2008-10#1)(2008-2#1)
other layers##7##2##(1994-2#3)(1997-3#1)(1997-6#1)(2008-12#1)(2011-2#1)
other leaf rust##2##3##(2008-10#2)
other lepidopteran##2##2##(2007-12#1)(2008-11#1)
other lesions in the##2##4##(1993-8#1)(2008-7#1)
other lesions##7##2##(1993-8#1)(2006-12#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-5#1)(2010-7#1)
other less common##4##3##(2007-6#1)(2007-7#1)(2009-12#1)(2012-12#1)
other less##9##2##(1992-9#1)(2005-10#1)(2005-8#1)(2007-6#1)(2007-7#1)(2008-1#1)(2009-12#1)(2012-12#1)(2012-2#1)
other levels of##3##3##(2007-11#1)(2012-2#1)(2013-8#1)
other levels##5##2##(2006-5#1)(2007-11#1)(2009-6#1)(2012-2#1)(2013-8#1)
other libraries##2##2##(1990-5#1)(1993-1#1)
other life##2##2##(2006-7#1)(2008-11#1)
other life-threatening##2##2##(1993-9#1)(2008-10#1)
other lifestyle factors##4##3##(1993-11#1)(1996-6#1)(2006-6#1)(2011-2#1)
other lifestyle##8##2##(1993-11#1)(1996-6#1)(2006-6#1)(2008-11#1)(2009-5#1)(2011-2#1)(2013-8#2)
other ligands##7##2##(1996-2#1)(1996-5#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-8#1)
other light##2##2##(2006-12#1)(2012-3#1)
other limitations##2##2##(2011-2#1)(2012-12#1)
other lineages##2##2##(2009-8#1)(2013-1#1)
other linguistic##4##2##(2012-1#3)(2013-8#1)
other links##2##2##(2006-10#1)(2006-8#1)
other lipid##6##2##(1990-2#1)(1992-8#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-11#1)
other lipids##3##2##(1990-2#1)(1996-5#1)(2007-1#1)
other lipoprotein##5##2##(1992-3#1)(1993-11#1)(1995-6#2)(1997-2#1)
other liquid##3##2##(1991-10#1)(2008-10#1)(2011-2#1)
other liver##5##2##(1993-7#3)(2006-6#1)(2007-11#1)
other living organisms##2##3##(2008-10#1)(2011-2#1)
other living##4##2##(1994-2#1)(2008-10#2)(2011-2#1)
other local##10##2##(1994-12#1)(1995-3#1)(1996-10#1)(1996-9#1)(2006-10#1)(2006-6#1)(2007-1#1)(2008-5#1)(2012-12#2)
other localizations##2##2##(1995-9#1)(2011-1#1)
other location##3##2##(2007-12#1)(2007-8#2)
other locations##13##2##(1995-11#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-5#1)(2010-1#1)(2010-8#1)(2012-3#1)
other loci##3##2##(2008-12#1)(2008-4#1)(2009-4#1)
other loculoascomycetes##2##2##(2008-10#2)
other locus##3##2##(2008-10#2)(2012-12#1)
other locusts##4##2##(2012-2#4)
other long-term##2##2##(2007-12#1)(2008-1#1)
other low molecular weight##2##4##(1991-12#1)(1994-3#1)
other low##3##2##(1991-12#1)(1994-3#1)(2008-10#1)
other lung##3##2##(2005-11#1)(2007-8#1)(2008-5#1)
other luteoviruses##2##2##(2008-10#2)
other lymphoid##3##2##(2008-4#1)(2010-11#1)(2010-8#1)
other lymphomas##2##2##(1994-9#1)(2005-10#1)
other lymphoproliferative##2##2##(2005-8#1)(2013-8#1)
other lysosomal##3##2##(1990-9#1)(1991-7#1)(1993-9#1)
other mAbs##2##2##(1997-7#1)(2008-11#1)
other mRNAs##2##2##(1990-11#1)(1995-8#1)
other machine##2##2##(1997-6#1)(2007-9#1)
other macromolecules##4##2##(1990-8#1)(1991-11#1)(1993-7#1)(1994-8#1)
other macrophage##2##2##(1995-2#1)(2011-1#1)
other main##3##2##(1994-6#1)(2007-8#1)(2012-2#1)
other maize##2##2##(2011-2#2)
other major##26##2##(1990-4#1)(1991-2#1)(1991-3#1)(1991-8#1)(1994-8#1)(1995-9#2)(1997-1#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-11#1)(2007-5#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-2#1)(2011-10#1)(2011-2#1)(2012-2#1)(2012-3#2)
other males##5##2##(1993-11#1)(1995-1#1)(2006-7#1)(2008-8#1)(2009-6#1)
other malformations##5##2##(1996-12#1)(1996-3#1)(1996-6#1)(2008-10#1)(2011-1#1)
other malignancies##6##2##(1991-10#1)(1993-1#1)(2008-4#1)(2008-6#1)(2009-8#1)(2010-3#1)
other malignant##3##2##(1991-9#1)(1992-10#1)(2008-5#1)
other mammalian species##3##3##(1991-2#1)(1994-12#2)
other mammalian##12##2##(1991-2#1)(1991-6#1)(1991-7#1)(1992-9#1)(1994-12#4)(1994-6#1)(2006-11#1)(2007-11#1)(2008-10#1)
other mammals##19##2##(1991-2#1)(1992-11#1)(1992-12#2)(1992-8#1)(1993-3#1)(1994-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-2#1)(2006-8#1)(2008-5#1)(2008-7#2)(2010-12#2)(2011-2#1)(2013-1#1)
other manifestations of##4##3##(2006-10#1)(2006-4#1)(2008-1#1)(2010-2#1)
other manifestations##7##2##(2006-10#1)(2006-4#1)(2008-1#1)(2008-9#1)(2009-4#1)(2010-2#1)(2013-1#1)
other manipulations##2##2##(1991-12#1)(2007-12#1)
other markers of##5##3##(2008-1#1)(2008-5#1)(2010-5#1)(2012-5#1)(2013-8#1)
other markers##12##2##(1997-5#1)(2004-10#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-5#1)(2010-5#1)(2012-3#1)(2012-5#1)(2013-7#1)(2013-8#1)
other material##3##2##(1994-8#1)(2008-2#1)(2008-3#1)
other materials##15##2##(1990-2#1)(2006-12#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-8#1)(2013-1#2)(2013-8#1)
other matrix metalloproteinases##2##3##(2008-4#1)(2008-9#1)
other matrix##7##2##(1992-6#1)(2005-4#1)(2008-10#3)(2008-4#1)(2008-9#1)
other meaningful##2##2##(2009-10#1)(2012-3#1)
other means of##6##3##(1994-6#1)(1996-3#1)(2006-10#1)(2006-6#1)(2008-4#1)(2011-2#1)
other means##9##2##(1994-6#1)(1996-3#1)(1997-5#1)(2006-10#1)(2006-6#1)(2008-2#1)(2008-4#1)(2008-9#1)(2011-2#1)
other measures of##10##3##(1992-12#1)(1994-12#1)(1996-12#1)(1996-8#1)(2008-12#1)(2010-10#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
other measures##14##2##(1990-9#1)(1992-12#1)(1994-12#1)(1996-12#1)(1996-8#1)(2008-12#1)(2008-2#1)(2010-10#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
other mechanical##2##2##(2006-2#1)(2009-7#1)
other mechanism##2##2##(2006-2#1)(2009-9#1)
other mechanisms also##2##3##(1993-5#1)(2008-10#1)
other mechanisms by which##2##4##(1997-7#1)(2008-4#1)
other mechanisms of resistance##2##4##(2008-1#1)(2008-10#1)
other mechanisms of##6##3##(1991-9#1)(1992-8#1)(2005-8#1)(2008-1#1)(2008-10#1)(2008-4#1)
other mechanisms such as##2##4##(1997-4#1)(2010-12#1)
other mechanisms##28##2##(1990-9#1)(1991-9#2)(1992-6#1)(1992-8#1)(1993-5#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-4#4)(2008-7#1)(2010-12#1)
other media##5##2##(2008-10#2)(2008-2#1)(2010-12#1)(2011-1#1)
other mediators that activate##2##4##(2008-4#2)
other mediators##5##2##(1994-11#1)(2006-2#1)(2008-4#2)(2008-5#1)
other medical conditions##5##3##(2006-1#1)(2008-6#1)(2009-7#1)(2011-2#2)
other medical disciplines##2##3##(2005-1#1)(2012-2#1)
other medical problems##2##3##(2009-12#1)(2013-1#1)
other medical##32##2##(1991-12#1)(1992-1#1)(1992-6#1)(1996-1#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-7#1)(2005-1#1)(2006-1#2)(2006-10#2)(2007-11#1)(2007-3#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
other medication##3##2##(1992-2#1)(2011-1#1)(2012-12#1)
other medications that##2##3##(2007-8#2)
other medications##14##2##(2006-10#3)(2006-2#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-1#2)(2009-8#1)(2010-12#1)(2011-1#1)(2012-3#1)
other members of the family##6##5##(1993-11#1)(1994-8#1)(1995-1#1)(2008-10#1)(2009-10#1)(2012-12#1)
other members of the##44##4##(1990-6#1)(1991-11#2)(1991-2#1)(1991-4#1)(1992-3#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-3#1)(1996-4#1)(1997-7#2)(2006-10#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2009-10#2)(2011-2#1)(2012-12#1)(2013-1#1)
other members of this family of##2##6##(1994-8#1)(1996-12#1)
other members of this family##6##5##(1994-8#1)(1995-3#1)(1996-12#1)(2008-10#1)(2008-4#1)(2010-3#1)
other members of this##7##4##(1990-7#1)(1994-8#1)(1995-3#1)(1996-12#1)(2008-10#1)(2008-4#1)(2010-3#1)
other members of##57##3##(1990-6#1)(1990-7#1)(1991-11#2)(1991-2#1)(1991-4#1)(1992-3#1)(1992-7#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-3#2)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-7#2)(2006-10#1)(2007-12#2)(2007-8#2)(2008-1#2)(2008-10#10)(2008-11#1)(2008-3#1)(2008-4#4)(2008-5#1)(2009-10#2)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
other members##60##2##(1990-6#1)(1990-7#1)(1991-11#2)(1991-2#1)(1991-4#1)(1992-3#1)(1992-7#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-3#2)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-7#2)(2005-8#1)(2006-10#1)(2006-7#1)(2007-12#2)(2007-8#2)(2008-1#2)(2008-10#10)(2008-11#1)(2008-3#1)(2008-4#4)(2008-5#1)(2009-10#2)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
other membrane proteins##2##3##(1993-8#1)(1995-12#1)
other membrane##6##2##(1990-4#1)(1991-1#1)(1993-8#1)(1995-12#1)(2008-10#1)(2008-4#1)
other membranes##9##2##(1990-3#2)(1997-4#1)(2007-7#2)(2008-1#2)(2008-10#2)
other memory##2##2##(2008-11#1)(2008-12#1)
other men##5##2##(1995-12#1)(2009-5#2)(2010-8#1)(2011-2#1)
other mental disorders##3##3##(2006-9#1)(2009-10#1)(2010-2#1)
other mental health professionals##2##4##(2005-7#1)(2009-1#1)
other mental health##5##3##(2005-7#1)(2008-9#1)(2009-1#1)(2009-7#1)(2013-8#1)
other mental##10##2##(1993-12#1)(2005-7#1)(2006-9#1)(2007-11#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-7#1)(2010-2#1)(2013-8#1)
other mesenchymal tumors##3##3##(2007-9#1)(2012-2#1)(2013-1#1)
other mesenchymal##5##2##(2007-9#1)(2008-1#1)(2008-11#1)(2012-2#1)(2013-1#1)
other metabolic##8##2##(1990-2#1)(1994-12#1)(2005-1#1)(2007-12#1)(2008-11#1)(2008-4#1)(2010-8#1)(2013-1#1)
other metal cations##3##3##(2008-10#3)
other metal complexes##2##3##(2008-10#1)(2008-5#1)
other metal ion##2##3##(1991-4#1)(2008-10#1)
other metal ions##17##3##(1997-2#2)(2007-11#1)(2008-10#14)
other metal##26##2##(1991-4#1)(1997-2#2)(2007-11#1)(2008-10#21)(2008-5#1)
other metallic##3##2##(2008-10#2)(2008-7#1)
other metals in##2##3##(1994-6#1)(2008-10#1)
other metals such as##2##4##(2006-12#1)(2008-10#1)
other metals##16##2##(1990-4#2)(1994-6#1)(1996-4#1)(1996-7#1)(2006-12#1)(2008-10#8)(2008-5#1)(2010-11#1)
other metastases##2##2##(1990-9#1)(2008-3#1)
other metastatic##3##2##(1991-10#1)(1997-3#1)(2008-11#1)
other method##5##2##(2008-10#2)(2008-3#1)(2008-7#1)(2013-1#1)
other methods are##3##3##(1992-11#1)(1997-5#1)(2008-11#1)
other methods can##2##3##(2008-5#1)(2009-10#1)
other methods for##4##3##(2006-4#1)(2008-10#1)(2010-3#1)(2012-12#1)
other methods in##2##3##(2010-2#1)(2013-7#1)
other methods is##2##3##(1995-4#1)(2011-1#1)
other methods of##9##3##(1990-12#1)(2004-3#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-8#1)(2011-2#1)
other methods such as##4##4##(2007-11#1)(2008-10#1)(2008-11#1)(2010-4#1)
other methods used##2##3##(1990-3#1)(2007-11#1)
other methods##81##2##(1990-12#1)(1990-3#2)(1990-4#1)(1991-11#1)(1991-2#1)(1992-11#1)(1993-12#1)(1994-12#1)(1994-4#1)(1994-8#1)(1995-1#2)(1995-4#1)(1996-12#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-7#1)(2004-3#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-2#6)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-3#2)(2013-7#2)(2013-8#3)
other microbes##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
other microorganisms and##2##3##(2005-7#1)(2008-5#1)
other microorganisms##4##2##(2005-7#1)(2008-10#2)(2008-5#1)
other midline##2##2##(1997-3#2)
other minimally invasive approaches##2##4##(2013-1#2)
other minimally invasive##3##3##(2007-8#1)(2013-1#2)
other minor loci##2##3##(2008-10#1)(2010-5#1)
other minor##10##2##(1990-5#1)(1993-11#1)(1993-12#1)(1996-11#1)(2006-8#1)(2008-10#2)(2009-12#1)(2010-5#1)(2012-11#1)
other mitochondrial proteins##3##3##(1991-10#1)(1994-11#1)(2005-8#1)
other mitochondrial##9##2##(1991-10#1)(1993-2#1)(1994-11#1)(1995-5#1)(1997-2#1)(1997-4#1)(2005-8#2)(2008-7#1)
other mitogens##2##2##(1990-3#1)(1990-7#1)
other modalities of treatment##3##4##(2006-8#2)(2007-1#1)
other modalities of##4##3##(2006-8#3)(2007-1#1)
other modalities##13##2##(1993-5#1)(2006-10#1)(2006-8#3)(2007-1#1)(2007-11#1)(2007-6#1)(2008-1#2)(2008-5#1)(2010-6#1)(2013-1#1)
other mode##3##2##(2008-10#1)(2009-6#1)(2010-4#1)
other model organisms##2##3##(2008-4#1)(2008-7#1)
other model##7##2##(1992-6#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-1#1)
other models of##4##3##(1996-10#1)(2008-4#1)(2008-5#1)(2008-9#1)
other models##13##2##(1992-2#1)(1992-4#1)(1996-10#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#2)(2011-1#1)
other modes of##3##3##(2006-11#1)(2010-8#1)(2011-2#1)
other modes##4##2##(1990-8#1)(2006-11#1)(2010-8#1)(2011-2#1)
other modified##2##2##(1995-5#1)(2008-10#1)
other modular##3##2##(2008-11#1)(2008-4#1)(2008-5#1)
other modules##2##2##(2008-11#2)
other molecular##11##2##(1990-6#1)(2005-7#1)(2006-8#1)(2007-4#1)(2008-8#1)(2009-9#1)(2011-2#2)(2012-2#2)(2013-8#1)
other molecules involved in##2##4##(1997-4#1)(2009-12#1)
other molecules##14##2##(1992-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-5#1)(2013-1#2)
other monoamine##3##2##(1990-12#1)(1993-3#1)(1996-5#1)
other mononuclear cells##2##3##(2008-11#1)(2008-4#1)
other mononuclear##3##2##(2008-11#1)(2008-4#2)
other monosaccharides##2##2##(1990-2#1)(1996-2#1)
other monovalent##2##2##(1992-3#1)(1994-12#1)
other more aggressive##2##3##(2009-8#1)(2013-1#1)
other more conventional##2##3##(1992-3#1)(2004-12#1)
other more##19##2##(1991-6#1)(1992-3#1)(1997-1#1)(2004-12#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-4#1)(2010-9#1)(2013-1#2)
other morphological##4##2##(2006-6#1)(2008-7#1)(2009-8#1)(2012-3#1)
other motor##3##2##(1997-4#1)(2008-7#1)(2012-3#1)
other mouse##3##2##(2008-4#3)
other mulberry##2##2##(2008-4#2)
other multiple##3##2##(2008-4#1)(2011-1#2)
other multivariate statistical##2##3##(2008-10#1)(2010-8#1)
other murine##4##2##(1996-1#1)(1997-1#2)(2011-2#1)
other musculoskeletal##3##2##(2006-10#1)(2008-5#1)(2009-3#1)
other mutant##5##2##(1992-3#1)(1993-3#1)(1996-2#1)(1997-4#1)(2006-9#1)
other mutants##7##2##(1990-6#1)(1991-2#1)(1993-11#1)(1995-3#1)(1995-6#1)(2008-10#1)(2008-8#1)
other mutation##2##2##(1991-5#1)(1992-11#1)
other mutations in the##2##4##(1995-1#1)(2012-12#1)
other mutations in##3##3##(1992-11#1)(1995-1#1)(2012-12#1)
other mutations##9##2##(1990-8#1)(1992-11#1)(1993-6#1)(1994-3#1)(1995-1#1)(1996-6#1)(1997-4#1)(2006-8#1)(2012-12#1)
other mycotoxins##4##2##(2009-3#1)(2010-4#1)(2013-8#2)
other nanoparticles##3##2##(2010-1#1)(2012-11#2)
other national##2##2##(2005-12#1)(2008-8#1)
other nations##5##2##(1993-2#1)(2006-8#2)(2008-1#1)(2012-1#1)
other native##2##2##(1995-4#1)(2007-3#1)
other natural enemies##3##3##(2008-8#1)(2011-12#2)
other natural##10##2##(1996-4#1)(2007-11#1)(2008-8#1)(2009-3#1)(2009-7#1)(2011-12#2)(2013-1#3)
other naturally occurring##3##3##(1990-11#1)(1996-11#1)(2008-10#1)
other naturally##4##2##(1990-11#1)(1996-11#1)(2008-10#1)(2009-12#1)
other necessary##5##2##(2005-11#1)(2007-4#1)(2012-2#1)(2013-1#2)
other neighboring##3##2##(2007-12#1)(2008-12#1)(2008-4#1)
other nematodes##5##2##(2007-11#1)(2007-12#4)
other neoplasms##4##2##(1990-12#1)(2007-12#1)(2007-6#1)(2012-2#1)
other nervous system##2##3##(2010-3#1)(2012-3#1)
other nervous##3##2##(2006-10#1)(2010-3#1)(2012-3#1)
other neural##3##2##(1994-9#1)(2008-7#1)(2009-4#1)
other neurochemical##2##2##(1991-5#1)(1996-12#1)
other neurodegenerative diseases##3##3##(2008-5#1)(2010-12#1)(2010-5#1)
other neurodegenerative disorders##3##3##(1994-11#1)(2007-12#1)(2008-7#1)
other neurodegenerative##9##2##(1994-11#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-5#1)(2013-7#1)
other neurologic##3##2##(1995-1#1)(2007-10#2)
other neurological conditions and##2##4##(2010-8#1)(2012-2#1)
other neurological diseases##2##3##(1990-10#1)(1996-12#1)
other neurological disorders##4##3##(1990-10#1)(1996-6#2)(2006-10#1)
other neurological signs##2##3##(2008-5#1)(2013-1#1)
other neurological##15##2##(1990-10#2)(1993-8#1)(1996-12#1)(1996-6#2)(2006-10#1)(2006-12#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
other neuromuscular##2##2##(1994-8#1)(2008-8#1)
other neuronal##2##2##(1990-2#1)(1991-11#1)
other neurons##7##2##(1994-10#1)(1995-7#1)(1997-3#1)(2008-11#1)(2008-7#1)(2009-12#1)(2009-8#1)
other neuropeptides##3##2##(1991-9#1)(1992-7#1)(1993-4#1)
other neuropsychiatric disorders##2##3##(2012-1#1)(2012-2#1)
other neuropsychiatric##3##2##(1990-2#1)(2012-1#1)(2012-2#1)
other neurotransmitter systems##2##3##(1996-4#1)(2008-5#1)
other neurotransmitter##5##2##(1993-12#1)(1995-12#1)(1996-4#1)(2008-5#1)(2009-6#1)
other neurotransmitters##4##2##(1993-12#1)(2006-10#1)(2006-9#1)(2008-7#1)
other neutral##2##2##(1991-3#1)(1995-4#1)
other new##5##2##(1994-3#1)(2005-12#1)(2007-12#1)(2008-11#1)(2009-2#1)
other non-affective psychoses##2##3##(1992-8#1)(1997-2#1)
other nonlinear##4##2##(1996-8#1)(2007-12#3)
other nonpharmacologic##2##2##(1993-12#1)(1996-7#1)
other nonspecific##3##2##(1992-3#1)(1993-3#1)(1997-1#1)
other nonsteroidal antiinflammatory drugs##2##4##(2006-10#1)(2008-5#1)
other normal tissues##2##3##(1990-3#1)(1995-8#1)
other normal##3##2##(1990-3#1)(1995-8#1)(2007-11#1)
other not only##2##3##(2008-10#1)(2008-9#1)
other notable##3##2##(1995-8#1)(2005-12#1)(2006-12#1)
other novel##8##2##(1996-1#1)(2008-4#1)(2009-11#1)(2010-12#1)(2013-8#4)
other nuclear proteins##3##3##(1991-12#1)(1996-5#1)(1997-6#1)
other nuclear##7##2##(1991-12#1)(1993-6#1)(1994-3#1)(1996-5#1)(1997-4#1)(1997-6#1)(2008-10#1)
other nuclei##2##2##(1990-4#1)(1995-6#1)
other nucleic acids##2##3##(2008-5#2)
other nucleoside analogs##2##3##(2006-11#2)
other nucleoside triphosphates##2##3##(1990-11#2)
other nucleoside##6##2##(1990-11#2)(1995-11#1)(2006-11#2)(2008-1#1)
other nucleotide##2##2##(1997-7#1)(1997-8#1)
other nucleotides##4##2##(2008-4#4)
other nurses##2##2##(1995-3#1)(1996-1#1)
other nutritional##3##2##(2007-7#1)(2011-2#1)(2013-1#1)
other objects##5##2##(1993-2#1)(2008-1#1)(2008-11#1)(2008-6#1)(2012-12#1)
other observations##4##2##(1991-12#1)(1993-6#1)(1994-5#1)(1996-5#1)
other obvious##2##2##(2007-7#1)(2012-2#1)
other occupational diseases##3##3##(1992-1#1)(2009-12#2)
other occupational##6##2##(1992-1#2)(1994-3#2)(2009-12#2)
other occupations##5##2##(1991-4#1)(1993-3#1)(1995-1#1)(2008-7#1)(2008-8#1)
other occurrences##2##2##(2008-4#1)(2010-8#1)
other ocular##4##2##(1994-9#1)(1996-1#1)(2008-7#1)(2009-4#1)
other of##15##2##(1990-2#1)(1991-3#1)(1991-8#1)(1992-12#1)(1993-2#2)(1995-8#1)(1996-12#1)(2006-6#1)(2006-8#1)(2007-6#1)(2008-10#2)(2008-5#1)(2008-6#1)
other official##2##2##(2008-5#1)(2009-7#1)
other older##2##2##(2008-3#2)
other on the##8##3##(1993-6#1)(1995-11#1)(1997-1#1)(2006-12#1)(2007-9#1)(2008-2#1)(2008-7#1)(2010-8#1)
other on##13##2##(1993-6#1)(1995-11#1)(1996-3#1)(1997-1#1)(2006-12#1)(2007-9#1)(2008-2#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-8#1)
other one is##4##3##(2005-11#1)(2006-2#1)(2008-11#1)(2008-2#1)
other one##29##2##(1990-8#1)(1990-9#1)(1991-10#1)(1992-10#1)(1995-1#1)(1995-3#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-3#1)(2007-6#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-11#1)(2013-1#1)
other ones##4##2##(2008-10#1)(2008-5#1)(2012-12#2)
other operative##2##2##(2010-2#1)(2013-1#1)
other opiate##2##2##(1990-2#1)(1991-3#1)
other opioids##2##2##(2006-7#1)(2008-7#1)
other opportunistic##3##2##(2005-8#1)(2008-4#1)(2008-5#1)
other optical systems##2##3##(2008-2#1)(2008-3#1)
other optical##8##2##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#4)(2011-1#1)
other optimization##3##2##(2008-2#2)(2011-1#1)
other option##2##2##(1991-12#1)(2008-1#1)
other options##4##2##(2007-11#1)(2007-7#1)(2008-3#1)(2010-5#1)
other or with##2##3##(1992-2#1)(1994-6#1)
other or##9##2##(1992-12#1)(1992-2#1)(1994-6#1)(2005-11#1)(2007-9#1)(2008-11#1)(2008-6#1)(2009-3#1)(2011-2#1)
other oral##6##2##(1994-4#1)(2007-12#1)(2008-5#2)(2012-3#1)(2013-8#1)
other orders of##4##3##(1993-12#1)(2007-12#2)(2008-5#1)
other organ systems##5##3##(1991-4#1)(1992-8#1)(1994-7#1)(1996-12#1)(2005-7#1)
other organ##10##2##(1991-4#1)(1992-8#1)(1994-7#1)(1995-1#1)(1996-12#2)(2005-7#1)(2007-2#1)(2008-7#1)(2010-12#1)
other organelles in##2##3##(2008-1#1)(2008-10#1)
other organelles##5##2##(1995-11#2)(2008-1#1)(2008-10#1)(2008-7#1)
other organic compounds##2##3##(2007-12#1)(2008-3#1)
other organic solvents##2##3##(1994-8#1)(2008-11#1)
other organic##10##2##(1990-3#1)(1994-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-11#1)(2013-8#1)
other organisms and##3##3##(1995-9#1)(2005-7#1)(2012-3#1)
other organisms in the##2##4##(1997-7#1)(2008-10#1)
other organisms##47##2##(1990-11#1)(1990-9#1)(1992-12#1)(1993-12#1)(1993-6#2)(1993-9#2)(1994-12#3)(1994-2#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-9#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-4#1)(2005-7#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-2#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-9#1)(2010-3#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)
other organizations involved in##2##4##(1995-5#1)(2012-2#1)
other organizations##8##2##(1993-1#1)(1994-12#1)(1994-7#1)(1995-1#1)(1995-5#1)(2007-7#1)(2008-7#1)(2012-2#1)
other organs and systems##3##4##(2007-11#1)(2008-9#1)(2012-3#1)
other organs and##5##3##(2007-11#1)(2007-5#1)(2008-9#1)(2011-2#1)(2012-3#1)
other organs is##3##3##(2008-4#1)(2008-5#1)(2012-12#1)
other organs or##3##3##(1995-2#1)(2008-7#1)(2013-1#1)
other organs##51##2##(1991-9#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-2#1)(1994-5#2)(1995-12#1)(1995-2#2)(2006-10#2)(2006-11#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-6#3)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#2)(2009-12#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-12#3)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-3#2)(2013-1#1)
other origins##2##2##(2006-12#1)(2011-2#1)
other outcome measures##2##3##(2005-7#1)(2013-1#1)
other outcome variables##2##3##(2007-12#1)(2007-2#1)
other outcome##4##2##(2005-7#1)(2007-12#1)(2007-2#1)(2013-1#1)
other outcomes##9##2##(1995-2#1)(2006-9#1)(2007-8#2)(2008-12#1)(2008-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
other outdoor and indoor allergens##2##5##(2013-1#2)
other outdoor##3##2##(2009-6#1)(2013-1#2)
other over##4##2##(1993-1#1)(1993-2#1)(2007-12#1)(2008-7#1)
other oxidant##2##2##(2008-10#2)
other oxidative stress##2##3##(1995-5#1)(2010-10#1)
other oxides##3##2##(2005-11#2)(2011-2#1)
other p53-regulated proteins##2##3##(1997-2#2)
other pH values##3##3##(1993-9#1)(2008-11#1)(2008-5#1)
other pairs of##2##3##(1994-3#1)(2006-5#1)
other palliative##3##2##(2006-2#1)(2007-5#1)(2011-2#1)
other papers##3##2##(1997-8#1)(2005-10#1)(2008-11#1)
other paradigms##2##2##(1996-5#1)(2011-2#1)
other parameter##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
other parameters also##2##3##(2008-9#1)(2013-1#1)
other parameters such as age##2##5##(1990-8#1)(2011-2#1)
other parameters such as##4##4##(1990-8#1)(1992-5#1)(2007-4#1)(2011-2#1)
other parameters were##3##3##(2008-10#2)(2009-8#1)
other parameters##32##2##(1990-8#1)(1992-5#2)(1992-8#1)(1992-9#1)(1996-1#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#2)(2011-2#2)(2012-2#1)(2013-1#2)
other part of the##4##4##(1990-11#1)(2008-1#1)(2008-9#1)(2011-2#1)
other part of##5##3##(1990-11#1)(2008-1#2)(2008-9#1)(2011-2#1)
other part##7##2##(1990-11#1)(2007-12#1)(2008-1#2)(2008-9#1)(2011-2#1)(2013-1#1)
other parties##3##2##(2007-11#1)(2010-12#1)(2011-2#1)
other partners##3##2##(1994-5#1)(1995-12#1)(2006-10#1)
other parts of the world##7##5##(1995-4#1)(2005-7#1)(2007-2#1)(2007-3#1)(2008-10#1)(2009-2#1)(2009-6#1)
other parts of the##21##4##(1994-5#2)(1995-4#1)(1996-2#1)(2004-9#1)(2005-11#1)(2005-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-2#2)(2009-6#1)(2010-5#1)
other parts of##34##3##(1990-4#1)(1991-12#1)(1994-5#2)(1995-4#1)(1996-1#1)(1996-2#1)(2004-9#1)(2005-11#1)(2005-7#1)(2006-2#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2009-2#2)(2009-6#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-12#1)
other party##3##2##(1992-2#1)(1996-12#1)(2008-8#1)
other patches##2##2##(2008-8#2)
other pathogenic##8##2##(1997-2#1)(2007-2#1)(2008-12#1)(2008-9#2)(2010-12#1)(2012-1#1)(2012-2#1)
other pathogens and##2##3##(2012-2#1)(2013-8#1)
other pathogens##14##2##(1991-12#1)(1995-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
other pathological conditions##3##3##(1993-2#1)(1996-4#1)(2013-1#1)
other pathological processes##2##3##(2006-6#1)(2009-5#1)
other pathological##10##2##(1993-2#1)(1996-4#1)(2006-6#1)(2008-7#2)(2009-5#1)(2010-11#1)(2012-12#1)(2013-1#2)
other pathologies##10##2##(1992-10#1)(1993-3#1)(1996-3#1)(2006-2#2)(2007-8#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-2#1)
other pathology##4##2##(2007-10#1)(2008-10#1)(2013-1#2)
other pathosystems##2##2##(2008-10#2)
other pathotypes##2##2##(2008-10#2)
other pathways##8##2##(2008-1#2)(2008-10#2)(2008-12#1)(2008-8#1)(2010-2#1)(2012-1#1)
other patient had the##2##4##(1995-1#1)(2006-4#1)
other patient had##5##3##(1991-4#1)(1992-3#1)(1995-1#1)(2006-4#1)(2013-1#1)
other patient with##2##3##(1996-12#1)(2008-1#1)
other patient##17##2##(1991-2#1)(1991-4#1)(1992-3#1)(1993-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-6#1)(2005-10#1)(2006-4#2)(2007-12#1)(2008-1#1)(2008-10#1)(2011-12#1)(2013-1#1)
other patients had##4##3##(1990-2#1)(1990-7#1)(2007-8#1)(2011-2#1)
other patients have##2##3##(1992-9#1)(2004-11#1)
other patients more##2##3##(2007-11#1)(2007-9#1)
other patients received##2##3##(1995-2#1)(2012-2#1)
other patients were##3##3##(1991-12#1)(2010-12#1)(2010-4#1)
other patients who##2##3##(1991-11#1)(1994-7#1)
other patients with a##3##4##(1990-12#1)(2006-10#2)
other patients with##8##3##(1990-12#1)(1996-12#2)(2006-10#2)(2008-7#1)(2010-3#1)(2012-12#1)
other patients##58##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1992-11#1)(1992-9#1)(1993-1#1)(1993-12#1)(1994-3#1)(1994-7#1)(1995-2#1)(1995-4#1)(1995-9#1)(1996-12#2)(1996-8#1)(1997-3#1)(1997-8#1)(2004-11#1)(2006-10#2)(2006-9#1)(2007-11#2)(2007-2#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-7#4)(2008-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#3)
other peaks##2##2##(2006-12#1)(2008-10#1)
other pediatric##2##2##(2006-10#1)(2010-7#1)
other pelvic organs##2##3##(1996-8#1)(2011-1#1)
other people##15##2##(1997-8#1)(2005-7#1)(2006-2#1)(2007-7#1)(2008-4#2)(2008-6#2)(2009-1#1)(2009-5#1)(2009-6#1)(2010-12#2)(2011-2#1)(2013-1#1)
other people's##3##2##(1997-5#1)(2007-12#1)(2008-11#1)
other peptide hormones##2##3##(1993-5#1)(2011-1#1)
other peptide##6##2##(1992-8#1)(1993-5#1)(1995-2#1)(2008-10#1)(2008-9#1)(2011-1#1)
other peptides derived from##2##4##(1991-2#1)(1997-4#1)
other peptides##16##2##(1990-7#1)(1991-12#2)(1991-2#2)(1991-5#2)(1991-7#1)(1991-9#1)(1992-12#1)(1993-5#1)(1995-3#1)(1997-4#2)(2008-9#1)(2010-12#1)
other percutaneous##2##2##(2006-6#1)(2012-12#1)
other perennial##2##2##(2008-5#1)(2011-2#1)
other performance##3##2##(1992-11#2)(2010-4#1)
other peripheral##4##2##(1990-2#1)(1994-8#1)(1996-4#1)(2008-5#1)
other person's##2##2##(1996-6#1)(2008-12#1)
other personality##3##2##(1995-11#1)(2007-7#1)(2009-8#1)
other persons##4##2##(1993-12#1)(1996-10#2)(1996-3#1)
other pharmaceutical##2##2##(2006-12#1)(2007-8#1)
other pharmacokinetic##3##2##(2005-8#1)(2006-10#1)(2007-10#1)
other phase##4##2##(1992-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
other phases of##2##3##(1992-1#1)(2007-8#1)
other phenolic##4##2##(2006-12#1)(2008-10#2)(2012-11#1)
other phenomena##3##2##(1993-9#1)(2008-3#1)(2012-3#1)
other phenotypes##4##2##(1994-2#1)(1996-12#1)(2008-9#1)(2012-3#1)
other phenotypic##3##2##(1992-6#1)(1995-11#1)(2008-10#1)
other phospholipids##7##2##(1990-3#2)(1992-2#1)(1996-4#1)(1997-3#1)(2007-8#1)(2011-1#1)
other photosensitivity diseases##2##3##(1993-12#2)
other phyla##2##2##(1992-6#1)(2011-2#1)
other phylogenetically##2##2##(2006-12#1)(2008-10#1)
other physical activities##2##3##(1995-6#1)(1996-6#1)
other physical##8##2##(1990-8#1)(1992-5#1)(1995-6#1)(1996-6#1)(2005-12#1)(2008-10#1)(2008-5#1)(2011-2#1)
other physicians##9##2##(1991-12#1)(1995-2#1)(2006-7#1)(2007-4#2)(2007-9#1)(2009-4#1)(2010-11#1)(2010-12#1)
other physico-chemical parameters##3##3##(2007-10#1)(2008-12#1)(2008-5#1)
other physico-chemical##4##2##(2007-10#1)(2008-1#1)(2008-12#1)(2008-5#1)
other physiological functions##3##3##(1997-5#1)(2005-6#1)(2012-1#1)
other physiological##12##2##(1990-11#1)(1994-3#1)(1995-9#1)(1997-5#1)(1997-7#1)(2005-11#1)(2005-6#1)(2007-12#1)(2008-2#1)(2008-4#1)(2010-10#1)(2012-1#1)
other physiologically##2##2##(1994-8#1)(2008-10#1)
other phytochemicals##3##2##(2008-12#1)(2010-1#1)(2012-2#1)
other phytopathogenic bacteria##2##3##(2008-10#2)
other phytopathogenic fungi##4##3##(1997-4#1)(2008-10#3)
other phytopathogenic##8##2##(1997-4#1)(2008-10#7)
other phytoplasmas##2##2##(2008-10#2)
other places in the##2##4##(1993-2#1)(2007-7#1)
other places in##3##3##(1993-2#1)(2007-7#1)(2008-10#1)
other places##5##2##(1993-2#1)(2007-3#1)(2007-7#1)(2008-10#1)(2009-10#1)
other plans##2##2##(1991-2#1)(2008-1#1)
other plant species##7##3##(2008-10#4)(2008-8#1)(2009-8#1)(2010-3#1)
other plant virus##2##3##(2008-10#1)(2008-9#1)
other plant viruses##2##3##(2008-10#1)(2008-9#1)
other plant##29##2##(1990-12#2)(1992-3#1)(1994-2#1)(2008-10#12)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#2)(2010-11#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)
other plant-based##2##2##(2006-10#1)(2007-11#1)
other plants##17##2##(2008-10#6)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
other plasma##7##2##(1992-4#1)(1992-8#1)(1995-2#1)(1996-3#1)(1997-8#1)(2008-10#1)(2009-8#1)
other platelet-derived##2##2##(1992-8#1)(1994-12#1)
other points##2##2##(2011-1#2)
other polar##2##2##(1991-9#1)(2008-5#1)
other pollutants##2##2##(2007-5#1)(2008-2#1)
other polycyclic aromatic hydrocarbons##2##4##(2008-10#2)
other polymers##4##2##(1991-6#1)(2004-9#1)(2005-11#1)(2011-1#1)
other polymorphic##3##2##(1992-1#1)(1996-2#1)(2008-4#1)
other polymorphisms##3##2##(2008-4#1)(2008-5#1)(2010-8#1)
other polypeptides##4##2##(1991-2#1)(1993-11#1)(1994-12#1)(1994-9#1)
other poorly##3##2##(2008-3#1)(2008-7#1)(2012-2#1)
other popular##2##2##(2008-11#2)
other population##3##2##(2006-8#1)(2008-8#1)(2008-9#1)
other populations of##2##3##(2008-10#1)(2011-1#1)
other populations##35##2##(1991-9#1)(1995-4#1)(1996-5#1)(2005-8#1)(2006-5#1)(2007-2#4)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-11#1)(2012-2#1)(2013-1#1)(2013-7#3)
other positive##4##2##(1992-4#1)(1996-6#1)(2007-2#1)(2007-3#1)
other possibilities##5##2##(1991-1#1)(2007-7#1)(2008-2#1)(2010-12#1)(2011-2#1)
other possibility##3##2##(2007-7#1)(2011-2#1)(2012-2#1)
other possible causes of these##2##5##(2007-7#1)(2008-7#1)
other possible causes of##3##4##(2007-7#1)(2008-7#1)(2008-8#1)
other possible causes##4##3##(2007-7#1)(2008-7#1)(2008-8#1)(2009-2#1)
other possible factors##2##3##(2009-5#1)(2013-1#1)
other possible mechanisms##2##3##(1992-3#1)(2008-10#1)
other possible##26##2##(1991-8#1)(1992-10#1)(1992-11#2)(1992-3#1)(1993-12#1)(1995-4#1)(1995-5#1)(1996-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2012-12#2)(2013-1#2)
other potent##3##2##(2008-10#1)(2008-3#1)(2010-10#1)
other potential causes of##3##4##(2008-9#1)(2013-1#2)
other potential confounders##2##3##(2008-3#1)(2013-1#1)
other potential sources of##2##4##(1996-5#1)(2008-10#1)
other potential##23##2##(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-10#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#2)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#3)(2013-7#1)
other potentially##5##2##(1991-12#1)(1992-3#1)(1994-6#1)(2007-11#1)(2013-1#1)
other poultry##2##2##(2005-9#2)
other powerful##2##2##(2005-11#1)(2010-4#1)
other practices##2##2##(1993-3#1)(2006-10#1)
other practitioners##3##2##(1991-1#1)(2008-7#1)(2012-1#1)
other pre-existing##3##2##(2006-10#1)(2007-11#1)(2007-6#1)
other precautions##2##2##(2006-8#1)(2010-12#1)
other precipitating factors##2##3##(2011-2#2)
other predictor variables##2##3##(2008-10#1)(2008-2#1)
other predisposing factors##3##3##(2007-8#2)(2009-3#1)
other preparation##2##2##(1994-3#1)(2008-1#1)
other preparations##2##2##(1991-8#1)(1992-2#1)
other prescription##2##2##(1992-12#1)(2006-1#1)
other pressures##2##2##(2007-8#1)(2012-3#1)
other preventive##2##2##(1996-12#1)(2012-11#1)
other previous##3##2##(2008-10#1)(2010-7#1)(2011-2#1)
other previously described##4##3##(1990-5#1)(1990-7#1)(1997-6#1)(2007-1#1)
other previously reported##3##3##(1994-8#1)(2008-10#1)(2012-3#1)
other previously##16##2##(1990-5#1)(1990-7#1)(1992-2#1)(1994-8#1)(1997-6#1)(2007-1#1)(2008-10#6)(2008-2#1)(2009-7#1)(2010-6#1)(2012-3#1)
other primary##10##2##(1993-1#1)(1993-11#1)(1996-12#1)(1996-9#1)(1997-6#1)(1997-8#1)(2007-2#1)(2007-4#1)(2010-4#1)(2013-8#1)
other principles##2##2##(1996-7#1)(2012-2#1)
other private##4##2##(1992-3#1)(1993-12#1)(1997-1#1)(2011-1#1)
other pro-inflammatory##2##2##(2007-11#1)(2012-2#1)
other probes##2##2##(1994-11#1)(2008-2#1)
other problems encountered with##2##4##(2007-10#1)(2008-7#1)
other problems in##3##3##(1993-7#1)(2008-7#1)(2012-2#1)
other problems##15##2##(1993-6#1)(1993-7#1)(2004-3#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#2)(2009-10#1)(2012-2#1)
other procedures using##2##3##(2008-4#1)(2008-9#1)
other procedures##18##2##(1990-10#1)(1990-7#1)(1991-2#1)(1993-5#1)(1993-8#1)(1995-1#2)(1995-12#1)(1997-7#1)(2005-9#1)(2006-8#1)(2008-10#2)(2008-4#3)(2008-9#1)(2012-11#1)
other processes##8##2##(1991-6#1)(2007-7#2)(2008-10#1)(2008-8#1)(2010-9#1)(2011-2#1)(2013-8#1)
other processing enzymes##2##3##(1993-5#2)
other processing##3##2##(1993-5#2)(1994-11#1)
other producing##2##2##(2007-11#1)(2008-11#1)
other products of##2##3##(1994-3#1)(1994-9#1)
other products##11##2##(1991-9#1)(1992-4#1)(1994-3#1)(1994-9#1)(2007-6#2)(2008-10#2)(2008-2#1)(2008-5#1)(2012-12#1)
other professional societies##2##3##(2007-4#2)
other professional##9##2##(1995-2#1)(1996-1#1)(2007-4#2)(2008-11#1)(2008-3#1)(2009-6#1)(2012-12#2)
other professionals##5##2##(1996-12#1)(2006-12#1)(2007-2#1)(2008-11#1)(2013-1#1)
other professions##3##2##(2007-8#1)(2008-12#2)
other prognostic factors##3##3##(1990-2#1)(1990-6#1)(2011-2#1)
other prognostic##4##2##(1990-2#1)(1990-6#1)(2011-2#1)(2012-3#1)
other programs##3##2##(1992-2#1)(2007-7#1)(2008-10#1)
other prokaryotes##2##2##(1994-11#1)(1997-6#1)
other promising##3##2##(2005-8#1)(2006-9#1)(2007-6#1)
other properties of the##3##4##(1991-5#1)(2005-11#1)(2012-2#1)
other properties of##5##3##(1991-5#1)(1996-5#1)(2005-11#1)(2008-9#1)(2012-2#1)
other properties##15##2##(1991-5#1)(1994-8#1)(1996-5#1)(1997-3#1)(2005-11#1)(2007-11#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-1#1)(2012-2#1)
other proposed##3##2##(1996-1#1)(2007-12#1)(2008-2#1)
other protease inhibitors##2##3##(1991-8#1)(2005-9#1)
other protease##3##2##(1991-8#1)(1996-5#1)(2005-9#1)
other proteases##4##2##(1991-1#1)(1994-8#1)(1996-10#1)(2008-5#1)
other protein components##2##3##(1991-12#1)(1995-2#1)
other protein kinases such as##2##5##(1993-8#1)(1997-6#1)
other protein kinases that##2##4##(1995-3#1)(2008-8#1)
other protein kinases##6##3##(1991-7#1)(1993-8#1)(1995-3#1)(1996-8#1)(1997-6#1)(2008-8#1)
other protein##28##2##(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-7#1)(1992-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-6#1)(2004-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-11#1)(2013-1#1)(2013-7#1)
other proteinase inhibitors##2##3##(1992-11#1)(2009-4#1)
other proteins and##3##3##(1992-4#1)(2008-5#1)(2011-1#1)
other proteins are##2##3##(1991-4#1)(1995-12#1)
other proteins encoded by the##2##5##(1997-4#1)(2008-10#1)
other proteins in the##4##4##(1990-3#1)(1996-10#1)(2006-10#1)(2010-4#1)
other proteins in##6##3##(1990-3#1)(1993-11#1)(1996-10#1)(2006-10#1)(2008-4#1)(2010-4#1)
other proteins involved in##3##4##(1996-2#1)(2006-10#1)(2009-8#1)
other proteins of##2##3##(1994-9#2)
other proteins or##3##3##(1995-10#1)(1996-2#1)(2008-4#1)
other proteins such as##3##4##(1991-1#1)(1993-8#1)(2008-10#1)
other proteins suggests##2##3##(1993-3#1)(1996-7#1)
other proteins that##4##3##(1992-3#1)(1995-1#1)(2008-10#1)(2013-8#1)
other proteins to##2##3##(1990-6#1)(1995-6#1)
other proteins were##3##3##(1994-9#1)(1997-2#1)(2008-12#1)
other proteins##92##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-1#2)(1991-4#2)(1991-6#1)(1992-3#2)(1992-4#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-8#2)(1994-9#6)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#2)(1996-10#4)(1996-11#1)(1996-2#2)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#4)(1997-7#3)(2005-12#1)(2005-7#1)(2006-1#1)(2006-10#3)(2007-11#2)(2007-8#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
other proteolytic##2##2##(1994-9#1)(2004-12#1)
other protocols##4##2##(2006-6#1)(2008-4#3)
other protons##2##2##(1991-4#1)(1997-4#1)
other providers##11##2##(1991-3#1)(1992-12#1)(1993-12#1)(1995-1#1)(1996-3#1)(2006-10#1)(2012-2#1)(2012-3#3)(2013-1#1)
other provinces##3##2##(2006-8#1)(2010-12#1)(2013-8#1)
other provocative tests##2##3##(2007-11#2)
other psychiatric disorders##10##3##(1991-1#1)(2005-10#1)(2008-1#2)(2008-2#1)(2009-11#1)(2009-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
other psychiatric##14##2##(1991-1#1)(1993-12#1)(1994-2#1)(2005-10#1)(2008-1#2)(2008-2#1)(2009-11#1)(2009-7#2)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
other psychological##4##2##(1992-5#1)(1996-2#1)(2010-11#1)(2013-1#1)
other public health##3##3##(1991-10#1)(1997-8#1)(2011-1#1)
other public##5##2##(1991-10#1)(1993-6#1)(1997-8#1)(2005-5#1)(2011-1#1)
other publications##2##2##(1993-7#1)(2008-6#1)
other published data##3##3##(1992-10#1)(1994-7#1)(2006-11#1)
other published methods##2##3##(2008-10#1)(2008-5#1)
other published reports##3##3##(1990-9#1)(2008-11#1)(2011-1#1)
other published##16##2##(1990-9#1)(1991-12#1)(1992-10#1)(1994-7#1)(1997-2#1)(1997-8#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2010-10#1)(2011-1#1)(2013-1#1)(2013-8#1)
other pulmonary diseases##3##3##(2006-10#1)(2006-6#1)(2009-10#1)
other purine##2##2##(1992-8#1)(2007-11#1)
other putative##5##2##(1992-9#1)(1995-8#1)(1996-8#1)(2008-8#1)(2010-2#1)
other pyrophosphatases##2##2##(1991-2#2)
other quantitative##2##2##(1990-8#1)(2008-10#1)
other questions##5##2##(1992-12#1)(2006-4#1)(2008-3#2)(2012-2#1)
other quinolones##2##2##(1991-12#1)(2005-7#1)
other race##2##2##(2008-10#2)
other races##4##2##(1995-2#1)(2007-2#1)(2008-10#1)(2008-11#1)
other racial and ethnic groups##2##5##(2008-5#1)(2009-5#1)
other racial##3##2##(2008-5#1)(2009-5#1)(2013-1#1)
other radiological##3##2##(1991-11#1)(2005-11#1)(2010-9#1)
other radiology##2##2##(1995-3#1)(2007-4#1)
other rare earth elements##5##4##(2005-4#2)(2008-10#3)
other rare##11##2##(2005-4#2)(2008-10#6)(2008-2#1)(2008-9#1)(2009-5#1)
other rat tissues##3##3##(1991-2#2)(1994-12#1)
other ratios##2##2##(2008-10#1)(2011-12#1)
other rats##3##2##(1993-3#1)(2004-11#1)(2007-8#1)
other reaction##2##2##(1996-6#1)(2008-10#1)
other reactions that##2##3##(1990-8#1)(1991-8#1)
other reactions##7##2##(1990-8#1)(1991-3#1)(1991-8#1)(1992-11#1)(1994-9#1)(1997-7#1)(2008-7#1)
other reactive oxygen species##4##4##(1995-1#1)(2007-8#1)(2008-10#1)(2008-8#1)
other reactive##6##2##(1995-1#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-12#1)
other reagents##4##2##(1990-12#1)(1991-7#1)(2008-10#1)(2008-11#1)
other reasons for##2##3##(1990-3#1)(2008-3#1)
other reasons##18##2##(1990-3#1)(1990-4#1)(1991-8#1)(1992-2#1)(1993-1#1)(1994-3#1)(1994-4#1)(1996-1#2)(1996-2#1)(2005-10#1)(2007-3#1)(2008-3#2)(2008-7#1)(2010-8#1)(2011-2#1)(2013-7#1)
other recent studies##3##3##(1995-7#1)(2009-11#1)(2010-4#1)
other recent##13##2##(1994-3#1)(1995-7#1)(1996-9#1)(1997-3#1)(2006-6#1)(2007-12#1)(2007-8#1)(2009-11#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
other recently published papers##2##4##(2009-8#2)
other recently##5##2##(1995-6#1)(2007-11#1)(2008-2#1)(2009-8#2)
other receptor properties##2##3##(1995-11#2)
other receptor##4##2##(1995-11#2)(1996-1#1)(1996-5#1)
other receptors##11##2##(1990-5#1)(1992-10#1)(1994-5#1)(1995-2#1)(1996-5#2)(2007-8#1)(2008-4#1)(2009-3#2)(2013-7#1)
other recognizable##2##2##(1993-3#1)(1996-12#1)
other recombinant##3##2##(2008-11#2)(2008-4#1)
other regions in##4##3##(1992-8#1)(2008-1#1)(2009-5#1)(2012-11#1)
other regions of the brain##5##5##(1993-7#1)(1994-10#1)(1997-5#1)(2009-12#1)(2009-9#1)
other regions of the world##8##5##(2005-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2011-11#1)(2011-2#1)(2012-1#1)(2012-3#1)
other regions of the##20##4##(1990-4#1)(1990-5#1)(1993-12#1)(1993-7#1)(1994-10#1)(1995-3#1)(1997-5#1)(2005-11#1)(2006-7#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2009-12#1)(2009-9#1)(2011-11#1)(2011-2#2)(2012-1#1)(2012-3#1)
other regions of##22##3##(1990-4#1)(1990-5#1)(1993-12#1)(1993-7#1)(1994-10#1)(1995-3#1)(1997-2#1)(1997-5#1)(2005-11#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-11#1)(2009-12#1)(2009-9#1)(2011-11#1)(2011-2#2)(2012-1#1)(2012-3#1)
other regions##51##2##(1990-10#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-6#1)(1992-8#1)(1993-12#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#1)(1995-3#1)(1997-2#1)(1997-5#2)(1997-7#2)(1997-8#2)(2005-11#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-9#1)(2011-1#3)(2011-11#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-3#1)(2013-7#1)(2013-8#1)
other regular##2##2##(2008-3#2)
other regulatory##6##2##(1991-3#1)(1997-4#1)(1997-7#1)(2006-8#1)(2008-6#1)(2008-7#1)
other related cytokines##2##3##(1992-8#1)(1995-12#1)
other related##31##2##(1991-2#1)(1991-6#1)(1992-8#1)(1993-4#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#1)(1997-5#2)(2006-5#1)(2006-8#1)(2007-2#1)(2007-3#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-11#3)(2013-1#1)(2013-7#1)
other relationships##2##2##(2008-11#1)(2009-9#1)
other relatives##5##2##(1990-4#1)(1997-3#1)(1997-8#1)(2011-1#1)(2011-2#1)
other relevant##14##2##(1991-4#1)(1994-3#1)(1996-8#1)(2005-10#1)(2006-2#1)(2007-2#1)(2008-10#2)(2008-3#2)(2008-8#1)(2008-9#1)(2010-8#1)(2012-3#1)
other reliable##2##2##(2008-11#1)(2008-4#1)
other remains##2##2##(2008-11#1)(2009-7#1)
other reported cases of##2##4##(1992-12#1)(2010-8#1)
other reported cases##3##3##(1992-12#1)(2010-8#1)(2013-1#1)
other reported methods##2##3##(2008-10#1)(2009-10#1)
other reported##21##2##(1990-7#1)(1991-1#1)(1991-6#1)(1992-12#1)(1992-8#1)(1994-8#1)(1996-9#1)(2007-10#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#1)(2009-10#1)(2010-8#1)(2013-1#2)(2013-8#1)
other reports for##2##3##(2007-3#1)(2008-7#1)
other reports in the literature##2##5##(1994-2#1)(1994-6#1)
other reports of##5##3##(1991-6#1)(1993-1#1)(2006-10#1)(2009-8#1)(2010-2#1)
other reports##25##2##(1990-3#1)(1991-6#1)(1992-5#1)(1993-1#1)(1994-2#1)(1994-6#1)(1995-10#1)(1996-11#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-2#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#2)(2010-2#1)(2011-2#1)
other representatives of##3##3##(2007-12#1)(2008-12#1)(2011-2#1)
other reproductive##3##2##(1995-2#1)(2008-8#1)(2013-8#1)
other research areas##2##3##(2007-8#1)(2010-5#1)
other research##13##2##(1997-3#1)(2005-9#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-6#1)(2009-4#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-1#1)
other researchers have##2##3##(2009-3#1)(2011-12#1)
other researchers##13##2##(2006-12#1)(2006-6#1)(2007-11#1)(2007-4#2)(2007-9#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-3#1)(2011-12#1)
other residents##2##2##(1992-1#1)(1994-7#1)
other residues##6##2##(1992-5#1)(1995-5#1)(1996-5#1)(1997-7#1)(2004-4#1)(2008-8#1)
other resistance genes##2##3##(2008-10#1)(2008-11#1)
other resistance##3##2##(2005-8#1)(2008-10#1)(2008-11#1)
other resistant##3##2##(2008-10#3)
other resource poor##2##3##(2007-2#1)(2010-8#1)
other resource##3##2##(2007-2#1)(2007-7#1)(2010-8#1)
other resources##9##2##(1993-12#1)(2007-2#1)(2007-4#2)(2008-10#2)(2008-12#1)(2009-9#1)(2013-7#1)
other respects##4##2##(1991-4#1)(1991-8#1)(1993-3#1)(1995-2#1)
other respiratory symptoms##2##3##(2006-8#1)(2008-11#1)
other respiratory##8##2##(2006-8#1)(2007-11#2)(2008-11#1)(2009-3#1)(2010-12#1)(2011-2#2)
other response##4##2##(2006-8#1)(2008-10#2)(2010-2#1)
other responses to##2##3##(1990-11#1)(1995-3#1)
other responses##8##2##(1990-11#1)(1995-3#1)(1996-1#1)(2007-11#1)(2008-10#1)(2008-11#2)(2012-2#1)
other results of##2##3##(2007-11#1)(2009-4#1)
other results##7##2##(1991-11#1)(1992-6#1)(1995-2#1)(2006-7#1)(2007-11#1)(2008-3#1)(2009-4#1)
other retinal##3##2##(2007-12#1)(2009-4#1)(2011-1#1)
other retroviral integrases##2##3##(1997-3#2)
other retroviral##3##2##(1997-3#2)(2008-5#1)
other rheumatic diseases##2##3##(1991-3#1)(2006-10#1)
other rheumatic##6##2##(1991-3#1)(2006-10#3)(2011-2#2)
other risk factor##2##3##(1993-9#1)(2011-1#1)
other risk factors for##6##4##(1992-8#1)(2006-12#1)(2008-1#1)(2008-3#1)(2012-1#1)(2012-11#1)
other risk factors of##4##4##(1990-9#1)(2008-11#1)(2008-4#1)(2010-9#1)
other risk factors such as##4##5##(1991-10#1)(1996-9#1)(2007-2#1)(2008-7#1)
other risk factors##36##3##(1990-3#1)(1990-9#1)(1991-10#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-9#2)(1996-1#1)(1996-9#2)(2005-10#2)(2005-6#1)(2006-12#1)(2007-10#3)(2007-2#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-6#1)(2010-10#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#1)
other risk##41##2##(1990-3#1)(1990-9#1)(1991-10#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-9#3)(1996-1#1)(1996-9#2)(2005-10#2)(2005-6#1)(2006-12#1)(2007-10#3)(2007-2#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#1)(2013-8#1)
other risks##4##2##(1997-4#1)(2008-7#1)(2009-12#1)(2011-2#1)
other rodents##6##2##(1995-5#1)(1996-11#1)(2008-4#1)(2010-11#2)(2011-2#1)
other routes of##2##3##(2006-10#1)(2007-11#1)
other routes##3##2##(2006-10#1)(2006-6#1)(2007-11#1)
other rural##2##2##(2007-8#1)(2008-7#1)
other safety##2##2##(2005-11#1)(2011-2#1)
other salts##2##2##(2008-5#2)
other samples##6##2##(1997-5#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-4#1)(2012-1#1)
other sampling##3##2##(2008-10#1)(2013-7#2)
other scales##3##2##(2006-4#1)(2008-1#1)(2012-1#1)
other scenarios##3##2##(2006-12#1)(2010-12#1)(2012-12#1)
other schemes##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
other schools##2##2##(2008-12#1)(2008-5#1)
other scientists##4##2##(2007-9#1)(2009-12#1)(2010-1#1)(2010-2#1)
other screening##2##2##(1992-3#1)(2008-10#1)
other seasonal allergens##3##3##(2011-2#3)
other second generation antihistamine agents##2##5##(2007-11#2)
other second generation##3##3##(2007-11#3)
other second##4##2##(1996-10#1)(2007-11#3)
other secondary##4##2##(1990-12#1)(2008-1#1)(2012-1#1)(2012-12#1)
other secretory##3##2##(1990-5#1)(1992-9#1)(1996-1#1)
other sections##2##2##(2006-10#1)(2008-4#1)
other sectors##2##2##(1990-12#1)(2008-11#1)
other seed crops##2##3##(2008-10#1)(2013-8#1)
other seed##3##2##(2008-10#2)(2013-8#1)
other segments of##2##3##(1997-2#1)(2005-10#1)
other segments##3##2##(1990-8#1)(1997-2#1)(2005-10#1)
other selected lanthanides##2##3##(2008-10#2)
other selected##6##2##(1991-12#1)(1995-7#1)(2008-10#2)(2010-5#1)(2011-2#1)
other selective##3##2##(1991-8#1)(1996-2#1)(2008-10#1)
other self-report##2##2##(1995-11#1)(2007-12#1)
other sensors##3##2##(2008-10#2)(2008-3#1)
other sensory##3##2##(1996-6#1)(2007-12#1)(2013-1#1)
other sequelae of##2##3##(2006-11#1)(2011-1#1)
other sequelae##3##2##(2006-11#1)(2007-12#1)(2011-1#1)
other sequence##2##2##(2008-4#1)(2008-7#1)
other sequenced##2##2##(2008-10#1)(2008-7#1)
other sequences##5##2##(1997-2#1)(1997-3#1)(2006-12#1)(2008-8#1)(2009-9#1)
other series of##2##3##(1993-5#1)(2005-11#1)
other series##5##2##(1993-5#1)(1994-7#1)(1995-3#1)(1996-6#1)(2005-11#1)
other serine proteases##6##3##(1991-2#2)(1991-9#1)(1995-5#1)(1995-6#1)(2008-4#1)
other serine##8##2##(1990-5#1)(1991-2#2)(1991-9#1)(1995-5#1)(1995-6#1)(2005-7#1)(2008-4#1)
other serine/threonine##2##2##(1995-2#1)(1996-6#1)
other serious##5##2##(1995-3#1)(2006-10#1)(2008-10#1)(2008-8#1)(2009-7#1)
other serpins##2##2##(1995-5#1)(2008-4#1)
other serum proteins##3##3##(1990-4#2)(1995-2#1)
other serum##4##2##(1990-4#2)(1995-2#1)(2006-2#1)
other service##3##2##(1994-12#1)(2008-11#1)(2012-3#1)
other services##3##2##(1994-1#1)(2008-1#1)(2010-9#1)
other settings##6##2##(1992-1#1)(1994-3#1)(1996-2#1)(1997-2#1)(2008-7#1)(2013-1#1)
other seven##3##2##(1991-4#1)(1991-5#1)(2008-2#1)
other several##2##2##(1992-2#1)(2008-10#1)
other severe##4##2##(2007-12#1)(2010-12#1)(2012-12#1)(2012-2#1)
other sexually transmitted diseases##4##4##(1993-6#1)(1993-9#1)(1997-6#1)(2010-12#1)
other sexually transmitted infections (STIs)##3##5##(2007-7#2)(2012-3#1)
other sexually transmitted infections##9##4##(2007-7#2)(2009-5#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-3#2)
other sexually transmitted##15##3##(1993-6#1)(1993-9#1)(1997-6#1)(2006-10#1)(2007-7#2)(2009-5#2)(2010-12#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-3#2)
other showed##2##2##(1993-6#1)(1994-2#1)
other side effects##4##3##(2006-9#1)(2009-7#1)(2010-7#1)(2013-1#1)
other side of the##6##4##(1993-7#1)(1994-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#1)
other side of##8##3##(1993-7#1)(1994-2#1)(1995-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)
other side##26##2##(1992-3#1)(1993-7#1)(1994-2#1)(1995-11#1)(2005-11#1)(2006-9#3)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
other side-effects##2##2##(2011-12#1)(2011-2#1)
other signal##2##2##(2005-8#1)(2010-8#1)
other signaling pathways##3##3##(2006-10#1)(2007-12#1)(2008-11#1)
other signaling##8##2##(1994-9#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-4#1)(2009-6#2)(2009-8#1)
other signalling##2##2##(1996-2#1)(2008-9#1)
other signals##5##2##(1996-10#1)(1997-3#1)(2006-10#1)(2008-11#1)(2012-12#1)
other significant differences##2##3##(1995-6#1)(1996-7#1)
other significant##14##2##(1990-10#1)(1994-5#1)(1995-6#1)(1996-7#1)(1997-8#1)(2006-1#1)(2007-4#1)(2007-8#1)(2008-1#1)(2009-10#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-3#1)
other signs of##3##3##(1997-1#1)(2008-1#1)(2013-7#1)
other signs##4##2##(1997-1#1)(2008-1#1)(2013-1#1)(2013-7#1)
other similar cases##2##3##(1992-2#1)(1997-3#1)
other similar##12##2##(1990-4#1)(1992-2#1)(1997-2#1)(1997-3#1)(2006-1#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-4#1)(2012-2#1)
other simple##2##2##(1990-5#1)(1995-6#1)
other simultaneous##2##2##(1992-12#1)(2008-3#1)
other single##3##2##(2008-2#1)(2008-8#1)(2011-2#1)
other sisters##2##2##(2011-2#2)
other site##4##2##(1992-12#1)(1993-3#1)(1997-4#1)(2009-8#1)
other sites are##2##3##(1995-6#1)(2008-5#1)
other sites in the##2##4##(2007-2#1)(2013-1#1)
other sites in##4##3##(2006-10#1)(2007-12#1)(2007-2#1)(2013-1#1)
other sites is##2##3##(2010-11#1)(2013-8#1)
other sites of##3##3##(1991-12#1)(1995-11#1)(2006-6#1)
other sites##45##2##(1991-12#2)(1991-9#1)(1992-12#1)(1993-10#1)(1993-2#3)(1994-3#1)(1995-10#1)(1995-11#1)(1995-6#1)(1996-12#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
other situations##9##2##(1991-12#1)(1991-6#1)(2005-10#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2011-10#1)
other six##6##2##(1996-2#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#1)
other skeletal##4##2##(1993-11#1)(2007-2#1)(2008-10#1)(2011-1#1)
other skin diseases##2##3##(1992-6#1)(2007-12#1)
other skin##7##2##(1991-6#1)(1992-6#1)(2006-12#1)(2007-12#2)(2008-5#2)
other skin-derived cell lines##2##4##(2010-7#2)
other small##16##2##(1990-12#1)(1991-1#1)(1993-11#1)(1995-10#1)(1996-7#1)(1996-8#1)(1997-4#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-8#1)(2011-1#1)(2011-12#1)(2011-2#1)
other snake##2##2##(1995-1#1)(1996-2#1)
other so-called##3##2##(2005-11#1)(2007-12#1)(2008-11#1)
other social Hymenoptera##2##3##(2008-8#2)
other social and##2##3##(1994-6#1)(2011-2#1)
other social behaviors##2##3##(2008-10#1)(2009-4#1)
other social##13##2##(1994-6#1)(1997-2#1)(2005-10#1)(2006-3#1)(2006-7#1)(2008-10#1)(2008-12#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-12#1)(2011-2#1)
other societies##2##2##(2012-1#1)(2012-2#1)
other sociodemographic and##2##3##(2005-10#1)(2011-2#1)
other sociodemographic##3##2##(2005-10#1)(2011-2#1)(2012-12#1)
other soft tissue##3##3##(2007-12#1)(2007-8#1)(2008-10#1)
other soft tissues##2##3##(2007-1#1)(2007-11#1)
other soft##5##2##(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)
other soil##2##2##(2008-10#1)(2008-11#1)
other solid organ##2##3##(2005-7#1)(2006-10#1)
other solid##11##2##(1994-10#1)(2005-6#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#3)
other soluble##3##2##(1995-1#1)(2006-2#1)(2008-10#1)
other solvents##6##2##(1993-2#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-4#1)
other somatic##3##2##(1993-5#1)(1996-12#1)(2005-7#1)
other sorbent materials##2##3##(2008-10#2)
other sources is##2##3##(2010-12#1)(2012-12#1)
other sources of funding##2##4##(1994-2#1)(1997-2#1)
other sources of##14##3##(1994-2#1)(1997-2#1)(2008-10#4)(2008-3#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
other sources##38##2##(1990-4#1)(1990-8#1)(1991-3#1)(1992-12#1)(1992-7#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(2006-4#1)(2006-5#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-12#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
other special##3##2##(1996-1#1)(2008-2#1)(2012-2#1)
other specialists and##2##3##(2011-2#1)(2011-3#1)
other specialities##2##2##(1990-10#1)(1996-1#1)
other specialized##2##2##(2006-6#1)(2009-8#1)
other specialties##6##2##(1996-2#1)(2006-6#1)(2007-4#1)(2009-11#1)(2011-7#1)(2012-3#1)
other species and##4##3##(1992-12#1)(1997-9#1)(2008-10#1)(2008-3#1)
other species are present##2##4##(1997-4#1)(2008-10#1)
other species are##4##3##(1997-4#1)(2008-10#1)(2008-4#1)(2008-5#1)
other species as##2##3##(2007-6#1)(2008-4#1)
other species for##2##3##(1994-7#1)(2007-1#1)
other species has##2##3##(2008-10#1)(2008-11#1)
other species in the##2##4##(2008-8#1)(2010-3#1)
other species in##5##3##(2004-4#1)(2008-5#2)(2008-8#1)(2010-3#1)
other species of Phytophthora##2##4##(2008-10#2)
other species of bacteria##2##4##(1992-7#1)(2011-2#1)
other species of plants##2##4##(2008-10#1)(2008-6#1)
other species of the##3##4##(2007-1#1)(2007-3#1)(2013-8#1)
other species of this##3##4##(2007-3#1)(2008-10#1)(2008-9#1)
other species of##29##3##(1992-7#1)(1993-12#1)(1995-5#1)(2004-11#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-3#3)(2008-10#6)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-9#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-2#2)(2013-8#1)
other species showed##3##3##(2007-7#1)(2010-4#1)(2013-1#1)
other species such as##3##4##(1990-10#1)(1990-12#1)(2008-10#1)
other species tested##2##3##(1992-7#1)(2006-8#1)
other species to##2##3##(1993-12#1)(2008-8#1)
other species was##2##3##(1990-5#1)(1994-3#1)
other species##174##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-5#1)(1991-1#1)(1991-10#1)(1991-12#3)(1991-3#2)(1991-4#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-7#2)(1992-9#1)(1993-12#2)(1993-2#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-12#2)(1994-3#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-4#2)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-9#1)(2004-11#1)(2004-4#1)(2005-7#1)(2005-9#1)(2006-5#1)(2006-7#1)(2006-8#3)(2007-1#2)(2007-11#1)(2007-12#7)(2007-3#4)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#20)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#9)(2008-5#11)(2008-6#3)(2008-7#5)(2008-8#9)(2008-9#3)(2009-4#4)(2009-5#1)(2009-8#2)(2010-11#1)(2010-3#3)(2010-4#1)(2010-8#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-2#2)(2012-5#1)(2013-1#2)(2013-7#1)(2013-8#3)
other species)##2##2##(1997-2#1)(2012-2#1)
other specific##8##2##(1991-4#1)(1993-8#1)(1995-11#1)(1996-12#1)(2007-1#1)(2007-2#1)(2008-10#1)(2008-8#1)
other specimens##3##2##(1994-6#1)(2007-4#1)(2008-5#1)
other spectra##2##2##(2007-12#1)(2012-1#1)
other spectral regions##2##3##(2008-3#2)
other spectral##3##2##(2008-3#2)(2008-7#1)
other spectroscopic##2##2##(2008-10#1)(2008-4#1)
other speech##2##2##(2008-4#2)
other spinal##2##2##(2007-11#1)(2011-2#1)
other spinicaudatans##2##2##(2007-12#2)
other spirochetes##2##2##(1990-2#1)(2008-9#1)
other squamous##2##2##(1992-9#1)(1994-6#1)
other stages of the##2##4##(2008-4#1)(2009-10#1)
other stages of##3##3##(2008-4#1)(2009-10#1)(2009-8#1)
other stages##7##2##(2006-10#1)(2007-3#1)(2008-1#1)(2008-4#1)(2009-10#1)(2009-8#1)(2011-2#1)
other standard##6##2##(1993-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-2#1)(2010-5#1)
other states##9##2##(1992-1#1)(1994-9#1)(1996-12#2)(1996-6#1)(1997-1#1)(2006-7#1)(2007-10#1)(2008-10#1)
other statins##4##2##(2006-5#1)(2008-5#3)
other stem##2##2##(2008-9#1)(2009-3#1)
other steps in the##2##4##(1991-10#1)(2011-2#1)
other steps##3##2##(1991-10#1)(2009-2#1)(2011-2#1)
other steroid##2##2##(1991-12#1)(1992-5#1)
other steroid-producing cells##2##3##(2005-8#2)
other steroids and##2##3##(1994-9#1)(1995-12#1)
other steroids##4##2##(1992-5#1)(1994-9#1)(1995-12#1)(2007-11#1)
other stimuli##9##2##(1990-5#1)(1991-11#1)(1991-7#2)(2005-7#1)(2008-3#1)(2008-4#1)(2009-10#2)
other strain##2##2##(1991-8#1)(2009-9#1)
other strains and##2##3##(2008-10#1)(2008-5#1)
other strains by##2##3##(2008-10#2)
other strains of mice##2##4##(1991-10#2)
other strains of##11##3##(1991-10#2)(1991-12#1)(1995-5#1)(2005-7#1)(2008-10#4)(2008-7#2)
other strains were##2##3##(2006-5#1)(2008-10#1)
other strains##34##2##(1990-2#1)(1991-10#2)(1991-12#1)(1993-2#1)(1995-5#1)(1995-9#1)(2005-7#1)(2006-5#1)(2006-8#2)(2008-10#14)(2008-12#1)(2008-5#2)(2008-7#2)(2008-9#1)(2011-1#1)(2012-12#1)(2012-3#1)
other strategies##5##2##(2008-1#2)(2008-11#1)(2010-7#1)(2012-12#1)
other stress##4##2##(1995-12#1)(2008-12#1)(2008-2#1)(2008-7#1)
other stresses##2##2##(1994-11#1)(2008-7#1)
other stressors##4##2##(1990-3#1)(1996-12#1)(2008-11#1)(2011-2#1)
other striatal##2##2##(1991-2#1)(1993-12#1)
other strong##2##2##(2006-4#1)(2008-8#1)
other structural abnormalities##2##3##(2007-12#1)(2008-11#1)
other structural##13##2##(1991-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1994-8#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-9#1)(2012-12#1)
other structurally related##3##3##(1995-1#1)(1997-8#1)(2008-7#1)
other structurally similar##3##3##(1990-8#1)(2008-7#1)(2008-8#1)
other structurally##7##2##(1990-8#1)(1994-5#1)(1995-1#1)(1997-8#1)(2008-7#2)(2008-8#1)
other structure##2##2##(1992-5#1)(2008-6#1)
other structures in##2##3##(2007-11#1)(2013-8#1)
other structures##6##2##(1993-12#2)(1994-2#1)(2007-11#1)(2012-2#1)(2013-8#1)
other students##3##2##(2007-1#1)(2008-11#2)
other studied##3##2##(2006-6#1)(2007-7#1)(2008-5#1)
other studies and##3##3##(1995-7#1)(2006-10#1)(2007-5#1)
other studies have suggested that##2##5##(1994-10#1)(1994-6#1)
other studies have##6##3##(1994-10#1)(1994-6#1)(2006-2#1)(2007-1#1)(2007-4#1)(2010-10#1)
other studies in which##2##4##(1991-8#1)(2013-8#1)
other studies in##5##3##(1991-8#1)(1994-1#1)(2009-8#1)(2013-7#1)(2013-8#1)
other studies of##4##3##(1990-5#1)(1993-8#1)(2008-9#1)(2011-2#1)
other studies on##5##3##(1994-2#1)(2007-12#1)(2008-2#1)(2008-5#1)(2010-4#1)
other studies suggest##2##3##(1996-1#1)(2005-11#1)
other studies that##3##3##(2006-11#1)(2007-2#1)(2008-3#1)
other studies to##2##3##(1994-9#1)(2008-5#1)
other studies using##2##3##(1992-9#1)(2010-2#1)
other studies we##2##3##(2008-12#1)(2008-3#1)
other studies##89##2##(1990-5#1)(1990-9#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-9#2)(1993-10#1)(1993-11#1)(1993-8#1)(1994-1#1)(1994-10#2)(1994-2#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-7#1)(1996-1#1)(1997-4#1)(1997-5#1)(1997-9#1)(2005-11#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-2#4)(2007-4#1)(2007-5#1)(2007-6#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#2)(2008-9#2)(2009-12#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-2#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
other study##2##2##(2007-8#1)(2008-10#1)
other subcellular organelles##2##3##(1990-11#1)(2008-4#1)
other subcellular##3##2##(1990-11#1)(2008-4#1)(2008-9#1)
other subcutaneous WAT depots##2##4##(2011-12#2)
other subcutaneous##3##2##(2011-12#3)
other subjects in the##2##4##(2010-11#1)(2011-2#1)
other subjects##10##2##(1991-2#1)(1991-8#1)(1995-9#1)(1996-6#1)(2006-8#1)(2008-10#2)(2008-5#1)(2010-11#1)(2011-2#1)
other subsets##2##2##(2008-10#2)
other substances such as##2##4##(1992-11#1)(1994-6#1)
other substances which##2##3##(1996-1#1)(2008-10#1)
other substances##18##2##(1991-3#1)(1992-11#1)(1994-6#1)(1996-1#1)(2006-9#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-5#1)
other substitutions##2##2##(1994-3#1)(1996-4#1)
other substrates##11##2##(1990-10#1)(1990-11#1)(1991-9#1)(1993-6#1)(1994-8#1)(1995-3#1)(1996-3#1)(2008-11#1)(2008-5#1)(2009-3#1)(2011-1#1)
other subtypes##8##2##(1991-12#1)(1992-7#1)(1996-12#1)(1997-5#1)(2008-8#1)(2010-6#1)(2012-2#1)(2013-1#1)
other subunit##2##2##(1992-1#1)(1993-11#1)
other subunits##6##2##(1991-5#1)(1994-9#1)(1996-5#1)(2005-8#1)(2009-2#1)(2009-9#1)
other such##7##2##(1995-2#1)(1997-3#1)(2004-3#1)(2007-2#1)(2008-4#1)(2008-5#1)(2008-6#1)
other sugars##4##2##(1990-2#1)(1992-4#1)(1995-8#2)
other suggests that##2##3##(1997-8#1)(2009-5#1)
other supporting##2##2##(2005-10#1)(2011-2#1)
other supportive measures##2##3##(2011-2#1)(2013-1#1)
other supportive therapy##2##3##(2007-7#2)
other supportive##5##2##(1993-10#1)(2007-7#2)(2011-2#1)(2013-1#1)
other surface##5##2##(1990-8#1)(1993-4#1)(2005-11#1)(2006-10#1)(2011-1#1)
other surfaces##2##2##(1992-8#1)(2008-5#1)
other surfactants##2##2##(2005-11#1)(2008-6#1)
other surgical and##2##3##(1990-6#1)(1994-3#1)
other surgical procedures##6##3##(1991-8#1)(1992-6#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-9#1)
other surgical techniques##3##3##(2006-12#1)(2007-8#1)(2012-3#1)
other surgical##14##2##(1990-6#1)(1991-8#1)(1992-6#1)(1994-3#1)(2006-10#2)(2006-12#2)(2006-3#1)(2007-5#1)(2007-8#2)(2007-9#1)(2012-3#1)
other surveys##2##2##(1997-4#1)(2006-4#1)
other susceptible##3##2##(2007-5#1)(2008-10#2)
other symptomatology##2##2##(1996-5#1)(2011-2#1)
other symptoms of##5##3##(1994-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-7#1)
other symptoms related to##2##4##(1997-5#1)(2008-5#1)
other symptoms##23##2##(1991-4#2)(1993-8#1)(1994-2#1)(1997-5#1)(2006-10#3)(2006-8#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-1#2)(2009-7#1)(2011-2#2)(2012-3#1)(2013-7#1)
other syndromes##6##2##(1993-12#1)(1996-12#1)(2006-10#1)(2007-3#1)(2010-1#1)(2011-2#1)
other synthetic##5##2##(1992-12#1)(1992-6#1)(1995-2#1)(1995-7#1)(2008-5#1)
other systemic diseases##2##3##(2006-10#1)(2007-11#1)
other systemic##11##2##(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-8#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
other systems are##2##3##(2005-8#1)(2008-5#1)
other systems in the##2##4##(1995-2#1)(2005-11#1)
other systems in##4##3##(1993-12#1)(1995-2#1)(2005-11#1)(2007-4#1)
other systems##38##2##(1991-2#1)(1991-6#1)(1992-3#2)(1993-12#1)(1994-10#1)(1994-3#1)(1995-10#1)(1995-2#1)(1995-4#1)(1996-1#1)(1996-5#1)(1997-7#1)(2005-11#2)(2005-8#1)(2006-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-6#1)(2010-4#1)(2010-9#1)
other target genes##2##3##(1996-12#1)(2011-1#1)
other target##4##2##(1995-2#1)(1996-12#1)(2006-11#1)(2011-1#1)
other targeted##2##2##(2008-2#1)(2010-12#1)
other targets##3##2##(1992-8#1)(1997-4#1)(2011-2#1)
other tasks##4##2##(1992-9#1)(2010-12#1)(2012-2#1)(2013-1#1)
other taxa in the genus##2##5##(2008-10#2)
other taxa##7##2##(2006-8#1)(2007-12#1)(2008-10#3)(2008-8#1)(2009-4#1)
other technique##3##2##(2008-10#2)(2008-11#1)
other techniques and##3##3##(2007-11#1)(2008-10#1)(2008-9#1)
other techniques for##3##3##(2008-2#1)(2008-9#1)(2013-7#1)
other techniques such as##3##4##(1996-8#1)(2008-2#1)(2012-12#1)
other techniques##45##2##(1990-10#1)(1990-6#1)(1991-11#1)(1991-2#1)(1994-2#1)(1995-4#1)(1996-8#1)(1997-3#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#7)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-4#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
other technological##2##2##(2008-7#1)(2009-11#1)
other technologies##6##2##(1993-2#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
other teleost##2##2##(2008-5#1)(2012-12#1)
other teleosts##3##2##(2007-3#1)(2007-9#1)(2009-4#1)
other ten##2##2##(1994-6#1)(2007-7#1)
other term##2##2##(2008-10#1)(2008-2#1)
other terms##2##2##(2008-5#1)(2011-2#1)
other terpenoids##2##2##(2006-12#2)
other test##3##2##(1997-8#1)(2007-4#1)(2008-10#1)
other tested##6##2##(1991-3#1)(1991-5#1)(1993-9#1)(1997-4#1)(2006-8#1)(2008-10#1)
other tests of##4##3##(1990-3#1)(2007-3#2)(2011-2#1)
other tests##12##2##(1990-3#1)(1995-9#1)(1996-7#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-3#2)(2007-7#1)(2008-1#1)(2008-5#1)(2011-2#1)
other texts##2##2##(2007-5#1)(2008-5#1)
other than Al(3+)##2##3##(2008-10#2)
other than C##2##3##(2007-12#1)(2008-4#1)
other than English##3##3##(1996-3#1)(2009-8#1)(2011-1#1)
other than P##2##3##(2005-8#1)(2008-10#1)
other than PKC##2##3##(1995-3#1)(1995-5#1)
other than a##6##3##(1996-10#1)(1996-4#1)(2004-3#1)(2005-12#1)(2007-2#1)(2013-8#1)
other than acetylglutamate##2##3##(1990-2#2)
other than an##4##3##(1997-7#1)(2006-10#1)(2010-12#1)(2012-2#1)
other than antibiosis##2##3##(2008-10#2)
other than at##2##3##(1992-9#1)(2013-1#1)
other than breast cancer##2##4##(1991-10#1)(1991-12#1)
other than breast##3##3##(1991-10#1)(1991-12#1)(1993-6#1)
other than classical##2##3##(1990-9#1)(2008-7#1)
other than differences##2##3##(2004-4#1)(2008-11#1)
other than human##2##3##(2006-10#1)(2008-6#1)
other than in Wilson's disease##2##5##(2008-9#2)
other than iron##2##3##(1994-3#1)(2013-7#1)
other than or in addition to##2##6##(1995-8#1)(1997-2#1)
other than sodium##2##3##(1993-11#1)(1995-12#1)
other than surgery##2##3##(2007-8#1)(2010-12#1)
other than that of the##2##5##(2008-3#1)(2008-6#1)
other than that of##3##4##(2007-6#1)(2008-3#1)(2008-6#1)
other than that##5##3##(1997-4#1)(2007-6#1)(2008-3#1)(2008-6#1)(2012-12#1)
other than the LAD##2##4##(2005-12#2)
other than the PCL##2##4##(2007-1#2)
other than the one##2##4##(1995-8#1)(2004-12#1)
other than the##64##3##(1990-5#1)(1991-10#1)(1991-12#1)(1992-10#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-10#1)(1994-12#2)(1994-8#1)(1995-1#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-4#1)(1997-8#1)(2004-12#1)(2005-12#2)(2005-8#2)(2006-10#2)(2006-11#1)(2006-6#1)(2007-1#3)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-2#3)(2008-5#1)(2008-7#2)(2009-8#1)(2012-2#1)(2013-1#2)(2013-8#2)
other than their##4##3##(1995-6#1)(2006-6#1)(2008-9#1)(2010-8#1)
other than those in stage##2##5##(2007-8#2)
other than those##10##3##(1992-11#1)(1993-9#1)(1994-3#1)(1997-5#1)(2004-4#1)(2006-10#1)(2007-8#3)(2008-5#1)
other than through##2##3##(1997-1#1)(2008-10#1)
other than type##2##3##(1991-1#1)(1992-12#1)
other than##343##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#5)(1990-4#2)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#2)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#3)(1991-7#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#3)(1992-8#1)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#2)(1993-6#2)(1993-8#3)(1993-9#1)(1994-10#1)(1994-12#3)(1994-3#3)(1994-4#1)(1994-5#2)(1994-8#3)(1994-9#4)(1995-1#4)(1995-11#4)(1995-12#3)(1995-2#6)(1995-3#2)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#6)(1995-9#1)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#3)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#4)(2004-1#1)(2004-12#2)(2004-2#1)(2004-3#1)(2004-4#2)(2005-10#2)(2005-12#3)(2005-7#2)(2005-8#3)(2006-10#7)(2006-11#1)(2006-12#1)(2006-2#2)(2006-5#3)(2006-6#3)(2007-1#3)(2007-11#3)(2007-12#7)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#3)(2007-7#6)(2007-8#11)(2007-9#1)(2008-1#2)(2008-10#31)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#10)(2008-6#3)(2008-7#7)(2008-8#7)(2008-9#4)(2009-10#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#3)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-4#2)(2010-8#5)(2011-1#4)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#4)
other the##7##2##(1991-5#1)(1992-10#1)(1993-7#1)(1993-8#1)(1996-9#1)(2007-12#1)(2008-3#1)
other therapeutic agents##4##3##(2007-11#1)(2008-5#2)(2013-1#1)
other therapeutic approaches##3##3##(2006-10#1)(2008-11#1)(2008-6#1)
other therapeutic strategies##2##3##(2010-12#1)(2012-12#1)
other therapeutic##16##2##(1992-9#1)(1993-3#1)(1996-1#1)(1996-2#1)(2006-10#2)(2007-11#1)(2007-8#1)(2008-11#1)(2008-5#2)(2008-6#1)(2009-2#1)(2010-12#1)(2012-12#1)(2013-1#1)
other therapies##8##2##(1990-5#1)(2005-8#1)(2006-12#2)(2008-5#1)(2008-8#1)(2010-8#1)(2012-3#1)
other therapy##2##2##(2008-5#1)(2008-8#1)
other things##20##2##(1990-2#1)(1991-10#1)(1992-12#1)(1993-10#1)(1993-11#1)(1993-4#1)(1994-2#1)(1996-3#1)(1996-6#1)(2006-2#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#1)(2010-12#1)
other thiol##2##2##(1997-2#1)(2008-4#1)
other thiols##3##2##(1990-3#1)(1991-9#2)
other third-party payers##2##3##(1994-12#1)(2006-10#1)
other thoracic##2##2##(2007-8#1)(2010-8#1)
other three##55##2##(1990-3#2)(1992-4#1)(1992-7#1)(1993-2#1)(1993-5#1)(1994-12#1)(1994-8#2)(1994-9#1)(1997-1#1)(1997-5#1)(1997-6#2)(2006-5#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#3)(2009-3#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-12#1)(2012-3#2)(2013-8#2)
other through##3##2##(2008-12#1)(2008-3#1)(2009-9#1)
other time##5##2##(1997-8#1)(2007-10#1)(2008-5#1)(2010-5#1)(2013-1#1)
other times it##2##3##(1993-3#1)(1995-3#1)
other times the AS instructs the epidermis##2##7##(2012-12#2)
other times##13##2##(1993-3#1)(1995-12#1)(1995-3#1)(1995-7#1)(2006-12#1)(2008-10#1)(2009-4#1)(2009-8#1)(2010-7#1)(2012-12#4)
other tissue##12##2##(1990-7#1)(1996-8#2)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-6#1)(2011-1#1)
other tissues and##2##3##(1994-12#1)(2008-1#1)
other tissues examined##3##3##(1993-7#1)(1994-6#1)(1997-4#1)
other tissues of the##2##4##(1995-1#1)(2008-4#1)
other tissues of##5##3##(1991-6#1)(1994-2#1)(1995-1#1)(1995-3#1)(2008-4#1)
other tissues such as##2##4##(2008-1#1)(2008-5#1)
other tissues##71##2##(1990-11#1)(1990-12#1)(1990-3#2)(1990-4#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#2)(1991-8#3)(1992-12#1)(1992-3#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-9#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#2)(1995-1#2)(1995-10#2)(1995-12#1)(1995-3#3)(1995-8#1)(1996-10#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-2#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-4#5)(2008-5#1)(2008-6#1)(2008-9#2)(2009-3#1)(2009-4#1)(2010-3#1)(2010-5#1)
other to allow##2##3##(2009-2#1)(2012-2#1)
other to##31##2##(1990-2#1)(1991-1#1)(1991-2#1)(1992-4#1)(1995-2#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
other tobacco##2##2##(1996-11#1)(2008-8#1)
other tobacco-related##2##2##(1990-10#1)(1990-4#1)
other tools##2##2##(2008-7#1)(2011-2#1)
other topics covered##2##3##(2005-8#1)(2006-10#1)
other topics##5##2##(1992-9#1)(1996-2#1)(2005-8#1)(2005-9#1)(2006-10#1)
other tospoviruses##7##2##(2008-10#7)
other toxic##3##2##(2007-10#1)(2008-10#1)(2008-11#1)
other toxicities##2##2##(2006-12#1)(2008-7#1)
other toxins##3##2##(1993-10#1)(2007-6#1)(2008-10#1)
other trace elements##2##3##(1996-7#1)(2004-4#1)
other traditional##7##2##(2006-10#1)(2006-11#1)(2008-11#1)(2008-4#1)(2009-5#1)(2010-12#1)(2013-1#1)
other transcription factors required for##2##5##(1990-5#1)(2008-9#1)
other transcription factors##10##3##(1990-5#1)(1991-12#1)(1994-12#1)(1996-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
other transcription##11##2##(1990-5#1)(1991-12#1)(1994-12#1)(1996-10#1)(2007-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
other transcriptional##4##2##(1993-12#1)(1993-6#1)(1996-4#1)(2007-12#1)
other transcripts##2##2##(1994-9#1)(2008-7#1)
other transfection methods##2##3##(2008-1#1)(2008-4#1)
other transfection##3##2##(2008-1#1)(2008-11#1)(2008-4#1)
other transgenic lines##2##3##(2006-12#1)(2008-12#1)
other transgenic##3##2##(2006-12#1)(2008-10#1)(2008-12#1)
other transient##2##2##(1996-4#1)(2008-4#1)
other transition metal##3##3##(2008-10#2)(2008-12#1)
other traumatic##3##2##(2009-5#1)(2009-6#1)(2013-1#1)
other treatment groups##2##3##(1994-5#1)(1995-3#1)
other treatment modalities##12##3##(1991-9#2)(1993-2#1)(1995-11#1)(2004-1#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-4#1)(2007-8#1)(2009-9#1)(2010-5#1)
other treatment options##6##3##(1993-11#1)(1996-3#1)(2009-6#1)(2011-1#1)(2012-12#1)(2012-2#1)
other treatment##32##2##(1991-4#1)(1991-9#2)(1992-1#1)(1993-11#1)(1993-2#1)(1994-5#1)(1995-11#1)(1995-3#1)(1996-3#1)(2004-1#1)(2004-3#1)(2005-11#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-4#1)(2007-8#2)(2008-10#1)(2008-5#2)(2009-6#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
other treatments##25##2##(2004-10#4)(2006-5#1)(2007-1#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-8#1)
other trials with##2##3##(1997-3#1)(2011-2#1)
other trials##9##2##(1992-6#1)(1996-6#1)(1997-3#1)(2007-2#1)(2007-3#1)(2007-9#1)(2011-2#1)(2012-1#2)
other trophic##2##2##(2007-7#1)(2008-5#1)
other tropical regions##3##3##(2007-3#2)(2008-5#1)
other tropical##8##2##(2007-3#4)(2007-5#1)(2008-3#1)(2008-5#2)
other tumor markers##2##3##(1991-8#1)(1995-4#1)
other tumor types##2##3##(1990-12#1)(2008-6#1)
other tumor##13##2##(1990-12#1)(1991-8#1)(1992-7#1)(1993-11#1)(1995-4#1)(2007-3#1)(2008-6#2)(2009-3#1)(2009-6#1)(2010-8#1)(2011-1#1)(2012-2#1)
other tumors of##3##3##(1992-9#1)(2006-12#1)(2011-2#1)
other tumors##18##2##(1991-2#1)(1992-9#1)(1994-12#1)(1996-4#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-11#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
other tumour##2##2##(1990-10#1)(2011-2#1)
other tumours##2##2##(2008-7#1)(2010-3#1)
other twin##2##2##(2010-1#1)(2010-8#1)
other two clones##2##3##(1993-2#1)(1994-12#1)
other two enzymes##2##3##(1990-7#1)(1997-7#1)
other two groups in##2##4##(2008-10#1)(2011-2#1)
other two groups##19##3##(1991-11#1)(1993-4#1)(1997-5#2)(2006-9#1)(2007-1#1)(2007-8#1)(2008-10#4)(2008-7#1)(2010-7#2)(2011-12#1)(2011-2#2)(2011-3#1)(2013-1#1)
other two patients##6##3##(1990-12#1)(2006-12#1)(2006-6#1)(2007-7#1)(2012-2#1)(2013-1#1)
other two##136##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-6#1)(1990-7#2)(1991-11#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-4#2)(1993-6#1)(1994-12#2)(1994-3#1)(1994-4#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#3)(1995-3#4)(1995-4#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-5#3)(1997-7#1)(2004-11#1)(2005-11#3)(2006-12#2)(2006-6#2)(2006-7#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#23)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#3)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-6#1)(2010-7#2)(2011-1#4)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
other type I##3##3##(1994-9#1)(2007-11#1)(2008-10#1)
other type II##2##3##(1990-7#1)(1997-5#1)
other type of##6##3##(2007-4#1)(2008-10#1)(2008-11#1)(2008-4#2)(2013-1#1)
other type##14##2##(1990-7#1)(1992-8#1)(1993-9#1)(1994-9#1)(1997-5#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2013-1#1)
other types of cancer##3##4##(1997-7#1)(2007-11#1)(2008-8#1)
other types of cells##6##4##(1991-9#1)(1995-3#1)(2005-1#1)(2008-12#1)(2008-4#2)
other types of molecular##2##4##(1993-7#1)(2008-9#1)
other types of neurons##2##4##(1990-2#1)(2007-10#1)
other types of stress##2##4##(1995-3#1)(2007-11#1)
other types of##94##3##(1990-11#1)(1990-2#1)(1990-3#2)(1990-6#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-9#2)(1993-11#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-10#1)(1994-2#1)(1994-9#1)(1995-3#2)(1995-6#1)(1996-12#1)(1997-7#1)(2004-11#1)(2005-1#1)(2005-10#1)(2005-7#1)(2006-5#1)(2006-8#4)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#3)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-8#2)(2010-9#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
other types##102##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#2)(1990-6#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-9#2)(1993-11#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-10#1)(1994-2#1)(1994-9#1)(1995-3#2)(1995-6#1)(1996-12#1)(1997-7#1)(2004-11#1)(2005-1#1)(2005-10#1)(2005-7#1)(2006-5#1)(2006-8#4)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#3)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#4)(2009-1#1)(2009-10#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-8#2)(2010-9#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
other types) and##2##3##(2008-12#1)(2011-2#1)
other uncharacterized##2##2##(2008-4#1)(2010-10#1)
other underlying##3##2##(2004-11#1)(2005-8#1)(2008-7#1)
other unexplained##2##2##(2010-7#1)(2012-2#1)
other unidentified##6##2##(1997-6#1)(1997-7#1)(2007-6#1)(2008-5#1)(2009-3#1)(2010-8#1)
other unique##3##2##(1993-8#1)(2008-10#1)(2010-7#1)
other units##2##2##(2008-9#1)(2012-2#1)
other unknown##4##2##(1993-6#1)(2010-12#1)(2012-3#2)
other unrelated##3##2##(1997-3#1)(2008-1#1)(2012-2#1)
other urinary##3##2##(1990-2#1)(1990-9#1)(1996-8#1)
other urological##2##2##(1990-4#1)(2008-10#1)
other useful##4##2##(1993-12#1)(2008-1#1)(2008-11#1)(2008-2#1)
other uses##5##2##(2008-4#1)(2008-7#1)(2009-3#1)(2010-5#1)(2012-1#1)
other using##2##2##(2008-10#2)
other vaccines##5##2##(1991-5#1)(1994-9#1)(1997-7#1)(2007-2#1)(2008-5#1)
other variable##2##2##(1994-8#1)(1995-10#1)
other variables such as##2##4##(1990-2#1)(2006-12#1)
other variables were##2##3##(1991-12#1)(1994-9#1)
other variables##35##2##(1990-2#1)(1991-12#1)(1991-6#1)(1991-7#1)(1994-9#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-3#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-4#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
other variants of##2##3##(1991-7#1)(2007-11#1)
other variants##5##2##(1991-7#1)(1994-12#1)(1994-2#1)(2007-11#1)(2008-10#1)
other various##4##2##(1997-4#1)(2008-10#1)(2008-9#1)(2011-2#1)
other vascular##9##2##(1991-3#1)(1997-8#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-8#1)(2009-8#1)(2010-6#1)
other vasoactive##2##2##(1991-12#1)(1993-12#1)
other vectors##3##2##(1990-9#1)(2008-4#1)(2010-8#1)
other vertebrate##7##2##(1990-11#1)(1993-6#1)(1996-7#1)(2006-8#1)(2008-5#1)(2008-8#1)(2010-3#1)
other vertebrates##5##2##(1993-6#1)(1995-2#2)(1996-11#1)(1997-5#1)
other viral infections##2##3##(2007-11#1)(2008-1#1)
other viral##9##2##(1994-9#2)(1997-8#1)(2007-11#1)(2008-1#1)(2008-3#1)(2012-2#2)(2013-1#1)
other virulence factors##2##3##(2006-10#1)(2012-11#1)
other virus##3##2##(2008-10#1)(2008-5#1)(2012-11#1)
other viruses##13##2##(1997-1#4)(1997-6#1)(2007-12#1)(2008-10#4)(2008-5#1)(2010-12#1)(2012-2#1)
other visceral##3##2##(2007-8#1)(2008-7#1)(2013-8#1)
other visual##5##2##(1990-10#1)(1993-11#1)(1993-2#1)(1993-6#1)(2009-9#1)
other vitamin K-dependent proteins##2##4##(1997-4#2)
other vitamin K-dependent##3##3##(1995-1#1)(1997-4#2)
other volatile##2##2##(2006-10#1)(2008-10#1)
other was##25##2##(1991-3#1)(1991-4#1)(1992-11#2)(1993-3#2)(1996-11#1)(1997-8#1)(2004-9#2)(2006-10#1)(2006-7#1)(2007-1#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-5#2)(2010-9#1)(2012-2#1)(2013-1#2)
other wavelengths##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
other weapons##2##2##(1997-2#1)(2008-2#1)
other well##2##2##(1994-9#1)(2008-2#1)
other well-characterized##3##2##(1991-12#1)(1996-7#1)(2008-4#1)
other well-known##2##2##(1990-12#1)(2008-2#1)
other well-studied##3##2##(1995-6#1)(2008-7#1)(2012-2#1)
other western##2##2##(1990-4#1)(2012-1#1)
other which##7##2##(1990-5#1)(1990-8#2)(1992-1#1)(1994-8#1)(1995-6#1)(1997-6#1)
other widely used##2##3##(1991-12#1)(1996-9#1)
other wine##2##2##(1995-3#1)(2008-10#1)
other with a##6##3##(1997-6#1)(2006-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-10#1)
other with##33##2##(1990-3#1)(1991-10#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-6#1)(1994-9#1)(1997-6#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
other within the##3##3##(1997-4#2)(2006-12#1)
other within##4##2##(1997-4#2)(2006-12#1)(2007-5#1)
other women##5##2##(1994-5#1)(1996-12#1)(1996-4#1)(2006-8#1)(2007-12#1)
other words##29##2##(1994-3#1)(1995-3#1)(1996-1#1)(1997-1#1)(2005-10#1)(2005-11#1)(2006-4#1)(2007-3#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#2)(2010-12#1)(2010-8#1)(2011-12#1)(2012-1#2)(2012-2#1)(2012-3#2)(2013-8#1)
other work##3##2##(1991-5#1)(1993-12#1)(2009-5#1)
other work-related##3##2##(1997-3#1)(2006-2#2)
other workers have##2##3##(2007-8#1)(2011-1#1)
other workers##12##2##(1990-2#1)(1991-11#1)(1993-4#1)(1996-1#1)(1996-11#1)(1996-12#1)(2006-6#1)(2007-2#1)(2007-8#1)(2008-7#1)(2008-8#1)(2011-1#1)
other works##3##2##(1994-1#1)(2008-10#1)(2010-12#1)
other xenobiotics##2##2##(1997-8#1)(2010-2#1)
other years##2##2##(2007-5#1)(2008-5#1)
other yet##2##2##(1990-11#1)(1996-8#1)
other young children##2##3##(1991-6#1)(2006-2#1)
other zinc##2##2##(2008-10#2)
other##14076##1##(1990-1#4)(1990-10#38)(1990-11#44)(1990-12#76)(1990-2#64)(1990-3#48)(1990-4#45)(1990-5#60)(1990-6#39)(1990-7#42)(1990-8#43)(1990-9#37)(1991-1#37)(1991-10#34)(1991-11#30)(1991-12#86)(1991-2#80)(1991-3#49)(1991-4#54)(1991-5#51)(1991-6#38)(1991-7#38)(1991-8#47)(1991-9#52)(1992-1#31)(1992-10#24)(1992-11#35)(1992-12#53)(1992-2#52)(1992-3#50)(1992-4#26)(1992-5#30)(1992-6#45)(1992-7#33)(1992-8#68)(1992-9#50)(1993-1#25)(1993-10#18)(1993-11#57)(1993-12#77)(1993-2#56)(1993-3#54)(1993-4#25)(1993-5#21)(1993-6#57)(1993-7#21)(1993-8#41)(1993-9#51)(1994-1#16)(1994-10#19)(1994-11#28)(1994-12#74)(1994-2#60)(1994-3#83)(1994-4#13)(1994-5#53)(1994-6#59)(1994-7#11)(1994-8#74)(1994-9#78)(1995-1#67)(1995-10#15)(1995-11#53)(1995-12#60)(1995-2#90)(1995-3#88)(1995-4#25)(1995-5#38)(1995-6#61)(1995-7#16)(1995-8#61)(1995-9#23)(1996-1#61)(1996-10#36)(1996-11#36)(1996-12#98)(1996-2#57)(1996-3#65)(1996-4#37)(1996-5#87)(1996-6#53)(1996-7#45)(1996-8#52)(1996-9#38)(1997-1#57)(1997-2#94)(1997-3#68)(1997-4#95)(1997-5#55)(1997-6#56)(1997-7#55)(1997-8#61)(1997-9#3)(2004-1#4)(2004-10#9)(2004-11#17)(2004-12#10)(2004-2#4)(2004-3#8)(2004-4#16)(2004-7#2)(2004-8#1)(2004-9#8)(2005-1#7)(2005-10#54)(2005-11#90)(2005-12#19)(2005-3#5)(2005-4#11)(2005-5#1)(2005-6#6)(2005-7#47)(2005-8#69)(2005-9#20)(2006-1#13)(2006-10#255)(2006-11#30)(2006-12#103)(2006-2#60)(2006-3#20)(2006-4#29)(2006-5#51)(2006-6#61)(2006-7#40)(2006-8#119)(2006-9#28)(2007-1#47)(2007-10#67)(2007-11#232)(2007-12#231)(2007-2#102)(2007-3#76)(2007-4#71)(2007-5#35)(2007-6#44)(2007-7#131)(2007-8#184)(2007-9#69)(2008-1#188)(2008-10#1314)(2008-11#306)(2008-12#124)(2008-2#237)(2008-3#287)(2008-4#318)(2008-5#392)(2008-6#126)(2008-7#308)(2008-8#244)(2008-9#198)(2009-1#8)(2009-10#62)(2009-11#32)(2009-12#39)(2009-2#32)(2009-3#49)(2009-4#63)(2009-5#58)(2009-6#48)(2009-7#40)(2009-8#83)(2009-9#46)(2010-1#23)(2010-10#35)(2010-11#43)(2010-12#152)(2010-2#75)(2010-3#41)(2010-4#53)(2010-5#57)(2010-6#39)(2010-7#48)(2010-8#100)(2010-9#29)(2011-1#158)(2011-10#3)(2011-11#4)(2011-12#47)(2011-2#337)(2011-3#7)(2011-7#2)(2011-9#1)(2012-1#89)(2012-11#38)(2012-12#165)(2012-2#237)(2012-3#157)(2012-4#1)(2012-5#3)(2012-6#2)(2013-1#280)(2013-4#1)(2013-7#73)(2013-8#158)
other&quot##2##1##(2007-9#1)(2008-11#1)
other's##19##1##(1991-7#1)(1995-11#1)(1995-5#1)(1996-12#2)(1996-7#1)(2006-3#1)(2006-5#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-4#1)(2009-6#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-8#1)
other) were##3##2##(1990-3#1)(2013-1#2)
other)##12##1##(1990-12#1)(1990-3#1)(1996-9#1)(2007-2#1)(2008-7#2)(2008-8#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
other-evaluative##2##1##(2013-8#2)
other-race faces##2##2##(2009-4#2)
other-race##3##1##(2008-11#1)(2009-4#2)
others (e##2##2##(2007-12#1)(2010-2#1)
others (i##3##2##(1991-7#1)(2008-10#1)(2009-12#1)
others a##4##2##(1995-5#1)(2008-11#1)(2008-12#1)(2008-4#1)
others all##2##2##(1992-3#1)(2009-5#1)
others and the##3##3##(1996-5#1)(2008-2#1)(2011-2#1)
others and##23##2##(1991-8#1)(1994-1#1)(1996-5#2)(1996-9#1)(2005-6#1)(2005-7#1)(2005-9#1)(2006-7#1)(2006-8#1)(2007-12#2)(2008-2#2)(2008-4#1)(2009-5#1)(2009-9#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-7#2)
others appear##3##2##(1991-3#1)(1994-8#1)(2009-5#1)
others are located##2##3##(1994-12#1)(1994-8#1)
others are not##4##3##(2006-10#2)(2010-8#1)(2013-8#1)
others are specific for the##2##5##(1995-8#1)(2013-8#1)
others are##47##2##(1990-7#1)(1990-8#1)(1991-3#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-3#1)(2006-10#3)(2006-12#3)(2007-11#2)(2007-2#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
others argue##2##2##(2010-3#1)(2012-12#1)
others as##12##2##(1991-7#1)(1991-8#1)(2006-9#2)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#2)(2010-4#1)(2011-1#1)
others at risk##2##3##(1990-3#1)(1993-6#1)
others at##5##2##(1990-3#1)(1993-6#1)(1994-12#1)(1996-11#1)(2006-5#1)
others become##2##2##(1991-11#1)(2006-4#1)
others but##2##2##(1997-5#1)(2008-11#1)
others by##9##2##(1990-11#1)(2006-6#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-1#1)(2011-2#1)
others can##5##2##(1990-12#1)(1996-5#1)(2008-10#1)(2009-6#1)(2012-1#1)
others did not##4##3##(1997-3#1)(2007-9#1)(2008-1#1)(2012-12#1)
others do not##9##3##(2007-6#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-9#2)(2010-2#1)(2010-3#1)(2012-3#1)
others do##12##2##(1990-8#1)(1996-3#1)(2006-10#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-9#2)(2010-2#1)(2010-3#1)(2012-3#1)
others emerge##2##2##(2006-7#1)(2008-11#1)
others follow##2##2##(1995-8#1)(2010-12#1)
others for the##3##3##(1990-7#1)(1996-11#1)(2008-5#1)
others for##15##2##(1990-2#1)(1990-7#1)(1996-11#1)(1997-5#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-5#1)(2012-1#1)(2012-12#1)
others found##3##2##(2008-1#1)(2008-11#1)(2008-3#1)
others from##2##2##(1993-7#1)(2007-5#1)
others had##9##2##(1995-2#1)(1996-6#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-3#1)(2012-2#1)
others has##3##2##(2006-10#1)(2008-10#1)(2009-8#1)
others have been##3##3##(2005-8#1)(2008-10#1)(2011-1#1)
others have proposed##2##3##(1996-1#1)(2008-4#1)
others have reported##3##3##(2007-11#2)(2012-3#1)
others have shown that##4##4##(2006-10#1)(2008-11#1)(2010-5#1)(2010-9#1)
others have shown##7##3##(1993-9#1)(1996-5#1)(2006-10#2)(2008-11#1)(2010-5#1)(2010-9#1)
others have##41##2##(1992-3#1)(1993-9#1)(1994-7#1)(1995-10#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-5#1)(1997-2#1)(1997-3#1)(2005-8#1)(2006-10#4)(2007-11#3)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#2)(2008-7#1)(2008-8#2)(2009-8#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#2)(2013-1#2)
others in a##4##3##(1991-7#1)(1992-3#1)(1994-12#1)(2007-2#1)
others in both##2##3##(1990-12#1)(2008-8#1)
others in the field##2##4##(2011-1#1)(2012-12#1)
others in the##9##3##(1995-4#1)(1996-12#1)(2006-1#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-1#1)(2012-12#1)
others in##35##2##(1990-10#1)(1990-12#1)(1991-7#1)(1992-3#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-4#1)(1996-12#1)(2004-4#1)(2006-1#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-8#2)(2008-9#1)(2010-2#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
others is the##2##3##(2004-2#1)(2011-2#1)
others is##10##2##(2004-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-11#1)(2011-2#2)(2013-8#1)
others it##3##2##(1993-5#1)(1996-10#1)(2007-6#1)
others may be##4##3##(1996-12#1)(2004-4#1)(2008-10#1)(2008-4#1)
others may require more##2##4##(2006-1#1)(2008-7#1)
others may##9##2##(1996-12#1)(2004-4#1)(2006-1#1)(2006-10#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-12#1)
others methods##2##2##(2007-8#1)(2010-3#1)
others no##3##2##(2006-10#1)(2008-4#1)(2008-7#1)
others of##5##2##(1991-6#1)(1994-1#1)(2007-7#1)(2009-3#2)
others on the basis of##3##5##(1993-11#1)(1996-11#1)(2008-11#1)
others on##5##2##(1993-11#1)(1993-3#1)(1996-11#1)(2008-11#1)(2009-9#1)
others present in the##2##4##(2008-10#1)(2008-7#1)
others presented##2##2##(1994-6#1)(1996-7#1)
others previously##3##2##(1992-11#1)(1995-3#1)(1995-9#1)
others produce##2##2##(2007-12#1)(2010-10#1)
others reported in the literature##3##5##(2006-10#1)(2007-10#1)(2008-2#1)
others reported##4##2##(2006-10#1)(2007-10#1)(2007-9#1)(2008-2#1)
others require##3##2##(2008-8#1)(2008-9#1)(2009-5#1)
others see##2##2##(1997-3#1)(2008-9#1)
others seek##2##2##(1993-7#1)(2010-10#1)
others should##2##2##(1994-12#1)(1997-8#1)
others show##2##2##(1995-8#1)(2009-5#1)
others showed##4##2##(1990-5#1)(1997-8#1)(2008-2#1)(2009-8#1)
others such as##3##3##(2006-10#1)(2008-4#1)(2008-7#1)
others suggest##2##2##(1990-10#1)(2010-5#1)
others than##2##2##(1997-8#1)(2006-10#1)
others that were##2##3##(2009-3#1)(2012-1#1)
others that##10##2##(1990-5#1)(1991-8#1)(2005-9#1)(2009-10#1)(2009-3#1)(2010-5#1)(2012-1#1)(2012-12#2)(2013-8#1)
others the##7##2##(1991-3#1)(1996-12#1)(2007-9#1)(2008-11#1)(2012-12#3)
others through##2##2##(2007-12#1)(2007-6#1)
others to follow##2##3##(1990-12#1)(2008-8#1)
others to the##2##3##(1990-8#1)(2005-10#1)
others to##29##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-8#1)(1993-3#3)(1994-9#1)(1995-1#1)(1995-12#1)(1997-3#1)(1997-5#2)(1997-8#1)(2004-2#1)(2005-10#1)(2007-11#1)(2007-4#3)(2008-12#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-4#1)(2010-8#1)(2013-1#2)
others use##2##2##(1991-12#1)(2006-10#1)
others using##3##2##(1992-2#1)(1994-3#1)(2008-1#1)
others usually##2##2##(1992-5#1)(2007-12#1)
others via##2##2##(2007-12#1)(2008-4#1)
others were found##2##3##(1995-12#1)(2007-10#1)
others were##23##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1991-4#1)(1992-6#1)(1993-1#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-5#1)(1997-6#1)(2004-4#1)(2006-10#1)(2007-10#2)(2007-7#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#1)(2011-12#1)(2013-1#1)
others when##2##2##(1991-12#1)(2008-7#1)
others which##4##2##(1990-5#1)(1994-8#1)(2008-10#1)(2012-12#1)
others who may##2##3##(1992-3#1)(2009-1#1)
others who##11##2##(1992-3#2)(1992-9#1)(1995-11#1)(2006-2#1)(2007-3#1)(2007-9#2)(2008-9#1)(2009-1#1)(2011-2#1)
others will require##2##3##(2008-6#1)(2012-2#1)
others will##4##2##(2007-12#1)(2008-2#1)(2008-6#1)(2012-2#1)
others with##11##2##(1996-12#1)(2004-3#1)(2006-10#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
others##1000##1##(1990-10#4)(1990-11#3)(1990-12#7)(1990-2#4)(1990-3#2)(1990-4#2)(1990-5#4)(1990-6#2)(1990-7#2)(1990-8#4)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#5)(1991-3#4)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#4)(1991-8#6)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#7)(1992-5#2)(1992-6#3)(1992-8#1)(1992-9#3)(1993-1#2)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#6)(1993-5#2)(1993-6#4)(1993-7#3)(1993-8#1)(1993-9#3)(1994-1#4)(1994-10#2)(1994-11#4)(1994-12#5)(1994-2#2)(1994-3#6)(1994-4#1)(1994-5#1)(1994-6#3)(1994-7#3)(1994-8#5)(1994-9#2)(1995-1#1)(1995-10#3)(1995-11#2)(1995-12#5)(1995-2#3)(1995-3#5)(1995-4#1)(1995-5#5)(1995-6#3)(1995-8#4)(1995-9#2)(1996-1#2)(1996-10#2)(1996-11#4)(1996-12#6)(1996-2#1)(1996-3#7)(1996-4#1)(1996-5#5)(1996-6#3)(1996-7#3)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#5)(1997-3#6)(1997-4#2)(1997-5#5)(1997-6#3)(1997-7#2)(1997-8#5)(2003-11#1)(2004-11#2)(2004-2#2)(2004-3#2)(2004-4#4)(2005-10#3)(2005-11#3)(2005-12#2)(2005-6#2)(2005-7#6)(2005-8#3)(2005-9#2)(2006-1#3)(2006-10#31)(2006-11#1)(2006-12#6)(2006-2#5)(2006-3#3)(2006-4#3)(2006-5#4)(2006-6#5)(2006-7#8)(2006-8#2)(2006-9#6)(2007-1#2)(2007-10#4)(2007-11#12)(2007-12#22)(2007-2#8)(2007-3#6)(2007-4#12)(2007-5#4)(2007-6#5)(2007-7#10)(2007-8#13)(2007-9#10)(2008-1#16)(2008-10#62)(2008-11#31)(2008-12#9)(2008-2#21)(2008-3#18)(2008-4#22)(2008-5#28)(2008-6#5)(2008-7#18)(2008-8#21)(2008-9#19)(2009-1#1)(2009-10#7)(2009-11#4)(2009-12#3)(2009-2#1)(2009-3#6)(2009-4#8)(2009-5#11)(2009-6#4)(2009-7#1)(2009-8#7)(2009-9#4)(2010-1#1)(2010-10#4)(2010-11#3)(2010-12#9)(2010-2#6)(2010-3#4)(2010-4#5)(2010-5#5)(2010-7#4)(2010-8#4)(2010-9#1)(2011-1#16)(2011-12#3)(2011-2#28)(2011-3#1)(2012-1#11)(2012-11#2)(2012-12#20)(2012-2#13)(2012-3#11)(2013-1#24)(2013-7#9)(2013-8#16)
others&quot##4##1##(2007-8#1)(2008-10#1)(2008-8#1)(2009-6#1)
others' schizophrenic illness##2##3##(1997-8#2)
others'##14##1##(1991-2#1)(1991-4#1)(1992-6#1)(1994-2#1)(1997-3#1)(1997-8#2)(2006-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-9#2)(2012-12#1)
others) and##2##2##(2007-10#1)(2008-3#1)
others)##20##1##(1992-3#1)(1997-5#1)(2006-2#1)(2007-1#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2009-7#2)(2009-8#1)(2010-2#1)(2011-1#1)(2011-12#1)(2012-11#1)(2013-1#1)(2013-7#1)
others?##2##1##(2008-9#1)(2013-8#1)
others]##2##1##(1991-6#1)(2008-8#1)
otherwise advantageous##2##2##(2008-4#1)(2008-5#1)
otherwise are##2##2##(1995-3#1)(2013-8#1)
otherwise asymptomatic##2##2##(2007-7#1)(2008-10#1)
otherwise be##14##2##(1991-3#1)(1992-3#1)(1994-11#1)(2005-7#1)(2006-12#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-2#2)(2008-8#1)(2010-12#1)(2011-1#1)
otherwise called##3##2##(2008-4#2)(2011-2#1)
otherwise clinically##2##2##(1992-5#1)(2011-2#1)
otherwise difficult##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
otherwise effective##2##2##(1994-3#1)(2007-11#1)
otherwise fit##3##2##(2006-12#1)(2007-2#2)
otherwise have##7##2##(1991-6#2)(1992-7#1)(1997-1#1)(2006-10#1)(2011-2#1)(2012-11#1)
otherwise healthy people##2##3##(2005-6#1)(2006-4#1)
otherwise healthy subjects##3##3##(1997-6#1)(2006-1#1)(2008-11#1)
otherwise healthy##21##2##(1991-8#1)(1994-11#1)(1994-9#1)(1997-1#1)(1997-6#1)(2005-6#1)(2006-1#1)(2006-10#2)(2006-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2010-7#1)(2010-8#1)(2012-12#2)(2012-2#1)(2013-7#1)
otherwise highly##3##2##(1994-8#1)(1995-5#1)(2013-1#1)
otherwise identical##6##2##(1990-3#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-8#1)
otherwise intact##3##2##(1994-8#1)(2007-8#1)(2008-7#1)
otherwise interfere with##3##3##(1990-11#1)(2008-10#2)
otherwise it##3##2##(1994-12#1)(2008-10#1)(2008-7#1)
otherwise known##3##2##(2006-7#1)(2008-8#1)(2008-9#1)
otherwise mentally##2##2##(2008-3#1)(2011-2#1)
otherwise normal or near-normal facial function in the immediate postoperative period##2##11##(2006-11#2)
otherwise normal##12##2##(1991-2#1)(1992-4#1)(1993-4#1)(1995-5#1)(1996-9#1)(1997-4#1)(2006-11#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-5#1)
otherwise not##5##2##(2008-2#1)(2009-6#1)(2011-2#1)(2013-1#2)
otherwise rare##2##2##(2008-2#1)(2008-9#1)
otherwise specified##8##2##(1993-12#1)(2007-7#1)(2009-5#2)(2011-2#1)(2012-2#2)(2012-3#1)
otherwise stable##2##2##(2008-11#1)(2013-1#1)
otherwise the##4##2##(1997-2#1)(2008-10#1)(2008-5#1)(2008-7#1)
otherwise they compromise system accuracy and make joint inference models less scalable and more expensive to train##2##17##(2013-1#2)
otherwise they were##2##3##(1991-6#1)(2007-12#1)
otherwise they##6##2##(1991-12#1)(1991-6#1)(2007-12#1)(2008-11#1)(2013-1#2)
otherwise undetectable##2##2##(1997-5#1)(2008-7#1)
otherwise unexplained##2##2##(1992-2#1)(2006-10#1)
otherwise unremarkable##2##2##(2008-11#1)(2013-1#1)
otherwise unstable##2##2##(2008-8#1)(2012-2#1)
otherwise would have##2##3##(2005-12#1)(2008-7#1)
otherwise would##5##2##(1992-4#1)(1996-12#1)(2005-12#1)(2008-7#1)(2010-2#1)
otherwise##308##1##(1990-10#2)(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#4)(1991-7#1)(1991-8#4)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#2)(1992-5#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#3)(1993-3#2)(1993-4#1)(1993-5#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-8#1)(2005-11#1)(2005-12#2)(2005-6#1)(2005-7#1)(2006-1#1)(2006-10#8)(2006-11#2)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#10)(2007-2#4)(2007-3#3)(2007-4#1)(2007-7#4)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#19)(2008-11#8)(2008-12#2)(2008-2#12)(2008-3#6)(2008-4#7)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#15)(2008-9#4)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#5)(2011-1#1)(2011-2#9)(2012-11#1)(2012-12#5)(2012-2#7)(2012-3#2)(2013-1#9)(2013-7#2)(2013-8#9)
otic capsule##5##2##(1993-12#1)(2006-12#3)(2011-2#1)
otic##10##1##(1993-12#1)(1995-3#1)(1996-4#2)(1997-1#1)(2006-12#3)(2008-3#1)(2011-2#1)
otitis externa##7##2##(1991-3#2)(2008-5#2)(2010-2#1)(2013-1#1)(2013-7#1)
otitis media (6 cases)##2##4##(2007-2#2)
otitis media and chronic##2##4##(1991-4#1)(2013-8#1)
otitis media and##13##3##(1991-4#1)(1996-12#1)(2006-10#2)(2007-9#7)(2008-9#1)(2013-8#1)
otitis media in a##2##4##(1990-3#1)(2010-9#1)
otitis media in##6##3##(1990-3#1)(1991-3#1)(2007-2#1)(2007-4#1)(2008-7#1)(2010-9#1)
otitis media was##2##3##(1991-3#1)(2007-2#1)
otitis media with effusion##6##4##(1996-12#3)(2006-10#1)(2008-9#1)(2013-8#1)
otitis media with##7##3##(1996-12#3)(2006-10#1)(2008-9#1)(2013-7#1)(2013-8#1)
otitis media##70##2##(1990-3#1)(1991-3#4)(1991-4#1)(1992-11#1)(1993-2#1)(1996-11#2)(1996-12#5)(1997-2#1)(2005-5#1)(2006-10#6)(2006-12#2)(2007-10#1)(2007-12#1)(2007-2#7)(2007-4#2)(2007-9#13)(2008-11#2)(2008-7#2)(2008-9#7)(2010-9#2)(2011-12#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
otitis media)##2##2##(1996-7#1)(2007-9#1)
otitis##102##1##(1990-10#1)(1990-3#2)(1991-3#6)(1991-4#1)(1992-11#1)(1993-2#1)(1994-3#1)(1995-4#1)(1995-9#1)(1996-11#2)(1996-12#5)(1996-7#1)(1997-2#1)(2005-5#1)(2006-10#6)(2006-12#2)(2007-10#3)(2007-12#1)(2007-2#8)(2007-4#2)(2007-7#1)(2007-9#16)(2008-11#2)(2008-4#1)(2008-5#7)(2008-7#2)(2008-9#7)(2009-5#1)(2010-2#2)(2010-9#2)(2011-1#1)(2011-12#2)(2011-2#1)(2012-12#2)(2013-1#4)(2013-7#2)(2013-8#2)
otoacoustic emission##3##2##(2008-1#3)
otoacoustic emissions##10##2##(1991-1#1)(2006-8#1)(2008-1#2)(2008-4#3)(2009-5#3)
otoacoustic##13##1##(1991-1#1)(2006-8#1)(2008-1#5)(2008-4#3)(2009-5#3)
otocyst-CVG##2##1##(1996-3#2)
otolaryngologic##5##1##(1996-3#2)(2006-6#1)(2007-2#1)(2010-12#1)
otolaryngological##3##1##(2006-12#1)(2007-3#1)(2010-12#1)
otolaryngologist##3##1##(1990-6#1)(2008-8#1)(2009-9#1)
otolaryngologists##6##1##(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#2)
otolaryngology##5##1##(2006-7#1)(2008-1#1)(2008-11#2)(2013-8#1)
otolith calcium##3##2##(2008-10#3)
otolith increments##2##2##(2007-5#2)
otolith length##2##2##(2013-7#2)
otolith was##2##2##(2008-7#1)(2013-7#1)
otolith##27##1##(1997-2#1)(2007-5#2)(2008-10#5)(2008-7#4)(2010-8#9)(2012-2#2)(2013-7#4)
otolithic function##2##2##(2011-1#2)
otoliths of##4##2##(2008-10#2)(2010-8#2)
otoliths##13##1##(2008-10#4)(2008-7#3)(2010-8#3)(2013-7#3)
otologic##3##1##(1993-6#1)(2006-8#1)(2011-2#1)
otological##2##1##(2006-4#2)
otorhinolaryngological##4##1##(2009-10#1)(2011-2#2)(2013-1#1)
otorhinolaryngologist##2##1##(1991-11#1)(2009-9#1)
otorrhagia and##2##2##(2012-12#2)
otorrhea##3##1##(2008-12#1)(2009-10#1)(2010-2#1)
otorrhoea##2##1##(2008-9#2)
otosclerosis##3##1##(1991-11#1)(2008-9#1)(2013-1#1)
ototoxic##4##1##(1991-11#1)(1995-10#1)(2007-7#1)(2008-4#1)
ototoxicity##12##1##(1995-10#1)(2005-7#1)(2006-12#1)(2007-7#4)(2008-2#4)(2008-3#1)
otter (Lutra lutra)##4##3##(1993-9#2)(2008-7#2)
otter populations##2##2##(1993-9#2)
otter##12##1##(1993-9#7)(1995-8#1)(2007-3#1)(2008-7#3)
otters##5##1##(1993-9#3)(1995-8#1)(2008-7#1)
ou des##2##2##(2012-2#2)
ou##19##1##(2008-10#1)(2008-5#2)(2008-6#1)(2011-2#5)(2012-2#6)(2013-1#4)
ouabain affinity##2##2##(1990-11#2)
ouabain and##5##2##(1990-11#1)(1991-1#1)(1991-4#1)(1991-7#1)(1992-8#1)
ouabain did not##2##3##(1997-6#1)(2008-8#1)
ouabain maximum binding##2##3##(1995-8#2)
ouabain or##3##2##(1990-5#1)(1994-3#1)(2006-5#1)
ouabain sensitive##2##2##(1991-1#1)(2008-4#1)
ouabain##47##1##(1990-11#7)(1990-12#1)(1990-2#1)(1990-5#1)(1991-1#2)(1991-2#2)(1991-4#1)(1991-7#1)(1992-11#3)(1992-12#1)(1992-3#1)(1992-8#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#4)(1995-1#2)(1995-8#2)(1997-1#1)(1997-6#2)(2005-8#1)(2006-5#1)(2007-10#1)(2008-1#1)(2008-4#1)(2008-6#2)(2008-8#3)
ouabain-insensitive##2##1##(1995-1#1)(2008-4#1)
ouabain-resistant##4##1##(1990-3#1)(1994-9#2)(2008-8#1)
ouabain-sensitive Na+##2##2##(1997-6#1)(2008-8#1)
ouabain-sensitive##9##1##(1990-3#1)(1991-1#1)(1992-11#2)(1994-8#1)(1997-5#1)(1997-6#1)(2008-4#1)(2008-8#1)
ought not to##2##3##(1994-2#1)(2012-11#1)
ought to be the##2##4##(1992-12#1)(2006-12#1)
ought to be##17##3##(1992-12#1)(1995-1#1)(1995-5#1)(1996-8#1)(1997-3#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#2)(2010-2#1)(2012-2#1)
ought to##23##2##(1992-12#2)(1993-6#1)(1993-9#1)(1995-1#1)(1995-5#1)(1996-8#1)(1997-3#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#2)(2010-2#1)(2012-1#1)(2012-2#1)
ought##25##1##(1992-12#2)(1993-6#1)(1993-9#1)(1994-2#1)(1995-1#1)(1995-5#1)(1996-8#1)(1997-3#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#2)(2010-2#1)(2012-1#1)(2012-11#1)(2012-2#1)
ounce of prevention##3##3##(1993-1#1)(2006-8#1)(2013-8#1)
ounce of##4##2##(1993-1#1)(1995-9#1)(2006-8#1)(2013-8#1)
our &quot##4##2##(2006-9#1)(2007-4#1)(2007-7#1)(2008-5#1)
our 27##2##2##(1990-7#1)(2012-1#1)
our 6##2##2##(2007-11#1)(2008-7#1)
our Center##2##2##(1992-8#1)(2007-7#1)
our Clinic##3##2##(2006-9#1)(2011-12#1)(2011-2#1)
our County##4##2##(2011-2#4)
our Department##13##2##(1991-5#1)(1992-10#1)(1992-4#1)(1992-5#1)(1992-6#1)(2007-11#1)(2007-7#2)(2007-8#2)(2012-2#1)(2012-3#1)(2013-1#1)
our HD##2##2##(2008-1#1)(2010-4#1)
our IRB##4##2##(2009-4#4)
our Institute##5##2##(1995-10#1)(2006-8#1)(2007-1#1)(2010-3#1)(2013-1#1)
our NMR##2##2##(2009-7#1)(2011-1#1)
our PD##2##2##(2011-2#2)
our ability to conduct##2##4##(2008-10#1)(2008-5#1)
our ability to diagnose##3##4##(2005-8#1)(2008-4#1)(2011-12#1)
our ability to do##2##4##(2008-6#1)(2008-7#1)
our ability to identify##2##4##(1997-8#1)(2008-3#1)
our ability to localize##2##4##(1994-9#1)(2010-2#1)
our ability to understand the##3##5##(1995-5#1)(2006-10#1)(2012-3#1)
our ability to understand##4##4##(1995-5#1)(2006-10#1)(2012-12#1)(2012-3#1)
our ability to##41##3##(1991-12#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-5#1)(1997-2#1)(1997-8#2)(2004-2#1)(2005-8#1)(2006-10#3)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
our ability##44##2##(1991-12#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-5#1)(1997-2#1)(1997-8#2)(2004-2#1)(2005-8#1)(2006-10#3)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
our aim was to assess the##2##6##(2011-2#1)(2013-1#1)
our aim was to##6##4##(1995-11#1)(2008-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
our aim##9##2##(1995-11#1)(1996-8#1)(2006-6#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
our algorithm and##2##3##(2008-2#2)
our algorithm to##2##3##(2006-10#1)(2008-6#1)
our algorithm##23##2##(2006-10#2)(2007-9#1)(2008-2#8)(2008-3#1)(2008-4#1)(2008-6#2)(2009-12#2)(2009-9#1)(2010-4#1)(2013-1#4)
our ambulatory##2##2##(1997-3#2)
our analyses##6##2##(1991-6#1)(1994-10#1)(2008-9#1)(2009-4#1)(2010-2#1)(2012-3#1)
our analysis and##2##3##(1997-1#1)(2007-12#1)
our analysis of the##6##4##(1996-3#1)(2007-5#1)(2008-6#1)(2010-4#1)(2012-3#2)
our analysis of##9##3##(1996-3#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-6#1)(2010-4#1)(2012-1#1)(2012-3#2)
our analysis on the##2##4##(2008-3#1)(2009-9#1)
our analysis on##3##3##(2008-3#1)(2009-9#1)(2012-2#1)
our analysis to##2##3##(1997-1#1)(2008-11#1)
our analysis we##3##3##(1991-8#1)(2006-7#1)(2008-2#1)
our analysis were##2##3##(1991-10#1)(2012-3#1)
our analysis##47##2##(1990-2#1)(1991-10#1)(1991-8#1)(1993-12#1)(1996-3#1)(1997-1#2)(1997-5#1)(1997-7#2)(2004-2#1)(2006-7#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#2)
our analytical##2##2##(2008-10#2)
our and##4##2##(1991-12#1)(1997-8#1)(2008-11#1)(2010-2#1)
our application##3##2##(2007-9#2)(2008-2#1)
our appreciation##2##2##(2004-11#1)(2010-2#1)
our approach by##4##3##(2009-8#1)(2011-1#1)(2012-3#2)
our approach is##10##3##(2006-10#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-8#1)(2009-12#1)(2009-8#1)(2013-1#2)
our approach to the ossified cochlea##2##6##(2008-9#2)
our approach to the##6##4##(1993-2#1)(1993-5#1)(2008-2#1)(2008-9#3)
our approach to##17##3##(1993-2#1)(1993-5#1)(1997-8#1)(2006-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#3)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
our approach was##2##3##(2008-2#1)(2012-3#1)
our approach we##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
our approach with##2##3##(2007-9#1)(2009-9#1)
our approach##71##2##(1993-2#1)(1993-5#1)(1996-7#1)(1997-8#1)(2006-10#3)(2007-11#2)(2007-12#3)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#2)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#7)(2013-1#6)(2013-8#1)
our article##2##2##(2006-3#1)(2008-11#1)
our assay##3##2##(2008-5#1)(2008-6#1)(2011-1#1)
our assumptions about the##2##4##(1996-3#1)(2008-9#1)
our assumptions about##3##3##(1996-3#1)(2005-10#1)(2008-9#1)
our assumptions##5##2##(1993-12#1)(1996-3#1)(2005-10#1)(2008-9#1)(2009-3#1)
our attempts to##4##3##(2007-3#1)(2008-8#1)(2010-5#1)(2010-6#1)
our attention on##5##3##(2005-11#1)(2005-6#1)(2007-8#1)(2008-1#1)(2008-10#1)
our attention to##2##3##(2007-1#1)(2008-10#1)
our attention##14##2##(1991-3#1)(1997-6#1)(2005-11#1)(2005-6#1)(2006-12#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-10#3)(2011-1#1)(2011-3#1)(2012-12#1)
our basic##6##2##(1993-2#1)(2006-7#1)(2007-11#1)(2008-8#1)(2010-8#1)(2013-1#1)
our best efforts##3##3##(2010-5#1)(2012-12#1)(2013-1#1)
our best knowledge##2##3##(2007-12#1)(2009-4#1)
our best##12##2##(1996-2#1)(2006-9#1)(2007-12#2)(2008-3#1)(2009-4#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
our boards##2##2##(2007-4#1)(2012-2#1)
our bodies##7##2##(1991-6#1)(2006-7#1)(2008-4#1)(2008-5#2)(2012-11#1)(2012-2#1)
our bodies?##2##2##(1992-1#2)
our body##8##2##(2005-3#1)(2008-1#1)(2008-11#1)(2008-3#1)(2011-1#1)(2011-3#1)(2013-1#2)
our business?##2##2##(1996-3#1)(2005-9#1)
our calculations show that##2##4##(2008-10#2)
our calculations##8##2##(1993-12#1)(1995-11#1)(2006-7#1)(2006-8#1)(2008-10#2)(2008-2#1)(2013-1#1)
our calibration##2##2##(2010-3#2)
our capabilities##2##2##(2008-3#1)(2008-7#1)
our capacity to##3##3##(2008-11#1)(2009-4#1)(2010-12#1)
our case demonstrates##2##3##(2011-2#1)(2013-1#1)
our case report##2##3##(2007-8#1)(2013-1#1)
our case was##4##3##(2007-9#1)(2008-1#2)(2011-1#1)
our case##48##2##(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#1)(1993-9#1)(1997-6#1)(2006-10#4)(2007-10#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#2)(2008-7#1)(2009-1#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#4)(2013-1#7)
our cases##16##2##(1990-2#1)(1990-3#1)(1995-11#1)(1995-4#1)(2006-11#1)(2007-10#1)(2007-12#1)(2007-7#4)(2007-8#3)(2010-5#1)(2012-2#1)
our center from##4##3##(1991-10#1)(2007-7#1)(2008-4#1)(2012-2#1)
our center##30##2##(1991-10#1)(1995-2#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-7#7)(2008-1#2)(2008-4#1)(2008-8#1)(2009-10#1)(2010-4#2)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#1)
our centre##11##2##(1995-10#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-6#1)(2009-10#1)(2010-10#1)(2011-1#1)(2011-12#1)(2013-1#1)(2013-8#1)
our characterization of##3##3##(2010-2#1)(2012-12#1)(2012-3#1)
our children and##2##3##(2010-5#1)(2011-1#1)
our children##4##2##(2006-10#1)(2010-5#1)(2011-1#1)(2013-1#1)
our children?]##2##2##(1996-11#1)(1996-7#1)
our choices##2##2##(2005-8#1)(2008-1#1)
our civilization##2##2##(1995-5#1)(2006-6#1)
our clinic between##3##3##(2007-8#1)(2012-3#1)(2013-1#1)
our clinic for##5##3##(2007-8#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
our clinic from##2##3##(2007-7#1)(2013-8#1)
our clinic with a##2##4##(1996-6#1)(2010-2#1)
our clinic with symptoms##2##4##(1997-1#1)(2005-12#1)
our clinic with##6##3##(1996-6#1)(1997-1#1)(2005-12#1)(2007-8#1)(2010-2#1)(2012-2#1)
our clinic##34##2##(1996-6#1)(1997-1#1)(2005-12#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#7)(2008-1#2)(2008-8#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
our clinical and##2##3##(2008-1#1)(2012-2#1)
our clinical case##2##3##(2012-2#1)(2013-1#1)
our clinical experience with##3##4##(2006-6#2)(2008-5#1)
our clinical experience##7##3##(1991-12#1)(2006-6#2)(2008-5#1)(2008-8#1)(2013-1#2)
our clinical practice##2##3##(1991-3#1)(2006-10#1)
our clinical##22##2##(1991-12#1)(1991-3#1)(1996-10#1)(1997-2#1)(2004-12#1)(2006-10#1)(2006-6#2)(2007-10#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-8#1)(2009-10#1)(2012-2#3)(2013-1#4)
our cohort of##2##3##(2007-10#1)(2012-12#1)
our cohort##4##2##(2006-7#1)(2007-10#1)(2012-12#1)(2012-3#1)
our collaborators##4##2##(1995-2#1)(2009-3#1)(2013-1#2)
our collection of##4##3##(1993-12#1)(1995-9#1)(2008-10#1)(2008-9#1)
our collection##6##2##(1993-12#1)(1995-9#1)(2008-10#2)(2008-9#1)(2013-1#1)
our combined##3##2##(1991-12#1)(2008-8#1)(2013-7#1)
our communities##3##2##(1994-12#1)(2006-2#1)(2008-11#1)
our community##6##2##(1994-12#1)(2007-1#1)(2007-2#1)(2008-1#1)(2008-7#1)(2012-3#1)
our comparative##3##2##(1994-11#1)(2008-10#1)(2008-7#1)
our computerized##4##2##(1990-3#1)(1993-1#1)(1994-3#2)
our concept of##4##3##(2007-12#1)(2008-11#1)(2008-8#1)(2012-2#1)
our concept##6##2##(2007-12#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-8#1)(2012-2#1)
our concern##3##2##(2004-8#1)(2013-1#2)
our conclusion##2##2##(1990-12#1)(2005-11#1)
our conclusions##8##2##(1996-3#1)(2007-7#1)(2008-12#1)(2008-6#1)(2008-8#2)(2009-8#1)(2009-9#1)
our conditions of##2##3##(2005-9#1)(2007-12#1)
our conditions##9##2##(1990-11#1)(1990-3#1)(1991-12#1)(1993-2#1)(2005-9#3)(2006-6#1)(2007-12#1)
our consideration##2##2##(2008-8#1)(2011-2#1)
our contemporary##2##2##(2007-3#1)(2007-5#1)
our contention##5##2##(1994-12#1)(1995-8#1)(2006-1#1)(2008-5#1)(2008-8#1)
our continued##2##2##(2006-10#1)(2007-12#1)
our continuing##3##2##(1993-11#1)(1996-2#1)(2012-3#1)
our control##2##2##(2007-11#1)(2008-11#1)
our countries##4##2##(2007-6#2)(2009-6#1)(2011-2#1)
our country##44##2##(1990-12#1)(1990-9#1)(1992-12#1)(1992-2#1)(1993-10#1)(1995-5#1)(1996-7#1)(2005-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-2#2)(2009-8#1)(2010-1#3)(2010-2#2)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
our country's##2##2##(2007-3#1)(2008-4#1)
our criteria for##3##3##(1997-7#1)(2013-1#2)
our criteria##7##2##(1997-7#1)(2007-10#1)(2007-8#1)(2008-10#1)(2013-1#3)
our culture conditions##3##3##(1995-11#1)(1995-9#1)(2007-5#1)
our culture##4##2##(1994-12#1)(1995-11#1)(1995-9#1)(2007-5#1)
our current diagnostic##2##3##(2006-10#1)(2006-4#1)
our current knowledge about##3##4##(1994-6#1)(2007-11#1)(2008-4#1)
our current knowledge of the mechanisms##2##6##(1996-7#1)(2008-7#1)
our current knowledge of the##7##5##(1996-7#1)(1997-7#1)(2008-1#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-8#1)
our current knowledge on the##2##5##(2007-12#1)(2010-5#1)
our current knowledge regarding##2##4##(2008-11#1)(2012-2#1)
our current knowledge##15##3##(1994-6#1)(1996-7#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-5#1)(2010-8#1)(2012-2#1)
our current limited##2##3##(1992-3#1)(2007-11#1)
our current study##3##3##(2006-8#1)(2013-8#2)
our current understanding of the role of##2##7##(2012-2#2)
our current understanding of the##15##5##(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-8#2)(2009-2#1)(2009-4#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#2)
our current understanding of##26##4##(2006-10#1)(2006-9#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#2)(2009-12#1)(2009-2#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#2)
our current view##2##3##(2008-11#1)(2011-1#1)
our current##66##2##(1990-12#1)(1992-3#2)(1994-6#1)(1995-12#1)(1996-2#2)(1996-4#1)(1996-7#1)(1997-7#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-4#1)(2006-8#2)(2006-9#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-11#4)(2008-4#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#3)(2013-1#2)(2013-8#4)
our daily lives##3##3##(2012-11#1)(2012-2#2)
our daily practice##2##3##(2007-8#1)(2009-6#1)
our daily##10##2##(1991-3#1)(2006-6#1)(2007-8#1)(2008-5#1)(2008-6#1)(2009-6#1)(2012-1#1)(2012-11#1)(2012-2#2)
our data also##3##3##(2008-1#1)(2008-8#1)(2009-3#1)
our data and##4##3##(2008-3#1)(2008-7#1)(2009-8#1)(2011-2#1)
our data are##3##3##(2007-12#1)(2008-7#1)(2008-8#1)
our data can##2##3##(1991-5#1)(2008-8#1)
our data confirm the##2##4##(1997-1#1)(2006-8#1)
our data demonstrate that##3##4##(2007-11#1)(2008-11#1)(2011-1#1)
our data demonstrate##4##3##(1992-11#1)(2007-11#1)(2008-11#1)(2011-1#1)
our data demonstrated that##2##4##(2008-5#1)(2010-12#1)
our data demonstrated##3##3##(2008-5#1)(2010-12#1)(2012-12#1)
our data do##2##3##(1996-4#1)(2009-5#1)
our data for##2##3##(1995-12#1)(2005-11#1)
our data in##3##3##(2006-10#1)(2007-12#1)(2009-8#1)
our data indicate that##6##4##(1997-5#1)(2006-11#1)(2008-7#1)(2010-4#1)(2012-3#1)(2013-7#1)
our data indicate##7##3##(1994-9#1)(1997-5#1)(2006-11#1)(2008-7#1)(2010-4#1)(2012-3#1)(2013-7#1)
our data on##3##3##(1991-3#1)(1994-12#1)(2007-7#1)
our data provide a##2##4##(2009-4#1)(2011-2#1)
our data provide##3##3##(2009-4#1)(2011-2#1)(2012-12#1)
our data show that##4##4##(1997-7#1)(2011-12#1)(2011-2#1)(2013-1#1)
our data show##6##3##(1997-7#1)(2011-12#1)(2011-2#2)(2013-1#1)(2013-7#1)
our data showed##2##3##(1997-6#1)(2008-10#1)
our data suggest a##3##4##(2008-7#1)(2008-8#1)(2009-9#1)
our data suggest that the##4##5##(1992-12#1)(1995-6#1)(2008-9#1)(2011-2#1)
our data suggest that this##2##5##(2010-8#1)(2012-3#1)
our data suggest that##23##4##(1990-3#1)(1991-10#1)(1992-12#1)(1994-11#1)(1995-12#1)(1995-6#1)(1997-1#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-4#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
our data suggest##27##3##(1990-3#1)(1991-10#1)(1992-12#1)(1994-11#1)(1995-12#1)(1995-6#1)(1996-4#1)(1997-1#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-4#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
our data support the hypothesis that##2##6##(2010-7#1)(2013-7#1)
our data support the hypothesis##3##5##(1993-7#1)(2010-7#1)(2013-7#1)
our data support the##5##4##(1993-7#1)(2007-10#1)(2010-3#1)(2010-7#1)(2013-7#1)
our data support##7##3##(1993-7#1)(2007-10#1)(2008-4#1)(2010-11#1)(2010-3#1)(2010-7#1)(2013-7#1)
our data we conclude that##3##5##(1990-8#1)(1991-2#1)(1994-3#1)
our data we##4##3##(1990-8#1)(1991-2#1)(1994-3#1)(2007-12#1)
our data with those##2##4##(2008-10#1)(2008-3#1)
our data with##5##3##(1994-7#1)(2008-10#2)(2008-12#1)(2008-3#1)
our data##140##2##(1990-3#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-12#1)(1993-4#1)(1993-7#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-9#3)(1995-11#1)(1995-12#5)(1995-2#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-4#2)(1996-5#1)(1997-1#2)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-7#3)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#6)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-11#2)(2010-12#1)(2010-3#3)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#2)(2013-7#3)(2013-8#1)
our decision making and##2##4##(1993-3#1)(2008-7#1)
our decision##3##2##(1993-3#1)(2004-3#1)(2008-7#1)
our department between##4##3##(1997-3#1)(2008-1#1)(2008-9#1)(2009-4#1)
our department due to##2##4##(2008-12#1)(2011-2#1)
our department during##3##3##(1990-9#1)(1991-8#1)(1992-2#1)
our department for##4##3##(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
our department from##2##3##(2009-6#1)(2013-1#1)
our department with a##4##4##(2007-10#1)(2008-12#1)(2011-2#2)
our department with##8##3##(1993-8#1)(2007-10#1)(2007-8#2)(2008-12#1)(2011-2#2)(2012-3#1)
our department##63##2##(1990-3#1)(1990-9#2)(1991-11#1)(1991-8#1)(1992-10#2)(1992-2#1)(1993-10#1)(1993-6#1)(1993-8#2)(1994-9#1)(1995-4#1)(1996-6#2)(1996-8#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-11#1)(2006-2#1)(2007-10#1)(2007-6#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#3)(2013-8#2)
our departments##2##2##(1994-8#1)(2007-7#1)
our design##2##2##(2008-2#1)(2010-10#1)
our device##4##2##(2005-11#1)(2007-11#1)(2007-12#1)(2009-6#1)
our devices##3##2##(2008-7#1)(2009-2#1)(2012-3#1)
our diagnosis##2##2##(2009-7#1)(2010-10#1)
our diagnostic##3##2##(1997-1#1)(2006-10#2)
our dialysis##3##2##(2007-7#2)(2008-1#1)
our diet##2##2##(1990-9#1)(1992-7#1)
our discipline##3##2##(2007-9#1)(2008-12#2)
our discussion to##2##3##(2005-7#1)(2008-3#1)
our discussion##7##2##(2005-7#1)(2008-3#1)(2010-10#1)(2010-3#1)(2011-1#1)(2012-3#1)(2013-1#1)
our district##2##2##(2008-7#1)(2010-5#1)
our dynamic##3##2##(1996-3#1)(2008-3#1)(2008-6#1)
our earlier evidence##2##3##(1993-7#1)(1994-9#1)
our earlier finding that##2##4##(1994-6#1)(1997-2#1)
our earlier findings##4##3##(1991-6#1)(1992-12#1)(2006-8#1)(2013-8#1)
our earlier hypothesis##2##3##(1993-2#1)(1995-5#1)
our earlier studies##4##3##(1990-3#1)(1994-11#1)(1996-12#1)(2008-10#1)
our earlier##28##2##(1990-3#1)(1991-6#1)(1992-12#1)(1993-2#1)(1993-4#1)(1993-7#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-5#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-3#1)(2006-8#2)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2010-12#2)(2013-8#2)
our early##2##2##(1997-6#1)(2009-8#1)
our economy##2##2##(1993-2#1)(1994-5#1)
our educational##3##2##(2007-6#1)(2008-12#1)(2010-9#1)
our effort to##5##3##(1991-1#1)(1994-5#1)(2007-4#1)(2008-7#1)(2013-8#1)
our efforts at##2##3##(2006-10#1)(2010-6#1)
our efforts to develop##2##4##(1994-5#1)(2006-12#1)
our efforts to##10##3##(1994-1#2)(1994-5#1)(1994-9#1)(1997-2#1)(1997-9#1)(2006-12#1)(2006-6#1)(2008-2#1)(2013-1#1)
our efforts towards##3##3##(2007-6#1)(2013-1#2)
our efforts##24##2##(1991-12#1)(1993-3#1)(1994-1#2)(1994-5#1)(1994-9#1)(1997-2#1)(1997-9#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-6#1)(2013-1#6)
our electron##2##2##(1990-7#1)(2007-8#1)
our empirical study##2##3##(1995-2#1)(2005-8#1)
our empirical##4##2##(1995-2#1)(2005-8#1)(2008-8#1)(2010-2#1)
our ensemble algorithm##2##3##(2012-2#2)
our environment##12##2##(1994-3#1)(2006-10#1)(2007-1#3)(2008-10#1)(2008-7#2)(2010-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
our error##2##2##(2009-11#2)
our estimate##2##2##(2008-3#2)
our estimates##3##2##(1992-9#1)(2008-8#1)(2012-11#1)
our evaluation of##2##3##(2009-2#1)(2011-12#1)
our evaluation##7##2##(2009-2#1)(2010-8#1)(2011-12#1)(2013-1#4)
our everyday##4##2##(2005-11#1)(2009-8#3)
our example##2##2##(1996-7#1)(2010-11#1)
our existing##2##2##(2006-10#1)(2008-2#1)
our expectations##2##2##(2007-11#1)(2008-11#1)
our experience and##6##3##(2006-10#2)(2006-2#1)(2008-11#1)(2008-6#1)(2010-12#1)
our experience as##3##3##(1994-2#1)(2006-6#1)(2009-2#1)
our experience in dealing with##2##5##(1990-10#1)(2007-3#1)
our experience in the##4##4##(1990-5#1)(2007-7#1)(2007-8#1)(2008-10#1)
our experience in##16##3##(1990-10#1)(1990-5#1)(1993-9#1)(2007-11#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-9#1)(2010-12#1)(2011-12#2)(2011-2#1)(2013-1#2)
our experience of a##2##4##(1991-9#1)(1997-3#1)
our experience of##18##3##(1991-9#1)(1995-10#1)(1997-3#2)(2005-11#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-6#1)(2009-6#1)(2010-7#1)(2010-8#1)(2012-2#1)
our experience on##2##3##(2007-7#2)
our experience the##4##3##(1991-3#1)(1992-3#1)(2007-7#1)(2008-5#1)
our experience we##4##3##(2007-7#1)(2008-6#1)(2011-2#1)(2013-1#1)
our experience with a##5##4##(2008-4#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
our experience with the use of##2##6##(2007-8#1)(2008-12#1)
our experience with the##6##4##(1996-8#1)(2006-6#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-12#1)
our experience with this##4##4##(2006-4#1)(2007-12#1)(2007-7#1)(2011-1#1)
our experience with##43##3##(1993-10#1)(1993-8#1)(1995-3#1)(1995-9#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
our experience##158##2##(1990-10#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-8#2)(1993-10#3)(1993-8#2)(1993-9#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-3#1)(1995-9#1)(1996-8#1)(1997-1#1)(1997-3#4)(1997-7#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#4)(2006-12#3)(2006-2#1)(2006-4#1)(2006-6#3)(2006-8#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#18)(2007-8#10)(2008-1#4)(2008-10#6)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#2)(2008-9#5)(2009-2#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#3)(2011-2#9)(2012-2#3)(2012-3#1)(2013-1#7)(2013-8#2)
our experience]##4##2##(1990-4#1)(1990-5#1)(1991-3#1)(2012-2#1)
our experiences##11##2##(1992-4#1)(1992-5#1)(1995-12#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-12#2)(2010-4#1)(2010-7#1)
our experiment##11##2##(1991-12#1)(2005-10#1)(2005-11#1)(2005-6#1)(2007-11#2)(2008-10#2)(2008-9#1)(2010-2#1)(2010-8#1)
our experimental conditions##11##3##(1990-3#1)(1991-10#1)(1991-12#1)(1994-6#2)(1997-4#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-8#1)
our experimental data##3##3##(1996-7#1)(2008-2#1)(2013-8#1)
our experimental observations##2##3##(2005-11#1)(2013-8#1)
our experimental results##5##3##(1997-2#1)(1997-4#1)(2006-10#1)(2006-4#1)(2007-12#1)
our experimental##34##2##(1990-3#1)(1991-10#2)(1991-12#1)(1994-6#2)(1996-7#1)(1997-2#1)(1997-4#2)(2005-11#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#3)(2008-3#3)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#1)(2012-12#1)(2013-7#1)(2013-8#3)
our experimentally##2##2##(2008-3#1)(2008-8#1)
our experiments and##3##3##(2008-3#1)(2013-1#2)
our experiments with##2##3##(1997-7#1)(2008-3#1)
our experiments##25##2##(1990-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-2#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)(2010-10#1)(2010-5#1)(2010-8#1)(2012-3#1)(2013-1#5)
our exploration of the##2##4##(1994-1#1)(1997-2#1)
our exploratory##3##2##(1997-2#1)(2008-5#2)
our extensive##2##2##(2007-4#1)(2009-8#1)
our eyes##2##2##(1994-12#1)(2007-8#1)
our facility##10##2##(1992-2#1)(1992-6#5)(1994-12#1)(2007-7#1)(2013-8#2)
our field of##2##3##(2008-10#1)(2012-11#1)
our field site##2##3##(2004-11#2)
our field##8##2##(2004-11#2)(2007-4#1)(2008-10#2)(2009-10#1)(2010-4#1)(2012-11#1)
our film##2##2##(2008-3#1)(2008-5#1)
our finding of a##2##4##(2008-7#1)(2012-2#1)
our finding of##3##3##(2008-7#1)(2011-1#1)(2012-2#1)
our finding that##3##3##(1996-10#1)(2007-7#1)(2009-4#1)
our finding##7##2##(1996-10#1)(2007-7#1)(2008-7#1)(2009-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
our findings are consistent with##3##5##(2007-10#1)(2008-8#1)(2011-2#1)
our findings are contrary to##2##5##(2009-7#2)
our findings are##7##3##(1992-10#1)(2007-10#1)(2008-8#1)(2009-7#2)(2010-9#1)(2011-2#1)
our findings demonstrate##2##3##(2007-7#1)(2008-9#1)
our findings in##4##3##(1995-11#1)(1995-12#1)(1997-1#1)(2008-9#1)
our findings indicate that##8##4##(1992-1#1)(1995-1#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-1#1)(2013-1#2)
our findings indicate##9##3##(1992-1#1)(1995-1#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-1#1)(2012-2#1)(2013-1#2)
our findings on the##2##4##(2008-8#1)(2008-9#1)
our findings on##3##3##(2007-7#1)(2008-8#1)(2008-9#1)
our findings provide a##2##4##(2007-2#1)(2009-8#1)
our findings provide##5##3##(1990-10#1)(2007-2#1)(2009-8#1)(2011-2#1)(2013-1#1)
our findings reveal##2##3##(2011-1#1)(2012-2#1)
our findings show that##2##4##(2010-4#1)(2012-7#1)
our findings suggest that an##2##5##(1991-8#1)(1993-4#1)
our findings suggest that##11##4##(1991-8#1)(1993-4#1)(1995-3#1)(1995-7#1)(2006-6#1)(2007-4#1)(2010-12#1)(2012-3#1)(2013-1#3)
our findings suggest##16##3##(1991-8#1)(1993-4#1)(1995-3#1)(1995-7#1)(2006-6#1)(2007-4#1)(2008-2#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
our findings support##2##3##(1991-5#1)(2009-2#1)
our findings to##4##3##(1990-6#1)(1993-12#1)(2013-1#2)
our findings with##4##3##(1996-9#1)(2008-10#1)(2010-12#1)(2012-3#1)
our findings##106##2##(1990-10#1)(1990-4#1)(1990-6#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-3#1)(1993-12#1)(1993-4#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-7#2)(1996-11#1)(1996-12#2)(1996-9#1)(1997-1#1)(2006-10#1)(2006-6#2)(2007-10#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#6)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#3)(2009-6#1)(2009-7#4)(2009-8#4)(2010-1#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#5)(2012-2#4)(2012-3#2)(2012-7#1)(2013-1#13)(2013-8#2)
our first attempt##2##3##(2007-5#1)(2008-3#1)
our first choice##2##3##(1997-4#1)(2007-7#1)
our first##21##2##(1996-12#1)(1997-1#1)(1997-4#1)(2006-3#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-9#1)(2012-12#2)(2013-8#1)
our focus to##2##3##(2010-12#1)(2012-3#1)
our focus##5##2##(1995-1#1)(2005-10#1)(2010-12#1)(2011-2#1)(2012-3#1)
our food##2##2##(2008-10#1)(2012-12#1)
our framework is##3##3##(2008-2#1)(2010-4#1)(2013-1#1)
our framework##9##2##(2008-2#2)(2008-7#1)(2010-4#1)(2010-9#1)(2012-1#1)(2012-3#1)(2013-1#2)
our future##9##2##(1993-12#1)(1994-12#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2010-6#1)
our general##4##2##(2007-7#1)(2008-8#2)(2009-10#1)
our genome##2##2##(1997-4#1)(2006-4#1)
our goal is to##2##4##(2008-2#1)(2013-8#1)
our goal is##3##3##(1990-12#1)(2008-2#1)(2013-8#1)
our goal##7##2##(1990-12#1)(2008-2#1)(2008-6#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
our goals##2##2##(2007-4#1)(2008-8#1)
our group and others##4##4##(2008-10#1)(2008-4#1)(2009-8#2)
our group and##7##3##(1991-12#1)(2006-5#1)(2008-10#1)(2008-4#1)(2009-8#2)(2012-12#1)
our group has##4##3##(2007-9#1)(2008-10#1)(2008-7#1)(2011-2#1)
our group reported##2##3##(1997-1#1)(2006-2#1)
our group to##2##3##(2008-5#1)(2008-9#1)
our group with##2##3##(2008-2#1)(2013-1#1)
our group##38##2##(1990-3#1)(1991-12#1)(1994-9#1)(1995-2#1)(1995-5#1)(1997-1#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-9#1)(2008-1#2)(2008-10#4)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-8#3)(2010-1#1)(2010-12#2)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
our groupwise registration##2##3##(2011-2#2)
our growing##3##2##(2008-12#1)(2011-2#1)(2012-1#1)
our hands##4##2##(2007-7#1)(2008-5#2)(2009-4#1)
our health care delivery##2##4##(1994-1#1)(2007-4#1)
our health care system##7##4##(1992-3#1)(1994-1#1)(1997-2#1)(2008-1#1)(2008-4#3)
our health care##12##3##(1992-3#1)(1994-1#3)(1996-3#1)(1997-1#1)(1997-2#1)(2007-4#1)(2008-1#1)(2008-4#3)
our health##17##2##(1992-3#1)(1994-1#3)(1995-3#1)(1996-3#1)(1997-1#1)(1997-2#1)(2007-10#1)(2007-4#1)(2007-6#1)(2008-1#2)(2008-11#1)(2008-4#3)
our healthcare##2##2##(1997-3#1)(2011-2#1)
our high##2##2##(1995-6#1)(2008-11#1)
our high-density##3##2##(1996-12#1)(1997-2#1)(1997-4#1)
our historic##2##2##(1990-12#1)(1995-3#1)
our hospital after##3##3##(2007-8#1)(2010-2#1)(2012-2#1)
our hospital and##3##3##(2007-10#1)(2007-8#1)(2012-2#1)
our hospital between##2##3##(2007-3#1)(2007-7#1)
our hospital during this period##2##5##(2007-2#1)(2008-7#1)
our hospital for evaluation of an##2##6##(2008-1#1)(2010-12#1)
our hospital for evaluation of##3##5##(2008-1#1)(2010-12#2)
our hospital for evaluation##4##4##(2008-1#1)(2010-12#3)
our hospital for the##2##4##(2006-6#1)(2008-1#1)
our hospital for##20##3##(1991-12#1)(1994-7#1)(2006-4#1)(2006-6#1)(2007-8#2)(2008-1#2)(2009-3#1)(2010-12#3)(2011-2#2)(2012-11#1)(2012-2#2)(2013-8#3)
our hospital from##2##3##(1993-11#1)(2013-8#1)
our hospital in the##3##4##(2007-7#1)(2007-8#1)(2012-2#1)
our hospital in##4##3##(2006-4#1)(2007-7#1)(2007-8#1)(2012-2#1)
our hospital on##2##3##(2007-7#1)(2007-8#1)
our hospital to##2##3##(2008-1#1)(2008-3#1)
our hospital with a##4##4##(2010-12#1)(2013-1#2)(2013-7#1)
our hospital with the##2##4##(2008-1#1)(2008-5#1)
our hospital with##20##3##(1993-6#1)(2005-12#1)(2006-10#1)(2006-4#1)(2007-10#2)(2007-12#1)(2008-1#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#5)(2013-7#1)
our hospital##119##2##(1990-6#2)(1990-9#1)(1991-12#1)(1991-2#1)(1992-5#2)(1992-8#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-7#1)(1995-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-12#1)(2006-10#1)(2006-2#1)(2006-4#5)(2006-6#1)(2006-8#1)(2007-10#4)(2007-11#1)(2007-12#2)(2007-2#3)(2007-3#2)(2007-7#8)(2007-8#7)(2007-9#1)(2008-1#7)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-1#1)(2009-3#1)(2010-12#4)(2010-2#1)(2010-6#4)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-11#1)(2012-12#3)(2012-2#9)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#6)
our hospitals##6##2##(1990-6#1)(1994-6#1)(1997-2#1)(1997-8#1)(2010-12#1)(2011-2#1)
our hybrid##2##2##(2006-5#1)(2008-3#1)
our hypotheses##3##2##(2010-8#1)(2011-2#1)(2012-3#1)
our hypothesis concerning##2##3##(1992-3#1)(2006-8#1)
our hypothesis that the##4##4##(1993-11#1)(1994-3#1)(1996-12#1)(1997-5#1)
our hypothesis that##19##3##(1991-12#1)(1991-7#1)(1993-11#1)(1994-10#1)(1994-3#1)(1995-11#1)(1995-5#2)(1996-1#1)(1996-11#1)(1996-12#1)(1997-5#1)(2008-10#2)(2008-3#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-2#1)
our hypothesis##35##2##(1991-12#1)(1991-7#1)(1992-3#1)(1993-11#2)(1994-10#1)(1994-3#1)(1995-11#2)(1995-5#2)(1996-1#1)(1996-11#1)(1996-12#1)(1997-5#1)(1997-8#2)(2005-11#1)(2006-3#1)(2006-8#1)(2008-10#3)(2008-3#1)(2009-4#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-5#1)(2012-7#1)(2013-7#1)(2013-8#1)
our idea##2##2##(2007-11#1)(2008-11#1)
our ideas##4##2##(1996-1#1)(2006-10#1)(2008-6#1)(2010-12#1)
our ignorance of##2##3##(2008-9#1)(2011-2#1)
our ignorance##3##2##(2008-9#1)(2011-2#1)(2012-2#1)
our imaging##3##2##(1994-12#1)(2008-1#1)(2012-2#1)
our impression that##2##3##(1994-6#1)(2008-7#1)
our in situ##3##3##(1997-1#1)(2008-7#1)(2008-8#1)
our in vitro##4##3##(1994-11#1)(2008-10#1)(2009-12#1)(2010-12#1)
our in##9##2##(1994-11#1)(1997-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2010-12#1)(2013-1#1)
our in-house##2##2##(2008-2#1)(2011-1#1)
our in-patient##2##2##(2008-3#2)
our increasing##2##2##(2005-8#1)(2008-7#1)
our increasingly##3##2##(2006-2#1)(2008-12#1)(2010-12#1)
our index##4##2##(1993-9#3)(2008-6#1)
our indications for##2##3##(1994-6#1)(2007-8#1)
our individual##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
our industrial##2##2##(1990-11#1)(2008-3#1)
our initial experience using##2##4##(2006-6#1)(2010-6#1)
our initial experience##6##3##(2006-6#1)(2007-8#1)(2010-6#1)(2011-1#1)(2012-12#2)
our initial findings##2##3##(1996-7#1)(2009-4#1)
our initial##14##2##(1992-2#1)(1996-7#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-6#1)(2009-4#1)(2010-6#1)(2011-1#1)(2012-12#4)(2013-1#1)
our institute##9##2##(1994-3#2)(1995-5#1)(2004-1#1)(2006-6#1)(2007-8#2)(2008-11#2)
our institution between January##2##4##(2007-7#1)(2012-2#1)
our institution between##7##3##(2007-2#1)(2007-7#1)(2007-8#1)(2008-6#2)(2012-2#1)(2013-8#1)
our institution for##3##3##(2008-12#1)(2008-6#1)(2012-2#1)
our institution has##2##3##(2007-11#1)(2009-11#1)
our institution in##2##3##(2007-11#1)(2011-2#1)
our institution with##7##3##(2006-10#1)(2007-8#1)(2007-9#1)(2008-8#1)(2012-2#1)(2013-1#2)
our institution##77##2##(1991-8#1)(1992-6#2)(1993-8#1)(1994-1#1)(1995-2#1)(1996-10#1)(1996-3#1)(1996-8#1)(2005-10#1)(2005-12#1)(2005-6#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-2#2)(2007-5#1)(2007-7#4)(2007-8#7)(2007-9#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-6#5)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-2#5)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#2)
our institution's##6##2##(1990-11#1)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#2)
our institutional experience##3##3##(2008-6#1)(2013-1#1)(2013-7#1)
our institutional##4##2##(2008-6#1)(2009-3#1)(2013-1#1)(2013-7#1)
our intent##2##2##(2005-12#1)(2007-10#1)
our interest in##2##3##(2004-3#1)(2009-2#1)
our interest##7##2##(1994-12#1)(1997-8#1)(2004-3#1)(2009-2#1)(2010-2#1)(2010-7#1)(2013-7#1)
our interpretation of##2##3##(2006-4#1)(2008-3#1)
our interpretation##3##2##(2006-4#1)(2008-12#1)(2008-3#1)
our investigation of the##2##4##(2006-3#1)(2008-3#1)
our investigation of##4##3##(2006-3#1)(2008-3#1)(2008-8#1)(2009-8#1)
our investigation on the##2##4##(1990-12#1)(2013-1#1)
our investigation##17##2##(1990-12#1)(2005-10#1)(2006-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-8#2)(2011-12#1)(2011-2#1)(2013-1#1)
our investigations of##5##3##(1992-5#1)(1995-7#1)(2007-12#1)(2008-11#1)(2008-2#1)
our investigations##11##2##(1992-5#1)(1995-7#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#1)(2013-1#1)
our joint##2##2##(2010-7#1)(2011-12#1)
our knowledge a##4##3##(2007-12#3)(2007-8#1)
our knowledge about the effects of##2##6##(2009-10#1)(2012-2#1)
our knowledge about the##8##4##(2006-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#1)
our knowledge about##14##3##(1997-8#1)(2006-10#1)(2006-11#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-5#1)(2011-2#2)(2012-2#1)
our knowledge and##11##3##(1990-12#1)(1997-3#1)(2006-10#2)(2007-7#1)(2008-1#1)(2008-3#1)(2008-4#1)(2010-12#1)(2010-7#1)(2011-2#1)
our knowledge are##3##3##(2008-2#2)(2011-12#1)
our knowledge as##2##3##(2007-8#1)(2013-8#1)
our knowledge for the first time##4##6##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
our knowledge for the first##5##5##(1990-7#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
our knowledge has##2##3##(2005-11#1)(2013-1#1)
our knowledge in the##2##4##(2005-7#1)(2008-8#1)
our knowledge in this area is##3##6##(2005-7#1)(2006-2#1)(2009-7#1)
our knowledge in##9##3##(2005-7#2)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-8#1)(2009-7#1)
our knowledge is a new##5##5##(2008-2#1)(2008-3#4)
our knowledge is a##9##4##(2008-2#2)(2008-3#7)
our knowledge is##14##3##(1990-8#1)(1992-11#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#7)(2010-5#1)
our knowledge it##2##3##(2008-10#1)(2012-12#1)
our knowledge no##2##3##(2009-4#1)(2012-12#1)
our knowledge of cancer biology##2##5##(2008-1#1)(2008-11#1)
our knowledge of cancer##3##4##(2008-1#1)(2008-11#1)(2010-12#1)
our knowledge of plant##2##4##(2008-9#1)(2009-8#1)
our knowledge of the molecular mechanisms##2##6##(2006-12#1)(2008-4#1)
our knowledge of the molecular##4##5##(2006-12#1)(2008-3#1)(2008-4#1)(2011-2#1)
our knowledge of the##26##4##(1990-7#1)(1991-11#1)(1993-12#1)(1994-5#1)(1995-5#1)(2005-7#1)(2006-10#2)(2006-12#3)(2007-11#1)(2007-5#1)(2008-3#2)(2008-4#2)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#1)(2013-8#1)
our knowledge of their##2##4##(2007-8#1)(2010-2#1)
our knowledge of these##2##4##(1995-9#1)(2006-10#1)
our knowledge of##59##3##(1990-7#1)(1991-11#1)(1993-12#1)(1994-5#1)(1995-5#1)(1995-9#1)(1996-8#1)(1997-1#1)(2005-11#1)(2005-7#1)(2006-10#7)(2006-12#3)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-4#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-6#2)(2011-1#3)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
our knowledge on the##3##4##(1991-3#1)(2006-2#1)(2010-2#1)
our knowledge on##12##3##(1991-3#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-2#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-2#1)(2012-2#1)(2013-1#1)
our knowledge only##3##3##(2008-2#1)(2008-7#1)(2010-3#1)
our knowledge the first##53##4##(2007-11#13)(2007-12#27)(2008-1#5)(2008-10#1)(2008-2#4)(2008-3#3)
our knowledge the##72##3##(2004-10#1)(2007-11#17)(2007-12#37)(2007-8#1)(2008-1#6)(2008-10#1)(2008-2#5)(2008-3#3)(2008-5#1)
our knowledge there are no reports##2##6##(2010-7#1)(2012-12#1)
our knowledge there##3##3##(2010-7#1)(2012-12#1)(2013-1#1)
our knowledge this is the first case##4##7##(1997-8#1)(2007-8#1)(2009-4#1)(2013-1#1)
our knowledge this is the first report of a##3##9##(1992-9#1)(2008-9#1)(2009-8#1)
our knowledge this is the first report of##9##8##(1992-4#1)(1992-9#1)(2007-12#1)(2007-8#2)(2008-9#1)(2009-8#1)(2012-3#1)(2013-8#1)
our knowledge this is the first report##12##7##(1992-4#1)(1992-9#1)(1997-4#1)(2007-12#1)(2007-8#2)(2008-5#1)(2008-9#1)(2009-3#1)(2009-8#1)(2012-3#1)(2013-8#1)
our knowledge this is the first##25##6##(1990-12#1)(1991-9#1)(1992-4#1)(1992-9#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#3)(2007-8#3)(2008-5#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
our knowledge this is the##31##5##(1990-12#1)(1991-9#1)(1992-4#1)(1992-9#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#4)(2007-7#1)(2007-8#3)(2008-5#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
our knowledge this is##32##4##(1990-12#1)(1991-9#1)(1992-4#1)(1992-9#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#5)(2007-7#1)(2007-8#3)(2008-5#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
our knowledge this##38##3##(1990-12#1)(1990-8#1)(1991-9#1)(1992-4#1)(1992-9#1)(1994-9#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#6)(2007-7#1)(2007-8#3)(2008-3#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
our knowledge##660##2##(1990-10#1)(1990-12#2)(1990-7#2)(1990-8#2)(1991-11#2)(1991-3#1)(1991-9#2)(1992-11#2)(1992-4#1)(1992-6#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-7#1)(1996-8#1)(1997-1#4)(1997-2#3)(1997-3#2)(1997-4#2)(1997-8#4)(2004-10#1)(2005-11#2)(2005-7#3)(2006-1#1)(2006-10#17)(2006-11#1)(2006-12#5)(2006-2#3)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#3)(2007-11#42)(2007-12#84)(2007-2#2)(2007-5#2)(2007-6#2)(2007-7#8)(2007-8#14)(2007-9#1)(2008-1#16)(2008-10#32)(2008-11#9)(2008-12#5)(2008-2#58)(2008-3#99)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#5)(2009-1#2)(2009-10#4)(2009-12#1)(2009-2#4)(2009-3#3)(2009-4#2)(2009-5#3)(2009-7#3)(2009-8#2)(2010-11#3)(2010-12#9)(2010-2#4)(2010-3#4)(2010-4#1)(2010-5#4)(2010-6#3)(2010-7#4)(2010-8#1)(2011-1#10)(2011-12#3)(2011-2#13)(2012-1#3)(2012-12#10)(2012-2#18)(2012-3#8)(2013-1#27)(2013-7#4)(2013-8#9)
our knowledge)##3##2##(2008-2#1)(2008-3#1)(2012-2#1)
our lab##15##2##(1996-12#1)(2006-11#1)(2007-11#1)(2008-10#2)(2008-6#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-8#1)(2011-2#1)(2013-1#1)
our laboratories##9##2##(1991-12#1)(1993-11#1)(1997-2#1)(2008-10#4)(2008-4#1)(2012-2#1)
our laboratory demonstrated##2##3##(2009-4#1)(2009-8#1)
our laboratory for##4##3##(1991-8#1)(1992-12#1)(1996-1#1)(2008-10#1)
our laboratory has focused on##2##5##(1996-11#1)(2010-3#1)
our laboratory has shown that##2##5##(1996-8#1)(2006-6#1)
our laboratory has##6##3##(1996-11#1)(1996-8#1)(2006-5#1)(2006-6#1)(2009-3#1)(2010-3#1)
our laboratory have demonstrated that##3##5##(1991-2#1)(1995-7#1)(2005-7#1)
our laboratory have demonstrated##4##4##(1991-2#1)(1993-6#1)(1995-7#1)(2005-7#1)
our laboratory have shown that##2##5##(1996-9#1)(2008-10#1)
our laboratory have shown##3##4##(1996-9#1)(2008-10#1)(2008-7#1)
our laboratory have##11##3##(1991-2#1)(1993-6#1)(1994-10#1)(1995-7#1)(1996-9#1)(2005-7#1)(2007-11#3)(2008-10#1)(2008-7#1)
our laboratory indicate that##2##4##(1993-4#1)(2007-11#1)
our laboratory showed that##3##4##(1992-5#1)(1993-1#1)(2009-8#1)
our laboratory that##2##3##(1996-4#1)(2006-6#1)
our laboratory to##3##3##(2008-3#1)(2008-5#1)(2009-12#1)
our laboratory##109##2##(1991-10#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-1#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#3)(1997-6#2)(2005-7#1)(2006-12#1)(2006-5#1)(2006-6#3)(2006-8#2)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#4)(2008-7#4)(2008-8#3)(2008-9#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-8#1)
our lack of knowledge##3##4##(1993-12#1)(1997-1#1)(2010-1#1)
our laser##3##2##(2007-11#2)(2008-3#1)
our latest##3##2##(2005-9#1)(2009-6#1)(2011-1#1)
our life##3##2##(2008-1#1)(2008-10#1)(2009-12#1)
our limited experience##2##3##(1991-9#1)(2007-8#1)
our limited knowledge of##2##4##(2012-2#1)(2012-3#1)
our limited understanding of##2##4##(2004-4#1)(2007-12#1)
our limited##6##2##(1991-9#1)(2004-4#1)(2007-12#1)(2007-8#1)(2012-2#1)(2012-3#1)
our literature review##2##3##(2006-10#1)(2008-8#1)
our literature##3##2##(2006-10#1)(2008-8#1)(2012-2#1)
our lives##5##2##(1993-2#1)(2008-11#1)(2008-2#1)(2011-2#1)(2012-2#1)
our local##2##2##(1993-2#1)(2013-8#1)
our long-term results##2##3##(2007-8#1)(2012-2#1)
our longitudinal##2##2##(2008-7#1)(2011-2#1)
our main##6##2##(1991-2#1)(1994-2#1)(2008-10#1)(2008-2#1)(2008-3#2)
our major##5##2##(2006-12#1)(2008-2#1)(2008-5#1)(2009-12#1)(2011-2#1)
our management##3##2##(2007-10#1)(2008-10#1)(2008-9#1)
our material##9##2##(1995-4#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#3)(2013-7#1)
our measured##2##2##(2008-3#2)
our measurement protocol##2##3##(1997-6#2)
our measurement##8##2##(1990-10#1)(1997-6#2)(2007-12#2)(2008-10#1)(2008-3#1)(2012-2#1)
our measurements##12##2##(1991-5#1)(1992-12#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#5)(2008-8#1)
our mechanistic##2##2##(2005-11#1)(2008-11#1)
our medical school##2##3##(2007-11#1)(2008-10#1)
our medical service##3##3##(2008-3#3)
our medical##13##2##(1992-9#1)(1997-1#1)(2005-1#1)(2007-11#2)(2008-10#1)(2008-3#3)(2008-7#1)(2012-12#2)(2012-2#1)
our members##2##2##(1997-3#1)(2011-2#1)
our method also helps to model behavior of annotators##2##9##(2013-1#2)
our method also##4##3##(2013-1#4)
our method are##2##3##(2008-3#1)(2008-6#1)
our method for##4##3##(1991-2#1)(2007-8#1)(2008-3#1)(2008-5#1)
our method generates##2##3##(2008-3#1)(2008-5#1)
our method have##2##3##(2007-12#1)(2008-3#1)
our method in##2##3##(2007-6#1)(2010-7#1)
our method is##7##3##(2007-12#1)(2008-10#1)(2008-2#2)(2008-7#1)(2012-3#1)(2013-1#1)
our method on##2##3##(2008-12#1)(2013-1#1)
our method to##8##3##(2007-12#1)(2008-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
our method using##3##3##(2007-7#1)(2013-1#2)
our method we##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
our method with##3##3##(2008-2#1)(2013-1#2)
our method##71##2##(1991-2#1)(1995-10#1)(2007-11#1)(2007-12#8)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#12)(2008-3#9)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2012-2#1)(2012-3#6)(2013-1#12)
our methodology##7##2##(1997-6#1)(2004-11#1)(2007-7#1)(2008-3#2)(2013-1#2)
our methods for adapting it to informatics##2##7##(2013-1#2)
our methods to##3##3##(2006-10#1)(2013-1#2)
our methods with##2##3##(2010-8#1)(2012-3#1)
our methods##16##2##(1993-5#1)(2006-10#1)(2008-10#1)(2008-6#1)(2010-8#2)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#6)
our microarray##2##2##(2008-7#1)(2009-8#1)
our model and##5##3##(1990-11#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-8#1)
our model for##2##3##(1997-2#1)(2008-2#1)
our model is##2##3##(2007-12#1)(2008-7#1)
our model of the##2##4##(1992-1#1)(2011-2#1)
our model of##7##3##(1992-1#1)(1993-4#1)(1996-7#1)(2006-10#1)(2008-9#1)(2011-2#1)(2012-2#1)
our model predicts##4##3##(2008-8#3)(2012-2#1)
our model the##2##3##(1996-2#1)(2008-3#1)
our model to include##2##4##(1992-3#1)(1994-2#1)
our model to##4##3##(1992-3#1)(1994-2#1)(2008-3#1)(2012-12#1)
our model##69##2##(1990-11#1)(1990-7#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-4#2)(1993-8#1)(1994-2#1)(1995-3#1)(1996-2#3)(1996-7#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#5)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#5)(2008-6#2)(2008-7#2)(2008-8#8)(2008-9#2)(2009-12#1)(2009-3#1)(2009-8#2)(2010-10#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)
our model's##2##2##(2008-8#1)(2013-8#1)
our modeling##2##2##(2008-3#1)(2013-8#1)
our models##5##2##(1996-4#1)(2008-10#1)(2008-11#1)(2008-8#2)
our modern##3##2##(2006-12#1)(2011-2#1)(2012-2#1)
our modification##3##2##(2006-10#1)(2006-3#1)(2006-7#1)
our molecular and##2##3##(1997-4#1)(2012-1#1)
our molecular##5##2##(1997-4#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-2#1)
our moral##3##2##(2008-11#3)
our most##5##2##(1997-8#1)(2006-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
our mouse model##4##3##(2008-10#1)(2008-11#2)(2010-3#1)
our multidisciplinary team##2##3##(2007-9#1)(2013-1#1)
our nation's health##5##3##(1995-2#1)(1995-3#1)(1996-12#1)(1997-2#1)(2010-1#1)
our nation's##11##2##(1993-2#1)(1994-12#1)(1995-2#2)(1995-3#1)(1996-12#1)(1996-2#1)(1997-2#1)(2004-1#1)(2005-10#1)(2010-1#1)
our national##3##2##(1990-2#1)(1994-2#1)(2008-9#1)
our natural##2##2##(2008-5#1)(2012-11#1)
our new method##3##3##(2008-5#1)(2012-2#1)(2013-1#1)
our new##22##2##(1990-8#1)(1991-9#1)(1993-4#1)(1994-11#1)(1996-12#1)(2005-11#1)(2006-3#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
our newly developed##2##3##(2008-2#1)(2010-8#1)
our newly##3##2##(2008-10#1)(2008-2#1)(2010-8#1)
our notion##2##2##(1995-12#1)(2008-2#1)
our novel##5##2##(2008-6#1)(2008-9#1)(2012-1#1)(2012-3#2)
our numerical model##2##3##(2008-3#2)
our numerical##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
our objective was to##2##4##(2010-4#1)(2011-1#1)
our objective##4##2##(1996-8#1)(2010-4#1)(2011-1#1)(2012-2#1)
our observation of the##2##4##(1992-3#1)(2007-12#1)
our observation of##4##3##(1992-3#1)(1995-10#1)(2007-12#1)(2009-12#1)
our observation that the##2##4##(1990-7#1)(2010-9#1)
our observation that##3##3##(1990-7#1)(2010-9#1)(2011-2#1)
our observation##14##2##(1990-7#1)(1991-3#1)(1991-6#1)(1992-3#1)(1995-10#1)(1996-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-12#1)(2010-9#1)(2011-2#1)(2012-12#1)
our observations are##2##3##(1997-6#1)(2008-7#1)
our observations of the##2##4##(1995-1#1)(2007-11#1)
our observations of##4##3##(1995-1#1)(1996-12#1)(2007-11#1)(2008-2#1)
our observations##13##2##(1995-1#1)(1996-12#1)(1996-5#1)(1997-6#1)(2006-7#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-7#2)(2009-8#1)(2013-1#1)
our ongoing study##2##3##(1997-5#1)(2008-5#1)
our ongoing##7##2##(1997-5#1)(2008-1#1)(2008-5#1)(2009-6#1)(2010-12#1)(2011-3#1)(2012-2#1)
our operating##2##2##(1994-1#1)(2013-8#1)
our opinion is##2##3##(1990-6#1)(2008-11#1)
our opinion##30##2##(1990-11#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-8#1)(1993-8#1)(1996-11#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-7#3)(2007-8#3)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-12#1)(2013-8#2)
our optical##8##2##(2007-11#1)(2008-2#2)(2008-3#5)
our optimized##3##2##(2008-11#2)(2008-5#1)
our original method##2##3##(2008-10#1)(2008-3#1)
our original##8##2##(1991-8#1)(1995-6#1)(2007-8#2)(2008-10#1)(2008-3#1)(2009-10#1)(2010-6#1)
our outpatient clinic because of##2##5##(1996-1#1)(1997-4#1)
our outpatient clinic##4##3##(1996-1#1)(1997-4#1)(2007-10#1)(2013-8#1)
our outpatient##5##2##(1996-1#1)(1997-4#1)(2007-10#1)(2010-12#1)(2013-8#1)
our own clinical experience##2##4##(2009-8#2)
our own clinical##3##3##(2007-7#1)(2009-8#2)
our own efforts##2##3##(2010-12#1)(2012-2#1)
our own experience with##3##4##(2007-7#1)(2007-8#1)(2010-8#1)
our own experience##13##3##(1993-10#1)(1997-7#1)(2005-11#1)(2006-6#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2010-12#1)(2010-8#1)(2011-2#1)
our own experiences##4##3##(1995-4#1)(2007-8#1)(2008-12#1)(2009-1#1)
our own laboratory##2##3##(1996-8#1)(2011-1#1)
our own patients##2##3##(1992-8#1)(2010-2#1)
our own research##4##3##(1997-1#1)(2007-9#1)(2010-2#1)(2013-1#1)
our own series##3##3##(1993-10#1)(2007-7#1)(2012-3#1)
our own studies##2##3##(1991-2#1)(1995-4#1)
our own##76##2##(1990-12#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-8#1)(1993-10#2)(1993-11#1)(1993-3#1)(1994-1#1)(1995-4#2)(1996-8#1)(1997-1#2)(1997-7#2)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#5)(2007-8#5)(2007-9#1)(2008-1#2)(2008-11#2)(2008-12#4)(2008-3#2)(2008-6#1)(2008-7#4)(2008-8#2)(2009-1#1)(2009-5#1)(2009-8#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
our paediatric##2##2##(2006-9#1)(2008-10#1)
our paper##9##2##(2005-11#1)(2006-3#1)(2007-7#2)(2007-8#1)(2008-1#1)(2013-1#3)
our particular##2##2##(2011-1#1)(2012-2#1)
our pathways##2##2##(2008-3#2)
our patient did not##2##4##(2005-11#1)(2010-6#1)
our patient fulfilled the diagnostic criteria for phenotypic expression of Marfan syndrome##2##12##(2013-1#2)
our patient had##4##3##(2007-10#1)(2007-2#1)(2010-7#1)(2012-2#1)
our patient is##2##3##(1994-11#1)(1994-6#1)
our patient presented with##2##4##(2006-10#1)(2011-2#1)
our patient was##5##3##(1992-12#1)(2007-2#1)(2009-3#2)(2012-2#1)
our patient who was##2##4##(2007-8#1)(2009-2#1)
our patient##65##2##(1992-12#1)(1994-11#1)(1994-6#1)(1995-8#1)(1996-6#1)(1996-8#2)(1997-6#1)(2004-2#1)(2005-11#1)(2006-1#2)(2006-10#6)(2006-12#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#6)(2009-6#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#2)
our patient's##3##2##(2007-8#1)(2008-9#1)(2012-3#1)
our patients and##5##3##(2006-10#1)(2007-5#1)(2007-8#1)(2013-1#1)(2013-8#1)
our patients are##3##3##(1995-10#1)(2006-10#1)(2007-2#1)
our patients in##4##3##(2007-7#1)(2009-2#1)(2010-2#1)(2012-3#1)
our patients there##2##3##(2011-2#1)(2013-1#1)
our patients was##2##3##(2007-7#1)(2012-12#1)
our patients were##4##3##(2008-1#2)(2008-7#1)(2008-9#1)
our patients with##11##3##(1990-8#1)(1993-11#1)(1996-3#1)(2006-10#1)(2007-7#3)(2008-1#1)(2008-8#1)(2011-2#1)(2012-2#1)
our patients##100##2##(1990-6#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#1)(1994-7#2)(1995-10#1)(1996-3#1)(1997-3#1)(1997-5#1)(2005-10#1)(2006-10#8)(2006-3#1)(2006-4#1)(2006-6#2)(2007-10#1)(2007-2#5)(2007-3#2)(2007-4#2)(2007-5#1)(2007-7#10)(2007-8#5)(2008-1#8)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
our patients'##2##2##(1997-3#1)(2006-10#1)
our patients?##2##2##(1993-8#1)(2007-8#1)
our personal experience##2##3##(2006-2#1)(2009-4#1)
our personal##3##2##(2006-2#1)(2007-7#1)(2009-4#1)
our pilot##3##2##(2007-7#2)(2010-12#1)
our pioneers##2##2##(2008-9#1)(2011-2#1)
our planet##3##2##(2010-5#1)(2012-1#1)(2013-8#1)
our policy##3##2##(1992-1#1)(2005-7#1)(2008-7#1)
our population ages##4##3##(1996-2#1)(2005-7#1)(2006-9#1)(2012-3#1)
our population and##2##3##(2007-7#2)
our population##31##2##(1990-3#1)(1992-11#1)(1992-4#1)(1994-11#1)(1994-12#1)(1995-12#1)(1996-2#1)(2005-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-8#1)(2009-3#1)(2010-1#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
our practice##7##2##(1996-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-9#1)(2010-4#1)(2011-2#1)
our predictions##6##2##(1992-3#1)(1996-9#1)(1997-2#1)(2008-8#1)(2010-2#1)(2013-1#1)
our preliminary experience##2##3##(2007-8#2)
our preliminary results##3##3##(2008-3#1)(2008-8#1)(2010-4#1)
our preliminary study##3##3##(2006-6#1)(2013-1#2)
our preliminary##12##2##(1990-6#1)(1995-2#1)(2003-11#1)(2006-6#1)(2007-7#1)(2007-8#2)(2008-3#1)(2008-8#1)(2010-4#1)(2013-1#2)
our present results##3##3##(1991-5#1)(1997-2#1)(1997-7#1)
our present study##2##3##(2008-10#1)(2011-2#1)
our present understanding##2##3##(1990-12#1)(2008-10#1)
our present##17##2##(1990-10#1)(1990-12#1)(1990-8#1)(1991-4#1)(1991-5#1)(1995-12#1)(1997-2#1)(1997-7#2)(2007-10#1)(2008-10#2)(2008-12#1)(2008-2#1)(2010-5#1)(2010-7#1)(2011-2#1)
our presentation will actively engage the audience in a discussion of what an evidence-based approach to implementation might mean at different institutions and explore practical implications of Implementation Science for decision-makers and technology implementers##2##34##(2013-1#2)
our presentation##3##2##(2009-8#1)(2013-1#2)
our previous data##2##3##(2008-10#2)
our previous finding that##4##4##(1990-8#1)(1993-7#1)(1996-12#1)(1996-6#1)
our previous finding##6##3##(1990-8#1)(1993-7#1)(1995-7#1)(1996-12#1)(1996-6#1)(2008-9#1)
our previous findings of##2##4##(2008-10#2)
our previous findings that##2##4##(1991-10#1)(1996-12#1)
our previous findings##13##3##(1991-10#1)(1993-1#1)(1994-3#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-5#2)(2006-6#1)(2008-10#2)(2008-8#1)
our previous observations##5##3##(1991-4#1)(1992-6#1)(1994-3#1)(1995-12#1)(1995-2#1)
our previous report##10##3##(1991-4#1)(1992-8#1)(1994-8#1)(1997-8#1)(2008-10#1)(2010-12#1)(2012-12#3)(2013-8#1)
our previous research##4##3##(2008-3#1)(2010-12#1)(2012-3#1)(2013-8#1)
our previous results##8##3##(1990-8#1)(1992-4#1)(1996-10#1)(1996-2#1)(1997-2#1)(1997-6#1)(2008-12#1)(2009-8#1)
our previous studies on##2##4##(2008-9#1)(2013-1#1)
our previous studies##7##3##(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(2008-8#1)(2008-9#1)(2013-1#1)
our previous study##17##3##(1991-2#1)(1993-11#1)(1993-12#1)(1993-5#2)(1993-6#1)(1994-8#1)(1997-6#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-9#1)(2011-1#1)(2012-2#1)
our previous work##17##3##(1992-2#1)(1994-10#1)(1994-2#1)(1997-2#1)(1997-5#1)(2005-9#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-7#1)(2010-11#1)(2012-1#1)(2012-11#1)(2013-1#2)
our previous##123##2##(1990-12#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-2#2)(1991-4#2)(1992-12#2)(1992-2#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#2)(1993-6#1)(1993-7#1)(1994-10#1)(1994-11#2)(1994-2#3)(1994-3#3)(1994-8#3)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-7#2)(1996-10#1)(1996-12#2)(1996-2#3)(1996-4#1)(1996-5#2)(1996-6#1)(1997-2#2)(1997-5#1)(1997-6#2)(1997-8#1)(2005-10#1)(2005-9#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-11#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#2)
our previously described##2##3##(1996-2#1)(2012-3#1)
our previously published##2##3##(2008-2#1)(2008-8#1)
our previously reported##2##3##(1990-12#1)(1997-4#1)
our previously##8##2##(1990-12#1)(1992-1#1)(1995-11#1)(1996-2#1)(1997-4#1)(2008-2#1)(2008-8#1)(2012-3#1)
our primary##6##2##(1995-8#1)(2007-3#1)(2008-7#1)(2013-1#1)(2013-8#2)
our prior##3##2##(1996-5#1)(2013-1#2)
our procedure##5##2##(1995-12#1)(1997-2#1)(2008-4#1)(2010-1#1)(2012-3#1)
our procedures##2##2##(1992-6#1)(2008-3#1)
our production##2##2##(1994-6#1)(2008-11#1)
our products##3##2##(2008-10#2)(2008-5#1)
our profession##11##2##(1992-2#1)(1993-12#1)(1994-12#1)(1995-1#2)(1996-2#1)(2007-4#1)(2008-4#2)(2008-5#1)(2012-2#1)
our professional##4##2##(1996-2#1)(2008-12#1)(2008-6#1)(2012-3#1)
our program##5##2##(1994-9#1)(1997-5#1)(2006-9#1)(2007-4#1)(2011-2#1)
our progress##2##2##(1995-11#1)(2009-4#1)
our proposal##10##2##(1994-5#1)(1997-1#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2009-4#1)
our proposed design##2##3##(2008-3#1)(2012-2#1)
our proposed##16##2##(1992-5#1)(1994-5#1)(2007-12#1)(2008-2#4)(2008-3#1)(2008-6#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
our prospective study##3##3##(1997-8#1)(2007-9#1)(2008-5#1)
our prospective##4##2##(1997-8#1)(2007-9#1)(2008-5#1)(2011-2#1)
our protocol##5##2##(1992-6#1)(2007-7#1)(2008-8#1)(2012-12#1)(2012-3#1)
our prototype##2##2##(2007-12#1)(2008-3#1)
our quality of##2##3##(2008-7#2)
our quantitative##2##2##(1992-8#1)(2008-10#1)
our quest##2##2##(2006-12#1)(2013-1#1)
our readers##4##2##(2008-8#2)(2009-9#2)
our recent data##2##3##(1993-6#1)(2008-5#1)
our recent experience with##2##4##(2004-9#1)(2007-5#1)
our recent experience##4##3##(2004-9#1)(2006-6#1)(2007-5#1)(2008-7#1)
our recent finding that##2##4##(1992-5#1)(2009-8#1)
our recent findings##2##3##(1994-8#1)(2009-8#1)
our recent paper in##6##4##(2009-6#1)(2009-8#5)
our recent paper##10##3##(2009-6#2)(2009-8#7)(2010-12#1)
our recent report##2##3##(2009-8#2)
our recent studies on the##4##5##(2004-11#1)(2008-4#1)(2008-5#1)(2011-2#1)
our recent studies##9##3##(1996-4#1)(1997-2#1)(2004-11#1)(2006-11#1)(2008-4#1)(2008-5#1)(2010-2#1)(2011-2#2)
our recent study##3##3##(2009-8#2)(2011-2#1)
our recent work##7##3##(1994-11#1)(2005-10#1)(2007-5#1)(2009-2#1)(2009-3#1)(2009-8#1)(2013-8#1)
our recent##60##2##(1991-8#1)(1992-11#1)(1992-5#1)(1993-6#1)(1994-11#1)(1994-8#2)(1996-4#1)(1997-2#1)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#1)(2006-11#1)(2006-3#1)(2006-4#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-6#2)(2009-8#16)(2010-12#1)(2010-2#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-8#1)
our recently developed##2##3##(2006-10#1)(2013-1#1)
our recently##5##2##(2006-10#1)(2006-12#1)(2008-10#1)(2008-3#1)(2013-1#1)
our recommendations##5##2##(2007-11#1)(2008-12#1)(2011-2#2)(2012-3#1)
our region##7##2##(2007-9#1)(2008-1#1)(2009-4#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-2#1)
our renal transplant##2##3##(2007-7#1)(2008-1#1)
our renal##4##2##(2007-7#2)(2008-1#2)
our report##2##2##(2007-7#1)(2009-9#1)
our research group##5##3##(2011-1#1)(2012-12#3)(2013-1#1)
our research##45##2##(1990-5#1)(1990-6#1)(1991-12#1)(1993-5#1)(1994-5#1)(1996-9#1)(2005-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#7)(2007-8#6)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-1#3)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#3)(2013-8#1)
our responsibilities##2##2##(1996-2#1)(2008-11#1)
our responsibility##2##2##(1994-1#1)(2010-5#1)
our result##4##2##(1994-8#1)(1994-9#1)(2008-10#1)(2009-2#1)
our results also##4##3##(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
our results and the##2##4##(2008-10#1)(2008-2#1)
our results and##9##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-5#2)(2009-8#1)(2011-1#1)
our results are consistent with##3##5##(2008-10#1)(2008-8#1)(2009-12#1)
our results are##10##3##(1993-11#1)(1993-7#1)(1995-6#1)(1997-8#1)(2008-10#2)(2008-2#1)(2008-8#2)(2009-12#1)
our results by##2##3##(2007-12#1)(2013-1#1)
our results demonstrate that the##2##5##(2008-5#1)(2011-2#1)
our results demonstrate that##11##4##(1994-6#1)(1996-8#1)(1997-1#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
our results demonstrate the##4##4##(1996-10#1)(2008-7#1)(2012-2#1)(2013-8#1)
our results demonstrate##16##3##(1994-6#1)(1996-10#1)(1996-8#1)(1997-1#1)(1997-7#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
our results demonstrated that##2##4##(2008-7#1)(2010-1#1)
our results demonstrated##4##3##(2007-8#1)(2008-7#1)(2008-8#1)(2010-1#1)
our results do not support##3##5##(1994-10#1)(2008-11#1)(2013-1#1)
our results do not##5##4##(1994-10#1)(1997-5#1)(2008-11#1)(2008-7#1)(2013-1#1)
our results for the##2##4##(2008-2#1)(2008-3#1)
our results for##6##3##(2008-2#1)(2008-3#2)(2008-9#1)(2013-1#2)
our results in##4##3##(1993-4#1)(2008-6#1)(2008-8#1)(2010-2#1)
our results indicate that the##6##5##(1993-9#1)(1994-3#1)(1995-12#1)(2008-7#1)(2010-5#1)(2011-2#1)
our results indicate that##17##4##(1991-10#1)(1993-9#1)(1994-3#1)(1994-4#1)(1995-1#1)(1995-12#1)(1995-2#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
our results indicate##18##3##(1991-10#1)(1993-9#1)(1994-3#1)(1994-4#1)(1995-1#1)(1995-12#1)(1995-2#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
our results is that##3##4##(1991-12#1)(1994-5#1)(2008-10#1)
our results of##2##3##(2007-8#1)(2012-1#1)
our results on##5##3##(1993-9#1)(2003-11#1)(2005-11#1)(2008-2#1)(2011-2#1)
our results provide##3##3##(1995-11#1)(2008-4#1)(2010-12#1)
our results show that the##4##5##(1994-8#1)(1997-2#1)(1997-7#1)(2008-1#1)
our results show that##17##4##(1990-12#1)(1991-12#1)(1993-4#1)(1993-9#1)(1994-8#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-9#1)(2009-2#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-3#2)
our results show##20##3##(1990-12#1)(1991-12#1)(1993-4#1)(1993-9#1)(1994-8#1)(1995-11#1)(1995-12#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-9#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-3#2)
our results showed that##5##4##(1990-12#1)(1994-2#1)(2008-10#1)(2008-9#1)(2009-3#1)
our results showed##6##3##(1990-12#1)(1994-2#1)(2008-10#1)(2008-9#1)(2009-3#2)
our results strongly suggest that##2##5##(1990-3#1)(2009-3#1)
our results suggest a##2##4##(1996-10#1)(2013-8#1)
our results suggest an##2##4##(1995-3#1)(2005-10#1)
our results suggest that the##10##5##(1991-6#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-12#1)(1995-2#1)(2006-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
our results suggest that this##2##5##(2008-11#1)(2012-3#1)
our results suggest that##38##4##(1990-4#1)(1991-1#1)(1991-6#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1997-8#1)(2006-12#1)(2008-10#1)(2008-11#3)(2008-4#3)(2009-10#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
our results suggest the##2##4##(1990-2#1)(2007-3#1)
our results suggest##44##3##(1990-2#1)(1990-4#1)(1991-1#1)(1991-6#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-10#1)(1997-8#1)(2005-10#1)(2006-12#1)(2007-3#1)(2008-10#1)(2008-11#3)(2008-4#3)(2009-10#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#2)
our results suggested that##2##4##(2008-8#2)
our results support the##5##4##(1995-12#1)(1997-2#2)(2010-10#1)(2013-8#1)
our results to##5##3##(2007-9#1)(2008-10#1)(2008-3#1)(2012-3#1)(2013-1#1)
our results we##3##3##(1990-5#1)(1990-9#1)(2011-1#1)
our results were##2##3##(2007-3#1)(2008-2#1)
our results with those##5##4##(2006-7#1)(2007-7#1)(2008-2#1)(2008-7#2)
our results with##8##3##(1990-2#1)(2006-7#1)(2007-6#1)(2007-7#1)(2008-2#1)(2008-7#3)
our results##255##2##(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#3)(1993-2#1)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#3)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#6)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#2)(1996-10#2)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#2)(2003-11#1)(2004-4#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-3#2)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#16)(2008-11#5)(2008-2#8)(2008-3#6)(2008-4#5)(2008-5#7)(2008-6#2)(2008-7#10)(2008-8#9)(2008-9#3)(2009-10#1)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#4)(2010-3#1)(2010-5#2)(2010-6#2)(2010-7#2)(2011-1#4)(2011-12#1)(2011-2#9)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#10)(2013-1#6)(2013-8#5)
our retrospective study##3##3##(2007-7#1)(2008-7#1)(2013-1#1)
our review of the literature##2##5##(2008-6#1)(2008-7#1)
our review of the##4##4##(2008-6#1)(2008-7#1)(2009-10#1)(2013-1#1)
our review##12##2##(1992-5#1)(2006-10#1)(2006-6#1)(2008-11#1)(2008-4#1)(2008-6#2)(2008-7#2)(2009-10#1)(2009-8#1)(2013-1#1)
our role as##2##3##(1995-3#1)(2008-10#1)
our role##3##2##(1995-3#1)(2004-8#1)(2008-10#1)
our roles##2##2##(1996-12#1)(2008-10#1)
our routine##2##2##(2006-9#1)(2012-2#1)
our routines##2##2##(1993-5#2)
our sample of women##2##4##(2008-3#1)(2011-2#1)
our sample of##7##3##(1995-11#1)(1997-5#1)(2006-9#1)(2008-1#1)(2008-3#1)(2011-1#1)(2011-2#1)
our sample##19##2##(1992-2#1)(1993-11#1)(1995-11#2)(1996-7#1)(1997-5#1)(2006-9#1)(2007-10#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
our samples##8##2##(1996-2#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#1)
our scheme##5##2##(2007-12#2)(2008-2#1)(2009-10#1)(2009-5#1)
our scientists##2##2##(2009-12#1)(2012-12#1)
our scoring function##2##3##(2011-3#2)
our search for##3##3##(1996-8#1)(2007-4#1)(2012-3#1)
our search##5##2##(1996-8#1)(2007-4#1)(2010-12#1)(2011-2#1)(2012-3#1)
our second##3##2##(2008-6#1)(2008-8#1)(2012-12#1)
our sedation##2##2##(2006-10#1)(2012-2#1)
our sense of##2##3##(1996-2#1)(2008-7#1)
our sequence##3##2##(1990-4#1)(1995-8#1)(1996-4#1)
our series of##2##3##(1997-3#1)(2006-9#1)
our series##26##2##(1990-12#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-8#1)(1993-5#2)(1993-8#1)(1997-3#1)(2006-6#1)(2006-9#2)(2007-10#1)(2007-11#1)(2007-7#5)(2007-8#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-1#1)(2012-3#1)
our service##3##2##(2007-7#1)(2007-8#1)(2008-5#1)
our services##2##2##(1994-12#1)(2005-9#1)
our setting##10##2##(1995-10#1)(1996-9#1)(2009-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
our setup##8##2##(2006-4#1)(2007-11#2)(2007-12#1)(2008-2#2)(2008-5#1)(2009-8#1)
our simple##6##2##(2007-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2009-5#1)
our simulation##8##2##(1990-8#1)(2008-2#2)(2008-3#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-3#1)
our simulations##4##2##(1993-12#1)(2007-12#1)(2008-12#1)(2008-2#1)
our social##2##2##(2008-10#1)(2008-11#1)
our society##27##2##(1990-9#1)(1994-12#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1997-2#2)(2005-10#1)(2005-11#1)(2006-5#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#3)(2009-9#1)(2011-1#1)(2011-2#1)
our software##2##2##(1995-6#1)(2009-2#1)
our species##2##2##(1997-4#1)(2008-8#1)
our specific##3##2##(1996-2#1)(2008-3#1)(2010-10#1)
our staff##2##2##(1991-12#2)
our standard##3##2##(1993-12#1)(2009-3#1)(2010-8#1)
our standards##2##2##(1997-7#1)(2011-1#1)
our state and##2##3##(1995-1#1)(1996-2#1)
our state##3##2##(1995-1#1)(1996-2#1)(2010-9#1)
our strategy##2##2##(1995-7#1)(2012-3#1)
our structure##2##2##(1996-7#1)(2007-12#1)
our studies are##2##3##(1994-6#1)(1996-3#1)
our studies of the##2##4##(2008-11#1)(2008-3#1)
our studies of##5##3##(1991-12#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-3#1)
our studies on##3##3##(1992-1#1)(2006-12#1)(2008-7#1)
our studies revealed##2##3##(2008-12#1)(2011-2#1)
our studies##26##2##(1991-12#1)(1992-1#1)(1992-2#1)(1994-6#1)(1995-1#1)(1995-4#1)(1996-10#1)(1996-3#1)(1997-4#1)(2006-12#1)(2006-6#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)
our study and##4##3##(2008-10#1)(2008-7#1)(2009-3#1)(2009-6#1)
our study area##2##3##(2006-4#1)(2007-5#1)
our study demonstrated##2##3##(1995-11#1)(2007-11#1)
our study demonstrates##2##3##(2007-8#1)(2012-11#1)
our study for##2##3##(2008-9#1)(2010-12#1)
our study indicate that##4##4##(2007-7#1)(2008-4#1)(2009-9#1)(2013-1#1)
our study indicates that##3##4##(1992-9#1)(2008-11#1)(2012-2#1)
our study is the##3##4##(2006-8#1)(2008-11#1)(2008-3#1)
our study is##19##3##(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-11#2)(2008-3#1)(2008-6#1)(2009-3#1)(2009-6#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
our study of##6##3##(1991-5#1)(1991-6#1)(1992-10#1)(2008-2#1)(2009-8#1)(2012-12#1)
our study population##5##3##(1990-2#1)(2006-8#1)(2007-3#1)(2012-1#1)(2013-1#1)
our study provides##2##3##(2009-9#1)(2013-1#1)
our study revealed##2##3##(2009-5#1)(2012-3#1)
our study reveals##2##3##(2012-2#1)(2013-1#1)
our study sample##2##3##(2006-11#1)(2012-3#1)
our study show##4##3##(2008-1#1)(2008-11#1)(2008-3#1)(2009-4#1)
our study showed that the##2##5##(2011-2#2)
our study showed that##5##4##(2008-4#1)(2008-7#1)(2011-2#2)(2013-1#1)
our study shows that##2##4##(2008-3#1)(2008-9#1)
our study shows##3##3##(2008-3#1)(2008-9#1)(2012-12#1)
our study suggest that the##3##5##(1992-12#1)(1997-3#1)(2011-2#1)
our study suggest that##4##4##(1992-12#1)(1997-3#1)(2008-8#1)(2011-2#1)
our study suggest##6##3##(1992-12#1)(1997-3#1)(2007-2#1)(2008-8#1)(2011-1#1)(2011-2#1)
our study suggests that##8##4##(2007-7#1)(2008-1#1)(2008-10#1)(2008-6#1)(2010-10#1)(2010-12#1)(2011-1#1)(2013-7#1)
our study suggests##10##3##(1996-12#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-6#1)(2010-10#1)(2010-12#1)(2011-1#1)(2013-7#1)
our study supports##2##3##(1996-12#1)(2008-7#1)
our study that##2##3##(2008-10#1)(2012-12#1)
our study the##2##3##(2007-9#1)(2011-7#1)
our study to##4##3##(2008-10#1)(2008-2#1)(2009-12#1)(2009-8#1)
our study was##100##3##(1990-5#1)(1991-3#1)(1993-12#1)(1995-6#1)(1997-8#3)(2004-9#1)(2006-10#3)(2006-11#2)(2006-6#2)(2006-8#2)(2007-1#1)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#23)(2007-8#15)(2007-9#3)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-7#1)(2011-1#2)(2011-2#6)(2012-12#1)(2012-3#2)(2012-6#1)(2013-1#4)(2013-7#1)(2013-8#3)
our study we present##2##4##(1993-8#1)(2008-5#1)
our study we wanted to##3##5##(2008-10#1)(2011-2#1)(2013-1#1)
our study we##14##3##(1990-2#1)(1993-8#1)(2005-10#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
our study were##7##3##(1994-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#2)
our study##330##2##(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#3)(1991-3#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-8#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-6#2)(1997-3#1)(1997-5#1)(1997-8#3)(2004-9#1)(2005-10#2)(2005-11#1)(2006-10#4)(2006-11#4)(2006-12#1)(2006-4#1)(2006-6#4)(2006-8#6)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#1)(2007-2#2)(2007-3#4)(2007-5#2)(2007-6#1)(2007-7#32)(2007-8#18)(2007-9#7)(2008-1#4)(2008-10#14)(2008-11#6)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#4)(2008-5#7)(2008-6#3)(2008-7#5)(2008-8#6)(2008-9#4)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#2)(2009-8#4)(2009-9#2)(2010-1#2)(2010-10#2)(2010-12#8)(2010-2#3)(2010-3#1)(2010-4#3)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#12)(2011-2#21)(2011-7#3)(2012-1#3)(2012-11#2)(2012-12#6)(2012-2#5)(2012-3#11)(2012-6#1)(2013-1#17)(2013-7#3)(2013-8#4)
our subjective##2##2##(1997-8#1)(2004-9#1)
our subjects##2##2##(2008-7#2)
our subsequent##3##2##(2005-11#1)(2009-8#1)(2013-1#1)
our success##5##2##(1996-12#1)(2007-12#2)(2007-5#1)(2008-6#1)
our successful##2##2##(2006-10#1)(2007-12#1)
our surgical technique##2##3##(2007-8#2)
our surgical##5##2##(1990-5#1)(2007-8#2)(2011-2#1)(2013-8#1)
our surprise##2##2##(1992-11#1)(2008-6#1)
our system does not require annotated region level training data nor assumes perfect segmentation results for the regions of interest##2##20##(2013-1#2)
our system has##2##3##(2007-11#2)
our system in##2##3##(2008-7#1)(2011-1#1)
our system is a##2##4##(2008-10#1)(2008-9#1)
our system is##5##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#1)
our system with the##2##4##(1990-5#1)(2008-2#1)
our system##35##2##(1990-5#1)(1992-7#1)(1994-5#1)(1997-7#1)(2005-11#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#2)(2008-6#3)(2008-7#1)(2008-9#1)(2009-3#1)(2011-1#1)(2013-1#8)
our systematic investigation##2##3##(2007-12#1)(2008-8#1)
our systematic##5##2##(2006-12#1)(2007-12#1)(2008-2#1)(2008-8#1)(2013-1#1)
our systems##3##2##(2006-10#1)(2008-7#1)(2010-2#1)
our target##2##2##(2010-10#1)(2011-2#1)
our team conducted the first randomized control trial of a health information technology-based intervention that significantly reduced falls in acute care hospitals##2##22##(2013-1#2)
our team##9##2##(1993-5#1)(2006-10#1)(2008-10#2)(2012-3#1)(2013-1#4)
our technical##2##2##(1993-1#1)(2008-5#1)
our technique with##3##3##(2007-11#1)(2007-12#1)(2008-5#1)
our technique##11##2##(2006-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#2)(2010-11#1)(2013-1#1)(2013-7#1)
our techniques##2##2##(2008-2#1)(2009-11#1)
our tensor##2##2##(2008-6#2)
our territory##2##2##(2007-12#1)(2013-8#1)
our tertiary##4##2##(2007-8#1)(2011-2#1)(2013-1#2)
our test statistic##2##3##(1995-4#1)(2009-2#1)
our test##7##2##(1995-4#1)(1997-4#1)(2008-7#1)(2009-2#1)(2010-7#1)(2013-1#2)
our testing##2##2##(2008-10#1)(2011-2#1)
our theoretical analysis##2##3##(2005-11#1)(2008-2#1)
our theoretical results##2##3##(2008-2#2)
our theoretical##12##2##(1996-2#1)(2005-11#1)(2006-4#1)(2007-12#1)(2007-9#1)(2008-2#3)(2008-3#3)(2010-9#1)
our theory was##2##3##(2010-2#2)
our theory##6##2##(1994-2#1)(2005-11#1)(2008-11#1)(2008-8#1)(2010-2#2)
our therapeutic approach to##2##4##(1990-2#1)(2006-2#1)
our therapeutic approach##3##3##(1990-2#1)(1993-2#1)(2006-2#1)
our therapeutic##8##2##(1990-2#1)(1993-2#1)(1996-3#1)(2006-2#1)(2007-7#2)(2008-11#1)(2008-12#1)
our thinking about##2##3##(2008-8#1)(2009-8#1)
our thinking##3##2##(1994-1#1)(2008-8#1)(2009-8#1)
our time##4##2##(1994-8#1)(2009-4#1)(2010-4#1)(2011-2#1)
our time]##2##2##(1993-8#1)(1996-1#1)
our traditional##3##2##(2006-7#1)(2007-4#1)(2013-8#1)
our transform##2##2##(2008-6#2)
our transplant##4##2##(1995-2#1)(2006-10#1)(2008-1#2)
our treatment##8##2##(1990-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-6#1)(2010-3#1)
our two##2##2##(2007-9#1)(2008-5#1)
our undergraduate##2##2##(2005-10#1)(2013-1#1)
our understanding about the##2##4##(2011-2#1)(2012-1#1)
our understanding about##3##3##(2008-1#1)(2011-2#1)(2012-1#1)
our understanding and##2##3##(2006-10#1)(2008-7#1)
our understanding concerning##2##3##(2005-11#1)(2006-10#1)
our understanding in##4##3##(2006-10#1)(2008-10#1)(2010-1#1)(2010-6#1)
our understanding of (1)##2##4##(1993-3#1)(2007-11#1)
our understanding of both##2##4##(2010-3#1)(2012-1#1)
our understanding of cellular##2##4##(2005-7#1)(2008-7#1)
our understanding of disease##2##4##(2006-10#2)
our understanding of how these##3##5##(2005-11#1)(2007-12#1)(2011-2#1)
our understanding of how##15##4##(1993-12#1)(2005-11#1)(2006-10#4)(2007-12#2)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-9#1)(2011-2#1)
our understanding of immune##2##4##(2007-11#1)(2008-4#1)
our understanding of individual##2##4##(2007-4#1)(2012-1#1)
our understanding of the basic##3##5##(2007-12#1)(2013-1#2)
our understanding of the biological##2##5##(1996-6#1)(2008-7#1)
our understanding of the biology of the##3##7##(2008-10#1)(2008-3#1)(2008-7#1)
our understanding of the biology of##5##6##(2007-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#1)
our understanding of the biology##6##5##(2006-10#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#1)
our understanding of the complex##2##5##(2007-12#1)(2012-1#1)
our understanding of the disease##2##5##(1995-5#1)(2005-8#1)
our understanding of the ecology of##2##6##(2008-10#2)
our understanding of the epidemiology##3##5##(2006-10#1)(2008-1#1)(2009-10#1)
our understanding of the evolution##2##5##(1994-5#1)(2008-7#1)
our understanding of the function of##2##6##(2007-8#2)
our understanding of the genetic##4##5##(2008-11#1)(2008-7#1)(2012-11#1)(2012-2#1)
our understanding of the immunology of##2##6##(1992-12#1)(2006-10#1)
our understanding of the interaction between##3##6##(2006-10#1)(2013-1#2)
our understanding of the link between##2##6##(2009-12#1)(2009-9#1)
our understanding of the mechanisms of evolution##2##7##(2008-7#1)(2010-3#1)
our understanding of the mechanisms of##5##6##(2006-10#1)(2007-4#1)(2008-7#2)(2010-3#1)
our understanding of the mechanisms that##3##6##(2006-10#1)(2008-9#1)(2012-2#1)
our understanding of the mechanisms##11##5##(2006-10#4)(2007-4#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-3#1)(2012-2#1)
our understanding of the molecular mechanisms of##2##7##(2008-11#1)(2009-3#1)
our understanding of the molecular##5##5##(2007-8#1)(2008-11#1)(2009-3#1)(2009-9#1)(2011-1#1)
our understanding of the neural##2##5##(2009-9#1)(2012-2#1)
our understanding of the pathophysiology of##2##6##(2006-10#1)(2013-8#1)
our understanding of the pathophysiology##5##5##(2005-10#1)(2005-8#1)(2006-10#1)(2013-7#1)(2013-8#1)
our understanding of the physiology and##2##6##(2006-10#1)(2010-3#1)
our understanding of the process##2##5##(2007-8#1)(2011-2#1)
our understanding of the relationship between##2##6##(2006-10#1)(2012-5#1)
our understanding of the role of##9##6##(1992-2#1)(1996-5#1)(2007-12#1)(2008-5#1)(2010-11#1)(2010-9#1)(2011-1#1)(2012-1#1)(2013-1#1)
our understanding of the role##10##5##(1992-2#1)(1996-5#1)(2007-12#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-9#1)(2011-1#1)(2012-1#1)(2013-1#1)
our understanding of the roles##2##5##(2004-12#1)(2009-8#1)
our understanding of the##158##4##(1990-5#1)(1990-8#1)(1991-3#2)(1992-12#2)(1992-2#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#3)(2004-11#1)(2004-12#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-8#2)(2006-10#22)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-4#1)(2007-8#5)(2007-9#2)(2008-1#5)(2008-10#5)(2008-11#8)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#12)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#3)(2010-11#1)(2010-2#1)(2010-3#2)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#2)(2012-1#4)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#7)(2013-7#1)(2013-8#2)
our understanding of their effects##2##5##(2006-10#1)(2008-1#1)
our understanding of their##5##4##(2006-10#2)(2008-1#1)(2008-10#1)(2011-1#1)
our understanding of these##9##4##(2007-6#1)(2007-7#1)(2009-3#1)(2009-5#2)(2010-5#1)(2012-2#1)(2012-3#1)(2013-8#1)
our understanding of this complex##2##5##(2008-5#1)(2008-7#1)
our understanding of this disease##3##5##(2006-10#1)(2006-9#1)(2013-8#1)
our understanding of this##9##4##(1995-12#1)(2006-10#2)(2006-9#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
our understanding of those##2##4##(1996-4#1)(2005-11#1)
our understanding of##325##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-3#3)(1992-12#3)(1992-2#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-11#2)(1996-2#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#5)(1997-3#1)(1997-5#1)(2004-11#3)(2004-12#1)(2005-10#3)(2005-11#4)(2005-12#1)(2005-2#1)(2005-7#1)(2005-8#3)(2006-10#42)(2006-11#1)(2006-12#1)(2006-5#2)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#9)(2007-4#2)(2007-6#1)(2007-7#2)(2007-8#8)(2007-9#2)(2008-1#7)(2008-10#11)(2008-11#12)(2008-12#3)(2008-3#3)(2008-4#5)(2008-5#5)(2008-7#19)(2008-8#8)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#5)(2009-4#2)(2009-5#4)(2009-6#1)(2009-8#4)(2009-9#3)(2010-11#2)(2010-12#4)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#4)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#7)(2011-12#2)(2011-2#5)(2011-7#1)(2012-1#12)(2012-11#1)(2012-12#6)(2012-2#10)(2012-3#3)(2012-5#1)(2013-1#15)(2013-7#1)(2013-8#6)
our understanding on the##3##4##(2009-9#1)(2011-2#1)(2013-1#1)
our understanding on##4##3##(2009-10#1)(2009-9#1)(2011-2#1)(2013-1#1)
our understanding the##2##3##(2007-12#1)(2010-7#1)
our understanding##346##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-3#3)(1992-12#3)(1992-2#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-5#1)(1996-11#2)(1996-2#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#5)(1997-3#1)(1997-5#1)(2004-11#3)(2004-12#1)(2005-10#3)(2005-11#5)(2005-12#1)(2005-2#1)(2005-7#1)(2005-8#3)(2006-10#45)(2006-11#1)(2006-12#1)(2006-5#2)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#10)(2007-4#2)(2007-6#1)(2007-7#2)(2007-8#8)(2007-9#2)(2008-1#8)(2008-10#12)(2008-11#12)(2008-12#3)(2008-3#3)(2008-4#5)(2008-5#5)(2008-7#20)(2008-8#8)(2008-9#6)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#5)(2009-4#2)(2009-5#4)(2009-6#1)(2009-8#4)(2009-9#4)(2010-1#1)(2010-11#2)(2010-12#4)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#7)(2011-12#2)(2011-2#7)(2011-7#1)(2012-1#13)(2012-11#1)(2012-12#6)(2012-2#10)(2012-3#3)(2012-5#1)(2013-1#17)(2013-7#1)(2013-8#6)
our unique##7##2##(1992-2#1)(1994-1#1)(2007-4#1)(2008-12#1)(2008-3#1)(2013-1#2)
our unit##10##2##(1993-10#1)(1993-12#1)(1994-6#1)(1995-5#1)(1997-1#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-9#1)
our university hospital##3##3##(2007-7#1)(2010-6#1)(2012-1#1)
our use of##5##3##(1995-12#1)(1995-2#1)(2006-10#1)(2013-1#2)
our view of the##4##4##(1995-4#1)(2008-7#1)(2011-2#1)(2012-2#1)
our view of##5##3##(1995-4#1)(2006-6#1)(2008-7#1)(2011-2#1)(2012-2#1)
our view##11##2##(1993-5#1)(1995-4#1)(2004-4#1)(2006-6#1)(2007-7#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
our views of##2##3##(2008-1#1)(2010-12#1)
our visual##3##2##(2008-3#1)(2013-1#2)
our way##2##2##(2008-2#1)(2011-2#1)
our website##2##2##(2008-7#1)(2013-7#1)
our women##2##2##(2007-1#1)(2008-3#1)
our work and##2##3##(2007-8#1)(2008-1#1)
our work in##2##3##(2007-11#1)(2008-7#1)
our work on##2##3##(2010-7#1)(2012-1#1)
our work was to present##2##5##(2008-5#1)(2009-2#1)
our work was to##4##4##(1997-7#1)(2005-11#1)(2008-5#1)(2009-2#1)
our work we##2##3##(1991-11#1)(2006-12#1)
our work with##2##3##(1990-8#1)(2008-8#1)
our work##33##2##(1990-12#1)(1990-8#1)(1991-11#1)(1992-12#1)(1993-8#1)(1993-9#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-7#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
our working##2##2##(2008-3#1)(2009-8#1)
our##6123##1##(1990-10#5)(1990-11#5)(1990-12#21)(1990-2#10)(1990-3#13)(1990-4#7)(1990-5#11)(1990-6#14)(1990-7#8)(1990-8#13)(1990-9#12)(1991-1#4)(1991-10#11)(1991-11#7)(1991-12#26)(1991-2#14)(1991-3#18)(1991-4#4)(1991-5#9)(1991-6#8)(1991-7#3)(1991-8#10)(1991-9#8)(1992-1#10)(1992-10#10)(1992-11#8)(1992-12#15)(1992-2#17)(1992-3#11)(1992-4#6)(1992-5#13)(1992-6#16)(1992-7#2)(1992-8#14)(1992-9#8)(1993-1#9)(1993-10#10)(1993-11#14)(1993-12#22)(1993-2#12)(1993-3#7)(1993-4#10)(1993-5#15)(1993-6#9)(1993-7#6)(1993-8#15)(1993-9#13)(1994-1#19)(1994-10#6)(1994-11#18)(1994-12#24)(1994-2#18)(1994-3#18)(1994-4#1)(1994-5#10)(1994-6#18)(1994-7#4)(1994-8#12)(1994-9#19)(1995-1#24)(1995-10#8)(1995-11#22)(1995-12#32)(1995-2#20)(1995-3#16)(1995-4#10)(1995-5#16)(1995-6#11)(1995-7#7)(1995-8#10)(1995-9#4)(1996-1#7)(1996-10#9)(1996-11#8)(1996-12#23)(1996-2#30)(1996-3#13)(1996-4#10)(1996-5#9)(1996-6#12)(1996-7#11)(1996-8#20)(1996-9#6)(1997-1#28)(1997-2#35)(1997-3#30)(1997-4#23)(1997-5#15)(1997-6#20)(1997-7#20)(1997-8#30)(1997-9#1)(2003-11#2)(2004-1#2)(2004-10#1)(2004-11#9)(2004-12#2)(2004-2#5)(2004-3#2)(2004-4#3)(2004-8#2)(2004-9#6)(2005-1#1)(2005-10#29)(2005-11#35)(2005-12#6)(2005-2#1)(2005-3#1)(2005-6#4)(2005-7#8)(2005-8#10)(2005-9#7)(2006-1#5)(2006-10#149)(2006-11#13)(2006-12#40)(2006-2#14)(2006-3#12)(2006-4#18)(2006-5#7)(2006-6#43)(2006-7#11)(2006-8#29)(2006-9#17)(2007-1#12)(2007-10#45)(2007-11#135)(2007-12#196)(2007-2#33)(2007-3#29)(2007-4#30)(2007-5#25)(2007-6#20)(2007-7#172)(2007-8#167)(2007-9#47)(2008-1#107)(2008-10#252)(2008-11#129)(2008-12#49)(2008-2#216)(2008-3#274)(2008-4#54)(2008-5#90)(2008-6#72)(2008-7#163)(2008-8#122)(2008-9#76)(2009-1#8)(2009-10#26)(2009-11#10)(2009-12#26)(2009-2#25)(2009-3#39)(2009-4#41)(2009-5#21)(2009-6#21)(2009-7#14)(2009-8#80)(2009-9#23)(2010-1#15)(2010-10#20)(2010-11#22)(2010-12#69)(2010-2#45)(2010-3#27)(2010-4#31)(2010-5#26)(2010-6#26)(2010-7#25)(2010-8#31)(2010-9#22)(2011-1#96)(2011-12#20)(2011-2#201)(2011-3#5)(2011-7#4)(2012-1#46)(2012-11#15)(2012-12#95)(2012-2#157)(2012-3#123)(2012-5#2)(2012-6#1)(2012-7#2)(2013-1#315)(2013-7#27)(2013-8#92)
ours is##2##2##(1991-12#1)(2010-12#1)
ours##13##1##(1990-8#1)(1991-12#1)(1992-6#1)(2006-3#1)(2007-6#1)(2007-8#1)(2008-4#1)(2010-12#1)(2010-5#1)(2011-2#2)(2013-8#2)
ourselves with##2##2##(2007-10#1)(2010-9#1)
ourselves##17##1##(1990-9#1)(1994-1#1)(1994-2#1)(1994-9#1)(1997-8#1)(2006-7#1)(2007-10#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-9#2)(2011-2#2)(2012-11#1)(2012-12#2)
ousted from##2##2##(1993-5#1)(2008-4#1)
out DNA##3##2##(1991-7#1)(1992-7#1)(1993-11#1)
out The##2##2##(2007-6#1)(2008-8#1)
out a plan for##2##4##(2007-9#1)(2008-11#1)
out a preliminary##2##3##(2008-2#1)(2010-9#1)
out a prospective##2##3##(2008-5#1)(2012-2#1)
out a questionnaire##4##3##(2006-8#1)(2007-12#1)(2007-6#1)(2011-2#1)
out a role##2##3##(2009-5#1)(2012-11#1)
out a series of##3##4##(2007-9#1)(2010-1#1)(2011-12#1)
out a single##2##3##(1997-2#1)(2008-6#1)
out a study##5##3##(1991-6#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-7#1)
out a theoretical##2##3##(2008-2#1)(2008-9#1)
out a##101##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-7#1)(1993-10#1)(1993-11#1)(1993-7#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#2)(1994-8#1)(1995-11#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#2)(2007-12#2)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#4)(2008-1#1)(2008-10#6)(2008-11#5)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#2)(2010-6#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#1)
out acute myocardial infarction##2##4##(2008-3#2)
out acute##3##2##(2005-1#1)(2008-3#2)
out after##8##2##(1993-12#1)(1996-9#1)(2007-12#1)(2008-5#1)(2010-11#1)(2010-12#1)(2013-1#1)(2013-8#1)
out again##3##2##(2008-10#1)(2013-1#2)
out along##2##2##(2007-12#1)(2013-1#1)
out among the##7##3##(2006-12#1)(2007-2#1)(2007-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)
out among##14##2##(1991-11#1)(1994-6#2)(2005-9#1)(2006-12#1)(2007-2#1)(2007-7#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-7#1)
out an analysis of the##2##5##(2006-6#1)(2010-3#1)
out an analysis##3##3##(2005-11#1)(2006-6#1)(2010-3#1)
out an##22##2##(1990-3#1)(1991-3#1)(1991-5#2)(1995-5#1)(1996-2#1)(1996-6#1)(2005-11#2)(2006-2#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-3#1)(2011-2#1)(2011-3#1)(2013-1#1)
out and a##2##3##(2008-10#1)(2008-4#1)
out and is##2##3##(2006-12#1)(2008-2#1)
out and the##9##3##(1992-3#1)(1993-12#1)(1997-1#1)(2005-11#2)(2007-4#1)(2008-10#1)(2010-12#1)(2012-3#1)
out and##58##2##(1990-7#1)(1991-4#1)(1992-3#2)(1992-9#1)(1993-12#1)(1997-1#1)(2004-2#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-8#2)(2006-9#1)(2007-10#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-10#7)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)
out any##5##2##(1994-12#1)(2007-11#1)(2008-5#2)(2012-2#1)
out as a major##2##4##(1990-8#1)(2008-12#1)
out as a##13##3##(1990-12#1)(1990-8#1)(1995-5#1)(1995-6#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2012-1#1)
out as part of##2##4##(2012-12#1)(2012-3#1)
out as the##6##3##(1997-2#1)(2008-10#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
out as##38##2##(1990-12#1)(1990-8#2)(1991-9#1)(1992-12#1)(1993-9#1)(1995-5#1)(1995-6#1)(1997-2#1)(2004-9#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-12#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
out at the##25##3##(1994-4#1)(1994-6#1)(1996-5#2)(1997-6#1)(2004-10#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-12#2)(2008-10#2)(2008-12#3)(2008-3#2)(2008-5#1)(2009-9#1)(2010-1#1)(2011-2#1)(2013-1#1)
out at##111##2##(1990-10#1)(1990-12#1)(1990-4#1)(1990-6#1)(1991-3#1)(1992-7#1)(1994-11#1)(1994-4#1)(1994-6#1)(1994-9#1)(1995-7#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-6#1)(2004-1#1)(2004-10#1)(2004-4#1)(2005-11#4)(2005-7#1)(2006-10#2)(2006-5#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#22)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#3)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#4)
out because of##2##3##(1997-1#1)(2007-5#1)
out before##6##2##(2006-2#1)(2006-3#1)(2007-10#1)(2007-6#1)(2008-6#1)(2010-12#1)
out better##2##2##(2008-9#1)(2012-3#1)
out between##13##2##(1990-10#1)(1990-5#1)(1991-8#1)(2004-12#1)(2005-8#1)(2007-2#1)(2007-3#1)(2011-2#2)(2012-11#1)(2012-3#1)(2013-1#1)(2013-7#1)
out by a##17##3##(1990-8#1)(1993-3#1)(1995-8#1)(1996-2#1)(2007-1#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-4#1)(2009-12#1)(2012-1#1)(2013-1#1)
out by studies##2##3##(2008-6#1)(2011-2#1)
out by the##42##3##(1990-12#1)(1990-3#1)(1991-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-7#2)(2005-5#1)(2005-8#1)(2006-10#2)(2006-8#1)(2007-10#2)(2008-1#1)(2008-10#10)(2008-2#3)(2008-7#2)(2008-8#1)(2009-10#1)(2010-10#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)
out by two##3##3##(1991-4#1)(2008-3#1)(2009-2#1)
out by use of the##2##5##(2008-1#1)(2008-2#1)
out by use of##7##4##(2008-1#1)(2008-2#4)(2008-3#1)(2010-6#1)
out by##249##2##(1990-12#1)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#2)(1990-8#3)(1991-10#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-7#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1995-4#1)(1995-8#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-5#1)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#2)(1997-6#1)(2004-1#1)(2005-11#2)(2005-5#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-1#2)(2007-10#3)(2007-11#6)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#3)(2008-1#4)(2008-10#74)(2008-11#1)(2008-12#1)(2008-2#9)(2008-3#4)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#2)(2009-12#2)(2009-2#2)(2009-3#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#9)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#3)(2012-7#1)(2013-1#2)(2013-7#1)(2013-8#1)
out clinical##2##2##(2005-7#1)(2008-11#1)
out come of##2##3##(2008-11#1)(2008-8#1)
out consultations##2##2##(2011-2#2)
out coronary artery disease##2##4##(2008-3#1)(2012-2#1)
out coronary artery##3##3##(2008-3#2)(2012-2#1)
out daily##2##2##(1994-3#1)(2013-1#1)
out due to##4##3##(1992-6#1)(2005-11#1)(2008-6#1)(2012-3#1)
out during the##10##3##(1992-8#1)(2006-10#2)(2006-5#1)(2008-5#2)(2010-1#1)(2012-2#1)(2013-1#2)
out during##18##2##(1991-10#1)(1992-8#1)(2006-10#2)(2006-4#1)(2006-5#1)(2007-11#1)(2008-5#3)(2008-8#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
out effective##2##2##(2007-10#1)(2008-1#1)
out either##5##2##(1995-5#1)(1997-4#1)(2007-11#1)(2007-7#1)(2008-10#1)
out financial##2##2##(1996-12#1)(2006-8#1)
out first##2##2##(1996-12#1)(2005-11#1)
out for evaluation of##2##4##(1991-11#1)(2008-12#1)
out for the##15##3##(1991-2#1)(1991-9#1)(1993-5#1)(1994-5#1)(1996-11#1)(2007-2#1)(2008-10#2)(2008-2#1)(2009-12#1)(2009-6#1)(2010-12#1)(2010-2#1)(2012-2#1)(2012-3#1)
out for##77##2##(1990-12#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-12#2)(2009-6#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#2)
out four##3##2##(1997-6#1)(2008-5#1)(2009-1#1)
out from a##2##3##(2008-10#1)(2008-4#1)
out from all##2##3##(1993-2#1)(1997-1#1)
out from the##15##3##(1994-5#1)(2005-11#3)(2006-7#1)(2007-12#2)(2008-10#4)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
out from##37##2##(1993-2#1)(1994-5#2)(1995-11#1)(1995-7#1)(1997-1#1)(1997-2#1)(2005-11#4)(2006-4#2)(2006-7#1)(2007-12#2)(2008-10#7)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#1)(2011-12#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
out how##11##2##(1990-2#1)(1992-8#1)(1993-5#1)(1994-6#1)(1996-3#1)(2006-4#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-5#1)(2011-2#1)
out if the##8##3##(1992-5#1)(1993-6#1)(1993-8#1)(1994-9#1)(1996-6#1)(2005-9#1)(2006-6#1)(2009-11#1)
out if##16##2##(1990-8#1)(1992-5#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-9#1)(1996-6#1)(2005-9#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-2#1)(2007-3#2)(2009-11#1)(2013-8#1)
out in 20##4##3##(1992-10#1)(1996-7#1)(2007-8#1)(2008-6#1)
out in The##2##3##(1992-5#1)(1996-2#1)
out in a##52##3##(1990-12#1)(1991-8#1)(1992-3#1)(1992-8#2)(1993-9#1)(1994-2#1)(1994-5#1)(1996-5#1)(1997-2#1)(2004-8#1)(2006-10#1)(2006-4#2)(2007-11#2)(2007-3#2)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#15)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#2)(2009-4#1)(2011-2#2)(2012-2#2)(2013-1#3)
out in an##12##3##(1992-6#1)(2007-7#1)(2008-10#4)(2008-2#3)(2008-3#1)(2011-1#1)(2013-7#1)
out in order to##26##4##(1990-10#2)(1991-9#1)(1992-6#1)(1993-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-5#1)(1997-8#1)(2004-12#1)(2005-11#2)(2006-6#1)(2007-11#1)(2007-5#1)(2007-8#2)(2008-10#6)(2012-3#1)(2013-1#1)
out in parallel##2##3##(2008-3#1)(2013-1#1)
out in specific##2##3##(2008-5#1)(2012-12#1)
out in the following##2##4##(2006-10#1)(2008-6#1)
out in the presence##13##4##(1991-1#1)(1991-3#1)(1992-3#1)(1996-11#1)(1996-5#1)(1997-2#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-4#1)(2011-2#1)
out in the##91##3##(1990-6#1)(1991-1#1)(1991-3#2)(1991-6#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-6#1)(1995-12#1)(1996-11#1)(1996-5#1)(1997-1#3)(1997-2#1)(1997-5#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-6#1)(2007-8#5)(2008-10#20)(2008-11#1)(2008-12#2)(2008-2#6)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-11#1)(2012-3#1)(2013-1#1)
out in this##8##3##(1994-6#1)(1994-9#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-10#1)(2011-1#1)
out in##471##2##(1990-10#3)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#4)(1990-8#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-6#3)(1991-8#1)(1991-9#3)(1992-10#4)(1992-11#1)(1992-3#2)(1992-4#3)(1992-5#2)(1992-6#5)(1992-7#2)(1992-8#4)(1993-1#1)(1993-10#1)(1993-11#2)(1993-3#3)(1993-5#2)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#2)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#6)(1994-7#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-4#1)(1995-5#1)(1995-7#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-5#4)(1996-6#1)(1996-7#3)(1997-1#3)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#2)(1997-7#1)(1997-8#3)(2004-11#2)(2004-12#1)(2004-8#1)(2004-9#3)(2005-11#4)(2005-12#1)(2005-2#1)(2005-8#1)(2005-9#2)(2006-10#8)(2006-12#3)(2006-2#5)(2006-4#5)(2006-6#2)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#13)(2007-12#1)(2007-2#7)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#4)(2007-7#5)(2007-8#11)(2007-9#2)(2008-1#2)(2008-10#81)(2008-11#8)(2008-12#4)(2008-2#11)(2008-3#11)(2008-4#5)(2008-5#14)(2008-6#8)(2008-7#11)(2008-8#2)(2008-9#5)(2009-10#1)(2009-12#2)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-3#2)(2010-5#4)(2011-1#9)(2011-2#12)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#7)(2012-3#8)(2013-1#16)(2013-7#4)(2013-8#3)
out into the##6##3##(1991-1#1)(1992-3#1)(1995-1#1)(1996-12#1)(1996-5#1)(2006-10#1)
out into##8##2##(1991-1#1)(1992-3#2)(1995-1#1)(1996-12#1)(1996-5#1)(2006-10#1)(2008-9#1)
out its##6##2##(1995-2#1)(2006-6#1)(2010-8#1)(2012-12#1)(2012-2#2)
out kinetic##2##2##(2007-8#1)(2012-1#1)
out left##2##2##(2007-8#1)(2008-7#1)
out maximum##2##2##(2010-8#1)(2012-2#1)
out measurements##4##2##(2005-11#1)(2007-12#1)(2008-3#1)(2009-5#1)
out mice##3##2##(1995-12#1)(2007-10#1)(2008-9#1)
out more##4##2##(1991-12#1)(1997-4#1)(2005-12#1)(2008-7#1)
out most##2##2##(2007-12#1)(2007-8#1)
out of 10 (range##2##4##(2008-12#1)(2012-12#1)
out of 10 and##2##4##(2009-2#2)
out of 10 patients##6##4##(1996-9#1)(2006-9#1)(2008-1#1)(2008-7#1)(2010-10#1)(2012-12#1)
out of 10##22##3##(1992-12#1)(1994-3#1)(1996-9#1)(2006-2#1)(2006-7#1)(2006-9#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-5#1)(2008-7#2)(2009-2#2)(2010-10#1)(2010-12#1)(2012-12#2)(2013-8#1)
out of 100##7##3##(1992-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#1)(2011-1#1)(2012-2#1)
out of 109##2##3##(2006-8#1)(2007-11#1)
out of 11 patients with##2##5##(1991-9#1)(1995-7#1)
out of 11 were##2##4##(1995-4#1)(2008-9#1)
out of 11##11##3##(1990-8#1)(1991-8#1)(1991-9#1)(1995-4#1)(1995-7#1)(1997-4#1)(2008-1#1)(2008-4#2)(2008-9#2)
out of 12 patients##3##4##(1991-5#1)(1997-7#1)(2008-5#1)
out of 12##14##3##(1990-10#1)(1990-11#1)(1990-4#1)(1991-5#1)(1997-7#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#1)(2010-12#1)(2013-1#2)(2013-7#1)
out of 13 patients##2##4##(1990-2#1)(1991-11#1)
out of 13##8##3##(1990-2#1)(1991-11#1)(1994-2#1)(1997-2#1)(2006-8#1)(2007-7#2)(2011-2#1)
out of 130##2##3##(2006-10#1)(2007-7#1)
out of 133 responded##2##4##(1995-6#2)
out of 14##5##3##(1991-5#1)(1997-5#1)(2007-10#1)(2011-2#1)(2013-1#1)
out of 15 patients##3##4##(1990-4#1)(1990-8#1)(2008-7#1)
out of 15##12##3##(1990-4#1)(1990-6#1)(1990-8#1)(1991-4#1)(1992-8#1)(1994-8#2)(2006-8#1)(2007-10#1)(2008-12#1)(2008-4#1)(2008-7#1)
out of 16##8##3##(1990-10#1)(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(2007-7#1)(2008-5#1)(2009-2#1)
out of 17##2##3##(1990-4#1)(2008-5#1)
out of 18 patients##4##4##(1990-8#1)(1992-6#1)(2008-10#1)(2008-6#1)
out of 18##10##3##(1990-8#1)(1992-6#1)(2008-10#4)(2008-6#1)(2009-8#3)
out of 19##5##3##(1992-3#1)(1995-7#1)(1996-11#1)(2004-1#1)(2008-11#1)
out of 20 patients##4##4##(1990-8#1)(1992-8#1)(2007-7#2)
out of 20##10##3##(1990-10#1)(1990-8#1)(1991-8#1)(1992-8#1)(1996-9#1)(2006-8#1)(2007-7#2)(2009-8#1)(2013-8#1)
out of 20)##3##3##(2008-5#3)
out of 21 patients##2##4##(1991-9#1)(2008-1#1)
out of 21##5##3##(1991-9#1)(2004-1#1)(2008-1#1)(2008-6#1)(2011-2#1)
out of 22 patients##2##4##(1991-9#1)(1997-3#1)
out of 22##9##3##(1991-9#1)(1993-12#1)(1994-3#1)(1997-3#2)(2007-7#1)(2007-8#1)(2008-4#1)(2011-11#1)
out of 23##2##3##(1990-12#1)(2008-10#1)
out of 24##7##3##(1994-3#2)(2008-6#1)(2009-2#1)(2009-8#2)(2012-11#1)
out of 25 with the##3##5##(2006-8#3)
out of 25 with##4##4##(2006-8#4)
out of 25##10##3##(1991-9#1)(1994-11#1)(1994-2#1)(2006-8#4)(2008-5#2)(2009-8#1)
out of 26##6##3##(1990-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-1#1)
out of 260##2##3##(2011-1#2)
out of 28##4##3##(1990-2#1)(2008-4#1)(2012-2#1)(2013-1#1)
out of 29##3##3##(1993-3#1)(2007-8#1)(2013-1#1)
out of 3##4##3##(1991-4#1)(1992-9#1)(2008-1#1)(2012-2#1)
out of 30##5##3##(1990-12#1)(1991-12#1)(1996-5#1)(2008-8#1)(2010-12#1)
out of 31##2##3##(1992-3#1)(2007-11#1)
out of 32##2##3##(1990-3#1)(2008-1#1)
out of 33##2##3##(2008-12#1)(2009-5#1)
out of 34##4##3##(1990-10#1)(1997-6#1)(2007-6#1)(2013-8#1)
out of 35 patients##2##4##(1991-11#1)(2008-9#1)
out of 35##3##3##(1991-11#1)(1996-12#1)(2008-9#1)
out of 38##2##3##(2008-8#1)(2013-8#1)
out of 39##2##3##(1994-9#1)(2006-12#1)
out of 4##3##3##(1990-6#1)(1992-9#1)(1997-7#1)
out of 40##3##3##(1996-12#1)(1996-6#1)(2008-12#1)
out of 400##2##3##(1993-6#1)(2007-7#1)
out of 42 (with equipment aids##2##6##(2011-2#2)
out of 42##3##3##(1996-6#1)(2011-2#2)
out of 44##2##3##(1996-5#1)(2007-6#1)
out of 45 patients##2##4##(1992-5#1)(2008-1#1)
out of 45##4##3##(1990-10#1)(1992-5#1)(2008-1#1)(2008-9#1)
out of 46##4##3##(1991-8#1)(2007-2#1)(2008-10#1)(2008-5#1)
out of 48##3##3##(1994-6#1)(2007-7#1)(2008-5#1)
out of 49##2##3##(2008-12#1)(2008-5#1)
out of 5 patients##2##4##(1990-10#1)(2008-1#1)
out of 5##8##3##(1990-10#1)(1992-3#1)(1997-6#2)(2008-1#1)(2008-4#1)(2009-2#2)
out of 50##8##3##(1990-12#2)(1992-6#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-5#1)
out of 53##4##3##(1991-11#1)(2008-10#1)(2011-12#1)(2013-8#1)
out of 575##2##3##(1991-10#1)(2012-11#1)
out of 58##3##3##(1994-10#1)(2008-1#1)(2011-1#1)
out of 59##2##3##(2007-5#1)(2009-8#1)
out of 6##6##3##(1992-3#1)(1996-1#1)(2009-2#1)(2009-5#1)(2010-2#1)(2012-2#1)
out of 60##2##3##(1992-8#1)(2008-8#1)
out of 68 patients##2##4##(1990-2#1)(2007-11#1)
out of 68##4##3##(1990-2#1)(2007-11#1)(2011-2#1)(2012-3#1)
out of 7##4##3##(1991-2#1)(2007-6#1)(2008-12#1)(2012-2#1)
out of 72##3##3##(1992-5#1)(2007-11#1)(2007-9#1)
out of 8##9##3##(1992-3#1)(1992-5#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-2#2)(2010-2#1)(2011-2#1)
out of 84##2##3##(1990-11#1)(2007-6#1)
out of 89##3##3##(2007-8#2)(2011-1#1)
out of 9 cases##2##4##(1995-4#1)(2007-7#1)
out of 9##5##3##(1993-11#1)(1995-4#1)(2007-7#1)(2008-7#1)(2011-12#1)
out of 98##3##3##(1990-3#1)(2007-11#1)(2008-7#1)
out of a number of##2##5##(1995-3#1)(1996-1#1)
out of a possible##2##4##(2008-6#1)(2012-2#1)
out of a total of##7##5##(1992-9#1)(2006-6#1)(2007-7#1)(2007-9#1)(2011-1#1)(2012-2#1)(2013-7#1)
out of a total##9##4##(1991-9#1)(1992-9#1)(1993-6#1)(2006-6#1)(2007-7#1)(2007-9#1)(2011-1#1)(2012-2#1)(2013-7#1)
out of a##26##3##(1990-10#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-6#1)(1993-8#1)(1993-9#1)(1995-3#1)(1996-1#1)(1997-4#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-2#2)(2008-6#1)(2011-1#1)(2012-2#2)(2013-7#1)
out of about 2##2##4##(1996-2#1)(2008-5#1)
out of all##2##3##(2008-11#1)(2009-7#1)
out of approximately##2##3##(1991-10#1)(1993-6#1)
out of control##5##3##(2008-6#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
out of court##3##3##(1996-11#1)(1996-6#1)(2007-9#1)
out of date##2##3##(2008-1#1)(2013-1#1)
out of eight##4##3##(1991-12#1)(1992-11#1)(2004-10#1)(2008-10#1)
out of every##3##3##(1995-12#1)(1996-8#1)(2006-7#1)
out of favor##3##3##(2008-12#1)(2008-3#1)(2008-9#1)
out of five##14##3##(1991-9#1)(1993-8#1)(1996-12#1)(1996-5#1)(1997-6#1)(2004-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-3#1)(2012-12#2)(2013-1#1)
out of four and##2##4##(1990-4#1)(1997-3#1)
out of four patients##2##4##(1990-4#1)(1992-7#1)
out of four##11##3##(1990-4#2)(1991-10#1)(1991-2#1)(1992-4#1)(1992-5#1)(1992-7#1)(1996-9#1)(1997-3#1)(2008-10#1)(2009-10#1)
out of hours##12##3##(1990-3#2)(1993-1#1)(1993-10#1)(1995-9#1)(1997-3#1)(1997-5#2)(2004-7#4)
out of its##2##3##(2009-10#1)(2010-9#1)
out of nine##5##3##(1993-6#1)(1994-8#2)(1997-1#1)(2008-2#1)
out of pocket##2##3##(1991-2#1)(2011-12#1)
out of poverty##2##3##(2008-11#2)
out of proportion to##2##4##(1990-4#1)(2007-7#1)
out of reach##2##3##(1997-7#1)(2013-8#1)
out of school##3##3##(2008-9#1)(2009-7#1)(2011-2#1)
out of seven patients##2##4##(2004-10#1)(2007-8#1)
out of seven##11##3##(1990-7#1)(1990-8#1)(1991-9#1)(2004-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-12#1)(2012-2#1)
out of six##6##3##(1992-1#1)(1996-12#2)(2007-12#1)(2007-7#1)(2008-2#1)
out of solution##2##3##(1994-2#1)(2008-4#1)
out of state##2##3##(1994-2#1)(2007-10#1)
out of ten##11##3##(1991-7#1)(1991-8#1)(1991-9#1)(1992-3#1)(1994-11#1)(1994-2#1)(1995-11#1)(1997-6#1)(2006-8#1)(2008-7#1)(2010-7#1)
out of the 10##4##4##(2007-1#1)(2008-10#1)(2008-12#1)(2012-1#1)
out of the 100##2##4##(2007-9#2)
out of the 11 patients##2##5##(1990-9#1)(2008-10#1)
out of the 11##3##4##(1990-9#1)(1995-8#1)(2008-10#1)
out of the 15##2##4##(2008-9#1)(2010-8#1)
out of the 18##3##4##(1996-1#1)(2008-10#1)(2008-5#1)
out of the 23##2##4##(1991-10#1)(1991-9#1)
out of the 24##4##4##(1991-10#1)(1991-9#1)(1997-6#1)(2007-4#1)
out of the 7 patients##3##5##(2007-8#1)(2010-2#2)
out of the active site and##2##6##(1991-2#1)(1994-8#1)
out of the active site##3##5##(1991-2#2)(1994-8#1)
out of the cell##4##4##(1995-6#1)(2005-12#1)(2006-8#1)(2008-11#1)
out of the eight##3##4##(1996-12#1)(2007-4#1)(2008-10#1)
out of the five##4##4##(1991-8#1)(1995-3#1)(1996-5#1)(2008-5#1)
out of the four##3##4##(1997-3#1)(2006-7#1)(2008-9#1)
out of the hospital##2##4##(1996-3#1)(2008-12#1)
out of the operating room##2##5##(1991-1#1)(2006-10#1)
out of the plane of incidence##4##6##(2007-12#1)(2008-1#1)(2008-3#2)
out of the plate##2##4##(2008-2#1)(2008-3#1)
out of the seven##3##4##(1994-3#2)(2006-8#1)
out of the study##4##4##(1992-11#1)(2006-2#1)(2007-10#1)(2011-2#1)
out of the system##3##4##(1992-3#1)(2008-10#2)
out of the three##3##4##(1995-6#1)(2006-11#1)(2011-2#1)
out of the total number of##2##6##(1997-3#1)(2005-10#1)
out of the water##2##4##(1990-9#1)(2009-6#1)
out of the##207##3##(1990-12#1)(1990-5#1)(1990-9#2)(1991-1#1)(1991-10#2)(1991-12#2)(1991-2#2)(1991-5#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-3#3)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#2)(1995-3#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-7#2)(1996-9#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#2)(2005-12#2)(2006-10#3)(2006-11#1)(2006-2#3)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#5)(2008-1#3)(2008-10#16)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#3)(2009-3#1)(2009-5#2)(2009-6#1)(2009-9#1)(2010-11#1)(2010-2#2)(2010-5#3)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#2)
out of their##5##3##(2005-11#1)(2006-10#1)(2007-7#1)(2008-11#1)(2008-7#1)
out of these##13##3##(1991-9#1)(1992-9#1)(1993-5#1)(1997-1#1)(2007-9#1)(2008-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
out of this##5##3##(1996-7#1)(2007-3#1)(2009-2#1)(2009-6#1)(2010-3#1)
out of three##8##3##(1990-6#1)(1991-12#1)(1994-8#1)(1996-12#1)(2006-12#1)(2008-1#1)(2008-5#1)(2010-4#1)
out of total##2##3##(2008-10#1)(2010-12#1)
out of touch##3##3##(1995-9#1)(2007-10#1)(2007-12#1)
out of trouble##2##3##(2008-6#1)(2010-2#1)
out of twelve##2##3##(1992-4#1)(2013-1#1)
out of two##2##3##(1992-5#1)(2008-12#1)
out of whack##2##3##(2007-9#1)(2008-11#1)
out of which 11##2##4##(2007-2#1)(2010-9#1)
out of which##18##3##(2005-8#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#4)(2008-5#1)(2010-4#1)(2010-9#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
out of whom##3##3##(1993-8#1)(2012-3#1)(2013-1#1)
out of work##4##3##(1997-2#1)(2006-8#2)(2011-2#1)
out of##925##2##(1990-10#10)(1990-11#3)(1990-12#9)(1990-2#5)(1990-3#5)(1990-4#8)(1990-5#2)(1990-6#3)(1990-7#2)(1990-8#6)(1990-9#3)(1991-1#2)(1991-10#6)(1991-11#3)(1991-12#5)(1991-2#7)(1991-4#3)(1991-5#5)(1991-6#1)(1991-7#1)(1991-8#5)(1991-9#12)(1992-1#3)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#9)(1992-4#2)(1992-5#8)(1992-6#4)(1992-7#2)(1992-8#4)(1992-9#7)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-5#2)(1993-6#6)(1993-8#5)(1993-9#3)(1994-1#2)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#7)(1994-3#10)(1994-6#2)(1994-7#2)(1994-8#8)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#2)(1995-4#3)(1995-6#6)(1995-7#2)(1995-8#1)(1995-9#3)(1996-1#3)(1996-11#4)(1996-12#8)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#5)(1996-6#4)(1996-7#3)(1996-8#1)(1996-9#4)(1997-1#4)(1997-2#4)(1997-3#7)(1997-4#3)(1997-5#3)(1997-6#7)(1997-7#7)(1997-8#1)(1997-9#1)(2004-1#2)(2004-10#2)(2004-11#3)(2004-12#1)(2004-4#1)(2004-7#5)(2005-10#1)(2005-11#4)(2005-12#2)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#7)(2006-11#2)(2006-12#4)(2006-2#6)(2006-4#2)(2006-5#3)(2006-6#1)(2006-7#4)(2006-8#16)(2006-9#5)(2007-1#2)(2007-10#7)(2007-11#13)(2007-12#14)(2007-2#13)(2007-3#5)(2007-4#5)(2007-5#2)(2007-6#4)(2007-7#29)(2007-8#13)(2007-9#14)(2008-1#21)(2008-10#40)(2008-11#27)(2008-12#11)(2008-2#10)(2008-3#11)(2008-4#13)(2008-5#28)(2008-6#13)(2008-7#13)(2008-8#10)(2008-9#16)(2009-10#5)(2009-11#4)(2009-2#14)(2009-3#1)(2009-4#1)(2009-5#5)(2009-6#3)(2009-7#3)(2009-8#9)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#5)(2010-3#3)(2010-4#3)(2010-5#3)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#12)(2011-11#1)(2011-12#8)(2011-2#23)(2012-1#2)(2012-11#2)(2012-12#7)(2012-2#20)(2012-3#12)(2013-1#23)(2013-7#4)(2013-8#16)
out on a##30##3##(1990-6#1)(1991-10#1)(1992-2#2)(1992-5#1)(1997-4#1)(2005-12#1)(2006-2#1)(2008-10#7)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
out on an##8##3##(1995-2#1)(2006-8#1)(2008-2#1)(2008-4#1)(2008-6#1)(2010-9#1)(2011-1#2)
out on the basis of##2##5##(2005-11#1)(2008-7#1)
out on the##46##3##(1991-11#1)(1993-9#1)(1994-6#1)(1996-7#2)(1997-1#1)(2005-10#1)(2005-11#3)(2005-9#1)(2006-5#1)(2007-2#1)(2007-6#2)(2007-8#1)(2007-9#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
out on##210##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-4#1)(1991-6#1)(1991-9#2)(1992-12#1)(1992-2#2)(1992-5#1)(1993-12#2)(1993-3#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#4)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-5#3)(2006-8#2)(2006-9#1)(2007-1#2)(2007-11#3)(2007-12#1)(2007-2#2)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#27)(2008-11#2)(2008-12#2)(2008-2#8)(2008-3#6)(2008-4#6)(2008-5#10)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#1)(2009-12#2)(2009-2#3)(2009-7#2)(2010-1#1)(2010-11#1)(2010-12#6)(2010-2#3)(2010-5#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#9)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#3)
out only##6##2##(1992-12#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-7#1)
out or##5##2##(1990-1#1)(1990-2#1)(1996-12#1)(2010-9#1)(2012-2#1)
out other##2##2##(2007-7#1)(2009-6#1)
out our##3##2##(1993-12#1)(1995-12#1)(2008-2#1)
out over the##6##3##(1990-11#1)(2008-10#3)(2008-2#1)(2012-2#1)
out over time##3##3##(1991-11#1)(2011-1#1)(2011-2#1)
out over##16##2##(1990-11#1)(1991-11#1)(1994-2#1)(2006-2#1)(2007-1#1)(2007-3#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#2)
out patient department of##2##4##(2007-8#1)(2010-5#1)
out patient##3##2##(2007-8#1)(2010-5#1)(2013-1#1)
out patients department##2##3##(2008-7#1)(2011-1#1)
out patients##4##2##(2007-7#1)(2008-7#1)(2010-5#1)(2011-1#1)
out possible##3##2##(1996-12#1)(2007-10#1)(2008-1#1)
out potential##2##2##(2005-10#1)(2008-11#1)
out previously##2##2##(1994-9#1)(1995-2#1)
out properly##2##2##(2011-1#1)(2013-1#1)
out selective##2##2##(1997-6#1)(2008-7#1)
out several##3##2##(1996-4#1)(1997-2#1)(2012-2#1)
out similar##2##2##(2008-2#1)(2010-5#1)
out simultaneously##5##2##(2008-10#1)(2009-2#2)(2010-4#1)(2011-2#1)
out some of the causes##2##5##(1991-6#1)(2007-11#1)
out some of the##5##4##(1991-6#1)(2007-11#1)(2008-5#1)(2010-2#1)(2012-12#1)
out some##12##2##(1991-6#1)(1993-4#1)(1993-8#1)(1994-3#1)(1995-2#1)(2007-11#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-2#1)(2012-12#1)(2013-8#1)
out specific##3##2##(2006-2#1)(2008-10#1)(2009-5#1)
out stress##2##2##(2010-12#1)(2013-1#1)
out successful##2##2##(1995-12#1)(1995-5#1)
out such##4##2##(1991-6#1)(1992-6#1)(2011-2#1)(2012-3#1)
out ten##2##2##(1993-5#1)(2006-1#1)
out that a##2##3##(2008-2#1)(2009-9#1)
out that all##2##3##(2008-10#1)(2008-2#1)
out that in##2##3##(2006-10#1)(2009-3#1)
out that one##2##3##(1994-12#1)(2007-12#1)
out that the##21##3##(1990-2#1)(1991-7#1)(1996-1#1)(2006-4#1)(2007-3#1)(2007-5#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-2#2)(2008-4#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-8#1)
out that this##3##3##(2007-11#1)(2008-2#1)(2013-7#1)
out that when##2##3##(1993-9#1)(2007-11#1)
out that##77##2##(1990-12#1)(1990-2#2)(1991-7#1)(1992-3#2)(1992-5#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-4#1)(1996-1#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-6#2)(2006-8#1)(2007-1#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-8#3)(2008-10#5)(2008-11#3)(2008-2#9)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#4)(2013-1#1)(2013-7#1)(2013-8#1)
out the advantages and##2##4##(2006-12#1)(2012-11#1)
out the agreement between general broad principles of research ethics and Islamic teachings concerning life##2##15##(2007-10#1)(2007-12#1)
out the analysis##3##3##(1991-8#1)(2008-10#1)(2008-2#1)
out the clinical##2##3##(1997-2#1)(2006-10#1)
out the differences##2##3##(1991-6#1)(2007-11#1)
out the effects of##2##4##(2007-10#1)(2012-1#1)
out the first##3##3##(1995-8#1)(2007-4#1)(2010-12#1)
out the historical##2##3##(2008-5#1)(2008-9#1)
out the idea that##2##4##(1993-4#1)(2008-12#1)
out the level of##2##4##(2006-4#1)(2007-12#1)
out the life##2##3##(1991-8#1)(2010-1#1)
out the measurements##2##3##(2008-2#1)(2008-3#1)
out the most##3##3##(2006-2#1)(2007-8#1)(2009-4#1)
out the need to##2##4##(1991-8#1)(2013-7#1)
out the need##4##3##(1991-8#1)(2007-10#1)(2012-3#1)(2013-7#1)
out the possibility of##5##4##(1994-9#1)(2008-1#1)(2008-3#1)(2010-4#1)(2011-2#1)
out the possibility that##2##4##(1997-8#1)(2013-1#1)
out the possibility##7##3##(1994-9#1)(1997-8#1)(2008-1#1)(2008-3#1)(2010-4#1)(2011-2#1)(2013-1#1)
out the potential##3##3##(1990-10#1)(2008-10#1)(2010-2#1)
out the prevalence of##3##4##(2007-8#1)(2009-6#1)(2012-2#1)
out the prevalence##5##3##(2007-7#1)(2007-8#1)(2008-1#1)(2009-6#1)(2012-2#1)
out the role of##2##4##(2011-1#1)(2012-2#1)
out the same##3##3##(2007-8#1)(2008-10#1)(2011-1#1)
out the specific##2##3##(1993-10#1)(2008-3#1)
out the##233##2##(1990-10#4)(1990-12#1)(1990-2#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-3#2)(1992-5#1)(1993-10#2)(1993-12#1)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#1)(1993-7#1)(1994-2#1)(1994-5#1)(1994-9#2)(1995-12#1)(1995-8#2)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-4#1)(2006-1#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#2)(2006-8#1)(2007-10#4)(2007-11#2)(2007-12#5)(2007-2#3)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#7)(2007-8#4)(2007-9#3)(2008-1#7)(2008-10#17)(2008-11#3)(2008-12#3)(2008-2#10)(2008-3#13)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#3)(2009-6#2)(2010-1#1)(2010-12#5)(2010-2#2)(2010-4#1)(2010-5#3)(2010-8#4)(2010-9#1)(2011-1#5)(2011-2#7)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#6)(2012-3#3)(2012-8#1)(2013-1#7)(2013-7#1)(2013-8#3)
out their##6##2##(2006-2#1)(2008-4#1)(2009-5#1)(2010-2#1)(2011-1#2)
out these##6##2##(2007-8#1)(2008-1#1)(2010-2#1)(2011-2#2)(2012-3#1)
out this activity##2##3##(2006-12#1)(2007-1#1)
out this##14##2##(1992-4#1)(1992-8#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-4#1)(2007-8#1)(2007-9#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
out those##2##2##(1992-10#1)(2008-4#1)
out three##3##2##(2006-12#1)(2008-9#1)(2013-1#1)
out through the##4##3##(1996-12#1)(2008-11#1)(2008-4#1)(2013-7#1)
out through##17##2##(1996-1#1)(1996-12#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-7#1)
out to a##2##3##(2008-10#1)(2008-3#1)
out to all##2##3##(2008-1#2)
out to assess the##9##4##(1994-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2013-1#1)
out to assess##20##3##(1991-5#1)(1993-8#1)(1994-3#1)(1996-6#1)(1996-9#1)(1997-5#1)(2005-9#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-1#2)
out to be a very##4##5##(1991-5#1)(2008-11#1)(2012-2#2)
out to be a##15##4##(1991-5#1)(1992-4#1)(1994-3#1)(1997-6#1)(2007-11#2)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-2#3)
out to be highly##3##4##(2007-11#1)(2008-10#1)(2011-2#1)
out to be more##2##4##(1991-4#1)(2013-1#1)
out to be the##2##4##(2007-7#1)(2009-5#1)
out to be very##3##4##(2005-11#1)(2008-10#1)(2008-9#1)
out to be##72##3##(1990-3#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-5#2)(1992-12#1)(1992-4#1)(1993-3#2)(1993-5#1)(1994-3#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-12#1)(2007-11#3)(2007-12#2)(2007-7#3)(2007-9#2)(2008-10#6)(2008-11#2)(2008-2#4)(2008-3#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#2)(2009-9#1)(2010-12#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-2#7)(2013-1#5)(2013-8#1)
out to compare the##4##4##(2007-3#1)(2007-7#1)(2008-6#1)(2012-12#1)
out to compare##6##3##(1990-9#1)(2007-3#1)(2007-7#1)(2008-6#1)(2012-1#1)(2012-12#1)
out to demonstrate##6##3##(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-11#1)
out to determine how##2##4##(2007-12#1)(2008-5#1)
out to determine the prevalence of##5##6##(1996-12#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)
out to determine the##25##4##(1990-8#1)(1994-3#1)(1996-12#1)(2004-9#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-6#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#2)
out to determine whether##6##4##(1991-8#1)(1993-7#1)(1993-8#1)(1997-5#1)(2012-2#1)(2012-5#1)
out to determine##45##3##(1990-8#1)(1991-8#1)(1993-7#1)(1993-8#1)(1994-3#1)(1995-7#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-5#1)(2004-9#1)(2006-12#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-6#1)(2010-12#2)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#4)(2012-5#1)(2013-1#2)
out to develop a##5##4##(2008-10#2)(2008-5#1)(2011-1#1)(2013-1#1)
out to develop##7##3##(2008-10#2)(2008-5#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
out to establish##7##3##(1996-2#1)(2007-6#1)(2008-5#1)(2009-10#1)(2010-11#1)(2011-2#1)(2012-3#1)
out to evaluate the##17##4##(1990-2#1)(1991-2#1)(1992-4#1)(1992-6#1)(1996-1#1)(2006-11#1)(2007-1#2)(2008-10#2)(2008-12#2)(2008-3#1)(2010-5#1)(2011-12#1)(2011-2#1)(2013-8#1)
out to evaluate##22##3##(1990-11#1)(1990-2#1)(1991-2#1)(1992-4#1)(1992-6#1)(1996-1#1)(2006-11#1)(2007-1#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#3)(2008-3#1)(2008-8#1)(2010-5#1)(2011-12#1)(2011-2#1)(2013-8#1)
out to examine##5##3##(1997-6#1)(2007-12#1)(2009-4#1)(2010-2#2)
out to explore##3##3##(2007-9#1)(2008-7#2)
out to have##5##3##(1991-3#1)(2006-8#2)(2008-10#1)(2008-2#1)
out to identify##3##3##(1992-10#1)(2008-1#2)
out to investigate##27##3##(1990-3#1)(1991-6#1)(1996-4#1)(1997-5#1)(1997-8#1)(2004-10#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#3)(2008-8#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-11#2)(2013-1#2)(2013-8#1)
out to produce##3##3##(1997-4#1)(2005-11#1)(2013-7#1)
out to provide##3##3##(2006-2#1)(2007-12#1)(2008-3#1)
out to test##5##3##(1996-7#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)
out to the##7##3##(1997-3#1)(2007-11#1)(2008-3#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-2#1)
out to##392##2##(1990-11#1)(1990-2#1)(1990-3#3)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-3#3)(1992-4#2)(1992-6#1)(1993-11#1)(1993-3#3)(1993-5#1)(1993-7#1)(1993-8#2)(1994-3#4)(1994-6#1)(1995-12#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#3)(1996-9#1)(1997-2#3)(1997-3#2)(1997-4#4)(1997-5#3)(1997-6#2)(1997-7#1)(1997-8#3)(2004-10#1)(2004-9#2)(2005-11#5)(2005-12#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-8#4)(2007-1#2)(2007-10#4)(2007-11#10)(2007-12#9)(2007-2#3)(2007-3#4)(2007-4#2)(2007-6#1)(2007-7#10)(2007-8#4)(2007-9#5)(2008-1#9)(2008-10#31)(2008-11#7)(2008-12#9)(2008-2#17)(2008-3#16)(2008-4#4)(2008-5#14)(2008-6#6)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#1)(2009-5#5)(2009-6#3)(2009-7#2)(2009-9#3)(2010-11#4)(2010-12#4)(2010-2#3)(2010-4#1)(2010-5#4)(2010-6#1)(2010-8#5)(2011-1#9)(2011-12#2)(2011-2#13)(2011-3#2)(2012-1#2)(2012-11#3)(2012-12#7)(2012-2#13)(2012-3#2)(2012-5#1)(2013-1#16)(2013-7#2)(2013-8#4)
out treatment##2##2##(2007-2#1)(2013-8#1)
out two##5##2##(1990-7#1)(2008-5#1)(2008-9#1)(2013-1#2)
out under##23##2##(1995-8#1)(1996-8#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-12#1)(2007-1#1)(2007-11#2)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)
out using a##22##3##(1991-3#1)(1991-5#1)(1994-2#1)(1996-2#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-3#1)(2010-8#1)(2013-1#1)(2013-7#1)
out using##121##2##(1990-11#1)(1990-6#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-9#1)(1992-2#1)(1993-12#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-9#1)(1995-3#1)(1995-8#2)(1996-10#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-8#2)(2005-11#2)(2005-12#1)(2006-10#1)(2006-2#1)(2006-5#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#45)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#2)(2010-2#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
out weekly##2##2##(1991-11#1)(2013-1#1)
out what##6##2##(1992-8#1)(1994-12#1)(2008-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
out when##3##2##(2007-11#1)(2007-5#1)(2008-5#1)
out which##6##2##(1991-12#1)(2007-6#1)(2008-10#1)(2011-2#3)
out with a##16##3##(1997-1#1)(1997-4#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2009-11#1)(2010-4#1)(2012-12#1)(2013-1#1)
out with these##3##3##(2005-11#1)(2008-10#1)(2008-7#1)
out with##148##2##(1990-10#3)(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-4#3)(1991-6#2)(1991-7#1)(1991-9#1)(1992-10#1)(1992-6#1)(1993-2#2)(1993-6#2)(1993-9#1)(1994-3#3)(1994-6#1)(1995-1#1)(1995-11#1)(1995-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-11#3)(2006-2#1)(2006-4#2)(2007-11#4)(2007-12#3)(2007-4#1)(2007-7#1)(2008-10#27)(2008-11#1)(2008-2#7)(2008-3#11)(2008-4#3)(2008-5#4)(2008-6#4)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#3)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#6)(2012-2#1)(2013-1#5)(2013-7#2)
out within##12##2##(1990-3#2)(1995-11#2)(2007-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2010-7#1)(2011-2#1)
out worldwide##2##2##(1996-2#1)(2005-9#1)
out##4450##1##(1990-1#1)(1990-10#25)(1990-11#12)(1990-12#21)(1990-2#21)(1990-3#22)(1990-4#13)(1990-5#12)(1990-6#15)(1990-7#10)(1990-8#17)(1990-9#8)(1991-1#6)(1991-10#14)(1991-11#14)(1991-12#13)(1991-2#16)(1991-3#10)(1991-4#14)(1991-5#19)(1991-6#16)(1991-7#8)(1991-8#17)(1991-9#27)(1992-1#6)(1992-10#8)(1992-11#4)(1992-12#8)(1992-2#6)(1992-3#26)(1992-4#9)(1992-5#17)(1992-6#15)(1992-7#7)(1992-8#15)(1992-9#12)(1993-1#3)(1993-10#6)(1993-11#9)(1993-12#14)(1993-2#10)(1993-3#19)(1993-4#5)(1993-5#13)(1993-6#16)(1993-7#5)(1993-8#14)(1993-9#12)(1994-1#4)(1994-10#3)(1994-11#8)(1994-12#9)(1994-2#20)(1994-3#30)(1994-4#3)(1994-5#11)(1994-6#25)(1994-7#3)(1994-8#9)(1994-9#11)(1995-1#8)(1995-10#2)(1995-11#7)(1995-12#15)(1995-2#7)(1995-3#7)(1995-4#6)(1995-5#8)(1995-6#9)(1995-7#7)(1995-8#8)(1995-9#5)(1996-1#13)(1996-10#1)(1996-11#10)(1996-12#30)(1996-2#14)(1996-3#15)(1996-4#5)(1996-5#19)(1996-6#15)(1996-7#15)(1996-8#8)(1996-9#12)(1997-1#18)(1997-2#25)(1997-3#16)(1997-4#21)(1997-5#11)(1997-6#20)(1997-7#16)(1997-8#10)(1997-9#1)(2003-11#1)(2004-1#4)(2004-10#4)(2004-11#5)(2004-12#3)(2004-2#1)(2004-4#5)(2004-7#5)(2004-8#1)(2004-9#10)(2005-1#2)(2005-10#9)(2005-11#52)(2005-12#8)(2005-2#1)(2005-4#1)(2005-5#1)(2005-7#5)(2005-8#8)(2005-9#8)(2006-1#4)(2006-10#42)(2006-11#4)(2006-12#25)(2006-2#27)(2006-3#5)(2006-4#20)(2006-5#22)(2006-6#16)(2006-7#10)(2006-8#35)(2006-9#7)(2007-1#20)(2007-10#35)(2007-11#80)(2007-12#55)(2007-2#46)(2007-3#25)(2007-4#19)(2007-5#13)(2007-6#22)(2007-7#77)(2007-8#73)(2007-9#39)(2008-1#68)(2008-10#531)(2008-11#81)(2008-12#45)(2008-2#117)(2008-3#112)(2008-4#61)(2008-5#145)(2008-6#49)(2008-7#72)(2008-8#43)(2008-9#47)(2009-1#2)(2009-10#17)(2009-11#6)(2009-12#11)(2009-2#26)(2009-3#10)(2009-4#16)(2009-5#22)(2009-6#19)(2009-7#15)(2009-8#16)(2009-9#14)(2010-1#6)(2010-10#5)(2010-11#13)(2010-12#52)(2010-2#28)(2010-3#10)(2010-4#15)(2010-5#29)(2010-6#5)(2010-7#5)(2010-8#31)(2010-9#12)(2011-1#74)(2011-11#1)(2011-12#18)(2011-2#134)(2011-3#4)(2012-1#22)(2012-11#12)(2012-12#67)(2012-2#105)(2012-3#57)(2012-5#1)(2012-7#1)(2012-8#1)(2013-1#129)(2013-7#26)(2013-8#57)
out&quot##10##1##(1993-2#1)(1995-6#1)(1996-6#1)(2005-11#3)(2007-1#1)(2008-12#1)(2012-2#1)(2012-3#1)
out'##4##1##(1996-2#1)(2007-11#2)(2008-9#1)
out)##4##1##(2008-10#1)(2009-7#1)(2011-1#1)(2011-2#1)
out-migration##5##1##(2011-2#3)(2012-3#2)
out-of-band reflectance##2##2##(2008-3#2)
out-of-band##4##1##(2008-3#4)
out-of-class##3##1##(2007-12#1)(2008-2#2)
out-of-core parallel applications##2##3##(2008-3#2)
out-of-court##2##1##(1995-12#1)(1995-6#1)
out-of-focus images##3##2##(2007-12#1)(2008-3#2)
out-of-focus##12##1##(2007-12#3)(2008-2#4)(2008-3#4)(2008-4#1)
out-of-hospital cardiac arrest##5##3##(1992-5#1)(1993-8#1)(1997-7#1)(2007-7#2)
out-of-hospital cardiac##6##2##(1992-5#1)(1993-8#2)(1997-7#1)(2007-7#2)
out-of-hospital in the##2##3##(2006-10#2)
out-of-hospital in##3##2##(2006-10#3)
out-of-hospital ventricular fibrillation##3##3##(1990-12#2)(2006-10#1)
out-of-hospital##15##1##(1990-12#2)(1992-5#1)(1993-8#2)(1997-7#1)(2006-10#5)(2007-7#2)(2008-11#1)(2008-9#1)
out-of-hours primary care##4##3##(2012-11#4)
out-of-hours services##3##2##(1997-8#3)
out-of-hours##11##1##(1997-8#3)(2012-11#7)(2013-1#1)
out-of-phase##9##1##(1995-11#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-3#1)(2009-6#1)
out-of-plane anisotropy##2##2##(2007-11#2)
out-of-plane branching##2##2##(2008-2#2)
out-of-plane component##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
out-of-plane deformation##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
out-of-plane deformations##3##2##(2007-11#1)(2008-3#2)
out-of-plane rotation##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
out-of-plane scattering##4##2##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
out-of-plane##47##1##(1991-12#1)(1995-1#1)(1997-7#1)(2005-4#1)(2006-3#1)(2007-11#5)(2007-12#4)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#11)(2008-3#16)(2009-7#1)
out-of-pocket costs##8##2##(1991-2#2)(1994-3#1)(2006-8#2)(2008-11#1)(2008-4#1)(2009-4#1)
out-of-pocket expenditures##3##2##(2007-2#1)(2010-1#1)(2011-2#1)
out-of-pocket expenses##3##2##(1995-12#1)(2009-8#1)(2011-1#1)
out-of-pocket health care##2##3##(2006-8#1)(2010-1#1)
out-of-pocket health##3##2##(2006-8#1)(2008-4#1)(2010-1#1)
out-of-pocket payments##2##2##(2011-1#1)(2013-8#1)
out-of-pocket physician costs and discount##2##5##(2006-8#2)
out-of-pocket physician##3##2##(2006-8#3)
out-of-pocket spending##3##2##(1992-3#2)(1997-3#1)
out-of-pocket##30##1##(1991-2#2)(1992-3#2)(1994-3#1)(1995-12#1)(1997-1#1)(1997-3#1)(2006-8#6)(2007-2#1)(2007-6#1)(2008-11#1)(2008-4#2)(2009-4#1)(2009-8#1)(2010-1#2)(2011-1#3)(2011-2#1)(2013-1#2)(2013-8#1)
out-of-position airbag tests##3##3##(2007-4#3)
out-of-position airbag##5##2##(2007-4#5)
out-of-position##12##1##(2006-11#2)(2007-4#10)
out-of-school adolescents##6##2##(2007-3#6)
out-of-school##9##1##(2007-3#7)(2010-8#2)
out-of-town teens##3##2##(2013-1#3)
out-of-town##5##1##(2013-1#5)
out-patient clinic##3##2##(1994-11#1)(1995-9#1)(2012-2#1)
out-patient clinics##2##2##(2006-1#1)(2013-8#1)
out-patient treatment##4##2##(1990-2#1)(1990-5#1)(1995-11#1)(2006-10#1)
out-patient##37##1##(1990-2#1)(1990-3#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-5#1)(1993-12#1)(1994-1#1)(1994-11#1)(1994-3#3)(1995-11#1)(1995-9#1)(2005-3#1)(2006-1#1)(2006-10#2)(2007-12#1)(2007-8#2)(2008-1#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-2#7)(2012-2#1)(2013-8#2)
out-patients with##2##2##(1996-7#1)(2004-11#1)
out-patients##12##1##(1990-10#1)(1990-6#1)(1991-6#1)(1992-5#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-5#1)(1996-7#1)(2004-11#1)(2006-6#1)(2012-1#1)
out?##7##1##(1993-2#1)(1994-6#1)(2008-12#1)(2008-6#1)(2010-2#1)(2010-3#1)(2013-1#1)
out?]##2##1##(1990-6#1)(1996-12#1)
outbound##5##1##(2008-1#1)(2008-2#1)(2008-8#1)(2010-5#2)
outbreak and##4##2##(1997-3#1)(2011-3#1)(2013-1#1)(2013-8#1)
outbreak associated with consumption of raw##2##6##(1992-5#1)(1994-4#1)
outbreak associated with##4##3##(1990-3#1)(1992-5#1)(1994-4#1)(2013-7#1)
outbreak by##2##2##(2007-7#1)(2013-1#1)
outbreak cases##2##2##(2008-3#1)(2008-8#1)
outbreak control##3##2##(1994-11#1)(2007-12#1)(2008-12#1)
outbreak data##2##2##(2005-12#1)(2008-8#1)
outbreak detection##6##2##(2008-8#2)(2012-2#2)(2013-1#2)
outbreak for##2##2##(2007-5#1)(2008-8#1)
outbreak in 2000##2##3##(2008-1#1)(2008-12#1)
outbreak in a##3##3##(1996-2#1)(2006-4#1)(2010-12#1)
outbreak in the##3##3##(1995-6#1)(2007-8#1)(2008-10#1)
outbreak in##29##2##(1990-8#1)(1991-8#1)(1994-5#1)(1995-6#1)(1996-2#1)(2005-12#1)(2006-4#1)(2006-5#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#5)(2008-5#2)(2010-12#2)(2011-1#3)(2011-2#1)(2012-12#1)(2013-8#2)
outbreak investigation practicum##3##3##(1996-1#3)
outbreak investigation##7##2##(1996-1#4)(1996-6#1)(2008-1#1)(2008-8#1)
outbreak investigations and##2##3##(2013-1#2)
outbreak investigations in##2##3##(1996-1#1)(2006-10#1)
outbreak investigations##7##2##(1996-1#2)(2006-10#1)(2008-1#1)(2013-1#3)
outbreak isolates##3##2##(2008-5#1)(2008-6#1)(2012-3#1)
outbreak management##2##2##(2008-4#1)(2008-7#1)
outbreak occurred in##3##3##(2005-12#1)(2006-4#1)(2010-5#1)
outbreak occurred##4##2##(1990-3#1)(2005-12#1)(2006-4#1)(2010-5#1)
outbreak of acute##2##3##(1993-5#1)(1996-4#1)
outbreak of cholera##2##3##(1992-5#1)(2008-1#1)
outbreak of community-associated methicillin-resistant Staphylococcus aureus##2##6##(2008-10#1)(2008-11#1)
outbreak of cryptosporidiosis##2##3##(2008-8#1)(2013-1#1)
outbreak of foodborne##2##3##(2007-12#2)
outbreak of influenza##2##3##(1992-2#1)(1996-6#1)
outbreak of methicillin-resistant##2##3##(1994-7#1)(2007-7#1)
outbreak of the##2##3##(2012-1#1)(2012-2#1)
outbreak of tuberculosis##3##3##(1992-2#1)(2008-7#1)(2010-12#1)
outbreak of##81##2##(1990-11#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-2#2)(1992-5#1)(1993-2#1)(1993-5#2)(1994-5#1)(1994-7#1)(1995-4#2)(1995-6#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-7#2)(2006-8#1)(2007-12#7)(2007-3#1)(2007-7#5)(2007-9#1)(2008-1#5)(2008-10#6)(2008-11#1)(2008-12#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#1)(2013-8#1)
outbreak on##4##2##(1991-3#1)(2005-7#1)(2010-12#1)(2011-2#1)
outbreak species##4##2##(2008-8#4)
outbreak spread##2##2##(1990-3#1)(2008-12#1)
outbreak strain##5##2##(2006-8#1)(2008-11#2)(2008-7#1)(2012-3#1)
outbreak was##5##2##(1994-4#1)(2007-12#1)(2008-5#1)(2008-6#1)(2013-8#1)
outbreak##240##1##(1990-11#1)(1990-12#1)(1990-3#3)(1990-8#2)(1990-9#2)(1991-11#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-8#2)(1992-2#2)(1992-5#2)(1993-2#1)(1993-3#1)(1993-5#2)(1994-11#1)(1994-4#2)(1994-5#2)(1994-7#2)(1995-4#2)(1995-6#2)(1996-1#6)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-12#5)(2005-7#3)(2006-10#1)(2006-4#2)(2006-5#1)(2006-8#2)(2007-12#13)(2007-2#2)(2007-3#4)(2007-5#1)(2007-7#8)(2007-8#2)(2007-9#1)(2008-1#11)(2008-10#10)(2008-11#3)(2008-12#13)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#12)(2008-6#4)(2008-7#3)(2008-8#18)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#5)(2010-5#2)(2011-1#5)(2011-2#8)(2011-3#1)(2012-1#3)(2012-12#2)(2012-2#10)(2012-3#6)(2013-1#10)(2013-7#1)(2013-8#7)
outbreak-associated##2##1##(1994-9#1)(2008-11#1)
outbreaks among##2##2##(1992-1#1)(2010-5#1)
outbreaks and##12##2##(1997-3#1)(2007-6#1)(2007-7#1)(2008-4#1)(2008-8#2)(2010-12#1)(2011-2#2)(2013-1#1)(2013-8#2)
outbreaks are##2##2##(2012-1#1)(2012-2#1)
outbreaks as##2##2##(2007-2#1)(2010-12#1)
outbreaks caused by##4##3##(2008-6#1)(2010-12#2)(2011-2#1)
outbreaks continue to##2##3##(2006-10#1)(2011-12#1)
outbreaks during##2##2##(1996-8#1)(2006-10#1)
outbreaks have occurred##2##3##(2008-7#1)(2010-7#1)
outbreaks have##3##2##(2005-10#1)(2008-7#1)(2010-7#1)
outbreaks in Taiwan##3##3##(2007-6#3)
outbreaks in long term care facilities##3##6##(2007-12#3)
outbreaks in the##5##3##(1991-12#1)(1991-2#1)(1996-12#1)(2007-2#1)(2012-2#1)
outbreaks in##25##2##(1991-12#1)(1991-2#1)(1996-12#2)(1997-6#1)(2007-12#4)(2007-2#2)(2007-6#3)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-2#1)
outbreaks occur in##3##3##(2007-12#1)(2010-12#1)(2012-2#1)
outbreaks occur##4##2##(1991-8#1)(2007-12#1)(2010-12#1)(2012-2#1)
outbreaks occurred in##3##3##(1996-6#1)(1997-3#1)(2011-1#1)
outbreaks occurred##4##2##(1996-6#1)(1997-3#1)(2010-12#1)(2011-1#1)
outbreaks of acute##2##3##(2012-2#1)(2013-1#1)
outbreaks of bacterial##2##3##(2008-10#1)(2012-11#1)
outbreaks of diarrhoea##2##3##(1994-4#2)
outbreaks of foot and mouth disease##2##6##(2005-5#2)
outbreaks of infectious intestinal disease in England and Wales##2##9##(1996-3#2)
outbreaks of infectious##4##3##(1996-3#2)(1997-3#1)(2008-1#1)
outbreaks of influenza##3##3##(1991-8#1)(2007-12#1)(2010-12#1)
outbreaks of invasive meningococcal disease serogroup C##2##7##(2008-11#2)
outbreaks of invasive##3##3##(1990-8#1)(2008-11#2)
outbreaks of laminitis##2##3##(1992-10#2)
outbreaks of the##4##3##(2007-10#1)(2008-8#1)(2011-1#1)(2013-8#1)
outbreaks of##73##2##(1990-3#1)(1990-6#1)(1990-8#1)(1991-11#2)(1991-3#1)(1991-8#2)(1992-10#3)(1992-5#1)(1993-5#1)(1994-3#1)(1994-4#2)(1994-6#1)(1996-11#1)(1996-3#2)(1996-6#2)(1996-8#1)(1997-3#1)(1997-6#1)(2005-5#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#4)(2008-7#2)(2008-8#1)(2009-3#2)(2009-6#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-1#3)(2012-11#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
outbreaks reported in##3##3##(1996-3#1)(2009-2#2)
outbreaks reported##6##2##(1992-1#1)(1992-6#1)(1996-3#2)(2009-2#2)
outbreaks should##2##2##(2012-2#2)
outbreaks were##6##2##(2006-2#1)(2009-2#1)(2010-12#1)(2011-1#1)(2012-2#2)
outbreaks##228##1##(1990-3#1)(1990-6#1)(1990-8#1)(1991-11#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#4)(1992-1#2)(1992-10#3)(1992-5#2)(1992-6#1)(1993-5#2)(1994-3#1)(1994-4#2)(1994-6#1)(1995-3#1)(1996-11#1)(1996-12#3)(1996-3#7)(1996-6#3)(1996-8#3)(1997-3#4)(1997-6#4)(2005-10#1)(2005-12#2)(2005-5#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#11)(2007-2#5)(2007-3#1)(2007-6#4)(2007-7#2)(2008-1#7)(2008-10#9)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#6)(2008-8#7)(2009-2#7)(2009-3#2)(2009-4#1)(2009-6#1)(2009-9#3)(2010-1#2)(2010-12#14)(2010-2#1)(2010-4#2)(2010-5#2)(2010-7#1)(2011-1#6)(2011-12#1)(2011-2#11)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#14)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#4)
outbred##10##1##(1993-5#1)(1996-10#1)(1996-3#1)(2006-12#1)(2008-10#3)(2008-12#1)(2008-4#1)(2010-12#1)
outbreeding##4##1##(2008-8#4)
outburst##4##1##(2008-10#2)(2009-2#2)
outcome (P &lt##2##3##(1994-12#1)(2007-10#1)
outcome (P =##2##3##(2007-10#1)(2007-8#1)
outcome (P##4##2##(1994-12#1)(2007-10#2)(2007-8#1)
outcome (P=0##5##2##(2013-1#5)
outcome (i##2##2##(2008-1#1)(2010-3#1)
outcome (measured##2##2##(2005-10#1)(2008-6#1)
outcome (p##2##2##(1993-2#1)(2007-7#1)
outcome according to the##3##4##(2007-7#3)
outcome after AVM-ICH##2##3##(2012-3#2)
outcome after abdominal myomectomy##2##4##(2004-10#2)
outcome after anterior cruciate ligament##2##5##(2009-6#1)(2009-9#1)
outcome after ischemic stroke##6##4##(2007-10#6)
outcome after laparoscopic##3##3##(2011-1#2)(2013-7#1)
outcome after primary percutaneous coronary intervention##2##6##(2009-12#1)(2009-5#1)
outcome after repair##2##3##(2007-7#1)(2007-8#1)
outcome after resection##2##3##(2007-8#1)(2008-6#1)
outcome after the##2##3##(2007-8#1)(2010-5#1)
outcome after##70##2##(1992-12#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-5#1)(1994-12#1)(1995-8#1)(1996-7#1)(2004-10#3)(2005-12#1)(2006-10#2)(2006-11#1)(2007-10#6)(2007-11#2)(2007-2#2)(2007-7#5)(2007-8#7)(2007-9#3)(2008-12#1)(2008-3#1)(2008-6#3)(2008-7#3)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-11#1)(2010-5#1)(2011-1#5)(2011-2#2)(2012-3#4)(2013-1#1)(2013-7#1)
outcome also##2##2##(2006-6#1)(2008-7#1)
outcome among##9##2##(2006-7#1)(2007-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-5#2)(2012-2#1)(2013-1#1)
outcome analysis##6##2##(2005-10#1)(2006-12#1)(2006-8#1)(2007-8#2)(2008-4#1)
outcome and a##2##3##(2011-2#1)(2012-3#1)
outcome and continuous quality improvement##3##5##(1993-12#3)
outcome and duration of##2##4##(1995-9#1)(2006-8#1)
outcome and its##3##3##(2007-2#1)(2008-11#1)(2009-4#1)
outcome and management##2##3##(2006-10#1)(2006-6#1)
outcome and possible treatment##2##4##(2008-7#1)(2010-12#1)
outcome and possible##3##3##(2008-7#1)(2010-12#1)(2012-3#1)
outcome and quality##2##3##(2006-10#1)(2008-8#1)
outcome and reduce##2##3##(1997-5#1)(2009-4#1)
outcome and survival##3##3##(2006-10#1)(2007-9#1)(2011-2#1)
outcome and that##2##3##(2007-1#1)(2009-3#1)
outcome and the##7##3##(1995-2#2)(2007-7#1)(2007-8#3)(2010-5#1)
outcome and to##2##3##(2006-2#1)(2008-10#1)
outcome and##73##2##(1993-12#3)(1993-5#1)(1993-9#1)(1995-2#2)(1995-9#1)(1996-2#2)(1997-5#1)(2005-6#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-2#2)(2006-6#2)(2006-8#1)(2007-1#1)(2007-2#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-4#2)(2008-7#4)(2008-8#2)(2009-3#1)(2009-4#3)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-1#4)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#3)
outcome are discussed##3##3##(2006-6#1)(2007-3#1)(2007-7#1)
outcome are##12##2##(1990-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-1#1)
outcome as a function of##2##5##(1991-1#1)(2006-10#1)
outcome as a##4##3##(1991-1#1)(1997-4#1)(2005-2#1)(2006-10#1)
outcome as measured by##2##4##(2008-5#1)(2013-1#1)
outcome as##12##2##(1990-10#1)(1991-1#1)(1997-4#1)(2005-2#1)(2006-10#2)(2006-11#1)(2008-5#1)(2009-10#1)(2010-3#1)(2013-1#1)(2013-8#1)
outcome assessment##10##2##(1997-1#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-7#4)(2008-8#1)
outcome at 3 months##2##4##(2007-10#1)(2008-8#1)
outcome at 6 months and 2 years##3##7##(2007-10#3)
outcome at 6 months##4##4##(2007-10#4)
outcome at birth##2##3##(1994-6#1)(2004-10#1)
outcome at post-treatment##2##3##(2007-12#2)
outcome at the##3##3##(2005-9#1)(2007-8#1)(2009-4#1)
outcome at##22##2##(1991-11#1)(1994-6#1)(1995-11#1)(2004-10#1)(2005-9#1)(2006-10#1)(2006-2#1)(2007-10#6)(2007-12#2)(2007-8#1)(2008-7#1)(2008-8#1)(2009-4#3)(2011-2#1)
outcome based on##2##3##(1990-12#1)(2007-4#1)
outcome between the two##2##4##(1997-3#1)(2010-3#1)
outcome between the##3##3##(1997-3#1)(2010-3#1)(2011-2#1)
outcome between these##2##3##(1990-2#1)(2011-2#1)
outcome between##9##2##(1990-2#1)(1997-3#1)(2007-1#1)(2007-9#1)(2008-5#1)(2008-6#1)(2010-3#1)(2011-2#2)
outcome but##2##2##(2007-8#1)(2008-4#1)
outcome by##9##2##(2006-10#1)(2006-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-6#1)(2011-2#2)(2012-2#1)
outcome can be##5##3##(2007-10#1)(2008-11#1)(2010-2#1)(2010-3#1)(2012-12#1)
outcome caused by##2##3##(1990-12#1)(2011-1#1)
outcome compared with the rest of##2##6##(2009-2#1)(2011-2#1)
outcome compared with##5##3##(2006-10#1)(2009-2#2)(2011-2#1)(2012-3#1)
outcome could be##2##3##(1995-11#1)(2009-10#1)
outcome could##4##2##(1995-11#1)(2007-10#1)(2009-10#1)(2013-1#1)
outcome data and##2##3##(2006-6#1)(2012-3#1)
outcome data from##2##3##(1993-3#1)(1995-12#1)
outcome data##25##2##(1993-3#2)(1995-12#1)(1996-7#2)(1997-2#1)(2006-10#1)(2006-6#1)(2006-8#2)(2007-12#1)(2007-2#1)(2008-1#3)(2008-12#1)(2008-3#1)(2008-9#1)(2010-3#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
outcome definitions##3##2##(2008-3#1)(2011-1#2)
outcome demonstrates##2##2##(2008-3#1)(2008-8#1)
outcome depends on##2##3##(2007-11#1)(2007-8#1)
outcome depends##4##2##(2007-11#2)(2007-8#1)(2008-10#1)
outcome despite##3##2##(2009-4#1)(2011-2#1)(2013-8#1)
outcome domains##3##2##(2009-7#1)(2011-1#1)(2011-2#1)
outcome due to the##2##4##(2004-10#1)(2007-8#1)
outcome during##2##2##(2008-2#1)(2008-6#1)
outcome evaluation tools##3##3##(2011-12#3)
outcome evaluation##9##2##(2006-2#1)(2007-10#1)(2007-7#1)(2011-12#5)(2011-2#1)
outcome events (stroke##2##3##(1991-11#2)
outcome events##6##2##(1990-5#1)(1991-11#2)(2007-10#1)(2008-4#1)(2008-8#1)
outcome focus on##2##3##(1997-4#2)
outcome following the##2##3##(2007-8#2)
outcome following##24##2##(1992-1#1)(1992-3#1)(1994-12#2)(1995-9#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-7#2)(2007-8#4)(2008-7#2)(2008-9#2)(2009-10#2)(2009-5#2)(2010-7#1)(2013-8#1)
outcome for a##2##3##(2004-2#1)(2012-12#1)
outcome for an##2##3##(2005-9#1)(2009-2#1)
outcome for both the##2##4##(1991-1#1)(2008-10#1)
outcome for both##3##3##(1991-1#1)(2008-10#1)(2010-10#1)
outcome for mother and##2##4##(2006-10#1)(2008-7#1)
outcome for patients with##6##4##(2007-10#2)(2007-7#1)(2008-3#1)(2008-9#1)(2010-3#1)
outcome for patients##8##3##(2007-10#2)(2007-7#1)(2008-3#1)(2008-9#1)(2010-12#1)(2010-3#1)(2012-2#1)
outcome for the patient##4##4##(1990-10#1)(2008-7#2)(2012-3#1)
outcome for the##9##3##(1990-10#1)(1995-3#1)(2006-10#1)(2007-11#1)(2008-7#2)(2011-1#1)(2012-3#1)(2013-8#1)
outcome for these##3##3##(2006-10#1)(2007-12#1)(2011-2#1)
outcome for##46##2##(1990-10#1)(1991-1#1)(1991-12#1)(1994-6#1)(1994-9#1)(1995-3#1)(2004-2#1)(2005-9#1)(2006-10#4)(2006-7#1)(2007-10#2)(2007-11#4)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-8#1)
outcome from a##2##3##(2006-6#1)(2011-2#1)
outcome from the##2##3##(1995-2#1)(1995-5#1)
outcome from##14##2##(1992-1#1)(1995-2#1)(1995-5#1)(1995-9#1)(2006-10#3)(2006-11#2)(2006-2#1)(2006-6#1)(2008-8#1)(2011-2#1)(2012-12#1)
outcome group##3##2##(1994-12#1)(2009-4#2)
outcome groups##3##2##(2004-10#1)(2008-7#1)(2009-4#1)
outcome has been##2##3##(2006-9#1)(2007-12#1)
outcome has##7##2##(2006-12#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-3#1)(2012-1#1)
outcome have##2##2##(2006-10#1)(2011-2#1)
outcome in 36##2##3##(2007-7#1)(2007-8#1)
outcome in 50 patients with lesions around the motor cortex##2##10##(2006-10#2)
outcome in 50##3##3##(2006-10#2)(2008-6#1)
outcome in RA##2##3##(2007-11#1)(2007-7#1)
outcome in a cohort of##2##5##(2011-12#1)(2012-1#1)
outcome in a group of##3##5##(2006-10#1)(2007-7#1)(2008-6#1)
outcome in a series of##4##5##(2007-8#1)(2007-9#1)(2008-10#2)
outcome in a##20##3##(1990-2#1)(1993-2#1)(1995-11#1)(2006-10#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-6#1)(2009-10#1)(2010-11#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
outcome in acute##3##3##(2007-10#1)(2009-7#1)(2013-1#1)
outcome in both##2##3##(1994-11#1)(2007-7#1)
outcome in cases of##2##4##(2004-10#1)(2013-8#1)
outcome in children##2##3##(2007-8#1)(2009-7#1)
outcome in idiopathic scoliosis##2##4##(2007-7#2)
outcome in patients suffering from##2##5##(2007-8#1)(2008-6#1)
outcome in patients treated with##2##5##(1994-8#1)(2011-2#1)
outcome in patients undergoing##3##4##(2006-10#1)(2007-8#1)(2010-8#1)
outcome in patients with acute##3##5##(1994-10#1)(2007-10#1)(2007-9#1)
outcome in patients with##24##4##(1994-10#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#3)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2011-12#2)(2011-2#1)(2012-2#1)
outcome in patients##41##3##(1994-10#1)(1994-8#1)(2005-10#1)(2006-10#3)(2006-12#1)(2007-10#2)(2007-11#4)(2007-7#3)(2007-8#8)(2007-9#2)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-8#1)(2011-12#2)(2011-2#3)(2012-2#1)(2013-1#1)
outcome in response to##2##4##(2006-10#1)(2010-12#1)
outcome in schizophrenia##3##3##(2006-9#2)(2010-1#1)
outcome in scoliosis##2##3##(2007-7#2)
outcome in terms of##5##4##(2006-8#1)(2007-10#1)(2007-7#1)(2008-11#1)(2012-3#1)
outcome in the treatment of##2##5##(2007-11#1)(2007-7#1)
outcome in the##18##3##(1995-6#1)(1997-1#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)
outcome in these patients##3##4##(2007-8#1)(2007-9#1)(2013-7#1)
outcome in these##6##3##(1995-12#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-7#1)(2013-7#1)
outcome in this##6##3##(2006-10#1)(2007-8#1)(2009-10#1)(2009-6#1)(2010-12#1)(2013-1#1)
outcome in women with##3##4##(1994-3#1)(2007-10#1)(2013-7#1)
outcome in women##4##3##(1994-3#1)(2007-10#1)(2008-10#1)(2013-7#1)
outcome in##225##2##(1990-2#1)(1990-9#2)(1991-1#1)(1991-12#2)(1991-5#1)(1992-1#1)(1992-12#2)(1992-2#1)(1993-2#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#1)(1997-1#2)(2004-10#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#12)(2006-11#1)(2006-12#2)(2006-4#1)(2006-7#2)(2006-8#1)(2006-9#3)(2007-10#8)(2007-11#8)(2007-12#4)(2007-2#2)(2007-3#1)(2007-4#2)(2007-7#27)(2007-8#20)(2007-9#5)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#7)(2008-7#8)(2008-8#2)(2009-10#4)(2009-2#1)(2009-4#1)(2009-6#2)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#6)(2010-7#1)(2010-8#2)(2011-1#3)(2011-12#3)(2011-2#10)(2012-1#1)(2012-12#8)(2012-2#5)(2012-3#2)(2013-1#5)(2013-7#4)(2013-8#2)
outcome including##2##2##(2006-2#1)(2008-8#1)
outcome indicators##5##2##(1995-3#1)(1997-1#4)
outcome information##6##2##(1992-1#1)(1995-2#1)(1995-3#1)(2006-2#1)(2008-6#1)(2013-1#1)
outcome is a##2##3##(1993-3#1)(2006-2#1)
outcome is determined by##2##4##(2007-4#1)(2007-9#1)
outcome is generally##2##3##(2006-10#1)(2007-11#1)
outcome is still##2##3##(2005-10#1)(2007-8#1)
outcome is to be##2##4##(1995-8#1)(2008-10#1)
outcome is to##3##3##(1995-8#1)(2008-10#1)(2008-11#1)
outcome is##46##2##(1990-12#1)(1992-2#1)(1993-3#1)(1994-11#1)(1995-2#1)(1995-8#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#1)(2004-2#1)(2005-10#2)(2005-8#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
outcome may be##5##3##(1995-7#1)(2007-8#1)(2009-5#1)(2010-11#1)(2012-12#1)
outcome measure in##4##3##(1996-3#1)(2006-12#1)(2011-2#2)
outcome measure of##2##3##(2007-7#1)(2013-1#1)
outcome measure was the##3##4##(1992-10#1)(2008-10#1)(2013-1#1)
outcome measure was##9##3##(1992-10#1)(2006-7#1)(2008-10#1)(2008-7#1)(2009-3#1)(2011-2#3)(2013-1#1)
outcome measure##29##2##(1992-10#1)(1993-1#1)(1993-5#2)(1994-4#1)(1995-5#1)(1996-3#1)(2006-12#3)(2006-7#1)(2007-11#1)(2007-7#2)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#5)(2013-1#4)
outcome measure)##3##2##(2008-12#1)(2011-2#2)
outcome measurement##6##2##(1993-12#1)(1995-2#1)(1997-2#1)(2007-11#1)(2007-7#1)(2012-1#1)
outcome measurements##3##2##(2008-3#1)(2010-12#1)(2011-2#1)
outcome measures and##3##3##(2008-6#1)(2008-7#1)(2013-8#1)
outcome measures are##2##3##(1992-10#1)(2008-11#1)
outcome measures for##2##3##(1996-1#1)(2011-2#1)
outcome measures in##9##3##(1995-1#1)(2006-12#1)(2007-11#1)(2008-4#1)(2009-11#1)(2010-12#2)(2011-12#2)
outcome measures included the##2##4##(2007-10#1)(2008-12#1)
outcome measures included##6##3##(2007-10#1)(2008-12#1)(2008-3#1)(2010-8#1)(2011-2#2)
outcome measures of##7##3##(1994-11#1)(1996-1#1)(2006-10#1)(2009-11#1)(2011-1#3)
outcome measures to##2##3##(1995-3#1)(2005-9#1)
outcome measures used##3##3##(1996-3#1)(2007-11#1)(2008-11#1)
outcome measures were the##2##4##(2006-10#1)(2008-3#1)
outcome measures were##20##3##(2006-10#1)(2006-12#1)(2006-7#1)(2007-7#2)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2011-11#1)(2011-2#5)(2012-1#1)(2013-1#1)(2013-8#1)
outcome measures##117##2##(1991-2#1)(1992-10#1)(1992-4#1)(1993-7#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-3#2)(1996-1#2)(1996-3#2)(1996-7#1)(1997-3#1)(2005-12#1)(2005-7#1)(2005-9#1)(2006-10#3)(2006-12#3)(2006-2#2)(2006-3#1)(2006-7#2)(2007-10#2)(2007-11#9)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#2)(2010-1#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#6)(2011-11#1)(2011-12#2)(2011-2#13)(2012-1#5)(2012-2#4)(2013-1#5)(2013-8#2)
outcome obtained##2##2##(2006-3#1)(2007-11#1)
outcome of 16##2##3##(2006-10#1)(2013-1#1)
outcome of ART##2##3##(2009-6#1)(2010-12#1)
outcome of CMM##2##3##(1990-10#2)
outcome of a##13##3##(1993-11#1)(1994-1#2)(1994-11#1)(2006-11#1)(2007-3#1)(2007-7#2)(2008-2#1)(2008-6#1)(2009-6#1)(2010-12#1)(2013-8#1)
outcome of acute##4##3##(1993-2#1)(2006-10#1)(2010-11#1)(2010-12#1)
outcome of adult##2##3##(1993-2#1)(2008-1#1)
outcome of all##4##3##(1990-9#2)(2010-3#1)(2010-8#1)
outcome of an##6##3##(1994-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2012-11#1)(2012-3#1)
outcome of both##3##3##(1991-3#1)(1996-1#1)(2012-2#1)
outcome of breast cancer##3##4##(2010-12#1)(2013-1#2)
outcome of cardiac surgery##2##4##(2007-8#1)(2010-8#1)
outcome of cardiac##5##3##(2006-10#1)(2007-8#2)(2010-12#1)(2010-8#1)
outcome of cardiovascular##3##3##(2006-10#1)(2006-5#1)(2013-7#1)
outcome of care##2##3##(1994-3#1)(1997-3#1)
outcome of childhood##2##3##(1991-8#1)(2011-2#1)
outcome of children with##3##4##(2006-10#1)(2011-5#1)(2013-7#1)
outcome of extremely##3##3##(1996-11#1)(2006-7#1)(2006-8#1)
outcome of high-risk##3##3##(2006-10#1)(2007-7#1)(2008-11#1)
outcome of immediate##2##3##(2013-1#2)
outcome of infections##3##3##(2009-2#3)
outcome of interactions between##2##4##(2008-8#1)(2012-3#1)
outcome of interest##6##3##(1994-2#1)(1994-8#1)(2006-5#1)(2008-5#1)(2008-7#1)(2012-3#1)
outcome of lung##2##3##(2007-8#1)(2011-3#1)
outcome of lupus##2##3##(2006-10#1)(2007-9#1)
outcome of medical##2##3##(2006-12#1)(2008-8#1)
outcome of modified##2##3##(2013-1#2)
outcome of patients treated with##2##5##(2004-1#1)(2011-2#1)
outcome of patients treated##3##4##(2004-1#1)(2009-5#1)(2011-2#1)
outcome of patients who##2##4##(2006-8#1)(2007-8#1)
outcome of patients with acute##2##5##(2006-10#1)(2011-2#1)
outcome of patients with##16##4##(1994-4#2)(2005-10#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-5#1)(2007-7#1)(2008-6#2)(2010-3#2)(2010-9#1)(2011-2#2)(2012-3#1)
outcome of patients##22##3##(1994-4#2)(2004-1#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-6#2)(2009-5#1)(2010-3#2)(2010-9#1)(2011-2#3)(2012-3#1)
outcome of pediatric##3##3##(2007-3#1)(2011-2#1)(2012-3#1)
outcome of percutaneous##2##3##(2008-7#1)(2010-5#1)
outcome of pregnancy##12##3##(1990-9#1)(1991-2#1)(1997-4#1)(2005-10#1)(2007-8#3)(2008-3#1)(2009-2#1)(2010-12#1)(2012-12#1)(2013-8#1)
outcome of primary##3##3##(2006-10#1)(2007-7#2)
outcome of renal##2##3##(2008-1#1)(2008-8#1)
outcome of revision##2##3##(2007-7#2)
outcome of self-medication##2##3##(2007-7#2)
outcome of stroke##3##3##(2007-9#2)(2008-8#1)
outcome of surgery for##2##4##(2008-3#1)(2012-11#1)
outcome of surgery##3##3##(2008-3#1)(2009-7#1)(2012-11#1)
outcome of surgical treatment##4##4##(2006-8#1)(2007-7#2)(2007-8#1)
outcome of surgical##5##3##(2006-10#1)(2006-8#1)(2007-7#2)(2007-8#1)
outcome of systemic##2##3##(1993-11#1)(2006-10#1)
outcome of the case##3##4##(2010-12#1)(2013-1#2)
outcome of the disease##7##4##(1994-8#1)(2006-6#1)(2007-11#1)(2008-8#2)(2009-2#1)(2010-12#1)
outcome of the patient##3##4##(2007-3#1)(2010-6#1)(2012-2#1)
outcome of the seminal fluid parameters collected via##2##8##(2011-1#2)
outcome of the study##3##4##(1993-1#1)(2006-12#1)(2007-3#1)
outcome of the surgery##2##4##(2007-11#1)(2012-12#1)
outcome of the treatment##2##4##(2007-7#1)(2008-7#1)
outcome of the##81##3##(1990-8#1)(1992-3#1)(1993-1#1)(1993-5#1)(1994-8#1)(1995-12#1)(2004-7#1)(2005-5#1)(2006-10#6)(2006-12#2)(2006-6#2)(2006-8#3)(2007-11#6)(2007-2#2)(2007-3#3)(2007-4#1)(2007-5#3)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#2)(2009-12#1)(2009-2#1)(2009-4#3)(2009-5#3)(2009-9#1)(2010-12#2)(2010-6#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#2)
outcome of these##11##3##(1994-11#1)(2006-10#1)(2006-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)
outcome of this disease##3##4##(2006-2#1)(2008-8#1)(2009-8#1)
outcome of this study##2##4##(2006-6#1)(2011-2#1)
outcome of this##14##3##(1990-9#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-3#1)(2007-8#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#1)
outcome of treatment are##2##4##(1991-1#1)(2011-2#1)
outcome of treatment for##3##4##(2007-10#1)(2007-11#1)(2008-11#1)
outcome of treatment##11##3##(1991-1#1)(1991-6#1)(1993-1#1)(1996-9#2)(2007-10#1)(2007-11#1)(2008-11#2)(2011-1#1)(2011-2#1)
outcome of using##2##3##(2007-8#1)(2008-12#1)
outcome of##503##2##(1990-10#2)(1990-6#2)(1990-8#2)(1990-9#6)(1991-1#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-6#2)(1991-8#1)(1992-1#2)(1992-10#1)(1992-3#1)(1992-7#1)(1993-1#2)(1993-11#3)(1993-2#2)(1993-5#2)(1994-1#3)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#2)(1994-4#2)(1994-6#1)(1994-8#3)(1995-1#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-9#3)(1997-2#1)(1997-3#2)(1997-4#2)(1997-7#2)(1997-8#3)(2004-1#2)(2004-10#1)(2004-4#1)(2004-7#2)(2005-1#1)(2005-10#3)(2005-11#3)(2005-12#1)(2005-5#1)(2005-7#2)(2006-1#1)(2006-10#25)(2006-11#1)(2006-12#3)(2006-2#3)(2006-4#1)(2006-5#3)(2006-6#6)(2006-7#2)(2006-8#9)(2006-9#2)(2007-1#3)(2007-10#3)(2007-11#12)(2007-12#4)(2007-2#7)(2007-3#6)(2007-4#2)(2007-5#4)(2007-6#1)(2007-7#25)(2007-8#25)(2007-9#5)(2008-1#9)(2008-10#10)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#5)(2008-6#9)(2008-7#18)(2008-8#13)(2008-9#10)(2009-10#6)(2009-12#1)(2009-2#7)(2009-3#2)(2009-4#3)(2009-5#5)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#3)(2010-10#3)(2010-11#2)(2010-12#11)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#4)(2010-6#3)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#11)(2011-12#1)(2011-2#19)(2011-3#1)(2011-5#1)(2012-1#2)(2012-11#2)(2012-12#8)(2012-2#13)(2012-3#12)(2012-4#1)(2013-1#20)(2013-7#2)(2013-8#8)
outcome often##3##2##(2006-11#1)(2013-1#2)
outcome on##3##2##(1994-2#1)(2007-8#1)(2010-2#1)
outcome or##6##2##(1994-2#1)(1995-12#1)(2006-10#1)(2006-12#1)(2007-8#1)(2011-2#1)
outcome over##2##2##(2011-2#2)
outcome prediction##3##2##(2009-4#1)(2013-1#2)
outcome predictor##2##2##(1991-6#1)(2012-1#1)
outcome predictors##2##2##(1997-8#2)
outcome quality##2##2##(1993-12#1)(2008-11#1)
outcome questionnaires##3##2##(2008-9#1)(2012-12#2)
outcome rates##3##2##(1993-5#1)(2007-1#1)(2007-8#1)
outcome remain##2##2##(1992-5#1)(2011-2#1)
outcome research in the field##2##5##(1992-1#1)(1993-1#1)
outcome research##7##2##(1992-1#1)(1993-1#1)(2008-11#2)(2009-7#1)(2012-1#1)(2012-2#1)
outcome results##2##2##(1995-4#1)(2010-12#1)
outcome scales (e##2##3##(2007-9#2)
outcome scales##3##2##(2007-8#1)(2007-9#2)
outcome scores##2##2##(2006-12#1)(2008-8#1)
outcome seems to be##3##4##(2006-5#1)(2007-1#1)(2008-7#1)
outcome should be evaluated##2##4##(2008-6#1)(2012-2#1)
outcome should be##3##3##(2008-3#1)(2008-6#1)(2012-2#1)
outcome showed##2##2##(2005-11#1)(2007-9#1)
outcome studies have##2##3##(2006-10#1)(2013-7#1)
outcome studies##14##2##(1991-2#1)(2005-11#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-5#1)(2007-1#1)(2009-4#1)(2010-11#1)(2011-1#1)(2013-7#1)
outcome study##8##2##(2006-12#1)(2006-7#3)(2006-8#2)(2008-9#1)(2010-12#1)
outcome than that##2##3##(2008-5#1)(2008-6#1)
outcome than the##2##3##(2008-11#1)(2010-12#1)
outcome than##7##2##(1991-8#1)(1996-3#1)(2006-9#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-12#1)
outcome that has been##2##4##(1996-1#1)(2009-11#1)
outcome that##9##2##(1992-5#1)(1996-1#1)(1997-3#1)(2004-9#1)(2006-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-11#1)
outcome through##3##2##(1991-11#1)(2010-12#1)(2010-3#1)
outcome to##5##2##(2005-12#1)(2008-1#1)(2009-3#1)(2010-8#1)(2013-1#1)
outcome trials##2##2##(2012-2#1)(2013-1#1)
outcome using##4##2##(2006-12#1)(2007-11#1)(2007-8#1)(2010-7#1)
outcome variable is##2##3##(1994-8#1)(1995-12#1)
outcome variable##8##2##(1991-11#1)(1994-8#1)(1995-12#2)(1996-6#1)(1997-3#1)(1997-6#1)(2007-12#1)
outcome variables such as##2##4##(1993-9#1)(2009-11#1)
outcome variables##18##2##(1993-9#4)(1994-3#1)(2005-9#1)(2006-10#3)(2006-2#1)(2006-9#1)(2007-12#1)(2007-2#1)(2008-7#1)(2009-11#1)(2012-2#1)(2013-1#2)
outcome was achieved##2##3##(2007-7#1)(2008-12#1)
outcome was assessed##4##3##(1993-7#1)(1997-3#1)(2007-10#1)(2007-8#1)
outcome was defined as##3##4##(2007-1#1)(2007-10#1)(2013-1#1)
outcome was determined##2##3##(1991-12#1)(1996-12#1)
outcome was evaluated on the##2##5##(2007-11#2)
outcome was evaluated##4##3##(1994-9#1)(2006-12#1)(2007-11#2)
outcome was excellent in##2##4##(2007-9#1)(2011-2#1)
outcome was excellent##6##3##(1994-9#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-5#1)(2011-2#1)
outcome was fatal##2##3##(2010-8#1)(2012-2#1)
outcome was favorable##4##3##(2005-10#1)(2006-7#1)(2007-8#1)(2012-12#1)
outcome was good##4##3##(2007-1#1)(2007-11#1)(2007-8#1)(2008-4#1)
outcome was not##2##3##(2007-3#2)
outcome was observed##4##3##(1996-9#1)(2007-8#1)(2013-1#2)
outcome was obtained##2##3##(2007-10#1)(2007-8#1)
outcome was reported##2##3##(2007-8#2)
outcome was satisfactory##2##3##(1997-3#1)(2007-7#1)
outcome was successful##2##3##(2006-7#1)(2007-5#1)
outcome was that##2##3##(1997-1#1)(2012-12#1)
outcome was the proportion of patients##2##6##(2007-10#1)(2013-1#1)
outcome was the##6##3##(2007-10#1)(2007-8#1)(2008-12#1)(2008-9#1)(2011-2#1)(2013-1#1)
outcome was very good##2##4##(2007-7#1)(2011-1#1)
outcome was##99##2##(1990-5#1)(1991-12#1)(1992-2#1)(1993-2#1)(1993-7#2)(1994-9#2)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-3#3)(2005-10#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#3)(2007-1#2)(2007-10#7)(2007-11#9)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#16)(2007-9#2)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)
outcome we##2##2##(1994-6#1)(2007-11#1)
outcome were##13##2##(1995-9#1)(1997-3#1)(2007-3#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
outcome when##3##2##(1993-11#1)(1995-9#1)(2007-9#1)
outcome will be##2##3##(2007-12#1)(2007-8#1)
outcome will##4##2##(1995-3#1)(2006-10#1)(2007-12#1)(2007-8#1)
outcome with a##4##3##(1996-3#1)(2006-10#1)(2007-8#1)(2010-3#1)
outcome with respect to##4##4##(1992-10#1)(2008-6#1)(2009-8#1)(2011-2#1)
outcome with the##2##3##(1991-2#1)(2007-2#1)
outcome with##21##2##(1991-2#1)(1992-10#1)(1992-12#1)(1996-3#1)(2006-10#1)(2007-12#4)(2007-2#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-6#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
outcome without##3##2##(2010-5#1)(2011-12#1)(2012-12#1)
outcome##2380##1##(1990-10#4)(1990-12#5)(1990-2#2)(1990-5#2)(1990-6#2)(1990-8#4)(1990-9#9)(1991-1#4)(1991-10#1)(1991-11#7)(1991-12#9)(1991-2#10)(1991-3#3)(1991-5#1)(1991-6#6)(1991-8#2)(1991-9#2)(1992-1#8)(1992-10#5)(1992-12#9)(1992-2#4)(1992-3#9)(1992-4#3)(1992-5#2)(1992-7#4)(1992-8#2)(1992-9#5)(1993-1#5)(1993-11#4)(1993-12#7)(1993-2#7)(1993-3#4)(1993-4#1)(1993-5#8)(1993-6#1)(1993-7#4)(1993-8#1)(1993-9#5)(1994-1#3)(1994-10#1)(1994-11#7)(1994-12#8)(1994-2#10)(1994-3#4)(1994-4#3)(1994-6#5)(1994-7#1)(1994-8#6)(1994-9#3)(1995-1#5)(1995-11#3)(1995-12#8)(1995-2#13)(1995-3#8)(1995-4#3)(1995-5#4)(1995-6#3)(1995-7#1)(1995-8#3)(1995-9#8)(1996-1#4)(1996-11#2)(1996-12#1)(1996-2#7)(1996-3#6)(1996-5#2)(1996-6#3)(1996-7#4)(1996-8#1)(1996-9#6)(1997-1#9)(1997-2#5)(1997-3#12)(1997-4#8)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#7)(2004-1#3)(2004-10#13)(2004-12#1)(2004-2#3)(2004-4#1)(2004-7#2)(2004-9#1)(2005-1#2)(2005-10#15)(2005-11#9)(2005-12#6)(2005-2#1)(2005-5#2)(2005-6#2)(2005-7#6)(2005-8#7)(2005-9#5)(2006-1#1)(2006-10#102)(2006-11#13)(2006-12#25)(2006-2#20)(2006-3#4)(2006-4#3)(2006-5#8)(2006-6#21)(2006-7#18)(2006-8#20)(2006-9#10)(2007-1#11)(2007-10#68)(2007-11#67)(2007-12#27)(2007-2#26)(2007-3#19)(2007-4#6)(2007-5#7)(2007-6#2)(2007-7#113)(2007-8#144)(2007-9#44)(2008-1#33)(2008-10#28)(2008-11#46)(2008-12#20)(2008-2#7)(2008-3#22)(2008-4#14)(2008-5#20)(2008-6#46)(2008-7#77)(2008-8#39)(2008-9#34)(2009-1#1)(2009-10#20)(2009-11#12)(2009-12#4)(2009-2#14)(2009-3#7)(2009-4#25)(2009-5#15)(2009-6#12)(2009-7#6)(2009-8#9)(2009-9#11)(2010-1#2)(2010-10#8)(2010-11#14)(2010-12#39)(2010-2#9)(2010-3#23)(2010-4#7)(2010-5#12)(2010-6#3)(2010-7#8)(2010-8#14)(2010-9#4)(2011-1#52)(2011-11#1)(2011-12#20)(2011-2#117)(2011-3#1)(2011-5#1)(2012-1#19)(2012-11#4)(2012-12#52)(2012-2#50)(2012-3#45)(2012-4#1)(2013-1#95)(2013-7#12)(2013-8#23)
outcome)##2##1##(1996-3#1)(2007-8#1)
outcome-adaptive##2##1##(2011-2#2)
outcome-based##5##1##(1995-3#2)(1996-1#1)(1997-3#1)(2010-8#1)
outcome?##9##1##(2006-10#3)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
outcome]##8##1##(1993-6#1)(1996-3#1)(2005-10#1)(2008-11#2)(2009-5#1)(2012-1#1)(2012-2#1)
outcomes (e##2##2##(2008-11#1)(2010-8#1)
outcomes achieved##2##2##(2009-6#1)(2012-3#1)
outcomes across##4##2##(2009-11#1)(2010-4#1)(2012-2#1)(2012-3#1)
outcomes after ischemic stroke##2##4##(2007-10#2)
outcomes after surgery##2##3##(2007-8#1)(2012-2#1)
outcomes after surgical##2##3##(2007-7#1)(2010-5#1)
outcomes after##37##2##(1993-11#1)(2005-10#1)(2005-8#1)(2007-10#5)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#1)(2008-4#1)(2008-8#2)(2009-12#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#6)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
outcomes allows##2##2##(2007-11#1)(2010-6#1)
outcomes among patients with##2##4##(2009-12#1)(2013-1#1)
outcomes among patients##4##3##(2007-8#1)(2009-12#1)(2009-8#1)(2013-1#1)
outcomes among##13##2##(2005-10#2)(2005-8#1)(2007-2#1)(2007-8#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-8#1)(2012-3#1)(2013-1#2)(2013-8#1)
outcomes and costs##2##3##(2006-2#1)(2008-6#1)
outcomes and financial##2##3##(1996-12#1)(2008-3#1)
outcomes and hospital readmissions##2##4##(2013-1#2)
outcomes and in##2##3##(2006-5#1)(2009-10#1)
outcomes and lower##3##3##(2007-9#1)(2013-1#2)
outcomes and management of##2##4##(2008-3#1)(2010-4#1)
outcomes and patient satisfaction##5##4##(1995-1#1)(1997-1#1)(2006-3#1)(2007-12#1)(2009-3#1)
outcomes and quality##2##3##(1997-2#1)(1997-3#1)
outcomes and reduce costs##2##4##(1997-2#1)(2007-2#1)
outcomes and reduce##5##3##(1997-2#1)(2007-2#1)(2009-9#1)(2012-2#2)
outcomes and risk factors##2##4##(2008-7#1)(2013-8#1)
outcomes and the##5##3##(1994-1#1)(2006-12#1)(2007-4#1)(2008-11#1)(2010-11#1)
outcomes and their##2##3##(2010-10#1)(2012-3#1)
outcomes and to##3##3##(2007-11#1)(2007-2#1)(2012-2#1)
outcomes and##127##2##(1992-12#1)(1993-2#1)(1994-1#1)(1995-1#1)(1995-12#2)(1995-2#2)(1996-10#1)(1996-12#1)(1997-1#2)(1997-2#2)(1997-3#1)(2004-3#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-8#3)(2006-9#2)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#2)(2007-4#3)(2007-6#1)(2007-7#3)(2007-8#10)(2007-9#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-9#1)(2010-10#2)(2010-11#4)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#6)(2012-3#9)(2013-1#17)(2013-7#2)(2013-8#1)
outcomes are being##2##3##(2005-11#1)(2013-8#1)
outcomes are more##2##3##(2008-4#1)(2013-1#1)
outcomes are not##3##3##(1995-2#1)(2006-11#1)(2008-12#1)
outcomes are often##2##3##(1993-12#1)(2009-9#1)
outcomes are presented##3##3##(2007-4#1)(2008-3#1)(2012-2#1)
outcomes are used##2##3##(1997-1#1)(2006-12#1)
outcomes are##56##2##(1993-12#1)(1994-11#1)(1994-4#1)(1995-2#1)(1997-1#1)(1997-2#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#4)(2006-11#2)(2006-12#1)(2006-3#1)(2006-7#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#3)(2010-3#1)(2010-7#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#2)
outcomes as well as##4##4##(1994-1#1)(2007-11#1)(2010-12#1)(2011-12#1)
outcomes as##16##2##(1994-1#1)(1996-12#1)(1997-2#1)(2005-9#1)(2006-6#1)(2007-11#1)(2008-4#1)(2009-6#1)(2010-12#1)(2011-12#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#1)
outcomes assessment is##2##3##(1994-2#1)(2007-12#1)
outcomes assessment##15##2##(1994-2#2)(1995-2#1)(1996-2#1)(1996-3#2)(2006-1#1)(2007-12#2)(2013-1#6)
outcomes associated with novel##2##4##(2006-2#1)(2009-3#1)
outcomes associated with##18##3##(2006-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-9#2)(2010-9#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)
outcomes at 12 months##2##4##(2006-7#1)(2007-2#1)
outcomes at a##3##3##(1994-3#1)(2005-10#1)(2012-3#1)
outcomes at the##3##3##(1994-3#1)(2008-8#1)(2012-1#1)
outcomes at##20##2##(1994-3#2)(2005-10#1)(2006-10#1)(2006-7#2)(2007-10#1)(2007-2#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-11#1)(2010-12#1)(2010-6#2)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
outcomes based on##2##3##(2007-1#1)(2009-8#1)
outcomes between##4##2##(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
outcomes but##3##2##(2007-7#1)(2008-1#1)(2011-1#1)
outcomes by##6##2##(1994-1#1)(1997-4#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
outcomes can be##5##3##(1995-12#1)(2006-9#1)(2008-11#1)(2008-9#1)(2009-5#1)
outcomes can##7##2##(1995-12#1)(2006-9#1)(2008-11#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-2#1)
outcomes comparable to##2##3##(2007-8#1)(2011-2#1)
outcomes compared to##2##3##(2007-12#1)(2010-2#1)
outcomes compared with##4##3##(2006-10#1)(2007-6#1)(2008-3#1)(2012-12#1)
outcomes compared##6##2##(2006-10#1)(2007-12#1)(2007-6#1)(2008-3#1)(2010-2#1)(2012-12#1)
outcomes data##11##2##(1992-6#1)(1997-1#3)(2006-5#1)(2006-8#1)(2007-11#1)(2008-9#1)(2009-8#1)(2010-1#1)(2011-2#1)
outcomes demonstrated##2##2##(2008-3#1)(2011-2#1)
outcomes depend##2##2##(2008-3#1)(2008-8#1)
outcomes despite##2##2##(2008-9#1)(2012-12#1)
outcomes did not##2##3##(2011-1#1)(2012-12#1)
outcomes due to##2##3##(2008-3#1)(2012-12#1)
outcomes during##2##2##(1991-1#1)(2007-2#1)
outcomes evaluation##2##2##(2006-5#1)(2007-7#1)
outcomes following C-ADR##4##3##(2012-12#4)
outcomes following##16##2##(2007-11#1)(2008-3#1)(2008-8#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
outcomes for both##2##3##(1995-1#1)(2006-9#1)
outcomes for children in##2##4##(2009-4#1)(2012-12#1)
outcomes for children with##3##4##(2006-10#1)(2009-4#2)
outcomes for children##8##3##(2006-10#1)(2008-11#1)(2008-6#1)(2009-4#4)(2012-12#1)
outcomes for each##2##3##(1996-2#1)(1997-4#1)
outcomes for patients with##12##4##(2007-10#1)(2008-3#1)(2008-6#1)(2009-8#1)(2010-4#1)(2010-5#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-8#1)
outcomes for patients##18##3##(2006-8#1)(2007-10#1)(2007-11#1)(2008-3#2)(2008-6#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-8#2)
outcomes for the##7##3##(1994-12#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-6#1)(2010-2#1)(2010-6#1)
outcomes for this##2##3##(2005-11#1)(2013-1#1)
outcomes for young children##2##4##(2011-2#1)(2012-2#1)
outcomes for##86##2##(1994-12#2)(1995-1#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-4#1)(2004-10#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#1)(2008-11#5)(2008-12#2)(2008-3#3)(2008-6#3)(2008-7#3)(2008-9#1)(2009-10#1)(2009-4#5)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#2)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#3)
outcomes from the##3##3##(2007-4#1)(2007-8#1)(2012-3#1)
outcomes from this##2##3##(2007-11#1)(2012-12#1)
outcomes from##30##2##(1992-2#1)(1996-12#1)(1997-5#1)(2005-10#2)(2005-11#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-8#1)(2008-2#1)(2008-7#3)(2008-8#1)(2008-9#1)(2011-2#2)(2012-12#3)(2012-3#2)(2013-1#2)
outcomes had##2##2##(2007-9#1)(2008-9#1)
outcomes has##2##2##(2005-10#1)(2013-1#1)
outcomes have been demonstrated##2##4##(2008-3#1)(2013-1#1)
outcomes have been##7##3##(2006-12#1)(2008-1#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-1#1)(2013-1#1)
outcomes have improved##2##3##(2008-3#1)(2010-3#1)
outcomes have##12##2##(1996-9#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#2)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
outcomes highlight the##2##3##(2007-10#1)(2007-2#1)
outcomes in a large##2##4##(2005-11#1)(2008-12#1)
outcomes in a##9##3##(2005-11#1)(2006-2#1)(2008-12#2)(2008-9#2)(2010-2#1)(2010-6#1)(2012-3#1)
outcomes in acute##3##3##(2008-3#1)(2011-1#1)(2013-1#1)
outcomes in both##2##3##(2007-7#1)(2009-12#1)
outcomes in cancer##2##3##(2010-10#1)(2012-12#1)
outcomes in children with##4##4##(2006-10#2)(2008-10#1)(2012-2#1)
outcomes in children##6##3##(2006-10#2)(2007-9#1)(2008-10#1)(2008-11#1)(2012-2#1)
outcomes in high-risk##4##3##(2007-8#1)(2009-5#1)(2013-1#2)
outcomes in patients undergoing##2##4##(2006-10#1)(2011-2#1)
outcomes in patients with chronic##3##5##(2005-10#1)(2009-8#1)(2013-1#1)
outcomes in patients with##12##4##(2005-10#1)(2006-9#1)(2008-12#2)(2008-3#2)(2008-5#1)(2009-8#1)(2010-12#1)(2012-12#1)(2013-1#2)
outcomes in patients##17##3##(2005-10#1)(2006-10#1)(2006-9#1)(2008-12#2)(2008-3#3)(2008-5#1)(2009-8#1)(2010-12#1)(2011-2#3)(2012-12#1)(2013-1#2)
outcomes in persons##2##3##(2008-1#1)(2009-10#1)
outcomes in terms of##2##4##(2012-12#1)(2013-1#1)
outcomes in the context of##3##5##(2009-7#1)(2011-2#1)(2011-7#1)
outcomes in the treatment of##3##5##(2007-7#2)(2012-2#1)
outcomes in the##20##3##(1992-11#1)(2005-10#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#4)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-2#1)(2012-3#1)
outcomes in these patients##3##4##(1997-1#1)(2007-11#1)(2008-1#1)
outcomes in these##6##3##(1997-1#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-8#1)(2011-2#1)
outcomes in this##6##3##(1995-11#1)(2007-1#1)(2008-5#1)(2009-6#1)(2012-11#1)(2013-1#1)
outcomes in women with##2##4##(1993-12#1)(2013-8#1)
outcomes in women##3##3##(1993-12#1)(2006-2#1)(2013-8#1)
outcomes in##177##2##(1992-11#1)(1993-12#2)(1993-3#1)(1994-1#1)(1994-3#1)(1995-11#1)(1995-2#3)(1996-1#1)(1996-9#1)(1997-1#2)(1997-2#1)(2004-10#2)(2005-10#2)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#4)(2006-12#2)(2006-2#2)(2006-5#1)(2006-7#2)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#1)(2007-12#3)(2007-2#2)(2007-3#2)(2007-4#3)(2007-5#1)(2007-7#7)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#2)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#5)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#5)(2010-3#1)(2010-6#2)(2011-1#2)(2011-2#15)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#5)(2012-3#4)(2013-1#15)(2013-8#2)
outcomes include##4##2##(2008-8#2)(2011-1#1)(2012-2#1)
outcomes included##3##2##(2007-10#1)(2007-12#1)(2013-1#1)
outcomes including##4##2##(2007-12#1)(2007-6#1)(2010-6#1)(2012-2#1)
outcomes information##5##2##(1996-1#2)(1996-2#1)(1997-1#2)
outcomes is needed##2##3##(2005-10#1)(2011-2#1)
outcomes is##18##2##(1991-12#1)(2005-10#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-12#1)(2009-11#2)(2010-2#1)(2010-5#1)(2011-2#3)(2013-1#1)
outcomes it##2##2##(2008-7#1)(2010-2#1)
outcomes management##19##2##(1991-12#3)(1992-12#1)(1993-3#1)(1994-11#1)(1994-3#2)(1996-1#1)(1996-2#5)(1997-1#3)(1997-3#1)(2007-9#1)
outcomes may be##6##3##(2006-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-12#1)(2013-1#1)
outcomes may##10##2##(2006-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
outcomes measurement into##2##3##(1996-1#2)
outcomes measurement##8##2##(1994-12#1)(1996-1#3)(1997-1#1)(1997-3#1)(2007-10#1)(2007-9#1)
outcomes measures and##2##3##(2008-6#2)
outcomes measures##4##2##(1997-2#1)(2008-6#2)(2009-9#1)
outcomes monitoring##2##2##(1994-1#1)(1995-2#1)
outcomes movement##5##2##(1991-12#1)(1994-11#2)(1996-1#1)(1997-1#1)
outcomes obtained##3##2##(2007-8#1)(2011-2#1)(2013-1#1)
outcomes occurred##2##2##(1990-12#1)(2012-3#1)
outcomes of a##6##3##(2007-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-12#1)
outcomes of acute##2##3##(2007-8#1)(2009-2#1)
outcomes of an##2##3##(2008-3#1)(2010-8#1)
outcomes of care##12##3##(1991-12#1)(1993-3#2)(1994-2#1)(1996-2#1)(2006-1#2)(2008-6#1)(2012-3#2)(2013-1#2)
outcomes of children##2##3##(2007-9#1)(2012-2#1)
outcomes of competition##2##3##(2008-8#2)
outcomes of early##2##3##(2010-6#1)(2011-2#1)
outcomes of health care##2##4##(1996-2#1)(2008-4#1)
outcomes of home health care##2##5##(1995-3#2)
outcomes of in vitro##2##4##(2012-2#1)(2013-1#1)
outcomes of interest##2##3##(2006-2#1)(2012-2#1)
outcomes of interspecific competition##2##4##(2008-8#2)
outcomes of intervention##2##3##(2008-12#1)(2009-5#1)
outcomes of nutrition##3##3##(1994-3#1)(1995-2#1)(1995-3#1)
outcomes of patients with##5##4##(2005-8#1)(2007-11#1)(2008-12#1)(2010-3#1)(2012-3#1)
outcomes of patients##8##3##(2005-8#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2010-11#1)(2010-3#1)(2012-3#1)
outcomes of physical##2##3##(2008-12#1)(2011-1#1)
outcomes of primary##3##3##(2007-1#1)(2008-8#1)(2013-8#1)
outcomes of similar tumors treated with radiosurgery##2##7##(2005-5#2)
outcomes of surgical##2##3##(2009-5#1)(2012-3#1)
outcomes of the##20##3##(1996-1#1)(1996-5#1)(2006-1#1)(2006-8#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-11#1)(2008-12#2)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
outcomes of these##8##3##(1996-3#1)(2005-11#1)(2005-5#1)(2007-7#1)(2007-8#1)(2008-9#1)(2010-1#1)(2010-5#1)
outcomes of this##6##3##(1996-3#1)(2006-10#1)(2007-11#1)(2007-9#1)(2010-5#1)(2012-12#1)
outcomes of total##2##3##(2006-8#1)(2009-7#1)
outcomes of trauma patients##2##4##(2006-10#1)(2009-6#1)
outcomes of treatment##3##3##(2008-12#1)(2011-2#1)(2013-8#1)
outcomes of##223##2##(1990-3#1)(1991-1#1)(1991-12#2)(1993-3#3)(1994-2#1)(1994-3#1)(1995-1#2)(1995-2#1)(1995-3#3)(1996-1#1)(1996-2#2)(1996-3#4)(1996-5#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-5#4)(2005-7#1)(2005-8#3)(2006-1#3)(2006-10#5)(2006-12#1)(2006-2#3)(2006-3#2)(2006-7#3)(2006-8#2)(2007-1#2)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#7)(2007-8#7)(2007-9#4)(2008-1#1)(2008-10#2)(2008-11#6)(2008-12#8)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#6)(2008-9#6)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#2)(2010-3#3)(2010-5#3)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#9)(2012-1#2)(2012-12#9)(2012-2#7)(2012-3#9)(2013-1#17)(2013-8#4)
outcomes on the##2##3##(1993-2#1)(2009-3#1)
outcomes on##9##2##(1993-2#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-8#1)(2009-3#1)(2009-7#1)(2013-1#2)
outcomes or##5##2##(1995-2#1)(2008-11#1)(2008-6#1)(2008-8#1)(2010-4#1)
outcomes over time##3##3##(1993-12#1)(2008-12#1)(2012-3#1)
outcomes over##6##2##(1993-12#1)(2006-2#1)(2008-12#2)(2012-2#1)(2012-3#1)
outcomes rather than##2##3##(1994-2#1)(2006-10#1)
outcomes related to##2##3##(1995-3#1)(2013-8#1)
outcomes relative to##3##3##(1991-12#1)(2010-2#1)(2012-12#1)
outcomes remain suboptimal##2##3##(2010-11#1)(2012-12#1)
outcomes remain##5##2##(2008-3#1)(2008-4#1)(2010-11#1)(2012-1#1)(2012-12#1)
outcomes remains##3##2##(1997-1#1)(2008-9#1)(2009-10#1)
outcomes research in##3##3##(2006-5#1)(2008-8#1)(2008-9#1)
outcomes research is##2##3##(1992-6#1)(1995-2#1)
outcomes research##26##2##(1992-6#2)(1993-12#2)(1993-2#1)(1994-11#2)(1994-12#1)(1994-3#2)(1995-1#1)(1995-2#2)(1996-1#1)(1997-2#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#2)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-12#1)(2012-12#1)
outcomes significant changes##2##3##(2013-8#2)
outcomes significant##3##2##(2013-8#3)
outcomes studies##2##2##(2006-10#1)(2009-11#1)
outcomes study##4##2##(1992-4#2)(2005-10#1)(2006-8#1)
outcomes such as##9##3##(1993-9#1)(2005-10#2)(2007-8#1)(2008-11#1)(2008-8#1)(2010-12#1)(2010-7#1)(2013-8#1)
outcomes suggest that##3##3##(1992-11#1)(2008-9#1)(2012-1#1)
outcomes than do##2##3##(2005-10#1)(2012-1#1)
outcomes than##8##2##(2005-10#1)(2007-11#1)(2009-5#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
outcomes that have##2##3##(2007-2#2)
outcomes that will##2##3##(2008-11#1)(2009-3#1)
outcomes that##15##2##(1992-12#1)(1996-3#1)(2006-12#1)(2007-11#1)(2007-2#2)(2008-11#2)(2008-8#1)(2009-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#2)
outcomes through the##3##3##(2008-8#1)(2010-6#1)(2012-1#1)
outcomes through##6##2##(2008-8#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-3#1)
outcomes to the##3##3##(2009-6#1)(2012-3#1)(2013-1#1)
outcomes to##25##2##(2006-11#1)(2007-12#1)(2007-7#2)(2008-4#1)(2009-10#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2011-12#1)(2012-12#5)(2012-3#2)(2013-1#7)
outcomes under##3##2##(1995-3#1)(2012-1#2)
outcomes using##2##2##(2007-7#1)(2011-1#1)
outcomes varied##3##2##(2007-8#1)(2009-4#1)(2013-8#1)
outcomes was##8##2##(2005-10#1)(2007-11#1)(2007-9#1)(2009-7#1)(2010-2#2)(2012-2#2)
outcomes were also##2##3##(2007-2#1)(2011-1#1)
outcomes were analyzed##3##3##(2005-5#1)(2008-7#1)(2011-2#1)
outcomes were as##2##3##(2011-2#1)(2013-1#1)
outcomes were assessed##4##3##(2006-8#1)(2007-10#1)(2007-8#1)(2008-11#1)
outcomes were compared##2##3##(2007-9#2)
outcomes were documented##2##3##(2006-10#1)(2008-10#1)
outcomes were evaluated##3##3##(2007-7#1)(2007-8#2)
outcomes were measured##3##3##(2006-10#1)(2008-7#1)(2013-8#1)
outcomes were not##2##3##(2009-7#1)(2011-2#1)
outcomes were obtained##2##3##(2007-11#1)(2007-7#1)
outcomes were##47##2##(1995-3#1)(2005-5#1)(2006-10#2)(2006-8#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#4)(2009-11#1)(2009-3#2)(2009-4#1)(2009-7#2)(2009-9#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
outcomes when##9##2##(1995-2#1)(2006-5#1)(2006-8#1)(2008-2#1)(2008-4#1)(2009-3#1)(2009-4#1)(2009-7#1)(2012-12#1)
outcomes which##3##2##(1997-2#1)(2008-4#1)(2008-7#1)
outcomes while##3##2##(1997-1#1)(2009-8#1)(2013-1#1)
outcomes will##4##2##(2006-10#1)(2006-11#1)(2007-8#1)(2008-3#1)
outcomes with respect to##2##4##(2008-1#1)(2008-9#1)
outcomes with the##2##3##(2008-12#1)(2010-12#1)
outcomes with these##2##3##(2006-3#1)(2009-11#1)
outcomes with##27##2##(1994-12#1)(1997-6#1)(1997-7#1)(2005-9#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-12#2)(2008-3#1)(2008-9#1)(2009-11#2)(2009-5#1)(2010-12#3)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
outcomes##2167##1##(1990-12#2)(1990-2#1)(1990-3#1)(1991-1#4)(1991-11#1)(1991-12#11)(1992-1#2)(1992-11#2)(1992-12#4)(1992-2#5)(1992-3#2)(1992-4#3)(1992-6#4)(1993-11#1)(1993-12#7)(1993-2#9)(1993-3#8)(1993-7#1)(1993-9#3)(1994-1#8)(1994-10#1)(1994-11#9)(1994-12#10)(1994-2#7)(1994-3#11)(1994-4#1)(1994-5#1)(1994-6#2)(1995-1#5)(1995-11#1)(1995-12#4)(1995-2#20)(1995-3#11)(1995-4#1)(1996-1#16)(1996-10#1)(1996-12#9)(1996-2#20)(1996-3#10)(1996-4#1)(1996-5#1)(1996-9#3)(1997-1#22)(1997-2#10)(1997-3#5)(1997-4#4)(1997-5#2)(1997-6#1)(1997-7#6)(1997-8#1)(2004-10#5)(2004-12#1)(2004-2#1)(2004-3#1)(2004-9#1)(2005-10#28)(2005-11#12)(2005-12#1)(2005-5#8)(2005-7#5)(2005-8#8)(2005-9#4)(2006-1#7)(2006-10#42)(2006-11#5)(2006-12#16)(2006-2#17)(2006-3#8)(2006-5#20)(2006-6#3)(2006-7#14)(2006-8#15)(2006-9#5)(2007-1#9)(2007-10#28)(2007-11#34)(2007-12#40)(2007-2#33)(2007-3#3)(2007-4#10)(2007-5#3)(2007-6#4)(2007-7#39)(2007-8#104)(2007-9#21)(2008-1#20)(2008-10#18)(2008-11#57)(2008-12#37)(2008-2#11)(2008-3#55)(2008-4#23)(2008-5#18)(2008-6#26)(2008-7#32)(2008-8#42)(2008-9#38)(2009-1#1)(2009-10#15)(2009-11#14)(2009-12#17)(2009-2#10)(2009-3#19)(2009-4#15)(2009-5#25)(2009-6#7)(2009-7#20)(2009-8#14)(2009-9#15)(2010-1#6)(2010-10#12)(2010-11#21)(2010-12#30)(2010-2#29)(2010-3#22)(2010-4#10)(2010-5#7)(2010-6#17)(2010-7#8)(2010-8#14)(2010-9#9)(2011-1#40)(2011-12#8)(2011-2#95)(2011-3#1)(2011-7#1)(2012-1#22)(2012-11#1)(2012-12#66)(2012-2#70)(2012-3#69)(2012-8#1)(2013-1#182)(2013-7#10)(2013-8#37)
outcomes) and##2##2##(1996-12#1)(2011-2#1)
outcomes-based##2##1##(2006-5#1)(2009-3#1)
outcomes?##8##1##(1993-2#1)(2006-10#1)(2006-2#2)(2006-8#1)(2007-7#1)(2008-12#2)
outcoupled##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
outcoupler##2##1##(2007-11#2)
outcouplers##2##1##(2007-11#2)
outcoupling of the##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
outcoupling##4##1##(2007-12#1)(2008-10#1)(2008-2#2)
outcross success##3##2##(2008-9#3)
outcross##5##1##(2007-12#1)(2008-9#4)
outcrossed##2##1##(2008-8#1)(2008-9#1)
outcrossing in##4##2##(2008-10#4)
outcrossing species##2##2##(2012-3#1)(2013-1#1)
outcrossing##18##1##(2007-12#1)(2008-10#10)(2008-8#1)(2008-9#2)(2012-3#2)(2013-1#2)
outdated and##3##2##(2006-2#1)(2008-6#1)(2012-12#1)
outdated##13##1##(1994-2#2)(2006-2#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)
outdoor activities##4##2##(2011-2#3)(2012-3#1)
outdoor air pollutants##3##3##(1996-3#2)(2008-10#1)
outdoor air samples##3##3##(2008-10#1)(2010-5#2)
outdoor air##18##2##(1996-3#2)(2007-4#2)(2008-10#7)(2009-6#1)(2010-5#6)
outdoor and indoor##4##3##(2007-4#1)(2013-1#2)(2013-8#1)
outdoor and##5##2##(2005-12#1)(2007-4#1)(2013-1#2)(2013-8#1)
outdoor concentrations##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
outdoor environments##4##2##(1997-4#1)(2007-8#1)(2010-5#1)(2012-1#1)
outdoor exposure##3##2##(2006-8#1)(2008-10#1)(2008-11#1)
outdoor scenes##3##2##(2008-3#2)(2008-6#1)
outdoor##93##1##(1994-3#1)(1995-6#1)(1996-2#1)(1996-3#3)(1997-2#1)(1997-4#2)(2005-12#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-4#3)(2007-8#1)(2008-10#15)(2008-11#3)(2008-2#1)(2008-3#6)(2008-5#14)(2008-6#1)(2008-7#3)(2008-8#2)(2009-4#2)(2009-6#2)(2009-7#1)(2010-11#1)(2010-4#1)(2010-5#11)(2010-8#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#1)
outdoors and##5##2##(1991-3#1)(2006-12#1)(2008-10#1)(2010-5#1)(2012-12#1)
outdoors##18##1##(1991-3#1)(1993-10#1)(2006-12#1)(2007-2#1)(2008-10#4)(2008-3#1)(2008-6#1)(2010-5#2)(2011-12#2)(2011-2#1)(2012-12#3)
outer and inner##11##3##(1990-10#1)(1990-11#1)(1993-12#1)(1994-2#1)(1995-12#1)(2007-12#1)(2007-7#1)(2008-2#1)(2008-3#1)(2010-8#1)(2012-2#1)
outer and##12##2##(1990-10#1)(1990-11#1)(1991-5#1)(1993-12#1)(1994-2#1)(1995-12#1)(2007-12#1)(2007-7#1)(2008-2#1)(2008-3#1)(2010-8#1)(2012-2#1)
outer body##2##2##(2006-10#1)(2008-10#1)
outer cell wall##2##3##(2008-10#1)(2011-2#1)
outer cell##5##2##(1991-1#1)(1992-4#1)(2008-10#1)(2011-2#1)(2012-1#1)
outer coat##2##2##(2008-2#1)(2009-2#1)
outer core##2##2##(1994-2#1)(2008-10#1)
outer cortex##7##2##(2008-10#5)(2008-7#1)(2012-2#1)
outer cortical##4##2##(1995-6#2)(2008-10#1)(2008-3#1)
outer covering##3##2##(2006-10#1)(2008-5#1)(2008-7#1)
outer dendritic segments and##2##4##(2007-12#1)(2008-7#1)
outer dendritic segments##4##3##(2007-12#2)(2008-7#2)
outer dendritic##5##2##(2007-12#3)(2008-7#2)
outer diameter and##2##3##(2008-8#1)(2010-12#1)
outer diameter of##6##3##(1994-9#1)(1995-4#1)(1995-6#1)(2008-2#1)(2008-8#1)(2012-2#1)
outer diameter##12##2##(1994-2#1)(1994-9#1)(1995-4#1)(1995-6#1)(2007-12#2)(2008-2#1)(2008-5#1)(2008-8#2)(2010-12#1)(2012-2#1)
outer dorsal skin layers from##3##5##(2008-11#3)
outer doublet##2##2##(1991-2#2)
outer dynein arms##2##3##(1995-6#2)
outer edge##2##2##(1991-4#1)(2008-10#1)
outer hair cells and##2##4##(1995-3#1)(2009-5#1)
outer hair cells##10##3##(1993-9#1)(1995-10#2)(1995-3#2)(2008-4#1)(2008-9#1)(2009-5#1)(2009-9#1)(2013-8#1)
outer hair##13##2##(1993-9#1)(1995-10#2)(1995-3#3)(1997-7#2)(2008-4#1)(2008-9#1)(2009-5#1)(2009-9#1)(2013-8#1)
outer half##2##2##(2008-12#2)
outer islands##3##2##(2008-1#3)
outer layer is##2##3##(2008-10#1)(2008-2#1)
outer layer of##7##3##(1992-6#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)
outer layer was##2##3##(2008-5#1)(2009-5#1)
outer layer##21##2##(1992-6#2)(1997-3#1)(2006-12#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-4#2)(2011-1#1)
outer layers of##3##3##(2008-11#2)(2009-8#1)
outer layers##5##2##(2005-11#1)(2008-10#1)(2008-11#2)(2009-8#1)
outer leaflet of the##9##4##(1990-11#1)(1990-5#1)(1992-3#1)(1994-2#2)(1995-2#1)(2008-11#1)(2009-2#1)(2010-7#1)
outer leaflet##10##2##(1990-11#1)(1990-5#1)(1992-3#1)(1994-2#2)(1995-2#1)(1995-6#1)(2008-11#1)(2009-2#1)(2010-7#1)
outer lipid##3##2##(1991-5#1)(1993-4#1)(1994-11#1)
outer medulla##3##2##(1990-11#1)(1990-3#1)(1991-5#1)
outer membrane and periplasm##2##4##(2006-8#2)
outer membrane and##6##3##(1994-8#1)(2005-8#1)(2006-8#3)(2009-6#1)
outer membrane components##3##3##(1995-12#2)(2008-4#1)
outer membrane fraction##2##3##(1990-11#1)(1994-12#1)
outer membrane fractions##2##3##(1991-11#1)(2006-8#1)
outer membrane have been##2##4##(1993-9#1)(1994-5#1)
outer membrane in##3##3##(1994-12#1)(1997-8#1)(2008-5#1)
outer membrane of##8##3##(1990-11#1)(1991-9#1)(1992-7#1)(1996-9#2)(2006-8#1)(2008-8#1)(2009-8#1)
outer membrane protein (OMP)##4##4##(1993-9#1)(1995-12#1)(2007-2#1)(2008-5#1)
outer membrane protein A (OmpA)##3##5##(1993-3#1)(1997-4#1)(2008-1#1)
outer membrane protein PhoE##2##4##(1996-5#2)
outer membrane protein of Salmonella typhimurium##2##6##(1990-3#2)
outer membrane protein of##8##4##(1990-3#2)(1991-9#2)(1993-5#1)(1993-9#1)(1995-12#1)(2008-5#1)
outer membrane protein that##2##4##(1995-10#1)(1997-4#1)
outer membrane protein##28##3##(1990-11#1)(1990-3#2)(1991-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#2)(1995-10#1)(1995-12#2)(1996-5#2)(1997-2#1)(1997-4#2)(2006-8#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-5#3)(2010-12#1)
outer membrane proteins of##4##4##(1994-3#1)(1996-9#1)(2008-12#1)(2008-5#1)
outer membrane proteins##11##3##(1990-12#1)(1994-3#1)(1995-3#1)(1996-9#1)(1997-4#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2011-1#1)(2013-1#1)
outer membrane vesicles##3##3##(2011-1#2)(2013-8#1)
outer membrane##117##2##(1990-11#4)(1990-12#1)(1990-3#4)(1990-8#1)(1991-1#1)(1991-11#1)(1991-9#3)(1992-12#1)(1992-5#1)(1992-6#3)(1992-7#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-9#3)(1994-11#1)(1994-12#6)(1994-3#1)(1994-5#1)(1994-8#2)(1995-10#1)(1995-12#4)(1995-3#1)(1995-6#1)(1996-10#1)(1996-5#3)(1996-9#4)(1997-2#5)(1997-4#4)(1997-8#4)(2005-8#5)(2006-5#1)(2006-8#8)(2007-2#4)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#5)(2008-8#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-1#3)(2011-2#1)(2012-11#2)(2012-2#1)(2013-1#3)(2013-8#2)
outer membranes of##2##3##(1996-5#1)(2006-8#1)
outer membranes##10##2##(1990-5#1)(1991-10#1)(1994-6#1)(1996-12#1)(1996-5#3)(2005-8#1)(2006-8#1)(2012-1#1)
outer mitochondrial membrane##7##3##(1994-11#1)(1997-4#1)(2005-8#3)(2012-2#2)
outer mitochondrial membranes##4##3##(1990-3#1)(1993-6#2)(1994-12#1)
outer mitochondrial##12##2##(1990-3#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-8#1)(1997-4#1)(2005-8#3)(2012-2#2)
outer nuclear membrane##4##3##(1993-6#1)(2008-9#2)(2011-2#1)
outer nuclear##7##2##(1991-10#1)(1993-6#1)(2008-9#2)(2010-1#1)(2011-2#2)
outer plexiform layer##2##3##(1992-7#1)(2008-4#1)
outer plexiform##4##2##(1990-5#1)(1992-7#1)(1996-5#1)(2008-4#1)
outer retina##2##2##(1990-11#1)(1992-7#1)
outer retinal##2##2##(1997-3#1)(2009-2#1)
outer ring##6##2##(2007-12#1)(2008-10#3)(2012-2#2)
outer root sheath cells##2##4##(1990-6#1)(2013-8#1)
outer root sheath##3##3##(1990-6#1)(2008-5#1)(2013-8#1)
outer rotators##2##2##(2007-7#2)
outer scale L0##2##3##(2008-3#2)
outer scale is##2##3##(2008-2#1)(2008-3#1)
outer scale of turbulence##2##4##(2008-3#2)
outer scale of##4##3##(2008-2#1)(2008-3#3)
outer scale on the##2##4##(2008-2#2)
outer scale##19##2##(2008-2#11)(2008-3#8)
outer segment assembly##2##3##(2008-7#2)
outer segment proteins##2##3##(1993-4#1)(1995-9#1)
outer segment##15##2##(1990-11#1)(1990-6#1)(1990-7#1)(1993-4#1)(1994-8#1)(1995-10#1)(1995-9#1)(1996-5#1)(1996-9#2)(1997-1#1)(1997-4#1)(2008-7#3)
outer segments are present on##2##5##(1992-7#2)
outer segments are##5##3##(1992-7#5)
outer segments of##2##3##(1992-6#1)(1996-9#1)
outer segments##34##2##(1990-11#1)(1990-2#2)(1990-7#1)(1991-10#2)(1992-6#3)(1992-7#8)(1993-4#1)(1993-8#1)(1994-2#1)(1995-1#1)(1995-10#1)(1995-5#1)(1995-9#1)(1996-9#1)(1997-1#1)(1997-4#2)(2008-3#2)(2008-4#1)(2008-7#2)(2012-12#1)
outer sensillum-lymph##2##2##(2007-12#2)
outer shell##4##2##(2006-1#1)(2008-11#1)(2008-8#2)
outer side##2##2##(1995-6#1)(2008-5#1)
outer sphere##3##2##(1991-8#1)(2008-3#1)(2008-4#1)
outer surface protein##2##3##(1991-12#1)(1995-5#1)
outer surface##16##2##(1990-2#1)(1991-12#1)(1991-9#1)(1994-11#1)(1994-5#1)(1995-5#1)(1997-7#1)(2007-11#2)(2008-11#1)(2008-2#1)(2008-5#3)(2008-7#1)(2010-10#1)
outer surfaces##6##2##(1994-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-3#1)
outer to##3##2##(1995-12#1)(1996-2#1)(2012-2#1)
outer vestibule##5##2##(1995-8#1)(2008-8#4)
outer wall##3##2##(1996-11#1)(2008-9#2)
outer zone##3##2##(2008-10#1)(2008-7#2)
outer##528##1##(1990-10#1)(1990-11#15)(1990-12#1)(1990-2#4)(1990-3#7)(1990-5#3)(1990-6#3)(1990-7#3)(1990-8#1)(1991-1#2)(1991-10#4)(1991-11#1)(1991-12#1)(1991-2#5)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#6)(1992-1#1)(1992-12#3)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#9)(1992-7#14)(1992-9#1)(1993-11#1)(1993-12#3)(1993-3#2)(1993-4#4)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#4)(1994-10#1)(1994-11#4)(1994-12#7)(1994-2#8)(1994-3#1)(1994-5#3)(1994-6#2)(1994-7#2)(1994-8#5)(1994-9#1)(1995-1#1)(1995-10#5)(1995-12#6)(1995-2#1)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#8)(1995-8#1)(1995-9#2)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#10)(1996-8#1)(1996-9#7)(1997-1#3)(1997-2#6)(1997-3#3)(1997-4#8)(1997-6#1)(1997-7#3)(1997-8#7)(2004-9#1)(2005-1#1)(2005-11#4)(2005-4#1)(2005-8#9)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#3)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#10)(2007-11#4)(2007-12#18)(2007-2#4)(2007-3#1)(2007-5#3)(2007-7#5)(2007-8#3)(2007-9#2)(2008-1#5)(2008-10#29)(2008-11#13)(2008-12#6)(2008-2#17)(2008-3#18)(2008-4#7)(2008-5#16)(2008-7#17)(2008-8#10)(2008-9#5)(2009-12#1)(2009-2#3)(2009-3#1)(2009-5#2)(2009-6#3)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#9)(2012-1#3)(2012-11#2)(2012-12#2)(2012-2#11)(2013-1#4)(2013-8#5)
outer-chain-glycosylated##2##1##(1993-3#2)
outer-layer##2##1##(2008-10#2)
outer-membrane protein##2##2##(1990-3#1)(2011-2#1)
outer-membrane##4##1##(1990-3#1)(2005-11#1)(2008-4#1)(2011-2#1)
outer-membrane-protein-based serogroup B meningococcal vaccine##2##5##(1992-10#2)
outer-sphere##2##1##(2008-10#1)(2008-5#1)
outermost layer of the skin##3##5##(2008-5#3)
outermost layer of##4##3##(2008-5#4)
outermost##19##1##(1997-8#1)(2005-11#1)(2007-12#1)(2008-10#4)(2008-5#10)(2009-8#1)(2012-1#1)
outfall##2##1##(2007-5#1)(2009-6#1)
outflow and##3##2##(1991-7#1)(1993-2#1)(2008-3#1)
outflow in##8##2##(1991-5#1)(1995-12#1)(1995-7#1)(2005-10#4)(2006-6#1)
outflow obstruction##8##2##(1991-11#2)(2007-8#1)(2008-10#3)(2008-4#1)(2008-7#1)
outflow of the##6##3##(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#2)(2012-3#1)
outflow of##9##2##(1991-2#1)(1997-3#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-3#2)(2012-3#1)
outflow resistance##2##2##(2011-2#2)
outflow through##2##2##(2011-2#1)(2012-3#1)
outflow to the##2##3##(1992-6#2)
outflow tract obstruction##10##3##(1992-9#1)(2006-4#1)(2007-8#4)(2007-9#1)(2011-1#1)(2012-2#2)
outflow tract reconstruction##2##3##(2007-8#1)(2012-1#1)
outflow tract##28##2##(1992-9#3)(1997-1#1)(2006-4#1)(2006-9#2)(2007-8#7)(2007-9#2)(2008-4#2)(2011-1#3)(2012-1#1)(2012-2#2)(2013-1#1)(2013-2#1)(2013-8#2)
outflow##109##1##(1991-11#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#3)(1993-2#5)(1994-10#1)(1995-12#2)(1995-3#1)(1995-7#1)(1996-12#1)(1997-1#1)(1997-3#1)(2005-10#15)(2006-10#1)(2006-11#1)(2006-4#2)(2006-6#1)(2006-8#2)(2006-9#2)(2007-7#1)(2007-8#11)(2007-9#5)(2008-1#1)(2008-10#5)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#2)(2009-8#3)(2009-9#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-2#2)(2012-3#5)(2013-1#1)(2013-2#1)(2013-8#2)
outgoing##12##1##(1996-11#1)(2005-8#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-7#1)(2012-3#1)
outgroup A##3##2##(2008-10#3)
outgroup for##2##2##(2008-10#1)(2008-7#1)
outgroup members##2##2##(2009-11#1)(2012-3#1)
outgroup taxa##2##2##(1997-4#1)(2010-3#1)
outgroup##32##1##(1992-12#3)(1995-11#1)(1997-4#1)(2007-12#6)(2008-10#6)(2008-11#2)(2008-7#1)(2008-8#1)(2009-11#6)(2010-3#1)(2012-3#3)(2013-8#1)
outgroups##9##1##(1995-11#2)(1995-3#1)(2007-12#1)(2008-10#2)(2008-11#3)
outgrow##2##1##(2006-12#1)(2008-8#1)
outgrowing##5##1##(1995-1#1)(2007-12#1)(2008-10#1)(2008-5#1)(2011-1#1)
outgrowth and motility##2##3##(1995-11#2)
outgrowth and##21##2##(1990-2#1)(1991-1#1)(1991-11#1)(1992-6#1)(1993-12#1)(1995-11#2)(1995-2#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-6#1)(2008-11#2)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)
outgrowth from##7##2##(1990-8#1)(1993-5#1)(1996-7#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
outgrowth in##19##2##(1991-11#2)(1991-3#1)(1991-6#1)(1992-11#2)(1992-5#1)(1992-6#1)(1994-10#1)(1994-8#1)(1995-1#1)(1995-6#2)(1997-6#1)(2008-11#3)(2008-4#1)(2013-1#1)
outgrowth induced by##3##3##(1991-11#2)(2008-4#1)
outgrowth is##5##2##(1992-11#1)(1996-5#1)(2008-5#1)(2011-2#2)
outgrowth of a##3##3##(1991-12#1)(2008-11#1)(2008-3#1)
outgrowth of neurites##3##3##(1991-3#1)(2005-7#1)(2008-5#1)
outgrowth of smooth muscle cells##2##5##(1997-2#2)
outgrowth of spores##2##3##(2008-5#1)(2011-2#1)
outgrowth of the##7##3##(1991-3#1)(1997-4#1)(2006-4#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-8#1)
outgrowth of##35##2##(1991-11#1)(1991-12#1)(1991-3#2)(1992-1#1)(1993-9#1)(1995-2#1)(1997-2#3)(1997-4#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-2#2)(2008-11#6)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2011-2#3)(2012-7#1)(2013-1#1)
outgrowth ofneurites##2##2##(2008-11#2)
outgrowth or##3##2##(1995-11#2)(1996-3#1)
outgrowth promoting activity##3##3##(2008-11#3)
outgrowth promoting##4##2##(1993-4#1)(2008-11#3)
outgrowth stimulation##2##2##(1994-10#2)
outgrowth was##8##2##(1990-7#1)(1995-9#1)(2008-11#6)
outgrowth within##2##2##(1995-11#1)(2008-5#1)
outgrowth##180##1##(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#7)(1991-12#1)(1991-2#1)(1991-3#4)(1991-6#1)(1992-1#1)(1992-11#3)(1992-3#1)(1992-5#1)(1992-6#2)(1993-12#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-10#3)(1994-11#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-11#6)(1995-2#2)(1995-5#4)(1995-6#4)(1995-9#1)(1996-1#4)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-7#1)(1997-2#5)(1997-3#1)(1997-4#1)(1997-6#6)(2005-7#1)(2006-10#1)(2006-4#1)(2006-8#3)(2007-12#2)(2007-2#2)(2008-1#2)(2008-10#3)(2008-11#28)(2008-3#1)(2008-4#9)(2008-5#11)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#2)(2011-1#3)(2011-2#19)(2012-12#4)(2012-2#1)(2012-7#1)(2013-1#2)
outgrowths of##2##2##(2007-12#1)(2011-2#1)
outgrowths were observed##2##3##(2008-11#2)
outgrowths were##4##2##(1994-6#1)(2008-11#2)(2011-2#1)
outgrowths##12##1##(1994-6#2)(2007-12#2)(2008-11#4)(2008-9#1)(2011-2#3)
outlay for##2##2##(2007-9#2)
outlay##3##1##(2007-9#2)(2012-2#1)
outlays on##3##2##(2008-9#3)
outlays##8##1##(1992-3#2)(1993-3#1)(1995-1#1)(1996-11#1)(2008-9#3)
outlet and the##2##3##(2008-10#2)
outlet and##3##2##(2007-5#1)(2008-10#2)
outlet in##2##2##(1994-3#1)(2008-10#1)
outlet microvalves##2##2##(2007-2#2)
outlet obstruction (GOO)##2##3##(2006-8#1)(2012-2#1)
outlet obstruction and##2##3##(2008-10#1)(2008-12#1)
outlet obstruction##24##2##(1993-12#1)(2005-12#2)(2006-10#3)(2006-6#2)(2006-8#2)(2007-2#2)(2008-10#2)(2008-12#2)(2010-8#1)(2011-12#2)(2011-2#1)(2012-2#3)(2013-1#1)
outlet of##9##2##(2006-8#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-5#1)
outlet ports##2##2##(2008-11#2)
outlet syndrome##5##2##(2008-3#3)(2008-9#1)(2011-3#1)
outlet tenodesis##2##2##(2013-7#2)
outlet##69##1##(1991-7#1)(1993-12#1)(1994-3#2)(1996-9#2)(2005-12#2)(2006-10#4)(2006-6#2)(2006-8#4)(2007-12#2)(2007-2#4)(2007-5#1)(2007-8#6)(2008-10#12)(2008-11#4)(2008-12#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-8#1)(2011-12#2)(2011-2#1)(2011-3#1)(2012-2#3)(2013-1#2)(2013-7#2)
outlets in the##2##3##(2004-10#1)(2008-10#1)
outlets in##4##2##(2004-10#1)(2007-7#1)(2008-10#1)(2010-2#1)
outlets##20##1##(1997-1#2)(2004-10#1)(2006-10#4)(2006-5#1)(2007-7#3)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-2#2)(2011-2#1)(2013-8#1)
outlier data##4##2##(2008-10#4)
outlier detection##3##2##(2008-10#3)
outlier payments##4##2##(1992-12#3)(1997-1#1)
outlier##24##1##(1992-12#4)(1993-12#1)(1993-3#3)(1993-9#1)(1997-1#1)(2007-8#1)(2008-10#10)(2009-8#2)(2011-1#1)
outliers are##3##2##(1992-12#1)(2007-11#1)(2007-4#1)
outliers##25##1##(1991-12#1)(1992-12#4)(2007-11#3)(2007-4#1)(2007-6#1)(2008-10#10)(2008-2#3)(2008-6#1)(2011-1#1)
outliers)##3##1##(1991-12#1)(2008-10#2)
outline a new##2##3##(2008-4#1)(2008-8#1)
outline a##22##2##(1994-1#2)(2005-8#2)(2006-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#1)
outline an##2##2##(1991-3#1)(2006-2#1)
outline and##2##2##(1994-9#1)(1995-6#1)
outline current##3##2##(1990-5#1)(2012-2#1)(2013-1#1)
outline for##4##2##(1993-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
outline how the##2##3##(1992-3#1)(2012-2#1)
outline how##7##2##(1992-3#1)(1993-9#1)(2008-6#1)(2012-2#2)(2013-1#2)
outline important##3##2##(2011-1#1)(2012-12#2)
outline in this##2##3##(2010-12#1)(2010-5#1)
outline is given##2##3##(1993-7#1)(2007-5#1)
outline methods##3##2##(2006-2#1)(2008-2#1)(2008-4#1)
outline of a##2##3##(1992-8#1)(2012-2#1)
outline of the proposed##2##4##(2008-3#1)(2008-6#1)
outline of the##18##3##(1991-4#1)(1992-12#1)(1993-2#1)(1994-4#1)(1995-6#1)(1997-8#1)(2005-1#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2010-3#1)(2013-1#1)
outline of##33##2##(1991-4#1)(1991-5#1)(1992-12#1)(1992-8#1)(1993-2#1)(1994-4#1)(1995-6#1)(1996-2#1)(1997-8#2)(2005-1#1)(2006-10#2)(2006-3#1)(2006-6#1)(2006-7#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
outline on##2##2##(2005-1#1)(2007-12#1)
outline some of the##4##4##(2006-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
outline some of##5##3##(2006-10#2)(2008-11#1)(2008-7#1)(2008-9#1)
outline some##6##2##(1994-5#1)(2006-10#2)(2008-11#1)(2008-7#1)(2008-9#1)
outline the challenges##2##3##(2007-4#1)(2008-11#1)
outline the current##4##3##(1994-6#1)(2008-8#1)(2010-11#1)(2013-1#1)
outline the most##3##3##(2006-10#1)(2011-2#1)(2012-3#1)
outline the rationale##2##3##(2010-5#1)(2010-6#1)
outline the steps##2##3##(2006-5#1)(2011-2#1)
outline the##65##2##(1992-12#1)(1993-5#1)(1993-6#3)(1993-9#1)(1994-6#1)(1995-11#1)(1996-1#1)(1997-3#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-4#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-4#2)(2007-9#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
outline their##5##2##(1993-10#1)(1993-2#1)(2006-12#1)(2007-12#1)(2012-3#1)
outline was##2##2##(1992-3#1)(2011-2#1)
outline##207##1##(1990-5#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-12#2)(1992-3#2)(1992-8#1)(1993-10#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#4)(1993-7#1)(1993-9#2)(1994-1#2)(1994-4#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-6#3)(1996-1#2)(1996-2#1)(1997-3#1)(1997-7#1)(1997-8#2)(2005-1#3)(2005-10#1)(2005-11#1)(2005-2#1)(2005-3#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#7)(2006-12#1)(2006-2#3)(2006-3#2)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#3)(2006-9#2)(2007-11#1)(2007-12#4)(2007-4#3)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#10)(2008-12#3)(2008-2#6)(2008-3#7)(2008-4#4)(2008-5#6)(2008-6#3)(2008-7#9)(2008-8#3)(2008-9#5)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#9)(2012-1#2)(2012-12#4)(2012-2#8)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#1)
outlined above##3##2##(1990-12#1)(1994-12#1)(1996-3#1)
outlined and discussed##2##3##(1992-1#1)(2008-10#1)
outlined and##11##2##(1992-1#1)(1994-6#1)(1997-8#1)(2005-8#1)(2006-2#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#2)
outlined are##3##2##(2008-1#1)(2008-4#1)(2008-9#1)
outlined as to##2##3##(2008-10#1)(2009-10#1)
outlined as well as##2##4##(1993-3#1)(2011-2#1)
outlined as##5##2##(1993-3#1)(1997-2#1)(2008-10#1)(2009-10#1)(2011-2#1)
outlined by the##4##3##(1996-5#1)(2007-12#2)(2008-8#1)
outlined by##8##2##(1990-10#1)(1996-5#1)(2007-12#2)(2008-11#2)(2008-8#1)(2012-12#1)
outlined first##2##2##(2008-2#1)(2009-12#1)
outlined for the##3##3##(1991-10#1)(1991-8#1)(2010-5#1)
outlined for##9##2##(1991-10#1)(1991-8#1)(1993-2#1)(1993-5#1)(2007-12#1)(2008-4#1)(2008-9#1)(2010-5#1)(2012-12#1)
outlined here by##2##3##(2006-10#2)
outlined here##11##2##(1996-2#1)(1997-4#1)(2006-10#2)(2006-8#2)(2007-5#1)(2008-11#1)(2008-5#1)(2012-2#1)(2013-1#1)
outlined herein##3##2##(2008-1#1)(2008-10#1)(2010-11#1)
outlined in the##13##3##(1994-6#1)(1996-5#1)(2004-3#1)(2006-1#1)(2006-11#1)(2006-3#1)(2007-4#1)(2007-6#2)(2008-11#1)(2008-5#2)(2012-3#1)
outlined in this article##6##4##(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2012-2#1)(2012-3#1)
outlined in this paper##3##4##(2007-6#1)(2008-8#1)(2010-8#1)
outlined in this particular protocol##2##5##(2008-11#2)
outlined in this review##3##4##(2008-12#1)(2012-12#2)
outlined in this unit##3##4##(2008-2#1)(2008-4#2)
outlined in this##17##3##(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-8#1)(2010-8#1)(2012-12#2)(2012-2#1)(2012-3#1)
outlined in##37##2##(1994-6#1)(1996-5#1)(2004-3#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#3)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#3)(2008-4#3)(2008-5#2)(2008-8#1)(2009-4#1)(2010-8#1)(2012-12#2)(2012-2#1)(2012-3#2)
outlined many##2##2##(2006-2#1)(2010-12#1)
outlined that##2##2##(1990-9#1)(2008-4#1)
outlined the##7##2##(1990-9#1)(1991-9#1)(1996-12#1)(2008-10#1)(2010-7#1)(2010-8#1)(2013-1#1)
outlined##212##1##(1990-10#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-8#1)(1991-9#3)(1992-1#3)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-3#5)(1994-6#2)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-3#1)(2005-12#1)(2005-7#1)(2005-8#3)(2006-1#2)(2006-10#9)(2006-11#1)(2006-12#2)(2006-2#2)(2006-3#1)(2006-6#3)(2006-7#1)(2006-8#3)(2007-11#2)(2007-12#6)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#3)(2007-9#1)(2008-1#3)(2008-10#13)(2008-11#11)(2008-12#2)(2008-2#6)(2008-3#6)(2008-4#13)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-12#4)(2012-2#6)(2012-3#2)(2013-1#3)(2013-8#1)
outlines a method for##3##4##(2008-4#2)(2008-9#1)
outlines a simple##2##3##(2008-3#1)(2008-9#1)
outlines a##19##2##(1992-12#1)(1994-1#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#4)(2008-9#3)(2009-12#1)(2009-6#1)(2012-2#1)
outlines current##3##2##(1992-3#1)(2008-4#2)
outlines general##3##2##(1997-2#1)(2008-7#1)(2009-11#1)
outlines how the##4##3##(2006-8#1)(2007-11#1)(2008-11#2)
outlines how##7##2##(2006-8#1)(2007-11#1)(2008-11#3)(2010-9#1)(2011-2#1)
outlines methods for##2##3##(2008-4#2)
outlines methods##3##2##(2008-4#2)(2008-7#1)
outlines modifications for preparation and transfection of plant protoplasts##2##9##(2008-1#1)(2008-2#1)
outlines of the##2##3##(2005-1#2)
outlines of##4##2##(2005-1#2)(2007-5#1)(2008-3#1)
outlines recent##2##2##(2006-6#1)(2012-3#1)
outlines several areas##2##3##(1992-1#1)(2005-11#1)
outlines several##5##2##(1992-1#1)(1994-3#1)(2005-11#1)(2007-1#1)(2008-4#1)
outlines some of the##7##4##(1994-3#1)(1997-2#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-7#1)(2010-4#1)
outlines some##8##2##(1994-3#1)(1997-2#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-11#1)(2010-4#1)
outlines the authors'##2##3##(2006-3#2)
outlines the benefits##2##3##(1996-2#1)(2009-4#1)
outlines the criteria for##2##4##(1990-10#1)(2007-2#1)
outlines the current status of##2##5##(2006-10#1)(2008-5#1)
outlines the development of##2##4##(1996-1#1)(2010-5#1)
outlines the development##5##3##(1996-1#1)(2008-11#1)(2008-12#2)(2010-5#1)
outlines the essential elements of##2##5##(2007-11#1)(2008-4#1)
outlines the evidence##2##3##(1991-11#1)(2012-10#1)
outlines the impact of##2##4##(2008-1#1)(2010-12#1)
outlines the problems##2##3##(2008-4#1)(2008-7#1)
outlines the rationale##2##3##(2010-3#1)(2012-2#1)
outlines the steps##4##3##(1992-1#1)(1995-3#1)(2007-4#1)(2008-2#1)
outlines the##89##2##(1990-10#1)(1991-11#1)(1992-1#1)(1993-10#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-7#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#3)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(2004-12#1)(2004-2#1)(2005-1#1)(2005-5#1)(2006-10#2)(2006-3#2)(2006-4#2)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#1)(2008-1#4)(2008-10#1)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#9)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#3)(2010-9#1)(2011-2#2)(2012-1#1)(2012-10#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)
outlines this##2##2##(1994-3#1)(2008-12#1)
outlines various##2##2##(2008-11#1)(2008-3#1)
outlines##198##1##(1990-10#1)(1991-11#1)(1991-7#1)(1992-1#2)(1992-12#1)(1992-3#1)(1992-7#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-7#1)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#3)(1995-1#4)(1995-12#1)(1995-2#2)(1995-3#3)(1995-8#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-1#2)(1997-2#5)(1997-3#1)(2004-1#1)(2004-12#1)(2004-2#1)(2005-1#3)(2005-11#1)(2005-5#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-3#2)(2006-4#2)(2006-5#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#4)(2007-8#2)(2008-1#5)(2008-10#2)(2008-11#16)(2008-12#3)(2008-2#2)(2008-3#6)(2008-4#24)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#6)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-5#3)(2010-8#1)(2010-9#2)(2011-2#4)(2012-1#1)(2012-10#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)
outlining key##2##2##(2010-7#1)(2012-1#1)
outlining the##14##2##(1992-3#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-11#1)(2009-8#1)(2010-12#1)(2012-1#1)(2012-2#1)
outlining##23##1##(1992-3#1)(1994-3#1)(1995-1#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-1#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-12#1)(2010-7#1)(2012-1#2)(2012-2#1)
outlook for the##2##3##(1994-2#1)(1995-1#1)
outlook for##7##2##(1993-12#1)(1994-2#1)(1995-1#1)(2006-4#1)(2008-10#1)(2008-8#1)(2008-9#1)
outlook in##5##2##(1991-1#1)(1993-1#1)(1994-6#1)(1995-1#1)(1997-1#1)
outlook of##5##2##(1996-2#1)(1996-5#1)(2010-9#1)(2013-1#2)
outlook on the##3##3##(2007-7#1)(2008-5#1)(2008-8#1)
outlook on##6##2##(2007-7#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-10#1)(2012-3#1)
outlook##33##1##(1991-1#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-6#1)(1995-1#2)(1996-2#1)(1996-5#1)(1997-1#1)(2006-4#1)(2006-6#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-9#1)(2012-3#2)(2013-1#2)
outlooks##4##1##(1995-12#1)(1995-3#1)(1996-9#1)(2010-4#1)
outlying health##2##2##(2006-2#1)(2007-7#1)
outlying##5##1##(2006-2#1)(2007-7#1)(2008-4#1)(2008-7#1)(2008-9#1)
outmost##4##1##(2005-11#1)(2010-2#1)(2010-7#1)(2012-3#1)
outnumber##3##1##(2006-5#1)(2006-8#1)(2008-7#1)
outnumbered##8##1##(1991-5#1)(1992-1#1)(1993-6#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-5#1)
outpace the##2##2##(2007-9#1)(2008-8#1)
outpaced##3##1##(2007-11#1)(2010-5#1)(2013-1#1)
outpatient PPS##2##2##(1994-3#1)(1996-7#1)
outpatient and##5##2##(1995-12#1)(1996-3#1)(2006-10#1)(2007-2#1)(2010-2#1)
outpatient cardiac##2##2##(1992-1#1)(2008-11#1)
outpatient care##15##2##(1991-1#2)(1993-12#2)(1994-3#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-1#1)(2007-10#1)(2011-1#2)(2011-7#1)(2013-8#1)
outpatient cases##2##2##(1996-3#1)(2012-12#1)
outpatient chemotherapy##6##2##(1991-3#1)(2010-2#4)(2011-2#1)
outpatient clinic during##2##3##(1991-4#1)(2006-10#1)
outpatient clinic for##2##3##(1995-7#1)(2011-2#1)
outpatient clinic in##3##3##(1993-5#1)(1994-4#1)(2006-7#1)
outpatient clinic with##3##3##(1996-3#1)(2010-4#1)(2013-8#1)
outpatient clinic##30##2##(1990-4#1)(1991-4#1)(1992-3#1)(1993-5#1)(1994-4#1)(1995-11#1)(1995-7#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-4#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#1)
outpatient clinics and##3##3##(1995-8#1)(1996-2#1)(2007-12#1)
outpatient clinics##16##2##(1992-12#2)(1994-8#2)(1995-7#1)(1995-8#1)(1996-2#1)(1997-8#1)(2006-7#1)(2007-12#1)(2007-7#1)(2008-12#1)(2008-9#1)(2009-4#2)(2012-1#1)
outpatient clinics]##2##2##(1994-8#1)(1996-2#1)
outpatient commitment (OPC)##3##3##(2006-5#3)
outpatient commitment##21##2##(2006-5#21)
outpatient computed tomography center##3##4##(2007-4#3)
outpatient department##15##2##(1991-9#3)(1992-12#1)(1996-12#2)(1997-3#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-8#1)(2010-12#3)
outpatient departments were##2##3##(1996-1#1)(2007-7#1)
outpatient departments##5##2##(1996-1#2)(1997-2#1)(2006-2#1)(2007-7#1)
outpatient diagnostic##2##2##(1994-2#1)(2007-4#1)
outpatient drug##3##2##(1995-1#1)(1995-2#2)
outpatient drugs##2##2##(1995-1#2)
outpatient facilities##4##2##(2008-3#2)(2013-1#2)
outpatient health care##2##3##(2007-10#2)
outpatient health##4##2##(1993-12#1)(2007-10#2)(2011-2#1)
outpatient hospital##5##2##(1992-2#1)(1994-2#1)(1994-3#1)(1995-12#1)(1997-2#1)
outpatient management##2##2##(2006-5#1)(2008-11#1)
outpatient mental health services##2##4##(2006-3#1)(2009-7#1)
outpatient mental health##4##3##(1995-12#1)(2006-3#1)(2008-6#1)(2009-7#1)
outpatient mental##5##2##(1995-12#1)(2006-3#1)(2008-6#1)(2009-12#1)(2009-7#1)
outpatient oral and maxillofacial surgery##2##5##(1993-1#2)
outpatient paediatric##2##2##(2006-2#1)(2010-7#1)
outpatient percutaneous blind needle liver biopsy##3##6##(2007-3#3)
outpatient physical##2##2##(2008-12#1)(2008-4#1)
outpatient physiotherapy services##2##3##(2012-2#2)
outpatient physiotherapy##4##2##(2008-10#2)(2012-2#2)
outpatient prescription drug use##2##4##(1992-1#1)(1995-1#1)
outpatient prescription drug##5##3##(1992-1#2)(1995-1#3)
outpatient procedures##3##2##(1992-12#1)(1996-1#1)(2006-10#1)
outpatient program##2##2##(1991-1#1)(2008-3#1)
outpatient programs##2##2##(1992-2#1)(2008-3#1)
outpatient psychiatric##3##2##(2006-6#1)(2006-9#1)(2012-3#1)
outpatient pulmonary##3##2##(2010-12#2)(2013-7#1)
outpatient rehabilitation##3##2##(2007-7#1)(2008-8#1)(2013-1#1)
outpatient samples##2##2##(1994-2#2)
outpatient services in##3##3##(2007-11#1)(2009-9#1)(2010-6#1)
outpatient services##30##2##(1991-2#4)(1992-1#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-12#2)(1993-2#1)(1994-12#2)(1994-2#2)(1995-2#1)(1995-3#3)(1996-1#1)(2006-5#2)(2007-11#1)(2009-9#1)(2010-6#1)(2010-8#3)(2011-7#1)
outpatient setting##19##2##(1990-8#1)(1991-1#1)(1992-6#1)(1993-12#2)(1995-2#1)(2006-10#2)(2006-7#2)(2008-3#3)(2008-7#1)(2009-2#1)(2010-9#1)(2011-1#1)(2012-2#2)
outpatient settings and##2##3##(2010-8#1)(2011-2#1)
outpatient settings##7##2##(1991-12#1)(2007-8#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-11#1)(2013-1#1)
outpatient study##3##2##(1993-2#2)(2004-3#1)
outpatient surgeries##2##2##(1993-6#1)(2013-7#1)
outpatient surgery##11##2##(1991-2#1)(1995-12#1)(1996-1#1)(1996-3#3)(2006-10#3)(2009-10#1)(2010-9#1)
outpatient surgical care##2##3##(1992-6#1)(1995-2#1)
outpatient surgical services##2##3##(1995-12#2)
outpatient surgical##6##2##(1992-6#1)(1995-12#2)(1995-2#1)(2006-7#1)(2007-7#1)
outpatient treatment and##2##3##(1990-2#1)(2007-8#1)
outpatient treatment burdens##2##3##(2009-3#2)
outpatient treatment of##2##3##(2006-6#1)(2009-6#1)
outpatient treatment with##2##3##(1997-4#1)(2009-6#1)
outpatient treatment##15##2##(1990-11#1)(1990-2#1)(1990-6#1)(1997-3#1)(1997-4#1)(2006-6#1)(2007-8#3)(2008-4#1)(2009-3#2)(2009-6#2)(2011-7#1)
outpatient treatments##2##2##(2009-3#1)(2012-12#1)
outpatient versus inpatient##2##3##(2006-7#1)(2007-8#1)
outpatient visits##5##2##(1992-2#1)(1995-1#1)(1995-2#1)(2008-11#1)(2008-6#1)
outpatient##448##1##(1990-11#2)(1990-2#2)(1990-4#1)(1990-6#1)(1990-8#3)(1991-1#6)(1991-11#1)(1991-12#5)(1991-2#7)(1991-3#2)(1991-4#1)(1991-5#1)(1991-9#4)(1992-1#6)(1992-12#12)(1992-2#4)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1993-1#3)(1993-12#12)(1993-2#6)(1993-5#1)(1993-6#2)(1993-7#2)(1994-10#1)(1994-12#3)(1994-2#9)(1994-3#3)(1994-4#1)(1994-8#4)(1995-1#7)(1995-11#1)(1995-12#12)(1995-2#11)(1995-3#3)(1995-5#2)(1995-7#2)(1995-8#1)(1996-1#7)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#9)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#3)(1997-5#1)(1997-8#1)(2004-10#4)(2004-3#2)(2005-10#1)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#17)(2006-12#1)(2006-2#2)(2006-3#1)(2006-5#26)(2006-6#3)(2006-7#9)(2006-8#5)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#3)(2007-12#4)(2007-2#3)(2007-3#5)(2007-4#4)(2007-6#1)(2007-7#5)(2007-8#8)(2008-1#2)(2008-10#2)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#11)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#3)(2009-9#1)(2010-12#10)(2010-2#8)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#13)(2010-9#2)(2011-1#7)(2011-2#7)(2011-7#3)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#5)(2012-3#3)(2013-1#14)(2013-7#3)(2013-8#6)
outpatient-based##2##1##(2007-10#1)(2009-12#1)
outpatients and a##2##3##(2012-3#1)(2012-5#1)
outpatients and inpatients##2##3##(2007-2#1)(2011-2#1)
outpatients and##6##2##(2007-2#1)(2007-8#1)(2008-7#1)(2011-2#1)(2012-3#1)(2012-5#1)
outpatients at##3##2##(2006-7#1)(2012-1#1)(2012-2#1)
outpatients department##2##2##(1991-7#1)(2013-8#1)
outpatients in a##3##3##(2008-5#1)(2008-6#1)(2008-7#1)
outpatients in the##2##3##(2008-4#1)(2011-1#1)
outpatients in##9##2##(2006-8#1)(2007-2#1)(2007-7#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2011-1#1)
outpatients of##2##2##(2007-8#1)(2010-12#1)
outpatients under local##2##3##(1994-2#1)(2007-7#1)
outpatients was##2##2##(2006-7#1)(2010-12#1)
outpatients were##2##2##(2011-2#1)(2012-3#1)
outpatients who##2##2##(2008-6#1)(2011-2#1)
outpatients with bipolar disorder##2##4##(1997-2#1)(2013-8#1)
outpatients with nonpsychotic major##2##4##(2007-12#1)(2008-6#1)
outpatients with ovarian dysfunction##2##4##(2011-2#2)
outpatients with##25##2##(1990-12#1)(1991-9#1)(1993-11#1)(1995-11#1)(1997-2#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2009-7#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#2)(2013-8#2)
outpatients##108##1##(1990-12#1)(1991-3#1)(1991-4#1)(1991-7#1)(1991-9#1)(1993-11#2)(1993-8#1)(1994-2#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-7#3)(2006-8#2)(2007-11#1)(2007-12#2)(2007-2#3)(2007-4#1)(2007-7#7)(2007-8#7)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#6)(2008-5#2)(2008-6#3)(2008-7#2)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#2)(2011-1#4)(2011-2#10)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#3)(2012-5#1)(2013-1#1)(2013-7#2)(2013-8#4)
outpatients'##4##1##(2006-7#1)(2012-12#3)
outperform existing##2##2##(2008-2#1)(2010-1#1)
outperform other##2##2##(1991-8#1)(2008-2#1)
outperform the##4##2##(2008-2#1)(2010-3#1)(2012-3#2)
outperform##21##1##(1991-8#1)(1993-4#1)(2007-12#1)(2007-4#2)(2008-11#1)(2008-2#7)(2008-3#2)(2009-10#1)(2010-1#1)(2010-3#1)(2012-12#1)(2012-3#2)
outperformed the##4##2##(2007-8#1)(2008-10#1)(2009-8#1)(2012-2#1)
outperformed##14##1##(1994-5#1)(1996-12#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#1)(2009-8#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#2)
outperforming the Bayesian Networks learned by the M(3) and K2 structure learning algorithms##2##13##(2013-1#2)
outperforming the##5##2##(2009-11#1)(2010-2#1)(2013-1#2)(2013-7#1)
outperforms all##2##2##(2008-2#1)(2008-3#1)
outperforms conventional##2##2##(2008-10#1)(2008-5#1)
outperforms the conventional##2##3##(2008-1#1)(2008-2#1)
outperforms the##9##2##(2008-1#1)(2008-12#1)(2008-2#3)(2008-4#1)(2009-10#1)(2012-2#1)(2012-3#1)
outperforms##24##1##(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#6)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-2#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#2)
outpouching##2##1##(2008-10#1)(2008-5#1)
output (CO)##3##2##(2007-8#3)
output a##2##2##(2007-11#1)(2008-3#1)
output activity##2##2##(1991-6#1)(1993-12#1)
output after##2##2##(1993-10#1)(2008-5#1)
output and a##2##3##(1995-3#1)(2006-10#1)
output and the##5##3##(2005-8#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-2#1)
output and to##3##3##(2007-12#1)(2008-3#1)(2012-2#1)
output and##50##2##(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1995-3#3)(1995-9#2)(1997-5#3)(1997-7#1)(2005-8#1)(2006-10#2)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#6)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-2#1)(2010-4#1)(2012-2#4)(2012-3#3)
output are##7##2##(2007-12#2)(2008-2#2)(2008-3#2)(2011-2#1)
output as##3##2##(1997-5#1)(2007-11#1)(2008-10#1)
output at 2##2##3##(2007-12#2)
output at the##4##3##(1995-11#1)(2008-12#1)(2008-3#1)(2008-5#1)
output at##21##2##(1995-11#1)(2007-11#3)(2007-12#7)(2008-1#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#1)(2009-10#1)
output beam divergence##2##3##(2007-12#1)(2008-2#1)
output beam had##2##3##(2007-12#1)(2008-3#1)
output beam has a##2##4##(2007-12#1)(2008-2#1)
output beam profiles##2##3##(2008-2#1)(2008-3#1)
output beam was##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2011-1#1)
output beam with##2##3##(2007-12#1)(2008-2#1)
output beam##25##2##(2007-11#1)(2007-12#9)(2008-1#1)(2008-2#7)(2008-3#5)(2011-1#2)
output beams##2##2##(2008-3#1)(2010-12#1)
output but##4##2##(1997-5#1)(2007-1#1)(2008-12#1)(2008-9#1)
output by##4##2##(1995-11#1)(2005-8#1)(2008-4#1)(2008-9#1)
output calculation##2##2##(2008-2#2)
output can be##2##3##(1996-3#1)(2007-11#1)
output can##3##2##(1996-3#1)(2007-11#1)(2009-5#1)
output channel##2##2##(2008-3#1)(2011-1#1)
output characteristics of##3##3##(1995-3#1)(2008-2#1)(2008-3#1)
output characteristics##4##2##(1994-12#1)(1995-3#1)(2008-2#1)(2008-3#1)
output compared with##2##3##(2008-2#2)
output consequent matrix is##2##4##(2008-2#2)
output consequent matrix##3##3##(2008-2#3)
output consequents##2##2##(2008-2#2)
output contrast##2##2##(2008-2#1)(2008-3#1)
output correlation##3##2##(2008-2#1)(2008-3#2)
output coupler##16##2##(2007-12#2)(2008-1#1)(2008-2#9)(2008-3#4)
output couplers##7##2##(2007-12#5)(2008-3#2)
output coupling mirror##2##3##(2007-11#1)(2008-3#1)
output coupling of##2##3##(2007-12#1)(2007-9#1)
output coupling##15##2##(2007-11#2)(2007-12#3)(2007-9#1)(2008-2#4)(2008-3#5)
output couplings##2##2##(2008-2#2)
output delay##2##2##(2008-2#2)
output did not##2##3##(2007-8#1)(2011-2#1)
output end##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
output energies##2##2##(2008-2#1)(2008-3#1)
output energy at##2##3##(2007-11#1)(2008-3#1)
output energy of##6##3##(2007-12#4)(2008-1#1)(2008-2#1)
output energy was##3##3##(2008-2#1)(2008-3#2)
output energy##19##2##(2007-11#1)(2007-12#8)(2008-1#1)(2008-2#5)(2008-3#4)
output exhibited##2##2##(2007-12#2)
output factors##3##2##(2008-3#1)(2010-8#2)
output files##3##2##(2008-4#3)
output flux##2##2##(2008-3#2)
output for an##2##3##(2008-3#2)
output for##7##2##(1992-4#1)(1995-2#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-7#1)
output frequency##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
output from a##14##3##(2007-12#5)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#5)
output from the##10##3##(1991-2#1)(1991-7#1)(1996-12#1)(2006-2#1)(2007-12#2)(2008-2#1)(2008-3#3)
output from two proliferative populations##2##5##(1997-6#2)
output from##45##2##(1990-6#1)(1991-2#4)(1991-7#1)(1995-11#1)(1996-12#1)(1997-6#2)(2006-2#1)(2006-9#1)(2007-12#13)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#11)(2011-2#1)
output has been##2##3##(2011-3#1)(2012-1#1)
output has##3##2##(2007-3#1)(2011-3#1)(2012-1#1)
output image##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
output impedance of##2##3##(2013-7#2)
output impedance##4##2##(2013-7#4)
output in a##5##3##(1994-6#1)(1997-5#1)(2007-12#2)(2008-4#1)
output in the##18##3##(1991-2#1)(1994-6#1)(1995-10#1)(1997-5#1)(1997-6#1)(2007-1#1)(2007-12#1)(2007-6#1)(2008-3#1)(2008-4#1)(2008-6#6)(2009-10#1)(2012-1#1)
output in##30##2##(1991-2#1)(1994-6#4)(1995-10#1)(1997-5#2)(1997-6#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-6#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#6)(2009-10#1)(2009-4#1)(2012-1#1)(2012-2#1)(2013-1#1)
output increased##2##2##(2007-1#1)(2012-12#1)
output intensity of##2##3##(2007-11#1)(2010-6#1)
output intensity##7##2##(2007-11#1)(2007-12#4)(2008-2#1)(2010-6#1)
output into##2##2##(1991-4#1)(2007-12#1)
output is a##3##3##(2007-12#3)
output is obtained##3##3##(2007-12#1)(2008-3#1)(2010-8#1)
output is of##2##3##(2006-5#1)(2008-2#1)
output is##34##2##(1991-2#1)(1993-3#1)(1994-12#1)(1997-8#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#6)(2008-1#1)(2008-10#1)(2008-2#6)(2008-3#5)(2008-9#3)(2009-8#2)(2010-2#1)(2010-8#1)(2012-3#1)
output laser##2##2##(2008-3#2)
output layers##5##2##(2008-10#5)
output levels##2##2##(1996-2#1)(2009-4#1)
output light##2##2##(2007-11#1)(2007-12#1)
output mirror reflectivity##2##3##(2008-3#2)
output mirror##6##2##(2007-12#1)(2008-2#1)(2008-3#4)
output nodes##3##2##(2008-2#3)
output noise##2##2##(2007-12#1)(2010-8#1)
output of a cw##3##4##(2007-12#2)(2008-3#1)
output of a high-power##2##4##(2007-12#1)(2008-1#1)
output of a##41##3##(1993-9#1)(2007-1#1)(2007-11#7)(2007-12#16)(2008-1#2)(2008-10#2)(2008-2#6)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#1)
output of an InGaAs##2##4##(2007-12#2)
output of an amplified##2##4##(2007-11#1)(2007-12#1)
output of an optical##2##4##(2007-12#2)
output of an##13##3##(2007-11#2)(2007-12#8)(2008-1#1)(2008-2#1)(2008-3#1)
output of each##3##3##(2007-12#1)(2008-2#1)(2012-2#1)
output of the device is##2##5##(2008-2#2)
output of the device##3##4##(2008-2#3)
output of the fiber##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
output of the filter##2##4##(2008-2#1)(2008-3#1)
output of the system##2##4##(2008-2#2)
output of the##41##3##(1994-8#1)(1995-12#1)(1995-9#1)(1996-12#2)(1996-2#1)(1997-7#1)(2005-10#1)(2007-11#3)(2007-12#4)(2008-10#1)(2008-11#1)(2008-2#12)(2008-3#7)(2008-9#1)(2009-12#1)(2009-4#1)(2009-8#1)(2012-1#1)
output of##142##2##(1990-3#1)(1990-9#1)(1993-3#1)(1993-9#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-9#2)(1996-12#2)(1996-2#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#14)(2007-12#42)(2007-3#1)(2008-1#4)(2008-10#7)(2008-11#2)(2008-2#20)(2008-3#16)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#2)(2009-6#1)(2009-8#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)
output optical spectrum##3##3##(2013-8#3)
output optical##4##2##(2007-11#1)(2013-8#3)
output or##2##2##(1991-6#1)(2008-2#1)
output performance##2##2##(2007-12#1)(2008-2#1)
output pixel##2##2##(2006-5#1)(2008-2#1)
output polarization##2##2##(2007-11#1)(2008-2#1)
output ports##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
output power and efficiency##2##4##(2008-3#1)(2012-1#1)
output power and##12##3##(1990-3#1)(2007-12#4)(2008-2#2)(2008-3#3)(2011-1#1)(2012-1#1)
output power are##2##3##(2008-1#1)(2008-2#1)
output power as great as##2##5##(2007-12#2)
output power as##3##3##(2007-12#2)(2008-2#1)
output power at a##2##4##(2007-12#2)
output power at##9##3##(2007-12#4)(2008-2#5)
output power by##2##3##(2008-3#2)
output power enhancement and threshold reduction##2##6##(2007-12#2)
output power for the##2##4##(2007-11#1)(2008-3#1)
output power from a##2##4##(2007-11#1)(2008-3#1)
output power from##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
output power has been obtained at##2##6##(2007-12#1)(2008-2#1)
output power has been##4##4##(2007-11#2)(2007-12#1)(2008-2#1)
output power in the##3##4##(2007-11#1)(2007-12#2)
output power in##7##3##(2007-11#1)(2007-12#6)
output power is##6##3##(2007-12#3)(2008-2#1)(2008-3#2)
output power of &gt##2##4##(2007-12#1)(2008-2#1)
output power of 1 W##7##5##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#2)
output power of 1##12##4##(2007-11#2)(2007-12#3)(2008-2#3)(2008-3#4)
output power of 530 mW##2##5##(2007-12#2)
output power of 6##2##4##(2007-12#2)
output power of a##3##4##(2007-12#1)(2008-3#2)
output power of the##5##4##(2007-11#1)(2007-12#3)(2008-3#1)
output power of up to##2##5##(2007-11#1)(2007-12#1)
output power of##67##3##(2007-11#10)(2007-12#30)(2008-2#13)(2008-3#14)
output power was measured##2##4##(2007-11#1)(2008-2#1)
output power was##10##3##(2007-11#3)(2008-1#1)(2008-2#3)(2008-3#3)
output power with a##2##4##(2008-3#1)(2011-1#1)
output power with##7##3##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#1)(2011-1#1)
output power##187##2##(1990-3#1)(2007-11#25)(2007-12#71)(2008-1#3)(2008-2#45)(2008-3#38)(2011-1#2)(2012-1#1)(2013-7#1)
output powers and##2##3##(2007-12#1)(2008-3#1)
output powers as high as##4##5##(2007-12#2)(2008-2#1)(2008-3#1)
output powers as##5##3##(2007-12#3)(2008-2#1)(2008-3#1)
output powers from##2##3##(2007-12#1)(2008-3#1)
output powers in excess of##3##5##(2007-12#1)(2008-1#1)(2008-3#1)
output powers of 1##2##4##(2007-11#1)(2007-12#1)
output powers of as much as##2##6##(2007-11#1)(2007-12#1)
output powers of##13##3##(2007-11#9)(2007-12#3)(2008-3#1)
output powers##36##2##(2007-11#12)(2007-12#11)(2008-1#3)(2008-2#4)(2008-3#6)
output pressure##3##2##(2008-10#3)
output pulse duration of##2##4##(2007-12#1)(2008-2#1)
output pulse duration##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
output pulse energies##3##3##(2007-12#1)(2008-3#2)
output pulse energy of##3##4##(2007-12#2)(2008-2#1)
output pulse energy##6##3##(2007-12#3)(2008-2#2)(2008-3#1)
output pulse##22##2##(2005-4#1)(2007-11#2)(2007-12#9)(2008-2#4)(2008-3#6)
output pulses are##2##3##(2007-12#1)(2008-3#1)
output pulses##12##2##(2007-11#2)(2007-12#8)(2008-2#1)(2008-3#1)
output radiation##3##2##(2007-11#3)
output rate and##2##3##(2008-11#2)
output rate##3##2##(2008-10#1)(2008-11#2)
output rates were##2##3##(2008-10#2)
output rates##6##2##(1995-3#2)(2008-10#4)
output remains##2##2##(2007-12#1)(2008-3#1)
output response##3##2##(2007-12#1)(2008-11#1)(2012-12#1)
output second-harmonic##2##2##(2008-3#2)
output signal is##3##3##(2007-11#1)(2008-2#2)
output signal power variations##2##4##(2008-2#2)
output signal pulses##2##3##(2007-11#1)(2007-12#1)
output signal was##2##3##(2008-10#1)(2008-3#1)
output signal##21##2##(2007-11#3)(2007-12#3)(2008-10#2)(2008-2#7)(2008-3#4)(2008-7#1)(2013-7#1)
output signals##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
output state##3##2##(2006-2#1)(2007-12#1)(2007-8#1)
output structures##2##2##(1994-2#1)(2008-11#1)
output surface##6##2##(2007-12#1)(2008-2#2)(2008-3#3)
output syndrome##5##2##(1996-9#1)(2007-8#2)(2007-9#1)(2010-7#1)
output system##3##2##(1993-6#1)(2010-8#1)(2013-1#1)
output that##2##2##(2007-12#1)(2008-2#1)
output the##2##2##(2008-3#1)(2008-6#1)
output to a##2##3##(1991-6#1)(2012-12#1)
output to the##2##3##(2007-12#1)(2007-9#1)
output to##10##2##(1991-6#2)(2005-11#1)(2006-4#1)(2007-12#2)(2007-9#1)(2008-2#1)(2008-3#1)(2012-12#1)
output voltage##3##2##(2008-10#2)(2013-7#1)
output was observed##2##3##(1995-12#1)(2007-8#1)
output was obtained##2##3##(2007-11#1)(2007-12#1)
output was##24##2##(1990-6#1)(1993-11#2)(1995-11#1)(1995-12#1)(1996-12#1)(1996-9#1)(1997-5#4)(2007-1#1)(2007-11#2)(2007-12#3)(2007-8#3)(2008-10#1)(2008-3#1)(2012-12#1)(2013-1#1)
output waveform##2##2##(2007-11#1)(2007-12#1)
output wavelength##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
output wavelengths##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
output were##2##2##(1990-9#1)(1994-9#1)
output when##5##2##(2007-12#1)(2008-2#2)(2008-3#1)(2012-2#1)
output with a##3##3##(2008-2#1)(2008-3#2)
output with##15##2##(2007-12#5)(2008-1#2)(2008-2#3)(2008-3#4)(2010-3#1)
output##1287##1##(1990-12#1)(1990-3#3)(1990-5#1)(1990-6#2)(1990-9#3)(1991-12#2)(1991-2#16)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#9)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-11#3)(1993-12#3)(1993-3#4)(1993-6#3)(1993-9#1)(1994-12#4)(1994-2#1)(1994-6#5)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#8)(1995-12#3)(1995-2#1)(1995-3#8)(1995-4#1)(1995-9#4)(1996-1#1)(1996-11#1)(1996-12#5)(1996-2#3)(1996-3#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-5#17)(1997-6#3)(1997-7#4)(1997-8#4)(2004-11#1)(2005-1#1)(2005-10#5)(2005-11#1)(2005-4#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#9)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#1)(2006-7#2)(2006-9#1)(2007-1#8)(2007-10#3)(2007-11#103)(2007-12#271)(2007-3#2)(2007-4#2)(2007-6#1)(2007-8#18)(2007-9#5)(2008-1#24)(2008-10#43)(2008-11#18)(2008-12#6)(2008-2#210)(2008-3#214)(2008-4#16)(2008-5#4)(2008-6#10)(2008-7#5)(2008-8#8)(2008-9#12)(2009-10#4)(2009-12#3)(2009-2#2)(2009-4#5)(2009-5#1)(2009-6#1)(2009-8#6)(2010-1#4)(2010-10#2)(2010-12#2)(2010-2#5)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#14)(2011-1#7)(2011-2#7)(2011-3#1)(2012-1#6)(2012-12#5)(2012-2#12)(2012-3#5)(2013-1#10)(2013-7#8)(2013-8#5)
output)##7##1##(2006-1#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2011-2#1)
output-beam##2##1##(2007-12#2)
output-image intensity##2##2##(2008-2#2)
output-power##2##1##(2007-12#1)(2008-3#1)
outputs and inputs##2##3##(1992-2#1)(2010-8#1)
outputs and##8##2##(1992-12#1)(1992-2#1)(1993-1#1)(2005-5#1)(2007-12#1)(2008-2#1)(2008-7#1)(2010-8#1)
outputs are##5##2##(2008-2#2)(2008-3#1)(2013-1#2)
outputs can##3##2##(2007-12#1)(2008-11#1)(2013-1#1)
outputs could##2##2##(1992-2#1)(1995-12#1)
outputs from##2##2##(2007-12#1)(2007-7#1)
outputs in##7##2##(1991-2#2)(2006-10#1)(2007-7#1)(2008-2#1)(2008-6#1)(2009-8#1)
outputs of the##8##3##(1997-7#1)(2007-11#1)(2008-10#1)(2008-2#3)(2009-8#1)(2012-1#1)
outputs of these##5##3##(1995-12#1)(2008-10#2)(2008-2#2)
outputs of##20##2##(1992-6#1)(1995-12#1)(1997-7#1)(2004-11#2)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#6)(2008-7#1)(2009-8#1)(2012-1#1)
outputs on##2##2##(2008-3#1)(2010-11#1)
outputs processed by##2##3##(2008-10#2)
outputs that##2##2##(2008-11#1)(2008-2#1)
outputs to##3##2##(2006-4#1)(2007-12#1)(2013-7#1)
outputs were##2##2##(1990-12#1)(1991-2#1)
outputs with##4##2##(2007-12#1)(2007-6#1)(2008-2#1)(2008-7#1)
outputs##109##1##(1990-12#1)(1991-2#3)(1992-12#1)(1992-2#4)(1992-4#1)(1992-6#1)(1993-1#1)(1994-9#1)(1995-12#2)(1995-9#1)(1996-2#1)(1996-3#1)(1997-7#1)(2004-11#2)(2005-5#1)(2006-1#1)(2006-10#2)(2006-4#2)(2007-11#4)(2007-12#11)(2007-6#2)(2007-7#2)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#15)(2008-3#6)(2008-6#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-4#2)(2009-8#2)(2010-11#3)(2010-8#2)(2011-12#1)(2011-2#2)(2012-1#1)(2013-1#6)(2013-7#1)
outputs)##2##1##(1996-12#1)(2008-11#1)
outrage##2##1##(2008-10#1)(2008-7#1)
outreach and##5##2##(1995-1#1)(2006-5#1)(2012-11#2)(2013-1#1)
outreach programs for##2##3##(1992-2#1)(1994-12#1)
outreach programs##4##2##(1992-2#1)(1994-12#1)(1995-1#1)(1996-4#1)
outreach team##4##2##(2007-9#2)(2011-1#1)(2012-2#1)
outreach##44##1##(1992-1#1)(1992-2#1)(1993-7#1)(1994-12#1)(1994-2#1)(1995-1#3)(1995-3#1)(1996-1#1)(1996-4#1)(1997-2#2)(1997-5#1)(2005-8#1)(2006-5#1)(2007-9#4)(2008-1#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#3)(2012-11#3)(2012-12#2)(2012-2#7)(2013-1#3)(2013-8#1)
outright##4##1##(1992-10#1)(1997-6#1)(2007-5#1)(2008-7#1)
outs##7##1##(2005-10#1)(2008-11#1)(2008-3#3)(2011-2#1)(2012-12#1)
outset##21##1##(1991-9#1)(1993-1#1)(1995-1#1)(1995-12#1)(1996-9#1)(1997-4#1)(2005-11#3)(2005-12#1)(2007-1#1)(2007-7#2)(2008-10#1)(2008-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
outside Africa##2##2##(2006-4#1)(2007-6#1)
outside a##6##2##(1990-10#1)(1993-11#1)(2007-11#1)(2008-2#1)(2011-2#1)(2013-7#1)
outside agencies##5##2##(1991-12#1)(1996-12#2)(2007-2#2)
outside and##3##2##(2007-3#1)(2008-10#1)(2008-7#1)
outside diameter##3##2##(1993-6#1)(2008-3#1)(2011-12#1)
outside health##2##2##(1991-7#1)(2013-8#1)
outside home##2##2##(1995-5#1)(2011-2#1)
outside hospital and##2##3##(1990-4#1)(1991-9#1)
outside hospital##5##2##(1990-4#1)(1991-4#1)(1991-9#1)(1996-5#1)(2006-10#1)
outside hospitals##3##2##(1990-2#1)(1993-3#1)(2011-2#1)
outside in##2##2##(2009-5#1)(2010-12#1)
outside its##3##2##(1996-9#1)(2010-8#1)(2012-2#1)
outside marriage##2##2##(1996-12#1)(2012-3#1)
outside microsomes##2##2##(1997-7#2)
outside normal##2##2##(1991-5#1)(1996-12#1)
outside of a##4##3##(1997-3#1)(2008-8#1)(2009-6#1)(2012-12#1)
outside of academic##2##3##(1996-1#1)(2008-12#1)
outside of one's##2##3##(2009-5#1)(2010-2#1)
outside of the United States##3##5##(2007-12#1)(2008-2#1)(2010-9#1)
outside of the clinical##2##4##(2012-2#1)(2013-1#1)
outside of the##56##3##(1990-4#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-10#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-4#1)(2005-10#3)(2006-10#1)(2006-12#2)(2006-8#3)(2007-11#1)(2007-12#2)(2007-4#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-7#1)(2010-9#1)(2011-1#1)(2012-12#2)(2012-2#5)(2013-1#4)
outside of their##2##3##(2008-7#1)(2011-1#1)
outside of work##2##3##(2008-12#1)(2012-1#1)
outside of##98##2##(1990-4#1)(1990-5#1)(1991-9#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-10#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-3#2)(1997-4#1)(2005-10#4)(2006-10#2)(2006-12#2)(2006-8#3)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-9#2)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#6)(2013-1#5)
outside the US##2##3##(2008-5#2)
outside the United States##2##4##(2005-10#1)(2010-2#1)
outside the United##3##3##(2005-10#1)(2007-9#1)(2010-2#1)
outside the acinus##2##3##(2007-12#2)
outside the active##2##3##(1997-4#1)(1997-8#1)
outside the apron and 0 mREM inside the apron##2##9##(2006-8#2)
outside the apron##4##3##(2006-8#4)
outside the area##2##3##(1995-9#1)(2008-2#1)
outside the body##3##3##(2006-6#1)(2010-9#1)(2011-2#1)
outside the box##3##3##(1997-3#1)(2006-2#1)(2010-11#1)
outside the cell##2##3##(1991-9#1)(1997-4#1)
outside the cells##3##3##(1994-12#1)(1995-8#1)(1997-7#1)
outside the clinic##2##3##(2007-7#1)(2008-5#1)
outside the company##2##3##(2008-11#2)
outside the cyclodextrin##3##3##(2008-10#3)
outside the egg##2##3##(1991-5#1)(2008-12#1)
outside the focal##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
outside the genome##2##3##(2007-3#2)
outside the health##3##3##(1990-8#1)(1991-4#1)(1991-6#1)
outside the highly##2##3##(1994-2#1)(2012-3#1)
outside the home and##3##4##(1993-1#1)(2008-7#1)(2013-8#1)
outside the home##8##3##(1990-4#1)(1990-5#1)(1993-1#1)(1997-3#1)(2008-7#1)(2010-2#1)(2013-1#1)(2013-8#1)
outside the hospital environment##3##4##(1996-1#1)(2006-9#1)(2008-2#1)
outside the hospital in##2##4##(2006-10#2)
outside the hospital##7##3##(1996-1#1)(2006-10#2)(2006-9#1)(2008-2#1)(2008-8#1)(2011-2#1)
outside the human body##2##4##(2006-6#1)(2008-8#1)
outside the intercalation site##2##4##(1997-8#2)
outside the operating room for emergency procedures##2##7##(2006-10#2)
outside the operating room##9##4##(2006-10#9)
outside the operating##10##3##(2006-10#10)
outside the plane of##2##4##(2008-3#1)(2010-6#1)
outside the profession##3##3##(2012-12#3)
outside the province##2##3##(1994-1#1)(2006-2#1)
outside the range##3##3##(1991-9#1)(1997-2#1)(2008-7#1)
outside the region##3##3##(2008-3#1)(2008-4#2)
outside the resonator##2##3##(2008-1#1)(2008-2#1)
outside the scope of##3##4##(1996-12#1)(1997-5#1)(2007-4#1)
outside the##248##2##(1990-1#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#4)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-6#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-4#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#2)(1997-8#3)(2004-4#1)(2005-10#2)(2005-11#1)(2006-1#2)(2006-10#15)(2006-2#2)(2006-6#3)(2006-7#2)(2006-8#6)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#5)(2007-2#2)(2007-3#2)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#12)(2008-11#5)(2008-12#1)(2008-2#12)(2008-3#7)(2008-4#3)(2008-5#5)(2008-7#6)(2008-8#5)(2008-9#3)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#4)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#3)(2012-12#7)(2012-2#2)(2012-3#8)(2013-1#3)(2013-8#2)
outside their homes##2##3##(1991-12#1)(1994-4#1)
outside their##13##2##(1991-12#1)(1994-4#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-4#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
outside this##4##2##(1993-12#1)(1995-3#1)(2008-3#2)
outside##508##1##(1990-1#1)(1990-10#1)(1990-12#1)(1990-2#2)(1990-4#4)(1990-5#2)(1990-8#1)(1991-1#2)(1991-10#1)(1991-12#2)(1991-2#2)(1991-4#3)(1991-5#2)(1991-6#4)(1991-7#2)(1991-8#1)(1991-9#7)(1992-1#1)(1992-10#1)(1992-11#2)(1992-2#1)(1992-3#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#3)(1993-9#4)(1994-1#4)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#3)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#3)(1995-3#2)(1995-5#4)(1995-6#2)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#2)(1996-12#8)(1996-2#4)(1996-3#5)(1996-5#2)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#3)(1997-2#3)(1997-3#5)(1997-4#4)(1997-5#1)(1997-7#5)(1997-8#6)(2004-4#1)(2005-10#7)(2005-11#2)(2005-12#1)(2006-1#2)(2006-10#19)(2006-12#4)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#13)(2006-9#1)(2007-1#2)(2007-11#7)(2007-12#10)(2007-2#5)(2007-3#4)(2007-4#6)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#7)(2008-10#30)(2008-11#12)(2008-12#6)(2008-2#15)(2008-3#17)(2008-4#4)(2008-5#10)(2008-6#1)(2008-7#13)(2008-8#13)(2008-9#6)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#1)(2010-11#1)(2010-12#5)(2010-2#4)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#7)(2011-12#3)(2011-2#14)(2012-1#4)(2012-11#1)(2012-12#11)(2012-2#9)(2012-3#13)(2013-1#10)(2013-7#2)(2013-8#5)
outside-in##2##1##(2008-5#1)(2013-7#1)
outside-out patches##2##2##(1994-2#1)(1995-2#1)
outside-out##5##1##(1994-2#3)(1995-2#2)
outskirts##6##1##(1992-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2011-12#1)(2013-1#1)
outsourcing##5##1##(2008-1#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
outspoken##4##1##(1991-2#1)(2007-9#1)(2010-10#2)
outstanding feature of##2##3##(2010-4#1)(2013-8#1)
outstanding feature##4##2##(1995-8#1)(2008-5#1)(2010-4#1)(2013-8#1)
outstanding importance##4##2##(1994-5#1)(2006-10#1)(2006-6#1)(2008-11#1)
outstanding issues##2##2##(2007-7#1)(2008-5#1)
outstanding properties##3##2##(2008-12#1)(2008-5#1)(2010-7#1)
outstanding research##2##2##(2008-10#1)(2013-8#1)
outstanding##71##1##(1990-12#1)(1991-3#1)(1992-3#2)(1994-10#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-6#1)(1997-8#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-6#2)(2007-10#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-8#2)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-2#2)(2013-1#1)(2013-8#2)
outstrip the##2##2##(1996-12#1)(2008-4#1)
outstripped##2##1##(2007-4#1)(2010-8#1)
outward K+ current##2##3##(1991-9#1)(1994-5#1)
outward K+##4##2##(1991-9#1)(1994-5#1)(1995-12#1)(1997-1#1)
outward and##2##2##(2008-8#1)(2012-2#1)
outward by##2##2##(2007-10#1)(2008-11#1)
outward current and a##3##4##(1990-5#1)(1994-2#1)(1996-5#1)
outward current and##5##3##(1990-5#1)(1994-2#2)(1995-7#1)(1996-5#1)
outward current which##2##3##(1993-2#1)(1996-1#1)
outward current##22##2##(1990-11#1)(1990-5#1)(1991-5#1)(1993-12#1)(1993-2#2)(1993-3#2)(1994-2#3)(1994-3#2)(1995-7#2)(1996-1#1)(1996-3#1)(1996-5#1)(1997-1#1)(2008-8#3)
outward currents depolarize cells##2##4##(2005-10#2)
outward currents##11##2##(1991-9#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-3#4)(2005-10#2)(2009-2#1)
outward from##3##2##(1996-9#1)(2008-2#1)(2010-7#1)
outward growth of##3##3##(1995-3#1)(2008-10#1)(2009-1#1)
outward rectification##2##2##(1996-2#1)(2011-2#1)
outward rectifying potassium##4##3##(1994-2#4)
outward rectifying##6##2##(1993-12#1)(1994-2#4)(2011-2#1)
outward##78##1##(1990-11#1)(1990-2#1)(1990-5#1)(1991-11#1)(1991-5#2)(1991-9#2)(1992-11#1)(1993-12#3)(1993-2#2)(1993-3#2)(1994-12#1)(1994-2#8)(1994-3#3)(1994-5#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-7#2)(1996-1#3)(1996-2#1)(1996-3#5)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#1)(2005-10#2)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#5)(2009-1#1)(2009-12#1)(2009-2#2)(2009-7#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-2#1)
outward-facing##2##1##(1990-11#1)(1991-4#1)
outwardly directed##3##2##(1991-8#1)(1992-8#1)(2008-10#1)
outwardly healthy##3##2##(1994-10#2)(1995-7#1)
outwardly rectifying##3##2##(1995-6#2)(2008-4#1)
outwardly##10##1##(1991-8#1)(1992-8#1)(1994-10#2)(1995-6#2)(1995-7#1)(2008-10#2)(2008-4#1)
outwardly-directed##3##1##(1994-12#3)
outweigh any##2##2##(2007-2#1)(2008-10#1)
outweigh its##4##2##(1996-8#1)(2006-5#1)(2012-11#2)
outweigh the benefits in##2##4##(2007-10#1)(2007-11#1)
outweigh the benefits##3##3##(2007-10#1)(2007-11#1)(2012-12#1)
outweigh the costs##2##3##(2009-5#1)(2011-2#1)
outweigh the potential risks##3##4##(2007-2#1)(2007-8#1)(2008-8#1)
outweigh the potential##4##3##(2007-2#1)(2007-4#1)(2007-8#1)(2008-8#1)
outweigh the risk##2##3##(2009-3#1)(2012-2#1)
outweigh the risks##4##3##(2007-4#1)(2010-6#1)(2010-7#1)(2011-2#1)
outweigh the##26##2##(1992-3#1)(1993-3#1)(1993-8#1)(1996-6#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#3)(2007-8#1)(2008-1#1)(2008-8#2)(2009-3#1)(2009-5#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)
outweigh##39##1##(1992-3#1)(1993-3#1)(1993-8#1)(1996-6#1)(1996-8#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-4#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#1)
outweighed by the##6##3##(1993-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-12#1)(2008-9#1)
outweighed by##7##2##(1993-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-12#1)(2008-9#1)(2011-1#1)
outweighed the##5##2##(1991-7#1)(1992-12#1)(2004-12#1)(2005-7#1)(2013-1#1)
outweighed##15##1##(1991-7#1)(1992-12#1)(1993-8#1)(1995-3#1)(1996-11#1)(2004-12#1)(2005-7#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-12#1)(2008-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
outweighing##3##1##(2008-10#1)(2008-7#1)(2009-8#1)
outweighs its##2##2##(1995-8#1)(2013-1#1)
outweighs the##4##2##(1996-6#1)(1997-8#1)(2008-10#1)(2012-1#1)
outweighs##8##1##(1995-2#1)(1995-8#1)(1995-9#1)(1996-6#1)(1997-8#1)(2008-10#1)(2012-1#1)(2013-1#1)
outweight##2##1##(1990-9#1)(1994-7#1)
ovIL4##2##1##(1993-2#2)
ova and##2##2##(2007-12#1)(2012-2#1)
ova in##3##2##(1996-12#3)
ova of##2##2##(1996-12#1)(2008-9#1)
ova or##2##2##(2011-2#1)(2012-2#1)
ova were##4##2##(1996-12#3)(2006-5#1)
ova##29##1##(1994-12#1)(1995-8#2)(1996-12#11)(2005-8#1)(2006-5#3)(2007-1#1)(2007-12#1)(2008-5#1)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
ova)##2##1##(2007-11#1)(2007-3#1)
ova/embryos##2##1##(2006-5#2)
oval and irregular##2##3##(2008-5#2)
oval and##6##2##(2008-12#1)(2008-5#3)(2008-9#1)(2011-1#1)
oval cell##2##2##(2009-4#2)
oval cells or##2##3##(2009-2#1)(2009-4#1)
oval cells that##2##3##(2009-4#2)
oval cells##12##2##(2006-10#1)(2008-10#1)(2009-2#1)(2009-4#9)
oval or##2##2##(1997-3#1)(2007-12#1)
oval shape##4##2##(2007-12#1)(2007-9#1)(2010-10#1)(2013-8#1)
oval to##2##2##(2008-6#1)(2010-12#1)
oval##46##1##(1994-2#1)(1995-5#1)(1997-3#2)(1997-8#1)(2005-1#1)(2006-10#1)(2006-5#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-4#11)(2010-10#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-8#1)
oval-shaped##3##1##(2007-12#2)(2007-8#1)
ovalbumin (OVA)##4##2##(1996-10#1)(2006-12#1)(2008-11#1)(2009-9#1)
ovalbumin (OVA)-specific T cell receptor transgenic##2##6##(2008-11#2)
ovalbumin (OVA)-specific T cell receptor##3##5##(2008-11#3)
ovalbumin (OVA)-specific##4##2##(2008-11#4)
ovalbumin and used##2##3##(1990-5#1)(1992-12#1)
ovalbumin and##6##2##(1990-5#1)(1991-3#1)(1992-12#1)(1995-2#1)(1995-6#1)(2008-10#1)
ovalbumin content in six##2##4##(2007-8#2)
ovalbumin content##3##2##(2007-8#3)
ovalbumin on the##2##3##(2004-12#2)
ovalbumin upstream##2##2##(1994-9#1)(1996-5#1)
ovalbumin##55##1##(1990-5#1)(1991-3#2)(1992-12#1)(1992-3#1)(1994-9#3)(1995-2#4)(1995-6#1)(1996-10#2)(1996-11#1)(1996-12#2)(1996-5#1)(2004-12#4)(2005-10#1)(2006-12#1)(2007-8#4)(2008-10#11)(2008-11#11)(2008-7#2)(2009-9#1)(2012-1#1)
ovalbumin-specific##4##1##(1996-10#2)(1996-5#1)(2008-11#1)
ovale were rare##2##3##(2006-2#2)
ovale were##3##2##(2005-9#1)(2006-2#2)
ovale##43##1##(1991-11#1)(1992-10#1)(1992-9#3)(1994-2#1)(1996-11#2)(1996-3#1)(1996-6#2)(2005-9#2)(2006-2#2)(2006-8#1)(2007-10#4)(2007-12#1)(2007-8#4)(2007-9#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-10#1)(2009-5#2)(2010-12#1)(2011-2#6)(2012-2#1)
ovalis##5##1##(2008-11#3)(2008-5#1)(2012-2#1)
ovallesi##3##1##(2005-8#3)
ovarial##2##1##(1993-9#1)(2008-11#1)
ovarian Mr = 80##4##4##(1990-10#4)
ovarian Mr##5##2##(1990-10#5)
ovarian ablation##3##2##(2004-2#2)(2008-7#1)
ovarian activity##3##2##(2008-12#1)(2008-3#1)(2008-5#1)
ovarian adenocarcinoma cell line##3##4##(1990-9#1)(1993-9#1)(1994-6#1)
ovarian adenocarcinoma##9##2##(1990-9#1)(1993-9#1)(1994-6#1)(1995-5#1)(1997-8#1)(2010-12#3)(2013-1#1)
ovarian aging##2##2##(2012-2#2)
ovarian and testicular tissue##2##4##(1995-11#2)
ovarian and##11##2##(1990-9#1)(1994-12#1)(1995-11#2)(1995-8#1)(1997-8#1)(2008-4#2)(2008-5#1)(2010-12#1)(2011-2#1)
ovarian androgen##4##2##(2006-1#1)(2008-1#1)(2010-10#2)
ovarian blood supply##2##3##(1996-2#1)(2004-10#1)
ovarian cancer (EOC) is##3##4##(2010-12#1)(2010-7#1)(2010-8#1)
ovarian cancer (EOC)##4##3##(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#1)
ovarian cancer 20 years##2##4##(2011-2#2)
ovarian cancer and##7##3##(1992-12#1)(2006-6#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
ovarian cancer are##2##3##(1991-6#1)(1996-11#1)
ovarian cancer as##2##3##(2012-12#1)(2013-8#1)
ovarian cancer cells and##2##4##(2008-2#1)(2009-4#1)
ovarian cancer cells##15##3##(1990-2#1)(1993-9#2)(1994-2#1)(1995-5#2)(1996-4#1)(1997-7#2)(2008-11#1)(2008-2#3)(2009-4#1)(2013-1#1)
ovarian cancer families##2##3##(1992-12#2)
ovarian cancer in##2##3##(1992-12#1)(1993-9#1)
ovarian cancer is##3##3##(2012-12#2)(2013-8#1)
ovarian cancer occurs in approximately##2##5##(1992-12#1)(2012-3#1)
ovarian cancer patients##11##3##(1990-2#1)(1990-5#1)(1991-4#1)(1992-9#2)(1993-12#1)(1994-10#1)(1996-10#1)(1996-12#1)(2008-4#1)(2010-12#1)
ovarian cancer screening##2##3##(1994-6#1)(2010-12#1)
ovarian cancer##158##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#4)(1990-6#1)(1990-9#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-8#2)(1992-12#11)(1992-2#2)(1992-4#1)(1992-8#1)(1992-9#4)(1993-10#3)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#14)(1994-10#1)(1994-12#1)(1994-2#2)(1994-6#2)(1994-7#1)(1994-9#2)(1995-5#2)(1996-10#2)(1996-11#3)(1996-12#1)(1996-4#2)(1997-7#4)(2004-2#1)(2005-10#1)(2006-6#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#2)(2010-10#1)(2010-11#1)(2010-12#8)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#14)(2012-12#9)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#8)
ovarian cancer-associated##2##2##(1991-4#1)(1994-9#1)
ovarian cancer]##3##2##(1993-3#1)(2010-6#1)(2011-1#1)
ovarian cancers##9##2##(1992-12#1)(1993-11#1)(1996-11#2)(2009-4#3)(2010-11#1)(2011-1#1)
ovarian carcinogenesis##2##2##(2009-4#1)(2012-12#1)
ovarian carcinoma and##3##3##(1991-10#1)(1992-2#1)(1993-9#1)
ovarian carcinoma are##2##3##(2007-8#1)(2010-7#1)
ovarian carcinoma cell line##3##4##(1990-9#1)(1993-7#1)(2008-4#1)
ovarian carcinoma cell lines expressed αvβ8##2##6##(2012-12#2)
ovarian carcinoma cell lines##6##4##(1991-10#1)(2008-5#1)(2009-4#1)(2010-7#1)(2012-12#2)
ovarian carcinoma cell##9##3##(1990-9#1)(1991-10#1)(1993-7#1)(2008-4#1)(2008-5#1)(2009-4#1)(2010-7#1)(2012-12#2)
ovarian carcinoma cells##9##3##(1991-7#2)(1993-8#2)(1993-9#1)(1994-6#1)(1995-5#2)(2008-4#1)
ovarian carcinoma in##2##3##(1991-3#1)(1995-8#1)
ovarian carcinoma with##2##3##(1993-2#1)(2010-9#1)
ovarian carcinoma##54##2##(1990-12#1)(1990-2#2)(1990-4#1)(1990-6#2)(1990-9#1)(1991-10#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#3)(1991-8#1)(1992-1#2)(1992-2#1)(1993-2#1)(1993-7#1)(1993-8#2)(1993-9#3)(1994-4#1)(1994-6#1)(1994-8#1)(1995-5#2)(1995-8#1)(1997-3#1)(2004-10#1)(2005-11#1)(2007-7#1)(2007-8#1)(2008-4#2)(2008-5#2)(2009-4#1)(2009-5#1)(2010-10#1)(2010-7#2)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#3)
ovarian carcinoma-associated##2##2##(1992-12#1)(1994-2#1)
ovarian carcinoma]##3##2##(1993-9#1)(2005-11#1)(2013-1#1)
ovarian carcinomas##6##2##(1990-2#1)(1990-9#2)(1991-9#1)(2006-6#1)(2010-10#1)
ovarian cell line##2##3##(2008-11#1)(2008-5#1)
ovarian cell##4##2##(1991-7#1)(1996-8#1)(2008-11#1)(2008-5#1)
ovarian cells to FSH##2##4##(1996-8#2)
ovarian cells##4##2##(1996-11#1)(1996-8#3)
ovarian changes##2##2##(1995-2#1)(2008-4#1)
ovarian cyst##4##2##(1992-3#2)(2013-1#2)
ovarian cystectomy##4##2##(1993-3#1)(1996-3#2)(2004-10#1)
ovarian cystomas of intestinal type##2##5##(1990-2#2)
ovarian cystomas of intestinal##3##4##(1990-2#3)
ovarian cystomas##4##2##(1990-2#4)
ovarian cysts##9##2##(1991-5#2)(1994-9#1)(2009-2#1)(2011-1#1)(2012-12#4)
ovarian development##2##2##(1995-11#1)(2010-5#1)
ovarian disease##6##2##(1990-2#1)(1992-9#1)(2007-2#1)(2008-4#2)(2010-8#1)
ovarian dysfunction##4##2##(2006-4#1)(2008-3#1)(2011-2#2)
ovarian ectopic pregnancy##2##3##(1996-12#2)
ovarian endometriosis##3##2##(1994-9#2)(2010-12#1)
ovarian epithelial cells##2##3##(2009-4#1)(2011-2#1)
ovarian epithelial##6##2##(2006-10#3)(2009-4#1)(2011-2#1)(2013-8#1)
ovarian failure (POF)##2##3##(2008-1#1)(2012-3#1)
ovarian failure##10##2##(1996-2#2)(1996-6#1)(2008-1#2)(2008-4#1)(2008-7#1)(2010-10#1)(2012-3#1)(2013-8#1)
ovarian fibromatosis/massive ovarian oedema##4##4##(2008-6#4)
ovarian follicle##6##2##(1991-9#3)(2008-4#1)(2008-9#1)(2012-12#1)
ovarian follicles in##2##3##(2008-12#2)
ovarian follicles##17##2##(1992-4#1)(1995-12#1)(2008-11#1)(2008-12#9)(2008-9#1)(2009-4#1)(2010-10#1)(2010-8#1)(2011-1#1)
ovarian follicular##4##2##(1991-2#1)(1991-8#1)(2008-3#2)
ovarian function##5##2##(1991-4#1)(2008-4#1)(2008-9#1)(2010-12#2)
ovarian granulosa##2##2##(1991-5#1)(1994-7#1)
ovarian group##2##2##(1992-12#2)
ovarian growth of flightless##2##4##(2008-9#2)
ovarian growth##4##2##(2008-9#3)(2013-7#1)
ovarian hormones##4##2##(1990-5#1)(1993-6#1)(1994-4#1)(2008-2#1)
ovarian hyperandrogenism##2##2##(2006-10#1)(2008-4#1)
ovarian hyperstimulation (COH)##3##3##(1994-9#1)(2009-6#1)(2011-1#1)
ovarian hyperstimulation syndrome and##2##4##(2011-1#1)(2012-3#1)
ovarian hyperstimulation syndrome##6##3##(2007-11#1)(2008-3#2)(2011-1#1)(2012-3#1)(2013-1#1)
ovarian hyperstimulation##13##2##(1994-9#2)(1996-12#1)(2007-11#2)(2008-3#2)(2009-6#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
ovarian inhibin##2##2##(1995-9#2)
ovarian leiomyoma##2##2##(2013-8#2)
ovarian mass was##2##3##(1996-1#1)(2006-6#1)
ovarian mass##6##2##(1996-1#1)(2004-10#1)(2006-6#1)(2007-4#1)(2010-9#2)
ovarian masses##8##2##(1992-12#1)(1993-8#1)(1996-1#5)(2012-1#1)
ovarian metastases of##2##3##(1997-3#1)(2004-10#1)
ovarian metastases##3##2##(1997-3#2)(2004-10#1)
ovarian mucinous##2##2##(1996-9#1)(2012-3#1)
ovarian neoplasms##4##2##(1990-10#1)(1994-2#1)(2010-12#1)(2013-8#1)
ovarian or##2##2##(1994-6#1)(1996-1#1)
ovarian origin##2##2##(2009-7#1)(2010-12#1)
ovarian pathology##2##2##(2008-4#1)(2008-6#1)
ovarian reserve##3##2##(2008-12#1)(2012-2#2)
ovarian response##3##2##(2012-2#1)(2012-3#2)
ovarian serous##3##2##(1990-10#1)(2007-12#1)(2010-11#1)
ovarian sex cord tumor##2##4##(2010-9#2)
ovarian steroid##3##2##(1995-10#1)(1995-9#1)(2006-10#1)
ovarian stimulation in##2##3##(2007-7#1)(2012-3#1)
ovarian stimulation##13##2##(1994-9#1)(2007-11#3)(2007-7#1)(2010-12#2)(2011-2#1)(2012-2#2)(2012-3#3)
ovarian suppression##2##2##(1994-9#2)
ovarian surface epithelial cells##2##4##(1991-10#2)
ovarian surface##6##2##(1991-10#2)(1995-12#1)(2008-1#1)(2011-2#2)
ovarian surgery##5##2##(1992-3#5)
ovarian syndrome (PCOS)##4##3##(2008-3#2)(2013-8#2)
ovarian syndrome and##2##3##(2008-3#1)(2011-1#1)
ovarian syndrome##14##2##(2007-7#1)(2008-1#2)(2008-3#4)(2010-11#2)(2010-12#1)(2011-1#1)(2012-2#1)(2013-8#2)
ovarian tissue in##2##3##(1995-11#1)(2012-12#1)
ovarian tissue##12##2##(1990-8#1)(1995-11#2)(1996-2#1)(2008-10#1)(2008-11#1)(2009-5#1)(2009-6#1)(2010-12#2)(2012-12#1)(2012-3#1)
ovarian tissues##3##2##(1990-3#1)(2008-10#1)(2008-11#1)
ovarian tumor cell lines##3##4##(1992-2#2)(2008-5#1)
ovarian tumor cell##5##3##(1991-7#1)(1992-2#2)(2008-5#1)(2012-2#1)
ovarian tumor cells##3##3##(2008-11#1)(2008-4#2)
ovarian tumor promoter##2##3##(2007-12#2)
ovarian tumor##21##2##(1991-7#1)(1992-2#2)(1994-6#1)(1994-7#1)(2007-12#5)(2007-2#1)(2007-4#4)(2008-11#1)(2008-4#2)(2008-5#2)(2012-2#1)
ovarian tumorigenesis##2##2##(1995-2#1)(2009-4#1)
ovarian tumors##10##2##(1990-10#1)(1990-2#1)(1990-6#1)(1993-10#1)(1994-7#1)(1995-2#1)(2007-8#1)(2008-9#1)(2010-10#1)(2012-2#1)
ovarian tumour##5##2##(1992-10#1)(1992-12#1)(1992-9#1)(1993-7#1)(2008-5#1)
ovarian tumours##14##2##(1992-12#9)(2007-3#1)(2012-2#1)(2012-3#1)(2013-8#2)
ovarian##673##1##(1990-10#12)(1990-11#1)(1990-12#2)(1990-2#13)(1990-3#1)(1990-4#3)(1990-5#6)(1990-6#4)(1990-8#1)(1990-9#7)(1991-10#4)(1991-2#4)(1991-3#2)(1991-4#4)(1991-5#4)(1991-6#2)(1991-7#5)(1991-8#4)(1991-9#5)(1992-1#2)(1992-10#2)(1992-12#26)(1992-2#5)(1992-3#11)(1992-4#2)(1992-8#1)(1992-9#9)(1993-10#4)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-7#2)(1993-8#5)(1993-9#20)(1994-10#1)(1994-12#3)(1994-2#4)(1994-4#2)(1994-6#8)(1994-7#5)(1994-8#2)(1994-9#12)(1995-10#1)(1995-11#6)(1995-12#2)(1995-2#3)(1995-5#5)(1995-8#8)(1995-9#4)(1996-1#7)(1996-10#2)(1996-11#6)(1996-12#5)(1996-2#6)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-8#4)(1996-9#1)(1997-1#1)(1997-3#4)(1997-7#4)(1997-8#2)(2004-10#7)(2004-2#3)(2005-10#1)(2005-11#2)(2006-1#1)(2006-10#5)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#3)(2007-10#2)(2007-11#6)(2007-12#6)(2007-2#3)(2007-3#1)(2007-4#6)(2007-6#1)(2007-7#4)(2007-8#3)(2008-1#8)(2008-10#4)(2008-11#9)(2008-12#15)(2008-2#5)(2008-3#11)(2008-4#18)(2008-5#14)(2008-6#9)(2008-7#3)(2008-8#2)(2008-9#8)(2009-1#1)(2009-2#1)(2009-4#10)(2009-5#7)(2009-6#2)(2009-7#2)(2010-10#9)(2010-11#5)(2010-12#23)(2010-3#1)(2010-5#1)(2010-6#4)(2010-7#3)(2010-8#3)(2010-9#6)(2011-1#12)(2011-2#23)(2012-1#3)(2012-12#22)(2012-2#19)(2012-3#14)(2013-1#18)(2013-7#3)(2013-8#23)
ovariectomised##3##1##(1995-10#1)(2007-1#2)
ovariectomized (OVX) rats##2##3##(2009-8#1)(2013-1#1)
ovariectomized (OVX)##4##2##(2009-3#1)(2009-8#1)(2010-10#1)(2013-1#1)
ovariectomized animals##2##2##(1993-9#1)(2008-10#1)
ovariectomized baboons##2##2##(1991-7#2)
ovariectomized female##5##2##(1991-11#1)(1992-8#1)(1993-6#1)(1994-3#1)(1997-3#1)
ovariectomized females##3##2##(1997-4#1)(2012-11#2)
ovariectomized mice##6##2##(1995-7#1)(1997-4#3)(2009-3#1)(2012-2#1)
ovariectomized rat##2##2##(1997-5#2)
ovariectomized rats were##2##3##(1993-4#1)(2004-11#1)
ovariectomized rats##15##2##(1993-4#3)(1994-11#1)(1997-3#1)(1997-5#3)(2004-11#3)(2007-8#1)(2008-10#1)(2009-8#1)(2010-3#1)
ovariectomized##54##1##(1991-1#1)(1991-11#1)(1991-7#2)(1992-5#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-4#3)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-7#1)(1997-3#2)(1997-4#10)(1997-5#8)(2004-11#3)(2007-8#1)(2008-10#2)(2009-3#2)(2009-8#2)(2010-10#1)(2010-3#1)(2012-11#2)(2012-2#1)(2013-1#1)
ovariectomy and##2##2##(2004-2#2)
ovariectomy as##3##2##(1990-6#1)(2007-1#2)
ovariectomy did not differ##2##4##(2007-1#2)
ovariectomy##28##1##(1990-6#1)(1992-12#1)(1992-5#1)(1993-10#2)(1993-5#1)(1993-9#1)(1994-12#1)(1995-11#1)(1997-4#4)(2004-2#4)(2005-3#1)(2007-1#5)(2008-4#1)(2008-5#2)(2011-2#1)(2012-12#1)
ovaries and##11##2##(1992-12#3)(1994-2#1)(1995-2#1)(2007-6#1)(2008-5#1)(2009-6#1)(2011-1#1)(2012-2#1)(2013-7#1)
ovaries are##2##2##(1990-11#1)(2007-12#1)
ovaries for##2##2##(1992-3#2)
ovaries had##3##2##(2006-5#1)(2007-1#2)
ovaries in##2##2##(2006-6#1)(2012-2#1)
ovaries infected with C##2##4##(2008-10#2)
ovaries is##2##2##(2007-12#1)(2008-12#1)
ovaries of the##3##3##(2007-12#1)(2008-5#1)(2012-3#1)
ovaries of##10##2##(2006-5#1)(2007-12#2)(2008-12#1)(2008-5#5)(2012-3#1)
ovaries were##7##2##(1992-3#2)(2006-10#1)(2006-5#1)(2009-8#1)(2010-10#1)(2012-3#1)
ovaries##99##1##(1990-11#1)(1990-4#1)(1992-12#7)(1992-3#4)(1993-2#1)(1994-2#1)(1994-3#3)(1994-6#2)(1995-10#1)(1995-11#2)(1995-2#3)(1995-3#1)(1996-6#1)(2004-10#2)(2006-10#1)(2006-12#1)(2006-5#3)(2006-6#1)(2007-1#2)(2007-12#6)(2007-6#1)(2008-1#1)(2008-10#5)(2008-12#3)(2008-4#2)(2008-5#8)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-4#2)(2009-6#2)(2009-8#2)(2010-10#2)(2010-12#2)(2010-3#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#1)
ovarii with##2##2##(1994-6#2)
ovarii##6##1##(1994-12#2)(1994-6#2)(2004-10#1)(2009-5#1)
ovariohysterectomy in##2##2##(2004-2#1)(2013-1#1)
ovariohysterectomy##3##1##(2004-2#1)(2013-1#2)
ovariole formation##2##2##(2008-12#2)
ovariole##7##1##(2007-12#3)(2008-12#2)(2008-7#2)
ovarioles of the##2##3##(2008-12#1)(2008-7#1)
ovarioles of##6##2##(2007-12#4)(2008-12#1)(2008-7#1)
ovarioles##9##1##(2007-12#6)(2008-12#2)(2008-7#1)
ovary (CHO) cell line##5##4##(1996-7#1)(1997-4#1)(2008-11#3)
ovary (CHO) cell##11##3##(1992-7#1)(1994-3#1)(1996-7#1)(1997-2#1)(1997-4#1)(2008-11#4)(2008-7#2)
ovary (CHO)##64##2##(1990-12#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-12#3)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-4#1)(1994-11#2)(1994-12#2)(1994-3#3)(1994-5#1)(1994-8#2)(1995-11#1)(1995-3#1)(1995-6#2)(1995-7#1)(1996-10#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-11#19)(2008-4#1)(2008-7#7)
ovary Psi(w)##2##2##(2008-10#2)
ovary and oviduct##3##3##(2008-12#2)(2008-4#1)
ovary and testis##2##3##(1990-11#1)(1995-11#1)
ovary and##25##2##(1990-11#1)(1991-9#1)(1993-2#1)(1993-3#1)(1995-10#1)(1995-11#1)(1995-5#1)(2007-4#1)(2008-10#2)(2008-12#2)(2008-4#3)(2008-6#3)(2008-7#1)(2010-5#1)(2010-8#1)(2012-1#2)(2012-2#1)(2013-8#1)
ovary at##3##2##(1996-8#1)(2008-5#2)
ovary cancer -##2##3##(2007-11#2)
ovary cells##60##2##(1990-12#1)(1990-7#1)(1991-12#1)(1991-4#1)(1991-5#2)(1991-7#2)(1991-8#1)(1992-12#1)(1992-9#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#3)(1995-6#3)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-6#2)(1997-5#1)(1997-7#1)(2007-11#1)(2008-11#11)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
ovary during##4##2##(2008-10#1)(2008-12#1)(2008-9#2)
ovary in the##3##3##(2007-12#1)(2008-10#1)(2010-12#1)
ovary in##7##2##(2007-12#2)(2008-10#1)(2008-12#1)(2008-7#1)(2010-12#1)(2013-8#1)
ovary of##6##2##(1995-5#1)(2007-12#2)(2008-5#1)(2009-7#1)(2010-5#1)
ovary or##3##2##(1990-10#1)(1991-12#1)(1995-11#1)
ovary syndrome (PCOS) is##6##4##(2008-4#3)(2012-11#1)(2013-1#1)(2013-8#1)
ovary syndrome (PCOS)##22##3##(2006-2#1)(2008-1#1)(2008-3#3)(2008-4#8)(2009-3#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#2)
ovary syndrome and##2##3##(2012-12#1)(2013-1#1)
ovary syndrome##49##2##(1993-1#1)(1996-2#2)(2005-8#1)(2006-2#1)(2007-7#1)(2008-1#2)(2008-3#9)(2008-4#12)(2008-5#1)(2009-3#1)(2010-10#3)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#3)
ovary tissue##2##2##(1993-4#1)(2008-10#1)
ovary tumours##4##2##(2011-1#4)
ovary was longitudinally bivalved with a scalpel##2##7##(1992-3#2)
ovary was##13##2##(1990-8#1)(1992-12#1)(1992-3#5)(1996-8#1)(2008-3#2)(2009-7#1)(2010-5#1)(2011-1#1)
ovary with##3##2##(1993-1#1)(2004-10#1)(2011-1#1)
ovary##426##1##(1990-10#4)(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#2)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#2)(1991-4#2)(1991-5#7)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#6)(1992-10#1)(1992-11#1)(1992-12#8)(1992-3#9)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#3)(1993-10#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-4#2)(1993-8#1)(1993-9#6)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#5)(1994-5#5)(1994-6#3)(1994-8#2)(1994-9#2)(1995-10#1)(1995-11#8)(1995-12#6)(1995-2#3)(1995-3#5)(1995-5#6)(1995-6#5)(1995-7#2)(1995-8#1)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#7)(1996-4#2)(1996-5#4)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#3)(2004-10#3)(2005-8#2)(2006-12#1)(2006-2#1)(2006-5#2)(2007-11#4)(2007-12#4)(2007-4#4)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#12)(2008-11#46)(2008-12#5)(2008-3#15)(2008-4#21)(2008-5#10)(2008-6#5)(2008-7#14)(2008-8#3)(2008-9#7)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-7#4)(2010-10#3)(2010-12#5)(2010-4#1)(2010-5#6)(2010-7#1)(2010-8#3)(2011-1#12)(2011-2#4)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#10)(2013-7#1)(2013-8#10)
ovary-specific##3##1##(1995-2#1)(2008-4#1)(2008-7#1)
ovata##5##1##(2004-4#1)(2010-2#3)(2010-3#1)
ovatum##3##1##(2010-3#3)
ovatus##3##1##(1997-2#3)
ovcar-3##2##1##(2010-10#2)
oven at 450W##2##3##(2008-10#2)
oven at##10##2##(1993-11#1)(2008-10#6)(2008-2#1)(2010-4#1)(2013-7#1)
oven digestion##2##2##(1993-11#1)(2008-10#1)
oven is##3##2##(2007-11#1)(2008-10#1)(2011-12#1)
oven temperature was##2##3##(2005-12#1)(2008-10#1)
oven temperature##7##2##(2005-12#1)(2008-10#5)(2012-1#1)
oven##58##1##(1993-11#2)(1993-12#1)(1997-7#1)(2005-11#1)(2005-12#1)(2007-11#1)(2008-10#33)(2008-12#3)(2008-2#4)(2008-3#1)(2010-4#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
oven-dried##3##1##(2007-5#1)(2011-12#1)(2012-12#1)
ovens##2##1##(2008-10#1)(2009-6#1)
over $1##2##2##(1995-2#1)(2006-7#1)
over &quot##4##2##(1997-5#1)(2007-9#1)(2008-8#1)(2011-2#1)
over 0##10##2##(1995-2#1)(1997-6#2)(2005-12#1)(2007-5#1)(2008-10#3)(2008-8#1)(2013-1#1)
over 1 hour##3##3##(2006-4#2)(2007-1#1)
over 1 month##2##3##(2007-12#1)(2008-10#1)
over 1 to##3##3##(1991-1#1)(1992-7#1)(2009-7#1)
over 1 year of age##5##5##(2011-2#5)
over 1 year##16##3##(1990-11#1)(1991-2#1)(1995-1#1)(2008-10#1)(2008-7#2)(2011-2#7)(2012-12#3)
over 1##42##2##(1990-11#2)(1991-1#1)(1991-2#1)(1991-9#1)(1992-7#1)(1995-1#1)(1995-6#1)(1996-3#1)(2006-4#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#2)(2009-7#1)(2011-2#7)(2012-12#3)
over 1-2##2##2##(2008-1#1)(2008-8#1)
over 10 000##2##3##(1996-3#1)(2007-11#1)
over 10 months##3##3##(1992-10#1)(2008-1#1)(2008-6#1)
over 10 weeks##2##3##(2008-5#1)(2010-2#1)
over 10 years following spontaneous##2##5##(2012-1#2)
over 10 years of##4##4##(2012-12#1)(2013-1#3)
over 10 years##13##3##(2005-7#1)(2006-10#1)(2007-9#1)(2008-4#1)(2011-1#1)(2012-1#3)(2012-12#1)(2013-1#4)
over 10##40##2##(1990-4#1)(1992-10#1)(1992-6#1)(1993-6#1)(1994-10#1)(1996-3#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-6#2)(2009-8#1)(2010-2#1)(2010-4#2)(2011-1#2)(2012-1#3)(2012-12#1)(2013-1#5)
over 10%##2##2##(2007-5#1)(2008-10#1)
over 10(7)##3##2##(1994-9#1)(2008-11#2)
over 100 million##2##3##(1992-9#1)(2008-10#1)
over 100 times##2##3##(2007-8#1)(2008-10#1)
over 100 years of operative history##2##6##(2012-2#2)
over 100 years##4##3##(2005-8#1)(2006-11#1)(2012-2#2)
over 100##31##2##(1990-6#1)(1991-5#1)(1992-9#1)(1993-9#1)(1995-10#1)(1996-8#1)(2005-11#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-3#1)(2012-11#1)(2012-2#3)
over 100%##2##2##(1997-2#1)(2007-11#1)
over 100-fold##6##2##(1994-12#1)(1994-5#1)(1996-2#1)(2008-10#2)(2008-5#1)
over 1000##7##2##(2005-6#1)(2005-7#1)(2005-8#1)(2006-12#1)(2007-6#1)(2008-10#1)(2008-11#1)
over 100mg of##2##3##(2008-10#2)
over 11##7##2##(1993-9#1)(1995-10#1)(1997-6#1)(2005-11#1)(2007-1#1)(2008-10#1)(2008-3#1)
over 12 days##2##3##(2007-7#1)(2012-2#1)
over 12 h##2##3##(1995-10#1)(2008-7#1)
over 12 months##6##3##(2007-10#1)(2008-10#1)(2009-9#1)(2011-1#1)(2012-2#2)
over 12 weeks##4##3##(2006-10#1)(2008-10#1)(2008-2#1)(2008-5#1)
over 12##21##2##(1991-4#1)(1995-10#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-7#1)(2009-4#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#3)(2013-7#1)
over 1200##2##2##(1997-4#1)(2011-2#1)
over 13 years##2##3##(2008-12#1)(2010-2#1)
over 13##5##2##(1991-6#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-2#1)
over 130 years ago##2##4##(2007-10#1)(2009-8#1)
over 14##5##2##(1991-5#1)(2007-8#1)(2012-12#3)
over 140##2##2##(2012-2#1)(2012-3#1)
over 15 nm##2##3##(2007-12#1)(2008-2#1)
over 15 years##3##3##(1993-8#1)(2007-5#1)(2013-1#1)
over 15##11##2##(1991-5#1)(1993-8#1)(1997-1#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
over 150 days##2##3##(1990-3#2)
over 150##8##2##(1990-3#2)(1997-2#1)(1997-5#1)(2005-9#1)(2007-12#2)(2009-8#1)
over 1500##3##2##(1990-9#1)(2005-10#1)(2008-5#1)
over 16 weeks##2##3##(1991-1#1)(2012-12#1)
over 16 years##2##3##(2008-6#2)
over 16##9##2##(1991-1#1)(1992-6#1)(1996-4#1)(2007-12#2)(2008-10#1)(2008-6#2)(2012-12#1)
over 17##2##2##(1990-8#1)(2007-9#1)
over 18 h##2##3##(1990-6#1)(1995-11#1)
over 18 years old##2##4##(2008-8#1)(2011-2#1)
over 18 years##6##3##(1996-4#1)(2008-8#1)(2011-1#1)(2011-2#2)(2013-7#1)
over 18##14##2##(1990-6#1)(1992-3#1)(1995-11#1)(1996-4#1)(1997-8#1)(2007-12#1)(2008-8#2)(2011-1#1)(2011-2#3)(2013-7#2)
over 1800##2##2##(1996-2#1)(2005-8#1)
over 19##4##2##(2007-12#1)(2007-5#1)(2008-10#2)
over 2 months##3##3##(2008-10#2)(2009-8#1)
over 2 weeks##4##3##(2007-11#2)(2008-10#1)(2012-2#1)
over 2 years##15##3##(1996-12#2)(2006-10#1)(2006-2#2)(2007-7#1)(2008-10#6)(2009-4#1)(2010-10#1)(2010-8#1)
over 2##47##2##(1990-4#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-12#1)(1996-11#1)(1996-12#2)(1997-4#1)(1997-6#1)(2006-10#1)(2006-2#2)(2007-11#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#11)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
over 2-3##3##2##(1994-6#1)(1997-1#1)(2012-1#1)
over 20 million##2##3##(2006-10#1)(2007-2#1)
over 20 min##2##3##(1992-2#1)(2007-8#1)
over 20 years ago##5##4##(1993-5#1)(2007-11#1)(2008-2#1)(2011-12#1)(2012-2#1)
over 20 years##14##3##(1992-1#1)(1993-5#1)(1995-4#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
over 20##33##2##(1990-8#1)(1992-1#1)(1992-2#1)(1993-3#1)(1993-5#1)(1994-9#1)(1995-4#2)(2004-9#1)(2005-7#2)(2006-10#2)(2007-1#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
over 20% of those##2##4##(1992-6#1)(2007-6#1)
over 20% of##4##3##(1992-6#1)(2006-11#1)(2007-6#1)(2012-12#1)
over 20%##8##2##(1992-2#1)(1992-6#1)(2006-11#1)(2007-10#1)(2007-6#1)(2008-8#1)(2012-12#1)(2012-3#1)
over 20-fold##2##2##(1993-12#1)(1997-3#1)
over 200##17##2##(1991-12#1)(2005-9#1)(2006-10#1)(2007-11#2)(2008-10#6)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-3#1)(2012-2#1)
over 2000##8##2##(1993-12#2)(2005-8#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-3#1)(2010-5#1)
over 21 days##2##3##(2008-6#1)(2012-3#1)
over 23##2##2##(1991-2#1)(1992-3#1)
over 24 h##12##3##(1990-11#2)(1996-11#1)(1997-1#1)(1997-5#1)(2006-5#1)(2007-12#1)(2008-10#3)(2008-2#1)(2010-8#1)
over 24 hours##7##3##(1990-11#1)(1991-11#1)(1992-4#1)(1993-1#1)(1993-11#1)(2007-9#1)(2008-8#1)
over 24 hr##2##3##(1995-3#1)(2013-8#1)
over 24##23##2##(1990-11#3)(1991-11#1)(1992-4#1)(1993-1#1)(1993-11#1)(1995-3#1)(1996-11#1)(1997-1#1)(1997-5#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-8#1)(2010-8#1)(2013-8#1)
over 240 hr##2##3##(1995-3#2)
over 240##5##2##(1991-9#1)(1995-3#2)(2006-6#1)(2008-5#1)
over 24h##2##2##(2008-5#1)(2009-4#1)
over 25 years##2##3##(2008-12#1)(2008-4#1)
over 25##4##2##(2007-1#1)(2008-12#1)(2008-4#1)(2008-7#1)
over 26##3##2##(1996-12#1)(2007-6#1)(2011-2#1)
over 28##2##2##(1992-3#1)(2007-12#1)
over 29##2##2##(2006-2#1)(2007-5#1)
over 3 consecutive##2##3##(1991-8#1)(2006-5#1)
over 3 days##2##3##(1994-3#1)(2005-7#1)
over 3 hours##2##3##(2004-1#2)
over 3 months##4##3##(2006-12#1)(2006-8#1)(2008-3#1)(2012-3#1)
over 3 weeks##5##3##(1992-5#1)(1996-5#1)(2006-8#1)(2008-10#1)(2008-4#1)
over 3 years##12##3##(1990-6#1)(2006-7#2)(2007-8#1)(2008-10#5)(2008-12#1)(2012-11#1)(2013-8#1)
over 3##40##2##(1990-6#1)(1991-8#1)(1992-5#2)(1994-2#1)(1994-3#1)(1996-5#1)(2004-1#2)(2005-7#1)(2005-8#1)(2006-12#1)(2006-5#1)(2006-7#2)(2006-8#2)(2007-12#1)(2007-8#2)(2008-10#9)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-5#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-8#2)
over 3-fold##2##2##(1990-3#1)(1991-10#1)
over 30 days##2##3##(2006-7#1)(2012-1#1)
over 30 min##6##3##(1995-11#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)
over 30 minutes##2##3##(1997-2#1)(2006-6#1)
over 30 months##2##3##(2008-10#1)(2008-12#1)
over 30 years ago and##2##5##(2005-7#1)(2010-11#1)
over 30 years ago##3##4##(2005-7#1)(2010-11#2)
over 30 years of##2##4##(1991-8#1)(2008-10#1)
over 30 years##17##3##(1990-10#1)(1990-3#1)(1991-8#1)(1992-8#1)(1996-11#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-6#1)(2009-4#1)(2010-11#2)(2010-2#1)(2011-2#1)(2013-1#1)
over 30##44##2##(1990-10#1)(1990-3#1)(1991-8#1)(1992-8#1)(1993-2#1)(1995-11#1)(1995-3#1)(1996-11#1)(1997-2#1)(1997-8#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-11#2)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-12#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-11#3)(2010-2#1)(2010-3#1)(2011-2#2)(2012-1#1)(2013-1#1)
over 30% of the##2##4##(2006-9#1)(2012-12#1)
over 30% of##5##3##(1994-2#1)(2006-9#1)(2008-11#2)(2012-12#1)
over 30%##6##2##(1994-2#1)(2006-2#1)(2006-9#1)(2008-11#2)(2012-12#1)
over 300 million##2##3##(2012-2#1)(2013-7#1)
over 300##10##2##(1995-12#1)(2005-8#2)(2008-11#2)(2008-5#1)(2010-7#1)(2012-2#2)(2013-7#1)
over 3000##6##2##(1990-9#1)(1994-4#1)(2004-2#1)(2004-4#1)(2007-12#1)(2008-7#1)
over 31##2##2##(2007-11#1)(2012-3#1)
over 32##3##2##(1996-4#1)(2007-2#1)(2008-7#1)
over 320##2##2##(2008-5#1)(2010-2#1)
over 34##2##2##(1991-3#1)(2008-7#1)
over 35 years of age were treated##2##7##(2008-10#2)
over 35 years##5##3##(1995-1#1)(2008-10#4)
over 35##12##2##(1990-8#2)(1995-1#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-6#1)(2008-7#1)
over 36##5##2##(1990-3#1)(1994-3#1)(2007-8#1)(2008-6#1)(2010-4#1)
over 38##3##2##(2007-6#1)(2011-2#2)
over 4 days##3##3##(1996-2#1)(2008-6#1)(2012-1#1)
over 4 h##2##3##(1995-12#1)(2008-6#1)
over 4 months##5##3##(1995-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#1)
over 4 weeks of##2##4##(1997-6#1)(2008-7#1)
over 4 weeks##7##3##(1997-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)
over 4 years as##2##4##(1993-12#1)(2010-3#1)
over 4 years##4##3##(1993-12#1)(2008-10#1)(2010-3#1)(2012-1#1)
over 4##33##2##(1992-7#1)(1993-12#1)(1994-11#1)(1994-3#1)(1995-12#2)(1996-2#1)(1997-6#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2009-10#1)(2009-3#1)(2009-7#1)(2010-3#1)(2012-1#2)(2013-8#1)
over 40 years ago##3##4##(2008-8#1)(2013-1#2)
over 40 years of age##3##5##(1990-6#1)(2008-6#1)(2013-8#1)
over 40 years##13##3##(1990-6#1)(1991-10#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-8#2)(2013-1#4)(2013-8#1)
over 40##24##2##(1990-6#1)(1991-10#1)(1991-2#1)(1992-10#1)(1994-2#1)(1994-3#1)(2004-9#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-12#1)(2009-4#1)(2010-7#1)(2013-1#4)(2013-8#1)
over 40% of the##3##4##(1992-4#1)(2007-12#1)(2011-2#1)
over 40% of##7##3##(1992-4#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-8#1)(2011-2#1)
over 40%##9##2##(1992-4#1)(1992-7#1)(2006-10#1)(2006-8#1)(2007-12#2)(2008-10#1)(2008-8#1)(2011-2#1)
over 400##9##2##(1992-9#1)(1996-6#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2009-9#1)
over 42##3##2##(1990-5#1)(1993-3#1)(2009-8#1)
over 45 years##2##3##(2013-1#1)(2013-8#1)
over 45##4##2##(1994-2#1)(2008-10#1)(2013-1#1)(2013-8#1)
over 48 h##2##3##(1994-2#1)(1997-7#1)
over 48##5##2##(1990-12#1)(1994-2#1)(1997-7#1)(2008-3#1)(2010-7#1)
over 5 days##2##3##(2008-10#2)
over 5 years##8##3##(2007-10#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-5#1)(2010-2#1)(2010-6#1)
over 5##19##2##(2007-10#2)(2007-8#1)(2007-9#2)(2008-10#4)(2008-11#2)(2008-5#2)(2008-6#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2012-2#1)
over 50 percent##2##3##(1994-6#1)(1996-2#1)
over 50 years of age##6##5##(1993-2#1)(1995-4#1)(2004-2#1)(2006-12#1)(2012-12#1)(2013-8#1)
over 50 years##19##3##(1993-2#2)(1995-4#2)(2004-2#1)(2006-1#1)(2006-12#2)(2007-11#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#1)(2009-2#1)(2012-11#2)(2012-12#1)(2013-8#1)
over 50##44##2##(1990-6#1)(1992-9#1)(1993-2#2)(1993-6#1)(1994-6#1)(1995-4#2)(1995-6#1)(1996-2#1)(1996-3#1)(2004-2#1)(2004-9#1)(2006-1#1)(2006-12#2)(2006-5#1)(2007-11#2)(2008-1#2)(2008-10#4)(2008-12#2)(2008-3#2)(2008-4#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-2#1)(2011-2#4)(2012-11#2)(2012-12#3)(2013-8#1)
over 50% of the##8##4##(1990-3#1)(1993-1#1)(2007-5#1)(2008-10#2)(2009-4#1)(2011-1#1)(2013-7#1)
over 50% of##15##3##(1990-3#1)(1993-1#1)(2005-7#1)(2006-8#1)(2007-5#1)(2007-7#1)(2008-10#3)(2009-4#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)
over 50%##23##2##(1990-3#1)(1993-1#1)(2005-7#1)(2006-8#1)(2007-5#1)(2007-7#3)(2008-10#4)(2008-2#2)(2008-3#1)(2009-4#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
over 500##6##2##(1996-12#1)(2004-10#1)(2005-12#1)(2007-8#1)(2008-10#1)(2013-1#1)
over 5000##4##2##(1991-11#1)(1996-6#1)(2005-7#1)(2008-1#1)
over 55##5##2##(1996-4#1)(1997-2#1)(2007-10#1)(2012-3#1)(2013-1#1)
over 6 h##4##3##(1991-1#1)(1996-2#1)(2007-12#1)(2007-8#1)
over 6 months##4##3##(2007-8#1)(2008-10#1)(2009-6#1)(2011-2#1)
over 6 to##3##3##(1991-12#1)(2008-10#1)(2009-11#1)
over 6 weeks)##2##3##(2010-2#1)(2011-2#1)
over 6##19##2##(1991-1#1)(1991-12#1)(1995-3#1)(1996-2#1)(1997-7#1)(2007-12#2)(2007-8#3)(2008-10#2)(2008-7#1)(2009-11#1)(2009-6#1)(2010-12#1)(2010-2#1)(2011-2#2)
over 60 years of age##3##5##(2006-1#1)(2006-10#1)(2008-2#1)
over 60 years old##2##4##(2008-7#1)(2012-3#1)
over 60 years##15##3##(1991-10#1)(1996-6#1)(2006-1#1)(2006-10#1)(2007-7#2)(2008-2#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-1#2)(2012-3#3)
over 60##24##2##(1990-6#1)(1991-10#1)(1996-6#1)(1997-4#1)(1997-5#1)(2006-1#1)(2006-10#1)(2007-7#2)(2007-8#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-1#3)(2012-3#3)
over 60% of##4##3##(1992-6#1)(1997-6#1)(2008-8#1)(2013-1#1)
over 60%##11##2##(1991-1#1)(1992-6#1)(1992-7#1)(1997-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2013-1#2)
over 600##2##2##(2007-11#1)(2008-10#1)
over 65 who##3##3##(1992-9#1)(2013-1#2)
over 65 years in##2##4##(2011-2#1)(2012-12#1)
over 65 years of age##6##5##(2006-12#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-7#1)(2010-4#1)
over 65 years old were##2##5##(2011-2#1)(2012-12#1)
over 65 years old##4##4##(2007-7#1)(2011-2#2)(2012-12#1)
over 65 years##17##3##(1995-3#1)(2006-12#1)(2006-8#2)(2007-11#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-7#1)(2010-4#1)(2011-2#4)(2012-12#2)(2013-8#1)
over 65##26##2##(1992-10#1)(1992-9#1)(1993-6#1)(1995-3#1)(1996-6#1)(2006-12#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-4#1)(2011-2#4)(2012-12#2)(2013-1#3)(2013-8#1)
over 66%##2##2##(2006-5#1)(2012-3#1)
over 7##4##2##(1992-7#1)(1994-7#1)(2005-9#1)(2008-6#1)
over 70 percent of##2##4##(1994-2#1)(1996-3#1)
over 70 species##2##3##(2008-5#1)(2011-1#1)
over 70 years of age##2##5##(1990-10#1)(2009-7#1)
over 70 years of##3##4##(1990-10#1)(1991-8#1)(2009-7#1)
over 70 years old##2##4##(1990-6#1)(1991-10#1)
over 70 years##11##3##(1990-10#1)(1990-6#1)(1991-10#1)(1991-8#2)(1992-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-7#1)(2011-2#1)
over 70##18##2##(1990-10#1)(1990-12#1)(1990-6#1)(1991-10#1)(1991-8#2)(1992-2#1)(1993-10#1)(1994-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#1)
over 70% of the##2##4##(1995-6#1)(2008-10#1)
over 70% of##5##3##(1995-6#1)(2007-2#1)(2008-1#1)(2008-10#2)
over 70%##10##2##(1992-2#1)(1995-6#1)(1996-1#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2010-10#1)
over 700##4##2##(1997-1#1)(2007-11#1)(2008-10#1)(2010-3#1)
over 72##2##2##(2007-10#1)(2008-10#1)
over 75 years##2##3##(2008-4#1)(2011-2#1)
over 75##5##2##(1991-8#1)(1992-10#2)(2008-4#1)(2011-2#1)
over 75% of##2##3##(2007-8#1)(2008-1#1)
over 8 months##3##3##(2006-10#1)(2009-11#1)(2010-3#1)
over 8 years##2##3##(2008-10#1)(2012-2#1)
over 8##13##2##(1991-2#1)(1996-6#1)(1997-2#2)(2006-10#1)(2008-10#1)(2008-3#1)(2009-11#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
over 80##12##2##(1994-11#1)(1994-2#1)(1996-3#1)(1997-7#1)(2005-12#1)(2006-1#1)(2007-11#3)(2008-10#1)(2008-7#1)(2008-9#1)
over 80% of the##7##4##(1996-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-1#1)(2013-7#1)
over 80% of##14##3##(1991-7#1)(1996-1#1)(1996-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#2)(2009-7#1)(2011-1#1)(2011-2#2)(2013-7#1)
over 80%##22##2##(1991-7#2)(1996-1#1)(1996-12#1)(1996-6#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#2)(2009-7#1)(2011-1#1)(2011-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
over 85%##4##2##(2006-12#1)(2008-10#1)(2013-1#2)
over 9 weeks##2##3##(2010-9#1)(2011-1#1)
over 9##5##2##(1997-7#1)(2007-8#1)(2010-9#1)(2011-1#1)(2011-2#1)
over 90 days##2##3##(2008-10#1)(2010-6#1)
over 90##9##2##(1991-7#1)(1995-1#1)(2006-11#1)(2008-10#1)(2008-4#1)(2009-5#1)(2009-9#1)(2010-6#1)(2012-12#1)
over 90% by##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
over 90% for##2##3##(2008-9#1)(2010-8#1)
over 90% in##2##3##(1996-3#1)(2013-1#1)
over 90% of##10##3##(1990-12#1)(1990-9#1)(1992-9#1)(2006-2#1)(2008-10#2)(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#1)
over 90% were##2##3##(2008-10#1)(2008-12#1)
over 90%##32##2##(1990-12#1)(1990-6#1)(1990-9#1)(1992-11#1)(1992-9#1)(1993-3#1)(1994-9#1)(1995-9#1)(1996-3#1)(2006-2#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#3)
over 900##3##2##(1997-1#1)(2007-7#1)(2008-2#1)
over 95 percent##2##3##(1994-10#1)(2011-2#1)
over 95% and##2##3##(2008-12#1)(2012-12#1)
over 95%##9##2##(1990-6#1)(1992-1#1)(2006-2#1)(2007-7#1)(2008-12#1)(2008-2#1)(2010-8#1)(2012-12#1)(2012-2#1)
over 96 h##3##3##(1997-1#1)(2005-12#1)(2010-3#1)
over 96##5##2##(1997-1#1)(2005-12#1)(2006-2#1)(2008-10#1)(2010-3#1)
over 96% of##2##3##(1992-1#1)(1994-12#1)
over 97%##4##2##(2008-10#1)(2008-2#1)(2008-5#1)(2010-7#1)
over 98% of the##2##4##(2008-12#1)(2011-2#1)
over 98% of##3##3##(2008-12#1)(2008-3#1)(2011-2#1)
over 98%##6##2##(1995-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-2#1)(2011-2#1)
over Beijing##3##2##(2008-2#3)
over CT##2##2##(2008-1#1)(2008-8#1)
over K(+)##4##2##(2008-10#4)
over Land##2##2##(2008-2#1)(2008-3#1)
over Medicare##3##2##(1993-5#1)(2008-4#1)(2008-7#1)
over T##2##2##(1995-1#1)(2011-12#1)
over UFH##2##2##(2007-11#1)(2008-10#1)
over YUF##2##2##(2008-11#2)
over a 0##3##3##(2007-1#1)(2008-2#2)
over a 1##4##3##(1990-11#1)(2008-10#1)(2008-2#1)(2009-7#1)
over a 1-year period##4##4##(2008-5#1)(2009-3#1)(2011-2#1)(2013-8#1)
over a 10 year period##2##5##(2006-7#1)(2007-8#1)
over a 10##3##3##(2006-7#1)(2007-8#1)(2010-8#1)
over a 10-year period##8##4##(1990-10#1)(1997-6#1)(2004-10#1)(2007-12#1)(2008-10#1)(2008-7#2)(2010-12#1)
over a 100##2##3##(1993-3#1)(2008-11#1)
over a 12-month period##2##4##(2006-2#1)(2008-12#1)
over a 12-month##3##3##(1993-5#1)(2006-2#1)(2008-12#1)
over a 12-year period##3##4##(2006-8#2)(2008-10#1)
over a 14 month period##2##5##(2012-2#2)
over a 14##3##3##(2008-10#1)(2012-2#2)
over a 15##2##3##(1997-3#1)(2008-8#1)
over a 2 h period##2##5##(1995-5#1)(2007-12#1)
over a 2##6##3##(1994-1#1)(1995-5#1)(1996-6#1)(1997-8#1)(2007-12#1)(2007-3#1)
over a 2-week period##4##4##(2007-12#1)(2008-11#1)(2009-11#1)(2010-11#1)
over a 2-year period##9##4##(1991-6#1)(1994-12#1)(1996-3#1)(2006-2#1)(2006-8#1)(2008-10#2)(2008-9#1)(2012-5#1)
over a 2-year##10##3##(1991-6#1)(1994-12#1)(1996-12#1)(1996-3#1)(2006-2#1)(2006-8#1)(2008-10#2)(2008-9#1)(2012-5#1)
over a 20 year period##2##5##(2005-9#1)(2008-6#1)
over a 20-year period##4##4##(2005-8#1)(2006-9#1)(2013-8#2)
over a 20-year##5##3##(2005-8#1)(2006-9#1)(2012-1#1)(2013-8#2)
over a 21-day##2##3##(2004-2#1)(2008-11#1)
over a 24##2##3##(1990-2#1)(1995-3#1)
over a 24-h period##2##4##(1992-9#1)(2008-3#1)
over a 24-h##3##3##(1992-9#1)(2008-10#1)(2008-3#1)
over a 3##2##3##(1995-10#1)(2010-6#1)
over a 3-month period##6##4##(1992-5#1)(2006-1#1)(2008-10#2)(2011-2#1)(2012-2#1)
over a 3-year period from##2##5##(1993-9#1)(2008-1#1)
over a 3-year period##11##4##(1993-9#1)(2008-1#1)(2008-10#4)(2008-8#2)(2010-2#1)(2011-2#1)(2012-2#1)
over a 30 min period##2##5##(1991-9#1)(1993-12#1)
over a 35##2##3##(2006-8#1)(2010-8#1)
over a 4-week period##3##4##(2008-3#1)(2008-7#1)(2012-3#1)
over a 4-year period##4##4##(2005-10#1)(2007-12#1)(2008-10#1)(2008-5#1)
over a 5 year##2##4##(1993-9#1)(2008-10#1)
over a 5##3##3##(1991-9#1)(1993-9#1)(2008-10#1)
over a 5-year period##7##4##(2006-8#1)(2007-2#1)(2007-8#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-1#1)
over a 6##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
over a 6-day##2##3##(1992-8#1)(2008-11#1)
over a 6-month period##4##4##(2004-1#1)(2008-10#1)(2012-12#1)(2012-3#1)
over a 6-year period##7##4##(2004-9#1)(2005-9#1)(2006-2#1)(2007-1#1)(2008-10#2)(2013-1#1)
over a 7-day period##2##4##(1992-12#1)(2009-11#1)
over a 7-year period##4##4##(1994-1#1)(1996-11#1)(2007-8#1)(2011-2#1)
over a bandwidth of##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
over a broad bandwidth##2##4##(2007-12#1)(2008-1#1)
over a broad pH range##3##5##(1991-5#1)(1996-5#1)(2013-1#1)
over a broad range of##11##5##(1994-3#1)(1997-7#1)(2007-12#1)(2008-3#3)(2008-8#1)(2009-4#1)(2012-12#1)(2012-2#2)
over a broad range##14##4##(1994-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-3#3)(2008-8#1)(2009-4#1)(2010-12#1)(2012-12#2)(2012-2#2)
over a broad spectral range##6##5##(2007-11#1)(2007-12#2)(2008-1#1)(2008-3#2)
over a broad temperature range##3##5##(2008-2#2)(2008-3#1)
over a broad wavelength##2##4##(2007-12#1)(2008-3#1)
over a broad##32##3##(1991-5#1)(1994-3#1)(1996-5#1)(1997-7#1)(2007-11#2)(2007-12#5)(2007-8#1)(2008-1#2)(2008-2#2)(2008-3#8)(2008-8#1)(2009-4#1)(2010-12#1)(2012-12#2)(2012-2#2)(2013-1#1)
over a broader##2##3##(2008-10#2)
over a century ago##2##4##(2005-11#1)(2008-9#1)
over a century##9##3##(1990-5#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-12#1)(2008-9#1)(2009-12#1)(2010-2#1)(2010-4#1)
over a certain##2##3##(1991-10#1)(2008-3#1)
over a circular aperture##3##4##(2008-2#3)
over a concentration range of 0##2##6##(2008-10#2)
over a concentration range of 1##2##6##(2008-10#1)(2011-2#1)
over a concentration range of##6##5##(1996-3#1)(2008-10#3)(2010-2#1)(2011-2#1)
over a concentration range##9##4##(1996-3#1)(1997-4#1)(2008-10#5)(2010-2#1)(2011-2#1)
over a decade without##2##4##(2011-2#1)(2012-1#1)
over a decade##14##3##(1994-2#1)(1995-1#2)(1996-1#1)(2008-2#1)(2010-11#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-8#1)
over a distance of##3##4##(1995-6#1)(2007-12#1)(2008-1#1)
over a distance##4##3##(1995-6#1)(2007-12#1)(2008-1#1)(2008-10#1)
over a dose range##2##4##(1994-5#1)(2010-12#1)
over a dozen##3##3##(1996-6#1)(2007-12#1)(2008-1#1)
over a duration of upto six years##2##7##(2008-7#2)
over a dynamic range of##2##5##(2007-12#1)(2008-3#1)
over a few days##2##4##(1991-8#1)(1996-6#1)
over a few##3##3##(1991-8#1)(1996-6#1)(2008-3#1)
over a finite##3##3##(2008-3#3)
over a five-year period from##2##5##(2007-3#1)(2008-12#1)
over a five-year period##6##4##(1991-12#1)(1992-1#1)(2007-3#1)(2007-7#2)(2008-12#1)
over a four##2##3##(1992-2#1)(1997-8#1)
over a four-year period##4##4##(1995-3#1)(2007-2#1)(2008-7#1)(2008-8#1)
over a frequency range of##2##5##(1996-5#1)(2008-2#1)
over a hundred years##2##4##(2007-7#1)(2012-12#1)
over a hundred##3##3##(1993-12#1)(2007-7#1)(2012-12#1)
over a large bandwidth##2##4##(2008-3#2)
over a large number of anions##2##6##(2008-10#2)
over a large number of cations##2##6##(2008-10#2)
over a large number of##8##5##(1991-8#1)(2007-11#1)(2008-10#6)
over a large range of values##2##6##(2008-10#1)(2008-3#1)
over a large range of##5##5##(2008-10#1)(2008-2#1)(2008-3#2)(2011-1#1)
over a large spectral range##2##5##(2007-11#1)(2008-2#1)
over a large spectral##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
over a large##34##3##(1991-8#1)(1993-11#1)(1995-2#1)(2006-2#1)(2007-11#4)(2007-12#2)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#9)(2008-7#1)(2008-8#1)(2011-1#1)(2012-1#1)(2012-3#1)
over a larger area##2##4##(2008-2#1)(2008-3#1)
over a larger##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
over a lifetime##2##3##(1997-8#1)(2006-5#1)
over a limited##4##3##(2006-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
over a linear concentration range of 1##2##7##(2008-10#1)(2010-12#1)
over a linear range of##3##5##(2008-10#3)
over a linear##6##3##(2008-10#4)(2008-9#1)(2010-12#1)
over a long distance##2##4##(1997-4#1)(2012-12#1)
over a long period of time##5##6##(2006-12#1)(2008-9#1)(2010-10#1)(2010-6#1)(2011-2#1)
over a long period##7##4##(2006-12#1)(2007-11#1)(2008-9#1)(2010-10#1)(2010-6#1)(2010-8#1)(2011-2#1)
over a long##10##3##(1991-11#1)(1997-4#1)(2006-12#1)(2007-11#1)(2008-9#1)(2010-10#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)
over a longer period##6##4##(1995-11#1)(1997-7#1)(2005-7#1)(2006-7#1)(2008-10#1)(2008-2#1)
over a longer##7##3##(1995-11#1)(1997-7#1)(2005-7#1)(2006-7#1)(2008-10#1)(2008-2#1)(2008-3#1)
over a mean follow-up of##2##5##(2007-10#1)(2013-1#1)
over a mean of 12##2##5##(1996-7#1)(2012-3#1)
over a mean of##4##4##(1996-7#1)(2007-8#1)(2008-4#1)(2012-3#1)
over a mean##8##3##(1996-7#1)(2007-10#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-3#1)(2013-1#1)
over a more than##2##4##(2008-2#2)
over a much wider##2##4##(2006-5#1)(2008-3#1)
over a much##3##3##(1994-3#1)(2006-5#1)(2008-3#1)
over a new##2##3##(2007-1#1)(2008-10#1)
over a number of years##2##5##(2004-11#1)(2012-12#1)
over a number of##5##4##(1991-2#1)(2004-11#1)(2005-7#1)(2008-10#1)(2012-12#1)
over a one year##2##4##(1996-2#1)(2013-1#1)
over a one##3##3##(1996-2#1)(2011-1#1)(2013-1#1)
over a one-year period##4##4##(1997-1#1)(2007-2#1)(2007-3#1)(2012-2#1)
over a one-year##5##3##(1997-1#1)(2007-2#1)(2007-3#1)(2010-7#1)(2012-2#1)
over a pH range from 3##2##6##(2008-10#2)
over a pH range of 3##2##6##(2008-10#2)
over a pH range of 7##2##6##(1992-12#1)(2012-2#1)
over a pH range of##6##5##(1991-9#1)(1992-12#1)(2008-10#3)(2012-2#1)
over a pH range##8##4##(1991-9#1)(1992-12#1)(2008-10#5)(2012-2#1)
over a pH##9##3##(1991-9#2)(1992-12#1)(2008-10#5)(2012-2#1)
over a period of 1 year##2##6##(2007-10#1)(2012-12#1)
over a period of 1##5##5##(1990-3#1)(2006-8#1)(2007-10#1)(2008-10#1)(2012-12#1)
over a period of 10 months##2##6##(2008-11#1)(2013-8#1)
over a period of 10 years##4##6##(2007-7#1)(2009-4#1)(2011-12#1)(2013-8#1)
over a period of 10##10##5##(1994-12#1)(1995-3#1)(2006-10#1)(2007-7#1)(2008-11#1)(2009-4#1)(2011-1#1)(2011-12#1)(2013-8#2)
over a period of 14##2##5##(2007-7#1)(2008-10#1)
over a period of 16 years##2##6##(1997-8#1)(2007-3#1)
over a period of 18 months##2##6##(2007-8#1)(2008-10#1)
over a period of 18##3##5##(2004-11#1)(2007-8#1)(2008-10#1)
over a period of 2 years##2##6##(2007-7#1)(2008-7#1)
over a period of 2##4##5##(1991-2#1)(2007-7#1)(2008-7#1)(2009-5#1)
over a period of 20 years##2##6##(1997-8#1)(2007-2#1)
over a period of 24 h##3##6##(1996-1#1)(1997-2#1)(2008-10#1)
over a period of 24##4##5##(1993-10#1)(1996-1#1)(1997-2#1)(2008-10#1)
over a period of 3 months##2##6##(2006-6#1)(2008-10#1)
over a period of 3 years##4##6##(1990-5#1)(2007-7#1)(2008-10#1)(2008-8#1)
over a period of 3##8##5##(1990-5#1)(1994-3#1)(2006-6#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-8#1)
over a period of 4 months##4##6##(2006-10#1)(2008-10#2)(2011-2#1)
over a period of 4 years##2##6##(2006-8#1)(2011-1#1)
over a period of 4##7##5##(1991-3#1)(2006-10#1)(2006-8#1)(2008-10#2)(2011-1#1)(2011-2#1)
over a period of 5 years##2##6##(1997-2#1)(2008-7#1)
over a period of 5##3##5##(1997-2#1)(2008-10#1)(2008-7#1)
over a period of 6 months##6##6##(1992-10#1)(1992-6#1)(1997-3#1)(2008-10#1)(2011-2#1)(2012-12#1)
over a period of 6 weeks##2##6##(2008-11#1)(2008-6#1)
over a period of 6##10##5##(1992-10#1)(1992-6#1)(1997-3#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#1)
over a period of 72##2##5##(1991-2#1)(1994-12#1)
over a period of about##3##5##(1991-2#1)(1997-7#1)(2013-7#1)
over a period of at least##2##6##(1996-5#1)(2008-10#1)
over a period of five years##3##6##(2008-1#1)(2009-2#1)(2012-2#1)
over a period of five##4##5##(1995-1#1)(2008-1#1)(2009-2#1)(2012-2#1)
over a period of four months##2##6##(2007-8#1)(2011-2#1)
over a period of four##3##5##(1991-6#1)(2007-8#1)(2011-2#1)
over a period of more than##4##6##(2006-2#1)(2007-3#1)(2007-8#1)(2008-10#1)
over a period of nine months##2##6##(2008-1#1)(2008-9#1)
over a period of nine##3##5##(2007-3#1)(2008-1#1)(2008-9#1)
over a period of one month##4##6##(1993-6#1)(2008-10#1)(2010-1#1)(2011-1#1)
over a period of one year##8##6##(1997-6#1)(2007-11#1)(2007-3#3)(2007-5#1)(2007-7#1)(2008-3#1)
over a period of one##13##5##(1993-6#1)(1997-6#1)(2004-9#1)(2007-11#1)(2007-3#3)(2007-5#1)(2007-7#1)(2008-10#1)(2008-3#1)(2010-1#1)(2011-1#1)
over a period of six years##2##6##(1991-2#1)(2011-2#1)
over a period of six##3##5##(1991-2#1)(2008-6#1)(2011-2#1)
over a period of three months##2##6##(2006-10#1)(2008-11#1)
over a period of three##4##5##(1996-6#1)(2006-10#1)(2008-11#1)(2008-8#1)
over a period of time can##2##6##(1996-1#1)(2008-11#1)
over a period of time##13##5##(1990-8#1)(1996-1#1)(1997-4#1)(2008-11#4)(2008-3#1)(2009-11#1)(2010-2#1)(2011-1#1)(2013-1#1)(2013-8#1)
over a period of two years##4##6##(1991-12#1)(2007-8#1)(2008-1#1)(2008-5#1)
over a period of two##7##5##(1991-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-8#1)
over a period of weeks##2##5##(1996-11#1)(2008-7#1)
over a period of##157##4##(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-12#1)(1991-2#4)(1991-3#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-6#1)(1992-8#2)(1993-10#1)(1993-6#1)(1994-12#2)(1994-3#2)(1994-8#1)(1995-1#2)(1995-3#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2004-9#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-3#6)(2007-4#1)(2007-5#1)(2007-7#7)(2007-8#5)(2008-1#4)(2008-10#15)(2008-11#7)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#2)(2009-5#1)(2010-1#1)(2010-2#1)(2010-6#2)(2011-1#4)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#3)
over a period##162##3##(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-12#1)(1991-2#4)(1991-3#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-2#1)(1992-6#1)(1992-8#2)(1993-10#1)(1993-6#1)(1994-12#2)(1994-3#2)(1994-8#1)(1995-1#2)(1995-3#2)(1996-1#2)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2004-9#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-3#7)(2007-4#1)(2007-5#1)(2007-7#7)(2007-8#5)(2008-1#4)(2008-10#15)(2008-11#7)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#2)(2009-5#1)(2010-1#1)(2010-2#1)(2010-5#1)(2010-6#2)(2011-1#4)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#3)
over a previous##2##3##(1990-8#1)(2008-2#1)
over a prolonged period##3##4##(1995-8#1)(2008-3#1)(2008-9#1)
over a range from##3##4##(1993-9#1)(2008-10#2)
over a range of 0##7##5##(1990-12#1)(1993-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2010-12#1)
over a range of 20##2##5##(1993-12#1)(2007-12#1)
over a range of 3##2##5##(1996-9#1)(1997-2#1)
over a range of concentrations##2##5##(1992-6#2)
over a range of inoculum densities##2##6##(2008-10#2)
over a range of pH##2##5##(2008-10#2)
over a range of temperatures between##2##6##(1992-2#1)(2005-11#1)
over a range of temperatures from##2##6##(2008-10#1)(2008-3#1)
over a range of temperatures##11##5##(1990-3#1)(1992-2#1)(1995-11#1)(2005-11#1)(2008-10#2)(2008-3#3)(2008-4#1)(2008-8#1)
over a range of wavelengths##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
over a range of##80##4##(1990-12#1)(1990-3#1)(1991-7#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-12#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-11#3)(1996-9#1)(1997-2#2)(1997-3#1)(2005-11#1)(2006-11#2)(2006-5#1)(2007-11#4)(2007-12#5)(2007-8#1)(2008-10#12)(2008-11#1)(2008-2#9)(2008-3#9)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#2)(2010-12#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
over a range##85##3##(1990-12#1)(1990-3#1)(1991-7#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-12#2)(1993-9#2)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#3)(1996-9#1)(1997-2#2)(1997-3#1)(2005-11#1)(2006-11#2)(2006-5#1)(2007-11#4)(2007-12#5)(2007-8#1)(2008-10#14)(2008-11#1)(2008-2#9)(2008-3#10)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#2)(2010-12#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
over a relatively wide range of##2##6##(2008-10#1)(2008-2#1)
over a relatively wide##3##4##(2008-10#2)(2008-2#1)
over a relatively##6##3##(1993-7#1)(2005-11#1)(2008-10#2)(2008-2#1)(2008-8#1)
over a restricted##2##3##(2008-2#1)(2008-5#1)
over a series of##2##4##(1993-6#1)(2008-9#1)
over a set of##3##4##(2008-2#1)(2008-3#1)(2012-2#1)
over a seven##2##3##(1996-2#1)(2008-12#1)
over a seven-month period##2##4##(2007-7#1)(2008-9#1)
over a seven-year period##2##4##(1992-5#1)(2011-3#1)
over a short period of time##4##6##(1993-3#1)(1995-3#1)(1996-3#1)(2008-11#1)
over a short period##7##4##(1990-6#1)(1993-3#1)(1995-3#1)(1996-3#1)(2008-1#1)(2008-11#1)(2013-8#1)
over a short##8##3##(1990-6#1)(1993-3#1)(1993-7#1)(1995-3#1)(1996-3#1)(2008-1#1)(2008-11#1)(2013-8#1)
over a similar##3##3##(1993-12#1)(2008-3#1)(2008-5#1)
over a six month period##2##5##(2007-11#1)(2008-12#1)
over a six##3##3##(2007-11#1)(2008-12#1)(2009-10#1)
over a six-month period##3##4##(1996-11#1)(2008-1#2)
over a small##3##3##(1993-6#1)(2010-6#1)(2011-12#1)
over a span of##2##4##(2008-3#1)(2012-3#1)
over a specified##3##3##(2007-1#1)(2008-10#1)(2008-3#1)
over a standard##3##3##(1997-3#1)(2006-7#1)(2007-7#1)
over a temperature range from##4##5##(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
over a temperature range##6##4##(1990-11#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
over a ten year period##2##5##(2006-8#1)(2012-2#1)
over a thousand##2##3##(2006-10#1)(2007-12#1)
over a three##2##3##(2012-1#2)
over a three-week##2##3##(2004-2#1)(2013-8#1)
over a three-year period##3##4##(1997-1#1)(2013-1#2)
over a time course of##3##5##(1997-3#1)(2008-11#1)(2008-9#1)
over a time course##4##4##(1997-3#1)(2008-11#1)(2008-9#1)(2011-2#1)
over a time period of##5##5##(1994-3#1)(2006-5#2)(2008-1#1)(2008-9#1)
over a time period##6##4##(1994-3#1)(2006-5#2)(2006-8#1)(2008-1#1)(2008-9#1)
over a time##11##3##(1994-3#1)(1997-3#1)(2006-5#2)(2006-8#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-9#2)(2011-2#1)
over a total of##2##4##(1994-7#1)(2008-10#1)
over a total##3##3##(1994-7#1)(1996-7#1)(2008-10#1)
over a two##2##3##(2007-1#1)(2010-9#1)
over a two-dimensional##2##3##(2008-3#1)(2008-6#1)
over a two-week period in##2##5##(2008-10#1)(2008-3#1)
over a two-week##3##3##(2006-10#1)(2008-10#1)(2008-3#1)
over a two-year period##5##4##(1993-8#1)(2006-8#1)(2007-3#1)(2010-2#1)(2013-1#1)
over a typical##2##3##(2008-2#1)(2011-2#1)
over a variety of##3##4##(2008-10#2)(2008-2#1)
over a vast##2##3##(2008-1#1)(2008-5#1)
over a very wide concentration##2##5##(2008-10#2)
over a very##4##3##(2007-12#1)(2008-10#2)(2008-3#1)
over a wavelength range from##2##5##(2008-2#2)
over a wavelength range of##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
over a wavelength range##5##4##(2007-11#1)(2008-2#3)(2008-3#1)
over a wavelength##6##3##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)
over a wide concentration range (1##8##6##(2008-10#8)
over a wide concentration range (5##3##6##(2008-10#3)
over a wide concentration range 5##2##6##(2008-10#2)
over a wide concentration range of##2##6##(2008-10#2)
over a wide concentration range##25##5##(1993-8#1)(2007-11#1)(2008-10#23)
over a wide dynamic range##3##5##(2007-11#1)(2008-10#1)(2010-11#1)
over a wide frequency range##5##5##(2007-11#1)(2007-12#1)(2007-5#1)(2008-2#1)(2008-3#1)
over a wide pH range of##3##6##(2008-10#2)(2010-2#1)
over a wide pH range##12##5##(1993-8#1)(2008-10#10)(2010-2#1)
over a wide range from##2##5##(1994-6#1)(2007-8#1)
over a wide range of amplifier##2##6##(2007-11#1)(2008-2#1)
over a wide range of concentrations##3##6##(2005-11#1)(2008-10#2)
over a wide range of conditions##3##6##(1990-8#1)(1993-4#1)(2008-10#1)
over a wide range of doses##2##6##(1992-5#1)(1996-9#1)
over a wide range of pH##3##6##(1994-3#1)(2005-11#1)(2008-10#1)
over a wide range of parameter values##2##7##(2008-3#1)(2008-9#1)
over a wide range of solution##2##6##(2005-11#1)(2008-10#1)
over a wide range of solvent composition (0-60 wt%##2##9##(2008-10#2)
over a wide range of temperatures##3##6##(1991-4#1)(2006-12#1)(2008-5#1)
over a wide range of wavelengths##2##6##(2007-11#1)(2008-10#1)
over a wide range of##60##5##(1990-7#2)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-5#1)(1993-2#1)(1993-4#1)(1994-3#1)(1994-8#1)(1996-4#1)(1996-7#1)(1996-9#1)(2005-11#4)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#3)(2008-3#6)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-9#1)(2011-1#1)(2012-2#2)
over a wide range##73##4##(1990-7#2)(1990-8#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-4#1)(1992-5#1)(1993-2#1)(1993-4#1)(1994-3#1)(1994-6#1)(1994-8#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#1)(2005-11#4)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#3)(2007-12#1)(2007-8#4)(2008-1#2)(2008-10#13)(2008-11#2)(2008-2#8)(2008-3#7)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-9#1)(2011-1#1)(2012-2#2)
over a wide spectral range##8##5##(2007-12#1)(2008-2#2)(2008-3#5)
over a wide spectral##9##4##(2007-12#1)(2008-2#2)(2008-3#6)
over a wide temperature range##2##5##(1993-8#1)(2008-2#1)
over a wide variety of metal ions##3##7##(2008-10#3)
over a wide variety of other anions##2##7##(2008-10#2)
over a wide variety of other cations including alkali##2##9##(2008-10#2)
over a wide variety of other metal ions and could be used in##2##13##(2008-10#2)
over a wide variety of other metal ions##5##8##(2008-10#5)
over a wide variety of other##9##6##(2008-10#9)
over a wide variety of##17##5##(2008-10#16)(2008-12#1)
over a wide wavelength range##2##5##(2007-12#1)(2008-2#1)
over a wide##165##3##(1990-7#2)(1990-8#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-4#1)(1992-2#1)(1992-5#1)(1993-2#1)(1993-4#3)(1993-8#3)(1994-3#1)(1994-6#1)(1994-8#1)(1995-8#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#1)(2005-11#4)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#6)(2007-12#8)(2007-5#1)(2007-8#4)(2008-1#2)(2008-10#66)(2008-11#2)(2008-12#1)(2008-2#15)(2008-3#15)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-4#1)(2011-1#2)(2012-2#2)(2013-7#1)
over a wider range of##3##5##(2007-11#1)(2008-10#1)(2008-2#1)
over a wider##6##3##(2006-4#1)(2007-11#1)(2008-10#2)(2008-2#2)
over a year##5##3##(1993-9#1)(2007-7#1)(2008-10#1)(2008-5#1)(2012-12#1)
over a##1111##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#3)(1990-5#6)(1990-6#3)(1990-7#3)(1990-8#5)(1991-10#3)(1991-11#1)(1991-12#3)(1991-2#6)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#8)(1992-1#2)(1992-10#1)(1992-12#2)(1992-2#4)(1992-3#2)(1992-5#3)(1992-6#3)(1992-8#4)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#6)(1993-2#2)(1993-3#2)(1993-4#4)(1993-5#1)(1993-6#3)(1993-7#2)(1993-8#4)(1993-9#5)(1994-1#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#7)(1994-5#3)(1994-6#1)(1994-7#1)(1994-8#4)(1995-1#5)(1995-10#1)(1995-11#4)(1995-12#1)(1995-2#1)(1995-3#7)(1995-5#2)(1995-6#1)(1995-8#2)(1996-1#3)(1996-11#3)(1996-12#2)(1996-2#4)(1996-3#3)(1996-4#2)(1996-5#6)(1996-6#4)(1996-7#3)(1996-9#2)(1997-1#3)(1997-2#4)(1997-3#5)(1997-4#4)(1997-6#3)(1997-7#3)(1997-8#5)(2004-1#1)(2004-10#2)(2004-11#5)(2004-2#2)(2004-9#2)(2005-10#1)(2005-11#11)(2005-7#3)(2005-8#1)(2005-9#3)(2006-1#2)(2006-10#9)(2006-11#3)(2006-12#6)(2006-2#6)(2006-4#1)(2006-5#6)(2006-6#2)(2006-7#3)(2006-8#12)(2006-9#2)(2007-1#6)(2007-10#3)(2007-11#36)(2007-12#60)(2007-2#4)(2007-3#12)(2007-4#1)(2007-5#2)(2007-7#15)(2007-8#16)(2007-9#1)(2008-1#19)(2008-10#178)(2008-11#22)(2008-12#5)(2008-2#75)(2008-3#93)(2008-4#4)(2008-5#18)(2008-6#6)(2008-7#21)(2008-8#16)(2008-9#16)(2009-10#3)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#2)(2009-7#1)(2009-8#4)(2009-9#4)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#7)(2010-2#10)(2010-3#1)(2010-4#7)(2010-5#3)(2010-6#6)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#10)(2011-12#2)(2011-2#21)(2011-3#1)(2012-1#9)(2012-12#11)(2012-2#20)(2012-3#6)(2012-5#1)(2013-1#13)(2013-7#3)(2013-8#11)
over about two orders of magnitude##2##6##(2008-10#2)
over about##9##2##(1991-2#1)(1993-11#1)(1996-6#1)(2005-7#1)(2008-10#3)(2010-4#1)(2012-1#1)
over abundance##3##2##(2006-12#1)(2008-12#1)(2012-2#1)
over after##2##2##(2008-10#1)(2008-9#1)
over age 50##3##3##(1994-3#2)(2008-4#1)
over age 60##2##3##(1990-4#1)(2008-5#1)
over age 65##2##3##(1995-10#1)(1995-2#1)
over age##14##2##(1990-4#1)(1991-3#1)(1994-3#3)(1995-10#1)(1995-2#1)(1996-7#1)(1997-3#1)(2007-9#1)(2008-2#1)(2008-4#1)(2008-5#2)
over alkali##7##2##(2008-10#7)
over all four##3##3##(2010-5#2)(2011-2#1)
over all loci##2##3##(2008-10#1)(2013-8#1)
over all of##2##3##(1992-8#1)(2010-2#1)
over all other##2##3##(1995-12#1)(2008-5#1)
over all possible##2##3##(1994-5#1)(2008-2#1)
over all temperatures##2##3##(2008-10#2)
over all ten##2##3##(1992-12#1)(2008-10#1)
over all the##8##3##(1990-3#1)(1990-5#1)(1994-3#1)(2008-10#2)(2008-2#1)(2008-3#2)
over all##53##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-4#1)(1992-12#2)(1992-8#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1996-11#1)(1997-6#1)(2005-11#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-2#2)(2010-3#1)(2010-5#2)(2011-2#2)(2012-3#1)(2012-6#1)(2013-8#1)
over almost##3##2##(2007-11#1)(2008-10#2)
over an 18##2##3##(2008-4#1)(2010-12#1)
over an 18-month period##2##4##(2007-8#1)(2008-9#1)
over an 8-year period##4##4##(2007-6#1)(2008-10#1)(2008-3#1)(2012-2#1)
over an angular range of##2##5##(2008-2#2)
over an angular##3##3##(2007-12#1)(2008-2#2)
over an approximately##2##3##(1995-11#1)(2007-12#1)
over an area of##5##4##(1990-7#1)(1996-3#1)(2011-2#1)(2013-7#2)
over an area##6##3##(1990-7#1)(1996-3#1)(2008-3#1)(2011-2#1)(2013-7#2)
over an average##3##3##(1990-6#1)(2009-9#1)(2010-2#1)
over an eight week period##2##5##(1996-12#1)(2007-5#1)
over an eight##3##3##(1996-12#1)(2007-5#1)(2008-2#1)
over an entire##4##3##(2006-10#1)(2006-4#1)(2008-10#1)(2012-7#1)
over an extended period##3##4##(2007-9#1)(2009-11#1)(2011-2#1)
over an extended##4##3##(2007-9#1)(2008-11#1)(2009-11#1)(2011-2#1)
over an extensive##2##3##(2007-1#1)(2012-2#1)
over an observation##2##3##(1992-11#1)(2007-12#1)
over an order of magnitude##2##5##(1992-6#1)(2005-11#1)
over an##71##2##(1990-12#1)(1990-6#1)(1990-7#1)(1990-8#1)(1992-11#1)(1992-6#1)(1992-9#1)(1994-3#1)(1995-11#1)(1996-12#1)(1996-3#1)(1997-2#1)(2004-11#1)(2005-11#2)(2006-10#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-6#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#4)(2008-4#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-2#2)(2011-2#2)(2012-2#3)(2012-7#1)(2013-7#2)
over and above all##2##4##(1991-11#1)(2008-5#1)
over and above that##5##4##(1995-3#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)
over and above the##3##4##(2008-7#1)(2011-1#1)(2012-2#1)
over and above##17##3##(1991-11#1)(1994-2#1)(1995-3#1)(2005-8#1)(2006-3#1)(2008-1#1)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-2#1)
over and##28##2##(1991-11#1)(1991-12#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-3#1)(1996-5#1)(2005-10#1)(2005-8#1)(2006-3#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#2)
over another##9##2##(1995-4#1)(1996-12#1)(2007-12#1)(2007-4#1)(2007-8#2)(2012-12#1)(2013-7#1)(2013-8#1)
over appropriate##2##2##(1991-5#1)(2008-3#1)
over approximately##5##2##(1992-9#1)(1993-6#1)(2008-2#1)(2008-3#1)(2009-10#1)
over areas##2##2##(2008-10#1)(2008-7#1)
over as##3##2##(1996-9#1)(2007-8#1)(2008-5#1)
over aspirin##2##2##(2007-10#1)(2008-10#1)
over at least two##3##4##(1994-4#1)(1997-4#1)(2008-10#1)
over at least##12##3##(1991-1#1)(1992-7#1)(1994-4#1)(1996-5#1)(1997-4#1)(2006-6#1)(2008-10#2)(2008-5#1)(2010-4#1)(2011-1#1)(2012-4#1)
over at##13##2##(1991-1#1)(1992-7#1)(1992-9#1)(1994-4#1)(1996-5#1)(1997-4#1)(2006-6#1)(2008-10#2)(2008-5#1)(2010-4#1)(2011-1#1)(2012-4#1)
over basal##5##2##(1992-4#1)(1993-8#1)(1996-6#1)(1996-9#1)(2008-10#1)
over baseline values##2##3##(1991-3#1)(1992-1#1)
over baseline##5##2##(1991-3#1)(1992-1#1)(1993-2#1)(2007-7#1)(2011-2#1)
over baseline)##2##2##(1997-5#2)
over batch##2##2##(2008-11#1)(2008-6#1)
over both the short and##2##5##(2007-9#1)(2008-8#1)
over both the##3##3##(2007-9#1)(2008-3#1)(2008-8#1)
over both time##2##3##(1992-6#1)(2008-1#1)
over both years##2##3##(2008-10#2)
over both##11##2##(1992-6#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-8#1)
over broad##2##2##(2007-11#1)(2011-2#1)
over by the##2##3##(2009-5#1)(2010-8#1)
over by##6##2##(1991-5#1)(2005-7#1)(2005-8#1)(2009-5#1)(2010-8#1)(2011-2#1)
over case 2 waters##2##4##(2008-2#2)
over case##3##2##(2008-2#2)(2012-3#1)
over cell##2##2##(1992-9#1)(2009-6#1)
over central##2##2##(1990-3#1)(2008-2#1)
over chemotherapy##2##2##(1995-9#1)(2005-10#1)
over chest##3##2##(2006-4#1)(2007-7#1)(2012-2#1)
over classical##4##2##(2008-10#1)(2008-3#1)(2008-5#1)(2012-3#1)
over clinical##2##2##(1993-9#1)(2008-3#1)
over computed tomography##2##3##(2004-1#1)(2008-7#1)
over control##8##2##(1990-12#2)(1992-4#1)(1994-5#2)(1995-8#1)(1997-6#1)(2008-12#1)
over conventional spectrophotometry for##2##4##(2008-10#2)
over conventional##32##2##(1994-12#1)(1994-9#1)(1996-2#1)(2004-2#1)(2005-7#2)(2005-8#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#2)(2010-12#1)(2011-2#1)
over cryopreservation##2##2##(2006-5#2)
over current##10##2##(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-5#1)(2010-6#1)
over currently##2##2##(2010-1#1)(2013-1#1)
over data##2##2##(2008-9#1)(2010-1#1)
over death##2##2##(2008-4#2)
over decades##4##2##(2005-9#1)(2007-11#1)(2007-12#1)(2008-10#1)
over dense##2##2##(2008-2#1)(2008-3#1)
over different time##2##3##(2011-2#1)(2012-1#1)
over different types of##2##4##(1993-3#1)(2008-3#1)
over different##12##2##(1993-11#1)(1993-3#1)(1995-2#1)(2005-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
over distances##2##2##(2008-2#1)(2008-8#1)
over dry thin porous substrates##2##5##(2005-11#2)
over dry##3##2##(2005-11#3)
over dual##3##2##(2007-8#2)(2012-2#1)
over each##2##2##(2008-11#1)(2009-11#1)
over eight##4##2##(2006-6#1)(2007-7#1)(2007-8#1)(2010-7#1)
over eighteen months##3##3##(1997-8#2)(2007-10#1)
over eighteen##4##2##(1997-8#2)(2007-10#1)(2007-11#1)
over endoscopic##2##2##(2006-10#1)(2010-2#1)
over entire##3##2##(1996-3#1)(2008-10#2)
over euthanasia##2##2##(1996-6#1)(2005-2#1)
over evolutionary time##4##3##(1996-3#1)(2008-8#2)(2010-3#1)
over evolutionary##5##2##(1996-3#1)(2008-8#3)(2010-3#1)
over existing methods##2##3##(2008-10#1)(2010-5#1)
over existing techniques##2##3##(2007-8#1)(2008-2#1)
over existing##17##2##(1991-9#1)(1996-12#1)(2005-7#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
over expressed##2##2##(2005-7#1)(2008-11#1)
over expression of##4##3##(1996-2#1)(2007-12#1)(2011-2#1)(2011-3#1)
over expression##7##2##(1996-2#1)(2007-12#1)(2010-12#1)(2010-7#1)(2011-2#1)(2011-3#1)(2013-1#1)
over extended periods of time##3##5##(1996-12#1)(2008-10#2)
over extended time periods##3##4##(1997-1#1)(2008-10#1)(2008-6#1)
over extended time##4##3##(1997-1#2)(2008-10#1)(2008-6#1)
over extended##8##2##(1996-12#1)(1997-1#2)(2008-10#3)(2008-3#1)(2008-6#1)
over extremities and##2##3##(2007-7#1)(2012-2#1)
over fetal##2##2##(1990-8#1)(2007-11#1)
over film##2##2##(1995-8#1)(2008-12#1)
over first##2##2##(1995-2#1)(2010-6#1)
over five years##2##3##(1997-8#1)(2010-12#1)
over five##7##2##(1991-10#1)(1997-8#1)(2007-7#1)(2009-8#1)(2010-12#2)(2012-3#1)
over fives##2##2##(2005-11#1)(2008-2#1)
over food##2##2##(2008-1#1)(2009-10#1)
over four decades##3##3##(2008-10#1)(2013-1#2)
over four seasons in##2##4##(2005-7#1)(2008-10#1)
over four years##2##3##(2007-2#1)(2007-7#1)
over four##12##2##(1990-2#1)(1992-9#1)(1994-7#1)(2005-7#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-5#1)(2013-1#2)
over from##3##2##(1991-3#1)(2007-9#1)(2009-10#1)
over frontal##2##2##(2008-5#1)(2010-5#1)
over fungal##2##2##(2008-10#1)(2008-8#1)
over generations##2##2##(2009-3#1)(2011-2#1)
over genetic##2##2##(1997-8#1)(2008-8#1)
over half a century##3##4##(2012-3#1)(2013-1#1)(2013-8#1)
over half a##4##3##(2007-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
over half of the##3##4##(1992-8#1)(2006-9#1)(2007-7#1)
over half of which were caused by##2##7##(1996-3#2)
over half of which were##3##5##(1996-3#2)(2006-8#1)
over half of##11##3##(1992-2#1)(1992-8#1)(1994-2#1)(1996-3#2)(2006-8#1)(2006-9#1)(2007-7#1)(2010-3#1)(2011-2#1)(2012-2#1)
over half##18##2##(1992-2#1)(1992-8#1)(1994-2#1)(1996-3#2)(2006-2#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
over health care reform##4##4##(1993-12#1)(1994-3#1)(1994-8#1)(1995-1#1)
over health care##6##3##(1993-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1996-12#1)(1997-3#1)
over health##9##2##(1993-12#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-1#1)(1996-12#1)(1997-3#1)(2009-12#1)(2012-12#1)
over hepatitis##2##2##(1995-11#1)(2006-10#1)
over her##3##2##(1993-11#1)(2006-10#2)
over his##3##2##(1993-11#1)(2005-8#1)(2010-5#1)
over how to##2##3##(1995-3#1)(2009-9#1)
over how##3##2##(1995-3#1)(2008-4#1)(2009-9#1)
over human##2##2##(1994-3#1)(1995-8#1)
over hundreds of##2##3##(2007-1#1)(2008-10#1)
over in the##3##3##(1997-4#1)(2006-4#1)(2011-1#1)
over in##8##2##(1995-6#1)(1995-9#1)(1997-4#2)(2006-4#1)(2008-8#1)(2011-1#2)
over individual##2##2##(2008-3#1)(2012-3#1)
over interfering cations##2##3##(2008-10#2)
over into##4##2##(1995-11#1)(2006-6#1)(2008-12#1)(2009-7#1)
over its entire##2##3##(2008-2#1)(2008-3#1)
over its##11##2##(1993-4#1)(2004-12#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-5#1)(2010-8#1)(2013-1#1)
over land and##2##3##(2008-2#1)(2008-3#1)
over land##6##2##(1990-6#1)(2008-2#2)(2008-3#3)
over large areas and##2##4##(1993-4#1)(2008-7#1)
over large areas with##2##4##(2008-7#1)(2010-4#1)
over large areas##5##3##(1993-4#1)(2008-10#1)(2008-7#2)(2010-4#1)
over large distances##2##3##(2007-12#1)(2008-11#1)
over large##13##2##(1992-2#1)(1993-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-7#2)(2010-4#1)
over larger areas##2##3##(2008-3#1)(2012-11#1)
over last##2##2##(2007-12#1)(2009-10#1)
over left hemisphere##2##3##(1993-2#2)
over left##7##2##(1993-2#2)(1995-2#1)(2008-10#4)
over linear##2##2##(1993-9#1)(2008-3#1)
over local##3##2##(2007-12#1)(2008-8#2)
over long distances in##3##4##(2007-12#1)(2008-10#1)(2008-11#1)
over long distances##14##3##(1990-3#1)(1991-4#1)(2006-4#1)(2007-12#2)(2007-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)
over long horizontal paths##2##4##(2008-2#1)(2008-3#1)
over long period##2##3##(1990-6#1)(2005-3#1)
over long periods of time##8##5##(1993-9#1)(1995-1#1)(2006-7#1)(2008-10#2)(2008-11#2)(2011-1#1)
over long periods of##9##4##(1993-9#1)(1995-1#1)(2006-7#1)(2008-10#3)(2008-11#2)(2011-1#1)
over long periods##13##3##(1993-9#1)(1995-1#1)(1996-11#1)(1997-4#1)(2006-7#1)(2008-10#3)(2008-11#4)(2011-1#1)
over long##34##2##(1990-3#1)(1990-6#1)(1991-4#1)(1993-9#1)(1995-1#1)(1996-11#1)(1997-4#1)(2005-3#1)(2006-4#1)(2006-7#1)(2007-12#3)(2007-5#1)(2008-10#5)(2008-11#5)(2008-2#2)(2008-3#3)(2008-8#1)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#1)
over longer##5##2##(1995-3#1)(2006-5#1)(2007-10#1)(2007-11#1)(2008-7#1)
over many decades##2##3##(2008-1#1)(2008-5#1)
over many months##2##3##(2008-9#1)(2010-4#1)
over many years is##2##4##(2005-7#1)(2008-10#1)
over many years##15##3##(1991-4#1)(1994-12#1)(1994-3#1)(1995-11#1)(1997-1#1)(1997-4#1)(2005-6#1)(2005-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-9#1)
over many##30##2##(1991-4#1)(1994-12#1)(1994-3#1)(1995-11#1)(1997-1#1)(1997-4#1)(2005-6#1)(2005-7#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-9#1)(2013-8#1)
over methods that##2##3##(2004-9#1)(2009-7#1)
over millions of years##2##4##(1996-8#1)(2008-7#1)
over monosialylated compounds##2##3##(1995-3#2)
over months##2##2##(1995-9#1)(2012-2#1)
over more conventional##3##3##(1996-7#1)(2008-1#1)(2012-12#1)
over more than 10##2##4##(2007-11#1)(2007-12#1)
over more than one##2##4##(2008-11#1)(2011-2#1)
over more than##9##3##(1996-7#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#1)
over more##14##2##(1996-11#1)(1996-7#2)(2006-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
over most of the##4##4##(1992-1#1)(1992-9#1)(2008-8#1)(2009-4#1)
over most##5##2##(1992-1#1)(1992-9#1)(2008-10#1)(2008-8#1)(2009-4#1)
over mountainous terrain##3##3##(2008-2#3)
over mountainous##4##2##(2008-2#3)(2008-3#1)
over much of the##2##4##(1996-10#1)(2008-2#1)
over much of##3##3##(1996-10#1)(2008-2#1)(2010-1#1)
over much##6##2##(1996-10#1)(2007-12#1)(2008-2#1)(2008-7#1)(2009-8#1)(2010-1#1)
over multiple##13##2##(1992-6#1)(2005-11#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-3#1)
over narrow##3##2##(2008-10#1)(2008-2#1)(2008-9#1)
over nearly##3##2##(2007-11#1)(2007-12#1)(2011-1#1)
over night and##2##3##(2006-10#1)(2007-8#1)
over nine##4##2##(1991-2#1)(2007-11#1)(2008-10#1)(2008-5#1)
over noisy channels##4##3##(2008-2#3)(2010-8#1)
over non-specific##2##2##(1990-2#1)(1994-12#1)
over normal##4##2##(1990-3#1)(1991-9#1)(1992-2#1)(2012-2#1)
over one hundred##3##3##(2007-10#1)(2009-10#1)(2011-1#1)
over one month##2##3##(2010-8#1)(2011-2#1)
over one period##2##3##(2008-1#1)(2011-2#1)
over one year##6##3##(1991-11#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-8#1)
over one##27##2##(1991-11#1)(1992-4#1)(1993-5#1)(1994-9#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)
over one's##2##2##(1993-9#1)(2013-1#1)
over one-half of##2##3##(1990-12#1)(1992-1#1)
over only a##3##3##(1994-4#1)(1995-6#1)(2007-12#1)
over open##3##2##(2006-3#1)(2006-6#1)(2011-2#1)
over optical paths of##2##4##(2008-3#2)
over or##3##2##(2007-6#1)(2008-10#1)(2012-12#1)
over oral##4##2##(1996-2#1)(2005-7#1)(2006-9#1)(2007-11#1)
over other alkali metal cations##2##5##(2008-10#2)
over other alkali metal##3##4##(2008-10#3)
over other alkali##4##3##(2008-10#4)
over other forms of##2##4##(2007-12#1)(2009-1#1)
over other mono-##2##3##(2008-10#2)
over other techniques and##2##4##(2007-11#1)(2008-10#1)
over other techniques##4##3##(2007-11#1)(2008-1#1)(2008-10#1)(2010-4#1)
over other##58##2##(1990-7#1)(1992-2#1)(1994-1#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-2#1)(2004-12#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#14)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-4#1)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
over others in##2##3##(2011-2#2)
over others##7##2##(2004-2#1)(2007-5#1)(2007-8#1)(2008-5#1)(2008-8#1)(2011-2#2)
over pH range##2##3##(1997-2#1)(2008-10#1)
over pH##3##2##(1997-2#1)(1997-6#1)(2008-10#1)
over part of the##2##4##(2007-8#1)(2008-2#1)
over periods of##2##3##(1991-8#1)(2009-9#1)
over periods##3##2##(1991-8#1)(2005-7#1)(2009-9#1)
over placebo in##2##3##(2006-10#1)(2007-8#1)
over placebo##9##2##(1994-2#1)(2006-10#2)(2007-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2012-2#1)
over planar##2##2##(2008-7#1)(2010-12#1)
over potassium ion##2##3##(2008-10#2)
over previous##10##2##(1990-8#1)(1991-9#1)(1997-7#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-4#1)(2010-3#1)
over previously described methods##2##4##(1994-8#1)(2007-11#1)
over previously reported##4##3##(2006-2#1)(2007-11#1)(2008-10#1)(2008-2#1)
over previously##8##2##(1994-8#1)(2006-2#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)
over production##2##2##(2008-10#1)(2008-8#1)
over prolonged##3##2##(2007-11#1)(2008-10#1)(2012-2#1)
over ranges of##2##3##(2007-11#1)(2008-3#1)
over recent centuries##2##3##(2006-7#1)(2009-5#1)
over recent years##8##3##(2005-5#1)(2005-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2011-1#1)(2013-8#1)
over recent##10##2##(2005-5#1)(2005-9#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-5#1)(2011-1#1)(2013-8#1)
over relatively short distances##2##4##(2007-8#1)(2013-8#1)
over relatively##6##2##(1995-10#1)(1996-2#1)(2007-12#1)(2007-2#1)(2007-8#1)(2013-8#1)
over repeated##3##2##(2007-12#1)(2007-7#1)(2010-7#1)
over reproductive##6##2##(2008-11#1)(2008-8#5)
over right##2##2##(2008-11#2)
over sea##3##2##(2006-10#1)(2008-2#1)(2008-3#1)
over seven##6##2##(1997-4#1)(2006-5#1)(2008-12#1)(2009-5#1)(2012-12#1)(2012-3#1)
over several days##3##3##(1995-1#1)(2008-10#1)(2008-2#1)
over several generations##5##3##(1995-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-2#1)
over several hours##5##3##(1995-12#1)(1995-2#1)(1997-1#1)(2007-11#2)
over several months##2##3##(1990-2#1)(2010-2#1)
over several seconds##2##3##(2007-11#1)(2009-5#1)
over several weeks##5##3##(2008-10#2)(2008-11#1)(2009-8#1)(2012-1#1)
over several years and##2##4##(2008-10#2)
over several years to##2##4##(2008-2#1)(2013-1#1)
over several years##7##3##(2004-10#1)(2006-8#1)(2008-10#2)(2008-2#1)(2008-6#1)(2013-1#1)
over several##44##2##(1990-2#1)(1990-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-8#1)(1997-1#1)(2004-10#1)(2006-8#1)(2007-11#4)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-2#4)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-5#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
over sex allocation##2##3##(2008-8#2)
over sex##5##2##(1991-10#1)(2008-8#4)
over sexual##2##2##(2008-7#1)(2012-3#1)
over short distances##4##3##(2008-10#3)(2008-3#1)
over short time scales##2##4##(2007-12#1)(2013-8#1)
over short time##3##3##(2007-12#1)(2012-2#1)(2013-8#1)
over short##9##2##(2007-11#1)(2007-12#2)(2008-10#3)(2008-3#1)(2012-2#1)(2013-8#1)
over shorter##3##2##(1991-8#1)(1994-6#1)(2009-9#1)
over similar##3##2##(2007-9#1)(2008-2#1)(2008-3#1)
over single##2##2##(1993-11#1)(2009-8#1)
over six months##3##3##(2008-1#1)(2010-4#1)(2013-1#1)
over six years##2##3##(2007-8#1)(2008-5#1)
over six##12##2##(1996-2#1)(2007-8#2)(2008-1#1)(2008-3#1)(2008-5#1)(2009-4#2)(2009-5#1)(2010-4#1)(2012-3#1)(2013-1#1)
over small areas##2##3##(1995-12#2)
over small##8##2##(1995-12#2)(2007-11#3)(2007-12#1)(2008-3#1)(2010-8#1)
over snow##2##2##(2013-8#2)
over some##2##2##(2008-10#1)(2008-9#1)
over space and time##4##4##(2007-6#1)(2008-10#2)(2010-8#1)
over spatial##2##2##(2008-3#1)(2009-7#1)
over standard fiber by use of dispersion##2##7##(2007-12#2)
over standard fiber##3##3##(2007-12#3)
over standard##10##2##(1991-2#1)(2006-10#1)(2007-12#5)(2007-6#1)(2008-3#1)(2012-1#1)
over subsequent##2##2##(2010-2#1)(2012-2#1)
over successive spawnings##4##3##(2010-8#4)
over successive years##3##3##(2008-10#2)(2011-2#1)
over successive##8##2##(2008-10#3)(2010-8#4)(2011-2#1)
over synthetic##3##2##(2007-7#2)(2008-10#1)
over systematic##2##2##(2008-10#2)
over tainted##2##2##(1992-7#1)(1997-5#1)
over tamoxifen##3##2##(2008-5#3)
over ten years##3##3##(2007-11#1)(2008-1#1)(2009-8#1)
over ten##7##2##(2007-11#1)(2007-6#1)(2008-1#1)(2008-3#1)(2008-5#1)(2009-8#1)(2013-1#1)
over than##2##2##(1993-2#1)(2008-7#1)
over that obtained from the##2##5##(1990-3#1)(2008-11#1)
over that of control##4##4##(2008-11#4)
over that of the##6##4##(1996-4#1)(2005-11#1)(2007-11#1)(2008-2#2)(2008-3#1)
over that of##24##3##(1991-1#1)(1991-10#1)(1992-3#1)(1993-8#1)(1995-1#1)(1996-4#1)(1997-3#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2010-2#1)
over that##37##2##(1990-3#1)(1991-1#1)(1991-10#1)(1991-8#1)(1992-3#1)(1993-8#1)(1995-1#1)(1995-6#1)(1996-4#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-9#1)(2007-11#2)(2007-12#2)(2008-10#4)(2008-11#5)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#1)(2010-11#1)(2010-2#1)
over the 0##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
over the 1##2##3##(2008-10#2)
over the 10##3##3##(1997-8#1)(2008-3#1)(2010-11#1)
over the 10-year period##2##4##(1993-2#1)(1997-2#1)
over the 10-year##3##3##(1993-2#1)(1997-2#1)(2007-12#1)
over the 15##2##3##(1994-6#1)(2007-7#1)
over the 2##4##3##(1994-3#1)(1996-2#1)(2008-10#2)
over the 21-year##2##3##(2007-12#2)
over the 24-h##2##3##(2008-10#1)(2008-9#1)
over the 3##5##3##(1994-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
over the 3-year period##2##4##(2005-12#1)(2008-6#1)
over the 30-day experimental period##2##5##(2008-5#2)
over the 4 years##2##4##(2008-10#1)(2010-4#1)
over the 4##3##3##(1995-6#1)(2008-10#1)(2010-4#1)
over the 5 years##2##4##(2008-10#1)(2011-2#1)
over the 5##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
over the 6##3##3##(2004-10#1)(2008-10#1)(2009-4#1)
over the 6-year period##2##4##(2008-10#1)(2012-2#1)
over the Internet##7##3##(2006-4#1)(2006-6#1)(2007-8#1)(2008-4#2)(2008-7#2)
over the United States##2##4##(2008-3#1)(2010-4#1)
over the age of 50 years##2##6##(1994-12#1)(2007-2#1)
over the age of 50##4##5##(1994-12#2)(2007-2#1)(2013-1#1)
over the age of 60##2##5##(1990-4#1)(2011-2#1)
over the age of 65##3##5##(2007-8#1)(2008-3#1)(2009-4#1)
over the age of##22##4##(1990-4#1)(1990-8#2)(1992-6#1)(1994-12#2)(1996-2#1)(1996-3#1)(2004-2#1)(2006-2#2)(2007-2#1)(2007-8#1)(2008-3#1)(2008-6#1)(2009-4#1)(2011-2#4)(2012-12#1)(2013-1#1)
over the analyzed period##2##4##(2013-8#2)
over the anterior wall of the maxillary sinus##2##8##(2012-12#2)
over the anterior##3##3##(2012-12#2)(2012-2#1)
over the assessment period##2##4##(2012-12#2)
over the average##2##3##(1996-11#1)(2008-3#1)
over the basal level##2##4##(1993-8#1)(1995-5#1)
over the basal##4##3##(1992-3#1)(1993-8#1)(1995-1#1)(1995-5#1)
over the body##8##3##(1992-3#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-10#1)
over the central##2##3##(1992-5#1)(2008-5#1)
over the cerebral##2##3##(1996-5#1)(2012-2#1)
over the chest##2##3##(2007-7#1)(2008-11#1)
over the choice##2##3##(1996-11#1)(2013-1#1)
over the coming years##2##4##(1993-12#1)(2006-10#1)
over the composition##2##3##(2007-12#1)(2008-7#1)
over the concentration range 0##15##5##(1990-9#1)(1993-2#1)(2008-10#13)
over the concentration range 1##4##5##(2008-10#4)
over the concentration range 10(-1)-10(-5) mol l(-1)##2##7##(2008-10#2)
over the concentration range 10(-6)-10(-2)##2##5##(2008-10#2)
over the concentration range 6##2##5##(2008-10#2)
over the concentration range from 0##2##6##(2008-10#1)(2012-12#1)
over the concentration range from##5##5##(2008-10#4)(2012-12#1)
over the concentration range of 0##10##6##(1990-12#1)(2008-10#6)(2011-3#1)(2012-12#2)
over the concentration range of 1##4##6##(2008-10#3)(2008-5#1)
over the concentration range of 5##2##6##(2008-10#2)
over the concentration range of##28##5##(1990-12#1)(1996-8#1)(2006-12#1)(2008-10#19)(2008-5#1)(2010-12#1)(2010-2#1)(2011-3#1)(2012-12#2)
over the concentration range##75##4##(1990-12#2)(1990-9#1)(1993-2#1)(1996-8#1)(2006-12#1)(2008-10#62)(2008-5#1)(2010-12#1)(2010-2#1)(2011-3#1)(2012-12#3)
over the concentration ranges of##3##5##(2007-8#1)(2008-10#2)
over the concentration ranges##6##4##(1992-7#1)(2007-8#1)(2008-10#4)
over the concentration##82##3##(1990-12#2)(1990-9#1)(1992-7#1)(1993-2#1)(1996-8#1)(2006-12#1)(2007-8#1)(2008-10#66)(2008-5#1)(2009-12#1)(2010-12#1)(2010-2#1)(2011-3#1)(2012-12#3)
over the contralateral##2##3##(1993-2#1)(1996-5#1)
over the control##3##3##(1992-7#1)(1997-7#1)(2008-11#1)
over the conventional##11##3##(1991-6#1)(1994-1#1)(1997-8#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-6#1)(2009-9#1)(2010-8#1)
over the corresponding##4##3##(1990-11#1)(2010-6#2)(2012-3#1)
over the counter medicines##2##4##(1996-3#1)(2008-7#1)
over the counter##10##3##(1995-5#1)(1996-3#2)(1996-5#1)(2006-12#1)(2006-8#1)(2008-2#1)(2008-7#2)(2010-5#1)
over the course of a##6##5##(2007-12#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-8#1)(2012-2#1)
over the course of the experiment##2##6##(2008-10#2)
over the course of the##12##5##(1992-3#1)(1993-3#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-8#1)(2010-3#1)(2010-8#1)(2012-1#1)
over the course of treatment##4##5##(1996-2#1)(1996-7#1)(2008-12#1)(2012-2#1)
over the course of##41##4##(1992-3#1)(1993-3#1)(1993-6#1)(1994-12#1)(1996-2#1)(1996-7#1)(2007-11#2)(2007-12#3)(2008-10#6)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-8#2)(2009-12#4)(2010-10#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#1)(2013-8#1)
over the current##2##3##(1992-8#1)(2008-10#1)
over the cyclic##2##3##(1992-6#1)(2006-9#1)
over the dam##2##3##(2005-10#2)
over the decades##3##3##(2008-7#2)(2012-2#1)
over the dose range##3##4##(1993-6#1)(1994-8#1)(2005-7#1)
over the duration of the##5##5##(1993-5#1)(2004-2#1)(2005-11#1)(2006-10#1)(2008-7#1)
over the ensuing##4##3##(1993-3#1)(2006-3#1)(2006-7#1)(2007-1#1)
over the entire bandwidth##2##4##(2007-12#2)
over the entire concentration range##3##5##(1997-3#2)(2008-10#1)
over the entire dosage range##2##5##(1991-9#2)
over the entire length##2##4##(1996-6#1)(2007-8#1)
over the entire range of##2##5##(2008-10#1)(2008-6#1)
over the entire range##4##4##(1992-8#1)(2007-12#1)(2008-10#1)(2008-6#1)
over the entire spectrum##2##4##(2007-11#1)(2008-2#1)
over the entire temperature range##4##5##(1991-5#1)(1995-2#2)(2005-11#1)
over the entire time##2##4##(1990-8#1)(1997-4#1)
over the entire tuning range##2##5##(2007-12#1)(2008-2#1)
over the entire visible##2##4##(2007-11#1)(2008-7#1)
over the entire##59##3##(1990-8#1)(1991-5#1)(1991-9#2)(1992-3#2)(1992-7#1)(1992-8#1)(1994-3#1)(1995-1#1)(1995-2#2)(1996-1#1)(1996-6#1)(1997-2#1)(1997-3#3)(1997-4#1)(2005-11#1)(2007-11#2)(2007-12#6)(2007-7#2)(2007-8#1)(2007-9#2)(2008-10#6)(2008-12#1)(2008-2#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#2)
over the existing##3##3##(2006-12#1)(2008-11#1)(2008-2#1)
over the exposed##2##3##(1991-8#1)(2007-7#1)
over the face##5##3##(2007-7#5)
over the first 12 months of##2##6##(2005-8#1)(2012-12#1)
over the first 12 months##3##5##(2005-8#1)(2008-3#1)(2012-12#1)
over the first 2##2##4##(1991-3#1)(2008-10#1)
over the first 24##3##4##(1994-11#1)(1996-3#1)(2008-6#1)
over the first 3##2##4##(2006-3#1)(2008-5#1)
over the first 4 weeks##2##5##(2006-9#1)(2008-10#1)
over the first 5##2##4##(1992-1#1)(1994-4#1)
over the first 6 weeks##3##5##(2007-11#1)(2008-11#1)(2010-2#1)
over the first 6##4##4##(2005-8#1)(2007-11#1)(2008-11#1)(2010-2#1)
over the first few##2##4##(1996-9#1)(2007-10#1)
over the first five years of##2##6##(1993-1#1)(2011-2#1)
over the first year of##2##5##(1997-2#1)(2013-1#1)
over the first year##6##4##(1995-8#1)(1997-2#1)(2005-8#1)(2007-9#1)(2013-1#2)
over the first##39##3##(1991-2#1)(1991-3#1)(1992-1#1)(1993-1#1)(1994-11#1)(1994-12#1)(1994-4#1)(1995-8#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(2004-11#2)(2005-8#3)(2006-3#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
over the five##3##3##(2008-10#1)(2008-5#1)(2012-12#1)
over the following##6##3##(1990-5#1)(1991-2#1)(1991-5#1)(2005-11#1)(2006-3#1)(2007-7#1)
over the four##3##3##(1991-5#1)(1994-12#1)(1996-9#1)
over the frequency range##4##4##(2007-11#2)(2008-10#1)(2008-3#1)
over the frequency##5##3##(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)
over the full range of##2##5##(1997-1#1)(2009-3#1)
over the full##6##3##(1993-9#1)(1997-1#1)(2006-5#2)(2007-11#1)(2009-3#1)
over the future##2##3##(1994-3#1)(2008-7#1)
over the general##2##3##(2007-12#1)(2010-11#1)
over the glans penis##2##4##(2007-7#2)
over the growing season##4##4##(2008-10#4)
over the human##3##3##(2007-5#1)(2011-1#1)(2012-1#1)
over the interference##2##3##(1995-1#1)(2008-10#1)
over the investigated##2##3##(1995-3#1)(2008-2#1)
over the landscape##3##3##(2008-10#1)(2008-9#2)
over the last 10 years##6##5##(1996-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2012-12#1)
over the last 10##7##4##(1996-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-9#1)(2012-12#1)
over the last 12 years##2##5##(1993-3#1)(2006-8#1)
over the last 15 years##2##5##(1992-10#1)(1994-6#1)
over the last 2 decades are##2##6##(2008-6#1)(2012-2#1)
over the last 2 decades##4##5##(2008-2#1)(2008-6#1)(2008-9#1)(2012-2#1)
over the last 20 years##6##5##(1991-4#1)(2006-9#2)(2009-10#1)(2011-2#1)(2012-11#1)
over the last 25 years##7##5##(1996-1#1)(1996-11#1)(2007-12#1)(2007-5#1)(2008-2#1)(2008-4#1)(2008-6#1)
over the last 30 years##3##5##(1994-12#1)(2008-10#2)
over the last 4 years##2##5##(2006-3#1)(2008-10#1)
over the last 5 years##6##5##(1996-11#1)(1997-4#1)(2005-7#1)(2006-5#1)(2007-11#1)(2008-10#1)
over the last 50 years##3##5##(1990-6#1)(2005-8#1)(2007-7#1)
over the last 6 years##2##5##(1990-4#1)(2008-8#1)
over the last century##7##4##(2004-10#1)(2006-7#1)(2006-8#1)(2007-8#2)(2008-2#1)(2012-3#1)
over the last decade and##2##5##(1992-1#1)(2005-7#1)
over the last decade in the treatment of##2##8##(2008-1#1)(2008-7#1)
over the last decade in##3##5##(2006-11#1)(2008-1#1)(2008-7#1)
over the last decade##32##4##(1992-1#1)(1993-6#1)(1997-7#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-6#1)(2007-11#1)(2008-1#3)(2008-10#3)(2008-12#1)(2008-4#3)(2008-7#1)(2009-12#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2012-2#1)(2013-1#1)
over the last decades##6##4##(1996-4#1)(2007-10#1)(2007-11#1)(2009-4#1)(2011-2#1)(2012-12#1)
over the last few decades in##2##6##(1995-1#1)(2005-10#1)
over the last few decades##7##5##(1995-1#1)(1997-7#1)(2005-10#1)(2006-2#1)(2008-11#1)(2008-4#1)(2008-5#1)
over the last few years##11##5##(1993-3#1)(1993-8#1)(1995-3#1)(2006-6#1)(2006-8#1)(2007-7#1)(2008-11#1)(2009-3#1)(2010-12#2)(2013-8#1)
over the last few##20##4##(1993-3#1)(1993-8#1)(1995-1#1)(1995-3#1)(1997-7#1)(2005-10#1)(2005-9#1)(2006-2#1)(2006-6#1)(2006-8#2)(2007-7#1)(2008-11#2)(2008-4#1)(2008-5#1)(2009-3#1)(2010-12#2)(2013-8#1)
over the last fifteen years##2##5##(2007-11#1)(2009-7#1)
over the last four decades##3##5##(1997-7#1)(2008-1#1)(2008-3#1)
over the last several years##6##5##(1993-2#1)(1995-2#1)(2007-11#2)(2007-9#1)(2010-6#1)
over the last several##7##4##(1993-2#1)(1995-2#1)(2007-11#2)(2007-9#1)(2010-2#1)(2010-6#1)
over the last ten years##2##5##(2005-9#1)(2012-3#1)
over the last three decades##4##5##(2005-11#1)(2006-4#1)(2010-12#1)(2012-2#1)
over the last twenty years##2##5##(1990-12#1)(2012-2#1)
over the last two decades in##2##6##(2006-2#1)(2011-3#1)
over the last two decades##12##5##(1994-3#1)(2005-7#1)(2006-2#1)(2008-11#1)(2008-2#1)(2009-12#1)(2009-8#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
over the last two years##3##5##(1996-12#1)(2007-4#1)(2008-7#1)
over the last two##16##4##(1994-3#1)(1996-12#1)(2005-7#1)(2006-2#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-8#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
over the last year##2##4##(2005-8#1)(2007-3#1)
over the last years##9##4##(1997-5#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-6#1)(2011-2#2)
over the last##173##3##(1990-12#1)(1990-4#1)(1990-6#1)(1991-12#1)(1991-4#1)(1992-1#2)(1992-10#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-3#2)(1996-4#1)(1997-4#1)(1997-5#2)(1997-7#3)(2004-10#1)(2005-10#2)(2005-11#1)(2005-7#3)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#1)(2006-11#1)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#3)(2006-8#4)(2006-9#2)(2007-10#1)(2007-11#6)(2007-12#1)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#10)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-12#5)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#3)(2010-8#2)(2011-2#5)(2011-3#1)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#2)
over the left##9##3##(1992-7#1)(1993-9#2)(2007-7#1)(2008-10#3)(2012-12#1)(2012-3#1)
over the lesion##2##3##(1994-9#1)(2008-5#1)
over the life course##5##4##(2009-10#1)(2012-1#1)(2012-12#3)
over the lifetime of##3##4##(1993-9#1)(2006-12#1)(2010-12#1)
over the linear##2##3##(2008-10#2)
over the long term##10##4##(1991-9#1)(1992-8#1)(1995-12#1)(2007-10#1)(2008-11#1)(2008-6#1)(2008-8#2)(2008-9#1)(2011-2#1)
over the long##11##3##(1991-9#1)(1992-8#1)(1995-12#1)(2007-10#1)(2007-9#1)(2008-11#1)(2008-6#1)(2008-8#2)(2008-9#1)(2011-2#1)
over the long-term##2##3##(1991-8#1)(2007-11#1)
over the medial##2##3##(2010-3#1)(2011-2#1)
over the most##2##3##(2008-9#1)(2012-2#1)
over the motor##2##3##(2006-3#1)(2010-7#1)
over the neck##3##3##(2007-7#1)(2011-1#1)(2011-2#1)
over the network##2##3##(2008-10#1)(2008-9#1)
over the next 10 years##2##5##(2007-12#1)(2007-8#1)
over the next 10##3##4##(1990-11#1)(2007-12#1)(2007-8#1)
over the next 2 years##3##5##(1990-5#1)(1996-9#1)(2006-5#1)
over the next 2##4##4##(1990-5#1)(1994-12#1)(1996-9#1)(2006-5#1)
over the next 20##2##4##(2007-2#1)(2011-2#1)
over the next 3 days##2##5##(1991-2#1)(2008-10#1)
over the next 3 years##2##5##(1992-5#1)(1996-2#1)
over the next 3##5##4##(1991-2#1)(1992-5#1)(1994-7#1)(1996-2#1)(2008-10#1)
over the next 4##2##4##(1990-11#1)(2008-4#1)
over the next 6##2##4##(1997-6#1)(2005-10#1)
over the next 60##2##4##(1993-11#1)(2008-10#1)
over the next decade##5##4##(1991-12#1)(1991-2#1)(2006-10#2)(2008-3#1)
over the next decades##3##4##(1990-4#1)(2008-7#1)(2011-2#1)
over the next few years##6##5##(1993-3#1)(1994-3#1)(2007-1#1)(2007-11#1)(2008-3#1)(2010-12#1)
over the next few##8##4##(1993-3#1)(1994-3#1)(2007-1#1)(2007-11#1)(2008-3#1)(2008-4#1)(2010-12#1)(2010-9#1)
over the next several##2##4##(1997-1#1)(2012-12#1)
over the next two decades##2##5##(1991-5#1)(2009-3#1)
over the next two weeks##2##5##(1990-11#1)(2006-4#1)
over the next two##4##4##(1990-11#1)(1991-5#1)(2006-4#1)(2009-3#1)
over the next##58##3##(1990-11#3)(1990-4#1)(1990-5#1)(1991-12#1)(1991-2#2)(1991-5#1)(1992-5#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-6#1)(2005-10#1)(2006-10#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-8#1)(2008-10#2)(2008-3#2)(2008-4#2)(2008-7#1)(2009-3#1)(2010-12#2)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
over the nine##2##3##(2008-10#1)(2008-5#1)
over the number of##2##4##(2007-12#1)(2007-4#1)
over the number##3##3##(1991-11#1)(2007-12#1)(2007-4#1)
over the ocean by##2##4##(2008-2#1)(2008-3#1)
over the ocean##4##3##(2008-2#3)(2008-3#1)
over the oceans##2##3##(2008-2#1)(2008-3#1)
over the omentum##2##3##(2007-2#1)(2012-2#1)
over the original##4##3##(1990-4#1)(2007-4#1)(2008-11#1)(2010-12#1)
over the other in##2##4##(2008-3#1)(2012-12#1)
over the other two##2##4##(2008-10#2)
over the other##11##3##(1996-9#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#1)
over the overall##2##3##(1995-8#1)(2013-1#1)
over the pH range 0##2##5##(2008-10#1)(2008-6#1)
over the pH range of 6##2##6##(1993-3#1)(1997-8#1)
over the pH range of##5##5##(1991-9#1)(1992-7#1)(1993-3#1)(1997-8#1)(2008-10#1)
over the pH range##17##4##(1990-5#1)(1991-9#1)(1992-6#1)(1992-7#1)(1993-3#1)(1994-3#1)(1995-5#1)(1997-8#1)(2008-10#8)(2008-6#1)
over the pH##19##3##(1990-5#1)(1991-9#1)(1992-6#1)(1992-7#1)(1993-3#1)(1994-3#1)(1995-5#1)(1997-8#1)(2008-10#10)(2008-6#1)
over the past 10 years##13##5##(1991-4#1)(1992-3#1)(1993-8#1)(1996-5#1)(2005-7#1)(2006-1#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-7#1)(2010-11#1)(2010-8#1)(2013-8#1)
over the past 14##2##4##(2006-4#1)(2007-9#1)
over the past 15 years##6##5##(1997-1#1)(2008-11#1)(2008-4#1)(2012-1#1)(2012-2#2)
over the past 20 years has##2##6##(1992-8#1)(2010-6#1)
over the past 20 years##14##5##(1992-8#1)(2005-10#1)(2006-10#1)(2007-1#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2009-6#1)(2010-5#2)(2010-6#1)(2010-7#1)
over the past 20##15##4##(1992-8#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2009-6#1)(2010-5#2)(2010-6#1)(2010-7#1)
over the past 25 years##10##5##(1997-1#1)(1997-2#1)(2007-12#2)(2008-12#1)(2008-2#1)(2008-3#1)(2010-7#1)(2011-1#1)(2012-2#1)
over the past 3 decades##2##5##(2009-2#1)(2012-2#1)
over the past 3##3##4##(1996-3#1)(2009-2#1)(2012-2#1)
over the past 30 years##5##5##(2006-8#1)(2008-7#1)(2010-1#1)(2012-1#1)(2012-2#1)
over the past 30##6##4##(2006-8#1)(2007-8#1)(2008-7#1)(2010-1#1)(2012-1#1)(2012-2#1)
over the past 35 years##3##5##(2010-4#1)(2012-12#1)(2013-8#1)
over the past 40 years##6##5##(1993-11#1)(2006-7#2)(2006-9#1)(2010-3#1)(2011-2#1)
over the past 5 years##4##5##(1995-3#1)(2006-4#1)(2007-11#1)(2007-4#1)
over the past 5##5##4##(1995-3#1)(2005-8#1)(2006-4#1)(2007-11#1)(2007-4#1)
over the past 50 years##5##5##(2008-11#1)(2008-7#1)(2008-8#1)(2009-4#1)(2012-12#1)
over the past 500 million years##2##6##(1992-1#1)(2010-7#1)
over the past decade and##3##5##(2008-4#1)(2008-7#1)(2010-5#1)
over the past decade has##3##5##(2006-1#1)(2007-11#1)(2008-10#1)
over the past decade to##2##5##(2005-8#1)(2008-3#1)
over the past decade##45##4##(1993-1#1)(1997-1#1)(2004-10#1)(2005-8#1)(2006-1#2)(2006-10#2)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-5#2)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)
over the past decades have attempted to##2##7##(2006-9#1)(2008-5#1)
over the past decades##7##4##(2006-2#1)(2006-9#1)(2008-5#1)(2010-5#1)(2011-2#1)(2013-1#2)
over the past few decades##6##5##(2005-7#1)(2006-10#2)(2011-2#1)(2012-1#1)(2013-1#1)
over the past few years has##2##6##(2006-10#1)(2007-8#1)
over the past few years##17##5##(1992-9#1)(1995-12#1)(1995-3#1)(2006-10#4)(2007-11#2)(2007-2#1)(2007-8#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#2)(2013-8#1)
over the past few##23##4##(1992-9#1)(1995-12#1)(1995-3#1)(2005-7#1)(2006-10#6)(2007-11#2)(2007-2#1)(2007-8#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2013-1#1)(2013-8#1)
over the past five years##2##5##(1996-7#1)(2007-7#1)
over the past five##3##4##(1996-7#1)(2007-7#1)(2010-8#1)
over the past four decades##3##5##(1997-1#1)(2006-10#1)(2011-2#1)
over the past million years##2##5##(1994-3#2)
over the past month##2##4##(2011-2#2)
over the past several years##7##5##(1991-1#1)(1992-2#1)(2006-10#1)(2007-4#2)(2008-4#1)(2008-7#1)
over the past several##8##4##(1991-1#1)(1992-2#1)(2006-10#1)(2007-4#2)(2008-4#1)(2008-7#1)(2009-7#1)
over the past ten years##4##5##(1990-6#1)(1996-3#1)(2005-8#1)(2007-12#1)
over the past three decades##12##5##(1991-12#1)(1996-2#1)(2006-10#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-11#2)(2010-3#1)(2010-5#1)(2010-8#2)
over the past three##13##4##(1991-12#1)(1996-2#1)(2006-10#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-11#2)(2010-3#1)(2010-5#1)(2010-8#2)(2012-3#1)
over the past twenty years##2##5##(1992-1#1)(2013-8#1)
over the past two decades##19##5##(1993-4#1)(1995-4#1)(2005-7#1)(2006-1#1)(2006-10#1)(2007-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)
over the past two years##3##5##(1994-1#1)(1996-8#1)(2013-8#1)
over the past two##22##4##(1993-4#1)(1994-1#1)(1995-4#1)(1996-8#1)(2005-7#1)(2006-1#1)(2006-10#1)(2007-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#1)
over the past year in the##3##6##(2006-10#3)
over the past year##14##4##(1994-3#1)(1996-12#1)(2005-7#1)(2006-10#11)
over the past years##5##4##(1996-3#1)(2008-11#1)(2008-3#1)(2011-12#1)(2011-2#1)
over the past##247##3##(1990-6#1)(1991-1#1)(1991-12#2)(1991-4#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-4#1)(1993-8#1)(1994-1#1)(1994-3#3)(1995-1#1)(1995-12#1)(1995-3#2)(1995-4#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#4)(1997-2#1)(1997-6#1)(2004-10#1)(2005-10#1)(2005-7#4)(2005-8#4)(2006-1#4)(2006-10#26)(2006-2#2)(2006-3#1)(2006-4#2)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#2)(2007-1#1)(2007-11#5)(2007-12#7)(2007-2#3)(2007-3#1)(2007-4#5)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#3)(2009-2#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-3#3)(2010-4#1)(2010-5#6)(2010-6#2)(2010-7#3)(2010-8#4)(2011-1#6)(2011-12#1)(2011-2#14)(2012-1#5)(2012-12#4)(2012-2#6)(2012-3#1)(2013-1#5)(2013-8#5)
over the pelvic##2##3##(2007-6#2)
over the period from##4##4##(1992-6#1)(2006-12#1)(2008-10#1)(2012-12#1)
over the period of##9##4##(1993-2#1)(1996-12#1)(2007-7#1)(2008-11#2)(2008-6#1)(2009-2#1)(2010-12#1)(2010-3#1)
over the period##29##3##(1990-3#1)(1990-4#1)(1990-6#1)(1991-6#1)(1992-6#1)(1993-2#1)(1993-8#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-7#1)(2006-12#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2009-2#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
over the physiological##3##3##(1993-6#1)(2008-10#1)(2008-5#1)
over the posterior##2##3##(2006-8#1)(2007-10#1)
over the potential##4##3##(2006-11#1)(2008-10#2)(2013-1#1)
over the preceding##2##3##(1992-5#1)(2013-1#1)
over the previous six##3##4##(2004-3#1)(2013-1#2)
over the previous year##3##4##(1991-3#1)(1996-12#1)(2006-10#1)
over the previous##9##3##(1990-11#1)(1991-3#1)(1996-12#1)(2004-3#1)(2005-8#1)(2006-10#1)(2008-2#1)(2013-1#2)
over the previously##3##3##(2007-12#1)(2008-2#1)(2011-2#1)
over the range 0##27##4##(1990-6#1)(1996-8#1)(1997-3#1)(2007-12#1)(2008-10#22)(2008-5#1)
over the range 0-0##2##4##(2008-10#1)(2008-6#1)
over the range 1##7##4##(2007-12#1)(2008-10#6)
over the range 3##2##4##(2008-10#2)
over the range 5##2##4##(2008-10#2)
over the range from##7##4##(1991-9#1)(2007-12#1)(2008-10#4)(2008-3#1)
over the range of 0##21##5##(1992-8#1)(1997-8#2)(2005-12#1)(2007-8#1)(2008-10#16)
over the range of 1##2##5##(2008-10#1)(2008-11#1)
over the range of 2##4##5##(2008-10#4)
over the range of##54##4##(1991-4#1)(1992-8#1)(1996-8#1)(1997-8#4)(2005-12#1)(2006-11#1)(2007-8#1)(2008-10#37)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-5#1)(2013-1#1)
over the range studied##2##4##(2008-10#1)(2008-11#1)
over the range##135##3##(1990-12#1)(1990-6#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-8#1)(1995-10#1)(1995-2#1)(1996-5#1)(1996-7#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-8#4)(2005-12#1)(2006-11#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#94)(2008-11#2)(2008-2#3)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2013-1#1)
over the ranges 0##3##4##(2007-8#1)(2008-10#2)
over the ranges##8##3##(1991-10#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#4)
over the release of##3##4##(2008-12#1)(2009-12#1)(2010-1#1)
over the release##4##3##(2008-12#2)(2009-12#1)(2010-1#1)
over the rest of##2##4##(1992-10#1)(2008-2#1)
over the right##4##3##(1990-12#1)(2006-10#1)(2006-8#1)(2007-7#1)
over the safety of##3##4##(2009-10#1)(2010-4#1)(2013-8#1)
over the safety##4##3##(2008-11#1)(2009-10#1)(2010-4#1)(2013-8#1)
over the same period of time##2##6##(1995-1#1)(2006-7#1)
over the same period##4##4##(1991-6#1)(1995-1#1)(2006-7#1)(2007-3#1)
over the same time period##2##5##(2008-10#1)(2012-11#1)
over the same##15##3##(1990-5#1)(1991-6#1)(1991-8#1)(1995-1#1)(1995-8#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-3#1)(2008-10#1)(2008-2#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-2#1)
over the season##2##3##(2008-10#1)(2008-8#1)
over the second##3##3##(2008-12#1)(2010-3#1)(2012-2#1)
over the short-term##3##3##(1996-8#1)(2004-11#1)(2008-3#1)
over the solvent##2##3##(2006-10#2)
over the source##2##3##(2008-10#1)(2008-3#1)
over the specimen surface##2##4##(2012-2#2)
over the spectral range##4##4##(2007-11#1)(2008-3#3)
over the spectral##5##3##(2007-11#1)(2007-12#1)(2008-3#3)
over the standard##5##3##(1994-9#1)(2008-11#1)(2008-3#2)(2008-7#1)
over the studied##2##3##(2006-10#1)(2008-10#1)
over the study period##11##4##(1992-5#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-7#1)(2008-5#1)(2008-8#1)(2011-12#1)(2012-12#1)(2012-3#1)
over the study##13##3##(1992-5#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-7#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-3#2)
over the subsequent 15##2##4##(1993-11#1)(2005-10#1)
over the subsequent##8##3##(1993-11#1)(1996-2#1)(2005-10#1)(2006-4#1)(2007-10#1)(2008-1#2)(2012-12#1)
over the surface and##2##4##(2007-12#1)(2013-1#1)
over the surface of the##4##5##(2007-1#1)(2008-2#1)(2008-7#1)(2010-2#1)
over the surface of##7##4##(2007-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2010-2#1)
over the surface##10##3##(2007-1#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2010-2#1)(2013-1#1)
over the temperature range 10-90 degrees C##2##7##(2006-10#2)
over the temperature range of##2##5##(1994-12#1)(2009-9#1)
over the temperature range##9##4##(1990-2#1)(1991-7#1)(1992-12#1)(1994-12#1)(1994-5#1)(1997-4#1)(2006-10#2)(2009-9#1)
over the temporal lobe##2##4##(1991-3#2)
over the temporal##3##3##(1991-3#2)(2010-3#1)
over the three##4##3##(1994-11#1)(2006-5#1)(2008-7#1)(2011-3#1)
over the time course of##2##5##(1992-9#1)(2011-1#1)
over the time of##4##4##(2005-9#1)(2008-10#1)(2008-11#1)(2012-12#1)
over the time period##4##4##(2008-10#1)(2009-4#1)(2010-4#1)(2013-7#1)
over the time##16##3##(1992-9#1)(1995-1#1)(2005-11#1)(2005-9#1)(2007-8#1)(2008-10#3)(2008-11#1)(2009-4#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
over the total##2##3##(2006-10#1)(2008-1#1)
over the traditional##9##3##(1990-6#1)(1997-4#1)(2004-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2013-7#1)
over the trunk##3##3##(2007-7#2)(2007-8#1)
over the two days##2##4##(2008-3#2)
over the two seasons##3##4##(2008-10#2)(2008-5#1)
over the two##8##3##(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#1)
over the upper##3##3##(2007-7#3)
over the use of##3##4##(2005-12#1)(2006-10#1)(2008-1#1)
over the various##2##3##(2007-11#1)(2008-11#1)
over the visible and near-infrared##3##5##(2007-11#1)(2008-2#2)
over the wavelength range from##2##5##(2008-2#2)
over the wavelength range of##4##5##(2006-12#1)(2008-2#1)(2008-3#2)
over the wavelength range##15##4##(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#6)(2008-3#5)
over the wavelength##16##3##(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#6)(2008-3#6)
over the week##3##3##(2007-12#1)(2009-11#2)
over the whole body##2##4##(2008-5#1)(2012-2#1)
over the whole head##2##4##(1996-5#1)(2011-1#1)
over the whole pH range##2##5##(2008-10#1)(2008-5#1)
over the whole tuning range##2##5##(2007-11#1)(2007-12#1)
over the whole##26##3##(1994-2#1)(1994-9#1)(1996-5#1)(1997-1#1)(1997-4#1)(2005-11#1)(2007-1#1)(2007-11#3)(2007-12#3)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#2)(2008-8#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-8#1)
over the wide range##2##4##(2008-10#1)(2012-12#1)
over the wide##5##3##(2008-1#1)(2008-10#2)(2008-3#1)(2012-12#1)
over the working range##2##4##(2008-10#2)
over the working##3##3##(2008-10#3)
over the world##39##3##(1992-2#1)(1992-5#1)(1993-8#1)(1994-9#1)(1996-2#1)(1996-6#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)(2010-1#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#3)(2012-2#3)(2013-1#1)(2013-8#1)
over the year of##2##4##(1995-2#1)(2006-6#1)
over the year##3##3##(1995-2#1)(2006-6#1)(2007-10#1)
over the years has##2##4##(1991-12#1)(2008-2#1)
over the years have##2##4##(2006-7#1)(2008-3#1)
over the years in##2##4##(2011-2#1)(2012-3#1)
over the years to##4##4##(2006-3#1)(2007-11#1)(2008-5#1)(2010-8#1)
over the years with##2##4##(2008-10#1)(2008-2#1)
over the years##52##3##(1991-12#2)(1994-12#1)(1996-3#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-10#1)(2006-10#3)(2006-11#1)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#4)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-3#2)(2013-8#3)
over the##2005##2##(1990-10#1)(1990-11#6)(1990-12#7)(1990-2#3)(1990-3#4)(1990-4#7)(1990-5#4)(1990-6#6)(1990-8#4)(1990-9#2)(1991-1#3)(1991-10#2)(1991-11#2)(1991-12#7)(1991-2#7)(1991-3#5)(1991-4#3)(1991-5#8)(1991-6#3)(1991-7#1)(1991-8#5)(1991-9#6)(1992-1#6)(1992-10#3)(1992-11#1)(1992-12#2)(1992-2#6)(1992-3#6)(1992-4#1)(1992-5#7)(1992-6#4)(1992-7#6)(1992-8#5)(1992-9#3)(1993-1#3)(1993-11#4)(1993-12#2)(1993-2#6)(1993-3#7)(1993-4#1)(1993-5#2)(1993-6#7)(1993-7#1)(1993-8#7)(1993-9#6)(1994-1#2)(1994-11#4)(1994-12#10)(1994-2#3)(1994-3#13)(1994-4#1)(1994-5#1)(1994-6#5)(1994-7#2)(1994-8#2)(1994-9#7)(1995-1#9)(1995-10#1)(1995-11#4)(1995-12#4)(1995-2#7)(1995-3#5)(1995-4#2)(1995-5#6)(1995-6#4)(1995-8#4)(1995-9#1)(1996-1#6)(1996-11#6)(1996-12#4)(1996-2#10)(1996-3#10)(1996-4#2)(1996-5#11)(1996-6#4)(1996-7#5)(1996-8#6)(1996-9#5)(1997-1#10)(1997-2#7)(1997-3#8)(1997-4#8)(1997-5#5)(1997-6#2)(1997-7#7)(1997-8#9)(2004-10#3)(2004-11#7)(2004-2#3)(2004-3#1)(2004-4#1)(2004-9#1)(2005-10#9)(2005-11#12)(2005-12#5)(2005-2#1)(2005-7#13)(2005-8#13)(2005-9#3)(2006-1#5)(2006-10#54)(2006-11#4)(2006-12#12)(2006-2#9)(2006-3#8)(2006-4#9)(2006-5#6)(2006-6#11)(2006-7#11)(2006-8#13)(2006-9#8)(2007-1#6)(2007-10#10)(2007-11#43)(2007-12#50)(2007-2#8)(2007-3#7)(2007-4#12)(2007-5#6)(2007-6#4)(2007-7#39)(2007-8#36)(2007-9#9)(2008-1#17)(2008-10#320)(2008-11#40)(2008-12#15)(2008-2#67)(2008-3#76)(2008-4#25)(2008-5#38)(2008-6#15)(2008-7#41)(2008-8#19)(2008-9#26)(2009-1#1)(2009-10#8)(2009-11#4)(2009-12#12)(2009-2#5)(2009-3#5)(2009-4#9)(2009-5#5)(2009-6#4)(2009-7#4)(2009-8#5)(2009-9#6)(2010-1#5)(2010-10#2)(2010-11#7)(2010-12#17)(2010-2#6)(2010-3#12)(2010-4#11)(2010-5#11)(2010-6#9)(2010-7#7)(2010-8#15)(2010-9#2)(2011-1#28)(2011-12#5)(2011-2#50)(2011-3#3)(2012-1#12)(2012-11#6)(2012-12#34)(2012-2#40)(2012-3#20)(2013-1#41)(2013-7#6)(2013-8#23)
over their entire##2##3##(1997-2#1)(2008-5#1)
over their##29##2##(1991-12#1)(1992-1#1)(1995-1#1)(1995-4#1)(1996-1#1)(1997-2#1)(1997-4#1)(2004-10#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-8#3)(2010-10#1)(2010-11#1)(2010-12#2)(2011-1#2)(2012-2#2)(2012-3#1)(2013-1#1)
over them##2##2##(1993-9#1)(1995-6#1)
over thermal##2##2##(2006-12#1)(2008-10#1)
over these##3##2##(1992-7#1)(2007-6#1)(2008-2#1)
over this period##4##3##(1996-9#1)(1997-5#1)(2008-10#1)(2008-2#1)
over this range of pH values##2##6##(1992-8#2)
over this range##3##3##(1992-8#2)(2008-3#1)
over this time period##2##4##(2007-5#1)(2008-6#1)
over this time##4##3##(2006-7#1)(2007-5#1)(2008-6#1)(2008-9#1)
over this year##2##3##(2007-9#2)
over this##27##2##(1992-8#2)(1993-12#1)(1994-12#1)(1995-6#1)(1996-9#1)(1997-5#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-9#1)(2009-7#1)(2011-2#1)(2013-1#1)
over those of##2##3##(1997-3#1)(2004-12#1)
over those##14##2##(1991-10#1)(1992-3#1)(1993-9#1)(1994-2#2)(1995-3#1)(1996-1#1)(1997-3#1)(2004-12#1)(2008-3#2)(2008-7#1)(2009-2#1)(2012-2#1)
over three commercial products##2##4##(2008-10#2)
over three days##2##3##(2007-2#1)(2009-9#1)
over three decades##2##3##(2010-12#1)(2011-1#1)
over three orders of magnitude and the##2##7##(2008-10#2)
over three orders of magnitude##6##5##(1991-5#1)(2008-10#5)
over three successive##2##3##(2007-10#1)(2008-10#1)
over three years##4##3##(1990-9#1)(1993-1#1)(2008-12#1)(2011-2#1)
over three##32##2##(1990-9#1)(1991-5#1)(1992-11#1)(1993-1#1)(1993-11#1)(1997-4#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-2#1)(2007-3#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)
over time after##2##3##(1996-7#1)(2011-12#1)
over time and between##2##4##(2007-2#1)(2009-5#1)
over time and in##2##4##(2008-10#1)(2010-8#1)
over time and space##2##4##(2008-10#1)(2008-8#1)
over time and the##2##4##(1994-11#1)(2011-1#1)
over time and with##2##4##(1990-12#1)(2006-10#1)
over time and##27##3##(1990-12#2)(1992-11#1)(1993-11#1)(1994-11#1)(1997-3#2)(2005-8#1)(2006-10#1)(2006-5#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-8#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
over time as##3##3##(1996-3#1)(2007-8#1)(2008-10#1)
over time by##3##3##(1994-12#1)(1997-3#1)(2008-10#1)
over time can##2##3##(2008-10#1)(2009-9#1)
over time could##2##3##(2008-10#1)(2012-2#1)
over time followed a##2##4##(2008-10#2)
over time for##5##3##(1996-3#1)(2004-9#1)(2008-10#2)(2010-5#1)
over time from##4##3##(2008-10#2)(2008-9#1)(2013-8#1)
over time in both##2##4##(2010-2#1)(2012-1#1)
over time in the##12##4##(1990-12#1)(1997-2#1)(2007-3#1)(2008-10#5)(2008-2#1)(2009-7#1)(2012-12#2)
over time in##40##3##(1990-12#1)(1993-5#1)(1994-5#1)(1995-2#1)(1996-3#1)(1997-2#1)(1997-6#1)(2006-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#3)
over time into a##2##4##(1994-3#1)(2009-9#1)
over time is##5##3##(2007-11#1)(2008-10#1)(2008-7#1)(2012-1#1)(2013-8#1)
over time may be##3##4##(1994-9#1)(2008-2#1)(2013-1#1)
over time may##4##3##(1994-9#1)(2008-2#1)(2013-1#2)
over time on##2##3##(2006-12#1)(2008-10#1)
over time scales of##2##4##(2008-3#2)
over time scales##3##3##(2008-3#3)
over time that##3##3##(2008-10#1)(2008-3#1)(2012-12#1)
over time to the##2##4##(1995-2#1)(2007-8#1)
over time to##5##3##(1995-2#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-5#1)
over time was##5##3##(2006-12#1)(2008-10#2)(2008-6#1)(2013-1#1)
over time were##5##3##(2008-10#2)(2009-8#1)(2012-12#1)(2012-3#1)
over time when##2##3##(2008-10#2)
over time with##5##3##(2008-10#1)(2008-5#1)(2008-7#1)(2009-2#1)(2012-3#1)
over time within##3##3##(2008-10#1)(2008-7#1)(2012-12#1)
over time##445##2##(1990-12#5)(1991-1#1)(1991-11#1)(1991-2#4)(1992-1#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-6#3)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-5#2)(1993-7#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#4)(1995-2#2)(1995-6#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#6)(1996-4#1)(1996-6#1)(1996-7#2)(1997-2#2)(1997-3#4)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#1)(2004-11#1)(2004-9#2)(2005-11#2)(2005-7#1)(2005-8#2)(2006-10#4)(2006-11#1)(2006-12#3)(2006-4#2)(2006-5#3)(2007-10#4)(2007-11#3)(2007-12#3)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#4)(2007-8#10)(2007-9#3)(2008-1#3)(2008-10#72)(2008-11#9)(2008-12#8)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#13)(2008-6#5)(2008-7#8)(2008-8#8)(2008-9#12)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#6)(2009-5#2)(2009-6#1)(2009-7#5)(2009-8#3)(2009-9#2)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#3)(2010-3#5)(2010-4#4)(2010-5#4)(2010-7#4)(2010-8#5)(2010-9#2)(2011-1#6)(2011-12#3)(2011-2#19)(2011-3#1)(2012-1#8)(2012-12#12)(2012-2#12)(2012-3#10)(2013-1#18)(2013-7#1)(2013-8#7)
over time)##4##2##(1997-5#1)(2008-10#1)(2008-9#1)(2010-3#1)
over time?##4##2##(2007-8#1)(2008-12#1)(2008-9#1)(2010-12#1)
over to the other##2##4##(1995-2#1)(2007-8#1)
over to the##9##3##(1991-3#1)(1995-11#1)(1995-2#1)(1996-2#1)(2007-8#1)(2010-12#1)(2011-2#1)(2013-1#2)
over to##15##2##(1990-4#1)(1991-3#1)(1993-6#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(2007-8#1)(2007-9#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#2)
over traditional##17##2##(1993-3#1)(2004-9#1)(2005-11#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#1)(2010-8#1)
over turbid coastal##2##3##(2008-3#2)
over turbid##3##2##(2008-3#3)
over two consecutive##3##3##(2008-10#1)(2008-6#1)(2008-7#1)
over two decades##4##3##(2005-12#1)(2010-12#1)(2010-3#1)(2012-11#1)
over two growing seasons##4##4##(2008-10#3)(2013-1#1)
over two hours##2##3##(2008-1#1)(2010-8#1)
over two orders of magnitude##4##5##(1990-5#1)(2008-10#3)
over two seasons##4##3##(2007-11#1)(2008-10#3)
over two thirds##2##3##(2006-10#1)(2009-3#1)
over two weeks##4##3##(1992-10#1)(2006-9#1)(2007-2#1)(2013-1#1)
over two years##6##3##(1997-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-2#1)(2013-8#1)
over two##53##2##(1990-5#1)(1990-6#1)(1991-10#1)(1992-10#1)(1993-11#1)(1993-7#1)(1997-2#1)(2004-4#1)(2005-12#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-6#1)(2008-1#2)(2008-10#15)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
over twofold##2##2##(2008-10#1)(2008-8#1)
over use of##2##3##(1995-9#1)(1996-2#1)
over various##6##2##(1992-1#1)(2005-11#1)(2007-9#1)(2008-3#2)(2012-2#1)
over varying##4##2##(1990-3#1)(1993-5#1)(2008-10#1)(2008-2#1)
over weight##3##2##(2011-2#3)
over were##3##2##(2008-7#1)(2011-1#1)(2012-2#1)
over what##5##2##(2007-11#1)(2007-8#2)(2008-10#1)(2008-11#1)
over whether the##2##3##(2007-11#1)(2009-3#1)
over whether##6##2##(2006-9#1)(2007-11#1)(2008-10#1)(2009-12#1)(2009-3#1)(2012-12#1)
over which the method was##2##5##(2008-10#2)
over which the##5##3##(1995-6#1)(2006-11#1)(2008-10#2)(2011-2#1)
over which##31##2##(1990-8#1)(1994-6#1)(1995-6#1)(1995-8#1)(1996-4#1)(1996-9#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#7)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#1)
over who should##2##3##(2007-4#1)(2007-8#1)
over wide concentration range##2##4##(2008-10#2)
over wide concentration##3##3##(2008-10#3)
over wide geographic##2##3##(1997-4#1)(2008-3#1)
over wide##10##2##(1992-8#1)(1997-4#1)(2008-10#5)(2008-2#1)(2008-3#1)(2010-8#1)
over women and##2##3##(2008-11#1)(2010-12#1)
over years or##2##3##(2008-10#1)(2013-1#1)
over years were##2##3##(1990-10#1)(2008-10#1)
over years##9##2##(1990-10#1)(2006-12#1)(2008-10#4)(2012-11#1)(2012-2#1)(2013-1#1)
over zirconia supported heteropolyacids##2##4##(2013-1#2)
over##6836##1##(1990-10#6)(1990-11#15)(1990-12#28)(1990-2#10)(1990-3#21)(1990-4#11)(1990-5#16)(1990-6#22)(1990-7#6)(1990-8#21)(1990-9#8)(1991-1#14)(1991-10#16)(1991-11#9)(1991-12#15)(1991-2#24)(1991-3#12)(1991-4#14)(1991-5#19)(1991-6#9)(1991-7#6)(1991-8#17)(1991-9#20)(1992-1#18)(1992-10#11)(1992-11#9)(1992-12#8)(1992-2#22)(1992-3#16)(1992-4#9)(1992-5#15)(1992-6#19)(1992-7#14)(1992-8#17)(1992-9#24)(1993-1#10)(1993-10#3)(1993-11#16)(1993-12#20)(1993-2#17)(1993-3#24)(1993-4#10)(1993-5#10)(1993-6#23)(1993-7#6)(1993-8#14)(1993-9#24)(1994-1#9)(1994-10#3)(1994-11#15)(1994-12#28)(1994-2#29)(1994-3#40)(1994-4#4)(1994-5#15)(1994-6#14)(1994-7#7)(1994-8#11)(1994-9#17)(1995-1#31)(1995-10#9)(1995-11#20)(1995-12#19)(1995-2#24)(1995-3#28)(1995-4#8)(1995-5#9)(1995-6#24)(1995-8#12)(1995-9#9)(1996-1#15)(1996-10#2)(1996-11#20)(1996-12#23)(1996-2#30)(1996-3#32)(1996-4#13)(1996-5#27)(1996-6#21)(1996-7#13)(1996-8#11)(1996-9#12)(1997-1#27)(1997-2#26)(1997-3#23)(1997-4#34)(1997-5#20)(1997-6#24)(1997-7#21)(1997-8#25)(2004-1#4)(2004-10#8)(2004-11#14)(2004-12#4)(2004-2#9)(2004-3#1)(2004-4#3)(2004-7#2)(2004-9#10)(2005-10#15)(2005-11#51)(2005-12#10)(2005-2#2)(2005-3#1)(2005-5#2)(2005-6#2)(2005-7#38)(2005-8#30)(2005-9#15)(2006-1#14)(2006-10#100)(2006-11#14)(2006-12#35)(2006-2#28)(2006-3#10)(2006-4#25)(2006-5#25)(2006-6#29)(2006-7#24)(2006-8#40)(2006-9#16)(2007-1#20)(2007-10#33)(2007-11#162)(2007-12#211)(2007-2#28)(2007-3#27)(2007-4#24)(2007-5#30)(2007-6#16)(2007-7#99)(2007-8#134)(2007-9#45)(2008-1#78)(2008-10#952)(2008-11#134)(2008-12#60)(2008-2#256)(2008-3#284)(2008-4#72)(2008-5#134)(2008-6#62)(2008-7#145)(2008-8#109)(2008-9#89)(2009-1#2)(2009-10#25)(2009-11#16)(2009-12#19)(2009-2#17)(2009-3#20)(2009-4#34)(2009-5#20)(2009-6#13)(2009-7#25)(2009-8#33)(2009-9#31)(2010-1#14)(2010-10#14)(2010-11#23)(2010-12#53)(2010-2#40)(2010-3#39)(2010-4#38)(2010-5#31)(2010-6#21)(2010-7#24)(2010-8#52)(2010-9#10)(2011-1#81)(2011-12#17)(2011-2#187)(2011-3#7)(2011-9#1)(2012-1#56)(2012-11#16)(2012-12#108)(2012-2#133)(2012-3#68)(2012-4#1)(2012-5#2)(2012-6#1)(2012-7#1)(2013-1#149)(2013-7#37)(2013-8#70)
over- or##3##2##(1994-6#1)(2008-8#1)(2008-9#1)
over-##4##1##(1994-6#1)(2008-8#1)(2008-9#1)(2010-12#1)
over-activation##2##1##(2006-12#1)(2008-11#1)
over-dominance##4##1##(2008-12#1)(2008-8#3)
over-estimated mortality##2##2##(2007-8#2)
over-estimated##5##1##(1994-8#1)(1995-7#1)(2007-8#2)(2008-10#1)
over-exploitation##2##1##(2008-5#1)(2013-1#1)
over-expressed genes##2##2##(2007-2#1)(2010-12#1)
over-expressed in a variety of##2##5##(2008-8#1)(2009-3#1)
over-expressed in##11##2##(1990-4#1)(1991-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-8#1)(2012-2#1)
over-expressed##18##1##(1990-4#1)(1991-1#1)(1991-8#1)(1996-11#1)(2005-10#2)(2007-2#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-8#1)(2012-2#1)
over-expressing Hela cells##2##3##(2011-1#2)
over-expressing NSP 5a3a##2##3##(2011-2#2)
over-expressing##11##1##(1990-12#1)(2008-11#2)(2008-5#1)(2010-11#2)(2011-1#2)(2011-2#2)(2013-8#1)
over-expression in##2##2##(1991-7#1)(1994-9#1)
over-expression of the##5##3##(1993-2#1)(1995-8#1)(2008-11#2)(2011-2#1)
over-expression of##28##2##(1990-3#3)(1993-2#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-12#2)(2006-12#1)(2007-10#1)(2007-12#2)(2008-11#6)(2008-8#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-2#3)(2012-2#1)
over-expression on##2##2##(1994-12#1)(2008-11#1)
over-expression##46##1##(1990-3#3)(1991-7#1)(1991-9#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-9#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-7#1)(1997-7#1)(2006-12#2)(2006-7#1)(2007-10#1)(2007-12#2)(2008-11#9)(2008-4#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-7#1)(2011-2#3)(2012-2#1)
over-fitting##3##1##(2008-11#1)(2013-1#2)
over-five##2##1##(2008-2#2)
over-head traction before##2##3##(2007-8#2)
over-head traction##5##2##(2007-8#5)
over-nutrition##3##1##(2010-8#1)(2012-1#2)
over-pressure##2##1##(1990-6#1)(2006-8#1)
over-produced##4##1##(1990-12#1)(1990-3#1)(1993-8#1)(1997-6#1)
over-production of UVDRP binding activity##2##5##(1993-8#2)
over-production of##4##2##(1993-12#1)(1993-8#3)
over-production##6##1##(1990-12#2)(1993-12#1)(1993-8#3)
over-recovery##3##1##(1996-3#3)
over-reporting##2##1##(2007-2#1)(2012-1#1)
over-represented in##6##2##(2006-12#1)(2008-12#2)(2008-4#1)(2010-6#1)(2011-1#1)
over-represented##11##1##(2006-12#1)(2008-10#1)(2008-12#2)(2008-4#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-6#1)(2011-1#1)
over-the-counter (OTC)##3##2##(2007-10#1)(2013-1#1)(2013-8#1)
over-the-counter accessibility##2##2##(2006-5#1)(2013-1#1)
over-the-counter cosmetics##2##2##(2008-5#1)(2010-8#1)
over-the-counter drugs and beverages##2##4##(2010-9#2)
over-the-counter drugs and food additives in##2##6##(2010-9#2)
over-the-counter drugs and##4##3##(2010-9#4)
over-the-counter drugs##6##2##(1990-4#1)(2006-8#1)(2010-9#4)
over-the-counter medications##2##2##(2007-9#1)(2010-5#1)
over-the-counter##24##1##(1990-4#1)(1992-11#1)(2006-10#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-9#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-5#1)(2010-8#1)(2010-9#4)(2013-1#3)(2013-8#1)
over-use of##2##2##(2006-10#1)(2007-8#1)
over-utilization##2##1##(1995-1#1)(2009-4#1)
over-weight##2##1##(1990-3#1)(1997-8#1)
over-wintering carp##2##2##(2008-7#2)
over-wintering##5##1##(2008-7#5)
overactive bladder##11##2##(1997-5#1)(2006-9#2)(2008-10#1)(2008-12#1)(2008-9#1)(2009-2#1)(2009-5#2)(2011-1#1)(2011-12#1)
overactive##15##1##(1997-5#1)(2006-9#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#2)(2009-5#2)(2011-1#1)(2011-12#1)(2013-1#1)
overactivity and##2##2##(2008-5#1)(2011-1#1)
overactivity in##3##2##(1993-1#1)(1993-9#1)(1994-11#1)
overactivity of##3##2##(1996-3#1)(1996-9#1)(2008-10#1)
overactivity that##2##2##(2008-1#1)(2008-2#1)
overactivity##17##1##(1993-1#1)(1993-5#1)(1993-9#1)(1994-11#1)(1996-3#1)(1996-9#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)(2010-8#1)(2011-1#1)(2012-2#1)
overall 10-year##2##2##(2007-8#1)(2013-1#1)
overall 18%##2##2##(2006-8#1)(2012-11#1)
overall 21##2##2##(2007-3#2)
overall 5##2##2##(1996-6#1)(2011-2#1)
overall 5-year##4##2##(2006-6#1)(2007-9#1)(2010-3#1)(2011-1#1)
overall Adair##3##2##(1990-8#3)
overall DHP-R/RyR##2##2##(1993-12#2)
overall GLF scores##3##3##(1996-7#3)
overall HIV##2##2##(2008-10#1)(2012-3#1)
overall HMD##2##2##(2008-2#2)
overall Strehl##3##2##(2008-3#3)
overall acceptability and##2##3##(2010-4#2)
overall acceptability##6##2##(2010-2#2)(2010-4#4)
overall accuracy and precision##2##4##(2008-10#1)(2008-2#1)
overall accuracy of##7##3##(1990-4#1)(1990-9#1)(1993-5#1)(2007-5#1)(2008-2#2)(2010-5#1)
overall accuracy##16##2##(1990-4#1)(1990-6#1)(1990-9#1)(1992-2#1)(1993-5#1)(2004-1#2)(2007-5#2)(2008-10#1)(2008-2#3)(2008-7#1)(2010-5#1)(2010-8#1)
overall activity##7##2##(1991-10#1)(1993-12#2)(2006-10#1)(2008-5#2)(2012-1#1)
overall adequacy of##2##3##(2011-1#1)(2013-8#1)
overall age-standardized##5##2##(1991-6#1)(1995-5#3)(2013-1#1)
overall agreement with##2##3##(1997-2#1)(2012-1#1)
overall agreement##8##2##(1992-10#1)(1997-2#1)(2008-10#1)(2009-5#1)(2009-8#2)(2010-12#1)(2012-1#1)
overall aim of##5##3##(2006-10#1)(2008-11#2)(2012-12#1)(2012-2#1)
overall aim##6##2##(2006-10#1)(2008-11#2)(2012-12#1)(2012-2#2)
overall amino acid identity##2##4##(1995-6#1)(1996-3#1)
overall amino acid##3##3##(1992-11#1)(1995-6#1)(1996-3#1)
overall analysis of the##2##4##(2005-11#1)(2008-7#1)
overall analysis##6##2##(2005-11#1)(2008-10#2)(2008-7#2)(2013-8#1)
overall analytical##3##2##(2008-10#2)(2010-2#1)
overall and disease-free survival##4##4##(2006-10#1)(2007-11#2)(2008-10#1)
overall and in##4##3##(2008-5#1)(2011-2#3)
overall and the##2##3##(2008-3#1)(2008-8#1)
overall and##24##2##(1991-12#1)(1991-6#1)(1994-2#1)(1997-2#1)(2006-10#1)(2006-6#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-2#1)(2009-4#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-7#1)(2011-2#3)
overall annual##2##2##(1996-6#1)(2008-8#1)
overall approach##3##2##(2007-11#1)(2008-10#1)(2008-9#1)
overall architecture of the##3##4##(1991-4#1)(2008-8#1)(2011-2#1)
overall architecture##4##2##(1991-4#1)(2008-11#1)(2008-8#1)(2011-2#1)
overall assessment of##2##3##(2007-11#1)(2010-9#1)
overall assessment##5##2##(1991-4#1)(2006-7#1)(2007-11#1)(2010-9#1)(2011-2#1)
overall average recoveries##2##3##(1991-8#1)(2008-10#1)
overall average##9##2##(1991-8#1)(1997-2#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-4#1)(2011-2#1)
overall awareness##2##2##(2005-7#1)(2012-1#1)
overall balance of##3##3##(2005-7#1)(2008-5#1)(2010-6#1)
overall benefit##3##2##(2008-1#1)(2008-5#1)(2012-2#1)
overall body size##2##3##(2007-12#1)(2008-8#1)
overall body##7##2##(2007-12#1)(2008-11#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-12#1)
overall brain##2##2##(1990-4#1)(2008-10#1)
overall cancer mortality##4##3##(1990-4#1)(1997-1#1)(2007-4#1)(2011-2#1)
overall cancer##6##2##(1990-2#1)(1990-4#1)(1997-1#1)(2007-4#1)(2011-2#1)(2012-12#1)
overall care of##2##3##(2011-3#1)(2012-3#1)
overall care##4##2##(2007-8#1)(2011-2#1)(2011-3#1)(2012-3#1)
overall catalytic##2##2##(1996-7#1)(2006-10#1)
overall classification##3##2##(2008-6#1)(2010-8#1)(2012-1#1)
overall clinical##6##2##(1990-6#1)(1991-12#1)(1994-6#1)(2004-3#1)(2005-10#1)(2008-1#1)
overall comorbidity##2##2##(2006-7#1)(2011-1#1)
overall complication rate was##3##4##(2007-7#1)(2013-1#1)(2013-8#1)
overall complication rate##4##3##(2007-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
overall complication rates##2##3##(2011-2#1)(2012-3#1)
overall complication##6##2##(2007-7#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
overall concentrations of##3##3##(1995-5#1)(1997-3#1)(2007-5#1)
overall concentrations##4##2##(1995-5#1)(1997-3#1)(2007-5#2)
overall conclusions##2##2##(1997-8#1)(2010-9#1)
overall confidence##2##2##(1994-5#1)(1997-2#1)
overall consequence##3##2##(1996-9#1)(2007-11#1)(2008-8#1)
overall conversion efficiency##2##3##(2007-11#1)(2007-12#1)
overall conversion##3##2##(2007-11#1)(2007-12#1)(2007-8#1)
overall correlation between##2##3##(1991-2#1)(1995-3#1)
overall correlation##3##2##(1991-2#1)(1995-3#1)(2012-2#1)
overall cost savings to##2##4##(1993-12#1)(1997-3#1)
overall cost##10##2##(1993-12#1)(1997-3#1)(2007-4#1)(2008-2#1)(2008-5#2)(2009-7#1)(2012-3#2)(2013-1#1)
overall costs associated with##2##4##(2007-11#1)(2008-9#1)
overall costs##5##2##(2007-11#3)(2007-5#1)(2008-9#1)
overall data##3##2##(2007-12#1)(2008-3#1)(2010-1#1)
overall death##2##2##(1991-12#1)(2012-2#1)
overall decay##2##2##(1994-12#1)(2008-3#1)
overall decline in##2##3##(1990-4#1)(2008-1#1)
overall decrease in##8##3##(1994-10#1)(1994-12#2)(1996-7#1)(1997-8#1)(2005-10#1)(2007-12#1)(2008-6#1)
overall decrease##10##2##(1993-9#1)(1994-10#1)(1994-12#2)(1996-7#1)(1997-8#1)(2005-10#1)(2007-12#1)(2008-6#1)(2013-8#1)
overall desirability##2##2##(2004-12#2)
overall detection##2##2##(2008-10#1)(2011-1#1)
overall diagnostic##5##2##(1996-11#1)(2007-12#1)(2010-2#1)(2011-2#1)(2013-8#1)
overall differences##2##2##(2007-12#1)(2008-10#1)
overall dimensions of random knots##2##5##(2006-4#2)
overall discriminatory##2##2##(1995-8#1)(2012-1#1)
overall disease##2##2##(2006-2#1)(2008-10#1)
overall effect of ethanol on BTEX##2##6##(2006-10#2)
overall effect of##7##3##(1992-4#1)(1997-5#1)(2006-10#2)(2007-9#1)(2008-6#1)(2010-2#1)
overall effect##10##2##(1992-4#1)(1997-5#1)(2005-11#1)(2006-10#2)(2007-9#1)(2008-10#1)(2008-6#1)(2009-4#1)(2010-2#1)
overall effectiveness##4##2##(1994-3#1)(2008-10#1)(2012-1#1)(2012-2#1)
overall efficacy##4##2##(1991-2#1)(1993-11#1)(2007-1#1)(2007-11#1)
overall efficiency of##9##3##(1990-10#1)(1995-2#1)(1996-9#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)
overall efficiency##13##2##(1990-10#1)(1995-2#1)(1996-9#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-6#1)(2010-8#1)
overall energy##4##2##(1995-12#1)(2008-4#1)(2010-4#1)(2010-7#1)
overall estimated##4##2##(1996-3#1)(1997-1#1)(2008-10#1)(2013-1#1)
overall evaluation of##2##3##(1997-2#2)
overall exposure##2##2##(2008-12#1)(2008-3#1)
overall extraction equilibrium constants##3##4##(2008-10#3)
overall extraction equilibrium##4##3##(2008-10#4)
overall extraction##8##2##(2008-10#8)
overall family##2##2##(2009-12#1)(2011-1#1)
overall favorable##2##2##(2011-2#1)(2012-2#1)
overall features##3##2##(1993-6#1)(2007-11#1)(2008-3#1)
overall financial##2##2##(2009-2#1)(2010-10#1)
overall findings##2##2##(2004-12#1)(2013-7#1)
overall fitness##4##2##(2008-10#1)(2008-9#1)(2009-5#1)(2012-2#1)
overall five-year survival##2##3##(2007-2#1)(2011-2#1)
overall folding of##3##3##(1990-7#1)(1993-2#1)(1995-1#1)
overall folding##4##2##(1990-7#1)(1993-2#1)(1995-1#1)(1996-5#1)
overall for the##2##3##(1991-8#1)(2004-3#1)
overall for##3##2##(1991-8#1)(1996-6#1)(2004-3#1)
overall frequency of##3##3##(1991-6#1)(2008-10#1)(2012-2#1)
overall frequency##7##2##(1991-6#1)(2006-12#1)(2007-11#1)(2008-10#2)(2012-2#2)
overall functioning##3##2##(2008-11#1)(2012-12#2)
overall gene expression##2##3##(1997-8#2)
overall geometry##2##2##(1996-2#1)(2006-8#1)
overall goal##2##2##(1996-2#1)(2010-8#1)
overall growth of##2##3##(2010-12#1)(2012-12#1)
overall growth##3##2##(1995-8#1)(2010-12#1)(2012-12#1)
overall health and##4##3##(1996-3#1)(2005-11#1)(2013-1#1)(2013-7#1)
overall health status##2##3##(2006-8#1)(2006-9#1)
overall health##21##2##(1990-12#1)(1996-3#1)(2005-11#1)(2006-8#1)(2006-9#1)(2007-11#1)(2008-7#4)(2008-8#1)(2009-6#1)(2010-1#1)(2010-7#2)(2010-9#1)(2013-1#1)(2013-7#2)(2013-8#2)
overall homology of##3##3##(1992-12#1)(1993-3#1)(1994-12#1)
overall homology to##2##3##(1992-12#1)(1995-2#1)
overall homology with the##2##4##(1991-2#1)(1991-9#1)
overall homology with##3##3##(1991-11#1)(1991-2#1)(1991-9#1)
overall homology##8##2##(1991-11#1)(1991-2#1)(1991-9#1)(1992-12#2)(1993-3#1)(1994-12#1)(1995-2#1)
overall hospital stay##3##3##(1996-3#1)(2007-8#1)(2012-2#1)
overall hospital##9##2##(1992-9#1)(1993-3#1)(1994-1#1)(1996-3#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-4#1)(2012-2#1)
overall hydrolysis##2##2##(1995-11#1)(2008-5#1)
overall identities of##2##3##(1991-6#1)(1996-10#1)
overall identity to##2##3##(1995-8#1)(1996-3#1)
overall identity##4##2##(1991-9#1)(1995-8#1)(1996-10#1)(1996-3#1)
overall image quality##3##3##(2008-2#2)(2008-8#1)
overall image##4##2##(2007-11#1)(2008-2#2)(2008-8#1)
overall impact##6##2##(2006-11#1)(2006-4#1)(2007-8#1)(2008-12#1)(2011-2#1)(2013-1#1)
overall impression##4##2##(2010-8#2)(2012-2#2)
overall improvement in##5##3##(1997-3#1)(2007-7#1)(2008-1#1)(2008-7#1)(2012-2#1)
overall improvement of mastalgia##2##4##(1994-5#2)
overall improvement of##7##3##(1994-5#2)(1995-2#1)(2008-12#2)(2010-2#1)(2011-2#1)
overall improvement##13##2##(1992-6#1)(1994-5#2)(1995-2#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-12#2)(2008-7#1)(2010-2#1)(2011-2#1)(2012-2#1)
overall in##3##2##(2007-11#1)(2009-5#1)(2010-3#1)
overall incidence of##21##3##(2005-8#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-4#2)(2008-9#1)(2009-10#1)(2009-3#1)(2010-4#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
overall incidence##26##2##(1993-2#1)(1994-12#1)(2005-8#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-4#2)(2008-9#1)(2009-10#1)(2009-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
overall increase in the##3##4##(2008-4#1)(2009-8#1)(2011-12#1)
overall increase in##9##3##(1993-3#1)(1995-12#1)(1997-1#1)(2006-8#1)(2008-4#1)(2008-6#1)(2009-8#1)(2011-12#1)(2012-12#1)
overall increase##10##2##(1991-10#1)(1993-3#1)(1995-12#1)(1997-1#1)(2006-8#1)(2008-4#1)(2008-6#1)(2009-8#1)(2011-12#1)(2012-12#1)
overall infection##2##2##(2006-2#1)(2011-1#1)
overall intensity of##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
overall intensity##4##2##(1991-2#1)(2008-10#1)(2008-3#1)(2012-2#1)
overall isoform number I##2##4##(2007-8#2)
overall job satisfaction##3##3##(1991-2#2)(1993-3#1)
overall knowledge##3##2##(2007-3#1)(2007-6#1)(2013-1#1)
overall length of##4##3##(1992-11#1)(1994-2#1)(2006-12#1)(2010-7#1)
overall length##5##2##(1992-11#1)(1994-2#1)(2006-12#1)(2010-7#1)(2013-8#1)
overall lethality##2##2##(1993-1#1)(2013-1#1)
overall level of##8##3##(1990-12#2)(1990-4#1)(1997-3#1)(1997-8#2)(2005-11#1)(2010-2#1)
overall levels of##4##3##(1990-12#1)(1993-6#1)(1996-3#1)(2008-12#1)
overall life##2##2##(2007-10#1)(2011-2#1)
overall liking##4##2##(2010-4#3)(2013-1#1)
overall loss##2##2##(1990-3#1)(1995-9#1)
overall male-to-female##2##2##(2008-9#2)
overall management##6##2##(2007-6#1)(2008-7#1)(2008-9#1)(2010-3#1)(2012-12#1)(2012-2#1)
overall mean intercept##2##3##(2008-10#2)
overall mean of##2##3##(1990-10#1)(2010-3#1)
overall mean regression slope and intercept##2##6##(2008-10#2)
overall mean value##4##3##(2008-3#3)(2008-7#1)
overall mean##24##2##(1990-10#1)(1990-12#1)(1991-8#1)(1995-12#1)(2004-11#1)(2006-10#1)(2007-11#1)(2008-10#6)(2008-3#4)(2008-7#1)(2008-9#2)(2010-3#1)(2011-2#1)(2013-8#2)
overall mechanism##3##2##(1990-5#1)(1995-4#1)(2006-10#1)
overall median survival##2##3##(2008-6#1)(2009-11#1)
overall median##4##2##(2008-6#1)(2008-8#2)(2009-11#1)
overall medical##3##2##(2006-2#1)(2006-5#1)(2011-1#1)
overall membrane##3##2##(1990-12#1)(1993-12#1)(1997-6#1)
overall metabolic##2##2##(2008-11#1)(2013-1#1)
overall method##5##2##(2008-10#4)(2011-1#1)
overall microbial##2##2##(2008-10#1)(2008-9#1)
overall model##4##2##(2006-6#1)(2012-1#1)(2013-1#2)
overall molecular##3##2##(1991-5#1)(1992-1#1)(1996-7#1)
overall mortality of##4##3##(2007-11#1)(2007-7#1)(2007-8#1)(2012-2#1)
overall mortality rate was##5##4##(1994-11#1)(1994-7#1)(2007-7#1)(2007-8#1)(2008-9#1)
overall mortality rate##10##3##(1990-9#1)(1993-9#1)(1994-11#1)(1994-7#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-9#1)(2013-8#1)
overall mortality##28##2##(1990-9#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-7#1)(1995-4#1)(1996-12#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
overall negative##2##2##(2007-11#1)(2010-5#1)
overall network activity##2##3##(2013-8#2)
overall network##3##2##(2012-3#1)(2013-8#2)
overall number##3##2##(1990-12#1)(1992-8#1)(2013-1#1)
overall objective of##4##3##(1994-10#1)(2006-5#1)(2008-11#1)(2012-2#1)
overall objective##8##2##(1994-10#1)(2006-5#1)(2007-11#1)(2008-11#1)(2008-4#1)(2012-2#1)(2013-1#1)(2013-7#1)
overall of##2##2##(1991-3#1)(2011-1#1)
overall operating##2##2##(2007-5#1)(2008-10#1)
overall operative time##2##3##(2009-3#2)
overall operative##4##2##(1990-3#1)(2007-8#1)(2009-3#2)
overall optical performance##2##3##(2008-2#1)(2008-3#1)
overall optical##5##2##(2008-2#2)(2008-3#2)(2011-1#1)
overall optical-to-optical efficiency##2##3##(2007-12#2)
overall optical-to-optical##3##2##(2007-12#3)
overall or in##2##3##(2012-2#1)(2013-8#1)
overall or##4##2##(2008-6#1)(2010-8#1)(2012-2#1)(2013-8#1)
overall organization of the##2##4##(1990-8#1)(2008-7#1)
overall outcome in##2##3##(2007-7#1)(2010-12#1)
overall outcome of##8##3##(1997-7#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-7#1)(2010-3#1)(2013-1#2)
overall outcome##12##2##(1997-7#1)(2007-10#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-7#2)(2010-12#1)(2010-3#2)(2013-1#2)
overall outcomes##2##2##(2005-5#1)(2008-6#1)
overall oxygen##2##2##(2005-11#1)(2007-12#1)
overall patient satisfaction##2##3##(1993-12#1)(2010-8#1)
overall patient survival##2##3##(2008-1#1)(2013-1#1)
overall patient##7##2##(1993-12#1)(1993-9#1)(2008-1#1)(2010-8#1)(2011-2#2)(2013-1#1)
overall pattern of##4##3##(1990-9#1)(1993-11#1)(1997-4#1)(2013-1#1)
overall pattern##6##2##(1990-9#1)(1993-11#1)(1994-12#1)(1996-5#1)(1997-4#1)(2013-1#1)
overall perceptions of##2##3##(2007-12#1)(2008-4#1)
overall performance of the##6##4##(1992-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)
overall performance of##10##3##(1992-12#1)(1992-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-11#1)(2010-12#1)
overall performance##15##2##(1992-12#1)(1992-8#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-11#1)(2009-6#1)(2010-12#1)(2012-2#1)
overall physical attractiveness##2##3##(2007-12#2)
overall physical##4##2##(2007-12#2)(2009-11#1)(2013-1#1)
overall physician##2##2##(2010-8#2)
overall picture##4##2##(1995-6#1)(2008-11#1)(2010-12#1)(2012-5#1)
overall plan##2##2##(2007-11#1)(2012-3#1)
overall plant##2##2##(2008-8#1)(2009-8#1)
overall population of##2##3##(1990-5#1)(2008-10#1)
overall population##5##2##(1990-5#1)(1993-5#1)(1995-9#1)(2008-10#1)(2008-7#1)
overall positive##3##2##(2008-11#1)(2010-2#1)(2013-8#1)
overall power##5##2##(1996-8#2)(2008-2#1)(2008-3#1)(2010-4#1)
overall precision of##5##3##(2008-10#1)(2013-1#4)
overall precision##8##2##(1996-6#1)(1997-2#1)(2008-10#2)(2013-1#4)
overall prevalence of##32##3##(1990-2#1)(2006-10#1)(2007-12#4)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
overall prevalence rate of##2##4##(1994-6#1)(2008-3#1)
overall prevalence##37##2##(1990-2#1)(1994-6#1)(2006-10#1)(2006-8#1)(2007-12#4)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#2)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
overall probability##2##2##(1992-11#1)(2007-8#1)
overall procedure##2##2##(1991-5#1)(2010-7#1)
overall process##7##2##(1996-5#1)(2005-11#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2009-3#1)
overall productivity##4##2##(1992-12#1)(1994-2#1)(2007-5#1)(2008-11#1)
overall profile##3##2##(1995-3#1)(2005-9#1)(2009-4#1)
overall prognosis for patients##2##4##(2006-10#1)(2009-10#1)
overall prognosis for##3##3##(2006-10#1)(2008-7#1)(2009-10#1)
overall prognosis##10##2##(2006-10#1)(2007-12#1)(2007-2#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-10#1)(2013-8#1)
overall protein##3##2##(1996-4#1)(2008-5#1)(2008-6#1)
overall psychological and##2##3##(2008-4#1)(2009-7#1)
overall psychological##3##2##(2008-4#1)(2009-7#1)(2012-2#1)
overall public health performance##2##4##(1995-12#1)(1996-12#1)
overall public health##3##3##(1995-12#1)(1996-12#1)(1997-3#1)
overall quality of life##4##4##(2005-10#1)(2008-1#1)(2008-6#1)(2009-7#1)
overall quality of##13##3##(1995-12#1)(2005-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#2)(2008-8#1)(2009-7#1)(2010-1#1)(2011-1#1)(2013-1#2)
overall rate of##19##3##(1991-11#1)(1991-2#1)(1991-8#1)(1993-11#2)(1994-2#1)(1994-8#2)(1995-2#1)(1996-11#1)(1997-1#1)(2006-10#2)(2006-8#1)(2007-3#1)(2008-10#1)(2008-7#2)(2012-2#1)
overall rate##24##2##(1991-11#1)(1991-2#1)(1991-8#1)(1993-11#3)(1994-2#1)(1994-8#2)(1995-10#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#1)(1997-1#1)(2006-10#2)(2006-8#1)(2007-3#2)(2008-10#1)(2008-7#2)(2012-2#1)
overall rate-determining step##2##3##(1997-4#2)
overall rates of##3##3##(1992-10#1)(1993-9#1)(2011-2#1)
overall rating##2##2##(1992-1#2)
overall ratio##5##2##(2010-2#5)
overall reaction##7##2##(1990-7#1)(1994-8#1)(2007-10#1)(2008-10#3)(2010-5#1)
overall recovery##2##2##(1993-9#1)(1996-6#1)
overall reduction in the number of##2##6##(2007-7#1)(2008-10#1)
overall reduction in the##3##4##(2007-7#1)(2008-10#2)
overall reduction in##5##3##(1994-6#1)(2007-10#1)(2007-7#1)(2008-10#2)
overall reduction##8##2##(1994-6#1)(2007-10#1)(2007-7#1)(2008-10#4)(2008-3#1)
overall relationship between##2##3##(1993-3#1)(1996-9#1)
overall relative risk##2##3##(1993-9#2)
overall relative##3##2##(1993-9#2)(2008-5#1)
overall response of##3##3##(2007-1#1)(2008-7#1)(2012-1#1)
overall response rate was##10##4##(1990-10#1)(1991-4#1)(1991-8#1)(1992-10#1)(1993-1#1)(2005-7#1)(2006-6#1)(2010-12#2)(2012-2#1)
overall response rate##18##3##(1990-10#1)(1991-4#1)(1991-8#1)(1992-10#1)(1993-1#1)(2005-7#2)(2006-12#1)(2006-6#1)(2007-11#2)(2008-10#3)(2008-6#1)(2010-12#2)(2012-2#1)
overall response rates##2##3##(1997-5#1)(2007-11#1)
overall response to##3##3##(1997-1#1)(2007-2#1)(2007-8#1)
overall response##29##2##(1990-10#1)(1991-4#1)(1991-8#1)(1992-10#1)(1993-1#1)(1994-6#1)(1997-1#1)(1997-5#1)(1997-6#1)(2005-7#2)(2006-12#1)(2006-6#1)(2007-1#1)(2007-11#3)(2007-2#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-6#1)(2008-7#1)(2010-12#2)(2012-1#1)(2012-2#1)
overall responsibility for##3##3##(2004-7#1)(2007-10#1)(2008-12#1)
overall responsibility##5##2##(1990-8#1)(1993-3#1)(2004-7#1)(2007-10#1)(2008-12#1)
overall results are##2##3##(1997-1#1)(2008-10#1)
overall results in##3##3##(2007-11#1)(2007-12#1)(2008-1#1)
overall results provide##2##3##(2008-2#1)(2008-8#1)
overall results##21##2##(1994-8#1)(1996-5#1)(1997-1#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-8#1)(2009-8#1)(2011-1#1)(2012-2#1)
overall retention##2##2##(1992-6#2)
overall rheology of##2##3##(2008-5#1)(2011-1#1)
overall risk##6##2##(1994-2#1)(2005-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-1#1)
overall role##2##2##(1993-11#1)(2010-3#1)
overall rotational##2##2##(1990-3#1)(1992-9#1)
overall sample##3##2##(1994-11#1)(2008-2#1)(2011-2#1)
overall sampling##2##2##(2008-10#1)(2008-3#1)
overall satisfaction##14##2##(1991-3#1)(1996-3#1)(1997-1#1)(1997-3#2)(2007-8#2)(2008-4#1)(2008-8#5)(2009-3#1)
overall score##5##2##(1996-7#2)(2008-7#1)(2009-11#2)
overall scores and##2##3##(2008-7#1)(2011-1#1)
overall scores##4##2##(1995-12#1)(2008-7#1)(2010-3#1)(2011-1#1)
overall secondary##4##2##(1994-9#1)(1995-8#1)(2006-10#1)(2008-4#1)
overall sensitivity and specificity of##2##5##(2006-5#1)(2007-7#1)
overall sensitivity and##3##3##(2006-5#1)(2007-7#1)(2008-3#1)
overall sensitivity of##5##3##(1996-12#1)(1997-5#1)(1997-8#1)(2005-8#1)(2010-12#1)
overall sensitivity##11##2##(1995-8#1)(1996-12#1)(1997-5#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-7#1)(2008-3#1)(2010-12#1)(2011-2#1)
overall sequence homology##2##3##(1991-2#1)(1995-12#1)
overall sequence##3##2##(1991-2#1)(1995-12#1)(2008-10#1)
overall service##5##2##(1995-3#3)(2008-8#2)
overall shape of the##4##4##(1994-9#1)(1997-5#1)(2008-3#1)(2012-2#1)
overall shape of##5##3##(1994-9#1)(1997-5#1)(2008-3#1)(2009-11#1)(2012-2#1)
overall shape##7##2##(1992-6#1)(1994-9#2)(1997-5#1)(2008-3#1)(2009-11#1)(2012-2#1)
overall similarities##2##2##(1991-6#1)(2008-10#1)
overall similarity of##3##3##(1991-9#1)(1995-5#1)(2008-9#1)
overall similarity##5##2##(1991-9#1)(1992-9#1)(1995-5#1)(2008-10#1)(2008-9#1)
overall size of the##3##4##(2007-12#1)(2008-8#1)(2012-2#1)
overall size##4##2##(2007-12#1)(2008-8#1)(2008-9#1)(2012-2#1)
overall stability constants##4##3##(2008-10#3)(2008-5#1)
overall stability of the##4##4##(1992-6#1)(1993-9#1)(2008-7#1)(2008-8#1)
overall stability of##7##3##(1992-2#1)(1992-6#1)(1993-6#1)(1993-9#1)(2008-7#1)(2008-8#1)(2013-1#1)
overall stability##11##2##(1992-2#1)(1992-6#1)(1993-6#1)(1993-9#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
overall strategy##4##2##(1991-3#1)(1993-1#1)(1994-3#1)(1996-1#1)
overall strength of evidence##3##4##(2012-12#3)
overall strength of##4##3##(2008-11#1)(2012-12#3)
overall strength##5##2##(2007-7#1)(2008-11#1)(2012-12#3)
overall structural similarity##2##3##(1995-3#1)(2011-1#1)
overall structural##5##2##(1994-8#1)(1994-9#1)(1995-3#1)(2007-8#1)(2011-1#1)
overall structure is similar##2##4##(1993-8#1)(1994-12#1)
overall structure is##3##3##(1993-8#2)(1994-12#1)
overall structure of the##5##4##(1991-5#1)(1991-6#1)(1995-1#1)(2008-3#1)(2011-12#1)
overall structure of##7##3##(1991-5#1)(1991-6#1)(1994-8#1)(1995-1#1)(1996-8#1)(2008-3#1)(2011-12#1)
overall structure##17##2##(1991-5#1)(1991-6#1)(1991-7#1)(1992-6#1)(1993-11#1)(1993-8#2)(1994-12#1)(1994-8#1)(1995-1#1)(1996-8#1)(1997-9#1)(2008-3#1)(2009-11#1)(2009-2#1)(2011-1#1)(2011-12#1)
overall success of the##2##4##(2012-12#1)(2013-1#1)
overall success of##3##3##(2012-12#1)(2013-1#2)
overall success rate in##2##4##(1990-6#1)(2008-12#1)
overall success rate##6##3##(1990-6#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-2#1)
overall success##12##2##(1990-6#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-12#3)(2012-2#1)(2013-1#2)
overall surgery##2##2##(1991-8#1)(2011-1#1)
overall surgical##2##2##(1990-10#1)(2011-2#1)
overall survival (OS) and##2##4##(2008-10#1)(2011-2#1)
overall survival (OS) in a##2##5##(1993-1#1)(2010-4#1)
overall survival (OS)##17##3##(1991-8#1)(1992-10#1)(1993-1#1)(2004-2#1)(2007-3#1)(2007-6#1)(2008-10#2)(2008-6#3)(2009-4#1)(2010-4#1)(2011-2#4)
overall survival advantage##2##3##(2006-9#1)(2008-3#1)
overall survival and disease-free##2##4##(1994-2#1)(2011-2#1)
overall survival and##10##3##(1990-6#1)(1991-4#1)(1992-4#1)(1994-2#1)(2007-10#1)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#2)
overall survival for##5##3##(2004-1#1)(2010-12#1)(2010-3#2)(2011-2#1)
overall survival has##3##3##(1997-6#1)(2006-10#1)(2009-3#1)
overall survival in patients with##2##5##(2009-8#1)(2010-11#1)
overall survival in patients##3##4##(2008-6#1)(2009-8#1)(2010-11#1)
overall survival in##6##3##(1994-6#1)(2004-2#1)(2008-3#1)(2008-6#1)(2009-8#1)(2010-11#1)
overall survival is##5##3##(2004-11#1)(2007-10#1)(2007-11#1)(2008-6#1)(2009-5#1)
overall survival of the##2##4##(2008-6#1)(2013-8#1)
overall survival of##10##3##(1996-11#1)(2004-1#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-6#2)(2010-5#1)(2011-2#1)(2013-8#1)
overall survival rate of##3##4##(2004-1#1)(2008-6#2)
overall survival rate##10##3##(1994-7#1)(1995-10#1)(2004-1#1)(2005-5#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-6#2)(2010-3#1)
overall survival rates were##2##4##(2006-6#1)(2009-2#1)
overall survival rates##5##3##(1996-6#1)(2006-6#1)(2007-8#1)(2009-2#1)(2010-3#1)
overall survival to##2##3##(1992-2#1)(2010-3#1)
overall survival was 14##2##4##(2006-6#1)(2010-12#1)
overall survival was 95%##2##4##(1991-8#1)(2007-8#1)
overall survival was##22##3##(1990-12#1)(1991-8#2)(1992-12#1)(1993-1#1)(2006-6#3)(2007-8#1)(2008-6#4)(2010-12#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
overall survival##161##2##(1990-12#2)(1990-2#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-4#2)(1991-8#3)(1992-10#1)(1992-12#1)(1992-2#2)(1992-4#1)(1993-1#2)(1994-12#1)(1994-2#1)(1994-6#1)(1994-7#1)(1995-10#1)(1995-4#1)(1995-8#1)(1996-11#2)(1996-6#1)(1997-6#1)(2004-1#3)(2004-11#1)(2004-2#2)(2005-5#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-6#10)(2006-9#2)(2007-10#2)(2007-11#6)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-5#3)(2008-6#25)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-11#3)(2010-12#4)(2010-3#6)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#15)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#3)
overall system performance##2##3##(2008-10#1)(2008-3#1)
overall system##13##2##(1994-12#1)(1994-8#1)(1996-8#1)(2006-10#1)(2008-10#1)(2008-2#5)(2008-3#2)(2013-1#1)
overall tendency##2##2##(1992-11#1)(2013-8#1)
overall than##2##2##(1995-5#1)(2006-5#1)
overall the##3##2##(1990-2#1)(2008-5#1)(2011-2#1)
overall therapeutic##2##2##(1990-2#1)(2008-5#1)
overall time of##2##3##(2005-11#1)(2008-10#1)
overall time##3##2##(2005-11#1)(2008-10#1)(2012-1#1)
overall tissue##2##2##(2007-11#1)(2007-8#1)
overall topology of##3##3##(1993-6#1)(1994-2#1)(1994-5#1)
overall treatment effect##2##3##(1996-3#1)(2013-1#1)
overall treatment time##5##3##(1992-10#2)(1994-4#1)(1994-7#1)(1995-4#1)
overall treatment##18##2##(1991-12#1)(1992-10#2)(1993-2#1)(1994-4#2)(1994-7#1)(1995-1#1)(1995-2#1)(1995-4#1)(1996-3#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-6#1)(2010-10#1)(2013-1#2)
overall trend##3##2##(2006-8#1)(2007-12#1)(2009-12#1)
overall trends##2##2##(1991-8#1)(2008-7#1)
overall tumor##2##2##(2008-6#1)(2009-11#1)
overall uncertainty##5##2##(2008-10#2)(2008-3#2)(2011-2#1)
overall understanding of the##2##4##(1997-1#1)(2008-10#1)
overall use of##3##3##(1994-2#1)(2006-7#1)(2013-1#1)
overall usefulness in##2##3##(1996-9#1)(2008-3#1)
overall usefulness##4##2##(1996-9#1)(2007-1#1)(2008-11#1)(2008-3#1)
overall variability##2##2##(2008-10#1)(2010-3#1)
overall view of the##2##4##(1990-3#1)(2009-12#1)
overall water splitting##2##3##(2010-7#2)
overall weight##2##2##(2004-11#1)(2011-2#1)
overall were##3##2##(1992-10#1)(2006-8#1)(2011-2#1)
overall with##3##2##(1990-11#1)(1991-3#1)(2010-8#1)
overall yield and##2##3##(1996-5#1)(2008-10#1)
overall yield of##9##3##(1990-12#1)(1990-3#1)(1990-7#1)(1992-1#1)(1996-3#1)(1996-5#2)(2005-11#1)(2008-4#1)
overall yield##16##2##(1990-12#1)(1990-3#1)(1990-7#1)(1992-1#1)(1996-3#1)(1996-5#5)(2005-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)(2013-8#1)
overall yields##5##2##(1996-5#1)(2007-11#2)(2008-4#1)(2009-5#1)
overall##1993##1##(1990-10#6)(1990-11#3)(1990-12#16)(1990-2#6)(1990-3#5)(1990-4#5)(1990-5#2)(1990-6#6)(1990-7#3)(1990-8#8)(1990-9#4)(1991-10#2)(1991-11#2)(1991-12#6)(1991-2#13)(1991-3#7)(1991-4#6)(1991-5#7)(1991-6#7)(1991-7#2)(1991-8#11)(1991-9#5)(1992-1#4)(1992-10#9)(1992-11#7)(1992-12#9)(1992-2#9)(1992-3#1)(1992-4#4)(1992-6#10)(1992-7#1)(1992-8#5)(1992-9#7)(1993-1#5)(1993-11#10)(1993-12#9)(1993-2#3)(1993-3#9)(1993-4#1)(1993-5#4)(1993-6#5)(1993-7#2)(1993-8#2)(1993-9#12)(1994-1#1)(1994-10#2)(1994-11#2)(1994-12#13)(1994-2#8)(1994-3#3)(1994-4#2)(1994-5#4)(1994-6#10)(1994-7#3)(1994-8#8)(1994-9#8)(1995-1#9)(1995-10#3)(1995-11#2)(1995-12#10)(1995-2#8)(1995-3#11)(1995-4#7)(1995-5#11)(1995-6#5)(1995-7#2)(1995-8#7)(1995-9#6)(1996-1#2)(1996-10#4)(1996-11#7)(1996-12#9)(1996-2#5)(1996-3#11)(1996-4#4)(1996-5#13)(1996-6#7)(1996-7#10)(1996-8#8)(1996-9#5)(1997-1#14)(1997-2#13)(1997-3#10)(1997-4#5)(1997-5#8)(1997-6#3)(1997-7#4)(1997-8#13)(1997-9#1)(2003-11#1)(2004-1#5)(2004-11#4)(2004-12#3)(2004-2#3)(2004-3#4)(2004-4#1)(2004-7#1)(2004-9#1)(2005-10#5)(2005-11#15)(2005-12#1)(2005-4#1)(2005-5#4)(2005-7#5)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#31)(2006-11#9)(2006-12#10)(2006-2#11)(2006-4#3)(2006-5#7)(2006-6#14)(2006-7#3)(2006-8#14)(2006-9#5)(2007-1#5)(2007-10#11)(2007-11#48)(2007-12#36)(2007-2#8)(2007-3#10)(2007-4#7)(2007-5#12)(2007-6#5)(2007-7#21)(2007-8#34)(2007-9#10)(2008-1#27)(2008-10#153)(2008-11#33)(2008-12#24)(2008-2#41)(2008-3#52)(2008-4#27)(2008-5#38)(2008-6#49)(2008-7#44)(2008-8#37)(2008-9#18)(2009-1#1)(2009-10#4)(2009-11#9)(2009-12#4)(2009-2#7)(2009-3#8)(2009-4#7)(2009-5#7)(2009-6#2)(2009-7#4)(2009-8#10)(2009-9#4)(2010-1#5)(2010-10#4)(2010-11#4)(2010-12#20)(2010-2#20)(2010-3#18)(2010-4#19)(2010-5#8)(2010-6#4)(2010-7#9)(2010-8#14)(2010-9#8)(2011-1#33)(2011-10#1)(2011-12#5)(2011-2#69)(2011-3#3)(2012-1#15)(2012-11#1)(2012-12#24)(2012-2#50)(2012-3#17)(2012-4#1)(2012-5#1)(2013-1#61)(2013-7#6)(2013-8#29)
overall)##4##1##(1992-8#1)(2008-1#1)(2010-4#1)(2012-3#1)
overarching theme##2##2##(2007-8#1)(2012-3#1)
overarching##19##1##(1993-12#1)(1996-2#1)(1996-3#1)(2006-6#2)(2007-4#1)(2007-8#2)(2008-1#1)(2008-4#1)(2008-7#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#1)
overbite##5##1##(2010-2#3)(2012-12#2)
overburdened##2##1##(2009-12#1)(2013-8#1)
overcame the resistance##2##3##(2008-10#2)
overcame the##5##2##(1993-12#1)(2007-12#1)(2007-3#1)(2008-10#2)
overcame##8##1##(1993-12#1)(1994-8#1)(2007-12#1)(2007-3#1)(2008-10#3)(2012-2#1)
overcast conditions##2##2##(2008-10#1)(2008-3#1)
overcast##7##1##(1994-3#1)(2008-10#2)(2008-3#4)
overcoat##2##1##(2007-10#1)(2010-4#1)
overcoating##3##1##(2008-2#1)(2008-3#2)
overcome a##4##2##(1993-12#1)(2008-1#1)(2008-7#2)
overcome and##3##2##(1997-8#1)(2007-7#1)(2008-10#1)
overcome any##2##2##(1995-1#1)(2008-10#1)
overcome barriers to##2##3##(2006-4#1)(2013-1#1)
overcome by increasing the concentration of##2##6##(1990-5#1)(1997-2#1)
overcome by increasing the##3##4##(1990-5#1)(1994-8#1)(1997-2#1)
overcome by increasing##4##3##(1990-5#1)(1994-8#1)(1997-2#1)(2008-4#1)
overcome by the##7##3##(1990-2#1)(1994-3#1)(1994-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2013-8#1)
overcome by use of##2##4##(2008-3#2)
overcome by##51##2##(1990-2#3)(1990-5#1)(1990-6#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-3#3)(1994-8#4)(1995-7#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-7#1)(2007-12#2)(2007-6#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-6#1)(2011-1#1)(2011-12#1)(2012-1#1)(2013-1#1)(2013-8#1)
overcome existing##2##2##(1992-12#1)(2012-12#1)
overcome if##2##2##(2008-10#1)(2009-6#1)
overcome in##5##2##(1994-5#1)(2006-10#1)(2007-11#1)(2008-10#1)(2012-3#1)
overcome its##2##2##(2008-10#1)(2009-11#1)
overcome limitations of##3##3##(2008-1#1)(2008-11#1)(2010-2#1)
overcome limitations##4##2##(2006-7#1)(2008-1#1)(2008-11#1)(2010-2#1)
overcome or##2##2##(2006-10#1)(2007-4#1)
overcome problems of##3##3##(1992-1#1)(1994-11#1)(2012-12#1)
overcome problems related to the##2##5##(1996-12#1)(2008-10#1)
overcome problems##5##2##(1992-1#1)(1994-11#1)(1996-12#1)(2008-10#1)(2012-12#1)
overcome some of the limitations##5##5##(2008-1#1)(2008-10#1)(2010-6#1)(2013-1#2)
overcome some of the##7##4##(2005-5#1)(2006-6#1)(2008-1#1)(2008-10#1)(2010-6#1)(2013-1#2)
overcome some of these limitations##2##5##(2008-5#1)(2008-7#1)
overcome some of these##3##4##(2005-8#1)(2008-5#1)(2008-7#1)
overcome some of##10##3##(2005-5#1)(2005-8#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-6#1)(2013-1#2)
overcome some##13##2##(2005-5#1)(2005-8#1)(2006-6#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-6#1)(2011-2#1)(2013-1#2)
overcome spectral##2##2##(1994-11#1)(2007-12#1)
overcome such problems##3##3##(1993-2#1)(2007-6#1)(2008-2#1)
overcome such##7##2##(1993-2#1)(1994-6#1)(2007-11#1)(2007-6#1)(2008-2#1)(2008-4#1)(2008-8#1)
overcome the challenge##2##3##(2008-10#1)(2008-2#1)
overcome the challenges of##2##4##(1996-1#1)(2006-8#1)
overcome the difficulties##3##3##(1995-6#1)(2008-2#1)(2012-12#1)
overcome the inhibition##2##3##(1994-2#1)(2008-8#1)
overcome the inhibitory effects of##2##5##(1990-11#1)(2007-11#1)
overcome the inhibitory##3##3##(1990-11#1)(1997-4#1)(2007-11#1)
overcome the limitations of##6##4##(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-3#1)
overcome the limitations##7##3##(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-3#1)
overcome the limits of##2##4##(2006-2#1)(2010-8#1)
overcome the problem of##4##4##(2006-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
overcome the problem##6##3##(2006-10#1)(2006-12#1)(2008-2#1)(2008-3#2)(2008-9#1)
overcome the shortcomings##2##3##(2005-9#1)(2011-1#1)
overcome the weaknesses of##2##4##(1997-3#1)(2011-1#1)
overcome the##116##2##(1990-11#1)(1991-11#2)(1991-2#3)(1991-5#1)(1991-9#1)(1992-3#1)(1992-5#1)(1993-6#1)(1994-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-8#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#6)(2007-12#6)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#14)(2008-11#1)(2008-2#5)(2008-3#7)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#3)(2011-1#2)(2012-12#6)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#1)
overcome their##4##2##(1996-7#1)(2005-4#1)(2007-8#1)(2008-2#1)
overcome these barriers##5##3##(2010-11#1)(2013-1#4)
overcome these challenges##5##3##(1996-2#1)(2006-6#1)(2007-5#1)(2011-2#1)(2013-8#1)
overcome these difficulties##5##3##(2007-8#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-12#1)
overcome these drawbacks##3##3##(2008-7#1)(2010-5#1)(2010-6#1)
overcome these limitations by##2##4##(2007-11#1)(2009-6#1)
overcome these limitations##13##3##(1996-4#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-6#1)(2012-12#1)(2012-3#2)
overcome these problems##10##3##(1996-3#1)(2007-7#1)(2008-1#1)(2008-11#1)(2009-11#1)(2009-2#1)(2010-12#1)(2011-1#1)(2013-1#2)
overcome these two problems##3##4##(2008-2#1)(2008-3#1)(2008-5#1)
overcome these##50##2##(1996-2#1)(1996-3#1)(1996-4#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-3#2)(2013-1#6)(2013-8#1)
overcome this difficulty##4##3##(2009-11#1)(2012-2#1)(2013-1#2)
overcome this drawback##4##3##(1997-7#1)(2008-10#1)(2009-10#1)(2013-7#1)
overcome this limitation##12##3##(1991-9#1)(1994-2#1)(2006-12#1)(2007-11#2)(2008-1#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-7#1)
overcome this problem##16##3##(1992-2#1)(1995-2#1)(1996-12#1)(1997-1#1)(1997-4#2)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-6#1)(2012-2#1)(2013-1#2)
overcome this##55##2##(1991-9#1)(1992-2#1)(1994-2#1)(1994-6#1)(1995-2#1)(1996-12#1)(1997-1#1)(1997-4#2)(1997-7#1)(1997-8#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-11#2)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#2)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)
overcome treatment##2##2##(2009-11#1)(2011-2#1)
overcome using##2##2##(2008-10#1)(2009-11#1)
overcome with##6##2##(1990-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-1#1)
overcome##485##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#1)(1991-11#3)(1991-2#3)(1991-5#1)(1991-7#2)(1991-9#3)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#5)(1994-5#1)(1994-6#3)(1994-8#4)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-1#3)(1996-11#1)(1996-12#5)(1996-2#3)(1996-3#2)(1996-4#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#4)(1997-2#1)(1997-3#3)(1997-4#4)(1997-6#1)(1997-7#1)(1997-8#3)(2004-2#1)(2005-4#1)(2005-5#1)(2005-6#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#7)(2006-11#2)(2006-12#3)(2006-2#4)(2006-4#1)(2006-6#4)(2006-7#3)(2006-8#2)(2006-9#2)(2007-11#13)(2007-12#13)(2007-4#2)(2007-5#6)(2007-6#3)(2007-7#6)(2007-8#7)(2007-9#2)(2008-1#11)(2008-10#51)(2008-11#17)(2008-12#2)(2008-2#13)(2008-3#14)(2008-4#7)(2008-5#13)(2008-6#9)(2008-7#12)(2008-8#6)(2008-9#7)(2009-10#3)(2009-11#9)(2009-12#4)(2009-2#3)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#3)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#5)(2010-2#2)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#5)(2010-9#1)(2011-1#6)(2011-12#4)(2011-2#6)(2011-7#1)(2012-1#4)(2012-11#2)(2012-12#16)(2012-2#9)(2012-3#9)(2013-1#21)(2013-7#4)(2013-8#3)
overcomes some##2##2##(2008-2#1)(2012-3#1)
overcomes the limitations##2##3##(1997-2#1)(2007-11#1)
overcomes the##24##2##(1995-12#1)(1996-5#1)(1997-2#1)(2005-9#1)(2007-11#2)(2007-12#3)(2007-7#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-12#1)(2013-7#1)
overcomes these problems##2##3##(2008-5#1)(2008-7#1)
overcomes these##5##2##(2007-11#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)
overcomes this##3##2##(2007-12#1)(2008-1#1)(2008-2#1)
overcomes##42##1##(1995-12#1)(1995-6#1)(1996-5#2)(1997-2#1)(2005-9#1)(2007-11#3)(2007-12#6)(2007-7#2)(2008-1#2)(2008-10#6)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-12#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
overcoming limitations##2##2##(2008-3#1)(2012-1#1)
overcoming of##3##2##(1991-9#1)(1996-9#1)(2008-8#1)
overcoming problems of##2##3##(2008-10#1)(2008-4#1)
overcoming problems##3##2##(2008-10#1)(2008-4#1)(2008-5#1)
overcoming some of the##2##4##(1995-3#1)(2008-4#1)
overcoming the limitations of##2##4##(2008-2#1)(2008-3#1)
overcoming the problem of##4##4##(1993-12#1)(2007-10#1)(2008-11#2)
overcoming the##26##2##(1991-3#1)(1991-5#1)(1993-12#1)(1993-3#1)(1994-6#1)(1997-8#1)(2005-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#1)(2009-12#1)(2010-3#1)(2012-1#1)(2012-2#1)
overcoming them##2##2##(1997-3#1)(2011-1#1)
overcoming these limitations##2##3##(2008-2#1)(2008-4#1)
overcoming this limitation##2##3##(2008-10#1)(2013-7#1)
overcoming this##7##2##(1991-8#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2012-12#1)(2013-7#1)
overcoming##79##1##(1990-10#1)(1990-3#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1993-12#1)(1993-3#1)(1994-6#2)(1995-3#1)(1995-4#1)(1996-11#1)(1996-9#1)(1997-3#2)(1997-8#1)(2005-7#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-2#4)(2008-3#3)(2008-4#5)(2008-5#1)(2008-8#1)(2009-12#2)(2009-2#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
overcompensation##6##1##(2005-11#3)(2008-8#2)(2008-9#1)
overcomplete##4##1##(2006-4#1)(2008-2#3)
overcorrection##2##1##(2008-3#2)
overcoupled##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
overcoverage##2##1##(2011-12#2)
overcrowded##2##1##(1992-6#1)(2007-7#1)
overcrowding and##2##2##(1997-7#1)(2013-1#1)
overcrowding in##5##2##(2007-5#1)(2007-7#1)(2009-4#1)(2012-11#1)(2013-8#1)
overcrowding##25##1##(1997-4#1)(1997-7#1)(2006-2#1)(2007-3#1)(2007-5#2)(2007-7#3)(2008-11#6)(2008-3#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-11#2)(2012-2#1)(2013-1#1)(2013-8#1)
overdenture##4##1##(2009-4#2)(2011-12#1)(2013-1#1)
overdentures##8##1##(2008-4#2)(2011-12#1)(2013-1#5)
overdetermined##5##1##(2008-10#1)(2008-3#2)(2008-6#1)(2008-7#1)
overdiagnosis##6##1##(2007-9#1)(2013-1#5)
overdispersed##3##1##(2008-10#1)(2008-8#2)
overdispersion of disease##2##3##(2008-10#2)
overdispersion##5##1##(2008-10#4)(2008-8#1)
overdominance or underdominance##2##3##(2008-10#2)
overdominance##5##1##(1995-2#1)(2008-10#3)(2013-1#1)
overdosage in a##2##3##(2011-1#2)
overdosage##9##1##(1991-9#2)(2006-4#2)(2007-11#1)(2007-12#1)(2008-11#1)(2011-1#2)
overdose and##6##2##(2005-8#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-6#1)
overdose have been reported##2##4##(2010-1#1)(2010-3#1)
overdose have##3##2##(2010-1#2)(2010-3#1)
overdose in a##2##3##(2006-4#1)(2009-6#1)
overdose in infants##2##3##(1990-6#1)(1996-8#1)
overdose in##6##2##(1990-6#1)(1991-8#1)(1993-8#1)(1996-8#1)(2006-4#1)(2009-6#1)
overdose is##3##2##(2006-4#1)(2009-9#1)(2013-1#1)
overdose mortality##2##2##(1991-2#2)
overdose of##9##2##(1991-6#1)(1997-5#1)(2005-8#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-4#1)(2011-1#1)
overdose with##5##2##(1990-6#1)(1991-8#1)(2007-7#2)(2012-12#1)
overdose##80##1##(1990-6#3)(1991-1#1)(1991-2#6)(1991-6#1)(1991-8#4)(1993-8#1)(1995-8#1)(1996-1#1)(1996-8#1)(1997-3#1)(1997-5#2)(2005-8#6)(2006-10#1)(2006-2#1)(2006-4#7)(2007-12#2)(2007-7#7)(2007-8#2)(2008-10#2)(2008-11#1)(2008-4#3)(2008-6#1)(2009-6#5)(2009-8#1)(2009-9#3)(2010-1#5)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#3)
overdose)##2##1##(1991-9#1)(2008-6#1)
overdoses are##2##2##(2010-9#1)(2012-12#1)
overdoses##11##1##(1991-2#1)(2005-9#2)(2006-10#1)(2007-7#1)(2009-6#1)(2010-1#1)(2010-9#1)(2012-12#2)(2013-1#1)
overdosing is##2##2##(1996-11#1)(2008-3#1)
overdosing##6##1##(1996-11#1)(1996-9#2)(2005-8#1)(2006-10#1)(2008-3#1)
overdrainage##3##1##(2006-8#1)(2009-6#1)(2012-12#1)
overdue for##3##2##(2010-8#3)
overdue##8##1##(1992-10#1)(2007-2#1)(2008-11#1)(2010-8#4)(2013-1#1)
overeating##4##1##(1995-12#1)(1996-1#1)(2011-2#1)(2013-1#1)
overestimate the degree of##3##4##(2007-12#2)(2008-7#1)
overestimate the risk of##2##4##(1996-4#1)(2010-8#1)
overestimate the##9##2##(1992-6#1)(1993-2#1)(1996-4#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-7#1)(2010-8#1)
overestimate##19##1##(1992-6#1)(1993-2#1)(1995-4#1)(1996-12#1)(1996-4#2)(2005-10#1)(2007-12#2)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2010-8#1)(2012-11#1)(2013-1#1)
overestimated at##2##2##(2008-10#2)
overestimated by##2##2##(2008-10#1)(2012-2#1)
overestimated in the##3##3##(1990-11#1)(1997-3#1)(2008-10#1)
overestimated in##4##2##(1990-11#1)(1997-3#1)(2008-10#2)
overestimated the##11##2##(2005-10#1)(2006-12#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-5#1)(2009-7#1)(2011-12#2)(2013-1#1)
overestimated their##2##2##(2007-12#1)(2012-12#1)
overestimated##50##1##(1990-11#1)(1993-2#1)(1993-7#1)(1995-2#1)(1996-8#2)(1997-3#1)(1997-6#1)(2005-10#1)(2005-11#1)(2006-12#1)(2006-3#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-8#3)(2007-9#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-7#1)(2010-5#1)(2010-8#1)(2011-12#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#1)
overestimates the##2##2##(1990-5#1)(2009-3#1)
overestimates##8##1##(1990-5#1)(1995-1#1)(2007-12#1)(2007-9#1)(2008-3#1)(2008-6#1)(2009-3#1)(2013-1#1)
overestimating the##2##2##(1994-3#1)(2008-10#1)
overestimating##5##1##(1994-3#1)(2008-10#1)(2008-3#1)(2010-8#1)(2012-3#1)
overestimation of the##8##3##(1990-2#1)(1992-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-7#2)
overestimation of##20##2##(1990-2#1)(1992-8#1)(1992-9#1)(1994-3#1)(1994-4#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-2#1)(2009-7#2)(2011-1#1)(2011-2#1)
overestimation was##2##2##(2007-12#2)
overestimation##27##1##(1990-2#1)(1992-8#1)(1992-9#1)(1993-7#1)(1994-3#1)(1994-4#1)(2007-12#4)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#1)(2009-2#1)(2009-7#2)(2011-1#1)(2011-2#1)
overexposed##2##1##(1996-12#1)(2013-8#1)
overexposure##3##1##(2007-11#1)(2007-8#1)(2013-8#1)
overexpress the##7##2##(1992-7#1)(1997-7#1)(2007-9#1)(2008-11#2)(2008-6#1)(2012-2#1)
overexpress##22##1##(1990-5#1)(1990-9#1)(1992-7#1)(1993-1#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-6#1)(1997-7#1)(2007-9#2)(2008-11#3)(2008-6#1)(2009-3#1)(2009-8#1)(2011-1#1)(2012-2#1)
overexpressed a##2##2##(1994-9#1)(2008-10#1)
overexpressed and##2##2##(1995-2#1)(2008-4#1)
overexpressed in E##3##3##(1991-11#1)(1995-12#1)(2008-7#1)
overexpressed in Escherichia coli##10##4##(1990-4#1)(1991-8#1)(1992-3#1)(1992-6#1)(1994-12#1)(1995-8#2)(2008-10#2)(2011-2#1)
overexpressed in human##3##3##(2008-4#1)(2010-12#2)
overexpressed in most human cancers##3##5##(2012-2#3)
overexpressed in senescent human fibroblasts##2##5##(1992-9#2)
overexpressed in the##7##3##(1994-12#1)(1994-8#1)(2006-10#1)(2008-11#1)(2009-10#1)(2010-11#1)(2010-2#1)
overexpressed in##53##2##(1990-4#1)(1991-11#1)(1991-8#1)(1992-11#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#2)(1994-11#1)(1994-12#2)(1994-8#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#3)(1997-4#1)(1997-7#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-2#2)(2011-2#3)(2012-1#1)(2012-2#3)(2013-8#1)
overexpressed maize AChE gene in##2##5##(2009-8#2)
overexpressed the##2##2##(1995-2#1)(2008-10#1)
overexpressed##106##1##(1990-4#2)(1990-9#2)(1991-11#1)(1991-7#3)(1991-8#1)(1992-11#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#2)(1994-11#3)(1994-12#4)(1994-3#1)(1994-5#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-8#5)(1996-4#1)(1996-5#1)(1997-4#1)(1997-6#2)(1997-7#1)(2005-12#1)(2005-8#1)(2006-10#1)(2007-11#2)(2007-8#1)(2008-10#9)(2008-11#6)(2008-4#2)(2008-5#3)(2008-7#3)(2009-10#1)(2009-2#1)(2009-7#1)(2009-8#6)(2010-11#1)(2010-12#4)(2010-2#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#3)(2013-1#2)(2013-8#1)
overexpressing EGFR##2##2##(2008-11#2)
overexpressing bcl-2##2##2##(1997-2#1)(1997-7#1)
overexpressing cell line##2##3##(1995-1#2)
overexpressing cell##3##2##(1994-5#1)(1995-1#2)
overexpressing cells##3##2##(1994-5#1)(1995-1#1)(1997-6#1)
overexpressing either##3##2##(1995-2#1)(1997-1#1)(2012-12#1)
overexpressing mutant##2##2##(1994-12#1)(2012-12#1)
overexpressing the human##5##3##(1992-12#1)(1992-8#2)(1995-6#1)(2007-1#1)
overexpressing the##12##2##(1991-5#1)(1992-12#1)(1992-8#2)(1993-6#1)(1994-11#1)(1995-6#2)(1997-3#1)(2007-1#1)(2012-3#1)(2013-1#1)
overexpressing transfectants##2##2##(1993-1#2)
overexpressing##71##1##(1991-2#1)(1991-5#1)(1992-12#1)(1992-8#2)(1993-1#3)(1993-11#2)(1993-3#1)(1993-6#1)(1994-11#4)(1994-12#1)(1994-5#2)(1995-1#3)(1995-2#2)(1995-6#3)(1995-8#1)(1996-11#3)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#3)(2007-1#3)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-4#2)(2008-8#3)(2009-10#1)(2009-8#2)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)
overexpression and its relationship to##2##5##(2013-1#2)
overexpression and##12##2##(1993-1#1)(1995-6#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
overexpression has been##4##3##(2010-7#1)(2011-12#1)(2012-12#1)(2013-1#1)
overexpression in breast##2##3##(1993-11#1)(2010-7#1)
overexpression in human cancers##3##4##(1997-7#1)(2011-1#1)(2012-12#1)
overexpression in human##5##3##(1993-1#1)(1995-1#1)(1997-7#1)(2011-1#1)(2012-12#1)
overexpression in the##3##3##(1995-8#1)(2005-11#1)(2013-1#1)
overexpression in##21##2##(1990-3#1)(1992-8#1)(1993-1#1)(1993-11#1)(1995-1#1)(1995-8#1)(1995-9#1)(1997-7#1)(2005-11#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-1#4)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
overexpression is##2##2##(2008-5#1)(2009-8#1)
overexpression may##2##2##(1994-11#1)(2004-1#1)
overexpression of EGFR##2##3##(1992-12#2)
overexpression of LDL receptors##2##4##(1990-11#2)
overexpression of MEK kinase##3##4##(1996-5#3)
overexpression of Pck##2##3##(1994-11#2)
overexpression of Sp1##2##3##(1992-12#2)
overexpression of a##4##3##(1996-5#2)(1997-4#1)(1997-7#1)
overexpression of copper- and zinc-containing superoxide dismutase##2##7##(1995-6#2)
overexpression of cyclin D1##2##4##(2010-11#1)(2010-12#1)
overexpression of human##2##3##(1995-6#2)
overexpression of p53 protein##2##4##(2008-10#1)(2009-8#1)
overexpression of p53##6##3##(1990-9#1)(2008-10#3)(2009-8#1)(2010-10#1)
overexpression of recombinant##2##3##(2008-1#1)(2008-4#1)
overexpression of the human##2##4##(1994-8#1)(1996-8#1)
overexpression of the##27##3##(1991-2#1)(1991-8#1)(1992-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-4#1)(1995-8#2)(1996-8#1)(1997-6#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#1)
overexpression of this##2##3##(1995-1#1)(2009-8#1)
overexpression of two##2##3##(1994-8#1)(1996-5#1)
overexpression of##148##2##(1990-11#3)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-12#6)(1992-8#1)(1993-11#1)(1993-3#1)(1993-5#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-2#2)(1995-3#2)(1995-4#1)(1995-6#7)(1995-8#2)(1996-11#1)(1996-4#1)(1996-5#8)(1996-8#1)(1997-1#1)(1997-4#4)(1997-6#2)(1997-7#2)(2003-11#1)(2005-11#2)(2005-7#1)(2006-12#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#7)(2008-11#12)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#4)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-2#5)(2012-12#1)(2012-2#3)(2013-1#6)(2013-8#1)
overexpression on the##2##3##(2008-7#1)(2012-2#1)
overexpression on##8##2##(1997-7#2)(2004-1#1)(2008-7#1)(2009-10#1)(2009-8#1)(2012-2#1)(2013-8#1)
overexpression system##2##2##(1995-8#1)(2008-2#1)
overexpression was not sufficient to##2##5##(1994-9#1)(1997-7#1)
overexpression was seen in##2##4##(2004-1#1)(2007-10#1)
overexpression was##6##2##(1994-9#1)(1997-7#1)(2004-1#2)(2007-10#1)(2011-2#1)
overexpression##264##1##(1990-11#3)(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-12#2)(1991-2#2)(1991-8#1)(1992-11#1)(1992-12#6)(1992-7#1)(1992-8#2)(1993-1#2)(1993-11#2)(1993-3#1)(1993-5#1)(1993-8#1)(1994-10#1)(1994-11#4)(1994-12#1)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#4)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-6#8)(1995-8#4)(1995-9#1)(1996-11#1)(1996-4#2)(1996-5#8)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#4)(1997-6#2)(1997-7#7)(2003-11#1)(2004-1#4)(2005-11#3)(2005-7#1)(2005-8#1)(2006-12#1)(2007-1#1)(2007-10#5)(2007-11#1)(2007-2#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#12)(2008-11#16)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#9)(2008-8#3)(2008-9#2)(2009-10#6)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#9)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#4)(2010-9#1)(2011-1#12)(2011-12#2)(2011-2#10)(2012-12#7)(2012-2#6)(2012-3#3)(2013-1#13)(2013-7#1)(2013-8#4)
overexpressors##3##1##(2009-10#1)(2009-8#2)
overfeeding##2##1##(2005-10#2)
overfilling##3##1##(1991-2#1)(1991-3#1)(2007-10#1)
overfished##2##1##(2011-2#1)(2013-7#1)
overfishing##3##1##(2007-5#2)(2013-7#1)
overfitted##4##1##(1996-2#2)(2006-5#2)
overfitting and##2##2##(2008-10#1)(2008-4#1)
overfitting##8##1##(1995-2#1)(1995-6#3)(1995-9#1)(2008-10#1)(2008-4#2)
overflow of##3##2##(1990-11#1)(2007-8#1)(2008-2#1)
overflow##11##1##(1990-11#1)(1992-10#1)(1993-12#1)(1996-1#1)(1997-1#1)(1997-2#1)(2006-10#1)(2007-8#1)(2008-2#1)(2008-7#1)(2013-7#1)
overglaze##2##1##(1997-4#2)
overgo##2##1##(2008-7#1)(2012-3#1)
overgrow##2##1##(2009-5#1)(2011-2#1)
overgrown##4##1##(1992-10#1)(1997-5#1)(2008-10#1)(2012-12#1)
overgrowth and##2##2##(2007-2#1)(2013-7#1)
overgrowth as##2##2##(2007-2#1)(2011-2#1)
overgrowth by macroalgae##2##3##(2011-2#2)
overgrowth in##3##2##(2006-8#1)(2008-9#1)(2011-2#1)
overgrowth of##5##2##(1991-11#1)(1992-10#1)(2008-11#1)(2008-9#1)(2009-4#1)
overgrowth or##2##2##(2012-2#1)(2013-7#1)
overgrowth syndrome##2##2##(2010-12#1)(2011-2#1)
overgrowth##45##1##(1991-11#2)(1992-10#1)(2006-10#1)(2006-2#1)(2006-8#2)(2007-2#3)(2007-8#1)(2008-11#6)(2008-5#1)(2008-8#1)(2008-9#3)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#2)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#3)
overhang##9##1##(1990-10#2)(1993-12#1)(2006-8#1)(2008-11#1)(2010-2#4)
overhangs##5##1##(1990-10#1)(2008-4#3)(2010-2#1)
overhaul of the##3##3##(1992-12#1)(1994-8#1)(1996-5#1)
overhaul of##5##2##(1992-12#1)(1994-8#1)(1995-2#1)(1996-2#1)(1996-5#1)
overhaul##12##1##(1992-12#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-7#1)(2007-8#1)(2012-3#1)
overhauling##2##1##(1995-1#1)(1996-2#1)
overhead costs##2##2##(1995-2#1)(2007-9#1)
overhead drilling##3##2##(2008-12#3)
overhead power##2##2##(1992-2#1)(2008-3#1)
overhead sprinkling irrigation##2##3##(2008-10#2)
overhead throwing##2##2##(2008-8#2)
overhead##33##1##(1991-2#1)(1991-3#1)(1992-2#1)(1992-9#1)(1995-2#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#3)(2008-6#1)(2008-8#3)(2013-1#3)(2013-8#1)
overheating and##3##2##(1992-11#1)(1993-12#1)(2012-11#1)
overheating##6##1##(1992-11#1)(1992-4#3)(1993-12#1)(2012-11#1)
overhydration##3##1##(2007-11#2)(2010-1#1)
overinflation##3##1##(2005-11#1)(2006-10#1)(2009-8#1)
overinfuse if##2##2##(2011-2#2)
overjet and overbite##3##3##(2010-2#1)(2012-12#2)
overjet##9##1##(2009-7#1)(2010-2#3)(2011-2#3)(2012-12#2)
overlaid on the##2##3##(1993-4#1)(2006-5#1)
overlaid on##4##2##(1993-4#1)(2006-5#1)(2007-11#1)(2008-3#1)
overlaid with##2##2##(2008-4#1)(2008-8#1)
overlaid##11##1##(1993-4#1)(2004-2#1)(2006-5#1)(2007-11#2)(2008-3#3)(2008-4#1)(2008-8#1)(2012-2#1)
overlap among##5##2##(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#2)
overlap and##12##2##(1994-11#1)(1994-12#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-4#1)(2009-2#1)
overlap at the##2##3##(2008-2#1)(2011-2#1)
overlap at##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2011-2#1)
overlap between species##2##3##(2006-12#1)(2007-3#1)
overlap between the two##2##4##(2007-11#1)(2008-10#1)
overlap between the##15##3##(1994-12#1)(1995-11#1)(1995-12#1)(1995-8#1)(2005-8#1)(2006-10#1)(2006-12#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-2#1)(2009-8#1)(2011-1#1)
overlap between##34##2##(1991-11#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-1#1)(2005-8#1)(2006-10#2)(2006-12#3)(2007-11#2)(2007-12#2)(2007-3#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-8#2)(2010-3#1)(2011-1#1)(2011-2#1)
overlap each other##6##3##(1994-3#1)(1997-8#1)(2007-8#1)(2008-11#1)(2008-6#2)
overlap extension##2##2##(2008-5#1)(2010-12#1)
overlap in expression##2##3##(2008-8#1)(2009-8#1)
overlap in the imaging##2##4##(1997-8#1)(2008-2#1)
overlap in the##11##3##(1991-4#1)(1994-3#1)(1997-8#1)(2007-12#1)(2007-4#1)(2008-2#1)(2008-7#1)(2008-8#2)(2009-4#1)(2012-11#1)
overlap in their##2##3##(2007-12#1)(2012-2#1)
overlap in##28##2##(1991-4#1)(1993-7#1)(1994-3#1)(1996-3#2)(1997-3#1)(1997-8#1)(2006-9#1)(2007-12#2)(2007-4#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#1)(2009-8#2)(2010-4#1)(2012-11#1)(2012-2#1)(2013-1#1)
overlap is##7##2##(2006-2#1)(2007-12#2)(2008-10#1)(2008-12#2)(2008-3#1)
overlap model##2##2##(1995-5#1)(2006-10#1)
overlap occurred##2##2##(2007-10#2)
overlap of the##7##3##(1990-12#1)(2008-10#3)(2008-2#1)(2010-5#1)(2011-2#1)
overlap of##28##2##(1990-12#1)(1992-12#1)(1993-4#1)(1994-8#1)(1995-1#1)(1995-12#1)(1997-7#1)(2006-2#2)(2007-12#1)(2007-3#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-9#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-2#1)
overlap over##2##2##(2007-12#2)
overlap syndrome##5##2##(1992-11#1)(2006-10#1)(2008-12#2)(2012-2#1)
overlap syndromes##4##2##(2006-10#1)(2008-12#2)(2011-2#1)
overlap the##5##2##(1995-5#1)(1996-2#1)(2007-12#1)(2008-2#1)(2011-2#1)
overlap to the##2##3##(1995-8#1)(1997-7#1)
overlap to##6##2##(1992-12#1)(1995-8#1)(1996-7#1)(1997-7#1)(2006-5#1)(2008-10#1)
overlap was##5##2##(1993-2#1)(2008-10#3)(2009-2#1)
overlap with actin##2##3##(1990-4#2)
overlap with other##3##3##(1994-2#1)(2008-8#1)(2009-7#1)
overlap with the##11##3##(1993-11#2)(1995-3#1)(1995-6#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-8#1)(2010-8#1)(2011-2#1)
overlap with those of##2##4##(2005-8#1)(2009-7#1)
overlap with those##3##3##(2005-8#1)(2009-3#1)(2009-7#1)
overlap with##30##2##(1990-1#1)(1990-4#2)(1993-11#2)(1994-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-5#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-11#1)(2009-3#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#1)
overlap##272##1##(1990-1#1)(1990-12#1)(1990-4#2)(1991-11#1)(1991-4#1)(1992-11#1)(1992-12#2)(1992-2#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-4#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#3)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#4)(1995-3#1)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#2)(1996-12#4)(1996-2#4)(1996-3#3)(1996-5#1)(1996-7#1)(1997-1#2)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2005-11#1)(2005-8#4)(2006-10#11)(2006-11#1)(2006-12#3)(2006-2#3)(2006-4#1)(2006-5#2)(2006-7#1)(2006-9#1)(2007-10#3)(2007-11#5)(2007-12#18)(2007-3#3)(2007-4#2)(2007-6#1)(2007-8#4)(2008-1#2)(2008-10#27)(2008-11#3)(2008-12#8)(2008-2#11)(2008-3#5)(2008-4#6)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#7)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#3)(2009-2#4)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#3)(2009-8#7)(2010-1#1)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-11#1)(2012-2#6)(2012-3#1)(2013-1#5)(2013-8#1)
overlap-written fiber Bragg gratings##2##4##(2007-12#2)
overlapped CE peaks##2##3##(2008-10#2)
overlapped a##2##2##(1997-5#1)(2008-10#1)
overlapped absorption##2##2##(2008-10#2)
overlapped at##2##2##(1992-7#1)(1996-12#1)
overlapped in##3##2##(1997-3#1)(2005-11#1)(2009-6#1)
overlapped linear frequency-chirped##2##3##(2007-11#2)
overlapped peaks##3##2##(2008-10#2)(2011-1#1)
overlapped the##5##2##(1990-5#1)(1993-2#1)(1996-10#1)(2010-8#1)(2012-1#1)
overlapped those##2##2##(2008-10#1)(2012-2#1)
overlapped with QTL##2##3##(2012-3#2)
overlapped with##6##2##(1992-9#1)(2008-10#1)(2012-1#1)(2012-3#2)(2013-8#1)
overlapped##63##1##(1990-3#1)(1990-5#1)(1992-7#1)(1992-9#1)(1993-2#1)(1996-10#1)(1996-12#1)(1996-3#1)(1997-2#4)(1997-3#1)(1997-5#1)(1997-6#1)(2005-11#2)(2007-11#2)(2007-3#1)(2008-10#24)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#2)(2009-6#1)(2010-8#2)(2011-1#2)(2012-1#2)(2012-2#1)(2012-3#2)(2013-8#1)
overlapping ORFs##3##2##(1996-3#1)(2008-10#2)
overlapping a##2##2##(1992-12#1)(2008-10#1)
overlapping among##2##2##(1994-3#1)(2008-2#1)
overlapping and##8##2##(1993-11#1)(1995-9#1)(1996-9#1)(2007-10#1)(2008-10#1)(2008-3#1)(2009-6#1)(2010-12#1)
overlapping antisense##2##2##(2008-7#2)
overlapping areas##2##2##(1995-12#1)(2008-8#1)
overlapping associations##2##2##(2013-1#2)
overlapping between##2##2##(2007-10#1)(2008-10#1)
overlapping but distinct##2##3##(1991-3#1)(1996-5#1)
overlapping but##3##2##(1991-3#1)(1993-12#1)(1996-5#1)
overlapping cDNA clones encoding##2##4##(1991-5#1)(1993-3#1)
overlapping cDNA clones##7##3##(1991-5#1)(1991-6#1)(1993-3#2)(1996-10#1)(1996-12#2)
overlapping chromatographic##2##2##(2008-10#2)
overlapping clinical features##3##3##(1991-2#1)(2007-7#1)(2012-12#1)
overlapping clinical##4##2##(1991-2#1)(2005-8#1)(2007-7#1)(2012-12#1)
overlapping clones covering the##3##4##(1991-12#1)(2008-8#1)(2013-8#1)
overlapping clones##9##2##(1990-10#1)(1990-12#1)(1990-9#1)(1991-12#1)(1992-6#1)(1994-8#1)(2008-10#1)(2008-8#1)(2013-8#1)
overlapping cortical##2##2##(1995-12#1)(2008-11#1)
overlapping deletions##3##2##(1993-3#3)
overlapping features##3##2##(2006-2#1)(2010-12#1)(2012-3#1)
overlapping fluorescence##2##2##(2008-10#2)
overlapping gene##2##2##(1992-12#1)(2008-7#1)
overlapping genes in##3##3##(1996-8#1)(1997-7#2)
overlapping genes##6##2##(1990-3#1)(1996-8#1)(1997-7#4)
overlapping genomic DNA##2##3##(1991-4#1)(1995-3#1)
overlapping genomic clones##2##3##(1992-11#1)(1997-8#1)
overlapping genomic##4##2##(1991-4#1)(1992-11#1)(1995-3#1)(1997-8#1)
overlapping host##2##2##(2008-10#2)
overlapping in##2##2##(2008-11#1)(2010-2#1)
overlapping neural networks##2##3##(1994-8#2)
overlapping of the##4##3##(2008-10#1)(2008-11#1)(2010-2#1)(2012-2#1)
overlapping of##11##2##(1994-5#1)(1994-9#1)(2008-10#5)(2008-11#1)(2010-2#1)(2011-2#1)(2012-2#1)
overlapping or##3##2##(1994-5#1)(2012-2#1)(2013-1#1)
overlapping pathways##3##2##(1994-6#1)(1996-12#1)(2012-3#1)
overlapping patterns##2##2##(1991-6#1)(2008-2#1)
overlapping peaks##8##2##(1991-5#1)(2008-10#5)(2011-1#2)
overlapping peptides##3##2##(1993-3#1)(1996-11#1)(2008-11#1)
overlapping regions##5##2##(1997-2#1)(2006-4#1)(2012-3#2)(2013-8#1)
overlapping relationships##2##2##(2009-9#2)
overlapping side effects##2##3##(2007-12#1)(2011-2#1)
overlapping signals##2##2##(2008-10#2)
overlapping spectra of##2##3##(2008-10#1)(2011-2#1)
overlapping spectra##5##2##(2008-10#3)(2010-5#1)(2011-2#1)
overlapping spectrophotometric signals##2##3##(2008-10#2)
overlapping substrate specificities and##2##4##(1992-12#1)(1994-2#1)
overlapping substrate##3##2##(1992-12#1)(1994-2#1)(2010-2#1)
overlapping the##7##2##(1990-10#1)(1990-4#1)(1991-6#1)(1993-8#1)(1995-11#1)(2008-10#1)(2010-8#1)
overlapping tissue-specific##2##2##(2006-12#1)(2009-8#1)
overlapping windows##2##2##(2008-2#2)
overlapping with the##3##3##(1990-7#1)(2007-7#1)(2008-10#1)
overlapping with##6##2##(1990-7#1)(1994-6#1)(2007-7#1)(2008-10#1)(2008-8#1)(2012-3#1)
overlapping##296##1##(1990-10#3)(1990-12#1)(1990-3#3)(1990-4#1)(1990-7#1)(1990-9#3)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#4)(1991-7#1)(1992-11#1)(1992-12#4)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#6)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#4)(1994-9#2)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#2)(1996-11#5)(1996-12#4)(1996-2#1)(1996-3#3)(1996-5#4)(1996-6#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#3)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#5)(1997-8#1)(2005-11#1)(2005-8#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-4#3)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#2)(2007-12#5)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#51)(2008-11#9)(2008-2#13)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#9)(2008-8#8)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-8#5)(2009-9#5)(2010-10#1)(2010-12#3)(2010-2#3)(2010-5#4)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#8)(2013-1#5)(2013-7#2)(2013-8#2)
overlaps both the##2##3##(1991-7#1)(2008-7#1)
overlaps in##4##2##(1995-12#1)(2008-4#1)(2009-12#1)(2013-8#1)
overlaps the##13##2##(1991-7#1)(1994-11#1)(1994-8#2)(1996-4#1)(1996-5#2)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-8#1)
overlaps with the##4##3##(1995-6#1)(2008-10#1)(2009-8#1)(2013-1#1)
overlaps with##7##2##(1992-12#1)(1995-6#1)(2008-10#1)(2009-8#1)(2011-1#1)(2012-11#1)(2013-1#1)
overlaps##39##1##(1990-1#1)(1990-11#1)(1991-7#2)(1992-12#1)(1994-11#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-5#2)(1997-3#1)(2005-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#4)(2008-4#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-8#1)(2011-1#1)(2012-11#1)(2013-1#3)(2013-8#1)
overlay and##2##2##(1997-4#1)(2005-7#1)
overlay assay##7##2##(1995-11#1)(1997-4#1)(1997-7#2)(2008-10#2)(2012-1#1)
overlay assays##2##2##(1997-6#1)(2008-10#1)
overlay material##2##2##(2007-11#2)
overlay of##4##2##(2007-11#1)(2007-5#1)(2008-10#1)(2008-5#1)
overlay technique##2##2##(1990-8#1)(1991-1#1)
overlay waveguide##3##2##(2008-3#3)
overlay waveguides##2##2##(2008-3#2)
overlay##37##1##(1990-8#1)(1991-1#1)(1991-3#1)(1991-5#1)(1991-7#1)(1994-11#1)(1995-11#2)(1996-8#1)(1997-4#2)(1997-6#1)(1997-7#2)(2005-7#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#5)(2008-2#1)(2008-3#7)(2008-5#1)(2010-12#1)(2012-1#1)
overlayer is##2##2##(2007-12#1)(2008-1#1)
overlayer##12##1##(1991-5#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-2#4)(2008-3#2)
overlayers##5##1##(2007-12#2)(2008-2#2)(2009-10#1)
overlaying##3##1##(2007-11#1)(2009-8#2)
overlays##6##1##(2007-11#1)(2007-12#1)(2008-3#2)(2010-12#1)(2013-1#1)
overlearned##2##1##(1993-2#1)(2006-3#1)
overload and the##2##3##(2005-10#1)(2006-10#1)
overload and##19##2##(1994-9#2)(1996-2#1)(2005-10#2)(2005-8#1)(2006-10#1)(2006-5#1)(2006-9#1)(2008-1#1)(2008-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
overload in the##5##3##(2006-9#1)(2010-12#1)(2010-3#1)(2013-8#2)
overload in##6##2##(2006-9#1)(2010-12#1)(2010-3#1)(2012-2#1)(2013-8#2)
overload may##2##2##(2007-8#1)(2008-3#1)
overload of##4##2##(1997-6#1)(2005-1#1)(2013-1#2)
overload on##2##2##(1992-8#1)(2006-12#1)
overload phenomenon##4##2##(2008-7#4)
overload syndrome##5##2##(2007-7#4)(2008-8#1)
overload to##3##2##(2010-3#1)(2013-1#2)
overload with##2##2##(2008-3#1)(2008-8#1)
overload##117##1##(1990-9#1)(1991-2#1)(1992-5#1)(1992-8#1)(1993-2#1)(1994-3#2)(1994-6#1)(1994-9#2)(1995-6#1)(1995-8#3)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-4#2)(1997-6#1)(2004-10#3)(2005-1#1)(2005-10#2)(2005-8#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-5#1)(2006-9#6)(2007-1#1)(2007-11#1)(2007-2#1)(2007-6#4)(2007-7#9)(2007-8#5)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#6)(2008-8#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#3)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#7)(2013-8#3)
overload&quot##2##1##(2006-9#2)
overload)##2##1##(2008-10#1)(2013-8#1)
overloaded by##2##2##(2011-1#1)(2013-1#1)
overloaded##3##1##(2008-1#1)(2011-1#1)(2013-1#1)
overloading##9##1##(1990-6#1)(2007-11#1)(2008-10#1)(2008-7#3)(2011-1#1)(2011-2#1)(2012-2#1)
overloads##2##1##(2008-12#1)(2008-7#1)
overlook the##5##2##(2006-12#1)(2007-8#1)(2009-11#1)(2010-5#2)
overlook##9##1##(2006-12#1)(2007-8#1)(2009-11#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#1)(2012-12#1)
overlooked and##4##2##(1991-9#1)(2006-8#1)(2008-3#1)(2010-3#1)
overlooked because of##3##3##(1993-1#1)(2009-2#1)(2010-4#1)
overlooked because##7##2##(1993-1#1)(1996-12#1)(1996-6#1)(2006-10#1)(2009-2#1)(2009-5#1)(2010-4#1)
overlooked by##5##2##(1991-2#1)(2008-12#1)(2008-2#1)(2011-2#1)(2012-2#1)
overlooked foreign body##2##3##(2007-8#1)(2009-2#1)
overlooked in the##4##3##(2007-11#1)(2008-11#1)(2012-2#1)(2013-8#1)
overlooked in##9##2##(1990-6#1)(2007-1#1)(2007-11#1)(2008-11#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
overlooked the##2##2##(2008-11#1)(2011-3#1)
overlooked##87##1##(1990-6#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1993-1#2)(1993-12#1)(1994-12#1)(1995-3#1)(1995-4#1)(1996-12#1)(1996-4#1)(1996-6#2)(1996-7#1)(1997-3#1)(1997-6#1)(2005-11#1)(2006-10#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#1)(2007-4#3)(2007-7#2)(2007-8#2)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-2#2)(2009-5#1)(2009-6#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#2)(2012-5#1)(2013-1#2)(2013-7#1)(2013-8#2)
overlooking##2##1##(1996-8#1)(2007-7#1)
overly sensitive##2##2##(2009-6#1)(2013-8#1)
overly##9##1##(1995-3#1)(2006-10#1)(2008-10#1)(2008-11#1)(2009-6#1)(2011-2#1)(2012-1#2)(2013-8#1)
overlying a##3##2##(2007-12#1)(2008-2#1)(2010-6#1)
overlying mucosa##3##2##(2008-5#2)(2008-8#1)
overlying skin##2##2##(2007-7#1)(2010-3#1)
overlying the##6##2##(1995-11#1)(1997-3#1)(2008-11#1)(2009-1#1)(2010-11#1)(2011-2#1)
overlying##37##1##(1990-6#1)(1991-11#1)(1993-6#2)(1995-11#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-12#3)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#3)(2008-6#1)(2008-8#1)(2009-1#2)(2010-11#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-12#1)
overmodulation##2##1##(2008-3#2)
overnadant##2##1##(2007-10#2)
overnight and##2##2##(2007-9#1)(2008-4#1)
overnight at##3##2##(2008-10#1)(2010-4#2)
overnight cultured##2##2##(1991-8#1)(2007-2#1)
overnight darkness##2##2##(2008-10#2)
overnight fast##4##2##(1991-2#1)(1995-12#1)(1995-4#2)
overnight incubation with##3##3##(1990-9#1)(1995-8#1)(2008-4#1)
overnight incubation##5##2##(1990-9#1)(1995-8#1)(2007-2#1)(2008-10#1)(2008-4#1)
overnight lens wear on corneal epithelial##2##6##(2005-11#2)
overnight urine##5##2##(1990-11#1)(1991-7#1)(1992-8#1)(1996-3#1)(2007-8#1)
overnight urines##2##2##(1993-7#1)(1995-7#1)
overnight with##3##2##(1993-7#1)(1994-3#1)(1996-5#1)
overnight##75##1##(1990-11#1)(1990-2#1)(1990-9#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-7#2)(1994-3#2)(1994-4#1)(1995-11#1)(1995-12#2)(1995-4#2)(1995-7#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(2004-11#1)(2005-11#4)(2005-8#1)(2007-1#1)(2007-2#2)(2007-3#1)(2007-8#4)(2007-9#2)(2008-10#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#2)(2010-4#2)(2010-5#1)(2010-7#1)(2011-2#8)(2012-12#1)(2012-8#1)(2013-1#1)
overoxidation##3##1##(2008-10#1)(2009-10#2)
overoxidized PPy film##2##3##(2008-10#2)
overoxidized sulfonated polypyrrole film##2##4##(2008-10#2)
overoxidized sulfonated polypyrrole##3##3##(2008-10#3)
overoxidized##5##1##(2008-10#5)
overpass##2##1##(2011-2#1)(2012-12#1)
overpayments##2##1##(1992-2#1)(2006-8#1)
overpopulation##2##1##(1992-5#1)(2007-2#1)
overpotential of##2##2##(2008-10#2)
overpotential was##2##2##(2007-8#1)(2008-10#1)
overpotential##11##1##(2007-8#1)(2008-10#10)
overpriced##2##1##(1994-1#2)
overproduce##2##1##(1991-4#1)(2007-8#1)
overproduced by##2##2##(1991-3#1)(1995-8#1)
overproduced in Escherichia coli##4##4##(1993-9#1)(1995-1#1)(1995-2#1)(2009-2#1)
overproduced in##6##2##(1993-9#1)(1995-1#1)(1995-2#1)(1997-1#1)(1997-4#1)(2009-2#1)
overproduced the##2##2##(1994-12#1)(1997-4#1)
overproduced##20##1##(1990-4#1)(1990-9#1)(1991-3#1)(1991-7#1)(1991-9#1)(1993-9#1)(1994-12#2)(1994-8#1)(1995-1#2)(1995-2#1)(1995-6#1)(1995-8#1)(1997-1#2)(1997-4#2)(2008-10#1)(2009-2#1)
overproducer##4##1##(1990-3#1)(1995-2#1)(1996-12#1)(2012-3#1)
overproduces##3##1##(1991-7#1)(1992-7#1)(2008-10#1)
overproducing strain##2##2##(1997-1#1)(1997-8#1)
overproducing the AddAB##2##3##(1995-8#2)
overproducing the##3##2##(1995-8#2)(1997-3#1)
overproducing##15##1##(1991-11#1)(1991-12#1)(1992-5#1)(1995-1#1)(1995-8#3)(1997-1#1)(1997-3#1)(1997-8#1)(2008-2#2)(2010-12#1)(2012-2#1)(2012-3#1)
overproduction and##3##2##(1995-6#1)(2007-8#1)(2011-2#1)
overproduction in##4##2##(1996-8#1)(2006-10#1)(2012-12#1)(2012-3#1)
overproduction of H(2)O(2)##2##3##(2008-10#1)(2008-5#1)
overproduction of NO##3##3##(2005-7#1)(2011-1#2)
overproduction of the##2##3##(1990-4#1)(1997-7#1)
overproduction of##31##2##(1990-11#1)(1990-4#1)(1991-12#1)(1991-4#1)(1992-10#1)(1992-11#1)(1992-2#1)(1993-4#1)(1994-12#1)(1995-8#3)(1997-3#1)(1997-4#1)(1997-7#1)(2005-7#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-7#1)(2011-1#3)(2011-2#1)(2013-8#1)
overproduction##47##1##(1990-11#1)(1990-4#1)(1991-12#1)(1991-4#1)(1992-10#1)(1992-11#1)(1992-2#1)(1993-4#1)(1994-12#1)(1994-9#1)(1995-6#1)(1995-8#3)(1996-8#1)(1997-3#1)(1997-4#2)(1997-7#1)(2005-7#1)(2006-10#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-7#1)(2011-1#4)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
overreactivity##2##1##(2012-2#2)
overreporters##2##1##(2008-9#2)
overreporting##4##1##(1992-4#1)(2008-9#3)
overrepresentation of##3##2##(1993-12#1)(1994-2#1)(2011-1#1)
overrepresented among the##2##3##(1990-6#1)(1991-5#1)
overrepresented in the##3##3##(2006-3#1)(2009-7#1)(2009-8#1)
overrepresented in##6##2##(2006-10#1)(2006-3#1)(2008-11#1)(2009-6#1)(2009-7#1)(2009-8#1)
overrepresented##18##1##(1990-6#1)(1991-5#1)(1995-8#3)(1997-2#1)(2006-10#2)(2006-3#1)(2007-7#1)(2008-11#1)(2008-7#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-5#2)(2012-2#1)
override the effect of##2##4##(2005-10#1)(2008-8#1)
override the##4##2##(1994-8#1)(1996-12#1)(2005-10#1)(2008-8#1)
override##12##1##(1991-3#1)(1994-8#1)(1995-1#1)(1996-12#1)(2005-10#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-5#1)(2008-8#1)(2009-10#1)(2012-12#1)
overrides##2##1##(1994-3#1)(2008-10#1)
overriding##15##1##(1990-7#1)(1994-3#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-4#1)(2008-7#2)(2009-12#1)(2010-11#2)(2010-5#1)(2011-1#1)(2012-1#2)
overrode##2##1##(2008-10#1)(2011-2#1)
overruled##2##1##(1993-12#1)(2012-2#1)
oversampling##3##1##(2008-3#3)
overseas and##4##2##(1990-12#1)(2007-2#1)(2008-12#1)(2013-1#1)
overseas military hospitals##3##3##(1995-6#3)
overseas recruitment##2##2##(2008-11#1)(2009-4#1)
overseas##32##1##(1990-12#1)(1991-5#2)(1992-6#2)(1992-9#2)(1994-3#1)(1994-4#1)(1995-6#3)(1997-2#1)(2004-9#1)(2005-7#1)(2007-2#4)(2008-1#1)(2008-11#5)(2008-12#1)(2008-8#1)(2009-4#1)(2010-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
oversee##4##1##(1991-12#1)(1994-3#1)(1996-2#1)(2010-3#1)
oversees##2##1##(1992-8#1)(1997-2#1)
overselection of comorbid cases##3##4##(1997-5#3)
overshadow the##2##2##(1996-11#1)(2008-10#1)
overshadow##5##1##(1994-3#1)(1996-11#1)(2006-4#1)(2008-10#1)(2010-6#1)
overshadowed by the##3##3##(1992-11#1)(2005-7#1)(2010-3#1)
overshadowed by##6##2##(1991-2#1)(1992-11#1)(2005-7#1)(2007-11#1)(2008-8#1)(2010-3#1)
overshadowed##11##1##(1991-2#1)(1992-11#1)(1993-7#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)
overshadowing##3##1##(2008-5#3)
overshadows##2##1##(1991-2#1)(2010-6#1)
overshoot of##3##2##(2008-11#1)(2008-7#1)(2010-8#1)
overshoot##8##1##(1990-2#1)(2007-9#1)(2008-11#4)(2008-7#1)(2010-8#1)
overshoot'##3##1##(1997-6#3)
overshot the##2##2##(1993-12#1)(1997-1#1)
overshot##3##1##(1993-12#1)(1994-3#1)(1997-1#1)
oversight and##3##2##(1995-12#1)(1995-3#1)(2010-12#1)
oversight of##6##2##(1990-7#1)(2006-4#1)(2006-7#1)(2008-9#1)(2012-3#1)(2013-8#1)
oversight##24##1##(1990-7#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-2#2)(1996-6#1)(1997-1#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-4#1)(2008-11#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-12#1)(2012-12#1)(2012-3#3)(2013-7#1)(2013-8#1)
oversimplified##3##1##(1993-6#1)(2008-1#1)(2009-4#1)
oversized##2##1##(2011-2#1)(2013-1#1)
overspray##2##1##(2011-2#2)
overstaging##3##1##(1993-5#2)(2008-5#1)
overstated##3##1##(2010-3#1)(2011-1#1)(2012-11#1)
overstates##2##1##(1992-3#1)(1996-12#1)
overstimulation##2##1##(1994-6#1)(2007-12#1)
oversupplied##2##1##(2008-9#2)
oversupply of##2##2##(1992-11#1)(2008-1#1)
oversupply##4##1##(1992-11#1)(2007-4#1)(2008-1#2)
overt aggression##4##2##(2008-10#2)(2008-12#1)(2010-11#1)
overt and covert face##2##4##(2009-4#2)
overt and covert##4##3##(1995-12#1)(2009-4#2)(2012-1#1)
overt and##5##2##(1995-12#1)(2008-10#1)(2009-4#2)(2012-1#1)
overt behavioural##2##2##(1995-12#1)(2009-9#1)
overt clinical##6##2##(1996-5#1)(2006-10#1)(2006-8#1)(2008-3#1)(2009-1#1)(2011-2#1)
overt diabetes and##2##3##(2007-7#1)(2008-1#1)
overt diabetes##3##2##(1994-12#1)(2007-7#1)(2008-1#1)
overt production##2##2##(2012-1#2)
overt renal##2##2##(2006-10#1)(2008-1#1)
overt signs of##4##3##(2006-2#1)(2008-5#1)(2011-11#1)(2011-2#1)
overt##84##1##(1990-3#1)(1990-6#1)(1991-10#1)(1991-2#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-12#3)(1995-2#1)(1995-6#1)(1996-5#1)(1996-6#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#5)(2006-2#2)(2006-7#3)(2006-8#2)(2006-9#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#3)(2009-1#1)(2009-11#1)(2009-4#5)(2009-6#1)(2009-9#2)(2010-11#3)(2010-2#1)(2010-6#1)(2010-8#1)(2011-11#2)(2011-2#5)(2012-1#4)
overtaken##2##1##(1990-12#1)(2010-3#1)
overtime##11##1##(1994-3#1)(1995-5#1)(1996-6#1)(1997-8#1)(2008-4#1)(2009-3#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
overtly##4##1##(1997-4#1)(2008-11#1)(2010-6#1)(2012-3#1)
overtone absorption##2##2##(2008-10#1)(2008-3#1)
overtone band##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
overtone bands##3##2##(2007-12#2)(2008-2#1)
overtone##18##1##(2007-12#5)(2008-10#2)(2008-2#5)(2008-3#5)(2010-7#1)
overtones and##2##2##(2008-10#1)(2008-2#1)
overtones##6##1##(2008-10#1)(2008-12#1)(2008-2#2)(2009-7#1)(2010-2#1)
overtraining##9##1##(1993-2#3)(1993-8#1)(2008-5#2)(2012-1#3)
overtreatment of##2##2##(2006-12#1)(2013-1#1)
overtreatment##6##1##(1997-7#1)(2005-11#1)(2006-12#1)(2007-12#1)(2011-9#1)(2013-1#1)
overturn##6##1##(1992-11#1)(1995-6#1)(1996-11#1)(2006-11#1)(2008-10#1)(2008-12#1)
overturned##6##1##(1991-12#1)(1996-11#1)(1997-1#1)(1997-5#1)(2006-10#1)(2007-3#1)
overturning##4##1##(2007-12#1)(2007-5#1)(2009-8#1)(2013-7#1)
overuse and##3##2##(2006-1#1)(2006-10#1)(2008-1#1)
overuse injuries in##2##3##(2008-7#1)(2013-1#1)
overuse injuries##7##2##(2008-7#3)(2009-6#2)(2011-2#1)(2013-1#1)
overuse of##4##2##(1997-1#1)(2008-8#1)(2011-1#1)(2013-8#1)
overuse##35##1##(1990-8#1)(1994-3#2)(1996-2#1)(1997-1#1)(2006-1#1)(2006-10#4)(2006-8#1)(2007-7#4)(2008-1#1)(2008-11#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-6#3)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
overused##2##1##(1994-3#1)(2005-7#1)
overusers##2##1##(1990-8#1)(1993-6#1)
overutilization of##3##2##(2007-4#3)
overutilization##7##1##(1997-2#1)(2007-4#6)
overutilized##3##1##(1996-12#1)(1996-9#1)(2009-3#1)
overview about the##5##3##(2006-10#1)(2007-11#1)(2007-12#1)(2008-5#1)(2010-10#1)
overview about##7##2##(2006-10#1)(2007-11#1)(2007-12#1)(2008-5#2)(2010-10#1)(2013-1#1)
overview also##2##2##(2008-10#1)(2012-12#1)
overview and discussion##2##3##(2006-9#1)(2010-2#1)
overview and##22##2##(1991-11#1)(1991-12#1)(1992-7#1)(1992-9#1)(1996-2#1)(1996-7#1)(2004-12#1)(2005-7#1)(2006-5#1)(2006-7#2)(2006-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-2#1)(2011-2#2)(2012-3#1)
overview concerning the##2##3##(2008-2#1)(2013-1#1)
overview describes##8##2##(1997-3#1)(2008-1#1)(2008-11#1)(2008-4#5)
overview discusses##14##2##(1994-12#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-2#1)(2008-4#8)
overview focuses##3##2##(2008-4#3)
overview for##4##2##(1992-3#1)(1996-2#1)(2008-4#1)(2008-9#1)
overview is given##3##3##(2008-1#1)(2008-11#1)(2008-2#1)
overview is presented of##2##4##(1990-8#1)(2007-5#1)
overview is presented on##2##4##(1992-1#1)(1996-11#1)
overview is presented##5##3##(1990-8#1)(1992-1#1)(1996-11#1)(2007-5#1)(2008-10#1)
overview is##11##2##(1990-8#1)(1991-2#1)(1992-1#1)(1996-11#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-8#1)
overview of a##7##3##(1991-12#1)(1995-3#1)(2008-10#1)(2008-9#1)(2010-2#1)(2011-2#1)(2013-1#1)
overview of all##3##3##(1994-2#1)(2006-9#1)(2011-2#1)
overview of current issues##2##4##(1994-1#1)(2006-11#1)
overview of current##12##3##(1994-1#1)(2005-9#1)(2006-11#1)(2007-9#1)(2008-12#1)(2008-4#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-11#2)(2012-2#1)
overview of currently available##2##4##(2006-6#1)(2010-9#1)
overview of different##4##3##(2008-3#1)(2012-1#1)(2012-2#2)
overview of disease##2##3##(2006-6#1)(2009-9#1)
overview of existing##4##3##(2008-2#1)(2012-12#2)(2013-1#1)
overview of how##5##3##(2006-4#1)(2007-4#1)(2008-11#2)(2008-9#1)
overview of infections##2##3##(2006-7#1)(2008-1#1)
overview of issues##3##3##(2008-4#2)(2010-4#1)
overview of known##2##3##(2009-10#1)(2010-11#1)
overview of major##2##3##(2008-10#1)(2008-4#1)
overview of modern##3##3##(2008-4#1)(2010-8#1)(2013-1#1)
overview of multiple sequence alignment##2##5##(2008-4#2)
overview of our##6##3##(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2011-2#1)(2012-1#1)
overview of over##2##3##(2005-12#1)(2008-7#1)
overview of published##4##3##(1992-1#1)(2007-11#1)(2008-8#1)(2010-11#1)
overview of recent developments in the##2##6##(2008-1#1)(2008-10#1)
overview of recent developments in##3##5##(2008-1#1)(2008-10#1)(2008-5#1)
overview of recent developments##4##4##(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)
overview of recent##10##3##(2006-10#3)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-5#1)
overview of selected##2##3##(1996-12#1)(2006-5#1)
overview of several techniques##2##4##(2008-3#1)(2008-4#1)
overview of several##3##3##(2008-3#1)(2008-4#1)(2008-7#1)
overview of some of the##7##5##(2004-12#1)(2006-10#1)(2007-4#1)(2007-5#1)(2008-12#1)(2008-4#1)(2008-7#1)
overview of some of##8##4##(2004-12#1)(2006-10#1)(2007-4#1)(2007-5#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-11#1)
overview of some##10##3##(1995-1#1)(2004-12#1)(2006-10#1)(2007-4#1)(2007-5#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-11#1)
overview of stress##2##3##(2009-4#1)(2013-8#1)
overview of the U##2##4##(1993-3#1)(1994-12#1)
overview of the advantages and##2##5##(1990-12#1)(2011-1#1)
overview of the application of##2##5##(2008-10#1)(2008-11#1)
overview of the cellular##2##4##(2011-2#2)
overview of the clinical##8##4##(2005-8#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-7#1)(2013-1#2)
overview of the current knowledge on##2##6##(2008-11#1)(2009-4#1)
overview of the current state of##2##6##(2009-4#1)(2011-2#1)
overview of the current status of##2##6##(2008-1#1)(2010-2#1)
overview of the current##17##4##(2004-7#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-2#1)(2009-4#2)(2009-8#1)(2010-10#1)(2010-2#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#1)
overview of the database##2##4##(1994-12#1)(2008-4#1)
overview of the development of##2##5##(2007-5#1)(2008-5#1)
overview of the development##3##4##(1996-12#1)(2007-5#1)(2008-5#1)
overview of the existing##2##4##(2010-12#1)(2013-1#1)
overview of the field of##5##5##(2007-12#1)(2008-4#2)(2010-11#1)(2012-1#1)
overview of the field##6##4##(2007-12#1)(2008-4#2)(2009-9#1)(2010-11#1)(2012-1#1)
overview of the literature on##3##5##(1993-11#1)(2008-10#1)(2012-2#1)
overview of the literature##8##4##(1993-11#1)(1994-8#1)(2008-10#1)(2009-1#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
overview of the main##2##4##(2007-7#1)(2007-9#1)
overview of the major##3##4##(1995-12#1)(2006-2#1)(2009-3#1)
overview of the management of##2##5##(2008-7#1)(2010-5#1)
overview of the most##7##4##(1991-6#1)(2006-5#1)(2008-4#1)(2010-11#1)(2010-9#1)(2011-2#1)(2011-3#1)
overview of the pathophysiology of##2##5##(2008-12#1)(2011-2#1)
overview of the process##2##4##(2005-7#1)(2007-4#1)
overview of the published##2##4##(2008-6#1)(2011-1#1)
overview of the recent literature##2##5##(2011-2#1)(2013-1#1)
overview of the recent##3##4##(2011-2#1)(2012-3#1)(2013-1#1)
overview of the techniques##2##4##(2011-1#1)(2012-2#1)
overview of the theory##2##4##(2009-3#1)(2013-8#1)
overview of the types of##3##5##(1992-12#1)(1997-2#1)(2008-2#1)
overview of the use of##2##5##(2006-10#1)(2008-3#1)
overview of the various##5##4##(1992-12#1)(2005-7#1)(2008-5#1)(2010-12#1)(2011-1#1)
overview of the##264##3##(1990-12#1)(1991-1#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-3#2)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#4)(1994-1#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#3)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#3)(1997-4#1)(2004-7#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-7#5)(2005-8#2)(2006-10#6)(2006-11#1)(2006-2#2)(2006-5#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#4)(2007-12#4)(2007-4#3)(2007-5#2)(2007-7#3)(2007-9#1)(2008-1#7)(2008-10#11)(2008-11#8)(2008-12#3)(2008-2#5)(2008-3#5)(2008-4#11)(2008-5#8)(2008-6#5)(2008-7#4)(2008-8#1)(2008-9#8)(2009-1#1)(2009-10#1)(2009-2#2)(2009-3#3)(2009-4#3)(2009-6#3)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#4)(2010-12#5)(2010-2#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#6)(2011-1#7)(2011-12#1)(2011-2#13)(2011-3#2)(2012-1#1)(2012-11#2)(2012-12#6)(2012-2#4)(2012-3#6)(2013-1#15)(2013-8#4)
overview of these##8##3##(1992-1#1)(1992-12#1)(1993-2#1)(2005-8#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-4#1)
overview of this##9##3##(1994-2#1)(1996-1#1)(2005-8#1)(2008-11#1)(2008-6#1)(2010-5#1)(2011-2#2)(2013-8#1)
overview of various##6##3##(1991-1#1)(2007-9#1)(2008-4#1)(2010-7#1)(2010-9#1)(2012-2#1)
overview of what##3##3##(2008-12#1)(2008-5#1)(2008-8#1)
overview of##556##2##(1990-12#1)(1990-4#1)(1990-6#1)(1991-1#4)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#3)(1992-12#3)(1992-3#4)(1993-11#3)(1993-12#2)(1993-2#4)(1993-3#4)(1993-6#1)(1994-1#3)(1994-10#1)(1994-12#5)(1994-2#4)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#3)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-9#1)(1996-1#2)(1996-12#5)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#2)(1997-5#1)(2004-12#2)(2004-4#1)(2004-7#1)(2005-1#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-7#5)(2005-8#5)(2005-9#2)(2006-10#15)(2006-11#2)(2006-2#2)(2006-4#1)(2006-5#4)(2006-6#3)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#10)(2007-12#14)(2007-2#1)(2007-4#5)(2007-5#6)(2007-7#5)(2007-9#3)(2008-1#11)(2008-10#22)(2008-11#19)(2008-12#7)(2008-2#7)(2008-3#8)(2008-4#44)(2008-5#13)(2008-6#8)(2008-7#11)(2008-8#5)(2008-9#16)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#4)(2009-4#6)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#2)(2009-9#4)(2010-1#2)(2010-10#3)(2010-11#11)(2010-12#7)(2010-2#3)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#4)(2010-8#4)(2010-9#11)(2011-1#12)(2011-12#2)(2011-2#26)(2011-3#2)(2012-1#4)(2012-11#5)(2012-12#16)(2012-2#13)(2012-3#7)(2013-1#19)(2013-7#1)(2013-8#8)
overview on the generation of##2##5##(2008-4#2)
overview on the##12##3##(1995-4#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2009-7#1)(2010-11#1)
overview on##18##2##(1994-6#1)(1995-4#1)(2004-12#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2009-7#1)(2010-11#1)(2012-12#1)(2013-8#1)
overview summarizes##4##2##(1993-8#1)(1996-1#1)(2008-4#1)(2009-8#1)
overview that##2##2##(2008-11#1)(2008-4#1)
overview to##2##2##(2008-2#1)(2011-2#1)
overview will##4##2##(1997-1#1)(2004-11#1)(2006-10#1)(2007-11#1)
overview with##2##2##(2007-7#1)(2012-2#1)
overview##798##1##(1990-10#1)(1990-12#1)(1990-4#1)(1990-6#1)(1990-8#2)(1991-1#4)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#4)(1991-3#1)(1991-6#1)(1991-8#2)(1992-1#5)(1992-12#4)(1992-3#7)(1992-7#1)(1992-9#1)(1993-10#1)(1993-11#4)(1993-12#4)(1993-2#4)(1993-3#4)(1993-5#1)(1993-6#1)(1993-8#1)(1994-1#4)(1994-10#1)(1994-12#6)(1994-2#4)(1994-3#1)(1994-6#3)(1994-8#1)(1995-1#3)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-4#1)(1995-9#3)(1996-1#3)(1996-11#1)(1996-12#6)(1996-2#3)(1996-3#4)(1996-4#1)(1996-6#1)(1996-7#1)(1997-1#4)(1997-2#5)(1997-3#4)(1997-4#2)(1997-5#1)(1997-8#1)(2004-11#1)(2004-12#4)(2004-4#1)(2004-7#1)(2005-1#1)(2005-10#2)(2005-11#4)(2005-12#1)(2005-7#7)(2005-8#5)(2005-9#2)(2006-10#19)(2006-11#3)(2006-12#1)(2006-2#4)(2006-3#1)(2006-4#2)(2006-5#6)(2006-6#3)(2006-7#5)(2006-8#3)(2006-9#7)(2007-1#2)(2007-10#1)(2007-11#17)(2007-12#15)(2007-2#2)(2007-3#1)(2007-4#7)(2007-5#7)(2007-6#1)(2007-7#9)(2007-8#1)(2007-9#5)(2008-1#19)(2008-10#43)(2008-11#28)(2008-12#8)(2008-2#18)(2008-3#9)(2008-4#83)(2008-5#19)(2008-6#10)(2008-7#11)(2008-8#5)(2008-9#21)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#4)(2009-4#7)(2009-5#1)(2009-6#4)(2009-7#2)(2009-8#4)(2009-9#7)(2010-1#2)(2010-10#5)(2010-11#12)(2010-12#8)(2010-2#4)(2010-4#3)(2010-5#4)(2010-6#1)(2010-7#5)(2010-8#4)(2010-9#11)(2011-1#14)(2011-12#2)(2011-2#36)(2011-3#2)(2012-1#5)(2012-11#5)(2012-12#20)(2012-2#16)(2012-3#9)(2013-1#24)(2013-7#1)(2013-8#10)
overview]##4##1##(2005-11#1)(2011-12#2)(2012-1#1)
overviewed##7##1##(1991-8#1)(2005-8#1)(2007-10#1)(2008-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
overviews of randomized trials##2##4##(1993-12#1)(2009-9#1)
overviews of##4##2##(1993-12#2)(2008-6#1)(2009-9#1)
overviews the##3##2##(1996-3#1)(2008-3#1)(2010-6#1)
overviews##15##1##(1993-12#7)(1996-3#1)(2005-9#1)(2008-11#1)(2008-3#1)(2008-6#2)(2009-9#1)(2010-6#1)
overweight (BMI##2##2##(2008-10#1)(2008-3#1)
overweight adolescents##3##2##(2011-2#2)(2012-12#1)
overweight among##5##2##(1991-5#1)(2006-2#1)(2008-3#1)(2009-9#1)(2010-11#1)
overweight and hypertension##3##3##(2012-2#3)
overweight and obese compared to##2##5##(2006-1#1)(2013-1#1)
overweight and obese patients##4##4##(2006-6#1)(2007-8#1)(2011-2#1)(2013-7#1)
overweight and obese women##2##4##(2011-1#1)(2013-1#1)
overweight and obese##20##3##(2006-1#2)(2006-10#3)(2006-2#1)(2006-6#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#2)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
overweight and obesity among##8##4##(2006-1#3)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
overweight and obesity and subsequent NCD that are significant factors in the morbidity and mortality of the population##2##18##(2013-8#2)
overweight and obesity and subsequent NCD that are##4##8##(2013-8#4)
overweight and obesity and subsequent NCD that##6##7##(2013-8#6)
overweight and obesity and subsequent NCD##7##6##(2013-8#7)
overweight and obesity and subsequent##8##5##(2013-8#8)
overweight and obesity and##9##4##(2006-8#1)(2013-8#8)
overweight and obesity for##2##4##(2011-2#1)(2012-12#1)
overweight and obesity in##10##4##(2006-1#1)(2006-10#2)(2008-3#2)(2009-6#1)(2011-1#2)(2012-12#1)(2012-3#1)
overweight and obesity is##2##4##(2011-2#1)(2012-2#1)
overweight and obesity were##2##4##(2012-12#1)(2012-3#1)
overweight and obesity##50##3##(1996-1#1)(2006-1#5)(2006-10#3)(2006-8#1)(2007-12#1)(2008-3#2)(2009-6#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#4)(2012-12#6)(2012-2#7)(2012-3#2)(2013-8#9)
overweight and##94##2##(1993-2#1)(1996-1#1)(2006-1#7)(2006-10#7)(2006-2#1)(2006-6#2)(2006-8#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-3#8)(2008-5#1)(2008-7#1)(2009-2#2)(2009-6#2)(2009-8#2)(2009-9#1)(2010-8#1)(2010-9#1)(2011-1#8)(2011-2#5)(2012-12#6)(2012-2#11)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#13)
overweight as##2##2##(1990-9#1)(2010-11#1)
overweight children##6##2##(2006-1#1)(2009-8#3)(2011-12#1)(2013-1#1)
overweight has##3##2##(1991-10#1)(2008-11#1)(2008-7#1)
overweight in##12##2##(1993-9#1)(2006-1#1)(2006-12#1)(2006-2#1)(2008-1#1)(2008-10#1)(2009-9#2)(2010-11#2)(2011-2#2)
overweight or obese and##3##4##(2008-10#1)(2013-8#2)
overweight or obese##20##3##(2006-8#1)(2007-3#1)(2008-10#2)(2008-3#5)(2010-7#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#7)
overweight or##27##2##(2006-6#1)(2006-8#1)(2007-12#4)(2007-3#1)(2008-10#2)(2008-3#6)(2008-4#1)(2010-7#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#7)
overweight patients##8##2##(1991-2#1)(2006-6#1)(2008-10#3)(2009-8#1)(2010-10#1)(2012-1#1)
overweight premenopausal women##2##3##(2008-3#2)
overweight preoccupation##3##2##(2007-12#3)
overweight prevalence##2##2##(2006-9#1)(2012-2#1)
overweight subjects##4##2##(2006-2#1)(2006-9#1)(2008-6#2)
overweight was##2##2##(2008-3#1)(2011-2#1)
overweight were##2##2##(1995-12#1)(2007-12#1)
overweight women but##2##3##(1991-12#1)(2007-12#1)
overweight women##12##2##(1991-12#1)(1991-5#2)(2007-12#5)(2008-5#2)(2012-12#1)(2013-1#1)
overweight youth##4##2##(2008-3#4)
overweight##286##1##(1990-2#1)(1990-9#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-5#3)(1993-2#1)(1993-9#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-2#1)(1997-7#1)(1997-8#1)(2006-1#13)(2006-10#9)(2006-12#1)(2006-2#9)(2006-6#4)(2006-8#4)(2006-9#3)(2007-12#29)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#14)(2008-11#2)(2008-12#2)(2008-3#26)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#2)(2009-2#3)(2009-4#1)(2009-6#2)(2009-8#7)(2009-9#6)(2010-10#1)(2010-11#9)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#8)(2011-12#2)(2011-2#12)(2012-1#2)(2012-12#11)(2012-2#17)(2012-3#8)(2013-1#8)(2013-7#1)(2013-8#25)
overweight-obesity##2##1##(2010-12#2)
overweight/obese subjects##2##2##(2006-6#1)(2013-1#1)
overweight/obese##5##1##(2006-6#1)(2008-5#1)(2009-6#1)(2013-1#2)
overweight/obesity##6##1##(2009-6#1)(2009-7#1)(2011-1#2)(2013-1#1)(2013-7#1)
overwhelm the##2##2##(1993-12#1)(2008-9#1)
overwhelm##7##1##(1993-12#1)(1995-12#1)(2007-11#1)(2008-5#1)(2008-9#1)(2010-5#1)(2012-12#1)
overwhelmed and##2##2##(2009-7#1)(2010-7#1)
overwhelmed by the##2##3##(2008-11#1)(2008-12#1)
overwhelmed by##6##2##(1994-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2013-1#2)
overwhelmed##12##1##(1994-2#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-7#1)(2010-2#1)(2010-7#1)(2010-9#1)(2013-1#2)
overwhelming anxiety##2##2##(1992-3#1)(2008-4#1)
overwhelming infections##2##2##(2006-10#1)(2007-2#1)
overwhelming majority of##8##3##(1997-6#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
overwhelming majority##10##2##(1997-6#1)(2005-10#1)(2006-10#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
overwhelming sepsis##2##2##(2007-9#1)(2010-2#1)
overwhelming##54##1##(1991-1#1)(1992-3#1)(1992-9#1)(1993-6#1)(1994-3#2)(1994-9#1)(1997-6#1)(2005-10#1)(2006-10#4)(2006-7#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#4)(2008-9#2)(2009-6#1)(2010-2#2)(2010-3#1)(2011-1#1)(2011-11#1)(2011-2#5)(2012-1#1)(2012-11#1)(2013-1#5)
overwhelmingly positive##4##2##(2007-3#1)(2011-2#3)
overwhelmingly preferred the##2##3##(1995-8#1)(2008-10#1)
overwhelmingly##12##1##(1995-4#1)(1995-8#1)(2006-2#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-4#1)(2011-2#3)
overwinter in##2##2##(2008-10#1)(2008-8#1)
overwinter##4##1##(1997-7#1)(2008-10#2)(2008-8#1)
overwintered##6##1##(2008-10#6)
overwintering by##2##2##(2008-10#1)(2008-9#1)
overwintering ectotherms##2##2##(2008-8#2)
overwintering in##2##2##(2008-10#1)(2008-5#1)
overwintering##20##1##(2004-11#1)(2008-10#11)(2008-5#2)(2008-8#2)(2008-9#2)(2010-8#1)(2011-2#1)
overwinters as##2##2##(2008-10#1)(2011-1#1)
overwinters##4##1##(2008-10#3)(2011-1#1)
overzealous##2##1##(1995-9#1)(2006-12#1)
oviduct and##7##2##(1990-8#1)(1991-5#1)(2006-5#1)(2008-11#1)(2008-5#3)
oviduct by##2##2##(1991-5#2)
oviduct transferrin receptor##2##3##(1990-8#2)
oviduct##38##1##(1990-8#4)(1991-5#3)(1991-6#1)(1992-9#1)(1993-8#1)(1994-9#1)(1995-6#1)(1997-8#1)(2004-4#1)(2006-5#3)(2007-1#1)(2007-12#1)(2008-11#3)(2008-12#5)(2008-2#1)(2008-4#1)(2008-5#5)(2008-7#1)(2008-9#1)(2011-1#1)(2012-3#1)
oviductal parts##3##2##(2008-12#3)
oviductal##5##1##(1997-6#1)(2008-12#4)
oviducts and##4##2##(1990-8#1)(1992-2#1)(1995-11#2)
oviducts##6##1##(1990-8#1)(1992-2#1)(1995-11#2)(2007-12#1)(2008-5#1)
ovigerous females##5##2##(2013-1#1)(2013-7#4)
ovigerous##6##1##(2007-3#1)(2013-1#1)(2013-7#4)
ovine Mx##2##2##(1993-12#2)
ovine adenovirus##3##2##(1997-3#3)
ovine and##3##2##(1990-12#2)(2006-8#1)
ovine fetal##2##2##(1990-11#2)
ovine footrot##2##2##(1995-8#1)(2011-2#1)
ovine head impact model##2##4##(2008-7#2)
ovine herpesvirus-2##2##2##(2011-1#2)
ovine hypothalamic##3##2##(1990-7#1)(1992-9#2)
ovine model##2##2##(2009-10#1)(2010-6#1)
ovine pars tuberalis##2##3##(1994-9#2)
ovine prolactin##3##2##(1992-6#1)(2008-12#1)(2008-5#1)
ovine prostaglandin endoperoxide##2##3##(1991-4#1)(1992-3#1)
ovine tumor necrosis factor-alpha##2##4##(1991-12#2)
ovine##72##1##(1990-11#3)(1990-12#2)(1990-7#1)(1991-12#4)(1991-4#1)(1991-5#1)(1992-3#3)(1992-4#2)(1992-6#1)(1992-9#2)(1993-10#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#2)(1995-11#1)(1995-8#1)(1996-12#2)(1997-3#3)(1997-6#2)(2005-7#1)(2006-5#1)(2006-8#3)(2008-11#2)(2008-12#2)(2008-5#2)(2008-7#2)(2008-8#3)(2009-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-11#3)(2012-12#2)(2013-8#3)
oviparae##5##1##(2008-9#5)
oviparasitica strain 50##2##3##(2008-10#2)
oviparasitica##9##1##(2008-10#9)
oviparous##3##1##(1994-12#1)(2007-12#1)(2008-8#1)
ovipneumoniae##11##1##(2005-7#11)
oviposit##8##1##(2007-6#2)(2008-5#1)(2008-6#1)(2008-9#2)(2009-4#1)(2013-8#1)
oviposited in##2##2##(2004-11#1)(2013-8#1)
oviposited##4##1##(2004-11#1)(2007-12#1)(2011-1#1)(2013-8#1)
ovipositing##4##1##(2007-12#1)(2007-4#1)(2007-6#1)(2008-8#1)
oviposition activity##2##2##(2004-11#2)
oviposition and egg##2##3##(2012-12#2)
oviposition and##5##2##(2007-12#1)(2008-9#1)(2009-9#1)(2012-12#2)
oviposition behaviour##2##2##(2007-12#2)
oviposition in the##2##3##(2004-11#1)(2010-8#1)
oviposition preference##2##2##(2008-8#2)
oviposition process##2##2##(2007-12#2)
oviposition was##2##2##(2009-9#1)(2010-8#1)
oviposition##43##1##(1991-5#1)(1997-2#1)(2004-11#8)(2007-12#13)(2007-6#1)(2008-12#1)(2008-5#2)(2008-8#3)(2008-9#3)(2009-6#1)(2009-9#3)(2010-8#2)(2011-2#1)(2012-12#2)(2012-3#1)
oviposition)##2##1##(2006-10#1)(2008-9#1)
ovipositor is##2##2##(2007-12#2)
ovipositor sheaths##2##2##(2007-12#2)
ovipositor##12##1##(2007-12#12)
ovipositors##2##1##(2007-12#1)(2008-5#1)
oviposits##2##1##(2007-12#1)(2011-12#1)
ovis and##3##2##(1996-12#3)
ovis##12##1##(1994-4#1)(1996-12#4)(2005-7#3)(2010-10#2)(2012-2#2)
oviuria##3##1##(2007-2#3)
ovo##19##1##(1990-3#7)(1996-12#3)(1996-5#1)(1997-8#1)(2007-12#1)(2008-11#3)(2008-12#1)(2013-8#2)
ovoid cells of the branchial heart##2##6##(2008-7#2)
ovoid cells of##3##3##(2008-7#3)
ovoid cells with##2##3##(2004-2#1)(2009-7#1)
ovoid cells##7##2##(2004-2#1)(2008-5#1)(2008-7#4)(2009-7#1)
ovoid##11##1##(1993-9#1)(2004-2#1)(2007-12#1)(2008-5#1)(2008-7#4)(2009-7#1)(2011-2#1)(2012-1#1)
ovomucoid third##2##2##(1991-8#2)
ovomucoid##5##1##(1991-8#2)(1995-10#1)(2008-11#2)
ovotransferrin##4##1##(1992-12#1)(2010-4#3)
ovulate##5##1##(2006-5#2)(2009-4#1)(2012-12#2)
ovulated in the##2##3##(2006-5#1)(2008-3#1)
ovulated in##3##2##(1994-7#1)(2006-5#1)(2008-3#1)
ovulated##6##1##(1994-7#1)(1995-2#1)(2006-5#1)(2008-3#1)(2009-4#2)
ovulation and conception##3##3##(2011-1#1)(2013-8#2)
ovulation and##13##2##(1992-4#1)(1996-11#1)(2005-7#1)(2006-5#2)(2007-1#2)(2008-1#1)(2009-4#1)(2011-1#2)(2013-8#2)
ovulation did not occur##2##4##(2009-4#2)
ovulation in loggerhead sea turtles##2##5##(2009-4#2)
ovulation in##9##2##(1990-9#1)(1995-8#1)(2007-3#1)(2008-9#1)(2009-4#2)(2010-8#1)(2012-12#2)
ovulation induction in women with##2##5##(2007-11#1)(2007-7#1)
ovulation induction##9##2##(1994-5#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-3#1)(2009-2#2)(2011-1#1)(2012-2#1)
ovulation of the##2##3##(2005-7#1)(2008-12#1)
ovulation rate##2##2##(2006-5#2)
ovulation tests##2##2##(2011-2#2)
ovulation was##3##2##(1994-7#1)(2006-5#2)
ovulation##80##1##(1990-4#1)(1990-9#2)(1991-11#1)(1992-10#2)(1992-12#1)(1992-4#2)(1992-7#1)(1993-1#1)(1994-5#1)(1994-7#5)(1994-9#1)(1995-8#1)(1996-11#1)(1997-4#2)(2005-7#2)(2006-5#14)(2007-1#4)(2007-11#2)(2007-12#2)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-2#2)(2009-4#7)(2010-11#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#5)
ovulations##5##1##(1994-7#2)(2008-3#3)
ovulatory cycle##2##2##(2008-12#1)(2012-2#1)
ovulatory##6##1##(1992-4#1)(2006-5#1)(2008-12#1)(2008-4#1)(2011-1#1)(2012-2#1)
ovule##4##1##(2008-10#1)(2008-8#2)(2009-12#1)
ovules and##2##2##(2008-10#1)(2009-8#1)
ovules##15##1##(1993-10#1)(2008-10#1)(2008-5#1)(2008-8#9)(2009-12#1)(2009-8#2)
ovules&quot##3##1##(1993-10#3)
ovum##5##1##(1994-7#1)(1994-8#1)(2006-5#1)(2007-11#1)(2011-12#1)
owe much to##2##3##(2006-6#1)(2008-5#1)
owe to##2##2##(2006-9#1)(2013-8#1)
owe##9##1##(1994-2#1)(2005-3#1)(2006-6#1)(2006-7#1)(2006-9#1)(2008-5#1)(2009-5#1)(2012-2#1)(2013-8#1)
owed##5##1##(1996-6#1)(1997-5#1)(2008-5#1)(2009-4#1)(2012-12#1)
owes a##2##2##(2005-12#1)(2010-7#1)
owes its success to the##2##5##(2008-11#1)(2008-4#1)
owes its success##3##3##(2008-11#1)(2008-4#1)(2011-1#1)
owes##7##1##(2005-12#1)(2007-5#1)(2008-11#1)(2008-4#1)(2010-7#1)(2011-1#1)(2012-2#1)
owing in##2##2##(1995-12#1)(1997-5#1)
owing to a low##2##4##(1995-2#1)(2012-1#1)
owing to a reduction in##2##5##(1990-11#1)(2008-3#1)
owing to a##20##3##(1990-11#1)(1991-12#1)(1995-2#1)(1995-5#1)(2007-12#3)(2008-1#1)(2008-2#2)(2008-3#3)(2008-9#1)(2009-11#3)(2009-2#1)(2012-1#1)(2013-1#1)
owing to an##5##3##(2007-12#1)(2008-9#1)(2011-12#1)(2012-11#1)(2012-3#1)
owing to different##2##3##(2008-5#1)(2009-11#1)
owing to either the role of##2##6##(2007-11#2)
owing to either##3##3##(2007-11#2)(2011-2#1)
owing to environmental##2##3##(2007-12#1)(2013-8#1)
owing to impaired##2##3##(1995-8#1)(2012-12#1)
owing to its complexity and##2##5##(2007-12#1)(2012-1#1)
owing to its concomitant consideration of tumor stage##4##8##(2013-8#4)
owing to its relative##2##4##(1992-4#1)(2008-10#1)
owing to its simplicity##2##4##(2012-12#2)
owing to its##30##3##(1990-4#1)(1992-4#2)(1992-9#1)(1994-9#1)(1996-5#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-12#2)(2011-2#1)(2012-1#1)(2012-12#3)(2013-1#1)(2013-8#5)
owing to lack of##4##4##(1992-11#1)(1993-2#1)(1995-5#1)(1996-11#1)
owing to self-phase modulation##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
owing to strong##2##3##(2007-12#1)(2011-1#1)
owing to surface##2##3##(2008-2#2)
owing to the better##2##4##(1994-4#1)(2013-1#1)
owing to the excellent##2##4##(2008-2#1)(2008-7#1)
owing to the fact that##4##5##(1990-3#1)(2006-10#1)(2008-10#1)(2009-2#1)
owing to the high##4##4##(1996-9#1)(2007-8#1)(2008-5#1)(2011-2#1)
owing to the increase##2##4##(1993-10#1)(2008-3#1)
owing to the lack of##6##5##(2006-2#1)(2008-4#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)
owing to the large##3##4##(1994-6#1)(2006-2#1)(2008-3#1)
owing to the need to##2##5##(2008-3#1)(2010-12#1)
owing to the small##3##4##(1997-5#1)(2007-11#1)(2010-5#1)
owing to the strong##2##4##(2008-10#1)(2010-12#1)
owing to the use of##3##5##(1992-6#1)(2008-10#1)(2008-2#1)
owing to the##107##3##(1990-3#1)(1990-9#1)(1991-1#1)(1991-2#1)(1992-10#1)(1992-6#2)(1993-10#1)(1993-5#1)(1993-9#1)(1994-4#1)(1994-6#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-5#1)(1997-8#1)(2004-3#1)(2005-11#1)(2006-10#2)(2006-2#2)(2007-10#1)(2007-11#2)(2007-12#10)(2007-8#1)(2008-1#3)(2008-10#8)(2008-12#1)(2008-2#11)(2008-3#11)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-5#6)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#1)
owing to their ability to##2##5##(2007-8#1)(2013-8#1)
owing to their high##2##4##(2008-10#1)(2013-1#1)
owing to their##17##3##(2007-11#1)(2007-4#1)(2007-8#3)(2008-10#1)(2008-5#1)(2008-7#2)(2009-11#1)(2010-5#1)(2010-7#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
owing to various##2##3##(2005-8#1)(2010-5#1)
owing to##303##2##(1990-11#2)(1990-12#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-4#2)(1992-5#1)(1992-6#2)(1992-9#1)(1993-10#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-4#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-5#2)(1997-8#2)(2004-3#1)(2004-8#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-2#2)(2007-10#2)(2007-11#9)(2007-12#33)(2007-4#1)(2007-8#9)(2008-1#7)(2008-10#17)(2008-12#1)(2008-2#24)(2008-3#22)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#8)(2009-2#2)(2009-3#2)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#7)(2010-2#1)(2010-5#8)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#5)(2012-11#2)(2012-12#10)(2012-2#6)(2012-3#4)(2013-1#8)(2013-8#10)
owing##312##1##(1990-11#2)(1990-12#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-4#2)(1992-5#1)(1992-6#2)(1992-9#1)(1993-10#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-4#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-5#3)(1997-8#2)(2004-3#1)(2004-8#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-2#2)(2007-10#2)(2007-11#9)(2007-12#33)(2007-4#1)(2007-8#9)(2008-1#7)(2008-10#17)(2008-12#1)(2008-2#24)(2008-3#22)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#9)(2009-2#2)(2009-3#2)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#8)(2010-2#1)(2010-5#8)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#8)(2011-3#1)(2012-1#5)(2012-11#2)(2012-12#10)(2012-2#6)(2012-3#5)(2013-1#8)(2013-8#11)
owl (Bubo bubo) with##2##4##(2010-3#2)
owl monkeys (Aotus##3##3##(2008-11#1)(2013-1#2)
owl monkeys##6##2##(2008-11#3)(2013-1#3)
owl##19##1##(1990-5#2)(1996-9#3)(1997-6#1)(2008-11#3)(2008-5#2)(2010-3#5)(2013-1#3)
own abilities##2##2##(2007-11#1)(2009-9#1)
own ability##2##2##(2007-11#1)(2009-3#1)
own academic##2##2##(2011-2#2)
own account]##2##2##(2005-11#1)(2008-9#1)
own action##2##2##(2007-8#1)(2012-1#1)
own actions##2##2##(1997-8#2)
own activities##2##2##(2009-4#1)(2013-1#1)
own alcohol##2##2##(1990-5#1)(2009-7#1)
own and##16##2##(1991-11#1)(1992-3#1)(1997-8#1)(2006-5#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-8#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#2)
own as well as##2##4##(1993-3#1)(1995-5#1)
own body##3##2##(2006-12#1)(2006-2#1)(2013-1#1)
own car##2##2##(2013-1#1)(2013-7#1)
own case##2##2##(1991-10#1)(2008-7#1)
own cells##2##2##(2010-8#1)(2011-2#1)
own characteristics##2##2##(1996-2#1)(2011-2#1)
own cigarette##2##2##(2009-7#2)
own classification##3##2##(1990-11#1)(2007-8#2)
own clinical experience##3##3##(2007-11#1)(2009-8#2)
own clinical material##4##3##(2007-11#1)(2007-7#3)
own clinical##10##2##(1991-4#1)(2007-11#2)(2007-7#3)(2008-8#1)(2009-8#2)(2010-12#1)
own communities##2##2##(2006-2#1)(2008-1#1)
own constituents##2##2##(1997-1#1)(2008-7#1)
own control##2##2##(2006-6#1)(2012-3#1)
own country##2##2##(2005-12#1)(2012-12#1)
own data##5##2##(2005-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)
own devices##2##2##(2006-10#1)(2008-2#1)
own experience and the##2##4##(2007-11#1)(2007-8#1)
own experience and##4##3##(1991-11#1)(1995-1#1)(2007-11#1)(2007-8#1)
own experience at##2##3##(1992-2#1)(1994-3#1)
own experience based on##2##4##(1997-7#1)(2013-1#1)
own experience in the##3##4##(2007-11#1)(2007-5#1)(2007-8#1)
own experience in##4##3##(2007-11#2)(2007-5#1)(2007-8#1)
own experience of##3##3##(1995-6#1)(2006-6#1)(2008-12#1)
own experience with##6##3##(2007-11#1)(2007-7#1)(2007-8#3)(2010-8#1)
own experience##49##2##(1991-11#1)(1992-2#1)(1993-10#2)(1994-3#1)(1995-1#1)(1995-6#1)(1997-7#1)(2004-12#1)(2005-11#1)(2006-6#1)(2007-11#11)(2007-5#1)(2007-7#2)(2007-8#10)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#2)(2009-5#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#1)(2011-3#1)(2013-1#2)
own experiences with##2##3##(2007-8#1)(2009-1#1)
own experiences##12##2##(1991-6#1)(1995-4#1)(1997-8#1)(2007-11#2)(2007-8#3)(2008-11#1)(2008-12#1)(2009-1#1)(2010-7#1)
own experiments##2##2##(2008-10#1)(2008-11#1)
own for##2##2##(1995-12#1)(2008-2#1)
own formation##2##2##(1992-6#1)(1996-5#1)
own future##2##2##(1993-2#1)(2005-3#1)
own genome##2##2##(2010-12#1)(2011-1#1)
own health care##2##3##(1993-3#1)(2008-6#1)
own health##14##2##(1991-12#1)(1991-4#1)(1993-3#1)(1994-2#1)(1994-6#1)(1996-6#3)(2005-8#1)(2006-9#1)(2007-9#1)(2008-6#1)(2008-9#1)(2013-7#1)
own initiative##5##2##(1992-2#1)(1996-9#1)(2006-8#1)(2008-1#1)(2011-12#1)
own institution##5##2##(1994-2#1)(1994-3#1)(2009-4#3)
own laboratories##2##2##(2007-12#1)(2008-4#1)
own laboratory##4##2##(1990-8#1)(1996-8#1)(2011-1#1)(2011-2#1)
own learning##2##2##(2007-1#1)(2008-11#1)
own life##2##2##(1991-2#1)(2010-11#1)
own material##7##2##(1996-1#1)(2007-11#2)(2007-7#1)(2007-8#1)(2012-12#2)
own measurements##2##2##(1997-7#1)(2011-2#1)
own medical##3##2##(1992-12#1)(1993-12#1)(2008-12#1)
own merits##2##2##(2005-10#1)(2012-12#1)
own method of##3##3##(2006-7#1)(2007-11#1)(2007-8#1)
own modification of##2##3##(1991-11#1)(2007-11#1)
own name and##2##3##(2006-6#1)(2013-8#1)
own opinion##2##2##(1995-2#1)(2007-10#1)
own or in combination with##4##5##(1994-10#1)(2004-2#1)(2006-2#1)(2008-7#1)
own or##7##2##(1994-10#1)(2004-2#1)(2006-2#1)(2007-10#1)(2008-10#1)(2008-7#1)(2009-12#1)
own particular##2##2##(2006-8#1)(2012-1#1)
own patient##3##2##(1991-8#1)(2007-8#1)(2008-10#1)
own perception of##2##3##(2007-6#2)
own perception##3##2##(1992-2#1)(2007-6#2)
own personal experience##3##3##(1994-12#1)(2006-7#1)(2008-11#1)
own personal##10##2##(1992-3#1)(1994-12#1)(2006-2#1)(2006-7#2)(2006-9#1)(2008-1#1)(2008-11#2)(2008-2#1)
own practice that##2##3##(2004-3#1)(2007-4#1)
own practice##4##2##(1992-3#1)(2004-3#1)(2007-4#1)(2013-8#1)
own primary##2##2##(1997-2#1)(2006-1#1)
own processes##3##2##(1995-12#1)(1995-3#1)(2009-4#1)
own promoter##4##2##(1995-2#2)(1995-3#1)(2008-10#1)
own relationship formation behaviors##2##4##(2010-10#2)
own research group##2##3##(2008-10#1)(2010-2#1)
own research##10##2##(1997-1#1)(2007-11#2)(2007-9#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-2#1)(2012-12#1)(2013-1#1)
own responsibility##2##2##(1991-4#1)(2008-11#1)
own results##4##2##(1990-7#1)(1992-8#1)(1993-3#1)(2006-10#1)
own right to##2##3##(1990-12#1)(1995-12#1)
own right##14##2##(1990-12#1)(1992-2#1)(1995-12#1)(2006-10#2)(2008-11#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
own sake##2##2##(2008-11#1)(2010-7#1)
own series of##2##3##(1994-3#1)(2012-3#1)
own series##4##2##(1993-10#1)(1994-3#1)(2007-7#1)(2012-3#1)
own set of##3##3##(1994-3#1)(2006-7#1)(2013-8#1)
own software##2##2##(1996-12#1)(2008-7#1)
own species##3##2##(2008-8#1)(2011-12#1)(2012-2#1)
own specific##2##2##(1996-9#1)(2008-11#1)
own studies##4##2##(1991-2#1)(1995-4#1)(2008-7#2)
own survival##2##2##(2007-10#1)(2008-11#1)
own system##3##2##(1990-2#1)(1994-9#1)(2010-12#1)
own transcription##2##2##(1993-6#1)(1997-4#1)
own unique##2##2##(1995-2#1)(2012-12#1)
own use##4##2##(1991-7#1)(1994-12#1)(2007-2#1)(2008-11#1)
own value##2##2##(2007-8#1)(2011-2#1)
own way##3##2##(2005-11#1)(2010-4#1)(2011-1#1)
own weight##3##2##(2007-12#2)(2013-1#1)
own with##2##2##(1993-12#1)(2010-2#1)
own words##6##2##(1995-1#1)(2008-4#1)(2008-6#1)(2011-2#3)
own work and##2##3##(1992-11#1)(2013-7#1)
own work with##2##3##(2008-12#1)(2008-5#1)
own work##5##2##(1992-11#1)(2008-12#1)(2008-5#1)(2009-2#1)(2013-7#1)
own##857##1##(1990-10#3)(1990-11#2)(1990-12#4)(1990-2#2)(1990-3#3)(1990-5#6)(1990-6#3)(1990-7#3)(1990-8#3)(1990-9#1)(1991-10#3)(1991-11#6)(1991-12#2)(1991-2#4)(1991-3#5)(1991-4#5)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#6)(1991-9#2)(1992-1#2)(1992-11#3)(1992-12#3)(1992-2#4)(1992-3#10)(1992-4#3)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#4)(1993-1#3)(1993-10#4)(1993-11#1)(1993-12#6)(1993-2#6)(1993-3#11)(1993-6#2)(1993-9#1)(1994-1#4)(1994-10#2)(1994-12#5)(1994-2#5)(1994-3#8)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#10)(1995-10#1)(1995-11#1)(1995-12#8)(1995-2#9)(1995-3#3)(1995-4#2)(1995-5#4)(1995-6#2)(1995-7#2)(1995-9#4)(1996-1#4)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#4)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#4)(1997-8#6)(2004-1#1)(2004-12#2)(2004-2#2)(2004-3#1)(2004-4#1)(2005-1#1)(2005-10#3)(2005-11#8)(2005-12#3)(2005-3#1)(2005-5#1)(2005-7#2)(2005-8#3)(2006-1#1)(2006-10#8)(2006-12#6)(2006-2#6)(2006-3#1)(2006-4#2)(2006-5#5)(2006-6#7)(2006-7#7)(2006-8#4)(2006-9#2)(2007-1#2)(2007-10#8)(2007-11#33)(2007-12#15)(2007-2#12)(2007-3#4)(2007-4#8)(2007-5#2)(2007-6#3)(2007-7#12)(2007-8#23)(2007-9#11)(2008-1#11)(2008-10#19)(2008-11#28)(2008-12#12)(2008-2#11)(2008-3#10)(2008-4#10)(2008-5#11)(2008-6#10)(2008-7#16)(2008-8#15)(2008-9#13)(2009-1#1)(2009-10#6)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#8)(2009-5#4)(2009-6#2)(2009-7#8)(2009-8#4)(2009-9#2)(2010-10#8)(2010-11#3)(2010-12#10)(2010-2#11)(2010-3#3)(2010-4#4)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#8)(2011-1#15)(2011-12#4)(2011-2#24)(2011-3#2)(2012-1#4)(2012-11#2)(2012-12#20)(2012-2#13)(2012-3#10)(2013-1#16)(2013-7#4)(2013-8#8)
own-health data##3##2##(2008-1#3)
owned a##5##2##(1997-4#1)(2008-10#2)(2010-12#1)(2012-3#1)
owned and##2##2##(1995-3#1)(2007-12#1)
owned by##5##2##(1991-12#1)(1995-11#1)(2007-8#1)(2008-10#1)(2008-5#1)
owned the##3##2##(2008-10#1)(2008-9#1)(2012-12#1)
owned##21##1##(1990-12#1)(1991-12#1)(1995-11#1)(1995-3#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-5#1)(2008-9#1)(2009-8#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
owner and##3##2##(1992-12#1)(2008-5#1)(2011-2#1)
owner##17##1##(1991-2#1)(1992-12#1)(1994-1#1)(1996-1#1)(1996-5#2)(1997-3#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-2#2)(2011-4#1)(2012-11#1)(2013-1#2)(2013-8#1)
owner-evaluated chronic pain index and pain##3##6##(2008-10#3)
owner/dog walkers##4##2##(2013-1#4)
owner/non-dog walkers##2##2##(2013-1#2)
owners and##2##2##(2007-4#1)(2010-8#1)
owners in the##2##3##(1996-12#1)(2008-10#1)
owners in##3##2##(1996-12#1)(2008-10#1)(2010-10#1)
owners may##2##2##(2008-8#2)
owners of hunting dogs##3##4##(1991-11#3)
owners of##4##2##(1991-11#3)(1996-11#1)
owners to##3##2##(2008-8#1)(2012-12#1)(2013-1#1)
owners were surveyed##2##3##(2011-2#1)(2013-1#1)
owners were##4##2##(2007-2#1)(2008-8#1)(2011-2#1)(2013-1#1)
owners##45##1##(1991-11#3)(1993-2#1)(1994-1#1)(1995-11#1)(1995-12#1)(1996-11#2)(1996-12#1)(1997-7#1)(2007-2#1)(2007-4#3)(2008-10#1)(2008-12#2)(2008-5#1)(2008-8#6)(2008-9#1)(2010-10#1)(2010-2#2)(2010-8#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#9)(2013-8#1)
ownership and##5##2##(1995-1#2)(1995-2#1)(2008-12#1)(2010-2#1)
ownership categories##2##2##(1992-12#1)(2005-11#1)
ownership form##2##2##(1995-2#1)(2005-11#1)
ownership of ancillary services##2##4##(1996-1#2)
ownership of the##3##3##(1992-1#1)(1993-3#1)(2007-8#1)
ownership of##15##2##(1992-1#1)(1993-2#1)(1993-3#1)(1996-1#2)(1997-3#1)(2006-4#1)(2007-8#1)(2008-10#2)(2009-4#1)(2011-2#1)(2013-1#3)
ownership status##3##2##(1995-2#1)(2008-11#1)(2013-1#1)
ownership##48##1##(1992-1#1)(1992-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-3#1)(1995-1#4)(1995-2#5)(1996-1#2)(1997-1#1)(1997-3#1)(1997-7#1)(2004-9#1)(2005-11#3)(2006-4#1)(2007-4#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-2#2)(2013-1#4)
owning##5##1##(1991-1#1)(1993-8#1)(2012-12#1)(2013-1#2)
owns##5##1##(1993-8#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)
ox and##2##2##(1991-6#1)(1995-7#1)
ox brain prothrombin##2##3##(1993-6#2)
ox liver MAO-B##2##3##(1995-7#2)
ox liver##8##2##(1994-8#2)(1995-7#5)(2008-4#1)
ox##15##1##(1991-6#2)(1992-2#1)(1993-6#2)(1994-8#2)(1995-7#7)(2008-4#1)
ox-LDL##3##1##(1992-1#1)(1995-6#1)(2012-2#1)
oxa cages##3##2##(1996-5#3)
oxa##4##1##(1996-5#4)
oxacillin##4##1##(2006-10#3)(2010-8#1)
oxacillin-resistant Staphylococcus aureus##2##3##(2005-8#2)
oxacillin-resistant##4##1##(2005-8#2)(2011-2#2)
oxacillin-sensitive##2##1##(2005-8#1)(2011-2#1)
oxadiazole##4##1##(1992-10#1)(2010-4#2)(2012-11#1)
oxadiazoles##3##1##(2007-11#2)(2010-6#1)
oxaferrocene##2##1##(2008-10#2)
oxalacetate##5##1##(1990-2#1)(1990-3#1)(1991-3#2)(1993-11#1)
oxalate (CaOx)##3##2##(1993-9#1)(1995-7#1)(2010-2#1)
oxalate absorption##4##2##(2012-2#4)
oxalate and acetate have been synthesized and characterized on the basis of their physical##2##14##(2008-5#2)
oxalate and##12##2##(1990-10#3)(1990-12#1)(1990-8#1)(2008-10#3)(2008-5#3)(2012-2#1)
oxalate as a##2##3##(1990-8#1)(2006-10#1)
oxalate contents##2##2##(2008-10#1)(2012-2#1)
oxalate crystals rather than##2##4##(1991-11#1)(1992-9#1)
oxalate crystals##5##2##(1991-11#1)(1992-5#1)(1992-9#1)(2010-12#2)
oxalate determination in urine##2##4##(1990-12#1)(2008-10#1)
oxalate determination##3##2##(1990-12#1)(2008-10#2)
oxalate films on marble##2##4##(2008-10#2)
oxalate films##3##2##(2008-10#3)
oxalate form of##2##3##(2008-10#2)
oxalate in##8##2##(1990-12#1)(1995-7#1)(2008-10#5)(2012-2#1)
oxalate ion##2##2##(2008-10#2)
oxalate monohydrate##3##2##(1995-8#2)(2010-12#1)
oxalate on the##2##3##(1990-11#1)(2008-10#1)
oxalate or##2##2##(1990-10#1)(1994-12#1)
oxalate oxidase##3##2##(2007-8#1)(2008-10#2)
oxalate that is##2##3##(2012-2#2)
oxalate that##3##2##(2008-10#1)(2012-2#2)
oxalate was lower##2##3##(1995-7#1)(2007-8#1)
oxalate was##5##2##(1990-10#1)(1995-7#1)(2007-8#2)(2008-10#1)
oxalate##132##1##(1990-10#8)(1990-11#1)(1990-12#3)(1990-8#2)(1991-11#1)(1991-12#2)(1992-5#4)(1992-6#1)(1992-9#5)(1993-3#2)(1993-9#1)(1994-12#7)(1995-7#8)(1995-8#2)(2005-11#1)(2005-12#3)(2006-10#1)(2006-3#2)(2007-11#1)(2007-8#5)(2008-10#48)(2008-5#3)(2010-12#4)(2010-2#2)(2010-5#3)(2011-1#1)(2012-2#11)
oxalate)##3##1##(1993-10#1)(1993-8#1)(1995-12#1)
oxalate-degrading##2##1##(2012-2#2)
oxalate/creatinine clearance ratios in##2##4##(1990-10#2)
oxalates##2##1##(2008-10#2)
oxalic acid digests of##2##4##(1990-8#2)
oxalic acid in##5##3##(1990-8#1)(2008-10#2)(2013-1#2)
oxalic acid induces##2##3##(2009-8#2)
oxalic acid is##2##3##(2009-8#1)(2012-2#1)
oxalic acid was##2##3##(2013-1#2)
oxalic acid##28##2##(1990-8#3)(2008-10#6)(2009-2#1)(2009-7#1)(2009-8#7)(2010-5#1)(2012-2#3)(2013-1#6)
oxalic##34##1##(1990-8#3)(1994-9#1)(2008-10#10)(2009-2#1)(2009-7#1)(2009-8#7)(2010-5#1)(2012-2#3)(2013-1#7)
oxalicum##10##1##(2007-7#2)(2008-10#8)
oxaliplatin or irinotecan##2##3##(2008-5#2)
oxaliplatin with##2##2##(2008-3#1)(2010-11#1)
oxaliplatin##24##1##(1990-5#2)(2007-4#1)(2008-1#1)(2008-3#6)(2008-4#2)(2008-5#6)(2008-8#1)(2009-4#1)(2010-11#3)(2011-12#1)
oxaliplatin-based##2##1##(2008-3#1)(2009-2#1)
oxaliplatin-induced peripheral neuropathy##2##3##(2008-3#1)(2008-7#1)
oxaloacetate##17##1##(1990-3#3)(1991-4#3)(1991-8#1)(1992-1#1)(1992-5#1)(1995-11#1)(1996-2#1)(2004-4#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
oxalosis##9##1##(1991-1#1)(1991-11#3)(1992-5#1)(2007-7#2)(2011-2#2)
oxamate##3##1##(1994-9#1)(2010-4#2)
oxamide ligand##2##2##(2008-3#2)
oxamide##4##1##(2008-10#1)(2008-3#2)(2010-12#1)
oxamniquine##5##1##(2010-12#5)
oxandrolone##2##1##(2005-10#1)(2007-11#1)
oxathiaphospholane monomers##2##2##(2008-4#2)
oxathiaphospholane##3##1##(2008-4#3)
oxathiazinane dioxides##2##2##(2010-8#2)
oxazepam##6##1##(1990-11#1)(1991-12#1)(2008-6#4)
oxazole##4##1##(1993-2#1)(1996-8#2)(2008-4#1)
oxazoles##2##1##(1996-5#1)(2008-6#1)
oxazolidinedione derived bicalutamide analogs##2##4##(2007-12#2)
oxazolidinedione##3##1##(1994-9#1)(2007-12#2)
oxazolidinone antibacterial##2##2##(2005-7#1)(2006-8#1)
oxazolidinone##8##1##(2005-7#2)(2006-10#1)(2006-8#3)(2008-3#1)(2008-8#1)
oxazolidinones##5##1##(2005-7#1)(2006-8#2)(2007-12#1)(2009-2#1)
oxazoline##2##1##(1996-2#1)(2005-8#1)
oxazolone control group##2##3##(2011-3#2)
oxazolone##5##1##(1995-2#1)(2011-3#2)(2012-12#1)(2013-1#1)
oxazolone-induced##3##1##(2011-3#3)
oxcarbazepine##3##1##(1990-6#1)(2008-8#1)(2010-12#1)
oxendolone##7##1##(1990-11#7)
oxibendazole treatment##2##2##(2007-6#2)
oxibendazole##5##1##(2007-6#2)(2008-10#3)
oxic and anoxic##2##3##(1992-3#1)(2006-6#1)
oxic##3##1##(1992-3#1)(2005-12#1)(2006-6#1)
oxid-LDL##2##1##(1992-5#2)
oxidant and antioxidant enzymes##3##4##(2010-7#3)
oxidant and antioxidant status##3##4##(2008-12#2)(2009-9#1)
oxidant and antioxidant##6##3##(2008-12#2)(2009-9#1)(2010-7#3)
oxidant and##10##2##(1992-3#1)(1994-3#1)(2008-10#1)(2008-12#2)(2009-9#1)(2010-7#3)(2011-1#1)
oxidant compounds##3##2##(2008-10#3)
oxidant concentration##4##2##(1995-8#1)(2008-10#3)
oxidant for##2##2##(2008-10#1)(2010-5#1)
oxidant generation and##2##3##(1995-6#1)(1996-2#1)
oxidant generation##3##2##(1995-6#1)(1996-2#2)
oxidant in##3##2##(2008-10#2)(2008-5#1)
oxidant injury##2##2##(1996-8#1)(1996-9#1)
oxidant is##3##2##(2008-10#3)
oxidant sensitivity##2##2##(1997-6#1)(2010-8#1)
oxidant solution##2##2##(2008-10#2)
oxidant status##2##2##(2012-2#2)
oxidant stress##13##2##(1991-9#1)(1994-3#2)(1994-6#2)(1995-1#1)(2004-4#1)(2005-7#1)(2007-8#1)(2010-8#3)(2012-11#1)
oxidant than##2##2##(2008-10#1)(2012-12#1)
oxidant to##3##2##(2008-10#3)
oxidant was##2##2##(2008-10#2)
oxidant##114##1##(1990-5#1)(1991-10#1)(1991-9#2)(1992-10#1)(1992-3#1)(1994-3#5)(1994-6#2)(1995-1#1)(1995-3#1)(1995-6#1)(1995-8#3)(1996-2#3)(1996-8#2)(1996-9#2)(1997-6#1)(2004-12#1)(2004-4#1)(2005-7#1)(2005-8#1)(2006-3#1)(2006-8#1)(2007-10#3)(2007-11#8)(2007-8#1)(2008-10#45)(2008-12#2)(2008-5#2)(2008-6#2)(2009-9#2)(2010-5#2)(2010-7#3)(2010-8#4)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)
oxidant-antioxidant balance##2##2##(1991-9#1)(2008-7#1)
oxidant-antioxidant system in##2##3##(2009-2#1)(2009-6#1)
oxidant-antioxidant##5##1##(1991-9#2)(2008-7#1)(2009-2#1)(2009-6#1)
oxidant-induced##3##1##(1991-9#1)(1994-10#1)(2013-1#1)
oxidant-mediated##4##1##(1993-7#1)(1994-6#1)(1997-3#1)(2007-8#1)
oxidants and##5##2##(1990-7#1)(1996-2#1)(1996-9#1)(2008-11#1)(2013-8#1)
oxidants are##2##2##(1997-2#1)(2008-10#1)
oxidants as##2##2##(2008-10#2)
oxidants can be##2##3##(1991-9#1)(2008-5#1)
oxidants can##4##2##(1991-9#1)(1996-2#2)(2008-5#1)
oxidants in liquid phase##2##4##(2008-10#2)
oxidants in##3##2##(2008-10#2)(2010-8#1)
oxidants is##2##2##(1994-3#1)(2006-9#1)
oxidants of##2##2##(1997-7#1)(2008-10#1)
oxidants to##2##2##(1990-9#1)(2008-10#1)
oxidants##48##1##(1990-5#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-9#2)(1993-4#1)(1994-3#1)(1996-2#3)(1996-9#2)(1997-2#1)(1997-7#2)(2006-10#1)(2006-3#1)(2006-9#1)(2007-11#2)(2007-8#2)(2008-1#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-5#1)(2010-1#1)(2010-5#3)(2010-8#1)(2011-2#1)(2012-11#2)(2013-8#1)
oxidase (AOX)##4##2##(1994-6#1)(1997-7#1)(2008-9#1)(2009-8#1)
oxidase (CO)##3##2##(1995-5#1)(1997-2#1)(1997-4#1)
oxidase (ChOx) and##2##3##(2008-10#2)
oxidase (ChOx)##6##2##(2007-9#1)(2008-10#5)
oxidase (EC 1##3##3##(1990-2#1)(1995-2#1)(2008-10#1)
oxidase (GOD) and##2##3##(2008-10#2)
oxidase (GOD) was immobilized##2##4##(2008-10#2)
oxidase (GOD)##6##2##(2008-10#6)
oxidase (XO)##5##2##(1996-6#1)(2008-10#2)(2008-11#1)(2010-8#1)
oxidase (XOD)##3##2##(1993-12#1)(2008-10#2)
oxidase (as##2##2##(2007-8#1)(2009-12#1)
oxidase A##8##2##(1991-12#1)(1993-4#2)(1995-11#1)(1997-5#1)(2005-9#1)(2009-8#1)(2011-2#1)
oxidase B inhibitor##2##3##(1997-5#1)(2010-12#1)
oxidase B##7##2##(1992-11#2)(1993-4#1)(1996-5#1)(1997-5#1)(2009-12#1)(2010-12#1)
oxidase I gene##2##3##(2008-6#1)(2011-2#1)
oxidase I##8##2##(1997-7#1)(2007-12#1)(2008-6#2)(2011-2#3)(2013-7#1)
oxidase activating##2##2##(1993-12#2)
oxidase activation##10##2##(1990-6#5)(1991-2#1)(1992-7#1)(1993-12#2)(2008-1#1)
oxidase activities of##3##3##(1991-7#1)(1994-3#1)(1996-6#1)
oxidase activities##8##2##(1990-2#1)(1990-4#1)(1990-8#1)(1991-10#1)(1991-7#1)(1994-3#1)(1995-6#1)(1996-6#1)
oxidase activity and the##2##4##(1996-2#1)(2007-11#1)
oxidase activity and##3##3##(1995-1#1)(1996-2#1)(2007-11#1)
oxidase activity by##2##3##(1992-6#2)
oxidase activity has##2##3##(1991-5#1)(2009-8#1)
oxidase activity in human##2##4##(1990-10#1)(1992-6#1)
oxidase activity in##12##3##(1990-10#1)(1990-12#1)(1990-3#1)(1992-6#1)(1994-11#1)(1996-12#1)(1996-2#1)(1997-3#2)(1997-5#1)(2008-10#1)(2008-3#1)
oxidase activity of##9##3##(1990-11#2)(1990-4#1)(1992-9#2)(1994-12#3)(1996-2#1)
oxidase activity was##13##3##(1990-10#1)(1990-3#1)(1990-4#2)(1991-2#1)(1992-5#1)(1994-12#1)(1996-2#1)(1997-5#1)(1997-6#1)(2008-10#1)(2008-7#2)
oxidase activity##80##2##(1990-10#3)(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#4)(1990-4#3)(1990-5#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-5#3)(1992-3#1)(1992-5#1)(1992-6#4)(1992-9#4)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#6)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-3#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-2#4)(1997-3#4)(1997-5#2)(1997-6#1)(1997-8#1)(2006-8#2)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-8#1)(2012-2#1)
oxidase and a##2##3##(1992-3#1)(1995-3#1)
oxidase and is##2##3##(1994-2#1)(2012-2#1)
oxidase and its##2##3##(1995-2#1)(2008-10#1)
oxidase and the##3##3##(1994-9#1)(2008-10#2)
oxidase and to##2##3##(1990-6#1)(1994-6#1)
oxidase and##46##2##(1990-5#1)(1990-6#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-12#1)(1992-3#3)(1993-6#1)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-7#1)(1996-5#1)(1997-2#1)(1997-6#1)(2007-1#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#2)(2012-2#1)
oxidase are##2##2##(1990-11#1)(1997-6#1)
oxidase as##3##2##(2008-10#3)
oxidase at##5##2##(1990-10#1)(1990-3#2)(1997-7#1)(2008-10#1)
oxidase based##2##2##(2008-10#2)
oxidase by##6##2##(1990-10#1)(1991-2#1)(1993-6#1)(1994-9#2)(1997-6#1)
oxidase can be activated##2##4##(1993-8#1)(2008-1#1)
oxidase can be##4##3##(1990-11#1)(1993-8#1)(1994-9#1)(2008-1#1)
oxidase can##5##2##(1990-11#1)(1990-3#1)(1993-8#1)(1994-9#1)(2008-1#1)
oxidase complex and##3##3##(1992-3#3)
oxidase complex##7##2##(1991-2#2)(1992-3#3)(1993-8#1)(1995-6#1)
oxidase complexes##2##2##(1990-12#1)(1994-8#1)
oxidase content##2##2##(1991-3#1)(2008-10#1)
oxidase electrode##3##2##(2008-10#2)(2009-10#1)
oxidase enzyme activity##3##3##(2008-10#3)
oxidase enzyme was##3##3##(2008-10#3)
oxidase enzyme##11##2##(1990-7#1)(1994-3#1)(2008-10#7)(2008-5#1)(2008-6#1)
oxidase enzymes##4##2##(2008-10#2)(2008-5#1)(2010-1#1)
oxidase for##2##2##(1991-10#1)(1993-8#1)
oxidase from Arthrobacter##3##3##(1990-2#1)(1994-3#1)(2009-9#1)
oxidase from Escherichia coli##3##4##(1995-11#1)(1995-5#2)
oxidase from the##3##3##(1990-4#1)(1991-2#1)(2010-9#1)
oxidase from##23##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-2#2)(1991-5#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-4#1)(1995-5#2)(1997-3#1)(1997-7#3)(2008-10#1)(2009-9#1)(2010-9#1)(2011-2#1)
oxidase gene##5##2##(1991-3#2)(1995-3#1)(2005-10#1)(2006-12#1)
oxidase has been##5##3##(1992-8#1)(1994-12#1)(1994-9#1)(2008-10#1)(2009-8#1)
oxidase has##6##2##(1990-4#1)(1992-8#1)(1994-12#1)(1994-9#1)(2008-10#1)(2009-8#1)
oxidase immobilized##8##2##(2008-10#8)
oxidase in Saccharomyces##2##3##(1993-2#1)(1994-9#1)
oxidase in a##4##3##(1990-5#2)(1993-8#1)(2008-5#1)
oxidase in conjunction with the##2##5##(2008-10#2)
oxidase in the##5##3##(1994-9#1)(2008-10#3)(2008-3#1)
oxidase in##30##2##(1990-2#2)(1990-3#1)(1990-5#2)(1991-5#1)(1991-9#2)(1992-8#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-8#3)(1994-9#2)(1995-1#1)(1995-8#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)
oxidase inhibition##2##2##(1996-10#1)(2009-9#1)
oxidase inhibitor##11##2##(1990-2#1)(1991-5#1)(1994-6#1)(1996-9#1)(1997-5#1)(2007-7#1)(2008-10#3)(2008-11#2)
oxidase inhibitors##5##2##(1991-9#1)(1992-8#1)(2008-1#1)(2008-6#1)(2011-2#1)
oxidase into##4##2##(1990-5#1)(1991-5#1)(2008-10#2)
oxidase is a##3##3##(1994-6#1)(2008-1#1)(2008-10#1)
oxidase is##12##2##(1990-4#1)(1992-12#1)(1992-3#1)(1992-8#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-6#1)(1997-6#1)(2008-1#2)(2008-10#1)
oxidase levels in##2##3##(1990-4#2)
oxidase levels##3##2##(1990-4#3)
oxidase mRNA##2##2##(1995-3#1)(2010-4#1)
oxidase modified carbon##2##3##(2008-10#2)
oxidase of##12##2##(1990-11#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-7#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(2008-10#2)
oxidase on the##5##3##(1992-11#1)(2008-10#4)
oxidase on##8##2##(1991-9#1)(1992-11#1)(2007-9#1)(2008-10#5)
oxidase onto##2##2##(2007-8#2)
oxidase or##3##2##(2006-2#1)(2007-11#1)(2010-12#1)
oxidase pH 6##3##3##(1995-6#3)
oxidase pH##5##2##(1995-6#5)
oxidase promoter##3##2##(1994-11#1)(1995-3#1)(1997-4#1)
oxidase protein##2##2##(1994-6#1)(1997-6#1)
oxidase requires##2##2##(1993-6#1)(1995-1#1)
oxidase subunit I##6##3##(1990-2#1)(1993-2#1)(2010-4#3)(2011-2#1)
oxidase subunit IV (COX IV)##2##5##(1994-11#1)(2008-10#1)
oxidase subunit IV##4##3##(1991-9#1)(1992-6#1)(1994-11#1)(2008-10#1)
oxidase subunit##16##2##(1990-2#1)(1990-5#1)(1991-6#1)(1991-9#1)(1992-6#1)(1993-2#1)(1994-11#1)(1997-3#1)(2005-8#1)(2008-10#2)(2009-10#1)(2010-4#3)(2011-2#1)
oxidase subunits##2##2##(1994-8#1)(1995-6#1)
oxidase system##6##2##(1990-5#1)(1990-8#1)(1993-4#1)(1993-8#1)(2008-10#1)(2010-12#1)
oxidase to##3##2##(1991-7#1)(1993-8#1)(2009-11#1)
oxidase type A from human liver##2##6##(1990-12#2)
oxidase type A##4##3##(1990-12#2)(1995-11#1)(2007-8#1)
oxidase type B##3##3##(1993-4#2)(2008-7#1)
oxidase type##7##2##(1990-12#2)(1993-4#2)(1995-11#1)(2007-8#1)(2008-7#1)
oxidase was immobilized on##2##4##(2008-10#2)
oxidase was immobilized##4##3##(2008-10#4)
oxidase was##21##2##(1991-6#1)(1992-11#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-9#2)(1995-6#1)(2007-8#1)(2008-10#8)(2008-7#1)(2009-8#1)(2011-1#1)
oxidase were##6##2##(1990-12#1)(1993-4#1)(1994-12#1)(1995-2#2)(2008-10#1)
oxidase which##4##2##(1991-7#2)(1994-12#1)(2008-10#1)
oxidase with a##2##3##(1990-10#1)(1993-8#1)
oxidase with##9##2##(1990-10#1)(1993-8#1)(1994-8#2)(1996-9#1)(2008-10#4)
oxidase##748##1##(1990-10#8)(1990-11#9)(1990-12#9)(1990-2#12)(1990-3#11)(1990-4#11)(1990-5#8)(1990-6#6)(1990-7#3)(1990-8#2)(1990-9#1)(1991-10#5)(1991-11#1)(1991-12#9)(1991-2#10)(1991-3#5)(1991-4#1)(1991-5#14)(1991-6#6)(1991-7#7)(1991-8#1)(1991-9#7)(1992-11#11)(1992-12#5)(1992-3#11)(1992-5#3)(1992-6#6)(1992-7#3)(1992-8#9)(1992-9#4)(1993-11#1)(1993-12#6)(1993-2#2)(1993-3#1)(1993-4#9)(1993-6#8)(1993-8#12)(1994-11#3)(1994-12#16)(1994-2#3)(1994-3#15)(1994-6#8)(1994-8#17)(1994-9#15)(1995-1#6)(1995-11#5)(1995-2#10)(1995-3#9)(1995-4#2)(1995-5#5)(1995-6#18)(1995-7#1)(1995-8#4)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#7)(1996-5#6)(1996-6#3)(1996-7#2)(1996-8#2)(1996-9#3)(1997-2#3)(1997-3#6)(1997-4#3)(1997-5#8)(1997-6#10)(1997-7#9)(1997-8#2)(2005-10#1)(2005-8#3)(2005-9#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-8#4)(2007-1#3)(2007-11#3)(2007-12#1)(2007-2#2)(2007-6#3)(2007-7#1)(2007-8#16)(2007-9#2)(2008-1#7)(2008-10#153)(2008-11#6)(2008-3#3)(2008-4#2)(2008-5#8)(2008-6#5)(2008-7#8)(2008-8#3)(2008-9#3)(2009-10#3)(2009-11#1)(2009-12#4)(2009-6#1)(2009-8#5)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-4#6)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#11)(2012-12#3)(2012-2#7)(2013-7#1)(2013-8#2)
oxidase)##6##1##(1990-2#1)(1994-3#1)(1996-2#1)(2008-10#3)
oxidase-B inhibitors##2##2##(1995-6#1)(2010-12#1)
oxidase-B##6##1##(1994-8#1)(1995-6#2)(1995-7#2)(2010-12#1)
oxidase-based enzyme##2##2##(2008-10#2)
oxidase-based##3##1##(2008-10#3)
oxidase-derived##2##1##(1991-9#1)(2009-12#1)
oxidase-like##5##1##(1995-3#4)(2008-10#1)
oxidases and##3##2##(1991-5#1)(1994-8#1)(2008-8#1)
oxidases in##3##2##(1991-10#1)(1994-2#1)(2008-7#1)
oxidases##33##1##(1990-12#1)(1990-7#3)(1991-10#1)(1991-5#1)(1992-11#1)(1992-12#1)(1993-9#1)(1994-2#1)(1994-8#5)(1995-3#1)(1995-6#1)(1996-10#2)(1996-7#1)(1997-2#1)(2008-10#2)(2008-7#2)(2008-8#2)(2009-8#2)(2009-9#1)(2012-2#2)(2013-8#1)
oxidation activity##4##2##(1990-4#1)(1992-12#1)(2009-2#1)(2013-1#1)
oxidation agent##3##2##(2008-10#2)(2010-5#1)
oxidation and dry heat##2##4##(2008-10#2)
oxidation and lipid##2##3##(2008-8#1)(2010-4#1)
oxidation and reduction##4##3##(2008-10#4)
oxidation and the##2##3##(2007-8#1)(2008-10#1)
oxidation and##60##2##(1990-7#1)(1991-12#1)(1991-5#2)(1992-11#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-7#1)(2006-12#1)(2006-7#2)(2007-11#2)(2007-3#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#15)(2008-4#1)(2008-5#2)(2008-8#2)(2009-2#1)(2010-12#1)(2010-4#6)(2010-8#1)(2011-1#1)(2011-12#1)(2012-1#2)
oxidation appears##2##2##(1990-3#1)(1993-7#1)
oxidation are##3##2##(1991-2#1)(1995-1#1)(2012-12#1)
oxidation as a##2##3##(1995-5#1)(2009-3#1)
oxidation as##4##2##(1995-5#1)(1997-8#1)(2006-12#1)(2009-3#1)
oxidation at a##2##3##(1991-5#1)(1991-7#1)
oxidation at pH##2##3##(1995-6#2)
oxidation at the##2##3##(2008-5#1)(2009-2#1)
oxidation at##18##2##(1991-5#1)(1991-7#1)(1994-3#1)(1995-3#1)(1995-6#2)(1996-5#1)(2007-8#1)(2008-10#5)(2008-5#4)(2009-2#1)
oxidation by cupric ions##2##4##(2011-2#2)
oxidation by dioxygen catalysed by horseradish##2##6##(2006-10#2)
oxidation by hydrogen peroxide##3##4##(2008-10#2)(2011-2#1)
oxidation by macrophages##2##3##(1993-3#1)(2005-8#1)
oxidation by mouse##2##3##(1990-7#1)(1995-7#1)
oxidation by ozone##2##3##(1997-1#2)
oxidation by the##5##3##(1990-2#1)(1994-9#1)(2008-10#3)
oxidation by##48##2##(1990-2#1)(1990-7#1)(1991-4#1)(1992-1#1)(1992-5#2)(1992-7#1)(1992-9#1)(1993-3#1)(1994-9#1)(1995-12#1)(1995-6#2)(1995-7#3)(1996-11#1)(1996-5#1)(1997-1#2)(1997-6#2)(1997-7#1)(2005-8#1)(2006-10#2)(2006-3#1)(2007-12#1)(2007-8#1)(2008-10#12)(2008-5#4)(2011-2#3)
oxidation can##3##2##(1995-11#1)(2011-1#1)(2013-7#1)
oxidation capacity##2##2##(1991-12#1)(2008-1#1)
oxidation catalysed by##2##3##(2006-10#1)(2008-10#1)
oxidation catalyzed by##5##3##(1990-7#1)(1991-8#1)(1996-7#2)(2008-10#1)
oxidation chemistry##2##2##(2008-5#1)(2008-6#1)
oxidation compared to##2##3##(2006-2#1)(2008-5#1)
oxidation compared##3##2##(1994-9#1)(2006-2#1)(2008-5#1)
oxidation current##3##2##(2007-8#1)(2008-10#2)
oxidation decreased##4##2##(1994-5#1)(2005-8#1)(2008-10#1)(2010-4#1)
oxidation during##8##2##(1991-12#3)(2007-6#1)(2008-10#1)(2008-5#2)(2013-1#1)
oxidation dyes##2##2##(2008-5#2)
oxidation efficiency##3##2##(2008-10#3)
oxidation for##7##2##(2005-8#1)(2008-10#6)
oxidation generates##2##2##(2005-11#1)(2010-4#1)
oxidation had##2##2##(1990-12#1)(2008-5#1)
oxidation has##2##2##(2007-8#1)(2008-10#1)
oxidation have##2##2##(1990-12#1)(2008-10#1)
oxidation in a##2##3##(1992-7#1)(2008-10#1)
oxidation in bovine and porcine muscle model systems##2##8##(2010-4#2)
oxidation in the presence of##4##5##(1991-8#1)(2006-12#1)(2008-10#1)(2008-5#1)
oxidation in the##11##3##(1990-5#1)(1991-8#1)(1995-6#1)(1997-8#1)(2005-8#1)(2006-12#1)(2008-1#2)(2008-10#2)(2008-5#1)
oxidation in##55##2##(1990-3#1)(1990-5#2)(1990-9#1)(1991-2#1)(1991-8#1)(1992-7#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-5#1)(1996-9#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-8#2)(2006-12#1)(2006-3#1)(2007-11#1)(2007-8#1)(2008-1#4)(2008-10#7)(2008-3#1)(2008-5#2)(2008-8#2)(2010-12#1)(2010-4#7)(2011-1#2)(2011-12#1)(2012-2#1)(2013-1#1)
oxidation induced##2##2##(2005-8#1)(2006-12#1)
oxidation is##11##2##(1994-5#1)(1997-4#1)(1997-8#1)(2006-12#2)(2008-1#1)(2008-10#4)(2008-5#1)
oxidation level##3##2##(1994-11#1)(2010-7#2)
oxidation markers in##3##3##(2010-4#3)
oxidation markers##4##2##(2010-4#4)
oxidation may##3##2##(2005-7#1)(2008-8#1)(2009-3#1)
oxidation metabolites##2##2##(2011-1#1)(2011-3#1)
oxidation method##3##2##(2008-10#3)
oxidation occur##2##2##(1997-4#1)(2008-3#1)
oxidation occurs##2##2##(1996-2#1)(1997-8#1)
oxidation of 1##4##3##(1992-5#2)(2008-10#2)
oxidation of 2##2##3##(2008-10#2)
oxidation of AA##2##3##(2008-10#2)
oxidation of As(III)##2##3##(2008-10#2)
oxidation of Cr(III) to Cr(VI)##2##5##(2008-10#2)
oxidation of Cr(III)##3##3##(2008-10#3)
oxidation of HSO(3)(-)##3##3##(2008-10#3)
oxidation of LDL was##2##4##(1997-2#1)(2005-8#1)
oxidation of LDL##11##3##(1995-12#1)(1997-2#5)(1997-6#1)(2005-7#1)(2005-8#1)(2008-10#1)(2009-10#1)
oxidation of MeBr##3##3##(2006-3#3)
oxidation of N##8##3##(1991-3#1)(2008-10#6)(2008-3#1)
oxidation of N-(3-sulfopropyl)-3##2##3##(2008-10#2)
oxidation of NAD(P)H##2##3##(1995-6#2)
oxidation of NADH in##2##4##(1993-4#1)(2008-6#1)
oxidation of NADH##6##3##(1993-4#1)(1995-6#1)(2008-10#3)(2008-6#1)
oxidation of NADPH##4##3##(1994-3#1)(1995-6#2)(2008-5#1)
oxidation of NO##4##3##(2008-10#4)
oxidation of TMPD##2##3##(1991-3#2)
oxidation of a##5##3##(1995-6#1)(2008-10#4)
oxidation of alcohols##4##3##(2007-11#2)(2008-10#1)(2010-12#1)
oxidation of all##2##3##(1996-3#1)(2008-10#1)
oxidation of ammonia to nitrite##2##5##(2008-10#2)
oxidation of ammonia with##2##4##(2008-10#2)
oxidation of ammonia##4##3##(2008-10#4)
oxidation of ascorbate##4##3##(1996-2#1)(1996-8#1)(2008-10#2)
oxidation of ascorbic acid##3##4##(2008-10#3)
oxidation of benzoins to##2##4##(2007-11#2)
oxidation of benzoyl hydrazine##2##4##(2008-10#2)
oxidation of captopril##2##3##(1994-3#2)
oxidation of cisatracurium##2##3##(2008-10#2)
oxidation of cysteine residues##2##4##(1991-7#1)(1993-9#1)
oxidation of cysteine##5##3##(1991-5#2)(1991-7#1)(1993-9#2)
oxidation of cytochrome##2##3##(1996-4#1)(2008-10#1)
oxidation of dopamine##2##3##(1991-9#2)
oxidation of etodolac##3##3##(2008-10#3)
oxidation of fatty acids##2##4##(2006-8#1)(2008-5#1)
oxidation of glucose and##3##4##(1990-7#1)(2007-8#1)(2008-10#1)
oxidation of glucose in the presence of##2##7##(2008-10#2)
oxidation of glucose##7##3##(1990-7#1)(2007-8#3)(2008-10#3)
oxidation of heme##2##3##(1995-11#1)(1996-3#1)
oxidation of human low-density##2##4##(1993-12#1)(2006-12#1)
oxidation of human plasma##2##4##(1997-8#2)
oxidation of human##4##3##(1993-12#1)(1997-8#2)(2006-12#1)
oxidation of hydrazine at##2##4##(2008-10#2)
oxidation of hydrazine##5##3##(2008-10#5)
oxidation of hydrogen peroxide##3##4##(2008-10#3)
oxidation of indole-3-acetic acid##2##4##(2006-10#2)
oxidation of iodide##4##3##(2007-8#2)(2008-10#2)
oxidation of leuco##2##3##(2008-10#2)
oxidation of low density##2##4##(1996-5#1)(2011-2#1)
oxidation of luminol by##4##4##(1991-5#1)(2008-10#3)
oxidation of luminol##9##3##(1991-5#1)(2008-10#8)
oxidation of lung lipids##2##4##(1992-9#2)
oxidation of mercury in methyl ethyl ketone##2##7##(2008-10#2)
oxidation of mercury##3##3##(2008-10#3)
oxidation of methyl##2##3##(2006-3#1)(2008-10#1)
oxidation of nitrite ion##5##4##(2008-10#5)
oxidation of organic##3##3##(2004-4#1)(2008-10#1)(2010-5#1)
oxidation of palmitic##2##3##(1993-9#1)(2013-1#1)
oxidation of paracetamol##2##3##(2008-10#2)
oxidation of phenol##2##3##(2008-10#2)
oxidation of phenols##2##3##(1994-5#2)
oxidation of plasma##3##3##(1996-5#1)(1997-8#1)(2004-12#1)
oxidation of primary##2##3##(1994-5#1)(2007-11#1)
oxidation of purpurogallin##2##3##(2008-10#2)
oxidation of pyrogallol##3##3##(2008-10#3)
oxidation of resveratrol##2##3##(2008-10#2)
oxidation of secondary alcohols##3##4##(2005-8#1)(2007-11#1)(2008-8#1)
oxidation of substrates##4##3##(1990-2#1)(1993-9#1)(1994-8#2)
oxidation of the corresponding##2##4##(1992-12#1)(2007-11#1)
oxidation of the##51##3##(1990-12#1)(1990-3#1)(1991-1#1)(1991-5#1)(1992-12#2)(1992-5#1)(1993-6#1)(1994-5#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-6#1)(1995-7#1)(1996-2#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#22)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-9#1)(2012-2#1)
oxidation of these compounds##3##4##(2007-11#1)(2008-10#2)
oxidation of these##5##3##(1994-8#1)(2007-11#1)(2008-10#3)
oxidation of thiols##2##3##(2007-11#1)(2008-10#1)
oxidation of this##3##3##(1995-7#1)(2008-10#2)
oxidation of uric acid##4##4##(1991-2#2)(2008-5#2)
oxidation of very-long-chain fatty acids##2##5##(1993-9#1)(1995-2#1)
oxidation of##471##2##(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#3)(1990-7#2)(1990-8#2)(1991-1#5)(1991-12#2)(1991-2#2)(1991-3#4)(1991-4#2)(1991-5#4)(1991-7#1)(1991-9#6)(1992-12#5)(1992-3#3)(1992-5#5)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#2)(1993-12#4)(1993-3#2)(1993-4#3)(1993-6#3)(1993-9#6)(1994-11#1)(1994-2#1)(1994-3#4)(1994-5#9)(1994-7#1)(1994-8#7)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#8)(1995-7#3)(1996-1#1)(1996-2#4)(1996-3#2)(1996-4#1)(1996-5#3)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#5)(1997-6#2)(1997-7#2)(1997-8#3)(2004-12#1)(2004-4#1)(2004-9#1)(2005-11#2)(2005-12#2)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#2)(2006-12#5)(2006-3#7)(2006-8#1)(2007-11#13)(2007-12#1)(2007-2#1)(2007-8#8)(2008-1#1)(2008-10#216)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#7)(2008-6#5)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#4)(2010-2#2)(2010-4#1)(2010-5#2)(2010-7#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
oxidation on the##4##3##(1992-2#1)(1993-4#1)(1997-2#1)(2008-10#1)
oxidation on##6##2##(1992-2#1)(1993-4#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-5#1)
oxidation or##4##2##(1992-11#1)(1993-11#1)(1993-9#1)(2009-3#1)
oxidation peak at 0##2##4##(2008-10#2)
oxidation peak current##3##3##(2008-10#3)
oxidation peak was##3##3##(2008-10#3)
oxidation peak##23##2##(2007-9#1)(2008-10#22)
oxidation peaks of##2##3##(2008-10#2)
oxidation peaks##7##2##(2008-10#6)(2010-5#1)
oxidation potential of##5##3##(2005-11#1)(2008-10#3)(2009-7#1)
oxidation potential##13##2##(1996-5#1)(2004-4#1)(2005-11#1)(2008-10#8)(2009-7#1)(2010-5#1)
oxidation process in##2##3##(2008-10#1)(2010-4#1)
oxidation process##14##2##(1996-6#1)(2005-11#1)(2007-8#2)(2008-10#7)(2008-5#2)(2010-4#1)
oxidation processes in the##2##4##(1991-2#1)(2008-8#1)
oxidation processes in##3##3##(1991-2#1)(2008-5#1)(2008-8#1)
oxidation processes##9##2##(1991-2#1)(2007-10#1)(2008-10#2)(2008-5#2)(2008-8#1)(2010-5#2)
oxidation product in##2##3##(1992-12#1)(1993-4#1)
oxidation product of##9##3##(1992-12#1)(1992-6#1)(1995-5#1)(2004-11#1)(2005-7#1)(2008-10#3)(2008-5#1)
oxidation product##22##2##(1991-1#1)(1991-8#2)(1992-12#3)(1992-6#1)(1993-4#1)(1994-9#1)(1995-5#1)(1996-2#2)(1996-8#1)(2004-11#1)(2005-7#1)(2008-10#4)(2008-5#2)(2010-4#1)
oxidation products and##2##3##(2004-11#1)(2012-1#1)
oxidation products in##5##3##(1990-4#1)(1992-1#1)(1996-7#1)(1997-5#1)(2008-10#1)
oxidation products of##3##3##(1990-7#1)(1994-5#1)(2008-10#1)
oxidation products were##4##3##(1991-9#1)(1992-5#1)(2004-11#1)(2008-10#1)
oxidation products##24##2##(1990-4#2)(1990-7#1)(1991-9#1)(1992-1#1)(1992-5#1)(1994-5#1)(1996-7#1)(1997-5#1)(2004-11#2)(2008-1#1)(2008-10#6)(2008-11#1)(2010-4#4)(2012-1#1)
oxidation rate of##3##3##(1994-2#1)(2005-11#1)(2008-10#1)
oxidation rate was##3##3##(1994-5#1)(1997-8#1)(2007-6#1)
oxidation rate##11##2##(1994-2#1)(1994-5#2)(1996-6#2)(1997-8#2)(2005-11#1)(2007-6#2)(2008-10#1)
oxidation rates##7##2##(1990-12#1)(1995-10#1)(2007-6#1)(2008-3#1)(2008-5#3)
oxidation reaction of##15##3##(2008-10#14)(2008-8#1)
oxidation reaction with##2##3##(2008-10#2)
oxidation reaction##24##2##(1992-12#1)(1993-12#1)(2008-10#21)(2008-8#1)
oxidation reactions##3##2##(1990-12#1)(2008-9#1)(2009-2#1)
oxidation results in the##2##4##(2008-10#1)(2010-5#1)
oxidation sensitized by##2##3##(2008-10#2)
oxidation signal##3##2##(1993-7#1)(2008-10#2)
oxidation site##2##2##(1992-12#1)(1997-7#1)
oxidation smoothing##2##2##(2007-12#2)
oxidation state in##3##3##(2008-5#3)
oxidation state marker band##3##4##(1990-10#3)
oxidation state of##16##3##(1992-8#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-11#1)(1997-6#1)(1997-7#1)(2008-10#6)(2008-2#1)(2010-5#1)
oxidation state##44##2##(1990-10#3)(1991-4#1)(1992-8#1)(1993-8#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-8#1)(1996-2#1)(1997-6#1)(1997-7#2)(2007-11#1)(2008-10#15)(2008-2#1)(2008-5#7)(2009-6#1)(2010-2#1)(2010-5#1)
oxidation state)##3##2##(2010-10#2)(2013-1#1)
oxidation states of##3##3##(1990-2#1)(1996-11#1)(2008-10#1)
oxidation states##20##2##(1990-2#1)(1990-7#1)(1993-8#1)(1994-5#1)(1996-11#1)(1996-2#1)(2007-11#1)(2008-10#11)(2010-6#1)(2012-2#1)
oxidation step of##2##3##(1996-8#1)(2012-3#1)
oxidation step##5##2##(1996-8#1)(2008-10#3)(2012-3#1)
oxidation system##3##2##(1994-12#1)(1994-2#1)(1997-8#1)
oxidation systems##2##2##(1991-8#1)(2008-8#1)
oxidation than##4##2##(1994-9#1)(2004-11#1)(2008-10#1)(2010-4#1)
oxidation to CO(2)##2##3##(2004-4#1)(2012-12#1)
oxidation to the##5##3##(1995-3#1)(1996-5#1)(1997-2#1)(1997-6#1)(2013-8#1)
oxidation to##23##2##(1993-4#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-5#2)(1997-2#2)(1997-6#1)(1997-8#2)(2004-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-10#1)(2009-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
oxidation was reduced##2##3##(1993-3#1)(1995-7#1)
oxidation was##21##2##(1990-3#2)(1990-4#1)(1993-3#2)(1993-8#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-7#2)(1997-2#1)(1997-5#1)(1997-8#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-4#2)(2011-2#1)
oxidation wave of the##2##4##(2008-10#2)
oxidation wave##3##2##(2008-10#3)
oxidation were##3##2##(1992-2#1)(1995-8#1)(2010-4#1)
oxidation when##2##2##(2007-3#1)(2008-5#1)
oxidation with N-bromosuccinimide##2##3##(2008-10#2)
oxidation with the##2##3##(2008-10#1)(2009-5#1)
oxidation with##12##2##(1995-2#1)(2007-8#1)(2008-10#8)(2008-5#1)(2009-5#1)
oxidation##1354##1##(1990-10#3)(1990-12#10)(1990-2#4)(1990-3#9)(1990-4#9)(1990-5#6)(1990-7#8)(1990-8#3)(1990-9#1)(1991-1#6)(1991-10#1)(1991-12#9)(1991-2#6)(1991-3#4)(1991-4#4)(1991-5#7)(1991-6#1)(1991-7#2)(1991-8#6)(1991-9#7)(1992-1#2)(1992-11#3)(1992-12#13)(1992-2#3)(1992-3#3)(1992-5#8)(1992-6#4)(1992-7#5)(1992-8#3)(1992-9#5)(1993-11#1)(1993-12#5)(1993-3#7)(1993-4#6)(1993-6#3)(1993-7#4)(1993-8#4)(1993-9#8)(1994-11#5)(1994-12#3)(1994-2#5)(1994-3#5)(1994-5#17)(1994-6#3)(1994-7#1)(1994-8#12)(1994-9#9)(1995-1#8)(1995-10#3)(1995-11#6)(1995-12#9)(1995-2#4)(1995-3#7)(1995-5#4)(1995-6#19)(1995-7#8)(1995-8#3)(1995-9#2)(1996-1#3)(1996-11#2)(1996-2#9)(1996-3#4)(1996-4#1)(1996-5#17)(1996-6#4)(1996-7#8)(1996-8#4)(1996-9#1)(1997-1#5)(1997-2#11)(1997-3#1)(1997-4#8)(1997-5#2)(1997-6#8)(1997-7#10)(1997-8#18)(2004-11#7)(2004-12#3)(2004-4#3)(2004-9#1)(2005-11#9)(2005-12#2)(2005-4#1)(2005-7#6)(2005-8#11)(2006-1#1)(2006-10#7)(2006-12#14)(2006-2#3)(2006-3#16)(2006-7#2)(2006-8#2)(2007-10#1)(2007-11#22)(2007-12#4)(2007-2#1)(2007-3#4)(2007-5#1)(2007-6#4)(2007-8#24)(2007-9#1)(2008-1#15)(2008-10#451)(2008-11#11)(2008-12#1)(2008-2#3)(2008-3#14)(2008-4#6)(2008-5#60)(2008-6#8)(2008-7#4)(2008-8#15)(2008-9#2)(2009-10#3)(2009-11#1)(2009-2#8)(2009-3#4)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#4)(2010-10#2)(2010-12#10)(2010-2#5)(2010-4#45)(2010-5#12)(2010-6#1)(2010-7#5)(2010-8#1)(2010-9#3)(2011-1#11)(2011-12#3)(2011-2#10)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#6)(2012-2#6)(2012-3#2)(2013-1#10)(2013-7#4)(2013-8#5)
oxidation)##6##1##(1994-8#2)(2004-11#1)(2005-12#1)(2008-10#1)(2010-8#1)
oxidation-antioxidation##2##1##(2006-6#1)(2012-12#1)
oxidation-negative ionizing##2##2##(2005-11#2)
oxidation-reduction potential##2##2##(1995-8#1)(2006-6#1)
oxidation-reduction reactions##4##2##(1992-12#1)(2008-10#2)(2008-5#1)
oxidation-reduction##15##1##(1991-8#1)(1992-12#1)(1993-3#1)(1995-6#1)(1995-8#2)(1997-4#1)(2006-6#1)(2007-12#3)(2007-8#1)(2008-10#2)(2008-5#1)
oxidation-related##2##1##(1992-4#1)(2012-1#1)
oxidation/reduction##2##1##(1991-5#1)(2008-10#1)
oxidations and##3##2##(1991-2#1)(2006-10#1)(2010-5#1)
oxidations##14##1##(1990-12#1)(1991-2#2)(1991-9#1)(1994-2#2)(1995-6#1)(2006-10#3)(2008-4#1)(2008-5#2)(2010-5#1)
oxidative DNA damage and##3##4##(1994-12#1)(2008-4#1)(2009-3#1)
oxidative DNA damage in##5##4##(1993-7#1)(1994-12#1)(1994-6#1)(2008-10#1)(2008-11#1)
oxidative DNA damage##17##3##(1993-7#3)(1994-12#4)(1994-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2009-3#3)(2010-3#1)
oxidative DNA##20##2##(1993-7#3)(1994-12#4)(1994-6#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2009-3#4)(2010-3#1)(2012-12#1)
oxidative RNA damage##4##3##(2009-3#4)
oxidative activation of##2##3##(1992-9#2)
oxidative activation##3##2##(1990-9#1)(1992-9#2)
oxidative activity of ceruloplasmin##2##4##(2006-8#2)
oxidative activity##7##2##(1991-10#1)(1996-9#1)(2006-8#4)(2011-2#1)
oxidative agents##2##2##(2007-8#1)(2008-10#1)
oxidative and chemical##2##3##(2004-9#1)(2008-7#1)
oxidative and nitrosative stress in##2##5##(2013-1#2)
oxidative and nitrosative stress##3##4##(2013-1#3)
oxidative and##14##2##(1995-1#1)(1995-8#1)(2004-9#1)(2008-11#2)(2008-7#1)(2009-5#2)(2010-4#1)(2010-8#1)(2011-1#1)(2013-1#3)
oxidative burst in##6##3##(1991-2#1)(1994-3#1)(1995-6#1)(2008-10#3)
oxidative burst of##2##3##(2004-12#1)(2008-10#1)
oxidative burst was##2##3##(1995-6#1)(2004-12#1)
oxidative burst##28##2##(1990-9#1)(1991-2#3)(1991-7#1)(1994-3#2)(1995-6#7)(1997-4#1)(2004-12#4)(2008-10#7)(2008-9#1)(2009-6#1)
oxidative changes##4##2##(1991-9#1)(1994-5#1)(2007-3#1)(2009-9#1)
oxidative cleavage mechanism##2##3##(1993-11#1)(2013-1#1)
oxidative cleavage of prolyl peptides##2##5##(1990-5#2)
oxidative cleavage of##4##3##(1990-5#3)(1997-7#1)
oxidative cleavage##8##2##(1990-5#3)(1993-11#1)(1994-8#2)(1997-7#1)(2013-1#1)
oxidative conditions##6##2##(1995-1#1)(1995-8#1)(2007-11#1)(2008-4#1)(2010-12#1)(2011-2#1)
oxidative coupling##12##2##(2008-10#10)(2011-1#2)
oxidative cyclization of spiroacetals##2##4##(2007-11#2)
oxidative cyclization##4##2##(2007-11#2)(2010-6#2)
oxidative damage and##6##3##(1992-11#1)(1995-6#2)(2006-12#1)(2007-11#1)(2012-2#1)
oxidative damage by##2##3##(2004-11#1)(2009-10#1)
oxidative damage during##2##3##(2008-1#1)(2008-3#1)
oxidative damage in the##2##4##(1991-9#1)(2009-12#1)
oxidative damage in##6##3##(1991-9#1)(1997-4#1)(2009-12#3)(2012-2#1)
oxidative damage is##4##3##(1995-6#1)(2008-3#1)(2010-12#1)(2013-1#1)
oxidative damage of DNA##2##4##(2008-4#1)(2011-2#1)
oxidative damage of the##2##4##(1992-2#1)(2008-10#1)
oxidative damage of##6##3##(1992-2#1)(1992-9#1)(2008-10#1)(2008-4#1)(2011-1#1)(2011-2#1)
oxidative damage to DNA##4##4##(1995-6#1)(1997-6#1)(2008-10#1)(2008-8#1)
oxidative damage to lipid##2##4##(2005-10#1)(2008-1#1)
oxidative damage to the##3##4##(1992-12#1)(2013-8#2)
oxidative damage to##16##3##(1992-12#1)(1992-4#1)(1995-6#1)(1997-5#1)(1997-6#1)(2005-10#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#1)(2013-8#2)
oxidative damage##81##2##(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#2)(1992-9#2)(1995-3#1)(1995-6#6)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-8#3)(2006-12#2)(2007-11#2)(2008-1#4)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-8#2)(2009-10#3)(2009-12#6)(2009-3#1)(2009-5#3)(2009-6#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#3)(2013-8#4)
oxidative damages##3##2##(1995-8#1)(2008-10#1)(2013-8#1)
oxidative deamination##5##2##(1992-11#1)(2006-8#1)(2007-11#1)(2009-8#1)(2010-8#1)
oxidative dearomatization##2##2##(2006-9#1)(2009-10#1)
oxidative decarboxylation of##2##3##(1997-4#1)(2007-11#1)
oxidative decarboxylation##3##2##(1997-4#1)(2007-11#1)(2008-6#1)
oxidative decomposition##2##2##(2008-10#2)
oxidative defense##2##2##(2006-8#2)
oxidative degradation of##6##3##(1992-2#1)(2008-10#3)(2010-1#1)(2011-1#1)
oxidative degradation##9##2##(1992-2#1)(2008-10#3)(2008-5#1)(2010-1#1)(2011-1#1)(2013-1#2)
oxidative destruction##2##2##(1994-2#1)(1996-1#1)
oxidative deterioration of##2##3##(2008-10#1)(2012-12#1)
oxidative deterioration##4##2##(2008-10#1)(2010-4#1)(2012-1#1)(2012-12#1)
oxidative effects on##2##3##(1992-6#1)(2008-5#1)
oxidative effects##3##2##(1992-6#1)(2008-5#2)
oxidative energy##2##2##(1994-5#2)
oxidative enzymes##3##2##(2008-10#2)(2011-2#1)
oxidative fermentation##3##2##(2011-2#3)
oxidative inactivation of##2##3##(1992-12#1)(1992-6#1)
oxidative inactivation##4##2##(1991-8#1)(1992-12#2)(1992-6#1)
oxidative injury and##2##3##(1997-3#1)(2013-1#1)
oxidative injury##9##2##(1996-4#1)(1997-3#1)(2008-5#1)(2009-10#1)(2009-12#1)(2010-8#1)(2013-1#2)(2013-7#1)
oxidative insults##6##2##(1997-5#1)(2008-11#1)(2009-3#2)(2010-12#1)(2010-4#1)
oxidative iodination of various##2##4##(2007-11#2)
oxidative iodination of##5##3##(2007-11#5)
oxidative loss##2##2##(2005-8#2)
oxidative metabolism and##2##3##(2008-10#1)(2008-4#1)
oxidative metabolism in##3##3##(1993-4#1)(1994-2#1)(2006-7#1)
oxidative metabolism of##2##3##(1993-6#1)(1995-7#1)
oxidative metabolism##21##2##(1990-3#1)(1990-7#1)(1992-11#1)(1993-2#1)(1993-4#2)(1993-6#1)(1994-2#4)(1995-7#1)(1996-3#1)(1997-8#2)(2006-7#2)(2008-10#1)(2008-4#2)(2008-9#1)
oxidative metabolite##3##2##(2006-12#2)(2010-4#1)
oxidative metabolites of##2##3##(1993-4#1)(2008-10#1)
oxidative metabolites##5##2##(1990-5#1)(1993-4#1)(2008-10#1)(2008-4#1)(2011-3#1)
oxidative modification of LDL##3##4##(2008-10#2)(2009-8#1)
oxidative modification of proteins##4##4##(2008-1#1)(2008-4#3)
oxidative modification of the##2##4##(2005-7#1)(2009-8#1)
oxidative modification of##15##3##(1990-5#1)(1991-5#1)(1992-9#1)(1997-2#1)(2005-7#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-4#3)(2009-8#2)(2010-12#1)
oxidative modification##33##2##(1990-12#1)(1990-5#1)(1991-12#3)(1991-2#2)(1991-5#1)(1991-8#1)(1992-9#1)(1993-12#1)(1994-11#3)(1994-9#1)(1995-1#1)(1995-12#2)(1997-2#1)(1997-7#1)(2005-7#1)(2006-10#1)(2008-1#2)(2008-10#2)(2008-4#3)(2009-8#3)(2010-12#1)
oxidative modifications of lipids##2##4##(2009-8#2)
oxidative modifications of##5##3##(2004-11#1)(2009-8#4)
oxidative modifications##9##2##(1993-11#1)(2004-11#1)(2009-8#7)
oxidative phosphorylation and the##2##4##(1994-12#1)(1996-9#1)
oxidative phosphorylation and##6##3##(1992-7#1)(1994-11#1)(1994-12#1)(1996-9#1)(2008-1#1)(2008-7#1)
oxidative phosphorylation by##2##3##(1997-8#2)
oxidative phosphorylation in##9##3##(1994-11#1)(1994-12#5)(1996-9#1)(2005-8#1)(2007-10#1)
oxidative phosphorylation of##2##3##(1990-8#1)(1994-12#1)
oxidative phosphorylation was##3##3##(1994-12#1)(1995-3#1)(1997-7#1)
oxidative phosphorylation##59##2##(1990-2#3)(1990-8#4)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-7#1)(1994-11#2)(1994-12#12)(1994-5#1)(1994-8#1)(1995-3#1)(1995-7#3)(1996-5#2)(1996-9#4)(1997-7#3)(1997-8#3)(2005-8#2)(2007-10#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#2)(2009-9#1)(2012-3#1)(2013-1#1)(2013-8#2)
oxidative polymerization and##2##3##(2008-10#1)(2008-7#1)
oxidative polymerization##3##2##(2008-10#1)(2008-7#2)
oxidative pressure##2##2##(2010-5#1)(2012-6#1)
oxidative protein refolding at##2##4##(2011-2#2)
oxidative radical cyclizations##2##3##(2007-11#2)
oxidative reaction of##4##3##(2008-10#4)
oxidative reaction##5##2##(2008-10#5)
oxidative reactions##6##2##(1995-6#1)(2008-10#2)(2008-5#1)(2010-12#1)(2010-4#1)
oxidative refolding of##2##3##(2011-2#2)
oxidative screen mode##2##3##(1990-8#1)(2008-10#1)
oxidative screen##3##2##(1990-8#2)(2008-10#1)
oxidative single##2##2##(1990-8#2)
oxidative stability##2##2##(2008-12#1)(2012-11#1)
oxidative status and##3##3##(2010-4#2)(2011-2#1)
oxidative status##5##2##(2007-1#1)(2010-4#2)(2011-2#1)(2012-2#1)
oxidative steps of the##2##4##(1993-6#1)(2011-1#1)
oxidative steps##3##2##(1991-2#1)(1993-6#1)(2011-1#1)
oxidative stress and altered erythrocyte membrane fluidity##2##7##(1995-3#2)
oxidative stress and antioxidant defence##2##5##(2009-6#1)(2012-12#1)
oxidative stress and antioxidant##5##4##(2005-10#1)(2009-6#1)(2009-8#1)(2010-8#1)(2012-12#1)
oxidative stress and inflammation##2##4##(2010-7#1)(2012-2#1)
oxidative stress and metabolism##2##4##(2010-3#2)
oxidative stress and the##4##4##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
oxidative stress and to##3##4##(1994-2#1)(2008-7#1)(2010-2#1)
oxidative stress and##66##3##(1991-12#1)(1992-9#1)(1994-2#1)(1994-8#1)(1995-3#2)(1995-5#1)(1996-9#1)(1997-6#1)(1997-7#1)(2004-12#1)(2005-10#1)(2005-7#1)(2006-7#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#2)(2010-7#3)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#3)(2012-2#4)(2012-5#2)(2013-1#2)(2013-8#1)
oxidative stress and/or##2##3##(1995-12#1)(2010-3#1)
oxidative stress are##3##3##(1994-6#1)(1995-5#1)(2008-4#1)
oxidative stress as a##2##4##(1994-10#1)(2009-5#1)
oxidative stress as##6##3##(1994-10#1)(2004-11#1)(2007-1#1)(2008-1#1)(2008-5#1)(2009-5#1)
oxidative stress biomarkers##4##3##(2007-8#3)(2011-2#1)
oxidative stress by##4##3##(1991-9#1)(1997-7#1)(2008-7#1)(2009-10#1)
oxidative stress can be##2##4##(2005-1#1)(2008-1#1)
oxidative stress caused by##3##4##(1997-6#1)(2008-10#1)(2010-7#1)
oxidative stress conditions##2##3##(2010-10#1)(2012-12#1)
oxidative stress could be##2##4##(2006-12#1)(2008-10#1)
oxidative stress damage##2##3##(2008-7#1)(2011-1#1)
oxidative stress during##3##3##(2007-8#1)(2008-1#1)(2010-8#1)
oxidative stress for##2##3##(1992-9#1)(2009-6#1)
oxidative stress has##2##3##(2008-10#1)(2010-4#1)
oxidative stress have been##4##4##(2005-10#1)(2006-8#1)(2012-11#2)
oxidative stress in aging##2##4##(2009-12#1)(2010-3#1)
oxidative stress in plasma##2##4##(1993-2#1)(2013-1#1)
oxidative stress in the heart##3##5##(2008-7#1)(2013-1#2)
oxidative stress in the##18##4##(1990-4#1)(1992-8#1)(1997-6#1)(2007-2#1)(2007-8#1)(2008-7#3)(2008-8#1)(2009-10#2)(2009-4#1)(2010-12#2)(2010-7#1)(2011-1#1)(2013-1#2)
oxidative stress in vivo##3##4##(1997-2#3)
oxidative stress in##78##3##(1990-4#1)(1992-8#1)(1993-2#1)(1994-10#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-9#3)(1997-2#4)(1997-6#1)(2004-11#1)(2007-1#1)(2007-2#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#2)(2009-4#1)(2009-6#3)(2010-12#3)(2010-3#3)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#2)(2012-12#1)(2012-2#2)(2012-5#1)(2013-1#6)(2013-8#2)
oxidative stress induced by##2##4##(2007-1#1)(2013-1#1)
oxidative stress induced##4##3##(2007-1#1)(2008-10#1)(2012-3#1)(2013-1#1)
oxidative stress involved in##2##4##(2008-10#1)(2013-1#1)
oxidative stress is a##2##4##(1995-6#1)(2008-5#1)
oxidative stress is##16##3##(1992-9#1)(1995-6#1)(2006-8#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-4#1)(2013-8#1)
oxidative stress levels##2##3##(2009-5#1)(2011-1#1)
oxidative stress markers in the##2##5##(2010-4#1)(2010-5#1)
oxidative stress markers in##4##4##(2010-4#1)(2010-5#1)(2011-2#1)(2013-1#1)
oxidative stress markers##10##3##(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-5#2)(2013-1#2)
oxidative stress may be##2##4##(1994-10#1)(1994-3#1)
oxidative stress may##5##3##(1991-9#1)(1992-12#1)(1994-10#1)(1994-3#1)(2004-12#1)
oxidative stress of tumor cells##2##5##(2008-11#2)
oxidative stress of##4##3##(1992-6#1)(2008-11#2)(2008-5#1)
oxidative stress on##7##3##(1991-9#1)(1994-10#1)(1994-6#1)(1995-6#1)(2007-1#1)(2008-5#1)(2012-2#1)
oxidative stress resistance##2##3##(2008-4#2)
oxidative stress response##4##3##(2006-12#1)(2006-8#2)(2012-12#1)
oxidative stress responses##4##3##(1991-11#1)(2008-10#2)(2008-7#1)
oxidative stress status##2##3##(1997-2#1)(2011-2#1)
oxidative stress than##4##3##(1990-6#1)(1992-11#1)(1995-9#1)(2012-12#1)
oxidative stress that##3##3##(2008-5#1)(2008-6#1)(2012-12#1)
oxidative stress theory##2##3##(2009-5#2)
oxidative stress under##2##3##(1996-9#1)(2008-10#1)
oxidative stress via##2##3##(2009-12#1)(2013-8#1)
oxidative stress was assessed by##2##5##(2012-2#1)(2013-8#1)
oxidative stress was assessed##3##4##(2005-8#1)(2012-2#1)(2013-8#1)
oxidative stress was##10##3##(2005-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-4#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
oxidative stress were##3##3##(2011-2#1)(2011-3#1)(2013-8#1)
oxidative stress which##3##3##(1992-1#1)(1996-1#1)(2009-6#1)
oxidative stress with##2##3##(2008-6#1)(2012-1#1)
oxidative stress##540##2##(1990-4#2)(1990-6#2)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-9#4)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-2#1)(1993-6#2)(1994-10#4)(1994-2#1)(1994-3#6)(1994-5#1)(1994-6#6)(1994-8#1)(1994-9#1)(1995-1#3)(1995-12#1)(1995-3#2)(1995-5#3)(1995-6#5)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#1)(1996-3#2)(1996-5#1)(1996-8#2)(1996-9#6)(1997-1#1)(1997-2#8)(1997-4#1)(1997-5#2)(1997-6#6)(1997-7#2)(1997-8#2)(2004-11#4)(2004-12#2)(2005-1#2)(2005-10#5)(2005-11#1)(2005-7#1)(2005-8#7)(2005-9#1)(2006-12#3)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#10)(2006-9#4)(2007-1#4)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#3)(2007-5#1)(2007-7#1)(2007-8#18)(2007-9#3)(2008-1#14)(2008-10#28)(2008-11#16)(2008-3#7)(2008-4#11)(2008-5#23)(2008-6#3)(2008-7#21)(2008-8#7)(2008-9#8)(2009-10#15)(2009-11#6)(2009-12#5)(2009-3#2)(2009-4#4)(2009-5#7)(2009-6#8)(2009-8#7)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#6)(2010-2#5)(2010-3#6)(2010-4#15)(2010-5#6)(2010-7#9)(2010-8#9)(2011-1#14)(2011-12#2)(2011-2#14)(2011-3#2)(2012-1#8)(2012-11#2)(2012-12#11)(2012-2#13)(2012-3#2)(2012-5#5)(2013-1#19)(2013-7#2)(2013-8#13)
oxidative stress-induced##5##2##(2008-7#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-2#1)
oxidative stress-related parameters##4##3##(1997-2#3)(1997-7#1)
oxidative stress-related##7##2##(1995-6#1)(1997-2#4)(1997-7#1)(2011-1#1)
oxidative stress/damage indices in##2##4##(2008-8#2)
oxidative stress/damage indices##3##3##(2008-8#3)
oxidative stresses##2##2##(1992-6#1)(2011-2#1)
oxidative system##5##2##(2009-12#1)(2011-1#4)
oxidative titrations of##2##3##(1994-11#2)
oxidative##1086##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#4)(1990-5#5)(1990-6#2)(1990-7#3)(1990-8#8)(1990-9#4)(1991-10#2)(1991-11#1)(1991-12#5)(1991-2#9)(1991-5#2)(1991-7#1)(1991-8#3)(1991-9#8)(1992-1#1)(1992-11#6)(1992-12#4)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#7)(1992-7#2)(1992-8#1)(1992-9#8)(1993-11#2)(1993-12#1)(1993-2#2)(1993-4#3)(1993-6#4)(1993-7#3)(1993-8#2)(1994-10#4)(1994-11#7)(1994-12#16)(1994-2#7)(1994-3#8)(1994-5#5)(1994-6#8)(1994-8#5)(1994-9#2)(1995-1#6)(1995-12#4)(1995-3#5)(1995-5#3)(1995-6#21)(1995-7#4)(1995-8#4)(1995-9#2)(1996-1#2)(1996-10#1)(1996-3#3)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#2)(1996-9#11)(1997-1#1)(1997-2#15)(1997-3#1)(1997-4#6)(1997-5#4)(1997-6#7)(1997-7#8)(1997-8#9)(2004-11#6)(2004-12#6)(2004-9#1)(2005-1#2)(2005-10#6)(2005-11#3)(2005-7#2)(2005-8#17)(2005-9#1)(2006-10#1)(2006-12#9)(2006-2#2)(2006-4#1)(2006-6#1)(2006-7#3)(2006-8#18)(2006-9#5)(2007-1#5)(2007-10#2)(2007-11#20)(2007-12#4)(2007-2#3)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#19)(2007-9#3)(2008-1#22)(2008-10#93)(2008-11#20)(2008-12#1)(2008-2#1)(2008-3#12)(2008-4#21)(2008-5#35)(2008-6#5)(2008-7#28)(2008-8#14)(2008-9#10)(2009-10#24)(2009-11#6)(2009-12#13)(2009-3#13)(2009-4#4)(2009-5#14)(2009-6#10)(2009-8#21)(2009-9#5)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#13)(2010-2#6)(2010-3#8)(2010-4#26)(2010-5#9)(2010-6#2)(2010-7#11)(2010-8#14)(2010-9#1)(2011-1#28)(2011-12#2)(2011-2#30)(2011-3#3)(2012-1#9)(2012-11#3)(2012-12#15)(2012-2#18)(2012-3#3)(2012-5#5)(2012-6#1)(2013-1#32)(2013-7#4)(2013-8#22)
oxidative-stress##2##1##(2008-7#1)(2012-2#1)
oxidative/nitrosative stress##3##2##(2009-10#1)(2011-2#2)
oxidatively damaged##8##2##(1995-2#4)(1997-6#2)(1997-8#2)
oxidatively modified##5##2##(1993-6#1)(1995-2#1)(2005-7#1)(2010-12#1)(2012-2#1)
oxidatively##21##1##(1991-7#1)(1992-9#1)(1993-6#1)(1995-2#5)(1995-3#1)(1996-7#1)(1997-4#1)(1997-6#2)(1997-8#2)(2005-7#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-12#1)(2012-2#1)
oxide (EtO)##2##2##(1990-3#1)(2007-4#1)
oxide (GO)##2##2##(2008-10#1)(2012-2#1)
oxide (ITO) electrode##2##3##(2008-10#1)(2010-5#1)
oxide (ITO)##13##2##(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2009-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)
oxide (NO) has been implicated in##2##6##(1993-6#1)(1997-6#1)
oxide (NO) has been##4##4##(1993-6#1)(1997-6#1)(2007-11#1)(2010-6#1)
oxide (NO) has##6##3##(1992-8#1)(1993-6#1)(1997-6#1)(2007-11#1)(2010-6#1)(2011-2#1)
oxide (NO) in##9##3##(1992-8#1)(2005-7#1)(2008-10#3)(2008-8#1)(2010-4#1)(2012-2#1)(2013-1#1)
oxide (NO) is a##6##4##(2008-7#1)(2009-10#2)(2011-1#1)(2013-8#2)
oxide (NO) is one of the##2##6##(2005-1#1)(2008-10#1)
oxide (NO) is##13##3##(1992-11#1)(1994-2#1)(2005-1#1)(2008-10#2)(2008-7#1)(2009-10#2)(2010-4#1)(2010-7#1)(2011-1#1)(2013-8#2)
oxide (NO) pathway##2##3##(1993-8#1)(2006-2#1)
oxide (NO) production##9##3##(1994-11#1)(1995-11#1)(1996-10#1)(2008-10#2)(2010-12#1)(2010-4#1)(2011-12#1)(2012-3#1)
oxide (NO) synthase (NOS)##2##4##(2011-1#1)(2011-2#1)
oxide (NO) synthase##15##3##(1992-11#1)(1992-6#1)(1992-7#1)(1992-9#1)(1995-11#1)(1995-12#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-5#1)(2004-11#1)(2011-1#1)(2011-2#1)
oxide (NO) was##2##3##(1992-9#1)(1994-2#1)
oxide (NO)##146##2##(1990-6#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-11#2)(1992-12#2)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#2)(1993-12#1)(1993-3#2)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#2)(1994-2#4)(1994-5#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1996-1#1)(1996-10#3)(1996-2#1)(1996-5#2)(1996-6#2)(1996-8#1)(1997-2#3)(1997-3#1)(1997-5#1)(1997-6#6)(1997-7#1)(2004-11#1)(2005-1#1)(2005-10#1)(2005-7#2)(2006-10#1)(2006-11#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#16)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#3)(2009-6#2)(2009-8#1)(2010-12#1)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#2)(2013-8#3)
oxide (TOPO)##4##2##(2008-10#3)(2010-7#1)
oxide and other##2##3##(2005-10#1)(2006-10#1)
oxide and the##4##3##(1993-12#1)(2005-1#1)(2008-10#1)(2008-11#1)
oxide and##78##2##(1990-7#1)(1991-5#1)(1992-6#1)(1993-12#1)(1993-4#1)(1994-6#1)(1995-12#1)(1995-5#4)(1996-11#1)(1996-2#2)(1997-4#4)(1997-5#2)(2004-12#1)(2005-1#1)(2005-10#1)(2005-11#4)(2006-10#7)(2006-12#3)(2007-1#1)(2007-2#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-2#1)(2009-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
oxide anion##2##2##(2008-10#1)(2010-8#1)
oxide are##4##2##(1994-5#1)(2004-4#1)(2006-10#2)
oxide as a##4##3##(1994-2#1)(2008-10#3)
oxide as an##2##3##(2008-10#1)(2010-4#1)
oxide as the##2##3##(1991-12#1)(2008-10#1)
oxide as##12##2##(1991-12#1)(1994-2#1)(2005-11#1)(2008-10#7)(2008-6#1)(2010-4#1)
oxide at##4##2##(1991-7#2)(2008-10#2)
oxide based##5##2##(2006-12#2)(2008-6#1)(2012-11#2)
oxide by chemical spectrographic##2##4##(2005-4#2)
oxide by##16##2##(1990-11#1)(1991-12#1)(1991-3#1)(1992-5#1)(1993-11#1)(1993-4#1)(2005-11#1)(2005-4#5)(2007-11#1)(2008-10#1)(2008-5#1)(2010-4#1)
oxide coated##5##2##(2008-10#1)(2008-3#1)(2008-8#2)(2009-3#1)
oxide content##5##2##(2005-11#1)(2007-8#1)(2008-10#2)(2010-5#1)
oxide did not##2##3##(1994-11#1)(1994-2#1)
oxide donors##5##2##(1996-9#1)(1997-4#1)(1997-6#1)(2007-10#1)(2008-5#1)
oxide electrodes##3##2##(2008-10#2)(2008-11#1)
oxide film##5##2##(1992-7#1)(2008-10#2)(2008-2#1)(2009-7#1)
oxide films##14##2##(2004-9#1)(2008-10#1)(2008-2#7)(2008-3#1)(2008-8#3)(2010-4#1)
oxide for##9##2##(1991-8#1)(1994-2#1)(1997-1#1)(1997-2#1)(2006-10#3)(2008-10#1)(2008-2#1)
oxide formation##8##2##(1992-5#2)(1992-8#1)(1996-5#1)(1996-9#1)(2005-11#1)(2007-8#1)(2008-8#1)
oxide formed##2##2##(1992-11#1)(2009-2#1)
oxide from##9##2##(1991-10#1)(1991-12#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-7#1)(2008-3#1)(2009-9#1)
oxide gas##3##2##(1994-8#1)(2009-12#2)
oxide has been studied##2##4##(2005-11#1)(2008-10#1)
oxide has been##5##3##(1997-6#1)(2005-11#1)(2006-10#1)(2008-10#2)
oxide has##7##2##(1997-6#1)(2005-11#2)(2006-10#1)(2007-1#1)(2008-10#2)
oxide in neuroanaesthesia##2##3##(2006-10#2)
oxide in the##7##3##(1991-10#1)(1992-8#1)(1993-6#1)(1995-6#1)(1996-5#1)(2005-11#1)(2006-12#1)
oxide in##48##2##(1990-11#1)(1991-10#1)(1991-5#1)(1991-6#1)(1992-6#1)(1992-8#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-7#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-8#1)(2004-12#1)(2004-4#1)(2004-9#1)(2005-11#3)(2005-8#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-2#1)(2007-9#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)(2009-6#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
oxide is a##7##3##(1991-10#1)(1993-8#1)(1993-9#1)(1996-10#1)(2008-12#1)(2008-5#1)(2013-8#1)
oxide is also##2##3##(1993-3#1)(2008-10#1)
oxide is##24##2##(1991-10#1)(1991-7#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-5#1)(1995-12#1)(1996-10#1)(1996-3#1)(1996-9#1)(2006-10#2)(2007-10#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2010-12#2)(2013-8#1)
oxide layer was##2##3##(2008-10#1)(2009-11#1)
oxide layer##6##2##(1994-2#1)(2007-11#1)(2008-10#3)(2009-11#1)
oxide layers##2##2##(2008-10#2)
oxide levels in chronic##2##4##(2009-8#1)(2013-8#1)
oxide levels in##4##3##(2007-10#1)(2007-11#1)(2009-8#1)(2013-8#1)
oxide levels##7##2##(2007-10#3)(2007-11#1)(2009-8#1)(2013-8#2)
oxide materials##5##2##(2008-3#1)(2010-4#4)
oxide may##7##2##(1991-10#1)(1991-3#1)(1994-7#1)(1997-1#1)(2004-12#1)(2006-10#1)(2013-8#1)
oxide multilayer##2##2##(2007-12#1)(2010-4#1)
oxide multilayers##2##2##(2007-12#1)(2010-4#1)
oxide nanoparticles were##3##3##(2007-9#1)(2012-12#1)(2013-1#1)
oxide nanoparticles##18##2##(2005-11#1)(2006-12#1)(2007-9#2)(2008-10#1)(2008-7#2)(2009-2#1)(2009-8#2)(2012-12#4)(2012-2#1)(2013-1#3)
oxide nanowire##2##2##(2006-12#1)(2009-2#1)
oxide nanowires##3##2##(2006-12#1)(2009-2#1)(2010-7#1)
oxide of##3##2##(1995-5#1)(2007-9#1)(2011-2#1)
oxide on the##5##3##(1993-11#1)(1993-3#1)(1994-2#1)(2008-1#1)(2010-12#1)
oxide on##16##2##(1990-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-2#1)(1994-7#1)(1997-6#1)(2006-10#1)(2007-1#1)(2008-1#1)(2010-12#1)(2010-8#2)(2013-8#1)
oxide or##5##2##(1991-3#1)(1992-3#1)(1995-5#1)(2007-11#1)(2009-7#1)
oxide particles##6##2##(2005-11#2)(2006-5#1)(2007-11#1)(2008-10#1)(2008-3#1)
oxide pathway by##2##3##(1993-3#1)(1994-8#1)
oxide pathway in##3##3##(1993-8#1)(1995-12#1)(2009-4#1)
oxide pathway##10##2##(1993-3#1)(1993-8#1)(1994-2#2)(1994-8#2)(1994-9#1)(1995-12#1)(2005-7#1)(2009-4#1)
oxide powder##4##2##(2004-9#3)(2007-9#1)
oxide production by##4##3##(1994-11#1)(1994-3#1)(2006-8#1)(2008-10#1)
oxide production from##2##3##(2008-11#1)(2008-6#1)
oxide production##31##2##(1993-4#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#2)(1996-11#2)(1996-5#1)(1997-6#1)(2006-10#3)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#4)(2011-1#1)(2012-1#1)(2013-1#2)(2013-8#1)
oxide reductase from##4##3##(1992-3#1)(1992-8#2)(1997-7#1)
oxide reductase##11##2##(1991-3#1)(1992-3#2)(1992-8#2)(1994-8#1)(1995-2#3)(1997-7#1)(2009-3#1)
oxide semiconductor##4##2##(2007-11#2)(2008-7#1)(2009-5#1)
oxide signaling##2##2##(1995-2#1)(2010-11#1)
oxide single##4##2##(2007-9#1)(2008-3#3)
oxide stimulates the ADP-ribosylation of##2##5##(1993-3#2)
oxide stimulates##3##2##(1993-3#2)(1994-8#1)
oxide surface##3##2##(2008-10#1)(2009-11#2)
oxide surfaces##8##2##(1990-11#1)(2005-11#3)(2007-5#1)(2008-10#1)(2010-6#1)(2012-1#1)
oxide synthase (NOS) activity##2##4##(1994-11#1)(1995-6#1)
oxide synthase (NOS)##25##3##(1992-12#1)(1992-8#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-12#2)(1995-5#2)(1995-6#1)(1996-12#1)(1996-3#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-10#2)(2009-7#1)(2009-9#1)(2013-1#1)
oxide synthase activity##10##3##(1993-11#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1995-12#1)(1995-5#1)(2008-3#1)(2012-12#1)(2013-1#1)
oxide synthase from cerebellum##2##4##(1992-11#1)(1992-6#1)
oxide synthase from##3##3##(1992-11#1)(1992-6#1)(1993-9#1)
oxide synthase in##15##3##(1992-7#2)(1993-6#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-3#1)(1997-6#1)(2005-12#1)(2008-5#1)(2011-2#1)(2013-1#1)
oxide synthase inhibitors##2##3##(1992-3#1)(2009-4#1)
oxide synthase##151##2##(1991-10#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#2)(1992-7#2)(1992-8#4)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#5)(1993-4#1)(1993-6#6)(1993-8#4)(1993-9#4)(1994-11#6)(1994-2#4)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-12#11)(1995-5#7)(1995-6#2)(1995-7#2)(1995-8#2)(1996-10#2)(1996-12#6)(1996-2#2)(1996-3#2)(1996-5#3)(1996-6#2)(1997-2#1)(1997-3#1)(1997-6#6)(1997-7#3)(1997-8#1)(2004-11#1)(2004-12#1)(2005-12#1)(2006-10#2)(2006-11#1)(2006-2#1)(2007-10#2)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#5)(2008-7#3)(2008-9#1)(2009-10#3)(2009-2#1)(2009-4#1)(2009-7#1)(2009-9#2)(2010-12#2)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#4)
oxide that##2##2##(2008-10#1)(2008-8#1)
oxide thicknesses of the diodes##2##5##(2008-3#2)
oxide thin films were##2##4##(2008-10#1)(2008-2#1)
oxide thin films##5##3##(2007-8#1)(2008-10#2)(2008-2#2)
oxide thin##6##2##(2007-8#1)(2008-10#3)(2008-2#2)
oxide to the##2##3##(2004-12#1)(2008-10#1)
oxide to##7##2##(1994-5#1)(1994-8#1)(1995-5#1)(1997-5#1)(2004-12#1)(2005-11#1)(2008-10#1)
oxide toxicity in##2##3##(1994-3#2)
oxide toxicity##3##2##(1994-3#2)(2005-7#1)
oxide using##6##2##(2005-11#1)(2006-12#1)(2008-10#4)
oxide was##13##2##(1992-6#1)(1993-12#1)(2005-11#3)(2007-1#2)(2008-10#2)(2008-12#1)(2008-2#1)(2010-2#2)
oxide were##6##2##(1994-9#1)(2006-12#2)(2008-10#1)(2008-2#2)
oxide wire##2##2##(2005-7#1)(2008-10#1)
oxide with##7##2##(1993-8#1)(2008-10#4)(2008-3#1)(2008-5#1)
oxide within##3##2##(1994-9#1)(2005-10#1)(2008-10#1)
oxide##1313##1##(1990-11#6)(1990-2#1)(1990-3#3)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#2)(1991-10#8)(1991-11#1)(1991-12#6)(1991-3#7)(1991-5#2)(1991-6#6)(1991-7#5)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#7)(1992-12#4)(1992-3#7)(1992-5#5)(1992-6#9)(1992-7#7)(1992-8#13)(1992-9#3)(1993-1#2)(1993-11#5)(1993-12#13)(1993-3#18)(1993-4#11)(1993-5#1)(1993-6#14)(1993-8#13)(1993-9#11)(1994-11#12)(1994-12#1)(1994-2#23)(1994-3#5)(1994-5#10)(1994-6#5)(1994-7#5)(1994-8#12)(1994-9#7)(1995-1#1)(1995-10#2)(1995-11#6)(1995-12#18)(1995-2#7)(1995-3#1)(1995-5#24)(1995-6#4)(1995-7#4)(1995-8#2)(1996-1#4)(1996-10#8)(1996-11#6)(1996-12#11)(1996-2#5)(1996-3#5)(1996-5#11)(1996-6#9)(1996-8#1)(1996-9#3)(1997-1#3)(1997-2#6)(1997-3#2)(1997-4#9)(1997-5#7)(1997-6#19)(1997-7#6)(1997-8#3)(2004-11#2)(2004-12#11)(2004-4#3)(2004-9#7)(2005-1#3)(2005-10#5)(2005-11#43)(2005-12#1)(2005-4#6)(2005-7#8)(2005-8#4)(2006-10#42)(2006-11#3)(2006-12#20)(2006-2#5)(2006-5#2)(2006-7#1)(2006-8#2)(2007-1#7)(2007-10#12)(2007-11#17)(2007-12#15)(2007-2#4)(2007-4#2)(2007-5#4)(2007-7#1)(2007-8#9)(2007-9#12)(2008-1#5)(2008-10#156)(2008-11#14)(2008-12#9)(2008-2#42)(2008-3#31)(2008-4#11)(2008-5#32)(2008-6#12)(2008-7#18)(2008-8#16)(2008-9#3)(2009-10#8)(2009-11#6)(2009-12#3)(2009-2#10)(2009-3#5)(2009-4#4)(2009-5#2)(2009-6#6)(2009-7#5)(2009-8#8)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#12)(2010-2#2)(2010-4#19)(2010-5#7)(2010-6#6)(2010-7#6)(2010-8#8)(2010-9#1)(2011-1#15)(2011-12#5)(2011-2#21)(2012-1#5)(2012-11#3)(2012-12#8)(2012-2#8)(2012-3#4)(2012-8#3)(2013-1#32)(2013-7#7)(2013-8#11)
oxide) (PEO)##5##2##(2005-11#2)(2008-10#1)(2008-5#2)
oxide) diblock copolymer films##2##4##(2005-11#1)(2008-11#1)
oxide) dodecyl##3##2##(1994-12#2)(2005-11#1)
oxide)##37##1##(1994-12#2)(1994-2#1)(1997-1#1)(2005-11#13)(2008-10#11)(2008-11#1)(2008-3#1)(2008-5#4)(2010-7#2)(2012-12#1)
oxide)-b-polymethacrylate##2##1##(2005-11#2)
oxide-generating vasodilators inhibit##2##3##(1990-8#2)
oxide-generating vasodilators##3##2##(1990-8#3)
oxide-generating##5##1##(1990-8#3)(1994-3#1)(1997-5#1)
oxide-induced##4##1##(1990-8#1)(1997-5#1)(2008-7#1)(2013-7#1)
oxide-like##4##1##(1990-10#1)(1990-11#3)
oxide-mediated##7##1##(1992-6#2)(1993-11#3)(1994-11#1)(2008-7#1)
oxide-modified##2##1##(2007-2#1)(2008-10#1)
oxide-releasing##6##1##(1992-3#1)(2006-10#2)(2009-2#2)(2010-12#1)
oxides and##12##2##(2004-4#1)(2005-11#2)(2007-11#1)(2007-2#4)(2008-10#3)(2008-3#1)
oxides are##3##2##(2007-2#1)(2012-2#2)
oxides for##2##2##(2005-11#1)(2007-8#1)
oxides have been##4##3##(2005-8#1)(2007-5#1)(2008-10#1)(2012-2#1)
oxides have##5##2##(2005-11#1)(2005-8#1)(2007-5#1)(2008-10#1)(2012-2#1)
oxides in the##3##3##(2008-10#3)
oxides in##4##2##(2008-10#3)(2012-2#1)
oxides of##2##2##(2008-10#1)(2011-2#1)
oxides on the dissolution temperature in aqueous media##2##8##(2005-11#2)
oxides to##3##2##(2007-11#1)(2008-5#2)
oxides upon##2##2##(1996-2#1)(2010-4#1)
oxides was##4##2##(2005-11#1)(2007-8#1)(2008-10#1)(2009-7#1)
oxides were##3##2##(2005-11#1)(2008-10#1)(2010-4#1)
oxides##105##1##(1991-6#2)(1996-12#1)(1996-2#1)(1996-5#4)(1996-8#1)(2004-4#1)(2005-11#16)(2005-8#2)(2006-12#2)(2006-7#2)(2007-11#6)(2007-2#7)(2007-5#2)(2007-8#4)(2008-10#24)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#5)(2008-8#1)(2009-7#1)(2010-12#3)(2010-4#2)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#8)(2013-1#1)
oxidimetric##2##1##(2008-10#1)(2008-11#1)
oxidisable##3##1##(2008-10#3)
oxidise##6##1##(1997-2#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2012-3#1)
oxidised LDL is##3##3##(2005-7#3)
oxidised LDL##5##2##(1997-2#1)(2005-7#4)
oxidised by##5##2##(1991-12#1)(2007-8#1)(2008-10#3)
oxidised in##2##2##(2008-10#2)
oxidised##30##1##(1990-5#1)(1991-12#1)(1996-8#4)(1997-2#1)(1997-5#1)(2005-7#5)(2006-8#1)(2007-8#1)(2008-10#14)(2008-11#1)
oxidises##4##1##(2008-10#3)(2010-5#1)
oxidising##5##1##(1994-5#1)(1997-2#1)(2008-10#3)
oxidizability of##3##2##(1997-2#1)(1997-6#1)(2005-8#1)
oxidizability##5##1##(1995-12#1)(1997-2#1)(1997-6#1)(2005-8#1)(2010-12#1)
oxidizable amino acids##3##3##(2008-10#3)
oxidizable molecules##2##2##(2008-10#2)
oxidizable species such as##2##4##(2008-10#2)
oxidizable species##5##2##(2008-10#5)
oxidizable##20##1##(1991-7#1)(1991-9#1)(1996-6#1)(2008-10#14)(2008-6#1)(2013-8#2)
oxidization of##2##2##(2008-10#2)
oxidization##3##1##(2008-10#3)
oxidize glucose##2##2##(2006-8#1)(2013-1#1)
oxidize lignoceric acid##2##3##(1993-9#2)
oxidize them##2##2##(1997-4#1)(2013-1#1)
oxidize##41##1##(1990-10#1)(1990-7#1)(1991-2#1)(1992-3#1)(1993-12#1)(1993-4#1)(1993-9#2)(1994-11#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#2)(2004-12#1)(2006-8#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-3#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#2)
oxidized Escherichia coli thioredoxin##2##4##(1991-4#1)(1991-7#1)
oxidized LDL (OxLDL)##2##3##(1995-1#1)(2013-7#1)
oxidized LDL in a##2##4##(1996-2#1)(2009-10#1)
oxidized LDL in##3##3##(1991-2#1)(1996-2#1)(2009-10#1)
oxidized LDL to##2##3##(1991-8#1)(1997-8#1)
oxidized LDL##22##2##(1990-8#1)(1991-2#1)(1991-7#2)(1991-8#1)(1992-6#1)(1993-6#1)(1995-1#1)(1996-2#4)(1997-8#1)(2005-8#1)(2009-10#2)(2009-8#2)(2010-3#1)(2012-2#1)(2013-1#1)(2013-7#1)
oxidized LDL-induced##4##2##(1995-12#4)
oxidized NADH##2##2##(1994-12#1)(1995-10#1)
oxidized NOS##2##2##(1993-6#2)
oxidized Pdx##3##2##(1994-5#3)
oxidized R1##2##2##(1993-11#2)
oxidized and reduced##15##3##(1992-6#1)(1992-9#1)(1993-11#1)(1994-8#1)(1995-1#1)(1997-4#2)(2004-11#3)(2008-10#1)(2008-4#1)(2009-7#2)(2010-2#1)
oxidized and the##2##3##(1997-4#1)(2007-12#1)
oxidized and two-electron-reduced##2##3##(1992-3#1)(1995-10#1)
oxidized and##25##2##(1990-5#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1997-4#3)(2004-11#3)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-7#2)(2010-2#1)(2012-1#1)
oxidized at potentials##2##3##(1990-8#1)(2008-10#1)
oxidized at##6##2##(1990-8#2)(1993-9#1)(2007-8#1)(2008-10#2)
oxidized by H(2)O(2) system containing Cu(2+)##2##6##(2008-10#2)
oxidized by heating##2##3##(2008-10#1)(2008-5#1)
oxidized by the##4##3##(2006-3#1)(2008-10#2)(2010-12#1)
oxidized by##27##2##(1990-8#1)(1991-1#1)(1992-5#1)(1992-6#2)(1993-4#1)(1997-8#1)(2005-11#1)(2006-3#1)(2008-10#13)(2008-4#1)(2008-5#1)(2009-8#1)(2010-12#1)(2010-8#1)
oxidized carbon nanotubes##2##3##(2008-10#1)(2010-3#1)
oxidized carbon##4##2##(2005-11#1)(2007-8#1)(2008-10#1)(2010-3#1)
oxidized cytochrome##2##2##(1994-5#1)(1994-8#1)
oxidized dextrans##3##2##(2010-12#3)
oxidized enzyme##3##2##(1990-10#2)(1995-10#1)
oxidized fibrinogen##4##2##(2010-12#4)
oxidized form of##8##3##(1991-4#1)(1992-1#1)(1993-6#1)(1995-10#1)(2006-12#2)(2008-10#2)
oxidized form##13##2##(1991-4#1)(1992-1#1)(1993-6#1)(1995-10#1)(1995-3#1)(1997-4#1)(2006-12#3)(2008-10#3)(2008-11#1)
oxidized forms of##3##3##(1994-3#1)(2009-7#2)
oxidized forms##4##2##(1994-3#1)(2006-12#1)(2009-7#2)
oxidized from##2##2##(1990-10#1)(2011-2#1)
oxidized glutathione (GSSG)##5##3##(1990-8#1)(1994-3#1)(2009-10#1)(2011-2#1)(2012-12#1)
oxidized glutathione levels##3##3##(1995-1#1)(2008-4#1)(2010-8#1)
oxidized glutathione##17##2##(1990-8#1)(1991-1#1)(1991-9#1)(1994-3#1)(1994-9#2)(1995-1#1)(1995-12#1)(1996-9#1)(2005-9#1)(2008-11#2)(2008-4#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-12#1)
oxidized hemoglobin##3##2##(1990-8#3)
oxidized in peroxisomes##4##3##(1990-10#1)(1993-9#2)(1997-7#1)
oxidized in the##2##3##(2008-10#1)(2011-2#1)
oxidized in vitro##2##3##(1992-3#1)(1996-5#1)
oxidized in##12##2##(1990-10#1)(1992-3#1)(1993-9#2)(1996-5#1)(1997-7#1)(1997-8#1)(2008-10#3)(2010-5#1)(2011-2#1)
oxidized insulin##3##2##(1991-4#1)(1994-6#1)(2008-10#1)
oxidized iron##2##2##(1996-2#1)(2009-8#1)
oxidized iron-doped##2##2##(2007-12#2)
oxidized lipid##2##2##(2008-5#1)(2010-12#1)
oxidized lipids##2##2##(1990-4#1)(2013-8#1)
oxidized low density lipoprotein##3##4##(1995-2#3)
oxidized low density lipoproteins##3##4##(1992-1#1)(1992-2#1)(1992-6#1)
oxidized low density##6##3##(1992-1#1)(1992-2#1)(1992-6#1)(1995-2#3)
oxidized low-density lipoprotein##3##3##(1993-6#1)(1995-6#1)(1996-2#1)
oxidized low-density##4##2##(1993-6#1)(1995-6#2)(1996-2#1)
oxidized manganese##2##2##(2008-10#2)
oxidized mitochondrial pyridine nucleotides##2##4##(1994-8#2)
oxidized more rapidly##2##3##(1994-9#1)(2008-10#1)
oxidized more##3##2##(1994-12#1)(1994-9#1)(2008-10#1)
oxidized nucleoside##2##2##(1993-7#1)(2008-4#1)
oxidized oil##2##2##(1991-2#1)(2009-5#1)
oxidized oil-fed##2##2##(2009-5#2)
oxidized on the##2##3##(2008-10#1)(2010-5#1)
oxidized on##3##2##(2008-10#2)(2010-5#1)
oxidized or##2##2##(2008-3#1)(2008-4#1)
oxidized palm oil diet##2##4##(2009-5#2)
oxidized phospholipids##3##2##(1996-5#2)(2011-12#1)
oxidized preferentially by##2##3##(1990-5#1)(2005-8#1)
oxidized product##4##2##(2008-10#2)(2008-3#1)(2010-2#1)
oxidized products##2##2##(1994-8#1)(2013-1#1)
oxidized protein##5##2##(1991-7#1)(1995-6#1)(1997-1#1)(1997-4#1)(2008-3#1)
oxidized sample##2##2##(2005-11#1)(2008-10#1)
oxidized species##5##2##(1992-12#1)(1996-2#1)(2008-10#2)(2010-5#1)
oxidized state##6##2##(1990-12#1)(1990-7#2)(1991-4#1)(1997-6#1)(2007-6#1)
oxidized states##3##2##(1993-11#1)(1994-8#1)(1996-2#1)
oxidized to nitrate##2##3##(2008-10#2)
oxidized to the corresponding##2##4##(1994-8#1)(1997-8#1)
oxidized to the##3##3##(1994-8#1)(1996-2#1)(1997-8#1)
oxidized to##35##2##(1990-12#1)(1990-2#1)(1991-12#1)(1992-3#1)(1993-12#2)(1993-4#1)(1994-3#1)(1994-8#1)(1996-2#1)(1996-5#2)(1997-7#1)(1997-8#1)(2005-12#1)(2006-3#1)(2008-10#15)(2008-11#1)(2010-8#1)(2013-1#2)
oxidized using##2##2##(2005-11#2)
oxidized with##10##2##(1990-4#1)(1991-1#1)(1992-3#2)(2008-10#5)(2008-4#1)
oxidized zirconium##2##2##(2011-2#2)
oxidized##402##1##(1990-10#4)(1990-12#3)(1990-2#1)(1990-4#2)(1990-5#3)(1990-7#3)(1990-8#12)(1991-1#3)(1991-12#1)(1991-2#2)(1991-4#6)(1991-7#7)(1991-8#1)(1991-9#3)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#7)(1992-5#2)(1992-6#6)(1992-8#1)(1992-9#1)(1993-11#5)(1993-12#2)(1993-3#2)(1993-4#3)(1993-6#5)(1993-7#1)(1993-8#2)(1993-9#4)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#4)(1994-5#8)(1994-6#1)(1994-8#11)(1994-9#6)(1995-1#3)(1995-10#5)(1995-11#2)(1995-12#7)(1995-2#5)(1995-3#2)(1995-5#2)(1995-6#4)(1995-7#1)(1995-8#2)(1996-2#11)(1996-5#7)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#4)(2004-11#4)(2005-11#11)(2005-12#1)(2005-8#3)(2005-9#1)(2006-12#5)(2006-3#2)(2006-8#2)(2007-11#1)(2007-12#6)(2007-6#1)(2007-8#4)(2008-10#70)(2008-11#9)(2008-2#1)(2008-3#5)(2008-4#10)(2008-5#5)(2009-10#6)(2009-5#6)(2009-7#4)(2009-8#4)(2010-12#9)(2010-2#2)(2010-3#2)(2010-5#3)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#1)
oxidized-and-tritiated glycophorin A##2##3##(1990-4#2)
oxidizer##2##1##(2007-1#1)(2012-3#1)
oxidizers##3##1##(1995-3#1)(2008-9#1)(2009-3#1)
oxidizes the##3##2##(1991-7#1)(2008-10#2)
oxidizes##12##1##(1990-7#2)(1991-7#1)(1992-3#1)(1993-4#1)(1994-12#1)(1996-2#1)(2008-10#4)(2011-2#1)
oxidizing agent is used##2##4##(2008-10#2)
oxidizing agent to##2##3##(2008-10#2)
oxidizing agent##15##2##(1996-2#1)(1996-5#1)(2008-10#11)(2012-12#1)(2012-3#1)
oxidizing agents##3##2##(2008-1#1)(2008-10#2)
oxidizing and reducing##2##3##(2010-4#1)(2010-5#1)
oxidizing and##3##2##(2008-10#1)(2010-4#1)(2010-5#1)
oxidizing conditions##2##2##(2008-10#1)(2009-10#1)
oxidizing power##2##2##(2009-3#1)(2011-2#1)
oxidizing species##3##2##(1995-3#1)(1995-5#1)(2008-5#1)
oxidizing system##2##2##(1992-4#1)(1994-9#1)
oxidizing##58##1##(1991-9#1)(1992-3#2)(1992-4#1)(1992-9#1)(1994-2#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-7#3)(1997-8#2)(2005-11#1)(2006-2#1)(2007-8#1)(2008-1#1)(2008-10#25)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2012-8#1)
oxido-reductase##2##1##(1990-5#1)(1996-2#1)
oxido-reduction##5##1##(1994-9#4)(2008-10#1)
oxidoreductase (NDH-1)##2##2##(1991-1#2)
oxidoreductase (POR)##3##2##(1995-5#1)(1997-4#1)(2009-9#1)
oxidoreductase activities##2##2##(1994-9#1)(2009-6#1)
oxidoreductase activity of##2##3##(1992-8#1)(1992-9#1)
oxidoreductase activity##6##2##(1990-11#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-3#1)
oxidoreductase and##2##2##(1990-7#1)(2011-1#1)
oxidoreductase from##4##2##(1993-11#1)(1994-11#1)(1997-4#1)(2008-6#1)
oxidoreductase##67##1##(1990-11#3)(1990-12#1)(1990-7#1)(1991-1#2)(1991-2#1)(1991-4#2)(1992-11#3)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#5)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#5)(1994-9#1)(1995-1#4)(1995-10#1)(1995-5#1)(1996-10#1)(1997-3#1)(1997-4#4)(1997-6#1)(1997-8#2)(2008-10#2)(2008-11#1)(2008-4#2)(2008-6#2)(2009-10#1)(2009-6#2)(2009-9#2)(2010-11#1)(2011-1#1)
oxidoreductase)##2##1##(1990-11#1)(1996-10#1)
oxidoreductases##11##1##(1994-6#1)(1996-6#1)(1996-9#2)(1997-4#2)(2008-10#2)(2009-9#1)(2011-1#2)
oxidoreduction##5##1##(1990-3#3)(1994-6#2)
oxidosqualene##3##1##(1992-5#1)(1992-8#2)
oximate oxygen from a symmetry-related [Cu(Hdmg)(dmg)](-) fragment##2##7##(1997-7#2)
oximate oxygens##2##2##(1997-7#2)
oximate##5##1##(1997-7#5)
oxime alkyl halide solid##2##4##(2008-3#2)
oxime##19##1##(1996-10#1)(1996-5#3)(1997-7#1)(2006-12#2)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-3#5)(2013-1#2)
oxime)##2##1##(1996-12#1)(2010-2#1)
oximes##7##1##(1993-11#2)(1995-1#1)(2007-11#2)(2008-3#1)(2012-3#1)
oximeter##6##1##(1993-1#1)(2007-1#1)(2008-3#3)(2013-1#1)
oximeters##3##1##(1990-4#1)(1995-3#1)(2008-3#1)
oximetry in##2##2##(1993-1#1)(2007-7#1)
oximetry##27##1##(1993-1#4)(1993-7#1)(1997-1#1)(2006-1#1)(2006-10#7)(2006-7#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-2#3)(2008-3#1)(2008-7#2)(2009-5#1)(2010-4#1)(2010-9#1)
oxinate##2##1##(2008-10#2)
oxine and##2##2##(2008-10#2)
oxine##6##1##(2007-8#1)(2008-10#5)
oxine-impregnated##2##1##(2008-10#2)
oxiracetam##3##1##(1992-8#3)
oxo and##2##2##(1993-6#1)(1997-7#1)
oxo group##4##2##(1994-9#2)(1996-5#1)(2008-5#1)
oxo##12##1##(1993-6#1)(1994-9#2)(1996-5#1)(1996-6#1)(1997-7#2)(2008-10#1)(2008-5#3)(2010-5#1)
oxo-arsenosugar-phosphate##2##1##(2008-10#2)
oxo-transfer##2##1##(1996-2#1)(2012-12#1)
oxocarbenium ion##6##2##(1992-12#1)(1995-1#3)(2009-8#1)(2010-4#1)
oxoferrylporphyrin cation radical##3##3##(1990-3#3)
oxoiron(IV)##4##1##(2012-12#4)
oxolinic acid in##2##3##(1996-6#1)(2008-10#1)
oxolinic acid##6##2##(1996-6#2)(2005-12#2)(2008-10#2)
oxon##3##1##(2008-10#1)(2010-2#2)
oxonate was##2##2##(1997-3#2)
oxonate##3##1##(1997-3#3)
oxonium salt##2##2##(1996-2#2)
oxonium##3##1##(1996-2#2)(2010-7#1)
oxonol##4##1##(1990-3#2)(1990-8#1)(1992-11#1)
oxotremorine or nicotine##2##3##(1991-2#2)
oxotremorine##10##1##(1990-2#2)(1991-2#2)(1993-12#3)(1994-2#1)(1995-12#1)(1997-7#1)
oxotremorine-M##2##1##(1991-9#1)(1994-2#1)
oxovanadium##2##1##(1997-7#1)(2010-5#1)
oxy form of##2##3##(1994-9#2)
oxy form##3##2##(1992-8#1)(1994-9#2)
oxy##10##1##(1992-8#1)(1993-6#1)(1994-8#1)(1994-9#3)(1996-4#1)(1997-4#1)(2007-10#1)(2010-5#1)
oxy- and chromanoxyl free radicals##2##5##(1991-2#2)
oxy- and deoxy-hemoglobin##3##3##(2011-1#2)(2011-12#1)
oxy- and##7##2##(1991-2#2)(1997-6#2)(2011-1#2)(2011-12#1)
oxy-##8##1##(1991-2#2)(1997-6#2)(2007-10#1)(2011-1#2)(2011-12#1)
oxy-P450##2##1##(1997-4#2)
oxy-PAH##2##1##(2008-11#2)
oxy-acetylene##3##1##(1994-6#2)(2008-10#1)
oxy-sporum##2##1##(2008-10#2)
oxyR function##2##2##(2008-9#2)
oxyR##3##1##(2008-9#3)
oxyanion hole##4##2##(1991-2#1)(1991-3#1)(1996-7#1)(2012-2#1)
oxyanion##7##1##(1990-2#1)(1991-2#1)(1991-3#1)(1992-3#1)(1992-9#1)(1996-7#1)(2012-2#1)
oxyanions##5##1##(1992-3#1)(2008-10#3)(2013-8#1)
oxybenzone and##3##2##(1996-6#1)(2008-5#2)
oxybenzone##6##1##(1996-6#1)(2008-5#5)
oxybutynin and tolterodine in##2##4##(2008-3#2)
oxybutynin and tolterodine##3##3##(2008-3#3)
oxybutynin##18##1##(1997-5#8)(2005-9#1)(2006-9#1)(2008-10#3)(2008-3#5)
oxychloride##3##1##(2007-11#1)(2008-10#2)
oxychlorination##2##1##(2009-8#2)
oxychlorine species with chloride in the potential buffer##2##8##(2008-10#2)
oxychlorine species##5##2##(2008-10#5)
oxycocci and##2##2##(2008-10#2)
oxycocci##4##1##(2008-10#4)
oxycodone and##2##2##(2008-3#2)
oxycodone in##2##2##(2006-6#1)(2008-3#1)
oxycodone is##5##2##(2006-6#3)(2008-3#2)
oxycodone##19##1##(2005-8#1)(2006-3#1)(2006-6#4)(2007-2#1)(2007-5#1)(2008-3#8)(2008-7#1)(2010-4#1)(2011-1#1)
oxycomplex of isozyme##3##3##(1990-2#3)
oxycomplex of##4##2##(1990-2#4)
oxycomplex##7##1##(1990-2#7)
oxycomplexes##2##1##(1990-2#2)
oxyethylene units##5##2##(1990-3#1)(1994-12#1)(2008-10#3)
oxyethylene##8##1##(1990-3#2)(1994-12#1)(2005-11#1)(2008-10#4)
oxyfluorfen##6##1##(2005-12#5)(2008-10#1)
oxygen (##3##2##(1995-5#1)(1997-7#1)(2008-10#1)
oxygen (1O2)##6##2##(1991-2#1)(1992-6#1)(1992-9#1)(2007-8#1)(2008-5#2)
oxygen (DO)##13##2##(2007-9#1)(2008-10#5)(2008-11#3)(2010-2#1)(2010-4#1)(2010-8#1)(2011-12#1)
oxygen (O(2))##2##2##(2007-8#1)(2010-5#1)
oxygen (O)##2##2##(2007-12#1)(2008-6#1)
oxygen (O2)##4##2##(1996-12#1)(2007-2#1)(2011-1#1)(2013-8#1)
oxygen (or##2##2##(1995-6#1)(2008-10#1)
oxygen A-band absorption##2##3##(2008-2#2)
oxygen absorbing capacity of 7##2##5##(2007-6#2)
oxygen activation##2##2##(1997-4#1)(2008-11#1)
oxygen affinities##2##2##(1990-7#1)(1993-6#1)
oxygen affinity and a##2##4##(1990-8#1)(1993-6#1)
oxygen affinity and##4##3##(1990-8#1)(1992-3#1)(1993-6#1)(1994-12#1)
oxygen affinity of Hb##2##4##(1993-6#1)(1994-9#1)
oxygen affinity of##5##3##(1990-8#1)(1992-9#1)(1993-6#1)(1994-9#1)(1996-7#1)
oxygen affinity##23##2##(1990-7#2)(1990-8#6)(1991-5#1)(1992-3#1)(1992-9#1)(1993-6#4)(1993-9#1)(1994-12#1)(1994-9#2)(1996-7#1)(2007-11#1)(2013-8#2)
oxygen after##3##2##(1993-1#1)(1994-3#1)(2005-11#1)
oxygen and a##2##3##(1994-5#1)(2008-10#1)
oxygen and carbon dioxide##3##4##(1990-10#1)(2005-10#1)(2006-10#1)
oxygen and glucose deprivation##3##4##(1995-7#2)(1996-6#1)
oxygen and glucose##5##3##(1995-7#2)(1996-6#2)(2006-3#1)
oxygen and hydrogen peroxide##3##4##(1996-1#1)(1996-10#1)(2008-10#1)
oxygen and nitrogen##5##3##(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#1)
oxygen and nutrition##2##3##(2006-10#1)(2008-5#1)
oxygen and other##4##3##(2006-10#1)(2008-2#1)(2008-7#1)(2008-8#1)
oxygen and reactive##3##3##(1995-1#1)(1996-11#1)(2009-8#1)
oxygen and the##7##3##(1993-6#1)(1994-2#1)(2006-10#1)(2008-10#2)(2008-3#1)(2010-2#1)
oxygen and water vapor##2##4##(2007-11#1)(2008-3#1)
oxygen and water##4##3##(1994-3#1)(2007-11#1)(2008-3#1)(2010-7#1)
oxygen and##86##2##(1990-10#1)(1990-3#1)(1991-8#1)(1993-1#2)(1993-11#1)(1993-12#3)(1993-6#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-7#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-6#2)(1997-6#1)(2005-10#1)(2006-10#5)(2006-3#1)(2007-11#3)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#4)(2009-10#1)(2009-4#1)(2009-8#3)(2010-2#2)(2010-4#2)(2010-5#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
oxygen are##2##2##(1995-1#1)(2008-6#1)
oxygen as a##2##3##(1996-11#1)(2010-4#1)
oxygen as the##3##3##(1990-7#1)(2008-3#2)
oxygen as##10##2##(1990-7#2)(1994-11#1)(1996-11#1)(2008-10#1)(2008-3#2)(2008-5#1)(2010-4#1)(2011-2#1)
oxygen at##10##2##(1992-2#1)(1993-12#2)(1994-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2011-12#1)(2012-12#1)(2013-7#1)
oxygen atom of the##3##4##(1991-3#1)(2008-3#2)
oxygen atom of##7##3##(1991-3#1)(1993-8#1)(1996-5#2)(2008-3#2)(2008-8#1)
oxygen atom transfer##2##3##(1996-2#1)(2008-8#1)
oxygen atom##20##2##(1990-8#1)(1991-3#1)(1992-9#2)(1993-8#1)(1994-5#1)(1995-10#2)(1996-2#1)(1996-5#2)(1997-7#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-8#2)(2010-5#1)(2013-8#1)
oxygen atoms are##2##3##(1991-12#1)(2010-12#1)
oxygen atoms in the##2##4##(1996-12#1)(2010-2#1)
oxygen atoms of the##4##4##(1995-5#1)(2007-11#1)(2008-5#1)(2012-2#1)
oxygen atoms of##5##3##(1995-5#1)(1997-1#1)(2007-11#1)(2008-5#1)(2012-2#1)
oxygen atoms##30##2##(1990-9#1)(1991-12#1)(1994-8#1)(1995-10#1)(1995-5#1)(1996-12#1)(1997-1#2)(1997-7#4)(2005-11#1)(2007-11#3)(2008-10#1)(2008-5#3)(2008-7#1)(2009-2#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#2)(2013-8#3)
oxygen availability in the##2##4##(1995-12#1)(2013-8#1)
oxygen availability##8##2##(1995-11#1)(1995-12#1)(2006-10#1)(2008-7#1)(2012-12#1)(2012-2#2)(2013-8#1)
oxygen balance##2##2##(2006-10#1)(2010-12#1)
oxygen barriers##2##2##(2008-5#2)
oxygen between##2##2##(2008-3#1)(2008-5#1)
oxygen binding by##2##3##(1991-5#2)
oxygen binding is##2##3##(1990-8#1)(2010-2#1)
oxygen binding to the##3##4##(1990-8#1)(1993-6#1)(1993-8#1)
oxygen binding to##7##3##(1990-8#4)(1993-6#2)(1993-8#1)
oxygen binding##26##2##(1990-8#5)(1991-5#2)(1991-6#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-5#1)(1994-9#4)(1997-1#1)(2009-9#1)(2010-11#1)(2010-2#1)(2012-12#1)(2013-8#3)
oxygen but##2##2##(1993-12#1)(2008-9#1)
oxygen by##6##2##(1992-11#1)(1994-5#1)(1996-11#1)(1997-1#1)(1997-6#1)(2013-8#1)
oxygen can##3##2##(2009-3#1)(2010-5#1)(2011-1#1)
oxygen carrier##2##2##(1991-8#1)(2008-10#1)
oxygen carriers in##3##3##(2006-10#2)(2008-11#1)
oxygen carriers may##2##3##(2006-10#1)(2007-12#1)
oxygen carriers##15##2##(2005-7#2)(2006-10#8)(2007-12#3)(2008-10#1)(2008-11#1)
oxygen carrying##2##2##(2007-11#1)(2008-11#1)
oxygen concentration in the##3##4##(2006-10#1)(2008-10#1)(2008-7#1)
oxygen concentration in##5##3##(2006-10#2)(2008-10#1)(2008-3#1)(2008-7#1)
oxygen concentration##19##2##(1994-2#1)(1995-6#1)(1997-4#2)(1997-6#1)(2006-10#2)(2007-12#1)(2007-8#1)(2008-10#4)(2008-3#2)(2008-7#2)(2010-4#1)(2011-2#1)
oxygen concentrations and##2##3##(1994-3#1)(1997-4#1)
oxygen concentrations in##2##3##(2008-10#1)(2008-5#1)
oxygen concentrations##8##2##(1994-3#1)(1995-6#1)(1997-4#1)(2006-12#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-5#1)
oxygen conditions##4##2##(1995-5#1)(2006-9#2)(2008-10#1)
oxygen consumption and##9##3##(1995-3#3)(2005-8#1)(2007-12#1)(2008-4#1)(2009-6#1)(2010-5#1)(2013-1#1)
oxygen consumption by##3##3##(1997-1#1)(1997-8#1)(2008-5#1)
oxygen consumption in the##4##4##(1992-11#1)(1995-6#1)(1997-1#1)(1997-6#1)
oxygen consumption in##7##3##(1992-11#1)(1994-12#1)(1995-6#1)(1997-1#2)(1997-6#1)(2008-7#1)
oxygen consumption of##3##3##(1997-8#1)(2005-8#1)(2009-4#1)
oxygen consumption rate##3##3##(1994-8#2)(2008-1#1)
oxygen consumption##60##2##(1990-3#1)(1991-3#1)(1991-9#1)(1992-11#1)(1994-12#1)(1994-8#3)(1995-3#3)(1995-6#3)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#4)(1997-6#2)(1997-8#2)(2005-1#2)(2005-8#2)(2006-10#1)(2007-10#2)(2007-12#1)(2007-3#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-5#1)(2009-6#4)(2010-11#2)(2010-5#1)(2013-1#1)(2013-8#3)
oxygen consumption)##2##2##(1996-5#1)(2013-8#1)
oxygen content in##2##3##(2005-11#1)(2008-10#1)
oxygen content##14##2##(1994-12#1)(2005-11#7)(2006-10#1)(2006-7#1)(2007-7#1)(2008-10#2)(2009-7#1)
oxygen contents##2##2##(2008-10#1)(2008-2#1)
oxygen could be##2##3##(1995-4#1)(2008-10#1)
oxygen deficiency##7##2##(1990-10#2)(1992-5#1)(1995-11#1)(2007-12#1)(2011-2#1)(2012-1#1)
oxygen delivery and##5##3##(1996-3#1)(2006-10#1)(2006-7#1)(2010-11#1)(2012-2#1)
oxygen delivery in##3##3##(1996-3#1)(2008-6#1)(2012-3#1)
oxygen delivery to the tissues##2##5##(1996-3#1)(2010-7#1)
oxygen delivery to the##4##4##(1996-3#1)(2005-8#1)(2008-1#1)(2010-7#1)
oxygen delivery##21##2##(1991-9#1)(1992-2#1)(1996-3#3)(2005-8#1)(2006-10#5)(2006-4#1)(2006-7#1)(2008-1#1)(2008-6#1)(2010-11#1)(2010-7#1)(2010-9#1)(2012-2#2)(2012-3#1)
oxygen demand (BOD)##3##3##(2007-10#1)(2008-10#2)
oxygen demand and##2##3##(2008-1#1)(2008-6#1)
oxygen demand##31##2##(2005-1#1)(2006-10#2)(2006-8#1)(2007-10#2)(2007-11#1)(2007-9#1)(2008-1#2)(2008-10#14)(2008-5#1)(2008-6#2)(2010-12#1)(2011-2#2)(2013-1#1)
oxygen demands##2##2##(1991-3#1)(2008-11#1)
oxygen depletion##2##2##(1993-8#1)(2009-8#1)
oxygen desaturation (SpO2##2##3##(1993-1#2)
oxygen desaturation##5##2##(1993-1#2)(2007-1#1)(2007-12#1)(2007-8#1)
oxygen diffusion in##2##3##(2010-12#1)(2010-4#1)
oxygen diffusion##8##2##(2008-2#2)(2008-3#1)(2008-7#1)(2010-12#3)(2010-4#1)
oxygen during##4##2##(1991-9#1)(1994-10#1)(2006-10#1)(2010-2#1)
oxygen electrode##7##2##(1992-11#1)(1995-3#1)(2008-10#5)
oxygen environment##4##2##(2005-11#1)(2008-10#1)(2009-10#2)
oxygen equilibrium curves for##3##4##(1990-8#2)(1993-8#1)
oxygen equilibrium curves of##2##4##(1990-8#2)
oxygen equilibrium curves##7##3##(1990-8#6)(1993-8#1)
oxygen equilibrium##10##2##(1990-8#6)(1992-9#1)(1993-8#3)
oxygen evolution by##2##3##(1994-12#1)(1997-4#1)
oxygen evolution##11##2##(1994-12#5)(1994-8#1)(1997-4#1)(2005-11#1)(2007-10#1)(2008-6#1)(2010-5#1)
oxygen exchange##5##2##(1990-12#1)(1995-5#1)(1996-5#1)(1997-4#1)(2007-12#1)
oxygen exposure##4##2##(1990-12#1)(1994-8#3)
oxygen extraction fraction (OEF)##2##4##(2007-10#1)(2008-7#1)
oxygen extraction fraction##6##3##(2006-11#1)(2007-10#2)(2007-9#2)(2008-7#1)
oxygen extraction##7##2##(2006-11#1)(2007-10#2)(2007-8#1)(2007-9#2)(2008-7#1)
oxygen flow##2##2##(2008-10#1)(2010-10#1)
oxygen for##12##2##(1993-1#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-6#1)(1996-5#1)(2008-11#1)(2008-6#1)(2010-12#1)(2010-8#1)(2012-3#1)(2013-7#1)
oxygen formation##5##2##(1992-12#2)(2010-5#3)
oxygen free radical production##2##4##(1992-1#1)(1996-6#1)
oxygen free radical##8##3##(1991-9#1)(1992-1#1)(1995-1#1)(1996-6#1)(2007-9#1)(2008-8#1)(2011-3#1)(2012-3#1)
oxygen free radicals and the##2##5##(1990-4#1)(2013-8#1)
oxygen free radicals and##4##4##(1990-4#1)(1995-8#1)(1996-2#1)(2013-8#1)
oxygen free radicals##24##3##(1990-11#1)(1990-4#1)(1991-9#3)(1992-1#3)(1992-12#1)(1993-4#1)(1994-10#1)(1994-2#1)(1994-9#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-2#2)(1996-8#1)(1996-9#1)(2007-9#1)(2008-4#1)(2013-8#1)
oxygen free##33##2##(1990-11#1)(1990-4#1)(1991-9#4)(1992-1#4)(1992-12#1)(1993-4#1)(1994-10#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-2#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(2007-9#2)(2008-4#1)(2008-8#1)(2011-3#1)(2012-3#1)(2013-8#1)
oxygen from the##3##3##(2006-10#1)(2008-10#1)(2009-8#1)
oxygen from##5##2##(1997-7#2)(2006-10#1)(2008-10#1)(2009-8#1)
oxygen functions##2##2##(1992-5#1)(2006-12#1)
oxygen gas##4##2##(2008-10#1)(2008-3#2)(2008-7#1)
oxygen generation##5##2##(1994-3#1)(1994-8#1)(2008-7#1)(2009-4#1)(2010-5#1)
oxygen in a##5##3##(1997-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
oxygen in aqueous##2##3##(2005-11#1)(2006-10#1)
oxygen in rat##2##3##(1994-12#1)(1995-8#1)
oxygen in the##13##3##(1990-11#2)(1994-6#1)(1996-6#1)(2006-10#2)(2007-10#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-2#1)(2010-2#1)
oxygen in##33##2##(1990-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-8#1)(1996-6#1)(1997-8#1)(2005-11#1)(2006-10#3)(2007-10#1)(2007-8#1)(2008-10#9)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-2#1)(2010-2#1)(2012-12#2)
oxygen intermediates (ROIs)##3##3##(1993-7#1)(1995-8#1)(2008-7#1)
oxygen intermediates##7##2##(1991-9#1)(1993-7#2)(1995-8#2)(2006-10#1)(2008-7#1)
oxygen iodine##3##2##(2008-1#1)(2008-3#2)
oxygen is##9##2##(1990-7#1)(1990-8#1)(1994-5#1)(1995-2#1)(1996-7#1)(1997-6#1)(2008-10#2)(2008-5#1)
oxygen isotope##2##2##(1994-2#1)(2007-9#1)
oxygen kinetics##2##2##(1994-2#1)(2009-5#1)
oxygen level##7##2##(1996-3#1)(2007-9#1)(2008-10#3)(2009-9#1)(2011-2#1)
oxygen levels##5##2##(1994-3#1)(2005-7#2)(2009-11#1)(2010-7#1)
oxygen limitation and##2##3##(2005-11#1)(2008-11#1)
oxygen limitation##3##2##(2005-11#1)(2008-11#1)(2008-6#1)
oxygen lone pair##2##3##(1990-8#1)(2010-2#1)
oxygen may be##2##3##(2005-11#1)(2010-4#1)
oxygen may##3##2##(2005-11#1)(2008-2#1)(2010-4#1)
oxygen metabolism during##2##3##(2006-7#1)(2007-8#1)
oxygen metabolism##11##2##(2005-8#1)(2006-7#3)(2007-10#2)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#2)
oxygen metabolites##10##2##(1991-9#1)(1992-12#2)(1993-6#2)(2010-8#1)(2012-12#3)(2012-3#1)
oxygen molecule##5##2##(1991-9#1)(1993-8#1)(1994-9#1)(2008-10#1)(2009-12#1)
oxygen molecules##5##2##(1990-8#2)(1992-3#1)(2008-10#1)(2013-8#1)
oxygen monitoring in subcutaneous adipose tissue##2##6##(2007-8#2)
oxygen of the##3##3##(1993-11#1)(1996-2#1)(2008-5#1)
oxygen of##11##2##(1991-3#1)(1992-6#1)(1993-11#1)(1993-3#1)(1995-8#1)(1996-2#2)(1996-5#1)(1996-7#2)(2008-5#1)
oxygen on the##4##3##(1996-7#1)(2008-10#2)(2008-8#1)
oxygen on##8##2##(1995-3#1)(1996-7#1)(2008-10#3)(2008-3#1)(2008-8#1)(2008-9#1)
oxygen or##7##2##(1994-5#1)(1994-8#1)(1997-8#1)(2006-3#1)(2008-11#1)(2008-4#1)(2008-9#1)
oxygen oxidoreductase##2##2##(1994-3#1)(1994-8#1)
oxygen partial pressure and##2##4##(2006-10#1)(2013-8#1)
oxygen partial pressure during##2##4##(2008-11#1)(2008-2#1)
oxygen partial pressure##14##3##(2005-11#1)(2006-10#1)(2007-12#1)(2008-11#6)(2008-2#2)(2010-8#1)(2013-8#2)
oxygen partial pressures##2##3##(1990-8#1)(2010-4#1)
oxygen partial##16##2##(1990-8#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-11#6)(2008-2#2)(2010-4#1)(2010-8#1)(2013-8#2)
oxygen percentage##2##2##(1996-6#1)(2008-2#1)
oxygen persufflation##7##2##(2007-8#7)
oxygen plasma treatment of##2##4##(2005-11#2)
oxygen plasma treatment##3##3##(2005-11#2)(2008-11#1)
oxygen plasma##5##2##(2005-11#3)(2008-11#1)(2008-3#1)
oxygen plus##2##2##(2011-2#2)
oxygen present in the##2##4##(2008-10#1)(2008-5#1)
oxygen pressure##11##2##(1991-5#1)(2006-10#4)(2008-11#1)(2008-2#2)(2010-10#1)(2013-1#2)
oxygen pressures##3##2##(1990-8#1)(2007-12#1)(2008-2#1)
oxygen products##3##2##(1991-9#2)(2008-4#1)
oxygen quenching of##2##3##(2008-10#2)
oxygen quenching##3##2##(2008-10#2)(2008-3#1)
oxygen radical damage##2##3##(1992-12#1)(1994-2#1)
oxygen radical##8##2##(1991-9#1)(1992-12#1)(1994-2#2)(1995-1#1)(1996-9#1)(2008-10#1)(2008-7#1)
oxygen radicals and##4##3##(1993-8#1)(1994-3#1)(2010-7#1)(2013-1#1)
oxygen radicals in##4##3##(1991-11#2)(1994-2#2)
oxygen radicals##33##2##(1990-5#1)(1991-11#4)(1991-9#3)(1992-11#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-2#3)(1994-3#3)(1995-8#1)(1996-2#4)(1996-9#1)(2006-8#2)(2007-11#1)(2008-5#1)(2008-8#2)(2010-12#1)(2010-7#1)(2013-1#1)
oxygen reaction##2##2##(1992-8#1)(2008-10#1)
oxygen reactivity##3##2##(1994-8#1)(1995-5#2)
oxygen rebound mechanism##2##3##(1997-7#2)
oxygen rebound##3##2##(1994-5#1)(1997-7#2)
oxygen reduction at##2##3##(1995-11#1)(2012-2#1)
oxygen reduction##5##2##(1990-7#1)(1993-12#1)(1994-5#1)(1995-11#1)(2012-2#1)
oxygen release from roots##2##4##(2009-8#2)
oxygen release##3##2##(2009-4#1)(2009-8#2)
oxygen removal##2##2##(2008-10#2)
oxygen requirement##2##2##(1992-11#1)(1992-2#1)
oxygen responsible for##2##3##(2006-10#1)(2007-10#1)
oxygen rich##5##2##(2007-5#1)(2009-2#1)(2009-4#1)(2011-1#2)
oxygen saturation (SpO2)##2##3##(1993-1#1)(2007-2#1)
oxygen saturation and symptoms among##2##5##(2007-1#2)
oxygen saturation and water##2##4##(1997-6#1)(2011-1#1)
oxygen saturation and##11##3##(1993-5#2)(1997-6#1)(2006-10#2)(2007-1#2)(2007-8#1)(2009-4#1)(2011-1#1)(2011-2#1)
oxygen saturation in##4##3##(1993-5#1)(2008-3#1)(2010-3#1)(2011-12#1)
oxygen saturation levels##2##3##(2011-1#2)
oxygen saturation of##5##3##(2007-10#1)(2008-2#1)(2008-3#2)(2010-7#1)
oxygen saturation was##2##3##(2007-8#2)
oxygen saturation##62##2##(1993-1#2)(1993-5#3)(1996-3#1)(1997-6#1)(2006-10#3)(2006-2#1)(2006-4#1)(2006-7#1)(2007-1#3)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#2)(2007-8#4)(2008-2#2)(2008-3#7)(2008-4#1)(2008-7#1)(2009-11#1)(2009-4#1)(2010-10#4)(2010-3#2)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#4)(2011-12#3)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
oxygen saturations##2##2##(1993-5#1)(2008-4#1)
oxygen scavenger to##2##3##(2008-10#2)
oxygen sensing##8##2##(2008-10#7)(2008-11#1)
oxygen sensitive##3##2##(1994-6#1)(2007-8#2)
oxygen sensitivity##2##2##(2008-2#1)(2010-4#1)
oxygen sensor was##2##3##(2008-10#2)
oxygen sensor##7##2##(1994-12#1)(2007-8#3)(2008-10#3)
oxygen sensors##5##2##(2006-7#2)(2010-4#2)(2010-5#1)
oxygen sites##2##2##(1990-2#1)(2008-10#1)
oxygen species (ROS) are involved in##2##6##(2008-10#1)(2009-8#1)
oxygen species (ROS) are##8##4##(2008-10#2)(2009-8#2)(2010-4#1)(2010-7#1)(2012-12#2)
oxygen species (ROS) is##2##4##(2009-8#1)(2011-1#1)
oxygen species (ROS)##89##3##(1992-12#1)(1992-3#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-1#4)(2008-10#10)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#2)(2009-5#3)(2009-6#1)(2009-8#10)(2010-1#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#2)(2011-10#1)(2011-12#1)(2011-2#7)(2012-1#2)(2012-12#4)(2012-2#2)(2012-6#1)(2013-1#2)(2013-8#2)
oxygen species and##16##3##(1990-9#2)(1992-5#1)(2006-2#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-4#3)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
oxygen species are generated##2##4##(1990-7#1)(2007-1#1)
oxygen species are##6##3##(1990-7#1)(1991-9#2)(2007-1#1)(2007-10#1)(2008-11#1)
oxygen species by##7##3##(1992-6#1)(1994-2#1)(2006-10#1)(2008-10#1)(2008-11#1)(2009-3#1)(2010-1#1)
oxygen species generated by##3##4##(1993-11#1)(2005-8#1)(2008-4#1)
oxygen species have been##5##4##(1994-6#1)(1995-7#1)(1996-8#1)(2008-10#1)(2009-6#1)
oxygen species in##18##3##(1991-9#1)(1992-6#3)(1994-2#1)(1994-3#1)(1994-6#1)(1995-8#1)(1997-4#1)(2007-1#1)(2007-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-10#1)
oxygen species may be##2##4##(2008-10#1)(2008-3#1)
oxygen species may##3##3##(2005-9#1)(2008-10#1)(2008-3#1)
oxygen species such as superoxide##2##5##(1992-12#1)(2008-5#1)
oxygen species##251##2##(1990-11#1)(1990-3#1)(1990-7#1)(1990-9#4)(1991-9#8)(1992-12#2)(1992-3#1)(1992-5#3)(1992-6#7)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#5)(1994-3#2)(1994-5#1)(1994-6#4)(1995-1#1)(1995-7#2)(1995-8#2)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#4)(1997-6#2)(1997-8#2)(2005-10#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#3)(2006-2#2)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#2)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#8)(2008-10#23)(2008-11#10)(2008-2#1)(2008-3#2)(2008-4#12)(2008-5#7)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#1)(2009-10#2)(2009-12#5)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#13)(2010-1#2)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#3)(2010-5#1)(2010-7#3)(2011-1#8)(2011-10#1)(2011-12#2)(2011-2#9)(2012-1#3)(2012-12#4)(2012-2#3)(2012-6#1)(2013-1#6)(2013-8#5)
oxygen supply and##2##3##(2007-11#1)(2008-1#1)
oxygen supply in##2##3##(2008-11#1)(2009-11#1)
oxygen supply is##2##3##(1996-3#1)(2008-6#1)
oxygen supply or##2##3##(2007-12#1)(2007-8#1)
oxygen supply##15##2##(1994-2#2)(1996-3#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-12#1)(2011-1#1)
oxygen tension and##4##3##(1994-4#1)(2006-10#1)(2008-7#1)(2011-1#1)
oxygen tension in the##2##4##(1991-8#1)(1992-3#1)
oxygen tension in##3##3##(1991-8#1)(1992-3#1)(2006-6#1)
oxygen tension of##3##3##(2007-2#1)(2008-11#1)(2011-2#1)
oxygen tension##34##2##(1991-2#1)(1991-7#1)(1991-8#2)(1992-3#1)(1994-12#1)(1994-3#4)(1994-4#1)(1994-5#1)(1994-9#1)(1997-3#1)(2005-9#1)(2006-10#3)(2006-6#1)(2006-7#1)(2007-2#1)(2008-1#1)(2008-11#3)(2008-7#2)(2008-9#2)(2009-3#1)(2011-1#2)(2011-2#2)
oxygen tensions##4##2##(1994-3#1)(1995-5#1)(1997-6#1)(2009-4#1)
oxygen that##2##2##(2007-8#1)(2012-3#1)
oxygen therapy for##2##3##(1991-2#1)(2008-1#1)
oxygen therapy in##3##3##(2008-8#3)
oxygen therapy may##2##3##(2009-12#1)(2009-2#1)
oxygen therapy##28##2##(1991-2#3)(1991-6#1)(1993-7#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-4#1)(2007-6#1)(2008-1#2)(2008-8#5)(2009-12#2)(2009-2#2)(2010-10#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
oxygen to##18##2##(1990-8#1)(1991-10#1)(1991-9#1)(1992-8#1)(1993-3#1)(1995-2#1)(1996-7#2)(2005-7#1)(2007-9#1)(2008-10#2)(2008-3#2)(2008-5#1)(2009-11#1)(2009-8#1)(2012-2#1)
oxygen tolerance##2##2##(1992-6#2)
oxygen transfer coefficient##2##3##(2008-11#1)(2008-6#1)
oxygen transfer##10##2##(1994-11#1)(1994-2#2)(2008-11#4)(2008-6#1)(2008-7#2)
oxygen transport##4##2##(2006-10#1)(2007-11#1)(2008-5#1)(2008-6#1)
oxygen uptake (VO(2))##2##3##(2010-12#1)(2012-11#1)
oxygen uptake and carbon dioxide production rates##3##7##(2008-11#3)
oxygen uptake and carbon dioxide##6##5##(2008-11#6)
oxygen uptake and##10##3##(1992-7#1)(2007-8#1)(2008-11#6)(2008-7#1)(2013-8#1)
oxygen uptake between the estimation and production##2##7##(2013-8#2)
oxygen uptake by##2##3##(1996-8#1)(2008-5#1)
oxygen uptake in the##2##4##(1991-1#1)(1992-11#1)
oxygen uptake in##4##3##(1991-1#1)(1992-11#1)(2008-12#1)(2013-8#1)
oxygen uptake rate (OUR)##3##4##(2008-11#1)(2008-7#2)
oxygen uptake rate##8##3##(1995-1#1)(2008-11#4)(2008-7#3)
oxygen uptake rates##2##3##(1995-1#1)(2008-11#1)
oxygen uptake was##3##3##(1992-11#1)(1993-8#1)(2013-8#1)
oxygen uptake##64##2##(1991-1#3)(1992-11#2)(1992-7#1)(1993-8#1)(1995-1#3)(1996-8#1)(1997-6#1)(2006-3#1)(2007-8#1)(2008-10#1)(2008-11#12)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#5)(2009-5#1)(2010-12#1)(2010-8#1)(2012-11#1)(2013-1#1)(2013-7#1)(2013-8#17)
oxygen use##2##2##(2010-2#1)(2011-2#1)
oxygen using##2##2##(2007-9#1)(2008-10#1)
oxygen utilization and##2##3##(1991-11#1)(1995-3#1)
oxygen utilization##8##2##(1990-5#3)(1991-11#1)(1995-3#1)(2008-7#1)(2009-4#1)(2012-2#1)
oxygen was generated##2##3##(2007-8#1)(2008-8#1)
oxygen was##13##2##(1991-10#1)(1994-2#1)(2006-3#1)(2007-8#3)(2008-10#1)(2008-3#1)(2008-8#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-7#1)
oxygen were##2##2##(2008-3#1)(2009-2#1)
oxygen with a##2##3##(2008-10#1)(2009-2#1)
oxygen with the##2##3##(1992-8#1)(1992-9#1)
oxygen with##10##2##(1992-8#1)(1992-9#1)(1995-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2009-2#1)
oxygen##1802##1##(1990-1#1)(1990-10#5)(1990-11#5)(1990-12#7)(1990-2#1)(1990-3#5)(1990-4#1)(1990-5#8)(1990-7#10)(1990-8#27)(1990-9#7)(1991-1#3)(1991-10#5)(1991-11#5)(1991-12#2)(1991-2#12)(1991-3#5)(1991-5#6)(1991-6#4)(1991-7#2)(1991-8#5)(1991-9#28)(1992-1#4)(1992-11#8)(1992-12#8)(1992-2#3)(1992-3#5)(1992-4#1)(1992-5#5)(1992-6#12)(1992-7#3)(1992-8#4)(1992-9#9)(1993-1#11)(1993-10#1)(1993-11#4)(1993-12#17)(1993-3#7)(1993-4#3)(1993-5#5)(1993-6#14)(1993-7#3)(1993-8#13)(1993-9#2)(1994-10#5)(1994-11#9)(1994-12#17)(1994-2#22)(1994-3#20)(1994-4#1)(1994-5#14)(1994-6#9)(1994-8#14)(1994-9#9)(1995-1#9)(1995-10#4)(1995-11#7)(1995-12#4)(1995-2#4)(1995-3#6)(1995-4#1)(1995-5#9)(1995-6#10)(1995-7#4)(1995-8#9)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#8)(1996-2#10)(1996-3#9)(1996-5#9)(1996-6#5)(1996-7#14)(1996-8#3)(1996-9#7)(1997-1#11)(1997-2#1)(1997-3#2)(1997-4#13)(1997-6#12)(1997-7#12)(1997-8#8)(2004-11#1)(2005-1#3)(2005-10#2)(2005-11#23)(2005-12#1)(2005-4#1)(2005-7#13)(2005-8#8)(2005-9#2)(2006-10#51)(2006-11#2)(2006-12#5)(2006-2#3)(2006-3#4)(2006-4#4)(2006-5#1)(2006-6#3)(2006-7#10)(2006-8#4)(2006-9#3)(2007-1#8)(2007-10#19)(2007-11#21)(2007-12#21)(2007-2#5)(2007-3#3)(2007-4#1)(2007-5#3)(2007-6#4)(2007-7#3)(2007-8#43)(2007-9#20)(2008-1#18)(2008-10#184)(2008-11#56)(2008-12#1)(2008-2#31)(2008-3#50)(2008-4#20)(2008-5#53)(2008-6#18)(2008-7#43)(2008-8#23)(2008-9#10)(2009-10#6)(2009-11#5)(2009-12#10)(2009-2#8)(2009-3#8)(2009-4#13)(2009-5#6)(2009-6#8)(2009-7#2)(2009-8#24)(2009-9#2)(2010-1#2)(2010-10#8)(2010-11#6)(2010-12#14)(2010-2#13)(2010-3#2)(2010-4#17)(2010-5#17)(2010-6#1)(2010-7#9)(2010-8#8)(2010-9#1)(2011-1#23)(2011-10#1)(2011-12#8)(2011-2#32)(2011-3#1)(2012-1#5)(2012-11#2)(2012-12#14)(2012-2#22)(2012-3#7)(2012-6#1)(2013-1#23)(2013-7#5)(2013-8#53)
oxygen(s)##2##1##(1990-7#1)(2009-2#1)
oxygen)##10##1##(1990-9#1)(1993-8#1)(1994-2#1)(1994-8#1)(2008-10#2)(2012-12#4)
oxygen-##2##1##(1990-7#1)(2010-5#1)
oxygen-17##7##1##(1990-5#7)
oxygen-atom concentrations##2##2##(2008-3#2)
oxygen-binding behavior of the 24-meric##2##5##(1990-8#2)
oxygen-binding data##4##2##(1990-8#4)
oxygen-binding##12##1##(1990-8#11)(2010-4#1)
oxygen-carrying##4##1##(1992-8#1)(2006-10#1)(2007-11#1)(2010-2#1)
oxygen-consuming##3##1##(1994-10#1)(1994-12#2)
oxygen-containing groups on the surface##2##5##(2005-11#2)
oxygen-containing##3##1##(2005-11#2)(2009-3#1)
oxygen-deficient##3##1##(2007-12#3)
oxygen-dependent##6##1##(1991-3#1)(1993-6#1)(1994-5#1)(1995-5#1)(2006-12#1)(2009-2#1)
oxygen-deprived##2##1##(1995-3#1)(2005-7#1)
oxygen-derived free radicals and##2##4##(1995-8#1)(2008-10#1)
oxygen-derived free radicals are##2##4##(2010-10#2)
oxygen-derived free radicals##9##3##(1990-4#1)(1995-8#1)(1996-9#1)(2008-10#1)(2010-10#2)(2010-3#3)
oxygen-derived free##10##2##(1990-4#1)(1991-12#1)(1995-8#1)(1996-9#1)(2008-10#1)(2010-10#2)(2010-3#3)
oxygen-derived species##2##2##(1995-1#1)(2007-11#1)
oxygen-derived##13##1##(1990-4#1)(1991-12#1)(1995-1#1)(1995-8#1)(1996-2#1)(1996-9#1)(2007-11#1)(2008-10#1)(2010-10#2)(2010-3#3)
oxygen-enriched##2##1##(1990-9#2)
oxygen-evolving activity of##2##3##(1997-4#2)
oxygen-evolving center##2##2##(2008-8#2)
oxygen-evolving complex##9##2##(1993-6#2)(1994-12#2)(1995-8#1)(1996-10#2)(2009-2#2)
oxygen-evolving##16##1##(1992-4#1)(1993-6#2)(1994-12#3)(1994-8#1)(1995-8#1)(1996-10#2)(1997-4#2)(2008-8#2)(2009-2#2)
oxygen-free radicals##2##2##(1991-12#1)(1996-2#1)
oxygen-free##4##1##(1991-12#1)(1993-11#1)(1996-2#1)(2006-7#1)
oxygen-glucose deprivation or NMDA##2##4##(1996-6#2)
oxygen-glucose deprivation##9##2##(1994-2#2)(1996-1#4)(1996-6#2)(1997-8#1)
oxygen-induced##3##1##(1993-12#1)(2008-10#1)(2010-7#1)
oxygen-linked Cl-##2##2##(1994-9#2)
oxygen-mediated##2##1##(1992-6#1)(2010-5#1)
oxygen-ozone therapy##2##2##(2007-10#2)
oxygen-ozone##3##1##(2007-10#2)(2007-11#1)
oxygen-plasma##2##1##(2005-11#2)
oxygen-rich##5##1##(2006-5#1)(2008-10#1)(2008-11#2)(2011-2#1)
oxygen-saturated##2##1##(2007-9#1)(2008-10#1)
oxygen-sensitive dye ion-pair##2##3##(2008-10#2)
oxygen-sensitive α-subunit##2##2##(2012-12#2)
oxygen-sensitive##10##1##(1997-1#1)(2007-9#1)(2008-1#1)(2008-10#5)(2012-12#2)
oxygen-sensitivity of optical sensor using pyrene carboxylic acid##2##8##(2008-10#2)
oxygen-sensitivity##3##1##(2008-10#3)
oxygen-uptake rate##3##2##(1994-2#3)
oxygenase (HO)##3##2##(1994-5#1)(1996-3#1)(2008-4#1)
oxygenase (HO)-1##2##2##(2010-1#1)(2012-11#1)
oxygenase 1##6##2##(1994-3#4)(2007-10#1)(2012-1#1)
oxygenase activity##3##2##(1990-4#1)(1996-3#1)(2007-11#1)
oxygenase and##3##2##(1996-1#1)(2007-11#1)(2008-4#1)
oxygenase domain of inducible##2##4##(1997-4#1)(2009-9#1)
oxygenase domain of##3##3##(1997-4#2)(2009-9#1)
oxygenase domain##4##2##(1997-4#2)(2008-10#1)(2009-9#1)
oxygenase reaction of acetolactate##2##4##(1994-10#2)
oxygenase##35##1##(1990-4#1)(1992-4#1)(1993-6#1)(1994-10#2)(1994-11#1)(1994-3#9)(1994-5#2)(1995-2#1)(1996-1#1)(1996-3#3)(1997-4#2)(2007-10#1)(2007-11#2)(2008-10#1)(2008-4#2)(2009-9#1)(2010-1#1)(2010-10#1)(2012-1#1)(2012-11#1)
oxygenase-1##8##1##(2006-9#1)(2008-10#1)(2010-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
oxygenase-2##2##1##(1995-12#2)
oxygenases##2##1##(1991-7#1)(1995-2#1)
oxygenate##4##1##(2005-9#1)(2006-10#1)(2007-8#1)(2008-10#1)
oxygenated and##7##2##(1992-9#1)(1995-11#1)(1996-6#1)(2007-8#1)(2008-11#1)(2009-3#1)(2011-1#1)
oxygenated blood##2##2##(1991-3#1)(1996-9#1)
oxygenated species##3##2##(1990-8#1)(1992-8#2)
oxygenated sterols##2##2##(1990-2#2)
oxygenated##44##1##(1990-2#2)(1990-8#2)(1991-3#1)(1992-8#4)(1992-9#1)(1993-8#1)(1993-9#1)(1994-6#1)(1995-11#1)(1995-5#4)(1996-11#3)(1996-6#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-6#2)(2005-12#1)(2006-10#1)(2007-1#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-6#1)(2009-3#1)(2011-1#1)(2011-2#1)
oxygenates##3##1##(2008-10#1)(2008-11#1)(2010-12#1)
oxygenation and haemodynamics##2##3##(1997-6#2)
oxygenation and perfusion##2##3##(1997-6#2)
oxygenation and the##2##3##(1993-7#1)(2013-1#1)
oxygenation and vascularization##2##3##(2008-11#2)
oxygenation and##22##2##(1993-5#1)(1993-7#1)(1994-6#3)(1994-7#1)(1995-5#1)(1997-6#4)(2005-12#1)(2006-10#3)(2008-11#2)(2009-7#1)(2010-2#1)(2010-7#1)(2011-1#1)(2013-1#1)
oxygenation during##5##2##(1995-12#1)(1997-6#1)(2007-9#1)(2011-2#2)
oxygenation dynamics of tumors##2##4##(2008-3#2)
oxygenation for##2##2##(2006-4#1)(2009-6#1)
oxygenation in the##3##3##(2006-4#1)(2008-3#1)(2009-5#1)
oxygenation in##7##2##(1993-4#1)(1994-7#1)(2005-11#1)(2006-4#1)(2008-3#1)(2009-5#1)(2012-12#1)
oxygenation is##4##2##(1995-5#2)(2005-11#1)(2006-7#1)
oxygenation non-invasively##2##2##(1997-6#1)(2007-8#1)
oxygenation of the tumors was##2##5##(1995-5#2)
oxygenation of the##5##3##(1991-5#1)(1995-5#2)(1995-6#1)(2006-10#1)
oxygenation of##10##2##(1991-5#1)(1995-5#3)(1995-6#1)(2006-10#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-8#1)
oxygenation status##2##2##(1995-9#1)(2008-11#1)
oxygenation such as##2##3##(1996-3#1)(2006-10#1)
oxygenation to##2##2##(1991-2#1)(1997-6#1)
oxygenation##131##1##(1990-8#5)(1991-2#1)(1991-5#2)(1992-1#1)(1992-2#1)(1992-4#1)(1992-5#1)(1993-10#1)(1993-4#2)(1993-5#1)(1993-7#1)(1994-6#3)(1994-7#3)(1995-12#1)(1995-4#1)(1995-5#7)(1995-6#1)(1995-9#2)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#13)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#14)(2006-4#5)(2006-7#1)(2007-10#1)(2007-8#8)(2007-9#5)(2008-11#6)(2008-3#5)(2008-8#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-2#3)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#1)
oxygenation)##2##1##(2008-10#1)(2008-11#1)
oxygenator with##2##2##(2007-8#2)
oxygenator##7##1##(2007-8#7)
oxygenic photosynthesis##4##2##(1995-6#1)(1996-12#1)(2009-2#1)(2011-1#1)
oxygenic##6##1##(1994-12#1)(1994-8#1)(1995-6#1)(1996-12#1)(2009-2#1)(2011-1#1)
oxygens and##3##2##(1992-1#1)(2008-10#1)(2008-5#1)
oxygens from##2##2##(1997-7#2)
oxygens in##3##2##(1991-7#1)(1996-2#1)(1997-7#1)
oxygens of the##2##3##(1995-10#1)(1996-7#1)
oxygens##17##1##(1991-7#1)(1992-1#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-7#3)(2008-10#2)(2008-5#3)
oxyhaemoglobin##7##1##(1990-10#1)(1997-6#3)(2006-10#1)(2006-4#1)(2013-7#1)
oxyhalides and##3##2##(2008-10#3)
oxyhalides##4##1##(2008-10#4)
oxyhemoglobin and##4##2##(1990-8#1)(2007-12#1)(2007-9#2)
oxyhemoglobin##24##1##(1990-11#1)(1990-7#1)(1990-8#3)(1991-1#1)(1992-11#1)(1993-1#1)(1994-2#1)(1995-5#1)(1997-2#1)(2007-12#1)(2007-9#9)(2008-11#2)(2008-2#1)
oxylipins##2##1##(2006-12#1)(2012-12#1)
oxymatrine (OMT)##2##2##(2008-10#1)(2010-2#1)
oxymatrine##5##1##(2005-10#1)(2008-10#2)(2010-2#1)(2013-8#1)
oxymetazoline and##3##2##(1995-11#1)(2008-10#2)
oxymetazoline##7##1##(1995-11#5)(2008-10#2)
oxymethylene##2##1##(2009-2#2)
oxymyoglobin oxidation in##2##3##(2010-4#2)
oxymyoglobin oxidation##5##2##(2010-4#5)
oxyntic mucosal histidine decarboxylase activity##2##5##(1995-5#2)
oxyntic mucosal##3##2##(1995-5#3)
oxyntic##5##1##(1995-5#3)(2009-3#2)
oxyphenbutazone and diazepam##2##3##(1990-6#2)
oxyphenbutazone##5##1##(1990-6#2)(1990-9#1)(2007-7#1)(2007-8#1)
oxyphilic##2##1##(1994-12#1)(2009-5#1)
oxypurines##2##1##(1990-4#2)
oxypurinol##5##1##(1996-6#2)(2008-5#3)
oxyradical formation##2##2##(1992-11#2)
oxyradical##3##1##(1992-11#2)(2008-10#1)
oxyradicals##2##1##(1996-9#1)(2008-5#1)
oxysporum Fo 90105##2##3##(2008-10#2)
oxysporum MSA 35##2##3##(2008-4#2)
oxysporum and F##3##3##(2008-10#3)
oxysporum and##9##2##(2008-10#9)
oxysporum based on##2##3##(2008-10#2)
oxysporum complex was##2##3##(2008-10#2)
oxysporum complex##5##2##(2008-10#5)
oxysporum density##2##2##(2013-8#2)
oxysporum expressing##2##2##(2008-10#2)
oxysporum f##203##2##(1996-7#2)(2008-10#199)(2008-4#2)
oxysporum from##5##2##(2008-10#5)
oxysporum in the##2##3##(2008-10#2)
oxysporum in##7##2##(1997-4#1)(2007-7#1)(2008-10#5)
oxysporum isolates from the##2##4##(1996-7#2)
oxysporum isolates from##3##3##(1996-7#2)(2008-10#1)
oxysporum isolates##6##2##(1996-7#2)(2008-10#4)
oxysporum strain##4##2##(2008-10#2)(2008-4#1)(2009-3#1)
oxysporum were##3##2##(2008-10#3)
oxysporum##306##1##(1996-7#5)(1997-4#1)(1997-7#1)(2007-7#3)(2008-10#281)(2008-3#1)(2008-4#8)(2008-5#2)(2009-3#1)(2013-8#3)
oxysterol binding site##3##3##(1990-2#3)
oxysterol binding##5##2##(1990-2#5)
oxysterol##10##1##(1990-2#6)(1991-10#1)(1991-8#2)(1992-1#1)
oxysterols in##3##2##(1990-2#1)(1992-1#1)(1996-5#1)
oxysterols on##2##2##(1991-10#1)(1993-6#1)
oxysterols were##3##2##(1992-1#2)(1996-5#1)
oxysterols##12##1##(1990-2#3)(1991-10#1)(1992-1#3)(1993-6#3)(1996-5#2)
oxytetracycline (OTC)##4##2##(2008-10#4)
oxytetracycline and##6##2##(1996-6#2)(2007-2#1)(2008-10#2)(2013-8#1)
oxytetracycline treatment##2##2##(1996-6#2)
oxytetracycline##21##1##(1991-3#2)(1996-6#5)(1997-8#1)(2007-2#1)(2008-10#10)(2013-8#2)
oxythiamine##2##1##(1990-9#2)
oxytoca##11##1##(1993-9#1)(1995-3#4)(2008-5#1)(2008-8#2)(2010-4#1)(2010-6#2)
oxytocin (OT)##4##2##(1995-10#1)(1996-12#1)(1997-8#1)(2005-7#1)
oxytocin (OXT)##2##2##(1990-9#1)(1993-12#1)
oxytocin and aluminum##2##3##(1994-11#2)
oxytocin and angiotensin##3##3##(1994-3#3)
oxytocin and vasopressin neurons##2##4##(1994-10#1)(1996-9#1)
oxytocin and vasopressin##8##3##(1990-9#1)(1994-10#2)(1995-12#1)(1995-5#2)(1996-9#1)(1997-4#1)
oxytocin and##15##2##(1990-9#1)(1994-10#2)(1994-11#2)(1994-3#3)(1994-9#1)(1995-12#1)(1995-5#2)(1996-9#1)(1997-4#2)
oxytocin cells in the supraoptic##2##5##(1994-10#2)
oxytocin challenge test##2##3##(2011-2#2)
oxytocin during##2##2##(1991-8#1)(2008-6#1)
oxytocin gene expression in##2##4##(1992-11#1)(1995-10#1)
oxytocin gene##7##2##(1991-2#2)(1992-11#4)(1995-10#1)
oxytocin genes##2##2##(1991-2#2)
oxytocin in##2##2##(1994-9#1)(1995-12#1)
oxytocin induced##2##2##(1992-1#1)(1993-4#1)
oxytocin infusion##2##2##(1994-6#1)(2012-2#1)
oxytocin mRNA##2##2##(1995-12#1)(1996-12#1)
oxytocin receptor##3##2##(1994-9#1)(1996-11#2)
oxytocin##78##1##(1990-9#2)(1991-2#4)(1991-8#2)(1992-1#2)(1992-11#4)(1992-9#1)(1993-12#1)(1993-4#3)(1994-10#4)(1994-11#2)(1994-3#3)(1994-6#1)(1994-9#3)(1995-10#2)(1995-12#6)(1995-5#3)(1996-11#3)(1996-12#3)(1996-9#4)(1997-4#7)(1997-7#1)(1997-8#2)(2004-10#1)(2005-7#1)(2007-1#1)(2007-6#1)(2007-8#1)(2008-4#3)(2008-5#1)(2008-6#1)(2009-6#1)(2011-2#2)(2012-2#1)(2013-7#1)
oxytocin-injected##2##1##(1992-1#1)(1997-7#1)
oxytocin-labeled cells##2##2##(1996-9#2)
oyster tissue##4##2##(2008-10#4)
oyster##12##1##(1997-4#4)(2008-10#5)(2008-11#2)(2008-7#1)
oysters from##4##2##(1997-4#1)(2007-5#2)(2008-7#1)
oysters##9##1##(1997-4#1)(2007-5#6)(2008-4#1)(2008-7#1)
ozonated##7##1##(1992-5#3)(2008-10#1)(2010-12#1)(2013-8#2)
ozonation and##2##2##(1992-5#2)
ozonation of##3##2##(1992-5#1)(2005-12#1)(2008-9#1)
ozonation process##2##2##(2008-10#2)
ozonation product 1-hydroxy-1-hydroperoxyheptane##2##3##(1994-8#2)
ozonation products##3##2##(1992-5#2)(1994-8#1)
ozonation treatment##2##2##(2008-10#1)(2010-5#1)
ozonation were##2##2##(1992-5#1)(2008-10#1)
ozonation##28##1##(1992-5#7)(1994-8#3)(2005-12#2)(2008-1#1)(2008-10#8)(2008-9#1)(2010-5#2)(2013-1#4)
ozone (O(3))##3##2##(2008-2#2)(2008-5#1)
ozone -##3##2##(2007-11#2)(2007-8#1)
ozone absorption##2##2##(2008-2#1)(2008-3#1)
ozone abundances##6##2##(2008-2#6)
ozone amounts##2##2##(2008-2#2)
ozone and water vapor##2##4##(2008-3#2)
ozone and##13##2##(1992-3#2)(1995-7#1)(2004-4#1)(2005-10#1)(2007-10#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#3)
ozone as well##2##3##(2008-3#1)(2011-1#1)
ozone as##4##2##(2008-10#2)(2008-3#1)(2011-1#1)
ozone can##2##2##(1992-3#1)(2008-3#1)
ozone concentration profiles by##2##4##(2008-3#2)
ozone concentration profiles##3##3##(2008-3#3)
ozone concentration##7##2##(2006-12#1)(2008-10#2)(2008-3#4)
ozone correction##2##2##(2008-3#2)
ozone depleting##2##2##(1992-3#1)(1996-1#1)
ozone depletion##6##2##(1991-5#1)(1991-6#1)(1992-3#1)(1992-4#1)(1995-4#1)(1996-1#1)
ozone destruction##6##2##(2012-2#6)
ozone differential absorption lidar##2##4##(2008-2#1)(2008-3#1)
ozone exposure##2##2##(1992-3#1)(2008-10#1)
ozone formation in##2##3##(2007-8#2)
ozone formation##4##2##(2007-11#1)(2007-8#3)
ozone has##4##2##(1992-3#1)(2007-11#1)(2008-10#1)(2008-2#1)
ozone hole##4##2##(1991-5#2)(2012-2#2)
ozone in##8##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2011-2#1)
ozone is##5##2##(1992-8#1)(2008-10#3)(2008-2#1)
ozone layer and##2##3##(1991-6#2)
ozone layer depletion##6##3##(2009-4#6)
ozone layer##13##2##(1991-6#3)(1996-1#3)(2009-4#6)(2010-12#1)
ozone levels##2##2##(2008-10#1)(2008-11#1)
ozone lidar##3##2##(2008-3#3)
ozone losses##2##2##(1991-5#2)
ozone measured##2##2##(2008-2#1)(2010-9#1)
ozone measurements and##2##3##(2008-2#1)(2008-3#1)
ozone measurements in clouds##2##4##(2008-3#2)
ozone measurements in the##2##4##(2008-3#2)
ozone measurements in##6##3##(2008-3#6)
ozone measurements##16##2##(2008-2#6)(2008-3#10)
ozone monitoring##7##2##(2008-10#3)(2008-2#3)(2008-3#1)
ozone on##4##2##(1992-3#2)(1997-2#1)(2008-5#1)
ozone profile##6##2##(2008-2#3)(2008-3#3)
ozone profiles##10##2##(2008-2#6)(2008-3#4)
ozone retrieval##5##2##(2008-2#5)
ozone retrievals##3##2##(2008-2#3)
ozone therapy has been##2##4##(2007-11#1)(2012-2#1)
ozone therapy was##3##3##(2007-11#1)(2007-8#1)(2013-8#1)
ozone therapy##11##2##(2007-11#4)(2007-8#1)(2008-7#1)(2012-2#1)(2013-8#4)
ozone to##3##2##(2008-10#1)(2008-3#2)
ozone treatment##3##2##(2005-11#1)(2008-10#1)(2009-3#1)
ozone was##2##2##(2007-11#1)(2008-10#1)
ozone##264##1##(1991-12#1)(1991-5#6)(1991-6#4)(1991-9#3)(1992-3#12)(1992-4#1)(1992-8#3)(1995-3#1)(1995-4#1)(1995-7#1)(1996-1#8)(1996-5#1)(1997-1#2)(1997-2#2)(2004-4#1)(2005-10#2)(2005-11#1)(2006-12#2)(2007-10#1)(2007-11#10)(2007-12#1)(2007-8#15)(2008-1#2)(2008-10#35)(2008-11#8)(2008-2#60)(2008-3#44)(2008-5#2)(2008-7#1)(2009-3#1)(2009-4#6)(2010-12#4)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#10)(2013-1#2)(2013-8#5)
ozone-column density##3##2##(2008-3#3)
ozone-depleting##2##1##(1996-12#1)(1996-5#1)
ozone-treated carbon surfaces##2##3##(2009-3#2)
ozonide##3##1##(1996-5#2)(2009-3#1)
ozonides##8##1##(1996-5#7)(2009-3#1)
ozonization##2##1##(2005-11#2)
ozonized kraft##2##2##(2005-11#2)
ozonized##3##1##(2005-11#3)
ozonolysis of norbornene derivatives##2##4##(1996-5#2)
ozonolysis##5##1##(1992-12#1)(1996-5#2)(2008-10#1)(2009-3#1)
ozonotherapy##4##1##(2007-11#4)
p &gt##9##2##(2007-2#1)(2007-3#1)(2008-4#1)(2008-5#1)(2011-2#4)(2013-8#1)
p &lt##370##2##(1992-10#2)(1992-12#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#6)(1994-12#1)(1994-6#4)(1994-7#2)(1994-8#1)(1995-12#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-9#4)(1996-1#3)(1996-12#8)(1996-2#5)(1996-3#5)(1996-5#3)(1996-7#1)(1997-1#1)(1997-2#5)(1997-3#8)(1997-6#2)(1997-8#7)(2004-3#1)(2005-1#2)(2005-8#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#4)(2006-6#9)(2006-8#3)(2006-9#3)(2007-10#5)(2007-12#5)(2007-2#1)(2007-3#1)(2007-5#6)(2007-6#3)(2007-7#2)(2007-8#1)(2007-9#4)(2008-1#9)(2008-10#6)(2008-11#5)(2008-12#5)(2008-3#40)(2008-4#10)(2008-5#20)(2008-6#1)(2008-7#13)(2008-8#3)(2008-9#8)(2009-11#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-8#6)(2009-9#6)(2010-2#4)(2010-3#4)(2010-4#2)(2010-5#1)(2010-8#10)(2011-1#5)(2011-2#22)(2012-12#4)(2012-2#5)(2012-3#9)(2013-1#15)(2013-7#1)(2013-8#10)
p -/+ 0##2##3##(2008-11#2)
p -nitrophenol##2##2##(2005-4#2)
p 0##4##2##(1995-9#2)(2010-11#1)(2010-7#1)
p 1##7##2##(2010-5#2)(2012-2#5)
p = &lt##3##3##(2008-4#1)(2010-12#2)
p = -0##2##3##(2008-10#1)(2011-2#1)
p = 0##245##3##(1990-12#1)(1990-6#1)(1991-11#1)(1991-3#3)(1991-8#4)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#5)(1992-4#7)(1992-9#1)(1993-2#6)(1994-2#3)(1994-7#1)(1994-9#5)(1995-12#1)(1995-9#5)(1996-1#1)(1996-12#1)(1996-5#1)(1996-9#2)(1997-2#2)(1997-8#3)(2005-1#2)(2006-10#4)(2006-11#2)(2006-12#5)(2006-6#2)(2007-1#2)(2007-11#9)(2007-2#3)(2007-5#1)(2007-7#2)(2008-1#5)(2008-10#1)(2008-11#6)(2008-12#2)(2008-3#22)(2008-4#3)(2008-5#13)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#2)(2009-11#3)(2010-12#3)(2010-2#2)(2010-3#4)(2010-4#2)(2010-6#1)(2010-7#3)(2010-9#3)(2011-1#4)(2011-2#31)(2012-2#6)(2012-3#7)(2013-1#7)(2013-7#4)(2013-8#9)
p =##275##2##(1990-12#1)(1990-6#1)(1991-11#1)(1991-3#3)(1991-5#1)(1991-8#4)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#5)(1992-4#7)(1992-6#1)(1992-9#1)(1993-2#6)(1994-2#3)(1994-7#1)(1994-9#5)(1995-12#1)(1995-9#5)(1996-1#1)(1996-12#1)(1996-5#1)(1996-9#2)(1997-2#2)(1997-8#3)(2005-1#2)(2005-10#5)(2006-10#6)(2006-11#2)(2006-12#5)(2006-2#1)(2006-6#2)(2007-1#2)(2007-11#9)(2007-2#3)(2007-5#1)(2007-7#2)(2008-1#5)(2008-10#2)(2008-11#8)(2008-12#2)(2008-3#24)(2008-4#4)(2008-5#13)(2008-6#1)(2008-7#8)(2008-8#5)(2008-9#2)(2009-11#3)(2009-5#1)(2009-9#2)(2010-12#5)(2010-2#2)(2010-3#8)(2010-4#2)(2010-6#1)(2010-7#3)(2010-9#3)(2011-1#4)(2011-2#32)(2012-12#2)(2012-2#6)(2012-3#7)(2013-1#8)(2013-7#4)(2013-8#9)
p =0##2##2##(1997-2#1)(2008-11#1)
p K (a##4##3##(2008-10#4)
p and the##2##3##(2008-10#1)(2010-8#1)
p and##9##2##(1991-4#1)(1996-12#1)(2006-10#1)(2007-12#1)(2008-10#3)(2010-3#1)(2010-8#1)
p beta 5##3##3##(2006-10#3)
p beta 6##3##3##(2006-10#3)
p beta##6##2##(2006-10#6)
p instruments##3##2##(1997-8#3)
p is##2##2##(2007-12#1)(2008-2#1)
p less than 0##58##4##(1990-12#7)(1990-2#1)(1990-3#3)(1990-4#2)(1990-6#5)(1990-7#1)(1990-9#5)(1991-10#1)(1991-11#3)(1991-3#1)(1991-4#4)(1991-5#1)(1991-6#3)(1991-9#7)(1992-12#3)(1992-2#3)(1992-5#4)(1992-9#3)(2006-9#1)
p less than##64##3##(1990-12#9)(1990-2#3)(1990-3#3)(1990-4#2)(1990-6#6)(1990-7#1)(1990-9#5)(1991-10#1)(1991-11#3)(1991-3#1)(1991-4#4)(1991-5#1)(1991-6#3)(1991-9#8)(1992-12#3)(1992-2#3)(1992-5#4)(1992-9#3)(2006-9#1)
p of##5##2##(1991-4#2)(2008-10#2)(2008-3#1)
p polarization##6##2##(2007-11#2)(2007-12#1)(2008-3#3)
p polarized##2##2##(2007-12#1)(2008-2#1)
p value of 0##3##4##(2006-6#1)(2008-8#2)
p value of##5##3##(1997-2#1)(2006-6#1)(2008-8#2)(2013-8#1)
p value was##2##3##(1990-12#1)(1994-9#1)
p value##10##2##(1990-12#1)(1994-9#1)(1996-12#1)(1996-6#1)(1997-2#1)(2006-6#1)(2008-3#1)(2008-8#2)(2013-8#1)
p values &lt##5##3##(2005-10#1)(2008-3#3)(2011-2#1)
p values##7##2##(1995-1#1)(2005-10#1)(2008-10#1)(2008-3#3)(2011-2#1)
p ≤ 0##3##3##(2013-8#3)
p ≥ 0##2##3##(2013-8#2)
p##1496##1##(1990-10#1)(1990-11#2)(1990-12#11)(1990-2#12)(1990-3#6)(1990-4#4)(1990-5#15)(1990-6#9)(1990-7#1)(1990-8#7)(1990-9#7)(1991-1#2)(1991-10#1)(1991-11#4)(1991-12#2)(1991-2#10)(1991-3#6)(1991-4#10)(1991-5#2)(1991-6#13)(1991-8#8)(1991-9#10)(1992-10#4)(1992-11#1)(1992-12#11)(1992-2#12)(1992-3#8)(1992-4#7)(1992-5#9)(1992-6#1)(1992-7#1)(1992-8#10)(1992-9#11)(1993-1#3)(1993-11#8)(1993-12#2)(1993-2#17)(1993-3#9)(1993-4#4)(1993-5#7)(1993-6#2)(1993-7#7)(1993-8#1)(1993-9#2)(1994-10#2)(1994-11#3)(1994-12#1)(1994-2#9)(1994-3#2)(1994-5#14)(1994-6#6)(1994-7#7)(1994-8#9)(1994-9#9)(1995-1#1)(1995-10#3)(1995-11#5)(1995-12#39)(1995-2#3)(1995-3#5)(1995-5#8)(1995-6#1)(1995-7#1)(1995-9#11)(1996-1#5)(1996-10#14)(1996-11#3)(1996-12#54)(1996-2#22)(1996-3#6)(1996-4#1)(1996-5#4)(1996-6#3)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#17)(1997-3#11)(1997-4#7)(1997-5#2)(1997-6#8)(1997-7#8)(1997-8#20)(2004-3#1)(2004-9#1)(2005-1#4)(2005-10#11)(2005-11#2)(2005-12#3)(2005-4#4)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#22)(2006-11#3)(2006-12#8)(2006-2#3)(2006-3#6)(2006-4#4)(2006-5#8)(2006-6#12)(2006-8#6)(2006-9#4)(2007-1#3)(2007-10#5)(2007-11#19)(2007-12#23)(2007-2#7)(2007-3#4)(2007-4#1)(2007-5#7)(2007-6#5)(2007-7#13)(2007-8#1)(2007-9#4)(2008-1#14)(2008-10#46)(2008-11#27)(2008-12#17)(2008-2#9)(2008-3#90)(2008-4#18)(2008-5#57)(2008-6#4)(2008-7#30)(2008-8#11)(2008-9#11)(2009-10#1)(2009-11#5)(2009-2#1)(2009-3#8)(2009-4#2)(2009-5#5)(2009-6#4)(2009-8#6)(2009-9#9)(2010-1#5)(2010-10#2)(2010-11#2)(2010-12#9)(2010-2#6)(2010-3#13)(2010-4#7)(2010-5#12)(2010-6#2)(2010-7#7)(2010-8#19)(2010-9#3)(2011-1#27)(2011-2#71)(2012-11#2)(2012-12#8)(2012-2#33)(2012-3#18)(2013-1#35)(2013-7#7)(2013-8#26)
p&gt##12##1##(1996-12#1)(1997-7#2)(2007-2#1)(2007-7#1)(2007-9#1)(2008-9#1)(2009-1#1)(2011-1#2)(2012-1#1)(2013-1#1)
p&lt##220##1##(1994-12#1)(1997-8#1)(2006-10#5)(2006-11#5)(2006-12#3)(2006-6#5)(2006-7#2)(2006-8#17)(2006-9#14)(2007-10#1)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#5)(2007-8#6)(2007-9#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#6)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#1)(2009-12#3)(2009-7#2)(2009-8#1)(2009-9#1)(2010-12#3)(2010-2#2)(2010-4#2)(2010-6#13)(2010-8#1)(2010-9#4)(2011-1#15)(2011-11#1)(2011-2#11)(2012-1#7)(2012-12#6)(2012-2#5)(2012-3#11)(2013-1#12)(2013-7#7)(2013-8#10)
p&quot##2##1##(1994-10#1)(2009-3#1)
p'-DBP)##2##1##(2008-10#2)
p'-DDD##5##1##(2007-7#2)(2008-10#3)
p'-DDE##4##1##(2007-7#1)(2008-10#3)
p'-DDT and p##2##3##(2008-10#2)
p'-DDT and##5##2##(2008-10#2)(2008-11#3)
p'-DDT##11##1##(2007-7#2)(2008-10#5)(2008-11#4)
p'-DDT)##2##1##(2008-10#2)
p(low)##5##1##(2008-10#5)
p(m(H)) values##2##2##(2008-10#2)
p(t)##4##1##(2008-10#3)(2008-2#1)
p(tPA/PAZoA)##2##1##(2008-10#2)
p) basis set##2##3##(2013-1#2)
p) in##2##2##(1995-1#1)(2010-12#1)
p)##14##1##(1991-4#1)(1991-6#1)(1995-1#1)(2007-6#1)(2008-10#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-8#1)(2013-1#5)
p- and s-polarized components##2##4##(2008-2#1)(2008-3#1)
p- and s-polarized##3##3##(2008-2#2)(2008-3#1)
p- and##6##2##(1996-6#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-4#1)
p-##9##1##(1991-4#1)(1995-7#2)(1996-6#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-4#1)
p-(dimethylamino)benzaldehyde (DAB) and p-nitrobenzaldehyde (NB)##2##5##(2008-10#2)
p-CMBS##4##1##(1992-6#4)
p-CPA##2##1##(1993-3#2)
p-ERK##2##1##(2008-4#2)
p-HPPH and m-HPPH##2##3##(1990-12#2)
p-HPPH and##3##2##(1990-12#3)
p-IPPA##3##1##(1992-10#3)
p-N##2##1##(2007-12#1)(2008-10#1)
p-NCC6F4C6F4CNSSN*##2##1##(2007-11#2)
p-NF-kBp65 (Ser 536)##4##3##(2010-3#4)
p-NF-kBp65##7##1##(2010-3#7)
p-TCCS##4##1##(2007-9#4)
p-aminoacetophenone##5##1##(2008-10#5)
p-aminobenzenesulfonate)-thiourea##2##1##(2008-10#2)
p-aminobenzoate in##2##2##(2008-10#2)
p-aminobenzoate##4##1##(2008-10#3)(2012-3#1)
p-aminobenzoic acid##4##2##(2008-10#3)(2008-5#1)
p-aminohippurate##2##1##(1994-5#1)(2008-1#1)
p-aminophenol and 5-amino-o-cresol##2##3##(2008-5#2)
p-aminophenol and p-nitrophenol##2##3##(1990-12#2)
p-aminophenol and##4##2##(1990-12#2)(2008-5#2)
p-aminophenol##15##1##(1990-12#4)(1995-11#1)(2008-10#7)(2008-5#2)(2010-4#1)
p-aminophenyl##2##1##(2008-10#1)(2009-12#1)
p-aminophenylalanine6 angiotensin II##4##3##(1990-6#4)
p-benzoquinone (PBQ)##2##2##(2008-10#2)
p-benzoquinone##5##1##(2008-10#5)
p-bromophenacyl bromide##3##2##(1994-3#3)
p-bromophenacyl##4##1##(1994-3#3)(2009-8#1)
p-chloranil##2##1##(2008-10#2)
p-chloromercuriphenylsulfonic acid##3##2##(1992-3#1)(1997-1#2)
p-chloromercurybenzoate##2##1##(2006-10#1)(2010-11#1)
p-chlorophenylalanine##2##1##(1992-11#1)(1993-12#1)
p-chlorotoluene##2##1##(1990-3#1)(1991-8#1)
p-coumaric acid and##3##3##(2006-12#1)(2008-10#2)
p-coumaric acid##12##2##(1994-11#3)(2006-12#1)(2006-8#3)(2008-10#3)(2008-11#1)(2008-6#1)
p-coumaric and##2##2##(2008-10#1)(2008-5#1)
p-coumaric##19##1##(1994-11#3)(2006-12#1)(2006-8#3)(2007-11#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-5#2)(2008-6#2)
p-cresol and##2##2##(1996-5#1)(2011-1#1)
p-cresol##14##1##(1990-12#1)(1990-8#1)(1991-5#3)(1996-5#1)(2008-10#3)(2011-1#2)(2011-2#3)
p-cyclophane as##2##2##(2008-10#2)
p-cymene##2##1##(2008-11#1)(2012-2#1)
p-dichlorobenzene##2##1##(2008-10#2)
p-dimensional##2##1##(2012-1#2)
p-dimethylaminobenzalhyde##2##1##(2008-10#2)
p-halogenophenyl)- and 3-(4-m-chlorophenyl)-1-piperazinyl]propyl derivatives of amides of 7-methyl-3-phenyl-2##2##8##(2008-6#2)
p-hydroxy-m-methoxyscopolamine##2##1##(2008-10#2)
p-hydroxybenzaldehyde##6##1##(1992-5#2)(2008-10#1)(2008-5#3)
p-hydroxybenzoate)##2##1##(1995-11#1)(2008-10#1)
p-hydroxybenzoic acid##3##2##(2007-8#1)(2008-10#1)(2008-5#1)
p-hydroxybenzoic##4##1##(2007-8#1)(2008-10#2)(2008-5#1)
p-hydroxyphenobarbital##2##1##(1997-3#2)
p-hydroxyphenyl##2##1##(2006-12#1)(2007-11#1)
p-i-n##2##1##(2008-2#2)
p-iodophenol##4##1##(1991-5#1)(2008-10#3)
p-methoxyanilino-(1##2##1##(2008-10#2)
p-methoxybenzyl##3##1##(1997-4#1)(2005-12#1)(2008-11#1)
p-nitroanilide##3##1##(1990-7#2)(1995-5#1)
p-nitroaniline##7##1##(2008-10#3)(2010-7#3)(2012-12#1)
p-nitrobenzoxosulfamate##2##1##(2008-10#2)
p-nitrobenzoyl group##2##2##(1991-12#2)
p-nitrobenzoyl##3##1##(1991-12#2)(1991-8#1)
p-nitrobenzyl##3##1##(1994-12#1)(1997-5#2)
p-nitrophenol and##2##2##(1990-12#1)(1997-1#1)
p-nitrophenol glucuronidation##2##2##(1994-3#2)
p-nitrophenol hydroxylase activity##2##3##(1994-8#1)(1997-3#1)
p-nitrophenol hydroxylase##3##2##(1994-8#1)(1997-3#2)
p-nitrophenol hydroxylation##3##2##(1994-8#2)(1995-3#1)
p-nitrophenol in##2##2##(1990-12#1)(2005-11#1)
p-nitrophenol##25##1##(1990-12#4)(1990-6#1)(1991-5#2)(1994-3#3)(1994-8#4)(1995-3#1)(1997-1#1)(1997-3#2)(2005-11#1)(2008-10#1)(2008-8#2)(2009-8#2)(2010-4#1)
p-nitrophenyl beta-D-cellobioside##2##2##(1992-3#2)
p-nitrophenyl phosphate (NpP)##2##3##(1991-2#2)
p-nitrophenyl phosphate and##2##3##(1991-7#1)(1997-2#1)
p-nitrophenyl phosphate##6##2##(1991-2#2)(1991-7#2)(1995-10#1)(1997-2#1)
p-nitrophenyl##29##1##(1990-10#1)(1990-7#1)(1991-2#2)(1991-4#1)(1991-7#2)(1991-8#1)(1992-3#4)(1992-9#1)(1995-10#1)(1995-2#1)(1996-6#2)(1997-2#1)(1997-4#4)(2005-11#3)(2008-10#2)(2008-4#1)(2011-1#1)
p-nitrophenylphosphatase activity##3##2##(1990-3#1)(1990-5#1)(1990-7#1)
p-nitrophenylphosphate as##2##2##(1991-5#1)(2008-10#1)
p-nitrophenylphosphate##6##1##(1991-5#1)(1994-11#1)(1994-6#1)(1997-1#1)(2008-10#2)
p-order##2##1##(2008-3#2)
p-polarized light##5##2##(2008-2#1)(2008-3#4)
p-polarized##20##1##(1993-5#1)(2007-11#2)(2007-12#2)(2007-8#2)(2008-2#6)(2008-3#6)(2009-11#1)
p-quinone##2##1##(2008-10#2)
p-substituted N-phenylsulfonylbenzamides##3##2##(2007-11#3)
p-t-butyl calix[4]arene and ethyl bromoacetate##2##5##(2008-10#2)
p-terphenyl##4##1##(2006-12#2)(2007-12#1)(2008-11#1)
p-tert-butyl-calix[6]arene-bonded silica gel stationary phase##2##5##(2008-10#2)
p-tert-butyl-calix[8]arene##2##1##(2008-10#2)
p-tert-butyl-calix[8]arene-bonded silica gel stationary phase##6##5##(2008-10#6)
p-tert-butylcalix[4]arene-oxacrown-4##3##1##(2008-10#3)
p-toluenesulfonic acid##5##2##(1996-5#1)(2008-10#2)(2008-5#1)(2009-9#1)
p-toluenesulfonic##6##1##(1996-5#1)(2008-10#3)(2008-5#1)(2009-9#1)
p-tolyl resonances##2##2##(1996-2#2)
p-tolyl##3##1##(1996-2#3)
p-type##11##1##(1992-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2009-11#1)(2009-2#2)(2010-9#1)(2012-2#1)(2013-8#2)
p-value &lt##7##2##(2011-1#6)(2013-1#1)
p-value of 0##3##3##(2008-8#1)(2012-2#1)(2012-3#1)
p-value of##4##2##(1997-6#1)(2008-8#1)(2012-2#1)(2012-3#1)
p-value##22##1##(1997-6#1)(2008-8#1)(2011-1#8)(2011-2#1)(2012-2#1)(2012-3#6)(2013-1#3)(2013-7#1)
p-values of##3##2##(1994-2#1)(2012-2#1)(2012-3#1)
p-values##14##1##(1993-9#1)(1994-11#1)(1994-2#1)(1996-6#1)(2009-11#1)(2011-2#1)(2012-2#1)(2012-3#5)(2013-8#2)
p-xylene##7##1##(2007-11#2)(2008-10#5)
p1 and free TP##3##4##(1997-5#3)
p1##8##1##(1997-5#6)(2008-9#2)
p10 promoters##2##2##(1997-4#2)
p10##8##1##(1993-8#1)(1995-12#1)(1996-5#1)(1997-4#5)
p100##3##1##(1994-12#1)(1994-6#2)
p101 and##2##2##(1996-2#2)
p101##4##1##(1996-2#4)
p107wee1##4##1##(1991-2#4)
p11##9##1##(1991-6#6)(1996-3#1)(1996-6#2)
p110 catalytic##2##2##(1993-6#2)
p110 subunit##2##2##(1994-3#1)(1996-2#1)
p110##8##1##(1991-9#2)(1993-6#3)(1994-12#1)(1994-3#1)(1996-2#1)
p110-negative lesions##2##2##(1991-9#2)
p110alpha and##3##2##(1997-4#3)
p110alpha##9##1##(1996-8#5)(1997-4#4)
p110delta##7##1##(1997-4#7)
p115-RhoGEF##2##1##(2008-6#2)
p116(Rip)##4##1##(1997-6#4)
p117 and##2##2##(1996-2#2)
p120 protein##2##2##(1990-11#2)
p120##12##1##(1990-11#6)(1992-9#1)(1993-8#1)(1996-2#4)
p120-GAP##2##1##(1995-11#2)
p123##2##1##(1997-6#2)
p125##3##1##(1994-9#3)
p125FAK and paxillin##3##3##(1994-9#3)
p125FAK##7##1##(1994-9#7)
p13 of##2##2##(1990-6#1)(2011-1#1)
p13##3##1##(1990-6#1)(2011-1#1)(2012-12#1)
p130 was##2##2##(1994-12#1)(1994-9#1)
p130##12##1##(1994-12#8)(1994-9#3)(1997-6#1)
p130(Cas)##2##1##(2012-12#2)
p130Cas SD tyrosine phosphorylation##2##4##(2011-1#2)
p130Cas##12##1##(2011-1#9)(2012-12#3)
p13suc1##2##1##(1997-6#2)
p140##2##1##(1990-7#2)
p15##5##1##(1997-1#3)(1997-2#1)(1997-6#1)
p150 and p60##3##3##(1995-6#3)
p150##6##1##(1994-6#1)(1995-6#5)
p150Glued##12##1##(1995-2#9)(2012-2#3)
p16 and##5##2##(1997-2#1)(2006-10#1)(2008-4#1)(2009-1#1)(2012-2#1)
p16 expression##3##2##(1997-7#1)(2013-1#2)
p16##34##1##(1991-3#1)(1997-2#1)(1997-7#3)(2006-10#5)(2007-6#1)(2007-8#1)(2008-4#2)(2008-6#1)(2008-9#8)(2009-1#1)(2010-7#3)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
p16(INK4A)##7##1##(2013-1#7)
p16INK4A##7##1##(1997-7#7)
p16INK4a and p16beta transcripts in B-lymphoblastoid cells from##2##8##(1997-7#2)
p16INK4a and p16beta transcripts##3##4##(1997-7#3)
p16INK4a and##4##2##(1997-7#3)(2011-1#1)
p16INK4a##13##1##(1996-4#5)(1997-7#7)(2011-1#1)
p16beta##4##1##(1997-7#4)
p16ink4a##2##1##(2013-8#2)
p17##4##1##(1990-2#2)(1990-8#1)(1992-7#1)
p18##3##1##(1996-5#3)
p180##2##1##(1990-7#1)(1994-8#1)
p180erbB3##2##1##(1995-3#2)
p180erbB4##2##1##(1995-3#2)
p185##4##1##(1994-6#4)
p185HER2 overexpression##2##2##(1993-1#2)
p185HER2##5##1##(1993-1#4)(1995-2#1)
p185HER2-overexpressing breast cancer cells##2##4##(1995-2#2)
p185HER2-overexpressing##4##1##(1995-2#4)
p185erbB2 was##2##2##(1990-9#2)
p185erbB2##11##1##(1990-9#8)(1995-2#3)
p185erbB2/neu##3##1##(1995-3#3)
p185neu##6##1##(1994-9#5)(1995-3#1)
p190 GAP##4##2##(1996-2#4)
p190 RhoGAP##3##2##(2006-10#3)
p190##7##1##(1996-2#4)(2006-10#3)
p195-212 and p259-271##2##3##(1996-4#2)
p195-212##3##1##(1996-4#3)
p2 and p3##2##3##(1995-2#2)
p2##3##1##(1995-2#3)
p20 and##2##2##(1990-5#1)(1996-5#1)
p20 or##2##2##(1996-5#1)(2008-10#1)
p20##13##1##(1990-5#1)(1996-10#3)(1996-5#4)(2008-10#2)(2008-9#3)
p20/p10##3##1##(1996-5#3)
p21 and Gadd45##2##3##(2008-9#2)
p21 and##8##2##(1990-8#1)(1990-9#1)(1996-5#1)(2008-11#1)(2008-9#2)(2010-12#1)(2010-6#1)
p21 expression##3##2##(1995-6#1)(1995-8#1)(2011-2#1)
p21 in the##2##3##(1994-12#1)(1997-7#1)
p21 in##4##2##(1994-12#1)(1996-5#1)(1997-7#1)(2012-12#1)
p21 is##3##2##(1992-5#1)(1996-5#1)(1996-6#1)
p21 or##2##2##(1992-1#1)(1996-5#1)
p21 protein is known to##2##5##(1991-12#2)
p21 protein is##3##3##(1991-12#2)(1997-7#1)
p21 protein##8##2##(1990-7#1)(1991-12#5)(1997-7#1)(2003-11#1)
p21 repression##2##2##(1995-6#2)
p21 was##4##2##(1992-11#1)(1992-5#2)(1997-7#1)
p21 with##2##2##(1991-5#1)(1996-5#1)
p21##89##1##(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#7)(1991-5#2)(1992-1#10)(1992-11#2)(1992-5#8)(1994-12#1)(1994-9#1)(1995-6#7)(1995-8#1)(1996-5#12)(1996-6#3)(1997-2#1)(1997-7#3)(2003-11#3)(2005-10#1)(2006-10#1)(2008-11#1)(2008-7#3)(2008-9#4)(2009-4#2)(2010-12#1)(2010-2#1)(2010-6#1)(2011-2#5)(2012-12#2)(2012-3#1)(2013-1#1)
p21(Sdi1/CIP1/WAF1)##2##1##(2008-11#2)
p21(as)/MCF-7##2##1##(2008-9#2)
p21-activated kinase 1##2##3##(2008-7#2)
p21-activated kinase##3##2##(2008-7#2)(2010-5#1)
p21-activated##4##1##(2008-7#2)(2009-3#1)(2010-5#1)
p21-related##2##1##(1991-12#1)(1992-5#1)
p21/WAF1##3##1##(1995-8#3)
p21Ras##2##1##(1994-3#1)(1994-8#1)
p21cip1##3##1##(1994-8#1)(2013-1#2)
p21rac##2##1##(1991-5#2)
p21ras GTPase-activating protein##2##3##(1992-12#2)
p21ras by##2##2##(1994-12#1)(1995-3#1)
p21ras in##4##2##(1994-12#1)(1995-3#3)
p21ras is##4##2##(1993-8#1)(1994-12#1)(1995-11#1)(1995-3#1)
p21ras##31##1##(1991-5#3)(1992-12#7)(1993-11#1)(1993-4#1)(1993-8#2)(1994-12#3)(1995-11#3)(1995-3#11)
p21ras-GTP formation##4##2##(1994-12#4)
p21ras-GTP##9##1##(1993-4#1)(1994-12#8)
p22##3##1##(1996-5#3)
p22phox##3##1##(2013-8#3)
p23 and p7##7##3##(1992-6#7)
p23 and##8##2##(1992-6#7)(1996-5#1)
p23##15##1##(1992-6#8)(1996-5#3)(2008-10#3)(2008-4#1)
p24 antigen in##2##3##(1994-5#1)(2011-3#1)
p24 antigen production##2##3##(1991-4#1)(1994-5#1)
p24 antigen##8##2##(1991-12#1)(1991-4#1)(1992-7#1)(1994-3#1)(1994-5#2)(1997-4#1)(2011-3#1)
p24##26##1##(1990-8#1)(1991-10#3)(1991-12#1)(1991-4#1)(1992-11#1)(1992-7#2)(1993-8#1)(1994-3#1)(1994-5#2)(1995-5#1)(1997-3#1)(1997-4#4)(2006-11#1)(2007-3#1)(2008-4#1)(2011-1#3)(2011-3#1)
p25##10##1##(1990-2#1)(1992-11#7)(1996-5#1)(2008-10#1)
p27 as##2##2##(2007-12#1)(2008-7#1)
p27 expression in##3##3##(2007-12#1)(2007-8#2)
p27 expression##8##2##(2007-12#5)(2007-8#3)
p27 in thymic epithelial tumors##2##5##(2007-8#2)
p27 protein##3##2##(2007-6#3)
p27 was##2##2##(1996-5#1)(2007-8#1)
p27##35##1##(1993-9#1)(1996-5#2)(2006-10#1)(2007-12#7)(2007-6#5)(2007-8#8)(2008-11#1)(2008-6#1)(2008-7#3)(2009-3#1)(2010-12#1)(2011-2#3)(2012-12#1)
p27(Kip1)##3##1##(2007-6#2)(2010-2#1)
p27kip1##4##1##(2010-4#4)
p27rex##3##1##(1991-2#3)
p28 light chain##2##3##(1996-5#2)
p28##5##1##(1992-9#1)(1996-5#2)(1997-4#2)
p29##4##1##(1990-11#4)
p3##11##1##(1990-3#4)(1994-9#1)(1995-2#4)(1996-5#2)
p30##3##1##(1992-9#2)(2012-3#1)
p300##4##1##(1996-11#1)(2011-2#3)
p300/CBP acetylates##2##2##(1996-11#2)
p300/CBP is##2##2##(1996-11#2)
p300/CBP##7##1##(1996-11#7)
p31 was##2##2##(1997-6#2)
p31##10##1##(1997-6#10)
p33 binds##2##2##(1996-5#2)
p33##11##1##(1996-5#11)
p34##8##1##(1994-8#8)
p34cdc2 and CDK2##2##3##(1993-11#2)
p34cdc2 kinase in##3##3##(1994-9#3)
p34cdc2 kinase##9##2##(1994-9#9)
p34cdc2 or##2##2##(1993-11#1)(1997-6#1)
p34cdc2 protein kinase##6##3##(1991-6#2)(1993-9#2)(1994-11#1)(1994-3#1)
p34cdc2 proteins##2##2##(1993-5#2)
p34cdc2 was##2##2##(1997-6#2)
p34cdc2##47##1##(1990-11#5)(1991-1#3)(1991-6#2)(1993-11#9)(1993-5#4)(1993-9#4)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#12)(1997-6#5)
p35##17##1##(1991-11#1)(1995-5#1)(1995-6#2)(1996-10#3)(1997-3#4)(1997-7#1)(2008-8#5)
p37##5##1##(1995-6#2)(1997-6#3)
p38 MAP kinase##6##3##(1995-3#1)(1996-5#1)(2008-3#2)(2008-7#1)(2010-12#1)
p38 MAP##8##2##(1995-3#1)(1996-5#2)(2008-3#2)(2008-4#1)(2008-7#1)(2010-12#1)
p38 MAPK##6##2##(2008-11#1)(2008-4#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-2#1)
p38 activation##2##2##(1995-3#1)(1995-6#1)
p38 and JNK##3##3##(2008-9#1)(2009-6#1)(2012-2#1)
p38 and JNK-1 mitogen-activated##2##4##(1996-5#2)
p38 and##7##2##(1996-3#1)(1996-5#2)(2007-11#1)(2008-9#1)(2009-6#1)(2012-2#1)
p38 is##2##2##(1995-3#1)(2011-2#1)
p38 kinase##2##2##(2011-2#2)
p38 mitogen-activated protein kinase (MAPK)##4##5##(2009-9#1)(2011-2#1)(2012-3#1)(2013-7#1)
p38 mitogen-activated protein kinase##9##4##(1995-3#1)(1996-5#1)(2008-7#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
p38##58##1##(1995-3#5)(1995-6#1)(1996-3#3)(1996-5#6)(2007-11#2)(2008-11#1)(2008-3#4)(2008-4#2)(2008-7#3)(2008-9#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#3)(2010-8#1)(2011-2#10)(2012-2#4)(2012-3#2)(2013-7#3)(2013-8#1)
p38) and##2##2##(1996-2#1)(2012-2#1)
p38)##3##1##(1996-2#1)(2009-6#1)(2012-2#1)
p38-##2##1##(2009-9#1)(2012-3#1)
p38MAPK##2##1##(2005-9#1)(2013-8#1)
p38α in##2##2##(2012-3#2)
p38α##8##1##(2012-12#2)(2012-3#6)
p4##5##1##(1990-11#3)(2008-10#1)(2013-8#1)
p40 and p35 mRNA##5##4##(2008-8#5)
p40 and p35##6##3##(1997-7#1)(2008-8#5)
p40 gene##2##2##(1996-10#1)(2008-9#1)
p40 of BALB/MK-2 cells was##2##5##(1990-11#2)
p40 of BALB/MK-2 cells##3##4##(1990-11#3)
p40 subunit##2##2##(1996-10#1)(2007-2#1)
p40 was##2##2##(1990-11#2)
p40##29##1##(1990-11#7)(1994-8#2)(1996-10#10)(1997-7#1)(2005-11#1)(2007-2#1)(2008-8#6)(2008-9#1)
p40phox in the##2##3##(1994-3#2)
p40phox##7##1##(1994-3#7)
p42 and p44##3##3##(1994-12#2)(1995-3#1)
p42##5##1##(1994-12#2)(1995-3#1)(1996-8#1)(2008-8#1)
p42-MAPK##2##1##(1994-12#2)
p42/p44##2##1##(1996-2#2)
p42mapk/erk2##2##1##(1995-2#2)
p43##3##1##(1990-5#2)(1993-8#1)
p44 and##3##2##(1995-6#1)(1997-7#2)
p44##16##1##(1994-12#2)(1995-3#1)(1995-6#2)(1997-7#10)(2008-8#1)
p44/42##2##1##(2008-4#1)(2009-4#1)
p44mapk activity##2##2##(1995-3#2)
p44mapk##9##1##(1995-3#9)
p45 in##4##2##(1994-8#1)(1995-3#2)(1996-5#1)
p45 is##6##2##(1994-8#1)(1996-2#1)(1996-4#1)(1996-5#3)
p45 mRNA is transcribed only from aNF-E2 promoter##2##8##(1996-2#2)
p45 mRNA is transcribed##3##4##(1996-2#3)
p45 mRNA is##5##3##(1996-2#5)
p45 mRNA##6##2##(1996-2#6)
p45##36##1##(1994-8#4)(1995-3#5)(1996-2#10)(1996-4#3)(1996-5#13)(2008-5#1)
p450##4##1##(2010-12#1)(2013-1#2)(2013-8#1)
p46-61##6##1##(1995-2#6)
p47 is##2##2##(1992-7#2)
p47##7##1##(1991-5#1)(1992-7#5)(1996-2#1)
p47-p67##2##1##(1993-12#2)
p47-phox and p67-phox precipitated##2##4##(1990-11#2)
p47-phox and p67-phox##4##3##(1990-11#3)(1993-8#1)
p47-phox##10##1##(1990-11#4)(1993-8#2)(1994-3#4)
p48(Cre/+)-LSL-Kras(G12D/+) mice##3##2##(2013-1#3)
p48(Cre/+)-LSL-Kras(G12D/+)##4##1##(2013-1#4)
p50 and p65##2##3##(1994-8#1)(1995-1#1)
p50 and##3##2##(1994-8#2)(1995-1#1)
p50##11##1##(1991-7#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-3#2)(1995-8#1)(1997-3#2)
p53 Abs were##3##3##(2011-2#3)
p53 Abs##6##2##(2011-2#6)
p53 HAPLOINSUFFICIENT MICE##5##3##(2008-8#1)(2008-9#4)
p53 accumulation##3##2##(2006-6#2)(2011-2#1)
p53 activation##4##2##(1996-10#1)(2007-11#1)(2007-8#1)(2009-2#1)
p53 activity##3##2##(1995-8#1)(1997-7#1)(2009-5#1)
p53 allele##3##2##(1993-11#1)(2009-2#2)
p53 and NF-B##4##3##(2010-10#4)
p53 and T antigen##2##4##(1993-8#2)
p53 and bcl-2##2##3##(2006-6#1)(2008-10#1)
p53 and c-erbB-2##3##3##(1994-7#3)
p53 and its 14 kDa C-terminal domain##2##7##(1995-6#2)
p53 and nuclear factor-B systems##2##5##(2010-10#2)
p53 and nuclear##3##3##(2010-10#3)
p53 and p21 proteins##2##4##(2003-11#2)
p53 and p21##4##3##(1996-5#1)(2003-11#2)(2011-2#1)
p53 and the##2##3##(1990-8#1)(1994-12#1)
p53 and##49##2##(1990-8#1)(1991-2#1)(1991-8#1)(1992-9#1)(1993-8#3)(1993-9#1)(1994-12#1)(1994-3#1)(1994-7#3)(1995-10#1)(1995-2#1)(1995-6#2)(1996-5#2)(2003-11#2)(2006-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-2#1)(2010-10#7)(2010-2#1)(2011-2#6)(2012-12#1)(2012-2#3)(2013-1#3)
p53 are##3##2##(2006-10#1)(2007-11#1)(2008-10#1)
p53 binding site##2##3##(2010-12#2)
p53 binding##3##2##(2010-12#3)
p53 by##3##2##(1995-2#1)(1995-9#1)(2009-10#1)
p53 cDNA##3##2##(1993-9#3)
p53 can##5##2##(1990-8#1)(1991-5#1)(1995-8#1)(1997-4#1)(2010-12#1)
p53 cancer rescue##2##3##(2009-9#2)
p53 cancer##3##2##(2009-9#3)
p53 cells##7##2##(2007-11#2)(2007-9#5)
p53 codon##2##2##(2010-12#1)(2012-2#1)
p53 during##2##2##(1993-12#1)(1995-8#1)
p53 expression and c-erbB-2 expression##3##5##(1994-7#3)
p53 expression and##5##3##(1994-7#3)(2008-7#1)(2009-10#1)
p53 expression in##7##3##(2004-2#1)(2008-7#2)(2008-8#1)(2009-10#1)(2012-1#1)(2012-12#1)
p53 expression##20##2##(1994-7#4)(1995-8#1)(1996-4#1)(1997-2#1)(2003-11#1)(2004-2#3)(2008-7#4)(2008-8#1)(2009-10#2)(2012-1#1)(2012-12#1)
p53 function in##2##3##(1994-3#1)(2007-9#1)
p53 function##6##2##(1994-12#2)(1994-3#2)(1994-5#1)(2007-9#1)
p53 gene in##3##3##(1990-8#1)(1993-11#2)
p53 gene is##3##3##(1990-8#1)(1993-4#1)(1996-4#1)
p53 gene were##2##3##(2008-10#1)(2012-3#1)
p53 gene##32##2##(1990-8#2)(1991-10#4)(1991-11#3)(1992-3#1)(1993-10#1)(1993-11#2)(1993-3#1)(1993-4#1)(1994-2#1)(1996-4#1)(2005-12#3)(2007-11#2)(2007-5#1)(2007-9#1)(2008-10#3)(2008-6#2)(2008-7#1)(2012-3#2)
p53 haploinsufficient mice administered##3##4##(2008-9#3)
p53 haploinsufficient mice exposed to##5##5##(2008-8#1)(2008-9#4)
p53 haploinsufficient mice were administered##4##5##(2008-9#4)
p53 haploinsufficient mice were exposed to##8##6##(2008-9#8)
p53 haploinsufficient mice were exposed##9##5##(2008-9#9)
p53 haploinsufficient mice were##16##4##(2008-8#1)(2008-9#15)
p53 haploinsufficient mice##31##3##(2008-8#4)(2008-9#27)
p53 haploinsufficient##35##2##(2008-8#7)(2008-9#28)
p53 has##4##2##(1993-8#1)(2008-10#1)(2008-9#1)(2011-2#1)
p53 have been##2##3##(1990-8#1)(2009-4#1)
p53 immunoexpression##2##2##(2013-8#2)
p53 in a##2##3##(1993-12#1)(1996-4#1)
p53 in cells##2##3##(1993-12#1)(2012-12#1)
p53 in human##2##3##(1993-9#1)(2009-4#1)
p53 in response to DNA##2##5##(1995-8#1)(2012-3#1)
p53 in the##7##3##(1991-2#2)(1992-12#1)(2007-4#1)(2008-9#1)(2009-10#1)(2012-1#1)
p53 in##32##2##(1991-2#2)(1992-12#2)(1993-12#2)(1993-9#1)(1994-3#1)(1995-8#4)(1996-4#1)(1997-4#1)(1997-7#1)(2007-4#1)(2008-6#1)(2008-9#3)(2009-10#1)(2009-4#1)(2009-9#1)(2010-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
p53 is a##4##3##(1996-1#1)(1996-4#1)(2010-2#1)(2012-3#1)
p53 is required for##2##4##(1997-4#1)(2008-5#1)
p53 is##16##2##(1990-8#2)(1993-3#1)(1994-2#1)(1995-8#1)(1996-1#1)(1996-4#1)(1997-4#1)(2005-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-2#1)(2011-2#1)(2012-3#1)
p53 itself and##2##3##(2008-9#1)(2012-3#1)
p53 level##3##2##(1995-8#1)(1997-7#2)
p53 levels##3##2##(1995-8#1)(2007-8#1)(2012-12#1)
p53 locus##3##2##(1995-9#1)(1997-7#1)(2008-4#1)
p53 mRNA was##2##3##(1993-4#2)
p53 mRNA##5##2##(1990-9#1)(1993-4#3)(1995-8#1)
p53 may also##2##3##(1994-12#1)(1996-10#1)
p53 may##7##2##(1994-12#1)(1995-6#1)(1996-10#1)(2006-10#1)(2007-9#1)(2009-5#1)(2011-2#1)
p53 mice##2##2##(2007-8#1)(2008-9#1)
p53 mutant##4##2##(1990-8#1)(2006-10#1)(2008-7#1)(2012-2#1)
p53 mutants##3##2##(2009-9#2)(2012-12#1)
p53 mutation##3##2##(1991-11#1)(2006-12#1)(2012-12#1)
p53 mutations in##3##3##(1990-12#1)(1995-5#1)(1997-8#1)
p53 mutations may##3##3##(1992-3#1)(2009-10#1)(2011-2#1)
p53 mutations##19##2##(1990-12#3)(1991-10#1)(1992-3#2)(1993-11#1)(1993-8#1)(1994-12#1)(1995-5#1)(1997-8#1)(2007-5#1)(2008-6#1)(2009-10#1)(2009-9#1)(2011-2#2)(2012-12#2)
p53 on##3##2##(1991-5#1)(1993-9#1)(2012-1#1)
p53 or##5##2##(1993-8#1)(1994-12#1)(2004-1#1)(2010-10#1)(2012-12#1)
p53 overexpression##2##2##(2008-10#1)(2009-10#1)
p53 protein and##4##3##(1994-3#1)(1995-10#1)(2003-11#1)(2005-12#1)
p53 protein expression##3##3##(1994-2#1)(2006-12#1)(2008-7#1)
p53 protein is increased##2##4##(1996-1#1)(2005-12#1)
p53 protein is##4##3##(1991-2#2)(1996-1#1)(2005-12#1)
p53 protein##46##2##(1990-12#2)(1990-8#3)(1991-2#4)(1991-5#1)(1992-3#3)(1993-3#2)(1993-8#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-10#2)(1995-2#1)(1996-1#3)(1996-11#1)(1996-4#1)(2003-11#1)(2005-12#6)(2005-5#1)(2006-12#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-8#1)(2010-2#1)(2013-7#1)
p53 proteins##3##2##(1991-5#1)(1995-6#1)(2011-2#1)
p53 sequence-specific DNA binding##2##4##(1995-6#2)
p53 that##4##2##(1990-9#1)(1995-6#2)(2009-9#1)
p53 to##5##2##(1990-8#1)(1993-12#1)(1994-8#2)(1996-10#1)
p53 tumor suppressor gene in##3##5##(1993-9#2)(2007-5#1)
p53 tumor suppressor gene##7##4##(1993-9#2)(1994-8#1)(1996-1#1)(1996-6#1)(2007-5#1)(2009-5#1)
p53 tumor suppressor protein##2##4##(1994-12#1)(1995-6#1)
p53 tumor suppressor##13##3##(1993-9#2)(1994-12#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-1#1)(1996-6#1)(1997-7#1)(2007-5#1)(2008-1#1)(2009-5#1)(2011-2#1)
p53 tumor-suppressor##2##2##(1995-5#1)(1995-8#1)
p53 tumour suppressor gene##5##4##(1994-2#2)(1996-10#1)(2008-6#1)(2008-7#1)
p53 tumour suppressor##6##3##(1994-2#2)(1996-10#1)(2003-11#1)(2008-6#1)(2008-7#1)
p53 was not##2##3##(2004-2#1)(2012-12#1)
p53 was##5##2##(1993-9#1)(2004-2#1)(2007-5#1)(2008-10#1)(2012-12#1)
p53 were##4##2##(1990-8#1)(1993-9#1)(2008-10#1)(2011-2#1)
p53 with##2##2##(1991-5#1)(1993-9#1)
p53 without##2##2##(1995-8#1)(2008-7#1)
p53##638##1##(1990-12#6)(1990-8#18)(1990-9#3)(1991-10#5)(1991-11#4)(1991-2#8)(1991-5#9)(1991-8#1)(1992-12#6)(1992-3#7)(1992-5#3)(1992-8#1)(1992-9#3)(1993-10#1)(1993-11#5)(1993-12#7)(1993-3#5)(1993-4#5)(1993-8#9)(1993-9#20)(1994-12#14)(1994-2#8)(1994-3#8)(1994-5#4)(1994-7#7)(1994-8#5)(1994-9#5)(1995-10#3)(1995-11#1)(1995-2#4)(1995-5#2)(1995-6#19)(1995-8#19)(1995-9#3)(1996-1#6)(1996-10#6)(1996-11#1)(1996-4#11)(1996-5#2)(1996-6#1)(1997-2#4)(1997-4#8)(1997-7#9)(1997-8#2)(2003-11#10)(2004-1#3)(2004-2#5)(2005-12#17)(2005-5#1)(2006-10#6)(2006-12#2)(2006-6#3)(2007-11#14)(2007-4#3)(2007-5#4)(2007-8#7)(2007-9#10)(2008-1#2)(2008-10#16)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#13)(2008-6#6)(2008-7#15)(2008-8#13)(2008-9#47)(2009-10#8)(2009-2#6)(2009-4#7)(2009-5#5)(2009-7#1)(2009-8#1)(2009-9#12)(2010-10#13)(2010-12#10)(2010-2#5)(2010-3#4)(2010-8#2)(2011-2#37)(2012-1#3)(2012-12#19)(2012-2#11)(2012-3#7)(2013-1#4)(2013-7#1)(2013-8#3)
p53'##2##1##(2007-8#2)
p53's##2##1##(2007-8#1)(2012-12#1)
p53(-/-)##4##1##(2008-11#1)(2012-2#3)
p53)##2##1##(2007-6#1)(2008-6#1)
p53-carrying##2##1##(2009-4#2)
p53-deficient cells##3##2##(1995-8#2)(2009-4#1)
p53-deficient##5##1##(1995-8#4)(2009-4#1)
p53-dependent##13##1##(1994-3#1)(1995-8#3)(1997-4#1)(1997-7#2)(2008-11#1)(2008-7#2)(2008-9#1)(2011-2#1)(2013-1#1)
p53-independent apoptotic mechanism that operates in a committed##2##8##(1995-6#2)
p53-independent##11##1##(1993-9#1)(1995-6#3)(1997-4#1)(2003-11#1)(2008-7#2)(2009-9#1)(2013-1#2)
p53-induced##2##1##(1995-8#1)(2010-3#1)
p53-mediated cellular response to DNA damage in##2##7##(1995-2#2)
p53-mediated transactivation##6##2##(1993-8#3)(1994-12#1)(1994-3#1)(2012-12#1)
p53-mediated##12##1##(1993-8#3)(1994-12#1)(1994-3#2)(1995-2#2)(1996-10#1)(1997-7#1)(2010-2#1)(2012-12#1)
p53-null##2##1##(1994-9#1)(1997-2#1)
p53-regulated##3##1##(1994-8#1)(1997-2#2)
p53/CD95##2##1##(2012-1#2)
p53/CD95L##4##1##(2012-1#4)
p53175P##3##1##(2008-7#3)
p54 subunit##3##2##(1997-7#3)
p54##4##1##(1997-7#4)
p55 TNF receptor##2##3##(1996-5#2)
p55 TNFR and##2##3##(1996-5#2)
p55 TNFR##5##2##(1996-5#5)
p55##18##1##(1991-1#3)(1994-8#2)(1996-5#7)(1997-6#1)(2005-11#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-11#1)
p55R##3##1##(1994-2#3)
p56 is##2##2##(1990-5#2)
p56##6##1##(1990-5#4)(2008-5#1)(2012-3#1)
p56lck in##3##2##(1994-12#1)(1994-3#1)(1994-9#1)
p56lck##24##1##(1991-11#5)(1992-7#1)(1993-3#1)(1994-12#6)(1994-3#5)(1994-9#5)(1996-6#1)
p56lyn##2##1##(1994-8#2)
p57##3##1##(1996-5#3)
p58 protein kinase##5##3##(1990-8#4)(1994-12#1)
p58##7##1##(1990-8#5)(1994-11#1)(1994-12#1)
p58-M1 is##2##2##(1991-8#2)
p58-M1##3##1##(1991-8#3)
p59##6##1##(1992-9#1)(1993-8#4)(2012-3#1)
p6##3##1##(1993-11#1)(1994-1#1)(1996-3#1)
p60 TNF receptor##4##3##(1997-5#1)(1997-6#3)
p60##16##1##(1992-8#1)(1995-6#4)(1996-5#4)(1997-5#2)(1997-6#4)(2008-5#1)
p60TRAK##3##1##(1997-6#3)
p60v-src##10##1##(1990-11#4)(1990-9#3)(1994-9#3)
p62##3##1##(1997-7#1)(2010-4#1)(2012-2#1)
p62/TCF##2##1##(1993-6#2)
p63##11##1##(1993-8#3)(2009-5#2)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
p64k##2##1##(1997-5#2)
p65 and##3##2##(1994-9#1)(1995-3#1)(1995-8#1)
p65 subunit of##2##3##(1995-3#1)(1995-6#1)
p65 subunit##4##2##(1994-8#1)(1995-3#1)(1995-6#1)(1996-9#1)
p65 with##2##2##(1995-3#2)
p65##26##1##(1990-12#1)(1994-8#3)(1994-9#2)(1995-1#1)(1995-3#8)(1995-6#5)(1995-8#1)(1996-9#1)(1997-3#1)(2010-10#1)(2012-2#2)
p66 delta 16/p51##2##3##(1995-3#2)
p66 delta 23/p51##2##3##(1995-3#2)
p66 delta 8/p51##2##3##(1995-3#2)
p66 delta##6##2##(1995-3#6)
p66##11##1##(1992-3#1)(1992-8#1)(1995-3#8)(1995-5#1)
p66/p51##2##1##(1991-9#1)(1995-3#1)
p67 and##2##2##(1994-5#1)(1996-2#1)
p67 in the##2##3##(1994-5#2)
p67##13##1##(1991-5#1)(1993-12#1)(1994-5#10)(1996-2#1)
p67-deglycosylase##2##1##(1994-5#2)
p67-phox##7##1##(1990-11#4)(1993-6#1)(1993-8#2)
p67phox##9##1##(1994-3#9)
p68##7##1##(1990-2#5)(1991-8#2)
p7##8##1##(1992-6#8)
p70 S6##2##2##(1997-6#2)
p70 in##2##2##(1993-4#1)(2008-8#1)
p70##15##1##(1992-5#2)(1993-4#5)(1995-1#1)(1996-10#1)(1997-6#2)(1997-7#1)(2008-8#2)(2011-2#1)
p70/p85 ribosomal S6 protein kinase##4##5##(1995-6#4)
p70/p85 ribosomal protein S6 kinase##2##5##(1996-2#2)
p70/p85 ribosomal##6##2##(1995-6#4)(1996-2#2)
p70S6k##4##1##(1994-6#1)(2010-4#3)
p72syk in##5##2##(1992-6#1)(1994-12#2)(1994-5#2)
p72syk is##6##2##(1992-6#3)(1993-11#3)
p72syk to the cytoskeleton##2##4##(1994-12#2)
p72syk##26##1##(1992-6#6)(1993-11#7)(1994-12#8)(1994-5#5)
p73 and##3##2##(2010-2#1)(2010-3#2)
p73##6##1##(2010-2#1)(2010-3#4)(2011-2#1)
p75 TNFR##3##2##(1996-5#3)
p75 knockout mice##2##3##(1997-5#2)
p75 neurotrophin receptor##3##3##(2005-8#1)(2010-8#2)
p75##28##1##(1992-8#1)(1995-8#4)(1996-10#1)(1996-12#4)(1996-5#3)(1997-5#4)(2005-8#2)(2006-6#1)(2007-11#3)(2010-8#2)(2012-12#3)
p75(NTR)##2##1##(2008-7#2)
p75ICD##4##1##(2010-8#4)
p75LNGFR##2##1##(1996-12#2)
p75NGFR##2##1##(1993-9#2)
p75NTR##2##1##(2010-8#2)
p75R##8##1##(1994-2#8)
p76##3##1##(1992-9#3)
p80##5##1##(1992-3#1)(1994-8#2)(1997-5#1)(2007-11#1)
p80cdc25##2##1##(1994-11#2)
p85 SH2##2##2##(1994-6#2)
p85 adaptor##2##2##(1997-4#2)
p85 subunit of##2##3##(1994-3#1)(1995-6#1)
p85 subunit##6##2##(1993-6#2)(1994-3#2)(1995-6#1)(1996-2#1)
p85##18##1##(1992-10#1)(1993-6#3)(1994-12#1)(1994-3#3)(1994-6#3)(1995-6#3)(1996-2#1)(1997-4#3)
p85alpha and p110alpha##3##3##(1996-8#3)
p85alpha and##4##2##(1996-8#3)(1997-4#1)
p85alpha##7##1##(1996-8#5)(1997-4#1)(2013-1#1)
p86##3##1##(1995-1#3)
p90(rsk) was##2##2##(1996-5#2)
p90(rsk)##6##1##(1996-5#6)
p94 kinase is##2##3##(1992-3#2)
p94##3##1##(1992-3#3)
p95vav##6##1##(1995-3#6)
p97mix##2##1##(1991-9#2)
p97pos##4##1##(1991-9#4)
p= 0##4##2##(2011-1#1)(2012-12#2)(2012-3#1)
p=##9##1##(2006-6#1)(2008-5#1)(2011-1#2)(2012-12#2)(2012-3#3)
p=0##175##1##(2004-9#1)(2005-10#1)(2006-10#2)(2006-6#1)(2006-7#4)(2006-8#6)(2006-9#4)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#7)(2008-10#11)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#3)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#2)(2009-4#6)(2009-5#1)(2009-7#2)(2010-12#6)(2010-2#3)(2010-3#4)(2010-6#1)(2011-1#15)(2011-2#21)(2012-12#9)(2012-2#2)(2012-3#16)(2013-1#12)(2013-7#2)(2013-8#8)
p=2##2##1##(2008-2#1)(2011-2#1)
p=NS)##2##1##(2006-6#2)
pA at##3##2##(1990-2#1)(2006-5#1)(2013-7#1)
pA##9##1##(1990-2#1)(1994-2#1)(2006-5#1)(2007-11#1)(2008-2#1)(2009-12#1)(2012-3#1)(2013-7#2)
pA2 8##5##2##(1996-10#2)(1997-5#3)
pA2 =##2##2##(1993-11#1)(1993-3#1)
pA2 value for##2##3##(1995-12#1)(2004-12#1)
pA2 value##5##2##(1995-12#1)(1996-10#1)(1996-2#2)(2004-12#1)
pA2 values of##2##3##(1994-3#1)(1995-12#1)
pA2 values##3##2##(1994-3#2)(1995-12#1)
pA2##16##1##(1993-11#1)(1993-3#1)(1994-3#2)(1995-12#2)(1996-10#4)(1996-2#2)(1997-5#3)(2004-12#1)
pAB is##2##2##(1992-5#2)
pAB##5##1##(1992-5#5)
pACYC177##5##1##(1990-9#3)(1995-8#1)(2008-10#1)
pACYC184##4##1##(1991-9#2)(1993-9#1)(1995-8#1)
pAEA##3##1##(2009-10#3)
pAF##2##1##(2013-8#2)
pAGluT##2##1##(2008-8#2)
pAKT and pAMPK levels##2##4##(2012-11#2)
pAL7002##2##1##(1990-5#2)
pAM1Luc##2##1##(1991-9#2)
pAN7-1##2##1##(1991-9#1)(2008-10#1)
pANCA##7##1##(2007-2#6)(2010-11#1)
pAS2##2##1##(2008-8#1)(2008-9#1)
pASK75##2##1##(1994-12#2)
pASMM##2##1##(2008-8#2)
pAT112##4##1##(1991-9#4)
pAb##3##1##(1992-9#1)(2008-10#2)
pAs1##2##1##(2008-5#2)
pBEf##2##1##(1994-12#2)
pBLCAT2##3##1##(1994-6#3)
pBP244##3##1##(2013-1#3)
pBPAB##6##1##(1994-3#6)
pBR 322##4##2##(1990-11#1)(1990-5#1)(1990-7#2)
pBR322 plasmid DNA##3##3##(1997-2#1)(2004-12#1)(2008-11#1)
pBR322 plasmid##4##2##(1997-2#1)(2004-12#1)(2008-11#1)(2013-1#1)
pBR322##23##1##(1990-11#2)(1990-3#1)(1990-5#2)(1990-9#1)(1991-7#1)(1991-8#2)(1993-9#1)(1994-9#1)(1995-1#1)(1996-2#1)(1997-2#3)(2004-12#1)(2006-12#1)(2006-8#1)(2008-11#1)(2008-5#1)(2008-8#1)(2013-1#1)
pBS##2##1##(1993-12#1)(2008-9#1)
pBluescript##3##1##(1993-4#1)(2008-6#1)(2008-8#1)
pBmgp64Luc##3##1##(2008-11#3)
pC194##2##1##(1993-6#2)
pCCS11##3##1##(1993-12#3)
pCEC fingerprints##2##2##(2011-1#2)
pCEC##6##1##(2008-10#1)(2011-1#5)
pCEN1##5##1##(1993-12#5)
pCFC1##2##1##(2008-5#2)
pCG##4##1##(2009-4#4)
pCIS7##4##1##(1990-9#4)
pCMBS##3##1##(1991-2#3)
pCN8B12##2##1##(2008-8#2)
pCO(2) and##2##2##(1996-3#1)(2008-11#1)
pCO(2) measurements##3##2##(2008-10#3)
pCO(2)##15##1##(1996-3#5)(2008-10#9)(2008-11#1)
pCO2 in##2##2##(2008-11#2)
pCO2##12##1##(1990-9#1)(1997-4#2)(2008-11#9)
pCO2)##2##1##(2006-6#1)(2010-8#1)
pCOR2##3##1##(2008-10#3)
pCP##4##1##(2008-10#4)
pCPA-RSV complex##3##2##(1994-3#3)
pCPA-RSV##5##1##(1994-3#5)
pCVCs##2##1##(2007-7#2)
pCa18b##3##1##(1992-3#3)
pCpGL##2##1##(2007-10#2)
pDA1 and pDA2##3##3##(1990-1#3)
pDA1##4##1##(1990-1#4)
pDA2##5##1##(1990-1#5)
pDC##4##1##(2011-1#4)
pDC-TNF##2##1##(2008-8#2)
pDCs##3##1##(2011-1#3)
pDNA in##2##2##(2013-1#2)
pDNA##10##1##(2008-3#1)(2013-1#9)
pDPRIS##2##1##(1997-3#2)
pEA29##7##1##(2008-10#7)
pEGF##4##1##(2008-7#4)
pEGFP##3##1##(2008-11#2)(2010-1#1)
pEH74##4##1##(2008-6#4)
pEJ30##4##1##(2008-10#4)
pEP2##2##1##(1990-11#1)(2008-10#1)
pEP36##4##1##(2008-10#4)
pEPSP##2##1##(1997-5#2)
pERISH2##4##1##(1991-7#4)
pERK##2##1##(2008-12#1)(2011-2#1)
pERK1/2##4##1##(2012-12#1)(2012-3#3)
pET3a##2##1##(1990-7#1)(1991-12#1)
pETH2##3##1##(2008-10#3)
pF##2##1##(2008-10#1)(2008-11#1)
pFFK##2##1##(2008-10#2)
pFGST##2##1##(2005-11#2)
pFNeo##4##1##(1993-5#4)
pFn and##2##2##(1995-5#2)
pFn##3##1##(1995-5#3)
pG101##2##1##(2008-10#2)
pGDM##6##1##(2008-3#6)
pGEM-T##4##1##(2005-11#1)(2008-10#1)(2008-8#1)(2008-9#1)
pGEX-2T##3##1##(1994-12#1)(1997-4#1)(2008-9#1)
pGH##2##1##(1992-9#2)
pGP1##3##1##(1995-8#3)
pGP315##2##1##(1991-5#2)
pGPPVPS##2##1##(2008-10#2)
pGRM-B11##3##1##(1990-3#3)
pGT-trp##2##1##(2008-10#2)
pGlu-Glu-ProNH2 is present in the porcine pituitary but##2##8##(1991-12#2)
pGlu-Glu-ProNH2##4##1##(1991-12#4)
pGluHA##4##1##(2008-7#4)
pH &gt##6##2##(1994-12#1)(1997-5#1)(2006-10#1)(2006-8#1)(2008-10#1)(2009-12#1)
pH &lt##4##2##(1994-12#2)(1997-5#1)(2008-10#1)
pH (5##6##2##(1990-2#1)(1992-2#1)(1994-12#1)(1997-1#1)(2008-10#1)(2008-6#1)
pH (6##7##2##(1990-1#1)(1990-12#1)(1990-8#1)(1991-7#1)(1994-3#1)(2008-8#1)(2010-4#1)
pH (7##6##2##(1990-8#1)(1994-12#3)(2011-1#1)(2013-1#1)
pH (9##2##2##(2006-3#1)(2008-10#1)
pH (D)##5##2##(1991-9#5)
pH (i##3##2##(2005-11#1)(2007-10#1)(2008-10#1)
pH (pH 6##2##3##(1990-12#1)(1991-12#1)
pH (pH##6##2##(1990-12#1)(1990-5#1)(1991-12#1)(2009-11#1)(2010-1#2)
pH (pHi) and##2##3##(1991-5#1)(1992-4#1)
pH (pHi) was##3##3##(1991-1#1)(2008-9#1)(2010-8#1)
pH (pHi)##14##2##(1990-2#1)(1991-1#1)(1991-5#1)(1991-9#1)(1992-4#1)(1992-5#1)(1993-2#1)(1993-4#1)(1994-6#1)(2007-10#1)(2008-5#1)(2008-9#1)(2010-8#2)
pH 0##2##2##(2008-10#2)
pH 1 and##2##3##(2008-10#2)
pH 1##24##2##(1990-5#1)(1992-12#1)(1995-3#2)(2008-10#18)(2008-11#1)(2013-8#1)
pH 10##41##2##(1990-2#1)(1991-2#1)(1991-4#2)(1994-11#1)(1996-12#1)(1996-5#1)(1996-8#2)(1997-6#1)(2004-9#1)(2005-11#3)(2008-10#17)(2008-3#1)(2008-5#4)(2012-12#1)(2012-3#1)(2013-1#3)
pH 10)##2##2##(2008-10#2)
pH 11##6##2##(1990-5#1)(1990-8#1)(1992-12#1)(2007-8#1)(2008-10#1)(2009-3#1)
pH 11-12##2##2##(2008-10#2)
pH 12##17##2##(1990-8#1)(1996-5#1)(2005-10#1)(2006-10#1)(2008-10#10)(2008-11#2)(2008-8#1)
pH 12)##2##2##(2008-10#1)(2009-12#1)
pH 13##4##2##(2008-10#3)(2013-1#1)
pH 2 and##7##3##(1990-8#2)(1991-12#1)(1994-9#1)(2008-10#3)
pH 2##93##2##(1990-8#2)(1991-12#1)(1991-3#3)(1991-4#1)(1991-5#1)(1991-8#1)(1992-2#1)(1993-11#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-9#2)(1995-2#1)(1995-8#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-2#4)(1997-3#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-8#3)(2008-10#48)(2008-3#1)(2008-5#2)(2008-6#1)(2010-3#1)(2010-5#1)(2012-2#1)(2013-1#1)
pH 3 and##2##3##(2008-10#2)
pH 3##98##2##(1990-10#1)(1990-12#1)(1990-2#3)(1990-6#1)(1990-8#1)(1991-1#1)(1991-2#1)(1992-12#3)(1994-11#1)(1994-3#1)(1994-8#1)(1995-5#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-7#1)(1997-8#1)(2005-12#2)(2007-8#4)(2007-9#1)(2008-10#54)(2008-5#1)(2008-6#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#2)(2011-12#1)
pH 4 and 6##3##4##(2008-10#1)(2008-5#2)
pH 4 and pH##3##4##(1991-5#1)(1995-8#1)(2008-8#1)
pH 4 and##9##3##(1991-5#1)(1994-2#1)(1995-8#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-8#1)
pH 4 or##3##3##(2008-10#2)(2012-9#1)
pH 4 solution##3##3##(1990-5#1)(2008-10#2)
pH 4##131##2##(1990-1#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-9#2)(1991-12#1)(1991-5#1)(1992-1#1)(1992-3#1)(1992-4#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-10#1)(1995-8#1)(1996-5#1)(1996-8#2)(1997-2#2)(1997-4#3)(1997-8#1)(2004-8#1)(2005-11#5)(2006-10#2)(2008-10#67)(2008-12#1)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#2)(2009-3#1)(2009-7#1)(2010-11#2)(2010-12#1)(2010-2#3)(2011-2#1)(2012-12#1)(2012-9#1)(2013-1#2)
pH 4-5##2##2##(2008-10#2)
pH 5 and##4##3##(1990-6#1)(1997-1#1)(2008-10#2)
pH 5 medium was##2##4##(1992-8#2)
pH 5 medium##3##3##(1992-8#3)
pH 5##179##2##(1990-12#1)(1990-2#6)(1990-3#1)(1990-6#2)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#2)(1992-1#1)(1992-12#2)(1992-4#1)(1992-6#1)(1992-8#3)(1993-11#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-7#4)(1997-8#2)(2004-8#1)(2005-11#1)(2005-12#3)(2005-4#1)(2006-6#1)(2006-8#2)(2007-8#2)(2008-10#87)(2008-11#6)(2008-3#1)(2008-5#6)(2008-6#5)(2009-10#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)
pH 5)##2##2##(1995-8#1)(2008-10#1)
pH 5-6##3##2##(2008-10#3)
pH 5-7##2##2##(1991-2#1)(2008-5#1)
pH 5/EDTA##3##2##(1990-11#3)
pH 6 and##5##3##(1990-8#1)(2006-8#3)(2008-7#1)
pH 6 in the presence of##2##6##(1990-8#1)(1993-9#1)
pH 6 in##3##3##(1990-8#1)(1993-9#1)(2011-2#1)
pH 6 to 9##2##4##(1993-6#1)(2010-5#1)
pH 6 to##3##3##(1993-6#1)(2008-10#1)(2010-5#1)
pH 6##173##2##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#6)(1990-9#1)(1991-1#1)(1991-3#1)(1991-4#3)(1991-5#1)(1991-7#3)(1991-8#3)(1991-9#2)(1992-11#1)(1992-12#4)(1992-3#1)(1992-6#1)(1992-7#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-6#1)(1994-8#5)(1995-2#3)(1995-5#1)(1995-6#9)(1995-8#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(2004-11#1)(2004-9#1)(2005-11#3)(2005-12#1)(2006-1#1)(2006-12#1)(2006-8#9)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#49)(2008-11#2)(2008-3#1)(2008-5#6)(2008-6#3)(2008-7#1)(2009-11#1)(2010-1#1)(2010-2#3)(2010-3#2)(2010-5#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
pH 6-7##2##2##(2008-10#1)(2010-4#1)
pH 6-8##3##2##(1994-8#1)(2008-10#2)
pH 7 and##11##3##(1990-9#1)(1991-8#1)(1992-4#1)(1994-5#1)(1994-8#1)(1995-1#1)(2005-11#1)(2008-10#2)(2008-8#1)(2013-1#1)
pH 7 buffered##2##3##(1994-9#1)(2008-10#1)
pH 7 phosphate buffer##2##4##(2007-8#1)(2008-10#1)
pH 7 with##3##3##(1996-8#1)(2008-10#1)(2010-5#1)
pH 7##301##2##(1990-11#1)(1990-12#4)(1990-2#9)(1990-3#4)(1990-5#3)(1990-6#2)(1990-7#5)(1990-8#3)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#4)(1991-3#2)(1991-5#2)(1991-7#2)(1991-8#5)(1991-9#3)(1992-1#1)(1992-10#2)(1992-12#2)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-8#8)(1994-11#4)(1994-3#4)(1994-5#3)(1994-8#8)(1994-9#5)(1995-1#2)(1995-10#4)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#3)(1996-3#1)(1996-4#1)(1996-7#2)(1996-8#4)(1997-1#3)(1997-2#4)(1997-5#1)(1997-7#2)(1997-8#1)(2004-9#1)(2005-11#11)(2005-12#3)(2005-4#1)(2006-10#3)(2006-12#2)(2006-3#1)(2006-8#7)(2007-1#1)(2007-2#1)(2007-8#3)(2008-10#87)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#8)(2008-6#3)(2008-8#4)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2011-3#2)(2013-1#1)
pH 8 and##3##3##(1990-5#1)(2008-10#2)
pH 8 from##2##3##(1990-5#1)(1995-8#1)
pH 8 to##2##3##(1992-7#1)(2011-2#1)
pH 8##132##2##(1990-12#2)(1990-4#1)(1990-5#5)(1990-8#1)(1991-11#1)(1991-2#2)(1991-4#1)(1991-7#2)(1991-8#3)(1991-9#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-8#1)(1993-9#3)(1994-8#5)(1994-9#1)(1995-2#2)(1995-6#8)(1995-8#1)(1996-12#1)(1996-5#2)(1996-7#3)(1997-1#1)(1997-3#1)(1997-7#1)(2004-9#1)(2005-11#5)(2006-8#3)(2007-5#1)(2008-10#45)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#3)(2008-8#1)(2008-9#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
pH 9 and##4##3##(1990-8#1)(1994-9#1)(2008-10#2)
pH 9##61##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-2#3)(1992-12#1)(1992-6#1)(1993-2#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-8#1)(2008-10#30)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#2)(2013-1#2)(2013-8#1)
pH = 3##2##3##(2008-10#2)
pH = 7##4##3##(2008-12#1)(2008-5#3)
pH = 8##2##3##(1997-3#1)(2006-5#1)
pH =##16##2##(1990-3#1)(1994-8#1)(1997-3#1)(2005-4#1)(2006-5#1)(2008-10#2)(2008-12#1)(2008-5#4)(2008-6#1)(2009-11#1)(2009-12#2)
pH a##2##2##(2008-10#1)(2013-8#1)
pH accuracy##2##2##(2008-10#2)
pH across the##2##3##(1990-11#1)(2011-1#1)
pH adjusted to 4##3##4##(1990-6#1)(2008-10#1)(2011-1#1)
pH adjusted to##8##3##(1990-6#1)(2008-10#2)(2010-12#1)(2010-5#1)(2011-1#2)(2013-7#1)
pH adjusted##10##2##(1990-6#1)(2008-10#3)(2010-12#1)(2010-5#1)(2011-1#2)(2012-2#1)(2013-7#1)
pH adjustment##4##2##(1990-5#1)(2008-10#3)
pH after##2##2##(1995-7#1)(2011-1#1)
pH and 25 degrees C##2##5##(1991-2#1)(2005-11#1)
pH and EC##2##3##(2007-10#1)(2008-12#1)
pH and acidity##2##3##(2008-10#1)(2013-8#1)
pH and available##2##3##(2008-10#2)
pH and base excess values##2##5##(1994-7#2)
pH and base excess##3##4##(1994-7#3)
pH and bicarbonate##2##3##(1994-12#2)
pH and buffer##3##3##(1994-9#1)(1997-3#1)(2008-10#1)
pH and calcium##2##3##(2008-5#1)(2008-9#1)
pH and column temperature##2##4##(2008-10#2)
pH and concentration##5##3##(2005-11#1)(2007-7#1)(2008-10#3)
pH and dose##2##3##(2006-8#2)
pH and flow rate##5##4##(2008-10#5)
pH and flow##6##3##(2008-10#6)
pH and high##3##3##(1997-1#1)(2005-12#1)(2008-10#1)
pH and increasing##2##3##(2008-10#1)(2008-5#1)
pH and incubation time##2##4##(2008-10#1)(2010-5#1)
pH and ionic strength of the##3##6##(2008-10#3)
pH and ionic strength##15##4##(1990-12#1)(1991-4#1)(1993-11#1)(1996-2#1)(1997-3#2)(2005-11#1)(2008-10#4)(2008-4#1)(2008-7#1)(2009-2#1)(2013-1#1)
pH and osmolarity##2##3##(2008-11#2)
pH and phosphate concentration of##2##5##(2008-10#2)
pH and potassium##2##3##(1990-12#1)(2008-1#1)
pH and sample volume##2##4##(2008-10#2)
pH and sample##4##3##(2008-10#4)
pH and shows##2##3##(1992-5#1)(1992-9#1)
pH and sodium chloride##3##4##(1990-8#2)(2008-10#1)
pH and soil##3##3##(2010-5#1)(2013-8#2)
pH and substrate##2##3##(2006-8#1)(2011-1#1)
pH and supporting electrolyte##2##4##(2008-10#2)
pH and temperature conditions##2##4##(1991-3#1)(2008-6#1)
pH and temperature for##3##4##(1994-11#1)(2008-10#1)(2008-5#1)
pH and temperature on the##3##5##(1991-11#1)(1995-8#1)(1996-5#1)
pH and temperature on##4##4##(1990-8#1)(1991-11#1)(1995-8#1)(1996-5#1)
pH and temperature were 7##2##5##(1991-12#1)(2007-12#1)
pH and temperature were##3##4##(1991-12#1)(1992-11#1)(2007-12#1)
pH and temperature##30##3##(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-11#1)(1993-8#1)(1994-11#1)(1995-2#1)(1995-8#2)(1996-11#1)(1996-5#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-5#3)(2008-6#1)(2012-2#1)
pH and that the##2##4##(1991-12#1)(1993-6#1)
pH and that##3##3##(1991-12#1)(1993-6#1)(2008-10#1)
pH and the amount of##2##5##(1995-8#1)(2008-10#1)
pH and the concentration of##3##5##(1996-5#1)(2005-10#1)(2008-10#1)
pH and the presence of##2##5##(2008-6#1)(2008-8#1)
pH and the##23##3##(1991-7#1)(1995-8#1)(1996-5#1)(2005-10#1)(2005-11#2)(2006-8#1)(2008-10#11)(2008-12#1)(2008-6#1)(2008-8#1)(2013-8#2)
pH and time of##2##4##(2008-10#2)
pH and volume##2##3##(2006-9#1)(2008-10#1)
pH and was##2##3##(1995-10#1)(2005-11#1)
pH and##265##2##(1990-12#2)(1990-2#1)(1990-4#1)(1990-7#3)(1990-8#3)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#2)(1991-4#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#3)(1993-4#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-5#1)(1994-7#3)(1994-8#3)(1994-9#2)(1995-1#1)(1995-10#1)(1995-2#2)(1995-4#1)(1995-5#1)(1995-8#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#3)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#7)(2005-12#1)(2006-10#2)(2006-12#1)(2006-8#6)(2006-9#1)(2007-10#3)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#92)(2008-11#8)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#12)(2008-6#4)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-3#1)(2010-4#3)(2010-5#3)(2011-1#2)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#6)(2013-8#7)
pH approximately 5##2##3##(2005-11#2)
pH approximately##7##2##(1992-8#1)(2005-11#2)(2008-10#3)(2008-3#1)
pH are found##2##3##(2008-5#1)(2009-12#1)
pH are##11##2##(1991-5#1)(1994-12#1)(2008-10#2)(2008-5#4)(2009-12#1)(2009-4#1)(2012-11#1)
pH around##2##2##(2008-10#1)(2008-7#1)
pH as a##2##3##(1994-4#1)(1996-11#1)
pH as##5##2##(1994-12#1)(1994-4#1)(1994-8#1)(1996-11#1)(2008-10#1)
pH at 7##2##3##(2008-10#1)(2008-11#1)
pH at the##3##3##(2004-9#1)(2005-11#1)(2008-10#1)
pH at##13##2##(1990-2#1)(1990-6#1)(1991-3#1)(2004-9#1)(2005-11#1)(2008-10#5)(2008-11#1)(2008-5#1)(2013-8#1)
pH below##4##2##(1994-11#1)(1997-8#1)(2008-10#2)
pH between 4 and##2##4##(1990-7#1)(2008-10#1)
pH between##5##2##(1990-7#1)(2008-10#1)(2008-5#3)
pH buffers##2##2##(1992-11#1)(2008-10#1)
pH but not##2##3##(1993-11#1)(2005-12#1)
pH by a##2##3##(1995-3#1)(2005-11#1)
pH by##7##2##(1990-12#1)(1991-9#1)(1994-12#1)(1995-3#1)(2005-11#1)(2008-10#2)
pH change from##2##3##(1993-8#1)(2008-10#1)
pH change in##2##3##(2004-9#1)(2008-10#1)
pH change of##2##3##(2008-5#1)(2013-1#1)
pH change was##2##3##(2009-12#2)
pH change##18##2##(1993-8#1)(1994-9#1)(2004-9#1)(2007-10#1)(2008-10#5)(2008-5#3)(2008-7#1)(2009-12#3)(2010-5#1)(2013-1#1)
pH changes and##2##3##(2004-9#1)(2008-10#1)
pH changes##10##2##(2004-9#1)(2008-10#4)(2010-1#1)(2012-12#2)(2013-1#2)
pH close to##5##3##(1992-10#1)(1992-2#1)(2008-10#2)(2008-5#1)
pH conditions##20##2##(1991-5#1)(1994-8#1)(1995-2#1)(2005-10#1)(2007-8#2)(2008-10#7)(2008-5#1)(2009-11#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-5#1)(2013-1#1)
pH control##9##2##(1997-2#2)(2004-8#2)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)
pH decline##2##2##(2010-4#2)
pH decreased##2##2##(2008-10#1)(2008-5#1)
pH decreases from##2##3##(1992-7#1)(1994-9#1)
pH decreases##3##2##(1992-12#1)(1992-7#1)(1994-9#1)
pH dependence is##2##3##(1994-8#1)(1997-4#1)
pH dependence of the binding##2##5##(1990-12#1)(1995-2#1)
pH dependence of the folding reaction##2##6##(1992-3#2)
pH dependence of the##21##4##(1990-12#1)(1990-5#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-3#2)(1993-3#1)(1993-8#1)(1994-11#1)(1995-10#1)(1995-2#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-8#1)(2008-10#3)(2010-4#1)
pH dependence of##31##3##(1990-12#2)(1990-3#1)(1990-5#1)(1991-4#1)(1991-7#2)(1991-8#2)(1991-9#1)(1992-3#2)(1993-3#1)(1993-8#2)(1994-11#1)(1994-8#1)(1995-10#2)(1995-2#1)(1995-5#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-8#1)(2006-10#1)(2008-10#3)(2008-3#1)(2010-4#1)
pH dependence##44##2##(1990-12#3)(1990-3#1)(1990-5#1)(1991-4#2)(1991-7#2)(1991-8#4)(1991-9#1)(1992-3#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-8#2)(1994-11#2)(1994-8#2)(1995-10#2)(1995-2#1)(1995-5#1)(1996-12#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-8#1)(2005-11#1)(2006-10#1)(2008-10#3)(2008-3#1)(2008-4#1)(2010-4#1)
pH dependency##3##2##(1991-2#1)(1995-5#2)
pH dependent##23##2##(1990-10#1)(1990-7#1)(1991-10#1)(1991-4#1)(1992-7#2)(1992-9#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-10#1)(1996-8#1)(2008-10#6)(2008-3#1)(2009-12#1)(2013-1#1)
pH determination##2##2##(2008-10#2)
pH did not##2##3##(2008-10#2)
pH dropped##2##2##(2008-10#1)(2008-5#1)
pH due to##2##3##(2005-11#1)(2008-8#1)
pH during##2##2##(2006-8#1)(2008-10#1)
pH effect on##3##3##(2008-10#3)
pH effect##10##2##(1992-11#1)(1995-2#1)(2007-10#1)(2008-10#7)
pH effects on the##2##4##(2008-10#1)(2009-12#1)
pH effects##4##2##(1994-11#1)(2008-10#2)(2009-12#1)
pH electrodes##2##2##(2008-10#2)
pH favored##2##2##(2008-10#2)
pH for the##14##3##(1990-2#1)(1990-4#1)(1990-7#2)(1991-5#1)(1996-7#1)(1997-2#1)(2008-10#6)(2008-3#1)
pH for##35##2##(1990-2#2)(1990-4#1)(1990-7#2)(1991-5#2)(1991-9#2)(1993-3#1)(1994-11#1)(1996-5#1)(1996-7#1)(1997-2#1)(2004-11#1)(2005-11#1)(2008-10#11)(2008-3#1)(2008-4#1)(2008-5#1)(2009-3#1)(2011-2#2)(2012-2#1)(2013-8#1)
pH from 1 to##2##4##(2008-10#2)
pH from 2##4##3##(1994-3#1)(1994-8#1)(2008-10#2)
pH from 5##2##3##(1991-9#1)(2008-10#1)
pH from the##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
pH from##18##2##(1991-8#1)(1991-9#1)(1993-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1996-7#1)(2008-10#8)(2008-8#1)(2011-1#1)(2011-2#1)
pH gating##3##2##(2008-8#3)
pH gave##3##2##(1990-5#1)(2008-10#1)(2008-5#1)
pH glass electrode##2##3##(2008-10#2)
pH glass##3##2##(2008-10#3)
pH gradient was##3##3##(1990-3#1)(1994-9#1)(2008-10#1)
pH gradient##23##2##(1990-3#3)(1991-9#1)(1992-2#2)(1993-12#1)(1994-6#1)(1994-9#1)(1995-2#1)(1996-9#1)(2008-10#6)(2008-4#1)(2008-7#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-3#1)
pH has been determined##2##4##(1994-9#1)(2008-10#1)
pH has been##5##3##(1994-9#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-8#1)
pH has##7##2##(1994-9#1)(2006-10#1)(2007-10#1)(2008-10#3)(2008-8#1)
pH higher than##6##3##(1990-2#1)(1994-3#1)(2007-8#1)(2008-10#3)
pH in 1998 was##2##4##(2004-4#2)
pH in a##3##3##(1991-4#1)(1991-7#1)(1997-7#1)
pH in the absence of##2##5##(1994-8#1)(1997-7#1)
pH in the presence of##3##5##(1990-2#1)(1995-5#1)(2005-11#1)
pH in the range of 6##2##6##(2007-9#1)(2008-8#1)
pH in the range of##5##5##(1995-2#1)(2007-9#1)(2008-10#2)(2008-8#1)
pH in the range##8##4##(1991-12#1)(1991-5#1)(1992-6#1)(1995-2#1)(2007-9#1)(2008-10#2)(2008-8#1)
pH in the##24##3##(1990-2#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-6#1)(1994-8#1)(1995-2#2)(1995-5#1)(1997-2#1)(1997-7#2)(2004-9#1)(2005-11#1)(2006-6#1)(2007-9#1)(2008-10#7)(2008-8#1)
pH in##55##2##(1990-12#1)(1990-2#3)(1990-7#1)(1991-12#1)(1991-4#2)(1991-5#1)(1991-7#1)(1992-2#1)(1992-6#1)(1993-5#1)(1993-8#1)(1994-8#1)(1995-2#2)(1995-5#1)(1995-7#1)(1997-2#1)(1997-7#3)(2004-4#2)(2004-9#1)(2005-11#1)(2006-6#1)(2007-12#1)(2007-9#1)(2008-10#14)(2008-5#2)(2008-8#3)(2010-3#1)(2010-4#2)(2010-8#2)(2011-2#1)
pH increase##3##2##(2004-4#1)(2008-10#1)(2008-11#1)
pH increased##6##2##(2008-10#4)(2008-6#1)(2013-8#1)
pH independent over the##2##4##(1991-9#1)(1993-3#1)
pH independent##5##2##(1990-7#1)(1991-7#1)(1991-9#1)(1993-3#1)(1996-8#1)
pH indicator##8##2##(1994-2#1)(2008-10#7)
pH is a##5##3##(1992-11#1)(2008-10#1)(2008-5#2)(2008-9#1)
pH is changed##2##3##(2006-11#1)(2006-12#1)
pH is decreased##3##3##(1990-8#1)(1994-8#1)(1996-4#1)
pH is lowered to 5##2##5##(1995-3#1)(1997-7#1)
pH is lowered##3##3##(1995-3#1)(1997-7#1)(2008-8#1)
pH is the##2##3##(1996-9#1)(2008-5#1)
pH is##32##2##(1990-8#1)(1991-2#1)(1992-11#1)(1993-9#1)(1994-8#2)(1995-3#2)(1996-11#1)(1996-4#1)(1996-9#1)(1997-7#2)(2005-11#2)(2006-11#1)(2006-12#1)(2008-10#3)(2008-11#1)(2008-5#6)(2008-8#3)(2008-9#1)(2010-5#1)
pH leading to##2##3##(1991-12#2)
pH level##2##2##(2005-10#1)(2007-3#1)
pH levels##8##2##(1994-8#1)(2004-4#1)(2005-12#1)(2006-8#1)(2008-10#2)(2008-5#1)(2012-2#1)
pH lower than##2##3##(1992-2#1)(2007-8#1)
pH maximum##2##2##(1994-3#1)(2008-10#1)
pH may##2##2##(1994-6#1)(2009-4#1)
pH measurement##4##2##(1994-7#1)(2008-10#2)(2013-1#1)
pH measurements and##2##3##(2008-10#2)
pH measurements in##4##3##(1993-11#1)(2006-10#1)(2008-10#1)(2010-8#1)
pH measurements were##2##3##(1994-7#1)(2008-10#1)
pH measurements##16##2##(1992-9#1)(1993-11#1)(1994-7#1)(2006-10#1)(2008-10#11)(2010-8#1)
pH media##2##2##(2010-2#2)
pH monitoring##3##2##(2006-10#2)(2012-2#1)
pH near##2##2##(1990-2#1)(1992-10#1)
pH occurring##2##2##(1994-11#1)(2008-10#1)
pH of 1##2##3##(2008-10#2)
pH of 2##2##3##(2008-10#2)
pH of 3##5##3##(1990-12#1)(1994-11#1)(2008-10#3)
pH of 4##6##3##(1991-6#1)(1994-6#1)(2007-12#1)(2008-10#2)(2012-2#1)
pH of 5##7##3##(1992-2#1)(2008-10#3)(2008-4#1)(2008-5#1)(2013-7#1)
pH of 6##3##3##(1990-4#1)(2008-10#2)
pH of 7##11##3##(1990-3#1)(1993-3#3)(2006-5#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-6#1)(2011-1#1)
pH of 8##4##3##(2008-10#1)(2008-4#2)(2009-4#1)
pH of a##2##3##(2007-8#1)(2008-11#1)
pH of approximately##3##3##(1990-5#1)(2011-2#2)
pH of buffer##2##3##(2008-10#2)
pH of buffers##2##3##(2008-10#2)
pH of control or NaCl-treated samples significantly##2##7##(2007-3#2)
pH of culture##2##3##(1996-12#1)(2007-12#1)
pH of mobile phase##3##4##(1997-3#1)(2008-10#1)(2011-1#1)
pH of sample solution##3##4##(2008-10#3)
pH of sample##4##3##(2008-10#4)
pH of the aqueous extraction##2##5##(2008-10#1)(2008-5#1)
pH of the aqueous phase##4##5##(2008-10#4)
pH of the aqueous##6##4##(2008-10#5)(2008-5#1)
pH of the buffer##3##4##(1990-8#1)(1991-5#1)(2008-10#1)
pH of the bulk solution##2##5##(2008-6#2)
pH of the bulk##3##4##(2008-10#1)(2008-6#2)
pH of the culture##3##4##(1994-12#1)(1995-6#1)(2013-7#1)
pH of the medium##6##4##(1994-6#1)(1994-8#1)(2006-3#1)(2008-10#1)(2008-6#1)(2013-1#1)
pH of the mixed solution was##3##6##(2008-10#3)
pH of the mixed##4##4##(2008-10#3)(2008-6#1)
pH of the mobile phase##5##5##(1990-8#1)(1997-3#1)(2008-10#2)(2011-1#1)
pH of the reaction##2##4##(1994-9#1)(2008-10#1)
pH of the sample solution##2##5##(2008-10#2)
pH of the sample##3##4##(2008-10#3)
pH of the solution was##2##5##(1990-8#1)(2013-1#1)
pH of the solution##10##4##(1990-11#1)(1990-5#1)(1990-8#1)(2004-9#1)(2005-11#1)(2008-10#3)(2008-5#1)(2013-1#1)
pH of the substrate##2##4##(2008-10#1)(2008-6#1)
pH of the##84##3##(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-8#3)(1991-5#1)(1991-9#1)(1992-6#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-6#2)(1997-3#1)(1997-8#1)(2004-9#2)(2005-11#5)(2006-3#1)(2006-8#1)(2007-8#2)(2008-10#33)(2008-11#1)(2008-5#8)(2008-6#6)(2011-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
pH of##195##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#3)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-12#2)(1993-3#4)(1994-11#1)(1994-12#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-6#2)(1996-12#1)(1997-1#1)(1997-3#4)(1997-8#1)(2004-9#2)(2005-10#1)(2005-11#7)(2005-4#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-12#3)(2007-2#1)(2007-3#2)(2007-8#5)(2008-10#81)(2008-11#2)(2008-12#1)(2008-4#3)(2008-5#14)(2008-6#7)(2008-8#1)(2008-9#1)(2009-4#1)(2010-4#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#2)(2013-8#1)
pH on the##22##3##(1990-6#1)(1991-5#1)(1991-9#1)(2004-9#1)(2005-11#2)(2008-10#8)(2008-5#5)(2008-8#1)(2010-4#1)(2011-2#1)
pH on their##3##3##(1991-5#1)(2008-10#2)
pH on##45##2##(1990-6#1)(1991-10#1)(1991-5#3)(1991-9#2)(1992-2#1)(1992-7#1)(1994-12#1)(1994-6#1)(1997-3#1)(2004-4#2)(2004-9#1)(2005-11#3)(2008-10#13)(2008-5#6)(2008-6#1)(2008-8#2)(2009-12#1)(2010-4#1)(2011-12#1)(2011-2#1)(2013-8#1)
pH optima##5##2##(1991-11#1)(1991-12#2)(1991-5#1)(2010-3#1)
pH optimum and##2##3##(1992-7#1)(1995-2#1)
pH optimum at pH##2##4##(1990-6#1)(1991-2#1)
pH optimum at##7##3##(1990-2#1)(1990-6#1)(1991-10#1)(1991-2#1)(1993-9#1)(1994-12#2)
pH optimum between##2##3##(1990-2#1)(2011-1#1)
pH optimum of 4##3##4##(1990-2#1)(1996-1#1)(2004-8#1)
pH optimum of the##2##4##(1992-12#1)(1993-11#1)
pH optimum of##13##3##(1990-12#2)(1990-2#2)(1991-7#1)(1991-9#1)(1992-12#1)(1993-11#1)(1994-5#1)(1995-8#1)(1996-1#1)(1996-5#1)(2004-8#1)
pH optimum was##3##3##(1990-5#1)(1996-5#1)(1996-7#1)
pH optimum##35##2##(1990-12#2)(1990-2#4)(1990-5#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-7#1)(1993-11#1)(1993-4#1)(1993-9#1)(1994-12#2)(1994-5#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-5#2)(1996-7#1)(1997-8#1)(2004-8#1)(2006-10#2)(2008-4#1)(2008-9#1)(2011-1#1)
pH or by##2##3##(1995-5#1)(1997-6#1)
pH or##14##2##(1990-5#1)(1990-6#1)(1992-8#1)(1995-11#1)(1995-3#1)(1995-5#1)(1997-1#1)(1997-6#1)(2004-12#1)(2007-8#1)(2008-10#2)(2008-4#1)(2013-1#1)
pH oscillations##3##2##(2006-10#3)
pH over the range##2##4##(1991-12#1)(2008-10#1)
pH produced##2##2##(1997-8#1)(2008-10#1)
pH profile##3##2##(1990-8#1)(1996-5#1)(1997-1#1)
pH profiles for##3##3##(1990-7#1)(1991-9#1)(1994-9#1)
pH profiles of##2##3##(1990-7#1)(2010-3#1)
pH profiles##7##2##(1990-7#2)(1990-8#1)(1991-9#1)(1994-9#1)(2008-10#1)(2010-3#1)
pH range (6##2##3##(2008-10#2)
pH range (pH##2##3##(1991-5#1)(2008-10#1)
pH range 0##3##3##(2008-10#2)(2008-6#1)
pH range 1##3##3##(2008-10#3)
pH range 2##6##3##(2008-10#6)
pH range 3-6##2##3##(1997-2#1)(2008-10#1)
pH range 5##6##3##(1992-6#1)(1996-11#1)(2008-10#3)(2008-3#1)
pH range 7##5##3##(1992-12#1)(1995-5#1)(1997-1#1)(2008-10#2)
pH range and##5##3##(2008-10#3)(2008-3#1)(2013-1#1)
pH range between##2##3##(2008-10#1)(2008-11#1)
pH range close to deprotonation of##2##6##(2008-10#2)
pH range for##4##3##(1994-9#1)(1997-2#1)(2008-10#2)
pH range from 2##2##4##(2008-10#2)
pH range from 3##3##4##(2008-10#3)
pH range from 4##2##4##(2008-10#1)(2008-11#1)
pH range from##13##3##(1994-3#1)(2008-10#11)(2008-11#1)
pH range of 2##11##4##(2008-10#10)(2010-2#1)
pH range of 3##7##4##(2005-11#1)(2008-10#6)
pH range of 4##5##4##(2008-10#3)(2008-6#1)(2010-9#1)
pH range of 5##4##4##(2008-10#3)(2013-8#1)
pH range of 6##8##4##(1992-7#1)(1993-3#1)(1997-8#1)(2008-10#4)(2008-7#1)
pH range of 7##3##4##(1992-12#1)(2008-4#1)(2012-2#1)
pH range of 8##2##4##(2008-10#2)
pH range of the##3##4##(2008-10#3)
pH range of##69##3##(1990-12#1)(1990-7#1)(1991-9#2)(1992-12#1)(1992-7#2)(1993-3#2)(1995-2#1)(1997-8#1)(2005-11#1)(2006-1#1)(2007-12#1)(2007-8#1)(2008-10#46)(2008-4#1)(2008-6#1)(2008-7#1)(2010-2#1)(2010-9#1)(2012-11#1)(2012-2#1)(2013-8#1)
pH range studied##3##3##(1997-3#1)(2008-10#1)(2008-6#1)
pH range was between 1 and 8##2##7##(2008-10#2)
pH range was##4##3##(2008-10#4)
pH range within##2##3##(2008-5#1)(2010-8#1)
pH range##208##2##(1990-12#1)(1990-5#1)(1990-7#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-12#2)(1992-4#1)(1992-6#1)(1992-7#2)(1993-3#2)(1993-8#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-5#2)(1996-11#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-8#1)(2005-11#1)(2006-1#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#144)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
pH ranges for quantitative sorption##3##5##(2008-10#3)
pH ranges##8##2##(2005-11#1)(2008-10#6)(2008-4#1)
pH ranging from##2##3##(1990-11#1)(2008-10#1)
pH rate##2##2##(1991-9#2)
pH readings##2##2##(2008-10#2)
pH reduction##4##2##(1995-9#1)(2008-10#1)(2008-2#1)(2011-2#1)
pH region##6##2##(1990-11#1)(1990-4#1)(2006-10#1)(2008-10#3)
pH regions##2##2##(1991-4#1)(2008-10#1)
pH response##5##2##(1997-7#1)(2008-10#4)
pH sensing##3##2##(2008-10#2)(2009-12#1)
pH sensitive and##3##3##(1992-10#1)(2008-10#1)(2013-7#1)
pH sensitive##10##2##(1991-12#1)(1992-10#1)(1997-1#1)(1997-3#1)(2008-10#2)(2009-10#1)(2009-12#1)(2013-1#1)(2013-7#1)
pH sensitivity of##3##3##(1997-3#1)(1997-4#1)(2009-11#1)
pH sensitivity##9##2##(1994-9#1)(1997-3#1)(1997-4#2)(2008-10#2)(2009-11#1)(2012-11#2)
pH sensor and##2##3##(2008-10#2)
pH sensor##9##2##(1997-4#2)(2008-10#7)
pH sensors based on##3##4##(2008-10#3)
pH sensors##7##2##(2007-8#1)(2008-10#5)(2008-11#1)
pH shift##2##2##(1990-4#1)(1994-8#1)
pH showed that##2##3##(1992-12#1)(2008-10#1)
pH signature for##2##3##(2009-8#2)
pH stability and synthesis##2##4##(1996-6#2)
pH stat##2##2##(1990-2#1)(2005-12#1)
pH studies##2##2##(2008-10#2)
pH than##5##2##(1997-1#1)(2008-10#2)(2008-11#1)(2013-1#1)
pH the##7##2##(1992-10#1)(1994-3#1)(1996-2#1)(2008-10#2)(2008-11#1)(2009-12#1)
pH titration##8##2##(1990-2#1)(2005-11#1)(2008-10#4)(2008-5#1)(2008-9#1)
pH titrations in##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
pH to##14##2##(1990-2#1)(1991-8#2)(1994-8#2)(2005-11#1)(2006-5#1)(2008-10#4)(2008-3#1)(2008-4#1)(2010-4#1)
pH towards##2##2##(1990-3#1)(1997-1#1)
pH unit##10##2##(1990-2#1)(1991-2#1)(1991-6#1)(1996-4#1)(1997-1#1)(1997-5#1)(2005-11#2)(2007-8#1)(2008-10#1)
pH units##8##2##(1992-2#1)(1995-5#2)(2008-10#5)
pH up to##2##3##(2006-10#1)(2008-5#1)
pH using##4##2##(1995-5#1)(2007-8#1)(2008-10#2)
pH value and##3##3##(2008-10#1)(2011-1#1)(2012-2#1)
pH value for##5##3##(1991-8#1)(2008-10#3)(2011-2#1)
pH value of 10##2##4##(2008-10#2)
pH value of buffer##2##4##(2008-10#2)
pH value of the solution##2##5##(2005-11#1)(2007-8#1)
pH value of the##5##4##(2005-11#1)(2007-8#1)(2008-10#2)(2008-5#1)
pH value of##14##3##(1993-8#1)(2005-11#2)(2007-8#1)(2008-10#8)(2008-5#1)(2012-12#1)
pH value##56##2##(1990-8#1)(1991-8#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-3#1)(1997-7#1)(2005-11#3)(2007-10#1)(2007-8#1)(2008-10#28)(2008-12#1)(2008-5#3)(2009-11#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
pH values &gt##2##3##(1994-11#1)(2008-10#1)
pH values &lt##2##3##(1994-11#1)(2008-10#1)
pH values (2##2##3##(2008-10#2)
pH values (7##3##3##(1994-11#1)(2012-2#1)(2013-8#1)
pH values (pH##2##3##(1992-8#1)(1994-8#1)
pH values and##7##3##(1992-10#1)(1993-11#1)(2005-11#1)(2007-8#1)(2008-10#2)(2013-8#1)
pH values are##3##3##(2008-10#1)(2008-5#2)
pH values at##2##3##(2008-10#1)(2010-4#1)
pH values below 5##3##4##(1994-5#1)(2008-5#2)
pH values below##5##3##(1990-10#1)(1993-9#1)(1994-5#1)(2008-5#2)
pH values examined##2##3##(1993-8#1)(1993-9#1)
pH values for##4##3##(1996-7#1)(2008-10#3)
pH values measured##2##3##(1994-8#1)(2008-10#1)
pH values of the##2##4##(2008-10#2)
pH values of##10##3##(1992-12#1)(1994-11#1)(1994-7#1)(2008-10#4)(2008-11#1)(2010-4#1)(2012-12#1)
pH values ranging from 1##2##5##(2008-10#2)
pH values ranging from##4##4##(2008-10#3)(2010-4#1)
pH values tested##2##3##(2008-10#2)
pH values were investigated##2##4##(2006-8#1)(2008-5#1)
pH values were##9##3##(2004-9#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-5#2)(2008-7#2)
pH values where the##2##4##(2005-11#1)(2006-10#1)
pH values##134##2##(1990-10#1)(1990-2#1)(1991-2#3)(1991-3#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#2)(1992-6#3)(1992-8#5)(1993-11#1)(1993-8#1)(1993-9#2)(1994-11#7)(1994-5#3)(1994-7#1)(1994-8#3)(1994-9#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-7#2)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#1)(2004-9#1)(2005-11#3)(2005-4#1)(2006-10#4)(2006-8#1)(2007-10#1)(2007-8#1)(2008-10#42)(2008-11#1)(2008-3#2)(2008-5#10)(2008-7#2)(2009-3#1)(2010-12#1)(2010-4#6)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
pH variations##2##2##(2008-10#2)
pH was 2##2##3##(2008-10#1)(2008-6#1)
pH was 5##4##3##(1997-2#1)(2005-6#1)(2008-10#1)(2013-8#1)
pH was adjusted to##3##4##(2008-10#3)
pH was adjusted##5##3##(1991-4#1)(2008-10#4)
pH was found##3##3##(1994-10#1)(2010-4#1)(2012-12#1)
pH was greater##2##3##(1996-7#1)(2009-4#1)
pH was investigated##2##3##(1994-8#1)(2008-10#1)
pH was raised##2##3##(1993-3#1)(1993-6#1)
pH was##48##2##(1990-12#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-4#1)(1991-5#1)(1991-6#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-10#1)(1994-8#1)(1995-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(2004-9#1)(2005-11#2)(2005-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-10#15)(2008-3#1)(2008-6#2)(2008-8#1)(2009-4#1)(2010-4#1)(2012-12#2)(2013-8#1)
pH were studied##3##3##(2006-10#1)(2008-10#2)
pH were the##2##3##(2008-10#1)(2008-6#1)
pH were used##2##3##(1992-2#1)(2008-10#1)
pH were##22##2##(1992-2#1)(1994-11#1)(1996-11#1)(1997-3#1)(1997-4#1)(2004-4#1)(2006-10#2)(2008-10#7)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2011-2#1)
pH whereas##2##2##(1990-8#1)(2008-10#1)
pH which is##2##3##(1990-3#1)(1993-3#1)
pH which##5##2##(1990-12#2)(1990-3#1)(1993-3#1)(2011-2#1)
pH while##3##2##(1991-8#1)(2008-10#1)(2008-3#1)
pH will##2##2##(2008-6#1)(2011-2#1)
pH with a slope of##2##5##(2008-10#2)
pH with a##4##3##(1990-5#1)(1995-8#1)(2008-10#2)
pH with##12##2##(1990-5#1)(1993-2#1)(1995-8#1)(1996-8#1)(2005-11#1)(2007-10#2)(2008-10#4)(2008-5#1)
pH within the##2##3##(1996-3#1)(2006-6#1)
pH without##3##2##(1997-6#1)(2008-5#1)(2010-4#1)
pH would##2##2##(2006-10#1)(2008-10#1)
pH##3903##1##(1990-1#2)(1990-10#5)(1990-11#10)(1990-12#33)(1990-2#54)(1990-3#19)(1990-4#9)(1990-5#31)(1990-6#14)(1990-7#29)(1990-8#33)(1990-9#8)(1991-1#8)(1991-10#4)(1991-11#6)(1991-12#21)(1991-2#32)(1991-3#15)(1991-4#21)(1991-5#22)(1991-6#4)(1991-7#18)(1991-8#27)(1991-9#32)(1992-1#3)(1992-10#7)(1992-11#11)(1992-12#28)(1992-2#20)(1992-3#9)(1992-4#6)(1992-5#5)(1992-6#15)(1992-7#13)(1992-8#14)(1992-9#8)(1993-11#17)(1993-12#10)(1993-2#4)(1993-3#17)(1993-4#7)(1993-5#1)(1993-6#6)(1993-7#2)(1993-8#28)(1993-9#9)(1994-10#1)(1994-11#34)(1994-12#24)(1994-2#5)(1994-3#14)(1994-4#1)(1994-5#19)(1994-6#9)(1994-7#6)(1994-8#55)(1994-9#31)(1995-1#4)(1995-10#10)(1995-11#2)(1995-2#29)(1995-3#10)(1995-4#1)(1995-5#20)(1995-6#30)(1995-7#3)(1995-8#18)(1995-9#1)(1996-1#1)(1996-11#7)(1996-12#8)(1996-2#4)(1996-3#6)(1996-4#5)(1996-5#21)(1996-6#8)(1996-7#21)(1996-8#17)(1996-9#5)(1997-1#28)(1997-2#26)(1997-3#22)(1997-4#13)(1997-5#7)(1997-6#8)(1997-7#18)(1997-8#19)(2004-11#3)(2004-12#1)(2004-2#1)(2004-4#10)(2004-8#5)(2004-9#15)(2005-10#5)(2005-11#91)(2005-12#15)(2005-4#5)(2005-6#1)(2006-1#2)(2006-10#35)(2006-11#2)(2006-12#10)(2006-2#2)(2006-3#5)(2006-4#1)(2006-5#6)(2006-6#4)(2006-8#38)(2006-9#1)(2007-1#4)(2007-10#26)(2007-11#1)(2007-12#7)(2007-2#2)(2007-3#9)(2007-5#2)(2007-7#2)(2007-8#45)(2007-9#6)(2008-1#5)(2008-10#1463)(2008-11#59)(2008-12#11)(2008-2#1)(2008-3#25)(2008-4#25)(2008-5#172)(2008-6#48)(2008-7#18)(2008-8#37)(2008-9#17)(2009-10#4)(2009-11#7)(2009-12#18)(2009-2#1)(2009-3#8)(2009-4#12)(2009-5#1)(2009-6#7)(2009-7#2)(2009-8#5)(2009-9#3)(2010-1#5)(2010-11#4)(2010-12#12)(2010-2#16)(2010-3#9)(2010-4#33)(2010-5#31)(2010-8#6)(2010-9#2)(2011-1#22)(2011-12#8)(2011-2#33)(2011-3#5)(2012-11#10)(2012-12#17)(2012-2#21)(2012-3#6)(2012-6#2)(2012-9#1)(2013-1#41)(2013-7#7)(2013-8#33)
pH&gt##7##1##(2008-10#6)(2009-11#1)
pH&lt##3##1##(2008-10#3)
pH's##4##1##(1995-10#1)(2008-10#1)(2008-3#2)
pH(24)##2##1##(2010-2#1)(2010-4#1)
pH) and##3##2##(1991-2#1)(2008-10#2)
pH)##11##1##(1991-2#1)(1993-8#1)(1996-9#1)(2004-9#1)(2005-11#1)(2008-10#4)(2008-12#1)(2013-8#1)
pH*##2##1##(1991-9#1)(2008-10#1)
pH- and thermal stability##2##4##(2008-5#2)
pH-ISEs with##2##2##(2008-10#2)
pH-ISEs##3##1##(2008-10#3)
pH-Metric determination of acid##2##4##(2008-10#2)
pH-Metric##3##1##(2008-10#3)
pH-controlled##2##1##(1994-12#1)(2008-7#1)
pH-dependence of##5##2##(1991-5#1)(1992-2#1)(1994-8#1)(2008-8#2)
pH-dependent and##2##2##(1994-2#1)(2005-11#1)
pH-dependent changes##2##2##(1991-4#1)(1992-7#1)
pH-dependent conformational changes##2##3##(1992-7#1)(1997-7#1)
pH-dependent conformational##5##2##(1991-4#1)(1992-7#2)(1997-7#1)(2008-10#1)
pH-dependent phospholipase A2##3##3##(1991-1#3)
pH-dependent shift in pyruvate metabolism##2##5##(2008-6#2)
pH-dependent spectral changes##2##3##(1992-6#1)(1995-2#1)
pH-dependent spectral##3##2##(1992-6#1)(1995-2#1)(2008-10#1)
pH-dependent stability##2##2##(1990-8#1)(2008-5#1)
pH-dependent##63##1##(1990-2#2)(1990-3#1)(1990-5#3)(1990-8#1)(1991-1#3)(1991-4#3)(1991-5#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#3)(1992-8#2)(1993-9#1)(1994-2#3)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-11#1)(1996-7#2)(1997-3#2)(1997-5#1)(1997-7#4)(2005-11#2)(2006-10#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)(2012-11#2)(2012-2#1)
pH-electrode##2##1##(2008-10#2)
pH-independent intrinsic enthalpy of acylation##2##5##(1990-8#2)
pH-independent##6##1##(1990-5#1)(1990-8#2)(1991-9#1)(1994-11#1)(2009-3#1)
pH-induced##6##1##(1992-12#1)(1995-3#1)(1995-6#1)(1996-11#1)(2008-5#2)
pH-insensitive##3##1##(1990-2#1)(1997-4#1)(2009-8#1)
pH-metric data##2##2##(2008-10#2)
pH-metric titration##4##2##(2008-10#4)
pH-metric##17##1##(1996-2#1)(2006-2#1)(2008-10#15)
pH-metrically##2##1##(2008-10#1)(2008-5#1)
pH-metry and##3##2##(1996-3#3)
pH-metry##6##1##(1996-3#5)(2005-1#1)
pH-neutral##2##1##(2006-12#1)(2011-2#1)
pH-potentiometric##2##1##(2008-10#1)(2010-5#1)
pH-rate profile indicated specific##2##4##(2008-10#1)(2008-6#1)
pH-rate profile##4##2##(2008-10#2)(2008-3#1)(2008-6#1)
pH-rate##5##1##(1995-2#1)(2008-10#2)(2008-3#1)(2008-6#1)
pH-responsive hydrogel##2##2##(2007-10#2)
pH-responsive##4##1##(2007-10#2)(2012-11#2)
pH-selective##2##1##(2005-11#1)(2008-10#1)
pH-sensitive dye##2##2##(1997-1#1)(2007-12#1)
pH-sensitive field-effect transistors##3##3##(2008-10#3)
pH-sensitive hydrogels##2##2##(2013-7#2)
pH-sensitive polymer prepared##2##3##(2008-10#2)
pH-sensitive polymer##3##2##(2008-10#3)
pH-sensitive##30##1##(1990-2#1)(1990-5#1)(1992-7#1)(1993-9#1)(1997-1#2)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#2)(2009-10#1)(2009-11#2)(2009-2#1)(2012-1#1)(2013-1#1)(2013-7#3)
pH-sensitive-liposomes##2##1##(1997-1#2)
pH-sensitivity##2##1##(2009-10#1)(2013-8#1)
pH-sensors##2##1##(2008-10#1)(2013-8#1)
pH-stat##5##1##(2007-8#4)(2008-6#1)
pH-static titration##2##2##(2008-10#2)
pH-static##3##1##(2008-10#3)
pH-values##2##1##(2008-10#1)(2013-1#1)
pH/min##2##1##(1997-1#2)
pH1N1 and##2##2##(2012-2#2)
pH1N1##7##1##(2012-2#7)
pH6##4##1##(1990-11#1)(1992-11#1)(2008-10#2)
pH7##4##1##(1992-7#1)(1996-2#1)(2005-11#1)(2005-4#1)
pH=3##2##1##(2008-10#2)
pH=5##2##1##(2010-4#1)(2012-2#1)
pH=6##2##1##(2010-4#1)(2011-2#1)
pH=8##4##1##(2007-8#3)(2013-1#1)
pHAG3-1##2##1##(1996-7#2)
pHGP34##2##1##(1991-5#2)
pHSV-IL-1ra particles##2##2##(2008-8#2)
pHSV-IL-1ra##3##1##(2008-8#3)
pHSVLac##2##1##(2008-8#2)
pHg##2##1##(2008-10#1)(2011-1#1)
pHg/pSILBAγ was##2##2##(2011-1#2)
pHg/pSILBAγ##6##1##(2011-1#6)
pHi (7##2##2##(1992-4#2)
pHi and##2##2##(1991-5#1)(2008-9#1)
pHi decreased from 7##2##4##(1994-8#1)(2008-5#1)
pHi greater than##2##3##(1990-3#1)(1992-4#1)
pHi in##2##2##(1995-7#1)(2008-5#1)
pHi of##2##2##(1990-2#1)(1994-11#1)
pHi recovery##2##2##(1990-2#2)
pHi reduction##2##2##(1990-2#2)
pHi responses##2##2##(1994-11#2)
pHi set point##3##3##(1991-9#1)(1992-4#2)
pHi to##2##2##(1991-5#2)
pHi was##3##2##(1994-11#2)(2008-9#1)
pHi##50##1##(1990-2#11)(1990-3#1)(1991-5#5)(1991-9#2)(1992-4#6)(1992-5#1)(1994-11#11)(1994-6#2)(1994-8#2)(1995-7#1)(1997-1#1)(2007-10#1)(2008-5#3)(2008-9#2)(2010-8#1)
pHo 7##2##2##(1992-5#2)
pHo##3##1##(1991-1#1)(1992-5#2)
pHs of the##2##3##(2004-9#1)(2008-10#1)
pHs of##3##2##(2004-9#1)(2005-11#1)(2008-10#1)
pHs were##4##2##(1991-1#1)(2004-9#2)(2009-7#1)
pHs##29##1##(1990-10#1)(1991-1#1)(1991-7#1)(1991-8#1)(1992-12#1)(1993-9#2)(1994-11#1)(2004-9#4)(2005-11#6)(2008-10#8)(2009-7#1)(2011-12#1)(2013-1#1)
pHu##3##1##(2010-4#3)
pHvG38##2##1##(2008-5#2)
pH 8##2##1##(2012-12#2)
pI &gt##4##2##(1993-8#4)
pI &lt##3##2##(2010-8#3)
pI (5##2##2##(1994-8#1)(1994-9#1)
pI 4##4##2##(1992-1#2)(1994-12#1)(1997-1#1)
pI 5##3##2##(1990-7#1)(2008-11#2)
pI 6##5##2##(1992-7#2)(1993-4#2)(2008-8#1)
pI 7##3##2##(1992-1#1)(1992-7#1)(1993-4#1)
pI =##3##2##(1991-8#1)(1992-11#1)(1994-11#1)
pI of 10##3##3##(1991-6#1)(1991-8#1)(1995-2#1)
pI of 4##7##3##(1990-1#1)(1990-4#1)(1994-8#2)(1996-2#1)(2008-10#2)
pI of 5##4##3##(1990-5#1)(1990-7#1)(1995-6#1)(1996-5#1)
pI of 8##2##3##(1990-12#1)(2008-10#1)
pI of##25##2##(1990-1#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-8#1)(1994-8#2)(1995-2#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-1#1)(2006-10#1)(2007-7#1)(2008-10#5)
pI value of 5##2##4##(1991-11#1)(1993-3#1)
pI value of##5##3##(1991-11#2)(1993-3#1)(1994-8#1)(2008-6#1)
pI value##8##2##(1991-11#2)(1992-7#1)(1993-3#1)(1994-8#1)(2008-6#1)(2010-8#2)
pI values##6##2##(1990-10#1)(1990-7#1)(1992-12#1)(1992-2#1)(1994-8#1)(1996-12#1)
pI##85##1##(1990-1#1)(1990-10#2)(1990-11#1)(1990-12#2)(1990-4#1)(1990-5#3)(1990-7#4)(1991-11#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#3)(1991-9#1)(1992-1#4)(1992-11#1)(1992-12#2)(1992-2#1)(1992-7#4)(1992-8#1)(1993-3#1)(1993-4#3)(1993-8#4)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#5)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#2)(1997-3#1)(1997-6#1)(2006-10#1)(2007-7#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-4#1)(2010-8#5)(2011-2#1)
pI50##3##1##(1993-12#1)(1995-3#2)
pI6##3##1##(1991-12#3)
pIDM-T##3##1##(2013-1#3)
pIJ702 and expressed in##2##4##(1990-1#1)(1995-8#1)
pIJ702 as##2##2##(1990-3#1)(2008-9#1)
pIJ702##5##1##(1990-1#2)(1990-3#1)(1995-8#1)(2008-9#1)
pINSAT2##2##1##(1995-2#2)
pIRE##2##1##(1996-5#2)
pIVET8##3##1##(1995-1#3)
pIcalc =##2##2##(1991-8#2)
pIs of##2##2##(2008-10#1)(2008-6#1)
pJ of##2##2##(2007-11#1)(2007-12#1)
pJ to##2##2##(2007-11#2)
pJ##8##1##(2007-11#3)(2007-12#5)
pJM1##2##1##(2011-2#2)
pJM103##2##1##(1990-11#2)
pJalpha##3##1##(2008-7#3)
pK (a##2##2##(2008-10#2)
pK =##2##2##(1990-8#1)(1991-9#1)
pK of##11##2##(1990-12#1)(1990-8#1)(1991-3#1)(1992-7#2)(1993-8#1)(1994-2#1)(1994-5#2)(1995-8#1)(1996-5#1)
pK values for the##2##4##(1991-9#1)(2008-10#1)
pK values for##3##3##(1990-8#1)(1991-9#1)(2008-10#1)
pK values##11##2##(1990-11#3)(1990-7#1)(1990-8#1)(1991-4#1)(1991-9#2)(1995-2#1)(2008-10#2)
pK##40##1##(1990-11#5)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#4)(1991-3#1)(1991-4#1)(1991-9#3)(1992-7#3)(1993-8#1)(1994-2#1)(1994-5#3)(1994-9#1)(1995-10#1)(1995-2#3)(1995-8#1)(1996-5#1)(2005-11#2)(2008-10#4)(2008-9#2)
pK(0)##3##1##(2008-10#3)
pK(00)##3##1##(2008-10#3)
pK(1)##2##1##(2008-10#2)
pK(2)##3##1##(2008-10#3)
pK(2)&gt##2##1##(2008-10#2)
pK(K(+))(int)##2##1##(2005-11#2)
pK(Li(+))(int)##2##1##(2005-11#2)
pK(Na(+))(int)##2##1##(2005-11#2)
pK(a) and##4##2##(2008-10#3)(2009-9#1)
pK(a) of##4##2##(2008-10#4)
pK(a) values for##3##3##(1996-2#1)(2008-10#2)
pK(a) values from##2##3##(2008-10#2)
pK(a) values in##2##3##(2007-12#1)(2008-10#1)
pK(a) values of the##2##4##(2008-10#2)
pK(a) values of##6##3##(2008-10#5)(2008-4#1)
pK(a) values were##2##3##(2008-10#2)
pK(a) values##21##2##(1996-2#1)(2007-12#1)(2008-10#18)(2008-4#1)
pK(a) was##2##2##(2008-10#2)
pK(a)##46##1##(1996-2#2)(2006-12#1)(2007-12#3)(2008-10#36)(2008-4#1)(2009-8#1)(2009-9#1)(2010-5#1)
pK(a)'s##2##1##(2008-10#1)(2009-3#1)
pK(a)(T)##2##1##(2008-10#2)
pK(a)(T)(=)8##2##1##(2008-10#2)
pK(a)=10##2##1##(2006-10#2)
pK(a)s##2##1##(2008-10#2)
pK(a2)##2##1##(2008-10#2)
pK(app) values##2##2##(2008-10#2)
pK(app)##4##1##(2008-10#4)
pK(b)##2##1##(2008-10#2)
pKF2##6##1##(1993-12#6)
pKF3##5##1##(1993-12#5)
pKH47##2##1##(1996-2#2)
pKIL18/19##2##1##(1995-8#2)
pKK223-3##5##1##(1990-5#2)(1994-12#2)(1995-8#1)
pKK233-2##2##1##(1992-12#1)(1993-6#1)
pKYM is##3##2##(1997-6#3)
pKYM##6##1##(1997-6#6)
pKZ1##5##1##(2008-7#5)
pKa =##3##2##(1991-7#1)(1995-2#1)(1997-2#1)
pKa for the##2##3##(1995-3#1)(2005-11#1)
pKa of 11##2##3##(1995-5#1)(2008-10#1)
pKa of Asp 26##2##4##(1991-7#2)
pKa of a##2##3##(1991-5#1)(1991-7#1)
pKa of about 2##2##4##(1991-5#1)(1995-5#1)
pKa of the carboxylic acid##2##5##(1995-5#2)
pKa of the##7##3##(1991-7#3)(1993-8#2)(1995-5#2)
pKa of##21##2##(1990-8#1)(1991-4#1)(1991-5#2)(1991-7#7)(1991-8#1)(1993-2#1)(1993-8#2)(1995-5#5)(2008-10#1)
pKa shifts##3##2##(1996-8#2)(1997-2#1)
pKa value for the##2##4##(1991-4#1)(1994-11#1)
pKa value##9##2##(1991-4#2)(1991-7#1)(1992-6#1)(1994-11#1)(1995-5#1)(1997-2#1)(2008-10#1)(2008-6#1)
pKa values for##3##3##(1994-9#1)(1997-6#1)(2009-9#1)
pKa values of buried##2##4##(1997-2#2)
pKa values of##8##3##(1990-8#1)(1994-11#1)(1995-5#1)(1997-2#2)(2007-11#1)(2008-10#1)(2008-3#1)
pKa values were determined##3##4##(2007-11#2)(2009-9#1)
pKa values##19##2##(1990-8#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-5#3)(1997-2#3)(1997-6#1)(2007-11#3)(2008-10#2)(2008-3#1)(2009-9#2)
pKa##72##1##(1990-5#1)(1990-8#2)(1991-4#5)(1991-5#2)(1991-7#12)(1991-8#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-9#2)(1995-10#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#9)(1996-8#3)(1997-2#7)(1997-6#1)(2005-11#1)(2007-11#3)(2008-10#4)(2008-3#1)(2008-5#1)(2008-6#1)(2009-9#2)
pKa's of the##2##3##(2009-9#2)
pKa's##3##1##(1995-10#1)(2009-9#2)
pKa2##3##1##(1990-5#1)(2008-10#2)
pKi##2##1##(1991-5#1)(1994-9#1)
pL##4##1##(1990-11#1)(1990-9#1)(1993-9#1)(2006-5#1)
pLDH##4##1##(2006-10#4)
pLH and##2##2##(1994-12#2)
pLH##6##1##(1994-12#6)
pM and 1##2##3##(1990-3#1)(1991-2#1)
pM and a##2##3##(1990-5#1)(1992-6#1)
pM and maximum##2##3##(1994-2#1)(1995-5#1)
pM and##15##2##(1990-2#1)(1990-3#1)(1990-5#1)(1991-2#1)(1991-7#1)(1992-6#2)(1993-11#1)(1994-2#1)(1995-5#2)(1996-10#1)(1997-5#1)(2007-8#2)
pM for##4##2##(1991-7#2)(2008-10#1)(2011-1#1)
pM in the##2##3##(1991-7#1)(1995-6#1)
pM of##3##2##(2008-11#1)(2012-11#2)
pM to##2##2##(1994-11#1)(2005-8#1)
pM##66##1##(1990-2#2)(1990-3#2)(1990-5#1)(1990-7#1)(1990-9#1)(1991-2#3)(1991-4#1)(1991-7#4)(1992-6#4)(1992-8#1)(1992-9#1)(1993-11#2)(1993-7#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#2)(1995-2#1)(1995-3#1)(1995-5#5)(1995-6#1)(1996-10#3)(1996-5#1)(1997-5#2)(2005-8#1)(2007-8#3)(2008-10#3)(2008-11#6)(2008-5#2)(2010-4#1)(2011-1#1)(2012-11#2)
pM) and##3##2##(1993-11#1)(1994-8#1)(1995-2#1)
pM)##31##1##(1990-8#2)(1991-10#2)(1991-2#3)(1991-4#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#5)(1993-3#4)(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#4)(1995-5#1)(1996-5#1)(2009-3#1)
pMAG15##2##1##(2008-8#2)
pMAL##2##1##(1993-9#1)(2008-10#1)
pMBLcos##2##1##(1995-8#2)
pMCAO##2##1##(2011-2#2)
pMCP9 was##2##2##(1994-11#2)
pMCP9##3##1##(1994-11#3)
pMD18-T##3##1##(2005-11#3)
pMG36eF##2##1##(2005-11#2)
pMH-Neo##2##1##(1993-5#2)
pMIRY2##2##1##(1991-8#2)
pMLZ-4##6##1##(1993-2#6)
pMM237##2##1##(1990-11#2)
pMNC##3##1##(1996-3#3)
pMOSFET##5##1##(2009-3#5)
pMRfP##2##1##(1994-12#2)
pMT2-cytochrome P450##2##2##(1994-8#2)
pMW119##2##1##(1992-9#2)
pN##4##1##(1991-8#1)(1994-8#1)(2005-11#1)(2007-12#1)
pN0##2##1##(2007-6#1)(2007-8#1)
pN1##2##1##(2007-6#1)(2007-8#1)
pN2##3##1##(1992-5#1)(2007-8#2)
pNF-CAT##3##1##(1994-6#3)
pNF2176##2##1##(1997-2#2)
pNGT##6##1##(2008-3#6)
pNJI##2##1##(1990-5#2)
pNL-1##2##1##(2008-8#2)
pNPP##4##1##(1997-1#4)
pO(2) following##3##2##(2006-7#3)
pO(2) in##3##2##(2006-7#2)(2008-11#1)
pO(2)##15##1##(2006-7#9)(2008-11#5)(2008-4#1)
pO2##3##1##(1990-9#1)(1995-5#1)(2006-7#1)
pOCs into OCLs##2##3##(2008-11#2)
pOCs into##4##2##(2008-11#4)
pOCs##8##1##(2008-11#8)
pOGCT+OGTT-##4##1##(2008-3#4)
pOSEX##4##1##(1994-12#4)
pOX1054##2##1##(1995-8#2)
pPGN##4##1##(1995-3#4)
pPM927##2##1##(1990-9#2)
pPROM##5##1##(2006-8#5)
pQE30 vector##2##2##(1994-9#1)(1997-4#1)
pQE30##4##1##(1994-9#1)(1997-4#1)(2005-11#2)
pQuattro vectors##3##2##(2008-11#3)
pR490##6##1##(1991-7#6)
pRB binding##2##2##(1995-2#2)
pRB was##2##2##(1996-2#1)(2008-11#1)
pRB##11##1##(1993-6#3)(1995-2#3)(1996-2#2)(1997-1#1)(2008-11#1)(2013-1#1)
pRB's##2##1##(1993-6#2)
pRMT1 and##2##2##(1993-4#2)
pRMT3##2##1##(1993-4#2)
pRMT5##2##1##(1993-4#2)
pRNA synthesis##3##2##(1995-6#3)
pRNA##5##1##(1995-6#3)(2010-5#2)
pRT-9 protein##2##2##(1994-6#2)
pRT-9##3##1##(1994-6#3)
pRb##4##1##(1997-7#1)(2008-6#2)(2013-1#1)
pS (n = 11) at##2##5##(1995-6#2)
pS (n =##3##3##(1995-6#2)(1995-8#1)
pS at##2##2##(1994-12#1)(1994-3#1)
pS in##5##2##(1990-10#1)(1992-8#3)(1993-3#1)
pS state##2##2##(1990-7#2)
pS##27##1##(1990-10#1)(1990-11#1)(1990-7#2)(1991-2#5)(1991-5#1)(1992-7#1)(1992-8#3)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-11#2)(1995-6#2)(1995-8#1)(1996-9#1)(1997-7#1)
pS) and##2##2##(1994-3#2)
pS) were##2##2##(1994-3#1)(1995-8#1)
pS)##7##1##(1990-2#1)(1990-7#1)(1994-3#4)(1995-8#1)
pS1##2##1##(1993-9#1)(1995-8#1)
pS2 gene##4##2##(1990-2#4)
pS2 is##2##2##(1990-2#1)(1996-3#1)
pS2 protein##5##2##(1990-2#2)(1995-9#3)
pS2##18##1##(1990-2#8)(1995-9#3)(1996-11#2)(1996-3#5)
pSAM2##3##1##(1990-9#3)
pSC101##2##1##(1997-2#1)(2006-10#1)
pSD5C##2##1##(1997-4#2)
pSG5tag##2##1##(1992-5#2)
pSILBA##2##1##(2011-1#2)
pSILBAγ##4##1##(2011-1#4)
pSK6##4##1##(1992-9#4)
pSKStrB##2##1##(1994-12#2)
pSR1##2##1##(1991-8#2)
pSS##2##1##(1992-3#2)
pSTL70##6##1##(2008-10#6)
pSV2cat##2##1##(1990-3#2)
pSV2neo and##2##2##(1992-5#1)(1994-5#1)
pSV2neo##4##1##(1992-5#1)(1994-5#1)(1995-11#1)(1996-6#1)
pSVL##3##1##(1993-12#1)(2008-11#2)
pT1##2##1##(2011-2#2)
pT2##4##1##(2006-6#1)(2011-1#1)(2011-2#2)
pT3##8##1##(1992-5#1)(2006-6#1)(2011-1#1)(2011-2#5)
pT4##2##1##(1992-5#1)(2011-2#1)
pTC excitability##2##2##(2012-2#2)
pTC using##2##2##(2012-2#2)
pTC##6##1##(2012-2#6)
pTLA-GH##3##1##(2010-5#3)
pTNM##3##1##(1994-8#1)(2007-1#1)(2008-10#1)
pTRE-CAT expression##2##2##(1994-6#2)
pTRE-CAT##3##1##(1994-6#3)
pTet-tTAk##4##1##(2008-1#2)(2008-2#2)
pTyr mimetic##2##2##(1994-6#1)(2006-12#1)
pTyr##11##1##(1994-5#7)(1994-6#2)(2006-12#2)
pU6RZ107##3##1##(2008-9#3)
pUB110##2##1##(1990-9#2)
pUC plasmids##2##2##(1990-9#2)
pUC##5##1##(1990-5#1)(1990-7#1)(1990-9#2)(1995-8#1)
pUC-derived##2##1##(1991-9#1)(1994-12#1)
pUC-type##2##1##(1990-9#1)(1993-11#1)
pUC118##2##1##(1990-10#1)(1990-5#1)
pUC18##12##1##(1991-5#1)(1991-9#1)(1992-3#1)(1993-11#1)(1994-12#1)(1996-5#2)(2005-11#1)(2006-8#1)(2008-10#2)(2008-5#1)
pUC19 and##3##2##(1991-7#1)(1992-3#1)(1994-12#1)
pUC19 plasmid##2##2##(1990-5#1)(1995-11#1)
pUC19##12##1##(1990-5#1)(1991-7#3)(1991-9#1)(1992-3#1)(1993-11#1)(1993-4#1)(1994-12#1)(1995-11#1)(2008-4#1)(2008-8#1)
pUC19-based gene bank in E##2##5##(1990-10#1)(1990-3#1)
pUC19-based##3##1##(1990-10#1)(1990-3#1)(1996-12#1)
pUCR1##2##1##(2008-7#2)
pUCR2##2##1##(2008-7#2)
pUFR027##2##1##(1990-3#2)
pUFR034##2##1##(1990-3#2)
pUK##3##1##(1994-12#3)
pUS9##3##1##(2013-8#3)
pUS9-deleted ILTV##2##2##(2013-8#2)
pVAX1hsp70##2##1##(2009-5#2)
pVHL##2##1##(2012-12#2)
pVIII##3##1##(2008-10#1)(2009-2#2)
pVK102##2##1##(1990-3#1)(2008-6#1)
pVL1393##2##1##(1997-4#2)
pVO2##3##1##(2005-1#3)
pW##2##1##(2008-3#2)
pWH14##2##1##(1997-8#2)
pYFC1##2##1##(1997-2#2)
pYME1 and pYME2##2##3##(1993-12#2)
pYZ4##2##1##(1990-11#2)
pYeDP1/8-2##2##1##(1990-12#2)
p[H]##2##1##(2008-10#2)
pa##5##1##(1996-2#4)(2008-11#1)
paCO2##2##1##(1990-4#1)(1997-4#1)
pac##5##1##(1990-3#5)
paca##7##1##(2007-9#2)(2008-5#4)(2013-7#1)
pace and##3##2##(1993-2#1)(2008-12#1)(2013-8#1)
pace in##2##2##(1994-2#1)(2008-12#1)
pace of information##2##3##(1995-2#1)(1996-2#1)
pace of##16##2##(1990-4#1)(1995-2#1)(1996-2#1)(2006-12#1)(2007-12#1)(2007-4#1)(2008-3#2)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)
pace than##2##2##(2008-7#1)(2013-8#1)
pace with the rapid##2##4##(1996-2#1)(2007-6#1)
pace with the##6##3##(1996-2#1)(1996-5#1)(2005-5#1)(2007-11#1)(2007-6#1)(2008-10#1)
pace with this##2##3##(2008-3#1)(2013-1#1)
pace with##14##2##(1991-2#1)(1996-2#2)(1996-5#1)(2005-5#1)(2006-2#1)(2006-8#2)(2007-11#1)(2007-6#1)(2008-10#1)(2008-3#1)(2010-11#1)(2013-1#1)
pace##57##1##(1990-4#1)(1991-12#1)(1991-2#1)(1992-3#1)(1993-2#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-2#3)(1996-3#1)(1996-5#1)(1996-7#1)(1997-3#1)(2005-5#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#4)(2008-7#1)(2009-3#1)(2009-5#1)(2009-6#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
paced at a##2##3##(1990-2#1)(1995-12#1)
paced rhythm##4##2##(2007-8#2)(2012-2#1)(2013-1#1)
paced##15##1##(1990-2#1)(1992-5#1)(1995-12#1)(1996-9#1)(2007-8#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#2)(2009-3#1)(2012-2#2)(2013-1#1)
pacemaker activity in##2##3##(1996-2#2)
pacemaker and##4##2##(1995-5#1)(1996-3#1)(2006-9#1)(2008-12#1)
pacemaker for##2##2##(2007-9#1)(2008-7#1)
pacemaker implantation##10##2##(1993-10#1)(1997-1#3)(2008-3#2)(2010-7#1)(2011-2#1)(2013-8#2)
pacemaker in the eye##2##4##(1994-2#2)
pacemaker induction##2##2##(1993-4#2)
pacemaker lead##2##2##(2006-9#1)(2010-2#1)
pacemaker neurons##2##2##(1994-2#2)
pacemaker or##3##2##(2011-2#1)(2012-2#2)
pacemaker systems##2##2##(2006-9#1)(2012-2#1)
pacemaker was##5##2##(1992-5#1)(2007-8#1)(2008-4#1)(2009-4#1)(2010-4#1)
pacemaker##83##1##(1992-1#1)(1992-4#1)(1992-5#1)(1993-10#2)(1993-4#2)(1993-8#1)(1994-11#2)(1994-2#6)(1995-12#1)(1995-5#2)(1996-2#3)(1996-3#1)(1996-6#1)(1997-1#5)(1997-4#4)(1997-5#1)(2006-10#1)(2006-9#6)(2007-8#1)(2007-9#2)(2008-11#1)(2008-12#1)(2008-3#5)(2008-4#3)(2008-5#2)(2008-7#2)(2009-2#1)(2009-4#3)(2009-5#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-2#7)(2013-8#2)
pacemaker]##3##1##(1990-12#1)(1992-4#1)(1997-4#1)
pacemakers and defibrillators##2##3##(2010-5#2)
pacemakers and##5##2##(2009-12#1)(2010-5#2)(2011-2#2)
pacemakers for sick sinus syndrome##2##5##(1997-1#1)(2007-8#1)
pacemakers from##2##2##(1992-6#1)(1994-11#1)
pacemakers have##2##2##(1990-12#1)(2008-5#1)
pacemakers were##2##2##(1994-11#1)(2011-2#1)
pacemakers##31##1##(1990-12#1)(1992-10#1)(1992-4#1)(1992-6#1)(1994-11#3)(1994-5#1)(1995-8#1)(1997-1#1)(2006-10#1)(2006-9#6)(2007-8#1)(2008-4#3)(2008-5#1)(2009-12#1)(2010-5#2)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#1)
pacemaking##5##1##(1997-4#3)(2008-1#1)(2009-5#1)
pachydermatis isolated##2##2##(2007-7#1)(2008-5#1)
pachydermatis##6##1##(2007-7#4)(2008-5#2)
pachymeningitis##2##1##(1996-9#1)(2008-7#1)
pachymetry##5##1##(2007-3#1)(2010-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
pachyrhizi and P##3##3##(2008-10#3)
pachyrhizi and##4##2##(2008-10#4)
pachyrhizi##11##1##(2008-10#11)
pachyrhyncha##3##1##(2007-2#3)
pachytene and##2##2##(2008-5#2)
pachytene bivalents with##2##3##(2008-9#2)
pachytene spermatocytes and##2##3##(1992-5#1)(2012-2#1)
pachytene spermatocytes##7##2##(1990-11#2)(1992-2#1)(1992-5#1)(2012-2#3)
pachytene##16##1##(1990-11#2)(1990-8#1)(1992-2#1)(1992-5#1)(1995-8#1)(2008-5#4)(2008-9#2)(2012-2#4)
pacific division meeting##6##3##(2008-11#6)
pacific yew##2##2##(1994-11#2)
pacific##17##1##(1994-11#2)(2007-3#1)(2008-1#2)(2008-10#2)(2008-11#6)(2012-2#2)(2013-1#1)(2013-7#1)
pacifica##3##1##(2011-2#1)(2012-2#2)
pacificus nymphs##2##2##(2004-11#2)
pacificus##15##1##(2004-11#4)(2007-12#7)(2007-7#1)(2010-6#2)(2010-9#1)
pacifier stiffness##3##2##(2009-6#3)
pacifier use##8##2##(2007-1#1)(2007-10#6)(2013-7#1)
pacifier##13##1##(2007-1#1)(2007-10#6)(2009-2#1)(2009-6#4)(2013-7#1)
pacifiers##7##1##(2007-10#2)(2007-9#1)(2009-6#4)
pacifism##2##1##(2013-8#2)
pacing are##2##2##(1992-5#1)(2012-2#1)
pacing at##2##2##(1992-5#1)(1997-1#1)
pacing for##3##2##(1997-1#1)(2005-12#1)(2006-9#1)
pacing in##5##2##(1992-5#1)(2006-9#1)(2008-2#1)(2008-4#1)(2012-2#1)
pacing is##3##2##(1997-4#1)(2007-8#1)(2008-4#1)
pacing of##2##2##(1997-1#1)(2012-2#1)
pacing significantly reduces the incidence of atrial fibrillation##2##8##(2007-8#2)
pacing site##3##2##(2006-9#2)(2011-2#1)
pacing was##2##2##(1992-5#1)(2007-8#1)
pacing##64##1##(1990-12#3)(1990-3#1)(1992-5#8)(1993-8#1)(1996-12#1)(1996-9#4)(1997-1#3)(1997-4#1)(2005-12#1)(2006-9#15)(2007-8#7)(2008-1#1)(2008-2#1)(2008-4#5)(2009-11#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#1)
pacing-induced##2##1##(1996-12#1)(2005-10#1)
pack warnings##2##2##(2012-2#2)
pack##27##1##(1991-9#1)(1993-8#1)(1995-5#1)(1995-7#1)(1996-1#1)(1997-7#1)(2006-10#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#2)(2010-12#1)(2012-12#5)(2012-2#2)(2013-4#1)(2013-8#1)
package and##6##2##(1991-8#1)(1995-8#1)(2008-10#1)(2008-3#1)(2012-1#1)(2012-3#1)
package can be##2##3##(2008-4#2)
package can##3##2##(2006-10#1)(2008-4#2)
package effects##3##2##(2008-3#3)
package for social sciences (SPSS)##2##5##(2007-7#1)(2012-2#1)
package for social sciences##3##4##(2007-7#1)(2012-2#2)
package for##15##2##(1996-12#1)(2006-5#2)(2007-7#2)(2008-4#2)(2008-7#1)(2009-6#1)(2010-5#1)(2011-1#2)(2011-3#1)(2012-2#2)
package has##3##2##(2008-11#1)(2008-4#1)(2012-2#1)
package in##4##2##(1995-3#1)(2008-3#1)(2011-1#1)(2011-2#1)
package insert##5##2##(1997-6#1)(2006-10#2)(2006-11#1)(2006-8#1)
package inserts##3##2##(1992-12#1)(2006-10#1)(2008-11#1)
package is##8##2##(1991-5#1)(2006-11#1)(2006-5#2)(2008-11#1)(2008-2#1)(2008-4#1)(2010-11#1)
package of the##2##3##(1992-5#1)(2008-3#1)
package of##13##2##(1991-5#2)(1992-5#1)(1993-3#1)(1994-2#1)(1995-6#1)(2006-10#1)(2008-1#1)(2008-3#1)(2008-9#1)(2010-12#1)(2010-2#1)(2012-3#1)
package sizing##4##2##(2005-10#4)
package that##4##2##(2006-10#1)(2007-1#1)(2008-10#1)(2008-12#1)
package the##2##2##(1992-8#1)(2011-1#1)
package to##6##2##(1997-5#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-4#1)(2011-1#1)
package was##2##2##(2007-7#1)(2012-2#1)
package will##2##2##(1994-8#1)(2008-6#1)
package##171##1##(1990-5#1)(1991-3#3)(1991-5#3)(1991-8#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-8#3)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#2)(1997-5#1)(1997-6#1)(2005-10#4)(2006-10#6)(2006-11#2)(2006-12#1)(2006-5#4)(2006-7#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-7#3)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#5)(2008-11#6)(2008-12#2)(2008-2#9)(2008-3#15)(2008-4#17)(2008-5#4)(2008-6#1)(2008-7#3)(2008-9#4)(2009-11#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-5#3)(2010-8#2)(2011-1#6)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#8)(2012-3#4)(2013-1#1)
package)##2##1##(2006-12#1)(2008-10#1)
packaged and##4##2##(1990-5#1)(1991-5#1)(2010-1#1)(2010-4#1)
packaged beef was##2##3##(2010-4#2)
packaged beef##6##2##(2010-4#4)(2011-1#2)
packaged in vitro##2##3##(1990-11#1)(1994-3#1)
packaged in##9##2##(1990-11#1)(1994-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#2)
packaged into the##2##3##(1997-1#1)(2013-8#1)
packaged into##5##2##(1992-5#1)(1995-8#1)(1997-1#1)(2008-8#1)(2013-8#1)
packaged single-stranded##2##2##(1990-9#1)(1991-5#1)
packaged##57##1##(1990-11#1)(1990-5#2)(1990-9#1)(1991-5#5)(1992-5#1)(1992-8#1)(1993-6#1)(1994-3#1)(1995-8#1)(1996-2#1)(1997-1#1)(2007-12#5)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-1#1)(2010-4#12)(2011-1#2)(2011-2#1)(2013-1#4)(2013-8#1)
packages and##3##2##(1992-12#1)(1997-2#1)(2008-4#1)
packages have##2##2##(1994-12#1)(2010-7#1)
packages that##2##2##(2008-12#1)(2008-7#1)
packages##36##1##(1992-12#1)(1992-2#1)(1994-12#2)(1994-8#2)(1995-12#1)(1997-2#1)(1997-7#1)(2006-2#1)(2006-8#2)(2007-11#1)(2007-4#1)(2008-10#4)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-7#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-7#1)(2013-1#3)(2013-7#1)
packaging and##7##2##(2008-1#1)(2008-11#1)(2008-6#2)(2008-9#1)(2009-11#1)(2010-4#1)
packaging approach in which free-space optical##2##6##(2008-3#2)
packaging architecture is based on a modified folded##2##8##(2008-3#2)
packaging cell lines##3##3##(1990-5#2)(2008-4#1)
packaging cell##4##2##(1990-5#2)(2008-4#1)(2008-9#1)
packaging cells##2##2##(1995-5#1)(2008-8#1)
packaging for##3##2##(2010-7#1)(2011-1#1)(2013-7#1)
packaging in##3##2##(1991-5#1)(1993-6#1)(2006-10#1)
packaging is##3##2##(1994-3#1)(1994-9#1)(2010-7#1)
packaging materials##4##2##(2008-10#2)(2008-5#1)(2010-7#1)
packaging motor##3##2##(2010-5#3)
packaging of DNA##2##3##(1993-2#1)(1994-9#1)
packaging of the##4##3##(2005-8#1)(2008-11#1)(2008-2#1)(2010-2#1)
packaging of##14##2##(1990-5#1)(1993-2#1)(1994-9#2)(1996-12#1)(1997-5#1)(1997-6#1)(2005-8#1)(2008-11#1)(2008-2#1)(2008-4#2)(2009-8#1)(2010-2#1)
packaging should##2##2##(1994-3#2)
packaging signal##2##2##(1994-12#1)(1996-4#1)
packaging solution##2##2##(2008-3#2)
packaging system##8##2##(1996-2#2)(1996-8#1)(2008-4#1)(2008-8#4)
packaging systems##2##2##(2008-4#1)(2008-9#1)
packaging technique##2##2##(2008-2#1)(2012-11#1)
packaging that##2##2##(1994-3#1)(2008-2#1)
packaging##142##1##(1990-11#4)(1990-3#3)(1990-5#4)(1991-5#2)(1992-2#1)(1992-8#2)(1993-2#1)(1993-6#1)(1994-12#1)(1994-3#4)(1994-9#3)(1995-5#1)(1996-12#2)(1996-2#3)(1996-4#1)(1996-8#4)(1997-1#2)(1997-3#1)(1997-5#1)(1997-6#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#3)(2006-4#1)(2007-12#2)(2007-4#1)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#5)(2008-2#5)(2008-3#11)(2008-4#7)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#6)(2008-9#5)(2009-11#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-4#7)(2010-5#3)(2010-7#8)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#1)
packed against a##3##3##(1992-8#1)(1994-11#1)(2010-10#1)
packed and##7##2##(1994-5#1)(1994-9#1)(2008-10#2)(2008-7#1)(2008-9#2)
packed bed##4##2##(1997-2#1)(2008-11#3)
packed by##2##2##(2008-10#1)(2008-9#1)
packed cell volume (PCV)##2##4##(2007-1#1)(2013-8#1)
packed cell volume##6##3##(2007-1#1)(2007-2#1)(2009-5#1)(2010-2#1)(2012-1#1)(2013-8#1)
packed cell##7##2##(2007-1#1)(2007-2#1)(2008-11#1)(2009-5#1)(2010-2#1)(2012-1#1)(2013-8#1)
packed cells##3##2##(2008-10#3)
packed column for the##2##4##(2005-12#1)(2008-10#1)
packed column supercritical fluid chromatography##6##5##(2008-10#6)
packed column supercritical fluid##7##4##(2008-10#7)
packed column##16##2##(2005-12#1)(2008-10#14)(2010-4#1)
packed in a column and determined##5##6##(2008-10#5)
packed in a column##8##4##(2008-10#8)
packed in a flow cell##2##5##(2008-10#2)
packed in a mini-column##2##4##(2008-10#2)
packed in a minicolumn##4##4##(2008-10#4)
packed in a##22##3##(1991-5#1)(2008-10#21)
packed in the##3##3##(1990-7#1)(2006-10#1)(2007-8#1)
packed in##29##2##(1990-7#1)(1991-5#1)(2006-10#1)(2006-5#1)(2007-8#1)(2008-10#23)(2008-5#1)
packed into a column##2##4##(1990-8#1)(1991-8#1)
packed into a small##2##4##(2008-10#2)
packed into a##10##3##(1990-8#1)(1991-8#1)(2007-8#2)(2008-10#6)
packed into##16##2##(1990-7#1)(1990-8#1)(1991-8#1)(2007-8#3)(2008-10#8)(2010-5#1)(2013-8#1)
packed minicolumn is proposed for##2##5##(2008-10#2)
packed minicolumn##4##2##(2008-10#4)
packed red blood cell transfusion##2##5##(2008-7#1)(2012-2#1)
packed red blood cell##5##4##(2007-11#1)(2008-7#2)(2010-7#1)(2012-2#1)
packed red blood cells##2##4##(2010-7#1)(2010-8#1)
packed red blood##7##3##(2007-11#1)(2008-7#2)(2010-7#2)(2010-8#1)(2012-2#1)
packed red cells##3##3##(2006-10#1)(2008-10#1)(2013-1#1)
packed red##10##2##(2006-10#1)(2007-11#1)(2008-10#1)(2008-7#2)(2010-7#2)(2010-8#1)(2012-2#1)(2013-1#1)
packed with 1##2##3##(2008-10#2)
packed with Amberlite##2##3##(2008-10#2)
packed with Chlorella vulgaris immobilised on silica gel##2##8##(2008-10#2)
packed with YPA(4) chelating resin##2##5##(2008-10#2)
packed with a solid##2##4##(2008-10#2)
packed with a##9##3##(2008-10#9)
packed with activated carbon##3##4##(2008-10#3)
packed with activated##5##3##(2008-10#5)
packed with autologous bone##2##4##(2006-8#2)
packed with immobilized##2##3##(2008-10#2)
packed with polytetrafluoroethylene (PTFE)##2##4##(2008-10#2)
packed with polyurethane foam##2##4##(2008-10#2)
packed with silica gel modified with##4##6##(2008-10#4)
packed with silica gel##6##4##(2008-10#6)
packed with the##3##3##(2008-10#3)
packed with##83##2##(1990-3#1)(1990-6#1)(1990-8#2)(1991-5#1)(1991-7#1)(1991-8#1)(1997-3#1)(2005-11#1)(2005-4#1)(2006-8#2)(2007-7#2)(2008-10#63)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-9#1)(2012-3#1)
packed##256##1##(1990-3#1)(1990-6#1)(1990-7#2)(1990-8#4)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1992-12#1)(1992-6#1)(1992-8#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-12#1)(1996-3#2)(1996-4#1)(1997-2#1)(1997-3#2)(2005-11#5)(2005-12#2)(2005-4#1)(2005-7#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-12#6)(2007-2#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-10#130)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#4)(2008-6#4)(2008-7#8)(2008-8#1)(2008-9#4)(2009-2#1)(2009-3#1)(2009-5#4)(2009-7#1)(2010-10#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
packed-bed bioreactor##4##2##(2008-11#2)(2008-7#2)
packed-bed reactor at 37 degrees C##2##6##(2004-8#2)
packed-bed reactor for##2##3##(2004-8#1)(2008-11#1)
packed-bed reactor##6##2##(2004-8#5)(2008-11#1)
packed-bed systems##2##2##(1996-8#2)
packed-bed##15##1##(1996-8#4)(2004-8#5)(2008-10#1)(2008-11#3)(2008-7#2)
packed-bedreactor##3##1##(2008-11#3)
packed-column##2##1##(2008-10#2)
packet loss rate##6##3##(2008-3#6)
packet switches##4##2##(2008-3#4)
packet switching##3##2##(2007-12#1)(2008-3#2)
packet##42##1##(1993-10#1)(1993-5#1)(2004-9#1)(2007-1#1)(2007-12#6)(2008-2#10)(2008-3#20)(2008-5#2)
packets and##4##2##(1995-11#1)(2008-2#3)
packets for##2##2##(1995-7#1)(2008-2#1)
packets in##2##2##(2007-12#1)(2008-3#1)
packets with##2##2##(2008-2#1)(2008-3#1)
packets##26##1##(1993-10#1)(1995-11#1)(1995-7#1)(2007-12#3)(2008-11#1)(2008-2#8)(2008-3#7)(2008-5#1)(2013-1#2)(2013-8#1)
packing and its##2##3##(2008-10#1)(2009-11#1)
packing and##10##2##(1992-6#1)(1993-8#1)(2005-11#1)(2008-10#1)(2008-4#2)(2008-8#1)(2009-11#1)(2010-4#1)(2011-2#1)
packing arrangement##3##2##(1992-6#1)(1993-6#1)(2008-5#1)
packing by##4##2##(1996-4#1)(2012-12#2)(2013-8#1)
packing densities##4##2##(1996-4#1)(2008-3#2)(2010-4#1)
packing density of the##2##4##(1994-11#1)(2008-3#1)
packing density of##6##3##(1994-11#1)(2008-12#1)(2008-3#2)(2008-9#1)(2013-1#1)
packing density##23##2##(1990-11#1)(1990-4#1)(1990-5#1)(1991-3#1)(1992-1#1)(1994-11#1)(1996-4#3)(1997-4#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-9#1)(2013-1#1)(2013-7#1)
packing effects##2##2##(1990-7#1)(1997-1#1)
packing gels##2##2##(1990-3#2)
packing has been##2##3##(2008-10#1)(2009-11#1)
packing has##3##2##(2008-10#2)(2009-11#1)
packing in the##6##3##(1991-2#2)(1995-8#1)(2005-11#1)(2007-8#1)(2008-10#1)
packing in##11##2##(1991-10#1)(1991-2#3)(1992-6#1)(1995-8#1)(1996-4#1)(2005-11#2)(2007-8#1)(2008-10#1)
packing interactions in the##2##4##(1997-4#1)(2011-2#1)
packing interactions##6##2##(1991-4#2)(1992-12#1)(1996-4#1)(1997-4#1)(2011-2#1)
packing is##2##2##(2007-11#1)(2008-10#1)
packing material for##2##3##(2007-8#1)(2008-10#1)
packing material##9##2##(2006-8#1)(2007-8#1)(2008-10#5)(2012-12#1)(2013-8#1)
packing materials##7##2##(1990-12#4)(2008-10#2)(2013-8#1)
packing may##2##2##(2008-7#1)(2009-11#1)
packing of lipid##2##3##(1996-1#1)(2006-10#1)
packing of the##15##3##(1990-2#1)(1991-2#1)(1992-7#1)(1995-4#1)(1996-9#1)(1997-3#1)(1997-6#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#2)(2012-3#1)
packing of##30##2##(1990-2#1)(1991-2#2)(1992-6#1)(1992-7#2)(1993-11#1)(1994-5#1)(1995-4#1)(1996-1#1)(1996-4#1)(1996-9#1)(1997-3#1)(1997-6#1)(2005-11#3)(2006-10#1)(2006-12#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2012-3#1)
packing structure##2##2##(1991-12#1)(2005-11#1)
packing the##3##2##(2008-10#3)
packing unit##2##2##(1993-6#2)
packing##194##1##(1990-11#2)(1990-12#5)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#1)(1991-10#2)(1991-12#1)(1991-2#5)(1991-3#1)(1991-4#3)(1991-5#2)(1991-8#1)(1992-1#2)(1992-12#2)(1992-6#6)(1992-7#3)(1992-9#1)(1993-11#1)(1993-6#3)(1993-8#2)(1994-11#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-4#2)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#2)(1996-1#1)(1996-4#9)(1996-6#1)(1996-8#4)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#1)(2005-11#9)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#4)(2007-12#2)(2007-8#6)(2008-10#31)(2008-12#1)(2008-2#5)(2008-3#7)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#4)(2008-9#2)(2009-11#3)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#2)(2012-12#7)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#5)
packinghouse##2##1##(2008-10#1)(2011-2#1)
packinghouses##4##1##(2008-10#4)
packings##15##1##(1990-12#4)(1990-3#1)(1991-8#6)(2008-10#4)
packs of##2##2##(2008-6#1)(2013-1#1)
packs to##2##2##(2006-10#1)(2006-4#1)
packs##19##1##(1991-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1997-4#1)(2006-10#2)(2006-4#1)(2007-2#1)(2008-6#3)(2009-10#1)(2009-6#2)(2010-12#1)(2010-3#2)(2013-1#1)
paclitaxel (Taxol)##2##2##(2005-11#1)(2008-1#1)
paclitaxel and carboplatin##3##3##(2005-8#1)(2012-3#1)(2013-1#1)
paclitaxel and docetaxel##2##3##(1997-1#2)
paclitaxel and doxorubicin##2##3##(2010-2#1)(2011-2#1)
paclitaxel and##13##2##(1997-1#2)(2005-8#1)(2006-10#1)(2008-2#1)(2008-7#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
paclitaxel at##2##2##(2004-1#1)(2008-3#1)
paclitaxel for##2##2##(2005-11#1)(2008-8#1)
paclitaxel formulation##2##2##(2008-3#2)
paclitaxel in##5##2##(2007-10#1)(2008-3#1)(2009-4#1)(2012-11#1)(2013-7#1)
paclitaxel resistance##6##2##(2010-11#6)
paclitaxel therapy##3##2##(2005-11#1)(2008-9#2)
paclitaxel treatment##2##2##(2010-11#2)
paclitaxel was##2##2##(2011-2#1)(2012-11#1)
paclitaxel with##3##2##(1996-10#1)(1997-4#1)(2011-2#1)
paclitaxel##94##1##(1995-8#1)(1996-10#1)(1997-1#2)(1997-4#7)(2003-11#1)(2004-1#3)(2005-11#4)(2005-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-7#3)(2008-1#1)(2008-2#1)(2008-3#11)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#3)(2009-4#5)(2009-8#2)(2010-11#10)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#6)(2012-11#6)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
paclitaxel-eluting stent##3##2##(2008-11#2)(2009-5#1)
paclitaxel-eluting stents##4##2##(2008-11#2)(2008-12#1)(2009-5#1)
paclitaxel-eluting##10##1##(2008-11#5)(2008-12#1)(2009-5#2)(2010-4#1)(2010-5#1)
paclitaxel-induced##2##1##(2008-1#1)(2009-4#1)
paclitaxel-mediated##2##1##(2008-7#1)(2011-2#1)
pact##8##1##(1990-2#2)(1992-6#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-7#1)(2013-1#1)
pacts with##2##2##(1990-7#1)(2008-8#1)
pacts##4##1##(1990-7#1)(1994-2#1)(1997-7#1)(2008-8#1)
pacu (Piaractus mesopotamicus)##2##3##(2008-7#2)
pacu##6##1##(2008-7#6)
pad and##2##2##(2006-3#1)(2011-1#1)
pad is##2##2##(2006-4#1)(2011-12#1)
pad of##2##2##(1995-11#1)(2012-3#1)
pad##39##1##(1990-11#2)(1992-1#1)(1993-6#1)(1995-11#1)(2006-3#1)(2006-4#2)(2006-8#1)(2007-12#1)(2007-4#2)(2008-11#2)(2008-12#3)(2008-5#4)(2008-9#4)(2009-10#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-12#5)(2011-2#1)(2012-12#3)(2012-3#1)
padded interfaces##2##2##(2007-4#2)
padded##11##1##(2006-11#2)(2007-4#8)(2008-5#1)
padding and##2##2##(2007-4#2)
padding materials##2##2##(2007-4#2)
padding##13##1##(2007-4#13)
paddle and##2##2##(2008-4#1)(2010-12#1)
paddle##9##1##(2006-3#2)(2008-1#1)(2008-11#1)(2008-4#2)(2010-12#2)(2012-2#1)
paddles##2##1##(2010-9#2)
paddlewheel##3##1##(2009-11#2)(2009-3#1)
paddock##2##1##(1991-8#1)(2005-5#1)
paddocks##4##1##(1996-12#2)(2007-8#1)(2012-12#1)
paddy field##2##2##(2013-8#2)
paddy fields##3##2##(2008-3#2)(2012-1#1)
paddy##13##1##(2008-12#6)(2008-3#2)(2012-1#1)(2013-8#4)
padi and##2##2##(2008-10#2)
padi can##2##2##(2008-10#2)
padi clones##2##2##(2008-10#2)
padi during##2##2##(2008-10#2)
padi was##2##2##(2008-10#2)
padi##19##1##(2008-10#19)
padlock probes##4##2##(2008-4#3)(2008-9#1)
pads are##3##2##(2008-3#2)(2008-4#1)
pads for##2##2##(2008-2#1)(2008-3#1)
pads in##2##2##(1996-2#1)(1997-4#1)
pads##27##1##(1991-7#1)(1993-7#1)(1995-12#1)(1995-8#1)(1996-2#2)(1997-3#1)(1997-4#3)(2006-12#1)(2007-4#3)(2007-5#2)(2008-11#4)(2008-2#2)(2008-3#3)(2008-4#1)(2012-12#1)
padus##2##1##(2008-10#2)
paediatric Cushing's disease##5##3##(2006-9#5)
paediatric HIV##2##2##(2009-3#1)(2009-7#1)
paediatric acute##2##2##(2008-11#1)(2009-5#1)
paediatric age group##10##3##(2006-4#2)(2007-8#1)(2008-11#1)(2009-10#1)(2012-2#2)(2013-8#3)
paediatric age##12##2##(2006-4#2)(2007-8#1)(2008-11#1)(2008-9#1)(2009-10#1)(2012-2#2)(2013-1#1)(2013-8#3)
paediatric airway##5##2##(2005-11#1)(2006-10#2)(2013-1#2)
paediatric ambulatory##3##2##(2006-10#2)(2008-11#1)
paediatric anaesthesia##9##2##(2006-10#7)(2010-7#1)(2013-1#1)
paediatric and adult##6##3##(2008-4#1)(2008-9#3)(2010-10#1)(2012-1#1)
paediatric and##14##2##(2006-10#1)(2008-11#3)(2008-4#1)(2008-9#4)(2010-10#1)(2012-1#1)(2012-12#2)(2012-3#1)
paediatric asthma##2##2##(2005-11#2)
paediatric cancer##2##2##(2008-11#2)
paediatric cardiac centres##2##3##(2008-11#1)(2010-3#1)
paediatric cardiac surgery##4##3##(2005-12#1)(2007-8#1)(2007-9#2)
paediatric cardiac##12##2##(2005-12#1)(2007-8#1)(2007-9#6)(2008-11#1)(2010-3#1)(2013-1#2)
paediatric cardiology##2##2##(2010-11#1)(2010-3#1)
paediatric case of##3##3##(2008-11#2)(2013-1#1)
paediatric case##6##2##(1996-9#1)(2008-11#2)(2009-11#1)(2013-1#2)
paediatric cases of##2##3##(2007-12#1)(2009-10#1)
paediatric cases##3##2##(2007-12#1)(2008-7#1)(2009-10#1)
paediatric centre in##2##3##(2006-2#1)(2012-2#1)
paediatric cochlear implant users##3##4##(2008-9#2)(2011-1#1)
paediatric cochlear implant##6##3##(2008-9#5)(2011-1#1)
paediatric cochlear implantation##9##3##(2008-9#9)
paediatric cochlear##16##2##(2008-9#15)(2011-1#1)
paediatric dentistry##3##2##(2007-2#1)(2011-1#1)(2013-1#1)
paediatric departments##4##2##(1990-3#1)(1993-5#2)(1996-9#1)
paediatric emergency department##6##3##(2008-11#5)(2013-1#1)
paediatric emergency medicine##2##3##(2008-11#2)
paediatric emergency##9##2##(2008-11#7)(2010-7#1)(2013-1#1)
paediatric heart##2##2##(2007-8#2)
paediatric hospital in##3##3##(1992-10#1)(2008-11#1)(2013-7#1)
paediatric hospitals##2##2##(2008-11#2)
paediatric intensive care##7##3##(2006-4#3)(2007-11#1)(2007-9#1)(2010-7#1)(2013-1#1)
paediatric liver transplantation##2##3##(2005-7#1)(2007-11#1)
paediatric minor head injuries##2##4##(2008-11#2)
paediatric minor##3##2##(2008-11#3)
paediatric neurosurgical##2##2##(2006-10#1)(2013-1#1)
paediatric office##2##2##(2009-5#2)
paediatric oncology##5##2##(2007-12#1)(2008-11#1)(2009-10#1)(2010-11#1)(2012-3#1)
paediatric pain management##2##3##(2006-10#1)(2008-11#1)
paediatric pain##3##2##(2006-10#1)(2008-11#2)
paediatric patient##4##2##(2006-10#2)(2012-2#1)(2013-1#1)
paediatric patients and##2##3##(2008-11#1)(2013-8#1)
paediatric patients were##2##3##(2007-8#1)(2011-2#1)
paediatric patients with##4##3##(2006-9#1)(2008-9#1)(2012-3#1)(2013-1#1)
paediatric patients##39##2##(1994-3#1)(2006-10#6)(2006-4#2)(2006-9#1)(2007-4#1)(2007-8#1)(2007-9#4)(2008-10#1)(2008-11#2)(2008-7#3)(2008-9#3)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#3)
paediatric physiotherapists##2##2##(2012-12#2)
paediatric physiotherapy practice##2##3##(2012-12#2)
paediatric physiotherapy##3##2##(2011-2#1)(2012-12#2)
paediatric population##11##2##(1996-6#1)(2008-10#3)(2008-11#2)(2008-7#1)(2010-3#1)(2013-1#2)(2013-8#1)
paediatric regional anaesthesia##4##3##(2006-10#2)(2013-1#2)
paediatric residents and##2##3##(2008-11#2)
paediatric residents##4##2##(2008-11#3)(2011-2#1)
paediatric respiratory##2##2##(2005-11#2)
paediatric rotavirus gastroenteritis##3##3##(2007-11#3)
paediatric setting##2##2##(2008-11#2)
paediatric surgeon##2##2##(2009-10#1)(2012-2#1)
paediatric surgeons##2##2##(2008-10#2)
paediatric surgery##4##2##(2006-10#1)(2008-11#1)(2010-7#1)(2012-2#1)
paediatric surgical##2##2##(2013-1#2)
paediatric trauma##2##2##(2006-10#2)
paediatric urology##6##2##(2008-10#6)
paediatric##357##1##(1990-2#1)(1990-3#2)(1992-10#1)(1993-10#1)(1993-12#1)(1993-5#3)(1994-3#1)(1995-9#1)(1996-2#1)(1996-6#1)(1996-9#3)(1997-4#1)(1997-8#2)(2005-11#9)(2005-12#1)(2005-7#1)(2006-10#33)(2006-2#4)(2006-4#8)(2006-8#3)(2006-9#7)(2007-11#13)(2007-12#2)(2007-2#2)(2007-4#3)(2007-8#6)(2007-9#12)(2008-1#1)(2008-10#15)(2008-11#64)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#8)(2008-8#1)(2008-9#30)(2009-10#6)(2009-11#1)(2009-3#1)(2009-5#4)(2009-7#2)(2010-10#1)(2010-11#2)(2010-3#3)(2010-6#1)(2010-7#12)(2011-1#4)(2011-2#7)(2012-1#1)(2012-12#11)(2012-2#11)(2012-3#3)(2013-1#31)(2013-7#1)(2013-8#8)
paediatrician##9##1##(2005-11#1)(2008-11#3)(2008-12#1)(2008-3#1)(2010-12#1)(2010-5#1)(2013-1#1)
paediatricians for##2##2##(2008-11#2)
paediatricians##19##1##(1990-1#1)(2007-11#1)(2008-11#9)(2008-7#4)(2009-5#1)(2012-2#2)(2013-8#1)
paediatrics and##2##2##(2008-11#1)(2012-12#1)
paediatrics##25##1##(1990-3#3)(1993-5#1)(2005-11#2)(2006-6#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-11#4)(2008-7#1)(2010-3#1)(2010-5#2)(2010-7#1)(2012-12#1)(2013-1#4)
paeoniflorin and 5-ASA groups (P &lt##2##6##(2011-3#2)
paeoniflorin##13##1##(1992-2#5)(2008-10#2)(2011-3#6)
paeonol##3##1##(2008-10#2)(2012-12#1)
pag gene##2##2##(1991-10#2)
pag##3##1##(1991-10#3)
page retrieval##2##2##(2008-3#2)
page swap outs##3##3##(2008-3#3)
page##66##1##(1990-3#1)(1990-9#3)(1991-5#1)(1992-2#3)(1994-2#1)(1995-3#1)(1996-2#1)(2007-11#6)(2007-12#2)(2007-5#1)(2007-8#2)(2007-9#11)(2008-11#1)(2008-12#1)(2008-3#10)(2008-4#1)(2008-7#1)(2009-10#2)(2010-2#1)(2012-12#3)(2012-3#7)(2013-1#1)(2013-7#1)(2013-8#4)
page)##2##1##(1997-4#1)(2007-12#1)
page-oriented memories##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
page-oriented##10##1##(2007-11#2)(2007-12#5)(2008-2#2)(2008-3#1)
pageant##3##1##(2006-7#3)
pager##2##1##(2010-8#2)
pagers##5##1##(2010-8#5)
pages advertising##3##2##(1993-12#2)(1997-1#1)
pages can##2##2##(2008-3#2)
pages for##2##2##(1996-12#1)(2007-12#1)
pages in##6##2##(2006-8#1)(2007-12#3)(2008-1#1)(2008-3#1)
pages of##7##2##(2008-1#1)(2008-2#1)(2008-4#1)(2009-10#1)(2011-2#1)(2012-12#2)
pages that##4##2##(2006-3#1)(2008-3#3)
pages with illustrations##4##3##(2007-2#4)
pages with##6##2##(2007-2#4)(2008-1#1)(2008-3#1)
pages##74##1##(1991-11#1)(1993-12#2)(1996-1#1)(1996-12#2)(1997-1#4)(2005-8#1)(2006-3#1)(2006-8#1)(2007-11#5)(2007-12#8)(2007-2#11)(2007-5#1)(2008-1#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#17)(2008-4#2)(2008-7#2)(2009-10#1)(2009-5#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#2)
pages) ISBN 0##9##3##(2006-10#9)
pages) ISBN##15##2##(2006-10#14)(2008-4#1)
pages)##29##1##(2006-10#14)(2008-4#15)
paging is##2##2##(2006-4#1)(2010-8#1)
paging system##3##2##(2010-8#3)
paging systems are##2##3##(2010-8#2)
paging systems in##2##3##(2010-8#2)
paging systems##5##2##(2010-8#5)
paging##14##1##(2006-4#1)(2008-3#1)(2010-8#12)
paid a##8##2##(1990-9#1)(1995-3#1)(2005-8#1)(2007-9#1)(2008-11#1)(2009-11#1)(2009-7#1)(2012-3#1)
paid and##3##2##(1996-2#1)(2011-2#2)
paid blood donors##2##3##(1992-2#1)(2013-1#1)
paid by the##3##3##(1997-6#1)(2006-10#1)(2008-11#1)
paid by##9##2##(1990-10#1)(1992-12#1)(1994-2#1)(1996-3#2)(1997-1#1)(1997-6#1)(2006-10#1)(2008-11#1)
paid employment of##2##3##(1991-2#2)
paid employment##8##2##(1991-2#4)(1991-9#1)(1993-6#1)(1995-1#1)(2013-1#1)
paid for the##3##3##(1992-2#1)(1997-2#1)(2008-12#1)
paid for##18##2##(1991-2#1)(1991-8#2)(1992-2#1)(1992-3#1)(1993-3#1)(1995-11#1)(1996-11#1)(1996-3#1)(1997-2#1)(2005-12#1)(2007-4#2)(2007-9#1)(2008-12#1)(2012-3#2)(2013-1#1)
paid in##2##2##(2009-2#1)(2011-3#1)
paid more attention##3##3##(1997-4#1)(2012-3#1)(2013-8#1)
paid much attention to the##2##5##(1996-12#1)(2009-7#1)
paid to a##3##3##(1995-12#1)(1997-6#1)(2006-6#1)
paid to interactions##2##3##(1991-8#1)(2009-6#1)
paid to it##2##3##(1995-5#1)(2006-7#1)
paid to the design of##2##5##(1997-2#1)(2011-2#1)
paid to the factors##2##4##(2007-8#1)(2008-2#1)
paid to the pulmonary##2##4##(2007-2#1)(2010-1#1)
paid to the relationship between##3##5##(1992-3#1)(2008-3#1)(2008-9#1)
paid to the role of##3##5##(1997-4#1)(2009-4#1)(2011-1#1)
paid to the use of##2##5##(2006-2#1)(2008-11#1)
paid to the##75##3##(1990-2#1)(1990-4#1)(1990-6#1)(1991-3#1)(1991-5#1)(1992-3#3)(1993-12#1)(1994-3#2)(1995-1#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-8#2)(2006-10#2)(2006-12#3)(2006-2#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#3)(2009-4#2)(2009-5#2)(2009-8#2)(2010-1#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2013-2#1)
paid to##155##2##(1990-2#2)(1990-4#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-3#2)(1991-5#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1994-3#2)(1994-7#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#2)(1996-12#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-12#1)(2004-2#1)(2005-10#2)(2005-11#2)(2005-8#2)(2006-10#3)(2006-11#2)(2006-12#3)(2006-2#1)(2006-6#3)(2006-7#3)(2006-9#1)(2007-1#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#3)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#7)(2008-9#3)(2009-1#1)(2009-10#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-8#2)(2010-1#2)(2010-11#2)(2010-12#2)(2010-8#2)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#4)(2013-1#3)(2013-2#1)(2013-8#2)
paid unofficially to##2##3##(2012-3#2)
paid work##3##2##(2008-7#1)(2008-9#1)(2011-2#1)
paid workers##4##2##(1992-3#4)
paid##255##1##(1990-10#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-2#5)(1991-3#2)(1991-5#1)(1991-8#3)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#3)(1992-2#2)(1992-3#11)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1994-2#1)(1994-3#2)(1994-7#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#2)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#4)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#3)(2004-12#1)(2004-2#1)(2004-3#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-8#3)(2006-10#5)(2006-11#2)(2006-12#3)(2006-2#1)(2006-6#3)(2006-7#3)(2006-9#1)(2007-1#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#5)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#10)(2008-11#5)(2008-12#4)(2008-2#4)(2008-3#4)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#5)(2009-1#1)(2009-10#2)(2009-11#2)(2009-2#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#2)(2010-1#2)(2010-11#2)(2010-12#2)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#7)(2011-3#2)(2012-1#3)(2012-12#3)(2012-2#5)(2012-3#11)(2013-1#6)(2013-2#1)(2013-8#3)
pailasensis##4##1##(2007-3#4)
pain (0##2##2##(2006-12#1)(2009-8#1)
pain (P##2##2##(2006-10#1)(2013-8#1)
pain (p##2##2##(2009-10#1)(2010-4#1)
pain (pain##2##2##(2008-7#1)(2010-12#1)
pain -##3##2##(2008-11#1)(2008-3#1)(2010-10#1)
pain 2##3##2##(1995-3#1)(2009-3#1)(2013-1#1)
pain 48##2##2##(2012-12#1)(2012-3#1)
pain abdomen##3##2##(2006-1#1)(2011-12#1)(2012-12#1)
pain accompanied by##2##3##(2006-8#1)(2008-12#1)
pain affects##4##2##(1996-7#1)(2006-11#2)(2009-12#1)
pain after a##3##3##(1995-3#1)(2006-10#1)(2008-9#1)
pain after laparoscopic##2##3##(2009-3#1)(2010-7#1)
pain after##26##2##(1990-3#1)(1991-11#1)(1991-5#1)(1993-2#1)(1995-3#2)(2005-8#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-8#3)(2007-11#1)(2008-10#1)(2008-9#2)(2009-3#1)(2010-7#3)(2012-2#1)(2013-7#1)
pain alleviation##2##2##(2006-3#1)(2010-7#1)
pain alone or##2##3##(2005-10#1)(2007-5#1)
pain also##4##2##(1996-7#1)(2006-8#1)(2008-11#1)(2010-7#1)
pain among##6##2##(1993-10#1)(1997-4#1)(2007-11#1)(2008-3#1)(2010-12#1)(2012-11#1)
pain and a##14##3##(1991-10#1)(2005-1#2)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#1)(2009-9#1)(2010-1#1)(2012-12#1)
pain and allodynia##4##3##(1996-6#1)(2006-12#1)(2008-9#1)(2009-7#1)
pain and anxiety in##3##4##(1995-9#1)(2010-3#1)(2012-2#1)
pain and anxiety##13##3##(1992-12#1)(1995-9#1)(2010-3#5)(2011-1#2)(2012-2#4)
pain and associated##3##3##(2006-8#2)(2013-1#1)
pain and bowel##3##3##(2006-2#2)(2008-8#1)
pain and burning##3##3##(2007-11#1)(2008-7#1)(2008-9#1)
pain and can##2##3##(2006-6#1)(2008-1#1)
pain and chronic##2##3##(2006-10#1)(2008-10#1)
pain and depression##5##3##(2008-10#1)(2010-3#1)(2013-1#3)
pain and diminished##2##3##(2008-7#1)(2011-1#1)
pain and disability and outcome measures##2##6##(2007-11#2)
pain and disability at 1 year##2##6##(2008-9#2)
pain and disability in##2##4##(2008-9#1)(2013-1#1)
pain and disability##18##3##(1997-6#1)(2006-10#1)(2007-11#6)(2008-11#1)(2008-12#1)(2008-9#4)(2012-12#2)(2013-1#2)
pain and discomfort associated with##2##5##(2008-12#1)(2011-1#1)
pain and discomfort##5##3##(2007-2#1)(2008-12#3)(2011-1#1)
pain and distress##2##3##(2008-10#1)(2008-11#1)
pain and dysfunction##4##3##(2006-8#2)(2007-11#1)(2008-7#1)
pain and fatigue among breast cancer surgery patients##2##8##(2008-11#2)
pain and fatigue##7##3##(2008-11#7)
pain and fever in##2##4##(2008-10#1)(2011-1#1)
pain and fever##9##3##(1991-2#1)(1991-8#1)(2006-10#2)(2008-10#1)(2009-8#1)(2011-1#3)
pain and function in patients##2##5##(2008-12#1)(2010-9#1)
pain and function##5##3##(2006-10#1)(2008-12#1)(2010-9#3)
pain and functional disability were##2##5##(2010-12#1)(2012-1#1)
pain and functional outcomes##4##4##(2012-1#1)(2012-12#3)
pain and functional##9##3##(1995-9#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-1#2)(2012-12#3)
pain and had##2##3##(2006-3#1)(2009-3#1)
pain and headache##2##3##(2006-12#1)(2010-12#1)
pain and improve physical##2##4##(2006-10#1)(2010-11#1)
pain and improve##6##3##(2006-10#1)(2006-8#1)(2007-11#1)(2008-10#1)(2010-11#1)(2013-1#1)
pain and in##3##3##(1997-5#1)(1997-6#1)(2005-10#1)
pain and inflammation##7##3##(1995-5#1)(2005-8#1)(2006-10#1)(2007-6#1)(2007-8#1)(2008-12#1)(2008-4#1)
pain and injury##2##3##(2007-10#1)(2008-12#1)
pain and instability##2##3##(2012-3#1)(2013-1#1)
pain and its##4##3##(1996-7#1)(2006-12#1)(2006-4#1)(2012-1#1)
pain and joint##2##3##(1990-6#1)(2012-2#1)
pain and loss of##4##4##(1990-4#1)(1996-6#1)(2010-11#1)(2012-2#1)
pain and lower##3##3##(2006-8#1)(2007-11#1)(2011-2#1)
pain and massive##2##3##(2006-10#1)(2011-2#1)
pain and mild##2##3##(2008-12#1)(2009-3#1)
pain and mood scores##3##4##(2005-9#3)
pain and much##2##3##(2007-8#1)(2010-9#1)
pain and muscle##4##3##(2009-1#1)(2013-1#3)
pain and nausea##6##3##(2006-10#2)(2012-2#2)(2013-1#2)
pain and no##3##3##(2008-3#2)(2012-2#1)
pain and numbness##2##3##(2006-10#1)(2008-12#1)
pain and of##2##3##(1991-9#1)(2012-2#1)
pain and other##8##3##(1994-11#1)(2006-10#1)(2006-11#1)(2006-8#1)(2009-5#1)(2010-7#1)(2012-2#1)(2012-3#1)
pain and physical function in##2##5##(2006-10#1)(2013-1#1)
pain and physical function##4##4##(2006-10#1)(2010-9#2)(2013-1#1)
pain and physical##7##3##(1996-2#1)(2006-10#1)(2009-5#1)(2010-9#2)(2013-1#2)
pain and radicular##2##3##(2007-11#1)(2012-2#1)
pain and radiculopathy##2##3##(2006-8#2)
pain and recurrent##3##3##(1990-3#1)(2006-10#1)(2013-8#1)
pain and related disorders##5##4##(2008-12#5)
pain and related##7##3##(2008-12#7)
pain and sensory##3##3##(1990-12#1)(2010-7#1)(2012-12#1)
pain and severe##2##3##(2010-12#1)(2013-8#1)
pain and stiffness##8##3##(2006-10#7)(2011-2#1)
pain and suffering##4##3##(1997-5#1)(2006-10#1)(2013-1#2)
pain and swelling of##3##4##(2006-10#1)(2008-6#1)(2012-2#1)
pain and swelling##6##3##(2006-10#1)(2006-8#1)(2008-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
pain and symptom management in##2##5##(2005-10#1)(2007-12#1)
pain and symptom management##3##4##(2005-10#2)(2007-12#1)
pain and symptoms of##2##4##(2007-11#1)(2013-1#1)
pain and symptoms##5##3##(2005-10#1)(2007-11#1)(2008-1#1)(2013-1#2)
pain and tenderness over the##2##5##(2006-10#2)
pain and tenderness##7##3##(1992-5#1)(2006-10#3)(2008-1#1)(2009-10#1)(2009-3#1)
pain and the presence of##2##5##(2006-10#2)
pain and the treatment##2##4##(2005-7#1)(2006-11#1)
pain and the##16##3##(1990-6#1)(1991-2#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#2)(2006-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-7#1)
pain and they##3##3##(2004-3#1)(2006-12#1)(2008-12#1)
pain and to##7##3##(1995-9#1)(2006-10#2)(2006-7#1)(2010-11#1)(2011-2#1)(2013-8#1)
pain and transient##2##3##(2007-5#1)(2012-1#1)
pain and vomiting##5##3##(1990-6#1)(1997-8#1)(2006-10#1)(2011-12#1)(2013-1#1)
pain and was diagnosed with##2##5##(2005-10#1)(2008-7#1)
pain and was##4##3##(1992-11#1)(2005-10#1)(2008-7#2)
pain and watery##2##3##(1993-7#1)(2007-7#1)
pain and weakness of##2##4##(1992-11#1)(2006-3#1)
pain and weakness##5##3##(1992-11#1)(2006-3#1)(2010-2#1)(2013-7#2)
pain and weight loss##4##4##(1997-3#1)(2008-12#1)(2010-12#1)(2011-1#1)
pain and weight##6##3##(1997-3#1)(2007-8#1)(2007-9#1)(2008-12#1)(2010-12#1)(2011-1#1)
pain and##534##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#4)(1991-10#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#4)(1992-5#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-12#2)(1995-5#1)(1995-9#4)(1996-1#1)(1996-2#3)(1996-6#2)(1996-7#3)(1996-9#2)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#3)(1997-6#2)(1997-8#1)(2004-3#1)(2005-1#2)(2005-10#5)(2005-12#1)(2005-7#2)(2005-8#2)(2005-9#3)(2006-10#40)(2006-11#4)(2006-12#13)(2006-2#4)(2006-3#3)(2006-4#3)(2006-6#2)(2006-7#5)(2006-8#24)(2007-10#1)(2007-11#24)(2007-12#4)(2007-2#4)(2007-3#2)(2007-5#3)(2007-6#2)(2007-7#10)(2007-8#8)(2007-9#3)(2008-1#5)(2008-10#9)(2008-11#12)(2008-12#26)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#18)(2008-8#7)(2008-9#13)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#8)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#5)(2010-12#10)(2010-2#1)(2010-3#8)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#4)(2010-9#6)(2011-1#15)(2011-12#4)(2011-2#11)(2012-1#4)(2012-12#14)(2012-2#20)(2012-3#6)(2012-8#1)(2013-1#32)(2013-7#4)(2013-8#8)
pain and/or##5##2##(1992-6#1)(2007-11#1)(2008-7#1)(2010-3#1)(2012-2#1)
pain are discussed##3##3##(2004-12#1)(2006-7#2)
pain are likely##2##3##(2012-2#1)(2013-8#1)
pain are##24##2##(1992-12#1)(1996-6#1)(2004-12#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-7#2)(2006-8#4)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-11#2)(2009-12#1)(2012-12#2)(2012-2#1)(2013-8#1)
pain areas of##3##3##(2010-9#3)
pain as a##7##3##(1993-9#1)(2006-10#1)(2007-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-3#1)
pain as measured##2##3##(2008-12#1)(2012-1#1)
pain as the##2##3##(2006-10#1)(2012-12#1)
pain as their##2##3##(2006-11#1)(2006-9#1)
pain as well as##9##4##(1996-1#1)(2006-11#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-12#2)(2009-3#1)(2011-1#1)
pain as well##10##3##(1996-1#1)(2006-11#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-12#2)(2009-3#1)(2011-1#1)
pain as##30##2##(1993-9#1)(1996-1#1)(2006-10#2)(2006-11#2)(2006-8#2)(2006-9#1)(2007-11#2)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#2)(2009-3#1)(2009-9#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
pain assessment and management##6##4##(2006-9#2)(2007-12#1)(2008-7#1)(2010-7#1)(2012-2#1)
pain assessment##33##2##(1993-4#1)(2006-10#1)(2006-12#1)(2006-9#2)(2007-12#3)(2008-11#6)(2008-7#3)(2009-3#1)(2010-11#6)(2010-7#2)(2012-2#5)(2013-1#2)
pain assessments##2##2##(2010-6#1)(2012-2#1)
pain associated with contained disc herniation##2##6##(2006-8#2)
pain associated with##43##3##(1991-8#1)(1992-2#1)(1993-2#1)(1993-9#2)(1995-2#2)(1996-7#1)(2005-10#2)(2005-7#3)(2005-8#1)(2006-10#5)(2006-12#3)(2006-7#1)(2006-8#3)(2007-11#3)(2007-7#1)(2007-8#3)(2008-1#1)(2008-7#1)(2009-5#2)(2010-1#1)(2010-12#2)(2010-4#1)(2011-2#1)(2012-2#1)
pain associated##44##2##(1991-8#1)(1992-2#1)(1993-2#1)(1993-9#2)(1995-2#2)(1996-7#1)(2005-10#2)(2005-7#3)(2005-8#1)(2006-10#5)(2006-12#3)(2006-7#1)(2006-8#3)(2007-11#3)(2007-7#1)(2007-8#3)(2008-1#1)(2008-7#1)(2009-5#2)(2010-1#2)(2010-12#2)(2010-4#1)(2011-2#1)(2012-2#1)
pain at injection site##2##4##(2007-11#1)(2012-2#1)
pain at least##2##3##(2008-7#1)(2013-1#1)
pain at the injection site##3##5##(2006-8#1)(2007-11#1)(2011-2#1)
pain at the##15##3##(1991-3#1)(2006-3#1)(2006-8#2)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-6#2)(2008-8#1)(2010-4#1)(2010-6#2)(2011-2#1)
pain at##28##2##(1991-3#1)(1994-12#1)(1997-1#1)(2006-10#2)(2006-3#1)(2006-8#2)(2007-11#3)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-3#1)(2010-4#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
pain based on the##3##4##(2006-8#2)(2012-2#1)
pain based on##6##3##(2006-8#3)(2008-9#2)(2012-2#1)
pain be##2##2##(1995-9#1)(2010-12#1)
pain because##3##2##(2008-7#1)(2010-9#2)
pain before##5##2##(2004-2#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-7#1)
pain behavior can##2##3##(2006-12#2)
pain behavior##7##2##(2006-12#3)(2006-8#2)(2008-6#2)
pain behaviors##2##2##(1996-8#1)(2008-7#1)
pain behaviour##3##2##(2008-11#2)(2008-4#1)
pain being##3##2##(1990-6#1)(2008-10#1)(2013-1#1)
pain both##2##2##(1997-2#1)(2009-12#1)
pain but a##2##3##(2008-3#1)(2009-3#1)
pain but also##2##3##(2008-7#1)(2013-1#1)
pain but no##2##3##(1995-3#1)(2008-7#1)
pain but##8##2##(1995-3#1)(2006-8#1)(2008-3#1)(2008-7#3)(2009-3#1)(2013-1#1)
pain by restoring##2##3##(2008-8#1)(2011-1#1)
pain by the##3##3##(1990-6#1)(1994-2#1)(2008-2#1)
pain by##18##2##(1990-3#1)(1990-6#2)(1994-2#1)(1996-8#1)(1996-9#1)(2006-11#1)(2006-7#1)(2006-8#2)(2007-7#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-1#1)(2012-2#1)
pain can also##3##3##(2006-11#1)(2006-12#1)(2009-3#1)
pain can be##11##3##(1991-11#1)(1993-8#1)(1996-7#1)(2006-7#1)(2006-8#1)(2007-2#1)(2008-4#1)(2008-8#2)(2008-9#1)(2013-1#1)
pain can##20##2##(1991-11#2)(1993-8#1)(1996-7#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-3#1)(2013-1#1)
pain care##5##2##(2006-12#1)(2009-12#1)(2010-7#3)
pain caused by bone metastases##2##5##(2006-6#2)
pain caused by nerve##2##4##(1993-9#1)(2006-6#1)
pain caused by##12##3##(1991-2#1)(1993-6#1)(1993-9#1)(1995-2#1)(1995-9#1)(2006-2#1)(2006-6#3)(2007-10#1)(2008-5#1)(2013-1#1)
pain center as##2##3##(2006-7#1)(2008-3#1)
pain center##9##2##(2006-7#3)(2008-3#6)
pain centers##9##2##(2006-12#1)(2006-7#1)(2008-3#7)
pain characteristics##7##2##(2006-8#1)(2008-3#1)(2008-7#1)(2010-6#4)
pain clinics##2##2##(2006-10#1)(2006-12#1)
pain compared##2##2##(2005-7#1)(2011-2#1)
pain complaints in##2##3##(2007-8#2)
pain complaints##7##2##(2007-11#1)(2007-8#3)(2008-5#1)(2011-2#1)(2013-8#1)
pain condition associated with##2##4##(2011-1#1)(2011-12#1)
pain condition##5##2##(2006-7#1)(2009-7#1)(2011-1#1)(2011-12#1)(2011-2#1)
pain conditions##13##2##(1995-9#1)(1996-7#1)(2006-10#1)(2006-12#1)(2006-8#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-1#1)(2010-2#1)(2013-1#2)
pain continues to be a##3##5##(2007-8#1)(2008-4#1)(2009-5#1)
pain continues to be##4##4##(2006-12#1)(2007-8#1)(2008-4#1)(2009-5#1)
pain continues to##6##3##(2006-12#2)(2007-8#1)(2008-4#1)(2009-5#1)(2010-8#1)
pain control and##11##3##(1996-7#1)(2006-10#2)(2006-12#1)(2008-7#2)(2009-4#1)(2010-11#1)(2010-7#1)(2013-1#2)
pain control can##2##3##(1996-7#1)(2006-10#1)
pain control in The##2##4##(1994-4#1)(2006-12#1)
pain control in a##2##4##(2006-7#1)(2010-7#1)
pain control in##10##3##(1990-8#1)(1994-4#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-3#1)(2008-3#1)(2010-7#1)(2012-2#1)(2012-3#1)
pain control is##4##3##(1990-12#1)(2006-10#2)(2010-2#1)
pain control##69##2##(1990-10#1)(1990-12#1)(1990-8#1)(1994-4#1)(1996-12#2)(1996-7#2)(1997-3#1)(2006-10#16)(2006-12#5)(2006-6#1)(2006-7#2)(2006-8#1)(2007-11#1)(2007-2#3)(2007-3#1)(2007-9#1)(2008-3#6)(2008-5#4)(2008-7#4)(2009-4#1)(2009-5#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-7#2)(2012-2#2)(2012-3#1)(2013-1#2)
pain controlling##2##2##(1990-5#1)(2008-10#1)
pain could##2##2##(2005-7#1)(2008-7#1)
pain crisis##2##2##(1992-2#1)(2008-10#1)
pain depend on##2##3##(1993-4#1)(2006-12#1)
pain diagnoses##3##2##(1993-1#1)(2013-1#2)
pain disappearance##3##2##(2013-1#3)
pain disappeared##4##2##(1991-5#1)(1991-8#1)(1993-3#1)(2008-7#1)
pain disorder##3##2##(2006-3#1)(2008-9#1)(2011-12#1)
pain disorders##6##2##(1997-8#1)(2007-1#1)(2008-12#2)(2008-7#1)(2010-6#1)
pain due to##10##3##(1991-2#1)(1993-7#1)(1997-7#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-8#1)(2010-1#1)(2010-4#1)(2012-2#1)
pain during injection of##3##4##(1990-3#1)(2009-10#2)
pain during the procedure as mild or moderate##2##8##(1996-12#2)
pain during the##8##3##(1993-10#1)(1996-12#2)(2007-12#2)(2007-6#1)(2009-10#1)(2011-2#1)
pain during##28##2##(1990-3#1)(1993-10#1)(1996-12#2)(1997-5#2)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-6#1)(2008-12#2)(2008-7#1)(2008-9#1)(2009-10#3)(2010-11#1)(2010-4#1)(2010-9#2)(2011-2#1)(2012-12#1)
pain education program##2##3##(2009-12#2)
pain education##4##2##(2008-11#1)(2009-12#3)
pain episodes##3##2##(2008-11#1)(2008-7#2)
pain evaluation##5##2##(2006-3#1)(2006-6#1)(2007-7#2)(2012-2#1)
pain even##2##2##(1990-12#1)(2007-12#1)
pain evoked by##2##3##(1995-12#1)(2010-9#1)
pain experience##5##2##(2006-12#1)(2008-3#1)(2009-3#1)(2012-2#2)
pain experienced during the imaging##2##5##(2007-2#2)
pain experienced during the##3##4##(2007-2#2)(2012-3#1)
pain experienced during##4##3##(1997-5#1)(2007-2#2)(2012-3#1)
pain experienced##7##2##(1997-5#1)(2007-2#2)(2007-5#1)(2010-11#1)(2011-2#1)(2012-3#1)
pain following a##2##3##(2004-10#1)(2007-7#1)
pain following treatment##2##3##(1992-5#1)(2010-7#1)
pain following##12##2##(1992-11#1)(1992-5#1)(1995-9#1)(2004-10#1)(2006-8#2)(2007-7#1)(2008-3#1)(2008-6#1)(2010-7#1)(2011-2#1)(2012-12#1)
pain for home-dwelling persons with dementia##3##6##(2010-8#3)
pain for the##4##3##(1993-12#1)(2007-8#1)(2008-10#1)(2008-11#1)
pain for##18##2##(1993-12#1)(1993-6#1)(1996-3#1)(1996-6#1)(1997-5#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-8#3)(2010-9#1)(2012-12#2)(2013-1#1)
pain free##5##2##(1993-4#1)(1996-3#1)(2006-1#1)(2007-11#2)
pain from bone##2##3##(1997-3#1)(2008-10#1)
pain from##13##2##(1995-12#1)(1997-3#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-1#1)
pain generation##3##2##(2006-7#1)(2006-8#2)
pain generator##5##2##(2006-12#1)(2006-8#3)(2012-2#1)
pain generators##5##2##(2006-7#1)(2006-8#4)
pain group with##2##3##(2006-8#2)
pain had##4##2##(1993-10#1)(2004-12#1)(2009-3#1)(2010-5#1)
pain has been established##2##4##(2006-12#1)(2006-8#1)
pain has been reported##2##4##(2006-7#1)(2008-7#1)
pain has been##9##3##(1991-9#1)(2006-10#1)(2006-12#2)(2006-6#1)(2006-7#1)(2006-8#1)(2008-4#1)(2008-7#1)
pain has not been##2##4##(2006-12#2)
pain has not##4##3##(2006-10#1)(2006-12#2)(2008-12#1)
pain has received##2##3##(2006-8#1)(2009-3#1)
pain has##25##2##(1991-2#1)(1991-9#1)(2006-10#5)(2006-12#4)(2006-6#1)(2006-7#1)(2006-8#3)(2007-7#2)(2007-8#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-4#1)(2011-2#1)
pain have been##2##3##(2006-2#1)(2011-2#1)
pain have##6##2##(1991-3#1)(2006-2#1)(2008-7#1)(2009-12#1)(2011-1#1)(2011-2#1)
pain in 15% to 45% of the patients##3##8##(2006-12#1)(2006-7#1)(2006-8#1)
pain in MS##3##3##(2008-8#3)
pain in a patient with##3##5##(2006-4#1)(2007-7#1)(2010-4#1)
pain in a patient##4##4##(2006-4#1)(2007-7#1)(2008-5#1)(2010-4#1)
pain in a##19##3##(1992-3#1)(1993-8#1)(1995-12#2)(1996-7#1)(1997-5#1)(2006-4#1)(2006-8#4)(2007-6#1)(2007-7#1)(2008-5#1)(2009-12#1)(2010-12#2)(2010-4#2)
pain in abdomen##2##3##(2010-12#1)(2010-2#1)
pain in adolescents##2##3##(2008-7#2)
pain in all##2##3##(2007-6#1)(2008-7#1)
pain in an##3##3##(1997-3#1)(2006-8#1)(2013-8#1)
pain in athletes##2##3##(2006-3#1)(2006-8#1)
pain in both##3##3##(1996-11#1)(2006-10#1)(2013-8#1)
pain in cancer patients##5##4##(1993-7#1)(2007-2#2)(2008-4#1)(2009-4#1)
pain in childhood##4##3##(1992-5#1)(2006-8#1)(2008-11#2)
pain in children##7##3##(2006-10#1)(2006-12#1)(2006-2#1)(2008-11#2)(2010-3#1)(2013-8#1)
pain in chronic discogenic LBP patients##2##6##(2006-12#2)
pain in chronic##8##3##(2005-10#1)(2006-12#2)(2006-8#3)(2008-12#1)(2008-5#1)
pain in her right##4##4##(2006-10#1)(2009-3#1)(2012-1#1)(2012-3#1)
pain in her##5##3##(2006-10#2)(2009-3#1)(2012-1#1)(2012-3#1)
pain in his##2##3##(1991-5#1)(2010-9#1)
pain in humans##2##3##(2006-12#1)(2008-9#1)
pain in infants##2##3##(2012-1#2)
pain in multiple sclerosis##2##4##(2008-7#1)(2008-8#1)
pain in older adults##2##4##(2007-12#1)(2013-1#1)
pain in older patients##2##4##(1996-7#1)(2008-7#1)
pain in older##4##3##(1996-7#1)(2007-12#1)(2008-7#1)(2013-1#1)
pain in one##2##3##(1990-6#1)(2006-8#1)
pain in order to##2##4##(1997-2#1)(1997-8#1)
pain in osteoarthritis##3##3##(2007-11#1)(2011-1#2)
pain in patients who failed to respond to##2##8##(2006-8#2)
pain in patients who have##2##5##(2008-5#1)(2010-12#1)
pain in patients who##6##4##(2006-8#3)(2008-5#1)(2010-12#1)(2010-7#1)
pain in patients with chronic##2##5##(2006-8#1)(2010-6#1)
pain in patients with##15##4##(2006-10#2)(2006-7#2)(2006-8#1)(2007-8#1)(2008-12#2)(2008-7#1)(2009-4#2)(2009-9#1)(2010-6#1)(2011-1#1)(2012-12#1)
pain in patients##25##3##(2006-10#2)(2006-7#3)(2006-8#5)(2007-11#1)(2007-8#1)(2008-12#2)(2008-5#1)(2008-7#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-12#1)
pain in postlumbar laminectomy syndrome##2##5##(2006-8#2)
pain in postlumbar laminectomy##3##4##(2006-8#3)
pain in primary care##2##4##(2008-11#2)
pain in rodents##2##3##(2006-12#1)(2010-4#1)
pain in some##2##3##(1994-9#1)(2006-8#1)
pain in the area of the##2##6##(2007-6#1)(2009-3#1)
pain in the distribution of the##2##6##(1996-4#1)(2010-12#1)
pain in the elderly##5##4##(2006-12#1)(2007-12#2)(2008-5#2)
pain in the knee and##2##5##(1995-3#1)(2013-1#1)
pain in the knee##4##4##(1990-2#2)(1995-3#1)(2013-1#1)
pain in the left##6##4##(1990-9#1)(1992-7#1)(1995-3#1)(2006-12#1)(2007-8#1)(2012-12#1)
pain in the low back##2##5##(2004-10#1)(2013-8#1)
pain in the lower back##2##5##(2006-12#1)(2009-3#1)
pain in the lower##5##4##(2005-10#1)(2006-12#1)(2007-2#1)(2009-1#1)(2009-3#1)
pain in the neck##2##4##(2007-7#1)(2008-9#1)
pain in the past##3##4##(2011-2#1)(2013-1#2)
pain in the rat##3##4##(2008-4#2)(2008-5#1)
pain in the right upper quadrant##2##6##(2005-12#1)(2010-12#1)
pain in the right upper##3##5##(1990-9#1)(2005-12#1)(2010-12#1)
pain in the right##6##4##(1990-9#1)(2005-12#1)(2007-12#1)(2008-1#1)(2010-12#1)(2012-12#1)
pain in the terminally ill##2##5##(1996-2#2)
pain in the upper##4##4##(1990-3#1)(1991-9#1)(1993-2#1)(2006-8#1)
pain in the##90##3##(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-9#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-2#1)(1995-3#2)(1996-2#2)(1996-4#1)(1997-2#1)(1997-3#1)(2004-10#1)(2005-10#1)(2005-12#1)(2006-10#3)(2006-11#1)(2006-12#3)(2006-3#1)(2006-8#6)(2007-11#2)(2007-12#5)(2007-2#1)(2007-6#1)(2007-7#5)(2007-8#2)(2007-9#1)(2008-1#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#3)(2010-12#2)(2010-3#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#2)
pain in these##2##3##(2006-12#2)
pain in this##3##3##(2006-10#1)(2008-4#1)(2008-5#1)
pain in three##2##3##(2006-3#1)(2008-9#1)
pain in women##4##3##(1996-4#1)(2006-10#1)(2009-12#2)
pain in young##3##3##(2008-7#1)(2010-10#1)(2010-9#1)
pain in##303##2##(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#2)(1990-9#2)(1991-11#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-7#1)(1993-2#1)(1993-7#1)(1993-8#2)(1994-9#1)(1995-12#2)(1995-3#2)(1996-1#1)(1996-11#1)(1996-2#3)(1996-3#1)(1996-4#2)(1996-7#3)(1997-2#2)(1997-3#3)(1997-5#1)(1997-8#2)(2004-10#1)(2004-2#1)(2005-10#2)(2005-12#1)(2005-7#1)(2005-9#2)(2006-10#15)(2006-11#1)(2006-12#15)(2006-2#1)(2006-3#3)(2006-4#1)(2006-7#5)(2006-8#35)(2007-1#1)(2007-11#9)(2007-12#6)(2007-2#8)(2007-6#3)(2007-7#6)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#8)(2008-12#4)(2008-3#3)(2008-4#5)(2008-5#7)(2008-6#1)(2008-7#11)(2008-8#6)(2008-9#6)(2009-1#1)(2009-10#1)(2009-12#5)(2009-3#4)(2009-4#4)(2009-8#1)(2009-9#2)(2010-10#2)(2010-12#7)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#2)(2011-1#3)(2011-2#5)(2012-1#5)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#5)
pain include##2##2##(2006-8#1)(2008-11#1)
pain increased##3##2##(1992-10#1)(2013-1#2)
pain intensity and##3##3##(2006-10#1)(2007-2#1)(2008-12#1)
pain intensity in##3##3##(1990-8#1)(1995-12#1)(2009-3#1)
pain intensity levels##2##3##(2009-12#2)
pain intensity was##5##3##(1995-12#1)(2006-12#2)(2007-7#1)(2010-7#1)
pain intensity##36##2##(1990-12#1)(1990-8#1)(1995-12#2)(2006-10#2)(2006-12#2)(2006-8#3)(2007-11#1)(2007-2#2)(2007-7#2)(2008-12#3)(2008-9#1)(2009-12#7)(2009-3#1)(2010-12#3)(2010-7#2)(2010-9#1)(2012-2#1)(2013-1#1)
pain interference##2##2##(2008-12#2)
pain is a common problem in##2##6##(2006-3#1)(2008-9#1)
pain is a common problem##4##5##(2006-11#1)(2006-3#1)(2006-8#1)(2008-9#1)
pain is a common##11##4##(2006-11#1)(2006-3#1)(2006-8#4)(2007-6#1)(2007-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
pain is a major##3##4##(2007-11#1)(2008-3#1)(2010-12#1)
pain is a subjective##2##4##(2010-6#1)(2012-2#1)
pain is a very##3##4##(2006-12#1)(2007-2#1)(2011-12#1)
pain is a widespread##2##4##(2009-12#1)(2010-4#1)
pain is a##33##3##(1990-1#1)(1994-4#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-3#1)(2006-8#5)(2007-11#1)(2007-2#3)(2007-6#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#2)
pain is an important##3##4##(2006-8#1)(2008-8#1)(2012-2#1)
pain is an##6##3##(1996-7#1)(2006-8#1)(2008-1#1)(2008-8#1)(2009-5#1)(2012-2#1)
pain is associated with a##2##5##(2010-11#1)(2010-12#1)
pain is associated with##3##4##(2008-2#1)(2010-11#1)(2010-12#1)
pain is based on##2##4##(1990-5#1)(1996-7#1)
pain is common##2##3##(2008-12#1)(2011-1#1)
pain is completely##2##3##(1992-2#1)(2009-3#1)
pain is not##4##3##(1990-12#1)(1993-9#1)(2012-2#2)
pain is often##4##3##(2006-10#1)(2008-3#1)(2008-4#1)(2008-7#1)
pain is one of the most prevalent##2##7##(2008-7#1)(2009-5#1)
pain is one of the most##3##6##(2008-7#1)(2009-5#1)(2012-12#1)
pain is presented##3##3##(2005-12#1)(2007-12#1)(2010-7#1)
pain is reported##2##3##(2006-10#1)(2006-8#1)
pain is still##2##3##(2006-10#1)(2006-6#1)
pain is the main##2##4##(2007-7#1)(2008-7#1)
pain is the##5##3##(2005-10#1)(2007-7#1)(2008-7#1)(2009-5#1)(2009-7#1)
pain is well##2##3##(2008-11#1)(2009-3#1)
pain is##132##2##(1990-1#1)(1990-12#1)(1990-5#1)(1990-6#1)(1992-11#1)(1992-2#1)(1993-1#1)(1993-6#1)(1993-9#1)(1994-4#1)(1995-2#1)(1996-7#3)(1996-8#1)(2005-10#1)(2005-12#1)(2005-7#1)(2006-10#7)(2006-11#2)(2006-12#4)(2006-3#2)(2006-6#1)(2006-7#3)(2006-8#15)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#3)(2007-6#1)(2007-7#6)(2008-1#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#6)(2008-8#3)(2008-9#4)(2009-12#1)(2009-3#3)(2009-5#5)(2009-6#3)(2009-7#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#4)(2013-8#1)
pain it##2##2##(1992-2#1)(2011-2#1)
pain level##7##2##(2006-10#1)(2007-11#2)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
pain levels and##2##3##(2012-12#1)(2013-1#1)
pain levels##8##2##(1994-3#1)(2007-2#1)(2008-12#1)(2008-7#1)(2010-8#1)(2012-12#1)(2013-1#2)
pain localized##2##2##(2006-3#1)(2011-1#1)
pain located##2##2##(2008-10#1)(2011-2#1)
pain management after##3##3##(2005-12#1)(2008-11#1)(2010-2#1)
pain management and##10##3##(2006-10#2)(2006-7#1)(2006-8#1)(2007-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2013-1#2)
pain management are##3##3##(2007-12#2)(2008-7#1)
pain management by##2##3##(1993-12#1)(2011-2#1)
pain management during##2##3##(2006-12#1)(2009-5#1)
pain management for the elderly patient##2##6##(1996-7#1)(2010-1#1)
pain management for##6##3##(1996-7#1)(2007-12#1)(2007-8#1)(2008-3#1)(2010-1#1)(2010-11#1)
pain management has##2##3##(2006-10#1)(2006-7#1)
pain management in end-of-life care##3##5##(2007-12#3)
pain management in older adults##4##5##(2007-12#1)(2010-7#2)(2010-8#1)
pain management in patients undergoing##2##5##(2006-10#1)(2010-7#1)
pain management in patients##5##4##(2006-10#1)(2007-7#1)(2010-7#1)(2012-3#2)
pain management in the##5##4##(1996-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)
pain management in##27##3##(1996-7#1)(2006-10#2)(2006-12#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-12#6)(2007-2#1)(2007-7#2)(2008-11#1)(2009-12#1)(2010-7#3)(2010-8#1)(2012-2#1)(2012-3#2)(2013-8#1)
pain management is##4##3##(2006-8#3)(2007-12#1)
pain management practice who##2##4##(2006-8#2)
pain management practice##9##3##(2006-7#1)(2006-8#8)
pain management practices##2##3##(2006-8#1)(2010-11#1)
pain management strategies##2##3##(2006-10#1)(2007-12#1)
pain management technique##3##3##(2006-8#2)(2007-11#1)
pain management was##4##3##(2006-1#1)(2006-7#2)(2012-2#1)
pain management will##2##3##(2007-11#1)(2007-8#1)
pain management##212##2##(1991-1#1)(1991-5#1)(1992-8#1)(1993-12#1)(1994-1#1)(1996-7#3)(1997-5#1)(1997-8#1)(2005-12#1)(2006-1#1)(2006-10#17)(2006-11#2)(2006-12#7)(2006-7#19)(2006-8#52)(2006-9#2)(2007-11#5)(2007-12#18)(2007-2#6)(2007-7#2)(2007-8#5)(2007-9#1)(2008-11#4)(2008-3#6)(2008-5#1)(2008-7#7)(2008-8#1)(2009-12#3)(2009-5#1)(2010-1#1)(2010-11#5)(2010-2#1)(2010-6#1)(2010-7#7)(2010-8#4)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#6)(2012-3#4)(2013-1#4)(2013-8#1)
pain may be##4##3##(1990-6#1)(1996-2#1)(2006-6#1)(2012-2#1)
pain may##13##2##(1990-6#1)(1993-9#1)(1996-2#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-11#1)(2009-12#1)(2010-7#1)(2011-1#1)(2012-12#2)(2012-2#1)
pain measurement##3##2##(2006-10#1)(2006-12#2)
pain mechanisms##9##2##(2006-10#1)(2006-12#2)(2007-12#1)(2008-7#2)(2008-8#1)(2012-2#2)
pain mediators##2##2##(2008-5#1)(2011-2#1)
pain medication##3##2##(2005-7#1)(2010-1#1)(2011-2#1)
pain medications##7##2##(1996-7#1)(2008-7#2)(2010-2#1)(2010-4#1)(2011-2#2)
pain medicine##8##2##(2006-12#1)(2006-8#7)
pain model##4##2##(1996-1#1)(2008-7#1)(2008-9#2)
pain modulation##2##2##(2008-5#1)(2008-9#1)
pain more effectively##3##3##(1993-9#1)(2006-2#1)(2010-4#1)
pain more##4##2##(1993-9#1)(2006-2#1)(2010-4#1)(2012-12#1)
pain must be##5##3##(2006-7#1)(2007-2#1)(2008-11#1)(2008-3#1)(2009-5#1)
pain must##7##2##(2006-10#1)(2006-7#1)(2007-2#1)(2008-11#1)(2008-3#2)(2009-5#1)
pain observation##4##2##(2007-7#1)(2008-3#2)(2011-2#1)
pain occurred##2##2##(2007-11#1)(2007-7#1)
pain occurring##4##2##(2004-12#1)(2006-12#1)(2007-11#1)(2007-2#1)
pain occurs in##3##3##(2011-2#1)(2013-1#2)
pain of a##2##3##(2006-7#1)(2009-5#1)
pain of acute onset##2##4##(2006-10#1)(2013-1#1)
pain of at least 6 months##2##6##(2006-12#1)(2006-8#1)
pain of both##2##3##(1996-8#1)(2012-12#1)
pain of facet##3##3##(2006-7#2)(2006-8#1)
pain of the##3##3##(1994-2#1)(1995-4#1)(2007-11#1)
pain of##50##2##(1990-9#1)(1991-4#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-2#1)(1994-3#1)(1995-4#1)(1996-12#1)(1996-8#1)(2004-2#1)(2005-6#1)(2006-10#8)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#3)(2006-8#6)(2007-11#1)(2007-12#1)(2007-6#1)(2009-3#1)(2009-5#2)(2009-9#2)(2010-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
pain often##3##2##(2006-12#1)(2007-8#1)(2008-12#1)
pain on a##3##3##(2006-10#1)(2006-12#1)(2011-2#1)
pain on day##2##3##(2008-3#2)
pain on injection##2##3##(2007-7#1)(2013-7#1)
pain on movement##2##3##(1990-9#2)
pain on quality of life##2##5##(2006-11#1)(2011-2#1)
pain on the left##3##4##(2007-8#1)(2010-2#1)(2012-3#1)
pain on the##8##3##(1992-5#1)(2006-10#1)(2006-7#2)(2007-8#1)(2010-2#1)(2012-2#1)(2012-3#1)
pain on##32##2##(1990-3#1)(1990-9#3)(1992-5#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-7#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
pain one##2##2##(1995-4#1)(2011-2#1)
pain or discomfort##2##3##(2006-10#2)
pain or##42##2##(1990-12#1)(1991-12#1)(1992-2#1)(1995-8#1)(1996-12#1)(2005-7#1)(2006-10#2)(2006-12#4)(2006-2#1)(2006-7#3)(2006-8#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-6#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#2)
pain originating from the##3##4##(2006-8#2)(2009-5#1)
pain originating from##4##3##(2006-8#2)(2008-7#1)(2009-5#1)
pain outcomes##3##2##(2010-2#1)(2010-3#1)(2013-7#1)
pain over the##3##3##(1992-7#1)(2006-8#1)(2008-11#1)
pain over##5##2##(1992-7#1)(2006-6#1)(2006-8#1)(2008-11#1)(2012-2#1)
pain pathway##2##2##(2008-5#1)(2008-8#1)
pain pathways##2##2##(2008-8#2)
pain patients in##7##3##(2006-8#1)(2008-3#4)(2012-2#2)
pain patients with##4##3##(2006-8#3)(2008-3#1)
pain patients##45##2##(1991-1#1)(1993-1#5)(1993-11#1)(2006-10#3)(2006-12#6)(2006-7#1)(2006-8#8)(2007-2#2)(2007-7#1)(2008-3#10)(2008-4#1)(2008-7#1)(2008-9#1)(2010-7#1)(2010-9#1)(2012-2#2)
pain patients]##2##2##(1997-8#1)(2008-12#1)
pain pattern##2##2##(2006-8#2)
pain patterns and##2##3##(2007-11#1)(2010-9#1)
pain patterns##4##2##(2006-8#1)(2007-11#1)(2010-9#1)(2013-1#1)
pain perception and##3##3##(2005-8#1)(2009-3#1)(2011-2#1)
pain perception##8##2##(1993-2#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-7#1)(2009-3#1)(2010-11#1)(2011-2#1)
pain physicians##3##2##(2006-8#3)
pain population##3##2##(2006-12#1)(2006-7#1)(2009-11#1)
pain practice is##2##3##(2006-11#1)(2006-8#1)
pain practice##6##2##(2006-11#2)(2006-12#1)(2006-8#3)
pain practices##5##2##(2006-12#3)(2006-8#2)
pain problems##5##2##(2006-10#2)(2006-8#1)(2008-9#1)(2010-2#1)
pain problems]##2##2##(1991-5#1)(1997-5#1)
pain procedures##3##2##(2006-12#2)(2006-8#1)
pain processing##5##2##(2006-10#1)(2008-3#1)(2008-7#2)(2008-9#1)
pain protocol##2##2##(2007-2#1)(2008-3#1)
pain provocation##8##2##(2006-11#2)(2006-12#4)(2007-10#1)(2007-11#1)
pain quality##2##2##(2008-7#1)(2012-2#1)
pain radiating##2##2##(2006-10#1)(2006-8#1)
pain rating##7##2##(2008-12#3)(2008-7#1)(2008-9#2)(2012-2#1)
pain ratings and##3##3##(1994-2#1)(2006-10#1)(2006-12#1)
pain ratings##9##2##(1994-2#1)(2006-10#1)(2006-12#6)(2011-1#1)
pain reduction##6##2##(1993-3#1)(1994-3#1)(2006-10#1)(2006-8#1)(2007-5#1)(2007-8#1)
pain reference patterns##2##3##(2006-12#2)
pain rehabilitation##5##2##(1995-2#1)(2013-1#4)
pain related to##8##3##(1996-12#1)(1996-3#1)(2006-12#1)(2006-3#1)(2006-6#1)(2006-7#1)(2008-10#1)(2009-11#1)
pain relief (VAS scale)##2##4##(2007-11#2)
pain relief after surgery##2##4##(1990-6#1)(2007-2#1)
pain relief after##6##3##(1990-6#1)(2006-12#2)(2006-7#1)(2007-11#1)(2007-2#1)
pain relief and##10##3##(2005-9#1)(2006-7#2)(2007-11#2)(2007-2#1)(2008-7#1)(2009-3#1)(2010-10#1)(2012-12#1)
pain relief during##5##3##(2006-10#4)(2010-7#1)
pain relief for patients##3##4##(2006-10#1)(2007-8#1)(2013-1#1)
pain relief for##5##3##(1993-4#1)(2006-10#2)(2007-8#1)(2013-1#1)
pain relief from##4##3##(1992-5#1)(2006-8#2)(2008-9#1)
pain relief has been##2##4##(2006-8#1)(2010-11#1)
pain relief in some patients##2##5##(2005-10#1)(2006-10#1)
pain relief in##10##3##(2005-10#1)(2006-10#2)(2006-11#1)(2006-8#2)(2007-2#1)(2007-8#1)(2007-9#1)(2010-7#1)
pain relief is##5##3##(1992-5#1)(2006-10#2)(2008-7#2)
pain relief of##3##3##(2006-8#2)(2008-8#1)
pain relief or##4##3##(1993-4#1)(2007-2#1)(2008-3#1)(2011-2#1)
pain relief was achieved##2##4##(2007-11#1)(2007-7#1)
pain relief was##4##3##(2007-11#2)(2007-7#1)(2008-9#1)
pain relief were##2##3##(2007-11#1)(2008-9#1)
pain relief with##3##3##(1995-10#1)(2006-11#1)(2008-7#1)
pain relief##142##2##(1990-6#1)(1991-2#1)(1992-1#2)(1992-5#3)(1993-4#2)(1995-1#1)(1995-10#1)(1996-2#2)(1996-7#2)(1997-3#1)(1997-5#1)(1997-7#1)(2005-10#2)(2005-7#2)(2005-9#1)(2006-10#20)(2006-11#2)(2006-12#4)(2006-2#2)(2006-3#1)(2006-6#3)(2006-7#3)(2006-8#9)(2006-9#1)(2007-10#1)(2007-11#19)(2007-2#9)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-3#1)(2008-7#9)(2008-8#1)(2008-9#5)(2009-12#1)(2009-3#1)(2009-6#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-7#3)(2011-12#3)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)
pain relievers##2##2##(2006-8#1)(2013-8#1)
pain remains a##2##3##(1996-7#1)(2006-10#1)
pain remains##7##2##(1992-5#1)(1996-7#1)(2005-10#1)(2006-10#1)(2008-3#1)(2009-3#1)(2012-11#1)
pain reported##3##2##(1992-8#1)(2009-4#1)(2012-3#1)
pain requiring##3##2##(1992-3#1)(1996-7#1)(2008-7#1)
pain research##2##2##(2009-12#1)(2012-2#1)
pain resistant to##2##3##(2006-12#1)(2010-3#1)
pain resolved##4##2##(2005-10#1)(2008-10#1)(2013-1#2)
pain response of infants##2##4##(2010-4#2)
pain response##6##2##(1996-12#1)(2008-5#1)(2008-6#1)(2009-6#1)(2010-4#2)
pain responses and##2##3##(2008-6#1)(2011-1#1)
pain responses of##2##3##(2010-4#2)
pain responses##6##2##(1990-2#2)(2008-6#1)(2010-4#2)(2011-1#1)
pain resulting from##3##3##(1990-8#1)(1992-6#2)
pain resulting##4##2##(1990-8#1)(1992-12#1)(1992-6#2)
pain results from##2##3##(2008-9#1)(2010-7#1)
pain scale##4##2##(2006-9#1)(2007-2#1)(2007-7#1)(2010-11#1)
pain scales##5##2##(1996-7#1)(2006-12#1)(2007-12#1)(2008-5#1)(2011-2#1)
pain school classes##2##3##(1991-5#2)
pain school##4##2##(1991-5#4)
pain score (VAS)##2##3##(1991-5#1)(2007-11#1)
pain score at##2##3##(2006-10#1)(2007-3#1)
pain score was##2##3##(2011-12#1)(2013-7#1)
pain score##16##2##(1990-8#1)(1991-5#1)(1994-3#2)(2005-10#1)(2006-10#1)(2007-11#2)(2007-2#1)(2007-3#1)(2008-7#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-7#2)
pain scores as##2##3##(2006-7#1)(2012-2#1)
pain scores in##2##3##(2006-12#1)(2008-7#1)
pain scores of##3##3##(2006-10#1)(2006-8#1)(2008-7#1)
pain scores on##2##3##(2008-7#1)(2012-2#1)
pain scores was##2##3##(2006-10#1)(2006-8#1)
pain scores were recorded##2##4##(2006-12#1)(2008-7#1)
pain scores were##7##3##(1993-4#1)(1996-12#1)(2006-12#1)(2008-7#1)(2010-7#1)(2011-1#1)(2013-8#1)
pain scores##34##2##(1993-4#1)(1995-3#1)(1996-12#1)(2004-2#1)(2006-10#2)(2006-12#4)(2006-7#1)(2006-8#4)(2006-9#1)(2007-11#1)(2008-10#1)(2008-7#5)(2008-8#1)(2010-7#1)(2010-9#1)(2011-1#2)(2012-12#2)(2012-2#3)(2013-8#1)
pain secondary to lumbar##2##4##(2006-8#2)
pain secondary to##17##3##(1993-9#1)(2006-7#2)(2006-8#9)(2007-6#3)(2008-7#1)(2008-9#1)
pain seen##2##2##(2007-12#1)(2008-12#1)
pain sensation##9##2##(2005-11#1)(2008-12#2)(2008-4#3)(2008-7#2)(2008-8#1)
pain sensations##3##2##(1992-5#1)(1995-11#1)(2008-4#1)
pain sensitivity and##2##3##(1994-3#1)(2008-3#1)
pain sensitivity##6##2##(1993-11#1)(1994-3#2)(2008-3#1)(2009-12#1)(2009-7#1)
pain severity##7##2##(1992-11#1)(2006-8#1)(2009-3#1)(2010-11#1)(2010-6#3)
pain should be##5##3##(1992-8#1)(2006-10#1)(2006-11#1)(2008-4#1)(2012-12#1)
pain should##6##2##(1992-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2008-4#1)(2012-12#1)
pain signaling##3##2##(2008-2#1)(2008-4#2)
pain signals from##2##3##(2010-1#1)(2012-2#1)
pain specialists##2##2##(2006-12#1)(2008-5#1)
pain state##3##2##(1993-4#1)(1996-1#1)(1996-5#1)
pain states##11##2##(1995-9#1)(1996-3#1)(1996-5#1)(2006-10#1)(2006-12#1)(2007-6#1)(2008-4#2)(2008-7#3)
pain stimulus##3##2##(2007-5#1)(2010-4#2)
pain subsided##4##2##(1990-12#1)(2007-11#1)(2013-1#2)
pain such as##3##3##(1996-2#1)(2008-5#1)(2008-8#1)
pain symptoms and##2##3##(2007-1#1)(2009-10#1)
pain symptoms on##3##3##(2007-7#1)(2013-1#2)
pain symptoms##19##2##(2006-10#1)(2006-8#2)(2007-1#3)(2007-11#1)(2007-7#2)(2007-8#1)(2008-12#2)(2008-9#1)(2009-10#1)(2009-9#1)(2010-8#1)(2012-2#1)(2013-1#2)
pain syndrome and##3##3##(2007-11#1)(2008-6#1)(2010-10#1)
pain syndrome in##7##3##(1995-2#1)(1997-1#1)(2008-12#1)(2011-2#3)(2012-3#1)
pain syndrome is unknown##2##4##(1995-2#1)(2008-6#1)
pain syndrome was##2##3##(1995-2#1)(2006-6#1)
pain syndrome with##2##3##(2006-3#1)(2007-11#1)
pain syndrome##77##2##(1995-2#5)(1996-3#1)(1997-1#2)(2006-10#7)(2006-12#7)(2006-3#1)(2006-6#1)(2006-7#2)(2006-8#5)(2006-9#1)(2007-11#5)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#6)(2008-4#3)(2008-5#1)(2008-6#5)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-2#5)(2012-3#5)(2013-7#1)
pain syndrome]##2##2##(2012-3#2)
pain syndromes and##3##3##(2006-10#1)(2006-7#1)(2008-4#1)
pain syndromes are##2##3##(2007-7#1)(2010-7#1)
pain syndromes such as##2##4##(1990-12#2)
pain syndromes##45##2##(1990-12#3)(1995-5#1)(1995-6#1)(2005-7#1)(2006-10#1)(2006-12#6)(2006-3#1)(2006-5#2)(2006-7#1)(2006-8#3)(2007-11#3)(2007-7#3)(2008-12#2)(2008-4#5)(2008-7#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-7#2)(2012-2#3)
pain than##7##2##(1993-12#1)(1995-11#1)(1997-4#1)(2006-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
pain that demonstrates no limitation of motion##2##7##(2006-12#2)
pain that is challenging to diagnose##2##6##(2006-12#2)
pain that is##8##3##(2006-10#1)(2006-12#2)(2006-8#1)(2007-12#1)(2008-12#1)(2008-5#1)(2011-12#1)
pain that lasted##2##3##(2004-12#1)(2006-8#1)
pain that may##2##3##(2005-9#1)(2010-8#1)
pain that was##2##3##(2010-2#1)(2013-8#1)
pain that##26##2##(1991-9#1)(1995-2#1)(2004-12#1)(2005-5#1)(2005-9#1)(2006-10#1)(2006-12#5)(2006-8#2)(2007-12#1)(2007-7#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-12#1)(2013-8#1)
pain the##3##2##(1996-2#1)(2007-8#1)(2009-4#1)
pain therapy##19##2##(1992-5#1)(1996-2#1)(2006-10#9)(2006-6#1)(2007-7#1)(2008-11#4)(2008-5#1)(2011-1#1)
pain threshold in##2##3##(2008-8#1)(2010-12#1)
pain threshold to##2##3##(1996-8#1)(2007-6#1)
pain threshold##17##2##(1990-4#1)(1990-6#2)(1991-2#2)(1996-2#1)(1996-8#2)(2007-6#1)(2008-5#2)(2008-8#1)(2010-12#3)(2013-1#2)
pain thresholds to##3##3##(1993-1#3)
pain thresholds##6##2##(1990-4#1)(1993-1#4)(2009-2#1)
pain to a##2##3##(2010-3#1)(2012-12#1)
pain to be##3##3##(1993-2#1)(2006-8#2)
pain to the##3##3##(2005-6#1)(2006-1#1)(2011-12#1)
pain to##16##2##(1991-11#1)(1993-2#1)(1993-8#1)(2005-6#1)(2006-1#1)(2006-12#2)(2006-8#2)(2008-5#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-3#1)(2011-12#1)(2012-12#1)
pain tolerance##7##2##(2008-10#2)(2009-2#1)(2011-1#4)
pain transmission##6##2##(1991-3#1)(1996-12#1)(2008-4#3)(2008-9#1)
pain treated with##2##3##(2006-7#1)(2013-1#1)
pain treated##3##2##(2006-7#1)(2006-8#1)(2013-1#1)
pain treatment in##3##3##(1997-3#1)(2012-12#1)(2013-8#1)
pain treatment##24##2##(1996-2#1)(1997-3#5)(2006-10#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-7#1)(2009-12#4)(2009-3#1)(2012-12#2)(2012-2#1)(2013-8#2)
pain undergoing##2##2##(1996-2#1)(2009-12#1)
pain underwent a##2##3##(2008-12#1)(2008-9#1)
pain underwent##3##2##(2008-12#1)(2008-7#1)(2008-9#1)
pain upon##2##2##(1995-2#1)(2006-8#1)
pain using##2##2##(1993-4#1)(2012-2#1)
pain very##2##2##(2006-2#1)(2007-11#1)
pain was achieved in##3##4##(1995-9#1)(2007-11#1)(2008-6#1)
pain was evaluated with##2##4##(2007-2#1)(2008-7#1)
pain was evaluated##3##3##(2007-2#1)(2008-10#1)(2008-7#1)
pain was found in the##2##5##(1993-3#1)(2007-7#1)
pain was found##3##3##(1993-3#1)(2007-7#1)(2009-4#1)
pain was observed##5##3##(1991-2#1)(2006-10#1)(2006-12#1)(2007-8#2)
pain was reported##2##3##(2004-12#1)(2010-11#1)
pain was seen##3##3##(2006-10#1)(2006-8#1)(2012-12#1)
pain was the##6##3##(1991-2#1)(1992-1#1)(1992-9#1)(2007-7#1)(2013-1#1)(2013-8#1)
pain was##65##2##(1990-3#1)(1991-2#2)(1992-1#1)(1992-5#1)(1992-9#1)(1993-3#1)(1995-10#1)(1995-9#1)(1996-3#1)(1996-6#1)(1997-4#2)(2004-12#1)(2006-10#3)(2006-12#4)(2006-7#1)(2006-8#5)(2007-10#2)(2007-11#2)(2007-2#2)(2007-7#3)(2007-8#2)(2008-10#1)(2008-6#3)(2008-7#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#6)(2013-8#2)
pain were found##2##3##(1991-12#1)(2008-3#1)
pain were included in the study##2##6##(2004-2#1)(2007-3#1)
pain were included in##3##4##(2004-2#1)(2007-3#1)(2012-3#1)
pain were measured##2##3##(1993-2#1)(1996-6#1)
pain were significantly##2##3##(2007-6#1)(2008-11#1)
pain were the most##2##4##(1991-2#1)(2013-1#1)
pain were##29##2##(1991-12#1)(1991-2#1)(1991-8#1)(1993-2#1)(1996-6#1)(1997-4#1)(2004-2#1)(2005-7#1)(2006-10#1)(2006-12#3)(2006-6#1)(2006-8#3)(2007-2#2)(2007-3#1)(2007-6#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
pain when they##2##3##(2006-12#1)(2008-5#1)
pain when##9##2##(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-8#1)(2008-5#1)(2009-3#1)(2009-9#1)(2012-12#1)
pain which is##2##3##(1996-3#1)(2009-9#1)
pain which##7##2##(1995-3#1)(1996-3#1)(2006-12#1)(2007-11#1)(2009-9#1)(2013-1#2)
pain while##3##2##(1992-8#1)(2007-11#1)(2007-8#1)
pain who##7##2##(1991-4#1)(1995-9#1)(2006-12#1)(2006-8#2)(2008-3#1)(2013-1#1)
pain will be##3##3##(2005-9#1)(2006-8#1)(2007-11#1)
pain will##4##2##(2005-9#1)(2006-10#1)(2006-8#1)(2007-11#1)
pain with and without##2##4##(2007-6#1)(2007-8#1)
pain with botulinum neurotoxins##3##4##(2006-11#3)
pain with nausea and vomiting##2##5##(1995-7#1)(2007-8#1)
pain with or without lower extremity##2##6##(2006-8#2)
pain with or without##7##4##(2006-8#6)(2008-12#1)
pain with the##2##3##(2006-12#1)(2012-2#1)
pain with##60##2##(1992-12#2)(1992-2#1)(1995-7#1)(1995-9#1)(1997-3#1)(1997-6#1)(2004-12#1)(2005-7#1)(2006-10#2)(2006-11#3)(2006-12#5)(2006-4#1)(2006-7#5)(2006-8#11)(2007-11#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-10#1)(2008-12#2)(2008-3#1)(2008-9#1)(2009-7#2)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#1)
pain without##10##2##(1992-2#1)(1993-3#1)(2005-10#1)(2006-12#2)(2006-8#1)(2008-7#1)(2012-2#2)(2013-8#1)
pain would be##2##3##(2009-9#2)
pain would##4##2##(2005-9#1)(2008-7#1)(2009-9#2)
pain##4807##1##(1990-1#1)(1990-10#2)(1990-11#4)(1990-12#14)(1990-2#6)(1990-3#11)(1990-4#4)(1990-5#9)(1990-6#18)(1990-7#2)(1990-8#8)(1990-9#7)(1991-1#3)(1991-10#1)(1991-11#9)(1991-12#2)(1991-2#18)(1991-3#12)(1991-4#6)(1991-5#12)(1991-6#2)(1991-7#1)(1991-8#7)(1991-9#5)(1992-1#5)(1992-10#4)(1992-11#5)(1992-12#8)(1992-2#13)(1992-3#7)(1992-4#4)(1992-5#16)(1992-6#5)(1992-7#2)(1992-8#5)(1992-9#6)(1993-1#15)(1993-10#7)(1993-11#12)(1993-12#4)(1993-2#9)(1993-3#7)(1993-4#11)(1993-5#6)(1993-6#7)(1993-7#7)(1993-8#6)(1993-9#16)(1994-1#3)(1994-10#2)(1994-11#3)(1994-12#2)(1994-2#9)(1994-3#11)(1994-4#4)(1994-5#1)(1994-9#3)(1995-1#2)(1995-10#3)(1995-11#3)(1995-12#11)(1995-2#13)(1995-3#10)(1995-4#7)(1995-5#4)(1995-6#4)(1995-7#3)(1995-8#2)(1995-9#15)(1996-1#9)(1996-11#2)(1996-12#15)(1996-2#28)(1996-3#19)(1996-4#5)(1996-5#4)(1996-6#7)(1996-7#44)(1996-8#8)(1996-9#5)(1997-1#6)(1997-2#8)(1997-3#18)(1997-4#11)(1997-5#16)(1997-6#5)(1997-7#4)(1997-8#9)(2004-10#10)(2004-12#9)(2004-2#6)(2004-3#1)(2004-4#1)(2004-7#1)(2004-9#1)(2005-1#4)(2005-10#25)(2005-11#5)(2005-12#7)(2005-5#1)(2005-6#3)(2005-7#23)(2005-8#12)(2005-9#10)(2006-1#7)(2006-10#303)(2006-11#42)(2006-12#253)(2006-2#24)(2006-3#35)(2006-4#11)(2006-5#3)(2006-6#32)(2006-7#107)(2006-8#412)(2006-9#15)(2007-1#13)(2007-10#9)(2007-11#175)(2007-12#63)(2007-2#79)(2007-3#7)(2007-5#14)(2007-6#31)(2007-7#90)(2007-8#80)(2007-9#8)(2008-1#19)(2008-10#63)(2008-11#64)(2008-12#96)(2008-2#7)(2008-3#108)(2008-4#60)(2008-5#57)(2008-6#41)(2008-7#200)(2008-8#64)(2008-9#107)(2009-1#8)(2009-10#11)(2009-11#7)(2009-12#57)(2009-2#7)(2009-3#46)(2009-4#22)(2009-5#30)(2009-6#20)(2009-7#22)(2009-8#8)(2009-9#20)(2010-1#18)(2010-10#10)(2010-11#34)(2010-12#59)(2010-2#18)(2010-3#34)(2010-4#21)(2010-5#7)(2010-6#26)(2010-7#52)(2010-8#23)(2010-9#37)(2011-1#62)(2011-12#17)(2011-2#109)(2012-1#13)(2012-11#3)(2012-12#75)(2012-2#146)(2012-3#46)(2012-8#1)(2013-1#160)(2013-7#18)(2013-8#53)
pain&quot##13##1##(2006-11#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-9#1)(2009-12#1)(2009-4#3)(2011-1#1)(2012-12#2)(2013-1#1)
pain'##2##1##(1996-1#1)(1996-8#1)
pain)##13##1##(1992-9#1)(1996-7#1)(1996-8#1)(1997-3#1)(2006-12#2)(2006-7#2)(2007-11#1)(2008-7#2)(2008-8#1)(2010-7#1)
pain-discomfort##2##1##(2008-6#2)
pain-free within 4##2##3##(1990-12#1)(2004-12#1)
pain-free##14##1##(1990-12#1)(1992-2#1)(1993-8#1)(1994-5#1)(2004-12#1)(2004-3#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-9#1)(2012-12#1)(2012-2#2)(2013-1#1)
pain-producing##4##1##(1991-9#1)(1996-7#1)(2006-12#1)(2007-5#1)
pain-related behavior##2##2##(2012-2#2)
pain-related##13##1##(1995-12#1)(1996-8#1)(2006-10#1)(2006-12#2)(2007-2#2)(2008-7#1)(2010-2#1)(2012-2#2)(2013-1#1)(2013-7#1)
pain-relief##2##1##(2007-2#1)(2008-3#1)
pain/discomfort##7##1##(2007-6#4)(2008-12#1)(2008-3#2)
pain?##12##1##(1992-6#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-7#2)(2008-5#1)(2008-7#1)(2009-5#1)(2011-1#1)
pain]##20##1##(1991-2#1)(1991-3#1)(1991-4#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-2#1)(1993-9#1)(1994-4#1)(1996-1#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-6#1)(2006-6#1)(2007-7#1)(2012-3#2)
painfree##2##1##(1993-5#1)(2007-11#1)
painful and disabling##5##3##(1995-9#1)(2006-10#1)(2007-11#1)(2009-2#1)(2009-5#1)
painful and##13##2##(1990-6#1)(1995-12#1)(1995-9#1)(1997-5#1)(2006-10#2)(2007-11#2)(2008-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2012-12#1)
painful area##3##2##(2008-1#1)(2010-7#2)
painful bone metastases##4##3##(1994-7#1)(2006-6#3)
painful bone metastasis##2##3##(1996-2#1)(2012-2#1)
painful bone##6##2##(1994-7#1)(1996-2#1)(2006-6#3)(2012-2#1)
painful bruising##2##2##(2012-12#2)
painful chronic pancreatitis##3##3##(2006-10#3)
painful condition that##3##3##(1992-5#1)(2008-12#1)(2008-7#1)
painful condition##5##2##(1992-5#1)(2006-12#1)(2008-12#1)(2008-7#1)(2009-12#1)
painful conditions##8##2##(1996-7#2)(2006-10#1)(2006-11#1)(2006-8#1)(2007-3#1)(2009-7#1)(2013-1#1)
painful crises##6##2##(1991-6#1)(2007-3#5)
painful death##2##2##(1996-5#1)(2010-11#1)
painful diabetic##3##2##(2008-4#2)(2008-9#1)
painful discs##2##2##(2006-7#1)(2009-5#1)
painful experiences##2##2##(1992-3#1)(2010-7#1)
painful flexible flatfoot##2##3##(2008-8#2)
painful hip##2##2##(2008-8#1)(2010-9#1)
painful mass in the##3##4##(2009-3#1)(2010-5#1)(2013-1#1)
painful mass##4##2##(2007-7#1)(2009-3#1)(2010-5#1)(2013-1#1)
painful neuropathies##3##2##(2008-7#1)(2008-9#2)
painful or##2##2##(2005-11#1)(2009-10#1)
painful osseous metastases##2##3##(2007-11#2)
painful periods##2##2##(1996-3#1)(2013-1#1)
painful peripheral neuropathies##2##3##(2008-7#2)
painful peripheral##4##2##(1996-5#2)(2008-7#2)
painful procedures##4##2##(1994-12#1)(2008-10#2)(2010-7#1)
painful regional lymphadenitis##2##3##(1991-4#2)
painful scoliosis##2##2##(2010-12#2)
painful sensations##2##2##(1995-12#1)(2008-4#1)
painful sensory input##2##3##(2007-5#2)
painful skin##2##2##(1996-6#2)
painful stimuli##5##2##(1996-1#1)(2005-7#1)(2008-4#1)(2011-2#2)
painful swelling of the##4##4##(1990-11#1)(1991-3#1)(2007-6#1)(2008-1#1)
painful swelling of##5##3##(1990-11#1)(1991-3#1)(2007-6#1)(2007-7#1)(2008-1#1)
painful swelling##8##2##(1990-11#1)(1991-3#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-6#1)(2008-7#1)(2010-3#1)
painful symptoms##4##2##(1992-5#1)(1995-7#1)(2008-1#2)
painful than##2##2##(1996-12#1)(2011-2#1)
painful to the patient##2##4##(1994-5#1)(2012-12#1)
painful ulceration of the##2##4##(2008-3#1)(2008-7#1)
painful vertebral compression fractures##2##4##(2006-8#2)
painful vertebral##3##2##(2006-8#3)
painful##258##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#2)(1990-7#2)(1991-3#1)(1991-4#2)(1991-6#1)(1991-8#2)(1992-11#1)(1992-3#1)(1992-5#3)(1993-9#1)(1994-10#1)(1994-12#1)(1994-4#1)(1994-5#2)(1994-7#1)(1995-12#4)(1995-5#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#3)(1996-6#3)(1996-7#2)(1996-9#1)(1997-1#2)(1997-4#1)(1997-5#1)(2004-2#1)(2005-10#3)(2005-11#2)(2005-7#2)(2006-1#1)(2006-10#9)(2006-11#2)(2006-12#9)(2006-3#4)(2006-6#4)(2006-7#3)(2006-8#12)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#11)(2007-12#2)(2007-2#2)(2007-3#6)(2007-5#3)(2007-6#1)(2007-7#6)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#4)(2008-11#3)(2008-12#5)(2008-3#2)(2008-4#5)(2008-6#2)(2008-7#11)(2008-8#6)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#3)(2009-5#2)(2009-7#2)(2009-9#4)(2010-1#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#4)(2010-9#1)(2011-1#2)(2011-2#8)(2012-1#1)(2012-12#5)(2012-2#6)(2013-1#7)(2013-7#2)(2013-8#4)
painfully##2##1##(1990-2#1)(2008-11#1)
painkiller##2##1##(2007-11#1)(2013-8#1)
painkillers##3##1##(2006-10#1)(2007-8#1)(2010-12#1)
painless and non##2##3##(2009-4#1)(2010-12#1)
painless and##4##2##(2008-10#1)(2009-4#1)(2010-12#1)(2010-8#1)
painless central chondrosarcoma of pubis##2##5##(2008-5#2)
painless mass##2##2##(2012-3#2)
painless swelling on the##2##4##(2011-12#1)(2011-2#1)
painless swelling##7##2##(2005-12#1)(2007-7#1)(2008-12#2)(2010-3#1)(2011-12#1)(2011-2#1)
painless##60##1##(1990-6#1)(1991-11#1)(1994-7#1)(1997-5#1)(2005-12#2)(2006-1#1)(2006-10#3)(2006-12#1)(2006-8#1)(2007-11#2)(2007-7#5)(2008-1#1)(2008-10#3)(2008-12#3)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#3)(2009-2#1)(2009-4#3)(2009-7#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#1)
pains and##5##2##(2005-11#1)(2006-7#1)(2007-7#1)(2010-10#1)(2012-2#1)
pains in##5##2##(2006-6#2)(2008-11#1)(2008-4#1)(2013-1#1)
pains##40##1##(1991-5#1)(1993-3#1)(1995-10#1)(1996-2#1)(2004-7#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-4#1)(2006-6#3)(2006-7#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-10#1)(2011-2#1)(2012-2#2)(2013-1#2)
painstaking##2##1##(2006-7#1)(2008-12#1)
paint a##2##2##(2004-9#1)(2009-8#1)
paint and##6##2##(1996-3#2)(2008-10#2)(2008-11#1)(2008-5#1)
paint are##2##2##(2007-12#2)
paint layer##4##2##(2007-12#3)(2008-3#1)
paint or##2##2##(2008-3#2)
paint samples##2##2##(2007-8#2)
paint surface##2##2##(2008-10#1)(2008-3#1)
paint##54##1##(1991-3#1)(1993-9#4)(1995-6#1)(1996-3#2)(2004-9#1)(2006-6#1)(2007-12#10)(2007-7#2)(2007-8#4)(2008-10#9)(2008-11#1)(2008-3#9)(2008-5#1)(2009-8#1)(2010-4#3)(2012-1#1)(2013-8#3)
painted in green##2##3##(2008-6#2)
painted in##3##2##(1997-1#1)(2008-6#2)
painted metal##2##2##(2007-12#1)(2008-3#1)
painted with##2##2##(2008-10#2)
painted##20##1##(1990-10#1)(1997-1#1)(2007-12#3)(2008-10#7)(2008-3#1)(2008-6#3)(2009-7#2)(2010-4#1)(2013-8#1)
painters##8##1##(1994-6#5)(2006-1#1)(2006-10#2)
painting and##3##2##(2007-7#1)(2008-6#1)(2012-3#1)
painting from the##2##3##(2008-10#2)
painting from##3##2##(2008-10#3)
painting in##2##2##(2007-8#1)(2008-10#1)
painting is##2##2##(2011-2#1)(2012-2#1)
painting of previously##2##3##(2008-10#1)(2008-4#1)
painting of##3##2##(2007-8#1)(2008-10#1)(2008-4#1)
painting on##2##2##(1992-2#1)(2008-7#1)
painting to##3##2##(2008-3#1)(2008-6#1)(2010-3#1)
painting##52##1##(1991-2#1)(1992-2#1)(1992-4#1)(1995-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#15)(2008-3#1)(2008-4#1)(2008-6#10)(2008-7#2)(2008-9#4)(2009-2#1)(2010-3#3)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)
paintings from##2##2##(2008-10#1)(2008-3#1)
paintings##28##1##(1995-12#1)(1995-6#1)(2006-10#3)(2007-8#2)(2007-9#1)(2008-10#15)(2008-2#1)(2008-3#2)(2012-2#2)
paints from##2##2##(2008-10#2)
paints##13##1##(1993-9#1)(1995-10#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-2#1)(2008-3#2)
pair (bp)##7##2##(1991-1#1)(1993-3#1)(1993-9#1)(1994-2#1)(1995-6#1)(2005-8#1)(2009-5#1)
pair 3##2##2##(2008-11#1)(2010-3#1)
pair DNA##3##2##(1991-11#1)(1991-8#1)(1995-3#1)
pair adenosine##3##2##(2005-8#1)(2006-12#2)
pair and recombine##2##3##(2008-5#1)(2008-7#1)
pair and the##3##3##(1992-2#1)(2008-3#1)(2010-8#1)
pair and##11##2##(1992-2#1)(1994-8#1)(1995-1#1)(2004-9#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-8#1)
pair are##5##2##(1991-7#1)(1994-5#1)(2007-12#1)(2008-9#1)(2009-8#1)
pair as a##3##3##(1993-11#1)(2008-11#1)(2011-1#1)
pair as##6##2##(1993-11#1)(2008-10#3)(2008-11#1)(2011-1#1)
pair at the##2##3##(1995-5#1)(1995-6#1)
pair at##4##2##(1995-5#1)(1995-6#1)(2007-12#1)(2008-2#1)
pair based on##3##3##(2008-10#2)(2008-3#1)
pair between##2##2##(1997-8#1)(2008-10#1)
pair bonding##2##2##(1995-12#2)
pair cDNA was isolated##2##4##(1992-8#1)(1993-7#1)
pair cDNA##6##2##(1991-3#1)(1992-12#1)(1992-8#1)(1993-7#1)(1994-12#1)(1994-8#1)
pair formation##7##2##(1993-3#1)(1997-4#1)(2008-10#2)(2008-5#1)(2009-5#1)(2010-6#1)
pair fragment##4##2##(1991-9#1)(1995-3#1)(2008-10#2)
pair from##3##2##(1990-9#1)(1991-11#1)(2013-7#1)
pair had##3##2##(2008-12#2)(2008-2#1)
pair in the##4##3##(1993-3#1)(1994-9#1)(2006-3#1)(2008-2#1)
pair in##13##2##(1991-4#1)(1991-7#1)(1993-3#1)(1994-9#1)(1997-1#1)(2006-3#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-5#1)(2009-4#1)
pair insert##2##2##(1990-8#1)(1991-2#1)
pair is##11##2##(1992-3#1)(1995-5#1)(1995-6#1)(1997-4#1)(1997-7#2)(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
pair of Ac elements derived from##2##6##(2012-3#2)
pair of adjacent##2##3##(1997-5#1)(2007-4#1)
pair of basic amino acids##2##5##(1995-5#1)(2008-8#1)
pair of cells##4##3##(1992-7#2)(2007-12#2)
pair of eyes##2##3##(1992-6#1)(2008-5#1)
pair of genes##2##3##(1994-8#1)(2008-5#1)
pair of phase-conjugate reference beams##2##5##(2007-12#2)
pair of primers flanking##2##4##(2006-12#1)(2006-6#1)
pair of primers##6##3##(1990-2#1)(1997-6#1)(2006-12#1)(2006-6#1)(2008-10#2)
pair of prism##2##3##(2007-11#1)(2008-3#1)
pair of signal and idler##2##5##(2007-12#1)(2008-2#1)
pair of symmetry-related##2##3##(1992-9#2)
pair of well-defined redox##3##4##(2008-10#3)
pair of well-defined##5##3##(2008-10#5)
pair of##216##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-11#4)(1992-6#1)(1992-7#2)(1992-9#2)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-8#2)(1995-11#1)(1995-2#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#2)(1996-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-12#3)(2006-4#2)(2006-6#1)(2007-1#1)(2007-11#10)(2007-12#30)(2007-4#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#19)(2008-11#4)(2008-12#2)(2008-2#15)(2008-3#21)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#11)(2008-9#4)(2009-12#1)(2009-2#1)(2010-10#1)(2010-12#2)(2010-2#3)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#6)(2013-1#2)(2013-7#2)(2013-8#2)
pair on the##2##3##(2008-10#1)(2008-2#1)
pair on##3##2##(1996-2#1)(2008-10#1)(2008-2#1)
pair potential##2##2##(2006-5#1)(2010-2#1)
pair production in##2##3##(1992-9#1)(1994-10#1)
pair promoter##2##2##(1994-12#1)(1995-3#1)
pair region##2##2##(1994-9#1)(2008-10#1)
pair sequence##7##2##(1991-11#1)(1994-9#1)(1995-6#1)(1996-12#2)(1996-6#1)(1997-4#1)
pair specific##3##2##(1992-2#1)(1997-1#1)(2007-8#1)
pair through##2##2##(1994-9#1)(2008-2#1)
pair to the##3##3##(1990-8#1)(2007-12#1)(2007-8#1)
pair to##6##2##(1990-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-3#1)
pair was found to##2##4##(1997-1#1)(2008-10#1)
pair was used to##2##4##(2007-11#1)(2007-12#1)
pair was used##3##3##(1996-6#1)(2007-11#1)(2007-12#1)
pair was##15##2##(1990-12#1)(1991-1#1)(1993-12#1)(1994-9#1)(1995-5#1)(1996-6#1)(1996-7#1)(1997-1#2)(2007-11#1)(2007-12#2)(2008-10#2)(2009-12#1)
pair while##2##2##(1996-7#1)(2008-1#1)
pair wise procedure##2##3##(2011-2#2)
pair with##9##2##(1991-2#1)(1994-8#2)(1997-1#1)(2005-4#1)(2007-12#1)(2008-10#3)
pair##588##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#4)(1990-9#3)(1991-1#2)(1991-11#5)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#7)(1991-8#1)(1991-9#3)(1992-1#3)(1992-11#5)(1992-12#3)(1992-2#4)(1992-3#4)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#4)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#12)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#3)(1994-8#7)(1994-9#6)(1995-1#4)(1995-10#5)(1995-11#2)(1995-12#5)(1995-2#2)(1995-3#3)(1995-4#1)(1995-5#4)(1995-6#9)(1995-8#2)(1996-1#2)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#6)(1996-8#2)(1997-1#8)(1997-2#2)(1997-3#1)(1997-4#5)(1997-5#6)(1997-6#1)(1997-7#5)(1997-8#1)(2004-9#1)(2005-11#2)(2005-4#1)(2005-7#1)(2005-8#2)(2006-10#4)(2006-12#9)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#1)(2007-1#3)(2007-10#1)(2007-11#18)(2007-12#38)(2007-3#1)(2007-4#2)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#4)(2008-10#77)(2008-11#11)(2008-12#12)(2008-2#25)(2008-3#33)(2008-4#4)(2008-5#17)(2008-6#1)(2008-7#7)(2008-8#13)(2008-9#6)(2009-12#4)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#6)(2010-3#4)(2010-4#1)(2010-5#5)(2010-6#2)(2010-7#2)(2010-8#3)(2011-1#4)(2011-12#1)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#10)(2013-1#3)(2013-7#3)(2013-8#3)
pair-fed control animals##2##3##(1993-3#1)(1993-6#1)
pair-fed##9##1##(1991-1#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1996-10#2)(2004-11#1)(2010-6#1)
pair-rule##5##1##(1991-11#4)(1993-9#1)
pair-wise##15##1##(1992-12#1)(2006-10#1)(2007-8#2)(2008-12#1)(2008-2#2)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#4)
paired Student's##3##2##(2006-9#1)(2010-1#1)(2010-9#1)
paired and##2##2##(1993-6#1)(2010-8#1)
paired basic amino acid residues##2##5##(1991-3#1)(1994-12#1)
paired basic amino acid##3##4##(1991-3#1)(1993-5#1)(1994-12#1)
paired basic amino acids##2##4##(1991-9#2)
paired basic amino##5##3##(1991-3#1)(1991-9#2)(1993-5#1)(1994-12#1)
paired basic residues##2##3##(1992-2#1)(1992-5#1)
paired basic##7##2##(1991-3#1)(1991-9#2)(1992-2#1)(1992-5#1)(1993-5#1)(1994-12#1)
paired bihemispheric##2##2##(1996-3#2)
paired blood cultures##2##3##(2007-7#1)(2011-2#1)
paired blood##3##2##(2007-2#1)(2007-7#1)(2011-2#1)
paired comparisons##2##2##(2008-10#1)(2010-8#1)
paired controls##2##2##(1991-5#1)(2013-8#1)
paired data##4##2##(1990-6#1)(1996-12#1)(2008-7#1)(2013-1#1)
paired ducts##2##2##(2007-12#2)
paired helical filaments (PHFs)##2##4##(1992-6#1)(1995-8#1)
paired helical filaments##12##3##(1991-3#1)(1991-8#1)(1992-1#1)(1992-6#2)(1994-9#2)(1995-10#1)(1995-11#1)(1995-8#2)(2004-12#1)
paired helical##14##2##(1990-7#1)(1991-1#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-6#2)(1994-9#2)(1995-10#1)(1995-11#1)(1995-8#2)(2004-12#1)
paired normal##3##2##(1994-2#1)(2007-11#1)(2011-2#1)
paired organs##2##2##(1995-6#1)(2007-12#1)
paired pulse##4##2##(1992-1#1)(1997-5#2)(1997-7#1)
paired recordings##2##2##(2008-11#2)
paired samples##4##2##(1992-3#1)(2004-9#1)(2007-2#1)(2008-5#1)
paired t tests##3##3##(2006-10#1)(2008-7#1)(2012-2#1)
paired t##6##2##(1990-12#1)(2005-10#1)(2006-10#1)(2008-7#1)(2010-10#1)(2012-2#1)
paired t-test##16##2##(2007-10#1)(2007-8#1)(2008-10#9)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
paired t-tests##6##2##(2008-1#1)(2008-5#1)(2009-2#1)(2010-6#1)(2010-8#1)(2012-1#1)
paired tests##2##2##(2007-7#2)
paired to##4##2##(1993-11#1)(1997-5#1)(2008-7#1)(2011-7#1)
paired with a##6##3##(1996-2#1)(1996-6#1)(1997-8#2)(2007-5#1)(2008-4#1)
paired with the##4##3##(1992-9#1)(1993-8#2)(1995-3#1)
paired with##22##2##(1992-1#2)(1992-9#3)(1993-12#1)(1993-4#1)(1993-8#2)(1994-9#1)(1995-3#1)(1996-2#1)(1996-6#1)(1997-8#2)(2006-12#1)(2007-5#1)(2007-8#1)(2008-4#1)(2009-11#2)(2012-2#1)
paired##203##1##(1990-10#1)(1990-12#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#5)(1992-10#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-9#3)(1993-11#1)(1993-12#3)(1993-4#2)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#3)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#3)(1996-6#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-5#3)(1997-7#1)(1997-8#3)(2004-12#1)(2004-9#1)(2005-10#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#13)(2007-2#4)(2007-5#1)(2007-7#5)(2007-8#2)(2008-1#1)(2008-10#16)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#8)(2008-8#2)(2009-11#2)(2009-2#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#9)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#1)(2013-8#2)
paired-helical filaments##3##2##(2008-7#3)
paired-pulse facilitation (PPF)##2##3##(1993-2#1)(1997-5#1)
paired-pulse facilitation##3##2##(1993-12#1)(1993-2#1)(1997-5#1)
paired-pulse inhibition of##2##3##(1995-5#1)(1996-10#1)
paired-pulse inhibition##7##2##(1995-5#1)(1996-10#2)(1997-5#4)
paired-pulse responses##2##2##(1997-5#2)
paired-pulse stimulation##3##2##(1995-5#1)(1997-5#2)
paired-pulse##17##1##(1993-12#1)(1993-2#2)(1995-5#2)(1996-10#3)(1997-5#9)
pairing a##3##2##(1992-10#1)(2008-4#1)(2010-11#1)
pairing an##2##2##(2007-5#1)(2009-11#1)
pairing and chiasma formation were##2##5##(2008-5#2)
pairing and chiasma formation##3##4##(2008-5#3)
pairing and##14##2##(1995-4#1)(1997-4#1)(2005-11#1)(2006-7#1)(2008-10#1)(2008-2#2)(2008-4#2)(2008-5#3)(2008-7#1)(2011-2#1)
pairing between##3##2##(1990-5#1)(1995-2#1)(1995-3#1)
pairing is the##2##3##(1990-10#1)(2008-5#1)
pairing of the##4##3##(1991-2#1)(1991-6#1)(1993-9#1)(2009-6#1)
pairing of##10##2##(1991-2#1)(1991-5#1)(1991-6#1)(1993-9#1)(1994-5#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-6#1)
pairing partner##2##2##(2008-5#1)(2012-3#1)
pairing properties##2##2##(2006-12#1)(2008-4#1)
pairing with##5##2##(1993-11#1)(1997-1#1)(2008-7#1)(2011-2#2)
pairing##93##1##(1990-10#2)(1990-5#2)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#3)(1991-6#2)(1991-7#1)(1992-10#1)(1992-4#1)(1992-6#2)(1992-8#2)(1993-11#3)(1993-9#1)(1994-10#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#2)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#3)(2006-12#1)(2006-7#1)(2007-5#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#4)(2008-4#6)(2008-5#11)(2008-7#5)(2009-11#1)(2009-5#2)(2009-6#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)
pairing)##5##1##(1992-9#2)(1996-4#1)(1997-1#1)(2007-8#1)
pairings between clients and##2##4##(1996-3#2)
pairings of a##2##3##(1992-9#1)(2009-11#1)
pairings of##3##2##(1992-9#1)(2006-12#1)(2009-11#1)
pairings##20##1##(1990-4#1)(1992-2#2)(1992-9#2)(1993-4#1)(1996-3#2)(2006-12#1)(2008-10#2)(2008-5#3)(2008-9#1)(2009-11#2)(2011-1#1)(2012-1#1)(2012-2#1)
pairs also##2##2##(2008-10#1)(2008-5#1)
pairs and one##2##3##(2006-12#1)(2008-3#1)
pairs and their##2##3##(1996-12#1)(2008-1#1)
pairs and##29##2##(1990-2#1)(1990-4#1)(1991-4#1)(1993-11#1)(1993-3#1)(1993-6#1)(1995-1#2)(1995-6#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-5#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-2#1)(2009-5#1)(2010-8#1)(2011-2#1)
pairs are##12##2##(1990-5#1)(1991-7#1)(1991-8#1)(1994-8#2)(1995-1#1)(1997-7#2)(2006-10#1)(2008-10#1)(2008-3#1)(2011-2#1)
pairs as the##2##3##(1990-9#1)(2007-6#1)
pairs ascertained through##2##3##(1997-5#2)
pairs at##4##2##(1992-6#2)(1993-3#1)(2007-11#1)
pairs between##3##2##(1991-11#1)(2008-10#1)(2008-2#1)
pairs by a##2##3##(1991-3#1)(1996-5#1)
pairs by##3##2##(1991-3#1)(1996-4#1)(1996-5#1)
pairs can##2##2##(1996-7#1)(2008-2#1)
pairs except##2##2##(1994-8#1)(2011-12#1)
pairs for each##2##3##(1993-8#1)(2008-10#1)
pairs for the##2##3##(1990-8#1)(2013-8#1)
pairs for##6##2##(1990-8#1)(1993-8#1)(2007-12#1)(2008-10#1)(2012-12#1)(2013-8#1)
pairs from##7##2##(1993-9#1)(1997-5#1)(2007-5#1)(2008-10#1)(2008-12#1)(2013-1#2)
pairs generated##3##2##(2007-12#2)(2008-10#1)
pairs in a##5##3##(1995-12#1)(2007-11#2)(2007-12#2)
pairs in the##15##3##(1991-10#1)(1991-9#1)(1993-9#1)(1994-12#1)(1995-10#1)(2006-12#1)(2007-11#1)(2007-12#3)(2008-2#1)(2008-7#1)(2008-8#1)(2012-12#2)
pairs in##38##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-5#1)(1991-7#1)(1991-9#1)(1993-9#1)(1994-11#1)(1994-12#2)(1995-10#1)(1995-12#1)(1995-2#1)(1997-9#1)(2006-12#1)(2007-11#3)(2007-12#6)(2008-10#1)(2008-2#5)(2008-7#1)(2008-8#1)(2010-7#1)(2012-12#2)(2013-8#1)
pairs involving##2##2##(1995-6#1)(2008-4#1)
pairs is##6##2##(1995-3#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-1#1)
pairs may##3##2##(1997-8#1)(2007-2#1)(2007-9#1)
pairs of Cys residues##2##4##(1991-11#1)(1995-5#1)
pairs of adjacent##4##3##(1991-7#1)(1994-5#1)(1995-8#1)(2008-10#1)
pairs of alleles##2##3##(1992-3#1)(2008-10#1)
pairs of autosomes and##2##4##(2007-11#1)(2008-8#1)
pairs of closely##2##3##(2007-11#1)(2013-7#1)
pairs of extended##2##3##(2008-10#2)
pairs of lateral cardiac arteries and##2##6##(2007-12#2)
pairs of lateral##3##3##(2007-12#2)(2008-5#1)
pairs of loci##2##3##(2008-10#2)
pairs of neurons##5##3##(1991-6#1)(1995-11#2)(2008-11#2)
pairs of populations##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
pairs of primers designed##2##4##(2005-11#1)(2013-8#1)
pairs of primers##7##3##(2005-11#2)(2006-10#1)(2008-10#2)(2008-8#1)(2013-8#1)
pairs of residues##2##3##(1995-10#2)
pairs of species##2##3##(2007-5#2)
pairs of specific primers##2##4##(2013-8#2)
pairs of stimuli##3##3##(1993-12#1)(2011-2#1)(2012-11#1)
pairs of tests##2##3##(2006-11#2)
pairs of the##9##3##(1991-11#1)(1992-4#1)(1994-9#1)(1995-3#1)(1997-7#1)(2007-10#1)(2008-5#1)(2008-6#1)(2010-8#1)
pairs of these##4##3##(1990-12#1)(1996-12#1)(2007-12#1)(2008-10#1)
pairs of tumor and##2##4##(1996-11#1)(2008-1#1)
pairs of wavelengths##3##3##(2008-10#1)(2008-3#1)(2012-11#1)
pairs of words##2##3##(2008-10#1)(2009-8#1)
pairs of##247##2##(1990-12#2)(1990-2#1)(1990-5#2)(1991-1#2)(1991-10#1)(1991-11#2)(1991-6#5)(1991-7#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-9#2)(1994-3#2)(1994-5#3)(1994-9#3)(1995-1#1)(1995-10#2)(1995-11#3)(1995-2#2)(1995-3#3)(1995-5#2)(1995-6#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#3)(1996-6#2)(1996-7#3)(1997-2#1)(1997-3#2)(1997-4#2)(1997-7#2)(1997-9#1)(2005-11#3)(2005-12#1)(2006-10#4)(2006-11#4)(2006-12#1)(2006-5#2)(2007-1#2)(2007-10#3)(2007-11#11)(2007-12#22)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#31)(2008-11#3)(2008-12#4)(2008-2#7)(2008-3#8)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#5)(2008-8#6)(2008-9#2)(2009-11#1)(2009-12#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#3)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#4)
pairs on the##2##3##(2007-12#1)(2009-5#1)
pairs or##6##2##(1994-9#1)(1995-3#1)(2008-12#1)(2008-2#1)(2012-3#1)(2013-1#1)
pairs previously##3##2##(1992-8#1)(2008-5#1)(2012-2#1)
pairs produced##3##2##(2008-3#1)(2008-5#1)(2012-2#1)
pairs reported##3##2##(1997-5#2)(2008-10#1)
pairs show that##2##3##(2007-5#1)(2012-2#1)
pairs that##5##2##(1991-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2012-2#1)
pairs to the##2##3##(1992-7#1)(1995-1#1)
pairs to##6##2##(1992-7#1)(1994-9#1)(1995-1#1)(2008-10#1)(2010-2#1)(2013-1#1)
pairs used##3##2##(1997-5#1)(2008-10#2)
pairs was##8##2##(1992-11#1)(1995-12#1)(1997-5#1)(2007-1#1)(2009-9#2)(2012-12#2)
pairs were analyzed##2##3##(1993-11#1)(2008-2#1)
pairs were designed##2##3##(2008-10#2)
pairs were enrolled##2##3##(1994-2#1)(2008-1#1)
pairs were identified##2##3##(1993-4#1)(2006-10#1)
pairs were positive##2##3##(2011-2#2)
pairs were then##2##3##(2007-8#1)(2012-12#1)
pairs were##25##2##(1990-9#1)(1993-11#1)(1993-12#2)(1993-4#1)(1994-2#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-5#1)(2010-6#1)(2011-2#4)(2012-12#1)(2013-1#1)
pairs which##2##2##(1991-4#1)(2009-12#1)
pairs with a##6##3##(1991-9#1)(1997-8#1)(1997-9#1)(2007-11#1)(2007-12#1)(2009-6#1)
pairs with an##3##3##(1991-12#1)(1991-4#1)(2008-2#1)
pairs with high##2##3##(1993-3#1)(1993-4#1)
pairs with the##2##3##(1995-1#1)(2005-11#1)
pairs with##23##2##(1991-12#1)(1991-4#1)(1991-9#1)(1992-11#1)(1993-3#1)(1993-4#1)(1995-1#1)(1997-5#2)(1997-8#1)(1997-9#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-5#1)(2009-6#1)
pairs within##2##2##(1996-7#1)(2009-12#1)
pairs##737##1##(1990-10#1)(1990-12#4)(1990-2#3)(1990-4#1)(1990-5#6)(1990-7#1)(1990-8#1)(1990-9#4)(1991-1#3)(1991-10#5)(1991-11#7)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#3)(1991-5#1)(1991-6#5)(1991-7#5)(1991-8#4)(1991-9#4)(1992-11#2)(1992-12#2)(1992-2#4)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#5)(1992-7#4)(1992-8#3)(1993-1#1)(1993-11#6)(1993-12#5)(1993-2#2)(1993-3#4)(1993-4#4)(1993-6#5)(1993-8#3)(1993-9#6)(1994-11#3)(1994-12#4)(1994-2#2)(1994-3#4)(1994-5#7)(1994-6#1)(1994-8#7)(1994-9#11)(1995-1#6)(1995-10#7)(1995-11#4)(1995-12#5)(1995-2#6)(1995-3#9)(1995-5#3)(1995-6#4)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-4#1)(1996-5#9)(1996-6#6)(1996-7#11)(1996-8#1)(1997-1#3)(1997-2#3)(1997-3#6)(1997-4#2)(1997-5#16)(1997-6#1)(1997-7#9)(1997-8#2)(1997-9#3)(2004-3#1)(2005-10#1)(2005-11#4)(2005-12#1)(2006-10#12)(2006-11#5)(2006-12#8)(2006-5#2)(2006-8#1)(2007-1#5)(2007-10#4)(2007-11#19)(2007-12#38)(2007-2#4)(2007-3#2)(2007-4#2)(2007-5#4)(2007-6#2)(2007-7#1)(2007-8#3)(2007-9#4)(2008-1#4)(2008-10#81)(2008-11#6)(2008-12#14)(2008-2#27)(2008-3#17)(2008-4#13)(2008-5#19)(2008-6#3)(2008-7#14)(2008-8#11)(2008-9#10)(2009-11#2)(2009-12#4)(2009-2#1)(2009-5#5)(2009-6#2)(2009-8#3)(2009-9#4)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#5)(2010-3#3)(2010-6#1)(2010-7#3)(2010-8#6)(2011-1#1)(2011-12#2)(2011-2#15)(2011-3#2)(2012-1#3)(2012-11#2)(2012-12#11)(2012-2#6)(2012-3#6)(2013-1#8)(2013-7#2)(2013-8#8)
pairs) and##3##2##(1997-5#2)(2007-10#1)
pairs)##20##1##(1991-8#2)(1991-9#1)(1992-3#1)(1995-1#2)(1997-5#3)(2006-4#1)(2007-1#1)(2007-10#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-6#1)(2010-8#2)
pairs/mm##7##1##(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#3)
pairwise F(ST)##2##2##(2008-10#1)(2011-2#1)
pairwise HAMMER##2##2##(2011-2#2)
pairwise combinations##2##2##(2008-10#1)(2008-8#1)
pairwise comparisons##5##2##(1991-9#1)(1995-11#1)(2006-11#1)(2008-10#1)(2008-5#1)
pairwise contrasts##2##2##(2008-10#2)
pairwise distances##4##2##(2007-9#3)(2008-5#1)
pairwise fuzzy group decision-making##2##4##(2008-2#2)
pairwise fuzzy group##4##3##(2008-2#4)
pairwise interactions##3##2##(2008-7#1)(2008-8#1)(2012-3#1)
pairwise relationships between the##2##4##(2008-1#1)(2008-6#1)
pairwise relationships##3##2##(1992-4#1)(2008-1#1)(2008-6#1)
pairwise residue correlations##3##3##(1995-8#3)
pairwise residue##4##2##(1994-9#1)(1995-8#3)
pairwise rms differences##3##3##(1995-10#3)
pairwise rms##4##2##(1994-5#1)(1995-10#3)
pairwise virulence associations##2##3##(2008-10#2)
pairwise##73##1##(1990-6#1)(1991-9#1)(1992-4#1)(1994-5#2)(1994-9#1)(1995-10#3)(1995-11#1)(1995-6#1)(1995-8#3)(2006-10#1)(2006-11#1)(2006-9#2)(2007-10#2)(2007-3#1)(2007-9#3)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#7)(2010-11#1)(2010-9#2)(2011-2#4)(2012-1#2)(2012-2#1)(2012-3#6)(2013-8#1)
paitensis is##2##2##(2007-3#2)
paitensis##4##1##(2007-3#4)
pal-1##3##1##(1991-5#3)
pal-KTTKS##2##1##(2008-5#2)
palF##2##1##(1997-7#2)
palF15##2##1##(1997-7#2)
palaeoenvironmental##2##1##(2012-7#1)(2012-9#1)
palaeontology##3##1##(1991-9#2)(1994-3#1)
palanosetron (0##3##2##(2011-12#3)
palanosetron##4##1##(2011-12#4)
palatability##11##1##(1993-9#1)(2008-9#2)(2010-4#7)(2012-2#1)
palatable conditions##2##2##(1997-8#2)
palatable food##3##2##(2008-4#3)
palatable##11##1##(1993-9#1)(1997-8#3)(2008-4#3)(2009-5#1)(2009-6#1)(2012-2#2)
palatal depth##4##2##(2012-12#4)
palatal flap##2##2##(2007-12#2)
palatal root##5##2##(2011-12#1)(2013-1#4)
palatal roots##6##2##(2013-1#6)
palatal##37##1##(1991-9#1)(2007-12#3)(2008-12#1)(2009-7#1)(2009-8#2)(2011-1#1)(2011-12#1)(2012-12#5)(2012-2#1)(2013-1#19)(2013-7#2)
palate and##8##2##(1990-6#1)(1993-3#1)(2006-6#1)(2007-7#1)(2009-8#2)(2011-2#1)(2013-1#1)
palate are##4##2##(2007-9#2)(2010-3#1)(2012-12#1)
palate have##2##2##(2010-5#1)(2013-1#1)
palate in a##2##3##(2008-12#1)(2012-3#1)
palate in##6##2##(1996-3#1)(2008-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
palate is presented##2##3##(1991-2#1)(2007-2#1)
palate is the most common##2##5##(2009-6#1)(2012-12#1)
palate is##7##2##(1991-2#1)(1991-3#1)(2007-2#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
palate patient##3##2##(2007-12#1)(2013-1#2)
palate repair##3##2##(2007-12#1)(2010-7#1)(2011-2#1)
palate were##2##2##(1996-3#1)(2005-7#1)
palate with##2##2##(1996-3#1)(2012-3#1)
palate##113##1##(1990-1#1)(1990-6#1)(1991-1#2)(1991-11#2)(1991-2#2)(1991-3#1)(1993-3#1)(1994-3#2)(1995-2#1)(1995-3#2)(1996-12#2)(1996-3#4)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#1)(2005-7#1)(2006-2#1)(2006-6#1)(2007-12#6)(2007-2#2)(2007-7#2)(2007-9#5)(2008-10#1)(2008-12#3)(2008-3#2)(2008-4#1)(2009-1#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#7)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#13)(2012-12#13)(2012-2#3)(2012-3#2)(2013-1#13)(2013-8#1)
palates and##2##2##(1993-12#1)(2008-3#1)
palates##4##1##(1993-12#1)(2008-3#1)(2009-7#1)(2011-2#1)
palatinose##2##1##(1992-12#2)
pale and##2##2##(2008-1#1)(2008-5#1)
pale eggs##3##2##(2008-8#3)
pale in comparison to the##2##5##(1994-3#1)(2008-11#1)
pale in comparison to##3##4##(1994-3#1)(2007-9#1)(2008-11#1)
pale spots##2##2##(2007-12#2)
pale yellow##2##2##(2005-7#1)(2008-3#1)
pale##25##1##(1994-3#1)(1997-6#1)(2005-7#1)(2007-12#2)(2007-2#1)(2007-9#3)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#4)(2008-8#6)(2010-4#1)(2012-1#1)(2013-1#1)
palea and##3##2##(2008-10#2)(2008-8#1)
palea##10##1##(2008-10#9)(2008-8#1)
paleness##2##1##(2008-5#1)(2009-5#1)
paleoamygdala##4##1##(2009-2#4)
paleoanthropologists##2##1##(2008-1#2)
paleoanthropology##2##1##(2008-1#1)(2008-4#1)
paleoclimate##2##1##(1993-4#1)(2007-9#1)
paleontological data##2##2##(2007-12#1)(2010-5#1)
paleontological##5##1##(1993-6#1)(2007-12#1)(2008-8#1)(2010-4#1)(2010-5#1)
paleontologists##2##1##(2007-9#1)(2012-12#1)
paleopathologic##2##1##(2013-1#2)
paleopathological##3##1##(2009-2#3)
paleorecords of##2##2##(2008-8#2)
palette of##3##2##(2007-12#1)(2008-10#1)(2013-1#1)
palette##5##1##(2007-12#1)(2007-9#1)(2008-10#2)(2013-1#1)
paliative##2##1##(2007-11#1)(2008-8#1)
palifermin##2##1##(2008-3#1)(2008-7#1)
palindrome##6##1##(1991-2#1)(1994-3#1)(1996-7#2)(1997-2#1)(1997-4#1)
palindromes##5##1##(1993-9#4)(1994-12#1)
palindromic sequence##6##2##(1990-11#1)(1993-3#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-8#1)
palindromic##20##1##(1990-11#3)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-3#1)(1996-7#2)(1996-8#1)(2006-10#1)(2006-3#1)(2008-10#4)(2012-1#1)
palindromic&quot##3##1##(1996-7#3)
palinopsia##3##1##(2006-8#3)
palisading##5##1##(1992-4#1)(1996-9#1)(2009-3#1)(2012-12#1)(2013-1#1)
palladacycles##4##1##(2008-7#4)
palladin##2##1##(2009-7#2)
palladium (II)##3##2##(2007-11#1)(2008-10#2)
palladium (Pd)##4##2##(2008-10#3)(2010-4#1)
palladium and##7##2##(2007-11#2)(2008-10#4)(2008-11#1)
palladium as##2##2##(2008-10#2)
palladium associated aryne##2##3##(2009-3#2)
palladium by graphite furnace atomic absorption##2##6##(2008-10#2)
palladium by##4##2##(2008-10#4)
palladium catalysts##3##2##(2008-10#2)(2009-3#1)
palladium chloride and##3##3##(2007-11#3)
palladium chloride##5##2##(2007-11#5)
palladium complexes##6##2##(2008-10#2)(2008-5#1)(2010-5#3)
palladium content##2##2##(2007-11#1)(2008-10#1)
palladium determination##3##2##(2008-10#3)
palladium film##2##2##(2008-10#2)
palladium in environmental samples##2##4##(2007-8#1)(2008-10#1)
palladium in##10##2##(2007-11#1)(2007-8#1)(2008-10#8)
palladium is##5##2##(2007-11#2)(2007-8#2)(2008-10#1)
palladium nanoparticles##2##2##(2010-4#1)(2010-7#1)
palladium on the##2##3##(2007-11#1)(2008-10#1)
palladium on##4##2##(2007-11#1)(2007-12#1)(2008-10#2)
palladium with##3##2##(1991-12#1)(2008-10#2)
palladium##115##1##(1991-12#4)(2004-9#1)(2005-4#1)(2006-12#1)(2007-11#18)(2007-12#1)(2007-8#5)(2008-10#63)(2008-11#1)(2008-5#2)(2008-6#1)(2009-3#3)(2010-4#7)(2010-5#4)(2010-7#3)
palladium(0)##2##1##(1996-5#1)(2009-12#1)
palladium(II) and##4##2##(2008-10#4)
palladium(II) in##4##2##(2008-10#4)
palladium(II)##40##1##(2007-11#1)(2007-8#2)(2008-10#33)(2009-3#1)(2010-3#1)(2013-1#2)
palladium-catalyzed cross-coupling reactions##2##3##(2009-12#1)(2009-3#1)
palladium-catalyzed hydrostannation of ethyl ethynyl ether##2##6##(2009-12#2)
palladium-catalyzed hydrostannation of##3##3##(2009-12#3)
palladium-catalyzed##11##1##(1996-8#1)(2005-8#2)(2007-11#1)(2009-12#4)(2009-3#2)(2011-2#1)
palladium-magnesium nitrate and ammonium dihydrogenphosphate##2##5##(2008-10#2)
palladium-magnesium nitrate##4##2##(2008-10#4)
palladium-magnesium##6##1##(2008-10#6)
palladium-zirconium##3##1##(2008-10#3)
pallens##7##1##(2006-8#4)(2007-12#1)(2008-8#2)
palliate##5##1##(2007-8#1)(2008-7#2)(2012-12#1)(2013-1#1)
palliating##2##1##(2006-6#1)(2008-7#1)
palliation and##4##2##(2007-10#1)(2007-8#1)(2008-4#1)(2009-5#1)
palliation for##5##2##(2006-10#2)(2008-5#1)(2008-6#1)(2010-12#1)
palliation in advanced##2##3##(1990-2#1)(2008-5#1)
palliation in##7##2##(1990-2#1)(2007-11#2)(2008-4#1)(2008-5#1)(2010-12#1)(2012-2#1)
palliation of a patient with##2##5##(2008-4#1)(2008-6#1)
palliation of malignant gastric outlet obstruction##3##6##(2006-10#1)(2012-2#2)
palliation of malignant##6##3##(2006-10#1)(2007-5#1)(2007-8#1)(2008-12#1)(2012-2#2)
palliation of symptoms##4##3##(1991-2#1)(2007-11#1)(2008-6#1)(2012-12#1)
palliation of##28##2##(1991-2#1)(2005-4#1)(2006-10#2)(2006-2#1)(2006-6#3)(2007-11#1)(2007-5#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#2)(2010-3#1)(2010-6#1)(2010-8#2)(2012-12#1)(2012-2#2)
palliation or##2##2##(2007-11#1)(2011-2#1)
palliation with##2##2##(2007-4#1)(2007-8#1)
palliation##67##1##(1990-2#1)(1991-12#1)(1991-2#1)(1991-3#2)(1993-6#1)(1994-6#1)(1994-7#1)(1996-3#1)(2005-4#1)(2006-10#5)(2006-2#1)(2006-6#3)(2007-10#3)(2007-11#4)(2007-4#1)(2007-5#1)(2007-8#5)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#5)(2008-6#4)(2008-7#2)(2009-5#1)(2010-12#3)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#5)
palliative and##5##2##(2007-11#1)(2008-6#1)(2009-2#1)(2010-7#1)(2012-12#1)
palliative benefit##2##2##(2008-7#2)
palliative care and##3##3##(2010-10#1)(2011-2#1)(2012-3#1)
palliative care clinic##2##3##(2008-7#1)(2010-7#1)
palliative care in the##3##4##(2009-10#1)(2012-12#1)(2012-2#1)
palliative care in##4##3##(2007-2#1)(2009-10#1)(2012-12#1)(2012-2#1)
palliative care nurses##2##3##(2007-8#1)(2010-10#1)
palliative care team##5##3##(1996-2#2)(2009-9#2)(2010-8#1)
palliative care##85##2##(1992-2#2)(1996-2#2)(2004-8#1)(2005-4#3)(2006-4#8)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#3)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#4)(2009-10#1)(2009-2#1)(2009-4#2)(2009-8#1)(2009-9#3)(2010-10#5)(2010-2#1)(2010-7#4)(2010-8#3)(2010-9#1)(2011-2#5)(2012-11#4)(2012-12#3)(2012-2#6)(2012-3#8)(2013-1#2)(2013-8#1)
palliative chemotherapy with##2##3##(2007-8#1)(2009-8#1)
palliative chemotherapy##8##2##(1990-12#1)(2007-8#1)(2008-6#3)(2009-8#2)(2012-1#1)
palliative effects##2##2##(1996-1#1)(2008-5#1)
palliative form of##2##3##(1991-3#1)(2004-1#1)
palliative home care##3##3##(2006-4#2)(2012-2#1)
palliative laser##2##2##(2008-5#2)
palliative management##2##2##(2007-11#2)
palliative measures##2##2##(1991-8#1)(2010-7#1)
palliative medicine##7##2##(2006-12#2)(2008-7#2)(2012-3#3)
palliative operation##4##2##(1990-9#3)(2008-7#1)
palliative or##2##2##(2007-7#1)(2008-12#1)
palliative procedure##4##2##(1991-9#1)(1996-12#1)(2006-2#2)
palliative procedures##4##2##(1990-9#1)(1991-8#1)(1991-9#1)(2008-4#1)
palliative radiation therapy in##2##4##(2008-7#2)
palliative radiation therapy##9##3##(2008-7#7)(2012-12#1)(2012-2#1)
palliative radiation##12##2##(2008-7#7)(2010-7#1)(2012-12#1)(2012-2#3)
palliative radiotherapy to##2##3##(2008-10#1)(2008-6#1)
palliative radiotherapy##16##2##(1992-10#1)(2007-11#4)(2007-4#1)(2007-6#5)(2007-7#1)(2008-10#2)(2008-11#1)(2008-6#1)
palliative role##2##2##(2006-9#1)(2012-2#1)
palliative setting##3##2##(2007-8#1)(2012-2#1)(2013-8#1)
palliative surgery##4##2##(1990-9#1)(1993-3#1)(2011-2#1)(2012-1#1)
palliative therapy for##4##3##(1992-4#1)(2010-3#1)(2012-12#1)(2013-7#1)
palliative therapy of##2##3##(1992-4#1)(2007-11#1)
palliative therapy using strontium 89##2##5##(2007-11#2)
palliative therapy##14##2##(1992-4#2)(1994-8#1)(2006-8#1)(2007-11#3)(2008-7#2)(2010-3#1)(2012-12#2)(2012-3#1)(2013-7#1)
palliative treatment for##5##3##(1996-8#1)(2006-10#1)(2006-6#2)(2010-5#1)
palliative treatment in patients with##2##5##(1993-6#1)(2007-11#1)
palliative treatment in##4##3##(1993-6#1)(1996-12#1)(2007-11#1)(2012-2#1)
palliative treatment of##13##3##(1990-6#1)(2006-10#1)(2006-2#1)(2007-4#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-5#1)(2012-12#2)(2013-1#1)(2013-8#1)
palliative treatment##28##2##(1990-6#1)(1993-6#1)(1996-12#1)(1996-8#1)(1997-3#1)(2006-10#2)(2006-2#1)(2006-6#2)(2007-11#3)(2007-4#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-5#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
palliative treatments##2##2##(2006-6#1)(2007-4#1)
palliative##268##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-4#1)(1990-6#3)(1990-8#1)(1990-9#5)(1991-12#1)(1991-3#1)(1991-4#1)(1991-8#2)(1991-9#2)(1992-10#2)(1992-2#2)(1992-4#3)(1992-5#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-8#1)(1996-1#1)(1996-12#2)(1996-2#3)(1996-8#1)(1997-3#1)(2004-1#1)(2004-8#1)(2005-4#3)(2005-9#1)(2006-10#6)(2006-12#2)(2006-2#4)(2006-3#1)(2006-4#10)(2006-6#3)(2006-8#1)(2006-9#1)(2007-11#17)(2007-12#2)(2007-2#2)(2007-4#4)(2007-5#2)(2007-6#6)(2007-7#3)(2007-8#11)(2008-10#2)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#7)(2008-7#20)(2008-9#1)(2009-10#1)(2009-2#2)(2009-4#4)(2009-8#5)(2009-9#4)(2010-10#6)(2010-2#2)(2010-3#1)(2010-5#2)(2010-7#7)(2010-8#3)(2010-9#1)(2011-2#9)(2012-1#2)(2012-11#4)(2012-12#9)(2012-2#14)(2012-3#12)(2013-1#3)(2013-7#1)(2013-8#3)
palliatively##4##1##(1990-9#1)(1991-9#1)(2007-11#1)(2008-6#1)
pallida in##2##2##(2006-11#1)(2008-10#1)
pallida populations##2##2##(2008-10#2)
pallida##14##1##(2006-11#4)(2007-1#2)(2008-10#6)(2008-2#1)(2013-7#1)
pallida)##3##1##(2008-10#3)
pallidal stimulation##4##2##(2005-10#4)
pallidal structures##2##2##(2009-2#2)
pallidal##16##1##(1993-12#2)(1994-2#1)(1995-5#1)(2005-10#5)(2008-4#1)(2008-7#4)(2009-2#2)
pallidipes##4##1##(2006-5#4)
pallidotomies##2##1##(2008-7#2)
pallidotomy##7##1##(2008-7#7)
pallidum and##3##2##(1994-2#1)(2008-9#1)(2012-12#1)
pallidum is##2##2##(2008-7#2)
pallidum to the##2##3##(1991-5#2)
pallidum##32##1##(1990-3#1)(1991-5#3)(1992-7#1)(1993-6#1)(1994-2#1)(1995-5#2)(1997-2#1)(1997-3#1)(1997-5#2)(2006-10#2)(2007-12#1)(2008-11#1)(2008-7#5)(2008-9#3)(2009-10#1)(2009-2#2)(2010-7#1)(2012-12#2)(2013-7#1)
pallidus and##4##2##(1993-11#1)(2008-7#1)(2009-2#2)
pallidus##33##1##(1990-7#2)(1991-9#4)(1992-10#1)(1992-7#1)(1993-11#3)(1993-12#2)(1993-7#1)(1994-2#3)(1996-12#1)(2005-10#1)(2008-11#3)(2008-5#2)(2008-7#2)(2009-10#1)(2009-2#3)(2012-1#1)(2012-2#2)
pallor and##2##2##(2012-2#1)(2013-7#1)
pallor of##3##2##(1993-2#1)(2005-7#1)(2012-2#1)
pallor##9##1##(1993-2#1)(2005-7#1)(2007-2#1)(2008-10#1)(2008-7#1)(2012-2#2)(2013-1#1)(2013-7#1)
palm and##3##2##(1996-7#1)(2008-10#1)(2008-6#1)
palm creases to##2##3##(2010-12#2)
palm creases was##2##3##(2010-12#2)
palm creases were##2##3##(2010-12#2)
palm creases##10##2##(2010-12#10)
palm in##2##2##(2006-3#1)(2008-10#1)
palm oil as##2##3##(2008-6#2)
palm oil diets##3##3##(2009-5#3)
palm oil##15##2##(2007-8#2)(2008-12#1)(2008-5#1)(2008-6#3)(2009-5#6)(2010-4#1)(2013-1#1)
palm sequences##2##2##(2012-2#2)
palm shell##3##2##(2013-1#3)
palm trees and##3##3##(2007-3#2)(2012-12#1)
palm trees in##2##3##(2008-6#2)
palm trees##13##2##(2007-3#4)(2008-10#3)(2008-6#4)(2012-12#2)
palm wine and Lipton tea##3##5##(2007-1#3)
palm wine##4##2##(2007-1#4)
palm##106##1##(1994-5#1)(1996-7#5)(1997-1#1)(1997-8#1)(2006-3#1)(2006-4#1)(2007-1#4)(2007-12#1)(2007-3#4)(2007-7#2)(2007-8#2)(2008-10#17)(2008-12#1)(2008-5#10)(2008-6#10)(2009-5#9)(2010-12#12)(2010-4#1)(2011-2#7)(2012-1#2)(2012-12#4)(2012-2#3)(2013-1#7)
palm-grove soils##2##2##(1996-7#2)
palmar and dorsal##2##3##(2008-9#2)
palmar and##3##2##(2008-9#2)(2012-1#1)
palmar arch##4##2##(2008-9#3)(2011-2#1)
palmar defect##2##2##(2008-9#2)
palmar hyperhidrosis with##2##3##(2005-11#1)(2010-1#1)
palmar hyperhidrosis##6##2##(2005-11#1)(2007-1#1)(2007-8#3)(2010-1#1)
palmar lip##4##2##(2006-3#4)
palmar##37##1##(1993-3#1)(1994-10#1)(1994-8#1)(1997-3#1)(2005-11#1)(2006-3#6)(2006-4#1)(2007-1#1)(2007-2#1)(2007-7#1)(2007-8#4)(2008-10#2)(2008-12#1)(2008-9#10)(2010-1#1)(2011-2#2)(2012-1#1)(2012-2#1)
palmaris longus tendon##2##3##(2008-9#2)
palmaris longus##4##2##(2008-9#3)(2009-1#1)
palmaris##5##1##(2008-12#1)(2008-9#3)(2009-1#1)
palmarosa##2##1##(2010-3#2)
palmata##6##1##(1990-11#1)(2007-5#1)(2008-10#2)(2011-2#2)
palmeri##3##1##(2009-8#2)(2011-2#1)
palmetto##2##1##(2006-9#2)
palmitate (16##3##2##(1990-2#1)(1991-2#1)(1995-8#1)
palmitate and##10##2##(1993-10#1)(2008-5#2)(2008-8#7)
palmitate as##3##2##(1992-9#1)(2008-5#1)(2010-10#1)
palmitate in##3##2##(1990-4#1)(2008-8#2)
palmitate turnover rate##3##3##(1995-3#3)
palmitate##66##1##(1990-10#3)(1990-2#1)(1990-4#3)(1991-10#1)(1991-2#1)(1991-5#2)(1991-9#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-8#1)(1994-12#3)(1994-3#2)(1994-6#1)(1994-9#1)(1995-3#7)(1995-8#1)(1996-2#1)(1996-4#1)(2004-4#1)(2005-11#2)(2007-1#1)(2007-3#1)(2008-5#5)(2008-7#1)(2008-8#17)(2010-10#4)(2010-2#1)
palmitate-induced insulin resistance##2##3##(2010-10#2)
palmitic acid (C16##2##3##(1990-8#1)(2011-1#1)
palmitic acid and##3##3##(1990-4#1)(1991-5#1)(1991-9#1)
palmitic acid content##3##3##(2012-11#3)
palmitic acid on##4##3##(1995-5#1)(2008-5#2)(2010-12#1)
palmitic acid were##2##3##(1994-5#1)(2010-4#1)
palmitic acid##36##2##(1990-4#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-8#1)(1993-11#1)(1994-12#1)(1994-5#2)(1995-5#2)(1995-8#1)(1996-8#1)(1996-9#1)(1997-7#1)(2006-12#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#5)(2009-6#1)(2010-12#1)(2010-4#1)(2011-1#2)(2012-11#4)
palmitic and##3##2##(1993-9#1)(1994-8#1)(2008-12#1)
palmitic fatty acid##4##3##(2011-2#1)(2013-1#3)
palmitic saturated fatty acid (C##2##5##(2013-1#2)
palmitic saturated fatty acid##5##4##(2013-1#5)
palmitic triglycerides##2##2##(2013-1#2)
palmitic##63##1##(1990-4#1)(1990-8#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-9#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-8#2)(1995-5#2)(1995-8#1)(1996-8#1)(1996-9#1)(1997-7#1)(2006-12#3)(2007-8#1)(2008-10#4)(2008-12#3)(2008-4#1)(2008-5#5)(2008-7#1)(2009-6#2)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-11#4)(2012-2#1)(2013-1#10)
palmitoleic acid (16##2##3##(1993-6#1)(2006-12#1)
palmitoleic acid##5##2##(1993-6#2)(2006-12#1)(2007-9#1)(2011-1#1)
palmitoleic##9##1##(1993-6#2)(1996-2#1)(1996-4#1)(2006-12#1)(2007-9#1)(2008-10#2)(2011-1#1)
palmitoyl pentapeptide##2##2##(2008-5#2)
palmitoyl##7##1##(1995-2#1)(1996-4#2)(2007-11#1)(2008-10#1)(2008-5#2)
palmitoyl-CoA ligase##6##2##(1993-9#6)
palmitoyl-CoA was##2##2##(1990-5#1)(1993-6#1)
palmitoyl-CoA##16##1##(1990-2#2)(1990-5#3)(1992-11#1)(1993-3#1)(1993-6#1)(1993-9#7)(1995-3#1)
palmitoyl-L-carnitine##3##1##(1990-11#1)(1992-8#2)
palmitoyl-lysophosphatidylcholine##2##1##(1994-3#2)
palmitoylated##9##1##(1993-11#2)(1994-3#1)(1995-3#1)(1996-8#2)(1997-7#1)(2008-7#1)(2008-8#1)
palmitoylation and##2##2##(1997-6#1)(2008-7#1)
palmitoylation of##5##2##(1994-3#4)(1996-8#1)
palmitoylation sites##3##2##(1997-6#3)
palmitoylation##17##1##(1991-9#1)(1994-3#5)(1996-8#4)(1997-6#5)(2008-7#1)(2008-8#1)
palmitoylation-deficient mutants##2##2##(1997-6#2)
palmitoyloleoylphosphatidylcholine##3##1##(1993-6#1)(1994-12#1)(2012-2#1)
palmitoyltransferase I##3##2##(1997-4#1)(1997-5#2)
palmitoyltransferase II (CPT II)##2##4##(2008-3#2)
palmitoyltransferase##19##1##(1990-11#1)(1990-2#1)(1991-6#2)(1991-7#4)(1992-8#1)(1994-8#1)(1997-3#2)(1997-4#1)(1997-5#2)(2004-11#1)(2008-3#2)(2012-2#1)
palmityl##3##1##(1990-8#2)(1994-8#1)
palmivora were##2##2##(2008-10#2)
palmivora##19##1##(2008-10#19)
palmo-plantar##2##1##(2007-7#1)(2009-8#1)
palmoplantar keratoderma##4##2##(2005-11#1)(2007-7#3)
palmoplantar##7##1##(2005-11#1)(2006-10#1)(2007-7#4)(2012-12#1)
palms and soles and##2##4##(1997-3#1)(2007-7#1)
palms and soles##4##3##(1997-3#1)(2007-7#1)(2007-8#1)(2010-6#1)
palms and##5##2##(1997-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2010-6#1)
palms##18##1##(1997-3#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-5#2)(2010-12#1)(2010-6#1)(2012-12#4)(2012-2#1)(2012-3#1)
palpable adenopathy##2##2##(1995-1#1)(2012-2#1)
palpable and##2##2##(1994-3#1)(2006-10#1)
palpable breast cancer##3##3##(1995-10#3)
palpable breast lumps##3##3##(2006-1#3)
palpable breast##11##2##(1990-10#1)(1995-10#3)(1996-9#1)(2006-1#4)(2006-9#1)(2008-12#1)
palpable mass##6##2##(2008-10#1)(2010-3#1)(2012-2#1)(2013-1#3)
palpable nodules##4##2##(1991-4#1)(2007-10#1)(2010-11#1)(2010-7#1)
palpable purpura and##2##3##(2006-10#1)(2007-8#1)
palpable purpura##8##2##(1992-8#2)(1994-8#1)(1997-4#1)(2006-10#1)(2007-8#3)
palpable tumors##2##2##(1992-2#1)(2012-12#1)
palpable##74##1##(1990-10#2)(1990-9#2)(1991-4#2)(1992-2#1)(1992-4#1)(1992-8#2)(1993-10#2)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-10#3)(1995-9#2)(1996-12#1)(1996-9#1)(1997-4#1)(1997-6#1)(2004-2#1)(2005-11#1)(2006-1#4)(2006-10#4)(2006-3#1)(2006-5#1)(2006-9#1)(2007-10#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#3)(2008-12#1)(2008-7#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#6)(2013-7#1)
palpal##2##1##(2007-12#1)(2008-4#1)
palpated in the##3##3##(1994-7#1)(2011-2#1)(2013-8#1)
palpated##9##1##(1993-7#1)(1994-7#1)(1996-3#1)(2007-8#1)(2008-12#1)(2008-2#1)(2011-2#1)(2012-12#1)(2013-8#1)
palpation and##4##2##(1990-9#1)(2006-7#1)(2008-8#2)
palpation in##2##2##(1990-12#1)(2007-8#1)
palpation of##2##2##(1995-4#1)(2008-12#1)
palpation##31##1##(1990-12#1)(1990-2#1)(1990-9#1)(1991-8#1)(1992-10#1)(1993-7#1)(1995-4#1)(1996-6#2)(1997-8#1)(2006-10#1)(2006-7#1)(2007-11#6)(2007-5#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-8#4)(2009-6#1)(2010-3#1)(2010-9#1)(2011-2#1)
palpatory##5##1##(1990-4#1)(1992-1#1)(2007-11#1)(2009-6#1)(2009-9#1)
palpebral fissures##2##2##(1996-3#1)(1997-3#1)
palpebral##8##1##(1991-5#1)(1996-3#1)(1997-3#1)(2005-11#1)(2007-3#1)(2008-7#1)(2011-1#1)(2013-1#1)
palpitation and##2##2##(1993-6#1)(2010-12#1)
palpitation##4##1##(1993-6#1)(2006-12#1)(2010-12#1)(2011-1#1)
palpitations and the onset of chest pain in the past 2-7 days as predictors of minor cardiac disease##2##18##(2013-1#2)
palpitations and##3##2##(2008-7#1)(2013-1#2)
palpitations or##2##2##(1991-8#1)(2007-7#1)
palpitations##18##1##(1991-8#1)(1993-2#1)(1994-11#1)(1996-2#1)(1996-6#1)(1997-3#1)(2004-3#1)(2005-1#1)(2006-12#1)(2006-9#2)(2007-7#1)(2008-12#1)(2008-7#1)(2012-3#1)(2013-1#3)
palps of##2##2##(2007-12#2)
palps##6##1##(2007-12#6)
palsies of the##2##3##(2006-2#1)(2011-2#1)
palsies##24##1##(1996-9#2)(1997-3#1)(2006-12#1)(2006-2#1)(2007-10#2)(2008-7#4)(2008-8#2)(2009-10#1)(2010-11#1)(2011-2#7)(2012-2#1)(2012-3#1)
palsy (CP)##9##2##(2006-10#2)(2009-4#2)(2010-12#1)(2011-2#2)(2012-1#2)
palsy (PSP) and multiple system atrophy (MSA)##2##7##(2008-11#1)(2008-7#1)
palsy (PSP) and##3##3##(1990-7#1)(2008-11#1)(2008-7#1)
palsy (PSP)##7##2##(1990-7#1)(1991-3#1)(1992-8#1)(2008-11#2)(2008-7#1)(2012-12#1)
palsy and muscle weakness patients##2##5##(2012-1#2)
palsy and the##3##3##(2006-12#1)(2011-2#1)(2012-2#1)
palsy and##22##2##(1990-7#1)(1991-6#1)(1991-8#1)(1993-8#1)(2004-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-10#2)(2007-8#1)(2008-12#1)(2009-3#2)(2010-9#1)(2011-2#2)(2012-1#4)(2012-2#1)
palsy are##2##2##(2006-3#1)(2008-9#1)
palsy caused by##4##3##(2006-12#1)(2007-10#1)(2009-9#1)(2010-7#1)
palsy due to##2##3##(2008-11#1)(2008-9#1)
palsy during##2##2##(1996-8#1)(2006-11#1)
palsy following a##2##3##(2006-10#1)(2012-2#1)
palsy following##4##2##(2006-10#1)(2009-3#1)(2012-2#1)(2012-3#1)
palsy has##2##2##(2011-1#1)(2012-3#1)
palsy in an##2##3##(2007-8#1)(2011-1#1)
palsy in the##2##3##(1995-6#1)(2009-8#1)
palsy in##10##2##(1995-6#1)(1997-5#1)(2006-10#2)(2007-10#1)(2007-7#1)(2007-8#1)(2009-8#1)(2011-1#1)(2011-2#1)
palsy is##5##2##(1995-6#3)(1996-9#1)(2008-9#1)
palsy patients##4##2##(2009-3#1)(2011-12#1)(2012-1#1)(2012-3#1)
palsy was##3##2##(2009-7#1)(2011-1#2)
palsy##225##1##(1990-7#2)(1990-8#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-8#1)(1992-7#1)(1992-8#2)(1993-8#1)(1994-3#1)(1995-6#7)(1995-8#1)(1996-11#1)(1996-8#2)(1996-9#1)(1997-3#1)(1997-5#1)(1997-6#1)(2004-10#1)(2005-10#1)(2005-5#1)(2005-8#2)(2006-10#23)(2006-11#3)(2006-12#7)(2006-2#1)(2006-3#5)(2006-4#2)(2006-5#1)(2006-8#1)(2007-10#7)(2007-11#2)(2007-2#1)(2007-7#9)(2007-8#5)(2008-1#1)(2008-11#10)(2008-12#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#5)(2009-10#1)(2009-2#1)(2009-3#15)(2009-4#6)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#4)(2010-12#4)(2010-7#1)(2010-9#2)(2011-1#9)(2011-12#5)(2011-2#13)(2012-1#14)(2012-12#4)(2012-2#4)(2012-3#8)(2013-1#2)(2013-8#4)
palsy)##2##1##(2006-11#1)(2007-3#1)
palsy]##3##1##(1994-3#1)(2010-6#1)(2011-1#1)
paltry##2##1##(1994-3#1)(2007-9#1)
palustris and##2##2##(1994-3#1)(2008-8#1)
palustris##8##1##(1993-8#2)(1994-3#1)(1995-8#1)(2008-8#2)(2010-3#1)(2012-2#1)
palustris)##3##1##(2008-5#1)(2010-3#2)
palynological##2##1##(1991-8#1)(2011-2#1)
pamidronate and##2##2##(2008-6#1)(2012-12#1)
pamidronate in##3##2##(1990-3#1)(1993-10#1)(2008-7#1)
pamidronate treatment##3##2##(2006-10#3)
pamidronate##16##1##(1990-3#1)(1993-10#1)(1995-1#1)(2005-3#1)(2006-10#3)(2007-11#2)(2008-1#1)(2008-6#2)(2008-7#3)(2012-12#1)
pamphlet##3##1##(1995-7#2)(2008-10#1)
pamphlets about##2##2##(1990-2#1)(2013-1#1)
pamphlets##18##1##(1990-2#10)(1992-12#1)(1995-7#3)(2010-8#1)(2011-1#2)(2013-1#1)
pan coefficient##2##2##(2013-8#2)
pan##16##1##(1992-7#1)(1992-8#3)(1997-1#1)(1997-3#1)(2004-12#2)(2006-1#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2010-7#1)(2013-8#2)
pan-Canadian public health##2##3##(2008-11#2)
pan-Canadian##4##1##(2008-11#2)(2010-12#2)
pan-RAR##3##1##(2012-11#3)
panacea for##2##2##(1991-12#1)(2006-2#1)
panacea##11##1##(1991-12#1)(1993-7#1)(1994-2#1)(1996-3#1)(1997-3#1)(2006-2#1)(2006-3#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-1#1)
panamensis##3##1##(2007-11#1)(2013-7#2)
panax##3##1##(2008-10#3)
panbronchiolitis##3##1##(1995-8#3)
pancake##4##1##(2005-11#2)(2006-7#1)(2008-1#1)
pancarpal##2##1##(2006-10#1)(2013-8#1)
pancreas &gt##2##2##(1994-11#1)(1994-9#1)
pancreas after##2##2##(1995-2#1)(2010-12#1)
pancreas and islet##2##3##(1992-6#1)(2009-6#1)
pancreas and liver##3##3##(1994-11#1)(2008-7#2)
pancreas and stomach##2##3##(2008-1#1)(2008-7#1)
pancreas and##43##2##(1990-12#1)(1990-3#2)(1990-6#1)(1990-8#1)(1991-3#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-5#2)(1994-11#1)(1994-12#2)(1994-8#1)(1995-11#1)(1995-2#1)(1996-9#1)(2005-10#1)(2006-10#1)(2006-6#1)(2008-1#2)(2008-10#1)(2008-3#2)(2008-7#5)(2008-8#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
pancreas are##6##2##(2006-10#1)(2006-6#1)(2008-1#1)(2011-12#1)(2013-1#2)
pancreas as a##3##3##(2012-12#2)(2013-1#1)
pancreas as##6##2##(1995-11#1)(2008-7#1)(2012-12#2)(2012-2#1)(2013-1#1)
pancreas by##4##2##(1996-7#1)(2006-6#1)(2009-4#1)(2010-11#1)
pancreas can##4##2##(2008-7#1)(2010-12#1)(2012-12#2)
pancreas development##4##2##(2009-11#1)(2009-3#1)(2010-11#2)
pancreas divisum is##2##3##(1995-4#2)
pancreas divisum##9##2##(1991-9#1)(1995-4#3)(2006-6#2)(2011-2#3)
pancreas divisum]##2##2##(1995-4#1)(2007-5#1)
pancreas has##2##2##(2008-5#1)(2010-12#1)
pancreas have##4##2##(2008-8#1)(2009-5#1)(2012-11#2)
pancreas in Nepalese##2##3##(2012-3#2)
pancreas in the gallbladder wall##3##5##(1997-8#3)
pancreas in the gallbladder##4##4##(1997-8#3)(2013-8#1)
pancreas in the##5##3##(1997-8#3)(2011-12#1)(2013-8#1)
pancreas in##16##2##(1992-5#1)(1997-8#5)(2006-10#1)(2007-4#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
pancreas is a rare##3##4##(2008-3#1)(2011-12#1)(2013-1#1)
pancreas is a##7##3##(2006-10#1)(2006-8#1)(2008-3#1)(2010-12#1)(2011-12#1)(2012-2#1)(2013-1#1)
pancreas is##22##2##(1990-3#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-6#1)(2005-10#1)(2006-10#5)(2006-8#1)(2008-3#3)(2010-12#1)(2011-12#1)(2012-2#2)(2013-1#2)(2013-7#1)
pancreas of the##2##3##(1997-8#1)(2006-12#1)
pancreas of##15##2##(1990-2#1)(1992-12#1)(1992-2#1)(1994-3#1)(1995-3#2)(1997-8#1)(2004-12#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
pancreas or##4##2##(1993-5#1)(2006-4#1)(2010-12#2)
pancreas to##3##2##(1996-5#1)(2010-10#1)(2010-12#1)
pancreas transplant##5##2##(1995-2#1)(2007-11#4)
pancreas transplantation##14##2##(1990-5#1)(1991-10#1)(1992-6#1)(1995-2#2)(2007-11#6)(2008-1#2)(2012-2#1)
pancreas was##8##2##(1992-2#1)(1992-4#1)(2006-10#1)(2007-10#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
pancreas were treated by##2##4##(2008-3#2)
pancreas were##6##2##(1990-9#1)(1997-8#1)(2008-3#2)(2008-4#1)(2012-3#1)
pancreas which##3##2##(2009-5#1)(2012-3#1)(2013-7#1)
pancreas with##7##2##(1990-3#2)(1991-9#1)(2005-10#1)(2008-3#2)(2008-7#1)
pancreas##455##1##(1990-11#1)(1990-12#5)(1990-2#2)(1990-3#12)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#8)(1991-1#2)(1991-10#3)(1991-2#1)(1991-3#2)(1991-5#4)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#8)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#5)(1992-4#4)(1992-5#4)(1992-6#7)(1992-8#3)(1992-9#4)(1993-10#1)(1993-3#2)(1993-5#7)(1993-6#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#5)(1994-5#3)(1994-6#1)(1994-7#2)(1994-8#2)(1994-9#3)(1995-10#2)(1995-11#6)(1995-2#7)(1995-3#3)(1995-4#4)(1995-5#1)(1995-6#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#5)(1997-5#1)(1997-8#9)(2004-12#3)(2005-10#6)(2005-12#1)(2006-10#24)(2006-12#1)(2006-2#1)(2006-4#2)(2006-6#12)(2006-8#1)(2007-10#2)(2007-11#11)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#3)(2007-6#3)(2007-8#1)(2008-1#13)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#16)(2008-4#6)(2008-5#3)(2008-7#18)(2008-8#7)(2009-11#3)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2010-1#1)(2010-10#2)(2010-11#15)(2010-12#22)(2010-4#1)(2011-1#2)(2011-12#6)(2011-2#6)(2012-1#1)(2012-11#4)(2012-12#11)(2012-2#15)(2012-3#12)(2013-1#21)(2013-7#8)(2013-8#2)
pancreas) and##2##2##(1990-5#1)(2011-12#1)
pancreas)##8##1##(1990-5#1)(1991-9#1)(1997-5#1)(2008-1#1)(2010-4#1)(2011-12#3)
pancreas-kidney transplantation##5##2##(2006-10#2)(2007-5#2)(2010-12#1)
pancreas-specific##2##1##(1991-11#1)(1992-12#1)
pancreas]##5##1##(1991-3#1)(1992-2#1)(2006-6#1)(2006-8#1)(2007-5#1)
pancreases of normal##2##3##(1991-10#2)
pancreases of##3##2##(1991-10#2)(2012-3#1)
pancreases##13##1##(1991-10#5)(2010-11#1)(2012-11#6)(2012-3#1)
pancreastatin and somatostatin##6##3##(1992-6#6)
pancreastatin##8##1##(1992-6#6)(1992-9#1)(1997-7#1)
pancreata as##2##2##(1991-3#1)(2010-11#1)
pancreata##10##1##(1991-3#5)(1992-7#1)(2009-2#1)(2010-11#2)(2010-12#1)
pancreatectomy and##3##2##(2006-10#1)(2008-3#1)(2013-1#1)
pancreatectomy##18##1##(1990-6#1)(1990-9#1)(2006-10#2)(2006-2#1)(2006-6#1)(2008-1#1)(2008-3#2)(2010-1#1)(2010-12#4)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
pancreatectomy)##2##1##(2006-10#1)(2013-8#1)
pancreatic B-cells##4##2##(1990-3#1)(1997-5#3)
pancreatic IAPP##2##2##(1992-1#1)(1992-7#1)
pancreatic OPN##3##2##(2010-11#3)
pancreatic acinar cell function##2##4##(2006-10#2)
pancreatic acinar cell##8##3##(1991-1#1)(1992-8#1)(1993-3#1)(1997-7#1)(2006-10#4)
pancreatic acinar cells and##2##4##(1992-6#1)(2008-7#1)
pancreatic acinar cells##19##3##(1990-11#1)(1991-1#1)(1991-10#1)(1991-5#1)(1991-7#1)(1992-4#2)(1992-6#1)(1993-4#2)(1993-6#2)(1994-9#1)(2006-10#3)(2008-7#1)(2009-7#2)
pancreatic acinar##30##2##(1990-11#1)(1991-1#2)(1991-10#1)(1991-5#1)(1991-7#1)(1992-4#2)(1992-6#1)(1992-8#1)(1993-3#1)(1993-4#2)(1993-6#2)(1994-6#1)(1994-9#1)(1997-7#2)(2006-10#8)(2008-7#1)(2009-7#2)
pancreatic acini and gastric chief cells from guinea pig##3##9##(1994-8#3)
pancreatic acini and##5##3##(1994-8#3)(2006-10#2)
pancreatic acini##23##2##(1990-3#2)(1991-1#1)(1991-10#1)(1991-5#3)(1991-7#1)(1991-8#2)(1992-12#2)(1994-2#1)(1994-6#1)(1994-8#3)(1995-11#4)(2006-10#2)
pancreatic adenocarcinoma##14##2##(1991-2#1)(2006-2#1)(2006-6#3)(2008-1#1)(2008-3#4)(2008-9#1)(2012-12#2)(2013-1#1)
pancreatic alpha-amylase were##2##3##(1992-12#1)(1992-2#1)
pancreatic alpha-amylase##10##2##(1990-7#1)(1990-9#2)(1992-12#2)(1992-2#2)(1996-7#3)
pancreatic amyloid##2##2##(1992-2#1)(1993-4#1)
pancreatic and biliary##2##3##(2011-2#2)
pancreatic and duodenal homeobox gene-1##2##5##(2007-5#2)
pancreatic and gastric cancer patients##2##5##(1997-7#2)
pancreatic and gastric cancer##3##4##(1997-7#3)
pancreatic and gastric##5##3##(1997-7#4)(2006-2#1)
pancreatic and peripancreatic##3##3##(2008-3#1)(2010-5#1)(2012-2#1)
pancreatic and renal##3##3##(1992-6#2)(2006-4#1)
pancreatic and##24##2##(1991-3#1)(1991-9#1)(1992-3#1)(1992-6#2)(1993-12#1)(1996-6#1)(1997-7#5)(2006-2#1)(2006-4#1)(2007-5#2)(2008-3#2)(2010-5#1)(2011-2#4)(2012-2#1)
pancreatic artery##3##2##(1997-8#1)(2008-7#2)
pancreatic beta cell##2##3##(1991-6#1)(2008-11#1)
pancreatic beta cells and##3##4##(1993-4#1)(1997-4#1)(2008-1#1)
pancreatic beta cells in##2##4##(1990-5#1)(2008-10#1)
pancreatic beta cells##14##3##(1990-5#2)(1992-8#1)(1993-4#1)(1996-2#1)(1997-4#2)(2008-1#1)(2008-10#1)(2009-3#1)(2009-8#1)(2010-11#2)(2010-2#1)
pancreatic beta##16##2##(1990-5#2)(1991-6#1)(1992-8#1)(1993-4#1)(1996-2#1)(1997-4#2)(2008-1#1)(2008-10#1)(2008-11#1)(2009-3#1)(2009-8#1)(2010-11#2)(2010-2#1)
pancreatic beta-cell##5##2##(1994-12#1)(1995-10#1)(1996-6#1)(2008-1#1)(2008-11#1)
pancreatic beta-cells##23##2##(1990-2#1)(1991-1#2)(1991-12#1)(1992-12#1)(1994-11#2)(1995-10#1)(1995-7#1)(1996-2#2)(1996-5#2)(2005-1#1)(2007-5#1)(2008-1#3)(2008-11#1)(2008-12#1)(2009-3#1)(2012-3#1)(2013-1#1)
pancreatic blood flow##2##3##(1996-6#2)
pancreatic calculi##2##2##(1995-7#2)
pancreatic cancer and##5##3##(1990-9#1)(1991-2#1)(2007-6#1)(2008-3#1)(2010-12#1)
pancreatic cancer are##2##3##(2006-10#2)
pancreatic cancer cases##2##3##(1995-5#1)(2011-2#1)
pancreatic cancer cell line##2##4##(1997-7#1)(2011-2#1)
pancreatic cancer cell##6##3##(1991-2#2)(1993-3#1)(1997-7#2)(2011-2#1)
pancreatic cancer cells in##2##4##(2009-4#1)(2013-1#1)
pancreatic cancer cells##8##3##(1997-7#3)(2009-4#2)(2013-1#3)
pancreatic cancer has##3##3##(1991-5#1)(2006-6#1)(2008-3#1)
pancreatic cancer in##9##3##(1990-9#1)(1995-5#1)(1996-9#1)(2006-10#2)(2008-3#2)(2010-12#1)(2013-1#1)
pancreatic cancer mortality##2##3##(1990-6#1)(2009-7#1)
pancreatic cancer remains##3##3##(2006-10#1)(2008-3#1)(2011-2#1)
pancreatic cancer who##2##3##(2011-2#1)(2013-8#1)
pancreatic cancer##123##2##(1990-6#4)(1990-9#3)(1991-2#7)(1991-5#2)(1992-4#1)(1993-11#1)(1993-3#1)(1994-3#1)(1995-5#6)(1995-7#1)(1996-9#2)(1997-7#10)(2005-9#1)(2006-10#16)(2006-6#5)(2007-11#1)(2007-6#3)(2008-3#11)(2008-7#1)(2008-9#4)(2009-4#4)(2009-5#1)(2009-7#1)(2010-12#2)(2010-2#1)(2011-2#12)(2012-12#6)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#3)
pancreatic cancer]##4##2##(1990-11#1)(1990-9#2)(2012-3#1)
pancreatic cancers##7##2##(1997-7#1)(2005-12#1)(2006-10#1)(2011-1#1)(2013-1#3)
pancreatic carcinogenesis##4##2##(1992-4#3)(2006-10#1)
pancreatic carcinoid tumor##2##3##(1991-9#1)(1994-8#1)
pancreatic carcinoma##12##2##(1990-12#1)(1991-2#1)(1994-11#1)(1994-6#1)(2005-9#1)(2006-10#2)(2007-11#1)(2008-1#1)(2008-9#1)(2010-12#2)
pancreatic cell##4##2##(1991-2#1)(2009-4#3)
pancreatic cells##7##2##(1994-6#1)(2006-10#1)(2008-9#2)(2010-11#3)
pancreatic cholesterol##2##2##(1995-11#2)
pancreatic colipase##5##2##(1990-2#4)(1991-8#1)
pancreatic damage in##2##3##(2006-10#1)(2013-7#1)
pancreatic damage##3##2##(2006-10#1)(2006-6#1)(2013-7#1)
pancreatic development##4##2##(2006-10#3)(2013-7#1)
pancreatic disease##8##2##(1993-12#1)(1993-5#1)(2006-10#3)(2007-5#2)(2009-8#1)
pancreatic diseases and##2##3##(2006-2#1)(2012-3#1)
pancreatic diseases in##2##3##(2006-6#1)(2007-3#1)
pancreatic diseases##9##2##(1997-7#1)(2006-10#3)(2006-2#2)(2006-6#1)(2007-3#1)(2012-3#1)
pancreatic duct anatomy##2##3##(2007-5#1)(2011-2#1)
pancreatic duct and##5##3##(2006-6#2)(2009-2#1)(2010-12#1)(2013-1#1)
pancreatic duct goblet##2##3##(1994-11#2)
pancreatic duct##27##2##(1993-5#1)(1994-11#2)(1995-4#1)(2005-10#1)(2006-10#1)(2006-6#3)(2007-5#1)(2008-10#2)(2008-3#1)(2009-2#1)(2009-7#1)(2010-12#3)(2011-2#4)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
pancreatic ductal adenocarcinoma##3##3##(2007-2#1)(2010-12#1)(2013-1#1)
pancreatic ductal##8##2##(2006-10#2)(2007-2#1)(2007-5#2)(2010-12#1)(2012-2#1)(2013-1#1)
pancreatic ducts##4##2##(1994-11#1)(2007-5#1)(2008-3#1)(2013-1#1)
pancreatic elastase##10##2##(1990-2#1)(1991-3#2)(1992-3#2)(1994-6#1)(1994-9#1)(2008-5#3)
pancreatic endocrine neoplasms##2##3##(2011-2#2)
pancreatic endocrine tumor##2##3##(2009-4#1)(2010-9#1)
pancreatic endocrine tumors##2##3##(1992-7#1)(2010-9#1)
pancreatic endocrine##10##2##(1992-7#1)(1994-6#1)(1995-3#1)(2005-10#1)(2009-4#1)(2010-11#1)(2010-9#2)(2011-2#2)
pancreatic enzyme##4##2##(1991-2#2)(1991-3#1)(2011-1#1)
pancreatic enzymes and##2##3##(2006-6#1)(2008-8#1)
pancreatic enzymes##6##2##(2006-10#1)(2006-6#2)(2008-8#1)(2011-1#1)(2011-2#1)
pancreatic epithelial##3##2##(2010-11#1)(2012-12#2)
pancreatic exocrine secretion in##2##4##(1992-6#1)(2004-12#1)
pancreatic exocrine secretion##10##3##(1992-6#1)(2004-12#1)(2006-10#7)(2007-5#1)
pancreatic exocrine secretory flow##3##4##(2007-5#2)(2011-2#1)
pancreatic exocrine##18##2##(1991-5#1)(1992-6#1)(1993-3#1)(2004-12#1)(2006-10#7)(2007-5#3)(2008-1#1)(2008-3#1)(2009-7#1)(2011-2#1)
pancreatic extracts were##2##3##(1991-2#1)(1991-3#1)
pancreatic extracts##4##2##(1991-2#1)(1991-3#1)(1992-7#1)(1995-10#1)
pancreatic fistula##6##2##(1991-3#1)(1991-4#2)(1994-3#1)(2006-10#1)(2008-3#1)
pancreatic fistulae##3##2##(1990-3#1)(1992-6#2)
pancreatic function in##2##3##(1990-6#1)(1992-11#1)
pancreatic function test##2##3##(1991-2#1)(2006-10#1)
pancreatic function##8##2##(1990-6#1)(1991-2#1)(1992-11#1)(2006-10#3)(2008-5#1)(2013-7#1)
pancreatic growth##4##2##(1993-6#1)(2006-10#1)(2012-12#2)
pancreatic hamartoma##4##2##(2013-1#4)
pancreatic head resection##3##3##(2008-3#1)(2013-7#2)
pancreatic head##11##2##(1990-9#1)(1993-3#1)(2008-10#2)(2008-3#1)(2008-6#1)(2013-1#1)(2013-7#4)
pancreatic heterotopia##2##2##(2013-7#2)
pancreatic hormone##2##2##(1995-6#1)(1997-8#1)
pancreatic injuries##3##2##(2008-8#3)
pancreatic injury##6##2##(2005-10#1)(2006-10#2)(2010-1#2)(2010-12#1)
pancreatic insufficiency##7##2##(1991-2#5)(1991-3#1)(1994-7#1)
pancreatic insulin##5##2##(1990-12#1)(1992-1#2)(1994-11#1)(2010-11#1)
pancreatic islet beta cells##2##4##(1992-4#1)(1997-4#1)
pancreatic islet beta-cells##2##3##(1991-10#1)(2010-12#1)
pancreatic islet cell carcinoma##2##4##(2007-2#2)
pancreatic islet cell##7##3##(1997-1#1)(2007-2#2)(2008-2#2)(2010-11#1)(2012-2#1)
pancreatic islet cells##8##3##(1990-2#1)(1992-4#1)(1994-3#1)(1995-7#1)(1996-2#2)(2008-4#1)(2010-11#1)
pancreatic islet isolation##4##3##(2008-11#4)
pancreatic islet progenitor##2##3##(2008-1#2)
pancreatic islet##41##2##(1990-2#1)(1990-8#2)(1991-10#1)(1991-2#1)(1991-7#1)(1992-1#1)(1992-4#2)(1994-3#1)(1995-7#1)(1996-2#2)(1996-6#1)(1997-1#1)(1997-4#1)(2007-2#2)(2008-1#3)(2008-11#4)(2008-2#2)(2008-4#1)(2010-10#3)(2010-11#7)(2010-12#1)(2010-9#1)(2012-2#1)
pancreatic islets and the##2##4##(1991-1#1)(1995-10#1)
pancreatic islets and##9##3##(1991-1#1)(1992-11#1)(1992-4#1)(1994-12#1)(1994-3#1)(1995-10#1)(1995-8#1)(1996-2#1)(2008-10#1)
pancreatic islets as well as##2##5##(1991-1#1)(1994-12#1)
pancreatic islets as##3##3##(1991-1#1)(1994-12#1)(1996-2#1)
pancreatic islets by##2##3##(1991-10#1)(1992-5#1)
pancreatic islets from##2##3##(1994-8#1)(2010-10#1)
pancreatic islets in##3##3##(1996-6#1)(1997-8#1)(2008-10#1)
pancreatic islets of Langerhans##3##4##(1995-7#1)(1997-4#1)(2010-12#1)
pancreatic islets of transgenic mice##2##5##(1994-8#1)(1995-10#1)
pancreatic islets of##5##3##(1994-8#1)(1995-10#1)(1995-7#1)(1997-4#1)(2010-12#1)
pancreatic islets##56##2##(1990-12#1)(1990-8#1)(1991-1#2)(1991-10#3)(1991-2#1)(1991-6#1)(1992-11#1)(1992-4#1)(1992-5#1)(1994-12#2)(1994-3#1)(1994-8#2)(1995-10#2)(1995-7#2)(1995-8#2)(1996-2#2)(1996-5#2)(1996-6#3)(1997-4#2)(1997-8#1)(2005-7#1)(2007-5#1)(2008-10#2)(2008-11#3)(2009-3#1)(2009-8#1)(2010-10#3)(2010-11#6)(2010-12#4)(2012-12#1)
pancreatic juice and##5##3##(1991-8#1)(1996-7#1)(2004-12#1)(2009-7#1)(2010-12#1)
pancreatic juice drainage through a percutaneous endoscopic drainage tube##2##9##(2008-5#2)
pancreatic juice leakage##4##3##(2008-5#4)
pancreatic juice##21##2##(1990-12#1)(1990-3#1)(1991-4#1)(1991-8#1)(1992-4#1)(1992-7#1)(1996-7#3)(2004-12#2)(2008-5#6)(2009-7#3)(2010-12#1)
pancreatic lesions##4##2##(1991-3#1)(1991-9#1)(2008-3#1)(2011-12#1)
pancreatic lipase##10##2##(1992-12#1)(1992-3#2)(1995-5#3)(1996-7#2)(2006-10#1)(2012-3#1)
pancreatic lymphoma##2##2##(2006-8#2)
pancreatic malignancies##3##2##(1991-3#1)(1992-2#1)(2006-10#1)
pancreatic malignancy##4##2##(2005-12#1)(2008-3#1)(2013-1#1)(2013-8#1)
pancreatic mass##5##2##(2008-3#3)(2013-1#1)(2013-8#1)
pancreatic microsomal vesicles##2##3##(1991-10#2)
pancreatic necrosis##9##2##(1995-7#2)(2009-5#1)(2010-12#1)(2012-3#2)(2013-1#3)
pancreatic neoplasia##2##2##(2006-10#1)(2012-2#1)
pancreatic neoplasm##3##2##(2007-4#1)(2012-2#1)(2013-8#1)
pancreatic neoplasms##5##2##(1992-9#1)(2006-10#1)(2012-2#3)
pancreatic or periampullary cancer##3##4##(2006-6#1)(2013-1#2)
pancreatic or periampullary##4##3##(2006-6#1)(2013-1#3)
pancreatic or##6##2##(1994-8#1)(2006-2#1)(2006-6#1)(2013-1#3)
pancreatic parasympathetic nerves##2##3##(1997-8#2)
pancreatic peptide##2##2##(1991-1#1)(1996-5#1)
pancreatic phospholipase A2 (PLA2)##2##4##(1991-2#1)(1993-6#1)
pancreatic phospholipase A2##6##3##(1990-3#1)(1991-2#2)(1992-5#1)(1992-9#1)(1993-6#1)
pancreatic polypeptide 1##3##3##(1996-12#3)
pancreatic polypeptide##17##2##(1990-2#1)(1990-8#2)(1992-11#1)(1993-3#1)(1996-12#4)(1996-5#1)(1997-5#2)(1997-8#1)(2006-10#1)(2007-4#1)(2008-1#1)(2010-11#1)
pancreatic protein##4##2##(1992-6#1)(1996-4#2)(2008-7#1)
pancreatic pseudocyst##3##2##(2008-3#2)(2009-2#1)
pancreatic pseudocysts##7##2##(1991-8#2)(2005-10#1)(2008-3#1)(2010-12#3)
pancreatic resection##6##2##(1991-4#1)(2006-10#2)(2008-3#1)(2008-8#1)(2013-1#1)
pancreatic resections##3##2##(1991-3#1)(2006-10#1)(2010-12#1)
pancreatic response##2##2##(1996-4#1)(2008-7#1)
pancreatic ribonuclease##5##2##(1991-2#1)(1992-12#2)(1994-8#1)(2005-8#1)
pancreatic secretion and##2##3##(1996-4#1)(2006-10#1)
pancreatic secretion##21##2##(1992-6#2)(1992-8#1)(1994-6#1)(1996-4#1)(2004-12#4)(2006-10#8)(2006-6#1)(2008-10#1)(2008-7#1)(2012-1#1)
pancreatic secretory trypsin inhibitor II##2##5##(1990-3#2)
pancreatic secretory trypsin inhibitor##6##4##(1990-12#2)(1990-3#2)(1990-8#1)(2006-10#1)
pancreatic secretory trypsin##7##3##(1990-12#2)(1990-3#2)(1990-8#1)(1996-6#1)(2006-10#1)
pancreatic secretory##9##2##(1990-12#2)(1990-3#4)(1990-8#1)(1996-6#1)(2006-10#1)
pancreatic stent##2##2##(2007-5#1)(2013-8#1)
pancreatic stenting##2##2##(2007-5#1)(2008-6#1)
pancreatic stones and anastomotic stricture after end-to-side pancreaticojejunostomy##2##8##(2013-7#2)
pancreatic surgery##3##2##(2006-10#3)
pancreatic tissue##6##2##(1997-8#1)(2011-12#1)(2012-2#2)(2013-8#2)
pancreatic tissues##4##2##(2010-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
pancreatic trypsin inhibitor (BPTI)##3##4##(1991-11#1)(1997-2#1)(2006-10#1)
pancreatic trypsin inhibitor##15##3##(1991-11#1)(1991-5#1)(1992-6#2)(1994-9#1)(1995-10#1)(1995-2#2)(1995-4#3)(1997-2#1)(1997-4#1)(1997-5#1)(2006-10#1)
pancreatic trypsin##16##2##(1991-11#1)(1991-3#1)(1991-5#1)(1992-6#2)(1994-9#1)(1995-10#1)(1995-2#2)(1995-4#3)(1997-2#1)(1997-4#1)(1997-5#1)(2006-10#1)
pancreatic tumor##4##2##(2006-10#1)(2007-4#1)(2007-5#1)(2007-6#1)
pancreatic tumors##2##2##(2012-1#1)(2013-1#1)
pancreatic zymogen granules##2##3##(1991-5#1)(1993-3#1)
pancreatic zymogen##3##2##(1991-5#1)(1993-3#1)(1994-9#1)
pancreatic β##2##2##(2013-7#2)
pancreatic β-cell##7##2##(2010-10#2)(2010-11#4)(2013-1#1)
pancreatic β-cells##9##2##(2010-10#1)(2010-11#7)(2012-12#1)
pancreatic##990##1##(1990-10#1)(1990-11#2)(1990-12#7)(1990-2#8)(1990-3#10)(1990-4#1)(1990-5#2)(1990-6#5)(1990-7#2)(1990-8#7)(1990-9#9)(1991-1#8)(1991-10#9)(1991-11#2)(1991-12#3)(1991-2#27)(1991-3#13)(1991-4#4)(1991-5#10)(1991-6#2)(1991-7#3)(1991-8#7)(1991-9#5)(1992-1#4)(1992-10#1)(1992-11#3)(1992-12#9)(1992-2#7)(1992-3#5)(1992-4#11)(1992-5#3)(1992-6#14)(1992-7#4)(1992-8#4)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#3)(1993-3#6)(1993-4#4)(1993-5#5)(1993-6#7)(1994-11#11)(1994-12#3)(1994-2#2)(1994-3#4)(1994-6#9)(1994-7#1)(1994-8#8)(1994-9#6)(1995-10#6)(1995-11#6)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#4)(1995-5#9)(1995-6#1)(1995-7#9)(1995-8#2)(1996-12#7)(1996-2#8)(1996-4#6)(1996-5#7)(1996-6#9)(1996-7#8)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#6)(1997-5#6)(1997-7#20)(1997-8#10)(2004-12#7)(2005-1#1)(2005-10#6)(2005-11#2)(2005-12#2)(2005-7#1)(2005-8#2)(2005-9#2)(2006-10#90)(2006-2#8)(2006-4#1)(2006-6#20)(2006-8#6)(2007-11#2)(2007-2#3)(2007-3#1)(2007-4#3)(2007-5#22)(2007-6#4)(2007-8#2)(2008-1#13)(2008-10#8)(2008-11#10)(2008-12#1)(2008-2#2)(2008-3#37)(2008-4#1)(2008-5#13)(2008-6#2)(2008-7#10)(2008-8#8)(2008-9#9)(2009-2#2)(2009-3#3)(2009-4#8)(2009-5#2)(2009-7#9)(2009-8#4)(2010-1#5)(2010-10#9)(2010-11#42)(2010-12#25)(2010-2#2)(2010-5#1)(2010-9#3)(2011-1#5)(2011-12#2)(2011-2#26)(2012-1#2)(2012-12#17)(2012-2#15)(2012-3#13)(2013-1#48)(2013-7#18)(2013-8#12)
pancreatic-type##2##1##(1992-7#1)(1996-8#1)
pancreatico-duodenal##2##1##(1990-9#2)
pancreaticobiliary##4##1##(2006-2#3)(2010-12#1)
pancreaticoduodenal artery##6##2##(1990-10#1)(1991-6#2)(2008-7#3)
pancreaticoduodenal##11##1##(1990-10#1)(1991-6#3)(1995-2#1)(2008-7#4)(2013-1#2)
pancreaticoduodenectomy ad modum Whipple due to##2##6##(2013-1#2)
pancreaticoduodenectomy ad modum Whipple##3##4##(2013-1#3)
pancreaticoduodenectomy with##2##2##(1991-3#1)(2006-6#1)
pancreaticoduodenectomy##14##1##(1991-3#1)(2006-10#2)(2006-6#4)(2012-2#1)(2013-1#5)(2013-7#1)
pancreaticojejunostomy##6##1##(2008-10#4)(2013-7#2)
pancreaticus caused by##2##3##(2011-2#2)
pancreaticus##5##1##(2011-2#5)
pancreatin and##2##2##(2008-10#1)(2012-11#1)
pancreatin##5##1##(2007-8#1)(2008-10#3)(2012-11#1)
pancreatitic##2##1##(1991-9#1)(2007-11#1)
pancreatitis (AP) is##6##3##(2005-10#2)(2009-8#1)(2013-1#3)
pancreatitis (AP)##8##2##(2005-10#2)(2006-6#1)(2009-8#2)(2013-1#3)
pancreatitis (CP)##4##2##(2005-10#3)(2008-3#1)
pancreatitis acuta##3##2##(1996-9#3)
pancreatitis after kidney transplantation##2##4##(2012-12#2)
pancreatitis after##4##2##(1992-4#1)(2006-6#1)(2012-12#2)
pancreatitis and abdominal pain##2##4##(1991-9#1)(1995-4#1)
pancreatitis and the##4##3##(1994-3#1)(2008-3#1)(2013-1#2)
pancreatitis and##38##2##(1991-2#3)(1991-9#1)(1992-11#1)(1993-5#1)(1994-10#1)(1994-3#1)(1994-7#1)(1995-4#2)(1995-7#1)(2005-10#2)(2006-10#5)(2006-6#7)(2007-11#2)(2007-2#1)(2007-5#1)(2008-12#1)(2008-3#2)(2008-9#1)(2011-2#1)(2013-1#2)(2013-7#1)
pancreatitis are##3##2##(1993-5#2)(2006-6#1)
pancreatitis associated with the##2##4##(2006-4#1)(2007-2#1)
pancreatitis associated with##4##3##(1995-7#1)(2006-4#1)(2006-6#1)(2007-2#1)
pancreatitis at##2##2##(1994-10#1)(2006-7#1)
pancreatitis but##3##2##(2007-11#1)(2011-2#1)(2013-1#1)
pancreatitis can be##2##3##(2006-6#1)(2013-1#1)
pancreatitis created by##2##3##(2009-2#1)(2012-1#1)
pancreatitis develops in##2##3##(2006-6#2)
pancreatitis develops##7##2##(2006-4#1)(2006-6#6)
pancreatitis following##4##2##(1992-4#1)(2008-12#1)(2012-2#1)(2013-1#1)
pancreatitis from the aspect of##2##5##(2006-6#2)
pancreatitis has##5##2##(1993-5#1)(2008-3#2)(2009-2#1)(2012-12#1)
pancreatitis have been##2##3##(1994-7#1)(2009-2#1)
pancreatitis have##5##2##(1994-7#1)(2005-10#2)(2007-5#1)(2009-2#1)
pancreatitis in Caroli's disease##2##4##(2006-2#2)
pancreatitis in a##4##3##(2007-2#1)(2008-3#1)(2010-6#1)(2012-3#1)
pancreatitis in##21##2##(1991-6#1)(1993-5#1)(1993-7#1)(1994-10#1)(1994-7#1)(2005-10#1)(2006-10#1)(2006-2#2)(2006-6#2)(2006-7#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-3#2)(2010-6#2)(2011-2#1)(2012-3#1)
pancreatitis induced by##2##3##(1990-9#1)(2012-1#1)
pancreatitis is a##8##3##(2005-1#1)(2006-10#3)(2006-6#1)(2009-7#1)(2012-12#1)(2013-8#1)
pancreatitis is more##3##3##(2006-6#3)
pancreatitis is usually##2##3##(2006-6#2)
pancreatitis is##32##2##(1995-7#1)(2005-1#1)(2006-10#8)(2006-4#1)(2006-6#15)(2009-7#1)(2012-12#1)(2013-1#3)(2013-8#1)
pancreatitis of##2##2##(1990-3#1)(2013-8#1)
pancreatitis or##3##2##(1995-4#1)(2006-10#1)(2011-2#1)
pancreatitis presenting##2##2##(2008-3#1)(2012-2#1)
pancreatitis remains a##2##3##(2006-10#2)
pancreatitis remains##5##2##(2006-10#4)(2012-12#1)
pancreatitis seems to be##2##4##(2006-10#2)
pancreatitis should##3##2##(1995-7#1)(2006-10#1)(2006-4#1)
pancreatitis was diagnosed##2##3##(1994-7#1)(2012-3#1)
pancreatitis was##7##2##(1990-3#1)(1994-7#3)(2011-2#1)(2012-3#1)(2013-8#1)
pancreatitis which was##2##3##(2008-5#1)(2013-8#1)
pancreatitis which##3##2##(2008-3#1)(2008-5#1)(2013-8#1)
pancreatitis with##8##2##(1995-7#1)(2006-6#2)(2007-6#1)(2008-7#1)(2011-2#1)(2012-12#2)
pancreatitis##455##1##(1990-3#5)(1990-9#3)(1991-2#6)(1991-6#1)(1991-8#4)(1991-9#1)(1992-11#2)(1992-4#2)(1992-9#1)(1993-5#10)(1993-7#2)(1994-10#4)(1994-3#2)(1994-7#13)(1995-1#1)(1995-4#5)(1995-7#7)(1996-7#1)(1996-8#3)(1996-9#4)(1997-8#1)(2005-1#4)(2005-10#22)(2005-8#1)(2006-10#76)(2006-12#1)(2006-2#4)(2006-4#9)(2006-6#74)(2006-7#7)(2007-11#4)(2007-2#5)(2007-3#4)(2007-5#9)(2007-6#1)(2007-8#4)(2008-10#2)(2008-12#3)(2008-3#28)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#4)(2009-12#3)(2009-2#4)(2009-6#1)(2009-7#8)(2009-8#6)(2010-12#2)(2010-6#3)(2011-1#1)(2011-2#11)(2012-1#2)(2012-12#11)(2012-2#3)(2012-3#6)(2013-1#31)(2013-7#1)(2013-8#17)
pancreatitis]##22##1##(1993-5#2)(1997-3#1)(2005-1#1)(2005-10#1)(2006-6#12)(2006-8#1)(2009-2#3)(2012-3#1)
pancreatobiliary##2##1##(2007-5#1)(2008-5#1)
pancreatoduodenectomy##6##1##(2006-10#1)(2008-3#3)(2010-12#1)(2013-1#1)
pancreatography##2##1##(1991-3#1)(2010-1#1)
pancuronium##2##1##(2006-8#1)(2009-4#1)
pancytopaenia and##2##2##(1992-4#1)(2006-4#1)
pancytopaenia##3##1##(1992-4#1)(2006-4#1)(2008-12#1)
pancytopenia and a##3##3##(2008-4#2)(2010-11#1)
pancytopenia and##6##2##(2006-10#1)(2007-12#1)(2008-4#2)(2010-11#1)(2013-8#1)
pancytopenia##33##1##(1990-9#1)(1992-10#1)(1993-11#1)(1997-3#1)(2005-12#3)(2006-10#9)(2006-4#1)(2006-8#1)(2007-12#2)(2008-4#2)(2009-1#1)(2009-6#2)(2009-9#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
panda##8##1##(2008-8#4)(2008-9#4)
pandemic (H1N1) 2009 virus infection in##2##6##(2012-1#2)
pandemic (H1N1) 2009 virus##6##4##(2011-2#3)(2012-1#3)
pandemic (H1N1) 2009##10##3##(2011-1#1)(2011-2#4)(2012-1#5)
pandemic H1N1 and seasonal human##2##5##(2013-1#2)
pandemic H1N1##6##2##(2010-9#1)(2011-2#2)(2013-1#3)
pandemic because##2##2##(2007-12#1)(2010-9#1)
pandemic flu##4##2##(2009-4#1)(2011-1#1)(2012-1#1)(2012-11#1)
pandemic in##7##2##(2007-7#1)(2009-7#1)(2010-7#1)(2011-1#2)(2011-2#2)
pandemic influenza A (H1N1) 2009##3##5##(2011-2#3)
pandemic influenza A (H1N1)##6##4##(2011-1#1)(2011-2#3)(2012-2#2)
pandemic influenza A##7##3##(2011-1#1)(2011-2#3)(2012-11#1)(2012-2#2)
pandemic influenza A(H1N1) 2009##3##4##(2011-2#3)
pandemic influenza in##2##3##(2010-4#1)(2010-5#1)
pandemic influenza virus##3##3##(2010-12#1)(2011-1#1)(2011-2#1)
pandemic influenza##18##2##(2007-3#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#7)(2012-11#1)(2012-2#2)(2013-1#1)
pandemic is##2##2##(2006-8#1)(2010-9#1)
pandemic of##4##2##(2008-5#1)(2009-7#1)(2011-2#2)
pandemic spread##6##2##(2008-10#6)
pandemic virus##3##2##(2011-1#3)
pandemic##148##1##(1990-11#1)(1992-5#1)(1994-1#1)(1994-10#1)(1994-2#1)(1996-11#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-11#1)(2007-12#6)(2007-2#1)(2007-3#2)(2007-7#2)(2008-10#9)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#1)(2009-4#6)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#4)(2010-5#1)(2010-7#4)(2010-8#2)(2010-9#6)(2011-1#15)(2011-2#34)(2012-1#7)(2012-11#3)(2012-12#7)(2012-2#3)(2013-1#8)(2013-8#1)
pandemic?##2##1##(1993-7#1)(2007-12#1)
pandemics and##3##2##(2011-2#1)(2012-2#2)
pandemics are##2##2##(2010-9#1)(2011-2#1)
pandemics from##2##2##(2007-12#1)(2010-4#1)
pandemics##16##1##(2007-12#1)(2008-10#1)(2009-4#1)(2010-4#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#1)(2013-8#1)
paneer##3##1##(2007-8#3)
panel RBRF##2##2##(2008-2#2)
panel also##2##2##(2010-12#2)
panel analysis##2##2##(1997-2#1)(2007-12#1)
panel and##4##2##(1997-8#1)(2006-5#3)
panel data##6##2##(1994-4#1)(2008-7#2)(2009-11#1)(2010-4#1)(2013-1#1)
panel for##6##2##(1995-6#1)(2009-6#1)(2010-4#2)(2012-3#1)(2013-1#1)
panel found##2##2##(1996-11#1)(2007-8#1)
panel has##3##2##(2006-6#1)(2007-9#1)(2009-6#1)
panel in##5##2##(1994-2#1)(1995-12#1)(1996-11#1)(2008-2#1)(2010-12#1)
panel included##2##2##(2007-4#1)(2008-7#1)
panel is##5##2##(1996-6#1)(2007-12#1)(2008-2#2)(2010-12#1)
panel of 100##2##3##(1994-8#1)(2007-12#1)
panel of 14##3##3##(1993-7#1)(2012-12#2)
panel of 28##2##3##(2006-12#1)(2007-10#1)
panel of Canadian##2##3##(2007-12#1)(2008-6#1)
panel of antibodies##3##3##(1992-11#1)(1995-11#1)(2008-10#1)
panel of cell lines##2##4##(1993-4#1)(1997-1#1)
panel of experts##3##3##(1991-3#1)(2008-3#1)(2008-9#1)
panel of human##4##3##(2007-4#1)(2008-6#1)(2009-10#1)(2009-4#1)
panel of mAbs##2##3##(1993-8#1)(1996-12#1)
panel of monoclonal antibodies##10##4##(1990-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1993-1#1)(1993-9#1)(1995-2#1)(2005-9#1)(2007-12#1)(2011-2#1)
panel of monoclonal##11##3##(1990-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1993-1#1)(1993-9#1)(1995-2#1)(1997-3#1)(2005-9#1)(2007-12#1)(2011-2#1)
panel of##142##2##(1990-12#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#3)(1991-9#1)(1992-11#2)(1992-3#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-12#2)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-12#1)(1994-2#1)(1994-3#3)(1994-6#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#2)(1996-12#1)(1996-4#1)(1996-5#2)(1996-6#3)(1996-7#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#2)(2004-12#1)(2005-9#1)(2006-12#4)(2006-2#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#9)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#6)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
panel or##2##2##(1990-5#1)(2012-3#1)
panel press##2##2##(1990-10#2)
panel reactive antibodies (PRA)##2##4##(2007-2#1)(2008-1#1)
panel reactive##3##2##(2007-2#2)(2008-1#1)
panel says that##2##3##(2007-9#2)
panel says##4##2##(1996-1#1)(2007-9#3)
panel selection##2##2##(2012-3#2)
panel studies##5##2##(1995-6#1)(2008-10#1)(2010-2#3)
panel study of##3##3##(2007-12#2)(2008-5#1)
panel study##7##2##(1995-6#1)(2006-9#1)(2007-12#2)(2007-3#1)(2008-5#1)(2009-7#1)
panel survey##5##2##(2006-4#2)(2006-8#1)(2009-12#1)(2013-7#1)
panel test##3##2##(2008-10#2)(2008-5#1)
panel that##4##2##(1997-5#1)(2005-10#1)(2006-4#1)(2007-11#1)
panel to##5##2##(1997-6#1)(2007-8#1)(2012-12#1)(2012-3#2)
panel uniformity##2##2##(2008-2#2)
panel was convened##2##3##(2007-4#1)(2008-3#1)
panel was##4##2##(2007-2#1)(2007-4#1)(2008-10#1)(2008-3#1)
panel were##2##2##(1994-2#1)(2007-4#1)
panel with##3##2##(2008-2#1)(2008-4#1)(2011-2#1)
panel##338##1##(1990-10#3)(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-7#4)(1991-9#1)(1992-11#2)(1992-3#2)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-12#3)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-12#1)(1994-2#4)(1994-3#3)(1994-4#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#7)(1995-3#2)(1995-5#2)(1995-6#7)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-4#1)(1996-5#3)(1996-6#9)(1996-7#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#3)(1997-6#4)(1997-8#2)(2004-12#1)(2005-10#1)(2005-7#6)(2005-8#1)(2005-9#2)(2006-12#6)(2006-2#1)(2006-4#3)(2006-5#4)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#10)(2007-2#5)(2007-3#3)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#3)(2007-9#5)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#19)(2008-3#5)(2008-4#2)(2008-5#13)(2008-6#5)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-6#3)(2009-7#2)(2009-9#3)(2010-12#11)(2010-2#4)(2010-3#1)(2010-4#6)(2010-5#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#4)(2012-12#7)(2012-2#4)(2012-3#10)(2013-1#6)(2013-7#1)(2013-8#1)
panelists and##2##2##(2008-5#1)(2008-7#1)
panelists rated##4##2##(2007-10#2)(2008-5#1)(2010-12#1)
panelists with##3##2##(2008-5#2)(2008-7#1)
panelists##25##1##(2006-4#1)(2007-10#4)(2008-5#13)(2008-6#1)(2008-7#2)(2010-12#1)(2010-4#3)
panelists'##3##1##(2008-5#1)(2010-12#2)
panellists##4##1##(2008-5#2)(2010-4#2)
panels are##2##2##(2007-8#1)(2008-9#1)
panels for##2##2##(1991-12#1)(2008-3#1)
panels have##2##2##(2007-9#2)
panels of##13##2##(1993-12#1)(1993-3#1)(1994-12#1)(1995-3#1)(1996-12#1)(1996-2#1)(2004-9#1)(2007-8#2)(2008-12#1)(2008-3#1)(2009-2#1)(2012-2#1)
panels that##2##2##(2008-2#1)(2008-3#1)
panels to##3##2##(2008-2#1)(2012-1#1)(2013-1#1)
panels with##3##2##(1997-6#1)(2008-3#1)(2009-9#1)
panels##59##1##(1990-5#1)(1991-12#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-6#1)(2004-9#2)(2005-7#5)(2006-11#1)(2006-8#2)(2007-2#1)(2007-8#3)(2007-9#2)(2008-10#2)(2008-12#2)(2008-2#7)(2008-3#5)(2008-9#4)(2009-2#1)(2009-9#1)(2010-4#2)(2011-2#1)(2012-1#3)(2012-2#1)(2012-3#1)(2013-1#1)
panhandle structure##2##2##(2008-10#1)(2008-8#1)
panhandle##3##1##(2008-10#2)(2008-8#1)
panic and##4##2##(1990-11#1)(2010-2#1)(2011-2#1)(2012-2#1)
panic attacks and social phobia after##2##6##(2007-9#2)
panic attacks and##3##3##(2007-9#3)
panic attacks##6##2##(2005-10#1)(2006-9#1)(2007-9#3)(2008-6#1)
panic disorder and agoraphobia##2##4##(1990-11#1)(2012-2#1)
panic disorder and##5##3##(1990-11#1)(1996-1#2)(1997-6#1)(2012-2#1)
panic disorder in##3##3##(2007-5#3)
panic disorder with agoraphobia##3##4##(2005-7#2)(2008-2#1)
panic disorder with##4##3##(2005-7#2)(2008-2#1)(2012-2#1)
panic disorder##46##2##(1990-11#1)(1991-2#1)(1993-12#2)(1995-1#2)(1995-11#2)(1996-1#2)(1996-3#2)(1996-7#3)(1997-6#1)(2004-3#1)(2005-7#2)(2006-3#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-5#3)(2007-6#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#2)(2009-4#1)(2012-2#5)(2013-1#1)(2013-7#1)(2013-8#4)
panic disorders##4##2##(2005-9#2)(2007-9#1)(2009-7#1)
panic##86##1##(1990-11#2)(1991-2#1)(1992-12#1)(1992-2#1)(1993-12#2)(1993-2#1)(1995-1#5)(1995-11#2)(1996-1#2)(1996-3#3)(1996-7#3)(1997-6#1)(2004-12#2)(2004-3#1)(2005-10#3)(2005-7#2)(2005-9#3)(2006-3#1)(2006-9#3)(2007-1#1)(2007-10#2)(2007-5#4)(2007-6#1)(2007-9#5)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-6#3)(2008-7#1)(2009-4#1)(2009-7#1)(2010-2#3)(2011-1#1)(2011-2#2)(2012-2#6)(2013-1#2)(2013-7#1)(2013-8#5)
panic-agoraphobia disorder##3##2##(2008-2#3)
panicle and paddy by##2##4##(2008-12#2)
panicle and shoot blight of pistachio leaves and fruit##2##9##(2008-10#2)
panicle and shoot blight of pistachio##6##6##(2008-10#6)
panicle and shoot blight severity##3##5##(2008-10#3)
panicle and shoot blight##10##4##(2008-10#10)
panicle and##12##2##(2008-10#10)(2008-12#2)
panicle blast severity##2##3##(2008-10#2)
panicle blast##10##2##(2008-10#10)
panicle##42##1##(2006-9#1)(2008-10#23)(2008-12#7)(2008-8#2)(2008-9#2)(2009-10#7)
panicles##6##1##(2008-10#1)(2008-12#3)(2008-8#1)(2008-9#1)
paniculata mother plants##2##3##(2008-10#2)
paniculata##8##1##(2005-12#3)(2008-10#4)(2012-2#1)
paniculate##2##1##(2008-11#2)
panitumumab##2##1##(2012-12#1)(2013-8#1)
panmictic population##3##2##(2008-10#1)(2008-9#2)
panmictic populations##2##2##(2008-10#1)(2010-8#1)
panmictic##7##1##(2008-10#3)(2008-9#3)(2010-8#1)
panned##2##1##(1994-12#1)(1994-3#1)
pannexin##2##1##(2007-10#1)(2008-7#1)
pannexins##3##1##(2008-7#3)
panniculitis (Weber-Christian disease) with##2##4##(2006-10#2)
panniculitis and##3##2##(2006-10#2)(2012-12#1)
panniculitis is a rare##2##4##(2006-4#1)(2008-7#1)
panniculitis of##2##2##(2010-9#1)(2012-2#1)
panniculitis with##2##2##(2006-4#2)
panniculitis##26##1##(2006-10#6)(2006-4#6)(2007-7#2)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#2)(2010-9#1)(2012-1#1)(2012-12#4)(2012-2#1)
panning##9##1##(1991-12#1)(1992-7#1)(1994-12#1)(2007-2#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)
pannus##4##1##(2006-10#1)(2007-11#1)(2008-5#1)(2012-3#1)
panoply of##5##2##(1993-9#1)(2003-11#1)(2008-8#1)(2013-1#2)
panorama##2##1##(1990-6#1)(2008-7#1)
panoramic cameras##3##2##(2008-6#3)
panoramic images##2##2##(2007-5#1)(2010-3#1)
panoramic radiograph##2##2##(2012-12#1)(2013-8#1)
panoramic radiographs for##3##3##(2008-12#1)(2012-2#1)(2013-8#1)
panoramic radiographs were##3##3##(2012-2#1)(2013-8#2)
panoramic radiographs##12##2##(2008-12#2)(2009-12#1)(2012-2#5)(2013-8#4)
panoramic##29##1##(2007-12#1)(2007-5#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-6#6)(2009-12#1)(2010-3#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-8#5)
panpleuropneumonectomy##3##1##(2007-8#3)
pansy##4##1##(2008-10#1)(2008-7#3)
pantaneiro##3##1##(2010-8#3)
panthenol (2%)##2##2##(2008-5#2)
panthenol##9##1##(2008-5#9)
pantohematogen##2##1##(2012-1#2)
pantoprazole##8##1##(1997-1#1)(2008-12#1)(2008-5#3)(2011-2#1)(2012-3#2)
pantothenate##2##1##(1995-6#1)(2009-7#1)
pantothenic acid##5##2##(2006-10#4)(2008-5#1)
pantropical distribution##2##2##(2007-12#1)(2008-10#1)
pantropical##5##1##(2007-12#1)(2008-10#1)(2010-6#3)
pants##2##1##(2009-10#1)(2011-2#1)
panuveitis##6##1##(2006-10#5)(2012-12#1)
pap and##2##2##(1997-4#1)(2006-10#1)
pap before serving##2##3##(1997-4#2)
pap smear images##2##3##(2008-3#2)
pap smear test##4##3##(2011-2#4)
pap smear##16##2##(1990-6#1)(1992-8#1)(2006-10#4)(2007-7#1)(2008-3#2)(2011-2#7)
pap smears##6##2##(2006-10#5)(2006-9#1)
pap test##5##2##(1990-6#2)(2006-10#2)(2007-6#1)
pap##37##1##(1990-6#3)(1992-8#1)(1997-4#6)(2006-10#14)(2006-9#1)(2007-6#1)(2007-7#1)(2008-3#2)(2011-2#8)
pap1##2##1##(1994-9#2)
papain and##2##2##(1990-2#1)(1994-12#1)
papain cleavage##2##2##(1994-8#2)
papain digestion##2##2##(1990-2#1)(2008-4#1)
papain treatment##3##2##(1990-2#1)(1990-4#2)
papain##34##1##(1990-2#5)(1990-4#3)(1991-12#1)(1991-2#2)(1991-3#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-9#1)(1994-12#5)(1994-8#2)(1997-4#2)(2006-10#2)(2007-6#1)(2008-1#1)(2008-11#3)(2008-4#2)
papain-treated RBCs##2##2##(1994-12#1)(1994-9#1)
papanicolaou smear##2##2##(2006-10#2)
papanicolaou##3##1##(2006-10#3)
papatasi and##2##2##(2004-11#2)
papatasi##9##1##(2004-11#9)
papaveracea and##4##2##(2008-10#4)
papaveracea caused##2##2##(2008-10#2)
papaveracea conidia##2##2##(2008-10#2)
papaveracea was more##2##3##(2008-10#2)
papaveracea was##3##2##(2008-10#3)
papaveracea##25##1##(2008-10#25)
papaverine hydrochloride##2##2##(2008-10#2)
papaverine infusion##2##2##(2007-9#2)
papaverine##23##1##(1993-3#1)(1993-7#1)(1994-3#1)(1996-12#1)(1996-5#1)(2006-11#4)(2007-1#1)(2007-8#1)(2007-9#6)(2008-10#6)
papaya proteinase omega##2##3##(1993-5#2)
papaya##18##1##(1993-5#4)(2006-4#2)(2008-10#12)
papayae##3##1##(2011-2#3)
paper I##16##2##(1994-5#1)(1995-12#1)(1995-9#1)(1996-11#1)(1997-8#1)(2004-7#1)(2005-10#1)(2008-7#1)(2009-2#1)(2009-9#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#3)
paper [Appl##6##2##(2008-2#4)(2008-3#2)
paper a new##2##3##(2008-10#1)(2008-2#1)
paper a##23##2##(1990-11#1)(1992-1#1)(1992-9#1)(1994-12#1)(1996-8#1)(2006-10#1)(2007-9#2)(2008-10#8)(2008-11#2)(2008-2#1)(2011-12#1)(2012-1#1)(2013-1#2)
paper addresses some##2##3##(2008-11#1)(2012-12#1)
paper addresses the##16##3##(1991-5#1)(1992-3#1)(1997-8#1)(2004-12#1)(2006-5#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-12#1)(2009-6#1)(2010-1#1)(2012-2#2)
paper addresses this gap##2##4##(2009-11#1)(2010-4#1)
paper addresses##29##2##(1991-5#1)(1992-2#1)(1992-3#1)(1996-7#1)(1997-8#1)(2004-12#1)(2006-5#1)(2007-10#1)(2007-3#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#2)(2009-11#1)(2009-12#1)(2009-6#1)(2010-1#1)(2010-4#1)(2012-12#2)(2012-2#3)
paper adds##2##2##(2007-10#1)(2010-4#1)
paper aims at##5##3##(1991-6#1)(2007-10#1)(2008-2#1)(2008-4#1)(2011-2#1)
paper aims to evaluate##2##4##(2009-10#1)(2012-3#1)
paper aims to explore##4##4##(2008-11#1)(2012-2#1)(2013-1#2)
paper aims to review the##3##5##(1993-3#1)(2007-11#1)(2013-1#1)
paper aims to review##4##4##(1993-3#1)(2007-11#1)(2012-2#1)(2013-1#1)
paper aims to##27##3##(1993-3#1)(1996-3#1)(2007-11#1)(2008-11#3)(2008-12#2)(2008-7#2)(2009-1#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
paper aims##32##2##(1991-6#1)(1993-3#1)(1996-3#1)(2007-10#1)(2007-11#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#1)(2008-7#2)(2009-1#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
paper also considers##2##3##(2006-6#1)(2008-10#1)
paper also describes##3##3##(2006-6#1)(2008-2#1)(2008-6#1)
paper also discusses the##3##4##(1990-6#1)(2007-2#1)(2009-10#1)
paper also discusses##4##3##(1990-6#1)(2007-2#1)(2009-10#1)(2013-8#1)
paper also shows that##3##4##(2006-12#1)(2008-10#1)(2008-2#1)
paper also shows##4##3##(2006-12#1)(2008-10#2)(2008-2#1)
paper also##30##2##(1990-6#1)(1991-4#1)(1993-3#1)(1995-9#1)(1996-1#1)(2006-12#1)(2006-6#2)(2007-11#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-9#1)(2012-12#2)(2013-1#1)(2013-8#1)
paper analyses the##11##3##(1991-6#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-9#4)(2010-4#1)(2013-7#1)
paper analyses##12##2##(1991-6#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-9#4)(2009-2#1)(2010-4#1)(2013-7#1)
paper analyzes the##8##3##(2008-4#1)(2008-9#1)(2009-4#1)(2009-7#1)(2012-2#1)(2013-1#2)(2013-8#1)
paper analyzes##15##2##(2005-10#1)(2008-4#1)(2008-5#1)(2008-9#3)(2009-4#1)(2009-7#1)(2010-1#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
paper and wood impregnates##2##4##(2008-9#2)
paper and##25##2##(1995-2#1)(1997-1#2)(2004-4#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2008-10#7)(2008-3#3)(2008-4#1)(2008-9#2)(2010-12#1)(2013-1#1)(2013-7#1)
paper applies##4##2##(2005-8#1)(2008-10#1)(2008-5#1)(2009-2#1)
paper are based on##2##4##(1990-12#1)(2008-12#1)
paper are##31##2##(1990-12#1)(1992-9#2)(1994-6#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-4#1)(2006-6#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#1)(2009-9#1)(2010-3#1)(2011-1#1)(2013-7#1)(2013-8#1)
paper argues for the##2##4##(2008-12#1)(2008-7#1)
paper argues for##3##3##(2008-12#1)(2008-7#1)(2012-2#1)
paper argues that the##7##4##(2006-3#1)(2006-7#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-11#1)(2012-2#1)
paper argues that##16##3##(2005-11#1)(2006-3#1)(2006-7#1)(2007-1#1)(2007-7#1)(2008-11#1)(2008-12#2)(2008-5#1)(2009-12#1)(2010-1#1)(2010-10#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
paper argues##21##2##(1996-8#1)(2005-11#1)(2006-3#1)(2006-7#1)(2007-1#1)(2007-7#1)(2008-11#1)(2008-12#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-1#1)(2010-10#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#1)
paper arose##2##2##(2008-12#1)(2008-9#1)
paper as a##2##3##(2008-12#1)(2012-3#1)
paper as##15##2##(1993-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2011-2#9)(2012-3#1)(2013-8#1)
paper asserts that##2##3##(1991-3#1)(1993-3#1)
paper assesses the##5##3##(2007-2#1)(2008-1#1)(2008-9#1)(2009-7#1)(2013-8#1)
paper assesses##7##2##(2007-2#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-7#1)(2013-7#1)(2013-8#1)
paper at##3##2##(2007-7#1)(2007-9#1)(2012-2#1)
paper attempts to highlight##2##4##(2006-2#1)(2007-10#1)
paper attempts to provide##2##4##(2006-10#1)(2008-11#1)
paper attempts to##15##3##(1990-3#1)(1992-3#1)(1993-3#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-3#1)(2007-10#1)(2008-1#2)(2008-10#1)(2008-11#1)(2009-4#1)(2010-9#1)
paper based##3##2##(2008-12#1)(2008-2#1)(2013-8#1)
paper begins by examining##2##4##(1996-1#1)(2008-12#1)
paper begins by##4##3##(1996-1#1)(2008-1#1)(2008-12#2)
paper begins##7##2##(1992-1#1)(1996-1#1)(2007-5#1)(2008-1#1)(2008-12#2)(2008-4#1)
paper briefly##10##2##(1990-12#1)(1991-11#1)(1993-9#1)(1997-2#1)(2007-12#1)(2007-4#1)(2008-5#1)(2010-12#1)(2011-12#1)(2013-7#1)
paper by the European Society of Radiology##2##7##(2012-2#2)
paper by the##3##3##(2005-11#1)(2012-2#2)
paper by##23##2##(1996-1#1)(1996-4#1)(1997-2#1)(2005-11#1)(2007-7#1)(2008-10#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-9#1)(2009-11#1)(2010-8#1)(2012-2#2)(2013-1#3)
paper can be applied##2##4##(2005-11#1)(2012-1#1)
paper can##3##2##(2005-11#1)(2012-1#1)(2013-8#1)
paper chase##2##2##(2007-3#1)(2010-3#1)
paper chromatography##4##2##(1992-8#1)(1994-9#1)(1997-2#1)(2005-9#1)
paper claims##2##2##(2006-7#1)(2009-6#1)
paper closes with a discussion of##2##6##(1997-4#1)(2010-9#1)
paper closes with##3##3##(1997-4#1)(2010-9#1)(2012-1#1)
paper combines##2##2##(2005-4#1)(2009-9#1)
paper compares the results##3##4##(1997-4#1)(2008-10#1)(2012-2#1)
paper compares the##12##3##(1991-12#1)(1991-5#1)(1997-4#1)(2006-11#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-3#1)(2010-12#1)(2012-2#1)(2013-8#1)
paper compares##18##2##(1991-12#1)(1991-5#1)(1995-4#1)(1997-4#1)(2006-11#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
paper concerns the##4##3##(1991-2#1)(1996-12#1)(1996-3#1)(1997-7#1)
paper concerns##9##2##(1990-6#1)(1991-2#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-7#1)(2008-2#1)(2010-2#1)(2011-1#1)
paper concludes by discussing##2##4##(2008-11#1)(2008-12#1)
paper concludes by##9##3##(1991-3#1)(1992-12#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-8#1)
paper concludes that##3##3##(1992-5#1)(2010-8#1)(2012-1#1)
paper concludes with a##7##4##(2006-2#1)(2006-5#1)(2008-12#2)(2008-7#1)(2011-1#1)(2012-1#1)
paper concludes with##9##3##(2006-2#1)(2006-5#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-1#1)
paper concludes##21##2##(1991-3#1)(1992-12#1)(1992-5#1)(2006-2#1)(2006-5#1)(2008-11#4)(2008-12#3)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-1#1)(2012-1#2)
paper considers the##10##3##(1990-3#1)(1992-1#1)(1997-3#1)(2005-7#1)(2007-1#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-6#1)(2011-1#1)
paper considers##24##2##(1990-3#1)(1992-1#1)(1995-9#1)(1997-3#1)(2005-7#1)(2006-7#1)(2007-1#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#3)(2009-6#1)(2010-2#2)(2011-1#2)(2013-1#4)
paper constitutes##2##2##(2008-10#1)(2009-4#1)
paper contains##3##2##(1995-6#1)(1996-2#1)(2008-11#1)
paper could be##2##3##(2006-10#1)(2013-7#1)
paper covers##5##2##(2006-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-8#1)
paper deals with a new##2##5##(2007-8#1)(2012-3#1)
paper deals with a##3##4##(2007-8#1)(2008-10#1)(2012-3#1)
paper deals with the influence of##2##6##(1993-12#1)(2008-8#1)
paper deals with the problem of##2##6##(2010-8#1)(2013-8#1)
paper deals with the##20##4##(1992-11#1)(1993-12#1)(1997-8#1)(2006-11#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-8#1)(2010-2#1)(2010-8#1)(2012-12#2)(2013-8#1)
paper deals with##33##3##(1992-11#1)(1993-12#1)(1997-8#1)(2006-11#1)(2006-5#1)(2007-11#2)(2007-4#1)(2007-8#3)(2008-10#6)(2008-12#1)(2008-2#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-8#2)(2012-12#2)(2012-3#1)(2013-8#1)
paper deals##34##2##(1992-11#1)(1993-12#1)(1997-8#1)(2006-11#1)(2006-5#1)(2007-11#2)(2007-4#1)(2007-8#3)(2008-10#6)(2008-12#1)(2008-2#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-2#1)(2010-8#2)(2012-12#2)(2012-3#1)(2013-8#1)
paper defines##2##2##(2007-8#1)(2008-5#1)
paper demonstrates how##2##3##(1997-8#1)(2008-11#1)
paper demonstrates that##2##3##(2008-10#1)(2008-7#1)
paper demonstrates the application of##3##5##(1991-1#1)(2007-6#1)(2008-10#1)
paper demonstrates the potential##2##4##(1990-8#1)(2011-1#1)
paper demonstrates the##9##3##(1990-8#1)(1991-1#1)(1997-2#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-1#1)(2012-12#1)
paper demonstrates##17##2##(1990-8#1)(1991-1#1)(1997-2#1)(1997-8#1)(2005-8#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2010-4#1)(2011-1#1)(2012-11#2)(2012-12#1)
paper described##2##2##(1993-2#1)(2008-10#1)
paper describes a case of spontaneous##3##6##(1990-9#1)(2013-1#2)
paper describes a case of##8##5##(1990-9#1)(2006-2#1)(2007-7#1)(2011-2#1)(2012-3#1)(2013-1#3)
paper describes a case##9##4##(1990-9#1)(2006-2#1)(2007-7#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#3)
paper describes a fast and##2##5##(2008-10#2)
paper describes a method for the##2##6##(2008-10#1)(2008-11#1)
paper describes a method for##5##5##(2006-2#1)(2008-10#1)(2008-11#1)(2008-2#2)
paper describes a method##6##4##(1996-12#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-2#2)
paper describes a new##5##4##(2008-10#3)(2008-5#1)(2008-6#1)
paper describes a procedure that##3##5##(1996-8#1)(2008-10#2)
paper describes a procedure##5##4##(1996-8#1)(2008-10#4)
paper describes a series of##2##5##(1992-6#1)(2008-5#1)
paper describes a technique##3##4##(1992-6#1)(1994-2#1)(2010-7#1)
paper describes a##97##3##(1990-11#1)(1990-12#1)(1990-9#2)(1991-5#1)(1992-2#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-1#1)(1993-2#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-7#1)(1994-9#1)(1995-2#1)(1996-12#2)(1996-8#2)(1997-2#2)(1997-3#1)(1997-8#1)(2006-2#2)(2006-3#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-10#21)(2008-11#6)(2008-12#2)(2008-2#5)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#7)(2013-7#1)
paper describes an integrated##2##4##(2008-10#1)(2013-7#1)
paper describes an##21##3##(1993-12#1)(1996-11#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#1)(2010-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
paper describes how the##5##4##(1991-2#1)(1997-2#1)(2009-4#1)(2009-8#1)(2010-3#1)
paper describes how##12##3##(1991-2#1)(1997-2#1)(1997-6#1)(2007-2#1)(2008-11#2)(2008-12#2)(2009-4#1)(2009-8#1)(2010-11#1)(2010-3#1)
paper describes in detail##2##4##(2007-4#2)
paper describes the application of##4##5##(1993-2#1)(2005-11#1)(2006-12#1)(2006-3#1)
paper describes the development of##10##5##(1997-1#1)(2006-12#1)(2006-3#1)(2007-10#1)(2008-10#3)(2008-11#1)(2010-8#1)(2012-12#1)
paper describes the development##17##4##(1997-1#1)(2006-12#1)(2006-3#1)(2007-10#2)(2007-3#1)(2008-10#5)(2008-11#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#2)
paper describes the project##2##4##(1992-2#1)(2008-1#1)
paper describes the use of##7##5##(1990-6#1)(1993-10#1)(1996-12#1)(2008-10#2)(2008-5#1)(2008-6#1)
paper describes the##156##3##(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#2)(1990-9#1)(1991-5#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1993-10#2)(1993-12#2)(1993-2#2)(1993-6#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-8#1)(1996-12#1)(1996-3#3)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2004-12#1)(2005-11#1)(2005-5#1)(2006-11#3)(2006-12#3)(2006-3#2)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-8#1)(2008-1#5)(2008-10#27)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-11#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#10)
paper describes these##2##3##(2006-2#1)(2008-9#1)
paper describes##351##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#2)(1990-9#3)(1991-1#1)(1991-2#1)(1991-5#3)(1992-12#1)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#3)(1993-12#3)(1993-2#3)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-12#3)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#4)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#3)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#1)(2004-10#1)(2004-12#1)(2005-11#1)(2005-5#1)(2006-11#3)(2006-12#3)(2006-2#4)(2006-3#3)(2006-5#3)(2006-6#2)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#2)(2007-12#3)(2007-2#4)(2007-3#1)(2007-4#4)(2007-5#4)(2007-6#1)(2007-7#5)(2007-8#2)(2008-1#5)(2008-10#62)(2008-11#24)(2008-12#10)(2008-2#7)(2008-3#3)(2008-4#2)(2008-5#10)(2008-6#7)(2008-7#6)(2008-9#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-11#6)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#23)(2013-7#2)
paper describing the##3##3##(2008-11#1)(2013-1#2)
paper details the##4##3##(1991-12#1)(1995-11#1)(2008-7#1)(2012-1#1)
paper develops a##5##3##(2007-12#1)(2008-10#1)(2009-3#1)(2012-2#1)(2012-3#1)
paper develops an##2##3##(2008-6#1)(2013-8#1)
paper develops##7##2##(2007-12#1)(2008-10#1)(2008-6#1)(2009-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
paper disc##3##2##(1994-11#2)(2008-12#1)
paper discuss the##2##3##(2008-9#1)(2009-4#1)
paper discusses a##5##3##(1995-8#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-3#1)
paper discusses how##5##3##(1991-3#1)(1992-12#1)(2008-11#1)(2008-12#1)(2009-6#1)
paper discusses recent##3##3##(1996-1#1)(2005-10#1)(2008-9#1)
paper discusses the advantages and disadvantages##2##6##(1990-8#1)(2008-10#1)
paper discusses the benefits##2##4##(2007-10#1)(2008-3#1)
paper discusses the current##2##4##(2008-11#1)(2008-5#1)
paper discusses the implications of##2##5##(2005-8#1)(2010-8#1)
paper discusses the need to##2##5##(1993-6#1)(2007-1#1)
paper discusses the need##3##4##(1993-6#1)(1997-3#1)(2007-1#1)
paper discusses the role of##2##5##(1995-6#1)(2012-2#1)
paper discusses the role##3##4##(1995-6#1)(2009-2#1)(2012-2#1)
paper discusses the significance of##2##5##(2008-10#1)(2008-11#1)
paper discusses the##59##3##(1990-8#1)(1991-3#1)(1993-3#1)(1993-6#1)(1995-6#1)(1995-9#1)(1997-3#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-4#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#10)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#2)(2009-5#2)(2009-7#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#2)(2013-1#2)
paper discusses these##3##3##(2007-12#1)(2008-1#1)(2008-10#1)
paper discusses##97##2##(1990-8#1)(1991-12#1)(1991-3#2)(1992-12#1)(1992-9#1)(1993-3#1)(1993-6#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1997-1#1)(1997-3#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-8#2)(2005-9#1)(2006-2#2)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-4#2)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#6)(2008-11#11)(2008-12#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-2#2)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#2)(2010-12#1)(2010-2#2)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#3)(2012-2#3)(2012-3#2)(2013-1#3)
paper documents the##5##3##(1994-2#1)(2007-5#1)(2008-11#1)(2013-1#2)
paper documents##6##2##(1994-2#1)(2007-3#1)(2007-5#1)(2008-11#1)(2013-1#2)
paper draws on##4##3##(2008-1#1)(2008-12#1)(2012-11#1)(2012-3#1)
paper draws##5##2##(2008-1#1)(2008-12#1)(2010-4#1)(2012-11#1)(2012-3#1)
paper elaborates on the##2##4##(1994-12#1)(2011-1#1)
paper electrophoresis##4##2##(1991-2#1)(1993-11#1)(2008-10#2)
paper emphasizes the importance of##3##5##(2008-2#1)(2010-2#1)(2010-4#1)
paper emphasizes the##7##3##(1992-1#1)(1993-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-2#1)(2010-4#1)
paper employs##3##2##(1997-2#1)(2010-1#1)(2013-1#1)
paper evaluates the##9##3##(1994-3#1)(1995-2#1)(2005-12#1)(2006-9#1)(2007-12#1)(2008-10#1)(2010-8#1)(2012-11#1)(2012-12#1)
paper evaluates##11##2##(1994-3#1)(1995-2#1)(2005-12#1)(2006-7#1)(2006-9#1)(2007-12#1)(2008-10#1)(2010-3#1)(2010-8#1)(2012-11#1)(2012-12#1)
paper examines a##2##3##(1994-11#1)(2007-5#1)
paper examines some of the##2##5##(2008-5#1)(2010-12#1)
paper examines the cultural##2##4##(2007-3#1)(2008-11#1)
paper examines the##42##3##(1990-4#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(2005-10#1)(2006-2#1)(2006-7#2)(2007-10#1)(2007-12#1)(2007-3#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-2#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
paper examines whether##2##3##(2008-4#1)(2008-7#1)
paper examines##73##2##(1990-4#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-1#3)(1992-12#1)(1993-6#1)(1994-11#1)(1995-1#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-3#1)(2004-3#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-7#3)(2007-10#2)(2007-12#1)(2007-3#2)(2007-5#2)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#2)(2009-8#1)(2010-12#1)(2010-2#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#5)
paper expands##2##2##(2007-5#1)(2008-1#1)
paper explains the##4##3##(1996-3#1)(2004-12#1)(2007-4#1)(2008-10#1)
paper explains##6##2##(1996-3#1)(2004-12#1)(2007-11#1)(2007-4#1)(2008-10#1)(2009-11#1)
paper explored the##2##3##(2007-12#1)(2009-4#1)
paper explores the##28##3##(1992-2#1)(1992-6#1)(1992-9#1)(1994-1#1)(1995-2#1)(1995-5#1)(1997-4#1)(1997-7#1)(2004-10#2)(2006-7#1)(2007-12#2)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-10#1)(2011-1#2)(2011-2#2)
paper explores##46##2##(1992-2#1)(1992-6#1)(1992-9#1)(1994-1#1)(1995-2#1)(1995-5#1)(1997-4#1)(1997-7#1)(2004-10#2)(2006-7#1)(2007-12#2)(2007-2#2)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#2)(2008-4#2)(2008-7#4)(2008-9#1)(2009-2#1)(2009-7#1)(2010-10#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
paper extends##4##2##(1996-7#1)(2008-6#1)(2008-8#1)(2010-3#1)
paper finally##2##2##(2008-11#1)(2010-1#1)
paper first describes the##2##4##(2005-5#1)(2010-8#1)
paper first##4##2##(2005-5#1)(2006-12#1)(2009-2#1)(2010-8#1)
paper focuses on an##2##4##(2008-12#1)(2012-3#1)
paper focuses on the role of##3##6##(2006-10#1)(2008-10#1)(2008-3#1)
paper focuses on the##29##4##(1991-2#1)(1992-1#1)(1993-11#1)(1995-9#1)(1996-3#1)(1996-7#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2009-10#1)(2009-5#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
paper focuses on##48##3##(1991-2#1)(1992-1#1)(1993-11#1)(1995-9#1)(1996-3#1)(1996-7#1)(1997-1#1)(2005-11#1)(2006-10#2)(2006-11#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-4#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#5)(2008-3#1)(2008-5#2)(2008-6#1)(2009-10#2)(2009-5#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
paper focuses##49##2##(1991-2#1)(1992-1#1)(1993-11#1)(1995-9#1)(1996-3#1)(1996-7#1)(1997-1#1)(2005-11#1)(2006-10#2)(2006-11#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-4#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#5)(2008-3#1)(2008-5#2)(2008-6#1)(2009-10#2)(2009-5#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
paper for the determination of##2##5##(2008-10#2)
paper for the##3##3##(2008-10#3)
paper for##7##2##(1991-6#1)(1996-6#1)(2007-12#1)(2008-10#3)(2008-5#1)
paper from a##2##3##(2007-12#1)(2008-2#1)
paper from this laboratory##2##4##(2008-10#2)
paper from##6##2##(2007-12#1)(2008-10#4)(2008-2#1)
paper further##4##2##(1995-12#1)(1995-9#1)(1996-3#1)(2010-1#1)
paper gives an overview of##2##5##(1990-6#1)(2005-11#1)
paper gives an overview##4##4##(1990-6#1)(2005-11#1)(2008-10#1)(2013-1#1)
paper gives an##8##3##(1990-6#1)(2005-11#1)(2005-9#1)(2006-6#1)(2007-11#1)(2008-10#1)(2010-1#1)(2013-1#1)
paper gives the##3##3##(1994-11#1)(2007-12#1)(2008-6#1)
paper gives##20##2##(1990-6#1)(1993-9#1)(1994-11#1)(1997-8#1)(2005-11#1)(2005-9#1)(2006-6#2)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-1#1)(2013-1#1)
paper grades##2##2##(2006-12#2)
paper has a##2##3##(2008-2#1)(2013-7#1)
paper has been##3##3##(1996-5#1)(2007-10#1)(2012-3#1)
paper has two##2##3##(2008-2#1)(2010-12#1)
paper has##16##2##(1991-1#1)(1991-4#1)(1995-11#1)(1995-5#1)(1996-10#1)(1996-5#1)(2007-10#1)(2007-4#1)(2008-10#1)(2008-2#2)(2010-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
paper have been##2##3##(2007-12#1)(2009-8#1)
paper have##3##2##(2007-12#1)(2008-11#1)(2009-8#1)
paper helps to##2##3##(2009-2#1)(2009-6#1)
paper highlights the dependence##2##4##(2008-10#1)(2009-7#1)
paper highlights the##12##3##(2006-11#1)(2006-12#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-3#2)(2009-7#1)(2011-1#2)
paper highlights##24##2##(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#2)(2009-6#1)(2009-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
paper illustrates a method##3##4##(1990-7#1)(1992-9#1)(2009-10#1)
paper illustrates the##3##3##(1990-9#1)(1991-3#1)(1994-3#1)
paper illustrates##10##2##(1990-7#1)(1990-9#1)(1991-3#1)(1992-9#1)(1993-1#1)(1994-3#1)(1996-1#1)(1996-3#1)(2009-10#1)(2009-2#1)
paper in the##2##3##(2008-10#1)(2009-8#1)
paper in this issue)]##6##4##(1990-10#1)(1990-2#1)(1991-2#2)(1991-7#1)(1992-12#1)
paper in this journal##2##4##(1990-3#2)
paper in this##12##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#2)(1991-2#2)(1991-7#1)(1992-12#1)(1995-11#1)(2006-10#1)(2010-5#1)
paper in which##2##3##(2009-6#1)(2013-1#1)
paper in##27##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#2)(1991-2#2)(1991-7#1)(1992-12#1)(1995-11#1)(1996-9#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#1)(2009-8#7)(2010-5#1)(2013-1#1)
paper includes##2##2##(2008-3#1)(2013-1#1)
paper indicates that##4##3##(1991-12#1)(1991-9#1)(1992-1#1)(1996-4#1)
paper indicates##5##2##(1991-12#1)(1991-9#1)(1992-1#1)(1996-4#1)(2011-2#1)
paper introduces a##15##3##(1990-8#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-6#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-1#3)(2013-1#2)
paper introduces the##4##3##(1995-9#1)(2011-2#1)(2012-3#2)
paper introduces##30##2##(1990-8#1)(1995-9#1)(1997-8#1)(2005-11#1)(2006-6#1)(2006-7#1)(2008-10#2)(2008-12#1)(2008-2#4)(2008-5#1)(2008-6#2)(2008-7#2)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
paper investigates the effects of##2##5##(2011-1#1)(2012-1#1)
paper investigates the##17##3##(1991-2#1)(1992-2#1)(1993-3#1)(1997-1#1)(2006-12#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2010-2#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)
paper investigates##23##2##(1991-2#1)(1992-2#1)(1993-3#1)(1995-3#1)(1997-1#1)(2006-12#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#2)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-1#2)(2012-12#2)
paper is a review of the##3##6##(2006-7#1)(2008-11#1)(2011-2#1)
paper is a review of##5##5##(2006-2#1)(2006-7#1)(2008-11#1)(2011-12#1)(2011-2#1)
paper is a##13##3##(2006-2#1)(2006-6#1)(2006-7#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)
paper is an attempt to##2##5##(2008-1#1)(2012-2#1)
paper is an attempt##3##4##(2008-1#1)(2012-2#1)(2012-3#1)
paper is an evaluation of##2##5##(1992-2#1)(2012-3#1)
paper is an##15##3##(1992-2#1)(1994-2#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-2#3)(2012-11#1)(2012-2#1)(2012-3#2)
paper is based on a##4##5##(2009-11#1)(2010-8#1)(2011-2#1)(2013-8#1)
paper is based on the##5##5##(2008-12#1)(2008-9#2)(2011-1#1)(2013-1#1)
paper is based on##13##4##(1997-6#1)(2007-10#1)(2008-12#1)(2008-9#2)(2009-11#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#1)
paper is based##15##3##(1997-6#1)(2007-10#1)(2008-12#1)(2008-9#2)(2009-11#1)(2009-2#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
paper is designed##2##3##(2011-1#1)(2012-2#1)
paper is its##2##3##(2009-8#1)(2010-2#1)
paper is not##2##3##(1993-7#1)(1994-1#1)
paper is presented##2##3##(1997-2#1)(2007-3#1)
paper is that##4##3##(1994-11#1)(2008-11#2)(2011-2#1)
paper is the first##2##4##(1990-12#1)(1990-7#1)
paper is the##15##3##(1990-12#1)(1990-7#1)(1996-1#1)(2006-2#1)(2006-6#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-7#1)(2010-10#1)(2010-12#1)(2012-1#1)
paper is to demonstrate the use of##2##7##(2008-11#1)(2009-8#1)
paper is to demonstrate the##3##5##(2008-11#2)(2009-8#1)
paper is to describe the##12##5##(1992-1#1)(1992-2#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-5#1)(2012-1#1)(2012-2#1)
paper is to describe##18##4##(1992-1#1)(1992-2#1)(1997-5#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-5#1)(2008-9#2)(2009-4#1)(2010-11#1)(2012-1#1)(2012-2#1)
paper is to develop and##2##5##(1995-8#1)(2006-5#1)
paper is to evaluate the##4##5##(1991-4#1)(2006-6#1)(2011-2#1)(2013-1#1)
paper is to evaluate##5##4##(1991-4#1)(2006-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
paper is to explore these##2##5##(2008-12#1)(2012-12#1)
paper is to introduce a##2##5##(2009-6#1)(2010-7#1)
paper is to present an overview##3##6##(2010-10#1)(2010-5#1)(2013-1#1)
paper is to present an##4##5##(2007-7#1)(2010-10#1)(2010-5#1)(2013-1#1)
paper is to present the##6##5##(2007-11#1)(2007-7#1)(2007-8#1)(2011-2#2)(2013-1#1)
paper is to present##16##4##(2007-11#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-4#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)
paper is to report the##4##5##(2006-6#1)(2007-11#1)(2013-1#2)
paper is to report##7##4##(2006-6#1)(2007-11#1)(2008-11#2)(2010-3#1)(2013-1#2)
paper is to review the literature on##2##7##(2006-2#1)(2007-6#1)
paper is to review the literature##4##6##(1993-5#1)(2006-2#1)(2007-6#1)(2008-3#1)
paper is to review the##10##5##(1993-5#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-6#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-10#1)(2013-1#1)
paper is to review##16##4##(1993-5#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-6#2)(2008-8#1)(2009-10#2)(2010-12#1)(2011-2#1)(2012-11#1)(2013-1#1)
paper is to##145##3##(1991-4#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-5#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-5#1)(1997-6#1)(2004-10#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-2#5)(2006-5#2)(2006-6#4)(2006-8#2)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#6)(2007-8#4)(2008-1#2)(2008-10#2)(2008-11#10)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#5)(2009-2#1)(2009-4#2)(2009-6#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#8)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#4)(2012-3#4)(2013-1#10)(2013-8#1)
paper is##271##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-4#1)(1992-1#1)(1992-2#2)(1992-3#2)(1993-1#1)(1993-3#1)(1993-5#1)(1993-7#1)(1994-1#1)(1994-11#1)(1994-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#2)(2004-10#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#7)(2006-3#2)(2006-5#2)(2006-6#7)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#5)(2007-12#2)(2007-2#9)(2007-3#2)(2007-4#4)(2007-5#3)(2007-6#3)(2007-7#7)(2007-8#4)(2007-9#2)(2008-1#4)(2008-10#8)(2008-11#13)(2008-12#9)(2008-2#5)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#6)(2009-10#5)(2009-11#1)(2009-2#4)(2009-3#1)(2009-4#2)(2009-6#2)(2009-8#2)(2009-9#2)(2010-10#3)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#4)(2011-1#7)(2011-12#1)(2011-2#12)(2011-3#1)(2012-1#4)(2012-11#4)(2012-12#6)(2012-2#9)(2012-3#10)(2013-1#16)(2013-8#5)
paper it##4##2##(1993-12#1)(1996-12#1)(2007-7#1)(2008-10#1)
paper looks at the##2##4##(2007-2#1)(2008-5#1)
paper looks at##5##3##(1996-3#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-7#1)
paper makes##3##2##(1990-6#1)(2008-1#1)(2008-6#1)
paper making##2##2##(2009-11#1)(2011-2#1)
paper may##3##2##(1995-6#1)(2012-12#2)
paper mill##4##2##(1992-6#1)(2008-10#1)(2008-5#1)(2011-1#1)
paper models the##2##3##(2009-4#1)(2012-2#1)
paper notes##2##2##(1995-9#1)(2006-7#1)
paper of the##2##3##(2008-10#1)(2012-2#1)
paper of##3##2##(2008-10#1)(2012-2#2)
paper offers a##4##3##(1993-12#1)(2007-11#1)(2008-10#1)(2008-2#1)
paper offers an overview of the##2##6##(1993-11#1)(2013-1#1)
paper offers an##5##3##(1993-11#1)(2008-10#1)(2008-9#1)(2010-12#1)(2013-1#1)
paper offers##14##2##(1993-11#1)(1993-12#1)(1997-2#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-9#1)(2010-1#1)(2010-12#1)(2013-1#2)
paper on##16##2##(1995-2#1)(1996-2#1)(2007-9#1)(2008-10#2)(2008-3#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
paper outlines a##4##3##(2008-11#1)(2008-3#1)(2009-12#1)(2009-6#1)
paper outlines some##4##3##(2006-5#1)(2007-11#1)(2007-7#1)(2008-11#1)
paper outlines the##16##3##(1990-10#1)(1993-10#1)(1993-7#1)(1997-2#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#1)(2013-1#1)
paper outlines##34##2##(1990-10#1)(1993-10#1)(1993-7#1)(1997-2#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#6)(2008-12#3)(2008-3#1)(2008-4#2)(2008-7#1)(2009-12#1)(2009-6#1)(2010-8#1)(2010-9#1)(2013-1#1)
paper points##3##2##(2010-8#1)(2013-1#2)
paper poses##2##2##(2006-10#1)(2012-2#1)
paper presented at##2##3##(2008-10#1)(2008-3#1)
paper presented##5##2##(2007-10#2)(2007-8#1)(2008-10#1)(2008-3#1)
paper presents a case of##3##5##(2008-11#1)(2010-12#1)(2011-2#1)
paper presents a case##4##4##(2008-11#1)(2010-12#1)(2011-2#1)(2012-2#1)
paper presents a new##9##4##(1990-9#1)(2007-9#1)(2008-2#2)(2008-6#1)(2009-10#1)(2009-9#1)(2013-1#2)
paper presents a review of the##3##6##(2007-11#1)(2010-1#1)(2010-12#1)
paper presents a review of##4##5##(2007-11#1)(2007-4#1)(2010-1#1)(2010-12#1)
paper presents a set of##2##5##(1996-5#1)(2008-2#1)
paper presents a##95##3##(1990-9#1)(1992-3#1)(1993-4#2)(1993-8#1)(1994-11#1)(1994-6#1)(1995-12#1)(1996-5#1)(1997-3#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-3#1)(2006-4#2)(2006-6#2)(2007-11#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#4)(2008-2#9)(2008-3#1)(2008-5#2)(2008-6#6)(2008-7#2)(2008-9#1)(2009-10#3)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-8#4)(2011-1#1)(2011-2#2)(2012-1#5)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)
paper presents an educational##2##4##(2007-5#1)(2008-12#1)
paper presents an##33##3##(1992-12#1)(1997-4#1)(1997-8#1)(2005-11#1)(2006-1#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#2)(2008-5#2)(2008-7#2)(2009-4#1)(2010-5#1)(2012-1#2)(2012-12#1)(2012-3#1)
paper presents and discusses##2##4##(1991-9#1)(2010-9#1)
paper presents and##5##3##(1991-9#1)(2009-3#1)(2010-9#1)(2013-1#2)
paper presents design##2##3##(2008-10#1)(2012-1#1)
paper presents results of##5##4##(1997-3#1)(2007-11#2)(2007-8#1)(2009-8#1)
paper presents results##8##3##(1992-5#1)(1997-3#1)(2007-11#2)(2007-3#1)(2007-8#1)(2008-6#1)(2009-8#1)
paper presents the case of a##3##6##(2011-12#1)(2012-3#1)(2013-7#1)
paper presents the case of##4##5##(1992-1#1)(2011-12#1)(2012-3#1)(2013-7#1)
paper presents the experience##2##4##(2007-3#1)(2008-6#1)
paper presents the results of a study##2##7##(2007-8#1)(2009-4#1)
paper presents the results of a##6##6##(2007-8#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-4#1)(2011-2#1)
paper presents the results of the##3##6##(1994-4#1)(2007-4#1)(2008-10#1)
paper presents the results of##16##5##(1994-4#1)(2006-11#1)(2007-11#1)(2007-4#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-7#1)(2009-10#1)(2009-4#2)(2011-2#2)
paper presents the results##18##4##(1994-4#1)(2006-11#1)(2007-11#1)(2007-4#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-4#2)(2010-8#1)(2011-2#2)
paper presents the##77##3##(1991-6#1)(1992-1#1)(1992-2#1)(1994-4#1)(1994-5#1)(1995-8#1)(2004-4#1)(2004-7#1)(2006-11#2)(2007-10#1)(2007-11#5)(2007-12#2)(2007-3#2)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#3)(2008-6#2)(2008-7#1)(2008-9#2)(2009-10#3)(2009-4#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#4)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#10)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
paper presents##267##2##(1990-9#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-8#1)(1994-11#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#2)(2004-4#1)(2004-7#1)(2005-11#3)(2006-1#1)(2006-10#3)(2006-11#3)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#3)(2007-1#1)(2007-10#4)(2007-11#12)(2007-12#2)(2007-2#1)(2007-3#3)(2007-4#4)(2007-5#3)(2007-7#3)(2007-8#6)(2007-9#1)(2008-1#4)(2008-10#25)(2008-11#9)(2008-12#3)(2008-2#16)(2008-3#1)(2008-5#4)(2008-6#11)(2008-7#8)(2008-8#1)(2008-9#4)(2009-10#6)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#5)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#8)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#18)(2012-12#4)(2012-2#7)(2012-3#3)(2013-1#10)(2013-7#3)(2013-8#1)
paper proposed a##2##3##(2005-4#1)(2013-8#1)
paper proposes a new##8##4##(2007-9#1)(2008-10#1)(2008-2#3)(2008-6#1)(2009-10#1)(2011-3#1)
paper proposes a##34##3##(1993-5#1)(1994-8#1)(1994-9#1)(1995-6#1)(2006-1#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#6)(2008-6#2)(2009-10#2)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-2#2)(2013-1#3)
paper proposes an overview##2##4##(2007-12#1)(2013-1#1)
paper proposes an##7##3##(2006-10#1)(2007-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-1#1)
paper proposes new##2##3##(2005-11#1)(2008-2#1)
paper proposes that##2##3##(2008-8#1)(2011-2#1)
paper proposes to##2##3##(2010-8#1)(2010-9#1)
paper proposes##49##2##(1992-2#1)(1993-5#1)(1994-8#1)(1994-9#1)(1995-6#1)(2005-11#1)(2006-1#1)(2006-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#7)(2008-6#2)(2008-8#1)(2009-10#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#4)(2012-2#2)(2013-1#4)
paper provide##3##2##(2004-11#1)(2008-6#1)(2008-7#1)
paper provides a brief##10##4##(1996-9#1)(2006-7#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#1)(2013-1#1)
paper provides a framework##2##4##(2007-7#1)(2009-6#1)
paper provides a##27##3##(1991-1#1)(1994-6#1)(1996-9#1)(2005-11#1)(2006-12#1)(2006-7#1)(2007-5#2)(2007-7#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
paper provides an overview of##7##5##(1992-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2011-1#1)(2013-1#1)
paper provides an##10##3##(1992-1#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-7#1)(2011-1#1)(2013-1#1)
paper provides details##2##3##(1995-11#1)(2010-9#1)
paper provides some##2##3##(2008-10#1)(2009-4#1)
paper provides strong evidence that##2##5##(2008-7#1)(2012-3#1)
paper provides the##2##3##(2008-2#1)(2008-7#1)
paper provides useful##2##3##(2005-4#1)(2008-10#1)
paper provides##56##2##(1991-1#1)(1992-1#1)(1994-6#1)(1995-11#1)(1995-4#1)(1996-9#1)(1997-3#1)(2005-11#1)(2005-4#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
paper reflects on the##2##4##(2008-12#1)(2012-3#1)
paper reflects on##4##3##(2008-12#1)(2010-10#1)(2010-9#1)(2012-3#1)
paper reflects##5##2##(2007-4#1)(2008-12#1)(2010-10#1)(2010-9#1)(2012-3#1)
paper regarding##2##2##(2012-12#1)(2013-8#1)
paper report the##3##3##(1992-10#1)(1992-2#1)(2010-12#1)
paper reports a case of##8##5##(1990-10#1)(1990-6#2)(1991-10#1)(1991-5#1)(1992-6#1)(1993-10#1)(2012-1#1)
paper reports a case##9##4##(1990-10#1)(1990-6#2)(1991-10#1)(1991-5#1)(1992-6#1)(1993-10#1)(2008-12#1)(2012-1#1)
paper reports a study##3##4##(1991-5#1)(2008-11#1)(2011-1#1)
paper reports a##27##3##(1990-10#1)(1990-6#4)(1991-10#1)(1991-5#2)(1992-6#1)(1993-10#2)(1995-11#1)(1997-8#1)(2004-1#1)(2005-4#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-1#2)(2011-2#1)(2012-1#1)
paper reports on a##12##4##(2005-11#1)(2006-6#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2010-11#1)(2012-12#1)(2013-8#1)
paper reports on the##21##4##(1990-12#1)(1992-5#1)(1993-5#1)(1994-3#1)(1996-7#1)(2007-1#1)(2007-10#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-2#1)(2008-5#1)(2008-7#1)(2009-4#1)(2012-3#1)
paper reports on##50##3##(1990-12#1)(1990-4#1)(1992-5#1)(1993-5#1)(1994-1#1)(1994-3#1)(1995-1#1)(1996-3#1)(1996-7#1)(2005-11#1)(2005-2#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-4#2)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#4)(2008-12#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-10#2)(2010-11#1)(2012-12#1)(2012-3#2)(2013-8#1)
paper reports that##3##3##(1990-5#1)(1992-7#1)(2006-4#1)
paper reports the case of a##2##6##(1992-6#1)(2008-12#1)
paper reports the results obtained##2##5##(1990-6#1)(2008-10#1)
paper reports the results of a study carried out##2##9##(1993-3#1)(2008-5#1)
paper reports the results of a study##3##7##(1992-5#1)(1993-3#1)(2008-5#1)
paper reports the results of a##8##6##(1991-6#1)(1992-5#1)(1993-3#1)(1994-12#1)(1996-1#1)(2004-10#1)(2004-9#1)(2008-5#1)
paper reports the results of##13##5##(1990-10#1)(1990-6#1)(1991-6#1)(1992-5#1)(1993-3#1)(1994-12#1)(1996-1#1)(2004-10#1)(2004-9#1)(2008-5#1)(2008-6#1)(2008-8#1)(2013-1#1)
paper reports the results##15##4##(1990-10#1)(1990-6#2)(1991-6#1)(1992-5#1)(1993-3#1)(1994-12#1)(1996-1#1)(2004-10#1)(2004-9#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2013-1#1)
paper reports the study of##3##5##(1991-3#1)(2008-10#1)(2008-5#1)
paper reports the use of##5##5##(2008-10#3)(2010-4#1)(2013-1#1)
paper reports the##63##3##(1990-10#1)(1990-12#1)(1990-6#2)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#1)(1991-9#1)(1992-5#1)(1992-6#1)(1993-3#1)(1994-12#2)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-6#1)(2004-10#1)(2004-9#1)(2005-4#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-5#2)(2008-6#3)(2008-8#1)(2009-6#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#4)
paper reports two##3##3##(1992-8#1)(1993-3#1)(2008-5#1)
paper reports##175##2##(1990-10#2)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#2)(1990-6#6)(1991-10#1)(1991-3#1)(1991-4#2)(1991-5#5)(1991-6#1)(1991-9#1)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#2)(1993-12#1)(1993-3#2)(1993-5#1)(1994-1#2)(1994-12#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#2)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-6#1)(1996-7#1)(1997-8#1)(2004-1#1)(2004-10#1)(2004-9#1)(2005-11#1)(2005-2#1)(2005-4#2)(2006-12#1)(2006-4#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#5)(2007-8#1)(2008-1#4)(2008-10#20)(2008-11#13)(2008-12#7)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#3)(2010-11#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#4)(2013-1#4)(2013-8#1)
paper responds to##2##3##(2009-6#1)(2011-2#1)
paper results##2##2##(2006-6#1)(2007-7#1)
paper reveals##2##2##(1996-1#1)(2012-3#1)
paper reviews and discusses##2##4##(1992-6#1)(2008-11#1)
paper reviews and##4##3##(1991-12#1)(1992-6#1)(2008-11#1)(2009-2#1)
paper reviews relevant##2##3##(2005-10#1)(2009-10#1)
paper reviews research##5##3##(2004-12#1)(2006-9#1)(2008-3#1)(2008-7#1)(2010-1#1)
paper reviews the available##7##4##(2006-7#1)(2007-2#1)(2007-7#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-2#1)
paper reviews the current##10##4##(2006-12#1)(2006-8#1)(2007-11#1)(2008-6#1)(2010-12#1)(2011-1#2)(2012-2#1)(2013-1#2)
paper reviews the recent##3##4##(1994-6#1)(2006-10#1)(2010-2#1)
paper reviews the role##2##4##(2006-2#1)(2007-7#1)
paper reviews the situation##2##4##(1995-9#1)(2008-1#1)
paper reviews the##84##3##(1991-1#1)(1992-2#1)(1993-10#1)(1993-3#2)(1994-3#1)(1994-4#1)(1994-6#2)(1995-9#1)(1996-1#1)(2004-2#1)(2004-7#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#4)(2006-11#2)(2006-12#2)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#2)(2008-6#2)(2008-7#5)(2008-8#3)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#4)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#6)(2013-1#4)
paper reviews##152##2##(1990-6#1)(1991-1#1)(1991-12#1)(1992-1#1)(1992-2#1)(1992-4#1)(1992-6#1)(1993-10#1)(1993-3#2)(1994-3#1)(1994-4#1)(1994-6#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#1)(1997-1#1)(1997-7#1)(2004-12#2)(2004-2#1)(2004-7#1)(2005-10#2)(2005-11#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#3)(2007-2#4)(2007-3#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-1#3)(2008-10#9)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#9)(2008-8#4)(2008-9#2)(2009-10#1)(2009-2#1)(2009-7#2)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#3)(2011-2#6)(2011-3#1)(2012-1#2)(2012-11#3)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
paper samples##2##2##(2006-12#1)(2013-1#1)
paper seeks to identify##2##4##(2006-7#1)(2008-11#1)
paper seeks to##5##3##(2006-7#1)(2007-3#1)(2008-11#1)(2008-12#1)(2008-7#1)
paper shares##3##2##(2008-12#1)(2009-4#1)(2013-1#1)
paper sheet phantom##6##3##(2008-2#6)
paper should be##2##3##(2007-4#1)(2008-10#1)
paper should##3##2##(2005-11#1)(2007-4#1)(2008-10#1)
paper show that the##2##4##(1991-9#1)(1993-6#1)
paper show that##3##3##(1991-9#1)(1993-3#1)(1993-6#1)
paper showed that##2##3##(2008-8#1)(2008-9#1)
paper shows how##8##3##(1996-3#1)(2006-7#2)(2007-12#1)(2007-7#1)(2008-7#1)(2009-3#1)(2012-12#1)
paper shows that the##2##4##(2008-10#1)(2008-5#1)
paper shows that##9##3##(1994-2#1)(1994-6#1)(1994-8#1)(1995-3#1)(2008-10#2)(2008-5#1)(2010-5#1)(2011-2#1)
paper shows##23##2##(1994-2#1)(1994-6#2)(1994-8#1)(1995-3#1)(1996-3#1)(2006-2#1)(2006-7#2)(2007-12#1)(2007-7#1)(2008-10#5)(2008-5#1)(2008-7#1)(2009-3#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)
paper some##3##2##(1991-12#1)(1993-10#1)(2008-10#1)
paper stresses##2##2##(1990-4#1)(1992-2#1)
paper studied the effects of##4##5##(2013-8#4)
paper studied the##12##3##(2008-10#1)(2013-8#11)
paper studied##14##2##(2008-10#1)(2013-8#13)
paper substrates##3##2##(2007-12#1)(2012-2#2)
paper such##2##2##(1993-8#1)(2006-12#1)
paper suggests a##4##3##(1993-3#1)(1996-12#1)(1997-8#1)(2008-10#1)
paper suggests that##5##3##(1990-12#1)(1991-2#1)(1991-9#1)(1994-2#1)(2008-11#1)
paper suggests##13##2##(1990-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1993-3#1)(1994-2#1)(1996-12#1)(1997-1#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
paper summarises##3##2##(2007-11#1)(2008-10#2)
paper summarizes the##14##3##(1992-12#1)(1992-4#1)(2006-10#2)(2006-2#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-7#1)(2010-11#1)(2011-2#1)(2013-1#1)
paper summarizes##25##2##(1991-12#1)(1992-1#1)(1992-12#1)(1992-4#1)(2006-10#3)(2006-2#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2009-11#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
paper takes##2##2##(2005-11#1)(2008-11#1)
paper tests##4##2##(1990-6#1)(2008-2#1)(2008-7#1)(2008-8#1)
paper that##13##2##(1993-2#1)(2006-10#2)(2006-3#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-8#1)(2012-12#2)(2012-3#1)
paper the author##3##3##(1995-5#1)(2006-5#1)(2006-6#1)
paper the authors review the##2##5##(1990-2#1)(2006-11#1)
paper the authors review##3##4##(1990-2#1)(2006-11#1)(2006-6#1)
paper the authors##13##3##(1990-2#1)(1993-3#1)(2006-11#1)(2006-2#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-5#1)(2010-9#1)(2012-3#1)
paper the main##2##3##(2006-6#1)(2012-3#1)
paper the##54##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-5#1)(1992-4#1)(1992-9#2)(1993-3#1)(1993-5#1)(1995-1#1)(1995-10#1)(1995-4#1)(1995-5#1)(1996-3#1)(2005-11#3)(2005-4#2)(2006-11#1)(2006-2#2)(2006-5#2)(2006-6#3)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#1)
paper then##3##2##(2008-10#1)(2008-11#1)(2008-6#1)
paper three##2##2##(2008-8#1)(2011-2#1)
paper to##11##2##(1994-5#1)(1995-12#1)(2005-4#1)(2006-12#1)(2007-10#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-7#1)
paper towels##2##2##(2008-11#1)(2008-4#1)
paper used##3##2##(2008-10#1)(2008-8#1)(2012-1#1)
paper uses a##4##3##(1991-3#1)(2012-2#1)(2013-1#2)
paper uses##11##2##(1991-3#1)(1994-9#1)(2008-7#1)(2008-9#3)(2009-7#1)(2012-2#1)(2012-3#1)(2013-1#2)
paper using##4##2##(2005-4#1)(2008-11#1)(2009-11#1)(2013-7#1)
paper was placed in##2##4##(2008-10#1)(2008-5#1)
paper was to assess##2##4##(2007-7#1)(2009-8#1)
paper was to examine##2##4##(2008-4#1)(2011-1#1)
paper was to investigate##3##4##(2006-10#1)(2013-1#2)
paper was to present the##2##5##(2007-7#1)(2008-5#1)
paper was to present##5##4##(2007-7#1)(2007-8#1)(2008-11#1)(2008-5#2)
paper was to show##2##4##(2008-1#1)(2011-2#1)
paper was to verify##2##4##(1991-9#1)(2008-10#1)
paper was to##34##3##(1991-9#3)(1992-2#1)(1992-6#1)(2006-10#2)(2006-5#1)(2006-6#1)(2007-11#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#3)(2009-8#2)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#3)
paper was written##3##3##(1994-3#2)(2006-9#1)
paper was##52##2##(1990-5#1)(1991-9#3)(1992-2#1)(1992-6#1)(1994-3#2)(1994-9#1)(2005-4#1)(2006-10#2)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#2)(2008-5#4)(2009-11#1)(2009-8#2)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#4)
paper wasp##3##2##(2007-12#2)(2008-9#1)
paper wasps##2##2##(2006-8#1)(2008-9#1)
paper we analyze the##2##4##(1990-8#1)(2008-11#1)
paper we are##3##3##(2008-7#1)(2013-1#2)
paper we consider a##2##4##(2012-3#1)(2013-8#1)
paper we consider##4##3##(1996-8#1)(2012-3#1)(2013-8#2)
paper we demonstrated that##3##4##(1991-12#1)(1991-7#1)(1994-3#1)
paper we describe a##7##4##(1990-12#1)(1990-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-1#1)(2012-12#1)
paper we describe##23##3##(1990-12#1)(1990-8#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-12#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)
paper we develop a##4##4##(1993-9#1)(2008-11#1)(2008-4#1)(2011-1#1)
paper we develop##5##3##(1991-11#1)(1993-9#1)(2008-11#1)(2008-4#1)(2011-1#1)
paper we discuss how##2##4##(1997-6#1)(2009-8#1)
paper we discuss##10##3##(1995-9#1)(1997-6#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-8#1)
paper we explore##4##3##(2005-8#1)(2007-12#1)(2007-9#1)(2008-12#1)
paper we give##4##3##(1991-2#1)(2006-10#2)(2009-3#1)
paper we have##8##3##(1991-5#1)(1994-2#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-2#1)(2012-3#1)
paper we introduce a##3##4##(2007-5#1)(2009-2#1)(2013-8#1)
paper we introduce##5##3##(2007-5#1)(2007-6#1)(2009-2#1)(2010-10#1)(2013-8#1)
paper we present a##10##4##(1992-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-9#1)(2010-8#1)(2012-12#1)(2013-1#2)
paper we present data##2##4##(2008-5#1)(2008-7#1)
paper we present##33##3##(1992-2#1)(1992-8#2)(1992-9#1)(1993-5#1)(1994-11#1)(1995-8#1)(1997-3#1)(2004-9#1)(2005-11#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2013-1#3)(2013-8#1)
paper we provide a##2##4##(1996-11#1)(2008-5#1)
paper we provide##3##3##(1996-11#1)(1996-3#1)(2008-5#1)
paper we report##15##3##(1990-11#1)(1991-9#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-11#2)(2008-2#1)(2009-9#1)(2010-11#1)(2012-1#1)(2012-2#1)(2013-1#3)
paper we will review##2##4##(2006-9#1)(2009-12#1)
paper we will##6##3##(2006-9#1)(2008-10#1)(2009-12#1)(2011-1#1)(2012-11#1)(2013-1#1)
paper we##223##2##(1990-11#1)(1990-12#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-5#3)(1993-6#3)(1993-9#2)(1994-11#3)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#2)(1995-2#2)(1995-4#2)(1995-8#4)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#1)(2004-1#1)(2004-9#1)(2005-11#3)(2005-2#1)(2005-8#2)(2006-10#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-9#1)(2007-10#2)(2007-11#4)(2007-12#2)(2007-3#2)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#4)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#9)(2008-11#8)(2008-12#2)(2008-2#6)(2008-3#2)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-10#2)(2010-11#1)(2010-2#1)(2010-5#2)(2010-8#1)(2011-1#6)(2011-12#3)(2011-2#2)(2012-1#4)(2012-11#1)(2012-12#3)(2012-2#9)(2012-3#5)(2013-1#21)(2013-8#7)
paper were##4##2##(1993-6#1)(2008-4#1)(2008-9#1)(2013-1#1)
paper will address##3##3##(1991-12#1)(1994-3#2)
paper will describe##8##3##(1992-12#1)(1995-3#1)(1997-2#1)(2006-11#1)(2007-10#1)(2007-11#1)(2008-8#1)(2010-10#1)
paper will explore the##2##4##(1996-1#1)(2007-8#1)
paper will explore##3##3##(1991-5#1)(1996-1#1)(2007-8#1)
paper will identify##2##3##(2008-11#2)
paper will provide a##4##4##(1994-3#2)(2008-12#1)(2010-10#1)
paper will provide##5##3##(1994-3#2)(2008-12#2)(2010-10#1)
paper will report##2##3##(1994-3#1)(1996-10#1)
paper will show##4##3##(1994-1#2)(1996-1#1)(2010-8#1)
paper will##66##2##(1991-12#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#3)(1994-1#4)(1994-3#6)(1995-3#1)(1996-1#2)(1996-10#1)(1996-2#1)(1997-2#1)(2004-3#1)(2005-9#1)(2006-10#1)(2006-11#2)(2006-12#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#5)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-9#1)(2013-8#1)
paper with##6##2##(1991-8#1)(2005-4#1)(2007-11#1)(2007-8#1)(2009-3#1)(2011-2#1)
paper##4338##1##(1990-1#1)(1990-10#7)(1990-11#7)(1990-12#16)(1990-2#7)(1990-3#7)(1990-4#4)(1990-5#4)(1990-6#15)(1990-7#5)(1990-8#10)(1990-9#6)(1991-1#8)(1991-10#1)(1991-11#4)(1991-12#12)(1991-2#10)(1991-3#16)(1991-4#9)(1991-5#14)(1991-6#7)(1991-7#4)(1991-8#3)(1991-9#11)(1992-1#17)(1992-10#1)(1992-11#2)(1992-12#12)(1992-2#17)(1992-3#14)(1992-4#4)(1992-5#5)(1992-6#13)(1992-7#2)(1992-8#6)(1992-9#16)(1993-1#7)(1993-10#9)(1993-11#4)(1993-12#10)(1993-2#6)(1993-3#15)(1993-4#2)(1993-5#8)(1993-6#13)(1993-7#2)(1993-8#5)(1993-9#6)(1994-1#9)(1994-10#1)(1994-11#11)(1994-12#8)(1994-2#10)(1994-3#22)(1994-4#2)(1994-5#5)(1994-6#12)(1994-7#1)(1994-8#7)(1994-9#10)(1995-1#5)(1995-10#1)(1995-11#12)(1995-12#7)(1995-2#10)(1995-3#6)(1995-4#6)(1995-5#4)(1995-6#8)(1995-7#1)(1995-8#12)(1995-9#12)(1996-1#14)(1996-10#2)(1996-11#9)(1996-12#19)(1996-2#9)(1996-3#19)(1996-4#2)(1996-5#9)(1996-6#5)(1996-7#7)(1996-8#10)(1996-9#4)(1997-1#14)(1997-2#18)(1997-3#14)(1997-4#11)(1997-5#1)(1997-6#9)(1997-7#11)(1997-8#22)(2004-1#2)(2004-10#6)(2004-11#1)(2004-12#6)(2004-2#1)(2004-3#2)(2004-4#2)(2004-7#4)(2004-9#2)(2005-10#9)(2005-11#33)(2005-12#3)(2005-2#3)(2005-3#1)(2005-4#40)(2005-5#2)(2005-6#3)(2005-7#4)(2005-8#9)(2005-9#6)(2006-1#4)(2006-10#39)(2006-11#21)(2006-12#28)(2006-2#28)(2006-3#15)(2006-4#7)(2006-5#30)(2006-6#34)(2006-7#24)(2006-8#9)(2006-9#9)(2007-1#9)(2007-10#36)(2007-11#54)(2007-12#58)(2007-2#35)(2007-3#22)(2007-4#33)(2007-5#26)(2007-6#14)(2007-7#52)(2007-8#38)(2007-9#17)(2008-1#63)(2008-10#482)(2008-11#185)(2008-12#106)(2008-2#173)(2008-3#61)(2008-4#29)(2008-5#89)(2008-6#66)(2008-7#90)(2008-8#29)(2008-9#59)(2009-1#1)(2009-10#32)(2009-11#19)(2009-12#13)(2009-2#25)(2009-3#19)(2009-4#35)(2009-5#11)(2009-6#29)(2009-7#21)(2009-8#30)(2009-9#21)(2010-1#16)(2010-10#16)(2010-11#19)(2010-12#33)(2010-2#30)(2010-3#16)(2010-4#23)(2010-5#19)(2010-6#7)(2010-7#10)(2010-8#56)(2010-9#15)(2011-1#72)(2011-12#15)(2011-2#102)(2011-3#8)(2012-1#83)(2012-11#18)(2012-12#52)(2012-2#95)(2012-3#77)(2012-9#1)(2013-1#209)(2013-7#28)(2013-8#74)
paper&gt##4##1##(2008-10#4)
paper's focus##2##2##(1992-6#1)(2008-12#1)
paper's##6##1##(1992-6#1)(2008-12#1)(2008-2#3)(2010-8#1)
paper)##7##1##(1990-2#1)(1990-6#2)(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
paper-and-pencil##2##1##(1996-3#1)(2009-4#1)
paper-based##4##1##(2008-10#1)(2009-11#1)(2009-9#1)(2013-1#1)
paperback##4##1##(2007-2#4)
paperless and filmless&quot##4##3##(2008-10#4)
paperless##5##1##(2008-10#4)(2010-5#1)
papers addressed##2##2##(1996-1#1)(2006-10#1)
papers and posters presented##3##4##(1994-6#1)(2008-10#2)
papers and##12##2##(1994-6#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#2)(2012-3#1)
papers are available##2##3##(1993-12#1)(2008-6#1)
papers are critically##2##3##(2007-8#1)(2008-3#1)
papers are reviewed which concern surgery whilst taking##2##8##(2008-8#2)
papers are reviewed##4##3##(1994-11#1)(2008-8#3)
papers are tabulated##33##3##(2007-8#33)
papers are##50##2##(1993-12#1)(1994-11#1)(2005-8#1)(2007-3#2)(2007-8#36)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#3)(2010-12#1)(2011-2#1)(2012-2#1)
papers as##3##2##(2007-2#1)(2010-12#1)(2012-3#1)
papers at the##2##3##(1997-8#1)(2008-12#1)
papers by##2##2##(1994-11#1)(2008-12#1)
papers concerning##2##2##(1994-6#1)(2008-5#1)
papers delivered at##2##3##(2009-2#2)
papers describe##2##2##(2006-3#1)(2008-10#1)
papers describing##3##2##(2006-10#2)(2008-2#1)
papers detailing##2##2##(1996-2#1)(2008-10#1)
papers discuss##2##2##(2006-10#1)(2009-4#1)
papers examined##2##2##(2013-1#2)
papers focused on##2##3##(2006-10#1)(2009-8#1)
papers from the##3##3##(2005-8#1)(2008-7#1)(2011-2#1)
papers from##7##2##(2005-8#1)(2008-3#2)(2008-7#2)(2009-8#1)(2011-2#1)
papers have addressed##2##3##(1994-9#1)(1995-3#1)
papers have been published##3##4##(1993-6#1)(2008-4#1)(2010-8#1)
papers have been written##2##4##(1997-6#1)(2008-11#1)
papers have been##8##3##(1993-6#1)(1997-6#1)(2005-7#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-4#1)(2010-8#1)
papers have reported##2##3##(2008-7#1)(2010-12#1)
papers have##14##2##(1993-6#1)(1994-9#1)(1995-3#1)(1997-6#1)(2005-7#1)(2006-10#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-8#2)
papers in this issue##2##4##(2007-8#2)
papers in this volume##2##4##(1997-8#1)(2008-2#1)
papers in this##8##3##(1997-8#2)(2007-11#1)(2007-8#3)(2008-2#1)(2010-7#1)
papers in##13##2##(1992-6#1)(1994-3#1)(1996-1#1)(1997-8#2)(2007-11#1)(2007-8#3)(2008-2#1)(2008-7#1)(2008-9#1)(2010-7#1)
papers is##3##2##(2007-3#1)(2008-2#1)(2011-2#1)
papers of##2##2##(2007-8#1)(2008-10#1)
papers on a##2##3##(2007-9#1)(2011-1#1)
papers on the##6##3##(2006-10#1)(2006-4#1)(2008-3#2)(2009-10#1)(2009-3#1)
papers on##21##2##(1996-1#1)(1997-8#1)(2006-10#2)(2006-4#1)(2006-9#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2009-10#1)(2009-3#1)(2011-1#1)(2012-3#1)
papers presented at the##12##4##(2008-10#10)(2008-2#1)(2010-3#1)
papers presented the best evidence to answer the clinical question##5##10##(2007-8#5)
papers presented the##6##3##(2007-3#1)(2007-8#5)
papers presented##19##2##(2005-7#1)(2007-3#1)(2007-8#5)(2008-10#10)(2008-2#1)(2010-3#1)
papers published from##2##3##(2008-8#1)(2012-2#1)
papers published in the##6##4##(2005-7#1)(2006-10#1)(2008-10#1)(2008-5#2)(2008-7#1)
papers published in##9##3##(2005-7#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-5#2)(2008-7#1)(2013-1#2)
papers published##25##2##(2005-7#1)(2006-10#5)(2006-2#1)(2007-2#6)(2008-10#2)(2008-5#2)(2008-7#1)(2008-8#2)(2010-12#1)(2012-2#1)(2013-1#3)
papers related to the##4##4##(2008-3#1)(2013-1#2)(2013-8#1)
papers related to##5##3##(2007-3#1)(2008-3#1)(2013-1#2)(2013-8#1)
papers relating to##2##3##(2005-8#1)(2006-10#1)
papers report##4##2##(2006-10#1)(2007-8#1)(2007-9#1)(2013-8#1)
papers reported##2##2##(2008-10#1)(2013-1#1)
papers represented the best evidence on the subject and##2##9##(2007-8#2)
papers represented the best evidence to answer the##2##8##(2007-8#2)
papers represented the best evidence##4##5##(2007-8#4)
papers that describe##2##3##(2008-3#2)
papers that have##2##3##(2006-10#2)
papers that were##2##3##(1993-12#1)(2008-5#1)
papers that##14##2##(1993-12#1)(2006-10#2)(2007-2#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2009-4#1)(2013-1#1)(2013-7#1)(2013-8#1)
papers to##3##2##(2007-2#1)(2008-11#1)(2012-2#1)
papers were found from Medline##2##5##(2007-8#2)
papers were found from##4##4##(2007-8#4)
papers were found in Medline##2##5##(2007-8#2)
papers were found using the reported search##39##7##(2007-8#39)
papers were found##48##3##(2007-8#47)(2013-1#1)
papers were identified on Medline##2##5##(2007-8#2)
papers were identified using the below mentioned search##5##8##(2007-8#5)
papers were identified using the reported search of which##2##9##(2007-8#2)
papers were identified using the reported search##3##7##(2007-8#3)
papers were identified using the##9##5##(2007-8#9)
papers were identified##14##3##(2007-8#13)(2013-8#1)
papers were presented##2##3##(2005-8#2)
papers were published##2##3##(1997-8#1)(2006-10#1)
papers were##72##2##(1997-8#1)(2005-8#2)(2006-10#1)(2007-8#60)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#2)(2013-8#3)
papers will##2##2##(2008-10#1)(2012-3#1)
papers##406##1##(1990-12#2)(1991-5#1)(1992-6#1)(1993-12#2)(1993-4#1)(1993-6#3)(1994-11#2)(1994-3#1)(1994-6#3)(1994-9#1)(1995-3#1)(1995-4#1)(1996-1#4)(1996-2#2)(1997-6#2)(1997-8#5)(2004-4#1)(2005-10#1)(2005-11#1)(2005-7#8)(2005-8#6)(2006-10#23)(2006-2#1)(2006-3#1)(2006-4#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#11)(2007-3#7)(2007-4#1)(2007-6#2)(2007-8#115)(2007-9#3)(2008-1#3)(2008-10#33)(2008-11#5)(2008-12#5)(2008-2#11)(2008-3#17)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#8)(2008-8#6)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#4)(2009-8#4)(2009-9#1)(2010-12#6)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#11)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#8)(2013-1#19)(2013-7#4)(2013-8#8)
paperwork##5##1##(1991-10#1)(1991-9#1)(1996-3#1)(2010-10#1)(2013-8#1)
papilla Vateri##2##2##(2006-6#1)(2008-9#1)
papilla and##3##2##(2007-9#1)(2008-5#1)(2013-7#1)
papilla formation in##2##3##(2008-10#2)
papilla formation##7##2##(2008-10#7)
papilla of##3##2##(2006-6#1)(2008-5#1)(2011-2#1)
papilla##36##1##(1990-3#1)(1991-9#1)(1995-4#1)(2006-2#2)(2006-6#3)(2007-5#4)(2007-9#2)(2008-10#9)(2008-3#1)(2008-5#3)(2008-9#1)(2009-2#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-2#2)(2013-7#1)(2013-8#1)
papilla)##2##1##(2011-2#2)
papillae formed##2##2##(2008-10#2)
papillae in##2##2##(2008-10#2)
papillae of the##2##3##(2008-10#1)(2011-2#1)
papillae of##5##2##(2007-3#1)(2008-10#2)(2008-5#1)(2011-2#1)
papillae was##2##2##(2008-10#2)
papillae were##4##2##(1993-12#1)(2005-11#2)(2008-5#1)
papillae##46##1##(1991-3#1)(1993-12#3)(1997-4#1)(2005-11#2)(2007-3#3)(2007-6#1)(2008-10#17)(2008-4#1)(2008-5#11)(2011-2#5)(2012-12#1)
papillary RCC##2##2##(2008-6#2)
papillary adenocarcinoma##4##2##(1992-2#3)(1994-9#1)
papillary adenomas and##2##3##(2011-2#2)
papillary adenomas##3##2##(1990-7#1)(2011-2#2)
papillary and##4##2##(1992-8#1)(1995-5#1)(2008-6#1)(2012-1#1)
papillary bleeding index##2##3##(2011-2#2)
papillary blood flow##3##3##(2011-2#3)
papillary cancer##2##2##(1995-5#1)(2008-2#1)
papillary carcinoma of the male breast##2##6##(1992-2#2)
papillary carcinoma of the##4##4##(1992-2#2)(1996-6#1)(2012-2#1)
papillary carcinoma of##5##3##(1992-2#2)(1996-6#1)(2007-8#1)(2012-2#1)
papillary carcinoma was##2##3##(1990-6#1)(2011-2#1)
papillary carcinoma##22##2##(1990-6#1)(1990-9#1)(1992-2#2)(1996-6#1)(2005-12#1)(2006-10#1)(2007-6#2)(2007-8#1)(2008-9#1)(2009-12#1)(2011-1#2)(2011-12#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
papillary carcinomas##2##2##(2013-8#2)
papillary conjunctivitis##3##2##(2005-11#1)(2007-11#2)
papillary dermal##2##2##(2008-5#1)(2010-6#1)
papillary dermis##5##2##(2010-6#4)(2012-3#1)
papillary distortions##2##2##(1993-2#2)
papillary fibroelastoma with##2##3##(2007-10#1)(2009-4#1)
papillary fibroelastoma##10##2##(2007-10#2)(2007-8#5)(2008-5#1)(2009-4#1)(2009-9#1)
papillary mucinous neoplasm##2##3##(2012-2#1)(2013-1#1)
papillary mucinous##6##2##(2006-10#1)(2008-3#1)(2012-2#2)(2012-3#1)(2013-1#1)
papillary muscle##10##2##(1997-7#2)(2007-8#3)(2008-10#2)(2009-5#2)(2012-2#1)
papillary muscles##5##2##(1995-12#3)(2007-8#1)(2009-4#1)
papillary necrosis causing bilateral ureteric obstruction##2##6##(2008-10#2)
papillary serous cystadenocarcinoma##2##3##(2012-2#2)
papillary thyroid cancer##5##3##(1996-5#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-1#1)
papillary thyroid carcinoma (PTC)##4##4##(2007-12#1)(2009-12#1)(2009-5#1)(2012-2#1)
papillary thyroid carcinoma and##2##4##(2013-1#1)(2013-8#1)
papillary thyroid carcinoma in a##3##5##(1990-6#1)(2012-2#1)(2013-1#1)
papillary thyroid carcinoma in children and##2##6##(2012-3#2)
papillary thyroid carcinoma in##5##4##(1990-6#1)(2012-2#1)(2012-3#2)(2013-1#1)
papillary thyroid carcinoma##23##3##(1990-4#3)(1990-6#2)(1993-8#1)(2007-11#1)(2007-12#2)(2009-12#1)(2009-5#2)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#1)
papillary thyroid carcinoma]##2##3##(2008-10#1)(2013-8#1)
papillary thyroid##33##2##(1990-4#3)(1990-6#2)(1993-8#1)(1996-5#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-5#1)(2009-12#1)(2009-5#2)(2010-12#1)(2011-1#1)(2012-2#2)(2012-3#3)(2013-1#8)(2013-8#2)
papillary transitional cell carcinoma##2##4##(1990-6#1)(2008-4#1)
papillary tumors##2##2##(1990-7#1)(2006-12#1)
papillary type##2##2##(2006-1#1)(2006-10#1)
papillary##160##1##(1990-11#1)(1990-4#3)(1990-6#4)(1990-7#2)(1990-9#2)(1991-10#1)(1991-2#1)(1992-2#5)(1992-8#1)(1993-2#3)(1993-8#1)(1994-9#1)(1995-12#4)(1995-5#2)(1995-8#2)(1996-5#1)(1996-6#1)(1997-7#2)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-12#3)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#10)(2007-9#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#3)(2008-9#1)(2009-12#2)(2009-4#2)(2009-5#4)(2009-9#1)(2010-12#3)(2010-6#5)(2011-1#3)(2011-12#4)(2011-2#10)(2012-1#1)(2012-2#9)(2012-3#7)(2013-1#11)(2013-7#4)(2013-8#4)
papillary-cystic tumor##2##2##(1992-5#2)
papilledema and##2##2##(2009-8#2)
papilledema in a patient with##2##5##(2008-5#2)
papilledema##9##1##(2008-5#4)(2009-8#3)(2011-1#1)(2012-12#1)
papilliferum##6##1##(2007-7#1)(2012-2#4)(2012-3#1)
papilloferous##2##1##(2008-11#2)
papilloma and##5##2##(1994-7#1)(2010-7#3)(2012-2#1)
papilloma at##2##2##(2008-9#1)(2010-7#1)
papilloma formation in response to skin tumor promotion in transgenic mice overexpressing the human ornithine decarboxylase gene##2##17##(1992-8#2)
papilloma formation in##3##3##(1992-8#2)(1993-9#1)
papilloma in a 12-year-old girl##2##5##(2008-10#2)
papilloma in##6##2##(2008-10#2)(2008-7#1)(2008-9#1)(2010-7#1)(2012-2#1)
papilloma is##4##2##(2010-7#4)
papilloma of the nasal cavity##2##5##(1993-4#2)
papilloma of the##7##3##(1993-4#2)(2008-10#1)(2008-9#4)
papilloma virus (HPV) is##2##4##(2008-3#1)(2010-7#1)
papilloma virus (HPV)##7##3##(1991-2#2)(1996-12#1)(2008-3#1)(2009-12#1)(2010-7#1)(2011-2#1)
papilloma virus and##2##3##(2008-11#1)(2008-7#1)
papilloma virus infection##3##3##(1991-2#1)(2011-1#1)(2013-1#1)
papilloma virus##21##2##(1990-7#1)(1991-2#3)(1992-12#1)(1994-8#2)(1996-12#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)(2010-7#1)(2011-1#2)(2011-2#2)(2013-1#1)
papilloma were##4##2##(2008-9#3)(2013-8#1)
papilloma yield##2##2##(1990-5#2)
papilloma##76##1##(1990-5#2)(1990-7#1)(1991-2#9)(1992-12#2)(1992-8#2)(1993-4#2)(1993-9#1)(1994-7#2)(1994-8#2)(1996-12#1)(2006-10#1)(2006-5#1)(2007-12#3)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#9)(2009-12#1)(2010-12#1)(2010-7#14)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-8#1)
papillomas at the site of application in##3##7##(2008-9#3)
papillomas at##4##2##(2008-9#4)
papillomas in##5##2##(1992-2#1)(1995-9#1)(2008-9#1)(2010-7#1)(2013-1#1)
papillomas of the skin at the site of dermal application##2##10##(2008-9#2)
papillomas of the##7##3##(2008-10#1)(2008-2#1)(2008-9#4)(2010-7#1)
papillomas per mouse##2##3##(1990-5#1)(1990-6#1)
papillomas per##3##2##(1990-5#1)(1990-6#1)(1992-8#1)
papillomas##35##1##(1990-5#5)(1990-6#1)(1992-2#1)(1992-8#2)(1993-2#4)(1995-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-9#10)(2010-7#6)(2013-1#2)
papillomatosis##4##1##(2007-7#1)(2012-1#1)(2013-1#1)(2013-8#1)
papillomavirus (BPV)##2##2##(1992-5#1)(2007-2#1)
papillomavirus (HPV) infection is##3##4##(2007-11#1)(2011-2#2)
papillomavirus (HPV) infection##10##3##(1992-2#1)(1992-3#1)(2007-11#1)(2008-2#1)(2011-2#5)(2012-2#1)
papillomavirus (HPV)##27##2##(1990-10#1)(1992-2#1)(1992-3#1)(1992-9#1)(1996-7#1)(1997-4#1)(1997-7#2)(2007-11#1)(2008-2#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
papillomavirus DNA##2##2##(1994-8#1)(2011-2#1)
papillomavirus E2 protein##3##3##(1997-2#2)(2012-12#1)
papillomavirus in##4##2##(1993-9#1)(2006-10#1)(2012-12#1)(2013-7#1)
papillomavirus infection and##5##3##(1994-2#2)(2007-11#1)(2012-2#1)(2013-7#1)
papillomavirus infection##14##2##(1992-6#1)(1994-2#2)(1994-4#1)(2007-11#1)(2007-4#1)(2008-4#1)(2010-5#1)(2010-7#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
papillomavirus type 16 (HPV-16)##2##4##(1993-9#1)(1995-2#1)
papillomavirus type 16##9##3##(1990-5#2)(1993-12#1)(1993-9#1)(1995-2#2)(2006-10#3)
papillomavirus type##13##2##(1990-10#1)(1990-5#2)(1993-12#1)(1993-9#1)(1995-2#2)(1997-4#1)(2006-10#3)(2007-2#1)(2008-4#1)
papillomavirus vaccine##6##2##(2006-10#2)(2008-10#1)(2008-11#1)(2011-12#1)(2013-1#1)
papillomavirus##121##1##(1990-10#2)(1990-5#2)(1991-7#1)(1991-9#2)(1992-2#2)(1992-3#3)(1992-5#2)(1992-6#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-9#2)(1994-1#2)(1994-2#2)(1994-4#1)(1994-8#2)(1995-2#2)(1996-1#1)(1996-4#1)(1996-7#1)(1997-2#2)(1997-4#3)(1997-7#2)(2006-10#17)(2006-11#1)(2007-11#4)(2007-12#2)(2007-2#2)(2007-4#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#3)(2008-9#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-7#3)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#12)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#1)
papillomaviruses (HPVs)##3##2##(1991-9#1)(2007-12#1)(2011-1#1)
papillomaviruses are##2##2##(2007-11#1)(2008-4#1)
papillomaviruses in##2##2##(1993-3#1)(1997-7#1)
papillomaviruses##19##1##(1991-9#1)(1993-3#1)(1994-8#1)(1997-7#1)(2006-10#5)(2007-11#2)(2007-12#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-7#1)
papillosphincterotomy##2##1##(1990-5#1)(2006-6#1)
papillotomy and##3##2##(1991-3#1)(1991-4#2)
papillotomy##13##1##(1991-12#2)(1991-3#2)(1991-4#2)(1993-5#1)(1997-8#3)(2007-5#1)(2010-12#1)(2011-2#1)
papulans##7##1##(2008-10#7)
papular and dome-shaped##2##3##(2006-12#2)
papular rash##2##2##(2007-2#1)(2007-8#1)
papular##9##1##(2006-12#5)(2007-2#1)(2007-8#2)(2010-6#1)
papule with##2##2##(2007-7#2)
papule##3##1##(2007-7#2)(2009-9#1)
papules and nodules##2##3##(2005-11#1)(2011-1#1)
papules and##9##2##(2005-11#2)(2006-8#1)(2007-7#1)(2009-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-8#1)
papules in##3##2##(2007-7#1)(2011-2#1)(2012-3#1)
papules of##3##2##(2005-11#1)(2013-8#2)
papules on the##3##3##(2006-10#1)(2010-6#1)(2013-8#1)
papules on##6##2##(2005-11#1)(2006-10#1)(2007-7#2)(2010-6#1)(2013-8#1)
papules were##2##2##(2007-7#1)(2007-8#1)
papules with##2##2##(2007-8#1)(2013-8#1)
papules##41##1##(2005-11#6)(2006-10#2)(2006-8#1)(2007-11#1)(2007-7#9)(2007-8#2)(2009-2#1)(2010-6#8)(2011-1#1)(2011-2#3)(2012-3#2)(2013-8#5)
papulonecrotic tuberculids of the glans penis##2##6##(2007-7#2)
papulonecrotic tuberculids##3##2##(2007-7#3)
papulonecrotic##4##1##(2005-11#1)(2007-7#3)
papulopustular##2##1##(1997-8#1)(2010-5#1)
papulosis##4##1##(1994-4#1)(1995-4#1)(2005-11#1)(2011-1#1)
papyraceous##3##1##(2004-10#1)(2010-8#2)
par des##5##2##(2011-2#2)(2012-2#1)(2013-1#2)
par la suite##2##3##(2012-2#2)
par la##4##2##(2012-2#4)
par le##5##2##(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
par les##3##2##(2008-3#1)(2008-5#2)
par rapport à##2##3##(2011-2#1)(2013-1#1)
par une##2##2##(2012-2#1)(2013-1#1)
par voie##3##2##(2011-2#1)(2013-1#2)
par with other##2##3##(2010-12#1)(2011-1#1)
par with##7##2##(1993-1#1)(2008-1#1)(2008-11#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-2#1)
par##52##1##(1990-4#1)(1993-1#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#7)(2008-6#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-2#13)(2013-1#13)
parA gene##2##2##(2013-1#2)
parA##3##1##(1990-3#1)(2013-1#2)
parC##3##1##(2011-2#3)
para 1##3##2##(1994-12#1)(2012-2#1)(2013-8#1)
para position##5##2##(1994-5#1)(1997-1#1)(2005-4#1)(2008-10#1)(2013-1#1)
para##22##1##(1990-12#1)(1992-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1997-1#1)(2005-4#1)(2005-5#1)(2006-4#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-11#1)(2009-2#1)(2010-7#1)(2012-11#1)(2012-2#2)(2013-1#1)(2013-8#1)
para- and##5##2##(1993-12#1)(2006-5#2)(2007-11#2)
para-##7##1##(1993-12#1)(1993-8#1)(2006-5#2)(2007-11#3)
para-Cl-phenylazo-R-acid##5##1##(2008-10#5)
para-acrosomal bodies##2##2##(2008-7#2)
para-anal##2##1##(1997-8#1)(2008-10#1)
para-aortic lymph nodes##2##3##(2007-7#1)(2011-1#1)
para-aortic##8##1##(2007-7#1)(2008-2#1)(2008-6#1)(2009-11#2)(2011-1#1)(2011-12#1)(2013-1#1)
para-esophageal bronchogenic##2##2##(2007-8#2)
para-phenylenediamine (PPD)##2##2##(2006-12#1)(2010-5#1)
para-position##2##1##(1996-1#1)(2009-11#1)
para-substituted phenols##3##2##(2008-10#3)
para-substituted##8##1##(1994-5#1)(1997-4#1)(1997-7#1)(2008-10#4)(2009-2#1)
paraaortic splanchnopleura##4##2##(1995-1#4)
paraaortic##7##1##(1991-3#1)(1994-2#2)(1995-1#4)
paraben##6##1##(1992-2#2)(2007-8#3)(2008-5#1)
parabens in##2##2##(2007-8#1)(2008-10#1)
parabens was##2##2##(2008-5#2)
parabens##13##1##(2007-8#4)(2008-10#5)(2008-5#4)
parable##2##1##(2006-7#1)(2012-10#1)
parabolic elements##4##2##(2005-10#4)
parabolic flight##2##2##(2009-9#2)
parabolic mirror##2##2##(2007-12#1)(2008-3#1)
parabolic mirrors##2##2##(2008-3#2)
parabolic quantum##2##2##(2008-2#2)
parabolic transitional taper##2##3##(2008-2#2)
parabolic##56##1##(1991-10#1)(1991-9#1)(1993-4#1)(2005-10#4)(2007-11#2)(2007-12#5)(2008-1#1)(2008-10#1)(2008-2#18)(2008-3#11)(2008-5#1)(2008-7#1)(2009-9#4)(2012-12#2)(2013-8#3)
parabolic-index##3##1##(2008-2#2)(2008-3#1)
paraboliclike quantum##2##2##(2008-2#2)
paraboliclike##3##1##(2008-2#3)
paraboloid##4##1##(2008-2#2)(2008-3#2)
parabrachial nuclei##2##2##(1992-10#2)
parabrachial nucleus##9##2##(1991-11#1)(1993-12#4)(1997-8#1)(2007-10#2)(2009-10#1)
parabrachial region##3##2##(1993-9#2)(1996-9#1)
parabrachial##16##1##(1991-11#1)(1992-10#2)(1993-12#4)(1993-9#2)(1995-7#1)(1996-9#1)(1997-8#1)(2007-10#2)(2009-10#2)
parabuchneri##2##1##(2012-11#2)
paracardiac##2##1##(2007-8#1)(2009-9#1)
paracaval##2##1##(2011-2#2)
paracellular barrier##3##2##(1994-6#2)(2009-8#1)
paracellular permeability##4##2##(1994-6#2)(1995-1#1)(2008-11#1)
paracellular##10##1##(1994-6#4)(1995-1#2)(2006-10#1)(2008-11#1)(2008-7#1)(2009-8#1)
paracentesis for##3##2##(2005-11#1)(2007-12#1)(2007-5#1)
paracentesis##14##1##(1995-5#1)(2005-11#1)(2006-8#1)(2007-12#2)(2007-5#1)(2007-9#1)(2008-12#1)(2008-5#2)(2009-8#2)(2013-1#2)
paracentral##4##1##(1991-12#2)(2007-9#1)(2008-2#1)
paracetamol (1##3##2##(1990-8#2)(1995-11#1)
paracetamol (acetaminophen)##5##2##(1990-2#1)(2007-11#3)(2008-10#1)
paracetamol administration##2##2##(2008-4#2)
paracetamol alone##4##2##(1990-10#4)
paracetamol and##13##2##(1990-10#2)(1990-8#1)(2008-10#5)(2008-4#4)(2010-12#1)
paracetamol are##2##2##(1995-11#1)(2008-10#1)
paracetamol by##3##2##(2008-10#3)
paracetamol concentration##3##2##(1993-7#1)(2008-10#2)
paracetamol for##3##2##(1995-11#1)(1995-3#1)(1996-4#1)
paracetamol gel##2##2##(2010-3#2)
paracetamol has##2##2##(1990-2#1)(1995-11#1)
paracetamol in pharmaceutical formulations using##2##5##(2008-10#2)
paracetamol in pharmaceutical formulations##4##4##(2008-10#4)
paracetamol in the##2##3##(1996-4#1)(2008-10#1)
paracetamol in##17##2##(1995-11#1)(1996-4#2)(2008-10#14)
paracetamol was##5##2##(1990-2#1)(2008-10#3)(2010-3#1)
paracetamol##129##1##(1990-10#7)(1990-2#5)(1990-3#1)(1990-8#5)(1991-7#1)(1991-9#1)(1993-2#1)(1993-5#1)(1993-7#2)(1995-11#9)(1995-3#1)(1995-5#1)(1995-7#2)(1996-11#1)(1996-4#5)(1997-5#1)(2005-11#3)(2006-10#1)(2006-2#1)(2007-11#3)(2007-2#2)(2007-8#2)(2008-10#51)(2008-4#11)(2009-6#1)(2010-12#1)(2010-3#5)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
paracetamol-induced fulminant hepatic failure##2##4##(1990-6#2)
paracetamol-induced##3##1##(1990-6#2)(2010-12#1)
paracetamol-sobrerol showed a##2##3##(1990-10#2)
paracetamol-sobrerol##4##1##(1990-10#4)
paracetamol-treated slices##6##2##(1996-4#6)
paraclinical##8##1##(2007-8#1)(2007-9#1)(2009-7#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-8#1)
paracoccidioidin##2##1##(2008-5#2)
paracoccidioidomycosis##6##1##(2007-7#1)(2008-5#5)
paraconfusus##3##1##(1995-8#3)
paracrine actions##3##2##(2007-11#2)(2008-4#1)
paracrine agents##2##2##(2006-10#2)
paracrine and autocrine mechanisms##2##4##(1991-7#1)(2011-2#1)
paracrine and autocrine##7##3##(1991-7#1)(1996-3#1)(2006-11#1)(2007-9#2)(2008-5#1)(2011-2#1)
paracrine and##8##2##(1991-7#1)(1996-3#1)(2006-11#1)(2007-9#2)(2008-4#1)(2008-5#1)(2011-2#1)
paracrine effects##7##2##(1990-3#1)(1994-9#1)(2006-10#1)(2012-12#2)(2013-1#2)
paracrine factor##3##2##(1994-11#1)(1994-3#1)(2010-10#1)
paracrine factors##6##2##(1994-9#1)(1996-4#1)(2006-11#2)(2008-9#1)(2011-1#1)
paracrine fashion##6##2##(1990-11#1)(1990-4#1)(1991-5#1)(1994-11#1)(2006-12#1)(2013-8#1)
paracrine growth factors##2##3##(1992-9#1)(2008-6#1)
paracrine manner##6##2##(1991-10#1)(2008-4#2)(2008-5#2)(2013-1#1)
paracrine mechanisms##3##2##(1994-9#1)(2006-10#1)(2012-1#1)
paracrine mediator##3##2##(1991-11#1)(1994-3#1)(1997-5#1)
paracrine or autocrine##3##3##(1995-12#1)(1996-3#2)
paracrine pathways##3##2##(2006-10#2)(2012-7#1)
paracrine regulation in##2##3##(2010-12#1)(2013-7#1)
paracrine regulators of##2##3##(1992-9#1)(2006-10#1)
paracrine signaling##2##2##(2008-4#1)(2008-7#1)
paracrine signalling##2##2##(1995-8#1)(2008-4#1)
paracrine##97##1##(1990-11#1)(1990-3#1)(1990-4#1)(1991-10#1)(1991-11#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-6#2)(1992-9#3)(1993-3#1)(1993-8#1)(1994-11#2)(1994-3#2)(1994-8#1)(1994-9#5)(1995-12#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-3#3)(1996-4#1)(1996-5#2)(1997-5#1)(2006-1#1)(2006-10#8)(2006-11#4)(2006-12#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-9#2)(2008-4#9)(2008-5#3)(2008-6#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-9#3)(2010-10#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-7#1)(2013-1#7)(2013-7#1)(2013-8#1)
paracrystallin##2##1##(2012-11#2)
paracrystalline inclusions##2##2##(2007-12#1)(2008-7#1)
paracrystalline##3##1##(2007-12#1)(2008-10#1)(2008-7#1)
paradigm and##9##2##(1993-6#1)(2008-11#1)(2008-12#1)(2008-2#1)(2010-10#1)(2010-2#1)(2012-11#1)(2012-12#1)(2013-7#1)
paradigm applied##2##2##(1997-2#1)(2007-11#1)
paradigm as a##2##3##(2008-10#1)(2012-2#1)
paradigm as it##2##3##(2010-4#1)(2012-2#1)
paradigm as##4##2##(2008-10#1)(2010-4#1)(2012-2#2)
paradigm change##2##2##(1994-12#1)(2010-4#1)
paradigm for clinical##2##3##(1993-2#1)(2013-8#1)
paradigm for studying##2##3##(1996-3#1)(2008-11#1)
paradigm for the##2##3##(1995-8#1)(2009-11#1)
paradigm for understanding##3##3##(1993-9#1)(2008-3#1)(2010-4#1)
paradigm for##56##2##(1993-1#1)(1993-2#1)(1993-9#2)(1994-11#1)(1994-6#1)(1995-8#1)(1996-11#1)(1996-3#2)(1997-7#1)(2005-9#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#4)(2008-5#1)(2008-8#1)(2009-10#1)(2009-11#3)(2009-12#2)(2010-10#1)(2010-12#2)(2010-4#2)(2011-1#1)(2011-2#5)(2011-9#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#4)(2013-8#1)
paradigm has##3##2##(2006-10#1)(2007-8#1)(2008-4#1)
paradigm in mice##2##3##(1991-5#1)(2013-7#1)
paradigm in the##3##3##(1991-11#1)(1996-2#1)(2012-1#1)
paradigm in which##2##3##(2004-11#1)(2006-12#1)
paradigm in##15##2##(1991-11#1)(1991-5#1)(1996-2#1)(1997-5#1)(2004-11#1)(2005-11#1)(2006-12#1)(2008-4#1)(2010-5#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
paradigm is##5##2##(1993-3#1)(2006-6#1)(2007-11#1)(2008-5#1)(2009-12#1)
paradigm may##3##2##(2008-8#1)(2013-1#1)(2013-8#1)
paradigm of the##7##3##(2008-2#1)(2008-4#1)(2008-7#1)(2010-8#1)(2012-12#1)(2013-1#2)
paradigm of##33##2##(1991-10#1)(1993-3#1)(1995-11#1)(1995-12#1)(2005-8#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-4#1)(2010-8#1)(2011-7#1)(2012-12#1)(2013-1#2)
paradigm shift in##13##3##(1996-2#1)(2006-9#1)(2008-11#2)(2008-12#1)(2009-5#1)(2010-12#1)(2012-1#1)(2012-12#3)(2012-2#2)
paradigm shift##32##2##(1994-3#1)(1995-3#1)(1996-2#1)(2004-11#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-1#2)(2010-12#2)(2010-3#1)(2010-4#1)(2011-7#1)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#1)
paradigm shifts##4##2##(2005-11#1)(2010-2#1)(2010-5#1)(2012-3#1)
paradigm that##8##2##(1993-11#1)(1994-12#2)(1995-4#1)(2006-10#1)(2006-3#1)(2006-7#1)(2008-11#1)
paradigm to assess##2##3##(1994-6#1)(2008-4#1)
paradigm to examine the##2##4##(1993-12#1)(2012-12#1)
paradigm to examine##4##3##(1993-12#1)(1994-9#1)(2008-11#1)(2012-12#1)
paradigm to improve##2##3##(2008-12#1)(2013-8#1)
paradigm to investigate##4##3##(2007-9#1)(2009-4#1)(2010-2#1)(2010-6#1)
paradigm to##19##2##(1992-3#1)(1993-12#1)(1994-6#1)(1994-9#1)(1997-2#1)(1997-4#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-4#1)(2009-2#1)(2009-4#1)(2010-2#1)(2010-6#1)(2012-12#1)(2013-1#2)(2013-8#1)
paradigm used##4##2##(1991-1#1)(1996-10#1)(2008-10#1)(2012-12#1)
paradigm was used to assess##2##5##(1993-1#1)(2009-10#1)
paradigm was used to##4##4##(1993-1#1)(1993-11#1)(2009-10#1)(2013-8#1)
paradigm was used##5##3##(1993-1#1)(1993-11#1)(1996-12#1)(2009-10#1)(2013-8#1)
paradigm was##10##2##(1993-1#1)(1993-11#1)(1996-12#1)(2008-11#1)(2009-10#2)(2009-3#1)(2011-1#1)(2013-8#2)
paradigm with##3##2##(1992-12#1)(2008-11#1)(2012-1#1)
paradigm would##2##2##(2008-9#1)(2010-7#1)
paradigm##387##1##(1990-11#1)(1990-2#2)(1991-1#4)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-5#2)(1991-7#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#4)(1993-1#3)(1993-11#2)(1993-12#1)(1993-2#8)(1993-3#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#3)(1994-11#2)(1994-12#3)(1994-3#2)(1994-5#1)(1994-6#2)(1994-7#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-3#3)(1995-4#1)(1995-5#2)(1995-8#2)(1996-1#2)(1996-10#3)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#2)(2005-11#2)(2005-7#1)(2005-8#4)(2005-9#1)(2006-10#5)(2006-12#2)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#6)(2006-7#2)(2006-8#1)(2006-9#2)(2007-10#2)(2007-11#4)(2007-12#2)(2007-2#1)(2007-4#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#9)(2008-11#21)(2008-12#10)(2008-2#9)(2008-3#8)(2008-4#13)(2008-5#8)(2008-7#9)(2008-8#8)(2008-9#5)(2009-1#1)(2009-10#3)(2009-11#4)(2009-12#3)(2009-2#4)(2009-3#1)(2009-4#5)(2009-5#3)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#3)(2010-12#4)(2010-2#4)(2010-3#1)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#8)(2011-7#2)(2011-9#1)(2012-1#7)(2012-11#2)(2012-12#11)(2012-2#13)(2012-3#5)(2013-1#15)(2013-7#3)(2013-8#14)
paradigmatic case##2##2##(2006-3#1)(2007-12#1)
paradigmatic##9##1##(2006-3#1)(2007-12#1)(2008-1#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-7#1)(2012-3#1)(2013-1#1)
paradigms and##2##2##(1994-2#1)(2008-3#1)
paradigms are##3##2##(2007-2#1)(2008-12#1)(2012-2#1)
paradigms as##2##2##(1992-12#1)(2012-2#1)
paradigms for##6##2##(1996-12#1)(2007-2#1)(2008-2#1)(2008-6#1)(2009-3#1)(2013-8#1)
paradigms in the##2##3##(2009-12#1)(2012-2#1)
paradigms in##10##2##(1993-12#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-12#1)(2010-4#1)(2010-9#1)(2012-2#1)
paradigms involving##2##2##(1993-2#1)(2009-7#1)
paradigms of##9##2##(1994-3#1)(2007-11#1)(2008-7#1)(2008-9#2)(2009-8#2)(2011-2#1)(2012-12#1)
paradigms such as##2##3##(2008-2#1)(2008-7#1)
paradigms that##3##2##(2007-12#1)(2010-6#1)(2012-12#1)
paradigms to##3##2##(2005-8#1)(2008-11#1)(2008-4#1)
paradigms##110##1##(1991-1#1)(1991-2#1)(1991-4#1)(1992-12#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-11#1)(1994-2#4)(1994-3#2)(1995-1#1)(1995-3#1)(1995-4#1)(1996-12#3)(1996-5#1)(1996-8#1)(1997-4#2)(2005-8#2)(2006-10#2)(2006-2#1)(2006-3#1)(2006-4#3)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#4)(2008-12#4)(2008-2#5)(2008-3#3)(2008-4#6)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#3)(2010-4#1)(2010-6#3)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#4)(2012-2#5)(2013-8#1)
paradisi##3##1##(2008-10#2)(2011-2#1)
paradox and##3##2##(1997-2#1)(2009-4#1)(2013-7#1)
paradox in##4##2##(2007-8#1)(2007-9#1)(2008-2#1)(2009-4#1)
paradox is##2##2##(2009-4#2)
paradox of##9##2##(1995-9#1)(2006-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#2)
paradox that##5##2##(1997-5#1)(2007-8#1)(2008-1#1)(2008-11#1)(2013-8#1)
paradox##54##1##(1991-12#2)(1991-3#1)(1992-5#1)(1994-11#1)(1994-3#1)(1995-9#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-5#1)(2006-10#1)(2006-11#1)(2006-3#2)(2006-4#1)(2007-12#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-4#7)(2009-6#2)(2011-2#1)(2012-3#2)(2013-7#2)(2013-8#2)
paradox&quot##3##1##(2005-10#1)(2006-4#1)(2009-4#1)
paradox?##2##1##(1996-9#1)(2012-2#1)
paradoxa##6##1##(1995-10#2)(1997-6#2)(2008-2#2)
paradoxes in##2##2##(2008-12#1)(2011-2#1)
paradoxes##6##1##(2007-11#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-7#1)(2011-2#1)
paradoxical embolism may be##2##4##(2008-7#2)
paradoxical embolism##8##2##(1992-10#1)(1994-7#1)(2007-12#1)(2008-7#3)(2012-12#1)(2013-8#1)
paradoxical reaction##2##2##(2007-2#2)
paradoxical reactions##2##2##(2008-9#1)(2013-1#1)
paradoxical sleep propensity##2##3##(1996-8#2)
paradoxical sleep##10##2##(1992-10#2)(1992-8#1)(1993-2#1)(1995-12#1)(1996-7#1)(1996-8#3)(2007-1#1)
paradoxical##60##1##(1990-12#1)(1990-5#1)(1991-12#1)(1991-9#1)(1992-10#5)(1992-7#1)(1992-8#1)(1993-2#1)(1993-7#1)(1993-8#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-7#1)(1996-8#3)(1997-1#1)(1997-3#1)(2004-12#1)(2007-1#1)(2007-12#2)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-12#1)(2008-5#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
paradoxically increased##3##2##(1990-11#1)(1994-2#1)(2010-11#1)
paradoxically##15##1##(1990-11#1)(1993-7#1)(1994-2#1)(1995-4#1)(1995-8#1)(1997-7#1)(2007-5#1)(2008-1#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
paradoxus##3##1##(1995-1#3)
paraduodenal hernia##2##2##(2009-8#2)
paraelectric phase##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
paraelectric##12##1##(2007-11#1)(2007-12#6)(2008-2#4)(2008-3#1)
paraesthesia##4##1##(2007-7#1)(2008-12#2)(2008-7#1)
parafascicular##3##1##(1991-12#1)(1996-10#1)(1996-6#1)
paraffin blocks##4##2##(2006-12#1)(2008-10#1)(2008-5#1)(2013-8#1)
paraffin embedded (FFPE) human tissues##2##5##(2012-12#2)
paraffin embedded##6##2##(1991-4#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-12#2)
paraffin inclusion##2##2##(2007-8#1)(2008-5#1)
paraffin oil##4##2##(1997-1#2)(2006-7#1)(2008-10#1)
paraffin sections of##3##3##(2008-4#2)(2009-2#1)
paraffin sections using##2##3##(1996-5#1)(2008-11#1)
paraffin sections##12##2##(1992-9#1)(1993-9#1)(1995-4#1)(1996-5#1)(2005-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2009-2#1)
paraffin was##2##2##(2008-10#1)(2011-2#1)
paraffin wax##4##2##(1991-2#1)(2008-10#1)(2011-2#1)(2012-3#1)
paraffin##58##1##(1991-2#1)(1991-4#1)(1992-9#1)(1993-9#1)(1995-11#1)(1995-4#1)(1996-5#1)(1997-1#2)(1997-8#1)(2005-11#1)(2006-12#1)(2006-7#1)(2007-8#2)(2008-1#1)(2008-10#12)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#3)(2008-7#1)(2008-9#1)(2009-2#3)(2010-9#1)(2011-2#3)(2012-12#4)(2012-3#1)(2013-8#1)
paraffin-embedded (FFPE)##3##2##(2008-1#1)(2012-3#1)(2013-1#1)
paraffin-embedded samples##2##2##(1997-7#1)(2013-8#1)
paraffin-embedded sections of the##2##4##(1993-12#1)(2006-5#1)
paraffin-embedded sections##4##2##(1993-12#1)(1996-1#1)(2006-5#1)(2008-11#1)
paraffin-embedded tissue blocks##2##3##(2004-2#1)(2009-8#1)
paraffin-embedded tissue sections of##2##4##(2008-4#1)(2010-3#1)
paraffin-embedded tissue sections##5##3##(2008-10#1)(2008-11#1)(2008-4#2)(2010-3#1)
paraffin-embedded tissue##15##2##(1993-10#1)(1996-5#1)(2004-2#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-9#3)(2009-8#1)(2010-2#1)(2010-3#1)(2013-7#1)
paraffin-embedded tissues from##2##3##(2007-2#1)(2013-1#1)
paraffin-embedded tissues##6##2##(1997-7#1)(2007-2#1)(2008-1#1)(2008-4#1)(2008-9#1)(2013-1#1)
paraffin-embedded tumor tissue##2##3##(2004-1#1)(2008-6#1)
paraffin-embedded tumor##3##2##(1994-12#1)(2004-1#1)(2008-6#1)
paraffin-embedded##48##1##(1991-7#1)(1993-10#2)(1993-11#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-10#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-7#2)(2004-1#1)(2004-2#1)(2005-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#6)(2008-6#2)(2008-9#4)(2009-8#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
paraffin-impregnated graphite electrodes##2##3##(2008-10#2)
paraffin-wax##2##1##(1991-2#2)
paraffinic##2##1##(2008-10#1)(2008-5#1)
parafilm##3##1##(2008-11#3)
paraformaldehyde and##2##2##(2007-9#1)(2008-5#1)
paraformaldehyde##8##1##(1994-9#1)(2007-10#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
parafoveal retina##3##2##(1992-7#3)
parafoveal##7##1##(1992-7#5)(2007-7#1)(2009-5#1)
paragallinarum after storage for##2##4##(2008-5#2)
paragallinarum from China##2##3##(1997-3#2)
paragallinarum from##3##2##(1997-3#3)
paragallinarum##18##1##(1997-3#5)(1997-6#3)(2008-5#10)
paraganglia##5##1##(1996-5#5)
paraganglioma of the##3##3##(2007-11#1)(2012-2#1)(2013-1#1)
paraganglioma of##5##2##(2007-11#1)(2012-2#2)(2013-1#1)(2013-8#1)
paraganglioma presenting as##2##3##(2009-9#2)
paraganglioma presenting##3##2##(1997-8#1)(2009-9#2)
paraganglioma was##3##2##(1996-8#1)(2007-8#1)(2011-2#1)
paraganglioma which##2##2##(1990-6#1)(2007-8#1)
paraganglioma##35##1##(1990-6#2)(1991-10#2)(1992-8#1)(1996-8#2)(1997-8#4)(2006-9#3)(2007-11#1)(2007-8#6)(2009-9#3)(2011-2#1)(2012-2#6)(2013-1#1)(2013-8#3)
paraganglioma-like pattern##4##2##(2009-7#4)
paraganglioma-like##5##1##(2009-7#5)
paragangliomas are extremely rare##2##4##(1997-8#1)(2009-9#1)
paragangliomas are rare##2##3##(1990-6#1)(1996-8#1)
paragangliomas are##5##2##(1990-6#1)(1996-8#1)(1997-8#1)(2006-9#1)(2009-9#1)
paragangliomas of the##2##3##(1991-10#1)(1996-8#1)
paragangliomas##20##1##(1990-6#1)(1991-10#3)(1996-8#3)(1997-8#2)(2005-10#1)(2006-9#4)(2007-8#1)(2009-9#1)(2011-2#1)(2012-2#3)
paragigantocellular nuclei##2##2##(1995-5#1)(1997-6#1)
paragigantocellular##3##1##(1993-7#1)(1995-5#1)(1997-6#1)
paragigantocellularis##4##1##(1990-9#2)(1994-2#1)(1997-2#1)
paragraph##6##1##(1990-9#2)(2007-12#1)(2008-11#1)(2009-4#1)(2013-1#1)
paragraphs##2##1##(1996-5#1)(2009-4#1)
paragynous antheridia##2##2##(2008-10#1)(2010-3#1)
parahaemolyticus##6##1##(1991-8#3)(2006-8#1)(2009-6#2)
parahippocampal gyrus##4##2##(1990-10#2)(1997-8#1)(2008-9#1)
parahippocampal region##3##2##(1991-3#1)(1993-5#2)
parahippocampal##12##1##(1990-10#2)(1991-3#2)(1992-11#1)(1993-5#3)(1995-12#2)(1997-8#1)(2008-9#1)
parahippocampus##5##1##(1990-11#3)(1993-2#2)
parainfluenza virus##5##2##(1990-5#2)(2008-11#1)(2012-2#2)
parainfluenza viruses##4##2##(2007-11#3)(2011-2#1)
parainfluenza##10##1##(1990-5#2)(1997-1#1)(2007-11#3)(2008-11#1)(2011-2#1)(2012-2#2)
parakeet##3##1##(2005-7#1)(2006-7#1)(2013-8#1)
parakeratosis##5##1##(2008-9#4)(2010-6#1)
parallax##4##1##(1995-11#1)(2008-3#1)(2009-3#1)(2010-3#1)
parallel algorithm for##6##3##(2007-11#1)(2007-9#2)(2008-2#1)(2010-8#1)(2011-2#1)
parallel algorithm on the##2##4##(2007-9#1)(2008-2#1)
parallel algorithm##10##2##(2007-11#1)(2007-9#4)(2008-2#3)(2010-8#1)(2011-2#1)
parallel algorithms and software to##2##5##(2010-7#2)
parallel algorithms are##2##3##(2008-2#2)
parallel algorithms##7##2##(2008-2#5)(2010-7#2)
parallel alpha/beta##2##2##(1991-5#1)(1993-11#1)
parallel and perpendicular to the##3##5##(2008-3#2)(2010-9#1)
parallel and perpendicular to##4##4##(2008-2#1)(2008-3#2)(2010-9#1)
parallel and perpendicular##6##3##(2008-2#2)(2008-3#3)(2010-9#1)
parallel and##25##2##(1991-3#1)(1992-6#1)(1995-12#1)(1995-2#1)(1996-6#1)(1997-3#1)(2005-10#1)(2006-2#1)(2007-12#1)(2008-2#7)(2008-3#4)(2008-4#1)(2008-7#1)(2009-9#1)(2010-2#1)(2010-9#1)
parallel architecture for##3##3##(2008-2#3)
parallel architecture##5##2##(2008-2#5)
parallel arrays of##3##3##(2007-3#1)(2008-10#1)(2008-5#1)
parallel arrays##4##2##(2007-3#1)(2008-10#1)(2008-3#1)(2008-5#1)
parallel assays##2##2##(2008-4#2)
parallel beam is##2##3##(2007-11#1)(2007-12#1)
parallel beta-sheet##3##2##(1994-8#1)(1995-1#1)(2009-5#1)
parallel but##2##2##(1997-8#1)(2008-3#1)
parallel changes in##2##3##(1995-10#1)(2008-7#1)
parallel changes##3##2##(1993-2#1)(1995-10#1)(2008-7#1)
parallel clinical trial##2##3##(1994-6#1)(2008-5#1)
parallel computation##2##2##(1990-11#1)(2008-3#1)
parallel computing architectures##2##3##(1990-11#1)(2006-2#1)
parallel computing##4##2##(1990-11#1)(2006-2#1)(2008-2#1)(2013-1#1)
parallel construct##3##2##(2011-2#3)
parallel correlator##2##2##(2008-3#2)
parallel data links##2##3##(2008-2#2)
parallel data##9##2##(1992-3#1)(1996-3#1)(2008-2#3)(2008-3#4)
parallel database processing##2##3##(2007-12#1)(2008-3#1)
parallel decrease in the##2##4##(1990-7#1)(1993-3#1)
parallel decrease in##4##3##(1990-7#1)(1992-1#1)(1993-3#1)(2008-11#1)
parallel detection##4##2##(2007-11#1)(2007-12#2)(2008-7#1)
parallel development##3##2##(2008-12#1)(2008-2#1)(2008-5#1)
parallel energy##2##2##(1993-8#2)
parallel evaluation of##2##3##(2008-3#1)(2010-12#1)
parallel experiments##5##2##(1992-11#1)(1993-4#1)(1997-2#1)(2006-8#1)(2008-7#1)
parallel factor analysis (PARAFAC)##4##4##(2008-10#4)
parallel factor analysis##6##3##(2008-10#5)(2010-5#1)
parallel fashion##4##2##(1994-9#1)(1997-5#1)(2008-10#1)(2008-4#1)
parallel fiber##6##2##(1991-11#2)(1995-8#1)(1996-4#1)(1997-7#1)(2008-3#1)
parallel fibers##3##2##(1991-11#1)(1991-6#1)(1995-5#1)
parallel gains or losses##2##4##(2008-10#2)
parallel gratings##2##2##(2008-3#2)
parallel group design##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
parallel group##6##2##(1990-3#1)(1990-8#1)(2006-10#1)(2008-10#1)(2008-7#1)(2013-1#1)
parallel groups##3##2##(1996-7#1)(1997-5#1)(2008-3#1)
parallel in the##5##3##(1993-1#1)(1995-1#1)(1995-5#1)(1997-7#1)(2008-10#1)
parallel in##9##2##(1990-2#1)(1993-1#1)(1995-1#2)(1995-5#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-5#1)
parallel increase in##7##3##(1991-12#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-2#1)(2006-10#1)(2008-4#1)
parallel interference##2##2##(2008-2#2)
parallel interferometer##2##2##(2007-11#2)
parallel joint transform correlator for##3##5##(2008-3#3)
parallel joint transform correlator##5##4##(2008-2#1)(2008-3#4)
parallel learning##3##2##(2008-3#2)(2012-12#1)
parallel line##2##2##(1990-11#1)(1996-11#1)
parallel lines##3##2##(1992-3#2)(1993-6#1)
parallel manner by##2##3##(1996-10#1)(2008-9#1)
parallel manner##4##2##(1994-2#1)(1996-10#1)(1997-7#1)(2008-9#1)
parallel measurement of##2##3##(1991-5#1)(2008-9#1)
parallel measurements of##2##3##(1991-5#1)(2008-10#1)
parallel measurements##5##2##(1991-5#1)(2005-9#2)(2008-10#2)
parallel molecular##2##2##(1991-3#1)(2005-11#1)
parallel nature##2##2##(2009-12#1)(2011-1#1)
parallel operation##2##2##(2007-12#1)(2008-2#1)
parallel opposed lateral and vertex fields##2##6##(1993-9#2)
parallel opposed##4##2##(1993-9#2)(2007-2#1)(2008-11#1)
parallel optical##7##2##(2007-12#1)(2008-2#2)(2008-3#3)(2012-2#1)
parallel or perpendicular to the##2##5##(2008-2#1)(2011-2#1)
parallel or##3##2##(2007-7#1)(2008-2#1)(2011-2#1)
parallel pathway##4##2##(1994-6#1)(1995-5#1)(1996-2#1)(2007-1#1)
parallel pathways##7##2##(1995-5#3)(2007-12#1)(2008-8#1)(2013-1#2)
parallel performance##3##2##(2007-9#2)(2013-1#1)
parallel phase-shifting digital holographic##2##4##(2011-1#2)
parallel photonic integrated circuit##2##4##(2008-3#2)
parallel plate diffusion denuder coupled capillary##2##6##(2008-10#2)
parallel plate diffusion denuder##3##4##(2008-10#3)
parallel plate electrode##2##3##(2010-7#2)
parallel plate##8##2##(2005-11#1)(2008-10#3)(2010-7#2)(2013-1#2)
parallel processes##2##2##(1997-3#1)(2008-11#1)
parallel processing of##2##3##(2008-10#1)(2008-2#1)
parallel processing systems##2##3##(2008-2#2)
parallel processing##12##2##(1992-7#1)(1996-5#1)(2008-10#1)(2008-2#6)(2008-3#2)(2010-7#1)
parallel processor for##2##3##(2008-3#2)
parallel processor##3##2##(2008-3#3)
parallel protein##2##2##(1992-4#1)(1994-9#1)
parallel reactions##4##2##(1997-3#1)(2008-10#2)(2008-11#1)
parallel read-write-erase##2##2##(2008-2#2)
parallel results##2##2##(1995-8#1)(2006-4#1)
parallel rows##3##2##(2007-9#2)(2008-7#1)
parallel sessions##2##2##(2005-7#2)
parallel studies are##2##3##(2006-10#1)(2009-6#1)
parallel studies##7##2##(1994-2#1)(1994-5#1)(2006-10#2)(2006-2#1)(2008-7#1)(2009-6#1)
parallel study of##2##3##(2008-10#1)(2011-1#1)
parallel study##6##2##(1992-10#1)(1996-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2011-1#1)
parallel surfaces##4##2##(2006-3#1)(2008-2#2)(2008-3#1)
parallel synthesis##4##2##(2005-7#1)(2008-10#3)
parallel systems##2##2##(2008-2#1)(2009-4#1)
parallel tests##2##2##(1997-3#1)(2008-10#1)
parallel thalamocortical##2##2##(1994-5#2)
parallel the##14##2##(1992-1#1)(1992-11#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-12#1)(1995-2#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-2#1)(2008-11#1)(2008-3#1)(2010-6#1)
parallel those containing##2##3##(1996-5#2)
parallel those observed##2##3##(1994-3#1)(2008-4#1)
parallel those##5##2##(1990-10#1)(1994-3#1)(1996-5#2)(2008-4#1)
parallel time series of reference##2##5##(2009-9#2)
parallel to each other##5##4##(1991-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-8#1)
parallel to its##4##3##(1991-2#1)(1992-12#1)(1993-6#1)(2005-11#1)
parallel to the acyl chains of the phospholipid bilayer##2##9##(1993-9#1)(1995-8#1)
parallel to the coast##4##4##(1996-4#1)(2007-5#2)(2008-5#1)
parallel to the glass##2##4##(2008-3#1)(2010-9#1)
parallel to the lines##2##4##(2008-3#2)
parallel to the longitudinal axis of the##2##7##(2006-3#1)(2007-12#1)
parallel to the plane of the##2##6##(1991-5#1)(2006-11#1)
parallel to the substrate surface##2##5##(2005-4#1)(2010-4#1)
parallel to the substrate##3##4##(2005-4#1)(2008-10#1)(2010-4#1)
parallel to the##78##3##(1990-3#1)(1991-10#2)(1991-5#1)(1992-7#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-9#1)(1995-3#1)(1995-8#2)(1996-2#1)(1996-4#3)(1996-5#1)(1997-7#2)(1997-8#1)(2005-4#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#1)(2007-11#4)(2007-12#4)(2007-5#3)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#11)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#1)(2009-8#1)(2010-4#2)(2010-9#1)(2011-7#1)(2012-1#1)(2012-2#1)(2013-8#1)
parallel to those##2##3##(1992-9#1)(1994-11#1)
parallel to##123##2##(1990-3#1)(1990-8#1)(1991-10#3)(1991-2#2)(1991-5#2)(1992-1#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-8#1)(1995-1#1)(1995-3#1)(1995-8#2)(1996-2#1)(1996-4#3)(1996-5#1)(1996-8#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#1)(2007-11#6)(2007-12#4)(2007-2#1)(2007-5#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#12)(2008-4#1)(2008-5#5)(2008-7#3)(2008-8#4)(2008-9#3)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-4#2)(2010-9#2)(2011-12#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#2)
parallel wire##4##2##(2009-3#4)
parallel with a##3##3##(1994-9#1)(2007-12#1)(2009-10#1)
parallel with that of##3##4##(1991-3#1)(1994-8#1)(2007-12#1)
parallel with the decrease in##2##5##(1992-9#1)(1994-3#1)
parallel with the decrease##3##4##(1992-3#1)(1992-9#1)(1994-3#1)
parallel with the##29##3##(1990-12#1)(1990-2#1)(1990-4#2)(1991-12#1)(1991-4#1)(1991-5#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-2#1)(2004-12#1)(2006-10#1)(2008-10#1)(2010-11#1)(2010-9#1)(2012-1#3)
parallel with this##2##3##(1997-2#1)(2008-6#1)
parallel with##70##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1991-12#1)(1991-3#1)(1991-4#2)(1991-5#2)(1992-3#1)(1992-4#1)(1992-6#3)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-7#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-4#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-3#3)(1995-8#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-7#1)(2004-12#1)(2006-10#2)(2007-12#2)(2007-9#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#1)(2010-11#1)(2010-9#1)(2012-1#3)(2012-3#1)
parallel within##2##2##(1995-3#1)(2008-7#1)
parallel##869##1##(1990-10#2)(1990-11#3)(1990-12#4)(1990-2#3)(1990-3#3)(1990-4#2)(1990-5#1)(1990-7#3)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#3)(1991-11#3)(1991-12#2)(1991-2#3)(1991-3#4)(1991-4#2)(1991-5#9)(1991-6#2)(1992-1#5)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#4)(1992-4#2)(1992-6#6)(1992-7#2)(1992-9#3)(1993-1#1)(1993-11#4)(1993-12#1)(1993-2#2)(1993-3#7)(1993-4#2)(1993-6#5)(1993-7#2)(1993-8#5)(1993-9#5)(1994-11#9)(1994-12#3)(1994-2#4)(1994-3#8)(1994-4#1)(1994-5#3)(1994-6#6)(1994-8#6)(1994-9#6)(1995-1#6)(1995-10#2)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#9)(1995-5#10)(1995-6#2)(1995-8#9)(1996-10#2)(1996-11#4)(1996-12#2)(1996-2#4)(1996-3#3)(1996-4#5)(1996-5#8)(1996-6#1)(1996-7#2)(1996-8#3)(1997-2#3)(1997-3#4)(1997-4#2)(1997-5#2)(1997-6#5)(1997-7#7)(1997-8#3)(2004-12#2)(2005-10#1)(2005-11#7)(2005-4#1)(2005-7#5)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#8)(2006-11#2)(2006-12#3)(2006-2#5)(2006-3#2)(2006-4#1)(2006-5#2)(2006-6#2)(2006-8#1)(2007-1#3)(2007-11#24)(2007-12#32)(2007-2#3)(2007-3#2)(2007-5#4)(2007-7#2)(2007-8#7)(2007-9#13)(2008-1#4)(2008-10#58)(2008-11#24)(2008-12#6)(2008-2#76)(2008-3#79)(2008-4#10)(2008-5#22)(2008-6#5)(2008-7#18)(2008-8#8)(2008-9#6)(2009-10#5)(2009-11#1)(2009-12#4)(2009-3#6)(2009-4#2)(2009-5#3)(2009-6#3)(2009-7#4)(2009-8#3)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#7)(2010-8#2)(2010-9#4)(2011-1#10)(2011-12#2)(2011-2#15)(2011-7#1)(2012-1#15)(2012-11#1)(2012-12#7)(2012-2#8)(2012-3#5)(2013-1#14)(2013-2#1)(2013-7#2)(2013-8#4)
parallel)##3##1##(1994-6#1)(1996-2#1)(2008-1#1)
parallel-coupled ring-resonator##2##2##(2007-11#2)
parallel-distributed blind deconvolution method##2##4##(2008-3#2)
parallel-fiber##2##1##(2008-3#2)
parallel-group study##3##2##(1993-11#1)(1997-1#1)(2012-12#1)
parallel-group##7##1##(1993-11#1)(1994-11#1)(1997-1#1)(2007-10#2)(2008-2#1)(2012-12#1)
parallel-hole SPECT##5##2##(2009-10#1)(2009-8#4)
parallel-hole collimators##2##2##(2009-10#1)(2009-8#1)
parallel-hole##9##1##(2009-10#3)(2009-8#6)
parallel-plate##5##1##(1990-12#1)(2005-11#2)(2007-11#2)
parallel-polarized##2##1##(2008-2#2)
parallel-processing##3##1##(2008-2#1)(2008-3#2)
parallel-rubbed##2##1##(2007-12#2)
parallel-slab##6##1##(2008-3#6)
parallel-stranded##5##1##(1994-9#5)
parallel-to-serial##2##1##(2008-2#1)(2008-3#1)
paralleled by a decrease in##3##5##(1990-3#1)(1993-11#1)(1995-12#1)
paralleled by a##15##3##(1990-2#1)(1990-3#2)(1993-11#1)(1993-9#1)(1994-12#1)(1995-12#1)(1996-12#1)(1996-5#1)(2007-5#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-2#1)
paralleled by an increase in##4##5##(1992-1#1)(1994-11#1)(1994-5#1)(2010-12#1)
paralleled by an increase##5##4##(1992-1#1)(1994-11#1)(1994-3#1)(1994-5#1)(2010-12#1)
paralleled by an##6##3##(1992-1#1)(1994-11#1)(1994-3#1)(1994-5#1)(2008-7#1)(2010-12#1)
paralleled by decreased##2##3##(1993-3#1)(1994-6#1)
paralleled by increased##2##3##(1992-2#1)(2008-10#1)
paralleled by reductions in##2##4##(1990-10#1)(1995-12#1)
paralleled by the##4##3##(1991-5#1)(2008-4#1)(2013-1#2)
paralleled by##43##2##(1990-10#1)(1990-2#1)(1990-3#2)(1991-5#1)(1992-1#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-12#2)(1996-12#1)(1996-5#2)(1996-8#1)(1997-5#1)(2006-10#1)(2007-1#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#2)(2009-4#1)(2010-12#3)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#2)
paralleled that of the##3##4##(1991-8#1)(1993-2#1)(1993-8#1)
paralleled that of##5##3##(1990-7#1)(1991-8#1)(1993-2#1)(1993-8#1)(1996-2#1)
paralleled the increase in##2##4##(1990-4#1)(2008-10#1)
paralleled the##20##2##(1990-2#1)(1990-4#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-2#1)(1992-7#1)(1993-2#1)(1994-5#1)(1994-7#1)(2004-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-9#1)(2012-12#1)
paralleled those in##2##3##(1995-3#1)(1995-6#1)
paralleled those of##2##3##(1991-4#1)(1996-12#1)
paralleled those##5##2##(1991-4#1)(1992-1#1)(1995-3#1)(1995-6#1)(1996-12#1)
paralleled with##2##2##(2008-11#1)(2011-2#1)
paralleled##88##1##(1990-10#2)(1990-2#3)(1990-3#3)(1990-4#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-2#2)(1992-7#1)(1992-8#2)(1993-11#1)(1993-2#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#1)(1995-10#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-8#1)(1997-5#1)(2004-3#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#2)(2008-7#2)(2009-4#1)(2009-9#1)(2010-12#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
parallelepiped##2##1##(1996-1#1)(2008-3#1)
paralleling the##3##2##(1992-12#1)(1994-3#1)(2011-2#1)
paralleling those##2##2##(2006-4#1)(2006-5#1)
paralleling##8##1##(1992-12#1)(1993-9#2)(1994-3#1)(2006-4#1)(2006-5#1)(2008-11#1)(2011-2#1)
parallelism and##3##2##(1992-1#1)(2007-12#1)(2008-2#1)
parallelism of##3##2##(2008-2#1)(2008-3#2)
parallelism##23##1##(1992-1#1)(1997-4#1)(2005-12#1)(2006-4#1)(2007-12#2)(2008-11#1)(2008-2#5)(2008-3#7)(2010-11#2)(2010-8#1)(2013-1#1)
parallelization of##2##2##(2007-9#1)(2009-3#1)
parallelization##4##1##(2007-8#1)(2007-9#1)(2008-3#1)(2009-3#1)
parallelized##6##1##(2008-3#1)(2008-4#1)(2010-2#1)(2011-2#1)(2013-1#2)
parallelled by##2##2##(1997-2#1)(2007-11#1)
parallelly##3##1##(2007-12#1)(2008-3#1)(2012-12#1)
parallelogrammic##2##1##(2008-2#2)
parallels between human##2##3##(2012-2#2)
parallels between the##3##3##(1995-4#1)(2008-4#1)(2012-2#1)
parallels between##9##2##(1995-4#1)(2005-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2012-2#3)
parallels in##2##2##(2008-6#1)(2008-7#1)
parallels that observed##2##3##(1992-6#1)(2007-3#1)
parallels that of##2##3##(2008-10#1)(2008-5#1)
parallels that##5##2##(1991-2#1)(1992-6#1)(2007-3#1)(2008-10#1)(2008-5#1)
parallels the activity of##2##4##(1996-5#2)
parallels the##14##2##(1990-2#1)(1991-3#1)(1992-7#1)(1994-8#1)(1995-6#1)(1996-5#2)(1997-7#1)(1997-8#1)(2005-10#1)(2007-12#1)(2008-10#1)(2011-12#1)(2012-1#1)
parallels with the##3##3##(1996-7#1)(2006-3#1)(2013-8#1)
parallels with##7##2##(1995-8#1)(1996-7#1)(2006-3#1)(2008-8#1)(2010-4#1)(2011-2#1)(2013-8#1)
parallels##50##1##(1990-2#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1994-8#1)(1994-9#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#2)(1996-7#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#2)(2006-3#1)(2006-8#1)(2007-12#3)(2007-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-8#2)
paralog##3##1##(1991-5#1)(2008-1#1)(2009-6#1)
paralogous##7##1##(1993-11#1)(2008-1#1)(2008-5#1)(2008-7#2)(2008-8#1)(2012-2#1)
paralogs##7##1##(2008-8#1)(2009-10#1)(2009-6#1)(2010-3#1)(2013-1#3)
paralogy##2##1##(2008-7#1)(2010-6#1)
paralysed##3##1##(1994-6#1)(2006-4#1)(2009-5#1)
paralyses##4##1##(2006-3#4)
paralysis after##3##2##(1993-1#1)(2012-2#2)
paralysis and##10##2##(1997-5#1)(2006-10#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-8#2)(2009-3#1)(2011-2#1)(2012-2#1)
paralysis as##2##2##(1996-11#1)(2013-8#1)
paralysis can##2##2##(2007-3#1)(2008-7#1)
paralysis cases##4##2##(2008-4#3)(2013-8#1)
paralysis caused by##2##3##(1995-12#1)(2010-8#1)
paralysis due to##2##3##(2007-3#1)(2010-8#1)
paralysis in##5##2##(1992-2#1)(2010-8#1)(2012-12#2)(2013-1#1)
paralysis is a##2##3##(2007-5#1)(2010-8#1)
paralysis is##6##2##(2006-11#1)(2006-3#1)(2007-5#2)(2009-3#1)(2010-8#1)
paralysis leading to##2##3##(2012-2#2)
paralysis of the##6##3##(1991-1#1)(1996-3#1)(2007-1#1)(2008-2#2)(2012-1#1)
paralysis of##8##2##(1991-1#1)(1996-3#1)(2007-1#1)(2007-3#1)(2008-2#2)(2012-1#1)(2012-3#1)
paralysis was##3##2##(1996-1#1)(2008-7#2)
paralysis with respiratory failure##2##4##(2006-4#1)(2008-1#1)
paralysis with##5##2##(1996-10#1)(2006-11#1)(2006-4#1)(2008-1#1)(2008-8#1)
paralysis##109##1##(1990-2#1)(1990-5#1)(1991-1#1)(1991-12#2)(1991-6#1)(1992-2#1)(1993-1#1)(1994-3#1)(1995-12#2)(1995-4#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-3#1)(1997-5#1)(2004-11#1)(2006-10#2)(2006-11#2)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-3#6)(2007-5#4)(2007-7#1)(2008-1#2)(2008-11#2)(2008-2#4)(2008-4#4)(2008-5#3)(2008-7#4)(2008-8#6)(2008-9#1)(2009-3#2)(2010-12#2)(2010-8#4)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#5)(2012-2#10)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#5)
paralysis)##2##1##(1990-4#1)(2013-1#1)
paralysis]##2##1##(1993-1#1)(1994-3#1)
paralytic acylpolyamines from the##2##4##(1990-5#2)
paralytic conditions affecting##2##3##(2008-5#2)
paralytic disease##2##2##(1995-5#1)(2010-12#1)
paralytic illness##2##2##(2007-12#1)(2007-8#1)
paralytic poliomyelitis##4##2##(1997-1#3)(2004-12#1)
paralytic shellfish poisoning (PSP)##2##4##(1994-12#1)(2009-12#1)
paralytic shellfish poisoning##3##3##(1994-12#2)(2009-12#1)
paralytic##25##1##(1990-5#3)(1991-12#1)(1994-11#1)(1994-12#2)(1995-5#3)(1997-1#3)(1997-8#1)(2004-12#1)(2006-12#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-5#2)(2009-12#1)(2009-3#2)(2010-12#1)
paralyze##2##1##(1990-5#1)(2004-9#1)
paralyzed and artificially ventilated rats##2##5##(1994-10#1)(1997-5#1)
paralyzed and artificially ventilated##4##4##(1993-12#1)(1994-10#2)(1997-5#1)
paralyzed and##5##2##(1993-12#1)(1994-10#2)(1997-5#1)(2009-3#1)
paralyzed by##2##2##(2008-8#1)(2013-1#1)
paralyzed##19##1##(1991-11#2)(1992-3#1)(1993-12#1)(1994-10#2)(1995-3#1)(1995-6#2)(1997-5#1)(1997-6#1)(2006-3#1)(2007-10#2)(2007-11#1)(2008-8#1)(2009-3#1)(2012-1#1)(2013-1#1)
paralyzing##2##1##(2006-8#1)(2011-2#1)
paramagnet##2##1##(2007-11#2)
paramagnetic broadening##2##2##(1994-5#2)
paramagnetic contrast agents##3##3##(1991-7#2)(2011-1#1)
paramagnetic contrast##6##2##(1991-7#2)(1992-12#1)(1995-6#1)(2008-10#1)(2011-1#1)
paramagnetic effect##2##2##(1993-6#2)
paramagnetic effects of Co2+ on##3##5##(1991-7#2)(1993-6#1)
paramagnetic effects of##5##3##(1991-7#3)(1993-6#2)
paramagnetic probes##2##2##(1990-10#1)(1990-5#1)
paramagnetic quenching##3##2##(1994-5#1)(2006-10#2)
paramagnetic resonance (EPR) and##2##4##(1993-11#1)(2009-4#1)
paramagnetic resonance (EPR) spectra of##2##5##(1990-2#1)(1994-2#1)
paramagnetic resonance (EPR) spectroscopy##8##4##(1991-9#1)(1993-9#1)(1994-11#1)(1994-5#1)(1997-4#1)(2008-10#2)(2008-5#1)
paramagnetic resonance (EPR)##19##3##(1990-2#1)(1991-7#2)(1991-9#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1997-4#1)(1997-7#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)
paramagnetic resonance spectroscopy##8##3##(1993-11#2)(1994-5#1)(1996-2#1)(1997-1#2)(2008-10#1)(2010-7#1)
paramagnetic resonance study##3##3##(1994-5#1)(1996-5#1)(2008-3#1)
paramagnetic resonance##48##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-7#2)(1991-9#1)(1992-3#2)(1993-11#4)(1993-9#1)(1994-11#2)(1994-2#1)(1994-5#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-1#3)(1997-4#1)(1997-7#2)(2007-12#1)(2007-3#2)(2008-10#5)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-7#1)
paramagnetic species in the##2##4##(1990-5#2)
paramagnetic species##3##2##(1990-5#2)(2008-10#1)
paramagnetic susceptibility##2##2##(1997-4#1)(2012-2#1)
paramagnetic##97##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-5#3)(1990-7#1)(1991-7#10)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-11#4)(1993-6#4)(1993-9#1)(1994-11#2)(1994-2#1)(1994-5#6)(1994-8#3)(1994-9#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-1#3)(1997-4#2)(1997-7#2)(1997-8#1)(2006-1#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-3#2)(2008-10#9)(2008-11#1)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#2)(2009-5#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
paramagnetism##2##1##(1990-4#1)(2007-11#1)
paramecia##7##1##(1992-6#1)(2008-5#6)
paramedian##8##1##(1993-2#1)(1997-6#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#1)(2012-3#1)
paramedic##5##1##(2005-8#1)(2007-9#3)(2008-3#1)
paramedical personnel##4##2##(2007-10#1)(2007-2#1)(2007-7#1)(2012-2#1)
paramedical##8##1##(1991-11#1)(1995-1#1)(2007-10#1)(2007-2#1)(2007-7#1)(2011-2#1)(2012-2#2)
paramedics##13##1##(1992-5#1)(2005-10#1)(2007-7#3)(2007-9#2)(2008-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#2)
parameningeal##2##1##(2008-6#1)(2008-7#1)
parameres##2##1##(2008-5#2)
parameter (the##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
parameter D##2##2##(1990-3#1)(2008-3#1)
parameter after##2##2##(2005-11#1)(2007-12#1)
parameter alpha##2##2##(2007-3#1)(2007-4#1)
parameter analyses##2##2##(2008-6#2)
parameter and the##4##3##(2007-11#1)(2008-11#1)(2008-2#1)(2009-4#1)
parameter and##17##2##(2006-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#1)(2008-7#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-2#1)(2011-2#1)(2013-1#1)
parameter are##3##2##(1995-6#1)(2008-2#1)(2008-3#1)
parameter as##2##2##(2007-12#1)(2008-5#1)
parameter associated with the##2##4##(1996-4#1)(2006-11#1)
parameter at the##2##3##(1994-10#1)(1996-2#1)
parameter at##4##2##(1994-10#1)(1996-2#1)(2005-11#1)(2008-2#1)
parameter based on##2##3##(2010-2#1)(2011-1#1)
parameter beta##3##2##(2007-3#1)(2008-2#2)
parameter called##2##2##(2012-2#1)(2013-1#1)
parameter can be##3##3##(1990-2#1)(2007-11#1)(2008-3#1)
parameter change##3##2##(2006-10#1)(2007-9#2)
parameter changes##3##2##(1992-4#1)(1997-1#1)(2006-4#1)
parameter choices##2##2##(2008-2#1)(2008-3#1)
parameter configurations##2##2##(2008-4#1)(2010-6#1)
parameter delta##2##2##(1990-5#1)(2008-2#1)
parameter depends on##2##3##(2008-2#1)(2010-12#1)
parameter determining the##2##3##(2006-6#1)(2007-12#1)
parameter determining##3##2##(2006-6#1)(2007-12#1)(2008-10#1)
parameter difference##2##2##(2008-3#1)(2011-2#1)
parameter estimates and##3##3##(1996-12#1)(2008-7#1)(2010-2#1)
parameter estimates derived from##2##4##(2008-10#2)
parameter estimates for##3##3##(2008-10#2)(2010-8#1)
parameter estimates were used to##2##5##(2008-10#2)
parameter estimates were##3##3##(2008-10#3)
parameter estimates##37##2##(1992-6#1)(1992-8#2)(1992-9#1)(1994-5#1)(1996-12#2)(2008-10#20)(2008-7#1)(2009-10#3)(2009-8#1)(2010-2#2)(2010-8#2)(2013-1#1)
parameter estimation and##4##3##(2009-12#1)(2010-2#1)(2012-3#1)(2013-8#1)
parameter estimation methods##3##3##(2008-10#1)(2009-12#1)(2013-7#1)
parameter estimation of##3##3##(2008-10#1)(2009-7#1)(2012-2#1)
parameter estimation##22##2##(1995-6#1)(1997-4#1)(2008-10#4)(2008-2#2)(2008-4#2)(2009-12#4)(2009-7#2)(2010-2#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
parameter evaluation and prediction##2##4##(2008-10#2)
parameter exceeds##2##2##(2007-11#1)(2008-3#1)
parameter for all##2##3##(1992-1#1)(2009-10#1)
parameter for diagnosing##2##3##(1991-7#1)(1994-7#1)
parameter for each##3##3##(1993-11#1)(2008-10#1)(2009-10#1)
parameter for early##2##3##(1991-11#1)(2009-5#1)
parameter for the automated##2##4##(2008-7#2)
parameter for the##12##3##(1992-3#1)(1993-12#1)(2007-12#1)(2008-10#3)(2008-7#3)(2009-12#1)(2012-2#1)(2012-3#1)
parameter for##47##2##(1991-11#1)(1991-2#1)(1991-7#1)(1992-1#1)(1992-3#2)(1993-11#2)(1993-12#1)(1993-4#1)(1993-8#1)(1994-7#1)(1994-8#1)(1995-1#1)(2004-9#1)(2005-10#1)(2006-5#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#4)(2008-9#2)(2009-10#2)(2009-12#1)(2009-5#1)(2010-7#2)(2012-2#1)(2012-3#2)(2013-1#1)
parameter from##3##2##(2006-12#1)(2008-10#1)(2011-2#1)
parameter governing the##2##3##(2008-3#1)(2009-10#1)
parameter governing##3##2##(2008-10#1)(2008-3#1)(2009-10#1)
parameter has##3##2##(2008-3#1)(2009-12#1)(2009-2#1)
parameter in a##3##3##(1990-12#1)(1995-6#1)(2010-12#1)
parameter in the model##2##4##(2007-9#1)(2010-2#1)
parameter in the##12##3##(1991-2#1)(1996-12#1)(1996-9#1)(2007-9#1)(2008-2#2)(2008-3#1)(2008-7#2)(2009-9#1)(2010-2#1)(2013-8#1)
parameter in##34##2##(1990-12#1)(1991-2#1)(1991-3#1)(1992-5#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-9#1)(2005-11#1)(2005-4#1)(2006-4#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#2)(2009-1#1)(2009-9#1)(2010-12#2)(2010-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
parameter influencing##2##2##(2008-10#1)(2008-8#1)
parameter is found##2##3##(1996-8#1)(2008-2#1)
parameter is not##2##3##(2008-3#1)(2010-2#1)
parameter is the##2##3##(2007-11#1)(2008-3#1)
parameter is##24##2##(1991-11#1)(1993-5#1)(1994-5#1)(1996-8#1)(1996-9#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#5)(2008-3#3)(2008-9#1)(2010-2#1)(2011-1#1)
parameter kappa##2##2##(2008-2#1)(2008-3#1)
parameter measured##2##2##(2008-1#1)(2008-7#1)
parameter measurements##3##2##(1993-3#1)(2008-3#2)
parameter model##3##2##(1994-11#1)(2007-1#1)(2009-3#1)
parameter n##2##2##(2008-3#1)(2008-7#1)
parameter of a##8##3##(1993-11#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2009-3#1)
parameter of interest##2##3##(2008-7#1)(2009-3#1)
parameter of response##2##3##(2008-10#1)(2008-5#1)
parameter of the beta-binomial distribution##4##5##(2008-10#4)
parameter of the beta-binomial##5##4##(2008-10#5)
parameter of the phase function##2##5##(2008-3#2)
parameter of the##16##3##(1990-7#1)(1992-9#1)(1997-4#1)(2005-10#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#3)(2008-7#1)(2010-4#1)
parameter of##56##2##(1990-7#1)(1990-9#1)(1991-10#1)(1991-2#1)(1992-9#1)(1993-11#1)(1994-8#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-10#2)(2007-11#2)(2007-12#2)(2008-10#7)(2008-11#2)(2008-2#8)(2008-3#9)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-3#2)(2009-8#1)(2010-4#1)
parameter range##5##2##(1996-9#1)(2007-12#4)
parameter relating##2##2##(2008-3#1)(2008-5#1)
parameter set##3##2##(1994-11#1)(2005-11#1)(2008-10#1)
parameter sets for##2##3##(2008-10#2)
parameter sets##5##2##(2008-10#3)(2008-11#1)(2008-2#1)
parameter settings##4##2##(2008-2#1)(2008-8#1)(2012-1#2)
parameter space for##2##3##(2008-2#1)(2010-8#1)
parameter space##19##2##(1993-8#1)(1993-9#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-2#3)(2008-6#1)(2008-8#2)(2009-8#1)(2010-10#1)(2010-6#1)(2010-8#1)(2012-3#1)
parameter that can be##2##4##(2008-3#1)(2010-12#1)
parameter that can##3##3##(2008-3#1)(2008-6#1)(2010-12#1)
parameter that depends on the##2##5##(2006-7#1)(2007-12#1)
parameter that##19##2##(1994-11#1)(2005-11#2)(2006-7#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#4)(2008-6#1)(2008-8#1)(2010-12#1)
parameter theta##2##2##(2008-10#1)(2008-8#1)
parameter to be##3##3##(2008-10#2)(2008-6#1)
parameter to estimate##2##3##(1992-12#1)(2008-8#1)
parameter to##20##2##(1992-12#1)(1996-8#1)(1997-3#1)(2006-10#1)(2008-10#5)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-2#1)(2010-7#1)(2011-2#1)(2013-1#3)
parameter under##2##2##(2008-5#1)(2012-2#1)
parameter v##2##2##(2013-8#2)
parameter value##2##2##(2008-10#2)
parameter values and##4##3##(1994-2#1)(2008-3#2)(2008-4#1)
parameter values for the##2##4##(2008-10#1)(2010-9#1)
parameter values for##4##3##(2008-10#2)(2008-2#1)(2010-9#1)
parameter values in##4##3##(1997-1#1)(2008-10#1)(2008-12#1)(2009-12#1)
parameter values##47##2##(1994-2#1)(1995-8#1)(1997-1#2)(1997-2#1)(2005-11#1)(2006-10#1)(2006-5#2)(2008-10#12)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-12#1)(2010-2#4)(2010-9#1)(2013-8#1)
parameter variations are studied##2##4##(2008-3#2)
parameter variations##5##2##(2008-2#1)(2008-3#4)
parameter was significantly##2##3##(2008-5#2)
parameter was##18##2##(1990-12#1)(1991-10#1)(1992-10#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-5#4)(2010-4#1)(2011-2#1)
parameter we##2##2##(2009-2#1)(2011-1#1)
parameter when##2##2##(2006-12#1)(2008-10#1)
parameter which##6##2##(1994-9#1)(2004-9#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-7#1)
parameter with a##2##3##(1995-5#1)(2011-1#1)
parameter with##5##2##(1995-5#1)(2008-5#1)(2011-1#3)
parameter yielded##2##2##(2007-4#1)(2011-1#1)
parameter##775##1##(1990-11#1)(1990-12#5)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#2)(1991-11#2)(1991-2#4)(1991-3#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#4)(1993-1#1)(1993-11#4)(1993-12#1)(1993-3#4)(1993-4#2)(1993-5#1)(1993-8#2)(1993-9#3)(1994-10#1)(1994-11#4)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-4#1)(1995-5#1)(1995-6#4)(1995-7#1)(1995-8#1)(1995-9#2)(1996-12#4)(1996-2#4)(1996-3#3)(1996-4#3)(1996-5#2)(1996-8#2)(1996-9#3)(1997-1#5)(1997-2#6)(1997-3#1)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-9#2)(2005-10#3)(2005-11#10)(2005-4#3)(2006-10#6)(2006-11#2)(2006-12#3)(2006-4#2)(2006-5#3)(2006-6#1)(2006-7#4)(2007-1#1)(2007-11#17)(2007-12#33)(2007-3#3)(2007-4#4)(2007-8#6)(2007-9#4)(2008-1#6)(2008-10#120)(2008-11#16)(2008-12#5)(2008-2#68)(2008-3#68)(2008-4#6)(2008-5#23)(2008-6#11)(2008-7#24)(2008-8#20)(2008-9#10)(2009-1#1)(2009-10#13)(2009-12#9)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#4)(2009-8#3)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#14)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#4)(2010-9#4)(2011-1#12)(2011-2#8)(2012-1#5)(2012-11#1)(2012-12#2)(2012-2#11)(2012-3#6)(2012-7#1)(2013-1#11)(2013-7#1)(2013-8#10)
parameter) values##2##2##(1995-3#2)
parameter)##6##1##(1995-3#2)(2008-10#1)(2008-2#2)(2011-1#1)
parameter-extended##2##1##(2009-4#2)
parameterization and##2##2##(2008-2#1)(2008-3#1)
parameterization of the##6##3##(1997-2#1)(2008-2#2)(2008-3#1)(2008-6#1)(2012-1#1)
parameterization of##10##2##(1992-2#1)(1996-7#1)(1997-2#1)(2008-2#3)(2008-3#1)(2008-6#1)(2008-8#1)(2012-1#1)
parameterization##22##1##(1992-2#1)(1993-7#1)(1995-8#1)(1996-7#1)(1997-2#2)(2008-11#2)(2008-2#5)(2008-3#4)(2008-6#1)(2008-8#1)(2010-12#1)(2010-2#1)(2012-1#1)
parameterizations are##2##2##(2008-2#2)
parameterizations of##2##2##(2008-2#1)(2010-3#1)
parameterizations##9##1##(1995-2#1)(2008-2#3)(2008-3#1)(2008-5#2)(2010-2#1)(2010-3#1)
parameterize the##6##2##(2007-12#1)(2008-3#1)(2009-11#1)(2010-3#1)(2012-1#2)
parameterize##8##1##(2007-12#1)(2008-3#1)(2008-8#2)(2009-11#1)(2010-3#1)(2012-1#2)
parameterized by##2##2##(2008-5#1)(2008-6#1)
parameterized for##2##2##(2008-10#1)(2008-11#1)
parameterized in##2##2##(1997-4#1)(2008-3#1)
parameterized with##3##2##(2007-5#1)(2008-8#1)(2008-9#1)
parameterized##24##1##(1990-3#1)(1992-3#1)(1992-9#2)(1997-4#1)(2006-11#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#6)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#1)
parameterizing##2##1##(1995-2#1)(2008-2#1)
parameters (AUC##2##2##(2011-2#2)
parameters (Vmax and##2##3##(1990-5#1)(1996-7#1)
parameters (alpha##2##2##(2008-10#2)
parameters (concentrations##2##2##(2008-10#2)
parameters (e##6##2##(2006-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2012-3#1)
parameters (i##7##2##(1995-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2013-8#1)
parameters (p##2##2##(2007-10#1)(2008-12#1)
parameters (pH##3##2##(2008-10#1)(2008-3#1)(2010-4#1)
parameters (such as##2##3##(2009-7#1)(2012-11#1)
parameters (temperature and##2##3##(2008-10#1)(2009-6#1)
parameters (temperature##3##2##(2008-10#2)(2009-6#1)
parameters (the##3##2##(2007-8#1)(2008-10#2)
parameters a =##4##3##(1995-3#1)(1997-6#1)(1997-7#1)(2007-11#1)
parameters a##6##2##(1995-3#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-8#1)
parameters affect the performance of##2##5##(2008-2#1)(2010-9#1)
parameters affect the##4##3##(1997-4#1)(2007-8#1)(2008-2#1)(2010-9#1)
parameters affect##5##2##(1997-4#1)(2007-2#1)(2007-8#1)(2008-2#1)(2010-9#1)
parameters affecting the production and collection of the##2##8##(2008-10#2)
parameters affecting the sensitivity of##2##5##(2008-10#1)(2010-5#1)
parameters affecting the##18##3##(1990-12#1)(2007-8#1)(2008-10#15)(2010-5#1)
parameters affecting##24##2##(1990-12#1)(1997-2#1)(2007-8#1)(2008-10#19)(2010-5#1)(2010-6#1)
parameters after##7##2##(1996-3#1)(1997-2#1)(2008-10#1)(2008-3#1)(2012-2#2)(2012-3#1)
parameters along##2##2##(1990-3#1)(2013-1#1)
parameters alpha and beta##2##4##(1995-6#1)(2008-9#1)
parameters alpha and##4##3##(1995-6#1)(2008-6#2)(2008-9#1)
parameters alpha##5##2##(1991-6#1)(1995-6#1)(2008-6#2)(2008-9#1)
parameters also##4##2##(1992-12#1)(2008-4#1)(2008-9#1)(2013-1#1)
parameters analyzed##2##2##(2008-11#1)(2008-5#1)
parameters and a##3##3##(1995-9#1)(2007-11#1)(2008-3#1)
parameters and between##3##3##(1996-9#1)(2007-1#2)
parameters and blood##2##3##(2007-7#1)(2013-8#1)
parameters and can be##2##4##(2010-4#1)(2012-12#1)
parameters and changes##2##3##(1996-11#1)(2009-2#1)
parameters and clinical##3##3##(2010-12#1)(2011-2#1)(2013-8#1)
parameters and fluid overload problems in patients on##2##8##(2007-7#2)
parameters and fluid overload problems in##3##6##(2007-7#3)
parameters and in##2##3##(2006-6#1)(2008-10#1)
parameters and serum##2##3##(2008-1#1)(2011-1#1)
parameters and the relative##2##4##(1994-8#1)(2010-4#1)
parameters and the##23##3##(1990-11#1)(1991-2#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-8#1)(1996-5#1)(2006-11#1)(2007-1#1)(2007-3#1)(2007-8#1)(2008-10#3)(2008-2#3)(2008-3#2)(2010-12#1)(2010-4#1)(2012-1#1)(2013-1#1)
parameters and their##6##3##(1994-6#1)(2008-10#2)(2008-5#1)(2011-2#2)
parameters and to##7##3##(1995-3#1)(1997-7#1)(2007-6#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#1)
parameters and with##2##3##(1996-5#1)(2006-5#1)
parameters and##235##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-2#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-8#2)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#2)(1995-3#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#2)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-7#2)(2005-11#2)(2005-5#1)(2005-8#3)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#3)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#23)(2008-11#2)(2008-12#3)(2008-2#14)(2008-3#15)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#4)(2009-2#2)(2009-5#3)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-2#4)(2010-4#8)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#8)(2012-1#3)(2012-12#7)(2012-2#1)(2012-3#2)(2012-5#1)(2012-9#1)(2013-1#4)(2013-7#4)(2013-8#5)
parameters applied##2##2##(2008-10#1)(2008-11#1)
parameters are also discussed##3##4##(2008-3#1)(2008-4#2)
parameters are also##5##3##(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#2)
parameters are associated with##2##4##(2005-8#1)(2011-12#1)
parameters are calculated##4##3##(1995-4#1)(2008-2#1)(2008-3#2)
parameters are considered##3##3##(1994-8#1)(2008-3#1)(2008-5#1)
parameters are derived##2##3##(2008-3#2)
parameters are determined by a##2##5##(2008-2#1)(2008-3#1)
parameters are determined##3##3##(2005-11#1)(2008-2#1)(2008-3#1)
parameters are discussed##4##3##(2007-9#1)(2008-2#1)(2008-7#1)(2012-1#1)
parameters are estimated by##2##4##(2008-2#2)
parameters are estimated##4##3##(2007-12#1)(2008-2#2)(2008-7#1)
parameters are evaluated##2##3##(2008-10#1)(2008-6#1)
parameters are extracted from##2##4##(2008-3#1)(2010-8#1)
parameters are found##2##3##(2006-10#1)(2008-2#1)
parameters are given##2##3##(1993-2#1)(1996-12#1)
parameters are highly##2##3##(1996-4#1)(1997-2#1)
parameters are known and##2##4##(1995-9#1)(2008-3#1)
parameters are necessary to specify the configuration of such a system##2##11##(2008-3#2)
parameters are not##4##3##(1995-6#1)(2005-1#1)(2008-5#1)(2010-11#1)
parameters are obtained##4##3##(1996-1#1)(2006-1#1)(2007-12#2)
parameters are optimized by##3##4##(2008-1#1)(2008-10#1)(2008-2#1)
parameters are presented##2##3##(2008-3#1)(2010-4#1)
parameters are reported##2##3##(1996-7#1)(2008-10#1)
parameters are shown##2##3##(1990-3#1)(2008-2#1)
parameters are the##4##3##(1993-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
parameters are then##2##3##(2008-2#1)(2008-3#1)
parameters are used##3##3##(1995-12#1)(2008-10#1)(2009-8#1)
parameters are##130##2##(1990-3#1)(1990-5#1)(1990-9#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-1#1)(1993-2#1)(1994-8#1)(1995-12#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-7#2)(2005-1#1)(2005-11#3)(2005-4#1)(2005-8#1)(2006-1#2)(2006-10#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-12#3)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#13)(2008-2#14)(2008-3#21)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#2)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
parameters as a##2##3##(1993-3#1)(2006-12#1)
parameters as large as##2##4##(2007-11#1)(2008-3#1)
parameters as well as the##3##5##(2005-11#1)(2010-2#1)(2013-8#1)
parameters as well as##6##4##(2005-11#2)(2008-12#1)(2010-2#1)(2013-1#1)(2013-8#1)
parameters as well##7##3##(2005-11#2)(2008-10#1)(2008-12#1)(2010-2#1)(2013-1#1)(2013-8#1)
parameters as##24##2##(1993-3#1)(1993-5#1)(1994-5#1)(1997-8#1)(2005-11#2)(2006-12#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#5)(2008-7#1)(2009-4#1)(2009-7#1)(2010-2#1)(2013-1#1)(2013-8#1)
parameters assessed##2##2##(2008-4#1)(2009-6#1)
parameters associated to##2##3##(2008-10#2)
parameters associated with the##5##4##(1993-1#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-3#1)
parameters associated with##10##3##(1992-1#1)(1993-1#1)(1995-5#1)(1997-6#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-12#1)
parameters associated##12##2##(1992-1#1)(1993-1#1)(1995-5#1)(1997-6#1)(2006-10#1)(2006-6#1)(2008-10#3)(2008-2#1)(2008-3#1)(2011-12#1)
parameters at each##3##3##(1990-8#1)(2008-2#1)(2008-6#1)
parameters at the##5##3##(2007-10#1)(2007-7#1)(2008-10#1)(2008-2#1)(2011-2#1)
parameters at##16##2##(1990-8#1)(1991-4#1)(1995-2#1)(1996-1#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-6#1)(2010-4#1)(2011-2#2)
parameters based on a##3##4##(2013-1#3)
parameters based on the##2##4##(2008-10#2)
parameters based on##10##3##(2008-10#3)(2008-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
parameters being##4##2##(1997-2#1)(2008-10#1)(2008-11#1)(2008-9#1)
parameters between the##3##3##(2007-8#1)(2008-10#1)(2010-7#1)
parameters between##11##2##(1994-11#1)(2004-12#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-7#1)(2012-12#1)
parameters both##2##2##(2008-12#1)(2012-1#1)
parameters but not##2##3##(2005-11#1)(2008-7#1)
parameters but##8##2##(1993-8#1)(2004-4#1)(2005-11#1)(2006-10#1)(2008-3#1)(2008-7#2)(2009-6#1)
parameters by a##2##3##(1997-8#1)(2008-2#1)
parameters by means of##2##4##(2007-12#1)(2008-2#1)
parameters by the##2##3##(1997-8#1)(2008-5#1)
parameters by##21##2##(1994-9#1)(1997-8#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#5)(2008-3#1)(2008-5#2)(2009-11#1)(2009-6#1)(2010-3#1)(2010-8#1)(2012-2#2)
parameters calculated for##2##3##(1991-11#1)(1995-8#1)
parameters calculated##3##2##(1990-3#1)(1991-11#1)(1995-8#1)
parameters can be determined##2##4##(2007-12#1)(2008-3#1)
parameters can be estimated##2##4##(2008-10#1)(2010-2#1)
parameters can be measured##3##4##(2008-3#3)
parameters can be obtained##2##4##(2008-10#1)(2008-2#1)
parameters can be used as##2##5##(2007-5#1)(2012-12#1)
parameters can be used to##2##5##(1997-7#1)(2008-2#1)
parameters can be used##6##4##(1997-7#1)(2007-5#1)(2008-2#1)(2009-5#1)(2011-1#1)(2012-12#1)
parameters can be##28##3##(1990-9#1)(1993-11#2)(1994-11#1)(1997-7#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#7)(2008-6#1)(2009-4#1)(2009-5#1)(2010-2#1)(2011-1#1)(2011-12#1)(2012-12#1)
parameters can lead##2##3##(2008-1#1)(2013-8#1)
parameters can##40##2##(1990-9#1)(1993-11#2)(1994-11#1)(1994-2#1)(1994-8#1)(1997-7#1)(2005-12#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#1)(2008-6#1)(2009-4#1)(2009-5#1)(2010-2#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2013-8#1)
parameters cannot be##2##3##(2008-10#1)(2008-3#1)
parameters changed##3##2##(2012-1#1)(2013-1#2)
parameters characteristic##2##2##(2008-3#1)(2013-1#1)
parameters characterizing the##3##3##(1997-2#1)(2006-9#1)(2011-1#1)
parameters characterizing##6##2##(1997-2#1)(2005-11#1)(2006-9#1)(2008-5#1)(2008-6#1)(2011-1#1)
parameters considered##8##2##(1990-10#1)(1990-11#1)(1993-7#1)(1997-1#1)(2004-4#1)(2006-11#1)(2008-3#1)(2008-5#1)
parameters controlling##3##2##(2006-10#1)(2008-10#1)(2011-1#1)
parameters corresponding to##3##3##(2008-2#2)(2010-10#1)
parameters could be##4##3##(1991-12#1)(1993-7#1)(2007-12#1)(2011-2#1)
parameters could##7##2##(1991-12#1)(1993-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)
parameters decreased##3##2##(1992-2#1)(1992-5#1)(2008-10#1)
parameters delta H##2##3##(1990-2#1)(1992-9#1)
parameters derived from the##3##4##(1995-8#1)(2008-10#1)(2008-5#1)
parameters derived from##10##3##(1991-11#1)(1995-5#1)(1995-8#1)(1996-9#1)(2006-11#1)(2008-10#3)(2008-2#1)(2008-5#1)
parameters describing the##6##3##(2005-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#2)
parameters describing##11##2##(1996-8#1)(2005-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-7#1)(2012-2#1)
parameters determined##2##2##(2005-11#1)(2006-12#1)
parameters did not##5##3##(1992-6#1)(1995-12#1)(1996-3#1)(2007-9#1)(2008-4#1)
parameters displayed##2##2##(1994-3#1)(2009-4#1)
parameters do not##4##3##(2007-11#1)(2008-3#1)(2012-12#2)
parameters do##5##2##(1994-3#1)(2007-11#1)(2008-3#1)(2012-12#2)
parameters during the study##2##4##(2006-8#1)(2008-5#1)
parameters during the##6##3##(2006-8#1)(2007-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)
parameters during##14##2##(1990-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)(2012-1#3)(2013-7#1)
parameters e##2##2##(2008-4#1)(2011-12#1)
parameters estimated by##3##3##(1994-9#1)(2008-6#1)(2008-7#1)
parameters estimated##4##2##(1994-9#1)(2008-5#1)(2008-6#1)(2008-7#1)
parameters evaluated by##2##3##(2011-1#1)(2011-7#1)
parameters evaluated were##2##3##(1995-6#1)(2008-1#1)
parameters evaluated##10##2##(1990-9#1)(1992-3#1)(1995-6#1)(2006-8#1)(2008-1#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-7#1)(2013-8#1)
parameters extracted##2##2##(2007-12#1)(2012-12#1)
parameters follow##2##2##(1992-7#1)(2008-10#1)
parameters for G##2##3##(1991-11#2)
parameters for a##4##3##(2008-10#2)(2008-3#1)(2009-4#1)
parameters for assessing the##2##4##(1990-3#1)(2008-10#1)
parameters for assessment of##2##4##(2008-4#1)(2013-1#1)
parameters for both##3##3##(1995-5#1)(2008-10#2)
parameters for describing##2##3##(1995-2#1)(2008-3#1)
parameters for determination of##4##4##(2007-12#1)(2008-10#2)(2013-1#1)
parameters for the determination of##3##5##(2008-10#3)
parameters for the formation of##2##5##(1992-3#1)(2008-10#1)
parameters for the interaction of##2##5##(2008-10#2)
parameters for the interconversion##3##4##(1990-9#1)(2008-10#2)
parameters for the##56##3##(1990-12#1)(1990-2#1)(1990-9#1)(1992-3#2)(1992-9#1)(1993-8#1)(1994-5#1)(1995-2#2)(1996-2#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-12#1)(2005-11#1)(2006-7#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#21)(2008-11#1)(2008-2#3)(2008-3#2)(2008-7#1)(2009-7#1)(2011-2#2)(2013-1#1)
parameters for this##2##3##(1992-6#1)(2013-1#1)
parameters for water quality##2##4##(2008-10#2)
parameters for##184##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-11#3)(1991-2#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-3#3)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-8#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-10#2)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#1)(1996-2#1)(1996-4#2)(1996-5#1)(1996-7#2)(1997-2#3)(1997-4#2)(1997-8#3)(2004-12#2)(2005-10#1)(2005-11#2)(2006-12#1)(2006-7#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#2)(2007-9#1)(2008-10#47)(2008-11#6)(2008-12#2)(2008-2#13)(2008-3#17)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2013-1#5)
parameters from a##3##3##(2008-8#1)(2010-2#1)(2011-2#1)
parameters from the##6##3##(1995-9#1)(2005-11#1)(2007-12#1)(2008-3#2)(2009-3#1)
parameters from##34##2##(1992-2#1)(1995-2#1)(1995-5#2)(1995-9#1)(2005-11#2)(2007-12#2)(2007-9#1)(2008-2#2)(2008-3#11)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
parameters gave##2##2##(2008-5#1)(2008-7#1)
parameters governing##3##2##(1991-8#1)(2008-2#1)(2008-5#1)
parameters had##4##2##(1994-5#1)(2008-10#3)
parameters has a##2##3##(2008-10#1)(2008-3#1)
parameters has been##4##3##(2005-11#1)(2007-11#1)(2008-10#1)(2008-2#1)
parameters has##9##2##(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2011-2#1)
parameters have a##3##3##(2005-11#1)(2008-10#1)(2010-12#1)
parameters have been determined##2##4##(2008-10#1)(2008-3#1)
parameters have been investigated##2##4##(2008-10#2)
parameters have been measured##2##4##(1992-12#1)(1994-9#1)
parameters have been optimised##2##4##(2008-10#2)
parameters have been optimized##3##4##(1993-2#1)(2008-10#2)
parameters have been##25##3##(1992-12#1)(1993-2#1)(1994-9#1)(1997-2#1)(2005-11#1)(2006-10#1)(2008-10#12)(2008-2#2)(2008-3#2)(2009-10#1)(2009-3#1)(2010-2#1)
parameters have not##2##3##(2007-12#1)(2009-10#1)
parameters have##33##2##(1992-12#1)(1992-8#1)(1993-2#1)(1994-9#1)(1997-2#1)(2005-11#2)(2006-10#1)(2007-12#1)(2008-10#15)(2008-2#2)(2008-3#2)(2009-10#2)(2009-3#1)(2010-12#1)(2010-2#1)
parameters in a##5##3##(1993-6#1)(2008-3#2)(2008-5#1)(2012-2#1)
parameters in all##3##3##(1992-1#1)(2008-10#1)(2011-1#1)
parameters in any##2##3##(1993-11#1)(1996-5#1)
parameters in comparison##2##3##(1996-12#1)(2010-4#1)
parameters in each##3##3##(1994-3#1)(1995-4#1)(2008-10#1)
parameters in healthy##4##3##(1991-12#1)(2006-9#1)(2010-12#2)
parameters in normal##4##3##(2005-10#1)(2006-12#1)(2012-12#1)(2013-8#1)
parameters in order to##3##4##(1995-8#1)(2008-12#1)(2013-1#1)
parameters in patients with##4##4##(2006-6#1)(2010-12#1)(2013-1#2)
parameters in patients##6##3##(2006-6#1)(2010-12#1)(2012-12#2)(2013-1#2)
parameters in the model##3##4##(2006-10#1)(2008-7#2)
parameters in the rat##2##4##(1991-5#1)(1996-5#1)
parameters in the##45##3##(1990-12#1)(1990-2#1)(1991-12#1)(1991-5#2)(1992-6#1)(1994-8#1)(1995-8#1)(1995-9#3)(1996-5#1)(1996-7#1)(1997-2#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-11#1)(2007-12#3)(2007-9#1)(2008-10#5)(2008-2#4)(2008-5#1)(2008-6#1)(2008-7#3)(2009-8#1)(2010-4#1)(2010-8#2)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
parameters in this##3##3##(2006-10#1)(2010-1#1)(2010-12#1)
parameters in##185##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-12#2)(1991-5#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-8#2)(1995-9#3)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-10#2)(2005-11#1)(2005-4#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-2#2)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#15)(2008-12#3)(2008-2#8)(2008-3#7)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#4)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#4)(2010-3#1)(2010-4#3)(2010-8#3)(2011-1#5)(2011-12#3)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#8)(2013-8#3)
parameters include the##2##3##(2007-12#1)(2007-8#1)
parameters include##9##2##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-9#1)(2012-2#1)
parameters included the##2##3##(2007-7#1)(2008-11#1)
parameters included##4##2##(2005-11#1)(2007-7#1)(2008-11#1)(2011-1#1)
parameters including pH##2##3##(2008-10#1)(2013-8#1)
parameters including reagent##2##3##(2008-10#2)
parameters including the##2##3##(2008-10#1)(2008-12#1)
parameters including##21##2##(1994-5#1)(1995-7#1)(1996-7#1)(2007-8#1)(2008-10#5)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
parameters increased with##3##3##(1997-4#1)(2007-2#1)(2008-5#1)
parameters increased##5##2##(1997-4#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-5#1)
parameters independently##2##2##(1995-4#1)(2008-7#1)
parameters indicated##3##2##(1996-9#1)(2008-10#1)(2012-12#1)
parameters influence the##3##3##(1996-5#1)(2008-2#1)(2008-3#1)
parameters influencing the##7##3##(1992-9#1)(1996-5#1)(2008-10#2)(2008-7#1)(2012-1#1)(2012-3#1)
parameters influencing##8##2##(1992-9#1)(1996-5#1)(2008-10#2)(2008-7#1)(2012-1#1)(2012-2#1)(2012-3#1)
parameters into##2##2##(2008-10#1)(2008-9#1)
parameters investigated include##2##3##(2004-12#1)(2009-5#1)
parameters investigated##10##2##(1991-1#1)(1994-6#1)(1995-4#1)(2004-12#1)(2006-8#2)(2008-10#2)(2008-3#1)(2009-5#1)
parameters involved in the##3##4##(2006-12#1)(2008-10#1)(2008-11#1)
parameters involved in##8##3##(1990-11#1)(1992-7#2)(1995-12#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
parameters involved##11##2##(1990-11#1)(1992-7#2)(1995-12#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2010-12#1)
parameters is determined by##2##4##(2012-1#1)(2012-3#1)
parameters is investigated##2##3##(2008-10#1)(2008-2#1)
parameters is obtained##3##3##(2008-10#1)(2008-3#2)
parameters is proposed##3##3##(2007-9#1)(2008-3#1)(2013-1#1)
parameters is##36##2##(1990-12#1)(1992-12#1)(1995-12#1)(1996-12#1)(1996-7#1)(1996-8#1)(2005-11#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#6)(2008-5#1)(2008-7#2)(2008-9#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
parameters known to##2##3##(2006-6#1)(2007-11#1)
parameters like the##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
parameters like##20##2##(1990-11#1)(1994-6#1)(2004-4#1)(2006-10#1)(2007-10#1)(2008-10#5)(2008-11#4)(2008-3#1)(2008-7#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-7#1)
parameters makes it##2##3##(2007-12#1)(2008-3#1)
parameters makes##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
parameters may be##5##3##(1995-6#1)(1997-1#1)(2008-12#1)(2008-6#1)(2008-7#1)
parameters may##6##2##(1995-6#1)(1997-1#1)(2006-6#1)(2008-12#1)(2008-6#1)(2008-7#1)
parameters measured by##2##3##(1995-5#1)(2008-3#1)
parameters measured for##2##3##(1995-10#1)(2012-2#1)
parameters measured in this##2##4##(1997-3#1)(2008-10#1)
parameters measured in##3##3##(1997-3#1)(2008-10#2)
parameters measured##9##2##(1995-10#1)(1995-5#1)(1996-1#1)(1997-3#1)(2008-10#2)(2008-3#1)(2012-2#2)
parameters mentioned##2##2##(1990-11#1)(2008-10#1)
parameters might##2##2##(2012-2#1)(2012-3#1)
parameters most often##2##3##(2008-10#1)(2008-3#1)
parameters namely##3##2##(2008-4#1)(2009-6#1)(2012-3#1)
parameters necessary for##2##3##(2008-9#1)(2009-4#1)
parameters need##2##2##(2008-2#1)(2008-7#1)
parameters needed to##5##3##(1994-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-7#1)
parameters needed##7##2##(1994-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2010-7#1)
parameters not##3##2##(2007-11#1)(2007-8#1)(2013-1#1)
parameters observed after##2##3##(1990-5#1)(1997-2#1)
parameters observed##3##2##(1990-5#1)(1997-2#1)(2006-4#1)
parameters obtained from the##2##4##(2008-2#1)(2008-3#1)
parameters obtained from##6##3##(1994-11#1)(1995-2#1)(1996-3#1)(2005-11#1)(2008-2#1)(2008-3#1)
parameters obtained were##4##3##(2008-10#2)(2008-5#1)(2013-7#1)
parameters obtained with##2##3##(2008-10#1)(2008-2#1)
parameters obtained##17##2##(1994-11#1)(1995-12#1)(1995-2#1)(1996-3#1)(2005-11#1)(2005-4#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-7#1)
parameters of RBC##2##3##(2008-12#2)
parameters of a particle##2##4##(2008-2#1)(2008-3#1)
parameters of a single##2##4##(1990-12#1)(2007-12#1)
parameters of a##23##3##(1990-12#1)(2004-12#1)(2005-4#1)(2006-4#1)(2007-12#6)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#2)(2012-3#1)
parameters of adsorption##2##3##(2007-10#1)(2008-2#1)
parameters of an##5##3##(2008-2#2)(2008-3#1)(2008-5#1)(2013-1#1)
parameters of arterial##2##3##(1991-4#1)(2013-8#1)
parameters of artificial##2##3##(2012-1#2)
parameters of blood##2##3##(2010-12#1)(2013-7#1)
parameters of both##6##3##(1990-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#1)
parameters of cell##2##3##(1992-9#1)(2009-10#1)
parameters of cirrus##2##3##(2008-3#2)
parameters of each##2##3##(2008-3#1)(2012-12#1)
parameters of forensic interest##3##4##(2008-12#3)
parameters of general##2##3##(2006-6#1)(2007-11#1)
parameters of healthy##2##3##(2008-5#1)(2011-1#1)
parameters of heart rate variability##2##5##(2013-1#1)(2013-8#1)
parameters of insulin resistance##2##4##(2005-1#1)(2008-1#1)
parameters of interest for##2##4##(2008-3#2)
parameters of interest##9##3##(1993-9#1)(1995-6#1)(1996-7#1)(2008-10#1)(2008-3#2)(2008-9#1)(2012-12#2)
parameters of large##2##3##(2008-2#1)(2008-4#1)
parameters of laser-induced potentials##2##4##(2012-1#2)
parameters of light##3##3##(2007-11#1)(2007-12#2)
parameters of neural##2##3##(2008-10#1)(2008-7#1)
parameters of oxidative stress##2##4##(2007-8#1)(2007-9#1)
parameters of protein##2##3##(2008-1#1)(2011-2#1)
parameters of rainbow trout (Oncorhynchus##2##5##(2008-7#2)
parameters of rat##2##3##(2009-6#1)(2013-7#1)
parameters of reproductive organs have been examined and discussed##3##9##(2008-5#3)
parameters of reproductive organs##5##4##(2008-3#1)(2008-5#4)
parameters of skin##3##3##(2009-9#1)(2012-3#1)(2013-8#1)
parameters of such##2##3##(2008-3#2)
parameters of synaptic transmission##2##4##(2008-7#1)(2009-9#1)
parameters of the RBFNNs##2##4##(2008-10#1)(2008-2#1)
parameters of the binary##2##4##(2008-10#2)
parameters of the calibration##2##4##(2008-10#1)(2009-8#1)
parameters of the cell##2##4##(1992-1#1)(2007-12#1)
parameters of the complex##2##4##(1991-4#1)(2008-7#1)
parameters of the instrument##2##4##(2008-2#1)(2013-8#1)
parameters of the log-normal distribution##2##5##(2005-11#2)
parameters of the method##3##4##(2007-8#1)(2008-10#2)
parameters of the model were##2##5##(1991-9#1)(2012-1#1)
parameters of the model##10##4##(1991-9#1)(1996-8#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-6#1)(2011-1#1)(2012-1#1)
parameters of the sample##2##4##(2008-10#1)(2011-2#1)
parameters of the skin##2##4##(2008-3#1)(2008-5#1)
parameters of the structure##2##4##(2007-12#1)(2008-3#1)
parameters of the study##2##4##(2011-2#1)(2013-1#1)
parameters of the system##2##4##(2007-11#1)(2008-10#1)
parameters of the tolerance distribution##2##5##(1995-4#2)
parameters of the two##2##4##(2007-12#1)(2008-10#1)
parameters of the underlying##3##4##(2008-4#1)(2008-7#1)(2009-11#1)
parameters of the##181##3##(1990-2#1)(1990-3#1)(1990-5#2)(1990-8#1)(1991-11#1)(1991-12#3)(1991-4#1)(1991-9#1)(1992-1#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-8#3)(1994-9#2)(1995-4#2)(1995-5#2)(1996-4#1)(1996-8#1)(1997-2#1)(1997-4#1)(2004-2#1)(2005-11#5)(2005-12#1)(2006-10#2)(2006-5#3)(2007-10#2)(2007-11#6)(2007-12#10)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#26)(2008-11#1)(2008-2#13)(2008-3#27)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#6)(2008-8#2)(2009-10#1)(2009-11#2)(2009-2#1)(2009-4#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#7)(2011-3#1)(2012-1#5)(2012-2#3)(2012-9#1)(2013-1#3)(2013-7#1)(2013-8#2)
parameters of their##2##3##(2009-4#1)(2011-1#1)
parameters of these##3##3##(1991-4#1)(1995-2#1)(2008-10#1)
parameters of this##5##3##(1996-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
parameters of various##2##3##(2008-12#1)(2008-3#1)
parameters of which##2##3##(2008-11#1)(2008-2#1)
parameters of##518##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#3)(1990-8#2)(1991-11#2)(1991-12#3)(1991-2#1)(1991-4#3)(1991-9#2)(1992-1#2)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#2)(1993-11#1)(1993-3#1)(1993-9#1)(1994-11#4)(1994-2#2)(1994-6#3)(1994-8#3)(1994-9#2)(1995-1#2)(1995-11#1)(1995-2#2)(1995-4#2)(1995-5#2)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#2)(1996-5#2)(1996-7#2)(1996-8#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-12#1)(2004-2#1)(2005-1#3)(2005-10#1)(2005-11#9)(2005-12#3)(2005-4#1)(2005-7#1)(2006-10#4)(2006-4#2)(2006-5#4)(2006-6#2)(2006-8#3)(2007-1#1)(2007-10#3)(2007-11#15)(2007-12#23)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#5)(2007-9#3)(2008-1#4)(2008-10#60)(2008-11#5)(2008-12#9)(2008-2#37)(2008-3#57)(2008-4#8)(2008-5#18)(2008-6#5)(2008-7#13)(2008-8#3)(2008-9#5)(2009-10#3)(2009-11#2)(2009-2#2)(2009-4#4)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-3#3)(2010-4#2)(2010-6#1)(2010-8#2)(2011-1#15)(2011-2#15)(2011-3#3)(2012-1#14)(2012-12#4)(2012-2#8)(2012-3#3)(2012-9#1)(2013-1#15)(2013-7#5)(2013-8#7)
parameters on the recovery of##2##5##(2008-10#2)
parameters on the resolution##2##4##(1997-8#1)(2008-10#1)
parameters on the response##2##4##(2008-10#2)
parameters on the retention##2##4##(1996-5#1)(2008-11#1)
parameters on the##32##3##(1991-5#1)(1995-9#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-2#2)(1997-8#1)(2005-11#1)(2007-12#1)(2008-10#10)(2008-11#5)(2008-2#2)(2008-3#2)(2010-4#1)(2011-2#2)
parameters on##54##2##(1991-5#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-2#2)(1997-8#1)(2005-11#1)(2006-9#1)(2007-11#1)(2007-12#2)(2008-10#17)(2008-11#7)(2008-2#3)(2008-3#4)(2008-6#2)(2008-7#2)(2010-4#1)(2011-2#2)(2013-1#1)
parameters only##4##2##(1994-8#1)(1996-9#1)(2008-3#1)(2011-10#1)
parameters optimized were##2##3##(2008-10#2)
parameters or the##2##3##(2008-2#2)
parameters or##5##2##(2007-12#1)(2008-2#2)(2009-4#1)(2011-3#1)
parameters over a##2##3##(2008-2#1)(2008-3#1)
parameters over##5##2##(2006-8#1)(2008-2#1)(2008-3#2)(2013-8#1)
parameters provide##2##2##(2008-4#1)(2009-10#1)
parameters ranged##2##2##(1990-2#1)(2013-7#1)
parameters rather than##2##3##(2008-3#1)(2010-12#1)
parameters reflecting the##2##3##(2008-10#1)(2012-1#1)
parameters related to the##14##4##(1992-9#1)(1993-6#1)(1994-6#1)(2008-10#7)(2008-2#1)(2008-7#2)(2010-8#1)
parameters related to##19##3##(1992-9#1)(1993-6#1)(1994-6#2)(2008-10#8)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-8#1)(2011-2#1)
parameters related##20##2##(1992-9#1)(1993-6#1)(1994-6#2)(2008-10#8)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-8#1)(2011-2#1)(2012-1#1)
parameters relevant to##2##3##(2008-10#1)(2012-1#1)
parameters remained##4##2##(1990-5#1)(1991-6#1)(2009-5#1)(2013-1#1)
parameters required for##2##3##(2008-2#1)(2008-7#1)
parameters required##3##2##(1990-10#1)(2008-2#1)(2008-7#1)
parameters returned to normal##2##4##(1992-8#1)(2005-12#1)
parameters returned to##3##3##(1992-8#1)(1993-12#1)(2005-12#1)
parameters revealed##3##2##(1996-9#1)(2007-10#1)(2008-5#1)
parameters should be taken##2##4##(1991-1#1)(2005-10#1)
parameters should be##6##3##(1991-1#1)(2005-10#1)(2008-10#3)(2008-3#1)
parameters should##9##2##(1991-1#1)(2005-10#1)(2006-10#1)(2006-4#1)(2008-10#3)(2008-2#1)(2008-3#1)
parameters show a##3##3##(1992-7#1)(1992-9#1)(1996-10#1)
parameters show that##2##3##(2008-10#1)(2010-4#1)
parameters show##6##2##(1992-7#1)(1992-9#1)(1996-10#1)(2008-10#1)(2010-4#1)(2012-1#1)
parameters showed##6##2##(1995-12#1)(1996-3#1)(1997-4#1)(2008-10#1)(2008-3#1)(2009-6#1)
parameters simultaneously##4##2##(2008-3#1)(2008-9#1)(2009-4#1)(2010-2#1)
parameters studied include##2##3##(2007-10#1)(2012-2#1)
parameters studied##10##2##(1994-6#1)(1994-8#1)(1995-1#1)(2006-6#1)(2007-10#1)(2008-10#1)(2008-4#1)(2010-4#1)(2011-1#1)(2012-2#1)
parameters successfully##2##2##(1996-4#1)(2008-10#1)
parameters such as blood##2##4##(1997-5#1)(2008-10#1)
parameters such as initial##2##4##(2007-10#1)(2008-2#1)
parameters such as membrane##2##4##(2008-10#1)(2011-12#1)
parameters such as pH##13##4##(1996-5#1)(2006-12#2)(2007-10#1)(2007-8#1)(2008-10#6)(2008-5#1)(2008-6#1)
parameters such as sample##3##4##(2008-10#3)
parameters such as temperature##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
parameters such as the##29##4##(2004-11#1)(2005-11#1)(2008-10#13)(2008-2#2)(2008-3#5)(2008-7#1)(2008-8#1)(2009-8#1)(2011-3#1)(2012-12#1)(2013-8#2)
parameters such as##119##3##(1990-8#1)(1992-5#1)(1994-5#1)(1995-2#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-8#1)(2004-11#1)(2005-11#3)(2006-12#2)(2006-5#1)(2006-9#2)(2007-10#2)(2007-12#1)(2007-4#1)(2007-8#3)(2008-1#1)(2008-10#43)(2008-12#1)(2008-2#4)(2008-3#11)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-8#2)(2010-12#4)(2010-7#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#4)
parameters such that##2##3##(1993-12#1)(2008-3#1)
parameters such##121##2##(1990-8#1)(1992-5#1)(1993-12#1)(1994-5#1)(1995-2#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-8#1)(2004-11#1)(2005-11#3)(2006-12#2)(2006-5#1)(2006-9#2)(2007-10#2)(2007-12#1)(2007-4#1)(2007-8#3)(2008-1#1)(2008-10#43)(2008-12#1)(2008-2#4)(2008-3#12)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-8#2)(2010-12#4)(2010-7#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#4)
parameters suggested that##2##3##(2008-3#1)(2010-9#1)
parameters suitable for##2##3##(2008-10#1)(2011-1#1)
parameters than##3##2##(1995-2#1)(2008-2#1)(2013-8#1)
parameters that affect the##8##4##(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2011-1#1)
parameters that affect##13##3##(1990-12#1)(1992-3#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-1#1)
parameters that are##7##3##(1990-5#1)(1997-8#1)(2005-12#1)(2007-3#1)(2008-2#1)(2008-3#2)
parameters that can be##3##4##(1991-7#1)(2008-11#1)(2008-3#1)
parameters that can##6##3##(1991-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-11#1)(2013-1#1)
parameters that characterize the surface##2##5##(2008-3#2)
parameters that characterize the##7##4##(2007-12#2)(2008-2#1)(2008-3#3)(2008-4#1)
parameters that characterize##8##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)
parameters that correspond to##2##4##(2008-3#2)
parameters that could be##2##4##(2007-8#1)(2012-2#1)
parameters that could##3##3##(2007-8#1)(2011-2#1)(2012-2#1)
parameters that describe the##3##4##(1990-8#1)(2008-10#1)(2008-5#1)
parameters that describe##4##3##(1990-8#1)(2008-10#1)(2008-3#1)(2008-5#1)
parameters that determine the##2##4##(2007-12#1)(2013-8#1)
parameters that determine##3##3##(2007-12#1)(2008-3#1)(2013-8#1)
parameters that have been##2##4##(2005-10#1)(2008-3#1)
parameters that have prognostic##2##4##(2008-9#1)(2010-10#1)
parameters that have##6##3##(2005-10#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-10#1)(2011-3#1)
parameters that influence the##4##4##(1996-1#1)(2008-10#3)
parameters that may##3##3##(2007-9#1)(2009-10#1)(2009-11#1)
parameters that were##2##3##(2008-10#1)(2008-6#1)
parameters that##93##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-7#1)(1992-3#1)(1993-5#1)(1995-9#1)(1996-1#1)(1997-8#1)(2005-10#1)(2005-12#1)(2006-12#1)(2007-1#1)(2007-12#4)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#18)(2008-11#2)(2008-2#4)(2008-3#15)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-2#2)(2010-3#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
parameters the##5##2##(2006-10#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-9#1)
parameters through##2##2##(2008-3#2)
parameters to a##2##3##(1991-11#1)(2005-4#1)
parameters to be determined##3##4##(2008-3#3)
parameters to be##9##3##(2006-7#1)(2008-10#3)(2008-2#1)(2008-3#4)
parameters to determine##2##3##(2006-12#1)(2009-10#1)
parameters to evaluate the##2##4##(2008-10#1)(2012-2#1)
parameters to guide##3##3##(2012-12#2)(2013-1#1)
parameters to obtain##2##3##(2008-2#1)(2012-12#1)
parameters to predict the##2##4##(2008-10#1)(2010-7#1)
parameters to predict##4##3##(2008-10#1)(2008-6#1)(2010-7#1)(2012-12#1)
parameters to the##6##3##(1997-8#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
parameters to##66##2##(1991-11#1)(1995-5#1)(1997-8#2)(2005-11#1)(2005-4#1)(2006-10#1)(2006-12#2)(2006-7#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#9)(2008-5#2)(2008-6#1)(2008-7#5)(2009-10#1)(2009-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#5)(2012-2#1)(2013-1#1)(2013-8#2)
parameters under##3##2##(1995-4#1)(1995-6#1)(2008-2#1)
parameters used in the##2##4##(1990-5#1)(2007-10#1)
parameters used in##3##3##(1990-5#1)(2007-10#1)(2013-1#1)
parameters used to##4##3##(2007-6#1)(2008-2#1)(2010-2#1)(2013-1#1)
parameters used##15##2##(1990-5#1)(1992-9#1)(2006-11#1)(2007-10#1)(2007-4#1)(2007-6#1)(2008-12#1)(2008-2#2)(2008-3#1)(2010-2#1)(2010-6#1)(2012-12#1)(2013-1#2)
parameters using maximum##2##3##(2008-4#1)(2012-3#1)
parameters using the##2##3##(2008-5#1)(2008-6#1)
parameters using##10##2##(1994-7#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-3#1)
parameters was built##2##3##(2005-12#1)(2008-2#1)
parameters was done##2##3##(2008-10#1)(2012-2#1)
parameters was evaluated##2##3##(1996-9#1)(2013-8#1)
parameters was needed##2##3##(1996-4#1)(2012-12#1)
parameters was observed##4##3##(1991-11#1)(2009-5#1)(2011-1#1)(2013-1#1)
parameters was obtained##2##3##(2008-3#1)(2012-2#1)
parameters was##34##2##(1991-11#1)(1992-3#1)(1996-4#1)(1996-9#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-11#1)(2006-9#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-5#1)(2011-1#3)(2011-12#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
parameters we##3##2##(2007-12#1)(2008-5#1)(2011-2#1)
parameters were also##5##3##(2008-10#1)(2008-7#1)(2010-4#2)(2013-1#1)
parameters were applied to##2##4##(2008-10#1)(2011-1#1)
parameters were assessed in##2##4##(2008-10#1)(2010-4#1)
parameters were assessed##7##3##(2008-10#2)(2008-4#1)(2009-6#1)(2010-4#1)(2013-1#1)(2013-8#1)
parameters were calculated for##2##4##(2010-7#1)(2012-12#1)
parameters were calculated using the##2##5##(2008-11#1)(2009-8#1)
parameters were calculated using##3##4##(2008-11#1)(2008-5#1)(2009-8#1)
parameters were calculated##11##3##(1995-6#1)(1997-8#1)(2005-4#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-8#1)(2010-7#1)(2012-12#1)
parameters were chosen##2##3##(1995-5#1)(2005-4#1)
parameters were compared with the##2##5##(1994-8#1)(2007-10#1)
parameters were compared with##3##4##(1994-8#1)(2007-10#1)(2010-12#1)
parameters were compared##7##3##(1992-7#1)(1994-8#1)(1995-4#1)(1996-9#1)(2007-10#1)(2008-5#1)(2010-12#1)
parameters were correlated##2##3##(2008-10#1)(2008-5#1)
parameters were derived from##3##4##(2006-11#1)(2008-10#1)(2008-5#1)
parameters were determined by##3##4##(1991-8#1)(2008-3#1)(2011-2#1)
parameters were determined for##4##4##(1990-6#1)(2006-8#1)(2007-11#1)(2008-3#1)
parameters were determined from##2##4##(2006-4#1)(2008-10#1)
parameters were determined in##3##4##(2006-8#1)(2008-7#1)(2012-12#1)
parameters were determined using##2##4##(2007-1#1)(2008-5#1)
parameters were determined##22##3##(1990-6#1)(1991-12#1)(1991-5#1)(1991-8#1)(1997-3#1)(2005-11#1)(2006-4#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-3#2)(2008-5#2)(2008-7#1)(2011-2#2)(2012-12#1)
parameters were established##2##3##(2008-10#2)
parameters were estimated##3##3##(2007-10#1)(2008-2#1)(2011-2#1)
parameters were evaluated in##3##4##(1994-8#1)(2008-7#1)(2010-4#1)
parameters were evaluated##14##3##(1990-3#1)(1994-8#1)(1997-1#1)(2005-1#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-10#1)(2010-12#1)(2010-4#1)(2013-8#1)
parameters were examined##2##3##(1991-11#1)(2006-6#1)
parameters were followed##3##3##(1991-11#1)(1991-9#1)(2007-7#1)
parameters were found to be##3##5##(1996-3#1)(2007-12#1)(2009-6#1)
parameters were found to##5##4##(1996-3#1)(2007-1#1)(2007-12#1)(2009-6#1)(2013-7#1)
parameters were found##7##3##(1996-3#1)(2005-1#1)(2007-1#1)(2007-12#1)(2008-10#1)(2009-6#1)(2013-7#1)
parameters were in good agreement##2##5##(2008-2#1)(2008-3#1)
parameters were investigated##6##3##(2008-10#6)
parameters were measured##8##3##(2007-7#1)(2007-8#1)(2008-8#1)(2009-2#1)(2010-4#1)(2011-2#1)(2013-8#2)
parameters were normalized after##2##4##(1996-3#1)(2009-10#1)
parameters were normalized##3##3##(1996-3#1)(2009-10#1)(2012-3#1)
parameters were not significantly##2##4##(1993-4#1)(2008-12#1)
parameters were not##7##3##(1992-11#1)(1993-4#1)(1994-6#1)(1996-9#1)(2008-10#1)(2008-12#1)(2008-6#1)
parameters were observed with##2##4##(2007-8#1)(2008-5#1)
parameters were observed##4##3##(1991-5#1)(2007-8#1)(2008-5#2)
parameters were obtained##7##3##(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#2)(2012-1#1)(2012-12#1)
parameters were optimised##4##3##(2008-10#4)
parameters were optimized for the determination of##3##7##(2008-10#3)
parameters were optimized for##4##4##(2008-10#4)
parameters were optimized##14##3##(2007-8#2)(2008-10#12)
parameters were quantified##2##3##(2008-10#1)(2009-7#1)
parameters were recorded##3##3##(1995-6#1)(2007-10#1)(2012-2#1)
parameters were significantly##2##3##(2006-8#1)(2007-9#1)
parameters were similar for##2##4##(1994-11#1)(1994-4#1)
parameters were similar in##2##4##(1993-4#1)(1996-4#1)
parameters were similar##4##3##(1993-4#1)(1994-11#1)(1994-4#1)(1996-4#1)
parameters were studied and##3##4##(2004-11#1)(2008-10#2)
parameters were studied in##2##4##(1994-3#1)(2008-4#1)
parameters were studied##13##3##(1994-3#1)(1994-5#1)(2004-11#1)(2006-9#1)(2008-1#1)(2008-10#6)(2008-4#1)(2008-5#1)
parameters were tested##3##3##(2008-10#3)
parameters were the##3##3##(1996-12#1)(2008-10#2)
parameters were used to determine the##2##6##(1993-1#1)(1996-12#1)
parameters were used to##5##4##(1993-1#1)(1996-12#1)(2007-11#2)(2008-7#1)
parameters were used##6##3##(1993-1#1)(1996-12#1)(2007-11#2)(2008-3#1)(2008-7#1)
parameters were##245##2##(1990-3#1)(1990-6#1)(1991-11#2)(1991-12#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-7#1)(1993-1#1)(1993-4#2)(1993-8#1)(1994-11#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#2)(1996-7#2)(1996-9#2)(1997-1#1)(1997-3#1)(1997-8#1)(2004-11#1)(2004-4#2)(2005-1#2)(2005-11#1)(2005-12#1)(2005-4#2)(2006-11#1)(2006-4#1)(2006-6#1)(2006-8#4)(2006-9#2)(2007-1#2)(2007-10#5)(2007-11#3)(2007-12#2)(2007-2#1)(2007-7#4)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#64)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#3)(2008-5#14)(2008-6#3)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#4)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-4#5)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#12)(2012-1#2)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#6)
parameters when##3##2##(2004-12#1)(2006-5#1)(2008-5#1)
parameters which are##3##3##(2006-9#1)(2008-10#1)(2008-7#1)
parameters which influence##2##3##(2008-10#1)(2012-2#1)
parameters which were##5##3##(2008-10#2)(2008-7#1)(2010-1#1)(2013-8#1)
parameters which##17##2##(1990-8#1)(1992-12#1)(1994-8#1)(2006-9#1)(2007-7#1)(2008-10#4)(2008-6#1)(2008-7#2)(2010-1#1)(2010-5#1)(2012-2#2)(2013-8#1)
parameters will##3##2##(1994-3#1)(2008-3#1)(2011-12#1)
parameters with a##5##3##(2008-10#1)(2008-2#1)(2008-3#2)(2013-1#1)
parameters with great##2##3##(2008-3#1)(2011-1#1)
parameters with those##3##3##(1994-3#1)(1996-2#1)(2012-1#1)
parameters with##19##2##(1994-3#1)(1996-2#1)(2006-6#1)(2006-8#3)(2008-10#1)(2008-2#1)(2008-3#4)(2009-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-10#1)(2012-1#1)(2013-1#1)
parameters within the##2##3##(2006-4#1)(2008-10#1)
parameters within##3##2##(2006-4#1)(2008-10#1)(2008-3#1)
parameters##3824##1##(1990-10#5)(1990-11#9)(1990-12#8)(1990-2#8)(1990-3#9)(1990-4#2)(1990-5#14)(1990-6#2)(1990-7#3)(1990-8#8)(1990-9#7)(1991-1#4)(1991-10#4)(1991-11#12)(1991-12#12)(1991-2#3)(1991-3#1)(1991-4#9)(1991-5#8)(1991-6#2)(1991-7#4)(1991-8#5)(1991-9#8)(1992-1#6)(1992-10#3)(1992-11#4)(1992-12#11)(1992-2#8)(1992-3#11)(1992-4#1)(1992-5#5)(1992-6#6)(1992-7#10)(1992-8#10)(1992-9#14)(1993-1#3)(1993-11#6)(1993-12#6)(1993-2#5)(1993-3#6)(1993-4#4)(1993-5#2)(1993-6#2)(1993-7#2)(1993-8#4)(1993-9#6)(1994-10#2)(1994-11#12)(1994-12#4)(1994-2#4)(1994-3#15)(1994-4#2)(1994-5#11)(1994-6#13)(1994-7#2)(1994-8#15)(1994-9#7)(1995-1#10)(1995-10#3)(1995-11#3)(1995-12#9)(1995-2#17)(1995-3#4)(1995-4#11)(1995-5#12)(1995-6#10)(1995-7#2)(1995-8#10)(1995-9#10)(1996-1#12)(1996-10#4)(1996-11#7)(1996-12#8)(1996-2#15)(1996-3#11)(1996-4#15)(1996-5#12)(1996-7#16)(1996-8#6)(1996-9#10)(1997-1#8)(1997-2#27)(1997-3#6)(1997-4#10)(1997-5#3)(1997-6#8)(1997-7#14)(1997-8#13)(2004-11#6)(2004-12#9)(2004-2#1)(2004-4#6)(2004-9#1)(2005-1#8)(2005-10#13)(2005-11#54)(2005-12#10)(2005-4#10)(2005-5#1)(2005-7#5)(2005-8#5)(2005-9#1)(2006-1#4)(2006-10#28)(2006-11#9)(2006-12#19)(2006-2#5)(2006-3#2)(2006-4#7)(2006-5#9)(2006-6#15)(2006-7#5)(2006-8#22)(2006-9#12)(2007-1#20)(2007-10#28)(2007-11#59)(2007-12#97)(2007-2#13)(2007-3#6)(2007-4#9)(2007-5#10)(2007-6#5)(2007-7#27)(2007-8#59)(2007-9#21)(2008-1#27)(2008-10#600)(2008-11#54)(2008-12#50)(2008-2#231)(2008-3#336)(2008-4#56)(2008-5#113)(2008-6#43)(2008-7#106)(2008-8#38)(2008-9#40)(2009-1#1)(2009-10#14)(2009-11#6)(2009-12#5)(2009-2#8)(2009-3#6)(2009-4#18)(2009-5#23)(2009-6#21)(2009-7#8)(2009-8#21)(2009-9#6)(2010-1#2)(2010-10#9)(2010-11#7)(2010-12#24)(2010-2#30)(2010-3#11)(2010-4#35)(2010-5#7)(2010-6#3)(2010-7#10)(2010-8#20)(2010-9#11)(2011-1#59)(2011-10#3)(2011-12#15)(2011-2#93)(2011-3#8)(2011-7#1)(2012-1#46)(2012-11#2)(2012-12#48)(2012-2#53)(2012-3#29)(2012-5#1)(2012-7#1)(2012-9#3)(2013-1#90)(2013-3#1)(2013-7#20)(2013-8#55)
parameters&quot##2##1##(1990-9#1)(2011-2#1)
parameters'##2##1##(2008-10#1)(2008-11#1)
parameters)##8##1##(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2012-2#1)
parameters?##3##1##(1993-6#1)(2006-10#1)(2007-11#1)
parameters]##6##1##(1990-8#1)(1991-11#1)(1992-4#1)(1994-4#1)(2011-2#1)(2012-3#1)
parametres##3##1##(2008-10#1)(2008-5#1)(2008-8#1)
parametric amplification by##2##3##(2007-12#1)(2008-3#1)
parametric amplification for##2##3##(2007-12#2)
parametric amplification in a##2##4##(2007-11#1)(2007-12#1)
parametric amplification in periodically poled KTiOPO(4)##2##6##(2007-11#1)(2007-12#1)
parametric amplification in##6##3##(2007-11#3)(2007-12#3)
parametric amplification of high-order harmonics##2##5##(2007-12#2)
parametric amplification of##7##3##(2007-12#6)(2008-2#1)
parametric amplification##30##2##(2007-11#7)(2007-12#21)(2008-2#1)(2008-3#1)
parametric amplifier by##2##3##(2007-11#1)(2007-12#1)
parametric amplifier is##4##3##(2007-12#3)(2008-1#1)
parametric amplifier pumped by a##3##5##(2007-11#1)(2007-12#1)(2008-1#1)
parametric amplifier pumped by##5##4##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)
parametric amplifier seeded with##2##4##(2007-12#1)(2008-2#1)
parametric amplifier with##2##3##(2007-11#2)
parametric amplifier##53##2##(2007-11#11)(2007-12#30)(2008-1#5)(2008-2#6)(2008-3#1)
parametric amplifiers##3##2##(2007-12#3)
parametric and non-parametric##2##3##(1995-4#1)(1997-7#1)
parametric and nonparametric components##4##4##(2009-10#1)(2010-2#2)(2010-7#1)
parametric and nonparametric##8##3##(2008-10#1)(2009-10#3)(2010-2#2)(2010-7#1)(2012-1#1)
parametric and##11##2##(1995-4#1)(1997-7#1)(2008-10#1)(2009-10#3)(2010-2#3)(2010-7#1)(2012-1#1)
parametric approach##2##2##(1996-12#1)(1997-2#1)
parametric assumptions on the dependence##2##5##(2010-8#2)
parametric assumptions##3##2##(1995-12#1)(2010-8#2)
parametric bootstrap##3##2##(2006-5#2)(2008-10#1)
parametric chirped pulse amplification##5##4##(2007-11#3)(2007-12#1)(2008-3#1)
parametric conversion##2##2##(2007-12#2)
parametric converter##2##2##(2007-12#1)(2008-1#1)
parametric downconversion in a##2##4##(2008-3#2)
parametric downconversion##9##2##(2007-11#2)(2007-12#4)(2008-2#1)(2008-3#2)
parametric equations##2##2##(2007-9#1)(2008-3#1)
parametric fluorescence##2##2##(2007-12#2)
parametric four-wave mixing##2##3##(2007-12#2)
parametric frequency conversion##2##3##(2007-12#2)
parametric gain in a##2##4##(2007-12#1)(2008-3#1)
parametric gain##8##2##(2007-11#4)(2007-12#3)(2008-3#1)
parametric gap solitons in##2##4##(2007-12#2)
parametric generation in##7##3##(2007-12#6)(2008-1#1)
parametric generation##8##2##(2007-12#7)(2008-1#1)
parametric generator based on##3##4##(2007-12#3)
parametric generator was##2##3##(2007-11#1)(2007-12#1)
parametric generator##15##2##(2007-11#2)(2007-12#12)(2008-2#1)
parametric generators##2##2##(2007-11#2)
parametric interaction in a##2##4##(2007-11#1)(2007-12#1)
parametric interaction in##5##3##(2007-11#1)(2007-12#4)
parametric interaction of##2##3##(2007-12#1)(2008-3#1)
parametric interaction##8##2##(2007-11#1)(2007-12#5)(2008-3#2)
parametric interactions##3##2##(2007-11#2)(2008-2#1)
parametric methods##3##2##(1992-8#1)(1997-6#1)(2008-11#1)
parametric model##7##2##(2008-10#2)(2008-11#1)(2008-2#2)(2010-1#1)(2011-1#1)
parametric models in##2##3##(1995-9#1)(2013-1#1)
parametric models##12##2##(1993-5#1)(1995-9#2)(1996-1#5)(2007-12#1)(2010-1#1)(2011-1#1)(2013-1#1)
parametric oscillation are##2##3##(2007-12#1)(2008-3#1)
parametric oscillation in periodically poled lithium niobate##2##7##(2007-12#1)(2008-3#1)
parametric oscillation in periodically poled##3##5##(2007-11#1)(2007-12#1)(2008-3#1)
parametric oscillation in##7##3##(2007-11#2)(2007-12#3)(2008-3#2)
parametric oscillation is##2##3##(2007-11#1)(2007-12#1)
parametric oscillation of##2##3##(2007-12#1)(2008-3#1)
parametric oscillation##23##2##(2007-11#5)(2007-12#11)(2008-3#7)
parametric oscillator based on##22##4##(2007-11#5)(2007-12#15)(2008-1#2)
parametric oscillator pumped by a##8##5##(2007-12#4)(2008-2#2)(2008-3#2)
parametric oscillator pumped by##10##4##(2007-12#5)(2008-2#3)(2008-3#2)
parametric oscillator pumped##11##3##(2007-12#6)(2008-2#3)(2008-3#2)
parametric oscillator using periodically poled##2##5##(2008-1#2)
parametric oscillator using##3##3##(2008-1#3)
parametric oscillator with a##4##4##(2007-11#1)(2007-12#2)(2008-3#1)
parametric oscillator with##11##3##(2007-11#1)(2007-12#8)(2008-1#1)(2008-3#1)
parametric oscillator##193##2##(2007-11#33)(2007-12#112)(2008-1#13)(2008-10#1)(2008-2#10)(2008-3#23)(2008-5#1)
parametric oscillators (OPO's)##5##3##(2007-12#3)(2008-3#2)
parametric oscillators##31##2##(2007-11#6)(2007-12#20)(2008-1#1)(2008-2#1)(2008-3#3)
parametric perspex##2##2##(1997-8#2)
parametric power##2##2##(2007-11#1)(2007-12#1)
parametric process##5##2##(2007-11#1)(2007-12#4)
parametric processes in##3##3##(2007-12#3)
parametric processes##5##2##(2007-11#1)(2007-12#4)
parametric regression##2##2##(1995-8#1)(2008-10#1)
parametric sensitivity##2##2##(2006-10#1)(2008-2#1)
parametric solitons##3##2##(2007-11#1)(2007-12#2)
parametric spectral##2##2##(2007-12#1)(2009-3#1)
parametric statistics##2##2##(2006-10#2)
parametric studies##2##2##(2006-11#1)(2008-2#1)
parametric study##4##2##(1991-2#1)(2007-4#2)(2008-3#1)
parametric survival##2##2##(1997-7#1)(2007-1#1)
parametric tests##2##2##(2008-7#1)(2009-4#1)
parametric wave mixing in##2##4##(2007-11#1)(2008-1#1)
parametric wave mixing##4##3##(2007-11#1)(2007-12#2)(2008-1#1)
parametric##571##1##(1991-12#1)(1991-2#1)(1992-8#1)(1993-5#2)(1993-6#1)(1995-12#1)(1995-4#1)(1995-8#2)(1995-9#2)(1996-1#5)(1996-12#1)(1996-7#3)(1997-2#2)(1997-4#1)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#3)(2004-9#1)(2005-4#1)(2006-10#5)(2006-11#1)(2006-5#2)(2007-1#1)(2007-11#93)(2007-12#277)(2007-4#2)(2007-9#2)(2008-1#23)(2008-10#12)(2008-11#3)(2008-2#33)(2008-3#45)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#3)(2009-11#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#3)(2010-12#2)(2010-2#4)(2010-5#1)(2010-7#2)(2010-8#4)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
parametrically defined##2##2##(2008-3#2)
parametrically varied##2##2##(2009-2#1)(2009-4#1)
parametrically##11##1##(2006-11#1)(2007-11#1)(2007-12#2)(2008-3#2)(2008-4#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-12#1)
parametrization of##3##2##(2006-4#1)(2007-9#1)(2008-6#1)
parametrization##4##1##(2006-4#1)(2007-9#1)(2008-6#1)(2010-11#1)
parametrized##3##1##(2006-10#1)(2008-3#1)(2011-1#1)
paramo##2##1##(2013-7#2)
paramos##2##1##(2013-7#2)
paramount importance to##12##3##(1991-5#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-7#1)(2010-11#1)(2011-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
paramount importance##29##2##(1990-10#1)(1990-5#1)(1991-5#1)(1994-12#1)(1996-2#1)(1997-7#1)(2004-11#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-7#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
paramount in order to##2##4##(2007-12#1)(2013-7#1)
paramount in##4##2##(2007-12#2)(2009-10#1)(2013-7#1)
paramount##52##1##(1990-10#1)(1990-5#1)(1991-10#1)(1991-5#1)(1994-12#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-7#1)(2004-11#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#2)(2008-12#1)(2008-2#3)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
paramyosin##5##1##(2006-10#5)
paramyxovirus##12##1##(1997-6#1)(2005-12#2)(2005-9#1)(2007-2#1)(2008-5#4)(2008-8#1)(2008-9#1)(2012-2#1)
paramyxoviruses##3##1##(1997-6#1)(2005-7#1)(2005-9#1)
paranasal sinus and skull base surgery##2##6##(2007-5#2)
paranasal sinus surgery##3##3##(2007-5#3)
paranasal sinus##9##2##(1991-11#1)(2007-5#5)(2008-7#2)(2013-1#1)
paranasal sinuses and##3##3##(2005-5#1)(2006-6#1)(2007-7#1)
paranasal sinuses is##2##3##(2007-4#1)(2009-2#1)
paranasal sinuses##23##2##(1990-6#1)(1991-6#1)(1992-10#1)(1993-4#2)(2005-5#1)(2006-12#3)(2006-6#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-3#2)(2009-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
paranasal sinusitis##5##2##(2010-6#1)(2013-1#4)
paranasal##42##1##(1990-6#1)(1991-11#2)(1991-6#1)(1992-10#1)(1993-4#2)(2005-5#1)(2006-12#3)(2006-6#1)(2007-4#1)(2007-5#5)(2007-7#1)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#2)(2009-2#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#7)(2013-8#2)
paraneoplasic neurological syndromes##3##3##(1996-11#3)
paraneoplasic##4##1##(1996-11#4)
paraneoplastic cerebellar degeneration##3##3##(1997-8#1)(2008-11#1)(2011-2#1)
paraneoplastic cholestasis##2##2##(1997-7#2)
paraneoplastic limbic encephalitis##3##3##(1994-3#1)(2013-7#2)
paraneoplastic neurologic syndrome##2##3##(1994-3#2)
paraneoplastic neurologic##4##2##(1994-3#2)(1996-11#1)(2012-12#1)
paraneoplastic neurological syndromes##2##3##(2008-11#1)(2013-1#1)
paraneoplastic neurological##4##2##(2008-11#2)(2013-1#2)
paraneoplastic sensory neuropathy##2##3##(2009-3#2)
paraneoplastic syndrome in##2##3##(1990-12#1)(2006-9#1)
paraneoplastic syndrome##10##2##(1990-12#1)(1996-1#1)(1997-5#1)(2006-10#1)(2006-9#2)(2008-6#2)(2013-1#1)(2013-7#1)
paraneoplastic syndromes associated with renal cell carcinoma##3##7##(2006-9#3)
paraneoplastic syndromes associated with##4##4##(2006-9#3)(2009-3#1)
paraneoplastic syndromes##13##2##(1994-9#1)(1996-1#1)(1997-7#1)(2006-9#3)(2009-3#2)(2009-5#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
paraneoplastic##52##1##(1990-12#1)(1992-5#1)(1994-3#3)(1994-9#1)(1996-1#3)(1996-11#1)(1997-5#1)(1997-7#7)(1997-8#1)(2005-11#1)(2006-10#2)(2006-9#5)(2007-9#1)(2008-11#3)(2008-6#2)(2009-3#4)(2009-5#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#5)(2013-7#4)(2013-8#1)
paranoia##5##1##(1991-1#1)(2004-3#1)(2008-7#1)(2011-1#1)(2011-2#1)
paranoid and##2##2##(1996-8#1)(2007-7#1)
paranoid patients##3##2##(1996-8#1)(2007-5#2)
paranoid personality##2##2##(2005-7#1)(2006-8#1)
paranoid psychoses##2##2##(1993-5#1)(1995-11#1)
paranoid schizophrenia we##2##3##(1997-8#1)(2011-2#1)
paranoid schizophrenia##14##2##(1997-8#5)(2007-7#2)(2009-9#2)(2010-6#1)(2011-2#2)(2012-2#2)
paranoid schizophrenic##2##2##(1992-12#1)(2007-7#1)
paranoid##33##1##(1992-12#1)(1993-5#1)(1995-11#1)(1996-7#1)(1996-8#2)(1997-2#1)(1997-8#6)(2005-7#1)(2006-8#1)(2007-5#3)(2007-7#6)(2009-9#2)(2010-6#1)(2011-2#2)(2012-2#3)(2013-7#1)
paranoid-hallucinatory psychosis##2##2##(1996-10#1)(1996-7#1)
paranoid-hallucinatory##3##1##(1996-10#2)(1996-7#1)
paraoesophageal lymph nodes##5##3##(2005-1#5)
paraoesophageal##8##1##(1997-3#1)(2005-1#7)
paraophthalmic##2##1##(2012-3#2)
paraoxon and##2##2##(1996-12#1)(2008-10#1)
paraoxon with##3##2##(1995-11#1)(2008-10#1)(2010-2#1)
paraoxon##23##1##(1991-7#1)(1995-11#1)(1996-12#2)(1997-4#2)(2007-11#2)(2008-10#11)(2010-2#2)(2012-11#2)
paraoxonase 1 (PON1)##3##3##(2010-2#1)(2012-12#1)(2013-8#1)
paraoxonase 1##9##2##(2009-12#1)(2009-2#1)(2010-2#1)(2012-12#5)(2013-8#1)
paraoxonase activity was##2##3##(1991-9#1)(1996-3#1)
paraoxonase activity##5##2##(1991-9#1)(1996-3#4)
paraoxonase##23##1##(1991-9#1)(1995-9#3)(1996-3#6)(2009-12#1)(2009-2#1)(2010-2#2)(2012-12#8)(2013-8#1)
paraparesis after##2##2##(2009-4#1)(2013-1#1)
paraparesis in a##2##3##(2008-7#1)(2009-4#1)
paraparesis in##4##2##(2006-10#1)(2008-7#1)(2009-4#2)
paraparesis##24##1##(1991-11#1)(1991-8#1)(1997-6#1)(2006-10#2)(2006-7#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2009-4#4)(2012-1#2)(2012-12#3)(2013-1#3)
parapatellar##4##1##(2009-3#1)(2012-12#1)(2013-1#2)
parapatric##2##1##(2008-6#1)(2010-8#1)
parapatry##2##1##(2010-8#2)
parapharyngeal abscess##4##2##(2008-8#1)(2008-9#1)(2009-7#2)
parapharyngeal space tumors##2##3##(2006-12#1)(2012-3#1)
parapharyngeal space##10##2##(2006-12#5)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#2)
parapharyngeal##16##1##(2006-12#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#2)(2011-2#2)(2012-2#2)(2012-3#2)
paraphernalia##2##1##(2008-11#1)(2012-11#1)
paraphrenia##4##1##(2011-2#4)
paraphyletic##3##1##(1997-4#1)(2007-12#2)
paraphyly of##2##2##(1993-6#1)(2012-12#1)
paraplantaricin C7##7##2##(2007-12#7)
paraplantarum C7##2##2##(2007-12#2)
paraplantarum##4##1##(2007-12#3)(2012-2#1)
paraplegia and##3##2##(2008-12#1)(2011-2#1)(2013-1#1)
paraplegia following##3##2##(1996-3#1)(2008-7#1)(2012-2#1)
paraplegia or paraparesis##3##3##(2009-4#1)(2012-1#2)
paraplegia##30##1##(1992-1#1)(1992-5#1)(1995-9#1)(1996-3#1)(2007-10#3)(2007-3#1)(2007-7#1)(2007-8#5)(2008-12#2)(2008-7#6)(2009-4#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#1)
paraplegic athletes##2##2##(2013-1#2)
paraplegic##6##1##(2006-12#1)(2011-2#1)(2012-1#2)(2013-1#2)
paraplegics##5##1##(1991-6#1)(1996-9#1)(2012-1#3)
paraprofessional home##2##2##(1992-1#1)(2012-2#1)
paraprofessional##3##1##(1991-12#1)(1992-1#1)(2012-2#1)
paraprosthetic leak##2##2##(2007-8#1)(2009-8#1)
paraprosthetic##3##1##(2007-8#2)(2009-8#1)
paraprotein##2##1##(1993-9#1)(2008-1#1)
paraproteinemia##2##1##(1991-7#1)(1992-12#1)
parapsilosis and##3##2##(2009-9#1)(2010-5#1)(2012-2#1)
parapsilosis in a##2##3##(2006-10#2)
parapsilosis##29##1##(1997-2#3)(2006-10#3)(2006-4#3)(2007-7#2)(2007-8#3)(2008-5#8)(2009-9#1)(2010-5#1)(2012-2#2)(2012-3#2)(2013-1#1)
parapyramidal##2##1##(1993-7#1)(1994-2#1)
paraquat herbicide##2##2##(2008-10#2)
paraquat in##8##2##(1993-3#1)(2008-10#7)
paraquat poisoning##2##2##(2012-2#2)
paraquat using a##2##3##(2008-10#2)
paraquat##30##1##(1993-3#4)(1995-7#2)(2008-10#19)(2008-3#1)(2008-5#1)(2012-2#2)(2013-8#1)
parasagittal AVM##3##2##(2008-7#3)
parasagittal##13##1##(1991-3#1)(1994-2#2)(1995-12#1)(1996-4#1)(2004-11#2)(2006-11#1)(2008-7#4)(2013-1#1)
parasellar##4##1##(2006-12#3)(2007-1#1)
parasexual recombination##4##2##(2008-10#2)(2008-8#1)(2010-10#1)
parasexual##8##1##(1996-9#1)(2008-10#5)(2008-8#1)(2010-10#1)
parasitaemia and##3##2##(2005-8#1)(2006-10#1)(2007-2#1)
parasitaemia##15##1##(1994-11#1)(1995-9#2)(2005-8#2)(2006-10#1)(2006-4#1)(2007-2#2)(2007-8#1)(2008-4#2)(2010-12#1)(2011-2#1)(2013-1#1)
parasitaemic##3##1##(1994-11#1)(2005-8#1)(2007-1#1)
parasite P##2##2##(2010-2#1)(2012-2#1)
parasite Plasmodium falciparum##6##3##(1993-2#1)(1997-1#1)(2006-11#1)(2008-1#1)(2012-2#2)
parasite Plasmodium##7##2##(1993-2#1)(1997-1#1)(2006-11#1)(2008-1#1)(2010-2#1)(2012-2#2)
parasite Toxoplasma gondii##3##3##(2006-10#1)(2007-7#1)(2009-7#1)
parasite abundance##4##2##(2010-8#2)(2011-12#1)(2013-1#1)
parasite and host##4##3##(1996-6#1)(2008-10#1)(2008-9#1)(2011-2#1)
parasite and##15##2##(1992-9#1)(1995-9#1)(1996-6#1)(1997-6#1)(2006-10#2)(2008-10#3)(2008-9#3)(2009-2#1)(2011-2#1)(2012-2#1)
parasite antigen from##2##3##(1996-8#1)(1997-3#1)
parasite antigen##6##2##(1996-8#1)(1997-3#1)(2006-10#1)(2007-2#2)(2007-6#1)
parasite antigens##2##2##(2005-8#1)(2006-10#1)
parasite are##3##2##(2008-3#1)(2008-4#1)(2008-8#1)
parasite belonging to##2##3##(2011-12#1)(2012-2#1)
parasite biology##3##2##(2005-8#1)(2006-10#2)
parasite biomass##2##2##(2006-11#1)(2008-10#1)
parasite clearance##4##2##(2005-8#1)(2007-2#1)(2012-2#2)
parasite control of##2##3##(1997-7#1)(2008-9#1)
parasite control##10##2##(1997-7#5)(2006-10#1)(2006-4#1)(2007-2#1)(2008-4#1)(2008-9#1)
parasite cytoplasm and##2##3##(2012-2#2)
parasite density##6##2##(1994-11#2)(2007-2#4)
parasite detection##4##2##(2007-2#1)(2007-7#1)(2007-8#2)
parasite development##5##2##(1994-8#2)(2006-10#1)(2008-8#1)(2012-2#1)
parasite eggs##2##2##(1996-10#1)(2006-10#1)
parasite epidemiology##2##2##(2006-10#1)(2008-4#1)
parasite growth##5##2##(1994-8#1)(2006-10#1)(2006-4#1)(2010-2#1)(2012-3#1)
parasite in##6##2##(2007-10#1)(2007-3#1)(2008-4#1)(2008-8#1)(2012-12#1)(2013-1#1)
parasite infection##6##2##(1997-7#1)(2006-4#1)(2007-6#1)(2008-5#1)(2008-7#1)(2008-8#1)
parasite infections##3##2##(2006-10#1)(2012-12#2)
parasite is##8##2##(1990-2#1)(2006-10#1)(2007-2#2)(2007-6#1)(2008-8#1)(2012-12#1)(2013-1#1)
parasite isolates##3##2##(2005-8#1)(2008-12#1)(2013-1#1)
parasite lactate dehydrogenase##2##3##(2007-7#2)
parasite life-history traits##4##3##(2006-10#1)(2008-8#3)
parasite life-history##6##2##(2006-10#3)(2008-8#3)
parasite load##2##2##(2007-1#1)(2008-4#1)
parasite may##3##2##(2006-10#1)(2008-8#2)
parasite multiplication##3##2##(2005-9#1)(2007-3#1)(2007-5#1)
parasite of the##4##3##(1994-6#1)(2011-2#3)
parasite of##18##2##(1991-5#1)(1994-6#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-9#2)(2010-3#1)(2011-2#3)(2012-2#1)(2013-1#1)
parasite on##2##2##(2008-8#1)(2010-8#1)
parasite or##3##2##(2006-10#1)(2008-10#1)(2008-11#1)
parasite population structure##3##3##(2006-10#2)(2012-12#1)
parasite population##5##2##(1997-7#1)(2006-10#2)(2008-9#1)(2012-12#1)
parasite populations##4##2##(1997-6#1)(2006-4#1)(2008-8#2)
parasite prevalence##5##2##(1994-11#2)(2005-8#1)(2006-2#1)(2008-4#1)
parasite resistance##3##2##(2009-6#3)
parasite species and diagnostic method##2##5##(2012-12#2)
parasite species##7##2##(1996-12#1)(2011-1#1)(2012-12#5)
parasite strain##2##2##(2006-12#1)(2010-12#1)
parasite success##2##2##(2008-8#2)
parasite that##6##2##(2007-7#1)(2007-9#1)(2008-11#1)(2008-9#2)(2012-2#1)
parasite through##2##2##(2009-5#1)(2010-8#1)
parasite to##4##2##(1996-12#1)(2008-9#1)(2012-12#1)(2012-2#1)
parasite transmission##2##2##(2006-10#1)(2012-12#1)
parasite virulence and##2##3##(2008-8#2)
parasite virulence##14##2##(2006-10#1)(2008-8#12)(2008-9#1)
parasite was##9##2##(1991-10#1)(1991-2#1)(1992-2#1)(2007-2#1)(2008-3#1)(2008-8#1)(2010-12#1)(2011-12#1)(2012-12#1)
parasite were##4##2##(2005-8#1)(2006-10#1)(2008-5#2)
parasite##418##1##(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#3)(1991-5#2)(1992-2#2)(1992-7#5)(1992-8#3)(1992-9#4)(1993-2#3)(1993-4#1)(1993-5#3)(1993-6#1)(1994-11#7)(1994-12#2)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#1)(1995-12#2)(1995-3#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#4)(1996-12#2)(1996-4#1)(1996-6#4)(1996-8#2)(1997-1#1)(1997-3#2)(1997-4#2)(1997-6#4)(1997-7#9)(2004-11#1)(2005-12#1)(2005-7#1)(2005-8#8)(2005-9#1)(2006-10#42)(2006-11#2)(2006-12#1)(2006-2#4)(2006-4#6)(2007-1#1)(2007-10#1)(2007-12#3)(2007-2#14)(2007-3#6)(2007-5#2)(2007-6#5)(2007-7#5)(2007-8#3)(2007-9#4)(2008-1#1)(2008-10#18)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#18)(2008-5#7)(2008-7#2)(2008-8#37)(2008-9#15)(2009-2#2)(2009-5#2)(2009-6#6)(2009-7#2)(2009-8#2)(2010-12#6)(2010-2#5)(2010-3#1)(2010-4#2)(2010-8#9)(2011-1#4)(2011-12#4)(2011-2#10)(2012-12#16)(2012-2#23)(2012-3#6)(2013-1#7)(2013-8#2)
parasite's##7##1##(1990-12#1)(1994-8#1)(2005-7#1)(2006-10#2)(2008-9#1)(2009-8#1)
parasite)##2##1##(2008-8#1)(2008-9#1)
parasite-containing##2##1##(1990-6#1)(1992-5#1)
parasite-host##4##1##(2007-3#2)(2008-8#1)(2008-9#1)
parasite-induced host sterility##3##3##(2008-9#3)
parasite-induced host##4##2##(2008-9#4)
parasite-mediated selection##3##2##(2012-3#3)
parasite-mediated##4##1##(2009-2#1)(2012-3#3)
parasite-specific##3##1##(2008-10#3)
parasitemia was##2##2##(1995-12#1)(2012-12#1)
parasitemia##6##1##(1991-2#1)(1995-12#1)(2012-12#2)(2012-2#2)
parasites among##6##2##(2006-12#1)(2008-12#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
parasites and diseases##2##3##(1997-7#2)
parasites and free-living animals##2##4##(2008-9#2)
parasites and the##4##3##(1997-7#1)(2006-10#2)(2006-4#1)
parasites and their hosts##2##4##(1997-7#1)(2012-3#1)
parasites and their prevalences##2##4##(2011-1#2)
parasites and their##4##3##(1997-7#1)(2011-1#2)(2012-3#1)
parasites and##29##2##(1997-7#4)(2005-10#1)(2005-11#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#3)(2009-10#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#2)
parasites are##12##2##(1996-8#1)(1997-3#1)(2005-9#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-2#1)
parasites at##2##2##(2008-4#1)(2012-2#1)
parasites by##3##2##(1992-12#1)(2008-8#1)(2010-4#1)
parasites capable of##2##3##(2008-9#1)(2010-12#1)
parasites causing##3##2##(2008-3#1)(2011-2#1)(2012-2#1)
parasites could##2##2##(1992-8#1)(2009-2#1)
parasites detected##2##2##(2007-8#1)(2012-3#1)
parasites face##2##2##(2010-3#2)
parasites from##4##2##(1996-12#1)(2010-12#1)(2013-8#2)
parasites in a##2##3##(1994-11#1)(2012-1#1)
parasites in the Umbozero Lake##2##5##(2011-2#2)
parasites in the##7##3##(1996-3#1)(2006-10#1)(2007-8#1)(2008-4#2)(2011-2#2)
parasites in##31##2##(1991-2#1)(1994-11#1)(1995-12#2)(1996-3#1)(1997-7#1)(2006-10#4)(2007-3#1)(2007-8#1)(2008-10#1)(2008-4#3)(2008-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)
parasites is##5##2##(2006-10#2)(2007-3#1)(2011-2#2)
parasites may##2##2##(2007-12#1)(2008-8#1)
parasites might##2##2##(2006-10#1)(2008-8#1)
parasites of plants##4##3##(2007-12#1)(2008-10#3)
parasites of the##4##3##(1997-6#1)(2006-10#1)(2008-10#1)(2013-1#1)
parasites of vertebrates##5##3##(2007-3#5)
parasites of##37##2##(1996-12#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-3#6)(2008-10#6)(2008-4#3)(2008-5#1)(2009-6#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)
parasites on##2##2##(2008-8#1)(2013-1#1)
parasites or##3##2##(1994-3#1)(1997-7#1)(2007-12#1)
parasites should##2##2##(2008-9#1)(2009-2#1)
parasites such as##3##3##(1996-12#1)(2006-10#1)(2012-2#1)
parasites than##2##2##(2008-8#1)(2009-2#1)
parasites that##9##2##(2007-2#1)(2008-1#1)(2008-5#1)(2008-8#4)(2008-9#1)(2012-12#1)
parasites to the##2##3##(2008-10#1)(2008-2#1)
parasites to##7##2##(2006-10#1)(2007-1#1)(2007-9#1)(2008-10#1)(2008-2#1)(2009-6#1)(2010-3#1)
parasites using##2##2##(2009-3#1)(2011-1#1)
parasites was##6##2##(1990-12#1)(2007-11#1)(2008-4#1)(2009-10#1)(2012-2#1)(2013-1#1)
parasites were detected##3##3##(2006-4#1)(2007-1#1)(2011-1#1)
parasites were exposed to##2##4##(1997-4#2)
parasites were found##2##3##(2007-2#1)(2011-1#1)
parasites were identified##2##3##(2008-4#1)(2011-2#1)
parasites were##21##2##(1993-5#1)(1997-4#2)(2005-8#1)(2006-4#1)(2007-1#1)(2007-2#2)(2007-3#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#2)(2009-10#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#1)
parasites which##2##2##(2006-11#1)(2013-8#1)
parasites with##3##2##(2007-7#1)(2008-8#1)(2009-3#1)
parasites##383##1##(1990-12#1)(1990-3#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-3#1)(1993-5#2)(1994-11#6)(1994-12#2)(1994-3#1)(1994-9#1)(1995-12#2)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#6)(1996-3#1)(1996-8#2)(1997-3#3)(1997-4#4)(1997-6#1)(1997-7#13)(2005-10#1)(2005-11#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#35)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#4)(2006-5#1)(2007-1#4)(2007-11#2)(2007-12#9)(2007-2#7)(2007-3#11)(2007-7#9)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#1)(2008-12#5)(2008-2#2)(2008-3#4)(2008-4#23)(2008-5#9)(2008-7#1)(2008-8#25)(2008-9#14)(2009-10#4)(2009-2#4)(2009-3#4)(2009-6#5)(2010-1#1)(2010-12#4)(2010-2#4)(2010-3#8)(2010-4#2)(2010-8#2)(2011-1#19)(2011-12#1)(2011-2#13)(2012-1#1)(2012-12#9)(2012-2#22)(2012-3#12)(2013-1#14)(2013-8#4)
parasitic and viral##2##3##(1995-5#1)(2007-2#1)
parasitic and##7##2##(1995-5#1)(1996-1#1)(2006-10#1)(2007-2#2)(2008-10#1)(2011-2#1)
parasitic cause##3##2##(2011-1#2)(2011-2#1)
parasitic dermatitis##2##2##(1996-6#2)
parasitic disease caused by##2##4##(2006-10#1)(2010-11#1)
parasitic disease of##3##3##(1996-10#1)(2007-3#1)(2011-2#1)
parasitic disease##11##2##(1996-10#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-3#1)(2008-8#1)(2010-1#1)(2010-11#1)(2011-2#2)
parasitic diseases in##3##3##(2011-12#1)(2011-2#1)(2012-3#1)
parasitic diseases##15##2##(1992-2#1)(1995-9#2)(1996-1#1)(1997-7#1)(2007-2#1)(2008-1#1)(2010-12#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-3#1)
parasitic female##2##2##(2008-8#2)
parasitic fitness##3##2##(2008-10#3)
parasitic flatworms##2##2##(2006-10#1)(2013-8#1)
parasitic helminths##3##2##(2006-10#1)(2008-4#1)(2013-1#1)
parasitic infection in##2##3##(2007-7#1)(2012-2#1)
parasitic infection rate##2##3##(2011-1#2)
parasitic infection##14##2##(1995-5#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-1#3)(2012-12#1)(2012-2#1)(2012-3#1)
parasitic infections in##2##3##(2006-10#1)(2007-12#1)
parasitic infections##14##2##(1997-6#1)(1997-7#1)(2006-10#2)(2007-12#1)(2007-7#1)(2008-12#2)(2008-4#1)(2010-12#1)(2012-12#1)(2012-2#2)(2013-7#1)
parasitic infestations##2##2##(1994-6#1)(2009-7#1)
parasitic lasing##3##2##(2007-12#3)
parasitic nematode##3##2##(1990-6#1)(1991-7#1)(2007-12#1)
parasitic nematodes##5##2##(2007-11#2)(2008-10#2)(2008-8#1)
parasitic on I##3##3##(2008-10#3)
parasitic on cowpea##2##3##(2008-10#2)
parasitic on##6##2##(2007-7#1)(2008-10#5)
parasitic protist Trichomonas vaginalis##2##4##(1997-4#1)(2008-7#1)
parasitic protozoa##4##2##(1990-7#1)(1997-7#1)(2006-10#1)(2006-11#1)
parasitic spawning##2##2##(2010-8#2)
parasitic species##3##2##(1996-1#1)(2006-10#2)
parasitic wasp##5##2##(1990-11#1)(2007-12#2)(2011-12#2)
parasitic wasps##5##2##(1990-11#1)(2007-12#1)(2009-8#2)(2011-12#1)
parasitic weed##2##2##(2008-10#2)
parasitic worms##2##2##(2009-8#1)(2013-8#1)
parasitic##187##1##(1990-11#2)(1990-2#1)(1990-6#1)(1990-7#2)(1991-7#1)(1992-1#1)(1992-2#1)(1994-6#1)(1995-1#1)(1995-5#2)(1995-9#2)(1996-1#3)(1996-10#1)(1996-6#2)(1997-4#1)(1997-6#1)(1997-7#4)(2005-11#1)(2006-10#12)(2006-11#1)(2006-12#1)(2006-5#2)(2007-1#1)(2007-11#3)(2007-12#9)(2007-2#7)(2007-3#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#18)(2008-12#2)(2008-2#5)(2008-3#3)(2008-4#2)(2008-6#4)(2008-7#2)(2008-8#9)(2008-9#4)(2009-6#1)(2009-7#1)(2009-8#5)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-8#4)(2011-1#7)(2011-12#7)(2011-2#11)(2012-12#5)(2012-2#8)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
parasitica and##3##2##(2008-10#3)
parasitica in North America##2##4##(2008-10#2)
parasitica in##6##2##(2008-10#6)
parasitica isolates##3##2##(2008-10#3)
parasitica on##3##2##(2008-10#3)
parasitica var##7##2##(2008-10#7)
parasitica was##4##2##(2008-10#4)
parasitica were##3##2##(2008-10#3)
parasitica##62##1##(1993-3#3)(1995-6#1)(1996-11#1)(2008-10#56)(2008-9#1)
parasitics##2##1##(2007-12#1)(2008-2#1)
parasiticus during infection of susceptible crops such as maize##2##9##(2008-10#2)
parasiticus##11##1##(1991-4#1)(1992-9#1)(2008-10#4)(2008-11#2)(2009-3#3)
parasitised by##2##2##(2010-2#2)
parasitised##4##1##(1996-11#1)(2010-2#3)
parasitism and##4##2##(1997-7#1)(2007-12#1)(2008-10#1)(2008-5#1)
parasitism by##3##2##(1995-3#1)(2008-6#1)(2008-8#1)
parasitism in birds##2##3##(2008-8#1)(2008-9#1)
parasitism in##11##2##(2007-3#1)(2008-6#2)(2008-8#4)(2008-9#2)(2012-12#2)
parasitism index##3##2##(2008-6#2)(2012-12#1)
parasitism is##2##2##(2008-8#1)(2008-9#1)
parasitism may##2##2##(2008-9#2)
parasitism of##9##2##(1991-2#2)(2007-6#1)(2008-10#2)(2008-6#3)(2008-8#1)
parasitism on##3##2##(2006-10#1)(2008-10#1)(2010-8#1)
parasitism rate##4##2##(2007-11#1)(2007-6#1)(2008-6#2)
parasitism rates##4##2##(2008-6#1)(2011-12#3)
parasitism##88##1##(1991-12#1)(1991-2#2)(1995-3#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-6#3)(2008-10#7)(2008-5#1)(2008-6#17)(2008-8#21)(2008-9#15)(2009-3#1)(2010-2#1)(2010-8#4)(2011-12#4)(2012-12#4)
parasitism-specific##2##1##(2007-12#2)
parasitization##3##1##(2008-8#1)(2010-4#1)(2011-12#1)
parasitize an##2##2##(2008-8#2)
parasitize##9##1##(2007-3#1)(2008-10#5)(2008-8#2)(2013-8#1)
parasitized by the##2##3##(1992-6#1)(2008-9#1)
parasitized by##10##2##(1992-6#1)(2008-10#1)(2008-5#1)(2008-6#3)(2008-9#3)(2010-4#1)
parasitized cells##6##2##(1990-2#1)(1997-1#5)
parasitized erythrocytes##5##2##(1990-2#2)(1993-8#2)(2007-9#1)
parasitized more##2##2##(2008-10#2)
parasitized red blood cells##3##4##(1990-12#1)(2008-4#1)(2012-12#1)
parasitized the##2##2##(2007-6#1)(2008-10#1)
parasitized##43##1##(1990-12#1)(1990-2#5)(1992-6#2)(1993-8#2)(1997-1#5)(2007-6#1)(2007-9#1)(2008-10#8)(2008-4#1)(2008-5#1)(2008-6#3)(2008-8#2)(2008-9#3)(2009-3#1)(2010-4#2)(2011-12#1)(2012-12#1)(2013-1#1)(2013-8#2)
parasitizes##5##1##(2007-12#3)(2008-10#1)(2010-4#1)
parasitizing the##3##2##(2008-5#1)(2008-8#1)(2012-2#1)
parasitizing##9##1##(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
parasitoid Hymenoptera##2##2##(2007-12#1)(2008-9#1)
parasitoid larva##3##2##(2007-12#3)
parasitoid larvae##3##2##(2007-12#3)
parasitoid of##2##2##(2007-6#1)(2011-12#1)
parasitoid species##9##2##(1995-1#1)(2007-6#1)(2008-8#2)(2010-2#3)(2011-12#2)
parasitoid taxa##2##2##(2007-12#2)
parasitoid virulence##2##2##(2008-8#2)
parasitoid wasp##3##2##(1992-6#1)(1995-1#1)(2008-8#1)
parasitoid##58##1##(1992-6#1)(1995-1#3)(2007-12#18)(2007-6#2)(2008-6#4)(2008-8#8)(2008-9#5)(2009-8#2)(2010-2#3)(2011-12#12)
parasitoids and##2##2##(2008-6#1)(2011-2#1)
parasitoids in##2##2##(2008-9#1)(2011-12#1)
parasitoids of##3##2##(2007-6#1)(2008-6#1)(2009-6#1)
parasitoids were##7##2##(2007-3#1)(2008-6#1)(2008-9#1)(2011-12#4)
parasitoids##39##1##(2007-12#1)(2007-3#2)(2007-6#2)(2008-6#6)(2008-8#1)(2008-9#8)(2009-6#3)(2009-8#3)(2010-2#1)(2011-12#10)(2011-2#1)(2013-8#1)
parasitological and##2##2##(2007-7#1)(2010-1#1)
parasitological data##2##2##(2008-8#2)
parasitological failure rates##2##3##(2005-8#2)
parasitological failure##3##2##(2005-8#2)(2009-6#1)
parasitological##22##1##(1992-2#1)(1996-12#1)(2005-8#2)(2006-10#1)(2007-2#3)(2007-7#1)(2008-12#1)(2008-8#2)(2009-6#2)(2010-1#1)(2010-12#1)(2012-12#3)(2012-2#1)(2013-1#2)
parasitologists##3##1##(1997-7#2)(2006-10#1)
parasitology in##2##2##(1997-7#1)(2008-9#1)
parasitology##20##1##(1994-12#1)(1997-7#5)(2006-10#2)(2008-8#3)(2008-9#1)(2009-10#1)(2010-1#5)(2010-12#1)(2010-3#1)
parasitoses##2##1##(2006-6#1)(2010-12#1)
parasitosis among##5##2##(1996-12#1)(2006-2#2)(2012-3#2)
parasitosis##15##1##(1996-12#1)(2006-2#2)(2006-4#2)(2007-11#1)(2007-7#3)(2009-10#1)(2011-1#2)(2012-3#3)
paraspinal activity##3##2##(2006-7#3)
paraspinal tumors##2##2##(2006-2#2)
paraspinal##16##1##(2006-2#3)(2006-7#8)(2007-1#2)(2008-12#2)(2009-9#1)
parasternal lymph nodes##3##3##(1993-8#3)
parasternal lymph##4##2##(1993-8#4)
parasternal##9##1##(1993-8#5)(1994-12#1)(2007-8#1)(2008-8#1)(2010-12#1)
parastomal hernias##4##2##(1992-4#1)(2010-8#1)(2011-2#2)
parastomal##5##1##(1992-4#1)(2010-8#1)(2011-2#3)
parasuis##8##1##(2013-1#8)
parasympathetic activity##5##2##(2008-7#1)(2009-10#1)(2013-8#3)
parasympathetic cardiac##2##2##(1991-4#1)(2008-8#1)
parasympathetic nerves##5##2##(1997-1#1)(1997-8#3)(2008-3#1)
parasympathetic neurons##3##2##(1994-3#2)(1995-6#1)
parasympathetic preganglionic neurons were##2##4##(1993-7#2)
parasympathetic preganglionic neurons##5##3##(1993-12#1)(1993-7#4)
parasympathetic##51##1##(1990-7#1)(1990-9#1)(1991-4#2)(1991-5#1)(1992-6#1)(1993-12#2)(1993-5#1)(1993-7#4)(1993-9#1)(1994-3#2)(1994-9#1)(1995-6#1)(1996-12#2)(1997-1#1)(1997-8#8)(2006-10#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-7#4)(2008-8#1)(2009-10#3)(2009-8#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-8#3)
parasystolic##2##1##(1991-9#2)
paratbc Ag##2##2##(1990-5#2)
paratbc) protoplasmic Ag##2##3##(1990-5#2)
paratesticular##5##1##(2007-10#1)(2007-11#1)(2010-1#2)(2010-12#1)
parathion##18##1##(1994-5#2)(1995-3#6)(2005-11#4)(2007-8#1)(2008-10#3)(2008-6#2)
parathormone level##2##2##(1991-11#1)(2006-10#1)
parathormone levels##2##2##(1991-11#1)(2008-1#1)
parathormone##16##1##(1990-9#1)(1991-11#3)(1992-5#1)(1997-7#1)(2006-10#1)(2007-7#3)(2008-1#2)(2008-7#2)(2010-7#1)(2011-1#1)
parathyroid adenoma and##4##3##(1996-9#1)(2008-5#1)(2013-1#1)(2013-8#1)
parathyroid adenoma in##3##3##(2009-7#1)(2010-12#2)
parathyroid adenoma##20##2##(1996-9#1)(2005-12#1)(2005-9#1)(2007-3#2)(2008-12#1)(2008-5#1)(2009-7#3)(2010-12#3)(2010-2#2)(2012-1#3)(2013-1#1)(2013-8#1)
parathyroid adenomas and##3##3##(2008-5#3)
parathyroid adenomas##7##2##(1991-11#1)(2008-10#1)(2008-5#3)(2009-7#1)(2010-2#1)
parathyroid assay##2##2##(2005-12#2)
parathyroid cell proliferation##2##3##(2010-2#2)
parathyroid cyst]##2##2##(1994-3#1)(2008-8#1)
parathyroid gland##4##2##(2007-3#1)(2008-10#1)(2011-1#1)(2011-2#1)
parathyroid glands##8##2##(1990-6#1)(1990-9#1)(1996-12#1)(2007-8#1)(2009-7#1)(2010-2#1)(2013-1#1)(2013-8#1)
parathyroid hormone (PTH##5##3##(1991-6#1)(1993-12#1)(1993-6#1)(2008-8#1)(2012-3#1)
parathyroid hormone (PTH) and##3##4##(1992-6#1)(1994-11#1)(1994-2#1)
parathyroid hormone (PTH) is##2##4##(1997-7#1)(2007-8#1)
parathyroid hormone (PTH) levels##2##4##(2008-3#1)(2012-1#1)
parathyroid hormone (PTH)##25##3##(1990-11#1)(1990-2#1)(1990-9#1)(1991-12#1)(1991-5#2)(1992-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1997-7#1)(2005-3#1)(2007-8#1)(2008-3#1)(2008-5#1)(2009-3#1)(2009-7#1)(2010-2#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-12#1)(2013-8#2)
parathyroid hormone (PTH)/PTH-related peptide receptor##2##5##(1996-5#2)
parathyroid hormone and 1##2##4##(1992-3#1)(2008-4#1)
parathyroid hormone and##6##3##(1992-3#1)(1992-6#1)(1992-9#1)(2008-4#1)(2010-10#1)(2010-2#1)
parathyroid hormone in##2##3##(1991-3#1)(2011-12#1)
parathyroid hormone is##2##3##(1991-3#1)(2008-8#1)
parathyroid hormone level##3##3##(1991-3#2)(2009-4#1)
parathyroid hormone levels##2##3##(1991-3#1)(2006-7#1)
parathyroid hormone on##2##3##(1991-8#1)(1994-12#1)
parathyroid hormone related##2##3##(1991-5#1)(1996-11#1)
parathyroid hormone##98##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-6#1)(1990-9#1)(1991-12#1)(1991-3#11)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#6)(1992-1#2)(1992-3#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-6#2)(1995-2#1)(1995-6#2)(1996-1#1)(1996-11#2)(1996-5#2)(1997-7#1)(2005-12#1)(2005-3#2)(2006-10#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-3#3)(2008-4#3)(2008-5#1)(2008-8#3)(2009-3#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-2#2)(2010-6#1)(2011-1#2)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#4)
parathyroid hormone-related peptide in##3##4##(1993-3#1)(1994-3#1)(1997-6#1)
parathyroid hormone-related peptide##5##3##(1993-3#1)(1994-3#2)(1995-6#1)(1997-6#1)
parathyroid hormone-related protein (PTHrP)##5##4##(1991-5#1)(1991-7#1)(1991-8#1)(1994-7#1)(1996-1#1)
parathyroid hormone-related protein##6##3##(1991-5#1)(1991-7#1)(1991-8#2)(1994-7#1)(1996-1#1)
parathyroid hormone-related##12##2##(1991-5#1)(1991-7#2)(1991-8#2)(1993-3#1)(1994-3#2)(1994-7#1)(1995-6#1)(1996-1#1)(1997-6#1)
parathyroid hyperplasia##6##2##(2007-8#1)(2008-5#5)
parathyroid scintigraphy##2##2##(2010-12#2)
parathyroid tissue##3##2##(2006-6#1)(2008-10#2)
parathyroid tumors##2##2##(2009-7#1)(2010-2#1)
parathyroid##191##1##(1990-10#2)(1990-11#1)(1990-2#2)(1990-6#3)(1990-9#3)(1991-11#1)(1991-12#1)(1991-3#11)(1991-5#5)(1991-6#2)(1991-7#3)(1991-8#9)(1992-1#2)(1992-3#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-6#2)(1994-7#1)(1995-2#1)(1995-6#3)(1996-1#2)(1996-11#2)(1996-12#1)(1996-5#2)(1996-9#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-12#4)(2005-3#2)(2005-9#1)(2006-10#1)(2006-6#3)(2006-7#1)(2007-1#1)(2007-11#1)(2007-3#3)(2007-8#5)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#11)(2008-8#4)(2009-3#1)(2009-4#2)(2009-7#8)(2010-10#1)(2010-12#6)(2010-2#12)(2010-6#1)(2011-1#4)(2011-12#2)(2011-2#2)(2012-1#4)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#8)
parathyroidectomy##16##1##(1991-11#1)(1991-5#1)(1993-3#2)(1995-11#1)(1996-12#1)(2005-12#1)(2008-10#1)(2008-12#1)(2011-1#1)(2011-2#3)(2012-12#3)
parathyroidectomy]##2##1##(1991-5#1)(2009-5#1)
paratracheal ganglion cells##3##3##(1991-8#3)
paratracheal##7##1##(1991-8#3)(2008-10#1)(2009-7#1)(2012-12#2)
paratuberculosis in cattle##2##3##(1991-8#1)(2010-12#1)
paratuberculosis in##3##2##(1991-8#1)(2010-12#2)
paratuberculosis was##2##2##(1993-2#1)(2010-12#1)
paratuberculosis##21##1##(1990-5#2)(1991-8#4)(1993-2#1)(1994-7#1)(2006-10#3)(2010-12#10)
paraventricular (PVN)##2##2##(1990-2#1)(2008-7#1)
paraventricular and supraoptic##4##3##(1995-12#1)(1995-7#1)(1996-12#1)(1997-8#1)
paraventricular and##6##2##(1990-11#1)(1994-10#1)(1995-12#1)(1995-7#1)(1996-12#1)(1997-8#1)
paraventricular hypothalamic nucleus##5##3##(1993-9#1)(1994-10#2)(1994-2#1)(2008-8#1)
paraventricular hypothalamic##6##2##(1993-7#1)(1993-9#1)(1994-10#2)(1994-2#1)(2008-8#1)
paraventricular nucleus (PVN) of the##4##5##(1993-12#1)(1995-12#2)(1996-12#1)
paraventricular nucleus (PVN)##12##3##(1993-12#1)(1993-7#1)(1994-12#1)(1994-8#1)(1995-12#3)(1995-7#1)(1996-12#1)(1997-8#1)(2005-10#1)(2008-4#1)
paraventricular nucleus and##3##3##(1994-9#1)(1995-12#1)(1997-2#1)
paraventricular nucleus of the hypothalamus##8##5##(1992-8#1)(1994-2#1)(1995-12#3)(1996-4#1)(1997-8#2)
paraventricular nucleus of the##10##4##(1991-3#1)(1992-8#1)(1994-2#1)(1995-12#3)(1996-12#1)(1996-4#1)(1997-8#2)
paraventricular nucleus##54##2##(1991-3#2)(1992-8#1)(1993-12#3)(1993-2#6)(1993-7#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-8#2)(1994-9#1)(1995-12#8)(1995-7#2)(1996-12#5)(1996-4#2)(1996-9#4)(1997-2#1)(1997-8#5)(2005-10#2)(2008-4#2)(2008-9#1)(2009-2#2)
paraventricular##79##1##(1990-11#2)(1990-2#1)(1991-3#2)(1992-8#1)(1993-12#7)(1993-2#6)(1993-7#2)(1993-9#1)(1994-10#6)(1994-12#2)(1994-2#2)(1994-8#2)(1994-9#1)(1995-12#9)(1995-7#5)(1996-12#7)(1996-4#2)(1996-9#4)(1997-2#1)(1997-8#6)(2005-10#2)(2006-5#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#2)
paravertebral block for##2##3##(2005-12#1)(2013-7#1)
paravertebral mass##2##2##(2006-10#1)(2012-2#1)
paravertebral muscles##6##2##(1991-8#1)(1997-2#3)(2009-3#1)(2010-12#1)
paravertebral space##4##2##(2006-10#1)(2012-12#3)
paravertebral##22##1##(1991-8#1)(1992-3#1)(1997-2#3)(1997-6#1)(2005-12#1)(2006-10#2)(2006-7#1)(2007-8#2)(2009-3#1)(2010-12#1)(2012-12#3)(2012-2#2)(2013-7#1)(2013-8#2)
paraxanthine##2##1##(1992-2#1)(2012-1#1)
paraxial Gaussian beam##2##3##(2007-12#2)
paraxial Gaussian##3##2##(2007-11#1)(2007-12#2)
paraxial approximation##10##2##(2007-11#2)(2007-12#3)(2008-2#4)(2008-3#1)
paraxial beams##2##2##(2007-12#2)
paraxial focus##3##2##(2008-2#2)(2008-3#1)
paraxial mesoderm##2##2##(2006-11#1)(2006-9#1)
paraxial wave##2##2##(2008-2#1)(2008-3#1)
paraxial##41##1##(1990-4#2)(2006-11#1)(2006-9#1)(2007-11#7)(2007-12#8)(2008-10#1)(2008-2#12)(2008-3#9)
parcel of##2##2##(2007-4#1)(2007-9#1)
parcel##3##1##(2007-4#1)(2007-9#1)(2008-11#1)
parcellated##3##1##(1991-11#3)
parcellation of##2##2##(1993-2#1)(2010-9#1)
parcellation##6##1##(1991-11#2)(1993-2#1)(2006-9#1)(2010-9#2)
parcelled##2##1##(1990-12#2)
parched##2##1##(2007-9#1)(2009-8#1)
parchment##2##1##(2004-4#1)(2008-3#1)
parchments##2##1##(2004-4#1)(2008-3#1)
pardaxin##2##1##(1994-2#2)
parecoxib##5##1##(2005-6#4)(2006-10#1)
pared##2##1##(1992-3#1)(2007-10#1)
parenchyma and##6##2##(1991-12#1)(1996-6#1)(2005-11#1)(2006-10#1)(2008-10#1)(2013-7#1)
parenchyma by##2##2##(2007-9#1)(2008-12#1)
parenchyma cells##14##2##(2006-12#2)(2008-10#9)(2008-11#2)(2012-5#1)
parenchyma in patients##2##3##(1991-3#1)(2013-7#1)
parenchyma in##5##2##(1991-3#1)(2007-9#1)(2008-11#1)(2009-8#1)(2013-7#1)
parenchyma is##5##2##(1996-1#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-12#1)
parenchyma of the##4##3##(1994-3#1)(2006-7#2)(2007-12#1)
parenchyma of##6##2##(1994-3#1)(1996-6#1)(1997-8#1)(2006-7#2)(2007-12#1)
parenchyma using##2##2##(2007-8#1)(2011-2#1)
parenchyma was observed##2##3##(2007-1#1)(2011-2#1)
parenchyma was##3##2##(1994-5#1)(2007-1#1)(2011-2#1)
parenchyma which##2##2##(2007-10#1)(2009-7#1)
parenchyma##136##1##(1990-3#2)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#2)(1992-1#1)(1992-12#1)(1993-12#2)(1993-2#1)(1993-9#2)(1994-3#1)(1994-5#2)(1994-6#1)(1995-11#1)(1995-6#1)(1996-1#2)(1996-2#2)(1996-6#4)(1997-3#1)(1997-8#1)(2005-10#1)(2005-11#2)(2005-8#2)(2006-10#3)(2006-12#2)(2006-6#1)(2006-7#3)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#9)(2007-9#5)(2008-1#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#3)(2010-11#1)(2010-12#4)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#2)(2012-5#2)(2013-1#3)(2013-7#3)(2013-8#1)
parenchyma)##3##1##(2007-7#1)(2008-10#1)(2008-4#1)
parenchymal and vascular##2##3##(1996-5#1)(2010-3#1)
parenchymal and##6##2##(1991-6#1)(1992-11#1)(1996-5#1)(2008-8#1)(2010-3#1)(2010-9#1)
parenchymal bleeding##2##2##(2008-8#1)(2013-1#1)
parenchymal cells##13##2##(1992-5#1)(1993-4#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-3#2)(2008-11#2)(2008-5#1)(2008-6#1)(2013-8#1)
parenchymal damage##2##2##(1996-4#1)(2008-7#1)
parenchymal disease##2##2##(1992-3#1)(2005-11#1)
parenchymal fibrosis##2##2##(1991-12#1)(2010-9#1)
parenchymal involvement##2##2##(1992-1#1)(2011-2#1)
parenchymal lesions##6##2##(1996-2#1)(2008-1#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)
parenchymal liver cells##4##3##(1994-11#1)(1996-2#1)(2006-2#1)(2011-2#1)
parenchymal lung disease##5##3##(2005-8#3)(2011-2#1)(2012-12#1)
parenchymal lung##9##2##(2005-8#3)(2007-11#2)(2011-2#1)(2012-12#3)
parenchymal mechanical inhomogeneity and stress##2##5##(2013-7#2)
parenchymal organs##2##2##(1991-11#1)(2004-2#1)
parenchymal renal##3##2##(2008-1#2)(2008-4#1)
parenchymal transection##2##2##(2008-3#1)(2009-2#1)
parenchymal tumors##3##2##(2012-2#3)
parenchymal##109##1##(1990-6#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-6#1)(1992-1#2)(1992-11#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#2)(1993-4#3)(1993-5#1)(1993-6#2)(1993-9#1)(1994-11#2)(1994-3#2)(1995-5#1)(1996-2#2)(1996-4#2)(1996-5#3)(1996-6#1)(2004-11#1)(2004-2#1)(2005-11#1)(2005-8#5)(2006-10#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-11#2)(2007-5#3)(2007-8#1)(2007-9#3)(2008-1#5)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#3)(2009-12#1)(2009-2#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-9#2)(2011-1#1)(2011-2#4)(2012-12#6)(2012-2#6)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#1)
parenchymatous organ##2##2##(1997-8#1)(2012-12#1)
parenchymatous##8##1##(1992-2#1)(1996-6#1)(1997-2#1)(1997-8#2)(2008-6#1)(2010-6#1)(2012-12#1)
parens patriae##2##2##(1996-9#1)(2006-5#1)
parent F(ab')2 fragment##3##3##(1990-9#3)
parent Fol007##2##2##(2008-10#2)
parent and child##5##3##(2005-7#2)(2009-12#3)
parent and offspring##2##3##(2008-9#2)
parent and progeny##2##3##(2008-10#2)
parent and teacher##8##3##(2008-10#2)(2008-2#1)(2009-11#1)(2010-8#1)(2012-2#3)
parent and the##2##3##(1992-9#1)(2012-2#1)
parent and##28##2##(1990-12#2)(1992-9#1)(1994-3#1)(1996-2#1)(2005-7#2)(2008-10#6)(2008-2#1)(2008-9#2)(2009-11#1)(2009-12#3)(2009-9#2)(2010-8#1)(2012-2#4)(2012-3#1)
parent antibody##2##2##(1994-12#1)(2008-4#1)
parent brain##2##2##(2009-9#2)
parent cell line##3##3##(1992-6#1)(1992-9#1)(2008-11#1)
parent cell##6##2##(1990-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(2008-11#2)
parent cells##3##2##(1991-4#1)(1992-8#1)(1994-12#1)
parent company##2##2##(1996-6#1)(2012-12#1)
parent compound and##3##3##(1990-2#1)(1996-7#2)
parent compound##38##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-7#2)(1991-5#1)(1992-5#1)(1993-2#1)(1993-4#1)(1994-11#1)(1994-5#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-10#2)(1996-7#2)(1996-9#1)(1997-2#2)(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-5#2)(2008-8#1)(2010-11#2)(2010-12#1)(2010-2#2)(2012-2#1)
parent compounds and##3##3##(2008-10#1)(2010-4#1)(2012-1#1)
parent compounds##8##2##(1994-3#1)(1995-7#1)(2007-11#1)(2008-10#2)(2009-12#1)(2010-4#1)(2012-1#1)
parent could##2##2##(1992-7#1)(2008-10#1)
parent drug and the##3##4##(1996-3#1)(2008-10#1)(2011-3#1)
parent drug##20##2##(1993-2#1)(1994-11#1)(1995-3#1)(1996-3#1)(2008-10#5)(2008-5#1)(2008-8#3)(2010-11#3)(2010-12#1)(2011-3#1)(2013-1#2)
parent drugs##2##2##(1997-6#1)(2008-8#1)
parent education programs##2##3##(1995-1#2)
parent education##8##2##(1991-2#1)(1995-1#4)(2008-9#1)(2011-2#1)(2012-2#1)
parent educational level##2##3##(1990-12#1)(2008-10#1)
parent in the##3##3##(2006-10#1)(2008-10#1)(2008-11#1)
parent in##6##2##(2006-10#1)(2008-10#1)(2008-11#2)(2008-3#1)(2010-5#1)
parent isolate and vaccine strain demonstrated##2##6##(2012-3#2)
parent isolates were##2##3##(2008-10#2)
parent isolates##6##2##(2008-10#6)
parent line##2##2##(2008-10#1)(2008-2#1)
parent material##5##2##(2005-11#1)(2008-10#1)(2008-11#1)(2008-12#2)
parent materials##5##2##(2008-12#2)(2013-8#3)
parent molecule##9##2##(1990-6#1)(1992-12#1)(2008-3#1)(2009-7#4)(2010-7#2)
parent monitoring##8##2##(2010-9#8)
parent of##3##2##(1997-1#1)(2005-10#1)(2008-10#1)
parent or##3##2##(2012-12#1)(2012-3#1)(2013-8#1)
parent peptide##4##2##(1992-4#1)(1994-10#2)(2005-11#1)
parent perceptions##3##2##(1994-2#1)(1995-1#1)(2012-2#1)
parent plants were##2##3##(2008-10#1)(2008-8#1)
parent plants##3##2##(2008-10#2)(2008-8#1)
parent populations##2##2##(2008-10#1)(2008-5#1)
parent protein##5##2##(1995-10#1)(1997-7#2)(2008-4#1)(2013-1#1)
parent questionnaire##2##2##(2005-9#1)(2008-10#1)
parent ratings of##2##3##(1994-3#1)(2006-3#1)
parent ratings##3##2##(1994-3#1)(2006-3#1)(2008-2#1)
parent report of##2##3##(2008-9#1)(2011-1#1)
parent reports##3##2##(2008-11#1)(2008-12#1)(2012-2#1)
parent sample##2##2##(1996-2#1)(2009-7#1)
parent species and##2##3##(2007-8#2)
parent species##3##2##(2007-8#2)(2010-3#1)
parent strain##11##2##(1995-2#1)(1996-9#1)(1997-7#1)(2005-11#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-12#1)(2013-1#2)
parent strains##3##2##(2008-4#1)(2009-12#1)(2011-12#1)
parent support groups##3##3##(1995-1#2)(1996-1#1)
parent support##4##2##(1991-12#1)(1995-1#2)(1996-1#1)
parent to##5##2##(1991-12#1)(1992-3#1)(2008-12#1)(2012-2#2)
parent training##2##2##(1991-2#1)(2006-10#1)
parent variables##2##2##(1995-2#1)(2008-11#1)
parent was##4##2##(2008-10#3)(2008-9#1)
parent were##2##2##(2008-10#2)
parent who##4##2##(1990-12#1)(2008-11#1)(2008-9#1)(2013-1#1)
parent with##4##2##(2007-3#1)(2009-12#1)(2010-8#1)(2013-8#1)
parent##459##1##(1990-11#1)(1990-12#7)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#2)(1990-7#2)(1990-9#3)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#5)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#5)(1993-1#1)(1993-2#3)(1993-4#1)(1993-8#1)(1994-10#2)(1994-11#3)(1994-12#6)(1994-2#2)(1994-3#6)(1994-4#1)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#7)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#8)(1995-3#3)(1995-5#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-10#2)(1996-2#5)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#3)(1996-9#3)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(2004-10#1)(2004-4#2)(2005-10#3)(2005-11#5)(2005-7#2)(2005-9#1)(2006-10#5)(2006-12#2)(2006-3#2)(2006-4#2)(2006-5#2)(2006-8#4)(2007-1#2)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#90)(2008-11#23)(2008-12#10)(2008-2#3)(2008-3#6)(2008-4#6)(2008-5#14)(2008-6#1)(2008-7#3)(2008-8#7)(2008-9#11)(2009-11#2)(2009-12#7)(2009-7#6)(2009-9#4)(2010-10#1)(2010-11#5)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#5)(2010-7#3)(2010-8#5)(2010-9#8)(2011-1#3)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#11)(2012-3#4)(2013-1#8)(2013-8#8)
parent's perspective##3##2##(1991-3#1)(1992-3#1)(2009-7#1)
parent's##21##1##(1991-3#1)(1992-3#1)(1993-2#1)(1993-3#2)(1995-9#2)(2007-6#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-7#4)(2010-2#1)(2010-8#2)(2012-1#1)(2012-12#1)(2013-1#1)
parent(s)##2##1##(2007-2#1)(2008-11#1)
parent)##2##1##(1995-5#1)(2007-2#1)
parent- and##2##2##(1996-1#1)(2007-9#1)
parent-adolescent communication##6##2##(1990-12#1)(2012-12#2)(2013-1#3)
parent-adolescent relationships##4##2##(2008-4#1)(2009-7#3)
parent-adolescent##13##1##(1990-12#2)(2008-4#1)(2009-7#3)(2010-1#1)(2012-12#3)(2013-1#3)
parent-centered goals for##2##3##(2012-12#2)
parent-centered##3##1##(2010-8#1)(2012-12#2)
parent-child interaction tasks##2##3##(2009-11#2)
parent-child interaction##4##2##(1992-12#1)(2009-11#3)
parent-child interactions##4##2##(1995-1#1)(2008-4#1)(2009-11#1)(2010-9#1)
parent-child pain##2##2##(2009-12#2)
parent-child relations and##2##3##(2007-12#1)(2008-11#1)
parent-child relations##4##2##(2007-12#1)(2008-11#1)(2013-1#2)
parent-child relationship##6##2##(1991-8#1)(1992-2#1)(1995-5#1)(1996-9#1)(2010-9#1)(2013-8#1)
parent-child##26##1##(1991-8#1)(1992-12#1)(1992-2#1)(1995-1#1)(1995-5#1)(1996-9#1)(2007-12#1)(2008-11#1)(2008-4#2)(2008-8#1)(2009-11#4)(2009-12#2)(2009-9#1)(2010-9#2)(2012-12#2)(2013-1#3)(2013-8#1)
parent-infant##4##1##(1991-12#1)(2006-8#1)(2009-9#2)
parent-offspring conflict over##2##3##(2008-8#1)(2008-9#1)
parent-offspring##4##1##(2008-10#1)(2008-8#1)(2008-9#2)
parent-packed##2##1##(2012-12#2)
parent-reported##3##1##(1996-1#1)(2009-2#1)(2010-6#1)
parentage##7##1##(2007-7#1)(2008-9#3)(2010-2#1)(2010-8#1)(2011-1#1)
parental 'alcohol pushing'##2##3##(1990-5#2)
parental DNA damage##2##3##(1996-6#2)
parental DNA##7##2##(1994-12#2)(1996-6#5)
parental HCT-8 cells##2##3##(1995-7#2)
parental MDCK cells##2##3##(2008-11#2)
parental Md5-BAC##2##2##(2013-8#2)
parental PC-3M-1E8 cell line##2##4##(2008-9#2)
parental and progeny##2##3##(2008-10#2)
parental and##15##2##(1993-9#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-4#1)(2008-10#3)(2008-11#2)(2008-9#1)(2009-2#1)(2010-8#1)(2012-2#1)
parental aspirations for their children's educational attainment##2##7##(2009-7#2)
parental aspirations for their##3##4##(2009-7#3)
parental aspirations##4##2##(2009-7#4)
parental attitudes##2##2##(2007-3#1)(2010-11#1)
parental behavior##4##2##(1991-1#1)(1993-3#1)(2006-3#1)(2008-8#1)
parental care and##4##3##(2008-8#3)(2008-9#1)
parental care can##2##3##(2008-8#2)
parental care in rats and mice##2##6##(2008-4#2)
parental care in##5##3##(2008-4#2)(2008-8#3)
parental care##25##2##(1995-6#1)(2008-4#2)(2008-8#15)(2008-9#6)(2010-8#1)
parental cell line##4##3##(1991-9#1)(1995-3#1)(2008-11#1)(2008-4#1)
parental cell lines##2##3##(1992-2#1)(1992-8#1)
parental cell##9##2##(1991-9#1)(1992-2#1)(1992-8#1)(1994-11#1)(1995-3#1)(1997-6#1)(2008-11#1)(2008-4#1)(2012-3#1)
parental cells under oxygenated##2##4##(1996-6#2)
parental cells##25##2##(1991-1#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-3#3)(1994-5#1)(1994-8#1)(1995-1#1)(1995-5#2)(1996-6#5)(2005-8#1)
parental chromosome##2##2##(1997-7#2)
parental chromosomes##3##2##(1996-3#1)(2008-10#1)(2008-8#1)
parental clone##2##2##(1994-11#1)(2008-10#1)
parental closeness##2##2##(2010-9#2)
parental cognitions##2##2##(1995-2#2)
parental consanguinity##2##2##(1996-6#1)(2008-10#1)
parental consent or##2##3##(1994-2#2)
parental consent##5##2##(1992-6#1)(1994-2#3)(1997-6#1)
parental control##2##2##(1996-5#1)(2008-10#1)
parental decisions##2##2##(1996-2#1)(2005-10#1)
parental density##2##2##(2008-9#2)
parental depression##3##2##(2010-2#1)(2010-9#2)
parental distress##5##2##(1992-2#1)(1996-2#3)(2008-9#1)
parental education and##5##3##(1992-2#1)(2009-4#1)(2009-7#1)(2010-9#1)(2013-8#1)
parental education is##2##3##(2006-10#1)(2010-11#1)
parental education##13##2##(1992-2#1)(1992-4#1)(2006-10#2)(2009-4#1)(2009-7#3)(2010-11#1)(2010-9#1)(2012-1#1)(2012-2#1)(2013-8#1)
parental educational attainment##2##3##(2008-10#1)(2009-7#1)
parental educational##3##2##(2008-10#1)(2009-7#1)(2010-11#1)
parental effects##3##2##(2008-9#2)(2010-8#1)
parental engagement##3##2##(2009-7#3)
parental family structure history##2##4##(2010-10#2)
parental generosity towards##2##3##(2009-10#2)
parental genes##2##2##(2009-10#2)
parental genomes##3##2##(1996-3#2)(2008-9#1)
parental genotypes##3##2##(2011-2#1)(2012-3#2)
parental history of alcohol problems##2##5##(2009-12#2)
parental history of alcohol##3##4##(2009-12#3)
parental history of##6##3##(2009-12#3)(2010-4#1)(2010-6#1)(2013-1#1)
parental history##8##2##(2009-12#3)(2010-4#3)(2010-6#1)(2013-1#1)
parental imprinting of##2##3##(1994-9#2)
parental imprinting##6##2##(1993-1#1)(1994-9#2)(2007-10#3)
parental imprints##3##2##(1993-2#2)(2010-12#1)
parental influence##2##2##(2004-12#1)(2007-12#1)
parental interviews##2##2##(1991-2#1)(2006-10#1)
parental investment and##2##3##(2006-10#1)(2008-9#1)
parental investment is##2##3##(2008-8#1)(2008-9#1)
parental investment##17##2##(2006-10#2)(2008-8#5)(2008-9#10)
parental involvement##4##2##(2005-12#1)(2009-6#1)(2012-11#1)(2012-12#1)
parental isolates##6##2##(2008-10#6)
parental line##6##2##(1994-11#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1997-7#1)
parental lines##8##2##(1994-12#1)(2008-10#3)(2008-11#1)(2008-5#2)(2011-2#1)
parental medical illness##2##3##(1993-12#2)
parental monitoring##5##2##(2010-2#4)(2010-4#1)
parental myeloma##3##2##(1991-12#3)
parental notice##3##2##(1991-10#1)(1997-6#2)
parental notification##3##2##(1994-2#1)(1997-1#2)
parental origin##7##2##(1993-1#1)(1993-2#2)(1997-3#1)(2007-10#1)(2010-12#1)(2010-8#1)
parental perceptions of##4##3##(2009-7#3)(2010-2#1)
parental presence##3##2##(2006-10#2)(2013-8#1)
parental quality##2##2##(2008-9#1)(2010-9#1)
parental responsibility for##2##3##(2009-5#1)(2010-7#1)
parental responsibility##3##2##(2009-5#1)(2010-5#1)(2010-7#1)
parental right to make##2##4##(1995-12#2)
parental role##3##2##(1992-2#1)(1995-1#1)(2007-10#1)
parental roles##3##2##(1990-12#1)(1995-1#1)(2013-1#1)
parental satisfaction##3##2##(1996-2#1)(1996-3#2)
parental smoking##4##2##(1990-10#1)(1991-11#1)(1994-6#1)(2012-1#1)
parental species##17##2##(1994-8#1)(2008-10#2)(2008-8#2)(2009-2#3)(2012-3#2)(2013-1#7)
parental strain on##2##3##(2008-10#1)(2009-6#1)
parental strain##16##2##(1990-12#1)(1993-11#1)(1993-9#1)(1995-8#1)(1997-3#1)(2008-10#6)(2008-4#1)(2008-5#1)(2009-6#1)(2013-8#2)
parental strains##8##2##(1993-2#1)(2005-11#1)(2008-10#4)(2008-12#2)
parental stress and##3##3##(2006-12#1)(2012-2#2)
parental stress##5##2##(1990-12#2)(2006-12#1)(2012-2#2)
parental stressors##2##2##(2009-7#2)
parental support##2##2##(2007-12#1)(2009-7#1)
parental tumor##3##2##(1990-8#1)(1995-5#2)
parental virus##4##2##(2008-10#1)(2008-9#1)(2013-8#2)
parental visitation##2##2##(1994-2#2)
parental warmth and psychological adjustment##2##5##(2009-11#2)
parental warmth##9##2##(2009-11#3)(2010-1#6)
parental wild-type##3##2##(1993-3#1)(2007-12#1)(2010-12#1)
parental##517##1##(1990-10#3)(1990-11#1)(1990-12#5)(1990-2#1)(1990-5#3)(1990-6#1)(1990-8#1)(1991-1#4)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#1)(1991-4#2)(1991-6#1)(1991-7#3)(1991-9#5)(1992-11#1)(1992-2#4)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-1#4)(1993-11#1)(1993-12#3)(1993-2#5)(1993-3#3)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#3)(1994-1#1)(1994-11#3)(1994-12#4)(1994-2#10)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#4)(1994-9#3)(1995-1#4)(1995-10#1)(1995-12#4)(1995-2#3)(1995-3#4)(1995-5#8)(1995-6#4)(1995-7#4)(1995-8#3)(1996-11#2)(1996-2#9)(1996-3#6)(1996-4#1)(1996-5#2)(1996-6#11)(1996-9#1)(1997-1#2)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#7)(1997-7#4)(2004-11#2)(2004-12#2)(2005-10#3)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#7)(2006-12#2)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#6)(2007-11#2)(2007-12#6)(2007-2#3)(2007-3#1)(2008-1#1)(2008-10#34)(2008-11#12)(2008-12#7)(2008-4#6)(2008-5#6)(2008-7#2)(2008-8#25)(2008-9#34)(2009-10#6)(2009-11#4)(2009-12#6)(2009-2#6)(2009-4#4)(2009-5#1)(2009-6#2)(2009-7#20)(2009-9#1)(2010-1#7)(2010-10#2)(2010-11#3)(2010-12#3)(2010-2#8)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#6)(2010-9#6)(2011-1#6)(2011-2#6)(2012-1#2)(2012-11#5)(2012-12#3)(2012-2#7)(2012-3#5)(2013-1#16)(2013-8#11)
parental-type##2##1##(2008-10#2)
parentality##2##1##(2008-4#2)
parentally imprinted in##2##3##(1992-8#1)(1994-9#1)
parentally##3##1##(1992-8#1)(1994-9#1)(2008-4#1)
parenteral administration of##3##3##(2008-8#1)(2008-9#1)(2010-12#1)
parenteral administration##8##2##(1991-12#1)(2007-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-1#1)(2010-12#2)
parenteral and oral##4##3##(1992-11#2)(2008-4#1)(2010-6#1)
parenteral and##5##2##(1992-11#2)(2007-8#1)(2008-4#1)(2010-6#1)
parenteral antibiotic therapy##2##3##(2010-12#2)
parenteral antibiotic##4##2##(2007-12#1)(2010-12#2)(2013-8#1)
parenteral antibiotics##2##2##(2006-5#1)(2007-3#1)
parenteral delivery##2##2##(2005-7#1)(2007-11#1)
parenteral depot##2##2##(2010-2#2)
parenteral drug##5##2##(1990-2#1)(1995-9#1)(2008-3#2)(2008-5#1)
parenteral iron therapy##3##3##(2005-10#3)
parenteral iron##11##2##(2005-10#7)(2008-5#1)(2008-7#2)(2013-8#1)
parenteral nutrition (PN)##3##3##(2008-10#1)(2012-2#1)(2013-1#1)
parenteral nutrition (TPN)##5##3##(1992-9#2)(1994-6#1)(2006-7#1)(2008-10#1)
parenteral nutrition admixture##3##3##(2006-10#1)(2011-2#2)
parenteral nutrition and##5##3##(2005-10#2)(2006-10#1)(2008-8#1)(2010-12#1)
parenteral nutrition for##2##3##(1996-8#1)(2005-10#1)
parenteral nutrition in##5##3##(1993-5#1)(2005-10#1)(2006-2#1)(2009-5#1)(2013-1#1)
parenteral nutrition infusion##2##3##(2005-10#1)(2006-7#1)
parenteral nutrition may be##2##4##(2006-2#1)(2011-2#1)
parenteral nutrition solutions##2##3##(2005-10#2)
parenteral nutrition was##3##3##(2006-10#1)(2006-2#1)(2012-2#1)
parenteral nutrition with##2##3##(1996-8#1)(2006-7#1)
parenteral nutrition##73##2##(1991-6#1)(1992-9#3)(1993-5#1)(1994-6#2)(1996-4#1)(1996-8#2)(2004-11#2)(2005-10#16)(2006-10#9)(2006-2#3)(2006-7#5)(2007-12#1)(2007-7#3)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-7#2)(2010-8#1)(2011-2#5)(2012-2#4)(2013-1#3)
parenteral nutrition]##2##2##(1991-5#1)(1996-8#1)
parenteral route##2##2##(2007-11#2)
parenteral solution##2##2##(2008-10#1)(2012-12#1)
parenteral solutions##3##2##(2008-10#3)
parenteral therapy##2##2##(2007-7#1)(2010-6#1)
parenteral treatment with##2##3##(1992-12#1)(1996-10#1)
parenteral viral hepatitis##2##3##(2009-9#2)
parenteral vitamin B12##2##3##(1992-12#1)(2010-12#1)
parenteral##176##1##(1990-11#1)(1990-2#1)(1990-9#2)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#3)(1992-12#2)(1992-9#3)(1993-11#1)(1993-5#1)(1994-6#2)(1995-9#1)(1996-10#1)(1996-4#1)(1996-8#4)(1997-8#1)(2004-11#3)(2004-12#2)(2005-10#23)(2005-7#1)(2005-9#1)(2006-10#13)(2006-11#1)(2006-12#1)(2006-2#5)(2006-5#1)(2006-7#6)(2007-11#8)(2007-12#3)(2007-3#1)(2007-7#5)(2007-8#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-5#1)(2009-9#4)(2010-10#1)(2010-12#7)(2010-2#2)(2010-4#1)(2010-6#3)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#6)(2013-1#6)(2013-8#3)
parenterally administered##3##2##(1993-3#1)(1996-5#1)(2008-5#1)
parenterally and##2##2##(1996-9#1)(2013-8#1)
parenterally##12##1##(1992-3#1)(1993-3#1)(1996-5#1)(1996-9#1)(2006-6#1)(2007-7#1)(2008-5#2)(2013-7#2)(2013-8#2)
parenterals##4##1##(2007-8#2)(2008-5#2)
parentheses)##3##1##(2008-5#1)(2011-1#1)(2012-2#1)
parenthood and its##3##3##(1995-1#1)(2007-2#1)(2009-10#1)
parenthood and##6##2##(1995-1#1)(1996-9#1)(2007-2#1)(2007-9#1)(2009-10#1)(2013-1#1)
parenthood##23##1##(1995-1#2)(1996-9#1)(2007-2#8)(2007-3#1)(2007-9#1)(2009-10#1)(2009-11#1)(2009-4#6)(2012-1#1)(2013-1#1)
parenting and cognitions##2##3##(2010-1#2)
parenting and##9##2##(2008-12#1)(2008-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#4)
parenting behaviors##9##2##(2007-2#1)(2009-10#1)(2009-12#2)(2009-7#2)(2009-9#1)(2010-2#2)
parenting distress and##2##3##(2009-9#2)
parenting distress##3##2##(2009-9#3)
parenting domains##2##2##(2007-8#2)
parenting experiences##2##2##(2007-2#1)(2011-1#1)
parenting factors##3##2##(2008-11#1)(2010-4#2)
parenting in##4##2##(2008-3#1)(2009-12#2)(2010-9#1)
parenting is##2##2##(2011-1#1)(2013-7#1)
parenting of##3##2##(2007-8#1)(2009-12#2)
parenting practices##3##2##(2008-11#1)(2009-7#1)(2009-9#1)
parenting problems##2##2##(2007-8#2)
parenting satisfaction and efficacy##2##4##(1995-2#2)
parenting self-esteem##2##2##(1995-2#1)(2009-11#1)
parenting skills##8##2##(1992-12#1)(1996-2#1)(1997-3#1)(2007-1#1)(2009-11#1)(2009-12#2)(2009-4#1)
parenting stress##12##2##(1995-1#1)(1996-1#1)(2007-10#6)(2007-8#3)(2012-2#1)
parenting style as more##2##4##(2004-11#2)
parenting style##7##2##(2004-11#3)(2008-12#1)(2009-7#3)
parenting styles##3##2##(2004-11#1)(2013-1#2)
parenting##131##1##(1991-7#1)(1992-12#1)(1993-5#1)(1995-1#2)(1995-2#4)(1996-1#2)(1996-2#1)(1997-3#1)(2004-11#4)(2007-1#1)(2007-10#8)(2007-2#8)(2007-8#13)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#1)(2009-10#1)(2009-11#4)(2009-12#9)(2009-4#1)(2009-5#1)(2009-7#16)(2009-9#13)(2010-1#7)(2010-2#5)(2010-4#3)(2010-9#3)(2011-1#2)(2012-11#1)(2012-2#2)(2013-1#4)(2013-7#4)
parents (diploid##2##2##(2013-8#2)
parents about the##5##3##(2006-10#1)(2007-2#1)(2010-11#1)(2010-3#1)(2012-2#1)
parents about##6##2##(2006-10#1)(2007-2#1)(2010-11#2)(2010-3#1)(2012-2#1)
parents after##2##2##(1996-9#1)(2008-11#1)
parents also completed##2##3##(2006-4#1)(2008-9#1)
parents also##3##2##(1990-5#1)(2006-4#1)(2008-9#1)
parents and F(1)##3##3##(2008-10#3)
parents and a##3##3##(1997-1#1)(2008-4#1)(2011-1#1)
parents and caregivers##3##3##(2007-8#1)(2010-12#1)(2010-8#1)
parents and child##3##3##(1990-12#1)(1993-7#1)(2006-8#1)
parents and children##10##3##(1994-2#1)(1995-1#1)(1996-4#1)(2008-2#1)(2009-10#2)(2009-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
parents and communities##2##3##(2008-11#1)(2009-7#1)
parents and guardians##3##3##(2006-4#1)(2008-9#1)(2013-8#1)
parents and health##2##3##(1990-12#1)(2013-1#1)
parents and other##2##3##(1991-8#1)(2008-11#1)
parents and others outside the profession##2##6##(2012-12#2)
parents and peers##3##3##(1990-2#3)
parents and professionals##4##3##(2006-10#2)(2006-7#1)(2013-1#1)
parents and teachers##6##3##(1997-5#1)(2006-7#1)(2009-11#1)(2011-2#1)(2012-12#2)
parents and the##7##3##(1990-12#1)(1994-1#1)(1995-1#1)(2007-6#1)(2008-10#1)(2009-10#1)(2009-9#1)
parents and their children##3##4##(1993-12#1)(2008-6#1)(2010-9#1)
parents and their##9##3##(1990-12#1)(1993-12#1)(2006-8#1)(2007-2#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-9#1)(2011-2#1)
parents and to##3##3##(1990-12#1)(2010-5#1)(2013-8#1)
parents and two##2##3##(2007-2#1)(2009-9#1)
parents and##114##2##(1990-12#6)(1990-2#3)(1991-8#1)(1993-12#2)(1993-7#1)(1994-1#1)(1994-2#1)(1995-1#2)(1995-12#1)(1996-4#1)(1997-1#2)(1997-5#1)(1997-7#2)(2004-10#1)(2006-10#2)(2006-4#1)(2006-7#2)(2006-8#4)(2007-2#4)(2007-6#1)(2007-8#1)(2008-10#11)(2008-11#5)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#2)(2009-10#3)(2009-11#3)(2009-4#1)(2009-7#1)(2009-9#3)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#4)(2012-12#7)(2012-2#2)(2012-3#1)(2013-1#10)(2013-7#1)(2013-8#5)
parents answered##2##2##(2006-7#1)(2011-1#1)
parents are advised##2##3##(1992-11#1)(2010-12#1)
parents are##17##2##(1991-2#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#1)(1995-12#1)(1995-5#1)(1996-5#1)(1997-1#1)(2008-10#2)(2008-12#1)(2008-9#2)(2010-12#1)(2011-1#2)
parents as well as##2##4##(2008-2#1)(2012-12#1)
parents as##6##2##(1992-2#1)(1993-1#1)(2008-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
parents at##4##2##(1993-5#1)(2007-11#1)(2008-2#1)(2012-2#1)
parents can##4##2##(1992-3#1)(2005-7#1)(2007-2#1)(2008-6#1)
parents cope##2##2##(1994-12#1)(2008-12#1)
parents during##2##2##(1991-8#1)(2006-2#1)
parents felt##2##2##(2008-9#1)(2010-8#1)
parents for##4##2##(1992-2#1)(2006-7#1)(2008-10#1)(2010-4#1)
parents from##4##2##(1995-1#1)(2006-4#1)(2008-10#1)(2008-3#1)
parents had##12##2##(1990-12#1)(2005-10#1)(2006-9#2)(2009-7#1)(2010-10#1)(2010-11#2)(2010-4#1)(2012-12#2)(2013-1#1)
parents have less##2##3##(1992-5#1)(2012-12#1)
parents have##5##2##(1990-12#1)(1992-5#1)(2011-1#1)(2012-12#1)(2013-1#1)
parents how##2##2##(2007-2#1)(2013-1#1)
parents in the##5##3##(1994-2#2)(2008-10#1)(2008-8#1)(2010-5#1)
parents in##28##2##(1994-2#2)(1994-3#1)(1995-12#2)(2007-2#2)(2007-3#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#2)(2009-4#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#5)
parents is##8##2##(1990-6#1)(1994-6#1)(1996-3#1)(2008-12#1)(2009-7#2)(2013-1#1)(2013-8#1)
parents may be##4##3##(1995-6#1)(2008-12#1)(2010-2#2)
parents may##7##2##(1994-2#1)(1995-12#1)(1995-6#1)(2008-12#1)(2009-7#1)(2010-2#2)
parents need##2##2##(1995-5#1)(2007-2#1)
parents obtain##2##2##(1993-12#1)(2008-11#1)
parents of children aged##2##4##(2006-2#1)(2007-7#1)
parents of children with asthma##3##5##(2009-8#1)(2013-1#2)
parents of children with cancer##2##5##(2010-7#1)(2010-9#1)
parents of children with chronic##2##5##(1991-8#1)(2009-8#1)
parents of children with medically complex needs##2##7##(1992-2#2)
parents of children with moderate mental retardation##2##7##(1993-3#2)
parents of children with severe##2##5##(1993-3#2)
parents of children with special needs##2##6##(2005-12#1)(2010-7#1)
parents of children with##22##4##(1991-8#1)(1992-2#2)(1993-1#1)(1993-3#5)(1995-2#1)(2005-12#1)(2008-11#1)(2008-9#1)(2009-8#2)(2010-7#2)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#2)
parents of children##34##3##(1991-8#1)(1992-2#3)(1993-1#1)(1993-3#5)(1995-2#1)(1996-3#1)(2005-12#1)(2006-2#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-9#2)(2009-4#2)(2009-8#3)(2010-7#3)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
parents of healthy children##2##4##(1995-2#2)
parents of healthy##3##3##(1995-2#2)(2012-12#1)
parents of high-risk newborns##2##4##(1993-3#2)
parents of high-risk##4##3##(1993-3#2)(2008-11#2)
parents of other##2##3##(1996-1#1)(2009-7#1)
parents of physically##2##3##(1995-2#1)(2012-12#1)
parents of students##2##3##(1997-5#1)(2012-2#1)
parents of the##5##3##(1995-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
parents of young children##3##4##(1994-3#1)(1995-2#1)(2006-8#1)
parents of##84##2##(1990-2#1)(1991-11#1)(1991-8#1)(1992-2#3)(1993-1#1)(1993-3#7)(1994-12#1)(1994-3#2)(1995-12#1)(1995-2#5)(1995-5#1)(1996-1#1)(1996-12#1)(1996-3#2)(1997-5#2)(2004-10#1)(2004-12#1)(2005-12#1)(2006-2#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-4#2)(2009-7#1)(2009-8#3)(2010-5#1)(2010-7#4)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#3)(2012-12#7)(2012-2#2)(2013-1#6)(2013-7#1)
parents often##2##2##(2007-12#1)(2013-7#1)
parents on##2##2##(2013-1#1)(2013-7#1)
parents or guardians##4##3##(1994-3#1)(2005-7#2)(2011-1#1)
parents or##11##2##(1994-3#1)(1995-5#2)(2005-7#3)(2006-7#1)(2007-7#1)(2010-4#1)(2011-1#1)(2011-2#1)
parents packing##2##2##(2012-12#2)
parents participated in##2##3##(1991-2#1)(2013-1#1)
parents participated##4##2##(1991-2#1)(2006-8#1)(2009-5#1)(2013-1#1)
parents rated##3##2##(2008-12#1)(2008-9#1)(2010-8#1)
parents regarding the##2##3##(2006-4#1)(2008-11#1)
parents regarding##3##2##(2006-4#1)(2007-12#1)(2008-11#1)
parents report##2##2##(1995-12#1)(1996-1#1)
parents reported more##2##3##(2006-8#1)(2010-1#1)
parents reported that##2##3##(1995-12#2)
parents reported##8##2##(1994-12#1)(1995-12#2)(2005-10#1)(2006-8#1)(2009-3#1)(2010-1#1)(2010-10#1)
parents revealed##2##2##(1996-6#1)(2009-10#1)
parents should be##4##3##(1990-2#1)(2006-2#1)(2008-1#1)(2008-12#1)
parents should##7##2##(1990-2#1)(1996-12#1)(2006-2#1)(2008-1#1)(2008-12#1)(2008-9#1)(2009-5#1)
parents showed##2##2##(1996-6#1)(2013-1#1)
parents than##2##2##(2008-8#1)(2010-2#1)
parents think about##2##3##(2008-9#1)(2012-3#1)
parents think##3##2##(2008-12#1)(2008-9#1)(2012-3#1)
parents through##2##2##(2006-7#1)(2010-7#1)
parents to##21##2##(1993-1#1)(1994-2#2)(1995-1#1)(2006-12#2)(2007-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#2)(2009-11#2)(2010-5#1)(2010-9#1)(2011-12#1)(2012-12#3)(2013-1#1)
parents towards##3##2##(1991-8#2)(2007-7#1)
parents using a##2##3##(1993-3#1)(2010-2#1)
parents using##3##2##(1993-3#1)(2010-2#1)(2012-2#1)
parents want##3##2##(2008-11#2)(2008-3#1)
parents was##4##2##(2006-7#1)(2007-2#2)(2009-7#1)
parents were also##2##3##(1995-12#1)(2008-10#1)
parents were asked to##2##4##(2007-7#1)(2010-7#1)
parents were asked##3##3##(2007-7#1)(2008-9#1)(2010-7#1)
parents were##41##2##(1990-12#1)(1991-11#2)(1991-2#1)(1991-8#1)(1992-2#2)(1993-12#1)(1994-6#3)(1995-12#2)(1995-2#1)(1996-6#1)(1997-5#1)(1997-8#1)(2006-12#2)(2006-4#1)(2006-7#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-9#1)(2009-7#1)(2010-4#1)(2010-7#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
parents when##3##2##(1993-3#1)(2009-3#1)(2010-3#1)
parents who fully##2##3##(2009-4#2)
parents who refuse immunization##2##4##(2008-12#2)
parents who##22##2##(1990-5#1)(1994-2#2)(1994-3#1)(1996-5#1)(2007-2#1)(2007-7#1)(2008-12#2)(2008-2#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#4)
parents whose children##3##3##(2005-7#1)(2007-12#1)(2007-8#1)
parents whose##4##2##(2005-6#1)(2005-7#1)(2007-12#1)(2007-8#1)
parents with a##3##3##(2006-8#1)(2008-11#1)(2013-1#1)
parents with children who##2##4##(1996-3#1)(2013-7#1)
parents with children##4##3##(1996-3#1)(2005-12#1)(2012-12#1)(2013-7#1)
parents with##17##2##(1995-12#1)(1996-3#1)(2005-12#1)(2006-8#1)(2006-9#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-11#1)(2009-1#1)(2009-7#1)(2012-12#2)(2013-1#3)(2013-7#1)
parents##850##1##(1990-12#15)(1990-2#6)(1990-4#2)(1990-5#3)(1990-6#2)(1990-9#2)(1991-10#1)(1991-11#3)(1991-12#1)(1991-2#3)(1991-5#1)(1991-7#1)(1991-8#9)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#1)(1992-2#12)(1992-3#2)(1992-4#2)(1992-5#1)(1993-1#9)(1993-12#6)(1993-2#2)(1993-3#10)(1993-5#2)(1993-7#2)(1993-9#1)(1994-1#2)(1994-12#4)(1994-2#10)(1994-3#8)(1994-6#5)(1995-1#8)(1995-11#2)(1995-12#16)(1995-2#6)(1995-5#8)(1995-6#4)(1996-1#2)(1996-12#2)(1996-2#3)(1996-3#5)(1996-4#2)(1996-5#3)(1996-6#4)(1996-9#1)(1997-1#4)(1997-2#2)(1997-4#1)(1997-5#5)(1997-7#2)(1997-8#2)(2004-10#2)(2004-12#1)(2005-10#5)(2005-12#3)(2005-6#2)(2005-7#5)(2006-10#6)(2006-12#7)(2006-2#4)(2006-3#1)(2006-4#9)(2006-6#1)(2006-7#13)(2006-8#11)(2006-9#6)(2007-1#2)(2007-11#2)(2007-12#15)(2007-2#29)(2007-3#6)(2007-4#2)(2007-6#2)(2007-7#13)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#51)(2008-11#27)(2008-12#15)(2008-2#6)(2008-3#6)(2008-4#3)(2008-5#5)(2008-6#6)(2008-7#2)(2008-8#9)(2008-9#24)(2009-1#2)(2009-10#4)(2009-11#8)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#10)(2009-5#3)(2009-6#2)(2009-7#22)(2009-8#5)(2009-9#4)(2010-1#3)(2010-10#9)(2010-11#6)(2010-12#3)(2010-2#12)(2010-3#3)(2010-4#7)(2010-5#4)(2010-6#2)(2010-7#7)(2010-8#5)(2010-9#13)(2011-1#20)(2011-12#2)(2011-2#19)(2012-1#4)(2012-12#44)(2012-2#18)(2012-3#2)(2013-1#48)(2013-7#10)(2013-8#20)
parents' adherence##2##2##(1994-3#2)
parents' and##3##2##(1993-12#1)(2006-12#1)(2008-9#1)
parents' education##2##2##(2006-7#1)(2009-7#1)
parents' educational##2##2##(2009-7#1)(2010-11#1)
parents' or nurses' concerns##3##4##(2010-8#3)
parents' own##2##2##(1990-5#1)(2012-12#1)
parents' perceptions of##3##3##(1993-12#1)(2010-8#1)(2011-1#1)
parents' persuasion##2##2##(2010-1#2)
parents' positive##2##2##(2006-8#1)(2008-12#1)
parents' ratings of##2##3##(1995-12#1)(2008-12#1)
parents' right to##2##3##(1993-12#1)(1995-5#1)
parents' trust##2##2##(1996-2#1)(2009-4#1)
parents'##76##1##(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#1)(1991-12#1)(1993-1#1)(1993-12#4)(1993-3#1)(1993-5#1)(1993-6#1)(1994-3#2)(1995-12#1)(1995-5#1)(1996-2#1)(1997-5#1)(2004-11#1)(2005-12#1)(2006-12#1)(2006-2#3)(2006-7#2)(2006-8#2)(2007-2#2)(2007-4#1)(2007-8#1)(2008-11#1)(2008-12#4)(2008-2#1)(2008-4#1)(2008-9#1)(2009-4#1)(2009-7#4)(2009-8#1)(2010-1#3)(2010-11#1)(2010-3#1)(2010-6#1)(2010-8#5)(2010-9#1)(2011-1#1)(2011-12#1)(2012-11#1)(2012-12#4)(2013-1#4)(2013-7#4)
parents'/guardians' health literacy##2##3##(2010-9#2)
parents)##3##1##(2009-7#1)(2012-1#1)(2013-7#1)
parents/guardians##10##1##(2006-4#1)(2006-8#1)(2008-9#6)(2010-9#2)
parents?##3##1##(1995-5#1)(1996-4#1)(2009-9#1)
parents]##4##1##(1990-5#1)(1993-1#1)(1997-2#1)(2008-4#1)
pareses in##2##2##(1990-4#1)(1990-8#1)
pareses of##2##2##(1990-4#2)
pareses##7##1##(1990-4#5)(1990-8#1)(1993-1#1)
paresis and##3##2##(1994-3#1)(2008-5#1)(2013-1#1)
paresis in##2##2##(1992-6#1)(2006-12#1)
paresis is##2##2##(1996-12#1)(2012-1#1)
paresis of the##2##3##(2007-7#1)(2011-2#1)
paresis##32##1##(1990-4#2)(1992-5#1)(1992-6#1)(1994-3#1)(1996-12#1)(1996-8#1)(1997-3#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-11#2)(2007-7#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#4)(2012-1#3)(2013-1#5)(2013-7#1)
paresis)##2##1##(2006-11#1)(2007-8#1)
paresthesia and##3##2##(2006-3#1)(2008-5#1)(2012-2#1)
paresthesia##13##1##(1990-11#1)(2005-5#1)(2006-10#1)(2006-3#2)(2007-5#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
paresthesiae to the##2##3##(2006-7#2)
paresthesias and##3##2##(1991-3#1)(1992-8#2)
paresthesias##8##1##(1991-3#1)(1992-8#2)(2006-3#1)(2007-7#1)(2008-1#1)(2008-9#1)(2013-8#1)
paretic muscles##2##2##(1992-2#1)(2007-10#1)
paretic##15##1##(1992-2#1)(2007-10#2)(2007-11#1)(2012-1#11)
parhelic circle##5##2##(2008-2#1)(2008-3#4)
paricalcitol##4##1##(2008-3#4)
parietal and occipital##4##3##(1997-6#1)(2006-8#1)(2008-7#1)(2010-7#1)
parietal and superior temporal##2##4##(2008-11#2)
parietal and visceral##2##3##(2012-1#2)
parietal and##16##2##(1991-10#1)(1992-9#1)(1993-5#1)(1995-6#1)(1997-6#1)(2006-8#1)(2007-8#1)(2008-11#2)(2008-7#2)(2010-7#1)(2011-2#1)(2012-1#2)(2013-8#1)
parietal areas##3##2##(1995-11#2)(1995-12#1)
parietal brain##2##2##(2012-1#1)(2013-7#1)
parietal cell mass##2##3##(1997-1#1)(2012-12#1)
parietal cell##18##2##(1995-11#4)(1997-1#4)(2006-10#8)(2012-12#2)
parietal cells and##4##3##(1994-2#1)(1997-1#1)(2006-10#1)(2012-1#1)
parietal cells by##2##3##(1993-9#1)(2013-8#1)
parietal cells in##2##3##(1994-2#1)(1997-1#1)
parietal cells of the##2##4##(1994-2#1)(2013-8#1)
parietal cells that##2##3##(2006-10#1)(2007-12#1)
parietal cells were##4##3##(1992-3#1)(1993-6#2)(2012-1#1)
parietal cells##48##2##(1992-3#4)(1992-6#1)(1993-6#9)(1993-9#3)(1994-2#4)(1995-11#3)(1995-6#2)(1996-1#1)(1997-1#7)(2006-10#3)(2007-12#5)(2012-1#3)(2012-2#1)(2013-8#2)
parietal cortex and##7##3##(1991-12#2)(1991-2#1)(1996-12#1)(1997-5#2)(1997-8#1)
parietal cortex for##2##3##(1993-7#1)(1997-6#1)
parietal cortex lesions plus##2##4##(1993-7#2)
parietal cortex lesions##3##3##(1993-7#3)
parietal cortex of##3##3##(1991-11#1)(1991-2#1)(2007-9#1)
parietal cortex were##2##3##(1992-8#1)(1993-7#1)
parietal cortex##50##2##(1991-11#1)(1991-12#3)(1991-2#3)(1992-8#5)(1993-2#1)(1993-6#1)(1993-7#5)(1994-12#1)(1994-3#2)(1995-12#1)(1996-12#3)(1996-4#2)(1996-5#1)(1997-2#3)(1997-5#3)(1997-6#3)(1997-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#3)(2010-7#1)(2013-7#1)(2013-8#2)
parietal cortical regions##2##3##(1994-12#1)(1996-9#1)
parietal cortical##7##2##(1990-5#1)(1994-12#2)(1994-2#1)(1996-9#1)(2008-2#1)(2010-12#1)
parietal cortices##5##2##(1994-12#1)(1994-3#1)(1997-5#1)(2010-2#1)(2010-7#1)
parietal foramina##3##2##(1996-3#1)(2007-2#2)
parietal layer##2##2##(2008-10#2)
parietal lobe##11##2##(1995-1#1)(1996-5#1)(1997-3#1)(1997-6#1)(2007-10#2)(2007-9#1)(2008-11#1)(2008-7#1)(2009-1#1)(2009-4#1)
parietal lobule##8##2##(1996-2#1)(1996-5#1)(2008-11#4)(2008-4#2)
parietal or##3##2##(1990-3#1)(1992-9#1)(2013-8#1)
parietal pleura##4##2##(2007-4#1)(2007-5#1)(2007-8#2)
parietal region##4##2##(2007-1#1)(2008-5#1)(2008-7#1)(2012-12#1)
parietal regions##7##2##(1991-12#1)(1996-12#1)(1997-2#1)(2008-11#1)(2009-4#1)(2010-2#1)(2012-1#1)
parietal scalp##2##2##(1994-2#1)(2008-5#1)
parietal##252##1##(1990-3#2)(1990-5#1)(1990-9#1)(1991-10#2)(1991-11#3)(1991-12#4)(1991-2#3)(1992-10#1)(1992-3#5)(1992-6#1)(1992-8#5)(1992-9#3)(1993-11#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#10)(1993-7#7)(1993-9#3)(1994-10#2)(1994-12#4)(1994-2#7)(1994-3#3)(1995-1#3)(1995-11#9)(1995-12#2)(1995-5#1)(1995-6#3)(1995-9#1)(1996-1#1)(1996-12#5)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#6)(1996-9#1)(1997-1#11)(1997-2#4)(1997-3#2)(1997-5#7)(1997-6#5)(1997-8#1)(2006-10#14)(2006-5#2)(2006-8#1)(2007-1#1)(2007-10#4)(2007-11#1)(2007-12#5)(2007-2#3)(2007-4#1)(2007-5#1)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#11)(2008-2#2)(2008-4#4)(2008-5#3)(2008-7#7)(2009-1#2)(2009-10#2)(2009-2#1)(2009-4#2)(2010-10#1)(2010-12#2)(2010-2#2)(2010-7#3)(2010-8#1)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#3)(2012-1#8)(2012-12#4)(2012-2#1)(2013-7#2)(2013-8#6)
parietalia permagna##2##2##(2010-3#1)(2013-1#1)
parieto-frontal##2##1##(1996-12#1)(2008-11#1)
parieto-occipital##5##1##(1995-12#1)(1997-1#1)(2006-4#1)(2007-10#1)(2012-2#1)
parietotemporal##6##1##(1994-2#1)(1994-5#1)(1995-2#2)(1997-3#1)(2005-5#1)
parinaroyl##3##1##(1990-4#3)
paris##2##1##(2006-9#1)(2008-2#1)
parish nurse##3##2##(2008-12#3)
parish of Manger##2##3##(1993-3#1)(1993-6#1)
parish of##4##2##(1992-1#1)(1993-12#1)(1993-3#1)(1993-6#1)
parish registers##2##2##(2011-2#1)(2013-1#1)
parish##14##1##(1990-3#1)(1991-12#1)(1992-1#1)(1993-12#2)(1993-3#1)(1993-6#1)(2008-1#2)(2008-12#3)(2011-2#1)(2013-1#1)
parish-based clergy##2##2##(2010-2#2)
parishes##2##1##(1993-12#1)(2008-9#1)
parishioners##2##1##(1993-12#1)(2004-12#1)
parities##7##1##(2008-3#1)(2012-1#6)
parity (p =##2##3##(2006-10#1)(2010-8#1)
parity and##10##2##(1992-9#2)(2006-2#1)(2007-10#1)(2007-4#2)(2008-1#1)(2008-11#1)(2009-4#1)(2009-5#1)
parity groups##3##2##(1990-6#3)
parity of##3##2##(2004-12#1)(2008-3#1)(2010-12#1)
parity or##3##2##(1991-9#1)(1993-10#1)(1993-2#1)
parity women##4##2##(2007-3#4)
parity##66##1##(1990-6#3)(1991-2#1)(1991-7#1)(1991-9#1)(1992-9#4)(1993-10#1)(1993-2#1)(1993-9#1)(1995-1#2)(1995-10#1)(1997-7#1)(2004-10#2)(2004-12#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-10#2)(2007-12#2)(2007-2#2)(2007-3#7)(2007-4#3)(2008-1#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-5#4)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#3)(2011-2#3)(2012-12#2)(2013-1#1)
parity-based##3##1##(1992-9#1)(2007-12#1)(2008-3#1)
park and##2##2##(2004-11#1)(2008-5#1)
park in##2##2##(2010-10#1)(2012-2#1)
park##24##1##(1994-11#1)(1996-12#2)(1996-6#3)(2004-11#2)(2006-12#2)(2007-2#1)(2007-5#1)(2007-8#3)(2008-5#2)(2008-8#1)(2010-10#2)(2010-8#1)(2012-2#1)(2012-6#1)(2013-1#1)
parkfield##2##1##(1990-9#1)(1991-3#1)
parkin##5##1##(2005-10#1)(2008-11#1)(2008-7#2)(2012-12#1)
parking facility##2##2##(1992-12#1)(1993-12#1)
parking lot##2##2##(1993-12#1)(2008-7#1)
parking security##2##2##(1992-12#2)
parking##14##1##(1991-12#1)(1992-12#3)(1992-2#1)(1993-12#4)(2007-4#1)(2008-10#2)(2008-7#1)(2009-10#1)
parkinsonian disorders##3##2##(2008-11#3)
parkinsonian motor fluctuations##2##3##(2008-7#2)
parkinsonian motor##4##2##(1996-8#1)(2008-7#2)(2012-2#1)
parkinsonian patients##9##2##(1993-4#1)(1994-10#2)(1995-6#3)(2008-7#3)
parkinsonian rats##5##2##(1994-10#1)(1996-9#1)(2008-12#3)
parkinsonian striatum##3##2##(1990-10#3)
parkinsonian symptoms##2##2##(1994-2#1)(1996-8#1)
parkinsonian syndrome##3##2##(1991-12#1)(1996-3#1)(1997-7#1)
parkinsonian syndromes##4##2##(1993-11#2)(2008-11#2)
parkinsonian tremor##2##2##(1991-11#1)(2008-11#1)
parkinsonian##51##1##(1990-10#3)(1991-11#1)(1991-12#1)(1991-9#1)(1993-11#2)(1993-2#1)(1993-4#2)(1994-10#3)(1994-2#1)(1995-6#4)(1996-3#1)(1996-8#3)(1996-9#1)(1997-7#1)(2008-11#7)(2008-12#3)(2008-7#11)(2012-12#1)(2012-2#4)
parkinsonism and tremor##2##3##(2008-7#2)
parkinsonism and##7##2##(1997-2#2)(2008-7#5)
parkinsonism has##2##2##(2008-11#1)(2008-7#1)
parkinsonism is##3##2##(2008-11#2)(2008-7#1)
parkinsonism with##3##2##(2008-7#3)
parkinsonism##56##1##(1990-11#1)(1993-3#1)(1997-1#1)(1997-2#2)(1997-8#3)(2006-12#1)(2007-10#1)(2007-7#1)(2008-11#14)(2008-7#26)(2009-11#1)(2009-6#1)(2013-7#1)(2013-8#2)
parks##11##1##(2007-2#1)(2008-5#1)(2011-1#8)(2013-1#1)
parlance##2##1##(2008-8#1)(2009-10#1)
parliament##7##1##(1995-3#1)(1996-3#1)(1997-6#1)(2006-10#1)(2007-9#1)(2008-11#1)(2013-8#1)
parliamentarian##2##1##(2009-10#1)(2009-7#1)
parliamentary##2##1##(2006-10#1)(2008-11#1)
parlour##4##1##(1996-11#1)(2006-12#1)(2008-5#2)
parochial##3##1##(1996-1#1)(2008-12#1)(2008-7#1)
parody##2##1##(2007-11#2)
paroecandrum##2##1##(2008-10#2)
parole##2##1##(1991-3#1)(2009-11#1)
paromomycin and##2##2##(1997-4#1)(2006-10#1)
paromomycin##9##1##(1992-6#1)(1997-4#1)(2005-9#1)(2006-10#1)(2007-6#4)(2009-4#1)
paronychia##4##1##(1990-9#1)(1993-1#1)(2008-9#1)(2010-9#1)
parosteal osteosarcoma##2##2##(1991-11#1)(2010-3#1)
parosteal##5##1##(1991-11#1)(2009-3#3)(2010-3#1)
parotid &lt##4##2##(2009-10#4)
parotid acinar cells##8##3##(1991-8#2)(1992-3#3)(1996-5#3)
parotid area##2##2##(1990-2#1)(2012-12#1)
parotid gland is##4##3##(1996-5#1)(2007-5#2)(2009-5#1)
parotid gland##40##2##(1991-6#2)(1992-5#2)(1993-4#2)(1996-5#1)(1996-6#1)(1997-5#2)(2006-10#2)(2006-4#1)(2007-10#1)(2007-5#6)(2008-11#1)(2008-4#1)(2009-3#1)(2009-5#4)(2010-12#4)(2010-2#1)(2012-2#3)(2013-1#1)(2013-8#4)
parotid glands##6##2##(1992-11#1)(1993-12#1)(1994-6#3)(2007-10#1)
parotid masses##3##2##(1992-10#2)(2007-12#1)
parotid region and##2##3##(2007-5#2)
parotid saliva##2##2##(1991-1#1)(1996-6#1)
parotid salivary glands##2##3##(1990-11#2)
parotid##91##1##(1990-11#2)(1990-2#1)(1991-1#1)(1991-3#3)(1991-6#2)(1991-8#3)(1992-10#3)(1992-11#1)(1992-3#3)(1992-5#2)(1993-10#3)(1993-12#1)(1993-4#2)(1994-6#3)(1996-5#4)(1996-6#4)(1997-5#2)(2006-10#2)(2006-4#1)(2007-10#3)(2007-12#1)(2007-5#10)(2008-11#1)(2008-4#2)(2009-10#6)(2009-3#1)(2009-4#1)(2009-5#5)(2010-12#4)(2010-2#2)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#2)(2013-8#4)
parotidectomy##9##1##(2007-5#2)(2009-5#1)(2011-2#3)(2012-12#1)(2013-8#2)
parotitis##2##1##(2007-2#1)(2011-2#1)
parous women##4##2##(1991-7#1)(1997-7#1)(2007-4#1)(2013-1#1)
parous##8##1##(1991-7#1)(1992-9#1)(1997-7#1)(2004-1#1)(2007-4#1)(2007-6#1)(2011-2#1)(2013-1#1)
paroxetine and##2##2##(1997-3#1)(2008-11#1)
paroxetine were##2##2##(1996-3#1)(1997-3#1)
paroxetine##16##1##(1991-1#1)(1991-5#1)(1996-1#2)(1996-3#2)(1997-3#4)(2005-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-3#1)
paroxysmal AF##2##2##(2008-10#1)(2012-3#1)
paroxysmal and persistent atrial fibrillation##2##5##(2006-2#1)(2009-10#1)
paroxysmal and persistent##3##3##(2006-2#1)(2009-10#1)(2010-12#1)
paroxysmal atrial fibrillation in##2##4##(2006-9#1)(2008-10#1)
paroxysmal atrial fibrillation##8##3##(1997-5#1)(2006-9#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)
paroxysmal atrial##9##2##(1997-5#1)(2006-9#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#1)
paroxysmal cold hemoglobinuria##2##3##(1992-3#2)
paroxysmal depolarization##2##2##(1990-3#1)(1996-6#1)
paroxysmal discharges##3##2##(2008-1#3)
paroxysmal dyskinesias##2##2##(2009-10#2)
paroxysmal nocturnal hemoglobinuria (PNH)##2##4##(2007-8#1)(2008-4#1)
paroxysmal nocturnal hemoglobinuria##7##3##(1992-12#2)(1993-9#1)(1996-5#1)(2007-8#2)(2008-4#1)
paroxysmal nocturnal##10##2##(1992-12#2)(1993-9#1)(1996-5#1)(2007-8#2)(2008-4#2)(2012-2#2)
paroxysmal positional vertigo and##2##4##(2008-4#1)(2012-2#1)
paroxysmal positional vertigo##10##3##(2008-4#4)(2011-1#1)(2012-12#1)(2012-2#3)(2013-1#1)
paroxysmal positional##11##2##(2008-4#4)(2011-1#1)(2012-12#1)(2012-2#3)(2013-1#2)
paroxysmal supraventricular tachycardia##4##3##(1995-6#2)(2008-7#1)(2010-5#1)
paroxysmal supraventricular##7##2##(1995-6#3)(1996-4#1)(2006-4#1)(2008-7#1)(2010-5#1)
paroxysmal##72##1##(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-10#1)(1992-12#2)(1992-3#2)(1993-5#2)(1993-9#1)(1995-11#1)(1995-6#3)(1996-4#2)(1996-5#1)(1996-6#1)(1997-5#2)(2006-2#1)(2006-4#1)(2006-9#3)(2007-11#2)(2007-4#1)(2007-8#4)(2007-9#2)(2008-1#4)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#7)(2008-7#1)(2009-10#5)(2010-12#2)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#2)
parrot disease (PPD)##2##3##(2008-5#2)
parrot##6##1##(2008-5#5)(2012-2#1)
parrots##5##1##(2006-10#1)(2007-2#2)(2009-2#1)(2012-2#1)
pars compacta##15##2##(1991-11#1)(1991-3#1)(1991-9#1)(1994-12#2)(1994-2#2)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#2)(1997-6#1)(2008-7#1)(2013-7#1)
pars distalis##2##2##(2008-9#1)(2009-2#1)
pars dorsalis##2##2##(1992-7#1)(2008-6#1)
pars interarticularis##4##2##(2006-3#1)(2008-5#1)(2010-12#2)
pars intermedia##3##2##(1993-2#1)(1996-3#2)
pars medialis##3##2##(1994-8#2)(1995-7#1)
pars plana vitrectomy##3##3##(2007-7#2)(2011-2#1)
pars plana##4##2##(2007-11#1)(2007-7#2)(2011-2#1)
pars reticulata (SNpr)##2##3##(1993-12#1)(2009-10#1)
pars reticulata##11##2##(1992-10#1)(1992-9#3)(1993-12#2)(1995-12#1)(1995-2#1)(2008-11#1)(2008-12#1)(2009-10#1)
pars triangularis and opercularis##2##4##(2010-2#2)
pars triangularis##3##2##(2010-2#3)
pars tuberalis##3##2##(1991-7#1)(1994-9#2)
pars ventralis##2##2##(1992-7#2)
pars##63##1##(1991-11#1)(1991-3#1)(1991-5#2)(1991-7#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-7#3)(1992-9#3)(1993-12#2)(1993-2#1)(1994-12#2)(1994-2#2)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-3#2)(1997-6#1)(2006-3#1)(2006-8#2)(2007-11#1)(2007-7#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-12#2)(2010-2#4)(2011-2#1)(2013-7#1)
parsed into##3##2##(2008-10#2)(2008-2#1)
parsed##5##1##(2008-10#3)(2008-2#1)(2008-7#1)
parser##7##1##(2007-12#1)(2013-1#6)
parsers##6##1##(2013-1#6)
parsimonious to##3##2##(1995-12#1)(2007-12#1)(2012-12#1)
parsimonious typology of physician financial incentives##2##6##(2010-10#2)
parsimonious typology##3##2##(2010-10#3)
parsimonious##13##1##(1995-12#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-10#3)(2010-2#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#1)
parsimoniously##2##1##(1993-12#1)(1995-8#1)
parsimony analyses##2##2##(1992-12#1)(2008-10#1)
parsimony analysis of##3##3##(2008-10#3)
parsimony analysis##7##2##(1992-12#1)(1992-4#1)(1995-2#2)(2008-10#3)
parsimony and Bayesian##3##3##(2008-10#1)(2010-4#1)(2010-6#1)
parsimony and distance methods##2##4##(1995-3#1)(2008-8#1)
parsimony and##6##2##(1995-3#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-4#1)(2010-6#1)
parsimony methods##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
parsimony of nature##2##3##(2006-10#2)
parsimony of##4##2##(2006-10#2)(2008-10#1)(2010-11#1)
parsimony##32##1##(1992-12#3)(1992-4#1)(1995-2#2)(1995-3#2)(2006-10#2)(2007-12#1)(2008-10#8)(2008-4#4)(2008-5#1)(2008-8#1)(2008-9#2)(2010-11#1)(2010-4#1)(2010-6#2)(2012-1#1)
parsing algorithm for##2##3##(2011-3#2)
parsing algorithm##4##2##(2011-3#4)
parsing and reanalysis##2##3##(2007-12#2)
parsing and##3##2##(2007-12#2)(2008-7#1)
parsing##20##1##(2007-12#4)(2008-1#1)(2008-10#1)(2008-7#1)(2009-2#3)(2010-12#1)(2011-3#7)(2013-1#2)
parsley cells##4##2##(1992-11#2)(1997-4#2)
parsley plastocyanin##5##2##(1994-5#5)
parsley seed##2##2##(2008-12#2)
parsley##21##1##(1992-11#3)(1994-5#5)(1995-8#1)(1997-1#2)(1997-4#3)(1997-7#1)(2008-10#3)(2008-11#1)(2008-12#2)
parsonsiae##2##1##(2012-11#2)
part (estimated by##2##3##(2009-8#2)
part (that##2##2##(2013-1#2)
part 1##14##2##(1995-1#1)(2006-12#1)(2007-10#1)(2007-2#2)(2007-4#1)(2007-8#1)(2008-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
part 2##14##2##(1995-3#1)(2007-12#1)(2007-2#1)(2007-4#3)(2007-8#1)(2008-1#1)(2008-10#1)(2009-10#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
part 3##2##2##(2007-8#1)(2008-10#1)
part 4##2##2##(2007-8#1)(2008-10#1)
part I of this##2##4##(2007-12#1)(2007-2#1)
part I of##4##3##(2007-12#1)(2007-2#1)(2008-3#1)(2008-7#1)
part I##28##2##(2005-12#1)(2006-1#1)(2006-4#6)(2007-12#2)(2007-2#1)(2007-3#1)(2008-2#2)(2008-3#3)(2008-4#4)(2008-7#4)(2009-10#1)(2010-3#2)
part II##27##2##(1990-9#1)(2005-6#1)(2005-8#1)(2006-2#1)(2006-4#6)(2007-12#2)(2007-3#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-7#2)(2008-8#1)(2010-3#1)(2010-5#1)(2010-9#1)
part III##4##2##(2004-9#1)(2006-4#1)(2007-6#1)(2010-3#1)
part a##4##2##(1997-3#1)(2008-3#1)(2008-6#1)(2008-8#1)
part and a##2##3##(2007-11#1)(2012-1#1)
part and the##6##3##(1990-12#1)(1994-8#2)(1995-3#1)(2004-2#1)(2008-10#1)
part and##15##2##(1990-12#1)(1993-5#1)(1994-8#2)(1995-3#1)(2004-2#1)(2006-10#2)(2007-11#1)(2007-4#1)(2008-10#1)(2008-3#1)(2009-4#1)(2012-1#1)(2012-2#1)
part article##2##2##(1993-6#1)(2010-11#1)
part as##4##2##(1991-12#1)(1997-4#1)(2007-2#1)(2008-8#1)
part at least##3##3##(1991-12#1)(1991-3#1)(1994-8#1)
part at the##2##3##(2004-4#1)(2008-5#1)
part at##5##2##(1991-12#1)(1991-3#1)(1994-8#1)(2004-4#1)(2008-5#1)
part be##8##2##(1990-12#1)(1994-11#1)(1996-3#1)(2006-10#1)(2007-12#1)(2007-8#1)(2009-12#1)(2013-1#1)
part because of the##5##4##(1990-11#1)(2007-10#1)(2007-11#1)(2010-1#1)(2013-8#1)
part because of##14##3##(1990-10#1)(1990-11#1)(1994-12#1)(1994-6#1)(1997-8#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-8#1)(2010-1#1)(2012-12#1)(2013-8#1)
part because the##3##3##(1990-5#1)(1994-1#1)(2008-10#1)
part because##27##2##(1990-10#1)(1990-11#1)(1990-5#1)(1994-1#1)(1994-12#1)(1994-6#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-1#1)(2012-12#1)(2013-8#1)
part both##2##2##(1991-4#1)(2010-2#1)
part but##2##2##(2006-10#1)(2006-8#1)
part by the##17##3##(1990-12#1)(1990-8#1)(1991-11#1)(1993-3#1)(1993-9#2)(1994-11#1)(1995-2#1)(2006-7#2)(2007-8#2)(2008-1#1)(2008-4#1)(2008-8#2)(2012-1#1)
part by##62##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-8#1)(1991-11#2)(1992-1#2)(1992-9#1)(1993-2#1)(1993-3#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1997-4#1)(1997-6#1)(2006-2#1)(2006-7#2)(2007-10#1)(2007-12#1)(2007-6#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#5)(2008-5#3)(2008-8#3)(2008-9#1)(2009-3#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-1#1)(2013-8#1)
part contains##2##2##(1990-11#1)(1997-7#1)
part dependent##4##2##(2006-10#2)(2006-2#1)(2008-1#1)
part describes the##2##3##(2010-11#1)(2012-2#1)
part discusses the##2##3##(2009-6#1)(2012-12#1)
part discusses##4##2##(2009-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
part due to its##4##4##(1990-10#1)(2009-12#1)(2010-2#1)(2012-2#1)
part due to the##8##4##(1995-10#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-9#1)(2011-12#1)(2012-12#1)
part due to##20##3##(1990-10#1)(1991-3#1)(1991-6#1)(1995-10#1)(1996-3#1)(1997-6#1)(2005-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-9#1)(2010-2#1)(2011-12#1)(2012-12#1)(2012-2#1)
part for##7##2##(1990-4#1)(1991-12#1)(1996-8#1)(1997-2#1)(2007-1#1)(2009-8#1)(2012-12#1)
part in 10(6)##2##3##(2008-2#2)
part in a##6##3##(1997-6#1)(2005-1#1)(2008-2#1)(2009-6#1)(2012-1#1)(2013-1#1)
part in an##3##3##(1995-5#1)(1995-6#1)(2008-10#1)
part in development of##3##4##(1991-9#1)(2011-2#2)
part in the development of##2##5##(2006-6#1)(2008-10#1)
part in the regulation of##2##5##(1997-3#1)(2010-10#1)
part in the research##3##4##(2007-9#1)(2011-1#1)(2011-2#1)
part in the study##10##4##(1991-8#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-7#1)(2009-7#1)(2010-9#1)(2012-1#1)(2013-1#1)
part in the##49##3##(1990-10#1)(1990-11#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-5#1)(1992-7#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-11#1)(1996-4#1)(1997-1#1)(1997-3#2)(1997-6#1)(2004-4#1)(2005-11#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-7#1)(2009-11#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#1)
part in these##2##3##(1996-1#1)(2008-11#1)
part in this##6##3##(1993-10#1)(1996-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
part in##133##2##(1990-10#2)(1990-11#2)(1990-8#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-3#3)(1992-5#1)(1992-7#1)(1993-10#1)(1993-2#1)(1993-3#1)(1993-9#2)(1994-2#1)(1994-6#1)(1995-11#1)(1995-5#3)(1995-6#1)(1996-1#2)(1996-11#2)(1996-3#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-6#2)(1997-7#1)(1997-8#1)(2004-4#1)(2005-1#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-11#3)(2007-12#4)(2007-3#1)(2007-4#1)(2007-7#3)(2007-9#2)(2008-10#7)(2008-11#5)(2008-2#6)(2008-3#6)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-6#7)(2009-7#1)(2010-10#1)(2010-12#2)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#4)(2012-2#1)(2012-8#1)(2013-1#3)(2013-8#2)
part is played by##2##4##(2006-6#2)
part is treated##2##3##(2006-10#2)
part is##27##2##(1992-10#1)(1993-2#1)(1995-2#1)(1996-9#1)(1997-4#1)(2006-10#2)(2006-6#2)(2007-12#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#5)(2008-8#2)(2009-3#1)(2009-8#1)(2012-1#1)(2013-1#1)
part it##2##2##(1990-12#1)(2008-10#1)
part mainly##2##2##(2012-1#2)
part may##2##2##(1997-1#1)(2011-2#1)
part of 1997##2##3##(1996-11#1)(2011-1#1)
part of Basel-Land##2##3##(1993-5#2)
part of Canton##2##3##(1993-5#1)(1996-11#1)
part of Denmark##4##3##(1993-5#3)(1996-9#1)
part of G1##2##3##(1993-9#1)(1996-7#1)
part of India##4##3##(2007-6#1)(2008-3#1)(2012-2#1)(2013-7#1)
part of NIHG750##3##3##(2005-11#3)
part of Norway##2##3##(1990-6#1)(1995-6#1)
part of a broader##4##4##(2007-8#1)(2008-11#1)(2009-4#1)(2013-1#1)
part of a complex##3##4##(1990-2#1)(1997-5#1)(2008-11#1)
part of a composite##2##4##(1992-12#1)(2006-10#1)
part of a comprehensive##3##4##(2008-10#1)(2010-12#2)
part of a conserved##4##4##(1990-9#1)(1991-4#1)(2012-12#2)
part of a dynamic##3##4##(1995-11#1)(2012-12#2)
part of a flow##2##4##(2008-10#2)
part of a functional##3##4##(1990-3#1)(1995-5#1)(2010-2#1)
part of a general##5##4##(1995-1#1)(2007-7#1)(2008-10#1)(2009-7#1)(2013-4#1)
part of a joint##2##4##(2006-10#1)(2007-7#1)
part of a large##5##4##(1990-11#1)(1991-9#1)(2008-10#1)(2008-4#1)(2008-9#1)
part of a larger study##4##5##(2008-11#2)(2009-12#1)(2010-7#1)
part of a larger##18##4##(1991-3#1)(1992-1#1)(2005-11#1)(2006-10#2)(2007-10#1)(2007-12#3)(2007-2#1)(2008-11#2)(2008-2#1)(2008-7#1)(2009-12#1)(2010-7#1)(2011-1#1)(2012-2#1)
part of a more##3##4##(1993-5#1)(1994-3#1)(2006-2#1)
part of a negative feedback##2##5##(1991-3#1)(2009-8#1)
part of a prevention programme##2##5##(1991-6#2)
part of a research##2##4##(1991-9#1)(2008-10#1)
part of a series of##3##5##(1990-6#1)(1995-12#1)(2011-1#1)
part of a set of##2##5##(2013-1#2)
part of a signal transduction##3##5##(1995-6#1)(2008-8#1)(2009-8#1)
part of a study of##4##5##(1995-12#1)(2006-8#1)(2008-6#1)(2009-4#1)
part of a study##7##4##(1995-12#1)(2006-8#1)(2007-3#1)(2008-11#1)(2008-6#1)(2009-4#1)(2013-8#1)
part of a training##2##4##(2011-2#1)(2012-12#1)
part of a wider##6##4##(1996-11#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2013-8#1)
part of a##245##3##(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#3)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#3)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#2)(1993-8#2)(1994-1#2)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#1)(2005-5#1)(2005-7#1)(2005-8#2)(2006-10#4)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#2)(2007-10#1)(2007-11#1)(2007-12#6)(2007-2#1)(2007-3#2)(2007-5#3)(2007-7#4)(2007-8#4)(2007-9#4)(2008-1#2)(2008-10#10)(2008-11#11)(2008-12#3)(2008-2#5)(2008-3#7)(2008-4#7)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#3)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#5)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#8)(2012-2#3)(2012-3#1)(2013-1#11)(2013-4#1)(2013-8#4)
part of all##5##3##(1992-3#1)(1994-12#1)(1995-1#1)(1996-12#1)(2009-1#1)
part of an integrated management##2##5##(2008-10#2)
part of an integrated##6##4##(2008-10#4)(2008-11#1)(2012-12#1)
part of an interdisciplinary##2##4##(1993-3#1)(2007-5#1)
part of an investigation##2##4##(1996-11#1)(2007-8#1)
part of an ongoing##9##4##(1992-5#1)(1993-6#1)(2004-10#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)
part of an operon that##2##5##(1990-11#1)(2008-10#1)
part of an operon##7##4##(1990-11#1)(1990-9#1)(1991-7#1)(1993-12#1)(1995-2#1)(1997-2#1)(2008-10#1)
part of an overall##3##4##(1992-2#1)(2006-10#1)(2008-12#1)
part of an##69##3##(1990-10#1)(1990-11#1)(1990-9#1)(1991-3#1)(1991-7#2)(1992-2#1)(1992-4#1)(1992-5#1)(1993-12#1)(1993-3#2)(1993-6#2)(1994-10#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-11#2)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(2004-10#1)(2005-8#1)(2006-10#3)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
part of any##9##3##(1991-11#1)(1995-2#1)(2005-5#1)(2006-10#1)(2007-7#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
part of both##2##3##(1995-1#1)(2012-1#1)
part of care##2##3##(1995-2#1)(1997-2#1)
part of cell##2##3##(1990-2#1)(2011-2#1)
part of clinical##4##3##(2007-12#1)(2008-11#1)(2009-8#1)(2011-11#1)
part of combination##2##3##(1994-2#1)(2007-11#1)
part of complex##4##3##(1993-12#1)(2007-11#1)(2009-12#1)(2013-1#1)
part of emergency##2##3##(1991-6#1)(2007-7#1)
part of every##3##3##(1994-2#1)(2005-8#1)(2007-4#1)
part of everyday life##2##4##(1993-3#1)(2010-7#1)
part of everyday##3##3##(1993-3#1)(2010-7#1)(2011-2#1)
part of exon##2##3##(1990-11#1)(1992-1#1)
part of family##3##3##(1995-3#1)(2007-6#1)(2008-2#1)
part of future##2##3##(2008-4#1)(2009-11#1)
part of health##3##3##(1992-1#1)(1994-6#1)(2008-1#1)
part of her##4##3##(1995-3#1)(1995-6#1)(1996-6#1)(2013-8#1)
part of human##4##3##(1990-8#1)(1992-3#1)(2006-6#1)(2010-12#1)
part of interventional pain management##2##5##(2006-8#2)
part of its##10##3##(1992-5#1)(2006-7#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-8#2)(2011-2#1)
part of lamina##2##3##(1995-6#1)(2011-2#1)
part of larger##2##3##(1994-12#1)(2011-2#1)
part of mainstream##3##3##(2008-11#1)(2008-7#1)(2013-1#1)
part of medical##7##3##(1992-6#2)(1995-4#1)(2006-10#2)(2006-12#1)(2006-2#1)
part of modern##5##3##(2007-11#1)(2008-1#1)(2008-2#1)(2008-4#1)(2013-1#1)
part of normal##3##3##(2006-9#1)(2008-12#1)(2012-1#1)
part of nursing##5##3##(1997-3#1)(1997-4#1)(1997-7#1)(2008-11#1)(2008-7#1)
part of ongoing##2##3##(2007-12#1)(2008-12#1)
part of our##17##3##(1994-8#1)(1996-2#1)(1997-1#1)(2006-12#1)(2006-7#1)(2007-10#1)(2008-10#1)(2008-5#2)(2008-9#1)(2009-1#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-2#1)(2013-1#2)
part of patient##2##3##(1993-12#1)(2007-7#1)
part of practice##3##3##(2008-11#1)(2013-1#2)
part of quality##5##3##(1993-8#1)(1994-6#1)(1995-3#1)(1996-3#1)(2010-7#1)
part of routine##5##3##(1990-6#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#1)
part of several##2##3##(2009-11#1)(2010-11#1)
part of skeleton##2##3##(2008-1#2)
part of spine##5##3##(2007-11#1)(2007-8#3)(2008-1#1)
part of surgical##2##3##(2007-7#1)(2009-7#1)
part of that##2##3##(2007-12#1)(2008-3#1)
part of the ATPase##2##4##(1995-3#2)
part of the European##4##4##(2006-10#2)(2010-8#1)(2013-8#1)
part of the Genomic Encyclopedia of Bacteria and Archaea project##39##10##(2011-2#39)
part of the Genomic Encyclopedia of##40##6##(2011-2#40)
part of the N-terminal domain##2##5##(1992-9#1)(1995-3#1)
part of the Netherlands##2##4##(1993-5#1)(2010-8#1)
part of the UK##2##4##(1991-3#1)(2011-2#1)
part of the X##2##4##(1995-11#2)
part of the active site##4##5##(1991-4#1)(1991-8#1)(1994-8#2)
part of the analysis##3##4##(1993-12#1)(2008-10#1)(2011-2#1)
part of the anterior##2##4##(2006-10#1)(2013-7#1)
part of the article##6##4##(1990-12#1)(1993-6#1)(1995-3#1)(2009-4#1)(2010-11#2)
part of the assessment of the##2##6##(1996-12#1)(2008-3#1)
part of the back##2##4##(1996-9#1)(2005-10#1)
part of the beta##2##4##(1992-7#1)(2008-11#1)
part of the bilayer##2##4##(2006-10#1)(2008-10#1)
part of the binding site##2##5##(1990-7#1)(1992-6#1)
part of the biological##2##4##(1994-3#1)(2013-8#1)
part of the body##4##4##(2007-8#2)(2010-12#1)(2013-1#1)
part of the brain##8##4##(1995-3#1)(1996-12#1)(1996-5#1)(1996-9#1)(2007-1#1)(2007-12#1)(2008-4#1)(2009-4#1)
part of the care##3##4##(1993-12#1)(2008-5#1)(2008-7#1)
part of the cell##5##4##(1997-8#1)(2008-10#2)(2008-7#1)(2012-12#1)
part of the central##2##4##(1995-7#1)(2006-1#1)
part of the clinical##2##4##(2007-8#1)(2008-9#1)
part of the community health##3##5##(1997-2#2)(2006-2#1)
part of the complex refractive index##5##6##(2008-3#5)
part of the complex##8##4##(1994-5#1)(2008-3#5)(2008-9#1)(2012-2#1)
part of the continuum of care##2##6##(1994-12#1)(1997-3#1)
part of the country##8##4##(1991-5#1)(1996-12#1)(1997-6#1)(2007-10#1)(2007-7#2)(2008-12#1)(2010-9#1)
part of the current##2##4##(1992-6#1)(2009-5#1)
part of the curriculum##3##4##(1994-1#2)(2011-2#1)
part of the cyst##3##4##(1991-8#1)(2008-5#1)(2012-2#1)
part of the data##3##4##(2008-5#1)(2008-7#1)(2010-8#1)
part of the diaphragm##2##4##(2007-8#1)(2010-5#1)
part of the diet##2##4##(2008-5#1)(2008-7#1)
part of the differential##2##4##(2006-10#1)(2008-3#1)
part of the disc##3##4##(2009-4#3)
part of the disease##2##4##(2008-7#2)
part of the dorsal##4##4##(1991-5#1)(1993-9#1)(1995-12#1)(1995-6#1)
part of the duodenum##3##4##(1997-5#1)(2009-6#1)(2012-12#1)
part of the embryonic brain in both insects and vertebrates##2##10##(2007-12#2)
part of the environment##2##4##(2008-9#1)(2012-1#1)
part of the enzyme##3##4##(1995-3#1)(2007-10#1)(2013-8#1)
part of the esophagus##2##4##(2007-6#1)(2009-3#1)
part of the evaluation of##5##5##(2004-11#1)(2008-8#1)(2008-9#1)(2010-9#1)(2012-2#1)
part of the evaluation##6##4##(2004-11#1)(2006-11#1)(2008-8#1)(2008-9#1)(2010-9#1)(2012-2#1)
part of the explanation##2##4##(1993-3#1)(2012-1#1)
part of the extracellular##2##4##(1992-12#1)(2008-5#1)
part of the femur and##2##5##(2007-11#1)(2008-7#1)
part of the femur##5##4##(2007-11#1)(2007-5#1)(2008-7#1)(2011-12#1)(2013-1#1)
part of the first##5##4##(1993-6#1)(1994-12#1)(1996-5#1)(2007-5#1)(2008-2#1)
part of the gastrointestinal tract##2##5##(1990-11#1)(2006-10#1)
part of the gene##2##4##(1991-12#1)(1997-2#1)
part of the gland##2##4##(2006-9#1)(2007-12#1)
part of the gulf##2##4##(2007-5#2)
part of the head##2##4##(2008-5#1)(2009-4#1)
part of the health care workforce##2##6##(2006-2#1)(2008-11#1)
part of the health care##4##5##(1996-3#1)(2006-2#1)(2007-3#1)(2008-11#1)
part of the health##5##4##(1994-4#1)(1996-3#1)(2006-2#1)(2007-3#1)(2008-11#1)
part of the heart##2##4##(2007-9#1)(2009-12#1)
part of the history of##2##5##(2010-12#1)(2010-6#1)
part of the human##3##4##(1995-12#1)(2007-8#1)(2012-2#1)
part of the index of refraction##3##6##(2008-2#1)(2008-3#2)
part of the index##4##4##(2008-2#1)(2008-3#3)
part of the inflammatory response##2##5##(1995-11#1)(2012-1#1)
part of the inflammatory##3##4##(1992-6#1)(1995-11#1)(2012-1#1)
part of the innate immune system##2##6##(2012-3#1)(2013-8#1)
part of the innate immune##3##5##(2010-12#1)(2012-3#1)(2013-8#1)
part of the international##2##4##(1991-9#1)(2008-7#1)
part of the intron downstream of##2##6##(1991-6#1)(1993-12#1)
part of the investigation of##2##5##(1991-5#1)(2008-4#1)
part of the investigation##5##4##(1990-9#1)(1991-5#1)(2006-8#1)(2008-4#1)(2009-10#1)
part of the jejunum##4##4##(1997-5#1)(2010-12#1)(2011-12#1)(2013-8#1)
part of the laser##2##4##(2007-12#1)(2008-2#1)
part of the lateral##3##4##(1992-9#1)(1996-9#1)(1997-8#1)
part of the left##4##4##(1991-9#1)(1996-2#1)(2006-11#1)(2008-7#1)
part of the lipid##3##4##(1992-9#1)(1993-4#1)(2008-10#1)
part of the long arm of##2##6##(1996-6#1)(2012-1#1)
part of the lung##2##4##(1994-12#2)
part of the main##3##4##(1994-6#1)(2012-12#2)
part of the mechanism##3##4##(1996-8#1)(2008-11#1)(2008-8#1)
part of the medial vestibular nucleus##2##6##(1996-11#2)
part of the medial##3##4##(1996-11#2)(2008-3#1)
part of the medical curriculum in##2##6##(2007-2#1)(2011-12#1)
part of the medical curriculum##3##5##(2007-2#1)(2010-12#1)(2011-12#1)
part of the metapopulation##3##4##(2008-9#3)
part of the modern##2##4##(1992-2#1)(1997-4#1)
part of the molecular##2##4##(1993-12#1)(2010-4#1)
part of the molecule##4##4##(1990-11#1)(1994-3#1)(1996-9#1)(1997-9#1)
part of the national##2##4##(1992-1#1)(2012-12#1)
part of the natural##4##4##(1991-12#1)(1991-3#1)(2010-12#1)(2011-2#1)
part of the new##2##4##(2006-11#1)(2006-5#1)
part of the nineteenth century##3##5##(1991-12#1)(2013-1#2)
part of the normal human##2##5##(2010-10#1)(2013-7#1)
part of the normal##10##4##(1995-2#1)(2005-9#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-9#1)(2010-10#1)(2013-1#1)(2013-7#1)
part of the nucleus##2##4##(1992-10#1)(1993-12#1)
part of the operation##2##4##(1996-2#1)(2006-6#1)
part of the outer##2##4##(1996-11#1)(2012-2#1)
part of the output##2##4##(2007-12#1)(2013-1#1)
part of the overall##3##4##(2008-10#1)(2008-7#1)(2010-3#1)
part of the paper##5##4##(1991-2#1)(2008-5#2)(2009-6#1)(2011-2#1)
part of the paraventricular nucleus##3##5##(1995-7#1)(1996-9#2)
part of the pathway##2##4##(1990-1#1)(1995-7#1)
part of the patient##3##4##(1990-4#1)(2008-5#1)(2012-12#1)
part of the peptide##2##4##(2006-10#1)(2011-1#1)
part of the permittivity##2##4##(2005-11#2)
part of the plant##3##4##(2005-11#1)(2008-10#1)(2012-1#1)
part of the population##3##4##(2008-3#1)(2008-8#1)(2012-12#1)
part of the practice of##2##5##(2006-12#1)(2006-8#1)
part of the problem##2##4##(2008-3#1)(2010-2#1)
part of the process##4##4##(2007-2#1)(2007-4#1)(2007-8#1)(2009-3#1)
part of the programme##2##4##(2008-1#1)(2008-12#1)
part of the project##2##4##(1993-3#1)(2010-9#1)
part of the protein##5##4##(1992-11#1)(1993-2#1)(1994-11#1)(1994-12#1)(1996-5#1)
part of the public##2##4##(2008-10#1)(2011-2#1)
part of the receptor-binding##2##4##(1992-11#1)(1992-9#1)
part of the rectum##2##4##(2011-2#1)(2012-1#1)
part of the refractive index is##2##6##(2007-11#1)(2008-3#1)
part of the refractive index of##2##6##(2008-2#1)(2008-3#1)
part of the refractive index##10##5##(2007-11#1)(2008-2#3)(2008-3#6)
part of the region##2##4##(1995-6#1)(2008-10#1)
part of the region's##2##4##(2007-2#1)(2008-2#1)
part of the regulatory##2##4##(1995-2#1)(1997-5#1)
part of the remaining##3##4##(1996-1#1)(1996-12#1)(2008-10#1)
part of the review##6##4##(1994-8#1)(1996-7#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-6#1)
part of the same##5##4##(2005-8#1)(2006-12#1)(2008-10#3)
part of the sequence##2##4##(1992-2#1)(1997-1#1)
part of the short review article summarizes some of the##2##10##(2008-10#2)
part of the signal transduction##2##5##(1993-8#1)(1995-12#1)
part of the smooth##2##4##(1990-7#1)(2008-5#1)
part of the solution##2##4##(2009-4#1)(2012-1#1)
part of the spectrum of##3##5##(2006-10#1)(2008-5#1)(2008-7#1)
part of the spectrum##7##4##(2006-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2011-2#2)
part of the standard treatment for##2##6##(2006-10#1)(2012-3#1)
part of the standard##7##4##(1993-4#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#1)(2012-3#1)
part of the stomach##2##4##(2006-2#1)(2009-3#1)
part of the stress response##2##5##(1995-12#2)
part of the study included##2##5##(2006-10#1)(2010-12#1)
part of the study##13##4##(1992-5#2)(1996-5#1)(2006-10#1)(2006-8#2)(2007-4#1)(2008-1#2)(2010-12#1)(2011-1#1)(2011-3#1)(2013-8#1)
part of the surface##2##4##(1991-7#1)(2007-12#1)
part of the surfactant##2##4##(2005-11#2)
part of the survey##4##4##(1990-3#4)
part of the system##4##4##(1994-2#1)(1996-3#1)(2008-2#2)
part of the temporal##2##4##(1993-12#1)(1994-2#1)
part of the therapeutic##3##4##(1990-12#1)(1994-8#1)(2009-9#1)
part of the third##2##4##(1996-2#1)(2007-12#1)
part of the thyroid##2##4##(2008-2#1)(2012-1#1)
part of the total##4##4##(1992-11#1)(1992-12#1)(1996-5#1)(2012-2#1)
part of the training##3##4##(1993-2#1)(1994-1#1)(2008-1#1)
part of the transgene mRNA##2##5##(2008-10#2)
part of the treatment of##6##5##(1992-1#1)(1992-6#1)(1996-6#1)(1996-8#1)(2005-7#1)(2008-1#1)
part of the treatment regimen##2##5##(2005-10#1)(2006-7#1)
part of the treatment##15##4##(1991-12#1)(1991-7#1)(1992-1#1)(1992-6#1)(1996-6#1)(1996-8#1)(2005-10#1)(2005-7#1)(2006-7#1)(2008-1#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-8#1)
part of the usual##2##4##(1997-3#1)(2006-8#1)
part of the variance##2##4##(2008-10#2)
part of the ventral##4##4##(1993-12#1)(1994-12#1)(1995-8#1)(1997-7#1)
part of the world##7##4##(2008-1#2)(2008-3#1)(2009-6#1)(2010-12#1)(2010-2#1)(2013-1#1)
part of the##1146##3##(1990-1#2)(1990-10#2)(1990-11#4)(1990-12#12)(1990-2#2)(1990-3#6)(1990-4#3)(1990-5#9)(1990-6#4)(1990-7#4)(1990-9#6)(1991-10#1)(1991-11#1)(1991-12#8)(1991-2#5)(1991-3#2)(1991-4#3)(1991-5#5)(1991-6#3)(1991-7#3)(1991-8#4)(1991-9#10)(1992-1#4)(1992-10#1)(1992-11#5)(1992-12#5)(1992-2#4)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#9)(1992-7#1)(1992-8#1)(1992-9#5)(1993-1#2)(1993-10#2)(1993-11#1)(1993-12#18)(1993-2#5)(1993-3#5)(1993-4#5)(1993-5#3)(1993-6#7)(1993-8#1)(1993-9#2)(1994-1#4)(1994-10#1)(1994-11#2)(1994-12#9)(1994-2#5)(1994-3#5)(1994-4#1)(1994-5#4)(1994-6#4)(1994-8#9)(1994-9#3)(1995-1#4)(1995-10#1)(1995-11#5)(1995-12#7)(1995-2#6)(1995-3#11)(1995-5#2)(1995-6#7)(1995-7#4)(1995-8#2)(1996-1#5)(1996-11#3)(1996-12#9)(1996-2#9)(1996-3#6)(1996-4#3)(1996-5#7)(1996-6#6)(1996-7#1)(1996-8#3)(1996-9#13)(1997-1#3)(1997-2#5)(1997-3#10)(1997-4#8)(1997-5#8)(1997-6#2)(1997-7#3)(1997-8#7)(1997-9#1)(2004-11#1)(2004-3#1)(2004-7#1)(2005-10#3)(2005-11#8)(2005-7#3)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#23)(2006-11#9)(2006-12#7)(2006-2#8)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#6)(2006-7#2)(2006-8#8)(2006-9#2)(2007-1#6)(2007-10#4)(2007-11#14)(2007-12#30)(2007-2#9)(2007-3#7)(2007-4#2)(2007-5#10)(2007-6#5)(2007-7#8)(2007-8#12)(2007-9#8)(2008-1#16)(2008-10#60)(2008-11#14)(2008-12#7)(2008-2#17)(2008-3#43)(2008-4#9)(2008-5#32)(2008-6#7)(2008-7#29)(2008-8#10)(2008-9#17)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#5)(2009-4#13)(2009-5#3)(2009-6#6)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#13)(2010-2#4)(2010-3#2)(2010-4#3)(2010-5#6)(2010-6#2)(2010-7#4)(2010-8#8)(2010-9#6)(2011-1#8)(2011-12#3)(2011-2#73)(2011-3#1)(2012-1#11)(2012-11#1)(2012-12#17)(2012-2#16)(2012-3#6)(2013-1#27)(2013-7#5)(2013-8#17)
part of their job##2##4##(2006-2#1)(2010-9#1)
part of their professional##2##4##(2008-11#1)(2009-7#1)
part of their work##2##4##(2008-7#1)(2013-8#1)
part of their##39##3##(1990-9#1)(1992-1#1)(1992-10#1)(1992-3#1)(1993-12#1)(1993-2#1)(1995-1#2)(2006-2#1)(2007-10#1)(2007-3#2)(2007-7#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-7#1)(2010-3#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#1)(2013-8#1)
part of therapy##2##3##(2008-12#1)(2009-9#1)
part of these##7##3##(1993-2#1)(1995-3#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)
part of this article##6##4##(1997-6#1)(2005-7#1)(2006-10#1)(2007-6#1)(2010-9#1)(2012-12#1)
part of this century##3##4##(2006-10#2)(2007-8#1)
part of this paper##3##4##(1997-4#1)(2008-7#1)(2009-2#1)
part of this range##2##4##(1991-11#1)(2008-3#1)
part of this review we##2##5##(2008-1#1)(2012-2#1)
part of this review##6##4##(2006-10#1)(2008-1#2)(2008-10#1)(2009-6#1)(2012-2#1)
part of this study##5##4##(2006-12#1)(2007-7#1)(2008-4#1)(2012-2#1)(2013-1#1)
part of this##54##3##(1990-11#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-9#1)(1994-6#1)(1995-12#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-5#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-7#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-2#2)(2008-3#2)(2008-4#3)(2008-7#1)(2008-8#1)(2009-2#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-12#3)(2012-2#2)(2013-1#1)
part of total##2##3##(1994-1#1)(2007-7#1)
part of treatment in##2##4##(2006-10#1)(2007-11#1)
part of treatment##4##3##(1997-2#1)(2005-1#1)(2006-10#1)(2007-11#1)
part of two##4##3##(1990-5#1)(2008-10#2)(2009-4#1)
part of water##2##3##(1991-6#1)(2009-6#1)
part of which##2##3##(1997-5#1)(1997-7#1)
part of##2060##2##(1990-1#2)(1990-10#3)(1990-11#11)(1990-12#17)(1990-2#7)(1990-3#7)(1990-4#4)(1990-5#13)(1990-6#9)(1990-7#7)(1990-8#1)(1990-9#10)(1991-10#2)(1991-11#4)(1991-12#12)(1991-2#7)(1991-3#6)(1991-4#5)(1991-5#10)(1991-6#8)(1991-7#7)(1991-8#4)(1991-9#13)(1992-1#13)(1992-10#2)(1992-11#8)(1992-12#8)(1992-2#6)(1992-3#10)(1992-4#3)(1992-5#5)(1992-6#12)(1992-7#2)(1992-8#3)(1992-9#7)(1993-1#2)(1993-10#2)(1993-11#2)(1993-12#23)(1993-2#9)(1993-3#9)(1993-4#5)(1993-5#10)(1993-6#12)(1993-7#1)(1993-8#6)(1993-9#5)(1994-1#9)(1994-10#2)(1994-11#2)(1994-12#16)(1994-2#7)(1994-3#11)(1994-4#2)(1994-5#6)(1994-6#8)(1994-8#11)(1994-9#6)(1995-1#10)(1995-10#1)(1995-11#6)(1995-12#13)(1995-2#10)(1995-3#17)(1995-4#2)(1995-5#5)(1995-6#13)(1995-7#4)(1995-8#4)(1995-9#1)(1996-1#6)(1996-11#11)(1996-12#14)(1996-2#11)(1996-3#10)(1996-4#5)(1996-5#12)(1996-6#10)(1996-7#3)(1996-8#3)(1996-9#16)(1997-1#6)(1997-2#9)(1997-3#15)(1997-4#13)(1997-5#11)(1997-6#6)(1997-7#6)(1997-8#9)(1997-9#1)(2004-10#1)(2004-11#1)(2004-3#1)(2004-4#1)(2004-7#1)(2004-9#1)(2005-1#2)(2005-10#5)(2005-11#14)(2005-12#1)(2005-4#2)(2005-5#3)(2005-6#1)(2005-7#5)(2005-8#8)(2005-9#1)(2006-1#1)(2006-10#46)(2006-11#10)(2006-12#12)(2006-2#12)(2006-3#3)(2006-4#2)(2006-5#3)(2006-6#12)(2006-7#7)(2006-8#17)(2006-9#6)(2007-1#8)(2007-10#10)(2007-11#26)(2007-12#44)(2007-2#15)(2007-3#11)(2007-4#6)(2007-5#16)(2007-6#10)(2007-7#27)(2007-8#24)(2007-9#18)(2008-1#34)(2008-10#102)(2008-11#41)(2008-12#18)(2008-2#34)(2008-3#60)(2008-4#22)(2008-5#47)(2008-6#16)(2008-7#55)(2008-8#26)(2008-9#27)(2009-1#3)(2009-10#5)(2009-11#4)(2009-12#5)(2009-2#7)(2009-3#8)(2009-4#18)(2009-5#4)(2009-6#11)(2009-7#6)(2009-8#13)(2009-9#2)(2010-1#2)(2010-10#3)(2010-11#9)(2010-12#20)(2010-2#7)(2010-3#5)(2010-4#6)(2010-5#11)(2010-6#4)(2010-7#8)(2010-8#10)(2010-9#11)(2011-1#22)(2011-11#1)(2011-12#4)(2011-2#98)(2011-3#2)(2012-1#18)(2012-10#1)(2012-11#1)(2012-12#32)(2012-2#32)(2012-3#17)(2013-1#59)(2013-4#1)(2013-7#11)(2013-8#26)
part on the##9##3##(1991-3#1)(1991-8#1)(1994-3#2)(2008-4#1)(2009-12#1)(2012-12#2)(2013-1#1)
part on##19##2##(1991-3#2)(1991-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-3#2)(1994-6#1)(1995-12#1)(1996-10#1)(2007-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2012-12#2)(2013-1#1)
part one of a##2##4##(1996-9#1)(2007-5#1)
part or full-time##3##3##(1992-6#1)(1995-12#2)
part or##8##2##(1992-12#1)(1992-6#1)(1995-12#2)(2007-11#1)(2007-8#1)(2008-10#1)(2012-3#1)
part per trillion##2##3##(2007-8#1)(2008-10#1)
part per##4##2##(1992-1#1)(2007-8#1)(2008-10#1)(2008-3#1)
part presents##2##2##(1997-2#1)(2010-12#1)
part provides##3##2##(2008-4#2)(2010-9#1)
part represents##2##2##(1996-2#1)(2007-12#1)
part reviews##4##2##(1995-6#1)(2008-8#2)(2009-4#1)
part similar to that of the##2##6##(1996-6#1)(2009-12#1)
part some##2##2##(1996-4#1)(2013-8#1)
part that is##2##3##(2008-2#1)(2010-2#1)
part that##4##2##(1996-12#1)(2008-2#1)(2008-7#1)(2010-2#1)
part the##13##2##(1991-3#1)(1991-6#1)(1994-3#1)(1997-7#1)(1997-8#2)(2007-12#1)(2007-4#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-4#1)(2013-1#1)
part these##3##2##(2007-8#1)(2013-1#2)
part this##2##2##(1990-12#1)(2013-8#1)
part to a##3##3##(2008-11#1)(2008-6#1)(2013-7#1)
part to an##4##3##(1994-3#2)(1997-5#1)(2008-9#1)
part to the ability##2##4##(2007-12#1)(2009-12#1)
part to the##25##3##(1990-10#1)(1990-8#2)(1993-6#1)(1995-9#1)(1996-1#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-4#3)(2004-9#1)(2006-10#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-12#1)(2012-12#1)(2012-3#1)
part to##74##2##(1990-10#1)(1990-2#2)(1990-4#1)(1990-8#3)(1991-2#1)(1992-1#1)(1992-7#1)(1993-10#1)(1993-6#1)(1994-2#1)(1994-3#2)(1994-6#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#2)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-4#3)(1997-5#2)(2004-9#1)(2005-12#1)(2005-9#1)(2006-10#4)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-1#1)(2010-2#1)(2011-1#1)(2011-7#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#1)
part was treated with##2##4##(2006-4#1)(2013-1#1)
part was##10##2##(1991-2#1)(1995-4#1)(1997-4#1)(1997-6#1)(2006-4#1)(2008-3#2)(2008-6#1)(2009-4#1)(2013-1#1)
part were##3##2##(1994-8#1)(2008-10#1)(2011-2#1)
part which##3##2##(1993-2#1)(1994-3#1)(2011-2#1)
part with a##2##3##(1993-9#1)(2007-11#1)
part with##6##2##(1993-9#1)(1995-5#1)(2007-11#1)(2008-10#2)(2009-8#1)
part##3178##1##(1990-1#2)(1990-10#9)(1990-11#17)(1990-12#26)(1990-2#16)(1990-3#10)(1990-4#10)(1990-5#17)(1990-6#11)(1990-7#7)(1990-8#9)(1990-9#12)(1991-1#3)(1991-10#2)(1991-11#7)(1991-12#18)(1991-2#11)(1991-3#13)(1991-4#7)(1991-5#14)(1991-6#12)(1991-7#8)(1991-8#7)(1991-9#14)(1992-1#19)(1992-10#3)(1992-11#8)(1992-12#10)(1992-2#6)(1992-3#14)(1992-4#4)(1992-5#10)(1992-6#15)(1992-7#5)(1992-8#4)(1992-9#8)(1993-1#3)(1993-10#5)(1993-11#5)(1993-12#27)(1993-2#15)(1993-3#15)(1993-4#6)(1993-5#12)(1993-6#15)(1993-7#1)(1993-8#9)(1993-9#14)(1994-1#10)(1994-10#2)(1994-11#7)(1994-12#23)(1994-2#15)(1994-3#24)(1994-4#2)(1994-5#8)(1994-6#22)(1994-8#22)(1994-9#10)(1995-1#17)(1995-10#4)(1995-11#11)(1995-12#23)(1995-2#20)(1995-3#24)(1995-4#4)(1995-5#14)(1995-6#20)(1995-7#4)(1995-8#6)(1995-9#2)(1996-1#11)(1996-10#5)(1996-11#15)(1996-12#19)(1996-2#17)(1996-3#16)(1996-4#11)(1996-5#15)(1996-6#11)(1996-7#8)(1996-8#7)(1996-9#20)(1997-1#9)(1997-2#15)(1997-3#19)(1997-4#23)(1997-5#16)(1997-6#12)(1997-7#12)(1997-8#15)(1997-9#1)(2003-11#1)(2004-10#1)(2004-11#1)(2004-12#2)(2004-2#1)(2004-3#1)(2004-4#3)(2004-7#1)(2004-9#5)(2005-1#3)(2005-10#10)(2005-11#21)(2005-12#3)(2005-4#2)(2005-5#3)(2005-6#2)(2005-7#8)(2005-8#12)(2005-9#3)(2006-1#2)(2006-10#65)(2006-11#11)(2006-12#20)(2006-2#18)(2006-3#5)(2006-4#16)(2006-5#6)(2006-6#17)(2006-7#11)(2006-8#21)(2006-9#8)(2007-1#14)(2007-10#16)(2007-11#42)(2007-12#70)(2007-2#23)(2007-3#19)(2007-4#17)(2007-5#18)(2007-6#13)(2007-7#34)(2007-8#38)(2007-9#27)(2008-1#48)(2008-10#156)(2008-11#68)(2008-12#19)(2008-2#60)(2008-3#89)(2008-4#48)(2008-5#74)(2008-6#27)(2008-7#71)(2008-8#47)(2008-9#40)(2009-1#5)(2009-10#9)(2009-11#8)(2009-12#12)(2009-2#8)(2009-3#13)(2009-4#23)(2009-5#7)(2009-6#22)(2009-7#7)(2009-8#23)(2009-9#6)(2010-1#5)(2010-10#6)(2010-11#12)(2010-12#35)(2010-2#13)(2010-3#9)(2010-4#11)(2010-5#12)(2010-6#4)(2010-7#9)(2010-8#13)(2010-9#16)(2011-1#30)(2011-11#1)(2011-12#7)(2011-2#127)(2011-3#2)(2011-7#1)(2012-1#28)(2012-10#1)(2012-11#2)(2012-12#48)(2012-2#44)(2012-3#29)(2012-8#1)(2013-1#87)(2013-4#1)(2013-7#15)(2013-8#39)
part)##8##1##(2006-10#2)(2008-4#2)(2008-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
part-time post qualifying nursing students##3##5##(2008-11#3)
part-time post qualifying##4##3##(2008-11#4)
part-time##13##1##(1991-12#1)(1995-12#1)(2006-5#1)(2007-5#1)(2008-11#6)(2010-9#1)(2011-2#1)(2013-7#1)
part_of##2##1##(2008-7#2)
partaking in##2##2##(2011-2#1)(2013-1#1)
parthenin##6##1##(2008-7#6)
parthenium##4##1##(2007-7#1)(2007-8#3)
parthenogenesis in##2##2##(2008-9#2)
parthenogenesis induction##3##2##(2008-8#3)
parthenogenesis##12##1##(2008-5#1)(2008-8#3)(2008-9#5)(2010-3#2)(2013-1#1)
parthenogenetic lizards##4##2##(2010-3#4)
parthenogenetic species##3##2##(2008-10#1)(2008-12#1)(2010-3#1)
parthenogenetic##19##1##(1993-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#4)(2008-9#4)(2010-3#6)(2012-2#1)
parthenogens are##2##2##(2008-5#1)(2012-3#1)
parthenogens##4##1##(2008-5#2)(2008-9#1)(2012-3#1)
parthogenesis of##2##2##(2007-11#2)
partial 16S rRNA gene##3##4##(2006-8#2)(2010-6#1)
partial 16S rRNA##4##3##(2005-12#1)(2006-8#2)(2010-6#1)
partial 16S##6##2##(2005-12#1)(2006-3#1)(2006-8#3)(2010-6#1)
partial AC##2##2##(1994-9#2)
partial Austin-Moore hip prosthesis##2##4##(2007-7#2)
partial CPB##2##2##(2007-8#2)
partial DNA library of Streptomyces ansochromogenes 7100##2##7##(2005-11#1)(2008-8#1)
partial DNA##3##2##(2005-11#1)(2008-8#2)
partial ITD##2##2##(2010-11#2)
partial N-terminal##2##2##(1993-4#1)(1994-3#1)
partial ORF##2##2##(1995-6#1)(2008-9#1)
partial Sau3A##2##2##(1996-5#1)(1997-6#1)
partial aa sequence##2##3##(1993-12#1)(1997-2#1)
partial acid hydrolysis##3##3##(1990-7#1)(1993-11#1)(2010-2#1)
partial activity##2##2##(1997-4#1)(2008-10#1)
partial agonism##2##2##(1991-1#1)(1996-10#1)
partial agonist activity##3##3##(1996-10#1)(1996-8#1)(2008-11#1)
partial agonist at alpha##2##4##(1995-11#2)
partial agonist at##12##3##(1990-11#1)(1990-2#2)(1991-11#1)(1993-11#2)(1995-11#2)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#1)
partial agonist in##2##3##(1990-10#1)(1996-11#1)
partial agonist##34##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-7#2)(1991-11#1)(1992-10#1)(1992-8#1)(1993-1#1)(1993-11#2)(1994-10#1)(1994-5#1)(1995-11#4)(1995-6#1)(1996-1#1)(1996-10#3)(1996-11#2)(1996-12#3)(1996-8#1)(1997-5#2)(2005-9#1)(2008-11#1)(2011-2#1)
partial agonists at##2##3##(1995-3#1)(1996-1#1)
partial agonists##10##2##(1991-5#1)(1992-3#1)(1992-8#1)(1993-11#1)(1994-12#1)(1995-3#1)(1996-1#1)(1996-8#1)(2009-6#2)
partial agreement##3##2##(1991-9#1)(1997-8#1)(2008-2#1)
partial alpha##2##2##(2006-10#1)(2011-2#1)
partial amino acid sequence of the##3##6##(1991-1#1)(1992-6#1)(1997-7#1)
partial amino acid sequence of##7##5##(1990-7#2)(1991-1#1)(1992-6#1)(1992-9#1)(1993-8#1)(1997-7#1)
partial amino acid sequence##12##4##(1990-7#2)(1991-1#1)(1992-12#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-8#1)(1993-9#1)(1997-2#1)(1997-7#1)
partial amino acid sequences of##2##5##(1996-8#1)(2008-10#1)
partial amino acid sequences were determined##2##6##(1994-12#1)(2008-8#1)
partial amino acid sequences were##4##5##(1992-11#1)(1994-12#2)(2008-8#1)
partial amino acid sequences##6##4##(1992-11#1)(1994-12#2)(1996-8#1)(2008-10#1)(2008-8#1)
partial amino acid##19##3##(1990-7#2)(1991-1#1)(1991-10#1)(1992-11#1)(1992-12#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-12#2)(1996-8#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-8#1)
partial and complete##4##3##(2006-4#1)(2006-6#1)(2007-11#1)(2007-8#1)
partial and full-swing##2##3##(2011-2#2)
partial and##18##2##(1992-9#1)(1993-6#1)(1994-11#1)(1996-9#1)(1997-7#1)(2006-4#1)(2006-6#2)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-10#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
partial anomalous pulmonary venous connection##3##5##(2007-8#1)(2008-10#1)(2010-9#1)
partial anomalous pulmonary venous##4##4##(2007-8#2)(2008-10#1)(2010-9#1)
partial area subtaxonomy##4##3##(2013-1#4)
partial area##7##2##(2010-2#1)(2013-1#6)
partial articular fracture of the##2##5##(2007-1#2)
partial atomic charges##3##3##(2006-10#1)(2007-9#2)
partial blast resistance in##2##4##(2008-10#2)
partial bone resection##3##3##(2007-11#3)
partial breast irradiation##5##3##(2007-11#1)(2009-8#2)(2013-1#2)
partial but##3##2##(1995-11#1)(1995-2#1)(2008-10#1)
partial cDNA clones##3##3##(1990-8#2)(1996-10#1)
partial cDNA encoding##2##3##(1993-6#1)(1995-2#1)
partial cDNA sequences##2##3##(1992-11#1)(1996-10#1)
partial cDNA to##2##3##(1990-3#1)(1995-2#1)
partial cDNA##25##2##(1990-3#1)(1990-8#2)(1991-3#1)(1992-11#1)(1992-5#1)(1992-7#1)(1993-12#2)(1993-3#1)(1993-6#2)(1994-6#2)(1994-8#1)(1995-2#2)(1996-10#2)(1996-5#1)(1997-1#2)(1997-2#1)(1997-6#1)(2008-7#1)
partial cDNAs##5##2##(1991-12#1)(1993-12#2)(1994-6#1)(2008-7#1)
partial characterization of a##4##4##(1990-2#1)(1994-3#1)(1994-8#1)(2008-10#1)
partial characterization of the##3##4##(1991-7#1)(1992-6#1)(1997-7#1)
partial characterization of##17##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-6#1)(1991-7#1)(1992-6#1)(1993-3#1)(1994-3#1)(1994-6#1)(1994-8#1)(1997-7#1)(2006-8#1)(2008-10#3)(2009-4#1)
partial characterization##19##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1991-7#1)(1992-6#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-8#1)(1997-7#1)(2006-8#1)(2008-10#3)(2009-4#1)
partial charge##2##2##(1994-9#1)(1997-7#1)
partial charges##10##2##(2006-10#2)(2007-9#4)(2008-11#1)(2010-2#1)(2010-7#1)(2012-12#1)
partial chemical##2##2##(1995-11#1)(2008-10#1)
partial cleavage##2##2##(1995-1#1)(1996-9#1)
partial clinical##3##2##(1993-2#1)(1995-5#1)(2006-11#1)
partial coherence##5##2##(2007-12#1)(2007-9#1)(2008-2#2)(2008-3#1)
partial collisions at the system##2##5##(2007-11#2)
partial collisions##4##2##(2007-11#2)(2007-12#2)
partial complementary DNA##2##3##(1990-5#1)(1991-5#1)
partial complex seizures##2##3##(1990-5#1)(1997-3#1)
partial complex##3##2##(1990-5#1)(1997-3#1)(1997-7#1)
partial correlation##2##2##(2010-4#1)(2013-8#1)
partial correlations##2##2##(1992-2#1)(2010-6#1)
partial cross-linking##2##2##(2011-2#2)
partial data sets##2##3##(2008-11#1)(2008-7#1)
partial deficiency of##3##3##(1995-9#1)(1996-9#1)(2011-2#1)
partial deficiency##7##2##(1995-9#2)(1996-9#1)(2005-9#1)(2007-7#1)(2008-1#1)(2011-2#1)
partial degradation of##3##3##(1992-7#1)(2009-7#1)(2010-12#1)
partial degradation##6##2##(1991-1#1)(1992-7#1)(1996-2#1)(2008-7#1)(2009-7#1)(2010-12#1)
partial dehiscence and##2##3##(2006-4#1)(2007-8#1)
partial deletion##3##2##(2005-11#2)(2007-2#1)
partial denture framework##2##3##(2012-2#2)
partial denture##8##2##(2008-4#1)(2010-10#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-2#3)
partial dentures##4##2##(2008-4#1)(2008-7#1)(2011-2#2)
partial derivatives##3##2##(1997-3#1)(2008-2#1)(2009-5#1)
partial differential equation (PDE)##3##4##(2008-2#1)(2008-6#1)(2008-7#1)
partial differential equation model of##2##5##(2013-8#2)
partial differential equation model##3##4##(2008-8#1)(2013-8#2)
partial differential equation##8##3##(2008-2#2)(2008-6#1)(2008-7#2)(2008-8#1)(2013-8#2)
partial differential equations##8##3##(1990-3#1)(1996-11#1)(2008-2#2)(2011-1#1)(2013-1#1)(2013-8#2)
partial differential##17##2##(1990-3#1)(1996-11#1)(2005-11#1)(2008-2#4)(2008-6#1)(2008-7#2)(2008-8#1)(2011-1#1)(2013-1#1)(2013-8#4)
partial digestion of genomic DNA##3##5##(2008-2#1)(2008-4#2)
partial digestion of##4##3##(2008-10#1)(2008-2#1)(2008-4#2)
partial digestion##6##2##(2006-12#1)(2008-10#2)(2008-2#1)(2008-4#2)
partial disability pension##2##3##(2006-10#2)
partial dissolution of the##2##4##(2008-10#2)
partial embolisation##2##2##(1996-6#1)(1996-9#1)
partial epilepsy with##2##3##(1991-4#2)
partial epilepsy##9##2##(1991-4#2)(1992-10#1)(1995-12#2)(1996-6#1)(1996-9#2)(2011-1#1)
partial erasing of##2##3##(2007-12#2)
partial exchange##2##2##(1995-10#1)(2008-10#1)
partial excision of##2##3##(2007-11#1)(2012-2#1)
partial excision##3##2##(2006-12#1)(2007-11#1)(2012-2#1)
partial explanation of##2##3##(1993-7#1)(2008-1#1)
partial explanation##4##2##(1992-1#1)(1992-9#1)(1993-7#1)(2008-1#1)
partial fluorescence##2##2##(1997-6#1)(2012-2#1)
partial gas##2##2##(2008-10#1)(2008-3#1)
partial gastrectomy in##2##3##(1993-2#1)(2009-7#1)
partial gastrectomy##6##2##(1991-6#1)(1993-2#1)(2007-4#1)(2007-8#1)(2008-5#1)(2009-7#1)
partial gastric##2##2##(2006-6#1)(2012-1#1)
partial gene##6##2##(2006-10#2)(2006-8#1)(2007-10#1)(2008-7#2)
partial hepatectomy and##3##3##(1994-8#1)(2013-1#1)(2013-7#1)
partial hepatectomy in##4##3##(1997-8#1)(2005-10#1)(2010-1#1)(2013-1#1)
partial hepatectomy or##4##3##(1991-1#1)(1991-4#1)(1991-5#1)(1992-7#1)
partial hepatectomy was##3##3##(1993-5#1)(1995-1#1)(2013-8#1)
partial hepatectomy were##2##3##(1997-8#1)(2013-7#1)
partial hepatectomy##54##2##(1990-11#1)(1990-12#4)(1991-1#2)(1991-2#3)(1991-4#2)(1991-5#5)(1991-6#1)(1991-7#1)(1992-1#2)(1992-4#3)(1992-7#2)(1993-5#1)(1993-7#1)(1994-11#3)(1994-6#3)(1994-8#1)(1995-1#2)(1995-6#2)(1996-11#1)(1996-2#1)(1997-8#3)(2005-10#1)(2008-5#1)(2009-4#1)(2010-1#1)(2013-1#2)(2013-7#2)(2013-8#2)
partial heterodyning##2##2##(2008-2#2)
partial hospital##2##2##(1991-1#2)
partial hospitalization##13##2##(1991-1#4)(1992-1#9)
partial hydatidiform mole##3##3##(1994-3#1)(2012-2#2)
partial hydrogenation##2##2##(2006-7#1)(2012-2#1)
partial hydrolysis##4##2##(1991-7#1)(1991-9#2)(2008-10#1)
partial improvement in##2##3##(2008-8#1)(2012-3#1)
partial improvement##3##2##(2008-8#1)(2012-2#1)(2012-3#1)
partial in##4##2##(1991-8#1)(1995-5#1)(2007-7#1)(2013-8#1)
partial information##2##2##(1997-1#1)(2008-8#1)
partial inhibition of##2##3##(1993-3#1)(2007-11#1)
partial inhibition##5##2##(1993-11#1)(1993-3#1)(2007-11#1)(2008-10#1)(2010-10#1)
partial intracellular##2##2##(1991-1#1)(1994-9#1)
partial inverse agonist##3##3##(1990-2#1)(1995-7#1)(1997-2#1)
partial least square (PLS)##3##4##(2008-10#2)(2010-4#1)
partial least square##9##3##(2008-10#5)(2010-4#1)(2011-2#1)(2013-8#2)
partial least squares (PLS) algorithm##2##5##(2008-10#2)
partial least squares (PLS) and##5##5##(2007-11#1)(2008-10#4)
partial least squares (PLS) calibration##5##5##(2007-8#1)(2008-10#4)
partial least squares (PLS) model##2##5##(2008-10#2)
partial least squares (PLS) multivariate calibration##4##6##(2008-10#4)
partial least squares (PLS) regression was##2##6##(2008-10#2)
partial least squares (PLS) regression##6##5##(2008-10#5)(2013-8#1)
partial least squares (PLS)##37##4##(2007-11#1)(2007-8#3)(2008-10#31)(2011-1#1)(2013-8#1)
partial least squares (PLS-1)##2##4##(2008-10#2)
partial least squares (PLS1) regression##2##5##(2008-6#2)
partial least squares analysis##2##4##(2008-8#1)(2011-1#1)
partial least squares and##4##4##(2008-10#3)(2010-4#1)
partial least squares based on##2##5##(2008-10#2)
partial least squares calibration model##2##5##(2008-10#2)
partial least squares calibration##8##4##(2008-10#8)
partial least squares modeling##3##4##(2008-10#3)
partial least squares regression (PLS)##5##5##(2008-10#5)
partial least squares regression and##2##5##(2008-10#2)
partial least squares regression##15##4##(2007-11#1)(2008-10#14)
partial least squares##104##3##(2007-11#3)(2007-8#4)(2008-10#85)(2008-3#1)(2008-6#2)(2008-8#1)(2009-3#1)(2010-4#1)(2010-5#1)(2011-1#3)(2013-1#1)(2013-8#1)
partial least##116##2##(2006-12#1)(2007-11#3)(2007-8#4)(2008-10#91)(2008-3#1)(2008-6#2)(2008-8#1)(2009-3#1)(2010-4#2)(2010-5#1)(2011-1#3)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
partial least-squares (PLS) calibration##3##4##(2008-10#3)
partial least-squares (PLS)##10##3##(2007-11#1)(2008-10#9)
partial least-squares (PLS-1) and##2##4##(2008-10#2)
partial least-squares method##2##3##(2008-10#2)
partial least-squares multivariate calibration##4##4##(2008-10#4)
partial least-squares regression##7##3##(2008-10#6)(2010-5#1)
partial least-squares##33##2##(2007-11#1)(2008-10#28)(2008-3#1)(2010-5#3)
partial lesion of the nigrostriatal##2##5##(1994-8#1)(1997-1#1)
partial lesion of##3##3##(1993-5#1)(1994-8#1)(1997-1#1)
partial library of##3##3##(1991-9#1)(2008-10#1)(2008-8#1)
partial likelihood##4##2##(1994-9#2)(1996-12#1)(1997-2#1)
partial lipodystrophy##3##2##(1996-3#2)(2008-1#1)
partial liquid ventilation##4##3##(2005-11#1)(2006-10#3)
partial liquid##5##2##(2005-11#1)(2006-10#3)(2006-4#1)
partial local##2##2##(1991-6#1)(2004-4#1)
partial loss of##5##3##(1990-8#1)(1994-3#1)(1994-9#1)(1995-2#1)(2008-9#1)
partial mastectomy##2##2##(2004-1#1)(2010-7#1)
partial maxillectomy##2##2##(2012-2#2)
partial meniscectomy##3##2##(1996-11#2)(2008-8#1)
partial metabolic##3##2##(1990-11#1)(1990-4#1)(2011-1#1)
partial migration##3##2##(1996-10#1)(2008-8#2)
partial mixing##2##2##(2008-6#1)(2008-7#1)
partial molar volumes of##3##4##(2006-10#3)
partial molar volumes##4##3##(2006-10#4)
partial molar##6##2##(1997-2#1)(2006-10#4)(2008-10#1)
partial molecular##2##2##(1995-5#1)(2008-8#1)
partial necrosis of stomach##2##4##(2008-9#2)
partial necrosis##3##2##(2008-9#3)
partial nephrectomy in##2##3##(2007-7#1)(2013-1#1)
partial nephrectomy##5##2##(2006-9#1)(2007-7#2)(2009-2#1)(2013-1#1)
partial neuroprotective activity##2##3##(2013-8#2)
partial nucleotide##4##2##(1992-11#1)(1992-8#1)(2008-10#2)
partial obstruction##2##2##(1996-2#1)(1997-8#1)
partial occlusion of##2##3##(2008-2#1)(2010-4#1)
partial occlusion##3##2##(2008-2#2)(2010-4#1)
partial optimization technique##2##3##(2010-7#2)
partial or complete response##2##4##(1990-6#1)(2006-12#1)
partial or complete##14##3##(1990-6#1)(1991-2#1)(1991-9#1)(1996-2#1)(2006-12#1)(2006-4#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-7#1)(2013-1#2)
partial or total##11##3##(1992-3#1)(1993-11#1)(1997-8#1)(2007-7#1)(2008-9#3)(2009-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
partial or##32##2##(1990-6#1)(1991-2#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-2#1)(1995-5#1)(1996-2#1)(1997-8#1)(2006-12#2)(2006-4#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-7#1)(2011-12#1)(2011-7#1)(2012-12#1)(2012-3#1)(2013-1#3)
partial out the##2##3##(2007-12#1)(2012-1#1)
partial oxygen##2##2##(2006-10#1)(2008-2#1)
partial pain relief##3##3##(1992-1#1)(2005-9#1)(2007-11#1)
partial phase diagram of##2##4##(2004-9#1)(2006-10#1)
partial phase diagram##3##3##(2004-9#2)(2006-10#1)
partial photobleaching##2##2##(2008-3#2)
partial positive##3##2##(1992-3#2)(1995-5#1)
partial pressure (pCO2)##2##3##(1991-10#1)(2008-11#1)
partial pressure of carbon dioxide##2##5##(2009-10#1)(2013-1#1)
partial pressure of oxygen##7##4##(1990-9#1)(1993-12#1)(2006-7#1)(2007-8#2)(2008-10#1)(2009-3#1)
partial pressure of##13##3##(1990-9#1)(1993-12#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-8#2)(2008-10#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#1)(2013-1#1)
partial pressure##35##2##(1990-9#1)(1991-10#1)(1993-12#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-12#2)(2007-8#2)(2008-10#1)(2008-11#7)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#3)(2009-10#2)(2009-3#1)(2010-8#1)(2013-1#1)(2013-8#2)
partial pressures of##4##3##(1990-2#1)(2005-10#1)(2007-5#1)(2008-3#1)
partial pressures##8##2##(1990-2#1)(1990-8#1)(1994-10#1)(2005-10#1)(2007-12#1)(2007-5#1)(2008-3#1)(2010-4#1)
partial protection##5##2##(1990-6#1)(1992-7#1)(1996-10#1)(2008-8#1)(2013-1#1)
partial proteolysis with##2##3##(1991-12#1)(1992-11#1)
partial proteolysis##3##2##(1990-12#1)(1991-12#1)(1992-11#1)
partial purification and characterization of##2##5##(1994-6#1)(1995-2#1)
partial purification and##3##3##(1994-6#1)(1995-2#2)
partial purification of a##4##4##(1990-8#1)(1992-3#1)(1995-3#1)(1996-9#1)
partial purification of##7##3##(1990-8#1)(1991-1#1)(1991-6#1)(1992-2#1)(1992-3#1)(1995-3#1)(1996-9#1)
partial purification##12##2##(1990-8#1)(1991-1#1)(1991-4#1)(1991-6#1)(1992-2#1)(1992-3#1)(1994-12#1)(1994-6#1)(1995-2#2)(1995-3#1)(1996-9#1)
partial pyruvate kinase gene sequences##2##5##(2006-8#2)
partial reaction of##2##3##(1990-7#1)(1995-1#1)
partial reaction##3##2##(1990-7#1)(1995-1#1)(1995-3#1)
partial reactions of the##2##4##(1991-5#1)(1993-6#1)
partial reactions of##3##3##(1991-5#1)(1993-4#1)(1993-6#1)
partial reactions##7##2##(1991-5#1)(1993-4#1)(1993-6#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-6#1)
partial recovery of##5##3##(1990-5#1)(1991-5#1)(1992-7#1)(1994-6#1)(2008-10#1)
partial recovery##12##2##(1990-5#1)(1991-5#1)(1992-7#1)(1994-3#2)(1994-6#1)(1995-7#1)(1997-6#1)(2008-10#3)(2012-12#1)
partial reduction##4##2##(1994-3#1)(2007-7#1)(2008-3#1)(2008-4#1)
partial regression of##2##3##(1990-2#1)(2008-6#1)
partial regression##6##2##(1990-2#1)(1996-4#1)(2005-1#1)(2008-6#1)(2010-12#2)
partial relief##2##2##(2007-7#1)(2008-12#1)
partial remission (PR)##4##3##(1990-10#1)(1991-10#1)(1991-8#1)(2010-4#1)
partial remission in##3##3##(1990-4#1)(2006-6#1)(2012-1#1)
partial remission was##3##3##(1997-3#1)(2008-6#2)
partial remission with##2##3##(1991-10#1)(2011-1#1)
partial remission##22##2##(1990-10#1)(1990-4#2)(1990-6#1)(1991-10#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-10#2)(1997-3#1)(2006-6#1)(2008-6#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)
partial remissions##4##2##(1990-2#2)(1991-2#1)(2007-8#1)
partial removal of the pulmonary artery##3##6##(2013-7#3)
partial removal of the##7##4##(1996-10#1)(2006-12#2)(2007-11#1)(2013-7#3)
partial removal of##8##3##(1996-10#1)(2006-12#2)(2007-11#1)(2008-10#1)(2013-7#3)
partial removal##9##2##(1996-10#1)(2006-12#3)(2007-11#1)(2008-10#1)(2013-7#3)
partial replacement of sodium chloride##2##5##(2010-4#2)
partial replacement of##3##3##(1992-7#1)(2010-4#2)
partial resection of the##5##4##(1992-9#1)(2006-10#1)(2006-6#1)(2007-7#1)(2008-1#1)
partial resection of##6##3##(1992-9#1)(2006-10#2)(2006-6#1)(2007-7#1)(2008-1#1)
partial resection##10##2##(1992-8#1)(1992-9#1)(2006-10#2)(2006-6#1)(2007-11#2)(2007-7#2)(2008-1#1)
partial resistance to STB##2##4##(2008-10#2)
partial resistance to##14##3##(2008-10#14)
partial resistance##43##2##(1994-11#1)(1995-5#1)(2008-10#38)(2012-11#3)
partial resolution of the##2##4##(1994-9#1)(2010-10#1)
partial resolution of##3##3##(1994-9#1)(2010-10#1)(2012-3#1)
partial response (PR)##3##3##(1991-4#1)(1997-7#1)(2007-6#1)
partial response and##2##3##(1992-6#1)(2008-6#1)
partial response in##2##3##(2008-6#1)(2013-1#1)
partial response was##8##3##(1992-12#1)(2006-12#2)(2006-6#1)(2007-8#3)(2008-6#1)
partial response##31##2##(1990-12#1)(1990-2#3)(1991-4#1)(1991-8#1)(1992-10#1)(1992-12#2)(1992-6#1)(1992-8#1)(1994-10#1)(1997-7#1)(2006-11#1)(2006-12#2)(2006-6#1)(2007-11#2)(2007-6#1)(2007-8#3)(2008-10#1)(2008-6#4)(2010-12#1)(2013-1#1)(2013-8#1)
partial responses were observed##2##4##(1990-10#1)(1990-12#1)
partial responses were##4##3##(1990-10#1)(1990-12#2)(2007-8#1)
partial responses##19##2##(1990-10#2)(1990-12#2)(1990-6#1)(1991-2#3)(1992-10#1)(1992-2#1)(1992-8#1)(1993-9#1)(1995-10#1)(2006-11#1)(2006-6#1)(2007-10#1)(2007-8#1)(2008-5#1)(2008-6#1)
partial responses)##2##2##(2008-5#1)(2012-1#1)
partial restoration of##2##3##(1992-5#1)(2006-5#1)
partial reversal of##3##3##(1990-2#1)(1995-6#1)(1996-11#1)
partial reversibility of##2##3##(1992-12#1)(2008-4#1)
partial seizures##3##2##(2006-12#1)(2009-9#1)(2010-12#1)
partial separation of##2##3##(2008-10#2)
partial separation##3##2##(1996-5#1)(2008-10#2)
partial sequence analysis##2##3##(1991-1#1)(1994-6#1)
partial sequence information##2##3##(1994-6#1)(2008-4#1)
partial sequence of a##2##4##(1993-12#1)(1997-7#1)
partial sequence of the##2##4##(1996-9#1)(2010-8#1)
partial sequence of##8##3##(1993-12#1)(1996-8#1)(1996-9#1)(1997-7#1)(2008-10#1)(2008-8#1)(2010-10#1)(2010-8#1)
partial sequence##18##2##(1991-1#1)(1991-2#1)(1991-5#1)(1993-12#1)(1994-6#2)(1995-2#1)(1996-8#1)(1996-9#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#2)(2010-10#1)(2010-8#1)
partial sequences from a 3'-directed cDNA library##2##7##(1996-10#1)(1996-2#1)
partial sequences from##3##3##(1996-10#1)(1996-2#1)(2007-12#1)
partial sequences of the##2##4##(2008-10#2)
partial sequences of##4##3##(1992-7#1)(1996-8#1)(2008-10#2)
partial sequences##12##2##(1991-2#1)(1992-7#1)(1994-6#1)(1996-10#1)(1996-2#1)(1996-8#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-9#1)
partial sequencing of##4##3##(2008-10#2)(2008-5#1)(2011-1#1)
partial sequencing##9##2##(1992-8#1)(1994-12#1)(1994-6#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-5#1)(2011-1#1)
partial similarity##2##2##(1996-4#1)(2006-12#1)
partial skin##3##2##(1991-4#2)(2009-1#1)
partial specific volume##2##3##(2006-10#1)(2008-10#1)
partial specific##3##2##(2006-10#2)(2008-10#1)
partial splenectomy##2##2##(1992-3#1)(2007-2#1)
partial splenic embolization##3##3##(2009-9#1)(2013-1#2)
partial sterility##3##2##(2008-8#1)(2010-3#1)(2011-2#1)
partial structural functions of##2##4##(2006-4#2)
partial structural##3##2##(1993-3#1)(2006-4#2)
partial structures##3##2##(1991-2#1)(2009-9#2)
partial substitution (50%) of animal fat by olive oil##2##9##(2010-4#2)
partial substitution of##2##3##(2007-12#1)(2010-4#1)
partial substitution##4##2##(2007-12#1)(2010-4#3)
partial success##2##2##(1991-8#1)(2011-2#1)
partial support##4##2##(1995-2#1)(1997-2#1)(2008-9#1)(2009-8#1)
partial suppression of##5##3##(1994-8#1)(1996-5#1)(2008-1#1)(2008-4#1)(2010-8#1)
partial tandem##2##2##(2008-10#1)(2011-3#1)
partial tear of the##2##4##(2009-9#1)(2013-1#1)
partial thickness flap##2##3##(2012-3#2)
partial thickness##4##2##(2007-11#2)(2012-3#2)
partial thromboplastin time (APTT)##2##4##(1990-11#1)(1994-9#1)
partial thromboplastin time##19##3##(1990-11#1)(1990-12#1)(1991-2#1)(1994-4#2)(1994-9#1)(1996-4#1)(1996-5#1)(2004-11#2)(2006-9#2)(2007-10#3)(2007-11#1)(2008-10#1)(2008-7#1)(2008-9#1)
partial thromboplastin##22##2##(1990-11#1)(1990-12#1)(1991-2#1)(1994-4#2)(1994-9#1)(1996-4#1)(1996-5#1)(2004-11#2)(2006-9#2)(2007-10#3)(2007-11#2)(2008-10#1)(2008-7#1)(2008-9#2)(2012-1#1)
partial tone##2##2##(2008-8#2)
partial trees##2##2##(2006-10#2)
partial trisomy 21##2##3##(1996-2#1)(1996-6#1)
partial tumor recurrence##2##3##(2007-12#2)
partial tumor regression##2##3##(1994-3#1)(2008-11#1)
partial tumor##5##2##(1994-3#1)(2006-5#1)(2007-12#2)(2008-11#1)
partial tumour##2##2##(1997-3#1)(2007-11#1)
partial unfolding##2##2##(1994-8#1)(1995-2#1)
partial volume##2##2##(2011-1#2)
partial##1473##1##(1990-10#4)(1990-11#6)(1990-12#15)(1990-2#14)(1990-3#6)(1990-4#4)(1990-5#5)(1990-6#5)(1990-7#6)(1990-8#6)(1990-9#1)(1991-1#15)(1991-10#5)(1991-11#1)(1991-12#5)(1991-2#14)(1991-3#6)(1991-4#9)(1991-5#14)(1991-6#6)(1991-7#4)(1991-8#7)(1991-9#9)(1992-1#14)(1992-10#6)(1992-11#6)(1992-12#4)(1992-2#4)(1992-3#8)(1992-4#5)(1992-5#2)(1992-6#8)(1992-7#10)(1992-8#9)(1992-9#4)(1993-1#2)(1993-10#1)(1993-11#6)(1993-12#8)(1993-2#3)(1993-3#6)(1993-4#4)(1993-5#4)(1993-6#6)(1993-7#2)(1993-8#1)(1993-9#4)(1994-1#1)(1994-10#3)(1994-11#7)(1994-12#9)(1994-2#4)(1994-3#10)(1994-4#2)(1994-5#3)(1994-6#13)(1994-8#10)(1994-9#12)(1995-1#5)(1995-10#3)(1995-11#8)(1995-12#3)(1995-2#13)(1995-3#4)(1995-4#1)(1995-5#7)(1995-6#9)(1995-7#2)(1995-8#1)(1995-9#2)(1996-1#2)(1996-10#10)(1996-11#7)(1996-12#5)(1996-2#8)(1996-3#2)(1996-4#4)(1996-5#9)(1996-6#6)(1996-8#5)(1996-9#12)(1997-1#4)(1997-2#14)(1997-3#7)(1997-4#2)(1997-5#3)(1997-6#9)(1997-7#11)(1997-8#6)(2004-1#1)(2004-11#3)(2004-4#1)(2004-9#3)(2005-1#1)(2005-10#3)(2005-11#10)(2005-12#1)(2005-3#2)(2005-7#2)(2005-9#4)(2006-10#29)(2006-11#3)(2006-12#13)(2006-2#2)(2006-3#2)(2006-4#8)(2006-5#3)(2006-6#11)(2006-7#2)(2006-8#9)(2006-9#5)(2007-1#3)(2007-10#6)(2007-11#32)(2007-12#28)(2007-2#7)(2007-4#4)(2007-5#1)(2007-6#2)(2007-7#16)(2007-8#23)(2007-9#10)(2008-1#8)(2008-10#216)(2008-11#21)(2008-12#2)(2008-2#28)(2008-3#21)(2008-4#13)(2008-5#17)(2008-6#13)(2008-7#26)(2008-8#26)(2008-9#18)(2009-1#1)(2009-10#3)(2009-12#2)(2009-2#3)(2009-3#5)(2009-4#2)(2009-5#5)(2009-6#5)(2009-7#5)(2009-8#4)(2009-9#10)(2010-1#2)(2010-10#7)(2010-11#4)(2010-12#9)(2010-2#6)(2010-3#3)(2010-4#12)(2010-5#5)(2010-6#2)(2010-7#5)(2010-8#3)(2010-9#4)(2011-1#12)(2011-12#4)(2011-2#33)(2011-3#3)(2011-7#1)(2012-1#9)(2012-11#5)(2012-12#5)(2012-2#14)(2012-3#10)(2013-1#30)(2013-7#7)(2013-8#22)
partial-area taxonomy##6##2##(2013-1#6)
partial-hospital program##2##2##(1992-1#2)
partial-hospital programs##2##2##(1992-1#2)
partial-hospital##4##1##(1992-1#4)
partial-onset seizures##2##2##(2008-7#1)(2010-12#1)
partial-secretor phenotype##3##2##(1996-2#3)
partial-thickness##2##1##(2005-10#1)(2009-3#1)
partially activated##4##2##(1991-3#1)(1992-3#1)(1994-2#2)
partially additive##2##2##(1995-10#1)(1997-6#1)
partially ameliorated by##2##3##(1993-12#1)(2010-7#1)
partially ameliorated##4##2##(1993-12#1)(2008-6#1)(2010-7#1)(2012-12#1)
partially and##5##2##(1995-2#2)(1995-3#2)(2008-11#1)
partially attenuated the##2##3##(1994-5#1)(2013-1#1)
partially attenuated##4##2##(1991-3#1)(1994-5#1)(1994-9#1)(2013-1#1)
partially attributed to##3##3##(1996-2#1)(2008-10#1)(2011-2#1)
partially blocked by the##2##4##(1993-3#1)(1996-7#1)
partially blocked by##11##3##(1991-2#1)(1991-6#1)(1993-3#1)(1994-10#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-7#1)(2008-4#1)(2008-8#1)(2011-12#1)
partially blocked the##2##3##(1990-8#1)(1992-3#1)
partially blocked##17##2##(1990-8#1)(1990-9#1)(1991-2#1)(1991-6#1)(1992-3#1)(1993-3#1)(1994-10#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-7#1)(2007-1#1)(2008-4#1)(2008-8#1)(2011-12#1)
partially broken##2##2##(1995-10#1)(2008-5#1)
partially buried##3##2##(1990-2#1)(2005-11#1)(2011-1#1)
partially by##7##2##(1990-3#1)(1991-5#1)(1995-10#1)(1995-3#1)(1996-9#1)(2010-2#1)(2011-2#1)
partially castrated##3##2##(2008-9#3)
partially caused by##2##3##(1994-11#1)(2008-4#1)
partially characterized from the##2##4##(1992-6#1)(2008-10#1)
partially characterized from##3##3##(1992-6#1)(1993-2#1)(2008-10#1)
partially characterized##17##2##(1990-12#1)(1991-10#1)(1992-2#1)(1992-6#1)(1993-2#1)(1994-8#1)(1997-6#1)(2008-1#1)(2008-10#5)(2008-4#1)(2008-6#1)(2011-1#1)(2012-1#1)
partially coherent anisotropic##3##3##(2007-11#3)
partially coherent beams##9##3##(2007-11#4)(2007-12#4)(2008-3#1)
partially coherent fields##5##3##(2007-11#1)(2007-12#4)
partially coherent illumination##2##3##(2007-12#2)
partially coherent imaging##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
partially coherent light##7##3##(2007-12#4)(2008-2#2)(2008-3#1)
partially coherent optical signals##2##4##(2007-12#2)
partially coherent optical##3##3##(2007-12#2)(2008-3#1)
partially coherent twisted anisotropic Gaussian-Schell model##2##6##(2007-11#2)
partially coherent twisted anisotropic##3##4##(2007-11#3)
partially coherent##48##2##(2007-11#15)(2007-12#20)(2008-2#3)(2008-3#9)(2010-12#1)
partially compensated by a##2##4##(2006-5#1)(2013-1#1)
partially compensated for##2##3##(1996-10#1)(2007-11#1)
partially compensated##5##2##(1996-10#1)(2006-5#1)(2007-11#1)(2008-3#1)(2013-1#1)
partially complementary##2##2##(1994-12#1)(2007-12#1)
partially complexed with##2##3##(2005-11#1)(2008-10#1)
partially converted##2##2##(1996-4#1)(2005-12#1)
partially corrected##3##2##(2006-9#1)(2007-12#1)(2008-2#1)
partially correcting##2##2##(2008-2#1)(2009-10#1)
partially correlated##2##2##(1990-8#1)(1994-9#1)
partially coupled##2##2##(2007-12#2)
partially covered##2##2##(2007-8#1)(2008-3#1)
partially cross-fertile plant species##2##4##(2008-8#2)
partially crosslinked fibers##2##3##(1995-2#2)
partially deafferented##2##2##(1994-10#2)
partially degraded##4##2##(1994-12#1)(2008-10#2)(2008-7#1)
partially denatured form##2##3##(1992-11#1)(1995-5#1)
partially denatured##4##2##(1991-5#1)(1992-11#1)(1995-5#1)(2008-8#1)
partially denervated rat##2##3##(1995-9#2)
partially denervated##6##2##(1995-9#6)
partially dependent on##7##3##(1990-2#1)(1993-2#1)(1994-12#1)(1994-2#1)(1996-5#1)(2008-10#2)
partially depolarized##3##2##(1990-8#1)(1991-3#1)(1992-11#1)
partially developed speckle##4##3##(2008-2#1)(2008-3#3)
partially digested with##2##3##(1990-5#1)(1991-6#1)
partially digested##3##2##(1990-5#1)(1991-6#1)(1995-8#1)
partially distinct##2##2##(1992-11#1)(1994-2#1)
partially dominant##6##2##(1990-10#1)(2008-10#5)
partially dried ORMOSIL##2##3##(2007-11#2)
partially due to its##2##4##(2007-11#1)(2013-1#1)
partially due to the##4##4##(1993-12#1)(2008-10#1)(2010-5#1)(2012-12#1)
partially due to##9##3##(1991-12#1)(1993-12#1)(1993-5#1)(1994-11#1)(2007-11#1)(2008-10#1)(2010-5#1)(2012-12#1)(2013-1#1)
partially edentulous patients##2##3##(1993-2#1)(2010-12#1)
partially edentulous##6##2##(1993-2#1)(2010-12#1)(2012-2#1)(2013-1#3)
partially effective in##2##3##(1991-3#1)(2007-1#1)
partially effective##8##2##(1991-3#1)(2007-1#1)(2008-10#4)(2008-9#1)(2012-2#1)
partially explain the##6##3##(1992-8#1)(1996-1#1)(1996-3#1)(2008-4#1)(2012-3#1)(2013-1#1)
partially explain##7##2##(1992-8#1)(1994-6#1)(1996-1#1)(1996-3#1)(2008-4#1)(2012-3#1)(2013-1#1)
partially explained by the##5##4##(1991-8#1)(2008-10#1)(2008-4#1)(2011-2#1)(2013-1#1)
partially explained by##11##3##(1991-8#1)(1993-11#1)(2008-10#3)(2008-4#1)(2008-5#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
partially explained##12##2##(1991-8#1)(1993-11#1)(2008-10#3)(2008-4#1)(2008-5#1)(2009-4#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
partially exposed##2##2##(1995-5#1)(2007-12#1)
partially fluorinated##2##2##(2005-11#2)
partially folded##9##2##(1993-9#1)(1995-2#1)(1995-5#1)(1997-1#1)(1997-2#5)
partially for##5##2##(1995-3#1)(1996-10#2)(2008-11#1)(2008-2#1)
partially functional##2##2##(1994-11#1)(2008-10#1)
partially homologous to##2##3##(1993-9#1)(2008-10#1)
partially hydrated##2##2##(2008-10#1)(2010-9#1)
partially hydrogenated##2##2##(1994-12#1)(2006-7#1)
partially hydrolyzed##2##2##(2008-10#1)(2008-8#1)
partially ill-defined##4##2##(1994-7#2)(1997-8#1)(2012-12#1)
partially in the##3##3##(1992-8#1)(2008-2#2)
partially in##7##2##(1992-8#1)(2008-10#2)(2008-2#2)(2012-12#1)(2013-8#1)
partially inactivated##5##2##(1993-11#2)(1993-2#1)(2008-5#1)(2008-8#1)
partially incoherent light##2##3##(2007-11#1)(2007-12#1)
partially incoherent##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
partially independent of##3##3##(1994-2#1)(1996-9#1)(2008-8#1)
partially independent##5##2##(1994-2#1)(1996-9#1)(2008-8#3)
partially indicate##2##2##(2008-2#1)(2010-4#1)
partially inhibit the##3##3##(1991-9#1)(1994-6#1)(2009-6#1)
partially inhibit##4##2##(1991-12#1)(1991-9#1)(1994-6#1)(2009-6#1)
partially inhibited MAP kinase activation by thrombin but##2##8##(1996-8#2)
partially inhibited by a##2##4##(1990-7#1)(1993-3#1)
partially inhibited by##16##3##(1990-2#1)(1990-3#2)(1990-7#1)(1990-9#1)(1991-7#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-5#1)(1997-4#1)(1997-7#1)(2005-12#1)(2009-9#1)
partially inhibited the##5##3##(1991-3#1)(1991-7#1)(1996-5#1)(2008-4#1)(2008-9#1)
partially inhibited##40##2##(1990-2#1)(1990-3#2)(1990-7#1)(1990-9#1)(1991-3#1)(1991-7#2)(1991-8#1)(1992-12#1)(1992-4#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-10#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-5#1)(1996-8#2)(1997-4#1)(1997-6#1)(1997-7#1)(2005-12#1)(2006-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-2#1)(2009-9#2)(2011-2#1)
partially inhibits##3##2##(1993-11#1)(1996-10#1)(1996-8#1)
partially interdigitated##2##2##(1993-8#2)
partially ionized fatty##2##3##(1990-2#2)
partially isogenic##2##2##(2006-12#2)
partially known##3##2##(2010-12#1)(2010-2#1)(2010-3#1)
partially liganded species##2##3##(1990-8#2)
partially ligated##6##2##(1990-8#2)(1996-7#1)(1996-9#1)(1997-2#2)
partially linear##2##2##(2009-5#1)(2010-2#1)
partially maintained##2##2##(2011-2#1)(2013-8#1)
partially mediate the##2##3##(2007-1#1)(2008-12#1)
partially mediated by##3##3##(1991-6#1)(2009-3#1)(2013-1#1)
partially mediated the relation between##2##5##(2007-12#1)(2008-12#1)
partially mediated the relationship between##2##5##(2007-12#2)
partially mediated the##5##3##(2007-12#3)(2008-12#1)(2010-1#1)
partially mediated##9##2##(1991-6#1)(1992-11#1)(2007-12#3)(2008-12#1)(2009-3#1)(2010-1#1)(2013-1#1)
partially mimicked##3##2##(1990-7#1)(1991-5#1)(1994-9#1)
partially modified##4##2##(1990-9#1)(1992-11#1)(2012-11#2)
partially observed##2##2##(1996-2#1)(2011-2#1)
partially obstructing##2##2##(2007-5#1)(2008-10#1)
partially offset##2##2##(2006-10#1)(2010-12#1)
partially or completely##2##3##(2008-4#2)
partially or##7##2##(1991-2#1)(2008-1#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-5#1)
partially overcome by##2##3##(1990-2#1)(1994-8#1)
partially overcome##7##2##(1990-2#1)(1990-3#1)(1994-6#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
partially overcomes##2##2##(2008-1#1)(2009-12#1)
partially overlap##2##2##(1996-3#1)(2008-10#1)
partially overlapped##3##2##(1996-3#1)(2008-10#1)(2013-8#1)
partially overlapping##13##2##(1990-3#1)(1990-7#1)(1993-4#1)(1994-2#1)(1995-12#1)(1996-3#1)(2006-5#1)(2008-8#1)(2009-10#1)(2009-8#2)(2010-5#1)(2012-1#1)
partially oxidized hemoglobin##2##3##(1990-8#2)
partially oxidized##6##2##(1990-8#3)(1992-6#1)(1995-2#1)(2010-2#1)
partially polarized light##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
partially polarized##13##2##(2007-11#2)(2007-12#5)(2008-2#1)(2008-3#5)
partially prevent##2##2##(1995-7#1)(2006-9#1)
partially prevented##9##2##(1990-5#1)(1991-7#1)(1994-2#1)(1997-2#1)(2005-8#2)(2008-5#1)(2009-8#1)(2010-5#1)
partially protected against##2##3##(1997-1#2)
partially protected##4##2##(1996-5#1)(1997-1#2)(2011-2#1)
partially purified and characterized##4##4##(1990-10#1)(1992-11#1)(1997-6#1)(2006-8#1)
partially purified and##10##3##(1990-10#1)(1990-5#1)(1991-1#1)(1992-11#1)(1994-11#1)(1997-6#1)(2006-10#1)(2006-8#2)(2008-10#1)
partially purified by##10##3##(1991-9#1)(1992-4#1)(1992-8#1)(1995-3#1)(1996-4#1)(1996-6#1)(2006-10#1)(2006-3#1)(2008-4#1)(2010-2#1)
partially purified chlorosis toxin##3##4##(2008-10#3)
partially purified cytosolic##2##3##(1990-11#1)(1995-11#1)
partially purified enzyme##3##3##(1991-12#1)(1993-3#1)(2008-10#1)
partially purified from culture##2##4##(2008-10#2)
partially purified from rat liver##2##5##(1991-9#1)(1993-8#1)
partially purified from the##4##4##(1991-4#1)(1996-8#1)(2008-11#2)
partially purified from##19##3##(1990-7#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-9#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-8#2)(1996-8#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-8#1)
partially purified preparation of##4##4##(1990-2#2)(1993-2#1)(1997-8#1)
partially purified protein##7##3##(1990-11#1)(1992-5#1)(1996-8#1)(1997-1#1)(1997-6#1)(2008-1#1)(2008-2#1)
partially purified yeast component##2##4##(1990-6#2)
partially purified##111##2##(1990-10#3)(1990-11#3)(1990-12#2)(1990-2#2)(1990-5#3)(1990-6#3)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-4#6)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#3)(1994-12#1)(1994-2#2)(1994-6#1)(1994-8#3)(1995-11#1)(1995-2#1)(1995-3#1)(1996-4#1)(1996-6#1)(1996-8#3)(1997-1#1)(1997-6#5)(1997-7#1)(1997-8#2)(2006-10#2)(2006-3#1)(2006-8#3)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-2#1)(2011-2#1)
partially rate-limiting##2##2##(1994-11#1)(1995-10#1)
partially reactivated##3##2##(1992-12#1)(1993-11#1)(1993-6#1)
partially recessive##3##2##(2008-10#3)
partially recovered##3##2##(1994-9#1)(2008-11#1)(2008-5#1)
partially reduced##5##2##(1990-5#1)(1994-9#1)(1996-4#1)(2006-8#1)(2007-11#1)
partially redundant##2##2##(2007-12#1)(2009-10#1)
partially reimbursed##2##2##(2008-12#2)
partially related to##3##3##(1990-7#1)(1993-3#1)(2009-10#1)
partially relieved by##2##3##(1994-2#1)(1995-12#1)
partially replacing##2##2##(1995-3#1)(1995-8#1)
partially replicated##2##2##(1996-8#1)(2007-12#1)
partially repress##2##2##(1997-4#1)(2012-3#1)
partially resected##4##2##(2006-5#1)(2007-8#1)(2009-9#1)(2011-2#1)
partially resistant cultivar##3##3##(2008-10#3)
partially resistant cultivars##3##3##(2008-10#3)
partially resistant to##3##3##(2008-10#2)(2013-8#1)
partially resistant wheat##2##3##(2008-10#2)
partially resistant##23##2##(2008-10#21)(2012-12#1)(2013-8#1)
partially resolved components##2##3##(1992-1#1)(1994-9#1)
partially resolved##5##2##(1991-9#1)(1992-1#1)(1994-9#2)(2008-5#1)
partially responded to##3##3##(1992-12#1)(1994-2#1)(2006-10#1)
partially responded##4##2##(1992-12#1)(1994-2#1)(2006-10#1)(2013-8#1)
partially responsible for the##7##4##(1990-12#1)(1990-5#1)(1992-12#1)(1993-2#1)(1994-12#1)(1997-5#1)(2010-3#1)
partially responsible for##8##3##(1990-12#1)(1990-5#1)(1991-9#1)(1992-12#1)(1993-2#1)(1994-12#1)(1997-5#1)(2010-3#1)
partially responsible##9##2##(1990-12#1)(1990-5#1)(1991-9#1)(1992-12#1)(1993-2#1)(1994-12#1)(1997-5#1)(2010-3#1)(2012-2#1)
partially restore##2##2##(1995-5#1)(2012-12#1)
partially restored by##2##3##(1994-8#1)(1997-1#1)
partially restored##5##2##(1991-10#1)(1994-8#1)(1996-5#1)(1997-1#1)(2012-12#1)
partially reversed by##5##3##(1990-10#1)(1992-5#1)(1997-5#1)(2008-2#1)(2008-4#1)
partially reversed the##5##3##(1991-9#2)(1994-9#1)(1995-5#1)(1995-7#1)
partially reversed##14##2##(1990-10#1)(1990-3#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-5#1)(1994-9#1)(1995-5#1)(1995-7#1)(1997-5#2)(2008-2#1)(2008-4#1)
partially reversible##3##2##(1991-11#1)(1996-5#1)(1997-6#1)
partially selective for each##2##4##(2008-4#2)
partially selective##4##2##(2008-10#2)(2008-4#2)
partially sequenced##7##2##(1990-12#1)(1992-3#1)(1993-2#1)(1995-8#1)(1996-10#1)(1997-2#1)(2008-7#1)
partially solves##2##2##(2006-12#1)(2007-5#1)
partially spatially incoherent##4##3##(2007-11#3)(2007-12#1)
partially spliced##3##2##(1994-3#1)(1997-4#2)
partially stimulated##2##2##(1992-9#1)(2006-5#1)
partially suppressed by##2##3##(1992-7#1)(2007-12#1)
partially suppressed the##3##3##(1990-5#1)(1996-5#1)(2008-9#1)
partially suppressed##9##2##(1990-5#1)(1991-4#1)(1992-7#1)(1996-5#1)(2006-4#1)(2007-12#1)(2007-7#1)(2008-8#1)(2008-9#1)
partially suppresses##3##2##(1991-5#1)(1994-9#1)(1997-4#1)
partially through##2##2##(1995-11#1)(1997-6#1)
partially to##6##2##(1991-7#1)(1994-8#1)(2007-8#2)(2008-10#2)
partially transformed##2##2##(1992-6#1)(2008-12#1)
partially treated##2##2##(2007-3#2)
partially unfolded states##3##3##(1995-3#2)(2009-5#1)
partially unfolded##6##2##(1994-8#1)(1995-3#4)(2009-5#1)
partially via##2##2##(2008-9#1)(2009-12#1)
partially##1015##1##(1990-10#6)(1990-11#5)(1990-12#8)(1990-2#13)(1990-3#6)(1990-4#1)(1990-5#11)(1990-6#3)(1990-7#6)(1990-8#13)(1990-9#4)(1991-1#1)(1991-10#3)(1991-11#3)(1991-12#7)(1991-2#7)(1991-3#10)(1991-4#9)(1991-5#5)(1991-6#4)(1991-7#6)(1991-8#4)(1991-9#10)(1992-1#3)(1992-11#7)(1992-12#7)(1992-2#4)(1992-3#7)(1992-4#2)(1992-5#2)(1992-6#5)(1992-7#3)(1992-8#3)(1992-9#4)(1993-1#1)(1993-11#8)(1993-12#4)(1993-2#8)(1993-3#6)(1993-4#2)(1993-5#2)(1993-6#6)(1993-8#6)(1993-9#5)(1994-10#3)(1994-11#8)(1994-12#9)(1994-2#12)(1994-3#4)(1994-5#2)(1994-6#8)(1994-7#2)(1994-8#12)(1994-9#11)(1995-1#2)(1995-10#8)(1995-11#2)(1995-12#4)(1995-2#8)(1995-3#12)(1995-5#9)(1995-6#3)(1995-7#3)(1995-8#9)(1995-9#6)(1996-1#1)(1996-10#7)(1996-12#1)(1996-2#5)(1996-3#5)(1996-4#6)(1996-5#10)(1996-6#1)(1996-7#2)(1996-8#8)(1996-9#3)(1997-1#6)(1997-2#10)(1997-3#2)(1997-4#8)(1997-5#5)(1997-6#15)(1997-7#3)(1997-8#3)(2004-9#2)(2005-10#1)(2005-11#8)(2005-12#3)(2005-8#3)(2006-10#11)(2006-12#7)(2006-3#1)(2006-4#1)(2006-5#5)(2006-7#2)(2006-8#5)(2006-9#3)(2007-1#4)(2007-11#28)(2007-12#45)(2007-3#3)(2007-5#4)(2007-6#1)(2007-7#4)(2007-8#4)(2007-9#4)(2008-1#7)(2008-10#94)(2008-11#13)(2008-12#8)(2008-2#16)(2008-3#27)(2008-4#19)(2008-5#20)(2008-6#5)(2008-7#8)(2008-8#18)(2008-9#11)(2009-10#6)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#4)(2009-6#2)(2009-7#2)(2009-8#5)(2009-9#3)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#6)(2010-2#8)(2010-3#5)(2010-4#2)(2010-5#3)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#6)(2011-12#3)(2011-2#13)(2012-1#4)(2012-11#2)(2012-12#13)(2012-2#6)(2012-3#7)(2012-7#1)(2013-1#10)(2013-7#1)(2013-8#8)
partials##2##1##(2008-8#2)
participant and##2##2##(2006-5#1)(2010-9#1)
participant characteristics##4##2##(2006-5#2)(2009-4#1)(2011-2#1)
participant fees##2##2##(1993-2#1)(1994-2#1)
participant in a##2##3##(1996-2#1)(2007-10#1)
participant in this##2##3##(2007-4#1)(2013-1#1)
participant in##13##2##(1991-7#1)(1993-3#1)(1995-11#1)(1996-2#1)(2006-10#1)(2007-10#1)(2007-12#3)(2007-4#1)(2008-3#1)(2012-3#1)(2013-1#1)
participant laboratories##2##2##(2008-10#1)(2008-12#1)
participant observation and##4##3##(2007-10#1)(2007-7#1)(2008-1#1)(2011-2#1)
participant observation##13##2##(2006-7#1)(2007-10#1)(2007-7#2)(2008-1#1)(2008-11#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)
participant observations##2##2##(2008-9#1)(2009-5#1)
participant received a##3##3##(1995-5#1)(2007-11#1)(2012-3#1)
participant reported##2##2##(2009-12#2)
participant was##5##2##(1996-4#1)(2004-10#1)(2010-9#1)(2013-1#1)(2013-8#1)
participant with##3##2##(2008-5#1)(2008-9#1)(2012-1#1)
participant##119##1##(1991-7#1)(1992-1#2)(1993-2#1)(1993-3#1)(1994-2#1)(1995-11#2)(1995-5#1)(1996-2#1)(1996-4#2)(1997-1#2)(1997-3#1)(2004-10#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#3)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-1#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-4#3)(2009-5#1)(2009-9#1)(2010-11#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#4)(2012-12#1)(2012-2#8)(2012-3#7)(2013-1#11)(2013-7#1)(2013-8#2)
participant's##13##1##(1996-11#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-2#3)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#2)
participants (N =##3##3##(2009-6#1)(2010-8#2)
participants (i##2##2##(2008-4#1)(2012-2#1)
participants (n =##7##3##(2007-10#1)(2008-5#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#1)(2012-3#1)
participants (p##2##2##(2006-4#1)(2008-12#1)
participants (total N =##2##4##(2009-1#1)(2009-4#1)
participants about the##2##3##(1997-3#1)(2010-11#1)
participants across##3##2##(2007-10#1)(2009-1#1)(2009-4#1)
participants aged##3##2##(1997-8#1)(2012-11#1)(2013-1#1)
participants also##7##2##(2007-9#1)(2008-11#1)(2008-12#1)(2011-1#1)(2012-12#1)(2013-1#2)
participants and the##4##3##(2006-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
participants and their##3##3##(2008-8#1)(2009-6#1)(2012-12#1)
participants and##32##2##(1991-4#1)(1995-2#1)(1996-3#1)(2006-12#1)(2006-8#1)(2007-12#2)(2007-4#2)(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#2)
participants are##8##2##(1995-2#1)(2007-11#1)(2007-12#1)(2008-7#2)(2010-2#1)(2012-2#2)
participants as##4##2##(2007-4#1)(2008-10#1)(2010-9#1)(2011-1#1)
participants assigned##3##2##(1991-10#1)(2011-1#1)(2012-3#1)
participants at the##2##3##(2008-11#1)(2008-7#1)
participants at##5##2##(2008-11#1)(2008-5#1)(2008-7#1)(2010-3#1)(2012-12#1)
participants attended to##2##3##(2008-11#2)
participants attended##3##2##(2008-11#2)(2008-6#1)
participants believed the##2##3##(2006-8#1)(2007-12#1)
participants believed##4##2##(2006-8#2)(2007-12#1)(2008-8#1)
participants can##2##2##(2006-6#1)(2010-11#1)
participants cannot##2##2##(2010-1#1)(2012-2#1)
participants compared with##2##3##(1993-1#1)(2008-10#1)
participants compared##3##2##(1993-1#1)(2008-10#1)(2008-11#1)
participants completed a##8##3##(2007-12#2)(2008-1#1)(2008-11#1)(2008-4#1)(2010-4#1)(2010-7#1)(2013-7#1)
participants completed an##4##3##(2007-12#1)(2007-2#1)(2008-1#1)(2010-9#1)
participants completed trauma-related questionnaires##2##4##(2009-4#2)
participants completed##19##2##(2007-12#3)(2007-2#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-6#1)(2009-4#2)(2009-9#1)(2010-4#1)(2010-7#1)(2010-9#1)(2012-1#1)(2013-1#1)(2013-7#1)
participants considered##3##2##(2008-12#1)(2010-12#1)(2011-2#1)
participants consisted of##2##3##(2010-5#1)(2012-11#1)
participants consumed##2##2##(2011-2#2)
participants could##3##2##(2007-7#1)(2008-10#1)(2012-3#1)
participants did not##6##3##(1995-1#1)(2007-12#1)(2007-2#1)(2009-10#1)(2009-4#1)(2009-7#1)
participants discussed the##3##3##(1994-7#1)(1995-5#1)(1996-3#1)
participants discussed##5##2##(1994-7#1)(1995-5#1)(1996-3#1)(2008-6#1)(2009-3#1)
participants during##5##2##(2008-10#1)(2009-7#1)(2010-7#1)(2012-2#1)(2012-3#1)
participants engaged in##2##3##(2010-12#1)(2013-8#1)
participants enrolled in the##2##4##(2009-3#1)(2012-12#1)
participants exhibited a##2##3##(2007-12#1)(2007-8#1)
participants exhibited##3##2##(2007-12#1)(2007-8#1)(2009-11#1)
participants expressed##2##2##(2007-3#1)(2007-9#1)
participants failed to##3##3##(2006-7#1)(2007-9#1)(2012-12#1)
participants for##6##2##(1990-11#1)(2007-11#1)(2008-4#2)(2009-6#1)(2012-3#1)
participants found##3##2##(2008-2#1)(2008-4#1)(2013-1#1)
participants from Britain and Malaysia were asked to rate a set of images of real##2##15##(2007-12#2)
participants from a##2##3##(2007-12#1)(2008-10#1)
participants from limited resource settings##2##5##(2009-6#2)
participants from the##8##3##(1991-10#1)(2006-8#2)(2008-5#2)(2009-1#1)(2012-2#1)(2013-1#1)
participants from##30##2##(1991-10#1)(1991-4#1)(1992-1#1)(1994-1#1)(2005-8#2)(2006-8#2)(2007-12#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#4)(2009-1#1)(2009-6#3)(2010-11#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
participants had a##7##3##(2006-8#1)(2009-10#1)(2009-3#2)(2010-10#1)(2012-12#1)(2013-8#1)
participants had received##2##3##(2007-7#1)(2013-7#1)
participants had the##2##3##(2008-11#1)(2012-2#1)
participants had to##2##3##(2006-3#1)(2008-4#1)
participants had##31##2##(1993-3#1)(1994-12#3)(2006-3#1)(2006-8#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-3#2)(2010-10#1)(2010-4#1)(2010-9#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#2)(2013-8#2)
participants having##2##2##(2008-8#1)(2012-1#1)
participants high on##2##3##(2007-12#1)(2009-11#1)
participants in Group##2##3##(2011-2#2)
participants in a##5##3##(1993-12#1)(2006-9#1)(2009-6#1)(2010-11#1)(2011-2#1)
participants in all##2##3##(2009-11#1)(2010-8#1)
participants in an##5##3##(1990-12#1)(1995-1#1)(2008-12#1)(2010-12#1)(2011-2#1)
participants in both##4##3##(2010-1#2)(2011-1#1)(2012-2#1)
participants in the study##3##4##(1994-3#1)(1997-8#1)(2009-4#1)
participants in the##28##3##(1991-11#1)(1991-8#1)(1994-3#1)(1994-4#1)(1995-1#1)(1995-2#1)(1996-3#1)(1997-8#1)(2006-4#1)(2006-6#1)(2006-8#1)(2008-12#1)(2008-5#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-3#1)(2010-4#3)(2011-1#3)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
participants in this study##2##4##(2008-3#1)(2013-1#1)
participants in this##4##3##(1992-1#1)(2008-3#1)(2011-2#1)(2013-1#1)
participants in##71##2##(1990-12#1)(1991-11#1)(1991-8#1)(1992-1#1)(1993-12#1)(1994-3#1)(1994-4#1)(1995-1#2)(1995-2#1)(1996-3#1)(1997-3#1)(1997-8#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-12#1)(2007-7#2)(2007-9#1)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#2)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#2)(2009-6#3)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#3)(2010-8#1)(2011-1#4)(2011-2#9)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
participants included##4##2##(2007-2#1)(2008-1#1)(2010-11#1)(2010-2#1)
participants indicated that##2##3##(1990-11#1)(2008-8#1)
participants indicated##4##2##(1990-11#1)(2006-7#2)(2008-8#1)
participants involved in##2##3##(2008-1#1)(2010-10#1)
participants is##3##2##(2007-12#1)(2010-11#1)(2012-1#1)
participants judged a##2##3##(2007-12#2)
participants made##3##2##(2008-11#2)(2009-4#1)
participants not##4##2##(2006-6#1)(2008-1#1)(2010-7#1)(2013-7#1)
participants of interracial interactions found race-related discussions##2##7##(2009-7#2)
participants of interracial##3##3##(2009-7#3)
participants of the study##3##4##(2010-1#1)(2012-2#1)(2012-3#1)
participants of the##11##3##(1996-12#1)(2006-6#1)(2006-8#1)(2007-4#1)(2010-1#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
participants of##18##2##(1996-12#1)(2006-6#1)(2006-8#1)(2007-4#1)(2008-12#1)(2009-7#3)(2010-1#1)(2010-11#1)(2010-12#1)(2011-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
participants on##6##2##(2007-11#1)(2007-9#1)(2008-1#1)(2008-3#1)(2009-10#1)(2013-1#1)
participants or##2##2##(2007-12#1)(2013-1#1)
participants performed a##5##3##(2008-11#1)(2009-2#1)(2010-2#1)(2012-3#1)(2013-8#1)
participants performed the##2##3##(2008-11#1)(2012-12#1)
participants performed##13##2##(2006-6#1)(2007-9#1)(2008-11#2)(2009-2#1)(2009-3#1)(2010-2#2)(2010-5#1)(2012-12#1)(2012-3#1)(2013-8#2)
participants rated##2##2##(2007-12#1)(2008-11#1)
participants registered##2##2##(1995-5#1)(2008-1#1)
participants reported symptoms##2##3##(2010-9#1)(2012-1#1)
participants reported that they##4##4##(2007-2#1)(2009-3#1)(2009-6#2)
participants reported using##2##3##(2007-2#1)(2009-5#1)
participants reported##20##2##(1995-1#1)(2006-7#2)(2007-2#2)(2007-9#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-12#2)(2012-2#1)
participants reporting##3##2##(2008-4#1)(2011-2#2)
participants representing##2##2##(2005-7#1)(2013-8#1)
participants responded to##2##3##(2008-4#1)(2012-2#1)
participants revealed##2##2##(2009-9#1)(2010-10#1)
participants scored##2##2##(2006-7#1)(2011-2#1)
participants should##2##2##(2009-9#1)(2010-6#1)
participants showed##10##2##(1996-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-8#1)(2010-4#1)(2012-11#3)
participants that##2##2##(2007-4#1)(2011-2#1)
participants thought##3##2##(2007-7#1)(2008-6#1)(2008-9#1)
participants to evaluate##2##3##(2007-7#1)(2008-12#1)
participants to rate##2##3##(2009-10#1)(2013-8#1)
participants to understand##2##3##(2007-11#1)(2008-11#1)
participants to##26##2##(1992-1#1)(1996-3#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-10#2)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
participants took part in##2##4##(2009-6#1)(2012-1#1)
participants took part##3##3##(2009-6#1)(2012-1#1)(2012-2#1)
participants took##5##2##(2006-8#1)(2008-2#1)(2009-6#1)(2012-1#1)(2012-2#1)
participants underwent functional magnetic resonance imaging##2##6##(2008-11#2)
participants underwent##5##2##(2007-8#1)(2008-11#2)(2011-2#1)(2012-3#1)
participants used##3##2##(2008-10#1)(2010-8#2)
participants using##6##2##(1990-11#1)(2008-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
participants viewed##6##2##(2006-7#1)(2008-11#3)(2008-4#1)(2010-3#1)
participants was##24##2##(1995-9#1)(2004-10#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-2#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
participants were able to##2##4##(2012-11#1)(2012-2#1)
participants were also##2##3##(2007-12#1)(2008-1#1)
participants were asked to##8##4##(2007-12#1)(2007-7#1)(2008-5#2)(2012-3#1)(2013-1#1)(2013-8#2)
participants were divided into two groups##2##6##(2007-12#1)(2013-8#1)
participants were divided into two##3##5##(2007-12#1)(2012-1#1)(2013-8#1)
participants were examined##2##3##(1991-12#1)(2006-7#1)
participants were exposed to##2##4##(2009-10#1)(2012-12#1)
participants were first##2##3##(2009-11#1)(2012-12#1)
participants were followed##2##3##(1995-12#1)(2007-8#1)
participants were from##3##3##(2007-7#1)(2008-7#1)(2009-6#1)
participants were included in the##2##5##(2013-1#2)
participants were included##4##3##(2013-1#2)(2013-8#2)
participants were instructed that##2##4##(2008-11#2)
participants were interviewed##4##3##(1995-9#1)(2010-10#1)(2011-1#1)(2011-2#1)
participants were more likely to##3##5##(2008-11#1)(2008-6#1)(2009-2#1)
participants were more likely##4##4##(2008-11#1)(2008-12#1)(2008-6#1)(2009-2#1)
participants were more reliant on body##2##6##(2007-12#2)
participants were more##6##3##(2007-12#2)(2008-11#1)(2008-12#1)(2008-6#1)(2009-2#1)
participants were not satisfied with##2##5##(2007-10#2)
participants were not##6##3##(1996-8#1)(2007-10#2)(2007-2#1)(2008-5#1)(2013-1#1)
participants were part of the##2##5##(2013-1#2)
participants were randomized to##3##4##(2009-9#1)(2011-1#1)(2013-1#1)
participants were randomized##4##3##(2009-9#1)(2010-4#1)(2011-1#1)(2013-1#1)
participants were randomly assigned to##2##5##(2008-2#1)(2010-10#1)
participants were randomly assigned##3##4##(2007-11#1)(2008-2#1)(2010-10#1)
participants were randomly##5##3##(2007-11#1)(2008-2#1)(2009-5#1)(2010-10#1)(2012-2#1)
participants were recruited from among##2##5##(2006-7#2)
participants were recruited from##3##4##(2006-7#2)(2009-6#1)
participants were recruited##5##3##(2006-7#2)(2007-9#1)(2008-10#1)(2009-6#1)
participants were tested##4##3##(2006-8#2)(2007-6#1)(2008-7#1)
participants were used to##2##4##(2007-7#1)(2010-5#1)
participants were##122##2##(1991-12#1)(1995-1#2)(1995-12#1)(1995-5#1)(1995-9#1)(1996-8#1)(2005-10#2)(2005-9#1)(2006-7#4)(2006-8#3)(2007-10#3)(2007-11#1)(2007-12#7)(2007-2#3)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#3)(2009-9#3)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#2)(2012-3#1)(2013-1#14)(2013-7#1)(2013-8#8)
participants who had##9##3##(1992-1#1)(2010-1#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-12#1)(2013-1#1)(2013-8#2)
participants who handled##2##3##(2007-12#2)
participants who received##2##3##(2010-3#1)(2013-1#1)
participants who reported##2##3##(2008-11#1)(2013-1#1)
participants who stopped##2##3##(1990-12#2)
participants who were##8##3##(1991-10#1)(2006-11#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
participants who##39##2##(1990-12#2)(1991-10#1)(1992-1#1)(2005-10#1)(2006-11#3)(2007-12#2)(2008-11#1)(2008-12#1)(2008-3#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#7)(2013-8#4)
participants with a history of##2##5##(2010-4#1)(2012-3#1)
participants with a##8##3##(2008-10#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#4)
participants with autism##2##3##(2006-3#2)
participants with greater##2##3##(2008-11#1)(2010-2#1)
participants with low##2##3##(2007-12#1)(2010-12#1)
participants with the##2##3##(2005-9#1)(2008-1#1)
participants with##57##2##(1991-7#1)(1993-12#1)(1994-12#1)(2004-10#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-3#2)(2006-6#1)(2006-7#1)(2007-12#3)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-6#1)(2008-7#1)(2009-10#1)(2009-4#3)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2011-1#3)(2011-2#2)(2012-11#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#9)(2013-8#2)
participants without previous##2##3##(2006-6#1)(2012-12#1)
participants without##5##2##(2006-6#1)(2007-12#2)(2008-5#1)(2012-12#1)
participants would##3##2##(1994-1#1)(2008-11#1)(2010-11#1)
participants##1082##1##(1990-1#1)(1990-11#3)(1990-12#5)(1991-10#4)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#2)(1991-7#1)(1991-8#2)(1992-1#4)(1992-12#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#2)(1994-12#4)(1994-2#1)(1994-3#2)(1994-4#1)(1994-7#1)(1995-1#13)(1995-11#1)(1995-12#1)(1995-2#3)(1995-5#3)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#7)(1996-4#1)(1996-7#1)(1996-8#1)(1997-3#4)(1997-8#3)(2004-10#5)(2005-10#6)(2005-12#1)(2005-7#1)(2005-8#5)(2005-9#4)(2006-10#4)(2006-11#3)(2006-12#2)(2006-2#2)(2006-3#4)(2006-4#3)(2006-6#8)(2006-7#18)(2006-8#18)(2006-9#3)(2007-10#17)(2007-11#18)(2007-12#55)(2007-2#14)(2007-3#3)(2007-4#7)(2007-5#1)(2007-6#2)(2007-7#15)(2007-8#5)(2007-9#10)(2008-1#18)(2008-10#20)(2008-11#47)(2008-12#26)(2008-2#13)(2008-3#9)(2008-4#17)(2008-5#19)(2008-6#12)(2008-7#10)(2008-8#11)(2008-9#5)(2009-1#3)(2009-10#12)(2009-11#12)(2009-12#2)(2009-2#4)(2009-3#8)(2009-4#27)(2009-5#6)(2009-6#20)(2009-7#9)(2009-8#4)(2009-9#13)(2010-1#7)(2010-10#9)(2010-11#13)(2010-12#13)(2010-2#15)(2010-3#10)(2010-4#9)(2010-5#6)(2010-6#3)(2010-7#14)(2010-8#11)(2010-9#11)(2011-1#23)(2011-12#4)(2011-2#48)(2012-1#16)(2012-11#11)(2012-12#44)(2012-2#33)(2012-3#23)(2013-1#68)(2013-7#11)(2013-8#31)
participants' demographics##2##2##(2012-3#1)(2013-8#1)
participants' experiences of##2##3##(2008-11#1)(2010-10#1)
participants' explanations of their##2##4##(2008-3#2)
participants' knowledge##2##2##(2008-3#1)(2009-7#1)
participants'##56##1##(2004-12#1)(2006-11#1)(2006-2#1)(2006-8#1)(2007-10#2)(2007-12#3)(2007-2#1)(2007-9#1)(2008-1#1)(2008-11#3)(2008-3#3)(2008-6#1)(2008-8#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
participants) on##2##2##(2009-4#1)(2011-1#1)
participants) were##2##2##(2010-9#1)(2012-11#1)
participants) with high heterogeneity between trials (I2 = 86%##2##9##(2013-8#2)
participants) with high heterogeneity between trials (I2 =##6##8##(2013-8#6)
participants) with##7##2##(2013-8#7)
participants)##18##1##(2008-11#1)(2009-4#1)(2010-9#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-8#12)
participate actively in##3##3##(1991-2#1)(2007-4#1)(2011-2#1)
participate actively##4##2##(1991-2#1)(2007-4#2)(2011-2#1)
participate in Michael addition reactions with##2##6##(2008-10#2)
participate in Michael##3##3##(2007-8#1)(2008-10#2)
participate in a##22##3##(1990-11#1)(1991-10#1)(1992-10#1)(1995-5#1)(1996-1#1)(1996-9#1)(1997-2#1)(2007-11#1)(2007-2#1)(2008-1#2)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#2)(2011-1#1)(2011-2#2)(2012-12#1)
participate in an##3##3##(1995-6#1)(2007-4#1)(2008-5#1)
participate in and##3##3##(1995-1#1)(2008-8#1)(2013-1#1)
participate in cancer##3##3##(2005-10#1)(2012-2#1)(2013-1#1)
participate in catalysis##2##3##(1992-6#1)(1994-3#1)
participate in collective##2##3##(2007-8#1)(2009-10#1)
participate in hydrogen bonding##2##4##(1996-6#1)(1997-4#1)
participate in immune##2##3##(2011-12#1)(2013-1#1)
participate in maintaining##2##3##(2006-5#1)(2012-12#1)
participate in protein##2##3##(1994-5#1)(1996-8#1)
participate in regulating the expression of##3##6##(1997-7#1)(2010-7#1)(2011-2#1)
participate in regulating##6##3##(1997-7#1)(2006-5#1)(2008-3#1)(2008-4#1)(2010-7#1)(2011-2#1)
participate in regulation of##2##4##(1997-8#1)(2006-10#1)
participate in research##6##3##(1992-6#1)(2007-10#1)(2009-6#1)(2010-11#1)(2012-2#1)(2012-3#1)
participate in several##2##3##(1995-2#1)(2003-11#1)
participate in sport##2##3##(2009-3#1)(2009-5#1)
participate in stabilization##2##3##(1992-6#1)(1994-9#1)
participate in the activation##2##4##(2005-8#1)(2012-2#1)
participate in the complex##3##4##(1995-11#1)(2009-8#1)(2013-1#1)
participate in the control of##4##5##(1990-12#1)(1993-2#1)(1994-6#1)(2008-7#1)
participate in the development of##5##5##(1991-11#1)(1993-12#1)(1996-12#1)(1996-2#1)(2008-7#1)
participate in the early##2##4##(1993-12#1)(1996-1#1)
participate in the events##2##4##(1996-8#1)(2008-11#1)
participate in the intracellular##3##4##(1993-11#1)(2008-1#1)(2008-2#1)
participate in the pathogenesis of the disease##2##7##(2007-11#1)(2012-12#1)
participate in the pathogenesis of##3##5##(2007-10#1)(2007-11#1)(2012-12#1)
participate in the process##2##4##(2011-2#1)(2012-11#1)
participate in the regulation of pancreatic secretion##2##7##(2006-10#2)
participate in the regulation of pancreatic##3##6##(1991-5#1)(2006-10#2)
participate in the regulation of##14##5##(1991-5#1)(1991-6#1)(1994-12#1)(1996-2#1)(1996-5#1)(2006-10#3)(2008-7#1)(2010-10#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-1#1)
participate in the study##6##4##(1994-12#1)(2008-11#1)(2010-1#1)(2010-6#1)(2012-2#2)
participate in the transport of##2##5##(1994-8#1)(2012-2#1)
participate in the##128##3##(1990-12#1)(1990-3#1)(1990-7#2)(1991-10#1)(1991-11#2)(1991-4#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#3)(1993-2#1)(1993-7#1)(1993-9#1)(1994-12#2)(1994-2#3)(1994-6#1)(1994-8#2)(1995-11#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-6#1)(1997-7#1)(2004-3#1)(2005-8#1)(2006-10#6)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-6#1)(2011-12#1)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#8)(2013-1#4)(2013-8#2)
participate in these##4##3##(1994-2#1)(2012-2#1)(2013-1#2)
participate in this##11##3##(1991-2#1)(1997-2#1)(1997-5#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-7#1)(2010-4#1)(2011-1#1)
participate in transcriptional##2##3##(2007-8#1)(2008-9#1)
participate in various##3##3##(1997-5#1)(2011-2#1)(2012-2#1)
participate in##331##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-10#2)(1991-11#2)(1991-2#1)(1991-4#2)(1991-5#1)(1991-6#2)(1991-7#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-5#2)(1992-6#3)(1992-8#2)(1992-9#1)(1993-11#4)(1993-12#3)(1993-2#1)(1993-5#1)(1993-6#2)(1993-7#2)(1993-9#1)(1994-1#1)(1994-12#3)(1994-2#4)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#5)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#3)(1995-6#5)(1995-8#3)(1996-1#2)(1996-12#2)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#2)(1996-9#1)(1997-2#7)(1997-4#5)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#1)(2003-11#1)(2004-3#1)(2005-10#1)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#9)(2006-11#1)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#3)(2006-8#1)(2007-1#1)(2007-10#7)(2007-11#8)(2007-12#1)(2007-2#2)(2007-4#2)(2007-5#2)(2007-7#3)(2007-8#6)(2007-9#1)(2008-1#7)(2008-10#3)(2008-11#13)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#8)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#3)(2009-1#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-5#4)(2009-6#7)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-12#2)(2011-2#14)(2012-1#4)(2012-11#1)(2012-12#7)(2012-2#13)(2012-3#2)(2013-1#12)(2013-7#1)(2013-8#2)
participate more##2##2##(1992-1#1)(2006-5#1)
participate to the##2##3##(1994-6#1)(2013-1#1)
participate to##5##2##(1994-6#1)(2007-10#1)(2008-10#1)(2011-2#1)(2013-1#1)
participate##386##1##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-7#4)(1990-8#1)(1990-9#1)(1991-10#2)(1991-11#3)(1991-2#2)(1991-4#3)(1991-5#1)(1991-6#2)(1991-7#1)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-5#2)(1992-6#3)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#4)(1993-12#4)(1993-2#1)(1993-5#1)(1993-6#2)(1993-7#2)(1993-9#1)(1994-1#1)(1994-12#3)(1994-2#5)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#5)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-5#3)(1995-6#6)(1995-8#3)(1996-1#2)(1996-12#3)(1996-2#5)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#3)(1996-8#2)(1996-9#1)(1997-2#7)(1997-4#5)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#1)(2003-11#1)(2004-2#1)(2004-3#1)(2005-10#1)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#10)(2006-11#1)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#4)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#9)(2007-11#8)(2007-12#1)(2007-2#2)(2007-4#6)(2007-5#2)(2007-7#3)(2007-8#7)(2007-9#2)(2008-1#8)(2008-10#4)(2008-11#15)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#8)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#3)(2009-1#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-5#4)(2009-6#9)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#5)(2010-2#2)(2010-3#3)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#6)(2011-12#2)(2011-2#16)(2012-1#6)(2012-11#1)(2012-12#8)(2012-2#15)(2012-3#2)(2013-1#18)(2013-7#3)(2013-8#2)
participated actively in the##2##4##(2008-12#1)(2010-5#1)
participated and##4##2##(2006-10#1)(2008-11#1)(2009-11#1)(2011-2#1)
participated as volunteers in##2##4##(2008-12#1)(2012-3#1)
participated as##4##2##(2008-12#1)(2009-2#1)(2011-2#1)(2012-3#1)
participated for four months in 1992##2##6##(1994-6#2)
participated for##5##2##(1990-6#1)(1991-2#1)(1994-6#2)(2010-3#1)
participated in a 12-week##5##4##(2004-3#1)(2007-10#1)(2007-12#1)(2008-5#2)
participated in a differential##2##4##(1996-6#1)(2009-2#1)
participated in a pilot study##2##5##(2007-10#1)(2010-8#1)
participated in a pilot##3##4##(2007-10#1)(2007-2#1)(2010-8#1)
participated in a study of##2##5##(2008-7#1)(2012-12#1)
participated in a workshop##2##4##(2010-5#1)(2011-2#1)
participated in a##45##3##(1991-1#1)(1992-1#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-4#2)(1996-6#2)(1997-3#1)(2004-3#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
participated in an##15##3##(1990-10#1)(1990-6#1)(1991-2#1)(1992-5#1)(1996-2#1)(1997-6#1)(2005-1#1)(2006-12#1)(2008-1#1)(2008-11#2)(2009-1#1)(2009-5#1)(2011-1#1)(2012-3#1)
participated in four##2##3##(2010-3#1)(2013-1#1)
participated in glycolytic flux with##2##5##(1995-1#2)
participated in glycolytic flux##3##4##(1995-1#3)
participated in one of##2##4##(1996-2#1)(2012-11#1)
participated in one##3##3##(1996-2#1)(2010-7#1)(2012-11#1)
participated in research##2##3##(2009-6#2)
participated in semistructured interviews##2##4##(2009-5#1)(2010-2#1)
participated in structured##2##3##(2007-5#1)(2013-7#1)
participated in the experiment##2##4##(1996-2#1)(2012-1#1)
participated in the program##2##4##(2010-9#1)(2012-3#1)
participated in the study##53##4##(1990-6#1)(1992-3#1)(1993-12#1)(1995-1#1)(1996-1#1)(1997-8#1)(2004-12#2)(2006-10#1)(2006-7#1)(2006-8#2)(2007-10#2)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-12#3)(2008-6#1)(2008-7#2)(2008-9#3)(2009-3#1)(2009-6#2)(2010-10#1)(2010-12#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#1)(2012-1#3)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
participated in the survey##6##4##(1992-11#1)(1994-12#1)(2008-12#1)(2008-9#1)(2010-10#1)(2012-2#1)
participated in the##90##3##(1990-6#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-8#1)(2004-12#2)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#3)(2007-10#2)(2007-12#3)(2007-2#2)(2007-6#1)(2007-8#2)(2008-1#1)(2008-12#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-11#1)(2009-3#1)(2009-6#2)(2009-7#2)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#3)(2011-1#2)(2011-2#2)(2012-1#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#1)
participated in their##2##3##(1991-7#1)(2007-12#1)
participated in this pilot##2##4##(2008-9#1)(2013-1#1)
participated in this study and were##2##6##(2007-1#1)(2007-6#1)
participated in this study##23##4##(1996-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
participated in this##40##3##(1991-12#1)(1996-8#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
participated in three##2##3##(2008-8#1)(2012-3#1)
participated in two##2##3##(2010-8#1)(2012-12#1)
participated in##259##2##(1990-10#1)(1990-6#2)(1991-1#1)(1991-12#2)(1991-2#2)(1991-7#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#5)(1995-3#1)(1995-4#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-6#2)(1996-8#1)(1997-3#1)(1997-6#1)(1997-8#2)(2004-12#2)(2004-3#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-10#4)(2006-12#2)(2006-7#2)(2006-8#7)(2006-9#2)(2007-1#1)(2007-10#7)(2007-11#1)(2007-12#6)(2007-2#4)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#2)(2007-8#5)(2007-9#1)(2008-1#4)(2008-11#4)(2008-12#6)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#3)(2008-9#6)(2009-1#1)(2009-11#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#4)(2009-7#3)(2010-1#1)(2010-10#6)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#5)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#5)(2011-1#9)(2011-2#6)(2012-1#7)(2012-11#1)(2012-12#5)(2012-2#6)(2012-3#7)(2013-1#16)(2013-7#3)(2013-8#5)
participated to##3##2##(2006-8#1)(2007-10#1)(2010-7#1)
participated##336##1##(1990-10#1)(1990-12#1)(1990-6#3)(1991-1#1)(1991-12#2)(1991-2#3)(1991-7#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#3)(1995-1#6)(1995-3#2)(1995-4#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-6#2)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#2)(2004-12#2)(2004-3#1)(2005-1#1)(2005-10#2)(2005-11#1)(2005-9#1)(2006-10#7)(2006-12#2)(2006-7#3)(2006-8#9)(2006-9#3)(2007-1#1)(2007-10#10)(2007-11#1)(2007-12#7)(2007-2#4)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#2)(2007-8#6)(2007-9#2)(2008-1#5)(2008-10#1)(2008-11#6)(2008-12#11)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#6)(2009-1#2)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#5)(2009-7#4)(2010-1#1)(2010-10#6)(2010-11#2)(2010-12#2)(2010-2#4)(2010-3#7)(2010-4#4)(2010-5#5)(2010-6#1)(2010-7#3)(2010-8#5)(2010-9#5)(2011-1#10)(2011-2#16)(2012-1#11)(2012-11#1)(2012-12#7)(2012-2#8)(2012-3#9)(2013-1#18)(2013-7#4)(2013-8#5)
participates in a variety of##2##5##(2007-8#1)(2009-12#1)
participates in a wide##2##4##(1995-8#1)(2011-2#1)
participates in a##7##3##(1995-8#1)(1996-12#1)(2007-8#1)(2008-1#1)(2009-12#1)(2011-2#1)(2012-1#1)
participates in an##2##3##(1990-9#1)(1993-3#1)
participates in diverse##2##3##(1996-7#1)(2009-6#1)
participates in multiple##2##3##(1996-2#1)(2006-1#1)
participates in regulating##2##3##(1996-7#1)(2008-3#1)
participates in regulation of the##2##5##(1995-8#1)(2008-9#1)
participates in the formation of##2##5##(1994-2#1)(2008-12#1)
participates in the maintenance of##2##5##(2012-12#1)(2013-7#1)
participates in the processes##2##4##(1992-8#1)(2008-12#1)
participates in the regulation of neuronal##2##6##(1995-11#1)(2010-12#1)
participates in the regulation of##11##5##(1990-12#1)(1991-8#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-5#1)(1996-4#1)(2006-10#1)(2008-8#1)(2010-12#1)(2013-1#1)
participates in the##42##3##(1990-12#1)(1990-7#1)(1991-2#1)(1991-8#2)(1992-12#1)(1992-6#1)(1992-8#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-11#1)(1995-5#3)(1996-4#3)(1996-7#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-1#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-12#2)(2008-8#1)(2009-8#1)(2009-9#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
participates in this##2##3##(1991-1#1)(2010-12#1)
participates in##93##2##(1990-12#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#2)(1991-6#1)(1991-8#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-4#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#2)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#3)(1996-5#1)(1996-7#3)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-1#1)(2006-1#1)(2006-10#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
participates##103##1##(1990-12#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#2)(1991-6#1)(1991-8#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-4#1)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#1)(1994-9#2)(1995-1#3)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#2)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#3)(1996-5#1)(1996-7#3)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-1#1)(2006-1#1)(2006-10#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
participating alliances##2##2##(2013-1#2)
participating community##2##2##(2007-11#1)(2008-3#1)
participating countries##5##2##(2006-10#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-6#1)
participating facilities##2##2##(2007-2#1)(2008-3#1)
participating hospitals and the##2##4##(1991-2#1)(1993-9#1)
participating hospitals##5##2##(1991-2#2)(1993-9#1)(1994-3#1)(2008-3#1)
participating in a 12-week##2##4##(2007-12#1)(2008-5#1)
participating in a smoking cessation##2##5##(2007-12#2)
participating in a smoking##3##4##(2007-12#2)(2009-5#1)
participating in a##26##3##(1991-3#1)(1994-4#1)(1996-3#1)(1997-2#1)(1997-4#1)(2007-12#6)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-9#1)(2009-12#1)(2009-5#1)(2010-9#1)(2012-2#1)
participating in activities##2##3##(1992-1#1)(1993-2#1)
participating in its##2##3##(1991-2#1)(2006-5#1)
participating in meaningful##2##3##(2007-10#1)(2010-9#1)
participating in signal transduction##2##4##(2009-6#1)(2009-8#1)
participating in sport##2##3##(2007-8#2)
participating in the Aligning Forces for Quality initiative##2##8##(2013-1#2)
participating in the Aligning Forces for Quality##3##7##(2013-1#3)
participating in the screening programme##2##5##(2004-2#2)
participating in the study##3##4##(2006-10#1)(2007-6#1)(2007-8#1)
participating in the##43##3##(1990-2#1)(1991-4#1)(1991-5#1)(1992-2#1)(1993-11#1)(1993-7#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-4#1)(2004-2#3)(2005-8#1)(2006-10#3)(2006-12#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-6#2)(2007-8#1)(2008-1#1)(2008-10#2)(2009-6#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#4)
participating in their##2##3##(2009-8#1)(2013-1#1)
participating in these##2##3##(2008-12#1)(2010-10#1)
participating in this##4##3##(2008-3#1)(2008-7#1)(2009-4#1)(2009-8#1)
participating in##116##2##(1990-2#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-6#2)(1996-9#1)(1997-2#1)(1997-4#2)(2004-2#3)(2005-1#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-5#1)(2006-8#1)(2006-9#2)(2007-10#2)(2007-12#8)(2007-2#1)(2007-5#1)(2007-6#3)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#4)(2008-12#3)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#4)(2010-1#2)(2010-10#1)(2010-3#2)(2010-9#3)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#3)(2013-1#6)(2013-7#1)
participating institutions##2##2##(2012-2#1)(2012-3#1)
participating laboratories##5##2##(2007-8#1)(2008-10#3)(2008-12#1)
participating physicians##2##2##(2012-3#2)
participating providers##2##2##(1997-1#1)(1997-3#1)
participating schools##2##2##(2008-12#1)(2013-1#1)
participating students##3##2##(2008-11#1)(2009-4#1)(2012-12#1)
participating##198##1##(1990-2#2)(1990-7#1)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#4)(1995-2#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#2)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(2004-2#3)(2005-1#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#6)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#3)(2007-11#1)(2007-12#8)(2007-2#3)(2007-5#1)(2007-6#4)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#6)(2008-3#9)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#2)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#3)(2009-8#6)(2010-1#2)(2010-10#1)(2010-3#3)(2010-5#1)(2010-7#1)(2010-9#3)(2011-1#3)(2011-2#3)(2011-9#1)(2012-12#1)(2012-2#5)(2012-3#7)(2013-1#12)(2013-7#1)
participation among##7##2##(2009-4#1)(2010-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
participation and a##2##3##(2008-7#1)(2011-2#1)
participation and communication##2##3##(2013-1#2)
participation and the##4##3##(1993-3#2)(1995-3#1)(2007-5#1)
participation and##45##2##(1993-1#1)(1993-3#2)(1994-6#1)(1995-3#1)(1995-5#1)(1996-6#1)(2007-10#2)(2007-3#1)(2007-5#1)(2007-7#4)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#3)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#1)(2013-1#4)
participation as a##2##3##(2007-10#1)(2008-6#1)
participation as##3##2##(2007-10#1)(2008-5#1)(2008-6#1)
participation by patients##2##3##(1992-12#1)(2008-10#1)
participation by the##3##3##(1992-6#1)(2007-10#1)(2008-10#1)
participation by##16##2##(1992-1#1)(1992-12#2)(1992-6#1)(1994-12#1)(1996-1#1)(1996-11#1)(1997-2#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-6#1)(2012-2#2)
participation can##3##2##(1994-12#1)(2007-4#1)(2013-1#1)
participation for##3##2##(1994-3#1)(2013-1#2)
participation from the##3##3##(2005-5#1)(2006-8#1)(2012-1#1)
participation from##6##2##(2005-5#1)(2006-8#1)(2008-12#1)(2010-1#1)(2011-2#1)(2012-1#1)
participation has been##2##3##(2008-11#1)(2013-1#1)
participation in a##15##3##(1992-10#1)(1993-11#1)(1996-2#1)(2005-9#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-4#1)(2010-10#1)(2010-7#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
participation in an##3##3##(2006-4#1)(2008-10#1)(2012-3#1)
participation in child rearing##4##4##(2004-11#4)
participation in clinical trials##2##4##(2008-11#1)(2012-3#1)
participation in clinical##4##3##(1995-3#1)(2008-11#1)(2008-12#1)(2012-3#1)
participation in health care##5##4##(1994-3#1)(1995-9#1)(1997-2#2)(2008-12#1)
participation in health##8##3##(1992-1#1)(1994-3#1)(1995-9#1)(1997-2#2)(1997-3#1)(2008-1#1)(2008-12#1)
participation in managed care##2##4##(1991-3#1)(2005-7#1)
participation in painting pictures or playing a musical instrument##2##9##(2012-12#2)
participation in physical activity##3##4##(2007-9#1)(2009-6#1)(2010-3#1)
participation in primary care reform##2##5##(2010-11#2)
participation in research and##2##4##(1997-8#1)(2008-8#1)
participation in research##5##3##(1992-6#1)(1997-8#1)(2007-5#1)(2008-1#1)(2008-8#1)
participation in routine housework##2##4##(2008-5#1)(2009-3#1)
participation in social##3##3##(1997-2#1)(2011-2#1)(2012-12#1)
participation in sports##2##3##(2011-12#1)(2011-2#1)
participation in studies##2##3##(1993-6#1)(1996-1#1)
participation in such##2##3##(2008-11#1)(2010-9#1)
participation in the 10-session##2##4##(2006-6#2)
participation in the community among stroke victims##2##7##(2012-2#2)
participation in the community##4##4##(2012-2#4)
participation in the operation of community mental health agencies##2##9##(1997-3#2)
participation in the process##3##4##(1994-1#1)(1994-9#1)(2009-6#1)
participation in the program##2##4##(1993-2#1)(2006-3#1)
participation in the study##3##4##(2011-2#2)(2013-1#1)
participation in the trial##2##4##(1990-2#1)(2008-8#1)
participation in the##48##3##(1990-2#1)(1990-3#1)(1991-2#1)(1993-1#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-9#1)(1995-3#2)(1995-9#1)(1997-2#2)(1997-3#3)(2006-3#1)(2006-4#1)(2006-6#2)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-1#1)(2011-1#2)(2011-2#4)(2012-2#4)(2013-1#2)
participation in treatment decisions##2##4##(2004-1#1)(2006-2#1)
participation in##202##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#2)(1992-10#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-6#2)(1993-8#1)(1994-1#2)(1994-3#3)(1994-8#2)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-9#2)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#1)(1997-2#6)(1997-3#5)(1997-6#1)(1997-8#1)(2004-1#1)(2004-11#4)(2005-12#1)(2005-7#2)(2005-9#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#2)(2006-6#2)(2006-8#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#6)(2008-11#7)(2008-12#7)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#4)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#4)(2010-7#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#11)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#7)(2012-3#3)(2013-1#7)(2013-8#1)
participation is not##2##3##(1993-6#1)(1997-1#1)
participation is##10##2##(1993-6#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-1#1)(2007-7#1)(2013-1#2)
participation of a##5##3##(1990-12#1)(1991-8#1)(1997-7#1)(2012-1#2)
participation of all##2##3##(1997-4#1)(2007-7#1)
participation of community residents in##2##5##(1995-3#2)
participation of persons with aphasia##2##5##(2012-3#2)
participation of several##2##3##(2006-10#1)(2008-10#1)
participation of the public##2##4##(1995-12#1)(2005-5#1)
participation of the##26##3##(1990-5#1)(1992-12#1)(1993-10#1)(1994-1#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-12#1)(1997-6#1)(1997-7#1)(2005-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-9#1)(2012-1#1)(2012-12#2)(2013-1#1)
participation of these##5##3##(1993-7#1)(2006-12#1)(2006-8#1)(2011-1#1)(2011-2#1)
participation of this##6##3##(1991-1#1)(1993-3#1)(1994-6#1)(1995-6#1)(2004-8#1)(2008-7#1)
participation of women in##2##4##(2012-2#1)(2013-1#1)
participation of women##4##3##(2006-4#1)(2009-4#1)(2012-2#1)(2013-1#1)
participation of##144##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-5#2)(1992-8#1)(1993-10#1)(1993-11#2)(1993-3#2)(1993-7#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#3)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#3)(1995-3#4)(1995-6#1)(1995-8#3)(1996-12#5)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-8#1)(2005-11#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#2)(2006-8#2)(2007-11#2)(2007-12#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-5#4)(2008-7#3)(2008-8#2)(2009-11#1)(2009-2#2)(2009-4#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#4)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#4)
participation on##2##2##(2008-1#1)(2008-11#1)
participation over##2##2##(2009-8#1)(2010-2#1)
participation rate was##3##3##(2006-10#1)(2008-11#1)(2012-3#1)
participation rate##7##2##(1994-6#1)(2006-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2012-3#1)
participation rates##4##2##(1994-3#1)(2013-1#2)(2013-8#1)
participation than##3##2##(1995-10#1)(2007-6#1)(2010-10#1)
participation through the##2##3##(1994-2#1)(2008-11#1)
participation through##4##2##(1994-2#1)(2008-11#1)(2012-1#1)(2012-12#1)
participation to##5##2##(1991-2#1)(1995-2#1)(2010-2#1)(2013-1#2)
participation was associated with##5##4##(1993-3#2)(2008-10#1)(2008-12#1)(2012-12#1)
participation was encouraged##2##3##(2005-8#1)(2012-2#1)
participation was##12##2##(1993-3#2)(2005-8#1)(2007-10#1)(2008-10#3)(2008-12#1)(2012-12#2)(2012-2#1)(2012-3#1)
participation were##3##2##(2007-10#1)(2010-10#1)(2013-7#1)
participation with##2##2##(2008-1#1)(2010-7#1)
participation within the##2##3##(1994-12#1)(2012-12#1)
participation##597##1##(1990-10#3)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#3)(1991-5#1)(1991-6#2)(1991-8#1)(1992-1#4)(1992-10#1)(1992-11#3)(1992-12#5)(1992-2#2)(1992-3#1)(1992-5#3)(1992-6#2)(1992-8#1)(1993-1#4)(1993-10#1)(1993-11#3)(1993-12#3)(1993-2#2)(1993-3#7)(1993-6#4)(1993-7#1)(1993-8#1)(1994-1#3)(1994-12#5)(1994-2#3)(1994-3#14)(1994-4#1)(1994-6#5)(1994-8#3)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#7)(1995-2#4)(1995-3#9)(1995-5#1)(1995-6#1)(1995-8#3)(1995-9#2)(1996-1#3)(1996-11#2)(1996-12#10)(1996-2#4)(1996-3#1)(1996-4#2)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#8)(1997-3#7)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#2)(2004-1#1)(2004-11#4)(2004-8#1)(2005-11#1)(2005-12#1)(2005-5#2)(2005-7#3)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#2)(2006-3#2)(2006-4#4)(2006-6#2)(2006-7#1)(2006-8#5)(2007-10#14)(2007-11#4)(2007-12#2)(2007-2#2)(2007-3#2)(2007-4#4)(2007-5#5)(2007-6#4)(2007-7#8)(2007-8#7)(2007-9#3)(2008-1#6)(2008-10#21)(2008-11#16)(2008-12#16)(2008-2#1)(2008-3#6)(2008-5#8)(2008-6#8)(2008-7#14)(2008-8#5)(2008-9#2)(2009-10#2)(2009-11#2)(2009-2#3)(2009-3#4)(2009-4#10)(2009-5#4)(2009-6#6)(2009-7#4)(2009-8#2)(2009-9#2)(2010-1#4)(2010-10#8)(2010-11#2)(2010-12#3)(2010-2#10)(2010-3#7)(2010-4#4)(2010-5#1)(2010-7#4)(2010-8#1)(2010-9#3)(2011-1#7)(2011-12#1)(2011-2#24)(2011-9#1)(2012-1#9)(2012-11#1)(2012-12#15)(2012-2#15)(2012-3#9)(2013-1#30)(2013-7#3)(2013-8#5)
participation&quot##3##1##(1994-3#1)(1997-3#2)
participation]##3##1##(1993-6#1)(1993-8#1)(2008-6#1)
participative##7##1##(1993-12#1)(1993-3#2)(1994-2#1)(1997-2#1)(2011-2#2)
participatory action research##3##3##(2008-1#1)(2008-7#1)(2009-4#1)
participatory action##4##2##(2008-1#1)(2008-7#1)(2009-4#1)(2012-3#1)
participatory approach to##3##3##(2009-12#1)(2009-4#1)(2012-3#1)
participatory approach##4##2##(2008-2#1)(2009-12#1)(2009-4#1)(2012-3#1)
participatory research in##3##3##(2008-7#1)(2009-4#1)(2012-2#1)
participatory research to build community capacity and address mental health disparities and##2##12##(2012-2#2)
participatory research to##3##3##(2011-2#1)(2012-2#2)
participatory research##21##2##(1997-3#4)(2008-7#2)(2009-4#6)(2009-7#1)(2009-8#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#3)
participatory##47##1##(1992-1#1)(1993-3#1)(1994-6#1)(1997-3#4)(2007-10#2)(2008-1#3)(2008-11#3)(2008-2#3)(2008-7#3)(2009-12#1)(2009-4#8)(2009-5#1)(2009-7#1)(2009-8#2)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-8#1)
particle X-ray##2##2##(2013-8#2)
particle aggregates##2##2##(2008-10#1)(2008-2#1)
particle aggregation##5##2##(2005-11#4)(2008-10#1)
particle analysis##5##2##(2005-11#1)(2008-10#4)
particle and surface##2##3##(2005-11#1)(2008-3#1)
particle and##18##2##(1990-12#1)(1990-7#1)(1993-2#1)(1996-11#1)(2005-11#4)(2007-12#1)(2008-2#3)(2008-3#4)(2008-7#1)(2009-6#1)
particle are##2##2##(2007-12#1)(2008-3#1)
particle assembly##4##2##(1993-8#1)(1995-9#1)(2008-7#1)(2008-8#1)
particle associated##2##2##(1994-8#1)(2008-11#1)
particle beam##3##2##(1993-2#1)(1997-2#2)
particle behavior##2##2##(2005-11#1)(2008-3#1)
particle bombardment with##2##3##(2008-10#2)
particle bombardment##12##2##(2006-12#1)(2008-10#9)(2008-5#1)(2008-9#1)
particle by use of its##2##5##(2008-3#2)
particle by use of##3##4##(2008-2#1)(2008-3#2)
particle by##5##2##(2007-8#1)(2008-2#1)(2008-3#3)
particle capture by##2##3##(2008-9#2)
particle capture in##2##3##(2008-5#1)(2008-9#1)
particle capture##8##2##(2008-3#1)(2008-5#2)(2008-9#5)
particle characterization##3##2##(2007-12#1)(2008-3#2)
particle columns##2##2##(2008-2#2)
particle composition##2##2##(2008-10#1)(2008-3#1)
particle concentration##8##2##(2004-9#1)(2007-12#1)(2008-2#2)(2008-3#1)(2011-1#2)(2012-3#1)
particle concentrations##5##2##(2005-11#1)(2007-12#1)(2008-3#3)
particle core##5##2##(1995-2#1)(2005-11#2)(2006-12#2)
particle correction function##2##3##(2008-3#2)
particle counters##3##2##(2008-2#1)(2008-3#2)
particle counting##4##2##(2008-10#1)(2008-3#1)(2011-2#2)
particle crystals##4##2##(2010-4#4)
particle delivery##3##2##(2008-10#1)(2008-3#2)
particle density and##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
particle density##6##2##(1997-5#1)(2008-1#2)(2008-2#2)(2008-3#1)
particle deposition efficiencies##2##3##(1991-12#2)
particle deposition##6##2##(1991-12#4)(1996-1#1)(1996-12#1)
particle diameter and##4##3##(2005-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
particle diameter of##2##3##(2008-2#2)
particle diameter##14##2##(2005-11#1)(2007-12#1)(2007-9#3)(2008-2#4)(2008-3#3)(2008-8#1)(2013-1#1)
particle diameters##5##2##(2007-9#1)(2008-3#3)(2009-9#1)
particle distribution##4##2##(1992-2#1)(1992-3#1)(2008-2#1)(2008-5#1)
particle emissions##3##2##(2008-11#2)(2008-3#1)
particle extinction coefficients##3##3##(2008-2#1)(2008-3#2)
particle extinction##4##2##(2008-2#1)(2008-3#3)
particle formation##3##2##(1991-3#1)(1992-5#1)(1996-12#1)
particle gel##2##2##(2005-11#1)(2007-12#1)
particle geometry##3##2##(2008-2#3)
particle growth and##2##3##(2005-11#2)
particle growth##4##2##(1996-12#1)(2005-11#2)(2006-12#1)
particle has been##3##3##(1996-11#2)(2005-11#1)
particle has##4##2##(1996-11#2)(2005-11#1)(2007-8#1)
particle image velocimetry (PIV)##2##4##(2008-2#2)
particle image velocimetry##9##3##(2008-2#6)(2008-3#3)
particle images##2##2##(2008-3#2)
particle in a##4##3##(1995-10#1)(2005-11#1)(2007-12#1)(2008-3#1)
particle in an##3##3##(2008-2#1)(2008-3#2)
particle in the##7##3##(1992-11#1)(2005-11#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)
particle in##17##2##(1992-11#1)(1995-10#1)(2005-11#3)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#5)
particle increases##3##2##(1995-4#1)(2005-11#2)
particle interactions##4##2##(2005-11#4)
particle is##14##2##(2005-11#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-2#4)(2008-3#4)(2008-7#1)
particle lithography##3##2##(2010-4#3)
particle mass##5##2##(1996-2#2)(1997-2#1)(2005-11#1)(2008-10#1)
particle matter##3##2##(2008-3#3)
particle morphology##2##2##(2008-10#1)(2011-3#1)
particle number##2##2##(2008-10#1)(2008-3#1)
particle of##2##2##(1991-7#1)(2008-3#1)
particle on the##2##3##(2005-11#2)
particle or##4##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)
particle over##2##2##(2008-10#1)(2008-2#1)
particle parameters##6##2##(2008-2#1)(2008-3#5)
particle phase##2##2##(2008-2#2)
particle physics##6##2##(1992-5#1)(2007-8#3)(2007-9#2)
particle population##3##2##(1995-6#1)(2012-2#2)
particle position##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2009-9#1)
particle refractive index##2##3##(2008-2#1)(2008-3#1)
particle removal##3##2##(2005-11#3)
particle scattering##3##2##(1994-3#1)(2005-11#1)(2008-3#1)
particle sedimentation##4##2##(1996-2#1)(2009-2#2)(2012-3#1)
particle separation in##2##3##(1995-1#1)(2008-6#1)
particle separation##3##2##(1995-1#1)(2007-12#1)(2008-6#1)
particle shape##7##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)
particle shapes##2##2##(2007-11#1)(2007-12#1)
particle size 3##2##3##(1990-8#1)(1996-5#1)
particle size 5##2##3##(1996-6#1)(2012-12#1)
particle size analysis##5##3##(2004-12#1)(2004-9#1)(2005-11#1)(2008-10#1)(2012-12#1)
particle size and concentration##4##4##(1995-3#1)(2008-3#2)(2011-2#1)
particle size and for##2##4##(1992-2#1)(2008-10#1)
particle size and shape##2##4##(2008-3#1)(2010-12#1)
particle size and the##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
particle size and##31##3##(1992-2#1)(1995-3#1)(2005-11#6)(2007-11#2)(2008-10#5)(2008-2#2)(2008-3#5)(2009-2#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-11#1)(2013-8#1)
particle size columns with a flow rate of 1 ml/min and using a UV detector to monitor the##2##18##(2010-12#1)(2010-2#1)
particle size determination##2##3##(2008-3#1)(2010-2#1)
particle size distribution (PSD)##3##4##(2005-11#1)(2008-3#1)(2012-11#1)
particle size distribution and##5##4##(1996-12#1)(2008-10#3)(2008-3#1)
particle size distribution is##2##4##(2008-3#1)(2008-7#1)
particle size distribution of fractal agglomerates##2##6##(2005-11#2)
particle size distribution of##3##4##(1992-2#1)(2005-11#2)
particle size distribution##26##3##(1992-2#1)(1992-3#1)(1993-2#1)(1996-12#1)(2004-9#1)(2005-11#5)(2007-11#1)(2008-10#3)(2008-3#5)(2008-5#1)(2008-7#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-11#1)(2013-1#1)
particle size distributions of##2##4##(1997-2#1)(2008-2#1)
particle size distributions##9##3##(1997-2#1)(2008-2#2)(2008-3#5)(2009-3#1)
particle size during##2##3##(2008-8#1)(2009-11#1)
particle size from##2##3##(2008-2#1)(2008-8#1)
particle size in the##2##4##(2005-11#1)(2008-10#1)
particle size in##5##3##(1990-8#1)(2005-11#1)(2008-10#2)(2011-1#1)
particle size is##3##3##(2008-10#1)(2008-2#1)(2013-8#1)
particle size measurements##2##3##(2008-2#1)(2008-3#1)
particle size of 3##3##4##(2008-10#1)(2013-8#2)
particle size of 5##2##4##(2004-9#1)(2010-3#1)
particle size of the##5##4##(1997-2#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-8#1)
particle size of##21##3##(1996-6#1)(1997-2#1)(2004-9#2)(2005-11#3)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#2)(2010-12#1)(2010-3#1)(2013-8#2)
particle size on##7##3##(2005-11#1)(2007-6#1)(2008-12#1)(2008-5#2)(2008-7#1)(2012-3#1)
particle size or fraction of the studied element##2##8##(2008-10#2)
particle size or##3##3##(2008-10#2)(2008-2#1)
particle size range##4##3##(2007-8#2)(2008-3#1)(2008-5#1)
particle size ranges and##2##4##(1997-2#1)(2007-8#1)
particle size ranges##3##3##(1997-2#1)(2007-8#1)(2008-5#1)
particle size reduction##2##3##(2006-2#1)(2008-5#1)
particle size selective##2##3##(1992-3#1)(2008-5#1)
particle size smaller than##2##4##(2008-10#1)(2008-5#1)
particle size structure of plankton##2##5##(2013-8#2)
particle size structure##3##3##(2013-8#3)
particle size was developed##2##4##(2008-10#1)(2009-2#1)
particle size was##4##3##(1996-8#1)(2008-10#2)(2009-2#1)
particle size##244##2##(1990-12#1)(1990-8#2)(1991-10#2)(1991-7#1)(1992-2#2)(1992-3#4)(1993-2#2)(1993-6#2)(1995-3#2)(1995-8#2)(1996-12#2)(1996-5#1)(1996-6#4)(1996-8#1)(1997-1#2)(1997-2#6)(2004-12#1)(2004-9#6)(2005-11#27)(2006-2#3)(2007-10#1)(2007-11#4)(2007-12#1)(2007-6#2)(2007-8#4)(2008-10#37)(2008-11#3)(2008-12#2)(2008-2#15)(2008-3#25)(2008-5#21)(2008-6#2)(2008-7#2)(2008-8#5)(2009-11#2)(2009-2#3)(2009-3#2)(2009-4#1)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#5)(2011-2#6)(2012-11#2)(2012-12#3)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#7)
particle size) with##2##3##(2008-10#1)(2010-3#1)
particle size)##8##2##(1996-8#1)(2005-11#3)(2007-8#1)(2008-10#1)(2008-5#1)(2010-3#1)
particle sizer##2##2##(1993-2#1)(2008-3#1)
particle sizers##2##2##(2008-3#2)
particle sizes and##4##3##(2005-11#1)(2006-2#1)(2008-10#1)(2008-3#1)
particle sizes in the##3##4##(2004-9#1)(2008-2#1)(2008-3#1)
particle sizes of##3##3##(2006-2#1)(2008-10#1)(2008-7#1)
particle sizes##25##2##(1990-12#1)(1991-3#1)(1995-6#1)(1997-3#1)(2004-9#1)(2005-11#3)(2006-2#2)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-5#3)(2008-7#1)(2009-4#1)(2013-8#1)
particle sizing in##2##3##(2008-2#1)(2008-3#1)
particle sizing##20##2##(1992-3#1)(1995-3#1)(2008-2#7)(2008-3#10)(2010-8#1)
particle structures##4##2##(2004-9#1)(2010-4#3)
particle surface##10##2##(2005-11#3)(2007-8#1)(2008-10#1)(2008-3#3)(2010-1#1)(2013-1#1)
particle surfaces##7##2##(2004-2#2)(2005-11#1)(2006-5#1)(2008-10#1)(2012-1#2)
particle suspensions##3##2##(2007-12#1)(2008-3#1)(2010-4#1)
particle swarm optimization (PSO)##2##4##(2007-9#1)(2013-1#1)
particle swarm optimization##4##3##(2007-9#1)(2013-1#3)
particle swarm##5##2##(2007-9#2)(2013-1#3)
particle system##2##2##(1995-11#1)(2008-3#1)
particle systems##2##2##(2008-3#1)(2008-8#1)
particle that##5##2##(1992-6#1)(1996-4#1)(2007-9#1)(2008-1#1)(2008-5#1)
particle to move##2##3##(1991-6#1)(2008-2#1)
particle to##6##2##(1991-6#1)(2005-11#1)(2007-11#1)(2008-1#1)(2008-2#1)(2009-5#1)
particle tracking##2##2##(2008-7#1)(2009-4#1)
particle trajectories##2##2##(1996-12#1)(2009-4#1)
particle traversal through##2##3##(2008-8#2)
particle traversal##3##2##(2008-8#3)
particle types and##2##3##(2008-3#1)(2008-9#1)
particle types##4##2##(2005-11#1)(2006-2#1)(2008-3#1)(2008-9#1)
particle vaporization velocimetry##2##3##(2007-12#2)
particle vaporization##3##2##(2007-12#2)(2008-10#1)
particle volume fraction##4##3##(2005-11#2)(2008-2#1)(2008-3#1)
particle volume##6##2##(2005-11#2)(2008-10#1)(2008-2#1)(2008-3#2)
particle was##7##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-4#1)(2011-1#1)
particle were##3##2##(1997-3#1)(1997-4#1)(2004-11#1)
particle which##2##2##(1995-4#1)(2005-10#1)
particle with a size##2##4##(2005-11#1)(2008-2#1)
particle with a##5##3##(1995-6#1)(2005-11#3)(2008-2#1)
particle with##10##2##(1990-11#1)(1994-8#1)(1995-6#2)(2005-11#3)(2008-2#3)
particle within##2##2##(2007-12#1)(2008-3#1)
particle##939##1##(1990-11#2)(1990-12#5)(1990-2#3)(1990-7#1)(1990-8#2)(1991-10#2)(1991-12#5)(1991-3#2)(1991-5#1)(1991-6#3)(1991-7#3)(1991-8#1)(1991-9#1)(1992-11#2)(1992-2#4)(1992-3#7)(1992-5#2)(1992-6#4)(1992-7#1)(1993-11#1)(1993-2#5)(1993-3#1)(1993-6#3)(1993-8#3)(1993-9#3)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-7#2)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#3)(1995-4#2)(1995-6#7)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#4)(1996-12#6)(1996-2#3)(1996-4#1)(1996-5#3)(1996-6#5)(1996-8#3)(1997-1#3)(1997-2#12)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-11#1)(2004-12#1)(2004-2#2)(2004-9#10)(2005-10#3)(2005-11#114)(2006-10#3)(2006-12#6)(2006-2#8)(2006-5#3)(2007-10#1)(2007-11#20)(2007-12#27)(2007-6#4)(2007-8#16)(2007-9#10)(2008-1#6)(2008-10#97)(2008-11#8)(2008-12#2)(2008-2#91)(2008-3#159)(2008-4#1)(2008-5#34)(2008-6#5)(2008-7#14)(2008-8#14)(2008-9#9)(2009-10#2)(2009-11#2)(2009-2#5)(2009-3#2)(2009-4#4)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#3)(2010-1#1)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#2)(2010-4#18)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#9)(2011-2#9)(2011-3#3)(2012-1#3)(2012-11#2)(2012-12#3)(2012-2#6)(2012-3#6)(2013-1#9)(2013-7#2)(2013-8#10)
particle's##3##1##(2007-11#1)(2008-3#2)
particle)##3##1##(1994-11#1)(2008-3#2)
particle-based##2##1##(2010-12#1)(2013-1#1)
particle-bound enzymes##2##2##(1997-7#2)
particle-bound##5##1##(1992-8#1)(1997-7#3)(2010-5#1)
particle-cell##2##1##(2008-10#1)(2012-3#1)
particle-free##2##1##(2008-2#1)(2008-9#1)
particle-image velocimetry in##2##3##(2008-3#2)
particle-image velocimetry##4##2##(2008-3#4)
particle-induced##4##1##(2008-10#2)(2008-3#2)
particle-laden##2##1##(2007-12#1)(2008-5#1)
particle-mediated##5##1##(1995-6#1)(2008-10#2)(2008-11#1)(2008-4#1)
particle-particle and##2##2##(1990-12#1)(2005-11#1)
particle-particle interactions##3##2##(2005-11#1)(2009-6#1)(2010-4#1)
particle-particle##6##1##(1990-12#1)(2005-11#2)(2009-6#1)(2010-4#1)(2010-7#1)
particle-reinforced##2##1##(2004-9#1)(2009-6#1)
particle-size and##3##2##(1992-3#1)(2008-3#1)(2012-1#1)
particle-size distribution from angular light-scattering data##2##6##(2008-3#2)
particle-size distribution##10##2##(2007-12#2)(2008-2#1)(2008-3#6)(2013-1#1)
particle-size distributions##7##2##(2008-2#5)(2008-3#2)
particle-size##27##1##(1992-3#1)(2007-12#2)(2008-2#9)(2008-3#13)(2012-1#1)(2013-1#1)
particle-sizing method##2##2##(2008-2#1)(2008-3#1)
particle-sizing##5##1##(2008-2#3)(2008-3#2)
particle/matrix##3##1##(2004-9#1)(2008-8#1)(2009-7#1)
particlelike##2##1##(2007-12#2)
particles &lt##3##2##(1995-3#1)(1996-12#1)(2008-11#1)
particles (&gt##2##2##(2004-9#1)(2008-10#1)
particles (approximately##3##2##(2005-11#2)(2010-4#1)
particles (e##2##2##(2008-10#1)(2008-3#1)
particles after##3##2##(1996-2#1)(2005-11#2)
particles along the##2##3##(2005-11#1)(2008-2#1)
particles also##4##2##(2009-7#1)(2010-2#1)(2010-4#1)(2010-7#1)
particles and are##2##3##(2007-6#1)(2008-10#1)
particles and in##2##3##(2008-11#1)(2008-9#1)
particles and large##2##3##(2008-10#2)
particles and the##7##3##(2005-11#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-11#1)
particles and their##5##3##(2005-11#2)(2008-10#1)(2008-11#1)(2012-11#1)
particles and to##2##3##(2008-3#2)
particles and##81##2##(1990-12#1)(1991-10#2)(1991-11#1)(1991-6#3)(1993-9#1)(1994-10#1)(1994-8#1)(1995-5#1)(1996-12#1)(1996-8#1)(2004-9#1)(2005-10#1)(2005-11#10)(2005-7#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-6#2)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#10)(2008-11#4)(2008-2#6)(2008-3#8)(2008-4#1)(2008-5#3)(2008-6#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-7#1)(2012-1#1)(2012-11#2)(2012-12#1)(2013-1#1)
particles are also##3##3##(1996-8#1)(2005-11#1)(2007-12#1)
particles are coated with##2##4##(2005-11#1)(2010-7#1)
particles are discussed##2##3##(2006-10#1)(2008-2#1)
particles are observed##2##3##(1997-3#1)(2008-2#1)
particles are presented##2##3##(1992-12#1)(2008-2#1)
particles are very##2##3##(2005-11#1)(2012-11#1)
particles are##52##2##(1992-12#1)(1993-2#1)(1995-6#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-3#4)(2005-10#1)(2005-11#8)(2006-10#2)(2006-5#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#5)(2008-2#5)(2008-3#6)(2008-5#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-1#1)(2010-4#1)(2010-7#1)(2012-11#1)
particles as a##3##3##(2005-11#1)(2008-3#1)(2008-7#1)
particles as well as##2##4##(2008-3#2)
particles as##19##2##(1990-6#1)(1990-8#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-5#1)(2005-11#2)(2008-10#1)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2012-2#1)
particles at the##2##3##(2004-9#1)(2005-11#1)
particles at various##2##3##(2005-11#1)(2007-6#1)
particles at##11##2##(2004-9#1)(2005-11#3)(2007-12#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-7#1)
particles by a##3##3##(2007-12#2)(2008-3#1)
particles by use of##2##4##(2007-12#1)(2008-2#1)
particles by using##2##3##(1991-7#1)(2007-8#1)
particles by##24##2##(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-6#1)(1996-3#1)(1997-3#1)(1997-6#1)(2005-11#1)(2007-12#3)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2009-5#1)(2010-1#1)(2012-3#1)(2013-8#1)
particles can be used to##2##5##(2006-2#1)(2007-12#1)
particles can be##9##3##(1992-6#1)(1994-2#1)(1997-1#1)(2005-11#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-1#1)
particles can##16##2##(1992-6#1)(1993-4#1)(1994-2#1)(1997-1#1)(2005-10#1)(2005-11#2)(2006-2#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2010-1#1)
particles coated with##5##3##(1996-12#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-9#1)
particles collected in the##2##4##(2008-10#1)(2008-12#1)
particles collected##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
particles constituting##2##2##(1992-3#1)(2004-9#1)
particles contained##2##2##(1990-12#1)(1994-9#1)
particles containing##7##2##(1993-4#2)(1996-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-12#1)
particles could##2##2##(2005-11#1)(2008-5#1)
particles covered with##2##3##(1990-12#1)(2005-11#1)
particles did not##2##3##(2008-10#1)(2008-5#1)
particles dispersed in##4##3##(2005-11#3)(2008-1#1)
particles dispersed##6##2##(1990-2#1)(2005-11#4)(2008-1#1)
particles due to the##2##4##(1992-12#1)(2006-2#1)
particles due to##3##3##(1990-12#1)(1992-12#1)(2006-2#1)
particles during##2##2##(2008-3#2)
particles for##11##2##(1994-3#1)(2005-11#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-11#1)(2013-1#1)
particles formed##5##2##(2005-11#1)(2006-12#1)(2008-10#3)
particles from a##3##3##(1995-7#1)(2005-11#1)(2013-7#1)
particles from spinach##3##3##(1992-11#2)(1995-11#1)
particles from##22##2##(1990-8#1)(1992-11#2)(1992-2#1)(1992-7#1)(1993-9#1)(1994-11#1)(1995-11#2)(1995-7#1)(2005-11#3)(2006-2#1)(2008-10#3)(2008-3#1)(2009-11#1)(2013-7#2)(2013-8#1)
particles generated from##2##3##(2008-10#1)(2008-8#1)
particles generated in##2##3##(2004-9#1)(2013-8#1)
particles generated##5##2##(2004-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2013-8#1)
particles had##4##2##(1992-6#1)(1994-9#1)(2005-11#1)(2008-10#1)
particles has been##4##3##(2005-11#2)(2007-11#1)(2008-2#1)
particles has##5##2##(1993-9#1)(2005-11#2)(2007-11#1)(2008-2#1)
particles have been##10##3##(1992-7#1)(1996-8#1)(2004-9#1)(2005-11#1)(2006-5#1)(2007-6#1)(2007-8#1)(2008-3#1)(2009-8#2)
particles have##15##2##(1990-12#1)(1992-7#1)(1996-8#1)(2004-9#1)(2005-11#1)(2006-5#1)(2007-6#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2009-8#2)
particles in IS##2##3##(2008-8#2)
particles in a solution##2##4##(2008-2#1)(2008-3#1)
particles in a two-dimensional##2##4##(1992-3#1)(2007-11#1)
particles in a##13##3##(1992-3#1)(2005-11#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-8#1)(2010-4#1)
particles in an##2##3##(2007-12#1)(2009-4#1)
particles in flow##2##3##(2008-2#1)(2008-7#1)
particles in plasma##2##3##(1993-2#1)(2009-4#1)
particles in suspension##2##3##(2005-11#1)(2008-3#1)
particles in the air##2##4##(2005-11#1)(2013-8#1)
particles in the atmosphere##2##4##(1996-8#1)(2008-3#1)
particles in the##35##3##(1990-8#1)(1991-12#1)(1994-10#1)(1996-8#1)(1997-2#2)(2005-11#4)(2006-10#1)(2007-11#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#2)(2008-8#2)(2010-6#1)(2013-7#1)(2013-8#1)
particles in water and##2##4##(2008-3#2)
particles in water##8##3##(2005-11#2)(2006-12#1)(2008-2#1)(2008-3#4)
particles in##115##2##(1990-2#1)(1990-6#1)(1990-8#1)(1991-12#2)(1992-3#1)(1992-7#1)(1993-11#1)(1993-2#1)(1994-10#1)(1994-12#1)(1994-9#1)(1995-5#1)(1996-10#1)(1996-12#1)(1996-8#1)(1997-2#2)(1997-6#1)(2004-9#1)(2005-11#12)(2005-4#1)(2006-10#2)(2006-12#2)(2006-2#2)(2007-11#4)(2007-12#3)(2007-2#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#11)(2008-3#16)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#6)(2009-4#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
particles injected##2##2##(1991-12#1)(2008-11#1)
particles inside##2##2##(2007-11#1)(2008-3#1)
particles into the##2##3##(2008-3#1)(2008-5#1)
particles into##4##2##(1991-3#1)(2008-3#1)(2008-5#1)(2011-1#1)
particles is measured##2##3##(2005-11#1)(2008-3#1)
particles is presented##3##3##(2006-12#1)(2008-11#1)(2008-2#1)
particles is##31##2##(1991-6#1)(1996-11#1)(2005-11#7)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2010-4#1)(2010-7#1)
particles less than##3##3##(2007-8#1)(2008-10#1)(2008-3#1)
particles located in the##2##4##(2008-10#1)(2008-2#1)
particles may be##3##3##(1992-6#1)(1997-2#1)(2008-7#1)
particles may##6##2##(1992-6#1)(1995-2#1)(1997-2#2)(2008-3#1)(2008-7#1)
particles much smaller than the##2##5##(2005-11#1)(2008-3#1)
particles much##3##2##(2005-11#1)(2008-2#1)(2008-3#1)
particles obtained by bulk polymerization##2##5##(2008-10#2)
particles obtained##3##2##(2008-10#2)(2009-3#1)
particles of approximately##2##3##(2008-10#2)
particles of different sizes##2##4##(2007-12#1)(2009-4#1)
particles of known size and##2##5##(2008-2#1)(2008-3#1)
particles of the##6##3##(1996-3#1)(2005-8#1)(2006-8#1)(2008-10#2)(2008-5#1)
particles of##55##2##(1990-6#1)(1991-10#1)(1991-12#1)(1992-5#1)(1992-7#1)(1994-3#2)(1995-2#1)(1996-12#1)(1996-2#2)(1996-3#2)(1997-3#2)(2005-11#4)(2005-8#2)(2006-8#1)(2007-12#2)(2008-10#16)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#4)(2008-6#1)(2009-4#1)(2009-6#1)(2011-2#1)(2012-12#1)
particles on a##2##3##(2008-2#1)(2008-3#1)
particles on surfaces##4##3##(2007-11#3)(2007-12#1)
particles on the##8##3##(1990-12#1)(2008-1#1)(2008-10#2)(2008-3#2)(2009-7#1)(2010-7#1)
particles on##18##2##(1990-12#1)(2005-11#1)(2005-7#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#3)(2009-7#1)(2010-7#1)
particles onto##2##2##(2005-11#2)
particles or holes##2##3##(2008-7#2)
particles or##10##2##(2005-11#1)(2008-2#4)(2008-3#1)(2008-7#2)(2009-3#1)(2009-7#1)
particles per##6##2##(1996-4#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)
particles possess##2##2##(2005-11#1)(2008-5#1)
particles present##2##2##(2007-3#1)(2008-8#1)
particles produced by##2##3##(1991-3#1)(2013-8#1)
particles produced##5##2##(1991-3#1)(1997-4#1)(2006-12#1)(2007-9#1)(2013-8#1)
particles required##2##2##(2008-12#1)(2008-4#1)
particles show##3##2##(1992-7#1)(2008-3#1)(2009-5#1)
particles showed##3##2##(1994-8#1)(2008-3#1)(2008-8#1)
particles size##3##2##(2005-11#2)(2012-3#1)
particles smaller than##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
particles such as##3##3##(2008-2#1)(2008-5#1)(2008-9#1)
particles such##4##2##(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)
particles suspended in##2##3##(2005-11#1)(2008-2#1)
particles than the##2##3##(2008-5#1)(2008-8#1)
particles than##4##2##(1993-6#1)(1995-3#1)(2008-5#1)(2008-8#1)
particles that are##6##3##(1990-6#1)(2005-11#1)(2008-2#1)(2008-3#3)
particles that can be##2##4##(1993-12#1)(2006-2#1)
particles that exhibit##2##3##(2008-10#1)(2008-2#1)
particles that##25##2##(1990-6#1)(1991-11#1)(1993-12#1)(1993-8#1)(1994-12#2)(1994-9#1)(1997-3#1)(2005-11#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#4)(2008-3#5)(2010-4#1)
particles the##8##2##(1990-3#1)(1997-6#1)(2005-11#2)(2008-2#2)(2008-3#2)
particles through a##2##3##(2006-2#1)(2009-5#1)
particles through the##2##3##(1997-1#1)(2008-7#1)
particles through##5##2##(1997-1#1)(2006-2#1)(2008-7#1)(2009-5#1)(2012-12#1)
particles to the##4##3##(1995-2#1)(2005-11#1)(2007-12#1)(2008-10#1)
particles to##21##2##(1991-8#1)(1995-2#1)(2005-11#3)(2006-5#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2009-2#1)(2010-1#1)(2010-4#1)(2011-2#1)
particles together##2##2##(2008-7#1)(2010-4#1)
particles undergoing##2##2##(2008-2#1)(2008-3#1)
particles upon##2##2##(2007-11#1)(2007-12#1)
particles used in##2##3##(2005-11#1)(2008-3#1)
particles used##3##2##(2005-11#1)(2008-3#1)(2008-9#1)
particles using##7##2##(1995-8#1)(1996-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-11#1)
particles via##2##2##(2006-12#1)(2007-8#1)
particles was found to##2##4##(1994-6#1)(2008-4#1)
particles was significantly##4##3##(1995-11#1)(2008-5#3)
particles was studied##3##3##(1990-12#1)(2005-11#2)
particles was##26##2##(1990-12#1)(1990-8#1)(1991-6#1)(1993-9#1)(1994-6#1)(1995-11#1)(1996-8#1)(1997-2#1)(2004-9#1)(2005-11#5)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#4)(2008-9#1)(2009-7#1)
particles were also##2##3##(2007-6#1)(2008-10#1)
particles were characterized by##2##4##(2010-1#1)(2013-1#1)
particles were characterized##5##3##(2008-10#1)(2008-5#1)(2010-1#2)(2013-1#1)
particles were deposited##2##3##(1992-12#1)(1997-1#1)
particles were found##2##3##(1994-10#1)(2007-6#1)
particles were observed in##3##4##(1997-8#1)(2008-10#2)
particles were observed##8##3##(1995-1#1)(1995-3#1)(1997-8#1)(2004-9#1)(2005-11#1)(2008-10#3)
particles were obtained##2##3##(1995-8#1)(2008-3#1)
particles were produced##2##3##(1991-7#1)(2008-10#1)
particles were then##2##3##(2007-8#1)(2008-10#1)
particles were##71##2##(1990-12#2)(1990-8#1)(1991-4#1)(1991-7#2)(1992-12#2)(1992-2#1)(1994-10#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1997-1#2)(1997-8#1)(2004-9#1)(2005-11#6)(2006-5#2)(2007-6#2)(2007-8#1)(2008-10#18)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-9#1)(2009-9#1)(2010-1#2)(2010-2#1)(2010-4#4)(2013-1#2)(2013-8#1)
particles which were##2##3##(2008-10#1)(2008-11#1)
particles which##5##2##(2008-10#2)(2008-11#1)(2008-8#1)(2012-2#1)
particles while##2##2##(1996-3#1)(2008-10#1)
particles whose##5##2##(1995-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2009-7#1)
particles with a##11##3##(2005-10#1)(2005-11#3)(2007-11#1)(2008-3#4)(2008-5#1)(2010-8#1)
particles with alumina##2##3##(2005-11#2)
particles with an outer##2##4##(1995-6#1)(2008-10#1)
particles with an##3##3##(1995-6#1)(1996-2#1)(2008-10#1)
particles with diameters##2##3##(2005-11#1)(2007-9#1)
particles with different aspect ratios##2##5##(2007-11#1)(2008-2#1)
particles with different##3##3##(2005-11#1)(2007-11#1)(2008-2#1)
particles with large complex refractive indices##3##6##(2008-3#3)
particles with large size##2##4##(2005-11#1)(2008-2#1)
particles with large##5##3##(2005-11#1)(2008-2#1)(2008-3#3)
particles with sizes##2##3##(2007-12#1)(2008-2#1)
particles with the##5##3##(1992-9#1)(1994-11#1)(2008-10#2)(2008-6#1)
particles with their##2##3##(2005-11#1)(2008-3#1)
particles with two##2##3##(2005-11#1)(2008-2#1)
particles with##79##2##(1990-12#1)(1990-2#1)(1990-5#1)(1992-6#1)(1992-9#1)(1994-11#1)(1995-5#1)(1995-6#1)(1996-2#1)(2004-9#1)(2005-10#1)(2005-11#16)(2006-12#1)(2006-2#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-8#1)(2007-9#2)(2008-10#6)(2008-11#1)(2008-2#5)(2008-3#22)(2008-5#1)(2008-6#1)(2008-7#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
particles within the sampling volume##2##5##(2008-3#2)
particles within the##3##3##(2008-10#1)(2008-3#2)
particles within##9##2##(1993-6#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-3#3)(2009-7#1)
particles##1511##1##(1990-12#14)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#4)(1990-7#2)(1990-8#8)(1991-1#1)(1991-10#4)(1991-11#2)(1991-12#8)(1991-2#1)(1991-3#4)(1991-4#1)(1991-5#4)(1991-6#5)(1991-7#5)(1991-8#1)(1991-9#3)(1992-11#8)(1992-12#8)(1992-2#2)(1992-3#7)(1992-5#3)(1992-6#9)(1992-7#6)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#3)(1993-4#4)(1993-5#1)(1993-6#6)(1993-8#3)(1993-9#7)(1994-10#4)(1994-11#7)(1994-12#6)(1994-2#1)(1994-3#6)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#8)(1994-9#8)(1995-1#5)(1995-11#4)(1995-12#1)(1995-2#7)(1995-3#5)(1995-4#2)(1995-5#10)(1995-6#7)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#3)(1996-10#3)(1996-11#3)(1996-12#13)(1996-2#5)(1996-3#4)(1996-4#4)(1996-8#7)(1997-1#7)(1997-2#9)(1997-3#11)(1997-4#9)(1997-6#3)(1997-7#1)(1997-8#1)(2004-9#15)(2005-10#6)(2005-11#192)(2005-12#1)(2005-4#1)(2005-7#2)(2005-8#4)(2006-10#6)(2006-11#2)(2006-12#13)(2006-2#12)(2006-5#13)(2006-8#1)(2007-10#1)(2007-11#30)(2007-12#32)(2007-2#1)(2007-3#3)(2007-4#1)(2007-6#8)(2007-8#17)(2007-9#14)(2008-1#6)(2008-10#183)(2008-11#32)(2008-12#11)(2008-2#111)(2008-3#158)(2008-4#17)(2008-5#51)(2008-6#13)(2008-7#23)(2008-8#20)(2008-9#14)(2009-10#4)(2009-11#4)(2009-12#2)(2009-2#2)(2009-3#4)(2009-4#4)(2009-5#5)(2009-6#1)(2009-7#12)(2009-8#4)(2009-9#1)(2010-1#6)(2010-11#2)(2010-12#5)(2010-2#3)(2010-4#18)(2010-5#1)(2010-6#4)(2010-7#7)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#8)(2011-3#2)(2012-1#2)(2012-11#19)(2012-12#5)(2012-2#11)(2012-3#6)(2013-1#8)(2013-7#4)(2013-8#13)
particles'##7##1##(2005-11#3)(2007-11#2)(2008-3#1)(2009-9#1)
particles) and##4##2##(2005-11#1)(2008-11#2)(2012-12#1)
particles)##12##1##(1990-11#1)(2005-11#2)(2005-7#1)(2005-8#1)(2007-9#1)(2008-11#2)(2008-3#1)(2008-7#2)(2012-12#1)
particles/flocs##2##1##(2005-11#2)
particular &quot##3##2##(1990-5#1)(1995-1#1)(2011-2#1)
particular a##4##2##(1991-1#1)(1994-2#1)(1997-6#1)(2007-8#1)
particular advantage##3##2##(2008-10#1)(2012-1#1)(2012-12#1)
particular advantages and##2##3##(2007-9#1)(2008-4#1)
particular advantages##6##2##(1993-11#1)(1995-4#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-5#1)
particular agent##4##2##(2006-10#1)(2006-7#1)(2009-8#1)(2010-5#1)
particular alignment##2##2##(2007-12#1)(2008-2#1)
particular amino acid##2##3##(1990-7#1)(1993-6#1)
particular amino##3##2##(1990-7#1)(1993-6#1)(2010-4#1)
particular anatomic##2##2##(2008-5#1)(2008-6#1)
particular and##5##2##(1990-4#1)(2004-3#1)(2008-10#1)(2008-8#1)(2010-4#1)
particular antigen##2##2##(1995-7#1)(2006-10#1)
particular application##7##2##(2008-2#3)(2008-3#3)(2011-1#1)
particular area##3##2##(1991-2#1)(1995-3#1)(2006-8#1)
particular areas##3##2##(1991-11#1)(1997-3#1)(2006-12#1)
particular aspects of##2##3##(1991-11#1)(2008-2#1)
particular aspects##6##2##(1991-11#1)(1991-5#1)(2005-8#1)(2008-2#1)(2008-7#1)(2012-3#1)
particular assay##3##2##(2007-12#1)(2008-10#1)(2012-3#1)
particular attention being paid to##2##5##(1993-5#1)(2009-6#1)
particular attention in##2##3##(1993-5#1)(2011-2#1)
particular attention is paid to##2##5##(2005-11#1)(2011-3#1)
particular attention is##3##3##(2005-11#1)(2008-6#1)(2011-3#1)
particular attention to the##14##4##(1990-3#1)(1990-4#1)(1990-9#1)(1994-1#1)(2004-1#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-11#2)(2007-8#1)(2008-4#1)(2008-6#1)(2011-2#1)
particular attention to##31##3##(1990-3#1)(1990-4#1)(1990-9#1)(1991-7#1)(1993-12#1)(1994-1#1)(1995-10#1)(2004-1#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-11#6)(2007-8#3)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-12#1)(2012-2#1)
particular attention##50##2##(1990-3#1)(1990-4#1)(1990-9#1)(1991-7#1)(1991-8#1)(1993-12#1)(1993-5#2)(1994-1#1)(1995-10#1)(2004-1#1)(2005-10#1)(2005-11#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2007-11#7)(2007-8#4)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#2)(2009-6#1)(2010-12#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#1)
particular back-calculation##2##2##(1996-12#2)
particular because##2##2##(1990-3#1)(2007-8#1)
particular behavior##2##2##(1997-7#1)(2008-11#1)
particular behaviour##3##2##(2008-10#1)(2010-2#1)(2011-2#1)
particular benefit##3##2##(2007-11#1)(2008-11#1)(2009-8#1)
particular biological##7##2##(1992-8#1)(1996-2#1)(2006-10#1)(2006-8#1)(2008-4#2)(2011-3#1)
particular by##9##2##(1991-2#1)(1992-5#1)(1994-12#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-5#1)(2011-2#1)
particular candidate##2##2##(1995-5#1)(1996-1#1)
particular case of a##6##4##(1997-7#1)(2005-11#1)(2007-12#2)(2008-2#2)
particular case of##9##3##(1997-7#1)(2005-11#1)(2007-12#3)(2008-2#3)(2012-12#1)
particular case##18##2##(1991-2#1)(1992-4#1)(1997-7#1)(2005-11#1)(2007-12#3)(2008-11#1)(2008-2#4)(2008-3#1)(2008-5#2)(2010-9#1)(2011-2#1)(2012-12#1)
particular cases##4##2##(2007-7#1)(2008-10#2)(2008-2#1)
particular category##2##2##(2007-7#1)(2013-8#1)
particular cell##8##2##(1994-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2012-12#3)
particular challenge##4##2##(2007-2#1)(2007-5#1)(2008-5#1)(2012-3#1)
particular challenges in##3##3##(2010-4#1)(2011-2#1)(2012-1#1)
particular challenges##5##2##(1992-3#1)(2008-11#1)(2010-4#1)(2011-2#1)(2012-1#1)
particular characteristics##5##2##(1995-12#1)(2007-11#1)(2008-4#1)(2008-5#1)(2010-2#1)
particular chemical##6##2##(2006-12#1)(2008-12#1)(2008-4#1)(2008-9#3)
particular choice of##2##3##(2008-2#2)
particular circumstances##2##2##(2006-8#1)(2007-4#1)
particular class of##4##3##(1991-10#1)(2007-11#1)(2007-8#1)(2008-1#1)
particular classes of##2##3##(2010-2#1)(2013-8#1)
particular clinical##5##2##(1997-3#1)(2006-8#1)(2007-11#1)(2008-6#1)(2011-2#1)
particular cognitive##2##2##(2007-11#1)(2008-11#1)
particular combinations of##2##3##(1994-9#1)(2008-7#1)
particular component of##2##3##(1992-9#1)(2008-10#1)
particular components##2##2##(2007-11#1)(2009-10#1)
particular concern##14##2##(1991-3#1)(1991-4#1)(1996-1#1)(2005-8#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-3#1)(2013-1#1)
particular conditions of##3##3##(2008-4#1)(2008-5#1)(2010-7#1)
particular conditions##10##2##(1992-12#2)(1997-6#1)(1997-7#1)(2008-4#2)(2008-5#2)(2010-7#1)(2013-8#1)
particular consideration##2##2##(1993-11#1)(2007-9#1)
particular country##3##2##(2005-12#2)(2011-2#1)
particular cytokine##2##2##(2006-10#1)(2007-11#1)
particular data##2##2##(2008-10#1)(2010-3#1)
particular definition##2##2##(2008-3#1)(2012-2#1)
particular difficulties##2##2##(1991-3#1)(1995-3#1)
particular difficulty##2##2##(2005-10#1)(2006-10#1)
particular direction##2##2##(1992-2#1)(2008-3#1)
particular domains##2##2##(2012-3#2)
particular effort must be made to understand the consequences of nucleotide release from cells in the cardiovascular system and the subsequent effects of P2 nucleotide receptor activation in blood vessels##2##30##(2008-4#2)
particular emphasis is placed on##3##5##(2008-10#1)(2008-4#1)(2012-1#1)
particular emphasis on the##22##4##(1992-12#1)(1993-1#1)(1993-6#1)(1994-9#1)(1995-3#1)(1996-5#1)(2006-10#1)(2007-1#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#2)(2009-5#1)(2010-9#1)(2012-12#2)(2012-3#1)
particular emphasis on##49##3##(1990-4#1)(1992-12#1)(1993-1#1)(1993-10#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-5#1)(2005-10#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-7#1)(2006-9#1)(2007-1#1)(2007-3#1)(2007-4#2)(2007-8#1)(2008-10#2)(2008-11#4)(2008-3#1)(2008-4#3)(2008-5#2)(2009-5#1)(2009-8#2)(2010-12#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-3#1)
particular emphasis placed on##2##4##(2008-10#1)(2012-2#1)
particular emphasis to the##2##4##(2011-2#1)(2013-1#1)
particular emphasis##59##2##(1990-4#1)(1992-12#1)(1993-1#1)(1993-10#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-5#1)(2005-10#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-7#1)(2006-9#1)(2007-1#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-8#1)(2008-10#4)(2008-11#4)(2008-3#2)(2008-4#4)(2008-5#2)(2009-5#1)(2009-8#2)(2010-12#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
particular environment##3##2##(1994-11#1)(2009-7#1)(2010-2#1)
particular environmental##2##2##(2008-8#2)
particular experimental##3##2##(2008-10#1)(2008-4#1)(2010-6#1)
particular feature of##3##3##(1990-11#1)(2010-12#1)(2012-2#1)
particular features##5##2##(1994-11#1)(2008-5#1)(2010-6#1)(2012-1#1)(2013-1#1)
particular fibre bundles##2##3##(2007-5#2)
particular field of research##2##4##(2007-11#1)(2008-7#1)
particular field##3##2##(2006-6#1)(2007-11#1)(2008-7#1)
particular flavonoids##2##2##(2008-10#1)(2008-5#1)
particular focus on the##6##4##(1996-2#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-11#1)(2010-5#1)
particular focus on their role in##2##6##(2008-1#1)(2010-1#1)
particular focus on their##3##4##(2008-1#1)(2009-5#1)(2010-1#1)
particular focus on##20##3##(1993-12#1)(1996-2#1)(2005-7#1)(2006-6#1)(2007-1#1)(2007-10#1)(2008-1#2)(2008-7#2)(2008-9#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
particular focus##23##2##(1993-12#1)(1996-2#1)(2005-7#1)(2006-6#1)(2007-1#1)(2007-10#1)(2008-1#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
particular food##4##2##(1993-12#1)(1994-3#1)(2006-10#1)(2010-1#1)
particular for##17##2##(1992-1#1)(1993-8#1)(2006-12#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-8#1)
particular form of##4##3##(1993-12#1)(2006-8#1)(2008-11#1)(2008-5#1)
particular forms of##2##3##(2008-10#1)(2012-2#1)
particular forms##3##2##(2008-10#1)(2008-4#1)(2012-2#1)
particular function##6##2##(1995-5#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-9#1)(2011-2#1)
particular functional##3##2##(1993-8#1)(1996-8#1)(2008-7#1)
particular gene is##2##3##(2012-11#1)(2012-2#1)
particular gene##7##2##(1997-6#1)(2006-10#1)(2008-4#2)(2009-4#1)(2012-11#1)(2012-2#1)
particular genetic##2##2##(2008-4#1)(2008-9#1)
particular group of##5##3##(1990-8#1)(1996-2#1)(2006-10#1)(2008-11#1)(2008-12#1)
particular group##7##2##(1990-8#1)(1994-4#1)(1996-2#1)(2006-10#1)(2008-11#1)(2008-12#1)(2012-11#1)
particular groups##3##2##(2007-12#1)(2008-5#2)
particular illness##2##2##(1992-12#1)(1996-12#1)
particular imaging##2##2##(1997-5#1)(2007-11#1)
particular implementation##2##2##(2008-2#1)(2008-3#1)
particular importance##25##2##(1990-2#1)(1991-12#1)(1991-8#1)(1992-4#1)(1992-5#1)(1993-3#1)(1994-9#1)(1995-12#1)(1995-4#1)(1996-3#1)(1997-7#1)(1997-8#1)(2004-12#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-2#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#2)(2013-1#1)
particular in vitro##2##3##(2007-8#1)(2008-10#1)
particular in##34##2##(1990-11#1)(1990-3#1)(1990-5#1)(1991-11#1)(1991-7#1)(1991-8#1)(1994-11#1)(1994-3#1)(1995-5#1)(1996-1#1)(1997-5#1)(2005-1#3)(2006-3#1)(2006-6#1)(2007-11#1)(2007-3#1)(2007-6#1)(2007-8#2)(2008-10#3)(2008-4#1)(2008-7#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#2)
particular instrument##2##2##(2006-2#1)(2008-3#1)
particular interest for##12##3##(1995-6#1)(1996-10#1)(2007-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#2)(2011-1#1)(2013-1#1)(2013-8#1)
particular interest in this##2##4##(2006-9#1)(2007-2#1)
particular interest in##10##3##(1991-3#1)(2005-8#1)(2006-9#1)(2007-2#2)(2008-8#1)(2008-9#1)(2012-1#1)(2012-2#1)(2013-8#1)
particular interest is##14##3##(1991-9#1)(1993-11#1)(1994-9#1)(1995-2#1)(1996-11#1)(2005-12#1)(2006-12#1)(2006-2#1)(2006-7#1)(2008-3#1)(2008-5#1)(2009-11#1)(2009-3#1)(2010-4#1)
particular interest to##13##3##(1992-8#1)(1993-12#2)(2005-8#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-11#1)(2013-1#2)(2013-8#1)
particular interest was##2##3##(1991-4#1)(2008-7#1)
particular interest##94##2##(1990-12#1)(1991-12#1)(1991-3#1)(1991-4#2)(1991-9#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-12#1)(2005-7#1)(2005-8#5)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#2)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#3)(2008-9#4)(2009-11#1)(2009-2#1)(2009-3#2)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#4)(2013-8#3)
particular intracellular##2##2##(1994-11#1)(1997-4#1)
particular isolate##2##2##(2008-10#2)
particular issue##2##2##(1996-1#1)(2005-7#1)
particular issues##2##2##(2009-10#1)(2010-2#1)
particular it##6##2##(1990-9#1)(1992-8#1)(1993-1#1)(2005-2#1)(2006-8#1)(2008-2#1)
particular kind of##2##3##(2007-11#1)(2012-3#1)
particular location##3##2##(1991-11#1)(2007-3#1)(2008-2#1)
particular medical##3##2##(2005-10#1)(2007-2#1)(2011-2#1)
particular method##4##2##(1991-9#1)(2008-11#1)(2012-2#2)
particular model##4##2##(1995-7#1)(2006-5#1)(2009-8#1)(2012-2#1)
particular myocardial infarction and##2##4##(2005-10#1)(2010-9#1)
particular needs##3##2##(1993-12#1)(2006-5#1)(2012-3#1)
particular of the##4##3##(1997-3#1)(2006-2#2)(2008-2#1)
particular of##8##2##(1992-10#1)(1994-5#1)(1997-3#1)(1997-8#1)(2006-2#2)(2008-2#1)(2008-7#1)
particular operating##2##2##(1990-4#1)(2006-10#1)
particular organ##2##2##(1995-11#1)(2010-3#1)
particular organization##2##2##(1993-12#1)(2005-10#1)
particular patient##12##2##(1991-2#1)(1992-8#2)(1996-12#1)(2006-10#1)(2007-11#1)(2008-4#1)(2009-10#1)(2010-6#1)(2011-1#1)(2013-1#2)
particular patients##2##2##(2007-7#1)(2009-7#1)
particular physiological##3##2##(1997-6#1)(2008-4#1)(2008-7#1)
particular plan##2##2##(1991-2#1)(2008-3#1)
particular plant##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2009-9#1)
particular points of##2##3##(2005-7#1)(2006-4#1)
particular population of##2##3##(2008-1#1)(2008-9#1)
particular population##3##2##(2006-11#1)(2008-1#1)(2008-9#1)
particular problem##6##2##(1996-3#1)(2006-12#1)(2008-10#1)(2008-8#1)(2009-10#1)(2010-9#1)
particular problems##4##2##(1991-12#1)(1994-3#1)(2007-11#1)(2010-12#1)
particular promise for##3##3##(2008-11#1)(2010-12#1)(2012-1#1)
particular properties of##2##3##(1995-5#1)(2008-4#1)
particular properties##4##2##(1995-5#1)(2008-4#1)(2008-5#1)(2009-8#1)
particular protein##7##2##(1992-1#1)(1993-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-2#1)
particular receptor##2##2##(2008-4#2)
particular reducing##2##2##(2009-3#1)(2013-1#1)
particular reference##30##2##(1990-5#1)(1991-4#1)(1992-2#1)(1993-2#1)(1993-7#1)(1993-9#1)(1994-6#1)(1996-6#1)(2004-7#1)(2005-5#1)(2006-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-12#1)(2011-12#2)(2012-12#1)
particular region of##3##3##(1994-2#1)(2007-11#1)(2010-12#1)
particular region##4##2##(1994-2#1)(2007-11#1)(2010-12#1)(2012-12#1)
particular relationship##2##2##(2006-2#1)(2009-7#1)
particular relevance for##3##3##(2007-12#1)(2012-2#1)(2012-3#1)
particular relevance to##3##3##(1994-8#1)(2006-10#1)(2008-1#1)
particular relevance##10##2##(1994-8#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
particular risk##12##2##(1990-7#1)(2004-4#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-10#1)(2009-9#1)(2011-2#1)(2012-12#1)
particular role for##2##3##(2007-12#1)(2011-2#1)
particular role##6##2##(1992-3#1)(1994-3#1)(2007-12#1)(2008-4#1)(2011-2#1)(2012-2#1)
particular sample##3##2##(1994-6#1)(2008-4#1)(2008-7#1)
particular sensitivity to##3##3##(1990-8#1)(2008-11#1)(2011-2#1)
particular sensory##2##2##(2008-12#1)(2010-2#1)
particular significance in##2##3##(1992-3#1)(2008-5#1)
particular significance##8##2##(1992-3#1)(1992-8#1)(1996-6#1)(2006-10#2)(2008-10#1)(2008-4#1)(2008-5#1)
particular site##3##2##(1997-4#1)(2004-4#1)(2010-8#1)
particular situation##4##2##(2005-9#1)(2008-12#1)(2008-2#1)(2009-4#1)
particular social##4##2##(1996-6#1)(2008-12#1)(2009-7#1)(2013-7#1)
particular soil##2##2##(1990-9#1)(2008-10#1)
particular species##5##2##(2006-8#1)(2008-12#2)(2008-4#1)(2010-12#1)
particular stage was##2##3##(2008-10#1)(2008-8#1)
particular stage##4##2##(1994-9#1)(1997-7#1)(2008-10#1)(2008-8#1)
particular stresses##2##2##(2008-7#1)(2009-8#1)
particular subcellular##2##2##(1995-11#1)(2008-4#1)
particular substrate##2##2##(1991-2#1)(2008-5#1)
particular suggestion##2##2##(2006-2#2)
particular surgical##2##2##(2007-11#1)(2009-3#1)
particular system##3##2##(2006-6#1)(2008-10#1)(2008-3#1)
particular target group##2##3##(2006-2#1)(2011-2#1)
particular target##3##2##(1997-2#1)(2006-2#1)(2011-2#1)
particular targets##2##2##(1991-3#1)(2007-11#1)
particular the##61##2##(1990-2#1)(1990-4#1)(1991-6#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-5#1)(1995-6#2)(1996-11#2)(1996-3#1)(1997-1#1)(1997-6#1)(1997-7#2)(2006-10#4)(2006-11#1)(2006-2#1)(2006-6#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#1)(2009-3#1)(2009-7#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#1)
particular they##3##2##(2006-11#1)(2008-5#1)(2008-7#1)
particular those##14##2##(1990-9#1)(1991-11#1)(1991-2#1)(1994-11#1)(1994-9#1)(2005-12#1)(2007-11#1)(2008-10#3)(2008-12#1)(2011-2#2)(2012-2#1)
particular three-dimensional##2##2##(1990-9#1)(1997-6#1)
particular time##5##2##(1996-12#1)(2008-1#2)(2008-2#1)(2008-4#1)
particular tissue##3##2##(1990-8#1)(2013-1#2)
particular tissues##2##2##(2009-2#1)(2012-12#1)
particular to the##7##3##(1993-5#1)(1997-1#1)(2007-4#1)(2008-10#1)(2008-8#1)(2010-4#1)(2010-6#1)
particular to##17##2##(1990-10#1)(1991-4#1)(1993-11#1)(1993-5#1)(1997-1#1)(2006-6#1)(2006-8#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-8#1)
particular type of##13##3##(1990-11#1)(1991-8#1)(1993-6#1)(1994-12#1)(1997-1#1)(1997-4#1)(2008-2#2)(2008-3#2)(2009-1#1)(2010-1#1)(2012-3#1)
particular types of##4##3##(2008-1#1)(2008-5#2)(2012-12#1)
particular virus##2##2##(1992-6#1)(2008-5#1)
particular way##5##2##(2006-7#1)(2008-8#1)(2010-2#1)(2012-2#1)(2013-1#1)
particular we##5##2##(1996-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2011-1#1)
particular when##7##2##(1991-12#1)(1991-7#1)(1994-11#1)(1997-2#1)(2008-10#1)(2008-3#1)(2013-1#1)
particular##2314##1##(1990-10#2)(1990-11#12)(1990-12#5)(1990-2#3)(1990-3#7)(1990-4#6)(1990-5#7)(1990-6#4)(1990-7#7)(1990-8#5)(1990-9#7)(1991-1#2)(1991-10#2)(1991-11#11)(1991-12#9)(1991-2#8)(1991-3#5)(1991-4#7)(1991-5#6)(1991-6#8)(1991-7#5)(1991-8#7)(1991-9#2)(1992-1#5)(1992-10#2)(1992-11#3)(1992-12#9)(1992-2#5)(1992-3#9)(1992-4#7)(1992-5#6)(1992-6#7)(1992-7#2)(1992-8#15)(1992-9#6)(1993-1#6)(1993-10#2)(1993-11#8)(1993-12#12)(1993-2#2)(1993-3#7)(1993-5#7)(1993-6#9)(1993-7#4)(1993-8#6)(1993-9#6)(1994-1#1)(1994-10#1)(1994-11#10)(1994-12#4)(1994-2#6)(1994-3#11)(1994-4#2)(1994-5#6)(1994-6#6)(1994-7#1)(1994-8#6)(1994-9#6)(1995-1#7)(1995-10#5)(1995-11#8)(1995-12#9)(1995-2#9)(1995-3#10)(1995-4#4)(1995-5#10)(1995-6#5)(1995-7#2)(1995-8#9)(1995-9#3)(1996-1#10)(1996-10#5)(1996-11#6)(1996-12#18)(1996-2#10)(1996-3#9)(1996-4#2)(1996-5#1)(1996-6#6)(1996-7#6)(1996-8#6)(1996-9#2)(1997-1#9)(1997-2#5)(1997-3#10)(1997-4#12)(1997-5#4)(1997-6#15)(1997-7#14)(1997-8#15)(2004-1#1)(2004-11#1)(2004-12#4)(2004-3#1)(2004-4#5)(2004-7#1)(2004-9#1)(2005-1#6)(2005-10#9)(2005-11#10)(2005-12#5)(2005-2#1)(2005-3#1)(2005-5#2)(2005-6#1)(2005-7#9)(2005-8#12)(2005-9#2)(2006-1#3)(2006-10#63)(2006-11#6)(2006-12#21)(2006-2#17)(2006-3#2)(2006-4#6)(2006-5#8)(2006-6#16)(2006-7#8)(2006-8#12)(2006-9#6)(2007-1#3)(2007-10#3)(2007-11#62)(2007-12#54)(2007-2#15)(2007-3#12)(2007-4#10)(2007-5#4)(2007-6#2)(2007-7#17)(2007-8#32)(2007-9#12)(2008-1#41)(2008-10#116)(2008-11#66)(2008-12#15)(2008-2#81)(2008-3#80)(2008-4#76)(2008-5#50)(2008-6#14)(2008-7#58)(2008-8#43)(2008-9#34)(2009-1#3)(2009-10#11)(2009-11#7)(2009-12#5)(2009-2#14)(2009-3#12)(2009-4#9)(2009-5#10)(2009-6#8)(2009-7#12)(2009-8#14)(2009-9#9)(2010-1#6)(2010-10#5)(2010-11#10)(2010-12#33)(2010-2#23)(2010-3#3)(2010-4#13)(2010-5#8)(2010-6#8)(2010-7#14)(2010-8#9)(2010-9#12)(2011-1#33)(2011-12#5)(2011-2#56)(2011-3#2)(2012-1#18)(2012-11#6)(2012-12#45)(2012-2#50)(2012-3#27)(2012-5#1)(2012-7#2)(2013-1#48)(2013-7#7)(2013-8#28)
particularities of the##2##3##(2007-10#1)(2009-4#1)
particularities of##9##2##(2007-10#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-4#2)(2012-12#1)(2013-1#1)
particularities##22##1##(1995-9#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-8#1)(2009-4#4)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
particularly &quot##2##2##(2008-4#2)
particularly Streptococcus##2##2##(2005-8#1)(2006-6#1)
particularly a##4##2##(1997-7#1)(2007-10#1)(2008-7#2)
particularly abdominal##3##2##(1995-12#1)(1997-8#1)(2009-7#1)
particularly abundant in##5##3##(1992-12#1)(1993-9#1)(1995-6#1)(2007-3#1)(2008-10#1)
particularly abundant##6##2##(1992-12#1)(1993-9#1)(1995-6#1)(2007-12#1)(2007-3#1)(2008-10#1)
particularly acute##3##2##(1991-12#1)(2008-2#1)(2008-4#1)
particularly advanced##2##2##(1992-6#1)(2011-1#1)
particularly advantageous##3##2##(1993-10#1)(2008-10#1)(2008-4#1)
particularly affecting##3##2##(1990-6#1)(1991-11#1)(2006-12#1)
particularly affects##2##2##(2007-7#1)(2011-1#1)
particularly after##8##2##(1993-10#1)(1996-11#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-12#1)(2012-3#1)
particularly against##3##2##(2005-8#1)(2008-5#1)(2011-12#1)
particularly aggressive##2##2##(1991-4#1)(2010-10#1)
particularly all##2##2##(2007-12#1)(2007-8#1)
particularly amino acids##2##3##(2008-11#1)(2013-8#1)
particularly among males##2##3##(1990-6#1)(1994-6#1)
particularly among older adults##2##4##(2013-1#2)
particularly among patients with##2##4##(2007-10#1)(2010-5#1)
particularly among patients##4##3##(1995-9#1)(2007-10#1)(2010-5#1)(2012-3#1)
particularly among racial ethnic minorities who are also sexual minorities##2##10##(2013-1#2)
particularly among the##4##3##(1993-10#1)(2005-8#1)(2008-7#1)(2012-11#1)
particularly among##29##2##(1990-11#1)(1990-6#1)(1993-10#1)(1993-3#1)(1994-4#1)(1994-6#1)(1995-3#1)(1995-9#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-11#1)(2012-3#4)(2013-1#4)
particularly an##2##2##(2007-8#1)(2008-7#1)
particularly antibiotics##2##2##(2013-1#1)(2013-8#1)
particularly apparent in##2##3##(2008-1#1)(2008-10#1)
particularly applicable to##2##3##(2008-11#1)(2012-12#1)
particularly applicable##5##2##(1992-6#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-12#1)
particularly appropriate##4##2##(1992-7#1)(2008-7#1)(2009-5#1)(2010-9#1)
particularly around##2##2##(2012-3#1)(2013-8#1)
particularly as a##3##3##(2007-9#1)(2008-10#1)(2012-3#1)
particularly as it pertains to the##2##6##(2008-3#1)(2010-5#1)
particularly as it##3##3##(2008-3#1)(2010-5#1)(2010-9#1)
particularly as the##2##3##(1991-1#1)(2008-3#1)
particularly as they##2##3##(2010-6#1)(2010-8#1)
particularly as##19##2##(1990-2#1)(1991-1#1)(1995-2#1)(2005-7#1)(2006-10#1)(2007-1#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-3#1)
particularly associated with##2##3##(1995-5#1)(1996-2#1)
particularly at high##3##3##(1993-11#1)(1993-3#1)(2008-7#1)
particularly at the higher##2##4##(1996-5#1)(2007-10#1)
particularly at the hip##2##4##(2008-3#1)(2010-10#1)
particularly at the local##2##4##(1994-3#1)(1997-3#1)
particularly at the##16##3##(1994-3#1)(1995-12#1)(1996-5#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-3#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-10#1)(2011-12#1)(2012-12#1)(2013-8#1)
particularly at##37##2##(1990-3#1)(1991-11#1)(1991-12#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#2)(1995-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-7#2)(2009-10#1)(2009-8#1)(2010-10#1)(2011-12#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-8#1)
particularly attractive for##6##3##(2008-10#2)(2008-5#2)(2008-8#1)(2010-7#1)
particularly attractive##11##2##(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2010-7#1)(2011-1#1)(2012-12#1)
particularly because of##2##3##(2007-10#1)(2012-3#1)
particularly because##6##2##(1992-11#1)(2006-10#1)(2007-10#1)(2008-8#1)(2012-3#1)(2013-1#1)
particularly beneficial##3##2##(1992-9#1)(2008-2#1)(2009-1#1)
particularly benefit from##2##3##(2006-10#1)(2008-10#1)
particularly benefit##4##2##(2006-10#1)(2008-10#1)(2008-3#1)(2012-2#1)
particularly between##5##2##(1990-5#1)(2007-9#1)(2008-5#1)(2009-7#1)(2011-2#1)
particularly by the##5##3##(1991-8#1)(2005-8#1)(2008-11#1)(2008-5#1)(2012-12#1)
particularly by##10##2##(1991-8#1)(1992-5#1)(1993-3#1)(2005-8#1)(2006-11#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
particularly challenging##12##2##(2006-10#1)(2006-8#1)(2007-11#1)(2007-6#1)(2008-4#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
particularly chronic##2##2##(1991-4#1)(1997-5#1)
particularly common in##3##3##(1995-6#1)(2006-1#1)(2007-11#1)
particularly common##6##2##(1995-6#1)(2005-12#1)(2006-1#1)(2007-11#1)(2008-9#1)(2009-5#1)
particularly complex##6##2##(1993-3#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#2)
particularly comprehensive##2##2##(2005-9#1)(2008-9#1)
particularly concerning##2##2##(1993-6#1)(2010-9#1)
particularly considering##2##2##(2005-10#1)(2008-5#1)
particularly convenient for##3##3##(1993-3#1)(2007-12#1)(2008-10#1)
particularly convenient##4##2##(1993-3#1)(2007-12#1)(2008-10#1)(2009-6#1)
particularly convincing##2##2##(2006-2#1)(2012-12#1)
particularly critical##3##2##(1992-6#1)(2008-2#1)(2008-8#1)
particularly dangerous##3##2##(1993-10#1)(1995-9#1)(2008-7#1)
particularly depression##3##2##(2006-2#1)(2008-11#1)(2008-3#1)
particularly different##2##2##(1997-7#1)(2008-9#1)
particularly difficult and##2##3##(1990-12#1)(2008-4#1)
particularly difficult to##3##3##(1997-6#1)(2008-2#1)(2010-4#1)
particularly difficult##11##2##(1990-12#1)(1996-8#1)(1997-6#1)(2006-2#1)(2007-11#1)(2008-2#2)(2008-4#1)(2008-8#1)(2010-2#1)(2010-4#1)
particularly due to##2##3##(1990-2#1)(2008-11#1)
particularly during the##4##3##(2006-9#1)(2007-5#1)(2008-12#1)(2008-2#1)
particularly during##10##2##(2006-9#1)(2007-5#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-8#1)(2011-2#2)(2012-12#1)(2013-7#1)
particularly early##2##2##(1996-5#1)(2005-11#1)
particularly effective for the detection of##2##6##(1994-9#1)(2006-6#1)
particularly effective for##4##3##(1994-9#1)(2006-6#1)(2008-3#1)(2008-4#1)
particularly effective in##6##3##(2007-10#1)(2007-8#1)(2008-5#1)(2009-9#1)(2010-10#1)(2013-1#1)
particularly effective##12##2##(1994-9#1)(2006-6#1)(2007-10#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-9#1)(2010-10#1)(2013-1#1)
particularly efficient##5##2##(2008-1#1)(2008-2#1)(2008-4#2)(2013-8#1)
particularly evident in##4##3##(1995-1#1)(2007-6#1)(2007-8#1)(2012-3#1)
particularly evident##5##2##(1995-1#1)(2007-6#1)(2007-8#1)(2009-3#1)(2012-3#1)
particularly exciting##3##2##(2008-1#1)(2009-4#1)(2010-12#1)
particularly focused on the##3##4##(2005-8#1)(2008-10#1)(2012-2#1)
particularly focusing on##2##3##(2008-10#2)
particularly focusing##3##2##(2006-10#1)(2008-10#2)
particularly for patients##3##3##(2008-9#1)(2010-12#1)(2010-3#1)
particularly for the##14##3##(1995-10#1)(2005-11#1)(2006-10#2)(2007-11#1)(2007-4#1)(2008-10#2)(2008-9#1)(2009-4#2)(2010-7#1)(2012-12#1)(2012-2#1)
particularly for those with##2##4##(2008-3#1)(2010-12#1)
particularly for those##3##3##(2008-2#1)(2008-3#1)(2010-12#1)
particularly for vulnerable populations##2##4##(1997-2#1)(2010-1#1)
particularly for##78##2##(1990-12#1)(1990-3#1)(1991-12#1)(1992-11#1)(1992-8#1)(1993-5#1)(1994-12#2)(1994-5#1)(1995-10#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-11#1)(2006-10#3)(2006-12#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-7#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#3)
particularly from a##2##3##(2006-2#1)(2008-5#1)
particularly from the electronic databases Cumulative Index to Nursing and Allied Health Literature##2##13##(2013-1#2)
particularly from the##5##3##(2006-10#1)(2008-5#1)(2008-9#1)(2013-1#2)
particularly from##13##2##(1994-12#1)(2006-10#1)(2006-2#1)(2008-5#4)(2008-9#1)(2010-9#1)(2011-2#2)(2013-1#2)
particularly given the##4##3##(2004-9#1)(2007-2#1)(2009-10#1)(2009-5#1)
particularly good##2##2##(2006-10#1)(2008-9#1)
particularly great##2##2##(1992-3#1)(1995-3#1)
particularly helpful for##2##3##(2006-10#1)(2008-1#1)
particularly helpful in patients##4##4##(1993-7#1)(2008-6#1)(2013-1#2)
particularly helpful in the##2##4##(2006-8#1)(2007-4#1)
particularly helpful in##6##3##(1993-7#1)(2006-8#1)(2007-4#1)(2008-6#1)(2013-1#2)
particularly helpful##11##2##(1993-7#1)(2006-10#1)(2006-8#1)(2007-4#1)(2008-1#1)(2008-4#1)(2008-6#1)(2010-2#1)(2012-3#1)(2013-1#2)
particularly hepatitis##3##2##(2008-12#1)(2009-9#1)(2012-2#1)
particularly high in##2##3##(2008-7#1)(2012-2#1)
particularly high levels of##2##4##(1995-12#1)(1997-5#1)
particularly high levels##3##3##(1995-12#1)(1997-5#1)(2011-1#1)
particularly high resolution##2##3##(2007-1#2)
particularly high##25##2##(1990-10#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-9#1)(1993-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1997-5#1)(2005-10#1)(2007-1#2)(2007-12#1)(2007-2#1)(2007-9#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
particularly hydrogen##3##2##(2008-10#2)(2008-2#1)
particularly if a##2##3##(1990-5#1)(2008-6#1)
particularly if combined with##2##4##(2008-6#1)(2010-12#1)
particularly if the##5##3##(1997-3#1)(2005-5#1)(2006-10#1)(2008-11#1)(2012-3#1)
particularly if they##2##3##(2005-7#1)(2008-7#1)
particularly if##23##2##(1990-5#1)(1991-10#1)(1992-4#1)(1995-12#1)(1997-3#1)(2005-5#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-8#1)
particularly important and##2##3##(1992-4#1)(2012-2#1)
particularly important because##4##3##(1993-11#1)(2007-12#1)(2008-8#1)(2010-4#1)
particularly important during##3##3##(1994-6#1)(2008-11#1)(2013-1#1)
particularly important for##10##3##(1997-7#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-4#1)(2011-2#2)(2012-2#1)
particularly important in the##5##4##(1992-11#1)(2006-10#1)(2007-9#1)(2008-12#1)(2008-7#1)
particularly important in##13##3##(1992-11#1)(1992-5#1)(1993-12#1)(1995-8#1)(1996-8#1)(2005-11#1)(2006-10#1)(2007-9#1)(2008-12#1)(2008-7#1)(2009-4#1)(2011-12#1)(2011-2#1)
particularly important when##6##3##(1991-1#1)(1995-1#1)(1996-3#1)(2008-3#1)(2009-2#1)(2013-1#1)
particularly important##60##2##(1991-1#1)(1992-11#1)(1992-4#2)(1992-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-6#1)(1995-1#1)(1995-8#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-7#1)(2005-11#2)(2006-10#2)(2006-6#1)(2007-12#3)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-4#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
particularly in Asian countries over the past decades##2##8##(2013-1#2)
particularly in Asian countries##4##4##(2013-1#4)
particularly in a##4##3##(1991-3#1)(1997-3#2)(2008-10#1)
particularly in acute##2##3##(2007-7#1)(2010-6#1)
particularly in an##4##3##(2004-11#1)(2007-10#1)(2007-12#1)(2009-6#1)
particularly in areas that##2##4##(1997-2#1)(2007-6#1)
particularly in areas##4##3##(1997-2#1)(2007-6#1)(2008-10#1)(2008-9#1)
particularly in association with##2##4##(1990-3#1)(2007-11#1)
particularly in association##3##3##(1990-3#1)(1997-7#1)(2007-11#1)
particularly in case of##2##4##(2007-12#1)(2013-1#1)
particularly in cases of##4##4##(1992-2#1)(1994-2#1)(2006-12#1)(2011-1#1)
particularly in children##5##3##(1991-4#1)(2006-8#1)(2008-9#1)(2012-12#2)
particularly in conjunction with other existing interventions operating in a new risk environment##2##13##(2013-1#2)
particularly in developing countries##5##4##(2005-8#1)(2006-2#1)(2007-2#1)(2010-12#1)(2013-8#1)
particularly in high##3##3##(2008-10#1)(2008-3#1)(2010-8#1)
particularly in infants##2##3##(2006-10#1)(2013-8#1)
particularly in light of the##2##5##(2011-2#1)(2012-2#1)
particularly in light of##3##4##(2011-2#1)(2012-12#1)(2012-2#1)
particularly in long-term##2##3##(2007-12#1)(2007-8#1)
particularly in males##2##3##(1997-4#1)(2010-7#1)
particularly in older##2##3##(2007-1#1)(2011-2#1)
particularly in patients at##2##4##(2007-3#1)(2008-12#1)
particularly in patients undergoing##2##4##(2006-10#1)(2009-8#1)
particularly in patients with##17##4##(1990-4#1)(1992-3#1)(2006-12#1)(2006-4#1)(2007-2#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-3#1)
particularly in patients##25##3##(1990-4#1)(1992-3#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#2)(2011-2#2)(2012-12#1)(2012-3#2)
particularly in populations##2##3##(2007-9#1)(2010-10#1)
particularly in regard to##4##4##(1997-6#1)(1997-8#1)(2006-10#1)(2008-4#1)
particularly in relation to the##2##5##(2006-9#1)(2009-1#1)
particularly in relation to##13##4##(1991-5#1)(1991-7#1)(1993-3#1)(1993-8#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-6#1)(2006-9#1)(2009-1#1)(2009-9#1)(2011-2#2)
particularly in respect of##2##4##(2008-10#1)(2013-8#1)
particularly in rural communities##2##4##(2009-7#1)(2010-4#1)
particularly in small##2##3##(1993-5#1)(1994-11#1)
particularly in terms of the##3##5##(1996-12#1)(2005-8#1)(2011-1#1)
particularly in terms of##6##4##(1996-12#1)(2005-8#2)(2007-10#1)(2008-11#1)(2011-1#1)
particularly in the areas of##2##5##(2006-10#1)(2011-1#1)
particularly in the case of##4##5##(2007-6#1)(2008-10#1)(2008-4#1)(2009-4#1)
particularly in the cases##2##4##(2008-10#1)(2011-1#1)
particularly in the context of##4##5##(2009-1#1)(2011-1#1)(2012-12#1)(2012-2#1)
particularly in the developing countries##2##5##(2007-7#2)
particularly in the developing world##2##5##(2006-10#1)(2008-10#1)
particularly in the developing##4##4##(2006-10#1)(2007-7#2)(2008-10#1)
particularly in the development of##2##5##(1996-8#1)(2008-9#1)
particularly in the elderly##3##4##(1992-8#1)(2004-3#1)(2008-8#1)
particularly in the field of##4##5##(2008-10#1)(2008-5#1)(2011-2#1)(2012-12#1)
particularly in the first##2##4##(2006-1#1)(2008-8#1)
particularly in the presence of##3##5##(1995-3#1)(2008-4#1)(2012-2#1)
particularly in the reduction of##2##5##(1994-11#1)(2007-10#1)
particularly in the setting of##2##5##(2007-10#1)(2008-4#1)
particularly in the treatment of##2##5##(1990-6#1)(2004-11#1)
particularly in the##108##3##(1990-12#2)(1990-6#2)(1991-4#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-3#3)(1993-6#1)(1993-8#1)(1994-11#2)(1994-8#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-6#1)(1996-8#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#2)(2004-3#1)(2005-8#2)(2006-1#1)(2006-10#9)(2006-11#1)(2006-2#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#3)(2008-1#3)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#2)(2008-8#3)(2008-9#4)(2009-1#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#1)
particularly in their##2##3##(2008-11#1)(2012-12#1)
particularly in those patients with an##2##6##(2006-10#1)(2007-8#1)
particularly in those with##4##4##(1995-9#1)(2006-10#1)(2010-12#1)(2012-2#1)
particularly in those##10##3##(1995-9#1)(2006-10#2)(2007-2#1)(2007-8#1)(2008-6#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
particularly in type 2 diabetes##2##5##(2008-1#2)
particularly in type##3##3##(2008-1#3)
particularly in urban##2##3##(2008-11#1)(2012-3#1)
particularly in view of##2##4##(1991-8#1)(2006-11#1)
particularly in women##3##3##(1997-1#1)(2008-3#1)(2012-2#1)
particularly in young adults##2##4##(1994-2#1)(2006-10#1)
particularly in young patients##3##4##(2007-7#1)(2008-8#1)(2011-1#1)
particularly in young##6##3##(1994-2#1)(2006-10#1)(2007-7#1)(2008-8#2)(2011-1#1)
particularly in younger##2##3##(2004-2#1)(2012-2#1)
particularly in##355##2##(1990-12#3)(1990-3#1)(1990-4#1)(1990-6#2)(1990-9#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#3)(1993-12#1)(1993-3#4)(1993-5#1)(1993-6#1)(1993-8#2)(1994-1#1)(1994-11#4)(1994-12#2)(1994-2#2)(1994-5#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-8#1)(1995-9#2)(1996-1#1)(1996-12#1)(1996-4#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#3)(2004-11#3)(2004-2#1)(2004-3#1)(2005-11#3)(2005-5#1)(2005-7#1)(2005-8#5)(2006-1#1)(2006-10#20)(2006-11#2)(2006-12#3)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#2)(2006-6#2)(2006-8#2)(2006-9#3)(2007-1#3)(2007-10#4)(2007-11#3)(2007-12#6)(2007-2#7)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#7)(2007-8#4)(2007-9#4)(2008-1#10)(2008-10#16)(2008-11#9)(2008-12#5)(2008-2#2)(2008-3#7)(2008-4#6)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#8)(2008-9#7)(2009-1#2)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#4)(2009-7#1)(2009-8#3)(2009-9#5)(2010-10#2)(2010-11#1)(2010-12#4)(2010-4#2)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#12)(2012-1#4)(2012-12#8)(2012-2#10)(2012-3#5)(2013-1#12)(2013-8#6)
particularly increased##3##2##(2006-10#1)(2008-10#1)(2011-2#1)
particularly indicated for##2##3##(2007-7#1)(2011-2#1)
particularly infectious##2##2##(2006-10#1)(2012-11#1)
particularly informative##2##2##(2006-8#1)(2008-10#1)
particularly interesting from##2##3##(2009-8#1)(2012-1#1)
particularly interesting in##2##3##(1992-9#1)(2008-5#1)
particularly interesting##18##2##(1990-5#1)(1991-6#1)(1992-9#1)(1995-11#1)(2005-8#1)(2006-5#1)(2006-7#1)(2006-8#1)(2008-3#1)(2008-5#1)(2009-4#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
particularly involving##2##2##(2006-10#1)(2008-7#1)
particularly its##2##2##(2008-2#1)(2008-5#1)
particularly large##4##2##(1990-11#1)(1993-12#1)(1997-7#1)(2013-8#1)
particularly low##2##2##(2010-8#1)(2011-1#1)
particularly myocardial infarction##2##3##(1990-2#1)(2009-5#1)
particularly needed##2##2##(1992-2#1)(1996-2#1)
particularly notable in the##2##4##(1991-8#1)(1996-12#1)
particularly notable##3##2##(1991-8#1)(1996-12#1)(2007-8#1)
particularly noteworthy##3##2##(2007-12#1)(2008-2#1)(2008-6#1)
particularly of the##7##3##(1995-12#1)(2004-11#1)(2006-4#1)(2007-8#1)(2009-6#1)(2010-12#1)(2013-8#1)
particularly of##17##2##(1990-4#1)(1995-11#1)(1995-12#1)(1996-9#1)(2004-11#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-6#1)(2007-8#1)(2008-10#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-9#1)(2013-8#1)
particularly older women##2##3##(2013-1#2)
particularly on its##2##3##(2008-11#2)
particularly on the##12##3##(1992-12#1)(1992-2#1)(1994-6#1)(1996-4#1)(2008-3#2)(2008-5#1)(2009-8#1)(2011-2#2)(2012-2#1)(2012-3#1)
particularly on##23##2##(1992-12#1)(1992-2#1)(1994-6#1)(1996-4#1)(2005-5#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#2)(2008-7#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)
particularly pertinent##3##2##(1992-1#1)(2009-6#1)(2012-3#1)
particularly powerful##4##2##(2008-2#2)(2008-4#2)
particularly prevalent##2##2##(2006-12#1)(2007-2#1)
particularly prominent##4##2##(1990-12#1)(1996-4#1)(2007-8#1)(2012-2#1)
particularly promising for##3##3##(2009-1#1)(2012-2#1)(2012-6#1)
particularly promising##7##2##(1993-3#1)(2007-2#1)(2007-9#1)(2008-1#1)(2009-1#1)(2012-2#1)(2012-6#1)
particularly prone to##4##3##(2008-5#1)(2012-1#1)(2012-12#1)(2012-3#1)
particularly pronounced in##2##3##(1996-12#1)(2007-7#1)
particularly pronounced##3##2##(1996-12#1)(2007-7#1)(2008-7#1)
particularly rare##2##2##(2012-1#1)(2013-1#1)
particularly reducing##2##2##(2008-11#1)(2009-11#1)
particularly regarding the##3##3##(2007-12#1)(2007-8#1)(2012-2#1)
particularly regarding##5##2##(1991-3#1)(2007-12#1)(2007-8#1)(2008-5#1)(2012-2#1)
particularly related to their##2##4##(2010-8#1)(2013-1#1)
particularly related to##3##3##(2010-8#1)(2012-12#1)(2013-1#1)
particularly relating to##2##3##(2006-4#1)(2008-12#1)
particularly relevant in the##3##4##(2006-10#1)(2007-10#1)(2007-7#1)
particularly relevant in##5##3##(2006-10#1)(2006-11#1)(2007-10#1)(2007-7#1)(2010-9#1)
particularly relevant to the##2##4##(1995-12#1)(2012-12#1)
particularly relevant to##4##3##(1991-10#1)(1995-12#1)(2007-5#1)(2012-12#1)
particularly relevant##12##2##(1991-10#1)(1995-12#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-12#1)(2008-5#1)(2010-9#1)(2011-1#1)(2012-12#1)
particularly responsive to##3##3##(1991-11#1)(2005-9#1)(2008-10#1)
particularly sensitive to##9##3##(1995-12#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-3#1)(2008-4#1)(2010-4#1)(2011-1#1)
particularly sensitive##14##2##(1993-1#1)(1993-5#1)(1995-12#1)(1996-3#1)(1996-5#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-3#1)(2008-4#2)(2010-4#1)(2011-1#1)
particularly severe##5##2##(1994-6#1)(1996-6#1)(2007-11#1)(2007-9#1)(2012-2#1)
particularly short##2##2##(1996-12#1)(2010-2#1)
particularly significant##6##2##(1991-10#1)(1995-2#1)(1996-11#1)(1997-7#1)(2007-7#1)(2013-7#1)
particularly since##5##2##(1990-4#1)(2008-5#3)(2008-9#1)
particularly small##3##2##(1991-12#1)(2009-10#1)(2012-2#1)
particularly striking##5##2##(1991-8#1)(2006-6#1)(2007-12#2)(2013-8#1)
particularly strong in##3##3##(1995-11#1)(2008-8#1)(2009-8#1)
particularly strong##6##2##(1995-11#1)(2005-8#1)(2008-7#1)(2008-8#2)(2009-8#1)
particularly successful##2##2##(2008-7#1)(2011-2#1)
particularly suitable for the##3##4##(1992-4#1)(1997-3#1)(2006-10#1)
particularly suitable for##14##3##(1992-4#1)(1994-5#1)(1997-3#1)(2006-10#1)(2006-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-12#1)(2011-12#1)(2012-2#1)
particularly suitable##16##2##(1992-4#1)(1992-8#1)(1994-5#1)(1996-1#1)(1997-3#1)(2006-10#1)(2006-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-12#1)(2011-12#1)(2012-2#1)
particularly suited for##6##3##(1991-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-12#1)(2012-1#1)
particularly suited to##7##3##(1991-5#1)(1997-3#1)(2007-11#2)(2008-6#1)(2008-7#1)(2008-9#1)
particularly suited##14##2##(1991-5#1)(1991-9#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-12#1)(2012-1#1)
particularly susceptible to the##2##4##(1992-1#1)(2009-8#1)
particularly susceptible to##6##3##(1992-1#1)(1993-12#1)(1996-8#1)(2007-5#1)(2009-8#1)(2010-3#1)
particularly susceptible##7##2##(1992-1#1)(1993-12#1)(1996-8#1)(2007-5#1)(2009-8#1)(2010-3#1)(2012-12#1)
particularly that of##2##3##(2007-11#1)(2007-12#1)
particularly that##5##2##(2005-7#1)(2007-11#1)(2007-12#1)(2009-9#1)(2010-1#1)
particularly the case for##4##4##(2005-11#1)(2008-10#1)(2008-11#1)(2012-2#1)
particularly the case##6##3##(1990-6#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
particularly the importance##2##3##(2006-5#1)(2012-2#1)
particularly the use of##3##4##(2006-7#1)(2007-8#1)(2008-11#1)
particularly the##87##2##(1990-1#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-10#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-6#1)(1993-12#1)(1994-1#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-2#1)(2004-4#1)(2005-11#1)(2005-5#1)(2006-10#4)(2006-11#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-12#1)(2007-2#1)(2007-3#2)(2007-6#2)(2007-7#2)(2007-8#3)(2008-10#3)(2008-11#5)(2008-12#2)(2008-2#2)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#5)(2013-1#2)
particularly their##5##2##(2005-7#1)(2007-8#1)(2010-5#1)(2012-2#1)(2012-3#1)
particularly those containing##2##3##(1996-3#1)(2008-9#1)
particularly those in developing countries##2##5##(2006-4#1)(2012-12#1)
particularly those in##6##3##(1991-3#1)(2005-12#1)(2006-4#1)(2008-11#1)(2011-2#1)(2012-12#1)
particularly those involving##3##3##(2007-9#1)(2010-2#1)(2012-2#1)
particularly those of the##3##4##(1991-4#1)(2004-11#1)(2009-5#1)
particularly those of##6##3##(1991-4#1)(2004-11#1)(2007-4#1)(2007-9#1)(2009-12#1)(2009-5#1)
particularly those originating from##2##4##(1990-8#1)(2010-12#1)
particularly those that##6##3##(1994-7#1)(1994-8#1)(1996-12#1)(2008-11#1)(2009-3#1)(2010-9#1)
particularly those which are##2##4##(2008-10#1)(2010-12#1)
particularly those who##2##3##(2007-11#1)(2009-9#1)
particularly those with##10##3##(1991-7#1)(2006-10#2)(2006-2#1)(2007-1#1)(2007-12#1)(2007-2#1)(2008-4#1)(2009-7#1)(2010-12#1)
particularly those##57##2##(1990-8#1)(1991-10#1)(1991-3#1)(1991-4#2)(1991-7#1)(1993-3#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#1)(2004-11#1)(2005-12#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-10#2)(2008-11#2)(2008-4#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#3)(2010-2#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)
particularly through expression of chemokines##2##5##(2013-1#2)
particularly through##5##2##(2005-9#1)(2006-8#1)(2008-10#1)(2013-1#2)
particularly to##17##2##(1990-2#1)(1993-8#1)(1994-5#1)(1995-3#1)(1997-7#1)(2006-10#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2010-8#1)(2010-9#1)(2012-12#1)
particularly true for##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)
particularly true in the##4##4##(1992-1#1)(1994-12#1)(2010-11#1)(2013-1#1)
particularly true in##6##3##(1992-1#1)(1994-12#1)(2007-5#1)(2010-11#1)(2012-3#1)(2013-1#1)
particularly true##11##2##(1992-1#1)(1994-12#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-4#1)(2010-11#1)(2012-3#1)(2013-1#1)
particularly under##2##2##(1995-5#1)(2009-10#1)
particularly urgent##2##2##(1990-2#1)(2006-6#1)
particularly useful as##4##3##(1997-4#1)(2006-8#1)(2008-10#1)(2008-3#1)
particularly useful because##2##3##(1993-12#1)(2009-2#1)
particularly useful for detecting##2##4##(2008-12#1)(2009-7#1)
particularly useful for studying the##2##5##(1991-8#1)(2008-9#1)
particularly useful for the##4##4##(1994-6#1)(1995-2#1)(1996-12#1)(2008-10#1)
particularly useful for##39##3##(1990-11#1)(1991-1#1)(1991-8#1)(1992-2#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#1)(2004-12#1)(2006-12#1)(2006-5#2)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#6)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2010-2#1)(2010-3#1)(2012-11#1)(2013-1#1)
particularly useful in the##2##4##(2008-3#1)(2008-8#1)
particularly useful in##19##3##(1991-1#1)(1992-8#1)(1997-1#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-9#1)(2010-3#1)(2010-6#1)(2011-2#1)
particularly useful to##8##3##(1993-3#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-12#2)
particularly useful when there is a##3##6##(2008-10#1)(2008-4#2)
particularly useful when##5##3##(2008-10#1)(2008-2#1)(2008-4#2)(2013-1#1)
particularly useful##86##2##(1990-11#1)(1991-1#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-6#1)(2004-12#1)(2006-12#1)(2006-5#2)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#11)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-2#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-3#2)(2010-6#1)(2011-2#2)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)
particularly valuable in##3##3##(2006-10#1)(2008-11#1)(2012-2#1)
particularly valuable##7##2##(2006-10#1)(2008-10#1)(2008-11#2)(2008-9#2)(2012-2#1)
particularly vulnerable to##8##3##(1991-1#1)(1995-12#1)(1995-3#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-12#1)(2010-9#1)
particularly vulnerable##11##2##(1991-1#1)(1995-12#1)(1995-3#1)(1996-9#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-12#1)(2010-9#1)(2011-2#1)(2013-1#1)
particularly well adapted##2##3##(2006-2#1)(2012-3#1)
particularly well suited for##5##4##(1993-11#1)(1997-6#1)(2008-3#1)(2008-4#2)
particularly well suited to##6##4##(1991-5#2)(2007-6#1)(2008-3#2)(2013-1#1)
particularly well suited##11##3##(1991-5#2)(1993-11#1)(1997-6#1)(2007-6#1)(2008-3#3)(2008-4#2)(2013-1#1)
particularly well##18##2##(1991-11#1)(1991-5#2)(1993-11#1)(1996-3#1)(1997-6#1)(2006-2#1)(2007-1#1)(2007-6#1)(2008-10#2)(2008-3#3)(2008-4#2)(2012-3#1)(2013-1#1)
particularly when it is##2##4##(2011-1#1)(2011-2#1)
particularly when it##4##3##(2006-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
particularly when the##5##3##(1996-8#1)(2008-10#2)(2008-3#1)(2011-1#1)
particularly when they are##2##4##(1996-2#1)(2013-1#1)
particularly when##45##2##(1992-1#1)(1992-12#1)(1994-3#1)(1995-6#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-1#1)(2005-9#1)(2006-10#2)(2006-4#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-11#1)(2011-1#4)(2011-10#1)(2011-2#2)(2012-8#1)(2013-1#6)
particularly where the##2##3##(2008-10#1)(2012-1#1)
particularly where##5##2##(1994-6#1)(2008-10#1)(2009-6#1)(2010-5#1)(2012-1#1)
particularly with bisphosphonates##2##3##(2010-3#2)
particularly with reference to##2##4##(2004-4#1)(2008-10#1)
particularly with regard to the##5##5##(1990-6#1)(2006-11#1)(2007-11#1)(2008-9#1)(2011-2#1)
particularly with regard to##13##4##(1990-6#1)(1991-1#1)(1995-1#1)(1996-8#1)(2006-11#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-9#2)(2011-2#1)
particularly with respect to the##2##5##(2007-12#1)(2008-10#1)
particularly with respect to##12##4##(1992-9#1)(1996-3#1)(1997-2#1)(2004-11#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-1#1)
particularly with the##3##3##(1993-11#1)(1994-12#1)(2009-11#1)
particularly with##56##2##(1990-12#1)(1990-6#1)(1991-1#1)(1991-3#1)(1992-9#1)(1993-11#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(2004-11#1)(2004-4#1)(2006-10#2)(2006-11#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-9#3)(2009-11#1)(2009-3#2)(2010-12#1)(2010-3#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
particularly within the##5##3##(1996-10#1)(1996-8#1)(2006-8#1)(2008-11#1)(2013-1#1)
particularly within##10##2##(1995-12#1)(1996-10#1)(1996-11#1)(1996-8#1)(2006-8#1)(2007-9#1)(2008-11#1)(2009-4#1)(2009-5#1)(2013-1#1)
particularly worrisome##2##2##(2008-2#1)(2008-8#1)
particularly##1931##1##(1990-1#1)(1990-10#3)(1990-11#4)(1990-12#10)(1990-2#6)(1990-3#4)(1990-4#6)(1990-5#7)(1990-6#7)(1990-8#1)(1990-9#2)(1991-1#7)(1991-10#6)(1991-11#5)(1991-12#7)(1991-2#1)(1991-3#7)(1991-4#6)(1991-5#8)(1991-6#2)(1991-7#3)(1991-8#7)(1991-9#5)(1992-1#6)(1992-10#2)(1992-11#6)(1992-12#4)(1992-2#5)(1992-3#7)(1992-4#5)(1992-5#5)(1992-6#5)(1992-7#1)(1992-8#8)(1992-9#4)(1993-1#1)(1993-10#4)(1993-11#4)(1993-12#9)(1993-2#1)(1993-3#17)(1993-4#1)(1993-5#3)(1993-6#4)(1993-7#1)(1993-8#3)(1993-9#2)(1994-1#2)(1994-11#4)(1994-12#8)(1994-2#3)(1994-3#6)(1994-4#2)(1994-5#4)(1994-6#8)(1994-7#1)(1994-8#6)(1994-9#3)(1995-1#5)(1995-10#2)(1995-11#6)(1995-12#11)(1995-2#6)(1995-3#10)(1995-5#5)(1995-6#3)(1995-8#5)(1995-9#7)(1996-1#4)(1996-10#1)(1996-11#4)(1996-12#8)(1996-2#8)(1996-3#5)(1996-4#3)(1996-5#7)(1996-6#4)(1996-7#4)(1996-8#11)(1996-9#3)(1997-1#6)(1997-2#4)(1997-3#12)(1997-4#4)(1997-5#4)(1997-6#5)(1997-7#10)(1997-8#7)(2004-11#7)(2004-12#1)(2004-2#3)(2004-3#2)(2004-4#4)(2004-9#1)(2005-10#4)(2005-11#9)(2005-12#3)(2005-5#5)(2005-7#7)(2005-8#18)(2005-9#4)(2006-1#3)(2006-10#68)(2006-11#8)(2006-12#13)(2006-2#16)(2006-3#5)(2006-4#7)(2006-5#10)(2006-6#8)(2006-7#7)(2006-8#16)(2006-9#4)(2007-1#10)(2007-10#15)(2007-11#27)(2007-12#40)(2007-2#15)(2007-3#9)(2007-4#9)(2007-5#6)(2007-6#8)(2007-7#19)(2007-8#27)(2007-9#17)(2008-1#30)(2008-10#106)(2008-11#47)(2008-12#22)(2008-2#33)(2008-3#42)(2008-4#62)(2008-5#48)(2008-6#11)(2008-7#38)(2008-8#32)(2008-9#34)(2009-1#5)(2009-10#16)(2009-11#5)(2009-12#6)(2009-2#3)(2009-3#10)(2009-4#15)(2009-5#14)(2009-6#13)(2009-7#10)(2009-8#12)(2009-9#11)(2010-1#3)(2010-10#7)(2010-11#5)(2010-12#24)(2010-2#9)(2010-3#9)(2010-4#11)(2010-5#9)(2010-6#5)(2010-7#4)(2010-8#8)(2010-9#12)(2011-1#29)(2011-10#1)(2011-12#7)(2011-2#54)(2011-3#1)(2012-1#17)(2012-11#7)(2012-12#35)(2012-2#50)(2012-3#30)(2012-6#1)(2012-8#1)(2013-1#59)(2013-7#4)(2013-8#25)
particulars##6##1##(1991-2#1)(1991-4#1)(1993-3#1)(1994-8#1)(2008-4#1)(2011-1#1)
particulary those##3##2##(2007-11#2)(2008-7#1)
particulary##5##1##(2007-11#3)(2008-7#1)(2009-2#1)
particulate PKC##2##2##(1993-8#1)(1997-4#1)
particulate and dissolved##3##3##(2008-2#1)(2008-3#1)(2009-11#1)
particulate and soluble fractions##2##4##(1997-2#1)(2005-8#1)
particulate and##6##2##(1996-12#1)(1997-2#1)(2005-8#1)(2008-2#1)(2008-3#1)(2009-11#1)
particulate by##2##2##(2008-11#1)(2012-2#1)
particulate cyclic##2##2##(1992-3#1)(1997-7#1)
particulate evidence##3##2##(2012-2#3)
particulate form##2##2##(1996-12#1)(2009-3#1)
particulate forms##2##2##(2013-1#2)
particulate fraction of rat spleen##2##5##(1993-7#2)
particulate fraction of##7##3##(1990-2#1)(1993-7#2)(1995-12#1)(1996-5#2)(1997-1#1)
particulate fraction##28##2##(1990-11#1)(1990-2#1)(1991-2#1)(1992-11#3)(1992-4#1)(1992-8#2)(1993-7#2)(1994-12#2)(1994-8#1)(1995-12#1)(1995-3#2)(1995-8#1)(1996-11#3)(1996-5#3)(1996-9#1)(1997-1#2)(1997-6#1)
particulate fractions of the##2##4##(1992-3#1)(1996-5#1)
particulate fractions of##4##3##(1992-3#2)(1996-4#1)(1996-5#1)
particulate fractions was##3##3##(1991-7#1)(1994-12#1)(1996-4#1)
particulate fractions##17##2##(1991-2#1)(1991-7#2)(1992-3#2)(1993-6#1)(1994-12#1)(1994-9#1)(1995-3#1)(1996-4#2)(1996-5#3)(1997-4#1)(2008-10#1)(2013-1#1)
particulate guanylate cyclase activity##2##4##(1994-9#2)
particulate guanylate cyclase##5##3##(1993-11#1)(1994-9#4)
particulate inoculum##3##2##(2008-10#3)
particulate matter (PM)##5##3##(2008-10#1)(2008-6#1)(2008-9#1)(2009-7#1)(2010-5#1)
particulate matter and 1649a##2##4##(2007-8#1)(2008-10#1)
particulate matter and daily mortality##2##5##(2010-12#2)
particulate matter and the##2##4##(2008-3#1)(2013-8#1)
particulate matter and##11##3##(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-12#2)(2013-1#1)(2013-8#1)
particulate matter collected##4##3##(2008-10#4)
particulate matter in the##2##4##(2008-10#1)(2009-6#1)
particulate matter in##4##3##(2008-10#2)(2008-3#1)(2009-6#1)
particulate matter is##5##3##(2007-12#1)(2008-10#3)(2008-3#1)
particulate matter less than 10##2##5##(2009-6#1)(2010-12#1)
particulate matter less than##3##4##(2009-6#1)(2010-12#1)(2010-2#1)
particulate matter of emissions and working areas##3##7##(2008-10#3)
particulate matter of emissions and##4##5##(2008-10#4)
particulate matter of##6##3##(2007-8#1)(2008-10#5)
particulate matter was##2##3##(2008-10#2)
particulate matter##81##2##(2006-11#1)(2006-12#1)(2007-12#4)(2007-8#6)(2008-10#42)(2008-11#2)(2008-12#1)(2008-3#5)(2008-6#3)(2008-9#3)(2009-6#3)(2009-7#1)(2010-12#3)(2010-2#1)(2010-5#2)(2013-1#2)(2013-8#1)
particulate organic##2##2##(2008-10#1)(2008-5#1)
particulate phase##4##2##(2009-11#3)(2010-4#1)
particulate samples##6##2##(2007-8#2)(2008-10#1)(2008-3#1)(2008-9#2)
particulate##236##1##(1990-11#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-7#3)(1992-11#4)(1992-3#4)(1992-4#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#3)(1994-12#3)(1994-5#1)(1994-8#2)(1994-9#6)(1995-12#1)(1995-3#5)(1995-5#2)(1995-8#1)(1996-11#3)(1996-12#2)(1996-3#1)(1996-4#2)(1996-5#7)(1996-9#1)(1997-1#4)(1997-2#1)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#1)(2004-4#1)(2005-11#2)(2005-8#1)(2006-11#1)(2006-12#1)(2006-2#1)(2007-12#6)(2007-8#10)(2008-10#56)(2008-11#3)(2008-12#1)(2008-2#10)(2008-3#16)(2008-4#1)(2008-5#2)(2008-6#4)(2008-9#5)(2009-11#4)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#3)(2009-7#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-5#2)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#5)(2013-8#1)
particulate-phase mercury##3##2##(2008-10#3)
particulates and##6##2##(1996-12#1)(2008-10#1)(2008-3#1)(2008-4#2)(2012-2#1)
particulates##23##1##(1993-3#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2010-2#1)(2010-8#1)(2012-2#1)
parties are##2##2##(1992-2#1)(2007-4#1)
parties in the##3##3##(1996-12#1)(2007-2#1)(2011-2#1)
parties in##4##2##(1994-5#1)(1996-12#1)(2007-2#1)(2011-2#1)
parties involved in the##2##4##(1994-12#1)(2007-11#1)
parties involved in##4##3##(1994-12#1)(2007-11#1)(2007-2#1)(2012-12#1)
parties involved##6##2##(1994-12#1)(2006-7#1)(2007-11#1)(2007-2#1)(2009-11#1)(2012-12#1)
parties that##2##2##(2007-4#1)(2010-12#1)
parties to the##2##3##(1990-2#1)(2011-1#1)
parties to##6##2##(1990-2#1)(2006-8#1)(2009-10#1)(2011-1#1)(2013-1#2)
parties##68##1##(1990-2#1)(1991-1#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-12#1)(1996-12#2)(1997-7#1)(2005-5#1)(2005-7#2)(2006-12#1)(2006-7#3)(2006-8#2)(2007-11#1)(2007-2#2)(2007-4#7)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-5#4)(2010-12#1)(2010-3#3)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#4)
parties'##3##1##(2007-4#1)(2008-8#1)(2009-4#1)
partir##5##1##(2008-5#4)(2013-1#1)
partisan##3##1##(1997-8#1)(2008-6#1)(2008-7#1)
partition and the##2##3##(1990-12#1)(2011-2#1)
partition and##3##2##(1990-12#1)(1990-3#1)(2011-2#1)
partition behavior##2##2##(2008-10#2)
partition chromatography and##2##3##(1994-12#1)(2008-10#1)
partition chromatography##5##2##(1994-12#4)(2008-10#1)
partition coefficient (K)##2##3##(2008-6#2)
partition coefficient (log P)##4##4##(1996-2#1)(2005-10#1)(2007-11#1)(2008-5#1)
partition coefficient between##2##3##(1990-4#1)(1996-1#1)
partition coefficient of##9##3##(1990-4#1)(1990-5#2)(2004-12#1)(2008-10#2)(2008-5#2)(2012-1#1)
partition coefficient##35##2##(1990-4#2)(1990-5#2)(1990-9#1)(1993-1#1)(1993-4#1)(1996-1#1)(1996-2#1)(2004-12#3)(2005-10#2)(2005-11#2)(2006-10#1)(2007-11#1)(2008-10#5)(2008-5#5)(2008-6#5)(2011-2#1)(2012-1#1)
partition coefficients for##5##3##(1992-6#1)(2008-10#2)(2010-8#2)
partition coefficients of the##2##4##(1990-5#1)(2008-10#1)
partition coefficients of##12##3##(1990-5#2)(2006-12#2)(2008-10#4)(2008-5#1)(2008-7#2)(2013-1#1)
partition coefficients##37##2##(1990-11#1)(1990-3#1)(1990-5#2)(1990-8#1)(1991-5#1)(1992-12#1)(1992-6#1)(1993-4#1)(1997-8#1)(2006-10#1)(2006-12#3)(2007-11#2)(2008-10#12)(2008-5#1)(2008-6#1)(2008-7#3)(2010-8#2)(2013-1#2)
partition equilibrium with##3##3##(1991-9#2)(1994-9#1)
partition equilibrium##4##2##(1990-11#1)(1991-9#2)(1994-9#1)
partition experiments##2##2##(1994-9#1)(2008-10#1)
partition from##2##2##(1993-4#1)(1995-12#1)
partition function of a##2##4##(2006-10#1)(2009-9#1)
partition function##6##2##(1990-8#1)(2006-10#1)(2009-11#1)(2009-9#2)(2011-1#1)
partition functions of ring##2##4##(2006-10#2)
partition functions##6##2##(1990-8#2)(2006-10#3)(2008-3#1)
partition into the##2##3##(2008-1#1)(2008-10#1)
partition into##3##2##(1993-7#1)(2008-1#1)(2008-10#1)
partition is##2##2##(2007-11#1)(2012-3#1)
partition of the##3##3##(1990-11#1)(1994-12#1)(1997-1#1)
partition of##10##2##(1990-11#1)(1992-7#1)(1994-12#2)(1997-1#1)(1997-7#1)(2006-5#1)(2008-11#1)(2008-2#1)(2010-5#1)
partition ratio##3##2##(1991-5#1)(1993-8#1)(2009-9#1)
partition the##3##2##(1991-7#1)(1992-6#1)(2008-8#1)
partition with##3##2##(1995-8#1)(2005-12#1)(2008-2#1)
partition##167##1##(1990-11#3)(1990-12#1)(1990-3#3)(1990-4#3)(1990-5#4)(1990-8#4)(1990-9#1)(1991-5#2)(1991-7#1)(1991-9#2)(1992-12#1)(1992-6#2)(1992-7#1)(1993-1#1)(1993-4#3)(1993-7#1)(1993-8#1)(1994-12#7)(1994-5#2)(1994-9#2)(1995-11#1)(1995-12#4)(1995-8#2)(1996-1#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-4#4)(1997-7#1)(1997-8#1)(2004-12#3)(2005-10#2)(2005-11#2)(2005-12#1)(2006-10#6)(2006-11#1)(2006-12#3)(2006-5#1)(2007-11#7)(2007-3#1)(2008-1#1)(2008-10#30)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#10)(2008-7#4)(2008-8#2)(2009-11#1)(2009-5#1)(2009-9#3)(2010-10#1)(2010-2#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-3#2)(2013-1#2)
partition-diffusion##2##1##(1996-11#2)
partitioned between##2##2##(2006-12#1)(2008-10#1)
partitioned in##3##2##(1992-11#1)(2008-7#1)(2011-2#1)
partitioned into the##2##3##(1991-1#1)(1994-5#1)
partitioned into##8##2##(1991-1#1)(1992-7#1)(1994-5#1)(2005-10#1)(2006-10#1)(2007-11#1)(2008-2#1)(2008-8#1)
partitioned preferentially into##2##3##(1990-4#2)
partitioned##30##1##(1990-3#1)(1990-4#2)(1991-1#1)(1991-5#1)(1992-11#1)(1992-7#1)(1994-5#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2010-4#1)(2010-5#1)(2011-2#2)
partitioning analysis##5##2##(1991-12#4)(2008-3#1)
partitioning and##3##2##(2010-2#3)
partitioning as##2##2##(2008-10#2)
partitioning at##2##2##(1992-6#1)(2008-5#1)
partitioning behavior##2##2##(1993-8#1)(2008-7#1)
partitioning between the##2##3##(1994-5#1)(1997-2#1)
partitioning between##12##2##(1991-3#2)(1992-6#1)(1993-8#2)(1994-5#1)(1995-3#1)(1995-4#1)(1997-2#1)(2008-10#2)(2008-8#1)
partitioning demonstrated##2##2##(1996-2#1)(2008-10#1)
partitioning effects##2##2##(1990-5#1)(2008-11#1)
partitioning in hierarchical##3##3##(2008-2#3)
partitioning in##8##2##(1993-6#1)(2008-10#1)(2008-2#3)(2010-12#1)(2010-8#1)(2012-9#1)
partitioning into##4##2##(1992-12#1)(1992-2#1)(2006-9#1)(2008-10#1)
partitioning is##4##2##(2005-11#1)(2006-10#1)(2008-3#1)(2008-5#1)
partitioning mechanism##3##2##(1990-3#2)(2008-10#1)
partitioning method##2##2##(2006-2#1)(2008-5#1)
partitioning methods##3##2##(1995-2#1)(2007-8#2)
partitioning model##2##2##(2013-1#2)
partitioning of failure time##2##4##(1997-3#2)
partitioning of the##14##3##(1992-12#1)(1992-6#2)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-9#1)(2009-8#1)(2011-1#1)
partitioning of##44##2##(1990-4#1)(1991-3#1)(1991-7#1)(1992-12#2)(1992-6#2)(1993-6#1)(1993-9#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-3#2)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#5)(2008-9#2)(2009-8#1)(2010-6#1)(2011-1#1)(2012-2#1)
partitioning the##2##2##(2008-5#1)(2009-9#1)
partitioning were##2##2##(1990-5#1)(1992-12#1)
partitioning##153##1##(1990-3#2)(1990-4#1)(1990-5#4)(1991-10#1)(1991-12#5)(1991-3#3)(1991-7#2)(1992-11#1)(1992-12#5)(1992-2#2)(1992-6#5)(1992-9#1)(1993-6#4)(1993-8#6)(1993-9#1)(1994-12#1)(1994-5#3)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#1)(1996-10#1)(1996-2#2)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#1)(2005-11#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-8#6)(2008-1#1)(2008-10#22)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#4)(2008-5#5)(2008-6#5)(2008-7#2)(2008-8#8)(2008-9#3)(2009-8#1)(2009-9#2)(2010-12#1)(2010-2#3)(2010-6#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-9#1)(2013-1#2)(2013-8#1)
partitions have##2##2##(1990-3#1)(2008-1#1)
partitions into the##2##3##(1994-8#1)(2008-5#1)
partitions into##3##2##(1990-2#1)(1994-8#1)(2008-5#1)
partitions##16##1##(1990-2#1)(1990-3#1)(1994-11#1)(1994-8#1)(1995-10#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-8#2)(2009-9#1)(2010-2#1)(2011-1#1)(2012-3#1)
partitus##4##1##(2007-5#4)
partly a##2##2##(1996-5#1)(2007-8#1)
partly abolished##2##2##(1995-8#1)(2011-1#1)
partly as a result of##2##5##(2004-4#1)(2006-7#1)
partly as a##4##3##(1992-7#1)(2004-4#1)(2006-7#1)(2008-7#1)
partly as##9##2##(1990-6#1)(1992-4#2)(1992-7#1)(1995-11#1)(1997-8#1)(2004-4#1)(2006-7#1)(2008-7#1)
partly attributable to the##2##4##(1996-5#1)(2008-1#1)
partly based on##3##3##(1996-12#1)(2008-1#1)(2012-10#1)
partly be explained by the##2##5##(1990-4#1)(2006-8#1)
partly be explained##3##3##(1990-4#1)(2006-8#1)(2007-12#1)
partly because of the##6##4##(1990-9#1)(1992-2#2)(2005-8#1)(2008-7#1)(2010-12#1)
partly because of##10##3##(1990-9#1)(1992-10#1)(1992-2#2)(2005-8#1)(2008-6#1)(2008-7#1)(2010-12#1)(2012-12#2)
partly because the##2##3##(1992-3#1)(1995-11#1)
partly because they##2##3##(2006-2#1)(2009-9#1)
partly because##19##2##(1990-9#1)(1992-10#1)(1992-2#2)(1992-3#1)(1995-11#1)(2005-8#1)(2006-2#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)(2012-12#3)(2012-2#1)
partly by the##4##3##(1990-2#1)(2005-11#1)(2008-7#1)(2012-12#1)
partly by##13##2##(1990-2#1)(1990-4#1)(1991-3#1)(1991-9#1)(1993-12#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#2)
partly dependent on the##3##4##(1992-3#1)(2008-10#1)(2013-8#1)
partly dependent on##7##3##(1992-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-6#1)(2010-5#1)(2013-8#1)
partly depends on##2##3##(2008-11#1)(2008-5#1)
partly determined by the##2##4##(2006-10#1)(2007-9#1)
partly determined##3##2##(2006-10#1)(2007-9#1)(2008-2#1)
partly due to a##3##4##(2009-5#1)(2010-12#1)(2013-8#1)
partly due to the##11##4##(1990-6#1)(1991-11#1)(1995-12#1)(1996-5#1)(1997-2#1)(1997-7#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
partly due to##30##3##(1990-6#1)(1991-11#1)(1991-12#1)(1992-12#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-5#1)(1997-2#2)(1997-7#3)(2006-10#2)(2007-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-8#1)(2009-5#1)(2010-12#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
partly explain the##6##3##(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2012-2#1)
partly explain##10##2##(2006-10#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2012-2#1)(2012-3#1)
partly explained by an increase in##2##6##(1990-12#1)(1990-2#1)
partly explained by the##4##4##(2006-11#1)(2010-12#1)(2010-8#1)(2012-3#1)
partly explained by##11##3##(1990-12#1)(1990-2#1)(1992-1#1)(1992-6#1)(2006-11#1)(2006-8#1)(2008-11#1)(2010-12#1)(2010-8#1)(2012-1#1)(2012-3#1)
partly folded apomyoglobin intermediate##3##4##(1990-9#2)(1991-4#1)
partly folded states##2##3##(1990-9#1)(1995-4#1)
partly folded##8##2##(1990-9#4)(1991-4#2)(1995-4#2)
partly for##2##2##(1993-5#1)(1997-5#1)
partly free##2##2##(2007-12#2)
partly helical##2##2##(1991-4#2)
partly in##3##2##(1991-8#1)(2008-4#1)(2012-12#1)
partly inconsistent##2##2##(2006-10#1)(2008-11#1)
partly inhibited the##2##3##(1993-11#1)(1994-3#1)
partly inhibited##4##2##(1990-7#1)(1991-2#1)(1993-11#1)(1994-3#1)
partly involved in##3##3##(1991-7#1)(1996-11#1)(2008-10#1)
partly mediated by##4##3##(1991-7#1)(1993-1#1)(1996-2#1)(2013-8#1)
partly mediated##5##2##(1991-7#1)(1993-1#1)(1996-2#1)(2008-1#1)(2013-8#1)
partly on the basis of##2##5##(1993-9#1)(1995-5#1)
partly on the##4##3##(1993-9#1)(1994-2#1)(1995-5#1)(2009-9#1)
partly on##7##2##(1993-2#1)(1993-9#1)(1994-2#1)(1995-5#1)(2008-5#1)(2009-9#1)(2010-12#1)
partly or##2##2##(1993-7#1)(1995-3#1)
partly preventable##2##2##(2008-7#2)
partly recovered##2##2##(1996-12#1)(1997-7#1)
partly related to##4##3##(2008-1#1)(2008-10#1)(2008-6#1)(2013-8#1)
partly responsible for##6##3##(1991-1#1)(1991-9#1)(2006-7#1)(2008-7#1)(2010-7#1)(2012-1#1)
partly restored##3##2##(1992-8#1)(1994-10#1)(2008-10#1)
partly results from##2##3##(1995-10#1)(2012-2#1)
partly the##2##2##(1995-8#1)(2007-8#1)
partly through##3##2##(1990-9#1)(2008-11#1)(2013-7#1)
partly to the##5##3##(1990-5#1)(2005-11#1)(2008-10#1)(2010-8#1)(2012-2#1)
partly to##9##2##(1990-5#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-8#1)(2012-2#1)
partly understood##3##2##(1997-6#1)(2006-10#1)(2011-12#1)
partly with##4##2##(1995-8#1)(2005-11#1)(2011-2#1)(2012-3#1)
partly##318##1##(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#3)(1990-5#1)(1990-6#2)(1990-7#3)(1990-9#7)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#3)(1991-4#5)(1991-7#3)(1991-8#1)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#3)(1992-4#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-7#1)(1993-9#2)(1994-10#2)(1994-12#3)(1994-2#2)(1994-3#3)(1994-8#3)(1995-10#1)(1995-11#2)(1995-12#2)(1995-3#3)(1995-4#2)(1995-5#2)(1995-8#3)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#5)(1997-1#1)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#6)(1997-8#3)(2004-4#1)(2005-10#1)(2005-11#5)(2005-6#1)(2005-8#1)(2006-1#1)(2006-10#7)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#2)(2006-8#5)(2007-1#2)(2007-11#5)(2007-12#6)(2007-2#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#4)(2008-10#19)(2008-11#12)(2008-2#2)(2008-3#6)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#8)(2008-8#6)(2008-9#1)(2009-10#2)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-12#6)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-12#1)(2011-2#5)(2012-1#3)(2012-10#1)(2012-12#5)(2012-2#8)(2012-3#5)(2012-5#1)(2013-1#4)(2013-7#1)(2013-8#5)
partner abuse##2##2##(1993-12#1)(1997-2#1)
partner and##11##2##(1992-7#1)(1994-12#1)(1994-5#1)(1995-6#1)(2009-12#1)(2009-7#1)(2010-12#1)(2012-12#2)(2012-2#1)(2012-3#1)
partner as##2##2##(1992-9#1)(1994-9#1)
partner benefits##2##2##(1997-3#1)(2008-12#1)
partner during##3##2##(2007-8#1)(2010-9#1)(2012-3#1)
partner for the##3##3##(1995-12#1)(2010-2#1)(2013-1#1)
partner has##2##2##(2007-4#1)(2007-7#1)
partner in the##4##3##(2005-7#1)(2007-12#1)(2007-9#1)(2008-1#1)
partner in##10##2##(1991-11#1)(1993-2#1)(1996-1#1)(2005-7#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-5#1)(2009-4#1)
partner is##6##2##(1995-12#1)(2007-12#1)(2007-2#1)(2008-6#1)(2008-7#1)(2008-8#1)
partner of##2##2##(1990-6#1)(1994-5#1)
partner on##2##2##(2010-12#1)(2012-3#1)
partner or##3##2##(2007-12#1)(2011-1#1)(2012-3#1)
partner selection in##2##3##(1990-11#1)(2009-5#1)
partner selection##6##2##(1990-11#1)(2009-5#4)(2013-8#1)
partner status##2##2##(2010-2#2)
partner study##2##2##(1995-6#2)
partner to##7##2##(1991-12#1)(1992-9#2)(2009-5#2)(2011-2#1)(2012-12#1)
partner violence and##4##3##(2008-12#1)(2008-4#1)(2008-6#1)(2012-1#1)
partner violence##28##2##(2008-12#3)(2008-4#4)(2008-6#1)(2009-5#3)(2010-11#2)(2010-2#2)(2010-3#1)(2010-4#2)(2011-1#1)(2012-1#1)(2012-12#4)(2012-3#2)(2013-1#1)(2013-7#1)
partner was##5##2##(2006-10#1)(2009-4#2)(2010-4#1)(2010-5#1)
partner were##3##2##(1993-3#1)(2012-3#1)(2013-7#1)
partner with##6##2##(1995-3#1)(2005-11#1)(2010-10#1)(2012-12#1)(2012-2#2)
partner##246##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-12#1)(1992-12#2)(1992-3#1)(1992-7#1)(1992-9#5)(1993-12#2)(1993-2#1)(1993-3#2)(1993-9#1)(1994-12#2)(1994-5#2)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#6)(1995-2#1)(1995-3#1)(1995-6#4)(1995-8#1)(1996-1#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2004-12#1)(2005-11#1)(2005-7#4)(2006-10#2)(2006-12#1)(2006-2#2)(2006-7#1)(2006-9#1)(2007-1#2)(2007-11#1)(2007-12#9)(2007-2#2)(2007-4#1)(2007-7#7)(2007-8#2)(2007-9#1)(2008-1#1)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#8)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#5)(2008-9#3)(2009-10#1)(2009-12#2)(2009-4#4)(2009-5#11)(2009-7#2)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#8)(2010-3#1)(2010-4#4)(2010-5#6)(2010-9#3)(2011-1#5)(2011-2#7)(2011-3#1)(2012-1#2)(2012-12#12)(2012-2#9)(2012-3#23)(2013-1#3)(2013-7#2)(2013-8#3)
partner's feeding method##4##3##(2007-10#4)
partner's support##2##2##(1995-1#2)
partner's##23##1##(1992-9#1)(1995-1#2)(1995-12#1)(2006-9#2)(2007-10#4)(2007-11#1)(2007-12#1)(2007-3#1)(2008-12#1)(2008-3#1)(2008-8#2)(2009-6#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
partner(s)##4##1##(1990-6#1)(1996-2#2)(2013-1#1)
partner)##2##1##(2008-12#2)
partnered gay men##2##3##(2010-8#2)
partnered men##2##2##(2010-8#2)
partnered research##2##2##(2012-2#2)
partnered with the##2##3##(2006-11#1)(2012-3#1)
partnered with##3##2##(2006-11#1)(2008-11#1)(2012-3#1)
partnered##11##1##(2006-11#1)(2008-11#1)(2010-8#4)(2012-2#4)(2012-3#1)
partnering with##2##2##(2010-11#1)(2012-2#1)
partnering##7##1##(1994-12#1)(1996-9#1)(2008-11#1)(2010-11#1)(2010-12#1)(2012-12#1)(2012-2#1)
partners about##2##2##(2008-7#1)(2009-6#1)
partners and not##2##3##(2011-1#1)(2012-3#1)
partners and their##4##3##(2005-7#1)(2007-2#1)(2009-4#1)(2012-2#1)
partners and##34##2##(1995-12#1)(1995-2#1)(1997-3#3)(1997-4#1)(2005-7#1)(2006-4#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#2)(2009-4#7)(2010-10#1)(2010-5#1)(2011-1#3)(2012-12#3)(2012-2#3)(2012-3#2)
partners are more##2##3##(2009-5#1)(2009-7#1)
partners are##9##2##(2007-5#1)(2008-9#2)(2009-4#2)(2009-5#1)(2009-7#1)(2011-1#1)(2012-3#1)
partners as##4##2##(1993-6#1)(2005-7#1)(2007-12#1)(2010-5#1)
partners at##3##2##(2009-5#1)(2009-7#1)(2013-1#1)
partners can##2##2##(2008-11#1)(2012-3#1)
partners for##3##2##(1994-5#1)(1995-12#1)(2005-8#1)
partners from##3##2##(2008-12#2)(2010-7#1)
partners has##2##2##(2008-8#1)(2013-1#1)
partners have##3##2##(1997-6#1)(2008-10#2)
partners in a##3##3##(1993-3#1)(2008-9#1)(2011-2#1)
partners in care##2##3##(1992-3#1)(2008-11#1)
partners in health care##2##4##(1991-3#1)(1992-12#1)
partners in the past 30 days##3##6##(2011-12#2)(2013-1#1)
partners in the past##6##4##(2007-12#1)(2011-12#2)(2012-1#1)(2012-12#1)(2013-1#1)
partners in the research##2##4##(2007-1#1)(2009-4#1)
partners in the same##2##4##(2008-4#1)(2012-12#1)
partners in the##18##3##(1990-2#1)(1991-3#1)(1997-3#1)(2007-1#1)(2007-12#1)(2007-3#1)(2008-12#1)(2008-4#1)(2009-4#1)(2010-5#1)(2011-1#1)(2011-12#2)(2012-1#1)(2012-12#2)(2013-1#2)
partners in##41##2##(1990-2#1)(1991-3#2)(1992-12#1)(1992-3#2)(1993-3#2)(1994-12#1)(1995-12#1)(1996-1#1)(1997-3#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#4)
partners is##2##2##(2007-12#1)(2011-1#1)
partners may##2##2##(2009-5#1)(2010-4#1)
partners of HIV positive pregnant women##2##6##(2007-12#2)
partners of HIV positive##3##4##(2007-12#3)
partners of HIV##5##3##(2007-12#5)
partners of infertile##2##3##(2008-12#1)(2013-8#1)
partners of##22##2##(1991-2#2)(1992-2#1)(2004-8#1)(2006-10#1)(2007-10#1)(2007-12#6)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-9#1)(2012-2#1)(2012-3#2)(2013-8#1)
partners or##3##2##(2009-5#1)(2011-2#1)(2013-1#1)
partners reported by##2##3##(1993-9#2)
partners reported##3##2##(1993-9#2)(2008-12#1)
partners should be##3##3##(1995-12#1)(2008-7#1)(2009-6#1)
partners that##2##2##(1996-1#1)(2006-11#1)
partners to##6##2##(1996-1#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#2)
partners was low##2##3##(2012-3#2)
partners was##9##2##(1995-2#2)(2007-12#1)(2008-1#1)(2008-12#1)(2011-2#1)(2012-3#3)
partners were##10##2##(2006-10#1)(2007-12#3)(2008-6#1)(2009-5#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-1#1)
partners who##5##2##(1994-2#1)(2008-12#1)(2009-4#1)(2009-5#1)(2010-2#1)
partners with##6##2##(1997-3#1)(2005-9#1)(2007-4#1)(2008-6#1)(2009-7#1)(2012-3#1)
partners within the##2##3##(2008-3#1)(2008-4#1)
partners##382##1##(1990-11#2)(1990-2#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-2#3)(1991-3#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#3)(1994-12#2)(1994-2#1)(1994-5#3)(1995-11#1)(1995-12#6)(1995-2#6)(1995-3#1)(1995-6#1)(1996-1#7)(1996-11#3)(1996-12#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-3#6)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(2004-8#1)(2005-10#2)(2005-5#2)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-4#2)(2006-6#1)(2006-8#4)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#16)(2007-2#4)(2007-3#3)(2007-4#2)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#5)(2008-10#5)(2008-11#5)(2008-12#10)(2008-2#3)(2008-3#1)(2008-4#5)(2008-5#2)(2008-6#7)(2008-7#4)(2008-8#11)(2008-9#5)(2009-10#1)(2009-3#1)(2009-4#20)(2009-5#14)(2009-6#4)(2009-7#7)(2009-8#5)(2009-9#5)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#4)(2010-4#3)(2010-5#6)(2010-7#1)(2010-9#3)(2011-1#15)(2011-12#3)(2011-2#17)(2012-1#3)(2012-11#3)(2012-12#9)(2012-2#5)(2012-3#36)(2013-1#16)(2013-8#2)
partners' positive feedback##2##3##(2009-9#2)
partners'##12##1##(1996-1#1)(1997-7#1)(2006-7#1)(2007-11#1)(2009-5#1)(2009-7#1)(2009-9#3)(2010-9#1)(2012-3#2)
partners)##4##1##(1991-6#1)(2004-12#1)(2011-2#2)
partnership and##4##2##(1994-1#1)(1996-12#1)(2008-11#1)(2010-8#1)
partnership between the##6##3##(1992-12#1)(1995-3#1)(1996-3#1)(2007-10#1)(2007-11#1)(2010-5#1)
partnership between##15##2##(1992-12#1)(1994-1#1)(1995-3#1)(1996-3#2)(1997-2#1)(2007-10#1)(2007-11#1)(2008-9#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#2)
partnership factors##3##2##(2009-5#3)
partnership for##4##2##(1995-3#1)(2008-12#1)(2008-2#1)(2012-2#1)
partnership has##3##2##(1992-1#1)(2008-11#1)(2009-11#1)
partnership in the##2##3##(2008-11#1)(2012-12#1)
partnership in##5##2##(1992-1#1)(2006-10#1)(2008-11#2)(2012-12#1)
partnership is##2##2##(1992-1#1)(2008-2#1)
partnership model for##2##3##(2008-12#2)
partnership model##4##2##(2008-1#1)(2008-12#3)
partnership models##3##2##(1994-1#1)(2008-11#2)
partnership of##2##2##(1994-12#1)(2010-4#1)
partnership that has##2##3##(1996-12#1)(2008-11#1)
partnership that##4##2##(1996-12#1)(2008-11#1)(2010-10#1)(2012-2#1)
partnership to address##2##3##(2006-5#1)(2013-7#1)
partnership to##4##2##(1996-2#1)(2006-5#1)(2008-11#1)(2013-7#1)
partnership with the##9##3##(1997-3#1)(2005-12#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-12#2)
partnership with##24##2##(1992-1#1)(1993-1#1)(1993-12#1)(1993-2#1)(1995-12#1)(1997-3#1)(2005-12#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#3)(2008-5#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-12#1)
partnership##127##1##(1990-12#1)(1991-3#1)(1992-1#7)(1992-12#1)(1992-3#2)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#2)(1994-1#4)(1994-12#3)(1995-12#1)(1995-3#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-7#1)(1997-2#4)(1997-3#2)(2005-10#1)(2005-12#1)(2006-10#4)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#4)(2008-10#1)(2008-11#15)(2008-12#8)(2008-2#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-11#1)(2009-4#4)(2009-5#4)(2009-8#2)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#2)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#2)
partnerships and##9##2##(1996-2#1)(2005-8#1)(2008-11#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
partnerships are##4##2##(1995-1#1)(2008-3#1)(2009-11#1)(2012-2#1)
partnerships between##3##2##(1997-2#1)(2009-4#1)(2012-11#1)
partnerships for##3##2##(1996-12#1)(1996-3#1)(1997-1#1)
partnerships in##6##2##(2006-12#1)(2008-2#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
partnerships to facilitate##2##3##(2008-1#1)(2012-11#1)
partnerships to##5##2##(2007-2#1)(2007-5#1)(2008-1#1)(2008-8#1)(2012-11#1)
partnerships with##7##2##(1996-12#2)(1997-2#1)(1997-3#2)(2006-2#1)(2012-12#1)
partnerships##89##1##(1992-11#1)(1992-12#1)(1992-3#1)(1994-2#1)(1995-1#2)(1995-2#1)(1995-3#2)(1996-12#4)(1996-2#3)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#4)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-8#2)(2009-11#1)(2009-4#5)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#5)(2011-1#2)(2011-2#11)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#4)(2012-3#8)(2013-1#2)
partogram##6##1##(1992-5#5)(2010-7#1)
partons##2##1##(1993-3#1)(1993-8#1)
partridge##3##1##(2008-5#3)
parts and in##2##3##(2008-10#1)(2008-12#1)
parts and##21##2##(1996-11#2)(2004-4#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
parts are##6##2##(1990-12#1)(2006-2#1)(2007-10#1)(2007-12#1)(2008-11#1)(2010-4#1)
parts at##2##2##(2008-10#1)(2009-8#1)
parts by##3##2##(1991-11#1)(2007-1#1)(2008-10#1)
parts for##2##2##(2008-3#1)(2008-9#1)
parts have different##2##3##(2008-3#1)(2008-5#1)
parts have##4##2##(2006-11#1)(2008-3#1)(2008-5#1)(2008-9#1)
parts in 10(12) (ppt)##2##4##(2007-12#1)(2008-3#1)
parts in 10(6) by volume##3##5##(2007-12#2)(2008-2#1)
parts in 10(6) for##4##4##(2008-2#2)(2008-3#2)
parts in 10(6) was##2##4##(2007-12#1)(2008-3#1)
parts in 10(6)##13##3##(2007-11#1)(2007-12#3)(2008-2#4)(2008-3#5)
parts in 10(9) (ppb)##2##4##(2008-2#1)(2008-3#1)
parts in 10(9) by volume##2##5##(2007-12#2)
parts in 10(9) by##3##4##(2007-12#2)(2008-3#1)
parts in 10(9)##8##3##(2007-12#2)(2008-2#1)(2008-3#5)
parts in one##2##3##(1993-3#1)(2008-2#1)
parts in the##2##3##(1995-11#1)(2007-12#1)
parts in##43##2##(1990-3#1)(1991-11#1)(1993-3#1)(1995-11#1)(1997-8#1)(2007-11#2)(2007-12#12)(2008-11#1)(2008-2#6)(2008-3#14)(2008-7#1)(2008-9#1)(2012-2#1)
parts is##4##2##(1994-8#1)(2007-11#1)(2008-2#1)(2008-3#1)
parts must be##2##3##(1991-3#1)(2008-8#1)
parts of Africa##5##3##(1991-11#1)(2007-12#2)(2007-6#1)(2008-9#1)
parts of Asia##4##3##(1992-2#1)(2006-10#1)(2008-9#1)(2013-1#1)
parts of Brazil##4##3##(2006-4#1)(2008-9#2)(2013-1#1)
parts of Canada##2##3##(2007-12#1)(2008-10#1)
parts of China and##2##4##(2010-3#1)(2011-1#1)
parts of China##4##3##(2010-3#1)(2011-1#3)
parts of Europe##8##3##(2004-4#1)(2005-8#1)(2006-10#1)(2007-2#1)(2008-10#1)(2011-2#1)(2012-1#1)(2013-8#1)
parts of India##2##3##(2009-6#1)(2013-1#1)
parts of PNG##2##3##(2006-2#2)
parts of Saudi Arabia##2##4##(2007-2#2)
parts of a##5##3##(1992-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#1)
parts of all##2##3##(1991-2#1)(1992-8#1)
parts of an##2##3##(2008-2#1)(2012-2#1)
parts of epididymis##2##3##(2008-12#2)
parts of the array##2##4##(2007-8#1)(2009-10#1)
parts of the body##8##4##(1992-6#1)(1997-8#1)(2006-8#1)(2007-11#1)(2007-7#2)(2007-8#1)(2011-2#1)
parts of the brain##5##4##(1990-5#1)(1994-10#1)(1997-7#1)(2008-7#1)(2009-10#1)
parts of the cell cycle##2##5##(1996-4#1)(2004-9#1)
parts of the country##5##4##(1993-12#1)(2007-8#1)(2008-1#1)(2011-1#1)(2011-11#1)
parts of the dielectric##2##4##(2008-2#1)(2008-3#1)
parts of the environment##2##4##(2008-9#1)(2010-5#1)
parts of the female##2##4##(2008-5#1)(2009-2#1)
parts of the gastrointestinal tract##3##5##(2008-6#1)(2008-7#1)(2012-1#1)
parts of the human##2##4##(2005-11#1)(2008-11#1)
parts of the molecule##6##4##(1990-2#1)(1992-12#1)(1994-11#1)(1994-3#1)(1995-11#1)(2008-10#1)
parts of the nervous system##2##5##(1993-6#1)(2008-8#1)
parts of the object##2##4##(2008-3#1)(2012-2#1)
parts of the plant##8##4##(1994-3#2)(2007-11#1)(2008-1#1)(2008-10#4)
parts of the plants##2##4##(2007-1#1)(2008-10#1)
parts of the rat brain##2##5##(1994-5#1)(2005-8#1)
parts of the western##2##4##(1990-2#1)(2006-10#1)
parts of the world (e##2##5##(1997-4#1)(2011-2#1)
parts of the world and##2##5##(2005-11#1)(2012-2#1)
parts of the world to##2##5##(2010-9#1)(2012-12#1)
parts of the world##39##4##(1990-2#1)(1995-4#1)(1997-4#1)(1997-6#1)(2005-11#1)(2005-7#3)(2005-8#1)(2006-10#1)(2006-2#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#2)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
parts of the##261##3##(1990-11#1)(1990-12#2)(1990-2#3)(1990-5#1)(1990-6#1)(1990-7#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-3#4)(1994-4#1)(1994-5#2)(1994-9#1)(1995-11#3)(1995-12#4)(1995-2#1)(1995-3#3)(1995-4#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-4#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#1)(2004-9#2)(2005-11#5)(2005-7#3)(2005-8#2)(2006-10#3)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-11#6)(2007-12#10)(2007-2#2)(2007-3#1)(2007-5#3)(2007-7#5)(2007-8#3)(2007-9#3)(2008-1#3)(2008-10#19)(2008-11#14)(2008-12#4)(2008-2#14)(2008-3#10)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#6)(2009-10#3)(2009-2#2)(2009-4#2)(2009-6#2)(2009-9#1)(2010-12#1)(2010-3#2)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-11#1)(2011-12#1)(2011-2#10)(2012-1#3)(2012-12#1)(2012-2#8)(2012-3#1)(2013-1#4)(2013-8#1)
parts of their##4##3##(2007-3#2)(2008-7#1)(2008-9#1)
parts of this##6##3##(1995-11#1)(1996-1#1)(2007-12#1)(2007-3#1)(2008-10#1)(2011-2#1)
parts of##427##2##(1990-11#1)(1990-12#2)(1990-2#4)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#3)(1992-9#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-3#4)(1994-4#1)(1994-5#2)(1994-9#3)(1995-11#4)(1995-12#5)(1995-2#1)(1995-3#3)(1995-4#2)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#4)(1997-7#2)(1997-8#1)(2004-4#1)(2004-9#2)(2005-11#7)(2005-7#3)(2005-8#4)(2006-10#7)(2006-11#1)(2006-12#3)(2006-2#4)(2006-4#3)(2006-5#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-1#18)(2007-11#9)(2007-12#18)(2007-2#6)(2007-3#5)(2007-5#3)(2007-6#1)(2007-7#5)(2007-8#6)(2007-9#4)(2008-1#3)(2008-10#29)(2008-11#16)(2008-12#8)(2008-2#17)(2008-3#11)(2008-4#3)(2008-5#8)(2008-6#2)(2008-7#9)(2008-8#3)(2008-9#13)(2009-10#4)(2009-2#2)(2009-4#3)(2009-6#3)(2009-9#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#10)(2011-11#1)(2011-12#1)(2011-2#15)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#3)(2012-2#13)(2012-3#2)(2013-1#14)(2013-7#1)(2013-8#3)
parts per billion (ppb)##4##4##(2008-2#1)(2008-3#1)(2008-5#1)(2013-8#1)
parts per billion in##2##4##(2008-2#1)(2008-3#1)
parts per billion##9##3##(2007-8#1)(2008-2#2)(2008-3#4)(2008-5#1)(2013-8#1)
parts per million (ppm)##4##4##(2008-3#2)(2011-12#1)(2013-7#1)
parts per million##16##3##(1994-7#3)(2008-10#1)(2008-2#2)(2008-3#6)(2008-5#1)(2008-7#1)(2011-12#1)(2013-7#1)
parts per trillion##4##3##(1996-5#1)(2008-10#3)
parts per##32##2##(1994-7#3)(1996-5#1)(2007-8#1)(2008-10#4)(2008-2#5)(2008-3#11)(2008-5#2)(2008-7#1)(2011-1#1)(2011-12#1)(2013-7#1)(2013-8#1)
parts that##4##2##(2007-11#1)(2007-8#1)(2007-9#1)(2008-12#1)
parts to##5##2##(2007-12#1)(2008-11#2)(2010-1#1)(2010-9#1)
parts using##2##2##(2008-11#1)(2008-6#1)
parts was##4##2##(2006-11#1)(2008-10#1)(2008-4#1)(2012-1#1)
parts were##4##2##(1991-11#1)(2008-12#1)(2009-4#1)(2011-2#1)
parts with##3##2##(2004-9#1)(2008-10#1)(2012-2#1)
parts##734##1##(1990-11#2)(1990-12#3)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#1)(1991-11#6)(1991-12#2)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-6#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#3)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-3#4)(1994-4#1)(1994-5#2)(1994-6#1)(1994-7#3)(1994-8#1)(1994-9#3)(1995-11#5)(1995-12#5)(1995-2#1)(1995-3#3)(1995-4#2)(1995-6#1)(1995-7#2)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#4)(1996-2#2)(1996-3#4)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-5#2)(1997-6#6)(1997-7#3)(1997-8#5)(2004-4#2)(2004-9#3)(2005-11#10)(2005-7#3)(2005-8#4)(2005-9#1)(2006-10#7)(2006-11#3)(2006-12#5)(2006-2#6)(2006-3#1)(2006-4#4)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#22)(2007-10#1)(2007-11#14)(2007-12#40)(2007-2#6)(2007-3#12)(2007-4#2)(2007-5#4)(2007-6#1)(2007-7#6)(2007-8#11)(2007-9#7)(2008-1#5)(2008-10#57)(2008-11#31)(2008-12#15)(2008-2#37)(2008-3#46)(2008-4#7)(2008-5#16)(2008-6#5)(2008-7#12)(2008-8#5)(2008-9#17)(2009-10#5)(2009-2#2)(2009-3#2)(2009-4#6)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#4)(2010-1#2)(2010-11#2)(2010-12#4)(2010-2#2)(2010-3#4)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#5)(2010-8#3)(2010-9#2)(2011-1#13)(2011-11#1)(2011-12#5)(2011-2#19)(2011-3#1)(2012-1#7)(2012-11#1)(2012-12#5)(2012-2#23)(2012-3#3)(2013-1#23)(2013-7#3)(2013-8#4)
parts-per-billion level##2##2##(2008-10#2)
parts-per-billions##2##1##(2008-10#2)
parts-per-million##2##1##(2008-10#1)(2012-2#1)
parts?##2##1##(1997-8#1)(2011-12#1)
partum##24##1##(1990-3#1)(1990-6#2)(1992-12#1)(1993-10#1)(1994-7#1)(2005-7#1)(2006-4#1)(2006-5#4)(2007-7#2)(2008-11#2)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#3)
parturient with##2##2##(1993-10#1)(1993-7#1)
parturient woman##3##2##(2006-10#1)(2011-2#1)(2012-3#1)
parturient##9##1##(1993-10#3)(1993-7#1)(2006-10#2)(2009-10#1)(2011-2#1)(2012-3#1)
parturients undergoing##2##2##(1993-4#1)(2011-2#1)
parturients##5##1##(1993-4#2)(1993-7#1)(2011-1#1)(2011-2#1)
parturition and##4##2##(1994-6#1)(2006-5#1)(2008-4#1)(2012-2#1)
parturition##27##1##(1990-6#1)(1992-1#1)(1992-2#1)(1992-5#1)(1993-10#1)(1994-2#1)(1994-3#1)(1994-6#3)(1994-9#1)(1996-11#1)(1996-12#1)(1996-4#1)(1997-4#1)(2006-5#2)(2006-8#1)(2007-11#2)(2008-10#1)(2008-4#1)(2010-2#3)(2012-2#1)(2013-8#1)
party and##2##2##(1991-9#1)(2010-12#1)
party is##2##2##(2008-8#1)(2010-6#1)
party payers##3##2##(1992-1#1)(1992-9#1)(1996-12#1)
party to##4##2##(1992-2#2)(2006-7#1)(2008-8#1)
party##50##1##(1991-1#1)(1991-2#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#2)(1992-9#1)(1995-2#1)(1995-4#1)(1995-7#1)(1996-12#3)(1996-2#2)(2005-5#1)(2006-10#1)(2006-5#1)(2006-7#3)(2007-1#5)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#3)(2009-6#2)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)
parva##6##1##(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)
parva)##3##1##(2007-12#1)(2008-7#2)
parvalbumin (PV) and##2##3##(1994-2#1)(1995-5#1)
parvalbumin (PV)##4##2##(1994-2#2)(1995-5#1)(1996-5#1)
parvalbumin and calbindin##2##3##(1991-3#2)
parvalbumin and##5##2##(1991-2#1)(1991-3#2)(1991-9#1)(1994-5#1)
parvalbumin in the##2##3##(1995-1#1)(2010-12#1)
parvalbumin in##4##2##(1994-2#1)(1995-1#1)(1995-5#1)(2010-12#1)
parvalbumin mutant##2##2##(1994-8#2)
parvalbumin were##2##2##(1995-1#1)(2010-12#1)
parvalbumin##28##1##(1991-2#1)(1991-3#3)(1991-9#1)(1994-11#1)(1994-2#7)(1994-5#1)(1994-8#3)(1995-1#3)(1995-5#4)(1996-5#2)(2010-12#2)
parvalbumin-ir smooth fibers##2##3##(1994-5#2)
parvalbumin-ir##3##1##(1994-5#3)
parvicellular part of the##2##4##(1995-7#1)(1996-9#1)
parvicellular##9##1##(1991-3#1)(1995-7#6)(1996-9#1)(2008-4#1)
parviflora##4##1##(2008-10#1)(2008-11#3)
parvocellular neurons of the paraventricular##2##5##(1990-11#1)(1996-4#1)
parvocellular neurons##3##2##(1990-11#1)(1996-4#1)(2010-10#1)
parvocellular##13##1##(1990-11#1)(1993-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-2#1)(2010-10#5)
parvovirus B19 infection##9##3##(1996-3#1)(2006-10#4)(2007-11#1)(2011-2#1)(2013-1#2)
parvovirus B19##16##2##(1994-8#1)(1996-3#1)(1996-7#2)(2006-10#4)(2007-11#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#4)
parvovirus##30##1##(1991-6#2)(1994-6#1)(1994-8#1)(1996-3#1)(1996-7#2)(1997-4#1)(2006-10#7)(2006-12#1)(2007-11#1)(2007-2#1)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#7)
parvulin##2##1##(2008-7#2)
parvum and C##2##3##(2011-1#2)
parvum and##5##2##(2006-10#2)(2011-1#2)(2013-1#1)
parvum in##4##2##(1995-3#1)(2006-10#1)(2011-1#1)(2013-1#1)
parvum plus C##3##3##(2013-1#3)
parvum plus##4##2##(2013-1#4)
parvum##36##1##(1991-9#1)(1995-3#1)(1996-12#2)(1997-3#1)(1997-4#1)(2005-12#2)(2006-10#5)(2006-3#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-5#1)(2011-1#5)(2011-2#1)(2013-1#10)
parvus##4##1##(2007-3#1)(2008-6#3)
pas##10##1##(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-2#4)(2013-1#2)
pass a##3##2##(1994-8#1)(2006-6#1)(2008-3#1)
pass and##2##2##(2008-10#1)(2013-1#1)
pass before##2##2##(1996-4#1)(2005-10#1)
pass filter##2##2##(2008-7#1)(2010-2#1)
pass into the##2##3##(2008-10#1)(2008-5#1)
pass of the##3##3##(2007-9#1)(2008-2#1)(2008-7#1)
pass of##9##2##(2006-6#1)(2007-11#1)(2007-9#2)(2008-10#3)(2008-2#1)(2008-7#1)
pass on##3##2##(1991-11#1)(2007-1#1)(2008-7#1)
pass rate##2##2##(1993-8#1)(2011-2#1)
pass rates##2##2##(2012-3#2)
pass the##10##2##(1991-1#1)(1995-3#1)(1996-7#1)(2006-12#2)(2007-9#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-5#1)
pass through a common##2##4##(2008-2#1)(2008-6#1)
pass through a##8##3##(2007-12#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)
pass through an##3##3##(1990-11#1)(2007-11#1)(2008-10#1)
pass through the column##2##4##(1990-12#1)(2008-9#1)
pass through the disk to drain##2##6##(2008-10#2)
pass through the entire gastrointestinal tract##2##6##(2006-10#1)(2011-2#1)
pass through the##20##3##(1990-12#1)(1996-11#1)(1997-7#1)(2006-10#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-3#3)(2008-7#2)(2008-9#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#1)
pass through##46##2##(1990-11#1)(1990-12#1)(1990-5#2)(1992-11#1)(1993-10#1)(1993-12#1)(1993-3#1)(1996-11#1)(1996-12#1)(1997-7#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-9#2)(2008-10#4)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-6#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#2)(2013-1#1)
pass##131##1##(1990-1#1)(1990-11#1)(1990-12#1)(1990-5#2)(1991-1#1)(1991-11#2)(1992-11#1)(1992-3#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-4#1)(1996-7#1)(1997-7#1)(1997-8#1)(2005-1#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-12#3)(2006-6#3)(2007-1#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#5)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#7)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#8)(2008-9#5)(2009-2#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#2)(2011-2#3)(2012-2#3)(2012-3#5)(2013-1#3)(2013-8#1)
passage 2##2##2##(2008-9#2)
passage and are##2##3##(1995-6#1)(2006-11#1)
passage and##9##2##(1994-10#1)(1995-6#1)(2006-11#1)(2008-12#1)(2011-1#1)(2012-12#2)(2013-1#2)
passage cells##11##2##(1996-3#8)(2008-11#2)(2008-5#1)
passage cultures##2##2##(2008-10#1)(2012-12#1)
passage during##4##2##(1990-5#1)(1991-9#1)(2011-1#1)(2011-2#1)
passage from the##3##3##(2008-10#1)(2008-5#1)(2009-4#1)
passage human##2##2##(1996-3#1)(2011-12#1)
passage in the##2##3##(1992-11#1)(2008-9#1)
passage in##11##2##(1992-11#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-10#1)(2013-8#3)
passage into the##2##3##(1996-9#1)(2008-4#1)
passage number##5##2##(2007-6#3)(2008-11#1)(2008-5#1)
passage of a guidewire##2##4##(2010-12#2)
passage of a##7##3##(2007-11#1)(2007-12#1)(2008-10#2)(2010-12#2)(2012-2#1)
passage of aqueous samples through##2##5##(2008-10#2)
passage of aqueous##3##3##(2008-10#3)
passage of cells##3##3##(1995-2#1)(2004-11#1)(2008-9#1)
passage of maternal##2##3##(2006-9#1)(2010-6#1)
passage of the Medicare##2##4##(1991-3#1)(1996-3#1)
passage of the##19##3##(1990-12#1)(1991-3#1)(1992-8#1)(1994-10#2)(1996-11#1)(1996-3#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-2#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-4#1)(2010-3#1)(2011-2#1)(2012-1#1)
passage of##72##2##(1990-12#1)(1991-12#1)(1991-3#1)(1992-4#1)(1992-8#1)(1992-9#1)(1994-10#2)(1994-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-2#2)(2004-11#1)(2006-10#3)(2006-2#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#10)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-12#2)(2009-4#1)(2009-7#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-11#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-2#4)
passage rate of feed through##2##5##(2008-10#2)
passage through an##2##3##(1995-12#1)(2012-2#1)
passage through the Golgi##2##4##(1992-11#1)(2009-2#1)
passage through the##15##3##(1992-11#1)(1992-6#1)(1992-9#1)(1993-9#1)(1995-6#1)(1997-5#1)(2006-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-2#2)(2012-12#1)
passage through##26##2##(1992-11#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-5#1)(1997-3#1)(1997-5#1)(2006-2#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-2#2)(2011-1#1)(2012-12#1)(2012-2#1)
passage time##3##2##(2008-7#1)(2009-8#2)
passage to##3##2##(1996-4#1)(2008-9#2)
passage was##2##2##(2013-8#2)
passage##240##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-5#1)(1991-7#2)(1991-9#2)(1992-1#1)(1992-11#3)(1992-4#2)(1992-6#1)(1992-8#2)(1992-9#3)(1993-9#1)(1994-10#3)(1994-12#1)(1994-3#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-3#11)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#2)(1997-5#2)(1997-7#1)(1997-8#2)(2004-10#2)(2004-11#1)(2006-10#5)(2006-11#1)(2006-2#2)(2006-9#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-4#1)(2007-6#4)(2007-8#4)(2008-10#22)(2008-11#18)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#9)(2008-7#4)(2008-9#8)(2009-10#1)(2009-12#2)(2009-2#4)(2009-4#2)(2009-7#2)(2009-8#2)(2010-1#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#6)(2011-11#1)(2011-12#3)(2011-2#5)(2011-3#8)(2012-1#3)(2012-12#8)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#9)
passage)##2##1##(1993-6#1)(2008-11#1)
passaged in##2##2##(1991-2#1)(2010-7#1)
passaged##13##1##(1991-2#1)(1992-6#1)(1992-9#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-7#1)(2012-2#1)(2013-1#2)(2013-8#1)
passages and##8##2##(1991-3#1)(1992-9#1)(1994-12#1)(2008-11#2)(2008-9#1)(2011-1#1)(2012-12#1)
passages following##2##2##(1992-4#1)(2008-10#1)
passages in the##3##3##(1991-10#1)(2006-10#1)(2008-10#1)
passages in##15##2##(1991-10#1)(1991-7#1)(1992-2#1)(1992-9#1)(2006-10#1)(2007-6#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2010-3#1)(2012-12#1)(2013-1#1)
passages of##4##2##(1994-8#2)(2008-10#1)(2011-2#1)
passages through##4##2##(1994-12#1)(2008-5#1)(2010-7#1)(2010-8#1)
passages##87##1##(1990-4#2)(1990-5#1)(1991-10#2)(1991-3#1)(1991-7#1)(1992-1#1)(1992-2#2)(1992-4#1)(1992-9#4)(1993-4#1)(1994-12#2)(1994-8#2)(1994-9#1)(1995-2#1)(1995-5#2)(1997-4#1)(2004-10#1)(2006-10#2)(2007-11#1)(2007-6#4)(2008-10#6)(2008-11#11)(2008-12#3)(2008-3#1)(2008-5#10)(2008-8#1)(2008-9#1)(2010-3#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2011-3#2)(2012-1#1)(2012-12#7)(2013-1#4)(2013-8#1)
passages) and##2##2##(1990-4#1)(2010-8#1)
passages)##4##1##(1990-4#1)(2008-11#1)(2009-12#1)(2010-8#1)
passaging in##2##2##(1997-3#1)(2013-8#1)
passaging suspension cultures##4##3##(2008-2#1)(2008-4#2)(2008-9#1)
passaging##13##1##(1993-6#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-8#1)(2008-9#1)(2010-7#1)(2012-2#1)(2013-8#1)
passalid##2##1##(2007-12#2)
passband width##3##2##(2007-11#1)(2007-12#2)
passband##20##1##(2007-11#7)(2007-12#5)(2008-2#6)(2008-3#2)
passbands##6##1##(2008-1#1)(2008-2#2)(2008-3#3)
passed a##9##2##(1992-3#1)(1993-3#1)(1994-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-7#1)(2010-10#1)
passed all##2##2##(1994-11#1)(2008-10#1)
passed and##3##2##(1991-1#1)(2008-1#1)(2008-9#1)
passed away##5##2##(2007-3#1)(2008-10#1)(2011-1#1)(2012-1#1)(2013-8#1)
passed by the##4##3##(1990-9#1)(1997-1#1)(1997-2#1)(2008-10#1)
passed by##6##2##(1990-9#1)(1994-8#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-8#1)
passed from the##2##3##(2008-10#1)(2008-7#1)
passed from##5##2##(2006-12#1)(2008-10#2)(2008-7#1)(2012-3#1)
passed in##7##2##(1991-4#1)(1992-2#1)(1996-6#1)(1997-3#1)(2008-10#1)(2012-3#1)(2013-8#1)
passed into##2##2##(1993-11#1)(2008-10#1)
passed on to##2##3##(1997-8#1)(2006-1#1)
passed over a##3##3##(1990-5#1)(2005-11#1)(2008-2#1)
passed over##7##2##(1990-5#1)(2005-11#1)(2006-4#1)(2008-10#1)(2008-2#1)(2013-1#2)
passed since the##7##3##(1996-6#1)(2004-1#1)(2006-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2013-1#1)
passed the##7##2##(1993-3#1)(1995-12#1)(1996-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)
passed through a 0##2##4##(2008-10#1)(2008-5#1)
passed through a##25##3##(1991-2#1)(1991-8#1)(1992-12#1)(1996-6#1)(1996-8#1)(1997-8#1)(2006-5#1)(2007-12#2)(2008-10#8)(2008-11#1)(2008-2#2)(2008-5#2)(2011-1#1)(2011-2#1)(2013-7#1)
passed through an##2##3##(2008-10#2)
passed through the flow##2##4##(2008-10#2)
passed through the##31##3##(1990-4#1)(1996-9#3)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#17)(2008-2#2)(2008-3#2)(2010-2#1)(2013-1#1)(2013-8#1)
passed through three##2##3##(1997-2#1)(2008-10#1)
passed through##68##2##(1990-3#1)(1990-4#1)(1991-2#1)(1991-8#2)(1991-9#1)(1992-12#1)(1996-6#1)(1996-8#1)(1996-9#3)(1997-2#1)(1997-6#1)(1997-8#2)(2006-5#1)(2007-12#4)(2008-10#28)(2008-11#1)(2008-2#4)(2008-3#2)(2008-5#3)(2008-7#2)(2010-2#2)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
passed to##8##2##(1993-1#1)(1993-8#1)(2004-9#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)
passed two##2##2##(2007-8#1)(2008-11#1)
passed with a##2##3##(2008-2#1)(2008-3#1)
passed##182##1##(1990-3#2)(1990-4#1)(1990-5#3)(1990-9#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-8#3)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-8#2)(1995-12#1)(1996-11#1)(1996-12#1)(1996-6#3)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#3)(1997-8#3)(2004-1#2)(2004-9#1)(2005-11#1)(2006-1#1)(2006-10#4)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#4)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#44)(2008-11#4)(2008-12#1)(2008-2#9)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#6)(2008-9#2)(2009-7#1)(2010-10#1)(2010-2#4)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#3)
passenger airbag##2##2##(2007-4#2)
passenger cars##3##2##(2007-1#1)(2007-4#1)(2008-11#1)
passenger compartment##2##2##(1996-11#2)
passenger instability were##2##3##(2013-1#2)
passenger protein##2##2##(1991-10#1)(1992-6#1)
passenger restraint use##2##3##(1991-8#2)
passenger ships##2##2##(2011-2#2)
passenger##43##1##(1991-10#1)(1991-8#2)(1992-6#3)(1995-12#1)(1996-10#5)(1996-11#2)(1996-12#3)(2006-11#2)(2007-1#1)(2007-2#6)(2007-4#4)(2007-7#2)(2008-10#1)(2008-11#1)(2008-8#1)(2009-9#1)(2011-2#2)(2013-1#5)
passenger-side##2##1##(2006-11#2)
passengers and crew##2##3##(2006-7#1)(2011-2#1)
passengers in##3##2##(2006-11#2)(2007-2#1)
passengers on##3##2##(2006-7#2)(2007-2#1)
passengers##24##1##(1996-12#2)(2006-11#2)(2006-7#4)(2007-2#9)(2008-6#1)(2009-9#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
passerine birds##4##2##(1993-2#1)(2006-5#2)(2009-7#1)
passerine species##4##2##(2007-2#1)(2009-7#3)
passerine##11##1##(1993-2#1)(2006-5#2)(2007-2#1)(2008-5#2)(2009-7#4)(2013-1#1)
passerines##3##1##(2008-9#3)
passerinii in##2##2##(2008-10#2)
passerinii##5##1##(2008-10#5)
passes a##2##2##(2008-11#1)(2008-3#1)
passes the##2##2##(2008-3#1)(2010-9#1)
passes through a##6##3##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#1)
passes through an##2##3##(2008-10#2)
passes through the test section##2##5##(2008-3#2)
passes through the##14##3##(2006-4#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#3)(2008-7#1)(2010-8#1)
passes through##26##2##(2006-4#1)(2007-11#4)(2007-12#3)(2008-10#6)(2008-2#4)(2008-3#4)(2008-5#1)(2008-7#1)(2009-2#1)(2010-8#1)
passes##49##1##(1994-8#1)(1995-6#1)(1996-5#1)(1996-6#1)(2005-11#1)(2006-4#1)(2007-11#5)(2007-12#3)(2007-9#1)(2008-10#11)(2008-11#2)(2008-2#4)(2008-3#8)(2008-5#1)(2008-7#2)(2009-2#1)(2009-9#1)(2010-8#2)(2010-9#1)(2013-7#1)
passiflora isolates##2##2##(2008-10#2)
passiflora##9##1##(2008-10#9)
passing a##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2012-2#1)(2013-7#1)
passing and##2##2##(2007-4#1)(2010-8#1)
passing from##3##2##(2007-8#1)(2008-3#1)(2010-4#1)
passing of##2##2##(2006-8#1)(2012-3#1)
passing on##2##2##(1992-3#1)(1996-8#1)
passing the##11##2##(1997-8#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-9#1)
passing through a##5##3##(1991-3#1)(2007-11#1)(2007-12#1)(2008-10#2)
passing through the##15##3##(1992-11#1)(1994-12#1)(2007-12#1)(2007-9#1)(2008-10#6)(2008-3#4)(2008-9#1)
passing through##28##2##(1990-11#1)(1991-3#1)(1992-11#1)(1994-12#2)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#10)(2008-2#1)(2008-3#5)(2008-8#1)(2008-9#1)(2012-1#1)
passing##93##1##(1990-11#1)(1991-3#1)(1992-11#2)(1992-3#1)(1993-12#1)(1993-9#1)(1994-12#2)(1996-12#1)(1996-8#1)(1997-8#1)(2004-12#1)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#7)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#24)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-7#1)
passion for##3##2##(1995-2#1)(2010-8#2)
passion##8##1##(1992-7#1)(1994-2#1)(1995-2#1)(2008-12#1)(2008-6#1)(2010-8#2)(2011-1#1)
passionate##3##1##(1996-6#1)(2009-10#1)(2013-1#1)
passivated by##2##2##(2007-8#1)(2008-1#1)
passivated##4##1##(1995-7#1)(2006-6#1)(2007-8#1)(2008-1#1)
passivating layer##3##2##(2008-10#2)(2010-4#1)
passivating##5##1##(2006-12#1)(2008-10#2)(2009-6#1)(2010-4#1)
passivation##7##1##(2005-11#1)(2008-10#2)(2010-2#1)(2010-4#3)
passive Ca2+##2##2##(1993-11#1)(1994-2#1)
passive EDF##2##2##(2007-12#2)
passive Fourier transform infrared##2##4##(2006-12#2)
passive IR##2##2##(2008-2#2)
passive Q switch##3##3##(2007-11#1)(2008-3#2)
passive Q switching of a 1##2##6##(2008-3#2)
passive Q switching of a##4##5##(2007-11#1)(2008-3#3)
passive Q switching##6##3##(2007-11#2)(2008-3#4)
passive Q##10##2##(2007-11#3)(2008-3#7)
passive Q-switching##2##2##(2008-2#1)(2008-3#1)
passive and active##8##3##(2006-11#1)(2007-12#1)(2008-7#1)(2009-10#1)(2009-11#1)(2010-12#1)(2012-12#1)(2012-3#1)
passive and attentional processing of faces##2##6##(1993-2#2)
passive and##16##2##(1993-2#2)(2006-11#2)(2006-12#2)(2007-11#1)(2007-12#1)(2008-7#1)(2009-10#1)(2009-11#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
passive avoidance (PA)##3##3##(1991-4#1)(1992-3#1)(1993-11#1)
passive avoidance and##2##3##(1993-12#1)(1997-4#1)
passive avoidance behavior of##2##4##(1996-12#2)
passive avoidance behavior##7##3##(1991-5#1)(1992-6#1)(1992-7#1)(1993-3#1)(1994-10#1)(1996-12#2)
passive avoidance learning##2##3##(1992-3#1)(1994-5#1)
passive avoidance reaction (PAR)##2##4##(1992-10#2)
passive avoidance response##3##3##(1993-11#1)(1994-5#1)(2012-1#1)
passive avoidance task##9##3##(1991-2#1)(1992-10#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-5#1)(1995-9#1)(2008-6#1)
passive avoidance tasks##2##3##(1993-11#1)(1997-6#1)
passive avoidance test##6##3##(1991-5#3)(1992-8#1)(1994-5#2)
passive avoidance##48##2##(1991-2#1)(1991-4#1)(1991-5#7)(1992-10#5)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#5)(1993-12#2)(1993-3#2)(1994-10#2)(1994-2#1)(1994-5#6)(1995-9#1)(1996-12#5)(1997-4#1)(1997-6#1)(2008-6#2)(2012-1#1)
passive bleeding##2##2##(2007-7#2)
passive coping##2##2##(2011-1#1)(2012-1#1)
passive creep-induced stretching##2##3##(2009-7#2)
passive cutaneous anaphylactoid response##2##4##(2010-12#2)
passive cutaneous anaphylactoid##4##3##(2010-12#4)
passive cutaneous anaphylaxis##3##3##(1995-11#1)(2008-10#2)
passive cutaneous##7##2##(1995-11#1)(2008-10#2)(2010-12#4)
passive device##3##2##(2008-1#1)(2008-3#1)(2012-1#1)
passive diffusion and##2##3##(2010-12#1)(2011-2#1)
passive diffusion##8##2##(1994-11#1)(1995-11#1)(2006-10#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#2)
passive dynamic walker##2##3##(2012-1#2)
passive electrical properties##3##3##(1991-2#2)(1993-2#1)
passive entry of##2##3##(2006-8#1)(2008-10#1)
passive exoskeleton##2##2##(2012-1#2)
passive exposure to tobacco smoke##2##5##(1991-4#1)(1994-2#1)
passive exposure to##3##3##(1991-4#1)(1994-2#1)(2013-1#1)
passive haemagglutination##3##2##(1992-1#1)(1995-2#2)
passive heterodyne##2##2##(2008-2#1)(2008-3#1)
passive immunisation with##2##3##(2007-11#2)
passive immunization##5##2##(1996-3#1)(1997-6#1)(2007-8#1)(2009-6#1)(2012-2#1)
passive immunoprophylaxis with##2##3##(2007-11#1)(2009-8#1)
passive immunotherapy##4##2##(1994-2#1)(1997-7#1)(2007-11#1)(2012-2#1)
passive knee##2##2##(2007-11#1)(2013-1#1)
passive membrane properties##2##3##(1991-8#1)(2011-2#1)
passive membrane##3##2##(1991-5#1)(1991-8#1)(2011-2#1)
passive method##2##2##(2007-12#1)(2008-10#1)
passive mode locking of a diode-pumped##2##6##(2007-11#1)(2008-2#1)
passive mode locking of##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
passive mode locking##6##3##(2007-11#2)(2007-12#3)(2008-2#1)
passive mode##8##2##(2007-11#2)(2007-12#3)(2008-2#1)(2012-1#2)
passive mode-locking##2##2##(2007-11#2)
passive motion (CPM)##4##3##(2007-11#1)(2007-7#1)(2007-8#2)
passive motion##8##2##(2006-12#2)(2007-11#2)(2007-7#2)(2007-8#2)
passive movement of##2##3##(2010-5#1)(2011-2#1)
passive movements##3##2##(1990-7#1)(1996-9#2)
passive neutral##3##2##(2008-10#3)
passive optical##8##2##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#2)
passive permeability##3##2##(1990-2#1)(1992-6#1)(1993-3#1)
passive quadrature digital##2##3##(2007-12#2)
passive quadrature##4##2##(2007-12#2)(2008-2#2)
passive range of motion and##2##5##(2006-10#1)(2007-11#1)
passive range of motion##3##4##(2006-10#2)(2007-11#1)
passive range of##4##3##(1992-9#1)(2006-10#2)(2007-11#1)
passive remote-sensing##2##2##(2008-3#2)
passive resignation and diabetes integration coping##2##6##(2012-1#2)
passive rewarming##2##2##(2011-2#2)
passive roles##2##2##(1990-9#1)(2008-7#1)
passive safety##2##2##(2007-4#2)
passive sampler##11##2##(2005-4#1)(2008-10#9)(2008-11#1)
passive samplers##2##2##(2008-10#1)(2008-11#1)
passive sampling##4##2##(2005-4#1)(2008-10#3)
passive scattering##2##2##(2007-12#1)(2010-9#1)
passive single-mode##2##2##(2008-2#2)
passive smoking and##3##3##(2005-11#1)(2012-1#1)(2012-2#1)
passive smoking during pregnancy##2##4##(2012-1#1)(2012-2#1)
passive smoking##14##2##(1990-6#1)(1997-5#1)(2005-11#1)(2007-2#1)(2010-12#1)(2011-12#1)(2011-2#2)(2012-1#4)(2012-2#2)
passive stability##2##2##(2007-11#1)(2007-8#1)
passive stretching##2##2##(2006-10#1)(2009-7#1)
passive surveillance##2##2##(1995-3#1)(1997-3#1)
passive targeting##2##2##(2012-12#1)(2013-7#1)
passive technique##2##2##(2007-11#1)(2007-12#1)
passive to##2##2##(2008-11#1)(2010-12#1)
passive transfer of##4##3##(1992-12#1)(1996-11#1)(2006-2#1)(2007-2#1)
passive transfer status in##2##4##(2007-2#2)
passive transfer##7##2##(1991-9#1)(1992-12#1)(1996-11#1)(2006-2#1)(2007-2#3)
passive transport##3##2##(1994-3#1)(2008-4#1)(2010-5#1)
passive viewing##2##2##(1994-3#1)(2012-3#1)
passive##442##1##(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-2#3)(1991-4#2)(1991-5#9)(1991-8#1)(1991-9#1)(1992-1#4)(1992-10#5)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#3)(1993-11#6)(1993-12#3)(1993-2#3)(1993-3#7)(1993-5#1)(1994-10#2)(1994-11#1)(1994-2#4)(1994-3#2)(1994-5#6)(1994-9#1)(1995-11#3)(1995-2#2)(1995-3#1)(1995-5#5)(1995-8#3)(1995-9#1)(1996-11#2)(1996-12#5)(1996-3#2)(1996-5#4)(1996-6#1)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-4#2)(2006-10#6)(2006-11#3)(2006-12#7)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#30)(2007-12#32)(2007-2#4)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#7)(2008-1#3)(2008-10#28)(2008-11#5)(2008-12#3)(2008-2#22)(2008-3#34)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#2)(2009-6#2)(2009-7#3)(2009-8#3)(2010-10#4)(2010-11#1)(2010-12#9)(2010-3#1)(2010-5#6)(2010-8#4)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#10)(2012-1#24)(2012-12#3)(2012-2#5)(2012-3#2)(2012-9#1)(2013-1#4)(2013-7#4)
passively Q -switched##9##3##(2007-11#5)(2007-12#4)
passively Q switched with a##2##5##(2007-12#1)(2008-3#1)
passively Q switched##3##3##(2007-12#1)(2008-3#2)
passively Q##12##2##(2007-11#5)(2007-12#5)(2008-3#2)
passively Q-switched Nd##3##3##(2007-12#2)(2008-2#1)
passively Q-switched Yb##2##3##(2007-11#1)(2008-3#1)
passively Q-switched diode-pumped##2##3##(2008-1#1)(2008-3#1)
passively Q-switched laser##2##3##(2008-3#2)
passively Q-switched lasers##2##3##(2007-11#1)(2007-12#1)
passively Q-switched operation##2##3##(2008-2#1)(2008-3#1)
passively Q-switched##23##2##(2007-11#6)(2007-12#5)(2008-1#2)(2008-2#2)(2008-3#8)
passively mode locked by a##2##5##(2007-12#1)(2008-1#1)
passively mode locked by##3##4##(2007-12#2)(2008-1#1)
passively mode locked##4##3##(2007-12#3)(2008-1#1)
passively mode-locked Nd##6##3##(2007-11#4)(2007-12#2)
passively mode-locked Yb##2##3##(2007-11#1)(2007-12#1)
passively mode-locked fiber laser##4##4##(2007-12#2)(2008-1#2)
passively mode-locked fiber##5##3##(2007-12#3)(2008-1#2)
passively mode-locked thin-disk Yb##3##4##(2007-11#3)
passively mode-locked##24##2##(2007-11#13)(2007-12#8)(2008-1#2)(2008-3#1)
passively quenched##2##2##(2007-12#1)(2008-3#1)
passively supported gait training exoskeleton##2##5##(2012-1#2)
passively##91##1##(1991-9#1)(1993-1#1)(1994-12#1)(1994-6#1)(1996-5#1)(2005-8#1)(2006-10#1)(2007-11#25)(2007-12#22)(2007-3#1)(2008-1#5)(2008-10#2)(2008-2#2)(2008-3#16)(2008-4#1)(2008-8#1)(2009-3#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-1#3)(2012-3#1)
passivity of##2##2##(2012-1#2)
passivity##4##1##(2004-12#1)(2012-1#3)
password is##2##2##(2007-12#1)(2013-8#1)
password practices##2##2##(2007-12#2)
password##7##1##(2007-12#3)(2007-4#2)(2007-6#1)(2013-8#1)
passwords and##2##2##(2006-6#1)(2008-11#1)
passwords##5##1##(2006-6#1)(2007-12#3)(2008-11#1)
past 10 years##35##3##(1991-4#2)(1992-3#1)(1993-8#1)(1996-5#1)(1997-1#1)(2005-7#2)(2006-1#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
past 10##36##2##(1991-4#2)(1992-3#1)(1993-8#1)(1996-5#1)(1997-1#1)(2005-7#2)(2006-1#1)(2006-10#2)(2006-3#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
past 2##19##2##(1992-8#1)(1994-9#1)(1997-6#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-12#2)(2007-11#2)(2007-4#1)(2007-9#1)(2008-10#1)(2008-7#1)(2009-11#1)(2011-1#1)(2013-8#1)
past 20##46##2##(1990-10#1)(1992-2#1)(1992-7#1)(1992-8#2)(1994-3#1)(1995-1#1)(1995-12#1)(2004-1#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-11#1)(2007-1#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
past 25 years##17##3##(1993-3#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-8#1)(2006-12#1)(2007-12#2)(2007-9#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-7#1)(2011-1#1)(2012-2#1)
past 30 years have##2##4##(2006-10#1)(2010-1#1)
past 30 years##21##3##(1991-9#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
past 30##28##2##(1991-9#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-1#1)(2010-11#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
past 5 years##9##3##(1995-3#1)(2006-4#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#1)(2010-4#1)(2012-1#1)(2012-3#1)
past 5##11##2##(1995-3#1)(2005-8#1)(2006-4#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-6#1)(2010-4#1)(2012-1#1)(2012-3#1)
past 6 years##2##3##(1991-3#1)(2013-1#1)
past 6##4##2##(1991-3#2)(2007-9#1)(2013-1#1)
past UV photoproducts##2##3##(2009-8#2)
past a##2##2##(1996-11#1)(2007-11#1)
past achievements##3##2##(2012-12#1)(2012-3#2)
past and current##5##3##(1996-3#1)(2005-7#1)(2008-11#1)(2008-4#1)(2011-2#1)
past and future##3##3##(1996-2#1)(2008-1#1)(2012-12#1)
past and present##7##3##(1995-12#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2012-1#1)(2012-2#1)
past and the##2##3##(2007-4#1)(2009-10#1)
past and##27##2##(1991-3#3)(1994-6#1)(1995-12#1)(1996-2#1)(1996-3#1)(2005-7#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2009-10#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-5#1)
past as##3##2##(1994-2#1)(2007-9#1)(2013-8#1)
past attempts##2##2##(1993-3#1)(2007-12#1)
past climatic conditions##2##3##(2007-9#2)
past clinical##2##2##(2006-10#1)(2013-8#1)
past decade has##12##3##(1993-1#1)(1993-12#1)(1994-1#1)(2006-1#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#1)
past decade##169##2##(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-7#1)(1992-8#1)(1993-1#2)(1993-12#2)(1993-3#1)(1994-1#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-4#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-8#1)(2004-10#1)(2005-10#1)(2005-5#1)(2005-8#3)(2006-1#2)(2006-10#9)(2006-11#1)(2006-2#1)(2006-3#1)(2006-6#2)(2006-8#2)(2006-9#2)(2007-1#1)(2007-11#5)(2007-12#5)(2007-2#1)(2007-5#1)(2007-6#2)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#13)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#7)(2008-5#3)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-5#5)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#7)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#2)
past decades##20##2##(1993-5#1)(2005-10#1)(2006-2#1)(2006-6#1)(2006-9#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#3)(2012-12#1)(2013-1#3)
past editions##2##2##(2008-10#2)
past eight##3##2##(1997-2#1)(2007-10#1)(2008-2#1)
past events##3##2##(1991-3#1)(2008-9#1)(2013-8#1)
past evidence##2##2##(1994-1#1)(2012-3#1)
past experience##11##2##(1991-5#1)(2005-10#1)(2006-11#1)(2006-5#1)(2008-11#1)(2009-10#2)(2009-12#1)(2010-5#1)(2011-2#1)(2013-7#1)
past experiences##3##2##(1997-3#1)(2007-8#1)(2013-8#1)
past exposures##2##2##(1994-6#1)(2010-8#1)
past few decades have##2##4##(2006-8#1)(2013-8#1)
past few decades##19##3##(1994-5#1)(2005-7#1)(2006-10#3)(2006-8#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
past few years have##4##4##(1995-4#1)(1997-8#1)(2006-10#1)(2008-8#1)
past few years##72##3##(1992-9#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-4#1)(1997-8#1)(2006-10#16)(2006-2#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#4)(2009-5#1)(2009-9#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#2)(2013-8#1)
past few##93##2##(1992-9#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-4#1)(1997-8#1)(2005-7#1)(2006-10#19)(2006-2#1)(2006-8#2)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#5)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#4)(2009-5#1)(2009-9#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#4)(2013-7#2)(2013-8#2)
past glacial##2##2##(1991-6#1)(2008-9#1)
past have been##2##3##(1994-12#1)(2013-1#1)
past history of##10##3##(1990-3#1)(1992-2#1)(2006-10#2)(2007-7#1)(2008-12#1)(2008-8#1)(2011-2#2)(2013-1#1)
past history##20##2##(1990-3#1)(1991-12#1)(1992-2#1)(1992-7#2)(1993-6#1)(1996-12#1)(1997-4#1)(2006-10#2)(2007-12#1)(2007-3#1)(2007-7#1)(2008-12#1)(2008-8#1)(2009-3#1)(2010-9#1)(2011-2#2)(2013-1#1)
past human##2##2##(2008-7#1)(2012-9#1)
past in the##2##3##(2008-10#1)(2008-5#1)
past in##6##2##(2006-3#1)(2007-11#1)(2008-10#2)(2008-5#1)(2009-10#1)
past medical history and##4##4##(2006-12#1)(2006-9#1)(2008-7#1)(2010-10#1)
past medical history of##3##4##(2007-12#1)(2011-12#1)(2013-7#1)
past medical history was##2##4##(2012-1#1)(2012-2#1)
past medical history##15##3##(2006-10#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-8#1)(2008-7#1)(2009-3#1)(2010-10#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
past month alcohol use##6##4##(2009-12#5)(2010-9#1)
past month maternal mental health##2##5##(2010-2#2)
past month use##5##3##(2010-9#5)
past month##21##2##(2009-12#8)(2010-2#2)(2010-9#6)(2011-2#2)(2012-1#1)(2013-1#1)(2013-7#1)
past or present##2##3##(2007-9#1)(2013-8#1)
past or##4##2##(2007-7#1)(2007-9#1)(2012-3#1)(2013-8#1)
past populations##2##2##(2006-2#1)(2012-9#1)
past reports of##2##3##(1997-8#1)(2012-12#1)
past research and##2##3##(1996-2#1)(2007-6#1)
past research##6##2##(1996-2#1)(2007-6#1)(2008-11#1)(2012-1#1)(2012-2#1)(2013-1#1)
past selection##2##2##(2008-8#1)(2011-1#1)
past seven years##2##3##(1997-2#1)(2013-1#1)
past several decades##11##3##(1992-12#1)(2008-6#1)(2009-10#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)
past several years##25##3##(1991-1#1)(1991-12#1)(1992-2#1)(1992-3#2)(1995-10#1)(1995-12#1)(1997-5#1)(2006-10#2)(2007-12#1)(2007-4#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#2)(2009-3#1)(2010-7#1)(2010-9#1)(2011-2#1)
past several##37##2##(1991-1#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-3#2)(1995-10#1)(1995-12#1)(1997-5#1)(2006-10#2)(2006-8#1)(2007-12#1)(2007-4#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-3#1)(2009-7#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#1)
past sexual##2##2##(1990-12#1)(2007-12#1)
past studies as##2##3##(2007-7#1)(2008-6#1)
past studies that##2##3##(1994-3#1)(2006-7#1)
past studies##10##2##(1994-3#1)(2006-4#1)(2006-7#1)(2007-7#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-12#1)
past tense and##2##3##(2012-1#2)
past tense##4##2##(2012-1#4)
past the estimated date of##2##5##(2006-2#2)
past the##17##2##(1990-5#1)(1991-1#1)(1997-4#1)(2004-4#1)(2005-11#1)(2006-2#2)(2006-8#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#2)(2013-8#1)
past to##6##2##(1994-3#1)(2006-10#1)(2008-3#1)(2011-2#1)(2012-2#2)
past two decades have##2##4##(2008-3#1)(2009-9#1)
past two decades##47##3##(1990-6#1)(1992-11#1)(1992-4#1)(1993-4#1)(1995-1#1)(1995-4#1)(2005-7#2)(2006-1#1)(2006-10#4)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#3)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
past two##63##2##(1990-6#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-4#1)(1993-4#1)(1994-1#1)(1995-1#1)(1995-4#1)(1996-8#1)(2005-7#3)(2006-1#1)(2006-10#5)(2006-11#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#3)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#3)(2013-8#1)
past work##2##2##(2008-7#1)(2011-1#1)
past year and##4##3##(1994-3#1)(2006-10#2)(2011-2#1)
past year are##4##3##(2005-7#1)(2006-10#3)
past year has##9##3##(2006-10#8)(2010-5#1)
past year use of##2##4##(2009-7#1)(2010-2#1)
past year##96##2##(1994-3#1)(1996-12#1)(1996-2#1)(2005-7#2)(2006-10#73)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-2#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#1)
past year's##3##2##(2006-10#3)
past years##28##2##(1990-9#1)(1991-3#1)(1992-1#1)(1993-6#1)(1996-3#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2009-10#1)(2009-3#1)(2010-2#1)(2010-5#1)(2011-12#2)(2011-2#1)(2012-12#2)(2012-3#1)
past##1372##1##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#3)(1990-9#1)(1991-1#3)(1991-11#1)(1991-12#9)(1991-2#2)(1991-3#12)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#3)(1992-1#6)(1992-11#1)(1992-12#8)(1992-2#4)(1992-3#7)(1992-4#1)(1992-5#4)(1992-7#4)(1992-8#5)(1992-9#3)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#7)(1993-2#1)(1993-3#7)(1993-4#4)(1993-5#2)(1993-6#2)(1993-7#1)(1993-8#1)(1994-1#6)(1994-11#1)(1994-12#4)(1994-2#4)(1994-3#9)(1994-5#1)(1994-6#4)(1994-7#1)(1994-9#1)(1995-1#4)(1995-10#1)(1995-11#3)(1995-12#9)(1995-2#2)(1995-3#7)(1995-4#3)(1995-5#2)(1995-6#2)(1996-1#1)(1996-11#3)(1996-12#4)(1996-2#6)(1996-3#6)(1996-4#2)(1996-5#1)(1996-6#3)(1996-7#1)(1996-8#1)(1997-1#7)(1997-2#5)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#5)(1997-7#2)(1997-8#7)(2004-1#1)(2004-10#2)(2004-12#1)(2004-3#3)(2004-4#1)(2005-10#6)(2005-11#3)(2005-2#1)(2005-5#1)(2005-7#14)(2005-8#11)(2006-1#5)(2006-10#149)(2006-11#5)(2006-12#9)(2006-2#8)(2006-3#4)(2006-4#4)(2006-5#3)(2006-6#12)(2006-7#7)(2006-8#13)(2006-9#5)(2007-1#2)(2007-10#2)(2007-11#17)(2007-12#25)(2007-2#13)(2007-3#3)(2007-4#16)(2007-5#2)(2007-6#8)(2007-7#12)(2007-8#25)(2007-9#20)(2008-1#21)(2008-10#67)(2008-11#40)(2008-12#12)(2008-2#15)(2008-3#20)(2008-4#22)(2008-5#19)(2008-6#9)(2008-7#27)(2008-8#25)(2008-9#17)(2009-1#1)(2009-10#9)(2009-11#3)(2009-12#11)(2009-2#4)(2009-3#8)(2009-4#7)(2009-5#18)(2009-6#4)(2009-7#4)(2009-8#5)(2009-9#7)(2010-1#2)(2010-10#4)(2010-11#4)(2010-12#10)(2010-2#6)(2010-3#9)(2010-4#7)(2010-5#14)(2010-6#2)(2010-7#7)(2010-8#12)(2010-9#12)(2011-1#19)(2011-12#8)(2011-2#51)(2012-1#24)(2012-11#1)(2012-12#25)(2012-2#30)(2012-3#18)(2012-5#1)(2012-7#3)(2012-9#4)(2013-1#32)(2013-7#13)(2013-8#18)
past-president##2##1##(1991-3#1)(2007-10#1)
past-temporal##3##1##(2009-5#3)
past-year##3##1##(2010-4#1)(2010-7#1)(2013-1#1)
past]##3##1##(1991-3#1)(1993-3#1)(1997-5#1)
pasta and##2##2##(2008-10#2)
pasta##7##1##(1991-5#1)(2008-10#3)(2008-6#1)(2009-4#1)(2012-1#1)
paste and##4##2##(2006-10#1)(2008-10#1)(2008-5#1)(2010-12#1)
paste based electrodes##2##3##(2008-10#2)
paste based##3##2##(2008-10#3)
paste electrode are##2##3##(2008-10#2)
paste electrode##91##2##(2008-10#90)(2008-6#1)
paste electrodes##19##2##(2007-2#2)(2007-8#2)(2008-10#15)
paste extracts##3##2##(2008-10#3)
paste is##3##2##(2005-10#1)(2008-10#2)
paste of##2##2##(2006-4#2)
paste on##2##2##(2006-4#1)(2008-10#1)
paste was##2##2##(2008-10#1)(2012-2#1)
paste were##2##2##(2006-10#2)
paste##178##1##(1991-5#1)(2005-10#2)(2006-10#4)(2006-11#1)(2006-4#3)(2007-2#2)(2007-8#2)(2007-9#1)(2008-10#142)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-12#2)(2010-2#1)(2010-4#4)(2011-2#1)(2012-11#1)(2012-2#3)(2013-1#2)(2013-8#2)
paste)##2##1##(2006-4#1)(2008-10#1)
pasted##2##1##(1990-12#1)(1995-6#1)
pastes at##2##2##(2008-10#1)(2010-4#1)
pastes##6##1##(2005-10#1)(2008-10#3)(2010-4#2)
pasteurellosis##2##1##(1990-3#1)(2008-5#1)
pasteurianum##5##1##(1990-6#4)(1994-10#1)
pasteurianus strain##2##2##(1997-8#2)
pasteurianus##3##1##(1997-8#3)
pasteurised##2##1##(2008-10#1)(2010-3#1)
pasteurization##7##1##(1996-12#1)(2008-10#4)(2012-2#2)
pasteurized bone##2##2##(2008-6#2)
pasteurized milk##4##2##(2008-10#1)(2008-12#3)
pasteurized soil##2##2##(2008-10#2)
pasteurized##13##1##(2008-10#5)(2008-12#4)(2008-6#3)(2009-3#1)
pastor##3##1##(1993-12#1)(2008-1#1)(2012-3#1)
pastor's##2##1##(2005-7#1)(2009-1#1)
pastoral areas##2##2##(2010-2#1)(2011-2#1)
pastoral care##7##2##(1992-1#2)(1993-12#1)(1993-2#1)(1996-1#1)(2008-12#1)(2010-2#1)
pastoral systems##2##2##(2011-2#2)
pastoral theology##2##2##(2009-10#2)
pastoral##24##1##(1991-2#1)(1992-1#3)(1993-12#2)(1993-2#1)(1996-1#1)(2007-7#1)(2008-12#1)(2008-2#1)(2009-10#2)(2010-1#2)(2010-2#3)(2010-9#2)(2011-2#4)
pastoris and##3##2##(2007-6#1)(2008-11#1)(2008-4#1)
pastoris by##2##2##(1996-9#1)(2008-4#1)
pastoris showed##2##2##(2008-4#1)(2013-1#1)
pastoris with##2##2##(2008-4#2)
pastoris##43##1##(1992-7#1)(1994-11#2)(1994-3#2)(1996-11#1)(1996-9#2)(1997-1#1)(1997-4#8)(1997-7#2)(1997-8#1)(2007-11#1)(2007-6#1)(2008-11#1)(2008-4#6)(2008-7#4)(2008-8#1)(2009-9#1)(2010-5#2)(2011-2#2)(2013-1#3)(2013-8#1)
pasture (P)##2##2##(2007-8#1)(2010-4#1)
pasture feeding##2##2##(2010-2#1)(2010-4#1)
pasture##39##1##(1994-1#1)(1996-12#4)(2005-7#1)(2007-8#1)(2008-10#5)(2008-5#8)(2009-3#1)(2010-2#7)(2010-4#6)(2011-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
pastures and##4##2##(2006-5#1)(2008-5#1)(2013-7#2)
pastures of##3##2##(2005-7#1)(2008-5#2)
pastures##21##1##(2005-7#1)(2006-5#1)(2007-8#3)(2008-10#1)(2008-5#5)(2010-2#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-7#2)(2013-7#3)
pat##2##1##(1991-7#1)(2004-11#1)
patch and the##7##3##(2003-11#1)(2006-10#1)(2008-8#3)(2010-2#1)(2011-3#1)
patch and##17##2##(1992-7#1)(2003-11#1)(2006-10#1)(2007-8#3)(2008-3#2)(2008-4#1)(2008-8#3)(2010-2#2)(2011-2#1)(2011-3#1)(2013-7#1)
patch area##5##2##(2008-8#4)(2013-8#1)
patch at the##3##3##(1996-7#1)(2007-8#2)
patch at##5##2##(1993-11#1)(1996-7#1)(2007-8#2)(2009-5#1)
patch clamp and##2##3##(2008-8#1)(2009-12#1)
patch clamp recording techniques##2##4##(1990-7#1)(1996-7#1)
patch clamp recording##3##3##(1990-7#1)(1996-7#1)(2008-11#1)
patch clamp recordings were obtained##3##5##(1996-1#1)(1997-5#2)
patch clamp recordings##7##3##(1993-9#1)(1996-1#2)(1997-5#2)(2008-1#1)(2008-8#1)
patch clamp technique was used##2##5##(1994-11#1)(1996-3#1)
patch clamp technique##8##3##(1991-1#1)(1991-5#1)(1993-12#2)(1993-3#1)(1994-11#1)(1996-3#1)(2008-8#1)
patch clamp##27##2##(1990-7#1)(1991-1#1)(1991-2#1)(1991-5#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-8#1)(1996-1#2)(1996-10#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-5#2)(2008-1#1)(2008-11#2)(2008-8#3)(2009-12#1)(2011-2#1)
patch closure##4##2##(2007-8#1)(2008-11#1)(2011-2#1)(2012-1#1)
patch configurations##2##2##(1994-12#1)(2008-8#1)
patch containing tamarind fruit extract##2##5##(2008-5#2)
patch density##3##2##(2008-8#3)
patch diameter and pseudothecia development##2##5##(2008-10#2)
patch diameter##3##2##(2008-10#3)
patch dynamics##3##2##(2008-8#1)(2010-2#2)
patch extinction rate##2##3##(2008-8#2)
patch extinction##3##2##(2008-8#3)
patch for##4##2##(2006-12#1)(2007-8#1)(2008-5#2)
patch in the##3##3##(1991-11#1)(2007-11#1)(2008-2#1)
patch in##6##2##(1991-11#1)(1993-10#1)(2007-11#1)(2007-7#1)(2008-2#1)(2011-3#1)
patch is##3##2##(2007-7#1)(2007-8#1)(2007-9#1)
patch isolation##2##2##(2008-8#2)
patch may##2##2##(2009-9#1)(2010-2#1)
patch network##3##2##(2008-8#3)
patch networks##2##2##(2008-8#2)
patch occupancy##17##2##(2007-9#2)(2008-8#11)(2008-9#4)
patch of##11##2##(1990-12#1)(1992-10#1)(1995-10#1)(1995-2#1)(2007-7#1)(2007-8#1)(2008-5#2)(2010-12#1)(2010-6#1)(2012-11#1)
patch on one##2##3##(1991-6#1)(2005-10#1)
patch on the##2##3##(2005-10#1)(2012-3#1)
patch on##7##2##(1990-3#1)(1991-6#1)(2005-10#2)(2007-7#1)(2011-2#1)(2012-3#1)
patch or##2##2##(2007-1#1)(2010-2#1)
patch pipette was##2##3##(1993-12#1)(1995-12#1)
patch pipette##5##2##(1993-12#1)(1995-12#2)(1996-1#1)(2009-12#1)
patch plasty##3##2##(1992-3#1)(2007-8#2)
patch reconstruction on##2##3##(2005-10#2)
patch reconstruction##4##2##(2005-10#3)(2013-1#1)
patch recording configuration##2##3##(1995-6#1)(1996-1#1)
patch reefs##3##2##(2007-5#1)(2008-5#1)(2012-2#1)
patch repair of##2##3##(2005-12#1)(2007-8#1)
patch rupture##2##2##(2005-10#2)
patch size##7##2##(1996-4#1)(2008-8#4)(2008-9#2)
patch technique##5##2##(1993-2#2)(2005-12#1)(2007-7#1)(2012-2#1)
patch test protocol##2##3##(2008-5#2)
patch test reactions##2##3##(2005-11#1)(2012-2#1)
patch test##13##2##(1992-6#1)(2005-11#1)(2007-8#1)(2008-5#6)(2009-6#2)(2012-2#1)(2012-3#1)
patch testing##2##2##(1997-2#1)(2007-7#1)
patch tests##3##2##(2007-9#1)(2008-5#2)
patch to##3##2##(2003-11#1)(2007-8#1)(2010-6#1)
patch using##2##2##(2007-8#1)(2008-5#1)
patch was applied to##2##4##(2006-3#2)
patch was##9##2##(1990-2#1)(2006-3#2)(2007-8#2)(2008-5#1)(2012-12#2)(2012-2#1)
patch were##2##2##(2006-3#1)(2010-2#1)
patch##324##1##(1990-12#1)(1990-2#4)(1990-3#2)(1990-4#1)(1990-7#2)(1991-1#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-7#3)(1993-10#3)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#5)(1994-5#1)(1994-8#1)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#1)(1996-1#4)(1996-10#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#2)(1997-2#1)(1997-5#2)(2003-11#2)(2004-12#1)(2005-10#9)(2005-11#1)(2005-12#2)(2006-10#1)(2006-12#3)(2006-3#6)(2007-1#1)(2007-11#1)(2007-5#1)(2007-7#8)(2007-8#31)(2007-9#6)(2008-1#1)(2008-10#9)(2008-11#11)(2008-2#1)(2008-3#6)(2008-4#5)(2008-5#21)(2008-6#1)(2008-8#50)(2008-9#14)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-9#2)(2010-12#2)(2010-2#9)(2010-6#3)(2011-2#6)(2011-3#3)(2012-1#2)(2012-11#1)(2012-12#13)(2012-2#5)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#2)
patch&quot##5##1##(2007-7#3)(2009-10#1)(2009-11#1)
patch-clamp analysis##2##2##(1997-4#1)(2008-8#1)
patch-clamp configuration##2##2##(1990-5#1)(1994-6#1)
patch-clamp method##5##2##(1990-7#1)(1996-12#1)(1996-9#1)(1997-5#1)(2008-8#1)
patch-clamp recording technique##2##3##(1997-1#1)(1997-5#1)
patch-clamp recording##8##2##(1991-12#1)(1995-12#2)(1997-1#1)(1997-5#1)(2008-11#1)(2008-8#1)(2011-2#1)
patch-clamp recordings##4##2##(1995-12#1)(1995-6#1)(2008-4#1)(2008-8#1)
patch-clamp technique was used to##2##5##(1992-11#1)(1994-3#1)
patch-clamp technique##18##2##(1990-10#1)(1990-3#1)(1991-5#1)(1991-6#1)(1992-11#2)(1993-3#1)(1994-3#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-2#1)(2007-12#1)(2012-2#1)
patch-clamp techniques in##2##3##(1994-11#1)(1997-7#1)
patch-clamp techniques were##3##3##(1993-12#1)(1994-2#1)(1997-5#1)
patch-clamp techniques##6##2##(1993-12#1)(1994-11#1)(1994-2#1)(1997-5#1)(1997-7#2)
patch-clamp##52##1##(1990-10#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-11#2)(1993-12#1)(1993-3#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#3)(1997-7#2)(1997-8#2)(2007-12#1)(2008-11#1)(2008-4#1)(2008-8#5)(2011-2#1)(2012-2#1)(2012-3#1)
patch-occupancy##2##1##(2007-9#2)
patched CEA##10##2##(2005-10#10)
patched and##4##2##(2005-10#3)(2012-2#1)
patched gene##2##2##(1997-3#1)(1997-6#1)
patched in##2##2##(1995-8#2)
patched##27##1##(1994-3#2)(1995-8#2)(1997-3#1)(1997-6#1)(2005-10#15)(2006-8#1)(2007-12#1)(2008-3#1)(2008-5#2)(2012-2#1)
patches and##16##2##(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#2)(2010-6#1)(2012-1#1)(2013-1#4)
patches are##7##2##(1992-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#2)(2012-2#1)
patches as well as##2##4##(2008-8#2)
patches as##5##2##(2006-7#1)(2008-8#3)(2008-9#1)
patches at##3##2##(1991-11#1)(2008-5#2)
patches for##5##2##(2004-12#2)(2008-6#1)(2008-8#1)(2010-1#1)
patches from##4##2##(1990-4#1)(1991-9#1)(1994-12#1)(1994-2#1)
patches have##3##2##(2008-11#2)(2008-9#1)
patches in the##4##3##(1997-1#1)(2008-11#1)(2008-5#1)(2012-3#1)
patches in##8##2##(1995-11#1)(1997-1#1)(2008-11#1)(2008-5#3)(2008-8#1)(2012-3#1)
patches is##8##2##(1997-1#1)(2007-12#1)(2007-9#1)(2008-6#1)(2008-8#3)(2008-9#1)
patches may##2##2##(2007-7#1)(2010-6#1)
patches of cultured##3##3##(1990-2#1)(1994-3#2)
patches of neurons##2##3##(1995-12#1)(1995-6#1)
patches of##25##2##(1990-2#1)(1992-10#1)(1992-12#1)(1994-10#1)(1994-3#2)(1995-1#1)(1995-12#1)(1995-6#1)(1997-7#1)(2007-12#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)(2013-8#1)
patches on the##5##3##(1990-7#1)(1996-12#1)(2008-7#1)(2010-6#1)(2012-3#1)
patches on##8##2##(1990-7#1)(1996-12#2)(2008-7#1)(2008-9#1)(2010-6#2)(2012-3#1)
patches or##4##2##(1994-7#1)(2010-4#1)(2010-6#2)
patches that##4##2##(2007-10#1)(2008-8#3)
patches to##4##2##(2006-5#1)(2008-5#1)(2008-9#2)
patches were investigated##2##3##(2004-12#1)(2008-10#1)
patches were##6##2##(1990-7#1)(2004-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2012-2#1)
patches with##9##2##(2005-11#1)(2008-11#1)(2008-5#3)(2008-8#2)(2008-9#2)
patches within##2##2##(2008-11#1)(2008-8#1)
patches##239##1##(1990-11#2)(1990-2#2)(1990-4#1)(1990-5#2)(1990-7#2)(1991-11#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-10#2)(1992-12#4)(1992-7#2)(1994-10#2)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#5)(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-12#4)(1996-4#3)(1996-9#1)(1997-1#2)(1997-6#1)(1997-7#1)(2004-12#4)(2005-11#1)(2006-12#2)(2006-5#2)(2006-7#2)(2007-10#1)(2007-11#2)(2007-12#7)(2007-7#1)(2007-9#5)(2008-1#1)(2008-10#4)(2008-11#10)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#15)(2008-6#6)(2008-7#6)(2008-8#46)(2008-9#33)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#8)(2010-7#1)(2010-8#1)(2012-1#2)(2012-2#3)(2012-3#2)(2012-9#1)(2013-1#4)(2013-8#1)
patches)##3##1##(1991-5#1)(2009-2#1)(2012-2#1)
patchily distributed##2##2##(1993-2#1)(2008-8#1)
patchiness##7##1##(2007-9#4)(2008-10#2)(2011-12#1)
patching is##2##2##(1993-10#1)(2012-12#1)
patching treatment##3##2##(1992-7#3)
patching##12##1##(1992-7#3)(1993-10#4)(2006-8#1)(2008-3#1)(2008-5#1)(2009-10#1)(2012-12#1)
patchwork##6##1##(1995-6#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2011-2#1)
patchy consolidation##2##2##(2005-8#1)(2011-2#1)
patchy infiltrations##2##2##(2008-1#2)
patchy landscapes##2##2##(2008-8#2)
patchy necrosis&quot##2##2##(2007-5#2)
patchy##40##1##(1991-11#4)(1993-7#1)(1994-12#1)(2005-8#1)(2006-9#1)(2007-5#3)(2007-7#1)(2007-9#6)(2008-1#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#5)(2008-9#2)(2009-2#1)(2009-8#3)(2010-12#2)(2011-2#2)(2012-12#1)(2012-2#1)
patella and##8##2##(2007-1#1)(2007-7#4)(2008-8#1)(2012-12#1)(2012-2#1)
patella component##2##2##(2013-1#2)
patella fracture##4##2##(2006-11#3)(2009-3#1)
patella fractures##3##2##(2006-11#1)(2009-3#2)
patella is##2##2##(2006-11#1)(2013-1#1)
patella tendon##2##2##(2011-2#1)(2013-1#1)
patella##53##1##(1993-7#1)(1996-2#2)(2005-7#1)(2006-10#1)(2006-11#10)(2007-1#1)(2007-11#2)(2007-2#1)(2007-7#5)(2007-8#6)(2008-12#1)(2008-8#1)(2009-3#5)(2009-4#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#9)
patellamide D##5##2##(1993-7#5)
patellar cartilage defects (chondromalacia NUD)##2##5##(2007-11#2)
patellar cartilage defects##5##3##(2007-11#5)
patellar cartilage##6##2##(2007-11#5)(2008-7#1)
patellar dislocation##5##2##(2007-7#1)(2009-3#4)
patellar hypomobility##3##2##(2007-7#3)
patellar realignment##2##2##(2007-7#2)
patellar resurfacing##2##2##(2012-1#1)(2013-1#1)
patellar tendon and##2##3##(2009-9#2)
patellar tendon rupture##8##3##(2009-4#5)(2011-2#1)(2012-12#2)
patellar tendon##32##2##(2007-4#1)(2008-1#5)(2008-9#4)(2009-3#1)(2009-4#7)(2009-9#7)(2011-2#2)(2012-12#2)(2013-1#3)
patellar##70##1##(1995-8#1)(1997-8#1)(2007-11#5)(2007-4#1)(2007-6#3)(2007-7#10)(2008-1#5)(2008-4#1)(2008-7#2)(2008-9#4)(2009-3#5)(2009-4#7)(2009-6#1)(2009-9#7)(2010-9#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#7)
patellar-pubic percussion test##2##3##(2008-12#2)
patello-femoral##8##1##(2006-11#1)(2007-1#2)(2007-7#3)(2007-8#2)
patellofemoral dysfunction##2##2##(2007-7#2)
patellofemoral pain syndrome##7##3##(1996-3#1)(2008-12#4)(2009-7#1)(2012-3#1)
patellofemoral pain##10##2##(1996-3#1)(2007-6#2)(2008-12#4)(2009-7#1)(2011-2#1)(2012-3#1)
patellofemoral##33##1##(1996-3#2)(2007-6#5)(2007-7#4)(2007-8#3)(2008-12#6)(2008-7#1)(2008-8#1)(2009-3#3)(2009-7#1)(2011-2#5)(2012-3#1)(2013-1#1)
patencies##2##1##(2007-8#1)(2011-3#1)
patency and lower##2##3##(2007-10#1)(2007-7#1)
patency and##9##2##(1993-1#1)(2007-10#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2013-1#1)
patency at##3##2##(2007-11#1)(2007-7#1)(2007-8#1)
patency following##3##2##(1997-2#1)(2007-7#1)(2007-8#1)
patency in##7##2##(1990-8#1)(2006-11#1)(2007-7#1)(2007-8#4)
patency is##3##2##(1991-11#1)(2006-10#1)(2007-7#1)
patency of the stoma##2##4##(2006-5#2)
patency of the##15##3##(1990-4#1)(1990-6#1)(1993-10#1)(2006-5#2)(2007-7#1)(2007-8#5)(2008-6#1)(2010-12#1)(2011-2#2)
patency of##25##2##(1990-4#2)(1990-6#1)(1993-10#1)(2006-5#2)(2007-7#3)(2007-8#5)(2007-9#1)(2008-6#2)(2010-12#1)(2011-2#2)(2011-3#2)(2012-12#1)(2013-7#2)
patency rate and##2##3##(1993-1#1)(1996-2#1)
patency rate of natural arteriovenous fistula but not##2##8##(2007-7#2)
patency rate of natural##3##4##(2007-7#3)
patency rate of the##2##4##(2007-7#1)(2007-8#1)
patency rate of##10##3##(1994-2#1)(2007-7#6)(2007-8#3)
patency rate##22##2##(1993-1#1)(1994-2#1)(1996-2#1)(2007-10#2)(2007-7#12)(2007-8#5)
patency rates at 12##2##4##(2007-7#2)
patency rates at##5##3##(2007-11#1)(2007-7#4)
patency rates of primary radiocephalic fistulae##2##6##(2007-7#2)
patency rates##19##2##(1997-3#1)(2007-11#2)(2007-7#14)(2007-8#1)(2013-7#1)
patency than##4##2##(2006-6#1)(2007-8#3)
patency was achieved##2##3##(1993-1#1)(2007-7#1)
patency was restored##2##3##(2007-9#1)(2011-3#1)
patency was##13##2##(1993-1#1)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#1)(2011-3#1)(2013-1#1)
patency with##2##2##(2007-11#1)(2007-8#1)
patency##142##1##(1990-4#2)(1990-6#1)(1990-8#1)(1991-11#1)(1993-1#3)(1993-10#1)(1993-7#2)(1994-12#1)(1994-2#1)(1996-2#2)(1997-2#1)(1997-3#1)(1997-6#1)(2006-10#1)(2006-11#1)(2006-5#2)(2006-6#1)(2007-10#4)(2007-11#5)(2007-7#45)(2007-8#38)(2007-9#3)(2008-1#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2009-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2011-3#3)(2012-12#1)(2013-1#3)(2013-7#3)(2013-8#1)
patent airway##4##2##(1997-4#1)(2005-8#1)(2007-8#2)
patent applications filed##2##3##(2008-1#2)
patent applications##15##2##(2005-7#1)(2005-8#1)(2007-2#2)(2008-1#4)(2010-12#7)
patent arterial duct##3##3##(1992-10#1)(2012-12#2)
patent blue V##2##3##(2008-10#2)
patent documents##2##2##(2008-1#2)
patent ductus arteriosus (PDA) and##2##5##(2006-8#1)(2007-8#1)
patent ductus arteriosus (PDA)##3##4##(2006-8#1)(2007-7#1)(2007-8#1)
patent ductus arteriosus##18##3##(1993-10#1)(1995-6#1)(1997-8#1)(2006-8#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-4#1)(2009-10#2)(2010-10#2)(2010-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
patent ductus##19##2##(1993-10#1)(1995-6#1)(1996-9#1)(1997-8#1)(2006-8#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-4#1)(2009-10#2)(2010-10#2)(2010-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
patent foramen ovale (PFO)##6##4##(1996-6#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-7#1)(2011-2#1)
patent foramen ovale and##2##4##(2007-10#1)(2008-7#1)
patent foramen ovale in##2##4##(2008-7#1)(2012-2#1)
patent foramen ovale thrombus##3##4##(2011-2#3)
patent foramen ovale##20##3##(1996-6#1)(2006-8#1)(2007-10#3)(2007-12#1)(2007-8#2)(2008-7#3)(2009-10#1)(2009-5#1)(2010-12#1)(2011-2#5)(2012-2#1)
patent grafts##3##2##(2007-8#2)(2013-1#1)
patent in##2##2##(1992-10#1)(2008-1#1)
patent landscape##4##2##(2009-11#4)
patent law##2##2##(2005-11#1)(2010-7#1)
patent literature for##3##3##(2005-6#1)(2005-8#1)(2008-1#1)
patent literature##16##2##(2005-6#1)(2005-7#3)(2005-8#3)(2008-1#9)
patent medicines##3##2##(2005-12#3)
patent offices##6##2##(2009-11#1)(2010-12#5)
patent on##2##2##(2008-1#1)(2009-3#1)
patent protection for##2##3##(2005-11#1)(2008-7#1)
patent protection##7##2##(2005-11#1)(2005-7#1)(2007-2#1)(2008-1#1)(2008-7#2)(2011-3#1)
patent publications##2##2##(2010-12#2)
patent rights##4##2##(1991-11#1)(1997-8#1)(2005-7#1)(2010-7#1)
patent system is##2##3##(2007-2#1)(2008-7#1)
patent system##6##2##(2007-2#1)(2008-7#2)(2009-11#1)(2010-7#2)
patent with##2##2##(1996-9#1)(2006-4#1)
patent##195##1##(1990-3#1)(1990-6#1)(1991-11#2)(1992-10#2)(1993-10#1)(1994-6#1)(1995-6#1)(1996-2#1)(1996-6#1)(1996-9#2)(1997-2#1)(1997-4#1)(1997-8#4)(2005-11#2)(2005-12#3)(2005-6#5)(2005-7#7)(2005-8#8)(2005-9#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-6#1)(2006-8#2)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#7)(2007-7#1)(2007-8#12)(2007-9#3)(2008-1#23)(2008-10#5)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#1)(2009-10#3)(2009-11#8)(2009-3#2)(2009-5#1)(2010-10#2)(2010-12#18)(2010-2#1)(2010-7#7)(2011-2#9)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)
patentability requirements##2##2##(2009-11#1)(2011-1#1)
patentability##3##1##(2008-7#1)(2009-11#1)(2011-1#1)
patented drugs##2##2##(2008-1#2)
patented for##2##2##(2008-1#2)
patented##29##1##(1992-8#1)(1993-11#1)(2005-11#1)(2005-7#1)(2007-8#1)(2008-1#13)(2008-10#1)(2008-5#1)(2010-7#6)(2011-2#1)(2012-12#1)(2012-2#1)
patenting##5##1##(2007-2#2)(2007-8#1)(2008-1#1)(2009-2#1)
patents and##8##2##(2005-10#1)(2008-1#4)(2009-11#1)(2010-7#1)(2013-1#1)
patents are##7##2##(2007-2#3)(2008-1#1)(2009-11#1)(2010-7#2)
patents for##3##2##(2008-1#3)
patents from##2##2##(2008-1#1)(2008-5#1)
patents have been##2##3##(2008-1#2)
patents have described##3##3##(2008-1#3)
patents have##6##2##(2008-1#6)
patents in the field##2##4##(2007-8#1)(2008-1#1)
patents in the##3##3##(2007-8#1)(2008-1#1)(2009-11#1)
patents in this##5##3##(2008-1#5)
patents in##9##2##(2007-2#1)(2007-8#1)(2008-1#6)(2009-11#1)
patents on stem##2##3##(2005-11#2)
patents on##12##2##(2005-11#2)(2007-3#1)(2008-1#4)(2008-6#2)(2010-7#3)
patents related to##3##3##(2008-1#2)(2010-7#1)
patents relating to##2##3##(2008-5#2)
patents search##2##2##(2008-1#1)(2009-7#1)
patents that##5##2##(2008-1#4)(2008-5#1)
patents to##3##2##(2006-6#1)(2008-5#1)(2008-8#1)
patents were##3##2##(2008-1#1)(2010-7#1)(2013-1#1)
patents##104##1##(1992-4#1)(1992-5#1)(1994-12#1)(1995-11#1)(1997-3#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-6#2)(2006-8#1)(2007-2#6)(2007-3#1)(2007-8#1)(2008-1#47)(2008-2#1)(2008-5#8)(2008-6#2)(2008-8#1)(2009-11#6)(2009-12#1)(2009-7#1)(2010-7#9)(2011-1#2)(2013-1#2)
patents?##2##1##(1991-10#1)(2009-11#1)
paternal (aOR 1##2##3##(2011-1#2)
paternal (aOR##3##2##(2011-1#3)
paternal allele##3##2##(1992-8#1)(2010-12#1)(2010-9#1)
paternal care is##4##3##(2008-8#3)(2008-9#1)
paternal care##11##2##(2008-8#5)(2008-9#5)(2010-8#1)
paternal effects##3##2##(2008-9#2)(2011-2#1)
paternal investment by mating with##2##5##(2008-8#2)
paternal investment##7##2##(2008-8#6)(2008-9#1)
paternal serum HBV-DNA##3##3##(2011-1#3)
paternal smoking##2##2##(1990-10#2)
paternal##83##1##(1990-10#3)(1990-11#1)(1992-1#1)(1992-8#2)(1993-2#1)(1994-9#1)(1995-10#1)(1995-11#2)(1996-12#2)(1996-3#3)(1996-6#1)(1997-3#2)(1997-4#1)(2004-11#2)(2006-10#1)(2006-7#2)(2007-12#2)(2007-7#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#13)(2008-9#13)(2009-11#2)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#9)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
paternalism##6##1##(2007-10#1)(2010-11#1)(2010-8#4)
paternalistic##6##1##(1993-10#1)(2006-3#2)(2007-12#1)(2009-2#1)(2011-2#1)
paternally derived deletions##4##3##(1997-3#4)
paternally derived##5##2##(1996-3#1)(1997-3#4)
paternally silenced dataset##2##3##(2008-7#2)
paternally silenced##5##2##(2008-7#5)
paternally##12##1##(1996-3#2)(1997-3#4)(2008-7#5)(2010-11#1)
paternity analysis##2##2##(2008-8#1)(2008-9#1)
paternity and##4##2##(1991-7#3)(2008-9#1)
paternity casework##5##2##(2008-12#4)(2010-9#1)
paternity in##5##2##(2008-8#2)(2008-9#3)
paternity index (PI)##2##3##(2010-9#2)
paternity index##3##2##(2008-12#1)(2010-9#2)
paternity testing##9##2##(1990-3#1)(1993-7#1)(2008-12#4)(2008-4#1)(2008-5#1)(2010-9#1)
paternity##53##1##(1990-3#3)(1991-7#3)(1993-7#3)(2005-9#1)(2006-5#2)(2006-9#1)(2007-12#1)(2008-12#15)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#6)(2008-9#7)(2010-2#1)(2010-9#6)
path &quot##2##2##(2008-11#1)(2008-2#1)
path analyses indicated##2##3##(2007-12#1)(2009-7#1)
path analyses##4##2##(2007-11#1)(2007-12#1)(2009-7#1)(2010-2#1)
path analysis##8##2##(1990-12#1)(1995-11#1)(2004-11#1)(2008-8#1)(2008-9#1)(2010-3#1)(2012-1#1)(2012-3#1)
path and the##2##3##(2008-2#2)
path and##11##2##(1992-9#1)(1993-12#1)(2006-6#1)(2007-12#2)(2008-2#4)(2008-3#1)(2011-1#1)
path are##2##2##(2008-3#1)(2009-7#1)
path by##4##2##(2007-11#2)(2008-10#1)(2008-3#1)
path delay##2##2##(2008-3#2)
path difference between the two##3##5##(2008-2#2)(2008-3#1)
path difference between the##5##4##(2008-2#3)(2008-3#2)
path difference between##7##3##(2008-2#5)(2008-3#2)
path difference to##2##3##(2008-2#1)(2013-8#1)
path difference##42##2##(2007-12#8)(2008-2#14)(2008-3#14)(2013-8#6)
path differences##4##2##(2007-11#2)(2008-1#1)(2008-3#1)
path enhancement##2##2##(2008-2#2)
path equality##2##2##(2008-2#2)
path for the##2##3##(1994-2#1)(2008-3#1)
path for##14##2##(1992-9#1)(1994-2#1)(1995-12#1)(2007-7#1)(2008-1#1)(2008-3#3)(2008-4#1)(2008-6#1)(2009-4#1)(2011-1#1)(2012-12#2)
path from the##3##3##(2008-11#1)(2008-2#1)(2012-12#1)
path from##8##2##(2005-7#1)(2008-11#1)(2008-2#2)(2009-7#2)(2010-5#1)(2012-12#1)
path geometry##2##2##(2008-3#1)(2008-7#1)
path in the##2##3##(1990-5#1)(2008-2#1)
path in##8##2##(1990-4#1)(1990-5#1)(1993-12#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-2#2)
path integrals##2##2##(1994-2#1)(2008-2#1)
path is##5##2##(2007-2#1)(2007-7#1)(2008-2#1)(2008-3#2)
path length L##2##3##(2008-3#2)
path length and a##2##4##(2008-10#1)(2008-2#1)
path length and##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
path length during##2##3##(2008-10#1)(2010-2#1)
path length for##2##3##(2008-3#1)(2011-11#1)
path length in the##2##4##(2005-11#1)(2008-2#1)
path length is##2##3##(1997-6#1)(2007-12#1)
path length of##5##3##(2008-2#3)(2008-3#2)
path length was##2##3##(1997-6#1)(2008-11#1)
path length were##2##3##(1997-6#1)(2008-7#1)
path length with##2##3##(2005-11#1)(2008-2#1)
path length##61##2##(1991-11#1)(1997-6#7)(2005-11#2)(2007-11#1)(2007-12#5)(2008-10#9)(2008-11#1)(2008-2#13)(2008-3#18)(2008-4#1)(2008-7#1)(2010-2#1)(2011-11#1)
path lengths in##2##3##(2008-3#2)
path lengths##20##2##(1997-6#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-2#4)(2008-3#8)
path of a##5##3##(1992-6#1)(2008-3#2)(2008-5#1)(2009-4#1)
path of the light##2##4##(2007-12#1)(2007-3#1)
path of the scattering medium##2##5##(2008-3#2)
path of the##20##3##(1997-2#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#1)(2008-10#1)(2008-2#3)(2008-3#6)(2008-6#2)(2010-8#1)(2013-8#1)
path of##42##2##(1992-6#1)(1993-6#1)(1996-5#1)(1997-2#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-2#7)(2008-3#10)(2008-5#2)(2008-6#2)(2009-4#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-8#1)
path problems##2##2##(2008-2#2)
path radiance##6##2##(2008-2#5)(2008-3#1)
path that##5##2##(2008-1#1)(2008-10#1)(2008-3#2)(2012-3#1)
path through##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2009-9#1)
path throughout##3##2##(2007-12#1)(2008-2#2)
path to the##3##3##(1996-3#1)(2007-4#1)(2010-3#1)
path to##24##2##(1990-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-3#1)(2005-10#1)(2006-5#1)(2006-7#1)(2007-4#1)(2008-3#2)(2008-6#2)(2009-3#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-8#1)
path toward##5##2##(1990-12#1)(1991-4#1)(2006-7#1)(2007-4#1)(2008-3#1)
path was##2##2##(2007-11#1)(2008-3#1)
path with##2##2##(2008-11#1)(2008-2#1)
path##439##1##(1990-10#1)(1990-12#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-4#1)(1992-1#1)(1992-2#1)(1992-6#1)(1992-7#4)(1992-8#1)(1992-9#5)(1993-12#6)(1993-3#1)(1993-6#1)(1994-1#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-11#2)(1995-12#6)(1996-1#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-5#1)(1997-6#8)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#3)(2006-9#1)(2007-11#15)(2007-12#34)(2007-2#1)(2007-3#2)(2007-4#4)(2007-5#3)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#6)(2008-10#20)(2008-11#7)(2008-2#80)(2008-3#108)(2008-4#2)(2008-5#4)(2008-6#5)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#2)(2009-4#2)(2009-7#6)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#5)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#2)(2011-1#4)(2011-11#1)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#6)(2013-8#9)
path)##2##1##(1990-10#1)(2008-2#1)
path-average dispersion##4##2##(2007-12#4)
path-averaged Gabitov-Turitsyn equation##2##3##(2007-12#2)
path-averaged##7##1##(2007-12#6)(2008-2#1)
path-difference##2##1##(2007-11#1)(2007-12#1)
path-difference-dependent##2##1##(2008-2#2)
path-history##2##1##(2008-3#2)
path-independent##2##1##(2008-3#2)
path-integral##3##1##(2006-4#1)(2009-9#2)
path-integrated##2##1##(2008-2#2)
path-length differences##3##2##(2007-11#2)(2007-12#1)
path-length distribution is##2##3##(2007-12#2)
path-length distribution##6##2##(2007-12#4)(2008-3#2)
path-length offsets##2##2##(2008-3#2)
path-length parameter##2##2##(2008-2#2)
path-length spectroscopy##4##2##(2007-12#2)(2008-3#2)
path-length##30##1##(2007-11#2)(2007-12#8)(2008-2#8)(2008-3#12)
path-reversed substrate-guided-wave##2##2##(2008-3#2)
path?##2##1##(2007-12#1)(2008-2#1)
pathfinding##3##1##(1991-11#1)(2008-2#1)(2008-7#1)
pathlength absorbance spectroscopy##2##3##(2008-10#2)
pathlength and##2##2##(2008-10#1)(2010-7#1)
pathlength##24##1##(2006-12#1)(2007-8#2)(2008-10#15)(2010-3#1)(2010-7#1)(2011-1#3)(2012-12#1)
patho##2##1##(1990-12#1)(2008-1#1)
patho-physiological##8##1##(1995-6#2)(2007-8#1)(2008-1#1)(2008-4#2)(2008-7#1)(2009-10#1)
patho-physiology##2##1##(2007-10#1)(2007-12#1)
patho-types##4##1##(2008-10#4)
pathobiologic##2##1##(2010-12#1)(2012-12#1)
pathobiological##2##1##(2005-10#1)(2008-7#1)
pathobiology of##5##2##(1991-12#1)(2006-2#2)(2008-7#1)(2010-5#1)
pathobiology##12##1##(1991-12#1)(1993-2#1)(2006-2#2)(2008-10#1)(2008-7#1)(2009-10#1)(2010-5#2)(2011-1#1)(2012-12#1)(2012-2#1)
pathogen Alternaria##2##2##(1992-8#1)(2008-10#1)
pathogen Aphanomyces euteiches##2##3##(2008-10#2)
pathogen Candida albicans is##2##4##(2007-7#1)(2008-4#1)
pathogen Candida albicans##5##3##(1992-8#1)(2007-7#1)(2008-4#1)(2009-8#1)(2010-12#1)
pathogen Cercospora sorghi##2##3##(2008-10#2)
pathogen Cercospora##3##2##(2008-10#3)
pathogen Colletotrichum gloeosporioides##2##3##(2008-10#2)
pathogen Colletotrichum lindemuthianum##2##3##(2008-10#1)(2010-10#1)
pathogen Colletotrichum##4##2##(2008-10#3)(2010-10#1)
pathogen DNA##18##2##(2008-10#18)
pathogen Elsinoë fawcettii##2##3##(2010-10#2)
pathogen Fusarium oxysporum f##4##4##(2008-10#4)
pathogen Fusarium##5##2##(2008-10#4)(2011-10#1)
pathogen Listeria monocytogenes##3##3##(1992-7#1)(2008-7#1)(2011-2#1)
pathogen Mycosphaerella##2##2##(2008-10#2)
pathogen P##2##2##(2008-10#1)(2009-2#1)
pathogen Phytophthora##5##2##(2008-10#4)(2009-2#1)
pathogen Pseudomonas syringae pv##3##4##(2008-10#3)
pathogen Pseudomonas syringae##4##3##(2008-10#3)(2011-1#1)
pathogen Puccinia##3##2##(2008-10#3)
pathogen Pythium##2##2##(2008-10#2)
pathogen Venturia inaequalis##3##3##(2008-10#3)
pathogen Verticillium##2##2##(2008-10#2)
pathogen Xanthomonas oryzae pv##2##4##(2008-10#2)
pathogen Xanthomonas##4##2##(2008-10#3)(2010-10#1)
pathogen adaptation##2##2##(2008-10#2)
pathogen also##4##2##(2008-10#4)
pathogen and a##2##3##(2007-7#1)(2008-10#1)
pathogen and host DNA##2##4##(2008-10#2)
pathogen and its##3##3##(1991-1#1)(1995-5#1)(2008-9#1)
pathogen and##35##2##(1991-1#1)(1995-5#1)(2006-10#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#22)(2008-8#1)(2008-9#2)(2012-1#1)(2013-1#1)
pathogen are##4##2##(2007-7#1)(2008-10#1)(2008-9#2)
pathogen as the##2##3##(2008-4#2)
pathogen as##7##2##(2008-10#4)(2008-3#1)(2008-4#2)
pathogen associated with##4##3##(1995-2#1)(2008-7#1)(2012-12#1)(2012-2#1)
pathogen associated##5##2##(1995-2#1)(2008-7#1)(2012-12#1)(2012-2#2)
pathogen at##3##2##(2008-10#3)
pathogen attack and##2##3##(2008-10#2)
pathogen attack##9##2##(2008-10#7)(2009-6#1)(2010-9#1)
pathogen attacks##2##2##(1992-11#1)(2009-8#1)
pathogen based on##2##3##(2008-10#2)
pathogen by##6##2##(2008-10#5)(2009-6#1)
pathogen can be##6##3##(2008-10#6)
pathogen can have##2##3##(2008-10#2)
pathogen can spread##2##3##(2008-10#2)
pathogen can##14##2##(1990-11#1)(2006-5#1)(2008-10#12)
pathogen causes##2##2##(2008-10#2)
pathogen causing##9##2##(1995-2#1)(2006-3#1)(2008-1#1)(2008-10#4)(2008-8#1)(2011-2#1)
pathogen cell##2##2##(2008-10#2)
pathogen cells##2##2##(2007-12#1)(2008-10#1)
pathogen control by##2##3##(2008-10#2)
pathogen control##8##2##(2008-10#7)(2012-2#1)
pathogen culture collections##3##3##(2008-10#3)
pathogen defense in the absence of##2##6##(2008-10#2)
pathogen defense##5##2##(2008-10#4)(2012-1#1)
pathogen densities##2##2##(2008-10#2)
pathogen detection##9##2##(2007-9#2)(2008-10#5)(2011-1#1)(2011-2#1)
pathogen development##4##2##(2008-10#4)
pathogen did not##4##3##(2008-10#4)
pathogen dissemination##2##2##(2008-10#2)
pathogen distribution##2##2##(2008-10#2)
pathogen diversity##2##2##(2008-10#2)
pathogen dose##2##2##(2008-10#2)
pathogen elimination##2##2##(2008-2#2)
pathogen entry##2##2##(2009-8#1)(2012-1#1)
pathogen evolution in cultivar mixtures##2##5##(2008-10#2)
pathogen evolution in##3##3##(2008-10#3)
pathogen evolution##7##2##(2008-10#5)(2011-10#1)(2013-1#1)
pathogen fitness##2##2##(2008-10#1)(2008-9#1)
pathogen for##4##2##(2006-10#1)(2008-10#1)(2012-2#2)
pathogen free##5##2##(1991-11#2)(1991-6#1)(2008-10#1)(2008-5#1)
pathogen from##9##2##(2007-12#1)(2007-7#1)(2008-10#7)
pathogen genome##2##2##(2008-10#1)(2012-2#1)
pathogen genotype##2##2##(2008-10#2)
pathogen genotypes##6##2##(2008-10#6)
pathogen germination##2##2##(2008-10#2)
pathogen growth and##2##3##(2008-10#1)(2009-8#1)
pathogen growth##10##2##(2008-10#9)(2009-8#1)
pathogen had##3##2##(1993-2#1)(2008-10#2)
pathogen has##6##2##(2008-10#5)(2008-9#1)
pathogen hyphae##3##2##(2008-10#3)
pathogen in Australia##2##3##(2008-10#1)(2012-11#1)
pathogen in Canada##2##3##(2007-12#2)
pathogen in a##2##3##(2008-10#2)
pathogen in neonatal##2##3##(2007-7#2)
pathogen in planta##3##3##(2008-10#3)
pathogen in the##8##3##(2008-10#4)(2008-5#1)(2008-9#1)(2012-2#2)
pathogen in vitro##2##3##(2008-10#2)
pathogen in##47##2##(2005-8#1)(2007-11#1)(2007-12#2)(2007-7#4)(2008-10#29)(2008-11#1)(2008-5#2)(2008-9#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#1)
pathogen infection in##2##3##(2008-10#1)(2008-9#1)
pathogen infection##10##2##(1997-2#1)(1997-3#1)(2008-10#3)(2008-9#2)(2009-2#1)(2009-8#2)
pathogen infection-induced##2##2##(2008-8#2)
pathogen ingress##5##2##(2008-10#5)
pathogen inhibitory activity of##2##4##(2008-10#2)
pathogen inhibitory activity##5##3##(2008-10#5)
pathogen inoculation was##2##3##(2008-10#2)
pathogen inoculation##5##2##(2008-10#5)
pathogen inoculum##6##2##(2008-10#6)
pathogen into##5##2##(2008-10#4)(2011-2#1)
pathogen invasion and##2##3##(2008-10#1)(2008-9#1)
pathogen invasion##6##2##(2008-10#3)(2008-9#1)(2009-8#1)(2012-1#1)
pathogen is not##3##3##(2007-5#1)(2008-10#2)
pathogen is therefore##2##3##(2008-5#1)(2011-2#1)
pathogen is##21##2##(2006-10#1)(2007-5#1)(2007-7#1)(2008-10#10)(2008-5#1)(2008-8#1)(2009-3#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#1)
pathogen isolate##2##2##(2008-10#2)
pathogen isolated from##3##3##(2007-7#1)(2007-8#1)(2013-1#1)
pathogen isolates##4##2##(2008-10#4)
pathogen life cycle component##2##4##(2008-10#2)
pathogen life cycle##4##3##(2008-10#4)
pathogen like##2##2##(2007-8#1)(2012-2#1)
pathogen lineages##2##2##(2008-10#2)
pathogen migration between##2##3##(2008-10#2)
pathogen occurs in##2##3##(1995-5#1)(2008-10#1)
pathogen of a##3##3##(2008-10#3)
pathogen of citrus##2##3##(2008-10#2)
pathogen of humans##3##3##(1991-9#1)(2007-12#1)(2008-10#1)
pathogen of the##2##3##(2007-5#2)
pathogen of wheat##2##3##(2008-10#2)
pathogen of##35##2##(1991-9#1)(1992-7#1)(1993-9#1)(1994-12#1)(1997-2#1)(2006-12#1)(2007-12#1)(2007-5#2)(2008-10#23)(2008-9#1)(2011-1#1)(2012-2#1)
pathogen on##9##2##(2008-10#9)
pathogen or##6##2##(2008-10#2)(2009-6#1)(2012-11#1)(2012-2#1)(2013-1#1)
pathogen penetration##2##2##(2008-10#2)
pathogen population in##2##3##(2008-10#2)
pathogen population size##2##3##(2008-10#2)
pathogen population structure##2##3##(2008-10#2)
pathogen population was##3##3##(2005-11#1)(2008-10#2)
pathogen population##38##2##(2005-11#1)(2008-10#35)(2008-2#1)(2008-8#1)
pathogen populations##17##2##(2008-10#16)(2008-8#1)
pathogen presence##2##2##(2008-10#2)
pathogen propagules##2##2##(2008-10#2)
pathogen race##3##2##(2008-10#2)(2008-8#1)
pathogen races##3##2##(2008-10#3)
pathogen recognition##3##2##(2009-2#1)(2013-1#2)
pathogen resistance in##2##3##(2006-12#1)(2008-10#1)
pathogen resistance##8##2##(2006-12#2)(2008-10#5)(2009-8#1)
pathogen responsible for##2##3##(2008-10#1)(2011-2#1)
pathogen species##6##2##(2008-10#6)
pathogen specific##2##2##(2008-10#1)(2012-2#1)
pathogen spores##2##2##(2008-10#2)
pathogen sporulation##4##2##(2008-10#4)
pathogen spread##5##2##(2006-5#1)(2008-10#4)
pathogen strains##6##2##(2008-10#6)
pathogen suppression##5##2##(2008-10#5)
pathogen survival##4##2##(2008-10#4)
pathogen that causes##5##3##(2006-11#1)(2007-12#2)(2007-8#1)(2008-10#1)
pathogen that has been##2##4##(2011-2#1)(2012-3#1)
pathogen that is##3##3##(2008-10#2)(2010-10#1)
pathogen that##19##2##(2006-11#1)(2007-12#2)(2007-8#1)(2008-10#7)(2008-9#1)(2010-10#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#1)
pathogen through##4##2##(2008-1#1)(2008-10#2)(2013-8#1)
pathogen to##11##2##(2008-10#7)(2009-2#1)(2009-8#2)(2011-1#1)
pathogen variability##2##2##(2008-10#2)
pathogen virulence##5##2##(2008-10#3)(2008-9#2)
pathogen was found to##2##4##(2008-10#1)(2010-10#1)
pathogen was found##3##3##(2008-10#2)(2010-10#1)
pathogen was isolated##3##3##(2008-10#1)(2013-1#2)
pathogen was observed on##2##4##(2008-10#2)
pathogen was visualized##2##3##(2008-10#2)
pathogen was##28##2##(2007-2#1)(2007-5#1)(2008-10#21)(2010-10#1)(2012-3#1)(2013-1#3)
pathogen were##11##2##(2008-10#11)
pathogen with a##2##3##(2008-10#2)
pathogen with##4##2##(2008-10#3)(2012-3#1)
pathogen##1110##1##(1990-11#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-5#1)(1992-7#2)(1992-8#2)(1993-11#1)(1993-2#1)(1993-9#2)(1994-12#2)(1994-6#1)(1995-2#3)(1995-5#3)(1995-8#1)(1996-10#3)(1996-11#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-2#3)(1997-3#1)(1997-5#1)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#5)(2006-3#1)(2006-5#5)(2006-8#3)(2007-1#1)(2007-11#1)(2007-12#15)(2007-2#2)(2007-5#7)(2007-7#12)(2007-8#6)(2007-9#2)(2008-1#3)(2008-10#763)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#4)(2008-5#10)(2008-6#1)(2008-7#4)(2008-8#12)(2008-9#25)(2009-12#1)(2009-2#5)(2009-3#1)(2009-5#1)(2009-6#6)(2009-8#19)(2010-1#1)(2010-10#10)(2010-12#5)(2010-3#3)(2010-4#1)(2010-5#1)(2010-9#2)(2011-1#10)(2011-10#4)(2011-2#23)(2012-1#5)(2012-11#4)(2012-12#4)(2012-2#20)(2012-3#8)(2013-1#22)(2013-7#1)(2013-8#9)
pathogen's life cycle##3##3##(2008-10#3)
pathogen's life##4##2##(2008-10#4)
pathogen's##12##1##(2008-10#8)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#1)
pathogen(s)##2##1##(2012-2#2)
pathogen)##4##1##(2008-10#3)(2008-2#1)
pathogen-associated molecular patterns (PAMPs)##3##4##(2005-10#1)(2012-12#1)(2013-1#1)
pathogen-associated molecular patterns##7##3##(2005-10#1)(2008-4#2)(2009-8#1)(2012-1#1)(2012-12#1)(2013-1#1)
pathogen-associated molecular##8##2##(2005-10#1)(2008-4#2)(2009-8#2)(2012-1#1)(2012-12#1)(2013-1#1)
pathogen-associated##9##1##(2005-10#1)(2008-4#2)(2009-8#2)(2010-12#1)(2012-1#1)(2012-12#1)(2013-1#1)
pathogen-derived resistance##3##2##(2008-10#3)
pathogen-derived##8##1##(1995-5#1)(2006-10#1)(2008-10#3)(2010-12#1)(2011-1#1)(2012-1#1)
pathogen-free chickens##4##2##(2008-5#4)
pathogen-free##10##1##(1992-10#1)(1992-5#1)(1997-6#1)(2008-10#1)(2008-5#6)
pathogen-host combinations##2##2##(2008-10#1)(2008-9#1)
pathogen-host##3##1##(2007-7#1)(2008-10#1)(2008-9#1)
pathogen-induced##3##1##(2008-10#2)(2008-9#1)
pathogen-infested##3##1##(2008-10#3)
pathogen-mimicking##2##1##(2012-2#2)
pathogen-related##2##1##(2009-8#1)(2011-2#1)
pathogen-specific##6##1##(2007-5#3)(2008-10#1)(2012-2#1)(2012-3#1)
pathogeneses##3##1##(2006-12#1)(2007-3#1)(2010-5#1)
pathogenesis and clinical##3##3##(1994-6#1)(2008-3#1)(2013-8#1)
pathogenesis and development of##3##4##(2008-9#1)(2011-2#1)(2012-1#1)
pathogenesis and growth of##2##4##(2008-10#1)(2008-4#1)
pathogenesis and implications for##2##4##(1996-12#1)(2006-2#1)
pathogenesis and its##2##3##(2007-7#1)(2010-5#1)
pathogenesis and management of##5##4##(2006-10#1)(2008-7#1)(2009-4#1)(2010-2#1)(2013-1#1)
pathogenesis and management##7##3##(2006-10#1)(2008-1#1)(2008-7#1)(2009-4#1)(2010-2#1)(2011-2#1)(2013-1#1)
pathogenesis and may##2##3##(2005-8#1)(2010-2#1)
pathogenesis and medical##2##3##(2006-10#1)(2007-11#1)
pathogenesis and molecular##2##3##(1995-3#1)(2008-10#1)
pathogenesis and potential##3##3##(2006-10#1)(2010-12#1)(2011-12#1)
pathogenesis and the##3##3##(2007-11#1)(2008-7#1)(2010-5#1)
pathogenesis and therapy##2##3##(2006-10#1)(2008-4#1)
pathogenesis and treatment of##12##4##(1990-11#1)(1993-9#1)(1995-1#1)(1996-8#1)(2008-1#2)(2008-12#1)(2008-4#1)(2010-10#1)(2010-6#1)(2011-1#1)(2013-8#1)
pathogenesis and treatment##16##3##(1990-11#1)(1993-9#1)(1995-1#1)(1996-8#1)(2008-1#2)(2008-12#1)(2008-4#1)(2009-2#1)(2010-10#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
pathogenesis and##95##2##(1990-11#1)(1990-6#1)(1991-11#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-5#1)(1993-9#2)(1994-6#1)(1995-1#1)(1995-3#1)(1996-12#2)(1996-8#1)(2005-7#1)(2005-8#2)(2006-10#7)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#3)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#3)(2008-12#2)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-9#2)(2010-10#2)(2010-12#3)(2010-2#2)(2010-5#4)(2010-6#2)(2011-1#2)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#4)
pathogenesis are still##2##3##(2010-12#1)(2013-8#1)
pathogenesis are##7##2##(2006-10#1)(2008-11#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-11#1)(2013-8#1)
pathogenesis as##2##2##(2007-12#1)(2008-1#1)
pathogenesis by##2##2##(2007-11#1)(2013-8#1)
pathogenesis can##2##2##(2005-10#1)(2007-7#1)
pathogenesis factors##2##2##(2012-3#2)
pathogenesis for##2##2##(2006-10#1)(2007-8#1)
pathogenesis has not been##3##4##(2005-11#1)(2005-8#1)(2013-8#1)
pathogenesis has not yet been##2##5##(2005-11#1)(2011-2#1)
pathogenesis has not##5##3##(2005-11#2)(2005-8#1)(2011-2#1)(2013-8#1)
pathogenesis has##6##2##(2005-11#2)(2005-8#1)(2006-10#1)(2011-2#1)(2013-8#1)
pathogenesis have##3##2##(1991-7#1)(1997-5#1)(2006-10#1)
pathogenesis in the##4##3##(2007-11#1)(2008-10#1)(2009-7#1)(2009-8#1)
pathogenesis in##15##2##(1996-3#1)(1996-9#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-8#1)
pathogenesis is not##2##3##(2006-10#1)(2008-11#1)
pathogenesis is still not##3##4##(2006-6#1)(2007-9#1)(2011-1#1)
pathogenesis is still unclear##2##4##(1992-8#1)(1994-8#1)
pathogenesis is still##7##3##(1992-8#1)(1994-8#1)(2006-6#1)(2007-9#1)(2008-5#1)(2009-8#1)(2011-1#1)
pathogenesis is supported##2##3##(1994-8#1)(1996-3#1)
pathogenesis is##22##2##(1991-4#1)(1992-8#1)(1994-2#1)(1994-8#2)(1996-3#1)(1997-4#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-8#1)(2010-12#2)(2011-1#1)(2012-12#1)(2013-1#1)
pathogenesis may be##2##3##(2006-10#1)(2013-7#1)
pathogenesis of AMD##3##3##(2013-1#3)
pathogenesis of Alzheimer's Disease##3##4##(1993-11#1)(2010-2#1)(2011-3#1)
pathogenesis of Alzheimer's##11##3##(1993-11#1)(1993-12#1)(1995-10#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-7#1)(2010-2#1)(2011-3#1)(2013-7#2)
pathogenesis of CD##2##3##(2011-1#1)(2013-8#1)
pathogenesis of CP##2##3##(2005-10#1)(2008-3#1)
pathogenesis of CRS##2##3##(2008-3#2)
pathogenesis of DR##2##3##(2008-1#2)
pathogenesis of HIV infection##2##4##(2007-11#1)(2009-6#1)
pathogenesis of IHD##3##3##(2008-3#1)(2013-1#2)
pathogenesis of MS##3##3##(2008-7#1)(2012-3#1)(2013-1#1)
pathogenesis of NPSLE##3##3##(2007-9#1)(2012-3#1)(2013-1#1)
pathogenesis of PSC is##2##4##(2004-11#1)(2006-2#1)
pathogenesis of PTDM##2##3##(2008-1#2)
pathogenesis of Parkinson's disease##6##4##(1997-7#1)(2007-12#1)(2008-11#1)(2008-7#2)(2012-1#1)
pathogenesis of S##2##3##(1995-2#1)(2005-11#1)
pathogenesis of VC##2##3##(2009-1#2)
pathogenesis of acne vulgaris##3##4##(2006-8#1)(2010-5#2)
pathogenesis of acne##8##3##(2006-12#1)(2006-8#1)(2010-3#1)(2010-5#5)
pathogenesis of adhesions formation after intraabdominal##2##6##(2012-3#2)
pathogenesis of atopic##2##3##(1991-2#1)(2008-10#1)
pathogenesis of cancer and##2##4##(2011-1#1)(2013-8#1)
pathogenesis of cancer##7##3##(1990-11#1)(1990-2#1)(2007-5#1)(2008-4#1)(2009-9#1)(2011-1#1)(2013-8#1)
pathogenesis of chronic##11##3##(2006-10#1)(2006-9#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-12#2)(2012-2#1)(2012-3#1)
pathogenesis of diabetes and##2##4##(2005-8#1)(2008-1#1)
pathogenesis of diabetes##4##3##(2005-8#1)(2007-5#1)(2008-1#2)
pathogenesis of diabetic nephropathy##5##4##(1994-2#1)(2008-1#3)(2009-4#1)
pathogenesis of diabetic##16##3##(1993-11#1)(1994-2#1)(1994-8#1)(2006-1#2)(2007-2#1)(2007-8#1)(2008-1#8)(2009-4#1)
pathogenesis of diseases##3##3##(1995-2#1)(2007-7#2)
pathogenesis of disorders##2##3##(1990-11#1)(1997-2#1)
pathogenesis of esophageal##2##3##(2006-10#1)(2007-6#1)
pathogenesis of essential##2##3##(1993-12#1)(2013-1#1)
pathogenesis of gastric cancer##3##4##(2007-11#2)(2009-3#1)
pathogenesis of heart failure##2##4##(1996-9#1)(2010-10#1)
pathogenesis of heart##3##3##(1996-9#1)(2008-7#1)(2010-10#1)
pathogenesis of hepatic##2##3##(1997-5#1)(2006-10#1)
pathogenesis of human##10##3##(2004-12#1)(2006-10#2)(2007-11#1)(2008-1#1)(2008-4#1)(2009-9#1)(2012-12#3)
pathogenesis of idiopathic##2##3##(2005-10#1)(2006-10#1)
pathogenesis of immune-mediated inflammatory diseases##2##5##(2011-2#2)
pathogenesis of infection##3##3##(1993-12#1)(1994-3#1)(2013-7#1)
pathogenesis of infections##3##3##(2006-10#2)(2007-7#1)
pathogenesis of inflammatory bowel disease (IBD)##2##6##(2006-10#1)(2009-9#1)
pathogenesis of inflammatory bowel disease##5##5##(2006-10#3)(2009-9#1)(2010-12#1)
pathogenesis of inflammatory diseases##2##4##(2005-8#1)(2013-1#1)
pathogenesis of inflammatory##14##3##(2005-11#1)(2005-8#1)(2006-10#3)(2007-11#1)(2009-9#5)(2010-12#1)(2013-1#1)(2013-8#1)
pathogenesis of insulin resistance##6##4##(2008-3#3)(2012-2#2)(2013-1#1)
pathogenesis of liver injury##2##4##(2006-10#1)(2008-4#1)
pathogenesis of malignant##3##3##(2011-2#3)
pathogenesis of metabolic syndrome##2##4##(2008-3#1)(2013-1#1)
pathogenesis of most##3##3##(2006-4#1)(2011-1#1)(2012-3#1)
pathogenesis of moyamoya disease##3##4##(2006-11#3)
pathogenesis of non-alcoholic##2##3##(2008-9#1)(2013-1#1)
pathogenesis of nonalcoholic##2##3##(2006-10#1)(2011-1#1)
pathogenesis of osteoarthritis##2##3##(2005-8#1)(2007-11#1)
pathogenesis of osteoporosis##2##3##(2009-3#1)(2012-2#1)
pathogenesis of other##2##3##(2008-8#1)(2012-12#1)
pathogenesis of psoriasis##3##3##(1991-12#1)(1995-5#1)(2009-11#1)
pathogenesis of renal##3##3##(1997-7#1)(2005-12#1)(2008-7#1)
pathogenesis of rheumatoid arthritis##6##4##(1991-10#1)(2006-10#3)(2007-11#1)(2009-1#1)
pathogenesis of several##6##3##(1995-12#1)(1997-8#1)(2006-10#1)(2010-4#1)(2010-5#1)(2013-8#1)
pathogenesis of severe##2##3##(2008-3#1)(2008-9#1)
pathogenesis of some##6##3##(1992-11#1)(1996-10#1)(2006-10#1)(2006-2#2)(2007-9#1)
pathogenesis of the disease##14##4##(1992-10#1)(1992-6#1)(1993-11#1)(1993-7#1)(1996-3#1)(1997-6#1)(2005-8#1)(2006-11#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2012-12#1)(2013-8#1)
pathogenesis of the##48##3##(1990-11#1)(1990-8#1)(1991-4#1)(1991-5#1)(1992-10#1)(1992-6#1)(1993-11#1)(1993-7#1)(1994-10#1)(1994-6#1)(1995-10#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-6#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#2)(2006-2#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-3#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
pathogenesis of these lesions##2##4##(2006-5#1)(2007-10#1)
pathogenesis of these##12##3##(1996-6#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)
pathogenesis of this disease and##2##5##(2008-3#1)(2013-7#1)
pathogenesis of this disease##9##4##(1993-8#1)(1997-8#1)(2006-10#2)(2008-3#1)(2010-2#1)(2010-6#1)(2012-1#1)(2013-7#1)
pathogenesis of this disorder##4##4##(2006-12#1)(2007-10#1)(2007-7#1)(2009-3#1)
pathogenesis of this rare##2##4##(2008-8#1)(2013-1#1)
pathogenesis of this##26##3##(1992-2#1)(1993-8#1)(1993-9#1)(1995-11#1)(1996-10#1)(1997-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-11#1)(2009-3#2)(2009-6#1)(2010-2#1)(2010-6#1)(2012-1#1)(2013-1#1)(2013-7#1)
pathogenesis of ulcerative##2##3##(2008-12#1)(2013-8#1)
pathogenesis of vascular##3##3##(1993-2#1)(2009-6#1)(2010-4#1)
pathogenesis of vitiligo##2##3##(2007-7#1)(2009-6#1)
pathogenesis of##713##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-10#2)(1991-12#2)(1991-2#2)(1991-3#4)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#3)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#2)(1993-11#4)(1993-12#5)(1993-2#2)(1993-7#2)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#5)(1994-4#1)(1994-5#2)(1994-6#4)(1994-7#1)(1994-8#3)(1995-1#1)(1995-10#2)(1995-11#3)(1995-12#3)(1995-2#5)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#4)(1996-11#3)(1996-12#5)(1996-2#1)(1996-3#2)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#3)(1997-8#7)(2004-11#3)(2004-12#3)(2005-10#4)(2005-11#4)(2005-12#2)(2005-7#2)(2005-8#10)(2006-1#2)(2006-10#48)(2006-11#6)(2006-12#4)(2006-2#5)(2006-4#3)(2006-5#4)(2006-6#6)(2006-7#1)(2006-8#6)(2006-9#3)(2007-1#3)(2007-10#9)(2007-11#21)(2007-12#7)(2007-2#5)(2007-3#1)(2007-4#2)(2007-5#3)(2007-6#1)(2007-7#10)(2007-8#13)(2007-9#7)(2008-1#33)(2008-10#8)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#19)(2008-4#13)(2008-5#10)(2008-6#2)(2008-7#20)(2008-8#8)(2008-9#5)(2009-1#4)(2009-10#2)(2009-11#3)(2009-12#2)(2009-2#4)(2009-3#6)(2009-4#3)(2009-5#2)(2009-6#6)(2009-7#2)(2009-8#5)(2009-9#9)(2010-1#1)(2010-10#2)(2010-12#18)(2010-2#3)(2010-3#1)(2010-4#5)(2010-5#10)(2010-6#2)(2010-8#1)(2010-9#2)(2011-1#9)(2011-12#1)(2011-2#17)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#17)(2012-2#15)(2012-3#15)(2013-1#31)(2013-3#1)(2013-7#8)(2013-8#22)
pathogenesis will##2##2##(2006-10#1)(2009-11#1)
pathogenesis##1100##1##(1990-11#4)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#2)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#5)(1991-4#3)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#3)(1991-9#4)(1992-10#1)(1992-11#1)(1992-12#7)(1992-2#3)(1992-3#4)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#2)(1993-10#2)(1993-11#5)(1993-12#7)(1993-2#2)(1993-5#1)(1993-7#2)(1993-8#3)(1993-9#4)(1994-10#2)(1994-11#2)(1994-2#3)(1994-3#5)(1994-4#1)(1994-5#2)(1994-6#6)(1994-7#1)(1994-8#5)(1995-1#2)(1995-10#2)(1995-11#3)(1995-12#4)(1995-2#5)(1995-3#3)(1995-5#3)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#4)(1996-11#4)(1996-12#7)(1996-2#1)(1996-3#4)(1996-6#2)(1996-7#2)(1996-8#3)(1996-9#3)(1997-1#3)(1997-2#3)(1997-3#2)(1997-4#5)(1997-5#4)(1997-6#3)(1997-7#3)(1997-8#7)(2004-11#4)(2004-12#3)(2005-10#5)(2005-11#7)(2005-12#3)(2005-7#4)(2005-8#18)(2006-1#3)(2006-10#90)(2006-11#6)(2006-12#7)(2006-2#11)(2006-4#5)(2006-5#7)(2006-6#9)(2006-7#1)(2006-8#8)(2006-9#3)(2007-1#3)(2007-10#9)(2007-11#33)(2007-12#14)(2007-2#8)(2007-3#2)(2007-4#4)(2007-5#3)(2007-6#1)(2007-7#19)(2007-8#18)(2007-9#10)(2008-1#45)(2008-10#19)(2008-11#11)(2008-12#4)(2008-2#2)(2008-3#23)(2008-4#19)(2008-5#18)(2008-6#3)(2008-7#28)(2008-8#10)(2008-9#13)(2009-1#5)(2009-10#3)(2009-11#5)(2009-12#2)(2009-2#7)(2009-3#7)(2009-4#9)(2009-5#3)(2009-6#8)(2009-7#4)(2009-8#11)(2009-9#12)(2010-1#1)(2010-10#6)(2010-12#30)(2010-2#6)(2010-3#1)(2010-4#6)(2010-5#15)(2010-6#6)(2010-8#4)(2010-9#3)(2011-1#15)(2011-12#3)(2011-2#32)(2011-3#1)(2012-1#8)(2012-10#1)(2012-11#3)(2012-12#23)(2012-2#22)(2012-3#22)(2013-1#46)(2013-3#1)(2013-7#10)(2013-8#39)
pathogenesis- related##2##2##(2008-10#2)
pathogenesis-related (PR) genes##4##3##(2008-10#4)
pathogenesis-related (PR) proteins in##2##4##(2008-10#2)
pathogenesis-related (PR) proteins##4##3##(1997-6#1)(2008-10#3)
pathogenesis-related (PR)##9##2##(1997-6#1)(2008-10#8)
pathogenesis-related gene##2##2##(2008-10#2)
pathogenesis-related protein P14a##2##3##(1997-2#2)
pathogenesis-related protein##9##2##(1997-2#2)(2008-10#4)(2008-5#1)(2009-8#1)(2011-10#1)
pathogenesis-related proteins##5##2##(1994-3#1)(2008-10#4)
pathogenesis-related##33##1##(1992-8#1)(1994-3#1)(1997-2#2)(1997-6#1)(2006-12#1)(2008-10#22)(2008-5#1)(2009-8#1)(2011-10#3)
pathogenesis]##3##1##(1991-2#1)(2005-11#1)(2011-2#1)
pathogenetic and##3##2##(1990-10#1)(1991-10#1)(2011-2#1)
pathogenetic experimentation##4##2##(2008-10#4)
pathogenetic factor in##2##3##(1991-3#2)
pathogenetic factor##5##2##(1990-3#1)(1991-3#2)(1996-8#1)(2006-6#1)
pathogenetic factors##4##2##(1994-12#1)(2008-5#1)(2008-7#1)(2012-1#1)
pathogenetic hypotheses##2##2##(1991-12#1)(2006-2#1)
pathogenetic hypothesis##2##2##(1990-1#1)(1992-10#1)
pathogenetic implications##3##2##(1997-6#1)(2006-9#1)(2011-2#1)
pathogenetic importance##2##2##(1992-2#1)(1995-8#1)
pathogenetic mechanism##9##2##(1990-6#1)(1994-6#1)(1996-3#1)(2006-12#1)(2008-3#1)(2009-7#1)(2012-2#2)(2013-1#1)
pathogenetic mechanisms of##4##3##(2005-7#1)(2008-8#1)(2011-1#1)(2013-8#1)
pathogenetic mechanisms##20##2##(1994-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(2005-7#1)(2006-2#2)(2006-6#1)(2007-4#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
pathogenetic pathways##2##2##(2005-11#1)(2009-7#1)
pathogenetic principles##2##2##(2006-10#1)(2006-6#1)
pathogenetic role in##3##3##(1990-3#1)(2007-9#1)(2008-1#1)
pathogenetic role of##3##3##(2006-2#2)(2008-1#1)
pathogenetic role##6##2##(1990-3#1)(2006-2#2)(2007-9#1)(2008-1#2)
pathogenetic##90##1##(1990-1#1)(1990-10#1)(1990-3#2)(1990-5#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-3#2)(1991-9#1)(1992-10#1)(1992-2#1)(1992-4#1)(1993-3#1)(1994-12#1)(1994-6#2)(1995-8#1)(1996-12#1)(1996-3#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#6)(2006-6#4)(2006-9#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2009-5#1)(2009-7#2)(2010-11#1)(2010-12#2)(2010-5#2)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
pathogenetically##8##1##(1991-12#1)(1993-7#1)(1994-6#1)(1996-1#1)(1996-3#1)(1997-2#1)(2009-2#1)(2010-12#1)
pathogenic E##3##2##(1997-6#1)(2008-9#1)(2011-2#1)
pathogenic Escherichia coli##3##3##(1997-6#1)(2006-10#1)(2011-2#1)
pathogenic F##2##2##(2008-10#1)(2008-4#1)
pathogenic Fusarium##2##2##(2008-10#1)(2013-1#1)
pathogenic IBV##2##2##(2008-5#1)(2013-8#1)
pathogenic Leptospira##5##2##(2008-9#4)(2011-2#1)
pathogenic NDV##2##2##(2008-5#2)
pathogenic Pythium spp##2##3##(2008-10#2)
pathogenic T cells##3##3##(1991-12#2)(2013-1#1)
pathogenic agents##2##2##(1993-3#1)(2011-1#1)
pathogenic and non-pathogenic##3##3##(2008-1#1)(2008-7#1)(2008-9#1)
pathogenic and nonpathogenic isolates from##2##5##(2008-10#2)
pathogenic and nonpathogenic lifestyles##2##4##(2008-10#2)
pathogenic and nonpathogenic##5##3##(2008-10#5)
pathogenic and##19##2##(1992-3#1)(2006-10#2)(2008-1#1)(2008-10#8)(2008-4#1)(2008-7#1)(2008-9#2)(2010-4#1)(2010-5#1)(2011-2#1)
pathogenic autoantibodies##2##2##(2012-3#2)
pathogenic avian influenza##3##3##(2007-6#1)(2010-4#1)(2011-3#1)
pathogenic bacteria and##2##3##(1996-12#1)(2011-1#1)
pathogenic bacteria can be##2##4##(2006-10#1)(2010-12#1)
pathogenic bacteria in##7##3##(1993-9#1)(1997-4#3)(2007-7#1)(2008-10#1)(2011-12#1)
pathogenic bacteria to##2##3##(1996-8#1)(2013-8#1)
pathogenic bacteria##46##2##(1990-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-1#1)(1996-12#1)(1996-8#1)(1997-4#4)(1997-6#1)(2006-10#1)(2006-12#3)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-10#2)(2008-7#2)(2008-9#1)(2009-5#2)(2009-6#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
pathogenic bacterial##2##2##(2006-9#1)(2008-5#1)
pathogenic bacterium##3##2##(1997-6#1)(2008-10#1)(2013-1#1)
pathogenic cause##2##2##(2010-11#1)(2013-7#1)
pathogenic clone(s)##2##2##(1991-12#2)
pathogenic contamination##2##2##(1997-4#1)(2011-12#1)
pathogenic effect of##2##3##(2007-11#1)(2008-4#1)
pathogenic effects of##2##3##(1994-3#1)(2011-2#1)
pathogenic effects##3##2##(1993-4#1)(1994-3#1)(2011-2#1)
pathogenic factors##4##2##(1991-6#1)(2008-1#1)(2008-7#1)(2008-9#1)
pathogenic feature##2##2##(1995-5#1)(2008-5#1)
pathogenic fitness##5##2##(2008-10#5)
pathogenic for humans##2##3##(2007-2#1)(2008-4#1)
pathogenic for##6##2##(2007-2#1)(2008-4#1)(2008-5#3)(2010-2#1)
pathogenic fungi and##7##3##(2008-10#2)(2008-5#5)
pathogenic fungi##27##2##(2007-11#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-5#6)(2008-7#3)(2009-2#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
pathogenic fungus##7##2##(1996-6#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-11#1)
pathogenic human##2##2##(2008-10#1)(2011-2#1)
pathogenic immune##2##2##(2006-10#1)(2008-1#1)
pathogenic impact##2##2##(2010-12#1)(2011-2#1)
pathogenic in##5##2##(1994-3#1)(2008-10#3)(2009-10#1)
pathogenic isoform##2##2##(2006-10#2)
pathogenic isolates from##3##3##(2008-10#3)
pathogenic isolates##7##2##(2008-10#7)
pathogenic mechanism for##2##3##(2008-1#1)(2010-5#1)
pathogenic mechanism of##7##3##(1996-2#1)(1997-3#1)(2006-2#1)(2008-2#2)(2012-2#1)(2013-1#1)
pathogenic mechanism##11##2##(1996-2#1)(1997-3#1)(2006-2#1)(2008-1#2)(2008-2#2)(2010-1#1)(2010-5#1)(2012-2#1)(2013-1#1)
pathogenic mechanisms of the##2##4##(2010-6#1)(2012-12#1)
pathogenic mechanisms of##7##3##(1996-11#1)(2005-10#1)(2006-10#2)(2008-4#1)(2010-6#1)(2012-12#1)
pathogenic mechanisms##19##2##(1996-11#1)(2005-10#1)(2006-10#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-3#1)
pathogenic members##2##2##(2008-9#1)(2010-12#1)
pathogenic microorganisms such as##2##4##(2007-2#1)(2012-2#1)
pathogenic microorganisms##19##2##(1994-11#1)(1994-5#1)(1997-2#1)(2005-7#1)(2007-2#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-7#1)
pathogenic mutations##3##2##(1991-10#1)(1996-6#1)(2006-11#1)
pathogenic mycoplasmas##2##2##(2005-10#1)(2008-5#1)
pathogenic nematodes##2##2##(2008-10#2)
pathogenic on RL and not on MIN##2##7##(2008-10#2)
pathogenic on both##2##3##(2008-10#2)
pathogenic on lettuce##2##3##(2008-10#2)
pathogenic on potato##3##3##(2008-10#3)
pathogenic on the##2##3##(2008-10#2)
pathogenic on##39##2##(2008-10#39)
pathogenic only on##3##3##(2008-10#3)
pathogenic or are##2##3##(2008-10#1)(2011-2#1)
pathogenic organism is##2##3##(2007-7#1)(2010-6#1)
pathogenic organism##3##2##(2007-7#1)(2010-6#1)(2013-1#1)
pathogenic organisms##5##2##(1994-11#1)(2007-6#1)(2008-4#2)(2011-2#1)
pathogenic pathways##2##2##(2005-8#1)(2009-7#1)
pathogenic populations##2##2##(2008-10#2)
pathogenic potential and##2##3##(2011-1#1)(2011-2#1)
pathogenic potential##11##2##(1996-12#1)(2005-7#1)(2007-8#1)(2008-10#3)(2008-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
pathogenic process of##2##3##(1993-12#1)(2006-2#1)
pathogenic process##5##2##(1993-12#1)(1996-6#1)(2006-2#1)(2008-1#1)(2010-1#1)
pathogenic races 0##2##3##(2008-10#2)
pathogenic races##4##2##(2008-10#3)(2012-11#1)
pathogenic role for##3##3##(1994-9#1)(1996-8#1)(2008-5#1)
pathogenic role in##3##3##(2007-11#1)(2008-1#1)(2013-1#1)
pathogenic role of##8##3##(1991-7#1)(1997-7#1)(2005-11#1)(2009-8#1)(2010-1#1)(2010-7#1)(2011-1#1)(2012-2#1)
pathogenic role##19##2##(1991-7#1)(1994-2#1)(1994-9#1)(1996-8#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-5#2)(2009-8#1)(2010-1#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
pathogenic species of##4##3##(2006-10#1)(2007-7#1)(2008-5#1)(2008-9#1)
pathogenic species##12##2##(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#1)
pathogenic spectrum of hand##2##4##(2013-8#2)
pathogenic strain and##2##3##(2008-4#1)(2011-1#1)
pathogenic strain of##4##3##(1992-3#1)(2005-9#1)(2008-10#2)
pathogenic strain##6##2##(1992-3#1)(2005-9#1)(2008-10#2)(2008-4#1)(2011-1#1)
pathogenic strains of##3##3##(2006-2#1)(2006-8#1)(2008-10#1)
pathogenic strains##7##2##(2006-2#1)(2006-8#1)(2008-10#3)(2008-5#1)(2012-12#1)
pathogenic target##2##2##(1992-3#1)(2006-11#1)
pathogenic to all##2##3##(2008-10#2)
pathogenic to asparagus##2##3##(2008-10#2)
pathogenic to pear##2##3##(2008-10#2)
pathogenic to pistachio##2##3##(2008-10#2)
pathogenic to strawberry##3##3##(2008-10#3)
pathogenic to##35##2##(1996-7#1)(2007-12#1)(2008-10#31)(2009-6#1)(2010-3#1)
pathogenic variability of##2##3##(2008-10#2)
pathogenic variability##3##2##(2008-10#3)
pathogenic variation##7##2##(2008-10#7)
pathogenic viruses##3##2##(2006-7#1)(2008-4#1)(2008-7#1)
pathogenic yeast##2##2##(2007-7#1)(2012-2#1)
pathogenic yeasts##3##2##(1994-2#1)(2008-3#1)(2008-6#1)
pathogenic##576##1##(1990-12#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#6)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-2#1)(1992-3#3)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-7#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-6#4)(1996-7#2)(1996-8#2)(1997-2#2)(1997-3#1)(1997-4#7)(1997-6#6)(1997-7#2)(1997-8#1)(2004-11#2)(2005-10#2)(2005-11#2)(2005-7#2)(2005-8#2)(2005-9#2)(2006-10#17)(2006-11#2)(2006-12#4)(2006-2#3)(2006-3#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#5)(2007-2#4)(2007-3#1)(2007-5#4)(2007-6#5)(2007-7#9)(2007-8#4)(2007-9#5)(2008-1#10)(2008-10#178)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#17)(2008-5#31)(2008-6#2)(2008-7#14)(2008-8#3)(2008-9#16)(2009-10#3)(2009-2#1)(2009-5#3)(2009-6#5)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#3)(2010-11#1)(2010-12#7)(2010-2#1)(2010-3#1)(2010-4#5)(2010-5#4)(2010-6#2)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#8)(2011-12#3)(2011-2#18)(2011-3#1)(2012-1#3)(2012-11#2)(2012-12#3)(2012-2#12)(2012-3#5)(2013-1#14)(2013-7#3)(2013-8#9)
pathogenically##2##1##(2008-10#2)
pathogenicity and host##3##3##(2008-10#2)(2008-5#1)
pathogenicity and virulence##2##3##(2008-10#1)(2009-2#1)
pathogenicity and##12##2##(2007-12#1)(2008-10#8)(2008-5#1)(2009-2#1)(2012-3#1)
pathogenicity as##2##2##(2008-10#2)
pathogenicity assays##5##2##(2008-10#5)
pathogenicity determinant##3##2##(2008-10#3)
pathogenicity factor##4##2##(2008-10#4)
pathogenicity factors##2##2##(2008-10#2)
pathogenicity for##3##2##(2008-5#2)(2008-6#1)
pathogenicity groups based on##2##4##(2008-10#2)
pathogenicity groups##6##2##(2008-10#6)
pathogenicity in both##2##3##(1995-6#2)
pathogenicity in the##2##3##(2008-10#2)
pathogenicity in##12##2##(1995-6#3)(2008-10#6)(2008-5#1)(2012-3#1)(2013-8#1)
pathogenicity index##5##2##(1997-3#2)(2005-9#1)(2008-5#2)
pathogenicity is##2##2##(2008-10#1)(2013-8#1)
pathogenicity island##3##2##(2008-10#1)(2008-11#1)(2011-1#1)
pathogenicity of B##2##3##(2007-2#1)(2008-10#1)
pathogenicity of M##2##3##(2007-12#1)(2008-10#1)
pathogenicity of isolates##2##3##(2008-10#2)
pathogenicity of the##12##3##(2005-11#1)(2005-9#1)(2006-10#2)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#1)(2013-8#1)
pathogenicity of these##2##3##(2008-10#1)(2009-5#1)
pathogenicity of this##2##3##(2007-7#1)(2008-10#1)
pathogenicity of two##2##3##(2008-10#1)(2008-5#1)
pathogenicity of##46##2##(2005-11#1)(2005-9#1)(2006-10#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#27)(2008-12#1)(2008-5#5)(2008-6#1)(2009-5#1)(2012-3#1)(2013-7#1)(2013-8#1)
pathogenicity on tomato##2##3##(2008-10#2)
pathogenicity on##22##2##(2008-10#22)
pathogenicity test##3##2##(2007-8#1)(2008-10#2)
pathogenicity tests on##4##3##(2008-10#4)
pathogenicity tests##22##2##(2008-10#19)(2008-12#2)(2008-4#1)
pathogenicity to muskmelon##2##3##(2008-10#2)
pathogenicity to onion##2##3##(2008-10#2)
pathogenicity to##14##2##(2005-9#1)(2008-10#12)(2013-8#1)
pathogenicity toward##2##2##(2008-10#2)
pathogenicity was##8##2##(2008-10#6)(2008-4#1)(2011-2#1)
pathogenicity##261##1##(1990-3#1)(1995-6#3)(1996-4#2)(1996-7#1)(1997-2#1)(1997-3#2)(2005-11#1)(2005-9#4)(2006-10#4)(2007-12#4)(2007-2#1)(2007-6#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#178)(2008-11#1)(2008-12#3)(2008-4#5)(2008-5#16)(2008-6#2)(2008-9#2)(2009-2#1)(2009-5#1)(2010-10#1)(2010-6#1)(2011-1#3)(2011-2#4)(2012-3#5)(2013-1#1)(2013-7#1)(2013-8#6)
pathogens affecting##3##2##(2008-10#1)(2008-12#1)(2009-2#1)
pathogens among##2##2##(2008-10#1)(2012-3#1)
pathogens and host##2##3##(2006-10#2)
pathogens and in##2##3##(2006-10#1)(2008-8#1)
pathogens and pests##2##3##(2008-10#2)
pathogens and should##2##3##(2008-10#1)(2008-9#1)
pathogens and that##2##3##(2008-10#2)
pathogens and the##5##3##(2005-11#1)(2008-10#2)(2009-3#1)(2012-12#1)
pathogens and their hosts##2##4##(2010-12#1)(2011-1#1)
pathogens and their##8##3##(1994-3#1)(2006-10#2)(2007-12#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
pathogens and to##2##3##(1996-1#1)(2008-10#1)
pathogens and toxins##2##3##(2006-10#1)(2009-10#1)
pathogens and##69##2##(1991-10#1)(1993-11#1)(1994-3#1)(1996-1#1)(2005-11#2)(2006-10#8)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#4)(2007-7#1)(2008-10#21)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#2)(2010-12#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#5)(2013-1#3)(2013-8#2)
pathogens appear to be##2##4##(2006-10#1)(2010-3#1)
pathogens are associated with##2##4##(2005-11#1)(2011-2#1)
pathogens are##23##2##(1991-12#1)(1995-2#1)(2005-11#1)(2005-8#1)(2006-10#3)(2007-11#1)(2008-10#7)(2008-9#2)(2009-8#1)(2011-2#3)(2013-1#2)
pathogens as well as##2##4##(2008-8#1)(2011-2#1)
pathogens as well##3##3##(2008-8#1)(2009-12#1)(2011-2#1)
pathogens as##6##2##(1995-5#1)(2008-10#1)(2008-8#1)(2009-12#1)(2011-2#1)(2013-1#1)
pathogens associated with##4##3##(2005-11#1)(2006-8#1)(2008-3#1)(2013-7#1)
pathogens at the##3##3##(2005-7#1)(2008-10#1)(2011-10#1)
pathogens at##5##2##(2005-7#1)(2006-10#1)(2008-10#2)(2011-10#1)
pathogens but##3##2##(2008-10#2)(2008-6#1)
pathogens by##18##2##(1990-6#2)(1996-10#1)(2006-8#1)(2008-10#8)(2008-4#2)(2008-6#1)(2012-3#1)(2013-1#2)
pathogens can cause##2##3##(2007-11#1)(2007-12#1)
pathogens can##6##2##(2007-11#2)(2007-12#1)(2008-10#2)(2012-12#1)
pathogens causing##6##2##(2008-10#3)(2009-4#1)(2010-12#2)
pathogens except##2##2##(2008-10#2)
pathogens for which##2##3##(2008-10#1)(2013-1#1)
pathogens for##9##2##(2008-10#4)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)(2013-1#1)
pathogens from the##3##3##(1995-5#1)(2008-10#1)(2010-3#1)
pathogens from##15##2##(1995-5#1)(2005-11#1)(2007-12#1)(2007-9#1)(2008-10#6)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2013-1#1)
pathogens had##2##2##(2008-10#2)
pathogens has been##5##3##(2005-7#1)(2005-8#1)(2008-10#1)(2010-6#1)(2011-2#1)
pathogens has##8##2##(2005-7#2)(2005-8#1)(2007-9#1)(2008-10#1)(2010-6#1)(2011-1#1)(2011-2#1)
pathogens have been shown to##2##5##(2008-10#1)(2012-1#1)
pathogens have been##5##3##(1991-12#1)(2006-12#1)(2008-10#1)(2008-7#1)(2012-1#1)
pathogens have##14##2##(1991-12#1)(2006-12#1)(2008-10#4)(2008-7#1)(2008-9#2)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
pathogens identified##3##2##(1992-6#1)(1993-2#1)(2008-10#1)
pathogens in a##2##3##(2008-10#2)
pathogens in adult##2##3##(2006-8#1)(2010-11#1)
pathogens in foods##2##3##(2007-12#1)(2011-12#1)
pathogens in nature##2##3##(2008-10#1)(2008-8#1)
pathogens in relation to host specialization##2##6##(2008-10#2)
pathogens in the##10##3##(2005-8#1)(2007-11#1)(2007-5#1)(2008-10#7)
pathogens in##48##2##(1996-11#1)(1996-8#1)(2005-8#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#1)(2008-10#21)(2008-11#2)(2008-12#1)(2008-8#1)(2009-12#1)(2010-11#1)(2011-12#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
pathogens including##4##2##(2006-10#1)(2011-12#1)(2011-2#1)(2013-1#1)
pathogens is a##2##3##(2008-10#2)
pathogens is##14##2##(1991-12#1)(1993-2#1)(2006-10#2)(2008-10#6)(2008-4#1)(2009-10#1)(2010-12#1)(2012-2#1)
pathogens isolated##2##2##(2008-10#1)(2008-7#1)
pathogens like##2##2##(2007-8#1)(2011-2#1)
pathogens may have##2##3##(1996-6#1)(2008-10#1)
pathogens may##6##2##(1991-12#2)(1996-6#1)(2008-10#2)(2008-9#1)
pathogens of GSM larvae##2##4##(2009-6#2)
pathogens of Greenshell mussel##2##4##(2009-6#2)
pathogens of cereals and grasses##2##5##(2008-10#2)
pathogens of man##2##3##(2007-6#1)(2007-7#1)
pathogens of nosocomial infections##2##4##(1991-7#1)(2008-11#1)
pathogens of##36##2##(1991-7#1)(1995-2#1)(1997-6#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-10#17)(2008-11#2)(2008-3#1)(2008-5#1)(2009-6#4)(2010-10#1)(2010-12#1)(2012-2#1)(2013-8#2)
pathogens often##2##2##(2008-10#2)
pathogens on##4##2##(2008-10#3)(2011-2#1)
pathogens or##8##2##(2006-10#2)(2008-1#1)(2008-10#2)(2008-7#1)(2012-1#1)(2013-7#1)
pathogens remains##2##2##(2007-7#1)(2010-12#1)
pathogens responsible for##4##3##(1994-11#1)(2006-8#1)(2008-10#1)(2012-2#1)
pathogens standard##4##2##(1992-12#1)(1993-2#1)(1994-3#2)
pathogens such as Clostridium##2##4##(2010-11#1)(2011-2#1)
pathogens such as Salmonella##2##4##(2010-4#1)(2011-1#1)
pathogens such as##18##3##(1992-2#1)(1996-11#1)(1997-5#1)(2006-10#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#1)
pathogens than##3##2##(2008-10#1)(2009-5#1)(2013-1#1)
pathogens that cause##5##3##(2008-3#1)(2008-9#1)(2009-8#1)(2010-12#1)(2012-3#1)
pathogens that co-occur##2##3##(2008-10#1)(2010-3#1)
pathogens that could##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
pathogens that##22##2##(1995-2#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
pathogens to the##2##3##(1991-12#1)(2008-3#1)
pathogens to##13##2##(1991-12#1)(2005-10#1)(2005-8#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2009-2#1)(2010-12#1)
pathogens under##3##2##(2008-10#3)
pathogens using##2##2##(2005-11#1)(2008-10#1)
pathogens via##4##2##(2007-12#1)(2008-9#1)(2009-8#1)(2012-1#1)
pathogens was tested##2##3##(2008-10#2)
pathogens was##5##2##(2008-10#5)
pathogens were found##2##3##(1994-11#1)(2005-10#1)
pathogens were##15##2##(1994-11#1)(2005-10#1)(2005-11#1)(2006-8#1)(2008-10#8)(2008-12#1)(2011-1#1)(2012-2#1)
pathogens which##4##2##(2006-10#1)(2008-7#2)(2013-7#1)
pathogens will##3##2##(1991-12#1)(2006-10#1)(2008-10#1)
pathogens with a##2##3##(2008-10#2)
pathogens with##10##2##(2005-7#1)(2007-12#1)(2008-1#1)(2008-10#7)
pathogens within##2##2##(2008-9#1)(2011-1#1)
pathogens##912##1##(1990-6#3)(1991-10#1)(1991-11#1)(1991-12#14)(1991-7#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-2#5)(1993-8#1)(1994-11#3)(1994-2#1)(1994-3#6)(1994-6#1)(1995-1#1)(1995-2#4)(1995-5#4)(1995-7#1)(1996-1#1)(1996-10#2)(1996-11#2)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#1)(2005-10#3)(2005-11#12)(2005-7#12)(2005-8#8)(2005-9#1)(2006-10#41)(2006-12#4)(2006-2#2)(2006-5#4)(2006-6#1)(2006-7#1)(2006-8#15)(2007-1#1)(2007-10#1)(2007-11#10)(2007-12#25)(2007-2#4)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#8)(2007-8#2)(2007-9#4)(2008-1#5)(2008-10#326)(2008-11#10)(2008-12#7)(2008-2#2)(2008-3#10)(2008-4#19)(2008-5#8)(2008-6#5)(2008-7#17)(2008-8#12)(2008-9#23)(2009-10#2)(2009-12#3)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#13)(2009-7#1)(2009-8#9)(2010-10#3)(2010-11#5)(2010-12#15)(2010-2#1)(2010-3#5)(2010-4#12)(2010-6#4)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#20)(2011-10#3)(2011-12#4)(2011-2#27)(2012-1#11)(2012-11#1)(2012-12#8)(2012-2#23)(2012-3#8)(2013-1#24)(2013-7#4)(2013-8#10)
pathogens)##6##1##(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-6#1)(2011-2#1)
pathogens]##2##1##(1994-11#1)(2012-3#1)
pathognomonic feature##2##2##(2005-8#1)(2009-7#1)
pathognomonic for##6##2##(2005-7#1)(2005-8#1)(2006-10#1)(2006-8#1)(2012-3#1)(2013-7#1)
pathognomonic of##2##2##(2006-8#1)(2007-7#1)
pathognomonic sign of##2##3##(2009-7#1)(2012-2#1)
pathognomonic##19##1##(1990-2#1)(1990-5#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-8#2)(2007-7#1)(2009-10#1)(2009-7#2)(2011-1#2)(2012-2#1)(2012-3#1)(2013-7#1)
pathohistological##2##1##(2008-10#1)(2011-2#1)
pathologic anatomy##2##2##(1992-6#1)(2010-11#1)
pathologic and physiologic##2##3##(1991-12#1)(2006-10#1)
pathologic and##9##2##(1991-12#1)(1992-12#1)(1992-6#1)(2006-10#1)(2006-9#1)(2008-5#1)(2008-7#1)(2009-3#1)(2011-2#1)
pathologic calcification##2##2##(2008-4#2)
pathologic changes and##2##3##(1990-3#1)(2007-8#1)
pathologic changes in##2##3##(2010-12#1)(2010-6#1)
pathologic changes of the##2##4##(1990-3#1)(2010-8#1)
pathologic changes##10##2##(1990-3#2)(1993-11#1)(1996-6#1)(2007-10#1)(2007-8#1)(2010-12#1)(2010-6#1)(2010-8#1)(2012-12#1)
pathologic complete response##4##3##(1990-6#1)(1991-4#1)(2006-10#1)(2012-3#1)
pathologic condition##3##2##(2007-12#1)(2007-8#1)(2011-1#1)
pathologic conditions##16##2##(1990-12#2)(1991-9#1)(1993-12#1)(1994-8#1)(1996-6#1)(2006-10#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-7#1)(2009-3#1)(2010-6#1)(2012-12#1)
pathologic criteria##3##2##(2006-10#1)(2010-12#2)
pathologic diagnosis and the##2##4##(2008-8#1)(2011-2#1)
pathologic diagnosis and##3##3##(2008-8#1)(2010-5#1)(2011-2#1)
pathologic diagnosis was##2##3##(2007-8#1)(2013-8#1)
pathologic diagnosis##7##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-5#1)(2011-2#1)(2013-8#1)
pathologic effects##4##2##(1991-12#1)(2006-10#2)(2010-6#1)
pathologic entity that##2##3##(2007-8#1)(2008-10#1)
pathologic entity##3##2##(2007-8#1)(2008-10#1)(2012-3#1)
pathologic evaluation##2##2##(2011-2#1)(2013-1#1)
pathologic examination of the##3##4##(2007-2#1)(2012-2#1)(2012-3#1)
pathologic examination of##4##3##(2007-2#1)(2009-3#1)(2012-2#1)(2012-3#1)
pathologic examination##7##2##(2007-2#1)(2008-9#1)(2009-3#1)(2012-2#1)(2012-3#3)
pathologic features of##5##3##(1990-6#1)(1991-8#1)(1992-2#1)(2008-1#1)(2009-1#1)
pathologic features##11##2##(1990-6#1)(1991-8#1)(1992-2#1)(1996-7#1)(2006-2#1)(2008-1#1)(2009-1#1)(2010-12#1)(2011-2#2)(2012-3#1)
pathologic findings in##2##3##(2008-1#1)(2011-2#1)
pathologic findings of##3##3##(1991-8#1)(2006-10#1)(2008-9#1)
pathologic findings##13##2##(1991-8#1)(1997-8#1)(2006-10#2)(2008-1#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
pathologic fracture##4##2##(2007-11#1)(2008-7#1)(2009-3#2)
pathologic fractures##4##2##(2007-11#1)(2008-7#3)
pathologic gamblers##2##2##(2008-3#1)(2011-1#1)
pathologic increase in##2##3##(1997-5#1)(2008-7#1)
pathologic lesions##2##2##(2008-4#1)(2011-2#1)
pathologic patterns##2##2##(1990-12#1)(1993-12#1)
pathologic positive sensory phenomena##3##4##(2012-2#3)
pathologic process##4##2##(1992-8#1)(2008-8#1)(2008-9#1)(2013-1#1)
pathologic processes##8##2##(2005-7#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-8#1)(2011-12#1)(2012-3#1)
pathologic response##3##2##(1990-6#1)(2008-10#1)(2012-3#1)
pathologic results##2##2##(2010-10#1)(2011-2#1)
pathologic significance##2##2##(2007-8#2)
pathologic stage##3##2##(1995-8#1)(2013-1#2)
pathologic tissue##4##2##(1992-8#2)(2006-2#1)(2011-1#1)
pathologic tissues##2##2##(1990-12#1)(2008-4#1)
pathologic##241##1##(1990-11#2)(1990-12#6)(1990-3#2)(1990-6#4)(1990-8#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#2)(1991-9#2)(1992-10#2)(1992-12#1)(1992-2#1)(1992-6#2)(1992-8#4)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-6#2)(1996-7#1)(1997-5#1)(1997-8#2)(2004-2#2)(2005-1#1)(2005-7#1)(2005-8#1)(2006-10#18)(2006-2#3)(2006-7#1)(2006-9#4)(2007-10#3)(2007-11#6)(2007-12#5)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#11)(2007-9#2)(2008-1#2)(2008-10#9)(2008-11#4)(2008-3#2)(2008-4#7)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#9)(2009-1#1)(2009-12#1)(2009-3#8)(2009-4#1)(2009-5#1)(2010-10#2)(2010-11#1)(2010-12#8)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#10)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#10)(2013-1#13)(2013-7#1)(2013-8#3)
pathological EEG patterns##2##3##(2010-11#2)
pathological acid gastro-oesophageal reflux and frequent sinoatrial blocks##2##8##(1996-3#2)
pathological activities were##2##3##(2006-8#2)
pathological aging##2##2##(2010-1#1)(2012-2#1)
pathological analysis##4##2##(2007-11#1)(2007-12#1)(2009-4#1)(2013-1#1)
pathological anatomy##3##2##(1990-10#1)(1990-9#1)(1993-11#1)
pathological and clinical features##2##4##(2006-5#1)(2013-1#1)
pathological and clinical##3##3##(2006-5#1)(2011-1#1)(2013-1#1)
pathological and epidemiological##2##3##(1997-3#1)(2008-4#1)
pathological and physiological processes##2##4##(1992-8#1)(2008-10#1)
pathological and physiological##4##3##(1990-10#1)(1992-8#1)(2008-10#1)(2012-2#1)
pathological and##21##2##(1990-10#1)(1992-8#1)(1994-5#1)(1995-6#1)(1997-3#1)(2005-8#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-2#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
pathological assessment of lymphadenectomy##2##4##(2007-8#2)
pathological assessment##5##2##(2007-8#3)(2008-6#1)(2011-12#1)
pathological basis##4##2##(2005-8#1)(2007-11#1)(2008-11#1)(2008-7#1)
pathological brain##5##2##(1996-6#1)(2006-8#2)(2008-7#1)(2009-8#1)
pathological cases##2##2##(1990-9#1)(1995-3#1)
pathological change##2##2##(1991-9#1)(2011-3#1)
pathological changes associated with##3##4##(2006-11#1)(2008-1#1)(2009-6#1)
pathological changes in the lungs##2##5##(2008-5#1)(2012-1#1)
pathological changes in the##15##4##(1990-2#1)(1991-3#1)(1993-1#1)(1997-3#1)(2007-11#4)(2007-7#1)(2008-5#1)(2012-1#1)(2013-1#2)(2013-7#2)
pathological changes in##27##3##(1990-10#1)(1990-2#1)(1990-5#1)(1991-3#1)(1992-10#1)(1992-3#1)(1993-1#1)(1997-3#1)(2005-1#1)(2007-11#5)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-1#1)(2013-1#2)(2013-7#2)
pathological changes of the##4##4##(1990-9#1)(1991-6#1)(2004-11#1)(2007-11#1)
pathological changes of##6##3##(1990-9#1)(1991-6#1)(2004-11#1)(2007-11#1)(2011-2#1)(2013-7#1)
pathological changes taking place in the##2##6##(2007-11#2)
pathological changes that##4##3##(2005-8#1)(2008-11#1)(2008-5#1)(2011-12#1)
pathological changes were##2##3##(2007-11#1)(2008-12#1)
pathological changes##70##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#3)(1990-9#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-10#1)(1992-3#1)(1993-1#1)(1995-3#1)(1996-11#1)(1997-2#1)(1997-3#1)(2004-11#1)(2005-1#1)(2005-8#1)(2006-11#1)(2007-11#12)(2007-12#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#4)(2009-2#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#4)(2013-7#3)
pathological characteristics of##4##3##(1991-9#1)(2007-8#1)(2008-9#1)(2013-8#1)
pathological characteristics##7##2##(1991-9#1)(1996-9#1)(2007-4#1)(2007-8#1)(2008-9#1)(2013-8#2)
pathological class level annotation system for medical volumetric brain images##2##10##(2013-1#2)
pathological class level annotation system for##4##6##(2013-1#4)
pathological classification##2##2##(2005-10#1)(2012-12#1)
pathological complications##2##2##(2008-7#1)(2010-4#1)
pathological condition##10##2##(1990-5#1)(1996-8#1)(1997-1#1)(2006-5#1)(2006-6#1)(2008-6#1)(2009-5#1)(2011-2#2)(2013-1#1)
pathological conditions and##2##3##(1996-1#1)(2008-4#1)
pathological conditions in##2##3##(1994-11#1)(2005-7#1)
pathological conditions of##2##3##(2006-8#1)(2011-2#1)
pathological conditions such as##6##4##(1992-11#1)(1992-2#1)(2006-9#1)(2010-2#1)(2012-1#1)(2013-1#1)
pathological conditions##64##2##(1990-8#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-5#2)(1993-2#1)(1994-11#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-4#2)(1996-6#1)(1997-2#1)(1997-6#1)(2005-1#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#2)(2006-12#1)(2006-2#1)(2006-8#2)(2006-9#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#6)(2008-7#1)(2008-8#1)(2009-10#2)(2009-8#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#4)(2013-1#5)(2013-8#2)
pathological consequences##2##2##(2005-7#1)(2008-10#1)
pathological continuant entities##2##3##(2008-7#2)
pathological diagnosis of##4##3##(2005-8#1)(2007-12#1)(2007-6#1)(2012-2#1)
pathological diagnosis was##4##3##(2008-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
pathological diagnosis##15##2##(1992-5#1)(1994-8#1)(2005-8#1)(2007-12#2)(2007-6#1)(2007-9#1)(2008-10#1)(2008-12#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
pathological disorders##2##2##(2008-8#1)(2013-1#1)
pathological effects of##5##3##(1995-8#1)(2005-10#1)(2008-6#1)(2010-12#1)(2010-4#1)
pathological entities##3##2##(2006-7#1)(2006-8#1)(2008-7#1)
pathological entity##3##2##(2006-7#1)(2009-5#1)(2013-1#1)
pathological evaluation of##2##3##(2008-5#1)(2010-7#1)
pathological evaluation##5##2##(2006-12#2)(2008-5#1)(2010-3#1)(2010-7#1)
pathological events##5##2##(2006-8#1)(2008-4#1)(2010-9#1)(2012-12#1)(2012-3#1)
pathological examination in##2##3##(2007-8#1)(2012-1#1)
pathological examination of the##2##4##(2007-8#1)(2010-1#1)
pathological examination##17##2##(1997-3#1)(2006-10#1)(2006-9#1)(2007-6#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-9#1)(2010-1#1)(2010-12#1)(2012-1#3)(2012-12#1)(2013-7#2)
pathological factors##3##2##(2006-8#1)(2007-5#1)(2013-1#1)
pathological feature of Alzheimer's disease##2##5##(1996-9#1)(2008-7#1)
pathological feature of##3##3##(1996-9#1)(2008-7#1)(2010-12#1)
pathological feature##5##2##(1996-9#1)(1997-3#1)(2008-7#1)(2008-9#1)(2010-12#1)
pathological features of the##4##4##(1991-12#1)(2005-10#1)(2008-7#1)(2009-2#1)
pathological features of##26##3##(1991-12#1)(1991-6#1)(1994-8#1)(1995-3#1)(1996-6#1)(1997-4#1)(2005-10#1)(2005-8#1)(2006-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-2#1)(2008-7#4)(2009-2#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-12#1)(2013-7#2)
pathological features##37##2##(1991-12#1)(1991-6#1)(1992-3#1)(1994-8#1)(1995-3#1)(1996-6#1)(1997-4#1)(2004-2#1)(2005-10#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-5#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-2#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-2#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)
pathological findings and##2##3##(1995-11#1)(1996-12#1)
pathological findings in##3##3##(1992-5#1)(1993-3#1)(2012-2#1)
pathological findings may##2##3##(2006-4#1)(2012-2#1)
pathological findings were##5##3##(1996-9#1)(2007-8#2)(2008-5#1)(2013-1#1)
pathological findings##34##2##(1991-9#1)(1992-10#2)(1992-11#1)(1992-5#1)(1993-3#1)(1993-6#1)(1995-10#1)(1995-11#1)(1996-12#1)(1996-9#1)(2004-2#1)(2006-4#1)(2006-5#2)(2007-12#2)(2007-8#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-1#2)(2011-12#1)(2012-2#3)(2013-1#1)
pathological forms of##2##3##(1995-3#1)(1996-4#1)
pathological fracture of the proximal##2##5##(2007-11#1)(2007-7#1)
pathological fracture of the##4##4##(2006-8#1)(2007-11#1)(2007-7#1)(2008-12#1)
pathological fracture of##7##3##(2006-8#1)(2007-11#4)(2007-7#1)(2008-12#1)
pathological fracture or##4##3##(2007-11#1)(2007-7#3)
pathological fracture##29##2##(2006-8#1)(2007-11#18)(2007-7#7)(2008-12#1)(2008-6#1)(2011-12#1)
pathological fractures and impending long bone fractures##2##7##(2007-11#2)
pathological fractures and##4##3##(2007-11#4)
pathological fractures are##2##3##(1992-10#1)(2012-2#1)
pathological fractures in##4##3##(2007-11#3)(2007-7#1)
pathological fractures of the##2##4##(2007-11#1)(2008-12#1)
pathological fractures of##3##3##(2007-11#2)(2008-12#1)
pathological fractures##31##2##(1992-10#1)(2006-2#1)(2007-11#21)(2007-7#4)(2008-12#1)(2010-3#1)(2010-7#1)(2012-2#1)
pathological gambling (PG)##2##3##(2011-1#1)(2013-8#1)
pathological gambling in##3##3##(1992-6#1)(2012-12#1)(2013-8#1)
pathological gambling##10##2##(1992-6#2)(1996-1#1)(2008-11#1)(2008-6#1)(2011-1#1)(2012-12#2)(2013-8#2)
pathological grief&quot##3##2##(1993-6#3)
pathological growth##2##2##(2008-10#1)(2013-7#1)
pathological hallmark of##3##3##(1996-6#1)(2008-11#1)(2008-7#1)
pathological images##2##2##(2007-11#1)(2007-4#1)
pathological impact of##2##3##(2009-9#2)
pathological lesions##6##2##(1990-3#1)(1994-6#1)(2006-4#1)(2008-5#3)
pathological magnetic##2##2##(2006-8#2)
pathological manifestations##2##2##(2008-10#1)(2012-2#1)
pathological mechanism##4##2##(2009-10#1)(2009-2#1)(2012-12#2)
pathological mechanisms##6##2##(1995-12#1)(2007-11#1)(2007-5#2)(2008-11#1)(2012-12#1)
pathological or##2##2##(1994-6#1)(2010-4#1)
pathological outcome of##2##3##(2007-8#2)
pathological pain##3##2##(2006-10#1)(2008-4#2)
pathological parameters##11##2##(2006-8#9)(2006-9#1)(2011-1#1)
pathological pathways##4##2##(2008-11#1)(2008-7#1)(2010-10#1)(2012-3#1)
pathological phenomena##3##2##(2013-1#3)
pathological process and##2##3##(2006-5#1)(2013-1#1)
pathological process that##2##3##(2010-12#1)(2012-12#1)
pathological process##15##2##(1991-4#1)(1995-5#1)(1997-3#1)(2006-5#1)(2006-7#1)(2007-6#1)(2008-1#1)(2008-4#2)(2010-12#1)(2012-1#2)(2012-12#1)(2013-1#2)
pathological processes and##2##3##(2007-6#1)(2010-11#1)
pathological processes in the##2##4##(1994-2#1)(2006-6#1)
pathological processes of##2##3##(1996-11#1)(2006-8#1)
pathological processes such as##2##4##(2009-5#1)(2012-12#1)
pathological processes that##2##3##(2008-11#1)(2010-1#1)
pathological processes##29##2##(1992-2#1)(1992-6#1)(1993-2#1)(1994-2#1)(1995-4#1)(1996-11#1)(1996-2#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#3)
pathological reaction##2##2##(1990-6#2)
pathological reactions##2##2##(2010-12#1)(2011-2#1)
pathological report##2##2##(2010-12#1)(2013-8#1)
pathological response##2##2##(2007-11#1)(2007-8#1)
pathological responses to##2##3##(1996-8#1)(2012-2#1)
pathological responses##5##2##(1992-3#1)(1996-8#1)(2008-10#1)(2008-5#1)(2012-2#1)
pathological results##2##2##(2007-8#1)(2012-2#1)
pathological role in##2##3##(2008-5#1)(2013-1#1)
pathological role of##6##3##(1990-12#1)(1997-2#1)(2008-10#1)(2008-4#3)
pathological role##8##2##(1990-12#1)(1997-2#1)(2008-10#1)(2008-4#3)(2008-5#1)(2013-1#1)
pathological roles of##3##3##(1991-8#1)(2008-8#1)(2012-2#1)
pathological roles##5##2##(1991-8#1)(2008-8#1)(2010-5#1)(2012-2#1)(2012-3#1)
pathological scar##2##2##(2008-9#1)(2009-4#1)
pathological significance##2##2##(1996-12#1)(1997-2#1)
pathological situations##7##2##(1993-3#1)(1994-5#1)(1997-5#1)(2005-8#1)(2008-7#1)(2010-12#1)(2012-12#1)
pathological specimens##2##2##(2006-8#1)(2010-11#1)
pathological spectrum##2##2##(2006-6#1)(2008-6#1)
pathological stage##9##2##(1990-9#1)(2007-8#1)(2008-12#1)(2010-11#1)(2010-12#1)(2011-11#2)(2012-2#1)(2013-7#1)
pathological staging##2##2##(1991-9#1)(2008-10#1)
pathological state##3##2##(1995-3#1)(2008-3#1)(2013-7#1)
pathological states##7##2##(1992-8#1)(1996-7#1)(1997-6#1)(2006-6#1)(2008-1#1)(2008-5#1)(2012-12#1)
pathological studies##4##2##(2008-5#1)(2008-7#1)(2010-4#1)(2012-1#1)
pathological study##4##2##(2006-1#1)(2007-2#1)(2011-2#1)(2013-1#1)
pathological tests##2##2##(2007-9#1)(2011-1#1)
pathological tissue##3##2##(1991-7#1)(1994-9#1)(2012-12#1)
pathological verification##2##2##(2011-1#1)(2012-3#1)
pathological##810##1##(1990-10#4)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#8)(1990-8#2)(1990-9#7)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#3)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#5)(1992-10#4)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#5)(1992-4#1)(1992-5#6)(1992-6#4)(1992-8#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#3)(1993-3#2)(1993-6#6)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#2)(1995-10#5)(1995-11#1)(1995-12#3)(1995-3#6)(1995-4#1)(1995-5#4)(1995-6#1)(1995-8#3)(1996-1#3)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#3)(1996-4#4)(1996-6#5)(1996-7#1)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#4)(1997-3#8)(1997-4#3)(1997-5#2)(1997-6#3)(2004-11#1)(2004-2#2)(2005-1#3)(2005-10#4)(2005-11#3)(2005-12#1)(2005-7#2)(2005-8#10)(2005-9#2)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#4)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#6)(2006-6#5)(2006-7#4)(2006-8#25)(2006-9#3)(2007-1#1)(2007-10#2)(2007-11#64)(2007-12#8)(2007-2#3)(2007-3#1)(2007-4#2)(2007-5#6)(2007-6#7)(2007-7#15)(2007-8#23)(2007-9#4)(2008-1#8)(2008-10#18)(2008-11#12)(2008-12#9)(2008-2#1)(2008-3#1)(2008-4#19)(2008-5#20)(2008-6#9)(2008-7#26)(2008-8#8)(2008-9#6)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#3)(2009-4#4)(2009-5#9)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-1#3)(2010-10#3)(2010-11#10)(2010-12#13)(2010-2#4)(2010-3#3)(2010-4#5)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#12)(2011-11#2)(2011-12#7)(2011-2#19)(2011-3#1)(2012-1#15)(2012-11#1)(2012-12#21)(2012-2#24)(2012-3#11)(2013-1#43)(2013-7#13)(2013-8#13)
pathological&quot##2##1##(1992-3#1)(2008-4#1)
pathologically as##2##2##(1996-3#1)(2010-12#1)
pathologically diagnosed##5##2##(1992-2#1)(2011-12#1)(2012-12#1)(2013-1#2)
pathologically increased##2##2##(2008-10#1)(2009-2#1)
pathologically proven##3##2##(2007-8#1)(2010-12#1)(2011-2#1)
pathologically significant##2##2##(1992-9#1)(2008-7#1)
pathologically##43##1##(1991-12#1)(1991-8#1)(1992-2#1)(1992-9#1)(1995-10#1)(1995-3#2)(1996-3#1)(1997-3#1)(1997-6#1)(2004-2#1)(2006-10#2)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-1#1)(2009-12#1)(2009-2#1)(2010-1#1)(2010-12#5)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#3)
pathologie##6##1##(2011-2#1)(2012-2#3)(2013-1#2)
pathologies affecting##2##2##(1997-3#1)(2013-1#1)
pathologies and is##2##3##(2008-1#1)(2010-12#1)
pathologies and##9##2##(1993-10#1)(1993-9#1)(1995-12#1)(2006-1#1)(2008-1#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-8#1)
pathologies are##5##2##(2008-12#1)(2008-4#1)(2008-8#1)(2009-2#1)(2013-1#1)
pathologies associated with##4##3##(1995-12#1)(2008-1#1)(2008-6#1)(2011-1#1)
pathologies associated##5##2##(1992-10#1)(1995-12#1)(2008-1#1)(2008-6#1)(2011-1#1)
pathologies can##2##2##(2008-9#1)(2012-2#1)
pathologies in the##3##3##(1993-5#1)(1996-3#1)(2012-3#1)
pathologies in##8##2##(1992-10#1)(1993-5#1)(1996-3#1)(2006-6#1)(2008-1#1)(2009-2#1)(2012-3#2)
pathologies including##3##2##(2010-4#1)(2012-2#1)(2013-1#1)
pathologies is##4##2##(2007-12#1)(2007-8#1)(2012-12#2)
pathologies of the biliary tract##2##5##(1992-9#2)
pathologies of the##9##3##(1992-9#2)(1993-2#1)(2006-2#1)(2007-8#1)(2008-7#1)(2009-9#1)(2013-1#2)
pathologies of##14##2##(1992-9#2)(1993-2#1)(2006-2#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-7#1)(2009-2#1)(2009-9#1)(2011-1#1)(2013-1#2)
pathologies or##4##2##(1991-12#1)(1991-4#1)(2007-12#1)(2009-5#1)
pathologies such as##4##3##(2008-1#1)(2008-8#1)(2009-2#1)(2011-3#1)
pathologies that##5##2##(2009-2#1)(2010-10#1)(2012-3#1)(2013-1#2)
pathologies were##2##2##(1994-12#1)(2012-3#1)
pathologies which##2##2##(1992-9#1)(2009-2#1)
pathologies with##4##2##(1991-4#1)(1991-9#1)(2006-12#1)(2007-7#1)
pathologies##183##1##(1990-3#2)(1990-5#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-4#3)(1991-7#1)(1991-9#2)(1992-10#3)(1992-9#3)(1993-10#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1995-12#2)(1995-3#1)(1996-3#1)(1996-9#1)(1997-3#2)(2004-1#1)(2005-9#1)(2006-1#1)(2006-12#5)(2006-2#7)(2006-3#2)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-2#3)(2007-5#1)(2007-7#1)(2007-8#5)(2008-1#7)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#8)(2009-4#1)(2009-5#3)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#9)(2011-12#1)(2011-2#4)(2011-3#2)(2012-1#1)(2012-12#8)(2012-2#11)(2012-3#5)(2013-1#14)(2013-7#2)(2013-8#2)
pathologies)##2##1##(1992-9#1)(2012-3#1)
pathologist and##2##2##(1992-8#1)(2007-7#1)
pathologist##30##1##(1991-2#3)(1991-5#1)(1992-12#1)(1992-2#1)(1992-8#2)(1993-1#2)(1997-5#1)(2005-12#1)(2006-10#1)(2006-2#2)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-1#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)
pathologists and##4##2##(1997-2#1)(2008-10#1)(2009-10#1)(2011-2#1)
pathologists for##2##2##(2011-2#1)(2013-8#1)
pathologists in##4##2##(2005-8#1)(2008-3#1)(2010-9#1)(2011-2#1)
pathologists should##2##2##(1990-4#1)(2006-8#1)
pathologists to##3##2##(1996-3#1)(1997-3#1)(2008-10#1)
pathologists were called upon to help manage##2##7##(2008-10#2)
pathologists who##2##2##(2005-8#1)(2009-10#1)
pathologists##58##1##(1990-10#1)(1990-4#1)(1991-12#1)(1991-2#2)(1992-8#2)(1994-12#1)(1996-3#1)(1997-2#2)(1997-3#1)(2005-7#1)(2005-8#4)(2005-9#1)(2006-5#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-10#3)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#9)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
pathologoanatomical##2##1##(2008-8#2)
pathology among##2##2##(2005-12#1)(2008-10#1)
pathology and cell biology##2##4##(1991-11#1)(2008-9#1)
pathology and clinical##2##3##(1991-4#1)(2008-5#1)
pathology and in##2##3##(1992-4#1)(1994-12#1)
pathology and the##6##3##(1990-10#1)(2006-2#1)(2007-8#1)(2009-12#1)(2011-1#1)(2012-1#1)
pathology and therapeutic actions##2##4##(2006-6#2)
pathology and therapeutics##2##3##(2008-5#1)(2013-1#1)
pathology and treatment##2##3##(2007-6#1)(2008-10#1)
pathology and##58##2##(1990-10#1)(1991-11#1)(1991-2#3)(1991-4#1)(1992-10#1)(1992-4#1)(1994-12#2)(1995-6#1)(1997-2#1)(1997-3#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-2#2)(2006-6#2)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#2)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-3#1)(2013-1#1)
pathology are discussed##2##3##(2006-10#1)(2008-10#1)
pathology are##8##2##(1992-6#1)(1993-11#1)(1994-12#1)(2004-12#1)(2006-10#1)(2008-10#2)(2010-1#1)
pathology as well as##2##4##(2006-7#2)
pathology as##7##2##(1990-9#1)(2006-7#2)(2007-9#1)(2008-9#1)(2012-2#1)(2013-8#1)
pathology associated with##3##3##(2008-7#1)(2011-1#1)(2012-2#1)
pathology associated##4##2##(2008-7#1)(2009-2#1)(2011-1#1)(2012-2#1)
pathology at##4##2##(1996-11#1)(2008-9#1)(2012-3#1)(2013-8#1)
pathology can be challenging to clinicians##2##6##(2006-12#2)
pathology can be##7##3##(2006-12#3)(2006-8#1)(2007-8#1)(2007-9#1)(2008-9#1)
pathology can##9##2##(2005-7#1)(2006-12#3)(2006-8#1)(2007-8#1)(2007-9#1)(2008-6#1)(2008-9#1)
pathology caused by##2##3##(1996-10#1)(2009-4#1)
pathology could##2##2##(1996-12#1)(2007-3#1)
pathology department##4##2##(2011-1#2)(2011-2#1)(2012-1#1)
pathology examination##4##2##(1990-6#1)(1997-7#1)(2012-12#2)
pathology following##2##2##(1993-12#1)(1997-2#1)
pathology for the##4##3##(2008-10#2)(2011-2#1)(2013-1#1)
pathology for##8##2##(2006-8#2)(2008-10#3)(2010-1#1)(2011-2#1)(2013-1#1)
pathology had##2##2##(1991-1#1)(2008-10#1)
pathology has been##3##3##(1991-3#1)(2008-1#1)(2008-7#1)
pathology has##7##2##(1991-12#1)(1991-3#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-9#1)
pathology have been##3##3##(1995-5#1)(2006-10#1)(2008-1#1)
pathology in a##4##3##(1995-4#1)(2010-12#1)(2011-1#1)(2011-2#1)
pathology in an##2##3##(1990-5#1)(2008-7#1)
pathology in children##2##3##(1990-1#1)(2013-1#1)
pathology in diabetes##2##3##(2004-11#1)(2008-10#1)
pathology in patients with##2##4##(2011-2#1)(2013-1#1)
pathology in patients##3##3##(2011-2#1)(2013-1#1)(2013-7#1)
pathology in the form of##3##5##(1992-3#1)(2008-12#1)(2008-9#1)
pathology in the spinal cords of##2##6##(1996-9#1)(2012-1#1)
pathology in the##20##3##(1990-9#1)(1992-10#1)(1992-3#1)(1995-10#1)(1996-12#1)(1996-9#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
pathology in these##2##3##(1992-5#1)(2006-4#1)
pathology in##64##2##(1990-1#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-3#1)(1992-10#2)(1992-3#2)(1992-5#1)(1994-6#1)(1995-10#1)(1995-4#1)(1996-12#2)(1996-9#1)(1997-3#2)(2004-11#1)(2006-10#1)(2006-4#1)(2007-11#3)(2007-5#1)(2008-10#1)(2008-11#6)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-12#2)(2011-1#2)(2011-12#1)(2011-2#3)(2011-7#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
pathology increases##2##2##(1996-5#1)(2006-7#1)
pathology is a##2##3##(1992-10#1)(2006-5#1)
pathology is strain-specific##2##3##(2008-10#2)
pathology is the##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
pathology is usually##2##3##(1992-6#1)(2007-12#1)
pathology is##25##2##(1990-3#1)(1992-10#1)(1992-6#1)(1993-11#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-5#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-4#1)(2011-12#1)(2013-1#1)
pathology laboratories##2##2##(2006-2#1)(2009-8#1)
pathology laboratory##2##2##(2008-12#1)(2013-1#1)
pathology may be##3##3##(2005-9#1)(2008-7#1)(2012-2#1)
pathology may##8##2##(1994-10#1)(2005-9#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2012-2#1)
pathology not##2##2##(2007-12#1)(2011-1#1)
pathology observed##2##2##(1992-12#1)(1995-2#1)
pathology of a##2##3##(1992-3#1)(2008-9#1)
pathology of the small##3##4##(1990-5#1)(2008-10#1)(2008-8#1)
pathology of the urinary##2##4##(1991-6#1)(1996-12#1)
pathology of the##32##3##(1990-10#2)(1990-3#1)(1990-5#1)(1990-6#1)(1991-6#1)(1992-10#1)(1996-12#1)(1997-1#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-2#3)(2010-12#2)(2010-4#1)(2012-1#1)
pathology of##82##2##(1990-10#2)(1990-3#1)(1990-5#2)(1990-6#1)(1991-3#1)(1991-6#2)(1991-8#1)(1992-10#1)(1992-3#1)(1992-8#1)(1993-8#1)(1995-11#1)(1995-2#1)(1996-12#1)(1997-1#1)(2004-11#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#1)(2009-2#3)(2009-4#2)(2009-8#3)(2010-11#2)(2010-12#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-12#2)(2013-1#4)(2013-8#3)
pathology on the##2##3##(2007-11#1)(2007-8#1)
pathology or##10##2##(1991-8#1)(1991-9#1)(1992-10#1)(1996-3#1)(2006-8#1)(2007-6#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)
pathology rather than##2##3##(2007-8#1)(2012-12#1)
pathology report##3##2##(2011-2#1)(2012-12#1)(2013-1#1)
pathology reports##3##2##(2006-7#1)(2006-8#1)(2009-9#1)
pathology request forms##2##3##(2012-1#2)
pathology revealed##3##2##(2006-8#1)(2007-2#1)(2008-4#1)
pathology studies##2##2##(2005-10#1)(2006-5#1)
pathology study##2##2##(2008-9#1)(2012-2#1)
pathology that is##2##3##(1991-2#1)(2007-12#1)
pathology that may##3##3##(2006-12#1)(2006-3#1)(2007-12#1)
pathology that##12##2##(1991-2#1)(1992-6#1)(2006-12#1)(2006-3#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-8#2)(2011-2#1)
pathology to##5##2##(1991-10#1)(1993-11#1)(1994-6#1)(2008-9#1)(2012-3#1)
pathology under##2##2##(2006-3#1)(2006-6#1)
pathology usually##2##2##(2007-8#1)(2012-2#1)
pathology was##8##2##(1991-12#1)(1996-3#1)(1996-9#1)(2007-9#1)(2008-7#1)(2011-12#1)(2012-1#1)(2013-1#1)
pathology were##4##2##(1990-6#1)(1993-10#1)(2006-10#1)(2013-7#1)
pathology with##3##2##(1991-3#1)(1992-3#1)(2010-12#1)
pathology##772##1##(1990-1#2)(1990-10#4)(1990-11#2)(1990-12#3)(1990-3#4)(1990-4#3)(1990-5#5)(1990-6#6)(1990-8#2)(1990-9#2)(1991-1#3)(1991-10#2)(1991-11#4)(1991-12#2)(1991-2#4)(1991-3#8)(1991-4#4)(1991-5#1)(1991-6#3)(1991-8#2)(1991-9#2)(1992-10#8)(1992-12#3)(1992-3#7)(1992-4#1)(1992-5#2)(1992-6#3)(1992-8#3)(1992-9#2)(1993-10#4)(1993-11#4)(1993-12#1)(1993-3#2)(1993-5#3)(1993-6#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-12#7)(1994-4#2)(1994-6#2)(1994-8#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#3)(1995-2#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#8)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#3)(1996-8#3)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#5)(1997-4#1)(1997-5#1)(1997-7#1)(2004-11#2)(2004-12#1)(2005-10#2)(2005-11#4)(2005-12#3)(2005-7#2)(2005-8#3)(2005-9#3)(2006-1#1)(2006-10#34)(2006-11#2)(2006-12#6)(2006-2#8)(2006-3#2)(2006-4#3)(2006-5#6)(2006-6#5)(2006-7#10)(2006-8#22)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#14)(2007-12#15)(2007-2#7)(2007-3#5)(2007-4#2)(2007-5#5)(2007-6#3)(2007-7#2)(2007-8#21)(2007-9#9)(2008-1#14)(2008-10#41)(2008-11#16)(2008-12#6)(2008-4#10)(2008-5#14)(2008-6#9)(2008-7#22)(2008-8#12)(2008-9#24)(2009-10#4)(2009-12#4)(2009-2#7)(2009-3#5)(2009-4#7)(2009-5#3)(2009-6#1)(2009-8#4)(2009-9#3)(2010-1#3)(2010-10#1)(2010-11#4)(2010-12#13)(2010-3#3)(2010-4#3)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#11)(2011-12#4)(2011-2#29)(2011-3#1)(2011-7#2)(2012-1#13)(2012-12#13)(2012-2#15)(2012-3#8)(2013-1#38)(2013-7#4)(2013-8#8)
pathology)##5##1##(2005-8#1)(2006-8#1)(2009-2#1)(2009-4#1)(2009-9#1)
pathology-based##3##1##(2005-7#1)(2006-3#2)
pathology]##6##1##(1992-6#1)(1993-10#1)(2004-8#1)(2007-8#1)(2008-8#1)(2013-1#1)
pathomechanical##2##1##(2006-11#1)(2007-8#1)
pathomechanics##5##1##(2006-12#1)(2007-7#2)(2007-8#2)
pathomechanism of##8##2##(1991-12#1)(2007-11#6)(2011-2#1)
pathomechanism##12##1##(1991-12#1)(1995-12#1)(1996-2#1)(1997-3#1)(2007-11#7)(2011-2#1)
pathomechanisms and##2##2##(2007-7#1)(2007-8#1)
pathomechanisms of##2##2##(1995-1#1)(2013-7#1)
pathomechanisms##12##1##(1990-1#1)(1995-1#1)(1997-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-11#1)(2011-1#1)(2012-12#2)(2013-7#1)
pathomorphological features##2##2##(2007-8#1)(2008-5#1)
pathomorphological study of##2##3##(2008-7#1)(2012-1#1)
pathomorphological##8##1##(1996-3#1)(2007-8#1)(2008-4#2)(2008-5#1)(2008-7#1)(2012-1#2)
pathophysiologic and##2##2##(2010-12#1)(2012-3#1)
pathophysiologic basis as##2##3##(2008-9#1)(2012-3#1)
pathophysiologic basis of##2##3##(2007-10#1)(2010-4#1)
pathophysiologic basis##6##2##(2006-7#1)(2006-8#1)(2007-10#1)(2008-9#1)(2010-4#1)(2012-3#1)
pathophysiologic changes##4##2##(2006-9#1)(2007-10#2)(2013-1#1)
pathophysiologic concept of##2##3##(2006-10#1)(2008-10#1)
pathophysiologic concept##3##2##(2006-10#1)(2008-10#2)
pathophysiologic features##3##2##(1993-1#1)(2007-10#1)(2008-11#1)
pathophysiologic meaning##2##2##(2006-7#1)(2008-1#1)
pathophysiologic mechanisms of##2##3##(2007-10#2)
pathophysiologic mechanisms##9##2##(1991-11#1)(1991-7#1)(2007-10#3)(2007-7#1)(2008-4#1)(2008-9#1)(2011-2#1)
pathophysiologic##65##1##(1990-2#1)(1991-11#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-4#1)(1992-7#1)(1993-1#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-2#1)(1997-4#1)(2003-11#1)(2005-10#1)(2005-7#1)(2006-10#6)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#9)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-9#2)(2009-12#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
pathophysiological activation of##2##3##(1991-5#1)(2006-11#1)
pathophysiological and##3##2##(2006-10#1)(2008-6#1)(2012-2#1)
pathophysiological aspects##2##2##(1992-3#1)(2008-5#1)
pathophysiological basis of chronic##2##4##(2005-7#1)(2006-5#1)
pathophysiological basis of##3##3##(2005-7#1)(2006-5#1)(2010-12#1)
pathophysiological basis##4##2##(1997-5#1)(2005-7#1)(2006-5#1)(2010-12#1)
pathophysiological changes##4##2##(1996-2#1)(2006-2#1)(2008-4#1)(2010-10#1)
pathophysiological characteristics##2##2##(1996-9#1)(2011-1#1)
pathophysiological concept##2##2##(2010-12#1)(2010-4#1)
pathophysiological concepts##2##2##(2005-8#1)(2008-1#1)
pathophysiological conditions including##2##3##(1995-12#1)(1996-9#1)
pathophysiological conditions such as##2##4##(1990-5#1)(2006-10#1)
pathophysiological conditions##18##2##(1990-3#1)(1990-5#1)(1992-9#1)(1994-12#1)(1995-12#1)(1996-9#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-12#1)(2008-4#1)(2008-8#1)(2010-11#1)(2011-1#2)(2012-1#1)(2012-12#1)
pathophysiological consequences##2##2##(2006-11#1)(2008-2#1)
pathophysiological effects of##3##3##(2006-8#1)(2007-2#2)
pathophysiological events##4##2##(1990-2#1)(1992-7#1)(2005-8#1)(2008-1#1)
pathophysiological features of##2##3##(2006-9#1)(2010-9#1)
pathophysiological functions of##4##3##(1994-2#1)(1996-9#1)(2006-10#1)(2008-5#1)
pathophysiological functions##7##2##(1994-2#1)(1995-6#1)(1996-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2008-5#1)
pathophysiological implications##3##2##(2008-5#1)(2008-6#1)(2010-11#1)
pathophysiological mechanism##5##2##(1995-12#1)(2005-10#1)(2008-3#1)(2011-2#2)
pathophysiological mechanisms and##2##3##(2008-4#1)(2010-3#1)
pathophysiological mechanisms of##9##3##(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)
pathophysiological mechanisms##29##2##(1994-2#1)(1997-4#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#2)(2006-12#2)(2006-8#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-12#2)(2010-3#1)(2011-2#1)(2012-1#1)(2013-8#1)
pathophysiological parameters##2##2##(1992-8#1)(1997-3#1)
pathophysiological processes of the##2##4##(2007-11#1)(2009-10#1)
pathophysiological processes of##3##3##(1990-2#1)(2007-11#1)(2009-10#1)
pathophysiological processes that##3##3##(2006-10#1)(2007-11#1)(2008-4#1)
pathophysiological processes##11##2##(1990-2#1)(2005-8#1)(2006-10#1)(2007-11#2)(2007-2#1)(2008-4#2)(2009-10#2)(2011-2#1)
pathophysiological relationship between##2##3##(2006-2#1)(2008-3#1)
pathophysiological relevance##3##2##(2005-7#1)(2008-5#1)(2010-7#1)
pathophysiological role of##3##3##(1994-9#1)(2008-12#1)(2009-10#1)
pathophysiological role##5##2##(1994-9#1)(2007-11#2)(2008-12#1)(2009-10#1)
pathophysiological roles of the##2##4##(2009-12#1)(2010-11#1)
pathophysiological roles of##4##3##(2007-11#1)(2008-7#1)(2009-12#1)(2010-11#1)
pathophysiological roles##5##2##(2007-11#1)(2008-7#1)(2009-12#1)(2010-11#1)(2012-12#1)
pathophysiological significance of##3##3##(1992-7#1)(1993-9#1)(1994-12#1)
pathophysiological significance##6##2##(1992-7#1)(1993-9#1)(1994-12#1)(1996-6#1)(2008-4#1)(2008-5#1)
pathophysiological##175##1##(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1991-4#1)(1991-5#1)(1992-3#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-9#1)(1995-12#2)(1995-6#1)(1996-12#3)(1996-2#2)(1996-6#1)(1996-9#4)(1997-3#2)(1997-4#1)(1997-5#1)(2005-10#4)(2005-7#4)(2005-8#5)(2006-10#8)(2006-11#5)(2006-12#4)(2006-2#3)(2006-5#1)(2006-8#2)(2006-9#1)(2007-11#7)(2007-12#1)(2007-2#3)(2007-8#1)(2007-9#2)(2008-1#7)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#7)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-8#2)(2010-1#1)(2010-10#3)(2010-11#4)(2010-12#6)(2010-3#2)(2010-4#2)(2010-7#1)(2010-9#1)(2011-1#5)(2011-2#4)(2012-1#2)(2012-12#4)(2012-2#2)(2013-1#2)(2013-8#2)
pathophysiologically##6##1##(1992-3#1)(1992-8#1)(1993-3#1)(2009-6#1)(2011-2#2)
pathophysiology and clinical issues##2##4##(2007-11#2)
pathophysiology and clinical##7##3##(1995-6#1)(1996-9#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-7#1)
pathophysiology and development of##2##4##(1994-6#1)(2012-2#1)
pathophysiology and management of the complications of cirrhosis and portal hypertension##2##11##(2006-10#2)
pathophysiology and management of##7##4##(2006-10#3)(2006-12#1)(2007-12#1)(2008-3#1)(2010-2#1)
pathophysiology and management##10##3##(2006-10#4)(2006-12#1)(2006-4#2)(2007-12#1)(2008-3#1)(2010-2#1)
pathophysiology and possible##2##3##(1993-5#1)(2006-10#1)
pathophysiology and potential##2##3##(2007-11#1)(2013-1#1)
pathophysiology and the##2##3##(2008-8#1)(2008-9#1)
pathophysiology and therapeutic##2##3##(2008-7#1)(2012-3#1)
pathophysiology and therapy of##3##4##(1992-5#1)(2007-7#1)(2008-5#1)
pathophysiology and treatment of##11##4##(1992-8#1)(2005-10#1)(2006-9#1)(2007-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-2#1)(2013-1#1)
pathophysiology and treatment##15##3##(1992-8#1)(1996-9#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-2#1)(2013-1#1)
pathophysiology and##80##2##(1990-1#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-5#1)(1994-6#1)(1995-6#1)(1996-9#2)(2005-1#1)(2005-10#3)(2005-12#1)(2006-10#10)(2006-12#1)(2006-4#2)(2006-8#1)(2006-9#3)(2007-10#2)(2007-11#6)(2007-12#2)(2007-2#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-5#1)(2010-12#3)(2010-2#2)(2010-6#1)(2010-9#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)
pathophysiology are##3##2##(2006-10#1)(2007-12#1)(2010-12#1)
pathophysiology for##3##2##(1996-5#1)(2006-5#1)(2011-2#1)
pathophysiology has##4##2##(2006-8#1)(2008-6#1)(2008-9#1)(2010-12#1)
pathophysiology in##3##2##(2006-10#2)(2011-1#1)
pathophysiology instruction##2##2##(2005-12#2)
pathophysiology is still##2##3##(2007-8#1)(2008-11#1)
pathophysiology is unknown##2##3##(1996-1#1)(2011-1#1)
pathophysiology is##7##2##(1996-1#1)(1996-11#1)(2007-8#1)(2008-11#1)(2011-1#1)(2012-12#1)(2012-3#1)
pathophysiology may##2##2##(2008-11#1)(2010-10#1)
pathophysiology of GVHD##2##3##(1995-12#1)(2007-11#1)
pathophysiology of NAFLD##2##3##(2010-12#1)(2013-1#1)
pathophysiology of a##6##3##(1997-5#1)(2005-7#1)(2009-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
pathophysiology of acute##3##3##(2006-10#1)(2008-10#1)(2009-7#1)
pathophysiology of asthma and##2##4##(2007-11#1)(2011-12#1)
pathophysiology of asthma##4##3##(2005-11#1)(2007-11#1)(2008-11#1)(2011-12#1)
pathophysiology of atherosclerotic lesions##2##4##(2006-6#1)(2010-9#1)
pathophysiology of cartilage diseases##3##4##(2007-11#3)
pathophysiology of cerebral##3##3##(2008-9#1)(2009-9#1)(2012-3#1)
pathophysiology of chronic##4##3##(1993-9#1)(2008-11#1)(2008-12#1)(2012-11#1)
pathophysiology of coronary##2##3##(2005-1#1)(2006-6#1)
pathophysiology of depression##5##3##(2006-1#1)(2008-7#2)(2009-10#1)(2013-1#1)
pathophysiology of diabetes##3##3##(2008-1#1)(2008-4#1)(2013-7#1)
pathophysiology of ischemic##2##3##(2007-9#1)(2008-6#1)
pathophysiology of lung##2##3##(2006-10#2)
pathophysiology of migraine##4##3##(2004-12#2)(2008-5#1)(2012-2#1)
pathophysiology of neuropsychiatric##3##3##(2008-12#1)(2008-4#1)(2011-1#1)
pathophysiology of stroke##2##3##(2007-9#1)(2008-3#1)
pathophysiology of the disease##7##4##(2005-8#1)(2006-6#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-12#1)
pathophysiology of the syndrome##3##4##(1996-12#1)(2007-7#1)(2012-11#1)
pathophysiology of the##28##3##(1995-12#1)(1995-2#1)(1996-12#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-3#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2011-1#2)(2012-11#1)(2012-12#1)
pathophysiology of these lesions##2##4##(2006-2#1)(2008-7#1)
pathophysiology of these##9##3##(1992-9#1)(1997-6#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-7#1)(2011-1#1)(2013-8#1)
pathophysiology of this##11##3##(1993-11#1)(1995-2#1)(1995-9#1)(2005-10#1)(2006-5#1)(2008-1#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-12#1)(2012-2#1)
pathophysiology of##250##2##(1990-3#1)(1992-1#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-9#2)(1995-11#1)(1995-12#5)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-5#1)(1997-6#2)(1997-7#1)(2004-11#1)(2004-12#3)(2005-1#1)(2005-10#4)(2005-11#1)(2005-7#6)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#16)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#2)(2006-9#5)(2007-1#1)(2007-10#2)(2007-11#12)(2007-2#2)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#13)(2008-10#7)(2008-11#5)(2008-12#3)(2008-3#5)(2008-4#6)(2008-5#2)(2008-6#5)(2008-7#9)(2008-8#5)(2008-9#2)(2009-1#1)(2009-10#2)(2009-12#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#8)(2010-2#2)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#8)(2012-11#3)(2012-12#4)(2012-2#8)(2012-3#5)(2013-1#8)(2013-7#1)(2013-8#3)
pathophysiology that##2##2##(2011-2#1)(2013-1#1)
pathophysiology to##3##2##(2008-5#1)(2008-9#1)(2010-8#1)
pathophysiology##471##1##(1990-1#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-8#1)(1992-1#1)(1992-3#3)(1992-4#2)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#3)(1993-2#1)(1993-3#1)(1993-5#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#5)(1995-2#2)(1995-3#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-9#2)(1997-1#2)(1997-5#1)(1997-6#2)(1997-7#1)(2004-1#1)(2004-11#1)(2004-12#3)(2005-1#2)(2005-10#8)(2005-11#3)(2005-12#4)(2005-7#7)(2005-8#6)(2005-9#1)(2006-1#1)(2006-10#38)(2006-11#2)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#5)(2006-6#4)(2006-7#3)(2006-8#7)(2006-9#9)(2007-1#1)(2007-10#8)(2007-11#18)(2007-12#3)(2007-2#3)(2007-6#4)(2007-7#4)(2007-8#4)(2007-9#3)(2008-1#15)(2008-10#9)(2008-11#8)(2008-12#7)(2008-2#1)(2008-3#8)(2008-4#9)(2008-5#8)(2008-6#7)(2008-7#12)(2008-8#8)(2008-9#7)(2009-1#1)(2009-10#4)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#4)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#4)(2010-11#1)(2010-12#15)(2010-2#7)(2010-3#3)(2010-4#2)(2010-6#3)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#9)(2011-12#1)(2011-2#14)(2012-1#3)(2012-11#3)(2012-12#7)(2012-2#10)(2012-3#10)(2013-1#18)(2013-7#4)(2013-8#5)
pathos of##2##2##(2007-1#1)(2013-7#1)
pathosystem to##2##2##(2008-10#1)(2009-8#1)
pathosystem was##2##2##(2008-10#2)
pathosystem##31##1##(2008-10#27)(2009-8#2)(2011-10#1)(2012-2#1)
pathosystems that##2##2##(2008-10#2)
pathosystems##15##1##(2008-10#15)
pathotype 1##4##2##(2008-10#4)
pathotype 2##4##2##(2008-10#4)
pathotype of A##3##3##(2008-10#3)
pathotype of##4##2##(2008-10#4)
pathotype##44##1##(2005-9#1)(2008-10#39)(2008-4#1)(2011-1#1)(2013-8#2)
pathotypes of Alternaria alternata##2##4##(2008-10#2)
pathotypes of##8##2##(2008-10#8)
pathotypes should##2##2##(2008-10#2)
pathotypes were identified##3##3##(2008-10#3)
pathotypes were##5##2##(2008-10#5)
pathotypes##61##1##(2008-10#59)(2011-1#1)(2013-8#1)
pathovar of##2##2##(2008-10#2)
pathovar##12##1##(2008-10#12)
pathovars of P##2##3##(2008-10#2)
pathovars of X##5##3##(2008-10#5)
pathovars of Xanthomonas##2##3##(2008-10#2)
pathovars of##12##2##(2008-10#11)(2013-1#1)
pathovars were##3##2##(2008-10#3)
pathovars##39##1##(1990-3#1)(1993-9#2)(2008-10#35)(2013-1#1)
paths and##4##2##(1997-2#1)(2008-11#1)(2008-2#1)(2008-7#1)
paths are##4##2##(1993-3#2)(2008-2#1)(2008-6#1)
paths as##2##2##(1995-12#1)(2008-3#1)
paths at##2##2##(1995-12#1)(2011-2#1)
paths between##3##2##(2008-3#1)(2008-8#1)(2009-9#1)
paths but also##2##3##(2008-3#1)(2011-2#1)
paths by##2##2##(2008-2#1)(2008-3#1)
paths can##3##2##(1995-12#2)(2009-10#1)
paths for##5##2##(2007-11#1)(2008-9#1)(2009-6#1)(2012-1#1)(2013-1#1)
paths from the##2##3##(2009-7#1)(2013-8#1)
paths from##3##2##(2008-11#1)(2009-7#1)(2013-8#1)
paths have been##4##3##(1993-3#1)(2006-11#1)(2008-11#1)(2008-3#1)
paths in a##2##3##(1995-12#1)(2012-3#1)
paths in the##3##3##(2006-11#1)(2008-2#1)(2010-10#1)
paths in##11##2##(1995-12#1)(2006-11#1)(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#1)(2010-10#1)(2012-3#1)
paths is performed##2##3##(2007-12#1)(2009-10#1)
paths is##6##2##(2007-12#1)(2008-2#4)(2009-10#1)
paths of a##2##3##(2008-2#1)(2008-6#1)
paths of the##3##3##(2008-3#1)(2009-6#1)(2011-12#1)
paths of##18##2##(1997-2#1)(2005-11#1)(2006-4#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-6#1)(2009-4#1)(2009-6#1)(2010-9#1)(2011-12#1)
paths that##2##2##(2008-2#2)
paths through the atmosphere##3##4##(2008-2#2)(2008-3#1)
paths through the##5##3##(1992-2#1)(2007-12#1)(2008-2#2)(2008-3#1)
paths to##5##2##(1993-1#1)(1996-1#1)(2004-10#1)(2009-11#1)(2011-2#1)
paths within the##2##3##(2007-11#1)(2009-7#1)
paths##143##1##(1990-10#1)(1991-2#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-3#4)(1995-12#8)(1996-1#3)(1997-2#3)(2004-10#1)(2005-11#1)(2006-11#2)(2006-4#1)(2006-6#1)(2007-11#4)(2007-12#7)(2007-8#1)(2007-9#2)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#23)(2008-3#23)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#2)(2009-11#3)(2009-4#1)(2009-6#2)(2009-7#4)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-12#1)(2011-2#6)(2012-1#2)(2012-3#3)(2013-1#1)(2013-8#1)
paths)##3##1##(2007-12#1)(2008-3#1)(2013-1#1)
pathway (ACP)##3##2##(1991-7#1)(1992-1#1)(2005-9#1)
pathway activation##9##2##(1994-11#2)(2008-11#1)(2009-6#2)(2010-12#1)(2013-1#1)(2013-8#2)
pathway activity in##2##3##(1992-1#1)(2008-4#1)
pathway activity##5##2##(1992-1#1)(2005-7#1)(2008-4#3)
pathway along##2##2##(1994-12#1)(1996-12#1)
pathway also##4##2##(1993-12#1)(1994-12#1)(2007-12#1)(2009-4#1)
pathway analysis of##2##3##(2012-2#1)(2013-8#1)
pathway analysis##12##2##(2010-12#2)(2010-5#1)(2010-9#1)(2012-2#1)(2012-3#3)(2013-8#4)
pathway and a##4##3##(1994-12#1)(2007-12#1)(2008-4#1)(2012-2#1)
pathway and are##3##3##(1993-11#1)(1994-3#1)(1994-6#1)
pathway and is##2##3##(2008-5#1)(2008-6#1)
pathway and its##4##3##(1994-11#1)(2007-8#1)(2012-2#1)(2013-1#1)
pathway and protein##2##3##(1995-11#1)(2013-8#1)
pathway and released##2##3##(1990-5#1)(1993-11#1)
pathway and that the##3##4##(1993-2#1)(2008-11#1)(2008-8#1)
pathway and that##7##3##(1993-2#1)(1995-12#1)(1995-8#1)(1996-3#1)(1996-4#1)(2008-11#1)(2008-8#1)
pathway and the##15##3##(1992-11#1)(1992-5#1)(1994-3#1)(1996-1#1)(2005-10#1)(2007-12#2)(2008-1#1)(2008-11#2)(2008-8#1)(2009-8#1)(2010-11#1)(2012-2#1)(2013-8#1)
pathway and##103##2##(1990-10#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-5#1)(1993-11#2)(1993-2#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#3)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-8#2)(1996-1#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-7#1)(1997-2#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-1#1)(2006-10#1)(2007-11#2)(2007-12#5)(2007-8#1)(2008-1#4)(2008-10#2)(2008-11#4)(2008-3#2)(2008-4#6)(2008-5#2)(2008-6#1)(2008-8#5)(2009-11#1)(2009-8#3)(2010-11#1)(2010-12#2)(2010-4#3)(2010-7#1)(2011-10#1)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#5)(2013-1#2)(2013-8#3)
pathway appears to be##5##4##(1991-3#1)(1995-1#1)(1996-5#1)(2006-10#1)(2008-11#1)
pathway are##13##2##(1993-3#1)(1994-11#1)(1994-8#1)(1994-9#1)(1996-10#1)(2007-12#1)(2008-1#1)(2009-10#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
pathway as a##3##3##(1994-8#1)(2008-3#1)(2011-2#1)
pathway as##8##2##(1993-12#1)(1994-8#1)(2005-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2010-2#1)(2011-2#1)
pathway at##4##2##(1994-9#1)(2009-8#1)(2010-5#1)(2013-1#1)
pathway between the##4##3##(1996-11#1)(1997-7#1)(2006-8#1)(2010-11#1)
pathway between##6##2##(1994-8#1)(1996-11#1)(1997-7#1)(2006-8#1)(2010-11#1)(2012-1#1)
pathway but##2##2##(1990-11#1)(1994-6#1)
pathway by which##6##3##(1994-6#1)(1995-10#1)(1995-3#1)(1997-4#1)(2008-1#1)(2012-2#1)
pathway by##32##2##(1990-5#1)(1992-10#1)(1993-3#1)(1994-11#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-12#2)(1995-3#1)(1996-5#2)(1997-4#2)(1997-7#1)(1997-8#1)(2005-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-3#1)(2009-7#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#1)
pathway can be##6##3##(1995-3#1)(2006-10#1)(2009-6#1)(2009-8#1)(2010-4#1)(2012-3#1)
pathway can mediate##2##3##(1995-10#1)(1997-7#1)
pathway can##12##2##(1995-10#1)(1995-3#1)(1997-7#1)(2006-10#1)(2008-1#1)(2009-6#1)(2009-8#2)(2010-4#1)(2012-2#2)(2012-3#1)
pathway common to##2##3##(1994-9#1)(1995-8#1)
pathway components in the##2##4##(1995-5#1)(2007-12#1)
pathway components##6##2##(1995-5#1)(2007-12#2)(2008-9#1)(2009-3#1)(2011-2#1)
pathway contributes to the##2##4##(2008-9#1)(2010-3#1)
pathway contributes to##3##3##(2008-9#1)(2009-4#1)(2010-3#1)
pathway controlling##2##2##(1996-2#1)(2009-8#1)
pathway could be##2##3##(1992-2#1)(1995-2#1)
pathway could##5##2##(1992-2#1)(1995-2#1)(2009-6#1)(2010-2#1)(2011-2#1)
pathway data##3##2##(2008-7#1)(2010-10#2)
pathway database##3##2##(2008-4#1)(2008-7#2)
pathway distinct from##4##3##(1993-8#1)(1994-11#1)(1995-3#1)(1997-6#1)
pathway does not##2##3##(1995-6#1)(1997-2#1)
pathway effectors##3##2##(1993-11#1)(2013-8#2)
pathway enzyme##3##2##(1992-6#1)(2008-9#2)
pathway enzymes##4##2##(1993-11#1)(1996-3#1)(2008-9#2)
pathway evaluation##2##2##(2008-4#2)
pathway exchange##2##2##(2010-10#2)
pathway exhibits##2##2##(1995-3#2)
pathway exists##2##2##(1990-4#1)(1995-8#1)
pathway flux##4##2##(1992-12#1)(2008-7#1)(2011-2#2)
pathway following##2##2##(1994-3#1)(2009-3#1)
pathway for ATP release##2##4##(2008-4#2)
pathway for a##3##3##(2011-1#1)(2011-2#1)(2011-3#1)
pathway for degradation##2##3##(1992-12#1)(2009-10#1)
pathway for management of##2##4##(2008-3#2)
pathway for the management of atrial fibrillation and atrial flutter##2##10##(2008-3#2)
pathway for the management of##5##5##(2008-3#5)
pathway for the##22##3##(1992-6#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-8#1)(1997-1#1)(2005-12#1)(2006-12#1)(2006-3#1)(2008-3#6)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-2#1)(2013-1#1)
pathway for##93##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-9#1)(1992-12#3)(1992-6#1)(1992-9#2)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-4#2)(1997-6#1)(1997-8#1)(2005-12#1)(2006-1#1)(2006-12#2)(2006-3#1)(2006-4#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-3#17)(2008-4#2)(2008-7#2)(2009-10#2)(2009-6#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-11#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
pathway found##2##2##(1992-6#1)(2008-11#1)
pathway from Pseudomonas##2##3##(1994-12#1)(1995-2#1)
pathway from the##4##3##(1995-12#1)(1997-7#1)(2009-2#1)(2013-1#1)
pathway from##13##2##(1994-12#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-9#1)(1997-7#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-2#1)(2012-1#1)(2013-1#2)
pathway gene##2##2##(1991-7#1)(2008-10#1)
pathway genes##6##2##(1990-1#1)(2008-10#1)(2008-6#1)(2012-12#2)(2012-2#1)
pathway has been implicated in##2##5##(2008-1#1)(2010-3#1)
pathway has been recognized##2##4##(2006-2#1)(2010-3#1)
pathway has been##14##3##(1993-3#1)(1996-9#1)(2005-11#1)(2006-2#1)(2007-12#2)(2008-1#1)(2008-3#2)(2008-7#1)(2010-11#1)(2010-3#2)(2012-1#1)
pathway has not been##2##4##(1991-10#1)(2007-12#1)
pathway has##19##2##(1991-10#1)(1993-3#1)(1995-12#1)(1996-9#1)(2005-11#1)(2006-2#1)(2007-12#3)(2008-1#1)(2008-3#2)(2008-7#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-3#2)(2012-1#1)
pathway have##5##2##(2005-7#1)(2006-1#1)(2008-5#1)(2010-4#1)(2013-7#1)
pathway in Drosophila##3##3##(1992-1#1)(1995-8#1)(2007-12#1)
pathway in T##3##3##(1993-11#1)(2008-10#1)(2008-3#1)
pathway in a##8##3##(1994-9#1)(1996-5#1)(2007-10#1)(2008-7#1)(2010-10#1)(2010-5#1)(2012-2#1)(2013-1#1)
pathway in an##3##3##(1990-10#1)(1991-2#1)(2008-6#1)
pathway in autism spectrum##2##4##(2009-4#1)(2011-2#1)
pathway in different##2##3##(2008-9#1)(2010-7#1)
pathway in human##9##3##(1992-12#1)(1993-7#1)(1994-11#1)(1994-6#1)(2008-1#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
pathway in porcine##2##3##(1990-10#2)
pathway in rat liver##2##4##(1994-3#2)
pathway in rat##4##3##(1994-3#3)(1997-1#1)
pathway in regulating##2##3##(2011-2#1)(2013-1#1)
pathway in the##23##3##(1993-3#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-4#1)(1996-5#2)(1997-2#1)(2006-1#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-10#2)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
pathway in these##2##3##(1991-12#1)(2009-8#1)
pathway in this##2##3##(1991-10#1)(1993-8#1)
pathway in which##7##3##(1990-11#1)(1994-6#1)(1995-1#1)(1995-6#1)(1995-8#1)(2006-8#1)(2012-2#1)
pathway in##160##2##(1990-10#3)(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#2)(1990-7#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#2)(1992-1#1)(1992-12#2)(1993-11#1)(1993-3#2)(1993-7#2)(1993-8#3)(1994-11#4)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-5#4)(1996-9#1)(1997-1#2)(1997-2#1)(1997-6#2)(1997-8#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-8#2)(2007-10#2)(2007-12#1)(2008-1#4)(2008-10#4)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#2)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#1)(2009-8#3)(2010-10#3)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#7)(2011-3#2)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#5)
pathway including##2##2##(1994-8#1)(2009-8#1)
pathway independent of##2##3##(1995-8#1)(1997-7#1)
pathway induced by##2##3##(2008-8#1)(2011-1#1)
pathway induces##2##2##(1995-12#1)(1996-5#1)
pathway inhibition##2##2##(2005-8#1)(2012-3#1)
pathway inhibitor##5##2##(1992-10#2)(1995-8#2)(2012-12#1)
pathway inhibitors##5##2##(2005-8#1)(2009-11#1)(2010-12#1)(2012-3#1)(2013-7#1)
pathway interacts with##2##3##(1992-6#1)(2008-4#1)
pathway intermediates##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2013-8#2)
pathway into the##2##3##(2008-12#1)(2012-1#1)
pathway into##4##2##(1990-11#1)(2008-12#1)(2008-3#1)(2012-1#1)
pathway involved in the##3##4##(2010-10#1)(2010-12#1)(2013-7#1)
pathway involved in##9##3##(1991-5#1)(1992-7#1)(1993-11#1)(1996-2#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-2#1)(2013-7#1)
pathway involves##2##2##(1995-3#1)(2007-12#1)
pathway involving the##3##3##(1991-2#1)(1995-1#1)(2008-3#1)
pathway involving##9##2##(1991-2#1)(1994-11#1)(1995-1#1)(1995-8#2)(1997-6#1)(2007-12#1)(2008-3#1)(2010-12#1)
pathway is a##5##3##(1995-3#1)(1997-7#1)(2008-2#1)(2010-3#1)(2012-2#1)
pathway is activated##2##3##(1992-12#1)(2008-1#1)
pathway is also##3##3##(1990-11#1)(2008-1#2)
pathway is blocked by##2##4##(2008-11#1)(2008-7#1)
pathway is highly conserved##2##4##(1995-11#1)(2007-12#1)
pathway is important in##2##4##(2010-3#1)(2013-1#1)
pathway is important##3##3##(2010-3#1)(2012-2#1)(2013-1#1)
pathway is initiated by##2##4##(1995-6#1)(1995-8#1)
pathway is involved in the##2##5##(1994-2#1)(2009-9#1)
pathway is involved in##4##4##(1994-2#1)(1996-5#1)(2008-8#1)(2009-9#1)
pathway is not##3##3##(1992-6#1)(2007-8#1)(2010-12#1)
pathway is the##5##3##(1991-10#1)(1996-5#1)(2009-8#1)(2010-12#1)(2012-2#1)
pathway is used##2##3##(2008-2#1)(2011-2#1)
pathway is##73##2##(1990-11#2)(1991-10#1)(1991-12#1)(1991-2#3)(1991-7#1)(1992-12#2)(1992-6#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-2#2)(1996-5#2)(1996-8#1)(1997-2#1)(1997-7#1)(2005-11#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#2)(2009-12#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-12#3)(2010-3#2)(2011-2#4)(2012-2#5)(2013-1#2)
pathway known as##2##3##(2008-11#1)(2011-2#1)
pathway leading from the##2##4##(1995-11#1)(2008-9#1)
pathway leading to the##3##4##(1995-2#1)(2008-9#1)(2010-6#1)
pathway leading to##9##3##(1991-1#1)(1994-11#1)(1995-2#1)(1996-10#1)(2007-8#2)(2008-10#1)(2008-9#1)(2010-6#1)
pathway leading##11##2##(1991-1#1)(1994-11#1)(1995-11#1)(1995-2#1)(1996-10#1)(2007-8#2)(2008-10#1)(2008-9#2)(2010-6#1)
pathway leads to##2##3##(2006-11#1)(2011-2#1)
pathway left the Edinger-Westphal nucleus##2##5##(1993-12#2)
pathway may be involved in##4##5##(1992-9#1)(1995-12#1)(2012-3#2)
pathway may be##11##3##(1990-10#1)(1992-9#1)(1995-12#1)(1995-4#1)(1996-9#1)(2008-9#1)(2009-12#1)(2009-6#1)(2012-3#2)(2013-1#1)
pathway may function##2##3##(1995-10#1)(2009-2#1)
pathway may play a role in the##2##7##(1992-3#1)(1993-7#1)
pathway may play a role in##3##6##(1992-3#1)(1993-7#1)(2008-10#1)
pathway may play an important role in##2##7##(1993-3#1)(1995-2#1)
pathway may play##5##3##(1992-3#1)(1993-3#1)(1993-7#1)(1995-2#1)(2008-10#1)
pathway may##24##2##(1990-10#1)(1992-3#1)(1992-9#1)(1993-3#2)(1993-7#1)(1994-12#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-4#1)(1996-9#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-3#2)(2013-1#1)
pathway mediated by##4##3##(1990-11#1)(1997-4#1)(2008-11#1)(2011-2#1)
pathway mediating##2##2##(1994-11#1)(2004-12#1)
pathway might##7##2##(1991-9#1)(1993-3#1)(2006-11#1)(2008-11#1)(2011-2#1)(2013-1#2)
pathway model##3##2##(1991-5#1)(2008-3#1)(2008-7#1)
pathway models##2##2##(2008-7#2)
pathway obstruction##2##2##(2006-5#1)(2007-9#1)
pathway occurs##4##2##(1990-6#1)(1992-6#1)(1993-3#1)(1995-3#1)
pathway of Saccharomyces cerevisiae##4##4##(1996-2#1)(1997-4#1)(1997-6#2)
pathway of apoptosis in##2##4##(2012-1#1)(2012-2#1)
pathway of apoptosis##4##3##(2008-11#1)(2009-9#1)(2012-1#1)(2012-2#1)
pathway of cell##2##3##(1995-12#1)(2009-5#1)
pathway of cellular##3##3##(1995-4#1)(2013-1#2)
pathway of complement##6##3##(1996-4#1)(2005-8#1)(2008-4#3)(2009-6#1)
pathway of elimination of GEM 91##2##6##(1995-3#2)
pathway of evolution##2##3##(2007-12#1)(2009-5#1)
pathway of folding of##2##4##(1993-6#2)
pathway of gene activity##2##4##(1993-2#1)(1995-11#1)
pathway of human##2##3##(1992-12#1)(2008-12#1)
pathway of plants##2##3##(1991-7#1)(2008-7#1)
pathway of secretion##2##3##(1990-3#2)
pathway of the complement system##4##5##(1995-9#1)(1997-1#1)(2010-4#1)(2012-3#1)
pathway of the complement##5##4##(1995-9#1)(1997-1#2)(2010-4#1)(2012-3#1)
pathway of the##22##3##(1992-1#1)(1992-10#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-3#2)(1995-9#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-4#1)(2012-3#1)(2012-5#1)
pathway of##153##2##(1990-10#1)(1990-3#2)(1990-4#1)(1990-7#3)(1990-9#1)(1991-1#2)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#2)(1992-10#1)(1992-12#4)(1992-3#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-2#1)(1993-6#5)(1993-9#1)(1994-11#2)(1994-12#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#7)(1995-4#2)(1995-5#1)(1995-6#3)(1995-7#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-4#2)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-4#1)(1997-6#3)(2005-11#3)(2005-4#1)(2005-7#1)(2005-8#1)(2006-12#4)(2006-2#1)(2006-8#1)(2007-11#2)(2007-12#4)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#5)(2008-5#1)(2008-7#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-2#1)(2010-4#1)(2011-2#1)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#5)(2013-8#3)
pathway on the##2##3##(1996-5#1)(2008-3#1)
pathway on##8##2##(1992-6#1)(1996-12#1)(1996-5#1)(2008-3#1)(2008-9#2)(2010-8#1)(2011-1#1)
pathway or the##2##3##(2008-7#1)(2010-7#1)
pathway or##8##2##(1994-2#1)(1994-6#1)(2006-12#1)(2007-9#1)(2008-7#1)(2010-7#1)(2011-12#1)(2013-7#1)
pathway other than##4##3##(1992-6#1)(1993-4#1)(1995-8#1)(2004-12#1)
pathway participates##2##2##(2008-1#1)(2013-1#1)
pathway play a##2##3##(1991-8#1)(2010-10#1)
pathway play##3##2##(1991-8#1)(1994-11#1)(2010-10#1)
pathway plays a crucial role in##3##6##(2008-1#1)(2010-9#1)(2013-1#1)
pathway plays a##5##3##(2008-1#1)(2010-9#1)(2011-2#1)(2013-1#2)
pathway plays an important role in the##2##7##(2009-5#1)(2013-7#1)
pathway plays an important role in##6##6##(2009-5#1)(2009-8#1)(2010-4#1)(2011-2#1)(2013-7#2)
pathway plays an##7##3##(2009-5#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-7#2)
pathway plays##12##2##(2008-1#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-7#2)
pathway potentiates##2##2##(1996-11#1)(2008-4#1)
pathway proteins##3##2##(2011-2#1)(2012-2#1)(2013-8#1)
pathway proves##2##2##(2008-11#1)(2008-3#1)
pathway provides a##3##3##(2011-1#1)(2011-2#1)(2013-7#1)
pathway reconstruction##2##2##(2008-7#2)
pathway required for##2##3##(2009-8#1)(2011-2#1)
pathway required##3##2##(2009-8#1)(2010-11#1)(2011-2#1)
pathway requires##2##2##(1995-1#1)(2006-10#1)
pathway responsible for##2##3##(1993-2#1)(2009-8#1)
pathway resulting in##2##3##(1995-2#1)(2005-3#1)
pathway seems to be##2##4##(1991-1#1)(2010-12#1)
pathway seems to##3##3##(1991-1#1)(2008-4#1)(2010-12#1)
pathway seems##4##2##(1991-1#1)(2006-12#1)(2008-4#1)(2010-12#1)
pathway specific##2##2##(2012-1#1)(2012-3#1)
pathway such as##2##3##(2005-10#1)(2005-11#1)
pathway systems##2##2##(2009-5#2)
pathway than##3##2##(1993-6#1)(2006-1#1)(2009-12#1)
pathway that are##2##3##(1995-8#1)(2009-6#1)
pathway that is the##2##4##(2012-2#1)(2013-8#1)
pathway that is##7##3##(1993-7#2)(1994-12#1)(2009-3#1)(2010-2#1)(2012-2#1)(2013-8#1)
pathway that leads to##3##4##(1995-7#1)(2008-10#1)(2011-2#1)
pathway that may##2##3##(2006-8#1)(2010-3#1)
pathway that regulate##2##3##(1997-2#1)(2005-11#1)
pathway that##42##2##(1991-2#1)(1993-11#1)(1993-3#1)(1993-7#2)(1994-12#3)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1997-2#1)(2005-11#2)(2006-7#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-3#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
pathway the##2##2##(1995-6#1)(1996-2#1)
pathway through##5##2##(1994-5#1)(1996-2#1)(2008-7#1)(2012-12#1)(2013-8#1)
pathway to activate##3##3##(1994-11#1)(2012-1#1)(2012-2#1)
pathway to control##2##3##(2012-12#1)(2013-1#1)
pathway to the##6##3##(1991-2#1)(1992-12#1)(1994-8#1)(2007-7#1)(2009-8#1)(2013-1#1)
pathway to##44##2##(1991-2#1)(1992-12#1)(1992-8#2)(1993-3#1)(1994-11#2)(1994-2#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-5#1)(1996-9#1)(1997-1#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-6#2)(2008-7#1)(2009-10#2)(2009-2#1)(2009-8#3)(2009-9#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#4)
pathway towards##4##2##(2006-10#1)(2008-11#1)(2013-1#2)
pathway upstream of##2##3##(1996-8#1)(2010-12#1)
pathway used by##4##3##(1996-5#1)(1997-2#1)(2006-12#1)(2010-12#1)
pathway usually##2##2##(2011-2#1)(2011-3#1)
pathway via the##2##3##(1993-11#1)(2010-12#1)
pathway was activated in##2##4##(2012-2#2)
pathway was found to be##2##5##(2008-10#1)(2009-3#1)
pathway was investigated in##3##4##(1993-6#1)(1993-8#1)(1996-5#1)
pathway was##25##2##(1991-10#1)(1992-10#2)(1993-2#1)(1993-6#1)(1993-8#1)(1995-2#1)(1996-5#1)(2007-11#1)(2008-10#2)(2008-11#4)(2008-3#1)(2009-3#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
pathway were investigated##2##3##(1997-1#1)(2008-5#1)
pathway were##12##2##(1992-3#1)(1993-12#1)(1996-5#1)(1997-1#1)(2006-12#1)(2008-11#1)(2008-5#1)(2009-3#1)(2010-11#2)(2010-6#1)(2012-2#1)
pathway which has##2##3##(1992-12#1)(1992-3#1)
pathway which may be##2##4##(1996-12#1)(2008-11#1)
pathway which##9##2##(1992-12#1)(1992-3#1)(1992-8#1)(1994-8#1)(1995-6#1)(1996-12#1)(1996-3#1)(2008-11#1)(2012-3#1)
pathway will##2##2##(2008-3#1)(2008-9#1)
pathway with a##2##3##(2008-1#1)(2008-4#1)
pathway with an##2##3##(1992-1#1)(2010-12#1)
pathway with##16##2##(1991-2#1)(1992-1#1)(1994-9#1)(1995-6#1)(1996-5#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#1)(2010-12#1)(2011-3#2)(2012-12#2)
pathway within##2##2##(1991-6#1)(2009-5#1)
pathway##2010##1##(1990-1#1)(1990-10#7)(1990-11#12)(1990-12#11)(1990-2#3)(1990-3#6)(1990-4#5)(1990-5#5)(1990-6#5)(1990-7#11)(1990-8#2)(1990-9#1)(1991-1#6)(1991-10#6)(1991-11#2)(1991-12#11)(1991-2#13)(1991-3#6)(1991-4#1)(1991-5#9)(1991-6#11)(1991-7#5)(1991-8#4)(1991-9#6)(1992-1#7)(1992-10#7)(1992-11#5)(1992-12#19)(1992-2#1)(1992-3#5)(1992-5#4)(1992-6#12)(1992-7#3)(1992-8#4)(1992-9#5)(1993-11#12)(1993-12#11)(1993-2#6)(1993-3#17)(1993-4#3)(1993-6#13)(1993-7#5)(1993-8#7)(1993-9#2)(1994-11#34)(1994-12#26)(1994-2#9)(1994-3#20)(1994-5#8)(1994-6#11)(1994-7#1)(1994-8#20)(1994-9#24)(1995-1#10)(1995-10#4)(1995-11#10)(1995-12#21)(1995-2#24)(1995-3#21)(1995-4#5)(1995-5#4)(1995-6#23)(1995-7#6)(1995-8#32)(1995-9#5)(1996-1#3)(1996-10#7)(1996-11#9)(1996-12#7)(1996-2#14)(1996-3#5)(1996-4#11)(1996-5#32)(1996-6#2)(1996-7#3)(1996-8#8)(1996-9#7)(1997-1#20)(1997-2#16)(1997-3#1)(1997-4#10)(1997-5#5)(1997-6#12)(1997-7#11)(1997-8#6)(2003-11#1)(2004-11#1)(2004-12#2)(2005-10#3)(2005-11#10)(2005-12#2)(2005-3#1)(2005-4#1)(2005-7#6)(2005-8#8)(2005-9#5)(2006-1#6)(2006-10#18)(2006-11#4)(2006-12#23)(2006-2#3)(2006-3#3)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#8)(2006-9#6)(2007-1#5)(2007-10#4)(2007-11#13)(2007-12#47)(2007-3#3)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#9)(2007-9#6)(2008-1#42)(2008-10#38)(2008-11#63)(2008-12#2)(2008-2#4)(2008-3#59)(2008-4#55)(2008-5#15)(2008-6#11)(2008-7#42)(2008-8#24)(2008-9#27)(2009-1#1)(2009-10#12)(2009-11#3)(2009-12#8)(2009-2#6)(2009-3#11)(2009-4#11)(2009-5#9)(2009-6#17)(2009-7#7)(2009-8#40)(2009-9#6)(2010-10#14)(2010-11#15)(2010-12#30)(2010-2#16)(2010-3#17)(2010-4#14)(2010-5#4)(2010-6#2)(2010-7#9)(2010-8#4)(2010-9#8)(2011-1#18)(2011-10#1)(2011-12#3)(2011-2#58)(2011-3#17)(2012-1#12)(2012-11#1)(2012-12#34)(2012-2#54)(2012-3#33)(2012-5#1)(2013-1#65)(2013-7#17)(2013-8#38)
pathway&quot##5##1##(1991-4#2)(1997-4#1)(2007-1#1)(2013-1#1)
pathway(s)##8##1##(1993-3#1)(1995-1#1)(1996-5#1)(2003-11#1)(2008-8#1)(2009-6#1)(2009-8#1)(2011-1#1)
pathway) or##3##2##(2011-1#2)(2012-2#1)
pathway)##16##1##(1991-9#1)(1992-6#1)(1994-12#1)(1994-3#1)(1995-3#1)(2008-6#1)(2008-8#1)(2010-10#2)(2011-1#3)(2012-2#3)(2012-3#1)
pathway-based QTL mappings##4##3##(2012-3#4)
pathway-based QTL##5##2##(2012-3#5)
pathway-based##9##1##(2012-3#9)
pathway-specific DNA-binding proteins##2##3##(1994-6#2)
pathway-specific##7##1##(1994-6#2)(2005-10#1)(2008-10#1)(2008-11#1)(2010-10#2)
pathway-targeted##2##1##(2009-11#2)
pathway?##2##1##(1992-6#1)(1993-11#1)
pathway]##3##1##(2013-7#2)(2013-8#1)
pathways -##2##2##(2006-9#1)(2011-2#1)
pathways activate the##2##3##(2008-1#1)(2008-11#1)
pathways activated by##7##3##(1997-7#1)(2008-4#4)(2008-7#2)
pathways activated##10##2##(1996-5#1)(1997-7#3)(2008-4#4)(2008-7#2)
pathways activation##2##2##(2013-1#1)(2013-8#1)
pathways affected by##2##3##(2006-11#1)(2013-1#1)
pathways allows##3##2##(2009-5#1)(2009-6#1)(2009-8#1)
pathways also##2##2##(2007-12#1)(2009-5#1)
pathways and a##2##3##(1995-2#1)(1996-12#1)
pathways and biological processes##2##4##(2008-7#2)
pathways and cellular##3##3##(2005-7#1)(2012-12#2)
pathways and identify##2##3##(2008-10#1)(2008-4#1)
pathways and involves##2##3##(2008-10#1)(2008-4#1)
pathways and kinetics##2##3##(2006-3#1)(2011-1#1)
pathways and networks##2##3##(2008-7#1)(2012-2#1)
pathways and that##2##3##(1991-9#1)(1992-8#1)
pathways and the##14##3##(1996-3#1)(2006-10#2)(2006-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)
pathways and##92##2##(1991-11#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-8#1)(1993-12#1)(1993-7#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-12#4)(1996-2#1)(1996-3#1)(1997-1#1)(1997-6#1)(1997-7#3)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-3#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-2#1)(2008-4#6)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-5#2)(2009-6#2)(2009-7#1)(2010-12#5)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#2)(2013-1#1)(2013-8#2)
pathways are involved in the##3##5##(1996-1#1)(2008-10#1)(2011-1#1)
pathways are involved in##5##4##(1994-11#1)(1996-1#1)(2006-2#1)(2008-10#1)(2011-1#1)
pathways are involved##6##3##(1994-11#1)(1996-1#1)(2006-2#1)(2008-10#1)(2010-5#1)(2011-1#1)
pathways are not##4##3##(1995-12#1)(1995-8#1)(2010-12#1)(2012-2#1)
pathways are similar##2##3##(2008-4#1)(2009-7#1)
pathways are used##2##3##(2007-12#1)(2008-3#1)
pathways are##65##2##(1990-12#1)(1991-3#1)(1993-8#1)(1994-11#1)(1994-4#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1997-1#1)(2004-11#1)(2005-10#1)(2006-1#2)(2006-10#4)(2006-2#2)(2007-11#1)(2007-12#4)(2007-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#4)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#2)(2010-2#4)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
pathways as a##2##3##(2008-3#1)(2010-12#1)
pathways as well as##3##4##(2010-10#1)(2011-1#2)
pathways as well##4##3##(2007-12#1)(2010-10#1)(2011-1#2)
pathways as##10##2##(2006-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-12#1)(2011-1#2)
pathways associated with##8##3##(2008-1#1)(2008-10#1)(2008-11#1)(2010-11#1)(2010-2#1)(2012-3#2)(2013-8#1)
pathways at##4##2##(1995-3#1)(1995-4#1)(2006-10#1)(2009-2#1)
pathways believed to be involved in the##2##7##(2007-11#1)(2008-7#1)
pathways between the##4##3##(2004-9#1)(2008-1#1)(2008-9#1)(2010-1#1)
pathways between##7##2##(1997-1#1)(2004-9#1)(2008-1#1)(2008-9#2)(2009-5#1)(2010-1#1)
pathways but##2##2##(2006-7#1)(2008-11#1)
pathways by which##10##3##(1994-11#1)(1997-4#1)(2006-11#1)(2008-1#1)(2008-10#2)(2008-9#1)(2013-1#2)(2013-8#1)
pathways by##29##2##(1993-7#1)(1994-11#1)(1994-5#1)(1995-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-1#1)(2006-11#1)(2006-6#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-6#1)(2010-11#1)(2012-12#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
pathways can be##3##3##(1993-3#1)(2006-5#1)(2008-10#1)
pathways can have##2##3##(2007-9#1)(2008-8#1)
pathways can##10##2##(1993-3#1)(2006-5#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-8#1)(2009-10#1)(2011-1#1)(2013-1#2)
pathways characterized##2##2##(1995-3#1)(2008-7#1)
pathways contribute##2##2##(1991-2#1)(2008-5#1)
pathways controlling##6##2##(1995-6#1)(1997-2#1)(2008-10#1)(2008-9#1)(2010-3#1)(2012-12#1)
pathways could##5##2##(1997-7#1)(2008-11#1)(2008-4#1)(2010-10#1)(2013-1#1)
pathways coupled to##3##3##(1994-12#1)(2005-7#1)(2006-10#1)
pathways databases##3##2##(2008-7#3)
pathways downstream of##5##3##(1995-8#1)(1996-5#2)(2008-4#1)(2012-3#1)
pathways downstream##6##2##(1995-8#1)(1996-5#2)(2008-11#1)(2008-4#1)(2012-3#1)
pathways during##4##2##(2008-10#1)(2008-11#1)(2009-8#1)(2012-1#1)
pathways for patients##2##3##(2008-3#2)
pathways for the synthesis of##2##5##(1991-3#1)(1996-2#1)
pathways for the##9##3##(1991-3#1)(1992-7#1)(1996-2#1)(2007-3#1)(2008-11#1)(2008-8#1)(2009-1#1)(2009-12#1)(2011-2#1)
pathways for##54##2##(1990-11#1)(1990-12#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#2)(1992-7#1)(1993-3#1)(1994-12#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-8#1)(2006-11#1)(2007-12#1)(2007-3#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#7)(2008-7#3)(2008-8#3)(2008-9#1)(2009-1#1)(2009-12#1)(2009-8#1)(2010-2#1)(2010-7#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
pathways from the##2##3##(1995-12#1)(1996-7#1)
pathways from##8##2##(1995-12#1)(1996-7#1)(2007-7#1)(2008-7#1)(2009-7#1)(2010-2#1)(2011-1#1)(2012-2#1)
pathways has been##2##3##(2008-3#1)(2009-12#1)
pathways has##6##2##(1996-2#1)(2008-1#1)(2008-3#1)(2008-4#1)(2009-12#1)(2009-4#1)
pathways have been##9##3##(1992-2#1)(2006-1#1)(2008-10#1)(2008-7#2)(2009-3#1)(2010-10#1)(2011-1#1)(2013-8#1)
pathways have##16##2##(1990-1#1)(1992-2#1)(2006-1#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#3)(2009-3#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
pathways implicated in the##2##4##(2005-11#1)(2008-7#1)
pathways implicated in##3##3##(2005-11#1)(2005-8#1)(2008-7#1)
pathways important for##2##3##(2008-5#1)(2010-2#1)
pathways important##3##2##(2008-5#1)(2009-3#1)(2010-2#1)
pathways in C##3##3##(2007-12#3)
pathways in Drosophila##2##3##(2007-8#1)(2010-5#1)
pathways in a##3##3##(1993-11#1)(2006-10#1)(2008-10#1)
pathways in modulating##2##3##(1993-3#1)(2006-10#1)
pathways in order to##2##4##(2007-3#1)(2012-2#1)
pathways in plants##2##3##(2009-8#1)(2011-2#1)
pathways in rat##3##3##(1992-1#1)(1995-6#1)(2008-11#1)
pathways in the CNS##2##4##(2007-11#1)(2010-11#1)
pathways in the central nervous system (CNS)##2##7##(1994-2#1)(2007-11#1)
pathways in the rat##2##4##(1996-6#1)(2010-2#1)
pathways in the regulation of##2##5##(1997-4#1)(2011-2#1)
pathways in the##31##3##(1990-2#1)(1992-11#1)(1992-3#1)(1992-5#1)(1993-5#1)(1994-2#1)(1995-2#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-6#1)(2004-4#1)(2007-11#2)(2008-3#1)(2008-4#2)(2008-7#1)(2009-8#1)(2010-11#2)(2010-2#1)(2010-4#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
pathways in these##2##3##(1995-3#1)(2006-10#1)
pathways in this##2##3##(1995-5#1)(2012-2#1)
pathways in various cell##2##4##(1992-1#1)(2010-7#1)
pathways in which##4##3##(1995-1#1)(2008-4#2)(2013-1#1)
pathways in##130##2##(1990-11#1)(1990-2#1)(1991-2#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#3)(1996-2#2)(1996-5#4)(1996-6#1)(1996-9#1)(1997-4#2)(1997-6#1)(1997-7#1)(2004-4#1)(2005-11#1)(2006-10#7)(2007-11#4)(2007-12#4)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#7)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#4)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#7)(2012-1#2)(2012-2#7)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
pathways including##8##2##(1993-4#1)(1995-2#1)(1996-5#1)(2007-11#1)(2008-10#1)(2011-2#2)(2013-7#1)
pathways inside##2##2##(1991-9#1)(2008-1#1)
pathways into##3##2##(1994-2#1)(2009-3#1)(2010-2#1)
pathways involved are not##3##4##(1993-12#1)(2008-2#1)(2008-4#1)
pathways involved in cardiac##2##4##(2008-7#2)
pathways involved in the development of##2##6##(2010-6#1)(2011-2#1)
pathways involved in the pathogenesis of##2##6##(2011-1#1)(2013-8#1)
pathways involved in the regulation of##2##6##(1991-11#1)(2008-4#1)
pathways involved in the##12##4##(1991-11#2)(1994-3#1)(2008-4#2)(2008-7#1)(2009-1#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
pathways involved in this##2##4##(2006-1#1)(2009-11#1)
pathways involved in##36##3##(1991-11#2)(1994-3#1)(1997-2#1)(2006-1#2)(2006-10#2)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#4)(2008-8#1)(2009-1#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-4#2)(2010-6#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-7#1)(2013-8#1)
pathways involved##49##2##(1991-1#1)(1991-11#2)(1993-12#1)(1994-3#1)(1996-10#1)(1996-3#1)(1997-2#1)(2006-1#2)(2006-10#2)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#4)(2008-8#1)(2009-1#1)(2009-11#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-4#2)(2010-6#3)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-3#2)(2013-7#1)(2013-8#1)
pathways involving##8##2##(1991-2#1)(1994-8#1)(1995-2#1)(1995-5#1)(2006-10#1)(2007-12#1)(2008-4#1)(2012-12#1)
pathways is##13##2##(1994-6#1)(1995-12#1)(1996-2#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-7#1)(2008-9#1)(2009-6#2)(2010-3#1)(2012-2#1)(2012-3#1)
pathways leading from##2##3##(1996-2#1)(2007-11#1)
pathways leading to cell##2##4##(2005-7#1)(2012-12#1)
pathways leading to##17##3##(1992-12#2)(1994-6#1)(1996-3#1)(1996-8#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-2#1)(2006-8#1)(2008-4#1)(2009-6#1)(2011-2#1)(2012-12#2)(2012-2#1)
pathways leading##20##2##(1992-12#2)(1994-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-2#1)(2006-8#1)(2007-11#1)(2008-4#1)(2009-6#1)(2011-2#1)(2012-12#2)(2012-2#1)
pathways linked to##2##3##(1996-9#1)(2008-8#1)
pathways linked##3##2##(1996-9#1)(2008-8#1)(2013-7#1)
pathways linking##4##2##(1995-12#1)(2007-12#1)(2009-2#1)(2010-10#1)
pathways may also##2##3##(1994-5#1)(2007-11#1)
pathways may be##3##3##(2006-12#1)(2008-7#1)(2011-2#1)
pathways may have##2##3##(2008-4#1)(2008-6#1)
pathways may##19##2##(1994-5#1)(1995-12#1)(1996-11#1)(1996-5#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-12#1)(2011-1#2)(2011-2#2)
pathways mediated by##2##3##(2010-3#1)(2013-7#1)
pathways mediating##4##2##(1990-5#1)(1992-9#1)(2008-1#1)(2013-8#1)
pathways might##2##2##(1990-7#1)(1997-4#1)
pathways must##3##2##(1994-5#1)(2011-1#1)(2012-2#1)
pathways not##3##2##(1993-6#1)(1995-8#1)(1996-2#1)
pathways of apoptosis##5##3##(2003-11#1)(2008-7#1)(2013-1#2)(2013-8#1)
pathways of entry##3##3##(2008-10#3)
pathways of the complement##2##4##(2005-8#1)(2007-1#1)
pathways of the##21##3##(1992-5#1)(1992-8#2)(1994-12#1)(1995-11#1)(1996-12#1)(1996-2#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-9#1)(2007-1#1)(2007-12#1)(2009-8#1)(2010-11#1)(2010-2#2)(2013-1#2)(2013-7#1)
pathways of this##2##3##(1996-2#1)(2008-1#1)
pathways of##121##2##(1990-11#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-7#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-8#2)(1993-12#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#2)(1996-8#1)(1997-4#1)(2003-11#1)(2004-11#1)(2005-11#1)(2005-8#2)(2006-10#2)(2006-12#3)(2006-2#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#6)(2008-3#1)(2008-4#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-11#2)(2010-12#2)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-11#1)(2012-12#3)(2012-2#3)(2012-8#1)(2013-1#8)(2013-7#2)(2013-8#3)
pathways on##4##2##(2008-3#1)(2010-8#1)(2011-1#1)(2011-2#1)
pathways operate##2##2##(1991-11#1)(2008-5#1)
pathways or the##2##3##(1991-12#1)(1994-3#1)
pathways or##12##2##(1990-7#1)(1991-12#1)(1993-2#1)(1994-3#2)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)
pathways present in the##2##4##(1997-6#1)(2011-1#1)
pathways present in##3##3##(1997-6#1)(2011-1#1)(2012-3#1)
pathways regulate##4##2##(2008-8#1)(2008-9#1)(2010-7#1)(2012-2#1)
pathways regulated by##3##3##(1990-3#1)(1995-3#1)(2008-1#1)
pathways regulating cell##2##3##(1996-2#1)(2008-5#1)
pathways regulating##8##2##(1996-2#1)(2005-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-3#1)(2011-12#1)
pathways relevant##2##2##(2008-7#1)(2012-1#1)
pathways require##2##2##(2008-2#1)(2012-2#1)
pathways responsible for##6##3##(1997-7#2)(2008-4#1)(2009-11#1)(2012-12#1)(2013-1#1)
pathways resulting in the##2##4##(2006-10#1)(2012-12#1)
pathways resulting in##3##3##(2006-10#1)(2012-12#2)
pathways revealed##2##2##(1990-8#1)(2008-7#1)
pathways share##2##2##(2008-11#1)(2012-2#1)
pathways such as glycolysis##2##4##(2010-7#1)(2012-1#1)
pathways such as the##2##4##(2007-12#1)(2008-5#1)
pathways such as##10##3##(1991-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-7#2)(2012-1#1)
pathways than##4##2##(1992-7#1)(2007-11#1)(2009-8#1)(2012-3#1)
pathways that are##12##3##(1994-6#1)(2006-3#1)(2007-5#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-1#1)
pathways that can##2##3##(2005-10#1)(2008-7#1)
pathways that cause##2##3##(2008-1#1)(2009-10#1)
pathways that control##2##3##(2009-8#1)(2010-12#1)
pathways that involve##2##3##(1995-4#1)(2006-10#1)
pathways that lead to##5##4##(1996-5#1)(2008-4#1)(2008-8#1)(2009-5#1)(2011-1#1)
pathways that may be##3##4##(2010-2#1)(2013-1#1)(2013-8#1)
pathways that may##5##3##(2010-12#1)(2010-2#2)(2013-1#1)(2013-8#1)
pathways that mediate##3##3##(1994-4#1)(1997-1#1)(2011-1#1)
pathways that might##2##3##(2009-3#1)(2010-12#1)
pathways that normally##2##3##(1993-9#1)(1996-8#1)
pathways that play a##2##4##(2005-11#1)(2009-5#1)
pathways that regulate the##2##4##(2008-1#1)(2009-12#1)
pathways that regulate##8##3##(2007-12#1)(2008-1#2)(2008-7#1)(2009-10#1)(2009-12#1)(2011-12#1)(2012-3#1)
pathways that stimulate##2##3##(1992-2#1)(1997-7#1)
pathways that were##2##3##(2010-10#1)(2012-3#1)
pathways that##84##2##(1991-3#1)(1992-2#1)(1993-9#1)(1994-4#1)(1994-6#1)(1994-8#2)(1995-4#1)(1996-11#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-6#1)(1997-7#1)(2005-10#2)(2005-11#1)(2006-10#1)(2006-3#1)(2007-12#3)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#5)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#3)(2009-12#1)(2009-3#1)(2009-5#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#5)(2010-2#2)(2010-3#1)(2010-7#1)(2011-1#4)(2011-12#2)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
pathways through the##3##3##(1995-2#1)(2007-11#1)(2013-1#1)
pathways through which##2##3##(1993-12#1)(2012-3#1)
pathways through##13##2##(1993-12#1)(1995-2#1)(1995-6#2)(1997-6#1)(2007-11#1)(2008-8#1)(2010-12#1)(2010-7#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
pathways to elevate##2##3##(1995-8#1)(2010-4#1)
pathways to improve##2##3##(2008-3#1)(2009-8#1)
pathways to the##6##3##(1995-12#1)(2008-10#1)(2008-4#1)(2009-8#1)(2010-2#1)(2012-2#1)
pathways to##40##2##(1992-1#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-12#2)(1995-5#1)(1995-8#1)(1997-5#1)(2005-8#1)(2006-10#2)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-2#1)(2009-8#3)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#2)
pathways triggered by##3##3##(2008-11#1)(2008-9#1)(2009-8#1)
pathways triggered##4##2##(1996-5#1)(2008-11#1)(2008-9#1)(2009-8#1)
pathways underlying the##2##3##(2006-10#1)(2008-11#1)
pathways underlying##8##2##(1996-12#1)(2006-10#1)(2008-11#1)(2008-7#2)(2009-3#1)(2009-8#1)(2012-12#1)
pathways upon##3##2##(2007-12#1)(2008-8#1)(2012-1#1)
pathways used by##2##3##(1995-1#1)(2007-8#1)
pathways used##3##2##(1995-1#1)(2007-8#1)(2008-4#1)
pathways using a##3##3##(1995-6#1)(2008-11#2)
pathways via##3##2##(1990-12#1)(2010-10#1)(2012-2#1)
pathways was investigated##2##3##(1996-5#1)(1997-6#1)
pathways was##5##2##(1996-5#1)(1997-6#1)(2006-12#1)(2008-11#1)(2010-12#1)
pathways we##2##2##(2009-8#1)(2010-11#1)
pathways were activated##2##3##(2008-7#1)(2012-2#1)
pathways were examined##2##3##(2009-7#1)(2010-8#1)
pathways were##16##2##(1991-12#1)(1991-9#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-8#2)(2012-1#1)(2012-2#1)
pathways which are##2##3##(2008-5#1)(2012-12#1)
pathways which regulate##2##3##(2008-8#1)(2009-8#1)
pathways which##16##2##(1990-2#1)(1991-3#1)(1992-7#2)(1995-2#1)(1995-6#1)(1997-7#1)(2005-8#1)(2006-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-4#1)(2012-12#1)(2013-8#1)
pathways with##7##2##(2008-1#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
pathways within the##4##3##(1992-9#1)(1995-10#1)(1995-8#1)(2011-2#1)
pathways within##6##2##(1992-9#1)(1994-8#1)(1995-10#1)(1995-8#1)(2008-7#1)(2011-2#1)
pathways##1710##1##(1990-1#1)(1990-11#6)(1990-12#7)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#3)(1990-7#3)(1990-8#3)(1990-9#1)(1991-1#3)(1991-11#5)(1991-12#5)(1991-2#5)(1991-3#7)(1991-4#2)(1991-6#2)(1991-7#2)(1991-8#3)(1991-9#8)(1992-1#6)(1992-10#1)(1992-11#4)(1992-12#6)(1992-2#2)(1992-3#5)(1992-4#2)(1992-5#4)(1992-6#1)(1992-7#8)(1992-8#4)(1992-9#2)(1993-11#3)(1993-12#9)(1993-2#1)(1993-3#7)(1993-4#3)(1993-5#1)(1993-6#6)(1993-7#5)(1993-8#4)(1993-9#4)(1994-10#2)(1994-11#11)(1994-12#9)(1994-2#7)(1994-3#6)(1994-4#4)(1994-5#5)(1994-6#9)(1994-7#1)(1994-8#13)(1994-9#2)(1995-1#6)(1995-10#1)(1995-11#5)(1995-12#12)(1995-2#15)(1995-3#12)(1995-4#8)(1995-5#8)(1995-6#14)(1995-7#2)(1995-8#11)(1996-1#1)(1996-10#5)(1996-11#7)(1996-12#9)(1996-2#17)(1996-3#4)(1996-4#1)(1996-5#23)(1996-6#1)(1996-7#3)(1996-8#5)(1996-9#6)(1997-1#6)(1997-2#7)(1997-3#1)(1997-4#9)(1997-5#1)(1997-6#8)(1997-7#17)(1997-8#2)(2003-11#1)(2004-11#3)(2004-4#1)(2004-9#1)(2005-10#8)(2005-11#7)(2005-7#3)(2005-8#8)(2005-9#1)(2006-1#8)(2006-10#40)(2006-11#4)(2006-12#9)(2006-2#6)(2006-3#3)(2006-5#4)(2006-6#4)(2006-7#2)(2006-8#4)(2006-9#4)(2007-1#2)(2007-10#3)(2007-11#23)(2007-12#42)(2007-3#6)(2007-4#1)(2007-5#3)(2007-6#4)(2007-7#2)(2007-8#13)(2007-9#2)(2008-1#34)(2008-10#47)(2008-11#58)(2008-12#9)(2008-2#7)(2008-3#34)(2008-4#77)(2008-5#23)(2008-6#10)(2008-7#73)(2008-8#32)(2008-9#31)(2009-1#3)(2009-10#15)(2009-11#3)(2009-12#9)(2009-2#7)(2009-3#11)(2009-4#6)(2009-5#16)(2009-6#17)(2009-7#9)(2009-8#34)(2009-9#3)(2010-1#4)(2010-10#15)(2010-11#11)(2010-12#35)(2010-2#25)(2010-3#7)(2010-4#12)(2010-5#7)(2010-6#6)(2010-7#11)(2010-8#8)(2010-9#3)(2011-1#34)(2011-12#7)(2011-2#56)(2011-3#2)(2012-1#25)(2012-11#1)(2012-12#34)(2012-2#50)(2012-3#31)(2012-7#1)(2012-8#2)(2013-1#42)(2013-7#12)(2013-8#23)
patience of##2##2##(1992-8#1)(2007-9#1)
patience##6##1##(1992-8#1)(1995-2#1)(2006-9#2)(2007-9#1)(2010-12#1)
patiens with##2##2##(2006-10#1)(2006-6#1)
patiens##4##1##(2006-10#1)(2006-6#3)
patient &quot##3##2##(1997-1#1)(2007-8#1)(2011-2#1)
patient (0##5##2##(1994-2#1)(2005-9#1)(2006-2#1)(2007-11#1)(2007-3#1)
patient (2##2##2##(2006-6#1)(2012-2#1)
patient (5%)##3##2##(1996-9#1)(2006-9#1)(2010-7#1)
patient (6##3##2##(2008-1#2)(2008-10#1)
patient (a##4##2##(1991-8#1)(2007-7#1)(2008-11#1)(2011-2#1)
patient (p &lt##3##3##(2008-6#3)
patient (the##2##2##(2008-10#1)(2010-7#1)
patient - doctor relationships##2##4##(2013-7#2)
patient - doctor##3##3##(2013-7#3)
patient -##6##2##(2007-11#1)(2007-7#1)(2013-1#1)(2013-7#3)
patient 1##4##2##(1995-2#1)(2007-12#1)(2007-8#1)(2013-1#1)
patient 2##4##2##(1995-2#1)(2007-12#1)(2007-8#1)(2009-10#1)
patient 4##2##2##(2007-7#1)(2011-3#1)
patient 6 years after##3##4##(2011-2#1)(2012-12#2)
patient B##2##2##(1996-5#1)(1996-6#1)
patient ID##2##2##(1997-1#1)(2011-1#1)
patient PBMC cultures but in##2##5##(1992-8#2)
patient a##15##2##(1992-10#1)(1995-2#1)(1995-8#1)(1996-2#1)(2006-11#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-3#1)(2008-6#1)(2010-12#1)(2012-2#3)
patient acceptance##5##2##(2005-3#1)(2008-1#1)(2008-3#1)(2008-8#1)(2012-3#1)
patient access to##7##3##(2006-8#1)(2007-12#1)(2008-6#2)(2008-7#1)(2011-1#1)(2011-3#1)
patient access##13##2##(1993-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(2006-8#2)(2007-12#1)(2008-11#1)(2008-6#2)(2008-7#1)(2011-1#1)(2011-3#1)
patient according to a##2##4##(1990-4#1)(2006-6#1)
patient according to##4##3##(1990-4#1)(1992-6#1)(2006-1#1)(2006-6#1)
patient account##2##2##(2007-9#1)(2008-11#1)
patient achieved complete remission##3##4##(1992-6#1)(2007-6#1)(2008-10#1)
patient achieved complete##5##3##(1991-10#1)(1992-6#1)(2007-10#1)(2007-6#1)(2008-10#1)
patient achieved##8##2##(1991-10#1)(1992-6#1)(2007-10#2)(2007-6#2)(2008-10#1)(2009-8#1)
patient activity##3##2##(1996-1#1)(2007-7#1)(2009-12#1)
patient acuity##2##2##(2007-3#1)(2013-1#1)
patient adherence with##2##3##(1993-9#1)(2009-9#1)
patient adherence##7##2##(1993-9#2)(2006-12#1)(2008-3#2)(2009-9#1)(2010-8#1)
patient admissions##2##2##(2007-12#1)(2008-8#1)
patient admitted to hospital##2##4##(1992-5#1)(2013-8#1)
patient admitted to##3##3##(1992-5#1)(2011-2#1)(2013-8#1)
patient admitted with##3##3##(2005-12#1)(2012-2#2)
patient admitted##8##2##(1992-5#1)(2005-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
patient advocacy##6##2##(1990-12#1)(1995-3#2)(2008-10#2)(2008-2#1)
patient affected by an##2##4##(1990-3#1)(1993-5#1)
patient affected by##14##3##(1990-3#1)(1991-1#1)(1992-12#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-9#1)(2007-6#1)(2008-5#2)(2009-4#1)(2010-7#1)(2012-2#1)(2013-8#1)
patient affected with##2##3##(1993-6#1)(2011-1#1)
patient affected##16##2##(1990-3#1)(1991-1#1)(1992-12#1)(1993-12#1)(1993-5#1)(1993-6#2)(1993-9#1)(2007-6#1)(2008-5#2)(2009-4#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
patient after surgical##2##3##(2006-10#1)(2012-2#1)
patient after##21##2##(1995-3#1)(2005-10#1)(2006-10#3)(2006-8#1)(2007-11#5)(2008-10#1)(2008-4#1)(2008-7#1)(2012-12#3)(2012-2#3)(2013-1#1)
patient against##2##2##(1992-12#1)(2009-2#1)
patient age at##3##3##(2006-5#1)(2009-3#2)
patient age or##2##3##(1990-1#1)(1991-6#1)
patient age was##9##3##(1992-4#1)(2006-5#1)(2007-10#1)(2007-8#1)(2009-12#1)(2009-3#1)(2010-12#1)(2012-3#1)(2013-1#1)
patient age##36##2##(1990-1#1)(1990-12#1)(1991-6#1)(1992-4#1)(1993-12#1)(1995-2#1)(1996-3#1)(1996-9#1)(2006-10#1)(2006-5#3)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-12#2)(2008-4#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#3)(2010-12#2)(2010-2#1)(2011-2#1)(2012-3#2)(2013-1#4)
patient aged##3##2##(1992-11#1)(2007-8#1)(2012-12#1)
patient all##2##2##(2010-12#1)(2013-1#1)
patient also had##5##3##(1994-12#1)(2007-7#2)(2010-4#1)(2012-2#1)
patient also has##3##3##(1995-2#1)(1996-12#1)(2008-6#1)
patient also presented##3##3##(1996-3#1)(2006-11#1)(2006-6#1)
patient also##22##2##(1994-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-7#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-12#1)(2007-7#2)(2008-6#1)(2009-4#2)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#4)
patient anatomy##2##2##(2009-5#1)(2010-9#1)
patient and a##3##3##(1994-2#1)(1994-8#1)(2007-3#1)
patient and admission characteristics##2##4##(2013-1#2)
patient and care##2##3##(2010-5#1)(2011-1#1)
patient and caregiver##4##3##(2006-10#1)(2008-6#1)(2010-12#1)(2010-5#1)
patient and community##2##3##(1992-12#1)(2007-6#1)
patient and control groups##4##4##(2006-10#1)(2007-10#1)(2009-10#1)(2011-2#1)
patient and control##5##3##(1994-8#1)(2006-10#1)(2007-10#1)(2009-10#1)(2011-2#1)
patient and disease##2##3##(2006-2#1)(2007-8#1)
patient and doctor##2##3##(2007-12#1)(2011-12#1)
patient and each##2##3##(2007-8#1)(2008-10#1)
patient and family satisfaction##2##4##(2007-6#1)(2010-2#1)
patient and family##15##3##(1991-7#1)(1996-4#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-11#1)(2008-3#2)(2008-7#1)(2010-2#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#1)
patient and for##3##3##(1993-3#1)(2007-11#1)(2012-12#1)
patient and from the##2##4##(1992-11#1)(1995-9#1)
patient and from##5##3##(1992-11#1)(1993-8#1)(1995-9#1)(2009-6#1)(2011-1#1)
patient and graft survival##4##4##(2007-11#2)(2007-7#1)(2008-1#1)
patient and graft##5##3##(2007-11#2)(2007-7#1)(2008-1#1)(2008-8#1)
patient and his/her##3##3##(2010-3#1)(2010-6#1)(2013-8#1)
patient and parents##2##3##(1996-6#1)(2008-10#1)
patient and physician##8##3##(2008-11#2)(2008-6#1)(2008-8#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-1#1)
patient and provider satisfaction##2##4##(2006-1#1)(2007-9#1)
patient and surgeon##4##3##(2007-5#1)(2008-10#1)(2011-2#1)(2013-1#1)
patient and the physician##2##4##(2006-9#1)(2013-8#1)
patient and the##36##3##(1990-10#1)(1991-12#1)(1991-3#1)(1991-4#1)(1993-7#2)(1994-11#1)(1994-2#1)(1995-2#1)(1995-9#1)(2004-2#1)(2006-10#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-8#1)
patient and their##3##3##(1995-12#1)(2007-3#1)(2009-11#1)
patient and therapist##2##3##(1993-5#1)(2012-1#1)
patient and those##2##3##(2006-10#1)(2007-12#1)
patient and will##2##3##(2010-12#1)(2010-3#1)
patient and##257##2##(1990-10#1)(1990-2#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-4#2)(1991-6#1)(1991-7#3)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#4)(1992-8#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-5#2)(1993-7#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-7#1)(1994-8#2)(1995-12#1)(1995-2#2)(1995-5#1)(1995-8#1)(1995-9#2)(1996-12#1)(1996-3#1)(1996-4#2)(1996-6#5)(1996-8#4)(1997-1#1)(1997-2#4)(1997-4#1)(1997-5#2)(2004-2#1)(2004-9#1)(2005-12#1)(2005-4#1)(2006-1#1)(2006-10#8)(2006-12#2)(2006-2#5)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#6)(2007-12#6)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#5)(2007-7#6)(2007-8#7)(2007-9#1)(2008-1#7)(2008-10#7)(2008-11#6)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#6)(2008-7#2)(2008-8#7)(2008-9#4)(2009-10#3)(2009-11#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-3#3)(2010-4#3)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#5)(2011-3#1)(2012-1#5)(2012-12#4)(2012-2#2)(2012-3#5)(2013-1#11)(2013-7#1)(2013-8#4)
patient and/or##3##2##(2008-10#1)(2008-8#1)(2012-12#1)
patient anger##2##2##(2006-12#1)(2008-4#1)
patient anti-dumping##3##2##(1993-1#1)(1993-2#2)
patient anxiety and##2##3##(1993-11#1)(1995-1#1)
patient anxiety##3##2##(1993-11#1)(1995-1#1)(1996-2#1)
patient are discussed##2##3##(2006-4#1)(2008-8#1)
patient are##15##2##(1996-3#1)(1997-5#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-5#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-1#1)(2009-11#1)(2009-3#1)(2009-7#1)(2011-12#1)(2012-1#1)
patient arrival##2##2##(2007-9#1)(2008-3#1)
patient arrived##4##2##(2007-12#1)(2010-1#1)(2013-1#2)
patient arrives##4##2##(2007-11#1)(2011-12#1)(2013-1#2)
patient as a result of##2##5##(2007-8#1)(2010-10#1)
patient as a whole##2##4##(2008-8#1)(2012-3#1)
patient as a##8##3##(2007-8#1)(2008-3#1)(2008-8#1)(2010-10#1)(2012-3#1)(2013-1#2)(2013-8#1)
patient as well as##2##4##(2007-11#1)(2011-2#1)
patient as##19##2##(1992-8#1)(1993-12#1)(1996-6#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-8#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
patient assessment and prevention of pulmonary side effects in surgery##2##10##(2010-9#2)
patient assessment and##3##3##(2007-12#1)(2010-9#2)
patient assessment##12##2##(1997-2#1)(2005-8#1)(2007-12#2)(2008-3#1)(2010-2#1)(2010-8#1)(2010-9#3)(2011-2#1)(2012-12#1)
patient associated with##3##3##(2008-10#1)(2008-7#1)(2012-12#1)
patient at increased risk for##2##5##(1992-8#1)(2008-8#1)
patient at the time of##2##5##(2008-7#1)(2008-9#1)
patient at the##10##3##(1992-4#1)(1993-12#1)(1993-7#1)(1994-7#1)(2006-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-5#1)(2012-2#1)
patient at##19##2##(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-12#2)(1993-7#1)(1994-7#1)(1996-12#1)(2006-12#1)(2007-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-5#1)(2012-2#1)
patient autonomy##7##2##(1991-2#2)(1992-3#1)(2005-7#1)(2006-4#2)(2007-2#1)
patient awareness of##2##3##(2007-8#2)
patient awareness##3##2##(2007-8#2)(2013-1#1)
patient background##3##2##(1995-10#1)(2010-12#1)(2011-2#1)
patient based on##3##3##(2008-7#1)(2013-1#2)
patient based##4##2##(2008-7#1)(2012-12#1)(2013-1#2)
patient became##11##2##(1992-12#1)(1992-4#1)(1996-3#2)(1997-3#1)(2006-10#1)(2006-5#1)(2007-8#1)(2012-2#1)(2013-1#2)
patient becomes##3##2##(1993-8#1)(2004-3#1)(2011-12#1)
patient before the##4##3##(1997-4#1)(2007-10#1)(2007-8#1)(2008-12#1)
patient before##8##2##(1997-4#1)(2007-10#2)(2007-11#1)(2007-8#1)(2008-12#1)(2011-2#1)(2013-8#1)
patient behavior##2##2##(1996-2#1)(2007-10#1)
patient behaviors##2##2##(1994-2#1)(2008-6#1)
patient being##4##2##(1991-2#1)(1996-9#1)(2007-11#1)(2013-8#1)
patient benefit and##2##3##(1992-3#1)(2011-2#1)
patient benefit##5##2##(1992-3#1)(1997-3#1)(2008-11#1)(2009-8#1)(2011-2#1)
patient blood##3##2##(2004-11#1)(2008-10#2)
patient both##2##2##(1990-11#1)(1990-3#1)
patient but also##2##3##(1993-11#1)(2013-1#1)
patient but##5##2##(1993-11#1)(2006-12#1)(2008-10#1)(2009-3#1)(2013-1#1)
patient by##14##2##(1990-10#2)(1990-11#1)(1994-2#1)(1995-12#1)(2005-8#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-12#1)
patient came to##2##3##(2006-2#1)(2011-1#1)
patient came##5##2##(1992-1#1)(1995-3#1)(2006-2#1)(2007-7#1)(2011-1#1)
patient can be##3##3##(2006-12#1)(2006-2#1)(2010-2#1)
patient can##13##2##(1991-6#1)(1992-4#1)(1995-8#1)(1997-3#1)(2006-12#2)(2006-2#1)(2007-12#1)(2007-8#1)(2010-2#1)(2011-12#1)(2013-1#2)
patient care and management##2##4##(2005-11#1)(2010-4#1)
patient care and the##2##4##(1994-2#1)(1995-2#1)
patient care and##41##3##(1990-3#1)(1991-12#1)(1992-1#1)(1992-11#1)(1992-12#1)(1993-2#1)(1994-2#1)(1995-2#1)(1995-3#2)(1997-1#1)(1997-2#1)(2005-11#1)(2006-1#2)(2006-2#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-11#3)(2013-1#9)
patient care are the##3##4##(1994-1#2)(2007-8#1)
patient care are##5##3##(1994-1#2)(2006-10#1)(2007-8#1)(2012-12#1)
patient care by##2##3##(1994-3#1)(1995-3#1)
patient care can##2##3##(2012-2#2)
patient care data##2##3##(1996-1#1)(1997-3#1)
patient care delivery##5##3##(1994-12#1)(1995-12#1)(1995-2#1)(2007-4#1)(2010-8#1)
patient care has##3##3##(2008-11#1)(2010-6#1)(2013-1#1)
patient care in the##4##4##(1996-3#1)(1997-2#1)(2007-4#1)(2012-3#1)
patient care in##9##3##(1995-1#1)(1996-3#1)(1997-2#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-7#1)(2009-6#1)(2012-3#1)
patient care is##3##3##(1992-12#1)(2007-4#1)(2008-3#1)
patient care management##2##3##(1996-12#1)(2006-1#1)
patient care or##3##3##(2007-4#1)(2011-1#1)(2012-12#1)
patient care outcomes##2##3##(1994-3#1)(2007-4#1)
patient care processes##3##3##(1997-1#1)(2006-1#2)
patient care protocols##3##3##(1994-3#3)
patient care while##2##3##(1994-1#1)(2006-10#1)
patient care will##3##3##(1993-2#1)(1997-2#1)(2007-5#1)
patient care with##3##3##(1996-2#1)(2007-4#1)(2008-7#1)
patient care##285##2##(1990-12#1)(1990-3#1)(1991-12#5)(1992-1#1)(1992-11#2)(1992-12#4)(1992-2#1)(1993-1#1)(1993-2#3)(1993-3#4)(1993-9#1)(1994-1#8)(1994-12#3)(1994-2#2)(1994-3#6)(1995-1#2)(1995-12#4)(1995-2#5)(1995-3#11)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#3)(1997-1#6)(1997-2#6)(1997-3#4)(1997-5#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#2)(2005-12#1)(2006-1#6)(2006-10#7)(2006-2#2)(2006-5#1)(2006-9#1)(2007-10#5)(2007-11#2)(2007-12#8)(2007-2#2)(2007-4#16)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#11)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#2)(2009-2#1)(2009-4#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#2)(2010-8#6)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#5)(2012-11#3)(2012-12#3)(2012-2#7)(2012-3#2)(2013-1#42)(2013-7#1)(2013-8#1)
patient care?##3##2##(1993-2#1)(1995-9#1)(2008-11#1)
patient careflow##4##2##(2013-1#4)
patient case##4##2##(2007-10#1)(2008-11#1)(2010-12#2)
patient cases##3##2##(1997-3#2)(2011-1#1)
patient cells##3##2##(1994-11#1)(2011-1#1)(2012-12#1)
patient characteristics and##3##3##(1994-12#1)(1995-12#1)(2007-7#1)
patient characteristics##20##2##(1993-12#2)(1994-12#1)(1995-12#1)(2006-1#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-6#1)(2008-7#1)(2009-4#1)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-12#1)
patient charts##7##2##(1994-3#2)(1996-1#1)(2006-8#1)(2008-1#1)(2010-6#1)(2012-2#1)
patient choice##2##2##(2006-4#1)(2011-2#1)
patient classification system for ambulatory care##2##6##(1994-3#2)
patient classification system##4##3##(1994-3#3)(1995-2#1)
patient classification##13##2##(1993-12#1)(1994-3#3)(1994-4#1)(1995-2#2)(1996-2#1)(2005-8#1)(2006-10#2)(2010-10#2)
patient clinical##8##2##(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#5)
patient cohort##6##2##(1996-5#1)(2006-9#1)(2007-10#1)(2011-2#1)(2013-1#2)
patient cohorts##5##2##(2007-2#1)(2011-2#1)(2013-1#3)
patient comfort and##2##3##(2005-11#1)(2011-2#1)
patient comfort##7##2##(1995-9#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-8#1)(2011-2#1)(2013-7#1)
patient communication##2##2##(1995-12#1)(2007-11#1)
patient complained of##7##3##(2007-8#2)(2008-6#2)(2009-1#1)(2012-3#1)(2013-1#1)
patient complained##8##2##(1996-2#1)(2007-8#2)(2008-6#2)(2009-1#1)(2012-3#1)(2013-1#1)
patient complaint (&gt##4##3##(2013-1#4)
patient complaint (99%)##2##3##(2013-1#2)
patient complaint##9##2##(1991-1#1)(2013-1#8)
patient complaints##2##2##(2006-8#1)(2008-3#1)
patient compliance and##4##3##(1996-11#1)(2008-10#1)(2008-3#1)(2010-11#1)
patient compliance by##4##3##(2010-2#1)(2010-3#1)(2011-2#2)
patient compliance with##4##3##(1993-11#1)(2006-2#1)(2008-8#1)(2009-10#1)
patient compliance##36##2##(1991-6#1)(1992-8#1)(1993-11#1)(1993-9#2)(1995-4#1)(1996-11#2)(1996-3#2)(1997-2#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#4)(2012-2#1)
patient concerns##4##2##(1996-1#1)(2006-10#2)(2010-8#1)
patient conditions##7##2##(1992-12#1)(2004-11#1)(2009-3#1)(2011-2#1)(2012-1#1)(2013-1#2)
patient confidentiality##2##2##(1993-12#1)(2008-11#1)
patient consent##2##2##(1992-3#1)(2008-7#1)
patient contact##3##2##(1990-8#1)(2004-7#1)(2011-2#1)
patient contacts##2##2##(1991-2#1)(2011-1#1)
patient continued to##3##3##(2006-4#1)(2008-1#1)(2008-4#1)
patient continued##4##2##(2006-4#1)(2008-1#1)(2008-4#1)(2013-8#1)
patient continues to have##2##4##(2005-4#1)(2008-9#1)
patient continues to##4##3##(1993-3#1)(2005-4#1)(2007-7#1)(2008-9#1)
patient controlled analgesia##3##3##(1992-2#1)(2007-7#1)(2009-5#1)
patient controlled##6##2##(1992-2#1)(1993-4#1)(2007-7#1)(2009-5#1)(2010-8#1)(2012-3#1)
patient copayment##2##2##(1990-10#2)
patient costs##5##2##(1992-10#1)(1993-1#1)(1995-2#1)(1996-2#2)
patient could be##2##3##(2008-7#1)(2011-2#1)
patient could not be##2##4##(2007-8#1)(2008-3#1)
patient could not##4##3##(1996-2#1)(2007-7#1)(2007-8#1)(2008-3#1)
patient could##10##2##(1993-7#1)(1996-2#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-1#1)
patient counseling##3##2##(2004-3#1)(2008-5#1)(2011-1#1)
patient counselling were##2##3##(2010-5#2)
patient counselling##7##2##(2010-5#7)
patient data and##2##3##(1994-3#1)(2008-6#1)
patient data are sometimes stored in local repositories or institutions where they were collected##2##14##(2013-1#2)
patient data in##3##3##(1997-8#1)(2013-1#2)
patient data on##4##3##(2006-6#2)(2013-1#2)
patient data was##2##3##(1996-5#1)(2008-12#1)
patient data##53##2##(1991-2#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-1#1)(1996-12#1)(1996-5#1)(1997-8#1)(2006-6#4)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-6#1)(2010-8#4)(2011-2#1)(2012-1#1)(2013-1#26)
patient day##3##2##(1995-3#1)(2007-10#1)(2011-1#1)
patient days in##2##3##(1992-2#1)(2008-8#1)
patient days##4##2##(1992-2#1)(1995-1#1)(2007-12#1)(2008-8#1)
patient de##2##2##(2012-2#2)
patient death##2##2##(2007-12#1)(2008-8#1)
patient decision support and decision aids##2##6##(2013-1#2)
patient decision support##7##3##(2013-1#7)
patient decision##11##2##(2010-11#1)(2013-1#10)
patient delay##4##2##(1990-12#1)(1990-4#1)(2007-10#1)(2008-3#1)
patient demand##4##2##(1994-1#1)(2008-6#1)(2009-4#1)(2013-7#1)
patient demographic##3##2##(2009-11#1)(2013-1#2)
patient demographics and##2##3##(2011-2#2)
patient demographics##13##2##(1995-12#1)(2006-8#1)(2007-10#2)(2007-6#1)(2008-3#1)(2008-6#1)(2010-8#1)(2011-2#4)(2012-1#1)
patient demonstrated##4##2##(2006-8#1)(2008-12#1)(2010-10#1)(2012-2#1)
patient depends on##2##3##(1995-10#1)(2007-7#1)
patient depends##3##2##(1995-10#1)(2006-10#1)(2007-7#1)
patient details##3##2##(1996-2#1)(2013-1#2)
patient developed Hodgkin's##2##3##(1992-6#1)(2007-7#1)
patient developed a##11##3##(1992-2#1)(2005-5#1)(2007-11#1)(2007-8#2)(2008-9#1)(2009-7#1)(2011-2#1)(2012-1#1)(2013-1#2)
patient developed acute##3##3##(2006-4#1)(2008-1#1)(2009-3#1)
patient developed an##6##3##(2006-12#1)(2007-7#1)(2008-4#1)(2009-3#1)(2011-1#1)(2013-1#1)
patient developed paraplegia##2##3##(1996-3#1)(2008-7#1)
patient developed rhabdomyolysis##2##3##(1991-7#1)(1994-4#1)
patient developed severe##6##3##(1997-8#1)(2006-12#1)(2006-4#1)(2007-8#1)(2013-1#2)
patient developed##79##2##(1990-8#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-1#1)(1994-3#1)(1994-4#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-5#1)(1997-8#1)(2004-10#1)(2005-12#1)(2005-5#2)(2006-11#1)(2006-12#4)(2006-4#4)(2006-8#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#5)(2007-8#3)(2007-9#1)(2008-1#3)(2008-4#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#8)(2012-1#1)(2012-2#1)(2013-1#5)
patient develops##2##2##(2006-7#1)(2007-5#1)
patient diagnosed with##4##3##(2008-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
patient diagnosed##6##2##(2007-3#1)(2008-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
patient diagnosis and##2##3##(1996-12#1)(2012-2#1)
patient diagnosis##4##2##(1995-2#2)(1996-12#1)(2012-2#1)
patient did not have##4##4##(2005-11#1)(2007-5#1)(2008-1#1)(2009-8#1)
patient did not improve##2##4##(1997-4#1)(2008-5#1)
patient did not require##2##4##(2010-8#1)(2011-2#1)
patient did not respond to##3##5##(1991-11#1)(2007-4#1)(2007-7#1)
patient did not respond##4##4##(1991-11#1)(2007-4#1)(2007-7#1)(2012-2#1)
patient did not survive##2##4##(2007-11#1)(2007-9#1)
patient did not##22##3##(1990-7#1)(1991-11#1)(1997-4#1)(2005-11#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-5#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
patient did##24##2##(1990-7#1)(1991-11#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-5#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
patient died after the##3##4##(2009-4#1)(2013-1#2)
patient died after##5##3##(1991-8#1)(2009-4#1)(2011-1#1)(2013-1#2)
patient died as a##2##4##(1990-8#1)(2007-11#1)
patient died during the##2##4##(2011-12#1)(2011-3#1)
patient died following##2##3##(1997-8#1)(2010-5#1)
patient died from a##4##4##(1996-6#1)(2005-1#1)(2008-10#1)(2011-2#1)
patient died from##11##3##(1991-4#1)(1996-6#1)(1996-9#1)(2005-1#1)(2008-1#1)(2008-10#1)(2008-6#2)(2009-8#1)(2011-2#2)
patient died in##3##3##(2008-6#1)(2011-2#1)(2012-12#1)
patient died of disease##3##4##(1991-6#1)(2007-10#1)(2012-2#1)
patient died of her##2##4##(1997-3#1)(2010-12#1)
patient died of lung##2##4##(1993-8#1)(1994-12#1)
patient died of##23##3##(1990-2#1)(1990-6#1)(1991-12#1)(1991-6#1)(1993-8#1)(1994-12#1)(1997-3#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-6#5)(2008-7#1)(2010-12#1)(2012-2#3)
patient died on the##3##4##(2007-4#1)(2008-10#1)(2011-2#1)
patient died shortly thereafter##2##4##(2006-7#1)(2013-1#1)
patient died shortly##3##3##(2006-7#1)(2007-7#1)(2013-1#1)
patient died##91##2##(1990-2#1)(1990-6#1)(1990-8#2)(1991-11#2)(1991-12#1)(1991-4#1)(1991-6#1)(1991-8#2)(1992-6#2)(1993-3#1)(1993-5#2)(1993-6#1)(1993-8#1)(1994-12#1)(1995-7#2)(1995-9#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-8#1)(2005-1#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#2)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#3)(2008-10#2)(2008-3#1)(2008-6#8)(2008-7#2)(2009-1#1)(2009-10#1)(2009-4#2)(2009-8#2)(2010-12#1)(2010-5#2)(2011-1#2)(2011-12#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#3)(2013-1#3)
patient dies##2##2##(1993-3#1)(2010-2#1)
patient discharge##9##2##(1990-12#1)(1993-12#1)(1996-1#1)(1996-3#1)(2009-3#1)(2013-1#4)
patient discharged##2##2##(1994-7#1)(2007-8#1)
patient discomfort and##2##3##(2010-2#1)(2011-2#1)
patient discomfort##8##2##(1993-12#1)(2008-1#1)(2008-2#1)(2008-7#1)(2010-2#1)(2011-2#2)(2013-1#1)
patient discontinued##2##2##(2008-1#1)(2008-3#1)
patient displayed##3##2##(1993-6#1)(2007-12#1)(2012-12#1)
patient disposition##2##2##(2007-8#1)(2011-2#1)
patient distress##4##2##(2007-6#1)(2007-8#1)(2008-3#1)(2008-7#1)
patient dose##5##2##(2008-3#4)(2012-12#1)
patient doses are##2##3##(2008-3#2)
patient doses##4##2##(1992-3#1)(2008-3#3)
patient during the training##2##4##(2012-1#2)
patient during the##7##3##(1992-12#1)(1993-2#1)(2008-10#1)(2010-9#1)(2011-1#1)(2012-1#2)
patient during##16##2##(1992-12#1)(1992-8#1)(1993-2#1)(2005-9#1)(2006-2#1)(2006-8#1)(2007-11#1)(2008-10#1)(2009-8#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#3)
patient each##5##2##(2006-10#1)(2007-7#2)(2007-8#1)(2010-12#1)
patient education about##3##3##(1993-12#1)(2008-8#2)
patient education and##7##3##(1996-1#1)(1996-3#1)(2008-7#1)(2009-1#1)(2011-1#1)(2012-2#1)(2013-1#1)
patient education on##2##3##(1993-12#1)(2010-12#1)
patient education resources##2##3##(1991-3#2)
patient education tool among African American men with prostate cancer##2##10##(2009-5#2)
patient education tool among##3##4##(2009-5#3)
patient education##42##2##(1990-6#1)(1991-3#2)(1991-7#1)(1992-12#1)(1993-12#2)(1993-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-1#1)(2006-5#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-1#1)(2009-5#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
patient empowerment##3##2##(1996-7#2)(2009-8#1)
patient encounter##2##2##(1997-2#1)(2007-4#1)
patient encounters##4##2##(2013-1#4)
patient engagement and##2##3##(2008-6#1)(2012-1#1)
patient evaluation and##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
patient evaluation is##2##3##(2007-12#1)(2007-2#1)
patient evaluation##13##2##(1993-3#1)(2006-10#1)(2006-8#1)(2007-12#2)(2007-2#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2013-8#1)
patient evaluations##2##2##(1991-3#1)(2011-2#1)
patient event##2##2##(2008-11#2)
patient eventually died##2##3##(2006-7#1)(2006-9#1)
patient eventually##3##2##(2006-7#1)(2006-9#1)(2008-7#1)
patient exhibited##3##2##(1994-12#1)(2012-12#1)(2012-3#1)
patient expectations##4##2##(1995-2#1)(2008-8#1)(2009-6#1)(2010-2#1)
patient experience and##4##3##(1996-1#1)(2009-8#1)(2010-2#1)(2010-3#1)
patient experience in online health communities##2##6##(2011-2#2)
patient experience##13##2##(1993-12#1)(1996-1#1)(2005-9#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-2#4)(2012-3#1)(2013-1#1)
patient experienced a##3##3##(2006-8#1)(2007-8#1)(2012-12#1)
patient experienced transient##2##3##(2008-9#1)(2012-3#1)
patient experienced##15##2##(1992-4#1)(1994-6#1)(1995-1#1)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-8#1)(2008-5#1)(2008-9#2)(2010-2#1)(2012-12#1)(2012-3#2)
patient experiences##6##2##(1993-11#1)(1993-2#1)(2006-3#1)(2012-3#1)(2013-1#1)(2013-7#1)
patient exposure to##2##3##(2007-11#1)(2009-6#1)
patient exposure##5##2##(1992-3#1)(1996-1#1)(2007-11#1)(2008-5#1)(2009-6#1)
patient factors##10##2##(2006-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-3#2)(2009-4#1)(2013-1#3)
patient failed to respond to##3##5##(1990-2#2)(2012-12#1)
patient failed to##5##3##(1990-2#2)(2007-12#1)(2008-9#1)(2012-12#1)
patient failed##7##2##(1990-2#2)(2007-12#1)(2008-9#1)(2009-10#1)(2012-12#1)(2013-1#1)
patient fails to##2##3##(1995-9#1)(2006-3#1)
patient family caregivers##2##3##(2009-7#2)
patient feedback##4##2##(1996-12#3)(2010-12#1)
patient felt##2##2##(1994-6#1)(2007-12#1)
patient fibroblasts##2##2##(2009-10#1)(2012-12#1)
patient files and##3##3##(2004-2#1)(2011-2#1)(2013-7#1)
patient files##4##2##(2004-2#1)(2011-1#1)(2011-2#1)(2013-7#1)
patient first##3##2##(2006-10#1)(2009-3#1)(2013-8#1)
patient flow in##3##3##(2007-3#1)(2010-8#1)(2011-1#1)
patient flow##5##2##(2007-3#2)(2007-9#1)(2010-8#1)(2011-1#1)
patient focused care##11##3##(1993-1#1)(1993-2#3)(1993-3#2)(1994-3#1)(1996-12#1)(1996-2#3)
patient focused restructuring##4##3##(1993-1#1)(1993-12#3)
patient focused##23##2##(1993-1#3)(1993-12#3)(1993-2#4)(1993-3#3)(1994-1#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-2#4)(2010-12#1)
patient following##10##2##(2006-12#1)(2007-6#1)(2007-8#2)(2008-4#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
patient for the##3##3##(1996-8#1)(2007-6#1)(2013-8#1)
patient for##23##2##(1990-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1996-6#1)(1996-8#1)(1997-2#1)(2005-12#1)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-12#1)(2011-1#1)(2013-8#1)
patient friendly##2##2##(2007-11#1)(2010-7#1)
patient from a##3##3##(1992-12#1)(2007-11#1)(2013-1#1)
patient from the second##2##4##(1990-6#1)(1997-6#1)
patient from the##8##3##(1990-6#1)(1992-11#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-2#1)(2011-12#1)(2011-2#1)
patient from this##3##3##(1994-11#1)(2006-10#1)(2007-7#1)
patient from##27##2##(1990-6#1)(1992-1#1)(1992-11#1)(1992-12#1)(1994-11#3)(1997-6#1)(2006-10#2)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2010-8#2)(2011-12#2)(2011-2#2)(2012-2#3)(2013-1#1)(2013-8#1)
patient fully recovered##2##3##(2006-10#1)(2008-7#1)
patient functioning##2##2##(1994-2#1)(1997-5#1)
patient gave##2##2##(1990-9#1)(2007-8#1)
patient group and##5##3##(1992-6#1)(2007-8#2)(2008-11#1)(2011-2#1)
patient group studied##55##3##(2007-8#55)
patient group that##2##3##(2006-1#2)
patient group was##3##3##(2007-8#1)(2008-6#1)(2013-1#1)
patient group##109##2##(1990-2#1)(1992-4#1)(1992-6#2)(1994-2#1)(1996-3#2)(1996-5#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-1#1)(2006-1#2)(2006-11#1)(2006-12#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-8#64)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-4#2)(2010-9#1)(2011-1#4)(2011-2#6)(2012-2#2)(2013-1#3)(2013-8#1)
patient grouping##2##2##(1994-3#1)(1995-3#1)
patient groups as compared to normal controls##2##7##(2008-8#2)
patient groups at##2##3##(1992-5#1)(2008-4#1)
patient groups in##3##3##(1996-11#1)(2006-7#1)(2007-10#1)
patient groups##46##2##(1990-11#1)(1991-1#1)(1991-7#1)(1991-9#1)(1992-5#1)(1992-6#1)(1993-2#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-11#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#2)(2009-10#1)(2010-10#1)(2011-2#1)(2012-2#3)(2013-8#1)
patient had a full##2##4##(2006-10#1)(2007-8#1)
patient had a history of##10##5##(1992-9#1)(1996-6#1)(2006-12#1)(2006-7#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-9#1)(2012-12#1)(2013-1#1)
patient had a history##11##4##(1992-9#1)(1996-6#1)(2006-12#1)(2006-7#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-9#1)(2012-12#1)(2013-1#1)
patient had a##51##3##(1990-2#1)(1991-3#1)(1991-8#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-12#1)(1995-3#1)(1996-6#3)(1996-9#1)(2005-6#1)(2006-10#1)(2006-11#2)(2006-12#3)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#6)(2007-9#1)(2008-11#1)(2008-6#2)(2009-10#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
patient had an uneventful recovery##7##5##(2007-8#1)(2008-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
patient had an uneventful##9##4##(2007-8#1)(2008-12#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
patient had an##20##3##(1991-1#1)(1992-6#1)(1996-5#1)(2006-10#2)(2006-12#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
patient had any##2##3##(2006-3#1)(2010-7#1)
patient had been previously##2##4##(1994-12#1)(2007-10#1)
patient had been##15##3##(1990-12#1)(1991-3#1)(1994-12#1)(2006-10#1)(2006-7#1)(2007-10#2)(2007-8#2)(2008-5#1)(2008-7#1)(2010-10#1)(2010-7#1)(2013-1#2)
patient had bilateral##2##3##(2010-3#1)(2012-2#1)
patient had clinically##2##3##(2007-2#1)(2011-2#1)
patient had developed a##3##4##(2006-10#1)(2006-8#1)(2007-10#1)
patient had developed##4##3##(1992-10#1)(2006-10#1)(2006-8#1)(2007-10#1)
patient had multiple##2##3##(2011-1#1)(2013-1#1)
patient had no history of##4##5##(2006-10#1)(2006-2#1)(2007-12#1)(2007-4#1)
patient had no symptoms##3##4##(2006-9#1)(2008-9#1)(2010-9#1)
patient had no##20##3##(1996-8#1)(2005-12#1)(2006-10#2)(2006-2#1)(2006-9#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-7#1)(2008-9#2)(2010-2#1)(2010-3#1)(2010-9#1)(2011-2#1)(2013-1#2)(2013-7#1)
patient had returned to##2##4##(1995-2#1)(2006-4#1)
patient had several##2##3##(2013-8#2)
patient had severe##4##3##(2008-1#1)(2008-6#1)(2012-2#1)(2013-1#1)
patient had significant##2##3##(2007-10#1)(2008-7#1)
patient had significantly##2##3##(2006-8#1)(2009-6#1)
patient had suffered##3##3##(2006-4#1)(2007-11#1)(2008-1#1)
patient had symptoms##2##3##(1991-3#1)(2010-12#1)
patient had the bandage##2##4##(2006-4#2)
patient had the##4##3##(1995-1#1)(2006-4#2)(2011-1#1)
patient had undergone##3##3##(1993-6#1)(2006-11#1)(2008-2#1)
patient had##239##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-6#1)(1991-1#1)(1991-3#3)(1991-4#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-10#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-5#1)(1996-6#5)(1996-8#1)(1996-9#1)(1997-3#1)(1997-6#2)(2005-12#1)(2005-6#1)(2006-10#11)(2006-11#4)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#4)(2006-7#3)(2006-8#3)(2006-9#2)(2007-10#6)(2007-11#2)(2007-12#4)(2007-2#2)(2007-4#1)(2007-7#8)(2007-8#12)(2007-9#3)(2008-1#5)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#5)(2008-7#10)(2008-8#1)(2008-9#3)(2009-1#2)(2009-10#1)(2009-4#1)(2009-6#2)(2009-8#1)(2010-10#2)(2010-12#3)(2010-2#3)(2010-3#3)(2010-5#1)(2010-6#1)(2010-7#3)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#11)(2012-11#1)(2012-12#5)(2012-2#7)(2012-3#7)(2013-1#8)(2013-7#2)(2013-8#6)
patient has a##3##3##(1993-11#1)(1995-11#1)(2008-6#1)
patient has been asymptomatic##2##4##(2008-9#1)(2011-2#1)
patient has been shown##2##4##(2007-11#1)(2012-12#1)
patient has been##19##3##(1990-5#1)(1991-2#1)(1992-3#1)(1992-4#1)(1997-5#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-6#2)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
patient has failed to##2##4##(2008-7#1)(2012-2#1)
patient has had##6##3##(1990-4#1)(1993-1#1)(1993-6#1)(1996-3#1)(2010-12#1)(2012-12#1)
patient has multiple##2##3##(2008-5#1)(2008-6#1)
patient has reached##2##3##(2007-8#1)(2010-6#1)
patient has remained##2##3##(2006-11#1)(2008-4#1)
patient has shown##3##3##(2006-12#1)(2007-7#1)(2009-8#1)
patient has survived##2##3##(1990-6#1)(2007-8#1)
patient has##87##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-3#3)(1992-4#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-6#1)(1995-11#1)(1995-5#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-5#1)(2005-10#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#7)(2008-7#3)(2008-9#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-6#2)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#8)(2013-8#3)
patient having##6##2##(2006-10#1)(2007-8#2)(2007-9#1)(2009-6#1)(2013-1#1)
patient health information##4##3##(2007-12#4)
patient health##11##2##(1994-2#1)(2006-11#1)(2007-12#5)(2008-3#1)(2010-12#1)(2013-1#2)
patient history and##2##3##(2007-6#1)(2011-12#1)
patient history##5##2##(2006-10#1)(2007-6#1)(2008-11#1)(2009-7#1)(2011-12#1)
patient identification and##2##3##(1996-3#1)(2007-12#1)
patient identification##6##2##(1996-3#1)(2007-12#1)(2011-2#2)(2013-1#2)
patient illustrates##2##2##(1990-12#1)(2008-7#1)
patient improved##6##2##(1991-12#1)(2009-12#1)(2009-5#1)(2009-6#1)(2011-2#1)(2012-2#1)
patient improvement##2##2##(2011-2#1)(2012-12#1)
patient in a##8##3##(1990-5#1)(1994-3#1)(1997-5#1)(1997-6#1)(2006-12#1)(2011-2#2)(2013-1#1)
patient in an##3##3##(2008-4#1)(2013-1#2)
patient in different##2##3##(1992-12#1)(2007-11#1)
patient in group B##2##4##(1996-6#1)(2007-9#1)
patient in the##25##3##(1990-12#1)(1992-11#1)(1992-2#1)(1993-8#1)(1995-4#1)(1996-8#1)(2004-3#1)(2006-2#1)(2007-10#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-5#2)(2009-6#1)(2011-2#2)(2013-1#4)(2013-7#1)(2013-8#1)
patient in this report is##2##5##(2007-7#1)(2012-2#1)
patient in this##5##3##(1991-3#1)(2007-7#1)(2008-12#1)(2011-2#1)(2012-2#1)
patient in view of##2##4##(2007-8#1)(2008-7#1)
patient in whom##17##3##(1993-2#1)(1994-11#1)(1997-7#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-7#1)(2006-9#1)(2007-8#1)(2008-5#2)(2008-6#1)(2008-7#1)(2011-1#1)(2012-12#1)
patient in##102##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-6#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-4#1)(1996-6#1)(1996-8#2)(1997-5#1)(1997-6#1)(1997-7#1)(2004-1#1)(2004-3#1)(2005-6#1)(2006-10#4)(2006-11#1)(2006-12#3)(2006-2#2)(2006-4#1)(2006-5#2)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#3)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#3)(2013-1#8)(2013-7#2)(2013-8#1)
patient included##4##2##(2007-9#1)(2008-12#1)(2012-12#1)(2012-3#1)
patient incurred##2##2##(2007-7#1)(2012-12#1)
patient infected with##6##3##(1996-12#1)(2005-8#1)(2007-12#1)(2007-7#1)(2009-11#1)(2011-2#1)
patient information and##5##3##(2011-1#2)(2011-2#2)(2012-2#1)
patient information leaflets##4##3##(1996-1#1)(2010-5#2)(2012-3#1)
patient information on##2##3##(1991-3#1)(2004-10#1)
patient information system##4##3##(1996-3#1)(2012-12#1)(2013-1#2)
patient information to##4##3##(1993-2#2)(2013-1#2)
patient information##40##2##(1990-2#1)(1991-3#1)(1992-1#1)(1992-8#2)(1993-2#2)(1993-3#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-3#1)(2004-10#1)(2005-6#1)(2007-12#1)(2007-9#1)(2010-5#2)(2010-8#4)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#10)
patient injury##7##2##(1991-12#2)(1994-1#1)(2007-4#1)(2010-9#2)(2011-2#1)
patient interaction##2##2##(2012-3#1)(2013-1#1)
patient interest##3##2##(2006-10#1)(2012-2#2)
patient interview##3##2##(1991-2#1)(2007-8#1)(2010-5#1)
patient interviews##4##2##(1997-2#1)(2006-12#1)(2007-8#1)(2008-7#1)
patient into a##2##3##(1994-6#1)(1995-9#1)
patient into##4##2##(1994-6#1)(1995-9#1)(2009-11#1)(2012-1#1)
patient involvement##4##2##(2007-8#1)(2008-12#2)(2012-1#1)
patient is a##10##3##(1993-12#1)(1993-3#1)(2006-1#1)(2006-10#1)(2006-4#1)(2007-2#1)(2010-12#1)(2011-2#1)(2012-3#2)
patient is alive##3##3##(1990-2#1)(1991-6#1)(2013-8#1)
patient is an essential##3##4##(1991-11#1)(1991-5#1)(2006-10#1)
patient is an##7##3##(1991-11#1)(1991-5#1)(1996-6#1)(2006-10#2)(2007-7#2)
patient is at##5##3##(1997-2#1)(2006-8#1)(2007-8#1)(2010-2#1)(2013-1#1)
patient is discussed##6##3##(1991-1#1)(2006-11#1)(2008-4#1)(2010-4#1)(2012-2#1)(2013-1#1)
patient is doing well##4##4##(2007-11#1)(2007-8#2)(2013-1#1)
patient is essential in##2##4##(2007-8#1)(2009-5#1)
patient is essential##3##3##(2007-8#1)(2009-5#1)(2011-1#1)
patient is free of##3##4##(1991-2#1)(2005-10#1)(2006-10#1)
patient is in good##3##4##(2008-5#1)(2012-1#1)(2013-8#1)
patient is in##8##3##(1994-6#1)(2007-9#1)(2008-10#1)(2008-5#1)(2012-1#1)(2013-1#2)(2013-8#1)
patient is invited to##2##4##(2010-6#2)
patient is not##6##3##(1991-11#1)(1993-2#1)(1997-1#1)(2006-10#1)(2007-2#1)(2012-12#1)
patient is now##4##3##(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
patient is on##2##3##(2005-12#1)(2010-7#1)
patient is presented with BCC of inferior eyelid of 14##2##10##(2007-11#2)
patient is presented##5##3##(2007-11#2)(2010-3#1)(2012-12#1)(2013-7#1)
patient is rare##2##3##(2012-12#1)(2012-2#1)
patient is reported##3##3##(1991-9#1)(2012-2#2)
patient is still##2##3##(1995-3#1)(2007-8#1)
patient is the##7##3##(1990-4#1)(1992-3#1)(2007-2#1)(2010-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
patient is unable to##2##4##(2008-9#1)(2013-1#1)
patient is under##3##3##(2011-2#1)(2012-12#1)(2013-1#1)
patient is very##2##3##(2006-10#1)(2011-2#1)
patient is without##3##3##(1993-3#1)(1996-3#1)(2008-6#1)
patient is##184##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-4#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#2)(1994-11#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-9#1)(1996-3#1)(1996-6#1)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-10#1)(2005-12#1)(2006-1#3)(2006-10#10)(2006-11#1)(2006-4#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-11#4)(2007-12#1)(2007-2#3)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#7)(2007-9#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#4)(2008-8#3)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#1)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#6)(2011-2#7)(2011-3#1)(2012-1#2)(2012-12#7)(2012-2#6)(2012-3#6)(2013-1#11)(2013-7#1)(2013-8#5)
patient knowledge of##2##3##(2008-3#1)(2013-1#1)
patient knowledge##3##2##(2008-3#1)(2012-12#1)(2013-1#1)
patient left hospital##2##3##(1994-5#1)(2008-7#1)
patient left the##3##3##(2008-12#1)(2013-1#2)
patient left##6##2##(1994-5#1)(1997-1#1)(2008-12#1)(2008-7#1)(2013-1#2)
patient level##4##2##(1992-2#1)(1993-1#1)(2012-3#1)(2013-1#1)
patient loads##3##2##(2007-10#1)(2007-3#1)(2012-3#1)
patient lost##3##2##(2008-5#1)(2008-7#1)(2012-3#1)
patient made a full recovery##4##5##(2006-7#1)(2007-12#1)(2012-12#2)
patient made a##12##3##(1997-6#1)(2006-4#1)(2006-7#2)(2007-12#1)(2008-4#1)(2009-4#1)(2010-5#1)(2011-12#1)(2012-12#2)(2012-2#1)
patient made an uneventful recovery##3##5##(1993-9#1)(1997-3#1)(2007-10#1)
patient made an##4##3##(1993-9#1)(1997-3#1)(2007-10#1)(2012-3#1)
patient made##17##2##(1993-9#1)(1997-3#1)(1997-6#1)(2006-4#1)(2006-7#2)(2007-10#1)(2007-12#1)(2008-4#1)(2009-4#1)(2010-5#1)(2011-12#1)(2012-12#2)(2012-2#1)(2012-3#2)
patient maintained##2##2##(2008-1#1)(2010-4#1)
patient management and##8##3##(1991-3#1)(2007-11#1)(2008-10#1)(2009-10#1)(2012-2#4)
patient management in many##2##4##(2007-7#1)(2012-2#1)
patient management in##5##3##(2005-10#1)(2007-10#1)(2007-7#1)(2008-1#1)(2012-2#1)
patient management is##2##3##(1994-8#1)(2008-6#1)
patient management##45##2##(1991-3#1)(1992-2#1)(1992-6#1)(1994-8#1)(1995-5#1)(1996-2#2)(1997-5#1)(1997-8#1)(2005-10#1)(2006-10#3)(2007-10#2)(2007-11#2)(2007-12#1)(2007-7#2)(2008-1#2)(2008-10#2)(2008-3#4)(2008-4#1)(2008-6#1)(2009-10#1)(2009-11#1)(2011-2#3)(2012-2#7)(2012-3#2)(2013-7#1)
patient material##2##2##(1993-10#1)(1996-4#1)
patient may be##2##3##(1992-9#1)(1993-5#1)
patient may have##6##3##(1992-8#1)(1993-1#1)(2006-2#1)(2008-1#1)(2013-1#2)
patient may##15##2##(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-5#1)(1995-8#1)(2006-2#2)(2007-9#1)(2008-1#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
patient meets the##2##3##(2007-9#1)(2008-9#1)
patient misidentification##4##2##(2013-1#4)
patient mobility##2##2##(2008-3#1)(2011-2#1)
patient monitoring and##3##3##(1994-3#1)(2011-2#1)(2012-2#1)
patient monitoring in##2##3##(2006-1#1)(2009-3#1)
patient monitoring##8##2##(1993-11#1)(1994-3#1)(2006-1#1)(2006-5#1)(2007-4#1)(2009-3#1)(2011-2#1)(2012-2#1)
patient months had a mean Hct##2##6##(2006-5#2)
patient months in the##2##4##(2006-5#2)
patient months##5##2##(1996-6#1)(2006-5#4)
patient morbidity and mortality and##2##5##(2005-8#1)(2008-1#1)
patient morbidity and mortality##5##4##(2005-8#1)(2006-6#1)(2008-1#2)(2008-8#1)
patient morbidity and##8##3##(2004-2#1)(2005-8#1)(2006-6#1)(2008-1#2)(2008-8#1)(2010-8#1)(2011-7#1)
patient morbidity##12##2##(2004-2#1)(2005-8#1)(2006-6#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-8#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-7#1)
patient mortality##5##2##(1992-2#1)(2006-10#1)(2011-2#1)(2013-1#2)
patient motivation##3##2##(2005-3#1)(2007-11#1)(2012-11#1)
patient must be##4##3##(1996-6#1)(2007-7#1)(2013-1#1)(2013-8#1)
patient must##7##2##(1990-8#1)(1995-2#1)(1996-6#1)(2007-7#1)(2008-6#1)(2013-1#1)(2013-8#1)
patient need##5##2##(1993-12#2)(2006-4#1)(2008-10#1)(2012-12#1)
patient needed a##2##3##(2010-12#1)(2012-11#1)
patient needed##4##2##(1992-5#1)(2007-11#1)(2010-12#1)(2012-11#1)
patient needs for##2##3##(2013-1#2)
patient needs to be##3##4##(2006-2#1)(2008-4#1)(2010-1#1)
patient needs to##4##3##(1990-12#1)(2006-2#1)(2008-4#1)(2010-1#1)
patient needs##14##2##(1990-12#1)(1994-2#1)(1995-3#1)(2006-1#2)(2006-10#1)(2006-2#1)(2008-1#1)(2008-4#1)(2008-8#1)(2010-1#1)(2013-1#3)
patient numbers are##2##3##(2007-11#1)(2009-5#1)
patient numbers##5##2##(2007-11#3)(2008-6#1)(2009-5#1)
patient of the##7##3##(1990-6#1)(2005-2#3)(2008-5#1)(2010-9#1)(2013-1#1)
patient of##40##2##(1990-12#1)(1990-6#1)(1992-1#1)(1992-11#1)(1992-4#1)(1996-3#1)(2005-2#3)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#3)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#5)
patient on chronic hemodialysis##2##4##(2013-8#2)
patient on hemodialysis##2##3##(2009-4#2)
patient on long-term##2##3##(2006-10#1)(2008-3#1)
patient on the##4##3##(1997-3#1)(2008-2#1)(2008-4#1)(2011-2#1)
patient on##30##2##(1991-3#2)(1996-1#1)(1997-3#1)(1997-6#1)(2004-10#1)(2006-10#3)(2007-12#2)(2007-7#1)(2008-1#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#2)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#3)(2013-8#2)
patient operated on##3##3##(1993-10#1)(2011-12#1)(2013-1#1)
patient operated##4##2##(1993-10#1)(2007-11#1)(2011-12#1)(2013-1#1)
patient or a##2##3##(1992-3#1)(2013-8#1)
patient or to##2##3##(2007-11#1)(2008-8#1)
patient or##17##2##(1991-2#1)(1992-3#1)(1993-12#1)(1994-9#1)(1995-3#1)(1996-2#1)(2007-11#3)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
patient organizations##2##2##(2006-7#1)(2009-11#1)
patient oriented##2##2##(2007-10#1)(2007-8#1)
patient out of##3##3##(1990-8#1)(1996-1#1)(2008-2#1)
patient outcome as##2##3##(2005-2#1)(2008-5#1)
patient outcome##25##2##(1995-3#1)(2005-2#1)(2005-8#1)(2006-10#5)(2006-6#1)(2006-7#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-12#1)(2009-2#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#2)
patient outcomes and satisfaction##2##4##(1995-12#1)(2006-9#1)
patient outcomes and##17##3##(1993-2#1)(1995-12#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-4#1)(2008-12#1)(2008-8#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-1#6)
patient outcomes following##2##3##(2010-2#1)(2013-1#1)
patient outcomes for##2##3##(2010-12#1)(2012-2#1)
patient outcomes in##6##3##(1994-3#1)(1995-2#1)(2007-12#1)(2009-11#1)(2010-2#1)(2011-2#1)
patient outcomes of care##2##4##(2012-3#2)
patient outcomes of##4##3##(2012-3#2)(2013-1#2)
patient outcomes##94##2##(1993-2#2)(1994-1#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-1#1)(2006-1#1)(2006-5#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-4#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#23)(2013-8#1)
patient over##4##2##(1994-1#1)(2011-1#1)(2011-2#1)(2012-3#1)
patient participation and##2##3##(2008-11#1)(2010-10#1)
patient participation in##3##3##(1993-12#1)(2004-1#1)(2010-10#1)
patient participation##8##2##(1993-12#1)(2004-1#1)(2006-1#1)(2008-11#1)(2008-6#1)(2009-11#1)(2010-10#2)
patient passed##2##2##(2007-3#1)(2007-8#1)
patient perception of##2##3##(2006-9#1)(2013-1#1)
patient perceptions of the##2##4##(1995-2#2)
patient perceptions of##5##3##(1995-2#2)(1996-1#1)(2006-10#1)(2007-8#1)
patient perceptions##8##2##(1995-2#2)(1996-1#1)(2006-10#1)(2007-8#2)(2008-4#1)(2008-8#1)
patient perspective##9##2##(2006-7#3)(2007-8#1)(2008-7#1)(2012-3#1)(2013-1#3)
patient physician interaction##4##3##(2013-1#4)
patient plays##2##2##(1993-11#1)(1994-6#1)
patient population and##6##3##(2005-11#1)(2007-8#1)(2011-2#1)(2012-1#2)(2013-8#1)
patient population has##4##3##(2006-7#1)(2011-2#1)(2013-1#2)
patient population in##2##3##(2005-7#1)(2008-8#1)
patient population is##7##3##(2005-8#1)(2006-10#2)(2007-12#1)(2008-6#1)(2012-1#2)
patient population with##2##3##(2008-3#1)(2010-3#1)
patient population##99##2##(1992-3#1)(1992-4#1)(1992-5#1)(1993-5#1)(1995-1#1)(1995-2#1)(1996-6#1)(1996-9#2)(1997-8#1)(2004-11#1)(2005-11#1)(2005-7#3)(2005-8#1)(2006-10#5)(2006-11#1)(2006-2#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#2)(2007-8#4)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-11#2)(2009-6#2)(2010-11#2)(2010-12#2)(2010-3#1)(2010-5#1)(2010-8#3)(2011-1#3)(2011-2#4)(2012-1#4)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#6)(2013-8#3)
patient populations and##3##3##(2007-5#1)(2008-10#1)(2011-2#1)
patient populations for##2##3##(1992-3#1)(2012-2#1)
patient populations in##3##3##(1996-3#1)(2005-8#1)(2007-11#1)
patient populations will have to be##2##6##(1995-3#1)(2012-2#1)
patient populations with##3##3##(2007-12#1)(2013-1#2)
patient populations##41##2##(1992-12#1)(1992-3#3)(1994-6#1)(1995-2#2)(1995-3#1)(1996-3#1)(2005-10#2)(2005-8#2)(2006-10#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-10#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#2)
patient position##3##2##(1993-7#1)(2008-3#1)(2008-7#1)
patient positioning and##2##3##(1993-7#1)(2006-10#1)
patient positioning in##2##3##(2010-2#1)(2011-2#1)
patient positioning##9##2##(1993-7#2)(2006-10#1)(2007-6#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-1#1)
patient preference and##2##3##(2009-11#1)(2011-2#1)
patient preference##8##2##(1992-3#1)(2008-1#1)(2009-11#1)(2009-8#1)(2010-8#1)(2010-9#1)(2011-2#2)
patient preferences and##2##3##(2006-5#1)(2008-10#1)
patient preferences for##2##3##(2008-4#1)(2009-11#1)
patient preferences##8##2##(2006-10#1)(2006-5#1)(2006-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-11#1)(2012-2#1)
patient preparation##5##2##(2005-8#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-5#1)
patient presentation##2##2##(2007-10#1)(2008-10#1)
patient presented a##5##3##(1991-4#1)(1994-8#1)(2007-8#1)(2011-2#1)(2013-1#1)
patient presented at##2##3##(2008-6#1)(2008-7#1)
patient presented for##2##3##(2007-11#1)(2009-11#1)
patient presented to our##2##4##(2006-12#1)(2013-8#1)
patient presented to##3##3##(2006-12#1)(2006-4#1)(2013-8#1)
patient presented with a single##2##5##(2011-2#1)(2012-11#1)
patient presented with a##19##4##(1991-8#1)(1996-9#1)(1997-5#1)(2006-10#1)(2006-12#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-3#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-11#1)(2013-1#2)
patient presented with an acute##2##5##(2011-1#1)(2013-8#1)
patient presented with an##4##4##(1992-2#1)(2008-9#1)(2011-1#1)(2013-8#1)
patient presented with erythematous##2##4##(2005-11#1)(2006-10#1)
patient presented with pain##3##4##(2006-10#1)(2007-7#1)(2009-3#1)
patient presented with##67##3##(1991-8#1)(1992-2#1)(1996-9#1)(1997-5#1)(2005-10#1)(2005-11#3)(2005-12#1)(2006-10#10)(2006-12#1)(2006-4#1)(2006-9#1)(2007-12#1)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#5)(2008-9#1)(2009-3#2)(2009-7#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#8)(2013-8#1)
patient presented##89##2##(1990-12#1)(1991-4#1)(1991-8#1)(1992-2#1)(1994-8#1)(1996-9#1)(1997-5#1)(2005-10#1)(2005-11#3)(2005-12#1)(2006-10#10)(2006-11#1)(2006-12#2)(2006-4#2)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#4)(2007-8#2)(2008-1#4)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#2)(2008-7#6)(2008-9#1)(2009-11#1)(2009-3#2)(2009-7#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#9)(2013-8#2)
patient presenting with a##3##4##(1997-7#1)(2008-7#1)(2010-9#1)
patient presenting with acute##2##4##(2005-12#1)(2013-1#1)
patient presenting with obstructive jaundice##2##5##(2008-3#1)(2010-9#1)
patient presenting with##20##3##(1997-7#1)(2005-12#1)(2006-10#1)(2007-11#2)(2007-8#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-9#2)(2011-2#3)(2013-1#1)(2013-7#1)
patient presenting##23##2##(1997-7#1)(2005-12#1)(2006-10#1)(2007-11#2)(2007-8#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-5#1)(2010-9#2)(2011-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
patient presents with##9##3##(1997-1#1)(2006-10#1)(2007-2#1)(2007-9#1)(2009-6#1)(2010-8#1)(2011-1#1)(2013-1#2)
patient presents##13##2##(1997-1#1)(2006-10#3)(2007-2#1)(2007-9#1)(2008-7#1)(2009-3#1)(2009-6#1)(2010-8#1)(2011-1#1)(2013-1#2)
patient prior to##4##3##(1994-9#1)(2005-8#1)(2007-4#1)(2011-2#1)
patient privacy##8##2##(2007-4#1)(2008-7#1)(2010-8#1)(2011-1#1)(2013-1#4)
patient problem lists##4##3##(2013-1#4)
patient problems##5##2##(2005-12#1)(2007-12#1)(2008-12#1)(2013-1#2)
patient prognosis##4##2##(2006-2#1)(2008-1#1)(2008-11#1)(2009-3#1)
patient progress##2##2##(2012-1#1)(2013-7#1)
patient progressed##3##2##(1990-10#1)(2006-6#1)(2011-2#1)
patient prospects##2##2##(1997-1#2)
patient quality of life and##2##5##(2008-3#1)(2011-2#1)
patient quality of life##4##4##(2008-3#1)(2009-11#1)(2011-1#1)(2011-2#1)
patient race/ethnicity##2##2##(2011-2#2)
patient ratings of##2##3##(1991-3#1)(2008-4#1)
patient ratings##3##2##(1991-3#2)(2008-4#1)
patient reached a##2##3##(2011-2#2)
patient received a##6##3##(2006-10#1)(2006-12#1)(2007-11#1)(2007-8#1)(2010-12#1)(2012-3#1)
patient received both##2##3##(1992-1#1)(2008-6#1)
patient received radiotherapy##2##3##(2009-11#1)(2011-1#1)
patient received##26##2##(1991-9#1)(1992-1#2)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#1)(2010-12#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
patient receiving##4##2##(2005-9#1)(2007-12#1)(2007-2#1)(2007-3#1)
patient record##11##2##(1992-4#1)(1993-12#1)(1993-2#1)(1994-2#1)(1997-1#2)(1997-2#1)(2010-4#2)(2012-12#1)(2012-3#1)
patient records and##3##3##(2010-8#1)(2013-1#2)
patient records in##3##3##(2007-11#1)(2009-6#1)(2011-2#1)
patient records##28##2##(1993-12#2)(1994-12#1)(1997-1#2)(1997-4#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-7#3)(2009-6#1)(2010-8#3)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#6)
patient recovered within##2##3##(1991-8#1)(2011-2#1)
patient recovered##20##2##(1990-12#1)(1991-3#1)(1991-8#1)(1993-7#1)(1997-2#1)(1997-3#1)(2006-7#1)(2007-8#3)(2008-5#1)(2010-9#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
patient recovery##9##2##(1992-1#1)(2006-12#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-2#1)(2013-8#2)
patient referred##2##2##(2007-3#1)(2013-1#1)
patient refused to undergo##2##4##(2006-7#1)(2010-2#1)
patient refused##9##2##(2006-6#1)(2006-7#1)(2007-6#1)(2007-8#1)(2008-9#1)(2009-6#2)(2010-2#1)(2011-2#1)
patient regained##4##2##(1996-9#1)(2007-7#1)(2009-9#1)(2010-12#1)
patient rehabilitation##2##2##(1990-4#1)(2012-1#1)
patient remained free of##2##4##(2005-11#1)(2010-2#1)
patient remained##13##2##(1993-1#1)(1993-2#1)(1997-1#1)(1997-5#1)(2005-11#1)(2007-3#1)(2007-8#1)(2008-7#1)(2009-4#1)(2010-2#1)(2011-2#2)(2013-8#1)
patient remains asymptomatic##6##3##(2007-2#1)(2007-9#1)(2008-6#1)(2008-7#1)(2012-3#1)(2013-1#1)
patient remains disease free at##2##5##(2010-12#1)(2011-2#1)
patient remains##15##2##(1993-11#1)(2005-5#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
patient report##2##2##(2008-12#1)(2010-12#1)
patient reported pain##2##3##(2006-6#1)(2009-3#1)
patient reported that##4##3##(1992-1#1)(2005-11#1)(2008-1#1)(2011-2#1)
patient reported with##3##3##(2011-1#1)(2013-1#1)(2013-7#1)
patient reported##24##2##(1992-1#1)(1992-11#1)(1996-12#1)(2005-11#2)(2006-10#1)(2006-6#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-3#3)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
patient reports and ratings##2##4##(1991-3#2)
patient reports and##3##3##(1991-3#2)(2008-7#1)
patient reports##7##2##(1991-3#2)(1994-3#2)(2007-12#1)(2008-7#1)(2010-8#1)
patient request##3##2##(2007-8#1)(2010-2#1)(2011-1#1)
patient requests##2##2##(2006-12#1)(2010-2#1)
patient required##18##2##(2006-12#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-8#1)(2009-8#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#5)(2013-8#1)
patient requires a##3##3##(1996-2#1)(1996-8#1)(2010-2#1)
patient requires##7##2##(1996-2#1)(1996-8#1)(2007-12#2)(2008-5#1)(2010-2#1)(2011-2#1)
patient requiring##3##2##(2007-10#1)(2007-7#1)(2007-8#1)
patient responded to##5##3##(2007-7#2)(2008-3#1)(2010-12#1)(2012-2#1)
patient responded##18##2##(1995-8#1)(2006-10#2)(2007-12#1)(2007-6#1)(2007-7#6)(2008-3#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-2#2)(2013-8#1)
patient response##2##2##(2007-3#1)(2012-3#1)
patient responses##3##2##(2006-7#1)(2008-6#1)(2009-7#1)
patient retention##3##2##(2008-1#1)(2008-6#1)(2012-3#1)
patient returned to work##2##4##(2006-7#1)(2012-12#1)
patient returned to##8##3##(2006-7#1)(2008-1#1)(2008-7#1)(2008-9#1)(2010-3#1)(2012-12#2)(2013-1#1)
patient returned##11##2##(2006-10#1)(2006-7#1)(2008-1#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-12#3)(2013-1#1)
patient revealed that##2##3##(1991-9#1)(2013-8#1)
patient revealed##10##2##(1991-9#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-11#1)(2007-7#1)(2008-7#1)(2010-11#1)(2013-8#1)
patient risk factors##6##3##(1995-9#1)(2006-12#1)(2006-2#1)(2006-6#1)(2013-1#2)
patient risk##16##2##(1994-5#1)(1995-9#1)(2006-12#1)(2006-2#1)(2006-6#2)(2008-3#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#4)
patient risks##3##2##(1993-2#3)
patient room##3##2##(2010-12#3)
patient safety and##5##3##(2007-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
patient safety by##5##3##(2007-10#1)(2007-4#2)(2013-1#2)
patient safety concerns##2##3##(2005-9#1)(2013-1#1)
patient safety during the##2##4##(2006-7#1)(2011-2#1)
patient safety during##3##3##(2006-10#1)(2006-7#1)(2011-2#1)
patient safety have##2##3##(2006-10#2)
patient safety in##4##3##(2006-10#1)(2008-4#1)(2013-1#2)
patient safety incidents##2##3##(2009-2#1)(2011-1#1)
patient safety initiatives##2##3##(2011-2#1)(2013-8#1)
patient safety issues##2##3##(2007-4#1)(2010-9#1)
patient safety with##4##3##(2010-9#1)(2013-1#3)
patient safety##88##2##(1992-3#1)(1994-3#1)(2005-9#1)(2006-1#1)(2006-10#9)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-12#4)(2007-3#1)(2007-4#9)(2007-5#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-7#3)(2008-8#2)(2008-9#3)(2009-2#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-9#11)(2011-1#3)(2011-2#6)(2012-12#1)(2013-1#8)(2013-8#3)
patient samples##9##2##(1990-12#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
patient satisfaction and improved##2##4##(2006-10#1)(2006-7#1)
patient satisfaction and quality of##2##5##(1997-2#1)(2006-11#1)
patient satisfaction and service quality##2##5##(1995-1#1)(2010-8#1)
patient satisfaction and willingness to##2##5##(1993-12#1)(2007-1#1)
patient satisfaction and##19##3##(1993-12#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(1997-1#1)(1997-2#1)(2006-10#2)(2006-11#1)(2006-7#1)(2007-1#1)(2007-4#1)(2007-5#1)(2008-8#1)(2009-10#1)(2010-8#2)(2013-1#1)
patient satisfaction data##2##3##(1996-1#1)(1997-3#1)
patient satisfaction for##2##3##(2011-1#1)(2011-2#1)
patient satisfaction in##5##3##(1997-1#1)(2007-7#1)(2008-9#1)(2011-2#2)
patient satisfaction is##2##3##(1994-12#1)(2008-11#1)
patient satisfaction of##4##3##(2010-8#1)(2011-1#1)(2013-8#2)
patient satisfaction survey##5##3##(1995-12#1)(2008-12#4)
patient satisfaction surveys##3##3##(1996-3#3)
patient satisfaction using##2##3##(2012-12#1)(2013-7#1)
patient satisfaction was##2##3##(1995-3#1)(2007-11#1)
patient satisfaction with a##2##4##(2009-9#1)(2012-12#1)
patient satisfaction with the##2##4##(2007-7#1)(2010-10#1)
patient satisfaction with##15##3##(1993-4#1)(1995-12#1)(1996-3#2)(2005-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-12#1)(2009-9#1)(2010-10#1)(2010-8#2)(2011-1#1)(2012-12#1)
patient satisfaction##143##2##(1990-3#1)(1991-3#1)(1993-12#2)(1993-3#1)(1993-4#2)(1994-11#1)(1994-12#2)(1994-2#3)(1995-1#3)(1995-12#6)(1995-3#3)(1996-1#4)(1996-2#3)(1996-3#13)(1997-1#3)(1997-2#3)(1997-3#6)(2005-11#2)(2006-1#2)(2006-10#2)(2006-11#1)(2006-3#2)(2006-7#3)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#4)(2007-8#5)(2007-9#2)(2008-10#1)(2008-11#3)(2008-12#6)(2008-3#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-7#1)(2010-8#6)(2011-1#4)(2011-2#5)(2012-1#1)(2012-12#5)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
patient scheduled for##2##3##(1993-10#1)(2012-12#1)
patient scheduling can##2##3##(1996-2#2)
patient scheduling##5##2##(1994-2#1)(1996-2#4)
patient seems to##2##3##(1991-11#1)(2008-1#1)
patient selection and##14##3##(1995-3#1)(2006-10#3)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-5#1)(2010-9#3)(2011-2#1)
patient selection criteria##3##3##(1993-11#1)(2006-10#1)(2006-3#1)
patient selection for##5##3##(2004-2#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#1)
patient selection is important##2##4##(2008-7#1)(2011-2#1)
patient selection is##3##3##(2006-6#1)(2008-7#1)(2011-2#1)
patient selection##59##2##(1990-12#1)(1991-2#1)(1993-11#2)(1994-12#1)(1995-3#1)(1995-9#1)(1996-6#1)(2004-1#1)(2004-2#1)(2006-10#6)(2006-12#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-5#1)(2007-8#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-5#2)(2010-12#2)(2010-6#1)(2010-9#4)(2011-2#6)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
patient sera##5##2##(1992-12#1)(1997-4#2)(2008-8#1)(2008-9#1)
patient series##2##2##(2006-5#1)(2006-6#1)
patient serum##6##2##(1992-2#1)(1997-4#2)(2006-10#1)(2012-3#1)(2013-1#1)
patient served##2##2##(1992-4#1)(2012-3#1)
patient service##4##2##(1991-3#1)(1995-2#1)(1995-3#1)(2008-8#1)
patient services##2##2##(1991-1#1)(1992-10#1)
patient setup##7##2##(2009-11#1)(2009-2#1)(2012-12#5)
patient severity##7##2##(1990-12#1)(1994-5#1)(2011-1#1)(2013-1#4)
patient sexual behaviour##2##3##(1996-1#2)
patient should be considered##2##4##(1991-8#1)(2006-10#1)
patient should be treated##2##4##(1992-6#1)(2006-12#1)
patient should be##22##3##(1991-11#1)(1991-8#1)(1992-6#1)(1993-6#1)(1994-12#1)(1995-10#1)(1996-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-9#1)(2007-12#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-12#2)(2011-2#2)(2012-12#1)(2012-2#1)
patient should##26##2##(1991-11#1)(1991-8#1)(1992-6#1)(1993-6#2)(1994-12#1)(1995-10#1)(1996-1#1)(1996-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#2)(2006-9#1)(2007-12#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-12#2)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)
patient showed a##9##3##(1991-9#1)(1993-12#1)(1994-6#1)(2005-12#1)(2007-11#1)(2007-8#1)(2008-7#1)(2009-4#1)(2010-12#1)
patient showed an##2##3##(2007-7#1)(2012-3#1)
patient showed clinical##3##3##(1990-2#1)(1991-6#1)(1992-11#1)
patient showed no##4##3##(2011-2#1)(2012-11#1)(2012-2#1)(2013-8#1)
patient showed severe##2##3##(1992-5#1)(1995-10#1)
patient showed that##2##3##(1990-3#1)(2009-8#1)
patient showed##36##2##(1990-2#1)(1990-3#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-5#1)(1993-11#1)(1993-12#1)(1994-6#1)(1995-10#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-5#2)(2008-7#3)(2009-4#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
patient showing##2##2##(2006-7#1)(2007-1#1)
patient shows##4##2##(1992-6#1)(2006-2#1)(2011-1#1)(2012-2#1)
patient simulator##3##2##(2012-1#2)(2013-1#1)
patient simulators##2##2##(2006-10#2)
patient skin##2##2##(2008-5#1)(2010-5#1)
patient specific##11##2##(1993-1#1)(2007-8#1)(2009-3#4)(2013-1#5)
patient specimens##3##2##(2008-5#1)(2011-2#2)
patient started##2##2##(2010-12#1)(2013-7#1)
patient status##5##2##(1997-2#1)(2010-7#1)(2013-1#3)
patient still##4##2##(1993-2#1)(2006-12#1)(2009-3#1)(2011-2#1)
patient stratification##3##2##(2008-8#2)(2011-2#1)
patient study##2##2##(1997-8#1)(2011-1#1)
patient subgroups##7##2##(1996-3#1)(2006-10#1)(2006-9#1)(2007-8#1)(2008-12#1)(2008-3#1)(2011-2#1)
patient subpopulations##3##2##(2010-12#1)(2012-2#1)(2013-7#1)
patient subsequently##4##2##(1994-12#1)(2006-10#1)(2007-5#1)(2009-6#1)
patient subtypes##2##2##(1994-2#1)(2010-12#1)
patient successfully##3##2##(2008-5#1)(2009-3#1)(2011-2#1)
patient suddenly developed##3##3##(2005-11#1)(2006-10#1)(2010-6#1)
patient suffered a##6##3##(2006-11#2)(2006-4#1)(2006-5#1)(2008-8#1)(2013-1#1)
patient suffered an##2##3##(1997-6#1)(2012-12#1)
patient suffered from##18##3##(1990-9#1)(1993-2#1)(1994-7#1)(1995-12#1)(1995-4#1)(2006-2#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#2)(2008-12#1)(2009-4#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-8#1)
patient suffered##35##2##(1990-9#1)(1992-9#1)(1993-2#1)(1994-11#1)(1994-7#1)(1995-12#1)(1995-4#1)(1997-6#1)(2005-6#1)(2006-11#2)(2006-2#1)(2006-4#1)(2006-5#2)(2006-8#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#4)(2008-12#2)(2008-8#2)(2009-4#1)(2009-6#1)(2010-2#1)(2011-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
patient suffering from a##2##4##(1996-12#1)(2012-3#1)
patient suffering from##14##3##(1990-11#2)(1990-12#1)(1994-12#1)(1996-12#1)(1996-4#1)(2006-10#1)(2008-10#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-6#1)(2012-3#1)(2013-8#1)
patient suffering##19##2##(1990-11#2)(1990-12#1)(1994-12#1)(1996-12#1)(1996-4#1)(2004-3#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-7#1)(2009-4#1)(2009-6#1)(2010-12#2)(2010-6#1)(2012-3#1)(2013-7#1)(2013-8#1)
patient support##6##2##(1996-1#1)(2006-5#1)(2007-10#1)(2011-2#2)(2012-1#1)
patient surveys##5##2##(1991-3#1)(1996-3#2)(2010-2#1)(2010-8#1)
patient survival and##3##3##(2005-10#1)(2010-7#1)(2011-2#1)
patient survival at##2##3##(2008-1#1)(2011-2#1)
patient survival in##3##3##(2004-11#1)(2010-7#1)(2011-2#1)
patient survival of##3##3##(1992-6#1)(2007-12#1)(2008-1#1)
patient survival rates##3##3##(2008-1#1)(2008-11#1)(2012-3#1)
patient survival was##4##3##(1992-5#1)(1995-2#1)(2008-1#2)
patient survival with##2##3##(2007-8#1)(2008-5#1)
patient survival##52##2##(1992-5#1)(1992-6#1)(1995-2#1)(2004-11#3)(2005-10#1)(2006-10#1)(2006-12#2)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-7#4)(2011-1#1)(2011-2#7)(2012-3#1)(2013-1#6)
patient survived##3##2##(1990-9#1)(2008-1#1)(2008-6#1)
patient symptoms##5##2##(1993-10#1)(2007-8#2)(2009-12#1)(2010-12#1)
patient taking##3##2##(2006-10#1)(2007-12#1)(2007-9#1)
patient than##5##2##(1994-4#1)(1996-3#1)(1996-8#1)(1997-4#1)(2007-7#1)
patient that##5##2##(1994-12#1)(1996-2#1)(1996-8#1)(2005-11#1)(2006-12#1)
patient the##12##2##(1990-10#1)(1990-3#1)(1992-10#1)(1993-11#1)(1996-6#1)(1996-9#2)(2006-10#1)(2006-12#1)(2009-6#1)(2009-9#1)(2011-2#1)
patient therapy##2##2##(2011-2#2)
patient there was##2##3##(2008-4#1)(2008-6#1)
patient there##3##2##(2008-4#2)(2008-6#1)
patient through##3##2##(2004-3#1)(2006-12#1)(2012-12#1)
patient to a specialist##2##4##(1995-3#1)(2008-1#1)
patient to another##2##3##(1990-5#1)(1993-1#1)
patient to develop##2##3##(1990-6#1)(2008-8#1)
patient to patient##3##3##(1993-11#1)(2005-8#1)(2008-7#1)
patient to return to##2##4##(2009-6#1)(2012-12#1)
patient to return##3##3##(1993-12#1)(2009-6#1)(2012-12#1)
patient to the##5##3##(1992-3#1)(1993-9#1)(2007-8#1)(2008-3#1)(2008-9#1)
patient to##63##2##(1990-5#1)(1990-6#1)(1992-11#2)(1992-12#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-9#1)(1994-8#1)(1995-3#1)(1995-4#1)(1995-8#1)(2004-3#2)(2004-7#1)(2005-8#1)(2006-10#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#5)(2010-12#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
patient tolerance##4##2##(2004-1#1)(2006-10#1)(2007-12#1)(2011-1#1)
patient transfer##3##2##(2006-5#1)(2012-1#1)(2012-12#1)
patient transfers##2##2##(2005-8#1)(2007-7#1)
patient transport##2##2##(1994-3#1)(2011-2#1)
patient treated by##3##3##(2007-11#1)(2007-8#1)(2008-10#1)
patient treated for a long##2##5##(1991-11#1)(2013-1#1)
patient treated for##5##3##(1991-11#1)(1996-3#1)(1997-2#1)(2013-1#1)(2013-8#1)
patient treated in the##2##4##(2007-11#1)(2007-7#1)
patient treated in##3##3##(2007-11#1)(2007-7#1)(2008-10#1)
patient treated with##15##3##(1990-6#2)(1993-2#1)(1993-6#1)(1993-9#1)(1996-6#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#1)(2010-12#1)(2011-1#1)
patient treated##28##2##(1990-3#1)(1990-6#2)(1991-11#1)(1993-1#1)(1993-2#1)(1993-6#1)(1993-9#1)(1996-3#1)(1996-6#1)(1997-2#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-7#2)(2007-8#2)(2008-10#3)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
patient treatment##11##2##(1992-12#1)(1992-2#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-6#1)(2009-11#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
patient under##2##2##(2007-9#1)(2008-7#1)
patient undergoing##9##2##(2007-8#1)(2007-9#1)(2009-2#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-12#2)(2013-7#1)
patient underwent a##18##3##(2006-10#2)(2006-12#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-3#2)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
patient underwent an##6##3##(2006-10#1)(2006-12#1)(2008-6#1)(2011-2#1)(2012-2#2)
patient underwent cosmetic surgery##2##4##(2007-12#1)(2009-9#1)
patient underwent emergency laparotomy##2##4##(1993-10#1)(2005-12#1)
patient underwent emergency##3##3##(1993-10#1)(2005-12#1)(2010-12#1)
patient underwent open##2##3##(2008-12#1)(2012-12#1)
patient underwent orthotopic liver transplantation##2##5##(1991-11#1)(1992-12#1)
patient underwent radical surgery##2##4##(1992-10#2)
patient underwent radical##3##3##(1992-10#2)(2009-2#1)
patient underwent reoperation##2##3##(2006-12#1)(2007-8#1)
patient underwent successful##2##3##(1995-7#1)(2013-8#1)
patient underwent surgery##4##3##(2005-11#1)(2006-4#1)(2007-12#1)(2011-12#1)
patient underwent surgical intervention##2##4##(2006-8#1)(2011-1#1)
patient underwent surgical##5##3##(2006-8#1)(2007-8#1)(2008-4#1)(2009-8#1)(2011-1#1)
patient underwent total##2##3##(2006-10#1)(2013-8#1)
patient underwent##98##2##(1991-10#1)(1991-11#2)(1992-10#2)(1992-12#1)(1993-10#1)(1995-7#1)(2005-11#1)(2005-12#2)(2006-10#7)(2006-11#1)(2006-12#4)(2006-4#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-7#3)(2007-8#7)(2008-1#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#4)(2008-7#2)(2009-2#1)(2009-3#6)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#5)(2012-12#3)(2012-2#5)(2012-3#5)(2013-1#4)(2013-8#4)
patient until##2##2##(2007-7#1)(2012-11#1)
patient using##5##2##(1993-11#1)(2007-8#1)(2008-12#1)(2008-4#1)(2011-2#1)
patient utilization##4##2##(2013-1#4)
patient variables and##2##3##(1992-12#1)(2007-12#1)
patient variables##3##2##(1992-12#1)(2007-12#1)(2012-1#1)
patient visit##3##2##(2007-6#1)(2008-7#1)(2011-2#1)
patient visits##5##2##(2007-12#1)(2008-1#1)(2012-12#1)(2013-1#2)
patient volume and##3##3##(1994-2#1)(1996-12#1)(1996-3#1)
patient volume##8##2##(1994-2#2)(1995-2#1)(1996-12#1)(1996-3#1)(1997-1#1)(2007-10#1)(2013-7#1)
patient was a 35-year-old##2##4##(2008-1#1)(2008-7#1)
patient was a 58-year-old woman##2##5##(2007-12#1)(2012-2#1)
patient was a man##2##4##(1990-4#1)(1991-9#1)
patient was a##49##3##(1990-4#2)(1991-9#1)(1992-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-10#1)(1996-3#1)(1996-6#1)(2004-11#1)(2006-10#1)(2007-12#2)(2007-2#2)(2007-7#1)(2007-8#5)(2008-1#2)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#4)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#2)(2013-7#2)(2013-8#2)
patient was able to##6##4##(1993-1#1)(1993-2#1)(2008-4#1)(2009-3#1)(2012-1#2)
patient was admitted for##4##4##(2007-8#1)(2009-8#1)(2013-1#2)
patient was admitted to hospital because of##2##7##(1995-7#1)(2008-4#1)
patient was admitted to hospital##3##5##(1993-9#1)(1995-7#1)(2008-4#1)
patient was admitted to our department##2##6##(2007-8#1)(2012-3#1)
patient was admitted to our hospital with##3##7##(1993-6#1)(2005-12#1)(2011-2#1)
patient was admitted to our##6##5##(1993-6#1)(1996-1#1)(2005-12#1)(2007-8#1)(2011-2#1)(2012-3#1)
patient was admitted to the emergency room##2##7##(2007-12#1)(2007-8#1)
patient was admitted to the hospital with a##2##8##(2010-7#1)(2013-1#1)
patient was admitted to the hospital##4##6##(1992-3#1)(1993-6#1)(2010-7#1)(2013-1#1)
patient was admitted to the##10##5##(1992-3#1)(1993-6#1)(2006-7#1)(2007-12#1)(2007-8#1)(2009-6#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
patient was admitted to##19##4##(1992-3#1)(1993-6#2)(1993-9#1)(1995-7#1)(1996-1#1)(2005-12#1)(2006-7#1)(2007-12#1)(2007-8#2)(2008-4#1)(2009-6#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
patient was admitted with##3##4##(2006-12#1)(2013-1#2)
patient was admitted##37##3##(1991-8#1)(1992-3#1)(1993-6#2)(1993-9#1)(1995-7#2)(1996-1#1)(2005-12#1)(2006-12#1)(2006-4#1)(2006-7#1)(2007-12#1)(2007-8#4)(2008-1#1)(2008-4#1)(2008-5#1)(2009-6#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#10)(2013-8#1)
patient was also##5##3##(2006-10#2)(2008-5#1)(2010-12#1)(2011-1#1)
patient was asymptomatic##8##3##(1996-3#1)(2006-9#1)(2007-8#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
patient was brought##2##3##(2010-12#1)(2012-2#1)
patient was completely##5##3##(2006-6#1)(2007-7#1)(2007-8#1)(2011-2#1)(2012-12#1)
patient was confirmed##2##3##(2007-10#1)(2009-3#1)
patient was diagnosed as having##2##5##(1991-7#1)(2012-2#1)
patient was diagnosed as##3##4##(1991-7#1)(2012-2#2)
patient was diagnosed to have##2##5##(1997-8#1)(2008-6#1)
patient was diagnosed to##3##4##(1990-10#1)(1997-8#1)(2008-6#1)
patient was diagnosed with##12##4##(2004-2#1)(2006-10#1)(2008-12#1)(2008-8#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#3)(2013-8#1)
patient was diagnosed##20##3##(1990-10#1)(1991-7#1)(1997-8#1)(2004-2#1)(2006-10#1)(2008-12#1)(2008-6#2)(2008-8#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#1)
patient was discharged from the hospital##2##6##(2009-3#1)(2011-2#1)
patient was discharged from##3##4##(2007-10#1)(2009-3#1)(2011-2#1)
patient was discharged home##6##4##(2006-4#1)(2007-8#1)(2010-7#2)(2012-12#2)
patient was discharged on day##3##5##(2013-1#1)(2013-8#2)
patient was discharged on##9##4##(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#2)
patient was discharged##30##3##(1992-5#1)(1994-9#1)(1995-3#1)(2006-4#2)(2006-6#1)(2007-10#1)(2007-8#3)(2008-7#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-7#2)(2011-2#1)(2012-12#5)(2012-2#1)(2013-1#3)(2013-8#4)
patient was evaluated##2##3##(2007-3#1)(2012-2#1)
patient was examined##2##3##(1993-7#1)(2006-10#1)
patient was followed##5##3##(2007-8#1)(2011-1#1)(2012-2#1)(2013-1#2)
patient was found to have a##2##6##(1996-12#1)(2008-6#1)
patient was found to have##7##5##(1996-12#1)(2008-12#1)(2008-6#1)(2011-1#1)(2012-2#1)(2013-1#2)
patient was found to##8##4##(1996-12#1)(2008-12#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#2)
patient was found##9##3##(1996-12#1)(2008-12#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
patient was free of##4##4##(2006-8#1)(2009-1#1)(2011-2#2)
patient was free##5##3##(2006-8#1)(2009-1#1)(2011-2#2)(2013-8#1)
patient was given##8##3##(1991-10#1)(1992-2#1)(1992-5#1)(2006-10#1)(2007-7#2)(2008-1#1)(2011-1#1)
patient was having##2##3##(2007-7#2)
patient was hospitalized##2##3##(2005-12#1)(2009-1#1)
patient was in##7##3##(1990-5#1)(1993-12#1)(1994-3#1)(2004-10#1)(2007-12#1)(2008-4#1)(2013-8#1)
patient was included##2##3##(2007-3#1)(2012-2#1)
patient was initially treated##2##4##(2011-12#1)(2013-8#1)
patient was initially##3##3##(2007-10#1)(2011-12#1)(2013-8#1)
patient was investigated##2##3##(1990-12#1)(2010-12#1)
patient was not##6##3##(1997-6#1)(2005-10#1)(2006-7#1)(2008-1#1)(2011-12#1)(2012-12#1)
patient was on##7##3##(2006-10#1)(2008-7#1)(2010-12#1)(2012-11#1)(2013-1#2)(2013-7#1)
patient was operated on##3##4##(2006-6#2)(2013-1#1)
patient was operated##4##3##(2006-6#2)(2013-1#2)
patient was pain-free##2##3##(2007-9#1)(2012-2#1)
patient was posted for##3##4##(2008-7#1)(2010-12#1)(2010-5#1)
patient was referred to surgery##2##5##(1994-9#1)(2011-1#1)
patient was referred to the##2##5##(2008-6#1)(2009-8#1)
patient was referred to##9##4##(1994-9#1)(2008-1#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
patient was referred##16##3##(1991-11#1)(1994-9#1)(1995-5#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)
patient was seen##2##3##(2012-3#1)(2013-1#1)
patient was selected##2##3##(2012-12#1)(2013-8#1)
patient was started on corticosteroid therapy##2##6##(2006-7#1)(2007-5#1)
patient was started on##5##4##(2005-11#1)(2006-7#1)(2007-12#1)(2007-5#1)(2009-11#1)
patient was still##3##3##(1992-7#1)(2007-8#1)(2009-10#1)
patient was subjected to##3##4##(1990-10#1)(2007-7#1)(2008-11#1)
patient was submitted to##3##4##(1990-3#1)(2007-3#1)(2012-2#1)
patient was submitted##4##3##(1990-3#1)(2007-3#1)(2010-9#1)(2012-2#1)
patient was subsequently##3##3##(1993-8#1)(2012-12#1)(2012-2#1)
patient was successfully##6##3##(2006-10#1)(2007-8#1)(2008-7#1)(2011-12#1)(2013-1#2)
patient was taken##3##3##(2008-4#1)(2011-12#1)(2011-2#1)
patient was thought to have a##2##6##(2006-6#2)
patient was thought##3##3##(1992-9#1)(2006-6#2)
patient was totally##2##3##(2008-10#1)(2012-1#1)
patient was transferred to the intensive care unit##2##8##(2009-6#1)(2013-1#1)
patient was transferred to the##4##5##(2009-6#1)(2011-2#1)(2013-1#2)
patient was transferred to##6##4##(2007-9#1)(2009-6#1)(2011-2#1)(2013-1#2)(2013-8#1)
patient was transfused with two units of##2##7##(1994-6#1)(1994-9#1)
patient was transfused with##3##4##(1994-12#1)(1994-6#1)(1994-9#1)
patient was transfused##4##3##(1994-12#1)(1994-6#1)(1994-9#1)(2007-12#1)
patient was treated by##10##4##(1990-8#1)(1994-7#1)(2004-1#1)(2005-10#1)(2005-12#1)(2007-2#2)(2008-10#1)(2011-2#1)(2012-12#1)
patient was treated with antibiotics##2##5##(1996-11#1)(2013-1#1)
patient was treated with chemotherapy##2##5##(2007-7#1)(2007-9#1)
patient was treated with##51##4##(1992-2#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-6#1)(1996-11#1)(1997-6#1)(2005-1#1)(2006-10#4)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#5)(2007-9#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#4)(2008-7#1)(2009-8#2)(2010-10#1)(2010-12#1)(2011-2#2)(2012-12#3)(2012-2#3)(2013-1#3)(2013-8#2)
patient was treated##72##3##(1990-8#1)(1992-2#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-6#1)(1994-7#1)(1996-11#1)(1997-6#1)(2004-1#1)(2005-1#1)(2005-10#1)(2005-12#1)(2006-10#4)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#6)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#4)(2008-7#1)(2009-11#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-7#1)(2011-2#4)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#2)
patient was unable to##2##4##(2008-1#1)(2008-9#1)
patient was weaned##3##3##(2007-9#1)(2009-6#1)(2012-2#1)
patient was well##2##3##(1991-6#1)(2006-10#1)
patient was withdrawn##2##3##(1992-11#1)(1992-8#1)
patient was##534##2##(1990-10#2)(1990-12#1)(1990-3#2)(1990-4#2)(1990-5#2)(1990-8#2)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#4)(1992-3#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#2)(1993-7#3)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#4)(1994-3#2)(1994-6#3)(1994-7#1)(1994-9#3)(1995-10#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-7#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-6#3)(1997-8#1)(2004-1#1)(2004-10#1)(2004-11#1)(2004-2#1)(2005-1#1)(2005-10#3)(2005-11#1)(2005-12#4)(2005-5#1)(2006-1#2)(2006-10#14)(2006-12#2)(2006-2#1)(2006-4#9)(2006-6#8)(2006-7#3)(2006-8#4)(2006-9#1)(2007-10#5)(2007-11#5)(2007-12#10)(2007-2#4)(2007-3#4)(2007-4#2)(2007-5#1)(2007-7#17)(2007-8#23)(2007-9#8)(2008-1#11)(2008-10#4)(2008-11#2)(2008-12#12)(2008-3#1)(2008-4#6)(2008-5#6)(2008-6#11)(2008-7#14)(2008-8#4)(2008-9#3)(2009-1#2)(2009-10#2)(2009-11#4)(2009-2#1)(2009-3#8)(2009-4#3)(2009-6#7)(2009-8#6)(2010-1#1)(2010-10#5)(2010-12#11)(2010-2#1)(2010-3#1)(2010-5#3)(2010-7#6)(2010-9#4)(2011-1#10)(2011-12#7)(2011-2#27)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#21)(2012-2#28)(2012-3#5)(2013-1#42)(2013-7#3)(2013-8#18)
patient we##2##2##(1996-12#1)(2007-11#1)
patient well-being##2##2##(2004-2#1)(2006-10#1)
patient went on to##2##4##(2004-3#1)(2012-3#1)
patient went##5##2##(1992-2#1)(2004-3#1)(2012-1#1)(2012-3#1)(2013-1#1)
patient were##11##2##(1992-12#1)(1994-11#1)(1996-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-5#2)(2009-6#1)(2012-12#2)
patient where the##2##3##(2008-4#1)(2011-1#1)
patient where##3##2##(2007-11#1)(2008-4#1)(2011-1#1)
patient while##2##2##(2007-7#1)(2010-12#1)
patient who complained of##5##4##(2007-12#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
patient who developed a##5##4##(1993-8#1)(2007-2#1)(2008-12#1)(2008-8#1)(2009-4#1)
patient who developed##27##3##(1993-8#1)(2006-11#1)(2006-4#1)(2006-7#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)
patient who died##3##3##(1993-7#1)(1994-11#1)(2008-11#1)
patient who had a##2##4##(2007-10#1)(2008-7#1)
patient who had an##3##4##(1991-3#1)(1997-5#1)(2008-7#1)
patient who had been##5##4##(1994-7#1)(1995-11#1)(1997-6#1)(2005-12#1)(2013-8#1)
patient who had undergone##5##4##(1990-3#1)(2006-2#2)(2008-12#1)(2009-2#1)
patient who had##28##3##(1990-3#1)(1991-3#1)(1993-8#1)(1994-7#1)(1995-11#1)(1995-3#1)(1997-5#1)(1997-6#1)(2005-10#1)(2005-12#1)(2006-10#2)(2006-2#2)(2007-10#1)(2007-8#2)(2008-1#1)(2008-12#2)(2008-7#2)(2008-9#1)(2009-2#1)(2009-3#1)(2011-1#1)(2012-2#1)(2013-8#1)
patient who has##11##3##(1994-7#1)(1997-1#1)(2006-11#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-3#1)(2009-9#1)(2010-5#1)(2011-1#1)(2012-12#1)
patient who is not##3##4##(1994-7#1)(2010-12#1)(2010-5#1)
patient who is##7##3##(1994-7#1)(1995-9#1)(2007-8#1)(2008-3#1)(2010-12#1)(2010-5#1)(2013-1#1)
patient who presented with a##2##5##(1993-12#1)(2008-6#1)
patient who presented with acute##2##5##(2007-8#1)(2010-8#1)
patient who presented with##22##4##(1993-12#1)(2006-11#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-6#2)(2009-11#1)(2009-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-7#1)
patient who presented##24##3##(1993-12#1)(2006-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-4#1)(2008-6#2)(2009-11#1)(2009-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
patient who presents with##2##4##(1997-3#1)(2013-7#1)
patient who suffered posterior##2##4##(2012-1#1)(2012-2#1)
patient who suffered##6##3##(1990-9#1)(1991-4#1)(2007-4#1)(2010-6#1)(2012-1#1)(2012-2#1)
patient who suffers##2##3##(2008-8#1)(2011-2#1)
patient who sustained##3##3##(2009-4#1)(2012-11#1)(2012-2#1)
patient who underwent##16##3##(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-2#1)(2012-12#3)(2012-2#1)(2013-1#2)
patient who was on##3##4##(2013-1#2)(2013-7#1)
patient who was successfully treated with##2##6##(2007-8#1)(2012-3#1)
patient who was treated with##2##5##(1997-8#1)(2012-12#1)
patient who was treated##3##4##(1997-8#1)(2009-5#1)(2012-12#1)
patient who was##26##3##(1991-11#1)(1991-7#1)(1992-10#1)(1993-6#1)(1997-8#1)(2004-9#1)(2006-1#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-8#6)(2009-2#1)(2009-5#1)(2010-9#1)(2012-12#2)(2012-3#2)(2013-1#2)(2013-7#1)
patient who##196##2##(1990-12#1)(1990-3#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-10#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-7#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-7#3)(1995-11#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-11#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-12#1)(2006-1#1)(2006-10#4)(2006-11#3)(2006-2#4)(2006-4#2)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#3)(2007-11#2)(2007-12#6)(2007-2#1)(2007-3#3)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#19)(2007-9#3)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#2)(2009-3#3)(2009-4#3)(2009-5#1)(2009-6#1)(2009-9#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#4)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#6)(2012-1#3)(2012-11#2)(2012-12#11)(2012-2#7)(2012-3#4)(2013-1#6)(2013-7#4)(2013-8#3)
patient whose##13##2##(1990-9#1)(1993-5#1)(1993-7#1)(1994-7#1)(1997-1#1)(2006-10#2)(2006-12#1)(2007-7#1)(2007-9#1)(2008-7#1)(2009-6#1)(2012-2#1)
patient will be##3##3##(2011-1#1)(2012-12#1)(2013-8#1)
patient will##14##2##(1996-7#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-8#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
patient wishes##2##2##(1993-12#1)(2005-4#1)
patient with AAS##2##3##(2007-9#1)(2008-4#1)
patient with AIDS##9##3##(1994-7#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#3)(2009-2#1)(2013-7#1)
patient with Crohn's disease who##2##5##(1991-8#1)(2010-12#1)
patient with Crohn's disease##3##4##(1991-8#1)(2010-12#1)(2011-1#1)
patient with Fontan physiology##2##4##(2008-10#1)(2013-7#1)
patient with Graves' disease##2##4##(1991-9#1)(2007-7#1)
patient with Guillain-Barré syndrome##2##4##(1994-4#1)(2006-4#1)
patient with HIV##6##3##(1995-12#1)(1996-11#1)(2010-12#1)(2010-4#2)(2013-1#1)
patient with Marfan syndrome##2##4##(2007-8#1)(2009-4#1)
patient with SLE##4##3##(2006-10#3)(2012-12#1)
patient with Wegener's##2##3##(2006-10#1)(2008-5#1)
patient with a cervical##2##4##(2006-10#1)(2007-8#1)
patient with a clinical picture of##2##6##(2007-11#1)(2011-2#1)
patient with a complete##2##4##(1996-2#1)(2011-2#1)
patient with a complex##2##4##(2010-10#1)(2010-3#1)
patient with a de novo##2##5##(1997-1#1)(2012-12#1)
patient with a history of##10##5##(1992-10#1)(2005-11#1)(2007-11#1)(2008-6#1)(2009-4#1)(2010-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
patient with a large##4##4##(2007-8#1)(2008-1#1)(2009-8#1)(2012-12#1)
patient with a left lower lobe##2##6##(2008-1#2)
patient with a left##3##4##(2006-11#1)(2008-1#2)
patient with a painless right##2##5##(2009-7#2)
patient with a prior history of##2##6##(2006-2#1)(2013-8#1)
patient with a right##2##4##(1996-5#1)(2008-4#1)
patient with a severe##3##4##(2006-8#1)(2007-8#1)(2012-1#1)
patient with a small##2##4##(1996-12#1)(2007-9#1)
patient with a total##2##4##(2008-6#1)(2010-10#1)
patient with a##145##3##(1990-3#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-10#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-12#2)(1996-12#2)(1996-2#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(2004-11#1)(2005-11#1)(2005-5#1)(2005-9#2)(2006-10#8)(2006-11#2)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#6)(2007-12#1)(2007-3#1)(2007-6#2)(2007-8#11)(2007-9#1)(2008-1#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#2)(2008-6#4)(2008-7#5)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#5)(2013-1#1)(2013-8#3)
patient with abdominal pain##4##4##(1991-4#1)(2006-10#1)(2008-7#1)(2010-12#1)
patient with abdominal##5##3##(1991-4#1)(2006-10#1)(2008-7#1)(2010-12#1)(2011-1#1)
patient with acute coronary syndrome##4##5##(2007-8#1)(2008-10#3)
patient with acute lymphoblastic leukemia##4##5##(2009-8#2)(2012-12#2)
patient with acute##21##3##(1992-8#1)(1994-12#1)(1997-4#1)(2007-2#1)(2007-4#1)(2007-8#2)(2008-10#3)(2008-5#2)(2008-7#1)(2009-6#1)(2009-8#2)(2012-12#3)(2012-3#1)(2013-1#1)
patient with advanced##5##3##(1990-8#1)(2006-10#1)(2007-11#1)(2008-6#1)(2012-3#1)
patient with an atypical##2##4##(1995-1#1)(2007-10#1)
patient with an intracranial##2##4##(2006-12#1)(2006-4#1)
patient with an isolated##2##4##(1994-5#1)(2008-9#1)
patient with an undiagnosed##2##4##(2007-12#1)(2008-12#1)
patient with an##43##3##(1994-5#1)(1995-1#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(2005-1#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-8#2)(2008-12#2)(2008-7#3)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-2#3)(2013-1#4)(2013-8#1)
patient with ankylosing spondylitis##5##4##(2006-10#1)(2007-11#2)(2007-6#1)(2008-4#1)
patient with anorexia nervosa##2##4##(2005-12#1)(2006-7#1)
patient with aortic##2##3##(2011-2#1)(2012-2#1)
patient with arteria lusoria##2##4##(2008-11#2)
patient with asthma##2##3##(2010-10#1)(2012-12#1)
patient with bilateral##3##3##(1997-1#1)(2013-1#1)(2013-8#1)
patient with bleeding##2##3##(2008-10#2)
patient with brain##3##3##(1993-8#1)(2006-7#1)(2010-12#1)
patient with cancer##4##3##(2006-10#1)(2007-6#1)(2011-2#2)
patient with carcinoma of the##2##5##(1993-12#1)(2010-12#1)
patient with chemical corneal burn##2##5##(2010-10#2)
patient with chronic hepatitis##3##4##(2009-11#1)(2009-7#1)(2013-1#1)
patient with chronic liver disease##4##5##(1991-11#1)(2007-8#2)(2008-10#1)
patient with chronic pain##2##4##(2006-3#1)(2009-4#1)
patient with chronic renal##3##4##(2008-1#1)(2010-5#1)(2013-1#1)
patient with chronic##35##3##(1991-11#1)(2005-10#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#4)
patient with clinical features##2##4##(1996-2#1)(2009-6#1)
patient with clinical##4##3##(1996-2#1)(2009-6#1)(2012-3#1)(2013-1#1)
patient with congenital heart##2##4##(2009-10#2)
patient with diabetes mellitus##2##4##(2012-12#2)
patient with diabetes##8##3##(2007-11#1)(2008-1#1)(2008-4#1)(2009-4#2)(2010-10#1)(2012-12#2)
patient with disseminated##2##3##(2006-1#1)(2006-6#1)
patient with dysphagia##2##3##(2008-1#2)
patient with early##3##3##(2006-10#1)(2008-10#1)(2009-10#1)
patient with epidural anesthesia##2##4##(2012-3#2)
patient with essential hypertension##3##4##(1992-6#1)(2006-6#1)(2008-10#1)
patient with essential##5##3##(1992-6#1)(1997-7#1)(2006-6#1)(2008-10#1)(2010-2#1)
patient with extensive##2##3##(2007-7#1)(2008-7#1)
patient with familial Alzheimer's disease##3##5##(1992-3#3)
patient with familial##5##3##(1992-3#3)(1992-8#1)(2011-2#1)
patient with fatal##2##3##(1991-4#1)(2007-8#1)
patient with gastrointestinal##2##3##(2007-2#1)(2008-2#1)
patient with generalized##3##3##(1995-10#1)(2012-2#1)(2012-3#1)
patient with high##3##3##(1990-9#1)(2007-8#1)(2008-11#1)
patient with history of##2##4##(2010-9#1)(2012-12#1)
patient with hypercalcemia##2##3##(1996-9#1)(2008-6#1)
patient with isolated##2##3##(2007-8#1)(2011-2#1)
patient with left atrial##2##4##(2007-8#1)(2008-11#1)
patient with left##3##3##(2007-8#2)(2008-11#1)
patient with liver cirrhosis##2##4##(1990-8#1)(2008-1#1)
patient with liver##5##3##(1990-8#1)(1991-11#1)(2005-12#1)(2007-12#1)(2008-1#1)
patient with low##2##3##(1990-6#1)(1993-8#1)
patient with malignant melanoma of the##2##6##(2012-12#1)(2012-2#1)
patient with malignant##7##3##(1990-10#1)(1994-12#1)(2011-3#1)(2012-12#2)(2012-2#1)(2013-7#1)
patient with metastatic renal cell carcinoma##2##6##(1991-8#1)(2012-12#1)
patient with metastatic renal##3##4##(1990-12#1)(1991-8#1)(2012-12#1)
patient with metastatic##11##3##(1990-12#1)(1990-9#1)(1991-8#1)(1992-2#1)(2006-8#2)(2007-12#1)(2008-11#1)(2008-6#1)(2012-1#1)(2012-12#1)
patient with mitochondrial##2##3##(1996-2#1)(1997-2#1)
patient with mixed##4##3##(2005-1#1)(2007-5#1)(2011-1#1)(2012-12#1)
patient with moderate##2##3##(1992-11#1)(1993-11#1)
patient with multiple antibodies##2##4##(1993-9#2)
patient with multiple myeloma##7##4##(2005-1#1)(2005-12#3)(2007-12#1)(2007-5#2)
patient with multiple vertebral hemangiomas##2##5##(2012-2#2)
patient with multiple##23##3##(1992-12#1)(1993-12#1)(1993-9#2)(1997-8#1)(2005-1#1)(2005-12#3)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#2)(2007-7#1)(2008-11#1)(2009-4#2)(2011-2#1)(2012-2#2)(2013-8#1)
patient with myasthenia gravis##5##4##(2007-8#1)(2012-2#2)(2012-3#1)(2013-7#1)
patient with neck##2##3##(1991-8#1)(2007-11#1)
patient with neurological##2##3##(1997-6#1)(2008-12#1)
patient with newly##2##3##(2005-1#1)(2007-11#1)
patient with normal renal function##2##5##(2006-10#1)(2009-2#1)
patient with normal##5##3##(2006-10#1)(2006-8#1)(2007-8#1)(2009-2#1)(2010-5#1)
patient with painless##2##3##(2006-8#1)(2011-2#1)
patient with primary##7##3##(2006-12#1)(2008-1#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-7#2)
patient with progressive##3##3##(2006-10#1)(2012-2#1)(2013-1#1)
patient with pulmonary##3##3##(2007-12#1)(2008-7#1)(2012-3#1)
patient with radiologically##2##3##(2007-8#1)(2008-7#1)
patient with recurrent##10##3##(2006-7#2)(2006-8#1)(2007-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
patient with respiratory##2##3##(2008-2#1)(2008-6#1)
patient with rheumatoid arthritis##13##4##(2006-10#7)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
patient with sepsis and##2##4##(1992-12#1)(1993-12#1)
patient with severe hemophilia B##2##5##(1990-11#2)
patient with severe##20##3##(1990-11#2)(1990-12#1)(1996-12#1)(2004-11#1)(2006-10#1)(2006-4#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2009-5#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
patient with significant##3##3##(2008-4#1)(2009-10#1)(2013-1#1)
patient with stage IV##2##4##(2012-2#1)(2013-7#1)
patient with stage##3##3##(2006-10#1)(2012-2#1)(2013-7#1)
patient with suspected##4##3##(1993-10#1)(2006-2#1)(2008-5#1)(2010-9#1)
patient with symptomatic##4##3##(1993-2#1)(1997-4#1)(2012-12#1)(2012-3#1)
patient with symptoms of##2##4##(1993-10#1)(2010-8#1)
patient with systemic lupus erythematosus##13##5##(1991-5#1)(1993-11#1)(1994-9#1)(2006-10#5)(2007-11#1)(2007-12#1)(2008-9#1)(2010-12#1)(2013-8#1)
patient with systemic lupus##14##4##(1991-5#1)(1993-11#1)(1994-9#1)(2006-10#5)(2007-11#1)(2007-12#1)(2007-7#1)(2008-9#1)(2010-12#1)(2013-8#1)
patient with systemic sclerosis##3##4##(2006-10#1)(2011-2#1)(2012-1#1)
patient with systemic##18##3##(1991-5#1)(1993-11#1)(1994-9#1)(2006-10#7)(2007-11#1)(2007-12#1)(2007-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-8#1)
patient with the##9##3##(1991-10#1)(1991-12#1)(1994-10#1)(2006-10#3)(2006-12#1)(2007-3#1)(2013-1#1)
patient with this##5##3##(1991-4#1)(2005-10#1)(2007-10#1)(2008-11#1)(2008-3#1)
patient with thyroid##2##3##(2011-1#1)(2011-12#1)
patient with traumatic##2##3##(2007-11#1)(2008-5#1)
patient with type I##2##4##(2011-2#1)(2012-3#1)
patient with type II##3##4##(1997-2#1)(2008-7#1)(2009-4#1)
patient with type##7##3##(1997-2#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
patient with ulcerative colitis##6##4##(2006-10#1)(2007-10#1)(2007-4#1)(2010-12#2)(2012-12#1)
patient with undiagnosed##3##3##(2006-10#1)(2007-12#1)(2007-8#1)
patient with unilateral##3##3##(1990-2#1)(1996-8#1)(2009-2#1)
patient with unresectable##2##3##(2006-6#1)(2012-2#1)
patient with xeroderma pigmentosum##2##4##(1991-6#1)(1997-4#1)
patient with##1153##2##(1990-1#1)(1990-10#3)(1990-11#2)(1990-12#10)(1990-2#1)(1990-3#5)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#4)(1990-9#4)(1991-10#2)(1991-11#2)(1991-12#4)(1991-2#5)(1991-4#6)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#4)(1991-9#3)(1992-10#4)(1992-11#2)(1992-12#3)(1992-2#5)(1992-3#5)(1992-5#1)(1992-6#5)(1992-8#2)(1992-9#2)(1993-10#2)(1993-11#5)(1993-12#6)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#4)(1993-9#4)(1994-10#3)(1994-11#4)(1994-12#7)(1994-3#4)(1994-4#3)(1994-5#3)(1994-7#1)(1994-9#2)(1995-1#3)(1995-10#1)(1995-12#4)(1995-2#1)(1995-6#1)(1995-8#2)(1996-11#3)(1996-12#7)(1996-2#5)(1996-3#2)(1996-5#1)(1996-6#3)(1996-8#5)(1996-9#7)(1997-1#6)(1997-2#4)(1997-3#4)(1997-4#6)(1997-6#1)(1997-7#3)(1997-8#2)(2004-11#4)(2005-1#5)(2005-10#5)(2005-11#2)(2005-12#11)(2005-4#1)(2005-5#2)(2005-6#1)(2005-9#2)(2006-1#1)(2006-10#79)(2006-11#2)(2006-12#16)(2006-2#5)(2006-3#4)(2006-4#11)(2006-6#6)(2006-7#8)(2006-8#11)(2006-9#4)(2007-1#1)(2007-10#19)(2007-11#27)(2007-12#15)(2007-2#9)(2007-3#5)(2007-4#7)(2007-5#4)(2007-6#6)(2007-7#19)(2007-8#50)(2007-9#6)(2008-1#18)(2008-10#19)(2008-11#13)(2008-12#21)(2008-2#4)(2008-3#5)(2008-4#16)(2008-5#13)(2008-6#18)(2008-7#33)(2008-8#7)(2008-9#7)(2009-10#8)(2009-11#7)(2009-12#1)(2009-2#7)(2009-3#5)(2009-4#15)(2009-5#6)(2009-6#6)(2009-7#7)(2009-8#9)(2009-9#3)(2010-1#1)(2010-10#7)(2010-11#2)(2010-12#21)(2010-2#12)(2010-3#3)(2010-4#4)(2010-5#2)(2010-6#6)(2010-7#4)(2010-8#4)(2010-9#5)(2011-1#7)(2011-12#3)(2011-2#51)(2011-3#2)(2012-1#5)(2012-12#46)(2012-2#32)(2012-3#26)(2013-1#58)(2013-7#14)(2013-8#23)
patient without structural heart disease##2##5##(2006-9#1)(2011-2#1)
patient without##13##2##(1991-9#1)(1996-3#1)(1996-8#1)(2005-8#1)(2006-10#1)(2006-9#1)(2008-1#1)(2009-5#1)(2010-12#1)(2011-2#2)(2012-3#2)
patient years##5##2##(1993-8#1)(2006-10#2)(2007-8#2)
patient!##2##1##(1992-1#1)(2008-7#1)
patient##8392##1##(1990-1#4)(1990-10#19)(1990-11#14)(1990-12#33)(1990-2#16)(1990-3#21)(1990-4#14)(1990-5#9)(1990-6#15)(1990-7#4)(1990-8#16)(1990-9#18)(1991-1#10)(1991-10#7)(1991-11#18)(1991-12#25)(1991-2#23)(1991-3#28)(1991-4#23)(1991-5#10)(1991-6#15)(1991-7#11)(1991-8#16)(1991-9#15)(1992-1#21)(1992-10#16)(1992-11#21)(1992-12#31)(1992-2#32)(1992-3#42)(1992-4#15)(1992-5#16)(1992-6#24)(1992-7#1)(1992-8#26)(1992-9#9)(1993-1#23)(1993-10#12)(1993-11#32)(1993-12#54)(1993-2#38)(1993-3#24)(1993-4#4)(1993-5#13)(1993-6#21)(1993-7#18)(1993-8#21)(1993-9#21)(1994-1#17)(1994-10#5)(1994-11#25)(1994-12#41)(1994-2#26)(1994-3#38)(1994-4#9)(1994-5#9)(1994-6#12)(1994-7#11)(1994-8#10)(1994-9#9)(1995-1#17)(1995-10#9)(1995-11#8)(1995-12#31)(1995-2#41)(1995-3#40)(1995-4#6)(1995-5#7)(1995-6#6)(1995-7#5)(1995-8#10)(1995-9#16)(1996-1#28)(1996-11#12)(1996-12#39)(1996-2#47)(1996-3#53)(1996-4#6)(1996-5#10)(1996-6#38)(1996-7#8)(1996-8#27)(1996-9#26)(1997-1#44)(1997-2#33)(1997-3#34)(1997-4#17)(1997-5#13)(1997-6#19)(1997-7#13)(1997-8#21)(2004-1#7)(2004-10#6)(2004-11#14)(2004-2#10)(2004-3#10)(2004-7#3)(2004-8#1)(2004-9#2)(2005-1#9)(2005-10#33)(2005-11#22)(2005-12#39)(2005-2#4)(2005-3#4)(2005-4#4)(2005-5#9)(2005-6#5)(2005-7#9)(2005-8#20)(2005-9#8)(2006-1#31)(2006-10#335)(2006-11#26)(2006-12#85)(2006-2#49)(2006-3#16)(2006-4#72)(2006-5#32)(2006-6#45)(2006-7#49)(2006-8#64)(2006-9#43)(2007-1#10)(2007-10#95)(2007-11#148)(2007-12#171)(2007-2#48)(2007-3#35)(2007-4#61)(2007-5#26)(2007-6#35)(2007-7#198)(2007-8#368)(2007-9#64)(2008-1#133)(2008-10#111)(2008-11#83)(2008-12#92)(2008-2#24)(2008-3#102)(2008-4#93)(2008-5#83)(2008-6#133)(2008-7#194)(2008-8#87)(2008-9#67)(2009-1#10)(2009-10#42)(2009-11#40)(2009-12#13)(2009-2#26)(2009-3#67)(2009-4#53)(2009-5#27)(2009-6#57)(2009-7#20)(2009-8#46)(2009-9#25)(2010-1#5)(2010-10#28)(2010-11#19)(2010-12#123)(2010-2#57)(2010-3#33)(2010-4#21)(2010-5#51)(2010-6#40)(2010-7#42)(2010-8#81)(2010-9#59)(2011-1#132)(2011-10#1)(2011-12#54)(2011-2#392)(2011-3#15)(2011-7#2)(2012-1#72)(2012-11#22)(2012-12#216)(2012-2#226)(2012-3#131)(2013-1#601)(2013-2#1)(2013-7#56)(2013-8#144)
patient&quot##3##1##(2006-4#2)(2008-10#1)
patient'##2##1##(1994-2#1)(1994-3#1)
patient's RBCs typed as##2##4##(1994-12#2)
patient's RBCs##5##2##(1992-3#1)(1994-12#2)(1994-9#2)
patient's adherence##3##2##(2008-3#1)(2011-1#2)
patient's age and##4##3##(1996-1#1)(2006-12#1)(2012-12#1)(2012-2#1)
patient's age at##3##3##(1991-10#1)(2007-8#1)(2013-1#1)
patient's age##25##2##(1991-10#1)(1991-4#1)(1992-2#1)(1996-1#1)(1996-6#1)(1997-8#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-8#3)(2008-10#1)(2008-6#1)(2008-7#2)(2010-12#1)(2011-11#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#1)(2013-1#1)
patient's anatomy##2##2##(2006-12#1)(2008-9#1)
patient's and##4##2##(1993-8#1)(2006-6#1)(2006-7#1)(2010-9#1)
patient's best interests##2##3##(1991-2#1)(1997-8#1)
patient's best##5##2##(1991-2#1)(1997-8#2)(2008-10#1)(2012-2#1)
patient's blood##5##2##(1992-4#1)(2007-7#1)(2008-11#1)(2012-12#1)(2013-1#1)
patient's body##3##2##(1991-6#1)(2007-12#1)(2011-2#1)
patient's care##6##2##(1997-3#1)(2006-12#1)(2010-10#1)(2011-12#1)(2013-1#2)
patient's case##2##2##(2008-11#1)(2012-12#1)
patient's cells##2##2##(1991-12#1)(1996-2#1)
patient's clinical history##2##3##(1996-9#1)(2005-9#1)
patient's clinical progress##2##3##(2008-6#1)(2008-8#1)
patient's clinical status##4##3##(2007-11#1)(2008-4#1)(2009-5#1)(2011-2#1)
patient's clinical##24##2##(1996-9#1)(2005-9#1)(2006-1#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-9#1)(2011-2#2)(2012-3#2)(2013-1#3)
patient's complaint##2##2##(2006-1#1)(2008-4#1)
patient's complaints##2##2##(1996-3#1)(2006-10#1)
patient's condition##17##2##(1990-8#1)(1991-12#1)(1991-6#1)(1994-2#1)(2005-10#1)(2006-10#1)(2007-11#3)(2007-6#1)(2008-5#1)(2008-9#2)(2010-5#1)(2012-12#1)(2013-8#2)
patient's consent##4##2##(1994-1#2)(1996-6#1)(2010-8#1)
patient's current##4##2##(2007-7#1)(2010-12#1)(2013-1#2)
patient's daily##4##2##(2006-9#1)(2007-10#1)(2008-7#1)(2009-1#1)
patient's data##4##2##(2010-8#2)(2013-1#2)
patient's death##5##2##(1993-10#1)(1993-5#1)(2008-11#2)(2013-7#1)
patient's decision to##2##3##(1990-3#1)(1997-1#1)
patient's decision##3##2##(1990-3#1)(1995-9#1)(1997-1#1)
patient's dental##3##2##(2008-5#1)(2011-1#1)(2011-2#1)
patient's diet##3##2##(1990-8#1)(2004-3#1)(2005-10#1)
patient's disease##5##2##(1994-11#1)(2007-12#1)(2010-4#1)(2012-1#1)(2013-8#1)
patient's expectations##2##2##(2007-11#1)(2007-7#1)
patient's experience##2##2##(2006-10#1)(2009-10#1)
patient's family##6##2##(1994-3#1)(1995-3#1)(1996-2#1)(2007-7#1)(2008-5#1)(2012-3#1)
patient's functional level and##2##4##(1991-1#1)(2006-6#1)
patient's functional##6##2##(1991-1#1)(2006-5#1)(2006-6#1)(2007-12#1)(2010-10#1)(2012-1#1)
patient's future##2##2##(1990-5#1)(1993-12#1)
patient's gender##4##2##(1997-6#1)(2005-10#1)(2006-10#1)(2012-2#1)
patient's general condition##3##3##(2007-11#3)
patient's general##6##2##(1994-4#1)(1996-6#1)(2007-11#3)(2012-2#1)
patient's genetic##2##2##(2006-10#1)(2007-11#1)
patient's global assessment##2##3##(2006-10#2)
patient's global##3##2##(2006-10#3)
patient's health##11##2##(1992-2#1)(1994-3#1)(1997-4#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2013-1#2)
patient's history and##3##3##(1990-6#1)(2005-11#1)(2006-10#1)
patient's history##13##2##(1990-4#1)(1990-6#1)(1997-2#1)(2005-11#1)(2006-10#2)(2006-2#1)(2007-12#1)(2008-11#1)(2008-8#1)(2013-1#2)(2013-7#1)
patient's house##2##2##(2010-2#1)(2012-1#1)
patient's illness##4##2##(1990-10#1)(1991-1#1)(1996-12#1)(2006-10#1)
patient's immune system##4##3##(2008-5#1)(2010-11#1)(2013-8#2)
patient's individual##3##2##(1994-5#1)(2007-11#1)(2008-10#1)
patient's inflammatory##2##2##(2006-10#1)(2013-7#1)
patient's knowledge about##2##3##(2008-7#1)(2011-1#1)
patient's level of##2##3##(2008-8#1)(2010-2#1)
patient's life##16##2##(1990-5#1)(1992-12#2)(1993-8#1)(2007-11#1)(2007-12#1)(2009-4#1)(2009-6#1)(2010-5#1)(2010-8#2)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
patient's management##3##2##(2006-2#1)(2007-11#1)(2012-8#1)
patient's medical and##2##3##(2008-9#1)(2013-1#1)
patient's medical condition##3##3##(2006-10#1)(2006-8#2)
patient's medical history##3##3##(2007-12#1)(2007-9#1)(2009-6#1)
patient's medical record##4##3##(2006-8#2)(2007-10#1)(2010-8#1)
patient's medical records##2##3##(2007-10#1)(2012-12#1)
patient's medical##16##2##(2006-10#1)(2006-12#1)(2006-8#4)(2007-10#2)(2007-12#1)(2007-9#1)(2008-9#1)(2009-6#1)(2010-3#1)(2010-8#1)(2012-12#1)(2013-1#1)
patient's metabolic status##2##3##(2005-9#1)(2008-4#1)
patient's mother##8##2##(1990-1#6)(1990-11#1)(1995-4#1)
patient's motor##2##2##(2011-2#1)(2012-1#1)
patient's needs##6##2##(2005-7#1)(2006-8#2)(2010-11#1)(2010-2#1)(2011-2#1)
patient's neurologic##3##2##(2006-10#1)(2007-10#1)(2009-3#1)
patient's neurological##5##2##(1996-9#1)(2006-9#1)(2007-10#1)(2008-7#1)(2013-8#1)
patient's outcome##5##2##(1995-6#1)(1995-8#1)(1995-9#1)(2009-8#1)(2012-11#1)
patient's overall##2##2##(2006-2#1)(2011-2#1)
patient's own##7##2##(1992-4#2)(1994-5#1)(2006-10#1)(2006-8#1)(2007-11#1)(2011-3#1)
patient's pain##6##2##(2006-12#1)(2006-8#1)(2007-6#1)(2008-10#1)(2008-7#1)(2013-1#1)
patient's perception##2##2##(2008-7#1)(2012-12#1)
patient's perspective##8##2##(2007-4#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-8#2)(2012-3#1)
patient's physical and mental##3##4##(1996-3#1)(2007-11#1)(2007-8#1)
patient's physical##8##2##(1992-12#1)(1996-3#1)(2007-11#3)(2007-8#2)(2011-2#1)
patient's postoperative##4##2##(2004-10#1)(2006-12#1)(2008-1#2)
patient's presentation##4##2##(2010-8#2)(2010-9#1)(2011-2#1)
patient's prognosis##5##2##(1990-3#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-1#1)
patient's qualification##2##2##(2007-11#2)
patient's quality of life and##3##5##(2008-3#1)(2008-5#1)(2013-1#1)
patient's quality of life##17##4##(1991-8#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-9#1)(2010-8#1)(2011-12#1)(2012-12#1)(2013-1#1)
patient's quality of##19##3##(1991-8#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-9#1)(2010-8#1)(2011-12#1)(2012-12#1)(2013-1#1)
patient's response to##4##3##(2004-3#1)(2008-1#1)(2010-7#2)
patient's response##5##2##(1995-2#1)(2004-3#1)(2008-1#1)(2010-7#2)
patient's right to self-determination##2##4##(1991-2#2)
patient's right to##6##3##(1991-2#2)(1992-12#1)(1993-3#1)(1996-2#1)(2005-7#1)
patient's rights##4##2##(1997-8#1)(2008-2#3)
patient's risk of##5##3##(1995-9#1)(2008-4#1)(2009-5#1)(2010-9#1)(2012-3#1)
patient's risk##8##2##(1995-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-5#1)(2010-9#2)(2012-3#1)
patient's satisfaction and##2##3##(1990-6#1)(2013-1#1)
patient's satisfaction##3##2##(1990-6#1)(2009-6#1)(2013-1#1)
patient's serum at##2##3##(1992-9#2)
patient's serum was##2##3##(1992-3#1)(2012-2#1)
patient's serum##12##2##(1992-3#2)(1992-6#1)(1992-9#2)(1993-6#1)(1994-6#3)(2005-12#1)(2006-9#1)(2012-2#1)
patient's stay##3##2##(1991-12#1)(2008-3#1)(2008-5#1)
patient's subjective##5##2##(2006-6#1)(2006-8#1)(2009-5#1)(2011-2#1)(2013-1#1)
patient's survival##2##2##(1992-8#1)(1996-11#1)
patient's symptoms improved##2##3##(2006-12#1)(2009-3#1)
patient's symptoms##18##2##(1991-6#1)(1991-9#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-3#1)(2012-2#2)(2012-3#1)(2013-1#1)
patient's treatment##3##2##(2008-9#1)(2009-11#2)
patient's unique##2##2##(1991-4#1)(1991-5#1)
patient's urine##2##2##(1990-8#1)(2008-10#1)
patient's view##4##2##(1991-1#1)(1996-12#1)(2006-12#1)(2008-8#1)
patient's weight##3##2##(2006-9#1)(2008-3#1)(2012-3#1)
patient's with##2##2##(1991-7#1)(2008-1#1)
patient's##786##1##(1990-1#11)(1990-10#4)(1990-11#5)(1990-12#2)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#3)(1990-8#4)(1991-1#3)(1991-10#2)(1991-12#5)(1991-2#4)(1991-4#3)(1991-5#1)(1991-6#6)(1991-7#2)(1991-8#1)(1991-9#3)(1992-12#7)(1992-2#3)(1992-3#6)(1992-4#3)(1992-5#1)(1992-6#3)(1992-8#3)(1992-9#4)(1993-10#2)(1993-11#3)(1993-12#4)(1993-3#3)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#1)(1994-1#2)(1994-11#2)(1994-12#5)(1994-2#2)(1994-3#3)(1994-4#3)(1994-5#2)(1994-6#5)(1994-7#1)(1994-9#2)(1995-10#1)(1995-2#2)(1995-3#2)(1995-4#2)(1995-6#1)(1995-8#1)(1995-9#4)(1996-1#1)(1996-11#2)(1996-12#5)(1996-2#4)(1996-3#5)(1996-4#1)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#3)(1997-2#2)(1997-3#3)(1997-4#2)(1997-6#2)(1997-8#4)(2004-10#1)(2004-3#4)(2005-10#4)(2005-11#2)(2005-12#3)(2005-7#4)(2005-8#1)(2005-9#2)(2006-1#3)(2006-10#26)(2006-12#15)(2006-2#7)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#8)(2006-7#3)(2006-8#13)(2006-9#6)(2007-1#2)(2007-10#11)(2007-11#32)(2007-12#15)(2007-2#3)(2007-4#1)(2007-5#4)(2007-6#6)(2007-7#13)(2007-8#14)(2007-9#5)(2008-1#8)(2008-10#14)(2008-11#9)(2008-12#9)(2008-2#3)(2008-3#7)(2008-4#12)(2008-5#13)(2008-6#6)(2008-7#19)(2008-8#6)(2008-9#13)(2009-1#3)(2009-10#3)(2009-11#2)(2009-3#5)(2009-4#3)(2009-5#6)(2009-6#9)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#7)(2010-11#3)(2010-12#5)(2010-2#5)(2010-3#3)(2010-4#1)(2010-5#6)(2010-7#4)(2010-8#14)(2010-9#7)(2011-1#11)(2011-11#1)(2011-12#5)(2011-2#27)(2011-3#1)(2012-1#10)(2012-11#2)(2012-12#16)(2012-2#17)(2012-3#14)(2012-8#1)(2013-1#44)(2013-7#6)(2013-8#11)
patient) compared to the direct application of the cTAKES module to the Vanderbilt data##2##14##(2013-1#2)
patient) in which an information need arises to provide direct access to relevant information from knowledge resources##2##17##(2013-1#2)
patient) in##3##2##(2007-7#1)(2013-1#2)
patient) of##3##2##(2007-10#1)(2007-11#1)(2012-1#1)
patient) were##3##2##(1992-5#1)(2006-6#1)(2013-1#1)
patient)##37##1##(1990-2#1)(1992-5#1)(1992-8#2)(1995-2#1)(1995-6#3)(2006-4#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-2#4)(2007-7#1)(2007-8#3)(2008-11#1)(2008-4#1)(2010-6#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#1)
patient- and##7##2##(2008-3#1)(2008-7#2)(2010-4#1)(2010-8#1)(2011-2#2)
patient-##9##1##(2008-10#1)(2008-3#1)(2008-7#2)(2010-4#1)(2010-8#1)(2011-2#3)
patient-associated##2##1##(1993-2#1)(1996-3#1)
patient-based measurement systems##3##3##(1994-3#3)
patient-based##10##1##(1993-12#2)(1993-2#1)(1994-3#4)(2008-3#1)(2010-5#1)(2011-2#1)
patient-care##4##1##(1993-12#1)(2006-6#1)(2010-5#1)(2010-8#1)
patient-centered approach##4##2##(1997-1#1)(2005-10#1)(2013-1#2)
patient-centered care##9##2##(1994-3#1)(1995-5#1)(1997-3#1)(2007-4#1)(2008-8#1)(2012-12#1)(2012-3#1)(2013-8#2)
patient-centered or bottom-line?##2##3##(1994-1#2)
patient-centered treatment interventions##2##3##(2012-2#1)(2013-8#1)
patient-centered treatment##3##2##(2012-2#2)(2013-8#1)
patient-centered##27##1##(1992-3#1)(1994-1#2)(1994-12#1)(1994-3#1)(1995-5#1)(1997-1#1)(1997-3#1)(2005-10#1)(2007-4#1)(2008-1#1)(2008-8#1)(2010-4#1)(2011-1#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#4)
patient-centeredness##2##1##(2008-8#1)(2012-2#1)
patient-centred approach##2##2##(2006-12#1)(2008-11#1)
patient-centred##5##1##(1995-3#1)(2006-12#1)(2007-3#1)(2008-11#1)(2008-7#1)
patient-controlled analgesia (PCA)##3##3##(2007-2#2)(2008-3#1)
patient-controlled analgesia##11##2##(2006-10#3)(2007-2#3)(2008-11#1)(2008-3#1)(2008-8#1)(2009-5#1)(2009-6#1)
patient-controlled epidural analgesia##4##3##(1993-4#2)(2006-10#1)(2013-7#1)
patient-controlled##23##1##(1993-4#2)(2006-10#6)(2007-11#1)(2007-2#3)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#3)(2012-3#1)(2013-7#1)
patient-days##2##1##(2007-7#2)
patient-derived##4##1##(1993-12#1)(2006-2#1)(2012-12#2)
patient-doctor##4##1##(1993-9#1)(2008-3#1)(2009-5#1)(2011-2#1)
patient-driven##2##1##(2006-1#1)(2010-12#1)
patient-focused care##10##2##(1993-12#1)(1994-1#3)(1994-12#1)(1996-1#2)(1997-2#1)(1997-3#1)(2011-1#1)
patient-focused hospital##2##2##(1992-12#2)
patient-focused##17##1##(1992-12#2)(1993-12#1)(1994-1#3)(1994-12#1)(1994-2#1)(1996-1#2)(1996-3#1)(1997-2#1)(1997-3#1)(2006-8#1)(2008-11#2)(2011-1#1)
patient-friendly drug monitoring##2##3##(2010-11#2)
patient-friendly##9##1##(1996-3#1)(1997-4#1)(2009-5#1)(2010-11#5)(2012-2#1)
patient-level data##4##2##(1993-1#1)(1995-1#1)(1995-8#2)
patient-level##7##1##(1992-2#1)(1992-3#1)(1993-1#1)(1995-1#1)(1995-8#2)(2008-3#1)
patient-months (mean##3##2##(2011-2#3)
patient-oriented research##4##2##(2005-8#1)(2007-8#2)(2010-5#1)
patient-oriented##10##1##(1990-10#1)(1991-2#1)(1992-12#1)(1997-5#1)(2005-8#1)(2007-8#2)(2010-5#1)(2010-8#1)(2012-12#1)
patient-physician communication about##2##3##(2008-10#2)
patient-physician communication##3##2##(2008-10#2)(2011-12#1)
patient-physician relationship##5##2##(1990-12#1)(1993-3#1)(1995-12#1)(1997-4#1)(2007-12#1)
patient-physician##9##1##(1990-12#1)(1993-3#1)(1995-12#1)(1997-4#1)(2007-12#1)(2008-10#2)(2010-8#1)(2011-12#1)
patient-provider relationship##2##2##(1996-12#1)(2013-1#1)
patient-provider##7##1##(1996-12#1)(2009-5#1)(2012-11#1)(2013-1#4)
patient-rated##3##1##(2008-9#1)(2009-9#1)(2012-12#1)
patient-related factors##4##2##(2011-2#2)(2013-1#2)
patient-related service time for staff##2##5##(1995-3#2)
patient-related service time for##3##4##(1995-3#3)
patient-related##15##1##(1995-3#4)(1996-3#1)(2006-2#1)(2007-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-9#1)(2011-2#2)(2013-1#2)
patient-relevant##2##1##(2007-8#1)(2011-2#1)
patient-reported outcome (PRO)##3##3##(2009-11#1)(2013-1#2)
patient-reported outcome##4##2##(2009-11#1)(2013-1#3)
patient-reported outcomes##3##2##(2008-7#1)(2009-9#1)(2010-10#1)
patient-reported overall functioning##2##3##(2012-12#2)
patient-reported pain and disability##2##4##(2008-9#2)
patient-reported##24##1##(1995-2#2)(2005-9#1)(2006-10#1)(2008-7#5)(2008-9#2)(2009-11#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#3)
patient-satisfaction scores##3##2##(2010-8#3)
patient-satisfaction##6##1##(2007-9#1)(2010-8#3)(2013-1#1)(2013-8#1)
patient-specific##32##1##(1992-3#1)(1994-3#1)(1995-12#2)(2006-10#1)(2006-12#1)(2007-11#1)(2008-12#1)(2008-5#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#7)
patient-support##2##1##(2010-12#1)(2011-2#1)
patient-to-patient variation in##2##3##(2010-10#1)(2013-1#1)
patient-ventilator##2##1##(2006-10#1)(2010-5#1)
patient-year##3##1##(2006-1#1)(2011-2#1)(2013-7#1)
patient-years##3##1##(1990-12#1)(2007-10#1)(2012-2#1)
patient/clinician##2##1##(2007-12#1)(2010-8#1)
patient/graft##2##1##(2005-10#2)
patient/resident##2##1##(1993-12#1)(1997-1#1)
patient/visitor communication needs##3##3##(2009-9#3)
patient/visitor##4##1##(2009-9#4)
patient?##4##1##(2007-8#1)(2009-7#1)(2010-8#1)(2012-3#1)
patient?]##3##1##(1991-11#1)(1993-10#1)(1993-3#1)
patient]##41##1##(1990-10#1)(1990-3#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-4#1)(1993-10#2)(1993-11#1)(1993-3#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-5#1)(1997-6#2)(2005-1#1)(2005-11#2)(2005-3#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-5#2)(2007-6#2)(2008-4#1)(2008-8#1)(2009-9#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
patiente##6##1##(2012-2#3)(2013-1#3)
patientes##2##1##(2013-1#2)
patiently##3##1##(1990-8#1)(1991-1#1)(2012-3#1)
patients &gt##5##2##(1996-12#2)(2008-6#2)(2009-4#1)
patients &lt##2##2##(2007-7#1)(2008-7#1)
patients &quot##2##2##(2008-8#1)(2011-2#1)
patients ( 6 out of##2##5##(2013-8#2)
patients (##6##2##(1990-8#1)(2006-6#1)(2007-2#1)(2013-8#3)
patients (&gt##7##2##(1995-2#1)(2004-3#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-6#1)(2012-2#1)
patients (&lt##4##2##(2007-7#2)(2008-6#1)(2013-8#1)
patients (0##10##2##(1990-2#3)(1991-7#1)(1991-9#1)(1992-10#1)(2007-7#1)(2007-9#1)(2010-12#2)
patients (1##12##2##(1990-3#1)(1991-3#1)(1991-4#1)(1992-2#1)(1995-7#1)(2005-10#1)(2006-7#1)(2007-11#2)(2007-8#1)(2008-9#1)(2012-2#1)
patients (1%)##3##2##(1996-2#1)(2006-10#1)(2007-8#1)
patients (10 male##3##3##(2007-8#1)(2008-2#1)(2012-3#1)
patients (10 men and##2##4##(2006-8#1)(2007-7#1)
patients (10 men##3##3##(2006-8#1)(2007-7#1)(2011-3#1)
patients (10##19##2##(1990-9#1)(1991-11#1)(1993-5#1)(1995-1#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-2#1)(2009-3#1)(2010-4#1)(2011-3#1)(2012-3#3)
patients (10%)##2##2##(1992-1#1)(2005-10#1)
patients (11 males and##2##4##(1992-9#1)(2007-8#1)
patients (11##8##2##(1992-9#1)(1993-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2011-2#1)(2012-12#1)
patients (11%)##3##2##(1990-12#1)(1994-6#1)(1997-6#1)
patients (12 M##2##3##(2006-2#2)
patients (12##19##2##(1992-9#1)(1993-5#1)(1994-7#1)(1996-12#1)(1997-8#1)(2005-10#1)(2006-2#2)(2006-6#1)(2006-8#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
patients (12%)##7##2##(1990-11#2)(1992-3#1)(1993-8#1)(2006-2#1)(2006-6#1)(2008-1#1)
patients (13 men and##3##4##(2007-10#1)(2011-2#1)(2013-1#1)
patients (13##18##2##(1990-12#1)(1991-11#1)(1996-6#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-7#3)(2007-9#1)(2008-10#1)(2008-7#1)(2009-3#2)(2010-3#1)(2011-2#2)(2013-1#1)
patients (13%)##8##2##(1993-2#1)(2006-10#1)(2007-10#3)(2007-8#1)(2007-9#1)(2008-9#1)
patients (135##2##2##(1996-1#1)(2007-7#1)
patients (14 men and##2##4##(1990-8#1)(2011-2#1)
patients (14##9##2##(1990-8#1)(2005-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2011-2#1)
patients (14%) had##2##3##(2011-2#1)(2013-1#1)
patients (14%)##7##2##(1990-11#1)(1995-12#1)(2008-4#1)(2008-5#1)(2011-2#2)(2013-1#1)
patients (15 men##2##3##(2007-12#1)(2007-8#1)
patients (15##11##2##(1993-11#1)(1993-5#1)(2007-12#1)(2007-3#1)(2007-8#2)(2008-4#1)(2008-8#1)(2009-3#2)(2010-4#1)
patients (15%) had##2##3##(1991-10#1)(2007-9#1)
patients (15%)##4##2##(1991-10#1)(1991-12#1)(2006-10#1)(2007-9#1)
patients (16##9##2##(1990-9#1)(1991-5#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-9#1)(2011-2#1)(2013-1#2)
patients (16%)##5##2##(1990-9#1)(1992-9#1)(2006-8#1)(2008-8#1)(2011-2#1)
patients (17##4##2##(1992-2#1)(2007-7#1)(2007-9#1)(2013-1#1)
patients (17%)##2##2##(1993-5#1)(2008-1#1)
patients (18 men and##2##4##(1991-9#1)(2008-9#1)
patients (18 men##3##3##(1991-9#1)(1995-3#1)(2008-9#1)
patients (18##14##2##(1991-9#1)(1992-9#1)(1995-3#1)(1995-9#1)(1997-7#1)(2006-6#1)(2007-1#1)(2007-11#1)(2008-4#1)(2008-7#1)(2008-9#2)(2011-2#1)(2012-3#1)
patients (18%)##6##2##(1990-9#1)(1991-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)
patients (19##4##2##(1996-6#1)(2007-2#1)(2010-3#1)(2011-1#1)
patients (19%) had##2##3##(2004-12#1)(2007-9#1)
patients (19%)##10##2##(1995-9#1)(1996-11#1)(1996-6#1)(2004-12#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-2#1)(2008-7#1)(2011-2#1)
patients (2##20##2##(1990-7#1)(1991-4#1)(1992-10#1)(1992-8#1)(1993-2#1)(1994-6#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-8#1)(2006-11#2)(2007-11#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-7#1)(2011-1#1)(2012-2#1)
patients (20 men and 10 women)##2##6##(2007-9#2)
patients (20##10##2##(1996-7#1)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#2)(2011-2#1)(2013-1#2)
patients (20%)##6##2##(1990-10#1)(1993-9#1)(2006-11#1)(2007-10#2)(2008-9#1)
patients (21 men and 4##2##5##(2007-8#1)(2008-9#1)
patients (21##8##2##(2007-11#1)(2007-8#2)(2008-4#1)(2008-9#1)(2011-2#2)(2012-2#1)
patients (21%) had##2##3##(1996-7#1)(2012-2#1)
patients (21%) were##2##3##(1991-4#1)(1993-11#1)
patients (21%)##8##2##(1991-4#1)(1993-11#1)(1995-9#1)(1996-7#1)(2006-12#1)(2006-6#1)(2007-10#1)(2012-2#1)
patients (22 males##3##3##(1990-11#1)(2006-8#1)(2008-6#1)
patients (22##8##2##(1990-11#1)(1991-3#1)(1994-3#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-6#1)(2011-2#1)
patients (22%)##5##2##(1990-11#1)(1991-10#1)(2005-12#1)(2006-8#1)(2007-9#1)
patients (23 males##2##3##(2007-11#1)(2012-2#1)
patients (23##12##2##(1991-4#1)(1991-8#1)(1994-12#1)(1997-5#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-6#1)(2012-2#1)(2013-7#1)
patients (23%) developed##2##3##(2008-6#1)(2013-1#1)
patients (23%)##5##2##(1996-6#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#1)
patients (24##3##2##(1992-5#1)(2007-8#1)(2008-9#1)
patients (24%)##4##2##(1994-7#1)(2006-10#1)(2006-11#1)(2012-2#1)
patients (25 men##2##3##(1996-12#1)(2011-2#1)
patients (25##7##2##(1990-10#1)(1992-10#1)(1996-12#1)(1997-8#1)(2008-8#1)(2008-9#1)(2011-2#1)
patients (25%) had##2##3##(2007-10#1)(2008-6#1)
patients (25%)##5##2##(2007-10#2)(2008-6#1)(2010-4#1)(2011-2#1)
patients (26##11##2##(1990-12#1)(1992-10#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#3)
patients (26%)##2##2##(1997-3#1)(2006-10#1)
patients (27##2##2##(2007-7#1)(2008-1#1)
patients (27%)##4##2##(1991-3#1)(2007-10#2)(2009-3#1)
patients (28##10##2##(1991-5#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-3#1)
patients (28%) and##2##3##(2006-12#1)(2008-4#1)
patients (28%)##5##2##(1993-1#1)(2006-12#1)(2006-8#1)(2007-3#1)(2008-4#1)
patients (29##5##2##(1990-12#1)(1990-9#1)(2006-10#1)(2010-4#1)(2012-3#1)
patients (29%)##9##2##(1991-4#1)(1991-9#1)(1993-5#1)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#2)
patients (3 males and##2##4##(1993-9#1)(2007-7#1)
patients (3##15##2##(1990-10#1)(1990-3#1)(1991-2#1)(1992-4#1)(1993-9#1)(1995-10#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
patients (30 women##2##3##(1996-6#1)(2007-8#1)
patients (30##6##2##(1996-6#1)(2005-1#1)(2007-7#1)(2007-8#1)(2010-7#1)(2013-8#1)
patients (30%)##7##2##(1990-6#1)(1996-9#2)(2007-7#1)(2008-10#1)(2008-7#1)(2011-2#1)
patients (31##5##2##(2007-7#1)(2007-8#1)(2008-7#1)(2008-8#1)(2011-12#1)
patients (31%)##6##2##(1992-3#1)(2004-11#1)(2006-6#1)(2007-8#1)(2012-3#1)(2013-1#1)
patients (32 male##2##3##(2007-8#1)(2007-9#1)
patients (32##3##2##(2007-8#1)(2007-9#1)(2011-1#1)
patients (32%)##4##2##(1993-9#1)(1996-12#1)(1997-6#1)(2008-7#1)
patients (33##10##2##(1990-3#1)(1991-8#1)(2007-3#1)(2007-8#2)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#2)
patients (33%)##5##2##(1996-8#1)(2007-8#2)(2008-12#1)(2008-7#1)
patients (34##8##2##(1990-2#1)(2007-11#2)(2008-10#1)(2008-12#2)(2008-4#1)(2008-6#1)
patients (34%)##6##2##(1991-8#1)(1992-2#1)(2004-1#1)(2008-3#1)(2008-8#1)(2013-1#1)
patients (35##7##2##(2005-10#1)(2006-12#1)(2006-6#1)(2007-2#1)(2007-7#1)(2007-8#1)(2010-4#1)
patients (35%) had##2##3##(1996-11#1)(2008-6#1)
patients (35%)##7##2##(1991-3#1)(1994-9#1)(1996-11#1)(1997-5#1)(2008-1#1)(2008-6#1)(2008-7#1)
patients (36##6##2##(1990-12#1)(1990-3#1)(1992-1#1)(1992-9#1)(2006-12#1)(2006-8#1)
patients (37##5##2##(1990-10#1)(2006-5#1)(2008-6#1)(2008-7#1)(2008-9#1)
patients (38##4##2##(2007-2#1)(2007-7#1)(2008-5#1)(2009-9#1)
patients (38%)##2##2##(1991-9#1)(2008-1#1)
patients (39 women and##2##4##(2007-10#1)(2007-7#1)
patients (39##6##2##(1995-10#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-1#1)(2010-4#1)
patients (4##17##2##(1990-3#2)(1990-8#1)(1991-11#1)(1991-2#2)(1992-4#1)(1992-8#1)(1993-1#1)(1994-7#1)(1996-3#1)(2005-1#2)(2008-7#1)(2009-3#1)(2011-1#1)(2012-3#1)
patients (40##3##2##(1992-12#1)(2007-8#1)(2009-3#1)
patients (40%)##5##2##(2007-10#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#1)
patients (41##5##2##(2007-7#2)(2007-8#1)(2008-4#1)(2008-7#1)
patients (41%)##3##2##(1990-8#1)(2008-1#1)(2011-2#1)
patients (42##5##2##(1990-11#1)(1992-2#1)(2008-8#2)(2013-1#1)
patients (42%)##5##2##(1993-10#1)(2008-10#1)(2008-4#1)(2008-6#1)(2011-2#1)
patients (43##5##2##(1990-9#1)(2007-8#1)(2008-4#1)(2010-7#1)(2011-2#1)
patients (43%)##2##2##(2008-7#2)
patients (44##6##2##(1991-5#1)(1993-5#1)(2006-2#1)(2007-7#1)(2008-1#1)(2008-7#1)
patients (44%)##9##2##(1990-8#1)(1993-8#1)(1996-11#1)(2007-8#2)(2008-1#2)(2008-6#1)(2011-2#1)
patients (45##5##2##(2005-10#1)(2006-10#1)(2007-8#1)(2012-1#1)(2013-1#1)
patients (45%)##4##2##(1995-5#1)(2007-11#1)(2007-9#1)(2008-10#1)
patients (46##6##2##(1990-2#1)(2007-7#1)(2008-1#1)(2010-4#1)(2012-3#1)(2013-1#1)
patients (46%)##2##2##(2008-1#1)(2008-9#1)
patients (47##4##2##(1995-5#1)(2006-6#1)(2007-10#1)(2008-8#1)
patients (47%)##2##2##(2007-2#1)(2008-1#1)
patients (48##3##2##(2007-10#1)(2007-7#1)(2011-2#1)
patients (48%) were##2##3##(1993-10#1)(2006-12#1)
patients (48%)##7##2##(1990-6#1)(1993-10#1)(2006-12#1)(2007-11#1)(2008-3#2)(2008-7#1)
patients (49%)##2##2##(1997-8#1)(2007-8#1)
patients (5##16##2##(1990-8#1)(1991-2#1)(1991-8#1)(1992-5#1)(1993-5#1)(1996-12#1)(1996-2#1)(1996-6#1)(2005-1#1)(2007-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
patients (5%)##5##2##(2006-10#1)(2006-7#1)(2008-7#1)(2011-2#1)(2012-3#1)
patients (50##2##2##(1991-3#1)(2007-2#1)
patients (50%)##5##2##(1991-3#1)(1996-2#1)(2008-11#1)(2008-8#1)(2011-11#1)
patients (51##4##2##(2007-8#1)(2008-1#1)(2008-6#1)(2011-1#1)
patients (51%)##2##2##(2008-1#2)
patients (52##3##2##(1992-4#1)(2007-2#1)(2012-2#1)
patients (52%)##3##2##(1993-10#1)(2008-3#1)(2011-2#1)
patients (53##2##2##(1991-3#1)(2006-3#1)
patients (54%)##2##2##(2007-10#1)(2007-7#1)
patients (55##3##2##(2007-7#1)(2007-8#1)(2011-2#1)
patients (55%) had##2##3##(1990-4#1)(2006-12#1)
patients (55%)##8##2##(1990-12#1)(1990-4#1)(1990-9#1)(1996-9#2)(2006-12#1)(2008-11#1)(2008-6#1)
patients (56##6##2##(1995-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-7#1)
patients (56%)##4##2##(2006-12#1)(2006-8#1)(2007-3#1)(2011-2#1)
patients (57##5##2##(2007-7#2)(2007-8#1)(2011-2#1)(2012-2#1)
patients (57%) were##2##3##(1995-9#1)(1996-11#1)
patients (57%)##5##2##(1995-9#1)(1996-11#1)(2006-8#1)(2008-12#1)(2008-6#1)
patients (58##6##2##(1992-9#1)(2006-10#2)(2008-8#1)(2009-6#1)(2010-4#1)
patients (58%)##2##2##(2006-10#1)(2008-4#1)
patients (59##5##2##(1997-1#1)(2007-2#1)(2007-9#1)(2010-4#1)(2012-3#1)
patients (59%)##4##2##(1990-8#1)(2007-10#1)(2007-7#1)(2007-8#1)
patients (6##15##2##(1991-8#1)(1993-5#1)(1997-1#1)(2006-11#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
patients (6%)##3##2##(1993-8#1)(2007-11#1)(2007-9#1)
patients (60##2##2##(2007-8#1)(2012-3#1)
patients (60%)##10##2##(1990-12#1)(1990-4#1)(1993-10#1)(1993-9#1)(1995-5#1)(2007-10#2)(2008-6#1)(2010-12#1)(2012-12#1)
patients (61##4##2##(2007-7#1)(2008-1#1)(2008-7#1)(2011-2#1)
patients (61%)##3##2##(1990-10#1)(1990-12#1)(2006-6#1)
patients (62##8##2##(1996-11#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-10#2)
patients (62%)##2##2##(1991-6#1)(2010-12#1)
patients (63##4##2##(1991-3#1)(2006-12#1)(2006-8#1)(2011-1#1)
patients (63%)##3##2##(1995-11#1)(2007-3#2)
patients (64##4##2##(1995-6#1)(2008-7#1)(2011-1#1)(2013-8#1)
patients (65##2##2##(2007-9#1)(2008-3#1)
patients (65%)##4##2##(1996-8#1)(1997-6#1)(2007-3#1)(2008-7#1)
patients (66##3##2##(2008-8#1)(2012-3#1)(2013-1#1)
patients (66%)##2##2##(1997-4#1)(2007-7#1)
patients (67##5##2##(1997-8#1)(2006-10#1)(2006-8#1)(2011-1#1)(2012-2#1)
patients (67%##2##2##(1990-3#1)(2004-12#1)
patients (69##3##2##(1993-5#1)(2008-7#1)(2013-8#1)
patients (7##19##2##(1990-3#1)(1994-7#1)(2005-5#2)(2006-10#3)(2006-12#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2011-1#1)(2011-2#2)(2013-1#3)
patients (7%) had##3##3##(1991-10#1)(1991-2#1)(2007-12#1)
patients (7%)##5##2##(1991-10#1)(1991-2#1)(2006-11#1)(2007-12#1)(2008-9#1)
patients (70##5##2##(2007-8#2)(2008-4#1)(2010-4#1)(2013-7#1)
patients (70%) had##2##3##(2006-10#1)(2012-2#1)
patients (70%)##8##2##(1990-3#1)(1991-2#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-6#1)(2012-2#1)(2013-1#1)
patients (71%)##4##2##(2006-2#1)(2007-11#1)(2007-2#1)(2008-5#1)
patients (72%)##2##2##(1990-10#1)(2008-7#1)
patients (73##2##2##(1996-11#1)(2013-1#1)
patients (74##4##2##(1991-8#1)(2007-2#1)(2007-7#1)(2007-8#1)
patients (75##2##2##(2005-1#1)(2007-7#1)
patients (75%)##5##2##(2006-6#1)(2008-10#1)(2011-2#2)(2012-2#1)
patients (76##3##2##(2007-7#1)(2007-8#1)(2013-1#1)
patients (76%)##4##2##(1990-12#1)(2011-2#2)(2012-2#1)
patients (77##6##2##(1997-8#1)(2006-10#1)(2007-8#1)(2008-1#1)(2010-12#1)(2010-4#1)
patients (77%)##5##2##(2006-10#1)(2008-4#1)(2008-6#2)(2011-2#1)
patients (78%) had##2##3##(2005-12#1)(2011-2#1)
patients (78%)##4##2##(2005-12#1)(2008-4#1)(2008-5#1)(2011-2#1)
patients (8 men and##2##4##(2005-1#1)(2007-10#1)
patients (8 men##4##3##(1990-2#1)(1993-8#1)(2005-1#1)(2007-10#1)
patients (8##21##2##(1990-2#1)(1993-8#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-3#1)(2005-1#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#3)(2008-10#1)(2008-7#1)(2010-12#2)(2011-2#2)(2013-8#1)
patients (8%) had##2##3##(1991-6#1)(2007-7#1)
patients (8%)##4##2##(1991-6#1)(1993-8#1)(2006-6#1)(2007-7#1)
patients (80##5##2##(1991-11#1)(2007-8#3)(2007-9#1)
patients (80%) were##2##3##(2007-8#1)(2010-10#1)
patients (80%)##4##2##(2007-8#1)(2008-1#2)(2010-10#1)
patients (81##4##2##(2005-1#1)(2006-10#1)(2007-2#1)(2007-7#1)
patients (82##3##2##(1993-1#1)(2005-10#1)(2011-2#1)
patients (82%)##5##2##(1992-2#1)(1996-11#1)(2004-12#1)(2007-7#1)(2010-5#1)
patients (83##3##2##(2006-12#1)(2007-9#1)(2008-6#1)
patients (83%)##3##2##(2006-6#2)(2008-8#1)
patients (84##3##2##(1991-2#1)(2007-7#1)(2013-1#1)
patients (84%)##3##2##(1991-3#1)(2010-12#1)(2012-3#1)
patients (85##2##2##(2006-8#1)(2008-5#1)
patients (85%)##2##2##(2008-1#1)(2012-2#1)
patients (86##4##2##(1997-3#1)(2008-8#1)(2009-3#1)(2012-12#1)
patients (87##7##2##(2006-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-11#1)(2012-2#1)(2013-1#1)
patients (87%)##2##2##(1991-3#1)(2007-10#1)
patients (88##2##2##(2007-8#1)(2008-4#1)
patients (88%) had##2##3##(2007-10#1)(2007-7#1)
patients (88%)##4##2##(1992-5#1)(2007-10#1)(2007-7#1)(2008-7#1)
patients (89##3##2##(2005-5#1)(2007-11#1)(2012-12#1)
patients (9 women##2##3##(1992-5#1)(2007-11#1)
patients (9##15##2##(1992-5#1)(1997-8#1)(2005-1#1)(2007-11#1)(2007-7#2)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#4)(2013-1#2)
patients (9%) had##3##3##(2006-10#1)(2008-10#1)(2011-2#1)
patients (9%)##7##2##(2006-10#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2010-12#1)(2011-2#1)
patients (90%) were##2##3##(2007-8#1)(2012-2#1)
patients (90%)##4##2##(1992-1#1)(2005-10#1)(2007-8#1)(2012-2#1)
patients (91##4##2##(2006-12#1)(2007-9#1)(2008-10#1)(2011-2#1)
patients (91%)##2##2##(2007-8#1)(2007-9#1)
patients (92##2##2##(1997-7#1)(2012-2#1)
patients (92%)##2##2##(2011-2#2)
patients (93##2##2##(1991-8#1)(2007-8#1)
patients (94##3##2##(1992-4#1)(2006-2#1)(2007-8#1)
patients (95%)##5##2##(1992-1#1)(2007-8#1)(2008-1#1)(2008-6#1)(2013-1#1)
patients (96##2##2##(2012-2#1)(2012-3#1)
patients (96%)##3##2##(1991-1#1)(1993-10#1)(2008-1#1)
patients (97##2##2##(2006-11#1)(2006-12#1)
patients (97%)##2##2##(1991-4#1)(2011-2#1)
patients (98##2##2##(1991-8#1)(2007-7#1)
patients (98%)##2##2##(2005-12#1)(2006-10#1)
patients (Group 1)##2##3##(2007-8#1)(2012-2#1)
patients (Group 2)##2##3##(2007-8#1)(2012-2#1)
patients (Group 3)##2##3##(2007-8#1)(2012-2#1)
patients (Group A)##2##3##(1992-10#1)(2007-9#1)
patients (Group##11##2##(1992-10#2)(2007-8#3)(2007-9#1)(2012-12#1)(2012-2#4)
patients (MGMT##2##2##(2006-12#2)
patients (N =##3##3##(1994-2#1)(2011-2#2)
patients (OR =##2##3##(2010-2#1)(2012-1#1)
patients (OR##3##2##(2007-8#1)(2010-2#1)(2012-1#1)
patients (P &lt##6##3##(1995-4#1)(1996-11#1)(1997-8#1)(2007-7#1)(2007-8#2)
patients (P = 0##4##4##(2006-12#1)(2008-8#1)(2011-1#1)(2013-1#1)
patients (P =##5##3##(2006-12#1)(2007-10#1)(2008-8#1)(2011-1#1)(2013-1#1)
patients (P##11##2##(1995-4#1)(1996-11#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-8#1)(2011-1#1)(2013-1#1)
patients (P&lt##5##2##(1995-10#1)(2004-2#1)(2007-2#1)(2008-1#1)(2011-2#1)
patients (P=0##4##2##(2007-2#1)(2007-8#3)
patients (a##4##2##(1997-3#1)(1997-6#1)(2007-7#1)(2013-8#1)
patients (age 0##2##3##(2011-2#2)
patients (age range##3##3##(2004-3#1)(2007-10#1)(2012-12#1)
patients (age##20##2##(1990-10#1)(1992-8#1)(1993-12#1)(1993-5#1)(1996-8#1)(1997-8#1)(2004-3#1)(2007-10#1)(2007-7#1)(2008-5#1)(2009-9#1)(2011-12#1)(2011-2#4)(2012-12#2)(2012-3#1)(2013-8#1)
patients (aged##5##2##(2005-6#1)(2007-11#1)(2008-3#1)(2012-11#1)(2013-1#1)
patients (ages##2##2##(2006-10#1)(2011-2#1)
patients (all##5##2##(1991-2#1)(1995-6#1)(1997-8#1)(2006-9#1)(2007-9#1)
patients (average age##6##3##(2007-8#2)(2008-4#1)(2008-6#1)(2008-7#1)(2013-1#1)
patients (average##10##2##(2007-8#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2013-1#1)
patients (five##3##2##(2004-1#1)(2007-8#1)(2008-6#1)
patients (four##3##2##(2006-11#1)(2008-1#1)(2011-2#1)
patients (group 1)##2##3##(1991-3#1)(2009-10#1)
patients (group A)##2##3##(1996-6#1)(2008-3#1)
patients (group##9##2##(1991-3#1)(1996-6#1)(2007-9#1)(2008-1#2)(2008-3#1)(2009-10#1)(2009-9#1)(2011-1#1)
patients (i##2##2##(2008-7#1)(2009-10#1)
patients (in##3##2##(1991-6#1)(2008-11#1)(2010-4#1)
patients (including##3##2##(2007-9#1)(2008-3#2)
patients (male/female##2##2##(2011-1#1)(2011-2#1)
patients (mean age##28##3##(1990-5#1)(1991-5#1)(1995-11#1)(2004-1#2)(2005-9#2)(2006-12#1)(2006-8#1)(2007-10#2)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-3#1)(2010-9#1)(2011-2#3)(2013-1#1)
patients (mean##32##2##(1990-5#1)(1991-5#1)(1995-11#1)(1997-1#1)(2004-1#2)(2005-9#2)(2006-12#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-3#1)(2010-9#1)(2011-2#3)(2013-1#1)
patients (median age##2##3##(1995-9#1)(2011-2#1)
patients (median##6##2##(1992-12#1)(1995-9#1)(2007-8#1)(2007-9#1)(2011-2#1)(2013-7#1)
patients (n = 18)##3##4##(2007-10#1)(2013-1#2)
patients (n = 27)##3##4##(1996-7#1)(2013-1#2)
patients (n =##35##3##(1990-2#1)(1990-6#1)(1991-2#1)(1992-11#1)(1993-12#1)(1993-8#1)(1994-1#1)(1996-7#4)(1996-8#1)(2006-7#1)(2007-10#3)(2007-8#1)(2008-1#1)(2008-3#1)(2008-6#3)(2008-7#2)(2010-4#1)(2012-3#3)(2013-1#6)(2013-8#1)
patients (nine##4##2##(1994-3#1)(2006-11#1)(2007-8#2)
patients (one##3##2##(1995-5#1)(2008-6#1)(2011-2#1)
patients (p &gt##2##3##(2004-3#1)(2011-2#1)
patients (p &lt##7##3##(1993-11#1)(1994-6#1)(2008-11#1)(2008-8#1)(2010-4#1)(2011-1#2)
patients (p = 0##4##4##(1993-1#1)(2011-11#1)(2011-2#1)(2012-2#1)
patients (p less than 0##2##5##(1991-5#1)(1991-9#1)
patients (p##17##2##(1991-5#1)(1991-8#1)(1991-9#1)(1993-1#1)(1993-11#1)(1994-6#1)(2004-3#1)(2008-11#1)(2008-8#1)(2010-4#1)(2011-1#2)(2011-11#1)(2011-2#2)(2012-2#1)(2013-1#1)
patients (p=0##4##2##(2007-8#1)(2008-10#1)(2011-11#2)
patients (pts) with##3##3##(1996-3#1)(2006-6#1)(2010-12#1)
patients (pts)##5##2##(1996-3#1)(2006-6#1)(2007-7#1)(2010-12#1)(2010-3#1)
patients (r = 0##2##4##(1996-12#1)(2008-8#1)
patients (r =##3##3##(1992-9#1)(1996-12#1)(2008-8#1)
patients (range of 1##2##4##(2008-1#2)
patients (range##7##2##(1990-6#1)(1991-8#1)(2008-1#2)(2008-8#1)(2009-8#2)
patients (six##3##2##(1991-8#1)(2008-6#1)(2012-2#1)
patients (the##4##2##(1997-7#1)(2007-11#1)(2008-7#1)(2011-2#1)
patients (three##4##2##(1990-11#1)(2007-7#1)(2009-5#1)(2010-3#1)
patients (up to##2##3##(1991-3#1)(2006-10#1)
patients -##10##2##(1990-1#1)(2007-7#1)(2007-8#3)(2008-7#1)(2008-9#1)(2009-9#1)(2011-2#1)(2013-8#1)
patients 1 and 2##2##4##(1995-2#2)
patients 1##3##2##(1995-2#2)(2007-11#1)
patients 17 years of age or##2##6##(1993-12#1)(2006-12#1)
patients 17##3##2##(1993-12#1)(2006-12#1)(2011-2#1)
patients 18 years##2##3##(2009-4#1)(2009-8#1)
patients 18##3##2##(2009-4#1)(2009-8#1)(2013-1#1)
patients 3##3##2##(1995-9#1)(2013-1#2)
patients 65 years##2##3##(2006-12#1)(2013-1#1)
patients 83%##2##2##(1991-3#1)(2006-10#1)
patients a##22##2##(1990-2#1)(1992-1#1)(1992-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(2006-12#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-6#3)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
patients about the##9##3##(1990-4#1)(1992-5#1)(1993-7#1)(1997-8#1)(2007-5#1)(2007-7#1)(2008-8#1)(2009-12#1)(2011-1#1)
patients about their##4##3##(1992-12#1)(1995-12#1)(2007-2#1)(2013-8#1)
patients about##19##2##(1990-3#1)(1990-4#1)(1992-12#1)(1992-5#1)(1993-7#1)(1995-12#1)(1997-8#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-8#2)(2009-12#1)(2010-7#1)(2011-1#1)(2012-11#1)(2013-8#1)
patients above 35 years of age##2##6##(2012-3#2)
patients above##7##2##(1997-8#1)(2006-6#1)(2007-7#1)(2008-1#1)(2008-12#1)(2012-3#2)
patients accepted##2##2##(1991-7#1)(2007-8#1)
patients according to actuarial##2##4##(2011-2#2)
patients according to their##2##4##(2008-10#1)(2008-3#1)
patients according to##14##3##(1994-9#1)(1995-2#1)(1997-3#1)(1997-8#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-8#1)(2011-2#2)(2012-2#1)
patients achieve##7##2##(2006-10#1)(2008-3#1)(2008-5#1)(2009-6#1)(2011-12#1)(2011-2#1)(2013-8#1)
patients achieved CR##2##3##(1991-4#1)(2008-10#1)
patients achieved a##3##3##(1997-6#1)(2008-5#1)(2012-3#1)
patients achieved an##2##3##(1993-2#1)(2006-12#1)
patients achieved complete remission##2##4##(2007-3#1)(2011-2#1)
patients achieved complete##4##3##(2007-3#1)(2009-12#1)(2011-2#1)(2012-12#1)
patients achieved the target reduction##2##5##(2008-3#2)
patients achieved the##3##3##(2008-3#2)(2008-8#1)
patients achieved##24##2##(1991-4#1)(1992-3#1)(1992-4#1)(1993-2#1)(1997-6#1)(2006-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#2)(2009-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
patients achieving##9##2##(2006-12#1)(2007-3#1)(2008-3#1)(2008-8#1)(2010-8#2)(2012-2#2)(2013-1#1)
patients across##2##2##(2009-12#1)(2011-2#1)
patients actually##3##2##(1991-12#1)(1993-12#1)(2006-9#1)
patients administered##3##2##(2007-11#1)(2009-4#1)(2010-11#1)
patients admitted at Mathari##2##4##(2009-7#2)
patients admitted at##5##3##(1995-9#2)(2007-10#1)(2009-7#2)
patients admitted during the##2##4##(2006-10#1)(2007-9#1)
patients admitted during##4##3##(1994-2#1)(2004-12#1)(2006-10#1)(2007-9#1)
patients admitted for a##2##4##(1991-5#1)(2012-2#1)
patients admitted for acute##2##4##(1997-7#1)(2006-6#1)
patients admitted for##9##3##(1990-3#1)(1991-5#1)(1993-10#1)(1997-7#1)(2006-6#1)(2006-7#1)(2007-7#1)(2008-3#1)(2012-2#1)
patients admitted from##2##3##(1990-6#1)(2008-3#1)
patients admitted in the##3##4##(2007-10#1)(2007-2#1)(2008-3#1)
patients admitted in##10##3##(1994-3#1)(1997-8#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-3#1)(2010-4#1)(2012-11#1)(2012-3#1)
patients admitted to LSP##2##4##(2006-8#2)
patients admitted to SHR##2##4##(2006-8#2)
patients admitted to a##8##4##(1991-8#1)(1992-6#1)(1994-8#1)(1995-9#1)(2006-2#1)(2007-10#2)(2008-3#1)
patients admitted to hospital##7##4##(1990-9#1)(1992-3#1)(1993-10#1)(2006-6#1)(2007-7#1)(2012-12#1)(2013-8#1)
patients admitted to intensive care units##2##6##(2007-12#1)(2013-7#1)
patients admitted to our medical service##2##6##(2008-3#2)
patients admitted to our medical##3##5##(2005-1#1)(2008-3#2)
patients admitted to our##8##4##(1993-8#1)(2005-1#1)(2007-10#2)(2008-3#2)(2008-5#1)(2012-2#1)
patients admitted to the emergency department##4##6##(2011-2#2)(2013-1#2)
patients admitted to the emergency##5##5##(1991-2#1)(2011-2#2)(2013-1#2)
patients admitted to the hospital for##2##6##(2005-6#1)(2013-1#1)
patients admitted to the hospital##5##5##(2005-6#1)(2007-10#1)(2013-1#3)
patients admitted to the##20##4##(1990-3#1)(1991-2#1)(1991-5#1)(1992-3#1)(1997-4#1)(2005-6#1)(2006-2#2)(2007-10#2)(2007-9#1)(2009-10#1)(2011-2#2)(2012-3#1)(2013-1#5)
patients admitted to##71##3##(1990-10#1)(1990-3#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-10#1)(1993-8#1)(1994-8#1)(1995-9#2)(1997-4#1)(1997-8#2)(2005-1#1)(2005-6#1)(2005-8#1)(2006-2#3)(2006-6#1)(2006-8#5)(2007-10#7)(2007-11#1)(2007-12#1)(2007-7#2)(2007-9#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-10#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#3)
patients admitted with acute##7##4##(1990-3#2)(1997-3#1)(2007-10#1)(2008-3#3)
patients admitted with##15##3##(1990-3#2)(1993-9#1)(1995-9#1)(1997-3#1)(2006-8#1)(2007-10#3)(2007-9#1)(2008-3#3)(2008-7#1)(2011-1#1)
patients admitted##123##2##(1990-10#1)(1990-3#4)(1990-6#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-10#2)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-9#5)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#3)(2004-12#1)(2005-1#1)(2005-6#1)(2005-8#1)(2006-10#2)(2006-2#3)(2006-6#2)(2006-7#1)(2006-8#6)(2007-10#14)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#4)(2007-8#1)(2007-9#3)(2008-12#1)(2008-3#9)(2008-5#1)(2008-7#2)(2009-10#2)(2009-7#2)(2010-4#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#3)
patients affected by diabetes##2##4##(2008-1#1)(2013-1#1)
patients affected by diabetic nephropathy##2##5##(2008-1#2)
patients affected by insulin-dependent##2##4##(2013-1#2)
patients affected by malignancy of the gastrointestinal tract##2##8##(2006-2#2)
patients affected by metastatic##2##4##(1991-6#1)(2006-6#1)
patients affected by osteoarthritis##2##4##(2013-1#2)
patients affected by systemic##2##4##(1991-5#1)(1993-3#1)
patients affected by this##2##4##(1990-10#1)(2012-2#1)
patients affected by##77##3##(1990-10#3)(1990-4#1)(1990-5#1)(1990-6#3)(1990-8#2)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#2)(1991-9#1)(1992-10#1)(1992-7#1)(1993-3#2)(1994-9#1)(1995-12#1)(1996-3#1)(2006-2#6)(2006-6#9)(2007-7#1)(2008-1#5)(2008-10#2)(2008-5#4)(2008-6#1)(2008-7#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#10)
patients affected with##10##3##(1990-11#1)(1992-2#1)(1993-6#1)(1993-8#1)(1996-3#1)(2006-10#1)(2006-2#1)(2006-6#1)(2008-5#1)(2011-3#1)
patients affected##90##2##(1990-10#3)(1990-11#1)(1990-4#1)(1990-5#1)(1990-6#3)(1990-8#2)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#2)(1991-9#1)(1992-10#1)(1992-2#1)(1992-7#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-9#1)(1995-12#1)(1996-3#2)(2006-10#1)(2006-2#7)(2006-6#12)(2007-7#1)(2008-1#5)(2008-10#2)(2008-5#5)(2008-6#1)(2008-7#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#3)(2012-2#1)(2013-1#10)
patients after 10##3##3##(1997-8#1)(2005-8#1)(2007-11#1)
patients after MI##2##3##(1990-7#1)(2005-12#1)
patients after a##9##3##(1991-10#1)(1993-12#2)(2006-10#2)(2006-12#1)(2011-1#1)(2011-12#1)(2012-1#1)
patients after an average##2##4##(1993-8#1)(2009-2#1)
patients after an##3##3##(1991-11#1)(1993-8#1)(2009-2#1)
patients after cardiac surgery##5##4##(2006-4#1)(2007-9#2)(2012-3#2)
patients after cardiac##7##3##(2006-4#1)(2007-9#2)(2008-9#1)(2012-2#1)(2012-3#2)
patients after coronary##4##3##(1997-4#1)(2008-5#1)(2011-2#2)
patients after informed consent##2##4##(2006-8#1)(2012-3#1)
patients after major##4##3##(1996-1#1)(2009-6#2)(2012-2#1)
patients after more##2##3##(2006-10#1)(2007-11#1)
patients after myocardial infarction##3##4##(1990-7#2)(1996-4#1)
patients after one##2##3##(2008-5#2)
patients after prolonged##2##3##(2006-10#1)(2009-2#1)
patients after resection##3##3##(2007-11#1)(2008-6#1)(2009-2#1)
patients after termination of##2##4##(2008-1#1)(2012-12#1)
patients after the##6##3##(1997-8#1)(2004-3#1)(2006-6#1)(2008-10#1)(2008-12#1)(2008-4#1)
patients after therapy##2##3##(2007-2#1)(2008-8#1)
patients after total hip replacement##3##5##(2007-7#1)(2010-10#1)(2013-1#1)
patients after total##4##3##(2007-7#1)(2007-8#1)(2010-10#1)(2013-1#1)
patients after treatment with##2##4##(2007-11#1)(2008-7#1)
patients after treatment##4##3##(2007-10#1)(2007-11#1)(2008-7#1)(2009-3#1)
patients after##151##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-7#3)(1991-10#1)(1991-11#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-12#2)(1993-2#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#3)(1994-2#1)(1995-4#1)(1996-1#1)(1996-4#1)(1996-5#1)(1997-4#1)(1997-8#2)(2004-3#1)(2005-12#1)(2005-8#3)(2006-10#9)(2006-12#3)(2006-4#1)(2006-6#1)(2006-8#5)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#12)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#7)(2007-8#8)(2007-9#3)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#3)(2009-3#1)(2009-6#3)(2010-10#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#4)
patients against##4##2##(1993-9#1)(1996-9#1)(2007-2#1)(2010-12#1)
patients age 30 years and older##2##5##(2012-2#2)
patients age##4##2##(2007-11#1)(2011-2#1)(2012-2#2)
patients aged &gt##2##3##(2011-2#1)(2012-2#1)
patients aged 16 to##2##4##(1992-5#1)(2013-1#1)
patients aged 25##2##3##(1993-3#1)(2013-1#1)
patients aged 30##2##3##(2006-6#1)(2012-2#1)
patients aged 35 to##2##4##(1994-6#1)(2007-9#1)
patients aged 40 years and below##2##6##(2011-11#2)
patients aged 40##3##3##(2006-12#1)(2011-11#2)
patients aged 65 years and##2##5##(1994-2#1)(2011-1#1)
patients aged 65 years##3##4##(1994-2#1)(1997-6#1)(2011-1#1)
patients aged 65##4##3##(1994-2#1)(1994-6#1)(1997-6#1)(2011-1#1)
patients aged 85 years##2##4##(2007-10#1)(2008-7#1)
patients aged between##2##3##(2007-7#1)(2007-8#1)
patients aged from##2##3##(2007-8#1)(2011-2#1)
patients aged over 65##3##4##(1992-10#1)(1992-9#1)(2013-8#1)
patients aged over##6##3##(1990-6#1)(1991-8#1)(1992-10#1)(1992-9#1)(2008-10#1)(2013-8#1)
patients aged under##2##3##(1991-4#1)(1992-8#1)
patients aged##67##2##(1990-6#1)(1991-4#1)(1991-8#1)(1992-10#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-3#1)(1994-2#1)(1994-6#2)(1995-9#1)(1996-11#1)(1996-8#1)(1997-6#1)(2005-4#2)(2006-12#1)(2006-6#1)(2007-10#1)(2007-12#2)(2007-7#2)(2007-8#4)(2007-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-2#1)(2010-10#1)(2010-7#1)(2011-1#3)(2011-11#2)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#13)(2013-8#4)
patients alive##3##2##(1991-12#1)(2007-12#1)(2007-7#1)
patients all##6##2##(1993-5#1)(2006-10#1)(2008-4#1)(2008-7#1)(2011-12#1)(2012-2#1)
patients allocated endovascular##2##3##(2007-10#2)
patients allows for##2##3##(2006-10#1)(2007-11#1)
patients allows##3##2##(2006-10#1)(2007-11#1)(2011-2#1)
patients alone##3##2##(1996-1#1)(2007-7#1)(2007-8#1)
patients already##5##2##(2007-7#1)(2007-9#1)(2008-1#1)(2008-6#1)(2008-8#1)
patients also had##6##3##(1993-2#1)(1995-9#1)(2007-7#1)(2007-8#1)(2008-7#1)(2009-1#1)
patients also have##6##3##(2005-10#1)(2011-1#1)(2013-8#4)
patients also increased##2##3##(2006-6#1)(2013-8#1)
patients also received multi-agent##2##4##(2008-6#2)
patients also received##4##3##(2007-6#1)(2008-6#3)
patients also suffered from##2##4##(1990-3#1)(2010-5#1)
patients also##34##2##(1990-3#1)(1991-3#1)(1992-6#1)(1993-2#1)(1995-12#1)(1995-9#1)(1996-1#1)(2005-10#1)(2006-6#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-6#3)(2008-7#1)(2008-9#1)(2009-1#1)(2009-2#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#5)
patients among the##2##3##(1993-11#1)(2007-8#1)
patients among##8##2##(1992-4#1)(1993-11#1)(1994-7#1)(2005-10#1)(2006-6#2)(2007-8#1)(2011-2#1)
patients an average of##2##4##(1992-1#1)(2007-11#1)
patients an##8##2##(1990-7#1)(1992-1#1)(1992-8#1)(1995-1#1)(1996-3#1)(2004-10#1)(2007-11#1)(2010-12#1)
patients analyzed##2##2##(1996-12#1)(2010-3#1)
patients and 0##2##3##(1994-7#1)(2011-2#1)
patients and 1##2##3##(1996-2#1)(2007-8#1)
patients and 12##2##3##(1995-12#1)(1997-1#1)
patients and 13##2##3##(1995-5#1)(2009-6#1)
patients and 15##3##3##(1997-4#1)(2006-8#1)(2009-1#1)
patients and 18##2##3##(2008-8#1)(2011-1#1)
patients and 20 healthy##2##4##(2008-11#2)
patients and 20##4##3##(1993-6#1)(2007-3#1)(2008-11#2)
patients and 20%##2##3##(1992-6#1)(2007-7#1)
patients and 23##4##3##(1996-1#1)(2008-11#1)(2008-6#1)(2011-2#1)
patients and 27##2##3##(2008-1#1)(2008-4#1)
patients and 29##2##3##(1996-5#1)(1997-2#1)
patients and 3##3##3##(1991-9#1)(1993-7#1)(2011-2#1)
patients and 30##6##3##(1992-10#1)(1996-3#1)(2004-10#1)(2008-5#1)(2012-3#1)(2013-1#1)
patients and 32##3##3##(1996-7#1)(2008-1#1)(2008-4#1)
patients and 33%##2##3##(2006-2#1)(2006-8#1)
patients and 40##2##3##(2007-8#1)(2012-3#1)
patients and 42%##2##3##(2007-11#1)(2013-1#1)
patients and 5##2##3##(2009-10#1)(2010-12#1)
patients and 50##3##3##(2007-7#1)(2008-3#1)(2013-8#1)
patients and 54##2##3##(1997-5#1)(2009-3#1)
patients and 7##2##3##(1995-5#2)
patients and 77%##2##3##(1992-9#1)(2012-12#1)
patients and 92##2##3##(1997-6#1)(2005-4#1)
patients and HIV-infected##2##3##(2005-11#1)(2006-6#1)
patients and a##13##3##(1990-4#1)(1990-9#1)(1991-2#1)(1995-1#1)(1997-6#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2010-4#1)(2011-1#1)(2011-2#1)
patients and all##2##3##(2007-7#1)(2008-1#1)
patients and also in##2##4##(1991-5#1)(2005-10#1)
patients and also##8##3##(1991-5#1)(1992-2#1)(1996-8#1)(2005-10#1)(2008-11#1)(2010-10#1)(2011-2#1)(2012-2#1)
patients and an##5##3##(1990-11#1)(1993-8#1)(2007-8#1)(2012-12#1)(2013-1#1)
patients and appeared##2##3##(2005-7#1)(2007-11#1)
patients and associated##2##3##(2005-10#1)(2005-11#1)
patients and at##2##3##(2008-5#1)(2010-12#1)
patients and because##2##3##(2006-10#1)(2008-10#1)
patients and by##5##3##(1992-5#1)(1995-8#1)(2007-8#1)(2012-1#2)
patients and can be##2##4##(2010-12#1)(2010-5#1)
patients and can##5##3##(2007-7#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#1)
patients and care##2##3##(2010-5#1)(2013-8#1)
patients and caregivers##4##3##(2005-7#1)(2008-3#1)(2011-2#1)(2012-3#1)
patients and cause##2##3##(2008-8#1)(2012-12#1)
patients and clinicians##3##3##(2007-12#1)(2008-3#1)(2009-5#1)
patients and community##3##3##(1996-8#1)(1997-3#1)(2008-8#1)
patients and compared##2##3##(1993-11#1)(2008-11#1)
patients and conducted##2##3##(1993-2#1)(2009-10#1)
patients and consisted of##2##4##(1991-3#1)(2008-7#1)
patients and control subjects##6##4##(1995-5#2)(1996-7#2)(1996-9#1)(2009-6#1)
patients and control##9##3##(1995-5#2)(1996-7#2)(1996-9#1)(2006-10#1)(2009-6#1)(2012-1#1)(2013-1#1)
patients and controls were##3##4##(1996-8#1)(1997-5#1)(2008-1#1)
patients and controls with##2##4##(2008-8#1)(2013-1#1)
patients and controls##39##3##(1990-1#1)(1990-11#1)(1991-5#1)(1992-11#1)(1993-11#1)(1994-8#1)(1995-12#1)(1996-8#1)(1997-2#2)(1997-5#3)(1997-8#3)(2006-10#2)(2007-2#1)(2007-9#1)(2008-1#2)(2008-12#1)(2008-7#2)(2008-8#4)(2011-1#1)(2012-3#1)(2013-1#6)(2013-8#2)
patients and decreased##2##3##(1997-8#1)(2008-7#1)
patients and delayed##2##3##(1992-5#1)(2008-5#1)
patients and design##2##3##(2006-12#1)(2012-2#1)
patients and distant##2##3##(2008-10#1)(2011-2#1)
patients and doctors##3##3##(2007-2#1)(2008-3#1)(2011-2#1)
patients and elderly##2##3##(2008-7#1)(2013-1#1)
patients and even##2##3##(1992-12#1)(2007-7#1)
patients and examines##2##3##(2010-2#1)(2012-2#1)
patients and families about##2##4##(2007-10#1)(2007-12#1)
patients and families##12##3##(1990-12#1)(1991-2#1)(1994-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-4#1)(2010-7#1)(2010-8#1)
patients and family members##5##4##(1991-5#1)(1992-12#1)(1993-1#1)(2005-7#1)(2008-6#1)
patients and family##7##3##(1991-5#1)(1992-12#1)(1993-1#1)(1997-8#1)(2005-7#1)(2007-8#1)(2008-6#1)
patients and find##2##3##(1994-12#1)(2008-8#1)
patients and five##2##3##(1991-5#1)(2008-6#1)
patients and for##3##3##(1992-4#1)(1993-2#1)(1993-7#1)
patients and found no##2##4##(1995-3#1)(2005-9#1)
patients and from##2##3##(2008-5#2)
patients and good##2##3##(1992-2#1)(2007-10#1)
patients and grade III##2##4##(2005-5#1)(2008-1#1)
patients and grade##3##3##(2005-5#1)(2007-7#1)(2008-1#1)
patients and has##5##3##(1995-3#1)(2006-10#1)(2008-1#1)(2011-2#1)(2013-1#1)
patients and health care professionals##2##5##(2008-7#1)(2010-8#1)
patients and health care providers##2##5##(2007-12#1)(2007-7#1)
patients and health care##5##4##(2007-12#1)(2007-7#1)(2008-7#1)(2010-8#1)(2012-1#1)
patients and health professionals##2##4##(2012-11#1)(2013-8#1)
patients and health##10##3##(1992-4#1)(1994-4#1)(2007-12#1)(2007-7#1)(2008-7#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-11#1)(2013-8#1)
patients and healthcare##2##3##(2009-6#1)(2012-3#1)
patients and healthy controls##5##4##(1996-11#1)(2007-2#1)(2008-7#1)(2011-2#2)
patients and healthy individuals##4##4##(2011-11#1)(2011-2#1)(2012-2#2)
patients and healthy subjects##5##4##(1994-1#1)(2008-12#2)(2008-7#1)(2011-2#1)
patients and healthy volunteers##2##4##(1996-7#1)(2008-5#1)
patients and healthy##24##3##(1994-1#1)(1996-11#1)(1996-7#1)(2005-4#1)(2006-3#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-12#3)(2008-5#2)(2008-7#2)(2010-6#1)(2011-11#1)(2011-2#4)(2012-2#3)
patients and hospital##2##3##(1994-3#1)(2008-8#1)
patients and how##3##3##(1992-12#1)(2008-11#1)(2012-1#1)
patients and identify##4##3##(2012-1#1)(2012-12#1)(2012-3#1)(2012-4#1)
patients and improving##2##3##(2008-6#1)(2010-8#1)
patients and in 15##2##4##(2008-10#1)(2013-1#1)
patients and in 25##2##4##(2008-7#1)(2011-2#1)
patients and in a##2##4##(1996-1#1)(2012-12#1)
patients and in the##3##4##(1992-10#1)(1992-5#1)(2008-8#1)
patients and in##45##3##(1990-2#1)(1991-7#1)(1992-10#1)(1992-5#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-2#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-1#1)(2007-11#2)(2007-7#3)(2007-8#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#3)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
patients and is a##2##4##(2011-1#1)(2012-11#1)
patients and is characterized by##2##5##(2004-3#1)(2007-8#1)
patients and is##11##3##(1991-12#1)(1994-8#1)(2004-3#1)(2006-10#1)(2007-8#2)(2009-10#1)(2010-9#1)(2011-1#1)(2012-11#1)(2012-12#1)
patients and it##2##3##(2007-9#1)(2009-10#1)
patients and its##11##3##(1991-6#1)(1996-9#1)(2008-1#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-8#2)
patients and led to##2##4##(2006-10#1)(2007-7#1)
patients and less than##2##4##(1991-2#1)(2008-8#1)
patients and matched controls##2##4##(1997-5#1)(2013-1#1)
patients and matched##3##3##(1997-5#1)(2006-3#1)(2013-1#1)
patients and may be##5##4##(1990-11#1)(2004-2#1)(2006-10#1)(2008-1#1)(2008-7#1)
patients and may##9##3##(1990-11#1)(1991-12#1)(2004-2#1)(2006-10#1)(2007-7#1)(2008-1#2)(2008-7#1)(2010-10#1)
patients and might be##2##4##(2008-7#1)(2011-1#1)
patients and might##3##3##(1996-4#1)(2008-7#1)(2011-1#1)
patients and must be##2##4##(1997-3#1)(2010-12#1)
patients and no##4##3##(1996-8#1)(2008-9#1)(2009-2#1)(2011-2#1)
patients and nonobese patients##2##4##(2006-6#1)(2006-8#1)
patients and normal controls##5##4##(1997-8#1)(2007-2#1)(2008-7#1)(2008-8#1)(2009-1#1)
patients and normal in##2##4##(2008-7#2)
patients and normal##14##3##(1993-9#1)(1995-5#2)(1996-7#2)(1997-8#1)(2007-10#1)(2007-2#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-1#1)
patients and nurses##4##3##(2009-12#2)(2010-10#1)(2010-3#1)
patients and of##2##3##(1996-3#1)(2006-10#1)
patients and on##3##3##(1993-6#1)(2007-7#1)(2012-12#1)
patients and one##3##3##(2008-1#1)(2008-10#1)(2013-8#1)
patients and only##3##3##(1990-6#1)(1994-2#1)(2006-12#1)
patients and others##2##3##(1995-3#1)(1996-11#1)
patients and parents##2##3##(1994-2#1)(2007-2#1)
patients and patient##2##3##(2007-8#1)(2008-12#1)
patients and patients with##6##4##(1992-10#1)(1993-8#1)(2009-10#1)(2011-2#3)
patients and patients##10##3##(1990-11#1)(1992-10#1)(1993-8#1)(2007-5#1)(2009-10#1)(2011-2#4)(2012-3#1)
patients and physicians##13##3##(1993-9#1)(1994-2#1)(1996-1#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-9#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-1#2)
patients and practitioners##2##3##(2009-6#1)(2011-2#1)
patients and prevent##4##3##(2005-7#1)(2007-7#1)(2011-1#1)(2011-2#1)
patients and professionals##2##3##(1996-8#1)(2009-8#1)
patients and providers##9##3##(1991-3#1)(1995-12#1)(1996-1#1)(1996-12#1)(2006-10#1)(2008-1#1)(2008-4#1)(2009-11#1)(2013-1#1)
patients and service##2##3##(2011-1#1)(2013-1#1)
patients and should be##3##4##(1997-3#1)(2010-4#1)(2011-3#1)
patients and should##4##3##(1997-3#2)(2010-4#1)(2011-3#1)
patients and society##3##3##(2006-11#1)(2007-12#1)(2013-1#1)
patients and staff##9##3##(1990-12#1)(2007-7#1)(2010-4#2)(2010-8#3)(2011-2#1)(2013-8#1)
patients and subtotal##2##3##(2007-1#1)(2011-2#1)
patients and surgeons##2##3##(2007-12#1)(2013-1#1)
patients and that this##2##4##(2006-6#1)(2008-11#1)
patients and that##7##3##(2006-6#1)(2007-6#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-1#1)(2011-12#1)
patients and the control group##2##5##(1995-3#1)(2009-2#1)
patients and the controls##2##4##(1996-7#1)(2013-8#1)
patients and the elderly##3##4##(1992-6#1)(2008-9#1)(2012-2#1)
patients and the impact##2##4##(2007-10#1)(2007-9#1)
patients and the most frequent one was##2##7##(2006-6#2)
patients and the possibility##2##4##(2007-8#1)(2010-12#1)
patients and the results were compared with##2##7##(1995-2#1)(2007-8#1)
patients and the##68##3##(1990-11#1)(1991-11#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-12#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-7#1)(2004-1#1)(2006-10#1)(2006-4#1)(2006-6#4)(2007-10#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#5)(2007-9#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#2)
patients and their caregivers##2##4##(2006-2#1)(2010-2#1)
patients and their carers##2##4##(2008-11#1)(2010-12#1)
patients and their families and##2##5##(2007-9#1)(2008-11#1)
patients and their families##36##4##(1990-10#1)(1992-12#1)(1992-3#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-4#1)(1997-4#1)(2006-10#1)(2006-5#1)(2007-10#2)(2007-12#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-11#5)(2008-12#1)(2008-5#1)(2008-7#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-7#2)(2011-2#1)(2012-2#1)(2012-3#1)
patients and their family caregivers##3##5##(2007-12#1)(2011-2#2)
patients and their parents##3##4##(1995-12#1)(2008-10#1)(2010-3#1)
patients and their partners##3##4##(2008-7#2)(2011-2#1)
patients and their physicians##4##4##(1996-3#1)(2008-11#2)(2012-3#1)
patients and their relatives##8##4##(1991-6#1)(2006-1#1)(2006-6#1)(2006-8#1)(2007-7#1)(2008-11#1)(2011-2#1)(2013-8#1)
patients and their##83##3##(1990-10#1)(1991-6#1)(1992-12#1)(1992-3#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#2)(1996-4#1)(1997-4#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-10#2)(2007-12#3)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#9)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-7#2)(2010-8#1)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
patients and therapists##3##3##(1995-12#1)(2012-1#1)(2013-1#1)
patients and there##4##3##(2007-10#1)(2007-8#1)(2008-4#1)(2012-2#1)
patients and they are##2##4##(2006-10#1)(2013-8#1)
patients and they##6##3##(1992-6#1)(2006-10#1)(2007-9#1)(2010-12#1)(2012-2#1)(2013-8#1)
patients and this##3##3##(1990-4#1)(2006-6#1)(2008-9#1)
patients and those with##8##4##(1991-7#1)(1992-6#1)(1993-3#1)(1996-8#1)(2006-8#1)(2008-7#1)(2010-12#1)(2013-1#1)
patients and those##12##3##(1991-7#1)(1992-6#1)(1993-3#1)(1996-8#1)(2006-10#1)(2006-8#2)(2007-12#1)(2008-7#1)(2010-12#1)(2010-8#1)(2013-1#1)
patients and thus##2##3##(1991-3#1)(2009-6#1)
patients and to compare##2##4##(2010-10#1)(2013-8#1)
patients and to predict the##2##5##(2008-8#1)(2010-8#1)
patients and to##23##3##(1990-10#1)(1993-10#1)(1995-3#1)(1996-3#2)(2006-2#1)(2006-6#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-8#2)(2008-9#1)(2010-10#1)(2010-8#2)(2011-2#1)(2012-2#2)(2013-8#2)
patients and two##2##3##(1993-1#1)(2007-8#1)
patients and volunteers##4##3##(1992-3#2)(1996-7#1)(2009-4#1)
patients and was##7##3##(2006-9#1)(2007-3#2)(2008-12#1)(2008-3#1)(2010-12#1)(2013-1#1)
patients and were##2##3##(1997-1#1)(2008-5#1)
patients and with##4##3##(2008-7#1)(2009-9#1)(2012-11#1)(2013-1#1)
patients and young##2##3##(2006-7#1)(2010-5#1)
patients and##1086##2##(1990-1#1)(1990-10#2)(1990-11#6)(1990-12#4)(1990-2#2)(1990-4#6)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#5)(1991-4#3)(1991-5#7)(1991-6#3)(1991-7#4)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#6)(1992-11#1)(1992-12#5)(1992-2#5)(1992-3#5)(1992-4#2)(1992-5#5)(1992-6#6)(1992-8#3)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#4)(1993-12#4)(1993-2#5)(1993-3#2)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#5)(1993-9#5)(1994-1#3)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#6)(1994-3#2)(1994-4#1)(1994-6#1)(1994-7#1)(1994-8#3)(1995-1#6)(1995-11#1)(1995-12#5)(1995-2#6)(1995-3#6)(1995-5#7)(1995-6#1)(1995-8#1)(1996-1#6)(1996-11#5)(1996-12#3)(1996-2#5)(1996-3#7)(1996-4#3)(1996-5#3)(1996-7#10)(1996-8#8)(1996-9#4)(1997-1#4)(1997-2#12)(1997-3#5)(1997-4#2)(1997-5#5)(1997-6#2)(1997-7#1)(1997-8#10)(2004-1#1)(2004-10#1)(2004-2#2)(2004-3#1)(2004-9#1)(2005-1#2)(2005-10#4)(2005-11#4)(2005-4#3)(2005-5#2)(2005-6#1)(2005-7#4)(2005-8#1)(2005-9#2)(2006-1#4)(2006-10#27)(2006-11#4)(2006-12#6)(2006-2#4)(2006-3#3)(2006-4#5)(2006-5#2)(2006-6#14)(2006-7#4)(2006-8#11)(2006-9#1)(2007-1#2)(2007-10#8)(2007-11#13)(2007-12#15)(2007-2#10)(2007-3#9)(2007-4#3)(2007-5#3)(2007-6#1)(2007-7#29)(2007-8#32)(2007-9#14)(2008-1#23)(2008-10#19)(2008-11#25)(2008-12#12)(2008-2#2)(2008-3#14)(2008-4#17)(2008-5#18)(2008-6#10)(2008-7#36)(2008-8#23)(2008-9#7)(2009-1#2)(2009-10#9)(2009-11#2)(2009-12#2)(2009-2#4)(2009-3#4)(2009-4#4)(2009-5#2)(2009-6#6)(2009-7#4)(2009-8#2)(2009-9#5)(2010-10#4)(2010-11#4)(2010-12#17)(2010-2#4)(2010-3#6)(2010-4#6)(2010-5#10)(2010-6#2)(2010-7#4)(2010-8#13)(2010-9#2)(2011-1#19)(2011-11#1)(2011-12#2)(2011-2#57)(2011-3#1)(2011-9#1)(2012-1#13)(2012-11#3)(2012-12#19)(2012-2#17)(2012-3#15)(2012-4#1)(2012-5#1)(2013-1#44)(2013-7#3)(2013-8#24)
patients and/or##3##2##(1996-3#1)(2008-11#2)
patients apparently##2##2##(1992-1#1)(2006-10#1)
patients appear to##2##3##(2008-8#1)(2011-1#1)
patients appear##3##2##(2008-4#1)(2008-8#1)(2011-1#1)
patients appeared to have##2##4##(1991-6#1)(2008-4#1)
patients appeared##4##2##(1990-8#1)(1991-6#1)(2008-4#1)(2008-7#1)
patients appears to be##3##4##(1993-2#1)(2007-7#1)(2008-1#1)
patients appears##5##2##(1993-2#1)(2007-7#1)(2008-1#1)(2008-2#1)(2010-1#1)
patients appropriate##2##2##(2008-6#1)(2010-9#1)
patients are able to##6##4##(1995-9#2)(1996-1#1)(2007-7#1)(2012-1#1)(2013-1#1)
patients are admitted##2##3##(2008-3#1)(2012-2#1)
patients are advised to##3##4##(1997-4#1)(2008-7#1)(2012-2#1)
patients are affected by##2##4##(2006-10#1)(2009-4#1)
patients are affected##3##3##(2006-10#1)(2009-4#1)(2011-2#1)
patients are alive and##4##4##(1992-5#1)(1995-2#1)(2007-8#1)(2011-2#1)
patients are alive with##2##4##(2007-8#1)(2008-6#1)
patients are alive##9##3##(1992-5#1)(1995-2#1)(2007-8#2)(2008-6#2)(2011-2#3)
patients are all##2##3##(2012-2#1)(2013-8#1)
patients are also discussed##2##4##(2007-11#1)(2008-2#1)
patients are also##5##3##(1991-7#1)(2005-8#1)(2007-11#1)(2008-2#1)(2011-1#1)
patients are asymptomatic##4##3##(1993-1#1)(1993-9#1)(2008-7#1)(2013-1#1)
patients are at a##2##4##(2007-3#1)(2013-8#1)
patients are at greater risk of##2##6##(2008-8#1)(2010-10#1)
patients are at high risk##2##5##(1992-5#1)(2012-12#1)
patients are at increased risk of##2##6##(2006-10#1)(2011-2#1)
patients are at increased risk##3##5##(2006-10#1)(2007-2#1)(2011-2#1)
patients are at risk for##2##5##(2007-10#1)(2008-2#1)
patients are at risk of##2##5##(2005-10#1)(2005-8#1)
patients are at risk##4##4##(2005-10#1)(2005-8#1)(2007-10#1)(2008-2#1)
patients are at##17##3##(1992-5#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-3#1)(2008-2#2)(2008-7#1)(2008-8#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
patients are available##2##3##(2010-12#1)(2011-2#1)
patients are being##2##3##(2008-4#1)(2010-7#1)
patients are best##2##3##(2006-10#1)(2006-7#1)
patients are candidates for##3##4##(1991-12#1)(2006-6#1)(2010-4#1)
patients are carefully##2##3##(2007-8#1)(2008-10#1)
patients are characterized by a##2##5##(1990-4#1)(2008-10#1)
patients are characterized by##3##4##(1990-4#1)(2008-10#1)(2008-7#1)
patients are compared with##2##4##(2006-6#1)(2008-7#1)
patients are considered##4##3##(1997-4#1)(2007-11#1)(2009-11#1)(2011-2#1)
patients are cured##2##3##(2005-10#1)(2006-2#1)
patients are currently##5##3##(2005-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2013-8#1)
patients are described##9##3##(1990-2#1)(1991-11#1)(1992-2#1)(1993-7#1)(1994-7#1)(1995-7#1)(1996-3#1)(2007-3#1)(2008-3#1)
patients are diagnosed at##2##4##(2010-7#1)(2013-7#1)
patients are diagnosed##4##3##(2006-10#1)(2008-1#1)(2010-7#1)(2013-7#1)
patients are discussed in##3##4##(1993-11#1)(2012-12#2)
patients are discussed##9##3##(1991-8#1)(1993-11#1)(2006-9#1)(2008-8#1)(2009-11#1)(2012-12#2)(2012-2#1)(2012-3#1)
patients are disease free##2##4##(1990-6#1)(2008-6#1)
patients are exposed to##2##4##(1996-8#1)(1997-2#1)
patients are gaining##2##3##(2004-11#1)(2008-8#1)
patients are generally##3##3##(2007-12#1)(2008-4#1)(2011-2#1)
patients are given##2##3##(1992-2#1)(2007-4#1)
patients are healthy##2##3##(1997-3#1)(2007-11#1)
patients are impaired##2##3##(2008-10#1)(2008-7#1)
patients are in##5##3##(1993-1#1)(1997-6#1)(2005-8#1)(2007-7#1)(2007-8#1)
patients are less##2##3##(1994-12#1)(2008-1#1)
patients are more likely to##2##5##(2010-12#1)(2011-2#1)
patients are more##11##3##(2006-10#1)(2006-5#1)(2007-10#1)(2007-7#1)(2007-8#1)(2009-10#1)(2010-12#1)(2011-12#1)(2011-2#3)
patients are not##7##3##(2006-10#1)(2009-10#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
patients are of##2##3##(2007-10#1)(2008-3#1)
patients are often##12##3##(1990-5#1)(1991-4#1)(1995-5#1)(1997-3#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-2#1)(2011-2#2)
patients are older##2##3##(2007-1#1)(2007-12#1)
patients are presented##6##3##(1992-9#1)(1993-3#1)(2006-7#1)(2007-11#1)(2008-8#1)(2013-1#1)
patients are probably##2##3##(1992-8#1)(1997-3#1)
patients are prone to##3##4##(1995-10#1)(2007-11#1)(2008-11#1)
patients are prone##4##3##(1995-10#1)(2007-11#1)(2008-11#1)(2012-2#1)
patients are reported##3##3##(2006-10#1)(2007-2#1)(2011-2#1)
patients are resistant to##2##4##(2009-2#1)(2011-2#1)
patients are seen in##2##4##(2006-8#1)(2008-4#1)
patients are significantly##3##3##(1993-12#1)(2005-10#1)(2005-4#1)
patients are sometimes##2##3##(2007-12#1)(2013-1#1)
patients are still alive##6##4##(1990-9#1)(1991-4#1)(1992-9#1)(2006-6#1)(2008-3#1)(2011-2#1)
patients are still##8##3##(1990-2#1)(1990-9#1)(1991-4#1)(1992-9#1)(2006-6#1)(2008-10#1)(2008-3#1)(2011-2#1)
patients are suitable for##2##4##(2010-9#1)(2013-1#1)
patients are the##4##3##(2005-3#1)(2008-12#1)(2010-2#1)(2012-2#1)
patients are to##2##3##(2006-10#1)(2007-9#1)
patients are treated by##2##4##(2007-9#1)(2009-9#1)
patients are treated##5##3##(1997-2#1)(2007-9#1)(2009-9#1)(2010-3#1)(2013-8#1)
patients are unable to##2##4##(2008-7#1)(2011-2#1)
patients are undergoing##2##3##(2010-11#1)(2011-2#1)
patients are usually##3##3##(2006-10#1)(2007-9#1)(2011-2#1)
patients are very##2##3##(1992-10#1)(2008-10#1)
patients are young##2##3##(2007-12#1)(2008-4#1)
patients are##359##2##(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#3)(1991-11#2)(1991-12#2)(1991-4#4)(1991-7#1)(1991-8#2)(1991-9#2)(1992-10#2)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#2)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#5)(1993-3#1)(1993-5#1)(1993-7#2)(1993-8#4)(1993-9#2)(1994-12#1)(1994-3#1)(1994-7#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#3)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-2#2)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-10#3)(2005-3#1)(2005-4#1)(2005-7#2)(2005-8#3)(2006-1#1)(2006-10#18)(2006-12#3)(2006-2#2)(2006-4#1)(2006-5#2)(2006-6#5)(2006-7#2)(2006-8#3)(2006-9#3)(2007-1#2)(2007-10#4)(2007-11#8)(2007-12#4)(2007-2#3)(2007-3#2)(2007-4#3)(2007-6#1)(2007-7#8)(2007-8#13)(2007-9#5)(2008-1#3)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#9)(2008-5#2)(2008-6#3)(2008-7#13)(2008-8#6)(2008-9#1)(2009-10#2)(2009-11#2)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#7)(2010-2#2)(2010-3#3)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#8)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#26)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#9)(2012-3#3)(2013-1#12)(2013-7#2)(2013-8#12)
patients as a##7##3##(1994-6#1)(1995-12#1)(1997-7#1)(2007-7#1)(2007-8#1)(2008-10#1)(2009-10#1)
patients as compared to##5##4##(1994-10#1)(1996-4#1)(1997-8#1)(2008-7#1)(2013-8#1)
patients as compared with a##2##5##(1995-12#1)(1996-2#1)
patients as compared with controls##2##5##(2006-10#1)(2006-6#1)
patients as compared with##7##4##(1994-2#1)(1995-12#1)(1996-2#1)(2004-3#1)(2006-10#2)(2006-6#1)
patients as compared##12##3##(1994-10#1)(1994-2#1)(1995-12#1)(1996-2#1)(1996-4#1)(1997-8#1)(2004-3#1)(2006-10#2)(2006-6#1)(2008-7#1)(2013-8#1)
patients as controls##2##3##(1990-5#1)(2008-7#1)
patients as having##3##3##(2008-6#1)(2011-1#2)
patients as in##2##3##(2005-10#1)(2011-11#1)
patients as it##2##3##(2007-7#1)(2012-3#1)
patients as the first##2##4##(1993-8#1)(2006-8#1)
patients as the##5##3##(1993-8#1)(1996-3#1)(2006-4#1)(2006-8#1)(2012-2#1)
patients as well as the##2##5##(1996-12#1)(2008-10#1)
patients as well as to##2##5##(2006-10#1)(2008-2#1)
patients as well as##14##4##(1992-8#1)(1993-7#2)(1996-12#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-7#2)(2011-2#1)(2012-2#1)
patients as well##17##3##(1992-8#1)(1992-9#1)(1993-7#2)(1995-10#1)(1996-12#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-7#2)(2009-3#1)(2011-2#1)(2012-2#1)
patients as##79##2##(1990-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-7#2)(1993-8#1)(1994-10#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-12#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-4#1)(1997-7#2)(1997-8#1)(2004-11#1)(2004-3#2)(2005-10#1)(2005-7#1)(2006-10#3)(2006-4#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#4)(2008-10#2)(2008-11#1)(2008-2#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-1#3)(2011-11#2)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
patients assessed##2##2##(2005-10#1)(2008-10#1)
patients assigned to the##2##4##(1995-3#1)(2013-1#1)
patients assigned to##4##3##(1993-7#1)(1995-3#1)(2010-2#1)(2013-1#1)
patients assigned##6##2##(1993-7#1)(1995-3#1)(2008-9#1)(2010-2#2)(2013-1#1)
patients associated with##2##3##(1995-5#1)(2005-3#1)
patients associated##3##2##(1995-5#1)(2005-3#1)(2007-8#1)
patients at 5##2##3##(2007-8#1)(2013-8#1)
patients at ICUs of##2##4##(2012-2#2)
patients at a tertiary care##3##5##(2010-4#1)(2011-2#1)(2013-8#1)
patients at a tertiary##4##4##(2008-4#1)(2010-4#1)(2011-2#1)(2013-8#1)
patients at a##11##3##(1990-5#1)(1995-5#1)(1997-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-4#2)(2011-2#1)(2013-1#1)(2013-8#1)
patients at different##2##3##(1991-11#1)(2008-8#1)
patients at each##3##3##(2007-9#1)(2013-8#2)
patients at high cardiovascular risk##2##5##(2010-4#1)(2011-2#1)
patients at high risk for multidrug resistance##2##7##(2013-1#2)
patients at high risk for##11##5##(2006-10#2)(2007-8#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-6#2)(2013-1#3)
patients at high risk of##5##5##(1993-1#1)(2006-9#1)(2008-5#1)(2008-7#1)(2008-8#1)
patients at high risk##20##4##(1993-1#1)(1995-2#1)(1995-8#1)(2004-11#1)(2006-10#3)(2006-9#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2013-1#3)
patients at high##22##3##(1993-1#1)(1995-2#1)(1995-8#1)(2004-11#1)(2006-10#3)(2006-9#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2013-1#3)
patients at higher risk for##2##5##(2007-11#1)(2007-3#1)
patients at higher risk of##2##5##(2006-10#1)(2009-10#1)
patients at higher risk##8##4##(2006-10#2)(2006-12#1)(2006-6#1)(2007-11#1)(2007-3#1)(2009-10#1)(2010-10#1)
patients at highest risk##2##4##(1993-7#1)(2011-2#1)
patients at home##2##3##(1993-3#1)(1997-4#1)
patients at increased risk##2##4##(2006-10#1)(2007-11#1)
patients at least##4##3##(2006-11#2)(2007-9#1)(2009-10#1)
patients at nutritional risk##2##4##(1992-12#1)(2006-2#1)
patients at one##2##3##(2009-6#1)(2010-8#1)
patients at our institution##3##4##(2007-7#1)(2010-8#1)(2011-2#1)
patients at our##5##3##(2007-7#2)(2010-8#1)(2011-2#2)
patients at primary##2##3##(2010-3#1)(2011-1#1)
patients at relapse##2##3##(1994-5#1)(2011-2#1)
patients at rest##3##3##(2006-12#1)(2007-2#1)(2007-8#1)
patients at risk for##15##4##(1993-5#1)(1996-4#1)(1997-3#1)(2005-10#1)(2006-10#3)(2007-10#1)(2008-3#1)(2008-7#2)(2011-1#1)(2012-2#1)(2013-1#2)
patients at risk of FN and##2##6##(2007-12#2)
patients at risk of developing pressure##2##6##(2012-3#2)
patients at risk of developing##6##5##(1992-12#1)(2008-8#1)(2012-3#2)(2013-1#2)
patients at risk of##22##4##(1991-9#1)(1992-12#1)(1993-9#1)(2005-7#1)(2006-10#1)(2007-12#3)(2008-8#2)(2010-12#1)(2010-5#1)(2011-2#1)(2012-11#2)(2012-12#2)(2012-3#2)(2013-1#3)
patients at risk##54##3##(1991-9#2)(1992-12#1)(1993-4#1)(1993-5#2)(1993-9#1)(1996-4#1)(1997-3#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#7)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-3#2)(2008-7#2)(2008-8#2)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-11#3)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#5)
patients at surgery was 13##2##5##(2007-8#1)(2013-1#1)
patients at surgery was##3##4##(2007-7#1)(2007-8#1)(2013-1#1)
patients at the age from##2##5##(2007-11#1)(2007-7#1)
patients at the age##3##4##(2007-11#1)(2007-7#1)(2007-8#1)
patients at the end of the##2##6##(2007-1#1)(2008-1#1)
patients at the end of##5##5##(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2012-12#1)
patients at the lower##2##4##(2007-10#1)(2011-2#1)
patients at the same time##2##5##(1995-1#1)(2010-7#1)
patients at the same##3##4##(1995-1#1)(1997-8#1)(2010-7#1)
patients at the stage of##2##5##(2008-9#1)(2013-1#1)
patients at the time of##7##5##(1995-1#1)(1995-2#1)(2007-7#2)(2009-6#2)(2010-3#1)
patients at the time##8##4##(1995-1#1)(1995-2#1)(2007-7#2)(2009-6#2)(2010-3#1)(2011-2#1)
patients at the##43##3##(1991-5#1)(1992-5#1)(1993-12#1)(1995-1#2)(1995-10#1)(1995-2#1)(1995-9#1)(1996-2#1)(1996-3#1)(1997-8#1)(2005-10#1)(2006-10#3)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#5)(2007-8#2)(2008-1#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-6#2)(2010-3#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
patients at this##2##3##(1995-3#1)(2004-1#1)
patients at two##4##3##(1991-3#1)(2007-1#1)(2008-1#2)
patients at##236##2##(1990-5#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-12#2)(1992-5#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#2)(1993-7#1)(1993-9#1)(1994-5#1)(1995-1#2)(1995-10#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-2#2)(1996-3#1)(1996-4#1)(1997-3#2)(1997-4#1)(1997-8#1)(2004-1#1)(2004-11#1)(2004-4#1)(2005-10#4)(2005-3#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#18)(2006-11#2)(2006-12#2)(2006-2#2)(2006-4#1)(2006-6#2)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#3)(2007-11#7)(2007-12#5)(2007-2#1)(2007-3#1)(2007-7#10)(2007-8#7)(2007-9#6)(2008-1#5)(2008-10#1)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#6)(2008-8#5)(2008-9#2)(2009-10#2)(2009-2#1)(2009-4#1)(2009-6#3)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#3)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#3)(2011-2#16)(2012-11#3)(2012-12#6)(2012-2#9)(2012-3#6)(2013-1#11)(2013-7#1)(2013-8#5)
patients attended the##2##3##(1991-9#1)(2007-7#1)
patients attended##3##2##(1991-9#1)(2007-7#1)(2010-11#1)
patients attending a tertiary care##2##5##(2011-12#1)(2012-2#1)
patients attending a tertiary##3##4##(2011-12#1)(2012-2#1)(2013-1#1)
patients attending a##10##3##(1991-8#2)(2006-8#1)(2008-3#1)(2010-3#1)(2011-1#1)(2011-12#1)(2012-11#1)(2012-2#1)(2013-1#1)
patients attending an##2##3##(2006-10#1)(2008-3#1)
patients attending the##9##3##(1993-2#1)(2007-3#1)(2007-6#1)(2007-7#3)(2008-11#1)(2010-12#1)(2011-2#1)
patients attending##46##2##(1991-8#2)(1992-12#1)(1993-10#1)(1993-2#1)(1995-10#1)(2006-1#2)(2006-10#1)(2006-2#1)(2006-8#1)(2007-3#1)(2007-6#1)(2007-7#7)(2007-8#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#1)(2008-8#2)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-11#1)(2011-12#2)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
patients available for##2##3##(1991-1#1)(2006-8#1)
patients available##4##2##(1991-1#1)(2006-8#1)(2008-5#1)(2012-5#1)
patients awaiting##6##2##(1996-8#1)(2007-8#1)(2008-1#1)(2010-9#2)(2013-8#1)
patients away##2##2##(1991-3#1)(2008-6#1)
patients based on##6##3##(1996-12#1)(2006-4#1)(2007-10#1)(2007-12#1)(2009-4#1)(2012-1#1)
patients be##5##2##(1995-4#1)(1997-3#1)(1997-8#1)(2006-12#1)(2007-11#1)
patients bearing a colorectal carcinoma##2##5##(2006-6#2)
patients bearing a##3##3##(1992-10#1)(2006-6#2)
patients bearing##8##2##(1990-2#1)(1992-10#1)(1992-6#1)(1992-8#1)(2006-6#3)(2011-1#1)
patients became##5##2##(1990-4#1)(2005-8#1)(2006-11#1)(2007-1#1)(2007-7#1)
patients because of severe##2##4##(1991-3#1)(2006-12#1)
patients because of the##3##4##(2007-8#1)(2011-2#1)(2013-8#1)
patients because of##12##3##(1991-3#1)(1996-7#1)(2006-12#1)(2007-8#2)(2008-1#1)(2008-6#2)(2010-3#1)(2010-8#1)(2011-2#1)(2013-8#1)
patients because the##2##3##(1996-3#1)(2010-12#1)
patients because##18##2##(1991-3#1)(1995-6#1)(1996-3#1)(1996-7#1)(2006-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-6#2)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#2)
patients become##8##2##(1995-2#1)(1996-2#1)(1997-6#1)(2006-1#1)(2008-5#1)(2009-5#1)(2010-9#1)(2012-2#1)
patients before and after a##2##5##(2005-10#1)(2008-7#1)
patients before and after the##2##5##(1994-4#1)(2012-2#1)
patients before and after##9##4##(1990-4#1)(1994-4#1)(1996-2#1)(1996-7#1)(2005-10#1)(2007-11#1)(2008-7#1)(2012-2#1)(2013-7#1)
patients before surgery##2##3##(2007-8#1)(2009-3#1)
patients before the##3##3##(1994-12#1)(2007-11#1)(2010-4#1)
patients before treatment##2##3##(2008-10#2)
patients before##29##2##(1990-4#1)(1991-2#1)(1993-12#1)(1994-12#1)(1994-4#1)(1994-5#1)(1996-2#1)(1996-7#1)(2004-12#1)(2005-10#1)(2006-10#1)(2007-11#4)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-7#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)
patients began##2##2##(1991-12#1)(2012-12#1)
patients being dialyzed##2##3##(2007-7#2)
patients being in##2##3##(1990-10#1)(1995-12#1)
patients being treated with##4##4##(1991-2#1)(1993-10#1)(1993-2#1)(2008-11#1)
patients being treated##5##3##(1991-2#1)(1993-10#1)(1993-2#1)(2006-8#1)(2008-11#1)
patients being##21##2##(1990-10#1)(1991-2#1)(1993-10#1)(1993-2#1)(1995-12#1)(1995-3#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-1#1)(2012-2#1)
patients believed that##2##3##(1994-2#1)(1996-2#1)
patients belonged to the##2##4##(1990-12#1)(2007-8#1)
patients belonged to##6##3##(1990-12#1)(1996-12#1)(1997-8#1)(2007-8#1)(2011-12#1)(2011-2#1)
patients belonging to the##3##4##(1995-3#2)(1997-8#1)
patients belonging to##5##3##(1995-3#2)(1997-8#1)(2008-1#1)(2012-12#1)
patients below the age of##3##5##(1997-8#2)(2010-3#1)
patients benefit from##4##3##(2004-3#1)(2007-11#1)(2007-8#1)(2010-11#1)
patients benefit##7##2##(2004-3#1)(2007-11#1)(2007-8#1)(2008-6#1)(2008-8#1)(2010-11#1)(2013-1#1)
patients benefited##2##2##(2007-7#1)(2007-9#1)
patients better##4##2##(1995-1#1)(2006-10#1)(2007-6#1)(2009-6#1)
patients between the ages of##2##5##(2007-8#1)(2009-10#1)
patients between the##4##3##(2007-11#1)(2007-8#1)(2009-10#1)(2013-1#1)
patients between##18##2##(1990-10#1)(1992-6#2)(1992-8#2)(1993-5#1)(1996-9#1)(2005-8#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-4#1)(2008-9#1)(2009-10#1)(2011-2#1)(2013-1#2)
patients blood##2##2##(2006-1#1)(2008-7#1)
patients bone##2##2##(2007-11#1)(2007-8#1)
patients born in the##4##4##(2004-11#3)(2005-10#1)
patients born in##5##3##(1996-3#1)(2004-11#3)(2005-10#1)
patients born##7##2##(1996-3#1)(2004-11#4)(2005-10#1)(2007-7#1)
patients both##4##2##(1990-12#1)(1993-12#1)(2013-1#2)
patients but also##5##3##(1994-11#1)(1995-9#1)(2010-6#1)(2010-8#1)(2011-2#1)
patients but no##2##3##(1991-1#1)(1992-8#1)
patients but not##2##3##(1991-3#1)(2008-1#1)
patients but one##2##3##(1991-12#1)(2008-9#1)
patients but only##2##3##(1991-2#1)(2008-3#1)
patients but##33##2##(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-8#1)(1993-1#1)(1993-2#1)(1994-11#1)(1995-11#1)(1995-9#1)(2006-10#1)(2006-2#1)(2006-8#2)(2007-11#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
patients by a##8##3##(1990-12#1)(1995-6#1)(1996-12#1)(2007-11#1)(2007-8#1)(2010-2#1)(2012-1#1)(2013-8#1)
patients by means of##5##4##(1992-3#1)(1992-8#1)(2006-8#1)(2006-9#1)(2010-12#1)
patients by performing##2##3##(2007-12#1)(2013-8#1)
patients by the##8##3##(2006-10#1)(2006-12#1)(2007-9#1)(2009-2#1)(2011-2#1)(2012-3#1)(2013-1#2)
patients by##77##2##(1990-12#2)(1990-2#2)(1990-3#1)(1991-3#2)(1991-5#1)(1992-3#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-8#1)(1994-8#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#1)(1997-1#1)(2005-10#2)(2005-4#2)(2006-10#2)(2006-12#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#2)(2008-11#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-8#2)(2008-9#3)(2009-2#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#3)
patients came from##2##3##(1994-3#1)(2013-8#1)
patients came to that of##2##5##(2011-2#2)
patients came##6##2##(1994-3#1)(2007-10#1)(2008-7#1)(2011-2#2)(2013-8#1)
patients can be challenging##2##4##(2006-1#1)(2007-7#1)
patients can be cured##2##4##(1990-12#1)(1997-3#1)
patients can be recruited##2##4##(2008-11#1)(2008-8#1)
patients can be treated##3##4##(1994-12#1)(1996-12#1)(2007-9#1)
patients can be##33##3##(1990-12#1)(1991-3#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-6#1)(1996-12#1)(1997-3#2)(2004-2#1)(2004-3#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-9#1)(2007-11#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-1#2)(2008-11#1)(2008-5#2)(2008-8#1)(2009-11#1)(2011-1#1)(2013-8#1)
patients can experience different symptoms associated with irritation to the dural sleeve##2##12##(2006-11#1)(2006-12#1)
patients can experience##3##3##(2006-11#1)(2006-12#1)(2010-12#1)
patients can make##2##3##(2008-6#1)(2008-7#1)
patients can not##2##3##(1993-1#1)(2010-8#1)
patients can present with##4##4##(2006-12#2)(2006-7#1)(2010-9#1)
patients can result in##2##4##(1994-3#1)(2007-3#1)
patients can store verifiable health information and provide subsets of it to third parties##2##14##(2013-1#2)
patients can##74##2##(1990-11#1)(1990-12#1)(1991-3#1)(1992-3#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-3#2)(2004-1#1)(2004-2#1)(2004-3#1)(2005-9#1)(2006-1#2)(2006-10#3)(2006-11#2)(2006-12#3)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#3)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-11#2)(2010-1#2)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-11#1)(2013-1#4)(2013-8#1)
patients candidate for valvular heart surgery##4##6##(2013-1#4)
patients candidate##5##2##(2006-6#1)(2013-1#4)
patients cannot be##3##3##(1991-2#1)(2006-10#1)(2007-11#1)
patients cannot##5##2##(1991-2#1)(2006-10#1)(2007-11#1)(2007-5#1)(2013-1#1)
patients cared##2##2##(2008-3#1)(2009-3#1)
patients carried the##3##3##(1991-3#1)(2006-10#1)(2012-12#1)
patients carrying##2##2##(1996-5#1)(1997-1#1)
patients categorized by##2##3##(2012-2#1)(2013-7#1)
patients categorized##4##2##(1997-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
patients caused by##2##3##(2013-7#2)
patients change##2##2##(1996-2#1)(2009-7#1)
patients chosen##3##2##(2006-8#1)(2007-7#1)(2013-1#1)
patients chronically treated with##2##4##(1993-2#1)(1994-8#1)
patients chronically##4##2##(1993-2#1)(1994-8#1)(2008-11#2)
patients classified as##3##3##(2006-10#1)(2007-9#1)(2008-12#1)
patients clinical##3##2##(1992-1#1)(1995-4#1)(2007-7#1)
patients clinically##3##2##(2007-11#1)(2007-7#1)(2008-7#1)
patients co-infected with##2##3##(2008-8#1)(2010-4#1)
patients colonized##2##2##(2005-8#1)(2011-2#1)
patients combined with##4##3##(2007-8#1)(2008-6#1)(2012-3#2)
patients come##2##2##(1993-2#1)(2013-1#1)
patients coming to##2##3##(1995-12#1)(2013-1#1)
patients coming##5##2##(1990-9#1)(1995-12#1)(2012-2#1)(2013-1#2)
patients commonly##2##2##(2010-12#1)(2011-12#1)
patients compared to control##2##4##(2012-2#2)
patients compared to controls##8##4##(1993-7#1)(1997-2#1)(2006-11#1)(2008-4#1)(2008-8#1)(2009-6#1)(2010-5#1)(2011-2#1)
patients compared to the##3##4##(1997-2#1)(2007-11#1)(2008-7#1)
patients compared to##29##3##(1993-1#1)(1993-7#1)(1997-2#3)(2004-12#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#2)(2008-4#1)(2008-7#2)(2008-8#2)(2009-6#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#2)
patients compared with healthy controls##2##5##(2008-10#1)(2008-6#1)
patients compared with healthy##3##4##(1996-8#1)(2008-10#1)(2008-6#1)
patients compared with the##4##4##(1993-8#1)(2006-10#1)(2008-11#1)(2012-3#1)
patients compared with##15##3##(1991-5#1)(1993-8#1)(1995-11#1)(1996-3#1)(1996-8#1)(1996-9#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2012-3#1)
patients compared##44##2##(1991-5#1)(1993-1#1)(1993-7#1)(1993-8#1)(1995-11#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-2#3)(2004-12#1)(2006-10#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#3)(2009-11#1)(2009-6#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#3)
patients complain of##3##3##(1991-7#1)(2007-11#1)(2009-5#1)
patients complained of incontinence to##2##5##(2006-10#2)
patients complained of pain##2##4##(2006-3#1)(2008-6#1)
patients complained of severe##2##4##(1990-3#1)(1993-10#1)
patients complained of##14##3##(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-11#1)(1993-10#1)(1993-4#1)(1994-4#1)(2006-10#2)(2006-3#1)(2006-8#1)(2008-6#1)(2008-8#1)
patients complained##16##2##(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-11#1)(1993-10#1)(1993-4#1)(1994-4#1)(2006-10#2)(2006-3#1)(2006-8#1)(2008-6#1)(2008-7#2)(2008-8#1)
patients complaining of##8##3##(1993-6#1)(2006-2#1)(2007-11#2)(2009-5#1)(2011-1#1)(2012-12#1)(2012-2#1)
patients completed a##2##3##(1991-3#1)(2006-10#1)
patients completed the study##6##4##(1990-7#1)(1992-11#1)(2008-3#1)(2012-2#2)(2013-1#1)
patients completed the##12##3##(1990-7#1)(1991-3#1)(1992-11#1)(1992-12#1)(2008-3#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-9#1)(2012-2#2)(2013-1#1)
patients completed##26##2##(1990-7#1)(1991-3#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-5#1)(1996-7#1)(1997-5#1)(2006-10#1)(2006-9#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
patients compliance##2##2##(1990-2#1)(2005-10#1)
patients comprised##4##2##(1992-9#1)(2006-8#1)(2007-2#1)(2008-1#1)
patients condition##2##2##(2005-12#1)(2012-2#1)
patients confirmed that##2##3##(1997-8#1)(2007-3#1)
patients confirmed the##2##3##(1994-9#1)(2008-5#1)
patients confirmed these##2##3##(2006-6#1)(2008-4#1)
patients confirmed##6##2##(1994-9#1)(1997-8#1)(2006-6#1)(2007-3#1)(2008-4#1)(2008-5#1)
patients considered the##2##3##(1993-5#1)(2004-12#1)
patients considered##5##2##(1990-5#1)(1993-5#1)(2004-12#1)(2006-9#1)(2007-7#1)
patients considering##3##2##(2008-7#1)(2010-12#1)(2012-1#1)
patients consisted of##2##3##(2005-12#1)(2013-1#1)
patients consult##3##2##(2006-8#1)(2009-6#2)
patients contacted##3##2##(1994-3#1)(2011-2#1)(2012-2#1)
patients contained##2##2##(1993-9#1)(1996-8#1)
patients contains##2##2##(1993-12#1)(2009-8#1)
patients continue to##5##3##(1990-3#1)(1996-7#1)(2006-1#1)(2006-9#1)(2008-7#1)
patients continue##6##2##(1990-3#1)(1996-7#1)(2006-1#1)(2006-9#1)(2008-2#1)(2008-7#1)
patients continued to have##3##4##(1997-1#1)(1997-3#1)(2007-7#1)
patients continued to improve##2##4##(2013-7#2)
patients continued to##6##3##(1991-3#1)(1997-1#1)(1997-3#1)(2007-7#1)(2013-7#2)
patients continued##7##2##(1991-3#1)(1997-1#1)(1997-3#1)(2007-7#1)(2007-8#1)(2013-7#2)
patients continues to##2##3##(2008-3#1)(2010-5#1)
patients continuing insulin##2##3##(2013-1#2)
patients continuing##4##2##(2009-9#2)(2013-1#2)
patients correlated with##2##3##(2009-9#1)(2013-8#1)
patients could be evaluated##2##4##(1990-3#1)(1991-7#1)
patients could be##16##3##(1990-12#2)(1990-3#1)(1990-9#1)(1991-7#1)(1994-7#1)(1995-7#1)(2006-10#2)(2007-11#1)(2008-1#1)(2008-6#1)(2008-8#1)(2010-1#1)(2010-12#1)(2011-1#1)
patients could not be##4##4##(2007-2#1)(2009-6#1)(2011-7#1)(2012-2#1)
patients could not##5##3##(2007-2#1)(2007-7#1)(2009-6#1)(2011-7#1)(2012-2#1)
patients could##32##2##(1990-12#2)(1990-3#1)(1990-9#1)(1991-7#1)(1993-3#1)(1994-7#1)(1995-11#1)(1995-7#1)(1996-3#1)(1997-8#1)(2006-10#2)(2006-2#1)(2007-11#2)(2007-2#1)(2007-7#2)(2008-1#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-7#1)(2012-2#1)(2013-1#3)
patients currently##3##2##(1992-12#1)(2008-8#1)(2012-12#1)
patients deceased##2##2##(2006-6#1)(2010-9#1)
patients decide##2##2##(1994-3#1)(2013-1#1)
patients declared important##2##3##(2007-11#1)(2007-8#1)
patients declared##4##2##(2007-11#1)(2007-8#1)(2011-12#1)(2011-2#1)
patients declined##2##2##(1991-3#1)(2012-5#1)
patients decreased##3##2##(2006-10#1)(2007-2#1)(2013-1#1)
patients deficient in##2##3##(1990-8#1)(2007-7#1)
patients delayed##2##2##(1992-5#1)(2013-1#1)
patients delivered##4##2##(1992-12#1)(1994-2#1)(1994-9#1)(2013-8#1)
patients demonstrate##2##2##(2006-2#1)(2012-2#1)
patients demonstrated a##2##3##(2007-11#1)(2008-11#1)
patients demonstrated an improvement##2##4##(2006-10#1)(2008-9#1)
patients demonstrated an##3##3##(2006-10#1)(2008-5#1)(2008-9#1)
patients demonstrated significant##2##3##(2006-7#1)(2012-3#1)
patients demonstrated that##4##3##(1995-11#1)(2005-8#1)(2008-11#1)(2011-2#1)
patients demonstrated##19##2##(1991-12#1)(1991-8#1)(1995-11#1)(1996-11#1)(2005-8#2)(2006-10#2)(2006-7#1)(2007-11#1)(2007-8#1)(2008-11#2)(2008-5#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
patients demonstrating##4##2##(2005-8#1)(2007-11#1)(2008-7#2)
patients dependent on##2##3##(1991-12#2)
patients depends on the##2##4##(2008-5#1)(2010-12#1)
patients describe##2##2##(2006-7#1)(2007-8#1)
patients described a##2##3##(2007-8#1)(2013-1#1)
patients described in##2##3##(2006-8#1)(2010-12#1)
patients described##8##2##(1996-12#1)(1997-7#1)(2006-7#1)(2006-8#1)(2007-8#1)(2010-12#1)(2010-4#1)(2013-1#1)
patients despite##2##2##(2007-11#1)(2010-5#1)
patients deteriorated##3##2##(2007-3#1)(2008-1#1)(2012-2#1)
patients determined##2##2##(2006-8#1)(2009-2#1)
patients develop a##2##3##(1992-3#1)(2009-4#1)
patients develop##19##2##(1991-7#1)(1992-3#2)(1997-8#1)(2006-12#1)(2007-11#2)(2008-1#2)(2008-10#1)(2008-8#1)(2009-4#1)(2010-12#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
patients developed a##3##3##(1993-9#1)(2006-8#1)(2008-6#1)
patients developed complications##2##3##(1991-4#1)(2008-1#1)
patients developed local##3##3##(1991-6#1)(2007-6#1)(2008-1#1)
patients developed metastases##2##3##(1995-2#1)(2008-6#1)
patients developed neoplasia among##2##4##(2013-8#2)
patients developed recurrent##2##3##(1996-9#1)(2008-7#1)
patients developed##58##2##(1991-2#1)(1991-4#1)(1991-6#1)(1992-10#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-2#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-8#1)(2004-10#1)(2006-10#2)(2006-11#2)(2006-12#2)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-6#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#4)(2008-4#1)(2008-6#4)(2008-7#3)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-6#1)(2013-8#2)
patients developing##8##2##(1992-9#1)(1994-3#1)(1996-9#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-7#1)(2010-11#1)
patients diagnosed as having##2##4##(2007-7#1)(2008-8#1)
patients diagnosed as suffering from##2##5##(2006-12#2)
patients diagnosed as##6##3##(1997-8#1)(2006-12#2)(2007-7#1)(2008-11#1)(2008-8#1)
patients diagnosed by##2##3##(1997-8#1)(2010-8#1)
patients diagnosed in##3##3##(2007-12#1)(2008-1#2)
patients diagnosed to have##3##4##(2007-7#1)(2008-4#1)(2009-10#1)
patients diagnosed with CF##2##4##(2013-1#2)
patients diagnosed with HIV infection##2##5##(2013-1#2)
patients diagnosed with a variety of##2##6##(2008-7#1)(2010-12#1)
patients diagnosed with a##3##4##(2006-8#1)(2008-7#1)(2010-12#1)
patients diagnosed with acute##2##4##(2006-7#1)(2007-8#1)
patients diagnosed with colon carcinoma in##2##6##(2006-8#2)
patients diagnosed with colon##3##4##(2006-8#3)
patients diagnosed with colorectal cancer##2##5##(2011-2#2)
patients diagnosed with esophageal cancer##2##5##(2008-12#1)(2008-2#1)
patients diagnosed with schizophrenia##2##4##(1997-8#1)(2009-10#1)
patients diagnosed with soft tissue sarcomas##2##6##(2008-6#2)
patients diagnosed with##64##3##(1991-7#1)(1996-1#1)(1997-8#2)(2004-3#1)(2006-1#1)(2006-10#2)(2006-5#1)(2006-7#3)(2006-8#6)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-12#2)(2008-2#1)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#2)(2009-6#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#1)
patients diagnosed##83##2##(1990-10#1)(1991-7#1)(1991-8#1)(1996-1#1)(1997-7#1)(1997-8#4)(2004-3#1)(2006-1#1)(2006-10#3)(2006-12#2)(2006-5#1)(2006-7#3)(2006-8#6)(2007-12#3)(2007-3#1)(2007-7#3)(2007-8#1)(2008-1#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#3)(2009-6#1)(2010-12#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-2#7)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
patients dialyzed for##2##3##(1990-11#1)(2008-1#1)
patients dialyzed##3##2##(1990-11#1)(2008-1#2)
patients did have##2##3##(1992-12#1)(2006-7#1)
patients did not correlate with##2##5##(1990-11#1)(2007-3#1)
patients did not differ significantly from##2##6##(1995-11#1)(2010-12#1)
patients did not differ significantly##3##5##(1993-2#1)(1995-11#1)(2010-12#1)
patients did not differ##5##4##(1990-1#1)(1993-2#1)(1995-11#1)(1996-3#1)(2010-12#1)
patients did not exhibit##2##4##(1995-2#1)(2012-2#1)
patients did not have##4##4##(1990-12#1)(2006-2#1)(2007-8#1)(2012-12#1)
patients did not receive##2##4##(1997-8#1)(2007-9#1)
patients did not##34##3##(1990-1#1)(1990-11#1)(1990-12#1)(1991-12#2)(1991-5#1)(1991-9#1)(1993-2#1)(1994-10#1)(1995-11#1)(1995-2#1)(1996-3#1)(1997-8#1)(2006-2#1)(2006-9#1)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
patients did well##2##3##(1990-6#1)(2008-7#1)
patients did##41##2##(1990-1#1)(1990-11#1)(1990-12#1)(1990-6#1)(1991-12#2)(1991-5#1)(1991-9#1)(1992-12#1)(1993-2#1)(1994-10#1)(1995-11#1)(1995-2#1)(1996-3#1)(1997-8#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
patients die before##2##3##(2008-10#1)(2013-8#1)
patients die##5##2##(2007-11#1)(2008-10#1)(2009-12#1)(2013-8#2)
patients died (1##2##3##(2013-1#1)(2013-8#1)
patients died (6##3##3##(2007-3#2)(2010-12#1)
patients died during the observation period##2##6##(1991-9#1)(2008-3#1)
patients died during the study##2##5##(1992-5#1)(2007-7#1)
patients died during the##6##4##(1991-9#1)(1992-5#1)(1993-2#1)(1997-4#1)(2007-7#1)(2008-3#1)
patients died during##7##3##(1991-9#1)(1992-5#1)(1993-2#1)(1997-4#1)(2007-7#1)(2007-8#1)(2008-3#1)
patients died from##5##3##(1992-4#1)(1994-3#1)(1997-4#2)(2007-3#1)
patients died in##2##3##(2006-7#1)(2011-2#1)
patients died of cardiac failure##2##5##(2007-7#1)(2007-8#1)
patients died of other##2##4##(1992-10#1)(2006-7#1)
patients died of the disease##2##5##(1991-6#1)(2008-6#1)
patients died of##19##3##(1990-12#2)(1990-6#1)(1991-4#1)(1991-6#1)(1992-10#1)(1992-8#1)(1994-12#1)(1994-3#1)(2006-11#1)(2006-7#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-6#4)
patients died within##2##3##(1990-9#1)(2007-7#1)
patients died##77##2##(1990-12#2)(1990-6#2)(1990-8#1)(1990-9#2)(1991-4#3)(1991-6#1)(1991-9#1)(1992-10#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#2)(1996-6#1)(1997-4#3)(2006-11#2)(2006-6#1)(2006-7#2)(2007-10#1)(2007-2#4)(2007-3#3)(2007-7#4)(2007-8#5)(2007-9#2)(2008-1#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#6)(2010-12#1)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
patients differ from##2##3##(2008-3#1)(2011-2#1)
patients differ with##2##3##(1995-12#1)(2010-9#1)
patients differ##4##2##(1995-12#1)(2008-3#1)(2010-9#1)(2011-2#1)
patients differs##2##2##(1996-7#1)(2008-5#1)
patients directly##2##2##(1995-2#1)(2007-4#1)
patients discharged from SHR##2##4##(2006-8#2)
patients discharged from a##2##4##(2006-1#1)(2008-9#1)
patients discharged from##8##3##(1996-12#1)(1997-8#1)(2006-1#1)(2006-8#3)(2007-7#1)(2008-9#1)
patients discharged with##2##3##(1997-1#1)(2007-4#1)
patients discharged##11##2##(1990-12#1)(1996-12#1)(1997-1#1)(1997-8#1)(2006-1#1)(2006-8#3)(2007-4#1)(2007-7#1)(2008-9#1)
patients discontinued##8##2##(1990-5#1)(2006-12#1)(2008-1#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-3#1)
patients discovered##2##2##(1992-5#1)(2011-2#1)
patients display##2##2##(2006-7#1)(2013-1#1)
patients displayed a##2##3##(2011-2#1)(2013-1#1)
patients displayed##6##2##(1994-7#1)(2007-10#1)(2007-8#1)(2008-3#1)(2011-2#1)(2013-1#1)
patients divided into two##2##4##(2007-8#1)(2008-7#1)
patients divided into##3##3##(2007-8#1)(2008-7#1)(2012-4#1)
patients divided##4##2##(1993-11#1)(2007-8#1)(2008-7#1)(2012-4#1)
patients do not have##3##4##(2008-12#1)(2008-7#1)(2008-8#1)
patients do not need##2##4##(1996-11#1)(2008-1#1)
patients do not##23##3##(1994-12#1)(1994-9#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-9#1)(2005-11#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-12#2)(2008-7#1)(2008-8#1)(2009-7#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-7#1)
patients do##28##2##(1991-8#1)(1994-12#1)(1994-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(2005-11#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-7#2)(2008-8#1)(2009-6#1)(2009-7#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-7#1)
patients does not appear to be##2##6##(2006-12#1)(2013-1#1)
patients does not##8##3##(1993-3#1)(2006-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-7#1)(2012-2#1)(2013-1#1)
patients does##9##2##(1993-3#1)(2006-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
patients dropped out of the study##2##6##(1992-11#1)(2006-2#1)
patients dropped out of##3##4##(1992-11#1)(2006-2#1)(2011-2#1)
patients dropped out##5##3##(1992-11#1)(2006-2#1)(2008-8#1)(2011-2#1)(2013-1#1)
patients due to its##2##4##(2011-1#1)(2012-2#1)
patients due to the##2##4##(2005-5#1)(2008-5#1)
patients due to##14##3##(1992-7#1)(1993-1#1)(1997-4#1)(2005-5#1)(2008-1#1)(2008-4#1)(2008-5#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
patients during 6##2##3##(1992-11#1)(2006-7#1)
patients during a period of##2##5##(2007-10#1)(2008-12#1)
patients during a##7##3##(1994-11#1)(2006-10#1)(2007-10#1)(2008-12#1)(2010-4#1)(2011-2#2)
patients during acute##2##3##(1995-11#1)(2007-7#1)
patients during and after##2##4##(1997-7#1)(2009-8#1)
patients during surgery##2##3##(2006-6#1)(2007-8#1)
patients during the first##5##4##(1990-6#1)(2007-10#1)(2007-11#1)(2010-8#1)(2011-2#1)
patients during the period##2##4##(2006-6#1)(2006-7#1)
patients during the##19##3##(1990-10#1)(1990-6#1)(1992-6#1)(1996-5#1)(2004-12#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
patients during their##3##3##(1995-9#2)(2012-3#1)
patients during##74##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-6#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-11#2)(1995-9#2)(1996-5#1)(1997-7#4)(2004-12#1)(2006-10#3)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#2)(2006-7#2)(2007-10#2)(2007-11#3)(2007-12#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#5)(2012-1#3)(2012-3#2)(2013-1#1)(2013-8#3)
patients dying at##2##3##(2006-4#2)
patients dying##5##2##(2005-8#1)(2006-4#2)(2006-6#1)(2007-8#1)
patients each##7##2##(1997-8#1)(2005-10#1)(2007-10#1)(2008-1#1)(2008-7#2)(2009-2#1)
patients either do not##2##4##(1990-4#1)(2007-2#1)
patients either##6##2##(1990-4#1)(2005-8#1)(2006-8#1)(2007-2#1)(2007-7#1)(2011-2#1)
patients eligible for##7##3##(1997-8#1)(2005-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#1)
patients eligible##8##2##(1997-8#1)(2005-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-12#1)(2013-1#1)
patients enrolled in a##2##4##(1996-12#1)(2011-2#1)
patients enrolled in the study##2##5##(2008-11#1)(2012-3#1)
patients enrolled in the##5##4##(2006-11#1)(2008-11#1)(2010-4#1)(2012-2#1)(2012-3#1)
patients enrolled in##9##3##(1996-12#1)(2006-11#1)(2008-11#1)(2008-4#1)(2010-4#2)(2011-2#1)(2012-2#1)(2012-3#1)
patients enrolled into##2##3##(2008-5#1)(2010-8#1)
patients enrolled##23##2##(1990-7#1)(1996-12#1)(2004-1#1)(2006-11#1)(2006-2#1)(2007-1#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-4#2)(2010-8#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)
patients entered in##2##3##(1993-11#1)(1996-7#1)
patients entered the study##4##4##(1990-10#1)(1991-11#1)(1992-6#1)(2013-1#1)
patients entered the##5##3##(1990-10#1)(1991-11#1)(1992-6#1)(2008-7#1)(2013-1#1)
patients entered##10##2##(1990-10#1)(1991-11#1)(1992-10#1)(1992-6#1)(1993-11#1)(1996-7#1)(2005-7#1)(2007-6#1)(2008-7#1)(2013-1#1)
patients entering##4##2##(1994-5#1)(1996-6#1)(2006-10#1)(2011-2#1)
patients evaluable for##2##3##(1990-6#1)(1991-12#1)
patients evaluated at##2##3##(2007-9#1)(2013-1#1)
patients evaluated in##3##3##(2007-6#1)(2010-11#1)(2011-2#1)
patients evaluated the##2##3##(1991-3#1)(1992-11#1)
patients evaluated##13##2##(1990-8#1)(1991-3#1)(1992-11#1)(1996-9#1)(2006-10#1)(2007-10#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-3#1)(2010-11#1)(2011-2#1)(2013-1#1)
patients even##3##2##(1992-2#1)(2006-8#1)(2011-1#1)
patients eventually##5##2##(2006-10#1)(2006-11#1)(2010-3#1)(2010-5#1)(2013-8#1)
patients evolving##2##2##(2009-4#1)(2011-2#1)
patients examined##6##2##(1991-7#1)(1995-9#1)(2006-10#1)(2008-4#1)(2010-12#1)(2011-2#1)
patients except one##6##3##(1996-2#1)(1997-8#1)(2006-11#1)(2007-3#1)(2007-8#1)(2008-1#1)
patients except##9##2##(1996-2#1)(1997-8#1)(2006-11#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-3#2)
patients exhibit##2##2##(2007-8#1)(2008-7#1)
patients exhibited a##5##3##(1991-8#1)(1992-5#1)(1996-3#1)(2007-7#1)(2007-9#1)
patients exhibited no##2##3##(1995-3#2)
patients exhibited##18##2##(1991-1#1)(1991-8#2)(1992-5#1)(1995-3#2)(1996-3#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-8#1)(2008-9#1)(2009-1#2)(2009-9#1)(2010-12#1)(2013-8#1)
patients exhibiting##2##2##(2007-12#1)(2010-3#1)
patients experience a##4##3##(1992-5#1)(1995-6#1)(2007-11#1)(2007-8#1)
patients experience##16##2##(1992-5#1)(1995-1#1)(1995-6#1)(1995-9#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-3#1)(2009-2#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
patients experienced a significant##2##4##(1994-1#1)(2008-8#1)
patients experienced a##12##3##(1992-2#1)(1994-1#1)(2004-1#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-7#1)(2008-8#1)(2009-3#1)(2012-3#1)(2013-1#2)
patients experienced at least##2##4##(2008-10#1)(2008-6#1)
patients experienced delayed##2##3##(1991-9#1)(2006-5#1)
patients experienced moderate##2##3##(1992-12#1)(2007-2#1)
patients experienced##51##2##(1990-10#1)(1990-12#1)(1990-8#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#1)(1994-1#1)(1994-3#1)(2004-1#1)(2005-10#1)(2006-11#1)(2006-5#1)(2006-7#1)(2006-8#5)(2007-11#3)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-11#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-4#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
patients experiencing significant relief##2##4##(2006-8#2)
patients experiencing##13##2##(1994-2#1)(2006-8#3)(2007-11#1)(2008-11#1)(2008-12#1)(2008-6#3)(2008-7#1)(2010-3#1)(2012-2#1)
patients expired##2##2##(1997-3#1)(2008-1#1)
patients exposed to##7##3##(1996-9#1)(1997-2#1)(2004-11#1)(2005-8#1)(2008-7#1)(2010-5#1)(2013-1#1)
patients expressed##3##2##(1991-9#1)(2007-2#1)(2007-7#1)
patients fail to##3##3##(1996-1#1)(2009-10#1)(2010-12#1)
patients failed conservative management##2##4##(2006-8#1)(2008-8#1)
patients failed to##2##3##(1990-4#1)(2008-11#1)
patients failed##4##2##(1990-4#1)(2006-8#1)(2008-11#1)(2008-8#1)
patients failing##7##2##(2005-8#1)(2006-10#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)
patients feel##2##2##(2006-3#1)(2008-12#1)
patients fell##2##2##(2007-2#1)(2009-12#1)
patients filled##2##2##(1994-9#1)(2010-2#1)
patients find##2##2##(1997-3#1)(2006-10#1)
patients first##2##2##(1993-2#1)(1995-3#1)
patients follow a##2##3##(2009-8#1)(2010-12#1)
patients followed at##3##3##(2007-12#1)(2008-1#1)(2008-10#1)
patients followed for up to##2##5##(1991-2#1)(2007-8#1)
patients followed for##4##3##(1991-2#1)(2006-11#1)(2007-8#1)(2011-2#1)
patients followed in##2##3##(1993-5#1)(2011-2#1)
patients followed##14##2##(1991-2#1)(1993-5#1)(1997-6#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#2)
patients following the##2##3##(2007-7#1)(2007-8#1)
patients following treatment##2##3##(2006-11#1)(2006-9#1)
patients following##29##2##(1990-11#1)(1991-1#1)(1991-11#1)(1992-2#1)(2006-11#1)(2006-2#1)(2006-4#1)(2006-8#1)(2006-9#2)(2007-4#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#4)
patients for CEA##2##3##(1995-10#1)(2007-9#1)
patients for CRT##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
patients for HIV##2##3##(1994-4#1)(2010-12#1)
patients for a mean##2##4##(2006-8#1)(2007-9#1)
patients for a##5##3##(1993-9#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-9#1)
patients for active##2##3##(1991-12#1)(2011-2#1)
patients for cardiac##2##3##(2007-8#1)(2008-7#1)
patients for clinical##2##3##(1993-8#1)(2007-8#1)
patients for each##2##3##(2008-3#1)(2009-3#1)
patients for early##3##3##(2005-10#1)(2008-3#1)(2008-4#1)
patients for further##2##3##(2006-9#1)(2007-9#1)
patients for liver transplantation##2##4##(1990-10#1)(2008-12#1)
patients for operation##2##3##(1990-8#2)
patients for palliative radiotherapy##2##4##(2007-6#2)
patients for such##2##3##(2010-11#1)(2013-1#1)
patients for surgery##4##3##(2006-10#2)(2006-11#1)(2012-3#1)
patients for surgical treatment and##2##5##(2006-6#1)(2007-11#1)
patients for surgical treatment##3##4##(2006-6#1)(2007-11#1)(2008-9#1)
patients for the period##2##4##(2008-8#2)
patients for the##13##3##(1990-5#1)(1990-6#1)(2006-10#3)(2007-11#2)(2008-8#2)(2010-12#1)(2010-6#1)(2011-2#1)(2013-8#1)
patients for these##2##3##(2010-12#1)(2013-1#1)
patients for treatment##4##3##(1992-8#1)(1992-9#1)(1995-9#1)(1997-3#1)
patients for whom no##2##4##(1990-2#1)(2010-12#1)
patients for whom##12##3##(1990-2#1)(1992-3#1)(1992-5#1)(1995-11#1)(1996-1#1)(2006-10#1)(2006-11#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
patients for##156##2##(1990-10#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-12#2)(1991-2#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-8#1)(1995-10#2)(1995-11#1)(1995-4#1)(1995-9#1)(1996-1#2)(1996-3#1)(1996-4#1)(1997-3#1)(1997-8#2)(2004-3#1)(2005-10#2)(2005-7#1)(2006-10#9)(2006-11#3)(2006-12#2)(2006-6#2)(2006-8#3)(2006-9#2)(2007-11#5)(2007-12#4)(2007-2#1)(2007-4#1)(2007-6#3)(2007-7#4)(2007-8#7)(2007-9#7)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#1)(2009-4#2)(2009-8#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#2)
patients found that##2##3##(2008-2#1)(2008-6#1)
patients found##8##2##(1990-2#1)(2007-11#1)(2008-2#1)(2008-6#1)(2009-11#1)(2009-6#3)
patients frequently have##3##3##(1995-11#1)(2008-3#1)(2011-2#1)
patients frequently##9##2##(1995-11#1)(2005-8#1)(2006-10#2)(2008-3#1)(2009-7#1)(2010-12#1)(2011-2#1)(2011-3#1)
patients from 22##3##3##(2006-6#1)(2008-7#1)(2012-2#1)
patients from Odummara Obi-Orodo were##2##5##(2008-2#2)
patients from Umuneke Ugiri and##2##5##(2008-2#2)
patients from a single##3##4##(1994-4#1)(2007-7#1)(2010-12#1)
patients from a##18##3##(1992-12#1)(1994-4#1)(1995-1#1)(1996-2#1)(1996-3#1)(2006-8#1)(2007-2#1)(2007-7#2)(2009-5#1)(2010-12#1)(2010-5#2)(2011-2#1)(2012-12#1)(2013-1#3)
patients from all##5##3##(2006-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2010-8#1)
patients from an##3##3##(2007-12#1)(2013-1#2)
patients from both##3##3##(2007-11#1)(2007-8#1)(2012-2#1)
patients from controls##3##3##(1997-2#1)(2008-9#1)(2011-2#1)
patients from developing##3##3##(2006-10#1)(2011-2#2)
patients from each##2##3##(1991-2#1)(2008-8#1)
patients from endemic areas##2##4##(1993-3#1)(2007-12#1)
patients from group##5##3##(1996-3#2)(2007-8#1)(2008-3#1)(2008-5#1)
patients from our##2##3##(2008-8#1)(2010-3#1)
patients from that##2##3##(1993-1#1)(2007-9#1)
patients from the control group##2##5##(2007-10#1)(2011-2#1)
patients from the##27##3##(1990-3#1)(1991-5#1)(1992-5#1)(1993-10#1)(1993-8#2)(1995-1#1)(1995-4#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-3#1)(2010-6#1)(2011-2#4)(2012-3#1)
patients from those##2##3##(2007-12#1)(2012-12#1)
patients from two##3##3##(2008-8#1)(2011-1#1)(2012-12#1)
patients from unrelated##2##3##(2007-11#1)(2008-2#1)
patients from##161##2##(1990-3#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-5#1)(1993-1#2)(1993-10#1)(1993-12#2)(1993-3#2)(1993-4#1)(1993-8#2)(1994-12#1)(1994-4#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-4#1)(1995-8#1)(1996-2#1)(1996-3#4)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2005-8#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#2)(2006-8#2)(2007-10#1)(2007-11#5)(2007-12#5)(2007-2#4)(2007-3#2)(2007-4#1)(2007-7#6)(2007-8#9)(2007-9#3)(2008-1#1)(2008-10#2)(2008-2#6)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-10#3)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#2)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#11)(2012-1#1)(2012-12#8)(2012-2#4)(2012-3#1)(2013-1#8)
patients fulfilled the criteria##2##4##(2006-8#1)(2008-6#1)
patients fulfilled the diagnostic criteria for##2##6##(2008-7#1)(2013-8#1)
patients fulfilled the##8##3##(2006-10#1)(2006-8#1)(2007-3#2)(2008-1#1)(2008-6#1)(2008-7#1)(2013-8#1)
patients fulfilled##9##2##(2006-10#1)(2006-8#1)(2007-3#2)(2008-1#1)(2008-6#1)(2008-7#1)(2009-6#1)(2013-8#1)
patients fulfilling##4##2##(1995-11#1)(2006-12#1)(2008-11#1)(2012-3#1)
patients further##2##2##(2005-12#1)(2011-1#1)
patients gave a history of##2##5##(2004-10#1)(2008-3#1)
patients gave a##4##3##(1990-10#1)(2004-10#1)(2007-7#1)(2008-3#1)
patients gave##8##2##(1990-10#1)(1990-9#1)(1994-3#1)(2004-10#1)(2005-7#1)(2006-10#1)(2007-7#1)(2008-3#1)
patients generally##2##2##(2008-7#1)(2010-3#1)
patients given placebo##2##3##(1995-2#1)(2008-3#1)
patients given##7##2##(1990-6#1)(1995-2#1)(1996-5#1)(2008-3#2)(2013-1#2)
patients going##2##2##(1990-2#1)(2007-8#1)
patients got##2##2##(1993-1#1)(2012-2#1)
patients group##6##2##(2008-8#1)(2011-1#1)(2011-2#2)(2013-1#2)
patients groups##3##2##(1995-12#1)(2007-7#1)(2008-8#1)
patients had AIDS##2##3##(1993-11#1)(2007-7#1)
patients had NEC##2##3##(2012-2#2)
patients had a complete##2##4##(1992-10#1)(1993-5#1)
patients had a fistula##2##4##(1991-8#1)(2007-7#1)
patients had a greater##2##4##(2006-12#1)(2008-11#1)
patients had a history of##5##5##(2006-2#1)(2007-2#1)(2007-7#1)(2009-10#1)(2010-6#1)
patients had a longer##2##4##(2007-8#1)(2011-2#1)
patients had a mean##3##4##(2008-1#1)(2008-7#1)(2013-1#1)
patients had a normal##2##4##(1992-9#1)(2007-10#1)
patients had a positive##2##4##(1993-5#1)(2006-9#1)
patients had a significantly higher##2##5##(1991-3#1)(2011-2#1)
patients had a significantly##4##4##(1991-3#1)(2007-8#1)(2008-7#1)(2011-2#1)
patients had a similar##2##4##(2010-3#1)(2011-1#1)
patients had a standard##2##4##(2006-12#1)(2011-2#1)
patients had a total##2##4##(1992-11#1)(2006-10#1)
patients had a##92##3##(1990-2#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-5#3)(1994-11#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-3#1)(1997-3#1)(2004-1#1)(2004-4#1)(2005-10#1)(2006-10#3)(2006-12#3)(2006-2#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-7#7)(2007-8#5)(2007-9#4)(2008-1#2)(2008-11#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-3#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-2#3)(2013-1#5)
patients had acute##4##3##(1994-7#1)(2005-10#1)(2007-12#1)(2009-10#1)
patients had additional##3##3##(1993-8#1)(1997-8#1)(2004-11#1)
patients had advanced##2##3##(2007-7#1)(2012-12#1)
patients had an##22##3##(1990-11#1)(1992-2#1)(1993-11#1)(1995-1#1)(1996-6#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-8#2)(2008-6#1)(2008-7#1)(2010-1#1)(2010-3#1)(2011-11#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)
patients had antibodies##2##3##(1990-6#1)(1995-1#1)
patients had at least one##2##5##(2008-10#1)(2012-3#1)
patients had at least##5##4##(1994-2#1)(2008-10#1)(2012-3#1)(2013-8#2)
patients had been diagnosed as##2##5##(2007-7#2)
patients had been diagnosed with the##2##6##(2013-1#2)
patients had been diagnosed with##3##5##(2011-2#1)(2013-1#2)
patients had been diagnosed##5##4##(2007-7#2)(2011-2#1)(2013-1#2)
patients had been previously treated with##3##6##(1992-10#1)(1992-8#1)(2012-3#1)
patients had been submitted to##2##5##(1990-4#1)(2011-1#1)
patients had been treated with##2##5##(2006-4#1)(2008-5#1)
patients had been treated##5##4##(1997-6#1)(2006-4#1)(2007-8#1)(2008-5#1)(2012-3#1)
patients had been##31##3##(1990-12#1)(1990-3#1)(1990-4#3)(1991-5#1)(1992-10#1)(1992-8#1)(1994-5#1)(1995-1#1)(1995-4#1)(1997-6#1)(2004-11#1)(2005-8#1)(2006-4#2)(2007-11#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-3#2)(2013-1#2)
patients had bilateral##2##3##(2007-8#1)(2008-7#1)
patients had both##3##3##(1990-11#1)(1990-8#1)(2007-8#1)
patients had carcinoma of the##2##5##(1990-9#2)
patients had cardiovascular##3##3##(1997-5#1)(2007-3#2)
patients had chronic renal failure##2##5##(1994-6#1)(2006-6#1)
patients had clinical##3##3##(1991-2#1)(2007-12#1)(2008-7#1)
patients had complaints##3##3##(1990-5#1)(2006-8#2)
patients had complete remission##2##4##(2007-7#1)(2007-8#1)
patients had complete##11##3##(1995-2#1)(2006-11#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-3#3)(2008-8#1)(2010-4#1)(2012-3#1)
patients had concomitant##2##3##(2006-4#1)(2008-3#1)
patients had dermatoses known to be associated with##2##8##(2007-7#2)
patients had diabetes mellitus##2##4##(2008-8#1)(2013-8#1)
patients had diabetes##6##3##(2007-8#1)(2008-8#1)(2012-12#1)(2013-1#2)(2013-8#1)
patients had disease##3##3##(1995-12#3)
patients had elevated##4##3##(1991-4#2)(1992-3#1)(2006-10#1)
patients had evidence of##3##4##(2007-7#1)(2007-8#1)(2012-2#1)
patients had excellent results##3##4##(1990-6#1)(2006-10#1)(2007-8#1)
patients had excellent##4##3##(1990-6#1)(2006-10#1)(2007-8#1)(2013-1#1)
patients had experienced##3##3##(1994-11#1)(2004-11#1)(2007-7#1)
patients had failed##4##3##(1991-4#1)(2007-11#1)(2008-5#1)(2012-12#1)
patients had good##2##3##(1990-7#1)(2006-10#1)
patients had had##8##3##(1991-2#2)(1992-8#1)(1995-7#1)(1996-6#2)(2008-10#1)(2008-6#1)
patients had high##2##3##(1995-3#1)(2007-7#1)
patients had higher##6##3##(1994-10#1)(1997-5#1)(2008-11#1)(2011-2#1)(2013-1#2)
patients had history of##4##4##(2007-2#1)(2007-7#1)(2013-1#2)
patients had improved##2##3##(2006-7#1)(2009-3#1)
patients had known##4##3##(1991-12#1)(2007-10#1)(2008-6#1)(2012-12#1)
patients had left##2##3##(2007-10#1)(2013-1#1)
patients had longer##2##3##(2007-8#1)(2008-4#1)
patients had low##2##3##(2007-10#1)(2008-4#1)
patients had lower##4##3##(1996-8#1)(2007-10#1)(2009-3#1)(2013-8#1)
patients had major##2##3##(1992-6#1)(2007-8#1)
patients had marked##4##3##(2006-9#1)(2008-7#1)(2011-2#1)(2012-12#1)
patients had markedly##2##3##(2007-3#1)(2010-12#1)
patients had massive##2##3##(1992-9#1)(1994-12#1)
patients had moderate to##2##4##(2006-10#1)(2012-3#1)
patients had moderate##4##3##(1992-9#1)(2006-10#1)(2008-6#1)(2012-3#1)
patients had more##4##3##(1990-5#1)(2007-1#1)(2007-8#1)(2011-2#1)
patients had multiple##5##3##(1993-12#1)(1996-2#1)(2007-8#1)(2013-1#2)
patients had negative##2##3##(2006-9#1)(2012-3#1)
patients had no##17##3##(1991-3#1)(1991-6#1)(1992-10#3)(1995-12#1)(2004-2#1)(2005-10#1)(2006-12#1)(2007-6#1)(2007-9#1)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
patients had normal findings##2##4##(1990-3#1)(2006-8#1)
patients had normal##13##3##(1990-2#1)(1990-3#2)(1991-8#1)(1995-1#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-7#1)(2011-1#2)(2011-2#1)
patients had not been##2##4##(1992-9#1)(2008-10#1)
patients had not received##2##4##(1991-4#1)(2007-10#1)
patients had not##6##3##(1991-4#1)(1992-11#1)(1992-9#1)(1994-2#1)(2007-10#1)(2008-10#1)
patients had occlusive##2##3##(2007-10#2)
patients had one or more##3##5##(2007-3#1)(2011-1#1)(2011-2#1)
patients had only##2##3##(2008-4#1)(2008-8#1)
patients had pain##2##3##(1992-8#1)(2007-11#1)
patients had partial##2##3##(1990-2#1)(2007-10#1)
patients had persistent##5##3##(1993-1#1)(1993-3#1)(2006-12#1)(2007-8#1)(2011-2#1)
patients had poor##2##3##(2006-10#1)(2008-4#1)
patients had positive##4##3##(1991-5#1)(2008-5#1)(2008-6#1)(2008-8#1)
patients had previous##2##3##(1994-9#1)(2009-3#1)
patients had previously##4##3##(1991-9#1)(2006-6#1)(2006-7#1)(2008-7#1)
patients had primary##2##3##(1990-10#1)(2007-7#1)
patients had received previous treatment##2##5##(1990-4#1)(1992-8#1)
patients had received the##2##4##(1990-2#1)(2013-1#1)
patients had received##13##3##(1990-10#1)(1990-2#1)(1990-4#1)(1991-2#1)(1992-5#1)(1992-8#1)(2007-6#1)(2007-7#1)(2008-6#1)(2008-7#1)(2010-12#1)(2013-1#2)
patients had recurrent##4##3##(1992-6#1)(2007-8#1)(2008-4#1)(2011-2#1)
patients had reduced##2##3##(2007-11#1)(2011-2#1)
patients had renal##3##3##(2007-3#2)(2008-4#1)
patients had respiratory##2##3##(2007-2#1)(2011-1#1)
patients had right##2##3##(2007-10#1)(2010-3#1)
patients had serum##2##3##(2006-2#1)(2007-2#1)
patients had severe##4##3##(1990-6#1)(2006-7#1)(2007-8#2)
patients had significant##2##3##(2008-6#1)(2011-2#1)
patients had significantly elevated##2##4##(1995-6#1)(2008-7#1)
patients had significantly fewer##2##4##(2006-10#1)(2012-1#1)
patients had significantly higher##3##4##(2008-11#1)(2011-11#1)(2013-8#1)
patients had significantly lower##2##4##(2011-11#1)(2013-1#1)
patients had significantly more##2##4##(1996-3#1)(2007-10#1)
patients had significantly##14##3##(1995-6#2)(1996-3#1)(1996-5#1)(2005-10#1)(2006-10#1)(2007-10#1)(2008-11#1)(2008-7#1)(2011-11#2)(2012-1#1)(2013-1#1)(2013-8#1)
patients had similar##2##3##(1995-9#1)(2013-1#1)
patients had sinus node disease##2##5##(1992-4#1)(2008-3#1)
patients had sinus##3##3##(1992-4#1)(2007-8#1)(2008-3#1)
patients had skin##3##3##(2007-3#2)(2012-2#1)
patients had stable disease##4##4##(1991-12#1)(1992-12#1)(2006-6#1)(2008-6#1)
patients had stable##5##3##(1991-12#1)(1992-12#1)(2006-6#1)(2007-8#1)(2008-6#1)
patients had sustained a##2##4##(2006-8#2)
patients had sustained##3##3##(2006-8#2)(2008-7#1)
patients had symptoms of##2##4##(1991-2#1)(2008-6#1)
patients had the most##2##4##(2005-10#1)(2010-4#1)
patients had the##9##3##(1993-5#2)(2005-10#1)(2006-10#1)(2006-6#1)(2008-3#1)(2008-6#1)(2010-10#1)(2010-4#1)
patients had their initial##2##4##(2007-2#1)(2010-8#1)
patients had their##3##3##(1994-6#1)(2007-2#1)(2010-8#1)
patients had to be##2##4##(1990-8#1)(2007-8#1)
patients had to##4##3##(1990-8#1)(2006-10#1)(2006-6#1)(2007-8#1)
patients had transient##2##3##(2006-10#1)(2007-8#1)
patients had type##3##3##(1997-8#1)(2012-4#2)
patients had typical##2##3##(1991-3#1)(2007-8#1)
patients had undergone previous##2##4##(2007-8#1)(2011-2#1)
patients had undergone##6##3##(1991-2#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-4#1)(2011-2#1)
patients had used##2##3##(1995-9#1)(2010-2#1)
patients had vivax malaria##2##4##(2007-2#2)
patients had##742##2##(1990-1#1)(1990-10#4)(1990-11#2)(1990-12#3)(1990-2#8)(1990-3#4)(1990-4#6)(1990-5#2)(1990-6#4)(1990-7#1)(1990-8#6)(1990-9#3)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#8)(1991-3#3)(1991-4#7)(1991-5#4)(1991-6#3)(1991-8#4)(1991-9#4)(1992-1#1)(1992-10#6)(1992-11#4)(1992-12#4)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#5)(1992-8#4)(1992-9#6)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#6)(1993-8#2)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#4)(1995-10#1)(1995-11#2)(1995-12#7)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#5)(1995-7#3)(1995-9#5)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#7)(1996-8#1)(1996-9#2)(1997-1#1)(1997-3#5)(1997-5#2)(1997-6#1)(1997-8#4)(2004-1#1)(2004-11#5)(2004-2#2)(2004-4#1)(2005-10#5)(2005-8#1)(2006-10#23)(2006-11#4)(2006-12#8)(2006-2#2)(2006-3#2)(2006-4#5)(2006-5#1)(2006-6#7)(2006-7#5)(2006-8#12)(2006-9#4)(2007-1#1)(2007-10#17)(2007-11#9)(2007-12#5)(2007-2#13)(2007-3#23)(2007-6#3)(2007-7#36)(2007-8#44)(2007-9#12)(2008-1#8)(2008-10#7)(2008-11#7)(2008-2#1)(2008-3#7)(2008-4#10)(2008-5#5)(2008-6#18)(2008-7#26)(2008-8#12)(2008-9#2)(2009-10#2)(2009-2#2)(2009-3#6)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#5)(2010-4#4)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#13)(2011-11#3)(2011-12#3)(2011-2#32)(2012-1#1)(2012-12#11)(2012-2#12)(2012-3#13)(2012-4#2)(2013-1#34)(2013-8#11)
patients harboring##4##2##(2006-10#1)(2007-11#1)(2007-12#1)(2008-7#1)
patients harbouring##2##2##(2011-2#1)(2013-1#1)
patients has a##2##3##(1993-10#1)(1994-3#1)
patients has been performed##2##4##(2005-8#1)(2007-8#1)
patients has been reported to##2##5##(2007-1#1)(2007-8#1)
patients has been reported##4##4##(2006-10#1)(2007-1#1)(2007-8#1)(2010-12#1)
patients has been##21##3##(1993-4#1)(1995-8#1)(2004-11#1)(2005-8#1)(2006-10#2)(2006-8#1)(2007-1#1)(2007-11#3)(2007-2#1)(2007-8#2)(2008-2#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#2)
patients has not so far##2##5##(1991-12#1)(2007-2#1)
patients has not##4##3##(1991-12#1)(2007-2#1)(2008-1#1)(2010-3#1)
patients has shown##3##3##(2006-10#1)(2007-9#1)(2009-2#1)
patients has yielded##2##3##(1990-3#1)(2007-11#1)
patients has##54##2##(1990-3#1)(1991-12#1)(1993-10#1)(1993-4#1)(1994-3#1)(1995-8#1)(1996-9#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-4#1)(2006-8#2)(2007-1#1)(2007-11#4)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-1#1)(2009-2#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-1#2)(2012-2#2)(2013-1#4)(2013-8#1)
patients have a higher##2##4##(2008-8#1)(2012-2#1)
patients have a more##2##4##(2004-11#1)(2006-10#1)
patients have a reduced##2##4##(2007-7#1)(2008-7#1)
patients have a##27##3##(1996-11#1)(1997-3#1)(2004-11#1)(2006-10#2)(2007-7#1)(2007-8#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-9#1)(2010-10#2)(2010-3#1)(2010-7#2)(2012-12#2)(2012-2#2)(2013-1#3)
patients have an increased risk##2##5##(1990-12#1)(2007-12#1)
patients have an increased##4##4##(1990-12#1)(2006-9#1)(2007-12#1)(2008-7#1)
patients have an##6##3##(1990-12#1)(2006-9#1)(2007-12#1)(2008-5#1)(2008-6#1)(2008-7#1)
patients have been described in the##2##6##(2006-10#1)(2007-5#1)
patients have been described##3##4##(1997-3#1)(2006-10#1)(2007-5#1)
patients have been enrolled##2##4##(1995-11#1)(2010-3#1)
patients have been identified##2##4##(2005-10#1)(2006-10#1)
patients have been reported to##2##5##(1997-7#1)(2008-1#1)
patients have been reported##4##4##(1997-7#1)(2007-10#1)(2007-3#1)(2008-1#1)
patients have been treated with##5##5##(1992-10#1)(1995-2#1)(1996-8#1)(2006-6#1)(2008-8#1)
patients have been treated##9##4##(1990-5#1)(1991-2#1)(1991-3#1)(1992-10#1)(1992-8#1)(1995-2#1)(1996-8#1)(2006-6#1)(2008-8#1)
patients have been##51##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-10#1)(1992-8#1)(1993-11#1)(1993-5#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-9#1)(1996-8#1)(1997-3#1)(1997-7#1)(2005-10#2)(2006-10#2)(2006-6#2)(2006-8#1)(2007-10#2)(2007-11#4)(2007-12#1)(2007-3#1)(2007-5#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-8#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-12#1)(2011-7#1)(2012-2#1)(2013-1#2)
patients have contributed to##2##4##(1995-6#1)(2010-7#1)
patients have died##2##3##(2006-8#1)(2007-11#1)
patients have difficulty##2##3##(2008-4#1)(2012-12#1)
patients have experienced##3##3##(1990-6#1)(1997-6#1)(2008-6#1)
patients have expressed##2##3##(2007-1#1)(2013-1#1)
patients have had##2##3##(2007-8#1)(2008-1#1)
patients have increased##4##3##(1994-2#1)(2007-6#1)(2008-1#1)(2009-4#1)
patients have less##2##3##(2007-8#2)
patients have multiple##2##3##(1993-3#1)(2008-7#1)
patients have no##3##3##(2006-8#1)(2007-3#1)(2011-1#1)
patients have not been##2##4##(1990-1#1)(2006-10#1)
patients have not##4##3##(1990-1#1)(1997-3#1)(2006-10#1)(2008-3#1)
patients have relapsed##2##3##(1994-5#1)(2006-10#1)
patients have shown##3##3##(1992-9#1)(2006-10#1)(2008-9#1)
patients have started##2##3##(2007-7#1)(2008-10#1)
patients have to be##4##4##(1996-2#1)(2010-12#1)(2011-1#1)(2011-2#1)
patients have to##9##3##(1996-2#1)(2007-12#1)(2009-3#1)(2010-12#2)(2011-1#1)(2011-2#1)(2013-8#2)
patients have undergone##5##3##(2006-10#1)(2007-7#2)(2008-1#1)(2010-8#1)
patients have##210##2##(1990-1#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-9#1)(1995-11#2)(1995-2#2)(1995-4#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-8#1)(1997-1#1)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-9#1)(2005-10#2)(2005-8#1)(2006-1#1)(2006-10#13)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#4)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#7)(2007-12#6)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#3)(2007-7#6)(2007-8#8)(2008-1#6)(2008-10#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#7)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-10#3)(2010-12#7)(2010-3#4)(2010-7#4)(2010-8#2)(2011-1#5)(2011-12#2)(2011-2#1)(2011-7#1)(2012-12#6)(2012-2#5)(2012-3#2)(2013-1#8)(2013-8#5)
patients having a##5##3##(1996-2#1)(2004-11#1)(2007-11#1)(2010-3#1)(2012-3#1)
patients having chronic##2##3##(2005-10#1)(2007-7#1)
patients having the##2##3##(1991-5#1)(2005-11#1)
patients having undergone##4##3##(1995-12#1)(2006-6#1)(2008-6#1)(2009-6#1)
patients having##48##2##(1991-5#1)(1991-8#1)(1993-1#1)(1993-4#1)(1993-9#1)(1994-3#1)(1995-12#1)(1996-2#1)(2004-1#1)(2004-11#1)(2005-10#1)(2005-11#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-7#5)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
patients homozygous for the##2##4##(1992-12#1)(1995-12#1)
patients homozygous##3##2##(1992-12#1)(1995-12#1)(1997-7#1)
patients hospitalised at##2##3##(2004-10#1)(2010-9#1)
patients hospitalised in##2##3##(1991-11#1)(2007-8#1)
patients hospitalised##6##2##(1991-11#1)(2004-10#1)(2007-8#1)(2008-6#1)(2010-9#1)(2013-7#1)
patients hospitalized after stroke##2##4##(2007-10#2)
patients hospitalized for acute##3##4##(2008-10#1)(2008-5#1)(2008-7#1)
patients hospitalized for##12##3##(1997-3#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-6#1)(2012-12#1)(2012-3#1)
patients hospitalized in the same##2##5##(1990-3#1)(1993-9#1)
patients hospitalized in the##3##4##(1990-3#1)(1993-9#1)(1996-11#1)
patients hospitalized in##6##3##(1990-3#1)(1993-9#1)(1996-11#1)(2007-11#1)(2007-8#1)(2012-12#1)
patients hospitalized with severe##2##4##(1993-9#1)(2012-12#1)
patients hospitalized with##8##3##(1993-2#1)(1993-9#1)(2008-3#1)(2009-4#1)(2010-4#1)(2012-12#2)(2013-1#1)
patients hospitalized##33##2##(1990-12#1)(1990-3#1)(1993-2#2)(1993-5#1)(1993-9#2)(1996-11#1)(1997-3#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2010-4#1)(2010-6#1)(2012-12#4)(2012-3#1)(2013-1#1)
patients identified from##2##3##(2007-8#1)(2009-9#1)
patients identified##9##2##(1996-11#1)(2007-8#3)(2008-3#1)(2009-10#1)(2009-9#1)(2010-11#1)(2010-8#1)
patients if they are##2##4##(1991-5#1)(2008-1#1)
patients if they##4##3##(1991-5#1)(2005-10#1)(2007-11#1)(2008-1#1)
patients if##8##2##(1991-5#1)(1995-9#1)(2005-10#1)(2007-11#1)(2008-1#1)(2010-12#1)(2013-1#2)
patients immediately##2##2##(1990-9#1)(1996-9#1)
patients immunosuppressed by##2##3##(2008-12#1)(2008-5#1)
patients implanted with##2##3##(1997-1#1)(2008-9#1)
patients improve the##2##3##(2008-10#1)(2008-3#1)
patients improve##3##2##(2007-6#1)(2008-10#1)(2008-3#1)
patients improved in##2##3##(2007-7#1)(2007-8#1)
patients improved significantly##2##3##(2006-12#1)(2008-9#1)
patients improved their##2##3##(2011-12#1)(2011-2#1)
patients improved##14##2##(1995-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-8#3)(2007-7#1)(2007-8#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-12#1)(2011-2#1)
patients in CR##2##3##(2008-6#2)
patients in Calabar##3##3##(2008-4#2)(2013-1#1)
patients in Egypt##2##3##(2007-7#2)
patients in Europe##2##3##(2008-1#1)(2008-7#1)
patients in Germany##2##3##(1997-4#1)(2006-10#1)
patients in Group 1##3##4##(2006-11#1)(2011-1#1)(2012-2#1)
patients in Group I##3##4##(2006-5#1)(2006-8#2)
patients in Group II##2##4##(2006-8#2)
patients in Group##8##3##(2006-11#1)(2006-5#1)(2006-8#4)(2011-1#1)(2012-2#1)
patients in Japan##9##3##(1994-2#1)(1994-3#1)(2007-10#1)(2007-2#1)(2008-1#2)(2008-10#1)(2012-2#1)(2013-1#1)
patients in Norway##2##3##(1990-9#1)(1996-2#1)
patients in Ontario##3##3##(2007-12#2)(2011-2#1)
patients in Santo André##2##4##(2011-2#2)
patients in Saudi Arabia##4##4##(2006-2#2)(2007-3#1)(2008-1#1)
patients in a tertiary care hospital in##2##7##(2008-11#1)(2011-2#1)
patients in a tertiary care hospital##3##6##(2008-11#1)(2011-12#1)(2011-2#1)
patients in a tertiary care##4##5##(2006-7#1)(2008-11#1)(2011-12#1)(2011-2#1)
patients in a##51##3##(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-4#1)(1992-8#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-9#2)(1997-1#1)(2004-3#1)(2006-7#4)(2006-8#2)(2006-9#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2009-7#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
patients in accordance with the##3##5##(2007-8#1)(2008-6#1)(2013-1#1)
patients in acute##3##3##(1992-1#1)(2011-1#2)
patients in advanced##2##3##(2008-5#1)(2010-11#1)
patients in age##2##3##(2004-10#1)(2011-2#1)
patients in all groups##2##4##(2010-7#2)
patients in all##7##3##(1992-6#1)(1997-2#1)(2006-12#1)(2008-3#1)(2010-12#1)(2010-7#2)
patients in an interventional pain management practice##3##7##(2006-7#1)(2006-8#2)
patients in an interventional pain management setting##3##7##(2006-7#1)(2006-8#2)
patients in an interventional pain management##6##6##(2006-7#2)(2006-8#4)
patients in an##19##3##(1990-4#1)(1991-11#1)(1991-3#1)(1992-12#1)(1997-1#1)(2006-7#2)(2006-8#4)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2009-4#1)(2010-3#1)(2012-2#1)
patients in both groups were##3##5##(2007-7#1)(2008-8#1)(2012-3#1)
patients in both groups##10##4##(1994-5#1)(1995-6#1)(2004-3#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-8#1)(2009-12#1)(2012-2#1)(2012-3#1)
patients in chronic renal failure##2##5##(2005-10#1)(2006-10#1)
patients in chronic##3##3##(2005-10#1)(2005-7#1)(2006-10#1)
patients in classroom teaching##2##4##(2008-11#2)
patients in clinical##2##3##(1995-12#1)(2008-5#1)
patients in community##3##3##(1990-6#1)(1993-2#1)(2011-1#1)
patients in comparison to##2##4##(1995-12#1)(2009-6#1)
patients in comparison with control##2##5##(2006-10#1)(2013-7#1)
patients in comparison with##7##4##(2006-10#2)(2008-9#1)(2010-12#2)(2011-2#1)(2013-7#1)
patients in comparison##9##3##(1995-12#1)(2006-10#2)(2008-9#1)(2009-6#1)(2010-12#2)(2011-2#1)(2013-7#1)
patients in controlled##2##3##(1995-12#1)(2006-12#1)
patients in critical##3##3##(1991-2#1)(2013-1#2)
patients in different stages of##2##5##(2008-5#1)(2008-7#1)
patients in different##8##3##(2007-12#1)(2007-9#1)(2008-5#1)(2008-7#1)(2010-9#1)(2011-2#2)(2013-1#1)
patients in each group were##2##5##(2006-8#2)
patients in each group##8##4##(1993-7#1)(2006-10#1)(2006-7#1)(2006-8#3)(2006-9#1)(2009-6#1)
patients in each##9##3##(1993-7#1)(2006-10#1)(2006-7#1)(2006-8#3)(2006-9#1)(2009-6#1)(2011-2#1)
patients in early##3##3##(1990-11#1)(2012-3#1)(2013-1#1)
patients in either group##2##4##(2008-6#1)(2008-8#1)
patients in either##3##3##(2008-6#1)(2008-8#1)(2013-1#1)
patients in four##2##3##(2011-1#1)(2012-12#1)
patients in general practice##2##4##(1994-11#1)(1996-1#1)
patients in general##8##3##(1990-4#1)(1990-6#1)(1994-11#1)(1996-1#1)(1996-2#1)(2005-10#1)(2006-8#1)(2007-8#1)
patients in group 1##2##4##(2007-9#1)(2013-1#1)
patients in group 2##4##4##(1991-3#1)(2007-9#2)(2013-1#1)
patients in group A##8##4##(1996-6#2)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#3)
patients in group B##2##4##(2007-8#1)(2007-9#1)
patients in group C##3##4##(2005-7#1)(2007-8#1)(2007-9#1)
patients in group I##5##4##(2007-7#3)(2008-1#1)(2013-1#1)
patients in group II and##2##5##(2007-7#1)(2008-1#1)
patients in group II##5##4##(1991-3#1)(2006-8#1)(2007-7#2)(2008-1#1)
patients in group L##4##4##(1996-3#4)
patients in group S##2##4##(1996-3#1)(2007-8#1)
patients in group##39##3##(1991-3#2)(1996-3#5)(1996-6#2)(2005-7#1)(2006-8#1)(2007-11#3)(2007-2#1)(2007-7#5)(2007-8#4)(2007-9#9)(2008-1#3)(2013-1#3)
patients in intensive care units?##2##5##(2006-10#1)(2013-8#1)
patients in intensive care##5##4##(2006-10#2)(2007-11#1)(2011-12#1)(2013-8#1)
patients in long-term##3##3##(1995-3#1)(2008-3#1)(2008-6#1)
patients in need of##4##4##(1994-6#1)(1995-2#1)(2007-7#1)(2011-2#1)
patients in need##5##3##(1993-12#1)(1994-6#1)(1995-2#1)(2007-7#1)(2011-2#1)
patients in one##2##3##(2011-1#1)(2013-1#1)
patients in order to detect##2##5##(1990-8#1)(2011-2#1)
patients in order to evaluate##2##5##(2008-10#1)(2010-12#1)
patients in order to identify##2##5##(1996-12#1)(2008-4#1)
patients in order to##12##4##(1990-8#1)(1991-7#1)(1996-12#1)(2006-1#1)(2007-8#1)(2008-10#1)(2008-4#1)(2010-12#1)(2011-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
patients in other##5##3##(2007-10#1)(2008-7#1)(2009-6#1)(2009-8#1)(2013-1#1)
patients in our department##2##4##(1996-8#1)(2007-8#1)
patients in our study##2##4##(2008-6#1)(2010-12#1)
patients in our##9##3##(1996-8#1)(2006-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-6#1)(2009-10#1)(2010-12#2)
patients in pain##4##3##(2006-7#2)(2006-8#1)(2012-12#1)
patients in particular##2##3##(1996-11#1)(2006-6#1)
patients in primary care##4##4##(2009-4#1)(2010-4#1)(2010-8#1)(2013-1#1)
patients in question##2##3##(1990-5#1)(2007-9#1)
patients in rehabilitation##3##3##(1994-7#1)(1996-11#1)(1997-8#1)
patients in relation to##3##4##(1990-4#1)(1994-3#1)(2007-10#1)
patients in remission with##2##4##(2008-8#1)(2012-3#1)
patients in remission##11##3##(1990-11#1)(1990-3#1)(1991-5#1)(1992-3#1)(1993-12#1)(2008-8#5)(2012-3#1)
patients in several##3##3##(1992-4#1)(2010-8#1)(2012-4#1)
patients in society##2##3##(2008-2#1)(2008-5#1)
patients in stage##2##3##(1992-2#1)(2006-8#1)
patients in terms of##3##4##(2007-8#1)(2008-1#1)(2011-1#1)
patients in the Amazon##2##4##(2011-2#2)
patients in the ED##3##4##(2008-11#1)(2012-2#2)
patients in the Jeddah##2##4##(2007-7#2)
patients in the Pacific##2##4##(2008-1#2)
patients in the United States##4##5##(1991-3#1)(2005-7#2)(2008-1#1)
patients in the absence of##3##5##(2006-8#1)(2007-7#1)(2011-2#1)
patients in the acute##3##4##(1995-5#1)(1997-5#1)(2007-9#1)
patients in the chronic##4##4##(1992-11#1)(2007-10#2)(2009-2#1)
patients in the community##2##4##(1993-7#1)(2008-11#1)
patients in the control group##12##5##(2006-8#1)(2007-8#1)(2008-5#1)(2010-4#2)(2011-2#6)(2012-12#1)
patients in the early##4##4##(2007-11#1)(2007-7#3)
patients in the emergency department##5##5##(2007-4#1)(2008-3#3)(2012-2#1)
patients in the experimental##2##4##(1993-12#1)(2010-12#1)
patients in the first##3##4##(1990-12#1)(2006-9#1)(2008-6#1)
patients in the group##2##4##(2010-12#2)
patients in the intensive care unit##2##6##(2009-3#1)(2013-7#1)
patients in the intensive care##4##5##(1995-9#1)(2006-10#1)(2009-3#1)(2013-7#1)
patients in the intervention group##3##5##(2010-12#1)(2010-4#2)
patients in the latter group##2##5##(2008-1#1)(2008-7#1)
patients in the literature##2##4##(2006-10#1)(2011-2#1)
patients in the nifedipine group and##3##6##(2011-2#3)
patients in the non-violent group were##2##6##(1997-8#2)
patients in the perioperative period##2##5##(2006-7#1)(2010-7#1)
patients in the placebo group##3##5##(1990-12#1)(1991-7#1)(1992-1#1)
patients in the setting of##2##5##(2007-5#1)(2009-8#1)
patients in the study##8##4##(1994-3#1)(2004-10#1)(2006-2#1)(2006-8#1)(2006-9#1)(2008-7#1)(2009-7#1)(2011-1#1)
patients in the treatment group##3##5##(1995-9#1)(2006-10#1)(2007-7#1)
patients in the two groups##2##5##(1990-2#1)(1993-1#1)
patients in the whole##2##4##(2006-7#1)(2013-8#1)
patients in the##233##3##(1990-10#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-6#1)(1991-7#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-8#1)(1992-9#2)(1993-1#3)(1993-11#5)(1993-12#1)(1993-7#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-5#1)(1995-9#3)(1996-1#1)(1996-11#2)(1996-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#2)(1997-8#2)(2004-1#2)(2004-10#1)(2004-8#1)(2005-12#1)(2005-7#3)(2006-10#4)(2006-12#2)(2006-2#1)(2006-7#2)(2006-8#5)(2006-9#3)(2007-10#4)(2007-11#4)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#11)(2007-8#8)(2007-9#5)(2008-1#12)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#6)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-10#2)(2010-12#4)(2010-2#2)(2010-4#4)(2010-6#1)(2010-7#2)(2011-1#2)(2011-2#25)(2012-1#1)(2012-12#7)(2012-2#7)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
patients in their##7##3##(1992-12#1)(1996-1#1)(2005-9#1)(2006-2#1)(2006-7#2)(2012-3#1)
patients in these##3##3##(1992-8#1)(1993-10#1)(2009-6#1)
patients in this group##5##4##(1992-9#1)(1995-11#1)(2007-8#1)(2009-8#1)(2011-2#1)
patients in this series##2##4##(2008-1#1)(2011-2#1)
patients in this study were##2##5##(2007-7#1)(2008-12#1)
patients in this study##5##4##(2006-2#1)(2006-8#1)(2007-7#1)(2008-12#1)(2008-6#1)
patients in this##15##3##(1992-9#1)(1995-11#1)(2005-7#1)(2006-2#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-6#1)(2009-8#1)(2010-2#1)(2011-2#2)(2012-2#1)
patients in three##3##3##(2011-1#1)(2013-1#2)
patients in total##3##3##(2007-9#1)(2011-2#2)
patients in treatment##3##3##(2006-8#1)(2010-12#1)(2013-8#1)
patients in two##3##3##(2008-3#1)(2010-11#1)(2011-2#1)
patients in various##2##3##(1993-11#1)(2012-3#1)
patients in vitro##2##3##(1994-5#1)(2008-4#1)
patients in which the##3##4##(2006-2#1)(2008-3#1)(2011-2#1)
patients in which##7##3##(1990-5#1)(2006-2#1)(2008-3#1)(2008-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
patients in whom a##7##4##(1990-3#1)(2006-7#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-1#2)
patients in whom an##2##4##(1990-12#1)(2005-10#1)
patients in whom it##3##4##(1990-3#1)(1991-11#1)(2010-7#1)
patients in whom the##13##4##(1990-12#1)(1990-2#1)(1990-4#1)(1991-11#1)(1993-10#1)(1993-7#1)(2006-10#2)(2007-3#1)(2008-7#1)(2013-1#3)
patients in whom there##2##4##(1990-4#1)(2006-5#1)
patients in whom treatment##2##4##(2006-5#1)(2009-6#1)
patients in whom##75##3##(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#2)(1991-11#4)(1991-2#2)(1991-5#1)(1991-9#1)(1993-10#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-7#1)(2005-10#3)(2005-12#1)(2005-8#2)(2006-10#2)(2006-11#1)(2006-12#2)(2006-5#5)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#4)(2008-1#2)(2008-4#1)(2008-5#2)(2008-7#3)(2009-6#1)(2010-12#1)(2010-7#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#3)
patients in##869##2##(1990-10#1)(1990-11#3)(1990-12#7)(1990-2#5)(1990-3#4)(1990-4#5)(1990-5#4)(1990-6#2)(1990-8#3)(1990-9#1)(1991-11#6)(1991-12#3)(1991-2#7)(1991-3#4)(1991-5#2)(1991-6#3)(1991-7#2)(1991-9#2)(1992-1#3)(1992-11#1)(1992-12#5)(1992-2#3)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#2)(1992-8#4)(1992-9#3)(1993-1#3)(1993-10#2)(1993-11#6)(1993-12#3)(1993-2#1)(1993-5#1)(1993-7#4)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#4)(1994-5#2)(1994-6#1)(1994-7#2)(1994-8#1)(1995-1#2)(1995-11#2)(1995-12#5)(1995-2#3)(1995-3#4)(1995-5#2)(1995-6#1)(1995-9#5)(1996-1#3)(1996-11#4)(1996-12#1)(1996-2#5)(1996-3#6)(1996-6#2)(1996-8#2)(1996-9#2)(1997-1#3)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#2)(1997-7#2)(1997-8#3)(2004-1#2)(2004-10#2)(2004-2#1)(2004-3#2)(2004-8#1)(2005-10#6)(2005-12#2)(2005-7#6)(2005-8#4)(2005-9#3)(2006-1#1)(2006-10#18)(2006-11#2)(2006-12#6)(2006-2#6)(2006-4#2)(2006-5#7)(2006-6#2)(2006-7#16)(2006-8#32)(2006-9#9)(2007-10#9)(2007-11#14)(2007-12#8)(2007-2#8)(2007-3#5)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#39)(2007-8#28)(2007-9#22)(2008-1#28)(2008-10#8)(2008-11#12)(2008-12#6)(2008-2#4)(2008-3#16)(2008-4#6)(2008-5#9)(2008-6#13)(2008-7#20)(2008-8#10)(2008-9#2)(2009-10#2)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#5)(2009-5#1)(2009-6#6)(2009-7#2)(2009-8#7)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#13)(2010-2#5)(2010-3#1)(2010-4#7)(2010-5#1)(2010-6#1)(2010-7#7)(2010-8#4)(2010-9#2)(2011-1#13)(2011-11#1)(2011-12#2)(2011-2#65)(2012-1#4)(2012-11#2)(2012-12#18)(2012-2#20)(2012-3#10)(2012-4#1)(2012-6#1)(2013-1#41)(2013-7#3)(2013-8#13)
patients include##7##2##(2005-8#1)(2006-10#2)(2008-1#1)(2008-7#1)(2008-8#1)(2012-3#1)
patients included a##2##3##(1990-4#1)(1995-1#1)
patients included in the study##2##5##(2007-7#2)
patients included in##3##3##(2007-7#2)(2013-8#1)
patients included##18##2##(1990-4#1)(1990-9#1)(1991-12#1)(1995-1#1)(1997-1#1)(2006-10#1)(2006-9#1)(2007-7#3)(2008-3#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#2)(2013-8#1)
patients including##7##2##(1991-8#1)(1993-11#1)(2005-12#1)(2007-2#1)(2009-8#1)(2010-12#1)(2013-1#1)
patients increase##2##2##(2007-11#1)(2008-12#1)
patients increased##7##2##(1990-11#1)(1990-12#2)(2006-10#1)(2008-7#1)(2010-12#1)(2011-2#1)
patients increasingly##2##2##(2006-10#1)(2007-8#1)
patients incurred##3##2##(1993-4#1)(2013-1#2)
patients indicate##3##2##(1990-6#1)(1993-11#1)(2010-7#1)
patients indicated a##2##3##(2006-8#1)(2010-4#1)
patients indicated##4##2##(2006-8#2)(2007-8#1)(2010-4#1)
patients infected by the human immunodeficiency virus (HIV)##2##8##(1996-11#1)(2008-5#1)
patients infected by the##4##4##(1992-10#1)(1996-11#1)(2008-5#1)(2012-2#1)
patients infected with HIV##5##4##(1991-11#1)(1996-9#1)(2006-9#1)(2007-8#1)(2008-10#1)
patients infected with human immunodeficiency virus##3##6##(1991-2#1)(1994-7#1)(2008-11#1)
patients infected with the human immunodeficiency virus##2##7##(1993-6#2)
patients infected with##18##3##(1991-11#1)(1991-2#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-7#1)(1996-9#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2011-1#1)(2012-1#1)
patients infected##22##2##(1991-11#1)(1991-2#1)(1992-10#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-7#1)(1996-11#1)(1996-9#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2011-1#1)(2012-1#1)(2012-2#1)
patients initially treated##2##3##(2007-11#1)(2008-4#1)
patients initially##8##2##(1996-6#1)(2007-11#1)(2007-7#1)(2008-4#1)(2009-3#1)(2010-7#1)(2011-2#1)(2013-1#1)
patients initiating##3##2##(2007-12#1)(2012-2#1)(2013-1#1)
patients interviewed##2##2##(2007-10#1)(2009-7#1)
patients into risk groups##2##4##(2007-10#1)(2007-8#1)
patients into three##3##3##(2006-5#1)(2010-11#1)(2011-2#1)
patients into two groups##3##4##(2006-6#1)(2011-2#2)
patients into##28##2##(1992-2#1)(1992-3#1)(1996-9#1)(1997-2#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-3#2)(2007-8#2)(2008-1#2)(2008-4#2)(2008-7#1)(2008-8#1)(2010-11#1)(2010-12#2)(2011-2#3)(2012-12#1)(2013-1#2)(2013-8#1)
patients intolerant to##2##3##(2008-5#1)(2011-2#1)
patients invariably##2##2##(2005-10#1)(2012-1#1)
patients involved in##2##3##(1992-8#1)(2006-10#1)
patients involved##3##2##(1990-9#1)(1992-8#1)(2006-10#1)
patients involving##3##2##(1994-8#1)(2006-6#1)(2013-1#1)
patients irradiated due to bone metastases##4##6##(2007-11#4)
patients irradiated##5##2##(2007-11#4)(2013-1#1)
patients is a major cause##2##5##(2005-10#1)(2010-3#1)
patients is a major##4##4##(2005-10#1)(2006-5#1)(2008-6#1)(2010-3#1)
patients is a##20##3##(1991-6#1)(1995-4#1)(1996-11#1)(2005-10#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#2)(2013-1#2)
patients is also##2##3##(2004-11#1)(2006-3#1)
patients is an important##2##4##(2009-6#1)(2011-2#1)
patients is an##5##3##(1990-10#1)(1991-4#1)(2007-10#1)(2009-6#1)(2011-2#1)
patients is as##2##3##(2008-5#1)(2008-8#1)
patients is associated with adverse outcomes##2##6##(2012-2#1)(2013-1#1)
patients is associated with##6##4##(2006-10#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
patients is associated##7##3##(2006-10#1)(2008-5#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
patients is at##2##3##(1994-5#1)(1995-2#1)
patients is becoming##2##3##(2005-9#1)(2007-9#1)
patients is better##2##3##(2005-5#1)(2008-10#1)
patients is challenging##2##3##(2007-7#1)(2012-2#1)
patients is critical to##2##4##(1993-3#1)(1994-12#1)
patients is critical##3##3##(1993-3#1)(1994-12#1)(2009-12#1)
patients is defined##2##3##(2008-1#1)(2008-6#1)
patients is directed##2##3##(2006-10#1)(2012-12#1)
patients is discussed##4##3##(1992-5#1)(1993-4#1)(1995-11#1)(2010-2#1)
patients is high and##2##4##(2007-6#1)(2008-1#1)
patients is high##3##3##(2007-6#1)(2008-1#1)(2008-3#1)
patients is lacking##2##3##(2007-7#1)(2008-6#1)
patients is less##2##3##(1990-2#1)(2008-1#1)
patients is needed to##2##4##(2006-10#1)(2008-7#1)
patients is not associated with##2##5##(2007-11#1)(2008-7#1)
patients is not##10##3##(1992-12#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#2)(2010-10#1)(2010-3#1)
patients is recommended##2##3##(1995-5#1)(2007-11#1)
patients is reported##4##3##(1996-3#1)(2007-8#1)(2008-10#1)(2008-7#1)
patients is safe and##2##4##(2007-8#1)(2008-1#1)
patients is safe##3##3##(2007-8#1)(2008-1#1)(2008-8#1)
patients is significantly##2##3##(2005-4#1)(2011-1#1)
patients is the##5##3##(1994-11#1)(2006-2#1)(2007-7#1)(2007-8#1)(2008-5#1)
patients is very##4##3##(1993-11#1)(2007-8#1)(2008-6#1)(2009-4#1)
patients is##180##2##(1990-10#1)(1990-2#1)(1990-9#2)(1991-4#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-10#2)(1993-11#2)(1993-3#2)(1993-4#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-3#2)(1996-4#1)(1996-6#1)(1997-3#1)(1997-7#1)(2004-11#1)(2005-10#3)(2005-4#1)(2005-5#2)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#9)(2006-12#3)(2006-2#3)(2006-3#2)(2006-5#1)(2006-6#1)(2006-8#2)(2007-10#2)(2007-11#4)(2007-12#3)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#9)(2007-9#1)(2008-1#7)(2008-10#4)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#6)(2008-6#6)(2008-7#7)(2008-8#4)(2008-9#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-6#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#5)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#6)
patients it is##3##3##(2006-10#1)(2007-8#1)(2011-1#1)
patients it was##3##3##(1994-2#1)(1996-12#1)(2007-11#1)
patients it##9##2##(1994-2#2)(1996-12#1)(2006-10#1)(2007-11#2)(2007-2#1)(2007-8#1)(2011-1#1)
patients known to##4##3##(1996-12#1)(2006-10#2)(2008-7#1)
patients known##5##2##(1996-12#1)(2005-11#1)(2006-10#2)(2008-7#1)
patients lack##2##2##(2007-8#1)(2011-2#1)
patients left the hospital##2##4##(1993-6#1)(2012-12#1)
patients left the##3##3##(1993-6#1)(2007-8#1)(2012-12#1)
patients left##5##2##(1993-6#1)(2006-11#1)(2006-6#1)(2007-8#1)(2012-12#1)
patients less than 2 years##2##5##(2008-3#1)(2011-2#1)
patients less than##5##3##(1992-8#1)(2008-3#1)(2011-2#1)(2013-1#2)
patients less##6##2##(1992-8#1)(2006-10#1)(2008-3#1)(2011-2#1)(2013-1#2)
patients life##3##2##(1997-4#1)(2007-11#1)(2010-8#1)
patients likely to##3##3##(2008-3#1)(2009-2#1)(2012-2#1)
patients lived##4##2##(1993-3#1)(1993-7#1)(2013-1#2)
patients living in##9##3##(1990-4#1)(1992-1#1)(2006-10#1)(2006-4#1)(2007-9#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
patients living longer##2##3##(2006-12#1)(2009-10#1)
patients living##14##2##(1990-4#1)(1992-1#1)(1995-11#1)(1995-12#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-9#1)(2009-10#1)(2009-5#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
patients look##2##2##(2010-5#1)(2011-1#1)
patients lost##3##2##(2007-8#1)(2012-12#1)(2013-8#1)
patients made a good##2##4##(2006-11#1)(2006-12#1)
patients made a##5##3##(1996-8#1)(2006-11#1)(2006-12#1)(2007-12#1)(2009-10#1)
patients made##12##2##(1994-2#1)(1996-5#1)(1996-8#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-12#1)(2009-10#1)(2011-2#1)(2012-12#1)
patients maintain##3##2##(2006-10#1)(2010-8#1)(2013-1#1)
patients maintained##6##2##(1996-9#1)(2008-1#1)(2008-7#1)(2011-2#2)(2013-8#1)
patients make##4##2##(1990-5#1)(2006-4#1)(2008-12#1)(2011-2#1)
patients managed##5##2##(1995-10#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-4#1)
patients manifested##3##2##(1992-8#1)(1996-5#1)(2008-7#1)
patients may also be##2##4##(2007-11#1)(2009-12#1)
patients may also##4##3##(2007-11#1)(2009-12#1)(2009-7#1)(2011-2#1)
patients may be advised to##2##5##(2009-5#1)(2011-12#1)
patients may be at##3##4##(2006-6#1)(2011-2#2)
patients may be##33##3##(1990-7#1)(1991-2#1)(1991-3#1)(1993-3#1)(1994-6#1)(1997-5#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#2)(2008-8#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-12#1)
patients may become##2##3##(2006-12#1)(2010-12#1)
patients may benefit from##6##4##(1996-6#1)(1996-9#1)(2006-11#1)(2007-2#1)(2008-10#1)(2011-2#1)
patients may develop secondary##2##4##(2010-5#1)(2011-2#1)
patients may experience##5##3##(1996-2#1)(2007-10#1)(2007-8#1)(2013-1#1)(2013-8#1)
patients may face##2##3##(2009-12#1)(2012-12#1)
patients may have a##2##4##(1995-11#1)(1996-7#1)
patients may have##11##3##(1993-9#1)(1995-11#1)(1995-2#1)(1996-7#1)(2007-7#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)
patients may not##2##3##(2012-1#1)(2013-1#1)
patients may represent a##2##4##(1996-12#1)(1996-6#1)
patients may require##6##3##(1994-12#1)(2007-12#1)(2008-6#1)(2008-7#1)(2013-1#2)
patients may respond##2##3##(2010-1#1)(2012-3#1)
patients may##106##2##(1990-11#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#1)(1992-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#2)(1996-7#1)(1996-9#1)(1997-4#1)(1997-5#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#5)(2008-7#2)(2008-8#2)(2009-12#2)(2009-4#1)(2009-5#2)(2009-7#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#4)(2013-8#1)
patients meeting criteria##2##3##(2007-10#1)(2011-2#1)
patients meeting##5##2##(2007-10#2)(2011-2#1)(2012-2#1)(2012-3#1)
patients mentioned##2##2##(2006-12#1)(2012-12#1)
patients met inclusion criteria##3##4##(2006-7#1)(2007-8#1)(2011-2#1)
patients met the inclusion criteria##2##5##(2005-10#1)(2010-6#1)
patients met the##5##3##(1993-6#1)(2005-10#1)(2006-8#1)(2010-6#1)(2011-2#1)
patients met##11##2##(1993-6#1)(2005-10#1)(2006-7#1)(2006-8#1)(2007-8#1)(2007-9#1)(2009-10#1)(2010-6#1)(2011-2#2)(2012-12#1)
patients might also##2##3##(2006-7#1)(2009-7#1)
patients might##10##2##(1996-3#2)(2006-2#1)(2006-7#1)(2009-7#1)(2010-4#1)(2010-8#1)(2012-1#1)(2013-1#2)
patients more frequently##4##3##(1990-11#1)(1994-7#1)(2006-10#1)(2011-1#1)
patients more than 70 years##2##5##(2007-8#1)(2009-9#1)
patients more than 75 years of age##2##7##(2011-2#2)
patients more than##7##3##(1992-10#1)(1992-2#1)(2007-8#1)(2007-9#1)(2009-9#1)(2011-2#2)
patients more##18##2##(1990-11#1)(1990-2#1)(1992-10#1)(1992-2#1)(1994-7#1)(1996-11#1)(2006-10#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-3#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#3)
patients most likely to benefit from##2##6##(2007-10#1)(2013-8#1)
patients most likely to benefit##3##5##(2007-10#1)(2007-5#1)(2013-8#1)
patients most##8##2##(2007-10#1)(2007-5#1)(2008-12#1)(2008-7#1)(2009-9#1)(2011-12#1)(2011-2#1)(2013-8#1)
patients mostly##2##2##(1991-8#1)(2008-11#1)
patients moved##2##2##(2008-3#1)(2013-1#1)
patients must be considered##2##4##(1990-8#1)(1997-8#1)
patients must be##7##3##(1990-8#1)(1991-6#1)(1997-5#1)(1997-8#1)(2006-5#1)(2009-11#1)(2012-3#1)
patients must##14##2##(1990-8#1)(1991-6#1)(1997-5#1)(1997-8#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-8#1)(2009-11#1)(2011-2#1)(2012-11#1)(2012-3#1)
patients need to be##4##4##(1996-3#1)(2006-12#1)(2007-12#1)(2007-9#1)
patients need to##7##3##(1996-3#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-3#1)(2011-1#1)
patients need##19##2##(1996-3#1)(1996-8#1)(2006-1#1)(2006-12#1)(2007-12#1)(2007-2#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#2)(2013-8#2)
patients needed to##2##3##(1993-1#1)(2012-2#1)
patients needed##13##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1992-6#1)(1993-1#1)(2007-8#2)(2010-10#1)(2011-2#1)(2012-2#2)
patients needing##4##2##(1997-2#1)(2007-8#1)(2008-1#1)(2008-7#1)
patients needs##3##2##(2008-5#1)(2008-6#1)(2012-10#1)
patients negative for##2##3##(2010-12#1)(2011-2#1)
patients no##6##2##(1990-9#1)(1994-11#1)(2006-7#1)(2008-12#1)(2008-5#1)(2013-8#1)
patients not only##4##3##(2007-8#1)(2008-7#1)(2012-1#1)(2012-11#1)
patients not receiving##5##3##(1993-12#1)(1994-3#1)(2004-1#1)(2007-10#2)
patients not requiring##2##3##(2007-7#1)(2009-8#1)
patients not treated with##3##4##(1996-12#1)(2008-3#1)(2012-3#1)
patients not##37##2##(1990-6#1)(1991-4#1)(1992-2#1)(1993-12#1)(1993-5#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-12#1)(1997-3#1)(2004-1#1)(2004-10#1)(2006-10#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-7#2)(2007-8#4)(2008-3#1)(2008-4#3)(2008-7#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#2)
patients observed in##2##3##(1992-10#1)(2008-5#1)
patients observed##5##2##(1990-9#1)(1992-10#1)(2007-7#1)(2008-5#1)(2011-2#1)
patients of TA##2##3##(1997-8#2)
patients of a rheumatologic##2##4##(1995-4#1)(1997-8#1)
patients of a tertiary hospital##2##5##(2011-1#1)(2012-3#1)
patients of a tertiary##3##4##(2011-1#1)(2011-12#1)(2012-3#1)
patients of a##11##3##(1991-2#1)(1992-1#1)(1994-2#1)(1995-4#1)(1997-3#1)(1997-8#1)(2007-8#1)(2011-1#1)(2011-12#1)(2012-3#1)(2013-8#1)
patients of acute##5##3##(2008-1#1)(2009-11#1)(2010-5#1)(2010-8#1)(2011-1#1)
patients of all age groups##3##5##(1990-8#1)(2006-10#1)(2007-7#1)
patients of all ages##6##4##(1992-3#1)(1993-1#1)(1995-3#1)(1997-3#1)(2006-1#1)(2006-10#1)
patients of all##12##3##(1990-8#1)(1992-3#1)(1993-1#1)(1995-3#1)(1996-2#1)(1997-3#1)(2006-1#1)(2006-10#2)(2007-7#1)(2011-1#1)(2013-8#1)
patients of an##2##3##(1993-8#1)(1995-4#1)
patients of both sexes##2##4##(1990-10#1)(2010-12#1)
patients of chronic##5##3##(2007-7#1)(2007-8#1)(2009-4#1)(2010-6#1)(2012-2#1)
patients of different age##4##4##(1991-9#1)(2008-7#1)(2013-1#2)
patients of different##8##3##(1991-9#1)(2008-1#1)(2008-7#1)(2008-9#1)(2010-2#1)(2012-12#1)(2013-1#2)
patients of either##2##3##(2010-7#1)(2012-11#1)
patients of gastric carcinoma##2##4##(1992-11#1)(2011-2#1)
patients of group 1 and##2##5##(1991-3#2)
patients of group A##2##4##(2007-8#1)(2012-2#1)
patients of group##9##3##(1991-3#3)(2006-2#1)(2007-8#3)(2012-2#2)
patients of osteoarthritis of##2##4##(2008-5#1)(2011-2#1)
patients of other##2##3##(2010-2#1)(2012-3#1)
patients of pemphigus##2##3##(2007-7#2)
patients of primary##2##3##(2007-7#1)(2013-1#1)
patients of reproductive age##2##4##(2005-8#1)(2010-11#1)
patients of severe##2##3##(2008-11#1)(2010-7#1)
patients of similar##2##3##(1992-8#1)(1994-3#1)
patients of the other##2##4##(2010-2#1)(2011-1#1)
patients of the same age##2##5##(1991-12#1)(2012-2#1)
patients of the##30##3##(1990-10#2)(1991-12#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1994-4#1)(1995-8#1)(1996-11#1)(1996-2#1)(2005-12#1)(2006-2#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-2#1)(2011-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
patients of their##2##3##(2008-11#1)(2010-2#1)
patients of this group##3##4##(1993-1#1)(1994-1#1)(2009-2#1)
patients of this##6##3##(1993-1#1)(1994-1#1)(1995-9#1)(2008-10#1)(2009-2#1)(2011-1#1)
patients of type##2##3##(2011-1#1)(2012-2#1)
patients of whom##5##3##(1991-11#1)(2006-8#1)(2007-7#1)(2008-1#2)
patients of##210##2##(1990-10#3)(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#3)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#2)(1993-1#3)(1993-5#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-7#1)(1995-3#1)(1995-4#2)(1995-6#1)(1995-8#1)(1995-9#2)(1996-11#1)(1996-2#2)(1996-4#1)(1997-1#1)(1997-3#2)(1997-8#5)(2005-12#2)(2005-8#1)(2006-1#1)(2006-10#2)(2006-2#2)(2006-4#1)(2006-6#1)(2006-8#3)(2006-9#2)(2007-10#1)(2007-7#21)(2007-8#15)(2007-9#1)(2008-1#6)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#4)(2008-7#3)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#3)(2009-8#1)(2010-11#2)(2010-12#2)(2010-2#6)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#3)(2011-1#9)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#14)(2012-3#5)(2013-1#8)(2013-8#5)
patients often have##2##3##(1991-8#1)(2012-12#1)
patients often require##2##3##(2012-2#1)(2013-8#1)
patients often respond in dramatically different ways to various treatments##2##10##(2013-1#2)
patients often##14##2##(1991-8#1)(1994-6#1)(2006-8#1)(2008-4#2)(2009-8#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
patients older and younger than 65 years##2##7##(2009-8#2)
patients older than 15 years##2##5##(2007-4#1)(2008-7#1)
patients older than 60 years##5##5##(1995-9#1)(2007-9#1)(2009-12#1)(2011-2#1)(2012-3#1)
patients older than 65 years##3##5##(1992-5#1)(2009-1#1)(2011-2#1)
patients older than 65##5##4##(1992-5#1)(2007-11#1)(2007-8#1)(2009-1#1)(2011-2#1)
patients older than 70 years##2##5##(2007-8#1)(2011-2#1)
patients older than 75 years of age##2##7##(2005-2#1)(2008-3#1)
patients older than##21##3##(1992-5#1)(1995-9#1)(2005-2#1)(2007-11#1)(2007-4#1)(2007-8#3)(2007-9#1)(2008-3#1)(2008-7#1)(2009-1#1)(2009-12#1)(2009-8#2)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)
patients older##23##2##(1992-5#1)(1995-9#1)(2005-2#1)(2007-11#1)(2007-4#1)(2007-8#3)(2007-9#1)(2008-3#1)(2008-7#1)(2009-1#1)(2009-12#1)(2009-8#4)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)
patients on HD##6##3##(2007-7#4)(2008-1#2)
patients on a##7##3##(1995-2#1)(1997-2#1)(2006-1#1)(2007-7#1)(2008-10#1)(2010-10#1)(2013-1#1)
patients on an##2##3##(2007-9#1)(2010-10#1)
patients on chemotherapy##2##3##(2010-11#1)(2010-9#1)
patients on chronic dialysis##3##4##(2007-7#1)(2007-8#1)(2013-1#1)
patients on chronic##5##3##(2006-8#1)(2007-7#1)(2007-8#1)(2013-1#2)
patients on continuous ambulatory peritoneal dialysis##5##6##(1995-6#1)(2007-12#4)
patients on corticosteroids##2##3##(2012-2#2)
patients on dialysis in##2##4##(2007-7#1)(2012-2#1)
patients on dialysis##13##3##(1996-2#1)(2005-10#1)(2007-7#3)(2008-1#2)(2011-2#3)(2012-2#3)
patients on eight had##2##4##(2011-2#2)
patients on haemodialysis##2##3##(1991-11#1)(1996-9#1)
patients on hemodialysis (HD)##4##4##(2007-7#2)(2008-1#1)(2011-2#1)
patients on hemodialysis in##2##4##(1993-6#1)(2013-1#1)
patients on hemodialysis##16##3##(1991-6#1)(1993-6#1)(2007-7#7)(2007-8#1)(2008-1#3)(2010-12#1)(2011-2#1)(2013-1#1)
patients on long-term##7##3##(1993-11#1)(2004-11#1)(2006-8#2)(2008-7#1)(2013-1#2)
patients on maintenance HD##3##4##(2007-7#3)
patients on maintenance hemodialysis (MHD)##2##5##(2007-7#1)(2013-7#1)
patients on maintenance hemodialysis##9##4##(2007-7#3)(2008-1#4)(2009-4#1)(2013-7#1)
patients on maintenance##16##3##(2007-7#7)(2008-1#4)(2009-4#1)(2011-1#3)(2013-7#1)
patients on oral##2##3##(2007-2#1)(2010-12#1)
patients on peritoneal##2##3##(2007-12#2)
patients on placebo##4##3##(1991-3#1)(1993-1#1)(2005-9#1)(2008-5#1)
patients on prolonged##2##3##(1996-12#1)(2007-2#1)
patients on regular dialysis treatment##2##5##(2007-7#2)
patients on regular dialysis##4##4##(2007-7#2)(2008-1#1)(2011-2#1)
patients on regular hemodialysis##2##4##(2007-7#2)
patients on regular##8##3##(2007-7#4)(2008-1#3)(2011-2#1)
patients on the basis of##2##5##(2006-10#1)(2008-3#1)
patients on the##20##3##(1992-12#1)(1995-1#1)(2006-10#1)(2006-4#1)(2007-2#2)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-12#1)(2010-9#1)(2012-2#1)(2013-8#4)
patients on their##2##3##(2004-3#1)(2011-12#1)
patients on treatment##2##3##(2007-11#1)(2011-2#1)
patients on whom##3##3##(1992-12#1)(2006-6#1)(2007-7#1)
patients on##187##2##(1991-11#1)(1991-3#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#2)(1993-1#2)(1993-11#1)(1993-6#1)(1993-7#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-5#1)(2004-11#1)(2004-3#1)(2004-4#1)(2005-10#2)(2005-9#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-6#3)(2006-8#3)(2007-11#2)(2007-12#6)(2007-2#4)(2007-7#29)(2007-8#3)(2007-9#1)(2008-1#15)(2008-10#2)(2008-3#3)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#3)(2009-11#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#8)(2010-3#1)(2010-9#3)(2011-1#4)(2011-12#1)(2011-2#12)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#8)(2012-3#3)(2013-1#11)(2013-7#1)(2013-8#5)
patients one month after the beginning of##2##7##(1990-9#1)(2007-7#1)
patients one##5##2##(1990-8#1)(1990-9#1)(2007-7#2)(2013-1#1)
patients only##7##2##(1990-2#1)(2006-2#1)(2007-7#1)(2008-1#1)(2010-12#1)(2010-3#1)(2010-6#1)
patients ont##2##2##(2011-2#1)(2013-1#1)
patients operated at##2##3##(2007-7#1)(2009-10#1)
patients operated between##3##3##(1993-9#1)(2007-11#1)(2009-2#1)
patients operated during##2##3##(1990-2#1)(1991-6#1)
patients operated for##14##3##(1991-5#1)(1993-5#1)(1993-9#1)(1996-12#1)(2006-8#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-7#1)(2009-2#1)(2010-12#1)(2013-8#1)
patients operated from##2##3##(2007-8#2)
patients operated in the##4##4##(1991-9#1)(1992-6#1)(2007-11#1)(2008-9#1)
patients operated in##6##3##(1991-3#2)(1991-9#1)(1992-6#1)(2007-11#1)(2008-9#1)
patients operated on for##10##4##(1990-9#1)(1991-4#1)(1991-9#1)(1992-12#2)(1993-10#1)(2006-9#1)(2007-8#1)(2008-4#1)(2011-2#1)
patients operated on in##2##4##(2006-6#1)(2006-8#1)
patients operated on with##2##4##(2007-8#2)
patients operated on##21##3##(1990-6#1)(1990-9#1)(1991-4#1)(1991-9#1)(1992-12#2)(1993-10#1)(1996-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-8#6)(2008-4#1)(2011-2#1)(2012-2#1)
patients operated upon for##2##4##(2006-12#1)(2008-10#1)
patients operated upon##4##3##(1990-11#1)(1992-5#1)(2006-12#1)(2008-10#1)
patients operated using##2##3##(2007-11#1)(2007-8#1)
patients operated##64##2##(1990-11#1)(1990-2#1)(1990-6#1)(1990-9#3)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-12#2)(1992-5#1)(1992-6#1)(1993-10#1)(1993-11#1)(1993-5#1)(1993-9#2)(1994-2#1)(1996-12#1)(1996-2#1)(2006-12#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-11#5)(2007-7#6)(2007-8#11)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#2)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
patients or in the##2##4##(1992-12#1)(2012-2#1)
patients or in##6##3##(1992-12#1)(1992-9#1)(1996-3#1)(2007-8#1)(2010-6#1)(2012-2#1)
patients or more##4##3##(2011-1#1)(2011-2#3)
patients or normal##2##3##(1995-11#1)(2011-1#1)
patients or with##2##3##(2007-8#1)(2009-2#1)
patients or##44##2##(1991-2#1)(1992-12#1)(1992-9#1)(1993-9#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-7#1)(2006-8#2)(2007-10#2)(2007-11#1)(2007-7#2)(2007-8#3)(2008-11#1)(2008-7#1)(2009-2#2)(2009-4#1)(2010-2#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#1)(2013-1#2)
patients out of 11##3##4##(1995-4#1)(2008-1#1)(2008-4#1)
patients out of a total of##2##6##(2007-7#1)(2007-9#1)
patients out of##24##3##(1990-10#2)(1990-2#1)(1991-8#1)(1993-5#1)(1995-4#2)(1996-12#2)(2006-2#1)(2006-8#1)(2007-7#6)(2007-9#2)(2008-1#1)(2008-2#1)(2008-4#1)(2008-8#1)(2013-8#1)
patients outcome##2##2##(2008-1#1)(2011-1#1)
patients outside the##2##3##(2009-9#1)(2012-3#1)
patients outside##3##2##(2008-11#1)(2009-9#1)(2012-3#1)
patients over 1 year of age##2##6##(2011-2#2)
patients over 40 years##3##4##(1991-10#1)(2007-8#1)(2008-6#1)
patients over 60 years##3##4##(2006-10#1)(2007-7#1)(2012-3#1)
patients over 65 years##3##4##(2007-11#1)(2008-11#1)(2011-2#1)
patients over 65##4##3##(1996-6#1)(2007-11#1)(2008-11#1)(2011-2#1)
patients over 70 years of##2##5##(1991-8#1)(2009-7#1)
patients over 70 years##3##4##(1991-8#1)(2008-9#1)(2009-7#1)
patients over 70##4##3##(1991-8#1)(2008-4#1)(2008-9#1)(2009-7#1)
patients over 80 years##2##4##(2007-11#1)(2008-9#1)
patients over a period of 10 years##2##7##(2011-12#1)(2013-8#1)
patients over a period##3##4##(2011-12#1)(2011-2#1)(2013-8#1)
patients over a##11##3##(1991-5#1)(2006-1#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-4#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
patients over the age of##7##5##(1990-8#2)(1992-6#1)(2008-3#1)(2011-2#3)
patients over the##12##3##(1990-8#2)(1992-6#1)(2006-10#2)(2006-7#1)(2007-12#1)(2007-8#1)(2008-3#1)(2011-2#3)
patients over time##2##3##(1993-12#1)(2008-12#1)
patients over##56##2##(1990-8#2)(1991-10#1)(1991-11#1)(1991-5#1)(1991-8#2)(1992-6#1)(1993-12#1)(1996-6#1)(1997-7#1)(2005-7#1)(2006-1#1)(2006-10#4)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#9)(2012-2#1)(2012-3#1)(2013-8#1)
patients overall##2##2##(1991-2#1)(2006-10#1)
patients owing to##2##3##(2009-11#1)(2012-3#1)
patients participated in the study##2##5##(2006-10#1)(2012-1#1)
patients participated in the##3##4##(2006-10#1)(2009-7#1)(2012-1#1)
patients participated in##6##3##(1991-1#1)(1991-2#1)(2006-10#1)(2009-7#1)(2011-1#1)(2012-1#1)
patients participated##10##2##(1991-1#1)(1991-2#2)(2006-10#1)(2007-10#1)(2007-8#1)(2008-12#1)(2009-7#1)(2011-1#1)(2012-1#1)
patients participating in a##3##4##(1996-3#1)(1997-2#1)(2012-2#1)
patients participating in##6##3##(1996-3#1)(1997-2#1)(2006-9#1)(2008-6#1)(2010-1#1)(2012-2#1)
patients pathological##2##2##(2006-12#1)(2007-11#1)
patients per year##6##3##(1990-8#1)(1992-2#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-7#1)
patients per##13##2##(1990-8#1)(1992-2#1)(2006-10#2)(2007-11#1)(2007-8#1)(2008-1#4)(2008-7#2)(2011-1#1)
patients perceive##2##2##(1992-12#1)(2004-10#1)
patients performed significantly worse than##2##5##(1996-7#1)(1997-8#1)
patients performed##9##2##(1995-11#1)(1996-2#1)(1996-7#1)(1997-8#3)(2008-10#1)(2009-7#1)(2010-2#1)
patients performing##2##2##(2009-4#1)(2012-1#1)
patients place on##2##3##(1995-2#1)(2007-7#1)
patients population##2##2##(2008-4#1)(2008-8#1)
patients poses##2##2##(2011-1#1)(2013-1#1)
patients positive for##4##3##(1990-5#1)(1991-9#1)(1993-1#1)(2011-2#1)
patients post cardiac surgery##3##4##(2007-8#3)
patients post##5##2##(2007-8#3)(2008-1#1)(2009-9#1)
patients post-cardiac surgery##2##3##(2007-8#2)
patients posted for##2##3##(2009-6#1)(2010-7#1)
patients postoperatively##2##2##(2006-8#1)(2009-3#1)
patients prepared##3##2##(2008-8#1)(2012-12#2)
patients present to##3##3##(2005-11#1)(2007-6#1)(2007-7#1)
patients present with advanced##2##4##(2010-12#1)(2012-12#1)
patients present with##18##3##(2006-10#1)(2006-2#1)(2006-3#1)(2007-11#3)(2008-1#1)(2008-10#1)(2010-12#4)(2010-7#1)(2011-1#1)(2011-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
patients present##29##2##(1994-6#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-3#1)(2007-11#3)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-12#4)(2010-7#1)(2011-1#1)(2011-11#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
patients presented an##2##3##(2007-7#1)(2008-9#1)
patients presented at advanced##2##4##(2011-11#1)(2011-2#1)
patients presented to the##2##4##(2009-10#1)(2013-1#1)
patients presented with a##2##4##(1991-8#1)(2008-7#1)
patients presented with subarachnoid haemorrhage##2##5##(1997-3#1)(2008-7#1)
patients presented with##36##3##(1991-8#3)(1993-3#1)(1996-3#1)(1997-3#1)(2004-2#1)(2005-10#1)(2006-12#1)(2006-8#4)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#2)(2008-7#2)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#2)
patients presented within##2##3##(2007-10#1)(2007-9#1)
patients presented##68##2##(1990-5#1)(1991-8#3)(1992-4#1)(1993-3#1)(1994-3#1)(1996-3#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-2#1)(2005-10#1)(2005-12#1)(2006-12#1)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#5)(2008-5#1)(2008-7#3)(2008-9#2)(2009-10#1)(2010-5#1)(2011-1#3)(2011-11#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#4)
patients presenting for##3##3##(1991-5#1)(2010-8#2)
patients presenting to a##3##4##(2008-4#1)(2012-2#2)
patients presenting to an##2##4##(2006-8#1)(2008-3#1)
patients presenting to emergency##2##4##(2006-8#1)(2011-1#1)
patients presenting to the emergency department (ED)##2##7##(2007-7#1)(2008-3#1)
patients presenting to the emergency department with chest pain##2##9##(2008-3#2)
patients presenting to the emergency department with##3##7##(2007-10#1)(2008-3#2)
patients presenting to the emergency department##5##6##(2007-10#1)(2007-7#1)(2008-3#3)
patients presenting to the##7##4##(2007-10#1)(2007-7#2)(2008-3#4)
patients presenting to##17##3##(2006-8#3)(2007-10#1)(2007-7#2)(2007-8#1)(2008-3#5)(2008-4#1)(2011-1#1)(2012-12#1)(2012-2#2)
patients presenting with a symptomatic##2##5##(1992-9#1)(2008-8#1)
patients presenting with a##4##4##(1992-9#1)(2006-6#1)(2008-8#1)(2012-1#1)
patients presenting with acute##10##4##(2006-2#1)(2006-4#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-8#1)(2011-2#2)(2012-2#1)
patients presenting with chest pain##3##5##(2008-3#1)(2010-10#1)(2013-8#1)
patients presenting with chronic low back pain##2##7##(2006-8#2)
patients presenting with chronic low back##3##6##(2006-8#3)
patients presenting with clinical##4##4##(1993-11#1)(2006-10#1)(2007-8#1)(2008-1#1)
patients presenting with dyspnea##2##4##(2009-10#1)(2011-1#1)
patients presenting with metastatic disease##2##5##(2007-11#1)(2010-3#1)
patients presenting with symptomatic##2##4##(2008-10#1)(2008-3#1)
patients presenting with the##3##4##(1990-7#1)(2006-6#2)
patients presenting with this condition##2##5##(1991-7#1)(2008-10#1)
patients presenting with##79##3##(1990-12#1)(1990-7#1)(1991-7#1)(1992-9#1)(1993-11#1)(1993-8#2)(1995-10#1)(1995-5#1)(1995-9#1)(1996-11#1)(1997-1#1)(1997-7#1)(2004-2#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-6#4)(2006-8#5)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2009-10#1)(2009-5#1)(2010-1#1)(2010-10#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
patients presenting##117##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-5#1)(1991-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#2)(1995-10#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-11#1)(1997-1#1)(1997-7#1)(2004-2#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-6#4)(2006-8#8)(2007-1#1)(2007-10#7)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#8)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#4)(2009-1#1)(2009-10#1)(2009-5#2)(2010-1#1)(2010-10#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#6)(2013-1#2)(2013-7#1)(2013-8#3)
patients presents many##2##3##(2006-10#1)(2009-10#1)
patients pretreated with##7##3##(1991-6#1)(1992-12#2)(1992-8#2)(1994-8#1)(2008-3#1)
patients previously treated with##6##4##(2004-1#1)(2006-6#1)(2008-10#1)(2010-12#1)(2012-2#1)(2013-7#1)
patients previously treated##10##3##(2004-1#1)(2006-6#2)(2007-4#1)(2007-8#1)(2008-10#2)(2010-12#1)(2012-2#1)(2013-7#1)
patients previously##14##2##(1993-11#1)(2004-1#1)(2006-6#2)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-12#1)(2012-2#1)(2013-7#1)
patients prior to their##2##4##(1991-2#1)(2006-10#1)
patients prior to treatment##2##4##(1996-12#1)(2008-5#1)
patients prior to##13##3##(1991-2#1)(1991-6#1)(1996-1#1)(1996-12#1)(2006-10#1)(2007-3#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-3#2)(2010-5#1)(2010-8#1)
patients prior##14##2##(1991-2#1)(1991-6#1)(1996-1#1)(1996-12#1)(2006-10#1)(2007-3#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-2#1)
patients probably##5##2##(1995-4#1)(1997-6#1)(2004-11#1)(2008-8#1)(2011-2#1)
patients produced##3##2##(1991-3#1)(2009-10#1)(2009-2#1)
patients progress##3##2##(1993-5#1)(2007-11#1)(2007-9#1)
patients progressed##5##2##(1991-4#1)(1992-12#1)(1992-6#1)(1993-12#1)(2008-6#1)
patients prone to##3##3##(2008-1#2)(2012-12#1)
patients proved to be##2##4##(1990-12#1)(1991-3#1)
patients proved to have##3##4##(1995-4#1)(2008-1#2)
patients proved to##5##3##(1990-12#1)(1991-3#1)(1995-4#1)(2008-1#2)
patients proved##6##2##(1990-12#1)(1991-3#1)(1995-4#1)(2008-1#2)(2008-8#1)
patients provide##2##2##(2010-12#1)(2013-8#1)
patients quality of##2##3##(2007-11#2)
patients radiosurgery was performed after##2##5##(1996-3#2)
patients randomly divided into##2##4##(2008-6#1)(2010-7#1)
patients ranged from##9##3##(1997-8#1)(2006-4#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-7#1)(2012-12#1)(2013-1#1)
patients ranged##11##2##(1992-4#1)(1997-8#1)(2005-12#1)(2006-4#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-7#1)(2012-12#1)(2013-1#1)
patients ranges from##2##3##(1993-12#1)(2008-6#1)
patients ranging in age from 29 to##2##7##(1993-12#1)(2007-8#1)
patients ranging in age from##4##5##(1993-12#1)(2007-8#3)
patients ranging in##5##3##(1993-12#1)(1995-10#1)(2007-8#3)
patients rated##5##2##(1995-9#1)(2004-10#1)(2009-3#1)(2011-2#1)(2012-3#1)
patients reached##3##2##(1990-10#1)(2007-8#1)(2008-9#1)
patients readmitted within 90 days##2##5##(2011-2#2)
patients readmitted##3##2##(2009-3#1)(2011-2#2)
patients receive##14##2##(1990-8#1)(1991-4#1)(1996-9#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-4#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-8#1)(2013-1#2)
patients received &gt##2##3##(2008-6#1)(2008-7#1)
patients received &quot##2##3##(2012-3#2)
patients received 3##2##3##(1992-10#1)(2008-7#1)
patients received a daily##2##4##(1996-4#1)(2008-7#1)
patients received a total of##3##5##(2006-12#1)(2008-10#1)(2008-7#1)
patients received a##16##3##(1993-5#1)(1994-2#1)(1996-4#1)(2006-11#2)(2006-12#2)(2007-8#2)(2008-10#2)(2008-6#1)(2008-7#3)(2008-9#1)
patients received adjuvant chemotherapy##2##4##(2004-1#1)(2010-3#1)
patients received an##5##3##(1990-6#1)(2007-11#1)(2007-2#1)(2007-7#1)(2009-9#1)
patients received chemotherapy with or without##2##6##(2007-2#1)(2008-7#1)
patients received chemotherapy##3##3##(1993-10#1)(2007-2#1)(2008-7#1)
patients received cholesterol##2##3##(1997-1#2)
patients received domperidone##2##3##(2008-7#2)
patients received either##2##3##(1992-5#1)(2010-7#1)
patients received indinavir##2##3##(2008-5#2)
patients received kidneys from##2##4##(1995-2#1)(2007-7#1)
patients received only##3##3##(1993-1#1)(2007-7#1)(2007-8#1)
patients received oral##3##3##(2007-2#1)(2008-5#1)(2011-12#1)
patients received radiotherapy##2##3##(1992-10#1)(2008-6#1)
patients received the same##2##4##(2006-6#1)(2013-1#1)
patients received the##7##3##(1993-12#1)(2005-7#1)(2006-6#1)(2006-7#1)(2007-10#1)(2008-5#1)(2013-1#1)
patients received thrombolytic##2##3##(2007-10#1)(2007-9#1)
patients received treatment with##2##4##(1991-11#1)(2007-8#1)
patients received##151##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#3)(1990-9#1)(1991-10#1)(1991-11#1)(1991-9#1)(1992-10#5)(1992-3#1)(1992-5#1)(1992-6#2)(1993-1#3)(1993-10#2)(1993-12#1)(1993-2#1)(1993-5#1)(1994-2#1)(1995-2#2)(1996-12#1)(1996-3#1)(1996-4#1)(1997-1#2)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#1)(2004-1#1)(2005-7#1)(2006-10#2)(2006-11#2)(2006-12#2)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#5)(2007-11#4)(2007-2#7)(2007-3#2)(2007-6#1)(2007-7#7)(2007-8#12)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#7)(2008-6#6)(2008-7#11)(2008-9#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-2#3)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#1)
patients receiving HAART##2##3##(2009-4#1)(2010-12#1)
patients receiving Neuprex##2##3##(2008-5#2)
patients receiving a##5##3##(1990-6#1)(1995-3#1)(2007-11#1)(2007-8#2)
patients receiving an##2##3##(2008-7#1)(2008-9#1)
patients receiving antibiotics##2##3##(1996-12#1)(2006-10#1)
patients receiving blood##2##3##(1991-3#1)(1997-1#1)
patients receiving cancer chemotherapy##2##4##(2008-7#1)(2009-6#1)
patients receiving capecitabine and##2##4##(2008-7#2)
patients receiving chemotherapy for advanced##2##5##(1991-10#1)(2004-1#1)
patients receiving chemotherapy for##3##4##(1991-10#1)(2004-1#1)(2008-7#1)
patients receiving chemotherapy in##2##4##(2007-12#2)
patients receiving chemotherapy##9##3##(1991-10#1)(1991-4#1)(1995-9#1)(2004-1#1)(2007-12#2)(2007-4#1)(2008-7#2)
patients receiving corticosteroids##2##3##(2007-10#1)(2007-7#1)
patients receiving cranial##2##3##(2012-12#2)
patients receiving dialysis##3##3##(1990-6#1)(2005-12#1)(2011-1#1)
patients receiving either##2##3##(1992-2#1)(2004-1#1)
patients receiving hemodialysis##3##3##(2010-3#1)(2011-1#1)(2013-8#1)
patients receiving high-dose##3##3##(2008-12#1)(2008-5#1)(2008-7#1)
patients receiving long-term##3##3##(1995-9#1)(2005-10#2)
patients receiving low##2##3##(1990-6#1)(2008-8#1)
patients receiving meloxicam##2##3##(2006-10#1)(2008-11#1)
patients receiving moderately##2##3##(2008-7#1)(2010-12#1)
patients receiving other##2##3##(1996-12#1)(2008-11#1)
patients receiving placebo##2##3##(2006-10#1)(2008-7#1)
patients receiving the##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2013-1#1)
patients receiving these agents##2##4##(2006-10#1)(2007-12#1)
patients receiving these##3##3##(2006-10#1)(2007-12#1)(2009-2#1)
patients receiving this##2##3##(1990-12#1)(2005-7#1)
patients receiving treatment at the##2##5##(1996-2#1)(2012-2#1)
patients receiving treatment##4##3##(1996-2#1)(2008-7#1)(2011-2#1)(2012-2#1)
patients receiving##195##2##(1990-12#2)(1990-3#1)(1990-6#3)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-2#2)(1992-3#1)(1993-10#1)(1993-12#1)(1993-7#1)(1993-8#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-4#2)(1995-6#1)(1995-9#2)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(2004-1#3)(2004-2#1)(2005-10#2)(2005-12#1)(2005-7#3)(2005-8#1)(2006-1#1)(2006-10#9)(2006-12#2)(2006-7#2)(2006-8#2)(2007-1#1)(2007-10#4)(2007-11#9)(2007-12#5)(2007-2#2)(2007-4#2)(2007-7#2)(2007-8#5)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#5)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#21)(2008-8#2)(2008-9#1)(2009-11#2)(2009-2#3)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-12#4)(2010-3#1)(2010-5#2)(2010-7#2)(2010-9#1)(2011-1#4)(2011-2#11)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#10)(2013-8#2)
patients recently##4##2##(1993-6#1)(1997-4#1)(2007-8#1)(2010-3#1)
patients recover##3##2##(2006-10#2)(2010-12#1)
patients recovered rapidly##2##3##(2006-12#1)(2008-7#1)
patients recovered well##2##3##(1990-4#1)(2007-8#1)
patients recovered without sequelae##2##4##(1997-6#1)(2009-6#1)
patients recovered without##5##3##(1997-6#1)(2007-10#1)(2007-8#1)(2009-6#1)(2012-2#1)
patients recovered##14##2##(1990-4#1)(1997-6#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-8#3)(2007-9#1)(2008-7#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-2#1)
patients recovering from##5##3##(2007-11#2)(2007-7#1)(2007-8#1)(2008-5#1)
patients recovering##6##2##(2007-11#2)(2007-7#1)(2007-8#1)(2008-5#1)(2013-1#1)
patients recruited from##2##3##(1993-10#1)(2008-1#1)
patients recruited##9##2##(1992-2#1)(1993-10#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-7#1)(2011-1#2)(2013-7#1)
patients reduces##2##2##(2008-3#1)(2010-7#1)
patients referred for endoscopy##4##4##(2007-3#4)
patients referred for upper gastrointestinal##2##5##(2006-10#1)(2008-5#1)
patients referred for upper##3##4##(2006-10#2)(2008-5#1)
patients referred for##26##3##(1991-12#1)(1992-3#2)(1993-3#1)(1995-11#1)(1996-3#2)(1996-9#1)(2006-10#2)(2007-3#5)(2007-8#4)(2008-1#1)(2008-5#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
patients referred from the##2##4##(2007-7#1)(2011-2#1)
patients referred to the##12##4##(1992-5#1)(1993-2#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-8#1)(2008-10#1)(2008-6#2)(2010-8#1)(2011-2#1)
patients referred to##21##3##(1992-5#1)(1992-6#1)(1993-2#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-2#3)(2007-3#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-6#2)(2010-8#2)(2011-2#1)(2013-8#1)
patients referred##52##2##(1990-4#1)(1991-12#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-2#1)(1993-3#1)(1995-11#1)(1996-3#2)(1996-9#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-2#3)(2007-3#6)(2007-7#1)(2007-8#5)(2008-1#2)(2008-10#1)(2008-12#3)(2008-5#1)(2008-6#2)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#3)(2012-2#1)(2013-8#1)
patients refused##3##2##(1990-6#1)(1992-9#1)(1994-11#1)
patients regained##4##2##(1996-9#1)(2007-7#1)(2008-5#1)(2013-1#1)
patients regarding the##4##3##(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
patients regarding##8##2##(2006-8#1)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
patients regardless of##5##3##(1994-12#1)(2006-2#1)(2007-12#1)(2011-2#2)
patients registered for##2##3##(1997-7#1)(2009-3#1)
patients registered in the##2##4##(1994-3#1)(1997-7#1)
patients registered in##3##3##(1994-3#1)(1997-7#1)(2013-1#1)
patients registered##8##2##(1994-3#1)(1997-7#2)(2006-4#1)(2009-3#1)(2010-12#1)(2013-1#1)(2013-8#1)
patients rehabilitated##2##2##(2007-8#1)(2010-5#1)
patients relapsed after##2##3##(2007-7#1)(2008-1#1)
patients relapsed and##2##3##(1992-6#1)(2007-11#1)
patients relapsed##7##2##(1992-6#1)(2007-11#1)(2007-7#3)(2008-1#1)(2008-4#1)
patients relative to##2##3##(1994-11#1)(1995-3#1)
patients remain at##2##3##(2009-11#1)(2012-2#1)
patients remain refractory##2##3##(2008-1#1)(2010-12#1)
patients remain##12##2##(1995-5#1)(2004-10#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-4#1)(2009-10#1)(2009-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
patients remained stable##2##3##(2005-12#1)(2008-7#1)
patients remained##12##2##(1992-6#1)(1993-7#1)(2005-12#1)(2005-7#1)(2006-6#1)(2007-10#1)(2007-7#2)(2008-5#1)(2008-7#2)(2013-8#1)
patients remains a##2##3##(2007-7#1)(2008-7#1)
patients remains controversial##2##3##(2006-6#1)(2007-8#1)
patients remains##9##2##(1994-10#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#1)
patients report##3##2##(2007-11#1)(2009-5#1)(2011-2#1)
patients reported a##4##3##(1992-5#1)(1993-12#1)(2013-1#2)
patients reported by##2##3##(2007-11#1)(2008-2#1)
patients reported improvement##2##3##(1997-2#1)(2007-7#1)
patients reported no##2##3##(2008-6#1)(2010-8#1)
patients reported that##2##3##(2008-7#1)(2012-3#1)
patients reported##43##2##(1991-3#1)(1991-8#1)(1992-5#2)(1993-12#1)(1993-2#1)(1995-12#1)(1995-4#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-1#1)(2006-10#2)(2006-11#1)(2006-3#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-3#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)
patients reporting to a##2##4##(2007-7#1)(2012-12#1)
patients reporting to##3##3##(2007-7#1)(2012-12#1)(2012-2#1)
patients reporting##4##2##(2007-7#1)(2012-12#2)(2012-2#1)
patients represent a##4##3##(1992-9#1)(2008-6#1)(2009-11#1)(2010-1#1)
patients represent##5##2##(1992-9#1)(2006-5#1)(2008-6#1)(2009-11#1)(2010-1#1)
patients represents##2##2##(2008-11#1)(2008-4#1)
patients require a##2##3##(2007-10#1)(2007-8#1)
patients require##10##2##(1994-12#1)(2005-11#1)(2005-8#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-8#1)(2010-11#1)(2012-3#1)
patients required a##5##3##(1990-12#1)(2006-12#1)(2006-5#1)(2007-9#1)(2013-1#1)
patients required no##2##3##(2006-6#1)(2007-7#1)
patients required reoperation##2##3##(2006-5#1)(2008-6#1)
patients required##41##2##(1990-12#1)(1990-3#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-6#1)(2006-10#2)(2006-12#2)(2006-5#2)(2006-6#2)(2006-9#1)(2007-11#1)(2007-7#3)(2007-8#5)(2007-9#3)(2008-1#2)(2008-6#2)(2008-7#1)(2009-3#1)(2009-4#1)(2010-7#1)(2012-2#2)(2012-3#2)(2013-1#2)
patients requires a##2##3##(2005-8#1)(2007-12#1)
patients requires##6##2##(2005-8#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)
patients requiring cardiopulmonary bypass##2##4##(2007-8#1)(2008-1#1)
patients requiring dialysis##3##3##(1996-9#1)(2010-5#1)(2011-2#1)
patients requiring haemodialysis##2##3##(2007-7#2)
patients requiring hemodialysis##2##3##(2007-7#2)
patients requiring insulin treatment##2##4##(2005-7#2)
patients requiring insulin##3##3##(2005-7#3)
patients requiring surgery##3##3##(2006-10#1)(2007-11#1)(2007-12#1)
patients requiring##40##2##(1993-10#1)(1995-2#1)(1996-11#1)(1996-9#2)(2005-10#2)(2005-7#3)(2005-8#2)(2006-10#6)(2006-3#1)(2007-11#5)(2007-12#1)(2007-7#5)(2007-8#2)(2008-1#1)(2008-6#1)(2009-10#1)(2010-10#1)(2010-5#1)(2011-2#3)
patients residing in##4##3##(1995-5#2)(2007-9#1)(2012-2#1)
patients resistant to##3##3##(1990-2#1)(1991-12#1)(2011-2#1)
patients respectively##8##2##(1995-11#1)(2006-6#2)(2007-11#1)(2007-7#4)
patients respond to##3##3##(1993-2#1)(2006-12#1)(2012-3#1)
patients respond##4##2##(1993-2#1)(2006-12#1)(2006-3#1)(2012-3#1)
patients responded to treatment##3##4##(1990-2#1)(2007-7#1)(2010-11#1)
patients responded to##10##3##(1990-2#1)(2005-10#1)(2007-11#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-7#1)(2010-11#1)
patients responded well to##5##4##(2006-10#1)(2006-7#1)(2007-7#2)(2008-4#1)
patients responded##24##2##(1990-10#1)(1990-2#1)(1994-5#1)(1997-2#1)(2005-10#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-3#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-2#1)(2013-1#1)
patients responding to##2##3##(1990-11#1)(2005-10#1)
patients responding##3##2##(1990-11#1)(2005-10#1)(2007-6#1)
patients resulted in##4##3##(2007-11#1)(2007-3#1)(2007-7#1)(2009-2#1)
patients resulted##6##2##(2007-11#1)(2007-3#1)(2007-7#1)(2009-2#1)(2011-2#1)(2013-1#1)
patients results in##3##3##(1995-1#1)(2007-8#1)(2010-2#1)
patients results##5##2##(1995-1#1)(1996-2#1)(2007-8#1)(2009-1#1)(2010-2#1)
patients resuscitated##2##2##(1990-12#1)(2005-12#1)
patients retained##2##2##(1996-9#1)(2011-2#1)
patients return home##2##3##(2007-9#1)(2008-9#1)
patients return##3##2##(2004-1#1)(2007-9#1)(2008-9#1)
patients returned for a##2##4##(1993-2#1)(2008-9#1)
patients returned from##2##3##(1994-7#1)(2007-2#1)
patients returned to work##2##4##(1992-3#1)(2008-7#1)
patients returned to##4##3##(1992-3#1)(2006-6#1)(2008-1#1)(2008-7#1)
patients returned##8##2##(1992-3#1)(1993-2#1)(1994-7#1)(2006-6#1)(2007-2#1)(2008-1#1)(2008-7#1)(2008-9#1)
patients revealed##11##2##(1990-3#1)(1991-3#1)(1991-9#1)(1992-3#1)(1996-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2009-4#1)(2012-2#1)(2013-8#1)
patients reveals##2##2##(1995-2#1)(2010-5#1)
patients said##4##2##(1991-3#1)(2009-6#3)
patients satisfaction##2##2##(2007-11#1)(2012-2#1)
patients scheduled for elective##4##4##(2006-12#1)(2007-8#1)(2011-2#1)(2013-8#1)
patients scheduled for##12##3##(1994-2#1)(2006-12#1)(2007-8#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-5#1)(2010-5#1)(2011-2#2)(2013-8#1)
patients scheduled##14##2##(1994-2#1)(2006-12#1)(2006-6#1)(2007-8#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-5#1)(2010-5#1)(2011-2#2)(2013-1#1)(2013-8#1)
patients scored##3##2##(1991-6#1)(1996-3#1)(2006-7#1)
patients screened##5##2##(2007-7#1)(2007-9#1)(2008-1#1)(2008-3#1)(2011-2#1)
patients seek##6##2##(2004-1#1)(2007-9#1)(2008-3#1)(2011-12#1)(2012-2#2)
patients seeking medical##3##3##(1991-4#1)(1997-2#1)(2007-11#1)
patients seeking treatment for acute##2##5##(2008-3#1)(2013-1#1)
patients seeking treatment for##3##4##(2008-3#1)(2013-1#2)
patients seeking treatment##6##3##(2008-12#1)(2008-3#1)(2011-1#1)(2012-2#1)(2013-1#2)
patients seeking##11##2##(1991-4#1)(1997-2#1)(2007-11#1)(2008-12#1)(2008-3#1)(2009-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
patients seem##2##2##(1996-1#1)(2008-7#1)
patients seemed to##2##3##(1990-10#1)(2009-9#1)
patients seen at ACH##2##4##(2007-2#2)
patients seen at##4##3##(1994-3#1)(1994-4#1)(2007-2#2)
patients seen between January##2##4##(2008-7#1)(2012-3#1)
patients seen in an##2##4##(2006-10#1)(2012-1#1)
patients seen in general practice##2##5##(2010-4#2)
patients seen in the##3##4##(1996-3#1)(2006-8#1)(2008-8#1)
patients seen in##13##3##(1995-2#1)(1996-3#1)(1996-6#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-3#1)(2008-8#1)(2009-9#1)(2010-4#2)(2012-1#1)
patients seen over a##2##4##(2007-3#1)(2007-7#1)
patients seen##24##2##(1994-3#1)(1994-4#1)(1995-2#1)(1996-3#1)(1996-6#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#3)(2007-3#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-4#2)(2012-1#1)(2012-12#1)(2012-3#1)
patients selected for##3##3##(2006-2#1)(2007-11#1)(2013-1#1)
patients selected##7##2##(1990-2#1)(2006-2#1)(2007-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
patients selection##2##2##(2006-6#1)(2008-9#1)
patients sera##2##2##(1995-6#1)(2005-12#1)
patients served as controls##2##4##(2007-7#2)
patients served by##2##3##(1995-2#1)(2007-11#1)
patients served##5##2##(1995-2#1)(2007-11#1)(2007-7#2)(2008-1#1)
patients should be evaluated##2##4##(1995-1#1)(1996-3#1)
patients should be monitored##3##4##(2007-2#2)(2011-1#1)
patients should be observed##2##4##(2005-12#1)(2008-6#1)
patients should be provided with##2##5##(1992-3#1)(1995-8#1)
patients should be screened for##2##5##(2006-1#1)(2008-11#1)
patients should be treated##3##4##(1991-3#1)(1993-5#1)(2011-2#1)
patients should be##41##3##(1990-8#1)(1991-3#1)(1991-4#1)(1992-3#2)(1993-10#1)(1993-2#1)(1993-5#1)(1995-1#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-1#1)(2005-12#1)(2006-1#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-7#1)(2008-11#2)(2008-6#1)(2008-7#1)(2009-2#1)(2009-3#2)(2009-6#2)(2010-8#2)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-8#1)
patients should have been##2##4##(1992-11#1)(2011-2#1)
patients should have##3##3##(1992-11#1)(2007-11#1)(2011-2#1)
patients should include##4##3##(1994-5#1)(2008-5#1)(2009-12#1)(2012-11#1)
patients should receive##6##3##(1993-12#1)(1994-2#1)(1995-10#1)(1996-2#1)(2005-10#1)(2007-11#1)
patients should undergo##3##3##(1991-3#1)(2006-12#1)(2011-2#1)
patients should##74##2##(1990-8#1)(1991-3#2)(1991-4#1)(1992-11#1)(1992-3#2)(1993-10#2)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-2#2)(1994-5#1)(1995-1#1)(1995-10#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-1#2)(2006-10#2)(2006-12#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-2#2)(2007-7#1)(2007-8#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-6#2)(2009-8#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-11#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
patients show##9##2##(1992-1#1)(2006-2#1)(2006-3#1)(2006-9#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-6#1)
patients showed a higher##2##4##(1990-12#1)(1997-8#1)
patients showed a significant increase##2##5##(1991-6#1)(1994-11#1)
patients showed a significant##4##4##(1991-6#1)(1994-11#1)(2008-10#1)(2011-2#1)
patients showed a##20##3##(1990-12#1)(1990-9#1)(1991-6#1)(1991-9#1)(1994-11#1)(1994-12#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-1#2)
patients showed an improvement in##2##5##(1994-11#1)(2011-2#1)
patients showed an improvement##3##4##(1994-11#1)(2008-3#1)(2011-2#1)
patients showed an##5##3##(1994-11#1)(2008-3#2)(2011-2#2)
patients showed complete##2##3##(2012-1#1)(2013-1#1)
patients showed decreased##2##3##(1993-8#1)(2008-5#1)
patients showed elevated##2##3##(1997-7#1)(2010-12#1)
patients showed higher##2##3##(2010-12#1)(2013-8#1)
patients showed improvement##2##3##(2006-3#1)(2013-1#1)
patients showed increased serum levels of##2##6##(1990-9#1)(2006-10#1)
patients showed increased##4##3##(1990-9#1)(1996-2#1)(2006-10#1)(2010-12#1)
patients showed less##2##3##(2007-7#2)
patients showed marked##2##3##(2007-2#1)(2008-7#1)
patients showed much higher##2##4##(1990-10#1)(2007-2#1)
patients showed no response##2##4##(1997-5#1)(2013-1#1)
patients showed no##6##3##(1996-7#1)(1997-5#1)(2004-10#1)(2007-11#1)(2007-9#1)(2013-1#1)
patients showed normal##2##3##(1993-3#1)(2008-7#1)
patients showed partial##2##3##(1994-3#1)(2008-11#1)
patients showed significant##3##3##(1995-1#1)(2007-7#1)(2013-1#1)
patients showed significantly higher##2##4##(1997-8#1)(2010-3#1)
patients showed significantly##4##3##(1997-8#1)(2008-7#1)(2010-10#1)(2010-3#1)
patients showed that the##2##4##(1992-2#1)(1992-4#1)
patients showed that##4##3##(1990-9#1)(1992-2#1)(1992-4#1)(2010-9#1)
patients showed##112##2##(1990-10#1)(1990-12#2)(1990-3#1)(1990-9#3)(1991-12#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-4#1)(1996-7#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#3)(2004-10#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-3#1)(2006-8#1)(2007-10#2)(2007-11#3)(2007-2#2)(2007-3#1)(2007-7#5)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#5)(2009-7#1)(2010-10#2)(2010-12#3)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#9)(2013-7#1)(2013-8#3)
patients showing##10##2##(1990-2#1)(1992-2#1)(1996-1#1)(1996-2#1)(1996-9#1)(2007-9#1)(2008-1#2)(2013-1#1)(2013-8#1)
patients significantly##2##2##(2012-1#1)(2013-1#1)
patients signs##2##2##(2006-8#1)(2007-11#1)
patients similar to##2##3##(1994-2#1)(2008-10#1)
patients since##4##2##(2005-12#1)(2006-1#1)(2007-8#1)(2008-5#1)
patients so as to##2##4##(2005-11#1)(2013-8#1)
patients so that##3##3##(1993-2#1)(1995-3#1)(2008-8#1)
patients so##7##2##(1993-2#1)(1995-3#1)(2005-11#1)(2006-9#1)(2008-8#1)(2010-12#1)(2013-8#1)
patients spent##2##2##(2004-1#1)(2006-2#1)
patients started on ART##2##4##(2009-3#2)
patients started##4##2##(1993-9#1)(2007-7#1)(2009-3#2)
patients starting##5##2##(1995-9#1)(2007-12#1)(2008-5#1)(2010-8#1)(2011-2#1)
patients stated##2##2##(1991-3#1)(1996-12#1)
patients still alive##2##3##(1997-4#1)(2010-8#1)
patients still had##3##3##(1991-9#1)(2008-6#1)(2008-7#1)
patients still present with##2##4##(2008-6#1)(2010-12#1)
patients still remains##2##3##(2007-10#1)(2009-8#1)
patients still##22##2##(1991-9#1)(1993-9#1)(1996-4#1)(1997-4#1)(2007-10#1)(2007-7#1)(2008-1#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-8#1)
patients studied in##2##3##(1993-2#1)(1993-9#1)
patients studied##11##2##(1992-9#1)(1993-2#1)(1993-7#1)(1993-9#2)(1997-8#1)(2005-1#1)(2005-8#1)(2007-11#1)(2007-7#1)(2008-7#1)
patients subgroups##2##2##(2008-5#1)(2008-7#1)
patients subjected to the##2##4##(2008-1#1)(2011-2#1)
patients subjected to##13##3##(1991-9#1)(1993-10#1)(1997-6#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-11#1)(2010-7#1)(2011-2#2)(2013-1#1)
patients subjective##3##2##(2006-8#1)(2007-11#2)
patients submitted to biliopancreatic diversion##2##5##(1993-3#1)(1993-5#1)
patients submitted to esophagectomy##2##4##(2013-8#2)
patients submitted to neoadjuvant##2##4##(2013-8#2)
patients submitted to surgical##2##4##(1990-3#1)(2010-1#1)
patients submitted to##20##3##(1990-2#1)(1990-3#1)(1991-6#2)(1991-9#1)(1993-3#1)(1993-5#1)(1993-9#2)(1996-2#1)(2007-8#1)(2008-10#1)(2009-11#1)(2010-1#1)(2013-1#1)(2013-7#1)(2013-8#4)
patients subsequently underwent##2##3##(1995-11#1)(2008-9#1)
patients subsequently##5##2##(1995-11#1)(2007-2#2)(2008-7#1)(2008-9#1)
patients successfully##3##2##(2005-8#1)(2007-8#2)
patients succumb to##2##3##(2007-7#1)(2009-5#1)
patients succumbed##2##2##(2006-10#1)(2007-8#1)
patients such as##2##3##(1992-8#1)(2006-10#1)
patients suffer from##4##3##(1993-3#1)(2006-6#1)(2008-6#1)(2012-2#1)
patients suffer##6##2##(1993-3#1)(2006-6#1)(2007-3#1)(2008-6#1)(2008-8#1)(2012-2#1)
patients suffered from acute##2##4##(1991-8#1)(2007-8#1)
patients suffered from severe##2##4##(2007-8#2)
patients suffered from##18##3##(1991-8#1)(1993-3#1)(1993-9#1)(1996-1#1)(1996-12#1)(1997-8#1)(2005-5#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-8#4)(2010-10#1)(2010-12#1)(2011-3#1)(2013-8#1)
patients suffered##28##2##(1991-8#2)(1993-3#1)(1993-9#1)(1996-1#1)(1996-12#1)(1997-8#1)(2005-5#1)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#4)(2007-9#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-3#1)(2013-1#3)(2013-8#1)
patients suffering from &quot##2##4##(1991-7#1)(1997-6#1)
patients suffering from a##3##4##(1990-9#1)(1992-12#1)(2007-11#1)
patients suffering from acute type A aortic##2##7##(2007-8#2)
patients suffering from acute##8##4##(1996-7#1)(2006-7#1)(2006-9#1)(2007-2#1)(2007-8#2)(2009-6#1)(2011-2#1)
patients suffering from chronic##8##4##(1991-2#1)(1991-3#1)(1996-8#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-3#1)
patients suffering from coronary heart disease##2##6##(1991-12#1)(2012-3#1)
patients suffering from coronary##3##4##(1991-12#1)(1995-6#1)(2012-3#1)
patients suffering from coxarthrosis##3##4##(2007-11#3)
patients suffering from degenerative##2##4##(2008-7#1)(2011-2#1)
patients suffering from depression##2##4##(1996-12#1)(2012-12#1)
patients suffering from diabetes##2##4##(2008-7#1)(2010-12#1)
patients suffering from infertility##2##4##(1992-2#1)(2011-2#1)
patients suffering from ischemic heart disease##2##6##(2008-1#1)(2008-7#1)
patients suffering from ischemic##4##4##(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)
patients suffering from knee osteoarthritis##2##5##(2012-2#2)
patients suffering from liver##2##4##(2005-9#1)(2008-3#1)
patients suffering from moderate to##2##5##(1991-11#1)(2008-12#1)
patients suffering from recurrent##3##4##(1991-5#1)(1992-11#1)(1994-3#1)
patients suffering from rheumatoid arthritis##6##5##(1992-5#1)(1993-3#1)(1997-5#2)(2008-3#1)(2013-1#1)
patients suffering from sciatica##2##4##(1996-9#1)(2006-2#1)
patients suffering from this##2##4##(2008-6#1)(2010-10#1)
patients suffering from various##2##4##(1991-3#1)(1994-3#1)
patients suffering from##161##3##(1990-10#2)(1990-11#1)(1990-4#2)(1990-8#1)(1990-9#1)(1991-11#4)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#3)(1991-7#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-10#2)(1993-11#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-7#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#3)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#3)(2005-7#2)(2005-9#3)(2006-10#1)(2006-12#3)(2006-2#2)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-2#3)(2007-4#1)(2007-7#2)(2007-8#6)(2007-9#2)(2008-1#3)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#4)(2008-5#2)(2008-6#4)(2008-7#10)(2008-8#1)(2009-4#1)(2009-6#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#1)
patients suffering with chronic low back pain##3##7##(2006-12#1)(2006-8#2)
patients suffering with chronic##5##4##(2006-12#1)(2006-8#4)
patients suffering with##8##3##(2006-12#1)(2006-7#1)(2006-8#5)(2007-8#1)
patients suffering##177##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-4#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#4)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#3)(1991-7#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-10#2)(1993-11#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-7#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#3)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#3)(2005-7#2)(2005-9#3)(2006-10#1)(2006-11#1)(2006-12#4)(2006-2#2)(2006-6#2)(2006-7#2)(2006-8#6)(2006-9#1)(2007-10#1)(2007-11#4)(2007-2#3)(2007-4#1)(2007-7#2)(2007-8#7)(2007-9#2)(2008-1#3)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#4)(2008-5#4)(2008-6#4)(2008-7#10)(2008-8#1)(2009-4#1)(2009-5#1)(2009-6#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#6)(2013-7#1)
patients suggest that##3##3##(2006-10#1)(2007-10#1)(2010-3#1)
patients surgical treatment##2##3##(1995-4#1)(2007-8#1)
patients surgically treated for##3##4##(1990-9#1)(2007-11#1)(2012-12#1)
patients surgically treated##5##3##(1990-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2012-12#1)
patients surgically##6##2##(1990-9#1)(1995-4#1)(2007-11#1)(2007-7#1)(2007-8#1)(2012-12#1)
patients surveyed were##2##3##(1992-5#1)(2008-7#1)
patients surveyed##6##2##(1992-5#1)(2006-10#3)(2007-8#1)(2008-7#1)
patients survive##2##2##(2011-2#1)(2012-3#1)
patients survived with##2##3##(1990-12#1)(2008-4#1)
patients survived##18##2##(1990-12#1)(1990-2#1)(1991-2#1)(1991-8#1)(1992-5#1)(1993-8#2)(1994-3#1)(1997-3#1)(2006-10#1)(2006-11#1)(2007-8#3)(2007-9#1)(2008-4#1)(2011-2#2)
patients surviving for##2##3##(1991-8#1)(1997-6#1)
patients surviving##9##2##(1991-8#1)(1992-10#1)(1997-6#1)(2004-11#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-7#1)(2012-1#1)
patients susceptible to##2##3##(2005-9#1)(2008-8#1)
patients suspected of acute##2##4##(2007-2#1)(2010-8#1)
patients suspected of having##3##4##(2007-7#1)(2011-1#1)(2012-12#1)
patients suspected of##9##3##(1990-12#1)(1995-7#1)(1997-8#2)(2007-2#1)(2007-7#1)(2010-8#1)(2011-1#1)(2012-12#1)
patients suspected##10##2##(1990-12#1)(1995-7#1)(1997-8#2)(2007-2#1)(2007-7#1)(2008-5#1)(2010-8#1)(2011-1#1)(2012-12#1)
patients sustain##2##2##(2008-3#1)(2013-1#1)
patients sustained##5##2##(1996-3#1)(2006-11#1)(2007-8#1)(2008-1#1)(2009-3#1)
patients take##4##2##(1995-9#1)(1996-12#1)(2010-12#1)(2011-1#1)
patients taking##22##2##(1995-11#1)(1996-3#2)(2006-10#2)(2007-6#1)(2008-11#4)(2008-3#2)(2008-5#2)(2008-8#1)(2009-4#1)(2009-5#1)(2009-6#1)(2011-2#2)(2013-7#1)(2013-8#1)
patients tend to be##2##4##(2011-2#2)
patients tend to##4##3##(1993-11#1)(2011-2#3)
patients tended to be lower##2##5##(2006-10#1)(2013-8#1)
patients tended to be##3##4##(1996-2#1)(2006-10#1)(2013-8#1)
patients tended to##5##3##(1996-2#1)(2006-10#1)(2008-3#1)(2011-2#1)(2013-8#1)
patients test##2##2##(1992-2#1)(2008-10#1)
patients tested positive for##3##4##(2006-8#2)(2008-10#1)
patients tested##12##2##(1991-9#1)(1996-4#1)(2005-7#1)(2006-8#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-6#1)(2009-3#1)(2010-12#1)
patients than in controls (P##2##5##(1996-9#1)(1997-2#1)
patients than in controls and##2##5##(1997-8#1)(2011-2#1)
patients than in controls##12##4##(1992-12#1)(1994-11#1)(1995-12#1)(1995-3#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-8#1)(2011-2#2)(2013-8#1)
patients than in healthy subjects##2##5##(1995-11#1)(2007-11#1)
patients than in healthy##4##4##(1995-11#1)(2007-11#1)(2007-2#1)(2008-8#1)
patients than in normal volunteers##2##5##(1995-11#1)(1996-2#1)
patients than in the control group##3##6##(1991-12#1)(1993-2#1)(2011-1#1)
patients than in the controls##4##5##(2008-7#2)(2011-1#1)(2011-2#1)
patients than in the general population##2##6##(2008-1#1)(2008-6#1)
patients than in the normal subjects##2##6##(1996-1#1)(1996-5#1)
patients than in the##13##4##(1991-12#1)(1993-2#1)(1996-1#1)(1996-5#1)(1996-6#1)(2007-10#1)(2008-1#1)(2008-6#1)(2008-7#2)(2011-1#2)(2011-2#1)
patients than in those##3##4##(1996-9#1)(2007-10#1)(2012-12#1)
patients than in##46##3##(1990-4#1)(1991-12#1)(1991-9#1)(1992-12#1)(1993-2#1)(1994-11#1)(1994-7#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-9#2)(1997-2#1)(1997-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-6#2)(2008-7#2)(2008-8#1)(2010-12#1)(2011-1#2)(2011-2#4)(2012-12#1)(2013-8#2)
patients than the##3##3##(1993-7#1)(1994-6#1)(2007-7#1)
patients than with##2##3##(2010-2#2)
patients than##68##2##(1990-4#2)(1991-1#3)(1991-12#1)(1991-9#1)(1992-12#1)(1993-12#2)(1993-2#2)(1993-7#1)(1994-11#1)(1994-6#1)(1994-7#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-8#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#2)(2008-6#2)(2008-7#2)(2008-8#1)(2010-12#1)(2010-2#2)(2011-1#2)(2011-2#5)(2012-12#1)(2013-8#3)
patients that are##4##3##(1995-11#1)(2008-12#1)(2009-8#1)(2012-12#1)
patients that began dialysis in 2000##2##6##(2011-1#2)
patients that can be##2##4##(2006-1#1)(2011-2#1)
patients that developed##2##3##(2011-2#1)(2013-1#1)
patients that do not##3##4##(2008-1#1)(2009-7#1)(2010-12#1)
patients that had a##3##4##(2006-10#1)(2013-1#1)(2013-8#1)
patients that had##9##3##(1994-2#1)(1995-9#1)(1997-6#1)(2006-10#1)(2006-8#1)(2012-2#2)(2013-1#1)(2013-8#1)
patients that have##6##3##(2006-7#1)(2007-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
patients that received##3##3##(2007-8#2)(2011-2#1)
patients that they##2##3##(2006-2#1)(2013-1#1)
patients that underwent##2##3##(2007-8#1)(2013-1#1)
patients that was##2##3##(2006-10#1)(2012-12#1)
patients that were##9##3##(1995-12#1)(1997-2#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-9#1)(2010-7#1)(2011-2#2)
patients that would##3##3##(1996-8#1)(2010-12#1)(2012-1#1)
patients that##74##2##(1991-7#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-9#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-6#1)(2004-10#1)(2006-1#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-7#2)(2007-8#6)(2008-1#3)(2008-10#3)(2008-12#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-7#1)(2011-1#4)(2011-2#8)(2012-1#3)(2012-12#3)(2012-2#3)(2013-1#6)(2013-7#2)(2013-8#1)
patients the diagnosis##2##3##(1993-5#1)(2013-1#1)
patients the incidence of##2##4##(1992-8#1)(2007-11#1)
patients the procedure was##3##4##(1997-8#1)(2007-6#1)(2007-7#1)
patients the tumor##2##3##(2006-12#1)(2007-8#1)
patients the ultrasound diagnosis of##2##5##(2006-6#2)
patients the##100##2##(1990-1#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#2)(1990-7#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-10#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-3#3)(1996-6#2)(1996-9#2)(1997-3#1)(1997-8#3)(2004-11#1)(2005-3#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-6#5)(2006-8#1)(2007-10#2)(2007-11#8)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#6)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-2#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#7)
patients themselves##9##2##(1993-2#2)(1995-2#1)(1995-4#1)(1997-2#1)(2005-7#1)(2007-11#1)(2007-12#1)(2007-8#1)
patients then##4##2##(2007-2#1)(2007-7#1)(2007-8#2)
patients there are##2##3##(1996-9#1)(2012-1#1)
patients there is##3##3##(2008-7#1)(2009-5#1)(2010-9#1)
patients there was no##4##4##(2006-6#1)(2006-7#1)(2006-8#1)(2013-1#1)
patients there was##10##3##(1990-2#1)(1993-5#1)(1993-8#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-7#1)(2011-2#1)(2013-1#1)
patients there were##4##3##(1990-11#1)(1990-6#1)(1993-7#1)(2011-2#1)
patients there##19##2##(1990-11#1)(1990-2#1)(1990-6#1)(1993-5#1)(1993-7#1)(1993-8#1)(1996-9#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-7#1)(2008-7#1)(2009-5#1)(2010-9#1)(2011-2#2)(2012-1#1)(2013-1#1)
patients these##3##2##(2008-5#1)(2008-7#1)(2012-12#1)
patients they cared for##2##4##(1991-1#1)(2008-11#1)
patients they##8##2##(1990-4#1)(1991-1#1)(1991-2#1)(2007-11#1)(2008-11#1)(2008-8#1)(2009-6#1)(2012-3#1)
patients think?##2##2##(2005-10#1)(2012-2#1)
patients this##6##2##(2006-10#1)(2007-11#1)(2007-8#2)(2008-7#1)(2012-3#1)
patients thought##4##2##(1990-2#1)(2005-12#1)(2006-8#1)(2012-12#1)
patients through the##3##3##(1993-2#1)(2008-3#1)(2010-2#1)
patients through##13##2##(1991-12#1)(1993-2#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-1#1)(2010-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
patients throughout the##3##3##(1993-9#1)(1994-12#1)(2013-1#1)
patients throughout##5##2##(1993-9#1)(1994-12#1)(2006-10#1)(2012-2#1)(2013-1#1)
patients to a new##2##4##(1997-3#1)(2008-4#1)
patients to a##8##3##(1993-9#1)(1995-6#1)(1997-3#1)(2006-5#2)(2008-4#1)(2008-7#1)(2011-2#1)
patients to accept##2##3##(1993-11#1)(1995-11#1)
patients to access##2##3##(2007-12#1)(2008-10#1)
patients to achieve##5##3##(2008-3#1)(2010-3#1)(2010-9#1)(2012-2#1)(2013-1#1)
patients to an##3##3##(2008-3#2)(2013-7#1)
patients to avoid##2##3##(1991-1#1)(2007-9#1)
patients to be treated##2##4##(2008-10#1)(2008-8#1)
patients to be##12##3##(1997-8#1)(2006-6#2)(2007-10#1)(2007-7#2)(2008-10#1)(2008-8#2)(2010-12#1)(2011-1#1)(2012-3#1)
patients to become severely##2##4##(2007-11#1)(2007-12#1)
patients to become##3##3##(1993-9#1)(2007-11#1)(2007-12#1)
patients to cope##2##3##(2009-7#1)(2013-8#1)
patients to decide on the##2##5##(1995-2#1)(2009-8#1)
patients to define##2##3##(2006-10#1)(2007-7#1)
patients to demonstrate##2##3##(1997-5#1)(2005-9#1)
patients to determine##2##3##(2006-8#1)(2010-1#1)
patients to either##3##3##(2008-10#1)(2013-1#2)
patients to evaluate##2##3##(2012-12#1)(2013-1#1)
patients to exclude##3##3##(1993-4#1)(2006-10#1)(2007-9#1)
patients to goal##2##3##(2009-12#1)(2010-6#1)
patients to have##6##3##(1995-1#3)(2007-12#1)(2008-4#1)(2009-7#1)
patients to help##2##3##(1994-12#1)(2010-9#1)
patients to identify##2##3##(2007-7#1)(2010-12#1)
patients to implement##2##3##(2010-6#1)(2011-1#1)
patients to present##2##3##(2007-12#1)(2009-9#1)
patients to prevent##2##3##(2011-2#2)
patients to receive##4##3##(1995-12#1)(2008-5#1)(2008-7#1)(2012-1#1)
patients to recover##2##3##(2008-8#1)(2012-1#1)
patients to reduce##3##3##(2007-6#1)(2013-1#1)(2013-8#1)
patients to return to##3##4##(2005-7#1)(2007-2#1)(2013-7#1)
patients to return##4##3##(1996-12#1)(2005-7#1)(2007-2#1)(2013-7#1)
patients to seek emergency##2##4##(2007-7#1)(2007-9#1)
patients to seek##3##3##(2007-7#1)(2007-9#1)(2008-11#1)
patients to take##3##3##(2006-1#1)(2007-7#1)(2011-2#1)
patients to the home##2##4##(1990-12#1)(1996-2#1)
patients to the##13##3##(1990-12#1)(1991-11#1)(1991-3#1)(1996-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
patients to their##4##3##(1994-12#1)(2007-12#1)(2008-7#1)(2010-8#1)
patients to understand##3##3##(1996-6#1)(2013-1#2)
patients to use##3##3##(2008-3#1)(2009-6#1)(2011-1#1)
patients to whom##2##3##(2010-2#1)(2011-3#1)
patients to##244##2##(1990-1#2)(1990-12#3)(1990-2#1)(1990-4#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-6#2)(1991-8#1)(1992-12#2)(1992-3#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-9#4)(1994-12#2)(1994-2#1)(1994-6#2)(1995-1#3)(1995-11#3)(1995-12#2)(1995-2#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-6#3)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#2)(2005-10#1)(2005-3#1)(2005-7#1)(2005-9#1)(2006-1#2)(2006-10#7)(2006-11#1)(2006-12#3)(2006-2#1)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#2)(2007-10#3)(2007-11#5)(2007-12#6)(2007-2#4)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#10)(2007-8#2)(2007-9#6)(2008-1#4)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#7)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#9)(2008-8#6)(2009-12#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#3)(2010-6#3)(2010-8#2)(2010-9#4)(2011-1#7)(2011-12#1)(2011-2#12)(2011-3#1)(2012-1#3)(2012-11#3)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#10)(2013-7#2)(2013-8#3)
patients together with##2##3##(1991-2#1)(2013-1#1)
patients tolerate##3##2##(1995-1#1)(2006-10#1)(2010-12#1)
patients tolerated the##2##3##(2007-8#1)(2010-7#1)
patients took part in the##2##5##(2007-9#1)(2008-7#1)
patients took part##4##3##(2007-9#1)(2008-7#1)(2010-12#1)(2011-7#1)
patients took##9##2##(1991-3#1)(2007-7#1)(2007-9#1)(2008-7#1)(2010-12#1)(2011-2#1)(2011-7#1)(2012-2#1)(2012-3#1)
patients total##2##2##(1992-9#1)(2006-2#1)
patients toward##2##2##(2008-12#1)(2012-2#1)
patients towards##2##2##(1993-11#1)(2011-2#1)
patients transplanted##4##2##(1991-9#2)(1995-2#1)(2010-5#1)
patients transported##4##2##(1993-5#1)(1995-3#1)(2007-9#2)
patients treated according to##2##4##(2011-2#2)
patients treated at our##3##4##(2008-7#1)(2011-2#1)(2013-1#1)
patients treated at the same##2##5##(1990-6#1)(2008-5#1)
patients treated at the##13##4##(1990-6#1)(1993-12#1)(1995-11#1)(1996-4#1)(2007-11#2)(2007-8#2)(2008-5#1)(2008-6#1)(2009-5#1)(2010-9#1)(2011-2#1)
patients treated at##19##3##(1990-6#1)(1993-12#1)(1995-11#1)(1996-4#1)(2006-9#1)(2007-11#2)(2007-8#3)(2008-5#1)(2008-6#2)(2008-7#1)(2009-5#1)(2010-9#1)(2011-2#2)(2013-1#1)
patients treated by general practitioners##2##5##(1993-2#1)(1994-11#1)
patients treated by local##2##4##(1995-4#1)(1996-6#1)
patients treated by radiosurgery##2##4##(2008-7#2)
patients treated by the##2##4##(1992-8#1)(2007-6#1)
patients treated by##30##3##(1991-2#1)(1992-3#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-2#1)(1994-11#1)(1994-4#1)(1994-6#1)(1995-4#1)(1996-6#1)(1997-4#1)(2007-10#2)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-9#1)(2010-2#1)(2012-2#1)
patients treated conservatively##2##3##(2006-6#1)(2008-1#1)
patients treated for primary##2##4##(1993-8#1)(2008-6#1)
patients treated for sigmoid volvulus##2##5##(1993-5#1)(2011-11#1)
patients treated for the##2##4##(1995-6#1)(2006-10#1)
patients treated for##32##3##(1990-2#2)(1990-9#1)(1991-10#1)(1991-6#1)(1992-11#1)(1993-5#1)(1993-8#1)(1994-5#1)(1995-6#1)(1995-8#1)(1996-4#1)(1997-8#1)(2006-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-6#2)(2008-8#2)(2009-5#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-11#1)(2011-2#2)(2012-12#1)
patients treated in a single##2##5##(1997-5#1)(2012-2#1)
patients treated in a##8##4##(1991-6#1)(1996-3#1)(1997-5#1)(2006-10#1)(2006-6#1)(2009-6#1)(2012-2#2)
patients treated in the geriatric assessment unit##3##7##(1990-5#3)
patients treated in the##10##4##(1990-5#3)(2006-10#1)(2007-11#1)(2007-7#1)(2008-7#1)(2010-10#1)(2012-2#1)(2013-1#1)
patients treated in##29##3##(1990-5#3)(1991-4#1)(1991-6#1)(1995-1#1)(1996-3#1)(1997-5#1)(2006-10#2)(2006-6#1)(2007-11#2)(2007-7#2)(2008-3#1)(2008-7#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-2#5)(2013-1#2)
patients treated locally##2##3##(2007-10#1)(2007-11#1)
patients treated operatively##2##3##(2007-7#1)(2008-3#1)
patients treated or##2##3##(1990-8#1)(2007-11#1)
patients treated over##2##3##(2008-6#1)(2012-2#1)
patients treated surgically at the##2##5##(2007-11#1)(2007-7#1)
patients treated surgically for##6##4##(2004-1#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#2)
patients treated surgically##11##3##(2004-1#1)(2007-10#1)(2007-11#3)(2007-7#2)(2007-8#2)(2008-7#1)(2010-11#1)
patients treated using##2##3##(1991-3#1)(2008-8#1)
patients treated via##3##3##(2006-8#3)
patients treated with CT only##2##5##(2011-2#2)
patients treated with CT##3##4##(2011-2#3)
patients treated with HD##2##4##(1995-3#2)
patients treated with RTX##2##4##(2013-1#2)
patients treated with a##4##4##(1990-10#1)(1991-2#1)(2006-10#1)(2008-5#1)
patients treated with an##2##4##(2008-5#1)(2009-6#1)
patients treated with band ligation##2##5##(2013-1#2)
patients treated with chemotherapy##8##4##(1990-10#1)(2004-1#2)(2005-11#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-2#1)
patients treated with different##2##4##(1994-10#1)(2013-1#1)
patients treated with erythropoietin##3##4##(1995-1#1)(2006-5#1)(2008-1#1)
patients treated with fibrinolysis##2##4##(2008-3#2)
patients treated with hemodialysis##3##4##(2007-7#1)(2008-10#1)(2008-7#1)
patients treated with high##2##4##(1990-6#2)
patients treated with infliximab##4##4##(2008-5#1)(2008-8#1)(2011-2#2)
patients treated with low##3##4##(1997-8#1)(2008-5#1)(2008-8#1)
patients treated with placebo##3##4##(1990-6#1)(2007-9#1)(2008-2#1)
patients treated with the drug##2##5##(2007-11#2)
patients treated with the##9##4##(1990-6#1)(1997-3#1)(2007-11#4)(2007-8#1)(2008-10#1)(2008-11#1)
patients treated with this##3##4##(2004-1#1)(2008-8#1)(2013-1#1)
patients treated with three##2##4##(2012-2#1)(2013-1#1)
patients treated with wedge filters and##2##6##(2007-10#2)
patients treated with##216##3##(1990-10#2)(1990-11#2)(1990-3#1)(1990-6#4)(1991-10#1)(1991-11#1)(1991-2#2)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#3)(1992-10#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-9#1)(1994-1#1)(1994-10#2)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#2)(1995-2#1)(1995-3#3)(1995-4#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#3)(1997-6#1)(1997-8#2)(2004-1#3)(2004-12#2)(2004-2#1)(2004-3#1)(2005-10#2)(2005-11#2)(2006-10#3)(2006-12#1)(2006-2#3)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#3)(2007-11#13)(2007-4#1)(2007-6#2)(2007-7#6)(2007-8#4)(2007-9#2)(2008-1#5)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#8)(2008-6#5)(2008-7#12)(2008-8#7)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-8#2)(2010-3#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#12)(2012-1#1)(2012-12#4)(2012-2#3)(2013-1#13)(2013-7#1)(2013-8#2)
patients treated within##2##3##(2007-10#1)(2007-12#1)
patients treated##383##2##(1990-10#2)(1990-11#2)(1990-2#2)(1990-3#1)(1990-5#3)(1990-6#6)(1990-8#1)(1990-9#1)(1991-10#2)(1991-11#1)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#3)(1995-11#1)(1995-2#2)(1995-3#3)(1995-4#3)(1995-6#2)(1995-8#1)(1996-10#1)(1996-12#1)(1996-3#2)(1996-4#2)(1996-6#1)(1996-8#2)(1996-9#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#3)(2004-1#4)(2004-12#2)(2004-2#1)(2004-3#1)(2005-10#2)(2005-11#2)(2005-7#1)(2006-10#6)(2006-12#1)(2006-2#4)(2006-5#2)(2006-6#4)(2006-8#4)(2006-9#1)(2007-10#8)(2007-11#26)(2007-12#2)(2007-4#1)(2007-6#3)(2007-7#13)(2007-8#14)(2007-9#2)(2008-1#7)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#10)(2008-6#14)(2008-7#19)(2008-8#12)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#4)(2009-6#2)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-11#1)(2011-2#20)(2012-1#1)(2012-12#5)(2012-2#12)(2013-1#16)(2013-7#1)(2013-8#2)
patients treatment##4##2##(2007-7#1)(2008-6#1)(2011-1#1)(2011-2#1)
patients type##2##2##(1997-8#2)
patients typically##3##2##(1995-2#1)(2005-10#1)(2007-5#1)
patients ultimately##3##2##(1990-3#1)(2006-6#1)(2011-1#1)
patients unable to##5##3##(2006-10#1)(2010-4#1)(2011-7#1)(2012-12#2)
patients under 15 years of age##2##6##(2007-6#1)(2007-7#1)
patients under 18 years##2##4##(2006-2#1)(2008-9#1)
patients under study##2##3##(1990-10#1)(2010-12#1)
patients under tinidazole treatment##2##4##(1996-2#2)
patients under treatment##3##3##(1994-9#1)(2008-10#1)(2011-1#1)
patients under##36##2##(1990-10#1)(1990-5#1)(1993-1#1)(1993-2#1)(1994-3#1)(1994-9#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-9#1)(2005-8#1)(2006-10#1)(2006-2#2)(2007-11#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#3)(2008-10#3)(2008-4#1)(2008-9#1)(2010-12#2)(2011-1#1)(2011-2#3)(2013-1#2)
patients undergo##5##2##(1990-3#1)(1997-8#1)(2010-8#1)(2011-2#1)(2012-3#1)
patients undergoing HD##2##3##(2007-7#1)(2008-1#1)
patients undergoing a##3##3##(1991-4#1)(2008-8#1)(2013-1#1)
patients undergoing ambulatory##3##3##(1996-4#2)(2006-10#1)
patients undergoing beating heart coronary surgery##2##6##(2007-8#2)
patients undergoing bilateral##3##3##(2007-8#2)(2008-5#1)
patients undergoing cardiac surgery##20##4##(2006-10#2)(2007-8#14)(2007-9#3)(2008-12#1)
patients undergoing cardiac surgery?##5##4##(2007-8#5)
patients undergoing cardiac##26##3##(2006-10#2)(2007-8#19)(2007-9#4)(2008-12#1)
patients undergoing cardiopulmonary bypass##3##4##(2007-9#1)(2008-5#1)(2009-8#1)
patients undergoing cardiovascular##2##3##(2006-10#1)(2009-10#1)
patients undergoing chemotherapy for##2##4##(1990-9#1)(1991-11#1)
patients undergoing chemotherapy##4##3##(1990-9#1)(1991-11#1)(2007-7#1)(2012-2#1)
patients undergoing coronary angiography##2##4##(1995-12#1)(2008-7#1)
patients undergoing coronary artery bypass graft surgery##3##7##(2006-10#1)(2007-7#1)(2007-9#1)
patients undergoing coronary artery bypass graft##4##6##(2006-10#1)(2007-7#1)(2007-9#1)(2008-6#1)
patients undergoing coronary artery bypass grafting (CABG)##3##7##(2007-10#1)(2007-8#1)(2007-9#1)
patients undergoing coronary artery bypass grafting surgery##4##7##(2007-10#1)(2007-8#1)(2008-12#1)(2013-1#1)
patients undergoing coronary artery bypass grafting##14##6##(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-8#3)(2007-9#2)(2008-12#1)(2013-1#3)
patients undergoing coronary artery bypass##21##5##(1997-8#2)(2006-10#2)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#5)(2007-9#3)(2008-12#1)(2008-6#1)(2013-1#3)
patients undergoing coronary artery##24##4##(1997-3#1)(1997-8#2)(2006-10#2)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#5)(2007-9#4)(2008-12#2)(2008-6#1)(2013-1#3)
patients undergoing coronary bypass##2##4##(1991-9#1)(1996-9#1)
patients undergoing coronary##32##3##(1991-9#1)(1995-12#1)(1996-9#1)(1997-3#1)(1997-8#2)(2006-10#2)(2007-10#2)(2007-11#2)(2007-7#1)(2007-8#6)(2007-9#4)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2013-1#3)
patients undergoing diagnostic##2##3##(2006-10#2)
patients undergoing dialysis##5##3##(2007-12#1)(2008-1#1)(2010-4#1)(2013-1#2)
patients undergoing either##3##3##(2009-12#1)(2011-2#1)(2013-1#1)
patients undergoing elective mitral valve replacement##2##6##(2007-9#2)
patients undergoing elective##9##3##(1991-5#1)(1995-6#1)(2005-12#1)(2007-8#1)(2007-9#3)(2011-2#1)(2012-3#1)
patients undergoing endovascular##2##3##(2006-11#1)(2007-8#1)
patients undergoing first time##2##4##(2007-8#2)
patients undergoing gastrointestinal surgery##2##4##(2005-8#2)
patients undergoing hematopoietic stem cell transplantation##2##6##(2008-7#1)(2011-2#1)
patients undergoing hemodialysis##7##3##(1993-9#1)(2008-7#2)(2009-2#3)(2010-5#1)
patients undergoing interventional##2##3##(2006-8#2)
patients undergoing isolated CABG##2##4##(2007-8#2)
patients undergoing laparoscopic##5##3##(1994-3#1)(2010-11#1)(2010-7#1)(2012-12#1)(2013-8#1)
patients undergoing lung##3##3##(2006-10#2)(2007-8#1)
patients undergoing maintenance##3##3##(1995-2#1)(2009-2#1)(2010-4#1)
patients undergoing major##2##3##(2006-10#1)(2007-8#1)
patients undergoing noncardiac surgery##2##4##(2008-3#1)(2012-3#1)
patients undergoing open thoracotomy##2##4##(2012-12#2)
patients undergoing open##6##3##(1996-9#1)(2007-8#1)(2007-9#1)(2009-4#1)(2012-12#2)
patients undergoing oral surgery with##2##5##(1993-1#2)
patients undergoing oral surgery##4##4##(1993-1#4)
patients undergoing orthopedic surgery##2##4##(2007-7#1)(2011-2#1)
patients undergoing orthopedic##3##3##(2007-7#1)(2008-5#1)(2011-2#1)
patients undergoing percutaneous coronary intervention##5##5##(2008-3#3)(2013-1#1)(2013-7#1)
patients undergoing percutaneous coronary##6##4##(2005-7#1)(2008-3#3)(2013-1#1)(2013-7#1)
patients undergoing percutaneous##7##3##(2005-7#1)(2007-9#1)(2008-3#3)(2013-1#1)(2013-7#1)
patients undergoing primary total knee##2##5##(2011-1#1)(2011-2#1)
patients undergoing primary total##3##4##(2008-8#1)(2011-1#1)(2011-2#1)
patients undergoing primary##10##3##(2007-7#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
patients undergoing radical prostatectomy##2##4##(2007-11#1)(2009-4#1)
patients undergoing radical##4##3##(2006-9#1)(2007-11#2)(2009-4#1)
patients undergoing renal transplantation##2##4##(2007-11#1)(2013-1#1)
patients undergoing revision##2##3##(2012-3#1)(2013-1#1)
patients undergoing spinal##3##3##(2006-8#1)(2012-12#1)(2012-3#1)
patients undergoing surgery for##4##4##(2006-10#1)(2006-12#1)(2008-7#1)(2013-1#1)
patients undergoing surgery is##2##4##(2006-10#1)(2007-12#1)
patients undergoing surgery##16##3##(1990-10#1)(1991-8#1)(1993-10#1)(2006-10#3)(2006-12#1)(2007-12#2)(2007-8#1)(2008-7#3)(2008-8#1)(2011-12#1)(2013-1#1)
patients undergoing surgical correction of scoliosis##3##6##(2007-7#3)
patients undergoing surgical##5##3##(2007-7#3)(2008-7#1)(2010-11#1)
patients undergoing therapy for##2##4##(1993-12#1)(2006-9#1)
patients undergoing therapy##3##3##(1991-10#1)(1993-12#1)(2006-9#1)
patients undergoing this procedure##2##4##(2008-8#1)(2013-8#1)
patients undergoing thoracic surgery##3##4##(2006-10#1)(2012-12#2)
patients undergoing total hip arthroplasty##3##5##(2006-10#1)(2007-7#1)(2011-2#1)
patients undergoing total hip##6##4##(2006-10#1)(2006-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2011-2#1)
patients undergoing total knee##2##4##(2007-10#1)(2009-3#1)
patients undergoing total##9##3##(2006-10#1)(2006-8#1)(2007-10#2)(2007-7#1)(2007-8#1)(2009-3#1)(2011-2#1)(2012-12#1)
patients undergoing treatment##4##3##(2006-8#1)(2007-11#1)(2008-10#2)
patients undergoing upper gastrointestinal endoscopy##2##5##(1991-5#1)(2011-2#1)
patients undergoing##358##2##(1990-10#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-1#4)(1993-10#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-9#2)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#1)(1996-3#3)(1996-4#2)(1996-9#2)(1997-3#2)(1997-8#2)(2005-12#2)(2005-7#1)(2005-8#2)(2006-10#25)(2006-11#5)(2006-12#3)(2006-8#9)(2006-9#3)(2007-10#6)(2007-11#10)(2007-12#5)(2007-3#1)(2007-5#1)(2007-7#10)(2007-8#63)(2007-9#22)(2008-1#4)(2008-10#3)(2008-12#4)(2008-3#7)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#18)(2008-8#5)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#4)(2009-3#2)(2009-4#2)(2009-8#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#3)(2011-2#13)(2012-1#2)(2012-12#9)(2012-2#6)(2012-3#5)(2013-1#17)(2013-7#1)(2013-8#3)
patients underwent 12##2##3##(2007-10#1)(2008-4#1)
patients underwent CABG##3##3##(1993-5#1)(2007-8#2)
patients underwent a##24##3##(1990-3#1)(1990-9#1)(1991-9#1)(1993-5#1)(1997-8#1)(2005-10#1)(2006-12#4)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-9#3)(2011-2#2)
patients underwent an##3##3##(1990-5#1)(2007-8#1)(2013-1#1)
patients underwent anterior##2##3##(2007-11#1)(2007-8#1)
patients underwent bilateral##2##3##(2006-8#1)(2007-9#1)
patients underwent combined##2##3##(2006-11#1)(2007-8#1)
patients underwent complete##3##3##(1997-8#1)(2006-8#1)(2007-8#1)
patients underwent coronary artery bypass grafting##3##6##(2007-8#2)(2007-9#1)
patients underwent coronary##4##3##(2007-8#2)(2007-9#1)(2008-5#1)
patients underwent isolated coronary artery bypass grafting##2##7##(2007-8#2)
patients underwent magnetic resonance##2##4##(2006-3#1)(2010-3#1)
patients underwent primary##3##3##(2007-11#1)(2007-7#1)(2008-6#1)
patients underwent radical surgery##2##4##(1990-6#1)(1990-9#1)
patients underwent radical##3##3##(1990-3#1)(1990-6#1)(1990-9#1)
patients underwent resection of##2##4##(1991-8#1)(2006-12#1)
patients underwent surgery due to##2##5##(2007-11#2)
patients underwent surgery##12##3##(1991-10#1)(1991-6#1)(1992-6#1)(1992-8#1)(2005-5#1)(2007-11#2)(2007-8#2)(2008-6#1)(2012-3#1)(2013-1#1)
patients underwent surgical##6##3##(1991-12#1)(2006-10#1)(2006-12#1)(2007-8#2)(2011-2#1)
patients underwent the##4##3##(2007-8#1)(2008-7#1)(2012-12#1)(2012-2#1)
patients underwent this##2##3##(2006-12#1)(2006-5#1)
patients underwent treatment##2##3##(2006-11#1)(2008-7#1)
patients underwent##202##2##(1990-10#1)(1990-3#2)(1990-5#1)(1990-6#3)(1990-9#3)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-2#1)(1993-5#2)(1994-11#1)(1994-3#2)(1994-9#1)(1995-10#2)(1995-11#1)(1995-9#1)(1996-3#1)(1997-8#5)(2004-1#1)(2005-10#1)(2005-5#1)(2006-10#2)(2006-11#4)(2006-12#8)(2006-3#2)(2006-5#5)(2006-6#6)(2006-7#3)(2006-8#12)(2006-9#1)(2007-10#5)(2007-11#8)(2007-7#4)(2007-8#33)(2007-9#3)(2008-1#3)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#8)(2008-8#1)(2008-9#4)(2009-3#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#8)
patients unsuitable for##3##3##(2008-3#1)(2010-6#2)
patients unsuspected##2##2##(2007-12#1)(2008-5#1)
patients up to##2##3##(2008-7#1)(2010-12#1)
patients upon##2##2##(1990-3#1)(1995-9#1)
patients use##7##2##(1995-2#1)(1995-3#1)(1996-2#1)(2007-12#1)(2008-10#1)(2009-3#1)(2009-8#1)
patients used##3##2##(1991-12#1)(1992-2#1)(1995-5#1)
patients using LMA##2##3##(2008-8#1)(2010-7#1)
patients using a##6##3##(1992-1#1)(1996-1#1)(2007-11#1)(2008-9#1)(2010-3#1)(2013-1#1)
patients using the##4##3##(2005-9#1)(2007-10#1)(2007-7#1)(2008-8#1)
patients using##49##2##(1990-11#1)(1990-12#1)(1992-1#1)(1993-12#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-1#2)(1996-12#1)(1997-8#1)(2004-3#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2010-10#1)(2010-3#1)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
patients usually do not##2##4##(2006-1#1)(2006-10#1)
patients usually present with##3##4##(2006-8#1)(2007-11#1)(2008-1#1)
patients usually##6##2##(2006-1#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-1#1)(2009-4#1)
patients varied##2##2##(1996-7#1)(2008-1#1)
patients via##7##2##(1991-3#1)(1996-3#1)(1996-9#1)(2007-9#1)(2008-10#1)(2013-1#2)
patients visited##2##2##(1995-9#1)(2011-2#1)
patients visiting the##3##3##(2011-2#1)(2012-12#1)(2013-8#1)
patients visiting##6##2##(2008-11#1)(2009-3#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-8#1)
patients waiting for##2##3##(1992-1#1)(2009-10#1)
patients want##2##2##(2006-4#1)(2012-3#1)
patients was 0##2##3##(2008-8#2)
patients was 1##2##3##(2011-1#1)(2011-2#1)
patients was 10##3##3##(2005-1#1)(2007-2#1)(2012-2#1)
patients was 11##2##3##(1990-6#1)(1992-5#1)
patients was 12##2##3##(2008-6#1)(2013-8#1)
patients was 128##2##3##(2007-2#1)(2008-7#1)
patients was 13##2##3##(2007-7#2)
patients was 22##2##3##(1995-7#1)(2012-2#1)
patients was 3##2##3##(1992-6#1)(2007-7#1)
patients was 33##3##3##(1995-3#1)(2011-1#1)(2012-3#1)
patients was 39##4##3##(1991-8#1)(2008-1#2)(2011-1#1)
patients was 55##2##3##(1990-12#1)(2007-9#1)
patients was 56 years##2##4##(1995-4#1)(2008-11#1)
patients was 6##3##3##(2007-2#1)(2008-5#1)(2008-8#1)
patients was 63##3##3##(1993-2#1)(2007-11#1)(2007-7#1)
patients was 66##2##3##(1997-8#1)(2013-8#1)
patients was 68##3##3##(1991-12#1)(2007-7#1)(2011-3#1)
patients was 7##3##3##(2005-1#1)(2007-8#2)
patients was also##2##3##(1991-4#1)(1997-7#1)
patients was analyzed##3##3##(2007-2#1)(2007-8#1)(2012-12#1)
patients was as##2##3##(1990-12#1)(2007-8#1)
patients was between##2##3##(1991-3#1)(2008-9#1)
patients was carried out##2##4##(2007-2#1)(2008-5#1)
patients was compared to a##2##5##(1990-7#1)(2008-7#1)
patients was compared to##3##4##(1990-10#1)(1990-7#1)(2008-7#1)
patients was conducted##2##3##(2005-10#1)(2007-2#1)
patients was detected##2##3##(2008-7#1)(2013-1#1)
patients was diagnosed##2##3##(1990-4#1)(2010-8#1)
patients was done##3##3##(2007-7#1)(2007-8#1)(2011-1#1)
patients was evaluated before##2##4##(2007-9#1)(2012-1#1)
patients was evaluated##5##3##(2007-9#2)(2008-1#1)(2012-1#1)(2012-2#1)
patients was examined##3##3##(2007-3#1)(2008-4#1)(2008-5#1)
patients was far##2##3##(1991-2#1)(2007-2#1)
patients was found to be##2##5##(1995-12#1)(1997-2#1)
patients was found##5##3##(1993-12#1)(1995-11#1)(1995-12#1)(1997-2#1)(2006-6#1)
patients was greater##3##3##(2009-10#1)(2011-2#2)
patients was higher##3##3##(1993-10#1)(2007-2#1)(2012-2#1)
patients was investigated##2##3##(1995-9#1)(1996-12#1)
patients was lower##2##3##(1990-5#1)(2011-2#1)
patients was measured##2##3##(2008-7#1)(2009-6#1)
patients was not##3##3##(1992-2#1)(2006-3#1)(2011-1#1)
patients was performed##6##3##(1993-8#1)(2007-4#1)(2007-8#1)(2008-2#1)(2010-12#1)(2013-1#1)
patients was poor##2##3##(1996-8#1)(2012-12#1)
patients was recorded##2##3##(2007-11#1)(2007-7#1)
patients was reduced##2##3##(1992-6#1)(2006-10#1)
patients was significantly higher (P &lt##2##6##(1996-1#1)(2007-7#1)
patients was significantly higher than##2##5##(1991-4#1)(2008-10#1)
patients was significantly higher##4##4##(1991-4#1)(1996-1#1)(2007-7#1)(2008-10#1)
patients was significantly##11##3##(1991-4#1)(1991-9#2)(1995-11#1)(1996-1#1)(1996-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2011-1#1)(2012-2#1)
patients was statistically##3##3##(2007-2#1)(2007-9#1)(2008-7#1)
patients was studied in##2##4##(1993-11#1)(2008-7#1)
patients was studied##5##3##(1991-9#1)(1993-11#1)(2008-1#1)(2008-7#1)(2012-3#1)
patients was the##2##3##(2008-7#2)
patients was treated with##2##4##(1994-12#1)(2007-11#1)
patients was treated##3##3##(1994-12#1)(2006-12#1)(2007-11#1)
patients was very##2##3##(1994-8#1)(2009-8#1)
patients was##272##2##(1990-10#1)(1990-11#1)(1990-12#4)(1990-4#2)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#3)(1991-4#3)(1991-8#1)(1991-9#3)(1992-10#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#3)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#1)(1994-12#3)(1994-3#1)(1994-4#1)(1994-7#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-3#2)(1995-4#1)(1995-7#2)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-6#1)(1996-7#2)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-1#2)(2005-10#4)(2005-5#1)(2005-9#1)(2006-10#3)(2006-12#2)(2006-3#1)(2006-6#1)(2006-8#3)(2006-9#2)(2007-11#7)(2007-2#12)(2007-3#4)(2007-4#1)(2007-7#18)(2007-8#12)(2007-9#6)(2008-1#9)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#5)(2008-7#12)(2008-8#4)(2008-9#1)(2009-10#3)(2009-6#2)(2009-8#1)(2010-12#3)(2010-3#1)(2010-6#1)(2010-8#2)(2011-1#8)(2011-11#1)(2011-2#14)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#10)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#2)
patients we assessed the##2##4##(1996-2#1)(2008-6#1)
patients we diagnosed incongruence of the##2##6##(2007-8#2)
patients we found##4##3##(1990-10#1)(1993-8#1)(1996-9#1)(2008-5#1)
patients we observed##3##3##(1991-12#1)(1993-12#1)(2007-11#1)
patients we performed##3##3##(2007-8#2)(2007-9#1)
patients we selected a hybrid##2##5##(1990-12#2)
patients we studied##2##3##(1992-5#1)(2007-11#1)
patients we treated##2##3##(1996-9#1)(2011-2#1)
patients we##24##2##(1990-10#1)(1990-12#2)(1990-3#1)(1991-11#1)(1991-12#1)(1992-5#1)(1993-12#1)(1993-8#1)(1996-2#1)(1996-9#2)(2007-11#4)(2007-8#4)(2007-9#1)(2008-5#1)(2008-6#1)(2011-2#1)
patients wearing##4##2##(1990-12#1)(2007-7#1)(2013-1#2)
patients weighing##2##2##(1993-7#1)(2012-2#1)
patients were 5##2##3##(1997-2#1)(2007-8#1)
patients were able to##5##4##(1996-1#1)(2006-10#1)(2006-11#1)(2006-2#1)(2008-7#1)
patients were above##3##3##(1993-1#1)(2008-3#1)(2013-1#1)
patients were adequately##3##3##(1990-4#1)(2010-8#2)
patients were administered##6##3##(2007-9#2)(2008-10#1)(2010-2#1)(2010-7#1)(2011-1#1)
patients were administrated##3##3##(2012-3#3)
patients were admitted for##2##4##(2007-8#1)(2011-1#1)
patients were admitted to the ICU##2##6##(2004-1#1)(2006-10#1)
patients were admitted to##5##4##(1997-6#1)(2004-1#1)(2006-10#1)(2009-6#1)(2012-3#1)
patients were admitted with##3##4##(1997-8#1)(2007-8#1)(2007-9#1)
patients were admitted##15##3##(1991-9#1)(1996-9#1)(1997-6#1)(1997-8#1)(2004-1#1)(2006-10#1)(2007-7#1)(2007-8#2)(2007-9#2)(2009-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
patients were affected by##3##4##(1990-5#1)(1990-9#1)(1991-4#1)
patients were alive and##5##4##(1991-8#2)(1992-4#1)(2008-6#1)(2012-12#1)
patients were alive##13##3##(1990-6#1)(1991-10#1)(1991-2#1)(1991-8#2)(1992-4#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-6#2)(2012-12#1)(2012-3#1)
patients were allocated to##3##4##(1990-4#1)(1994-2#1)(2012-2#1)
patients were also##7##3##(1990-10#1)(1990-2#1)(1995-11#1)(1997-8#1)(2006-9#1)(2007-7#1)(2007-9#1)
patients were analysed##6##3##(1990-8#1)(1992-5#1)(1993-8#1)(2008-3#2)(2008-8#1)
patients were analyzed for##2##4##(1991-3#1)(1992-3#1)
patients were analyzed in##2##4##(1990-2#1)(2008-7#1)
patients were analyzed##16##3##(1990-12#1)(1990-2#1)(1991-3#1)(1992-3#1)(1993-11#1)(1995-3#1)(1996-12#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-7#1)(2009-2#1)(2010-4#1)(2013-1#1)(2013-8#1)
patients were approached##2##3##(2007-12#1)(2010-12#1)
patients were asked to##5##4##(1996-3#1)(2007-8#1)(2007-9#1)(2010-12#1)(2013-1#1)
patients were asked##6##3##(1996-3#1)(2007-2#1)(2007-8#1)(2007-9#1)(2010-12#1)(2013-1#1)
patients were assayed##2##3##(1990-1#1)(2013-1#1)
patients were assessed clinically##2##4##(2007-8#1)(2011-12#1)
patients were assessed for##2##4##(2007-2#1)(2012-3#1)
patients were assessed##12##3##(1990-10#1)(1990-5#1)(1995-3#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-9#1)(2009-9#1)(2011-12#1)(2012-1#1)(2012-3#1)
patients were assigned to##2##4##(1992-3#1)(2008-12#1)
patients were assigned##3##3##(1992-3#1)(2006-10#1)(2008-12#1)
patients were asymptomatic##3##3##(1993-5#1)(2008-3#1)(2012-2#1)
patients were at##4##3##(2006-7#1)(2008-5#1)(2010-10#1)(2011-2#1)
patients were available for follow-up##2##5##(1996-9#1)(2009-3#1)
patients were available for##5##4##(1996-9#1)(2006-10#2)(2009-3#1)(2012-3#1)
patients were between 20##2##4##(1993-5#1)(2007-7#1)
patients were between##5##3##(1993-5#1)(2004-10#1)(2007-6#1)(2007-7#1)(2007-8#1)
patients were categorised##2##3##(1997-3#1)(2007-9#1)
patients were categorized as##2##4##(2005-9#1)(2013-1#1)
patients were categorized##3##3##(2005-9#1)(2008-3#1)(2013-1#1)
patients were characterized##2##3##(1993-12#1)(1996-2#1)
patients were chosen##3##3##(2007-12#1)(2011-2#2)
patients were classified as a##2##5##(2007-8#1)(2013-1#1)
patients were classified as##12##4##(1993-2#1)(1993-5#1)(2007-7#1)(2007-8#1)(2008-12#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
patients were classified##13##3##(1993-2#1)(1993-5#1)(2007-7#2)(2007-8#1)(2008-12#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
patients were clinically##3##3##(1990-9#1)(2008-12#1)(2011-1#1)
patients were collected##2##3##(2005-10#1)(2010-2#1)
patients were compared to##2##4##(2004-12#1)(2008-7#1)
patients were compared with##4##4##(2005-5#1)(2006-10#1)(2009-7#1)(2012-12#1)
patients were compared##8##3##(1995-6#1)(2004-12#1)(2005-5#1)(2006-10#1)(2008-11#1)(2008-7#1)(2009-7#1)(2012-12#1)
patients were completely##4##3##(1992-3#1)(2006-6#1)(2007-7#1)(2008-9#1)
patients were considered##4##3##(1991-3#1)(1993-11#1)(1993-5#1)(1996-12#1)
patients were continued on opioid medication##2##6##(2006-8#2)
patients were cured##3##3##(1995-11#1)(2007-7#1)(2008-7#1)
patients were deemed##2##3##(1997-2#1)(2007-6#1)
patients were defined##2##3##(2007-7#1)(2012-12#1)
patients were determined##2##3##(1995-1#1)(2008-10#1)
patients were diagnosed as having##2##5##(1995-11#1)(2008-6#1)
patients were diagnosed as##3##4##(1995-11#1)(2008-6#1)(2012-12#1)
patients were diagnosed to have##2##5##(2007-7#1)(2009-10#1)
patients were diagnosed with##11##4##(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-8#2)(2008-4#1)(2008-7#1)
patients were diagnosed##19##3##(1995-11#1)(2006-10#1)(2006-12#1)(2006-6#2)(2006-8#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2012-12#1)(2012-2#1)
patients were discharged home##2##4##(2007-10#1)(2008-1#1)
patients were discharged in##2##4##(2007-8#2)
patients were discharged##8##3##(1990-8#1)(2007-10#1)(2007-8#4)(2008-1#1)(2011-1#1)
patients were dissatisfied##2##3##(1995-9#1)(2008-8#1)
patients were divided in##2##4##(1997-4#1)(2013-1#1)
patients were divided into 3 groups##2##6##(2008-4#1)(2008-7#1)
patients were divided into three groups##6##6##(1991-4#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2011-12#1)
patients were divided into two groups##9##6##(1992-7#1)(1995-12#1)(1995-7#1)(2006-8#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-1#1)
patients were divided into two##12##5##(1992-7#1)(1995-12#1)(1995-7#1)(1996-8#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)
patients were divided into##31##4##(1991-4#1)(1992-5#2)(1992-7#1)(1995-12#1)(1995-7#1)(1996-12#1)(1996-8#1)(1997-8#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-7#2)(2007-8#1)(2007-9#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#3)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)
patients were divided##35##3##(1991-4#1)(1992-5#2)(1992-7#1)(1995-12#1)(1995-7#1)(1996-12#1)(1996-8#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-7#3)(2007-8#1)(2007-9#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#3)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
patients were enrolled and##3##4##(2011-1#1)(2012-2#1)(2013-1#1)
patients were enrolled in a##3##5##(1995-9#1)(1996-3#1)(2006-6#1)
patients were enrolled in the study##4##6##(2006-10#1)(2008-7#1)(2010-4#1)(2012-2#1)
patients were enrolled in this study##4##6##(2007-8#1)(2008-1#1)(2008-8#1)(2012-3#1)
patients were enrolled in##13##4##(1995-9#1)(1996-3#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
patients were enrolled##36##3##(1995-9#1)(1996-3#1)(2004-1#1)(2004-11#1)(2005-7#1)(2006-10#2)(2006-6#2)(2007-10#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-3#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)
patients were entered in the##2##5##(2008-4#1)(2008-7#1)
patients were entered in##3##4##(1994-7#1)(2008-4#1)(2008-7#1)
patients were entered##5##3##(1994-7#1)(1996-8#1)(2004-2#1)(2008-4#1)(2008-7#1)
patients were equally##2##3##(1996-3#1)(2009-12#1)
patients were evaluable for response##3##5##(1991-6#1)(2007-10#1)(2008-6#1)
patients were evaluable for##5##4##(1990-10#1)(1991-6#1)(2007-10#1)(2008-6#2)
patients were evaluable##8##3##(1990-10#1)(1990-2#1)(1991-4#1)(1991-6#1)(2007-10#1)(2008-6#2)(2008-7#1)
patients were evaluated by##4##4##(1995-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
patients were evaluated clinically##3##4##(2007-8#2)(2008-3#1)
patients were evaluated in##6##4##(1993-8#1)(2007-7#1)(2008-3#1)(2008-7#1)(2013-8#2)
patients were evaluated prospectively##2##4##(1992-2#1)(2007-8#1)
patients were evaluated##34##3##(1991-12#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-8#1)(1995-9#1)(1997-5#1)(2006-8#2)(2007-3#1)(2007-7#4)(2007-8#4)(2007-9#1)(2008-3#3)(2008-7#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#4)
patients were examined at##2##4##(1990-12#1)(2012-2#1)
patients were examined by##2##4##(1994-6#1)(1997-3#1)
patients were examined clinically##2##4##(1991-12#1)(1992-3#1)
patients were examined in the##3##5##(1991-11#1)(2005-10#1)(2006-10#1)
patients were examined in this study##2##6##(1992-9#1)(2007-3#1)
patients were examined in this##3##5##(1990-12#1)(1992-9#1)(2007-3#1)
patients were examined in##6##4##(1990-12#1)(1991-11#1)(1992-9#1)(2005-10#1)(2006-10#1)(2007-3#1)
patients were examined with##2##4##(1991-12#1)(2008-8#1)
patients were examined##25##3##(1990-12#2)(1990-3#1)(1991-11#1)(1991-12#2)(1992-3#1)(1992-9#1)(1993-2#1)(1994-6#1)(1997-3#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-8#2)(2008-8#1)(2008-9#1)(2011-1#2)(2012-2#1)
patients were excluded from the##2##5##(2007-11#1)(2010-4#1)
patients were excluded##4##3##(1997-8#1)(2007-11#1)(2009-8#1)(2010-4#1)
patients were exposed to##2##4##(1990-2#1)(2008-8#1)
patients were female and##3##4##(1997-8#1)(2008-8#1)(2011-2#1)
patients were female##5##3##(1997-8#1)(2006-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
patients were females##4##3##(2006-10#1)(2006-8#1)(2011-1#1)(2013-1#1)
patients were first##2##3##(2007-8#1)(2011-2#1)
patients were fitted with##2##4##(2006-8#1)(2008-9#1)
patients were followed for an average of##2##7##(2006-5#1)(2009-10#1)
patients were followed for at least##2##6##(1996-1#1)(2006-10#1)
patients were followed for##5##4##(1996-1#1)(2006-10#1)(2006-5#1)(2008-5#1)(2009-10#1)
patients were followed up at##3##5##(2007-8#1)(2008-11#1)(2008-2#1)
patients were followed up for a mean##2##7##(1995-6#1)(2011-12#1)
patients were followed up for a##3##6##(1995-6#1)(2011-12#1)(2013-8#1)
patients were followed up for##10##5##(1992-1#1)(1995-5#1)(1995-6#1)(2007-7#1)(2007-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
patients were followed up##16##4##(1992-1#1)(1994-5#1)(1995-5#1)(1995-6#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-2#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-8#2)
patients were followed##24##3##(1992-1#1)(1994-5#1)(1995-5#1)(1995-6#1)(1996-1#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
patients were followed-up##3##3##(2008-1#1)(2009-6#1)(2011-2#1)
patients were found to be##2##5##(1996-3#1)(2012-12#1)
patients were found to have a##2##6##(2005-10#1)(2007-10#1)
patients were found to have##20##5##(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-9#2)(1997-2#1)(2005-10#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-4#2)(2008-9#2)(2009-10#1)(2009-2#1)(2011-12#1)(2013-1#1)
patients were found to##25##4##(1990-2#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-3#1)(1996-9#2)(1997-2#1)(2004-3#1)(2005-10#1)(2006-8#2)(2007-10#1)(2007-3#1)(2007-8#1)(2008-4#2)(2008-9#2)(2009-10#1)(2009-2#1)(2011-12#1)(2012-12#1)(2013-1#1)
patients were found##29##3##(1990-2#1)(1993-1#1)(1993-11#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-3#1)(1996-9#2)(1997-2#1)(2004-3#1)(2005-10#1)(2006-8#2)(2007-10#1)(2007-3#1)(2007-8#1)(2008-4#2)(2008-9#2)(2009-10#1)(2009-2#1)(2010-4#1)(2011-12#1)(2012-1#1)(2012-12#1)(2013-1#1)
patients were free of##2##4##(1992-5#1)(1994-2#1)
patients were fully##4##3##(1993-8#1)(1997-2#1)(2006-6#1)(2007-3#1)
patients were functionally##2##3##(2005-9#1)(2006-12#1)
patients were further##3##3##(2007-7#1)(2008-1#1)(2013-8#1)
patients were genotype 4##3##4##(2007-2#2)(2013-1#1)
patients were given##20##3##(1990-7#1)(1991-11#1)(1991-5#1)(1994-2#1)(2004-10#1)(2004-3#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-7#1)(2009-12#1)(2009-6#1)(2011-2#1)(2013-1#1)
patients were grouped##3##3##(1997-8#1)(2008-1#1)(2013-1#1)
patients were highly##2##3##(1990-9#1)(2013-1#1)
patients were hospitalised##3##3##(2007-11#1)(2007-2#1)(2007-8#1)
patients were hospitalized at that department and##2##7##(2013-1#2)
patients were hospitalized at##3##4##(2008-1#1)(2013-1#2)
patients were hospitalized##12##3##(1991-4#1)(1991-6#1)(1993-10#1)(1995-6#1)(1995-9#1)(1996-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2013-1#2)
patients were hypertensive##3##3##(1995-2#1)(2007-7#1)(2010-12#1)
patients were identified as##2##4##(2007-10#1)(2011-2#1)
patients were identified##14##3##(2007-10#3)(2007-8#1)(2008-6#3)(2008-9#2)(2011-1#1)(2011-2#1)(2012-3#2)(2013-8#1)
patients were improved##2##3##(2006-10#1)(2008-9#1)
patients were in NYHA class I and##2##7##(1994-11#1)(2007-8#1)
patients were in clinical##2##4##(1992-9#1)(1993-3#1)
patients were in the age group of##2##7##(2008-11#1)(2010-5#1)
patients were in the age group##3##6##(2008-11#1)(2010-5#1)(2011-1#1)
patients were in the##8##4##(1994-4#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-11#1)(2008-4#1)(2010-5#1)(2011-1#1)
patients were in##21##3##(1991-2#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
patients were included in a##2##5##(1997-7#2)
patients were included in the analyses##2##6##(2008-7#1)(2013-8#1)
patients were included in the study##7##6##(1993-10#1)(2006-8#1)(2007-7#1)(2007-9#1)(2008-8#1)(2011-2#1)(2012-1#1)
patients were included in the##11##5##(1993-10#1)(2006-8#1)(2007-7#1)(2007-9#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
patients were included in this study##4##6##(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
patients were included in##19##4##(1993-10#1)(1993-2#1)(1993-8#1)(1997-7#2)(2006-8#1)(2007-7#1)(2007-9#1)(2008-7#2)(2008-8#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#2)
patients were included to##2##4##(2007-11#1)(2011-2#1)
patients were included who had##2##5##(2007-7#1)(2013-8#1)
patients were included##36##3##(1990-6#1)(1993-10#1)(1993-2#1)(1993-8#1)(1997-7#2)(2006-8#2)(2007-11#1)(2007-7#4)(2007-9#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#4)
patients were independent##2##3##(1990-2#1)(2007-9#1)
patients were induced##2##3##(2010-7#2)
patients were infected in##2##4##(1996-11#1)(2012-3#1)
patients were infected##3##3##(1996-11#1)(2008-5#1)(2012-3#1)
patients were initially##2##3##(1994-2#1)(2011-2#1)
patients were initiated on##2##4##(2006-12#1)(2007-7#1)
patients were injected with##2##4##(2004-10#1)(2008-7#1)
patients were injured##2##3##(1990-2#1)(1990-9#1)
patients were instructed##2##3##(1994-2#1)(2013-8#1)
patients were interviewed using a##2##5##(2004-12#1)(2011-1#1)
patients were interviewed##4##3##(2004-12#1)(2005-7#1)(2008-5#1)(2011-1#1)
patients were investigated##5##3##(1996-7#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)
patients were involved in##2##4##(2006-10#1)(2008-1#1)
patients were less likely to have##3##6##(1995-11#1)(2007-8#1)(2007-9#1)
patients were less likely to##5##5##(1995-11#1)(1995-12#1)(2007-8#1)(2007-9#1)(2010-2#1)
patients were less##6##3##(1995-11#1)(1995-12#1)(2007-8#1)(2007-9#1)(2008-3#1)(2010-2#1)
patients were lost to follow up##3##6##(1993-12#1)(1996-3#1)(2006-8#1)
patients were lost to follow-up##4##5##(1991-12#1)(1993-12#1)(2010-7#1)(2013-1#1)
patients were lost to##7##4##(1991-12#1)(1993-12#2)(1996-3#1)(2006-8#1)(2010-7#1)(2013-1#1)
patients were lower than those##2##5##(1993-9#1)(2006-12#1)
patients were made##2##3##(2007-11#1)(2008-5#1)
patients were mainly of##2##4##(1994-12#2)
patients were male##7##3##(1990-9#1)(2005-12#1)(2006-7#1)(2007-8#1)(2012-2#1)(2013-1#2)
patients were males and##2##4##(1992-4#1)(2006-6#1)
patients were males##3##3##(1992-4#1)(2006-2#1)(2006-6#1)
patients were managed by##2##4##(1992-8#1)(2007-7#1)
patients were managed##6##3##(1992-8#1)(1994-2#1)(2007-7#1)(2007-8#1)(2013-1#2)
patients were matched##3##3##(1995-6#1)(2006-12#1)(2008-8#1)
patients were measured##3##3##(1995-3#1)(2008-4#1)(2011-2#1)
patients were men and##2##4##(1991-9#1)(2006-11#1)
patients were men##6##3##(1990-6#1)(1991-9#1)(2006-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
patients were monitored##4##3##(2006-8#2)(2010-4#1)(2010-5#1)
patients were more frequently##2##4##(1994-7#1)(2008-3#1)
patients were more likely to be##2##6##(1996-3#1)(2007-8#1)
patients were more likely to have##4##6##(1995-2#1)(2006-10#1)(2012-2#1)(2013-8#1)
patients were more likely to##8##5##(1995-12#1)(1995-2#1)(1996-3#1)(2006-10#1)(2007-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
patients were more##14##3##(1994-7#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-7#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-3#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
patients were not##7##3##(1990-10#1)(1996-8#1)(1996-9#1)(2006-8#1)(2008-11#1)(2008-5#1)(2008-7#1)
patients were noted to##2##4##(1992-3#1)(2008-6#1)
patients were observed for##2##4##(1990-8#1)(1991-2#1)
patients were observed##5##3##(1990-8#1)(1991-2#1)(1991-4#1)(2007-11#1)(2012-2#1)
patients were obtained##6##3##(2006-8#1)(2007-2#1)(2007-9#1)(2012-5#1)(2013-1#2)
patients were of##2##3##(2004-1#1)(2011-2#1)
patients were offered##3##3##(2012-2#1)(2013-8#2)
patients were older than##2##4##(2008-7#1)(2013-1#1)
patients were on##11##3##(1996-8#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#1)(2008-4#1)(2010-12#1)(2012-5#1)
patients were operated by##2##4##(1992-2#1)(1993-8#1)
patients were operated for##2##4##(1992-5#1)(2007-7#1)
patients were operated on##10##4##(1991-12#2)(1991-8#1)(1992-1#1)(1993-3#1)(1993-5#1)(1996-2#1)(2006-7#1)(2006-8#1)(2007-8#1)
patients were operated upon##3##4##(1991-6#1)(1992-6#1)(2009-2#1)
patients were operated using##2##4##(2007-7#1)(2013-1#1)
patients were operated##24##3##(1991-12#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-8#1)(1996-2#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-7#2)(2007-8#3)(2009-2#1)(2011-1#1)(2013-1#1)
patients were optimally cytoreduced##2##4##(2006-6#2)
patients were over##4##3##(1990-10#1)(2008-1#1)(2008-7#1)(2009-2#1)
patients were permitted##2##3##(2006-8#1)(2009-3#1)
patients were positive for##2##4##(1993-5#1)(2007-7#1)
patients were positive##3##3##(1993-5#1)(1995-2#1)(2007-7#1)
patients were prescribed##5##3##(2006-9#1)(2008-11#1)(2010-12#1)(2012-2#1)(2013-7#1)
patients were presented with##2##4##(2007-2#1)(2012-12#1)
patients were presented##5##3##(2005-8#1)(2007-2#1)(2012-12#1)(2013-1#2)
patients were pretreated with##2##4##(1992-8#1)(1996-2#1)
patients were prospectively##4##3##(2007-8#2)(2007-9#1)(2013-1#1)
patients were randomised to##3##4##(1993-2#1)(2008-3#1)(2010-4#1)
patients were randomized into two groups##3##6##(2005-1#1)(2008-5#1)(2012-2#1)
patients were randomized into##4##4##(2005-1#1)(2008-5#1)(2009-3#1)(2012-2#1)
patients were randomized to receive either##2##6##(1992-4#1)(2008-6#1)
patients were randomized to receive##7##5##(1992-4#1)(2006-2#1)(2008-6#1)(2008-7#1)(2010-4#1)(2010-8#1)(2013-8#1)
patients were randomized to##10##4##(1992-4#1)(1997-6#1)(2006-2#1)(2007-8#1)(2008-6#2)(2008-7#1)(2010-4#1)(2010-8#1)(2013-8#1)
patients were randomized##17##3##(1992-4#1)(1997-6#1)(2005-1#1)(2006-2#1)(2006-8#1)(2007-8#1)(2008-5#1)(2008-6#2)(2008-7#2)(2009-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
patients were randomly allocated into 3##2##6##(2006-12#1)(2011-12#1)
patients were randomly allocated into##3##5##(2006-12#2)(2011-12#1)
patients were randomly allocated to receive##2##6##(2009-10#1)(2010-12#1)
patients were randomly allocated to##3##5##(1990-11#1)(2009-10#1)(2010-12#1)
patients were randomly allocated##9##4##(1990-11#1)(2006-12#2)(2006-6#1)(2009-10#1)(2010-12#1)(2010-7#1)(2011-12#1)(2012-3#1)
patients were randomly assigned to receive##5##6##(1993-1#1)(2007-8#1)(2009-8#1)(2010-12#1)(2012-2#1)
patients were randomly assigned to##11##5##(1991-7#1)(1993-1#1)(1996-8#1)(2007-8#1)(2008-3#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-8#1)
patients were randomly assigned##13##4##(1991-7#1)(1993-1#1)(1996-8#1)(2006-8#1)(2007-8#1)(2008-3#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
patients were randomly divided into two groups##2##7##(1994-7#1)(2007-8#1)
patients were randomly divided into##5##5##(1994-7#1)(2007-8#1)(2009-7#1)(2010-7#1)(2013-7#1)
patients were randomly##31##3##(1990-11#1)(1991-7#1)(1993-1#1)(1993-2#1)(1994-7#1)(1996-8#1)(1997-6#1)(2006-12#2)(2006-6#1)(2006-8#2)(2007-8#2)(2008-3#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-7#2)(2011-12#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
patients were reassessed##4##3##(2006-7#1)(2007-1#1)(2007-2#1)(2011-1#1)
patients were receiving##9##3##(2005-10#1)(2007-2#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
patients were recorded##2##3##(2007-12#1)(2013-8#1)
patients were recruited for the##2##5##(2011-2#1)(2012-1#1)
patients were recruited in##2##4##(2006-12#1)(2009-2#1)
patients were recruited##6##3##(2006-12#1)(2009-2#1)(2011-2#1)(2012-1#2)(2013-1#1)
patients were referred to our##2##5##(2007-11#1)(2008-4#1)
patients were referred to the##2##5##(1993-9#1)(2007-11#1)
patients were referred to##5##4##(1993-9#1)(2007-11#2)(2008-4#1)(2011-2#1)
patients were referred##9##3##(1993-9#1)(2007-11#2)(2007-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-2#1)
patients were registered##2##3##(1995-9#1)(2013-1#1)
patients were reported##3##3##(2007-7#1)(2008-2#1)(2008-6#1)
patients were resuscitated##2##3##(1991-9#1)(1993-8#1)
patients were retrieved##2##3##(2006-10#1)(2006-8#1)
patients were reviewed at##2##4##(2007-8#1)(2010-10#1)
patients were reviewed##10##3##(1995-2#1)(1996-6#1)(2006-10#1)(2007-7#1)(2007-8#2)(2008-1#1)(2010-10#1)(2011-12#1)(2011-2#1)
patients were satisfied with the surgical##2##6##(2007-7#2)
patients were satisfied with the##5##5##(1990-4#1)(1997-2#1)(2007-7#2)(2013-1#1)
patients were satisfied with##6##4##(1990-4#1)(1997-2#1)(2007-7#2)(2008-9#1)(2013-1#1)
patients were satisfied##7##3##(1990-4#1)(1997-2#1)(1997-3#1)(2007-7#2)(2008-9#1)(2013-1#1)
patients were scored for##2##4##(1997-8#1)(2008-7#1)
patients were screened##3##3##(2006-10#1)(2006-7#1)(2012-3#1)
patients were seen during##3##4##(1992-6#1)(2007-7#1)(2008-1#1)
patients were seen##8##3##(1992-6#1)(1996-1#1)(2006-2#1)(2007-3#1)(2007-7#2)(2008-1#1)(2011-1#1)
patients were selected for##4##4##(1995-1#1)(2006-6#2)(2007-1#1)
patients were selected on##2##4##(2008-1#1)(2011-12#1)
patients were selected##10##3##(1992-10#1)(1995-1#1)(2006-6#3)(2007-1#1)(2008-1#1)(2008-3#1)(2008-8#1)(2011-12#1)
patients were sent for##2##4##(1995-4#1)(2013-1#1)
patients were separated##2##3##(2006-6#1)(2008-1#1)
patients were significantly higher than those in healthy subjects##2##9##(1995-2#1)(2005-10#1)
patients were significantly higher than those in##3##7##(1994-3#1)(1995-2#1)(2005-10#1)
patients were significantly higher than those of##2##7##(2008-10#1)(2011-12#1)
patients were significantly higher than those##5##6##(1994-3#1)(1995-2#1)(2005-10#1)(2008-10#1)(2011-12#1)
patients were significantly higher than##6##5##(1994-10#1)(1994-3#1)(1995-2#1)(2005-10#1)(2008-10#1)(2011-12#1)
patients were significantly##13##3##(1994-10#1)(1994-3#1)(1995-2#1)(2005-10#1)(2007-8#2)(2008-10#1)(2008-12#1)(2009-10#1)(2009-5#1)(2011-12#1)(2013-1#2)
patients were similar##2##3##(1992-4#1)(2007-8#1)
patients were slower than##2##4##(2008-7#2)
patients were stage##2##3##(2008-10#1)(2011-12#1)
patients were started##2##3##(2008-7#1)(2010-8#1)
patients were still##3##3##(1990-10#1)(1991-2#1)(2007-7#1)
patients were stratified by##2##4##(2007-7#1)(2011-2#1)
patients were stratified##5##3##(1995-11#1)(2006-2#1)(2007-7#1)(2011-2#2)
patients were studied by##2##4##(1991-11#1)(2007-7#1)
patients were studied in##2##4##(1993-2#1)(1993-8#1)
patients were studied retrospectively and##2##5##(1990-9#1)(1997-8#1)
patients were studied using##2##4##(1997-8#1)(2006-7#1)
patients were studied##33##3##(1990-8#1)(1990-9#1)(1991-11#1)(1991-3#1)(1992-2#1)(1993-2#1)(1993-8#1)(1996-1#2)(1997-7#1)(1997-8#3)(2005-10#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-3#1)(2011-1#2)(2012-2#5)(2013-1#1)
patients were subjected to##12##4##(1990-11#1)(1991-3#1)(1995-11#1)(1997-2#1)(2005-1#1)(2007-7#2)(2007-8#1)(2008-12#1)(2011-1#1)(2012-2#1)(2012-3#1)
patients were subjected##13##3##(1990-11#1)(1991-3#1)(1995-11#1)(1997-2#1)(2005-1#1)(2007-7#2)(2007-8#1)(2008-12#1)(2011-1#1)(2012-2#2)(2012-3#1)
patients were submitted to the##2##5##(1990-7#1)(2007-7#1)
patients were submitted to##9##4##(1990-6#1)(1990-7#1)(1992-5#1)(1995-4#1)(2007-7#1)(2009-4#1)(2011-2#2)(2013-1#1)
patients were subsequently##2##3##(1997-3#1)(2008-6#1)
patients were successfully##2##3##(1992-9#1)(2009-10#1)
patients were suffering from##3##4##(2007-7#1)(2007-9#1)(2013-1#1)
patients were surveyed##2##3##(1996-2#1)(2006-2#1)
patients were symptom-free##3##3##(1994-5#1)(2007-7#1)(2012-3#1)
patients were taken##3##3##(1991-2#1)(2007-9#1)(2012-2#1)
patients were taking##3##3##(2005-6#1)(2006-10#1)(2007-8#1)
patients were tested for##2##4##(2006-8#1)(2013-1#1)
patients were tested##4##3##(1991-3#1)(2006-8#1)(2007-7#1)(2013-1#1)
patients were the##2##3##(2007-10#1)(2007-2#1)
patients were then##4##3##(1992-9#1)(1995-11#1)(2010-8#1)(2011-2#1)
patients were totally##2##3##(1993-5#1)(2008-7#1)
patients were transferred##3##3##(1993-3#2)(1993-5#1)
patients were transported by##2##4##(2007-9#1)(2013-1#1)
patients were treated as outpatients##3##5##(2006-12#1)(2007-8#1)(2011-1#1)
patients were treated at the Department of##2##7##(2006-6#1)(2011-12#1)
patients were treated between##2##4##(2008-6#1)(2010-4#1)
patients were treated by laparotomy##2##5##(1991-2#1)(1991-3#1)
patients were treated by surgery##2##5##(1993-10#1)(2008-7#1)
patients were treated by##16##4##(1990-3#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-8#2)(1993-10#1)(1994-12#1)(1994-8#1)(2008-7#3)(2009-2#1)(2011-2#1)(2012-2#1)(2012-3#1)
patients were treated conservatively##5##4##(2006-6#1)(2008-1#1)(2008-7#2)(2012-12#1)
patients were treated for breast cancer##2##6##(1990-3#1)(2013-7#1)
patients were treated for##18##4##(1990-10#1)(1990-3#1)(1990-4#1)(1990-9#1)(1991-8#2)(1992-9#1)(1993-2#1)(1995-11#1)(1996-1#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-8#2)(2008-3#1)(2008-5#1)(2013-7#1)
patients were treated in the##2##5##(2007-7#1)(2012-2#1)
patients were treated in##3##4##(2007-7#1)(2008-3#1)(2012-2#1)
patients were treated initially##2##4##(1992-12#1)(1996-11#1)
patients were treated on##2##4##(1991-12#1)(2007-8#1)
patients were treated over##2##4##(2008-7#1)(2012-2#1)
patients were treated surgically##7##4##(1993-8#1)(2006-7#1)(2007-7#2)(2008-3#1)(2008-4#1)(2008-7#1)
patients were treated twice##2##4##(1992-3#1)(1997-8#1)
patients were treated using##3##4##(2007-11#1)(2008-6#1)(2013-7#1)
patients were treated with a##3##5##(1992-5#1)(2008-12#1)(2011-2#1)
patients were treated with antibiotics##2##5##(1996-1#1)(2013-8#1)
patients were treated with##69##4##(1990-12#1)(1990-2#1)(1990-6#1)(1991-4#1)(1991-9#2)(1992-12#1)(1992-5#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-9#1)(1997-3#2)(1997-6#1)(1997-8#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-7#1)(2007-10#1)(2007-11#2)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#3)
patients were treated##152##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#2)(1990-6#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#5)(1991-9#3)(1992-10#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-10#1)(1993-2#2)(1993-5#1)(1993-6#1)(1993-8#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#1)(1996-1#2)(1996-11#1)(1996-9#1)(1997-3#2)(1997-6#1)(1997-8#2)(2006-10#5)(2006-11#1)(2006-12#3)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#1)(2007-10#1)(2007-11#5)(2007-2#2)(2007-7#6)(2007-8#7)(2008-1#3)(2008-10#2)(2008-12#1)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#9)(2008-7#9)(2008-8#1)(2009-2#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#3)
patients were unable to##3##4##(1990-4#1)(2008-1#1)(2012-1#1)
patients were under##2##3##(1993-7#1)(2008-5#1)
patients were upstaged##2##3##(2007-6#1)(2012-12#1)
patients were used to##2##4##(1996-11#1)(2009-5#1)
patients were used##3##3##(1995-2#1)(1996-11#1)(2009-5#1)
patients were using##4##3##(1992-10#1)(2006-10#1)(2006-7#1)(2008-10#1)
patients were very##2##3##(1991-8#1)(2008-7#1)
patients were well##2##3##(1996-1#1)(2011-1#1)
patients were with##2##3##(2008-10#1)(2008-11#1)
patients were withdrawn from the##2##5##(1992-11#1)(2007-2#1)
patients were withdrawn##3##3##(1992-11#2)(2007-2#1)
patients were without##3##3##(1994-6#1)(1995-10#1)(2007-7#1)
patients were women##3##3##(2007-8#1)(2008-1#1)(2009-5#1)
patients were younger than 30 years##2##6##(1990-4#1)(1993-8#1)
patients were younger than##6##4##(1990-4#1)(1990-6#1)(1993-8#1)(1996-4#1)(2007-1#1)(2008-12#1)
patients were##1411##2##(1990-1#1)(1990-10#8)(1990-11#3)(1990-12#6)(1990-2#8)(1990-3#4)(1990-4#8)(1990-5#3)(1990-6#7)(1990-7#2)(1990-8#6)(1990-9#9)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#9)(1991-2#9)(1991-3#6)(1991-4#6)(1991-5#1)(1991-6#4)(1991-7#3)(1991-8#10)(1991-9#7)(1992-1#2)(1992-10#5)(1992-11#2)(1992-12#3)(1992-2#5)(1992-3#6)(1992-4#4)(1992-5#8)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#6)(1993-1#6)(1993-10#5)(1993-11#5)(1993-12#5)(1993-2#8)(1993-3#4)(1993-5#9)(1993-6#1)(1993-7#1)(1993-8#10)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#5)(1994-2#6)(1994-3#1)(1994-4#2)(1994-5#2)(1994-6#3)(1994-7#3)(1994-8#1)(1994-9#2)(1995-1#3)(1995-10#1)(1995-11#11)(1995-12#5)(1995-2#9)(1995-3#5)(1995-4#5)(1995-5#2)(1995-6#6)(1995-7#1)(1995-9#6)(1996-1#9)(1996-11#4)(1996-12#4)(1996-2#5)(1996-3#6)(1996-4#1)(1996-5#1)(1996-6#3)(1996-7#2)(1996-8#5)(1996-9#6)(1997-2#6)(1997-3#6)(1997-4#1)(1997-5#1)(1997-6#6)(1997-7#3)(1997-8#14)(2004-1#4)(2004-10#5)(2004-11#1)(2004-12#3)(2004-2#2)(2004-3#3)(2005-1#2)(2005-10#8)(2005-11#1)(2005-12#3)(2005-2#1)(2005-5#1)(2005-6#1)(2005-7#2)(2005-8#2)(2005-9#2)(2006-10#30)(2006-11#6)(2006-12#11)(2006-2#6)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#20)(2006-7#10)(2006-8#33)(2006-9#3)(2007-1#3)(2007-10#13)(2007-11#27)(2007-12#5)(2007-2#23)(2007-3#11)(2007-4#1)(2007-6#5)(2007-7#66)(2007-8#75)(2007-9#26)(2008-1#29)(2008-10#18)(2008-11#13)(2008-12#8)(2008-2#2)(2008-3#23)(2008-4#16)(2008-5#19)(2008-6#24)(2008-7#46)(2008-8#13)(2008-9#14)(2009-10#7)(2009-12#2)(2009-2#6)(2009-3#4)(2009-4#1)(2009-5#6)(2009-6#5)(2009-7#3)(2009-8#2)(2009-9#2)(2010-10#2)(2010-11#1)(2010-12#11)(2010-2#3)(2010-3#4)(2010-4#8)(2010-5#2)(2010-7#8)(2010-8#7)(2010-9#2)(2011-1#30)(2011-12#11)(2011-2#56)(2012-1#7)(2012-12#16)(2012-2#43)(2012-3#33)(2012-5#2)(2013-1#56)(2013-7#5)(2013-8#25)
patients what##2##2##(1996-8#1)(2011-2#1)
patients when compared to##2##4##(2011-1#1)(2012-2#1)
patients when compared with##6##4##(1993-11#1)(2008-3#2)(2008-7#2)(2009-9#1)
patients when compared##8##3##(1993-11#1)(2008-3#2)(2008-7#2)(2009-9#1)(2011-1#1)(2012-2#1)
patients when##24##2##(1990-9#1)(1993-11#1)(1993-3#1)(1995-3#1)(2006-10#1)(2006-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-3#2)(2008-7#2)(2009-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
patients where extensive##2##3##(1994-8#1)(2008-7#1)
patients where the##3##3##(1994-4#1)(1995-9#1)(2009-2#1)
patients where##14##2##(1991-11#1)(1993-3#1)(1993-5#1)(1993-7#1)(1994-4#1)(1994-8#1)(1995-9#1)(2006-10#1)(2007-8#2)(2008-1#1)(2008-3#1)(2008-7#1)(2009-2#1)
patients whereas##2##2##(2005-8#1)(2007-10#1)
patients whether##2##2##(1993-12#1)(2008-1#1)
patients which were##4##3##(1990-8#1)(1994-2#1)(2007-8#1)(2008-7#1)
patients which##13##2##(1990-8#1)(1991-8#1)(1994-11#1)(1994-2#1)(1997-4#1)(2006-10#1)(2006-8#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)
patients while maintaining a##2##4##(2008-7#1)(2011-2#1)
patients while maintaining##3##3##(2005-10#1)(2008-7#1)(2011-2#1)
patients while the##3##3##(1990-12#1)(1997-8#1)(2006-11#1)
patients while##12##2##(1990-12#1)(1992-10#1)(1992-3#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-11#1)(2007-8#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
patients who achieved complete##2##4##(1990-12#1)(2007-7#1)
patients who achieved##6##3##(1990-12#1)(1991-7#1)(2007-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
patients who all##2##3##(2006-8#1)(2011-2#1)
patients who already##2##3##(2005-6#1)(2007-2#1)
patients who also##3##3##(1995-9#1)(2007-10#1)(2010-11#1)
patients who appear to##2##4##(1995-2#1)(2008-8#1)
patients who are already##2##4##(2008-6#1)(2011-2#1)
patients who are at high risk for##2##7##(2005-12#1)(2009-3#1)
patients who are at risk for##2##6##(2006-10#1)(2007-8#1)
patients who are at risk##4##5##(2006-10#2)(2007-8#1)(2013-1#1)
patients who are at##8##4##(1994-12#1)(2005-12#1)(2006-10#2)(2007-8#1)(2008-7#1)(2009-3#1)(2013-1#1)
patients who are candidates for##2##5##(2007-4#1)(2009-12#1)
patients who are likely to##2##5##(2007-8#1)(2008-6#1)
patients who are not amenable##2##5##(2007-8#1)(2010-12#1)
patients who are not candidates for##2##6##(2007-7#1)(2013-1#1)
patients who are not likely to##2##6##(2009-8#1)(2010-12#1)
patients who are not##12##4##(1995-9#1)(2007-7#1)(2007-8#2)(2008-6#1)(2009-8#1)(2010-12#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
patients who are on##6##4##(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-6#1)(2011-2#1)
patients who are refractory to##2##5##(2007-7#1)(2012-3#1)
patients who are suspected of having##3##6##(2007-8#1)(2010-12#1)(2010-9#1)
patients who are treated##2##4##(2006-10#1)(2007-8#1)
patients who are undergoing##3##4##(2007-8#1)(2008-5#1)(2011-2#1)
patients who are##100##3##(1991-12#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-9#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-10#1)(2005-12#1)(2005-6#1)(2005-7#1)(2006-10#8)(2006-11#1)(2006-12#2)(2006-4#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#3)(2007-8#11)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#4)(2008-7#2)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#2)(2010-12#5)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#2)
patients who attended the##2##4##(2007-10#1)(2013-8#1)
patients who benefit most from##2##5##(2008-1#1)(2008-7#1)
patients who came for##2##4##(2011-1#1)(2012-2#1)
patients who can##5##3##(2007-10#1)(2007-9#1)(2009-8#1)(2010-5#1)(2013-1#1)
patients who cannot afford the##2##5##(2007-11#1)(2008-11#1)
patients who carry##2##3##(1996-6#1)(1997-4#1)
patients who choose##3##3##(1990-12#1)(2006-3#1)(2012-3#1)
patients who complained of##2##4##(1991-5#1)(2009-8#1)
patients who completed the study##2##5##(2006-12#1)(2008-7#1)
patients who completed the##4##4##(1993-11#1)(2006-12#1)(2007-7#1)(2008-7#1)
patients who completed##9##3##(1992-4#1)(1993-11#1)(2005-9#1)(2006-12#1)(2007-7#3)(2008-7#1)(2012-2#1)
patients who continued##3##3##(2005-9#1)(2012-2#1)(2013-1#1)
patients who could not be##2##5##(2008-3#1)(2008-6#1)
patients who could##7##3##(1993-12#1)(1994-2#1)(1997-2#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-6#1)
patients who currently##2##3##(2006-10#1)(2010-3#1)
patients who demonstrated##2##3##(1992-3#1)(1997-8#1)
patients who develop acute##2##4##(2007-7#1)(2007-9#1)
patients who develop spontaneous##2##4##(1993-5#1)(2006-5#1)
patients who develop##17##3##(1991-9#1)(1993-11#1)(1993-5#1)(2006-10#3)(2006-5#1)(2007-7#2)(2007-8#3)(2007-9#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
patients who developed dyskinesias##2##4##(2008-7#2)
patients who developed##22##3##(1990-6#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-8#1)(2004-10#1)(2006-11#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-7#3)(2009-2#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
patients who did not have an##2##6##(2006-2#1)(2007-10#1)
patients who did not have##5##5##(1992-11#1)(2006-2#1)(2007-10#2)(2013-1#1)
patients who did not receive any treatment##2##7##(2008-7#1)(2012-3#1)
patients who did not receive any##3##6##(2008-1#1)(2008-7#1)(2012-3#1)
patients who did not receive t-PA##2##6##(2007-9#1)(2010-12#1)
patients who did not receive##13##5##(1990-12#1)(1992-4#1)(1993-1#1)(2004-3#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-9#1)(2008-1#1)(2008-7#1)(2010-12#1)(2012-3#1)(2013-1#1)
patients who did not respond to##2##6##(1990-5#1)(1994-12#1)
patients who did not##34##4##(1990-12#1)(1990-5#1)(1991-12#1)(1992-11#2)(1992-4#1)(1993-1#1)(1993-12#1)(1994-12#1)(1996-2#1)(1997-2#2)(2004-3#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2007-10#2)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-3#2)(2013-1#3)
patients who did##37##3##(1990-12#1)(1990-5#1)(1991-12#1)(1992-11#2)(1992-4#1)(1993-1#2)(1993-12#1)(1994-12#1)(1996-2#1)(1997-2#2)(2004-3#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2007-10#2)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#3)
patients who died during##2##4##(1991-7#1)(1997-4#1)
patients who died had##3##4##(1991-8#1)(2012-12#1)(2012-3#1)
patients who died in##3##4##(1991-4#1)(2010-2#1)(2011-2#1)
patients who died of cancer##2##5##(2011-2#2)
patients who died of##3##4##(1994-7#1)(2011-2#2)
patients who died##17##3##(1990-7#1)(1991-4#1)(1991-7#1)(1991-8#2)(1994-7#1)(1996-11#1)(1996-6#1)(1997-4#1)(2008-2#1)(2008-7#1)(2010-2#1)(2011-2#3)(2012-12#1)(2012-3#1)
patients who do not ask for##2##6##(2009-6#2)
patients who do not have##3##5##(2005-10#1)(2006-2#1)(2006-9#1)
patients who do not respond to##8##6##(1993-12#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-3#1)(2010-4#1)(2010-5#1)(2011-2#1)
patients who do not##17##4##(1993-12#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-9#2)(2007-11#1)(2007-2#1)(2007-3#1)(2009-6#2)(2010-4#1)(2010-5#1)(2011-2#1)
patients who engage in##2##4##(2007-7#1)(2008-6#1)
patients who entered the study##2##5##(1991-2#1)(1992-4#1)
patients who entered the##3##4##(1991-2#1)(1992-10#1)(1992-4#1)
patients who exhibited##3##3##(2008-9#1)(2011-2#1)(2012-12#1)
patients who experience##6##3##(1991-11#1)(2008-1#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-1#1)
patients who experienced##3##3##(1993-12#1)(2006-8#1)(2012-2#1)
patients who fail to##2##4##(2011-3#1)(2012-2#1)
patients who fail##5##3##(2005-10#1)(2006-10#1)(2007-7#1)(2011-3#1)(2012-2#1)
patients who failed to respond to other##2##7##(2006-8#2)
patients who failed to respond to##4##6##(2006-8#3)(2008-1#1)
patients who failed##5##3##(2006-8#3)(2008-1#1)(2013-8#1)
patients who fall##5##3##(1994-12#1)(2006-9#1)(2008-7#1)(2009-3#1)(2013-1#1)
patients who felt##3##3##(1995-9#1)(2013-1#1)(2013-7#1)
patients who fulfilled the##2##4##(2008-3#1)(2011-2#1)
patients who had a##16##4##(1990-8#1)(1996-8#1)(1997-3#1)(2007-10#2)(2007-6#1)(2007-8#1)(2007-9#2)(2008-3#1)(2008-4#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#2)
patients who had an##6##4##(1995-6#1)(2007-10#1)(2007-8#1)(2008-3#1)(2008-6#1)(2010-7#1)
patients who had been operated##2##5##(1996-12#2)
patients who had been##13##4##(1991-3#1)(1991-5#1)(1995-9#1)(1996-12#2)(2007-10#1)(2007-11#1)(2007-3#1)(2008-11#1)(2008-7#1)(2009-6#1)(2011-2#2)
patients who had both##2##4##(2007-10#1)(2008-4#1)
patients who had died##2##4##(1990-10#1)(1996-5#1)
patients who had experienced##2##4##(2007-8#1)(2010-7#1)
patients who had failed##2##4##(2005-7#1)(2012-12#1)
patients who had had##4##4##(2007-10#1)(2007-3#1)(2008-9#1)(2009-4#1)
patients who had normal##2##4##(1993-12#1)(2007-9#1)
patients who had not had##2##5##(1991-2#1)(2010-3#1)
patients who had not responded to##2##6##(1997-7#1)(2006-10#1)
patients who had not##6##4##(1991-2#1)(1997-7#1)(2006-10#1)(2007-8#1)(2010-3#1)(2012-3#1)
patients who had previously undergone##3##5##(1992-3#1)(1997-7#1)(2006-8#1)
patients who had previously##5##4##(1992-3#1)(1997-7#1)(2006-8#1)(2007-11#1)(2008-5#1)
patients who had received a##2##5##(1997-5#1)(2013-8#1)
patients who had received intravenous##2##5##(1991-2#1)(2012-11#1)
patients who had received##15##4##(1990-12#1)(1990-2#1)(1991-2#1)(1993-10#1)(1997-5#1)(2004-2#1)(2006-10#1)(2006-6#1)(2007-2#2)(2007-8#2)(2008-6#1)(2012-11#1)(2013-8#1)
patients who had recently undergone##2##5##(2006-10#1)(2009-12#1)
patients who had severe##2##4##(1991-10#1)(2008-7#1)
patients who had undergone THA or TKA##2##7##(1994-3#2)
patients who had undergone THA##3##5##(1994-3#3)
patients who had undergone a##3##5##(2007-2#1)(2008-9#1)(2011-12#1)
patients who had undergone an##2##5##(1992-6#1)(2008-5#1)
patients who had undergone total##2##5##(1990-9#1)(1994-3#1)
patients who had undergone##19##4##(1990-9#1)(1992-10#1)(1992-6#1)(1994-3#4)(1995-11#1)(1996-8#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-11#1)(2011-12#1)(2013-1#1)
patients who had##185##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#3)(1991-3#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#3)(1993-6#1)(1994-3#4)(1995-11#1)(1995-6#2)(1995-9#2)(1996-12#2)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#3)(1997-8#1)(2004-1#1)(2004-11#1)(2004-2#1)(2005-7#1)(2006-1#1)(2006-10#4)(2006-11#3)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#9)(2007-11#3)(2007-2#4)(2007-3#5)(2007-5#1)(2007-6#1)(2007-7#8)(2007-8#9)(2007-9#8)(2008-1#2)(2008-11#5)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#5)(2008-7#5)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-4#2)(2009-6#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#8)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#6)
patients who harbored##3##3##(2006-2#1)(2006-5#1)(2006-8#1)
patients who have ESRD##2##4##(2007-12#2)
patients who have a##5##4##(1997-3#1)(2006-10#1)(2007-7#1)(2008-1#1)(2011-12#1)
patients who have already##2##4##(2008-4#1)(2012-12#1)
patients who have an##2##4##(2007-8#1)(2010-12#1)
patients who have been##5##4##(1990-4#1)(1992-6#1)(2007-8#1)(2008-12#1)(2008-3#1)
patients who have chronic##3##4##(2006-9#1)(2007-8#2)
patients who have exhausted##2##4##(2007-7#1)(2009-6#1)
patients who have experienced##2##4##(2007-8#1)(2010-12#1)
patients who have had a##2##5##(2007-8#1)(2011-1#1)
patients who have had an##2##5##(2004-1#1)(2007-10#1)
patients who have had##11##4##(1992-3#1)(1997-6#1)(2004-1#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-6#1)(2011-1#1)(2012-2#1)
patients who have not##3##4##(2006-1#1)(2008-5#1)(2010-3#1)
patients who have or##2##4##(1995-12#1)(2006-9#1)
patients who have previously##3##4##(1990-12#1)(1997-3#1)(2010-2#1)
patients who have received##3##4##(2008-12#1)(2008-3#1)(2013-8#1)
patients who have suffered a##2##5##(2005-7#1)(2007-9#1)
patients who have suffered##5##4##(1995-11#1)(2005-7#1)(2006-10#1)(2007-9#2)
patients who have undergone##14##4##(1990-9#1)(1991-4#1)(1992-8#1)(1996-3#1)(2004-12#1)(2005-8#1)(2006-11#1)(2008-7#2)(2010-6#1)(2012-12#3)(2013-8#1)
patients who have##131##3##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-9#1)(1994-5#1)(1994-7#1)(1995-11#1)(1995-12#1)(1996-11#1)(1996-3#1)(1997-3#2)(1997-6#1)(2004-1#1)(2004-11#1)(2004-12#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#4)(2006-11#1)(2006-7#2)(2006-9#8)(2007-10#2)(2007-11#1)(2007-12#10)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#4)(2007-8#8)(2007-9#3)(2008-1#1)(2008-12#2)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#5)(2009-10#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#3)
patients who initially##2##3##(1993-8#1)(1996-6#1)
patients who lack##2##3##(2007-10#1)(2008-10#1)
patients who may be##3##4##(2010-10#1)(2012-1#1)(2013-1#1)
patients who may##9##3##(1993-12#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-7#1)(2010-10#1)(2012-1#1)(2012-12#1)(2013-1#1)
patients who met the inclusion criteria##2##6##(2010-6#1)(2012-3#1)
patients who met the##5##4##(2007-10#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
patients who met##8##3##(1996-3#1)(2007-10#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#2)
patients who need##2##3##(1996-12#1)(2007-8#1)
patients who present to##3##4##(2007-11#1)(2008-3#2)
patients who present with##16##4##(2006-10#1)(2007-4#1)(2007-7#2)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#2)(2009-11#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
patients who present##22##3##(1992-3#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#2)(2008-1#1)(2008-12#1)(2008-3#5)(2008-5#1)(2008-6#2)(2009-11#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
patients who presented to our##2##5##(2007-9#1)(2010-4#1)
patients who presented to##4##4##(2007-5#1)(2007-9#1)(2010-4#1)(2011-1#1)
patients who presented with##21##4##(1991-12#1)(1992-12#1)(1993-12#1)(1996-2#1)(2005-8#3)(2005-9#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-9#2)(2008-6#1)(2009-10#1)(2011-1#1)(2012-11#1)
patients who presented##29##3##(1990-3#1)(1991-12#1)(1992-12#1)(1993-12#1)(1996-2#1)(2005-8#3)(2005-9#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-5#1)(2007-9#3)(2008-6#1)(2009-10#1)(2010-4#1)(2011-1#3)(2011-2#1)(2012-11#1)(2013-1#1)
patients who progress to##2##4##(2012-2#1)(2013-1#1)
patients who receive##12##3##(1994-5#1)(1997-8#1)(2006-10#1)(2006-9#2)(2007-8#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-11#1)(2011-2#1)(2013-8#1)
patients who received an IABP##2##5##(2007-8#2)
patients who received an##3##4##(1995-4#1)(2007-8#2)
patients who received i##2##4##(2007-7#2)
patients who received radiotherapy##2##4##(1992-12#1)(2008-6#1)
patients who received renal##2##4##(2008-1#1)(2008-4#1)
patients who received the combination and##2##6##(2007-8#2)
patients who received the combination##3##5##(2007-8#3)
patients who received the##8##4##(1992-6#1)(2006-3#2)(2007-11#1)(2007-8#3)(2009-8#1)
patients who received##78##3##(1990-11#1)(1990-12#1)(1990-6#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-7#1)(1995-4#1)(2004-2#1)(2004-3#1)(2005-6#3)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#2)(2006-5#1)(2006-8#3)(2007-10#1)(2007-11#4)(2007-2#1)(2007-5#1)(2007-7#4)(2007-8#12)(2007-9#2)(2008-1#6)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-9#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
patients who relapsed or##2##4##(2007-11#1)(2013-7#1)
patients who relapsed##3##3##(1990-8#1)(2007-11#1)(2013-7#1)
patients who remain##3##3##(1993-2#1)(1993-8#1)(2012-2#1)
patients who remained##2##3##(1992-11#1)(2004-3#1)
patients who require##13##3##(1993-6#1)(2006-1#1)(2006-10#2)(2006-9#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-9#1)(2010-7#1)(2013-8#1)
patients who required##9##3##(1993-2#1)(1996-3#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-7#1)(2009-3#1)(2012-2#1)(2013-1#1)
patients who responded to##3##4##(1996-4#1)(2007-1#1)(2013-8#1)
patients who scored##3##3##(2008-1#3)
patients who should be##2##4##(1991-8#1)(2006-10#1)
patients who should have##2##4##(1994-8#1)(2012-2#1)
patients who should##5##3##(1991-8#1)(1994-8#1)(2006-10#1)(2010-5#1)(2012-2#1)
patients who showed##7##3##(1991-11#1)(1994-2#1)(2007-10#1)(2008-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
patients who smoke##2##3##(1994-7#2)
patients who subsequently##4##3##(1995-2#1)(2006-10#1)(2007-6#1)(2010-6#1)
patients who successfully underwent##4##4##(1992-12#1)(2007-3#1)(2008-11#2)
patients who successfully##5##3##(1992-12#1)(2007-3#1)(2007-7#1)(2008-11#2)
patients who suffer from##4##4##(2007-5#1)(2008-1#1)(2010-5#1)(2012-2#1)
patients who suffer##11##3##(1997-2#1)(2006-10#1)(2007-10#2)(2007-5#1)(2007-8#1)(2008-1#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)
patients who suffered from##2##4##(1990-12#1)(2013-8#1)
patients who suffered##4##3##(1990-12#1)(1992-8#1)(2007-10#1)(2013-8#1)
patients who survived##8##3##(1991-8#2)(1992-6#1)(1993-2#2)(1995-2#1)(2007-8#1)(2008-11#1)
patients who sustain##2##3##(2008-7#1)(2009-5#1)
patients who sustained cardiac##2##4##(2008-1#1)(2008-3#1)
patients who sustained##5##3##(2007-10#3)(2008-1#1)(2008-3#1)
patients who take##2##3##(1990-5#1)(1995-9#1)
patients who tested positive##2##4##(1995-2#1)(2008-10#1)
patients who tested##3##3##(1995-2#1)(2008-10#1)(2008-3#1)
patients who took##5##3##(1996-7#2)(2007-7#1)(2007-8#1)(2013-8#1)
patients who undergo##10##3##(1993-1#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2009-5#1)(2013-1#1)
patients who underwent CABG##3##4##(2007-10#2)(2013-1#1)
patients who underwent IDET##2##4##(2006-12#2)
patients who underwent a total##3##5##(2010-12#1)(2010-3#1)(2011-12#1)
patients who underwent a##8##4##(2006-12#1)(2007-10#1)(2008-6#1)(2008-9#1)(2010-12#1)(2010-3#1)(2011-12#1)(2012-2#1)
patients who underwent amniocentesis##2##4##(2012-3#2)
patients who underwent anterior##2##4##(2005-5#1)(2007-7#1)
patients who underwent biopsy##2##4##(2010-11#1)(2012-3#1)
patients who underwent cardiac##2##4##(2007-8#1)(2012-3#1)
patients who underwent carotid##2##4##(2006-11#1)(2007-10#1)
patients who underwent complete##2##4##(1990-10#1)(1990-8#1)
patients who underwent coronary angiography##3##5##(1993-12#1)(2008-7#1)(2013-8#1)
patients who underwent coronary##4##4##(1993-12#1)(2007-8#1)(2008-7#1)(2013-8#1)
patients who underwent curative##2##4##(1995-10#1)(2011-2#1)
patients who underwent either##2##4##(2006-8#1)(2011-2#1)
patients who underwent elective##3##4##(2007-8#1)(2012-12#1)(2013-8#1)
patients who underwent endoscopic##2##4##(2011-2#1)(2012-2#1)
patients who underwent microsurgery##2##4##(2005-5#1)(2006-11#1)
patients who underwent renal biopsies at##2##6##(2008-1#1)(2010-4#1)
patients who underwent renal##3##4##(2008-1#1)(2010-4#1)(2013-1#1)
patients who underwent surgery for##5##5##(2006-11#1)(2007-7#1)(2008-3#1)(2008-8#1)(2011-1#1)
patients who underwent surgery in##2##5##(2007-11#1)(2008-7#1)
patients who underwent surgery##11##4##(2006-11#1)(2006-8#1)(2007-11#3)(2007-7#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-1#1)
patients who underwent surgical##5##4##(1992-4#1)(1996-3#1)(2007-7#1)(2007-8#1)(2011-2#1)
patients who underwent the same##2##5##(2007-7#1)(2012-12#1)
patients who underwent the##4##4##(1990-8#1)(2006-12#1)(2007-7#1)(2012-12#1)
patients who underwent thoracic##3##4##(2007-8#2)(2012-2#1)
patients who underwent total##3##4##(2007-11#1)(2008-8#1)(2011-2#1)
patients who underwent##139##3##(1990-10#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-4#1)(1993-12#1)(1993-9#1)(1994-3#1)(1995-10#1)(1995-9#2)(1996-3#2)(1996-9#2)(2005-12#1)(2005-5#3)(2006-11#4)(2006-12#6)(2006-6#2)(2006-8#5)(2007-10#4)(2007-11#9)(2007-3#2)(2007-7#5)(2007-8#14)(2007-9#2)(2008-1#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-12#2)(2011-2#13)(2012-12#5)(2012-2#5)(2012-3#4)(2013-1#8)(2013-8#3)
patients who use their hand repetitively##2##6##(2008-9#2)
patients who use##3##3##(1992-9#1)(2008-9#2)
patients who utilized##2##3##(1996-2#1)(2012-3#1)
patients who were admitted during##2##5##(2012-2#2)
patients who were admitted to##2##5##(2007-8#1)(2012-2#1)
patients who were admitted##8##4##(2007-10#1)(2007-8#1)(2008-3#1)(2012-2#3)(2012-3#1)(2013-1#1)
patients who were at##2##4##(2007-8#1)(2008-11#1)
patients who were considered##2##4##(2008-12#1)(2011-12#1)
patients who were diagnosed##2##4##(2006-3#1)(2012-3#1)
patients who were discharged from##3##5##(2012-2#1)(2013-1#2)
patients who were discharged##7##4##(1992-6#1)(2006-1#1)(2007-10#1)(2008-7#1)(2012-2#1)(2013-1#2)
patients who were evaluated##2##4##(1993-11#1)(2012-5#1)
patients who were experiencing##2##4##(2007-8#1)(2011-2#1)
patients who were followed up##2##5##(2006-10#1)(2008-10#1)
patients who were followed##4##4##(2006-10#1)(2007-12#1)(2008-10#1)(2012-3#1)
patients who were given##2##4##(2005-10#1)(2008-5#1)
patients who were hospitalized##3##4##(2006-8#1)(2009-12#1)(2012-2#1)
patients who were in##4##4##(1991-10#1)(1996-7#1)(2006-7#1)(2007-11#1)
patients who were negative##2##4##(1991-9#1)(2007-8#1)
patients who were not##6##4##(1992-10#1)(1993-11#1)(2005-8#1)(2006-8#1)(2007-10#1)(2008-8#1)
patients who were on haemodialysis##2##5##(2013-8#2)
patients who were on##5##4##(2007-9#1)(2011-2#1)(2013-8#3)
patients who were operated##4##4##(1996-9#1)(2007-11#1)(2008-1#1)(2012-2#1)
patients who were overweight##2##4##(2008-10#2)
patients who were receiving##2##4##(1993-10#1)(2007-8#1)
patients who were referred to##4##5##(2007-2#3)(2007-8#1)
patients who were scheduled for##3##5##(1996-3#1)(2006-12#1)(2006-6#1)
patients who were seeking##2##4##(1997-2#1)(2012-12#1)
patients who were selected##2##4##(1994-12#1)(2008-11#1)
patients who were still##3##4##(1994-6#2)(2007-1#1)
patients who were switched##2##4##(2009-9#2)
patients who were treated at the##2##6##(2007-7#1)(2012-2#1)
patients who were treated at##3##5##(2007-7#2)(2012-2#1)
patients who were treated in##2##5##(2007-8#1)(2011-2#1)
patients who were treated with##6##5##(1991-12#1)(2007-7#1)(2007-8#1)(2008-7#1)(2011-2#1)(2012-12#1)
patients who were treated##15##4##(1991-12#1)(1996-11#1)(2005-6#1)(2007-7#4)(2007-8#2)(2008-3#1)(2008-7#1)(2011-2#2)(2012-12#1)(2012-2#1)
patients who were undergoing##3##4##(1990-12#1)(2011-1#1)(2013-8#1)
patients who were##154##3##(1990-12#1)(1990-4#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-6#2)(1995-2#1)(1996-11#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-6#1)(2005-10#2)(2005-6#1)(2005-8#1)(2006-1#2)(2006-10#2)(2006-12#2)(2006-3#1)(2006-6#2)(2006-7#1)(2006-8#4)(2007-1#1)(2007-10#7)(2007-11#3)(2007-12#2)(2007-2#3)(2007-7#5)(2007-8#14)(2007-9#3)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#4)(2008-9#1)(2009-12#1)(2009-2#1)(2009-9#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#8)(2012-3#4)(2012-5#1)(2013-1#4)(2013-7#1)(2013-8#4)
patients who will##11##3##(2006-10#1)(2007-11#1)(2008-6#1)(2009-4#1)(2010-3#1)(2010-5#1)(2012-3#1)(2013-1#2)(2013-7#2)
patients who would benefit from##2##5##(2007-8#1)(2013-7#1)
patients who would benefit##3##4##(2007-8#1)(2010-4#1)(2013-7#1)
patients who would otherwise##3##4##(1993-3#1)(2006-8#1)(2007-7#1)
patients who would##9##3##(1993-3#1)(2006-8#1)(2006-9#1)(2007-7#1)(2007-8#1)(2010-3#1)(2010-4#1)(2012-1#1)(2013-7#1)
patients who##1303##2##(1990-10#2)(1990-11#2)(1990-12#10)(1990-2#1)(1990-3#2)(1990-4#4)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#6)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#7)(1991-2#6)(1991-3#2)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#7)(1991-9#2)(1992-1#1)(1992-10#6)(1992-11#4)(1992-12#4)(1992-2#1)(1992-3#11)(1992-4#4)(1992-5#2)(1992-6#7)(1992-8#3)(1992-9#2)(1993-1#6)(1993-10#2)(1993-11#5)(1993-12#12)(1993-2#7)(1993-3#4)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#3)(1994-12#4)(1994-2#3)(1994-3#5)(1994-4#1)(1994-5#2)(1994-6#2)(1994-7#4)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#6)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-9#8)(1996-11#3)(1996-12#6)(1996-2#4)(1996-3#6)(1996-4#1)(1996-5#2)(1996-6#4)(1996-7#3)(1996-8#2)(1996-9#5)(1997-1#1)(1997-2#6)(1997-3#4)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#6)(2004-1#2)(2004-10#3)(2004-11#2)(2004-12#1)(2004-2#2)(2004-3#3)(2005-10#5)(2005-12#2)(2005-5#3)(2005-6#7)(2005-7#4)(2005-8#7)(2005-9#4)(2006-1#6)(2006-10#38)(2006-11#13)(2006-12#17)(2006-2#7)(2006-3#5)(2006-4#2)(2006-5#6)(2006-6#6)(2006-7#5)(2006-8#24)(2006-9#18)(2007-1#3)(2007-10#40)(2007-11#28)(2007-12#13)(2007-2#15)(2007-3#11)(2007-4#2)(2007-5#7)(2007-6#2)(2007-7#47)(2007-8#85)(2007-9#26)(2008-1#28)(2008-10#11)(2008-11#13)(2008-12#4)(2008-2#3)(2008-3#24)(2008-4#16)(2008-5#15)(2008-6#24)(2008-7#37)(2008-8#10)(2008-9#10)(2009-10#3)(2009-11#3)(2009-12#3)(2009-2#3)(2009-3#7)(2009-4#3)(2009-5#2)(2009-6#5)(2009-7#1)(2009-8#5)(2009-9#3)(2010-10#3)(2010-11#3)(2010-12#13)(2010-2#2)(2010-3#9)(2010-4#7)(2010-5#7)(2010-6#4)(2010-7#5)(2010-8#3)(2010-9#4)(2011-1#17)(2011-12#7)(2011-2#57)(2011-3#1)(2012-1#7)(2012-11#3)(2012-12#20)(2012-2#35)(2012-3#26)(2012-5#1)(2013-1#50)(2013-7#7)(2013-8#32)
patients whose age##3##3##(2010-12#2)(2013-8#1)
patients whose disease##2##3##(2006-9#1)(2011-2#1)
patients whose leukemic cells##2##4##(1991-2#1)(2008-8#1)
patients whose symptoms##2##3##(1991-3#1)(2006-5#1)
patients whose tumors##4##3##(1993-1#1)(2008-5#1)(2012-12#2)
patients whose##56##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-8#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-5#2)(1995-2#1)(1997-3#1)(1997-5#1)(2004-11#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#1)(2010-12#2)(2010-4#1)(2011-2#5)(2012-12#3)(2012-2#1)(2012-3#2)(2013-8#2)
patients will achieve##2##3##(2007-5#1)(2010-5#1)
patients will also##3##3##(2006-5#1)(2009-7#1)(2012-1#1)
patients will be randomized to##2##5##(2007-9#1)(2008-5#1)
patients will be randomized##3##4##(2007-9#2)(2008-5#1)
patients will be treated##2##4##(1994-9#1)(2006-12#1)
patients will be##20##3##(1993-11#1)(1994-9#1)(1996-12#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-10#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-5#2)(2008-7#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
patients will develop##3##3##(2007-8#1)(2009-3#1)(2010-11#1)
patients will experience##2##3##(2011-2#1)(2012-2#1)
patients will have##5##3##(1996-12#1)(2004-11#1)(2006-10#1)(2008-5#1)(2012-2#1)
patients will likely##3##3##(2007-8#1)(2010-12#2)
patients will need##3##3##(1992-8#1)(2006-10#1)(2013-8#1)
patients will present with##2##4##(2009-10#1)(2012-1#1)
patients will require##3##3##(2007-2#1)(2007-8#1)(2010-8#1)
patients will##67##2##(1992-2#1)(1992-8#1)(1993-11#1)(1994-9#1)(1996-12#2)(2004-11#1)(2006-10#4)(2006-12#1)(2006-5#2)(2006-9#1)(2007-10#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#3)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
patients with &quot##8##3##(1990-11#1)(1992-4#1)(1992-9#1)(1995-4#1)(2007-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
patients with 'no option'##2##4##(2007-8#2)
patients with 1-3 positive nodes##2##5##(1992-12#1)(1993-1#1)
patients with 11##2##3##(2008-1#1)(2013-1#1)
patients with 23##2##3##(2008-9#1)(2011-2#1)
patients with ACS and##2##4##(2011-12#2)
patients with ACS without ST elevation##2##6##(2006-6#2)
patients with ACS##9##3##(2006-6#2)(2008-3#3)(2011-12#3)(2013-8#1)
patients with AD##5##3##(2007-9#1)(2008-6#1)(2011-1#1)(2012-1#1)(2012-2#1)
patients with ADHD##2##3##(2009-9#1)(2011-2#1)
patients with ADPKD##4##3##(2007-8#1)(2013-1#3)
patients with AECOPDs##2##3##(2012-12#2)
patients with AF who##2##4##(2007-8#1)(2013-1#1)
patients with AF##7##3##(2007-10#2)(2007-8#1)(2010-6#2)(2012-3#1)(2013-1#1)
patients with AIDS and##5##4##(1996-11#1)(2006-10#1)(2006-11#1)(2008-11#1)(2011-2#1)
patients with AIDS##21##3##(1991-2#1)(1991-5#2)(1992-12#1)(1994-4#1)(1996-11#1)(1996-7#1)(2005-10#1)(2006-10#4)(2006-11#1)(2006-7#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-5#3)(2011-2#1)
patients with AIDS-related complex##2##4##(1991-12#2)
patients with AIH##2##3##(2008-12#1)(2013-1#1)
patients with ALL##4##3##(1996-3#1)(2011-2#3)
patients with AMD##3##3##(2005-7#1)(2011-2#1)(2013-1#1)
patients with AMI were##2##4##(1995-12#1)(2007-11#1)
patients with AMI##8##3##(1990-12#1)(1995-12#1)(2007-11#2)(2008-3#1)(2008-5#1)(2011-1#1)(2013-1#1)
patients with AML##2##3##(2008-5#1)(2011-2#1)
patients with AN##4##3##(2006-1#3)(2007-7#1)
patients with ANCA-associated##2##3##(2007-2#1)(2007-8#1)
patients with AOD##3##3##(2012-12#3)
patients with AOSD##3##3##(2006-10#3)
patients with APS##2##3##(2006-10#2)
patients with ARC##2##3##(1991-12#1)(1991-5#1)
patients with ARDS##7##3##(1990-2#1)(1991-9#1)(1997-1#2)(2005-11#1)(2005-8#1)(2009-6#1)
patients with ARF##2##3##(2006-7#1)(2008-4#1)
patients with ARMD##2##3##(2011-1#1)(2011-2#1)
patients with AS##2##3##(2006-10#1)(2008-10#1)
patients with AVMs##4##3##(2006-2#2)(2008-7#1)(2012-3#1)
patients with Addison's disease##2##4##(2006-9#1)(2010-12#1)
patients with Alport##2##3##(2011-2#2)
patients with Alzheimer disease##4##4##(1990-3#1)(1994-8#1)(1995-1#1)(2008-8#1)
patients with Alzheimer disease]##2##4##(1995-5#1)(2008-8#1)
patients with Alzheimer##6##3##(1990-3#1)(1994-8#1)(1995-1#1)(1995-5#1)(2008-8#2)
patients with Alzheimer's Disease##3##4##(1993-12#1)(1996-1#1)(2011-2#1)
patients with Alzheimer's disease (AD) and##3##6##(1991-3#1)(1996-5#1)(2008-1#1)
patients with Alzheimer's disease (AD)##7##5##(1991-3#1)(1995-3#1)(1996-5#1)(2008-1#1)(2008-7#2)(2012-2#1)
patients with Alzheimer's disease and##3##5##(1991-1#1)(1996-1#1)(2009-3#1)
patients with Alzheimer's disease by##2##5##(2009-6#1)(2013-8#1)
patients with Alzheimer's disease##33##4##(1990-10#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-12#2)(1994-5#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-5#1)(1996-9#1)(2005-4#1)(2006-1#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#4)(2009-3#1)(2009-6#1)(2009-9#1)(2012-2#1)(2013-8#1)
patients with Alzheimer's##37##3##(1990-10#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-8#2)(1993-12#3)(1994-5#1)(1995-3#1)(1995-5#1)(1996-1#2)(1996-5#1)(1996-9#1)(2005-4#1)(2006-1#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#4)(2009-3#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
patients with B cell lineage acute and chronic lymphocytic leukemia##2##10##(2005-10#2)
patients with B##3##3##(2005-10#2)(2009-2#1)
patients with BD##8##3##(2007-10#2)(2007-11#3)(2013-8#3)
patients with BPD who do not##2##6##(1997-5#2)
patients with BPD who##3##4##(1997-5#3)
patients with BPD##5##3##(1997-5#5)
patients with Barrett esophagus##8##4##(2006-10#7)(2007-6#1)
patients with Barrett##9##3##(2006-10#8)(2007-6#1)
patients with Barrett's esophagus##2##4##(2006-2#1)(2013-1#1)
patients with Barrett's##3##3##(2006-2#1)(2011-12#1)(2013-1#1)
patients with Behçet's##3##3##(1997-8#2)(2013-7#1)
patients with Buerger disease##3##4##(1997-8#3)
patients with C##2##3##(2007-11#2)
patients with CA##2##3##(2011-1#1)(2011-2#1)
patients with CAD and##3##4##(1997-8#1)(2006-6#1)(2006-9#1)
patients with CAD##11##3##(1991-10#1)(1996-1#1)(1997-8#1)(2005-12#1)(2006-6#2)(2006-9#1)(2010-3#1)(2010-4#2)(2012-2#1)
patients with CAFs##2##3##(2008-4#2)
patients with CAI##2##3##(2013-1#2)
patients with CCBIP##2##3##(2008-7#2)
patients with CD will##2##4##(2008-4#1)(2010-12#1)
patients with CD##5##3##(2008-2#2)(2008-4#1)(2010-12#1)(2012-2#1)
patients with CD4+ counts##2##4##(2007-11#1)(2010-8#1)
patients with CDH##3##3##(2004-12#3)
patients with CES##2##3##(2012-3#2)
patients with CF##3##3##(1997-1#1)(2008-5#1)(2012-12#1)
patients with CFS##2##3##(1991-3#2)
patients with CHB should##2##4##(2009-11#2)
patients with CHB##7##3##(2008-5#2)(2009-11#3)(2010-12#2)
patients with CHD##4##3##(1990-7#2)(2010-12#2)
patients with CHF##6##3##(2007-11#2)(2010-11#1)(2010-8#1)(2012-3#2)
patients with CHSS##3##3##(2005-1#3)
patients with CIN##3##3##(1990-12#1)(2006-10#1)(2012-3#1)
patients with CKD##8##3##(2007-8#2)(2008-5#1)(2009-1#1)(2011-2#3)(2013-8#1)
patients with CLL##3##3##(1991-4#1)(2008-8#2)
patients with CML##5##3##(2007-11#1)(2009-3#3)(2010-11#1)
patients with CNS##3##3##(2008-7#2)(2011-2#1)
patients with CNS-MPS##2##3##(2007-8#2)
patients with COPD and##4##4##(1997-1#1)(1997-4#1)(2006-9#1)(2008-7#1)
patients with COPD in##2##4##(2008-12#1)(2009-1#1)
patients with COPD##21##3##(1997-1#1)(1997-4#1)(1997-7#2)(2006-5#2)(2006-9#1)(2008-12#1)(2008-7#2)(2009-1#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-7#2)(2013-8#4)
patients with CP##4##3##(2005-10#2)(2008-3#2)
patients with CPT II deficiency and##2##6##(2008-3#2)
patients with CPT II deficiency##4##5##(2008-3#4)
patients with CRC##2##3##(2012-3#2)
patients with CRF is##2##4##(2007-11#1)(2011-2#1)
patients with CRF##8##3##(1995-3#2)(2007-11#1)(2007-7#2)(2008-1#1)(2009-2#1)(2011-2#1)
patients with CSX##2##3##(2008-12#1)(2011-2#1)
patients with CTEPH##3##3##(2010-6#3)
patients with CVC occlusions and##2##5##(2008-7#2)
patients with CVRM##2##3##(2013-8#2)
patients with ChP##4##3##(2006-6#4)
patients with Chiari I malformation and##2##6##(2005-10#1)(2006-5#1)
patients with Chiari I malformation##9##5##(2005-10#1)(2006-5#8)
patients with Chiari I##11##4##(2005-10#1)(2006-5#10)
patients with Chiari##12##3##(2005-10#1)(2006-5#10)(2006-9#1)
patients with Clostridium difficile##2##4##(1995-4#1)(2007-7#1)
patients with Crohn disease##3##4##(2006-10#3)
patients with Crohn's disease and ulcerative##2##6##(2010-12#2)
patients with Crohn's disease who##2##5##(2008-5#1)(2010-12#1)
patients with Crohn's disease##14##4##(1994-2#1)(2006-10#1)(2007-11#3)(2007-12#1)(2008-12#1)(2008-5#1)(2010-12#4)(2012-2#2)
patients with Crohn's disease]##3##4##(2012-11#2)(2013-8#1)
patients with Crohn's##17##3##(1994-2#1)(2006-10#1)(2007-11#3)(2007-12#1)(2008-12#1)(2008-5#1)(2010-12#4)(2012-11#2)(2012-2#2)(2013-8#1)
patients with Cushing's disease##3##4##(1995-12#1)(2006-9#1)(2011-2#1)
patients with Cushing's##5##3##(1995-12#1)(2006-6#2)(2006-9#1)(2011-2#1)
patients with DHF##2##3##(2009-10#1)(2010-12#1)
patients with DM2 and##2##4##(2011-2#1)(2012-3#1)
patients with DNM##2##3##(2007-8#2)
patients with DSM-IV##2##3##(2004-3#1)(2013-8#1)
patients with Down's syndrome and##2##5##(1990-7#1)(2006-9#1)
patients with Down's syndrome##5##4##(1990-7#1)(1991-1#1)(2006-9#3)
patients with Duchenne muscular dystrophy##2##5##(1995-12#1)(2011-2#1)
patients with Duchenne##3##3##(1995-12#1)(2008-4#1)(2011-2#1)
patients with Dukes'##3##3##(1992-8#2)(2008-10#1)
patients with ER negative##2##4##(1996-11#1)(2007-10#1)
patients with ER##4##3##(1991-12#1)(1996-11#1)(2004-2#1)(2007-10#1)
patients with ESRD##15##3##(2007-7#3)(2007-8#7)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-1#1)
patients with Eisenmenger syndrome##2##4##(2008-4#1)(2010-10#1)
patients with ErbB-2##2##3##(1996-6#2)
patients with Ewing's tumours who##2##5##(2008-6#2)
patients with FH##2##3##(1993-9#2)
patients with FHF##2##3##(1991-8#2)
patients with FM##2##3##(2006-10#1)(2010-12#1)
patients with FMF from##2##4##(2013-1#2)
patients with FMS##4##3##(2006-10#4)
patients with FN##2##3##(2012-12#2)
patients with Forestier's disease##2##4##(2007-8#2)
patients with GBS##3##3##(2007-11#3)
patients with GC##2##3##(2013-1#2)
patients with GCS##2##3##(2006-8#1)(2007-10#1)
patients with GHF##2##3##(2011-2#2)
patients with GI-complications##3##3##(2007-8#3)
patients with Graves' disease##9##4##(1990-7#1)(1990-8#3)(1991-12#1)(1991-7#1)(1991-8#1)(1994-11#1)(2008-5#1)
patients with Graves' hyperthyroidism##2##4##(2009-2#1)(2011-2#1)
patients with Graves'##13##3##(1990-7#1)(1990-8#3)(1991-12#1)(1991-7#1)(1991-8#1)(1994-11#1)(2008-5#1)(2008-7#1)(2009-2#2)(2011-2#1)
patients with HARS##3##3##(2007-11#3)
patients with HBV##2##3##(2007-11#1)(2009-8#1)
patients with HC##3##3##(2012-3#3)
patients with HCC##9##3##(1992-3#1)(1993-7#2)(2008-10#2)(2009-3#1)(2010-12#1)(2013-1#1)(2013-7#1)
patients with HCM and##2##4##(2008-7#1)(2010-6#1)
patients with HCM##4##3##(2008-7#3)(2010-6#1)
patients with HCV##13##3##(1994-8#1)(2006-10#3)(2006-2#1)(2008-8#1)(2009-7#1)(2009-8#1)(2012-12#4)(2013-1#1)
patients with HD##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
patients with HER2/neu-positive tumors was##2##5##(2004-1#2)
patients with HF and##2##4##(2005-7#1)(2010-6#1)
patients with HF##4##3##(2005-7#1)(2007-1#1)(2010-6#1)(2013-1#1)
patients with HIT##3##3##(2007-11#3)
patients with HIV and##3##4##(1993-3#1)(1993-5#1)(2008-10#1)
patients with HIV infection and##3##5##(1996-11#1)(2010-4#1)(2010-9#1)
patients with HIV infection should be##2##6##(1990-6#1)(1993-3#1)
patients with HIV infection##14##4##(1990-6#2)(1993-1#1)(1993-3#1)(1994-4#1)(1996-11#1)(1996-3#1)(2007-11#1)(2007-2#2)(2008-7#1)(2008-8#1)(2010-4#1)(2010-9#1)
patients with HIV##26##3##(1990-6#2)(1991-11#1)(1993-1#1)(1993-3#2)(1993-5#1)(1994-4#3)(1995-12#1)(1996-11#1)(1996-3#1)(2007-11#2)(2007-2#2)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#2)(2010-4#1)(2010-9#1)
patients with HIV-1 infection##5##4##(1990-2#2)(1991-9#1)(2010-11#2)
patients with HIV-1##6##3##(1990-2#2)(1991-9#1)(2010-11#2)(2012-2#1)
patients with HIV-associated wasting##6##4##(2007-11#6)
patients with HIV/AIDS##4##3##(2005-7#1)(2007-12#2)(2007-7#1)
patients with Hashimoto's thyroiditis##2##4##(1994-11#2)
patients with Hodgkin's disease##5##4##(1990-4#1)(1997-7#2)(2008-1#1)(2008-3#1)
patients with Hodgkin's##7##3##(1990-4#1)(1997-7#2)(2008-1#1)(2008-3#1)(2008-7#2)
patients with Human##2##3##(2008-4#1)(2009-2#1)
patients with Huntington's disease##2##4##(2006-8#1)(2008-7#1)
patients with IBD##5##3##(2006-10#3)(2006-2#1)(2010-12#1)
patients with IGT##2##3##(2007-9#1)(2008-3#1)
patients with IP##2##3##(2008-7#2)
patients with IgA nephropathy##4##4##(2007-8#3)(2009-6#1)
patients with IgA##6##3##(2007-8#4)(2009-6#1)(2012-2#1)
patients with IgG##3##3##(1990-2#1)(2007-10#1)(2007-2#1)
patients with JRA##3##3##(2006-10#1)(2007-11#2)
patients with LC##2##3##(2008-10#2)
patients with LRRK2-associated Parkinson's disease##2##5##(2012-1#2)
patients with LVEF##3##3##(2007-9#1)(2009-10#2)
patients with Laron syndrome##2##4##(2008-1#1)(2008-4#1)
patients with Laron##3##3##(2008-1#2)(2008-4#1)
patients with Luminal##2##3##(2010-12#2)
patients with MCA intrinsic disease##2##5##(2007-9#2)
patients with MCA##4##3##(2007-10#1)(2007-9#3)
patients with MG##4##3##(1994-3#1)(2007-8#2)(2012-2#1)
patients with MM have##2##4##(2008-1#1)(2010-4#1)
patients with MM##7##3##(1991-12#1)(1996-9#1)(2007-12#1)(2008-1#1)(2008-7#1)(2010-4#1)(2011-1#1)
patients with MPM##3##3##(2008-10#1)(2010-9#2)
patients with MR##3##3##(1995-3#1)(2010-11#2)
patients with MS and##4##4##(1993-5#1)(2006-12#1)(2007-2#1)(2010-12#1)
patients with MS on##2##4##(2006-12#2)
patients with MS##22##3##(1990-12#1)(1993-5#1)(1994-7#1)(1995-12#1)(2006-12#3)(2007-11#3)(2007-2#1)(2008-10#1)(2008-3#3)(2008-5#1)(2010-12#3)(2012-3#3)
patients with MSF##2##3##(2013-8#2)
patients with Marfan syndrome##4##4##(2007-8#1)(2008-8#1)(2009-3#1)(2009-7#1)
patients with Marfan##5##3##(2007-8#1)(2008-8#2)(2009-3#1)(2009-7#1)
patients with MetS and##2##4##(2008-3#1)(2013-1#1)
patients with MetS##5##3##(2008-3#1)(2013-1#3)(2013-8#1)
patients with N-SCLC##2##3##(1990-12#2)
patients with NCAH##2##3##(2008-1#2)
patients with NF2##3##3##(2006-11#2)(2006-12#1)
patients with NFPAH##5##3##(2010-10#5)
patients with NPH##3##3##(2006-8#3)
patients with NSCLC##8##3##(1991-2#1)(2004-1#4)(2007-4#1)(2012-3#2)
patients with NSIP##2##3##(2005-8#2)
patients with NT-SDH##2##3##(2007-10#2)
patients with NUGB##2##3##(2008-9#2)
patients with OA##2##3##(1993-2#1)(2008-9#1)
patients with OCD##2##3##(2006-9#1)(2007-6#1)
patients with OSA##2##3##(2012-2#1)(2013-7#1)
patients with P falciparum malaria##2##5##(2012-2#2)
patients with PAD##2##3##(1992-8#2)
patients with PAOD##2##3##(2008-7#2)
patients with PBC##3##3##(2006-10#1)(2007-11#1)(2008-12#1)
patients with PC##2##3##(2010-12#2)
patients with PCNSL##3##3##(2005-10#1)(2007-12#2)
patients with PCR##4##3##(1991-4#2)(2008-12#2)
patients with PD and##3##4##(2006-9#1)(2007-5#1)(2013-1#1)
patients with PD##17##3##(1990-4#1)(1994-12#1)(2006-4#1)(2006-9#2)(2007-5#3)(2008-10#1)(2008-11#2)(2008-7#1)(2012-1#1)(2013-1#3)(2013-8#1)
patients with PDTC##2##3##(2012-3#2)
patients with PE##2##3##(1993-2#1)(2013-8#1)
patients with PHP seen at ACH##2##6##(2007-2#2)
patients with PHP seen##3##4##(2007-2#3)
patients with PHP##6##3##(2007-2#4)(2010-6#1)(2011-1#1)
patients with PICH and##2##4##(2007-10#2)
patients with PM##2##3##(2006-6#2)
patients with PMP##3##3##(2006-6#3)
patients with PNALT##3##3##(2012-1#3)
patients with PRS and PRDA##2##5##(2010-10#2)
patients with PRS##4##3##(2010-10#4)
patients with PSC##2##3##(2006-10#1)(2008-12#1)
patients with PSP##2##3##(2007-8#2)
patients with PSS##2##3##(2007-10#1)(2007-9#1)
patients with PTDM##2##3##(2008-1#2)
patients with PTE##3##3##(2007-7#3)
patients with PTSD##3##3##(2005-10#1)(2008-6#1)(2008-9#1)
patients with Paget's disease##2##4##(1990-6#1)(1991-5#1)
patients with Parkinson disease##3##4##(2006-8#1)(2013-8#2)
patients with Parkinson disease]##2##4##(2012-12#1)(2013-8#1)
patients with Parkinson##5##3##(2006-8#1)(2012-12#1)(2013-8#3)
patients with Parkinson's disease (PD) is##2##6##(1994-2#1)(2008-7#1)
patients with Parkinson's disease (PD)##9##5##(1991-4#1)(1994-2#1)(1995-3#1)(2008-11#1)(2008-7#5)
patients with Parkinson's disease##27##4##(1991-4#1)(1991-5#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-4#1)(1995-3#1)(2005-12#2)(2008-11#3)(2008-7#9)(2012-1#2)(2012-12#1)(2013-1#2)
patients with Parkinson's disease]##2##4##(2005-10#1)(2010-2#1)
patients with Parkinson's##29##3##(1991-4#1)(1991-5#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-4#1)(1995-3#1)(2005-10#1)(2005-12#2)(2008-11#3)(2008-7#9)(2010-2#1)(2012-1#2)(2012-12#1)(2013-1#2)
patients with PsA##2##3##(2006-10#2)
patients with RA and##2##4##(1994-3#1)(2006-10#1)
patients with RA may##2##4##(2006-10#2)
patients with RA were##2##4##(1993-2#1)(2008-7#1)
patients with RA##25##3##(1993-2#1)(1994-3#1)(2005-10#1)(2006-10#13)(2007-3#1)(2008-3#1)(2008-7#3)(2011-2#1)(2012-2#1)(2012-3#2)
patients with RCC##2##3##(2007-8#1)(2013-1#1)
patients with RD##2##3##(1991-4#2)
patients with SA##2##3##(2013-1#1)(2013-8#1)
patients with SAH##5##3##(1995-11#1)(1995-5#1)(2007-10#1)(2008-7#1)(2013-8#1)
patients with SARS##2##3##(2007-7#2)
patients with SCD##4##3##(2007-3#3)(2009-4#1)
patients with SCOS##2##3##(2012-12#2)
patients with SICH##4##3##(2007-10#4)
patients with SLE##11##3##(1990-6#2)(1994-3#1)(2006-10#4)(2007-8#3)(2011-2#1)
patients with SLOS##3##3##(1995-4#2)(1997-1#1)
patients with SMA##2##3##(2007-7#2)
patients with SS##7##3##(2007-1#1)(2007-11#6)
patients with SSc##2##3##(2006-10#1)(2012-12#1)
patients with ST-segment elevation myocardial infarction##4##6##(2008-3#1)(2009-12#1)(2009-5#2)
patients with ST-segment elevation myocardial##5##5##(2008-12#1)(2008-3#1)(2009-12#1)(2009-5#2)
patients with ST-segment elevation##6##4##(2008-12#1)(2008-3#1)(2009-12#1)(2009-5#3)
patients with STEMI##5##3##(2008-3#5)
patients with STS and synchronous metastases##2##6##(2008-6#2)
patients with STS and##3##4##(2008-6#3)
patients with STS##4##3##(2008-6#4)
patients with T-cell##3##3##(2007-2#1)(2008-5#2)
patients with T1##2##3##(1991-4#1)(2007-8#1)
patients with T1D##4##3##(2006-1#1)(2007-5#2)(2013-8#1)
patients with T2DM##4##3##(2008-1#1)(2012-1#2)(2013-1#1)
patients with TA##4##3##(1997-8#1)(2006-10#3)
patients with TAR##2##3##(2007-8#2)
patients with TB##3##3##(1996-11#1)(2008-1#1)(2010-10#1)
patients with TBI##2##3##(2008-9#1)(2011-1#1)
patients with TIA##2##3##(2007-10#1)(2008-8#1)
patients with TSAT&gt##2##3##(2007-7#2)
patients with Takayasu arteritis and severe aortic regurgitation##4##8##(1997-8#4)
patients with Takayasu arteritis##7##4##(1997-8#6)(2006-10#1)
patients with Type 2##2##4##(2006-1#1)(2008-3#1)
patients with Type II odontoid fractures##2##6##(2006-7#2)
patients with Type##6##3##(2006-1#1)(2006-7#2)(2008-1#1)(2008-3#2)
patients with VDDR##2##3##(2011-1#2)
patients with VTE##2##3##(2006-2#1)(2012-3#1)
patients with WG##3##3##(2006-10#2)(2007-8#1)
patients with Wegener's granulomatosis##2##4##(1996-1#1)(2008-5#1)
patients with Werner's syndrome##2##4##(1994-12#2)
patients with Wilson disease##2##4##(1995-3#1)(2008-3#1)
patients with X-linked##2##3##(1995-3#1)(2007-2#1)
patients with a Chiari##2##4##(2005-5#1)(2006-9#1)
patients with a body mass index (BMI)##2##7##(2007-8#1)(2012-12#1)
patients with a body mass index##4##6##(2005-10#2)(2007-8#1)(2012-12#1)
patients with a cerebrovascular##2##4##(1992-2#1)(2006-6#1)
patients with a clinical##3##4##(2006-12#1)(2006-8#1)(2007-12#1)
patients with a diagnosis of##8##5##(1993-10#1)(2006-10#1)(2007-10#1)(2007-9#1)(2010-8#1)(2012-2#2)(2013-8#1)
patients with a duration of##2##5##(1997-8#1)(2008-9#1)
patients with a functioning##2##4##(1995-2#1)(2007-11#1)
patients with a hereditary##2##4##(2012-11#2)
patients with a high BSA##2##5##(2011-2#2)
patients with a high probability of##2##6##(2007-11#1)(2008-3#1)
patients with a high probability##3##5##(2005-10#1)(2007-11#1)(2008-3#1)
patients with a high##10##4##(1990-3#1)(1997-8#1)(2004-1#1)(2005-10#1)(2006-9#1)(2007-11#2)(2008-3#1)(2011-2#2)
patients with a higher risk of##2##6##(1996-4#1)(2007-8#1)
patients with a higher##3##4##(1996-4#1)(2007-8#1)(2013-8#1)
patients with a history of exposure to##2##7##(1994-6#1)(1995-11#1)
patients with a history of exposure##3##6##(1994-6#1)(1995-11#1)(2007-2#1)
patients with a history of previous##2##6##(2007-11#1)(2008-11#1)
patients with a history of##33##5##(1990-12#1)(1990-3#1)(1992-5#1)(1992-8#1)(1994-6#1)(1995-11#1)(1997-1#1)(2005-1#1)(2006-1#1)(2006-10#2)(2006-8#1)(2007-10#6)(2007-11#3)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#4)
patients with a large##2##4##(1992-5#1)(2007-8#1)
patients with a less##2##4##(2007-11#1)(2008-7#1)
patients with a longer##2##4##(1990-12#1)(2006-1#1)
patients with a mean age of 42##2##7##(2008-1#1)(2008-12#1)
patients with a mean age of##10##6##(2005-10#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-12#1)(2011-2#1)(2013-1#3)
patients with a mean age##11##5##(2005-10#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-12#1)(2011-2#1)(2013-1#3)(2013-8#1)
patients with a mean##17##4##(1991-11#1)(1991-9#1)(2005-10#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2011-11#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
patients with a median age of##2##6##(2011-2#1)(2013-1#1)
patients with a median##3##4##(2010-8#1)(2011-2#1)(2013-1#1)
patients with a minimum##2##4##(1996-6#1)(2008-6#1)
patients with a more##2##4##(2007-8#1)(2009-8#1)
patients with a negative##2##4##(1993-11#1)(2005-1#1)
patients with a poor##2##4##(1993-10#1)(2007-8#1)
patients with a positive##4##4##(2007-12#1)(2010-10#1)(2011-2#1)(2013-1#1)
patients with a previous##3##4##(2007-6#1)(2007-7#1)(2011-1#1)
patients with a previously implanted##2##5##(2008-10#2)
patients with a primary##2##4##(2007-7#1)(2008-6#1)
patients with a prior history of##2##6##(2006-9#1)(2007-7#1)
patients with a prior##4##4##(2006-9#1)(2007-7#1)(2008-3#1)(2010-12#1)
patients with a progressive##2##4##(1990-12#1)(1991-6#1)
patients with a range of##2##5##(1994-10#1)(2007-12#1)
patients with a recent##2##4##(1996-3#1)(1996-9#1)
patients with a severe##4##4##(1996-1#1)(1996-12#1)(2007-7#1)(2011-2#1)
patients with a similar##3##4##(2006-10#1)(2008-4#1)(2013-1#1)
patients with a solitary##2##4##(2008-3#1)(2012-12#1)
patients with a superficial##2##4##(2008-6#2)
patients with a total##2##4##(2006-12#1)(2008-6#1)
patients with a tumor located in the##2##7##(2007-8#2)
patients with a tumor##6##4##(1990-12#1)(1994-12#1)(1996-6#1)(2007-8#3)
patients with a variety of clinical##2##6##(2008-2#2)
patients with a variety of##9##5##(1991-12#1)(2006-12#2)(2008-11#2)(2008-2#2)(2008-7#1)(2012-12#1)
patients with a very##2##4##(2006-11#1)(2007-7#1)
patients with a wide range of##2##6##(2007-11#1)(2008-7#1)
patients with a worse prognosis and##2##6##(2008-10#1)(2011-1#1)
patients with a wrist ganglion##2##5##(2008-9#2)
patients with a##289##3##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#4)(1990-3#3)(1990-4#1)(1990-5#1)(1990-9#1)(1991-10#2)(1991-11#2)(1991-12#1)(1991-4#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-2#3)(1992-5#2)(1992-8#1)(1993-10#2)(1993-11#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#2)(1995-9#2)(1996-1#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#2)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#6)(2004-1#1)(2004-10#1)(2005-1#2)(2005-10#5)(2005-5#2)(2005-7#2)(2006-1#2)(2006-10#6)(2006-11#1)(2006-12#4)(2006-2#1)(2006-3#1)(2006-6#3)(2006-8#7)(2006-9#5)(2007-10#12)(2007-11#11)(2007-12#4)(2007-2#1)(2007-3#1)(2007-6#2)(2007-7#8)(2007-8#17)(2007-9#4)(2008-1#4)(2008-10#6)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#8)(2008-7#6)(2008-8#1)(2008-9#6)(2009-3#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-12#2)(2010-3#3)(2010-5#1)(2010-8#2)(2011-1#3)(2011-11#1)(2011-2#14)(2011-3#1)(2012-11#2)(2012-12#3)(2012-2#8)(2013-1#10)(2013-7#3)(2013-8#5)
patients with abdominal##7##3##(1991-2#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
patients with abnormal lower urinary tracts##2##6##(1991-11#2)
patients with abnormal thermograms##4##4##(1993-11#4)
patients with abnormal##18##3##(1990-11#1)(1990-6#1)(1991-11#2)(1992-12#1)(1993-11#4)(1994-2#1)(1994-9#1)(2006-1#1)(2006-10#1)(2006-9#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)
patients with acanthosis nigricans##3##4##(2007-7#3)
patients with access to medical care##2##6##(2007-9#2)
patients with acetabular##2##3##(1993-8#1)(2007-7#1)
patients with achalasia##2##3##(1992-9#1)(2013-1#1)
patients with achondroplasia##3##3##(2008-5#2)(2013-1#1)
patients with acne##3##3##(2006-10#1)(2008-2#1)(2010-8#1)
patients with acoustic neuromas##2##4##(1991-12#1)(2006-11#1)
patients with acquired immunodeficiency syndrome (AIDS)##3##6##(1994-6#1)(2005-10#1)(2007-2#1)
patients with acquired immunodeficiency syndrome##5##5##(1994-6#1)(2005-10#1)(2007-12#1)(2007-2#1)(2008-2#1)
patients with acquired##9##3##(1994-3#1)(1994-6#1)(2005-10#1)(2006-7#1)(2007-12#1)(2007-2#1)(2008-2#1)(2009-4#1)(2011-1#1)
patients with active RA##5##4##(2007-3#4)(2008-7#1)
patients with active disease as compared##2##6##(2008-7#2)
patients with active disease##7##4##(1991-5#1)(1993-7#2)(1996-4#1)(2006-10#1)(2008-7#2)
patients with active pulmonary##3##4##(2010-6#1)(2010-7#2)
patients with active scars##2##4##(2009-6#2)
patients with active##33##3##(1991-5#1)(1993-7#3)(1996-4#1)(1997-2#1)(2006-10#1)(2007-3#4)(2008-7#3)(2008-8#2)(2009-11#1)(2009-6#2)(2009-9#1)(2010-12#2)(2010-6#2)(2010-7#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#4)
patients with acute PTSD##2##4##(2008-9#2)
patients with acute abdominal##2##4##(1990-10#1)(1992-8#1)
patients with acute and chronic##3##5##(1992-5#1)(2013-1#1)(2013-8#1)
patients with acute and##4##4##(1992-5#1)(2008-3#1)(2013-1#1)(2013-8#1)
patients with acute appendicitis##3##4##(2009-2#2)(2010-8#1)
patients with acute chest pain##5##5##(1990-3#2)(1991-9#1)(2008-3#2)
patients with acute cholecystitis##3##4##(1997-8#1)(2008-5#2)
patients with acute coronary syndrome (ACS)##2##6##(2008-3#1)(2011-12#1)
patients with acute coronary syndrome##18##5##(2007-8#1)(2008-11#4)(2008-3#7)(2008-7#1)(2011-12#2)(2011-2#2)(2012-2#1)
patients with acute coronary syndromes and##3##6##(2008-3#3)
patients with acute coronary syndromes##19##5##(2005-12#1)(2005-7#1)(2006-10#1)(2008-10#1)(2008-3#10)(2008-4#1)(2008-7#1)(2009-12#2)(2011-1#1)
patients with acute coronary##43##4##(2005-12#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-8#2)(2008-10#3)(2008-11#4)(2008-3#17)(2008-4#1)(2008-7#2)(2009-10#1)(2009-12#2)(2011-1#1)(2011-12#2)(2011-2#2)(2012-2#1)(2013-8#1)
patients with acute dizziness##3##4##(2011-1#3)
patients with acute exacerbation of chronic##3##6##(2007-11#1)(2008-10#1)(2011-2#1)
patients with acute hepatitis##2##4##(1990-8#1)(1996-4#1)
patients with acute ischaemic stroke##3##5##(1997-5#1)(2007-11#1)(2009-11#1)
patients with acute ischemic stroke and##2##6##(2007-9#1)(2008-10#1)
patients with acute ischemic stroke##18##5##(2007-10#7)(2007-9#6)(2008-10#1)(2012-12#2)(2013-1#1)(2013-7#1)
patients with acute ischemic##19##4##(2007-10#8)(2007-9#6)(2008-10#1)(2012-12#2)(2013-1#1)(2013-7#1)
patients with acute leukemia##4##4##(2008-7#1)(2010-11#1)(2011-2#2)
patients with acute liver failure##3##5##(1993-7#1)(2009-8#1)(2010-12#1)
patients with acute lung injury##4##5##(2006-10#4)
patients with acute myeloid leukemia##4##5##(2005-10#1)(2010-11#1)(2011-2#2)
patients with acute myeloid##5##4##(2005-10#1)(2010-11#1)(2011-2#2)(2012-3#1)
patients with acute myocardial infarction (AMI) by##2##7##(1997-6#1)(2008-5#1)
patients with acute myocardial infarction (AMI)##5##6##(1992-3#1)(1995-12#1)(1997-6#1)(2008-5#1)(2013-1#1)
patients with acute myocardial infarction and##6##6##(1991-9#1)(1997-8#1)(2007-11#1)(2008-10#2)(2009-10#1)
patients with acute myocardial infarction who##2##6##(1990-3#1)(2008-3#1)
patients with acute myocardial infarction##39##5##(1990-3#1)(1990-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-9#2)(1993-12#1)(1995-12#1)(1995-9#1)(1997-6#1)(1997-8#4)(2005-7#1)(2007-11#2)(2008-10#3)(2008-3#6)(2008-5#3)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-11#1)(2010-7#1)(2011-1#1)(2013-1#2)
patients with acute myocardial##43##4##(1990-12#1)(1990-3#1)(1990-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-9#2)(1993-10#1)(1993-12#1)(1995-12#1)(1995-9#1)(1997-6#1)(1997-8#4)(2005-7#1)(2007-11#2)(2008-10#3)(2008-3#7)(2008-5#3)(2008-6#2)(2008-7#1)(2009-10#1)(2009-5#1)(2010-11#1)(2010-7#1)(2011-1#1)(2013-1#2)
patients with acute necrotizing pancreatitis##2##5##(2012-2#1)(2012-3#1)
patients with acute necrotizing##4##4##(2006-6#1)(2012-2#1)(2012-3#2)
patients with acute neurological##2##4##(1994-10#1)(2010-12#1)
patients with acute pancreatitis##6##4##(1990-3#1)(2006-6#1)(2006-7#1)(2009-2#2)(2009-8#1)
patients with acute pulmonary embolism##2##5##(1993-2#1)(1997-8#1)
patients with acute pulmonary##3##4##(1993-2#1)(1997-8#1)(2013-7#1)
patients with acute renal failure and##2##6##(2007-7#2)
patients with acute renal failure##8##5##(2006-7#2)(2007-7#3)(2007-8#1)(2008-4#2)
patients with acute renal##9##4##(2006-4#1)(2006-7#2)(2007-7#3)(2007-8#1)(2008-4#2)
patients with acute respiratory failure##5##5##(2005-8#2)(2006-10#1)(2006-4#1)(2006-9#1)
patients with acute stroke are##2##5##(2007-10#1)(2008-8#1)
patients with acute stroke##18##4##(1994-6#1)(2006-10#1)(2007-10#9)(2007-11#1)(2007-9#3)(2008-8#2)(2010-11#1)
patients with acute##261##3##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#4)(1990-6#1)(1990-8#1)(1991-11#1)(1991-8#1)(1991-9#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#2)(1992-9#2)(1993-10#1)(1993-12#1)(1993-2#3)(1993-7#1)(1993-8#1)(1994-10#1)(1994-2#2)(1994-6#1)(1995-12#1)(1995-2#2)(1995-4#1)(1995-9#1)(1996-4#1)(1997-5#1)(1997-6#1)(1997-8#7)(2005-10#1)(2005-12#1)(2005-7#3)(2005-8#3)(2005-9#1)(2006-10#7)(2006-4#2)(2006-6#3)(2006-7#3)(2006-9#1)(2007-10#20)(2007-11#6)(2007-12#1)(2007-7#5)(2007-8#10)(2007-9#10)(2008-10#10)(2008-11#4)(2008-3#30)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#7)(2008-8#5)(2008-9#2)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#4)(2009-5#1)(2009-7#1)(2009-8#2)(2010-11#5)(2010-12#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-12#2)(2011-2#11)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#6)(2013-7#2)(2013-8#4)
patients with additional##5##3##(1991-4#1)(1995-9#1)(2009-7#1)(2012-2#1)(2013-1#1)
patients with adequate##2##3##(2008-7#1)(2010-4#1)
patients with adhesive acute SBO##2##5##(2006-6#2)
patients with adult onset##2##4##(1992-8#1)(1997-3#1)
patients with adult##7##3##(1992-2#1)(1992-8#1)(1992-9#1)(1993-3#1)(1997-3#1)(2007-7#1)(2012-12#1)
patients with adult-onset##2##3##(1991-1#1)(2009-4#1)
patients with advanced HCC##2##4##(2009-8#2)
patients with advanced Parkinson's disease##2##5##(1994-4#1)(1995-9#1)
patients with advanced RCC##2##4##(2009-11#1)(2013-1#1)
patients with advanced STS##2##4##(2008-6#2)
patients with advanced and metastatic##2##5##(2004-1#2)
patients with advanced breast cancer refractory to##3##7##(1990-6#1)(1993-12#1)(1997-7#1)
patients with advanced breast cancer##13##5##(1990-6#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-2#1)(1993-12#1)(1994-8#1)(1997-7#1)(2004-1#2)(2005-10#1)(2006-11#1)(2008-7#1)
patients with advanced breast##14##4##(1990-6#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-2#1)(1993-12#1)(1994-8#1)(1997-7#1)(2004-1#2)(2005-10#1)(2006-11#1)(2008-7#1)(2011-2#1)
patients with advanced cancer##7##4##(2007-11#1)(2007-6#1)(2008-7#3)(2009-4#1)(2012-3#1)
patients with advanced colorectal cancer##3##5##(1994-2#1)(2005-7#1)(2010-9#1)
patients with advanced disease##7##4##(1991-8#1)(2005-12#1)(2006-10#1)(2007-11#2)(2010-12#1)(2010-8#1)
patients with advanced gastric cancer##2##5##(1990-2#1)(2010-12#1)
patients with advanced heart##2##4##(2009-10#1)(2011-12#1)
patients with advanced liver disease##4##5##(1995-3#1)(2006-10#2)(2007-11#1)
patients with advanced liver##5##4##(1995-3#1)(2005-10#1)(2006-10#2)(2007-11#1)
patients with advanced malignancies##2##4##(2008-7#1)(2012-3#1)
patients with advanced malignant##2##4##(1990-1#1)(2012-3#1)
patients with advanced metastatic##2##4##(1996-4#1)(2012-12#1)
patients with advanced non-small cell lung cancer##3##7##(1990-12#1)(1990-2#1)(2005-8#1)
patients with advanced non-small cell lung cancer]##2##7##(2012-2#1)(2013-7#1)
patients with advanced non-small cell lung##5##6##(1990-12#1)(1990-2#1)(2005-8#1)(2012-2#1)(2013-7#1)
patients with advanced non-small-cell lung cancer##2##6##(2004-1#1)(2012-1#1)
patients with advanced ovarian cancer##2##5##(1991-8#2)
patients with advanced pulmonary##2##4##(2006-10#1)(2008-9#1)
patients with advanced renal cell carcinoma (RCC)##2##7##(2009-11#1)(2013-1#1)
patients with advanced renal cell carcinoma##4##6##(2008-6#2)(2009-11#1)(2013-1#1)
patients with advanced renal##5##4##(1991-6#1)(2008-6#2)(2009-11#1)(2013-1#1)
patients with advanced soft tissue sarcoma##2##6##(1990-10#1)(2008-6#1)
patients with advanced soft tissue##3##5##(1990-10#1)(2008-6#2)
patients with advanced stage##5##4##(1991-10#1)(1991-12#1)(2006-10#1)(2008-4#1)(2010-2#1)
patients with advanced stages of##2##5##(1997-6#1)(2011-2#1)
patients with advanced##125##3##(1990-1#1)(1990-10#3)(1990-12#1)(1990-2#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-4#2)(1991-6#2)(1991-8#4)(1992-10#1)(1992-2#1)(1993-10#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-4#1)(1994-8#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-4#1)(1996-8#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-1#5)(2005-10#2)(2005-12#1)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#6)(2006-11#1)(2006-6#1)(2007-11#5)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#11)(2008-7#5)(2008-9#1)(2009-10#1)(2009-11#2)(2009-4#1)(2009-8#4)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-8#1)(2010-9#1)(2011-12#3)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#3)(2013-7#2)
patients with advanced-stage cancers##2##4##(2010-8#2)
patients with advanced-stage##10##3##(2008-1#1)(2008-7#3)(2010-8#2)(2013-8#4)
patients with affective disorders##3##4##(1996-7#3)
patients with aggressive##2##3##(2007-11#1)(2012-2#1)
patients with agrammatic aphasia##2##4##(2007-4#1)(2010-2#1)
patients with alcohol dependence##3##4##(2008-2#2)(2010-1#1)
patients with alcohol##4##3##(1991-9#1)(2008-2#2)(2010-1#1)
patients with alcoholic cirrhosis##4##4##(1990-4#2)(1993-12#1)(2008-5#1)
patients with alcoholic liver disease##4##5##(1992-4#1)(1993-12#1)(1994-7#2)
patients with alcoholic liver##5##4##(1990-4#1)(1992-4#1)(1993-12#1)(1994-7#2)
patients with alcoholic##10##3##(1990-4#4)(1992-4#1)(1993-12#2)(1994-7#2)(2008-5#1)
patients with algodystrophy##2##3##(1991-7#1)(2006-10#1)
patients with all##3##3##(1992-3#1)(2010-12#1)(2011-2#1)
patients with allergic disorders##2##4##(2007-2#2)
patients with allergic rhinitis in##3##5##(2007-2#2)(2013-1#1)
patients with allergic rhinitis##10##4##(1992-8#1)(2007-2#5)(2008-4#1)(2012-12#1)(2013-1#2)
patients with allergic##16##3##(1992-8#1)(1996-2#1)(2007-11#1)(2007-2#7)(2008-4#1)(2009-6#1)(2010-5#1)(2012-12#1)(2013-1#2)
patients with alopecia areata##2##4##(2007-7#1)(2007-8#1)
patients with altered##2##3##(1991-10#1)(2006-10#1)
patients with ambiguous genitalia##2##4##(2008-10#2)
patients with amyotrophic lateral sclerosis##2##5##(2009-7#1)(2013-8#1)
patients with an acute myocardial infarction##3##6##(2008-11#2)(2008-3#1)
patients with an acute##5##4##(1994-12#1)(2008-11#2)(2008-3#1)(2008-5#1)
patients with an anorectal##2##4##(2011-2#2)
patients with an asymptomatic##2##4##(2010-6#1)(2012-3#1)
patients with an average age of##4##6##(2007-8#2)(2008-7#1)(2008-9#1)
patients with an average##5##4##(1996-3#1)(2007-8#2)(2008-7#1)(2008-9#1)
patients with an increased risk of##2##6##(1993-3#1)(2008-1#1)
patients with an increased##3##4##(1993-3#1)(2008-1#1)(2010-4#1)
patients with an isolated##2##4##(2008-7#1)(2011-2#1)
patients with an occupational history of exposure##2##7##(1994-6#1)(2008-8#1)
patients with an##59##3##(1990-11#1)(1990-8#1)(1991-6#1)(1992-12#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-2#2)(1993-3#1)(1994-12#1)(1994-6#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-7#1)(1997-8#2)(2006-10#1)(2006-7#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-6#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-6#1)(2011-2#4)(2012-3#1)
patients with anal##2##3##(1992-10#2)
patients with anaplastic##3##3##(1996-4#1)(2012-1#2)
patients with and without AIDS##2##5##(2011-2#2)
patients with and without neuropsychiatric##2##5##(2013-1#2)
patients with and without syringomyelia##2##5##(2006-5#2)
patients with and without##40##4##(1990-4#1)(1993-12#2)(1996-12#1)(1997-2#1)(1997-7#1)(2005-10#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-8#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#3)(2013-7#1)
patients with and##42##3##(1990-3#1)(1990-4#1)(1993-12#2)(1996-12#1)(1997-2#1)(1997-7#1)(2005-10#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#3)(2006-8#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#3)(2013-7#1)
patients with aneurysmal subarachnoid hemorrhage##3##5##(1995-11#1)(2006-11#1)(2007-10#1)
patients with aneurysmal##5##3##(1995-11#1)(2005-10#1)(2006-11#2)(2007-10#1)
patients with aneurysms##4##3##(2005-5#1)(2007-8#1)(2011-2#1)(2013-8#1)
patients with angina pectoris and##2##5##(1992-4#1)(1997-2#1)
patients with angina pectoris##4##4##(1992-4#1)(1997-2#1)(2008-5#1)(2012-2#1)
patients with angina##8##3##(1992-4#1)(1997-2#1)(2007-8#2)(2008-3#1)(2008-5#1)(2010-8#1)(2012-2#1)
patients with angiographically##3##3##(1990-8#1)(1993-12#1)(1994-11#1)
patients with ankylosing spondylitis##4##4##(2006-10#1)(2008-10#1)(2010-4#1)(2011-2#1)
patients with ankylosing##5##3##(2006-10#1)(2008-10#2)(2010-4#1)(2011-2#1)
patients with anorexia nervosa and##4##5##(2005-6#1)(2006-6#3)
patients with anorexia nervosa##10##4##(1995-11#2)(1996-1#1)(2005-6#1)(2006-6#5)(2007-7#1)
patients with anorexia nervosa]##2##4##(1996-6#1)(2006-6#1)
patients with anorexia##12##3##(1995-11#2)(1996-1#1)(1996-6#1)(2005-6#1)(2006-6#6)(2007-7#1)
patients with antibody deficiency##5##4##(2007-2#5)
patients with antibody##6##3##(2007-2#6)
patients with antiphospholipid antibodies##2##4##(1992-5#1)(2006-10#1)
patients with antiphospholipid syndrome##2##4##(2006-10#2)
patients with antiphospholipid##4##3##(1992-5#1)(2006-10#3)
patients with antiviral##2##3##(2009-8#1)(2012-2#1)
patients with anxiety disorders##2##4##(1996-1#1)(2013-8#1)
patients with aortic stenosis##4##4##(1990-8#1)(2011-2#1)(2012-2#2)
patients with aortic##12##3##(1990-12#1)(1990-8#1)(1992-8#1)(1995-3#1)(2007-8#2)(2008-8#1)(2011-2#1)(2012-1#2)(2012-2#2)
patients with arterial hypertension##7##4##(1990-6#1)(1991-4#1)(1992-7#1)(2006-10#1)(2008-7#1)(2011-1#1)(2012-12#1)
patients with arteriovenous##3##3##(1996-9#1)(2008-7#1)(2012-3#1)
patients with arthritis##5##3##(1992-3#1)(2006-10#1)(2006-3#1)(2008-9#1)(2013-8#1)
patients with ascites of##2##4##(1991-4#2)
patients with ascites##6##3##(1991-4#2)(2007-12#3)(2008-10#1)
patients with associated##6##3##(1991-2#1)(1992-10#1)(2007-8#2)(2008-5#1)(2013-1#1)
patients with asthma and##6##4##(1996-7#1)(2007-11#1)(2010-6#1)(2012-12#3)
patients with asthma##23##3##(1993-1#1)(1993-2#1)(1996-2#1)(1996-7#2)(2006-5#1)(2007-11#4)(2008-1#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#5)(2012-2#1)
patients with asymptomatic##10##3##(1993-2#2)(1996-3#1)(2006-9#1)(2007-10#1)(2007-9#1)(2008-7#1)(2008-8#1)(2009-12#1)(2012-2#1)
patients with at least one##3##5##(1993-5#1)(2007-9#1)(2013-1#1)
patients with at least##4##4##(1993-5#1)(2007-9#1)(2012-2#1)(2013-1#1)
patients with atherosclerosis of##2##4##(2009-2#2)
patients with atherosclerosis##5##3##(2006-6#1)(2007-10#1)(2008-3#1)(2009-2#2)
patients with atherosclerotic##4##3##(1990-9#1)(2006-6#2)(2007-10#1)
patients with atopic dermatitis and lichen planus##2##7##(2012-1#2)
patients with atopic dermatitis##8##4##(1992-10#1)(1992-9#1)(2007-11#1)(2008-5#1)(2011-1#1)(2012-1#3)
patients with atopic eczema##3##4##(1991-10#1)(2007-8#1)(2008-5#1)
patients with atopic##12##3##(1991-10#1)(1992-10#1)(1992-9#1)(2007-11#1)(2007-8#1)(2008-5#2)(2011-1#1)(2012-1#3)(2012-3#1)
patients with atrial fibrillation##15##4##(1996-6#1)(1997-3#1)(2006-10#2)(2006-8#4)(2007-8#1)(2007-9#1)(2008-3#1)(2008-5#1)(2009-12#1)(2012-12#1)(2013-1#1)
patients with atrial##16##3##(1996-6#1)(1997-3#1)(2006-10#2)(2006-8#4)(2007-8#1)(2007-9#1)(2008-3#1)(2008-5#1)(2009-12#1)(2012-12#1)(2013-1#2)
patients with atypical symptoms##2##4##(2006-10#1)(2010-2#1)
patients with atypical##4##3##(2005-8#1)(2006-10#1)(2010-12#1)(2010-2#1)
patients with auditory nerve disease (auditory neuropathy)##2##7##(2008-9#2)
patients with auditory##4##3##(2008-9#2)(2012-1#1)(2012-3#1)
patients with autism##2##3##(2009-9#1)(2010-12#1)
patients with autoimmune disorders##2##4##(1991-12#1)(2007-11#1)
patients with autoimmune##8##3##(1990-3#1)(1991-12#1)(1994-3#1)(1996-11#1)(2004-11#1)(2006-10#1)(2007-11#1)(2012-1#1)
patients with autosomal dominant polycystic kidney disease (ADPKD)##4##8##(1997-1#2)(2013-1#2)
patients with autosomal dominant polycystic kidney##5##6##(1997-1#2)(2013-1#3)
patients with bacteremia##4##3##(1990-3#1)(2005-8#1)(2008-7#1)(2013-1#1)
patients with bacterial##5##3##(1990-9#1)(1993-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
patients with basal##3##3##(2007-7#1)(2009-3#1)(2012-2#1)
patients with basilar invagination##2##4##(2006-9#1)(2008-4#1)
patients with basilar##4##3##(2006-9#1)(2007-10#1)(2008-4#1)(2008-8#1)
patients with benign and malignant##2##5##(1992-9#1)(2007-2#1)
patients with benign and##3##4##(1992-9#1)(2005-12#1)(2007-2#1)
patients with benign prostatic hyperplasia##6##5##(1990-9#2)(1992-8#1)(2006-8#1)(2006-9#2)
patients with benign##27##3##(1990-9#4)(1991-5#1)(1991-8#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-5#1)(1995-3#1)(2005-12#1)(2006-8#1)(2006-9#2)(2007-2#1)(2007-7#1)(2007-8#3)(2008-3#2)(2008-4#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#1)
patients with beta-thal major were subdivided into##2##7##(2006-10#2)
patients with beta-thal##3##3##(2006-10#3)
patients with beta-thalassemia##2##3##(1997-4#1)(2013-8#1)
patients with better QOL##2##4##(1995-10#2)
patients with better##3##3##(1995-10#2)(1997-8#1)
patients with bilateral occipital##2##4##(2006-12#1)(2006-2#1)
patients with bilateral##11##3##(1991-12#1)(1994-2#1)(1996-8#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-8#2)(2008-12#1)(2008-4#1)(2012-2#1)
patients with bile##2##3##(2005-12#1)(2007-3#1)
patients with biliary##3##3##(1992-8#1)(1994-6#1)(2006-2#1)
patients with biopsy proven GCToB##2##5##(2012-2#2)
patients with biopsy proven##4##4##(2007-7#1)(2008-1#1)(2012-2#2)
patients with biopsy-proven##4##3##(1995-4#1)(1997-3#1)(2007-11#2)
patients with bipolar disorder who##2##5##(2004-11#1)(2010-7#1)
patients with bipolar disorder##14##4##(1997-8#1)(2004-11#1)(2005-6#1)(2008-6#1)(2009-3#1)(2010-7#2)(2012-12#2)(2012-3#2)(2013-8#3)
patients with bipolar illness##2##4##(1996-1#1)(1997-8#1)
patients with bipolar##19##3##(1995-11#1)(1996-1#1)(1997-8#2)(2004-11#1)(2005-10#1)(2005-6#1)(2008-6#1)(2009-3#1)(2010-7#2)(2011-1#1)(2012-12#2)(2012-3#2)(2013-8#3)
patients with bladder exstrophy##2##4##(2008-10#2)
patients with bladder##4##3##(2007-7#1)(2007-9#1)(2008-10#2)
patients with bleeding##6##3##(2006-10#2)(2006-11#1)(2013-1#3)
patients with bleeding- and ischemic-type moyamoya disease##2##7##(2006-11#2)
patients with blood disorders##2##4##(2010-9#2)
patients with blood##4##3##(2008-1#2)(2010-9#2)
patients with blunt head trauma##3##5##(2011-2#3)
patients with blunt##5##3##(1990-2#1)(2011-2#3)(2012-2#1)
patients with bone metastases are##2##5##(2007-11#1)(2011-2#1)
patients with bone metastases from##5##5##(2008-10#1)(2008-7#4)
patients with bone metastases treated operatively in our Ward during##2##10##(2007-11#2)
patients with bone metastases##17##4##(1990-2#1)(1991-10#1)(2007-11#7)(2008-10#2)(2008-7#4)(2011-2#2)
patients with bone sarcomas high grade##2##6##(2011-1#2)
patients with bone sarcomas high##3##5##(2011-1#3)
patients with bone sarcomas##4##4##(2008-6#1)(2011-1#3)
patients with bone##26##3##(1990-2#2)(1991-10#1)(2007-11#9)(2008-10#2)(2008-6#1)(2008-7#4)(2008-9#1)(2011-1#4)(2011-2#2)
patients with borderline disorders##2##4##(1992-1#1)(1993-12#1)
patients with borderline personality disorder##2##5##(1997-5#2)
patients with borderline##4##3##(1992-1#1)(1993-12#1)(1997-5#2)
patients with both type 1 and type 2 diabetes##2##9##(2008-1#1)(2008-8#1)
patients with both##13##3##(1995-3#1)(1995-4#1)(2004-2#1)(2007-9#1)(2008-1#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-5#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
patients with bowel##2##3##(2008-5#1)(2011-12#1)
patients with brain tumors##5##4##(2006-12#1)(2006-7#1)(2006-8#1)(2008-12#1)(2012-1#1)
patients with brain##12##3##(1994-3#1)(1996-4#1)(2006-12#2)(2006-7#1)(2006-8#1)(2007-10#1)(2008-12#1)(2008-2#1)(2009-4#1)(2010-8#1)(2012-1#1)
patients with breast and prostate cancer##2##6##(2007-11#1)(2008-7#1)
patients with breast cancer and##10##5##(1990-2#1)(1992-12#1)(1992-2#1)(1993-11#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-6#1)
patients with breast cancer were##2##5##(1994-12#1)(2013-1#1)
patients with breast cancer who##2##5##(2012-3#1)(2013-1#1)
patients with breast cancer##42##4##(1990-1#1)(1990-2#1)(1990-8#1)(1992-10#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-11#4)(1993-8#1)(1994-12#2)(1996-6#1)(1997-7#1)(1997-8#3)(2004-2#1)(2005-12#1)(2007-1#2)(2007-10#1)(2007-11#3)(2007-2#1)(2007-6#2)(2008-10#1)(2008-5#1)(2008-7#4)(2012-3#1)(2013-1#5)
patients with breast cancers##2##4##(1992-4#1)(1995-5#1)
patients with breast##54##3##(1990-1#1)(1990-2#1)(1990-8#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-1#1)(1993-11#4)(1993-8#1)(1994-12#2)(1995-5#1)(1996-3#1)(1996-6#1)(1997-7#1)(1997-8#3)(2004-2#1)(2005-12#1)(2007-1#3)(2007-10#1)(2007-11#4)(2007-2#1)(2007-6#2)(2008-10#1)(2008-5#1)(2008-7#7)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#6)(2013-8#1)
patients with bronchial##2##3##(1990-10#1)(2006-6#1)
patients with bronchiolitis##3##3##(2007-2#3)
patients with bulimia##2##3##(1997-7#1)(2006-2#1)
patients with cGVHD##4##3##(2013-8#4)
patients with calcific chronic pancreatitis##2##5##(1995-7#1)(2006-10#1)
patients with calcific##3##3##(1995-7#1)(2006-10#1)(2008-5#1)
patients with cancer and##10##4##(1993-9#3)(1994-8#1)(1996-1#1)(2006-10#1)(2008-7#3)(2012-11#1)
patients with cancer in##2##4##(1992-8#1)(2011-2#1)
patients with cancer is##5##4##(2007-8#1)(2007-9#1)(2008-2#1)(2008-7#2)
patients with cancer may##2##4##(1996-1#1)(2008-7#1)
patients with cancer of the pancreas##6##6##(1990-9#1)(2008-7#5)
patients with cancer of the prostate##2##6##(1990-9#1)(1991-8#1)
patients with cancer of the stomach##11##6##(1991-2#2)(2008-7#9)
patients with cancer of the##23##5##(1990-9#3)(1991-2#2)(1991-8#1)(1992-11#1)(2006-1#1)(2008-7#15)
patients with cancer of##24##4##(1990-9#3)(1991-12#1)(1991-2#2)(1991-8#1)(1992-11#1)(2006-1#1)(2008-7#15)
patients with cancer receiving chemotherapy##6##5##(2008-7#5)(2010-8#1)
patients with cancer receiving##9##4##(2008-7#8)(2010-8#1)
patients with cancer who##3##4##(2008-7#3)
patients with cancer with bone metastases in##2##7##(2008-7#2)
patients with cancer with bone metastases##3##6##(2008-7#3)
patients with cancer with##5##4##(2008-7#4)(2012-11#1)
patients with cancer##130##3##(1990-6#1)(1990-9#3)(1991-12#1)(1991-2#2)(1991-4#1)(1991-7#2)(1991-8#1)(1992-11#1)(1992-8#1)(1993-9#3)(1994-8#1)(1996-1#3)(1996-10#1)(1996-11#1)(1996-9#2)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-6#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-2#2)(2008-3#1)(2008-7#64)(2008-8#1)(2009-12#1)(2009-7#1)(2010-11#7)(2010-4#1)(2010-8#1)(2010-9#2)(2011-2#4)(2012-1#1)(2012-11#3)(2012-3#2)(2013-1#3)
patients with candidosis and##2##4##(2008-5#2)
patients with carcinoid tumours##5##4##(1992-11#3)(1993-11#2)
patients with carcinoid##8##3##(1992-11#4)(1993-11#2)(2008-8#1)(2013-1#1)
patients with carcinoma and##2##4##(1992-5#1)(2006-6#1)
patients with carcinoma in##2##4##(1995-8#1)(2006-10#1)
patients with carcinoma of the lung##2##6##(1994-7#1)(2006-6#1)
patients with carcinoma of the##7##5##(1994-3#2)(1994-7#1)(2006-6#1)(2007-3#1)(2008-8#1)(2009-3#1)
patients with carcinoma##12##3##(1992-5#2)(1994-3#2)(1994-7#1)(1995-8#1)(2006-10#1)(2006-6#2)(2007-3#1)(2008-8#1)(2009-3#1)
patients with cardiac arrhythmias##2##4##(1995-11#1)(2007-9#1)
patients with cardiac disease##2##4##(1990-11#1)(2004-10#1)
patients with cardiac injuries##2##4##(2007-8#2)
patients with cardiac##17##3##(1990-11#1)(1991-9#1)(1995-11#1)(2004-10#1)(2006-10#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-6#1)(2011-2#2)(2012-2#2)
patients with cardiovascular disease##7##4##(2006-10#1)(2006-5#1)(2007-7#1)(2008-1#2)(2008-10#1)(2011-2#1)
patients with cardiovascular diseases##2##4##(2008-10#1)(2012-12#1)
patients with cardiovascular##15##3##(1993-5#1)(2006-10#2)(2006-5#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-8#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
patients with carotid artery##3##4##(2006-11#1)(2007-10#1)(2010-11#1)
patients with carotid stenosis##3##4##(1991-11#1)(2006-10#1)(2010-11#1)
patients with carotid##9##3##(1991-11#1)(1991-12#1)(2006-10#1)(2006-11#1)(2007-10#3)(2010-11#2)
patients with carpal##2##3##(2008-9#2)
patients with catatonia##3##3##(2008-1#1)(2010-12#2)
patients with celiac disease##4##4##(1995-3#1)(2007-5#1)(2011-2#2)
patients with cellulitis and##2##4##(2007-7#2)
patients with cellulitis##3##3##(2006-10#1)(2007-7#2)
patients with central Cushing's syndrome##2##5##(1997-1#2)
patients with central nervous system##3##5##(1994-9#1)(2007-3#1)(2011-2#1)
patients with central##8##3##(1994-9#1)(1997-1#2)(2006-3#1)(2007-3#1)(2008-6#1)(2008-9#1)(2011-2#1)
patients with cerebral arteriovenous malformations##2##5##(2006-2#1)(2008-7#1)
patients with cerebral infarction##3##4##(1994-9#1)(2007-9#1)(2010-12#1)
patients with cerebral##14##3##(1990-12#1)(1993-8#1)(1994-9#1)(2006-2#1)(2006-3#1)(2006-4#1)(2007-10#1)(2007-9#3)(2008-7#1)(2010-12#1)(2012-1#2)
patients with cerebrospinal fluid##2##4##(2006-5#1)(2011-2#1)
patients with cerebrovascular disease##4##4##(2006-7#1)(2007-10#2)(2008-7#1)
patients with cerebrovascular##11##3##(1990-6#1)(1991-11#1)(1992-4#2)(2005-1#1)(2006-7#1)(2007-10#3)(2008-7#1)(2011-1#1)
patients with certain##4##3##(1990-8#1)(1992-8#1)(1997-1#1)(2005-7#1)
patients with cervical dissection##2##4##(2007-10#1)(2008-8#1)
patients with cervical intraepithelial neoplasia##3##5##(1991-2#1)(1992-3#1)(2011-2#1)
patients with cervical spine##4##4##(2006-10#1)(2007-11#3)
patients with cervical##15##3##(1991-2#1)(1992-3#1)(2005-10#1)(2005-9#1)(2006-10#2)(2007-10#1)(2007-11#4)(2007-4#1)(2007-9#1)(2008-8#1)(2011-2#1)
patients with challenging##2##3##(2011-1#1)(2012-12#1)
patients with chest discomfort##2##4##(1991-12#1)(2007-7#1)
patients with chest injuries##2##4##(1991-4#2)
patients with chest pain and negative cardiac enzymes##2##8##(2013-8#2)
patients with chest pain and no ST-segment elevation##2##8##(2008-3#2)
patients with chest pain and##4##5##(2008-3#2)(2013-8#2)
patients with chest pain in the##2##6##(2008-3#2)
patients with chest pain##11##4##(1992-6#1)(2007-5#1)(2008-3#5)(2012-2#2)(2013-8#2)
patients with chest##16##3##(1991-12#1)(1991-4#3)(1992-6#1)(2007-5#1)(2007-7#1)(2008-3#5)(2012-2#2)(2013-8#2)
patients with childhood##2##3##(2006-11#1)(2011-2#1)
patients with choledocholithiasis##2##3##(2008-5#2)
patients with cholestasis##4##3##(1996-4#3)(2004-11#1)
patients with cholesterol gallstones##2##4##(1991-3#2)
patients with cholesterol##3##3##(1991-3#2)(2011-1#1)
patients with chronic HBV infection##2##5##(2010-8#1)(2012-3#1)
patients with chronic HBV##4##4##(2009-11#1)(2010-8#1)(2011-12#1)(2012-3#1)
patients with chronic HCV infection##6##5##(1996-9#1)(2006-6#2)(2008-8#2)(2009-8#1)
patients with chronic HCV##11##4##(1996-9#1)(2005-8#1)(2006-2#2)(2006-6#2)(2008-8#3)(2009-4#1)(2009-8#1)
patients with chronic active hepatitis##4##5##(1991-6#1)(1996-4#1)(2009-8#2)
patients with chronic ankle instability##4##5##(2009-10#3)(2013-1#1)
patients with chronic asthma##2##4##(2005-8#1)(2007-2#1)
patients with chronic bronchitis##4##4##(1990-5#1)(1994-3#1)(2008-11#1)(2008-5#1)
patients with chronic conditions##2##4##(2010-3#1)(2012-1#1)
patients with chronic diseases##5##4##(2006-10#1)(2009-9#2)(2011-2#1)(2012-1#1)
patients with chronic fatigue syndrome##2##5##(1991-3#1)(2007-12#1)
patients with chronic glomerulonephritis##2##4##(1992-7#1)(2006-6#1)
patients with chronic granulomatous disease##6##5##(1994-3#2)(2007-12#1)(2007-2#1)(2012-11#2)
patients with chronic heart failure##15##5##(1991-3#1)(1996-1#1)(2005-1#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#3)(2011-1#1)(2012-2#1)(2013-1#1)
patients with chronic heart##18##4##(1991-3#1)(1996-1#1)(2005-1#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#3)(2011-1#2)(2012-2#1)(2013-1#2)(2013-8#1)
patients with chronic hepatitis B (CHB)##2##6##(2009-11#2)
patients with chronic hepatitis B##17##5##(2006-10#1)(2007-11#2)(2009-11#3)(2009-8#3)(2010-12#2)(2010-8#1)(2011-2#2)(2012-2#3)
patients with chronic hepatitis C and##2##6##(2008-8#1)(2009-2#1)
patients with chronic hepatitis C infection##2##6##(2006-10#1)(2007-3#1)
patients with chronic hepatitis C virus infection##4##7##(2006-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
patients with chronic hepatitis C virus##7##6##(2006-10#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#2)(2013-7#1)
patients with chronic hepatitis C##34##5##(1994-8#1)(2006-10#3)(2006-2#1)(2007-11#10)(2007-3#3)(2008-8#3)(2009-10#1)(2009-2#1)(2009-9#2)(2010-12#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-1#3)(2013-7#1)
patients with chronic hepatitis and##3##5##(2007-2#1)(2009-8#1)(2009-9#1)
patients with chronic hepatitis##60##4##(1994-8#1)(2005-11#1)(2006-10#5)(2006-2#2)(2007-11#12)(2007-2#1)(2007-3#3)(2008-8#3)(2009-10#1)(2009-11#3)(2009-2#1)(2009-8#4)(2009-9#3)(2010-12#4)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#3)(2013-1#3)(2013-7#1)
patients with chronic idiopathic urticaria##3##5##(2007-11#1)(2007-7#1)(2012-3#1)
patients with chronic inflammatory##3##4##(2008-1#1)(2008-10#1)(2010-9#1)
patients with chronic ischaemic heart disease (IHD) and##2##8##(2005-1#2)
patients with chronic ischaemic heart##3##5##(2005-1#3)
patients with chronic kidney disease (CKD)##4##6##(2008-3#1)(2008-5#1)(2011-2#2)
patients with chronic kidney disease##9##5##(2007-8#2)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#4)
patients with chronic kidney##11##4##(2007-8#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#4)(2012-2#1)
patients with chronic liver disease##13##5##(1991-2#1)(1991-3#1)(1991-8#1)(1993-7#1)(1996-4#1)(2006-10#1)(2008-1#2)(2009-2#2)(2009-4#1)(2009-7#1)(2011-1#1)
patients with chronic liver diseases##5##5##(1990-10#1)(1997-8#1)(2006-2#1)(2008-4#2)
patients with chronic liver##18##4##(1990-10#1)(1991-2#1)(1991-3#1)(1991-8#1)(1993-7#1)(1996-4#1)(1997-8#1)(2006-10#1)(2006-2#1)(2008-1#2)(2008-4#2)(2009-2#2)(2009-4#1)(2009-7#1)(2011-1#1)
patients with chronic low back pain##14##6##(1993-11#1)(2006-10#1)(2006-7#1)(2006-8#7)(2007-6#1)(2008-10#1)(2012-12#2)
patients with chronic lymphocytic leukemia##2##5##(1993-2#1)(2010-12#1)
patients with chronic lymphocytic##3##4##(1993-2#1)(2010-12#1)(2012-2#1)
patients with chronic myeloid leukemia (CML)##3##6##(2005-12#1)(2009-3#1)(2010-4#1)
patients with chronic myeloid leukemia##7##5##(1996-2#2)(2005-12#1)(2008-4#1)(2009-3#2)(2010-4#1)
patients with chronic myeloid##8##4##(1996-2#2)(2005-12#1)(2006-6#1)(2008-4#1)(2009-3#2)(2010-4#1)
patients with chronic myeloproliferative diseases##3##5##(2008-4#3)
patients with chronic neck and low back pain##2##8##(2006-8#2)
patients with chronic neck pain##5##5##(2006-8#1)(2010-12#4)
patients with chronic neck##7##4##(2006-8#3)(2010-12#4)
patients with chronic nonrheumatic atrial fibrillation##2##6##(1997-1#2)
patients with chronic obstructive pulmonary disease (COPD)##5##7##(1997-7#1)(2007-3#1)(2007-8#1)(2008-7#1)(2011-2#1)
patients with chronic obstructive pulmonary disease##17##6##(1991-9#1)(1997-7#2)(2007-11#1)(2007-3#1)(2007-8#3)(2008-4#2)(2008-7#2)(2011-2#4)(2012-12#1)
patients with chronic obstructive pulmonary##18##5##(1991-9#1)(1993-11#1)(1997-7#2)(2007-11#1)(2007-3#1)(2007-8#3)(2008-4#2)(2008-7#2)(2011-2#4)(2012-12#1)
patients with chronic obstructive rhinitis##4##5##(2008-4#4)
patients with chronic obstructive##24##4##(1991-9#1)(1993-11#1)(1997-7#2)(2006-6#1)(2007-11#1)(2007-3#1)(2007-8#3)(2008-1#1)(2008-4#6)(2008-7#2)(2011-2#4)(2012-12#1)
patients with chronic pain##19##4##(1992-9#1)(1993-5#1)(1995-9#1)(1996-7#1)(1997-6#1)(2006-12#2)(2006-8#2)(2007-12#1)(2007-2#1)(2008-4#2)(2008-9#1)(2009-4#1)(2009-7#1)(2010-6#1)(2011-2#1)(2012-3#1)
patients with chronic pancreatitis and##4##5##(1991-2#2)(1992-11#1)(2008-9#1)
patients with chronic pancreatitis have##2##5##(1994-7#1)(2005-10#1)
patients with chronic pancreatitis##16##4##(1991-2#2)(1992-11#2)(1994-7#1)(1995-7#1)(2005-1#2)(2005-10#3)(2006-10#1)(2006-6#3)(2008-9#1)
patients with chronic periodontitis with##2##5##(2008-12#2)
patients with chronic periodontitis##7##4##(2008-12#3)(2010-4#1)(2012-3#1)(2013-1#2)
patients with chronic renal disease##3##5##(2007-7#1)(2008-1#1)(2008-10#1)
patients with chronic renal failure (CRF)##5##6##(2007-11#1)(2007-7#3)(2011-2#1)
patients with chronic renal failure and##2##6##(1991-5#1)(1993-11#1)
patients with chronic renal failure who##2##6##(1993-2#1)(1994-12#1)
patients with chronic renal failure##26##5##(1990-10#1)(1990-8#1)(1991-1#1)(1991-5#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-12#1)(1995-5#1)(1996-8#1)(2005-1#1)(2005-9#1)(2006-6#2)(2007-11#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-4#2)(2011-2#2)
patients with chronic renal insufficiency or##2##6##(2006-10#2)
patients with chronic renal insufficiency##3##5##(2005-10#1)(2006-10#2)
patients with chronic renal##34##4##(1990-10#1)(1990-8#1)(1991-1#1)(1991-5#1)(1991-8#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-12#1)(1995-5#1)(1996-8#1)(2005-1#1)(2005-10#1)(2005-9#1)(2006-10#2)(2006-6#2)(2007-11#1)(2007-7#4)(2007-8#1)(2008-1#4)(2008-10#1)(2008-4#2)(2011-2#2)
patients with chronic respiratory##2##4##(2008-1#1)(2013-1#1)
patients with chronic shoulder-hand pain##2##5##(2006-12#2)
patients with chronic sinusitis who underwent total spheno-ethmoidectomy##2##8##(2008-5#2)
patients with chronic sinusitis##3##4##(1995-8#1)(2008-5#2)
patients with chronic stable angina##2##5##(2008-3#1)(2012-11#1)
patients with chronic stable hypercapnic respiratory##2##6##(2008-1#2)
patients with chronic stable##5##4##(2008-1#2)(2008-3#1)(2009-4#1)(2012-11#1)
patients with chronic stroke##2##4##(2007-10#1)(2012-1#1)
patients with chronic thromboembolic##5##4##(2010-10#1)(2010-6#3)(2013-7#1)
patients with chronic traumatic ulcers##2##5##(2008-5#2)
patients with chronic venous##4##4##(2005-10#1)(2010-7#1)(2013-1#2)
patients with chronic wrist pain##3##5##(2008-9#3)
patients with chronic##418##3##(1990-10#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#4)(1991-3#3)(1991-4#2)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#4)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#3)(1993-2#2)(1993-5#1)(1993-7#1)(1994-11#2)(1994-12#1)(1994-3#3)(1994-7#1)(1994-8#1)(1995-2#2)(1995-4#1)(1995-5#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-2#3)(1996-4#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-1#9)(2005-10#5)(2005-11#1)(2005-12#1)(2005-4#2)(2005-8#3)(2005-9#1)(2006-10#15)(2006-11#1)(2006-12#6)(2006-2#6)(2006-6#10)(2006-7#4)(2006-8#14)(2006-9#1)(2007-10#2)(2007-11#20)(2007-12#3)(2007-2#4)(2007-3#4)(2007-6#1)(2007-7#5)(2007-8#9)(2007-9#1)(2008-1#11)(2008-10#5)(2008-11#3)(2008-12#3)(2008-3#4)(2008-4#21)(2008-5#11)(2008-7#8)(2008-8#10)(2008-9#5)(2009-10#8)(2009-11#4)(2009-2#4)(2009-3#2)(2009-4#4)(2009-6#1)(2009-7#2)(2009-8#7)(2009-9#5)(2010-10#1)(2010-11#1)(2010-12#11)(2010-3#3)(2010-4#3)(2010-6#5)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#20)(2012-1#5)(2012-11#3)(2012-12#5)(2012-2#7)(2012-3#4)(2013-1#17)(2013-7#2)(2013-8#2)
patients with chronic-phase##2##3##(2009-3#2)
patients with cirrhosis and##5##4##(2008-12#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
patients with cirrhosis is##2##4##(1995-3#1)(2006-10#1)
patients with cirrhosis or##3##4##(2008-4#1)(2008-5#1)(2009-4#1)
patients with cirrhosis than##2##4##(1991-9#1)(1994-7#1)
patients with cirrhosis##25##3##(1991-9#1)(1992-9#1)(1994-7#1)(1995-3#2)(1995-9#1)(2006-10#2)(2006-2#1)(2006-6#1)(2007-2#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-4#2)(2010-12#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
patients with citrullinaemia and argininosuccinic aciduria##2##6##(1992-7#2)
patients with class II##3##4##(2011-2#3)
patients with class IV or V LN##2##7##(2008-1#2)
patients with class IV##4##4##(1993-2#1)(2008-1#3)
patients with class##8##3##(1993-2#1)(2008-1#4)(2011-2#3)
patients with classic##2##3##(2005-7#1)(2009-10#1)
patients with classical##4##3##(1991-12#2)(1993-11#1)(1997-5#1)
patients with clear##3##3##(2008-6#2)(2011-1#1)
patients with cleft lip##2##4##(2013-1#2)
patients with cleft##3##3##(2007-12#1)(2013-1#2)
patients with clinical and##2##4##(2008-7#1)(2009-10#1)
patients with clinical symptoms suggesting a large stroke##2##8##(2007-9#2)
patients with clinical symptoms##3##4##(2006-11#1)(2007-9#2)
patients with clinical##15##3##(1990-2#1)(1991-2#1)(1995-3#1)(2006-11#1)(2007-9#2)(2008-4#1)(2008-7#1)(2009-10#1)(2011-2#4)(2013-1#1)(2013-8#1)
patients with clinically diagnosed##3##4##(1995-3#1)(1996-11#1)(2013-1#1)
patients with clinically evident##2##4##(2008-10#1)(2008-3#1)
patients with clinically##13##3##(1990-2#1)(1992-3#1)(1992-6#1)(1995-3#1)(1995-5#1)(1996-11#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
patients with clopidogrel exposure##3##4##(2007-8#3)
patients with closed-head injuries##3##4##(2007-11#3)
patients with coagulopathy versus##2##4##(2007-10#2)
patients with cocaine abuse##2##4##(2009-11#2)
patients with cocaine use disorders##2##5##(2004-3#2)
patients with cocaine##5##3##(2004-3#3)(2009-11#2)
patients with cochlear implants##6##4##(2008-9#6)
patients with coexisting##5##3##(2007-11#2)(2008-10#1)(2011-1#1)(2013-1#1)
patients with cognitive impairment##2##4##(2010-7#1)(2010-9#1)
patients with cognitive##5##3##(1990-8#1)(1991-5#1)(2008-7#1)(2010-7#1)(2010-9#1)
patients with colon##4##3##(1990-8#2)(1991-3#1)(1996-2#1)
patients with colonic##4##3##(1993-5#1)(2008-6#1)(2011-2#2)
patients with colorectal cancer liver metastases##2##6##(2008-10#2)
patients with colorectal cancer liver##3##5##(2008-10#2)(2012-1#1)
patients with colorectal cancer##12##4##(1991-7#1)(1996-1#1)(1996-10#1)(2006-10#1)(2008-10#2)(2009-12#2)(2011-12#1)(2011-2#2)(2012-1#1)
patients with colorectal cancer]##5##4##(2008-10#1)(2012-1#4)
patients with colorectal carcinoma##5##4##(1992-8#4)(1994-6#1)
patients with colorectal liver metastases##2##5##(2008-3#1)(2012-1#1)
patients with colorectal##27##3##(1991-7#1)(1992-8#4)(1994-6#1)(1996-1#1)(1996-10#1)(1997-5#1)(2006-10#1)(2008-10#3)(2008-3#1)(2008-4#1)(2009-12#2)(2011-12#1)(2011-2#2)(2012-1#6)(2012-2#1)
patients with combined##8##3##(2006-8#1)(2007-7#1)(2007-8#2)(2009-3#1)(2011-2#1)(2012-1#1)(2012-3#1)
patients with common variable immunodeficiency##2##5##(2007-2#1)(2012-3#1)
patients with common##3##3##(1997-8#1)(2007-2#1)(2012-3#1)
patients with communication related impairments in acute##2##7##(2011-1#2)
patients with community-acquired pneumonia and##3##5##(2013-1#3)
patients with community-acquired pneumonia##4##4##(2013-1#4)
patients with comparable##2##3##(1990-2#1)(2009-1#1)
patients with compensated##4##3##(1991-10#1)(2011-1#1)(2013-1#1)(2013-8#1)
patients with complete##11##3##(1992-4#1)(1993-1#1)(1995-11#1)(2004-2#1)(2007-11#2)(2007-7#1)(2008-5#1)(2010-4#1)(2012-2#1)(2013-1#1)
patients with completely##2##3##(1990-10#1)(1996-3#1)
patients with complex regional pain syndrome##2##6##(2006-12#2)
patients with complex##4##3##(2006-12#2)(2006-4#1)(2012-12#1)
patients with complicated and##2##4##(1991-6#1)(2008-4#1)
patients with complicated##7##3##(1991-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-12#1)(2012-12#1)(2013-7#1)
patients with complications##2##3##(1997-2#1)(2008-2#1)
patients with concomitant##5##3##(1990-2#1)(2005-12#1)(2012-12#1)(2012-3#1)(2013-8#1)
patients with concurrent substance use##2##5##(2008-9#2)
patients with concurrent##4##3##(2006-6#1)(2008-9#2)(2009-8#1)
patients with confirmed##11##3##(1991-3#1)(1996-3#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-3#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-3#1)(2012-2#1)
patients with congenital and acquired##2##5##(2012-2#1)(2013-1#1)
patients with congenital fibular##3##4##(2007-8#3)
patients with congenital heart disease (CHD)##4##6##(2010-10#1)(2012-1#1)(2012-2#1)(2013-1#1)
patients with congenital heart disease and##4##6##(2009-10#3)(2009-5#1)
patients with congenital heart disease##16##5##(1995-6#2)(2007-3#1)(2009-10#4)(2009-5#1)(2010-10#2)(2012-1#2)(2012-2#3)(2013-1#1)
patients with congenital heart##17##4##(1995-6#2)(2007-3#1)(2009-10#4)(2009-5#1)(2010-10#2)(2010-12#1)(2012-1#2)(2012-2#3)(2013-1#1)
patients with congenital##33##3##(1990-11#1)(1990-8#1)(1994-11#1)(1995-6#2)(1997-3#1)(2006-1#2)(2007-3#1)(2007-8#4)(2009-10#4)(2009-5#1)(2010-10#2)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-2#4)(2013-1#2)
patients with congestive heart failure##7##5##(1993-9#1)(1996-1#1)(1996-9#1)(2008-3#1)(2008-5#1)(2010-11#1)(2012-3#1)
patients with congestive##8##3##(1991-9#1)(1993-9#1)(1996-1#1)(1996-9#1)(2008-3#1)(2008-5#1)(2010-11#1)(2012-3#1)
patients with connective tissue##4##4##(2006-10#1)(2006-4#1)(2012-1#1)(2012-2#1)
patients with controlled##2##3##(2007-7#1)(2008-3#1)
patients with conventional##2##3##(2007-6#1)(2010-3#1)
patients with corneal##3##3##(2008-11#1)(2009-10#1)(2012-12#1)
patients with coronary artery disease (CAD)##3##6##(1996-1#1)(2008-7#1)(2012-2#1)
patients with coronary artery disease and##2##6##(1990-3#1)(1997-1#1)
patients with coronary artery disease##37##5##(1990-3#1)(1993-11#2)(1993-12#3)(1995-6#2)(1996-1#1)(1997-1#1)(1997-8#1)(2006-10#2)(2006-6#2)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
patients with coronary artery spasm##4##5##(1993-12#4)
patients with coronary artery##45##4##(1990-3#1)(1993-11#2)(1993-12#7)(1995-6#3)(1996-1#1)(1997-1#1)(1997-8#1)(2006-10#2)(2006-6#3)(2007-8#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
patients with coronary atherosclerosis##3##4##(1996-5#1)(2008-7#1)(2010-12#1)
patients with coronary disease and##2##5##(1995-6#1)(2011-2#1)
patients with coronary disease##5##4##(1993-3#1)(1993-9#1)(1995-11#1)(1995-6#1)(2011-2#1)
patients with coronary heart disease (CHD)##3##6##(1990-7#1)(2007-11#1)(2008-10#1)
patients with coronary heart disease##19##5##(1990-7#1)(1990-8#2)(1992-5#1)(1993-12#1)(1993-2#2)(2007-11#3)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-10#1)(2012-3#1)
patients with coronary heart##20##4##(1990-7#1)(1990-8#2)(1992-5#1)(1993-12#1)(1993-2#2)(2007-11#4)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-10#1)(2012-3#1)
patients with coronary##76##3##(1990-3#1)(1990-7#1)(1990-8#2)(1992-5#1)(1993-11#2)(1993-12#8)(1993-2#2)(1993-3#1)(1993-9#1)(1995-11#1)(1995-3#1)(1995-6#4)(1996-1#1)(1996-5#1)(1997-1#1)(1997-8#1)(2006-10#2)(2006-6#3)(2007-11#4)(2007-8#3)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#4)(2009-10#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
patients with cortical deafness##2##4##(2008-9#2)
patients with cortical##3##3##(2007-10#1)(2008-9#2)
patients with craniofacial##2##3##(2007-12#2)
patients with critical##4##3##(2007-8#3)(2008-7#1)
patients with cutaneous leishmaniasis##2##4##(2007-2#1)(2008-12#1)
patients with cutaneous##6##3##(1997-4#1)(2007-2#1)(2008-12#2)(2010-12#1)(2011-12#1)
patients with cystic fibrosis (CF)##2##5##(2008-5#1)(2012-12#1)
patients with cystic fibrosis were##2##5##(1991-12#1)(2007-8#1)
patients with cystic fibrosis##26##4##(1991-12#2)(1993-1#1)(1994-12#1)(1996-2#2)(2006-10#5)(2006-6#3)(2007-11#2)(2007-8#2)(2008-10#1)(2008-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#3)
patients with cystic##30##3##(1991-12#2)(1993-1#1)(1994-12#1)(1996-2#3)(2006-10#5)(2006-6#3)(2007-11#2)(2007-12#2)(2007-6#1)(2007-8#2)(2008-10#1)(2008-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#3)
patients with cystinosis##4##3##(1990-10#1)(2007-8#3)
patients with damage to the##2##5##(2007-11#1)(2008-4#1)
patients with damage to##3##4##(1995-8#1)(2007-11#1)(2008-4#1)
patients with damage##5##3##(1995-12#1)(1995-8#1)(2007-11#2)(2008-4#1)
patients with dandruff or seborrheic dermatitis##2##6##(2007-7#2)
patients with de novo##3##4##(2008-5#1)(2010-1#1)(2011-2#1)
patients with decreased##3##3##(1991-10#1)(1991-12#1)(2006-10#1)
patients with deep##6##3##(1994-2#1)(2007-11#2)(2007-2#1)(2008-8#1)(2008-9#1)
patients with deficiency of##2##4##(1995-8#1)(2005-8#1)
patients with deficient##2##3##(1995-12#1)(2005-8#1)
patients with degeneration disease##3##4##(2007-8#3)
patients with degenerative changes##3##4##(2007-7#1)(2007-8#2)
patients with degenerative discopathy##2##4##(2007-8#2)
patients with degenerative disease of the##3##6##(2007-11#2)(2012-12#1)
patients with degenerative##14##3##(2006-3#1)(2007-11#2)(2007-7#1)(2007-8#5)(2008-11#1)(2008-7#1)(2008-8#1)(2009-3#1)(2012-12#1)
patients with delayed##6##3##(1990-12#1)(2004-1#1)(2007-11#1)(2008-5#1)(2011-2#2)
patients with dementia and idiopathic##2##5##(2006-8#2)
patients with dementia and##6##4##(2006-8#3)(2008-6#1)(2011-2#1)(2013-8#1)
patients with dementia##21##3##(1991-11#1)(1994-11#1)(1995-11#1)(1996-11#1)(2006-8#4)(2007-3#1)(2008-1#1)(2008-6#1)(2008-7#4)(2008-8#1)(2011-2#3)(2013-8#2)
patients with depression##7##3##(1995-11#1)(2006-8#1)(2008-7#1)(2009-10#1)(2009-6#1)(2013-7#2)
patients with dermatitis##3##3##(1992-9#1)(2006-10#1)(2012-1#1)
patients with dermatomyositis##4##3##(1994-8#3)(2006-10#1)
patients with destructive##2##3##(1995-9#1)(2006-6#1)
patients with diabetes and other chronic diseases##2##7##(2013-8#2)
patients with diabetes and other##3##5##(2013-8#3)
patients with diabetes and##8##4##(2005-8#1)(2007-10#1)(2010-10#1)(2013-1#2)(2013-8#3)
patients with diabetes are good candidates for screening and treatment with folic acid until the results of ongoing clinical trials are available##2##22##(2005-10#1)(2008-3#1)
patients with diabetes are##3##4##(2005-10#1)(2008-3#1)(2010-12#1)
patients with diabetes mellitus and##3##5##(1996-3#1)(2006-6#1)(2013-8#1)
patients with diabetes mellitus##36##4##(1990-4#1)(1991-8#2)(1992-5#2)(1996-3#1)(2005-9#1)(2006-10#1)(2006-6#3)(2007-1#1)(2008-1#3)(2008-10#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-6#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
patients with diabetes mellitus]##2##4##(1996-11#1)(2006-6#1)
patients with diabetes##89##3##(1990-3#1)(1990-4#1)(1991-8#2)(1992-5#2)(1996-11#1)(1996-3#1)(2005-10#1)(2005-8#2)(2005-9#1)(2006-10#2)(2006-2#1)(2006-6#4)(2007-1#2)(2007-10#4)(2007-8#2)(2008-1#12)(2008-10#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#5)(2009-1#1)(2009-11#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#7)
patients with diabetic nephropathy##2##4##(1996-12#1)(2007-8#1)
patients with diabetic##9##3##(1994-12#1)(1996-12#1)(1996-9#1)(2005-10#1)(2007-7#1)(2007-8#1)(2008-1#2)(2011-1#1)
patients with diagnosed##2##3##(2006-10#1)(2010-8#1)
patients with diagnosis of##4##4##(2008-12#1)(2008-6#1)(2008-9#1)(2011-2#1)
patients with diarrhoea##2##3##(1992-12#1)(2007-7#1)
patients with diarrhoeic type IBS##2##5##(1997-6#2)
patients with diastolic##3##3##(1992-5#1)(2008-7#1)(2012-12#1)
patients with different clinical##2##4##(2007-8#1)(2012-3#1)
patients with different diseases##2##4##(1996-2#1)(2008-11#1)
patients with different types of##3##5##(2009-6#1)(2010-5#1)(2012-2#1)
patients with different##32##3##(1991-2#1)(1991-5#2)(1992-8#1)(1993-11#1)(1993-2#1)(1993-7#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-2#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#3)(2013-1#2)
patients with differentiated thyroid##2##4##(1993-10#1)(2013-1#1)
patients with differentiated##3##3##(1993-10#1)(1994-11#1)(2013-1#1)
patients with diffuse systemic sclerosis and antitopoisomerase 1 antibodies##2##9##(2009-8#2)
patients with diffuse systemic sclerosis##4##5##(2009-8#4)
patients with diffuse##12##3##(1991-6#1)(1993-8#1)(1994-11#1)(2007-8#1)(2009-2#2)(2009-8#4)(2010-5#1)(2013-8#1)
patients with dilated cardiomyopathy##5##4##(1993-2#2)(1995-6#1)(2011-2#1)(2012-2#1)
patients with dilated##6##3##(1993-2#2)(1995-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
patients with disabling##2##3##(2006-10#1)(2008-5#1)
patients with discitis##3##3##(1993-11#3)
patients with disease##4##3##(2006-11#1)(2010-12#1)(2013-8#2)
patients with diseases that##2##4##(2008-3#1)(2012-12#1)
patients with diseases##3##3##(2008-3#1)(2012-1#1)(2012-12#1)
patients with disorders associated with##2##5##(1991-8#2)
patients with disorders of##4##4##(1991-12#1)(1991-5#1)(1992-6#1)(2007-11#1)
patients with disorders##6##3##(1991-12#1)(1991-5#1)(1991-8#2)(1992-6#1)(2007-11#1)
patients with displaced##2##3##(2006-7#1)(2013-1#1)
patients with disseminated neoplasm and##2##5##(1996-12#2)
patients with disseminated neoplasm##4##4##(1996-12#4)
patients with disseminated##6##3##(1996-12#4)(2007-11#1)(2010-3#1)
patients with distal##4##3##(1991-12#1)(1996-12#1)(2007-11#1)(2009-12#1)
patients with distant disease##2##4##(2008-6#2)
patients with distant metastases##4##4##(1991-10#1)(1993-1#1)(2008-6#2)
patients with distant metastasis##2##4##(1992-4#1)(1993-8#1)
patients with distant##8##3##(1991-10#1)(1992-4#1)(1993-1#1)(1993-8#1)(2008-6#4)
patients with diverse##2##3##(1991-5#1)(1995-3#1)
patients with documented coronary artery##2##5##(1995-6#1)(2008-11#1)
patients with documented##5##3##(1991-3#1)(1995-6#1)(2005-8#1)(2006-8#1)(2008-11#1)
patients with drug abuse##2##4##(2006-7#2)
patients with drug addiction##2##4##(2009-7#2)
patients with drug##4##3##(2006-7#2)(2009-7#2)
patients with duodenal and gastric##2##5##(2006-2#1)(2008-12#1)
patients with duodenal ulcer##6##4##(1992-10#1)(2006-10#2)(2006-8#2)(2008-12#1)
patients with duodenal##10##3##(1992-10#1)(1993-3#1)(1995-3#1)(2006-10#2)(2006-2#1)(2006-8#2)(2008-12#2)
patients with dural arteriovenous fistulae##2##5##(1996-9#2)
patients with dyslipidemia##4##3##(1990-5#1)(2010-12#1)(2011-1#1)(2013-8#1)
patients with dysmotility-like functional dyspepsia##2##5##(2008-3#2)
patients with dyspepsia##4##3##(1993-10#1)(1993-8#2)(2006-10#1)
patients with dysphagia##6##3##(1994-8#1)(2007-10#2)(2010-2#1)(2013-8#2)
patients with dysthymic disorder##4##4##(2005-7#2)(2011-2#2)
patients with dysthymic##5##3##(2005-7#2)(2011-2#3)
patients with each type##2##4##(1991-5#1)(2011-2#1)
patients with each##3##3##(1991-5#1)(2007-11#1)(2011-2#1)
patients with early breast cancer who##2##6##(1991-8#1)(2011-2#1)
patients with early breast cancer##7##5##(1991-8#2)(1994-12#1)(1996-3#2)(2004-2#1)(2011-2#1)
patients with early gastric##3##4##(2005-10#1)(2008-5#1)(2012-2#1)
patients with early stage##3##4##(2008-5#1)(2009-5#1)(2011-1#1)
patients with early##34##3##(1991-12#1)(1991-8#2)(1992-6#1)(1994-12#1)(1996-3#2)(1996-4#2)(1997-5#1)(1997-7#1)(2004-2#1)(2005-10#1)(2006-10#2)(2007-10#1)(2007-6#1)(2007-8#3)(2008-5#2)(2009-5#1)(2009-8#2)(2010-11#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-2#1)
patients with early-stage##7##3##(2007-11#1)(2008-11#1)(2009-8#1)(2013-8#4)
patients with eating disorders##8##4##(1997-3#1)(2005-6#2)(2006-7#1)(2007-12#1)(2007-7#1)(2008-4#1)(2011-2#1)
patients with eating##9##3##(1997-3#1)(2005-6#2)(2006-7#1)(2007-12#1)(2007-7#1)(2008-4#1)(2011-2#1)(2013-1#1)
patients with either##13##3##(1995-10#1)(1996-3#1)(1996-4#1)(2006-1#1)(2006-11#1)(2006-7#1)(2007-11#2)(2008-10#1)(2008-3#2)(2009-10#1)(2013-1#1)
patients with elevated blood lead levels##2##6##(1993-6#2)
patients with elevated##13##3##(1990-2#1)(1990-9#1)(1991-6#1)(1993-6#2)(1995-7#1)(2005-12#1)(2006-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-5#1)(2011-2#1)
patients with end stage renal##2##5##(2007-7#1)(2008-1#1)
patients with end stage##4##4##(2007-7#1)(2008-1#1)(2008-3#1)(2011-1#1)
patients with end-stage kidney disease##2##5##(2012-12#1)(2013-1#1)
patients with end-stage kidney##4##4##(2007-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
patients with end-stage liver disease##2##5##(2008-12#1)(2013-8#1)
patients with end-stage renal disease (ESRD)##7##6##(2007-7#5)(2008-1#1)(2013-1#1)
patients with end-stage renal disease##17##5##(2006-10#1)(2007-12#1)(2007-7#7)(2007-8#2)(2008-1#3)(2012-12#1)(2013-1#2)
patients with end-stage renal failure##3##5##(2007-1#1)(2008-1#1)(2008-4#1)
patients with end-stage renal##21##4##(2006-10#1)(2007-1#1)(2007-12#1)(2007-7#7)(2007-8#2)(2008-1#4)(2008-4#1)(2008-7#1)(2012-12#1)(2013-1#2)
patients with end-stage##35##3##(2006-10#2)(2006-2#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#7)(2007-8#3)(2008-1#4)(2008-12#1)(2008-4#1)(2008-7#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#1)
patients with endometriosis##4##3##(1991-11#1)(1995-2#2)(2012-3#1)
patients with epidermolysis bullosa##3##4##(2007-7#1)(2012-3#2)
patients with epilepsy##7##3##(1995-1#1)(1997-8#1)(2007-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#1)
patients with epileptic##2##3##(2010-11#1)(2010-12#1)
patients with erectile dysfunction##2##4##(1990-6#1)(2006-7#1)
patients with esophageal cancer##4##4##(2007-8#1)(2008-12#1)(2009-3#1)(2010-12#1)
patients with esophageal##7##3##(1993-5#1)(1993-7#1)(2007-8#1)(2008-12#1)(2009-3#1)(2010-1#1)(2010-12#1)
patients with esophagitis##2##3##(2008-5#1)(2013-8#1)
patients with essential hypertension##8##4##(1990-10#1)(1992-12#2)(2008-1#1)(2008-12#1)(2008-5#2)(2012-1#1)
patients with essential thrombocythemia##2##4##(2008-4#1)(2011-2#1)
patients with essential##11##3##(1990-10#1)(1992-12#2)(1995-10#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#2)(2011-2#1)(2012-1#1)
patients with established coronary artery disease##2##6##(2008-1#1)(2009-12#1)
patients with established coronary##3##4##(2008-1#1)(2008-3#1)(2009-12#1)
patients with established##21##3##(1991-9#1)(1993-11#3)(2006-10#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-3#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2010-12#1)(2010-3#1)(2011-2#1)
patients with estrogen receptor##3##4##(1996-11#1)(2007-11#1)(2008-7#1)
patients with evidence of##4##4##(1993-9#1)(2006-6#1)(2008-5#1)(2009-8#1)
patients with evidence##5##3##(1993-9#1)(1996-9#1)(2006-6#1)(2008-5#1)(2009-8#1)
patients with exercise##2##3##(1996-6#1)(2006-6#1)
patients with extensive atherosclerosis in the ascending aorta##3##8##(2007-8#3)
patients with extensive atherosclerosis##4##4##(2007-8#4)
patients with extensive##17##3##(1993-8#1)(1995-6#1)(2004-1#2)(2006-6#3)(2007-11#1)(2007-8#4)(2008-3#1)(2010-12#1)(2010-5#1)(2012-2#1)(2013-7#1)
patients with extensive-stage##2##3##(2005-11#2)
patients with extrahepatic cholestasis##2##4##(1993-9#2)
patients with extrahepatic##3##3##(1993-9#2)(2006-2#1)
patients with extremity sarcomas##3##4##(2008-6#2)(2010-3#1)
patients with extremity##7##3##(2008-6#4)(2010-3#3)
patients with factitious stroke##2##4##(2007-9#2)
patients with failed##6##3##(2007-8#1)(2008-8#1)(2011-2#1)(2012-3#2)(2013-1#1)
patients with familial hypercholesterolemia##3##4##(1990-2#1)(1992-8#1)(1993-9#1)
patients with familial moyamoya disease##2##5##(2007-10#2)
patients with familial or##2##4##(2009-5#1)(2011-1#1)
patients with familial##17##3##(1990-2#1)(1992-12#1)(1992-8#1)(1993-9#1)(1995-3#1)(1996-3#1)(1996-5#1)(2007-10#2)(2007-6#1)(2008-1#1)(2008-12#1)(2009-12#1)(2009-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
patients with fatty##3##3##(1990-4#2)(2013-7#1)
patients with febrile neutropenia##2##4##(2007-11#1)(2012-12#1)
patients with febrile##5##3##(1993-11#1)(2007-11#1)(2011-2#1)(2012-12#2)
patients with femoral##2##3##(2007-11#1)(2007-8#1)
patients with fibromatosis##2##3##(1997-7#1)(2008-6#1)
patients with fibromyalgia##5##3##(1991-5#2)(1996-2#1)(2006-10#2)
patients with first##4##3##(2007-10#2)(2008-3#1)(2009-10#1)
patients with five##2##3##(1990-12#1)(1993-11#1)
patients with focal##6##3##(1997-3#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-11#1)(2011-2#1)
patients with fractures##3##3##(2007-11#1)(2008-9#2)
patients with frequent relapses##2##4##(2007-11#2)
patients with frequent##5##3##(1991-4#1)(2006-9#1)(2007-11#3)
patients with fulminant##4##3##(1990-10#1)(2006-10#1)(2008-11#1)(2013-1#1)
patients with functional tumors##2##4##(2008-3#2)
patients with functional##9##3##(1992-8#1)(1996-7#1)(2005-10#1)(2006-10#1)(2008-10#1)(2008-3#2)(2008-7#1)(2010-10#1)
patients with gait disturbance##2##4##(2007-9#2)
patients with gallstones##2##3##(1991-3#1)(2006-6#1)
patients with gastric cancer##11##4##(1992-6#1)(2006-10#2)(2007-11#1)(2007-3#1)(2008-6#1)(2010-12#3)(2011-2#2)
patients with gastric##17##3##(1990-2#2)(1992-6#1)(2006-10#2)(2006-2#1)(2007-11#1)(2007-3#1)(2008-12#1)(2008-6#1)(2010-12#3)(2011-2#2)(2012-12#1)(2013-1#1)
patients with gastroenteritis were##2##4##(2008-7#2)
patients with gastroenteritis##4##3##(1990-6#1)(2008-7#3)
patients with gastrointestinal bleeding and##2##5##(2007-8#1)(2013-8#1)
patients with gastrointestinal symptoms##3##4##(1991-10#1)(1997-8#1)(2006-8#1)
patients with gastrointestinal##13##3##(1990-6#1)(1990-8#1)(1991-10#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-8#2)(2007-4#1)(2007-8#1)(2008-3#1)(2013-7#1)(2013-8#1)
patients with generalized vitiligo##2##4##(2009-6#2)
patients with generalized##4##3##(1993-10#1)(2006-8#1)(2009-6#2)
patients with genetic##2##3##(1991-3#1)(1996-4#1)
patients with genital infection##2##4##(2005-10#1)(2013-1#1)
patients with genital##4##3##(2005-10#1)(2007-12#1)(2008-10#1)(2013-1#1)
patients with genotype 1##2##4##(2012-12#1)(2013-8#1)
patients with germ-cell tumors##3##4##(1991-9#1)(2006-10#1)(2007-10#1)
patients with gestational##2##3##(2008-10#1)(2012-2#1)
patients with giant##5##3##(1990-4#1)(2005-9#1)(2006-10#1)(2008-7#1)(2009-2#1)
patients with glaucoma##2##3##(1990-7#1)(2011-2#1)
patients with glioblastoma##5##3##(1994-4#1)(1996-4#1)(2008-11#1)(2010-9#1)(2011-2#1)
patients with glioblastomas##2##3##(2006-12#1)(2012-1#1)
patients with gliomas##2##3##(1997-7#1)(2007-5#1)
patients with glycogen##2##3##(1992-5#1)(1994-9#1)
patients with gonadal tumors##2##4##(1991-4#2)
patients with good##6##3##(2007-10#1)(2007-3#1)(2007-8#1)(2007-9#1)(2011-2#1)(2012-2#1)
patients with grade V atheromas##2##5##(1997-8#2)
patients with grade##8##3##(1997-8#3)(2008-7#5)
patients with graves' disease##2##4##(2007-2#1)(2008-5#1)
patients with greater than##2##4##(2006-11#1)(2010-12#1)
patients with greater##3##3##(1991-4#1)(2006-11#1)(2010-12#1)
patients with growth##2##3##(2007-11#1)(2007-7#1)
patients with gynecologic##2##3##(1991-3#1)(2006-8#1)
patients with gynecological##2##3##(1991-5#2)
patients with haematological malignancies##3##4##(2007-11#2)(2008-5#1)
patients with haematological##5##3##(2007-11#2)(2008-5#1)(2009-3#1)(2012-12#1)
patients with haemophilia A or B##3##6##(1991-6#1)(2007-11#2)
patients with haemophilia##6##3##(1991-6#1)(2007-11#5)
patients with hand##2##3##(2008-12#1)(2013-1#1)
patients with head and neck squamous cell carcinoma##2##8##(1994-6#1)(2009-10#1)
patients with head and neck##4##5##(1994-6#1)(2007-10#1)(2009-10#1)(2010-4#1)
patients with head injuries##5##4##(1990-3#1)(1996-8#1)(2007-7#1)(2008-7#2)
patients with head injury and##2##5##(1996-9#1)(2008-7#1)
patients with head injury##5##4##(1996-9#1)(2006-10#1)(2006-2#1)(2008-7#2)
patients with head##16##3##(1990-3#1)(1993-2#1)(1994-6#1)(1996-8#1)(1996-9#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-7#1)(2008-7#5)(2009-10#1)(2010-4#1)
patients with heart disease##3##4##(2006-10#1)(2008-5#1)(2011-2#1)
patients with heart failure (HF)##2##5##(2009-10#1)(2011-2#1)
patients with heart failure##19##4##(1993-2#1)(1996-8#1)(2005-10#1)(2006-10#1)(2006-9#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#3)(2009-9#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
patients with heart##29##3##(1990-12#1)(1990-2#1)(1993-2#1)(1996-8#1)(2005-10#1)(2006-10#2)(2006-8#1)(2006-9#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#3)(2009-9#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
patients with hematologic diseases##3##4##(2012-12#3)
patients with hematologic malignancies##13##4##(2007-12#1)(2008-7#10)(2012-12#2)
patients with hematologic##17##3##(2007-12#2)(2008-7#10)(2012-12#5)
patients with hematological##4##3##(1992-1#1)(2007-2#1)(2011-2#1)(2012-2#1)
patients with hemorrhagic fever with renal syndrome without affection of##2##10##(2013-1#2)
patients with hemorrhagic fever with renal syndrome##3##7##(2013-1#3)
patients with hemorrhagic##4##3##(2007-10#1)(2013-1#3)
patients with heparin-induced thrombocytopenia (HIT)##2##5##(2007-11#2)
patients with heparin-induced thrombocytopenia##6##4##(1997-2#1)(2006-10#2)(2007-11#2)(2009-8#1)
patients with hepatic dysfunction##2##4##(2005-7#1)(2005-8#1)
patients with hepatic##10##3##(1991-5#1)(1992-1#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-6#1)(2008-1#1)(2008-5#1)(2009-3#1)(2009-8#1)
patients with hepatitis B or##2##5##(2007-11#2)
patients with hepatitis C virus infection##3##6##(2006-10#1)(2006-9#1)(2011-2#1)
patients with hepatitis C virus##5##5##(2005-6#1)(2006-10#1)(2006-9#1)(2009-2#1)(2011-2#1)
patients with hepatitis C##7##4##(2005-6#1)(2006-10#2)(2006-9#1)(2008-1#1)(2009-2#1)(2011-2#1)
patients with hepatitis##14##3##(2005-6#1)(2006-10#3)(2006-2#1)(2006-9#1)(2007-11#2)(2007-12#1)(2008-1#1)(2009-2#1)(2009-3#1)(2009-6#1)(2011-2#1)
patients with hepatocellular carcinoma plus liver cirrhosis##2##7##(1995-4#2)
patients with hepatocellular carcinoma##11##4##(1992-3#1)(1995-4#2)(2006-10#2)(2006-6#1)(2008-12#1)(2010-12#1)(2012-12#1)(2013-7#1)(2013-8#1)
patients with hepatocellular##13##3##(1992-3#1)(1995-3#1)(1995-4#2)(2006-10#2)(2006-6#1)(2008-12#1)(2008-3#1)(2010-12#1)(2012-12#1)(2013-7#1)(2013-8#1)
patients with hepatorenal syndrome##2##4##(2006-8#1)(2008-5#1)
patients with hepatosplenic schistosomiasis##4##4##(2011-1#2)(2013-8#2)
patients with hereditary##4##3##(2006-10#1)(2006-9#1)(2008-3#1)(2010-3#1)
patients with herpes##2##3##(1995-5#1)(2007-7#1)
patients with heterozygous FH##2##4##(1993-9#2)
patients with heterozygous familial hypercholesterolemia##3##5##(1990-12#1)(1993-9#2)
patients with heterozygous familial##4##4##(1990-12#1)(1993-9#2)(2012-2#1)
patients with heterozygous##6##3##(1990-12#1)(1993-9#4)(2012-2#1)
patients with high grade dysplasia##2##5##(1994-2#1)(2006-2#1)
patients with high grade##4##4##(1994-2#1)(2006-2#1)(2008-6#1)(2010-3#1)
patients with high level of##2##5##(1992-3#1)(2005-8#1)
patients with high risk##5##4##(1997-3#1)(2007-6#1)(2008-7#1)(2013-1#2)
patients with high serum##3##4##(1991-3#2)(1991-7#1)
patients with high##38##3##(1990-12#1)(1990-2#1)(1991-3#2)(1991-7#1)(1992-3#1)(1994-2#1)(1997-3#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
patients with high-grade non-metastatic soft tissue sarcoma##2##7##(2008-6#2)
patients with high-grade osteosarcoma##2##4##(1992-6#1)(2008-6#1)
patients with high-grade##9##3##(1992-6#1)(2008-2#1)(2008-6#5)(2010-3#1)(2013-8#1)
patients with high-risk##11##3##(2007-8#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-2#5)(2013-1#2)
patients with higher##6##3##(1995-2#1)(2008-4#1)(2008-7#1)(2012-1#1)(2012-12#1)(2012-2#1)
patients with highly##2##3##(2007-8#1)(2008-10#1)
patients with hip fractures##2##4##(1990-2#1)(2011-2#1)
patients with hip##4##3##(1990-2#1)(1993-11#1)(2008-10#1)(2011-2#1)
patients with histologically confirmed##2##4##(1994-12#1)(2011-2#1)
patients with histologically proven##9##4##(1990-2#1)(1990-8#1)(1991-2#1)(1991-4#1)(2004-1#1)(2007-10#1)(2007-6#1)(2008-4#1)(2008-7#1)
patients with histologically##13##3##(1990-2#1)(1990-8#1)(1991-2#1)(1991-4#1)(1994-12#1)(1994-2#1)(2004-1#1)(2007-10#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)
patients with history of##3##4##(2006-8#1)(2011-2#2)
patients with homozygous##3##3##(1992-8#1)(1994-12#1)(2013-8#1)
patients with human immunodeficiency virus (HIV)##2##6##(2010-12#1)(2013-1#1)
patients with human immunodeficiency virus infection##5##6##(1993-2#1)(1993-6#1)(1996-2#1)(2009-12#1)(2010-12#1)
patients with human immunodeficiency virus##11##5##(1993-2#1)(1993-6#1)(1996-11#1)(1996-2#1)(2006-10#1)(2008-2#1)(2009-12#1)(2010-11#1)(2010-12#2)(2013-1#1)
patients with human immunodeficiency##12##4##(1993-2#1)(1993-6#1)(1996-11#1)(1996-2#1)(2006-10#1)(2007-2#1)(2008-2#1)(2009-12#1)(2010-11#1)(2010-12#2)(2013-1#1)
patients with human##13##3##(1993-2#1)(1993-6#1)(1996-11#1)(1996-2#1)(2006-10#1)(2007-2#1)(2008-2#1)(2009-12#1)(2010-11#1)(2010-12#2)(2012-3#1)(2013-1#1)
patients with hydrocephalus and##2##4##(2006-5#2)
patients with hydrocephalus##3##3##(2006-5#3)
patients with hyperacute cerebral infarction##4##5##(2010-12#4)
patients with hypercalcemia-associated cancer##2##4##(1996-1#2)
patients with hypercholesterolemia##2##3##(1990-11#1)(1991-6#1)
patients with hyperlipidaemia and##2##4##(2008-11#1)(2008-3#1)
patients with hyperlipidaemia##6##3##(1996-9#1)(1997-2#1)(2008-11#1)(2008-3#3)
patients with hyperparathyroidism##2##3##(1991-3#2)
patients with hyperprolactinemia##3##3##(2006-9#1)(2008-5#1)(2008-7#1)
patients with hypertension##12##3##(1997-2#1)(2005-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#3)
patients with hypertension]##2##3##(1991-11#1)(2013-8#1)
patients with hyperthyroidism##3##3##(1993-11#1)(2006-11#1)(2007-9#1)
patients with hypertrophic cardiomyopathy##3##4##(2008-7#2)(2009-5#1)
patients with hypertrophic obstructive cardiomyopathy##5##5##(1992-5#2)(2007-8#2)(2010-12#1)
patients with hypertrophic##9##3##(1990-7#1)(1992-5#2)(2007-8#2)(2008-7#2)(2009-5#1)(2010-12#1)
patients with hypocortisolism##2##3##(2006-9#2)
patients with hypothyroidism##3##3##(2006-11#1)(2006-2#1)(2009-12#1)
patients with idiopathic PD##2##4##(2008-7#1)(2013-1#1)
patients with idiopathic Parkinson's disease##2##5##(2006-8#1)(2008-7#1)
patients with idiopathic central DI##2##5##(1997-8#2)
patients with idiopathic chronic##2##4##(2006-10#1)(2013-1#1)
patients with idiopathic dilated cardiomyopathy and##2##6##(2007-11#1)(2010-8#1)
patients with idiopathic dilated cardiomyopathy##3##5##(2007-11#1)(2010-8#1)(2011-2#1)
patients with idiopathic mitral valve prolapse syndrome##4##7##(1995-6#4)
patients with idiopathic myelofibrosis##2##4##(2008-4#2)
patients with idiopathic pulmonary##3##4##(2009-10#1)(2010-6#1)(2013-1#1)
patients with idiopathic scoliosis##3##4##(2006-10#1)(2007-7#2)
patients with idiopathic ulcerative colitis##2##5##(1995-10#2)
patients with idiopathic##41##3##(1990-8#1)(1991-5#2)(1995-10#2)(1995-2#1)(1995-6#4)(1997-8#2)(2005-12#1)(2005-8#2)(2006-10#2)(2006-8#3)(2007-11#1)(2007-7#4)(2007-8#1)(2008-4#2)(2008-7#3)(2009-10#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#1)
patients with immune##2##3##(2009-12#1)(2013-8#1)
patients with immunodeficiency##4##3##(1997-3#1)(2007-2#2)(2011-2#1)
patients with impaired renal function##4##5##(1994-4#1)(2006-10#1)(2008-3#1)(2011-2#1)
patients with impaired##14##3##(1990-1#1)(1991-9#1)(1994-4#1)(2006-10#2)(2007-8#2)(2007-9#1)(2008-3#2)(2010-4#1)(2011-2#1)(2012-1#2)
patients with inactive disease##3##4##(2007-3#2)(2008-7#1)
patients with inactive##5##3##(2007-3#2)(2008-7#2)(2010-6#1)
patients with inadequate##2##3##(2008-7#1)(2012-3#1)
patients with incomplete##5##3##(2008-1#1)(2008-5#1)(2008-9#1)(2012-2#1)(2013-1#1)
patients with increased##11##3##(1992-11#1)(1992-4#1)(1993-2#1)(2005-10#1)(2008-12#2)(2008-4#2)(2011-2#1)(2013-1#2)
patients with infantile##6##3##(1991-2#1)(1991-3#1)(1993-4#2)(2009-4#2)
patients with infectious##2##3##(1990-9#1)(1997-8#1)
patients with infective##2##3##(2011-2#1)(2012-12#1)
patients with inflammatory bowel disease##17##5##(1992-6#1)(2006-10#2)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-12#3)(2010-6#1)(2012-12#1)(2013-1#3)(2013-8#2)
patients with inflammatory bowel disease]##3##5##(2012-11#3)
patients with inflammatory bowel diseases##3##5##(2006-10#1)(2012-2#2)
patients with inflammatory bowel##23##4##(1992-6#1)(2006-10#3)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-12#3)(2010-6#1)(2012-11#3)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#2)
patients with inflammatory diseases##2##4##(1992-12#1)(1995-7#1)
patients with inflammatory##33##3##(1992-12#1)(1992-6#1)(1993-10#1)(1995-7#1)(2006-10#5)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-6#1)(2009-9#1)(2010-12#3)(2010-6#1)(2010-9#1)(2012-11#3)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#2)
patients with inherited##4##3##(1994-8#1)(1997-7#1)(2007-2#1)(2008-10#1)
patients with inhibitors##3##3##(2005-10#3)
patients with initial##5##3##(1990-6#1)(2007-11#1)(2008-1#1)(2008-11#1)(2013-1#1)
patients with initially##2##3##(1996-1#1)(2008-3#1)
patients with injuries to the##4##5##(1992-2#1)(1992-6#1)(2007-11#2)
patients with inoperable##8##3##(1990-8#1)(1991-2#1)(1993-6#2)(1996-2#1)(2006-2#1)(2008-5#1)(2008-6#1)
patients with insomnia##3##3##(2004-3#2)(2008-10#1)
patients with insufficient##3##3##(1997-3#1)(2006-10#2)
patients with insulin-dependent diabetes mellitus (IDDM)##2##6##(1990-4#1)(2006-6#1)
patients with insulin-dependent diabetes##3##4##(1990-4#1)(1992-10#1)(2006-6#1)
patients with insulin-dependent##4##3##(1990-4#1)(1992-10#1)(2006-6#1)(2007-11#1)
patients with intermediate##3##3##(2006-10#1)(2010-11#1)(2013-1#1)
patients with internal##3##3##(1992-2#1)(2008-8#1)(2010-12#1)
patients with interstitial##2##3##(1991-2#1)(2007-9#1)
patients with intertrochanteric##2##3##(2008-12#1)(2013-1#1)
patients with intestinal##3##3##(1990-4#1)(1995-10#1)(2007-11#1)
patients with intracerebral hemorrhage##3##4##(2007-10#3)
patients with intracerebral##6##3##(2007-10#3)(2007-11#1)(2008-7#2)
patients with intracranial##9##3##(1990-9#1)(1991-2#1)(1995-11#1)(1996-6#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-6#1)(2008-7#1)
patients with intractable##4##3##(1993-1#1)(2006-7#1)(2006-9#1)(2009-9#1)
patients with intravenous##2##3##(2006-10#1)(2009-7#1)
patients with invasive bladder cancer##2##5##(2006-10#2)
patients with invasive cancer##2##4##(1992-8#1)(2008-5#1)
patients with invasive##12##3##(1992-8#1)(2004-2#1)(2005-10#1)(2006-10#2)(2006-6#1)(2007-11#1)(2008-10#1)(2008-5#3)(2012-2#1)
patients with involvement of##2##4##(2006-7#1)(2006-8#1)
patients with ipsilateral##2##3##(2008-10#1)(2013-1#1)
patients with irreversible##3##3##(2007-7#2)(2010-1#1)
patients with irritable bowel syndrome##3##5##(1990-8#1)(2005-12#1)(2007-12#1)
patients with irritable##4##3##(1990-8#2)(2005-12#1)(2007-12#1)
patients with ischaemic heart##4##4##(2007-8#2)(2008-7#1)(2012-2#1)
patients with ischaemic##7##3##(2007-8#3)(2008-7#1)(2008-8#2)(2012-2#1)
patients with ischemic heart disease and##2##6##(1996-9#1)(2008-5#1)
patients with ischemic heart disease##9##5##(1996-9#4)(1997-6#1)(2006-6#1)(2007-8#1)(2008-5#1)(2012-3#1)
patients with ischemic stroke in##2##5##(2007-10#1)(2013-7#1)
patients with ischemic stroke who were##3##6##(2007-10#3)
patients with ischemic stroke##12##4##(2007-10#8)(2007-9#2)(2008-8#1)(2013-7#1)
patients with ischemic##26##3##(1996-9#4)(1997-6#1)(2005-10#1)(2006-6#1)(2006-7#1)(2007-10#8)(2007-8#1)(2007-9#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-7#1)
patients with isolated##16##3##(2006-10#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#3)(2013-1#1)
patients with juvenile##3##3##(2007-11#2)(2010-12#1)
patients with kidney cancer##2##4##(2006-9#1)(2008-6#1)
patients with kidney disease##3##4##(2007-12#1)(2007-8#1)(2010-12#1)
patients with kidney failure##2##4##(2010-4#2)
patients with kidney##9##3##(1991-3#1)(2006-9#1)(2007-12#1)(2007-8#1)(2008-6#1)(2010-12#1)(2010-4#2)(2013-1#1)
patients with knee##6##3##(2007-8#2)(2010-4#1)(2012-2#1)(2013-1#2)
patients with known##11##3##(1991-8#1)(1996-12#1)(1997-8#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-5#1)(2010-7#1)(2012-2#1)
patients with lacunar##2##3##(2007-10#2)
patients with large pulmonary bullae##2##5##(2007-8#2)
patients with large tumors and##3##5##(2007-8#1)(2013-1#2)
patients with large##18##3##(1993-3#1)(2005-10#1)(2006-12#1)(2006-7#1)(2007-8#3)(2007-9#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
patients with laryngeal##2##3##(2009-10#1)(2012-2#1)
patients with late##3##3##(2007-11#2)(2012-3#1)
patients with latent##2##3##(1990-2#1)(2008-4#1)
patients with lateral##3##3##(2008-12#1)(2012-12#1)(2013-7#1)
patients with left anterior fascicle block##2##6##(2008-7#2)
patients with left hemisphere##2##4##(1993-12#1)(2008-6#1)
patients with left lung cancer##2##5##(2007-8#2)
patients with left main coronary artery##2##6##(2008-7#1)(2009-12#1)
patients with left unilateral neglect##2##5##(1995-12#1)(2009-10#1)
patients with left ventricular dysfunction##4##5##(1993-2#1)(2007-8#2)(2008-8#1)
patients with left ventricular##8##4##(1993-2#1)(1995-6#1)(2005-10#1)(2007-8#2)(2008-7#1)(2008-8#1)(2013-1#1)
patients with left##24##3##(1993-12#1)(1993-2#1)(1995-12#1)(1995-6#1)(1996-1#1)(1997-1#1)(2005-10#1)(2007-10#1)(2007-8#4)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#3)(2009-12#1)(2012-3#1)(2013-1#1)
patients with lesions in the##2##5##(1993-8#1)(2008-11#1)
patients with lesions in##4##4##(1990-3#1)(1993-8#1)(2007-2#1)(2008-11#1)
patients with lesions of##2##4##(2007-2#1)(2008-4#1)
patients with lesions##13##3##(1990-3#1)(1993-8#1)(2005-10#1)(2006-10#3)(2007-11#1)(2007-2#4)(2008-11#1)(2008-4#1)
patients with less than##2##4##(1997-4#1)(2009-5#1)
patients with less##4##3##(1997-4#1)(2006-10#1)(2009-5#1)(2012-2#1)
patients with leukemia and lymphoma##2##5##(1992-3#2)
patients with leukemia##4##3##(1992-3#2)(2008-1#1)(2010-11#1)
patients with life threatening##2##4##(2007-9#1)(2008-5#1)
patients with life-threatening##4##3##(2006-10#1)(2007-8#2)(2012-3#1)
patients with limited English proficiency##3##5##(2010-8#2)(2011-1#1)
patients with limited##13##3##(1992-10#1)(1993-5#1)(1995-8#1)(1996-1#1)(2007-7#1)(2008-4#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-1#1)
patients with little##2##3##(2007-12#1)(2010-12#1)
patients with liver cirrhosis and##2##5##(1991-2#1)(1992-2#1)
patients with liver cirrhosis were##3##5##(1995-4#2)(2007-8#1)
patients with liver cirrhosis##26##4##(1990-11#2)(1991-10#1)(1991-2#1)(1992-12#1)(1992-2#1)(1995-4#3)(1995-7#1)(1996-4#2)(2005-9#2)(2006-6#1)(2006-8#1)(2007-8#2)(2008-1#1)(2008-10#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#2)(2013-8#1)
patients with liver disease##5##4##(1990-8#1)(2006-10#1)(2009-4#1)(2013-1#2)
patients with liver diseases##3##4##(1996-4#1)(2008-10#1)(2008-4#1)
patients with liver fibrosis##2##4##(1996-4#1)(2006-2#1)
patients with liver metastases from##3##5##(2006-6#2)(2007-11#1)
patients with liver metastases##5##4##(1991-4#1)(1995-4#1)(2006-6#2)(2007-11#1)
patients with liver metastasis##3##4##(2006-6#2)(2008-8#1)
patients with liver##51##3##(1990-11#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-4#1)(1992-12#1)(1992-2#1)(1995-4#4)(1995-7#1)(1996-4#4)(2005-9#2)(2006-10#1)(2006-2#1)(2006-6#5)(2006-8#2)(2007-11#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-4#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#5)(2013-8#1)
patients with localized DNM##2##4##(2007-8#2)
patients with localized disease##4##4##(2008-6#1)(2010-3#3)
patients with localized scleroderma##2##4##(2011-2#2)
patients with localized##14##3##(1995-12#1)(2007-8#2)(2008-3#1)(2008-6#1)(2008-7#1)(2010-11#1)(2010-3#4)(2011-2#2)(2012-12#1)
patients with locally advanced and/or metastatic##2##6##(2008-6#2)
patients with locally advanced breast cancer##2##6##(1990-5#1)(1991-4#1)
patients with locally advanced or metastatic##3##6##(1991-10#1)(2008-6#1)(2009-9#1)
patients with locally advanced prostate cancer##2##6##(1997-7#1)(2008-7#1)
patients with locally advanced##18##4##(1990-5#1)(1991-10#3)(1991-4#1)(1994-7#1)(1997-7#1)(2007-3#1)(2008-10#2)(2008-6#3)(2008-7#2)(2009-5#1)(2009-9#1)(2012-2#1)
patients with locally##21##3##(1990-5#1)(1990-8#1)(1991-10#3)(1991-4#1)(1994-7#1)(1997-7#1)(2007-3#1)(2008-10#2)(2008-6#4)(2008-7#2)(2009-5#1)(2009-9#1)(2012-2#1)(2013-1#1)
patients with long bone metastases##2##5##(2007-11#2)
patients with long standing##2##4##(2007-7#1)(2012-2#1)
patients with long##10##3##(1990-4#1)(1990-8#1)(1992-1#1)(1994-7#1)(2007-11#3)(2007-7#1)(2010-9#1)(2012-2#1)
patients with long-standing##7##3##(1997-6#1)(2006-9#2)(2008-7#1)(2008-8#2)(2013-1#1)
patients with longstanding##3##3##(2006-10#2)(2012-3#1)
patients with low TE risk##2##5##(2013-8#2)
patients with low back pain and##3##6##(2007-11#1)(2007-7#1)(2008-12#1)
patients with low back pain with##3##6##(2006-7#2)(2006-8#1)
patients with low back pain##18##5##(1993-11#1)(2005-10#1)(2006-12#2)(2006-7#3)(2006-8#2)(2007-11#2)(2007-7#1)(2008-12#4)(2010-12#1)(2013-1#1)
patients with low back##20##4##(1993-11#1)(2005-10#1)(2006-12#2)(2006-7#4)(2006-8#2)(2007-11#2)(2007-7#2)(2008-12#4)(2010-12#1)(2013-1#1)
patients with low generation of reactive oxygen species and##2##9##(2008-4#2)
patients with low grade##2##4##(2006-2#1)(2007-10#1)
patients with low##50##3##(1990-2#1)(1992-3#1)(1993-11#1)(1993-12#1)(1995-5#1)(2005-10#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-6#1)(2006-7#4)(2006-8#2)(2007-10#1)(2007-11#3)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-3#2)(2008-4#2)(2008-7#1)(2009-2#1)(2010-12#1)(2010-8#3)(2011-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
patients with low-grade non-Hodgkin's lymphomas##2##5##(1990-12#1)(1993-6#1)
patients with low-grade##8##3##(1990-12#1)(1993-6#1)(1997-1#2)(2006-12#2)(2007-10#1)(2007-8#1)
patients with lower limb##3##4##(1990-3#1)(2005-10#2)
patients with lower##7##3##(1990-3#1)(2005-10#2)(2006-9#1)(2007-11#1)(2009-2#1)(2011-2#1)
patients with lumbar##8##3##(1992-5#1)(2006-12#1)(2006-7#1)(2006-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
patients with lung cancer and##2##5##(2007-2#1)(2008-7#1)
patients with lung cancer was##2##5##(1990-10#1)(2012-1#1)
patients with lung cancer##14##4##(1990-10#3)(1990-4#1)(1991-2#1)(1991-8#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-6#1)(2008-7#1)(2009-11#1)(2012-1#1)(2013-7#1)
patients with lung##18##3##(1990-10#3)(1990-4#1)(1991-2#1)(1991-8#1)(1996-9#1)(1997-4#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-6#1)(2008-7#1)(2009-11#1)(2009-4#1)(2012-1#1)(2012-2#1)(2013-7#1)
patients with lupus nephritis##2##4##(2006-10#1)(2008-1#1)
patients with lupus##5##3##(2006-10#2)(2008-1#1)(2013-1#2)
patients with lymph node##3##4##(1991-6#1)(2010-8#1)(2013-1#1)
patients with lymphoma and##2##4##(2006-12#1)(2009-2#1)
patients with lymphoma##8##3##(1997-8#1)(2005-10#1)(2006-12#1)(2007-11#1)(2008-4#1)(2008-5#2)(2009-2#1)
patients with lymphoproliferative##2##3##(2007-11#1)(2013-1#1)
patients with major burns##2##4##(2006-10#2)
patients with major depression##9##4##(1995-11#1)(1996-2#2)(2004-3#1)(2008-6#1)(2009-8#2)(2010-7#1)(2011-1#1)
patients with major depressive disorder##2##5##(1996-7#1)(2013-7#1)
patients with major depressive##3##4##(1996-7#1)(2005-9#1)(2013-7#1)
patients with major##16##3##(1995-11#1)(1996-2#2)(1996-7#1)(2004-3#1)(2005-9#1)(2006-10#2)(2007-9#1)(2008-6#1)(2009-8#2)(2010-7#1)(2011-1#1)(2011-2#1)(2013-7#1)
patients with malignancies and##2##4##(2007-4#1)(2011-2#1)
patients with malignancies##5##3##(2007-3#1)(2007-4#1)(2008-5#1)(2011-2#1)(2012-3#1)
patients with malignancy##2##3##(1991-8#1)(2005-3#1)
patients with malignant bone disease##2##5##(2008-1#1)(2008-7#1)
patients with malignant brain tumors##3##5##(2006-7#1)(2008-7#1)(2013-8#1)
patients with malignant brain##4##4##(2006-12#1)(2006-7#1)(2008-7#1)(2013-8#1)
patients with malignant disease##3##4##(1990-6#1)(2004-10#2)
patients with malignant melanoma##7##4##(1990-6#1)(1991-5#1)(1993-8#1)(1996-11#1)(2006-12#1)(2007-5#1)(2011-2#1)
patients with malignant pleural mesothelioma##2##5##(1990-12#1)(1992-12#1)
patients with malignant tumors##5##4##(1993-8#1)(1994-12#1)(2007-11#1)(2008-3#1)(2013-8#1)
patients with malignant tumours##2##4##(1997-2#1)(2008-7#1)
patients with malignant##38##3##(1990-12#1)(1990-2#1)(1990-6#2)(1991-5#1)(1992-12#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-3#1)(1995-7#1)(1995-9#1)(1996-11#1)(1997-2#1)(2004-10#2)(2005-12#1)(2006-10#1)(2006-12#2)(2006-7#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#2)(2010-5#1)(2011-2#1)(2012-3#2)(2013-8#2)
patients with mammary##2##3##(1996-3#1)(2007-8#1)
patients with many##2##3##(1996-4#1)(2009-10#1)
patients with massive##3##3##(2007-9#2)(2011-2#1)
patients with mastectomy##2##3##(1992-12#1)(2013-1#1)
patients with mean##2##3##(1995-6#1)(2012-2#1)
patients with measurable##2##3##(1990-12#1)(2008-6#1)
patients with mechanical jaundice##2##4##(2011-1#2)
patients with mechanical##7##3##(1995-11#1)(2007-7#1)(2008-12#2)(2011-1#2)(2012-3#1)
patients with medial temporal lobe epilepsy##2##6##(1995-7#2)
patients with medical##3##3##(1992-3#1)(2008-1#2)
patients with medically##3##3##(1990-3#1)(1997-3#1)(2006-8#1)
patients with melanoma##5##3##(1991-5#2)(1991-9#1)(2005-11#1)(2011-12#1)
patients with membranous nephropathy##2##4##(1995-1#1)(2007-11#1)
patients with meningitis##2##3##(1993-1#1)(1993-2#1)
patients with meningococcal##2##3##(1993-9#2)
patients with mental illness##2##4##(2011-2#2)
patients with mental retardation##2##4##(1995-1#1)(1995-11#1)
patients with mental##6##3##(1995-1#1)(1995-11#1)(2005-10#1)(2011-2#2)(2012-2#1)
patients with mesothelioma##2##3##(1992-11#2)
patients with metabolic syndrome##9##4##(2008-11#1)(2008-3#4)(2008-5#1)(2008-7#1)(2012-2#1)(2013-8#1)
patients with metabolic##17##3##(1993-8#2)(1996-7#1)(2004-11#1)(2007-5#1)(2007-9#1)(2008-11#1)(2008-3#4)(2008-5#1)(2008-7#1)(2009-4#1)(2011-1#1)(2012-2#1)(2013-8#1)
patients with metachromatic leukodystrophy##3##4##(1991-9#1)(1997-3#2)
patients with metastases in##4##4##(1991-10#1)(2007-11#3)
patients with metastases##9##3##(1990-10#1)(1991-10#1)(1997-7#1)(2007-11#5)(2008-7#1)
patients with metastasis##2##3##(1992-5#1)(2008-6#1)
patients with metastatic RCC and poor##2##6##(2010-12#2)
patients with metastatic RCC and##3##5##(2009-11#1)(2010-12#2)
patients with metastatic RCC##5##4##(2009-11#1)(2010-12#4)
patients with metastatic breast cancer who##2##6##(1992-10#2)
patients with metastatic breast cancer##10##5##(1990-1#3)(1992-10#2)(2007-11#1)(2008-3#1)(2008-7#2)(2010-8#1)
patients with metastatic colorectal cancer (CRC)##2##6##(2007-6#1)(2009-2#1)
patients with metastatic colorectal cancer##3##5##(1991-4#1)(2007-6#1)(2009-2#1)
patients with metastatic colorectal##5##4##(1990-2#1)(1991-4#1)(2007-6#2)(2009-2#1)
patients with metastatic disease##14##4##(1990-11#1)(2006-9#1)(2007-11#2)(2007-7#1)(2008-6#4)(2010-3#3)(2011-1#1)(2013-1#1)
patients with metastatic melanoma##7##4##(1990-6#1)(1997-2#1)(2007-11#3)(2008-3#1)(2012-2#1)
patients with metastatic or##2##4##(2008-6#1)(2009-8#1)
patients with metastatic prostate cancer##4##5##(1992-4#1)(1995-11#1)(2007-5#2)
patients with metastatic renal cell carcinoma##4##6##(2008-6#3)(2010-12#1)
patients with metastatic renal##5##4##(2007-11#1)(2008-6#3)(2010-12#1)
patients with metastatic##64##3##(1990-1#3)(1990-10#2)(1990-11#1)(1990-2#1)(1990-6#1)(1991-4#1)(1991-5#1)(1992-10#2)(1992-4#1)(1993-10#1)(1994-10#1)(1994-8#1)(1995-11#1)(1997-2#1)(1997-7#1)(2006-9#1)(2007-11#10)(2007-5#2)(2007-6#2)(2007-7#1)(2008-11#1)(2008-3#2)(2008-6#8)(2008-7#2)(2009-11#1)(2009-2#1)(2009-8#1)(2010-12#5)(2010-3#3)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
patients with micro invasive tumor in re-excision decisions##2##8##(2013-1#2)
patients with microalbuminuria##3##3##(1993-11#1)(2005-10#1)(2010-4#1)
patients with microscopic##2##3##(1990-11#1)(2007-8#1)
patients with migraine##6##3##(2007-10#1)(2007-2#1)(2008-9#1)(2012-2#2)(2012-3#1)
patients with mild CHI##2##4##(2013-8#2)
patients with mild OCA##2##4##(1997-4#2)
patients with mild anemia showed##2##5##(2008-7#2)
patients with mild anemia##3##4##(2008-7#3)
patients with mild or moderate multi-infarct dementia##2##7##(2006-4#2)
patients with mild or##3##4##(1995-5#1)(2006-4#2)
patients with mild to moderate##10##5##(1992-4#1)(1993-2#1)(1994-11#1)(2005-10#1)(2005-6#1)(2007-7#1)(2008-3#1)(2008-5#1)(2010-5#1)(2013-8#1)
patients with mild to##12##4##(1992-4#1)(1993-2#1)(1994-11#1)(2005-10#1)(2005-6#1)(2006-6#1)(2007-7#1)(2008-3#1)(2008-5#1)(2010-2#1)(2010-5#1)(2013-8#1)
patients with mild##34##3##(1990-4#1)(1991-9#1)(1992-2#1)(1992-4#1)(1993-11#1)(1993-2#1)(1994-11#1)(1995-5#1)(1997-4#2)(2005-10#1)(2005-6#1)(2006-4#2)(2006-6#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-5#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-7#1)(2013-8#5)
patients with mild-to-moderate hypertension##5##4##(1992-8#3)(1993-12#1)(1993-9#1)
patients with mild-to-moderate##9##3##(1991-6#1)(1992-8#4)(1993-12#2)(1993-9#1)(2007-11#1)
patients with minimal##3##3##(1997-2#1)(2007-11#2)
patients with minor head##2##4##(1992-6#1)(2007-7#1)
patients with minor##6##3##(1992-6#1)(1996-8#1)(2005-7#1)(2007-3#1)(2007-7#1)(2007-9#1)
patients with mitochondrial##4##3##(1991-4#2)(1996-12#1)(2006-11#1)
patients with mitral valve disease##2##5##(2007-9#1)(2011-2#1)
patients with mitral valve##3##4##(1995-6#1)(2007-9#1)(2011-2#1)
patients with mitral##4##3##(1995-6#1)(2006-12#1)(2007-9#1)(2011-2#1)
patients with mixed##3##3##(2005-9#1)(2006-2#1)(2008-1#1)
patients with moderate and##5##4##(2007-10#1)(2008-7#2)(2011-2#1)(2013-8#1)
patients with moderate hypercholesterolemia##2##4##(1991-7#2)
patients with moderate plaque-type psoriasis##2##5##(2007-8#2)
patients with moderate to severe##13##5##(1990-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#3)(2009-5#1)(2011-1#1)(2012-2#2)
patients with moderate##29##3##(1990-3#1)(1991-7#2)(1993-11#1)(2006-10#1)(2006-5#1)(2007-10#2)(2007-11#3)(2007-8#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#2)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
patients with moderate-to-severe chronic##2##4##(2005-8#1)(2013-1#1)
patients with moderately##3##3##(1995-4#1)(2007-9#1)(2008-3#1)
patients with mood disorders##4##4##(1996-2#2)(2004-11#1)(2010-2#1)
patients with more and &lt##2##5##(2011-1#2)
patients with more extensive##2##4##(2007-10#1)(2007-8#1)
patients with more than one metastatic site##2##7##(2008-8#2)
patients with more than##4##4##(1991-2#1)(2008-11#1)(2008-8#2)
patients with more##12##3##(1991-2#1)(2004-1#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-8#2)(2011-1#2)(2011-2#1)(2013-1#1)
patients with moyamoya disease has##2##5##(2007-8#1)(2008-7#1)
patients with moyamoya disease##8##4##(2006-11#6)(2007-8#1)(2008-7#1)
patients with multifocal##3##3##(2004-1#1)(2008-7#1)(2010-5#1)
patients with multimorbidity##2##3##(2011-2#1)(2012-3#1)
patients with multiple bone metastases##3##5##(2007-11#3)
patients with multiple brain metastases##7##5##(2006-7#6)(2008-6#1)
patients with multiple medical##2##4##(1994-3#1)(2006-10#1)
patients with multiple metastases##2##4##(2006-7#1)(2007-11#1)
patients with multiple myeloma##10##4##(1990-10#1)(1992-10#1)(1996-9#1)(2005-1#1)(2008-1#1)(2008-7#3)(2011-1#1)(2011-2#1)
patients with multiple osteoblastic-osteolytic##2##4##(2007-11#2)
patients with multiple sclerosis (MS)##3##5##(2007-11#1)(2012-3#2)
patients with multiple sclerosis and##3##5##(1994-10#1)(2007-11#1)(2010-12#1)
patients with multiple sclerosis##21##4##(1991-12#1)(1991-8#2)(1994-10#1)(1995-4#3)(2007-11#3)(2007-2#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#4)
patients with multiple##74##3##(1990-10#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-8#2)(1992-10#1)(1992-6#2)(1994-10#1)(1994-3#1)(1995-4#3)(1995-8#1)(1996-8#1)(1996-9#1)(1997-1#1)(2005-1#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-7#8)(2007-10#1)(2007-11#11)(2007-2#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-3#1)(2009-6#2)(2010-12#1)(2010-2#1)(2011-1#4)(2011-2#6)(2012-1#1)(2012-12#2)(2012-3#4)
patients with muscle##3##3##(2006-8#1)(2008-10#1)(2008-7#1)
patients with muscular##4##3##(1990-4#2)(2012-2#1)(2012-3#1)
patients with musculoskeletal##5##3##(1992-9#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-6#1)
patients with myasthenia gravis##4##4##(2007-8#4)
patients with myelodysplastic syndrome##3##4##(2005-7#1)(2006-10#1)(2007-9#1)
patients with myelodysplastic##6##3##(1992-12#1)(2005-7#1)(2006-10#1)(2007-9#1)(2008-5#1)(2012-2#1)
patients with myelofibrosis##2##3##(2012-12#2)
patients with myeloid##2##3##(1991-3#1)(2009-8#1)
patients with myeloma##8##3##(1990-9#1)(1996-9#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-4#1)
patients with myocardial infarction and##3##5##(1996-9#1)(2011-1#1)(2012-1#1)
patients with myocardial infarction##14##4##(1993-9#1)(1996-9#3)(2008-5#1)(2008-7#1)(2011-1#1)(2012-1#6)(2013-1#1)
patients with myocardial##18##3##(1991-9#1)(1993-9#1)(1996-7#1)(1996-9#3)(2008-5#2)(2008-7#1)(2011-1#1)(2012-1#6)(2012-3#1)(2013-1#1)
patients with nasal fracture##2##4##(2011-2#2)
patients with nasal##4##3##(1997-4#1)(2011-2#2)(2013-8#1)
patients with nasopharyngeal carcinoma##2##4##(1991-7#1)(2009-9#1)
patients with neck pain##5##4##(2008-11#1)(2008-12#3)(2010-12#1)
patients with necrotizing##2##3##(1991-11#1)(2012-3#1)
patients with negative##5##3##(1990-1#1)(1990-3#1)(2006-10#1)(2007-9#1)(2012-12#1)
patients with neither##3##3##(1996-3#1)(2009-2#1)(2011-1#1)
patients with neoplasia##2##3##(2011-2#1)(2013-8#1)
patients with neoplastic disease##4##4##(1992-10#1)(2007-11#2)(2007-7#1)
patients with neoplastic##8##3##(1992-10#1)(1992-4#2)(2006-12#1)(2007-11#2)(2007-7#1)(2012-3#1)
patients with nephrolithiasis##3##3##(1996-12#3)
patients with nephrotic##2##3##(2007-11#1)(2008-5#1)
patients with nerve##3##3##(1995-9#1)(1996-3#1)(2007-8#1)
patients with neural tumors and##2##5##(2012-1#2)
patients with neural##3##3##(2010-5#1)(2012-1#2)
patients with neuroblastoma##2##3##(1995-7#1)(2009-12#1)
patients with neuroendocrine##4##3##(1990-8#1)(1992-11#2)(2010-9#1)
patients with neurogenic##2##3##(2007-7#1)(2008-10#1)
patients with neurological deficits##2##4##(1993-12#1)(2007-7#1)
patients with neurological disorders##4##4##(1990-2#2)(1994-10#1)(2008-11#1)
patients with neurological##11##3##(1990-2#2)(1991-8#1)(1993-12#1)(1993-2#1)(1994-10#1)(2007-11#2)(2007-7#1)(2008-11#1)(2009-10#1)
patients with neuromuscular diseases##3##4##(2008-7#3)
patients with neuromuscular##4##3##(2008-7#4)
patients with neuropsychomotor disorders##2##4##(2008-12#2)
patients with new##2##3##(2011-1#1)(2013-1#1)
patients with newly diagnosed##8##4##(1996-11#1)(2006-9#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
patients with newly##9##3##(1990-11#1)(1996-11#1)(2006-9#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
patients with no complications##2##4##(1996-9#1)(2004-10#1)
patients with no evidence of##2##5##(1992-9#1)(2008-5#1)
patients with no history of##2##5##(2009-10#1)(2012-2#1)
patients with no other##2##4##(2006-6#1)(2013-7#1)
patients with no prior history of##2##6##(2006-9#1)(2013-1#1)
patients with no##32##3##(1990-11#1)(1990-4#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-5#1)(1996-9#1)(1997-2#1)(2004-10#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#2)(2011-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
patients with non schizophrenic psychiatric##2##5##(2012-2#2)
patients with non##7##3##(1990-8#1)(2007-7#2)(2007-8#1)(2008-8#1)(2012-2#2)
patients with non-Hodgkin's lymphoma and chemotherapy-induced anemia##2##7##(2008-7#2)
patients with non-Hodgkin's lymphoma##3##4##(2007-6#1)(2008-7#2)
patients with non-Hodgkin's lymphomas##2##4##(2010-12#2)
patients with non-Hodgkin's malignant lymphoma##2##5##(1991-6#1)(1993-1#1)
patients with non-Hodgkin's malignant##3##4##(1991-6#1)(1992-6#1)(1993-1#1)
patients with non-Hodgkin's##8##3##(1991-6#1)(1992-6#1)(1993-1#1)(2007-6#1)(2008-7#2)(2010-12#2)
patients with non-ST##2##3##(2008-3#1)(2013-8#1)
patients with non-ST-segment##2##3##(2008-3#1)(2009-5#1)
patients with non-Shiga toxin-associated hemolytic uremic syndrome##2##7##(2007-8#2)
patients with non-coronary chest pain##2##5##(2013-8#2)
patients with non-coronary##3##3##(1997-8#1)(2013-8#2)
patients with non-insulin dependent diabetes mellitus (NIDDM)##2##7##(1995-6#1)(2008-7#1)
patients with non-insulin dependent diabetes mellitus##4##6##(1994-12#1)(1995-6#2)(2008-7#1)
patients with non-insulin-dependent diabetes mellitus##4##5##(1991-1#1)(1992-12#1)(1992-9#1)(1995-8#1)
patients with non-invasive##2##3##(2012-2#1)(2013-1#1)
patients with non-malignant ovarian##2##4##(1990-2#2)
patients with non-malignant##5##3##(1990-2#2)(2005-12#1)(2007-8#1)(2012-12#1)
patients with non-neuroendocrine tumours##2##4##(1992-11#2)
patients with non-replicative HBV disease##2##5##(2007-8#2)
patients with non-small cell lung cancer##7##6##(1990-10#1)(2007-8#2)(2008-1#1)(2009-3#1)(2013-1#2)
patients with non-small cell lung##8##5##(1990-10#1)(1990-5#1)(2007-8#2)(2008-1#1)(2009-3#1)(2013-1#2)
patients with non-small##9##3##(1990-10#1)(1990-5#1)(2007-8#2)(2008-1#1)(2009-3#1)(2009-4#1)(2013-1#2)
patients with non-small-cell lung cancer (NSCLC)##3##6##(2004-1#1)(2007-4#1)(2013-7#1)
patients with non-small-cell lung cancer##4##5##(1994-12#1)(2004-1#1)(2007-4#1)(2013-7#1)
patients with non-traumatic##2##3##(1990-6#1)(2008-12#1)
patients with noncardiac##3##3##(1991-9#1)(2006-10#1)(2006-6#1)
patients with noncommunicating##2##3##(2006-5#2)
patients with nonrheumatic atrial fibrillation and##2##6##(1995-11#1)(2007-7#1)
patients with nonthyroidal illness##2##4##(2008-7#2)
patients with normal colonoscopy##3##4##(2012-3#3)
patients with normal renal function##2##5##(2009-7#1)(2011-2#1)
patients with normal serum creatinine##2##5##(2008-4#2)
patients with normal##29##3##(1991-11#1)(1993-11#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-2#3)(2012-1#1)(2012-2#3)(2012-3#3)
patients with normal-pressure hydrocephalus##2##4##(2006-8#2)
patients with nosocomial##3##3##(1990-9#1)(2011-2#1)(2012-2#1)
patients with numerous##2##3##(2010-10#1)(2013-1#1)
patients with obsessive-compulsive disorder##2##4##(2008-3#2)
patients with obstructive sleep apnea##5##5##(2007-3#1)(2007-6#1)(2012-2#2)(2013-1#1)
patients with obstructive##10##3##(1997-4#1)(2005-10#1)(2006-10#1)(2007-3#1)(2007-6#1)(2008-5#2)(2012-2#2)(2013-1#1)
patients with occluded##3##3##(1990-7#1)(1997-8#2)
patients with occupational history were##2##5##(2008-8#2)
patients with occupational##3##3##(1990-6#1)(2008-8#2)
patients with ocular##4##3##(2007-3#1)(2013-7#1)(2013-8#2)
patients with older##2##3##(1997-6#1)(2011-2#1)
patients with one or##4##4##(2007-8#1)(2008-9#1)(2011-11#1)(2013-1#1)
patients with one##9##3##(1994-11#1)(1995-1#1)(2007-8#1)(2008-8#2)(2008-9#1)(2011-11#1)(2012-12#1)(2013-1#1)
patients with only one##2##4##(2006-10#1)(2006-6#1)
patients with only##7##3##(1992-3#1)(2006-10#2)(2006-6#1)(2006-9#1)(2007-11#1)(2009-11#1)
patients with open angle##2##4##(2011-2#2)
patients with open##3##3##(2007-11#1)(2011-2#2)
patients with operable breast cancer##3##5##(1991-12#1)(1991-8#1)(2004-1#1)
patients with operable breast##4##4##(1991-12#1)(1991-8#1)(1994-12#1)(2004-1#1)
patients with operable##7##3##(1991-12#1)(1991-8#1)(1994-12#1)(1996-9#1)(2004-1#1)(2007-11#1)(2012-12#1)
patients with optic##2##3##(1995-12#1)(2008-7#1)
patients with or without somatization##2##5##(2006-8#2)
patients with or without##17##4##(1991-4#1)(1993-12#1)(1994-7#1)(1997-5#1)(2006-8#5)(2007-7#1)(2007-8#2)(2008-3#1)(2009-10#1)(2010-12#1)(2012-12#1)(2013-1#1)
patients with oral cancer##2##4##(2013-1#2)
patients with oral cavity##2##4##(2009-10#2)
patients with oral##12##3##(1991-5#1)(2006-2#2)(2008-1#1)(2008-4#1)(2009-10#3)(2011-1#1)(2012-3#1)(2013-1#2)
patients with oropharyngeal candidiasis##2##4##(2005-8#1)(2008-5#1)
patients with oropharyngeal##3##3##(2005-8#1)(2008-5#1)(2009-10#1)
patients with orthopedic implants##2##4##(2006-10#1)(2008-8#1)
patients with orthopedic##3##3##(2006-10#1)(2008-8#1)(2011-1#1)
patients with osteoarthritis of the knee##3##6##(2006-10#1)(2008-5#1)(2011-2#1)
patients with osteoarthritis of the##4##5##(2006-10#2)(2008-5#1)(2011-2#1)
patients with osteoarthritis of##6##4##(2006-10#3)(2008-5#2)(2011-2#1)
patients with osteoarthritis##15##3##(1991-5#1)(1993-11#1)(2006-10#3)(2006-5#1)(2007-11#3)(2007-8#1)(2008-5#2)(2011-2#1)(2012-1#1)(2013-1#1)
patients with osteoarthrosis##2##3##(2006-6#1)(2010-10#1)
patients with osteoporosis##9##3##(1997-6#1)(2005-1#1)(2007-11#3)(2008-4#1)(2008-8#3)
patients with osteoporotic##3##3##(1991-11#1)(2007-11#1)(2007-8#1)
patients with osteosarcoma has##2##4##(2010-3#2)
patients with osteosarcoma##9##3##(2008-1#1)(2010-3#8)
patients with other etiologies of renal failure##2##7##(2013-1#2)
patients with other liver tumors##2##5##(1993-7#2)
patients with other psychiatric disorders##2##5##(2008-1#1)(2011-1#1)
patients with other sarcomas##2##4##(2008-6#2)
patients with other##20##3##(1990-3#1)(1991-10#1)(1993-7#2)(1994-12#1)(1996-12#1)(1997-2#1)(1997-8#1)(2005-6#1)(2008-1#1)(2008-6#2)(2008-7#1)(2011-1#2)(2011-12#1)(2011-2#2)(2013-1#2)
patients with otherwise##2##3##(1995-12#1)(2007-8#1)
patients with ovarian cancer##5##4##(1991-6#1)(1992-8#1)(1996-10#1)(2010-12#2)
patients with ovarian carcinoma##3##4##(1991-4#1)(1991-5#1)(1992-1#1)
patients with ovarian epithelial cancer##2##5##(2006-10#2)
patients with ovarian epithelial##3##4##(2006-10#3)
patients with ovarian##16##3##(1990-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-8#1)(1994-2#1)(1994-6#1)(1996-1#1)(1996-10#1)(2006-10#3)(2010-12#3)
patients with overt##5##3##(2006-10#1)(2008-1#1)(2010-6#1)(2010-8#1)(2011-2#1)
patients with pTa##2##3##(2011-2#2)
patients with pacemakers##2##3##(1992-10#1)(2008-4#1)
patients with pain in the##2##5##(1990-3#1)(2007-8#1)
patients with pain##6##3##(1990-3#1)(1996-7#1)(2006-4#1)(2007-8#1)(2008-7#1)(2009-12#1)
patients with painful##4##3##(1997-1#2)(2006-7#1)(2007-11#1)
patients with palliative care needs##4##5##(2012-11#4)
patients with palpable purpura##2##4##(2007-8#2)
patients with palpable##5##3##(1990-9#1)(1991-4#1)(2006-1#1)(2007-8#2)
patients with pancreas divisum##2##4##(1995-4#1)(2011-2#1)
patients with pancreatic cancer##4##4##(1991-2#1)(1997-7#1)(2008-9#2)
patients with pancreatic##7##3##(1991-2#1)(1992-9#1)(1997-7#1)(2008-3#1)(2008-9#2)(2013-1#1)
patients with panic disorder##14##4##(1990-11#1)(1993-12#2)(1996-3#1)(1996-7#1)(2005-7#1)(2006-3#1)(2006-9#1)(2007-1#1)(2007-10#1)(2013-7#1)(2013-8#3)
patients with panic##15##3##(1990-11#1)(1993-12#2)(1996-3#1)(1996-7#1)(2005-7#1)(2006-3#1)(2006-9#1)(2007-1#1)(2007-10#2)(2013-7#1)(2013-8#3)
patients with para- and##3##4##(2006-5#1)(2007-11#2)
patients with paranoid schizophrenia##3##4##(1997-8#1)(2007-7#2)
patients with paranoid##4##3##(1997-8#1)(2005-7#1)(2007-7#2)
patients with parkinsonian##2##3##(1993-11#1)(2008-7#1)
patients with paroxysmal and persistent##2##5##(2009-10#1)(2010-12#1)
patients with paroxysmal nocturnal##2##4##(2007-8#1)(2012-2#1)
patients with paroxysmal##6##3##(2007-8#1)(2008-7#1)(2009-10#1)(2010-12#1)(2012-2#1)(2012-3#1)
patients with partial##4##3##(1992-4#1)(1996-2#1)(2007-11#1)(2008-9#1)
patients with patellofemoral pain syndrome##3##5##(2008-12#3)
patients with patellofemoral##4##3##(2007-7#1)(2008-12#3)
patients with patent##2##3##(1990-3#1)(2011-2#1)
patients with pathological fractures##2##4##(2007-11#2)
patients with pathological##4##3##(1992-5#1)(2007-11#2)(2008-11#1)
patients with pathologically confirmed##3##4##(1995-3#1)(2008-6#1)(2009-12#1)
patients with pediatric##2##3##(1996-1#1)(2006-11#1)
patients with pelvic##4##3##(1992-1#1)(2006-11#1)(2007-8#1)(2012-12#1)
patients with penetrating cardiac injuries from##2##6##(2008-1#2)
patients with penetrating##3##3##(2008-1#2)(2010-7#1)
patients with peptic ulcer disease##2##5##(2006-10#2)
patients with peptic ulcer##5##4##(1995-10#1)(2006-10#2)(2008-12#1)(2009-2#1)
patients with peptic##6##3##(1995-10#1)(2006-10#2)(2006-6#1)(2008-12#1)(2009-2#1)
patients with peri-implantitis##2##3##(2013-1#2)
patients with periodontal##2##3##(1996-1#1)(2011-1#1)
patients with periodontitis##3##3##(2006-2#1)(2006-8#1)(2013-1#1)
patients with peripheral arterial##2##4##(1995-2#1)(2008-7#1)
patients with peripheral neuropathy##5##4##(1993-12#3)(2011-1#1)(2012-3#1)
patients with peripheral##12##3##(1993-12#3)(1993-2#1)(1995-2#1)(2007-8#2)(2008-7#1)(2011-1#2)(2012-3#1)(2013-1#1)
patients with peritoneal surface malignancy##2##5##(2006-6#1)(2010-12#1)
patients with peritoneal surface##3##4##(2006-6#1)(2010-12#2)
patients with peritoneal##6##3##(2006-6#3)(2010-12#3)
patients with permanent pacemakers##2##4##(2011-2#1)(2012-2#1)
patients with permanent##7##3##(2007-7#2)(2007-8#1)(2011-2#1)(2012-2#1)(2013-8#2)
patients with peroxisomal##2##3##(1990-11#1)(1993-8#1)
patients with persistent or##2##4##(2009-3#1)(2010-12#1)
patients with persistent##9##3##(1991-8#1)(1992-5#1)(2007-10#1)(2008-12#1)(2008-3#1)(2008-9#2)(2009-3#1)(2010-12#1)
patients with persisting##2##3##(1992-5#1)(2010-12#1)
patients with personality disorders##2##4##(2005-7#1)(2006-3#1)
patients with phenylketonuria##2##3##(2006-1#1)(2012-2#1)
patients with pheochromocytoma##3##3##(1995-12#1)(1995-7#1)(2009-1#1)
patients with pituitary##5##3##(2009-2#1)(2011-2#1)(2013-1#1)(2013-8#2)
patients with pityriasis versicolor##4##4##(2007-7#1)(2008-5#2)(2011-2#1)
patients with plegia##2##3##(2007-11#2)
patients with pneumococcal meningitis##3##4##(2011-2#3)
patients with pneumococcal##4##3##(2011-2#4)
patients with pneumonia##4##3##(1990-9#1)(2005-11#1)(2013-1#2)
patients with polydisperse##2##3##(1995-6#2)
patients with polymyalgia rheumatica##2##4##(1994-11#1)(2006-10#1)
patients with polyps##2##3##(2006-2#1)(2011-2#1)
patients with poor prognoses##2##4##(2005-10#1)(2010-12#1)
patients with poor##17##3##(1996-10#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-5#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-7#1)(2010-12#4)(2011-2#2)
patients with poor-grade##2##3##(2012-3#2)
patients with positive direct antiglobulin tests##2##6##(1992-3#2)
patients with positive##17##3##(1991-4#1)(1992-3#2)(1993-3#1)(1994-9#1)(2006-10#1)(2007-12#1)(2007-2#2)(2008-6#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
patients with possible##3##3##(2006-10#1)(2007-7#1)(2010-8#1)
patients with post##2##3##(2008-10#1)(2008-9#1)
patients with posterior third ventricular##2##5##(2006-8#2)
patients with posterior##7##3##(2006-8#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-7#1)(2012-3#1)
patients with postmenopausal osteoporosis##2##4##(2005-1#1)(2007-8#1)
patients with postmenopausal##4##3##(1990-6#1)(1992-12#1)(2005-1#1)(2007-8#1)
patients with postoperative##7##3##(1993-10#1)(1996-3#1)(2006-6#1)(2007-7#2)(2010-7#2)
patients with posttraumatic##4##3##(1996-7#1)(2006-5#1)(2007-11#1)(2007-6#1)
patients with potential##2##3##(2008-11#1)(2008-3#1)
patients with pre-existing##4##3##(1990-2#1)(1991-8#1)(2006-10#1)(2007-12#1)
patients with preexisting##3##3##(1992-3#1)(1992-8#1)(1996-9#1)
patients with pregnancy-induced hypertension##3##4##(1990-3#1)(1992-2#2)
patients with premature##2##3##(1993-9#1)(2009-3#1)
patients with preoperative##3##3##(2008-7#1)(2013-1#2)
patients with preserved LVEF##2##4##(2010-11#2)
patients with pressure sores##2##4##(1996-1#1)(2007-11#1)
patients with presumed cardioembolic stroke##2##5##(2007-10#2)
patients with presumed##5##3##(2007-10#2)(2007-9#1)(2008-7#1)(2012-12#1)
patients with previous myocardial infarction##2##5##(2005-8#1)(2007-8#1)
patients with previous##11##3##(1990-11#1)(1992-10#1)(1992-8#1)(1996-3#1)(1997-7#1)(2005-8#1)(2007-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#1)
patients with previously untreated##6##4##(1991-8#1)(2007-11#1)(2007-3#1)(2008-10#1)(2009-8#1)(2010-11#1)
patients with previously##9##3##(1991-8#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-8#1)(2009-8#1)(2010-11#1)
patients with primary SS##2##4##(2006-10#2)
patients with primary and##3##4##(2011-1#1)(2013-1#2)
patients with primary antibody deficiency##4##5##(1992-8#2)(2007-2#2)
patients with primary antibody##5##4##(1992-8#2)(2007-2#3)
patients with primary biliary cirrhosis (PBC)##2##6##(1992-6#1)(2007-11#1)
patients with primary biliary cirrhosis and##2##6##(1990-3#1)(1991-1#1)
patients with primary biliary cirrhosis##11##5##(1990-3#1)(1991-1#3)(1991-5#1)(1992-6#1)(1992-9#1)(1994-2#1)(2004-11#1)(2007-11#2)
patients with primary breast cancer##4##5##(1990-8#1)(1996-3#1)(2007-5#1)(2013-1#1)
patients with primary breast##5##4##(1990-8#1)(1996-3#1)(2007-5#1)(2012-2#1)(2013-1#1)
patients with primary hypercholesterolemia##3##4##(1991-6#1)(1991-7#1)(2008-3#1)
patients with primary hyperparathyroidism##6##4##(1990-2#1)(1991-12#1)(1991-5#1)(2007-2#1)(2010-7#1)(2013-1#1)
patients with primary immunodeficiency##3##4##(2008-10#1)(2012-12#1)(2012-3#1)
patients with primary melanoma##2##4##(1991-9#1)(2007-8#1)
patients with primary or secondary Raynaud?s phenomenon##3##7##(2008-1#3)
patients with primary or secondary##4##5##(1995-10#1)(2008-1#3)
patients with primary or##6##4##(1990-9#1)(1993-8#1)(1995-10#1)(2008-1#3)
patients with primary pulmonary hypertension##3##5##(1991-2#1)(1997-5#1)(2006-10#1)
patients with primary tumours##2##4##(1997-3#1)(2008-6#1)
patients with primary untreated cancer##2##5##(1990-11#2)
patients with primary##90##3##(1990-11#2)(1990-2#1)(1990-3#1)(1990-8#1)(1990-9#3)(1991-1#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-9#2)(1992-11#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-8#1)(1993-9#1)(1994-2#2)(1994-5#1)(1994-7#1)(1995-10#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-11#1)(2005-12#1)(2006-10#5)(2006-6#1)(2007-11#3)(2007-2#6)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-7#1)(2011-1#3)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#6)
patients with prior##5##3##(2006-10#1)(2006-6#1)(2008-10#1)(2010-2#1)(2012-12#1)
patients with probable##3##3##(1995-11#1)(2006-12#1)(2008-7#1)
patients with proctological symptoms##2##4##(2013-1#2)
patients with progression of##2##4##(1992-10#1)(1995-12#1)
patients with progression##3##3##(1992-10#1)(1995-12#1)(2006-10#1)
patients with progressive LGG##2##4##(2006-12#2)
patients with progressive disease##5##4##(1995-10#1)(2007-7#1)(2007-8#1)(2009-3#1)(2010-11#1)
patients with progressive supranuclear palsy##3##5##(1990-7#1)(1992-8#2)
patients with progressive##18##3##(1990-7#1)(1991-3#1)(1992-8#2)(1995-10#1)(2006-12#3)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-6#2)(2008-7#1)(2009-3#1)(2010-11#1)(2010-12#1)
patients with prolonged##3##3##(1991-2#1)(2007-11#1)(2008-3#1)
patients with prophylactic##4##3##(2006-10#1)(2011-2#3)
patients with prostate cancer than##2##5##(2006-10#1)(2012-11#1)
patients with prostate cancer##9##4##(2006-10#1)(2007-2#2)(2008-1#2)(2008-7#2)(2012-11#1)(2012-3#1)
patients with prostate##10##3##(2006-10#1)(2007-2#2)(2008-1#2)(2008-7#2)(2012-11#2)(2012-3#1)
patients with prostatic cancer and 14 patients with benign##2##9##(1990-9#2)
patients with prostatic cancer##5##4##(1990-9#2)(1995-11#1)(1995-12#2)
patients with prostatic##8##3##(1990-3#1)(1990-9#2)(1993-6#1)(1995-11#1)(1995-12#2)(2011-1#1)
patients with prosthetic heart##3##4##(2007-8#3)
patients with prosthetic##4##3##(2007-8#3)(2013-1#1)
patients with proteinuria##3##3##(2007-7#2)(2007-8#1)
patients with proteinuric renal disease##2##5##(1993-12#2)
patients with proteinuric##3##3##(1993-12#2)(2008-1#1)
patients with proven##6##3##(1997-7#1)(2008-1#1)(2010-10#1)(2012-12#2)(2012-2#1)
patients with proximal femur##2##4##(2007-11#1)(2007-8#1)
patients with proximal##4##3##(2007-11#3)(2007-8#1)
patients with pseudomyxoma peritonei##2##4##(2006-6#2)
patients with psoriasis and##2##4##(1992-10#2)
patients with psoriasis##9##3##(1992-10#2)(2007-7#1)(2007-8#2)(2008-6#1)(2012-12#1)(2012-2#2)
patients with psoriatic arthritis##4##4##(2006-10#3)(2007-8#1)
patients with psoriatic##5##3##(2006-10#4)(2007-8#1)
patients with psychiatric disorders##2##4##(2007-8#1)(2012-2#1)
patients with psychiatric##3##3##(2007-8#1)(2012-1#1)(2012-2#1)
patients with psychosis##6##3##(1996-7#1)(2011-2#5)
patients with pulmonary arterial hypertension##2##5##(2007-9#1)(2008-4#1)
patients with pulmonary hypertension##4##4##(2008-12#1)(2008-7#1)(2009-6#1)(2010-10#1)
patients with pulmonary sarcoidosis##2##4##(2008-7#2)
patients with pulmonary tuberculosis##6##4##(2006-6#2)(2007-12#1)(2011-1#1)(2011-11#1)(2013-1#1)
patients with pulmonary##24##3##(1992-2#1)(1997-5#1)(2006-6#2)(2006-8#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-4#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-11#1)(2013-1#1)(2013-8#1)
patients with pyogenic liver abscess##2##5##(2006-10#2)
patients with rapid##2##3##(2009-8#1)(2012-11#1)
patients with rapid-cycling bipolar disorder##2##5##(1996-7#2)
patients with rare##2##3##(2009-5#1)(2012-2#1)
patients with recent infarcts in the##2##6##(2007-9#2)
patients with recent infarcts##3##4##(2007-10#1)(2007-9#2)
patients with recent transient##3##4##(2007-10#1)(2008-8#2)
patients with recent##11##3##(1997-8#1)(2005-12#1)(2006-11#1)(2007-10#3)(2007-9#2)(2008-8#2)(2012-2#1)
patients with rectal cancer##3##4##(2006-8#1)(2008-10#2)
patients with rectal##4##3##(1993-5#1)(2006-8#1)(2008-10#2)
patients with recurrence##6##3##(1995-10#2)(1996-6#2)(2008-5#1)(2011-2#1)
patients with recurrent breast cancer##2##5##(1994-12#2)
patients with recurrent fetal loss##2##5##(2004-10#1)(2007-2#1)
patients with recurrent high grade astrocytoma##2##6##(2008-7#2)
patients with recurrent or residual##2##5##(2008-1#1)(2010-5#1)
patients with recurrent or##3##4##(2008-1#1)(2008-5#1)(2010-5#1)
patients with recurrent pregnancy loss##2##5##(2011-2#2)
patients with recurrent##41##3##(1990-9#1)(1991-11#1)(1991-4#1)(1991-6#1)(1993-2#1)(1994-1#1)(1994-12#2)(1996-7#2)(2004-10#2)(2005-11#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-7#3)(2008-1#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-9#1)(2009-10#1)(2010-5#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-8#2)
patients with reduced##7##3##(2006-10#3)(2007-8#1)(2008-4#1)(2008-7#1)(2013-8#1)
patients with reflex sympathetic dystrophy##4##5##(1992-11#1)(1992-3#1)(2006-10#1)(2008-7#1)
patients with reflux##3##3##(1990-10#1)(1993-3#1)(2008-4#1)
patients with refractory asthma##2##4##(2010-5#2)
patients with refractory heart failure##3##5##(1995-6#1)(2011-2#2)
patients with refractory rheumatoid arthritis##2##5##(2007-11#1)(2008-8#1)
patients with refractory##20##3##(1995-6#1)(1996-1#1)(2006-3#1)(2007-10#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-12#1)(2008-8#1)(2009-8#1)(2010-5#2)(2011-1#1)(2011-2#3)(2013-1#3)
patients with regard to##3##4##(1993-11#1)(2007-9#1)(2010-11#1)
patients with rejection##2##3##(1995-2#2)
patients with relapsed##10##3##(1992-10#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-6#1)(2009-4#1)(2010-11#2)(2010-4#2)
patients with relapsed/refractory##2##3##(2009-12#2)
patients with relapsing##3##3##(2006-10#1)(2007-11#1)(2010-12#1)
patients with relapsing-remitting multiple sclerosis##4##5##(2007-11#3)(2010-12#1)
patients with relapsing-remitting##5##3##(2007-11#4)(2010-12#1)
patients with relatively##2##3##(1991-5#1)(1994-12#1)
patients with renal artery stenosis##3##5##(2006-10#2)(2009-5#1)
patients with renal artery##4##4##(2006-10#2)(2006-6#1)(2009-5#1)
patients with renal cancer##2##4##(2009-11#1)(2012-1#1)
patients with renal cell carcinoma (RCC)##3##6##(2006-9#2)(2007-8#1)
patients with renal cell carcinoma##6##5##(1995-12#2)(1997-6#1)(2006-9#2)(2007-8#1)
patients with renal cell##9##4##(1995-12#2)(1997-6#1)(2006-10#1)(2006-9#2)(2007-8#1)(2011-1#1)(2012-1#1)
patients with renal disease##4##4##(2006-10#1)(2007-12#1)(2007-7#1)(2013-1#1)
patients with renal failure##11##4##(1995-4#1)(1996-3#2)(1996-8#1)(2007-1#1)(2007-11#1)(2008-7#1)(2009-6#1)(2011-1#1)(2011-12#1)(2012-1#1)
patients with renal impairment##4##4##(1993-12#1)(1996-2#1)(2007-11#1)(2008-1#1)
patients with renal insufficiency##4##4##(1990-1#1)(2005-10#1)(2013-1#2)
patients with renal transplants##2##4##(1990-11#1)(2006-10#1)
patients with renal##54##3##(1990-1#1)(1990-11#1)(1990-12#1)(1993-12#1)(1995-12#2)(1995-4#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#1)(1997-6#1)(1997-8#1)(2005-10#2)(2005-7#1)(2006-10#5)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-4#1)(2008-6#3)(2008-7#1)(2009-11#1)(2009-5#1)(2009-6#1)(2011-1#2)(2011-12#1)(2012-1#3)(2012-3#1)(2013-1#3)
patients with renovascular hypertension##3##4##(1995-7#1)(2007-7#1)(2008-1#1)
patients with resectable##5##3##(1990-10#1)(2005-11#1)(2007-4#1)(2007-8#1)(2012-2#1)
patients with resected##5##3##(1993-10#1)(2007-4#2)(2007-8#1)(2010-11#1)
patients with residual##7##3##(1992-10#1)(1993-3#1)(2006-12#2)(2007-8#1)(2008-5#1)(2011-2#1)
patients with resistant disease##3##4##(1995-12#1)(2006-10#2)
patients with resistant##4##3##(1995-12#1)(2006-10#3)
patients with resistant/relapsing##2##3##(2008-1#2)
patients with respect to their##2##5##(1997-8#1)(2011-2#1)
patients with respect to##4##4##(1997-8#2)(2007-8#1)(2011-2#1)
patients with respiratory infections##3##4##(2012-2#3)
patients with respiratory motion##2##4##(2009-5#2)
patients with respiratory symptoms##2##4##(2010-9#1)(2011-1#1)
patients with respiratory##13##3##(1990-3#1)(1994-10#1)(1994-2#1)(1997-4#1)(2009-5#2)(2010-9#1)(2011-1#1)(2012-2#3)(2013-1#2)
patients with retained##2##3##(1991-3#1)(2012-2#1)
patients with retinopathy##2##3##(1991-12#1)(1993-1#1)
patients with retroperitoneal##2##3##(1990-9#1)(1992-12#1)
patients with rheumatic disease##4##4##(2006-10#4)
patients with rheumatic diseases##4##4##(1990-6#1)(2006-10#1)(2007-11#1)(2013-1#1)
patients with rheumatic##10##3##(1990-6#1)(2006-10#5)(2007-11#1)(2007-12#2)(2013-1#1)
patients with rheumatoid arthritis (RA)##4##5##(2006-10#2)(2007-11#1)(2008-8#1)
patients with rheumatoid arthritis and##2##5##(2006-10#1)(2007-12#1)
patients with rheumatoid arthritis or osteoarthritis##2##6##(1996-1#1)(2006-10#1)
patients with rheumatoid arthritis were given##2##6##(1992-11#2)
patients with rheumatoid arthritis were##3##5##(1992-11#2)(2013-8#1)
patients with rheumatoid arthritis who##3##5##(2006-10#2)(2008-9#1)
patients with rheumatoid arthritis##48##4##(1990-2#1)(1991-12#1)(1992-11#4)(1993-1#1)(1996-1#2)(2006-10#14)(2007-11#7)(2007-12#1)(2007-7#2)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-8#1)
patients with rheumatoid##50##3##(1990-2#1)(1991-12#1)(1992-11#4)(1993-1#1)(1996-1#2)(2006-10#15)(2007-11#8)(2007-12#1)(2007-7#2)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-8#1)
patients with right##5##3##(1996-2#1)(1996-5#1)(2007-10#1)(2008-4#1)(2010-7#1)
patients with rtN236T##2##3##(2013-1#2)
patients with ruptured##3##3##(2007-10#3)
patients with ruptures of the##2##5##(1996-11#1)(2006-3#1)
patients with sarcoidosis##9##3##(2005-8#1)(2007-10#1)(2007-11#1)(2010-10#1)(2010-6#5)
patients with sarcoma##7##3##(2008-6#7)
patients with schizophrenia (n =##2##5##(1996-2#1)(1996-7#1)
patients with schizophrenia and##7##4##(1996-5#1)(1996-7#3)(2010-1#1)(2010-6#1)(2011-1#1)
patients with schizophrenia as##2##4##(1996-8#1)(1997-8#1)
patients with schizophrenia in##3##4##(1996-2#1)(2006-12#1)(2006-2#1)
patients with schizophrenia on##2##4##(1997-8#1)(2013-1#1)
patients with schizophrenia were##3##4##(1997-8#1)(2008-11#1)(2013-1#1)
patients with schizophrenia who##2##4##(1996-8#1)(2005-10#1)
patients with schizophrenia##70##3##(1991-9#1)(1995-11#2)(1995-12#4)(1995-5#1)(1996-2#3)(1996-3#2)(1996-5#2)(1996-7#10)(1996-8#4)(1997-2#4)(1997-8#4)(2005-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-9#3)(2007-7#3)(2008-11#1)(2009-10#1)(2009-12#1)(2009-9#1)(2010-1#2)(2010-6#1)(2011-1#3)(2011-2#1)(2012-1#2)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#1)
patients with schizophrenia]##2##3##(2009-10#1)(2012-12#1)
patients with scleroderma##7##3##(1992-8#1)(2004-10#1)(2006-10#4)(2008-10#1)
patients with scoliosis##8##3##(2006-10#1)(2007-7#2)(2007-8#5)
patients with seasonal##4##3##(1995-11#1)(2007-9#1)(2010-4#1)(2010-8#1)
patients with secondary hyperparathyroidism##3##4##(1991-11#2)(1993-3#1)
patients with secondary syphilis##2##4##(1993-3#2)
patients with secondary##10##3##(1991-11#2)(1993-3#3)(2007-3#1)(2008-1#1)(2011-1#1)(2012-3#1)(2013-1#1)
patients with selective##2##3##(1991-2#1)(2013-1#1)
patients with self-reported##2##3##(1995-1#1)(2009-10#1)
patients with semantic dementia##2##4##(2008-4#2)
patients with senile##2##3##(1993-4#1)(2013-1#1)
patients with sensorineural hearing##2##4##(1992-2#1)(2008-9#1)
patients with sensory loss##3##4##(2012-1#3)
patients with sensory##5##3##(2012-1#5)
patients with sepsis and##2##4##(1993-12#1)(1993-2#1)
patients with sepsis##6##3##(1992-2#1)(1993-12#1)(1993-2#1)(2007-5#1)(2011-2#1)(2012-3#1)
patients with septic arthritis##2##4##(1993-11#1)(2006-10#1)
patients with septic shock##2##4##(1996-9#1)(2011-2#1)
patients with septic##5##3##(1993-11#1)(1996-9#1)(2006-10#1)(2011-2#1)(2013-1#1)
patients with serious##8##3##(1990-6#1)(1992-2#1)(1993-8#1)(2005-1#1)(2005-8#1)(2006-10#1)(2008-10#1)(2010-5#1)
patients with serum levels##2##4##(1995-10#1)(1997-5#1)
patients with serum##5##3##(1995-10#1)(1996-12#1)(1997-5#1)(1997-7#1)(2008-1#1)
patients with several##2##3##(1994-3#1)(2013-1#1)
patients with severe PEM##2##4##(2008-2#2)
patients with severe acute asthma##2##5##(1992-3#1)(1997-1#1)
patients with severe acute pancreatitis##3##5##(2006-10#1)(2009-8#1)(2013-1#1)
patients with severe acute##5##4##(1992-3#1)(1997-1#1)(2006-10#1)(2009-8#1)(2013-1#1)
patients with severe aortic stenosis##3##5##(2007-8#3)
patients with severe aortic##5##4##(2007-8#4)(2009-5#1)
patients with severe bacterial infections##2##5##(1993-2#1)(2007-5#1)
patients with severe chronic##3##4##(1991-3#1)(2006-10#2)
patients with severe coronary##3##4##(2008-12#1)(2008-5#1)(2011-2#1)
patients with severe disease##3##4##(2011-2#1)(2012-2#1)(2013-1#1)
patients with severe head injury##2##5##(2006-10#1)(2013-8#1)
patients with severe heart failure##2##5##(2005-10#1)(2010-5#1)
patients with severe immunosuppression##2##4##(1990-12#1)(2007-7#1)
patients with severe left ventricular dysfunction##2##6##(1997-1#2)
patients with severe mental##3##4##(1992-2#1)(1992-5#1)(1993-1#1)
patients with severe neurological##2##4##(2005-12#1)(2006-10#1)
patients with severe pulmonary hypertension##3##5##(2006-10#1)(2010-6#1)(2012-3#1)
patients with severe pulmonary##4##4##(2006-10#1)(2010-6#1)(2011-2#1)(2012-3#1)
patients with severe refractory##2##4##(2012-12#1)(2013-1#1)
patients with severe sepsis and##3##5##(2006-4#1)(2007-7#1)(2011-1#1)
patients with severe sepsis or septic shock##2##7##(2011-2#2)
patients with severe sepsis##14##4##(2006-4#2)(2007-12#1)(2007-7#1)(2009-6#5)(2011-1#2)(2011-2#2)(2012-2#1)
patients with severe symptomatic##2##4##(2008-5#1)(2012-12#1)
patients with severe##135##3##(1990-12#2)(1991-3#3)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-7#1)(1994-12#1)(1995-5#1)(1996-5#1)(1997-1#3)(1997-4#3)(1997-8#1)(2004-11#1)(2005-10#1)(2005-12#2)(2005-8#1)(2006-10#13)(2006-4#3)(2006-7#3)(2007-10#3)(2007-11#3)(2007-12#1)(2007-5#1)(2007-7#3)(2007-8#10)(2007-9#4)(2008-1#3)(2008-10#1)(2008-12#1)(2008-2#2)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#2)(2009-2#2)(2009-3#2)(2009-5#2)(2009-6#5)(2009-7#1)(2009-8#2)(2009-9#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#8)(2012-1#3)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
patients with severely##2##3##(1992-9#1)(2007-11#1)
patients with sexually transmitted infections##3##5##(2007-7#3)
patients with short stature##2##4##(2007-11#1)(2007-8#1)
patients with short##5##3##(2007-11#1)(2007-7#1)(2007-8#1)(2011-1#1)(2013-1#1)
patients with shoulder pain##2##4##(1996-2#1)(2007-11#1)
patients with shoulder##6##3##(1996-2#1)(2007-11#1)(2007-7#1)(2009-7#1)(2013-1#2)
patients with sickle cell anaemia##2##5##(1992-8#1)(2009-4#1)
patients with sickle cell disease and##2##6##(1992-3#2)
patients with sickle cell disease##11##5##(1992-3#4)(2006-7#1)(2007-3#3)(2009-2#1)(2009-4#1)(2013-8#1)
patients with sickle cell##13##4##(1992-3#4)(1992-8#1)(2006-7#1)(2007-3#3)(2009-2#1)(2009-4#2)(2013-8#1)
patients with significant##6##3##(2007-10#1)(2007-11#1)(2007-3#1)(2008-1#1)(2010-12#2)
patients with significantly##2##3##(2007-11#1)(2007-2#1)
patients with signs and symptoms##2##5##(2007-8#1)(2013-1#1)
patients with signs of##2##4##(1993-5#1)(1994-10#1)
patients with signs##4##3##(1993-5#1)(1994-10#1)(2007-8#1)(2013-1#1)
patients with silent myocardial ischemia##2##5##(1992-6#1)(2008-7#1)
patients with silent##4##3##(1990-11#1)(1992-6#1)(2008-7#2)
patients with similar##4##3##(1995-12#1)(1997-1#1)(2005-10#1)(2007-8#1)
patients with simple##2##3##(1995-8#1)(2013-1#1)
patients with simultaneous##4##3##(2007-9#1)(2008-10#1)(2008-7#1)(2012-3#1)
patients with single##4##3##(1992-4#1)(2005-12#1)(2007-11#1)(2008-9#1)
patients with single- or##2##4##(1996-9#1)(2008-11#1)
patients with sinus rhythm##3##4##(2007-9#1)(2008-1#1)(2011-2#1)
patients with sinus##4##3##(1997-1#1)(2007-9#1)(2008-1#1)(2011-2#1)
patients with sinusitis##2##3##(1993-2#2)
patients with skeletal metastases##4##4##(2007-11#2)(2009-8#2)
patients with skeletal##5##3##(2007-11#2)(2009-8#2)(2010-2#1)
patients with skin and##2##4##(2007-10#1)(2009-4#1)
patients with skin##7##3##(2007-10#1)(2007-11#1)(2007-7#1)(2008-12#2)(2009-4#1)(2012-2#1)
patients with sleep apnea##2##4##(2006-10#2)
patients with sleep##3##3##(2006-10#2)(2011-1#1)
patients with small cell lung cancer##2##6##(1994-10#1)(2013-8#1)
patients with small cell##3##4##(1994-10#1)(2009-1#1)(2013-8#1)
patients with small intestinal##2##4##(2010-6#1)(2013-1#1)
patients with small##14##3##(1990-4#1)(1992-10#1)(1994-10#1)(1996-9#1)(2007-5#1)(2008-8#1)(2009-1#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
patients with small-cell lung cancer (SCLC)##2##6##(1992-9#2)
patients with social phobia##2##4##(2006-6#1)(2008-4#1)
patients with social##3##3##(2006-6#1)(2008-4#1)(2008-6#1)
patients with soft tissue sarcoma of the##2##7##(2008-6#2)
patients with soft tissue sarcoma##5##5##(2008-6#5)
patients with soft tissue sarcomas##9##5##(2008-6#9)
patients with soft tissue##14##4##(2008-6#14)
patients with solitary tumors##3##4##(2006-11#3)
patients with solitary##5##3##(2005-1#1)(2006-11#4)
patients with some##3##3##(1997-7#1)(2007-8#1)(2008-1#1)
patients with specific##2##3##(2007-8#1)(2008-12#1)
patients with spinal cord injuries##3##5##(1991-6#2)(2007-8#1)
patients with spinal cord injuries]##3##5##(1991-6#1)(1993-2#1)(1995-9#1)
patients with spinal cord injury admitted##2##6##(2007-7#2)
patients with spinal cord injury##5##5##(1993-2#1)(2007-11#1)(2007-7#3)
patients with spinal cord##12##4##(1991-6#4)(1993-2#2)(1995-9#1)(2007-11#1)(2007-7#3)(2007-8#1)
patients with spinal injuries##2##4##(2007-11#1)(2008-10#1)
patients with spinal metastases##4##4##(2006-2#1)(2007-11#3)
patients with spinal##27##3##(1991-6#4)(1993-2#2)(1995-9#1)(2006-2#3)(2006-7#1)(2007-11#7)(2007-7#4)(2007-8#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-3#1)
patients with splenic focal lesions##2##5##(2006-6#2)
patients with spondylolisthesis##4##3##(2006-8#1)(2007-11#2)(2007-7#1)
patients with spontaneous ventricular##2##4##(2005-1#2)
patients with spontaneous##7##3##(1991-6#1)(2005-1#2)(2011-2#3)(2013-7#1)
patients with sporadic form of the disease##2##7##(2012-1#2)
patients with sporadic medullary thyroid carcinoma##2##6##(2008-1#2)
patients with sporadic##8##3##(1990-3#1)(1997-1#1)(2008-1#2)(2008-8#1)(2012-1#2)(2013-8#1)
patients with squamous cell carcinoma of the esophagus##2##8##(2010-12#1)(2013-8#1)
patients with squamous cell carcinoma##3##5##(1990-5#1)(2010-12#1)(2013-8#1)
patients with squamous##4##3##(1990-5#1)(2010-12#2)(2013-8#1)
patients with stable angina (SA)##2##5##(2013-1#1)(2013-8#1)
patients with stable angina pectoris##3##5##(1993-12#1)(2008-10#2)
patients with stable angina##16##4##(1993-12#1)(2005-8#2)(2007-9#6)(2008-1#1)(2008-10#2)(2008-5#2)(2013-1#1)(2013-8#1)
patients with stable disease##2##4##(1992-12#1)(2006-12#1)
patients with stable##29##3##(1992-12#1)(1993-12#1)(1996-9#1)(1997-1#1)(2005-1#1)(2005-6#1)(2005-7#1)(2005-8#2)(2006-12#1)(2007-9#8)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#3)(2008-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
patients with stage 1 or stage 2##2##7##(1996-9#1)(2008-8#1)
patients with stage 1##4##4##(1996-9#1)(2008-8#2)(2009-10#1)
patients with stage I##2##4##(2007-11#1)(2012-2#1)
patients with stage II or III##2##6##(2005-8#1)(2013-7#1)
patients with stage II##3##4##(1997-7#1)(2005-8#1)(2013-7#1)
patients with stage III or IV##3##6##(1997-6#1)(2006-10#1)(2007-11#1)
patients with stage III##7##4##(1990-9#1)(1997-6#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-6#1)
patients with stage III-IV##2##4##(1990-6#1)(2012-1#1)
patients with stage IIIC##2##4##(2011-2#2)
patients with stage T1##2##4##(2006-9#1)(2013-1#1)
patients with stage##32##3##(1990-6#1)(1990-9#1)(1992-12#1)(1996-9#1)(1997-6#1)(1997-7#1)(2004-1#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-9#2)(2007-11#3)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#3)(2009-10#2)(2009-8#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#1)(2013-7#1)
patients with stenosing##2##3##(2009-2#1)(2012-3#1)
patients with stenosis##2##3##(1993-8#2)
patients with sternal##2##3##(2007-8#2)
patients with steroid-resistant FSGS##2##4##(2007-8#2)
patients with stomach##2##3##(1992-5#1)(1997-3#1)
patients with stones in the##2##5##(1992-5#2)
patients with stroke in the##3##5##(1996-6#1)(2013-1#2)
patients with stroke or##2##4##(2007-10#1)(2008-2#1)
patients with stroke##26##3##(1996-6#1)(2007-10#17)(2007-9#1)(2008-2#1)(2008-8#1)(2012-1#1)(2012-11#1)(2013-1#2)(2013-8#1)
patients with structural##4##3##(2006-10#1)(2008-10#1)(2008-5#1)(2009-9#1)
patients with subarachnoid haemorrhage (SAH)##2##5##(2008-7#2)
patients with subarachnoid hemorrhage##3##4##(1995-11#1)(2006-4#1)(2007-10#1)
patients with subarachnoid##5##3##(1995-11#1)(2006-4#1)(2007-10#1)(2008-7#2)
patients with substance use##2##4##(2008-6#1)(2011-2#1)
patients with substance##4##3##(1996-5#2)(2008-6#1)(2011-2#1)
patients with such##2##3##(1993-1#1)(2007-11#1)
patients with sudden##3##3##(2007-10#1)(2008-4#1)(2009-11#1)
patients with suggestive##2##3##(1996-9#1)(2008-3#1)
patients with superior##2##3##(2007-9#1)(2011-1#1)
patients with supracondylar fractures##2##4##(2013-1#1)(2013-8#1)
patients with supracondylar##3##3##(2013-1#1)(2013-8#2)
patients with supraventricular##4##3##(1995-6#1)(2005-7#1)(2006-8#1)(2008-10#1)
patients with surgical##2##3##(2010-8#1)(2013-1#1)
patients with suspected SOD##2##4##(2006-2#2)
patients with suspected acute##5##4##(1996-11#1)(2008-3#2)(2011-2#2)
patients with suspected or known##2##5##(2006-10#1)(2010-7#1)
patients with suspected or##4##4##(2006-10#1)(2007-11#1)(2010-7#1)(2012-2#1)
patients with suspected scaphoid fractures##2##5##(2008-9#2)
patients with suspected viral hemorrhagic##2##5##(1995-6#2)
patients with suspected##53##3##(1990-2#1)(1990-6#1)(1991-3#1)(1991-4#1)(1995-6#2)(1996-11#1)(1996-9#2)(1997-1#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-2#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-12#3)(2008-3#4)(2008-4#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#4)
patients with sustained##2##3##(1990-3#1)(2008-5#1)
patients with symptomatic internal carotid occlusion##2##6##(2007-10#2)
patients with symptomatic##22##3##(1991-6#1)(1992-5#1)(1993-12#1)(1993-2#2)(1995-2#1)(2005-10#1)(2006-10#1)(2006-11#2)(2006-5#1)(2007-10#3)(2007-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-8#1)(2011-2#1)
patients with symptoms from the##2##5##(1992-12#1)(2006-10#1)
patients with symptoms of##5##4##(2007-2#1)(2007-7#2)(2009-6#1)(2013-8#1)
patients with symptoms##9##3##(1992-12#1)(1992-9#1)(1995-2#1)(2006-10#1)(2007-2#1)(2007-7#2)(2009-6#1)(2013-8#1)
patients with synovial sarcoma##3##4##(2008-6#3)
patients with synovial##4##3##(2006-10#1)(2008-6#3)
patients with syphilis##2##3##(1993-3#1)(2011-2#1)
patients with syringomyelia##4##3##(2005-8#1)(2006-5#2)(2007-8#1)
patients with systemic lupus erythematosus (SLE)##11##6##(1990-12#1)(1990-6#1)(1994-3#1)(2006-10#5)(2007-8#1)(2007-9#1)(2011-2#1)
patients with systemic lupus erythematosus and##2##6##(2006-10#2)
patients with systemic lupus erythematosus##28##5##(1990-10#1)(1990-12#1)(1990-6#1)(1992-5#1)(1994-3#1)(1997-8#1)(2006-10#14)(2007-8#2)(2007-9#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)
patients with systemic lupus##29##4##(1990-10#1)(1990-12#1)(1990-6#1)(1990-8#1)(1992-5#1)(1994-3#1)(1997-8#1)(2006-10#14)(2007-8#2)(2007-9#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)
patients with systemic sclerosis (SSc)##3##5##(2006-10#1)(2008-8#1)(2010-10#1)
patients with systemic sclerosis##6##4##(2006-10#1)(2008-8#1)(2009-8#1)(2010-10#1)(2011-12#1)(2012-2#1)
patients with systemic##41##3##(1990-10#1)(1990-12#1)(1990-6#1)(1990-8#1)(1992-5#1)(1994-11#1)(1994-3#1)(1997-8#1)(2006-10#15)(2007-2#1)(2007-8#2)(2007-9#1)(2008-5#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)
patients with tear deficiency##2##4##(2005-11#2)
patients with temporomandibular##3##3##(2007-12#1)(2008-9#1)(2013-1#1)
patients with terminal##4##3##(1992-5#1)(1994-12#1)(2006-4#1)(2007-2#1)
patients with tetralogy of Fallot##3##5##(1997-1#3)
patients with tetraplegia##2##3##(2007-11#2)
patients with that of##2##4##(2007-7#1)(2013-8#1)
patients with the acute##3##4##(2005-8#1)(2006-10#1)(2006-6#1)
patients with the clinical##2##4##(1992-12#1)(2008-3#1)
patients with the diagnosis of##3##5##(2007-10#1)(2008-1#1)(2008-6#1)
patients with the diagnosis##4##4##(1992-8#1)(2007-10#1)(2008-1#1)(2008-6#1)
patients with the disease##3##4##(2008-1#1)(2008-5#1)(2011-1#1)
patients with the disorder##2##4##(1991-3#1)(2011-1#1)
patients with the lowest##2##4##(1995-2#1)(2011-2#1)
patients with the metabolic syndrome##3##5##(2008-1#1)(2010-4#1)(2011-2#1)
patients with the most severe##2##5##(2006-10#1)(2007-10#1)
patients with the most##5##4##(1990-4#1)(2006-10#1)(2007-10#1)(2008-5#1)(2008-8#1)
patients with the nephrotic syndrome##6##5##(1990-8#1)(2008-1#5)
patients with the##98##3##(1990-10#1)(1990-12#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-3#1)(1992-12#1)(1992-8#2)(1993-2#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-3#1)(1995-2#2)(1995-6#1)(1996-8#1)(1997-1#2)(1997-7#1)(2004-11#2)(2005-8#2)(2006-10#8)(2006-3#1)(2006-6#3)(2006-8#1)(2006-9#2)(2007-10#3)(2007-11#4)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#9)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#4)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#2)(2011-2#6)(2012-12#1)(2012-3#2)(2013-1#5)
patients with their##2##3##(1995-3#1)(2007-7#1)
patients with these complex##2##4##(2007-11#1)(2008-6#1)
patients with these conditions##2##4##(2008-3#1)(2010-9#1)
patients with these lesions##2##4##(2008-7#1)(2012-2#1)
patients with these syndromes##2##4##(2005-7#1)(2010-12#1)
patients with these##21##3##(1991-5#1)(1992-8#1)(1994-11#1)(1995-5#1)(2005-6#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
patients with this condition##7##4##(2006-10#1)(2006-9#1)(2007-11#1)(2008-12#1)(2008-8#1)(2010-5#1)(2013-8#1)
patients with this disease were##2##5##(1993-7#1)(2008-7#1)
patients with this disease##12##4##(1990-5#1)(1992-2#1)(1993-7#1)(1996-3#1)(2007-11#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-7#1)(2010-3#1)
patients with this disorder##4##4##(1993-11#1)(1996-12#1)(2006-10#1)(2007-4#1)
patients with this pathology##2##4##(1993-9#1)(2009-2#1)
patients with this syndrome##3##4##(1991-5#1)(1997-6#1)(2007-8#1)
patients with this type of##3##5##(1991-11#1)(2007-7#1)(2010-3#1)
patients with this##53##3##(1990-5#1)(1991-11#1)(1991-5#2)(1992-2#1)(1993-11#1)(1993-7#1)(1993-9#2)(1996-12#1)(1996-3#1)(1996-7#1)(1997-6#1)(2006-1#1)(2006-10#7)(2006-8#1)(2006-9#1)(2007-11#2)(2007-4#1)(2007-7#2)(2007-8#1)(2008-12#2)(2008-3#1)(2008-6#3)(2008-7#2)(2008-8#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-2#1)(2010-3#2)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
patients with thoracic##8##3##(1991-4#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-7#1)(2012-12#1)
patients with those of##2##4##(1990-6#1)(1995-3#1)
patients with those##4##3##(1990-6#1)(1995-3#1)(1997-1#1)(2008-8#1)
patients with three##3##3##(1990-9#1)(2007-8#1)(2009-9#1)
patients with three-vessel##2##3##(2007-8#2)
patients with thrombocytopenia##2##3##(2005-10#1)(2013-7#1)
patients with thymoma##3##3##(1991-9#2)(2007-8#1)
patients with thyroid carcinoma##2##4##(2006-1#1)(2009-2#1)
patients with thyroid dysfunction##2##4##(2013-1#2)
patients with thyroid nodules##4##4##(2011-1#1)(2011-12#1)(2012-3#2)
patients with thyroid##14##3##(1992-10#1)(2006-1#1)(2006-10#1)(2009-2#1)(2011-1#1)(2011-12#3)(2012-1#2)(2012-3#2)(2013-1#2)
patients with tinea##2##3##(2007-7#2)
patients with total##4##3##(1996-11#1)(2007-9#1)(2008-7#1)(2010-7#1)
patients with toxic adenoma##2##4##(2006-11#2)
patients with toxic##3##3##(2006-11#2)(2009-2#1)
patients with tracheoesophageal##2##3##(1996-6#1)(2006-8#1)
patients with transient ischemic attack##2##5##(2007-10#1)(2007-9#1)
patients with transient ischemic##3##4##(2007-10#2)(2007-9#1)
patients with transient##4##3##(2007-10#2)(2007-9#1)(2008-7#1)
patients with transplanted##3##3##(1990-12#1)(1995-8#1)(2012-12#1)
patients with traumatic brain injury##3##5##(1995-4#1)(2006-10#1)(2007-8#1)
patients with traumatic spinal cord##2##5##(1991-6#1)(2007-11#1)
patients with traumatic##10##3##(1991-6#1)(1992-6#1)(1995-4#1)(2006-10#1)(2007-11#2)(2007-8#1)(2009-2#1)(2011-2#2)
patients with treated##2##3##(2010-5#1)(2013-1#1)
patients with treatment-refractory mood disorders##2##5##(2005-6#2)
patients with treatment-resistant##2##3##(2007-11#2)
patients with trochanteric##2##3##(2006-10#1)(2007-7#1)
patients with troublesome belching and##4##5##(2013-8#4)
patients with troublesome belching##5##4##(2013-8#5)
patients with tubal##3##3##(1990-10#1)(1990-2#1)(1994-12#1)
patients with tuberculosis##4##3##(1996-3#2)(2006-6#1)(2009-7#1)
patients with tumor##4##3##(2007-11#1)(2008-8#1)(2010-12#1)(2012-1#1)
patients with tumors of##2##4##(2009-2#1)(2013-1#1)
patients with tumors##8##3##(1990-10#1)(1990-12#1)(1992-10#1)(2006-2#1)(2007-8#1)(2009-2#1)(2011-2#1)(2013-1#1)
patients with tumours##2##3##(1990-8#1)(1996-4#1)
patients with two##5##3##(1990-11#1)(1994-11#1)(2007-2#1)(2007-7#1)(2007-8#1)
patients with type 1 and type 2 diabetes##5##8##(2008-7#1)(2012-12#2)(2012-4#2)
patients with type 1 and##6##5##(2007-8#1)(2008-7#1)(2012-12#2)(2012-4#2)
patients with type 1 diabetes and##2##6##(2009-9#2)
patients with type 1 diabetes##9##5##(1990-10#1)(2007-5#1)(2008-1#1)(2008-8#1)(2009-9#2)(2012-1#1)(2012-12#1)(2013-8#1)
patients with type 1##19##4##(1990-10#2)(1990-5#1)(2006-10#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-9#2)(2012-1#1)(2012-12#3)(2012-4#2)(2013-8#1)
patients with type 2 DM and IGT##2##7##(2010-10#2)
patients with type 2 DM##4##5##(2007-1#1)(2008-8#1)(2010-10#2)
patients with type 2 diabetes in##2##6##(2009-7#1)(2011-1#1)
patients with type 2 diabetes mellitus (DM)##3##7##(2007-1#1)(2008-8#1)(2011-1#1)
patients with type 2 diabetes mellitus (T2DM)##3##7##(2008-1#1)(2012-1#1)(2013-1#1)
patients with type 2 diabetes mellitus in##3##7##(1990-11#1)(2010-10#1)(2011-2#1)
patients with type 2 diabetes mellitus or metabolic syndrome##2##9##(2009-11#2)
patients with type 2 diabetes mellitus##26##6##(1990-11#1)(2006-9#1)(2007-1#1)(2007-2#1)(2008-1#2)(2008-3#2)(2008-8#2)(2009-11#3)(2010-10#2)(2011-1#1)(2011-2#3)(2012-1#2)(2013-1#3)(2013-8#2)
patients with type 2 diabetes treated##2##6##(2008-3#1)(2011-2#1)
patients with type 2 diabetes##73##5##(1990-11#1)(2005-10#3)(2006-9#2)(2007-1#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#6)(2008-3#12)(2008-8#2)(2009-1#1)(2009-11#6)(2009-7#1)(2010-10#3)(2010-4#2)(2011-1#2)(2011-2#8)(2012-1#3)(2012-12#3)(2012-2#2)(2012-3#2)(2012-5#2)(2013-1#3)(2013-7#1)(2013-8#3)
patients with type 2 diabetes?##2##5##(2010-12#1)(2012-5#1)
patients with type 2##82##4##(1990-11#1)(1993-4#1)(2005-10#3)(2006-9#2)(2007-1#3)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#6)(2008-3#12)(2008-8#3)(2009-1#1)(2009-11#6)(2009-7#1)(2010-10#5)(2010-12#1)(2010-4#2)(2011-1#2)(2011-2#8)(2012-1#3)(2012-12#3)(2012-2#2)(2012-3#2)(2012-5#3)(2013-1#3)(2013-7#2)(2013-8#3)
patients with type C##2##4##(1992-11#1)(1992-3#1)
patients with type I diabetes mellitus]##2##6##(1996-9#1)(2006-6#1)
patients with type I diabetes##3##5##(1996-9#1)(2006-6#1)(2009-2#1)
patients with type I fractures##2##5##(2007-11#1)(2007-8#1)
patients with type I##8##4##(1991-1#1)(1996-9#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-6#1)(2009-2#1)(2012-3#1)
patients with type II diabetes mellitus##6##6##(1993-12#2)(1996-1#2)(2006-6#2)
patients with type II diabetes##10##5##(1993-12#2)(1994-2#1)(1995-8#1)(1996-1#2)(1996-11#1)(2005-8#1)(2006-6#2)
patients with type II##12##4##(1993-12#2)(1994-2#1)(1995-8#1)(1996-1#2)(1996-11#1)(2005-8#1)(2006-6#2)(2007-2#1)(2007-8#1)
patients with type III##3##4##(2006-2#1)(2007-8#1)(2008-7#1)
patients with type##128##3##(1990-10#2)(1990-11#1)(1990-5#1)(1991-1#1)(1992-11#1)(1992-3#1)(1993-12#2)(1993-4#1)(1994-2#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-9#1)(2004-10#1)(2005-10#3)(2005-8#1)(2006-10#1)(2006-2#1)(2006-6#3)(2006-9#2)(2007-1#3)(2007-11#2)(2007-2#2)(2007-4#1)(2007-5#2)(2007-8#5)(2008-1#7)(2008-3#12)(2008-6#1)(2008-7#2)(2008-8#4)(2009-1#1)(2009-11#7)(2009-2#1)(2009-7#1)(2009-9#2)(2010-10#5)(2010-12#1)(2010-4#2)(2011-1#2)(2011-2#8)(2012-1#4)(2012-12#6)(2012-2#2)(2012-3#3)(2012-4#2)(2012-5#3)(2013-1#3)(2013-7#2)(2013-8#4)
patients with typical##3##3##(1995-1#1)(2005-1#1)(2012-2#1)
patients with ulcerative colitis were treated##2##6##(1992-9#1)(1994-2#1)
patients with ulcerative colitis##6##4##(1992-9#1)(1994-2#1)(2006-10#2)(2006-2#1)(2013-1#1)
patients with ulcerative##7##3##(1992-9#1)(1994-2#1)(2006-10#2)(2006-2#1)(2010-12#1)(2013-1#1)
patients with uncomplicated disease##2##4##(1990-8#1)(1992-2#1)
patients with uncomplicated hypertension##2##4##(2005-12#1)(2008-3#1)
patients with uncomplicated##7##3##(1990-8#1)(1992-2#2)(2005-12#1)(2007-8#1)(2008-3#2)
patients with underlying##7##3##(1990-3#1)(2006-10#1)(2007-3#1)(2007-7#1)(2011-2#1)(2012-11#1)(2012-12#1)
patients with unexplained##7##3##(2006-10#1)(2006-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-11#1)(2013-1#1)
patients with unilateral neglect##2##4##(1996-2#1)(2009-2#1)
patients with unilateral or bilateral##2##5##(2006-9#1)(2008-12#1)
patients with unilateral##21##3##(1995-4#1)(1996-1#1)(1996-2#1)(2005-10#1)(2006-10#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-7#4)(2008-12#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-8#1)(2011-1#2)(2012-12#1)
patients with unknown##2##3##(1992-12#1)(2007-7#1)
patients with unrelieved##2##3##(2008-7#1)(2010-8#1)
patients with unresectable liver metastases##2##5##(1995-4#1)(2006-6#1)
patients with unresectable pancreatic##2##4##(1991-2#1)(2006-6#1)
patients with unresectable##8##3##(1991-2#1)(1995-4#1)(2006-6#2)(2008-3#1)(2012-2#1)(2013-1#2)
patients with unstable angina (UA)##2##5##(2013-1#1)(2013-8#1)
patients with unstable angina and##3##5##(2005-10#2)(2005-12#1)
patients with unstable angina pectoris##4##5##(1990-12#3)(2007-11#1)
patients with unstable angina##19##4##(1990-12#3)(1991-9#1)(2005-10#2)(2005-12#2)(2005-7#1)(2007-11#4)(2007-7#1)(2008-5#1)(2012-1#2)(2013-1#1)(2013-8#1)
patients with unstable thoracolumbar##2##4##(2006-8#2)
patients with unstable##25##3##(1990-12#3)(1991-9#1)(2005-10#2)(2005-12#2)(2005-7#1)(2006-8#3)(2007-11#4)(2007-7#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-1#2)(2013-1#1)(2013-8#1)
patients with untreated or##2##4##(1992-9#1)(2008-7#1)
patients with untreated##7##3##(1992-2#1)(1992-9#1)(1996-11#1)(2004-1#1)(2008-7#1)(2012-3#2)
patients with upper tract##3##4##(2006-12#1)(2006-9#2)
patients with upper##9##3##(1990-8#1)(2006-12#1)(2006-9#2)(2007-3#1)(2008-9#1)(2010-3#1)(2011-2#1)(2013-1#1)
patients with ureteral##2##3##(1994-4#1)(2013-1#1)
patients with urinary bladder cancer and##2##6##(1995-12#2)
patients with urinary bladder##4##4##(1995-12#2)(2008-2#1)(2009-4#1)
patients with urinary tract infection and##3##6##(2008-4#3)
patients with urinary##10##3##(1995-12#2)(1996-12#1)(2008-10#1)(2008-2#1)(2008-4#3)(2009-4#1)(2013-8#1)
patients with urological##2##3##(2006-7#1)(2008-10#1)
patients with uterine##3##3##(1995-12#1)(2006-6#1)(2011-2#1)
patients with valvular heart disease##4##5##(2011-2#4)
patients with valvular heart##6##4##(2011-2#4)(2013-1#2)
patients with valvular##7##3##(1990-6#1)(2011-2#4)(2013-1#2)
patients with varicocele##2##3##(1990-3#1)(2008-7#1)
patients with varicose haemorrhage##2##4##(2006-6#2)
patients with various forms of##2##5##(1996-12#1)(2005-7#1)
patients with various liver diseases##2##5##(1996-4#2)
patients with various types of##5##5##(1997-4#1)(2008-5#1)(2010-4#1)(2011-1#1)(2011-2#1)
patients with various##30##3##(1990-1#1)(1990-8#1)(1991-3#1)(1992-11#1)(1993-2#3)(1994-9#1)(1996-12#1)(1996-4#2)(1997-4#1)(1997-7#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-9#1)(2007-3#1)(2008-4#1)(2008-5#1)(2009-2#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
patients with varying degrees of##3##5##(1990-4#1)(2007-7#2)
patients with vascular access##2##4##(2007-8#1)(2013-1#1)
patients with vascular dementia (VD)##2##5##(1996-5#1)(2008-7#1)
patients with vascular dementia##5##4##(1996-5#2)(1997-7#1)(2007-9#1)(2008-7#1)
patients with vascular disease##2##4##(1993-2#1)(2010-1#1)
patients with vascular##13##3##(1993-2#1)(1996-5#2)(1997-7#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-7#1)(2010-1#1)(2012-12#1)(2013-1#1)
patients with venous leg##2##4##(1997-3#2)
patients with venous##4##3##(1997-3#2)(2007-9#2)
patients with vertebral fractures##2##4##(2007-11#1)(2013-1#1)
patients with vertebral##3##3##(2007-11#1)(2008-7#1)(2013-1#1)
patients with vertebrobasilar insufficiency##2##4##(2006-11#1)(2008-7#1)
patients with vertebrobasilar##3##3##(2006-11#1)(2008-7#1)(2012-3#1)
patients with very high##2##4##(2006-10#1)(2008-3#1)
patients with very small##3##4##(2006-3#2)(2011-2#1)
patients with very##6##3##(1990-12#1)(2006-10#1)(2006-3#2)(2008-3#1)(2011-2#1)
patients with vestibular migraine##2##4##(2012-2#2)
patients with vestibular##4##3##(2005-5#1)(2008-4#1)(2012-2#2)
patients with viral##2##3##(1993-2#1)(2011-1#1)
patients with visceral obesity##2##4##(2013-8#2)
patients with visceral##4##3##(2007-8#1)(2013-8#3)
patients with visual loss due to##2##6##(2011-2#1)(2013-1#1)
patients with visual##3##3##(2011-2#1)(2013-1#1)(2013-7#1)
patients with vitiligo##3##3##(2007-7#2)(2009-6#1)
patients with vivax malaria##3##4##(2012-12#2)(2012-2#1)
patients with von##2##3##(2008-1#1)(2008-10#1)
patients with well-controlled##2##3##(2010-4#1)(2010-9#1)
patients with white##2##3##(2008-5#1)(2008-7#1)
patients with whom##3##3##(1991-8#1)(1994-4#1)(1995-1#1)
patients with wide##2##3##(2011-2#2)
patients with widespread##2##3##(2006-10#2)
patients with xerostomia##3##3##(2007-9#3)
patients with β-TM##3##3##(2013-8#3)
patients with##9747##2##(1990-1#12)(1990-10#33)(1990-11#31)(1990-12#43)(1990-2#39)(1990-3#33)(1990-4#28)(1990-5#12)(1990-6#40)(1990-7#10)(1990-8#44)(1990-9#36)(1991-1#14)(1991-10#25)(1991-11#26)(1991-12#35)(1991-2#30)(1991-3#35)(1991-4#41)(1991-5#40)(1991-6#29)(1991-7#12)(1991-8#31)(1991-9#29)(1992-1#11)(1992-10#25)(1992-11#28)(1992-12#24)(1992-2#26)(1992-3#27)(1992-4#17)(1992-5#29)(1992-6#16)(1992-7#8)(1992-8#47)(1992-9#23)(1993-1#19)(1993-10#17)(1993-11#53)(1993-12#41)(1993-2#54)(1993-3#19)(1993-4#5)(1993-5#15)(1993-6#8)(1993-7#19)(1993-8#22)(1993-9#36)(1994-1#1)(1994-10#12)(1994-11#20)(1994-12#27)(1994-2#18)(1994-3#20)(1994-4#16)(1994-5#6)(1994-6#12)(1994-7#16)(1994-8#13)(1994-9#7)(1995-1#14)(1995-10#14)(1995-11#27)(1995-12#32)(1995-2#21)(1995-3#37)(1995-4#29)(1995-5#14)(1995-6#33)(1995-7#11)(1995-8#12)(1995-9#13)(1996-1#37)(1996-10#7)(1996-11#25)(1996-12#25)(1996-2#29)(1996-3#35)(1996-4#27)(1996-5#12)(1996-6#16)(1996-7#39)(1996-8#16)(1996-9#45)(1997-1#39)(1997-2#23)(1997-3#28)(1997-4#21)(1997-5#18)(1997-6#15)(1997-7#39)(1997-8#77)(1997-9#1)(2004-1#26)(2004-10#11)(2004-11#13)(2004-12#3)(2004-2#9)(2004-3#10)(2004-4#2)(2004-8#1)(2005-1#33)(2005-10#82)(2005-11#15)(2005-12#29)(2005-3#1)(2005-4#3)(2005-5#5)(2005-6#18)(2005-7#29)(2005-8#47)(2005-9#13)(2006-1#23)(2006-10#402)(2006-11#46)(2006-12#53)(2006-2#64)(2006-3#17)(2006-4#20)(2006-5#37)(2006-6#136)(2006-7#54)(2006-8#99)(2006-9#63)(2007-1#16)(2007-10#205)(2007-11#389)(2007-12#63)(2007-2#92)(2007-3#43)(2007-4#15)(2007-5#24)(2007-6#29)(2007-7#222)(2007-8#371)(2007-9#124)(2008-1#167)(2008-10#121)(2008-11#59)(2008-12#82)(2008-2#24)(2008-3#189)(2008-4#107)(2008-5#161)(2008-6#152)(2008-7#373)(2008-8#126)(2008-9#95)(2009-1#10)(2009-10#63)(2009-11#31)(2009-12#23)(2009-2#61)(2009-3#37)(2009-4#32)(2009-5#25)(2009-6#34)(2009-7#21)(2009-8#65)(2009-9#26)(2010-1#10)(2010-10#44)(2010-11#53)(2010-12#168)(2010-2#17)(2010-3#43)(2010-4#35)(2010-5#33)(2010-6#39)(2010-7#22)(2010-8#47)(2010-9#21)(2011-1#163)(2011-11#3)(2011-12#37)(2011-2#409)(2011-3#4)(2011-7#1)(2012-1#108)(2012-11#25)(2012-12#163)(2012-2#196)(2012-3#141)(2012-4#2)(2012-5#3)(2012-6#1)(2012-8#1)(2013-1#371)(2013-7#57)(2013-8#193)
patients withdrew##2##2##(2007-11#1)(2008-3#1)
patients within a##3##3##(2007-7#1)(2008-1#1)(2013-8#1)
patients within the##9##3##(1990-1#1)(1995-11#1)(1997-2#1)(2005-11#1)(2006-12#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)
patients within##25##2##(1990-1#1)(1991-11#1)(1993-7#1)(1995-11#1)(1996-3#1)(1997-2#1)(2005-11#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-7#2)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
patients without ADHD##2##3##(2013-8#2)
patients without EPS##2##3##(2011-2#2)
patients without a history of##3##5##(1991-3#1)(2006-8#1)(2007-7#1)
patients without a##5##3##(1990-9#1)(1991-3#1)(1995-6#1)(2006-8#1)(2007-7#1)
patients without an##2##3##(1992-7#1)(2010-9#1)
patients without any##4##3##(1992-12#1)(1997-7#1)(2007-7#1)(2013-8#1)
patients without cancer##3##3##(1991-7#3)
patients without cirrhosis##3##3##(1994-7#2)(2006-10#1)
patients without clinical##2##3##(2006-12#1)(2008-10#1)
patients without diabetes mellitus##2##4##(1992-5#1)(2011-1#1)
patients without diabetes##4##3##(1992-5#1)(1997-7#1)(2008-3#1)(2011-1#1)
patients without evidence of##3##4##(1993-9#1)(1995-12#1)(2006-8#1)
patients without heart##2##3##(1990-3#1)(2007-9#1)
patients without history of##4##4##(1990-9#1)(1992-6#1)(2006-8#2)
patients without ischemic heart disease##2##5##(2008-7#2)
patients without previous myocardial infarction##2##5##(2005-1#1)(2005-8#1)
patients without previous##5##3##(2005-1#2)(2005-8#1)(2007-8#1)(2013-1#1)
patients without prior##3##3##(1996-12#1)(2005-1#1)(2010-12#1)
patients without recurrence##2##3##(1995-10#1)(1996-6#1)
patients without renal##2##3##(2010-12#1)(2012-3#1)
patients without such##2##3##(2007-10#1)(2013-8#1)
patients without the##2##3##(2013-1#2)
patients without these##2##3##(2007-10#1)(2008-4#1)
patients without##174##2##(1990-11#1)(1990-2#2)(1990-3#2)(1990-9#2)(1991-11#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-7#3)(1992-12#1)(1992-5#2)(1992-6#1)(1992-7#2)(1993-11#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-7#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-6#1)(1996-1#3)(1996-12#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-1#3)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#5)(2006-12#2)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#10)(2007-10#11)(2007-11#5)(2007-12#1)(2007-7#5)(2007-8#9)(2007-9#3)(2008-1#2)(2008-10#5)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#8)(2008-8#1)(2009-10#1)(2009-2#2)(2010-12#6)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#10)(2012-1#2)(2012-2#1)(2012-3#3)(2013-1#8)(2013-3#1)(2013-8#5)
patients worldwide##5##2##(1995-11#1)(2005-8#1)(2006-10#1)(2011-2#1)(2012-2#1)
patients would be##6##3##(1991-11#1)(1994-2#1)(1996-3#1)(2007-8#1)(2010-8#1)(2012-11#1)
patients would benefit from##3##4##(2004-10#1)(2007-8#1)(2010-3#1)
patients would##19##2##(1991-11#1)(1994-2#1)(1996-3#1)(1997-4#1)(1997-6#1)(2004-10#1)(2007-10#1)(2007-8#2)(2008-12#1)(2008-5#2)(2008-6#1)(2010-3#1)(2010-8#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
patients younger than 20 years##2##5##(1993-10#1)(2007-8#1)
patients younger than 20##3##4##(1993-10#1)(1993-8#1)(2007-8#1)
patients younger than 40 years##2##5##(2010-12#2)
patients younger than 40##3##4##(2007-4#1)(2010-12#2)
patients younger than##13##3##(1993-10#1)(1993-8#1)(2004-12#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-3#1)(2008-9#2)(2010-12#2)(2012-2#1)
patients##32850##1##(1990-1#26)(1990-10#121)(1990-11#95)(1990-12#165)(1990-2#131)(1990-3#112)(1990-4#96)(1990-5#67)(1990-6#131)(1990-7#30)(1990-8#139)(1990-9#111)(1991-1#48)(1991-10#53)(1991-11#95)(1991-12#127)(1991-2#142)(1991-3#150)(1991-4#119)(1991-5#113)(1991-6#93)(1991-7#48)(1991-8#132)(1991-9#104)(1992-1#47)(1992-10#98)(1992-11#59)(1992-12#102)(1992-2#95)(1992-3#116)(1992-4#52)(1992-5#97)(1992-6#82)(1992-7#21)(1992-8#114)(1992-9#84)(1993-1#94)(1993-10#79)(1993-11#133)(1993-12#148)(1993-2#141)(1993-3#88)(1993-4#20)(1993-5#103)(1993-6#31)(1993-7#59)(1993-8#111)(1993-9#107)(1994-1#17)(1994-10#23)(1994-11#63)(1994-12#102)(1994-2#92)(1994-3#84)(1994-4#34)(1994-5#33)(1994-6#62)(1994-7#60)(1994-8#37)(1994-9#34)(1995-1#86)(1995-10#48)(1995-11#101)(1995-12#110)(1995-2#121)(1995-3#95)(1995-4#71)(1995-5#51)(1995-6#83)(1995-7#28)(1995-8#35)(1995-9#109)(1996-1#118)(1996-10#10)(1996-11#90)(1996-12#106)(1996-2#134)(1996-3#151)(1996-4#63)(1996-5#37)(1996-6#76)(1996-7#102)(1996-8#79)(1996-9#135)(1997-1#93)(1997-2#102)(1997-3#129)(1997-4#68)(1997-5#55)(1997-6#66)(1997-7#89)(1997-8#251)(1997-9#3)(2004-1#73)(2004-10#41)(2004-11#46)(2004-12#24)(2004-2#33)(2004-3#37)(2004-4#5)(2004-5#1)(2004-8#2)(2004-9#5)(2005-1#69)(2005-10#232)(2005-11#42)(2005-12#69)(2005-2#2)(2005-3#12)(2005-4#16)(2005-5#27)(2005-6#34)(2005-7#91)(2005-8#140)(2005-9#48)(2006-1#70)(2006-10#1069)(2006-11#144)(2006-12#273)(2006-2#203)(2006-3#62)(2006-4#76)(2006-5#106)(2006-6#377)(2006-7#178)(2006-8#495)(2006-9#182)(2007-1#62)(2007-10#549)(2007-11#1003)(2007-12#306)(2007-2#359)(2007-3#216)(2007-4#65)(2007-5#70)(2007-6#94)(2007-7#1157)(2007-8#1463)(2007-9#480)(2008-1#692)(2008-10#407)(2008-11#278)(2008-12#205)(2008-2#96)(2008-3#544)(2008-4#360)(2008-5#499)(2008-6#499)(2008-7#1105)(2008-8#454)(2008-9#273)(2009-1#30)(2009-10#154)(2009-11#75)(2009-12#60)(2009-2#155)(2009-3#144)(2009-4#110)(2009-5#84)(2009-6#114)(2009-7#71)(2009-8#134)(2009-9#88)(2010-1#30)(2010-10#102)(2010-11#117)(2010-12#470)(2010-2#97)(2010-3#151)(2010-4#146)(2010-5#117)(2010-6#84)(2010-7#119)(2010-8#191)(2010-9#73)(2011-1#537)(2011-11#27)(2011-12#125)(2011-2#1560)(2011-3#21)(2011-7#7)(2011-9#1)(2012-1#246)(2012-10#1)(2012-11#75)(2012-12#500)(2012-2#708)(2012-3#461)(2012-4#8)(2012-5#12)(2012-6#3)(2012-8#1)(2013-1#1320)(2013-3#2)(2013-7#162)(2013-8#572)
patients&gt##2##1##(2007-7#2)
patients&quot##7##1##(2006-6#1)(2007-7#2)(2008-2#1)(2008-4#1)(2010-8#1)(2013-1#1)
patients' QoL##3##2##(2008-3#1)(2011-2#1)(2012-12#1)
patients' ability to##4##3##(2007-7#1)(2007-8#1)(2008-12#1)(2010-4#1)
patients' acceptance of##2##3##(1990-4#1)(2012-2#1)
patients' acceptance##4##2##(1990-4#2)(2007-8#1)(2012-2#1)
patients' adherence to their##2##4##(2008-8#1)(2012-1#1)
patients' adherence to##3##3##(2008-3#1)(2008-8#1)(2012-1#1)
patients' age and##2##3##(2010-8#1)(2012-2#1)
patients' age was##3##3##(1991-9#1)(2007-10#1)(2007-8#1)
patients' age##12##2##(1990-8#1)(1991-9#1)(1993-2#1)(2007-10#1)(2007-8#1)(2008-1#1)(2010-2#1)(2010-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
patients' ages##5##2##(2005-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2013-8#1)
patients' and##2##2##(1995-12#1)(1997-5#1)
patients' baseline##2##2##(1996-6#1)(2013-1#1)
patients' care##2##2##(1997-2#1)(2008-1#1)
patients' characteristics in##2##3##(2009-6#1)(2010-8#1)
patients' characteristics##3##2##(2009-6#1)(2010-8#2)
patients' children##2##2##(1995-9#2)
patients' clinical outcomes##2##3##(2012-12#1)(2013-7#1)
patients' clinical##5##2##(1991-12#1)(2007-8#1)(2008-4#1)(2012-12#1)(2013-7#1)
patients' co-occurring##2##2##(2008-6#2)
patients' complaints of##2##3##(2008-7#1)(2012-12#1)
patients' complaints##6##2##(1991-9#1)(2007-9#1)(2008-7#1)(2009-1#1)(2010-12#1)(2012-12#1)
patients' compliance##2##2##(2008-1#1)(2008-11#1)
patients' condition##2##2##(2007-7#1)(2009-8#1)
patients' consent##2##2##(1996-3#1)(2008-5#1)
patients' cultural##3##2##(2008-11#1)(2008-5#1)(2013-1#1)
patients' current##3##2##(1994-3#1)(2008-11#1)(2008-5#1)
patients' data##6##2##(1991-5#1)(2006-8#1)(2007-7#1)(2008-10#1)(2010-8#1)(2013-8#1)
patients' education##2##2##(1990-4#1)(2008-6#1)
patients' evaluation of##2##3##(1993-2#1)(2006-7#1)
patients' expectations##5##2##(1997-8#1)(2006-10#1)(2007-10#1)(2011-2#1)(2013-8#1)
patients' experience and knowledge about##2##5##(2011-1#2)
patients' experience and satisfaction##2##4##(2012-3#2)
patients' experience and##5##3##(2011-1#2)(2012-3#3)
patients' experience##8##2##(2010-10#1)(2011-1#2)(2011-2#1)(2012-3#4)
patients' experiences##2##2##(2010-4#1)(2011-12#1)
patients' genetic##2##2##(2007-3#1)(2008-1#1)
patients' health##3##2##(2006-8#1)(2007-4#1)(2008-6#1)
patients' height##2##2##(1995-3#1)(2011-2#1)
patients' immune##2##2##(1990-2#1)(2007-11#1)
patients' knowledge##3##2##(2008-10#1)(2008-3#2)
patients' lack of##2##3##(2011-2#1)(2012-2#1)
patients' lives##3##2##(2007-10#1)(2007-7#1)(2007-8#1)
patients' mean##2##2##(1990-3#1)(2007-7#1)
patients' medical records##2##3##(2007-10#1)(2009-5#1)
patients' medical##4##2##(2007-10#1)(2008-11#1)(2008-7#1)(2009-5#1)
patients' mobility and##2##3##(2007-11#1)(2012-12#1)
patients' needs##6##2##(1997-3#1)(2007-4#1)(2008-3#1)(2010-10#1)(2010-2#1)(2013-8#1)
patients' negative##2##2##(1994-8#1)(2011-1#1)
patients' organisations##2##2##(2013-1#2)
patients' out-of-pocket##2##2##(2008-4#1)(2011-2#1)
patients' overall##3##2##(1991-3#1)(1996-3#1)(2012-12#1)
patients' pain##2##2##(2006-9#1)(2010-6#1)
patients' perception of their##2##4##(2008-11#1)(2009-2#1)
patients' perception of##4##3##(2008-11#1)(2009-2#1)(2013-1#2)
patients' perceptions of the communication with##2##6##(2010-3#2)
patients' perceptions of the communication##3##5##(2010-3#3)
patients' perceptions of the##4##4##(2009-7#1)(2010-3#3)
patients' perceptions of##6##3##(1996-1#1)(2009-7#1)(2010-3#3)(2011-2#1)
patients' performance status##2##3##(2010-2#2)
patients' performance##3##2##(2010-2#2)(2013-1#1)
patients' personal##2##2##(1994-1#1)(2006-7#1)
patients' perspective##3##2##(2008-12#1)(2010-12#1)(2011-2#1)
patients' physical##4##2##(1996-2#1)(2007-10#1)(2007-12#1)(2010-2#1)
patients' physicians##2##2##(2006-10#1)(2008-8#1)
patients' plasma##4##2##(1992-2#1)(1997-1#1)(2006-9#2)
patients' preferences##3##2##(1994-6#1)(2007-8#1)(2008-7#1)
patients' problems##3##2##(1993-2#1)(2013-1#2)
patients' prognosis##2##2##(1991-4#1)(2013-8#1)
patients' quality of life and##3##5##(1992-5#1)(2008-3#1)(2011-12#1)
patients' quality of life##16##4##(1992-5#1)(2005-3#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-12#1)(2011-2#3)(2012-2#2)(2013-1#2)
patients' rating of##3##3##(1995-9#1)(2008-8#2)
patients' ratings of quality of life##2##6##(2008-7#2)
patients' records##4##2##(2007-2#1)(2008-1#1)(2010-12#1)(2013-1#1)
patients' requirements##2##2##(1990-10#2)
patients' rights were##2##3##(2013-8#2)
patients' rights##12##2##(1990-11#1)(1994-1#1)(1997-8#1)(2005-7#1)(2013-8#8)
patients' samples##4##2##(1990-12#1)(1994-6#3)
patients' satisfaction with##6##3##(1997-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2012-3#1)(2013-8#1)
patients' satisfaction##8##2##(1997-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2011-12#1)(2012-3#1)(2013-8#1)
patients' sera##6##2##(1991-9#1)(1995-3#1)(1996-8#1)(2005-12#3)
patients' speech##2##2##(2008-9#2)
patients' suffering##2##2##(2008-1#1)(2010-7#1)
patients' symptom##3##2##(2006-8#1)(2013-1#2)
patients' symptoms##3##2##(1993-5#1)(2012-11#1)(2012-3#1)
patients' views of##2##3##(1991-2#1)(2006-5#1)
patients' views##6##2##(1991-2#1)(1993-5#1)(2004-10#1)(2006-5#1)(2010-8#1)(2011-1#1)
patients' waiting times and##2##4##(2006-2#2)
patients' waiting##4##2##(2006-2#4)
patients' well-being##2##2##(2007-11#1)(2013-7#1)
patients' wishes##3##2##(1990-6#1)(2006-10#1)(2013-7#1)
patients'##470##1##(1990-10#3)(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#2)(1990-4#4)(1990-6#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-2#6)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#4)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#3)(1992-8#1)(1993-12#1)(1993-2#3)(1993-5#3)(1994-1#4)(1994-2#4)(1994-3#1)(1994-6#4)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#3)(1995-4#1)(1995-6#1)(1995-9#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#6)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#3)(1997-7#1)(1997-8#4)(2004-10#1)(2005-10#1)(2005-12#4)(2005-2#1)(2005-3#3)(2005-6#1)(2005-7#4)(2005-8#2)(2006-1#1)(2006-10#15)(2006-11#1)(2006-12#1)(2006-2#6)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#3)(2006-9#5)(2007-10#7)(2007-11#5)(2007-12#1)(2007-2#5)(2007-3#2)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#12)(2007-8#12)(2007-9#3)(2008-1#10)(2008-10#2)(2008-11#9)(2008-12#3)(2008-3#8)(2008-4#3)(2008-5#6)(2008-6#6)(2008-7#14)(2008-8#8)(2008-9#5)(2009-1#4)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#4)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#8)(2010-2#8)(2010-3#5)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#8)(2011-1#7)(2011-12#3)(2011-2#23)(2012-1#3)(2012-11#4)(2012-12#9)(2012-2#9)(2012-3#8)(2012-4#1)(2013-1#27)(2013-7#4)(2013-8#22)
patients(4##4##1##(1991-2#4)
patients) (P=0##2##2##(2007-8#2)
patients) and the elderly##2##4##(2008-11#2)
patients) and the##5##3##(1993-10#1)(2007-8#1)(2008-11#2)(2013-8#1)
patients) and##30##2##(1990-12#1)(1990-8#1)(1990-9#2)(1991-2#1)(1991-4#1)(1992-2#2)(1993-10#1)(1995-4#1)(1996-1#2)(2004-11#1)(2006-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-4#1)(2008-6#2)(2008-7#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-8#1)
patients) at##2##2##(1994-3#1)(2009-3#1)
patients) demonstrated##2##2##(2008-5#1)(2013-8#1)
patients) for tonsillitis##2##3##(2011-2#2)
patients) for##6##2##(1990-6#1)(1991-6#1)(1995-4#1)(2007-8#1)(2011-2#2)
patients) from##2##2##(1991-2#1)(1994-2#1)
patients) in the##6##3##(1990-8#1)(1990-9#1)(1997-5#1)(2011-2#2)(2013-1#1)
patients) in##7##2##(1990-8#1)(1990-9#2)(1997-5#1)(2011-2#2)(2013-1#1)
patients) of##2##2##(1990-5#1)(2008-5#1)
patients) or a##2##3##(2006-8#1)(2008-9#1)
patients) or with##2##3##(2007-11#1)(2007-9#1)
patients) or##15##2##(1990-6#1)(1990-9#1)(1991-3#1)(1991-4#1)(1991-6#1)(1997-4#1)(2006-8#1)(2007-11#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-7#1)(2008-9#1)(2009-12#1)
patients) was##6##2##(1991-8#1)(1992-8#1)(1994-7#1)(2006-9#1)(2008-1#1)(2008-6#1)
patients) were##7##2##(1990-12#1)(1992-2#1)(1996-1#1)(2007-9#1)(2008-4#1)(2008-9#1)(2011-2#1)
patients) with a##2##3##(2008-3#1)(2012-3#1)
patients) with##8##2##(1990-12#1)(1997-3#1)(2007-9#1)(2008-3#1)(2008-7#3)(2012-3#1)
patients)##261##1##(1990-10#1)(1990-12#6)(1990-2#1)(1990-5#1)(1990-6#2)(1990-8#3)(1990-9#6)(1991-10#1)(1991-2#3)(1991-3#1)(1991-4#3)(1991-5#1)(1991-6#2)(1991-8#1)(1992-2#3)(1992-3#1)(1992-8#2)(1992-9#2)(1993-10#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-2#2)(1994-3#2)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-4#2)(1995-5#1)(1995-6#2)(1996-1#6)(1996-12#1)(1996-2#1)(1997-3#4)(1997-4#3)(1997-5#1)(2004-11#1)(2005-1#2)(2005-10#2)(2006-10#4)(2006-12#7)(2006-4#2)(2006-6#3)(2006-8#4)(2006-9#7)(2007-11#5)(2007-2#14)(2007-3#5)(2007-7#10)(2007-8#24)(2007-9#7)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#2)(2008-3#3)(2008-4#4)(2008-5#3)(2008-6#4)(2008-7#15)(2008-9#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-2#1)(2011-1#2)(2011-2#18)(2012-12#5)(2012-2#4)(2012-3#3)(2013-1#3)(2013-8#5)
patients--a##2##1##(2012-2#2)
patients--and##3##1##(1992-6#1)(1995-1#1)(1996-3#1)
patients--two##2##1##(1993-10#1)(2008-9#1)
patients/families##4##1##(2008-1#2)(2010-2#2)
patients/visitors##2##1##(2009-9#2)
patients/year##2##1##(1993-10#2)
patients? A##2##2##(1995-3#1)(2011-2#1)
patients?##28##1##(1991-6#1)(1992-12#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-8#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-12#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2009-4#1)(2009-5#1)(2011-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
patients?]##8##1##(1990-2#1)(1991-2#1)(1993-11#2)(1994-12#1)(1995-8#1)(2009-2#1)(2011-12#1)
patientsA centAA##2##2##(2007-2#1)(2007-3#1)
patients]##178##1##(1990-1#1)(1990-10#2)(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#5)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#2)(1991-11#4)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#3)(1991-8#3)(1991-9#2)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#3)(1993-10#2)(1993-11#3)(1993-2#1)(1993-3#3)(1993-5#2)(1993-6#2)(1993-9#1)(1994-4#2)(1995-10#2)(1995-11#1)(1995-4#1)(1995-7#1)(1995-9#1)(1996-10#2)(1996-11#4)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#3)(2005-10#4)(2005-3#1)(2005-9#1)(2006-2#4)(2006-6#4)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-9#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-6#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#2)(2010-12#5)(2010-3#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#4)(2012-11#2)(2012-12#6)(2012-2#3)(2012-3#3)(2013-1#6)(2013-7#6)(2013-8#8)
patients`##2##1##(2013-1#2)
patientswith##2##1##(2009-8#2)
patientsâ##3##1##(2007-2#1)(2007-3#2)
pations##2##1##(2012-3#2)
patiënt##4##1##(2012-12#4)
patriarchal##3##1##(2006-12#1)(2007-12#1)(2010-2#1)
patriarchy##4##1##(1991-6#1)(2006-7#1)(2011-1#1)(2011-2#1)
patriciarum##6##1##(1995-1#2)(2006-8#4)
patrol##7##1##(1996-2#1)(2006-7#1)(2008-4#1)(2010-2#4)
patrollers##3##1##(2008-8#3)
patrols##3##1##(1993-2#1)(2010-2#2)
patron##3##1##(1991-1#1)(2007-12#1)(2008-8#1)
patronage##2##1##(1990-2#1)(2007-2#1)
patrons##7##1##(1992-12#1)(1993-1#2)(1997-3#1)(2006-8#1)(2009-7#1)(2012-2#1)
pattern (with##2##2##(1996-9#1)(1997-8#1)
pattern B##2##2##(2008-5#1)(2011-2#1)
pattern after the##2##3##(1994-12#1)(2008-11#1)
pattern after##3##2##(1994-12#1)(2006-10#1)(2008-11#1)
pattern among##5##2##(2006-4#1)(2007-12#1)(2007-8#1)(2012-12#1)(2012-2#1)
pattern analysis and##3##3##(2008-2#1)(2013-1#2)
pattern analysis of##6##3##(2008-10#5)(2008-2#1)
pattern analysis##22##2##(1994-12#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#3)(2008-4#1)(2011-2#1)(2013-1#4)(2013-7#1)
pattern and a##5##3##(1993-2#1)(1994-2#1)(1996-11#1)(2008-3#1)(2010-8#1)
pattern and bilateral##2##3##(2007-3#1)(2013-1#1)
pattern and for##2##3##(2006-10#1)(2007-7#1)
pattern and frequency of##3##4##(2009-5#1)(2010-10#1)(2011-2#1)
pattern and intensity of##3##4##(1995-11#1)(1997-2#1)(2008-5#1)
pattern and localization##2##3##(2008-12#1)(2012-2#1)
pattern and prevalence##2##3##(2007-6#1)(2008-1#1)
pattern and size##2##3##(1993-11#1)(2008-8#1)
pattern and that##2##3##(1991-7#1)(2008-11#1)
pattern and the##12##3##(1990-7#1)(1992-3#1)(1995-6#1)(1995-8#1)(1996-6#1)(2006-11#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-4#1)(2013-7#1)
pattern and to##3##3##(1990-12#1)(2012-2#1)(2013-1#1)
pattern and##123##2##(1990-12#2)(1990-7#1)(1991-10#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-2#1)(1992-3#3)(1992-4#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#3)(1994-12#2)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#2)(1996-11#1)(1996-2#2)(1996-4#1)(1996-6#1)(1996-9#2)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-12#5)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#3)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-2#2)(2013-1#3)(2013-7#2)(2013-8#1)
pattern appears##2##2##(2008-2#1)(2011-2#1)
pattern are##12##2##(1990-3#1)(1990-9#1)(1995-8#1)(2005-11#1)(2006-10#1)(2007-12#2)(2008-3#3)(2009-2#1)(2013-8#1)
pattern as a function of##2##5##(1991-12#1)(1994-9#1)
pattern as a##5##3##(1991-12#1)(1994-9#1)(1996-7#1)(2007-12#1)(2011-2#1)
pattern as that of##2##4##(1991-9#1)(2008-9#1)
pattern as the##4##3##(2007-12#1)(2008-10#2)(2010-1#1)
pattern as those##2##3##(2006-8#1)(2008-10#1)
pattern as well as##3##4##(2008-10#1)(2008-7#1)(2008-9#1)
pattern as##25##2##(1990-9#1)(1991-12#1)(1991-9#1)(1994-2#1)(1994-9#1)(1996-7#1)(1997-7#1)(2006-8#1)(2007-1#1)(2007-12#2)(2008-10#5)(2008-3#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-1#1)(2010-7#1)(2010-8#1)(2011-2#1)
pattern associated with##2##3##(2007-2#1)(2008-10#1)
pattern association##2##2##(2008-2#2)
pattern at an##2##3##(2008-2#1)(2008-3#1)
pattern at the##4##3##(1991-11#1)(1992-3#1)(2008-3#1)(2008-4#1)
pattern at##11##2##(1991-11#1)(1992-3#1)(1993-12#1)(1993-9#1)(1997-5#1)(2007-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)
pattern because##2##2##(2006-12#1)(2008-10#1)
pattern between the##3##3##(1996-8#1)(2009-8#1)(2011-2#1)
pattern between##5##2##(1996-5#1)(1996-8#1)(2009-8#1)(2011-2#1)(2012-3#1)
pattern but##3##2##(1995-2#1)(2004-9#1)(2007-11#1)
pattern by age##2##3##(1992-2#1)(1997-3#1)
pattern by##12##2##(1991-11#1)(1991-6#1)(1992-2#1)(1996-4#1)(1997-3#1)(2008-3#4)(2009-4#1)(2013-1#2)
pattern can be##6##3##(1993-6#1)(1994-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)
pattern can##8##2##(1993-6#1)(1994-8#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#1)
pattern changes in##3##3##(1997-1#1)(2013-8#2)
pattern changes##9##2##(1993-1#1)(1994-12#1)(1997-1#1)(2008-2#2)(2008-4#1)(2008-5#1)(2013-8#2)
pattern characteristic of##3##3##(1995-1#1)(1996-12#1)(2008-6#1)
pattern characterized by##4##3##(1992-4#1)(1993-3#1)(2006-2#1)(2010-6#1)
pattern code representation##2##3##(2008-2#2)
pattern code##3##2##(2008-2#3)
pattern completion##2##2##(2008-11#2)
pattern consisted of##4##3##(2006-1#2)(2007-7#1)(2008-7#1)
pattern consistent with##2##3##(1997-3#1)(2008-5#1)
pattern consisting of##3##3##(1993-2#1)(1993-6#1)(2006-1#1)
pattern consisting##4##2##(1993-2#1)(1993-6#1)(2006-1#1)(2008-5#1)
pattern containing##2##2##(2008-2#2)
pattern correlated##3##2##(1993-12#1)(1993-7#1)(2008-3#1)
pattern could be##3##3##(1996-3#1)(1997-8#1)(2007-1#1)
pattern curve##2##2##(2007-11#1)(2013-8#1)
pattern described##2##2##(1997-8#1)(2012-3#1)
pattern differences##2##2##(2012-7#1)(2013-1#1)
pattern discovery and visualization##2##4##(2006-5#2)
pattern discovery##4##2##(2006-5#2)(2008-2#2)
pattern discrimination##2##2##(1991-2#1)(1994-2#1)
pattern distinct from##3##3##(1995-3#1)(1996-2#1)(1997-4#1)
pattern during fictive cough##2##4##(1994-10#2)
pattern during the##3##3##(1991-6#2)(2008-10#1)
pattern during##11##2##(1991-6#2)(1994-10#2)(1996-10#1)(1996-5#1)(1997-4#1)(2008-10#2)(2008-11#2)
pattern dynamics##2##2##(2007-12#1)(2008-11#1)
pattern enumeration algorithm##2##3##(2006-12#2)
pattern evolution##3##2##(2008-9#2)(2013-8#1)
pattern features##3##2##(2005-11#1)(2008-2#1)(2008-6#1)
pattern for recording##2##3##(2007-12#2)
pattern for the##9##3##(1993-11#1)(1996-5#1)(1997-7#1)(2006-11#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
pattern for##26##2##(1991-10#1)(1991-9#1)(1993-11#1)(1996-5#1)(1997-7#1)(2006-11#1)(2006-5#1)(2007-12#4)(2007-5#1)(2007-6#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-2#2)(2013-8#1)
pattern formation are##2##3##(1997-6#1)(2009-5#1)
pattern formation during##5##3##(1991-5#1)(1997-4#1)(2006-6#1)(2009-8#1)(2010-12#1)
pattern formation in doubly resonant##2##5##(2007-12#2)
pattern formation in##8##3##(2007-12#2)(2007-9#2)(2008-6#1)(2008-7#1)(2009-8#1)(2012-12#1)
pattern formation##35##2##(1990-8#2)(1991-5#1)(1992-12#1)(1993-3#1)(1996-12#1)(1996-4#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-6#1)(2007-11#1)(2007-12#5)(2007-9#5)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-8#2)(2010-12#1)(2011-2#1)(2012-12#2)
pattern formed by##2##3##(2007-12#2)
pattern formed##4##2##(2007-11#1)(2007-12#2)(2007-4#1)
pattern found##3##2##(1993-11#1)(2007-5#1)(2008-5#1)
pattern from a##3##3##(2008-3#3)
pattern from the##6##3##(2008-1#2)(2008-2#1)(2008-5#1)(2010-2#1)(2011-2#1)
pattern from##13##2##(1992-2#1)(1993-8#1)(2008-1#2)(2008-2#2)(2008-3#3)(2008-5#1)(2010-11#1)(2010-2#1)(2011-2#1)
pattern generation##5##2##(1995-11#1)(2008-2#1)(2008-3#1)(2012-1#2)
pattern generator for##4##3##(1994-10#1)(2008-2#3)
pattern generator##15##2##(1992-9#1)(1994-10#1)(1997-7#2)(2007-12#2)(2008-2#4)(2008-6#1)(2009-12#1)(2009-6#1)(2013-1#2)
pattern generators##3##2##(2007-12#1)(2008-11#1)(2009-5#1)
pattern had a strong##2##4##(2005-7#1)(2012-2#1)
pattern had##3##2##(2005-7#1)(2008-2#1)(2012-2#1)
pattern has been observed##2##4##(2007-12#1)(2008-2#1)
pattern has been##5##3##(1990-9#1)(1996-12#1)(2007-12#1)(2008-2#1)(2010-5#1)
pattern has##10##2##(1990-9#1)(1996-12#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-5#1)(2013-1#1)
pattern have##3##2##(1996-2#1)(2006-9#1)(2011-2#1)
pattern identification and##2##3##(2006-5#1)(2008-11#1)
pattern identification##3##2##(2006-5#1)(2008-11#1)(2008-4#1)
pattern in a patient##2##4##(2006-9#1)(2013-1#1)
pattern in a##8##3##(2006-9#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-2#1)(2010-8#1)(2012-3#1)(2013-1#1)
pattern in all cell types##2##5##(1991-6#2)
pattern in all##4##3##(1991-6#2)(1993-3#1)(1994-8#1)
pattern in both##2##3##(2007-9#1)(2008-7#1)
pattern in growth##2##3##(2010-8#2)
pattern in liver##2##3##(1991-6#1)(1994-11#1)
pattern in patients with##2##4##(2006-8#1)(2011-2#1)
pattern in species richness##2##4##(2008-8#2)
pattern in the early##2##4##(1995-8#1)(2009-12#1)
pattern in the##30##3##(1993-11#1)(1994-10#1)(1995-12#1)(1995-8#1)(1996-10#1)(1996-4#2)(1996-7#1)(1997-3#1)(2005-11#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-8#1)(2009-12#1)(2010-5#1)(2010-8#1)
pattern in which the##2##4##(2008-3#1)(2012-12#1)
pattern in which##3##3##(1996-9#1)(2008-3#1)(2012-12#1)
pattern in##113##2##(1990-12#1)(1991-3#1)(1991-5#1)(1991-6#3)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-5#1)(1994-10#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-4#2)(1996-7#2)(1996-9#1)(1997-2#1)(1997-3#2)(1997-5#1)(2005-10#1)(2005-11#2)(2006-11#1)(2006-12#1)(2006-8#2)(2006-9#1)(2007-11#3)(2007-12#4)(2007-2#3)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#7)(2008-9#2)(2009-12#1)(2009-4#2)(2009-7#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-8#7)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#2)
pattern interferometer##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
pattern interferometry##18##2##(2007-12#1)(2008-2#10)(2008-3#5)(2008-8#1)(2009-7#1)
pattern involving##2##2##(1992-6#1)(2008-10#1)
pattern is a##10##3##(1996-4#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-11#1)(2012-2#3)
pattern is also##3##3##(1991-12#1)(2008-3#2)
pattern is compatible with##2##4##(2008-1#1)(2008-5#1)
pattern is considered to be##2##5##(2008-3#1)(2013-1#1)
pattern is consistent with##2##4##(2008-11#1)(2009-2#1)
pattern is more##3##3##(2007-10#1)(2008-3#1)(2010-2#1)
pattern is not##2##3##(2007-10#1)(2012-2#1)
pattern is the same##2##4##(1993-6#1)(2008-4#1)
pattern is the##4##3##(1993-6#1)(2007-7#1)(2008-4#1)(2013-8#1)
pattern is used##2##3##(2008-2#1)(2012-1#1)
pattern is very##2##3##(1997-4#1)(2008-11#1)
pattern is##82##2##(1990-3#1)(1990-7#1)(1991-12#1)(1991-6#1)(1993-12#1)(1993-6#1)(1994-3#1)(1994-5#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-4#1)(1997-7#1)(2006-10#3)(2006-11#2)(2006-8#1)(2007-10#2)(2007-12#4)(2007-7#1)(2008-1#4)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#14)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-11#1)(2010-2#1)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#2)(2013-8#2)
pattern like##2##2##(1990-5#1)(2007-8#1)
pattern match##2##2##(2011-1#1)(2012-12#1)
pattern matching##5##2##(2008-2#3)(2011-1#2)
pattern may be##3##3##(1996-2#1)(1997-3#1)(2012-12#1)
pattern may##7##2##(1994-9#1)(1996-2#1)(1997-3#1)(2008-1#1)(2008-10#1)(2009-8#1)(2012-12#1)
pattern near the##2##3##(1994-8#1)(2007-11#1)
pattern observed##5##2##(1992-3#1)(1994-9#1)(2005-10#1)(2005-11#1)(2008-10#1)
pattern obtained with the##2##4##(2008-10#1)(2008-5#1)
pattern obtained with##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
pattern obtained##6##2##(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)
pattern occurs##2##2##(2008-3#1)(2008-8#1)
pattern of DNA##2##3##(2007-11#1)(2008-2#1)
pattern of FGF-2##2##3##(1997-4#2)
pattern of GH secretion##2##4##(1995-10#1)(1997-2#1)
pattern of Helicobacter pylori##2##4##(2006-8#1)(2007-7#1)
pattern of NGF##2##3##(1992-8#1)(1996-12#1)
pattern of P##4##3##(1993-11#1)(2009-5#1)(2011-12#2)
pattern of Schistosoma haematobium in##2##5##(2007-7#2)
pattern of a population##2##4##(1990-8#1)(2008-2#1)
pattern of a##19##3##(1990-2#1)(1990-4#1)(1990-8#1)(1991-5#1)(1995-2#1)(1996-2#1)(1997-5#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)
pattern of accumulation of##3##4##(1995-8#1)(2008-10#1)(2008-7#1)
pattern of accumulation##5##3##(1995-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)
pattern of activation##2##3##(1995-8#1)(1997-8#1)
pattern of activity##4##3##(1992-10#1)(1992-9#1)(1997-2#1)(2008-11#1)
pattern of age-related##3##3##(1995-6#1)(2008-8#1)(2010-8#1)
pattern of alpha##2##3##(1990-12#1)(2005-11#1)
pattern of an##3##3##(2007-11#1)(2008-2#2)
pattern of apoptosis##2##3##(2003-11#1)(2008-5#1)
pattern of blood pressure##2##4##(1992-8#1)(1997-8#1)
pattern of both##2##3##(2007-12#1)(2013-7#1)
pattern of brain##3##3##(1995-5#1)(2008-11#1)(2008-6#1)
pattern of breast##2##3##(2006-1#1)(2011-1#1)
pattern of cancer##2##3##(2007-3#2)
pattern of care##2##3##(1990-10#1)(2008-8#1)
pattern of cerebral asymmetry##2##4##(1992-2#2)
pattern of cerebral##4##3##(1990-7#1)(1992-2#2)(2007-9#1)
pattern of change in the##2##5##(1990-10#1)(1994-12#1)
pattern of change in##3##4##(1990-10#1)(1994-12#1)(2012-2#1)
pattern of change##4##3##(1990-10#1)(1994-12#1)(2008-10#1)(2012-2#1)
pattern of changes in##4##4##(1991-2#1)(2007-2#1)(2010-6#1)(2010-8#1)
pattern of changes##7##3##(1990-2#1)(1991-2#1)(2007-2#1)(2008-11#2)(2010-6#1)(2010-8#1)
pattern of childhood##2##3##(2007-7#1)(2010-9#1)
pattern of connections##2##3##(1995-5#1)(1997-3#1)
pattern of connectivity##2##3##(1994-3#1)(2008-2#1)
pattern of cortisol##2##3##(2011-2#2)
pattern of deficits##3##3##(1995-11#1)(2009-1#1)(2009-4#1)
pattern of development##2##3##(1992-9#1)(1994-8#1)
pattern of disease##4##3##(1991-5#1)(2007-11#1)(2008-10#1)(2008-8#1)
pattern of distribution of##4##4##(1995-6#1)(2008-10#1)(2013-1#2)
pattern of distribution##11##3##(1992-8#1)(1993-6#1)(1995-6#1)(1996-3#1)(2008-10#5)(2013-1#2)
pattern of each##2##3##(2008-3#1)(2013-8#1)
pattern of errors##2##3##(2008-4#1)(2013-1#1)
pattern of evolution##3##3##(1991-3#1)(1995-11#1)(2008-8#1)
pattern of expression of the##4##5##(1994-11#1)(1995-2#1)(1995-5#1)(1997-4#1)
pattern of expression of##8##4##(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1997-4#1)(2007-1#1)
pattern of expression##15##3##(1990-5#1)(1991-5#1)(1991-9#1)(1992-2#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-4#1)(2007-1#1)(2010-6#1)
pattern of failure##2##3##(2008-6#1)(2012-3#1)
pattern of findings suggests##2##4##(2010-2#1)(2011-12#1)
pattern of findings##6##3##(2006-3#1)(2007-7#1)(2008-11#1)(2009-7#1)(2010-2#1)(2011-12#1)
pattern of frequency##2##3##(2010-4#1)(2011-2#1)
pattern of gene expression##6##4##(1992-1#1)(1993-11#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-6#1)
pattern of gene##7##3##(1992-1#1)(1993-11#1)(1995-11#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-6#1)
pattern of glomerulonephritis##2##3##(2007-7#2)
pattern of glycine##2##3##(1995-11#1)(1997-2#1)
pattern of growth##3##3##(2011-2#1)(2013-1#2)
pattern of hormonal##2##3##(1991-11#1)(1995-11#1)
pattern of human##4##3##(1997-7#1)(2008-5#1)(2011-1#1)(2011-2#1)
pattern of hydrogen##2##3##(1995-8#1)(2012-3#1)
pattern of increase##2##3##(1993-12#1)(2012-2#1)
pattern of increased##3##3##(1996-4#1)(2004-4#1)(2010-2#1)
pattern of inheritance##9##3##(1993-7#1)(1996-3#1)(1997-5#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-10#1)(2012-3#1)
pattern of inhibition##4##3##(1996-5#3)(2006-1#1)
pattern of injury##4##3##(1992-6#1)(1997-6#1)(2012-3#1)(2013-8#1)
pattern of labeling is##2##4##(1990-2#1)(1991-8#1)
pattern of left ventricular##2##4##(1990-5#1)(1995-6#1)
pattern of light##2##3##(2008-2#1)(2008-3#1)
pattern of loss##2##3##(2008-8#2)
pattern of methylation##2##3##(1997-4#1)(2007-11#1)
pattern of mortality in##2##4##(2011-2#1)(2013-1#1)
pattern of multiple##3##3##(1993-6#1)(2009-9#1)(2010-6#1)
pattern of neural##2##3##(1991-11#1)(2011-1#1)
pattern of neuronal##4##3##(1991-12#1)(1992-8#1)(2008-11#1)(2008-4#1)
pattern of normal##2##3##(1996-6#1)(2008-4#1)
pattern of occurrence##2##3##(2008-1#1)(2013-8#1)
pattern of performance##4##3##(2005-10#1)(2008-4#2)(2008-9#1)
pattern of phosphorylation##2##3##(1990-7#1)(1991-2#1)
pattern of presentation##2##3##(1991-8#1)(2010-12#1)
pattern of protein synthesis##2##4##(1993-9#1)(1994-11#1)
pattern of protein##5##3##(1991-1#1)(1993-9#1)(1994-11#1)(1995-6#1)(2008-5#1)
pattern of proton release##2##4##(1997-6#2)
pattern of proton##4##3##(1993-8#1)(1997-6#3)
pattern of pulmonary##2##3##(2008-4#1)(2010-3#1)
pattern of reactivity was##2##4##(1991-7#1)(1993-3#1)
pattern of reactivity##4##3##(1991-7#1)(1993-3#1)(1995-12#1)(2011-2#1)
pattern of readmission##2##3##(1992-6#2)
pattern of resistance##2##3##(1997-5#1)(2006-10#1)
pattern of responding##2##3##(2008-5#2)
pattern of response to##2##4##(2008-10#1)(2008-4#1)
pattern of response##4##3##(1990-6#1)(1991-2#1)(2008-10#1)(2008-4#1)
pattern of responses to##2##4##(1995-12#1)(1996-8#1)
pattern of results##7##3##(1993-12#1)(1994-3#1)(1996-1#1)(2004-12#1)(2008-2#1)(2008-9#1)(2012-11#1)
pattern of retinal##2##3##(1996-5#1)(2007-3#1)
pattern of secretion of [125I]IGF-II into milk##2##7##(1992-3#2)
pattern of sensitivity##2##3##(1990-11#1)(1996-9#1)
pattern of serum proteins in NAR##2##6##(1993-12#2)
pattern of serum##3##3##(1993-12#2)(1996-7#1)
pattern of sexual signalling##2##4##(2009-9#2)
pattern of skin diseases##2##4##(2007-3#1)(2007-7#1)
pattern of skin##4##3##(2006-4#2)(2007-3#1)(2007-7#1)
pattern of spread and##2##4##(1991-12#1)(2008-7#1)
pattern of spread##4##3##(1991-12#1)(2005-12#1)(2008-7#1)(2011-2#1)
pattern of the NR2C##2##4##(1996-12#2)
pattern of the disease##2##4##(1995-6#1)(2007-12#1)
pattern of the promoter region##2##5##(1990-5#1)(1995-1#1)
pattern of the##108##3##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-3#1)(1993-1#1)(1993-6#1)(1994-10#2)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-7#1)(1996-12#2)(1996-2#1)(1996-8#1)(1997-1#1)(1997-7#1)(1997-8#1)(2004-2#1)(2005-10#1)(2005-4#1)(2006-8#1)(2007-11#2)(2007-12#13)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#6)(2008-7#3)(2008-8#2)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-12#1)(2012-1#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#3)(2013-8#3)
pattern of their##5##3##(2007-12#1)(2008-10#1)(2008-11#1)(2011-12#1)(2013-7#1)
pattern of these##10##3##(1991-3#1)(1991-5#1)(1992-11#1)(1993-11#1)(2006-12#1)(2007-12#1)(2007-7#2)(2008-5#1)(2010-4#1)
pattern of this##3##3##(1995-2#1)(2007-12#1)(2012-3#1)
pattern of three##3##3##(1994-11#1)(1995-8#1)(2008-3#1)
pattern of treatment##2##3##(1991-4#1)(2011-2#1)
pattern of two##6##3##(1990-5#1)(1996-5#1)(2005-11#1)(2007-12#1)(2008-11#1)(2008-12#1)
pattern of use of indigenous medicines in diabetic patients##2##9##(2012-2#2)
pattern of use of##4##4##(2010-8#2)(2012-2#2)
pattern of use##7##3##(1996-9#1)(2006-8#1)(2010-8#2)(2011-1#1)(2012-2#2)
pattern of variation##2##3##(1994-9#1)(2013-1#1)
pattern of##992##2##(1990-10#4)(1990-11#4)(1990-12#6)(1990-2#8)(1990-3#1)(1990-4#5)(1990-5#7)(1990-6#2)(1990-7#4)(1990-8#3)(1990-9#3)(1991-1#5)(1991-10#2)(1991-11#4)(1991-12#6)(1991-2#4)(1991-3#5)(1991-4#2)(1991-5#7)(1991-6#1)(1991-7#3)(1991-8#3)(1991-9#5)(1992-1#4)(1992-10#2)(1992-11#2)(1992-12#5)(1992-2#4)(1992-3#4)(1992-4#2)(1992-5#2)(1992-6#5)(1992-7#1)(1992-8#7)(1992-9#8)(1993-1#3)(1993-11#3)(1993-12#10)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#4)(1993-7#1)(1993-8#3)(1993-9#4)(1994-10#3)(1994-11#6)(1994-12#5)(1994-2#4)(1994-3#3)(1994-5#5)(1994-6#4)(1994-8#7)(1994-9#6)(1995-1#9)(1995-10#2)(1995-11#11)(1995-12#10)(1995-2#6)(1995-3#3)(1995-5#7)(1995-6#9)(1995-7#6)(1995-8#9)(1996-1#1)(1996-12#7)(1996-2#4)(1996-3#4)(1996-4#4)(1996-5#10)(1996-6#5)(1996-7#3)(1996-8#4)(1996-9#6)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#10)(1997-5#5)(1997-6#9)(1997-7#6)(1997-8#6)(2003-11#1)(2004-11#2)(2004-12#1)(2004-2#2)(2004-4#2)(2005-10#6)(2005-11#4)(2005-12#3)(2005-4#1)(2005-7#1)(2005-8#3)(2005-9#2)(2006-1#3)(2006-10#4)(2006-11#4)(2006-12#10)(2006-2#1)(2006-3#3)(2006-4#4)(2006-6#1)(2006-7#3)(2006-8#10)(2006-9#2)(2007-1#6)(2007-10#4)(2007-11#10)(2007-12#43)(2007-2#7)(2007-3#7)(2007-7#20)(2007-8#4)(2007-9#2)(2008-1#8)(2008-10#61)(2008-11#22)(2008-12#7)(2008-2#19)(2008-3#18)(2008-4#17)(2008-5#25)(2008-6#9)(2008-7#25)(2008-8#20)(2008-9#15)(2009-1#2)(2009-10#4)(2009-2#1)(2009-3#2)(2009-4#7)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#2)(2009-9#6)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#4)(2010-2#6)(2010-3#2)(2010-4#3)(2010-6#5)(2010-7#1)(2010-8#9)(2010-9#1)(2011-1#14)(2011-12#7)(2011-2#19)(2012-1#9)(2012-11#1)(2012-12#6)(2012-2#18)(2012-3#11)(2012-8#1)(2013-1#22)(2013-7#7)(2013-8#7)
pattern on a##3##3##(2008-3#1)(2009-7#1)(2010-7#1)
pattern on the surface of##2##5##(2007-12#1)(2008-3#1)
pattern on the##9##3##(1991-12#1)(2007-12#1)(2008-3#3)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
pattern on##28##2##(1991-11#1)(1991-12#1)(1992-5#1)(1992-9#1)(1993-6#1)(2004-9#1)(2006-10#2)(2007-10#2)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#5)(2008-5#1)(2009-7#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#3)
pattern onto the##3##3##(2007-11#1)(2007-12#1)(2008-1#1)
pattern or by##3##3##(2007-12#1)(2008-3#1)(2010-5#1)
pattern or##6##2##(1993-9#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-5#1)
pattern output from##2##3##(2008-3#2)
pattern over the##2##3##(2011-2#1)(2013-8#1)
pattern over##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
pattern planning is##2##3##(2012-1#2)
pattern produced by##5##3##(1991-3#1)(2007-11#3)(2008-2#1)
pattern produced##6##2##(1991-3#1)(2007-11#3)(2008-2#1)(2008-4#1)
pattern recognition (PR)##2##3##(2008-10#2)
pattern recognition and##4##3##(2008-3#2)(2013-1#2)
pattern recognition based on##4##4##(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)
pattern recognition by use of a##2##6##(2007-12#1)(2008-3#1)
pattern recognition by use of##4##5##(2007-12#2)(2008-3#2)
pattern recognition by##5##3##(2007-12#2)(2008-3#3)
pattern recognition in##2##3##(2008-3#2)
pattern recognition is##3##3##(2006-12#1)(2008-10#1)(2008-3#1)
pattern recognition molecule##2##3##(2010-4#2)
pattern recognition of the##2##4##(2008-3#1)(2012-12#1)
pattern recognition of##6##3##(2008-10#2)(2008-3#3)(2012-12#1)
pattern recognition problems##2##3##(2008-2#1)(2008-3#1)
pattern recognition procedures##4##3##(2008-10#3)(2010-5#1)
pattern recognition receptor##3##3##(2010-2#1)(2010-4#1)(2011-1#1)
pattern recognition receptors (PRRs)##5##4##(2008-4#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-2#1)
pattern recognition receptors that##2##4##(2009-8#1)(2013-1#1)
pattern recognition receptors##10##3##(2008-1#1)(2008-4#1)(2009-6#1)(2009-8#2)(2010-12#2)(2010-8#1)(2011-2#1)(2013-1#1)
pattern recognition techniques##5##3##(2008-10#4)(2009-3#1)
pattern recognition that##4##3##(2007-12#2)(2008-3#1)(2013-8#1)
pattern recognition with##5##3##(2008-3#5)
pattern recognition##103##2##(1991-8#1)(2006-12#1)(2007-12#7)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#18)(2008-11#1)(2008-2#10)(2008-3#27)(2008-4#1)(2008-7#1)(2009-3#3)(2009-6#1)(2009-8#2)(2010-12#2)(2010-2#2)(2010-4#4)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#4)
pattern reflecting##2##2##(2008-7#1)(2010-8#1)
pattern regarding##2##2##(2010-1#1)(2010-3#1)
pattern search##3##2##(2008-2#2)(2012-1#1)
pattern seems to##2##3##(1995-5#1)(2006-10#1)
pattern seems##3##2##(1995-5#1)(2006-10#1)(2008-11#1)
pattern seen in##3##3##(1990-2#1)(1995-11#1)(2006-2#1)
pattern seen##4##2##(1990-2#1)(1990-6#1)(1995-11#1)(2006-2#1)
pattern separation and activity regulation##2##5##(1991-6#2)
pattern separation##5##2##(1991-6#3)(2008-11#1)(2013-8#1)
pattern showed##5##2##(1997-6#1)(2004-9#1)(2008-2#1)(2008-3#1)(2008-7#1)
pattern shows that the##2##4##(2008-10#1)(2013-8#1)
pattern shows##3##2##(2008-10#2)(2013-8#1)
pattern similar to that of the##2##6##(2007-12#1)(2008-5#1)
pattern similar to that##6##4##(1991-6#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-5#1)
pattern similar to##9##3##(1991-6#1)(1996-12#1)(1996-3#1)(2007-12#1)(2008-10#3)(2008-5#1)(2010-9#1)
pattern suggesting##3##2##(1991-10#1)(1997-7#1)(2008-10#1)
pattern suggests that the##2##4##(2008-4#1)(2008-5#1)
pattern suggests that##3##3##(1990-7#1)(2008-4#1)(2008-5#1)
pattern suggests##4##2##(1990-7#1)(1997-5#1)(2008-4#1)(2008-5#1)
pattern surfaces with##2##3##(2008-7#1)(2010-4#1)
pattern than by##2##3##(2005-11#1)(2008-6#1)
pattern than##5##2##(1997-6#1)(2005-11#1)(2008-3#2)(2008-6#1)
pattern that is##12##3##(1991-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-8#1)(2008-9#1)(2010-6#1)
pattern that was##3##3##(2007-12#1)(2008-10#2)
pattern that##32##2##(1991-6#1)(1994-5#1)(1994-8#1)(1996-7#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#7)(2008-3#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-6#1)(2012-1#1)
pattern the##2##2##(1993-12#1)(2008-2#1)
pattern through the##2##3##(2008-10#1)(2008-2#1)
pattern through##3##2##(2008-10#1)(2008-2#2)
pattern to a##2##3##(2008-10#1)(2008-3#1)
pattern to that of##2##4##(1990-12#1)(2012-12#1)
pattern to that##4##3##(1990-12#1)(1994-10#1)(2012-12#2)
pattern to the##4##3##(1990-4#1)(1994-2#1)(1996-2#1)(2008-3#1)
pattern to##28##2##(1990-10#1)(1990-12#1)(1990-4#1)(1991-5#1)(1991-6#1)(1994-10#1)(1994-2#1)(1995-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(2004-9#1)(2006-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-7#1)(2012-12#3)(2012-2#1)
pattern toward##2##2##(1995-6#1)(2006-8#1)
pattern towards##2##2##(1994-11#1)(2008-8#1)
pattern typically##2##2##(1992-9#1)(1997-7#1)
pattern using##2##2##(1994-6#1)(2008-10#1)
pattern varies##2##2##(1990-7#1)(2008-7#1)
pattern was also##2##3##(1993-5#1)(2008-10#1)
pattern was composed of##2##4##(1995-5#1)(2005-11#1)
pattern was correlated##2##3##(2008-11#1)(2013-8#1)
pattern was evident##2##3##(2008-10#2)
pattern was found for##4##4##(1991-7#1)(2007-10#1)(2007-5#1)(2008-9#1)
pattern was found to be##2##5##(2008-11#1)(2011-2#1)
pattern was found##9##3##(1991-7#1)(1993-1#1)(2006-11#1)(2007-10#1)(2007-5#1)(2008-11#2)(2008-9#1)(2011-2#1)
pattern was not##6##3##(1991-7#1)(1993-7#1)(1994-12#1)(1996-9#1)(2006-4#1)(2010-12#1)
pattern was observed for##4##4##(1991-7#1)(1993-12#1)(2007-9#1)(2008-10#1)
pattern was observed in##4##4##(1994-6#1)(1996-5#1)(2006-5#1)(2008-10#1)
pattern was observed##19##3##(1990-5#1)(1991-7#1)(1992-6#1)(1993-12#1)(1994-6#1)(1994-8#1)(1995-12#1)(1996-5#1)(2006-5#1)(2006-7#1)(2007-2#1)(2007-9#1)(2008-10#4)(2008-11#1)(2010-8#2)
pattern was similar to##2##4##(1992-11#1)(1995-5#1)
pattern was similar##4##3##(1992-11#1)(1995-5#1)(2004-4#1)(2006-8#1)
pattern was studied##3##3##(1993-12#2)(2007-9#1)
pattern was the##3##3##(1992-4#1)(2006-11#1)(2007-3#1)
pattern was##100##2##(1990-11#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-7#3)(1992-11#1)(1992-4#1)(1992-6#1)(1993-1#1)(1993-12#4)(1993-2#1)(1993-5#2)(1993-6#1)(1993-7#1)(1994-12#1)(1994-6#2)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-5#2)(1995-6#1)(1996-5#2)(1996-6#1)(1996-9#1)(2004-2#1)(2004-4#1)(2005-11#1)(2006-11#3)(2006-12#1)(2006-4#3)(2006-5#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-9#2)(2008-10#10)(2008-11#4)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#2)(2010-2#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
pattern were##4##2##(2006-10#1)(2008-10#1)(2010-10#1)(2012-11#1)
pattern where##3##2##(2007-7#1)(2010-6#1)(2012-1#1)
pattern whereas##2##2##(1994-8#1)(2007-12#1)
pattern which is##2##3##(1992-9#1)(2012-3#1)
pattern which##5##2##(1992-9#1)(1993-7#1)(1996-9#1)(2007-4#1)(2012-3#1)
pattern while##2##2##(1995-12#1)(2008-10#1)
pattern with a##4##3##(1994-8#1)(2008-10#2)(2008-3#1)
pattern with high##3##3##(2008-10#2)(2008-2#1)
pattern with reduced##2##3##(1992-12#1)(2010-9#1)
pattern with the##6##3##(1991-2#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2013-1#1)
pattern with##33##2##(1991-2#1)(1991-5#1)(1992-12#2)(1994-8#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#1)(2005-8#1)(2008-10#8)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-9#1)(2010-2#1)(2010-9#1)(2011-2#1)(2013-1#2)
pattern within the##2##3##(1996-5#1)(2006-12#1)
pattern within##4##2##(1991-2#1)(1994-6#1)(1996-5#1)(2006-12#1)
pattern##2757##1##(1990-10#6)(1990-11#7)(1990-12#13)(1990-2#10)(1990-3#4)(1990-4#9)(1990-5#10)(1990-6#4)(1990-7#10)(1990-8#7)(1990-9#6)(1991-1#6)(1991-10#8)(1991-11#9)(1991-12#10)(1991-2#11)(1991-3#8)(1991-4#5)(1991-5#14)(1991-6#20)(1991-7#8)(1991-8#8)(1991-9#8)(1992-1#5)(1992-10#3)(1992-11#3)(1992-12#11)(1992-2#7)(1992-3#12)(1992-4#9)(1992-5#3)(1992-6#8)(1992-7#2)(1992-8#8)(1992-9#15)(1993-1#5)(1993-11#9)(1993-12#24)(1993-2#6)(1993-3#5)(1993-4#1)(1993-5#5)(1993-6#9)(1993-7#4)(1993-8#5)(1993-9#12)(1994-10#9)(1994-11#9)(1994-12#14)(1994-2#9)(1994-3#9)(1994-5#9)(1994-6#10)(1994-7#1)(1994-8#17)(1994-9#13)(1995-1#12)(1995-10#4)(1995-11#17)(1995-12#21)(1995-2#12)(1995-3#5)(1995-5#13)(1995-6#17)(1995-7#7)(1995-8#18)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#12)(1996-2#15)(1996-3#14)(1996-4#11)(1996-5#18)(1996-6#10)(1996-7#10)(1996-8#7)(1996-9#14)(1997-1#3)(1997-2#9)(1997-3#10)(1997-4#15)(1997-5#10)(1997-6#16)(1997-7#20)(1997-8#12)(2003-11#1)(2004-11#3)(2004-12#1)(2004-2#4)(2004-4#3)(2004-9#8)(2005-10#9)(2005-11#16)(2005-12#3)(2005-4#2)(2005-7#4)(2005-8#6)(2005-9#3)(2006-1#8)(2006-10#23)(2006-11#15)(2006-12#23)(2006-2#4)(2006-3#3)(2006-4#11)(2006-5#7)(2006-6#5)(2006-7#5)(2006-8#22)(2006-9#5)(2007-1#11)(2007-10#12)(2007-11#40)(2007-12#126)(2007-2#15)(2007-3#10)(2007-4#2)(2007-5#6)(2007-6#3)(2007-7#43)(2007-8#21)(2007-9#17)(2008-1#30)(2008-10#189)(2008-11#65)(2008-12#13)(2008-2#143)(2008-3#167)(2008-4#32)(2008-5#59)(2008-6#27)(2008-7#58)(2008-8#49)(2008-9#41)(2009-1#3)(2009-10#8)(2009-11#4)(2009-12#5)(2009-2#3)(2009-3#8)(2009-4#15)(2009-5#14)(2009-6#5)(2009-7#16)(2009-8#18)(2009-9#8)(2010-1#5)(2010-10#7)(2010-11#10)(2010-12#17)(2010-2#17)(2010-3#6)(2010-4#12)(2010-5#8)(2010-6#10)(2010-7#6)(2010-8#26)(2010-9#7)(2011-1#25)(2011-12#11)(2011-2#63)(2011-3#1)(2012-1#22)(2012-11#4)(2012-12#29)(2012-2#54)(2012-3#19)(2012-7#1)(2012-8#1)(2013-1#57)(2013-7#14)(2013-8#36)
pattern&quot##3##1##(2006-10#1)(2011-2#2)
pattern) and##2##2##(2007-11#1)(2008-5#1)
pattern) in##2##2##(2008-11#1)(2012-12#1)
pattern)##13##1##(1991-11#1)(2005-8#2)(2007-10#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-12#1)
pattern-matching##2##1##(1996-2#1)(2008-2#1)
pattern-recognition techniques##2##2##(2007-12#1)(2008-10#1)
pattern-recognition##12##1##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#4)(2009-11#2)
pattern?##2##1##(1990-10#1)(2008-7#1)
patterned DNA##3##2##(2007-8#1)(2010-7#2)
patterned after##3##2##(1990-2#1)(1990-9#1)(1997-5#1)
patterned by##4##2##(2007-12#2)(2008-1#1)(2008-10#1)
patterned into a GaInAsP confining layer##2##6##(2007-11#1)(2007-12#1)
patterned into a##3##3##(2007-11#1)(2007-12#2)
patterned into##4##2##(2007-11#1)(2007-12#2)(2008-7#1)
patterned on##3##2##(2007-8#1)(2009-11#1)(2010-4#1)
patterned silane layers##2##3##(2005-11#2)
patterned structure##2##2##(1995-5#1)(2009-7#1)
patterned surface##6##2##(2005-11#1)(2006-12#1)(2006-2#2)(2008-7#1)(2009-12#1)
patterned surfaces##2##2##(1994-11#1)(2006-5#1)
patterned with a##2##3##(2008-3#1)(2008-7#1)
patterned with##4##2##(1994-9#1)(2008-11#1)(2008-3#1)(2008-7#1)
patterned##72##1##(1990-2#1)(1990-9#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-5#1)(1995-9#2)(1997-5#1)(2005-11#3)(2006-12#2)(2006-2#2)(2006-5#1)(2007-11#3)(2007-12#6)(2007-8#5)(2008-1#3)(2008-10#2)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#8)(2009-10#2)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-4#4)(2010-7#4)(2012-2#1)
patterning and morphogenesis##2##3##(2007-8#1)(2012-12#1)
patterning and##8##2##(1997-3#1)(2007-8#1)(2009-2#1)(2009-6#1)(2012-12#4)
patterning by##2##2##(2007-12#1)(2009-7#1)
patterning capabilities of##2##3##(2010-9#2)
patterning capabilities##3##2##(2010-9#3)
patterning for##3##2##(2006-5#1)(2010-4#1)(2010-9#1)
patterning functions##3##2##(2006-4#1)(2012-12#2)
patterning gene##2##2##(1996-12#1)(2007-12#1)
patterning in the##3##3##(1993-12#1)(2007-12#1)(2008-11#1)
patterning in##11##2##(1990-7#2)(1993-12#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2012-12#3)
patterning is##6##2##(2008-11#1)(2009-2#1)(2009-8#2)(2010-11#1)(2012-12#1)
patterning of micro-entities of different sizes##2##6##(2012-11#2)
patterning of micro-entities##6##3##(2012-11#6)
patterning of somites##2##3##(1994-12#2)
patterning of the##5##3##(1990-7#2)(1994-9#1)(2009-3#1)(2012-12#1)
patterning of##41##2##(1990-7#2)(1991-5#1)(1994-12#2)(1994-9#1)(1996-2#1)(1996-3#1)(2006-12#3)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#4)(2009-3#1)(2009-7#1)(2010-4#3)(2012-1#1)(2012-11#8)(2012-12#2)
patterning on##3##2##(2006-5#1)(2008-2#2)
patterning proteins##2##2##(1996-12#1)(2008-10#1)
patterning##145##1##(1990-7#4)(1991-5#1)(1993-12#1)(1994-12#2)(1994-9#2)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-3#1)(1997-4#1)(2006-11#2)(2006-12#4)(2006-4#1)(2006-5#4)(2007-11#1)(2007-12#12)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#11)(2008-2#2)(2008-3#3)(2008-4#2)(2008-7#5)(2009-12#1)(2009-2#7)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#6)(2010-11#2)(2010-12#1)(2010-4#6)(2010-9#5)(2011-2#1)(2012-1#3)(2012-11#9)(2012-12#22)(2012-2#1)(2013-1#1)
patterns (loss and gain) at AD and PD##2##8##(2011-2#2)
patterns acquired##2##2##(1991-2#1)(2008-2#1)
patterns across##7##2##(1991-12#1)(1995-3#1)(2006-5#1)(2008-10#1)(2008-8#1)(2009-6#1)(2013-8#1)
patterns after##2##2##(2008-10#1)(2012-1#1)
patterns also##2##2##(1991-11#1)(1995-3#1)
patterns among the##3##3##(1991-11#1)(2008-10#1)(2008-8#1)
patterns among##27##2##(1990-6#1)(1991-11#1)(1994-6#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-7#3)(2007-3#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-2#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
patterns amongst##2##2##(2008-4#1)(2010-10#1)
patterns and have##2##3##(1994-6#1)(2007-12#1)
patterns and impact##2##3##(2007-12#1)(2007-4#1)
patterns and of##2##3##(2007-12#1)(2013-1#1)
patterns and problems##2##3##(2005-10#2)
patterns and processes##4##3##(1996-6#1)(2007-7#1)(2009-12#1)(2009-8#1)
patterns and specific##2##3##(1994-3#1)(2007-3#1)
patterns and that##2##3##(2008-12#1)(2012-2#1)
patterns and the##8##3##(1991-2#1)(1992-2#1)(1993-11#1)(2008-10#1)(2008-2#2)(2010-12#1)(2013-8#1)
patterns and their##4##3##(2008-11#1)(2008-3#1)(2009-7#1)(2009-8#1)
patterns and to##3##3##(1991-5#1)(2007-11#1)(2009-2#1)
patterns and##145##2##(1991-2#1)(1991-5#1)(1991-6#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-3#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#2)(1997-3#2)(1997-4#1)(1997-7#2)(1997-8#1)(2004-12#1)(2005-10#6)(2005-9#1)(2006-10#2)(2006-2#1)(2006-5#1)(2007-11#6)(2007-12#5)(2007-3#2)(2007-4#1)(2007-5#3)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#7)(2008-11#3)(2008-12#4)(2008-2#5)(2008-3#8)(2008-4#2)(2008-6#4)(2008-7#1)(2008-8#5)(2008-9#1)(2009-12#2)(2009-2#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-12#1)(2010-4#1)(2010-8#3)(2010-9#3)(2011-1#1)(2011-12#5)(2011-2#1)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#1)(2013-8#2)
patterns are highly##2##3##(2008-7#1)(2012-11#1)
patterns are observed##2##3##(2008-3#2)
patterns are presented##2##3##(2007-11#1)(2008-3#1)
patterns are the##3##3##(1994-6#1)(2008-11#1)(2008-9#1)
patterns are##56##2##(1991-6#1)(1992-12#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-3#1)(1996-12#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-8#3)(2007-11#2)(2007-12#1)(2007-3#3)(2007-8#1)(2008-10#2)(2008-11#3)(2008-2#6)(2008-3#8)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-8#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-11#2)(2012-12#1)
patterns arising from##2##3##(2008-2#2)
patterns around##2##2##(1991-7#1)(2008-3#1)
patterns as a##3##3##(2007-12#1)(2008-3#1)(2010-9#1)
patterns as the##4##3##(1990-12#1)(1996-5#1)(2008-9#1)(2009-8#1)
patterns as##13##2##(1990-12#1)(1992-4#1)(1996-5#1)(2007-1#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-9#1)
patterns associated with##2##3##(2008-7#1)(2008-8#1)
patterns at a##2##3##(2008-3#1)(2008-7#1)
patterns at the##4##3##(1990-3#1)(2008-10#2)(2010-4#1)
patterns at##15##2##(1990-3#1)(1991-6#1)(2006-12#1)(2007-12#2)(2008-10#2)(2008-3#2)(2008-7#2)(2008-8#1)(2010-4#1)(2011-2#1)(2012-3#1)
patterns based on##4##3##(2006-10#1)(2006-9#1)(2008-10#1)(2008-2#1)
patterns based##5##2##(1995-6#1)(2006-10#1)(2006-9#1)(2008-10#1)(2008-2#1)
patterns because##2##2##(2008-9#1)(2010-4#1)
patterns before##2##2##(1992-6#1)(1997-3#1)
patterns between the##2##3##(1997-2#1)(2008-3#1)
patterns between##14##2##(1997-2#1)(2007-1#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-1#1)(2012-3#1)(2013-1#1)
patterns but##3##2##(1990-7#1)(1996-4#1)(2008-3#1)
patterns by a##2##3##(2008-3#1)(2009-2#1)
patterns by##12##2##(1990-2#1)(1991-5#1)(1991-6#1)(1993-9#1)(1996-3#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-2#1)(2013-1#1)
patterns calculated##2##2##(2008-2#1)(2008-3#1)
patterns can be used to##2##5##(2007-12#1)(2008-11#1)
patterns can be##17##3##(2006-12#1)(2006-2#1)(2006-5#1)(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#4)(2008-9#1)(2009-12#1)(2009-5#1)(2011-1#1)(2013-1#1)
patterns can##19##2##(2006-12#1)(2006-2#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#4)(2008-9#1)(2009-12#1)(2009-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
patterns cannot be##2##3##(2007-5#1)(2008-3#1)
patterns cannot##3##2##(2007-5#1)(2008-3#1)(2008-8#1)
patterns change##2##2##(1994-12#1)(2008-8#1)
patterns characteristic of##2##3##(2006-6#1)(2007-3#1)
patterns characteristic##3##2##(2006-6#1)(2007-3#1)(2008-12#1)
patterns characterized by##2##3##(1992-2#1)(2009-11#1)
patterns consisting of##2##3##(2008-10#2)
patterns convey##2##2##(2008-2#1)(2011-2#1)
patterns corresponding##2##2##(2007-7#1)(2008-11#1)
patterns could be##4##3##(1990-8#2)(1993-9#1)(2007-8#1)
patterns could##9##2##(1990-8#2)(1993-9#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-7#1)(2008-8#2)
patterns created##2##2##(2006-12#1)(2010-4#1)
patterns defined##2##2##(1993-5#1)(1994-3#1)
patterns described##2##2##(1997-3#1)(2011-12#1)
patterns did not##2##3##(1991-10#1)(1997-6#1)
patterns did##3##2##(1991-10#1)(1997-6#1)(2013-1#1)
patterns differ##2##2##(1992-12#1)(1994-9#1)
patterns due to##3##3##(1994-6#1)(1996-7#1)(2007-9#1)
patterns during the##3##3##(2007-2#1)(2007-9#1)(2013-1#1)
patterns during##11##2##(1992-1#1)(1992-2#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-10#1)(2009-8#1)(2013-1#1)
patterns emerge##3##2##(1995-8#1)(2006-2#1)(2009-7#1)
patterns emerged##2##2##(2007-7#1)(2011-2#1)
patterns encountered##2##2##(2005-8#1)(2010-11#1)
patterns exist##3##2##(2008-7#1)(2012-1#1)(2012-11#1)
patterns extracted##2##2##(2010-2#1)(2012-1#1)
patterns for both##3##3##(2008-12#1)(2008-8#1)(2009-9#1)
patterns for optimal##2##3##(2007-2#1)(2012-2#1)
patterns for studying cellular behavior##2##5##(2008-11#2)
patterns for the two##3##4##(1995-11#1)(1997-2#1)(2013-8#1)
patterns for the##13##3##(1991-2#1)(1994-2#1)(1995-11#1)(1997-2#1)(1997-7#1)(2004-2#1)(2004-4#1)(2005-6#1)(2008-10#2)(2008-8#1)(2010-2#1)(2013-8#1)
patterns for##51##2##(1990-12#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1993-1#1)(1994-2#1)(1995-11#2)(1995-3#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-7#1)(2004-2#1)(2004-4#1)(2005-11#1)(2005-6#1)(2006-10#2)(2007-2#1)(2007-9#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#3)(2008-5#2)(2008-8#2)(2009-8#1)(2009-9#1)(2010-2#1)(2012-2#3)(2013-7#1)(2013-8#1)
patterns formed by##2##3##(2008-3#2)
patterns found in##3##3##(2008-2#1)(2009-12#1)(2013-7#1)
patterns found##4##2##(2008-2#1)(2009-12#1)(2012-2#1)(2013-7#1)
patterns from the##6##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)
patterns from##27##2##(1990-12#1)(1992-9#1)(1995-5#1)(1997-7#1)(2006-9#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#4)(2008-5#1)(2013-1#2)
patterns generated by the##2##4##(2007-11#1)(2008-3#1)
patterns generated by##5##3##(2007-11#1)(2007-9#1)(2008-3#2)(2008-9#1)
patterns generated on##2##3##(2008-3#2)
patterns generated##11##2##(2007-11#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-9#1)
patterns given by##2##3##(2006-5#1)(2008-10#1)
patterns has##2##2##(1993-9#1)(2011-2#1)
patterns have a##2##3##(1993-3#1)(2007-12#1)
patterns have been##9##3##(1994-11#1)(2005-8#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-2#1)(2012-2#1)
patterns have##14##2##(1993-3#1)(1994-11#1)(2005-8#1)(2007-12#2)(2007-8#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
patterns having##2##2##(1996-3#1)(2008-3#1)
patterns in a##16##3##(1997-4#1)(2006-12#1)(2006-2#1)(2007-12#2)(2008-2#3)(2008-5#1)(2008-7#1)(2009-4#1)(2010-6#1)(2012-3#1)(2013-1#3)
patterns in all##3##3##(1995-3#1)(2004-4#1)(2008-10#1)
patterns in both##3##3##(2010-2#1)(2010-4#1)(2012-11#1)
patterns in combination with##2##4##(2011-12#1)(2012-3#1)
patterns in fish##2##3##(2007-9#1)(2008-10#1)
patterns in patients with##2##4##(2009-3#1)(2010-11#1)
patterns in patients##3##3##(2009-3#1)(2010-11#1)(2013-1#1)
patterns in photorefractive##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
patterns in response to##4##4##(1995-8#1)(2005-10#1)(2008-10#1)(2008-11#1)
patterns in the data##2##4##(2008-5#1)(2011-2#1)
patterns in the plasma##3##4##(1990-7#1)(2006-10#2)
patterns in the##50##3##(1990-7#1)(1990-9#1)(1991-6#1)(1992-12#1)(1993-11#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#1)(2004-9#1)(2006-10#2)(2007-11#2)(2007-12#4)(2007-2#1)(2007-5#5)(2008-10#2)(2008-2#5)(2008-5#1)(2008-8#4)(2008-9#1)(2009-6#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-12#1)(2012-2#1)
patterns in##194##2##(1990-4#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#3)(1992-12#1)(1993-11#1)(1993-12#1)(1994-2#2)(1994-6#2)(1994-7#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#2)(1995-3#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-4#1)(1997-7#2)(2004-11#1)(2004-4#1)(2004-9#1)(2005-10#2)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-2#2)(2006-4#2)(2006-5#2)(2006-7#1)(2006-9#1)(2007-11#5)(2007-12#10)(2007-2#2)(2007-4#1)(2007-5#5)(2007-6#1)(2007-7#2)(2007-9#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#8)(2008-3#3)(2008-4#2)(2008-5#4)(2008-7#7)(2008-8#7)(2008-9#4)(2009-10#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#8)(2012-1#5)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#2)(2012-7#1)(2013-1#7)(2013-7#1)(2013-8#2)
patterns including##2##2##(2006-8#1)(2008-3#1)
patterns indicate that##2##3##(1991-1#1)(2005-11#1)
patterns indicated##3##2##(2008-10#2)(2009-10#1)
patterns indicates##2##2##(1990-9#1)(1994-10#1)
patterns induced by##2##3##(2007-12#1)(2012-1#1)
patterns induced##3##2##(2007-12#2)(2012-1#1)
patterns into##3##2##(1995-12#1)(2007-12#1)(2009-11#1)
patterns is introduced##2##3##(2007-11#1)(2008-3#1)
patterns is presented##3##3##(2008-3#2)(2008-7#1)
patterns is##16##2##(1992-9#1)(1995-12#1)(1995-5#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)
patterns may be##5##3##(1990-3#1)(1995-3#1)(2005-8#1)(2006-8#1)(2008-10#1)
patterns may##12##2##(1990-3#1)(1994-3#1)(1995-3#1)(1996-4#1)(2005-8#1)(2006-10#1)(2006-8#2)(2008-10#1)(2008-9#1)(2009-8#1)(2009-9#1)
patterns not##2##2##(2006-10#1)(2007-12#1)
patterns observed in##5##3##(1994-9#1)(2008-10#1)(2008-11#1)(2012-12#2)
patterns observed##10##2##(1991-4#1)(1991-5#1)(1992-8#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-10#1)(2012-12#2)
patterns obtained by##2##3##(2007-12#1)(2007-8#1)
patterns obtained from##3##3##(1995-10#1)(2008-1#1)(2008-2#1)
patterns obtained in##3##3##(2005-12#1)(2008-2#1)(2008-3#1)
patterns obtained##10##2##(1995-10#1)(2005-12#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)
patterns of 692 Ontario chiropractors##2##5##(2007-6#2)
patterns of Ca(2+)##2##3##(2008-4#2)
patterns of DNA fragments##2##4##(2008-10#2)
patterns of DNA##7##3##(1992-11#1)(1993-3#1)(2008-10#3)(2009-4#1)(2010-4#1)
patterns of H##2##3##(2008-10#2)
patterns of S##3##3##(2010-8#1)(2013-7#1)(2013-8#1)
patterns of Staphylococcus##2##3##(2012-3#1)(2013-8#1)
patterns of a##9##3##(2007-1#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-1#1)(2012-1#1)(2013-1#1)
patterns of activity in##2##4##(1991-8#1)(1995-2#1)
patterns of activity##8##3##(1990-5#1)(1991-6#1)(1991-8#1)(1993-12#1)(1995-2#1)(2008-8#1)(2009-8#1)(2009-9#1)
patterns of adolescent##2##3##(2009-8#1)(2013-1#1)
patterns of alcohol use##2##4##(2005-10#1)(2008-12#1)
patterns of altered##2##3##(1996-9#1)(2013-8#1)
patterns of among-island variation in species richness##2##7##(2008-8#2)
patterns of an##2##3##(2008-5#1)(2009-12#1)
patterns of association between##2##4##(1995-2#1)(2008-9#1)
patterns of behavior and##2##4##(2008-9#1)(2013-1#1)
patterns of behavior##7##3##(1990-12#1)(2008-1#1)(2008-9#1)(2009-10#1)(2009-12#1)(2012-2#1)(2013-1#1)
patterns of both##5##3##(2007-3#1)(2008-3#1)(2009-4#1)(2012-3#1)(2013-1#1)
patterns of brain activity##2##4##(2008-11#1)(2009-9#1)
patterns of care for##2##4##(1990-4#1)(1991-2#1)
patterns of care##7##3##(1990-4#1)(1991-2#1)(1994-3#1)(1995-9#1)(2007-10#1)(2008-7#1)(2012-3#1)
patterns of cell##2##3##(2006-10#1)(2007-10#1)
patterns of change##2##3##(1991-5#1)(1997-7#1)
patterns of cognitive##2##3##(1995-1#1)(2004-10#1)
patterns of cortical##2##3##(2012-12#1)(2013-8#1)
patterns of cytokine##2##3##(1994-6#1)(2007-8#1)
patterns of de-escalation##3##3##(2009-7#3)
patterns of different##3##3##(2007-11#1)(2008-2#1)(2012-2#1)
patterns of disease and##3##4##(2006-10#1)(2008-1#1)(2011-2#1)
patterns of disease##11##3##(2006-10#1)(2008-1#1)(2008-10#5)(2011-2#2)(2013-1#2)
patterns of disfluency over##2##4##(2008-2#2)
patterns of disfluency##5##3##(2008-2#5)
patterns of distribution of##2##4##(1996-3#1)(2008-5#1)
patterns of distribution that##2##4##(2009-10#1)(2012-2#1)
patterns of distribution##9##3##(1991-12#1)(1994-6#1)(1995-11#1)(1996-12#1)(1996-3#1)(1997-6#1)(2008-5#1)(2009-10#1)(2012-2#1)
patterns of disturbed neural synchrony##2##5##(2008-11#2)
patterns of diversity and##2##4##(2012-3#2)
patterns of diversity##4##3##(2008-10#1)(2008-8#1)(2012-3#2)
patterns of drug use##2##4##(2008-3#1)(2011-1#1)
patterns of drug##5##3##(2006-11#1)(2008-1#1)(2008-3#1)(2011-1#1)(2012-2#1)
patterns of drug-induced lung disease##3##5##(2005-8#3)
patterns of dynamic##2##3##(2008-11#1)(2011-2#1)
patterns of early##2##3##(1993-12#1)(2007-12#1)
patterns of echinoderm larvae in La Parguera##2##7##(2011-2#2)
patterns of epiphyseal changes##2##4##(2008-4#2)
patterns of expression of##3##4##(1995-11#1)(1996-3#1)(2008-11#1)
patterns of expression##10##3##(1992-6#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#1)
patterns of failure##5##3##(2006-11#1)(2008-6#3)(2012-3#1)
patterns of family##2##3##(2006-10#1)(2011-1#1)
patterns of female##4##3##(2008-7#1)(2009-9#3)
patterns of flow##2##3##(1995-5#1)(2006-5#1)
patterns of functional##2##3##(1997-5#1)(2010-8#1)
patterns of gene expression in##3##5##(1994-11#1)(1994-3#1)(2008-11#1)
patterns of gene expression##10##4##(1991-12#1)(1994-10#1)(1994-11#1)(1994-3#1)(1997-6#1)(2008-11#1)(2008-7#2)(2008-8#1)(2010-5#1)
patterns of gene##12##3##(1991-12#1)(1994-10#1)(1994-11#1)(1994-3#1)(1997-6#1)(2008-11#1)(2008-7#4)(2008-8#1)(2010-5#1)
patterns of genetic##2##3##(2008-10#1)(2008-9#1)
patterns of geographic##2##3##(2008-10#1)(2008-7#1)
patterns of glomerular##3##3##(2005-10#1)(2007-7#1)(2008-1#1)
patterns of health##2##3##(1992-5#1)(2004-3#1)
patterns of human##3##3##(1994-9#1)(1995-12#1)(2013-8#1)
patterns of incidence##2##3##(2008-4#1)(2008-8#1)
patterns of injury##2##3##(2005-10#1)(2011-12#1)
patterns of isolated##2##3##(1995-6#1)(2008-2#1)
patterns of lactation##2##3##(2008-9#2)
patterns of lectin-binding##2##3##(1996-9#2)
patterns of mitotic##2##3##(2007-12#1)(2008-12#1)
patterns of molecular##2##3##(1991-9#1)(2013-1#1)
patterns of morphological##2##3##(2006-5#1)(2013-1#1)
patterns of natural##2##3##(2008-10#1)(2008-9#1)
patterns of neural##3##3##(1991-11#1)(2008-11#1)(2008-9#1)
patterns of noise##2##3##(2008-3#2)
patterns of patch occupancy##4##4##(2008-8#3)(2008-9#1)
patterns of paternity##2##3##(2007-12#1)(2008-9#1)
patterns of performance##2##3##(2005-10#1)(2009-9#1)
patterns of phytoplankton##2##3##(2007-5#1)(2008-8#1)
patterns of plant##2##3##(1996-4#1)(2008-10#1)
patterns of primary##2##3##(2008-10#1)(2011-2#1)
patterns of protein##2##3##(1992-5#1)(2009-6#1)
patterns of referral##2##3##(1992-12#1)(2007-5#1)
patterns of regional##5##3##(1997-3#1)(2008-11#3)(2009-4#1)
patterns of regulation##2##3##(1994-12#1)(2005-10#1)
patterns of renal##4##3##(2005-10#1)(2008-1#2)(2010-4#1)
patterns of resistance##2##3##(2008-10#1)(2013-8#1)
patterns of response##2##3##(1992-5#1)(2008-7#1)
patterns of rising type 2 diabetes prevalence in the world##2##10##(2010-4#2)
patterns of risk##3##3##(1991-9#1)(2007-10#1)(2011-1#1)
patterns of rt-PA use in##2##5##(2007-10#2)
patterns of rt-PA use##3##4##(2007-10#3)
patterns of selection##2##3##(2008-8#1)(2012-3#1)
patterns of service##2##3##(1994-2#1)(1996-3#1)
patterns of sexual##2##3##(2009-8#1)(2009-9#1)
patterns of skew##2##3##(2008-8#2)
patterns of smoking##2##3##(2008-8#2)
patterns of social##3##3##(2007-7#1)(2009-7#1)(2010-2#1)
patterns of soil##2##3##(2008-11#1)(2013-8#1)
patterns of some##2##3##(2008-10#1)(2008-11#1)
patterns of sperm##2##3##(2007-12#1)(2008-8#1)
patterns of spore deposition were##2##5##(2008-10#2)
patterns of spore deposition##3##4##(2008-10#3)
patterns of src splicing##2##4##(1992-5#2)
patterns of the 4 cell groups##2##6##(1993-2#2)
patterns of the##67##3##(1990-10#1)(1990-11#1)(1990-4#1)(1991-8#1)(1993-12#3)(1993-2#2)(1995-7#1)(1996-4#1)(1997-8#1)(2004-12#1)(2004-4#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-3#1)(2012-1#4)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
patterns of these##5##3##(1997-3#1)(2007-12#1)(2008-10#1)(2010-7#1)(2013-8#1)
patterns of this##2##3##(1992-10#1)(2008-10#1)
patterns of translation##2##3##(2007-12#2)
patterns of treatment##2##3##(2006-10#1)(2008-6#1)
patterns of tumour##2##3##(2008-1#1)(2012-2#1)
patterns of use of##3##4##(2004-4#1)(2008-11#1)(2013-1#1)
patterns of use##5##3##(2004-4#1)(2007-4#1)(2008-11#2)(2013-1#1)
patterns of variation in##2##4##(2009-8#1)(2013-1#1)
patterns of variation##7##3##(2004-11#1)(2008-8#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
patterns of water##2##3##(2004-4#1)(2013-8#1)
patterns of##835##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#4)(1990-5#2)(1990-6#1)(1990-7#1)(1991-1#2)(1991-10#2)(1991-11#5)(1991-12#4)(1991-2#2)(1991-5#2)(1991-6#1)(1991-8#3)(1991-9#4)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#3)(1992-5#6)(1992-6#3)(1992-7#2)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#6)(1993-2#3)(1993-3#2)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#4)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#5)(1994-3#5)(1994-5#2)(1994-6#4)(1994-7#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#5)(1995-12#5)(1995-2#3)(1995-3#2)(1995-5#6)(1995-6#1)(1995-7#1)(1995-8#3)(1995-9#2)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#8)(1996-2#1)(1996-3#4)(1996-4#7)(1996-6#2)(1996-8#1)(1996-9#5)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#3)(1997-5#3)(1997-6#3)(1997-7#3)(1997-8#3)(2004-10#1)(2004-11#3)(2004-12#1)(2004-3#1)(2004-4#3)(2005-1#1)(2005-10#6)(2005-11#2)(2005-8#5)(2005-9#1)(2006-10#13)(2006-11#3)(2006-12#3)(2006-2#1)(2006-4#2)(2006-5#7)(2006-6#1)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#7)(2007-11#5)(2007-12#24)(2007-2#4)(2007-3#8)(2007-4#2)(2007-5#4)(2007-6#5)(2007-7#9)(2007-8#5)(2007-9#2)(2008-1#17)(2008-10#70)(2008-11#28)(2008-12#6)(2008-2#17)(2008-3#15)(2008-4#9)(2008-5#23)(2008-6#6)(2008-7#22)(2008-8#37)(2008-9#16)(2009-10#4)(2009-11#3)(2009-12#3)(2009-2#2)(2009-4#5)(2009-5#1)(2009-6#1)(2009-7#7)(2009-8#12)(2009-9#8)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#8)(2010-3#2)(2010-4#8)(2010-5#5)(2010-6#1)(2010-7#5)(2010-8#7)(2010-9#1)(2011-1#7)(2011-12#4)(2011-2#19)(2011-3#1)(2012-1#10)(2012-11#1)(2012-12#8)(2012-2#26)(2012-3#12)(2013-1#39)(2013-7#4)(2013-8#19)
patterns on a##2##3##(2008-3#1)(2010-6#1)
patterns on silicon##2##3##(2008-3#1)(2008-7#1)
patterns on the##8##3##(1995-12#1)(2006-10#1)(2008-2#1)(2008-3#1)(2009-11#1)(2010-2#1)(2012-1#1)(2012-11#1)
patterns on##25##2##(1993-8#1)(1995-12#1)(1996-8#1)(2006-10#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-7#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2012-1#1)(2012-11#1)(2012-12#1)
patterns or##6##2##(2006-8#1)(2007-10#1)(2008-2#1)(2011-2#1)(2013-1#1)(2013-7#1)
patterns over##4##2##(1990-4#1)(2006-5#1)(2007-5#1)(2008-10#1)
patterns presented##3##2##(1995-8#1)(2007-5#1)(2010-5#1)
patterns produced by the##2##4##(2008-10#2)
patterns produced by##4##3##(1996-9#1)(2007-8#1)(2008-10#2)
patterns produced##5##2##(1996-9#1)(2007-8#1)(2008-10#2)(2008-9#1)
patterns reconstructed from##2##3##(2008-3#2)
patterns recurrence plots##2##3##(2008-11#2)
patterns related##2##2##(1991-6#1)(1996-1#1)
patterns reported##2##2##(1995-5#1)(2010-2#1)
patterns resulting from##4##3##(2008-10#2)(2008-3#1)(2012-2#1)
patterns resulting##5##2##(1995-9#1)(2008-10#2)(2008-3#1)(2012-2#1)
patterns seen##2##2##(2007-7#1)(2012-3#1)
patterns should be##2##3##(2008-12#1)(2008-9#1)
patterns show a##2##3##(1992-7#1)(2011-1#1)
patterns show that the##3##4##(2008-10#1)(2008-5#1)(2013-7#1)
patterns show that##4##3##(2008-10#2)(2008-5#1)(2013-7#1)
patterns show##7##2##(1992-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-1#1)(2013-7#1)
patterns showed that##3##3##(2005-11#1)(2006-12#1)(2008-5#1)
patterns showed##7##2##(1990-6#1)(1994-9#1)(2005-11#1)(2006-12#1)(2006-8#1)(2008-5#1)(2012-2#1)
patterns shown by##2##3##(1991-9#1)(2007-8#1)
patterns similar to those of##2##5##(1992-8#1)(2008-1#1)
patterns similar to##4##3##(1992-8#1)(1997-7#1)(2008-1#1)(2008-10#1)
patterns simulated##2##2##(2008-3#1)(2008-9#1)
patterns such as the##2##4##(2008-8#1)(2009-5#1)
patterns such as##7##3##(1997-1#1)(2008-12#1)(2008-8#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-2#1)
patterns suggest that##2##3##(1992-9#1)(2011-2#1)
patterns suggest##3##2##(1992-9#1)(2006-10#1)(2011-2#1)
patterns suggested that##6##3##(1990-2#1)(2008-10#4)(2008-7#1)
patterns suggesting that##2##3##(1996-6#1)(2007-8#1)
patterns suggesting##3##2##(1996-3#1)(1996-6#1)(2007-8#1)
patterns suggests that##3##3##(1995-12#1)(2008-5#1)(2008-8#1)
patterns surrounding the translation initiation sites##2##6##(1997-2#2)
patterns surrounding##3##2##(1997-2#3)
patterns than##2##2##(2005-11#1)(2008-3#1)
patterns that are due to##2##5##(2008-3#2)
patterns that are##5##3##(2007-3#1)(2008-3#2)(2008-4#1)(2008-8#1)
patterns that differ from those of##2##6##(1991-3#1)(2007-3#1)
patterns that have##2##3##(1990-11#1)(2012-1#1)
patterns that may not be##2##5##(2007-11#1)(2011-2#1)
patterns that may##5##3##(1996-9#1)(2007-11#1)(2008-2#1)(2008-8#1)(2011-2#1)
patterns that were indistinguishable##2##4##(1991-6#1)(2008-11#1)
patterns that were##4##3##(1991-6#1)(2008-10#2)(2008-11#1)
patterns that##44##2##(1990-11#1)(1991-3#1)(1991-6#1)(1992-7#1)(1994-12#1)(1996-9#1)(2005-10#1)(2007-11#1)(2007-12#2)(2007-3#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#5)(2009-5#1)(2009-8#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
patterns through##3##2##(2008-10#1)(2008-2#1)(2008-8#1)
patterns to be##6##3##(2006-12#1)(2008-1#1)(2008-2#3)(2008-3#1)
patterns to the##2##3##(1997-1#1)(2012-1#1)
patterns to those##3##3##(2008-8#1)(2009-5#1)(2010-4#1)
patterns to##27##2##(1992-7#1)(1993-2#1)(1993-9#1)(1994-2#1)(1995-1#1)(1997-1#1)(2006-12#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#2)(2008-8#1)(2009-5#1)(2009-7#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-8#2)
patterns typical of##2##3##(1990-11#1)(1995-6#1)
patterns under##2##2##(2008-2#1)(2008-3#1)
patterns upon##2##2##(1991-9#1)(2007-12#1)
patterns used in##2##3##(2008-3#1)(2009-7#1)
patterns used##3##2##(2008-3#2)(2009-7#1)
patterns using##3##2##(2006-12#1)(2008-7#1)(2009-8#1)
patterns varied##3##2##(2008-12#1)(2012-3#1)(2013-8#1)
patterns vary in##2##3##(2011-12#1)(2012-2#1)
patterns was developed and##2##4##(2008-2#1)(2008-8#1)
patterns was observed in##2##4##(2006-5#1)(2008-12#1)
patterns was performed##2##3##(2008-10#1)(2008-12#1)
patterns was##11##2##(1991-8#1)(1997-3#1)(1997-6#1)(2006-2#1)(2006-5#1)(2008-10#1)(2008-12#2)(2008-2#2)(2008-8#1)
patterns were almost##2##3##(1992-11#1)(1996-5#1)
patterns were analyzed##2##3##(2008-10#1)(2008-11#1)
patterns were associated with##2##4##(2007-3#1)(2008-10#1)
patterns were consistent##3##3##(1990-6#1)(2008-10#1)(2010-8#1)
patterns were constructed##2##3##(1990-9#1)(1991-10#1)
patterns were detected##2##3##(1991-11#1)(2005-10#1)
patterns were evaluated by##2##4##(2008-5#1)(2012-12#1)
patterns were evaluated##3##3##(2006-5#1)(2008-5#1)(2012-12#1)
patterns were examined##2##3##(2007-11#1)(2008-7#1)
patterns were found to be##2##5##(2006-6#1)(2007-11#1)
patterns were found##5##3##(2006-6#1)(2007-11#1)(2008-10#1)(2008-5#1)(2012-1#1)
patterns were identified##6##3##(1991-1#1)(1994-9#1)(2007-2#1)(2008-10#2)(2012-1#1)
patterns were monitored##2##3##(2006-5#1)(2006-7#1)
patterns were not##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
patterns were noted##3##3##(2008-10#1)(2010-8#1)(2013-8#1)
patterns were observed in##2##4##(1994-8#1)(2007-12#1)
patterns were observed##6##3##(1993-9#1)(1994-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-1#1)
patterns were obtained for##3##4##(2007-1#1)(2008-10#1)(2013-1#1)
patterns were obtained##6##3##(1990-2#1)(2007-1#1)(2007-12#1)(2008-10#1)(2009-2#1)(2013-1#1)
patterns were produced##2##3##(2008-10#1)(2008-8#1)
patterns were recorded##4##3##(1992-7#1)(1996-5#1)(2008-10#1)(2011-12#1)
patterns were seen##4##3##(1991-5#1)(2008-1#1)(2008-10#1)(2013-1#1)
patterns were significantly##2##3##(2004-11#1)(2008-7#1)
patterns were similar##2##3##(2008-5#1)(2012-12#1)
patterns were studied##3##3##(2006-6#1)(2008-10#1)(2008-11#1)
patterns were used##2##3##(2007-12#1)(2008-7#1)
patterns were##119##2##(1990-11#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-7#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-5#2)(1997-3#1)(1997-4#2)(1997-6#1)(2004-11#2)(2005-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#4)(2006-6#2)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-3#2)(2007-8#1)(2008-1#2)(2008-10#16)(2008-11#4)(2008-2#2)(2008-3#2)(2008-5#6)(2008-7#5)(2008-8#1)(2008-9#1)(2009-2#2)(2010-12#2)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#3)(2012-12#2)(2012-2#1)(2013-1#7)(2013-8#2)
patterns when compared with##2##4##(1993-9#1)(2008-7#1)
patterns when##7##2##(1993-12#1)(1993-9#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)
patterns where##2##2##(2007-11#1)(2008-2#1)
patterns which##8##2##(1992-10#1)(1996-4#1)(2005-10#1)(2006-10#2)(2007-8#1)(2008-10#1)(2008-11#1)
patterns while##2##2##(2008-3#1)(2009-2#1)
patterns will be##2##3##(2008-6#1)(2009-5#1)
patterns will##4##2##(2008-1#1)(2008-6#1)(2009-5#1)(2010-11#1)
patterns with respect to##2##4##(1995-8#1)(2012-2#1)
patterns with##26##2##(1991-6#1)(1995-8#1)(2005-11#1)(2006-7#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#3)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#1)(2009-2#1)(2009-3#1)(2010-9#1)(2011-2#1)(2012-2#1)
patterns within and##2##3##(1992-9#1)(2012-11#1)
patterns within the##3##3##(2007-12#1)(2008-11#1)(2013-8#1)
patterns within##14##2##(1992-9#1)(1993-11#1)(2005-10#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-4#1)(2009-6#1)(2012-11#1)(2012-2#2)(2013-8#1)
patterns without##3##2##(1991-4#1)(2007-12#1)(2013-8#1)
patterns##2659##1##(1990-10#2)(1990-11#5)(1990-12#6)(1990-2#4)(1990-3#2)(1990-4#7)(1990-5#3)(1990-6#5)(1990-7#6)(1990-8#5)(1990-9#3)(1991-1#6)(1991-10#8)(1991-11#10)(1991-12#7)(1991-2#8)(1991-3#2)(1991-4#5)(1991-5#11)(1991-6#10)(1991-7#4)(1991-8#5)(1991-9#9)(1992-1#3)(1992-10#3)(1992-11#2)(1992-12#8)(1992-2#7)(1992-3#6)(1992-4#2)(1992-5#6)(1992-6#6)(1992-7#7)(1992-8#6)(1992-9#6)(1993-1#3)(1993-11#8)(1993-12#16)(1993-2#6)(1993-3#4)(1993-5#5)(1993-6#4)(1993-7#3)(1993-8#2)(1993-9#13)(1994-1#2)(1994-10#3)(1994-11#6)(1994-12#9)(1994-2#14)(1994-3#11)(1994-4#1)(1994-5#2)(1994-6#11)(1994-7#2)(1994-8#5)(1994-9#16)(1995-1#4)(1995-10#6)(1995-11#10)(1995-12#11)(1995-2#4)(1995-3#11)(1995-5#9)(1995-6#6)(1995-7#1)(1995-8#13)(1995-9#3)(1996-1#6)(1996-10#2)(1996-11#2)(1996-12#15)(1996-2#6)(1996-3#12)(1996-4#11)(1996-5#4)(1996-6#8)(1996-7#1)(1996-8#3)(1996-9#9)(1997-1#6)(1997-2#12)(1997-3#9)(1997-4#10)(1997-5#6)(1997-6#12)(1997-7#13)(1997-8#6)(2003-11#1)(2004-10#1)(2004-11#7)(2004-12#2)(2004-2#1)(2004-3#1)(2004-4#5)(2004-9#1)(2005-1#1)(2005-10#25)(2005-11#10)(2005-12#2)(2005-6#1)(2005-7#1)(2005-8#10)(2005-9#4)(2006-1#2)(2006-10#41)(2006-11#6)(2006-12#22)(2006-2#10)(2006-3#2)(2006-4#5)(2006-5#23)(2006-6#6)(2006-7#10)(2006-8#16)(2006-9#5)(2007-1#8)(2007-10#12)(2007-11#37)(2007-12#93)(2007-2#14)(2007-3#21)(2007-4#7)(2007-5#18)(2007-6#7)(2007-7#21)(2007-8#25)(2007-9#11)(2008-1#41)(2008-10#208)(2008-11#76)(2008-12#22)(2008-2#128)(2008-3#134)(2008-4#24)(2008-5#55)(2008-6#21)(2008-7#62)(2008-8#95)(2008-9#37)(2009-10#10)(2009-11#6)(2009-12#7)(2009-2#13)(2009-3#5)(2009-4#10)(2009-5#13)(2009-6#7)(2009-7#16)(2009-8#28)(2009-9#16)(2010-1#6)(2010-10#2)(2010-11#8)(2010-12#17)(2010-2#17)(2010-3#5)(2010-4#23)(2010-5#8)(2010-6#6)(2010-7#7)(2010-8#15)(2010-9#8)(2011-1#22)(2011-10#1)(2011-12#14)(2011-2#59)(2011-3#1)(2012-1#42)(2012-11#12)(2012-12#29)(2012-2#66)(2012-3#30)(2012-5#1)(2012-7#1)(2013-1#100)(2013-7#17)(2013-8#41)
patterns)##2##1##(2008-2#1)(2013-1#1)
patters##2##1##(2008-4#1)(2012-1#1)
patties increased##2##2##(2010-4#2)
patties were##4##2##(2010-4#4)
patties##17##1##(2010-4#17)
patuletin##2##1##(2008-11#2)
patulin accumulation in##2##3##(2008-10#2)
patulin accumulation##3##2##(2008-10#3)
patulin and##5##2##(2008-10#2)(2010-3#2)(2010-7#1)
patulin##10##1##(2008-10#7)(2010-3#2)(2010-7#1)
pauciarticular JCA##3##2##(2006-10#3)
pauciarticular juvenile chronic arthritis##2##4##(2006-10#2)
pauciarticular juvenile##3##2##(2006-10#3)
pauciarticular##7##1##(2006-10#7)
paucibacillary##2##1##(2008-3#1)(2008-9#1)
paucicellular##2##1##(2004-2#1)(2012-12#1)
pauciflorus##2##1##(2011-12#2)
paucity in##2##2##(2012-12#1)(2013-8#1)
paucity of data on the##4##5##(2007-11#1)(2008-10#1)(2008-7#1)(2010-12#1)
paucity of data on##6##4##(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)
paucity of data##12##3##(2007-11#1)(2007-8#2)(2008-10#2)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#2)(2013-1#2)
paucity of direct evidence##2##4##(2007-10#1)(2013-8#1)
paucity of information exists about the##2##6##(2007-2#1)(2009-11#1)
paucity of information in the##2##5##(2008-1#1)(2013-1#1)
paucity of information regarding##2##4##(2006-10#2)
paucity of information##11##3##(2006-10#2)(2006-7#1)(2007-2#1)(2007-6#1)(2008-1#1)(2009-11#1)(2010-11#1)(2012-3#1)(2013-1#2)
paucity of literature on the##2##5##(2009-5#1)(2012-2#1)
paucity of literature##3##3##(2008-11#1)(2009-5#1)(2012-2#1)
paucity of prospective##2##3##(2007-6#1)(2011-2#1)
paucity of published data##2##4##(1995-1#1)(2013-1#1)
paucity of published##3##3##(1995-1#1)(2009-5#1)(2013-1#1)
paucity of reports##2##3##(1990-7#1)(2008-10#1)
paucity of studies##4##3##(2010-5#1)(2012-2#2)(2013-1#1)
paucity of##80##2##(1990-7#1)(1991-8#1)(1995-1#1)(1996-6#1)(1997-2#1)(1997-9#1)(2004-11#1)(2006-10#5)(2006-12#1)(2006-7#2)(2007-10#2)(2007-11#3)(2007-2#1)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#3)(2010-10#1)(2010-11#1)(2010-12#4)(2010-5#1)(2010-6#1)(2011-2#5)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#6)(2013-8#2)
paucity##82##1##(1990-7#1)(1991-8#1)(1995-1#1)(1996-6#1)(1997-2#1)(1997-9#1)(2004-11#1)(2006-10#5)(2006-12#1)(2006-7#2)(2007-10#2)(2007-11#3)(2007-2#1)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#3)(2010-10#1)(2010-11#1)(2010-12#4)(2010-5#1)(2010-6#1)(2011-2#5)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#6)(2013-8#3)
pause sites##3##2##(1994-8#1)(1995-3#2)
pause##21##1##(1991-3#1)(1994-8#1)(1995-3#3)(1996-8#1)(1997-5#2)(2005-10#1)(2007-12#1)(2008-10#1)(2008-4#5)(2008-7#1)(2009-10#1)(2009-6#1)(2011-2#2)
paused in##2##2##(1996-8#1)(2007-12#1)
pauses##8##1##(1992-2#1)(1993-10#1)(1995-1#2)(1996-12#1)(2007-2#1)(2008-4#2)
pausing at##2##2##(1996-8#1)(1997-5#1)
pausing or termination##2##3##(1997-5#2)
pausing##7##1##(1995-3#3)(1996-8#1)(1997-5#3)
pautensis vs##7##2##(2008-5#7)
pautensis##9##1##(2008-5#9)
pauvreté##4##1##(2008-11#4)
pave the way for the##2##5##(2011-1#1)(2012-2#1)
pave the way for##3##4##(2009-12#1)(2011-1#1)(2012-2#1)
pave the way to##3##4##(2008-7#2)(2011-1#1)
pave the way##7##3##(2008-7#2)(2009-12#1)(2010-12#1)(2011-1#2)(2012-2#1)
pave the##8##2##(2008-7#3)(2009-12#1)(2010-12#1)(2011-1#2)(2012-2#1)
pave##9##1##(2008-1#1)(2008-7#3)(2009-12#1)(2010-12#1)(2011-1#2)(2012-2#1)
paved the way for##5##4##(1995-3#1)(2007-8#1)(2007-9#1)(2008-4#1)(2009-10#1)
paved the way to##2##4##(2006-12#1)(2011-2#1)
paved the way##7##3##(1995-3#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-4#1)(2009-10#1)(2011-2#1)
paved##8##1##(1995-3#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-4#1)(2009-10#1)(2011-2#1)(2013-8#1)
pavement cells in FW larvae##2##5##(2008-5#2)
pavement cells##5##2##(2008-5#5)
pavement##7##1##(1993-4#1)(2008-5#6)
paves the way for the##2##5##(2005-8#1)(2009-8#1)
paves the way for##3##4##(2005-8#1)(2008-9#1)(2009-8#1)
paves the way##4##3##(2005-8#1)(2008-9#1)(2009-8#1)(2010-9#1)
paving the way for a##3##5##(2007-12#1)(2010-12#1)(2011-1#1)
paving the way for##6##4##(2005-11#1)(2007-10#1)(2007-12#1)(2007-2#1)(2010-12#1)(2011-1#1)
paving the way##7##3##(2005-11#1)(2006-11#1)(2007-10#1)(2007-12#1)(2007-2#1)(2010-12#1)(2011-1#1)
paving the##8##2##(2005-11#1)(2006-11#1)(2007-10#1)(2007-12#1)(2007-2#1)(2010-12#1)(2011-1#2)
paving##10##1##(2005-11#1)(2006-11#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2010-12#1)(2011-1#2)(2012-2#1)
pavlovskyi##2##1##(2013-1#2)
pavonina##3##1##(2008-11#3)
paw and##2##2##(1994-3#1)(2008-9#1)
paw during the##2##3##(1994-6#1)(2013-7#1)
paw edema and##2##3##(2011-1#1)(2013-7#1)
paw edema assay##2##3##(2011-1#2)
paw edema##11##2##(2007-1#2)(2008-10#1)(2010-2#1)(2011-1#3)(2012-11#1)(2013-7#3)
paw oedema##2##2##(2010-2#2)
paw preference test##2##3##(1994-8#1)(1997-2#1)
paw preference##8##2##(1991-5#1)(1992-9#4)(1994-8#2)(1997-2#1)
paw was##2##2##(1992-10#1)(1996-12#1)
paw withdrawal threshold##3##3##(1993-12#2)(2013-7#1)
paw withdrawal thresholds##2##3##(1993-12#2)
paw withdrawal##7##2##(1993-12#4)(1996-5#1)(2008-5#1)(2013-7#1)
paw##61##1##(1991-1#2)(1991-11#1)(1991-5#1)(1992-1#1)(1992-10#1)(1992-9#4)(1993-12#5)(1994-2#3)(1994-3#1)(1994-6#3)(1994-8#2)(1995-12#4)(1995-3#1)(1996-12#2)(1996-5#1)(1997-2#1)(2006-12#2)(2007-1#2)(2008-10#2)(2008-5#3)(2008-7#2)(2008-9#2)(2009-6#1)(2010-2#3)(2011-1#3)(2012-11#1)(2013-7#7)
paw-licking##2##1##(1992-3#2)
paw-preference##4##1##(1994-6#4)
paws was##2##2##(1996-1#1)(1996-3#1)
paws##6##1##(1996-1#1)(1996-3#3)(1997-2#1)(2008-9#1)
paxillin and##4##2##(1994-9#1)(1996-12#1)(1997-4#1)(1997-7#1)
paxillin family of##2##3##(2012-12#2)
paxillin family##3##2##(2012-12#3)
paxillin was##2##2##(1996-5#1)(1997-4#1)
paxillin##32##1##(1994-9#6)(1996-12#1)(1996-5#5)(1997-4#8)(1997-7#7)(2012-12#5)
pay $10##2##2##(1996-6#2)
pay $120##2##2##(1995-6#2)
pay a cost##2##3##(2008-9#1)(2012-3#1)
pay a##6##2##(1992-12#1)(1996-3#1)(1997-1#1)(2008-9#1)(2009-5#1)(2012-3#1)
pay according to##2##3##(1993-9#1)(1997-8#1)
pay and##5##2##(1992-2#1)(1997-1#1)(1997-8#1)(2008-1#1)(2012-12#1)
pay at##2##2##(1995-2#1)(1997-1#1)
pay attention to the##6##4##(2007-10#1)(2007-11#1)(2007-9#1)(2010-5#1)(2012-2#1)(2013-7#1)
pay attention to##15##3##(1990-11#1)(1992-10#1)(1992-2#1)(2007-10#1)(2007-11#2)(2007-9#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-5#1)(2012-2#2)(2013-1#1)(2013-7#1)
pay attention##17##2##(1990-11#1)(1992-10#1)(1992-2#1)(2005-3#1)(2007-10#1)(2007-11#2)(2007-9#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)
pay dividends##2##2##(1993-2#1)(1994-2#1)
pay for HIV##2##3##(2008-8#1)(2010-12#1)
pay for health##2##3##(1994-12#1)(2007-4#1)
pay for it##3##3##(1995-1#1)(2008-3#1)(2011-12#1)
pay for or##2##3##(1990-4#1)(2007-8#1)
pay for performance##6##3##(1996-3#3)(2007-4#1)(2008-4#1)(2008-6#1)
pay for the##7##3##(1992-5#1)(1996-6#1)(2006-10#1)(2007-4#1)(2007-7#2)(2012-12#1)
pay for##50##2##(1990-4#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-3#1)(1993-7#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#2)(1995-12#1)(1995-2#2)(1996-2#1)(1996-3#3)(1996-6#2)(2006-10#1)(2006-12#3)(2007-11#1)(2007-2#1)(2007-4#4)(2007-7#4)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-12#3)(2011-12#1)(2012-12#1)(2012-3#1)(2013-8#1)
pay hospitals for what they##2##5##(1992-12#2)
pay hospitals##3##2##(1992-12#2)(1995-2#1)
pay more attention to the##3##5##(2007-9#1)(2008-1#2)
pay more attention to##7##4##(1995-1#1)(2007-9#1)(2008-1#2)(2010-1#1)(2010-2#1)(2010-4#1)
pay more than##2##3##(1994-1#1)(2006-12#1)
pay more##11##2##(1994-1#1)(1995-1#1)(1996-1#1)(2006-12#1)(2007-4#1)(2007-9#1)(2008-1#2)(2010-1#1)(2010-2#1)(2010-4#1)
pay off##2##2##(2008-6#1)(2010-4#1)
pay physicians##2##2##(1992-1#1)(2006-8#1)
pay special attention to##2##4##(1996-8#1)(2008-11#1)
pay to##2##2##(2006-8#1)(2012-11#1)
pay##189##1##(1990-11#1)(1990-4#2)(1991-2#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#5)(1992-2#2)(1992-3#4)(1992-5#1)(1992-6#1)(1993-2#2)(1993-3#2)(1993-7#1)(1993-9#1)(1994-1#2)(1994-12#2)(1994-2#4)(1994-3#3)(1995-1#4)(1995-10#1)(1995-12#5)(1995-2#5)(1995-6#3)(1995-7#1)(1996-1#1)(1996-11#4)(1996-2#2)(1996-3#6)(1996-5#3)(1996-6#4)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#2)(1997-5#1)(1997-7#1)(1997-8#3)(2005-3#1)(2005-8#1)(2006-10#2)(2006-12#5)(2006-5#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#6)(2007-7#11)(2007-8#1)(2007-9#4)(2008-1#5)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#3)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-5#2)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
pay-for-performance##2##1##(2007-4#2)
payback##4##1##(1992-12#1)(1992-2#1)(2007-4#1)(2008-2#1)
payed##2##1##(2007-11#1)(2008-11#1)
payer and##2##2##(1994-12#1)(2006-12#1)
payer constraints##2##2##(1994-3#1)(2006-1#1)
payer environment##2##2##(1992-11#1)(2008-7#1)
payer##26##1##(1990-12#2)(1992-11#1)(1992-6#1)(1993-1#1)(1993-3#1)(1994-12#1)(1994-3#1)(1996-1#1)(2005-9#1)(2006-1#1)(2006-12#3)(2007-4#1)(2007-8#1)(2008-12#3)(2008-7#1)(2008-8#1)(2009-4#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
payers and##6##2##(1990-12#2)(1994-12#1)(2007-12#1)(2008-11#1)(2013-7#1)
payers for##4##2##(1992-1#2)(1994-12#1)(2005-10#1)
payers in##2##2##(2007-4#1)(2009-4#1)
payers to##3##2##(2006-10#1)(2007-4#1)(2008-7#1)
payers use##3##2##(1994-12#2)(2007-4#1)
payers##55##1##(1990-12#3)(1991-12#1)(1991-3#1)(1992-1#2)(1992-9#1)(1993-12#1)(1994-1#1)(1994-12#8)(1994-2#1)(1995-1#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-12#1)(1997-1#2)(1997-3#2)(1997-6#2)(2005-10#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-4#8)(2008-11#1)(2008-12#1)(2008-7#1)(2009-4#4)(2013-7#2)
payers'##2##1##(1993-1#1)(2006-5#1)
paying attention to the##2##4##(2005-7#1)(2008-10#1)
paying attention to##6##3##(1995-5#1)(1996-8#1)(2005-7#1)(2006-8#1)(2008-10#1)(2008-8#1)
paying for health care##2##4##(1996-3#1)(2008-7#1)
paying for##8##2##(1991-12#1)(1992-12#1)(1996-3#1)(2005-11#1)(2007-4#1)(2008-4#1)(2008-7#1)(2012-3#1)
paying hospitals for##2##3##(1992-12#1)(2007-12#1)
paying particular attention to##2##4##(1990-9#1)(2008-9#1)
paying special attention to the##3##5##(2005-11#1)(2008-5#1)(2013-1#1)
paying special attention to##5##4##(1997-2#1)(2005-11#2)(2008-5#1)(2013-1#1)
paying the usual fee##2##4##(1997-6#2)
paying the##5##2##(1997-6#2)(2007-7#1)(2008-11#1)(2010-8#1)
paying##40##1##(1990-12#1)(1990-9#1)(1991-12#1)(1992-12#2)(1992-2#1)(1992-5#1)(1994-3#1)(1995-5#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-6#2)(2005-11#3)(2005-7#1)(2006-8#1)(2007-12#1)(2007-4#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
payload##2##1##(2008-3#2)
payloads##4##1##(2008-12#1)(2009-2#1)(2013-1#1)(2013-8#1)
payment and cost##2##3##(1992-12#1)(1994-1#1)
payment and##7##2##(1992-12#1)(1993-2#1)(1994-1#1)(1994-2#1)(1995-9#2)(2007-4#1)
payment as##3##2##(1990-12#1)(1992-12#1)(1994-1#1)
payment changes##2##2##(1994-1#1)(2008-4#1)
payment data##3##2##(1993-3#1)(2010-11#2)
payment for##15##2##(1990-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1997-1#1)(2005-12#1)(2006-8#1)(2008-11#1)(2010-9#1)
payment formula##2##2##(1997-1#1)(1997-2#1)
payment in##2##2##(1994-3#1)(1995-2#1)
payment increases##2##2##(2007-2#2)
payment levels##3##2##(1990-12#1)(1992-2#1)(1992-3#1)
payment mechanism##2##2##(1993-3#1)(2011-1#1)
payment method##4##2##(1994-12#1)(1997-1#3)
payment methodologies##3##2##(1992-3#1)(1994-12#1)(1995-12#1)
payment methodology##4##2##(1996-3#1)(1997-3#1)(2006-3#1)(2007-2#1)
payment methods##4##2##(1992-3#1)(1994-1#1)(1994-12#1)(1995-2#1)
payment model##3##2##(1993-12#2)(1994-3#1)
payment models##2##2##(1997-1#1)(2013-7#1)
payment of##6##2##(1990-10#1)(1992-2#1)(1992-3#1)(1995-12#1)(2007-12#1)(2008-11#1)
payment on##2##2##(1994-1#1)(1994-2#1)
payment policies and##2##3##(1997-1#1)(1997-2#1)
payment policies##7##2##(1990-12#1)(1992-3#1)(1993-3#1)(1994-12#1)(1996-1#1)(1997-1#1)(1997-2#1)
payment policy##8##2##(1991-12#1)(1994-1#2)(1995-1#2)(2007-2#1)(2007-4#2)
payment rate##2##2##(1991-1#1)(1994-12#1)
payment rates for##3##3##(1990-12#2)(1992-1#1)
payment rates##11##2##(1990-12#3)(1991-1#2)(1992-1#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-12#1)(1995-3#1)
payment reform##14##2##(1991-12#1)(1991-2#1)(1992-12#1)(1993-12#1)(1994-1#4)(1994-12#1)(1995-12#3)(1997-1#1)(2013-1#1)
payment reforms in##2##3##(1997-1#2)
payment reforms##5##2##(1995-12#1)(1997-1#4)
payment system and other##2##4##(1990-12#2)
payment system and##6##3##(1990-12#2)(1991-3#1)(1992-12#1)(1993-3#1)(2007-2#1)
payment system for##8##3##(1991-1#2)(1991-3#2)(1992-1#1)(1992-12#1)(1992-2#2)
payment system of##2##3##(1993-12#1)(1993-3#1)
payment system that##2##3##(1993-3#1)(1995-2#1)
payment system##68##2##(1990-12#7)(1991-1#4)(1991-12#1)(1991-2#3)(1991-3#5)(1992-1#4)(1992-12#10)(1992-2#7)(1993-1#2)(1993-12#3)(1993-2#1)(1993-3#4)(1994-12#3)(1994-3#2)(1995-2#2)(1995-3#1)(1996-3#1)(1997-1#1)(2005-8#1)(2007-12#1)(2007-2#1)(2007-4#2)(2008-11#1)(2010-8#1)
payment systems in##2##3##(1992-3#1)(1994-12#1)
payment systems##15##2##(1990-12#4)(1991-1#1)(1992-3#3)(1993-12#2)(1994-12#2)(1996-1#1)(1996-2#1)(2010-8#1)
payment to health maintenance organizations##2##5##(1993-1#1)(1993-3#1)
payment to##8##2##(1992-1#1)(1992-10#1)(1992-2#1)(1993-1#1)(1993-3#2)(1997-5#1)(2006-10#1)
payment under##2##2##(1991-2#1)(1995-2#1)
payment##308##1##(1990-10#1)(1990-12#19)(1990-5#1)(1991-1#14)(1991-12#5)(1991-2#8)(1991-3#12)(1991-4#1)(1992-1#14)(1992-10#1)(1992-12#20)(1992-2#16)(1992-3#12)(1993-1#7)(1993-12#10)(1993-2#2)(1993-3#10)(1994-1#12)(1994-12#16)(1994-2#4)(1994-3#8)(1995-1#4)(1995-12#6)(1995-2#8)(1995-3#4)(1995-5#1)(1995-9#2)(1996-1#3)(1996-12#2)(1996-2#2)(1996-3#3)(1997-1#15)(1997-2#5)(1997-3#1)(1997-5#3)(1997-8#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#3)(2007-2#7)(2007-3#1)(2007-4#7)(2007-9#1)(2008-11#5)(2008-12#1)(2008-4#3)(2008-6#1)(2008-9#1)(2010-11#4)(2010-8#2)(2010-9#1)(2011-1#3)(2012-3#4)(2013-1#2)(2013-7#1)
payments and##6##2##(1992-12#1)(1995-1#1)(1997-2#1)(2007-2#1)(2012-2#1)(2012-3#1)
payments are##2##2##(1992-12#1)(1995-2#1)
payments by##3##2##(1990-12#1)(2005-9#1)(2010-8#1)
payments for##18##2##(1990-12#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-2#2)(1994-12#1)(1997-1#5)(2007-12#1)(2007-4#1)(2007-9#1)(2012-2#1)(2012-3#2)
payments in##4##2##(1992-12#1)(2012-3#3)
payments made##2##2##(2008-4#1)(2009-12#1)
payments to health##3##3##(1991-1#2)(1997-1#1)
payments to reflect##2##3##(1990-12#1)(1995-2#1)
payments to the##2##3##(1992-12#1)(1994-12#1)
payments to##16##2##(1990-10#1)(1990-12#4)(1991-1#2)(1992-12#1)(1993-12#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-12#1)(1997-1#1)(2008-7#1)(2010-11#1)
payments were##2##2##(1990-12#1)(2012-3#1)
payments##109##1##(1990-10#1)(1990-12#7)(1991-1#3)(1991-12#3)(1991-2#1)(1991-3#3)(1991-4#1)(1991-6#1)(1992-1#1)(1992-12#10)(1992-2#5)(1992-8#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#3)(1993-8#1)(1994-1#2)(1994-12#2)(1994-2#2)(1995-1#3)(1995-2#4)(1996-12#3)(1996-7#1)(1997-1#13)(1997-2#2)(2005-9#1)(2006-10#1)(2007-12#2)(2007-2#2)(2007-4#1)(2007-9#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-11#2)(2010-8#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#11)(2013-8#1)
payoff##8##1##(1992-2#2)(2006-5#1)(2007-9#1)(2008-2#1)(2008-8#2)(2008-9#1)
payoffs of##2##2##(2008-8#1)(2012-3#1)
payoffs##5##1##(2008-8#3)(2010-2#1)(2012-3#1)
payor net cost savings from a##2##6##(2008-11#2)
payor##9##1##(1990-12#1)(1992-1#2)(1993-12#1)(1994-1#1)(1996-3#1)(2008-11#3)
payors and##2##2##(1991-1#1)(1994-12#1)
payors##22##1##(1991-1#1)(1991-3#1)(1992-1#2)(1992-12#2)(1992-3#1)(1994-1#6)(1994-12#1)(1995-1#1)(1996-3#1)(2006-8#1)(2008-11#4)(2012-2#1)
payout##4##1##(1996-3#3)(2006-10#1)
payouts##2##1##(1993-3#1)(1996-3#1)
payroll##4##1##(1990-12#1)(1995-3#1)(2007-11#1)(2008-11#1)
pays for##2##2##(2008-5#1)(2009-11#1)
pays off##5##2##(1996-1#1)(1997-3#1)(2007-10#1)(2009-4#1)(2013-1#1)
pays##22##1##(1990-5#1)(1992-12#1)(1992-6#1)(1993-3#3)(1995-11#1)(1996-1#1)(1996-3#1)(1997-3#1)(2006-5#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-4#1)(2012-2#3)(2013-1#2)
pays&quot##2##1##(1994-8#1)(1996-1#1)
pazopanib and RT##5##3##(2013-1#5)
pazopanib##10##1##(2010-12#1)(2011-1#1)(2013-1#8)
pb##2##1##(2013-1#2)
pcDNA-TIMP3##2##1##(2005-10#2)
pcDNA-tum-5##2##1##(2008-11#2)
pcDNA3 transfectant and##2##3##(2008-9#2)
pcDNA3##18##1##(2005-10#3)(2005-6#5)(2007-1#1)(2008-11#1)(2008-5#1)(2008-8#4)(2008-9#2)(2012-3#1)
pcDNA3-PreS2/S and##2##2##(2005-10#2)
pcDNA3-TPO##2##1##(2008-8#2)
pcDNA6##2##1##(2011-2#2)
pcXII##2##1##(2008-10#2)
pcbC##2##1##(2011-1#2)
pd 14##3##2##(2008-7#3)
pd##7##1##(2008-7#7)
pdb)##2##1##(2010-12#2)
pdc1 deletion mutants had##2##4##(1990-3#2)
pdc1 deletion mutants##3##3##(1990-3#3)
pdc1##4##1##(1990-3#4)
pePOA##7##1##(1992-3#7)
pea (Pisum sativum L##2##4##(1995-1#1)(2006-9#1)
pea (Pisum sativum)##5##3##(1992-12#1)(1993-6#1)(2008-1#1)(2008-10#2)
pea (Pisum##7##2##(1992-12#1)(1993-6#1)(1995-1#1)(2006-9#1)(2008-1#1)(2008-10#2)
pea DRR206##2##2##(2008-10#2)
pea and lentil##2##3##(1993-8#1)(2008-10#1)
pea and##6##2##(1993-8#1)(2008-10#3)(2008-5#1)(2008-6#1)
pea aphids##3##2##(2008-8#3)
pea cultivar##3##2##(2006-9#2)(2008-10#1)
pea cultivars##6##2##(2008-10#6)
pea fields in##2##3##(2008-10#2)
pea is##5##2##(2006-9#1)(2008-10#1)(2008-5#2)(2009-8#1)
pea lectin and##2##3##(1993-8#2)
pea lectin##4##2##(1993-8#4)
pea lines##5##2##(2006-9#1)(2008-10#4)
pea plants##3##2##(2008-10#3)
pea production##2##2##(2008-10#2)
pea protein##3##2##(1993-6#3)
pea roots##3##2##(2008-10#3)
pea seedlings##3##2##(2009-8#1)(2011-2#2)
pea seeds##2##2##(2008-10#1)(2011-2#1)
pea##105##1##(1991-4#1)(1992-12#1)(1993-6#6)(1993-8#5)(1994-9#1)(1995-1#1)(1997-7#2)(2006-9#7)(2008-1#1)(2008-10#55)(2008-5#6)(2008-6#4)(2008-7#1)(2008-8#5)(2009-8#3)(2011-2#6)
pea-size##2##1##(2008-10#2)
peace##11##1##(1990-2#1)(1991-2#1)(1992-9#1)(1993-1#1)(1995-7#1)(2004-7#1)(2007-7#2)(2008-10#1)(2008-3#1)(2009-4#1)
peace-keeping##2##1##(1993-2#1)(2006-7#1)
peaceful##5##1##(2006-3#1)(2007-2#1)(2007-9#1)(2010-2#1)(2013-8#1)
peach (Prunus persica)##2##3##(2008-10#2)
peach and##2##2##(2008-10#1)(2011-2#1)
peach fruit by##2##3##(2008-10#2)
peach fruit##6##2##(2008-10#6)
peach leaves##2##2##(2008-10#2)
peach orchard##2##2##(2008-10#2)
peach orchards##4##2##(2008-10#3)(2011-12#1)
peach plants##2##2##(2008-10#2)
peach seedlings##4##2##(2008-10#4)
peach tree susceptibility to bacterial canker infection##2##7##(2008-10#2)
peach tree##3##2##(2008-10#3)
peach trees##3##2##(2008-10#2)(2011-12#1)
peach was##2##2##(2008-10#2)
peach##63##1##(2005-4#1)(2008-10#57)(2011-12#4)(2011-2#1)
peak 1##3##2##(2004-9#1)(2007-9#1)(2008-10#1)
peak 2##3##2##(1990-5#1)(2008-10#2)
peak 3##4##2##(1993-7#1)(1996-6#2)(2008-10#1)
peak BMD and age at peak BMD##2##7##(2010-3#2)
peak BMD##7##2##(2010-3#7)
peak IGly##2##2##(1996-9#2)
peak MSS and peak MPS##2##5##(2007-1#2)
peak VO2##3##2##(2007-10#3)
peak VO2/kg x min(-1)##2##4##(2008-3#2)
peak WBC in##4##3##(2013-1#4)
peak [Ca2+]i##2##2##(1992-6#1)(1996-11#1)
peak above##2##2##(2008-3#2)
peak absorption##6##2##(2008-2#1)(2008-3#4)(2012-12#1)
peak abundance##2##2##(2007-5#1)(2008-10#1)
peak acceleration of##3##3##(2008-11#2)(2012-2#1)
peak acceleration##5##2##(1993-7#1)(2008-11#2)(2010-2#1)(2012-2#1)
peak acid output##2##3##(2007-1#2)
peak action##2##2##(1994-2#1)(2007-10#1)
peak activation occurred between##2##4##(1997-3#2)
peak activation##3##2##(1995-2#1)(1997-3#2)
peak activity of##2##3##(1996-6#1)(1997-3#1)
peak activity##3##2##(1996-6#1)(1997-3#1)(2011-1#1)
peak after##3##2##(1990-5#1)(1991-9#1)(1997-5#1)
peak age group##2##3##(2007-10#2)
peak age##4##2##(2007-10#2)(2007-7#1)(2011-1#1)
peak alignment##2##2##(2011-1#2)
peak amplitude of##4##3##(1992-11#1)(1992-8#2)(1995-11#1)
peak amplitude##7##2##(1992-11#1)(1992-8#3)(1995-11#1)(1996-9#1)(2009-6#1)
peak and a##3##3##(1990-3#1)(2005-12#1)(2008-2#1)
peak and average power##2##4##(2008-1#1)(2012-1#1)
peak and average##3##3##(2007-12#1)(2008-1#1)(2012-1#1)
peak and the##6##3##(1995-3#1)(2004-9#1)(2005-11#1)(2008-10#2)(2008-8#1)
peak and two##2##3##(2008-10#1)(2008-3#1)
peak and##31##2##(1990-3#1)(1990-5#1)(1991-12#1)(1992-8#1)(1995-3#1)(1996-2#1)(1997-2#1)(2004-9#1)(2005-11#1)(2005-12#1)(2006-4#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#9)(2008-2#2)(2008-3#1)(2008-8#1)(2010-8#1)(2012-1#1)(2012-12#1)
peak angular##4##2##(2007-1#2)(2007-4#2)
peak annual sales##3##3##(2005-8#2)(2008-5#1)
peak antibody##2##2##(1991-3#1)(2008-10#1)
peak appeared at##2##3##(1995-8#1)(1997-2#1)
peak appeared##5##2##(1993-12#1)(1995-8#1)(1997-2#1)(2008-10#2)
peak appears in the##2##4##(1990-2#1)(2008-3#1)
peak appears##4##2##(1990-2#1)(2008-10#2)(2008-3#1)
peak are##2##2##(2007-12#1)(2008-10#1)
peak area and peak height##4##5##(2008-10#4)
peak area and##7##3##(2007-8#1)(2008-10#5)(2011-1#1)
peak area measurement##2##3##(2008-10#2)
peak area measurements##2##3##(2008-10#2)
peak area of the##2##4##(2008-10#2)
peak area of##8##3##(1990-8#1)(2008-10#6)(2011-1#1)
peak area ratio##2##3##(2008-7#1)(2013-8#1)
peak area ratios##3##3##(2008-10#2)(2008-6#1)
peak area was##3##3##(1990-8#1)(2008-10#2)
peak area were##2##3##(1997-5#1)(2008-10#1)
peak area##48##2##(1990-8#2)(1992-1#1)(1996-5#1)(1997-5#1)(2005-12#1)(2007-8#3)(2008-10#34)(2008-6#1)(2008-7#1)(2011-1#2)(2013-8#1)
peak areas of##3##3##(2008-10#2)(2011-1#1)
peak areas was##2##3##(1997-8#1)(2013-1#1)
peak areas were##3##3##(2007-8#1)(2008-10#2)
peak areas##18##2##(1994-9#1)(1997-8#1)(2005-11#1)(2006-12#1)(2007-8#2)(2008-10#9)(2008-4#1)(2011-1#1)(2013-1#1)
peak around 1##2##3##(2008-10#2)
peak around##10##2##(1990-2#1)(1991-4#1)(1997-7#1)(2008-10#5)(2011-2#2)
peak as##3##2##(1992-12#1)(2008-10#2)
peak at -0##6##3##(1990-5#1)(2008-10#4)(2008-8#1)
peak at -1##3##3##(2008-10#3)
peak at 10##2##3##(1997-3#1)(2005-11#1)
peak at 20##2##3##(1990-3#1)(2007-1#1)
peak at 329##3##3##(1992-10#2)(2008-4#1)
peak at a##2##3##(1995-7#1)(2008-10#1)
peak at about##6##3##(1992-8#1)(2007-9#1)(2008-10#4)
peak at approximately##2##3##(1995-8#1)(2009-9#1)
peak at around##3##3##(1997-5#1)(2008-10#1)(2008-5#1)
peak at m/z =##2##4##(2008-11#1)(2008-3#1)
peak at m/z##5##3##(1990-6#1)(2008-11#1)(2008-3#2)(2011-2#1)
peak at the##9##3##(1990-5#1)(1994-5#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-6#1)(2010-12#1)
peak at##83##2##(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1991-2#2)(1992-10#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-5#2)(1994-6#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#1)(1997-3#1)(1997-5#1)(2005-11#2)(2007-1#1)(2007-11#3)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#31)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#2)(2009-12#1)(2009-2#1)(2009-9#1)(2010-12#1)(2011-2#2)(2013-8#1)
peak being##2##2##(2005-11#1)(2008-10#1)
peak bone mass in##2##4##(2005-3#1)(2010-3#1)
peak bone mass##7##3##(1993-11#1)(2005-3#3)(2007-7#1)(2010-3#2)
peak bone mineral density##2##4##(2010-3#2)
peak bone##9##2##(1993-11#1)(2005-3#3)(2007-7#1)(2010-3#4)
peak broadening##2##2##(2006-5#1)(2008-2#1)
peak by the##2##3##(2006-8#1)(2008-10#1)
peak by##7##2##(1994-6#1)(2006-8#1)(2007-12#1)(2008-10#3)(2010-9#1)
peak capacity##3##2##(1996-5#1)(2008-10#1)(2011-1#1)
peak changes##2##2##(2007-10#1)(2008-4#1)
peak component##2##2##(1991-8#2)
peak concentration##8##2##(1992-9#1)(1993-7#1)(1995-4#1)(2006-10#1)(2008-10#1)(2008-11#1)(2012-12#2)
peak concentrations of##2##3##(1997-4#1)(2007-2#1)
peak concentrations##3##2##(1990-12#1)(1997-4#1)(2007-2#1)
peak conversion##2##2##(2007-12#2)
peak corresponding to the##2##4##(1997-7#1)(2008-10#1)
peak corresponding to##4##3##(1997-7#1)(2008-10#3)
peak could##2##2##(1990-11#1)(2008-10#1)
peak current and molybdenum concentration is linear##2##7##(2008-10#2)
peak current and the concentration##2##5##(2008-10#2)
peak current and##8##3##(2008-10#8)
peak current at -0##2##4##(2008-10#2)
peak current at##3##3##(2007-8#1)(2008-10#2)
peak current for##3##3##(2008-10#3)
peak current had##2##3##(2008-10#2)
peak current increased##3##3##(2007-8#1)(2008-10#2)
peak current is found to be linear##2##7##(2008-10#2)
peak current is proportional to DNA concentration##2##7##(2008-10#2)
peak current is proportional to the concentration of##4##8##(2008-10#4)
peak current is proportional to the##5##6##(2007-8#1)(2008-10#4)
peak current is proportional to##8##5##(2007-8#1)(2008-10#7)
peak current is proportional##9##4##(2007-8#2)(2008-10#7)
peak current is##13##3##(2007-8#2)(2008-10#11)
peak current of ARS##2##4##(2008-10#2)
peak current of the##3##4##(2008-10#3)
peak current of##13##3##(2008-10#12)(2012-2#1)
peak current response##2##3##(2008-10#2)
peak current was linear to##2##5##(2008-10#2)
peak current was##7##3##(1994-2#1)(2007-8#1)(2008-10#5)
peak current with##2##3##(2008-10#2)
peak current##78##2##(1994-2#1)(2007-8#6)(2008-10#68)(2009-3#1)(2010-6#1)(2012-2#1)
peak currents and##3##3##(2008-10#3)
peak currents of##4##3##(2008-10#3)(2012-2#1)
peak currents were found to be##2##6##(2008-10#2)
peak currents were##5##3##(2007-8#1)(2008-10#4)
peak currents##28##2##(2007-8#2)(2008-10#23)(2008-2#1)(2012-2#2)
peak density of##4##3##(1994-10#1)(1994-9#1)(1995-1#1)(1996-12#1)
peak due to##3##3##(1992-8#1)(1995-8#1)(2008-10#1)
peak during##7##2##(1991-5#1)(1991-6#1)(1997-1#1)(2007-10#2)(2008-11#1)(2010-3#1)
peak effect##2##2##(1996-5#1)(1996-6#1)
peak efficiencies##2##2##(2008-10#1)(2008-2#1)
peak efficiency of##2##3##(2007-11#1)(2008-3#1)
peak efficiency##6##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
peak ejection##2##2##(1993-12#1)(2008-7#1)
peak elbow##2##2##(2006-11#1)(2007-1#1)
peak electron##2##2##(2007-5#1)(2008-2#1)
peak endogenous##2##2##(2008-3#2)
peak enhancement##2##2##(2008-10#1)(2008-7#1)
peak experience##4##2##(2013-8#4)
peak experiences of psilocybin users and non-users##2##7##(2013-8#2)
peak experiences of psilocybin users##3##5##(2013-8#3)
peak experiences##8##2##(2013-8#8)
peak expiratory flow (PEF)##4##4##(1993-7#1)(2007-2#1)(2008-1#1)(2009-6#1)
peak expiratory flow rate (PEFR)##2##5##(2007-2#2)
peak expiratory flow rate with##2##5##(2007-1#1)(2013-8#1)
peak expiratory flow rate##8##4##(2004-12#1)(2007-1#1)(2007-11#1)(2007-2#4)(2013-8#1)
peak expiratory flow rates##2##4##(1996-1#1)(2008-1#1)
peak expiratory flow##21##3##(1990-6#2)(1993-7#1)(1996-1#1)(2004-12#1)(2006-5#2)(2007-1#1)(2007-11#1)(2007-2#5)(2008-1#2)(2008-3#1)(2009-6#2)(2013-1#1)(2013-8#1)
peak filling##2##2##(1993-12#1)(2008-7#1)
peak flow meter##2##3##(2010-2#1)(2012-12#1)
peak flow meters and##2##4##(2008-10#1)(2011-12#1)
peak flow meters##5##3##(1991-3#1)(1991-6#1)(2008-10#1)(2011-12#2)
peak flow velocity E/A ratio##2##5##(1995-6#2)
peak flow velocity##3##3##(1995-6#2)(2007-8#1)
peak flow##19##2##(1990-9#1)(1991-3#1)(1991-6#1)(1995-6#2)(1996-2#1)(2006-5#2)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-2#2)(2011-12#2)(2012-12#1)(2013-1#1)
peak for the##2##3##(1991-3#1)(2008-10#1)
peak for##4##2##(1990-10#1)(1990-3#1)(1991-3#1)(2008-10#1)
peak force##3##2##(2006-11#1)(2007-4#2)
peak frequencies##2##2##(1991-10#1)(1993-5#1)
peak frequency of##2##3##(2007-3#1)(2008-11#1)
peak frequency##4##2##(2007-11#1)(2007-3#1)(2008-11#1)(2008-2#1)
peak from##5##2##(1993-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)
peak glucose##3##2##(1994-12#1)(2010-8#1)(2012-2#1)
peak has been##2##3##(1993-6#1)(2008-10#1)
peak has##3##2##(1992-9#1)(1993-6#1)(2008-10#1)
peak heart rate##3##3##(2007-10#1)(2008-7#1)(2013-1#1)
peak height absorbance##2##3##(2008-10#2)
peak height and concentration##2##4##(2008-10#2)
peak height and peak area##3##5##(1996-5#1)(2008-10#2)
peak height and peak##4##4##(1996-5#1)(2008-10#3)
peak height and the##4##4##(2008-10#3)(2008-2#1)
peak height and##13##3##(1996-5#1)(2008-10#11)(2008-2#1)
peak height by using##3##4##(2007-8#1)(2008-10#2)
peak height by##4##3##(2007-8#1)(2008-10#3)
peak height of##5##3##(2005-4#1)(2006-12#1)(2008-10#3)
peak height ratios##2##3##(1990-12#1)(2008-3#1)
peak height values##2##3##(2008-10#2)
peak height was##3##3##(2008-10#3)
peak height##52##2##(1990-12#2)(1993-8#1)(1996-5#1)(2005-11#1)(2005-4#1)(2006-12#1)(2007-8#1)(2008-10#42)(2008-2#1)(2008-3#1)
peak heights of##2##3##(1996-8#1)(2008-10#1)
peak heights##12##2##(1996-8#1)(2008-10#10)(2008-2#1)
peak hip##2##2##(2011-2#2)
peak identification##5##2##(2007-5#3)(2008-10#2)
peak in the##24##3##(1990-5#1)(1990-9#1)(1992-8#1)(1994-10#1)(1995-1#1)(1997-1#1)(1997-7#1)(2006-1#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2010-11#1)(2010-4#1)(2010-8#1)(2012-1#1)(2013-1#1)
peak in##50##2##(1990-5#1)(1990-9#1)(1992-8#1)(1993-4#1)(1994-10#1)(1995-1#1)(1995-10#1)(1995-8#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-9#2)(2009-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-1#1)
peak incidence##4##2##(1992-9#1)(1993-9#1)(2007-1#1)(2007-2#1)
peak increases with##2##3##(2007-12#1)(2008-3#1)
peak increases##4##2##(1992-3#1)(2007-12#2)(2008-3#1)
peak inspiratory flow##2##3##(1992-3#1)(2012-2#1)
peak inspiratory pressure##4##3##(2005-11#1)(2006-10#1)(2007-2#1)(2008-6#1)
peak inspiratory##7##2##(1992-3#1)(1994-2#1)(2005-11#1)(2006-10#1)(2007-2#1)(2008-6#1)(2012-2#1)
peak integration##2##2##(1996-9#2)
peak intensities from##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
peak intensities of##2##3##(1992-9#1)(2007-12#1)
peak intensities##11##2##(1992-9#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#2)(2008-3#2)
peak intensity at##4##3##(1995-11#1)(2007-12#1)(2008-2#1)(2013-8#1)
peak intensity in##2##3##(2007-12#1)(2008-3#1)
peak intensity is##3##3##(2007-11#2)(2007-12#1)
peak intensity of##8##3##(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#1)
peak intensity##31##2##(1995-11#1)(2007-11#3)(2007-12#11)(2008-10#1)(2008-2#8)(2008-3#5)(2010-10#1)(2013-8#1)
peak is at##2##3##(1991-2#1)(2007-12#1)
peak is in the##2##4##(2007-12#1)(2010-3#1)
peak is in##3##3##(2007-12#1)(2010-3#2)
peak is produced##2##3##(1992-9#1)(2008-10#1)
peak is##21##2##(1990-2#1)(1991-2#1)(1992-9#1)(2006-10#1)(2007-12#3)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#2)(2010-12#1)(2010-3#2)(2012-1#1)(2013-8#2)
peak lactation##4##2##(2012-12#4)
peak latency##4##2##(1995-12#3)(2008-7#1)
peak level##5##2##(1994-2#1)(1996-12#2)(2004-10#1)(2006-10#1)
peak levels of##3##3##(1991-12#1)(2010-8#1)(2011-2#1)
peak levels##9##2##(1990-12#1)(1991-12#1)(1991-5#1)(1992-9#2)(2007-10#1)(2007-6#1)(2010-8#1)(2011-2#1)
peak load of##3##3##(2006-11#2)(2007-1#1)
peak load##7##2##(2006-11#4)(2007-1#1)(2007-10#1)(2008-9#1)
peak located##2##2##(1993-11#1)(2008-10#1)
peak lod score##2##3##(1992-5#1)(1997-5#1)
peak may##2##2##(2008-10#1)(2008-5#1)
peak near##4##2##(1990-8#1)(2005-11#1)(2008-2#1)(2008-3#1)
peak neck tension##2##3##(2007-4#2)
peak neck##3##2##(2007-4#3)
peak of activity was##3##4##(1992-9#1)(1997-7#2)
peak of activity##7##3##(1992-9#2)(1993-9#1)(1994-12#1)(1997-7#2)(2013-1#1)
peak of ammonia##2##3##(1992-11#2)
peak of differential labeling##2##4##(1992-1#2)
peak of the##28##3##(1990-11#1)(1990-3#1)(1992-12#1)(1994-3#1)(1995-11#1)(2004-9#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-2#7)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-12#2)(2011-1#1)
peak of which was##4##4##(1991-9#1)(2007-8#3)
peak of##121##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-5#1)(1991-9#3)(1992-1#4)(1992-11#2)(1992-12#1)(1992-8#1)(1992-9#4)(1993-4#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1995-11#1)(1995-3#1)(1995-4#1)(1995-7#1)(1995-8#2)(1996-12#2)(1996-8#1)(1997-5#1)(1997-7#3)(2004-9#1)(2005-4#2)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#7)(2007-9#3)(2008-1#2)(2008-10#15)(2008-11#1)(2008-2#9)(2008-3#1)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#2)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
peak on the##5##3##(1993-12#1)(2006-10#1)(2007-10#2)(2012-3#1)
peak on##8##2##(1993-11#2)(1993-12#1)(2006-10#1)(2007-10#2)(2008-7#1)(2012-3#1)
peak output power##3##3##(2007-11#2)(2007-12#1)
peak output##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
peak overlap##2##2##(2008-10#2)
peak oxygen consumption##4##3##(2005-1#1)(2007-10#2)(2007-8#1)
peak oxygen uptake##2##3##(2007-8#1)(2013-8#1)
peak oxygen##6##2##(2005-1#1)(2007-10#2)(2007-8#2)(2013-8#1)
peak periods##2##2##(1992-8#1)(2008-10#1)
peak plasma concentration (Cmax) of##2##5##(1990-12#1)(2012-12#1)
peak plasma concentration (Cmax)##3##4##(1990-12#1)(2004-12#1)(2012-12#1)
peak plasma concentration of##2##4##(1990-6#1)(1993-1#1)
peak plasma concentration##7##3##(1990-12#1)(1990-6#1)(1991-12#1)(1993-1#1)(2004-12#2)(2012-12#1)
peak plasma concentrations##2##3##(1997-8#1)(2011-2#1)
peak plasma levels##2##3##(1992-4#1)(1992-5#1)
peak plasma##14##2##(1990-12#1)(1990-6#1)(1991-12#1)(1992-4#2)(1992-5#1)(1993-1#1)(1993-7#1)(1997-8#1)(2004-12#2)(2011-2#1)(2012-12#1)(2013-8#1)
peak population##2##2##(2012-2#2)
peak position at maximum height##3##5##(2008-10#3)
peak position of the##3##4##(2007-11#2)(2008-3#1)
peak position of##4##3##(2007-11#2)(2008-10#1)(2008-3#1)
peak position##13##2##(2005-11#1)(2005-4#1)(2007-11#2)(2008-10#6)(2008-2#1)(2008-3#1)(2009-1#1)
peak positions##3##2##(2005-11#1)(2008-10#1)(2009-1#1)
peak potential is##3##3##(2008-10#3)
peak potential of##5##3##(2008-10#5)
peak potential shifted##2##3##(2008-10#2)
peak potential was##2##3##(2008-10#2)
peak potential##26##2##(1992-7#1)(2007-11#1)(2008-10#22)(2009-3#2)
peak potentials##5##2##(2008-10#5)
peak power and pulse width##2##5##(2008-3#2)
peak power and pulse##3##4##(2008-3#3)
peak power and##8##3##(2007-12#2)(2008-3#6)
peak power at##2##3##(2007-12#1)(2008-9#1)
peak power density##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
peak power in excess of##2##5##(2007-12#2)
peak power in##3##3##(2007-12#2)(2008-1#1)
peak power of the##3##4##(2007-12#1)(2008-3#2)
peak power of##19##3##(2007-11#6)(2007-12#8)(2008-1#1)(2008-2#1)(2008-3#3)
peak power##59##2##(2007-11#10)(2007-12#22)(2008-1#3)(2008-2#4)(2008-3#14)(2008-5#2)(2008-9#1)(2012-1#2)(2012-2#1)
peak powers in excess of##2##5##(2007-11#1)(2007-12#1)
peak powers of##3##3##(2007-12#2)(2008-2#1)
peak powers##9##2##(2007-11#1)(2007-12#6)(2008-1#1)(2008-2#1)
peak pump power##2##3##(2007-12#2)
peak purity##2##2##(1996-5#1)(1997-8#1)
peak rate##2##2##(2008-11#1)(2008-9#1)
peak reflectance of##2##3##(2007-12#1)(2008-3#1)
peak reflectance##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
peak reflectivity of##2##3##(2007-12#1)(2008-2#1)
peak reflectivity##6##2##(2007-11#1)(2007-12#2)(2008-2#3)
peak response##2##2##(1995-12#1)(2008-10#1)
peak responses##2##2##(2008-10#1)(2012-12#1)
peak sales##2##2##(2005-8#1)(2005-9#1)
peak separation##6##2##(1997-3#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)
peak serum level##3##3##(1993-11#3)
peak serum##6##2##(1993-11#4)(2006-9#1)(2009-6#1)
peak shape and##2##3##(1996-8#1)(2008-10#1)
peak shape##9##2##(1996-8#3)(2005-12#1)(2007-8#1)(2008-10#3)(2008-2#1)
peak shaped##2##2##(2008-10#2)
peak shapes and##3##3##(1994-9#1)(2007-8#2)
peak shapes were##2##3##(2007-12#1)(2011-1#1)
peak shapes##8##2##(1990-9#1)(1994-9#1)(2007-12#1)(2007-8#3)(2008-10#1)(2011-1#1)
peak sharpness##2##2##(2008-2#1)(2008-3#1)
peak shear##2##2##(2007-4#1)(2013-1#1)
peak shift##4##2##(2006-10#3)(2008-10#1)
peak shifted negatively as the##2##5##(2008-10#2)
peak shifts##2##2##(2008-10#2)
peak signal##2##2##(2008-10#2)
peak signal-to-noise ratio (PSNR)##3##4##(2008-2#3)
peak signal-to-noise ratio##4##3##(2006-10#1)(2008-2#3)
peak strength##2##2##(2005-4#1)(2007-10#1)
peak systolic velocity (PSV)##3##4##(2007-10#1)(2008-1#1)(2013-8#1)
peak systolic velocity in##2##4##(2007-10#1)(2011-2#1)
peak systolic velocity##6##3##(2007-10#3)(2008-1#1)(2011-2#1)(2013-8#1)
peak systolic##8##2##(1990-8#1)(1994-4#1)(2007-10#3)(2008-1#1)(2011-2#1)(2013-8#1)
peak tailing##2##2##(1997-3#1)(2008-10#1)
peak temperature rise in##2##4##(2008-2#1)(2008-3#1)
peak tensile##2##2##(2007-4#2)
peak tension and##2##3##(2007-4#2)
peak that is##5##3##(1996-8#1)(2007-11#1)(2007-12#1)(2008-3#2)
peak that##9##2##(1992-3#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-3#2)
peak time and##3##3##(1994-5#1)(2007-5#1)(2011-2#1)
peak time##5##2##(1994-5#1)(2007-5#1)(2007-7#1)(2008-10#1)(2011-2#1)
peak to peak acceleration of##2##5##(2008-11#2)
peak to peak##4##3##(1992-8#1)(2007-8#1)(2008-11#2)
peak to##11##2##(1991-12#1)(1992-8#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-8#1)
peak torque##6##2##(2007-10#4)(2010-3#1)(2012-1#1)
peak transmission##3##2##(2007-11#1)(2008-2#1)(2008-4#1)
peak transmittance##2##2##(2007-11#1)(2008-2#1)
peak value of##6##3##(1991-1#1)(2005-10#1)(2007-12#1)(2008-3#1)(2008-7#1)(2013-8#1)
peak value##11##2##(1990-5#1)(1991-1#1)(1996-10#1)(2005-10#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-8#1)
peak values for##4##3##(1990-3#1)(1991-12#1)(2005-10#1)(2008-10#1)
peak values in##2##3##(2008-5#2)
peak values of##5##3##(2008-2#1)(2008-3#2)(2008-8#1)(2013-8#1)
peak values##14##2##(1990-3#1)(1991-12#1)(2005-10#1)(2006-12#1)(2007-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-8#1)(2013-8#1)
peak velocity of##4##3##(2005-1#2)(2010-11#1)(2012-2#1)
peak velocity##9##2##(1993-2#2)(2005-1#2)(2007-10#1)(2008-3#1)(2008-4#1)(2010-11#1)(2012-2#1)
peak was also##3##3##(1996-8#1)(2008-10#2)
peak was determined to be##2##5##(1991-10#2)
peak was found##2##3##(1992-1#1)(2008-10#1)
peak was not##2##3##(1990-11#1)(2008-10#1)
peak was observed at##3##4##(2008-10#3)
peak was observed##10##3##(1992-10#1)(1995-1#1)(1996-5#1)(2008-10#5)(2009-12#1)(2011-2#1)
peak was obtained at -1##2##5##(2008-10#1)(2010-2#1)
peak was obtained in##2##4##(2008-10#2)
peak was obtained##7##3##(2005-11#1)(2007-1#1)(2008-10#4)(2010-2#1)
peak was sensitive to the##2##5##(2007-11#1)(2009-6#1)
peak was##55##2##(1990-11#1)(1990-3#1)(1991-10#2)(1991-7#1)(1992-1#2)(1992-10#1)(1992-3#1)(1992-7#1)(1992-9#2)(1993-3#2)(1995-1#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(2005-11#2)(2005-4#1)(2007-1#1)(2007-11#3)(2007-8#1)(2008-10#19)(2008-8#1)(2009-12#1)(2009-6#1)(2010-2#1)(2011-2#3)
peak wavelength at##2##3##(2007-11#1)(2007-12#1)
peak wavelength of the##2##4##(2008-2#2)
peak wavelength of##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
peak wavelength##13##2##(1995-2#1)(2007-11#1)(2007-12#4)(2008-2#3)(2008-3#3)(2013-8#1)
peak were observed##2##3##(1993-2#1)(2008-10#1)
peak were##6##2##(1992-2#1)(1993-2#1)(2008-10#1)(2008-3#1)(2009-6#1)(2011-1#1)
peak when the##2##3##(2008-3#1)(2008-6#1)
peak width##5##2##(1996-6#1)(1997-5#1)(2008-10#3)
peak widths##3##2##(2005-12#1)(2007-8#1)(2008-3#1)
peak with a##2##3##(2007-8#1)(2008-8#1)
peak with##9##2##(1990-3#1)(1995-8#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2012-2#1)
peak##1661##1##(1990-10#5)(1990-11#4)(1990-12#6)(1990-2#7)(1990-3#8)(1990-5#10)(1990-6#5)(1990-7#2)(1990-8#5)(1990-9#3)(1991-1#1)(1991-10#3)(1991-12#8)(1991-2#7)(1991-3#4)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#2)(1991-8#4)(1991-9#5)(1992-1#11)(1992-10#5)(1992-11#5)(1992-12#5)(1992-2#7)(1992-3#5)(1992-4#3)(1992-5#3)(1992-6#5)(1992-7#3)(1992-8#13)(1992-9#14)(1993-1#1)(1993-11#9)(1993-12#8)(1993-2#4)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#3)(1993-7#6)(1993-8#3)(1993-9#3)(1994-10#2)(1994-12#4)(1994-2#6)(1994-3#1)(1994-4#1)(1994-5#4)(1994-6#4)(1994-8#1)(1994-9#4)(1995-1#4)(1995-10#1)(1995-11#3)(1995-12#7)(1995-2#4)(1995-3#6)(1995-4#2)(1995-5#1)(1995-6#6)(1995-7#2)(1995-8#7)(1996-1#2)(1996-10#2)(1996-11#2)(1996-12#7)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#9)(1996-6#8)(1996-8#8)(1996-9#7)(1997-1#2)(1997-2#4)(1997-3#10)(1997-4#1)(1997-5#8)(1997-7#8)(1997-8#5)(2004-10#1)(2004-11#1)(2004-12#3)(2004-9#3)(2005-1#3)(2005-10#3)(2005-11#17)(2005-12#6)(2005-3#3)(2005-4#8)(2005-8#3)(2005-9#2)(2006-1#2)(2006-10#13)(2006-11#8)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#6)(2006-8#3)(2006-9#3)(2007-1#19)(2007-10#31)(2007-11#44)(2007-12#95)(2007-2#12)(2007-3#2)(2007-4#21)(2007-5#8)(2007-6#2)(2007-7#6)(2007-8#42)(2007-9#6)(2008-1#15)(2008-10#435)(2008-11#21)(2008-12#1)(2008-2#78)(2008-3#88)(2008-4#8)(2008-5#17)(2008-6#9)(2008-7#14)(2008-8#13)(2008-9#8)(2009-1#2)(2009-10#1)(2009-12#4)(2009-2#3)(2009-3#3)(2009-6#8)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#5)(2010-3#17)(2010-4#2)(2010-5#2)(2010-6#2)(2010-8#7)(2010-9#2)(2011-1#16)(2011-12#2)(2011-2#22)(2012-1#8)(2012-12#19)(2012-2#17)(2012-3#4)(2013-1#12)(2013-7#2)(2013-8#28)
peak)##7##1##(2007-12#1)(2007-4#2)(2008-10#2)(2008-2#1)(2008-3#1)
peak-power##8##1##(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#2)
peak-shape##3##1##(2008-10#3)
peak-to-peak amplitude of##2##3##(2008-2#1)(2008-7#1)
peak-to-peak amplitude##4##2##(2008-10#1)(2008-2#1)(2008-7#2)
peak-to-peak resolution##5##2##(2008-10#4)(2010-4#1)
peak-to-peak value of the##2##4##(2008-3#1)(2012-12#1)
peak-to-peak##14##1##(1993-12#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-7#2)(2010-4#1)(2012-12#1)
peak-to-trough##2##1##(1992-4#1)(2008-5#1)
peak-to-valley value##2##2##(2007-12#1)(2008-3#1)
peaked after##2##2##(1993-8#1)(2008-4#1)
peaked approximately##4##2##(1991-12#1)(1997-7#1)(2008-10#2)
peaked at 1##3##3##(1993-8#1)(2008-5#1)(2012-12#1)
peaked at 2 h##2##4##(1995-2#1)(2008-4#1)
peaked at 2##3##3##(1995-2#1)(2008-4#1)(2009-8#1)
peaked at 7##2##3##(2008-10#1)(2009-6#1)
peaked at the##2##3##(1994-9#1)(2008-11#1)
peaked at##28##2##(1990-2#1)(1990-4#1)(1993-11#2)(1993-8#3)(1994-5#1)(1994-9#2)(1995-12#1)(1995-2#2)(1996-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-6#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
peaked between 2 and 3 days##2##6##(2007-10#2)
peaked between##4##2##(1991-7#1)(2007-10#2)(2008-10#1)
peaked during the##2##3##(2008-10#1)(2010-8#1)
peaked during##3##2##(1997-1#1)(2008-10#1)(2010-8#1)
peaked in the##3##3##(1994-5#1)(2007-1#1)(2008-10#1)
peaked in##7##2##(1992-6#1)(1994-5#1)(1995-2#1)(1996-11#1)(2007-1#1)(2007-4#1)(2008-10#1)
peaked near##2##2##(1991-9#1)(1996-5#1)
peaked##75##1##(1990-10#1)(1990-2#1)(1990-4#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-6#1)(1993-11#2)(1993-12#1)(1993-8#5)(1994-10#1)(1994-5#2)(1994-9#2)(1995-12#1)(1995-2#3)(1995-5#1)(1996-1#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-7#3)(2004-11#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-12#2)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-8#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
peaking after##3##2##(1992-11#1)(1995-10#1)(1997-6#1)
peaking at day##2##3##(1995-2#1)(2008-4#1)
peaking at##10##2##(1992-1#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1995-2#2)(1996-6#1)(2008-4#1)
peaking early##2##2##(1991-10#1)(1992-9#1)
peaking in##3##2##(1992-5#1)(1992-6#1)(2012-3#1)
peaking##26##1##(1991-10#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#1)(1994-6#1)(1995-10#1)(1995-2#2)(1995-5#1)(1996-12#1)(1996-6#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2012-3#1)
peaks after##2##2##(1992-12#1)(1995-10#1)
peaks and the##4##3##(2008-10#2)(2011-1#1)(2013-7#1)
peaks and##15##2##(1997-2#1)(2007-11#1)(2007-12#2)(2007-4#1)(2008-10#6)(2008-2#1)(2009-11#1)(2011-1#1)(2013-7#1)
peaks appeared in the##2##4##(1995-4#1)(2013-7#1)
peaks appeared on the##2##4##(2008-10#2)
peaks appeared##4##2##(1995-4#1)(2008-10#2)(2013-7#1)
peaks are in the##2##4##(2010-5#1)(2013-8#1)
peaks are in##3##3##(2008-1#1)(2010-5#1)(2013-8#1)
peaks are observed in the##2##5##(2008-10#1)(2008-3#1)
peaks are observed##4##3##(2008-10#1)(2008-3#2)(2009-5#1)
peaks are separated##2##3##(2008-10#2)
peaks are##21##2##(1996-5#1)(1996-6#1)(2005-4#1)(2006-12#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-2#1)(2008-3#3)(2009-5#1)(2009-6#1)(2010-5#1)(2011-1#1)(2013-8#2)
peaks associated with##2##3##(1990-3#1)(2008-10#1)
peaks at a##2##3##(1991-4#1)(2008-10#1)
peaks at about##2##3##(2008-10#1)(2013-8#1)
peaks at pI##2##3##(1993-4#2)
peaks at the##2##3##(2007-11#1)(2008-3#1)
peaks at##34##2##(1990-5#2)(1991-4#1)(1991-5#1)(1993-4#2)(1994-3#1)(1995-1#1)(1997-7#1)(2004-9#1)(2005-11#1)(2005-4#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-2#1)(2008-10#7)(2008-2#1)(2008-3#1)(2011-1#2)(2011-2#1)(2013-8#2)
peaks between##2##2##(2011-2#1)(2012-12#1)
peaks by##3##2##(1997-2#1)(2008-10#1)(2008-5#1)
peaks can be##2##3##(2007-12#1)(2008-10#1)
peaks can##4##2##(2007-11#1)(2007-12#1)(2008-10#2)
peaks cannot be##2##3##(2008-10#2)
peaks corresponding to the##4##4##(1992-7#1)(2008-10#3)
peaks corresponding to##12##3##(1991-9#1)(1992-7#1)(1996-9#1)(2008-10#9)
peaks could##2##2##(1997-3#1)(2006-4#1)
peaks due to the##3##4##(1996-2#1)(2008-10#2)
peaks due to##4##3##(1996-2#1)(2008-10#2)(2010-12#1)
peaks during the##2##3##(1990-12#1)(1996-12#1)
peaks for each##2##3##(1994-3#1)(1997-2#1)
peaks for##12##2##(1994-3#1)(1996-8#1)(1997-2#1)(2007-8#1)(2008-10#8)
peaks found##2##2##(1996-5#1)(2008-10#1)
peaks from##9##2##(1990-12#1)(1991-7#1)(1995-3#1)(1996-7#1)(2008-10#1)(2010-12#1)(2011-1#2)(2012-3#1)
peaks in a##2##3##(1997-2#1)(2008-10#1)
peaks in the##24##3##(1991-3#1)(1993-2#1)(1996-6#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-3#4)(2008-8#1)(2009-11#1)(2009-3#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-7#1)
peaks in##44##2##(1990-7#1)(1991-3#1)(1993-2#1)(1996-4#1)(1996-6#1)(1997-2#1)(2005-4#1)(2007-1#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#2)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2010-6#1)(2011-1#3)(2011-2#2)(2012-1#2)(2013-7#1)(2013-8#1)
peaks is##4##2##(2008-10#1)(2008-3#2)(2011-1#1)
peaks located##2##2##(2008-10#1)(2008-3#1)
peaks may##2##2##(2008-3#1)(2011-1#1)
peaks near##2##2##(2007-12#1)(2008-2#1)
peaks observed in##2##3##(2008-2#1)(2010-8#1)
peaks observed##4##2##(1991-12#1)(2008-2#1)(2010-12#1)(2010-8#1)
peaks obtained from##2##3##(1990-8#1)(2008-10#1)
peaks obtained with##2##3##(2007-8#1)(2008-10#1)
peaks obtained##5##2##(1990-8#1)(2007-1#1)(2007-8#1)(2008-10#2)
peaks of activity##2##3##(1990-12#1)(1992-9#1)
peaks of dopamine##2##3##(2008-10#2)
peaks of the##17##3##(1990-5#1)(2004-2#1)(2006-4#1)(2007-11#3)(2008-10#9)(2013-1#2)
peaks of##74##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#2)(1990-7#1)(1991-4#2)(1992-1#3)(1992-12#2)(1992-3#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-7#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-5#1)(1996-8#1)(1997-7#2)(2004-2#1)(2005-12#1)(2006-4#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#25)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-4#1)(2011-2#2)(2013-1#2)(2013-8#1)
peaks on the##2##3##(1994-9#1)(2008-8#1)
peaks on##7##2##(1990-12#1)(1994-9#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-8#1)
peaks over the##2##3##(2006-5#1)(2008-3#1)
peaks produced by##2##3##(2008-10#1)(2008-3#1)
peaks separated##2##2##(1996-6#1)(2008-10#1)
peaks showed##2##2##(2008-10#2)
peaks than those##2##3##(2006-4#1)(2008-10#1)
peaks than##3##2##(2006-4#1)(2008-10#1)(2008-2#1)
peaks that are##2##3##(2007-11#1)(2007-12#1)
peaks that##9##2##(1996-9#1)(2005-11#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-4#1)(2008-8#1)
peaks the##3##2##(1997-4#1)(2008-10#2)
peaks to##3##2##(1990-2#1)(1991-5#1)(2008-10#1)
peaks was##5##2##(1990-11#1)(1995-6#1)(1997-2#1)(2008-10#1)(2013-8#1)
peaks were also observed##2##4##(2008-10#1)(2008-9#1)
peaks were also##4##3##(2008-10#3)(2008-9#1)
peaks were detected in##2##4##(1991-7#1)(2008-9#1)
peaks were detected##4##3##(1991-7#1)(1992-5#1)(1996-9#1)(2008-9#1)
peaks were identified##3##3##(1996-5#1)(2008-10#1)(2008-11#1)
peaks were observed at##2##4##(2010-12#1)(2010-4#1)
peaks were observed for##2##4##(2008-10#2)
peaks were observed##8##3##(1991-7#1)(1996-8#1)(2008-10#2)(2008-9#1)(2009-2#1)(2010-12#1)(2010-4#1)
peaks were obtained in##2##4##(1990-11#1)(2008-10#1)
peaks were obtained##4##3##(1990-11#1)(1991-2#1)(2008-10#2)
peaks were recorded##2##3##(1997-3#1)(2008-9#1)
peaks were symmetrical##2##3##(2005-11#1)(2008-10#1)
peaks were##45##2##(1990-11#1)(1991-2#1)(1991-7#3)(1992-12#1)(1992-5#1)(1993-12#1)(1996-5#1)(1996-8#1)(1996-9#2)(1997-3#1)(2005-11#1)(2007-1#1)(2007-11#1)(2008-10#17)(2008-11#1)(2008-2#2)(2008-8#1)(2008-9#4)(2009-12#1)(2009-2#1)(2010-12#1)(2010-4#1)
peaks when##2##2##(1991-7#1)(2008-3#1)
peaks which##4##2##(1990-7#1)(1991-10#1)(1996-9#1)(2004-9#1)
peaks with an##2##3##(2008-10#1)(2008-3#1)
peaks with##11##2##(1991-2#1)(1992-2#1)(1994-11#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-9#1)
peaks within a##2##3##(2007-12#1)(2007-8#1)
peaks##552##1##(1990-11#5)(1990-12#4)(1990-2#4)(1990-3#2)(1990-5#8)(1990-6#1)(1990-7#4)(1990-8#6)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-4#4)(1991-5#4)(1991-7#7)(1991-9#1)(1992-1#4)(1992-12#4)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-4#2)(1993-6#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-3#4)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#3)(1995-7#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#3)(1996-7#1)(1996-8#4)(1996-9#10)(1997-2#11)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#2)(2004-2#1)(2004-9#2)(2005-11#6)(2005-12#1)(2005-4#4)(2006-12#4)(2006-3#1)(2006-4#3)(2006-5#2)(2006-6#1)(2006-8#1)(2007-1#5)(2007-11#13)(2007-12#14)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#3)(2007-8#14)(2008-1#4)(2008-10#163)(2008-11#4)(2008-12#2)(2008-2#17)(2008-3#25)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#2)(2008-8#7)(2008-9#6)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#2)(2010-11#2)(2010-12#4)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#18)(2011-2#8)(2012-1#3)(2012-12#1)(2012-3#3)(2013-1#4)(2013-7#5)(2013-8#10)
peaks)##4##1##(1990-5#1)(2008-10#3)
peanut (Arachis hypogaea L##2##4##(2011-2#2)
peanut (Arachis hypogaea)##4##3##(2008-10#4)
peanut (Arachis##6##2##(2008-10#4)(2011-2#2)
peanut agglutinin##4##2##(1990-12#1)(1994-3#1)(1994-8#2)
peanut agglutinin-positive##2##2##(1994-3#1)(2008-5#1)
peanut allergen Ara h1##2##4##(2008-11#2)
peanut allergen##3##2##(2008-10#1)(2008-11#2)
peanut cotyledonary##2##2##(1990-10#2)
peanut cotyledons##3##2##(1990-10#3)
peanut peroxidase##2##2##(2008-10#2)
peanut rhizosphere##2##2##(2007-3#2)
peanut shells##3##2##(2008-5#3)
peanut stunt virus (PSV)##3##4##(2008-10#2)(2012-11#1)
peanut stunt virus##4##3##(2008-10#2)(2012-11#2)
peanut##69##1##(1990-10#5)(1990-12#1)(1994-3#2)(1994-8#2)(1996-11#4)(1996-8#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-3#3)(2007-7#1)(2007-8#2)(2008-10#27)(2008-11#2)(2008-5#4)(2009-2#1)(2009-3#1)(2010-5#1)(2011-2#4)(2012-11#2)(2012-12#1)(2012-3#2)
peanuts##3##1##(1990-6#1)(1994-3#1)(2008-10#1)
peapods##5##1##(2008-10#5)
pear and apple flowers##2##4##(2008-10#2)
pear and apple fruit##3##4##(2008-10#3)
pear and apple trees##4##4##(2008-10#4)
pear and apple##14##3##(2008-10#14)
pear and##17##2##(2008-10#16)(2009-6#1)
pear blossoms##5##2##(2008-10#5)
pear cultivars and##2##3##(2008-10#2)
pear cultivars##4##2##(2008-10#4)
pear fruit##5##2##(2008-10#5)
pear in##2##2##(2008-10#2)
pear juice##3##2##(2008-10#3)
pear leaves and##2##3##(2008-10#2)
pear leaves##3##2##(2008-10#3)
pear or apple##2##3##(2008-10#2)
pear orchards##4##2##(2008-10#4)
pear psylla##7##2##(2008-10#7)
pear scab##3##2##(2008-10#3)
pear slices##2##2##(2008-10#2)
pear trees with##2##3##(2008-10#2)
pear trees##4##2##(2008-10#4)
pear##94##1##(2007-1#1)(2008-10#92)(2009-6#1)
pear)##2##1##(2008-10#2)
pear-shaped##2##1##(2007-12#1)(2011-2#1)
pearl cichlid##2##2##(2008-10#2)
pearl millet##3##2##(2008-10#3)
pearl##10##1##(1997-4#1)(2008-10#5)(2008-5#2)(2008-7#1)(2012-11#1)
pearls##4##1##(2007-7#1)(2009-9#1)(2010-8#2)
pears stored##2##2##(2008-10#2)
pears was##2##2##(2008-10#2)
pears##10##1##(2008-10#10)
peas and##3##2##(2008-10#1)(2013-8#2)
peas##10##1##(1992-7#1)(2008-10#7)(2013-8#2)
peasants##4##1##(1993-3#1)(1993-6#1)(2010-8#2)
peaselenium##3##1##(1990-10#3)
peat and##2##2##(2008-10#2)
peat mix##11##2##(2008-10#10)(2009-3#1)
peat moss alone##2##3##(2008-10#2)
peat moss##5##2##(2008-10#5)
peat swamp forest##2##3##(2006-12#2)
peat was##3##2##(2008-10#3)
peat##47##1##(1992-3#2)(1996-8#1)(2004-4#1)(2005-11#1)(2006-12#2)(2008-10#36)(2008-2#1)(2008-8#2)(2009-3#1)
peat-bound metal species##2##3##(2008-10#2)
peat-bound##3##1##(2008-10#3)
peatland and the##2##3##(2008-8#1)(2013-7#1)
peatland and##3##2##(2008-8#1)(2013-7#2)
peatland##6##1##(1993-9#1)(2004-4#1)(2008-8#2)(2013-7#2)
peatlands##8##1##(2008-8#4)(2008-9#3)(2013-7#1)
pebble in the##2##3##(2008-4#1)(2011-1#1)
pebble##3##1##(1995-11#1)(2008-4#1)(2011-1#1)
pecan##3##1##(2008-10#3)
peck##2##1##(2008-6#1)(2012-12#1)
pecked##2##1##(2008-6#1)(2012-2#1)
pecking behavior of##2##3##(2008-6#2)
pecking behavior##3##2##(2008-6#3)
pecking##10##1##(1995-11#1)(2008-6#6)(2009-9#2)(2011-2#1)
pecks (habituation)##2##2##(2008-6#2)
pecks at##2##2##(1994-2#1)(2008-6#1)
pecks##6##1##(1994-2#1)(2008-6#5)
pectate lyase##6##2##(1993-9#1)(1997-7#1)(2008-10#4)
pectate##9##1##(1990-4#1)(1993-9#1)(1997-7#1)(2008-10#6)
pecten##5##1##(2008-5#5)
pectic##3##1##(2008-10#2)(2008-5#1)
pectin and##6##2##(2007-8#2)(2008-10#3)(2012-1#1)
pectin lyase##6##2##(1990-4#5)(2004-8#1)
pectin##43##1##(1990-4#5)(1990-9#2)(1991-9#2)(1995-4#1)(1997-2#1)(2004-11#1)(2004-8#1)(2007-8#4)(2008-10#16)(2010-5#4)(2011-10#1)(2011-2#4)(2012-1#1)
pectin-containing##2##1##(2008-10#1)(2011-1#1)
pectinase##4##1##(2008-10#2)(2008-9#1)(2010-10#1)
pectinases##2##1##(2008-10#1)(2008-6#1)
pectinata##3##1##(2007-3#1)(2009-3#2)
pectinatus##3##1##(2007-3#1)(2007-5#1)(2008-12#1)
pectinesterase##2##1##(1997-2#2)
pectinoschiza##2##1##(2006-8#2)
pectins##6##1##(2008-10#2)(2009-8#1)(2011-2#2)(2013-1#1)
pectolytic activity##2##2##(2008-10#2)
pectolytic enzymes##4##2##(1997-2#3)(2008-10#1)
pectolytic##9##1##(1997-2#4)(2008-10#5)
pectoral fascia##2##2##(2004-2#1)(2009-6#1)
pectoral fin cells##2##3##(2008-11#2)
pectoral fin##4##2##(2008-11#2)(2008-5#1)(2010-8#1)
pectoral muscle##2##2##(2006-9#1)(2013-1#1)
pectoral nerve##4##2##(2011-12#1)(2013-1#3)
pectoral##19##1##(1994-7#1)(1997-6#1)(2004-2#1)(2006-9#1)(2007-12#1)(2008-11#2)(2008-5#4)(2009-6#1)(2009-7#1)(2010-8#1)(2011-12#1)(2013-1#4)
pectoralis major myocutaneous flap##2##4##(2007-12#1)(2012-2#1)
pectoralis major##13##2##(1990-3#2)(1992-6#1)(1992-9#1)(2007-12#1)(2009-1#1)(2010-9#1)(2012-2#5)(2013-1#1)
pectoralis minor muscle##2##3##(2010-9#1)(2013-1#1)
pectoralis minor##9##2##(2010-9#4)(2013-1#5)
pectoralis##27##1##(1990-3#2)(1992-6#1)(1992-9#1)(1995-10#3)(2006-2#1)(2007-12#1)(2009-1#1)(2010-9#5)(2012-2#5)(2013-1#7)
pectoris in##4##2##(1990-9#1)(1991-3#1)(1993-10#1)(2007-8#1)
pectoris##60##1##(1990-12#3)(1990-3#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-3#1)(1991-5#1)(1991-9#5)(1992-12#1)(1992-4#3)(1992-5#2)(1993-10#1)(1993-12#2)(1994-11#1)(1995-11#1)(1995-4#1)(1995-9#1)(1996-9#1)(1997-2#1)(1997-6#1)(2005-1#3)(2005-10#1)(2005-8#1)(2006-12#1)(2006-4#2)(2006-6#2)(2006-8#1)(2007-11#1)(2007-8#4)(2008-10#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
pectus deformity in##3##3##(1997-3#1)(2007-8#2)
pectus excavatum in##4##3##(2007-8#4)
pectus excavatum##10##2##(2007-7#1)(2007-8#8)(2008-5#1)
pectus##15##1##(1997-3#1)(2007-7#1)(2007-8#11)(2008-5#1)(2009-8#1)
peculiar and##3##2##(1992-8#1)(2007-10#1)(2007-11#1)
peculiar characteristic of##2##3##(1990-5#1)(2010-12#1)
peculiar characteristics of##2##3##(1990-1#1)(2013-1#1)
peculiar characteristics##3##2##(1990-1#1)(2008-10#1)(2013-1#1)
peculiar features##2##2##(2008-7#1)(2011-2#1)
peculiar pattern of##2##3##(2008-6#1)(2012-2#1)
peculiar pattern##3##2##(2008-10#1)(2008-6#1)(2012-2#1)
peculiar properties##3##2##(1995-4#1)(2005-11#1)(2008-8#1)
peculiar to the##4##3##(1991-3#1)(1992-3#1)(1992-8#1)(2006-10#1)
peculiar to##11##2##(1991-3#1)(1992-3#1)(1992-8#1)(1993-1#1)(1996-2#1)(2006-10#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)
peculiar##87##1##(1990-1#1)(1990-10#2)(1990-3#1)(1990-4#1)(1990-5#1)(1991-3#1)(1992-10#1)(1992-3#1)(1992-8#3)(1992-9#1)(1993-1#1)(1995-4#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-6#3)(1997-4#1)(1997-8#1)(2005-11#1)(2006-10#2)(2007-10#1)(2007-11#4)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#2)(2010-12#1)(2010-7#1)(2011-12#1)(2011-2#5)(2012-12#3)(2012-2#2)(2013-1#3)
peculiarities associated with this##2##4##(2006-12#1)(2009-6#1)
peculiarities in##8##2##(1990-3#1)(2007-12#1)(2008-4#1)(2008-8#2)(2011-12#1)(2011-2#1)(2012-3#1)
peculiarities of the##8##3##(1991-6#1)(1992-11#1)(2006-2#1)(2008-10#1)(2008-3#1)(2009-2#1)(2012-3#2)
peculiarities of##35##2##(1991-6#1)(1992-11#1)(1996-6#1)(2005-11#1)(2006-2#1)(2006-5#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-8#2)(2009-2#4)(2010-12#4)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-2#1)(2012-3#4)(2013-1#1)
peculiarities##56##1##(1990-3#2)(1990-9#1)(1991-6#1)(1992-11#1)(1993-11#1)(1996-5#1)(1996-6#1)(2005-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#5)(2009-2#4)(2009-6#1)(2010-12#4)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#6)(2013-1#1)(2013-7#1)
peculiarity of the##3##3##(1990-11#1)(2008-3#1)(2013-7#1)
peculiarity of##7##2##(1990-11#1)(1990-12#1)(2008-3#1)(2010-1#1)(2010-9#1)(2011-2#1)(2013-7#1)
peculiarity##9##1##(1990-11#1)(1990-12#1)(2007-9#1)(2008-3#1)(2009-10#1)(2010-1#1)(2010-9#1)(2011-2#1)(2013-7#1)
pedagogic##7##1##(1991-6#1)(1992-11#1)(1994-6#1)(1995-6#1)(2005-7#1)(2011-2#1)(2012-12#1)
pedagogical content knowledge of##2##4##(2009-4#2)
pedagogical knowledge##3##2##(2009-4#3)
pedagogical##25##1##(1991-1#1)(1996-4#1)(2006-6#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-4#6)(2009-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-3#2)(2013-8#1)
pedagogies##2##1##(2008-12#1)(2008-7#1)
pedagogy and##3##2##(2005-12#3)
pedagogy##9##1##(1994-3#1)(2005-12#3)(2007-6#1)(2008-2#1)(2008-8#1)(2012-3#1)(2013-8#1)
pedal arteries##2##2##(1997-8#1)(2008-7#1)
pedal bypass##2##2##(2011-3#2)
pedal edema##4##2##(2010-2#4)
pedal##16##1##(1997-8#3)(2007-7#1)(2007-8#1)(2008-7#1)(2008-9#1)(2010-2#4)(2011-3#4)(2013-7#1)
pedaling technique##2##2##(2011-2#2)
pedaling##7##1##(2011-2#2)(2012-1#5)
pedestal antiresonant reflecting##2##3##(2007-12#2)
pedestal##13##1##(1994-9#1)(2007-11#1)(2007-12#5)(2008-2#1)(2008-3#2)(2008-9#1)(2012-2#1)(2013-8#1)
pedestal-free pulse##3##2##(2007-11#3)
pedestal-free##6##1##(2007-11#5)(2007-12#1)
pedestals##4##1##(2007-12#3)(2008-9#1)
pedestrian impact##2##2##(2006-11#1)(2007-4#1)
pedestrian model##4##2##(2006-11#2)(2007-4#2)
pedestrian movement##3##2##(2012-12#3)
pedestrian safety##3##2##(2006-11#2)(2012-12#1)
pedestrian##25##1##(2006-11#9)(2007-1#1)(2007-4#6)(2011-2#3)(2012-12#6)
pedestrian-vehicle##3##1##(2006-11#2)(2012-12#1)
pedestrians##13##1##(2006-11#2)(2007-4#3)(2011-2#5)(2012-12#3)
pediatric Crohn's disease##2##3##(2010-12#1)(2011-1#1)
pediatric HIV##4##2##(1996-1#1)(2006-10#1)(2007-1#1)(2012-2#1)
pediatric IBD##2##2##(2006-10#2)
pediatric PBSC collection##3##3##(2008-1#3)
pediatric TBI patients##2##3##(1996-1#2)
pediatric TBI##3##2##(1996-1#3)
pediatric abdominal surgical##3##3##(2011-2#3)
pediatric abdominal##5##2##(2007-1#2)(2011-2#3)
pediatric acute lymphoblastic leukemia##2##4##(2008-11#1)(2008-9#1)
pediatric acute##3##2##(2008-11#1)(2008-9#1)(2010-2#1)
pediatric age and##2##3##(1992-5#1)(2006-8#1)
pediatric age group##12##3##(2006-9#1)(2007-12#1)(2007-3#1)(2008-4#2)(2009-3#1)(2011-1#1)(2012-12#3)(2013-1#2)
pediatric age##16##2##(1992-5#1)(2006-11#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-4#2)(2009-3#1)(2011-1#1)(2012-12#3)(2013-1#2)
pediatric airway##2##2##(2013-8#2)
pediatric and adolescent patients with##3##5##(2005-10#1)(2010-3#1)(2012-12#1)
pediatric and adolescent patients##4##4##(2005-10#1)(2010-3#2)(2012-12#1)
pediatric and adolescent##8##3##(2005-10#1)(2009-11#1)(2010-3#4)(2012-12#1)(2013-8#1)
pediatric and adult patients##3##4##(2011-2#1)(2012-3#1)(2013-1#1)
pediatric and adult##7##3##(1993-12#1)(2006-10#1)(2008-1#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
pediatric and geriatric##2##3##(2012-2#2)
pediatric and neonatal##2##3##(2008-9#1)(2011-1#1)
pediatric and##23##2##(1990-6#1)(1993-12#1)(2005-10#1)(2006-1#1)(2006-10#2)(2008-1#1)(2008-4#2)(2008-9#1)(2009-11#1)(2010-3#4)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
pediatric anesthesia##5##2##(2006-10#4)(2011-2#1)
pediatric asthma##5##2##(2007-5#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#1)
pediatric brain tumors##3##3##(2005-10#2)(2006-8#1)
pediatric cardiac arrest##3##3##(2007-3#3)
pediatric cardiac intensive care##3##4##(2008-4#1)(2012-2#2)
pediatric cardiac surgery##4##3##(2007-8#1)(2010-12#2)(2013-1#1)
pediatric cardiac##13##2##(2007-3#3)(2007-8#4)(2008-4#1)(2010-12#2)(2012-2#2)(2013-1#1)
pediatric cardiologists##3##2##(2006-8#2)(2009-4#1)
pediatric cardiology##4##2##(2006-8#1)(2008-4#1)(2013-1#2)
pediatric cardiomyopathy##2##2##(2008-11#1)(2009-4#1)
pediatric care is##2##3##(2010-9#1)(2012-12#1)
pediatric care##7##2##(1992-3#1)(1996-1#1)(1996-12#1)(2010-9#2)(2012-12#1)(2013-1#1)
pediatric case of##4##3##(2008-10#1)(2008-5#1)(2013-1#2)
pediatric case##8##2##(2007-4#1)(2007-7#1)(2008-10#1)(2008-5#1)(2012-2#1)(2013-1#3)
pediatric cases##4##2##(1997-3#1)(2005-10#1)(2005-8#1)(2011-2#1)
pediatric centers##3##2##(2006-8#2)(2011-2#1)
pediatric chronic illness##2##3##(1990-12#1)(2010-9#1)
pediatric chronic##3##2##(1990-12#1)(2007-8#1)(2010-9#1)
pediatric clinic##2##2##(1993-2#1)(2005-6#1)
pediatric clinical##5##2##(1990-4#1)(2007-7#1)(2008-5#2)(2012-1#1)
pediatric clinics##2##2##(1996-2#1)(2013-1#1)
pediatric craniofacial##4##2##(2007-12#4)
pediatric dental##3##2##(2008-5#1)(2008-9#1)(2010-3#1)
pediatric dentist##2##2##(2011-2#1)(2012-12#1)
pediatric dentistry should##2##3##(2010-3#2)
pediatric dentistry##6##2##(2007-12#1)(2010-3#2)(2011-1#1)(2011-2#1)(2012-12#1)
pediatric department##3##2##(2007-12#1)(2007-8#1)(2008-4#1)
pediatric disaster##2##2##(2008-8#2)
pediatric disease##2##2##(2006-10#1)(2007-2#1)
pediatric emergency department##4##3##(2007-7#1)(2009-6#1)(2010-3#1)(2012-3#1)
pediatric emergency##9##2##(1992-3#1)(2007-5#1)(2007-7#1)(2008-8#1)(2009-6#2)(2010-3#1)(2011-12#1)(2012-3#1)
pediatric endocrinologist##2##2##(2006-1#1)(2013-1#1)
pediatric extremity##2##2##(2008-9#2)
pediatric flexible##2##2##(2012-2#1)(2012-3#1)
pediatric head##3##2##(2007-1#3)
pediatric health care##2##3##(2008-11#1)(2010-7#1)
pediatric health##4##2##(2008-11#1)(2009-6#1)(2010-7#1)(2012-2#1)
pediatric heart##8##2##(2007-8#3)(2008-4#5)
pediatric hip fibromatosis with severe joint destruction##2##7##(2011-2#2)
pediatric hip##4##2##(2007-11#2)(2011-2#2)
pediatric home##2##2##(1995-3#1)(2005-7#1)
pediatric hospital in##3##3##(1991-9#1)(2008-9#1)(2010-9#1)
pediatric hospital##11##2##(1991-9#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-10#3)(2010-9#1)(2011-2#1)(2013-1#2)
pediatric hospitals and general hospitals##2##5##(1994-1#2)
pediatric hospitals##8##2##(1994-1#3)(2008-10#1)(2008-11#1)(2009-9#1)(2013-1#2)
pediatric immunization##3##2##(2006-10#1)(2012-12#2)
pediatric inflammatory bowel##2##3##(2006-10#1)(2012-11#1)
pediatric intensive care unit##5##4##(2006-10#1)(2011-1#2)(2012-2#2)
pediatric intensive care##8##3##(2006-10#2)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#1)
pediatric intensive##9##2##(2005-9#1)(2006-10#2)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#1)
pediatric liver recipients##4##3##(1995-2#4)
pediatric liver##10##2##(1995-2#5)(1996-1#1)(2006-10#3)(2013-1#1)
pediatric medical settings##2##3##(2009-6#2)
pediatric medical##4##2##(1994-3#1)(2009-6#2)(2010-6#1)
pediatric nasal allergy##2##3##(2008-5#2)
pediatric neck##2##2##(2006-11#1)(2007-4#1)
pediatric needs##2##2##(2008-8#2)
pediatric nurse practitioners##4##3##(2009-9#2)(2010-10#1)(2010-7#1)
pediatric nurse##8##2##(1991-6#1)(2009-9#3)(2010-10#2)(2010-7#2)
pediatric nurses in##2##3##(2010-5#1)(2011-1#1)
pediatric nurses##6##2##(1992-1#1)(2010-5#1)(2011-1#4)
pediatric nurses'##4##2##(2010-5#1)(2011-1#3)
pediatric nursing care##2##3##(2010-9#1)(2011-2#1)
pediatric nursing##5##2##(1994-1#1)(1997-3#1)(2007-3#1)(2010-9#1)(2011-2#1)
pediatric obesity##2##2##(2012-3#1)(2013-1#1)
pediatric oncologists##2##2##(1992-12#1)(2012-2#1)
pediatric oncology patients and their##2##5##(1992-12#1)(1995-12#1)
pediatric oncology patients##5##3##(1992-12#1)(1994-12#2)(1995-12#1)(2006-12#1)
pediatric oncology##9##2##(1992-12#1)(1994-12#2)(1995-12#1)(2006-10#1)(2006-12#1)(2010-7#1)(2012-2#2)
pediatric or##3##2##(1997-3#1)(2006-10#1)(2012-12#1)
pediatric out-patient##2##2##(1994-3#2)
pediatric overweight##2##2##(2008-11#2)
pediatric pain management##2##3##(1994-1#1)(2006-12#1)
pediatric pain##3##2##(1994-1#2)(2006-12#1)
pediatric pathology##2##2##(2007-5#1)(2011-2#1)
pediatric patient population##2##3##(2006-10#1)(2008-10#1)
pediatric patient with##7##3##(2007-12#1)(2007-8#2)(2008-12#1)(2011-2#2)(2012-2#1)
pediatric patient##24##2##(1994-1#2)(2004-8#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)
pediatric patients and##4##3##(1994-2#1)(1995-3#1)(2009-10#1)(2012-12#1)
pediatric patients can##2##3##(2007-3#1)(2007-7#1)
pediatric patients is##2##3##(2007-7#1)(2008-5#1)
pediatric patients under##2##3##(2007-6#1)(2008-4#1)
pediatric patients with Chiari##2##4##(2005-10#1)(2006-9#1)
pediatric patients with##30##3##(2005-10#1)(2005-12#1)(2006-10#3)(2006-9#2)(2007-7#1)(2008-4#2)(2008-5#3)(2008-9#1)(2009-12#1)(2010-11#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#4)(2013-8#1)
pediatric patients##90##2##(1993-11#1)(1993-12#1)(1994-2#1)(1995-3#1)(1996-1#1)(2005-10#3)(2005-12#1)(2006-10#10)(2006-6#1)(2006-9#3)(2007-12#1)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#5)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#7)(2008-5#5)(2008-9#2)(2009-10#1)(2009-12#2)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#3)(2011-1#3)(2011-2#3)(2012-1#2)(2012-12#6)(2012-2#6)(2013-1#6)(2013-8#1)
pediatric physical therapy##2##3##(2006-10#2)
pediatric population##27##2##(1995-11#1)(1997-6#1)(2005-2#1)(2006-10#5)(2006-11#1)(2007-12#1)(2008-10#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-8#2)
pediatric populations##7##2##(2006-10#1)(2008-4#1)(2008-8#1)(2010-9#1)(2011-1#1)(2012-10#1)(2012-3#1)
pediatric practice##3##2##(1990-4#1)(2008-9#1)(2010-8#1)
pediatric primary care##2##3##(1996-12#1)(2007-10#1)
pediatric primary##3##2##(1993-6#1)(1996-12#1)(2007-10#1)
pediatric pulmonary##2##2##(2010-5#2)
pediatric radiation oncology##2##3##(2007-4#2)
pediatric renal##6##2##(1991-2#1)(1995-2#1)(2007-7#1)(2008-10#3)
pediatric research##3##2##(1994-3#1)(2006-3#1)(2012-11#1)
pediatric skull##2##2##(2007-1#2)
pediatric sleep disorders##2##3##(2007-6#1)(2013-7#1)
pediatric sleep medicine##2##3##(2007-6#2)
pediatric sleep##4##2##(2007-6#3)(2013-7#1)
pediatric studies##2##2##(2010-3#1)(2011-1#1)
pediatric surgeons##2##2##(2010-2#1)(2010-7#1)
pediatric surgery##4##2##(1997-8#1)(2005-9#1)(2007-12#1)(2008-10#1)
pediatric surgery]##4##2##(1990-5#1)(1991-3#1)(2005-9#1)(2011-2#1)
pediatric surgical##3##2##(2007-12#1)(2008-9#1)(2010-12#1)
pediatric trauma care##2##3##(2006-10#2)
pediatric trauma##7##2##(2006-10#7)
pediatric traumatic brain##2##3##(1996-1#1)(2010-5#1)
pediatric traumatic##4##2##(1996-1#1)(2010-5#1)(2012-12#1)(2013-7#1)
pediatric trials##2##2##(2008-11#1)(2010-5#1)
pediatric unit##4##2##(1994-12#1)(2007-7#1)(2010-11#1)(2011-2#1)
pediatric urologic##2##2##(2008-10#2)
pediatric urologists##2##2##(2006-9#2)
pediatric urology##6##2##(2006-10#1)(2006-9#2)(2008-10#2)(2009-5#1)
pediatric vaccination##3##2##(2009-4#3)
pediatric ward##3##2##(2007-2#1)(2010-5#1)(2011-2#1)
pediatric##741##1##(1990-12#2)(1990-4#2)(1990-5#1)(1990-6#1)(1991-11#2)(1991-2#2)(1991-3#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#3)(1992-3#3)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-6#2)(1994-1#10)(1994-12#3)(1994-2#3)(1994-3#4)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#6)(1995-2#6)(1995-3#2)(1995-5#1)(1996-1#9)(1996-11#1)(1996-12#2)(1996-2#2)(1996-9#1)(1997-3#3)(1997-6#1)(1997-8#1)(2004-12#1)(2004-8#1)(2005-10#12)(2005-12#2)(2005-2#1)(2005-6#2)(2005-7#2)(2005-8#1)(2005-9#3)(2006-1#2)(2006-10#67)(2006-11#5)(2006-12#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#13)(2006-9#9)(2007-1#12)(2007-10#2)(2007-11#2)(2007-12#18)(2007-2#3)(2007-3#13)(2007-4#9)(2007-5#4)(2007-6#4)(2007-7#15)(2007-8#17)(2007-9#1)(2008-1#6)(2008-10#22)(2008-11#10)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#25)(2008-5#14)(2008-6#1)(2008-7#2)(2008-8#10)(2008-9#18)(2009-10#3)(2009-11#2)(2009-12#5)(2009-2#1)(2009-3#1)(2009-4#11)(2009-5#2)(2009-6#5)(2009-7#1)(2009-8#1)(2009-9#9)(2010-1#1)(2010-10#5)(2010-11#5)(2010-12#7)(2010-2#4)(2010-3#10)(2010-5#12)(2010-6#2)(2010-7#5)(2010-8#3)(2010-9#9)(2011-1#26)(2011-12#4)(2011-2#42)(2012-1#7)(2012-10#1)(2012-11#2)(2012-12#36)(2012-2#32)(2012-3#10)(2013-1#35)(2013-7#3)(2013-8#7)
pediatrician##9##1##(1991-10#1)(1996-2#1)(2007-11#1)(2007-3#2)(2008-7#1)(2010-3#1)(2011-2#1)(2013-1#1)
pediatricians and##3##2##(2011-1#1)(2012-3#1)(2013-1#1)
pediatricians should##2##2##(2012-2#1)(2013-8#1)
pediatricians##30##1##(1992-11#1)(1993-9#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-1#1)(2006-10#1)(2007-11#1)(2007-12#5)(2007-3#2)(2009-9#2)(2010-8#1)(2011-1#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#3)
pediatrics and##4##2##(2007-10#1)(2009-10#2)(2012-11#1)
pediatrics in##5##2##(1993-1#3)(1993-5#2)
pediatrics##37##1##(1991-3#2)(1993-1#4)(1993-5#2)(1994-10#1)(1994-12#1)(1996-9#1)(2006-10#1)(2006-9#3)(2007-10#2)(2007-12#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#2)(2009-12#1)(2010-12#1)(2011-12#1)(2011-2#4)(2012-11#1)(2012-2#1)(2013-1#1)
pedicel##6##1##(2007-12#2)(2008-10#3)(2008-4#1)
pedicle and##3##2##(2012-12#2)(2012-3#1)
pedicle flap for##2##3##(2011-2#1)(2013-7#1)
pedicle flap##6##2##(2011-2#3)(2013-7#2)(2013-8#1)
pedicle of the##2##3##(1996-5#1)(2007-8#1)
pedicle screw fixation##5##3##(2006-8#1)(2007-5#2)(2011-2#2)
pedicle screw placement in##3##4##(2007-5#1)(2012-12#2)
pedicle screw placement##5##3##(2006-6#1)(2007-5#1)(2012-12#3)
pedicle screw##14##2##(2006-6#1)(2006-8#1)(2007-11#3)(2007-5#3)(2009-3#1)(2011-2#2)(2012-12#3)
pedicle screws##6##2##(2006-8#1)(2007-5#1)(2008-12#2)(2008-5#1)(2008-7#1)
pedicle subtraction osteotomy##4##3##(2012-12#3)(2013-8#1)
pedicle technique with a##2##4##(2011-2#2)
pedicle technique##3##2##(2011-2#3)
pedicle wall##2##2##(2007-5#1)(2012-12#1)
pedicle##76##1##(1990-12#3)(1991-4#1)(1995-2#1)(1996-5#1)(2006-6#1)(2006-8#2)(2007-1#2)(2007-11#5)(2007-12#2)(2007-2#1)(2007-5#8)(2007-7#1)(2007-8#4)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-3#1)(2009-5#2)(2010-12#3)(2010-8#1)(2011-2#11)(2012-12#11)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#2)
pedicled and##2##2##(2010-6#1)(2012-2#1)
pedicled autologous choroid##4##3##(2012-12#4)
pedicled dorsalis pedis flap##3##4##(2011-2#3)
pedicled flap##2##2##(2011-12#1)(2012-2#1)
pedicled flaps##5##2##(1997-6#2)(2008-9#1)(2009-9#1)(2011-2#1)
pedicled##32##1##(1990-4#1)(1997-6#2)(2006-4#1)(2007-8#3)(2008-9#2)(2009-9#3)(2010-6#1)(2011-12#4)(2011-2#4)(2012-12#8)(2012-2#2)(2013-1#1)
pedicles and##2##2##(2008-8#1)(2011-1#1)
pedicles of##3##2##(1996-9#1)(2006-8#1)(2007-5#1)
pedicles##14##1##(1990-12#4)(1996-9#1)(1997-3#1)(1997-6#1)(2006-8#2)(2007-5#2)(2008-7#1)(2008-8#1)(2011-1#1)
pedicular screw fixation##3##3##(2012-2#3)
pedicular##5##1##(2011-1#1)(2012-11#1)(2012-2#3)
pediculosis and scabies##2##3##(2008-12#2)
pediculosis##4##1##(1991-12#1)(2007-11#1)(2008-12#2)
pediculum##3##1##(2007-11#3)
pedigree analysis##3##2##(1997-5#1)(2007-10#1)(2008-5#1)
pedigree and##2##2##(1996-2#1)(2008-3#1)
pedigree of##3##2##(2008-2#3)
pedigree##37##1##(1990-12#1)(1992-11#1)(1992-5#4)(1994-12#1)(1994-2#1)(1995-11#1)(1996-2#1)(1996-5#1)(1997-5#4)(2005-7#1)(2006-8#1)(2007-10#1)(2008-10#6)(2008-2#3)(2008-3#1)(2008-5#1)(2009-2#1)(2010-4#1)(2012-1#2)(2012-3#4)
pedigrees and##5##2##(1996-6#1)(2005-10#1)(2008-1#1)(2012-3#2)
pedigrees with##2##2##(1994-12#1)(1995-8#1)
pedigrees##42##1##(1990-12#1)(1992-5#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#3)(1996-6#2)(1997-5#7)(2005-10#1)(2007-2#1)(2008-1#2)(2008-10#3)(2008-4#3)(2011-1#1)(2012-3#10)
pedis##16##1##(2006-12#1)(2007-7#1)(2007-8#4)(2010-11#2)(2010-7#2)(2010-9#1)(2011-2#5)
pedophil##3##1##(1991-3#3)
peduncle##13##1##(1991-8#4)(1991-9#2)(1992-11#1)(1996-5#3)(2008-10#2)(2013-7#1)
pedunculated mass##5##2##(2008-5#1)(2009-10#1)(2009-7#1)(2011-2#2)
pedunculated##21##1##(1992-5#1)(1993-9#2)(2007-11#1)(2007-3#2)(2007-8#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-7#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#4)(2013-7#1)(2013-8#1)
pedunculonigral##2##1##(2008-7#2)
pedunculopontine nucleus (PPN)##2##3##(2008-11#1)(2012-2#1)
pedunculopontine nucleus##5##2##(1994-3#1)(2008-11#2)(2012-2#1)(2013-7#1)
pedunculopontine tegmental nucleus##10##3##(1991-11#1)(1994-10#2)(1994-2#2)(1994-3#2)(1995-12#1)(1995-5#1)(2008-7#1)
pedunculopontine##17##1##(1991-11#1)(1992-1#2)(1994-10#2)(1994-2#2)(1994-3#3)(1995-12#1)(1995-5#1)(2008-11#2)(2008-7#1)(2012-2#1)(2013-7#1)
peek##2##1##(2009-6#1)(2010-8#1)
peel and##2##2##(2004-9#1)(2008-10#1)
peel as##2##2##(2010-4#1)(2013-1#1)
peel or##2##2##(2008-10#1)(2008-5#1)
peel tissue##2##2##(2008-10#2)
peel##24##1##(2004-9#2)(2008-10#7)(2008-3#2)(2008-5#7)(2010-4#2)(2011-12#1)(2012-3#2)(2013-1#1)
peeled grated cocoyam##6##3##(2008-4#6)
peeled##9##1##(1995-4#1)(2007-8#1)(2008-3#1)(2008-4#6)
peelii##6##1##(2010-8#6)
peeling of the##4##3##(2006-12#1)(2008-4#1)(2011-2#2)
peeling of##6##2##(2006-12#1)(2006-7#1)(2008-4#1)(2011-2#3)
peeling or##2##2##(2007-12#1)(2007-7#1)
peeling##17##1##(1992-4#1)(2004-1#1)(2004-12#2)(2006-12#1)(2006-7#1)(2007-12#1)(2007-7#2)(2008-11#1)(2008-4#1)(2008-5#2)(2011-2#4)
peels##10##1##(2005-11#2)(2006-12#1)(2007-7#2)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-8#1)
peer and friend influences##2##4##(2009-7#2)
peer and friend##3##3##(2009-7#3)
peer and##5##2##(2007-12#1)(2009-7#4)
peer assessment##11##2##(2008-11#6)(2013-1#1)(2013-7#4)
peer association##2##2##(2006-3#2)
peer communication##2##2##(2007-9#1)(2012-3#1)
peer connections##5##2##(2013-1#5)
peer drinking##2##2##(2010-9#2)
peer educator##3##2##(2007-3#2)(2012-3#1)
peer educators##2##2##(2010-8#2)
peer exclusion##3##2##(2012-2#3)
peer group control##3##3##(2009-8#3)
peer group processes##2##3##(2009-8#2)
peer group##15##2##(2005-9#1)(2008-10#1)(2008-11#2)(2009-5#1)(2009-7#1)(2009-8#6)(2010-4#1)(2011-1#1)(2013-7#1)
peer influence and##2##3##(2007-12#1)(2013-1#1)
peer influence##4##2##(2007-12#1)(2013-1#3)
peer mentor-tutor project##2##3##(2006-5#2)
peer network structures##2##3##(2010-4#2)
peer network##3##2##(2010-4#3)
peer networks##5##2##(2010-4#5)
peer norms##2##2##(2009-7#2)
peer pressure##8##2##(1991-4#1)(2006-2#1)(2007-3#2)(2008-10#1)(2008-9#1)(2009-7#1)(2013-7#1)
peer ratings##2##2##(2009-7#2)
peer rejection##3##2##(2012-2#3)
peer relationships##3##2##(1996-12#1)(2009-7#1)(2013-1#1)
peer review and##3##3##(1991-1#1)(1994-2#1)(1996-11#1)
peer review is##2##3##(1993-1#1)(2008-1#1)
peer review organization##2##3##(1991-1#1)(1996-2#1)
peer review organizations##4##3##(1991-3#1)(1991-4#1)(1993-2#1)(1995-12#1)
peer review process##8##3##(1992-12#1)(1993-1#1)(2005-7#1)(2006-1#3)(2006-6#1)(2008-11#1)
peer review##52##2##(1990-8#1)(1991-1#4)(1991-2#3)(1991-3#1)(1991-4#1)(1992-1#1)(1992-12#5)(1993-1#4)(1993-2#2)(1994-1#1)(1994-2#2)(1994-6#1)(1995-12#1)(1996-11#1)(1996-2#1)(1996-8#1)(1997-3#3)(2005-7#3)(2005-8#1)(2006-1#4)(2006-10#1)(2006-6#1)(2007-1#1)(2007-4#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-2#1)(2010-5#1)
peer review]##2##2##(1990-12#1)(2008-8#1)
peer reviewed literature##2##3##(2005-7#1)(2008-1#1)
peer reviewed##8##2##(2005-7#4)(2006-2#1)(2006-8#1)(2008-1#1)(2012-12#1)
peer reviews##2##2##(2007-4#2)
peer social##2##2##(2009-7#1)(2009-9#1)
peer support and##3##3##(2007-2#1)(2008-11#1)(2008-2#1)
peer support group##4##3##(1993-3#1)(2006-6#3)
peer support groups##3##3##(2006-6#2)(2007-2#1)
peer support program##2##3##(2006-6#1)(2008-2#1)
peer support##16##2##(1993-3#1)(1995-12#1)(2006-6#6)(2007-2#2)(2008-11#2)(2008-2#3)(2012-12#1)
peer support)##2##2##(2009-7#2)
peer tutoring system##2##3##(2005-10#2)
peer tutoring##5##2##(2005-10#5)
peer victimization in adolescence##2##4##(2009-7#2)
peer victimization##14##2##(2007-12#6)(2008-12#2)(2008-4#1)(2009-7#2)(2013-7#3)
peer##236##1##(1990-12#1)(1990-8#1)(1990-9#1)(1991-1#4)(1991-2#3)(1991-3#1)(1991-4#2)(1992-1#1)(1992-12#5)(1993-1#4)(1993-2#2)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#1)(1995-12#3)(1996-11#1)(1996-12#2)(1996-2#1)(1996-8#1)(1997-3#3)(2005-10#5)(2005-7#7)(2005-8#1)(2005-9#1)(2006-1#4)(2006-10#1)(2006-2#2)(2006-3#3)(2006-5#2)(2006-6#7)(2006-8#1)(2007-1#2)(2007-12#15)(2007-2#4)(2007-3#4)(2007-4#4)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#12)(2008-12#3)(2008-2#5)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#20)(2009-8#6)(2009-9#3)(2010-12#1)(2010-2#1)(2010-4#10)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#9)(2012-3#5)(2013-1#15)(2013-7#9)
peer's##2##1##(2010-2#2)
peer-group and##2##2##(1991-7#1)(2008-12#1)
peer-group##3##1##(1991-7#1)(2008-12#1)(2009-7#1)
peer-related belongingness##2##2##(2009-7#2)
peer-review and##3##2##(2005-7#3)
peer-review##8##1##(2005-7#5)(2007-4#2)(2012-12#1)
peer-reviewed articles##2##2##(2007-4#1)(2013-1#1)
peer-reviewed journals##5##2##(2005-7#2)(2007-4#2)(2008-7#1)
peer-reviewed literature##6##2##(2007-1#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-7#1)
peer-reviewed references##2##2##(2005-7#2)
peer-reviewed scientific literature##2##3##(2007-4#1)(2013-8#1)
peer-reviewed scientific##3##2##(2005-7#1)(2007-4#1)(2013-8#1)
peer-reviewed studies on##2##3##(2007-11#1)(2010-9#1)
peer-reviewed studies##4##2##(2005-7#1)(2007-11#1)(2010-9#1)(2012-12#1)
peer-reviewed##37##1##(1991-2#1)(2004-11#1)(2005-7#7)(2006-10#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-4#4)(2008-4#1)(2008-6#2)(2008-7#1)(2009-5#1)(2010-11#1)(2010-12#3)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
peers and the##5##3##(2010-12#3)(2012-2#1)(2013-1#1)
peers and##11##2##(2007-12#1)(2007-4#1)(2010-1#1)(2010-10#1)(2010-12#3)(2012-2#1)(2013-1#3)
peers during##2##2##(2012-12#1)(2012-2#1)
peers in terms of##2##4##(2005-6#1)(2012-3#1)
peers in##5##2##(1993-3#1)(2005-6#1)(2011-1#1)(2012-3#2)
peers is##2##2##(1990-2#1)(2008-9#1)
peers on##2##2##(1993-1#1)(2013-8#1)
peers were##2##2##(2010-7#1)(2012-3#1)
peers with##2##2##(1993-3#1)(2008-9#1)
peers##116##1##(1990-12#1)(1990-2#3)(1990-5#2)(1991-2#1)(1991-8#2)(1992-10#1)(1992-9#1)(1993-1#1)(1993-3#3)(1995-3#1)(1996-3#1)(1997-1#1)(1997-4#1)(2005-10#2)(2005-6#1)(2005-9#1)(2006-3#1)(2006-5#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#3)(2007-3#1)(2007-4#5)(2007-9#2)(2008-10#4)(2008-11#6)(2008-12#5)(2008-9#3)(2009-10#1)(2009-7#9)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-4#4)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#7)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#3)
pefloxacin and##4##2##(1993-2#4)
pefloxacin##9##1##(1991-12#1)(1993-2#5)(2007-7#2)(2008-10#1)
peg##11##1##(1993-11#1)(2007-12#2)(2008-10#3)(2008-7#1)(2010-11#3)(2010-12#1)
pegaptanib sodium##4##2##(2009-8#4)
pegfilgrastim and##4##2##(2008-7#4)
pegfilgrastim##10##1##(2005-11#1)(2008-7#9)
peginterferon plus ribavirin for##2##4##(2009-5#1)(2012-12#1)
peginterferon α-2a##2##2##(2012-2#2)
peginterferon##6##1##(2008-3#1)(2009-5#1)(2012-1#1)(2012-12#1)(2012-2#2)
pegs##6##1##(2007-12#2)(2007-2#1)(2008-10#2)(2008-7#1)
pegylated interferon alpha##2##3##(2010-2#1)(2013-1#1)
pegylated interferon and ribavirin in##2##5##(2005-11#1)(2011-2#1)
pegylated interferon and ribavirin##4##4##(2005-11#1)(2010-12#1)(2011-2#2)
pegylated interferon and##6##3##(2005-11#1)(2008-10#1)(2010-12#2)(2011-2#2)
pegylated interferon##14##2##(2005-11#1)(2006-10#1)(2008-10#1)(2009-3#1)(2010-12#2)(2010-2#2)(2010-3#1)(2011-12#1)(2011-2#2)(2012-1#1)(2013-1#1)
pegylated interferon-alpha##2##2##(2010-2#2)
pegylated interferon-α##2##2##(2010-12#1)(2013-1#1)
pegylated liposomal doxorubicin##2##3##(2006-6#1)(2008-7#1)
pegylated##25##1##(2005-11#1)(2006-10#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#3)(2010-2#5)(2010-3#1)(2011-12#1)(2011-2#3)(2012-1#1)(2013-1#2)
pekinensis##2##1##(2008-10#1)(2013-8#1)
pekinensis)##2##1##(1997-2#2)
pelagic larvae##2##2##(2008-8#1)(2013-1#1)
pelagic larval##3##2##(2007-5#1)(2008-8#1)(2008-9#1)
pelagic predator##2##2##(2008-5#2)
pelagic##20##1##(2007-12#1)(2007-3#1)(2007-5#1)(2008-4#1)(2008-5#4)(2008-8#4)(2008-9#3)(2010-3#1)(2010-6#1)(2012-2#1)(2013-1#2)
pelagicus##2##1##(2008-10#1)(2012-2#1)
peled##4##1##(2008-12#4)
pellagra##4##1##(1994-4#1)(2008-1#1)(2008-5#1)(2012-12#1)
pellet culture was##2##3##(2008-11#1)(2011-2#1)
pellet culture##3##2##(2008-11#2)(2011-2#1)
pellet fed rats##2##3##(1991-2#2)
pellet form##2##2##(2008-6#2)
pellet formation of##2##3##(2008-5#2)
pellet formation##4##2##(2008-5#4)
pellet fraction of##2##3##(1991-4#1)(1992-12#1)
pellet of##2##2##(1997-6#1)(2007-9#1)
pellet reward##2##2##(1993-12#2)
pellet size##3##2##(2008-7#3)
pellet to the##2##3##(1992-11#1)(2010-10#1)
pellet was##2##2##(1991-4#1)(1995-11#1)
pellet##62##1##(1991-2#3)(1991-4#2)(1991-6#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#2)(1994-3#1)(1995-11#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-8#1)(2007-5#1)(2007-9#3)(2008-10#9)(2008-11#6)(2008-4#1)(2008-5#4)(2008-6#5)(2008-7#5)(2010-10#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#1)
pellet-induced##2##1##(2013-7#2)
pelleted ration##3##2##(2011-1#3)
pelleted##9##1##(2008-10#1)(2008-11#2)(2008-7#1)(2009-4#1)(2011-1#3)(2012-2#1)
pelleting##2##1##(2008-4#1)(2011-2#1)
pelletized##12##1##(2004-4#3)(2008-1#3)(2008-10#1)(2008-5#3)(2008-6#2)
pellets and##3##2##(2007-1#1)(2008-1#1)(2008-4#1)
pellets for##2##2##(1994-3#1)(2008-5#1)
pellets from##2##2##(1990-6#1)(2008-5#1)
pellets in##2##2##(2007-5#1)(2008-11#1)
pellets is##2##2##(2008-7#2)
pellets of##6##2##(1992-6#1)(1995-7#1)(2008-10#3)(2010-4#1)
pellets results in##2##3##(1993-9#1)(2008-7#1)
pellets using##2##2##(2004-12#1)(2008-10#1)
pellets were##2##2##(1990-2#1)(1994-8#1)
pellets with a##2##3##(2008-5#1)(2009-7#1)
pellets with##3##2##(2008-10#1)(2008-5#1)(2009-7#1)
pellets##75##1##(1990-2#2)(1990-5#1)(1990-6#1)(1991-1#1)(1991-6#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-9#2)(1994-2#1)(1994-3#1)(1994-8#2)(1995-12#1)(1995-7#2)(1997-1#1)(2004-11#1)(2004-12#2)(2005-10#3)(2006-12#1)(2007-1#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#8)(2008-7#10)(2009-7#1)(2010-4#1)(2010-8#1)
pellets)##3##1##(1997-1#2)(2008-6#1)
pellicle strips##2##2##(2007-3#2)
pellicle##4##1##(2007-3#3)(2008-5#1)
pellistor sensor with##2##3##(2008-10#2)
pellucida binding##4##2##(1995-5#1)(2006-5#3)
pellucida##17##1##(1991-2#3)(1995-5#2)(1996-9#1)(1997-4#2)(2006-5#3)(2008-12#1)(2008-4#2)(2008-9#1)(2013-1#2)
pelt##2##1##(1996-12#1)(1997-5#1)
pelts##2##1##(1996-12#2)
pelvi-ureteric junction obstruction in##3##4##(2008-10#3)
pelvi-ureteric junction obstruction##4##3##(2008-10#3)(2008-7#1)
pelvi-ureteric junction##6##2##(2008-10#5)(2008-7#1)
pelvi-ureteric##7##1##(2008-10#6)(2008-7#1)
pelvic CS##2##2##(2008-6#2)
pelvic MRI##3##2##(2006-10#1)(2011-2#2)
pelvic afferent##5##2##(2008-4#5)
pelvic and femoral##2##3##(2006-11#2)
pelvic and limb##3##3##(2006-6#2)(2011-1#1)
pelvic and thoracic irradiation##2##4##(2012-12#2)
pelvic and##14##2##(1990-6#1)(1992-7#1)(1994-2#1)(1997-7#1)(2006-11#2)(2006-6#3)(2006-8#1)(2007-4#1)(2011-1#1)(2012-12#2)
pelvic angiography##2##2##(1994-1#2)
pelvic area##6##2##(1996-12#1)(2007-4#1)(2007-6#1)(2008-6#2)(2012-2#1)
pelvic cavity##4##2##(1992-3#1)(2008-12#1)(2008-7#1)(2012-2#1)
pelvic disease##2##2##(1990-6#1)(2008-6#1)
pelvic endometriosis##10##2##(1991-3#3)(1992-1#2)(1995-2#1)(2008-3#1)(2009-6#1)(2011-1#1)(2013-1#1)
pelvic examination is##2##3##(2007-5#2)
pelvic examination##10##2##(1991-2#1)(1991-3#1)(1992-8#5)(2007-5#2)(2009-5#1)
pelvic fins##4##2##(2008-5#4)
pelvic floor dysfunction##3##3##(2007-8#1)(2011-12#1)(2011-2#1)
pelvic floor exercises##3##3##(2006-7#3)
pelvic floor muscle##3##3##(2007-8#1)(2010-12#2)
pelvic floor##40##2##(1990-4#2)(1992-3#3)(2006-7#3)(2006-8#1)(2006-9#1)(2007-4#4)(2007-8#2)(2008-10#1)(2010-12#2)(2011-12#9)(2011-2#3)(2012-1#3)(2012-2#1)(2012-3#3)(2013-1#2)
pelvic fracture urethral##3##3##(2005-9#1)(2013-8#2)
pelvic fracture##10##2##(1997-6#1)(2005-9#1)(2006-11#5)(2013-1#1)(2013-8#2)
pelvic fractures##3##2##(2006-11#1)(2007-11#2)
pelvic girdle relaxation##6##3##(1990-6#5)(1991-2#1)
pelvic girdle##12##2##(1990-6#6)(1991-2#1)(2008-6#1)(2008-7#1)(2011-2#3)
pelvic inflammatory disease (PID)##3##4##(1995-2#1)(2007-7#1)(2013-8#1)
pelvic inflammatory disease##12##3##(1992-4#1)(1994-12#1)(1994-3#1)(1995-2#2)(2004-10#1)(2005-12#1)(2007-7#3)(2011-1#1)(2013-8#1)
pelvic inflammatory diseases##2##3##(2008-11#2)
pelvic inflammatory##15##2##(1992-4#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-2#2)(2004-10#1)(2005-12#1)(2007-7#3)(2008-11#2)(2011-1#1)(2013-8#1)
pelvic irradiation##7##2##(1990-10#1)(1993-9#1)(2008-6#1)(2009-3#1)(2012-12#1)(2013-1#2)
pelvic joint syndrome##4##3##(1990-6#3)(1991-2#1)
pelvic joint##5##2##(1990-6#4)(1991-2#1)
pelvic kidney is##2##3##(2005-10#1)(2011-1#1)
pelvic kidney##6##2##(2004-10#1)(2005-10#4)(2011-1#1)
pelvic limb##4##2##(2005-7#2)(2007-2#1)(2010-4#1)
pelvic lymph node metastases##2##4##(2007-8#1)(2013-1#1)
pelvic lymph node##6##3##(2007-8#1)(2013-1#5)
pelvic lymph nodes##4##3##(1991-9#1)(2006-9#1)(2011-2#1)(2013-7#1)
pelvic lymph##10##2##(1991-9#1)(2006-9#1)(2007-8#1)(2011-2#1)(2013-1#5)(2013-7#1)
pelvic lymphadenectomy##2##2##(1993-8#1)(2011-2#1)
pelvic malignancies##3##2##(1994-7#1)(2007-4#1)(2008-7#1)
pelvic mass##11##2##(1992-12#1)(1995-3#1)(1997-3#1)(1997-8#1)(2004-10#1)(2007-12#1)(2008-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2013-1#1)
pelvic masses##3##2##(1992-12#1)(1992-9#2)
pelvic muscles##3##2##(2007-7#2)(2011-2#1)
pelvic nerve afferents##2##3##(2008-4#2)
pelvic nerve##7##2##(1992-3#2)(1993-12#1)(2008-4#4)
pelvic obliquity in##2##3##(2007-7#1)(2012-2#1)
pelvic obliquity##8##2##(2007-7#2)(2009-9#1)(2012-1#4)(2012-2#1)
pelvic offset##3##2##(2007-4#3)
pelvic organ prolapse and##2##4##(2007-8#1)(2008-12#1)
pelvic organ prolapse##5##3##(2007-4#1)(2007-8#2)(2008-12#2)
pelvic organ##7##2##(2007-4#3)(2007-8#2)(2008-12#2)
pelvic organs##8##2##(1994-3#1)(1996-3#1)(1996-8#1)(2006-8#1)(2007-4#1)(2008-12#1)(2011-1#1)(2013-8#1)
pelvic osteotomies##5##2##(2007-7#3)(2007-8#2)
pelvic osteotomy in##3##3##(2008-10#2)(2009-3#1)
pelvic osteotomy##5##2##(2007-7#1)(2007-8#1)(2008-10#2)(2009-3#1)
pelvic pain in##2##3##(1991-2#1)(2006-10#1)
pelvic pain is##2##3##(2006-11#2)
pelvic pain syndrome##9##3##(2006-8#2)(2006-9#1)(2008-10#1)(2008-5#1)(2008-6#3)(2010-10#1)
pelvic pain##42##2##(1990-6#1)(1991-2#3)(1992-1#3)(1992-2#1)(1994-12#1)(1994-3#3)(2004-10#4)(2006-10#1)(2006-11#3)(2006-6#1)(2006-8#3)(2006-9#2)(2008-10#1)(2008-5#1)(2008-6#4)(2008-8#4)(2010-10#2)(2011-12#2)(2012-3#1)(2013-7#1)
pelvic pathology##3##2##(1991-3#2)(1992-3#1)
pelvic radiation##2##2##(2006-2#1)(2006-9#1)
pelvic radiotherapy##4##2##(1995-4#1)(2007-11#1)(2008-11#1)(2008-2#1)
pelvic region##7##2##(1993-8#1)(2006-10#1)(2006-12#1)(2007-4#1)(2007-6#1)(2008-10#1)(2012-1#1)
pelvic ring##6##2##(2006-11#1)(2007-11#2)(2008-6#3)
pelvic sarcomas##2##2##(2008-6#2)
pelvic schwannoma presenting##2##3##(2008-7#2)
pelvic soft##2##2##(2008-6#2)
pelvic surgery##9##2##(2007-2#1)(2007-7#2)(2009-1#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-7#1)
pelvic tumor##5##2##(1992-12#2)(2007-8#1)(2008-3#1)(2013-1#1)
pelvic##431##1##(1990-10#1)(1990-12#1)(1990-4#2)(1990-5#2)(1990-6#14)(1991-1#2)(1991-2#7)(1991-3#6)(1991-9#1)(1992-1#5)(1992-10#1)(1992-12#5)(1992-2#1)(1992-3#8)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#6)(1992-9#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-8#2)(1993-9#1)(1994-1#2)(1994-12#3)(1994-2#2)(1994-3#5)(1994-4#2)(1994-7#1)(1995-2#3)(1995-3#2)(1995-4#2)(1996-12#2)(1996-3#1)(1996-8#1)(1997-3#2)(1997-6#1)(1997-7#3)(1997-8#1)(2004-10#8)(2005-10#4)(2005-12#1)(2005-7#2)(2005-9#1)(2006-10#7)(2006-11#14)(2006-12#1)(2006-2#1)(2006-6#7)(2006-7#3)(2006-8#7)(2006-9#6)(2007-11#5)(2007-12#1)(2007-2#3)(2007-4#15)(2007-5#2)(2007-6#5)(2007-7#16)(2007-8#11)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#5)(2008-2#1)(2008-3#3)(2008-4#10)(2008-5#5)(2008-6#28)(2008-7#6)(2008-8#5)(2009-1#2)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#5)(2009-6#2)(2009-8#1)(2009-9#4)(2010-10#2)(2010-12#2)(2010-2#3)(2010-3#2)(2010-4#1)(2010-8#4)(2011-1#6)(2011-12#11)(2011-2#17)(2012-1#15)(2012-12#9)(2012-2#7)(2012-3#4)(2013-1#20)(2013-7#3)(2013-8#5)
pelvic-peritoneal tuberculosis##4##2##(2008-10#4)
pelvic-ureteric stone##2##2##(2008-8#2)
pelvicalyceal##2##1##(2008-1#1)(2012-12#1)
pelvimetry##7##1##(1994-4#6)(2009-2#1)
pelvis and femoral##2##3##(1991-11#1)(2012-12#1)
pelvis and the lower extremities##2##5##(2007-4#2)
pelvis and the##3##3##(1994-4#1)(2007-4#2)
pelvis and##20##2##(1990-4#1)(1991-11#2)(1992-3#1)(1993-7#1)(1994-4#1)(2006-11#1)(2007-10#1)(2007-4#3)(2007-7#1)(2008-10#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
pelvis by##2##2##(2007-7#1)(2012-1#1)
pelvis in the##2##3##(2007-4#1)(2012-1#1)
pelvis in##3##2##(2007-4#1)(2008-6#1)(2012-1#1)
pelvis of the##2##3##(2006-11#2)
pelvis of##4##2##(1992-9#1)(2006-11#2)(2007-10#1)
pelvis showed##3##2##(2009-2#1)(2009-8#1)(2010-8#1)
pelvis tests##2##2##(2006-11#1)(2007-4#1)
pelvis was##5##2##(2006-10#1)(2006-11#2)(2007-11#1)(2009-2#1)
pelvis##140##1##(1990-4#1)(1991-11#2)(1991-12#1)(1991-2#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-7#1)(1993-9#2)(1994-4#2)(1995-2#1)(2006-1#1)(2006-10#3)(2006-11#14)(2006-6#1)(2006-7#2)(2007-10#2)(2007-11#8)(2007-4#11)(2007-7#7)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#8)(2008-6#6)(2008-7#1)(2008-8#4)(2009-12#1)(2009-2#2)(2009-3#3)(2009-8#2)(2010-1#1)(2010-3#6)(2010-8#1)(2010-9#1)(2011-2#15)(2012-1#8)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#5)
pelvis/upper leg injuries##2##3##(2006-11#2)
pelvis/upper leg##3##2##(2006-11#3)
pelvises##2##1##(2007-2#2)
pemphigoid##20##1##(1995-3#2)(1996-4#1)(2005-12#2)(2007-1#2)(2007-10#1)(2007-7#8)(2007-8#1)(2008-1#1)(2008-12#1)(2009-3#1)
pemphigus vulgaris##12##2##(1991-11#1)(1991-12#1)(1992-12#3)(2006-12#1)(2007-7#3)(2012-12#1)(2013-8#2)
pemphigus##29##1##(1991-11#1)(1991-12#2)(1992-12#3)(2006-12#5)(2007-7#9)(2007-8#3)(2008-12#1)(2011-2#1)(2012-12#1)(2013-8#3)
pen for##2##2##(2008-7#1)(2009-6#1)
pen##14##1##(1995-2#1)(2007-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#5)(2009-6#2)(2010-2#1)(2012-2#1)
pen2 NahG pmr5##2##3##(2012-2#2)
penalization##3##1##(2008-6#1)(2009-12#1)(2010-5#1)
penalized likelihood##4##2##(2008-4#2)(2012-1#2)
penalized log-likelihood##2##2##(2010-5#2)
penalized profile sampler##2##3##(2010-5#2)
penalized regression methods##2##3##(2009-8#2)
penalized regression##5##2##(2009-8#2)(2010-7#1)(2012-3#2)
penalized spline##2##2##(2006-12#1)(2008-6#1)
penalized##23##1##(1997-8#1)(2006-11#1)(2006-12#1)(2008-11#1)(2008-4#3)(2008-6#1)(2009-8#2)(2010-2#2)(2010-5#4)(2010-7#1)(2011-1#1)(2012-1#2)(2012-3#3)
penalizing##2##1##(1995-12#1)(2010-2#1)
penalties for##6##2##(1990-3#1)(1996-1#1)(1997-5#1)(2007-8#1)(2008-11#1)(2013-1#1)
penalties##27##1##(1990-12#1)(1990-2#1)(1990-3#1)(1991-12#2)(1991-2#1)(1992-1#1)(1992-2#4)(1996-1#1)(1997-5#1)(2006-8#4)(2007-12#1)(2007-8#1)(2008-11#2)(2009-8#1)(2010-7#1)(2012-1#1)(2012-3#2)(2013-1#1)
penalty associated with##2##3##(1993-2#1)(2007-12#1)
penalty for imprecise hypotheses##2##4##(2008-3#2)
penalty for##8##2##(1991-7#1)(1996-4#1)(1997-5#1)(2007-12#2)(2008-2#1)(2008-3#2)
penalty functions##3##2##(2012-1#3)
penalty in##6##2##(2007-11#3)(2008-3#2)(2009-9#1)
penalty points##2##2##(1997-8#1)(2010-3#1)
penalty##45##1##(1991-7#1)(1993-2#1)(1996-4#1)(1996-5#2)(1997-5#1)(1997-8#1)(2006-11#1)(2007-11#6)(2007-12#6)(2008-10#1)(2008-2#7)(2008-3#5)(2008-6#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-3#1)(2012-1#3)(2012-3#3)
pencil beam##5##2##(2008-3#1)(2010-9#2)(2012-12#2)
pencil##16##1##(1991-9#1)(1995-5#1)(2007-8#3)(2008-10#2)(2008-2#1)(2008-3#1)(2010-9#2)(2011-2#1)(2012-12#2)(2013-1#2)
pencils##2##1##(1990-8#1)(2007-12#1)
pendant alkene group##2##3##(2009-10#2)
pendant drop##5##2##(2007-12#5)
pendant group##4##2##(2006-12#3)(2008-5#1)
pendant groups##3##2##(1997-7#2)(2008-10#1)
pendant le 2ème##2##3##(2013-1#2)
pendant le##3##2##(2013-1#3)
pendant##41##1##(1992-11#3)(1994-9#1)(1996-2#1)(1997-7#2)(1997-8#2)(2005-11#1)(2006-12#3)(2007-12#5)(2007-8#2)(2008-10#3)(2008-4#1)(2008-5#2)(2009-10#2)(2009-2#2)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#2)(2012-2#1)(2013-1#4)
pendant-drop##2##1##(2005-11#2)
pendants##3##1##(2008-10#2)(2010-5#1)
pendetide##3##1##(2007-11#3)
pendimethalin##16##1##(2008-10#4)(2008-11#5)(2011-1#7)
pending or##2##2##(2006-10#1)(2012-12#1)
pending##20##1##(1990-6#1)(1992-12#1)(1996-6#1)(1997-2#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-4#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-7#1)
pending)##2##1##(1997-1#1)(2008-10#1)
pendulous##4##1##(2007-7#1)(2008-10#2)(2008-5#1)
pendulum impact tests##3##3##(2006-11#1)(2007-4#2)
pendulum impacts##2##2##(2006-11#1)(2007-4#1)
pendulum tests##3##2##(2006-11#2)(2007-4#1)
pendulum##23##1##(1995-6#1)(2006-11#6)(2007-1#2)(2007-4#7)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)
penetrance and##5##2##(1996-3#1)(2007-1#1)(2009-12#1)(2009-8#1)(2012-11#1)
penetrance of C282Y homozygous##2##4##(2008-5#2)
penetrance of the##5##3##(1990-7#1)(2006-10#1)(2006-8#1)(2008-4#1)(2012-3#1)
penetrance of##9##2##(1990-7#1)(1997-5#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-4#1)(2008-5#2)(2012-3#1)
penetrance or##2##2##(1996-5#1)(2006-10#1)
penetrance##30##1##(1990-7#1)(1990-9#1)(1993-9#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-5#2)(2006-10#4)(2006-8#1)(2007-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#6)(2009-12#1)(2009-8#1)(2010-2#1)(2012-11#1)(2012-3#1)(2013-1#1)
penetrans was##2##2##(2006-12#1)(2008-10#1)
penetrans##10##1##(1993-2#1)(2006-12#1)(2008-10#7)(2011-1#1)
penetrant inherited##2##2##(2008-12#2)
penetrant##5##1##(1995-12#1)(2007-12#1)(2008-12#2)(2010-4#1)
penetrate a##2##2##(2006-12#1)(2008-7#1)
penetrate host##2##2##(2008-10#2)
penetrate into the##10##3##(1992-4#1)(1994-3#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-12#1)
penetrate into##14##2##(1992-4#1)(1994-3#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#4)(2008-7#2)(2010-12#1)
penetrate the blood-brain barrier##2##4##(1993-11#1)(1996-8#1)
penetrate the cell membrane##2##4##(2012-3#1)(2013-7#1)
penetrate the cuticle##4##3##(2008-10#2)(2011-1#2)
penetrate the outer membrane##2##4##(1992-12#1)(2005-8#1)
penetrate the##26##2##(1992-12#1)(1993-11#1)(1994-8#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(2005-11#1)(2005-8#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#3)(2010-3#1)(2011-1#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
penetrate through the##6##3##(1995-12#2)(1996-1#1)(2008-6#1)(2008-7#1)(2012-1#1)
penetrate through##8##2##(1995-12#2)(1996-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-1#1)
penetrate to the##3##3##(2007-11#1)(2008-10#1)(2008-6#1)
penetrate to##5##2##(2007-11#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#1)
penetrate well##2##2##(1991-12#1)(2010-12#1)
penetrate##77##1##(1991-12#1)(1991-3#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-3#2)(1994-8#1)(1995-12#2)(1996-1#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-12#1)(2007-11#3)(2007-12#1)(2007-9#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#2)(2010-2#1)(2010-3#1)(2011-1#4)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)
penetrated by the fungus##2##4##(2008-10#2)
penetrated by the##3##3##(2008-10#3)
penetrated by##6##2##(1990-6#1)(2006-5#1)(2007-3#1)(2008-10#3)
penetrated into the##4##3##(1992-1#1)(2006-7#1)(2008-10#2)
penetrated into##5##2##(1992-1#1)(1994-2#1)(2006-7#1)(2008-10#2)
penetrated the egg##2##3##(2008-10#2)
penetrated the host##2##3##(2008-10#2)
penetrated the##17##2##(1990-5#1)(1991-12#1)(1993-9#1)(1994-5#1)(1995-3#1)(1995-9#1)(2006-6#1)(2008-10#7)(2008-5#1)(2008-7#1)(2011-2#1)
penetrated##49##1##(1990-2#1)(1990-5#3)(1990-6#1)(1990-9#1)(1991-12#1)(1992-1#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-3#1)(1995-9#1)(1997-8#1)(2006-5#5)(2006-6#1)(2006-7#1)(2007-10#1)(2007-3#1)(2008-10#17)(2008-2#1)(2008-5#2)(2008-7#1)(2010-4#1)(2011-2#1)(2012-2#2)(2013-1#1)
penetrates into##2##2##(1994-2#1)(2010-11#1)
penetrates the##8##2##(1990-12#1)(1992-3#1)(1995-10#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-2#2)
penetrates##20##1##(1990-12#1)(1990-5#1)(1992-12#1)(1992-3#1)(1994-2#1)(1994-3#1)(1995-10#1)(1997-4#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-1#1)(2013-8#1)
penetrating atherosclerotic ulcer##3##3##(2009-10#1)(2010-7#1)(2011-2#1)
penetrating cardiac injuries##7##3##(2007-8#3)(2008-1#4)
penetrating cardiac##9##2##(2007-8#5)(2008-1#4)
penetrating injuries of lower extremity nerves##2##6##(2007-7#2)
penetrating injuries to the##3##4##(2007-7#2)(2013-1#1)
penetrating injuries##6##2##(2007-3#1)(2007-7#4)(2013-1#1)
penetrating injury##3##2##(1992-2#1)(2006-10#1)(2007-8#1)
penetrating into the##3##3##(1992-3#1)(2006-2#1)(2006-7#1)
penetrating keratoplasty##7##2##(1990-5#1)(2010-10#2)(2010-12#2)(2011-2#1)(2012-12#1)
penetrating neck##2##2##(2010-12#1)(2010-7#1)
penetrating ocular trauma##3##3##(1991-11#1)(2011-1#2)
penetrating rate##2##2##(2011-3#2)
penetrating the skull base##2##4##(2011-2#2)
penetrating the##13##2##(1990-12#1)(1991-9#1)(1993-4#1)(1995-9#1)(1996-3#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-8#1)(2009-10#1)(2011-2#2)(2013-1#1)
penetrating thoracic##2##2##(2007-8#1)(2008-1#1)
penetrating trauma and##2##3##(2007-7#1)(2009-6#1)
penetrating trauma##6##2##(2006-10#1)(2007-12#1)(2007-7#1)(2009-6#2)(2012-2#1)
penetrating viscous jet##2##3##(2005-11#2)
penetrating wound##2##2##(2008-8#1)(2013-1#1)
penetrating##113##1##(1990-12#1)(1990-5#1)(1991-11#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#2)(1993-4#1)(1995-9#1)(1996-3#1)(1996-8#1)(1997-6#1)(1997-8#1)(2005-11#2)(2006-10#4)(2006-2#2)(2006-4#1)(2006-5#2)(2006-7#1)(2007-10#3)(2007-12#1)(2007-3#1)(2007-7#6)(2007-8#9)(2008-1#5)(2008-10#7)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#3)(2009-10#2)(2009-2#1)(2009-6#3)(2010-10#3)(2010-12#4)(2010-3#1)(2010-7#2)(2011-1#3)(2011-2#8)(2011-3#2)(2012-12#2)(2012-2#2)(2013-1#8)(2013-8#1)
penetration after##3##2##(1997-8#1)(2006-5#1)(2008-9#1)
penetration and colonization##2##3##(2008-10#2)
penetration and infection##2##3##(2008-10#1)(2011-10#1)
penetration and percent##2##3##(2008-10#2)
penetration and the##3##3##(2006-10#1)(2008-10#1)(2012-3#1)
penetration and##35##2##(1991-12#1)(1991-5#1)(2004-9#1)(2006-10#2)(2006-8#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-3#2)(2008-5#5)(2008-6#1)(2008-8#2)(2010-12#1)(2011-10#1)(2012-2#2)(2012-3#1)(2013-1#1)
penetration as##3##2##(2007-8#1)(2008-10#1)(2009-5#1)
penetration by the##5##3##(2008-10#4)(2012-1#1)
penetration by##11##2##(1991-2#1)(1994-9#1)(2008-10#7)(2008-5#1)(2012-1#1)
penetration depth and##2##3##(2008-10#1)(2008-3#1)
penetration depth is##3##3##(1993-5#1)(2008-2#2)
penetration depth of the##3##4##(2008-2#1)(2008-3#1)(2008-5#1)
penetration depth of##6##3##(1992-8#1)(2008-2#1)(2008-3#2)(2008-5#1)(2011-1#1)
penetration depth##19##2##(1992-8#1)(1993-5#1)(2007-12#2)(2008-10#1)(2008-2#6)(2008-3#4)(2008-5#1)(2011-1#3)
penetration depths##4##2##(1994-2#1)(2008-3#2)(2012-12#1)
penetration domain##2##2##(1997-1#2)
penetration enhancers##3##2##(2004-12#1)(2008-5#2)
penetration in the##2##3##(2008-10#1)(2012-3#1)
penetration into deeper##2##3##(1993-11#1)(2008-5#1)
penetration into the##13##3##(1992-6#1)(1994-3#1)(1996-5#1)(1997-1#1)(2006-5#2)(2007-10#1)(2007-11#1)(2007-9#1)(2008-3#1)(2008-5#2)(2012-12#1)
penetration into##22##2##(1992-5#1)(1992-6#1)(1993-11#1)(1994-3#1)(1996-5#1)(1997-1#1)(2006-5#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-5#6)(2012-12#1)(2013-8#1)
penetration is##2##2##(2008-5#1)(2010-9#1)
penetration kinetics##2##2##(2005-11#1)(2008-5#1)
penetration of a##3##3##(1992-6#1)(2007-8#1)(2011-2#1)
penetration of host##3##3##(2007-12#1)(2007-7#1)(2008-10#1)
penetration of the active##2##4##(2008-5#1)(2012-2#1)
penetration of the cuticle##2##4##(2008-10#2)
penetration of the##28##3##(1990-10#1)(1990-3#1)(1991-2#1)(1992-1#1)(1994-5#1)(1995-9#1)(2005-11#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-3#2)(2008-5#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-4#2)(2012-2#2)
penetration of##82##2##(1990-10#1)(1990-3#3)(1991-12#3)(1991-2#1)(1991-9#2)(1992-1#1)(1992-6#1)(1992-9#1)(1994-3#1)(1994-5#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#16)(2008-2#3)(2008-3#3)(2008-5#7)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#2)(2010-12#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)
penetration pore##7##2##(2008-10#7)
penetration process##2##2##(2008-10#2)
penetration properties##2##2##(2008-1#1)(2008-5#1)
penetration rate##2##2##(1991-12#1)(2008-5#1)
penetration rates##7##2##(2006-5#4)(2007-11#1)(2008-8#2)
penetration resistance##5##2##(2008-10#4)(2012-2#1)
penetration significative##2##2##(2008-5#2)
penetration site##2##2##(2008-10#2)
penetration sites##3##2##(2008-10#3)
penetration study##2##2##(2004-12#1)(2008-10#1)
penetration test##3##2##(1995-8#2)(2010-8#1)
penetration through the##5##3##(1995-12#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-5#1)
penetration through##9##2##(1995-12#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#2)
penetration to the##2##3##(2007-8#1)(2008-7#1)
penetration via##2##2##(2008-10#1)(2008-5#1)
penetration was followed by##2##4##(2008-10#2)
penetration was not observed##2##4##(2006-5#1)(2008-10#1)
penetration was not##3##3##(2006-5#1)(2008-10#2)
penetration was##8##2##(1990-5#1)(2006-5#1)(2007-12#1)(2008-10#5)
penetration with##2##2##(1991-12#1)(2009-5#1)
penetration##359##1##(1990-10#1)(1990-12#1)(1990-2#3)(1990-3#3)(1990-5#2)(1991-11#1)(1991-12#7)(1991-2#2)(1991-5#1)(1991-9#3)(1992-1#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-4#1)(1993-5#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#3)(1996-8#2)(1997-1#5)(1997-4#1)(1997-6#1)(1997-8#1)(2004-12#2)(2004-9#1)(2005-11#7)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-11#2)(2006-12#2)(2006-5#10)(2006-6#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#7)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#7)(2007-9#1)(2008-1#2)(2008-10#96)(2008-11#4)(2008-12#1)(2008-2#12)(2008-3#14)(2008-5#46)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-8#1)(2010-10#3)(2010-12#2)(2010-2#2)(2010-4#2)(2010-7#5)(2010-8#1)(2010-9#1)(2011-1#4)(2011-10#2)(2011-2#2)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#6)(2013-8#2)
penetrations##3##1##(2005-8#1)(2007-12#1)(2008-10#1)
penetrative sex##2##2##(2009-5#1)(2009-7#1)
penetrative##3##1##(2009-5#2)(2009-7#1)
penguins and other##2##3##(1993-9#2)
penguins and##3##2##(1993-9#2)(2012-1#1)
penguins##8##1##(1993-9#3)(2008-5#4)(2012-1#1)
penicillamine (PA)##2##2##(2007-8#1)(2008-10#1)
penicillamine in##2##2##(2008-10#2)
penicillamine is##2##2##(1992-8#1)(2008-10#1)
penicillamine therapy##2##2##(1992-5#2)
penicillamine##20##1##(1991-8#1)(1992-5#4)(1992-8#1)(1994-9#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#10)
penicillatum produced##2##2##(2008-10#2)
penicillatum##11##1##(2008-10#11)
penicillin G acylase##6##3##(2005-11#1)(2006-9#2)(2008-8#1)(2012-11#2)
penicillin G and##4##3##(1990-9#1)(2007-12#1)(2008-12#1)(2013-8#1)
penicillin G benzathine##2##3##(1997-5#2)
penicillin G was##2##3##(1991-8#1)(2013-8#1)
penicillin G##30##2##(1990-9#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-2#1)(1993-7#1)(1994-11#1)(1994-8#1)(1997-5#2)(2005-11#1)(2005-12#1)(2006-5#1)(2006-9#2)(2007-12#1)(2008-10#4)(2008-12#2)(2008-8#1)(2010-4#1)(2012-11#2)(2013-8#3)
penicillin N##2##2##(2011-1#2)
penicillin V##5##2##(1992-2#1)(1994-9#1)(2006-8#2)(2008-10#1)
penicillin acylase##3##2##(1990-11#2)(1992-11#1)
penicillin allergy##2##2##(1995-3#1)(1996-3#1)
penicillin and cefotaxime##4##3##(2011-2#4)
penicillin and##15##2##(1990-12#1)(1992-8#1)(1995-7#1)(1997-3#1)(2006-10#2)(2006-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2011-2#4)
penicillin by##2##2##(1992-12#1)(2011-2#1)
penicillin in##2##2##(2007-8#1)(2011-2#1)
penicillin is##2##2##(2006-8#1)(2011-2#1)
penicillin resistance##2##2##(2010-4#1)(2012-2#1)
penicillin therapy##3##2##(1992-8#2)(2011-2#1)
penicillin treatment##2##2##(1990-8#1)(1993-3#1)
penicillin was##2##2##(1993-3#1)(2010-2#1)
penicillin were##2##2##(2007-12#1)(2011-2#1)
penicillin##148##1##(1990-11#2)(1990-12#2)(1990-8#2)(1990-9#5)(1991-10#1)(1991-12#2)(1991-7#2)(1991-8#2)(1992-11#2)(1992-12#3)(1992-2#3)(1992-8#4)(1992-9#1)(1993-3#2)(1993-7#1)(1994-11#1)(1994-8#2)(1994-9#1)(1995-3#3)(1995-7#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#1)(1997-3#1)(1997-5#2)(2005-11#2)(2005-12#2)(2005-7#2)(2006-10#4)(2006-4#1)(2006-5#1)(2006-8#8)(2006-9#2)(2007-12#5)(2007-2#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#8)(2008-11#5)(2008-12#7)(2008-7#3)(2008-8#3)(2009-5#1)(2010-2#1)(2010-4#3)(2011-1#5)(2011-2#14)(2012-11#2)(2012-12#2)(2012-2#3)(2013-1#2)(2013-8#4)
penicillin- or##3##2##(2005-11#1)(2011-2#2)
penicillin-G##8##1##(1996-1#4)(2013-8#4)
penicillin-allergic##2##1##(1996-3#1)(2006-10#1)
penicillin-intermediate and##2##2##(2006-8#1)(2008-7#1)
penicillin-resistant Streptococcus pneumoniae##3##3##(2005-7#1)(2008-7#1)(2011-2#1)
penicillin-resistant Streptococcus##4##2##(2005-7#1)(2008-7#1)(2010-11#1)(2011-2#1)
penicillin-resistant##13##1##(1991-12#1)(1991-7#1)(1993-5#1)(2005-7#2)(2007-11#1)(2008-7#1)(2010-11#1)(2010-4#1)(2011-2#2)(2012-2#2)
penicillinase and##2##2##(2008-10#1)(2008-4#1)
penicillinase##9##1##(1992-2#1)(1993-12#1)(2006-9#2)(2008-10#1)(2008-4#3)(2013-8#1)
penicillins and cephalosporins##3##3##(1990-6#1)(1996-3#1)(2006-12#1)
penicillins was##3##2##(1992-2#1)(2008-10#2)
penicillins##22##1##(1990-6#1)(1992-2#2)(1993-5#1)(1994-6#1)(1995-3#1)(1996-1#1)(1996-3#1)(2005-8#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-4#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#4)
penicilloyl##3##1##(1992-8#3)
penile cancer##4##2##(2007-11#1)(2009-2#1)(2010-2#1)(2013-8#1)
penile curvature##2##2##(2006-10#1)(2006-9#1)
penile deformity##2##2##(2006-10#1)(2008-7#1)
penile erection##3##2##(1990-7#1)(1993-11#1)(2011-1#1)
penile erections##2##2##(1992-7#1)(2013-8#1)
penile fracture##6##2##(2008-10#3)(2008-7#2)(2011-1#1)
penile length##4##2##(2008-10#1)(2011-1#3)
penile neurons##2##2##(1992-8#2)
penile pain##2##2##(2006-9#1)(2011-2#1)
penile prosthesis##2##2##(2006-12#1)(2013-8#1)
penile reconstruction##4##2##(2011-2#4)
penile shaft##5##2##(1991-2#1)(2006-9#1)(2007-7#1)(2008-10#2)
penile size##3##2##(2009-5#1)(2011-1#2)
penile skin##2##2##(2009-5#1)(2013-8#1)
penile##70##1##(1990-12#1)(1990-7#1)(1991-2#3)(1992-7#3)(1992-8#3)(1993-11#1)(1994-1#1)(1994-5#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-9#4)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-6#1)(2008-7#3)(2009-2#1)(2009-5#2)(2010-2#1)(2010-7#1)(2011-1#12)(2011-2#7)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#4)
peninsula##9##1##(1996-12#1)(2007-2#1)(2007-3#2)(2007-5#2)(2008-10#1)(2008-5#1)(2010-8#1)
peninsular Malaysia##8##2##(1997-2#1)(2008-10#1)(2008-12#4)(2008-8#2)
peninsular##9##1##(1997-2#1)(2008-10#2)(2008-12#4)(2008-8#2)
penis and the##2##3##(2007-7#1)(2008-10#1)
penis and##7##2##(2005-7#2)(2006-10#1)(2007-7#2)(2007-9#1)(2008-10#1)
penis in the##2##3##(2006-5#1)(2011-2#1)
penis in##5##2##(2006-5#2)(2008-10#2)(2011-2#1)
penis is a rare##2##4##(1990-12#1)(1991-8#1)
penis is##7##2##(1990-12#1)(1991-8#1)(1992-8#1)(2008-10#1)(2009-5#1)(2011-1#2)
penis with##2##2##(2008-1#1)(2010-7#1)
penis##78##1##(1990-12#2)(1991-2#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-8#4)(1994-1#1)(1995-5#1)(2004-4#1)(2005-7#2)(2006-10#1)(2006-5#11)(2007-10#1)(2007-3#1)(2007-5#1)(2007-7#7)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#8)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#7)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#1)(2013-1#4)(2013-8#1)
penis]##3##1##(1991-8#1)(2008-10#2)
peniscopy##3##1##(1991-2#3)
penitentiaries##2##1##(2007-12#1)(2012-11#1)
pennellii##2##1##(2006-12#1)(2008-10#1)
pennsylvanicus)##2##1##(1994-5#1)(2008-9#1)
penoscrotal elephantiasis##3##2##(2007-7#3)
penoscrotal hypospadias##2##2##(2008-10#1)(2009-5#1)
penoscrotal transposition##3##2##(2008-10#3)
penoscrotal##14##1##(1994-4#1)(2007-11#1)(2007-7#3)(2008-10#4)(2009-5#1)(2013-1#4)
pens and##3##2##(2005-9#1)(2007-8#1)(2010-4#1)
pens##15##1##(2005-9#1)(2007-8#2)(2008-5#2)(2009-11#2)(2010-2#2)(2010-4#2)(2010-8#1)(2011-1#1)(2012-2#2)
pension for workers exposed to asbestos at work##2##8##(2010-9#2)
pension fund##3##2##(2006-8#3)
pension levels##5##2##(2006-8#5)
pension plans##7##2##(1993-3#6)(1994-1#1)
pension##66##1##(1991-11#3)(1992-3#2)(1993-3#7)(1993-6#1)(1993-9#1)(1994-1#1)(1995-11#1)(1995-5#4)(1997-6#5)(2006-10#3)(2006-8#32)(2007-11#1)(2007-7#1)(2010-12#1)(2010-9#3)
pension)##2##1##(2006-10#1)(2006-8#1)
pensioners in##2##2##(1990-4#1)(2006-10#1)
pensioners##8##1##(1990-4#1)(2006-10#7)
pensions##5##1##(1991-3#1)(1993-6#2)(1995-5#1)(1997-8#1)
pensylvanica##3##1##(2008-10#2)(2008-9#1)
penta##3##1##(1990-6#1)(2008-4#1)(2011-12#1)
penta- and##4##2##(1996-5#1)(2007-6#1)(2008-10#2)
penta-##5##1##(1996-5#1)(2007-6#1)(2008-10#2)(2008-8#1)
penta-antennary &quot##2##2##(1995-10#2)
pentaacetic acid (DTPA)##2##3##(2008-10#2)
pentaacetic acid##3##2##(2005-10#1)(2008-10#2)
pentaacetic##5##1##(1997-5#2)(2005-10#1)(2008-10#2)
pentaacids##2##1##(2008-10#2)
pentaazadentate metal complexes##2##3##(2008-3#2)
pentaazadentate##3##1##(2008-3#3)
pentachloronitrobenzene##2##1##(1997-6#1)(2008-10#1)
pentachlorophenol (PCP) in##2##3##(2008-10#2)
pentachlorophenol (PCP)##4##2##(1997-7#1)(2008-10#3)
pentachlorophenol and##5##2##(1990-11#3)(2008-10#2)
pentachlorophenol in##3##2##(2008-10#3)
pentachlorophenol##14##1##(1990-11#3)(1997-7#1)(2006-3#1)(2008-10#8)(2009-3#1)
pentachlorophenolate##3##1##(2008-10#3)
pentacoordinate##9##1##(1992-12#1)(1997-4#2)(2005-11#1)(2008-10#2)(2010-5#3)
pentacoordinated##4##1##(1992-6#1)(1994-8#1)(1997-4#1)(2008-3#1)
pentacosapeptide representing the RNA-binding##2##4##(1992-9#2)
pentacyclic triterpenoids of the##2##4##(1991-10#2)
pentacyclic triterpenoids##3##2##(1991-10#2)(2006-12#1)
pentacyclic##9##1##(1991-10#2)(1992-8#2)(1996-5#1)(2006-12#1)(2007-1#1)(2009-3#2)
pentadecane##3##1##(2005-12#2)(2010-3#1)
pentadecapeptide BPC 157##2##3##(1997-7#2)
pentadecapeptide##7##1##(1995-2#3)(1997-7#4)
pentadentate##2##1##(2010-2#1)(2012-12#1)
pentadepsipeptide##2##1##(1995-2#2)
pentaerythritol tetranitrate (PETN)##3##3##(2008-10#2)(2008-3#1)
pentaerythritol tetranitrate##5##2##(2008-10#4)(2008-3#1)
pentaerythritol triacrylate mixture was used##2##5##(2008-9#2)
pentaerythritol triacrylate##14##2##(2008-9#14)
pentaerythritol##28##1##(1992-6#1)(2008-10#4)(2008-3#2)(2008-5#1)(2008-9#20)
pentaethylenehexamine##2##1##(2008-10#2)
pentafluorobenzyl alcohol##2##2##(1996-7#2)
pentafluorobenzyl##5##1##(1990-11#1)(1996-7#2)(1997-3#2)
pentafluorobenzylation##4##1##(2008-10#4)
pentagastrin in the##2##3##(1993-6#2)
pentagastrin##11##1##(1991-2#1)(1993-6#8)(2009-3#2)
pentagastrin-induced gastric acid secretion in##2##5##(1997-1#2)
pentagastrin-induced##3##1##(1991-2#1)(1997-1#2)
pentaglycosyl aldonic acid##2##3##(1991-9#2)
pentagon##3##1##(2010-12#3)
pentagonal##6##1##(1992-12#1)(1995-9#1)(1996-2#1)(2007-12#1)(2008-3#1)(2008-5#1)
pentagons##6##1##(1995-8#2)(2010-12#4)
pentahydrate##4##1##(2008-10#3)(2008-5#1)
pentahydrated##3##1##(2006-1#3)
pentahydrochloride##3##1##(1997-3#2)(2008-1#1)
pentakis- and##3##2##(1990-11#1)(1990-7#2)
pentakisphosphate##5##1##(1990-2#3)(1996-4#2)
pentalenolactone (3)##2##2##(1994-5#2)
pentalenolactone##5##1##(1994-5#5)
pentamer##10##1##(1990-7#2)(1991-5#1)(1992-6#2)(1993-11#1)(2006-8#1)(2007-8#1)(2008-10#1)(2009-2#1)
pentamer(+) cell##3##2##(2013-1#3)
pentamer(+) cells##2##2##(2013-1#2)
pentamer(+)##5##1##(2013-1#5)
pentameric complexes##2##2##(1994-9#1)(2013-1#1)
pentameric##9##1##(1990-4#1)(1992-12#1)(1993-9#1)(1994-8#1)(1994-9#2)(1995-6#1)(2011-1#1)(2013-1#1)
pentamers##2##1##(1990-7#1)(2008-5#1)
pentamethylcyclopentadienyl##3##1##(1996-2#2)(2006-4#1)
pentamidine aerosol##2##2##(1993-2#2)
pentamidine with##2##2##(1993-2#1)(1997-2#1)
pentamidine##17##1##(1990-9#1)(1992-3#1)(1993-2#9)(1996-12#2)(1996-2#1)(1997-2#1)(2008-10#2)
pentane##8##1##(2008-10#5)(2008-3#3)
pentane-2##4##1##(2007-10#1)(2007-11#3)
pentanoic acid##3##2##(1990-5#2)(2012-1#1)
pentanol##4##1##(1993-7#1)(2008-10#3)
pentapeptide amide which##2##3##(1992-11#1)(2008-10#1)
pentapeptide yield was##2##3##(2008-7#2)
pentapeptide##26##1##(1990-7#1)(1991-10#2)(1991-3#4)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-6#1)(1994-2#1)(1995-6#1)(1996-5#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#3)(2012-2#2)
pentapeptides##2##1##(1990-12#1)(2012-2#1)
pentaphosphate##3##1##(1996-7#2)(1997-7#1)
pentasaccharide and##2##2##(1992-10#1)(1994-11#1)
pentasaccharide hapten##2##2##(1992-12#2)
pentasaccharide##14##1##(1992-1#1)(1992-10#1)(1992-12#3)(1994-11#2)(1995-11#1)(1995-2#1)(1995-4#1)(1996-2#1)(1996-4#1)(1997-2#1)(2008-3#1)
pentasaccharides##3##1##(1990-9#1)(1997-4#2)
pentathia-15-crown-5 and##2##2##(2008-10#2)
pentathlon sportsmen##2##2##(2013-1#2)
pentaurelia##3##1##(2008-12#3)
pentavalent antimonials##2##2##(1990-7#1)(1997-7#1)
pentavalent arsenicals##4##2##(2009-6#4)
pentavalent##15##1##(1990-7#1)(1997-7#1)(2007-7#1)(2008-10#7)(2008-5#1)(2009-6#4)
pentazocine##3##1##(1995-9#1)(1997-5#2)
pentobarbital anesthetized##3##2##(1990-7#1)(1993-4#1)(1997-5#1)
pentobarbital coma##2##2##(2006-11#2)
pentobarbital overdose (see Basic Protocol 2)##2##6##(2008-4#2)
pentobarbital sodium in a dose of##2##6##(2005-10#2)
pentobarbital##28##1##(1990-7#2)(1991-3#1)(1992-4#3)(1993-2#1)(1993-4#1)(1993-7#1)(1994-12#1)(1995-12#2)(1996-10#1)(1996-4#1)(1996-5#1)(1997-5#2)(2005-10#2)(2006-11#3)(2008-4#4)(2008-6#1)(2010-12#1)
pentobarbital-anesthetized dogs##4##2##(1993-3#3)(1994-8#1)
pentobarbital-anesthetized##10##1##(1990-7#2)(1991-3#1)(1992-7#2)(1993-3#3)(1994-10#1)(1994-8#1)
pentobarbital-induced##2##1##(1991-3#1)(1996-4#1)
pentobarbitone##4##1##(1990-7#1)(1992-10#1)(1995-12#1)(2008-12#1)
pentons##3##1##(1994-9#2)(2008-8#1)
pentosan polysulfate##3##2##(1990-11#3)
pentosan##4##1##(1990-11#3)(2008-5#1)
pentose phosphate pathway in##4##4##(1991-6#1)(1992-12#1)(1994-3#1)(2009-5#1)
pentose phosphate pathway##18##3##(1991-5#1)(1991-6#2)(1992-12#4)(1994-3#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#3)(2009-10#1)(2009-5#1)(2010-12#1)
pentose phosphate##20##2##(1991-5#1)(1991-6#2)(1992-12#4)(1994-3#2)(1994-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#3)(2009-10#1)(2009-5#1)(2010-12#1)
pentose phosphates##2##2##(2006-12#1)(2012-1#1)
pentose sugars##2##2##(2008-5#1)(2012-3#1)
pentose##34##1##(1991-5#1)(1991-6#2)(1992-12#4)(1994-3#2)(1994-6#1)(1996-6#3)(2006-12#1)(2006-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#5)(2009-10#1)(2009-5#1)(2010-12#1)(2011-1#1)(2012-1#3)(2012-3#1)
pentose-rich##2##1##(2008-5#2)
pentoses##2##1##(2008-5#1)(2008-6#1)
pentosidine##2##1##(1992-7#1)(1994-8#1)
pentosus##2##1##(2007-12#1)(2008-5#1)
pentoxide##7##1##(1992-4#1)(1996-2#2)(1996-3#1)(2007-11#1)(2008-11#1)(2008-4#1)
pentoxifylline##7##1##(2006-10#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2010-6#1)
pentoxyverine##5##1##(2008-10#5)
pentoxyverine-tetraphenylborate##2##1##(2008-10#2)
pentraxin (Mptx)##2##2##(2008-10#2)
pentraxin##5##1##(2008-10#4)(2010-3#1)
pentraxins##5##1##(1992-12#1)(2006-5#1)(2008-10#1)(2010-3#2)
pentyl rhamnoside##2##2##(2008-5#2)
pentyl##6##1##(1994-8#1)(1997-2#1)(2006-12#1)(2008-5#3)
pentylamine##4##1##(1990-5#2)(1995-2#1)(2008-10#1)
pentylenetetrazol (PTZ)##3##2##(1991-11#1)(1996-10#1)(1996-2#1)
pentylenetetrazol##12##1##(1991-11#2)(1991-12#1)(1991-5#3)(1993-11#1)(1996-10#1)(1996-2#1)(1997-5#1)(2010-12#2)
pentylenetetrazol-kindling##2##1##(1997-5#2)
pentylenetetrazole (80 mg/kg)##2##3##(1995-12#1)(2010-3#1)
pentylenetetrazole##5##1##(1992-3#1)(1994-3#1)(1995-12#1)(2010-3#2)
pentylenetetrazole-induced##3##1##(1995-12#2)(2010-2#1)
penultimate leaf##3##2##(2008-10#3)
penultimate residues##2##2##(2013-8#2)
penultimate##15##1##(1992-6#2)(1995-8#1)(2007-11#1)(2007-8#1)(2008-10#4)(2009-11#2)(2013-8#4)
penumbra##17##1##(1994-4#1)(1997-2#2)(1997-7#1)(2007-9#9)(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)
penumbral CBF##2##2##(2007-9#2)
penumbral##4##1##(1997-2#1)(2007-9#3)
peony##3##1##(2011-3#3)
people (P &lt##2##3##(2011-2#2)
people a##4##2##(2005-8#1)(2007-8#1)(2010-4#1)(2011-2#1)
people about the##2##3##(2007-7#1)(2008-8#1)
people about##6##2##(1991-3#1)(1997-6#2)(2007-7#1)(2008-1#1)(2008-8#1)
people access to##2##3##(1995-12#1)(2007-2#1)
people achieve##3##2##(1990-12#1)(2008-7#1)(2013-1#1)
people adopt##2##2##(2010-2#1)(2012-12#1)
people affected by##4##3##(1994-4#2)(2008-5#1)(2012-3#1)
people affected##5##2##(1994-4#2)(2008-5#1)(2012-3#1)(2013-1#1)
people age##3##2##(2008-7#1)(2009-12#1)(2013-1#1)
people aged 60 years and over##2##6##(2011-1#2)
people aged 60##3##3##(1993-2#1)(2011-1#2)
people aged 65##2##3##(2007-4#1)(2010-10#1)
people aged between##2##3##(2009-4#1)(2011-2#1)
people aged over##2##3##(2012-3#1)(2013-1#1)
people aged##23##2##(1990-12#1)(1993-2#1)(1995-5#1)(2006-10#1)(2006-2#1)(2007-4#1)(2009-4#1)(2010-10#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#3)(2013-8#1)
people and in##2##3##(1992-9#1)(2013-1#1)
people and organizations##2##3##(2007-3#1)(2008-7#1)
people and their families##4##4##(1997-3#1)(2008-11#1)(2010-10#1)(2010-5#1)
people and their##6##3##(1997-3#1)(2008-11#1)(2009-4#1)(2010-10#1)(2010-5#1)(2011-1#1)
people and to##2##3##(2007-7#1)(2010-10#1)
people and##51##2##(1990-11#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#3)(1993-3#1)(1994-3#1)(1995-2#1)(1996-7#1)(1997-3#1)(2006-10#1)(2006-2#2)(2007-11#1)(2007-3#2)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#3)(2008-7#2)(2009-12#1)(2009-4#1)(2010-10#2)(2010-12#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#4)
people annually##2##2##(1995-9#1)(2005-10#1)
people are affected##3##3##(2008-11#1)(2008-4#1)(2012-12#1)
people are exposed##2##3##(2007-12#1)(2011-2#1)
people are still not##2##4##(1996-5#1)(2010-12#1)
people are##44##2##(1993-3#1)(1995-9#1)(1996-5#2)(1997-7#1)(2006-12#2)(2006-7#1)(2006-8#1)(2007-12#2)(2007-6#2)(2007-7#1)(2007-9#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
people as well as##3##4##(2006-12#1)(2010-10#2)
people as##12##2##(1992-9#1)(2006-12#1)(2007-3#1)(2007-8#1)(2008-12#1)(2008-7#1)(2009-9#1)(2010-10#3)(2010-8#1)(2012-12#1)
people at highest risk##2##4##(1996-5#1)(2007-10#1)
people at risk##2##3##(2011-1#1)(2011-2#1)
people at##8##2##(1995-7#1)(1996-5#1)(2007-10#1)(2008-8#1)(2010-7#1)(2011-1#2)(2011-2#1)
people attended the##2##3##(2005-8#1)(2008-5#1)
people be##2##2##(2010-8#1)(2013-8#1)
people become##3##2##(1993-3#1)(2012-12#1)(2012-2#1)
people believed that##2##3##(1994-3#1)(2012-2#1)
people benefit##2##2##(1995-10#1)(2008-10#1)
people born##3##2##(1992-8#1)(2011-1#1)(2011-2#1)
people by##2##2##(2007-8#1)(2011-1#1)
people can##8##2##(1994-12#1)(1995-9#1)(1997-8#1)(2009-5#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-8#1)
people choose##2##2##(2012-3#1)(2013-1#1)
people completed##2##2##(1994-12#1)(2010-12#1)
people consider##2##2##(1994-4#1)(1994-6#1)
people could##2##2##(1992-2#1)(2010-4#1)
people currently##2##2##(2007-11#1)(2008-7#1)
people die##4##2##(1990-6#1)(1997-7#1)(2009-10#1)(2010-11#1)
people died of##2##3##(1993-6#1)(1997-6#1)
people died##5##2##(1993-6#1)(1996-7#1)(1997-6#1)(2009-4#1)(2012-12#1)
people do not##6##3##(1997-6#1)(2007-3#1)(2008-5#1)(2009-12#1)(2013-1#2)
people during the##2##3##(2008-7#1)(2013-8#1)
people during##3##2##(2008-7#1)(2013-8#2)
people eligible for##2##3##(1994-2#1)(2010-2#1)
people employed in##2##3##(1994-6#1)(2006-7#1)
people engage in##2##3##(2009-5#1)(2012-1#1)
people even##2##2##(1995-5#1)(2008-2#1)
people experience##5##2##(2007-12#1)(2008-12#1)(2008-3#1)(2013-8#2)
people following##2##2##(2008-10#1)(2012-3#1)
people for##11##2##(1993-5#1)(2008-1#2)(2008-10#2)(2008-5#1)(2008-7#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-3#1)
people from the##2##3##(2006-4#1)(2009-4#1)
people from##25##2##(1992-12#2)(1994-6#1)(1997-3#1)(2006-10#2)(2006-4#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
people get##2##2##(2008-9#1)(2011-2#1)
people go##2##2##(1993-2#1)(2008-9#1)
people had##3##2##(2007-12#1)(2011-2#1)(2013-8#1)
people has##3##2##(2006-4#1)(2007-1#1)(2011-2#1)
people have become##2##3##(2010-9#1)(2012-2#1)
people have been##3##3##(2008-2#1)(2012-1#1)(2012-10#1)
people have used##2##3##(2006-9#1)(2007-11#1)
people have##24##2##(1993-3#1)(1995-1#1)(1995-3#1)(1996-1#1)(1997-6#2)(2005-10#1)(2006-12#1)(2006-9#1)(2007-11#2)(2007-4#1)(2008-1#1)(2008-2#2)(2008-7#1)(2010-12#1)(2010-7#1)(2010-9#1)(2012-1#1)(2012-10#1)(2012-2#3)
people healthier##2##2##(2010-8#2)
people identified as##2##3##(2006-7#1)(2011-2#1)
people in Burkina Faso##2##4##(1990-6#1)(2009-10#1)
people in Hong Kong##2##4##(1991-10#1)(2008-7#1)
people in New Zealand##4##4##(1991-2#1)(1996-12#2)(2008-1#1)
people in Uganda##2##3##(2008-5#2)
people in a##5##3##(1991-8#1)(1995-1#1)(2007-12#1)(2008-1#1)(2010-12#1)
people in an##2##3##(2008-7#1)(2008-8#1)
people in both##2##3##(2007-9#1)(2012-12#1)
people in order to##3##4##(2004-3#1)(2006-7#1)(2013-1#1)
people in poverty##2##3##(1995-1#1)(2008-11#1)
people in the UK##3##4##(1996-2#1)(2012-12#2)
people in the United States##6##5##(2006-10#1)(2006-8#1)(2006-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
people in the general population##2##5##(1990-11#1)(2011-12#1)
people in the##31##3##(1990-11#1)(1990-12#1)(1993-3#1)(1994-4#1)(1995-6#2)(1996-1#1)(1996-2#1)(2006-10#1)(2006-8#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-4#1)(2009-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#3)
people in their##4##3##(1994-6#1)(2005-9#1)(2010-10#2)
people in these areas##2##4##(2008-8#1)(2011-1#1)
people in this##3##3##(1995-12#1)(2008-11#1)(2012-11#1)
people in##125##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-10#1)(1991-2#1)(1991-7#1)(1991-8#3)(1992-1#1)(1993-1#1)(1993-3#2)(1993-5#1)(1993-6#2)(1994-4#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-6#2)(1996-1#1)(1996-12#2)(1996-2#2)(2004-3#1)(2005-9#1)(2006-10#2)(2006-4#2)(2006-7#7)(2006-8#2)(2006-9#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#4)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#4)(2010-12#2)(2010-7#2)(2010-8#3)(2011-1#5)(2011-12#1)(2011-2#6)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#4)
people infected with the##3##4##(1990-5#1)(1996-9#1)(2006-10#1)
people infected with##8##3##(1990-5#1)(1991-6#1)(1996-9#1)(2006-10#2)(2008-1#1)(2013-1#2)
people infected##11##2##(1990-5#1)(1991-6#1)(1996-9#1)(2006-10#2)(2008-1#1)(2008-10#1)(2011-12#1)(2012-12#1)(2013-1#2)
people interviewed##6##2##(1990-12#1)(2007-2#4)(2008-2#1)
people into##2##2##(1997-2#1)(2010-8#1)
people involved##2##2##(2008-2#1)(2008-5#1)
people is challenging because##2##4##(2007-5#1)(2008-3#1)
people is##12##2##(1997-6#1)(1997-8#1)(2005-3#1)(2006-1#1)(2007-5#1)(2008-3#1)(2009-5#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
people judge##2##2##(2008-7#1)(2009-6#1)
people live in##3##3##(1995-4#1)(2009-8#1)(2011-12#1)
people live##6##2##(1995-4#1)(1997-8#1)(2007-8#1)(2009-8#1)(2011-12#1)(2012-1#1)
people living at##2##3##(1992-4#1)(2008-4#1)
people living in the##6##4##(1996-6#1)(2008-3#2)(2011-1#1)(2011-2#1)(2012-12#1)
people living in##18##3##(1996-6#1)(2007-1#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-3#2)(2008-9#1)(2009-5#1)(2010-10#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)
people living with HIV and AIDS##3##6##(2007-7#1)(2007-9#1)(2010-8#1)
people living with HIV and##5##5##(2007-7#1)(2007-9#1)(2010-3#1)(2010-8#1)(2012-12#1)
people living with HIV##10##4##(2007-7#1)(2007-9#1)(2009-10#2)(2010-3#1)(2010-8#2)(2012-12#2)(2013-8#1)
people living with HIV/AIDS and##2##5##(2005-10#1)(2011-1#1)
people living with HIV/AIDS in##3##5##(2007-12#1)(2007-7#1)(2011-1#1)
people living with HIV/AIDS##20##4##(2005-10#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-12#2)(2008-4#1)(2010-12#2)(2010-8#1)(2011-1#7)(2012-12#2)(2013-1#1)
people living with##39##3##(2005-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-7#3)(2007-9#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#1)(2009-10#2)(2010-10#1)(2010-12#3)(2010-3#1)(2010-8#4)(2011-1#7)(2011-2#1)(2012-12#4)(2013-1#2)(2013-8#1)
people living##60##2##(1992-4#1)(1996-6#1)(2005-10#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#5)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-5#1)(2010-10#2)(2010-12#3)(2010-3#1)(2010-5#2)(2010-8#4)(2011-1#8)(2011-2#2)(2012-11#1)(2012-12#5)(2013-1#2)(2013-8#1)
people make##4##2##(1997-3#1)(2009-5#1)(2009-6#1)(2010-8#1)
people may##3##2##(1997-3#1)(2008-10#1)(2011-2#1)
people more##4##2##(2008-9#1)(2009-6#1)(2012-3#1)(2013-7#1)
people need##3##2##(1993-8#1)(1996-3#1)(2010-10#1)
people not##3##2##(1993-1#1)(1994-11#1)(1994-2#1)
people now##2##2##(2008-2#1)(2010-8#1)
people of the##2##3##(1993-12#1)(1997-4#1)
people of##25##2##(1993-12#1)(1995-1#1)(1995-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
people often##2##2##(2009-9#1)(2011-2#1)
people older than 65 years##3##5##(2008-8#1)(2010-4#1)(2011-2#1)
people older than##4##3##(2008-8#1)(2010-4#1)(2010-5#1)(2011-2#1)
people on##4##2##(1993-7#1)(1994-7#1)(2007-5#1)(2010-4#1)
people or##2##2##(2008-4#1)(2012-12#1)
people outside##2##2##(2008-7#1)(2012-12#1)
people over age##2##3##(2008-4#1)(2008-5#1)
people over the##3##3##(2008-10#1)(2010-4#1)(2013-1#1)
people over##13##2##(1992-10#1)(1993-9#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-10#1)(2010-4#3)(2012-1#1)(2013-1#1)
people per##5##2##(1996-12#1)(2007-10#1)(2010-11#3)
people perceived##2##2##(2008-12#1)(2012-3#1)
people perform##2##2##(2009-10#1)(2011-12#1)
people refuse to##2##3##(2009-6#2)
people reported##3##2##(2009-12#1)(2012-12#1)(2012-3#1)
people require##2##2##(2008-4#1)(2008-5#1)
people respond to##2##3##(2010-12#1)(2013-7#1)
people should be##2##3##(1990-5#1)(2006-7#1)
people should##4##2##(1990-5#1)(2006-7#1)(2007-12#1)(2008-1#1)
people suffering from severe##2##4##(2008-2#1)(2008-7#1)
people suffering from##15##3##(1992-3#2)(1992-5#1)(1993-3#1)(1997-4#1)(1997-8#1)(2006-8#1)(2008-2#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#1)
people suffering##17##2##(1992-3#2)(1992-5#1)(1993-3#1)(1997-4#1)(1997-8#1)(2006-8#1)(2008-2#3)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#1)
people that##5##2##(1996-1#1)(2007-5#1)(2008-11#1)(2009-4#1)(2011-2#1)
people the##2##2##(2008-7#1)(2010-8#1)
people themselves##2##2##(2007-3#1)(2010-4#1)
people through##3##2##(1996-8#1)(2008-10#1)(2012-3#1)
people to change##2##3##(2007-11#1)(2008-9#1)
people to evaluate##2##3##(1993-3#1)(1993-9#1)
people to remain living at home##2##6##(2013-1#2)
people to remain##4##3##(2010-10#1)(2013-1#3)
people to seek##2##3##(2010-4#1)(2012-12#1)
people to##54##2##(1992-2#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-1#1)(1996-1#1)(1996-12#1)(1997-5#1)(2004-9#1)(2006-7#3)(2007-11#1)(2007-3#2)(2007-4#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-6#1)(2010-10#4)(2010-4#2)(2010-9#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#2)(2013-1#6)(2013-7#1)(2013-8#1)
people towards old age homes##2##5##(2008-7#2)
people use to##2##3##(2008-1#1)(2011-12#1)
people use##6##2##(2007-10#1)(2008-1#1)(2011-12#1)(2013-7#2)(2013-8#1)
people using##3##2##(1994-3#1)(2008-9#1)(2013-7#1)
people was##3##2##(2006-10#1)(2013-1#2)
people were interviewed##2##3##(2013-1#2)
people were more likely to##2##5##(2008-12#1)(2009-4#1)
people were##25##2##(1992-1#1)(1992-9#1)(1995-2#1)(1995-8#1)(1996-6#2)(2006-2#1)(2006-4#1)(2007-2#3)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-12#1)(2009-4#2)(2009-7#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#2)
people who are not##4##4##(2006-2#1)(2008-3#1)(2008-4#1)(2013-8#1)
people who are##17##3##(1993-3#2)(1994-4#1)(1995-1#1)(1996-12#1)(2006-1#1)(2006-2#1)(2006-9#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-4#1)(2011-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
people who experience##2##3##(1995-5#1)(2013-8#1)
people who had##6##3##(1993-2#1)(1996-1#1)(2007-9#1)(2009-6#1)(2012-2#1)(2013-8#1)
people who have been##2##4##(1995-1#1)(1995-12#1)
people who have the##2##4##(1996-2#1)(2008-2#1)
people who have##12##3##(1992-3#1)(1995-1#1)(1995-12#1)(1996-2#1)(2006-10#2)(2008-2#3)(2008-7#1)(2012-11#1)(2012-2#1)
people who live in##2##4##(2007-1#1)(2008-7#1)
people who may be##2##4##(2008-11#1)(2008-7#1)
people who need##2##3##(1996-12#1)(2012-3#1)
people who present##2##3##(2012-12#1)(2013-8#1)
people who take##2##3##(1992-3#1)(1996-2#1)
people who use##2##3##(1994-2#1)(1996-3#1)
people who want to##2##4##(1993-12#1)(2012-12#1)
people who were interviewed##2##4##(2007-2#1)(2013-8#1)
people who were##4##3##(1993-2#1)(2007-2#1)(2007-8#1)(2013-8#1)
people who##92##2##(1991-5#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#2)(1993-12#1)(1993-2#3)(1993-3#2)(1994-1#2)(1994-2#1)(1994-4#1)(1995-1#2)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(2005-3#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-7#1)(2006-9#2)(2007-1#2)(2007-2#2)(2007-3#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#2)(2008-4#1)(2008-7#3)(2009-2#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-3#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#8)
people whose##5##2##(1991-10#1)(1996-2#1)(2008-11#1)(2008-7#1)(2010-7#1)
people will develop##2##3##(2005-6#1)(2013-1#1)
people will##7##2##(1993-5#1)(1994-8#1)(1996-1#1)(1996-5#1)(2005-6#1)(2008-5#1)(2013-1#1)
people with AIDS and##3##4##(1995-6#2)(1996-11#1)
people with AIDS##10##3##(1994-4#1)(1995-12#3)(1995-6#2)(1996-11#1)(1996-2#1)(1996-3#1)(1997-7#1)
people with HIV and AIDS##2##5##(1994-4#1)(1995-12#1)
people with HIV##8##3##(1992-1#1)(1994-4#1)(1995-12#2)(1995-6#2)(1996-6#1)(2012-3#1)
people with HIV/AIDS##4##3##(1992-12#1)(2007-1#2)(2012-11#1)
people with PD##2##3##(2010-10#2)
people with Parkinson's disease##2##4##(2008-11#1)(2011-2#1)
people with Parkinson's##3##3##(2008-11#1)(2010-10#1)(2011-2#1)
people with a learning disability##2##5##(2008-11#2)
people with a##12##3##(1997-8#1)(2006-9#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#1)
people with aphasia##2##3##(2012-3#1)(2013-7#1)
people with bipolar disorder##2##4##(2009-11#2)
people with cancer##4##3##(2005-10#2)(2009-10#1)(2012-2#1)
people with cerebral palsy##2##4##(2012-1#2)
people with chronic illness##3##4##(1997-1#3)
people with chronic##6##3##(1997-1#3)(1997-3#1)(2008-7#1)(2010-8#1)
people with dementia and##2##4##(2011-2#1)(2013-8#1)
people with dementia in residential care##3##6##(2011-2#3)
people with dementia in##5##4##(2011-1#1)(2011-2#3)(2013-8#1)
people with dementia##16##3##(1991-1#1)(2008-6#1)(2011-1#2)(2011-2#7)(2013-8#5)
people with developmental disabilities##5##4##(1997-2#1)(2007-9#4)
people with diabetes mellitus##3##4##(2011-2#2)(2012-12#1)
people with diabetes##15##3##(1997-3#2)(2006-2#2)(2008-6#1)(2009-2#1)(2010-10#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#2)
people with disabilities and##2##4##(2010-12#1)(2012-1#1)
people with disabilities in##3##4##(1995-6#1)(1996-1#1)(2010-2#1)
people with disabilities to##3##4##(2010-2#1)(2011-2#1)(2013-1#1)
people with disabilities were##2##4##(1996-1#1)(2010-2#1)
people with disabilities##26##3##(1995-12#1)(1995-6#2)(1996-1#6)(1997-1#1)(2007-2#1)(2009-6#2)(2010-12#1)(2010-2#6)(2010-7#1)(2011-2#2)(2012-1#2)(2013-1#1)
people with disability##4##3##(1994-7#1)(1996-12#1)(1997-1#2)
people with greater depressive symptoms##3##5##(2010-4#3)
people with high##3##3##(2008-8#1)(2010-2#1)(2013-1#1)
people with impaired##2##3##(2009-3#1)(2010-10#1)
people with medical##2##3##(1995-6#1)(2011-1#1)
people with mental disorders##5##4##(2008-2#3)(2012-11#1)(2012-12#1)
people with mental health problems in the##2##7##(1993-1#1)(2011-1#1)
people with mental health problems##7##5##(1993-1#3)(2008-11#2)(2008-2#1)(2011-1#1)
people with mental health##8##4##(1993-1#3)(2008-11#2)(2008-2#2)(2011-1#1)
people with mental illness##11##4##(2005-9#1)(2006-9#1)(2008-2#3)(2010-9#1)(2011-1#4)(2011-2#1)
people with mental retardation##4##4##(1990-8#1)(1993-3#1)(1997-8#1)(2006-9#1)
people with mental##31##3##(1990-8#1)(1990-9#1)(1993-1#3)(1993-3#1)(1997-8#1)(2005-9#1)(2006-9#2)(2008-11#2)(2008-2#9)(2010-9#1)(2011-1#5)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)
people with physical disabilities##2##4##(1995-12#2)
people with schizophrenia and##2##4##(2009-7#1)(2013-1#1)
people with schizophrenia in##2##4##(2006-9#1)(2009-6#1)
people with schizophrenia##11##3##(1995-11#2)(2006-9#1)(2009-6#1)(2009-7#2)(2011-1#2)(2013-1#3)
people with serious mental##2##4##(2008-2#1)(2011-2#1)
people with severe mental disorders##6##5##(2008-2#6)
people with severe mental illness##6##5##(2008-2#4)(2010-9#2)
people with severe mental##14##4##(2008-2#10)(2010-9#3)(2011-1#1)
people with severe##16##3##(1997-1#2)(2008-2#10)(2010-9#3)(2011-1#1)
people with spinal cord injury (SCI)##2##6##(2008-7#1)(2013-1#1)
people with spinal cord injury##3##5##(2007-7#1)(2008-7#1)(2013-1#1)
people with spinal##4##3##(2007-7#1)(2008-12#1)(2008-7#1)(2013-1#1)
people with the##2##3##(2007-9#1)(2008-3#1)
people with type##4##3##(2008-7#4)
people with##295##2##(1990-8#1)(1990-9#1)(1991-1#2)(1992-1#1)(1992-12#1)(1993-1#5)(1993-2#1)(1993-3#2)(1994-2#2)(1994-4#2)(1994-7#1)(1995-11#2)(1995-12#9)(1995-6#7)(1996-1#6)(1996-11#2)(1996-12#2)(1996-2#4)(1996-3#1)(1996-6#1)(1997-1#8)(1997-2#1)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#3)(2005-10#2)(2005-9#1)(2006-10#1)(2006-2#3)(2006-3#1)(2006-9#4)(2007-1#2)(2007-11#3)(2007-12#1)(2007-2#2)(2007-7#2)(2007-8#1)(2007-9#5)(2008-11#8)(2008-12#3)(2008-2#22)(2008-3#4)(2008-4#2)(2008-6#3)(2008-7#8)(2008-8#2)(2008-9#4)(2009-10#2)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#4)(2009-7#2)(2010-10#7)(2010-11#1)(2010-12#4)(2010-2#7)(2010-4#5)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#6)(2011-1#16)(2011-2#21)(2012-1#10)(2012-11#2)(2012-12#6)(2012-2#2)(2012-3#10)(2013-1#13)(2013-7#4)(2013-8#9)
people within##2##2##(2008-1#1)(2008-12#1)
people without##4##2##(1993-7#1)(2008-2#1)(2008-5#1)(2008-8#1)
people working in##4##3##(2007-2#1)(2010-1#1)(2012-1#2)
people working##5##2##(1996-11#1)(2007-2#1)(2010-1#1)(2012-1#2)
people worldwide and is##2##4##(2008-1#2)
people worldwide and##3##3##(2006-10#1)(2008-1#2)
people worldwide are affected##2##4##(2008-5#1)(2009-11#1)
people worldwide are##4##3##(2006-7#1)(2008-5#1)(2009-11#1)(2013-1#1)
people worldwide##18##2##(2006-10#2)(2006-7#1)(2007-12#1)(2008-1#3)(2008-10#3)(2008-4#2)(2008-5#1)(2009-11#1)(2009-5#1)(2011-1#1)(2012-12#1)(2013-1#1)
people##1687##1##(1990-11#3)(1990-12#7)(1990-2#1)(1990-3#4)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#3)(1990-8#4)(1990-9#1)(1991-1#4)(1991-10#5)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-5#1)(1991-6#5)(1991-7#1)(1991-8#6)(1991-9#2)(1992-1#6)(1992-10#1)(1992-12#5)(1992-2#4)(1992-3#5)(1992-4#1)(1992-5#4)(1992-8#2)(1992-9#3)(1993-1#10)(1993-11#3)(1993-12#3)(1993-2#8)(1993-3#13)(1993-5#5)(1993-6#3)(1993-7#2)(1993-8#1)(1993-9#3)(1994-1#2)(1994-11#1)(1994-12#6)(1994-2#9)(1994-3#5)(1994-4#10)(1994-6#6)(1994-7#3)(1994-8#1)(1994-9#1)(1995-1#9)(1995-10#1)(1995-11#3)(1995-12#13)(1995-2#5)(1995-3#4)(1995-4#2)(1995-5#5)(1995-6#11)(1995-7#1)(1995-8#2)(1995-9#3)(1996-1#14)(1996-11#9)(1996-12#9)(1996-2#10)(1996-3#9)(1996-5#6)(1996-6#4)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#10)(1997-2#2)(1997-3#8)(1997-4#3)(1997-5#4)(1997-6#10)(1997-7#4)(1997-8#12)(2004-11#1)(2004-12#1)(2004-2#1)(2004-3#1)(2004-8#1)(2004-9#3)(2005-1#1)(2005-10#5)(2005-11#1)(2005-3#2)(2005-6#1)(2005-7#2)(2005-8#3)(2005-9#3)(2006-1#3)(2006-10#19)(2006-11#1)(2006-12#7)(2006-2#16)(2006-3#1)(2006-4#11)(2006-6#3)(2006-7#23)(2006-8#6)(2006-9#11)(2007-1#13)(2007-10#4)(2007-11#15)(2007-12#14)(2007-2#26)(2007-3#16)(2007-4#5)(2007-5#5)(2007-6#6)(2007-7#23)(2007-8#9)(2007-9#17)(2008-1#34)(2008-10#38)(2008-11#36)(2008-12#18)(2008-2#52)(2008-3#19)(2008-4#20)(2008-5#20)(2008-6#13)(2008-7#48)(2008-8#15)(2008-9#14)(2009-1#1)(2009-10#11)(2009-11#6)(2009-12#7)(2009-2#4)(2009-3#4)(2009-4#15)(2009-5#12)(2009-6#15)(2009-7#8)(2009-8#3)(2009-9#3)(2010-1#4)(2010-10#44)(2010-11#7)(2010-12#25)(2010-2#15)(2010-3#6)(2010-4#17)(2010-5#8)(2010-7#8)(2010-8#25)(2010-9#11)(2011-1#54)(2011-12#10)(2011-2#95)(2011-7#1)(2012-1#26)(2012-10#1)(2012-11#6)(2012-12#57)(2012-2#31)(2012-3#45)(2013-1#64)(2013-7#20)(2013-8#49)
people&quot##2##1##(2007-7#1)(2013-8#1)
people's attention##2##2##(2009-10#1)(2010-6#1)
people's behaviour##3##2##(2006-12#2)(2012-11#1)
people's health in##2##3##(2006-8#1)(2012-3#1)
people's health##6##2##(1990-11#1)(2006-2#1)(2006-8#1)(2008-8#1)(2010-4#1)(2012-3#1)
people's willingness to##2##3##(1994-3#1)(2013-1#1)
people's##63##1##(1990-11#1)(1992-9#1)(1994-3#1)(1994-6#1)(1994-7#1)(1996-1#1)(1996-8#1)(1997-5#1)(2006-12#2)(2006-2#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#4)(2008-7#1)(2008-8#2)(2009-10#1)(2009-3#1)(2009-9#1)(2010-10#6)(2010-12#1)(2010-2#6)(2010-4#2)(2010-6#3)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
people)##6##1##(2006-4#1)(2009-4#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-8#1)
people?##4##1##(2011-2#3)(2013-1#1)
people]##7##1##(1991-7#1)(1993-9#1)(1996-6#1)(2008-9#1)(2011-2#2)(2013-7#1)
peoples and the##2##3##(1991-9#1)(2008-8#1)
peoples in##6##2##(2008-1#1)(2008-12#1)(2008-7#2)(2009-4#2)
peoples of##4##2##(2007-2#1)(2008-1#1)(2008-8#1)(2010-4#1)
peoples##24##1##(1991-9#1)(1997-4#1)(1997-8#1)(2007-1#1)(2007-2#1)(2007-9#1)(2008-1#3)(2008-12#1)(2008-7#2)(2008-8#2)(2009-4#2)(2010-12#1)(2010-4#1)(2011-1#2)(2012-3#2)(2013-1#2)
peoples'##2##1##(1991-3#1)(2008-11#1)
pepF##4##1##(1994-12#4)
pepO##3##1##(1993-3#3)
pepo##3##1##(2008-10#2)(2011-2#1)
pepo)##4##1##(2008-10#4)
pepper (Capsicum annuum)##2##3##(2008-10#2)
pepper (Capsicum##4##2##(2004-11#1)(2008-10#3)
pepper and##4##2##(2008-10#4)
pepper but##2##2##(2008-10#2)
pepper fruit##2##2##(2008-10#2)
pepper genotype##2##2##(2008-10#2)
pepper genotypes carrying##2##3##(2008-10#2)
pepper genotypes##5##2##(2008-10#5)
pepper huasteco virus##2##3##(2008-10#2)
pepper huasteco##3##2##(2008-10#3)
pepper in the##2##3##(2008-10#2)
pepper leaves##2##2##(2008-10#2)
pepper plants##13##2##(2008-10#13)
pepper tissues##3##2##(2008-10#3)
pepper to##3##2##(2008-10#3)
pepper was##2##2##(2008-10#2)
pepper##110##1##(1997-1#1)(1997-5#1)(1997-6#5)(2004-11#1)(2007-12#5)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#88)(2008-12#1)(2009-3#1)(2011-2#3)(2012-3#1)
pepper)##2##1##(2008-10#2)
peppermint oil##3##2##(2012-2#3)
peppermint##6##1##(2008-10#3)(2012-2#3)
peppers##4##1##(1990-7#1)(1995-11#1)(2008-10#1)(2009-3#1)
pepsin activity##2##2##(1992-12#1)(2008-7#1)
pepsin and trypsin##2##3##(1996-3#2)
pepsin and##6##2##(1996-3#2)(2008-1#1)(2008-10#1)(2010-12#1)(2011-1#1)
pepsin digestion##2##2##(1997-1#1)(2008-4#1)
pepsin secretion in##3##3##(1990-3#1)(1990-5#1)(2006-12#1)
pepsin secretion##7##2##(1990-3#3)(1990-5#1)(1997-1#2)(2006-12#1)
pepsin##43##1##(1990-2#3)(1990-3#4)(1990-5#3)(1992-10#1)(1992-12#1)(1992-4#1)(1992-8#1)(1995-10#1)(1995-3#1)(1996-12#1)(1996-3#4)(1996-5#5)(1997-1#4)(2006-10#2)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-4#2)(2008-7#1)(2010-12#1)(2011-1#1)
pepsin-like aspartic##2##2##(1990-5#1)(2008-4#1)
pepsin-resistant##2##1##(1996-8#1)(1997-1#1)
pepsinogen I##3##2##(2006-2#1)(2007-8#2)
pepsinogen secretion from guinea pig chief cells##3##7##(1995-8#3)
pepsinogen secretion from##5##3##(1995-8#5)
pepsinogen secretion##13##2##(1994-12#2)(1995-8#10)(1997-1#1)
pepsinogen##24##1##(1993-11#1)(1994-12#2)(1995-3#4)(1995-8#10)(1997-1#1)(2005-7#1)(2006-2#1)(2007-8#4)
pepstatin A##8##2##(1990-6#2)(1990-9#1)(1991-1#2)(1991-9#1)(1995-6#1)(1995-8#1)
pepstatin##16##1##(1990-6#2)(1990-9#1)(1991-1#2)(1991-2#2)(1991-6#2)(1991-9#1)(1992-11#1)(1995-10#2)(1995-6#2)(1995-8#1)
pepstatin-agarose##4##1##(1990-8#4)
peptic activity##2##2##(1997-1#2)
peptic ulcer and##2##3##(2008-1#1)(2011-1#1)
peptic ulcer bleeding##2##3##(2013-8#2)
peptic ulcer disease (PUD)##3##4##(2006-10#1)(2006-8#1)(2008-5#1)
peptic ulcer disease and##4##4##(2006-10#2)(2006-2#1)(2008-12#1)
peptic ulcer disease is##2##4##(1997-1#1)(2006-10#1)
peptic ulcer disease patients##5##4##(2007-7#1)(2008-5#4)
peptic ulcer disease##36##3##(1991-5#1)(1992-9#1)(1995-4#1)(1996-2#1)(1997-1#2)(1997-6#1)(2006-10#15)(2006-2#1)(2006-8#2)(2007-7#1)(2007-9#1)(2008-12#2)(2008-5#5)(2008-9#1)(2010-12#1)
peptic ulcer diseases##2##3##(2013-8#2)
peptic ulcer patients##3##3##(1992-9#1)(2006-8#1)(2008-5#1)
peptic ulcer with##2##3##(1991-4#1)(1992-10#1)
peptic ulcer##69##2##(1990-6#1)(1991-4#1)(1991-5#1)(1992-10#3)(1992-8#1)(1992-9#2)(1995-10#2)(1995-4#1)(1996-2#1)(1997-1#2)(1997-6#1)(2006-10#15)(2006-2#2)(2006-8#6)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-9#3)(2008-1#1)(2008-12#3)(2008-5#7)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#1)(2011-1#2)(2012-12#1)(2013-1#1)(2013-8#4)
peptic ulcer]##3##2##(1996-12#1)(2006-6#1)(2007-5#1)
peptic ulcers and##2##3##(1992-3#1)(1996-11#1)
peptic ulcers##13##2##(1990-3#1)(1990-5#1)(1991-11#1)(1991-6#1)(1992-3#1)(1993-8#1)(1995-3#1)(1996-11#2)(2006-6#1)(2008-12#1)(2013-1#1)(2013-8#1)
peptic##96##1##(1990-3#1)(1990-5#2)(1990-6#1)(1991-11#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-10#3)(1992-11#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-8#1)(1995-10#2)(1995-3#1)(1995-4#1)(1996-11#2)(1996-12#1)(1996-2#1)(1997-1#4)(1997-6#1)(2005-12#1)(2006-10#16)(2006-2#3)(2006-6#2)(2006-8#6)(2007-1#1)(2007-2#1)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#1)(2008-12#4)(2008-5#7)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#2)(2011-1#2)(2012-12#1)(2013-1#2)(2013-8#5)
peptidase IV##8##2##(1992-3#1)(1993-8#2)(1997-6#2)(2012-2#2)(2012-3#1)
peptidase activity which##2##3##(1990-11#2)
peptidase activity##10##2##(1990-11#5)(1990-3#5)
peptidase and##4##2##(1991-2#1)(1995-6#1)(2007-7#1)(2008-11#1)
peptidase family##5##2##(1994-12#3)(2008-4#1)(2013-8#1)
peptidase inhibitor##2##2##(1990-11#1)(2008-4#1)
peptidase inhibitors##2##2##(1991-3#1)(1997-4#1)
peptidase##59##1##(1990-11#7)(1990-3#5)(1991-10#1)(1991-11#1)(1991-2#3)(1991-3#2)(1992-3#1)(1992-9#1)(1993-12#3)(1993-8#2)(1994-12#5)(1995-6#1)(1997-4#1)(1997-6#2)(1997-7#4)(2007-7#1)(2008-10#4)(2008-11#1)(2008-4#5)(2008-5#4)(2008-9#1)(2012-2#2)(2012-3#1)(2013-8#1)
peptidase-4##3##1##(2010-4#1)(2011-2#1)(2013-1#1)
peptidases are##2##2##(1996-2#1)(2008-5#1)
peptidases in crude##2##3##(2008-4#1)(2010-3#1)
peptidases in the##2##3##(1990-11#1)(1996-2#1)
peptidases in##9##2##(1990-11#1)(1992-11#1)(1996-2#1)(2008-4#5)(2010-3#1)
peptidases that##2##2##(1991-3#1)(1996-2#1)
peptidases##26##1##(1990-11#2)(1991-2#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-5#1)(1994-8#1)(1996-2#3)(2005-8#1)(2006-12#2)(2008-4#8)(2008-5#2)(2008-6#1)(2010-3#1)
peptide (A##2##2##(1990-9#1)(1994-8#1)
peptide (CGRP) in##2##3##(1990-7#1)(1991-9#1)
peptide (CGRP) on##2##3##(1997-5#1)(2007-2#1)
peptide (CGRP)##29##2##(1990-10#1)(1990-6#1)(1990-7#1)(1991-2#2)(1991-8#1)(1991-9#2)(1992-8#2)(1992-9#1)(1993-11#2)(1993-3#1)(1994-5#1)(1995-5#1)(1995-8#1)(1996-3#1)(1997-3#2)(1997-4#1)(1997-5#1)(2004-3#1)(2006-10#1)(2006-9#1)(2007-2#1)(2008-4#2)(2012-3#1)
peptide (MAP)##4##2##(1995-2#1)(2008-4#3)
peptide (PTHrP)##2##2##(1993-3#1)(2013-7#1)
peptide (PTHrP)-responsive dual signal transduction systems##2##6##(1994-2#1)(1994-3#1)
peptide (SFLLRNPNDKYEPF##2##2##(1992-4#1)(1994-3#1)
peptide (beta/A4)##2##2##(1991-5#1)(1994-5#1)
peptide (residues##2##2##(1992-9#1)(1995-1#1)
peptide 1##8##2##(1992-8#1)(1993-11#1)(1994-11#1)(1994-2#1)(1995-8#1)(2006-10#1)(2007-5#1)(2012-3#1)
peptide 14##3##2##(1993-8#3)
peptide 2##3##2##(1992-8#1)(1994-12#1)(2006-10#1)
peptide 3##3##2##(1990-10#1)(1992-8#1)(1995-2#1)
peptide 4##2##2##(1994-9#1)(1995-2#1)
peptide 77-3##2##2##(2008-10#2)
peptide A##2##2##(1990-9#1)(1995-3#1)
peptide C28W##3##2##(1992-3#3)
peptide IR(TM)-AA was##2##3##(1994-11#2)
peptide IR(TM)-AA##3##2##(1994-11#3)
peptide IR(TM)-GP##4##2##(1994-11#4)
peptide Ile88-Arg105##2##2##(1992-11#2)
peptide Ile88-Lys121##3##2##(1992-11#3)
peptide P1##2##2##(1990-5#1)(1996-12#1)
peptide YY (PYY)##3##3##(1990-6#1)(1990-8#1)(2012-3#1)
peptide YY and##2##3##(1997-5#1)(2006-10#1)
peptide YY##11##2##(1990-6#2)(1990-8#2)(1993-3#1)(1996-12#3)(1997-5#1)(2006-10#1)(2012-3#1)
peptide abolishes##2##2##(1993-11#1)(1995-10#1)
peptide activity##2##2##(1992-4#1)(2008-10#1)
peptide aggregation##3##2##(1994-5#1)(2011-1#2)
peptide agonist##3##2##(1993-6#1)(1994-6#1)(1996-12#1)
peptide alone##3##2##(1991-8#1)(1993-6#1)(1997-4#1)
peptide also##8##2##(1991-2#1)(1991-5#1)(1991-7#1)(1992-5#1)(1992-9#1)(1994-9#1)(2008-12#1)(2008-3#1)
peptide amidation##2##2##(1990-9#1)(1992-8#1)
peptide amide##3##2##(1992-8#1)(1994-5#1)(2008-3#1)
peptide amino acid##2##3##(1993-1#1)(1995-1#1)
peptide amphiphile nanofibers##2##3##(2008-5#1)(2009-5#1)
peptide amphiphile##3##2##(2008-5#2)(2009-5#1)
peptide analog of the##2##4##(1992-12#1)(1995-6#1)
peptide analog of##3##3##(1992-12#1)(1995-6#1)(1996-9#1)
peptide analogs have##2##3##(1993-9#1)(1997-7#1)
peptide analogs of the##4##4##(1990-4#1)(1992-5#1)(1992-9#1)(2008-10#1)
peptide analogs##12##2##(1990-4#2)(1991-3#1)(1992-5#1)(1992-9#2)(1993-9#2)(1994-9#1)(1995-5#1)(1997-7#1)(2008-10#1)
peptide analogue##4##2##(1990-10#1)(1991-9#1)(1992-11#1)(1992-8#1)
peptide analogues with##2##3##(1990-2#1)(1996-8#1)
peptide analogues##7##2##(1990-2#1)(1991-9#2)(1992-5#1)(1993-5#1)(1996-8#2)
peptide analysis##2##2##(1991-7#1)(2010-1#1)
peptide and a##7##3##(1991-10#1)(1992-7#1)(1992-8#1)(1995-2#1)(1997-4#1)(2008-11#2)
peptide and azatyrosine##2##3##(1991-12#2)
peptide and its##4##3##(1991-8#1)(1993-11#1)(1996-12#1)(2006-12#1)
peptide and mRNA levels##3##4##(1991-2#2)(1995-10#1)
peptide and non-peptide##2##3##(1996-12#1)(2005-7#1)
peptide and nonpeptide##2##3##(1992-12#1)(1993-9#1)
peptide and protein##5##3##(1991-3#2)(1992-6#1)(2010-1#1)(2010-7#1)
peptide and the##16##3##(1990-10#1)(1990-12#2)(1990-6#1)(1991-2#2)(1993-12#1)(1993-3#2)(1993-4#1)(1995-5#2)(2008-10#1)(2009-6#1)(2010-6#1)(2012-2#1)
peptide and to##2##3##(1990-2#1)(1994-10#1)
peptide and##106##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#3)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#3)(1991-12#2)(1991-2#5)(1991-3#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#2)(1993-3#2)(1993-4#1)(1993-8#2)(1993-9#4)(1994-10#2)(1994-11#2)(1994-12#1)(1994-3#1)(1995-10#2)(1995-2#1)(1995-3#1)(1995-5#2)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-12#2)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#7)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
peptide antagonist##2##2##(1996-12#1)(1997-7#1)
peptide antagonists of##2##3##(1993-3#1)(2005-8#1)
peptide antagonists##3##2##(1993-3#2)(2005-8#1)
peptide antibiotic##3##2##(1991-1#1)(1996-5#2)
peptide antibiotics##8##2##(1992-10#1)(1994-2#1)(1994-6#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)
peptide antibodies raised in two rabbits##2##6##(1991-9#2)
peptide antibodies##4##2##(1990-12#1)(1991-9#2)(1997-4#1)
peptide antibody##2##2##(1994-3#1)(2013-8#1)
peptide antigen##5##2##(1992-8#1)(1994-12#1)(1995-5#1)(2008-11#1)(2008-4#1)
peptide antigenicity##3##2##(1997-6#3)
peptide antigens##7##2##(1990-5#1)(1991-12#1)(1992-8#1)(1995-8#1)(2008-4#2)(2009-9#1)
peptide appears##2##2##(1995-2#1)(2012-12#1)
peptide are##5##2##(1991-1#1)(1991-4#1)(1994-6#1)(1995-8#1)(1997-4#1)
peptide as a##4##3##(2006-10#2)(2008-3#1)(2010-10#1)
peptide as an##2##3##(1992-6#1)(2010-10#1)
peptide as the##2##3##(1991-7#1)(1995-2#1)
peptide as##14##2##(1991-2#1)(1991-7#1)(1992-6#2)(1993-2#1)(1994-2#1)(1994-5#1)(1995-2#1)(2006-10#2)(2008-10#1)(2008-3#1)(2010-10#2)
peptide associated with the##2##4##(1990-11#1)(1990-2#1)
peptide at the##8##3##(1990-12#1)(1991-7#1)(1992-4#1)(1992-9#1)(1993-3#1)(1994-9#1)(1995-2#1)(1996-12#1)
peptide at##13##2##(1990-12#1)(1991-5#1)(1991-7#1)(1992-4#1)(1992-9#1)(1993-3#1)(1994-9#1)(1995-2#1)(1996-12#1)(1997-4#1)(1997-6#1)(2009-10#1)(2013-1#1)
peptide backbone##15##2##(1990-8#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-11#3)(1994-3#1)(1995-10#1)(1997-7#1)(2007-10#1)(2008-4#3)(2010-5#1)
peptide based##2##2##(1990-4#1)(1993-3#1)
peptide binding to MHC##2##4##(1995-5#1)(2008-4#1)
peptide binding to##6##3##(1993-3#1)(1995-5#1)(1995-8#1)(2007-6#2)(2008-4#1)
peptide binding##19##2##(1991-7#4)(1992-11#1)(1993-11#1)(1993-3#1)(1995-5#1)(1995-8#3)(1996-3#1)(1996-8#1)(2007-6#3)(2008-4#2)(2008-7#1)
peptide binds to##2##3##(1990-4#1)(1993-3#1)
peptide binds##3##2##(1990-4#1)(1993-3#1)(1995-3#1)
peptide bioregulator##2##2##(2010-12#2)
peptide bond and##2##3##(1997-2#1)(2008-10#1)
peptide bond at##2##3##(1995-6#1)(2008-9#1)
peptide bond in##2##3##(1993-11#1)(1994-9#1)
peptide bond##31##2##(1990-10#1)(1990-12#1)(1990-2#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#2)(1992-8#1)(1993-11#2)(1994-12#1)(1994-9#2)(1995-3#1)(1995-6#1)(1997-2#2)(2006-12#2)(2008-10#3)(2008-9#2)(2012-3#1)
peptide bonds at##3##3##(1991-3#2)(2006-12#1)
peptide bonds in##2##3##(1990-10#1)(1991-4#1)
peptide bonds##18##2##(1990-10#1)(1991-1#2)(1991-2#1)(1991-3#2)(1991-4#2)(1992-9#1)(1994-12#1)(1994-5#1)(1995-1#1)(1996-5#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-4#2)
peptide bound to##2##3##(1995-3#1)(1995-8#1)
peptide bound##3##2##(1992-12#1)(1995-3#1)(1995-8#1)
peptide but##6##2##(1991-7#1)(1992-8#1)(1994-2#1)(1995-1#1)(1995-2#1)(2012-12#1)
peptide by##12##2##(1990-11#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-3#1)(1993-11#1)(1993-4#1)(1993-5#1)(1994-2#1)(1995-5#1)(1996-9#1)
peptide can be##3##3##(1992-10#1)(1996-2#1)(2010-2#1)
peptide can##7##2##(1992-10#1)(1996-2#1)(1997-4#1)(2005-11#1)(2008-4#1)(2008-8#1)(2010-2#1)
peptide causes##3##2##(1992-12#1)(1993-3#1)(1994-9#1)
peptide chain and##2##3##(1991-6#1)(1996-12#1)
peptide chain##12##2##(1990-5#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-3#2)(1993-11#1)(1994-9#1)(1996-12#1)
peptide chains##8##2##(1990-7#1)(1993-9#2)(1995-3#1)(1996-2#1)(2006-12#2)(2008-4#1)
peptide clearance##3##2##(1995-2#1)(1995-3#1)(2007-11#1)
peptide coding sequence##2##3##(1990-4#1)(1992-12#1)
peptide combinatorial libraries##3##3##(1997-3#2)(2008-4#1)
peptide competes##2##2##(1995-3#2)
peptide complex##3##2##(1990-12#1)(2005-7#1)(2008-2#1)
peptide composed of##3##3##(1990-5#1)(1995-6#1)(2008-10#1)
peptide compounds##2##2##(2008-10#1)(2008-3#1)
peptide comprising residues##4##3##(1991-7#4)
peptide comprising##5##2##(1991-7#4)(1995-12#1)
peptide concentration and##2##3##(1991-4#1)(1996-8#1)
peptide concentration in##3##3##(1992-8#1)(1995-10#1)(2012-2#1)
peptide concentration##11##2##(1991-2#1)(1991-4#2)(1992-8#2)(1994-12#1)(1995-10#1)(1996-8#1)(2005-12#1)(2008-5#1)(2012-2#1)
peptide concentrations##9##2##(1990-11#1)(1992-4#1)(1993-6#2)(1994-9#1)(2005-3#1)(2008-10#1)(2009-5#1)(2012-2#1)
peptide conformation##5##2##(1991-11#1)(1991-7#1)(1992-6#1)(1995-3#2)
peptide consisting of##2##3##(1995-5#1)(1997-8#1)
peptide containing the##3##3##(1991-7#1)(1991-9#1)(1995-2#1)
peptide containing##10##2##(1991-10#1)(1991-7#1)(1991-9#1)(1992-9#1)(1994-12#1)(1995-2#3)(2006-12#1)(2010-7#1)
peptide content in##2##3##(1995-10#2)
peptide content##4##2##(1992-3#1)(1993-11#1)(1995-10#2)
peptide corresponding to residues##11##4##(1990-9#1)(1991-12#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-5#2)(2006-12#1)
peptide corresponding to the N-terminal##3##5##(1991-7#2)(1993-11#1)
peptide corresponding to the##14##4##(1990-11#1)(1990-2#1)(1991-5#1)(1991-7#2)(1992-12#2)(1993-11#1)(1993-7#1)(1994-9#1)(1995-2#2)(1997-4#1)(1997-5#1)
peptide corresponding to this##4##4##(1992-3#1)(1994-5#1)(1994-9#1)(1997-4#1)
peptide corresponding to##34##3##(1990-11#1)(1990-2#1)(1990-9#2)(1991-12#1)(1991-5#1)(1991-7#2)(1992-12#2)(1992-3#1)(1993-11#1)(1993-7#1)(1994-12#1)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-2#3)(1996-5#2)(1997-4#2)(1997-5#1)(2006-12#1)(2010-11#1)
peptide could be##3##3##(1995-11#1)(1995-5#1)(1996-5#1)
peptide could##4##2##(1991-2#1)(1995-11#1)(1995-5#1)(1996-5#1)
peptide coupled##2##2##(1992-12#1)(1994-12#1)
peptide deformylase##6##2##(2005-11#3)(2008-5#3)
peptide deltorphin##3##2##(1995-3#2)(2010-12#1)
peptide demonstrated##2##2##(1991-1#1)(1991-2#1)
peptide demonstrates that##2##3##(1992-7#1)(1997-4#1)
peptide derivatives##4##2##(1997-2#1)(2006-12#1)(2009-12#1)(2010-6#1)
peptide derived from a##2##4##(1990-7#1)(1993-3#1)
peptide derived from the##10##4##(1990-11#1)(1991-2#3)(1991-9#1)(1993-3#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-5#1)
peptide derived from##14##3##(1990-11#1)(1990-7#1)(1991-2#3)(1991-9#1)(1992-6#1)(1993-3#2)(1994-9#1)(1995-2#1)(1995-3#1)(1996-5#1)(2013-1#1)
peptide derived##15##2##(1990-11#1)(1990-7#1)(1991-10#1)(1991-2#3)(1991-9#1)(1992-6#1)(1993-3#2)(1994-9#1)(1995-2#1)(1995-3#1)(1996-5#1)(2013-1#1)
peptide destabilizes##2##2##(1996-7#1)(1997-7#1)
peptide did not##4##3##(1991-10#1)(1991-7#1)(1995-3#1)(2008-5#1)
peptide did##5##2##(1991-10#1)(1991-7#1)(1994-12#1)(1995-3#1)(2008-5#1)
peptide dissociation##3##2##(1994-11#1)(2008-4#2)
peptide dissolved in##2##3##(1992-3#1)(1992-8#1)
peptide drugs##4##2##(1994-12#1)(2008-5#2)(2012-2#1)
peptide during##5##2##(1990-3#1)(1993-11#1)(1993-12#1)(1997-4#1)(2010-12#1)
peptide encoded by##4##3##(1990-12#1)(1992-8#1)(1993-8#1)(2008-8#1)
peptide encoded##5##2##(1990-12#1)(1992-8#1)(1993-8#1)(1995-10#1)(2008-8#1)
peptide encoding##2##2##(1995-6#1)(2008-4#1)
peptide epitope##4##2##(1990-5#1)(1991-7#1)(2006-12#1)(2006-6#1)
peptide exclusively##2##2##(1996-5#1)(1996-8#1)
peptide exposure##2##2##(1993-3#1)(1993-5#1)
peptide expressed in##3##3##(1996-12#1)(2005-11#2)
peptide expressed##4##2##(1992-3#1)(1996-12#1)(2005-11#2)
peptide expression in##2##3##(1995-12#1)(2010-12#1)
peptide expression##3##2##(1995-12#1)(2010-12#1)(2011-2#1)
peptide family##7##2##(1990-2#1)(1990-7#1)(1991-3#1)(1992-11#1)(1997-6#2)(1997-7#1)
peptide folding##2##2##(2008-8#1)(2010-5#1)
peptide for peroxisomal targeting##2##4##(1991-12#1)(1992-7#1)
peptide for the##2##3##(1994-8#1)(1995-6#1)
peptide for##13##2##(1991-12#1)(1991-2#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-7#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-6#1)(2007-11#1)(2009-9#1)
peptide found in##2##3##(1991-8#1)(2008-6#1)
peptide found##3##2##(1991-8#1)(1996-12#1)(2008-6#1)
peptide fragment 828-848##2##3##(1993-3#2)
peptide fragment##18##2##(1991-7#1)(1992-6#2)(1993-3#2)(1993-5#1)(1993-8#1)(1994-10#1)(1994-11#2)(1995-2#1)(1995-3#1)(1997-8#1)(2007-8#1)(2008-10#1)(2009-3#1)(2010-4#1)(2011-1#1)
peptide fragments and##2##3##(1993-11#1)(1995-1#1)
peptide fragments corresponding to##2##4##(1993-6#1)(1994-5#1)
peptide fragments derived##2##3##(1991-7#1)(1994-8#1)
peptide fragments in##2##3##(1996-5#1)(2008-7#1)
peptide fragments of PARP-1##2##4##(2006-12#2)
peptide fragments of the##2##4##(1991-7#1)(1994-11#1)
peptide fragments of##12##3##(1990-11#1)(1991-2#1)(1991-7#1)(1993-6#3)(1994-11#2)(1996-5#1)(2006-12#2)(2007-8#1)
peptide fragments were prepared##2##4##(1992-11#1)(2008-8#1)
peptide fragments were##5##3##(1992-11#1)(1992-7#1)(1996-5#1)(1997-4#1)(2008-8#1)
peptide fragments with##3##3##(1991-8#1)(1993-8#1)(2006-12#1)
peptide fragments##51##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-2#3)(1991-7#5)(1991-8#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-5#1)(1993-6#5)(1993-8#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-5#3)(1996-8#1)(1997-1#2)(1997-4#2)(1997-8#1)(2006-12#3)(2007-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#2)(2011-12#1)
peptide from a##4##3##(1992-12#2)(1992-4#1)(1994-3#1)
peptide from the##10##3##(1990-11#1)(1991-12#2)(1994-9#1)(1995-2#1)(1995-3#1)(1997-4#1)(2005-7#1)(2008-10#1)(2011-1#1)
peptide from##38##2##(1990-11#3)(1990-12#2)(1991-12#2)(1991-2#1)(1992-11#2)(1992-12#3)(1992-4#2)(1992-6#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-5#2)(1996-6#1)(1997-4#1)(1997-8#1)(2005-7#1)(2006-12#3)(2008-10#1)(2008-4#1)(2011-1#1)
peptide functioning##2##2##(1991-3#1)(1996-4#1)
peptide gene##3##2##(2008-8#1)(2010-12#2)
peptide growth factor##2##3##(1991-5#1)(1993-4#1)
peptide growth factors##4##3##(1991-12#1)(1994-2#1)(1994-8#1)(1995-2#1)
peptide growth##6##2##(1991-12#1)(1991-5#1)(1993-4#1)(1994-2#1)(1994-8#1)(1995-2#1)
peptide had no##2##3##(1993-11#1)(1995-6#1)
peptide had##6##2##(1991-9#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1995-6#1)
peptide has a##2##3##(1991-1#1)(1995-5#1)
peptide has been##9##3##(1990-8#1)(1991-10#1)(1991-7#1)(1993-6#2)(1994-3#1)(1995-10#1)(1997-8#1)(2008-1#1)
peptide has##14##2##(1990-3#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-7#1)(1992-7#1)(1993-6#2)(1994-3#1)(1995-10#1)(1995-5#1)(1997-8#1)(2008-1#1)(2010-12#1)
peptide histidine isoleucine (PHI)##2##4##(1992-9#1)(1993-3#1)
peptide histidine isoleucineamide##2##3##(1996-5#2)
peptide histidine##4##2##(1992-9#1)(1993-3#1)(1996-5#2)
peptide homologous to##2##3##(1991-9#1)(1994-12#1)
peptide hormone and neuropeptide precursors##2##5##(1996-4#2)
peptide hormone##13##2##(1992-6#2)(1994-11#1)(1995-12#2)(1996-4#3)(2006-10#1)(2006-6#1)(2008-8#1)(2011-1#1)(2012-3#1)
peptide hormones as##2##3##(1996-11#1)(2011-1#1)
peptide hormones in##2##3##(1990-3#1)(1996-10#1)
peptide hormones##18##2##(1990-3#1)(1990-5#2)(1993-5#1)(1994-12#1)(1995-9#1)(1996-10#1)(1996-11#2)(1996-5#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-4#1)(2010-4#1)(2011-1#2)(2012-12#1)
peptide identical to##2##3##(1990-5#1)(1995-3#1)
peptide identical##3##2##(1990-5#1)(1993-12#1)(1995-3#1)
peptide identification##2##2##(2008-4#1)(2010-7#1)
peptide in a##4##3##(1990-7#1)(1991-7#1)(1995-8#1)(2008-9#1)
peptide in brain##2##3##(1991-10#1)(1991-8#1)
peptide in human##3##3##(1991-1#1)(1992-6#1)(1994-12#1)
peptide in rat##4##3##(1991-5#1)(1992-6#1)(1993-3#1)(1995-5#1)
peptide in the brain##3##4##(1992-6#2)(2008-6#1)
peptide in the central nervous system##2##6##(1992-6#1)(2005-10#1)
peptide in the central##3##4##(1992-6#2)(2005-10#1)
peptide in the rat##3##4##(1990-11#1)(1992-6#2)
peptide in the regulation of##3##5##(1992-6#3)
peptide in the##26##3##(1990-11#1)(1991-10#1)(1992-11#1)(1992-5#1)(1992-6#10)(1992-9#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-11#1)(1996-4#1)(1996-5#1)(2005-10#1)(2006-10#1)(2008-10#2)(2008-6#1)
peptide in##84##2##(1990-11#1)(1990-12#1)(1990-7#2)(1991-1#2)(1991-10#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#5)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#17)(1992-9#2)(1993-11#1)(1993-3#2)(1993-6#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-4#1)(1996-5#3)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-10#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-4#2)(2012-3#1)
peptide incorporated##2##2##(1990-5#1)(2008-10#1)
peptide increased the##3##3##(1992-12#1)(1994-12#1)(2008-5#1)
peptide increased##4##2##(1992-12#1)(1994-12#1)(2008-5#2)
peptide increases##2##2##(1995-12#1)(1995-8#1)
peptide indicated that the##2##4##(1992-4#1)(1995-5#1)
peptide indicated that##3##3##(1992-4#1)(1992-5#1)(1995-5#1)
peptide induces##2##2##(1990-11#1)(1994-12#1)
peptide inhibited the##2##3##(1995-6#1)(1996-12#1)
peptide inhibited##7##2##(1991-10#1)(1991-5#1)(1995-11#1)(1995-6#1)(1996-12#1)(2008-10#1)(2013-7#1)
peptide inhibitor##4##2##(1991-2#1)(2008-11#1)(2009-6#2)
peptide inhibitors of##3##3##(1990-7#1)(1991-2#1)(1994-6#1)
peptide inhibitors##7##2##(1990-2#1)(1990-7#1)(1991-2#1)(1991-6#1)(1994-6#1)(2008-4#1)(2013-1#1)
peptide inhibits##2##2##(1993-8#1)(1996-2#1)
peptide inserted##2##2##(1991-3#1)(1992-12#1)
peptide interactions##3##2##(1990-12#1)(2008-1#1)(2008-9#1)
peptide interacts with the##2##4##(1991-10#1)(1992-12#1)
peptide interacts##3##2##(1991-10#1)(1992-12#1)(1997-4#1)
peptide into##2##2##(1994-10#1)(1996-12#1)
peptide involved in##2##3##(2008-10#1)(2008-3#1)
peptide ion##2##2##(2006-4#1)(2008-9#1)
peptide ions via interaction with##2##5##(2009-12#2)
peptide ions##3##2##(2006-4#1)(2009-12#2)
peptide is a##8##3##(1990-3#1)(1992-6#2)(1992-8#1)(1993-3#1)(1995-5#1)(1996-9#1)(2009-6#1)
peptide is able to##2##4##(1994-5#1)(2008-10#1)
peptide is an##2##3##(1994-11#1)(2012-2#1)
peptide is not##3##3##(1990-11#1)(1994-5#1)(1994-9#1)
peptide is released from##2##4##(1992-6#1)(2008-3#1)
peptide is##54##2##(1990-11#3)(1990-2#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-5#1)(1992-2#1)(1992-5#1)(1992-6#7)(1992-8#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#5)(1994-2#2)(1994-5#3)(1994-9#1)(1995-1#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-4#1)(2005-11#1)(2008-10#1)(2008-3#2)(2008-6#1)(2008-8#2)(2009-6#1)(2012-2#2)
peptide isolated from the##5##4##(1990-7#1)(1992-9#1)(1993-6#1)(1996-2#1)(2009-5#1)
peptide isolated from##7##3##(1990-7#2)(1991-2#1)(1992-9#1)(1993-6#1)(1996-2#1)(2009-5#1)
peptide isolated##8##2##(1990-7#2)(1991-2#1)(1992-9#2)(1993-6#1)(1996-2#1)(2009-5#1)
peptide levels in the##2##4##(1995-5#1)(2008-3#1)
peptide levels were##2##3##(1995-10#1)(2011-2#1)
peptide levels##14##2##(1991-10#1)(1995-10#3)(1995-5#2)(2007-10#1)(2008-3#1)(2011-2#1)(2012-2#5)
peptide libraries are##2##3##(2008-4#2)
peptide libraries##15##2##(1994-12#2)(1994-9#2)(1995-11#5)(1995-5#2)(2008-1#1)(2008-4#2)(2013-1#1)
peptide library and##2##3##(1997-2#1)(2008-8#1)
peptide library##10##2##(1994-9#1)(1996-9#2)(1997-2#1)(2005-11#1)(2007-2#1)(2008-10#2)(2008-8#2)
peptide ligand##2##2##(1996-2#1)(2005-7#1)
peptide ligands to##2##3##(1995-3#1)(2008-4#1)
peptide ligands##16##2##(1991-5#1)(1992-12#1)(1994-11#1)(1994-9#1)(1995-11#3)(1995-3#1)(2008-1#1)(2008-4#3)(2008-8#1)(2009-8#1)(2012-11#1)(2012-2#1)
peptide ligase activity##2##3##(1991-4#2)
peptide linker##2##2##(1994-9#1)(2009-9#1)
peptide mRNA##2##2##(1992-12#1)(1995-5#1)
peptide map of##3##3##(1995-2#2)(1997-6#1)
peptide map##7##2##(1990-11#1)(1990-8#1)(1992-7#1)(1992-9#1)(1995-2#2)(1997-6#1)
peptide mapping and##5##3##(1990-5#1)(1991-4#1)(1991-5#1)(1993-4#1)(1994-11#1)
peptide mapping indicated##2##3##(1991-10#1)(1992-1#1)
peptide mapping of##5##3##(1990-7#1)(1991-10#1)(1995-8#1)(1996-5#2)
peptide mapping##24##2##(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#2)(1991-4#2)(1991-5#1)(1992-1#1)(1992-11#1)(1992-9#1)(1993-4#1)(1994-11#1)(1995-5#1)(1995-8#1)(1996-5#3)(1996-7#1)(2008-10#1)(2008-4#2)
peptide maps of##2##3##(1991-2#1)(1996-5#1)
peptide maps##5##2##(1990-8#1)(1991-2#1)(1991-4#1)(1996-5#1)(2008-10#1)
peptide mass fingerprinting##3##3##(2007-12#1)(2007-5#1)(2008-4#1)
peptide mass##5##2##(2007-12#1)(2007-5#1)(2008-4#1)(2008-7#2)
peptide material##3##2##(2005-11#3)
peptide may be responsible for##2##5##(1995-12#1)(2006-4#1)
peptide may be##7##3##(1991-10#1)(1993-3#1)(1995-12#1)(2005-9#1)(2006-10#1)(2006-4#1)(2009-5#1)
peptide may##9##2##(1991-10#1)(1992-12#1)(1993-3#1)(1995-12#1)(2005-9#1)(2006-10#1)(2006-4#1)(2009-5#1)(2013-1#1)
peptide mimetics##3##2##(1992-5#1)(2006-12#1)(2008-5#1)
peptide mimicking the##2##3##(1991-12#1)(2010-12#1)
peptide mitogen##2##2##(1990-12#1)(1991-5#1)
peptide mixtures of##2##3##(2008-7#1)(2012-12#1)
peptide mixtures##9##2##(1994-9#1)(1995-3#1)(1996-5#1)(1997-2#1)(2004-12#2)(2007-8#1)(2008-7#1)(2012-12#1)
peptide model##2##2##(1993-6#1)(2009-7#1)
peptide modifiers##4##2##(2012-3#4)
peptide modules##3##2##(1997-6#2)(2007-6#1)
peptide motif##3##2##(1990-7#2)(1997-7#1)
peptide motifs##6##2##(1994-9#1)(1995-8#1)(1997-2#1)(2010-2#1)(2012-2#1)(2013-1#1)
peptide nanotubes##4##2##(2006-2#1)(2008-10#1)(2008-7#2)
peptide neurotransmitter##2##2##(1990-5#1)(1995-2#1)
peptide neurotransmitters##3##2##(1992-6#1)(1995-12#1)(2013-1#1)
peptide nitriles##2##2##(2007-6#2)
peptide nucleic acid (PNA)##3##4##(2007-10#1)(2008-1#1)(2008-4#1)
peptide nucleic acid##4##3##(1996-5#1)(2007-10#1)(2008-1#1)(2008-4#1)
peptide nucleic acids (PNAs)##3##4##(1996-5#1)(2005-7#1)(2008-4#1)
peptide nucleic acids##6##3##(1996-5#1)(2005-7#1)(2007-11#1)(2008-4#2)(2008-5#1)
peptide nucleic##10##2##(1996-5#2)(2005-7#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-4#3)(2008-5#1)
peptide of 20 amino acids##2##5##(1991-2#1)(1992-2#1)
peptide of 22 residues##2##4##(1990-7#1)(1994-12#1)
peptide of 22##4##3##(1990-7#1)(1993-2#1)(1994-12#1)(1995-2#1)
peptide of 39##2##3##(1995-6#1)(2010-10#1)
peptide of a##2##3##(1994-12#1)(1994-2#1)
peptide of interest##3##3##(2008-4#2)(2008-9#1)
peptide of the silkmoth Bombyx mori##2##6##(1996-6#2)
peptide of the##16##3##(1990-12#1)(1990-3#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-7#1)(1993-4#1)(1994-2#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-8#1)(1996-6#2)(2008-10#1)(2010-12#1)
peptide of unknown function##2##4##(1990-7#1)(1992-12#1)
peptide of which the##2##4##(2006-1#1)(2008-9#1)
peptide of##88##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#4)(1990-8#1)(1991-2#5)(1991-3#2)(1991-5#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-4#2)(1992-5#1)(1992-7#2)(1992-8#2)(1993-2#2)(1993-4#1)(1993-6#1)(1993-8#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-8#1)(1994-9#2)(1995-10#2)(1995-2#2)(1995-6#3)(1995-8#1)(1996-10#1)(1996-6#2)(1997-2#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-11#1)(2008-10#1)(2008-11#2)(2008-4#3)(2008-5#1)(2008-8#3)(2008-9#3)(2010-10#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
peptide on the##3##3##(1994-12#1)(2011-2#1)(2012-1#1)
peptide on##12##2##(1990-2#1)(1990-6#1)(1991-2#1)(1991-5#1)(1992-6#2)(1994-12#1)(1996-7#1)(1997-5#1)(2008-5#1)(2011-2#1)(2012-1#1)
peptide or a##2##3##(1991-7#1)(1994-3#1)
peptide or protein##2##3##(1994-3#1)(1995-4#1)
peptide or##12##2##(1991-7#1)(1994-3#2)(1995-4#1)(1995-5#1)(1997-3#1)(1997-4#2)(2008-7#1)(2008-8#1)(2010-10#1)(2010-5#1)
peptide pGlu-Glu-ProNH2##2##2##(1991-12#2)
peptide part##4##2##(1990-12#3)(1994-8#1)
peptide penetrates##2##2##(1992-3#1)(1997-4#1)
peptide phosphorylated##2##2##(1990-11#1)(1991-7#1)
peptide polymorphism was##2##3##(1997-8#2)
peptide polymorphism##4##2##(1996-9#1)(1997-8#3)
peptide precedes the##2##3##(1990-12#1)(1990-9#1)
peptide precursor##4##2##(1990-9#1)(1992-7#2)(1995-5#1)
peptide precursors and##2##3##(1996-2#1)(2012-2#1)
peptide preparations##3##2##(1996-3#2)(2004-12#1)
peptide previously isolated from##2##4##(1994-5#1)(2011-2#1)
peptide processing##2##2##(1993-12#1)(1993-5#1)
peptide products##3##2##(1996-8#1)(2006-12#1)(2009-12#1)
peptide reacted with##2##3##(1993-11#1)(2008-10#1)
peptide reactivity##2##2##(1996-11#1)(1996-5#1)
peptide receptor in##4##3##(1991-8#2)(1992-6#1)(1994-12#1)
peptide receptor##17##2##(1990-12#1)(1991-8#2)(1992-3#1)(1992-6#2)(1994-12#1)(1994-3#1)(1995-3#1)(1996-5#4)(2005-8#1)(2008-11#1)(2010-6#1)(2013-1#1)
peptide receptors in human##2##4##(1992-6#1)(1994-3#1)
peptide receptors in##3##3##(1990-3#1)(1992-6#1)(1994-3#1)
peptide receptors##11##2##(1990-11#1)(1990-12#1)(1990-3#1)(1992-11#2)(1992-6#2)(1994-10#1)(1994-3#1)(1994-9#1)(1995-3#1)
peptide region##2##2##(1992-12#1)(1993-11#1)
peptide release##8##2##(1992-6#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-5#2)(2008-7#1)(2012-12#1)
peptide representing the##3##3##(1995-11#1)(1996-5#1)(1997-4#1)
peptide representing##5##2##(1995-11#1)(1996-5#1)(1997-4#1)(2013-7#2)
peptide residues##5##2##(1990-10#2)(2006-12#1)(2008-4#1)(2009-12#1)
peptide resulted in a##2##4##(1991-7#1)(2008-10#1)
peptide resulted in##3##3##(1991-7#1)(1992-5#1)(2008-10#1)
peptide revealed##2##2##(1991-9#1)(1997-6#1)
peptide ring##3##2##(1994-2#1)(1996-8#1)(2006-10#1)
peptide secreted by the##2##4##(1991-1#1)(1991-6#1)
peptide secreted##3##2##(1991-1#1)(1991-12#1)(1991-6#1)
peptide segment##2##2##(1995-5#1)(2005-11#1)
peptide segments##2##2##(1992-9#1)(1995-5#1)
peptide separations##2##2##(1996-5#2)
peptide sequence is##2##3##(1992-11#1)(1994-9#1)
peptide sequence of the##4##4##(1991-8#1)(1995-2#1)(2006-12#1)(2008-10#1)
peptide sequence of##6##3##(1991-8#1)(1994-5#1)(1995-2#1)(2006-12#1)(2008-10#2)
peptide sequence on##2##3##(1992-11#1)(1995-6#1)
peptide sequence was used to##2##5##(1992-9#1)(2012-2#1)
peptide sequence was##4##3##(1992-9#1)(2005-11#1)(2012-12#1)(2012-2#1)
peptide sequence##48##2##(1991-2#1)(1991-8#1)(1991-9#1)(1992-11#3)(1992-8#1)(1992-9#3)(1993-6#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#3)(1995-3#1)(1995-6#2)(1995-8#2)(1996-10#1)(1996-12#1)(1996-5#1)(1996-8#1)(2005-11#1)(2006-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#3)(2010-6#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
peptide sequences from##2##3##(1990-5#1)(1991-2#1)
peptide sequences in##3##3##(1992-6#1)(1995-5#1)(2008-11#1)
peptide sequences of##6##3##(1990-5#1)(1991-2#1)(1991-5#1)(1994-8#1)(2006-10#1)(2008-10#1)
peptide sequences that##3##3##(1994-3#1)(2006-10#1)(2007-2#1)
peptide sequences were##3##3##(1994-3#1)(1995-11#1)(1997-1#1)
peptide sequences which##2##3##(1994-5#1)(1995-5#1)
peptide sequences##38##2##(1990-5#2)(1991-2#4)(1991-5#2)(1991-6#1)(1992-1#1)(1992-12#1)(1992-6#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#2)(1997-1#1)(1997-2#1)(2006-10#2)(2007-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-9#1)(2012-2#1)(2013-1#1)
peptide sequencing by##2##3##(2007-8#1)(2010-5#1)
peptide sequencing##11##2##(1990-7#1)(1994-12#3)(1996-5#1)(2006-5#1)(2007-8#1)(2008-4#1)(2009-11#2)(2010-5#1)
peptide serotyping##2##2##(1994-12#2)
peptide serum##4##2##(1991-2#1)(1992-4#1)(2008-3#1)(2012-2#1)
peptide sharing##2##2##(1994-8#1)(2012-2#1)
peptide showed a##2##3##(1994-12#2)
peptide showed##4##2##(1990-7#1)(1991-2#1)(1994-12#2)
peptide shows##2##2##(1992-12#1)(1993-6#1)
peptide solutions##2##2##(1992-10#2)
peptide specific##2##2##(1992-8#1)(1995-10#1)
peptide stimulated##3##2##(1994-3#1)(1996-2#1)(1996-4#1)
peptide stimulates##2##2##(1990-10#1)(1991-2#1)
peptide stretch##2##2##(1990-7#2)
peptide structure##5##2##(1990-10#1)(1992-4#1)(1995-12#1)(1995-2#1)(2008-1#1)
peptide substrate for##2##3##(1990-4#1)(1991-7#1)
peptide substrate specificities of##2##4##(1994-12#2)
peptide substrate##22##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-11#1)(1992-4#1)(1993-11#1)(1993-6#1)(1994-12#3)(1994-3#1)(1994-8#2)(1995-3#1)(2008-4#1)(2012-1#1)(2012-3#2)
peptide substrates by##2##3##(1990-8#1)(1994-5#1)
peptide substrates##17##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-2#1)(1994-5#2)(1994-9#1)(1995-5#1)(1995-6#1)(1995-8#1)(2008-5#1)
peptide synthesis##19##2##(1992-11#1)(1992-5#1)(1993-12#1)(1994-9#1)(1995-5#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#7)(2010-5#1)
peptide synthesized by##2##3##(1993-9#1)(1995-11#1)
peptide system##3##2##(1992-8#1)(2008-10#1)(2009-6#1)
peptide that accumulates in the##2##5##(1992-12#1)(1995-5#1)
peptide that binds##2##3##(2008-3#1)(2008-7#1)
peptide that is##2##3##(2006-7#1)(2013-7#1)
peptide that##24##2##(1990-2#1)(1991-2#1)(1992-12#2)(1992-8#1)(1992-9#1)(1994-12#3)(1994-5#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(2006-6#1)(2006-7#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2013-7#1)
peptide thioesters##2##2##(2012-2#2)
peptide to a##4##3##(1994-5#1)(2008-2#1)(2008-4#2)
peptide to its##2##3##(1993-3#1)(1994-9#1)
peptide to the##7##3##(1990-4#1)(1991-8#1)(1991-9#1)(1995-1#2)(2005-11#1)(2009-10#1)
peptide to##32##2##(1990-10#1)(1990-3#2)(1990-4#1)(1990-7#1)(1991-11#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-7#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#1)(1996-4#1)(1996-5#1)(1997-2#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-4#4)(2009-10#1)(2011-1#1)(2012-3#1)
peptide toxin##3##2##(1993-9#1)(1994-9#1)(2008-5#1)
peptide transport##4##2##(1994-10#1)(1995-5#1)(2012-1#2)
peptide transporter##3##2##(1994-8#3)
peptide tyrosine-tyrosine##2##2##(1992-11#1)(2012-2#1)
peptide under##2##2##(2005-9#1)(2011-1#1)
peptide undergoes a##2##3##(1993-3#1)(1993-6#1)
peptide units##3##2##(1990-8#1)(1991-7#1)(2008-11#1)
peptide unrelated to##2##3##(1992-9#1)(1995-1#1)
peptide upon##2##2##(1997-2#1)(2012-1#1)
peptide using##2##2##(1993-4#1)(1996-5#1)
peptide vaccines##6##2##(1991-5#1)(1995-5#2)(1996-10#1)(2007-11#1)(2009-9#1)
peptide variants##2##2##(1994-11#1)(1994-8#1)
peptide was able to##2##4##(2008-10#2)
peptide was cloned##2##3##(2008-10#2)
peptide was confirmed by##2##4##(1990-8#1)(1994-8#1)
peptide was designed##2##3##(1990-2#1)(1993-6#1)
peptide was determined by##2##4##(1997-8#1)(2008-8#1)
peptide was determined##3##3##(1991-7#1)(1997-8#1)(2008-8#1)
peptide was developed##2##3##(1994-9#1)(2011-1#1)
peptide was examined##2##3##(1994-12#1)(1995-5#1)
peptide was identified##4##3##(1990-12#1)(1992-9#1)(2007-11#1)(2008-8#1)
peptide was isolated and##2##4##(1990-12#1)(1991-2#1)
peptide was isolated from##2##4##(1990-7#1)(1991-12#1)
peptide was isolated##5##3##(1990-12#1)(1990-7#1)(1991-12#1)(1991-2#1)(1994-2#1)
peptide was obtained##3##3##(1992-11#1)(1993-11#1)(1993-8#1)
peptide was synthesized##2##3##(1991-12#1)(2010-10#1)
peptide was used##2##3##(2006-4#1)(2008-5#1)
peptide was##67##2##(1990-11#3)(1990-12#2)(1990-2#1)(1990-7#3)(1990-8#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#2)(1992-10#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#2)(1993-8#3)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-5#3)(1995-8#1)(1996-4#1)(1996-9#1)(1997-3#2)(1997-7#1)(1997-8#1)(2005-11#1)(2006-4#1)(2007-11#2)(2008-10#4)(2008-5#1)(2008-6#1)(2008-8#3)(2009-3#1)(2010-10#1)(2010-6#1)(2011-1#1)(2012-11#4)
peptide were analyzed##2##3##(1995-5#1)(2006-12#1)
peptide were measured##2##3##(1992-3#1)(1994-5#1)
peptide were used to##2##4##(1995-3#1)(2008-10#1)
peptide were##17##2##(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-9#1)(1994-5#1)(1995-3#1)(1995-5#3)(1996-5#1)(1996-9#1)(2006-12#2)(2008-10#1)(2012-2#1)
peptide when##2##2##(1991-3#1)(1991-9#1)
peptide which is##2##3##(1990-2#1)(1990-7#1)
peptide which##13##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-9#1)(1992-5#1)(1992-7#1)(1993-3#2)(1994-11#1)(1995-10#1)(1995-2#1)(2008-5#1)
peptide whose##2##2##(1991-4#1)(1993-11#1)
peptide with a##13##3##(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-7#1)(1995-5#1)(1995-8#2)(2008-10#1)(2010-1#1)(2013-7#1)
peptide with the same##3##4##(1994-12#1)(1997-4#1)(2006-6#1)
peptide with the sequence##2##4##(1992-4#1)(1993-6#1)
peptide with the##9##3##(1990-7#1)(1992-4#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-3#1)(1995-8#1)(1997-4#1)(2006-6#1)
peptide with##44##2##(1990-2#1)(1990-3#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-4#2)(1992-7#1)(1993-3#1)(1993-6#2)(1994-12#2)(1994-2#1)(1994-6#1)(1995-3#2)(1995-5#1)(1995-8#3)(1996-2#1)(1996-8#1)(1997-4#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-8#2)(2010-1#1)(2010-6#1)(2012-2#1)(2013-7#1)
peptide without##2##2##(1994-9#1)(1995-8#1)
peptide##2837##1##(1990-1#1)(1990-10#21)(1990-11#28)(1990-12#37)(1990-2#28)(1990-3#20)(1990-4#13)(1990-5#27)(1990-6#9)(1990-7#50)(1990-8#20)(1990-9#13)(1991-1#15)(1991-10#29)(1991-11#3)(1991-12#28)(1991-2#58)(1991-3#22)(1991-4#19)(1991-5#25)(1991-6#7)(1991-7#56)(1991-8#29)(1991-9#33)(1992-1#5)(1992-10#7)(1992-11#33)(1992-12#38)(1992-2#6)(1992-3#31)(1992-4#20)(1992-5#20)(1992-6#73)(1992-7#21)(1992-8#39)(1992-9#32)(1993-1#2)(1993-11#41)(1993-12#14)(1993-2#5)(1993-3#42)(1993-4#9)(1993-5#7)(1993-6#35)(1993-7#1)(1993-8#19)(1993-9#14)(1994-10#11)(1994-11#43)(1994-12#76)(1994-2#28)(1994-3#28)(1994-5#32)(1994-6#13)(1994-8#30)(1994-9#57)(1995-1#16)(1995-10#22)(1995-11#25)(1995-12#15)(1995-2#46)(1995-3#42)(1995-4#1)(1995-5#61)(1995-6#22)(1995-7#2)(1995-8#35)(1995-9#1)(1996-1#1)(1996-10#6)(1996-11#4)(1996-12#22)(1996-2#11)(1996-3#4)(1996-4#11)(1996-5#61)(1996-6#9)(1996-7#15)(1996-8#22)(1996-9#11)(1997-1#6)(1997-2#18)(1997-3#9)(1997-4#44)(1997-5#6)(1997-6#19)(1997-7#18)(1997-8#14)(2004-1#1)(2004-12#4)(2004-2#1)(2004-3#1)(2005-10#1)(2005-11#20)(2005-12#3)(2005-3#1)(2005-7#10)(2005-8#2)(2005-9#2)(2006-1#2)(2006-10#27)(2006-11#4)(2006-12#37)(2006-2#1)(2006-4#5)(2006-5#1)(2006-6#6)(2006-7#3)(2006-8#1)(2006-9#1)(2007-10#4)(2007-11#18)(2007-12#1)(2007-2#3)(2007-5#3)(2007-6#7)(2007-7#1)(2007-8#11)(2008-1#14)(2008-10#67)(2008-11#23)(2008-12#4)(2008-2#5)(2008-3#20)(2008-4#109)(2008-5#37)(2008-6#11)(2008-7#28)(2008-8#30)(2008-9#16)(2009-10#4)(2009-11#2)(2009-12#8)(2009-2#1)(2009-3#2)(2009-5#8)(2009-6#11)(2009-7#1)(2009-8#2)(2009-9#9)(2010-1#5)(2010-10#9)(2010-11#2)(2010-12#18)(2010-2#3)(2010-4#11)(2010-5#12)(2010-6#11)(2010-7#4)(2011-1#20)(2011-12#1)(2011-2#14)(2012-1#7)(2012-11#8)(2012-12#10)(2012-2#34)(2012-3#19)(2013-1#17)(2013-7#9)(2013-8#7)
peptide&quot##2##1##(1990-7#1)(1995-6#1)
peptide's##4##1##(1991-8#1)(1993-3#1)(1995-5#1)(2008-9#1)
peptide) and##3##2##(1990-11#1)(1991-1#1)(1991-9#1)
peptide) in the##2##3##(1991-9#1)(2008-2#1)
peptide) in##3##2##(1991-9#1)(2008-2#2)
peptide) is##2##2##(1995-2#1)(2007-11#1)
peptide)##22##1##(1990-11#1)(1991-1#1)(1991-9#2)(1994-11#1)(1994-5#2)(1995-11#1)(1995-2#3)(1995-5#1)(1996-12#1)(1997-6#2)(2007-11#1)(2008-1#1)(2008-2#4)(2013-8#1)
peptide-(142-155) inhibited APC##2##3##(1993-11#2)
peptide-(142-155) inhibited##3##2##(1993-11#3)
peptide-(142-155)##4##1##(1993-11#4)
peptide-1 (GLP-1)##4##2##(1995-8#1)(1996-2#1)(2008-1#1)(2010-4#1)
peptide-1##12##1##(1993-9#1)(1994-8#1)(1995-8#1)(1996-2#2)(2008-1#1)(2009-2#1)(2009-9#1)(2010-4#1)(2011-2#3)
peptide-2##3##1##(1995-3#2)(2006-9#1)
peptide-HLA binding##3##2##(1997-2#3)
peptide-MHC complexes##2##2##(2008-4#2)
peptide-MHC##3##1##(2008-4#3)
peptide-based##8##1##(2008-10#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-2#1)(2010-7#1)(2012-2#1)(2013-8#1)
peptide-binding##5##1##(1995-8#2)(2006-10#1)(2008-4#1)(2013-8#1)
peptide-biphenyl hybrids##4##2##(2006-12#4)
peptide-bond##2##1##(1992-8#1)(1993-6#1)
peptide-chain initiation##2##2##(1991-6#1)(1997-6#1)
peptide-chain##3##1##(1991-6#1)(1992-12#1)(1997-6#1)
peptide-coding##2##1##(2006-12#1)(2008-8#1)
peptide-containing##3##1##(1993-12#1)(1997-3#1)(2007-11#1)
peptide-imprinted scaffolds##2##2##(2009-3#2)
peptide-induced mast cell activation##3##4##(1995-11#3)
peptide-induced##7##1##(1992-10#1)(1992-8#1)(1994-5#1)(1995-11#4)
peptide-like immunoreactivity in##2##3##(1992-7#1)(1994-5#1)
peptide-like immunoreactivity##4##2##(1990-7#1)(1992-7#1)(1992-8#1)(1994-5#1)
peptide-like##10##1##(1990-5#1)(1990-7#1)(1991-4#2)(1991-8#1)(1992-7#1)(1992-8#2)(1994-5#1)(1994-8#1)
peptide-lipid interaction##2##2##(1992-10#1)(2007-8#1)
peptide-lipid membranes##3##2##(2008-11#3)
peptide-lipid##10##1##(1990-11#1)(1992-10#1)(1993-9#3)(1994-9#1)(2007-8#1)(2008-11#3)
peptide-membrane##2##1##(1997-7#1)(2008-10#1)
peptide-modified gold electrodes##2##3##(1990-5#2)
peptide-modified##3##1##(1990-5#2)(2007-8#1)
peptide-peptide##2##1##(1994-9#2)
peptide-phospholipid##2##1##(1993-9#1)(1994-5#1)
peptide-protein##4##1##(1990-5#1)(1992-9#2)(1997-6#1)
peptide-proteosome complexes##2##2##(1990-12#2)
peptide-proteosome##3##1##(1990-12#3)
peptide-receptor##2##1##(2008-1#1)(2008-4#1)
peptide-sensitive channel##2##2##(1997-2#2)
peptide-specific##4##1##(1994-5#1)(2006-12#1)(2011-2#1)(2012-12#1)
peptide-stimulated [35S]GTP gamma S binding##4##5##(1996-2#4)
peptide-stimulated acid secretion##2##3##(1997-1#2)
peptide-stimulated##8##1##(1996-11#1)(1996-2#5)(1997-1#2)
peptide-treated##2##1##(1992-8#1)(1994-10#1)
peptide/MHC##2##1##(1993-12#1)(1997-4#1)
peptide/major histocompatibility##2##2##(1997-4#1)(2007-12#1)
peptidergic innervation##2##2##(1992-8#2)
peptidergic##11##1##(1990-11#1)(1992-8#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-7#1)(1997-5#1)(2008-7#1)(2013-8#1)
peptides (AMPs)##2##2##(2011-1#1)(2011-2#1)
peptides (CPPs)##2##2##(2010-10#1)(2011-3#1)
peptides (SP)##2##2##(1993-3#2)
peptides (designated##2##2##(1996-10#1)(2011-2#1)
peptides (the##2##2##(1990-8#1)(2011-3#1)
peptides 1-30##2##2##(1990-11#2)
peptides 173-204##2##2##(1995-1#2)
peptides act##2##2##(1991-5#1)(2007-11#1)
peptides adopt##2##2##(1993-9#1)(1995-11#1)
peptides affect##3##2##(1990-12#1)(1997-7#2)
peptides after synthesis##2##3##(2008-4#2)
peptides after##3##2##(1994-5#1)(2008-4#2)
peptides allowed##2##2##(1990-2#1)(2005-7#1)
peptides also##2##2##(1992-9#1)(2008-10#1)
peptides and MHC##2##3##(1995-5#1)(2007-11#1)
peptides and amino acids##3##4##(2008-10#2)(2011-2#1)
peptides and other##3##3##(1991-1#1)(1994-9#1)(1997-2#1)
peptides and protein##2##3##(2006-10#1)(2008-4#1)
peptides and proteins of##2##4##(1996-5#1)(1997-4#1)
peptides and proteins##20##3##(1990-9#1)(1991-3#2)(1992-2#1)(1994-9#1)(1995-2#1)(1996-5#1)(1997-1#1)(1997-4#1)(2005-11#1)(2005-7#1)(2008-10#1)(2008-11#2)(2008-4#4)(2010-7#1)(2011-1#1)
peptides and small##3##3##(1997-6#1)(2008-2#1)(2008-4#1)
peptides and the##2##3##(1991-5#1)(2007-8#1)
peptides and their##6##3##(1990-12#1)(1993-9#1)(1994-10#1)(1996-4#1)(2005-11#1)(2009-10#1)
peptides and##95##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#3)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#3)(1991-3#2)(1991-4#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1993-5#1)(1993-9#3)(1994-10#1)(1994-12#1)(1994-6#2)(1994-8#2)(1994-9#3)(1995-10#1)(1995-2#2)(1995-5#1)(1996-3#1)(1996-4#2)(1996-5#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#2)(2005-11#3)(2005-7#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-11#4)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-4#11)(2008-5#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
peptides appear##2##2##(1992-5#1)(1994-10#1)
peptides are able to##3##4##(1994-10#1)(1994-9#2)
peptides are also##2##3##(1990-5#1)(1995-3#1)
peptides are determined by##2##4##(1993-8#1)(1994-3#1)
peptides are identified##2##3##(2008-4#2)
peptides are nearly identical##2##4##(1992-2#1)(1994-8#1)
peptides are not##2##3##(1991-2#1)(1995-8#1)
peptides are present in##2##4##(1991-8#1)(1994-10#1)
peptides are rapidly##2##3##(1994-5#1)(2007-11#1)
peptides are unable to##2##4##(2007-11#2)
peptides are used##2##3##(2008-4#2)
peptides are##63##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-2#2)(1991-4#1)(1991-8#1)(1992-2#2)(1992-6#1)(1993-3#3)(1993-8#1)(1993-9#2)(1994-10#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-11#1)(1995-3#1)(1995-8#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-4#1)(2005-7#2)(2006-10#1)(2006-11#1)(2007-1#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#11)(2008-5#1)(2008-9#1)(2010-1#1)(2010-12#2)(2011-2#2)
peptides as a##2##3##(1991-7#1)(2012-2#1)
peptides as potential##2##3##(2007-6#1)(2008-6#1)
peptides as well as##2##4##(1995-11#1)(2008-4#1)
peptides as##21##2##(1990-5#1)(1991-3#1)(1991-7#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-6#1)(2007-8#1)(2008-4#2)(2008-5#1)(2008-6#1)(2011-3#1)(2012-2#1)(2013-1#1)
peptides at the##5##3##(1990-10#1)(1993-12#1)(2007-1#1)(2008-10#1)(2008-3#1)
peptides at##9##2##(1990-10#1)(1990-9#1)(1991-3#1)(1993-12#1)(1994-12#1)(1995-2#1)(2007-1#1)(2008-10#1)(2008-3#1)
peptides based on the##2##4##(1994-6#1)(1997-4#1)
peptides based on##8##3##(1994-6#1)(1997-4#2)(2006-12#1)(2008-2#1)(2008-4#2)(2013-7#1)
peptides behave as##2##3##(1991-5#1)(1991-9#1)
peptides bind to the##2##4##(1990-5#1)(1991-7#1)
peptides bind to##4##3##(1990-5#1)(1991-7#1)(1992-4#1)(1994-12#1)
peptides bind##7##2##(1990-2#1)(1990-5#1)(1991-7#1)(1992-4#1)(1994-12#1)(1994-9#1)(1995-11#1)
peptides bound to##3##3##(1993-4#1)(1996-8#1)(1997-8#1)
peptides bound##7##2##(1993-4#1)(1994-5#1)(1995-11#2)(1996-3#1)(1996-8#1)(1997-8#1)
peptides but##2##2##(1992-8#1)(2012-2#1)
peptides by capillary electrophoresis##3##4##(1994-9#1)(1996-5#2)
peptides by capillary##4##3##(1994-9#1)(1996-5#2)(1997-2#1)
peptides by high-performance liquid chromatography##2##5##(1997-2#1)(2008-4#1)
peptides by the##2##3##(1997-3#1)(2008-4#1)
peptides by##21##2##(1991-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1996-5#2)(1997-2#3)(1997-3#1)(2007-8#2)(2008-4#5)(2013-8#1)
peptides can be##6##3##(2008-1#1)(2008-10#2)(2008-4#1)(2011-1#1)(2012-1#1)
peptides can##14##2##(1991-3#1)(1994-5#1)(1996-10#1)(1997-4#1)(2005-11#1)(2008-1#1)(2008-10#3)(2008-4#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)
peptides coded##2##2##(2008-1#2)
peptides compete for##2##3##(1991-5#1)(1994-8#1)
peptides comprising residues##2##3##(1995-1#1)(2005-12#1)
peptides contained##2##2##(1995-7#1)(1997-4#1)
peptides containing only##2##3##(2008-4#1)(2012-12#1)
peptides containing the consensus sequence##2##5##(1991-7#1)(2009-6#1)
peptides containing the##8##3##(1990-7#1)(1991-2#2)(1991-7#2)(1993-6#1)(2008-3#1)(2009-6#1)
peptides containing##25##2##(1990-7#1)(1991-2#4)(1991-4#1)(1991-5#1)(1991-7#2)(1992-11#1)(1993-6#1)(1994-5#3)(1995-11#1)(1995-3#1)(1995-6#2)(2008-11#1)(2008-3#2)(2008-4#1)(2009-12#1)(2009-6#1)(2012-12#1)
peptides corresponding to the##12##4##(1990-2#1)(1990-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(2006-10#1)
peptides corresponding to##19##3##(1990-2#1)(1990-7#2)(1991-10#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-6#2)(1994-12#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-2#2)(2006-10#1)(2010-11#1)
peptides could be##3##3##(1992-3#1)(1993-11#1)(1996-12#1)
peptides could##7##2##(1991-3#1)(1992-3#1)(1992-4#1)(1993-11#1)(1996-12#1)(1997-4#1)(2012-3#1)
peptides covering the##2##3##(2008-11#2)
peptides demonstrated the##2##3##(1992-11#1)(2013-1#1)
peptides demonstrated##3##2##(1992-11#1)(1992-8#1)(2013-1#1)
peptides derived from human##2##4##(1990-7#1)(1995-2#1)
peptides derived from the protein##2##5##(1990-5#1)(1994-12#1)
peptides derived from the##16##4##(1990-3#1)(1990-4#1)(1990-5#1)(1991-4#1)(1992-12#1)(1992-4#2)(1992-6#1)(1994-12#1)(1994-2#2)(1994-6#1)(1995-5#1)(1995-6#1)(2008-1#1)(2008-8#1)
peptides derived from##36##3##(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-4#2)(1992-6#1)(1992-7#1)(1992-8#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-6#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-8#1)(1997-4#1)(2008-1#1)(2008-4#3)(2008-8#1)(2010-12#1)(2010-2#1)
peptides did not##5##3##(1990-6#1)(1992-11#1)(1994-10#1)(1994-11#1)(2006-12#1)
peptides differ from##2##3##(1996-12#1)(2006-12#1)
peptides displayed on##2##3##(1995-5#1)(2008-8#1)
peptides displayed##3##2##(1995-5#1)(2007-2#1)(2008-8#1)
peptides do not##3##3##(1993-4#1)(1994-5#1)(2008-3#1)
peptides either##2##2##(1990-7#1)(2008-4#1)
peptides encoded by##2##3##(1990-7#1)(1990-8#1)
peptides established##2##2##(1992-1#1)(1994-12#1)
peptides exhibit##2##2##(1990-2#1)(1997-4#1)
peptides for the##4##3##(1993-9#2)(2007-11#1)(2013-8#1)
peptides for##19##2##(1993-5#1)(1993-9#5)(1994-5#1)(1996-11#2)(1997-4#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-4#3)(2009-12#1)(2010-6#1)(2013-8#1)
peptides from a##3##3##(1992-11#1)(1993-12#1)(2008-9#1)
peptides from both##2##3##(1996-5#1)(2008-10#1)
peptides from human##2##3##(1992-12#1)(2012-1#1)
peptides from the skin of##2##5##(1992-11#1)(1994-11#1)
peptides from the two##3##4##(1995-3#1)(2008-4#2)
peptides from the##18##3##(1990-6#1)(1992-11#1)(1993-12#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-8#1)(2008-4#2)(2008-9#1)
peptides from##45##2##(1990-5#1)(1990-6#1)(1990-7#1)(1991-7#1)(1992-11#2)(1992-12#1)(1993-12#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#3)(1995-3#4)(1995-6#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-8#2)(2005-7#1)(2007-11#1)(2008-10#3)(2008-4#3)(2008-8#1)(2008-9#2)(2009-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
peptides fused to##2##3##(2008-1#1)(2009-2#1)
peptides generated by##5##3##(1993-12#1)(1993-4#1)(1994-2#1)(1994-3#1)(1996-2#1)
peptides generated from the##2##4##(2008-4#1)(2008-9#1)
peptides generated##7##2##(1993-12#1)(1993-4#1)(1994-2#1)(1994-3#1)(1996-2#1)(2008-4#1)(2008-9#1)
peptides had##6##2##(1991-5#1)(1992-8#1)(1994-3#1)(1995-1#1)(1995-12#1)(1997-6#1)
peptides has been##4##3##(1990-7#1)(1992-11#1)(1993-4#1)(1995-2#1)
peptides has##5##2##(1990-7#1)(1992-11#1)(1993-4#1)(1995-2#1)(2009-12#1)
peptides have been found in##2##5##(1993-11#1)(2009-5#1)
peptides have been investigated##2##4##(1993-6#1)(1996-9#1)
peptides have been##14##3##(1990-11#2)(1991-9#1)(1993-11#1)(1993-5#1)(1993-6#2)(1994-12#1)(1996-9#1)(1997-6#1)(2006-12#1)(2008-5#1)(2009-5#1)(2011-2#1)
peptides have##22##2##(1990-11#2)(1991-5#1)(1991-9#1)(1993-11#1)(1993-5#1)(1993-6#2)(1994-12#1)(1994-6#1)(1996-9#1)(1997-6#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-12#2)(2008-1#1)(2008-5#1)(2008-8#1)(2009-5#1)(2011-2#1)
peptides having##4##2##(1990-2#1)(1992-7#1)(1994-5#1)(2008-7#1)
peptides homologous##2##2##(1991-9#1)(2008-4#1)
peptides identified in##3##3##(1993-5#1)(1994-12#1)(1995-11#1)
peptides identified##4##2##(1993-5#1)(1994-12#1)(1995-11#1)(1996-5#1)
peptides in a##3##3##(1994-11#1)(1997-7#1)(2008-9#1)
peptides in aqueous##3##3##(1997-1#1)(1997-4#1)(2006-12#1)
peptides in bone##2##3##(1990-11#2)
peptides in human plasma##2##4##(1991-9#1)(2012-1#1)
peptides in relation to##2##4##(1994-12#1)(1994-9#1)
peptides in reversed-phase chromatography##2##4##(1992-2#1)(1995-3#1)
peptides in reversed-phase##3##3##(1992-2#1)(1992-6#1)(1995-3#1)
peptides in solution##2##3##(1994-9#1)(2008-4#1)
peptides in the rat##2##4##(1991-2#1)(1994-12#1)
peptides in the regulation of##2##5##(1994-12#1)(2006-10#1)
peptides in the##19##3##(1990-10#1)(1990-11#1)(1991-1#1)(1991-2#1)(1992-11#1)(1992-4#1)(1992-9#1)(1993-2#1)(1993-5#1)(1994-12#2)(1994-8#1)(1995-12#1)(1995-5#1)(1997-2#1)(2006-10#1)(2008-1#1)(2008-4#1)(2011-1#1)
peptides in vitro##2##3##(1996-11#1)(2008-9#1)
peptides in which##2##3##(1994-6#1)(1994-9#1)
peptides in##80##2##(1990-10#1)(1990-11#3)(1990-12#3)(1990-5#2)(1990-7#1)(1991-1#2)(1991-2#1)(1991-5#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#6)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-6#1)(1994-8#4)(1994-9#3)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#4)(2008-9#2)(2009-6#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)
peptides increased##3##2##(1990-12#1)(1992-12#1)(1992-4#1)
peptides indicate that##2##3##(1993-3#1)(2008-5#1)
peptides indicate##3##2##(1993-3#2)(2008-5#1)
peptides indicated that##3##3##(1990-4#1)(1991-2#1)(1997-4#1)
peptides indicated##4##2##(1990-4#1)(1991-2#1)(1997-4#1)(2011-1#1)
peptides indicates a##2##3##(1994-6#1)(1995-8#1)
peptides induce##3##2##(1994-5#2)(2007-12#1)
peptides induced by the hydroxyl radical##2##6##(1990-5#2)
peptides induced##3##2##(1990-5#2)(1991-7#1)
peptides inhibit##4##2##(1990-7#1)(1991-2#1)(1991-9#1)(2006-12#1)
peptides inhibited the##2##3##(1995-11#1)(2012-3#1)
peptides inhibited##6##2##(1990-12#1)(1990-5#1)(1992-5#1)(1995-11#1)(1997-4#1)(2012-3#1)
peptides interact with##2##3##(1990-2#1)(2006-10#1)
peptides into the##2##3##(1994-2#1)(1994-9#1)
peptides into##5##2##(1994-12#1)(1994-2#1)(1994-9#1)(2008-10#1)(2010-5#1)
peptides investigated##2##2##(1991-2#1)(1993-6#1)
peptides is not##3##3##(1995-3#1)(2007-1#1)(2008-4#1)
peptides is##15##2##(1990-12#1)(1991-4#1)(1991-9#1)(1993-2#1)(1993-4#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-5#1)(2005-7#1)(2006-7#1)(2007-1#1)(2007-11#1)(2008-4#2)
peptides isolated from the##2##4##(1990-5#1)(1996-7#1)
peptides isolated from##3##3##(1990-5#1)(1992-11#1)(1996-7#1)
peptides isolated##4##2##(1990-12#1)(1990-5#1)(1992-11#1)(1996-7#1)
peptides labeled with##2##3##(1995-1#1)(1996-5#1)
peptides led##2##2##(1994-8#1)(1997-4#1)
peptides may be##3##3##(1990-7#1)(1995-10#1)(2008-4#1)
peptides may function##2##3##(1997-2#1)(2008-1#1)
peptides may##13##2##(1990-12#2)(1990-2#1)(1990-7#2)(1991-5#1)(1994-6#1)(1995-10#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-4#1)(2013-1#1)
peptides might##3##2##(1990-7#1)(1991-1#1)(1994-2#1)
peptides mixture from tumor cells##2##5##(2008-9#2)
peptides mixture##3##2##(2008-9#3)
peptides modulate##2##2##(1997-5#1)(2012-12#1)
peptides must be##2##3##(1991-5#1)(1995-5#1)
peptides obtained by##2##3##(1990-7#1)(1993-6#1)
peptides obtained from the##2##4##(1992-8#1)(1993-5#1)
peptides obtained from##3##3##(1992-8#1)(1993-5#1)(1994-8#1)
peptides obtained##7##2##(1990-7#1)(1991-12#1)(1991-8#1)(1992-8#1)(1993-5#1)(1993-6#1)(1994-8#1)
peptides of a##2##3##(1990-9#1)(2009-9#1)
peptides of low##2##3##(1992-8#1)(1993-12#1)
peptides of mouse##2##3##(1990-4#1)(1994-2#1)
peptides of the general##3##4##(1992-5#1)(1993-2#1)(2008-6#1)
peptides of the##15##3##(1990-11#1)(1990-2#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-3#3)(1994-9#1)(1995-11#1)(1995-12#1)(2007-1#1)(2008-6#1)(2010-5#1)(2011-2#1)
peptides of##43##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-3#3)(1994-12#1)(1994-2#1)(1994-9#2)(1995-11#1)(1995-12#1)(1996-11#1)(1997-6#2)(2007-1#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-6#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-2#1)
peptides often##2##2##(1993-12#1)(1994-9#1)
peptides on cerebral hemodynamics in##2##5##(1996-12#2)
peptides on the##8##3##(1992-2#1)(1993-12#1)(1996-5#1)(1997-7#1)(1997-8#1)(2004-12#1)(2010-2#1)(2012-1#1)
peptides on##20##2##(1990-7#1)(1991-1#1)(1992-2#1)(1993-12#1)(1993-5#1)(1996-12#3)(1996-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2008-11#1)(2008-4#2)(2010-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
peptides or antibodies##2##3##(1997-6#1)(2010-5#1)
peptides or proteins##2##3##(1995-2#2)
peptides or##10##2##(1994-11#1)(1995-2#4)(1997-4#1)(1997-6#1)(2008-4#1)(2010-5#1)(2012-12#1)
peptides originally##2##2##(1995-12#1)(2005-9#1)
peptides phosphorylated##2##2##(1996-2#1)(2008-4#1)
peptides possessing different##2##3##(2013-8#2)
peptides postulated to be##2##4##(1990-10#2)
peptides present in the##2##4##(1994-9#1)(1997-6#1)
peptides present in##5##3##(1992-12#1)(1994-11#1)(1994-9#1)(1995-5#1)(1997-6#1)
peptides presented by##5##3##(1991-12#1)(1994-12#1)(1995-2#1)(1996-10#1)(2012-2#1)
peptides presented##6##2##(1991-12#1)(1994-12#1)(1995-2#1)(1996-10#1)(2008-4#1)(2012-2#1)
peptides produced by##4##3##(1991-2#1)(1993-8#1)(2008-4#1)(2008-9#1)
peptides produced##7##2##(1991-2#1)(1991-3#1)(1992-5#1)(1993-8#1)(2006-10#1)(2008-4#1)(2008-9#1)
peptides recognized##3##2##(1990-5#1)(1992-12#1)(2008-4#1)
peptides represent##2##2##(1992-8#1)(1994-6#1)
peptides representing##6##2##(1991-12#1)(1991-6#1)(1993-6#1)(1993-8#1)(2008-10#1)(2008-5#1)
peptides revealed that##2##3##(1990-7#1)(1992-8#1)
peptides revealed##4##2##(1990-11#1)(1990-7#1)(1992-8#1)(1992-9#1)
peptides reveals##2##2##(1993-3#1)(2011-2#1)
peptides secreted by##2##3##(1991-9#1)(1992-4#1)
peptides secreted##3##2##(1991-9#1)(1992-4#2)
peptides should be##2##3##(2010-12#1)(2013-8#1)
peptides show##2##2##(1991-1#1)(1994-8#1)
peptides showed that##3##3##(1992-7#1)(1994-3#1)(1997-2#1)
peptides showed##11##2##(1990-6#1)(1992-7#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-5#2)(1997-2#1)(2005-11#1)(2008-10#1)(2008-6#1)
peptides such as##7##3##(1991-5#1)(1994-5#1)(1994-6#1)(1997-2#1)(2008-3#1)(2008-4#1)(2009-8#1)
peptides synthesized##2##2##(1990-9#1)(2008-11#1)
peptides tested##6##2##(1990-7#1)(1991-2#1)(1991-5#1)(1991-9#1)(1994-8#1)(1994-9#1)
peptides that are##5##3##(1994-12#1)(2005-11#1)(2005-8#1)(2007-11#1)(2008-4#1)
peptides that increase##2##3##(1992-9#1)(1993-3#1)
peptides that may##2##3##(2007-11#1)(2012-2#1)
peptides that specifically##2##3##(2008-7#1)(2009-6#1)
peptides that were##2##3##(1995-6#1)(1997-4#1)
peptides that##36##2##(1991-2#1)(1991-5#1)(1992-9#1)(1993-12#1)(1993-3#3)(1994-12#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-6#1)(1995-8#1)(1997-4#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-10#1)(2008-4#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-2#1)(2012-2#1)(2013-1#1)
peptides the##2##2##(1994-10#1)(1995-10#1)
peptides to be##2##3##(1996-9#1)(2008-4#1)
peptides to the##10##3##(1990-4#1)(1992-9#1)(1995-5#1)(1996-12#1)(1997-4#2)(2005-11#1)(2008-4#3)
peptides to##44##2##(1990-11#1)(1990-4#1)(1991-2#1)(1991-5#2)(1992-3#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-4#1)(1994-11#1)(1994-9#1)(1995-2#1)(1995-5#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-4#4)(2005-11#1)(2006-7#1)(2008-10#1)(2008-2#1)(2008-4#11)(2008-7#1)(2009-9#1)(2011-2#1)(2012-2#2)
peptides used in##2##3##(1995-11#1)(2006-7#1)
peptides used##3##2##(1992-8#1)(1995-11#1)(2006-7#1)
peptides using the##2##3##(2008-10#1)(2008-4#1)
peptides using##7##2##(1994-2#1)(1996-5#1)(1996-8#1)(2008-10#1)(2008-2#1)(2008-4#2)
peptides was##20##2##(1990-10#1)(1990-12#1)(1990-2#2)(1991-10#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-4#1)(1993-9#2)(1994-8#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-6#1)(1997-8#1)(2007-8#1)(2012-12#1)
peptides we have##2##3##(1994-12#1)(1995-2#1)
peptides were also##2##3##(1992-12#1)(1992-5#1)
peptides were assayed##2##3##(1991-3#1)(1994-9#1)
peptides were constructed##2##3##(1994-3#1)(1995-5#1)
peptides were designed##2##3##(1993-11#1)(1995-1#1)
peptides were found to##2##4##(1994-8#1)(1997-4#1)
peptides were identified by##2##4##(1992-12#1)(1994-6#1)
peptides were identified##3##3##(1991-5#1)(1992-12#1)(1994-6#1)
peptides were injected##2##3##(1993-11#1)(2013-8#1)
peptides were isolated from##3##4##(1992-11#1)(1992-12#1)(2008-5#1)
peptides were isolated##5##3##(1990-2#1)(1992-11#1)(1992-12#1)(1995-2#1)(2008-5#1)
peptides were measured##2##3##(1995-11#2)
peptides were separated by##2##4##(1992-1#1)(1995-8#1)
peptides were separated##4##3##(1992-1#1)(1995-8#1)(1996-5#2)
peptides were sequenced##2##3##(1992-1#1)(1995-1#1)
peptides were synthesized and##2##4##(1991-12#1)(1995-1#1)
peptides were synthesized##5##3##(1991-12#1)(1992-6#1)(1995-1#1)(1997-3#1)(2005-11#1)
peptides were used to##2##4##(1993-12#1)(1997-8#1)
peptides were##70##2##(1990-10#1)(1990-2#3)(1990-3#1)(1990-5#2)(1990-7#2)(1991-12#1)(1991-3#2)(1991-5#1)(1992-1#2)(1992-11#1)(1992-12#4)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#4)(1993-12#1)(1993-9#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#4)(1995-11#3)(1995-2#2)(1995-5#2)(1995-8#1)(1996-5#2)(1997-3#1)(1997-4#2)(1997-8#1)(2005-11#1)(2005-7#1)(2007-8#1)(2008-10#2)(2008-5#3)(2008-7#1)(2009-5#1)(2011-2#1)(2012-1#2)(2013-8#3)
peptides which are##2##3##(1990-3#1)(1992-12#1)
peptides which contain a##2##4##(1995-1#1)(2011-1#1)
peptides which contain##3##3##(1993-9#1)(1995-1#1)(2011-1#1)
peptides which##11##2##(1990-3#1)(1991-10#1)(1992-12#1)(1992-9#1)(1993-9#1)(1994-6#1)(1995-1#1)(1995-4#1)(1997-3#1)(2008-9#1)(2011-1#1)
peptides with a##4##3##(1991-7#1)(1994-3#1)(2005-11#1)(2008-10#1)
peptides with an##2##3##(1993-11#1)(1994-3#1)
peptides with identical##2##3##(1994-9#1)(1995-5#1)
peptides with lipid##2##3##(1993-5#1)(2005-11#1)
peptides with opioid activity##2##4##(1992-4#1)(1995-3#1)
peptides with phospholipid vesicles##2##4##(1991-9#2)
peptides with the same amino acid sequence##3##7##(1995-3#1)(2013-8#2)
peptides with the##6##3##(1990-6#1)(1991-5#1)(1994-10#1)(1995-3#1)(2013-8#2)
peptides with very##2##3##(1993-4#1)(1997-7#1)
peptides with##54##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#2)(1992-6#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-5#1)(1994-10#1)(1994-3#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-3#2)(1995-5#1)(1995-7#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-11#2)(2005-7#1)(2006-1#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-8#3)
peptides within##2##2##(2008-11#1)(2008-3#1)
peptides without##3##2##(2006-11#1)(2008-10#2)
peptides##1738##1##(1990-10#13)(1990-11#26)(1990-12#26)(1990-2#33)(1990-3#7)(1990-4#8)(1990-5#28)(1990-6#5)(1990-7#30)(1990-8#9)(1990-9#7)(1991-1#13)(1991-10#7)(1991-11#1)(1991-12#18)(1991-2#22)(1991-3#16)(1991-4#8)(1991-5#26)(1991-6#2)(1991-7#10)(1991-8#9)(1991-9#19)(1992-1#3)(1992-11#22)(1992-12#27)(1992-2#10)(1992-3#10)(1992-4#13)(1992-5#11)(1992-6#14)(1992-7#5)(1992-8#17)(1992-9#10)(1993-11#14)(1993-12#10)(1993-2#3)(1993-3#30)(1993-4#13)(1993-5#17)(1993-6#19)(1993-8#5)(1993-9#20)(1994-10#16)(1994-11#22)(1994-12#31)(1994-2#18)(1994-3#13)(1994-5#21)(1994-6#22)(1994-8#25)(1994-9#38)(1995-1#15)(1995-10#5)(1995-11#22)(1995-12#12)(1995-2#32)(1995-3#21)(1995-4#4)(1995-5#15)(1995-6#11)(1995-7#3)(1995-8#11)(1996-1#2)(1996-10#3)(1996-11#10)(1996-12#16)(1996-2#6)(1996-3#6)(1996-4#8)(1996-5#23)(1996-6#1)(1996-7#2)(1996-8#11)(1996-9#5)(1997-1#2)(1997-2#16)(1997-3#5)(1997-4#30)(1997-5#1)(1997-6#19)(1997-7#13)(1997-8#11)(2003-11#1)(2004-12#2)(2005-11#11)(2005-12#1)(2005-7#11)(2005-8#3)(2005-9#1)(2006-1#3)(2006-10#26)(2006-11#8)(2006-12#16)(2006-2#1)(2006-4#1)(2006-6#2)(2006-7#4)(2007-1#5)(2007-11#25)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#11)(2007-9#1)(2008-1#15)(2008-10#40)(2008-11#17)(2008-2#8)(2008-3#6)(2008-4#116)(2008-5#20)(2008-6#4)(2008-7#11)(2008-8#10)(2008-9#18)(2009-10#4)(2009-12#6)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#8)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#3)(2010-1#4)(2010-10#3)(2010-11#3)(2010-12#9)(2010-2#10)(2010-3#1)(2010-5#5)(2010-6#3)(2010-7#2)(2011-1#13)(2011-2#20)(2011-3#4)(2012-1#10)(2012-12#5)(2012-2#9)(2012-3#12)(2013-1#7)(2013-7#2)(2013-8#15)
peptides)##10##1##(1990-12#1)(1990-8#1)(1994-5#1)(1995-8#1)(1996-11#1)(1996-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2013-8#1)
peptides/proteins##6##1##(1995-2#1)(1997-4#1)(2006-12#2)(2008-1#1)(2013-8#1)
peptidic and##3##2##(1992-9#2)(1993-3#1)
peptidic##11##1##(1992-8#1)(1992-9#3)(1993-3#3)(1993-7#1)(1995-11#1)(1997-4#1)(2008-4#1)
peptidoglycan or##2##2##(2006-9#1)(2010-12#1)
peptidoglycan precursors##2##2##(1995-2#2)
peptidoglycan##39##1##(1990-2#1)(1990-7#3)(1993-12#2)(1995-2#6)(1997-4#1)(2005-12#1)(2006-9#17)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#1)
peptidoleukotriene receptor antagonist##2##3##(1993-11#2)
peptidolytic reaction of##2##3##(1991-9#2)
peptidolytic reaction##4##2##(1991-9#4)
peptidomimetic inhibitors##2##2##(1996-8#1)(2013-1#1)
peptidomimetic##8##1##(1995-2#1)(1996-8#1)(2005-7#1)(2008-1#1)(2009-4#1)(2012-3#1)(2013-1#2)
peptidomimetics##5##1##(2008-1#1)(2009-4#1)(2012-3#1)(2013-1#2)
peptidyl##13##1##(1990-7#1)(1992-12#1)(1992-4#1)(1993-11#1)(1993-2#2)(1994-11#1)(1994-3#1)(1996-8#1)(2004-12#1)(2008-5#1)(2008-8#1)(2009-7#1)
peptidyl-prolyl cis-trans isomerase##2##3##(1992-12#1)(2011-2#1)
peptidyl-prolyl cis/trans isomerase##2##3##(2008-7#2)
peptidyl-prolyl isomerase from Escherichia coli##2##5##(1993-6#2)
peptidyl-prolyl##7##1##(1992-12#1)(1993-6#2)(1996-5#1)(2008-7#2)(2011-2#1)
peptidyl-tRNA##6##1##(1990-5#1)(1992-8#2)(1994-12#2)(2006-12#1)
peptidylarginine deiminases##2##2##(2008-5#2)
peptidylglycine alpha-amidating monooxygenase##4##3##(1990-9#2)(1994-11#2)
peptidylglycine##5##1##(1990-9#3)(1994-11#2)
peptidyltransferase##2##1##(2006-12#2)
peptization##5##1##(2005-11#5)
peptoid##2##1##(2008-4#1)(2010-6#1)
peptoid-peptide hybrids are##2##3##(2010-6#2)
peptoids##4##1##(2008-4#4)
peptone after a preload##2##4##(1997-4#2)
peptone after##4##2##(1997-4#4)
peptone and peptone after##2##4##(1997-4#2)
peptone concentration##2##2##(2008-5#1)(2008-7#1)
peptone was found to be##2##5##(2008-10#1)(2012-2#1)
peptone was##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
peptone##32##1##(1992-6#1)(1993-11#1)(1997-4#8)(2004-4#1)(2005-11#2)(2008-10#3)(2008-4#1)(2008-5#9)(2008-7#5)(2012-2#1)
peptone-stimulated gastric acid secretion##2##4##(1993-11#2)
peptone-stimulated##3##1##(1993-11#3)
peptones##5##1##(2006-8#1)(2008-11#4)
per 0##4##2##(1995-7#1)(2008-10#1)(2008-11#1)(2008-12#1)
per 1##50##2##(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-4#3)(1991-5#1)(1992-4#3)(1993-1#1)(1993-8#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-11#1)(2005-8#1)(2006-10#1)(2007-8#4)(2008-10#3)(2008-3#1)(2008-8#1)(2010-12#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-11#2)(2012-2#8)(2013-1#3)(2013-7#1)
per 10 000##2##3##(2013-8#2)
per 10 ml##3##3##(2006-9#1)(2007-7#1)(2008-10#1)
per 10##16##2##(1992-3#1)(1994-9#1)(2006-9#1)(2007-2#2)(2007-7#3)(2008-10#1)(2008-7#1)(2010-7#2)(2012-2#1)(2013-1#1)(2013-8#2)
per 10(6) cells##4##3##(1990-6#1)(1991-1#3)
per 10(6)##7##2##(1990-6#1)(1991-1#4)(1992-1#1)(1996-11#1)
per 10(9)##4##2##(1992-2#3)(1994-8#1)
per 100 000##7##3##(2007-7#1)(2008-1#1)(2011-2#4)(2013-8#1)
per 100 g##2##3##(1997-8#1)(2011-2#1)
per 100 patients##2##3##(2008-7#1)(2013-1#1)
per 100##84##2##(1990-12#3)(1990-9#4)(1991-11#1)(1992-2#1)(1993-7#1)(1996-3#2)(1996-8#1)(1997-7#2)(1997-8#1)(2005-8#3)(2006-1#1)(2006-10#4)(2006-4#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-12#1)(2010-8#1)(2010-9#7)(2011-1#1)(2011-12#1)(2011-2#17)(2013-1#4)(2013-7#2)(2013-8#2)
per 1000 for##3##3##(1991-6#3)
per 1000 inhabitants##4##3##(1993-8#2)(1997-8#1)(2006-8#1)
per 1000 live and stillbirths##2##5##(2012-12#2)
per 1000 live births##7##4##(1990-9#1)(1991-11#2)(2011-2#1)(2012-2#1)(2012-3#2)
per 1000 live born##2##4##(1995-5#1)(2013-1#1)
per 1000 live##11##3##(1990-9#1)(1991-11#2)(1995-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
per 1000 livebirths##2##3##(1990-9#1)(2012-12#1)
per 1000 ml##3##3##(2008-10#3)
per 1000 person-years##2##3##(1993-7#1)(1996-9#1)
per 1000 population##2##3##(1993-2#1)(1993-7#1)
per 1000 women##3##3##(1991-11#1)(1994-2#1)(2004-2#1)
per 1000##48##2##(1990-9#2)(1991-11#3)(1991-6#3)(1993-2#1)(1993-7#2)(1993-8#3)(1994-2#2)(1994-7#1)(1995-5#1)(1996-9#1)(1997-8#3)(2004-2#3)(2006-2#1)(2006-8#1)(2007-7#3)(2007-8#1)(2008-10#4)(2009-6#1)(2011-2#2)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#1)
per 1000)##3##2##(1991-6#1)(1995-5#1)(2013-1#1)
per 100g##2##2##(2008-10#1)(2009-2#1)
per 15##2##2##(1991-10#1)(2010-2#1)
per 2##6##2##(1991-5#1)(1995-10#1)(2007-2#1)(2008-10#1)(2008-5#1)(2011-2#1)
per 20 mmHg##2##3##(1995-8#2)
per 20##4##2##(1991-5#1)(1995-8#2)(1996-12#1)
per 200 g of soil)##3##5##(2008-10#3)
per 200##5##2##(1993-9#1)(2006-10#1)(2008-10#3)
per 24##3##2##(1990-6#1)(1993-7#1)(2008-5#1)
per 25muL) of Se(IV)##2##4##(2008-10#2)
per 25muL)##3##2##(2008-10#3)
per 3##2##2##(2008-11#1)(2010-2#1)
per 5##2##2##(1990-4#1)(2007-7#1)
per 50##5##2##(1996-8#1)(2008-10#1)(2012-3#1)(2013-1#2)
per DNA##2##2##(1991-8#1)(1997-4#1)
per LDL##2##2##(1997-4#1)(1997-6#1)
per POPS##2##2##(1990-7#2)
per QALY gained##2##3##(2006-12#1)(2007-8#1)
per QALY##3##2##(2006-12#2)(2007-8#1)
per Sv##5##2##(1996-6#4)(1997-8#1)
per acetate taken up##2##4##(2007-6#2)
per active##2##2##(1992-3#1)(2011-2#1)
per additional##2##2##(2008-1#1)(2012-12#1)
per animal##5##2##(1992-8#1)(1996-12#3)(2013-1#1)
per annum##6##2##(1991-9#1)(2004-1#1)(2007-5#1)(2008-5#1)(2011-2#1)(2012-12#1)
per area of##2##3##(1995-10#1)(2008-10#1)
per area##4##2##(1995-10#1)(2007-3#1)(2008-10#1)(2008-12#1)
per asymmetric unit##6##3##(1994-6#1)(1995-2#1)(1997-2#1)(2008-9#2)(2011-1#1)
per atom##2##2##(2007-11#1)(2007-12#1)
per batch culture##2##3##(2008-11#2)
per billion by volume##2##4##(1992-1#1)(2008-3#1)
per billion by##4##3##(1992-1#1)(2008-10#1)(2008-3#2)
per billion in volume##2##4##(2008-2#1)(2008-3#1)
per billion in##3##3##(2008-2#2)(2008-3#1)
per billion##14##2##(1992-1#1)(2007-8#1)(2008-10#2)(2008-2#3)(2008-3#5)(2008-5#1)(2013-8#1)
per blastocyst##2##2##(2006-5#1)(2008-11#1)
per canker##6##2##(2008-10#6)
per capita consumption of##3##4##(2004-11#1)(2011-2#1)(2012-1#1)
per capita consumption##7##3##(2004-11#1)(2010-5#2)(2011-2#2)(2012-1#2)
per capita costs##3##3##(1991-6#1)(1993-3#1)(1996-3#1)
per capita expenditure##2##3##(1995-12#1)(2011-1#1)
per capita expenditures on##2##4##(2009-3#1)(2013-7#1)
per capita expenditures##4##3##(1994-2#1)(1997-3#1)(2009-3#1)(2013-7#1)
per capita gross##2##3##(2007-2#1)(2007-7#1)
per capita income##2##3##(2008-9#1)(2012-2#1)
per capita population growth rates##3##5##(2008-8#3)
per capita than##3##3##(1995-1#1)(1996-3#1)(2011-2#1)
per capita##68##2##(1990-12#1)(1990-2#1)(1991-3#1)(1991-6#1)(1993-2#1)(1993-3#4)(1994-1#2)(1994-2#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-3#2)(1997-1#3)(1997-3#2)(1997-8#1)(2004-11#1)(2006-8#2)(2007-2#1)(2007-3#2)(2007-7#1)(2008-7#1)(2008-8#9)(2008-9#2)(2009-3#1)(2009-4#1)(2010-5#2)(2010-8#5)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-7#2)(2013-8#1)
per caput effective dose##2##4##(1997-8#2)
per caput##3##2##(1997-8#2)(2012-2#1)
per case payment##3##3##(1995-9#2)(2005-11#1)
per case##19##2##(1992-12#5)(1995-9#2)(1996-12#2)(1996-2#1)(1996-3#3)(1996-9#1)(2004-1#1)(2005-11#1)(2007-4#1)(2010-4#1)(2012-12#1)
per cell after##2##3##(2008-10#1)(2008-11#1)
per cell and the##3##4##(1990-12#1)(1995-11#1)(2006-5#1)
per cell and##6##3##(1990-12#1)(1995-11#1)(1995-7#1)(2006-5#1)(2008-11#1)(2008-9#1)
per cell in##5##3##(2007-6#1)(2008-11#1)(2008-9#1)(2009-10#1)(2012-1#1)
per cell is##3##3##(1990-12#1)(2007-12#1)(2009-8#1)
per cell was##4##3##(1993-12#1)(1994-2#1)(2006-9#1)(2008-11#1)
per cell with##3##3##(1993-9#1)(1994-6#1)(1995-6#1)
per cell##73##2##(1990-12#5)(1990-2#1)(1990-4#1)(1990-9#2)(1991-10#1)(1991-2#1)(1991-8#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-7#2)(1995-8#1)(1997-1#4)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-6#1)(2008-10#1)(2008-11#12)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#7)(2009-10#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-1#1)
per cell)##3##2##(1993-6#1)(1995-10#1)(2013-1#1)
per cent and the##2##4##(1992-2#1)(1993-1#1)
per cent and##14##3##(1990-6#1)(1991-8#1)(1992-2#1)(1992-5#2)(1993-1#2)(1993-8#2)(1994-7#1)(1995-12#1)(1997-3#1)(1997-6#1)(2004-1#1)
per cent bias in the##2##5##(1997-6#2)
per cent digestible protein##2##4##(1992-10#2)
per cent for the ELISA and##2##6##(1992-5#2)
per cent for the ELISA##3##5##(1992-5#3)
per cent for the IHA##3##5##(1992-5#3)
per cent for the##6##4##(1992-5#6)
per cent for##11##3##(1992-5#6)(1994-7#1)(1995-12#4)
per cent had##4##3##(2006-8#1)(2007-3#1)(2008-10#1)(2011-1#1)
per cent in the first month##2##6##(1996-8#2)
per cent in the##4##4##(1992-2#1)(1994-8#1)(1996-8#2)
per cent in##10##3##(1991-2#1)(1991-3#1)(1992-2#3)(1994-8#1)(1996-8#2)(2012-12#2)
per cent increase##2##3##(1995-8#2)
per cent mortality##2##3##(1994-4#1)(2008-8#1)
per cent of all the##2##5##(1992-10#1)(1994-7#1)
per cent of all##6##4##(1992-10#1)(1994-7#1)(2008-2#2)(2012-12#1)(2012-2#1)
per cent of cases##2##4##(1991-4#1)(2012-8#1)
per cent of neonatal survivors##2##5##(1993-5#2)
per cent of patients##3##4##(1990-6#1)(1992-10#1)(2011-2#1)
per cent of subjects##2##4##(1992-6#2)
per cent of the cases##2##5##(1992-11#1)(1992-9#1)
per cent of the cultures##7##5##(1993-10#7)
per cent of the incidence##2##5##(2008-7#2)
per cent of the isolates##2##5##(2006-5#1)(2008-5#1)
per cent of the patients##2##5##(1990-12#1)(2008-9#1)
per cent of the population##2##5##(2008-1#1)(2008-3#1)
per cent of the respondents##3##5##(1995-12#1)(2006-12#2)
per cent of the vaccinated##2##5##(1995-9#1)(2011-2#1)
per cent of the##41##4##(1990-12#1)(1990-9#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-10#9)(1993-2#1)(1993-8#1)(1994-7#2)(1995-12#1)(1995-9#3)(1996-3#1)(1997-3#1)(1997-5#1)(2006-10#1)(2006-12#2)(2006-5#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-11#1)(2010-4#1)(2011-2#1)
per cent of##82##3##(1990-12#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-9#2)(1991-3#1)(1991-4#1)(1991-6#2)(1992-10#3)(1992-11#1)(1992-5#1)(1992-6#3)(1992-9#3)(1993-10#9)(1993-2#3)(1993-5#2)(1993-8#1)(1994-11#1)(1994-7#3)(1995-12#2)(1995-9#3)(1996-3#2)(1997-3#1)(1997-5#1)(2004-10#1)(2006-10#1)(2006-12#2)(2006-5#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#4)(2008-7#3)(2008-9#1)(2009-3#1)(2010-11#1)(2010-4#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-8#1)(2013-1#1)(2013-8#2)
per cent reported##2##3##(1991-6#2)
per cent volume of the stroma##2##6##(2012-12#2)
per cent volume of the##3##5##(2012-12#3)
per cent volume##4##3##(2008-10#1)(2012-12#3)
per cent were##3##3##(1990-5#2)(2007-3#1)
per cent with the##2##4##(1992-5#2)
per cent with##5##3##(1990-6#1)(1992-5#2)(1993-1#1)(1994-4#1)
per cent##219##2##(1990-12#1)(1990-4#2)(1990-5#5)(1990-6#7)(1990-9#3)(1991-2#3)(1991-3#2)(1991-4#1)(1991-6#4)(1991-8#1)(1992-10#5)(1992-11#1)(1992-2#7)(1992-3#1)(1992-5#14)(1992-6#3)(1992-9#3)(1993-1#9)(1993-10#10)(1993-11#1)(1993-2#3)(1993-5#2)(1993-8#6)(1993-9#1)(1994-11#1)(1994-4#4)(1994-7#6)(1994-8#1)(1995-12#10)(1995-8#6)(1995-9#3)(1996-3#2)(1996-6#2)(1996-7#1)(1996-8#4)(1996-9#1)(1997-3#5)(1997-5#1)(1997-6#6)(1997-8#1)(2004-1#1)(2004-10#2)(2006-10#1)(2006-12#3)(2006-5#1)(2006-8#1)(2006-9#1)(2007-3#3)(2007-6#1)(2007-7#2)(2007-8#5)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-3#1)(2010-11#1)(2010-2#1)(2010-4#2)(2011-1#1)(2011-2#4)(2012-12#9)(2012-2#3)(2012-3#1)(2012-8#1)(2013-1#1)(2013-8#2)
per cent) and##2##3##(1991-11#1)(1996-8#1)
per cent) of the##10##4##(1990-3#5)(1994-7#1)(1995-9#1)(1997-8#2)(2011-1#1)
per cent) of##11##3##(1990-3#5)(1994-7#1)(1995-9#1)(1997-8#2)(2011-1#2)
per cent)##24##2##(1990-3#5)(1990-9#1)(1991-11#4)(1994-7#1)(1995-9#1)(1996-8#5)(1996-9#1)(1997-8#2)(2007-8#1)(2011-1#3)
per centimeter of##2##3##(2006-8#1)(2008-10#1)
per chain##2##2##(1991-2#1)(1994-9#1)
per channel##11##2##(2005-4#1)(2007-12#2)(2008-2#3)(2008-3#3)(2008-4#1)(2012-3#1)
per chromosome##2##2##(2008-12#2)
per cluster##4##2##(2007-12#2)(2009-11#1)(2010-10#1)
per clutch##2##2##(2008-3#2)
per cm##2##2##(1991-3#1)(2008-10#1)
per cm(2) of##2##3##(2008-10#1)(2008-5#1)
per cm(2))##3##2##(2008-10#3)
per cm2##2##2##(2011-2#2)
per colony##3##2##(1997-2#1)(2006-4#1)(2008-10#1)
per concentration level) overestimated##2##4##(2008-10#2)
per concentration level)##4##3##(2008-10#4)
per concentration##11##2##(2008-10#11)
per cow##3##2##(2007-8#3)
per cubic centimeter##2##3##(2007-11#1)(2010-7#1)
per cubic meter of air)##2##5##(2006-12#1)(2008-5#1)
per cubic##6##2##(2005-11#1)(2006-12#1)(2007-11#1)(2008-5#1)(2010-7#1)(2013-8#1)
per culture##2##2##(1990-7#1)(2007-9#1)
per cycle of##2##3##(1996-4#1)(2008-7#1)
per cycle##10##2##(1992-2#2)(1996-4#1)(1997-6#1)(2006-5#1)(2008-10#3)(2008-7#2)
per cytokine)##3##2##(1992-8#3)
per d and the##2##4##(2008-12#2)
per d##4##2##(2007-8#1)(2008-12#2)(2008-6#1)
per data##2##2##(2008-2#1)(2008-3#1)
per day and##8##3##(1990-12#1)(1990-7#1)(1992-3#1)(1995-3#1)(1997-3#1)(2008-10#1)(2008-7#1)(2008-8#1)
per day can##2##3##(2008-5#1)(2008-7#1)
per day for 3##5##4##(1993-3#3)(2007-8#1)(2012-3#1)
per day for 5##2##4##(2007-8#1)(2008-12#1)
per day for##21##3##(1990-10#1)(1990-9#1)(1992-3#2)(1993-3#3)(1995-3#1)(1997-8#1)(2007-11#1)(2007-7#2)(2007-8#3)(2008-12#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-3#1)
per day in the##3##4##(1991-2#2)(2010-6#1)
per day in##7##3##(1991-2#2)(1991-6#1)(1995-12#1)(2007-9#1)(2008-12#1)(2010-6#1)
per day is##3##3##(1990-11#1)(1993-9#1)(2010-6#1)
per day of##9##3##(1990-9#1)(1994-6#1)(1995-3#2)(2007-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
per day on the##2##4##(2008-10#1)(2013-8#1)
per day on##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
per day showed##3##3##(1993-4#1)(2007-12#1)(2011-1#1)
per day to##2##3##(2011-11#1)(2013-1#1)
per day was##8##3##(1994-6#2)(1995-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-12#1)(2013-1#1)
per day were##2##3##(1991-11#1)(2008-10#1)
per day with##2##3##(2006-10#1)(2008-5#1)
per day##176##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-5#1)(1990-7#1)(1990-9#3)(1991-11#3)(1991-2#2)(1991-3#1)(1991-6#2)(1991-9#1)(1992-3#5)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#2)(1993-7#1)(1993-9#3)(1994-12#1)(1994-2#4)(1994-3#1)(1994-6#5)(1994-7#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-3#9)(1995-8#1)(1995-9#2)(1996-1#2)(1996-10#1)(1996-3#1)(1996-4#2)(1997-3#2)(1997-5#1)(1997-8#1)(2005-7#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#5)(2008-12#4)(2008-2#2)(2008-3#2)(2008-5#7)(2008-6#1)(2008-7#10)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-6#2)(2010-8#4)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#2)(2012-12#4)(2012-3#3)(2013-1#9)(2013-4#1)(2013-7#1)(2013-8#2)
per day) for##2##3##(1995-2#1)(2009-12#1)
per day) in##2##3##(1991-11#1)(2007-8#1)
per day) on##2##3##(1993-3#1)(2008-3#1)
per day) was##3##3##(1993-7#1)(1996-12#1)(2008-10#1)
per day)##34##2##(1991-11#1)(1991-7#1)(1991-8#1)(1992-12#1)(1993-3#1)(1993-7#1)(1994-2#3)(1994-6#3)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#4)(1996-12#3)(1997-7#2)(2005-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2009-12#1)(2011-12#1)(2013-1#2)
per decade and a detection limit of##2##7##(2008-10#2)
per decade and a detection limit##3##6##(2008-10#3)
per decade and a##4##4##(2008-10#4)
per decade and##6##3##(2008-10#6)
per decade change in##2##4##(2008-10#2)
per decade for##2##3##(2008-10#2)
per decade of activity##5##4##(2008-10#5)
per decade of##6##3##(2008-10#6)
per decade##41##2##(1996-5#1)(2008-10#40)
per decade)##6##2##(2008-10#5)(2011-1#1)
per degree of tilt##2##4##(2008-2#2)
per degree of##3##3##(2006-7#1)(2008-2#2)
per determination and##2##3##(2008-10#2)
per determination were also achieved##2##5##(2008-10#2)
per determination##16##2##(2007-10#1)(2007-8#1)(2008-10#14)
per determination)##3##2##(2008-10#3)
per diem cost##2##3##(1991-12#1)(1993-12#1)
per diem##6##2##(1990-12#1)(1991-12#2)(1993-12#2)(1994-2#1)
per dimer##2##2##(1990-5#1)(1991-11#1)
per dish)##2##2##(1995-3#1)(2008-10#1)
per dose##8##2##(2007-11#2)(2007-8#2)(2008-10#2)(2008-5#1)(2012-12#1)
per ear##4##2##(2008-10#1)(2011-2#3)
per enrollee##2##2##(1993-3#1)(1996-1#1)
per enrollee)##2##2##(1991-2#1)(2011-2#1)
per enzyme subunit##5##3##(1994-5#2)(1994-6#1)(1994-9#1)(1997-1#1)
per enzyme##11##2##(1992-6#1)(1994-5#2)(1994-6#1)(1994-9#1)(1996-7#3)(1997-1#1)(2008-7#2)
per episode##3##2##(2005-12#2)(2007-8#1)
per erythrocyte##2##2##(1990-12#2)
per explant for Mentha##2##4##(2013-1#2)
per female##3##2##(2008-3#1)(2008-8#1)(2011-2#1)
per field##3##2##(2008-10#2)(2008-6#1)
per flower##6##2##(2008-10#3)(2008-12#1)(2009-12#2)
per fraction##6##2##(1992-10#1)(1993-9#1)(2007-8#2)(2008-6#1)(2009-8#1)
per frame##2##2##(2008-3#1)(2011-1#1)
per g liver at##2##4##(1996-12#2)
per g of soil##8##4##(2008-10#8)
per g of tissue##7##4##(1991-8#1)(1995-2#3)(1996-5#1)(2008-10#2)
per g of##26##3##(1991-8#3)(1995-2#3)(1995-8#1)(1996-4#1)(1996-5#1)(2008-10#17)
per g##33##2##(1990-8#1)(1991-8#3)(1993-12#1)(1994-12#1)(1995-2#3)(1995-8#1)(1995-9#1)(1996-12#2)(1996-4#1)(1996-5#1)(2007-1#1)(2008-10#17)
per g)##2##2##(2012-1#2)
per gene##12##2##(1990-4#1)(1992-4#4)(1997-6#1)(1997-8#1)(2010-6#1)(2012-3#4)
per generation##5##2##(2008-10#2)(2008-8#3)
per genome per generation##2##4##(2008-8#2)
per genome##7##2##(1990-11#1)(1997-2#1)(2008-10#2)(2008-8#2)(2010-12#1)
per gram of cellulose##2##4##(2008-5#1)(2011-2#1)
per gram of root##3##4##(2008-10#3)
per gram of soil##9##4##(2008-10#9)
per gram of soil) significantly reduced##2##6##(2008-10#2)
per gram of soil)##6##4##(2008-10#6)
per gram of tissue##3##4##(2008-11#1)(2009-5#2)
per gram of##42##3##(1990-9#1)(1991-4#1)(1993-11#1)(1993-12#1)(2005-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#25)(2008-11#3)(2008-5#1)(2009-5#2)(2011-1#1)(2011-2#2)
per gram##50##2##(1990-8#1)(1990-9#1)(1991-4#1)(1993-11#1)(1993-12#1)(2005-11#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#26)(2008-11#3)(2008-5#2)(2009-5#2)(2010-10#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#1)
per group and##2##3##(2008-12#1)(2008-4#1)
per group##13##2##(1997-3#1)(2004-12#1)(2007-1#1)(2008-10#3)(2008-12#1)(2008-4#2)(2009-5#2)(2009-8#1)(2010-4#1)
per group)##7##2##(1990-5#1)(1996-3#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
per h in##3##3##(1991-5#2)(2007-8#1)
per h##39##2##(1991-1#1)(1991-5#3)(1992-10#2)(1992-2#1)(1992-6#1)(1995-3#1)(1996-5#1)(1997-2#1)(1997-5#3)(2007-8#3)(2008-10#22)
per h) with##2##3##(1992-10#1)(2008-10#1)
per h)##8##2##(1990-8#3)(1992-10#1)(1993-11#1)(2008-10#3)
per haploid genome##2##3##(1996-4#1)(1997-2#1)
per haploid##3##2##(1991-1#1)(1996-4#1)(1997-2#1)
per head##2##2##(2008-10#2)
per heart in the##2##4##(2010-6#2)
per hectare and##2##3##(2008-2#2)
per hectare##4##2##(2008-12#2)(2008-2#2)
per hexamer##3##2##(1992-11#2)(1995-11#1)
per hospital##4##2##(2007-8#1)(2008-11#3)
per hour and is##2##4##(2008-10#2)
per hour and relative standard##3##5##(2008-10#3)
per hour and##10##3##(2008-10#10)
per hour for a##2##4##(2008-10#2)
per hour using##2##3##(2008-10#1)(2011-1#1)
per hour was achieved##4##4##(2008-10#3)(2008-7#1)
per hour was##6##3##(2008-10#5)(2008-7#1)
per hour were achieved##2##4##(2008-10#2)
per hour were also achieved##2##5##(2007-10#1)(2008-10#1)
per hour were##5##3##(2007-10#1)(2007-8#1)(2008-10#3)
per hour with a relative standard deviation of##3##8##(2008-10#3)
per hour with a relative standard deviation##5##7##(2008-10#5)
per hour with a relative##6##5##(2008-10#6)
per hour with a##7##4##(2008-10#7)
per hour##103##2##(1993-8#1)(2005-4#1)(2007-10#2)(2007-8#3)(2007-9#3)(2008-10#84)(2008-2#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#5)
per hundred thousand in##2##4##(2012-3#2)
per hundred thousand##3##3##(2012-12#1)(2012-3#2)
per hundred##10##2##(1992-2#1)(2008-5#6)(2012-12#1)(2012-3#2)
per image##2##2##(2012-12#2)
per individual##4##2##(1994-6#1)(2008-11#1)(2008-4#1)(2008-5#1)
per infected##2##2##(2008-10#2)
per inhabitant##3##2##(1990-9#1)(1991-5#1)(2007-2#1)
per injection and the##2##4##(1992-2#1)(2008-10#1)
per injection##9##2##(1992-2#1)(1996-1#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#3)(2013-8#1)
per inter-spawning interval##2##3##(2010-8#2)
per isolate was##2##3##(2006-4#1)(2008-10#1)
per isolate##3##2##(2006-4#1)(2008-10#2)
per kg body weight##2##4##(1993-7#1)(2008-9#1)
per kg body wt##3##4##(1993-4#2)(2007-8#1)
per kg body##5##3##(1993-4#2)(1993-7#1)(2007-8#1)(2008-9#1)
per kg of body mass##2##5##(2008-5#2)
per kg of body##3##4##(1995-2#1)(2008-5#2)
per kg of diet##4##4##(2008-5#4)
per kg of##11##3##(1995-2#1)(2007-2#2)(2008-10#1)(2008-5#6)(2013-1#1)
per kg per##2##3##(1995-1#1)(2007-7#1)
per kg##26##2##(1991-11#3)(1991-5#1)(1993-4#2)(1993-7#1)(1995-1#1)(1995-2#1)(2007-2#3)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#7)(2008-9#1)(2009-6#1)(2013-1#1)
per kg)##2##2##(1994-3#1)(2008-10#1)
per kilogram body##2##3##(1991-2#1)(1997-8#1)
per kilogram of body weight##2##5##(2007-8#1)(2011-3#1)
per kilogram of body##5##4##(2006-4#2)(2007-8#1)(2008-5#1)(2011-3#1)
per kilogram of##8##3##(2004-11#1)(2006-4#2)(2007-8#1)(2008-10#2)(2008-5#1)(2011-3#1)
per kilogram##12##2##(1991-2#1)(1996-12#1)(1997-8#1)(2004-11#1)(2006-4#2)(2007-8#2)(2008-10#2)(2008-5#1)(2011-3#1)
per larva##3##2##(2008-12#2)(2008-7#1)
per leaf and##3##3##(2008-10#3)
per leaf##11##2##(2008-10#11)
per leaf)##2##2##(2008-10#2)
per leaflet##4##2##(2008-10#4)
per lesion were##2##3##(2008-10#2)
per lesion##9##2##(1995-1#1)(2008-10#8)
per life-year gained##5##3##(2006-12#4)(2012-12#1)
per life-year##6##2##(2006-12#5)(2012-12#1)
per liter culture##2##3##(1992-8#1)(2010-2#1)
per liter levels in the##2##5##(1997-4#1)(2010-6#1)
per liter levels in##4##4##(1997-4#1)(2008-10#2)(2010-6#1)
per liter levels##5##3##(1997-4#1)(2008-10#3)(2010-6#1)
per liter of culture##2##4##(1990-12#1)(1997-4#1)
per liter of##6##3##(1990-12#1)(1992-7#1)(1995-8#1)(1997-4#1)(2007-12#1)(2011-2#1)
per liter range##3##3##(2008-10#3)
per liter##28##2##(1990-12#1)(1992-7#1)(1992-8#1)(1993-11#1)(1995-8#1)(1997-4#2)(2006-3#2)(2007-12#1)(2007-8#1)(2008-10#12)(2008-5#1)(2008-6#1)(2010-2#1)(2010-6#1)(2011-2#1)
per litre##5##2##(1996-2#1)(2008-10#4)
per litter##3##2##(1996-12#1)(2008-8#1)(2013-7#1)
per m##3##2##(2007-3#2)(2008-10#1)
per m(2)##3##2##(2008-10#3)
per mL##3##2##(1991-3#1)(2008-11#1)(2008-8#1)
per meter##4##2##(1990-5#1)(2008-10#2)(2012-11#1)
per mg membrane protein##2##4##(1997-7#1)(2008-11#1)
per mg of membrane protein##3##5##(1990-5#3)
per mg of mitochondrial protein##3##5##(1994-12#3)
per mg of##12##3##(1990-5#3)(1991-10#1)(1992-12#1)(1992-7#1)(1994-12#3)(1995-8#1)(2006-8#1)(2008-4#1)
per mg protein##23##3##(1990-1#1)(1990-2#1)(1990-8#2)(1991-12#1)(1991-5#5)(1991-9#1)(1992-12#2)(1992-4#1)(1993-9#1)(1994-8#2)(1997-6#6)
per mg protein)##4##3##(1993-9#1)(1994-12#1)(2007-8#2)
per mg##45##2##(1990-1#1)(1990-2#1)(1990-5#3)(1990-8#2)(1991-10#1)(1991-12#1)(1991-3#1)(1991-5#5)(1991-9#1)(1992-12#3)(1992-4#1)(1992-7#1)(1993-9#2)(1994-12#4)(1994-8#2)(1995-1#1)(1995-8#2)(1997-6#6)(1997-7#1)(2006-8#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-4#1)
per milligram of dust##2##4##(2013-8#2)
per milligram of##3##3##(2008-10#1)(2013-8#2)
per milligram protein##2##3##(1990-4#1)(1994-3#1)
per milligram##7##2##(1990-4#1)(1994-3#1)(2008-10#1)(2008-4#2)(2013-8#2)
per milliliter level##2##3##(2008-10#2)
per milliliter levels##2##3##(2008-10#2)
per milliliter##10##2##(1991-1#1)(2004-4#1)(2006-10#1)(2008-1#1)(2008-10#5)(2011-12#1)
per millilitre##3##2##(2008-10#1)(2011-1#2)
per million (95%CI##4##3##(2011-2#4)
per million cells##2##3##(1990-4#1)(2008-11#1)
per million in##4##3##(1995-5#1)(2008-2#1)(2008-3#1)(2010-3#1)
per million males##2##3##(1995-5#2)
per million of##2##3##(1994-7#1)(2007-2#1)
per million per year##7##4##(1993-10#1)(1997-5#1)(2011-1#3)(2013-1#2)
per million persons per##2##4##(2010-3#2)
per million persons##3##3##(2010-3#3)
per million##56##2##(1990-4#1)(1992-6#1)(1993-10#2)(1994-3#2)(1994-7#3)(1995-5#5)(1997-5#1)(2004-9#2)(2006-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#7)(2008-5#1)(2008-7#2)(2010-3#4)(2011-1#3)(2011-12#1)(2011-2#4)(2012-12#5)(2013-1#2)(2013-7#1)
per million)##3##2##(2010-3#2)(2011-1#1)
per min and##2##3##(1993-12#1)(1994-8#1)
per min during##2##3##(1991-10#1)(1995-10#1)
per min in##2##3##(1991-5#1)(1997-5#1)
per min per mg protein##8##5##(1991-5#2)(1997-6#6)
per min per mg##9##4##(1991-5#2)(1995-1#1)(1997-6#6)
per min##25##2##(1991-10#1)(1991-5#4)(1991-6#1)(1992-3#3)(1993-12#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-12#1)(1997-5#1)(1997-6#6)(2008-10#2)(2008-11#1)
per min)##7##2##(1992-9#2)(1993-12#1)(1996-12#1)(1997-5#1)(2007-8#1)(2008-10#1)
per minute for##3##3##(1990-12#1)(1994-11#1)(2011-2#1)
per minute was##2##3##(2007-8#1)(2008-10#1)
per minute##24##2##(1990-12#1)(1990-4#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1996-3#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-6#1)(2010-7#1)(2011-12#5)(2011-2#2)(2012-2#2)
per minute)##2##2##(1996-8#1)(2008-10#1)
per ml in##2##3##(2008-11#1)(2011-12#1)
per ml of##6##3##(1990-6#1)(1993-8#1)(2006-8#1)(2008-10#3)
per ml using##2##3##(2008-10#2)
per ml was##2##3##(1990-12#1)(2008-10#1)
per ml##35##2##(1990-12#2)(1990-6#1)(1991-8#2)(1993-8#1)(1994-5#2)(2006-1#1)(2006-8#1)(2008-10#19)(2008-11#2)(2008-5#1)(2009-8#1)(2011-12#1)(2012-3#1)
per ml)##9##2##(1992-4#1)(2008-10#8)
per mm(2) of pellet at 713 cm(-1)##2##7##(2008-10#2)
per mm(2) of pellet at##4##5##(2008-10#4)
per mol of##7##3##(1990-10#2)(1992-11#1)(1994-11#1)(1996-10#1)(1996-9#1)(2008-10#1)
per mol##12##2##(1990-10#2)(1990-12#2)(1990-3#1)(1992-11#1)(1993-8#1)(1994-11#1)(1996-10#1)(1996-9#1)(2008-10#2)
per mole of enzyme##3##4##(1990-4#1)(1992-5#1)(1993-11#1)
per mole of protein##4##4##(1991-8#1)(1992-2#1)(1993-6#1)(1997-7#1)
per mole of##23##3##(1990-4#1)(1990-7#2)(1990-9#1)(1991-7#3)(1991-8#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-5#1)(1997-7#1)(2006-8#1)(2008-10#2)(2008-4#1)(2010-11#1)
per mole##24##2##(1990-4#1)(1990-7#2)(1990-9#1)(1991-7#3)(1991-8#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-5#1)(1997-4#1)(1997-7#1)(2006-8#1)(2008-10#2)(2008-4#1)(2010-11#1)
per molecule of the##2##4##(1991-9#1)(1993-3#1)
per molecule of##5##3##(1991-5#1)(1991-9#1)(1992-1#1)(1993-3#1)(1995-1#1)
per molecule##19##2##(1990-12#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-9#2)(1992-1#2)(1992-3#2)(1993-3#1)(1995-1#1)(1995-5#1)(1997-6#1)(1997-8#1)(2005-11#2)(2007-12#1)(2010-2#1)
per monomer##5##2##(1991-4#1)(1992-4#1)(1995-3#1)(1996-4#1)(2008-10#1)
per month and##2##3##(1990-12#1)(1993-9#1)
per month in##2##3##(1995-12#2)
per month##19##2##(1990-12#1)(1993-1#1)(1993-9#1)(1995-12#3)(1997-6#1)(2006-12#1)(2006-5#1)(2007-2#1)(2007-3#2)(2007-7#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-12#2)
per month)##3##2##(1992-11#1)(2008-10#2)
per mouse##11##2##(1990-5#1)(1990-6#1)(1990-7#4)(1992-7#1)(1993-8#1)(1995-2#1)(1996-11#1)(2008-12#1)
per mug##2##2##(2008-10#1)(2008-11#1)
per mutants##2##2##(1995-9#2)
per nucleotide##4##2##(1993-8#1)(1996-4#1)(2006-10#1)(2007-11#1)
per nucleus##3##2##(1993-12#1)(2006-5#1)(2008-5#1)
per nurse##2##2##(2008-1#1)(2013-8#1)
per one##5##2##(1990-9#1)(1991-1#1)(1992-5#1)(2008-1#1)(2011-1#1)
per operation decreased##2##3##(2007-8#2)
per operation##7##2##(1996-9#1)(2007-3#1)(2007-8#5)
per os for##2##3##(2006-2#2)
per os with##2##3##(2005-9#1)(2009-8#1)
per os##17##2##(1991-3#1)(1993-12#1)(1996-6#1)(1997-6#1)(2005-9#1)(2006-2#2)(2006-6#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-2#3)(2009-8#1)
per pH unit##3##3##(1996-4#1)(2007-8#1)(2008-10#1)
per pH##4##2##(1996-4#1)(2007-8#1)(2008-10#2)
per page##2##2##(2008-3#2)
per paid hour##2##3##(1992-3#2)
per part water##2##3##(2005-11#2)
per particle##2##2##(1993-6#1)(2008-3#1)
per patient and##6##3##(2006-8#2)(2007-8#2)(2011-1#1)(2013-7#1)
per patient eligible day##2##4##(1997-2#2)
per patient of##2##3##(2006-8#1)(2008-6#1)
per patient per##3##3##(2006-5#1)(2007-7#1)(2008-5#1)
per patient was##11##3##(1990-9#1)(1991-12#1)(1991-8#1)(2006-6#1)(2007-8#2)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
per patient with##3##3##(2007-11#2)(2011-2#1)
per patient##58##2##(1990-9#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-5#1)(1993-1#1)(1996-3#2)(1996-9#1)(1997-1#1)(1997-2#2)(2005-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#4)(2007-10#1)(2007-11#2)(2007-6#2)(2007-7#3)(2007-8#8)(2008-1#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2011-1#2)(2011-2#5)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
per patient) of##2##3##(2007-10#1)(2012-1#1)
per patient) were##2##3##(1992-5#1)(2013-1#1)
per patient)##9##2##(1992-5#1)(2007-10#1)(2007-8#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
per patient-year##2##2##(2006-1#1)(2013-7#1)
per pen##3##2##(2008-7#1)(2010-2#1)(2012-2#1)
per perithecium##2##2##(2008-10#2)
per person per day##4##4##(1990-9#2)(2013-1#2)
per person per##5##3##(1990-9#2)(1993-1#1)(2013-1#2)
per person##17##2##(1990-9#2)(1993-1#1)(1993-9#1)(1996-3#1)(2006-8#1)(2007-8#3)(2008-10#1)(2008-8#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
per petri dish##2##3##(2008-10#1)(2008-6#1)
per pixel##3##2##(2008-2#2)(2011-1#1)
per pl-carnitine##3##2##(2008-10#3)
per plant were##2##3##(2008-10#1)(2008-5#1)
per plant##26##2##(2007-1#5)(2008-10#12)(2008-12#4)(2008-5#2)(2008-8#1)(2011-2#1)(2013-8#1)
per plant)##3##2##(2006-12#1)(2008-10#1)(2013-8#1)
per plate##2##2##(1996-3#1)(2008-10#1)
per plot##3##2##(2008-10#3)
per plot)##2##2##(2008-10#2)
per population##2##2##(2008-10#1)(2009-5#1)
per porphyrin molecule##2##3##(2008-10#2)
per prescription##3##2##(2010-12#2)(2010-5#1)
per procedure was##2##3##(2006-8#2)
per procedure##5##2##(2006-8#5)
per product)##2##2##(2008-5#2)
per protein##4##2##(1992-4#1)(1992-6#1)(1992-9#1)(1994-5#1)
per protocol##4##2##(2007-10#1)(2008-7#2)(2010-12#1)
per pseudothecium##2##2##(2008-10#2)
per publication##2##2##(2013-1#2)
per pulse##6##2##(2007-12#4)(2008-2#1)(2010-1#1)
per pycnidium##2##2##(2008-10#2)
per quality-adjusted life year (QALY) gained##2##6##(2007-8#1)(2012-12#1)
per quality-adjusted##3##2##(2006-12#1)(2007-8#1)(2012-12#1)
per quarter##2##2##(1992-9#1)(2012-2#1)
per rat##3##2##(1993-11#1)(1993-7#1)(2010-12#1)
per reaction##3##2##(1994-8#1)(2008-4#1)(2013-1#1)
per recipient and##2##3##(1990-3#1)(1997-2#1)
per recipient##3##2##(1990-3#1)(1991-8#1)(1997-2#1)
per rectum##3##2##(1993-9#1)(2007-8#1)(2008-3#1)
per replicate##3##2##(2008-10#1)(2008-12#1)(2010-2#1)
per room in##2##3##(2008-2#2)
per room##3##2##(2008-2#3)
per round##2##2##(1997-4#1)(2007-11#1)
per run##2##2##(2008-10#1)(2008-11#1)
per s)##2##2##(1992-3#1)(1995-1#1)
per sample of##2##3##(2008-10#1)(2008-5#1)
per sample were##2##3##(2008-10#2)
per sample##20##2##(1990-6#1)(1995-12#1)(2008-10#14)(2008-2#1)(2008-4#1)(2008-5#1)(2011-2#1)
per sample) and##3##3##(2008-10#2)(2010-5#1)
per sample)##4##2##(2007-8#1)(2008-10#2)(2010-5#1)
per sampling unit##2##3##(2008-10#1)(2011-2#1)
per scan##2##2##(2007-11#2)
per school##2##2##(2006-10#1)(2007-7#1)
per se and in combination##2##5##(2012-2#2)
per se and##4##3##(1991-5#1)(2008-1#1)(2012-2#2)
per se are##3##3##(1994-9#1)(2008-1#1)(2008-5#1)
per se but##4##3##(1995-6#1)(2003-11#1)(2004-11#1)(2012-2#1)
per se did not affect##2##5##(1996-1#1)(1997-8#1)
per se did not##3##4##(1995-11#1)(1996-1#1)(1997-8#1)
per se does not affect##2##5##(1992-9#1)(1994-11#1)
per se does not##3##4##(1992-9#1)(1994-11#1)(2008-1#1)
per se in##2##3##(1995-12#1)(2013-8#1)
per se is not sufficient##2##5##(2008-1#1)(2008-10#1)
per se is##10##3##(1993-3#1)(1994-3#1)(2005-10#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-10#1)
per se may##3##3##(1990-11#1)(1995-12#1)(2007-11#1)
per se on##2##3##(1990-2#1)(1993-5#1)
per se or##2##3##(1991-5#1)(2008-1#1)
per se##103##2##(1990-11#1)(1990-2#3)(1990-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-5#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-8#1)(2003-11#1)(2004-11#1)(2005-10#1)(2005-6#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-3#1)(2007-11#2)(2007-12#2)(2007-7#2)(2008-1#6)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#7)(2008-6#1)(2008-7#1)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#3)
per season##3##2##(2008-10#2)(2013-7#1)
per second in##2##3##(2007-12#1)(2010-12#1)
per second##31##2##(1992-1#1)(1993-2#2)(1996-5#2)(1997-5#1)(2006-11#1)(2007-11#1)(2007-12#4)(2007-9#2)(2008-10#3)(2008-2#6)(2008-3#3)(2008-4#1)(2008-6#1)(2008-9#1)(2010-12#1)(2011-1#1)
per second)##5##2##(1993-2#1)(1996-12#1)(1996-5#1)(2008-10#1)(2011-1#1)
per seedling##2##2##(2008-10#2)
per session##4##2##(2007-9#1)(2008-1#1)(2012-1#1)(2013-7#1)
per side##2##2##(2007-8#1)(2011-2#1)
per side)##2##2##(1993-6#1)(1996-1#1)
per site##8##2##(1995-2#1)(2006-12#1)(2007-3#1)(2007-5#1)(2008-10#2)(2008-6#1)(2013-7#1)
per slide was##2##3##(2008-10#2)
per slide##3##2##(2008-10#2)(2008-11#1)
per specimen##2##2##(2006-10#1)(2006-8#1)
per spot##5##2##(2007-8#1)(2008-10#4)
per square centimeter of leaf surface##2##6##(2008-10#2)
per square centimeter of##3##4##(2008-10#3)
per square centimeter##12##3##(1993-2#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#1)
per square centimeter)##2##3##(1990-8#1)(2008-2#1)
per square meter per##5##4##(1991-11#4)(2008-10#1)
per square meter##10##3##(1991-11#4)(1995-8#1)(2007-11#1)(2008-10#4)
per square##28##2##(1990-8#1)(1991-11#4)(1991-2#1)(1992-2#1)(1993-2#1)(1995-12#1)(1995-8#1)(1995-9#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-2#2)
per standard##2##2##(2010-12#1)(2011-12#1)
per study)##2##2##(2007-8#1)(2008-3#1)
per subject##2##2##(2008-7#1)(2012-3#1)
per subunit with##2##3##(1993-6#1)(1994-11#1)
per subunit##11##2##(1990-5#2)(1991-12#1)(1991-4#1)(1992-8#1)(1993-6#1)(1994-11#2)(1994-5#2)(1997-7#1)
per subunit)##3##2##(1990-9#2)(1991-5#1)
per surface unit##2##3##(1995-8#1)(2005-11#1)
per surface##3##2##(1993-12#1)(1995-8#1)(2005-11#1)
per testis##3##2##(1992-12#3)
per thousand and##3##3##(1990-12#1)(2008-5#1)(2012-3#1)
per thousand inhabitants##3##3##(1996-10#1)(1996-2#1)(2011-1#1)
per thousand##24##2##(1990-12#1)(1992-2#1)(1996-10#1)(1996-2#1)(2008-10#2)(2008-2#3)(2008-5#3)(2008-7#5)(2009-4#2)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
per thousand) and##2##3##(2008-5#2)
per thousand)##12##2##(1991-9#1)(2008-5#7)(2010-3#4)
per time##7##2##(1996-1#1)(2008-10#2)(2008-11#1)(2009-6#1)(2010-5#1)(2011-1#1)
per titration)##2##2##(2008-10#2)
per total##4##2##(1993-8#1)(1994-8#2)(2008-10#1)
per trap##2##2##(2008-5#1)(2011-1#1)
per treatment##7##2##(1996-8#1)(2006-5#1)(2008-3#1)(2008-5#1)(2010-2#2)(2013-7#1)
per tree)##2##2##(2008-10#2)
per trillion levels##3##3##(2007-8#1)(2008-10#2)
per trillion##8##2##(1996-5#1)(2007-8#1)(2008-10#6)
per trimer##3##2##(1992-9#2)(1995-1#1)
per unit area and##3##4##(1995-12#1)(2008-3#1)(2010-8#1)
per unit area of##3##4##(1997-5#1)(2008-10#1)(2008-7#1)
per unit area##13##3##(1995-12#1)(1997-5#1)(2004-12#1)(2008-10#2)(2008-12#2)(2008-3#2)(2008-7#1)(2008-8#1)(2010-8#1)(2013-8#1)
per unit increase in##3##4##(2007-10#2)(2010-10#1)
per unit infection##2##3##(2008-10#2)
per unit length of##2##4##(2008-2#1)(2008-5#1)
per unit length##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
per unit mass##2##3##(2008-10#2)
per unit of sporulating##2##4##(2008-10#2)
per unit of time##2##4##(1996-3#1)(2008-9#1)
per unit of##22##3##(1996-3#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-3#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-12#1)
per unit time##2##3##(1996-4#1)(2008-7#1)
per unit volume of##2##4##(1994-3#1)(1996-10#1)
per unit volume##4##3##(1994-3#1)(1996-10#1)(2005-11#1)(2008-2#1)
per unit weight)##2##3##(2007-12#2)
per unit##71##2##(1994-3#1)(1995-12#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-4#1)(1997-5#1)(2004-12#1)(2005-11#2)(2006-12#1)(2006-7#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-3#1)(2007-5#1)(2008-10#18)(2008-11#4)(2008-12#3)(2008-2#3)(2008-3#7)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#1)(2013-8#2)
per visit in##2##3##(2006-7#1)(2010-8#1)
per visit##9##2##(1992-6#1)(1995-12#1)(1995-3#2)(1995-5#1)(2006-7#1)(2006-8#2)(2010-8#1)
per volume of##2##3##(2008-11#1)(2008-7#1)
per week and##6##3##(2006-8#1)(2008-11#1)(2011-2#2)(2012-11#1)(2012-12#1)
per week during##3##3##(2007-7#2)(2012-12#1)
per week for 14 weeks##5##5##(2008-9#4)(2009-8#1)
per week for 28##4##4##(2007-7#1)(2008-9#3)
per week for 3##4##4##(1992-1#1)(1996-9#1)(2008-9#2)
per week for##48##3##(1990-4#2)(1992-1#1)(1994-6#1)(1995-12#1)(1996-9#1)(1997-3#1)(2005-1#1)(2006-6#1)(2007-7#2)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#26)(2009-8#1)(2012-1#1)(2013-1#3)(2013-8#1)
per week in##3##3##(1994-2#1)(1995-8#1)(2009-12#1)
per week of##2##3##(2007-7#1)(2010-9#1)
per week was##4##3##(1991-7#1)(2011-11#1)(2012-12#1)(2013-1#1)
per week##112##2##(1990-4#2)(1991-12#1)(1991-5#1)(1991-7#2)(1992-1#1)(1992-2#1)(1992-6#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-9#1)(1997-3#1)(2004-11#1)(2004-2#1)(2005-1#2)(2005-10#1)(2006-10#2)(2006-3#2)(2006-6#2)(2006-8#5)(2007-11#1)(2007-2#2)(2007-7#7)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#27)(2009-12#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-11#2)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#3)(2013-1#9)(2013-7#2)(2013-8#2)
per week)##6##2##(1991-7#1)(1992-10#1)(2008-10#1)(2008-5#1)(2008-7#2)
per weight##2##2##(1990-2#1)(1990-7#1)
per well##6##2##(1991-2#1)(2008-10#1)(2008-11#2)(2011-12#1)(2011-2#1)
per woman##3##2##(1990-10#1)(2008-5#1)(2011-12#1)
per woman-year##2##2##(2011-3#2)
per worker##4##2##(1994-1#2)(2010-2#1)(2010-5#1)
per year and##4##3##(1992-1#1)(1997-1#1)(1997-8#1)(2008-10#1)
per year for each##2##4##(2010-8#1)(2013-1#1)
per year for the past##2##5##(2007-9#1)(2013-7#1)
per year for##8##3##(1994-12#1)(2006-8#1)(2007-9#1)(2008-10#1)(2010-8#1)(2012-1#1)(2013-1#1)(2013-7#1)
per year has##2##3##(2006-8#1)(2010-7#1)
per year in males##2##4##(2008-3#1)(2010-3#1)
per year in the United States##2##6##(2008-6#1)(2010-3#1)
per year in the##6##4##(1993-10#1)(1993-3#1)(2007-7#1)(2008-6#1)(2009-8#1)(2010-3#1)
per year in##13##3##(1990-12#2)(1993-10#1)(1993-3#1)(1994-3#1)(1994-6#1)(2007-7#1)(2008-3#1)(2008-6#1)(2009-8#1)(2010-3#2)(2011-2#1)
per year of life##2##4##(1993-9#2)
per year of treatment##2##4##(2007-11#2)
per year of##7##3##(1993-9#2)(1996-7#1)(2007-11#2)(2008-8#1)(2013-8#1)
per year or##2##3##(1990-6#1)(1997-3#1)
per year was##2##3##(1991-4#1)(2006-8#1)
per year were##3##3##(1994-2#1)(2007-7#1)(2009-3#1)
per year##167##2##(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-2#1)(1991-4#3)(1991-5#2)(1991-6#1)(1991-8#1)(1992-1#3)(1992-2#2)(1992-5#1)(1992-9#1)(1993-10#2)(1993-2#2)(1993-3#2)(1993-9#4)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-5#2)(1997-8#1)(2004-2#1)(2004-8#1)(2005-8#2)(2005-9#1)(2006-10#2)(2006-6#1)(2006-8#5)(2007-11#2)(2007-2#4)(2007-4#2)(2007-6#1)(2007-7#3)(2007-8#11)(2007-9#4)(2008-1#3)(2008-10#6)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#7)(2009-11#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-3#4)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#2)
per year) and##3##3##(2008-8#1)(2010-3#1)(2012-3#1)
per year)##12##2##(1992-2#1)(1992-7#1)(2004-9#1)(2006-1#1)(2007-2#1)(2008-10#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-3#1)(2012-3#1)
per##3480##1##(1990-1#1)(1990-10#4)(1990-11#5)(1990-12#30)(1990-2#8)(1990-3#9)(1990-4#15)(1990-5#17)(1990-6#16)(1990-7#13)(1990-8#12)(1990-9#27)(1991-1#10)(1991-10#8)(1991-11#25)(1991-12#8)(1991-2#15)(1991-3#8)(1991-4#11)(1991-5#26)(1991-6#13)(1991-7#10)(1991-8#15)(1991-9#7)(1992-1#14)(1992-10#10)(1992-11#6)(1992-12#12)(1992-2#24)(1992-3#21)(1992-4#13)(1992-5#20)(1992-6#12)(1992-7#6)(1992-8#6)(1992-9#12)(1993-1#14)(1993-10#14)(1993-11#8)(1993-12#15)(1993-2#15)(1993-3#17)(1993-4#5)(1993-5#4)(1993-6#7)(1993-7#8)(1993-8#22)(1993-9#18)(1994-1#5)(1994-10#2)(1994-11#8)(1994-12#15)(1994-2#17)(1994-3#12)(1994-4#4)(1994-5#12)(1994-6#19)(1994-7#14)(1994-8#19)(1994-9#9)(1995-1#14)(1995-10#6)(1995-11#9)(1995-12#28)(1995-2#16)(1995-3#21)(1995-4#1)(1995-5#16)(1995-6#3)(1995-7#7)(1995-8#23)(1995-9#14)(1996-1#10)(1996-10#6)(1996-11#5)(1996-12#24)(1996-2#8)(1996-3#21)(1996-4#11)(1996-5#12)(1996-6#7)(1996-7#7)(1996-8#16)(1996-9#8)(1997-1#12)(1997-2#16)(1997-3#16)(1997-4#11)(1997-5#14)(1997-6#25)(1997-7#10)(1997-8#19)(2003-11#1)(2004-1#3)(2004-10#3)(2004-11#10)(2004-12#2)(2004-2#6)(2004-4#1)(2004-8#1)(2004-9#3)(2005-1#2)(2005-10#4)(2005-11#14)(2005-12#3)(2005-4#2)(2005-6#1)(2005-7#2)(2005-8#8)(2005-9#3)(2006-1#4)(2006-10#25)(2006-11#2)(2006-12#22)(2006-2#6)(2006-3#6)(2006-4#7)(2006-5#15)(2006-6#5)(2006-7#3)(2006-8#33)(2006-9#3)(2007-1#12)(2007-10#14)(2007-11#30)(2007-12#45)(2007-2#25)(2007-3#24)(2007-4#5)(2007-5#8)(2007-6#10)(2007-7#37)(2007-8#97)(2007-9#17)(2008-1#36)(2008-10#616)(2008-11#60)(2008-12#34)(2008-2#61)(2008-3#64)(2008-4#22)(2008-5#93)(2008-6#17)(2008-7#62)(2008-8#41)(2008-9#55)(2009-10#1)(2009-11#3)(2009-12#6)(2009-2#5)(2009-3#3)(2009-4#7)(2009-5#7)(2009-6#9)(2009-8#13)(2009-9#3)(2010-1#3)(2010-10#8)(2010-11#8)(2010-12#13)(2010-2#13)(2010-3#15)(2010-4#9)(2010-5#8)(2010-6#7)(2010-7#9)(2010-8#21)(2010-9#9)(2011-1#46)(2011-11#3)(2011-12#16)(2011-2#100)(2011-3#4)(2012-1#12)(2012-11#5)(2012-12#56)(2012-2#36)(2012-3#26)(2012-6#1)(2012-8#1)(2013-1#76)(2013-4#1)(2013-7#24)(2013-8#40)
per- and##2##2##(2011-2#2)
per-cell##3##1##(1995-4#1)(1995-6#2)
per-episode prospective payment##2##3##(1995-3#2)
per-operative##3##1##(2007-11#2)(2007-8#1)
per-person##2##1##(2008-6#1)(2011-1#1)
per-plant##3##1##(2008-10#3)
per-sulfated##2##1##(2008-9#2)
per-wet-pellet volume##2##2##(2008-7#2)
peracarid##2##1##(2007-12#1)(2008-5#1)
peracetylated##2##1##(1996-2#2)
peracid##2##1##(2010-5#2)
peracute##3##1##(2007-2#1)(2008-7#2)
peralkylated diglycosyl hex-1-enitol##2##3##(1991-9#2)
perceive and##3##2##(2008-7#1)(2009-8#1)(2011-10#1)
perceive as##4##2##(1992-12#1)(2007-2#2)(2008-11#1)
perceive that##3##2##(2008-12#1)(2012-1#1)(2013-1#1)
perceive the##12##2##(1992-11#1)(1994-12#1)(2004-10#1)(2008-11#1)(2008-3#1)(2009-5#1)(2012-1#2)(2012-3#2)(2013-1#1)(2013-8#1)
perceive their general##2##3##(1991-11#1)(1996-6#1)
perceive their own health##3##4##(1994-6#1)(1996-6#2)
perceive their own##5##3##(1994-6#1)(1996-6#2)(2012-3#2)
perceive their##19##2##(1991-11#1)(1994-6#1)(1995-12#1)(1996-6#3)(2006-7#1)(2007-12#2)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#3)
perceive themselves as##3##3##(1996-1#1)(2007-12#1)(2008-11#1)
perceive themselves##5##2##(1996-1#1)(1997-7#1)(2007-12#1)(2007-2#1)(2008-11#1)
perceive##83##1##(1991-11#1)(1991-2#2)(1992-11#1)(1992-12#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-6#3)(1996-7#1)(1997-7#1)(2004-10#1)(2005-7#4)(2006-7#1)(2007-12#4)(2007-2#4)(2008-10#1)(2008-11#5)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#4)(2009-5#2)(2009-6#2)(2009-8#5)(2009-9#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-1#5)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#6)(2013-8#2)
perceived SL##2##2##(2012-12#2)
perceived a##5##2##(1994-1#1)(1997-3#1)(2008-9#1)(2011-2#1)(2012-3#1)
perceived advantages/disadvantages of texting##2##4##(2013-1#2)
perceived and actual##3##3##(2008-11#1)(2013-7#2)
perceived and##9##2##(2008-11#2)(2009-5#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-7#2)
perceived as a social##2##4##(2010-12#2)
perceived as a##9##3##(1990-11#1)(1994-6#1)(2006-2#1)(2007-7#1)(2010-12#4)(2010-4#1)
perceived as an##3##3##(2007-5#1)(2008-9#1)(2012-12#1)
perceived as being##3##3##(2006-4#1)(2011-2#1)(2012-1#1)
perceived as having##4##3##(2008-12#1)(2010-2#1)(2012-11#1)(2012-2#1)
perceived as the most##2##4##(2008-11#1)(2013-8#1)
perceived as the##3##3##(2008-11#2)(2013-8#1)
perceived as##49##2##(1990-11#1)(1994-6#1)(1996-1#1)(1996-12#1)(1996-2#2)(2005-10#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-5#1)(2007-7#2)(2008-10#1)(2008-11#4)(2008-12#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
perceived association##2##2##(2008-12#1)(2008-4#1)
perceived availability##2##2##(2013-1#2)
perceived barriers to a healthy##2##5##(2011-2#2)
perceived barriers to##7##3##(1997-1#1)(2005-10#1)(2007-12#1)(2010-7#1)(2011-2#3)
perceived barriers##9##2##(1995-12#1)(1997-1#1)(2005-10#1)(2007-12#1)(2008-7#1)(2010-7#1)(2011-2#3)
perceived behavioural control##4##3##(2009-9#1)(2010-2#1)(2010-3#2)
perceived benefits and barriers##2##4##(2006-10#1)(2007-12#1)
perceived benefits and##5##3##(1994-2#1)(2006-10#1)(2007-12#1)(2008-9#1)(2009-4#1)
perceived benefits of##2##3##(2007-8#1)(2011-2#1)
perceived benefits##10##2##(1994-2#1)(2006-10#1)(2007-12#3)(2007-8#1)(2008-11#1)(2008-9#1)(2009-4#1)(2011-2#1)
perceived by adolescents##2##3##(2009-7#1)(2010-9#1)
perceived by parents##2##3##(1992-2#1)(1995-1#1)
perceived by the patients##4##4##(2009-10#2)(2009-7#1)(2012-12#1)
perceived by the##15##3##(1991-8#2)(1994-1#1)(2008-11#1)(2008-3#1)(2009-10#2)(2009-6#2)(2009-7#1)(2009-8#1)(2012-12#2)(2013-1#2)
perceived by their##3##3##(2008-10#2)(2012-1#1)
perceived by##40##2##(1991-8#2)(1992-2#1)(1993-2#1)(1994-1#2)(1995-1#1)(2006-10#1)(2006-3#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-9#2)(2009-10#2)(2009-6#2)(2009-7#2)(2009-8#2)(2010-1#1)(2010-9#1)(2011-1#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)
perceived causes##2##2##(2006-2#1)(2006-7#1)
perceived coaching##2##2##(2008-9#2)
perceived competence##3##2##(2011-1#1)(2013-7#2)
perceived convenience of##2##3##(2011-2#1)(2012-12#1)
perceived declines in##3##3##(2011-2#3)
perceived degree of##2##3##(2012-2#1)(2013-8#1)
perceived differences##2##2##(1990-12#1)(2007-4#1)
perceived difficulty##4##2##(2013-1#4)
perceived discrimination##4##2##(2008-12#1)(2010-7#3)
perceived ease of use##3##4##(2009-9#1)(2013-1#2)
perceived effectiveness of##3##3##(2008-8#1)(2010-8#1)(2012-1#1)
perceived effectiveness##4##2##(1994-2#1)(2008-8#1)(2010-8#1)(2012-1#1)
perceived efficacy##3##2##(2008-11#1)(2010-6#1)(2010-9#1)
perceived emotional support##2##3##(2006-3#1)(2013-1#1)
perceived emotional##4##2##(2006-3#1)(2006-6#1)(2013-1#1)(2013-8#1)
perceived exertion##14##2##(2006-10#2)(2010-9#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#5)
perceived family functioning##2##3##(2006-7#2)
perceived family##4##2##(2006-7#2)(2009-7#1)(2010-10#1)
perceived feelings of being or thinking different##2##7##(2010-10#2)
perceived from##2##2##(1995-11#1)(2008-8#1)
perceived greater##2##2##(2009-4#1)(2011-1#1)
perceived health status##8##3##(2007-6#2)(2007-7#1)(2008-6#2)(2011-2#1)(2013-1#2)
perceived health##16##2##(1992-4#1)(1997-1#1)(2007-6#2)(2007-7#1)(2008-6#5)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#3)
perceived high##2##2##(1995-9#1)(2012-3#1)
perceived image##2##2##(2008-2#1)(2008-3#1)
perceived importance of social support##2##5##(2009-7#2)
perceived importance of##3##3##(1994-3#1)(2009-7#2)
perceived improvement##3##2##(1996-3#2)(2007-11#1)
perceived in the##2##3##(1994-12#1)(2008-10#1)
perceived in##5##2##(1994-12#1)(2008-10#1)(2009-7#1)(2010-11#1)(2010-8#1)
perceived intensity##5##2##(1992-4#2)(2008-10#3)
perceived lack of##2##3##(2008-10#1)(2013-1#1)
perceived learning outcome##3##3##(2011-2#3)
perceived learning##4##2##(2011-2#4)
perceived level of compliance##2##4##(2007-12#2)
perceived level of##4##3##(2007-11#1)(2007-12#2)(2012-2#1)
perceived levels of family##2##4##(2006-7#1)(2010-10#1)
perceived need for##4##3##(1991-2#1)(1994-12#1)(1995-12#1)(2005-7#1)
perceived need##5##2##(1991-2#1)(1994-12#1)(1995-12#1)(2005-12#1)(2005-7#1)
perceived neighborhood##3##2##(2009-7#2)(2011-2#1)
perceived norms regarding##2##3##(2013-1#2)
perceived norms##4##2##(2011-1#1)(2013-1#3)
perceived opportunity##2##2##(1994-3#1)(2009-5#1)
perceived parental##3##2##(2004-11#1)(2009-11#1)(2009-7#1)
perceived parenting##2##2##(2004-11#2)
perceived peer##5##2##(2009-7#3)(2010-9#1)(2013-1#1)
perceived pleasantness##2##2##(2008-5#1)(2012-12#1)
perceived prevalence of##3##3##(1991-12#1)(2013-1#2)
perceived problems with##2##3##(1997-7#1)(2011-2#1)
perceived problems##4##2##(1997-7#1)(2008-11#1)(2008-3#1)(2011-2#1)
perceived quality of life##2##4##(2010-12#1)(2011-1#1)
perceived quality of##10##3##(1993-12#1)(2007-7#1)(2007-8#1)(2008-11#2)(2009-4#1)(2010-12#1)(2010-4#1)(2011-1#1)(2013-1#1)
perceived quality##14##2##(1993-12#1)(1995-12#1)(1996-3#2)(2007-7#1)(2007-8#1)(2008-11#3)(2009-4#1)(2010-12#1)(2010-4#1)(2011-1#1)(2013-1#1)
perceived realism and subjective SA##2##5##(2011-2#2)
perceived realism##4##2##(2011-2#4)
perceived relationship satisfaction with mothers##2##5##(2009-7#2)
perceived relationship satisfaction##6##3##(2009-7#6)
perceived relationship##7##2##(2007-12#1)(2009-7#6)
perceived risk of##4##3##(1990-5#1)(1994-3#1)(2006-10#2)
perceived risk##9##2##(1990-5#1)(1994-3#4)(2006-10#2)(2008-11#1)(2008-8#1)
perceived safety when riding without support##2##6##(2012-12#2)
perceived safety##3##2##(2008-10#1)(2012-12#2)
perceived self-efficacy##3##2##(2006-6#1)(2009-3#1)(2010-9#1)
perceived service quality##2##3##(1995-2#1)(1996-3#1)
perceived service##3##2##(1993-12#1)(1995-2#1)(1996-3#1)
perceived severity and##2##3##(1990-8#1)(2010-3#1)
perceived severity##5##2##(1990-8#2)(2007-12#1)(2010-3#2)
perceived size##2##2##(2007-12#1)(2012-2#1)
perceived social support##5##3##(1992-2#1)(2009-7#1)(2010-1#2)(2010-7#1)
perceived social##6##2##(1992-2#1)(2009-7#2)(2010-1#2)(2010-7#1)
perceived stigma##2##2##(2007-7#1)(2012-12#1)
perceived strength##2##2##(2008-9#2)
perceived stress and depressive symptoms##8##5##(2006-9#2)(2012-11#6)
perceived stress and##10##3##(2006-9#4)(2012-11#6)
perceived stress##16##2##(2006-9#4)(2007-12#1)(2012-11#11)
perceived support##3##2##(2007-1#1)(2010-1#1)(2010-2#1)
perceived susceptibility to##2##3##(2008-4#1)(2011-2#1)
perceived susceptibility##6##2##(1990-8#3)(2008-4#2)(2011-2#1)
perceived that##9##2##(2007-11#1)(2007-7#1)(2009-7#1)(2010-8#1)(2011-2#1)(2013-1#3)(2013-8#1)
perceived the##10##2##(1992-2#1)(2007-9#1)(2008-11#1)(2009-5#1)(2010-11#1)(2012-12#1)(2012-3#2)(2013-1#2)
perceived their##5##2##(2008-9#1)(2009-7#1)(2011-2#2)(2012-3#1)
perceived themselves as##3##3##(1991-2#1)(1992-2#1)(2007-12#1)
perceived themselves to be at##2##5##(2012-3#2)
perceived themselves to be##3##4##(2012-2#1)(2012-3#2)
perceived themselves##6##2##(1991-2#1)(1992-2#1)(2007-12#1)(2012-2#1)(2012-3#2)
perceived they##2##2##(2008-11#1)(2010-7#1)
perceived to be a##2##4##(2007-2#1)(2008-7#1)
perceived to be at##2##4##(1993-3#1)(2010-2#1)
perceived to be in##2##4##(1991-2#1)(2006-4#1)
perceived to be more##2##4##(2006-7#1)(2009-7#1)
perceived to be##20##3##(1991-2#1)(1993-3#1)(1994-12#1)(1995-1#1)(2006-4#1)(2006-7#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-4#1)(2009-7#1)(2009-9#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)
perceived to have##2##3##(2008-11#1)(2009-7#1)
perceived to##25##2##(1991-2#1)(1993-3#1)(1994-12#1)(1995-1#1)(2006-4#1)(2006-7#1)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-4#1)(2009-7#2)(2009-9#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2012-3#1)(2013-1#1)
perceived usefulness##5##2##(2009-9#1)(2013-1#4)
perceived value##4##2##(1994-1#1)(2005-10#1)(2010-8#1)(2012-2#1)
perceived##598##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#6)(1990-9#1)(1991-1#4)(1991-12#1)(1991-2#3)(1991-8#2)(1992-1#1)(1992-10#1)(1992-2#5)(1992-4#3)(1993-12#4)(1993-2#2)(1993-3#1)(1994-1#4)(1994-12#3)(1994-2#3)(1994-3#7)(1994-6#3)(1995-1#3)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-1#2)(1996-12#3)(1996-2#6)(1996-3#8)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#1)(2004-11#3)(2005-10#3)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#9)(2006-12#4)(2006-2#2)(2006-3#3)(2006-4#3)(2006-5#1)(2006-6#2)(2006-7#6)(2006-9#5)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#23)(2007-2#5)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#8)(2007-8#5)(2007-9#3)(2008-1#3)(2008-10#14)(2008-11#24)(2008-12#14)(2008-2#1)(2008-3#7)(2008-4#3)(2008-5#10)(2008-6#7)(2008-7#7)(2008-8#4)(2008-9#13)(2009-10#2)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#5)(2009-5#4)(2009-6#2)(2009-7#28)(2009-8#2)(2009-9#6)(2010-1#7)(2010-10#5)(2010-11#2)(2010-12#7)(2010-2#6)(2010-3#10)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#9)(2010-8#7)(2010-9#6)(2011-1#8)(2011-2#33)(2012-1#5)(2012-11#14)(2012-12#16)(2012-2#8)(2012-3#16)(2013-1#52)(2013-7#9)(2013-8#11)
perceiver##2##1##(2009-9#2)
perceivers have##2##2##(2008-11#1)(2013-8#1)
perceivers spontaneously##2##2##(2008-11#2)
perceivers##5##1##(2008-11#4)(2013-8#1)
perceivers' explicit##2##2##(2008-11#2)
perceivers' mental representations of##2##4##(2013-8#2)
perceivers'##5##1##(2008-11#2)(2009-9#1)(2013-8#2)
perceives##4##1##(1992-9#1)(2006-2#1)(2008-3#1)(2009-8#1)
perceiving oneself as##2##3##(2012-2#2)
perceiving the##2##2##(2006-7#1)(2009-4#1)
perceiving##13##1##(1993-9#1)(2006-7#1)(2008-11#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
percent (95 percent CI =##3##5##(1996-1#3)
percent (95% C##2##3##(1990-6#2)
percent (95% CI##4##3##(2010-8#4)
percent (95%##7##2##(1990-6#3)(2010-8#4)
percent (all groups##2##3##(2011-1#2)
percent (mol##2##2##(2008-10#2)
percent (n =##6##3##(1992-9#1)(1993-8#1)(1996-3#1)(1997-2#1)(2006-5#1)(2013-1#1)
percent HCWA##2##2##(2008-10#2)
percent S##2##2##(2008-10#2)
percent accuracy of##2##3##(2008-3#1)(2012-2#1)
percent after##5##2##(1990-5#1)(2012-2#1)(2013-1#3)
percent agree it can##2##4##(2007-12#2)
percent and##14##2##(1991-3#1)(1992-5#1)(1992-6#1)(1993-3#1)(1996-5#1)(2006-10#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-9#1)(2009-9#1)(2010-7#1)(2013-1#2)
percent annually##2##2##(1990-12#1)(2010-8#1)
percent are##3##2##(2008-5#1)(2009-9#1)(2012-2#1)
percent at year-end 2008##3##4##(2011-2#3)
percent at##8##2##(1991-5#1)(1995-6#2)(2008-2#1)(2009-8#1)(2011-2#3)
percent between##3##2##(1991-1#1)(1993-1#1)(2008-11#1)
percent body fat##9##3##(2007-12#1)(2007-6#2)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)
percent body##10##2##(2007-12#1)(2007-6#2)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2013-1#1)
percent by##3##2##(1990-8#1)(1996-8#1)(2009-9#1)
percent change from baseline in##2##5##(2008-3#1)(2010-8#1)
percent change from##3##3##(1996-3#1)(2008-3#1)(2010-8#1)
percent change in##3##3##(1995-6#1)(2006-5#1)(2010-8#1)
percent change##7##2##(1995-6#1)(1995-9#1)(1996-3#1)(2006-5#1)(2008-3#1)(2010-8#2)
percent composition of blends of biodiesel and conventional diesel##2##9##(2011-1#2)
percent composition##3##2##(2011-1#3)
percent confidence interval##8##3##(1990-5#8)
percent confidence##10##2##(1990-5#8)(2007-2#1)(2008-11#1)
percent control##2##2##(2008-10#2)
percent correct##2##2##(1992-11#2)
percent decrease in##4##3##(1991-12#1)(1996-3#1)(1997-1#1)(2007-2#1)
percent decrease##5##2##(1991-12#1)(1993-8#1)(1996-3#1)(1997-1#1)(2007-2#1)
percent did not##2##3##(2010-7#1)(2013-1#1)
percent died##2##2##(1993-5#1)(1995-2#1)
percent differentiation at##2##3##(1991-10#2)
percent drug##3##2##(2010-5#1)(2011-2#1)(2012-12#1)
percent effective##2##2##(1991-6#1)(2008-10#1)
percent extraction and##3##3##(2008-10#3)
percent extraction##5##2##(2008-10#5)
percent for CAT and##2##4##(1993-9#2)
percent for STT##2##3##(1993-9#2)
percent for the##2##3##(1993-9#1)(1996-3#1)
percent for##11##2##(1993-9#5)(1996-3#1)(2008-3#2)(2008-6#2)(2012-11#1)
percent from the##3##3##(1990-12#1)(1992-12#1)(2008-11#1)
percent from##6##2##(1990-12#1)(1992-12#1)(1996-1#1)(1997-3#1)(2008-11#2)
percent group##2##2##(1993-5#2)
percent had been offered and##2##5##(1993-8#2)
percent had been##3##3##(1991-12#1)(1993-8#2)
percent had previously##2##3##(1993-5#1)(2009-10#1)
percent had##17##2##(1991-12#2)(1991-2#1)(1991-3#2)(1993-3#1)(1993-5#1)(1993-8#2)(2006-12#2)(2008-1#3)(2009-10#1)(2009-9#1)(2013-1#1)
percent have##2##2##(1995-12#1)(2008-10#1)
percent higher than##2##3##(1994-2#1)(2013-1#1)
percent higher##3##2##(1994-2#1)(2007-2#1)(2013-1#1)
percent hull##3##2##(2008-5#3)
percent ideal body weight##4##4##(2006-7#4)
percent identity##4##2##(1996-5#1)(2006-5#1)(2008-4#2)
percent in 1988##2##3##(1990-12#1)(1993-5#1)
percent in 2008##2##3##(2011-2#2)
percent in the 1-month##2##4##(2008-5#2)
percent in the 6-month##2##4##(2008-5#2)
percent in the##9##3##(1990-8#1)(1993-5#1)(2008-5#6)(2011-1#1)
percent in##25##2##(1990-12#1)(1990-8#1)(1992-12#2)(1992-3#1)(1993-10#1)(1993-5#3)(1996-9#1)(2007-4#1)(2008-5#8)(2009-9#1)(2011-1#1)(2011-2#4)
percent increase in##3##3##(1996-6#1)(2007-1#1)(2008-10#1)
percent increase##5##2##(1995-7#1)(1996-6#2)(2007-1#1)(2008-10#1)
percent infected spikelets (0##2##4##(2008-10#2)
percent infected##3##2##(2008-10#3)
percent inhibition of##2##3##(1992-12#1)(1992-7#1)
percent inhibition##6##2##(1991-8#1)(1992-12#1)(1992-7#1)(1993-8#1)(2010-7#1)(2013-1#1)
percent injected dose per##2##4##(1993-4#1)(2010-10#1)
percent is##2##2##(1992-3#1)(2008-6#1)
percent leaf area##3##3##(2008-10#3)
percent leaf##4##2##(2008-10#4)
percent less##2##2##(1994-2#1)(1996-2#1)
percent more##2##2##(1994-12#1)(2008-12#1)
percent nitrogen##2##2##(2008-10#1)(2011-12#1)
percent nucleotide sequence##2##3##(2008-10#2)
percent of 316##2##3##(2008-12#1)(2012-2#1)
percent of 401(k)##2##3##(2011-2#2)
percent of French (vs##3##4##(2011-1#3)
percent of French physicians##2##4##(2011-1#2)
percent of French##5##3##(2011-1#5)
percent of GDP##2##3##(1993-3#1)(2013-7#1)
percent of Medicaid##2##3##(1994-2#2)
percent of Medicare##2##3##(1994-1#1)(1996-3#1)
percent of PCPs##3##3##(2006-10#3)
percent of adult##2##3##(1996-6#1)(2008-1#1)
percent of all patients##2##4##(1997-6#1)(2006-1#1)
percent of all##19##3##(1990-12#1)(1991-3#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1997-6#1)(1997-7#1)(2006-1#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-10#1)(2008-4#1)(2010-8#1)(2011-2#2)
percent of body##2##3##(2008-3#1)(2010-8#1)
percent of cases##14##3##(1990-9#1)(1991-9#1)(1995-3#1)(1996-3#1)(1997-1#2)(2006-6#2)(2007-2#1)(2007-7#1)(2008-5#1)(2009-2#1)(2010-2#1)(2013-1#1)
percent of children had##2##4##(2013-8#2)
percent of children were##2##4##(2007-3#1)(2008-7#1)
percent of children##7##3##(2007-3#1)(2008-1#1)(2008-7#1)(2009-8#1)(2010-7#1)(2013-8#2)
percent of deaths in##2##4##(1997-2#1)(2012-2#1)
percent of dermatologists surveyed##2##4##(2010-8#2)
percent of eight year old children with##2##7##(2006-10#2)
percent of filters were##2##4##(2011-2#2)
percent of gastric##2##3##(1993-4#1)(2008-12#1)
percent of gross national product##2##5##(1990-12#1)(1991-12#1)
percent of health care##2##4##(1993-1#1)(1996-3#1)
percent of health##3##3##(1993-1#1)(1995-1#1)(1996-3#1)
percent of individuals##2##3##(1992-1#1)(2010-12#1)
percent of infants##2##3##(1995-6#1)(2007-7#1)
percent of isolates##2##3##(2008-10#2)
percent of its##2##3##(1995-9#1)(2007-10#1)
percent of men and##2##4##(1993-12#1)(2010-12#1)
percent of migraine patients##2##4##(2009-9#2)
percent of migraine##4##3##(2009-9#4)
percent of normal##2##3##(1992-12#1)(1996-5#1)
percent of office visits##2##4##(2010-8#2)
percent of one's##2##3##(1994-2#2)
percent of our patients##3##4##(1990-6#1)(2006-3#1)(2007-2#1)
percent of participants##4##3##(2006-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
percent of patients had##6##4##(1990-2#1)(1994-2#1)(2007-8#1)(2008-7#1)(2012-2#1)(2013-1#1)
percent of patients in##2##4##(2007-8#1)(2008-6#1)
percent of patients reported##2##4##(2010-8#1)(2012-2#1)
percent of patients underwent##3##4##(1990-10#1)(1992-2#1)(2008-6#1)
percent of patients who##2##4##(2008-3#1)(2011-2#1)
percent of patients with prophylactic filters##2##6##(2011-2#2)
percent of patients with##4##4##(1993-3#1)(2011-2#3)
percent of patients##34##3##(1990-10#1)(1990-2#1)(1992-2#1)(1992-5#1)(1993-2#1)(1993-3#1)(1994-2#1)(1995-11#1)(2006-8#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-3#1)(2008-6#2)(2008-7#2)(2009-11#1)(2010-12#1)(2010-8#1)(2011-2#5)(2012-2#4)(2013-1#3)(2013-8#1)
percent of pharmacists##2##3##(2008-1#1)(2011-1#1)
percent of prescriptions for##2##4##(2009-9#2)
percent of prescriptions##3##3##(2009-9#3)
percent of resistance##2##3##(2009-2#2)
percent of respondents reported##3##4##(1990-6#1)(2009-4#1)(2011-1#1)
percent of respondents were##3##4##(1993-3#1)(2009-10#1)(2011-1#1)
percent of respondents##11##3##(1990-6#1)(1993-1#1)(1993-3#1)(1995-3#1)(1996-3#1)(2009-10#3)(2009-4#1)(2011-1#2)
percent of subjects treated##2##4##(2010-8#2)
percent of subjects##5##3##(1991-2#1)(1995-12#1)(2006-4#1)(2010-8#2)
percent of the Nation's##2##4##(1990-12#1)(1993-3#1)
percent of the account balances of recently hired participants in their 20s##2##12##(2011-2#2)
percent of the applied MeBr##2##5##(1995-3#2)
percent of the cases##6##4##(1990-3#1)(1991-3#1)(1992-10#1)(1993-5#2)(1996-6#1)
percent of the child##2##4##(1997-2#1)(2007-12#1)
percent of the children were##2##5##(1996-1#1)(2006-3#1)
percent of the children##4##4##(1996-1#1)(2006-10#1)(2006-3#1)(2010-8#1)
percent of the diagnoses were initially##2##6##(2007-12#2)
percent of the females##2##4##(1994-2#1)(2008-4#1)
percent of the hospitals##2##4##(2007-12#1)(2007-7#1)
percent of the initial##2##4##(1990-5#1)(2008-10#1)
percent of the lesions were located##2##6##(2006-4#1)(2007-2#1)
percent of the lesions##3##4##(1993-5#1)(2006-4#1)(2007-2#1)
percent of the nonprofits##2##4##(1994-2#1)(1995-3#1)
percent of the participants##2##4##(2010-7#1)(2011-2#1)
percent of the patients had a##3##6##(2006-12#2)(2009-10#1)
percent of the patients had##8##5##(2006-10#1)(2006-12#2)(2006-8#1)(2007-3#2)(2008-3#1)(2009-10#1)
percent of the patients in group##2##6##(2007-2#1)(2007-9#1)
percent of the patients in the##2##6##(1994-3#1)(2006-10#1)
percent of the patients in##4##5##(1994-3#1)(2006-10#1)(2007-2#1)(2007-9#1)
percent of the patients were in##2##6##(2007-12#1)(2007-7#1)
percent of the patients were##11##5##(1997-6#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2012-3#1)(2013-1#1)
percent of the patients##36##4##(1991-12#1)(1992-5#1)(1994-3#1)(1996-7#1)(1997-6#1)(2004-1#1)(2006-10#5)(2006-12#3)(2006-8#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-7#4)(2007-8#3)(2007-9#2)(2008-1#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-10#1)(2012-3#1)(2013-1#1)
percent of the population##3##4##(1992-3#1)(1997-2#1)(2007-2#1)
percent of the respondents##3##4##(1992-5#1)(2008-2#1)(2009-7#1)
percent of the sample##4##4##(2008-12#1)(2008-4#1)(2013-1#2)
percent of the strains##2##4##(2008-5#1)(2012-12#1)
percent of the subjects##3##4##(1991-3#1)(1996-3#1)(2013-1#1)
percent of the total##7##4##(1990-8#1)(1992-3#2)(1994-3#1)(1994-6#1)(1997-4#1)(2005-11#1)
percent of the variance in##2##5##(1994-3#1)(2007-7#1)
percent of the women##2##4##(1990-8#1)(2008-7#1)
percent of the##187##3##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#3)(1990-8#2)(1990-9#1)(1991-1#4)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-10#2)(1992-12#3)(1992-3#3)(1992-5#3)(1992-6#1)(1993-12#1)(1993-3#2)(1993-5#3)(1993-7#1)(1994-12#2)(1994-2#2)(1994-3#4)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-6#2)(1995-7#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#5)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#1)(2004-1#1)(2004-11#1)(2005-11#1)(2005-12#1)(2006-10#10)(2006-12#3)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-2#4)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#6)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#3)(2008-7#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-7#2)(2010-3#1)(2010-7#1)(2010-8#2)(2011-12#2)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#12)(2013-8#1)
percent of their##4##3##(1994-2#1)(1996-3#2)(2010-8#1)
percent of these patients##3##4##(1995-2#1)(2004-10#1)(2012-2#1)
percent of these shortcomings##2##4##(2007-12#2)
percent of these##10##3##(1992-1#1)(1993-5#1)(1995-11#1)(1995-2#1)(1996-6#1)(2004-10#1)(2007-12#2)(2008-8#1)(2012-2#1)
percent of those interviewed##2##4##(1997-5#1)(2008-7#1)
percent of those with the##2##5##(1993-10#2)
percent of those with##3##4##(1993-10#2)(1996-3#1)
percent of those##11##3##(1993-10#2)(1993-2#2)(1996-3#2)(1997-5#1)(2008-7#1)(2010-8#1)(2012-3#1)(2013-8#1)
percent of total hospital##2##4##(1992-2#1)(1995-1#1)
percent of total##9##3##(1992-2#2)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1995-1#1)(1996-3#1)(2008-11#1)
percent of variance##2##3##(1995-2#1)(2009-9#1)
percent of women##6##3##(1993-2#1)(1996-2#1)(2007-10#1)(2008-10#1)(2008-3#1)(2013-8#1)
percent of##539##2##(1990-10#3)(1990-11#2)(1990-12#4)(1990-2#4)(1990-3#2)(1990-5#4)(1990-6#3)(1990-8#2)(1990-9#2)(1991-1#4)(1991-10#1)(1991-12#3)(1991-2#3)(1991-3#5)(1991-4#1)(1991-5#1)(1991-8#3)(1991-9#1)(1992-1#5)(1992-10#3)(1992-12#5)(1992-2#3)(1992-3#6)(1992-4#1)(1992-5#6)(1992-6#2)(1992-9#1)(1993-1#3)(1993-10#2)(1993-12#3)(1993-2#5)(1993-3#8)(1993-4#1)(1993-5#6)(1993-7#2)(1993-8#1)(1994-1#3)(1994-10#1)(1994-12#5)(1994-2#11)(1994-3#10)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#5)(1995-11#2)(1995-12#5)(1995-2#3)(1995-3#7)(1995-4#2)(1995-5#1)(1995-6#4)(1995-7#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#15)(1996-5#2)(1996-6#3)(1996-7#1)(1996-9#2)(1997-1#4)(1997-2#4)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(2004-1#1)(2004-10#1)(2004-11#1)(2004-7#1)(2005-11#1)(2005-12#1)(2006-1#1)(2006-10#16)(2006-12#3)(2006-3#2)(2006-4#2)(2006-5#1)(2006-6#4)(2006-7#6)(2006-8#3)(2007-10#5)(2007-11#2)(2007-12#9)(2007-2#11)(2007-3#4)(2007-4#2)(2007-6#1)(2007-7#9)(2007-8#8)(2007-9#3)(2008-1#7)(2008-10#14)(2008-11#8)(2008-12#6)(2008-2#2)(2008-3#6)(2008-4#8)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#1)(2009-10#6)(2009-11#1)(2009-2#5)(2009-4#1)(2009-7#2)(2009-8#2)(2009-9#12)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#14)(2011-1#10)(2011-12#3)(2011-2#22)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#14)(2012-3#5)(2013-1#26)(2013-7#2)(2013-8#7)
percent oil##2##2##(2007-9#2)
percent over the##2##3##(1991-3#1)(2011-2#1)
percent penetration and##2##3##(2008-10#2)
percent per year (95%CI##2##4##(2011-2#2)
percent per year for##2##4##(1994-12#1)(2007-9#1)
percent per year##6##3##(1994-12#2)(2007-9#2)(2011-2#2)
percent per##7##2##(1994-12#2)(2007-9#2)(2008-12#1)(2011-2#2)
percent recovery of copper##3##4##(2008-10#3)
percent recovery of##6##3##(2008-10#6)
percent recovery values were##2##4##(2008-10#2)
percent recovery##10##2##(2008-10#10)
percent reduction in mammary compliance##2##5##(2013-1#2)
percent reduction in the##2##4##(2009-11#1)(2010-3#1)
percent reduction in##8##3##(1992-12#1)(1993-12#1)(1997-1#1)(2008-10#1)(2009-11#1)(2010-3#1)(2013-1#2)
percent referred##2##2##(2006-10#1)(2011-1#1)
percent relative error##3##3##(2008-10#3)
percent relative standard deviation##3##4##(2008-10#2)(2010-12#1)
percent relative standard##4##3##(1990-12#1)(2008-10#2)(2010-12#1)
percent relative##8##2##(1990-12#1)(1995-1#1)(2008-10#5)(2010-12#1)
percent remineralization##2##2##(2013-8#2)
percent reported##3##2##(1991-12#1)(2007-9#1)(2008-12#1)
percent root colonization##3##3##(2010-10#3)
percent saturation of##2##3##(1991-2#1)(2008-10#1)
percent should##2##2##(1995-3#1)(1995-7#1)
percent stenosis##3##2##(2008-7#1)(2008-8#1)(2011-2#1)
percent survival##2##2##(2007-7#1)(2009-3#1)
percent to##10##2##(1992-2#1)(1992-6#1)(1993-5#1)(1994-12#1)(1995-3#1)(1996-1#3)(1996-12#1)(2008-3#1)
percent transmittance##2##2##(2008-10#1)(2012-12#1)
percent visual##2##2##(2008-10#2)
percent vs##7##2##(2012-3#4)(2013-1#3)
percent was##2##2##(1994-12#1)(2011-2#1)
percent were##23##2##(1990-12#1)(1991-12#1)(1991-2#2)(1991-3#2)(1992-5#1)(1993-5#1)(1994-12#1)(1995-2#1)(1996-3#1)(2004-2#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
percent when##2##2##(1992-6#1)(2008-11#1)
percent while##2##2##(1995-3#1)(2008-2#1)
percent##1186##1##(1990-10#3)(1990-11#3)(1990-12#11)(1990-2#9)(1990-3#7)(1990-5#19)(1990-6#6)(1990-8#5)(1990-9#3)(1991-1#7)(1991-10#3)(1991-11#1)(1991-12#13)(1991-2#8)(1991-3#16)(1991-4#3)(1991-5#5)(1991-6#2)(1991-8#4)(1991-9#1)(1992-1#9)(1992-10#3)(1992-11#2)(1992-12#12)(1992-2#4)(1992-3#10)(1992-4#1)(1992-5#11)(1992-6#8)(1992-7#1)(1992-9#2)(1993-1#8)(1993-10#5)(1993-12#4)(1993-2#6)(1993-3#18)(1993-4#2)(1993-5#22)(1993-7#2)(1993-8#6)(1993-9#6)(1994-1#6)(1994-10#2)(1994-12#12)(1994-2#14)(1994-3#13)(1994-5#1)(1994-6#5)(1994-9#1)(1995-1#10)(1995-11#2)(1995-12#7)(1995-2#5)(1995-3#16)(1995-4#2)(1995-5#1)(1995-6#9)(1995-7#5)(1995-9#3)(1996-1#13)(1996-11#1)(1996-12#3)(1996-2#5)(1996-3#25)(1996-5#5)(1996-6#5)(1996-7#1)(1996-8#1)(1996-9#5)(1997-1#9)(1997-2#10)(1997-3#11)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#1)(2004-1#1)(2004-10#1)(2004-11#1)(2004-2#1)(2004-7#1)(2005-11#2)(2005-12#1)(2005-4#2)(2006-1#1)(2006-10#20)(2006-12#5)(2006-3#3)(2006-4#3)(2006-5#4)(2006-6#4)(2006-7#11)(2006-8#6)(2007-1#2)(2007-10#6)(2007-11#3)(2007-12#20)(2007-2#22)(2007-3#4)(2007-4#4)(2007-5#1)(2007-6#6)(2007-7#17)(2007-8#12)(2007-9#11)(2008-1#13)(2008-10#87)(2008-11#19)(2008-12#11)(2008-2#8)(2008-3#21)(2008-4#16)(2008-5#22)(2008-6#7)(2008-7#12)(2008-8#11)(2008-9#1)(2009-10#7)(2009-11#2)(2009-2#6)(2009-3#1)(2009-4#2)(2009-7#2)(2009-8#3)(2009-9#18)(2010-10#5)(2010-11#1)(2010-12#7)(2010-2#2)(2010-3#4)(2010-4#1)(2010-5#1)(2010-7#5)(2010-8#28)(2011-1#26)(2011-11#1)(2011-12#4)(2011-2#41)(2012-1#3)(2012-11#4)(2012-12#8)(2012-2#23)(2012-3#15)(2013-1#60)(2013-7#2)(2013-8#12)
percent) and##5##2##(1992-10#1)(1993-10#1)(1994-1#1)(1995-1#1)(2008-5#1)
percent) favored a##2##3##(1996-1#2)
percent) in##5##2##(1996-3#1)(2007-2#1)(2008-10#1)(2008-5#1)(2011-2#1)
percent) of##4##2##(1994-12#1)(1996-1#1)(1996-3#1)(2007-11#1)
percent) or##2##2##(1993-5#2)
percent) than##3##2##(1994-1#1)(1997-2#1)(2007-2#1)
percent) were##4##2##(1993-10#1)(1994-9#1)(2013-1#2)
percent)##71##1##(1991-8#1)(1992-10#3)(1993-1#3)(1993-10#5)(1993-3#1)(1993-5#14)(1994-1#3)(1994-12#2)(1994-9#1)(1995-1#2)(1995-12#1)(1996-1#3)(1996-2#1)(1996-3#3)(1997-1#3)(1997-2#5)(1997-3#4)(2007-11#1)(2007-12#2)(2007-2#5)(2008-1#1)(2008-10#1)(2008-5#3)(2011-2#1)(2013-1#2)
percentage agreement##2##2##(2010-5#1)(2011-2#1)
percentage and distribution##2##3##(1991-4#1)(2013-1#1)
percentage and seedling growth of V##3##6##(2008-12#3)
percentage and the##2##3##(2008-5#1)(2013-1#1)
percentage and##17##2##(1991-4#1)(1995-12#1)(2005-10#1)(2008-10#1)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-1#1)(2013-1#3)
percentage at##2##2##(2007-8#1)(2008-10#1)
percentage by##3##2##(2007-3#1)(2008-5#2)
percentage change in##3##3##(2007-8#1)(2012-2#2)
percentage change##5##2##(1991-2#1)(1995-9#1)(2007-8#1)(2012-2#2)
percentage changes of##2##3##(2012-12#2)
percentage content of##3##3##(2008-10#2)(2013-1#1)
percentage cover of##2##3##(2008-9#2)
percentage cover##4##2##(2008-9#4)
percentage differences##4##2##(2006-12#2)(2008-10#1)(2008-2#1)
percentage distribution of##3##3##(1995-2#1)(2009-5#2)
percentage distribution##4##2##(1995-2#1)(2009-5#3)
percentage ejection fraction##2##3##(2012-2#2)
percentage error##2##2##(2007-8#1)(2008-10#1)
percentage extraction of##2##3##(2008-10#2)
percentage extraction##3##2##(2008-10#3)
percentage fat##2##2##(2008-7#2)
percentage fractional fiber shortening##2##4##(2012-2#2)
percentage in the##5##3##(1990-11#1)(1995-12#1)(2008-10#1)(2008-12#1)(2011-1#1)
percentage in##8##2##(1990-11#1)(1995-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2011-1#1)(2012-7#1)
percentage increase##2##2##(1990-12#1)(2010-9#1)
percentage increases or decreases##2##4##(2010-5#2)
percentage increases##4##2##(2007-10#1)(2010-5#2)(2013-7#1)
percentage inhibition of##4##3##(1991-2#1)(1996-3#1)(2008-10#1)(2008-5#1)
percentage inhibition##5##2##(1991-2#1)(1996-3#1)(2008-10#1)(2008-5#1)(2009-5#1)
percentage is##4##2##(1992-6#1)(1996-6#1)(2007-7#1)(2009-2#1)
percentage loss of##3##3##(1996-9#2)(1997-5#1)
percentage of M##3##3##(2008-10#3)
percentage of NAG B##3##4##(1990-11#3)
percentage of Purkinje##3##3##(1993-11#2)(1994-2#1)
percentage of a##2##3##(2007-8#1)(2013-1#1)
percentage of abnormal sperm##2##4##(2008-3#2)
percentage of adsorption##2##3##(2005-11#2)
percentage of adverse##2##3##(1994-6#1)(2010-5#1)
percentage of all##5##3##(1995-3#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#1)
percentage of antennal lobe neurons##2##5##(1997-6#2)
percentage of apoptotic##3##3##(2008-12#2)(2013-1#1)
percentage of atmospheric oxygen##2##4##(2013-1#2)
percentage of body fat##3##4##(1997-7#1)(2008-11#1)(2010-2#1)
percentage of cases##5##3##(2006-1#1)(2007-7#1)(2008-1#1)(2008-8#1)(2012-12#1)
percentage of cells in##3##4##(1996-11#1)(2005-12#1)(2008-4#1)
percentage of cells with##3##4##(1997-6#1)(2008-11#1)(2011-12#1)
percentage of cells within a##2##5##(1991-7#2)
percentage of cells##17##3##(1991-7#2)(1992-8#1)(1995-1#1)(1996-11#1)(1997-3#1)(1997-6#1)(2005-12#1)(2008-10#3)(2008-11#3)(2008-4#2)(2011-12#1)
percentage of children##5##3##(2007-2#1)(2008-1#1)(2008-7#1)(2012-1#1)(2013-8#1)
percentage of complete##2##3##(1991-2#1)(2006-6#1)
percentage of correct answers##2##4##(1993-12#2)
percentage of correct##6##3##(1993-12#2)(2006-8#1)(2008-10#1)(2008-9#1)(2011-1#1)
percentage of discolored kernels was##2##5##(2011-2#2)
percentage of discolored kernels##3##4##(2011-2#3)
percentage of elderly clients in the practice of mental health professionals##2##11##(1994-1#2)
percentage of elderly##3##3##(1994-1#2)(2011-12#1)
percentage of emergence##2##3##(2008-6#2)
percentage of energy##2##3##(1997-8#1)(2012-2#1)
percentage of excess weight##2##4##(2013-1#2)
percentage of expected##3##3##(2007-8#1)(2013-1#2)
percentage of fat##2##3##(2008-7#2)
percentage of field area affected by FCRR##3##7##(2008-10#3)
percentage of germinated conidia with appressoria and##2##7##(2008-10#2)
percentage of germination##3##3##(2008-10#1)(2008-12#2)
percentage of glutaraldehyde##2##3##(2008-10#2)
percentage of health care##2##4##(1990-12#1)(1993-12#1)
percentage of health##3##3##(1990-12#1)(1993-12#1)(2007-7#1)
percentage of human##2##3##(1994-2#1)(2008-4#1)
percentage of increase##2##3##(2007-9#1)(2008-8#1)
percentage of individuals##2##3##(2007-5#1)(2007-7#1)
percentage of infected cells increased with higher##2##7##(1997-4#2)
percentage of infected cells##3##4##(1997-4#2)(2007-10#1)
percentage of infected##10##3##(1997-4#2)(2007-10#2)(2007-12#1)(2008-10#4)(2008-5#1)
percentage of inhibition of##2##4##(2008-4#1)(2008-8#1)
percentage of inhibition##3##3##(1995-1#1)(2008-4#1)(2008-8#1)
percentage of larval##2##3##(1996-12#1)(2011-2#1)
percentage of live sperm##2##4##(2008-3#2)
percentage of lymphocytes##3##3##(1991-12#1)(1995-12#1)(2008-1#1)
percentage of m5Cyt in##3##4##(1991-5#3)
percentage of m5Cyt##4##3##(1991-5#4)
percentage of mature##4##3##(1992-1#1)(2007-8#1)(2008-10#1)(2008-12#1)
percentage of muscle##2##3##(2010-4#1)(2011-2#1)
percentage of neurons##2##3##(1991-8#1)(1997-6#1)
percentage of neutrophils in differential count##2##6##(2009-6#2)
percentage of neutrophils##5##3##(2006-5#2)(2009-6#2)(2011-1#1)
percentage of normal sperm##2##4##(2008-5#2)
percentage of older##3##3##(1990-12#2)(2011-2#1)
percentage of organic##2##3##(1990-6#1)(2008-10#1)
percentage of patients can##2##4##(1990-12#1)(2010-12#1)
percentage of patients requiring##2##4##(2010-10#1)(2011-2#1)
percentage of patients who##6##4##(1991-7#1)(1995-1#1)(1995-5#1)(2008-7#1)(2009-9#1)(2013-8#1)
percentage of patients with##8##4##(2006-10#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-3#1)(2008-4#1)(2011-11#1)(2013-7#1)
percentage of patients##35##3##(1990-12#1)(1991-7#1)(1992-10#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(2004-10#1)(2005-10#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-11#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#2)
percentage of perikaryal volume occupied by##2##6##(2007-9#2)
percentage of polychromatic erythrocytes##2##4##(2008-9#2)
percentage of population##2##3##(2007-10#2)
percentage of progeny##2##3##(2012-1#1)(2013-8#1)
percentage of recovery##3##3##(2007-8#1)(2008-10#1)(2008-5#1)
percentage of samples with hemolysis##2##5##(2013-1#2)
percentage of sclerosed glomeruli##3##4##(2007-8#3)
percentage of small and median enterprises##2##6##(2007-4#2)
percentage of smokers##4##3##(1991-4#1)(1991-8#1)(1994-5#1)(2013-1#1)
percentage of soil fungi and##2##5##(2013-8#2)
percentage of soil##6##3##(2008-12#1)(2013-8#5)
percentage of striated myotubes##2##4##(2009-9#2)
percentage of subjects##2##3##(2008-11#1)(2009-8#1)
percentage of survival##2##3##(2006-2#1)(2010-8#1)
percentage of the patients##2##4##(2006-7#1)(2012-12#1)
percentage of the population##5##4##(2006-10#1)(2007-10#1)(2008-11#1)(2008-4#1)(2012-12#1)
percentage of the total##5##4##(1991-5#1)(1995-9#1)(1997-5#1)(2006-6#1)(2009-11#1)
percentage of the##59##3##(1990-3#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-6#2)(1993-3#3)(1994-2#2)(1994-5#1)(1994-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-5#1)(2004-9#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2010-8#1)(2010-9#2)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)
percentage of those##3##3##(1994-8#1)(2006-10#1)(2008-1#1)
percentage of time##3##3##(1995-8#1)(2010-2#1)(2012-1#1)
percentage of total##9##3##(1990-8#1)(1992-11#1)(1992-8#1)(1997-2#2)(2006-5#1)(2007-8#1)(2008-11#1)(2011-1#1)
percentage of tumor##2##3##(2010-3#2)
percentage of viable##2##3##(2008-10#1)(2011-2#1)
percentage of women##2##3##(1996-12#1)(2004-10#1)
percentage of##694##2##(1990-10#1)(1990-11#4)(1990-12#5)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#2)(1990-8#4)(1990-9#1)(1991-11#3)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#8)(1991-6#2)(1991-7#4)(1991-8#5)(1991-9#3)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#1)(1992-6#5)(1992-7#2)(1992-8#6)(1992-9#3)(1993-1#1)(1993-10#2)(1993-11#4)(1993-12#4)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#2)(1993-8#2)(1994-1#2)(1994-11#4)(1994-12#1)(1994-2#8)(1994-3#1)(1994-5#2)(1994-6#4)(1994-7#1)(1994-8#3)(1995-1#4)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#4)(1995-8#3)(1995-9#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#5)(1996-5#2)(1996-6#1)(1996-8#1)(1997-2#4)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#5)(1997-8#1)(2004-10#2)(2004-11#1)(2004-3#1)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#4)(2005-12#1)(2006-1#1)(2006-10#6)(2006-11#2)(2006-12#5)(2006-2#3)(2006-4#2)(2006-5#10)(2006-6#8)(2006-7#1)(2006-8#4)(2006-9#1)(2007-1#3)(2007-10#10)(2007-11#7)(2007-12#8)(2007-2#6)(2007-3#5)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#16)(2007-8#14)(2007-9#5)(2008-1#6)(2008-10#101)(2008-11#15)(2008-12#9)(2008-2#3)(2008-3#13)(2008-4#10)(2008-5#20)(2008-6#5)(2008-7#10)(2008-8#5)(2008-9#6)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#3)(2009-8#1)(2009-9#3)(2010-10#2)(2010-11#3)(2010-12#4)(2010-2#4)(2010-3#2)(2010-4#10)(2010-5#2)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#11)(2011-11#2)(2011-12#4)(2011-2#27)(2011-7#1)(2012-1#5)(2012-12#10)(2012-2#11)(2012-3#7)(2012-4#1)(2013-1#27)(2013-7#2)(2013-8#18)
percentage point##2##2##(2011-2#2)
percentage points##6##2##(1993-1#1)(2007-2#2)(2010-2#1)(2013-1#2)
percentage recoveries were##2##3##(2008-10#2)
percentage recoveries##11##2##(2008-10#9)(2010-2#1)(2010-3#1)
percentage recovery##5##2##(2005-4#1)(2008-10#3)(2010-4#1)
percentage reduction in##3##3##(1991-2#1)(2008-9#1)(2011-1#1)
percentage reduction##4##2##(1991-2#1)(1994-8#1)(2008-9#1)(2011-1#1)
percentage retention##2##2##(2008-10#1)(2008-5#1)
percentage turnover rates##2##3##(2007-5#2)
percentage values##2##2##(2007-10#1)(2011-2#1)
percentage varied##2##2##(1990-2#1)(2007-3#1)
percentage was increased##2##3##(1993-4#1)(2008-5#1)
percentage was reduced##2##3##(1990-5#1)(2008-10#1)
percentage was significantly##2##3##(2008-10#1)(2009-3#1)
percentage was the same##2##4##(2007-7#1)(2008-10#1)
percentage was##21##2##(1990-5#1)(1993-4#1)(2007-7#2)(2008-10#5)(2008-12#2)(2008-5#1)(2008-6#3)(2008-7#1)(2009-2#1)(2009-3#1)(2009-7#1)(2012-2#2)
percentage weight gain##2##3##(2010-12#1)(2013-7#1)
percentage weight##3##2##(2007-3#1)(2010-12#1)(2013-7#1)
percentage with an##2##3##(2008-7#1)(2010-10#1)
percentage with##4##2##(1993-12#1)(2008-5#1)(2008-7#1)(2010-10#1)
percentage##996##1##(1990-10#4)(1990-11#5)(1990-12#7)(1990-2#3)(1990-3#2)(1990-4#2)(1990-5#2)(1990-6#3)(1990-7#1)(1990-8#7)(1990-9#3)(1991-1#2)(1991-10#1)(1991-11#3)(1991-12#3)(1991-2#8)(1991-3#2)(1991-4#2)(1991-5#8)(1991-6#2)(1991-7#4)(1991-8#6)(1991-9#3)(1992-1#1)(1992-10#2)(1992-11#4)(1992-12#2)(1992-2#2)(1992-6#6)(1992-7#2)(1992-8#6)(1992-9#5)(1993-1#2)(1993-10#2)(1993-11#5)(1993-12#5)(1993-3#3)(1993-4#2)(1993-5#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-1#3)(1994-11#4)(1994-12#1)(1994-2#8)(1994-3#1)(1994-5#3)(1994-6#4)(1994-7#1)(1994-8#4)(1994-9#1)(1995-1#5)(1995-12#5)(1995-2#3)(1995-3#2)(1995-5#5)(1995-8#3)(1995-9#2)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#6)(1996-4#1)(1996-5#3)(1996-6#2)(1996-8#1)(1996-9#2)(1997-2#6)(1997-3#3)(1997-4#2)(1997-5#2)(1997-6#4)(1997-7#5)(1997-8#2)(2004-10#2)(2004-11#2)(2004-3#1)(2004-9#1)(2005-1#1)(2005-10#3)(2005-11#6)(2005-12#2)(2005-4#1)(2005-8#1)(2006-1#2)(2006-10#8)(2006-11#2)(2006-12#8)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#11)(2006-6#8)(2006-7#1)(2006-8#4)(2006-9#2)(2007-1#3)(2007-10#13)(2007-11#10)(2007-12#11)(2007-2#8)(2007-3#10)(2007-4#3)(2007-5#5)(2007-6#2)(2007-7#22)(2007-8#19)(2007-9#5)(2008-1#9)(2008-10#147)(2008-11#17)(2008-12#20)(2008-2#5)(2008-3#18)(2008-4#13)(2008-5#34)(2008-6#8)(2008-7#16)(2008-8#8)(2008-9#12)(2009-10#1)(2009-11#2)(2009-2#4)(2009-3#3)(2009-4#5)(2009-5#5)(2009-6#4)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#6)(2010-2#7)(2010-3#4)(2010-4#16)(2010-5#6)(2010-7#2)(2010-8#6)(2010-9#3)(2011-1#17)(2011-11#2)(2011-12#4)(2011-2#36)(2011-7#1)(2012-1#5)(2012-12#13)(2012-2#24)(2012-3#9)(2012-4#1)(2012-7#1)(2013-1#40)(2013-7#6)(2013-8#20)
percentage)##4##1##(2007-2#1)(2008-10#1)(2009-6#1)(2009-7#1)
percentages (P &lt##3##3##(2010-2#3)
percentages and##2##2##(1995-12#1)(2011-1#1)
percentages in the##2##3##(2008-1#1)(2013-1#1)
percentages in##5##2##(1991-8#1)(1997-2#1)(2008-1#1)(2012-3#1)(2013-1#1)
percentages of motile##2##3##(2006-5#2)
percentages of neutrophils##2##3##(2008-10#2)
percentages of the##9##3##(1993-8#1)(1994-3#1)(2005-11#1)(2008-10#2)(2008-11#1)(2009-7#1)(2010-4#1)(2013-8#1)
percentages of women##2##3##(1993-6#1)(2008-11#1)
percentages of##93##2##(1990-4#1)(1991-11#1)(1991-12#1)(1991-4#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-7#2)(1996-8#1)(1997-1#3)(1997-2#1)(1997-8#1)(2005-10#2)(2005-11#2)(2006-10#1)(2006-5#3)(2006-7#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#29)(2008-11#3)(2008-12#2)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#1)(2009-7#1)(2010-10#1)(2010-4#4)(2011-2#2)(2012-1#2)(2012-2#2)(2012-3#1)(2013-8#5)
percentages ranging between##3##3##(1992-9#1)(2008-10#1)(2011-2#1)
percentages ranging##4##2##(1992-9#1)(2008-10#2)(2011-2#1)
percentages were##8##2##(1990-12#1)(1994-2#1)(2006-5#1)(2007-10#2)(2007-4#1)(2007-7#1)(2010-11#1)
percentages with##3##2##(1997-2#1)(2007-11#1)(2013-8#1)
percentages##152##1##(1990-12#2)(1990-2#1)(1990-4#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-8#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-12#2)(1996-12#1)(1996-7#2)(1996-8#1)(1997-1#3)(1997-2#3)(1997-8#1)(2005-10#2)(2005-11#2)(2006-10#1)(2006-11#1)(2006-5#4)(2006-7#1)(2007-10#3)(2007-11#2)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#38)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#3)(2008-9#1)(2009-2#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-2#4)(2010-4#5)(2010-6#1)(2011-1#4)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#8)
percentile curves of##3##3##(2013-8#3)
percentile curves##7##2##(2006-1#1)(2013-8#6)
percentile female Hybrid III##2##4##(2006-11#1)(2007-1#1)
percentile female##9##2##(2006-11#7)(2007-1#2)
percentile male##13##2##(2006-11#8)(2007-1#3)(2007-4#2)
percentile of OPs was##6##4##(2013-8#6)
percentile of##8##2##(2006-10#1)(2010-2#1)(2013-8#6)
percentile tables##2##2##(2008-1#2)
percentile##75##1##(1993-9#2)(1995-4#1)(1996-3#2)(1997-3#1)(1997-6#1)(2006-1#1)(2006-10#3)(2006-11#18)(2007-1#6)(2007-4#4)(2008-1#2)(2008-3#1)(2008-7#1)(2009-10#1)(2010-11#1)(2010-2#3)(2010-8#2)(2011-1#3)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#3)(2013-8#12)
percentile)##3##1##(1993-9#1)(2009-9#1)(2012-2#1)
percentiles##11##1##(1995-4#1)(1996-9#1)(1997-2#1)(2007-2#1)(2008-5#1)(2011-2#3)(2012-3#2)(2013-1#1)
percents##5##1##(2008-10#4)(2011-2#1)
percentual##3##1##(1991-4#1)(1996-9#1)(2008-11#1)
percept to##2##2##(1997-8#1)(2012-2#1)
percept##4##1##(1997-8#1)(2008-4#1)(2012-11#1)(2012-2#1)
perceptible influence on##2##3##(1993-12#1)(2008-1#1)
perceptible##13##1##(1993-12#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-12#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-7#1)
perception about the##3##3##(2006-10#1)(2007-9#1)(2012-3#1)
perception about##6##2##(2006-10#1)(2007-9#1)(2009-4#1)(2011-1#1)(2012-12#1)(2012-3#1)
perception and action##3##3##(2006-10#2)(2007-8#1)
perception and behavior##2##3##(2010-9#2)
perception and coping##3##3##(2008-4#1)(2013-1#2)
perception and interpretation of##3##4##(2008-11#1)(2008-6#1)(2012-2#1)
perception and production##4##3##(2008-11#2)(2008-4#1)(2009-8#1)
perception and sense of smell##2##5##(2013-1#2)
perception and the##4##3##(1992-1#1)(1994-2#1)(1996-4#1)(2008-9#1)
perception and visuomotor control##2##4##(2007-8#2)
perception and##65##2##(1990-10#1)(1990-9#1)(1992-1#1)(1994-12#2)(1994-2#1)(1996-4#1)(1997-2#1)(1997-8#3)(2005-8#1)(2006-10#2)(2006-12#2)(2006-6#1)(2006-8#1)(2007-8#3)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#4)(2008-6#2)(2008-8#1)(2008-9#3)(2009-3#1)(2009-4#2)(2009-8#5)(2010-9#3)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#6)
perception are##2##2##(2006-6#1)(2008-11#1)
perception between##2##2##(1993-2#1)(2007-2#1)
perception by##5##2##(1995-8#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)
perception can be##2##3##(1991-4#1)(2008-9#1)
perception changes over time##2##4##(1996-6#1)(2012-12#1)
perception during landing##3##3##(2011-2#3)
perception during##5##2##(1996-5#1)(2010-11#1)(2011-2#3)
perception in a##3##3##(2008-11#1)(2008-9#1)(2010-5#1)
perception in adult##3##3##(2008-9#3)
perception in children##3##3##(2008-10#1)(2008-9#1)(2012-3#1)
perception in the##4##3##(2007-5#1)(2008-11#1)(2008-5#1)(2009-4#1)
perception in##42##2##(1991-2#1)(1992-1#1)(1992-9#2)(1996-5#1)(1997-6#1)(2006-3#2)(2007-5#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#8)(2009-4#6)(2010-5#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-2#1)(2012-3#2)(2013-1#1)
perception is##12##2##(1991-3#1)(1994-3#1)(2006-10#1)(2006-7#1)(2007-12#2)(2008-7#1)(2008-9#2)(2009-7#1)(2012-2#1)(2013-1#1)
perception level of nursing activities##2##5##(1991-2#2)
perception level##3##2##(1991-2#3)
perception of a##7##3##(1994-1#1)(2006-5#1)(2007-9#1)(2009-4#1)(2010-10#1)(2011-2#1)(2012-12#1)
perception of aggression and##2##4##(2007-3#2)
perception of an##3##3##(1994-2#1)(2006-10#1)(2008-5#1)
perception of asthma##2##3##(2006-5#1)(2009-4#1)
perception of being##2##3##(2006-5#1)(2007-12#1)
perception of corruption in##2##4##(2012-3#2)
perception of corruption##3##3##(2012-3#3)
perception of depth##3##3##(1997-8#1)(2007-12#1)(2009-3#1)
perception of doneness##2##3##(2012-12#2)
perception of early TA##3##4##(2013-1#3)
perception of early##4##3##(2013-1#4)
perception of emotional##2##3##(2008-1#1)(2012-2#1)
perception of faces##3##3##(2009-10#1)(2009-4#1)(2012-11#1)
perception of facial##2##3##(2009-4#2)
perception of general health##2##4##(1992-3#2)
perception of health##8##3##(1995-2#1)(2005-8#1)(2007-11#2)(2010-10#1)(2011-2#3)
perception of information##2##3##(2009-4#2)
perception of its##2##3##(2005-10#1)(2008-9#1)
perception of motion and##2##4##(1997-8#1)(2008-2#1)
perception of motion##5##3##(1992-2#2)(1997-8#2)(2008-2#1)
perception of motor##2##3##(2009-1#1)(2013-7#1)
perception of nurses##2##3##(1996-7#1)(2012-3#1)
perception of pain##5##3##(1993-2#1)(1996-7#1)(2005-7#2)(2006-10#1)
perception of professional nursing functions##2##5##(1991-2#2)
perception of stress##4##3##(2007-10#3)(2011-2#1)
perception of symptoms##2##3##(2007-6#1)(2010-2#1)
perception of the disease as cyclical##3##6##(2008-11#3)
perception of the##37##3##(1991-2#1)(1992-11#1)(1992-12#1)(1993-3#1)(1995-6#1)(1996-12#1)(1996-7#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-6#1)(2010-7#2)(2011-2#2)(2011-7#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-7#1)
perception of their disease##2##4##(2009-2#1)(2010-12#1)
perception of their own##2##4##(2011-1#1)(2013-7#1)
perception of their##12##3##(1991-2#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-11#2)(2008-12#1)(2009-2#1)(2010-12#1)(2010-2#1)(2011-1#1)(2013-7#1)
perception of these##2##3##(2008-11#1)(2011-2#1)
perception of this##2##3##(1993-9#1)(2010-12#1)
perception of visual##2##3##(1992-2#1)(2008-7#1)
perception of##235##2##(1990-9#1)(1991-1#1)(1991-2#5)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#2)(1993-2#1)(1993-3#2)(1993-9#1)(1994-1#2)(1994-12#1)(1994-2#1)(1995-1#1)(1995-10#1)(1995-2#2)(1995-5#2)(1995-6#1)(1996-12#1)(1996-3#2)(1996-7#3)(1997-8#4)(2005-10#1)(2005-11#1)(2005-7#3)(2005-8#1)(2005-9#1)(2006-10#4)(2006-2#3)(2006-3#2)(2006-5#4)(2006-7#1)(2006-9#2)(2007-10#3)(2007-11#2)(2007-12#5)(2007-2#4)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#4)(2007-8#2)(2007-9#4)(2008-1#3)(2008-10#1)(2008-11#10)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#5)(2009-1#1)(2009-10#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#9)(2009-6#2)(2009-7#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#13)(2011-7#1)(2012-1#3)(2012-11#1)(2012-12#6)(2012-2#7)(2012-3#15)(2013-1#11)(2013-7#4)(2013-8#9)
perception on##4##2##(2006-2#1)(2010-11#1)(2011-1#1)(2012-12#1)
perception performance##9##2##(2008-9#7)(2012-2#2)
perception system##2##2##(2008-2#1)(2008-4#1)
perception test##2##2##(2008-9#1)(2012-12#1)
perception that they##2##3##(1992-2#1)(2008-7#1)
perception that##15##2##(1992-2#1)(1994-1#1)(1994-12#1)(1994-7#1)(1996-1#1)(1997-1#1)(2004-9#1)(2005-8#1)(2006-2#2)(2006-9#1)(2008-7#1)(2009-2#1)(2012-12#1)(2012-3#1)
perception threshold##2##2##(2008-6#1)(2012-1#1)
perception thresholds in##2##3##(2006-12#2)
perception thresholds##3##2##(2006-12#3)
perception to the##2##3##(2008-4#1)(2009-4#1)
perception to##4##2##(2008-11#1)(2008-4#1)(2008-8#1)(2009-4#1)
perception was evaluated##2##3##(2008-7#1)(2013-1#1)
perception was##5##2##(1991-2#1)(1995-1#1)(2008-6#1)(2008-7#1)(2013-1#1)
perception with##2##2##(1991-2#1)(2008-2#1)
perception##597##1##(1990-10#1)(1990-2#1)(1990-9#2)(1991-1#3)(1991-12#2)(1991-2#11)(1991-3#1)(1991-4#2)(1992-1#4)(1992-11#1)(1992-12#1)(1992-2#5)(1992-3#2)(1992-4#1)(1992-9#2)(1993-2#3)(1993-3#2)(1993-9#1)(1994-1#3)(1994-12#5)(1994-2#4)(1994-3#2)(1994-4#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-2#3)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#4)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#11)(2004-3#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#3)(2005-8#3)(2005-9#1)(2006-10#10)(2006-12#6)(2006-2#8)(2006-3#4)(2006-5#4)(2006-6#2)(2006-7#4)(2006-8#2)(2006-9#3)(2007-10#3)(2007-11#5)(2007-12#9)(2007-2#5)(2007-3#3)(2007-4#1)(2007-5#3)(2007-6#4)(2007-8#7)(2007-9#10)(2008-1#4)(2008-10#3)(2008-11#28)(2008-12#4)(2008-2#11)(2008-3#7)(2008-4#13)(2008-5#4)(2008-6#9)(2008-7#16)(2008-8#3)(2008-9#48)(2009-1#1)(2009-10#1)(2009-12#2)(2009-2#6)(2009-3#2)(2009-4#26)(2009-6#4)(2009-7#2)(2009-8#9)(2009-9#3)(2010-10#2)(2010-11#3)(2010-12#3)(2010-2#4)(2010-3#2)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#1)(2010-9#4)(2011-1#12)(2011-12#3)(2011-2#24)(2011-7#1)(2012-1#8)(2012-11#4)(2012-12#16)(2012-2#19)(2012-3#25)(2013-1#25)(2013-7#4)(2013-8#13)
perception)##2##1##(1995-5#1)(2009-4#1)
perception-assist##4##1##(2012-1#4)
perception]##2##1##(1991-11#1)(2013-8#1)
perceptions about the role##2##4##(2008-11#1)(2011-1#1)
perceptions about the##6##3##(2007-12#1)(2008-11#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
perceptions about##12##2##(2004-12#2)(2006-7#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
perceptions among##6##2##(2007-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
perceptions and attitudes of##3##4##(2007-3#1)(2008-1#2)
perceptions and attitudes##6##3##(2007-3#1)(2008-1#2)(2008-2#1)(2010-6#1)(2011-2#1)
perceptions and behavior##4##3##(2010-7#4)
perceptions and concerns##2##3##(2007-8#1)(2010-5#1)
perceptions and experience of##2##4##(2012-3#2)
perceptions and experience##3##3##(2012-3#3)
perceptions and experiences of##3##4##(2007-9#1)(2008-1#2)
perceptions and experiences##4##3##(2007-9#2)(2008-1#2)
perceptions and feelings##2##3##(1992-2#1)(1995-12#1)
perceptions and knowledge##2##3##(2008-11#1)(2011-1#1)
perceptions and practices##3##3##(2011-2#1)(2012-2#2)
perceptions and social##3##3##(2007-12#1)(2008-12#1)(2012-3#1)
perceptions and##54##2##(1992-2#1)(1993-2#1)(1995-12#1)(1996-2#1)(1997-5#1)(1997-8#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#1)(2007-9#2)(2008-1#4)(2008-11#2)(2008-12#5)(2008-2#1)(2009-3#1)(2009-5#1)(2009-7#2)(2010-11#2)(2010-5#1)(2010-6#1)(2010-7#4)(2011-1#3)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#2)
perceptions are##4##2##(1995-1#1)(1996-3#1)(1997-8#1)(2009-9#1)
perceptions as##2##2##(1997-8#1)(2007-11#1)
perceptions associated with##2##3##(2007-12#1)(2010-12#1)
perceptions between##2##2##(2011-1#1)(2013-8#1)
perceptions concerning##2##2##(1990-12#1)(2011-1#1)
perceptions in##5##2##(2009-4#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
perceptions of Turkish##2##3##(2008-12#1)(2010-10#1)
perceptions of a##6##3##(2006-10#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
perceptions of an individual with a laryngectomy##2##7##(2011-1#2)
perceptions of attractive##2##3##(2007-12#2)
perceptions of being overweight##2##4##(2007-12#1)(2010-7#1)
perceptions of body weight and##2##5##(2007-12#2)
perceptions of brain death##2##4##(2007-11#2)
perceptions of child behavior##2##4##(1995-2#1)(2010-2#1)
perceptions of childbearing##2##3##(2007-2#2)
perceptions of clinical decision-making##2##4##(2008-11#2)
perceptions of family##4##3##(2006-4#1)(2007-12#1)(2010-10#2)
perceptions of generic medicines##2##4##(2011-1#2)
perceptions of health care##3##4##(1993-12#1)(1994-12#1)(2005-7#1)
perceptions of health##6##3##(1993-12#1)(1994-12#1)(2005-7#1)(2008-1#1)(2008-6#1)(2012-2#1)
perceptions of mental health##3##4##(2007-3#2)(2008-2#1)
perceptions of mental illness##2##4##(2008-12#2)
perceptions of mental##6##3##(2007-3#2)(2008-12#3)(2008-2#1)
perceptions of nurses##2##3##(1991-2#1)(2012-3#1)
perceptions of nursing##2##3##(1996-1#1)(2008-11#1)
perceptions of oral health##3##4##(2006-2#3)
perceptions of parent and nurse roles in caring for hospitalized children##2##11##(1990-12#2)
perceptions of personal##2##3##(1997-5#1)(2011-2#1)
perceptions of quality##4##3##(1991-2#1)(1995-12#1)(1997-3#1)(2010-10#1)
perceptions of retirement as the result of a more##2##9##(2009-12#2)
perceptions of risk##2##3##(1997-3#1)(2009-4#1)
perceptions of robotically-assisted coronary artery bypass##2##6##(2007-8#2)
perceptions of service providers##2##4##(2012-3#2)
perceptions of service quality##2##4##(1993-12#1)(1994-2#1)
perceptions of service##4##3##(1993-12#1)(1994-2#1)(2012-3#2)
perceptions of social##2##3##(2008-12#1)(2008-5#1)
perceptions of support##2##3##(2008-12#1)(2010-1#1)
perceptions of the classroom##3##4##(2008-12#3)
perceptions of the community##2##4##(1992-1#1)(2006-11#1)
perceptions of the impact of the##2##6##(1996-1#1)(2008-12#1)
perceptions of the impact of##3##5##(1996-1#1)(2006-7#1)(2008-12#1)
perceptions of the quality##2##4##(1995-2#1)(2009-7#1)
perceptions of the##57##3##(1991-1#1)(1991-2#1)(1992-1#1)(1993-1#1)(1995-1#2)(1995-2#2)(1996-1#1)(2005-7#1)(2006-11#1)(2006-2#1)(2006-7#2)(2007-10#1)(2007-4#2)(2007-6#1)(2008-10#1)(2008-11#2)(2008-12#4)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-12#2)(2010-3#4)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#2)(2012-1#2)(2012-3#1)(2013-1#1)(2013-8#1)
perceptions of their husbands' satisfaction with their bodies##2##8##(2008-9#2)
perceptions of their own##3##4##(2006-9#1)(2007-12#1)(2007-9#1)
perceptions of their##22##3##(1992-1#1)(1995-1#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-9#2)(2009-9#1)(2010-11#1)(2010-2#2)(2012-1#1)(2013-1#4)
perceptions of these##2##3##(1996-1#1)(2011-2#1)
perceptions of##314##2##(1990-12#3)(1991-1#1)(1991-2#3)(1992-1#3)(1993-1#1)(1993-12#3)(1993-2#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#3)(1995-12#2)(1995-2#5)(1995-3#2)(1996-1#6)(1996-2#1)(1996-3#1)(1996-7#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#4)(2005-7#3)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#7)(2006-3#1)(2006-4#1)(2006-7#3)(2006-9#2)(2007-10#1)(2007-11#4)(2007-12#14)(2007-2#9)(2007-3#2)(2007-4#3)(2007-6#1)(2007-8#3)(2007-9#3)(2008-1#2)(2008-10#1)(2008-11#14)(2008-12#15)(2008-2#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#7)(2009-10#2)(2009-11#4)(2009-12#3)(2009-3#3)(2009-4#5)(2009-5#3)(2009-6#1)(2009-7#9)(2009-9#7)(2010-1#2)(2010-10#4)(2010-11#1)(2010-12#4)(2010-2#5)(2010-3#5)(2010-4#4)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#5)(2010-9#4)(2011-1#15)(2011-2#6)(2012-1#6)(2012-11#2)(2012-12#2)(2012-2#4)(2012-3#14)(2013-1#19)(2013-7#2)(2013-8#4)
perceptions on providing patient decision support##2##6##(2013-1#2)
perceptions on the##2##3##(1995-12#1)(2007-11#1)
perceptions on##8##2##(1995-12#1)(2007-11#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#2)
perceptions regarding##5##2##(2010-10#2)(2010-4#1)(2011-1#1)(2012-2#1)
perceptions that##3##2##(2008-8#1)(2009-5#1)(2011-2#1)
perceptions were##6##2##(1995-1#1)(2006-7#1)(2007-11#1)(2008-11#1)(2013-1#2)
perceptions##486##1##(1990-12#4)(1991-1#1)(1991-2#3)(1992-1#3)(1992-2#1)(1993-1#1)(1993-12#4)(1993-2#2)(1994-12#2)(1994-2#2)(1994-3#2)(1995-1#6)(1995-12#4)(1995-2#5)(1995-3#2)(1996-1#6)(1996-2#2)(1996-3#3)(1996-7#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-8#7)(2004-12#2)(2005-7#3)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#10)(2006-3#1)(2006-4#1)(2006-7#7)(2006-9#2)(2007-10#1)(2007-11#10)(2007-12#21)(2007-2#11)(2007-3#4)(2007-4#4)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#5)(2008-1#7)(2008-10#1)(2008-11#21)(2008-12#25)(2008-2#5)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#8)(2009-10#3)(2009-11#4)(2009-12#3)(2009-3#4)(2009-4#8)(2009-5#5)(2009-6#1)(2009-7#12)(2009-9#9)(2010-1#2)(2010-10#6)(2010-11#3)(2010-12#6)(2010-2#6)(2010-3#5)(2010-4#5)(2010-5#3)(2010-6#3)(2010-7#7)(2010-8#6)(2010-9#4)(2011-1#27)(2011-12#1)(2011-2#14)(2012-1#8)(2012-11#2)(2012-12#8)(2012-2#9)(2012-3#18)(2013-1#39)(2013-7#3)(2013-8#10)
perceptive##2##1##(1990-12#1)(2012-1#1)
perceptron (MLP) and radial basis function##2##6##(2008-10#1)(2008-2#1)
perceptron neural##4##2##(2008-3#1)(2009-3#1)(2010-8#1)(2012-1#1)
perceptron##10##1##(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2009-3#1)(2010-8#1)(2012-1#1)
percepts of head motion##2##4##(2012-2#2)
percepts##8##1##(2008-11#1)(2008-9#1)(2009-12#2)(2009-9#1)(2012-2#2)(2012-3#1)
perceptual and cognitive processes##2##4##(2007-8#1)(2009-12#1)
perceptual and cognitive##3##3##(2007-8#2)(2009-12#1)
perceptual and##7##2##(1997-8#1)(2007-12#1)(2007-8#2)(2008-11#1)(2008-3#1)(2009-12#1)
perceptual attributes##2##2##(2008-5#2)
perceptual categories##4##2##(1992-11#2)(1993-2#1)(1997-8#1)
perceptual deficits##2##2##(1997-8#1)(2008-1#1)
perceptual disorder##3##2##(2007-5#3)
perceptual error##3##2##(2008-9#2)(2013-8#1)
perceptual grouping##4##2##(2007-8#1)(2008-9#1)(2009-4#2)
perceptual inference##2##2##(1997-8#2)
perceptual judgment##3##2##(2006-8#1)(2013-1#2)
perceptual learning##11##2##(2010-5#6)(2012-2#5)
perceptual loop##3##2##(2007-10#3)
perceptual mechanisms##3##2##(2008-2#1)(2012-12#1)(2012-2#1)
perceptual or##3##2##(1993-2#1)(2008-5#1)(2011-2#1)
perceptual quality##2##2##(2008-2#2)
perceptual reports##2##2##(2007-8#1)(2009-3#1)
perceptual sensitivity##2##2##(2008-4#1)(2012-2#1)
perceptual skill learning##2##3##(2007-8#2)
perceptual training##2##2##(2012-2#1)(2013-1#1)
perceptual##133##1##(1991-12#1)(1992-11#2)(1992-12#1)(1993-2#2)(1994-2#1)(1995-5#1)(1997-2#1)(1997-8#10)(2006-3#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#3)(2007-12#8)(2007-5#6)(2007-7#1)(2007-8#12)(2007-9#2)(2008-1#2)(2008-11#7)(2008-2#6)(2008-3#2)(2008-4#1)(2008-5#6)(2008-8#1)(2008-9#4)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#5)(2009-9#2)(2010-5#9)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#4)(2012-12#2)(2012-2#10)(2013-1#4)(2013-8#4)
perceptual-motor##2##1##(1996-3#1)(2006-10#1)
perceptually##8##1##(2008-2#4)(2009-4#1)(2009-9#1)(2012-2#1)(2013-8#1)
perch##3##1##(2007-9#1)(2009-5#1)(2010-8#1)
perches##4##1##(2008-5#4)
perchlorate and##6##2##(1996-4#1)(2007-8#1)(2008-10#4)
perchlorate anion##6##2##(2007-8#5)(2008-10#1)
perchlorate anions##2##2##(1996-2#2)
perchlorate at##2##2##(2008-10#2)
perchlorate by##4##2##(2007-8#3)(2008-10#1)
perchlorate concentrations##2##2##(2007-8#2)
perchlorate discharge test##2##3##(2010-10#1)(2011-1#1)
perchlorate exposure##3##2##(2007-8#1)(2008-10#2)
perchlorate extraction##2##2##(1994-8#1)(2008-10#1)
perchlorate in California##2##3##(2007-8#2)
perchlorate in biological##2##3##(2007-8#2)
perchlorate in drinking water##2##4##(2008-10#2)
perchlorate in##23##2##(2007-8#14)(2008-10#9)
perchlorate ion##3##2##(2008-10#3)
perchlorate is##2##2##(2008-10#2)
perchlorate present##3##2##(2007-8#3)
perchlorate salts of##2##3##(2008-10#2)
perchlorate salts##3##2##(2007-11#1)(2008-10#2)
perchlorate system is##2##3##(2008-10#2)
perchlorate system##3##2##(2008-10#3)
perchlorate than##2##2##(2008-10#2)
perchlorate##131##1##(1994-8#2)(1996-2#2)(1996-4#1)(1996-8#1)(1997-3#2)(2005-11#2)(2005-4#1)(2007-11#1)(2007-8#53)(2008-1#1)(2008-10#59)(2008-2#1)(2009-4#1)(2010-10#1)(2010-2#1)(2011-1#1)(2012-2#1)
perchlorates##2##1##(2008-10#2)
perchloric acid extracts##4##3##(1990-5#1)(1991-1#2)(1992-4#1)
perchloric acid or##2##3##(2008-10#2)
perchloric acid solutions##2##3##(2008-10#1)(2012-1#1)
perchloric acid##22##2##(1990-2#1)(1990-5#1)(1991-1#2)(1992-4#1)(1993-2#1)(1994-12#1)(1995-3#1)(1996-6#1)(2008-10#11)(2008-5#1)(2012-1#1)
perchloric and hydrofluoric acids##2##4##(2008-10#2)
perchloric and##4##2##(1995-3#1)(2008-10#3)
perchloric##30##1##(1990-2#1)(1990-5#1)(1991-1#2)(1992-4#1)(1993-11#1)(1993-2#1)(1994-12#1)(1995-3#2)(1996-6#1)(2008-10#17)(2008-5#1)(2012-1#1)
perchloroethylene (PCE) and trichloroethylene (TCE)##2##5##(2004-4#1)(2008-10#1)
perchloroethylene (PCE)##3##2##(2004-4#1)(2008-10#1)(2009-2#1)
perchloroethylene##4##1##(1993-2#1)(2004-4#1)(2008-10#1)(2009-2#1)
percolate through the##2##3##(2007-12#1)(2007-9#1)
percolate##6##1##(2004-4#3)(2007-12#1)(2007-9#1)(2008-10#1)
percolating cluster##2##2##(2005-11#2)
percolating##8##1##(2005-11#4)(2008-10#2)(2008-5#1)(2010-4#1)
percolation and##2##2##(1993-6#1)(2005-11#1)
percolation for##2##2##(2012-2#2)
percolation model##2##2##(2005-11#1)(2008-10#1)
percolation temperature of##2##3##(2005-11#2)
percolation temperature##3##2##(2005-11#3)
percolation theory##2##2##(2008-2#1)(2013-8#1)
percolation threshold##4##2##(1995-2#1)(2005-11#2)(2010-4#1)
percolation##26##1##(1992-11#1)(1993-6#1)(1995-11#1)(1995-2#1)(2005-11#11)(2006-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-11#2)(2010-4#1)(2012-2#2)(2013-8#1)
percoll/metrizamide gradient##2##2##(2005-8#2)
percussion pistol##2##2##(2011-2#2)
percussion vibrator##2##2##(2010-12#2)
percussion##21##1##(1992-5#1)(1992-7#1)(1993-12#3)(1994-12#1)(1995-12#1)(1995-8#1)(1996-1#1)(2004-11#1)(2006-7#1)(2007-2#1)(2008-12#2)(2008-3#2)(2010-12#2)(2011-2#3)
percussive##2##1##(2008-5#1)(2009-3#1)
percutaneous ablation##3##2##(2006-2#1)(2008-2#1)(2013-8#1)
percutaneous absorption of##5##3##(2004-12#1)(2008-5#2)(2011-3#2)
percutaneous absorption##11##2##(2004-12#2)(2008-11#1)(2008-5#6)(2011-3#2)
percutaneous access##2##2##(2007-7#1)(2008-10#1)
percutaneous adhesiolysis##2##2##(2006-8#2)
percutaneous alcohol injection##5##3##(1990-8#1)(2013-8#4)
percutaneous and open surgical##2##4##(2006-11#1)(2006-6#1)
percutaneous and##6##2##(2006-11#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#1)
percutaneous angioplasty##3##2##(1990-2#1)(1991-3#1)(2007-7#1)
percutaneous approach##10##2##(1991-3#1)(1996-9#1)(2006-2#1)(2006-6#5)(2006-8#1)(2011-2#1)
percutaneous arterial##2##2##(1990-9#1)(2006-6#1)
percutaneous aspiration##4##2##(1991-3#1)(2006-10#1)(2008-1#1)(2012-2#1)
percutaneous balloon mitral##2##3##(2007-9#1)(2011-2#1)
percutaneous balloon##6##2##(1991-3#1)(2007-9#1)(2008-7#2)(2011-2#2)
percutaneous biopsies##2##2##(2010-12#2)
percutaneous biopsy of the##2##4##(2008-1#2)
percutaneous biopsy of##4##3##(1995-11#1)(2008-1#2)(2013-8#1)
percutaneous biopsy to diagnose##2##4##(2012-12#2)
percutaneous biopsy##10##2##(1995-11#1)(2007-8#1)(2008-1#2)(2010-12#2)(2012-12#3)(2013-8#1)
percutaneous blind needle liver biopsy##4##5##(2007-3#4)
percutaneous cannulation##2##2##(2007-7#2)
percutaneous catheter##3##2##(2006-7#1)(2007-7#1)(2009-9#1)
percutaneous closure of##4##3##(2010-5#1)(2011-2#1)(2012-12#2)
percutaneous coronary intervention (PCI) is##2##5##(2006-7#1)(2006-8#1)
percutaneous coronary intervention (PCI)##16##4##(2006-10#2)(2006-7#1)(2006-8#1)(2008-11#1)(2008-3#2)(2008-6#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-9#1)(2013-1#2)(2013-8#1)
percutaneous coronary intervention and##2##4##(2009-12#1)(2009-5#1)
percutaneous coronary intervention for ST elevation##2##6##(2008-3#1)(2013-8#1)
percutaneous coronary intervention for##7##4##(2008-3#1)(2008-8#1)(2009-12#2)(2009-5#1)(2011-2#1)(2013-8#1)
percutaneous coronary intervention in##3##4##(2008-3#2)(2011-2#1)
percutaneous coronary intervention or coronary artery bypass##2##7##(2008-3#2)
percutaneous coronary intervention through##2##4##(2011-2#1)(2013-1#1)
percutaneous coronary intervention with stenting##2##5##(2009-12#2)
percutaneous coronary intervention with##4##4##(2008-3#1)(2009-12#3)
percutaneous coronary intervention##63##3##(2006-10#2)(2006-7#1)(2006-8#1)(2007-8#1)(2008-11#2)(2008-3#17)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#7)(2009-5#10)(2010-11#2)(2010-12#1)(2010-7#3)(2010-9#1)(2011-2#3)(2013-1#4)(2013-7#1)(2013-8#3)
percutaneous coronary interventions (PCI)##2##4##(2011-12#1)(2011-2#1)
percutaneous coronary interventions in patients with##2##6##(2008-6#1)(2010-4#1)
percutaneous coronary interventions in##4##4##(2006-10#1)(2008-6#1)(2009-12#1)(2010-4#1)
percutaneous coronary interventions##17##3##(2006-10#1)(2007-8#1)(2008-11#1)(2008-6#2)(2008-7#1)(2009-1#1)(2009-12#1)(2009-5#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#4)
percutaneous coronary revascularization##3##3##(2008-10#1)(2008-12#2)
percutaneous coronary##90##2##(1992-2#1)(2005-7#1)(2006-10#3)(2006-7#1)(2006-8#1)(2007-8#2)(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#17)(2008-6#3)(2008-7#2)(2008-8#1)(2009-1#1)(2009-10#1)(2009-12#8)(2009-5#11)(2010-11#2)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#11)(2013-1#4)(2013-7#2)(2013-8#3)
percutaneous device closure##3##3##(2007-8#1)(2008-11#1)(2009-3#1)
percutaneous device##10##2##(2004-9#7)(2007-8#1)(2008-11#1)(2009-3#1)
percutaneous dilatational tracheostomy##3##3##(2012-12#3)
percutaneous disc decompression using Coblation##2##5##(2006-8#2)
percutaneous disc decompression using##3##4##(2006-8#3)
percutaneous disc##4##2##(2006-8#3)(2007-1#1)
percutaneous drainage and##3##3##(2010-12#2)(2011-2#1)
percutaneous drainage of##2##3##(2010-12#1)(2010-8#1)
percutaneous drainage through the##2##4##(2009-3#1)(2012-8#1)
percutaneous drainage##12##2##(1991-8#1)(2006-10#1)(2007-8#1)(2008-4#1)(2009-3#1)(2010-12#3)(2010-8#1)(2011-2#1)(2012-12#1)(2012-8#1)
percutaneous endoscopic gastrostomy tube##4##4##(1997-3#2)(2006-10#1)(2012-12#1)
percutaneous endoscopic gastrostomy##5##3##(1992-5#1)(1997-3#2)(2006-10#1)(2012-12#1)
percutaneous endoscopic##9##2##(1992-5#1)(1997-3#2)(2005-10#2)(2006-10#1)(2008-5#2)(2012-12#1)
percutaneous enhancers##2##2##(2007-11#2)
percutaneous fine needle biopsy##2##4##(1991-2#1)(2006-6#1)
percutaneous fixation##4##2##(2008-9#3)(2009-2#1)
percutaneous gastrostomy##2##2##(1996-3#1)(2006-10#1)
percutaneous implantation of##2##3##(1990-8#1)(2006-6#1)
percutaneous injection of ciment##2##4##(1995-9#2)
percutaneous injection of##3##3##(1995-9#2)(2008-7#1)
percutaneous injection##5##2##(1993-11#1)(1995-9#2)(2008-7#1)(2010-12#1)
percutaneous insertion of##2##3##(2007-7#2)
percutaneous intervention with##2##3##(2007-8#1)(2009-6#1)
percutaneous intervention##6##2##(2007-11#1)(2007-8#1)(2008-11#1)(2009-5#1)(2009-6#1)(2011-2#1)
percutaneous interventions and##2##3##(2007-8#1)(2008-5#1)
percutaneous interventions##8##2##(1996-12#1)(2007-5#1)(2007-8#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-7#1)(2011-2#1)
percutaneous laser disc decompression (PLDD)##3##5##(2007-8#3)
percutaneous liver biopsy##2##3##(1992-9#1)(2008-3#1)
percutaneous lumbar##3##2##(1996-6#1)(2007-8#1)(2011-2#1)
percutaneous mitral valvuloplasty for##2##4##(2011-2#2)
percutaneous needle aspiration##2##3##(2007-8#1)(2010-12#1)
percutaneous needle##4##2##(1990-3#2)(2007-8#1)(2010-12#1)
percutaneous nephrolithotomy for larger##2##4##(2006-6#2)
percutaneous nephrolithotomy in children##2##4##(2008-10#2)
percutaneous nephrolithotomy in##3##3##(2008-10#2)(2011-2#1)
percutaneous nephrolithotomy##11##2##(2006-6#3)(2006-9#1)(2007-10#1)(2008-10#2)(2011-2#3)(2012-12#1)
percutaneous or##5##2##(1991-3#2)(2006-6#1)(2008-4#1)(2009-11#1)
percutaneous placement##2##2##(2007-7#2)
percutaneous radiofrequency ablation##2##3##(2007-8#1)(2008-8#1)
percutaneous radiofrequency##4##2##(2006-12#1)(2007-8#1)(2008-8#1)(2010-12#1)
percutaneous release of##2##3##(2008-9#2)
percutaneous renal biopsy]##2##3##(1992-2#1)(1995-11#1)
percutaneous renal##4##2##(1992-2#1)(1992-5#1)(1995-11#2)
percutaneous technique##4##2##(2007-8#1)(2010-5#1)(2012-3#2)
percutaneous thrombectomy procedures##2##3##(2007-7#2)
percutaneous thrombectomy##3##2##(2007-7#3)
percutaneous tracheostomy##6##2##(2006-10#3)(2007-8#1)(2008-2#2)
percutaneous transaxillary##4##2##(2007-7#4)
percutaneous transcatheter##4##2##(1992-10#1)(2006-9#1)(2007-8#1)(2008-11#1)
percutaneous transhepatic gallbladder drainage##2##4##(2013-1#2)
percutaneous transhepatic##7##2##(2008-5#2)(2009-8#1)(2010-12#1)(2013-1#3)
percutaneous transluminal angioplasty (PTA)##6##4##(2005-10#1)(2006-11#1)(2007-7#1)(2008-7#1)(2011-2#2)
percutaneous transluminal angioplasty##11##3##(1991-3#1)(1993-8#1)(1997-1#1)(1997-3#1)(2005-10#1)(2006-11#1)(2007-7#1)(2008-1#1)(2008-7#1)(2011-2#2)
percutaneous transluminal coronary angioplasty (PTCA) or##2##6##(2007-5#1)(2008-7#1)
percutaneous transluminal coronary angioplasty (PTCA)##14##5##(1991-3#1)(1993-12#1)(1994-11#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-3#1)(2008-5#2)(2008-7#1)(2013-8#1)
percutaneous transluminal coronary angioplasty##27##4##(1991-3#1)(1993-12#1)(1994-11#2)(1995-2#1)(1995-8#1)(1996-12#2)(1997-8#1)(2006-10#2)(2006-8#1)(2007-10#2)(2007-11#2)(2007-5#1)(2007-8#4)(2008-3#1)(2008-5#3)(2008-7#1)(2013-8#1)
percutaneous transluminal coronary##28##3##(1991-3#1)(1993-12#1)(1994-11#2)(1995-2#1)(1995-8#1)(1996-12#2)(1997-8#1)(2006-10#2)(2006-8#1)(2007-10#2)(2007-11#2)(2007-5#1)(2007-8#4)(2008-3#1)(2008-5#3)(2008-7#1)(2009-10#1)(2013-8#1)
percutaneous transluminal##41##2##(1991-3#2)(1993-12#1)(1993-8#1)(1994-11#2)(1995-2#1)(1995-8#1)(1996-12#2)(1997-1#1)(1997-3#1)(1997-8#1)(2005-10#1)(2006-10#3)(2006-11#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2009-10#1)(2011-2#2)(2013-8#1)
percutaneous treatment of##5##3##(1997-8#1)(2008-3#1)(2009-5#1)(2010-5#1)(2011-2#1)
percutaneous treatment##9##2##(1990-12#1)(1997-8#1)(2006-10#1)(2006-6#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-5#1)(2011-2#1)
percutaneous trigger finger release##2##4##(2008-9#2)
percutaneous vertebroplasty##5##2##(2006-8#3)(2007-11#1)(2007-8#1)
percutaneous##463##1##(1990-12#2)(1990-2#3)(1990-3#2)(1990-4#1)(1990-8#4)(1990-9#1)(1991-2#1)(1991-3#8)(1991-8#1)(1991-9#1)(1992-10#1)(1992-2#2)(1992-5#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-5#1)(1993-8#1)(1994-11#2)(1995-11#3)(1995-2#1)(1995-8#1)(1995-9#2)(1996-12#4)(1996-3#2)(1996-6#2)(1996-9#3)(1997-1#1)(1997-3#3)(1997-6#1)(1997-8#2)(2004-12#2)(2004-9#7)(2005-10#4)(2005-7#1)(2006-10#15)(2006-11#2)(2006-12#4)(2006-2#3)(2006-3#1)(2006-4#1)(2006-6#19)(2006-7#2)(2006-8#17)(2006-9#2)(2007-1#1)(2007-10#6)(2007-11#6)(2007-12#1)(2007-3#4)(2007-5#3)(2007-7#21)(2007-8#25)(2007-9#3)(2008-1#5)(2008-10#7)(2008-11#7)(2008-12#5)(2008-2#4)(2008-3#20)(2008-4#7)(2008-5#14)(2008-6#4)(2008-7#11)(2008-8#4)(2008-9#8)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#10)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#16)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#16)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#4)(2010-8#2)(2010-9#1)(2011-12#1)(2011-2#36)(2011-3#2)(2012-12#12)(2012-2#5)(2012-3#4)(2012-8#1)(2013-1#7)(2013-7#2)(2013-8#13)
percutaneously and##3##2##(1990-8#1)(2007-1#1)(2008-4#1)
percutaneously during##2##2##(2008-10#1)(2008-7#1)
percutaneously in##3##2##(1990-11#1)(2006-6#1)(2013-7#1)
percutaneously placed##2##2##(2006-6#1)(2006-7#1)
percutaneously with##2##2##(2007-7#1)(2013-1#1)
percutaneously##27##1##(1990-11#1)(1990-8#1)(1992-4#1)(1993-12#1)(1993-5#1)(2006-12#2)(2006-6#2)(2006-7#1)(2007-1#1)(2007-7#4)(2008-10#1)(2008-4#2)(2008-7#1)(2009-10#1)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
percutaneus##2##1##(2007-8#1)(2011-2#1)
perdeuterated palmitic acid##2##3##(1994-5#1)(2008-10#1)
perdeuterated##8##1##(1991-4#1)(1992-1#1)(1993-3#2)(1994-11#1)(1994-5#1)(2008-10#2)
peregrina##9##1##(2012-11#3)(2012-2#6)
peregrine falcons (Falco peregrinus)##2##4##(2008-5#2)
perennial allergens##3##2##(2009-6#1)(2011-2#2)
perennial allergic rhinitis (PAR)##2##4##(2008-3#2)
perennial and annual Medicago species##3##5##(2008-5#3)
perennial and winter##2##3##(2012-2#2)
perennial and##6##2##(2008-5#3)(2012-2#2)(2013-1#1)
perennial canker##3##2##(2008-10#3)
perennial crops##2##2##(2008-10#2)
perennial grasses##3##2##(2008-10#2)(2008-9#1)
perennial herb##3##2##(2008-12#1)(2008-5#1)(2008-9#1)
perennial nature##2##2##(2008-10#1)(2011-2#1)
perennial plant##2##2##(2007-7#1)(2008-8#1)
perennial plants##2##2##(2008-10#1)(2010-1#1)
perennial ryegrass (Lolium perenne)##2##4##(2008-10#2)
perennial ryegrass (Lolium##3##3##(2008-10#3)
perennial ryegrass and tall fescue##2##5##(2008-10#2)
perennial ryegrass and##3##3##(2008-10#3)
perennial ryegrass seed crops##2##4##(2008-10#2)
perennial ryegrass turf##5##3##(2008-10#5)
perennial ryegrass##24##2##(2008-10#24)
perennial##84##1##(2005-8#2)(2007-11#2)(2007-2#1)(2007-3#2)(2007-7#1)(2008-10#40)(2008-12#1)(2008-3#2)(2008-5#5)(2008-8#6)(2008-9#5)(2009-5#1)(2009-6#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-11#1)(2012-2#3)(2012-7#1)(2013-1#1)(2013-8#1)
perennially##3##1##(2006-7#1)(2008-3#1)(2009-5#1)
perennials##6##1##(2008-9#6)
pereopod##2##1##(2008-6#2)
perfect agreement with the##2##4##(1990-9#1)(1993-3#1)
perfect agreement with##3##3##(1990-9#1)(1993-3#1)(2008-2#1)
perfect agreement##4##2##(1990-9#1)(1993-3#1)(2004-11#1)(2008-2#1)
perfect and##3##2##(2008-5#1)(2010-8#1)(2011-1#1)
perfect control of##2##3##(1994-12#1)(2009-2#1)
perfect correlation between##3##3##(1994-3#1)(2007-8#1)(2008-10#1)
perfect correlation##4##2##(1994-3#1)(2007-8#1)(2008-10#1)(2008-3#1)
perfect coupling##4##2##(1997-2#4)
perfect decoupled##2##2##(2008-10#2)
perfect double stranded##2##3##(2008-10#2)
perfect enzyme&quot##2##2##(1994-8#1)(1995-10#1)
perfect imaging##2##2##(2008-3#2)
perfect odd-periodic autocorrelation##2##3##(2008-2#2)
perfect odd-periodic##3##2##(2008-2#2)(2008-3#1)
perfect or##2##2##(1993-12#1)(2008-9#1)
perfect recall##3##2##(2007-12#1)(2008-8#2)
perfect repeats##3##2##(2008-3#2)(2011-12#1)
perfect sinusoidal fringe##2##3##(2008-3#2)
perfect sinusoidal##3##2##(2008-3#3)
perfect storm for##2##3##(2007-4#1)(2013-8#1)
perfect storm##3##2##(2007-4#2)(2013-8#1)
perfect surface##2##2##(2005-11#1)(2008-3#1)
perfect##163##1##(1990-1#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-12#4)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-3#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-2#5)(1997-3#1)(1997-6#1)(1997-7#1)(2004-11#1)(2005-10#2)(2005-11#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-5#1)(2006-6#2)(2006-7#1)(2007-11#7)(2007-12#9)(2007-2#1)(2007-4#3)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#13)(2008-3#20)(2008-5#5)(2008-7#2)(2008-8#2)(2008-9#4)(2009-10#1)(2009-2#3)(2010-11#1)(2010-12#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#7)(2013-7#1)(2013-8#1)
perfect-match##2##1##(2007-12#2)
perfect-shuffle##4##1##(2008-2#4)
perfection##6##1##(1993-12#1)(2007-12#1)(2008-4#1)(2009-8#1)(2013-1#2)
perfectionism##4##1##(2007-12#3)(2008-4#1)
perfectionistic self-presentation and##2##3##(2007-12#2)
perfectionistic self-presentation##7##2##(2007-12#7)
perfectly aligned arrays of##2##4##(2008-7#2)
perfectly aligned##5##2##(1995-3#1)(2008-2#2)(2008-7#2)
perfectly conducting##2##2##(2007-12#1)(2008-3#1)
perfectly conserved##2##2##(1994-3#1)(2012-2#1)
perfectly discriminated##2##2##(2008-10#1)(2010-4#1)
perfectly linear##2##2##(2008-10#1)(2008-7#1)
perfectly matched layer##4##3##(2008-3#3)(2013-7#1)
perfectly matched##6##2##(1995-12#1)(2008-3#3)(2008-4#1)(2013-7#1)
perfectly parallel##2##2##(2006-3#1)(2008-3#1)
perfectly periodic##2##2##(1996-4#1)(2007-12#1)
perfectly suited for##2##3##(2007-12#1)(2008-4#1)
perfectly suited##3##2##(2007-12#1)(2008-10#1)(2008-4#1)
perfectly synchronized##2##2##(2007-12#2)
perfectly to##3##2##(2008-10#2)(2009-12#1)
perfectly with##5##2##(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-2#1)
perfectly##73##1##(1991-12#1)(1992-2#1)(1993-11#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-4#1)(1997-2#1)(1997-7#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-12#8)(2007-3#1)(2008-1#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#8)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)
perfectsil##2##1##(2010-12#1)(2010-2#1)
perflubron emulsion##4##2##(1995-5#4)
perflubron##5##1##(1995-5#5)
perfluorinated chains##2##2##(2010-4#2)
perfluorinated##6##1##(2008-10#1)(2010-4#3)(2011-1#2)
perfluoroacyl derivatives##2##2##(1990-9#1)(2013-7#1)
perfluoroacylation reagents##2##2##(2008-10#2)
perfluoroalkyl and silicone-containing side chains##2##5##(2005-11#2)
perfluoroalkyl group content##4##3##(2005-11#4)
perfluoroalkyl##6##1##(2005-11#6)
perfluorocarbon emulsions##4##2##(2005-7#1)(2006-10#2)(2007-11#1)
perfluorocarbon##7##1##(2005-7#1)(2006-10#2)(2007-11#1)(2008-7#1)(2013-1#2)
perfluorocarbons##6##1##(2005-7#2)(2006-10#2)(2007-11#2)
perfluorodecanoic acid##2##2##(1994-8#2)
perfluorooctanesulfonamides##3##1##(2008-6#3)
perfluoropropane gas##2##2##(2011-1#2)
perforant path and##2##3##(1992-9#1)(1993-12#1)
perforant path evoked##2##3##(1992-7#2)
perforant path in##2##3##(1990-5#1)(1993-12#1)
perforant path##19##2##(1990-5#1)(1990-7#1)(1992-1#1)(1992-7#4)(1992-9#4)(1993-12#6)(1996-7#1)(1997-5#1)
perforant path-granule cell##2##3##(1993-2#1)(1995-12#1)
perforant pathway##3##2##(1992-1#3)
perforant##26##1##(1990-5#2)(1990-7#1)(1992-1#4)(1992-7#4)(1992-9#4)(1993-12#6)(1993-2#1)(1995-12#1)(1996-7#1)(1997-5#1)(2009-8#1)
perforata##3##1##(2012-2#3)
perforated appendicitis##2##2##(2005-12#1)(2007-12#1)
perforated by##2##2##(2006-2#1)(2007-7#1)
perforated duodenal##2##2##(1993-6#1)(2010-4#1)
perforated gastroduodenal ulcer##2##3##(1993-6#1)(2012-3#1)
perforated patch-clamp##3##2##(1994-9#1)(1997-1#1)(2008-8#1)
perforated peptic ulcer##2##3##(2006-10#1)(2006-8#1)
perforated pyloric ulcer##3##3##(1990-6#3)
perforated with##4##2##(2007-12#2)(2008-7#1)(2012-2#1)
perforated##44##1##(1990-6#4)(1993-10#1)(1993-6#2)(1993-9#2)(1994-2#2)(1994-9#1)(1995-11#2)(1995-6#1)(1996-2#1)(1997-1#1)(2005-12#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-7#3)(2007-8#2)(2008-10#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)
perforating external root resorption##2##4##(2013-1#2)
perforating##10##1##(1990-5#1)(1997-3#1)(2007-12#1)(2007-7#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
perforation after##5##2##(2007-3#1)(2007-8#3)(2007-9#1)
perforation and bleeding##2##3##(2006-10#1)(2010-8#1)
perforation and##11##2##(1990-6#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-6#1)(2009-8#1)(2010-8#2)(2011-2#2)(2013-8#1)
perforation by a##2##3##(2007-8#1)(2013-7#1)
perforation caused by##2##3##(2008-12#1)(2013-7#1)
perforation could##2##2##(1993-6#1)(2011-2#1)
perforation due to metastatic##2##4##(2012-2#2)
perforation due to##4##3##(2011-2#1)(2012-2#3)
perforation during##5##2##(1996-2#1)(1996-6#1)(1997-2#1)(2007-10#1)(2007-11#1)
perforation following##2##2##(2007-8#1)(2008-12#1)
perforation in a##2##3##(2007-8#1)(2013-1#1)
perforation in##6##2##(1990-12#1)(1991-3#1)(2007-2#1)(2007-8#1)(2012-2#1)(2013-1#1)
perforation is a##3##3##(2007-8#1)(2013-1#2)
perforation is##4##2##(2007-8#1)(2009-10#1)(2013-1#2)
perforation of a blind loop##2##5##(1991-9#2)
perforation of a##5##3##(1991-9#2)(1993-6#1)(2006-9#1)(2008-12#1)
perforation of an##2##3##(2008-10#1)(2008-3#1)
perforation of the rectum by##2##5##(1993-8#2)
perforation of the rectum##3##4##(1993-8#2)(2013-7#1)
perforation of the##21##3##(1991-8#1)(1993-8#2)(1996-2#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-3#2)(2008-4#1)(2009-3#1)(2009-4#1)(2009-8#1)(2011-2#3)(2013-1#1)(2013-7#1)
perforation of##31##2##(1991-8#1)(1991-9#2)(1993-6#1)(1993-8#2)(1996-2#1)(2006-12#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-12#2)(2008-3#3)(2008-4#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2011-2#3)(2013-1#1)(2013-7#1)
perforation or##2##2##(1990-11#1)(2011-2#1)
perforation was##3##2##(2006-2#1)(2007-8#1)(2008-6#1)
perforation with a##2##3##(2007-2#1)(2010-2#1)
perforation with##7##2##(1993-10#1)(1997-3#1)(2007-2#1)(2007-8#1)(2010-12#1)(2010-2#2)
perforation##160##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#2)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#2)(1993-10#1)(1993-6#4)(1993-8#2)(1995-10#2)(1996-2#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#2)(2006-10#2)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#2)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-2#4)(2007-3#1)(2007-5#3)(2007-7#4)(2007-8#17)(2007-9#2)(2008-10#1)(2008-11#3)(2008-12#5)(2008-2#3)(2008-3#3)(2008-4#1)(2008-6#7)(2008-7#1)(2009-10#4)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#2)(2010-12#2)(2010-2#3)(2010-4#2)(2010-8#4)(2010-9#1)(2011-12#1)(2011-2#19)(2012-2#7)(2013-1#7)(2013-7#3)(2013-8#4)
perforations and##3##2##(1990-12#1)(1990-5#1)(2006-3#1)
perforations are##3##2##(2010-12#2)(2013-8#1)
perforations due to##2##3##(2009-4#1)(2011-2#1)
perforations were##2##2##(2009-2#1)(2011-2#1)
perforations##29##1##(1990-12#1)(1990-2#1)(1990-5#1)(1996-2#1)(2006-10#1)(2006-3#1)(2006-9#3)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2009-2#1)(2009-4#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#4)(2012-8#2)(2013-1#1)(2013-8#1)
perforator flap##7##2##(2009-6#1)(2009-9#1)(2011-2#3)(2013-1#2)
perforator flaps##2##2##(2011-2#1)(2012-2#1)
perforator##19##1##(2006-6#4)(2008-9#2)(2009-6#1)(2009-9#1)(2011-2#4)(2012-2#2)(2013-1#5)
perforators##9##1##(2008-9#4)(2011-2#1)(2011-3#1)(2013-1#3)
perforatum##6##1##(2008-10#1)(2008-8#1)(2009-3#1)(2009-4#1)(2013-1#2)
perforin and granzymes##2##3##(2008-4#1)(2011-2#1)
perforin##16##1##(1992-4#1)(1993-3#2)(1994-5#7)(1995-12#1)(2007-2#1)(2008-4#1)(2011-2#3)
perform a &quot##2##3##(2008-7#1)(2013-7#1)
perform a risk##2##3##(2007-9#1)(2012-2#1)
perform a systematic review##2##4##(2009-3#1)(2010-11#1)
perform a##83##2##(1990-6#1)(1993-11#1)(1996-11#1)(2005-10#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-7#4)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#4)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#4)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#2)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#2)
perform abortions##2##2##(1995-6#1)(1995-9#1)
perform accurate##6##2##(2007-12#1)(2008-1#1)(2008-10#2)(2008-5#1)(2013-1#1)
perform activities of daily living (ADL)##3##6##(2004-3#1)(2012-1#1)(2012-2#1)
perform activities of daily living##5##5##(2004-3#1)(2006-8#1)(2007-7#1)(2012-1#1)(2012-2#1)
perform activities##6##2##(2004-3#1)(2006-8#1)(2007-7#1)(2008-6#1)(2012-1#1)(2012-2#1)
perform an##20##2##(1995-8#1)(2006-6#1)(2006-8#1)(2007-11#1)(2008-10#4)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-11#1)(2010-3#1)(2011-1#1)(2012-3#2)(2013-8#1)
perform analysis##2##2##(2006-10#1)(2011-3#1)
perform and##17##2##(1990-12#1)(1990-2#1)(1991-4#1)(1997-6#1)(2004-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-4#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-5#1)(2011-12#1)(2011-2#2)(2012-1#1)
perform any##5##2##(1992-6#1)(2008-2#1)(2009-1#1)(2009-3#1)(2011-12#1)
perform as well as##3##4##(2008-2#1)(2008-5#1)(2008-9#1)
perform as##5##2##(1996-12#1)(2006-6#1)(2008-2#1)(2008-5#1)(2008-9#1)
perform automated##2##2##(1990-3#2)
perform better in##4##3##(2006-8#1)(2010-12#1)(2012-1#2)
perform better than those##2##4##(2005-8#1)(2008-12#1)
perform better than##3##3##(2005-8#1)(2008-12#1)(2012-3#1)
perform better##13##2##(1994-12#1)(2005-10#1)(2005-8#1)(2006-8#1)(2008-11#1)(2008-12#1)(2008-6#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-1#2)(2012-3#1)
perform biochemical##2##2##(1993-12#1)(2011-1#1)
perform both##4##2##(2006-12#1)(2008-10#1)(2008-2#1)(2008-6#1)
perform chemical##2##2##(2005-11#1)(2008-10#1)
perform close to##2##3##(2008-1#1)(2008-3#1)
perform cognitive tasks##2##3##(1994-2#1)(2012-1#1)
perform complex##3##2##(2008-7#1)(2008-9#1)(2013-1#1)
perform daily activities##3##3##(2012-2#2)(2013-1#1)
perform experiments##2##2##(2008-7#1)(2010-7#1)
perform extensive##2##2##(1994-11#1)(2008-6#1)
perform functions##2##2##(1997-7#1)(2007-9#1)
perform further##2##2##(1991-9#1)(2011-1#1)
perform in the##3##3##(2007-8#1)(2010-1#1)(2011-2#1)
perform in##12##2##(2006-6#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#2)(2009-8#1)(2010-1#1)(2011-2#1)(2012-12#1)
perform like##2##2##(1994-10#1)(2007-1#1)
perform many##3##2##(1990-12#1)(2008-11#1)(2008-7#1)
perform measurements at##2##3##(1996-12#1)(2007-12#1)
perform measurements##3##2##(1996-12#1)(2007-12#1)(2008-3#1)
perform more accurately##2##3##(2010-8#1)(2012-1#1)
perform more work##2##3##(1993-2#1)(2011-2#1)
perform more##8##2##(1993-2#1)(2008-4#1)(2009-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
perform poorly on##3##3##(1995-1#1)(2006-3#1)(2012-3#1)
perform poorly##4##2##(1995-1#1)(2006-3#1)(2007-11#1)(2012-3#1)
perform quantitative##9##2##(1997-2#2)(2008-10#2)(2008-7#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
perform radical##2##2##(1990-9#1)(1992-6#1)
perform segmentation##2##2##(2008-6#1)(2008-9#1)
perform sensitivity##2##2##(2009-12#1)(2010-2#1)
perform significant##2##2##(1996-3#1)(2010-12#1)
perform significantly better than##2##4##(2006-11#1)(2008-2#1)
perform significantly worse##2##3##(2009-7#1)(2013-8#1)
perform significantly##5##2##(2006-11#1)(2008-2#1)(2009-7#1)(2011-2#1)(2013-8#1)
perform simultaneous##3##2##(2008-10#1)(2008-2#2)
perform some##3##2##(1993-12#1)(2007-8#1)(2010-2#1)
perform such a##2##3##(2007-11#1)(2007-12#1)
perform such##4##2##(2006-3#1)(2007-11#1)(2007-12#1)(2010-12#1)
perform tasks##5##2##(2006-8#1)(2007-9#1)(2008-7#1)(2008-9#1)(2010-12#1)
perform the desired##2##3##(2008-1#1)(2008-11#1)
perform the necessary##2##3##(1994-3#1)(2008-9#1)
perform the operation##2##3##(1993-9#1)(2011-2#1)
perform the procedure##2##3##(2006-6#1)(2012-12#1)
perform the same function##2##4##(1990-5#1)(2007-12#1)
perform the same##5##3##(1990-5#1)(1997-6#1)(2007-12#1)(2008-5#1)(2010-8#1)
perform the sequential##2##3##(2008-10#2)
perform the##83##2##(1990-5#1)(1990-8#1)(1991-2#1)(1991-8#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-3#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-12#2)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#18)(2008-11#1)(2008-12#2)(2008-2#8)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-4#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-1#3)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#2)
perform their duties##2##3##(1995-1#1)(1996-12#1)
perform their##9##2##(1990-12#1)(1991-3#2)(1993-12#1)(1995-1#1)(1996-12#1)(2007-12#1)(2008-7#1)(2011-2#1)
perform these##6##2##(1990-12#2)(2006-6#1)(2008-3#1)(2009-9#1)(2010-6#1)
perform this operation##2##3##(2006-6#1)(2007-11#1)
perform this task with##2##4##(1995-11#1)(2006-2#1)
perform this##15##2##(1995-11#1)(1995-8#1)(1996-12#1)(2005-12#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-9#1)(2011-2#1)(2013-1#2)
perform very well##2##3##(2007-11#1)(2008-3#1)
perform well in##5##3##(1992-9#1)(1997-3#1)(2008-12#1)(2008-6#1)(2013-1#1)
perform well when##2##3##(1996-8#1)(2007-11#1)
perform well with##2##3##(2010-2#1)(2010-8#1)
perform well##16##2##(1992-9#1)(1996-8#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-6#1)(2009-12#1)(2010-2#1)(2010-8#1)(2011-3#1)(2012-3#2)(2013-1#1)
perform with a##2##3##(2006-10#1)(2007-3#1)
perform with the##2##3##(1996-4#1)(2008-10#1)
perform with##5##2##(1996-4#1)(2006-10#1)(2007-3#1)(2008-10#1)(2009-12#1)
perform##740##1##(1990-12#6)(1990-2#1)(1990-3#3)(1990-4#3)(1990-5#1)(1990-6#2)(1990-8#3)(1990-9#2)(1991-2#2)(1991-3#3)(1991-4#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#4)(1993-2#5)(1993-3#1)(1993-5#1)(1993-6#4)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#3)(1995-1#2)(1995-11#4)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#2)(1995-8#2)(1995-9#2)(1996-1#1)(1996-11#2)(1996-12#6)(1996-3#2)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-2#4)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#3)(2004-2#3)(2004-3#1)(2004-8#1)(2004-9#1)(2005-10#2)(2005-11#4)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#17)(2006-11#2)(2006-12#4)(2006-2#4)(2006-3#4)(2006-4#1)(2006-5#3)(2006-6#15)(2006-7#2)(2006-8#12)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#11)(2007-12#21)(2007-2#1)(2007-3#2)(2007-4#6)(2007-5#6)(2007-6#1)(2007-7#9)(2007-8#11)(2007-9#4)(2008-1#17)(2008-10#74)(2008-11#14)(2008-12#7)(2008-2#31)(2008-3#43)(2008-4#21)(2008-5#8)(2008-6#9)(2008-7#21)(2008-8#1)(2008-9#11)(2009-1#1)(2009-10#5)(2009-12#6)(2009-2#3)(2009-3#3)(2009-4#4)(2009-5#4)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#6)(2010-2#9)(2010-3#4)(2010-4#2)(2010-5#3)(2010-6#3)(2010-7#3)(2010-8#7)(2010-9#3)(2011-1#6)(2011-12#4)(2011-2#27)(2011-3#2)(2012-1#13)(2012-11#2)(2012-12#6)(2012-2#14)(2012-3#13)(2013-1#23)(2013-7#9)(2013-8#16)
performa##2##1##(2008-4#1)(2010-5#1)
performance IQ##2##2##(2006-7#1)(2007-8#1)
performance achieved by##3##3##(1994-5#2)(2008-3#1)
performance achieved##4##2##(1994-5#2)(2005-1#1)(2008-3#1)
performance across##2##2##(2009-7#1)(2010-3#1)
performance advantage##2##2##(2008-2#1)(2008-9#1)
performance after##10##2##(1991-2#1)(1993-3#1)(1997-8#1)(2005-8#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2012-2#1)(2012-3#1)
performance against##3##2##(2008-2#3)
performance among the##2##3##(1996-8#1)(2009-12#1)
performance among##4##2##(1996-8#1)(2006-10#1)(2008-6#1)(2009-12#1)
performance analysis of##5##3##(2008-3#5)
performance analysis##7##2##(2007-12#1)(2008-3#5)(2011-1#1)
performance and a##2##3##(2008-9#1)(2011-1#1)
performance and accountability##2##3##(1996-11#2)
performance and accuracy##3##3##(2006-10#1)(2008-2#1)(2008-3#1)
performance and behaviour##2##3##(2008-11#1)(2008-12#1)
performance and cost-effectiveness##2##3##(1995-2#2)
performance and efficiency of##2##4##(2007-12#1)(2009-8#1)
performance and event-related##2##3##(1997-5#2)
performance and for##3##3##(1996-3#1)(2008-10#1)(2010-8#1)
performance and improve quality##2##4##(1996-3#2)
performance and in##2##3##(2009-12#1)(2013-1#1)
performance and increased##3##3##(1992-11#1)(2008-5#1)(2008-7#1)
performance and on##2##3##(1996-9#1)(2010-2#1)
performance and outcomes##2##3##(1994-12#1)(2008-6#1)
performance and patient##2##3##(2007-4#1)(2011-12#1)
performance and quality##2##3##(2008-10#1)(2008-11#1)
performance and reliability of##2##4##(2008-4#1)(2009-6#1)
performance and the##9##3##(1992-10#1)(1995-12#1)(2007-2#1)(2008-3#2)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
performance and to##2##3##(2011-1#1)(2013-1#1)
performance and##181##2##(1992-10#1)(1992-11#1)(1992-12#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-1#2)(1995-12#2)(1995-2#2)(1996-11#2)(1996-3#3)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-5#2)(1997-8#1)(2005-10#1)(2005-11#2)(2006-10#3)(2006-5#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#2)(2007-4#3)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#5)(2008-12#5)(2008-2#10)(2008-3#9)(2008-4#4)(2008-5#6)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#2)(2009-1#3)(2009-10#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#3)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#7)(2010-4#4)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#4)(2012-5#1)(2013-1#16)(2013-7#1)(2013-8#4)
performance anxiety type##2##3##(2004-11#2)
performance anxiety##3##2##(2004-11#3)
performance appears to be##3##4##(2008-10#1)(2009-4#1)(2012-2#1)
performance are also##2##3##(2007-9#1)(2008-10#1)
performance are discussed##4##3##(1994-2#1)(2007-11#1)(2008-3#2)
performance are given##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
performance are##22##2##(1990-9#1)(1992-12#1)(1994-2#1)(1996-8#1)(2006-4#1)(2007-11#2)(2007-9#1)(2008-10#2)(2008-2#4)(2008-3#3)(2008-4#1)(2008-8#1)(2010-5#1)(2010-7#1)(2013-1#1)
performance as a function of the##2##6##(2008-2#1)(2008-3#1)
performance as a function of##4##5##(2007-12#1)(2008-2#1)(2008-3#1)(2009-11#1)
performance as a##6##3##(2007-12#2)(2008-2#1)(2008-3#1)(2009-11#1)(2013-1#1)
performance as an##2##3##(2008-10#2)
performance as measured by the##2##5##(2006-10#1)(2010-9#1)
performance as measured by##5##4##(1993-1#1)(2006-10#1)(2007-8#1)(2010-9#1)(2013-1#1)
performance as the##2##3##(2007-8#1)(2008-10#1)
performance as well as##2##4##(2005-10#1)(2008-3#1)
performance as##30##2##(1993-1#1)(2005-10#1)(2006-10#2)(2007-11#2)(2007-12#2)(2007-4#1)(2007-8#2)(2008-10#4)(2008-2#2)(2008-3#5)(2009-11#1)(2010-9#1)(2012-11#1)(2012-3#2)(2013-1#2)(2013-7#1)
performance assessed##2##2##(1996-8#1)(2007-8#1)
performance assessment and##2##3##(1996-12#1)(2007-8#1)
performance assessment##9##2##(1993-12#1)(1994-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(2007-8#1)(2008-2#1)(2010-12#1)
performance associated##2##2##(1996-3#2)
performance at a##2##3##(1996-3#1)(2008-11#1)
performance at different temperatures##2##4##(2008-8#2)
performance at##15##2##(1996-3#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-8#5)(2010-12#1)(2011-2#1)(2012-2#1)
performance based##3##2##(2012-1#1)(2013-1#2)
performance benefits##2##2##(2008-3#1)(2008-5#1)
performance between the##6##3##(2006-2#1)(2008-4#1)(2008-7#1)(2010-8#1)(2013-1#2)
performance between##13##2##(2004-11#1)(2006-2#1)(2008-2#3)(2008-4#2)(2008-7#1)(2008-9#2)(2010-8#1)(2013-1#2)
performance both in##2##3##(1995-12#1)(2008-5#1)
performance both##4##2##(1993-12#1)(1995-12#1)(2008-1#1)(2008-5#1)
performance but can##2##3##(2006-12#1)(2008-2#1)
performance but##6##2##(1992-11#1)(2006-12#1)(2008-2#2)(2008-4#1)(2008-7#1)
performance by use of##2##4##(2008-2#1)(2008-3#1)
performance by##18##2##(1991-2#1)(1993-3#1)(1995-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-6#1)(2009-11#1)(2011-1#2)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
performance calculations##2##2##(2008-3#2)
performance can be achieved##2##4##(2007-11#1)(2010-8#1)
performance can be improved##2##4##(1996-3#1)(2008-3#1)
performance can be##12##3##(1996-12#1)(1996-3#2)(2007-11#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2010-8#1)(2011-2#1)
performance can##16##2##(1996-12#1)(1996-2#1)(1996-3#2)(2007-11#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#2)(2010-8#1)(2011-2#1)
performance capillary electrophoresis##3##3##(2008-10#3)
performance changes##2##2##(2007-8#1)(2009-7#1)
performance characteristics are##3##3##(2008-10#2)(2008-3#1)
performance characteristics for##3##3##(2008-10#2)(2012-1#1)
performance characteristics in##2##3##(2008-10#2)
performance characteristics of a##3##4##(2007-12#1)(2008-3#1)(2010-9#1)
performance characteristics of the##6##4##(2008-10#4)(2008-3#1)(2008-5#1)
performance characteristics of##16##3##(2007-12#1)(2008-10#8)(2008-2#1)(2008-3#3)(2008-5#1)(2010-3#1)(2010-9#1)
performance characteristics were##3##3##(2007-8#1)(2008-10#2)
performance characteristics##42##2##(1995-2#1)(2007-12#1)(2007-8#1)(2008-10#23)(2008-2#3)(2008-3#4)(2008-5#2)(2008-7#2)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-1#1)
performance comparable to##2##3##(2008-2#1)(2012-12#1)
performance compared to the##2##4##(2008-2#2)
performance compared to##5##3##(2008-1#1)(2008-10#2)(2008-2#2)
performance compared with##3##3##(2008-11#1)(2008-3#1)(2009-11#1)
performance compared##8##2##(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2009-11#1)
performance comparison of##2##3##(2007-12#1)(2013-7#1)
performance comparison##3##2##(2007-12#1)(2008-3#1)(2013-7#1)
performance conditions##2##2##(2008-10#2)
performance could be##2##3##(1993-3#1)(2008-2#1)
performance criteria and##2##3##(2007-4#1)(2008-2#1)
performance criteria such as##2##4##(2008-10#2)
performance criteria##11##2##(2007-4#2)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)
performance data##4##2##(1997-3#1)(2008-2#1)(2008-5#1)(2013-1#1)
performance decreased##2##2##(2008-8#1)(2012-3#1)
performance deficit##4##2##(1992-3#1)(1993-2#1)(1994-3#1)(2012-2#1)
performance deficits##4##2##(1992-11#3)(2013-1#1)
performance degradation##2##2##(2008-2#2)
performance depends on##2##3##(2008-10#1)(2011-2#1)
performance depends##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
performance deterioration##3##2##(1996-12#1)(2012-2#2)
performance did not differ##3##4##(2008-1#1)(2008-4#1)(2009-10#1)
performance does not##2##3##(2008-2#1)(2008-3#1)
performance duration in##4##3##(2012-12#4)
performance duration##7##2##(2012-12#7)
performance during the##3##3##(1996-1#1)(2007-8#1)(2008-2#1)
performance during##10##2##(1993-3#1)(1996-1#1)(1996-2#1)(2007-8#2)(2008-10#1)(2008-2#2)(2008-9#1)(2009-5#1)
performance efficiency of##2##3##(2007-10#2)
performance enhancement of##2##3##(2008-10#1)(2012-3#1)
performance enhancement##3##2##(2008-10#1)(2008-2#1)(2012-3#1)
performance enhancements##2##2##(2008-2#1)(2009-5#1)
performance estimate##2##2##(2008-3#2)
performance evaluation are##2##3##(2005-5#1)(2007-12#1)
performance evaluation of the##2##4##(2008-10#2)
performance evaluation of##7##3##(2008-10#3)(2008-2#1)(2008-3#1)(2010-12#1)(2010-8#1)
performance evaluation##15##2##(1995-1#2)(1996-2#1)(2005-5#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#2)(2010-12#1)(2010-8#1)(2012-12#1)
performance even when##2##3##(2007-8#1)(2008-9#1)
performance even##3##2##(2007-8#1)(2008-9#1)(2009-11#1)
performance factors##2##2##(1993-12#1)(1994-3#1)
performance feedback##7##2##(2006-7#1)(2007-10#4)(2008-11#1)(2012-2#1)
performance following##3##2##(2008-5#1)(2008-8#1)(2012-12#1)
performance for a##2##3##(2008-3#2)
performance for both##2##3##(2007-12#1)(2009-11#1)
performance for the measurement of##2##5##(2008-3#1)(2013-7#1)
performance for the##9##3##(1996-12#1)(2007-1#1)(2007-11#1)(2008-3#3)(2008-4#1)(2012-1#1)(2013-7#1)
performance for##44##2##(1996-12#1)(2007-1#2)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2010-5#1)(2011-1#1)(2012-1#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#2)
performance from##3##2##(1993-5#1)(2007-8#1)(2008-3#1)
performance gain##2##2##(2008-2#2)
performance has been compared with##2##5##(2007-11#1)(2010-8#1)
performance has been##7##3##(1994-8#1)(2007-11#1)(2008-2#1)(2009-6#1)(2010-8#2)(2011-12#1)
performance has##11##2##(1994-8#1)(2007-1#1)(2007-11#1)(2008-2#2)(2008-7#1)(2009-6#1)(2010-8#2)(2011-12#1)(2011-2#1)
performance have been studied##3##4##(2007-8#1)(2008-10#2)
performance have been##6##3##(2007-8#1)(2008-10#3)(2008-6#1)(2011-2#1)
performance have##9##2##(1996-3#1)(2004-9#1)(2007-8#1)(2008-10#3)(2008-6#1)(2011-2#1)(2012-3#1)
performance improved##2##2##(2008-1#1)(2010-7#1)
performance improvement and##2##3##(2007-5#1)(2010-11#1)
performance improvement is##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
performance improvement##17##2##(1995-12#1)(1995-3#1)(1997-1#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-8#1)(2009-4#1)(2010-11#3)(2013-1#1)
performance improvements of##2##3##(2008-2#1)(2008-3#1)
performance improvements##5##2##(2008-2#1)(2008-3#3)(2009-4#1)
performance improves##3##2##(1990-3#1)(1996-3#1)(2008-3#1)
performance in a two-way##2##4##(1996-5#1)(2012-2#1)
performance in a##16##3##(1993-2#1)(1996-3#1)(1996-5#2)(2006-10#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-3#2)(2008-5#1)(2009-10#1)(2012-1#1)(2012-2#1)(2012-7#1)(2013-8#1)
performance in adults##2##3##(2006-10#1)(2006-3#1)
performance in an##4##3##(1996-1#1)(2005-10#1)(2008-11#1)(2012-2#1)
performance in both##6##3##(1994-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#1)
performance in children and##2##4##(2008-9#2)
performance in children with##3##4##(2005-10#1)(2008-9#1)(2013-7#1)
performance in children##6##3##(2005-10#1)(2008-9#3)(2012-1#1)(2013-7#1)
performance in combination##2##3##(2007-10#1)(2008-10#1)
performance in comparison with##3##4##(2007-4#1)(2008-3#1)(2009-3#1)
performance in comparison##4##3##(2007-4#1)(2008-10#1)(2008-3#1)(2009-3#1)
performance in dental##2##3##(1993-12#1)(2005-9#1)
performance in each##2##3##(2008-10#1)(2013-1#1)
performance in either##2##3##(2006-4#1)(2009-10#1)
performance in high##2##3##(2007-8#1)(2008-10#1)
performance in noise##2##3##(2008-2#1)(2008-9#1)
performance in older##2##3##(2013-1#2)
performance in patients undergoing##2##4##(2009-10#1)(2013-1#1)
performance in patients with##4##4##(1996-1#1)(2006-3#1)(2007-7#1)(2011-2#1)
performance in patients##7##3##(1996-1#1)(2006-3#1)(2007-7#2)(2009-10#1)(2011-2#1)(2013-1#1)
performance in single-##2##3##(2008-2#1)(2008-3#1)
performance in studies and##2##4##(2006-8#2)
performance in studies##4##3##(2006-8#4)
performance in terms of detection##2##5##(2008-10#1)(2008-3#1)
performance in terms of##10##4##(2005-11#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-8#1)(2010-8#1)(2012-3#1)
performance in tests of##2##4##(1990-3#1)(2006-10#1)
performance in the 6-minute walk test##2##6##(2007-7#2)
performance in the presence of##2##5##(2008-2#1)(2008-3#1)
performance in the##53##3##(1990-10#1)(1991-2#3)(1991-3#2)(1992-11#1)(1992-12#2)(1992-9#1)(1993-2#1)(1993-9#1)(1994-1#1)(1994-12#1)(1995-12#2)(1996-2#1)(1996-3#1)(1996-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#4)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-10#1)(2010-12#1)(2010-2#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#1)
performance in their##2##3##(1993-1#1)(1996-2#1)
performance in these##2##3##(2008-12#1)(2009-9#1)
performance in this##2##3##(1994-6#1)(2008-8#1)
performance in##253##2##(1990-10#1)(1990-3#1)(1991-1#1)(1991-12#1)(1991-2#5)(1991-3#2)(1992-11#1)(1992-12#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#4)(1993-5#1)(1993-9#2)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#2)(1995-1#1)(1995-11#1)(1995-12#5)(1995-5#3)(1996-1#2)(1996-12#1)(1996-2#3)(1996-3#4)(1996-5#3)(1996-7#1)(1997-7#1)(2004-9#2)(2005-10#2)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-12#2)(2006-3#4)(2006-4#1)(2006-6#2)(2006-8#4)(2007-1#2)(2007-10#4)(2007-11#2)(2007-12#4)(2007-4#2)(2007-5#1)(2007-7#7)(2007-8#2)(2008-1#1)(2008-10#15)(2008-11#10)(2008-12#4)(2008-2#9)(2008-3#11)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#11)(2009-1#2)(2009-10#4)(2009-3#2)(2009-4#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-2#3)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-1#6)(2012-11#2)(2012-12#4)(2012-2#9)(2012-3#3)(2012-6#1)(2012-7#1)(2013-1#11)(2013-7#3)(2013-8#3)
performance independent of##3##3##(1993-12#1)(2006-3#1)(2009-11#1)
performance index##7##2##(1993-3#1)(1994-5#1)(2004-11#1)(2008-12#3)(2011-2#1)
performance indexes##5##2##(2011-2#5)
performance indicators for##3##3##(1993-2#1)(1994-2#1)(2006-8#1)
performance indicators to##2##3##(1994-2#1)(2008-11#1)
performance indicators##18##2##(1992-12#2)(1993-2#2)(1993-3#1)(1994-2#3)(2006-8#1)(2007-4#2)(2008-11#2)(2009-4#3)(2011-2#1)(2012-1#1)
performance indices##3##2##(1994-9#1)(2004-11#1)(2008-2#1)
performance information##7##2##(1996-3#2)(1997-3#1)(2008-7#1)(2008-8#1)(2013-1#2)
performance into##2##2##(2008-7#1)(2013-8#1)
performance is a function of the##2##6##(2008-2#2)
performance is a##3##3##(1995-2#1)(2008-2#2)
performance is achieved##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
performance is affected##2##3##(1990-11#1)(2008-7#1)
performance is also discussed##2##4##(2005-11#1)(2008-3#1)
performance is also##4##3##(2005-11#1)(2008-2#1)(2008-3#2)
performance is associated with##2##4##(2008-1#1)(2008-8#1)
performance is compared to that of##2##6##(2007-9#1)(2008-6#1)
performance is compared with##4##4##(1993-2#1)(2008-2#2)(2008-3#1)
performance is compared##6##3##(1993-2#1)(2007-9#1)(2008-2#2)(2008-3#1)(2008-6#1)
performance is demonstrated##5##3##(2007-12#1)(2008-2#3)(2008-3#1)
performance is evaluated##4##3##(1996-12#1)(2008-3#1)(2008-8#1)(2012-1#1)
performance is found to be##2##5##(2008-2#1)(2008-3#1)
performance is investigated##2##3##(2008-3#2)
performance is obtained##3##3##(2008-3#3)
performance is presented##2##3##(2006-6#1)(2008-10#1)
performance is reported##2##3##(1996-12#1)(2008-2#1)
performance is significantly##2##3##(1996-12#1)(2008-2#1)
performance is the##2##3##(2007-12#1)(2009-8#1)
performance is##78##2##(1990-11#1)(1993-2#1)(1993-5#1)(1995-2#1)(1995-6#1)(1996-12#3)(1997-2#1)(1997-3#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#25)(2008-3#17)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-11#1)(2010-4#1)(2012-1#2)(2012-12#1)(2012-2#1)
performance it##2##2##(1993-7#1)(2011-2#1)
performance level in##2##3##(1993-3#1)(2009-1#1)
performance level were in##2##4##(2008-8#2)
performance level##8##2##(1993-3#1)(2008-7#1)(2008-8#3)(2009-1#3)
performance levels of##2##3##(2007-2#1)(2007-4#1)
performance levels##6##2##(2006-8#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-3#1)(2011-1#1)
performance limits##2##2##(2008-10#1)(2008-3#1)
performance liquid chromatographic analysis##2##4##(1994-8#1)(2008-10#1)
performance liquid chromatographic determination of##3##5##(1993-2#1)(2008-10#2)
performance liquid chromatographic##31##3##(1993-11#2)(1993-2#1)(1994-8#1)(1995-1#1)(1996-3#1)(2005-12#3)(2007-1#1)(2008-10#10)(2010-12#1)(2010-2#2)(2010-3#1)(2011-1#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
performance liquid chromatography (HPLC) with##10##5##(1997-2#1)(1997-5#1)(2008-10#5)(2008-5#1)(2010-5#1)(2012-12#1)
performance liquid chromatography (HPLC)##69##4##(1990-9#1)(1991-8#2)(1992-11#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1995-10#1)(1995-7#1)(1996-11#1)(1997-2#1)(1997-3#1)(1997-5#1)(2005-12#1)(2007-8#1)(2008-10#36)(2008-11#1)(2008-5#3)(2008-8#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
performance liquid chromatography (RP-HPLC)##6##4##(1990-2#1)(1996-7#1)(2005-3#1)(2008-10#1)(2011-1#1)(2012-12#1)
performance liquid chromatography analysis##3##4##(1994-9#1)(2008-10#2)
performance liquid chromatography and##13##4##(1990-2#2)(1990-4#1)(1990-7#3)(1994-11#1)(1995-5#1)(2008-10#4)(2013-8#1)
performance liquid chromatography coupled with##5##5##(1992-7#1)(2004-11#1)(2012-3#2)(2013-1#1)
performance liquid chromatography coupled##7##4##(1992-7#1)(2004-11#1)(2010-9#1)(2012-1#1)(2012-3#2)(2013-1#1)
performance liquid chromatography for##4##4##(2008-10#3)(2013-8#1)
performance liquid chromatography in##3##4##(2007-1#1)(2008-10#1)(2008-5#1)
performance liquid chromatography method for##3##5##(2008-10#1)(2008-5#1)(2010-12#1)
performance liquid chromatography method##4##4##(2008-10#2)(2008-5#1)(2010-12#1)
performance liquid chromatography of##4##4##(1994-6#1)(2008-10#2)(2010-5#1)
performance liquid chromatography using a##2##5##(1994-9#1)(2011-1#1)
performance liquid chromatography using##5##4##(1994-9#1)(1995-4#1)(2004-11#1)(2008-10#1)(2011-1#1)
performance liquid chromatography with##21##4##(1993-2#1)(1995-6#1)(1996-5#1)(1996-9#1)(2007-8#1)(2008-10#14)(2008-5#1)(2012-12#1)
performance liquid chromatography##212##3##(1990-1#1)(1990-2#3)(1990-4#1)(1990-5#1)(1990-7#5)(1990-8#2)(1990-9#1)(1991-1#1)(1991-4#1)(1991-7#1)(1991-8#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-4#1)(1993-6#1)(1994-11#2)(1994-6#3)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-2#1)(1996-5#2)(1996-7#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2004-11#2)(2005-12#4)(2005-3#1)(2006-12#1)(2007-1#1)(2007-8#5)(2008-10#86)(2008-11#2)(2008-5#8)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#2)(2010-9#2)(2011-1#6)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#4)
performance liquid chromatography-electrospray ionization tandem mass##3##6##(2008-10#1)(2011-1#2)
performance liquid chromatography-electrospray ionization##5##4##(2005-11#1)(2008-10#2)(2011-1#2)
performance liquid chromatography-electrospray##8##3##(2005-11#1)(2008-10#2)(2008-8#2)(2011-1#2)(2012-3#1)
performance liquid chromatography-tandem mass spectrometry##3##5##(2011-1#2)(2012-12#1)
performance liquid chromatography-tandem mass spectrometry]##4##5##(2011-1#2)(2012-12#1)(2013-8#1)
performance liquid chromatography-tandem mass##7##4##(2011-1#4)(2012-12#2)(2013-8#1)
performance liquid chromatography-tandem##8##3##(2011-1#4)(2012-12#2)(2013-8#2)
performance liquid chromatography]##13##3##(2005-12#5)(2005-3#1)(2011-1#2)(2011-2#1)(2012-12#3)(2013-8#1)
performance liquid##293##2##(1990-1#1)(1990-12#2)(1990-2#3)(1990-4#1)(1990-5#2)(1990-7#5)(1990-8#2)(1990-9#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-7#1)(1991-8#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#3)(1993-2#2)(1993-4#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-6#3)(1994-8#2)(1994-9#3)(1995-1#2)(1995-10#1)(1995-12#1)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2004-11#2)(2005-11#1)(2005-12#12)(2005-3#2)(2006-12#1)(2007-1#2)(2007-8#5)(2008-10#110)(2008-11#2)(2008-5#8)(2008-7#1)(2008-8#3)(2008-9#2)(2010-12#3)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#2)(2010-9#2)(2011-1#17)(2011-2#3)(2012-1#2)(2012-12#11)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#9)
performance loss##2##2##(2007-12#1)(2010-10#1)
performance makes##3##2##(2008-10#2)(2008-11#1)
performance management##6##2##(1995-12#1)(2008-7#1)(2009-4#1)(2011-2#2)(2012-12#1)
performance may be##3##3##(1997-3#1)(2006-10#1)(2012-1#1)
performance may##6##2##(1996-3#1)(1997-3#1)(2006-10#1)(2008-10#1)(2009-5#1)(2012-1#1)
performance measure##8##2##(1993-3#1)(2008-2#1)(2008-3#1)(2010-12#1)(2011-2#2)(2013-1#2)
performance measured##2##2##(1994-8#1)(2008-7#1)
performance measurement and research##2##4##(2010-11#2)
performance measurement and##5##3##(1995-3#1)(2008-11#1)(2008-4#1)(2010-11#2)
performance measurement##25##2##(1993-1#1)(1995-3#1)(1996-12#1)(1996-2#4)(1996-3#1)(1997-1#1)(1997-2#2)(2007-4#3)(2007-5#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-3#1)(2010-11#2)(2011-2#1)(2013-1#3)
performance measures and##4##3##(1996-12#1)(1997-3#1)(2010-8#1)(2013-1#1)
performance measures based on##2##4##(1993-2#1)(1997-3#1)
performance measures##29##2##(1992-11#1)(1993-2#1)(1995-12#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#6)(2006-2#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-6#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#2)
performance metrics##4##2##(2008-2#2)(2008-3#1)(2012-1#1)
performance obtained with##2##3##(2004-8#1)(2008-6#1)
performance obtained##5##2##(2004-8#1)(2008-3#1)(2008-6#1)(2012-12#2)
performance of a delayed##2##4##(1990-10#1)(1992-11#1)
performance of a fiber-optic sensor##2##5##(2008-2#2)
performance of a functional##2##4##(2006-9#1)(2013-1#1)
performance of a joint##2##4##(2008-3#2)
performance of a new##5##4##(2007-7#1)(2008-10#3)(2008-3#1)
performance of a nonlinear##2##4##(2007-11#1)(2008-2#1)
performance of a novel##3##4##(2006-2#1)(2008-2#1)(2009-11#1)
performance of a number of##3##5##(1995-5#1)(2008-3#2)
performance of a simple##2##4##(2008-2#1)(2008-3#1)
performance of a spatial##4##4##(1991-2#1)(1994-3#2)(2008-11#1)
performance of a system##2##4##(1993-3#1)(1997-2#1)
performance of a##128##3##(1990-10#1)(1991-2#1)(1992-11#2)(1992-9#1)(1993-12#2)(1993-3#1)(1993-7#1)(1994-3#2)(1995-1#1)(1995-11#1)(1995-5#1)(1996-1#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-6#1)(2006-1#1)(2006-2#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#26)(2008-3#29)(2008-4#4)(2008-7#3)(2008-9#1)(2009-11#2)(2009-4#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#2)
performance of activities##3##3##(2012-2#1)(2013-1#1)(2013-7#1)
performance of adaptive##2##3##(2008-3#2)
performance of adult##2##3##(1992-11#1)(2008-9#1)
performance of all##4##3##(1994-9#1)(2008-10#1)(2008-6#1)(2012-3#1)
performance of an automated##2##4##(1993-5#1)(1993-8#1)
performance of an experimental all-in-one adhesive##2##6##(2013-8#2)
performance of an##22##3##(1993-5#1)(1993-8#1)(2007-11#3)(2007-12#1)(2008-10#2)(2008-2#5)(2008-3#3)(2008-5#1)(2009-11#1)(2013-1#2)(2013-8#2)
performance of any##4##3##(2006-4#1)(2007-10#1)(2008-2#1)(2008-6#1)
performance of axisymmetric##2##3##(2008-2#2)
performance of both the##2##4##(2008-10#1)(2008-2#1)
performance of both##10##3##(2006-11#1)(2008-10#5)(2008-2#2)(2008-3#2)
performance of capillary##2##3##(2008-10#2)
performance of carbons##2##3##(2005-11#1)(2010-4#1)
performance of cardiac CT##2##4##(2007-4#1)(2012-12#1)
performance of cardiac##3##3##(2007-4#1)(2007-8#1)(2012-12#1)
performance of cascaded##3##3##(2008-3#3)
performance of children##5##3##(2008-2#1)(2008-9#1)(2011-12#2)(2013-1#1)
performance of coherent Doppler lidar##2##5##(2008-3#2)
performance of college students##3##4##(2009-3#1)(2013-8#2)
performance of daily living##2##4##(2007-11#2)
performance of daily##3##3##(2007-11#3)
performance of dairy cows##2##4##(2005-7#2)
performance of dairy##3##3##(2005-7#3)
performance of devices##2##3##(2009-11#2)
performance of different##7##3##(2008-2#2)(2010-2#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-8#1)
performance of diffractive##2##3##(2008-2#1)(2008-3#1)
performance of direct##2##3##(2009-8#1)(2013-8#1)
performance of each##3##3##(2004-10#1)(2008-6#1)(2013-1#1)
performance of electrochemical##3##3##(2008-10#3)
performance of elite##2##3##(2007-11#1)(2008-5#1)
performance of emergency##2##3##(2006-10#1)(2007-7#1)
performance of four rapid##2##4##(2007-7#1)(2011-1#1)
performance of four##6##3##(1993-1#1)(1995-2#1)(2007-7#1)(2008-2#1)(2008-3#1)(2011-1#1)
performance of fully phase- and amplitude-based encryption##2##7##(2008-3#2)
performance of glucose oxidase##2##4##(2007-6#1)(2008-5#1)
performance of grating-assisted output couplers of finite extent##2##8##(2007-12#2)
performance of health maintenance organizations##2##5##(1991-3#1)(1994-2#1)
performance of health##6##3##(1991-3#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-2#1)(2007-4#1)
performance of highly neodymium-doped yttrium aluminum garnet##2##7##(2007-11#2)
performance of implantable##3##3##(2004-9#2)(2008-5#1)
performance of individuals with##2##4##(2007-8#1)(2009-7#1)
performance of individuals##3##3##(2007-8#1)(2008-9#1)(2009-7#1)
performance of integrated##2##3##(1995-12#1)(2008-3#1)
performance of low##2##3##(2007-3#1)(2013-7#1)
performance of many##4##3##(2006-8#1)(2008-7#1)(2011-2#1)(2012-1#1)
performance of methods##2##3##(2008-7#1)(2009-5#1)
performance of new##3##3##(1994-3#1)(2008-10#1)(2011-2#1)
performance of optical##3##3##(1997-6#1)(2007-12#1)(2008-2#1)
performance of our method##2##4##(2008-2#1)(2013-1#1)
performance of our system##3##4##(2008-2#2)(2008-6#1)
performance of our##11##3##(1997-2#1)(2008-2#4)(2008-3#1)(2008-6#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
performance of percutaneous##2##3##(2010-12#1)(2011-2#1)
performance of products##2##3##(2008-10#1)(2012-3#1)
performance of providers##2##3##(1994-1#1)(1996-1#1)
performance of rats in a##2##5##(1992-11#1)(2013-1#1)
performance of rats in##3##4##(1992-11#1)(1993-9#1)(2013-1#1)
performance of rats##7##3##(1992-11#1)(1992-9#1)(1993-12#1)(1993-9#1)(1996-12#1)(2007-1#1)(2013-1#1)
performance of schizophrenics##2##3##(2006-3#2)
performance of schoolchildren in##2##4##(1990-3#1)(2006-10#1)
performance of schoolchildren##4##3##(1990-3#1)(2005-8#1)(2006-10#2)
performance of scientific##2##3##(2008-9#1)(2010-2#1)
performance of several##2##3##(2007-1#1)(2012-3#1)
performance of socially-expected activities##2##4##(1997-8#2)
performance of such a##4##4##(2006-6#1)(2007-12#1)(2008-2#1)(2008-3#1)
performance of such devices##2##4##(1997-1#1)(2006-11#1)
performance of such systems##2##4##(2007-12#1)(2008-3#1)
performance of such##10##3##(1997-1#1)(2006-11#1)(2006-6#1)(2007-12#2)(2007-8#1)(2008-2#1)(2008-3#2)(2008-6#1)
performance of tests##2##3##(1990-11#1)(2007-7#1)
performance of the QA-810 V##2##5##(2008-10#2)
performance of the SIA system##2##5##(2008-10#2)
performance of the algorithm##6##4##(1997-3#1)(2008-2#2)(2008-3#3)
performance of the assay##2##4##(1994-12#1)(2010-4#1)
performance of the calibration models##2##5##(2007-11#1)(2008-10#1)
performance of the developed##2##4##(2008-3#1)(2009-3#1)
performance of the device is##2##5##(2007-11#1)(2008-3#1)
performance of the device##8##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2009-7#1)
performance of the different##2##4##(2008-10#1)(2011-1#1)
performance of the filter##2##4##(2007-12#1)(2008-2#1)
performance of the immunosensor##2##4##(2007-8#1)(2008-10#1)
performance of the laser##2##4##(2008-2#1)(2009-5#1)
performance of the method for##2##5##(2008-10#1)(2008-2#1)
performance of the method has been evaluated##2##7##(2008-10#2)
performance of the method has been##3##6##(2008-10#3)
performance of the method is##3##5##(2008-2#1)(2008-3#2)
performance of the method was##2##5##(2008-10#1)(2010-4#1)
performance of the method##18##4##(2008-10#9)(2008-2#3)(2008-3#3)(2010-4#1)(2012-1#2)
performance of the modified##2##4##(1994-8#1)(2008-2#1)
performance of the new algorithm##3##5##(2008-1#1)(2008-3#2)
performance of the new test##2##5##(2005-8#1)(2012-3#1)
performance of the new##12##4##(2005-8#1)(2006-2#1)(2006-3#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#2)(2008-3#3)(2012-3#1)
performance of the optical##4##4##(2008-10#1)(2008-2#2)(2008-3#1)
performance of the prepared##2##4##(2012-12#1)(2012-2#1)
performance of the proposed approach##5##5##(2008-10#1)(2008-2#1)(2011-1#2)(2012-1#1)
performance of the proposed method##13##5##(2008-10#6)(2008-2#1)(2008-3#1)(2008-6#1)(2010-2#1)(2010-7#1)(2012-3#2)
performance of the proposed procedure##2##5##(2008-10#1)(2009-9#1)
performance of the proposed technique##2##5##(2008-2#2)
performance of the proposed##31##4##(2007-9#1)(2008-10#11)(2008-2#6)(2008-3#1)(2008-6#2)(2009-10#1)(2009-9#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-3#2)
performance of the resulting##2##4##(2009-9#1)(2013-1#1)
performance of the same##2##4##(1991-1#1)(2008-2#1)
performance of the sensing##3##4##(2008-2#2)(2008-3#1)
performance of the sensor##5##4##(2008-10#2)(2008-2#1)(2008-3#1)(2013-1#1)
performance of the sensors##2##4##(2008-10#2)
performance of the system with respect to##2##7##(2008-10#1)(2008-2#1)
performance of the system with##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
performance of the system##14##4##(2007-8#1)(2008-10#9)(2008-2#1)(2008-3#2)(2012-1#1)
performance of the task##2##4##(1992-7#1)(2013-8#1)
performance of the technique##3##4##(2006-10#1)(2007-12#1)(2008-3#1)
performance of the test##3##4##(2004-9#1)(2007-2#1)(2008-11#1)
performance of the three##2##4##(1996-3#1)(2008-5#1)
performance of the two##5##4##(1991-2#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)
performance of the various##2##4##(2007-12#1)(2008-5#1)
performance of the##371##3##(1990-10#2)(1991-1#2)(1991-2#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-7#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-4#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-6#1)(2004-11#1)(2004-8#1)(2004-9#2)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#4)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#12)(2007-12#9)(2007-2#2)(2007-4#1)(2007-7#2)(2007-8#7)(2007-9#1)(2008-1#2)(2008-10#69)(2008-11#4)(2008-12#3)(2008-2#60)(2008-3#50)(2008-4#1)(2008-5#11)(2008-6#4)(2008-7#2)(2008-9#3)(2009-10#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#2)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#5)(2011-1#6)(2011-2#3)(2012-1#9)(2012-12#2)(2012-2#2)(2012-3#8)(2013-1#9)(2013-8#5)
performance of their##6##3##(1994-2#1)(1996-12#1)(2008-4#1)(2008-5#2)(2012-2#1)
performance of these electrodes##2##4##(2008-10#2)
performance of these systems##3##4##(1996-7#1)(2008-3#2)
performance of these##23##3##(1996-7#1)(1996-8#1)(1997-2#1)(2008-1#1)(2008-10#9)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2010-7#1)(2012-3#1)(2013-8#1)
performance of this device##2##4##(2007-11#1)(2008-2#1)
performance of this fungus##2##4##(2008-10#2)
performance of this sensor##2##4##(2008-10#2)
performance of this system##6##4##(2006-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)
performance of this##41##3##(1996-7#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#4)(2008-10#12)(2008-11#2)(2008-2#8)(2008-3#4)(2010-2#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
performance of three##8##3##(1993-12#1)(1994-9#1)(2004-8#1)(2008-10#2)(2008-2#1)(2013-1#2)
performance of two##7##3##(1991-2#1)(1994-3#1)(2008-3#3)(2008-5#1)(2012-3#1)
performance of unilateral##2##3##(1992-9#1)(2008-9#1)
performance of various##6##3##(2008-10#1)(2008-3#2)(2012-3#3)
performance of##1142##2##(1990-10#5)(1990-11#3)(1990-12#1)(1990-3#1)(1991-1#3)(1991-12#1)(1991-2#3)(1991-3#3)(1991-6#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#5)(1992-12#3)(1992-2#6)(1992-3#1)(1992-7#2)(1992-8#3)(1992-9#4)(1993-1#1)(1993-12#11)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#4)(1993-8#2)(1993-9#2)(1994-1#3)(1994-10#3)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#5)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#3)(1995-1#4)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#4)(1995-4#1)(1995-5#1)(1995-9#1)(1996-1#4)(1996-10#1)(1996-12#3)(1996-2#3)(1996-3#4)(1996-5#2)(1996-6#1)(1996-7#3)(1996-8#3)(1996-9#3)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#4)(1997-8#5)(2004-10#1)(2004-11#1)(2004-8#2)(2004-9#6)(2005-10#1)(2005-11#4)(2005-12#2)(2005-7#3)(2005-8#3)(2006-1#1)(2006-10#8)(2006-11#4)(2006-12#4)(2006-2#2)(2006-3#4)(2006-4#12)(2006-5#4)(2006-6#4)(2006-7#3)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#5)(2007-11#28)(2007-12#34)(2007-2#3)(2007-3#2)(2007-4#6)(2007-5#2)(2007-6#1)(2007-7#9)(2007-8#13)(2007-9#2)(2008-1#9)(2008-10#161)(2008-11#18)(2008-12#10)(2008-2#144)(2008-3#144)(2008-4#10)(2008-5#28)(2008-6#15)(2008-7#13)(2008-8#2)(2008-9#15)(2009-10#1)(2009-11#9)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#4)(2009-6#1)(2009-7#3)(2009-8#7)(2009-9#4)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#8)(2010-2#9)(2010-4#9)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#9)(2010-9#1)(2011-1#12)(2011-12#2)(2011-2#18)(2011-3#1)(2012-1#14)(2012-12#11)(2012-2#10)(2012-3#27)(2013-1#32)(2013-7#3)(2013-8#15)
performance on a##12##3##(1992-9#1)(1993-4#1)(1995-12#1)(2005-10#1)(2007-9#1)(2008-10#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-3#2)
performance on an attribute##2##4##(1997-3#2)
performance on an##4##3##(1993-12#1)(1997-3#2)(2012-12#1)
performance on novel##2##3##(2008-8#2)
performance on tests##2##3##(1993-12#1)(2008-2#1)
performance on the CPT and SPAN##2##6##(1997-2#2)
performance on the WCST##2##4##(1995-1#1)(1996-3#1)
performance on the##24##3##(1992-11#1)(1993-2#1)(1995-1#1)(1996-2#1)(1996-3#1)(1997-2#2)(2006-12#1)(2006-4#1)(2006-9#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-6#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-5#1)(2011-2#1)(2012-3#2)
performance on this##4##3##(1991-5#1)(2009-10#1)(2010-2#1)(2012-3#1)
performance on##99##2##(1990-3#1)(1991-5#1)(1992-11#1)(1992-9#1)(1993-12#4)(1993-2#2)(1993-4#1)(1993-9#1)(1994-1#1)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#2)(1996-3#1)(1997-2#2)(1997-3#2)(1997-8#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-9#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#3)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-10#2)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-7#2)(2010-2#1)(2010-3#2)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#8)(2013-1#2)(2013-7#1)(2013-8#2)
performance optimization##2##2##(2008-2#1)(2010-7#1)
performance or##9##2##(2007-11#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-1#1)(2011-1#2)(2013-1#2)
performance outcomes##2##2##(1993-2#1)(2008-9#1)
performance over a wide range of##2##6##(1996-7#1)(2008-5#1)
performance over a##3##3##(1996-7#1)(2008-2#1)(2008-5#1)
performance over the##2##3##(2005-11#1)(2011-1#1)
performance over time##4##3##(2007-4#1)(2008-12#1)(2009-9#1)(2011-2#1)
performance over##17##2##(1993-5#1)(1996-7#1)(2005-11#1)(2007-4#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#1)(2009-9#2)(2011-1#1)(2011-2#1)(2012-3#1)
performance parameters of a##2##4##(2007-12#2)
performance parameters##7##2##(1997-3#1)(2007-12#2)(2008-10#1)(2010-12#1)(2010-9#1)(2013-1#1)
performance potential##2##2##(2008-3#1)(2008-8#1)
performance procedures##2##2##(1992-10#2)
performance profiles##2##2##(1997-2#1)(2012-3#1)
performance rank##4##2##(2012-1#4)
performance regarding##2##2##(2010-8#1)(2012-12#1)
performance related to##3##3##(1996-2#1)(2008-12#1)(2012-2#1)
performance related##4##2##(1996-2#1)(2008-12#1)(2008-7#1)(2012-2#1)
performance relative to##3##3##(1992-10#1)(2008-8#1)(2008-9#1)
performance report##2##2##(1992-3#1)(1996-3#1)
performance reports##3##2##(1995-3#1)(2013-1#2)
performance requirements##7##2##(2006-11#1)(2008-1#1)(2008-2#1)(2008-3#2)(2011-2#1)(2012-1#1)
performance results##5##2##(2007-8#1)(2008-2#3)(2008-3#1)
performance score##2##2##(2008-6#1)(2011-2#1)
performance scores##3##2##(1990-10#1)(2006-10#1)(2008-12#1)
performance should be##3##3##(1991-3#1)(2008-3#1)(2012-2#1)
performance similar to##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
performance since##2##2##(2007-8#1)(2013-8#1)
performance standard##3##2##(1992-2#1)(2007-8#1)(2012-2#1)
performance standards##10##2##(1993-12#7)(2007-8#1)(2009-6#2)
performance statistics##3##2##(1992-2#1)(2008-9#2)
performance status (PS)##3##3##(2007-10#1)(2007-11#1)(2008-7#1)
performance status and##4##3##(1995-10#1)(2007-11#2)(2009-10#1)
performance status assessment##2##3##(2012-3#2)
performance status##35##2##(1991-2#2)(1992-10#3)(1992-8#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-10#1)(1996-12#1)(2004-1#1)(2007-10#1)(2007-11#4)(2007-7#1)(2008-6#1)(2008-7#5)(2009-10#1)(2010-12#1)(2010-2#3)(2011-2#2)(2012-12#1)(2012-3#3)
performance studies##2##2##(2007-5#1)(2007-8#1)
performance such as##2##3##(1992-12#1)(2008-10#1)
performance suggests that##3##3##(1991-2#1)(1992-12#1)(2012-1#1)
performance test##2##2##(2006-5#1)(2008-10#1)
performance testing in##2##3##(2012-3#1)(2013-7#1)
performance testing##5##2##(2008-3#1)(2012-3#1)(2013-1#1)(2013-7#2)
performance tests##3##2##(2008-10#1)(2013-1#2)
performance than the##7##3##(1992-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#3)
performance than##22##2##(1992-6#1)(1997-7#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#5)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#2)
performance that are##2##3##(2006-4#1)(2008-3#1)
performance that can be##2##4##(2008-2#1)(2008-3#1)
performance that is##3##3##(2006-10#1)(2008-2#2)
performance that##9##2##(2006-10#1)(2006-4#1)(2008-2#4)(2008-3#2)(2011-2#1)
performance the##4##2##(2005-8#1)(2008-3#2)(2008-5#1)
performance thin layer chromatography##5##4##(1994-9#1)(2009-7#1)(2010-5#2)(2012-2#1)
performance thin layer##7##3##(1994-9#1)(2009-7#1)(2010-2#2)(2010-5#2)(2012-2#1)
performance through##8##2##(2008-10#1)(2009-4#1)(2010-2#2)(2010-8#1)(2012-1#1)(2013-1#2)
performance to be##4##3##(1990-6#1)(2008-1#1)(2008-3#1)(2008-7#1)
performance to the##3##3##(1994-6#1)(2012-2#1)(2013-1#1)
performance to##24##2##(1990-6#1)(1994-3#2)(1994-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#2)(2006-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-8#1)(2009-9#2)(2012-2#1)(2013-1#1)
performance toward##2##2##(2008-10#1)(2013-1#1)
performance traits##3##2##(2008-7#1)(2012-1#2)
performance under a##2##3##(2008-2#1)(2012-9#1)
performance under different##3##3##(1993-12#1)(2008-2#1)(2008-5#1)
performance under##20##2##(1993-1#1)(1993-12#1)(1993-3#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#3)(2009-6#1)(2009-8#1)(2012-12#4)(2012-9#1)
performance using##8##2##(1993-12#1)(2004-9#1)(2009-11#1)(2012-12#1)(2012-3#1)(2013-1#3)
performance variables##3##2##(2008-2#1)(2010-12#1)(2010-8#1)
performance verification##2##2##(2008-2#1)(2008-3#1)
performance voltage##3##2##(2008-10#3)
performance was achieved##3##3##(2008-10#3)
performance was also##5##3##(1993-12#1)(2008-10#2)(2008-2#1)(2008-7#1)
performance was assessed##4##3##(2008-10#1)(2008-4#1)(2011-2#1)(2013-1#1)
performance was compared##3##3##(1993-12#1)(1996-1#1)(2006-11#1)
performance was discussed##2##3##(2005-4#1)(2008-10#1)
performance was evaluated by##8##4##(2008-10#5)(2008-3#1)(2012-12#1)(2013-1#1)
performance was evaluated in terms of the##2##7##(2007-9#1)(2008-10#1)
performance was evaluated using##2##4##(2007-9#1)(2013-1#1)
performance was evaluated with##3##4##(2008-10#3)
performance was evaluated##18##3##(2007-9#2)(2008-10#12)(2008-3#1)(2012-12#1)(2013-1#2)
performance was examined##4##3##(1991-1#1)(1991-9#1)(2009-7#1)(2010-7#1)
performance was found to be##3##5##(1997-8#1)(2008-10#1)(2008-9#1)
performance was found to##4##4##(1997-8#1)(2008-1#1)(2008-10#1)(2008-9#1)
performance was found##5##3##(1996-5#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-9#1)
performance was investigated##2##3##(2008-10#1)(2008-4#1)
performance was measured for##2##4##(2008-9#2)
performance was measured using##2##4##(2008-1#1)(2008-10#1)
performance was measured##4##3##(2008-1#1)(2008-10#1)(2008-9#2)
performance was observed##5##3##(2008-10#5)
performance was obtained##3##3##(2007-12#1)(2008-10#2)
performance was severely##2##3##(2008-8#1)(2011-2#1)
performance was significantly##2##3##(2008-2#1)(2010-7#1)
performance was studied##3##3##(1996-2#1)(2008-11#1)(2008-5#1)
performance was verified##2##3##(2010-2#1)(2010-8#1)
performance was##101##2##(1990-11#1)(1991-1#1)(1991-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-8#1)(2005-4#1)(2006-11#1)(2006-5#1)(2006-7#1)(2007-12#1)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#38)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-7#2)(2010-2#1)(2010-7#2)(2010-8#2)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#3)
performance we found in the##2##5##(2008-11#2)
performance we##3##2##(2008-11#2)(2013-1#1)
performance were examined##2##3##(2010-7#1)(2011-1#1)
performance were investigated##2##3##(2008-10#1)(2011-1#1)
performance were observed##2##3##(2008-10#1)(2013-1#1)
performance were studied##2##3##(1993-11#1)(2008-10#1)
performance were tested##2##3##(2010-5#1)(2013-1#1)
performance were##22##2##(1993-11#1)(1993-2#1)(1996-3#1)(1996-7#1)(1997-8#1)(2006-10#1)(2008-10#4)(2008-6#1)(2008-7#1)(2009-7#1)(2010-5#1)(2010-7#1)(2011-1#3)(2012-2#2)(2013-1#2)
performance when given##4##3##(1996-1#2)(2007-1#1)(2012-3#1)
performance when the##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
performance when##14##2##(1991-8#1)(1996-1#2)(2007-1#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2012-1#2)(2012-2#1)(2012-3#1)
performance while##2##2##(2005-9#1)(2008-7#1)
performance will##2##2##(2006-6#1)(2008-11#1)
performance with that of##3##4##(1997-1#1)(2008-3#1)(2008-5#1)
performance with the##4##3##(2005-9#1)(2007-11#1)(2008-7#1)(2012-2#1)
performance with##36##2##(1993-12#1)(1994-9#1)(1996-3#2)(1997-1#1)(1997-8#1)(2005-12#1)(2005-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-2#3)(2008-3#7)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#1)(2011-1#1)(2012-1#3)(2012-2#1)(2012-3#1)
performance within##2##2##(1997-1#1)(2008-10#1)
performance without##3##2##(1992-12#1)(2008-5#1)(2010-12#1)
performance would##2##2##(2005-11#1)(2007-1#1)
performance##4030##1##(1990-1#1)(1990-10#9)(1990-11#7)(1990-12#5)(1990-2#3)(1990-3#6)(1990-4#1)(1990-5#2)(1990-6#3)(1990-7#5)(1990-8#2)(1990-9#2)(1991-1#10)(1991-10#2)(1991-12#3)(1991-2#15)(1991-3#9)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#5)(1991-9#3)(1992-1#6)(1992-10#11)(1992-11#16)(1992-12#19)(1992-2#13)(1992-3#7)(1992-4#1)(1992-6#2)(1992-7#4)(1992-8#5)(1992-9#9)(1993-1#5)(1993-11#8)(1993-12#54)(1993-2#21)(1993-3#18)(1993-4#3)(1993-5#7)(1993-6#3)(1993-7#6)(1993-8#2)(1993-9#7)(1994-1#12)(1994-10#4)(1994-11#4)(1994-12#12)(1994-2#17)(1994-3#16)(1994-4#1)(1994-5#6)(1994-6#11)(1994-8#11)(1994-9#9)(1995-1#20)(1995-10#4)(1995-11#3)(1995-12#27)(1995-2#11)(1995-3#15)(1995-4#3)(1995-5#7)(1995-6#3)(1995-7#1)(1995-9#1)(1996-1#14)(1996-10#1)(1996-11#5)(1996-12#24)(1996-2#28)(1996-3#41)(1996-5#12)(1996-6#1)(1996-7#7)(1996-8#9)(1996-9#7)(1997-1#7)(1997-2#15)(1997-3#24)(1997-4#2)(1997-5#5)(1997-6#4)(1997-7#4)(1997-8#19)(2004-1#1)(2004-10#1)(2004-11#10)(2004-3#2)(2004-8#3)(2004-9#15)(2005-1#1)(2005-10#8)(2005-11#13)(2005-12#16)(2005-3#2)(2005-4#3)(2005-5#2)(2005-7#4)(2005-8#7)(2005-9#5)(2006-1#1)(2006-10#35)(2006-11#8)(2006-12#10)(2006-2#5)(2006-3#12)(2006-4#18)(2006-5#8)(2006-6#14)(2006-7#8)(2006-8#17)(2006-9#6)(2007-1#16)(2007-10#22)(2007-11#58)(2007-12#73)(2007-2#6)(2007-3#2)(2007-4#30)(2007-5#10)(2007-6#1)(2007-7#26)(2007-8#57)(2007-9#17)(2008-1#27)(2008-10#489)(2008-11#82)(2008-12#48)(2008-2#348)(2008-3#352)(2008-4#38)(2008-5#86)(2008-6#48)(2008-7#66)(2008-8#45)(2008-9#65)(2009-1#14)(2009-10#19)(2009-11#18)(2009-12#4)(2009-2#4)(2009-3#11)(2009-4#20)(2009-5#14)(2009-6#8)(2009-7#23)(2009-8#16)(2009-9#15)(2010-1#1)(2010-10#3)(2010-11#13)(2010-12#29)(2010-2#50)(2010-3#8)(2010-4#23)(2010-5#14)(2010-6#1)(2010-7#15)(2010-8#37)(2010-9#9)(2011-1#58)(2011-12#4)(2011-2#88)(2011-3#2)(2011-7#1)(2012-1#63)(2012-11#5)(2012-12#68)(2012-2#69)(2012-3#74)(2012-5#1)(2012-6#1)(2012-7#1)(2012-9#1)(2013-1#144)(2013-7#26)(2013-8#55)
performance&quot##2##1##(2009-9#1)(2013-1#1)
performance)##5##1##(1994-8#1)(2004-9#1)(2008-5#1)(2009-7#1)(2012-1#1)
performance-based objectives##2##2##(1996-2#2)
performance-based##9##1##(1996-2#2)(1997-8#1)(2006-10#1)(2007-5#1)(2008-10#1)(2011-1#1)(2011-2#2)
performance-critical data##2##2##(2008-2#2)
performance-enhancing##3##1##(2008-3#1)(2010-4#1)(2010-7#1)
performance-measurement system##2##2##(1996-2#2)
performance-oriented##2##1##(1994-2#1)(2006-8#1)
performance?##4##1##(1991-11#1)(1992-3#2)(1994-12#1)
performance]##3##1##(2010-12#1)(2010-6#1)(2011-1#1)
performances and##5##2##(1997-7#1)(2007-8#1)(2007-9#1)(2010-5#1)(2013-1#1)
performances are compared##3##3##(1996-8#1)(2008-10#2)
performances are##9##2##(1996-8#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)
performances for##8##2##(1993-9#1)(1997-2#1)(2008-10#1)(2008-3#2)(2009-10#1)(2009-2#1)(2010-2#1)
performances in a##2##3##(1996-6#1)(1997-2#1)
performances in the##3##3##(2008-3#1)(2009-1#1)(2012-2#1)
performances in##11##2##(1994-5#1)(1996-6#1)(1997-2#1)(2008-3#2)(2009-1#1)(2009-4#1)(2010-8#1)(2012-2#1)(2012-5#1)(2013-1#1)
performances of a##5##3##(1993-3#1)(2008-10#2)(2008-2#1)(2008-3#1)
performances of different##3##3##(1993-1#1)(2005-11#1)(2010-8#1)
performances of the method##2##4##(2008-2#1)(2008-3#1)
performances of the proposed##2##4##(2008-10#1)(2008-3#1)
performances of the two##2##4##(2008-10#1)(2012-12#1)
performances of the##22##3##(1996-11#1)(2007-1#1)(2007-8#2)(2008-10#9)(2008-2#3)(2008-3#4)(2011-2#1)(2012-12#1)
performances of these two##2##4##(2008-3#1)(2009-12#1)
performances of these##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2009-12#1)
performances of two##3##3##(1996-11#1)(2008-10#1)(2008-3#1)
performances of##58##2##(1990-10#1)(1991-3#1)(1993-1#1)(1993-2#1)(1993-3#1)(1996-11#2)(2005-11#1)(2005-4#1)(2007-1#1)(2007-11#1)(2007-8#3)(2008-10#19)(2008-11#1)(2008-2#6)(2008-3#9)(2008-6#1)(2009-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
performances to##2##2##(1990-12#1)(2008-2#1)
performances were assessed##2##3##(2012-1#1)(2013-7#1)
performances were##7##2##(1997-3#1)(2008-10#1)(2008-3#1)(2009-2#1)(2010-4#1)(2012-1#1)(2013-7#1)
performances with##3##2##(1994-2#1)(1996-8#1)(2008-3#1)
performances##152##1##(1990-10#1)(1990-12#1)(1990-6#1)(1991-3#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-2#1)(1996-11#2)(1996-3#1)(1996-6#1)(1996-8#2)(1997-2#2)(1997-3#1)(1997-7#1)(2005-11#1)(2005-4#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-8#5)(2007-9#1)(2008-10#34)(2008-11#4)(2008-12#1)(2008-2#19)(2008-3#20)(2008-6#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#2)(2009-2#5)(2009-4#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-8#4)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#2)(2013-7#2)(2013-8#2)
performed 1##3##2##(1992-4#1)(1996-12#1)(2013-1#1)
performed 12##3##2##(1992-8#1)(2008-12#1)(2013-1#1)
performed 14##2##2##(1993-10#1)(2007-8#1)
performed 2 days##2##3##(2006-3#1)(2008-5#1)
performed 2##4##2##(2006-3#1)(2008-5#1)(2012-12#1)(2013-7#1)
performed 24 hours##2##3##(2007-10#1)(2012-12#1)
performed 40##2##2##(1990-10#1)(1996-1#1)
performed 5##3##2##(1994-11#1)(2007-10#1)(2010-8#1)
performed 6 weeks##2##3##(2007-10#1)(2012-1#1)
performed 6##5##2##(2006-5#1)(2007-10#1)(2007-9#2)(2012-1#1)
performed SMBG##3##2##(2008-8#3)
performed a case-control##2##3##(2006-2#1)(2011-2#1)
performed a comparative##3##3##(2012-1#1)(2012-12#2)
performed a cross sectional study in##2##6##(2011-2#2)
performed a detailed analysis of the##2##6##(1994-12#1)(2009-8#1)
performed a detailed##3##3##(1994-12#1)(1997-4#1)(2009-8#1)
performed a genome-wide##3##3##(2010-5#1)(2012-3#2)
performed a literature review##3##4##(2008-1#1)(2012-2#1)(2013-1#1)
performed a meta-analysis of##2##4##(1995-8#1)(2010-7#1)
performed a parallel##2##3##(2008-11#1)(2010-12#1)
performed a pilot study##3##4##(1996-3#1)(2007-5#1)(2009-12#1)
performed a prospective##6##3##(1994-2#1)(2007-8#1)(2008-8#1)(2011-1#2)(2011-2#1)
performed a randomized##3##3##(2005-8#1)(2007-8#1)(2012-2#1)
performed a retrospective analysis of##4##5##(2006-11#2)(2007-7#2)
performed a retrospective analysis##6##4##(2006-11#2)(2007-7#2)(2007-8#1)(2011-2#1)
performed a retrospective chart review of##3##6##(2006-8#1)(2007-10#1)(2008-10#1)
performed a retrospective review of##2##5##(2006-10#1)(2012-2#1)
performed a retrospective review##3##4##(2006-10#1)(2008-9#1)(2012-2#1)
performed a retrospective##29##3##(2006-10#2)(2006-11#2)(2006-5#1)(2006-8#1)(2007-10#2)(2007-7#2)(2007-8#3)(2008-10#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-4#1)(2011-2#6)(2012-2#1)(2013-1#2)(2013-8#1)
performed a review of the literature##2##6##(2012-2#1)(2012-3#1)
performed a review of the##3##5##(2011-2#1)(2012-2#1)(2012-3#1)
performed a semiquantitative##2##3##(2008-7#1)(2013-8#1)
performed a series of##2##4##(1990-9#1)(2011-2#1)
performed a systematic##7##3##(2003-11#1)(2007-10#2)(2009-2#1)(2010-2#1)(2012-2#1)(2013-8#1)
performed a task##2##3##(2008-11#1)(2010-5#1)
performed a two-stage##2##3##(2006-3#1)(2008-6#1)
performed a visual##2##3##(2011-2#1)(2012-3#1)
performed a##161##2##(1990-11#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-8#2)(2003-11#1)(2005-8#1)(2006-10#3)(2006-11#2)(2006-12#1)(2006-2#2)(2006-3#1)(2006-5#1)(2006-8#1)(2007-10#4)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#4)(2007-8#8)(2007-9#1)(2008-1#5)(2008-10#3)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#3)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#16)(2012-1#1)(2012-12#5)(2012-2#9)(2012-3#11)(2013-1#7)(2013-7#1)(2013-8#7)
performed abdominal##3##2##(2009-2#1)(2011-12#1)(2012-12#1)
performed according to a##3##4##(1990-12#1)(2006-12#1)(2008-6#1)
performed according to the##2##4##(2008-7#1)(2008-9#1)
performed according to##13##3##(1990-12#1)(1991-3#1)(1993-3#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-1#1)(2012-1#1)
performed according##14##2##(1990-12#1)(1991-3#1)(1993-3#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-1#1)(2012-1#1)
performed accurately##2##2##(2006-8#1)(2008-10#1)
performed additional##2##2##(1992-5#1)(2007-9#1)
performed after a##5##3##(1990-11#1)(1996-7#1)(1997-4#1)(2008-10#1)(2011-2#1)
performed after the##5##3##(1997-3#1)(2007-3#1)(2012-1#1)(2013-1#2)
performed after##40##2##(1990-11#1)(1990-8#1)(1991-4#1)(1992-5#1)(1993-11#1)(1993-4#1)(1993-6#1)(1996-3#3)(1996-4#1)(1996-7#1)(1997-3#1)(1997-4#1)(2005-5#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-3#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
performed against the##2##3##(1996-5#1)(2008-11#1)
performed against##5##2##(1996-5#1)(2008-11#1)(2008-5#1)(2012-2#1)(2013-7#1)
performed all##2##2##(2007-8#1)(2008-12#1)
performed along with##2##3##(2012-12#1)(2012-2#1)
performed along##5##2##(2007-1#1)(2008-10#1)(2008-2#1)(2012-12#1)(2012-2#1)
performed also by##2##3##(1991-2#1)(1992-9#1)
performed also##3##2##(1991-2#1)(1992-6#1)(1992-9#1)
performed among##3##2##(2008-10#2)(2012-2#1)
performed an analysis of##3##4##(2009-4#1)(2010-2#1)(2011-2#1)
performed an analysis##4##3##(2008-5#1)(2009-4#1)(2010-2#1)(2011-2#1)
performed an experiment that##2##4##(1997-6#1)(2007-11#1)
performed an experiment##4##3##(1997-6#1)(2006-10#1)(2007-11#1)(2008-10#1)
performed an experimental study##2##4##(1993-3#1)(2007-11#1)
performed an experimental##4##3##(1993-3#1)(2007-11#1)(2008-2#1)(2012-2#1)
performed an extensive##3##3##(2008-7#1)(2013-1#2)
performed an in vitro##2##4##(1994-6#1)(1997-8#1)
performed an open##2##3##(2007-9#1)(2008-5#1)
performed an##36##2##(1991-6#1)(1993-3#1)(1994-6#1)(1995-7#1)(1996-2#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-2#3)(2008-5#3)(2008-7#1)(2009-3#1)(2009-4#1)(2010-2#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#3)
performed and a##3##3##(2008-10#1)(2010-6#1)(2011-2#1)
performed and compared with##4##4##(1993-9#1)(2008-2#1)(2009-10#1)(2012-2#1)
performed and only##2##3##(2007-8#1)(2013-8#1)
performed and replicated##2##3##(2008-10#1)(2010-1#1)
performed and revealed##2##3##(1992-5#1)(1997-3#1)
performed and showed##2##3##(1996-11#1)(2008-7#1)
performed and the results##2##4##(2009-8#1)(2013-7#1)
performed and the##30##3##(1990-3#1)(1990-5#1)(1991-7#1)(1991-9#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#1)(2009-8#2)(2009-9#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
performed and was##2##3##(2008-10#1)(2011-2#1)
performed and##104##2##(1990-2#1)(1990-3#2)(1990-5#1)(1991-10#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-9#1)(1994-8#1)(1996-11#1)(1996-12#1)(1997-3#1)(2004-11#1)(2005-11#1)(2006-10#4)(2006-11#2)(2006-2#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#5)(2007-9#2)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-6#1)(2011-12#1)(2011-2#8)(2012-12#2)(2012-2#6)(2013-1#8)(2013-7#1)(2013-8#5)
performed annually##4##2##(1990-9#1)(2006-8#1)(2008-10#1)(2010-11#1)
performed aortic root##2##3##(2007-8#1)(2012-2#1)
performed around the##2##3##(2011-1#1)(2011-2#1)
performed around##3##2##(2009-5#1)(2011-1#1)(2011-2#1)
performed as a##9##3##(1995-11#1)(2004-2#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-12#1)(2013-1#1)
performed as an##4##3##(1993-7#1)(2006-5#1)(2008-7#1)(2011-2#1)
performed as described##2##3##(2006-8#1)(2010-2#1)
performed as early##3##3##(2006-10#1)(2012-2#1)(2013-1#1)
performed as part of##3##4##(1993-1#1)(2006-10#1)(2010-3#1)
performed as soon as##2##4##(2009-4#1)(2012-2#1)
performed as the##5##3##(1996-5#1)(1996-6#2)(2006-5#1)(2008-7#1)
performed as well as##2##4##(1992-9#1)(2005-1#1)
performed as well##4##3##(1992-9#1)(1997-8#1)(2005-1#1)(2006-8#1)
performed as##43##2##(1990-6#1)(1991-2#1)(1992-9#1)(1993-1#1)(1993-7#1)(1995-11#2)(1995-2#1)(1996-5#1)(1996-6#2)(1997-8#1)(2004-2#1)(2005-1#1)(2006-10#3)(2006-5#2)(2006-6#1)(2006-8#2)(2007-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#1)
performed at 1##2##3##(1994-11#1)(2007-9#1)
performed at 2##2##3##(2007-11#1)(2012-12#1)
performed at 6##4##3##(2006-11#1)(2006-12#1)(2008-9#1)(2011-2#1)
performed at a constant##2##4##(2008-10#2)
performed at a##21##3##(1990-4#1)(1991-2#1)(1992-12#1)(1993-11#1)(1996-9#1)(1997-4#1)(2006-3#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-9#1)(2013-7#1)
performed at ambient temperature##2##4##(2008-10#1)(2012-12#1)
performed at an##6##3##(1991-1#1)(1993-8#1)(2007-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
performed at any##2##3##(1994-9#1)(2007-8#1)
performed at chance##2##3##(1993-3#1)(2012-1#1)
performed at concentrations##2##3##(1992-3#1)(2008-3#1)
performed at different##8##3##(1991-2#1)(2005-11#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2012-2#1)
performed at each##2##3##(2006-8#1)(2007-11#1)
performed at entry##2##3##(1991-4#1)(2008-5#1)
performed at high##2##3##(1997-8#1)(2008-7#1)
performed at least##3##3##(2007-7#1)(2010-7#2)
performed at low##2##3##(1997-1#1)(2006-4#1)
performed at our##4##3##(1995-1#1)(2007-7#1)(2007-8#1)(2012-2#1)
performed at regular intervals##2##4##(2006-1#1)(2007-7#1)
performed at the beginning and at the##2##7##(1991-7#1)(2008-11#1)
performed at the beginning##3##4##(1991-7#1)(2005-10#1)(2008-11#1)
performed at the same##3##4##(1995-12#1)(2006-8#1)(2007-1#1)
performed at the time##2##4##(1996-6#1)(2008-7#1)
performed at the##40##3##(1990-3#1)(1991-5#1)(1991-7#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-8#1)(2004-10#1)(2005-10#2)(2006-10#1)(2006-8#4)(2007-1#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-7#1)(2009-7#1)(2010-5#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-8#1)
performed at this##2##3##(2008-7#1)(2008-8#1)
performed at three##3##3##(1995-3#1)(1995-5#1)(2008-12#1)
performed at various##3##3##(1994-9#1)(2008-5#2)
performed at##205##2##(1990-11#2)(1990-3#3)(1990-4#1)(1990-9#1)(1991-1#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-11#1)(1993-3#3)(1993-8#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-7#1)(1994-9#3)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-3#2)(1996-6#2)(1996-9#3)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#2)(2004-10#1)(2004-4#1)(2005-10#3)(2005-11#2)(2005-7#1)(2006-1#1)(2006-10#4)(2006-11#3)(2006-12#2)(2006-3#1)(2006-4#2)(2006-6#1)(2006-8#8)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#5)(2007-8#8)(2007-9#3)(2008-1#2)(2008-10#19)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-7#3)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#5)(2012-2#7)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#2)
performed based on##3##3##(1997-1#1)(2007-11#1)(2008-10#1)
performed because of##11##3##(1993-1#1)(1993-6#1)(1997-8#1)(2008-10#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-11#1)
performed because##13##2##(1993-1#1)(1993-6#1)(1997-8#1)(2008-10#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-11#2)(2013-7#1)
performed before 35 weeks##2##4##(1993-4#2)
performed before and after##4##4##(1990-11#2)(1994-6#1)(2008-5#1)
performed before and##5##3##(1990-11#2)(1994-6#1)(2007-8#1)(2008-5#1)
performed before surgery##2##3##(2007-11#1)(2010-6#1)
performed before the first##2##4##(2006-10#1)(2012-12#1)
performed before the##6##3##(1990-12#1)(1996-11#1)(2006-10#1)(2008-4#1)(2009-3#1)(2012-12#1)
performed before##26##2##(1990-11#2)(1990-12#1)(1993-2#1)(1993-4#2)(1994-6#1)(1996-11#1)(2004-2#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-3#1)(2010-6#1)(2012-12#1)
performed best on##2##3##(2007-7#1)(2011-2#1)
performed best##6##2##(1993-8#1)(2007-7#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
performed better in terms of##2##5##(2006-12#1)(2006-7#1)
performed better in##4##3##(1995-3#1)(2006-12#1)(2006-7#1)(2011-12#1)
performed better on##2##3##(2010-7#1)(2013-7#1)
performed better than the##3##4##(2007-8#1)(2008-2#1)(2009-3#1)
performed better than##9##3##(1993-2#1)(1994-9#1)(2007-8#1)(2008-2#1)(2009-3#1)(2009-7#1)(2009-8#1)(2013-1#2)
performed better when rare variants were collapsed based on genes##2##10##(2012-3#2)
performed better##21##2##(1993-2#1)(1994-9#1)(1995-3#1)(2006-12#1)(2006-5#2)(2006-7#1)(2007-8#1)(2008-2#1)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-7#1)(2011-12#1)(2012-3#3)(2013-1#2)(2013-7#1)
performed between January 1994 and##2##5##(2007-2#1)(2013-1#1)
performed between January##4##3##(2007-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
performed between two##2##3##(1996-12#1)(2008-2#1)
performed between##19##2##(1990-6#1)(1992-11#1)(1992-2#1)(1992-7#1)(1994-11#1)(1996-12#1)(2006-10#1)(2007-2#1)(2008-10#4)(2008-2#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
performed both in##2##3##(1991-2#1)(2008-3#1)
performed both##6##2##(1991-2#1)(1993-10#1)(1994-9#1)(2008-3#1)(2008-4#1)(2013-7#1)
performed by GC/MS##2##3##(2006-12#1)(2012-12#1)
performed by HPLC using##2##4##(2008-10#1)(2009-3#1)
performed by HPLC##3##3##(1990-5#1)(2008-10#1)(2009-3#1)
performed by a flow injection##2##5##(2007-8#1)(2008-10#1)
performed by a##36##3##(1990-10#1)(1990-3#1)(1990-6#1)(1991-10#1)(1992-9#1)(1993-2#1)(1993-5#1)(2004-10#1)(2005-8#1)(2006-6#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#12)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#2)
performed by affinity chromatography##2##4##(1997-2#1)(2008-11#1)
performed by an experienced##2##4##(2008-5#1)(2012-12#1)
performed by an expert##2##4##(2008-6#1)(2010-12#1)
performed by an##10##3##(2006-8#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-6#1)(2010-12#1)(2012-12#1)(2013-1#1)
performed by comparing##4##3##(1996-6#1)(1997-6#1)(2008-10#1)(2008-5#1)
performed by comparison##3##3##(2008-10#1)(2008-3#1)(2009-6#1)
performed by direct##3##3##(1992-12#1)(2005-4#1)(2008-5#1)
performed by flame atomic absorption##2##5##(2008-10#2)
performed by flow cytometry##2##4##(2008-5#1)(2008-9#1)
performed by gas chromatography-mass spectrometry##2##5##(2008-10#2)
performed by gas##3##3##(2008-10#3)
performed by inductively coupled##2##4##(2008-10#1)(2009-6#1)
performed by laparoscopy##4##3##(1993-9#1)(1994-9#1)(1996-8#1)(2011-2#1)
performed by means of a##4##5##(2006-12#1)(2008-1#1)(2008-10#1)(2008-2#1)
performed by means of the##2##5##(2008-10#2)
performed by means of##14##4##(1992-2#1)(1994-9#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)(2013-7#1)
performed by measurement of the##2##5##(1997-3#1)(2008-3#1)
performed by measurement of##3##4##(1997-3#1)(2007-7#1)(2008-3#1)
performed by measuring the##5##4##(1994-8#1)(1995-2#1)(2008-10#2)(2008-11#1)
performed by measuring##6##3##(1992-5#1)(1994-8#1)(1995-2#1)(2008-10#2)(2008-11#1)
performed by minimally-invasive##2##3##(2011-2#1)(2013-8#1)
performed by monitoring the##2##4##(1992-12#1)(1996-8#1)
performed by one##5##3##(1995-2#1)(2006-8#1)(2008-10#1)(2008-7#2)
performed by physicians##2##3##(1991-6#1)(2007-4#1)
performed by reverse-phase##2##3##(1991-2#1)(2008-10#1)
performed by surgeons##2##3##(1996-9#1)(2007-8#1)
performed by the analysis of##2##5##(2008-10#2)
performed by the same surgeon##2##5##(2008-4#1)(2008-8#1)
performed by the same##4##4##(1995-1#1)(2008-3#1)(2008-4#1)(2008-8#1)
performed by the##52##3##(1990-5#1)(1991-4#1)(1991-9#1)(1993-11#1)(1993-12#3)(1995-1#2)(1996-1#1)(1996-12#1)(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2010-8#1)(2011-1#4)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
performed by three##4##3##(2007-8#2)(2009-6#1)(2011-1#1)
performed by treating##2##3##(1993-9#1)(1994-3#1)
performed by two different##2##4##(2008-10#1)(2013-1#1)
performed by two##5##3##(2008-10#2)(2008-3#1)(2013-1#2)
performed by use of a##2##5##(2008-3#1)(2008-9#1)
performed by use of ultrashort##2##5##(2008-2#1)(2008-3#1)
performed by use of##7##4##(2007-12#1)(2008-2#1)(2008-3#3)(2008-9#2)
performed by using a##4##4##(2008-10#2)(2011-2#1)(2013-8#1)
performed by using the##4##4##(2004-10#1)(2007-9#1)(2008-5#2)
performed by using##19##3##(1995-12#1)(1996-5#1)(2004-10#1)(2007-1#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-5#3)(2010-12#1)(2011-2#1)(2012-1#2)(2013-1#1)(2013-8#1)
performed by various##3##3##(2008-4#1)(2009-5#1)(2011-3#1)
performed by##410##2##(1990-1#1)(1990-10#2)(1990-12#4)(1990-2#1)(1990-3#3)(1990-5#3)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#4)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-5#1)(1993-7#1)(1993-9#2)(1994-11#2)(1994-3#2)(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-12#1)(1995-2#3)(1995-6#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#4)(1996-7#1)(1996-8#3)(1996-9#4)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-10#2)(2004-12#1)(2004-2#2)(2004-9#1)(2005-10#2)(2005-11#1)(2005-4#1)(2005-8#1)(2006-10#4)(2006-11#2)(2006-12#3)(2006-5#1)(2006-6#4)(2006-7#1)(2006-8#2)(2007-1#2)(2007-11#5)(2007-12#6)(2007-3#4)(2007-4#2)(2007-6#2)(2007-7#2)(2007-8#13)(2007-9#5)(2008-1#3)(2008-10#84)(2008-11#5)(2008-12#5)(2008-2#10)(2008-3#18)(2008-4#8)(2008-5#13)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#8)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#2)(2009-6#4)(2009-9#1)(2010-11#2)(2010-12#7)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-2#9)(2011-3#1)(2012-1#3)(2012-12#4)(2012-2#5)(2012-3#5)(2013-1#8)(2013-7#2)(2013-8#3)
performed clinically##2##2##(2008-2#1)(2012-12#1)
performed comparably to the##2##4##(1992-7#1)(2008-10#1)
performed coronary##2##2##(2008-5#1)(2011-1#1)
performed data##3##2##(2007-4#1)(2008-10#1)(2008-6#1)
performed demonstrating##3##2##(2008-8#1)(2013-1#2)
performed directly on the##2##4##(2008-10#1)(2010-5#1)
performed directly on##3##3##(2008-10#1)(2010-2#1)(2010-5#1)
performed directly##5##2##(1996-7#1)(2008-10#1)(2010-2#1)(2010-5#1)(2011-2#1)
performed due to##14##3##(2006-3#1)(2007-11#2)(2007-7#3)(2008-1#1)(2008-10#2)(2008-6#1)(2009-9#1)(2011-2#1)(2012-2#2)
performed during a##2##3##(1990-12#1)(2011-2#1)
performed during the first year##2##5##(2007-8#1)(2008-2#1)
performed during the first##3##4##(1990-8#1)(2007-8#1)(2008-2#1)
performed during the last##2##4##(1996-9#1)(2008-11#1)
performed during the##20##3##(1990-2#1)(1990-8#1)(1992-12#1)(1994-8#1)(1996-6#1)(1996-9#1)(1997-8#1)(2005-7#1)(2006-10#1)(2007-2#1)(2007-6#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-2#1)
performed during##43##2##(1990-12#1)(1990-2#1)(1990-8#1)(1992-12#1)(1992-2#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-8#1)(2005-7#1)(2006-10#4)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#4)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2011-12#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#1)
performed each##2##2##(1990-9#1)(2007-11#1)
performed early##4##2##(1996-11#1)(2007-8#1)(2008-5#1)(2010-12#1)
performed easily and##2##3##(1991-11#1)(2006-10#1)
performed easily##5##2##(1991-11#1)(2006-10#1)(2006-6#1)(2006-8#1)(2010-4#1)
performed efficiently##3##2##(2008-1#1)(2008-2#1)(2009-3#1)
performed either by##2##3##(1990-3#1)(2006-4#1)
performed either##6##2##(1990-3#1)(1993-7#1)(2006-10#1)(2006-4#1)(2006-8#1)(2008-4#1)
performed employing##3##2##(1994-11#1)(2006-11#1)(2007-11#1)
performed endoscopic##3##2##(2009-10#1)(2011-2#1)(2013-8#1)
performed endoscopically##3##2##(1997-2#1)(2006-6#1)(2010-12#1)
performed equally well##2##3##(2008-11#1)(2011-2#1)
performed equally##3##2##(2008-11#1)(2008-9#1)(2011-2#1)
performed every##5##2##(1991-7#1)(1995-9#1)(1996-11#1)(2007-7#1)(2008-5#1)
performed experiments in##2##3##(2008-11#1)(2008-2#1)
performed experiments with##2##3##(2008-3#2)
performed experiments##5##2##(2008-11#1)(2008-2#1)(2008-3#3)
performed first##3##2##(2006-7#1)(2007-11#1)(2008-10#1)
performed followed by a##2##4##(2006-3#1)(2008-8#1)
performed followed by##5##3##(1992-6#1)(2006-3#1)(2007-12#1)(2008-8#2)
performed following the##5##3##(2007-3#1)(2010-9#1)(2012-12#2)(2013-1#1)
performed following##9##2##(1997-6#1)(2007-3#1)(2008-10#1)(2009-6#1)(2010-4#1)(2010-9#1)(2012-12#2)(2013-1#1)
performed for 30##2##3##(2011-1#1)(2012-2#1)
performed for a##15##3##(1997-1#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-2#1)(2008-3#4)(2008-5#2)(2010-4#1)(2013-1#2)
performed for all##3##3##(1995-1#1)(2007-7#1)(2008-8#1)
performed for different##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2012-11#1)
performed for each##9##3##(1996-2#1)(2006-5#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)
performed for early##2##3##(2010-3#1)(2013-1#1)
performed for other reasons##3##4##(1991-8#1)(2008-7#1)(2011-2#1)
performed for other##4##3##(1991-8#1)(2007-7#1)(2008-7#1)(2011-2#1)
performed for over##4##3##(2006-10#1)(2006-12#1)(2012-11#2)
performed for seven##2##3##(2007-8#1)(2008-10#1)
performed for several##2##3##(2008-2#1)(2009-4#1)
performed for some##2##3##(1993-5#1)(2008-12#1)
performed for the detection of##2##5##(2007-8#1)(2011-2#1)
performed for the same##2##4##(1995-5#1)(2008-10#1)
performed for the##25##3##(1995-5#1)(1996-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#2)(2008-10#6)(2008-5#1)(2008-7#1)(2010-12#1)(2010-7#2)(2011-2#4)(2012-3#1)(2013-8#2)
performed for this##3##3##(2006-10#1)(2007-11#1)(2008-8#1)
performed for two##4##3##(1996-8#1)(2008-2#1)(2008-3#1)(2013-8#1)
performed for various##3##3##(2006-7#1)(2007-2#1)(2008-2#1)
performed for##162##2##(1990-10#1)(1990-9#2)(1991-8#1)(1992-8#1)(1993-10#1)(1993-5#1)(1995-1#1)(1995-5#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-8#2)(1997-1#1)(1997-5#1)(2005-5#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#4)(2007-8#6)(2008-1#4)(2008-10#19)(2008-12#2)(2008-2#6)(2008-3#12)(2008-5#7)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2010-10#3)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#3)(2011-1#2)(2011-2#10)(2011-3#1)(2012-1#2)(2012-11#3)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#4)
performed four times##2##3##(2007-2#1)(2008-10#1)
performed four##5##2##(2006-3#1)(2006-4#1)(2007-2#1)(2008-10#2)
performed from the##3##3##(2007-8#1)(2010-12#1)(2010-3#1)
performed from##20##2##(1990-5#1)(1994-8#1)(1995-7#1)(1996-2#1)(2004-11#1)(2007-11#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2010-12#1)(2010-3#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
performed genotype##2##2##(2011-1#1)(2013-8#1)
performed here##2##2##(1993-10#1)(2013-7#1)
performed if##6##2##(1990-12#1)(1997-4#1)(2005-12#1)(2006-3#1)(2008-10#1)(2008-6#1)
performed immediately after##3##3##(1991-8#1)(2010-12#1)(2013-1#1)
performed immediately##7##2##(1991-8#1)(1996-3#1)(2007-8#1)(2009-4#1)(2009-9#1)(2010-12#1)(2013-1#1)
performed immunocytochemical##2##2##(1991-11#1)(2007-6#1)
performed immunohistochemical##2##2##(1996-11#1)(2013-8#1)
performed in 0##3##3##(2008-10#3)
performed in 1##6##3##(2007-10#1)(2008-10#4)(2009-10#1)
performed in 11##3##3##(2008-5#2)(2013-1#1)
performed in 12##2##3##(1993-5#1)(2007-8#1)
performed in 14 patients##3##4##(1990-8#1)(1992-10#1)(2007-9#1)
performed in 14##5##3##(1990-3#1)(1990-8#1)(1992-10#1)(2006-6#1)(2007-9#1)
performed in 15 patients##2##4##(1990-9#1)(2006-5#1)
performed in 15##6##3##(1990-9#1)(2006-11#1)(2006-5#1)(2007-2#1)(2008-7#1)(2011-2#1)
performed in 2##3##3##(2007-10#1)(2007-8#1)(2009-10#1)
performed in 20##6##3##(1990-12#2)(1991-3#1)(2006-12#1)(2008-5#1)(2012-12#1)
performed in 23##3##3##(2007-2#1)(2008-4#1)(2009-5#1)
performed in 25##2##3##(2005-10#1)(2008-5#1)
performed in 26##2##3##(2006-11#1)(2008-9#1)
performed in 3##2##3##(2007-11#1)(2011-2#1)
performed in 37 patients##2##4##(1992-8#1)(2008-7#1)
performed in 37##3##3##(1992-8#1)(2007-9#1)(2008-7#1)
performed in 4##4##3##(1990-6#1)(2008-10#1)(2009-8#1)(2012-2#1)
performed in 40##3##3##(1990-8#1)(2009-2#1)(2013-8#1)
performed in 42 patients##4##4##(1992-6#1)(2007-11#1)(2007-8#1)(2013-1#1)
performed in 48##2##3##(2006-8#1)(2008-7#1)
performed in 49 patients##2##4##(1990-8#1)(1992-8#1)
performed in 49##3##3##(1990-8#1)(1992-8#1)(2007-8#1)
performed in 5##2##3##(1994-11#1)(2012-2#1)
performed in 57##2##3##(2006-6#1)(2008-4#1)
performed in 60 patients##2##4##(1991-6#1)(2007-11#1)
performed in 7 patients##2##4##(2013-1#1)(2013-8#1)
performed in 7##5##3##(1992-7#1)(2007-11#1)(2008-10#1)(2013-1#1)(2013-8#1)
performed in 74##2##3##(1990-10#1)(2013-7#1)
performed in 75##2##3##(2007-8#1)(2011-2#1)
performed in 87##2##3##(1990-6#1)(2008-5#1)
performed in 95 patients##2##4##(1997-8#1)(2008-5#1)
performed in 95##3##3##(1997-8#1)(2008-11#1)(2008-5#1)
performed in a 5##2##4##(2007-12#1)(2008-6#1)
performed in a day##2##4##(1992-4#1)(2004-11#1)
performed in a single##3##4##(2007-12#1)(2010-1#1)(2013-8#1)
performed in a##61##3##(1990-11#1)(1990-6#1)(1992-4#1)(1992-5#1)(1993-10#1)(1994-5#1)(1995-9#1)(1996-6#1)(2004-11#1)(2005-12#1)(2006-10#1)(2006-8#2)(2007-1#2)(2007-12#4)(2007-2#1)(2008-10#11)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#1)(2009-3#2)(2009-7#1)(2010-1#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#4)(2013-8#2)
performed in accordance with##2##4##(2010-9#1)(2013-8#1)
performed in accordance##3##3##(2007-8#1)(2010-9#1)(2013-8#1)
performed in addition to##2##4##(2006-10#1)(2013-1#1)
performed in all cases##5##4##(1991-4#1)(2007-8#2)(2008-5#2)
performed in all of##2##4##(2008-9#1)(2011-2#1)
performed in all patients and##2##5##(1993-3#1)(2006-6#1)
performed in all patients##8##4##(1990-9#1)(1992-5#1)(1993-3#1)(1994-5#1)(1997-5#1)(2006-6#1)(2006-8#1)(2007-9#1)
performed in all the##2##4##(2007-10#1)(2007-7#1)
performed in all##25##3##(1990-9#1)(1991-4#1)(1991-9#1)(1992-5#1)(1993-3#1)(1994-5#1)(1996-7#1)(1997-5#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-2#3)
performed in an aqueous##2##4##(2007-8#1)(2008-10#1)
performed in an attempt to##3##5##(1996-8#1)(2010-4#1)(2013-7#1)
performed in an##22##3##(1990-8#1)(1991-11#1)(1993-10#1)(1996-7#1)(1996-8#1)(2006-10#1)(2006-7#2)(2006-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-9#1)(2010-11#1)(2010-4#1)(2013-7#2)
performed in anaesthetized rats##2##4##(1993-11#1)(1996-5#1)
performed in any##2##3##(1996-12#1)(2008-1#1)
performed in both patients##3##4##(1997-6#1)(2006-12#1)(2007-8#1)
performed in both##9##3##(1997-6#1)(2006-12#2)(2007-1#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-7#1)(2012-12#1)
performed in children##2##3##(2005-11#1)(2006-10#1)
performed in conjunction with##2##4##(2008-10#1)(2012-2#1)
performed in conjunction##3##3##(2007-8#1)(2008-10#1)(2012-2#1)
performed in different##2##3##(2008-11#1)(2010-11#1)
performed in eight##2##3##(1991-10#1)(2011-1#1)
performed in every##2##3##(1993-5#1)(1994-9#1)
performed in group##2##3##(2009-2#1)(2012-12#1)
performed in human##2##3##(1992-2#1)(1996-8#1)
performed in large##2##3##(2005-11#1)(2007-2#1)
performed in mice##2##3##(2008-10#1)(2013-8#1)
performed in most##2##3##(1996-3#1)(2006-10#1)
performed in one##7##3##(1990-6#1)(1997-8#1)(2006-6#1)(2008-10#2)(2008-7#1)(2011-2#1)
performed in order to characterize##2##5##(1995-12#1)(2008-7#1)
performed in order to determine the##2##6##(2005-12#1)(2007-8#1)
performed in order to explain the##2##6##(2007-2#1)(2008-10#1)
performed in order to find out the##3##7##(2008-1#1)(2013-1#2)
performed in order to identify##4##5##(1992-12#1)(2006-10#1)(2007-8#1)(2008-10#1)
performed in order to obtain##2##5##(2008-10#1)(2008-7#1)
performed in order to##34##4##(1990-2#1)(1990-8#1)(1992-12#1)(1994-12#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-6#2)(1996-8#1)(1997-5#1)(2005-12#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-8#4)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-7#2)(2009-7#1)(2013-1#2)
performed in our department##2##4##(2008-9#1)(2013-7#1)
performed in our institution##2##4##(1991-8#1)(2007-11#1)
performed in our##9##3##(1991-8#1)(2006-9#1)(2007-11#1)(2007-7#2)(2008-11#1)(2008-9#1)(2011-1#1)(2013-7#1)
performed in outpatient##2##3##(1996-1#1)(2006-7#1)
performed in parallel by##2##4##(2008-3#1)(2008-5#1)
performed in parallel##4##3##(1992-6#1)(2008-3#1)(2008-5#2)
performed in patients who##3##4##(1990-12#1)(2006-7#1)(2009-12#1)
performed in patients with##15##4##(1991-4#1)(1996-9#1)(2006-10#1)(2006-2#1)(2007-7#2)(2007-8#3)(2011-2#3)(2012-2#1)(2013-8#2)
performed in patients##22##3##(1990-12#1)(1991-4#1)(1996-3#1)(1996-9#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-5#1)(2009-12#1)(2011-2#3)(2012-2#1)(2013-8#2)
performed in rabbits##2##3##(2008-5#1)(2010-12#1)
performed in selected patients##2##4##(2008-8#1)(2010-12#1)
performed in situ##3##3##(1990-11#1)(1996-12#1)(2008-3#1)
performed in small##5##3##(1992-1#1)(2007-12#1)(2008-9#1)(2010-2#2)
performed in succession##2##3##(1997-2#1)(2008-2#1)
performed in the Orthopedic##2##4##(2007-7#1)(2007-8#1)
performed in the absence of##2##5##(1992-6#1)(2008-4#1)
performed in the acute##2##4##(1990-12#1)(1997-3#1)
performed in the case of##2##5##(1995-9#1)(2008-10#1)
performed in the energy##2##4##(2008-2#2)
performed in the first##2##4##(2007-11#2)
performed in the hospital##3##4##(1995-2#2)(2008-3#1)
performed in the laboratory##2##4##(2006-10#1)(2008-3#1)
performed in the linear##2##4##(2008-10#1)(2008-5#1)
performed in the office##2##4##(2009-8#1)(2010-5#1)
performed in the operating##3##4##(1995-4#1)(2007-8#1)(2011-2#1)
performed in the past##2##4##(2007-11#1)(2013-1#1)
performed in the period##2##4##(2007-11#2)
performed in the presence of##6##5##(1991-4#1)(1994-12#1)(1996-12#1)(1997-5#1)(2007-8#1)(2008-10#1)
performed in the range of##3##5##(2008-10#2)(2008-6#1)
performed in the year##2##4##(2007-8#1)(2011-2#1)
performed in the years 1986-2001##2##5##(2007-11#1)(2007-8#1)
performed in the years##3##4##(2006-10#1)(2007-11#1)(2007-8#1)
performed in the##121##3##(1990-12#1)(1991-12#1)(1991-4#1)(1992-3#2)(1992-6#1)(1992-7#1)(1993-5#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-4#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-8#3)(2005-8#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#2)(2007-1#1)(2007-11#9)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#10)(2008-1#4)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#4)(2008-4#4)(2008-5#4)(2008-6#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#6)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#2)
performed in these##3##3##(1991-3#1)(2007-8#1)(2013-1#1)
performed in this##3##3##(2008-10#2)(2008-3#1)
performed in three##5##3##(2006-11#1)(2006-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
performed in two patients##3##4##(2006-11#1)(2006-6#1)(2007-7#1)
performed in two stages##3##4##(1992-10#1)(2008-11#1)(2009-3#1)
performed in two##16##3##(1991-4#1)(1992-10#1)(1993-3#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-3#1)(2009-4#1)(2010-3#1)(2012-3#1)
performed in vitro##4##3##(1994-3#1)(2008-6#1)(2008-8#1)(2011-3#1)
performed in vivo##5##3##(1990-2#1)(1990-4#1)(2006-12#1)(2008-2#1)(2008-8#1)
performed in water##2##3##(1995-8#1)(2008-10#1)
performed in which the##3##4##(1995-8#1)(2005-11#1)(2008-4#1)
performed in which##8##3##(1990-2#1)(1995-8#1)(1997-6#1)(2004-9#1)(2005-11#1)(2007-5#1)(2008-4#1)(2010-3#1)
performed in##784##2##(1990-10#1)(1990-11#3)(1990-12#6)(1990-2#6)(1990-3#3)(1990-4#2)(1990-6#7)(1990-8#7)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#4)(1991-4#6)(1991-5#3)(1991-6#2)(1991-8#2)(1991-9#2)(1992-1#2)(1992-10#4)(1992-12#3)(1992-2#2)(1992-3#2)(1992-4#4)(1992-5#2)(1992-6#4)(1992-7#2)(1992-8#2)(1992-9#2)(1993-1#1)(1993-10#2)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#3)(1993-5#3)(1993-6#2)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#3)(1994-5#2)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#4)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#2)(1996-1#4)(1996-11#2)(1996-12#8)(1996-2#2)(1996-3#4)(1996-5#2)(1996-6#4)(1996-7#2)(1996-8#6)(1996-9#2)(1997-2#3)(1997-3#2)(1997-5#3)(1997-6#5)(1997-7#2)(1997-8#10)(2004-11#1)(2004-4#1)(2004-9#1)(2005-10#2)(2005-11#4)(2005-12#2)(2005-8#1)(2006-1#3)(2006-10#20)(2006-11#9)(2006-12#9)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#9)(2006-7#4)(2006-8#10)(2006-9#3)(2007-1#5)(2007-10#6)(2007-11#26)(2007-12#10)(2007-2#7)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#20)(2007-8#48)(2007-9#4)(2008-1#12)(2008-10#65)(2008-11#14)(2008-12#3)(2008-2#18)(2008-3#20)(2008-4#17)(2008-5#31)(2008-6#7)(2008-7#13)(2008-8#7)(2008-9#7)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#4)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#5)(2010-2#3)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#5)(2011-2#30)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#10)(2012-2#5)(2012-3#7)(2013-1#24)(2013-7#6)(2013-8#13)
performed include##2##2##(1997-8#1)(2008-2#1)
performed included##2##2##(2006-8#1)(2007-7#1)
performed independently##2##2##(1991-5#1)(1995-4#1)
performed into the##2##3##(2007-4#1)(2008-10#1)
performed intraoperatively##2##2##(2006-3#1)(2008-3#1)
performed is##2##2##(2008-10#1)(2013-7#1)
performed it##3##2##(2006-10#1)(2007-12#1)(2007-8#1)
performed just before the##2##4##(2007-8#2)
performed just##3##2##(1990-4#1)(2007-8#2)
performed laparoscopically##4##2##(2008-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
performed later##2##2##(1994-6#1)(2006-4#1)
performed less well##2##3##(2007-9#1)(2011-1#1)
performed less##4##2##(1997-3#1)(2006-8#1)(2007-9#1)(2011-1#1)
performed manual##6##2##(2008-8#1)(2011-1#1)(2013-1#4)
performed monthly##3##2##(2008-12#1)(2009-5#1)(2013-1#1)
performed more frequently##2##3##(2007-5#1)(2009-10#1)
performed more poorly##2##3##(1995-11#1)(2009-1#1)
performed more than 5##2##4##(1991-6#1)(2006-10#1)
performed more##9##2##(1991-6#1)(1995-10#1)(1995-11#1)(2006-10#1)(2007-5#1)(2009-1#1)(2009-10#1)(2009-9#1)(2010-8#1)
performed most##2##2##(1992-8#1)(2006-8#1)
performed normally in##3##3##(1992-12#1)(1993-5#1)(2008-11#1)
performed normally on##2##3##(2008-4#2)
performed normally##5##2##(1992-12#1)(1993-5#1)(2008-11#1)(2008-4#2)
performed of the##4##3##(2007-8#1)(2008-10#1)(2008-2#1)(2012-2#1)
performed of##17##2##(1997-7#1)(2004-10#2)(2006-10#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#2)(2011-2#1)(2012-2#1)
performed on 10##4##3##(1992-10#1)(2006-5#1)(2008-3#1)(2010-12#1)
performed on 15##2##3##(2007-8#1)(2009-4#1)
performed on 18 patients##2##4##(2007-10#1)(2007-3#1)
performed on 27##2##3##(1996-3#1)(2008-4#1)
performed on 40##2##3##(2004-1#1)(2008-10#1)
performed on 50##3##3##(1994-4#1)(2006-8#1)(2013-8#1)
performed on a C18##3##4##(1992-2#1)(2010-12#1)(2011-3#1)
performed on a sample of##3##5##(1997-5#1)(2008-10#1)(2010-3#1)
performed on a series of##2##5##(1990-4#1)(2008-3#1)
performed on a synthetic##2##4##(1992-9#1)(2009-9#1)
performed on a##59##3##(1990-12#1)(1990-4#1)(1992-2#2)(1992-7#1)(1992-9#1)(1996-3#1)(1997-3#2)(1997-5#2)(2005-10#1)(2005-11#1)(2005-3#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#1)(2011-3#2)(2012-1#2)(2012-12#2)(2013-1#1)
performed on admission##3##3##(2007-10#2)(2008-3#1)
performed on adult male##2##4##(2008-5#1)(2008-8#1)
performed on all patients##5##4##(2007-11#1)(2007-7#3)(2008-6#1)
performed on all##14##3##(1992-12#1)(2007-11#1)(2007-7#3)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
performed on an out-patient basis##2##5##(2007-8#2)
performed on an outpatient basis in##2##6##(1993-7#1)(2006-8#1)
performed on an outpatient basis##10##5##(1990-8#1)(1993-6#1)(1993-7#1)(2006-10#1)(2006-8#4)(2007-3#1)(2012-2#1)
performed on an##21##3##(1990-8#1)(1993-6#1)(1993-7#1)(2006-10#1)(2006-5#1)(2006-8#4)(2007-12#1)(2007-3#1)(2007-8#3)(2008-10#3)(2008-12#1)(2011-1#2)(2012-2#1)
performed on blood with##2##4##(1997-4#2)
performed on blood##3##3##(1994-6#1)(1997-4#2)
performed on both##4##3##(2008-10#2)(2008-11#1)(2012-2#1)
performed on children##2##3##(2009-9#1)(2011-2#1)
performed on crude##2##3##(1994-9#1)(1995-2#1)
performed on cultured##2##3##(1994-9#1)(2008-2#1)
performed on day##7##3##(1993-12#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-11#1)(2013-8#2)
performed on different zones of##2##5##(2008-5#2)
performed on different##5##3##(1990-12#1)(1996-5#1)(2008-5#2)(2010-3#1)
performed on each##4##3##(1996-11#1)(2007-4#1)(2009-4#1)(2012-2#1)
performed on five##2##3##(2005-9#1)(2013-8#1)
performed on fresh##2##3##(2008-5#1)(2008-9#1)
performed on human##3##3##(1995-7#1)(2007-1#1)(2007-7#1)
performed on large##2##3##(1992-6#1)(2007-12#1)
performed on life insurance applicants##3##5##(1995-1#3)
performed on male##2##3##(1995-1#1)(2006-9#1)
performed on paraffin##2##3##(2008-4#1)(2011-2#1)
performed on patients with##2##4##(2007-7#1)(2013-8#1)
performed on patients##5##3##(2007-11#1)(2007-7#1)(2007-8#1)(2012-2#1)(2013-8#1)
performed on sections of##2##4##(1990-7#1)(1997-7#1)
performed on six##2##3##(2008-3#1)(2009-12#1)
performed on skin##3##3##(2010-5#1)(2012-1#1)(2013-7#1)
performed on the basis of##3##5##(1990-12#1)(2008-11#1)(2008-7#1)
performed on the basis##4##4##(1990-12#1)(1994-9#1)(2008-11#1)(2008-7#1)
performed on the combined##2##4##(2008-10#1)(2012-3#1)
performed on the model##3##4##(2008-2#1)(2008-7#1)(2011-2#1)
performed on the same##7##4##(1990-2#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)
performed on the##88##3##(1990-12#1)(1990-2#1)(1990-4#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-9#1)(1995-6#1)(1996-1#1)(1997-1#1)(1997-2#2)(1997-4#1)(2004-2#1)(2005-10#1)(2005-11#2)(2006-10#1)(2006-11#2)(2006-12#2)(2006-4#2)(2006-8#1)(2007-5#2)(2007-8#3)(2008-10#14)(2008-11#1)(2008-2#5)(2008-3#3)(2008-4#2)(2008-5#8)(2008-7#4)(2009-5#2)(2009-8#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
performed on these patients##2##4##(2007-8#1)(2008-8#1)
performed on these##7##3##(1990-4#1)(1995-6#1)(1995-7#1)(2007-8#1)(2008-5#2)(2008-8#1)
performed on this##3##3##(1990-3#1)(2008-10#2)
performed on touch imprint smears##2##5##(2007-2#2)
performed on two##7##3##(1994-3#1)(1996-2#1)(2007-12#1)(2008-5#1)(2010-8#1)(2011-2#1)(2013-1#1)
performed on various##2##3##(1992-7#1)(2008-5#1)
performed on younger##2##3##(1990-5#1)(2013-1#1)
performed on##493##2##(1990-12#4)(1990-2#1)(1990-3#3)(1990-4#3)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-6#2)(1991-9#1)(1992-10#1)(1992-12#3)(1992-2#4)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#2)(1993-3#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-4#1)(1994-6#4)(1994-8#2)(1994-9#3)(1995-1#4)(1995-11#1)(1995-2#2)(1995-6#3)(1995-7#2)(1996-1#3)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#4)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#3)(1997-4#3)(1997-5#3)(1997-6#1)(1997-7#1)(2004-1#1)(2004-2#1)(2005-10#4)(2005-11#4)(2005-3#1)(2005-5#1)(2005-9#1)(2006-10#6)(2006-11#3)(2006-12#4)(2006-4#3)(2006-5#5)(2006-6#3)(2006-7#1)(2006-8#9)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#7)(2007-12#11)(2007-2#8)(2007-3#3)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#13)(2007-8#25)(2007-9#4)(2008-1#3)(2008-10#45)(2008-11#5)(2008-12#6)(2008-2#12)(2008-3#20)(2008-4#9)(2008-5#22)(2008-6#2)(2008-7#8)(2008-8#5)(2008-9#6)(2009-10#1)(2009-11#3)(2009-12#2)(2009-4#3)(2009-5#2)(2009-6#2)(2009-8#1)(2009-9#4)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#12)(2011-12#1)(2011-2#12)(2011-3#2)(2012-1#4)(2012-11#1)(2012-12#3)(2012-2#8)(2012-3#2)(2013-1#13)(2013-7#1)(2013-8#10)
performed once##5##2##(1990-11#1)(2006-5#1)(2007-9#1)(2008-10#1)(2011-2#1)
performed one week##2##3##(2007-3#1)(2007-7#1)
performed one##3##2##(2007-3#1)(2007-7#1)(2011-2#1)
performed only by##3##3##(1994-3#1)(2006-3#1)(2006-6#1)
performed only in##6##3##(2005-11#1)(2006-10#1)(2007-11#1)(2012-12#2)(2012-2#1)
performed only on##2##3##(1991-11#1)(1994-2#1)
performed only##18##2##(1991-11#1)(1991-6#1)(1994-2#1)(1994-3#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-12#1)(2012-12#2)(2012-2#1)
performed optically##2##2##(2008-2#1)(2008-3#1)
performed or##4##2##(1991-11#1)(1991-12#1)(2007-11#1)(2007-12#1)
performed outside##2##2##(2006-10#1)(2013-1#1)
performed over a wide range of##2##6##(1991-12#1)(2008-10#1)
performed over a wide##3##4##(1991-12#1)(1993-8#1)(2008-10#1)
performed over a##10##3##(1990-11#1)(1991-12#1)(1993-8#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-4#1)(2012-2#1)(2013-1#1)
performed over the last##2##4##(2006-7#1)(2008-7#1)
performed over the past##3##4##(2005-8#1)(2006-1#1)(2009-4#1)
performed over the##7##3##(2005-8#1)(2006-1#1)(2006-7#1)(2008-2#1)(2008-7#1)(2009-4#1)(2011-2#1)
performed over##25##2##(1990-11#1)(1991-12#1)(1993-8#1)(2005-8#1)(2006-1#1)(2006-7#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
performed partial##2##2##(2007-8#1)(2011-2#1)
performed per##2##2##(1997-8#1)(2010-12#1)
performed percutaneous##2##2##(2008-8#1)(2008-9#1)
performed periodically##2##2##(2007-11#1)(2012-2#1)
performed poorly with##2##3##(2007-8#1)(2012-3#1)
performed poorly##4##2##(2007-8#1)(2008-10#1)(2009-7#1)(2012-3#1)
performed previously##2##2##(1991-2#1)(2011-2#1)
performed prior to injection of##2##5##(2006-8#1)(2007-11#1)
performed prior to##11##3##(1993-5#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-6#1)(2010-1#1)(2012-12#1)
performed procedure##4##2##(2006-8#1)(2007-12#1)(2007-8#1)(2008-7#1)
performed procedures in##2##3##(2011-1#1)(2011-2#1)
performed procedures##6##2##(1990-3#1)(2011-1#1)(2011-2#2)(2013-1#2)
performed proteomic analysis##2##3##(2007-5#1)(2010-12#1)
performed quantitative analysis of##2##4##(1994-6#1)(2012-1#1)
performed quantitative reverse##2##3##(2011-2#1)(2013-8#1)
performed quantitative##4##2##(1994-6#1)(2011-2#1)(2012-1#1)(2013-8#1)
performed regarding the##2##3##(2009-10#1)(2010-1#1)
performed regarding##3##2##(1997-8#1)(2009-10#1)(2010-1#1)
performed regularly##3##2##(1997-5#1)(2007-11#1)(2010-10#1)
performed routinely##6##2##(1990-8#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2011-12#1)
performed safely and effectively without##2##5##(2006-10#1)(2008-7#1)
performed safely and effectively##3##4##(2006-10#1)(2008-3#1)(2008-7#1)
performed safely and##4##3##(1991-3#1)(2006-10#1)(2008-3#1)(2008-7#1)
performed safely##6##2##(1991-3#2)(2006-10#1)(2008-3#1)(2008-7#1)(2010-8#1)
performed selectively##2##2##(2011-12#1)(2012-2#1)
performed separately##3##2##(2005-10#1)(2009-7#1)(2011-12#1)
performed showed##2##2##(2008-7#1)(2009-2#1)
performed significantly better than the##2##5##(2008-2#1)(2009-9#1)
performed significantly better than##3##4##(2007-3#1)(2008-2#1)(2009-9#1)
performed significantly more##2##3##(2009-9#1)(2011-2#1)
performed significantly worse than##4##4##(1996-7#1)(1997-8#1)(2005-10#1)(2013-1#1)
performed significantly worse##5##3##(1996-7#1)(1997-8#1)(2005-10#1)(2012-1#1)(2013-1#1)
performed significantly##12##2##(1996-7#1)(1997-8#1)(2005-10#1)(2006-7#1)(2007-3#1)(2008-12#1)(2008-2#1)(2009-9#2)(2011-2#1)(2012-1#1)(2013-1#1)
performed similarly to##4##3##(2007-8#1)(2008-6#1)(2009-3#1)(2012-3#1)
performed similarly##7##2##(1997-3#1)(2007-8#1)(2008-4#1)(2008-6#1)(2009-3#1)(2010-5#1)(2012-3#1)
performed simulations##2##2##(2008-8#1)(2011-3#1)
performed simultaneously at##2##3##(2008-10#1)(2008-7#1)
performed simultaneously with##4##3##(1992-6#1)(1995-2#1)(2007-9#1)(2008-3#1)
performed simultaneously##9##2##(1992-6#1)(1995-2#1)(2006-6#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)(2013-7#1)
performed six##4##2##(2006-3#1)(2008-10#1)(2012-8#1)(2013-1#1)
performed slightly better than##2##4##(1994-9#1)(1996-9#1)
performed so##2##2##(1994-4#1)(2006-10#1)
performed spinal##2##2##(2006-7#1)(2009-3#1)
performed studies##2##2##(2008-4#1)(2013-8#1)
performed successfully for##2##3##(2007-8#1)(2008-8#1)
performed successfully##9##2##(1996-12#1)(2006-6#3)(2007-2#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-8#1)
performed such that the##2##4##(2008-3#1)(2012-2#1)
performed surgery##4##2##(2006-9#1)(2007-10#1)(2012-12#1)(2013-8#1)
performed surgical##4##2##(2006-6#1)(2007-12#1)(2007-8#1)(2013-1#1)
performed that##5##2##(1995-12#1)(2007-12#1)(2007-8#1)(2008-2#2)
performed the best##5##3##(2010-5#1)(2012-3#2)(2013-1#2)
performed the same##3##3##(1994-9#1)(2008-11#1)(2008-5#1)
performed the test##2##3##(1996-6#1)(2006-7#1)
performed the##43##2##(1994-2#1)(1994-9#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-8#2)(2006-6#1)(2006-7#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#1)
performed this##4##2##(1990-8#1)(2008-1#1)(2009-10#1)(2011-2#1)
performed three##4##2##(1991-6#1)(2006-11#1)(2013-1#1)(2013-8#1)
performed through a##4##3##(2007-8#1)(2008-8#1)(2009-3#1)(2010-2#1)
performed through an##4##3##(2009-3#1)(2012-12#2)(2013-7#1)
performed through the##5##3##(1995-4#1)(1997-8#1)(2008-3#1)(2008-9#1)(2013-1#1)
performed through two##2##3##(2007-12#1)(2011-3#1)
performed through##27##2##(1991-2#1)(1991-6#1)(1995-4#1)(1997-8#1)(2006-6#1)(2007-12#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-3#2)(2010-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#2)
performed to achieve##4##3##(2006-8#1)(2008-3#1)(2010-12#1)(2013-8#1)
performed to analyze##2##3##(2011-2#2)
performed to ascertain##3##3##(1995-3#1)(2006-10#1)(2010-12#1)
performed to assess the##13##4##(1995-11#1)(1997-2#1)(2006-12#2)(2007-10#1)(2007-6#1)(2008-5#1)(2010-2#1)(2010-3#1)(2012-1#1)(2012-2#1)(2013-1#2)
performed to assess##23##3##(1995-11#1)(1997-2#1)(1997-8#1)(2006-12#2)(2006-7#1)(2007-10#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2010-10#1)(2010-2#1)(2010-3#1)(2012-1#1)(2012-2#1)(2013-1#4)(2013-8#1)
performed to better understand the##2##5##(2008-10#1)(2011-2#1)
performed to better understand##3##4##(2008-10#1)(2010-12#1)(2011-2#1)
performed to better##4##3##(2008-10#2)(2010-12#1)(2011-2#1)
performed to characterize the##6##4##(1990-7#1)(1991-10#1)(1994-2#1)(1996-11#1)(2007-11#1)(2008-10#1)
performed to characterize##10##3##(1990-3#1)(1990-7#1)(1991-10#1)(1992-3#1)(1993-2#1)(1994-2#1)(1996-11#1)(2007-11#1)(2008-10#1)(2013-7#1)
performed to compare the##5##4##(1991-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2013-1#1)
performed to compare##10##3##(1990-12#1)(1991-8#1)(1994-9#1)(2006-11#1)(2008-10#2)(2008-2#1)(2008-7#2)(2013-1#1)
performed to confirm the##5##4##(2006-12#1)(2007-10#1)(2007-6#1)(2008-10#1)(2008-12#1)
performed to confirm##9##3##(1991-11#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-6#1)(2008-10#1)(2008-12#1)(2009-12#1)(2013-8#1)
performed to demonstrate the##2##4##(2008-3#2)
performed to demonstrate##3##3##(2008-3#2)(2011-1#1)
performed to detect the##4##4##(2008-2#1)(2008-8#1)(2012-12#1)(2013-8#1)
performed to detect##8##3##(1996-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-8#2)
performed to determine if these##2##5##(1997-3#1)(2008-10#1)
performed to determine if##8##4##(1990-12#1)(1991-9#1)(1997-3#1)(2006-12#1)(2008-10#3)(2012-12#1)
performed to determine the amount of##2##6##(2008-4#1)(2012-1#1)
performed to determine the potential##2##5##(2007-4#1)(2008-7#1)
performed to determine the##24##4##(1990-9#1)(1993-11#1)(1994-9#1)(1995-2#1)(1996-2#1)(1997-6#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#2)(2009-4#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-8#1)
performed to determine whether##9##4##(1990-11#1)(1994-8#1)(1997-1#1)(2004-12#1)(2006-5#1)(2007-10#1)(2008-7#1)(2011-2#1)(2012-12#1)
performed to determine##52##3##(1990-11#1)(1990-12#1)(1990-9#1)(1991-9#1)(1993-11#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-6#2)(2004-11#1)(2004-12#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-4#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2009-4#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2013-8#2)
performed to elucidate the##5##4##(1990-5#1)(1997-1#1)(2005-11#1)(2008-10#1)(2008-4#1)
performed to elucidate##7##3##(1990-5#1)(1996-10#1)(1997-1#1)(2005-11#1)(2008-10#2)(2008-4#1)
performed to ensure##3##3##(2006-7#1)(2010-9#2)
performed to establish the##2##4##(2007-8#1)(2009-8#1)
performed to establish##4##3##(2007-2#1)(2007-5#1)(2007-8#1)(2009-8#1)
performed to estimate the##8##4##(1990-12#1)(2008-10#1)(2008-2#1)(2010-11#1)(2011-2#1)(2013-1#2)(2013-8#1)
performed to estimate##11##3##(1990-12#1)(2007-10#1)(2008-10#2)(2008-2#1)(2010-11#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
performed to evaluate the effect of##2##6##(2008-2#1)(2011-2#1)
performed to evaluate the effect##3##5##(2007-8#1)(2008-2#1)(2011-2#1)
performed to evaluate the performance of a##2##7##(2008-3#1)(2011-2#1)
performed to evaluate the performance of##3##6##(2008-2#1)(2008-3#1)(2011-2#1)
performed to evaluate the##23##4##(1992-12#1)(1992-6#1)(1994-9#2)(1995-3#1)(1996-7#1)(2005-9#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#2)(2011-2#3)(2012-1#1)(2013-1#1)
performed to evaluate##31##3##(1992-12#1)(1992-3#1)(1992-6#1)(1994-9#2)(1995-3#1)(1996-7#1)(2005-9#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#2)(2011-12#1)(2011-2#5)(2012-1#1)(2013-1#1)(2013-8#2)
performed to examine the effects of##2##6##(1993-9#1)(1997-5#1)
performed to examine the##10##4##(1993-9#1)(1994-2#1)(1995-12#1)(1997-5#1)(2005-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-7#1)
performed to examine##16##3##(1993-9#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-4#1)(1997-5#2)(2005-10#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-7#1)
performed to exclude##2##3##(1991-3#1)(2007-11#1)
performed to explore the##2##4##(1992-4#1)(1992-5#1)
performed to find the##2##4##(2007-2#1)(2008-12#1)
performed to generate##2##3##(2006-11#1)(2008-10#1)
performed to identify the##3##4##(2007-4#1)(2008-4#1)(2011-2#1)
performed to identify##12##3##(1991-12#1)(2007-4#1)(2008-12#1)(2008-4#1)(2009-4#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
performed to illustrate the##2##4##(2008-3#1)(2013-8#1)
performed to indirectly##2##3##(2008-10#1)(2013-7#1)
performed to investigate the##14##4##(1992-8#1)(1994-10#1)(1995-5#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-6#1)(2005-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)
performed to investigate##20##3##(1992-8#1)(1994-10#1)(1995-10#1)(1995-5#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-6#1)(2005-11#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)
performed to measure##2##3##(2007-8#1)(2010-12#1)
performed to obtain information on##2##5##(1991-1#1)(2008-4#1)
performed to obtain##8##3##(1991-1#1)(1994-11#1)(1996-2#1)(2006-8#1)(2007-8#1)(2008-4#1)(2011-1#1)(2012-3#1)
performed to optimize##5##3##(2008-10#2)(2008-5#3)
performed to reduce the##2##4##(1996-3#1)(2011-1#1)
performed to reduce##3##3##(1996-3#1)(2008-3#1)(2011-1#1)
performed to remove##3##3##(2006-5#1)(2007-8#2)
performed to repair##2##3##(2008-12#1)(2009-10#1)
performed to retrieve##3##3##(1990-12#1)(2008-3#1)(2013-1#1)
performed to rule out##3##4##(2007-8#1)(2011-2#1)(2012-12#1)
performed to show the##2##4##(2007-12#1)(2008-10#1)
performed to study the##5##4##(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
performed to test the##4##4##(1997-2#1)(2004-11#1)(2007-7#1)(2008-3#1)
performed to test##5##3##(1997-2#1)(2004-11#1)(2007-7#1)(2008-3#2)
performed to treat##4##3##(2005-12#1)(2006-8#1)(2009-3#1)(2012-12#1)
performed to validate the##3##4##(2008-10#1)(2008-3#2)
performed to validate##4##3##(2008-10#2)(2008-3#2)
performed to verify the feasibility of the##2##7##(2007-8#1)(2013-1#1)
performed to verify the##5##4##(2007-8#1)(2008-1#1)(2008-2#1)(2012-12#1)(2013-1#1)
performed to verify##6##3##(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2012-12#1)(2013-1#1)
performed to yield##3##3##(1991-7#1)(1996-12#1)(2008-3#1)
performed to##380##2##(1990-11#1)(1990-12#4)(1990-3#1)(1990-5#2)(1990-7#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-7#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-8#1)(1994-9#4)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#2)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#2)(1996-4#1)(1996-7#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#1)(2004-11#2)(2004-12#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-9#2)(2006-10#6)(2006-11#3)(2006-12#5)(2006-5#3)(2006-6#1)(2006-7#3)(2006-8#4)(2007-1#1)(2007-10#6)(2007-11#4)(2007-12#5)(2007-2#2)(2007-4#3)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#13)(2007-9#1)(2008-1#3)(2008-10#35)(2008-11#6)(2008-12#7)(2008-2#10)(2008-3#22)(2008-4#6)(2008-5#12)(2008-7#9)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-7#2)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#6)(2010-2#2)(2010-3#1)(2010-8#1)(2010-9#3)(2011-1#6)(2011-12#1)(2011-2#19)(2011-3#1)(2012-1#4)(2012-12#8)(2012-2#5)(2012-3#3)(2013-1#16)(2013-7#3)(2013-8#14)
performed together with##2##3##(1995-12#1)(2011-2#1)
performed twice##8##2##(2006-8#2)(2007-8#1)(2008-12#2)(2008-5#1)(2008-7#1)(2012-12#1)
performed two sequences##2##3##(2006-3#1)(2006-6#1)
performed two##11##2##(1995-6#1)(2006-3#2)(2006-6#1)(2008-11#3)(2008-5#1)(2012-1#1)(2013-1#2)
performed under a##2##3##(1994-11#1)(1996-5#1)
performed under both##2##3##(1995-10#1)(2007-4#1)
performed under general anaesthesia##3##4##(1997-6#1)(2006-10#1)(2007-8#1)
performed under general anesthesia##3##4##(1994-12#1)(1996-12#1)(2008-5#1)
performed under general##6##3##(1994-12#1)(1996-12#1)(1997-6#1)(2006-10#1)(2007-8#1)(2008-5#1)
performed under locoregional anesthesia##2##4##(2011-3#2)
performed under regional anaesthesia##3##4##(1992-11#1)(2006-10#1)(2010-7#1)
performed under the##2##3##(1991-8#1)(2012-2#1)
performed under##67##2##(1990-4#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-7#1)(1994-11#1)(1994-12#1)(1995-10#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-5#2)(1996-6#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-7#1)(2005-11#2)(2006-10#3)(2006-12#1)(2006-8#2)(2007-4#2)(2007-8#4)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#6)(2008-7#2)(2010-12#2)(2010-7#1)(2011-1#2)(2011-2#1)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
performed up to##2##3##(2006-11#1)(2011-7#1)
performed using a modified##3##4##(2007-8#1)(2008-10#1)(2013-1#1)
performed using a standard##2##4##(2004-9#2)
performed using a##56##3##(1990-3#1)(1991-8#1)(1992-9#1)(1995-7#1)(1996-2#1)(2004-9#3)(2005-12#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-5#1)(2007-8#4)(2008-1#1)(2008-10#8)(2008-2#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2009-10#2)(2009-3#1)(2010-12#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)
performed using an##5##3##(2005-8#1)(2007-10#1)(2007-3#1)(2007-7#1)(2008-9#1)
performed using data##2##3##(1993-12#1)(2008-10#1)
performed using gas chromatography##2##4##(2005-8#1)(2007-8#1)
performed using nuclear##2##3##(1995-10#1)(2010-10#1)
performed using sequential##2##3##(1992-9#1)(2008-10#1)
performed using standard##2##3##(2008-10#1)(2012-12#1)
performed using the same##2##4##(1990-12#1)(2008-7#1)
performed using the##43##3##(1990-12#1)(1992-3#3)(1994-3#1)(1996-8#1)(1997-8#1)(2006-11#1)(2006-3#1)(2006-8#1)(2007-1#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#4)(2009-2#1)(2009-3#2)(2009-6#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
performed using three##2##3##(1993-11#1)(2007-8#1)
performed using titanium##2##3##(2006-8#2)
performed using ventriculographic guidance##2##4##(2006-5#2)
performed using##264##2##(1990-12#1)(1990-3#2)(1991-3#1)(1991-5#1)(1991-8#1)(1992-3#3)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-7#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#2)(1997-4#1)(1997-5#2)(1997-8#3)(2004-11#1)(2004-9#5)(2005-10#1)(2005-12#2)(2005-8#2)(2006-10#1)(2006-11#4)(2006-2#2)(2006-3#3)(2006-5#3)(2006-6#2)(2006-8#6)(2007-1#3)(2007-10#2)(2007-11#5)(2007-12#4)(2007-2#4)(2007-3#3)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#13)(2007-9#1)(2008-1#4)(2008-10#45)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#3)(2008-5#8)(2008-6#3)(2008-7#12)(2008-8#2)(2008-9#3)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-6#2)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#2)(2010-4#3)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#10)(2013-7#1)(2013-8#2)
performed utilizing##3##2##(2006-8#1)(2007-8#1)(2013-1#1)
performed via a##5##3##(2006-8#1)(2008-10#1)(2011-2#2)(2012-12#1)
performed via the laparoscope##2##4##(1991-9#1)(1996-3#1)
performed via the##5##3##(1991-9#1)(1996-3#1)(2007-1#1)(2012-12#2)
performed via##15##2##(1991-9#1)(1996-3#1)(2006-8#1)(2007-1#1)(2007-8#2)(2008-10#1)(2011-2#3)(2012-11#1)(2012-12#3)(2013-1#1)
performed was##3##2##(1991-10#1)(2008-12#1)(2011-1#1)
performed well for##3##3##(2008-10#2)(2012-3#1)
performed well in##6##3##(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-7#1)(2011-2#1)
performed well##14##2##(1993-12#1)(1995-3#1)(2006-10#1)(2006-12#1)(2008-10#4)(2008-3#1)(2008-5#1)(2009-7#1)(2011-2#1)(2012-3#2)
performed were##8##2##(1995-11#1)(1995-9#1)(2005-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2013-1#1)(2013-8#1)
performed when##8##2##(1990-9#1)(1992-9#1)(1996-3#1)(2006-8#1)(2008-12#1)(2008-5#1)(2010-12#1)(2010-5#1)
performed where##2##2##(2007-8#1)(2008-7#1)
performed which revealed a##2##4##(2006-4#2)
performed which##9##2##(1992-4#1)(1993-2#1)(1995-12#1)(2005-11#1)(2006-4#2)(2007-7#1)(2008-10#1)(2008-3#1)
performed while the patient##2##4##(2006-12#1)(2007-1#1)
performed while##3##2##(2006-12#1)(2007-1#1)(2008-8#1)
performed with 1 ml of##2##5##(1990-9#1)(1992-3#1)
performed with a probability##2##4##(1990-3#1)(2012-7#1)
performed with a##68##3##(1990-10#1)(1990-12#2)(1990-3#2)(1991-2#2)(1991-3#1)(1991-9#1)(1994-11#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-9#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-4#1)(2006-6#3)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-2#7)(2008-3#10)(2008-4#2)(2008-5#1)(2008-7#1)(2009-2#1)(2009-3#2)(2010-5#1)(2011-1#1)(2011-2#4)(2012-7#1)
performed with acceptable##2##3##(2006-8#1)(2009-10#1)
performed with an excellent##2##4##(2007-8#1)(2012-12#1)
performed with an##16##3##(1990-9#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-12#1)(2008-2#3)(2010-9#1)(2012-12#1)
performed with conventional##2##3##(1994-3#1)(2008-7#1)
performed with different##2##3##(1992-11#1)(2011-2#1)
performed with either##3##3##(2006-3#1)(2006-8#1)(2008-4#1)
performed with no##2##3##(1991-11#1)(2008-2#1)
performed with picosecond##2##3##(2007-12#2)
performed with respect to##2##4##(2006-12#1)(2007-8#1)
performed with several##4##3##(2007-12#1)(2008-10#3)
performed with statins prior to the JUPITER##2##7##(2010-4#2)
performed with the aid of a##2##6##(2006-5#1)(2008-11#1)
performed with the aid of##3##5##(2006-5#1)(2008-10#1)(2008-11#1)
performed with the da Vinci##2##5##(2006-6#1)(2007-5#1)
performed with the same##2##4##(2009-3#1)(2013-1#1)
performed with the use of##5##5##(2006-10#1)(2007-7#1)(2007-8#1)(2008-5#1)(2013-7#1)
performed with the##57##3##(1990-12#1)(1990-5#1)(1991-3#1)(1993-8#1)(1994-12#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-7#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#10)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
performed with these##4##3##(1994-3#1)(1996-2#1)(2008-10#1)(2012-12#1)
performed with this##2##3##(2008-2#1)(2008-3#1)
performed with various##2##3##(2008-1#1)(2008-6#1)
performed with varying##2##3##(1996-7#1)(2008-10#1)
performed with##329##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#4)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-11#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-5#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-3#3)(1994-5#2)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#2)(1995-2#1)(1995-3#5)(1995-7#1)(1995-9#1)(1996-1#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#2)(2004-1#1)(2004-11#1)(2005-10#1)(2005-11#2)(2006-10#5)(2006-11#2)(2006-12#4)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#8)(2006-8#3)(2007-10#1)(2007-11#8)(2007-12#11)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#12)(2007-9#1)(2008-1#5)(2008-10#43)(2008-11#5)(2008-12#1)(2008-2#23)(2008-3#15)(2008-4#3)(2008-5#7)(2008-6#6)(2008-7#8)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#2)(2009-3#4)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-9#2)(2011-1#1)(2011-12#2)(2011-2#11)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#3)(2012-7#1)(2013-1#3)(2013-7#2)(2013-8#4)
performed within one##2##3##(2005-10#1)(2013-1#1)
performed within the range of##2##5##(1997-8#1)(2008-4#1)
performed within the##7##3##(1993-11#1)(1997-8#2)(2007-12#1)(2008-4#1)(2010-11#1)(2011-2#1)
performed within##25##2##(1990-12#2)(1990-8#1)(1992-12#1)(1993-11#1)(1995-5#1)(1997-8#2)(2005-10#1)(2006-11#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-11#1)(2010-11#1)(2011-2#2)(2012-1#1)(2013-1#1)
performed without any##2##3##(1991-3#1)(1992-2#1)
performed without knowledge of the underlying simulating model##2##8##(2012-3#2)
performed without knowledge of the##3##5##(2012-3#3)
performed without##27##2##(1991-3#1)(1992-2#1)(1992-9#1)(1993-10#1)(1993-12#1)(1994-3#1)(2005-12#1)(2006-5#1)(2006-6#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-8#1)(2010-12#1)(2011-1#1)(2012-12#2)(2012-3#3)
performed worldwide##2##2##(2007-11#1)(2008-1#1)
performed worse##3##2##(1991-2#1)(1995-9#1)(1996-2#1)
performed##5467##1##(1990-1#1)(1990-10#10)(1990-11#15)(1990-12#37)(1990-2#12)(1990-3#23)(1990-4#9)(1990-5#12)(1990-6#16)(1990-7#7)(1990-8#17)(1990-9#15)(1991-1#5)(1991-10#8)(1991-11#10)(1991-12#14)(1991-2#15)(1991-3#19)(1991-4#11)(1991-5#9)(1991-6#18)(1991-7#5)(1991-8#12)(1991-9#9)(1992-1#8)(1992-10#10)(1992-11#4)(1992-12#20)(1992-2#18)(1992-3#15)(1992-4#12)(1992-5#12)(1992-6#16)(1992-7#10)(1992-8#13)(1992-9#17)(1993-1#7)(1993-10#9)(1993-11#12)(1993-12#13)(1993-2#9)(1993-3#15)(1993-4#3)(1993-5#10)(1993-6#7)(1993-7#7)(1993-8#6)(1993-9#10)(1994-10#3)(1994-11#15)(1994-12#16)(1994-2#15)(1994-3#23)(1994-4#4)(1994-5#10)(1994-6#18)(1994-7#5)(1994-8#8)(1994-9#22)(1995-1#16)(1995-10#5)(1995-11#13)(1995-12#16)(1995-2#19)(1995-3#12)(1995-4#4)(1995-5#8)(1995-6#10)(1995-7#7)(1995-8#3)(1995-9#11)(1996-1#17)(1996-10#1)(1996-11#16)(1996-12#24)(1996-2#17)(1996-3#26)(1996-4#3)(1996-5#17)(1996-6#27)(1996-7#8)(1996-8#19)(1996-9#14)(1997-1#8)(1997-2#23)(1997-3#21)(1997-4#15)(1997-5#14)(1997-6#19)(1997-7#12)(1997-8#37)(1997-9#1)(2003-11#1)(2004-1#4)(2004-10#5)(2004-11#8)(2004-12#5)(2004-2#5)(2004-4#2)(2004-9#8)(2005-1#2)(2005-10#19)(2005-11#29)(2005-12#8)(2005-2#1)(2005-3#1)(2005-4#1)(2005-5#4)(2005-7#4)(2005-8#6)(2005-9#3)(2006-1#6)(2006-10#108)(2006-11#40)(2006-12#42)(2006-2#10)(2006-3#23)(2006-4#14)(2006-5#39)(2006-6#51)(2006-7#26)(2006-8#78)(2006-9#10)(2007-1#21)(2007-10#42)(2007-11#118)(2007-12#87)(2007-2#40)(2007-3#24)(2007-4#26)(2007-5#14)(2007-6#15)(2007-7#98)(2007-8#255)(2007-9#43)(2008-1#64)(2008-10#505)(2008-11#83)(2008-12#54)(2008-2#136)(2008-3#176)(2008-4#78)(2008-5#162)(2008-6#51)(2008-7#118)(2008-8#58)(2008-9#55)(2009-1#6)(2009-10#21)(2009-11#8)(2009-12#9)(2009-2#18)(2009-3#31)(2009-4#19)(2009-5#13)(2009-6#16)(2009-7#14)(2009-8#16)(2009-9#15)(2010-1#7)(2010-10#12)(2010-11#12)(2010-12#59)(2010-2#28)(2010-3#16)(2010-4#19)(2010-5#20)(2010-6#12)(2010-7#15)(2010-8#19)(2010-9#18)(2011-1#70)(2011-12#17)(2011-2#214)(2011-3#13)(2011-7#1)(2012-1#41)(2012-11#10)(2012-12#105)(2012-2#103)(2012-3#72)(2012-5#1)(2012-7#2)(2012-8#3)(2013-1#190)(2013-7#38)(2013-8#104)
performed?##3##1##(2006-10#1)(2011-12#1)(2011-2#1)
performer##2##1##(2007-4#1)(2011-2#1)
performers##5##1##(2007-8#1)(2010-2#1)(2013-7#2)(2013-8#1)
performing LM/SL##2##2##(2012-12#2)
performing a controlled##2##3##(1991-3#1)(2008-3#1)
performing a specific##2##3##(2008-4#2)
performing a##46##2##(1991-3#1)(1991-5#1)(1992-7#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-7#1)(2004-11#1)(2006-10#1)(2006-12#1)(2006-6#2)(2006-9#2)(2007-11#1)(2007-12#1)(2007-8#4)(2008-10#2)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-3#2)(2010-8#1)(2011-12#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
performing accurate##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
performing all##2##2##(1994-1#1)(2008-10#1)
performing an epidural##2##3##(1993-10#1)(2006-12#1)
performing an##7##2##(1993-10#1)(1996-6#1)(2006-12#1)(2008-2#1)(2009-3#1)(2009-6#1)(2012-2#1)
performing analysis##2##2##(2006-6#1)(2008-10#1)
performing any##3##2##(2008-11#1)(2008-4#1)(2010-12#1)
performing appropriate##2##2##(1992-5#1)(2012-3#1)
performing both cryosurgery and hyperthermia##2##5##(2006-6#2)
performing both##6##2##(1994-2#1)(2006-6#2)(2007-7#1)(2008-10#1)(2008-3#1)
performing clinical##2##2##(2005-8#1)(2006-6#1)
performing comparative##2##2##(2008-4#1)(2010-11#1)
performing complex##3##2##(1993-6#1)(2007-12#1)(2008-2#1)
performing dynamic##2##2##(2007-8#1)(2009-10#1)
performing each of##2##3##(1996-3#1)(1996-9#1)
performing extensive##2##2##(1993-11#1)(2008-5#1)
performing high-throughput##3##2##(2008-11#1)(2008-7#1)(2009-12#1)
performing in##3##2##(2007-10#1)(2009-8#1)(2010-1#1)
performing lumbar puncture##2##3##(2007-7#2)
performing lumbar##5##2##(2006-8#3)(2007-7#2)
performing minimally invasive##3##3##(2006-11#1)(2007-2#1)(2009-4#1)
performing more complex##2##3##(2008-8#1)(2013-1#1)
performing more##3##2##(2008-8#1)(2011-2#1)(2013-1#1)
performing multiple analyses##3##3##(1991-10#1)(2008-10#2)
performing multiple##4##2##(1991-10#1)(1994-6#1)(2008-10#2)
performing of##2##2##(2006-12#1)(2013-7#1)
performing real-time##2##2##(2007-12#2)
performing routine##3##2##(2008-10#1)(2008-2#1)(2008-7#1)
performing simple##4##2##(1993-9#1)(2004-9#1)(2006-9#1)(2008-2#1)
performing simultaneous##2##2##(2007-8#1)(2008-2#1)
performing skin##2##2##(2007-12#1)(2013-1#1)
performing specific##2##2##(2006-6#1)(2010-2#1)
performing such##4##2##(1992-4#1)(2008-1#1)(2008-2#1)(2010-10#1)
performing tasks##4##2##(1991-11#1)(2008-11#2)(2013-7#1)
performing testing##2##2##(2012-2#2)
performing the assay##2##3##(2007-8#1)(2013-8#1)
performing the##51##2##(1990-12#1)(1990-8#1)(1992-6#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-8#1)(1996-8#1)(1997-8#1)(2004-9#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#6)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#2)(2012-11#1)(2012-12#1)(2013-1#2)(2013-8#2)
performing their##2##2##(2008-12#1)(2010-4#1)
performing these procedures##3##3##(2006-10#2)(2007-12#1)
performing these##7##2##(2006-10#3)(2007-12#1)(2008-11#1)(2011-1#1)(2011-3#1)
performing this##4##2##(1991-4#1)(1993-7#1)(2008-2#1)(2012-3#1)
performing those##2##2##(1996-2#1)(1996-6#1)
performing well##2##2##(1993-3#1)(2008-10#1)
performing wrist##2##2##(1991-6#1)(2008-9#1)
performing##457##1##(1990-10#2)(1990-12#1)(1990-2#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#2)(1993-10#1)(1993-11#2)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#2)(1993-9#2)(1994-1#2)(1994-12#2)(1994-2#2)(1994-3#2)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-8#3)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#2)(2004-11#1)(2004-9#2)(2005-10#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#11)(2006-11#3)(2006-12#3)(2006-3#1)(2006-5#2)(2006-6#10)(2006-7#2)(2006-8#10)(2006-9#3)(2007-1#1)(2007-10#4)(2007-11#8)(2007-12#20)(2007-2#4)(2007-3#3)(2007-5#3)(2007-7#8)(2007-8#12)(2007-9#1)(2008-1#3)(2008-10#31)(2008-11#15)(2008-12#3)(2008-2#22)(2008-3#17)(2008-4#21)(2008-5#7)(2008-6#1)(2008-7#14)(2008-8#4)(2008-9#7)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#4)(2009-4#4)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#6)(2011-1#5)(2011-12#2)(2011-2#8)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#9)(2012-2#14)(2012-3#5)(2013-1#16)(2013-7#4)(2013-8#7)
performs a##11##2##(1990-6#1)(1992-1#1)(1995-6#1)(2006-3#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-9#1)(2012-3#1)
performs all##2##2##(2008-10#1)(2013-8#1)
performs an essential role##2##4##(2009-9#1)(2010-2#1)
performs an essential##3##3##(2008-8#1)(2009-9#1)(2010-2#1)
performs an##9##2##(1994-8#1)(1996-4#1)(2006-7#1)(2008-10#2)(2008-2#1)(2008-8#1)(2009-9#1)(2010-2#1)
performs as well##2##3##(2008-10#1)(2008-2#1)
performs as##5##2##(2008-10#1)(2008-2#3)(2011-2#1)
performs at##3##2##(2008-10#1)(2008-2#2)
performs best in##2##3##(1994-5#1)(2009-2#1)
performs better than the##3##4##(1995-8#1)(2008-2#1)(2013-7#1)
performs better than##8##3##(1995-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
performs better##9##2##(1995-8#1)(2006-7#1)(2007-12#1)(2008-2#1)(2008-3#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
performs in##2##2##(1994-2#1)(2008-10#1)
performs phase unwrapping##2##3##(2008-2#1)(2008-3#1)
performs the best##2##3##(1990-4#1)(2012-2#1)
performs the##13##2##(1990-4#1)(1994-5#1)(1994-6#1)(2006-6#1)(2008-10#3)(2008-2#1)(2008-3#3)(2012-2#1)(2013-1#1)
performs well in##3##3##(1995-2#1)(2008-10#1)(2008-2#1)
performs well##8##2##(1995-2#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-3#1)
performs##110##1##(1990-4#1)(1990-6#1)(1992-1#1)(1993-3#1)(1994-2#2)(1994-5#2)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-4#1)(1997-3#1)(2005-5#1)(2005-9#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#2)(2007-11#2)(2007-12#2)(2007-4#1)(2008-1#3)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#20)(2008-3#13)(2008-4#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-8#1)(2009-9#1)(2010-2#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
perfringens alpha-toxin##3##2##(2006-8#1)(2010-6#2)
perfringens enterotoxin (CPE)##2##3##(1994-2#1)(2011-2#1)
perfringens enterotoxin##4##2##(1994-2#2)(2011-2#1)(2013-1#1)
perfringens food poisoning##2##3##(2011-2#2)
perfringens growth in beef-in-sauce products##2##5##(2011-2#2)
perfringens growth##4##2##(2011-2#4)
perfringens in##5##2##(1996-3#1)(2007-6#2)(2013-1#1)(2013-8#1)
perfringens strains##4##2##(2007-6#1)(2011-2#3)
perfringens toxin genes##2##3##(2013-1#2)
perfringens type A##3##3##(2007-6#1)(2011-2#2)
perfringens type##8##2##(1997-8#1)(2006-5#1)(2006-8#2)(2007-6#1)(2010-12#1)(2011-2#2)
perfringens was isolated##2##3##(2013-1#2)
perfringens was##3##2##(2007-7#1)(2013-1#2)
perfringens##65##1##(1990-9#1)(1994-11#1)(1994-2#2)(1996-3#1)(1997-8#1)(2006-10#2)(2006-3#2)(2006-5#5)(2006-8#6)(2007-12#3)(2007-6#5)(2007-7#2)(2009-3#1)(2010-12#1)(2010-6#5)(2011-2#17)(2013-1#9)(2013-8#1)
perfume diffusion from skin##2##4##(2008-5#2)
perfume##10##1##(2006-12#1)(2008-5#7)(2008-6#1)(2011-1#1)
perfumery##5##1##(2006-12#5)
perfumes##5##1##(2008-5#3)(2009-6#2)
perfusate and##5##2##(1991-4#1)(1991-7#1)(1996-12#1)(2005-12#1)(2011-3#1)
perfusate from##3##2##(1990-6#1)(1990-7#1)(1996-12#1)
perfusate was##5##2##(1991-6#1)(1991-9#1)(1993-3#1)(1995-1#1)(2011-2#1)
perfusate##32##1##(1990-2#1)(1990-3#2)(1990-6#1)(1990-7#2)(1991-2#1)(1991-4#1)(1991-6#2)(1991-7#1)(1991-9#3)(1992-3#1)(1993-3#2)(1995-1#1)(1996-12#6)(1996-5#1)(1997-8#1)(2005-12#1)(2008-11#1)(2008-7#1)(2009-4#1)(2011-2#1)(2011-3#1)
perfused and##3##2##(1993-2#1)(1993-4#1)(2007-8#1)
perfused at##2##2##(1990-7#1)(1995-7#1)
perfused guinea pig##2##3##(1992-6#1)(2008-4#1)
perfused guinea-pig##2##2##(1991-2#1)(1994-5#1)
perfused heart##2##2##(1991-9#1)(1993-11#1)
perfused hearts##3##2##(1993-11#1)(1994-3#1)(1995-3#1)
perfused in##5##2##(1990-2#1)(1992-2#2)(1996-12#1)(1997-5#1)
perfused into the##2##3##(1997-3#1)(2008-11#1)
perfused kidney##2##2##(1997-5#1)(1997-7#1)
perfused liver##5##2##(1990-11#1)(1991-3#1)(1994-6#3)
perfused livers##5##2##(1991-3#2)(1991-8#1)(1995-1#1)(1996-12#1)
perfused pancreas##2##2##(1991-10#1)(2012-2#1)
perfused rat heart##2##3##(1995-3#1)(2010-12#1)
perfused rat hearts##4##3##(1991-9#1)(1994-12#1)(1995-3#1)(2007-9#1)
perfused rat liver##14##3##(1990-11#1)(1990-3#2)(1991-6#2)(1991-7#2)(1992-2#1)(1993-3#1)(1994-6#1)(1996-12#2)(1996-5#1)(2008-11#1)
perfused rat livers##2##3##(1991-3#1)(1995-1#1)
perfused rat pancreas##4##3##(1990-12#2)(1990-3#1)(1992-6#1)
perfused rat##34##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#3)(1991-3#1)(1991-6#3)(1991-7#2)(1991-9#1)(1992-2#1)(1992-6#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-3#2)(1996-10#3)(1996-12#3)(1996-5#1)(2007-9#1)(2008-10#1)(2008-11#1)(2010-12#1)
perfused sheep choroid plexus##2##4##(1997-8#2)
perfused tail arteries##3##3##(1996-10#3)
perfused through##2##2##(1994-2#1)(2008-10#1)
perfused with a##2##3##(2007-8#1)(2008-11#1)
perfused with##23##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-7#1)(1991-3#1)(1992-12#1)(1992-2#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-3#1)(1996-1#1)(1996-5#1)(1997-2#2)(2007-8#1)(2007-9#1)(2008-11#1)(2008-9#2)(2009-4#1)
perfused##143##1##(1990-10#2)(1990-11#4)(1990-12#4)(1990-2#5)(1990-3#3)(1990-6#2)(1990-7#4)(1990-8#1)(1991-10#2)(1991-2#2)(1991-3#5)(1991-5#2)(1991-6#3)(1991-7#2)(1991-8#2)(1991-9#3)(1992-12#1)(1992-2#4)(1992-6#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#2)(1993-6#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#5)(1994-8#2)(1995-1#2)(1995-11#1)(1995-3#4)(1995-7#1)(1996-1#1)(1996-10#7)(1996-12#5)(1996-5#2)(1996-6#1)(1997-2#4)(1997-3#1)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#3)(2005-10#1)(2006-1#1)(2006-10#1)(2007-4#1)(2007-8#3)(2007-9#3)(2008-10#2)(2008-11#6)(2008-4#2)(2008-6#1)(2008-9#3)(2009-12#1)(2009-4#1)(2009-7#1)(2010-12#1)(2012-2#1)
perfusing the##2##2##(1997-2#1)(2007-11#1)
perfusing##7##1##(1991-5#2)(1996-4#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-4#1)
perfusion CT##5##2##(2008-7#2)(2009-9#1)(2012-3#2)
perfusion MRI and##2##3##(2008-7#2)
perfusion MRI##5##2##(2008-7#4)(2010-12#1)
perfusion abnormalities##2##2##(1996-5#1)(2008-1#1)
perfusion after##2##2##(2008-7#2)
perfusion and oxygenation##2##3##(1996-3#1)(1997-6#1)
perfusion and subsequent##2##3##(1992-1#1)(2008-11#1)
perfusion and##27##2##(1991-5#1)(1992-1#1)(1992-10#1)(1996-3#2)(1997-1#1)(1997-6#1)(1997-8#1)(2006-10#5)(2006-4#1)(2006-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-7#1)(2009-11#1)(2013-1#2)
perfusion are##2##2##(2008-11#1)(2011-3#1)
perfusion as##6##2##(2006-4#1)(2007-8#1)(2008-10#1)(2013-1#3)
perfusion bioreactor##5##2##(2008-11#5)
perfusion bioreactors##4##2##(2008-11#3)(2012-3#1)
perfusion but##2##2##(1992-2#1)(2007-9#1)
perfusion by maintaining##2##3##(2006-10#1)(2011-2#1)
perfusion by##6##2##(1993-12#1)(1997-8#1)(2006-10#2)(2008-3#1)(2011-2#1)
perfusion chamber##7##2##(1992-6#1)(2008-11#6)
perfusion chambers and##2##3##(2008-11#2)
perfusion chambers##3##2##(1990-12#1)(2008-11#2)
perfusion circuit##3##2##(1990-12#2)(2008-6#1)
perfusion computed tomography (CT)##2##4##(2012-12#1)(2012-3#1)
perfusion cultivation##4##2##(2008-11#4)
perfusion cultivations##2##2##(2008-11#2)
perfusion culture##12##2##(1994-5#1)(2008-11#8)(2008-5#3)
perfusion cultures and##3##3##(1994-5#2)(2008-11#1)
perfusion cultures of hybridoma##2##4##(1994-5#1)(2008-11#1)
perfusion cultures of##4##3##(1994-5#1)(2008-11#3)
perfusion cultures##16##2##(1994-5#5)(2008-11#11)
perfusion defect##3##2##(2007-9#1)(2009-8#1)(2010-12#1)
perfusion defects are##2##3##(1996-5#1)(2009-10#1)
perfusion defects##13##2##(1992-5#2)(1996-5#3)(2006-10#1)(2007-11#1)(2007-9#1)(2009-10#1)(2010-12#1)(2010-2#2)(2010-6#1)
perfusion during##6##2##(1997-6#1)(2007-7#2)(2007-8#1)(2009-8#1)(2011-3#1)
perfusion fixation##3##2##(1995-2#1)(2004-9#1)(2008-4#1)
perfusion following##2##2##(1997-2#1)(2007-8#1)
perfusion for##3##2##(1996-9#1)(2006-6#1)(2007-9#1)
perfusion hyperthermia##2##2##(2013-1#2)
perfusion images##2##2##(2008-7#2)
perfusion imaging with##4##3##(2007-11#1)(2008-7#2)(2009-4#1)
perfusion imaging##20##2##(1992-2#1)(2007-11#1)(2008-1#2)(2008-7#6)(2009-10#1)(2009-4#3)(2009-5#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-7#2)
perfusion in patients with##2##4##(2006-10#1)(2013-8#1)
perfusion in the treatment of##4##5##(2006-6#4)
perfusion in the##12##3##(1997-5#1)(2006-6#4)(2007-10#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-11#1)(2011-2#1)
perfusion in##26##2##(1996-5#1)(1997-5#1)(2005-10#1)(2006-10#1)(2006-6#4)(2007-10#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-12#1)(2008-7#2)(2009-11#1)(2009-4#1)(2009-9#2)(2010-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
perfusion induced##2##2##(1997-2#2)
perfusion is##5##2##(2006-10#1)(2006-2#1)(2007-10#1)(2007-8#1)(2011-2#1)
perfusion may##3##2##(1992-8#1)(2006-10#1)(2006-6#1)
perfusion media##2##2##(1990-2#1)(1990-3#1)
perfusion medium##3##2##(1990-2#2)(2008-11#1)
perfusion mode##3##2##(2008-11#3)
perfusion model##4##2##(1993-12#1)(1994-5#2)(2011-3#1)
perfusion of the peritoneal cavity with##2##6##(1990-4#2)
perfusion of the##18##3##(1990-4#4)(1992-2#1)(1993-1#1)(1993-12#1)(1994-12#1)(1996-12#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-11#1)(2009-11#1)(2009-12#1)(2012-12#3)
perfusion of##51##2##(1990-11#1)(1990-4#4)(1991-1#1)(1991-10#1)(1991-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-6#1)(1995-3#2)(1995-5#1)(1995-6#3)(1996-12#2)(1996-3#1)(1996-9#1)(1997-1#1)(2005-11#1)(2006-9#1)(2007-1#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-12#1)(2010-8#1)(2012-12#5)(2012-3#1)(2013-8#1)
perfusion or oxygen##2##3##(2007-8#1)(2008-1#1)
perfusion or##5##2##(2007-8#3)(2008-1#1)(2008-7#1)
perfusion parameters##2##2##(2008-11#1)(2010-12#1)
perfusion pressure (CPP)##2##3##(1996-9#1)(2008-7#1)
perfusion pressure and##4##3##(1993-3#1)(2006-10#1)(2007-8#1)(2012-4#1)
perfusion pressure in##2##3##(1993-11#1)(1997-5#1)
perfusion pressure##29##2##(1990-2#1)(1990-6#3)(1990-8#1)(1991-6#1)(1993-11#1)(1993-3#4)(1995-12#1)(1996-10#2)(1996-9#1)(1997-5#1)(2006-10#4)(2006-4#1)(2007-8#1)(2008-7#4)(2008-9#1)(2010-2#1)(2012-4#1)
perfusion pressures and##2##3##(1990-10#1)(2007-8#1)
perfusion rate to##2##3##(2008-11#2)
perfusion rate##12##2##(2008-10#2)(2008-11#10)
perfusion rates##6##2##(2008-11#6)
perfusion reactor##3##2##(1994-2#2)(2008-11#1)
perfusion reserve##2##2##(2007-10#1)(2012-2#1)
perfusion scan##3##2##(2005-10#1)(2010-2#1)(2010-9#1)
perfusion scans##2##2##(1993-2#1)(2010-9#1)
perfusion scintigraphy##3##2##(2005-11#1)(2005-7#1)(2010-12#1)
perfusion system was##2##3##(2008-11#2)
perfusion system##11##2##(1991-12#1)(1997-8#1)(2007-11#1)(2008-11#5)(2010-9#1)(2012-1#1)(2012-2#1)
perfusion technique was used##2##4##(1990-2#1)(1996-11#1)
perfusion technique was##3##3##(1990-2#1)(1996-11#1)(2008-7#1)
perfusion technique##6##2##(1990-2#1)(1993-3#1)(1995-3#1)(1996-11#1)(2008-4#1)(2008-7#1)
perfusion techniques##2##2##(1992-2#1)(1995-7#1)
perfusion through##6##2##(1997-1#1)(2008-1#1)(2008-11#1)(2010-11#1)(2012-12#2)
perfusion to the##2##3##(1990-7#1)(1993-3#1)
perfusion to##3##2##(1990-7#1)(1993-3#1)(2008-4#1)
perfusion under##2##2##(2006-10#1)(2006-6#1)
perfusion was seen##2##3##(2007-9#1)(2008-7#1)
perfusion was##6##2##(1996-12#1)(1997-1#1)(2007-9#2)(2008-11#1)(2008-7#1)
perfusion were##4##2##(1997-2#1)(2007-9#1)(2008-5#1)(2011-3#1)
perfusion with##14##2##(1990-2#1)(1990-3#1)(1991-1#1)(1992-5#1)(1994-12#1)(1994-2#1)(1995-11#1)(1996-9#1)(2006-6#3)(2007-7#1)(2009-4#1)(2013-7#1)
perfusion##580##1##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#8)(1990-3#2)(1990-4#5)(1990-6#3)(1990-7#2)(1990-8#1)(1991-1#2)(1991-10#4)(1991-12#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-2#8)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#1)(1992-8#3)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#5)(1993-3#7)(1994-10#1)(1994-12#4)(1994-2#3)(1994-5#9)(1994-6#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#1)(1996-10#2)(1996-11#1)(1996-12#3)(1996-3#3)(1996-5#6)(1996-8#2)(1996-9#6)(1997-1#8)(1997-2#8)(1997-4#1)(1997-5#2)(1997-6#5)(1997-8#5)(2004-9#1)(2005-1#1)(2005-10#3)(2005-11#4)(2005-7#2)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#20)(2006-2#1)(2006-4#3)(2006-6#26)(2006-7#4)(2006-9#1)(2007-1#1)(2007-10#7)(2007-11#6)(2007-7#5)(2007-8#30)(2007-9#15)(2008-1#9)(2008-10#7)(2008-11#83)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#6)(2008-5#6)(2008-6#3)(2008-7#37)(2008-8#4)(2008-9#2)(2009-10#3)(2009-11#7)(2009-12#2)(2009-4#7)(2009-5#1)(2009-8#2)(2009-9#3)(2010-11#5)(2010-12#9)(2010-2#9)(2010-6#1)(2010-8#3)(2010-9#4)(2011-1#1)(2011-2#7)(2011-3#5)(2012-1#2)(2012-12#13)(2012-2#5)(2012-3#10)(2012-4#1)(2013-1#10)(2013-7#5)(2013-8#4)
perfusion-##2##1##(1997-1#1)(2006-7#1)
perfusion-contraction##2##1##(1996-9#2)
perfusion-fixed##3##1##(1995-12#1)(1996-1#1)(1996-8#1)
perfusion-weighted imaging##2##2##(2007-10#1)(2007-9#1)
perfusion-weighted##8##1##(2007-10#4)(2007-9#4)
perfusions in##2##2##(2006-6#1)(2008-6#1)
perfusions##10##1##(1990-11#1)(1994-12#3)(2006-6#4)(2008-6#2)
pergandiella eggs were killed by E##2##6##(2007-6#2)
pergandiella##9##1##(2007-6#9)
pergolide##7##1##(2008-7#7)
perhaps a##3##2##(1994-11#1)(2006-6#1)(2007-2#1)
perhaps allow##2##2##(1992-9#1)(2010-12#1)
perhaps also in##2##3##(2007-11#1)(2008-3#1)
perhaps also##6##2##(1994-3#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-3#1)(2008-9#1)
perhaps as a##2##3##(1994-11#1)(2008-11#1)
perhaps as much as##2##4##(1993-6#1)(1996-8#1)
perhaps as##4##2##(1993-6#1)(1994-11#1)(1996-8#1)(2008-11#1)
perhaps be more##2##3##(1996-3#1)(2008-7#1)
perhaps be##5##2##(1992-6#1)(1996-3#1)(2008-7#1)(2009-10#1)(2010-12#1)
perhaps because of a##2##4##(1990-9#1)(2006-8#1)
perhaps because of##7##3##(1990-9#1)(1992-12#1)(1993-12#1)(1996-8#1)(2006-8#1)(2009-10#1)(2010-4#1)
perhaps because##13##2##(1990-9#2)(1991-7#1)(1992-12#1)(1992-4#1)(1993-12#1)(1993-3#1)(1996-8#1)(2006-8#1)(2008-8#1)(2009-10#1)(2010-4#1)(2012-12#1)
perhaps best##3##2##(1997-2#1)(2008-9#1)(2012-2#1)
perhaps by the##2##3##(1990-12#1)(1993-12#1)
perhaps by##10##2##(1990-12#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-6#1)(1997-6#1)(2004-1#1)(2007-12#1)(2010-12#1)
perhaps due to the##2##4##(1994-8#1)(2004-11#1)
perhaps due to##9##3##(1990-12#1)(1994-8#1)(2004-11#1)(2006-9#1)(2008-10#1)(2008-11#1)(2009-12#1)(2011-1#1)(2012-11#1)
perhaps due##10##2##(1990-12#1)(1994-8#1)(2004-11#1)(2006-9#1)(2008-10#1)(2008-11#1)(2009-12#1)(2011-1#1)(2012-11#1)(2012-2#1)
perhaps even in##3##3##(1994-7#1)(2006-5#1)(2012-12#1)
perhaps even##8##2##(1994-7#1)(2006-10#1)(2006-5#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2012-12#1)
perhaps from##2##2##(1997-3#1)(2010-8#1)
perhaps greater##2##2##(1997-1#1)(2006-10#1)
perhaps implying##2##2##(2009-10#1)(2013-1#1)
perhaps in##6##2##(1990-11#1)(1990-8#1)(1992-7#1)(1994-8#1)(1996-1#1)(1997-4#1)
perhaps less##3##2##(2006-10#2)(2012-2#1)
perhaps mediated by##2##3##(1993-6#1)(2008-10#1)
perhaps more##5##2##(1992-4#1)(1994-6#1)(1995-1#1)(2008-9#1)(2012-12#1)
perhaps most important##3##3##(1997-8#1)(2006-3#1)(2008-4#1)
perhaps most importantly##3##3##(1997-4#1)(2009-5#1)(2012-3#1)
perhaps most##7##2##(1997-4#1)(1997-8#1)(2006-3#1)(2008-4#1)(2009-5#1)(2012-2#1)(2012-3#1)
perhaps necessary##2##2##(1992-9#1)(1997-8#1)
perhaps not##3##2##(1997-6#1)(2007-11#1)(2007-8#1)
perhaps on##2##2##(2008-10#1)(2013-1#1)
perhaps owing to##3##3##(1994-8#1)(1996-5#1)(2007-10#1)
perhaps reflecting the##2##3##(1990-9#1)(1994-4#1)
perhaps reflecting##3##2##(1990-9#1)(1994-4#1)(2012-11#1)
perhaps the best##2##3##(2006-10#1)(2010-8#1)
perhaps the most abundant##2##4##(2008-3#1)(2010-2#1)
perhaps the most important##2##4##(2010-3#1)(2011-1#1)
perhaps the most##14##3##(2005-7#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#1)(2012-3#1)
perhaps the only##2##3##(2008-7#1)(2009-3#1)
perhaps the result of##2##4##(1996-8#1)(2007-11#1)
perhaps the##36##2##(1991-7#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-3#1)(1995-1#1)(1996-8#1)(1997-5#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-3#2)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2012-3#2)
perhaps through regulation of##2##4##(1995-2#1)(2010-11#1)
perhaps through##6##2##(1995-2#1)(2006-10#2)(2008-5#1)(2010-11#1)(2012-12#1)
perhaps to##4##2##(1992-6#1)(1994-8#1)(2005-11#1)(2009-4#1)
perhaps with##2##2##(1991-10#1)(2008-3#1)
perhaps##284##1##(1990-11#1)(1990-12#4)(1990-2#3)(1990-4#1)(1990-6#2)(1990-8#3)(1990-9#3)(1991-10#1)(1991-11#3)(1991-12#3)(1991-2#1)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#1)(1992-4#2)(1992-6#5)(1992-7#2)(1992-9#2)(1993-12#3)(1993-3#2)(1993-6#2)(1994-11#4)(1994-12#2)(1994-2#2)(1994-3#2)(1994-4#1)(1994-6#1)(1994-7#1)(1994-8#5)(1995-1#3)(1995-10#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-7#1)(1996-1#3)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#7)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#2)(2004-1#2)(2004-11#2)(2005-10#1)(2005-11#3)(2005-12#2)(2005-7#2)(2006-10#10)(2006-12#1)(2006-3#1)(2006-5#2)(2006-6#5)(2006-7#1)(2006-8#2)(2006-9#3)(2007-10#1)(2007-11#5)(2007-12#3)(2007-2#2)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#7)(2008-12#1)(2008-3#6)(2008-4#6)(2008-5#2)(2008-7#8)(2008-8#7)(2008-9#7)(2009-10#4)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#2)(2009-7#1)(2009-9#2)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#1)(2012-11#2)(2012-12#6)(2012-2#5)(2012-3#5)(2013-1#4)
perhydroxyl-cucurbit[6]uril##2##1##(2008-10#2)
peri##2##1##(2008-3#2)
peri- and postmenopausal women##2##4##(2008-11#1)(2012-2#1)
peri- and##5##2##(1997-7#1)(2008-11#1)(2008-9#1)(2010-11#1)(2012-2#1)
peri- or##2##2##(1996-1#1)(2006-5#1)
peri-##8##1##(1996-1#1)(1997-7#1)(2006-5#1)(2008-11#1)(2008-9#1)(2010-11#1)(2010-12#1)(2012-2#1)
peri-acetabular bone malignancies##2##3##(2008-6#2)
peri-extubation period##3##2##(2006-4#3)
peri-extubation##4##1##(2006-4#4)
peri-implant bone##2##2##(2012-2#1)(2013-8#1)
peri-implant marginal bone level##2##4##(2013-1#2)
peri-implant marginal bone##3##3##(2013-1#3)
peri-implant mucositis##5##2##(2012-11#3)(2012-12#2)
peri-implant soft tissue unit##4##4##(2012-11#3)(2012-12#1)
peri-implant soft tissue##8##3##(2007-12#1)(2008-4#1)(2012-11#4)(2012-12#1)(2013-1#1)
peri-implant soft##9##2##(2007-12#1)(2008-4#1)(2012-11#4)(2012-12#1)(2013-1#2)
peri-implant soft-tissue unit##3##3##(2012-11#3)
peri-implant tissues##3##2##(2008-11#2)(2013-1#1)
peri-implant##32##1##(2007-12#1)(2008-11#2)(2008-4#1)(2012-11#12)(2012-12#6)(2012-2#2)(2013-1#7)(2013-8#1)
peri-implantitis##23##1##(2007-12#1)(2011-12#1)(2012-11#5)(2012-12#3)(2012-2#1)(2013-1#12)
peri-infarction##2##1##(2012-1#2)
peri-natal loss##2##2##(2008-12#2)
peri-natal##3##1##(2008-12#3)
peri-operative care##3##2##(2007-8#1)(2011-12#2)
peri-operative management##2##2##(1991-8#1)(2008-11#1)
peri-operative morbidity and mortality##2##4##(2007-8#1)(2011-12#1)
peri-operative##22##1##(1991-8#1)(2006-10#1)(2007-11#2)(2007-8#9)(2008-11#1)(2010-7#2)(2011-12#3)(2012-2#2)(2013-7#1)
peri-operatively##2##1##(2007-8#1)(2013-7#1)
peri-procedural##3##1##(2007-7#1)(2009-5#2)
peri-urban area of##2##3##(2007-2#2)
peri-urban areas##4##2##(2007-2#2)(2011-2#2)
peri-urban##12##1##(2007-2#6)(2009-6#1)(2011-1#1)(2011-2#3)(2013-8#1)
periacetabular osteotomy##6##2##(2007-7#3)(2007-8#3)
periacetabular##9##1##(2007-7#4)(2007-8#3)(2008-6#1)(2008-8#1)
periampullary tumour##2##2##(2008-3#1)(2013-1#1)
periampullary##9##1##(1990-9#1)(1991-3#2)(2006-6#1)(2008-3#1)(2013-1#4)
periamygdaloid cortex##7##2##(1995-5#1)(1996-6#5)(1997-6#1)
perianal Crohn's##2##2##(2006-10#1)(2012-11#1)
perianal Paget's disease##2##3##(2010-5#2)
perianal abscesses and fistulas##2##4##(1997-8#2)
perianal and##3##2##(2007-8#1)(2010-12#2)
perianal area and##2##3##(2010-12#1)(2010-6#1)
perianal surgery##2##2##(2010-12#2)
perianal ulcer##2##2##(2010-8#2)
perianal##29##1##(1990-6#1)(1994-1#1)(1997-8#4)(2006-10#1)(2006-2#1)(2006-6#1)(2007-7#2)(2007-8#1)(2008-9#1)(2010-12#7)(2010-5#4)(2010-6#1)(2010-8#3)(2012-11#1)
perianastomotic##2##1##(1990-3#1)(2007-8#1)
periapical lesion##3##2##(2009-8#1)(2013-1#2)
periapical lesions##3##2##(2011-2#1)(2013-1#2)
periapical radiographs##2##2##(2008-12#1)(2008-5#1)
periapical tissues##2##2##(2011-2#1)(2013-1#1)
periapical##23##1##(1991-9#1)(2005-10#1)(2007-12#1)(2008-12#1)(2008-5#3)(2009-8#1)(2010-12#1)(2011-12#2)(2011-2#4)(2012-3#1)(2013-1#6)(2013-8#1)
periaqueductal gray (PAG)##2##3##(1993-12#1)(2008-7#1)
periaqueductal gray area##3##3##(1993-11#2)(1993-12#1)
periaqueductal gray aversion##2##3##(1990-2#2)
periaqueductal gray matter##3##3##(1993-11#1)(1993-12#1)(1993-7#1)
periaqueductal gray##15##2##(1990-2#4)(1993-11#3)(1993-12#3)(1993-7#1)(1994-5#1)(1995-6#1)(1996-1#1)(2008-7#1)
periaqueductal grey##11##2##(1991-3#2)(1992-8#3)(1994-2#1)(1994-6#2)(1997-5#2)(2008-7#1)
periaqueductal##27##1##(1990-2#4)(1991-3#2)(1991-5#1)(1992-8#3)(1993-11#3)(1993-12#3)(1993-7#1)(1994-2#1)(1994-5#1)(1994-6#2)(1995-6#1)(1996-1#1)(1997-5#2)(2008-7#2)
periarthritis##5##1##(1991-11#1)(1995-5#1)(2005-7#1)(2006-10#2)
periarticular hip abscess##2##3##(1992-12#2)
periarticular injections##2##2##(2006-10#2)
periarticular##15##1##(1990-10#1)(1991-8#1)(1992-12#2)(2005-7#2)(2006-10#6)(2007-11#1)(2011-2#1)(2012-2#1)
periaxonal##3##1##(1994-2#1)(1994-6#2)
peribulbar and##2##2##(1992-2#1)(2013-1#1)
pericapillary microenvironment##2##2##(1995-1#2)
pericapillary##5##1##(1993-6#1)(1995-1#2)(2012-1#2)
pericardial aspiration##2##2##(2007-8#2)
pericardial disease##3##2##(2006-10#1)(2007-3#1)(2009-10#1)
pericardial edema##2##2##(2008-8#1)(2012-12#1)
pericardial effusion and##2##3##(2007-8#1)(2010-7#1)
pericardial effusion##17##2##(1993-10#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-7#1)(2007-8#4)(2009-9#1)(2010-5#3)(2010-7#1)(2011-11#1)(2012-2#1)(2013-8#1)
pericardial fluid##3##2##(2007-8#3)
pericardial fluids##2##2##(2007-8#2)
pericardial patch##7##2##(2007-8#6)(2013-1#1)
pericardial rupture##2##2##(2007-8#1)(2012-2#1)
pericardial sac was closed##2##4##(2007-8#2)
pericardial sac##4##2##(2005-7#1)(2007-8#3)
pericardial tamponade##6##2##(2006-10#1)(2007-3#1)(2007-8#2)(2008-2#1)(2011-2#1)
pericardial window##2##2##(2006-10#1)(2010-5#1)
pericardial##76##1##(1991-5#1)(1993-10#1)(1997-3#1)(1997-4#1)(2004-9#1)(2005-7#1)(2006-10#5)(2006-7#1)(2007-12#1)(2007-3#2)(2007-8#37)(2008-2#1)(2008-4#2)(2008-8#1)(2009-10#2)(2009-4#1)(2009-9#2)(2010-5#4)(2010-7#1)(2011-11#1)(2011-2#1)(2012-12#3)(2012-2#3)(2013-1#1)(2013-8#1)
pericardiectomy is##2##2##(2007-8#1)(2012-1#1)
pericardiectomy##8##1##(2007-5#1)(2007-8#6)(2012-1#1)
pericardio-peritoneal shunt##2##2##(2010-5#2)
pericardiocentesis and##3##2##(2006-10#2)(2007-8#1)
pericardiocentesis##4##1##(2006-10#2)(2007-8#1)(2010-5#1)
pericarditis and##3##2##(1997-4#1)(2006-10#2)
pericarditis due to##2##3##(2007-8#2)
pericarditis in##3##2##(1992-12#1)(2009-10#1)(2010-7#1)
pericarditis is a rare complication##2##5##(2010-7#1)(2012-1#1)
pericarditis with##4##2##(2006-10#1)(2009-10#1)(2011-2#1)(2012-1#1)
pericarditis##43##1##(1992-12#1)(1995-11#1)(1997-4#1)(1997-6#1)(1997-8#2)(2005-11#1)(2006-10#4)(2006-12#1)(2007-8#8)(2008-4#1)(2009-10#8)(2010-4#1)(2010-7#3)(2011-2#2)(2012-1#5)(2012-12#3)
pericardium and a##2##3##(2007-8#1)(2013-1#1)
pericardium and diaphragm##2##3##(2007-8#1)(2008-6#1)
pericardium and##10##2##(1992-2#1)(2007-4#1)(2007-8#4)(2008-6#1)(2008-9#1)(2010-8#1)(2013-1#1)
pericardium for##2##2##(2004-9#1)(2009-10#1)
pericardium treated with SDS##2##4##(2004-9#2)
pericardium was##2##2##(2006-6#1)(2007-8#1)
pericardium##55##1##(1992-2#1)(1992-4#1)(2004-9#12)(2006-6#1)(2007-2#1)(2007-4#3)(2007-8#13)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#2)(2009-9#1)(2010-5#2)(2010-8#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)
pericarp and aleurone tissues##2##4##(2008-10#2)
pericarp and##3##2##(2008-10#3)
pericarp of##3##2##(2008-10#1)(2011-2#1)(2012-12#1)
pericarp##12##1##(2008-10#8)(2009-8#1)(2011-2#2)(2012-12#1)
pericarps##4##1##(2009-3#4)
pericellular and##2##2##(1994-12#1)(2010-12#1)
pericellular fibrinolytic##2##2##(1993-12#2)
pericellular##11##1##(1993-12#2)(1993-4#1)(1993-7#1)(1994-12#2)(2008-4#3)(2010-12#1)(2011-2#1)
pericentral##3##1##(2008-7#3)
pericentric##3##1##(1993-12#1)(1996-6#1)(2010-3#1)
pericentromeric##6##1##(1995-8#1)(1997-5#1)(2008-12#2)(2008-5#1)(2012-11#1)
pericentrometric##2##1##(1995-11#2)
perichondrial cells##3##2##(2003-11#3)
perichondrial##5##1##(2003-11#3)(2007-11#1)(2007-8#1)
perichondrium##5##1##(2003-11#1)(2007-11#4)
periciliary fluid##2##2##(2005-11#2)
periclase##2##1##(1996-5#2)
periclinal##2##1##(2008-10#1)(2012-11#1)
periconceptional##2##1##(2004-10#2)
pericoronitis##2##1##(2007-12#2)
pericosines##4##1##(2009-3#4)
pericystectomies##3##1##(1991-8#3)
pericystectomy##2##1##(1993-6#1)(2008-10#1)
pericyte##4##1##(1993-3#2)(2011-2#1)(2012-4#1)
pericytes##17##1##(1993-3#6)(1993-6#1)(2007-11#1)(2008-1#2)(2009-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)
pericytic##3##1##(2012-1#3)
periderm##4##1##(2008-10#4)
peridinin##3##1##(2009-9#3)
peridomestic##2##1##(2006-10#1)(2012-12#1)
peridomiciliary##2##1##(1994-3#1)(1994-6#1)
perifocal/penumbral##2##1##(1997-2#2)
perifollicular##2##1##(2005-11#2)
perifornical area##2##2##(1993-2#1)(2008-9#1)
perifornical##6##1##(1993-2#2)(1994-10#1)(1995-7#1)(1996-1#1)(2008-9#1)
perifused goldfish pituitary fragments##2##4##(1994-8#2)
perifused##5##1##(1990-2#1)(1994-8#2)(1997-5#1)(2008-4#1)
perifusion##6##1##(1990-2#1)(1995-10#1)(1996-2#1)(1997-4#1)(2010-11#2)
periglomerular cells##4##2##(1996-5#2)(1996-7#2)
periglomerular##11##1##(1996-5#2)(1996-7#3)(2010-12#6)
perihepatic##2##1##(1997-8#1)(2008-6#1)
perihypoglossal neurons involved in##2##4##(1997-6#2)
perihypoglossal##4##1##(1997-6#4)
periimplant soft tissue##2##3##(2011-12#2)
periimplant##5##1##(2008-4#1)(2011-12#4)
periinfarction##2##1##(1997-6#1)(2012-1#1)
perikarya and dendrites##2##3##(1992-1#1)(1992-8#1)
perikarya and fibers##4##3##(1992-12#3)(2008-6#1)
perikarya and in##2##3##(1990-4#1)(1997-5#1)
perikarya and proximal##2##3##(1992-1#2)
perikarya and##13##2##(1990-4#1)(1992-1#3)(1992-12#3)(1992-8#1)(1995-7#2)(1997-5#1)(2008-6#1)(2011-2#1)
perikarya are##3##2##(1992-12#1)(1994-2#1)(1996-2#1)
perikarya in the##5##3##(1992-12#2)(1996-12#2)(1997-6#1)
perikarya in##6##2##(1992-12#2)(1996-12#2)(1997-6#1)(1997-7#1)
perikarya of##8##2##(1992-3#1)(1994-12#1)(1995-12#1)(1995-7#1)(1996-10#1)(1997-8#1)(2007-12#1)(2008-6#1)
perikarya were##5##2##(1993-9#1)(1995-11#1)(1995-5#1)(1997-3#1)(2008-6#1)
perikarya##50##1##(1990-4#3)(1990-5#1)(1991-12#1)(1991-6#1)(1992-1#3)(1992-12#6)(1992-3#1)(1992-8#2)(1993-9#1)(1994-12#1)(1994-2#1)(1995-11#3)(1995-12#1)(1995-5#1)(1995-7#4)(1996-10#1)(1996-12#3)(1996-2#1)(1996-8#1)(1997-3#3)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-12#2)(2008-6#3)(2011-2#1)
perikaryal##8##1##(1990-4#1)(1991-8#1)(1994-2#2)(1997-2#1)(2007-9#2)(2008-7#1)
perikaryon##7##1##(1994-2#1)(1997-8#1)(2007-9#1)(2008-7#4)
perikaryonic##2##1##(1992-8#2)
perilesional##6##1##(2007-12#1)(2007-2#1)(2007-7#1)(2009-9#1)(2011-1#1)(2013-1#1)
perilous##2##1##(2007-2#1)(2008-9#1)
perils of##5##2##(1992-7#1)(2006-5#1)(2007-11#1)(2007-2#1)(2008-7#1)
perils##6##1##(1992-7#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-2#1)(2008-7#1)
perilymphatic##3##1##(1996-3#2)(2007-7#1)
perimembranous VSD##2##2##(2007-8#1)(2010-6#1)
perimembranous ventricular septal defect##2##4##(2007-8#1)(2008-4#1)
perimembranous##6##1##(1995-8#1)(2007-8#2)(2008-4#1)(2010-6#1)(2013-1#1)
perimenopausal women with##2##3##(1994-2#1)(1994-9#1)
perimenopausal women##3##2##(1994-2#1)(1994-9#1)(2011-1#1)
perimenopausal##15##1##(1993-11#1)(1994-2#1)(1994-8#1)(1994-9#2)(2004-3#3)(2006-2#1)(2008-4#3)(2008-9#1)(2009-1#1)(2011-1#1)
perimenstrual##2##1##(2008-3#1)(2008-4#1)
perimesencephalic hemorrhage##2##2##(2007-10#2)
perimesencephalic##7##1##(2007-10#5)(2008-7#2)
perimeter and##2##2##(2007-12#1)(2007-6#1)
perimeter in##2##2##(2007-8#1)(2012-1#1)
perimeter of the##8##3##(1995-11#1)(1995-6#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-6#2)(2013-7#1)
perimeter of##9##2##(1995-11#1)(1995-6#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-6#2)(2013-7#1)
perimeter##22##1##(1995-11#1)(1995-6#1)(1996-3#2)(1997-8#1)(2004-1#1)(2005-11#1)(2007-12#2)(2007-6#1)(2007-8#2)(2008-1#1)(2008-2#2)(2008-3#1)(2008-6#2)(2008-7#1)(2012-1#1)(2012-5#1)(2013-7#1)
perimetry##10##1##(1992-7#1)(1995-8#1)(2007-6#7)(2010-2#1)
perimicrovillar##3##1##(2007-12#3)
perimysium##5##1##(2010-2#3)(2013-1#2)
perinatal and neonatal##2##3##(2008-11#1)(2012-3#1)
perinatal and##5##2##(2007-7#1)(2008-11#2)(2011-1#1)(2012-3#1)
perinatal asphyxia##3##2##(2012-12#3)
perinatal care##11##2##(1990-9#1)(1995-6#2)(2007-2#1)(2008-11#1)(2011-12#1)(2013-1#5)
perinatal centres##2##2##(2008-11#2)
perinatal conditions##2##2##(1990-12#2)
perinatal copper deficiency##2##3##(2008-10#2)
perinatal data##2##2##(1991-11#1)(1997-8#1)
perinatal death##4##2##(1990-6#1)(1996-12#1)(2007-2#1)(2007-3#1)
perinatal deaths in##2##3##(1990-6#1)(1990-9#1)
perinatal deaths##6##2##(1990-6#1)(1990-9#1)(2004-10#1)(2006-2#1)(2010-8#1)(2012-12#1)
perinatal development##3##2##(1996-11#1)(1996-5#1)(1997-7#1)
perinatal education program##4##3##(2007-2#4)
perinatal education##16##2##(2007-2#16)
perinatal educator##3##2##(2007-2#2)(2010-9#1)
perinatal events##2##2##(1991-6#1)(1997-1#1)
perinatal health##2##2##(2007-2#2)
perinatal injury##2##2##(1996-3#1)(2006-6#1)
perinatal loss##11##2##(2007-2#8)(2007-4#3)
perinatal morbidity and mortality##6##4##(1991-11#1)(1991-6#1)(2006-1#1)(2007-7#1)(2007-8#1)(2013-1#1)
perinatal morbidity##8##2##(1991-11#1)(1991-6#1)(2006-1#1)(2007-7#1)(2007-8#1)(2011-12#2)(2013-1#1)
perinatal mortality in a##2##4##(2010-6#1)(2011-1#1)
perinatal mortality in the##2##4##(2007-10#1)(2012-12#1)
perinatal mortality in##7##3##(2007-10#1)(2010-6#1)(2011-1#2)(2011-12#1)(2012-12#2)
perinatal mortality rate was##4##4##(1990-3#1)(2004-10#2)(2012-12#1)
perinatal mortality rate##9##3##(1990-3#1)(1995-6#1)(2004-10#4)(2006-2#1)(2011-12#1)(2012-12#1)
perinatal mortality##31##2##(1990-3#1)(1990-9#1)(1991-6#2)(1994-3#1)(1995-6#1)(1996-11#1)(1996-12#1)(2004-10#4)(2005-11#1)(2006-10#2)(2006-2#1)(2007-10#1)(2008-3#1)(2008-7#1)(2010-6#1)(2011-1#3)(2011-12#3)(2012-12#4)(2012-2#1)
perinatal neonatal injuries##2##3##(2012-2#2)
perinatal or##2##2##(2010-9#1)(2011-1#1)
perinatal outcome##10##2##(1990-9#1)(2004-10#1)(2006-9#1)(2008-7#2)(2011-12#2)(2012-12#1)(2012-3#2)
perinatal outcomes##11##2##(2007-2#1)(2008-12#1)(2008-9#4)(2012-3#2)(2013-1#2)(2013-8#1)
perinatal pathology##2##2##(2006-6#2)
perinatal period##15##2##(1993-6#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-12#1)(2006-8#1)(2007-2#1)(2009-2#1)(2009-9#2)(2011-2#2)(2012-3#1)(2013-1#1)
perinatal program##2##2##(2007-2#2)
perinatal torsion##2##2##(2008-10#2)
perinatal transmission##3##2##(1991-2#1)(1996-2#1)(2012-2#1)
perinatal##229##1##(1990-11#1)(1990-12#2)(1990-3#1)(1990-6#2)(1990-7#1)(1990-9#4)(1991-11#2)(1991-2#1)(1991-6#5)(1991-9#1)(1992-12#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-5#2)(1993-6#3)(1993-7#1)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#2)(1995-12#1)(1995-6#5)(1996-11#3)(1996-12#4)(1996-2#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#3)(1997-8#1)(2004-10#6)(2005-11#1)(2006-1#1)(2006-10#2)(2006-2#2)(2006-6#3)(2006-8#1)(2006-9#1)(2007-10#3)(2007-2#40)(2007-3#1)(2007-4#3)(2007-7#2)(2007-8#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-3#2)(2008-7#4)(2008-9#5)(2009-1#1)(2009-10#2)(2009-2#1)(2009-7#2)(2009-9#2)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#6)(2011-12#8)(2011-2#6)(2012-12#13)(2012-2#8)(2012-3#7)(2013-1#11)(2013-8#1)
perinatally HIV-infected##2##2##(2009-7#2)
perinatally acquired##3##2##(1993-5#1)(1996-2#1)(2007-7#1)
perinatally exposed to##2##3##(2009-7#1)(2010-11#1)
perinatally exposed##5##2##(1990-5#1)(1995-3#1)(2006-10#1)(2009-7#1)(2010-11#1)
perinatally infected##2##2##(1995-3#1)(2009-4#1)
perinatally##18##1##(1990-5#1)(1990-9#1)(1991-9#1)(1992-6#1)(1993-5#1)(1995-3#2)(1996-2#2)(2006-10#1)(2007-7#1)(2009-4#1)(2009-7#4)(2009-8#1)(2010-11#1)
perindopril and##2##2##(1991-5#2)
perindopril##7##1##(1991-5#3)(2005-10#1)(2008-1#2)(2013-8#1)
perineal muscles##3##2##(1992-7#1)(1995-5#2)
perineal urethrostomy##2##2##(2008-10#2)
perineal##30##1##(1992-2#1)(1992-6#1)(1992-7#1)(1993-6#1)(1993-9#2)(1994-1#1)(1995-5#2)(2006-10#2)(2006-8#1)(2007-10#1)(2008-10#4)(2010-12#1)(2010-2#2)(2011-2#4)(2012-2#3)(2013-1#2)(2013-8#1)
perineoplastic liver##2##2##(2008-4#2)
perineoplastic##3##1##(2008-4#3)
perineum and##2##2##(2008-7#1)(2010-12#1)
perineum##12##1##(1992-12#1)(1992-9#1)(1993-1#2)(2008-10#3)(2008-7#2)(2010-11#1)(2010-12#1)(2010-2#1)
perineural infiltration##2##2##(2008-1#1)(2013-1#1)
perineural invasion##5##2##(2006-9#1)(2007-2#1)(2007-7#1)(2011-1#1)(2013-8#1)
perineural##8##1##(2006-9#1)(2007-2#1)(2007-7#1)(2008-1#2)(2011-1#1)(2013-1#1)(2013-8#1)
perineurioma##3##1##(2010-12#3)
perineurium##3##1##(1991-9#1)(2007-12#1)(2009-5#1)
perineuronal glia##2##2##(2013-8#2)
perineuronal##3##1##(2013-8#3)
perinuclear and##2##2##(2007-12#1)(2008-7#1)
perinuclear distribution##2##2##(1993-11#1)(1995-3#1)
perinuclear region##3##2##(1990-5#1)(1992-11#1)(2012-3#1)
perinuclear translocation##2##2##(1994-6#2)
perinuclear##30##1##(1990-5#1)(1992-11#1)(1993-11#4)(1994-6#2)(1994-8#1)(1994-9#1)(1995-3#1)(2006-10#1)(2006-12#1)(2007-12#3)(2007-2#1)(2007-5#1)(2008-7#3)(2008-9#3)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)
periocular carboplatin##2##2##(2011-1#2)
periocular##8##1##(1997-3#1)(2005-7#1)(2008-5#1)(2009-2#1)(2011-1#4)
period (1##4##2##(1990-3#1)(1994-3#1)(2007-9#1)(2008-7#1)
period (2##2##2##(1993-1#1)(2008-10#1)
period (48##2##2##(2007-9#1)(2013-8#1)
period (6 months)##2##3##(1993-5#1)(2007-7#1)
period (April##2##2##(2007-7#1)(2012-12#1)
period (January##3##2##(2007-3#1)(2008-5#1)(2011-2#1)
period (P = 0##4##4##(1996-3#1)(2008-10#1)(2010-2#1)(2013-1#1)
period (P##5##2##(1996-3#1)(2008-10#1)(2010-2#1)(2013-1#2)
period (about##2##2##(1992-11#1)(2008-10#1)
period (first##2##2##(1995-2#1)(2009-9#1)
period (from##3##2##(1992-4#1)(2008-11#1)(2011-2#1)
period (mean##5##2##(1992-9#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-7#1)
period (n =##4##3##(2008-3#2)(2008-8#1)(2012-2#1)
period (p &lt##4##3##(1996-1#1)(1996-12#2)(2008-6#1)
period (p##6##2##(1990-8#1)(1996-1#1)(1996-12#2)(2008-6#1)(2012-2#1)
period 1##7##2##(1990-4#2)(1991-9#1)(1996-9#1)(2009-6#1)(2012-12#1)(2013-1#1)
period 1980-1991##2##2##(1993-7#1)(1996-5#1)
period 1987-91##2##2##(1992-9#1)(1993-8#1)
period 1989-94##2##2##(1995-5#2)
period 1991-2000##2##2##(2008-9#2)
period 2##2##2##(2007-5#1)(2013-1#1)
period 23##2##2##(1991-9#1)(2008-7#1)
period I##3##2##(2006-10#1)(2007-3#1)(2010-8#1)
period II##4##2##(2006-10#1)(2007-3#2)(2010-8#1)
period January 1##2##3##(2007-12#1)(2011-2#1)
period January##10##2##(1990-6#1)(1992-6#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-9#1)(2010-12#1)(2011-2#2)(2013-1#1)
period October##3##2##(2006-12#1)(2006-7#1)(2011-1#1)
period a total of##3##4##(2008-10#1)(2008-5#1)(2011-1#1)
period according to##2##3##(2005-1#1)(2011-1#1)
period after continuous epidural anesthesia combined with##2##7##(2006-4#2)
period after the##4##3##(1991-2#1)(1996-9#1)(2008-10#1)(2008-8#1)
period after##42##2##(1990-2#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-3#1)(1992-5#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-9#1)(2005-12#1)(2006-10#1)(2006-4#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#7)(2007-9#1)(2008-10#4)(2008-4#1)(2008-8#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-3#1)
period among##2##2##(2012-3#1)(2013-8#1)
period an##2##2##(1991-5#1)(2011-1#1)
period and a##7##3##(1994-2#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
period and after##2##3##(2010-4#1)(2012-12#1)
period and cohort##3##3##(1996-3#2)(2009-4#1)
period and decrement##2##3##(1996-5#2)
period and discuss the##2##4##(2007-11#1)(2011-1#1)
period and early##3##3##(1997-3#1)(2012-3#2)
period and growth##2##3##(1994-8#1)(2012-3#1)
period and in##3##3##(2008-1#1)(2008-10#1)(2013-7#1)
period and later##3##3##(1990-9#1)(2006-8#1)(2008-12#1)
period and reduced the##2##4##(1991-12#1)(1996-12#1)
period and reduced##3##3##(1991-12#1)(1991-4#1)(1996-12#1)
period and showed##2##3##(2008-1#1)(2011-1#1)
period and subsequently##2##3##(1991-2#1)(2007-9#1)
period and that##3##3##(1991-9#1)(2009-9#1)(2010-8#1)
period and the first##2##4##(1997-2#1)(2007-7#1)
period and the##20##3##(1991-1#1)(1991-12#1)(1996-1#1)(1997-2#1)(2005-3#1)(2005-7#1)(2006-12#1)(2007-1#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#2)(2013-7#1)(2013-8#1)
period and then##3##3##(2007-9#1)(2008-10#1)(2011-2#1)
period and to##4##3##(1990-8#1)(1992-7#1)(2006-9#1)(2007-2#1)
period and was##4##3##(1995-7#1)(2008-11#1)(2008-8#1)(2012-2#1)
period and were##4##3##(2008-10#1)(2008-5#1)(2011-12#1)(2013-1#1)
period and##156##2##(1990-11#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#3)(1991-12#4)(1991-2#1)(1991-4#2)(1991-9#1)(1992-3#1)(1992-7#1)(1993-11#1)(1994-2#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2004-3#1)(2005-11#4)(2005-3#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#3)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#3)(2008-7#6)(2008-8#3)(2009-10#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#3)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#7)(2013-7#2)(2013-8#2)
period are##18##2##(1990-11#1)(1991-6#1)(1993-1#1)(1993-11#1)(1994-6#1)(1996-1#1)(2005-9#1)(2006-10#2)(2006-4#1)(2008-1#1)(2008-3#3)(2008-7#1)(2010-10#1)(2010-8#1)(2013-8#1)
period as compared with the##2##5##(2007-9#1)(2008-10#1)
period as the##2##3##(2007-11#1)(2008-10#1)
period as well as##2##4##(2004-12#1)(2008-2#1)
period as##13##2##(1996-11#1)(2004-12#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2013-1#2)
period at a single##2##4##(2008-8#1)(2011-2#1)
period at a##4##3##(2007-2#1)(2008-8#1)(2011-2#1)(2012-12#1)
period at the##2##3##(2004-9#1)(2007-3#1)
period at##19##2##(1990-7#1)(1995-8#1)(1996-6#1)(2004-9#1)(2007-2#2)(2007-3#1)(2008-10#4)(2008-5#2)(2008-8#1)(2011-2#3)(2012-12#1)(2012-2#1)
period because##2##2##(2007-8#1)(2011-2#1)
period before the##4##3##(2007-2#1)(2007-8#1)(2008-6#1)(2010-8#1)
period before##15##2##(1990-11#1)(1991-3#1)(1993-2#1)(2006-3#1)(2006-4#1)(2007-10#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-6#1)(2009-10#1)(2009-3#1)(2010-5#1)(2010-8#1)(2012-12#1)
period being##2##2##(2008-10#1)(2013-8#1)
period between 1987 and##2##4##(2005-9#1)(2008-4#1)
period between January 1998 and##2##5##(2005-12#1)(2011-1#1)
period between the##2##3##(2007-7#1)(2008-11#1)
period between two##2##3##(2008-7#1)(2009-6#1)
period between##37##2##(1990-4#1)(1993-7#1)(1994-2#1)(1996-5#2)(1997-2#1)(1997-6#1)(1997-7#1)(2005-12#1)(2005-9#1)(2007-11#2)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-6#1)(2009-7#1)(2009-9#1)(2011-1#2)(2011-2#2)(2013-1#1)
period but not on##2##4##(2007-12#1)(2008-10#1)
period but##7##2##(1991-3#1)(1993-3#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-5#1)
period by means of##2##4##(1990-8#1)(1992-7#1)
period by the##3##3##(2007-8#1)(2008-5#1)(2008-9#1)
period by##16##2##(1990-8#1)(1992-7#1)(1995-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-9#1)(2010-12#1)(2010-7#1)(2011-2#1)
period can affect the##2##4##(2007-11#1)(2010-7#1)
period can be##5##3##(1990-6#1)(2005-12#1)(2008-2#1)(2008-3#1)(2010-8#1)
period can##9##2##(1990-6#1)(1993-3#1)(2005-12#1)(2007-11#1)(2008-2#1)(2008-3#1)(2010-7#1)(2010-8#1)(2012-2#1)
period compared to##3##3##(2008-7#1)(2012-1#1)(2013-8#1)
period compared with##4##3##(1990-12#1)(1992-6#1)(2008-11#1)(2011-2#1)
period compared##8##2##(1990-12#1)(1992-6#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-1#1)(2013-8#1)
period considered##2##2##(1990-2#1)(1990-4#1)
period could##5##2##(1990-12#1)(2006-5#1)(2010-8#1)(2013-1#1)(2013-8#1)
period covering##2##2##(2011-2#1)(2012-2#1)
period differed##2##2##(2005-9#1)(2008-10#1)
period due to##3##3##(2007-11#1)(2008-11#1)(2013-1#1)
period during the##4##3##(1993-3#1)(2008-10#2)(2008-7#1)
period during which the##3##4##(1990-12#1)(2008-7#1)(2012-12#1)
period during which##8##3##(1990-12#1)(1991-11#1)(1992-1#1)(2008-2#1)(2008-7#1)(2010-6#1)(2011-12#1)(2012-12#1)
period during##14##2##(1990-12#1)(1991-11#1)(1992-1#1)(1993-3#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#2)(2009-4#1)(2010-6#1)(2011-12#1)(2012-12#1)
period ends##2##2##(1995-1#1)(2009-4#1)
period estimates##2##2##(1991-2#1)(1994-2#1)
period even though##2##3##(1997-2#1)(2008-10#1)
period followed by##2##3##(2008-10#2)
period following a##2##3##(1995-8#1)(2010-6#1)
period following the##3##3##(1993-3#1)(1993-6#1)(2004-11#1)
period following##24##2##(1991-1#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1995-1#1)(1995-8#2)(2004-11#1)(2006-8#1)(2007-11#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-6#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
period for each##3##3##(1990-12#1)(2007-1#1)(2008-11#1)
period for the##9##3##(1993-2#1)(1994-3#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-6#1)(2012-2#1)
period for##42##2##(1990-12#1)(1992-10#1)(1992-9#1)(1993-2#1)(1994-3#1)(1995-5#1)(1995-6#2)(1997-4#1)(2006-6#1)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-6#1)(2009-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#1)(2013-1#1)
period free of intracranial disease##2##5##(2012-2#2)
period free of##3##3##(2012-2#3)
period from 1989 to##2##4##(1993-9#1)(2005-10#1)
period from 1996 to##3##4##(2005-10#2)(2007-3#1)
period from 2001 to 2005##2##5##(2008-12#1)(2012-12#1)
period from 2002 to 2005##2##5##(2008-9#1)(2013-8#1)
period from 2002 to##3##4##(2008-9#1)(2010-9#1)(2013-8#1)
period from 4##2##3##(1996-12#1)(2010-12#1)
period from April##2##3##(2005-10#1)(2006-1#1)
period from December##3##3##(2010-7#1)(2012-12#2)
period from January 1##2##4##(2007-7#1)(2007-8#1)
period from January 1st##3##4##(2006-7#2)(2011-2#1)
period from January##11##3##(2005-12#1)(2006-7#2)(2006-8#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-5#1)(2011-2#1)(2013-1#1)
period from an##2##3##(2008-10#2)
period from the##7##3##(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#3)
period from##106##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-6#2)(1992-8#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-5#1)(1995-9#1)(1996-12#1)(1997-3#1)(1997-7#1)(2004-10#1)(2005-10#4)(2005-12#1)(2006-1#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-4#1)(2006-7#3)(2006-8#4)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#2)(2007-7#5)(2007-8#2)(2008-1#4)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2010-12#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#3)(2012-2#2)(2013-1#4)(2013-8#2)
period gratings##4##2##(2008-10#1)(2008-3#3)
period had a##4##3##(2008-10#2)(2008-7#1)(2010-8#1)
period had##7##2##(1995-6#1)(2006-7#1)(2007-10#1)(2008-10#2)(2008-7#1)(2010-8#1)
period has been##2##3##(1991-2#1)(2006-4#1)
period has##8##2##(1991-2#1)(1995-8#1)(1997-3#1)(2005-12#1)(2005-2#1)(2006-4#1)(2007-9#2)
period have been##4##3##(2005-11#1)(2007-11#1)(2007-12#1)(2008-6#1)
period have##7##2##(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-6#2)
period immediately##3##2##(2007-11#1)(2008-10#2)
period in 1995##2##3##(1996-11#1)(2008-5#1)
period in 54##2##3##(2010-12#1)(2013-1#1)
period in Group##2##3##(2010-7#2)
period in Polish botany##2##4##(2009-2#2)
period in a##8##3##(1994-12#1)(1997-2#1)(2006-4#1)(2008-10#2)(2008-3#1)(2010-5#1)(2011-1#1)
period in patients##5##3##(2005-10#1)(2005-7#2)(2012-3#1)(2013-1#1)
period in question##5##3##(1990-8#1)(2007-8#2)(2008-9#1)(2011-2#1)
period in spite of a##2##5##(1993-5#1)(2008-12#1)
period in the history of##2##5##(2007-11#1)(2009-2#1)
period in the##27##3##(1991-2#1)(1991-9#1)(1992-9#1)(1995-11#1)(1995-4#1)(1996-11#1)(1996-12#1)(1997-3#1)(1997-8#2)(2004-11#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-2#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-7#1)
period in which##9##3##(1990-11#1)(1995-11#1)(2006-4#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
period in##118##2##(1990-11#2)(1990-8#1)(1991-12#2)(1991-2#1)(1991-6#1)(1991-9#1)(1992-9#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-11#3)(1995-3#1)(1995-4#2)(1996-11#2)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-8#2)(2004-11#2)(2005-10#1)(2005-7#2)(2006-10#2)(2006-4#2)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-10#8)(2008-11#1)(2008-12#3)(2008-3#2)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#2)(2009-2#5)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#2)(2011-1#4)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
period increased##7##2##(1996-10#1)(1997-7#1)(2008-10#3)(2010-4#1)(2011-2#1)
period induced##3##2##(1995-12#1)(1996-10#1)(2009-9#1)
period is a##2##3##(1991-5#1)(2010-10#1)
period is needed##2##3##(1994-12#1)(2007-7#1)
period is required##2##3##(2006-11#1)(2013-8#1)
period is##43##2##(1990-5#1)(1991-5#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-12#1)(1996-3#1)(1996-8#1)(1997-3#1)(2006-10#1)(2006-11#1)(2006-4#2)(2007-1#1)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-12#1)(2010-10#2)(2010-4#1)(2010-7#1)(2013-1#1)(2013-8#1)
period it##3##2##(2008-7#1)(2010-6#1)(2013-1#1)
period lasted##4##2##(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)
period length of 26 min##2##5##(2008-7#1)(2009-9#1)
period length of##4##3##(2006-1#1)(2008-7#2)(2009-9#1)
period length##8##2##(2006-1#1)(2008-10#2)(2008-5#1)(2008-7#3)(2009-9#1)
period may##5##2##(1997-5#1)(2006-5#1)(2007-11#1)(2008-5#1)(2011-2#1)
period might##2##2##(1991-9#1)(2012-11#1)
period modulation and##2##3##(2008-5#2)
period modulation##4##2##(2008-5#4)
period of 1 year##4##4##(2007-10#1)(2008-6#2)(2012-12#1)
period of 1##12##3##(1990-3#1)(1995-5#1)(2006-8#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-6#2)(2008-9#1)(2011-1#1)(2012-12#1)
period of 1-2##2##3##(2005-11#1)(2009-4#1)
period of 10 days##2##4##(2006-10#1)(2008-10#1)
period of 10 min##3##4##(1992-3#1)(1994-12#1)(2007-8#1)
period of 10##16##3##(1992-3#1)(1994-12#1)(1994-9#1)(1995-3#1)(1997-2#1)(2006-10#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2009-4#1)(2011-1#1)(2011-12#1)(2013-8#2)
period of 12 weeks##2##4##(1993-7#1)(2008-5#1)
period of 12 years##2##4##(1993-5#1)(2010-6#1)
period of 12##14##3##(1990-11#1)(1991-4#1)(1993-5#1)(1993-7#1)(1995-10#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-4#2)(2010-6#1)
period of 14##5##3##(1990-9#1)(2005-10#1)(2007-3#1)(2007-7#1)(2008-10#1)
period of 15##6##3##(1990-2#1)(1990-8#1)(1992-12#1)(2007-9#1)(2008-5#1)(2012-2#1)
period of 16##4##3##(1991-6#1)(1997-8#1)(2007-3#1)(2008-6#1)
period of 17##2##3##(2007-7#1)(2008-6#1)
period of 19##2##3##(1993-8#1)(1996-2#1)
period of 2 h##2##4##(2008-10#2)
period of 2 months##3##4##(2006-12#1)(2007-2#1)(2009-5#1)
period of 2 weeks##4##4##(1991-2#1)(1992-10#1)(2008-11#1)(2011-2#1)
period of 2##16##3##(1991-2#1)(1992-10#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-7#2)(2009-5#1)(2010-12#1)(2011-2#1)
period of 2-3##3##3##(1994-3#1)(2007-11#1)(2013-8#1)
period of 20 years from##2##5##(1995-11#1)(2008-7#1)
period of 20 years##5##4##(1995-11#1)(1997-8#1)(2007-2#1)(2008-7#2)
period of 20##9##3##(1995-11#1)(1995-9#1)(1996-5#1)(1997-8#1)(2007-12#1)(2007-2#1)(2008-3#1)(2008-7#2)
period of 2000-2008##2##3##(2011-1#1)(2011-2#1)
period of 21##4##3##(1994-5#1)(2007-7#1)(2008-4#1)(2008-7#1)
period of 24 h##6##4##(1996-1#1)(1997-2#1)(2008-10#2)(2010-11#1)(2010-8#1)
period of 24##8##3##(1993-10#1)(1996-1#1)(1997-2#1)(2008-10#2)(2008-5#1)(2010-11#1)(2010-8#1)
period of 3 h##2##4##(1996-7#1)(2010-12#1)
period of 3 months##5##4##(2006-6#1)(2008-10#2)(2008-7#1)(2009-8#1)
period of 3 years##8##4##(1990-5#1)(2006-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#1)
period of 3##20##3##(1990-5#1)(1994-3#1)(1996-7#1)(2006-3#1)(2006-6#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-12#1)
period of 30 days##4##4##(2006-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
period of 30 min##2##4##(1994-8#1)(2008-10#1)
period of 30##10##3##(1993-3#1)(1994-8#1)(1997-8#1)(2006-5#1)(2008-10#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
period of 4 weeks##4##4##(1990-8#1)(2007-7#1)(2008-10#1)(2008-3#1)
period of 4##12##3##(1990-8#1)(1991-3#1)(1991-6#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-10#3)(2008-3#1)(2011-1#1)(2011-2#1)
period of 43##2##3##(1993-8#1)(2009-10#1)
period of 45##2##3##(1993-12#1)(2006-5#1)
period of 48 hours##2##4##(1992-5#1)(2006-4#1)
period of 48##4##3##(1992-5#1)(2006-4#1)(2009-2#1)(2011-1#1)
period of 5 months##4##4##(1991-2#1)(1995-1#1)(2008-10#2)
period of 5 years##4##4##(1994-10#1)(1997-2#1)(2006-2#1)(2008-7#1)
period of 5##13##3##(1991-2#1)(1994-10#1)(1994-3#1)(1995-1#1)(1997-2#1)(2006-2#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)
period of 50##2##3##(1991-6#1)(2008-10#1)
period of 6 h##3##4##(2007-8#1)(2008-11#1)(2008-5#1)
period of 6 weeks##7##4##(2005-11#1)(2007-11#1)(2007-8#1)(2008-11#2)(2008-6#1)(2013-1#1)
period of 6 years##2##4##(2007-8#1)(2009-4#1)
period of 6##24##3##(1992-10#1)(1992-3#1)(1992-6#1)(1997-3#1)(2005-11#1)(2006-9#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-11#3)(2008-5#1)(2008-6#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
period of 7 days##3##4##(1990-2#1)(1992-3#1)(2009-5#1)
period of 7##8##3##(1990-2#1)(1992-3#1)(1995-3#1)(1996-5#1)(2007-10#1)(2007-2#1)(2008-10#1)(2009-5#1)
period of 8 months##2##4##(2008-12#1)(2008-5#1)
period of 8##6##3##(2004-11#1)(2008-1#1)(2008-12#1)(2008-5#1)(2010-1#1)(2012-12#1)
period of 9 days##2##4##(1990-6#1)(2011-2#1)
period of 9##4##3##(1990-6#1)(1996-3#1)(2007-12#1)(2011-2#1)
period of 90##2##3##(1990-8#1)(2009-5#1)
period of a##4##3##(1995-11#1)(2007-7#1)(2007-8#1)(2012-12#1)
period of about##7##3##(1991-2#1)(1991-5#1)(1996-9#1)(1997-7#1)(1997-8#1)(2008-6#1)(2013-7#1)
period of abstinence##3##3##(1996-5#3)
period of approximately##9##3##(1990-8#1)(1991-2#1)(1992-7#1)(1996-9#1)(2007-7#1)(2008-11#1)(2008-5#2)(2012-12#1)
period of at least 12##2##5##(2008-10#1)(2012-11#1)
period of at least 6 months##3##6##(1990-12#1)(2006-10#1)(2007-5#1)
period of at least 6##4##5##(1990-12#1)(1996-5#1)(2006-10#1)(2007-5#1)
period of at least##11##4##(1990-12#2)(1992-8#1)(1996-5#1)(2006-10#1)(2007-5#1)(2008-10#2)(2008-5#2)(2012-11#1)
period of berry susceptibility##2##4##(2008-10#2)
period of berry##3##3##(2008-10#3)
period of cardiac surgery##2##4##(2007-8#1)(2013-1#1)
period of culture##2##3##(1990-7#1)(2008-11#1)
period of decrease##2##3##(1994-3#1)(2009-8#1)
period of development##3##3##(1992-7#1)(2008-8#1)(2008-9#1)
period of eight##5##3##(1990-10#1)(2005-1#1)(2006-5#1)(2011-1#1)(2012-3#1)
period of exposure to the##2##5##(1993-6#1)(2006-8#1)
period of exposure##4##3##(1993-6#1)(1993-7#1)(2006-8#1)(2008-4#1)
period of fasting##2##3##(1996-5#1)(2012-3#1)
period of five years##8##4##(1990-4#1)(1997-5#1)(2007-6#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-2#1)(2012-2#1)
period of five##11##3##(1990-4#1)(1995-1#1)(1997-5#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-2#1)(2012-2#1)(2013-8#1)
period of follow-up##2##3##(1997-4#1)(2007-10#1)
period of four##5##3##(1991-6#1)(1997-5#1)(2007-8#1)(2008-1#1)(2011-2#1)
period of fruit susceptibility##4##4##(2008-10#4)
period of growth##4##3##(1995-3#1)(1996-3#1)(2008-10#1)(2011-2#1)
period of high##4##3##(1995-12#1)(1996-2#1)(1996-6#1)(2008-10#1)
period of hospitalization##2##3##(1996-6#1)(2011-2#1)
period of hypotension##2##3##(2005-10#2)
period of incubation##2##3##(1994-12#1)(2007-2#1)
period of infection##2##3##(1996-11#1)(2010-12#1)
period of investigation##3##3##(1991-11#1)(1992-6#1)(2012-7#1)
period of ischemia##3##3##(1991-8#1)(1991-9#1)(1994-10#1)
period of life##2##3##(1993-2#1)(2008-7#1)
period of maximum##4##3##(1990-5#1)(2008-10#3)
period of more than 20 years##2##6##(2008-7#1)(2012-2#1)
period of more than 20##4##5##(2006-2#1)(2007-9#1)(2008-7#1)(2012-2#1)
period of more than##11##4##(1995-7#1)(2004-11#2)(2006-2#2)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-7#1)(2012-2#1)
period of myocardial ischemia##2##4##(2006-10#2)
period of myocardial##3##3##(2006-10#2)(2009-4#1)
period of nine years##4##4##(1992-5#1)(2007-3#1)(2011-12#1)(2011-2#1)
period of nine##7##3##(1992-5#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-9#1)(2011-12#1)(2011-2#1)
period of observation was##2##4##(1991-12#1)(1992-6#1)
period of observation##10##3##(1990-5#1)(1990-8#1)(1991-12#1)(1992-6#2)(1994-7#1)(1997-7#1)(2009-6#1)(2012-1#1)(2013-1#1)
period of one year from##2##5##(2007-3#1)(2013-8#1)
period of one year##18##4##(1994-8#1)(1997-6#1)(2007-11#1)(2007-3#4)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2012-3#1)(2013-8#2)
period of one##26##3##(1993-6#1)(1994-8#1)(1997-6#1)(2004-9#1)(2007-11#1)(2007-3#4)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-1#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
period of rapid change##2##4##(1997-3#1)(2008-3#1)
period of rapid##3##3##(1997-3#1)(2007-4#1)(2008-3#1)
period of several##3##3##(2008-10#2)(2009-2#1)
period of six##11##3##(1990-12#1)(1991-12#1)(1991-2#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#1)(2013-7#1)
period of sleep##2##3##(1996-1#1)(2008-12#1)
period of stable disease##4##4##(2006-11#1)(2008-6#3)
period of storage##3##3##(2008-11#1)(2008-12#1)(2011-2#1)
period of study##6##3##(2007-2#1)(2008-12#1)(2008-6#1)(2009-6#1)(2011-1#1)(2012-12#1)
period of the grating##2##4##(2007-11#1)(2008-3#1)
period of the last##2##4##(2007-12#1)(2008-9#1)
period of the study##4##4##(2006-6#1)(2006-8#1)(2007-7#1)(2011-2#1)
period of the##53##3##(1991-1#2)(1991-12#1)(1991-3#1)(1992-3#3)(1993-3#1)(1993-6#1)(1994-11#1)(1994-8#2)(1996-12#1)(1997-1#1)(2005-1#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#5)(2007-12#3)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-2#5)(2008-3#5)(2008-5#2)(2008-9#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
period of therapy##2##3##(1992-5#1)(2012-1#1)
period of these##3##3##(2006-6#1)(2007-11#1)(2008-6#1)
period of this##3##3##(1996-9#1)(2005-5#1)(2013-7#1)
period of three months##6##4##(1991-4#1)(1992-11#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-11#1)
period of three years##5##4##(2008-1#1)(2008-4#1)(2008-8#1)(2009-5#1)(2011-1#1)
period of three##14##3##(1990-6#1)(1991-3#1)(1991-4#1)(1992-11#1)(1996-6#1)(2006-10#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-8#1)(2009-5#1)(2011-1#1)
period of time (30##2##4##(2008-1#1)(2009-12#1)
period of time after##3##4##(1992-3#1)(1996-11#1)(2008-10#1)
period of time as the##2##5##(1995-6#1)(2008-3#1)
period of time can##3##4##(1996-1#1)(2005-11#1)(2008-11#1)
period of time in##5##4##(1997-2#1)(2007-6#1)(2008-11#1)(2008-4#1)(2011-11#1)
period of time than##3##4##(1990-5#1)(1993-3#1)(2008-1#1)
period of time that##3##4##(1991-6#1)(2013-1#2)
period of time there##2##4##(1990-11#1)(2004-10#1)
period of time to##5##4##(1996-3#2)(2008-12#1)(2011-1#1)(2013-1#1)
period of time when##2##4##(1993-2#1)(2008-10#1)
period of time with##2##4##(1995-3#1)(2005-11#1)
period of time##124##3##(1990-11#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-6#2)(1991-8#1)(1992-11#1)(1992-3#2)(1992-8#1)(1993-2#1)(1993-3#3)(1993-5#1)(1993-8#1)(1994-10#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-5#2)(1995-6#4)(1996-1#1)(1996-11#1)(1996-3#2)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(2004-10#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-3#1)(2006-6#1)(2006-7#1)(2007-11#2)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#10)(2008-11#8)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#3)(2008-5#4)(2008-8#3)(2008-9#2)(2009-11#2)(2009-12#1)(2009-2#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-6#1)(2011-1#3)(2011-11#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2013-1#5)(2013-8#1)
period of treatment##6##3##(1992-3#1)(1993-9#1)(2006-6#1)(2007-8#2)(2008-2#1)
period of two weeks##4##4##(1992-2#1)(1993-5#1)(2008-4#1)(2008-8#1)
period of two##13##3##(1991-12#1)(1992-2#1)(1993-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)
period of up to##2##4##(1997-4#1)(2006-12#1)
period of##960##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#4)(1990-3#2)(1990-4#3)(1990-5#9)(1990-6#3)(1990-7#3)(1990-8#10)(1990-9#1)(1991-1#2)(1991-11#3)(1991-12#4)(1991-2#9)(1991-3#5)(1991-4#3)(1991-5#2)(1991-6#6)(1991-8#3)(1991-9#4)(1992-10#4)(1992-11#4)(1992-12#1)(1992-2#2)(1992-3#10)(1992-5#4)(1992-6#8)(1992-7#2)(1992-8#7)(1992-9#1)(1993-1#2)(1993-10#3)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#7)(1993-5#4)(1993-6#3)(1993-7#4)(1993-8#4)(1993-9#1)(1994-10#4)(1994-11#2)(1994-12#4)(1994-3#5)(1994-5#1)(1994-6#4)(1994-7#2)(1994-8#6)(1994-9#1)(1995-1#7)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#6)(1995-5#4)(1995-6#4)(1995-7#1)(1995-9#2)(1996-1#3)(1996-11#4)(1996-12#2)(1996-2#2)(1996-3#7)(1996-5#8)(1996-6#3)(1996-7#3)(1996-8#2)(1996-9#7)(1997-1#1)(1997-2#8)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#5)(2004-1#1)(2004-10#1)(2004-11#4)(2004-9#1)(2005-1#2)(2005-10#4)(2005-11#5)(2005-5#1)(2005-6#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#17)(2006-11#1)(2006-12#5)(2006-2#3)(2006-3#3)(2006-4#2)(2006-5#6)(2006-6#9)(2006-7#2)(2006-8#6)(2006-9#1)(2007-1#1)(2007-10#7)(2007-11#18)(2007-12#16)(2007-2#9)(2007-3#12)(2007-4#3)(2007-5#3)(2007-6#4)(2007-7#24)(2007-8#31)(2007-9#5)(2008-1#18)(2008-10#82)(2008-11#27)(2008-12#7)(2008-2#14)(2008-3#16)(2008-4#14)(2008-5#28)(2008-6#17)(2008-7#21)(2008-8#15)(2008-9#11)(2009-10#2)(2009-11#4)(2009-12#1)(2009-2#8)(2009-3#1)(2009-4#6)(2009-5#5)(2009-6#2)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#11)(2010-2#1)(2010-3#2)(2010-4#4)(2010-6#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#20)(2011-11#1)(2011-12#5)(2011-2#23)(2012-1#5)(2012-11#2)(2012-12#11)(2012-2#15)(2012-3#5)(2012-4#1)(2012-7#1)(2013-1#21)(2013-7#5)(2013-8#14)
period on the##4##3##(2007-8#1)(2008-4#1)(2008-8#1)(2013-8#1)
period on##19##2##(1991-3#1)(2006-8#1)(2007-8#2)(2008-10#6)(2008-3#2)(2008-4#1)(2008-8#1)(2010-11#1)(2012-12#1)(2013-1#2)(2013-8#1)
period only##3##2##(2006-10#1)(2007-8#1)(2008-10#1)
period or at##2##3##(2005-11#1)(2007-1#1)
period or##11##2##(2005-10#1)(2005-11#1)(2006-1#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-10#2)(2009-6#1)
period over the##2##3##(1991-2#1)(2006-10#1)
period preceding the##2##3##(1996-3#1)(2008-11#1)
period prevalence##4##2##(1994-2#1)(2011-1#3)
period prior to##5##3##(2006-12#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-11#1)
period ranging from##3##3##(1997-2#1)(2007-8#1)(2013-1#1)
period related to##3##3##(1990-9#1)(2006-10#1)(2007-10#1)
period represents##2##2##(2008-1#1)(2010-2#1)
period required for##3##3##(1990-9#1)(2008-10#1)(2011-1#1)
period required##4##2##(1990-9#1)(2008-10#1)(2011-1#1)(2012-1#1)
period resulted in##3##3##(1991-12#1)(1991-9#1)(1996-11#1)
period reviewed##2##2##(2006-10#1)(2007-12#1)
period should be##2##3##(1995-9#1)(2006-10#1)
period should##3##2##(1993-7#1)(1995-9#1)(2006-10#1)
period showed that##2##3##(2008-5#1)(2010-11#1)
period showed##7##2##(1991-5#1)(1995-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-11#1)(2012-1#1)
period since##2##2##(1996-3#1)(2008-10#1)
period studied##12##2##(1992-12#1)(1993-3#1)(1995-5#1)(1995-8#1)(1996-11#2)(1997-6#1)(2007-7#1)(2008-10#2)(2010-11#1)(2011-1#1)
period than during the##2##4##(1995-11#1)(2006-8#1)
period than in the##2##4##(1995-11#1)(1996-1#1)
period than##8##2##(1991-9#1)(1994-12#1)(1995-11#2)(1996-1#1)(2006-8#1)(2008-5#1)(2008-9#1)
period that the##2##3##(2008-10#1)(2008-3#1)
period that##12##2##(1994-8#1)(1996-9#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2009-8#1)(2011-2#1)
period the mean##2##3##(1990-11#1)(2008-4#1)
period the##23##2##(1990-11#1)(1991-6#1)(1993-10#1)(1993-8#1)(1995-9#1)(1997-1#1)(1997-3#1)(2005-1#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#1)(2011-3#1)(2012-3#1)(2013-7#1)
period there##2##2##(1990-9#1)(2011-2#1)
period they##2##2##(1995-5#1)(2008-10#1)
period three##2##2##(1995-5#2)
period through the##2##3##(2007-11#1)(2010-5#1)
period through##4##2##(2007-11#1)(2010-5#1)(2011-2#1)(2012-2#1)
period thus##2##2##(2007-8#1)(2012-2#1)
period to adult##2##3##(2009-10#1)(2010-12#1)
period to assess the##3##4##(2005-8#1)(2008-5#1)(2009-11#1)
period to determine##2##3##(2008-10#1)(2010-2#1)
period to evaluate##2##3##(2007-2#1)(2008-10#1)
period to produce##2##3##(2007-12#1)(2008-11#1)
period to the##3##3##(2007-2#1)(2010-10#1)(2012-2#1)
period to##38##2##(1992-7#1)(1992-9#1)(1994-1#1)(1997-3#1)(2005-8#1)(2006-1#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-2#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2009-10#1)(2009-11#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#1)
period under##5##2##(2006-10#2)(2006-8#1)(2007-5#1)(2013-1#1)
period until##3##2##(1996-11#1)(2008-1#1)(2011-2#1)
period up to##5##3##(1996-1#1)(2005-7#1)(2007-11#1)(2008-6#1)(2011-2#1)
period using##5##2##(1997-4#1)(2005-11#1)(2007-1#1)(2008-3#1)(2009-8#1)
period values##4##2##(1990-10#1)(2008-10#2)(2008-3#1)
period varied##3##2##(1991-12#1)(2008-11#1)(2011-1#1)
period via##2##2##(2008-10#2)
period was 19##2##3##(1990-9#1)(2007-8#1)
period was 24 months##2##4##(2006-12#1)(2011-2#1)
period was 4##3##3##(1996-8#1)(1997-8#1)(2007-8#1)
period was 8##2##3##(2007-11#1)(2007-2#1)
period was 9##2##3##(2007-11#1)(2007-7#1)
period was calculated##2##3##(2008-9#1)(2011-1#1)
period was determined##2##3##(2007-8#1)(2008-4#1)
period was followed##2##3##(2008-10#1)(2008-3#1)
period was from##3##3##(2007-7#1)(2012-2#1)(2013-7#1)
period was just##3##3##(2008-10#1)(2013-1#2)
period was measured##2##3##(2008-10#1)(2008-5#1)
period was not##3##3##(2008-10#2)(2008-7#1)
period was observed##2##3##(2007-11#1)(2008-10#1)
period was performed##2##3##(2007-8#1)(2012-5#1)
period was the##3##3##(2006-10#1)(2008-7#2)
period was uneventful##3##3##(1991-11#1)(2010-7#1)(2011-12#1)
period was used##2##3##(2011-1#1)(2012-12#1)
period was##111##2##(1990-9#1)(1991-11#1)(1991-3#1)(1991-9#1)(1992-12#1)(1994-10#1)(1995-7#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-8#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#3)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#5)(2007-8#7)(2008-1#2)(2008-10#19)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#5)(2008-9#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#3)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-5#1)(2013-1#4)(2013-7#2)(2013-8#4)
period we have##2##3##(1991-5#1)(2008-5#1)
period we##5##2##(1991-5#1)(1996-12#1)(1996-8#1)(2008-5#1)(2009-2#1)
period were achieved##2##3##(2004-11#1)(2008-7#1)
period were also evaluated##2##4##(1994-2#1)(2004-3#1)
period were also##3##3##(1991-11#1)(1994-2#1)(2004-3#1)
period were calculated##2##3##(2011-1#1)(2011-2#1)
period were determined##2##3##(2005-11#1)(2007-12#1)
period were not##2##3##(2007-5#1)(2007-7#1)
period were reviewed##2##3##(1996-12#1)(2012-1#1)
period were studied##6##3##(1994-2#1)(1995-3#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)
period were##45##2##(1990-12#1)(1991-11#1)(1991-12#1)(1991-8#1)(1992-5#1)(1994-2#3)(1994-3#1)(1995-1#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-8#1)(2004-11#1)(2004-3#1)(2005-11#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#3)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-7#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#2)
period when compared with##2##4##(1990-11#1)(2008-10#1)
period when the##5##3##(1990-12#1)(1995-11#1)(1996-12#1)(2009-4#1)(2009-6#1)
period when##24##2##(1990-11#2)(1990-12#1)(1992-6#1)(1992-8#1)(1994-12#1)(1994-7#1)(1994-9#1)(1995-11#1)(1996-12#1)(1996-5#1)(2004-4#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-6#1)(2011-2#1)(2012-12#1)
period where##2##2##(1995-3#1)(2013-8#1)
period which is##3##3##(1991-5#1)(1993-6#1)(1994-10#1)
period which##4##2##(1991-5#1)(1993-6#1)(1994-10#1)(2008-11#1)
period while##2##2##(2008-6#1)(2008-7#1)
period who##2##2##(2008-12#1)(2008-7#1)
period with a##3##3##(1991-2#1)(2008-10#1)(2011-2#1)
period with no##2##3##(1991-8#1)(2008-10#1)
period with the##4##3##(1992-6#1)(1997-6#1)(2011-2#1)(2012-2#1)
period with##33##2##(1990-12#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-6#1)(1993-4#1)(1996-3#1)(1997-2#1)(1997-6#1)(2006-10#1)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#3)(2008-9#1)(2011-2#3)(2012-11#1)(2012-2#1)(2013-1#2)(2013-8#1)
period without any##2##3##(2008-3#1)(2011-12#1)
period without##6##2##(1991-8#1)(1997-8#1)(2008-3#2)(2011-12#1)(2012-1#1)
period##4168##1##(1990-10#9)(1990-11#16)(1990-12#17)(1990-2#11)(1990-3#10)(1990-4#12)(1990-5#21)(1990-6#13)(1990-7#7)(1990-8#22)(1990-9#14)(1991-1#9)(1991-10#3)(1991-11#8)(1991-12#21)(1991-2#22)(1991-3#13)(1991-4#12)(1991-5#13)(1991-6#20)(1991-7#2)(1991-8#15)(1991-9#22)(1992-1#11)(1992-10#13)(1992-11#9)(1992-12#9)(1992-2#17)(1992-3#18)(1992-4#5)(1992-5#11)(1992-6#28)(1992-7#9)(1992-8#17)(1992-9#10)(1993-1#11)(1993-10#8)(1993-11#5)(1993-12#6)(1993-2#9)(1993-3#19)(1993-4#5)(1993-5#12)(1993-6#10)(1993-7#8)(1993-8#10)(1993-9#9)(1994-1#3)(1994-10#7)(1994-11#5)(1994-12#19)(1994-2#16)(1994-3#16)(1994-4#2)(1994-5#8)(1994-6#14)(1994-7#5)(1994-8#11)(1994-9#7)(1995-1#12)(1995-10#7)(1995-11#13)(1995-12#11)(1995-2#9)(1995-3#16)(1995-4#3)(1995-5#20)(1995-6#13)(1995-7#9)(1995-8#13)(1995-9#11)(1996-1#15)(1996-10#2)(1996-11#20)(1996-12#19)(1996-2#11)(1996-3#28)(1996-4#4)(1996-5#18)(1996-6#5)(1996-7#3)(1996-8#7)(1996-9#18)(1997-1#9)(1997-2#20)(1997-3#17)(1997-4#26)(1997-5#7)(1997-6#12)(1997-7#7)(1997-8#23)(2004-1#2)(2004-10#10)(2004-11#14)(2004-12#1)(2004-2#6)(2004-3#5)(2004-4#3)(2004-9#2)(2005-1#4)(2005-10#14)(2005-11#17)(2005-12#7)(2005-2#1)(2005-3#2)(2005-5#1)(2005-6#1)(2005-7#5)(2005-8#7)(2005-9#7)(2006-1#8)(2006-10#94)(2006-11#10)(2006-12#24)(2006-2#9)(2006-3#5)(2006-4#19)(2006-5#19)(2006-6#16)(2006-7#20)(2006-8#69)(2006-9#9)(2007-1#12)(2007-10#33)(2007-11#79)(2007-12#68)(2007-2#46)(2007-3#45)(2007-4#5)(2007-5#22)(2007-6#11)(2007-7#95)(2007-8#127)(2007-9#43)(2008-1#60)(2008-10#357)(2008-11#84)(2008-12#33)(2008-2#62)(2008-3#82)(2008-4#37)(2008-5#112)(2008-6#58)(2008-7#96)(2008-8#56)(2008-9#49)(2009-1#3)(2009-10#11)(2009-11#10)(2009-12#4)(2009-2#26)(2009-3#7)(2009-4#17)(2009-5#8)(2009-6#12)(2009-7#7)(2009-8#9)(2009-9#9)(2010-1#5)(2010-10#10)(2010-11#9)(2010-12#28)(2010-2#10)(2010-3#12)(2010-4#22)(2010-5#12)(2010-6#11)(2010-7#13)(2010-8#26)(2010-9#11)(2011-1#77)(2011-11#1)(2011-12#25)(2011-2#145)(2011-3#6)(2011-9#1)(2012-1#27)(2012-11#17)(2012-12#61)(2012-2#88)(2012-3#32)(2012-4#1)(2012-5#4)(2012-7#3)(2013-1#123)(2013-7#21)(2013-8#59)
period&quot##4##1##(1995-12#1)(1997-1#1)(2008-6#1)(2011-2#1)
period) and##4##2##(2006-10#1)(2008-10#1)(2008-12#1)(2008-7#1)
period)##39##1##(1991-12#1)(1997-2#2)(2005-8#1)(2006-10#1)(2007-8#2)(2008-1#1)(2008-10#10)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#3)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-6#1)(2012-12#2)(2013-8#1)
period-doubling##3##1##(2007-12#2)(2008-3#1)
period?##2##1##(2007-2#1)(2008-7#1)
period]##17##1##(1991-9#1)(1993-9#1)(1996-10#1)(1997-3#1)(2005-9#1)(2007-10#1)(2008-10#4)(2008-12#1)(2008-4#1)(2009-2#1)(2009-5#1)(2011-2#1)(2012-3#2)
periodate and##7##2##(2007-7#1)(2008-10#6)
periodate in##3##2##(1992-3#1)(2008-10#2)
periodate ions##2##2##(2008-10#2)
periodate oxidation and##2##3##(1991-12#1)(2008-8#1)
periodate oxidation of##5##3##(1992-3#1)(1995-3#1)(2008-10#3)
periodate oxidation##15##2##(1990-8#1)(1991-12#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-4#1)(1995-11#2)(1995-3#1)(2005-7#1)(2008-10#3)(2008-8#1)
periodate to the##2##3##(1991-1#1)(2008-10#1)
periodate to##3##2##(1991-1#1)(2008-10#2)
periodate was##2##2##(2008-10#2)
periodate with##3##2##(2008-10#3)
periodate##58##1##(1990-8#1)(1991-1#1)(1991-12#1)(1992-12#1)(1992-3#3)(1992-6#1)(1992-9#1)(1993-3#1)(1993-4#1)(1995-11#2)(1995-3#1)(1996-12#1)(2005-7#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#36)(2008-4#1)(2008-8#1)
periodate-bromate and##4##2##(2008-10#4)
periodic Bragg##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
periodic acid##2##2##(2005-12#1)(2009-7#1)
periodic acid-Schiff##7##2##(1990-6#1)(1992-6#1)(2008-4#1)(2010-12#1)(2010-7#1)(2010-8#1)(2012-3#1)
periodic and##6##2##(1996-5#1)(2005-10#1)(2008-2#1)(2008-3#2)(2009-11#1)
periodic array of##3##3##(1992-7#1)(2007-12#1)(2008-3#1)
periodic arrays of##3##3##(2006-12#1)(2008-3#1)(2009-2#1)
periodic arrays##4##2##(2006-12#1)(2008-3#2)(2009-2#1)
periodic autocorrelation functions##2##3##(2008-2#2)
periodic autocorrelation##3##2##(2008-2#3)
periodic behavior##4##2##(1990-8#1)(1992-4#1)(2006-10#1)(2007-9#1)
periodic bending##3##2##(2008-1#3)
periodic boundary conditions##5##3##(1991-2#1)(2007-9#1)(2008-2#1)(2008-3#1)(2010-7#1)
periodic catatonia##7##2##(1995-11#4)(1996-5#3)
periodic changes in##2##3##(1997-4#1)(2008-7#1)
periodic component##2##2##(1997-5#1)(2008-9#1)
periodic cycle##3##2##(2007-9#1)(2008-10#2)
periodic dielectric##3##2##(1992-3#1)(2008-3#1)(2010-4#1)
periodic dispersion##4##2##(2007-11#1)(2007-12#3)
periodic distribution of##3##3##(1990-5#2)(2007-9#1)
periodic domain##2##2##(2008-3#1)(2011-1#1)
periodic electric field##2##3##(2005-11#1)(2008-3#1)
periodic fibers##2##2##(2007-12#2)
periodic follow-up##2##2##(2008-12#1)(2008-4#1)
periodic gratings##2##2##(2007-12#2)
periodic in##2##2##(1990-11#1)(2007-11#1)
periodic interference##2##2##(1991-12#2)
periodic irradiation##3##2##(2006-10#3)
periodic length##2##2##(2007-12#1)(2008-2#1)
periodic limb movement disorder##2##4##(2008-8#1)(2012-3#1)
periodic limb movement##3##3##(2008-8#1)(2012-3#2)
periodic mesoporous##2##2##(2006-12#2)
periodic microbends##2##2##(2007-12#2)
periodic modulation of the##3##4##(2007-12#3)
periodic monitoring of serum##2##4##(1992-4#1)(2009-11#1)
periodic monitoring of##3##3##(1992-4#1)(2007-3#1)(2009-11#1)
periodic nonlinearity in##2##3##(2008-2#1)(2008-3#1)
periodic nonlinearity##6##2##(2008-2#2)(2008-3#4)
periodic or odd-periodic correlation##2##4##(2008-2#1)(2008-3#1)
periodic or##3##2##(2008-2#1)(2008-3#1)(2008-9#1)
periodic orbits##5##2##(1992-8#1)(1993-6#1)(1995-2#1)(2006-10#1)(2007-12#1)
periodic oscillation##2##2##(2006-10#1)(2007-11#1)
periodic oscillations##5##2##(2006-10#2)(2007-2#1)(2008-7#1)(2009-2#1)
periodic pain##2##2##(1995-10#1)(2007-7#1)
periodic paralysis is##2##3##(2007-5#2)
periodic paralysis##8##2##(1991-12#2)(2007-5#4)(2008-8#1)(2010-12#1)
periodic pattern of##3##3##(1990-5#1)(2007-11#1)(2008-2#1)
periodic pattern##5##2##(1990-5#1)(2007-11#1)(2008-2#1)(2008-3#2)
periodic patterns##2##2##(2007-12#1)(2008-2#1)
periodic phase##3##2##(2007-12#3)
periodic poling of ferroelectric##2##4##(2007-12#2)
periodic poling of##4##3##(2007-12#4)
periodic pulse train##2##3##(2007-12#2)
periodic pulse##5##2##(2007-12#3)(2008-2#1)(2008-3#1)
periodic regime##2##2##(2007-12#2)
periodic regimes##2##2##(2006-10#2)
periodic rhythmic##2##2##(2008-2#2)
periodic solution##2##2##(2007-12#2)
periodic solutions for##2##3##(2013-8#2)
periodic spectral##2##2##(2007-11#1)(2007-12#1)
periodic spin##2##2##(2007-11#2)
periodic structure##6##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#2)
periodic structures##10##2##(2007-12#2)(2008-3#6)(2012-2#1)(2013-8#1)
periodic target##4##2##(1993-2#1)(2008-2#3)
periodic variation in##2##3##(1995-8#1)(2007-12#1)
periodic variation##4##2##(1995-8#1)(2007-12#3)
periodic##346##1##(1990-11#1)(1990-5#4)(1990-6#1)(1990-8#3)(1991-11#1)(1991-12#5)(1991-2#2)(1991-4#1)(1992-3#1)(1992-4#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-2#3)(1993-6#3)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1995-10#2)(1995-11#4)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#3)(1996-5#4)(1996-9#1)(1997-1#1)(1997-4#2)(1997-5#2)(1997-8#1)(2005-10#2)(2005-11#2)(2005-12#1)(2006-10#14)(2006-12#4)(2006-7#2)(2007-11#21)(2007-12#65)(2007-2#1)(2007-3#1)(2007-5#4)(2007-7#1)(2007-8#1)(2007-9#7)(2008-1#5)(2008-10#13)(2008-11#2)(2008-12#2)(2008-2#26)(2008-3#45)(2008-4#2)(2008-5#4)(2008-7#6)(2008-8#5)(2008-9#2)(2009-11#2)(2009-12#2)(2009-2#4)(2009-7#2)(2010-12#2)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-12#4)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#3)(2013-8#4)
periodical cicadas##5##2##(2008-9#5)
periodical follicular renewal##2##3##(2008-1#2)
periodical##27##1##(1995-10#1)(1996-12#1)(1997-2#1)(2005-11#2)(2007-10#1)(2007-11#1)(2007-3#1)(2007-5#1)(2008-1#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#5)(2009-4#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#2)
periodically along##2##2##(2007-11#1)(2007-12#1)
periodically and##2##2##(2011-1#1)(2012-12#1)
periodically as##2##2##(2008-3#1)(2008-4#1)
periodically corrugated##2##2##(2007-12#2)
periodically coupled microring resonators##2##4##(2007-12#2)
periodically for##4##2##(1994-7#1)(2007-8#1)(2012-2#1)(2013-7#1)
periodically in 10 prune orchards##2##5##(2008-10#2)
periodically interrupted amperometric##2##3##(2008-10#2)
periodically interrupted##5##2##(1996-12#1)(2008-10#3)(2008-4#1)
periodically poled KTP crystal##2##4##(2007-12#1)(2008-1#1)
periodically poled KTP##17##3##(2007-11#6)(2007-12#7)(2008-1#2)(2008-2#2)
periodically poled KTiOAsO(4)##2##3##(2007-12#2)
periodically poled KTiOPO(4) and its application to spectroscopy##2##8##(2007-12#2)
periodically poled KTiOPO(4) crystal##3##4##(2007-12#3)
periodically poled KTiOPO(4)##20##3##(2007-11#3)(2007-12#17)
periodically poled KTiOPO4##3##3##(2007-12#1)(2008-3#2)
periodically poled LiNbO(3) (PPLN)##4##4##(2007-12#4)
periodically poled LiNbO(3) crystal in a four-mirror##2##7##(2007-11#1)(2007-12#1)
periodically poled LiNbO(3) crystal##5##4##(2007-11#2)(2007-12#3)
periodically poled LiNbO(3)##28##3##(2007-11#3)(2007-12#23)(2008-1#1)(2008-2#1)
periodically poled LiTaO(3) crystal##3##4##(2007-11#3)
periodically poled LiTaO(3)##4##3##(2007-11#3)(2007-12#1)
periodically poled RbTiOAsO(4)##9##3##(2007-12#6)(2008-1#2)(2008-3#1)
periodically poled Ti##2##3##(2007-12#2)
periodically poled lithium niobate (PPLN) optical parametric oscillator (OPO)##2##9##(2007-12#2)
periodically poled lithium niobate (PPLN) optical parametric##4##7##(2007-12#4)
periodically poled lithium niobate (PPLN)##9##5##(2007-12#8)(2008-3#1)
periodically poled lithium niobate by##2##5##(2007-11#2)
periodically poled lithium niobate crystal and##3##6##(2007-11#1)(2007-12#2)
periodically poled lithium niobate crystal##8##5##(2007-11#2)(2007-12#4)(2008-1#1)(2008-3#1)
periodically poled lithium niobate optical parametric oscillator##4##7##(2007-12#1)(2008-2#1)(2008-3#2)
periodically poled lithium niobate optical parametric##7##6##(2007-12#4)(2008-2#1)(2008-3#2)
periodically poled lithium niobate with##3##5##(2007-12#1)(2008-1#1)(2008-3#1)
periodically poled lithium niobate##71##4##(2007-11#15)(2007-12#41)(2008-1#7)(2008-2#2)(2008-3#6)
periodically poled lithium tantalate##4##4##(2007-12#4)
periodically poled lithium##75##3##(2007-11#15)(2007-12#45)(2008-1#7)(2008-2#2)(2008-3#6)
periodically poled neodymium-doped lithium niobate##2##5##(2007-11#2)
periodically poled nonlinear##3##3##(2007-12#2)(2008-2#1)
periodically poled structures##3##3##(2007-12#1)(2008-3#2)
periodically poled##183##2##(2007-11#35)(2007-12#116)(2008-1#13)(2008-2#6)(2008-3#13)
periodically segmented waveguides##2##3##(2008-2#1)(2008-3#1)
periodically segmented##3##2##(2008-2#1)(2008-3#2)
periodically updated##2##2##(1993-1#1)(1993-2#1)
periodically with##3##2##(2008-2#1)(2008-5#1)(2012-2#1)
periodically##260##1##(1990-8#1)(1991-2#1)(1991-3#1)(1992-5#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#2)(1994-12#1)(1994-2#1)(1994-7#1)(1996-12#2)(1997-2#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-12#1)(2007-11#43)(2007-12#129)(2007-4#1)(2007-8#1)(2008-1#13)(2008-10#11)(2008-2#9)(2008-3#19)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#3)(2013-7#1)(2013-8#1)
periodicals##6##1##(1991-3#1)(1995-12#1)(2008-7#1)(2008-9#1)(2011-2#2)
periodicities##3##1##(1990-11#1)(2008-2#2)
periodicity and the##2##3##(2009-2#1)(2013-8#1)
periodicity and##7##2##(1990-12#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-2#1)(2011-2#1)(2013-8#1)
periodicity in##4##2##(1990-2#1)(1992-9#1)(1996-4#1)(1997-5#1)
periodicity is##2##2##(2007-12#1)(2009-6#1)
periodicity of the##6##3##(2007-12#1)(2008-2#1)(2008-3#2)(2010-4#1)(2010-7#1)
periodicity of##15##2##(1993-3#1)(1993-5#1)(1996-2#1)(2007-12#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2010-4#1)(2010-7#1)(2010-8#1)
periodicity was##2##2##(1993-3#1)(1996-2#1)
periodicity##51##1##(1990-12#1)(1990-2#1)(1992-9#1)(1993-3#2)(1993-5#1)(1995-8#1)(1996-2#3)(1996-4#1)(1996-6#1)(1997-5#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#9)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-4#2)(2010-7#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
periodontal and endodontic lesions##2##4##(1991-9#1)(2012-3#1)
periodontal and##4##2##(1991-9#1)(2008-4#1)(2012-12#1)(2012-3#1)
periodontal bone loss measurements##3##4##(2008-12#3)
periodontal bone loss##5##3##(2008-12#5)
periodontal condition##2##2##(2012-12#2)
periodontal conditions##2##2##(1990-12#1)(2008-12#1)
periodontal defects after third molar##2##5##(2007-12#2)
periodontal defects after##3##3##(2007-12#3)
periodontal defects##7##2##(2007-12#6)(2010-5#1)
periodontal disease activity##2##3##(2008-6#1)(2012-2#1)
periodontal disease and##3##3##(2008-9#1)(2013-7#1)(2013-8#1)
periodontal disease has been##2##4##(1990-3#1)(2006-2#1)
periodontal disease in##4##3##(2006-8#1)(2008-9#1)(2011-1#1)(2013-1#1)
periodontal disease is##2##3##(2006-2#2)
periodontal disease may##2##3##(2006-8#1)(2010-4#1)
periodontal disease progression##3##3##(1995-2#2)(2006-2#1)
periodontal disease severity##2##3##(2013-1#1)(2013-8#1)
periodontal disease##55##2##(1990-3#2)(1990-5#1)(1991-1#1)(1995-2#2)(1996-11#2)(1997-4#1)(2005-3#1)(2006-10#2)(2006-2#6)(2006-8#6)(2007-2#1)(2008-1#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2010-4#4)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#4)
periodontal diseases and oral##2##4##(2006-2#1)(2013-7#1)
periodontal diseases and##4##3##(2006-2#1)(2006-8#1)(2008-1#1)(2013-7#1)
periodontal diseases##27##2##(1994-3#1)(1996-1#1)(2006-2#2)(2006-8#6)(2008-1#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-4#2)(2012-3#3)(2013-1#2)(2013-7#2)(2013-8#3)
periodontal health and##2##3##(2006-2#2)
periodontal health status##3##3##(2008-8#2)(2012-3#1)
periodontal health##14##2##(2006-2#3)(2007-12#2)(2008-7#1)(2008-8#2)(2011-2#1)(2012-3#3)(2013-7#2)
periodontal knowledge and periodontal status##2##5##(2006-2#2)
periodontal knowledge questions##2##3##(2006-2#2)
periodontal knowledge##4##2##(2006-2#4)
periodontal ligament (PDL)##3##3##(1995-8#1)(2008-11#1)(2013-1#1)
periodontal ligament cells##5##3##(2009-2#1)(2011-12#1)(2012-2#1)(2013-1#2)
periodontal ligament cells]##2##3##(2013-1#1)(2013-8#1)
periodontal ligament fibroblasts##2##3##(1995-8#1)(2013-1#1)
periodontal ligament##14##2##(1995-8#2)(2007-11#1)(2008-11#1)(2009-2#1)(2011-12#1)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#1)
periodontal masseteric reflex##2##3##(1996-2#2)
periodontal microbiology##2##2##(2006-2#2)
periodontal or##2##2##(2008-7#1)(2011-2#1)
periodontal parameters##7##2##(2007-12#1)(2008-12#1)(2008-6#2)(2008-8#3)
periodontal pathogen##2##2##(1991-1#1)(2006-5#1)
periodontal pathogens##8##2##(2005-10#1)(2006-2#1)(2006-8#4)(2013-7#2)
periodontal pocket##2##2##(2006-5#1)(2008-10#1)
periodontal pockets##10##2##(1990-12#1)(1997-4#1)(2006-10#1)(2006-2#2)(2006-8#2)(2012-12#2)(2013-7#1)
periodontal regeneration##3##2##(2012-3#3)
periodontal space##2##2##(2012-12#1)(2013-1#1)
periodontal status in##2##3##(2006-2#1)(2013-1#1)
periodontal status of the##3##4##(2006-8#2)(2013-1#1)
periodontal status of##5##3##(2006-2#1)(2006-8#2)(2008-8#1)(2013-1#1)
periodontal status##9##2##(2006-2#3)(2006-8#2)(2008-6#1)(2008-8#1)(2013-1#2)
periodontal surgery##2##2##(2012-3#2)
periodontal therapy##13##2##(2006-8#1)(2008-6#1)(2008-7#1)(2010-4#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-7#4)
periodontal tissue##9##2##(1991-1#1)(2005-3#1)(2010-2#3)(2012-12#1)(2012-3#1)(2013-1#2)
periodontal tissues##6##2##(1991-9#1)(2006-2#1)(2008-1#1)(2008-2#1)(2011-1#1)(2013-7#1)
periodontal treatment##8##2##(2006-2#1)(2008-1#1)(2010-2#1)(2012-11#1)(2012-12#1)(2012-3#3)
periodontal##274##1##(1990-11#1)(1990-12#2)(1990-3#3)(1990-4#1)(1990-5#1)(1990-9#1)(1991-1#3)(1991-2#1)(1991-9#2)(1994-3#1)(1995-11#3)(1995-2#2)(1995-8#2)(1996-1#1)(1996-11#2)(1996-2#2)(1997-4#2)(2004-3#2)(2005-10#1)(2005-3#2)(2005-7#1)(2006-10#4)(2006-2#32)(2006-5#3)(2006-8#22)(2007-11#1)(2007-12#11)(2007-2#1)(2008-1#5)(2008-10#1)(2008-11#1)(2008-12#10)(2008-2#2)(2008-4#2)(2008-5#2)(2008-6#7)(2008-7#4)(2008-8#6)(2008-9#3)(2009-2#1)(2010-2#5)(2010-4#7)(2010-5#1)(2011-1#6)(2011-12#2)(2011-2#3)(2012-11#1)(2012-12#15)(2012-2#8)(2012-3#26)(2013-1#20)(2013-7#18)(2013-8#8)
periodontally healthy##3##2##(2006-8#1)(2008-12#1)(2013-1#1)
periodontally##7##1##(2006-8#1)(2008-12#2)(2008-4#1)(2012-3#1)(2013-1#1)(2013-7#1)
periodontics##7##1##(2004-3#1)(2006-2#2)(2012-3#1)(2013-7#3)
periodontitis and##7##2##(2006-8#1)(2012-3#3)(2013-1#2)(2013-7#1)
periodontitis in##8##2##(1991-6#1)(2006-8#1)(2008-10#3)(2012-12#1)(2012-3#2)
periodontitis patients and##4##3##(2008-12#3)(2011-2#1)
periodontitis patients##6##2##(2008-12#3)(2011-2#1)(2012-3#1)(2013-7#1)
periodontitis with##6##2##(2008-12#3)(2012-3#1)(2013-8#2)
periodontitis##95##1##(1991-6#1)(1991-9#2)(1993-11#1)(1994-3#2)(2005-11#1)(2005-3#4)(2006-2#4)(2006-8#6)(2007-12#1)(2007-2#1)(2007-7#3)(2008-10#5)(2008-12#11)(2010-4#10)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#10)(2013-1#14)(2013-7#4)(2013-8#10)
periodontitis)##3##1##(2008-10#1)(2013-8#2)
periodontium is##2##2##(2012-3#1)(2013-1#1)
periodontium##19##1##(1990-3#1)(2006-2#2)(2007-12#1)(2008-6#2)(2009-8#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-3#4)(2013-1#3)(2013-7#2)
periodontopathic##3##1##(1994-3#1)(2012-12#2)
periodontopathogenic bacteria##2##2##(2006-8#1)(2012-12#1)
periodontopathogens##2##1##(2006-8#2)
periods (30##2##2##(1995-7#1)(2011-1#1)
periods 1982-90 and 1991-95##3##4##(2006-7#1)(2006-8#2)
periods I and II##2##4##(2006-12#2)
periods after surgery##3##3##(1995-4#2)(2007-8#1)
periods after##6##2##(1995-4#2)(2007-2#1)(2007-8#2)(2008-10#1)
periods and is##2##3##(1997-4#1)(2012-2#1)
periods and##24##2##(1990-11#1)(1992-8#1)(1993-11#1)(1993-4#1)(1994-6#1)(1995-4#1)(1997-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#2)(2010-11#1)(2011-2#1)(2012-2#2)(2013-8#1)
periods are##7##2##(1990-6#1)(1993-2#1)(1997-8#1)(2008-10#1)(2008-2#1)(2011-1#1)(2011-2#1)
periods as a##2##3##(2008-7#1)(2009-6#1)
periods as long as##3##4##(2005-7#1)(2007-12#1)(2008-5#1)
periods as##9##2##(2005-7#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)
periods at##7##2##(1996-12#1)(2007-8#1)(2008-10#2)(2009-9#1)(2010-12#1)(2010-4#1)
periods before##2##2##(2008-10#1)(2008-9#1)
periods between##3##2##(2007-5#1)(2008-10#1)(2008-2#1)
periods by##2##2##(2008-10#2)
periods compared with##2##3##(2007-2#1)(2013-1#1)
periods during the##3##3##(2007-10#1)(2008-5#2)
periods during##4##2##(2007-10#1)(2008-5#2)(2010-5#1)
periods examined##2##2##(2011-2#1)(2012-3#1)
periods exceeding##2##2##(2008-10#2)
periods for the##2##3##(1992-1#1)(2012-12#1)
periods for##7##2##(1992-1#1)(2008-10#2)(2008-3#1)(2012-12#1)(2012-2#1)(2013-7#1)
periods in a##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
periods in all##2##3##(1991-2#1)(2008-10#1)
periods in the##7##3##(1992-12#1)(1995-3#1)(1996-8#1)(1997-4#1)(2007-11#1)(2008-6#1)(2009-7#1)
periods in##23##2##(1991-2#1)(1992-12#1)(1993-12#1)(1995-3#1)(1996-8#1)(1997-4#1)(2006-7#1)(2007-11#1)(2007-6#1)(2008-10#6)(2008-5#1)(2008-6#2)(2009-7#1)(2010-4#1)(2011-2#2)(2012-3#1)
periods is##6##2##(1992-12#1)(1993-11#1)(1995-6#1)(2008-10#1)(2008-6#1)(2008-8#1)
periods may##2##2##(2007-6#1)(2009-4#1)
periods of 1 to##2##4##(1992-8#1)(2008-10#1)
periods of 1##4##3##(1992-8#1)(2008-10#1)(2010-6#1)(2011-2#1)
periods of 3 months to##2##5##(2007-8#1)(2008-7#1)
periods of 3##6##3##(1991-11#1)(1991-2#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-1#1)
periods of 5##2##3##(1993-9#1)(2008-2#1)
periods of 6##3##3##(2004-9#1)(2008-10#1)(2008-3#1)
periods of 8 months##2##4##(1991-8#2)
periods of 8##3##3##(1991-8#2)(2008-7#1)
periods of a##4##3##(1990-7#1)(1991-2#1)(2004-9#1)(2013-7#1)
periods of both##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
periods of development##5##3##(1996-10#2)(2007-12#1)(2010-7#1)(2012-2#1)
periods of drug##2##3##(1990-2#1)(1994-8#1)
periods of each##2##3##(1992-10#1)(2007-2#1)
periods of follow-up##2##3##(2006-2#1)(2007-8#1)
periods of high##2##3##(2008-10#1)(2012-12#1)
periods of higher##2##3##(2008-5#1)(2013-7#1)
periods of increased##2##3##(1994-7#1)(2010-9#1)
periods of incubation##2##3##(2008-10#1)(2013-8#1)
periods of ischemia##5##3##(1997-8#2)(2006-10#3)
periods of low##4##3##(1992-3#1)(1994-3#1)(2006-10#1)(2008-8#1)
periods of more than##2##4##(2008-10#1)(2012-12#1)
periods of observation##2##3##(1992-8#1)(2008-5#1)
periods of rapid##3##3##(1990-6#1)(1997-4#1)(2010-8#1)
periods of stability##2##3##(2007-2#1)(2008-3#1)
periods of temperatures &gt##2##4##(2008-10#2)
periods of temperatures##3##3##(2008-10#3)
periods of the year##3##4##(2007-3#1)(2008-5#2)
periods of the##12##3##(1994-3#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2011-1#1)
periods of time and##3##4##(1991-5#1)(1997-3#1)(2008-10#1)
periods of time in order to obtain##2##7##(1996-5#2)
periods of time in##4##4##(1996-5#2)(2008-2#1)(2011-1#1)
periods of time to##3##4##(2007-11#1)(2008-10#1)(2011-1#1)
periods of time without##2##4##(2007-11#1)(2008-10#1)
periods of time##61##3##(1990-12#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-5#1)(1993-9#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-5#3)(1997-3#2)(1997-7#1)(2005-10#1)(2005-11#1)(2006-4#1)(2006-5#1)(2006-7#2)(2007-10#1)(2007-11#2)(2007-7#1)(2008-1#3)(2008-10#8)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-9#1)(2011-1#4)(2011-2#1)(2012-2#1)
periods of treatment##4##3##(1993-9#1)(2008-10#1)(2008-5#1)(2012-3#1)
periods of up to##7##4##(1995-11#1)(1996-12#1)(2005-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-1#1)
periods of##274##2##(1990-12#2)(1990-2#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-11#3)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#3)(1991-9#1)(1992-1#2)(1992-10#1)(1992-3#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-7#2)(1993-9#3)(1994-1#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#3)(1996-10#4)(1996-12#2)(1996-2#1)(1996-5#5)(1996-6#2)(1996-7#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#2)(2004-4#1)(2004-9#3)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#1)(2006-1#1)(2006-10#7)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#3)(2006-7#4)(2007-10#2)(2007-11#3)(2007-12#4)(2007-2#4)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#5)(2008-1#5)(2008-10#42)(2008-11#7)(2008-2#7)(2008-3#8)(2008-4#3)(2008-5#9)(2008-6#3)(2008-7#7)(2008-8#5)(2008-9#1)(2009-2#2)(2009-3#1)(2009-5#2)(2009-6#2)(2009-9#1)(2010-12#3)(2010-3#1)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#2)
periods on##4##2##(1991-8#1)(2006-8#1)(2007-6#1)(2008-10#1)
periods or##2##2##(2005-5#1)(2007-11#1)
periods over##3##2##(2008-10#3)
periods ranged from##2##3##(1993-3#1)(2006-8#1)
periods ranging from##6##3##(1991-8#1)(1995-8#1)(2007-11#1)(2008-10#1)(2009-7#1)(2011-2#1)
periods showed##2##2##(2009-2#1)(2010-4#1)
periods than##2##2##(2008-10#1)(2010-4#1)
periods that##2##2##(2007-12#1)(2008-10#1)
periods to##2##2##(2007-12#1)(2010-8#1)
periods up to##5##3##(1994-3#1)(1996-12#1)(2008-10#3)
periods using##2##2##(2008-10#2)
periods was##7##2##(2008-10#3)(2008-5#1)(2008-7#1)(2013-1#1)(2013-8#1)
periods were almost##2##3##(2004-4#1)(2008-10#1)
periods were##17##2##(2004-4#1)(2006-8#1)(2007-3#1)(2008-10#7)(2008-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-4#1)
periods when compared to control##2##5##(2008-11#1)(2008-4#1)
periods when##6##2##(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)
periods which##3##2##(2007-8#1)(2008-10#1)(2013-8#1)
periods with##5##2##(2008-10#2)(2008-11#1)(2009-9#1)(2010-1#1)
periods##771##1##(1990-10#3)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#2)(1990-6#2)(1990-7#1)(1990-9#1)(1991-1#2)(1991-10#3)(1991-11#4)(1991-12#2)(1991-2#3)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#5)(1991-9#4)(1992-1#5)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#4)(1992-9#5)(1993-11#3)(1993-12#3)(1993-2#3)(1993-3#1)(1993-4#2)(1993-6#1)(1993-7#3)(1993-9#4)(1994-1#2)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#5)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1995-1#2)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#2)(1995-4#4)(1995-5#1)(1995-6#3)(1995-7#2)(1995-8#4)(1996-10#5)(1996-11#3)(1996-12#5)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#8)(1996-6#2)(1996-7#1)(1996-8#3)(1996-9#4)(1997-1#1)(1997-3#5)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2004-11#2)(2004-12#1)(2004-2#1)(2004-3#1)(2004-4#2)(2004-9#4)(2005-10#2)(2005-11#1)(2005-12#1)(2005-5#1)(2005-7#2)(2006-1#1)(2006-10#12)(2006-12#4)(2006-2#2)(2006-3#1)(2006-4#4)(2006-5#4)(2006-6#1)(2006-7#8)(2006-8#10)(2007-10#5)(2007-11#12)(2007-12#13)(2007-2#11)(2007-3#2)(2007-4#1)(2007-5#4)(2007-6#4)(2007-7#8)(2007-8#22)(2007-9#1)(2008-1#12)(2008-10#145)(2008-11#18)(2008-12#1)(2008-2#12)(2008-3#19)(2008-4#9)(2008-5#22)(2008-6#10)(2008-7#23)(2008-8#11)(2008-9#2)(2009-11#3)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#3)(2009-7#2)(2009-9#3)(2010-1#1)(2010-11#3)(2010-12#6)(2010-2#4)(2010-3#2)(2010-4#7)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#6)(2010-9#3)(2011-1#15)(2011-12#3)(2011-2#25)(2011-3#2)(2012-1#2)(2012-12#5)(2012-2#10)(2012-3#6)(2012-4#1)(2012-7#1)(2012-9#1)(2013-1#21)(2013-7#3)(2013-8#9)
periods)##5##1##(1994-2#1)(2007-12#2)(2008-3#1)(2008-5#1)
periods]##2##1##(2008-11#1)(2011-1#1)
perioperative anaesthesia environment##2##3##(2006-10#2)
perioperative anaesthetic management##3##3##(2010-7#1)(2013-1#2)
perioperative and early##2##3##(2007-8#1)(2011-2#1)
perioperative and postoperative##2##3##(2006-10#1)(2012-12#1)
perioperative and##7##2##(2005-10#1)(2006-1#1)(2006-10#2)(2007-8#1)(2011-2#1)(2012-12#1)
perioperative blood loss##2##3##(2006-10#1)(2007-8#1)
perioperative blood##5##2##(1991-8#1)(2006-10#2)(2007-8#2)
perioperative cardiac##2##2##(2005-10#1)(2006-10#1)
perioperative cardiovascular##2##2##(2006-10#1)(2008-3#1)
perioperative care of patients##2##4##(2006-10#1)(2010-2#1)
perioperative care of##4##3##(2006-10#1)(2007-12#1)(2008-4#1)(2010-2#1)
perioperative care##19##2##(2006-10#4)(2007-12#2)(2007-8#1)(2008-4#2)(2010-2#2)(2011-2#1)(2012-2#6)(2012-3#1)
perioperative chemotherapy##2##2##(2010-12#1)(2012-3#1)
perioperative complication rate##2##3##(1993-8#1)(2006-11#1)
perioperative complications in##2##3##(2008-8#1)(2010-3#1)
perioperative complications##18##2##(1991-11#1)(1996-9#1)(2006-10#5)(2006-7#1)(2007-3#1)(2007-8#3)(2008-8#1)(2009-5#1)(2010-3#1)(2010-7#1)(2013-1#2)
perioperative context##2##2##(2012-2#1)(2012-3#1)
perioperative course##3##2##(2006-10#1)(2007-8#1)(2007-9#1)
perioperative deaths##2##2##(1990-2#1)(2008-7#1)
perioperative factors##2##2##(2013-1#2)
perioperative fluid##4##2##(2010-2#2)(2013-1#2)
perioperative hypothermia##3##2##(2013-8#3)
perioperative infarction##2##2##(1990-12#1)(1994-11#1)
perioperative interventions##2##2##(2006-10#2)
perioperative intraperitoneal chemotherapy##6##3##(2006-6#1)(2008-9#1)(2010-12#4)
perioperative management and##3##3##(2007-8#1)(2010-9#2)
perioperative management of patients with##2##5##(2006-10#1)(2012-3#1)
perioperative management of patients##5##4##(2006-10#2)(2007-12#2)(2012-3#1)
perioperative management of these patients##2##5##(2007-9#1)(2011-2#1)
perioperative management of##13##3##(2006-10#3)(2007-12#3)(2007-8#1)(2007-9#1)(2008-10#1)(2011-2#1)(2012-3#1)(2013-1#2)
perioperative management##21##2##(2006-10#3)(2007-12#5)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#1)(2010-9#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
perioperative morbidity and mortality##7##4##(2006-10#2)(2006-11#1)(2007-12#1)(2008-7#1)(2012-1#1)(2012-12#1)
perioperative morbidity##11##2##(1995-12#1)(2006-10#3)(2006-11#1)(2007-12#1)(2007-9#1)(2008-7#2)(2012-1#1)(2012-12#1)
perioperative mortality##7##2##(1991-4#1)(1991-6#1)(2007-8#2)(2008-8#1)(2008-9#1)(2012-12#1)
perioperative myocardial infarction##3##3##(2007-8#3)
perioperative myocardial##7##2##(1990-12#1)(2006-10#2)(2007-8#4)
perioperative or postoperative##2##3##(2008-3#1)(2012-12#1)
perioperative or##3##2##(2005-10#1)(2008-3#1)(2012-12#1)
perioperative outcomes##3##2##(2006-10#3)
perioperative pain management##2##3##(2005-12#1)(2006-10#1)
perioperative pain##4##2##(2005-12#1)(2006-10#3)
perioperative period or##2##3##(2006-8#1)(2007-1#1)
perioperative period##36##2##(1992-3#1)(2004-2#1)(2005-12#2)(2006-1#1)(2006-10#10)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-8#2)(2010-2#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
perioperative pulmonary complications##2##3##(2010-9#2)
perioperative pulmonary##3##2##(2006-10#1)(2010-9#2)
perioperative renal dysfunction##2##3##(2006-10#2)
perioperative renal##3##2##(2006-10#3)
perioperative risk factors##2##3##(2010-7#1)(2011-2#1)
perioperative risk##4##2##(2007-12#1)(2009-5#1)(2010-7#1)(2011-2#1)
perioperative setting##4##2##(2006-10#1)(2012-12#2)(2012-3#1)
perioperative stroke##3##2##(1997-8#2)(2006-7#1)
perioperative trauma##3##2##(2012-12#3)
perioperative treatment with##2##3##(1997-6#1)(2009-7#1)
perioperative##287##1##(1990-11#1)(1990-12#2)(1990-2#2)(1991-11#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-5#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-10#1)(1995-12#1)(1996-9#1)(1997-6#1)(1997-8#2)(2004-2#2)(2005-10#4)(2005-12#4)(2006-1#2)(2006-10#72)(2006-11#3)(2006-6#1)(2006-7#3)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#16)(2007-2#1)(2007-3#1)(2007-4#4)(2007-8#31)(2007-9#3)(2008-10#2)(2008-3#3)(2008-4#2)(2008-7#4)(2008-8#5)(2008-9#2)(2009-4#1)(2009-5#4)(2009-7#1)(2010-12#6)(2010-2#5)(2010-3#1)(2010-5#2)(2010-7#5)(2010-9#5)(2011-1#2)(2011-2#8)(2012-1#2)(2012-12#13)(2012-2#12)(2012-3#8)(2013-1#18)(2013-8#4)
perioperatively##13##1##(1991-9#1)(1994-9#1)(1996-5#1)(2006-10#2)(2007-8#1)(2008-6#1)(2008-8#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#1)
perioptic##2##1##(2009-8#2)
perioral##7##1##(1991-11#2)(2005-11#1)(2007-12#1)(2008-5#2)(2008-7#1)
periorbit##2##1##(2010-8#2)
periorbital area##3##2##(2008-5#2)(2010-8#1)
periorbital edema##2##2##(1997-6#1)(2009-2#1)
periorbital lines##2##2##(2008-5#2)
periorbital##17##1##(1997-6#1)(2006-10#1)(2008-5#6)(2009-2#1)(2010-10#1)(2010-11#1)(2010-8#3)(2012-2#1)(2012-8#2)
periosteal and##2##2##(2007-11#2)
periosteal cells##5##2##(2008-11#1)(2008-5#4)
periosteal osteosarcoma##4##2##(2008-6#4)
periosteal pedicle flap##2##3##(2013-7#2)
periosteal reaction and##2##3##(1993-10#1)(2009-3#1)
periosteal reaction##4##2##(1993-10#1)(2009-3#1)(2011-1#2)
periosteal##30##1##(1993-10#1)(1993-9#1)(2007-11#4)(2008-11#1)(2008-5#4)(2008-6#6)(2009-3#3)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#1)(2012-12#1)(2013-7#3)
periosteum and##7##2##(1990-12#1)(1993-8#1)(2007-11#1)(2008-6#1)(2011-2#1)(2012-12#2)
periosteum cells##2##2##(2012-12#2)
periosteum transplantation##2##2##(2007-11#2)
periosteum##31##1##(1990-12#1)(1993-8#1)(1994-3#1)(1996-12#1)(2006-10#1)(2007-11#12)(2007-12#1)(2008-1#1)(2008-6#1)(2008-9#2)(2009-2#1)(2010-12#2)(2011-2#1)(2012-12#5)
periosteum-derived cells##6##2##(1993-9#2)(2012-12#4)
periosteum-derived##7##1##(1993-9#2)(2008-11#1)(2012-12#4)
periostitis##8##1##(2006-10#1)(2009-3#7)
periovarian adhesions##2##2##(1992-3#2)
periovulatory ovine follicles##2##3##(1992-4#2)
periovulatory##3##1##(1992-4#2)(2007-11#1)
peripancreatic##10##1##(1990-3#1)(1993-3#1)(1997-4#1)(2005-10#2)(2008-3#2)(2010-5#1)(2012-2#2)
peripartum cardiomyopathy##4##2##(2008-11#1)(2011-2#1)(2013-8#2)
peripartum##10##1##(2006-12#1)(2006-5#1)(2007-2#2)(2008-11#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
periparturient##3##1##(1993-1#1)(2004-2#1)(2005-7#1)
peripeduncular nucleus##2##2##(1993-12#1)(2010-10#1)
peripheral (P)##2##2##(1990-4#2)
peripheral RoDH##2##2##(1995-5#2)
peripheral T cell##3##3##(2007-8#1)(2008-8#1)(2009-8#1)
peripheral T cells##6##3##(1993-12#1)(1995-1#2)(1996-8#1)(1997-6#1)(2010-9#1)
peripheral T##11##2##(1993-12#1)(1994-9#1)(1995-1#2)(1996-8#1)(1997-6#1)(2007-8#1)(2008-8#1)(2009-8#1)(2010-4#1)(2010-9#1)
peripheral T-cell lymphoma##2##3##(2008-1#1)(2011-2#1)
peripheral T-cell lymphomas##2##3##(2009-8#2)
peripheral T-cell tolerance##2##3##(1994-3#1)(1996-10#1)
peripheral T-cell##8##2##(1994-3#1)(1996-10#1)(2007-3#1)(2008-1#1)(2009-8#2)(2011-2#1)(2013-8#1)
peripheral action##3##2##(1993-12#2)(2011-2#1)
peripheral administration of##6##3##(1991-6#1)(1992-8#1)(1992-9#1)(1993-4#1)(1997-8#2)
peripheral administration##8##2##(1991-6#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-4#1)(1997-8#2)(2008-3#1)
peripheral airway##2##2##(2006-9#2)
peripheral airways##2##2##(1996-3#1)(2006-9#1)
peripheral analgesia##2##2##(2006-12#1)(2008-7#1)
peripheral and central hemodynamics##2##4##(1996-12#2)
peripheral and central projections##2##4##(1993-12#1)(2009-3#1)
peripheral and central##17##3##(1991-11#1)(1992-2#1)(1993-12#2)(1996-12#2)(2005-10#1)(2006-10#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-8#1)(2009-3#1)(2010-1#1)(2012-2#1)
peripheral and portal blood##2##4##(1997-7#2)
peripheral and##36##2##(1990-11#1)(1990-4#3)(1991-11#1)(1991-12#1)(1991-3#1)(1992-2#1)(1993-12#3)(1994-11#1)(1994-8#1)(1996-1#1)(1996-12#2)(1996-9#1)(1997-7#2)(2005-10#1)(2006-10#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
peripheral androgen##2##2##(1990-11#1)(1995-12#1)
peripheral arterial blood##5##3##(1996-3#4)(2007-10#1)
peripheral arterial disease in##5##4##(1997-2#1)(2008-8#1)(2011-1#1)(2011-2#2)
peripheral arterial disease##18##3##(1990-11#1)(1995-2#1)(1997-2#1)(2005-10#1)(2005-9#1)(2007-10#1)(2008-3#1)(2008-8#2)(2009-4#2)(2011-1#2)(2011-2#3)(2012-2#2)
peripheral arterial occlusions##3##3##(2008-7#3)
peripheral arterial occlusive disease (PAOD)##2##5##(2005-10#1)(2008-7#1)
peripheral arterial occlusive disease##4##4##(2004-12#1)(2005-10#2)(2008-7#1)
peripheral arterial occlusive##5##3##(1997-5#1)(2004-12#1)(2005-10#2)(2008-7#1)
peripheral arterial##42##2##(1990-11#2)(1990-8#1)(1995-2#2)(1996-3#5)(1997-2#1)(1997-5#1)(2004-12#1)(2005-10#4)(2005-9#1)(2007-10#2)(2007-8#2)(2008-3#1)(2008-7#4)(2008-8#3)(2009-4#2)(2010-6#1)(2011-1#2)(2011-2#3)(2012-2#3)(2012-3#1)
peripheral arteries##4##2##(1990-2#1)(1994-4#1)(2007-9#2)
peripheral arteriovenous##2##2##(1990-8#1)(1991-5#1)
peripheral artery disease (PAD)##2##4##(2005-7#1)(2012-2#1)
peripheral artery disease##6##3##(2005-7#1)(2008-7#1)(2010-4#2)(2012-2#1)(2013-7#1)
peripheral artery##7##2##(2005-7#1)(2008-7#1)(2010-4#3)(2012-2#1)(2013-7#1)
peripheral arthritis##3##2##(1990-6#2)(2010-12#1)
peripheral axons##4##2##(1991-9#1)(2006-11#1)(2007-11#1)(2011-2#1)
peripheral benzodiazepine receptor (PBR)##2##4##(2012-2#2)
peripheral benzodiazepine receptor##4##3##(1995-12#1)(2008-8#1)(2012-2#2)
peripheral benzodiazepine receptors##3##3##(1991-1#1)(1995-12#1)(2008-6#1)
peripheral benzodiazepine##7##2##(1991-1#1)(1995-12#2)(2008-6#1)(2008-8#1)(2012-2#2)
peripheral blood (P &lt##2##4##(2008-5#1)(2011-2#1)
peripheral blood T cells##2##4##(1995-2#1)(2013-1#1)
peripheral blood T lymphocytes##2##4##(1992-6#1)(1996-3#1)
peripheral blood T##5##3##(1992-6#1)(1995-2#2)(1996-3#1)(2013-1#1)
peripheral blood and bone marrow##2##5##(1995-11#1)(2007-12#1)
peripheral blood and their##2##4##(2008-4#2)
peripheral blood and##15##3##(1990-5#1)(1994-9#1)(1995-11#1)(1995-2#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#4)(2010-10#1)
peripheral blood by##6##3##(1990-12#1)(1990-4#1)(1995-1#1)(1996-10#1)(2008-4#2)
peripheral blood cells and##3##4##(1990-3#1)(2006-9#1)(2008-4#1)
peripheral blood cells from pig-tailed macaques and from African green monkeys##2##11##(1995-2#2)
peripheral blood cells##27##3##(1990-3#2)(1995-2#4)(1996-2#2)(1996-4#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#6)(2008-8#1)(2008-9#1)(2012-1#1)(2012-12#1)(2013-1#1)
peripheral blood counts and##2##4##(1996-10#2)
peripheral blood counts##4##3##(1996-10#2)(1997-7#1)(2013-8#1)
peripheral blood during##2##3##(1990-6#1)(2008-4#1)
peripheral blood erythrocytes##11##3##(2008-8#1)(2008-9#10)
peripheral blood from##4##3##(1995-12#1)(2008-4#1)(2012-11#1)(2012-2#1)
peripheral blood granulocytes##2##3##(2008-9#2)
peripheral blood heterophilia##2##3##(2008-5#2)
peripheral blood in##4##3##(1992-6#1)(1995-2#1)(2008-3#1)(2008-4#1)
peripheral blood is##2##3##(1991-12#1)(1995-12#1)
peripheral blood leukocytes##11##3##(1992-6#1)(1993-11#1)(1994-2#1)(1995-3#1)(1996-12#1)(2008-10#1)(2008-3#1)(2009-6#1)(2010-12#1)(2012-1#2)
peripheral blood lymphocyte (PBL)##2##4##(1992-2#1)(1996-7#1)
peripheral blood lymphocyte##5##3##(1991-7#1)(1992-2#1)(1996-7#1)(2008-10#1)(2008-7#1)
peripheral blood lymphocytes (PBL)##7##4##(1990-10#1)(1990-4#1)(1991-9#1)(1995-12#1)(1997-6#1)(2008-11#1)(2008-9#1)
peripheral blood lymphocytes (PBLs)##3##4##(1994-2#1)(2008-11#1)(2013-8#1)
peripheral blood lymphocytes and cultured##3##5##(1991-12#1)(1995-7#1)(1996-3#1)
peripheral blood lymphocytes and monocytes##2##5##(1990-5#2)
peripheral blood lymphocytes and##9##4##(1990-5#2)(1991-12#1)(1991-9#2)(1995-7#1)(1996-12#1)(1996-3#1)(2007-8#1)
peripheral blood lymphocytes from##5##4##(1991-12#1)(1991-2#1)(1991-4#1)(1994-6#1)(1997-3#1)
peripheral blood lymphocytes in##3##4##(2008-11#1)(2010-12#1)(2012-1#1)
peripheral blood lymphocytes of migraineurs##2##5##(1996-3#2)
peripheral blood lymphocytes of##5##4##(1996-3#3)(1996-4#1)(2012-1#1)
peripheral blood lymphocytes to##2##4##(2006-10#1)(2008-4#1)
peripheral blood lymphocytes with##2##4##(1992-5#1)(1995-7#1)
peripheral blood lymphocytes##79##3##(1990-10#1)(1990-4#1)(1990-5#2)(1991-12#5)(1991-2#1)(1991-4#1)(1991-7#1)(1991-9#4)(1992-2#1)(1992-5#1)(1993-4#1)(1993-8#2)(1993-9#1)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#1)(1995-12#3)(1995-5#1)(1995-7#5)(1996-12#1)(1996-3#5)(1996-4#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-10#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-11#8)(2008-4#3)(2008-8#2)(2008-9#7)(2010-12#2)(2012-1#2)(2013-8#2)
peripheral blood monocytes##10##3##(1991-4#1)(1992-7#1)(1992-8#1)(1993-4#1)(1993-9#2)(1996-11#1)(2008-4#2)(2008-9#1)
peripheral blood mononuclear cell##5##4##(1995-3#1)(1996-4#1)(1997-2#1)(2005-8#1)(2008-7#1)
peripheral blood mononuclear cells (PBMC) by##2##6##(1992-8#1)(1997-7#1)
peripheral blood mononuclear cells (PBMC) from##3##6##(1992-8#1)(2006-8#1)(2009-9#1)
peripheral blood mononuclear cells (PBMC) to##2##6##(1992-12#1)(2008-10#1)
peripheral blood mononuclear cells (PBMC) was##2##6##(1992-9#1)(1995-2#1)
peripheral blood mononuclear cells (PBMC)##20##5##(1992-12#1)(1992-8#3)(1992-9#1)(1995-2#1)(1995-6#1)(1996-9#1)(1997-7#1)(2006-8#1)(2007-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-9#1)(2010-12#1)(2011-2#1)(2011-3#1)
peripheral blood mononuclear cells (PBMCs)##6##5##(1994-2#1)(1996-10#1)(2008-10#1)(2008-9#1)(2011-1#1)(2013-1#1)
peripheral blood mononuclear cells and##4##5##(1993-4#1)(1994-9#1)(1996-8#1)(2008-11#1)
peripheral blood mononuclear cells from##3##5##(1995-2#1)(1995-3#1)(2008-7#1)
peripheral blood mononuclear cells in##3##5##(1995-3#1)(2008-7#1)(2009-4#1)
peripheral blood mononuclear cells of##6##5##(1993-3#1)(1996-2#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
peripheral blood mononuclear cells or##2##5##(2008-4#2)
peripheral blood mononuclear cells##82##4##(1990-2#1)(1991-12#1)(1992-12#1)(1992-5#1)(1992-6#2)(1992-8#4)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-6#2)(1994-9#3)(1995-2#2)(1995-3#4)(1995-6#1)(1995-7#1)(1995-8#2)(1996-10#3)(1996-2#1)(1996-3#1)(1996-4#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-6#1)(1997-7#2)(2004-11#1)(2006-2#1)(2006-8#1)(2007-1#1)(2008-10#3)(2008-11#5)(2008-4#4)(2008-7#3)(2008-9#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2011-1#3)(2011-2#3)(2011-3#1)(2013-1#1)(2013-8#1)
peripheral blood mononuclear##89##3##(1990-2#1)(1991-12#1)(1992-12#1)(1992-5#1)(1992-6#2)(1992-8#4)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-6#2)(1994-9#3)(1995-2#3)(1995-3#5)(1995-6#1)(1995-7#1)(1995-8#2)(1996-10#3)(1996-2#1)(1996-3#1)(1996-4#2)(1996-8#2)(1996-9#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#2)(2004-11#1)(2005-8#1)(2006-2#1)(2006-8#1)(2007-1#1)(2008-10#3)(2008-11#5)(2008-4#4)(2008-7#4)(2008-9#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2011-1#3)(2011-2#3)(2011-3#1)(2013-1#1)(2013-8#1)
peripheral blood neutrophils##4##3##(1990-12#1)(1991-1#1)(1992-3#1)(2010-9#1)
peripheral blood of patients with chronic##2##6##(2008-4#1)(2010-4#1)
peripheral blood of patients with##4##5##(2008-10#1)(2008-4#1)(2010-4#1)(2012-1#1)
peripheral blood of##25##3##(1990-12#1)(1991-4#1)(1992-7#1)(1994-2#1)(1996-12#2)(1996-3#1)(1996-9#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-4#2)(2008-9#2)(2009-4#1)(2010-4#2)(2011-1#1)(2012-1#1)(2012-2#2)
peripheral blood or bone marrow##2##5##(2008-4#1)(2008-9#1)
peripheral blood or##4##3##(1995-12#1)(2008-4#2)(2008-9#1)
peripheral blood progenitor cell##2##4##(2007-11#1)(2012-12#1)
peripheral blood revealed##4##3##(1992-11#1)(2007-7#1)(2013-1#2)
peripheral blood samples##7##3##(1993-7#1)(1997-7#1)(2007-12#1)(2008-9#4)
peripheral blood showed##2##3##(1997-7#1)(2007-2#1)
peripheral blood smear##2##3##(1990-3#1)(2012-3#1)
peripheral blood smears##3##3##(1992-1#1)(2007-8#1)(2010-5#1)
peripheral blood stem cell transplantation##3##5##(1997-3#1)(2005-12#1)(2006-10#1)
peripheral blood stem cell##7##4##(1997-3#1)(2005-12#1)(2005-8#1)(2006-10#1)(2008-4#1)(2008-7#1)(2011-2#1)
peripheral blood stem cells##6##4##(2008-1#2)(2008-11#1)(2008-3#1)(2008-5#1)(2010-6#1)
peripheral blood stem##13##3##(1997-3#1)(2005-12#1)(2005-8#1)(2006-10#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#1)
peripheral blood was##5##3##(1997-2#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
peripheral blood##473##2##(1990-10#1)(1990-11#2)(1990-12#5)(1990-2#1)(1990-3#3)(1990-4#2)(1990-5#3)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#8)(1991-2#2)(1991-4#3)(1991-5#1)(1991-7#2)(1991-9#5)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#2)(1992-6#5)(1992-7#3)(1992-8#5)(1992-9#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-4#4)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#5)(1994-10#1)(1994-11#2)(1994-2#5)(1994-3#2)(1994-5#3)(1994-6#3)(1994-9#4)(1995-1#5)(1995-11#1)(1995-12#11)(1995-2#11)(1995-3#6)(1995-5#1)(1995-6#1)(1995-7#6)(1995-8#2)(1996-10#6)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#9)(1996-4#4)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#2)(1997-2#3)(1997-3#2)(1997-4#2)(1997-6#3)(1997-7#7)(2004-11#1)(2005-12#1)(2005-8#5)(2006-1#1)(2006-10#6)(2006-2#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#4)(2007-11#5)(2007-12#3)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#5)(2008-10#13)(2008-11#22)(2008-3#3)(2008-4#43)(2008-5#7)(2008-7#6)(2008-8#6)(2008-9#34)(2009-4#3)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#6)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-11#1)(2011-2#10)(2011-3#1)(2012-1#10)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#5)(2013-1#8)(2013-7#7)(2013-8#7)
peripheral blood-derived human##2##3##(2005-10#2)
peripheral buttressing bone##2##3##(2013-1#2)
peripheral cells##7##2##(1994-11#1)(1994-8#1)(1997-8#1)(2007-7#1)(2008-4#1)(2008-5#2)
peripheral cholinergic##2##2##(1990-2#1)(1997-3#1)
peripheral circulation##8##2##(1993-4#1)(1995-3#1)(2005-7#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-1#1)(2013-8#1)
peripheral component##3##2##(1991-1#1)(1994-9#1)(1995-12#1)
peripheral components##3##2##(2004-9#1)(2006-12#1)(2011-12#1)
peripheral conversion of##2##3##(2008-2#1)(2012-3#1)
peripheral conversion##3##2##(1995-1#1)(2008-2#1)(2012-3#1)
peripheral destruction##2##2##(2006-10#2)
peripheral disease##2##2##(1996-8#1)(2009-2#1)
peripheral dose (the dose encompassing##2##5##(1993-4#2)
peripheral dose##11##2##(1993-4#4)(2008-3#1)(2009-10#6)
peripheral edema##4##2##(1992-4#1)(1996-9#1)(2011-1#1)(2011-12#1)
peripheral effects##2##2##(2008-3#1)(2008-4#1)
peripheral embolism##5##2##(1995-4#1)(2007-11#1)(2008-7#1)(2008-8#2)
peripheral eosinophilia##2##2##(2006-10#1)(2013-8#1)
peripheral erosive##2##2##(2006-10#2)
peripheral facial##3##2##(1991-6#1)(2007-10#1)(2011-1#1)
peripheral fat##4##2##(2005-10#1)(2006-10#1)(2008-1#1)(2008-3#1)
peripheral form##2##2##(1995-5#2)
peripheral ganglia##2##2##(1996-3#1)(2008-1#1)
peripheral gangrene##6##2##(2012-2#2)(2013-1#4)
peripheral glial cells##2##3##(2008-7#2)
peripheral glial##3##2##(2007-12#1)(2008-7#2)
peripheral glucose##2##2##(1990-8#1)(1992-6#1)
peripheral halo##3##2##(2006-10#2)(2013-1#1)
peripheral health##3##2##(2007-2#1)(2012-12#1)(2012-2#1)
peripheral hemodynamic##2##2##(1996-12#2)
peripheral hospital##2##2##(2006-4#1)(2008-3#1)
peripheral hospitals##2##2##(2005-10#1)(2008-3#1)
peripheral immune##9##2##(1991-12#1)(1992-5#1)(1996-4#1)(2007-11#1)(2007-9#1)(2008-10#2)(2010-12#2)
peripheral inflammation and##2##3##(1995-3#1)(1997-2#1)
peripheral inflammation##4##2##(1995-3#1)(1997-2#3)
peripheral injection of##2##3##(1994-2#1)(1994-8#1)
peripheral injury##4##2##(1995-7#2)(2006-8#1)(2007-11#1)
peripheral inputs##3##2##(1994-10#2)(2005-10#1)
peripheral insulin resistance##3##3##(1992-8#1)(1994-11#1)(2007-12#1)
peripheral insulin sensitivity##3##3##(1992-6#1)(2008-3#1)(2013-8#1)
peripheral insulin##7##2##(1992-6#1)(1992-8#1)(1994-11#1)(1994-3#1)(2007-12#1)(2008-3#1)(2013-8#1)
peripheral interventions##2##2##(2011-2#2)
peripheral joints##3##2##(2007-11#2)(2012-12#1)
peripheral leukocytes##4##2##(1990-12#2)(2006-10#1)(2007-2#1)
peripheral level##3##2##(2007-8#1)(2008-3#1)(2013-8#1)
peripheral ligands##3##2##(1995-11#1)(2008-8#2)
peripheral limitation&quot##2##2##(2012-12#2)
peripheral loperamide administration##2##3##(2012-1#2)
peripheral lung cancer##4##3##(2008-1#2)(2008-5#2)
peripheral lung tumors##4##3##(2007-8#3)(2010-12#1)
peripheral lung##12##2##(2007-11#1)(2007-8#4)(2008-1#2)(2008-5#3)(2010-12#1)(2013-7#1)
peripheral lymph nodes##2##3##(1994-11#1)(2008-11#1)
peripheral lymph##3##2##(1994-11#1)(2007-3#1)(2008-11#1)
peripheral lymphadenopathy##5##2##(2005-12#1)(2006-7#1)(2008-5#1)(2010-6#1)(2011-2#1)
peripheral lymphocyte subsets##2##3##(2008-10#2)
peripheral lymphocyte##3##2##(1991-11#1)(2008-10#2)
peripheral lymphocytes##14##2##(1990-12#1)(1990-8#1)(1991-8#2)(1997-8#1)(2007-1#2)(2008-1#1)(2008-11#2)(2008-8#2)(2010-4#1)(2012-3#1)
peripheral lymphoid organs##5##3##(1991-11#1)(1994-9#1)(2008-3#1)(2008-4#1)(2011-2#1)
peripheral lymphoid tissues##2##3##(2006-10#1)(2008-4#1)
peripheral lymphoid##7##2##(1991-11#1)(1994-9#1)(2006-10#1)(2008-3#1)(2008-4#2)(2011-2#1)
peripheral marker of##2##3##(1996-3#1)(2007-10#1)
peripheral maternity##2##2##(1992-5#1)(2007-7#1)
peripheral mechanism##2##2##(1996-8#2)
peripheral mechanisms##2##2##(2007-5#1)(2009-12#1)
peripheral membrane protein##3##3##(1993-11#1)(2005-7#1)(2012-2#1)
peripheral membrane proteins##2##3##(1990-2#1)(2008-9#1)
peripheral membrane##7##2##(1990-2#1)(1993-11#1)(1995-5#1)(2005-7#1)(2006-5#1)(2008-9#1)(2012-2#1)
peripheral metabolism##2##2##(1997-8#1)(2011-1#1)
peripheral motion contrast threshold##2##4##(2012-12#2)
peripheral motor deficit##2##3##(2008-4#1)(2008-7#1)
peripheral myelin##6##2##(1991-10#2)(1992-7#2)(1993-4#1)(1995-12#1)
peripheral nerve axons##2##3##(1991-8#1)(2013-1#1)
peripheral nerve blockade##3##3##(2006-10#3)
peripheral nerve blocks##5##3##(2006-10#5)
peripheral nerve injuries##5##3##(1991-3#1)(2007-10#3)(2008-7#1)
peripheral nerve injury and adrenal medullary grafting##2##7##(1995-7#2)
peripheral nerve injury and adrenal medullary transplantation##2##7##(1996-8#2)
peripheral nerve injury and adrenal medullary##4##6##(1995-7#2)(1996-8#2)
peripheral nerve injury in##2##4##(1994-5#1)(1995-7#1)
peripheral nerve injury or##2##4##(1993-5#1)(2006-11#1)
peripheral nerve injury##21##3##(1991-3#1)(1993-4#1)(1993-5#1)(1994-5#1)(1995-7#6)(1996-8#2)(2005-10#1)(2006-11#1)(2007-11#1)(2008-4#1)(2008-7#1)(2008-9#2)(2011-2#2)
peripheral nerve lesion##2##3##(2008-4#1)(2008-9#1)
peripheral nerve lesions##5##3##(1990-7#1)(2008-5#1)(2011-1#2)(2011-2#1)
peripheral nerve myelin is##2##4##(1990-7#1)(1995-12#1)
peripheral nerve myelin##4##3##(1990-7#2)(1995-12#1)(1995-5#1)
peripheral nerve regeneration##3##3##(1990-7#1)(1992-6#1)(2008-7#1)
peripheral nerve sheath tumor arising in##2##6##(1991-2#1)(2009-1#1)
peripheral nerve sheath tumor##5##4##(1991-2#1)(2007-8#1)(2009-1#1)(2012-12#2)
peripheral nerve sheath tumors##2##4##(2008-7#2)
peripheral nerve sheath##11##3##(1991-2#1)(1997-8#1)(2007-8#1)(2008-6#3)(2008-7#2)(2009-1#1)(2012-12#2)
peripheral nerve trunk##3##3##(2008-4#2)(2013-8#1)
peripheral nerve##110##2##(1990-11#1)(1990-7#6)(1991-10#1)(1991-2#1)(1991-3#2)(1991-8#1)(1991-9#4)(1992-6#1)(1992-9#1)(1993-4#2)(1993-5#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-5#4)(1995-7#6)(1996-8#2)(1997-2#3)(1997-3#1)(1997-8#1)(2004-3#1)(2005-10#1)(2006-10#9)(2006-11#1)(2006-7#1)(2006-8#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-4#4)(2008-5#1)(2008-6#3)(2008-7#12)(2008-9#4)(2009-1#1)(2009-10#1)(2009-4#1)(2011-1#4)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
peripheral nerves and##3##3##(1990-2#1)(2006-12#1)(2008-7#1)
peripheral nerves are##3##3##(1994-3#1)(2006-12#1)(2008-4#1)
peripheral nerves in##4##3##(1992-8#1)(2008-7#1)(2008-9#1)(2011-2#1)
peripheral nerves or##2##3##(1991-2#1)(2009-11#1)
peripheral nerves##46##2##(1990-2#1)(1991-2#1)(1991-8#1)(1992-3#1)(1992-8#1)(1992-9#1)(1994-11#2)(1994-2#1)(1994-3#2)(1995-12#1)(1996-4#1)(1996-6#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-12#4)(2007-11#1)(2007-2#1)(2007-7#1)(2008-4#1)(2008-7#8)(2008-9#3)(2009-11#1)(2011-1#1)(2011-2#5)(2012-3#1)(2013-8#2)
peripheral nervous system (PNS)##5##4##(1991-10#1)(1993-6#1)(1996-12#1)(1996-3#1)(2010-12#1)
peripheral nervous system and##2##4##(2008-7#1)(2010-7#1)
peripheral nervous system is##2##4##(1990-8#1)(2013-7#1)
peripheral nervous system of##3##4##(1996-5#1)(1996-6#2)
peripheral nervous system##51##3##(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#1)(1992-12#1)(1992-4#1)(1993-11#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-8#1)(1995-12#2)(1995-3#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#5)(1996-5#1)(1996-6#2)(2005-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-3#1)(2008-7#5)(2008-8#1)(2009-10#1)(2010-12#1)(2010-7#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
peripheral nervous##63##2##(1990-7#1)(1990-8#2)(1991-10#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-4#1)(1993-11#1)(1993-6#2)(1993-9#2)(1994-10#1)(1994-11#1)(1994-8#1)(1995-12#2)(1995-3#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#5)(1996-5#1)(1996-6#2)(1996-8#1)(1997-2#1)(1997-6#1)(2005-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#1)(2009-10#1)(2010-12#1)(2010-7#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
peripheral neural##2##2##(2006-10#1)(2010-6#1)
peripheral neuritis##2##2##(2006-8#2)
peripheral neurons##9##2##(1990-7#1)(1991-11#1)(1991-12#1)(1996-12#3)(1997-6#1)(2008-1#1)(2009-10#1)
peripheral neuropathies##8##2##(2006-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#4)
peripheral neuropathy and##7##3##(1990-2#1)(1990-8#1)(2007-7#1)(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#1)
peripheral neuropathy are##2##3##(2007-10#1)(2012-3#1)
peripheral neuropathy due to##2##4##(1993-12#1)(1996-2#1)
peripheral neuropathy in##4##3##(2006-10#1)(2008-11#2)(2008-7#1)
peripheral neuropathy is a##2##4##(2006-10#1)(2008-4#1)
peripheral neuropathy is##3##3##(1996-3#1)(2006-10#1)(2008-4#1)
peripheral neuropathy may##2##3##(2008-3#1)(2011-2#1)
peripheral neuropathy to##2##3##(2006-6#1)(2007-9#1)
peripheral neuropathy was##2##3##(2008-8#1)(2012-2#1)
peripheral neuropathy##75##2##(1990-2#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-9#1)(1993-12#3)(1993-4#1)(1994-10#1)(1994-5#1)(1996-2#1)(1996-3#4)(1996-5#2)(1997-1#1)(1997-3#1)(2006-10#4)(2006-6#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-7#2)(2007-9#2)(2008-1#3)(2008-11#6)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#12)(2008-8#2)(2008-9#1)(2009-2#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
peripheral neurotoxicity##4##2##(1992-8#1)(2008-7#1)(2008-8#2)
peripheral nociceptors##3##2##(1996-7#2)(2008-9#1)
peripheral occlusive##2##2##(1993-1#1)(1996-8#1)
peripheral olfactory##2##2##(1991-5#1)(2007-12#1)
peripheral opioid receptors##2##3##(2007-11#1)(2008-3#1)
peripheral or central##3##3##(1993-9#1)(2008-9#1)(2012-2#1)
peripheral or##7##2##(1990-8#1)(1993-9#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-9#1)(2012-2#1)
peripheral organs##7##2##(1991-12#1)(1992-6#1)(1996-7#2)(2008-10#1)(2008-5#1)(2008-7#1)
peripheral origin##2##2##(1993-10#1)(2009-5#1)
peripheral osteoma##3##2##(2011-2#2)(2012-12#1)
peripheral oxygen saturation##2##3##(2007-2#1)(2010-10#1)
peripheral oxygen##3##2##(2007-2#1)(2008-2#1)(2010-10#1)
peripheral pain##2##2##(2008-8#1)(2013-1#1)
peripheral parts of the##3##4##(1994-12#1)(1996-3#1)(2012-1#1)
peripheral parts##4##2##(1994-12#1)(1996-3#2)(2012-1#1)
peripheral plasma##2##2##(1991-6#1)(2007-11#1)
peripheral production##3##2##(1990-8#1)(2007-11#1)(2008-2#1)
peripheral pulmonary lesions##5##3##(2010-8#5)
peripheral pulmonary##8##2##(1990-9#1)(2007-5#1)(2007-8#1)(2010-8#5)
peripheral resistance to insulin##2##4##(2006-2#1)(2010-10#1)
peripheral resistance##8##2##(1990-1#1)(1994-9#1)(2006-2#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-10#1)
peripheral retinal##4##2##(1992-7#1)(2011-1#2)(2011-2#1)
peripheral revascularization##3##2##(1997-3#1)(2009-7#2)
peripheral round shadow##2##3##(2007-10#2)
peripheral sections##2##2##(1992-9#1)(2006-6#1)
peripheral segments of the PCA##2##5##(2007-9#2)
peripheral sensory neurons##2##3##(2006-10#1)(2008-8#1)
peripheral sensory##7##2##(1991-3#1)(1993-12#1)(1995-8#1)(1997-6#1)(2006-10#1)(2008-8#1)(2013-1#1)
peripheral side-effects##2##2##(1993-11#2)
peripheral signals##2##2##(2008-10#1)(2009-5#1)
peripheral site##3##2##(2008-7#1)(2009-1#1)(2011-2#1)
peripheral smear##2##2##(2012-2#2)
peripheral stem cell##3##3##(2010-3#1)(2010-4#1)(2012-12#1)
peripheral stimulation of the##3##4##(1992-3#1)(2006-7#1)(2008-4#1)
peripheral stimulation##5##2##(1992-3#1)(1996-12#1)(2006-7#1)(2008-4#1)(2012-12#1)
peripheral subcutaneous tissue##2##3##(1990-11#2)
peripheral sudomotor##2##2##(2009-12#2)
peripheral target tissues##2##3##(1991-5#1)(2012-3#1)
peripheral target##3##2##(1991-5#1)(1996-3#1)(2012-3#1)
peripheral targets##6##2##(1990-8#1)(1991-10#2)(1992-8#1)(1993-7#1)(1996-3#1)
peripheral terminals of##3##3##(1991-9#1)(1996-3#1)(2007-11#1)
peripheral terminals##5##2##(1991-9#1)(1993-12#2)(1996-3#1)(2007-11#1)
peripheral thyroid##2##2##(1991-7#1)(1997-8#1)
peripheral tissue##9##2##(1991-3#1)(1991-7#1)(1993-11#4)(1994-12#1)(1997-4#1)(2008-7#1)
peripheral tissues as well as##2##5##(1995-5#1)(2008-2#1)
peripheral tissues is##2##3##(1991-2#1)(1991-7#1)
peripheral tissues of##3##3##(1990-11#2)(1994-3#1)
peripheral tissues tested##2##3##(1991-2#1)(1995-5#1)
peripheral tissues##44##2##(1990-11#3)(1990-2#1)(1990-8#1)(1991-11#2)(1991-2#2)(1991-7#2)(1991-9#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#2)(1994-2#1)(1994-3#2)(1995-12#5)(1995-3#1)(1995-5#8)(1997-7#1)(1997-8#1)(2006-1#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-9#1)(2012-2#1)
peripheral to the##2##3##(1991-3#1)(2006-7#1)
peripheral to##3##2##(1991-3#1)(2006-7#1)(2009-10#1)
peripheral tolerance##4##2##(1994-11#1)(1994-3#1)(2008-3#1)(2008-4#1)
peripheral trauma##2##2##(2008-11#2)
peripheral tumors##2##2##(1990-2#1)(2007-8#1)
peripheral tumour glands##2##3##(1991-7#2)
peripheral tumour##3##2##(1991-7#2)(2007-8#1)
peripheral type##2##2##(1991-11#1)(2011-2#1)
peripheral vascular disease (PVD)##2##4##(2007-8#1)(2008-1#1)
peripheral vascular disease##15##3##(1990-9#1)(1992-4#1)(1994-10#1)(1997-2#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-6#1)
peripheral vascular surgery##3##3##(1994-2#2)(2006-10#1)
peripheral vascular##30##2##(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#2)(1992-4#1)(1993-3#1)(1994-10#1)(1994-2#3)(1997-2#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-6#1)(2010-9#1)(2011-2#1)
peripheral vasculature##5##2##(2005-10#1)(2005-7#1)(2007-7#1)(2008-7#2)
peripheral vasoconstriction##3##2##(1990-1#1)(1992-4#1)(2010-7#1)
peripheral vasodilatation##2##2##(2006-10#2)
peripheral vein##3##2##(2007-7#1)(2011-2#2)
peripheral venous access##2##3##(2007-7#1)(2008-4#1)
peripheral venous blood samples were taken##2##6##(1990-3#1)(2013-1#1)
peripheral venous blood##6##3##(1990-3#1)(1992-8#1)(1993-12#1)(1995-7#1)(1996-8#1)(2013-1#1)
peripheral venous catheter##2##3##(1990-8#1)(2013-1#1)
peripheral venous##12##2##(1990-3#1)(1990-8#1)(1992-8#1)(1993-12#1)(1995-7#1)(1996-8#1)(2007-7#2)(2008-4#1)(2013-1#3)
peripheral vision##2##2##(1992-7#1)(1997-1#1)
peripheral visual field##3##3##(1993-7#2)(2011-2#1)
peripheral visual##4##2##(1993-7#2)(2010-5#1)(2011-2#1)
peripheral white blood cells##2##4##(2006-10#1)(2013-7#1)
peripheral zone##4##2##(1994-3#1)(1996-11#1)(2008-7#1)(2011-2#1)
peripheral zone&quot##3##2##(1996-4#3)
peripheral##1694##1##(1990-1#2)(1990-10#2)(1990-11#14)(1990-12#9)(1990-2#9)(1990-3#4)(1990-4#7)(1990-5#3)(1990-6#5)(1990-7#11)(1990-8#15)(1990-9#5)(1991-1#4)(1991-10#9)(1991-11#13)(1991-12#13)(1991-2#11)(1991-3#9)(1991-4#3)(1991-5#4)(1991-6#4)(1991-7#9)(1991-8#5)(1991-9#13)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#3)(1992-2#5)(1992-3#5)(1992-4#4)(1992-5#4)(1992-6#12)(1992-7#8)(1992-8#16)(1992-9#7)(1993-1#1)(1993-10#2)(1993-11#12)(1993-12#18)(1993-2#2)(1993-3#2)(1993-4#15)(1993-5#4)(1993-6#4)(1993-7#4)(1993-8#3)(1993-9#8)(1994-10#7)(1994-11#11)(1994-12#5)(1994-2#16)(1994-3#13)(1994-4#1)(1994-5#6)(1994-6#3)(1994-8#4)(1994-9#8)(1995-1#9)(1995-11#3)(1995-12#32)(1995-2#15)(1995-3#11)(1995-4#1)(1995-5#20)(1995-6#2)(1995-7#16)(1995-8#3)(1996-1#2)(1996-10#7)(1996-11#4)(1996-12#18)(1996-2#7)(1996-3#34)(1996-4#10)(1996-5#4)(1996-6#6)(1996-7#8)(1996-8#11)(1996-9#4)(1997-1#4)(1997-2#12)(1997-3#8)(1997-4#4)(1997-5#1)(1997-6#8)(1997-7#13)(1997-8#8)(2004-11#1)(2004-12#1)(2004-3#4)(2004-9#1)(2005-10#13)(2005-11#2)(2005-12#2)(2005-7#6)(2005-8#8)(2005-9#1)(2006-1#3)(2006-10#46)(2006-11#2)(2006-12#11)(2006-2#3)(2006-4#7)(2006-5#1)(2006-6#5)(2006-7#4)(2006-8#11)(2006-9#4)(2007-1#6)(2007-10#20)(2007-11#29)(2007-12#14)(2007-2#8)(2007-3#8)(2007-5#3)(2007-6#1)(2007-7#20)(2007-8#24)(2007-9#16)(2008-1#25)(2008-10#29)(2008-11#38)(2008-12#3)(2008-2#7)(2008-3#27)(2008-4#65)(2008-5#22)(2008-6#10)(2008-7#75)(2008-8#28)(2008-9#48)(2009-1#2)(2009-10#12)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#2)(2009-4#7)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#6)(2009-9#2)(2010-1#1)(2010-10#5)(2010-11#2)(2010-12#14)(2010-2#1)(2010-3#1)(2010-4#9)(2010-5#4)(2010-6#6)(2010-7#2)(2010-8#9)(2010-9#4)(2011-1#23)(2011-11#1)(2011-12#4)(2011-2#56)(2011-3#1)(2012-1#16)(2012-11#1)(2012-12#23)(2012-2#29)(2012-3#15)(2013-1#33)(2013-7#14)(2013-8#26)
peripheral&quot##3##1##(1991-2#1)(1996-4#2)
peripheral-type benzodiazepine receptor##2##3##(1991-5#1)(1997-5#1)
peripheral-type benzodiazepine##3##2##(1991-5#1)(1997-5#2)
peripheral-type##4##1##(1991-5#1)(1991-9#1)(1997-5#2)
peripheral-type&quot##2##1##(1996-8#2)
peripherally acting alpha 2 adrenoceptor agonist##2##6##(1996-8#2)
peripherally acting##8##2##(1993-11#1)(1996-12#1)(1996-7#1)(1996-8#2)(1997-8#1)(2008-7#2)
peripherally administered substance P##2##4##(1994-6#1)(1994-8#1)
peripherally administered##6##2##(1992-9#1)(1994-10#1)(1994-2#1)(1994-6#2)(1994-8#1)
peripherally and centrally##2##3##(1990-3#1)(1993-11#1)
peripherally and##3##2##(1990-3#1)(1993-11#1)(2007-11#1)
peripherally associated with##2##3##(1991-10#1)(2009-10#1)
peripherally charged brushes##2##3##(2005-11#2)
peripherally inserted central catheter##2##4##(2007-7#1)(2009-4#1)
peripherally inserted central catheters##2##4##(2006-6#1)(2009-4#1)
peripherally inserted central##4##3##(2006-6#1)(2007-7#1)(2009-4#2)
peripherally inserted##5##2##(2006-6#1)(2007-7#2)(2009-4#2)
peripherally##39##1##(1990-2#1)(1990-3#2)(1991-10#1)(1991-6#1)(1992-9#1)(1993-11#2)(1994-10#1)(1994-2#2)(1994-6#2)(1994-8#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-8#2)(1997-8#1)(2005-11#2)(2006-6#1)(2007-11#1)(2007-7#4)(2008-10#2)(2008-7#3)(2009-10#1)(2009-4#2)(2012-12#3)
peripherals##2##1##(1997-4#1)(2008-10#1)
peripherin gene##6##2##(1996-3#6)
peripherin##10##1##(1992-6#1)(1996-3#9)
peripherin/rds and##2##2##(1995-10#2)
peripherin/rds##5##1##(1995-10#5)
periphery and##6##2##(1995-12#1)(1996-3#1)(2008-4#1)(2009-2#1)(2010-1#1)(2010-2#1)
periphery are##4##2##(1991-7#1)(1994-3#1)(1995-12#1)(2008-11#1)
periphery is##5##2##(1991-7#1)(1995-12#2)(1996-4#1)(2005-8#1)
periphery may##2##2##(1991-7#1)(2006-10#1)
periphery of a##3##3##(1991-4#1)(2008-1#1)(2008-4#1)
periphery of the##20##3##(1990-10#1)(1991-11#1)(1991-2#1)(1994-3#1)(1995-4#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-2#1)(2010-7#1)(2011-2#1)(2013-1#1)
periphery of##38##2##(1990-10#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-4#1)(1994-3#1)(1995-10#1)(1995-4#1)(1997-8#1)(2006-10#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-10#1)(2009-2#2)(2010-7#1)(2011-2#3)(2012-12#1)(2013-1#1)
periphery or##4##2##(2006-7#1)(2008-7#1)(2009-10#1)(2009-11#1)
periphery to##4##2##(1990-2#1)(1996-5#1)(2005-11#1)(2008-7#1)
periphery##138##1##(1990-10#1)(1990-2#1)(1990-5#1)(1990-8#3)(1991-11#1)(1991-2#1)(1991-4#1)(1991-7#4)(1992-10#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-12#1)(1993-7#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#5)(1995-4#1)(1995-6#1)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#2)(1997-6#1)(1997-8#2)(2005-11#2)(2005-12#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#5)(2007-11#2)(2007-12#5)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#6)(2008-8#4)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#2)(2010-2#1)(2010-7#2)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
periplasm by##3##2##(1992-12#1)(1997-6#1)(2009-6#1)
periplasm##20##1##(1990-10#1)(1990-11#1)(1990-12#1)(1991-10#1)(1992-12#1)(1993-9#1)(1994-2#3)(1995-5#1)(1996-10#1)(1997-6#2)(2006-8#2)(2008-7#1)(2008-8#1)(2009-6#3)
periplasmic binding proteins##2##3##(1994-9#1)(2011-2#1)
periplasmic endonuclease I##2##3##(1995-2#2)
periplasmic fraction##2##2##(2006-8#1)(2009-2#1)
periplasmic space and##2##3##(1993-6#1)(1997-3#1)
periplasmic space##10##2##(1990-8#1)(1991-8#1)(1992-11#1)(1993-6#1)(1994-8#1)(1997-2#1)(1997-3#2)(2008-4#2)
periplasmic sugar-binding proteins##2##3##(1994-9#2)
periplasmic targeting##2##2##(1994-2#2)
periplasmic##44##1##(1990-10#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-8#1)(1992-11#1)(1993-3#2)(1993-6#3)(1994-12#1)(1994-2#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-12#1)(1995-2#2)(1996-10#2)(1996-11#2)(1997-2#3)(1997-3#2)(1997-6#2)(2006-8#2)(2008-10#2)(2008-4#2)(2009-2#1)(2011-2#2)
periportal and perivenous##2##3##(1991-12#2)
periportal fibrosis##2##2##(1993-7#1)(2008-5#1)
periportal hepatocytes##2##2##(1991-12#1)(2008-8#1)
periportal##10##1##(1991-12#3)(1993-7#1)(1996-2#1)(1997-2#1)(2004-11#1)(2008-5#1)(2008-8#1)(2009-3#1)
periprocedural and##2##2##(2006-11#1)(2009-12#1)
periprocedural##4##1##(2006-11#1)(2009-12#1)(2011-2#1)(2012-2#1)
periprosthetic femoral fracture##3##3##(2013-1#3)
periprosthetic femoral fractures##4##3##(2011-2#1)(2013-1#3)
periprosthetic femoral##7##2##(2011-2#1)(2013-1#6)
periprosthetic femur##2##2##(2008-8#1)(2011-2#1)
periprosthetic fracture##4##2##(2007-7#2)(2009-3#1)(2013-1#1)
periprosthetic fractures of the femur##2##5##(2007-7#2)
periprosthetic fractures##5##2##(2007-7#2)(2008-7#1)(2011-2#2)
periprosthetic infection##2##2##(2007-11#1)(2012-12#1)
periprosthetic##23##1##(2007-11#2)(2007-7#4)(2008-7#1)(2008-8#3)(2009-3#1)(2011-2#4)(2012-12#1)(2013-1#7)
periradicular lesion##5##2##(2012-2#2)(2013-1#2)(2013-8#1)
periradicular##10##1##(2008-7#1)(2012-2#4)(2013-1#4)(2013-8#1)
perirectal##3##1##(1990-3#1)(1991-12#2)
perirenal adipose tissue##3##3##(2007-8#3)
perirenal and##2##2##(2010-4#2)
perirenal fat were##2##3##(2010-4#1)(2013-1#1)
perirenal fat##10##2##(1990-4#1)(2010-4#7)(2013-1#2)
perirenal urinoma##2##2##(2011-2#2)
perirenal##19##1##(1990-4#1)(1997-1#2)(2007-8#3)(2010-4#9)(2011-2#2)(2013-1#2)
perirhinal and postrhinal cortices##2##4##(1997-7#2)
perirhinal and##4##2##(1992-11#1)(1996-12#1)(1997-7#2)
perirhinal cortex##4##2##(1991-11#1)(1996-7#1)(1997-2#1)(1997-7#1)
perirhinal##9##1##(1991-11#1)(1992-11#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-7#4)
perishable##3##1##(2007-7#1)(2009-5#1)(2010-7#1)
perished##3##1##(1997-7#1)(2007-2#1)(2007-9#1)
peristalsis after##2##2##(1993-10#1)(2012-2#1)
peristalsis and##2##2##(2006-10#1)(2008-12#1)
peristalsis in##2##2##(2012-2#2)
peristalsis##17##1##(1993-10#3)(1994-2#1)(2006-10#3)(2007-5#1)(2008-12#1)(2008-7#2)(2010-6#1)(2012-2#4)(2013-8#1)
peristalsis-suppressing effect##2##2##(2012-2#2)
peristaltic and##2##2##(2006-10#1)(2008-10#1)
peristaltic of the small##2##4##(2011-2#2)
peristaltic pressure##2##2##(1996-3#1)(2006-7#1)
peristaltic pump##13##2##(2005-4#1)(2007-8#1)(2008-10#10)(2008-11#1)
peristaltic pumps##5##2##(1991-8#1)(2008-10#4)
peristaltic transport##2##2##(2006-2#1)(2007-9#1)
peristaltic##31##1##(1991-8#1)(1994-8#1)(1996-3#1)(2005-4#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-8#2)(2007-9#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#2)
peristomial lip##2##2##(2008-9#2)
perisurgical##2##1##(2007-11#2)
perisylvian cortex##2##2##(1996-2#1)(2008-4#1)
perisynaptic##2##1##(2009-8#1)(2013-1#1)
peritalar destabilisation##2##2##(2010-11#2)
perithecia were##3##2##(2008-10#3)
perithecia##13##1##(2008-10#12)(2008-8#1)
perithecium##3##1##(2008-10#3)
perithyroid##2##1##(2011-1#1)(2013-8#1)
peritoneal Kt/V##3##2##(2007-12#3)
peritoneal adhesions##4##2##(1993-5#1)(2008-4#2)(2010-3#1)
peritoneal and hemodialysis##2##3##(2011-1#1)(2011-2#1)
peritoneal and spleen cells##2##4##(1995-9#2)
peritoneal and##9##2##(1991-4#1)(1995-9#2)(2008-10#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
peritoneal carcinomatosis from colorectal cancer##2##5##(2006-6#2)
peritoneal carcinomatosis from colorectal##3##4##(2006-6#2)(2012-1#1)
peritoneal carcinomatosis from##4##3##(2006-6#2)(2010-12#1)(2012-1#1)
peritoneal carcinomatosis##8##2##(2006-6#5)(2010-12#2)(2012-1#1)
peritoneal carcinosis##3##2##(1990-4#3)
peritoneal catheter was##2##3##(2007-7#1)(2008-1#1)
peritoneal catheter##7##2##(2007-12#1)(2007-7#1)(2008-1#1)(2011-2#3)(2012-12#1)
peritoneal catheters##2##2##(2011-2#1)(2012-12#1)
peritoneal cavity is##2##3##(1990-4#1)(1991-9#1)
peritoneal cavity##42##2##(1990-2#1)(1990-4#3)(1990-5#4)(1991-9#1)(1992-1#1)(1992-2#1)(1994-2#1)(1996-5#1)(2005-12#1)(2005-7#1)(2006-5#1)(2006-6#2)(2007-12#2)(2007-2#1)(2008-1#3)(2008-10#2)(2008-12#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-9#1)(2010-12#1)(2011-11#2)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)
peritoneal cells##8##2##(1991-12#2)(1995-9#1)(1997-2#2)(2006-9#1)(2008-10#2)
peritoneal dialysate##3##2##(2007-12#2)(2013-1#1)
peritoneal dialysis (PD) and##2##4##(2007-8#1)(2008-1#1)
peritoneal dialysis (PD) patients##5##4##(2007-12#1)(2011-2#3)(2013-7#1)
peritoneal dialysis (PD)##21##3##(2007-12#4)(2007-7#1)(2007-8#1)(2008-1#3)(2008-4#1)(2011-1#1)(2011-2#9)(2013-7#1)
peritoneal dialysis a##2##3##(2007-12#1)(2012-12#1)
peritoneal dialysis and##7##3##(2007-12#2)(2008-1#2)(2008-10#1)(2008-7#1)(2011-2#1)
peritoneal dialysis catheter##3##3##(2007-7#2)(2013-7#1)
peritoneal dialysis catheters##2##3##(2007-12#1)(2008-10#1)
peritoneal dialysis for##2##3##(1990-3#1)(1994-4#1)
peritoneal dialysis in##3##3##(1992-5#1)(2007-12#1)(2008-10#1)
peritoneal dialysis patients and##2##4##(1996-8#1)(2007-12#1)
peritoneal dialysis patients##23##3##(1995-1#1)(1996-8#1)(2007-12#12)(2007-8#2)(2008-1#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-7#1)
peritoneal dialysis solution##2##3##(2011-2#2)
peritoneal dialysis##153##2##(1990-3#1)(1990-6#1)(1990-9#1)(1991-8#1)(1992-5#1)(1994-4#1)(1994-5#1)(1995-1#2)(1995-12#2)(1995-3#1)(1995-6#2)(1996-8#1)(1996-9#1)(1997-5#1)(2006-5#1)(2007-12#44)(2007-7#10)(2007-8#7)(2008-1#11)(2008-10#8)(2008-4#3)(2008-5#5)(2008-7#3)(2011-1#6)(2011-12#1)(2011-2#29)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#3)
peritoneal dialysis)##3##2##(2007-9#1)(2008-1#1)(2012-3#1)
peritoneal dialysis?##2##2##(2007-12#2)
peritoneal dissemination##2##2##(2007-12#1)(2010-12#1)
peritoneal drainage##4##2##(2012-2#4)
peritoneal equilibration test##2##3##(2007-8#1)(2011-2#1)
peritoneal exposure##3##2##(2011-2#3)
peritoneal exudate cells##2##3##(1991-12#1)(2008-4#1)
peritoneal exudate##4##2##(1991-12#1)(1992-7#1)(2008-4#1)(2010-2#1)
peritoneal exudates##2##2##(2008-10#1)(2008-4#1)
peritoneal fluid and##2##3##(1991-11#1)(2008-10#1)
peritoneal fluid composition##2##3##(2006-5#2)
peritoneal fluid in##2##3##(2007-11#1)(2013-8#1)
peritoneal fluid of##2##3##(1992-9#1)(2012-12#1)
peritoneal fluid total##2##3##(2006-5#2)
peritoneal fluid values##2##3##(2006-5#2)
peritoneal fluid##26##2##(1991-11#1)(1992-9#2)(1994-9#3)(1995-12#1)(2005-7#2)(2006-5#9)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2012-12#2)(2012-2#1)(2013-8#1)
peritoneal function in patients##2##4##(2011-2#2)
peritoneal function##5##2##(2011-2#5)
peritoneal hemorrhage##2##2##(1991-6#1)(2006-10#1)
peritoneal implants##2##2##(2006-6#1)(2012-3#1)
peritoneal inflammation##4##2##(1997-2#1)(2008-12#3)
peritoneal involvement##2##2##(2006-6#1)(2007-12#1)
peritoneal lavage in##3##3##(1990-2#2)(2006-4#1)
peritoneal lavage##5##2##(1990-2#2)(2006-4#3)
peritoneal ligaments##3##2##(2008-1#3)
peritoneal macrophage##5##2##(1997-4#1)(2008-11#2)(2008-5#1)(2010-8#1)
peritoneal macrophages and##4##3##(1991-4#1)(1992-6#1)(1995-8#1)(1995-9#1)
peritoneal macrophages from mice##2##4##(2008-4#1)(2010-8#1)
peritoneal macrophages from##6##3##(1991-12#1)(1992-9#1)(1995-9#1)(2008-4#1)(2010-8#2)
peritoneal macrophages was##2##3##(1993-6#1)(2008-10#1)
peritoneal macrophages were##3##3##(2007-2#2)(2008-11#1)
peritoneal macrophages##64##2##(1990-2#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#2)(1992-11#2)(1992-6#5)(1992-7#1)(1992-9#1)(1993-12#1)(1993-4#4)(1993-6#2)(1994-8#2)(1994-9#2)(1995-12#2)(1995-2#4)(1995-8#1)(1995-9#3)(1997-2#2)(2007-2#2)(2008-10#5)(2008-11#2)(2008-12#2)(2008-4#3)(2008-8#1)(2008-9#1)(2010-8#6)(2012-3#1)(2013-1#1)
peritoneal mast cells##8##3##(1991-12#2)(1991-2#1)(1992-3#1)(1995-11#1)(1997-2#1)(2008-10#1)(2008-4#1)
peritoneal mast##9##2##(1991-12#2)(1991-2#1)(1992-3#1)(1995-11#1)(1997-2#1)(2008-10#1)(2008-4#1)(2010-12#1)
peritoneal membrane of CAPD patients##2##5##(2007-7#1)(2008-10#1)
peritoneal membrane status##2##3##(2007-7#1)(2011-2#1)
peritoneal membrane##9##2##(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#3)(2011-2#2)
peritoneal mesothelial##2##2##(2007-12#1)(2013-1#1)
peritoneal mesothelioma and##2##3##(2006-6#1)(2010-12#1)
peritoneal mesothelioma##10##2##(1991-12#2)(2006-6#3)(2010-12#5)
peritoneal mucinous carcinoma##2##3##(2008-9#2)
peritoneal neutrophils##7##2##(1991-2#2)(1992-1#1)(1992-7#2)(1994-8#1)(1996-2#1)
peritoneal penetration##2##2##(1990-2#2)
peritoneal permeability##4##2##(2007-12#1)(2011-2#3)
peritoneal phagocytes##2##2##(1992-6#2)
peritoneal recurrences##2##2##(1990-6#1)(2006-6#1)
peritoneal sclerosis (EPS)##4##3##(2007-12#1)(2011-2#3)
peritoneal sclerosis##9##2##(2007-12#2)(2007-7#2)(2011-2#5)
peritoneal spread of##2##3##(2006-6#2)
peritoneal spread##3##2##(2006-6#2)(2013-8#1)
peritoneal surface malignancies##2##3##(2006-6#2)
peritoneal surface malignancy##4##3##(2006-6#3)(2010-12#1)
peritoneal surface##9##2##(1994-9#1)(2006-6#5)(2010-12#3)
peritoneal transport##4##2##(2011-2#4)
peritoneal tumors##3##2##(1990-5#3)
peritoneal##543##1##(1990-12#1)(1990-2#6)(1990-3#1)(1990-4#7)(1990-5#7)(1990-6#2)(1990-7#2)(1990-9#3)(1991-11#1)(1991-12#9)(1991-2#4)(1991-4#2)(1991-6#4)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#2)(1992-2#2)(1992-3#1)(1992-5#2)(1992-6#7)(1992-7#4)(1992-9#3)(1993-12#1)(1993-4#4)(1993-5#1)(1993-6#4)(1994-2#1)(1994-4#1)(1994-5#1)(1994-8#4)(1994-9#6)(1995-1#3)(1995-11#1)(1995-12#7)(1995-2#4)(1995-3#2)(1995-6#2)(1995-8#1)(1995-9#6)(1996-11#1)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#6)(1997-4#1)(1997-5#1)(1997-7#1)(2005-12#2)(2005-7#3)(2006-10#2)(2006-4#3)(2006-5#12)(2006-6#27)(2006-9#1)(2007-11#2)(2007-12#69)(2007-2#4)(2007-7#16)(2007-8#9)(2007-9#2)(2008-1#26)(2008-10#24)(2008-11#4)(2008-12#8)(2008-4#15)(2008-5#9)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#5)(2010-12#17)(2010-2#1)(2010-3#1)(2010-8#7)(2011-1#9)(2011-11#2)(2011-12#3)(2011-2#70)(2012-1#2)(2012-12#14)(2012-2#9)(2012-3#5)(2013-1#10)(2013-7#3)(2013-8#2)
peritonectomy and##3##2##(2006-6#2)(2010-12#1)
peritonectomy##7##1##(2006-6#4)(2010-12#3)
peritonei (PMP)##2##2##(2006-6#1)(2009-5#1)
peritonei##19##1##(2006-6#6)(2006-9#1)(2007-2#1)(2008-2#1)(2008-9#2)(2009-1#1)(2009-5#2)(2009-6#2)(2011-1#3)
peritoneocele##2##1##(2011-2#2)
peritoneoscopy and##2##2##(2009-8#2)
peritoneoscopy##3##1##(2009-8#3)
peritoneum and##3##2##(1997-2#1)(2008-1#1)(2008-11#1)
peritoneum is##2##2##(1990-10#1)(2008-1#1)
peritoneum##29##1##(1990-10#2)(1990-2#1)(1990-4#1)(1991-12#1)(1992-4#1)(1992-8#1)(1993-6#1)(1994-5#1)(1996-5#1)(1997-2#1)(2006-6#3)(2006-8#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-5#2)(2009-7#1)(2010-12#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
peritonitis and the##2##3##(2007-7#1)(2008-4#1)
peritonitis and uroperitoneum##2##3##(2012-2#2)
peritonitis and##18##2##(1990-8#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-4#1)(2008-6#3)(2008-9#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#4)(2012-2#2)
peritonitis caused by##3##3##(2006-7#1)(2007-12#2)
peritonitis caused##4##2##(1990-4#1)(2006-7#1)(2007-12#2)
peritonitis due to##5##3##(1991-3#1)(2007-8#1)(2008-10#1)(2008-6#1)(2011-12#1)
peritonitis in a##4##3##(2006-12#1)(2008-5#1)(2013-1#2)
peritonitis in##17##2##(1991-2#1)(1992-5#1)(1995-3#1)(2006-12#1)(2007-12#3)(2007-7#2)(2008-1#1)(2008-12#2)(2008-5#1)(2012-2#1)(2013-1#2)(2013-8#1)
peritonitis is a rare##2##4##(1993-6#1)(2009-7#1)
peritonitis is a##3##3##(1993-6#1)(2006-10#1)(2009-7#1)
peritonitis is##6##2##(1992-5#1)(1993-6#1)(2006-10#1)(2009-2#1)(2009-7#1)(2011-12#1)
peritonitis of##2##2##(2007-9#1)(2009-2#1)
peritonitis rates##7##2##(2008-4#1)(2011-2#6)
peritonitis related##2##2##(2007-7#1)(2008-4#1)
peritonitis remains##2##2##(1992-5#1)(2011-2#1)
peritonitis was##4##2##(1992-5#1)(2007-7#1)(2009-10#1)(2009-2#1)
peritonitis were##4##2##(2008-12#1)(2008-4#2)(2011-2#1)
peritonitis with##2##2##(2005-8#1)(2011-2#1)
peritonitis##144##1##(1990-4#1)(1990-8#1)(1991-2#3)(1991-3#1)(1991-9#1)(1992-5#5)(1992-8#1)(1993-10#1)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#1)(1995-3#1)(1996-1#1)(1996-2#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-12#6)(2007-2#2)(2007-5#1)(2007-7#10)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#1)(2008-12#7)(2008-3#1)(2008-4#12)(2008-5#2)(2008-6#5)(2008-9#1)(2009-10#1)(2009-2#6)(2009-7#1)(2009-8#4)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#1)(2011-12#3)(2011-2#23)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#4)
peritonitis]##3##1##(2009-2#3)
peritracheal athrocytes have##2##3##(2007-12#2)
peritracheal athrocytes##4##2##(2007-12#4)
peritraumatic dissociation##2##2##(2011-2#2)
peritrochanteric fractures##2##2##(2007-11#2)
peritrochanteric##4##1##(2007-11#3)(2010-2#1)
peritrophic membrane##5##2##(1996-5#1)(2007-12#2)(2008-7#2)
peritubular##6##1##(2007-9#5)(2012-12#1)
peritumoral edema##5##2##(2007-12#5)
peritumoral lymphocytic infiltrate##2##3##(2006-8#2)
peritumoral tissue##2##2##(1990-2#1)(1994-2#1)
peritumoral##17##1##(1990-2#1)(1994-2#2)(1995-12#1)(2005-10#1)(2006-8#2)(2007-12#8)(2007-8#1)(2011-1#1)
peritumorally##2##1##(1990-12#1)(1995-12#1)
peritumoural##2##1##(2006-8#1)(2009-4#1)
periumbilical##2##1##(1991-12#1)(2012-2#1)
periurban##2##1##(2008-6#2)
periureteral fibrosis##2##2##(2008-10#2)
periureteral##3##1##(2008-10#2)(2008-3#1)
periurethral and corporal abscess##2##4##(2013-8#2)
periurethral##9##1##(1997-7#3)(2008-3#1)(2011-12#1)(2013-8#4)
perivalvular##2##1##(2005-12#1)(2011-2#1)
perivascular cells##2##2##(1993-4#1)(2011-12#1)
perivascular cuffing##3##2##(1997-8#1)(2007-8#1)(2008-5#1)
perivascular infiltration##2##2##(2007-7#1)(2012-12#1)
perivascular neutrophils##2##2##(2012-3#2)
perivascular spaces and##2##3##(1996-1#1)(2006-5#1)
perivascular spaces of the cerebrovasculature##2##5##(2007-11#2)
perivascular spaces##6##2##(1996-1#2)(2006-5#1)(2007-11#2)(2010-12#1)
perivascular##53##1##(1990-10#2)(1990-12#1)(1992-12#1)(1993-4#2)(1994-5#1)(1994-7#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-6#1)(1997-8#3)(2006-11#2)(2006-5#3)(2007-11#2)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-8#1)(2010-12#2)(2010-6#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#6)(2013-1#1)(2013-7#1)(2013-8#1)
perivenous hepatocytes##3##2##(1990-11#1)(1991-12#2)
perivenous##9##1##(1990-11#3)(1991-12#4)(1993-7#1)(2008-7#1)
periventricular and arcuate nuclei##3##4##(1995-5#2)(1995-7#1)
periventricular and arcuate##4##3##(1995-5#3)(1995-7#1)
periventricular and##5##2##(1995-5#3)(1995-7#1)(2007-10#1)
periventricular gray substance##3##3##(1997-8#3)
periventricular gray##4##2##(1993-7#1)(1997-8#3)
periventricular hypothalamus##2##2##(1993-12#1)(1996-4#1)
periventricular leucomalacia##2##2##(1996-11#2)
periventricular white matter##3##3##(1992-7#1)(2007-9#1)(2012-3#1)
periventricular##24##1##(1992-3#1)(1992-7#1)(1993-12#1)(1993-7#1)(1994-2#1)(1995-5#4)(1995-7#2)(1996-11#2)(1996-4#1)(1997-8#3)(2007-10#1)(2007-9#2)(2008-8#1)(2009-10#1)(2011-2#1)(2012-3#1)
periventricularis##2##1##(2008-6#2)
periventriculo-hypophyseal##3##1##(1995-7#3)
perivitelline##3##1##(1991-5#1)(2008-12#1)(2008-9#1)
periwinkle (Catharanthus##2##2##(2008-10#2)
periwinkle and##2##2##(2008-10#2)
periwinkle##13##1##(2005-11#4)(2008-10#7)(2008-5#2)
periwinkles##5##1##(2008-10#5)
perlecan##2##1##(2007-12#1)(2012-1#1)
perm-selective##2##1##(2008-10#2)
permafrost peatlands##2##2##(2008-9#2)
permafrost##9##1##(2006-5#4)(2008-9#3)(2012-12#1)(2012-3#1)
permanence of the##2##3##(2007-11#1)(2008-5#1)
permanence of##5##2##(1996-3#1)(2007-11#1)(2008-5#1)(2012-2#2)
permanence##7##1##(1993-1#1)(1996-3#1)(2007-11#1)(2008-5#1)(2012-2#2)(2013-7#1)
permanency##3##1##(1995-2#1)(2007-3#1)(2009-11#1)
permanent MCAO##2##2##(2005-9#1)(2007-10#1)
permanent acceptance of##2##3##(1995-2#1)(2007-11#1)
permanent access is##2##3##(2007-7#2)
permanent access##9##2##(2007-7#9)
permanent and transient focal cerebral ischemia##2##6##(1992-7#1)(2011-2#1)
permanent and transient focal##3##4##(1992-7#1)(2007-10#1)(2011-2#1)
permanent and transient##4##3##(1992-7#1)(2007-10#1)(2008-11#1)(2011-2#1)
permanent and##19##2##(1992-7#1)(1994-3#1)(1995-2#1)(2006-6#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-3#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#1)(2011-3#1)(2013-7#1)
permanent atrial fibrillation##5##3##(2006-9#1)(2007-8#2)(2013-8#2)
permanent bilateral##2##2##(1990-4#1)(1997-2#1)
permanent calves##5##2##(1996-12#5)
permanent catheter##5##2##(2007-7#5)
permanent catheters##2##2##(2006-6#1)(2007-7#1)
permanent cell lines##2##3##(1990-4#1)(2008-11#1)
permanent cell##3##2##(1990-4#1)(1991-6#1)(2008-11#1)
permanent central venous##3##3##(2007-7#3)
permanent changes in##2##3##(1996-12#1)(2008-7#1)
permanent changes##4##2##(1996-12#1)(2006-12#1)(2008-4#1)(2008-7#1)
permanent chemical modifier##4##3##(2008-10#4)
permanent chemical##5##2##(2008-10#5)
permanent damage##4##2##(1997-2#1)(2006-1#1)(2007-12#1)(2012-3#1)
permanent deficit##3##2##(1991-1#2)(1997-3#1)
permanent deficits##2##2##(2006-12#1)(2006-5#1)
permanent dentition##5##2##(2008-12#1)(2008-5#2)(2012-2#2)
permanent dentitions##6##2##(2008-12#1)(2008-5#1)(2010-2#1)(2012-2#3)
permanent dipole moments##2##3##(1997-6#2)
permanent dipoles##2##2##(1996-1#1)(2006-2#1)
permanent disability##3##2##(2007-7#1)(2008-7#1)(2009-2#1)
permanent first molars##2##3##(2008-5#1)(2011-1#1)
permanent first##3##2##(1992-4#1)(2008-5#1)(2011-1#1)
permanent focal ischemia##3##3##(1997-2#1)(2007-10#1)(2008-4#1)
permanent green cover##3##3##(2011-12#3)
permanent growth##2##2##(2008-2#1)(2011-2#1)
permanent hair##2##2##(2008-5#2)
permanent impairment##4##2##(1996-2#1)(2005-10#1)(2007-7#2)
permanent implants##3##2##(1993-4#2)(2011-2#1)
permanent inability to work in profession##2##6##(2009-4#2)
permanent increase##3##2##(1993-2#1)(2008-7#1)(2013-1#1)
permanent ischemia##3##2##(1992-7#1)(2007-10#2)
permanent jugular##2##2##(2007-7#2)
permanent lesions or##2##3##(1993-11#2)
permanent magnet attached to the##2##5##(1996-12#1)(2008-10#1)
permanent magnet##6##2##(1996-12#1)(2006-4#1)(2008-10#1)(2008-3#2)(2008-8#1)
permanent mandibular canines##2##3##(2012-3#2)
permanent mandibular##3##2##(2012-2#1)(2012-3#2)
permanent maxillary##7##2##(2008-5#5)(2013-1#2)
permanent middle cerebral artery occlusion##2##5##(1993-9#1)(2011-2#1)
permanent middle cerebral artery##3##4##(1993-9#1)(2007-9#1)(2011-2#1)
permanent modifier##15##2##(2008-10#15)
permanent modifiers for##2##3##(2008-10#2)
permanent modifiers##12##2##(2008-10#12)
permanent morbidity was##4##3##(2005-9#1)(2008-7#3)
permanent nature##2##2##(2007-9#1)(2013-1#1)
permanent neurological impairment##2##3##(2006-5#1)(2013-1#1)
permanent or##3##2##(2006-2#1)(2007-10#1)(2009-4#1)
permanent pacemaker implantation##3##3##(1993-10#1)(1997-1#1)(2010-7#1)
permanent pacemaker##9##2##(1993-10#2)(1997-1#1)(2006-9#1)(2008-4#1)(2010-7#1)(2011-2#1)(2012-2#2)
permanent position##2##2##(2007-8#2)
permanent reduction##2##2##(1996-7#1)(2007-12#1)
permanent resection##2##2##(2008-8#1)(2009-3#1)
permanent residence##2##2##(1991-4#1)(2010-12#1)
permanent resident##2##2##(2007-3#1)(2008-5#1)
permanent section##4##2##(1995-4#3)(2008-9#1)
permanent sequelae##4##2##(1995-11#1)(1996-8#1)(2007-7#1)(2011-1#1)
permanent structural##2##2##(2010-8#1)(2012-2#1)
permanent submicrometer##2##2##(2008-3#2)
permanent teeth and##3##3##(2007-12#1)(2008-12#1)(2008-9#1)
permanent teeth was##2##3##(2008-9#1)(2012-2#1)
permanent teeth##24##2##(1992-5#1)(1993-11#1)(2005-9#2)(2007-12#1)(2008-12#3)(2008-5#2)(2008-9#5)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
permanent tooth##3##2##(2009-3#2)(2010-12#1)
permanent transect##2##2##(2008-5#2)
permanent treatment of##2##3##(2008-11#1)(2008-6#1)
permanent vascular access##4##3##(2007-7#2)(2007-8#1)(2008-1#1)
permanent wave##2##2##(2008-10#1)(2012-12#1)
permanent with optimum pyrolysis and atomization temperatures of##2##8##(2008-10#2)
permanent##462##1##(1990-1#1)(1990-10#1)(1990-12#2)(1990-4#4)(1990-5#1)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#2)(1991-10#3)(1991-11#1)(1991-2#3)(1991-4#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-4#3)(1992-5#3)(1992-6#1)(1992-7#3)(1992-9#2)(1993-1#1)(1993-10#2)(1993-11#3)(1993-2#1)(1993-4#4)(1993-9#3)(1994-3#3)(1994-5#2)(1994-6#1)(1995-11#2)(1995-2#3)(1995-3#1)(1995-4#3)(1996-1#2)(1996-11#2)(1996-12#7)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#3)(1997-6#5)(1997-8#1)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#1)(2005-9#4)(2006-1#1)(2006-10#1)(2006-12#6)(2006-2#4)(2006-3#1)(2006-4#2)(2006-5#5)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#4)(2007-1#1)(2007-10#7)(2007-11#7)(2007-12#9)(2007-2#1)(2007-3#3)(2007-4#2)(2007-5#1)(2007-7#33)(2007-8#10)(2007-9#4)(2008-1#1)(2008-10#48)(2008-11#6)(2008-12#6)(2008-2#2)(2008-3#6)(2008-4#7)(2008-5#28)(2008-6#1)(2008-7#11)(2008-8#5)(2008-9#7)(2009-10#1)(2009-2#2)(2009-3#5)(2009-4#3)(2009-7#4)(2009-8#2)(2010-1#1)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#7)(2011-12#5)(2011-2#14)(2011-3#1)(2012-11#4)(2012-12#7)(2012-2#16)(2012-3#6)(2013-1#14)(2013-7#2)(2013-8#3)
permanente##3##1##(2010-8#2)(2011-2#1)
permanently after##2##2##(2007-12#1)(2008-3#1)
permanently ice-covered regions##2##3##(1994-7#2)
permanently impair##2##2##(2007-7#1)(2012-3#1)
permanently implanted##2##2##(1991-7#1)(2005-4#1)
permanently occluded##2##2##(1995-12#1)(1997-8#1)
permanently reduced##3##2##(2008-10#1)(2010-9#2)
permanently suppress##2##2##(2008-4#1)(2013-8#1)
permanently##67##1##(1991-12#1)(1991-6#1)(1991-7#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-2#2)(1994-7#2)(1995-12#1)(1995-3#2)(1995-7#1)(1996-5#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#2)(2009-10#1)(2009-5#1)(2010-12#1)(2010-8#2)(2010-9#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
permanganate and##5##2##(2008-10#5)
permanganate in sulfuric acid medium##2##5##(2008-10#2)
permanganate in sulphuric acid##2##4##(2008-10#2)
permanganate in##16##2##(2008-10#15)(2009-5#1)
permanganate solution##2##2##(2008-10#2)
permanganate was##3##2##(2008-10#1)(2009-5#2)
permanganate##55##1##(1991-4#1)(2007-7#1)(2007-8#1)(2008-10#47)(2008-4#1)(2009-5#4)
permanganates##3##1##(2008-10#3)
permeabilised cells##4##2##(1990-2#1)(1991-5#1)(1993-9#1)(2005-8#1)
permeabilised##10##1##(1990-12#2)(1990-2#4)(1991-5#1)(1993-4#1)(1993-9#1)(2005-8#1)
permeabilities of##2##2##(1991-5#1)(2008-7#1)
permeabilities were##2##2##(1994-12#1)(1994-6#1)
permeabilities##7##1##(1991-5#2)(1994-12#1)(1994-6#1)(2005-11#1)(2007-9#1)(2008-7#1)
permeability (decrease in TER)##2##4##(2008-11#2)
permeability across the##2##3##(2005-11#1)(2008-4#1)
permeability across##3##2##(2005-11#1)(2008-4#1)(2011-2#1)
permeability and effective##2##3##(2005-11#2)
permeability and the##2##3##(1992-6#1)(2009-8#1)
permeability and##30##2##(1990-12#2)(1990-2#2)(1992-3#1)(1992-6#1)(1993-11#1)(1994-10#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-6#1)(1997-8#1)(2005-11#4)(2006-2#1)(2007-11#1)(2007-9#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#2)
permeability assay##2##2##(1992-9#1)(2005-12#1)
permeability at the blood-nerve and blood-brain barriers##2##7##(1997-8#2)
permeability at##3##2##(1997-8#2)(2008-11#1)
permeability barrier##6##2##(1994-5#2)(2008-5#3)(2011-2#1)
permeability can be##3##3##(1992-9#1)(2008-7#1)(2010-1#1)
permeability changes##2##2##(1994-5#1)(1996-5#1)
permeability coefficient##11##2##(1990-11#3)(1992-9#2)(1996-5#1)(2005-11#2)(2007-8#1)(2010-11#1)(2011-3#1)
permeability coefficients were##2##3##(1992-3#1)(2008-5#1)
permeability coefficients##5##2##(1990-2#1)(1991-2#1)(1992-3#1)(2007-8#1)(2008-5#1)
permeability decreased##2##2##(1993-12#1)(2010-1#1)
permeability due to##2##3##(1992-1#1)(2008-5#1)
permeability factor (VPF)##3##3##(1991-10#1)(1991-2#1)(2008-9#1)
permeability factor is##2##3##(1991-9#1)(1994-3#1)
permeability factor##20##2##(1991-10#2)(1991-2#2)(1991-9#8)(1992-9#1)(1994-12#2)(1994-3#2)(1995-1#2)(2008-9#1)
permeability for##7##2##(1991-9#1)(1992-3#1)(1993-3#1)(1993-7#1)(2008-3#1)(2010-4#1)(2010-5#1)
permeability in the##3##3##(1992-6#1)(2008-1#1)(2008-7#1)
permeability in##19##2##(1990-9#1)(1991-2#1)(1992-6#1)(1992-7#1)(1993-11#2)(1994-12#1)(1996-8#1)(2005-12#1)(2006-10#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-7#3)
permeability increase by capsaicin##2##4##(2008-11#2)
permeability increase in##2##3##(2008-11#2)
permeability increase##6##2##(1991-5#1)(2008-11#5)
permeability induced by##4##3##(1990-11#1)(1992-12#1)(1994-6#1)(2011-2#1)
permeability is calculated##2##3##(1992-6#1)(1997-1#1)
permeability is##7##2##(1992-6#1)(1994-2#1)(1997-1#3)(1997-2#1)(2005-10#1)
permeability may be##2##3##(1993-11#1)(2007-8#1)
permeability of a##2##3##(1997-1#1)(2005-11#1)
permeability of bilayers##2##3##(1992-5#2)
permeability of both##2##3##(1992-6#1)(2006-8#1)
permeability of rat##2##3##(1993-3#1)(1996-2#1)
permeability of the membrane##3##4##(1994-12#1)(1996-1#1)(2008-10#1)
permeability of the##31##3##(1990-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-3#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-8#1)(1997-1#1)(2005-11#1)(2006-10#2)(2006-5#1)(2008-1#2)(2008-10#7)(2008-5#2)(2008-7#1)(2010-4#1)(2011-1#1)(2013-7#1)
permeability of these##3##3##(1991-5#1)(1993-9#1)(1996-5#1)
permeability of water flow through##2##5##(2005-11#2)
permeability of which is##2##4##(1990-5#1)(1994-2#1)
permeability of##77##2##(1990-2#1)(1990-3#1)(1990-5#2)(1991-3#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#4)(1992-6#3)(1993-12#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#3)(1994-8#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#3)(2005-11#9)(2006-10#2)(2006-5#1)(2006-8#1)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-7#1)
permeability ratio##2##2##(1994-12#1)(2007-8#1)
permeability ratios##3##2##(2007-8#3)
permeability reduction##2##2##(2013-8#2)
permeability results##2##2##(2006-10#1)(2008-5#1)
permeability sequence of##2##3##(1994-12#2)
permeability studies##4##2##(2006-10#1)(2007-8#2)(2012-1#1)
permeability that##2##2##(1991-9#1)(2009-2#1)
permeability through##3##2##(1991-3#1)(1996-11#1)(2006-10#1)
permeability to the##3##3##(1992-6#1)(2005-11#1)(2008-11#1)
permeability to water##2##3##(1996-8#1)(2008-5#1)
permeability to##15##2##(1990-11#1)(1990-5#1)(1991-8#1)(1992-6#2)(1992-7#1)(1995-12#1)(1996-8#1)(1997-8#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
permeability transition and##2##3##(2008-10#1)(2008-11#1)
permeability transition of##2##3##(1992-11#2)
permeability transition pore##7##3##(2005-8#1)(2008-1#1)(2008-7#1)(2010-12#1)(2010-3#1)(2012-2#2)
permeability transition was##2##3##(1992-11#1)(2005-8#1)
permeability transition##24##2##(1992-11#3)(1997-6#4)(2005-7#1)(2005-8#2)(2006-10#2)(2008-1#3)(2008-10#1)(2008-11#2)(2008-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2012-2#2)
permeability was found to be##3##5##(1990-11#1)(2008-5#1)(2013-7#1)
permeability was found##4##3##(1990-11#1)(1990-5#1)(2008-5#1)(2013-7#1)
permeability was##9##2##(1990-11#2)(1990-5#1)(1991-5#1)(1992-7#1)(1997-1#1)(2008-5#1)(2010-1#1)(2013-7#1)
permeability with##5##2##(1995-1#1)(2005-11#1)(2006-10#1)(2008-10#1)(2010-12#1)
permeability##417##1##(1990-11#8)(1990-12#2)(1990-2#7)(1990-3#1)(1990-4#1)(1990-5#4)(1990-9#2)(1991-1#1)(1991-10#3)(1991-11#1)(1991-2#6)(1991-3#2)(1991-5#5)(1991-7#1)(1991-8#4)(1991-9#12)(1992-1#1)(1992-11#3)(1992-12#2)(1992-3#4)(1992-5#4)(1992-6#11)(1992-7#4)(1992-9#7)(1993-11#6)(1993-12#2)(1993-2#1)(1993-3#3)(1993-7#2)(1993-9#1)(1994-10#2)(1994-12#10)(1994-2#6)(1994-3#2)(1994-5#3)(1994-6#5)(1994-8#3)(1995-1#4)(1995-12#2)(1995-2#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#3)(1997-1#14)(1997-2#1)(1997-4#1)(1997-6#4)(1997-7#1)(1997-8#6)(2004-3#1)(2005-10#1)(2005-11#29)(2005-12#2)(2005-7#1)(2005-8#3)(2006-10#17)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-8#11)(2007-9#3)(2008-1#10)(2008-10#15)(2008-11#17)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#20)(2008-6#2)(2008-7#13)(2008-8#3)(2008-9#10)(2009-12#1)(2009-2#3)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#3)(2010-11#1)(2010-12#5)(2010-3#1)(2010-4#5)(2010-5#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#10)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#5)(2013-1#1)(2013-7#4)(2013-8#7)
permeability)##2##1##(2006-10#1)(2013-1#1)
permeabilization by the##2##3##(1997-7#1)(2009-10#1)
permeabilization by##3##2##(1997-7#1)(2006-6#1)(2009-10#1)
permeabilization of the##5##3##(1992-1#1)(1997-7#1)(2005-8#1)(2009-10#1)(2009-11#1)
permeabilization of##8##2##(1992-1#1)(1992-10#1)(1994-9#1)(1997-7#2)(2005-8#1)(2009-10#1)(2009-11#1)
permeabilization##23##1##(1990-3#1)(1991-8#1)(1992-1#1)(1992-10#2)(1993-4#1)(1994-2#1)(1994-9#1)(1997-7#3)(2005-8#1)(2006-6#2)(2008-6#1)(2008-9#4)(2009-10#3)(2009-11#1)
permeabilized CS-B cells##2##3##(1997-4#2)
permeabilized cell##2##2##(1992-7#1)(2008-4#1)
permeabilized cells in##2##3##(1992-12#2)
permeabilized cells##12##2##(1990-3#1)(1991-8#1)(1992-12#2)(1992-7#1)(1992-8#1)(1996-8#1)(2008-1#3)(2008-4#1)(2009-4#1)
permeabilized hepatocytes##2##2##(1994-12#2)
permeabilized rat pancreatic acini##2##4##(1991-1#1)(1992-12#1)
permeabilized rat parotid##2##3##(1991-3#1)(1991-8#1)
permeabilized rat##6##2##(1991-1#1)(1991-3#1)(1991-8#1)(1992-11#2)(1992-12#1)
permeabilized with##5##2##(1992-5#1)(1992-6#2)(1994-12#1)(1995-12#1)
permeabilized##60##1##(1990-3#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-8#2)(1992-11#2)(1992-12#6)(1992-5#2)(1992-6#2)(1992-7#4)(1992-8#1)(1993-3#1)(1993-8#4)(1994-12#4)(1994-5#2)(1994-9#2)(1995-12#1)(1995-2#1)(1996-5#1)(1996-8#1)(1997-4#4)(1997-5#1)(2006-5#1)(2008-1#3)(2008-4#2)(2008-7#3)(2009-10#1)(2009-4#1)(2012-11#3)
permeabilizes##4##1##(1990-5#2)(1991-10#1)(1994-2#1)
permeabilizing the##3##2##(1992-9#1)(2008-9#1)(2009-10#1)
permeabilizing##11##1##(1992-4#1)(1992-9#1)(1994-11#3)(1994-2#1)(2006-6#1)(2008-4#1)(2008-9#1)(2009-10#2)
permeable chelators##2##2##(1994-8#2)
permeable membrane##5##2##(2006-6#1)(2008-10#3)(2008-11#1)
permeable to calcium##4##3##(1991-3#2)(1991-8#1)(1995-2#1)
permeable to small molecules##3##4##(1994-2#1)(2012-11#2)
permeable to##16##2##(1990-11#2)(1991-3#2)(1991-8#1)(1992-11#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-10#1)(1995-2#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-11#2)
permeable##46##1##(1990-11#2)(1990-12#1)(1990-3#1)(1990-6#1)(1991-2#1)(1991-3#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-9#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-10#1)(1995-2#1)(1995-5#2)(2005-11#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-11#2)(2009-3#1)(2009-8#1)(2010-2#1)(2011-12#1)(2012-11#2)(2012-12#1)(2013-8#1)
permeant cations##2##2##(1990-11#1)(2008-4#1)
permeant penetration##2##2##(2008-5#2)
permeant to##2##2##(1990-7#2)
permeant##20##1##(1990-11#3)(1990-2#1)(1990-7#2)(1991-5#1)(1992-8#1)(1996-12#1)(1996-5#1)(1997-1#1)(2008-4#1)(2008-5#5)(2008-8#1)(2009-11#1)(2010-6#1)
permease and##4##2##(1990-5#1)(1991-10#2)(1996-7#1)
permease folding or##2##3##(1993-11#1)(1993-3#1)
permease folding##3##2##(1993-11#1)(1993-3#2)
permease is##3##2##(1990-5#1)(1991-10#1)(1995-1#1)
permease mutant devoid of Cys residues (C-less permease)##3##8##(1993-11#1)(1993-3#1)(1995-1#1)
permease of##4##2##(1993-11#1)(1993-3#1)(1995-1#1)(1996-7#1)
permease##40##1##(1990-5#6)(1991-10#7)(1991-12#1)(1993-11#6)(1993-3#5)(1995-1#5)(1995-11#3)(1996-6#1)(1996-7#3)(1997-6#2)(2008-5#1)
permease)##6##1##(1993-11#1)(1993-3#1)(1995-1#2)(1995-11#1)(1997-3#1)
permeases is##2##2##(1995-1#1)(1996-9#1)
permeases##11##1##(1990-5#3)(1995-1#1)(1995-11#1)(1996-7#3)(1996-9#1)(1997-8#1)(2013-1#1)
permeate flux##3##2##(2005-11#2)(2008-7#1)
permeate into##2##2##(2007-8#1)(2008-7#1)
permeate medium##2##2##(2008-7#2)
permeate##21##1##(2004-8#1)(2005-11#2)(2007-4#1)(2007-8#2)(2008-10#4)(2008-4#1)(2008-6#1)(2008-7#5)(2008-9#2)(2009-5#1)(2012-3#1)
permeated by##2##2##(2011-2#1)(2012-3#1)
permeated##13##1##(1995-2#1)(1996-2#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-5#2)(2009-4#1)(2010-11#1)(2011-2#1)(2012-3#1)
permeates the##3##2##(2007-4#1)(2008-9#1)(2012-3#1)
permeates##9##1##(1991-4#1)(1991-9#1)(2004-8#1)(2007-11#1)(2007-4#1)(2008-7#1)(2008-9#1)(2010-9#1)(2012-3#1)
permeating##4##1##(2006-5#2)(2008-7#1)(2008-8#1)
permeation across##2##2##(2006-10#1)(2010-5#1)
permeation and##8##2##(1992-8#1)(1994-12#1)(1994-6#1)(1996-5#1)(1997-6#1)(2008-8#1)(2012-12#1)(2013-8#1)
permeation characteristics##3##2##(2005-11#1)(2008-5#1)(2012-12#1)
permeation chromatographic##5##2##(1990-11#1)(1993-7#2)(1995-8#1)(2011-1#1)
permeation chromatography##18##2##(1990-10#1)(1990-2#1)(1990-8#1)(1993-12#1)(1993-7#1)(1994-3#1)(1996-11#1)(1996-12#1)(2004-12#1)(2004-9#1)(2007-8#1)(2008-10#3)(2008-5#1)(2009-2#1)(2010-4#1)(2011-1#1)
permeation enhancer##3##2##(2005-11#3)
permeation experiments##2##2##(2008-10#1)(2008-5#1)
permeation in##2##2##(2007-2#1)(2012-1#1)
permeation is##2##2##(1991-5#1)(2005-11#1)
permeation of the UV filters##2##5##(2008-5#2)
permeation of the##4##3##(1994-3#1)(1996-4#1)(2008-5#2)
permeation of##16##2##(1990-2#1)(1992-8#1)(1994-3#1)(1996-4#1)(1997-1#1)(2008-10#2)(2008-5#7)(2010-12#1)(2011-3#1)
permeation pathway##3##2##(2007-3#1)(2008-8#2)
permeation profile of##4##3##(2008-10#1)(2008-5#2)(2012-12#1)
permeation properties##2##2##(2005-11#1)(2008-5#1)
permeation rate##6##2##(2007-2#5)(2008-5#1)
permeation studies were performed##2##4##(2008-5#1)(2012-12#1)
permeation study##2##2##(2008-5#1)(2010-12#1)
permeation through the##2##3##(2006-10#1)(2008-10#1)
permeation through##6##2##(2006-10#2)(2007-3#1)(2008-10#2)(2012-12#1)
permeation was##2##2##(2005-11#1)(2008-5#1)
permeation##128##1##(1990-10#1)(1990-11#2)(1990-2#2)(1990-6#1)(1990-8#1)(1991-5#2)(1992-11#1)(1992-3#1)(1992-8#2)(1993-12#1)(1993-7#3)(1994-12#1)(1994-3#3)(1994-6#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-4#2)(1996-5#1)(1997-1#1)(1997-6#2)(2004-1#1)(2004-12#1)(2004-9#1)(2005-11#7)(2006-10#6)(2007-10#2)(2007-2#7)(2007-3#4)(2007-8#1)(2008-10#11)(2008-11#1)(2008-5#23)(2008-7#1)(2008-8#7)(2009-2#1)(2009-4#1)(2010-12#2)(2010-4#1)(2010-5#3)(2011-1#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#7)(2012-2#1)(2013-8#1)
permed hair##2##2##(2008-5#2)
permet de##2##2##(2011-2#1)(2013-1#1)
permet##4##1##(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
permethrin and##2##2##(2007-5#1)(2012-2#1)
permethrin exposure is##2##3##(2004-11#2)
permethrin exposure##3##2##(2004-11#3)
permethrin resistance in##2##3##(2010-2#1)(2011-2#1)
permethrin##20##1##(1997-5#2)(2004-11#4)(2007-5#1)(2010-2#4)(2011-2#7)(2012-2#2)
permethylated alginic##2##2##(1992-3#2)
permethylated##5##1##(1991-9#1)(1992-3#3)(1993-11#1)
permettre##2##1##(2013-1#2)
permian extinctions##5##2##(1996-11#5)
permissible in##2##2##(2008-8#1)(2011-2#1)
permissible increment of##5##3##(1995-7#5)
permissible limit##3##2##(2005-11#1)(2008-10#1)(2008-7#1)
permissible limits##7##2##(1992-6#1)(2007-10#1)(2008-1#2)(2008-5#3)
permissible##40##1##(1990-6#1)(1991-2#1)(1992-6#1)(1993-3#1)(1993-9#1)(1995-7#5)(1996-3#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#4)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
permission from the##2##3##(1991-3#1)(1997-5#1)
permission from##3##2##(1991-3#1)(1997-5#1)(2008-9#1)
permission to##4##2##(1994-3#1)(1994-6#1)(2007-8#1)(2008-2#1)
permission##12##1##(1991-3#1)(1994-3#2)(1994-6#1)(1997-5#1)(2005-7#1)(2007-2#2)(2007-8#1)(2008-2#1)(2008-9#1)(2011-2#1)
permissive action of basic fibroblast growth factor##2##7##(1990-9#2)
permissive and non-permissive##4##3##(1993-4#1)(1993-8#1)(1995-11#2)
permissive and suppressive actions##2##4##(1994-11#2)
permissive and##6##2##(1993-4#1)(1993-8#1)(1994-11#2)(1995-11#2)
permissive environment##2##2##(2008-1#1)(2012-4#1)
permissive for##6##2##(1993-12#1)(1993-8#1)(1995-2#1)(2005-7#1)(2008-2#1)(2008-5#1)
permissive of##2##2##(2009-9#1)(2011-1#1)
permissive role in the##2##4##(1993-6#1)(2006-10#1)
permissive role in##3##3##(1991-9#1)(1993-6#1)(2006-10#1)
permissive temperature##4##2##(1993-9#1)(1995-6#1)(2009-8#2)
permissive to##4##2##(1995-11#1)(1997-4#1)(2008-2#1)(2008-4#1)
permissive##49##1##(1990-9#2)(1991-8#1)(1991-9#1)(1992-2#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#2)(1994-3#1)(1995-11#3)(1995-2#1)(1995-6#1)(1997-4#2)(2005-11#1)(2005-7#1)(2006-10#2)(2007-10#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#2)(2009-9#1)(2011-1#3)(2011-12#1)(2012-12#1)(2012-4#1)(2013-8#1)
permissively##2##1##(1994-11#2)
permissiveness##2##1##(2007-10#1)(2012-2#1)
permit a more##3##3##(1994-9#1)(2007-12#1)(2008-10#1)
permit a##13##2##(1994-9#2)(1996-12#2)(1997-1#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-7#1)(2013-1#1)
permit accurate##2##2##(2008-2#1)(2008-4#1)
permit an##7##2##(1991-11#1)(1992-6#1)(1993-6#1)(2008-10#2)(2008-3#1)(2012-12#1)
permit calculation of the##2##4##(2008-2#1)(2008-9#1)
permit complete##2##2##(1991-5#1)(2007-12#1)
permit construction of##3##3##(2007-12#1)(2008-4#1)(2008-7#1)
permit development of##2##3##(1993-12#1)(2007-11#1)
permit direct##2##2##(1990-5#1)(2008-7#1)
permit estimation of the##2##4##(1996-5#1)(2007-11#1)
permit high##4##2##(2008-10#1)(2008-2#3)
permit high-fidelity##2##2##(2007-11#1)(2007-12#1)
permit in##2##2##(1993-12#1)(2008-10#1)
permit its##3##2##(1991-8#1)(2006-10#1)(2008-10#1)
permit monitoring of##3##3##(1990-12#1)(2007-12#1)(2008-3#1)
permit more##5##2##(1995-12#1)(2006-10#1)(2008-3#2)(2008-9#1)
permit new##2##2##(2007-11#1)(2007-12#1)
permit other##2##2##(1993-12#1)(1993-2#1)
permit rapid##4##2##(1995-5#1)(2008-11#1)(2008-2#1)(2008-9#1)
permit simultaneous##2##2##(1996-11#1)(1996-12#1)
permit the analysis##2##3##(2007-12#1)(2009-4#1)
permit the development of##2##4##(1993-3#1)(2006-2#1)
permit the diagnosis of##2##4##(1991-12#1)(2009-3#1)
permit the estimation of##2##4##(2007-9#1)(2009-12#1)
permit the incorporation of##2##4##(1992-6#1)(2008-4#1)
permit the use of##5##4##(1993-9#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)
permit the##62##2##(1990-7#1)(1991-12#1)(1991-3#2)(1991-7#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-9#1)(1995-1#1)(1995-9#1)(1997-2#1)(2005-10#1)(2006-12#1)(2006-2#1)(2007-11#3)(2007-12#4)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#5)(2008-3#5)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
permit them to##2##3##(2007-8#1)(2010-3#1)
permit to##2##2##(2008-10#1)(2011-2#1)
permit us to##4##3##(1993-11#1)(2007-12#1)(2008-5#1)(2009-4#1)
permit##274##1##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#2)(1992-8#3)(1993-11#5)(1993-12#5)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-3#1)(1994-5#1)(1994-9#5)(1995-1#1)(1995-12#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#3)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-6#1)(2005-7#1)(2006-10#5)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#5)(2007-11#15)(2007-12#28)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#20)(2008-11#4)(2008-12#2)(2008-2#25)(2008-3#23)(2008-4#8)(2008-5#3)(2008-7#6)(2008-8#2)(2008-9#8)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#6)(2013-1#3)(2013-8#3)
permits a direct##5##3##(2007-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#1)
permits a rapid##2##3##(1995-5#1)(2008-1#1)
permits a##29##2##(1992-8#1)(1995-5#1)(1997-8#2)(2005-8#1)(2006-6#1)(2007-11#2)(2007-12#3)(2007-5#1)(2008-1#2)(2008-10#1)(2008-2#4)(2008-3#3)(2008-4#2)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)
permits accurate##5##2##(1990-8#1)(1992-2#1)(2007-11#1)(2007-12#2)
permits additional##2##2##(1997-8#1)(2007-11#1)
permits an##10##2##(1992-7#1)(1994-12#1)(1995-12#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)
permits analysis of the##2##4##(1996-6#1)(2008-10#1)
permits analysis of##4##3##(1992-8#1)(1996-6#1)(2008-10#1)(2008-4#1)
permits assessment of##2##3##(1991-2#1)(2008-7#1)
permits automatic##2##2##(2008-2#1)(2010-12#1)
permits complete##2##2##(2008-10#1)(2008-7#1)
permits continuous##2##2##(2008-2#2)
permits convenient##2##2##(1990-5#1)(2008-9#1)
permits correction##2##2##(2007-12#1)(2008-2#1)
permits determination of##3##3##(1990-5#1)(2008-10#1)(2008-9#1)
permits direct##7##2##(2007-12#4)(2008-1#1)(2008-3#2)
permits early##2##2##(2005-10#1)(2007-11#1)
permits efficient##3##2##(2007-12#2)(2008-3#1)
permits enhanced##2##2##(2007-11#1)(2007-12#1)
permits estimation##2##2##(2008-2#1)(2008-3#1)
permits fast##4##2##(2008-1#1)(2008-10#1)(2008-3#2)
permits highly##3##2##(1994-9#1)(2008-2#1)(2010-2#1)
permits identification of##2##3##(1993-7#1)(1997-2#1)
permits independent control of the##2##5##(2007-12#2)
permits it##2##2##(1995-8#1)(2007-11#1)
permits mapping of the##2##4##(2007-12#1)(2008-2#1)
permits measurement of##2##3##(2007-11#1)(2008-3#1)
permits non-invasive##3##2##(1990-3#1)(1993-6#1)(2008-4#1)
permits not only##2##3##(2008-11#1)(2009-8#1)
permits one to##11##3##(2007-12#1)(2008-1#1)(2008-2#4)(2008-3#4)(2008-9#1)
permits only##2##2##(2006-7#1)(2008-6#1)
permits precise##2##2##(2007-11#1)(2007-12#1)
permits quantitative##2##2##(2008-3#2)
permits rapid and##3##3##(2008-10#2)(2008-11#1)
permits rapid##6##2##(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)
permits real-time##2##2##(2007-11#1)(2007-12#1)
permits recovery and quantitative analysis of the immunoprecipitated DNA##2##9##(2008-1#1)(2008-2#1)
permits recovery and quantitative analysis of the immunoprecipitated##3##8##(2008-1#1)(2008-2#2)
permits selection for##2##3##(1990-10#1)(1997-4#1)
permits selective##2##2##(1990-5#1)(2012-12#1)
permits simultaneous##4##2##(2008-2#2)(2008-4#1)(2012-2#1)
permits strong##2##2##(1992-9#1)(2007-12#1)
permits sufficient timescale simulations for quantum chemical events such as ATP hydrolysis##2##12##(2013-1#2)
permits sufficient##3##2##(2012-3#1)(2013-1#2)
permits the assignment of##2##4##(1990-5#1)(1995-8#1)
permits the cloning##2##3##(1992-7#1)(1994-12#1)
permits the complete##2##3##(1996-5#1)(2007-12#1)
permits the construction of##2##4##(2008-2#2)
permits the detection of##2##4##(1995-12#1)(2008-10#1)
permits the detection##3##3##(1995-12#1)(2008-1#1)(2008-10#1)
permits the determination of the##2##5##(2008-2#2)
permits the determination of##9##4##(1990-2#1)(2008-10#6)(2008-2#2)
permits the direct##2##3##(2008-10#1)(2008-3#1)
permits the elimination of##2##4##(2007-11#1)(2007-12#1)
permits the extraction of##2##4##(2008-2#1)(2008-3#1)
permits the generation of##5##4##(1994-3#1)(2007-11#1)(2008-2#2)(2011-1#1)
permits the identification of##4##4##(1992-5#1)(1997-2#1)(2006-12#1)(2008-2#1)
permits the measurement of##3##4##(2008-10#1)(2008-3#2)
permits the measurement##4##3##(2007-11#1)(2008-10#1)(2008-3#2)
permits the monitoring##2##3##(1990-11#1)(2008-8#1)
permits the preservation of##2##4##(2006-6#1)(2008-9#1)
permits the quantification##2##3##(1993-11#1)(2008-10#1)
permits the separation of##2##4##(1996-5#1)(2008-10#1)
permits the simultaneous##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)
permits the use of a##2##5##(2008-1#1)(2008-3#1)
permits the use of##7##4##(2006-10#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#2)
permits the##125##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-9#1)(1992-5#1)(1992-7#2)(1993-11#2)(1993-9#1)(1994-12#2)(1994-3#2)(1995-12#1)(1995-3#1)(1995-8#1)(1996-5#2)(1996-8#1)(1997-2#2)(2006-10#2)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#8)(2007-12#14)(2007-8#2)(2008-1#2)(2008-10#19)(2008-11#3)(2008-2#19)(2008-3#15)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2011-1#1)(2012-11#1)(2012-12#1)
permits their##3##2##(2007-12#1)(2008-10#1)(2010-11#1)
permits to##19##2##(1990-2#1)(1991-5#1)(1992-2#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-2#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
permits us to##10##3##(1990-8#1)(1995-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)(2012-2#1)
permits##443##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#5)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-7#3)(1992-8#2)(1992-9#3)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#4)(1994-2#1)(1994-3#2)(1994-4#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-12#3)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#3)(1996-11#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#4)(1997-4#1)(1997-8#6)(2005-10#1)(2005-11#1)(2005-12#2)(2005-8#2)(2006-10#4)(2006-12#3)(2006-3#1)(2006-5#2)(2006-6#5)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#38)(2007-12#53)(2007-5#1)(2007-8#7)(2007-9#1)(2008-1#14)(2008-10#41)(2008-11#6)(2008-12#1)(2008-2#54)(2008-3#45)(2008-4#13)(2008-5#2)(2008-6#2)(2008-7#9)(2008-8#3)(2008-9#8)(2009-10#3)(2009-4#2)(2009-5#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#3)
permitted a good##2##3##(2007-8#1)(2008-10#1)
permitted a high##2##3##(2008-10#2)
permitted a##9##2##(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-3#1)
permitted an##4##2##(2006-6#1)(2008-10#2)(2012-2#1)
permitted analysis of##2##3##(1993-9#1)(1994-6#1)
permitted by the##4##3##(1991-12#1)(2006-10#1)(2008-10#1)(2013-7#1)
permitted by##6##2##(1991-12#1)(1992-2#1)(1993-3#1)(2006-10#1)(2008-10#1)(2013-7#1)
permitted differentiation##2##2##(1992-10#1)(2008-10#1)
permitted direct##2##2##(2007-11#1)(2008-5#1)
permitted evaluation of the##2##4##(1992-3#1)(2008-6#1)
permitted further discrimination##2##3##(1992-3#1)(2005-8#1)
permitted identification of##2##3##(2008-10#1)(2012-2#1)
permitted limit##2##2##(2008-10#1)(2011-2#1)
permitted studies of##3##3##(2007-11#1)(2008-11#1)(2010-10#1)
permitted the detection of##3##4##(1992-7#1)(2008-10#1)(2008-11#1)
permitted the detection##4##3##(1992-7#1)(2008-10#2)(2008-11#1)
permitted the determination of the##4##5##(1990-8#1)(2005-11#1)(2007-7#1)(2008-10#1)
permitted the determination of##6##4##(1990-8#1)(2005-11#1)(2007-7#1)(2008-10#3)
permitted the development of##3##4##(2008-4#1)(2011-1#1)(2012-3#1)
permitted the estimation of##2##4##(2006-3#1)(2008-3#1)
permitted the generation of##2##4##(1994-2#1)(1995-2#1)
permitted the identification of##3##4##(2007-6#1)(2008-10#1)(2010-2#1)
permitted the selective##2##3##(1992-3#1)(2008-10#1)
permitted the simultaneous##2##3##(2007-12#1)(2008-10#1)
permitted the study of##2##4##(1992-2#1)(2008-10#1)
permitted the##58##2##(1990-12#2)(1990-8#1)(1991-3#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#2)(1995-1#2)(1995-2#1)(1996-4#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-3#1)(2007-10#1)(2007-12#4)(2007-6#1)(2007-7#2)(2007-9#1)(2008-10#16)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
permitted to enter##2##3##(1990-12#1)(2005-10#1)
permitted to##15##2##(1990-12#1)(1991-4#1)(1993-8#1)(2005-10#1)(2006-11#1)(2006-8#1)(2008-1#2)(2008-10#4)(2011-2#1)(2013-1#2)
permitted us to##8##3##(1990-12#1)(1991-2#1)(1992-6#1)(1995-11#1)(2005-11#1)(2008-2#1)(2008-4#1)(2008-5#1)
permitted what is to our knowledge the first##2##8##(2007-12#2)
permitted##178##1##(1990-12#4)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-7#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-6#2)(1992-7#1)(1992-9#1)(1993-2#1)(1993-3#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#2)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-11#2)(2006-3#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#8)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#36)(2008-11#7)(2008-12#1)(2008-2#7)(2008-3#5)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#2)(2009-3#1)(2010-10#1)(2010-11#1)(2010-2#4)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
permitting a##9##2##(1990-12#1)(1991-3#1)(1992-5#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-12#1)
permitting analysis##2##2##(2008-10#1)(2008-9#1)
permitting detection##2##2##(2008-10#1)(2008-2#1)
permitting fast##2##2##(2010-12#1)(2010-2#1)
permitting more##2##2##(1997-8#1)(2012-3#1)
permitting simultaneous##2##2##(1997-8#1)(2008-4#1)
permitting the use of##3##4##(2007-8#1)(2008-3#1)(2011-12#1)
permitting the##29##2##(1990-9#1)(1992-1#1)(1992-10#1)(1993-3#1)(1996-8#1)(1997-2#1)(2005-7#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-12#3)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-12#1)(2012-2#1)
permitting##106##1##(1990-12#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-3#1)(1992-1#2)(1992-10#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-5#1)(1994-10#1)(1994-12#1)(1995-12#1)(1996-8#1)(1997-2#1)(1997-8#2)(2005-10#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-3#1)(2007-11#3)(2007-12#12)(2007-4#1)(2007-8#2)(2008-1#2)(2008-10#14)(2008-11#4)(2008-12#1)(2008-2#9)(2008-3#5)(2008-4#4)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#2)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
permittivities##3##1##(2006-2#1)(2008-3#2)
permittivity at the##3##3##(2008-11#1)(2008-3#2)
permittivity measurements##4##2##(2008-11#3)(2012-3#1)
permittivity of colloidal suspensions##2##4##(2005-11#2)
permittivity of the##3##3##(2005-11#1)(2006-10#1)(2008-3#1)
permittivity of##8##2##(1997-1#1)(2005-11#4)(2006-10#1)(2006-2#1)(2008-3#1)
permittivity##30##1##(1991-3#1)(1997-1#1)(2005-11#5)(2006-10#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-11#6)(2008-2#1)(2008-3#7)(2008-6#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-3#1)
permselective##3##1##(2008-10#3)
permselectivity of##2##2##(2005-11#1)(2008-10#1)
permselectivity properties##2##2##(2008-10#2)
permselectivity##7##1##(2005-11#2)(2007-8#1)(2008-10#4)
permutation network##2##2##(2008-2#1)(2008-3#1)
permutation procedure##5##2##(2012-3#5)
permutation test for##2##3##(2010-2#1)(2010-8#1)
permutation test##3##2##(2010-2#1)(2010-8#1)(2012-1#1)
permutation tests##3##2##(2008-12#1)(2008-7#1)(2010-2#1)
permutation##29##1##(1991-11#1)(1992-6#1)(1993-11#1)(1993-3#2)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-7#2)(2009-12#1)(2009-2#1)(2010-2#2)(2010-8#1)(2012-1#2)(2012-3#6)
permutations of the##2##3##(1992-6#1)(2012-1#1)
permutations of##5##2##(1992-6#1)(2007-4#1)(2008-3#1)(2008-7#1)(2012-1#1)
permutations##10##1##(1992-6#1)(2007-4#1)(2008-3#2)(2008-7#1)(2009-8#1)(2010-2#1)(2012-1#1)(2012-3#2)
permuted##9##1##(1991-1#1)(1991-11#2)(1991-4#1)(1993-3#2)(1995-1#1)(2010-4#1)(2012-2#1)
perniciosa##14##1##(2008-10#14)
perniciosa)##2##1##(2008-10#2)
perniciosus##4##1##(2008-8#4)
pernicious anemia##8##2##(1997-1#1)(2012-3#1)(2013-1#6)
pernicious##13##1##(1991-9#1)(1992-8#1)(1997-1#1)(2006-4#2)(2009-2#1)(2012-3#1)(2013-1#6)
pernyi SF films was##2##4##(2008-5#2)
pernyi SF films##3##3##(2008-5#3)
pernyi SF##5##2##(2008-5#5)
pernyi silk fibroin##2##3##(2008-5#2)
pernyi##8##1##(2008-5#8)
peroffskyana##3##1##(1994-11#3)
peroneal and posterior tibial##2##4##(2010-5#2)
peroneal and##4##2##(2007-7#2)(2010-5#2)
peroneal nerve palsy##3##3##(2007-7#1)(2009-9#1)(2013-8#1)
peroneal nerve##13##2##(2006-8#1)(2007-7#3)(2008-12#1)(2008-3#1)(2009-5#2)(2009-9#2)(2012-2#2)(2013-8#1)
peroneal neuropathy##2##2##(2008-8#1)(2009-5#1)
peroneal##27##1##(2005-10#1)(2006-8#1)(2007-7#8)(2008-12#1)(2008-3#1)(2008-8#2)(2009-3#1)(2009-5#4)(2009-9#2)(2010-5#2)(2012-2#2)(2012-3#1)(2013-8#1)
peroneus longus##4##2##(1997-8#1)(2009-3#3)
peroperative##8##1##(1994-2#1)(1995-7#1)(1996-8#1)(1997-6#1)(2007-8#2)(2008-5#1)(2012-2#1)
peroperatively##2##1##(1992-3#1)(2012-1#1)
peroral administration of##4##3##(1992-3#1)(1992-7#1)(2008-4#1)(2013-1#1)
peroral administration##6##2##(1992-3#1)(1992-7#1)(2008-4#1)(2013-1#3)
peroral##15##1##(1992-3#1)(1992-7#1)(1996-11#1)(1997-2#1)(2004-12#1)(2006-10#1)(2006-12#1)(2007-2#1)(2008-4#1)(2008-5#1)(2009-2#1)(2013-1#4)
perovskite##4##1##(1994-5#1)(1995-6#1)(2006-12#1)(2007-5#1)
perovskite-structure##3##1##(2010-12#2)(2012-2#1)
peroxidase (GPX) and##3##3##(1995-5#1)(1995-9#1)(2013-8#1)
peroxidase (GPX)##4##2##(1995-5#1)(1995-9#1)(2008-10#1)(2013-8#1)
peroxidase (GPx)##7##2##(1997-7#1)(2008-11#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
peroxidase (HRP) and##5##3##(2005-11#1)(2008-10#3)(2010-2#1)
peroxidase (HRP) was used##3##4##(2008-10#2)(2008-4#1)
peroxidase (HRP) was##5##3##(1991-6#1)(2007-8#1)(2008-10#2)(2008-4#1)
peroxidase (HRP)##45##2##(1990-4#1)(1990-5#1)(1991-6#1)(1991-8#1)(1992-9#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-7#1)(2005-11#1)(2007-6#1)(2007-8#1)(2008-10#27)(2008-11#1)(2008-4#1)(2008-5#1)(2010-2#1)(2010-5#1)(2012-2#1)
peroxidase (MnP)##4##2##(1994-12#1)(2005-12#1)(2008-7#1)(2011-1#1)
peroxidase (POD)##2##2##(2008-10#2)
peroxidase (POD)-like##2##2##(2008-10#2)
peroxidase (WGA-HRP) into##2##3##(1991-11#1)(1996-11#1)
peroxidase (WGA-HRP)##4##2##(1990-7#1)(1991-11#1)(1993-12#1)(1996-11#1)
peroxidase activities in##2##3##(1991-1#1)(2008-10#1)
peroxidase activities were##3##3##(1991-1#1)(1992-3#1)(2008-10#1)
peroxidase activities##13##2##(1991-1#2)(1991-12#2)(1992-3#1)(1992-4#1)(1994-5#1)(1997-6#3)(2008-10#3)
peroxidase activity and##2##3##(1992-5#1)(2008-11#1)
peroxidase activity in##5##3##(2008-10#3)(2008-12#1)(2013-1#1)
peroxidase activity of##3##3##(2008-10#3)
peroxidase activity was##4##3##(2008-10#1)(2008-2#1)(2008-5#2)
peroxidase activity##33##2##(1990-3#1)(1990-4#1)(1991-8#4)(1992-5#1)(1993-8#1)(1994-2#1)(1995-1#1)(2005-7#1)(2006-8#2)(2008-10#11)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#2)(2009-3#1)(2011-12#1)(2013-1#1)
peroxidase and glutathione reductase activities##2##5##(1994-9#1)(2013-1#1)
peroxidase and glutathione reductase##6##4##(1994-9#1)(2013-1#5)
peroxidase and glutathione##8##3##(1994-9#1)(1997-6#1)(2008-4#1)(2013-1#5)
peroxidase and the##4##3##(1992-5#1)(2007-8#1)(2009-8#1)(2013-8#1)
peroxidase and##37##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-12#3)(1992-5#1)(1993-2#1)(1994-9#2)(1995-6#1)(1996-1#1)(1997-6#3)(2007-12#2)(2007-8#1)(2008-10#8)(2008-4#1)(2008-6#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#5)(2013-8#1)
peroxidase as##2##2##(2008-10#2)
peroxidase by##2##2##(2008-5#1)(2008-7#1)
peroxidase can be##2##3##(2007-8#1)(2009-3#1)
peroxidase catalyzed##2##2##(1992-11#1)(2008-10#1)
peroxidase complex##2##2##(1996-2#1)(1996-6#1)
peroxidase conjugate##2##2##(1997-3#1)(2008-10#1)
peroxidase conjugated##2##2##(1991-2#1)(1992-9#1)
peroxidase cycle##3##2##(1991-9#1)(2006-10#2)
peroxidase enzyme##2##2##(2008-10#1)(2008-8#1)
peroxidase enzymes##2##2##(2008-7#1)(2008-8#1)
peroxidase following##2##2##(1992-1#1)(1993-8#1)
peroxidase from Phanerochaete chrysosporium##2##4##(1994-12#1)(2008-6#1)
peroxidase from the##2##3##(1991-11#1)(1995-7#1)
peroxidase from##9##2##(1991-11#1)(1994-12#2)(1995-5#3)(1995-7#1)(2008-10#1)(2008-6#1)
peroxidase gene##9##2##(1990-12#1)(1991-12#1)(1991-8#1)(1992-12#1)(1997-6#3)(2008-10#1)(2011-1#1)
peroxidase has been##3##3##(1991-8#1)(1995-10#1)(1995-5#1)
peroxidase in##11##2##(1990-5#1)(1991-5#1)(1992-3#1)(1994-6#2)(1995-4#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-2#1)
peroxidase is inhibited by##2##4##(1992-3#1)(2008-10#1)
peroxidase is##7##2##(1991-5#1)(1992-3#1)(2008-10#3)(2008-5#2)
peroxidase labeled##2##2##(1990-4#1)(1996-12#1)
peroxidase labelled##3##2##(1994-2#2)(2005-12#1)
peroxidase mRNA##7##2##(1990-3#1)(1992-5#1)(1993-6#3)(1997-6#2)
peroxidase on##2##2##(1991-9#1)(1992-12#1)
peroxidase or##3##2##(1992-6#1)(2008-2#1)(2008-4#1)
peroxidase secretion##2##2##(1997-5#2)
peroxidase system##6##2##(1990-12#4)(2006-8#1)(2008-10#1)
peroxidase to##3##2##(1992-7#1)(2008-10#2)
peroxidase was##9##2##(1991-12#1)(1994-5#1)(1995-12#1)(2006-8#1)(2008-10#3)(2008-5#1)(2008-7#1)
peroxidase were immobilized##2##3##(2008-10#2)
peroxidase were##10##2##(1990-3#1)(1992-7#1)(2004-4#1)(2008-10#3)(2008-5#3)(2008-8#1)
peroxidase with##2##2##(1991-9#1)(2011-2#1)
peroxidase##458##1##(1990-11#1)(1990-12#7)(1990-2#5)(1990-3#4)(1990-4#10)(1990-5#3)(1990-7#3)(1990-8#1)(1991-1#2)(1991-11#4)(1991-12#9)(1991-2#2)(1991-5#2)(1991-6#1)(1991-8#11)(1991-9#8)(1992-1#1)(1992-11#3)(1992-12#8)(1992-3#4)(1992-4#2)(1992-5#4)(1992-6#5)(1992-7#4)(1992-8#1)(1992-9#4)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#6)(1993-8#3)(1994-12#6)(1994-2#6)(1994-3#1)(1994-5#7)(1994-6#4)(1994-9#2)(1995-1#2)(1995-10#3)(1995-11#3)(1995-12#2)(1995-3#2)(1995-4#1)(1995-5#8)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#3)(1997-4#4)(1997-5#3)(1997-6#15)(1997-7#2)(2004-4#1)(2005-11#1)(2005-12#2)(2005-7#1)(2006-10#8)(2006-3#1)(2006-5#1)(2006-8#7)(2007-10#2)(2007-12#3)(2007-6#1)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#118)(2008-11#3)(2008-12#2)(2008-2#2)(2008-4#7)(2008-5#12)(2008-6#8)(2008-7#11)(2008-8#5)(2008-9#1)(2009-10#1)(2009-2#2)(2009-3#2)(2009-7#2)(2009-8#2)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#2)(2011-1#5)(2011-10#1)(2011-12#1)(2011-2#5)(2012-2#4)(2013-1#10)(2013-8#2)
peroxidase)##2##1##(2008-7#1)(2011-1#1)
peroxidase-antiperoxidase##2##1##(1990-4#1)(1995-11#1)
peroxidase-catalysed reaction##2##2##(2006-10#2)
peroxidase-catalyzed##6##1##(1992-11#1)(2006-10#2)(2007-6#1)(2008-10#2)
peroxidase-conjugated##4##1##(1990-12#1)(1992-11#1)(2005-12#1)(2008-4#1)
peroxidase-iodide-hydrogen peroxide combination##3##3##(2006-8#3)
peroxidase-iodide-hydrogen peroxide##4##2##(2006-8#4)
peroxidase-labeled bovine lactoferrin##2##3##(1996-12#2)
peroxidase-labeled goat##2##2##(1991-3#1)(1994-9#1)
peroxidase-labeled##10##1##(1991-3#1)(1992-8#1)(1993-11#1)(1994-9#1)(1995-1#1)(1996-1#2)(1996-12#2)(2008-10#1)
peroxidase-labelled##2##1##(1991-10#1)(1997-5#1)
peroxidase-like activity##2##2##(2008-5#1)(2008-7#1)
peroxidase-mediated##2##1##(1990-5#1)(2008-4#1)
peroxidase-oxidase reaction has##2##3##(1992-7#1)(2006-10#1)
peroxidase-oxidase reaction##7##2##(1992-7#3)(2006-10#4)
peroxidase-oxidase##9##1##(1992-7#3)(2006-10#4)(2008-10#2)
peroxidases and##2##2##(1993-4#1)(2008-10#1)
peroxidases in the##2##3##(1992-3#1)(2007-8#1)
peroxidases in##5##2##(1992-3#1)(2007-8#1)(2008-10#2)(2009-7#1)
peroxidases were##2##2##(1993-4#1)(2008-10#1)
peroxidases##34##1##(1990-2#2)(1990-4#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-4#2)(1994-12#3)(1994-5#1)(1995-8#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-7#2)(2009-8#1)
peroxidatic##2##1##(1991-10#1)(2009-10#1)
peroxidation and antioxidant##5##3##(1996-1#1)(1996-9#1)(2008-7#1)(2010-4#1)(2013-1#1)
peroxidation and the##3##3##(2008-4#1)(2008-7#1)(2013-8#1)
peroxidation and##36##2##(1990-11#1)(1990-12#1)(1992-4#2)(1995-1#4)(1996-1#1)(1996-2#2)(1996-9#1)(1997-7#1)(2006-12#2)(2007-8#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-12#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#3)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
peroxidation as##5##2##(1990-11#1)(1994-11#1)(1994-3#1)(2004-11#1)(2008-6#1)
peroxidation assay##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
peroxidation by##11##2##(1990-3#1)(1992-4#1)(1993-2#1)(1994-2#1)(1994-8#1)(1995-6#2)(1997-8#1)(2006-12#1)(2008-5#1)(2011-2#1)
peroxidation during##4##2##(1995-1#1)(2008-5#2)(2012-1#1)
peroxidation in human##3##3##(1996-6#1)(1997-8#1)(2008-5#1)
peroxidation in the##12##3##(1990-10#1)(1991-4#1)(1994-2#1)(1994-3#3)(1994-6#1)(1995-3#1)(1997-7#1)(2005-12#1)(2012-1#1)(2013-8#1)
peroxidation in##39##2##(1990-10#3)(1991-4#1)(1991-7#1)(1992-3#1)(1994-2#2)(1994-3#3)(1994-6#2)(1995-1#1)(1995-3#2)(1996-3#2)(1996-6#2)(1996-8#1)(1997-7#1)(1997-8#3)(2005-12#1)(2005-8#2)(2006-10#1)(2007-9#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2012-1#2)(2013-1#1)(2013-8#1)
peroxidation induced by##9##3##(1995-1#1)(1995-6#2)(1997-8#1)(2008-10#1)(2008-4#2)(2010-8#1)(2011-2#1)
peroxidation induced in##3##3##(1996-2#1)(1997-2#1)(1997-8#1)
peroxidation induced##12##2##(1995-1#1)(1995-6#2)(1996-2#1)(1997-2#1)(1997-8#2)(2008-10#1)(2008-4#2)(2010-8#1)(2011-2#1)
peroxidation inhibition##3##2##(1993-4#3)
peroxidation inhibitory activity##2##3##(2010-2#2)
peroxidation is##3##2##(1991-7#1)(1995-1#1)(2006-12#1)
peroxidation level##5##2##(1991-9#1)(2008-10#1)(2010-7#2)(2010-8#1)
peroxidation more##2##2##(1990-8#1)(2013-1#1)
peroxidation of arachidonic acid##2##4##(1994-3#1)(1995-1#1)
peroxidation of erythrocyte membrane lipids##2##5##(1991-2#2)
peroxidation of membrane##3##3##(1991-5#1)(2009-6#1)(2012-1#1)
peroxidation of membranes##2##3##(1990-12#1)(1991-9#1)
peroxidation of plasma##2##3##(1994-6#1)(2006-12#1)
peroxidation of##26##2##(1990-10#1)(1990-12#1)(1991-2#3)(1991-5#2)(1991-9#1)(1993-4#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1996-1#2)(1996-3#1)(1996-8#1)(1997-5#1)(2005-8#2)(2006-12#1)(2008-5#2)(2009-6#1)(2012-1#1)
peroxidation products and##3##3##(2007-8#1)(2008-8#1)(2010-4#1)
peroxidation products##16##2##(1990-5#1)(1992-4#2)(1994-11#1)(1994-8#1)(1995-12#1)(1997-8#1)(2007-8#1)(2008-1#2)(2008-4#1)(2008-8#1)(2009-8#3)(2010-4#1)
peroxidation reactions##2##2##(1990-11#1)(1995-1#1)
peroxidation was##11##2##(1990-11#1)(1991-5#1)(1995-1#2)(1995-6#1)(1996-3#1)(2007-9#1)(2008-4#1)(2008-7#1)(2008-8#2)
peroxidation were##5##2##(1997-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)
peroxidation with##5##2##(1994-8#1)(1995-1#1)(2008-10#1)(2008-5#2)
peroxidation##378##1##(1990-10#4)(1990-11#6)(1990-12#3)(1990-3#3)(1990-4#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#5)(1991-4#1)(1991-5#4)(1991-7#3)(1991-9#4)(1992-11#4)(1992-3#2)(1992-4#7)(1992-8#3)(1992-9#1)(1993-2#4)(1993-4#6)(1993-8#2)(1994-10#1)(1994-11#5)(1994-12#1)(1994-2#4)(1994-3#10)(1994-5#3)(1994-6#8)(1994-8#8)(1995-1#21)(1995-12#5)(1995-3#5)(1995-6#8)(1996-1#6)(1996-2#7)(1996-3#5)(1996-6#2)(1996-7#1)(1996-8#4)(1996-9#1)(1997-2#3)(1997-5#2)(1997-7#3)(1997-8#11)(2004-11#2)(2005-11#1)(2005-12#3)(2005-7#3)(2005-8#6)(2006-10#1)(2006-12#8)(2006-6#3)(2007-1#1)(2007-11#1)(2007-8#3)(2007-9#8)(2008-1#2)(2008-10#14)(2008-11#4)(2008-12#1)(2008-3#3)(2008-4#6)(2008-5#20)(2008-6#7)(2008-7#10)(2008-8#8)(2009-12#2)(2009-5#2)(2009-6#2)(2009-8#5)(2010-12#2)(2010-2#3)(2010-4#3)(2010-5#1)(2010-7#8)(2010-8#8)(2011-1#5)(2011-2#7)(2012-1#4)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#7)(2013-8#3)
peroxidation) of##2##2##(1997-7#1)(2005-8#1)
peroxidation)##4##1##(1997-7#2)(2005-8#1)(2008-6#1)
peroxidation-resistant membrane composition##3##3##(2009-5#3)
peroxidation-resistant##5##1##(2009-5#5)
peroxidative activity of human Cu##3##5##(1997-2#3)
peroxidative activity##6##2##(1997-2#5)(1997-8#1)
peroxidative damage##3##2##(2005-8#1)(2007-11#1)(2009-5#1)
peroxidative reaction##3##2##(1997-8#3)
peroxidative reactions##2##2##(1990-11#1)(1991-2#1)
peroxidative##20##1##(1990-11#1)(1991-2#2)(1993-9#1)(1995-1#1)(1995-7#1)(1997-2#7)(1997-8#4)(2005-8#1)(2007-11#1)(2009-5#1)
peroxide (H(2)O(2))##20##2##(2007-1#1)(2008-10#10)(2008-2#1)(2008-5#1)(2009-8#2)(2010-5#1)(2010-7#1)(2012-2#1)(2013-1#2)
peroxide (H2O2)##19##2##(1990-5#1)(1990-9#2)(1991-9#1)(1992-3#1)(1993-7#1)(1994-10#1)(1995-3#1)(1995-7#1)(1996-1#1)(1997-1#1)(1997-4#2)(1997-8#1)(2008-4#1)(2008-7#1)(2012-3#1)(2013-8#2)
peroxide (UHP)##2##2##(2007-11#2)
peroxide and superoxide##2##3##(1992-7#1)(1996-2#1)
peroxide and the##5##3##(2008-10#2)(2008-5#2)(2008-8#1)
peroxide and##53##2##(1990-3#1)(1991-9#1)(1992-5#1)(1992-7#1)(1993-12#1)(1994-10#1)(1994-3#1)(1995-8#1)(1996-2#1)(1997-6#1)(2007-10#1)(2008-10#23)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#2)(2009-4#1)(2009-5#1)(2010-2#1)(2010-5#2)(2011-2#3)(2013-1#2)
peroxide as##6##2##(1992-9#1)(2007-8#1)(2008-10#4)
peroxide complex##2##2##(1991-4#1)(2007-11#1)
peroxide concentration##5##2##(1997-3#1)(2004-9#1)(2008-10#3)
peroxide concentrations##5##2##(1990-5#1)(2008-10#3)(2008-5#1)
peroxide content##2##2##(1996-3#1)(2008-5#1)
peroxide formation##4##2##(1990-3#1)(1991-10#1)(2006-10#1)(2008-4#1)
peroxide generation##5##2##(1990-5#1)(1995-6#1)(2008-7#1)(2009-9#1)(2010-2#1)
peroxide in the presence of##3##5##(1996-5#1)(2008-10#2)
peroxide in the##9##3##(1994-8#1)(1995-8#1)(1996-5#1)(2008-10#6)
peroxide in##41##2##(1994-3#1)(1994-8#1)(1995-8#1)(1996-5#2)(2005-12#2)(2007-8#1)(2008-10#32)(2009-5#1)
peroxide is detected##2##3##(2008-10#2)
peroxide is##9##2##(1990-3#1)(1991-9#1)(1992-11#1)(1994-2#1)(2008-10#5)
peroxide levels in##2##3##(1996-9#1)(2008-11#1)
peroxide levels##8##2##(1990-5#1)(1994-10#1)(1994-6#1)(1996-9#1)(2008-10#2)(2008-11#1)(2008-5#1)
peroxide product##2##2##(2007-11#1)(2008-10#1)
peroxide production##4##2##(1991-5#1)(1995-8#1)(1997-3#1)(2006-10#1)
peroxide stress##2##2##(1995-8#2)
peroxide system##3##2##(1992-11#1)(2006-8#1)(2008-10#1)
peroxide value##6##2##(2007-3#1)(2008-10#5)
peroxide values##2##2##(1990-5#2)
peroxide was also##2##3##(1993-4#1)(2011-2#1)
peroxide was##13##2##(1990-3#1)(1993-4#1)(1994-3#1)(2005-12#1)(2006-8#1)(2008-10#5)(2008-3#1)(2010-4#1)(2011-2#1)
peroxide which##2##2##(2004-9#1)(2008-10#1)
peroxide##489##1##(1990-1#1)(1990-3#5)(1990-4#5)(1990-5#9)(1990-8#1)(1990-9#2)(1991-10#2)(1991-2#1)(1991-4#1)(1991-5#3)(1991-7#1)(1991-9#11)(1992-11#4)(1992-12#2)(1992-3#2)(1992-5#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-4#2)(1993-7#2)(1994-10#3)(1994-12#1)(1994-2#3)(1994-3#5)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-3#3)(1995-5#2)(1995-6#1)(1995-7#2)(1995-8#5)(1996-1#2)(1996-10#2)(1996-2#2)(1996-3#1)(1996-5#2)(1996-8#5)(1996-9#1)(1997-1#2)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#3)(1997-8#1)(2004-9#2)(2005-11#5)(2005-12#4)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-3#1)(2006-6#1)(2006-8#7)(2007-1#1)(2007-10#6)(2007-11#7)(2007-3#1)(2007-8#9)(2008-1#1)(2008-10#222)(2008-11#5)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#16)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#3)(2009-9#1)(2010-2#4)(2010-4#1)(2010-5#5)(2010-7#2)(2010-8#10)(2011-2#8)(2012-12#3)(2012-2#1)(2012-3#1)(2012-8#3)(2013-1#5)(2013-7#1)(2013-8#5)
peroxide) and##2##2##(2008-10#1)(2009-3#1)
peroxide)##6##1##(2007-8#1)(2008-10#3)(2009-3#1)(2013-1#1)
peroxide-dependent##4##1##(1990-5#1)(1994-2#1)(1995-1#1)(2010-12#1)
peroxide-induced changes in##2##3##(1991-7#1)(1995-5#1)
peroxide-induced haemolysis##3##2##(1991-12#3)
peroxide-induced##10##1##(1991-12#3)(1991-7#1)(1995-5#2)(1996-8#1)(1997-4#1)(1997-6#1)(2008-7#1)
peroxides are##2##2##(2004-4#1)(2011-2#1)
peroxides in the##2##3##(2008-10#1)(2013-1#1)
peroxides in##11##2##(1990-5#4)(1992-3#1)(1995-8#3)(2008-10#2)(2013-1#1)
peroxides##40##1##(1990-5#5)(1991-9#2)(1992-1#2)(1992-3#1)(1992-5#1)(1993-12#2)(1995-8#3)(1995-9#1)(1996-3#1)(1996-6#1)(1996-8#2)(2004-4#1)(2005-8#1)(2006-6#1)(2008-10#3)(2008-5#5)(2008-7#3)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
peroxidic tetrahydrofuran##2##2##(2007-12#2)
peroxidic##3##1##(1997-2#1)(2007-12#2)
peroxidized##3##1##(1990-8#1)(1994-3#1)(2005-8#1)
peroxidizing effects of##2##3##(1994-6#2)
peroxidizing##4##1##(1994-3#1)(1994-6#3)
peroxiredoxin hyperoxidation##3##2##(2010-4#3)
peroxiredoxin##6##1##(2008-10#1)(2009-10#1)(2009-6#1)(2010-4#3)
peroxiredoxins##6##1##(2009-10#2)(2009-12#1)(2010-4#3)
peroxisomal 3-ketoacyl-CoA thiolase##4##3##(1991-12#2)(1992-7#2)
peroxisomal acyl-CoA oxidase##3##3##(1992-3#1)(1994-9#2)
peroxisomal beta-oxidation system##3##3##(1992-4#1)(1994-6#1)(1997-7#1)
peroxisomal beta-oxidation##13##2##(1990-2#2)(1991-10#2)(1992-4#5)(1994-6#1)(1995-3#1)(1997-7#2)
peroxisomal bifunctional enzyme##5##3##(1992-4#1)(1992-5#3)(1995-2#1)
peroxisomal catalase##2##2##(1992-4#1)(1993-9#1)
peroxisomal defects##3##2##(1993-8#1)(1996-7#2)
peroxisomal disorder##2##2##(1991-10#2)
peroxisomal disorders##10##2##(1990-11#3)(1990-3#2)(1991-10#1)(1992-4#1)(1993-12#1)(1993-8#1)(2008-6#1)
peroxisomal enoyl-CoA hydratase-3-hydroxyacyl-CoA dehydrogenase bifunctional enzyme##2##6##(1992-5#2)
peroxisomal enzyme##3##2##(1995-12#1)(1997-4#1)(2007-12#1)
peroxisomal enzymes##3##2##(1992-4#1)(1995-12#1)(1995-6#1)
peroxisomal fatty acid beta-oxidation##2##4##(1992-11#1)(1994-6#1)
peroxisomal fatty acid##3##3##(1992-11#1)(1992-4#1)(1994-6#1)
peroxisomal functions##2##2##(1994-6#2)
peroxisomal marker##3##2##(1991-12#1)(1994-12#2)
peroxisomal membrane##3##2##(1995-2#1)(1995-3#1)(2009-8#1)
peroxisomal protein import##3##3##(1995-3#1)(2008-1#2)
peroxisomal protein##6##2##(1990-12#1)(1991-9#1)(1995-3#1)(1995-6#1)(2008-1#2)
peroxisomal proteins##3##2##(1992-3#1)(1992-6#1)(1997-7#1)
peroxisomal targeting signal##3##3##(1992-6#1)(1992-7#1)(1995-3#1)
peroxisomal targeting##9##2##(1991-12#2)(1992-6#1)(1992-7#2)(1995-3#1)(2008-1#1)(2009-10#2)
peroxisomal trifunctional enzyme##4##3##(1991-8#4)
peroxisomal##106##1##(1990-11#3)(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#2)(1991-10#5)(1991-12#5)(1991-8#4)(1991-9#1)(1992-11#1)(1992-3#4)(1992-4#12)(1992-5#6)(1992-6#3)(1992-7#4)(1993-12#1)(1993-8#4)(1993-9#2)(1994-12#4)(1994-6#4)(1994-9#2)(1995-12#2)(1995-2#2)(1995-3#5)(1995-6#2)(1995-9#1)(1996-7#4)(1997-4#1)(1997-7#6)(2007-12#1)(2008-1#3)(2008-11#1)(2008-5#1)(2008-6#1)(2009-10#2)(2009-8#1)
peroxisome assembly##2##2##(1992-2#2)
peroxisome biogenesis##5##2##(1993-12#2)(2007-8#1)(2009-8#1)(2012-3#1)
peroxisome proliferation in##4##3##(1992-8#1)(1995-3#2)(2009-8#1)
peroxisome proliferation##17##2##(1992-11#4)(1992-8#1)(1993-9#1)(1995-3#5)(2009-8#6)
peroxisome proliferator activated receptor alpha##3##5##(1994-2#2)(1997-7#1)
peroxisome proliferator activated receptor##7##4##(1992-8#2)(1994-2#2)(1997-7#1)(2012-2#1)(2013-8#1)
peroxisome proliferator activated receptors##2##4##(2005-7#1)(2008-10#1)
peroxisome proliferator activated##10##3##(1992-8#2)(1994-2#2)(1997-7#2)(2005-7#1)(2008-10#1)(2012-2#1)(2013-8#1)
peroxisome proliferator response##2##3##(1995-2#1)(1995-3#1)
peroxisome proliferator responsive##2##3##(1995-2#1)(1995-3#1)
peroxisome proliferator##20##2##(1992-4#1)(1992-8#3)(1994-2#2)(1994-8#2)(1995-2#2)(1995-3#3)(1997-7#2)(2005-7#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-8#1)
peroxisome proliferator-activated receptor (PPAR)##5##4##(1995-2#1)(1995-3#1)(1995-6#1)(2008-1#1)(2008-5#1)
peroxisome proliferator-activated receptor alpha##3##4##(1997-4#1)(2013-1#1)(2013-8#1)
peroxisome proliferator-activated receptor##20##3##(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#2)(1997-4#1)(2006-2#1)(2007-10#1)(2008-1#1)(2008-4#1)(2008-5#2)(2010-10#1)(2010-4#1)(2010-7#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#2)
peroxisome proliferator-activated receptor-alpha##2##3##(2009-11#2)
peroxisome proliferator-activated receptor-gamma##3##3##(2008-7#2)(2012-12#1)
peroxisome proliferator-activated receptors alpha and##2##5##(1997-4#2)
peroxisome proliferator-activated receptors##7##3##(1997-4#2)(2005-11#1)(2008-1#1)(2010-3#1)(2010-7#1)(2013-1#1)
peroxisome proliferator-activated##32##2##(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#2)(1997-4#3)(2005-11#1)(2006-2#1)(2007-10#1)(2008-1#2)(2008-4#1)(2008-5#2)(2008-7#2)(2009-11#2)(2010-10#1)(2010-3#1)(2010-4#1)(2010-7#2)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
peroxisome proliferator-responsive##2##2##(1991-3#2)
peroxisome proliferators##9##2##(1990-12#1)(1992-4#1)(1992-8#2)(1994-8#2)(1995-6#1)(2009-8#2)
peroxisome##98##1##(1990-10#1)(1990-12#1)(1991-3#2)(1992-11#5)(1992-2#3)(1992-4#2)(1992-8#6)(1993-12#2)(1993-9#1)(1994-2#2)(1994-8#5)(1995-12#1)(1995-2#3)(1995-3#9)(1995-6#3)(1995-9#1)(1997-4#4)(1997-7#2)(2005-11#1)(2005-7#1)(2006-2#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-4#1)(2008-5#2)(2008-7#3)(2009-11#2)(2009-8#13)(2010-10#1)(2010-3#1)(2010-4#1)(2010-7#2)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
peroxisome-deficient##2##1##(1995-9#2)
peroxisome-proliferating##3##1##(1990-2#3)
peroxisomes and microsomes##2##3##(1993-9#2)
peroxisomes and mitochondria##4##3##(2009-10#4)
peroxisomes and##10##2##(1993-9#4)(1995-3#1)(2009-10#4)(2009-8#1)
peroxisomes are involved in##2##4##(1994-12#1)(2007-12#1)
peroxisomes are##3##2##(1994-12#1)(1995-6#1)(2007-12#1)
peroxisomes in##5##2##(1995-3#2)(1995-9#1)(2007-8#1)(2009-8#1)
peroxisomes of##2##2##(1992-6#1)(1994-12#1)
peroxisomes were##2##2##(1995-9#1)(2008-7#1)
peroxisomes with##2##2##(1995-12#1)(2008-7#1)
peroxisomes##68##1##(1990-10#3)(1990-12#1)(1990-2#1)(1990-5#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-7#1)(1993-9#10)(1994-11#3)(1994-12#2)(1994-6#5)(1995-12#1)(1995-2#1)(1995-3#3)(1995-6#1)(1995-9#4)(1996-7#1)(1997-4#2)(1997-7#4)(2007-12#2)(2007-8#1)(2008-5#1)(2008-7#2)(2009-10#5)(2009-8#6)(2013-1#1)
peroxo complexes of vanadium##2##4##(2008-5#2)
peroxo niobic acid sol##6##4##(2005-11#6)
peroxo##9##1##(2005-11#6)(2008-5#2)(2010-5#1)
peroxodisulfate##5##1##(2008-10#5)
peroxovanadate##2##1##(1997-1#2)
peroxy radicals##4##2##(1993-12#2)(1997-5#1)(2006-10#1)
peroxy##6##1##(1993-12#2)(1993-6#1)(1995-10#1)(1997-5#1)(2006-10#1)
peroxyacetic acid##3##2##(2010-4#3)
peroxydisulphate##2##1##(2008-10#2)
peroxygenase##4##1##(1990-12#3)(1992-8#1)
peroxyl radical##12##2##(1990-10#1)(1990-5#2)(1991-10#2)(1991-9#1)(1992-9#1)(1993-3#1)(1993-4#2)(2008-10#1)(2008-7#1)
peroxyl radicals and##2##3##(1995-1#1)(1996-2#1)
peroxyl radicals in##2##3##(1992-9#1)(2008-10#1)
peroxyl radicals##8##2##(1992-9#2)(1995-1#2)(1996-2#1)(2008-10#2)(2012-1#1)
peroxyl##21##1##(1990-10#1)(1990-5#2)(1991-10#2)(1991-9#2)(1992-9#3)(1993-3#1)(1993-4#2)(1995-1#2)(1996-2#1)(2008-10#3)(2008-7#1)(2012-1#1)
peroxynitrate##5##1##(2010-5#5)
peroxynitrite (ONOO(-))##4##2##(2008-10#2)(2008-5#1)(2008-7#1)
peroxynitrite and##2##2##(2008-10#1)(2010-5#1)
peroxynitrite decomposition##3##2##(1994-9#2)(2008-10#1)
peroxynitrite in biological samples##2##4##(2008-10#2)
peroxynitrite in##6##2##(1994-9#1)(1996-6#1)(2004-12#1)(2008-10#3)
peroxynitrite production##2##2##(2006-10#1)(2011-1#1)
peroxynitrite scavenging##3##2##(1997-7#3)
peroxynitrite to##3##2##(1994-9#1)(2008-10#1)(2010-5#1)
peroxynitrite##56##1##(1994-5#2)(1994-9#7)(1996-5#1)(1996-6#2)(1997-4#1)(1997-7#5)(1997-8#1)(2004-12#6)(2006-10#1)(2008-10#19)(2008-5#2)(2008-7#1)(2010-5#5)(2011-1#1)(2011-2#2)
peroxynitrous acid##2##2##(2008-10#1)(2010-5#1)
peroxyoxalate chemiluminescence##2##2##(1990-8#2)
peroxyoxalate chemiluminescent##2##2##(2008-10#2)
peroxyoxalate##5##1##(1990-8#2)(2008-10#3)
perpendicular and##2##2##(2007-12#1)(2008-3#1)
perpendicular direction##2##2##(1997-6#1)(2010-4#1)
perpendicular or parallel##2##3##(2007-12#1)(2008-3#1)
perpendicular or##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
perpendicular polarized##3##2##(2007-12#2)(2008-3#1)
perpendicular to that of##2##4##(2008-2#1)(2008-3#1)
perpendicular to that##3##3##(1996-5#1)(2008-2#1)(2008-3#1)
perpendicular to the c axis##2##5##(1990-4#1)(1996-2#1)
perpendicular to the glass##2##4##(2010-9#2)
perpendicular to the grating##2##4##(2008-2#2)
perpendicular to the helix axis##2##5##(2006-12#2)
perpendicular to the optical axis##2##5##(2008-2#1)(2008-3#1)
perpendicular to the plane of the##3##6##(1994-12#1)(1995-5#1)(2008-3#1)
perpendicular to the plane of##5##5##(1994-12#1)(1995-5#1)(2008-3#3)
perpendicular to the propagation direction##2##5##(2007-12#1)(2008-3#1)
perpendicular to the substrate##3##4##(2008-3#2)(2010-7#1)
perpendicular to the surface of##2##5##(1995-5#1)(2007-11#1)
perpendicular to the surface##3##4##(1995-5#1)(2007-11#1)(2008-3#1)
perpendicular to the wind##2##4##(2008-10#2)
perpendicular to the##78##3##(1990-11#1)(1990-4#1)(1993-4#1)(1993-7#1)(1994-11#1)(1994-12#1)(1995-5#2)(1996-1#1)(1996-2#3)(1996-4#2)(2004-11#1)(2005-11#1)(2006-12#2)(2007-11#6)(2007-12#4)(2007-3#1)(2007-8#1)(2008-10#5)(2008-2#4)(2008-3#23)(2008-7#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-4#2)(2010-7#1)(2010-9#2)(2011-2#1)(2012-11#2)(2012-12#1)(2013-8#1)
perpendicular to##91##2##(1990-11#2)(1990-4#1)(1990-9#1)(1993-4#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-5#2)(1996-1#1)(1996-2#3)(1996-4#2)(1996-5#1)(1997-7#1)(2004-11#1)(2005-11#1)(2006-12#2)(2007-11#6)(2007-12#4)(2007-3#1)(2007-6#2)(2007-8#1)(2008-10#5)(2008-2#7)(2008-3#24)(2008-7#1)(2009-2#1)(2009-5#2)(2009-7#1)(2009-9#2)(2010-4#2)(2010-7#1)(2010-9#3)(2011-2#1)(2012-11#2)(2012-12#1)(2013-8#1)
perpendicular##133##1##(1990-11#2)(1990-2#1)(1990-4#1)(1990-9#2)(1993-4#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-5#2)(1996-1#1)(1996-2#3)(1996-4#2)(1996-5#1)(1997-6#1)(1997-7#3)(2004-11#1)(2005-11#1)(2006-12#2)(2007-11#8)(2007-12#9)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-10#5)(2008-2#12)(2008-3#35)(2008-5#2)(2008-6#1)(2008-7#1)(2009-2#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#2)(2010-12#1)(2010-4#3)(2010-7#2)(2010-8#2)(2010-9#3)(2011-2#1)(2012-11#2)(2012-12#3)(2013-8#1)
perpendicular)##2##1##(1996-2#1)(2008-10#1)
perpendicularly polarized##2##2##(2007-12#1)(2008-2#1)
perpendicularly to the##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
perpendicularly to##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
perpendicularly##11##1##(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#2)(2008-6#1)(2011-2#1)
perpetrated by##2##2##(1995-9#1)(1996-12#1)
perpetrated##5##1##(1991-12#1)(1995-9#1)(1996-12#1)(2006-4#1)(2013-1#1)
perpetrating IPV##2##2##(2010-11#1)(2013-1#1)
perpetrating##3##1##(2006-4#1)(2010-11#1)(2013-1#1)
perpetration of##2##2##(2009-5#1)(2010-11#1)
perpetration##24##1##(2009-5#7)(2009-7#5)(2010-11#2)(2010-4#5)(2013-1#5)
perpetrator and##2##2##(2008-11#1)(2012-12#1)
perpetrator is##2##2##(2007-2#1)(2010-12#1)
perpetrator or##2##2##(1996-12#1)(2010-4#1)
perpetrator##12##1##(1996-12#1)(2005-9#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-11#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
perpetrator's##2##1##(2009-5#1)(2012-12#1)
perpetrators and##3##2##(2007-2#1)(2007-3#1)(2008-11#1)
perpetrators of##3##2##(2006-9#1)(2007-9#1)(2009-5#1)
perpetrators were##2##2##(2007-3#1)(2010-4#1)
perpetrators##18##1##(2006-9#1)(2007-2#1)(2007-3#3)(2007-9#2)(2008-11#2)(2009-5#3)(2010-4#1)(2010-9#1)(2012-2#1)(2013-1#1)(2013-8#2)
perpetual change##2##2##(2006-10#1)(2008-1#1)
perpetual##7##1##(1993-11#1)(1994-7#1)(1995-8#1)(2006-10#1)(2008-1#1)(2010-3#1)(2012-2#1)
perpetually##3##1##(1995-3#1)(2008-4#1)(2008-7#1)
perpetuate the##2##2##(2008-9#1)(2010-12#1)
perpetuate##9##1##(1996-5#1)(2006-12#1)(2007-11#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-11#1)(2012-2#1)(2013-7#1)
perpetuated by the##2##3##(1994-11#1)(2006-10#1)
perpetuated by##6##2##(1994-11#1)(2006-10#2)(2007-7#1)(2008-7#2)
perpetuated##9##1##(1990-12#1)(1994-11#1)(2006-10#2)(2007-7#1)(2008-7#2)(2010-12#1)(2010-6#1)
perpetuates##2##1##(2007-4#1)(2010-3#1)
perpetuating the##2##2##(1994-2#1)(2006-8#1)
perpetuating##7##1##(1994-2#1)(2006-8#1)(2007-12#1)(2010-12#2)(2010-7#1)(2012-12#1)
perpetuation of a##2##3##(2006-10#1)(2010-12#1)
perpetuation of chronic##2##3##(2006-10#1)(2012-12#1)
perpetuation of the##2##3##(1993-10#1)(2013-1#1)
perpetuation of##20##2##(1993-10#1)(1994-8#1)(2006-10#2)(2006-7#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#3)(2008-5#1)(2008-6#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
perpetuation##22##1##(1993-10#1)(1994-8#1)(1995-3#1)(2006-10#2)(2006-7#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#3)(2008-5#1)(2008-6#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
perphenazine assay##2##2##(2008-10#2)
perphenazine was##2##2##(2008-10#2)
perphenazine##21##1##(1992-12#1)(2008-10#17)(2008-5#3)
perplexing problem##2##2##(2005-10#1)(2006-9#1)
perplexing##8##1##(2005-10#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-6#1)(2008-9#1)(2011-2#1)
persecution##4##1##(1996-6#2)(2008-6#2)
persecutory##3##1##(1997-8#1)(2006-3#1)(2012-1#1)
perseverance and##3##2##(2008-11#1)(2008-12#1)(2010-12#1)
perseverance##4##1##(2006-10#1)(2008-11#1)(2008-12#1)(2010-12#1)
perseveration##2##1##(1996-8#1)(2006-3#1)
perseverative errors##3##2##(1996-8#1)(2006-3#1)(2006-4#1)
perseverative##7##1##(1991-5#2)(1994-3#1)(1996-8#1)(2006-3#1)(2006-4#1)(2012-1#1)
persica##6##1##(2008-10#3)(2008-12#2)(2011-12#1)
persicae and##3##2##(2004-2#2)(2008-10#1)
persicae##11##1##(2004-2#4)(2008-10#6)(2009-8#1)
persicus and##3##2##(2008-12#3)
persicus were##2##2##(2008-12#1)(2008-5#1)
persicus##13##1##(2008-12#8)(2008-5#3)(2013-1#2)
persimmon fruits##2##2##(2008-10#2)
persimmon tannin gel##4##3##(2008-10#4)
persimmon##10##1##(2008-10#9)(2008-6#1)
persist after##3##2##(2007-11#1)(2010-11#1)(2011-1#1)
persist and the##2##3##(2006-12#1)(2011-2#1)
persist and##6##2##(1992-11#1)(2006-12#1)(2006-5#1)(2008-4#2)(2011-2#1)
persist at##4##2##(1995-11#1)(2008-8#1)(2011-1#1)(2011-3#1)
persist despite##7##2##(1996-9#1)(2006-11#1)(2006-9#1)(2011-1#1)(2011-2#1)(2012-2#2)
persist even after##2##3##(2006-10#1)(2007-9#1)
persist even with##2##3##(2007-11#1)(2010-2#1)
persist even##5##2##(1994-6#1)(2006-10#1)(2007-11#1)(2007-9#1)(2010-2#1)
persist for at least##2##4##(1996-11#1)(2007-2#1)
persist for##9##2##(1990-12#1)(1991-3#1)(1995-9#1)(1996-11#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-2#1)(2011-2#1)
persist in a##2##3##(2008-8#1)(2012-3#1)
persist in large numbers##2##4##(2008-11#1)(2012-2#1)
persist in the##6##3##(1990-5#1)(1992-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2009-8#1)
persist in vitro##2##3##(1994-8#1)(1997-6#1)
persist in##27##2##(1990-11#1)(1990-5#1)(1992-3#1)(1994-2#1)(1994-8#1)(1996-3#1)(1997-6#1)(2004-4#1)(2006-10#1)(2006-4#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#2)(2009-6#1)(2009-8#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
persist into adulthood##3##3##(1991-1#1)(2011-2#1)(2013-7#1)
persist into##5##2##(1991-1#1)(2006-9#1)(2008-11#1)(2011-2#1)(2013-7#1)
persist longer##2##2##(1997-6#1)(2008-9#1)
persist on##2##2##(2008-10#2)
persist over time##2##3##(2009-5#1)(2012-1#1)
persist well into##2##3##(2008-6#1)(2012-12#1)
persist well##3##2##(2006-8#1)(2008-6#1)(2012-12#1)
persist with##2##2##(2009-3#1)(2009-5#1)
persist##113##1##(1990-11#1)(1990-12#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-3#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-9#1)(1996-11#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-6#3)(1997-8#1)(2004-4#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-4#2)(2006-5#1)(2006-8#1)(2006-9#2)(2007-11#3)(2007-2#1)(2007-7#3)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#3)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#5)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#3)(2013-8#2)
persist?##2##1##(2008-8#2)
persistant##2##1##(1993-2#1)(2011-2#1)
persisted after the##2##3##(1993-2#1)(2008-10#1)
persisted after##9##2##(1990-5#1)(1991-11#1)(1991-5#1)(1992-8#1)(1993-2#1)(1995-3#1)(2006-10#1)(2008-10#1)(2008-5#1)
persisted and##2##2##(2008-9#1)(2010-12#1)
persisted at the##2##3##(1992-10#1)(1992-9#1)
persisted at##11##2##(1990-11#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-7#2)(1991-8#1)(1992-10#1)(1992-9#1)(1997-2#1)(2006-10#1)
persisted despite##2##2##(2006-11#1)(2010-7#1)
persisted during##5##2##(1990-9#1)(1993-5#1)(1995-11#1)(2007-7#1)(2007-9#1)
persisted even##2##2##(1992-6#1)(1994-3#1)
persisted following##2##2##(1991-8#1)(1997-5#1)
persisted for 30 weeks##2##4##(2009-12#2)
persisted for a##2##3##(2008-10#1)(2012-1#1)
persisted for at least##3##4##(1990-12#1)(1990-4#1)(2007-2#1)
persisted for longer##2##3##(2007-11#1)(2010-7#1)
persisted for several months##2##4##(1995-9#1)(1997-6#1)
persisted for several##5##3##(1995-9#1)(1997-6#1)(2008-10#1)(2011-1#1)(2012-2#1)
persisted for the duration of the experiment##2##7##(1991-12#1)(2008-10#1)
persisted for the duration of the##3##6##(1991-12#1)(2008-10#1)(2012-2#1)
persisted for the##5##3##(1991-12#1)(2005-1#1)(2008-10#1)(2009-2#1)(2012-2#1)
persisted for up to##3##4##(2008-10#2)(2008-8#1)
persisted for##36##2##(1990-12#1)(1990-4#1)(1991-12#1)(1991-3#1)(1993-12#1)(1994-4#1)(1995-1#1)(1995-7#1)(1995-9#1)(1997-6#1)(2005-1#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-6#1)(2008-10#6)(2008-8#1)(2009-12#2)(2009-2#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-8#1)
persisted in 2##2##3##(1992-6#1)(2008-5#1)
persisted in the##8##3##(1990-5#1)(1997-6#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-8#1)(2013-1#1)
persisted in##28##2##(1990-5#1)(1991-2#1)(1992-1#1)(1992-6#1)(1993-4#2)(1995-11#1)(1995-3#1)(1996-12#1)(1997-6#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-2#1)(2010-8#1)(2013-1#1)
persisted into adulthood##2##3##(1996-4#1)(1996-5#1)
persisted into##3##2##(1996-4#1)(1996-5#1)(2009-1#1)
persisted longer in##2##3##(2006-9#1)(2008-5#1)
persisted longer##4##2##(2006-9#1)(2008-10#1)(2008-5#1)(2008-9#1)
persisted on##2##2##(2007-11#1)(2008-5#1)
persisted over##3##2##(2005-7#1)(2006-12#1)(2008-11#1)
persisted through##2##2##(1996-4#1)(2005-9#1)
persisted throughout the study period##2##5##(2007-9#1)(2013-1#1)
persisted throughout the##7##3##(1990-5#1)(1995-2#1)(2007-8#1)(2007-9#1)(2008-5#1)(2011-2#1)(2013-1#1)
persisted throughout##8##2##(1990-5#1)(1995-2#1)(1997-2#1)(2007-8#1)(2007-9#1)(2008-5#1)(2011-2#1)(2013-1#1)
persisted under##2##2##(1993-10#1)(1995-12#1)
persisted until the##3##3##(1992-9#1)(1993-10#1)(2007-12#1)
persisted until##4##2##(1992-9#1)(1993-10#1)(2007-12#1)(2008-10#1)
persisted when##3##2##(1995-2#1)(1996-1#1)(1996-5#1)
persisted while##2##2##(1993-2#1)(1994-6#1)
persisted with##3##2##(1992-6#1)(2006-10#1)(2008-10#1)
persisted##158##1##(1990-11#2)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#4)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#2)(1991-8#2)(1992-1#1)(1992-10#1)(1992-5#1)(1992-6#4)(1992-8#1)(1992-9#3)(1993-10#2)(1993-12#1)(1993-2#3)(1993-4#2)(1993-5#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-7#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-4#2)(1996-5#2)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#1)(2005-1#1)(2005-7#1)(2005-9#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#14)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#2)(2009-1#1)(2009-12#2)(2009-2#2)(2010-12#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#4)(2011-3#1)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
persistence and dynamics##2##3##(1995-5#2)
persistence and##14##2##(1992-9#1)(1994-2#1)(1995-5#4)(1997-4#1)(2006-6#1)(2007-12#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-4#1)
persistence are##2##2##(2006-10#1)(2008-4#1)
persistence as##2##2##(1994-2#1)(1997-4#1)
persistence characteristics##2##2##(1995-5#1)(2011-12#1)
persistence in soil##2##3##(2008-10#1)(2008-4#1)
persistence in the##3##3##(1994-6#1)(1997-6#1)(2011-2#1)
persistence in vivo and in vitro##3##6##(1994-10#1)(1997-6#2)
persistence in##20##2##(1994-10#1)(1994-6#1)(1997-6#5)(2008-10#2)(2008-3#2)(2008-4#1)(2008-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
persistence is##2##2##(2007-12#1)(2008-4#1)
persistence length of##3##3##(1991-4#1)(2006-10#1)(2009-10#1)
persistence length##8##2##(1991-4#1)(2006-10#4)(2009-10#3)
persistence of antigen##2##3##(2008-2#1)(2008-5#1)
persistence of infection##2##3##(2006-8#1)(2008-8#1)
persistence of splenomegaly in##2##4##(2007-3#2)
persistence of splenomegaly##3##3##(2007-3#2)(2011-2#1)
persistence of the##17##3##(1991-8#1)(1993-7#1)(1996-10#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-5#1)(2008-8#3)(2009-3#1)(2010-6#1)(2011-2#2)(2013-8#1)
persistence of these##3##3##(1996-4#1)(2006-7#1)(2008-10#1)
persistence of this##2##3##(1991-11#1)(2008-8#1)
persistence of##111##2##(1990-11#1)(1991-11#1)(1991-8#2)(1992-1#1)(1993-2#1)(1993-7#1)(1993-8#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-7#1)(1995-9#1)(1996-10#1)(1996-4#1)(1997-4#1)(1997-5#4)(2004-11#1)(2006-10#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#5)(2006-9#2)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#4)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-4#3)(2008-5#7)(2008-8#13)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-6#2)(2011-1#1)(2011-12#1)(2011-2#5)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#3)
persistence on##2##2##(2006-2#1)(2009-7#1)
persistence or##5##2##(2006-10#1)(2006-11#1)(2008-7#1)(2012-2#1)(2013-8#1)
persistence threshold##2##2##(2008-8#2)
persistence with##3##2##(2009-6#2)(2010-4#1)
persistence##248##1##(1990-11#1)(1990-2#1)(1990-9#1)(1991-11#1)(1991-4#1)(1991-8#3)(1992-1#1)(1992-9#1)(1993-2#1)(1993-7#1)(1993-8#3)(1993-9#1)(1994-10#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#5)(1995-7#1)(1995-9#1)(1996-10#1)(1996-4#1)(1997-4#3)(1997-5#4)(1997-6#8)(2004-11#1)(2006-10#11)(2006-11#1)(2006-2#1)(2006-4#1)(2006-6#2)(2006-7#2)(2006-8#5)(2006-9#2)(2007-10#2)(2007-12#5)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#6)(2008-1#1)(2008-10#9)(2008-11#4)(2008-2#3)(2008-3#4)(2008-4#8)(2008-5#8)(2008-7#3)(2008-8#33)(2009-10#3)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#3)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-9#2)(2011-1#2)(2011-12#3)(2011-2#12)(2011-3#5)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#6)(2013-1#5)(2013-8#7)
persistent CSF leak after##2##4##(2006-12#2)
persistent CSF##3##2##(2006-12#3)
persistent TD##3##2##(2010-12#3)
persistent TGF-beta##2##2##(2008-9#2)
persistent activation of protein kinase C##2##6##(1992-9#2)
persistent activation of##3##3##(1992-9#2)(2012-12#1)
persistent activation##4##2##(1992-9#3)(2012-12#1)
persistent activity of##2##3##(2012-3#2)
persistent activity##3##2##(2008-11#1)(2012-3#2)
persistent air leak in##2##4##(2008-6#2)
persistent air leak##3##3##(2008-6#3)
persistent allergic rhinitis##2##3##(2008-3#1)(2012-12#1)
persistent allergic##3##2##(2008-3#1)(2008-5#1)(2012-12#1)
persistent alterations in##2##3##(2009-7#1)(2013-8#1)
persistent and chronic##2##3##(1997-3#1)(2012-12#1)
persistent and##10##2##(1994-3#2)(1997-3#1)(2005-12#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-8#1)(2012-12#1)(2012-3#1)
persistent asthma##13##2##(1990-9#1)(1996-7#1)(2005-8#1)(2007-11#3)(2009-8#1)(2010-5#2)(2011-2#2)(2012-3#2)
persistent atrial fibrillation##6##3##(2006-2#1)(2007-8#1)(2009-10#1)(2011-2#2)(2013-1#1)
persistent bone##2##2##(1993-4#1)(2013-8#1)
persistent changes##2##2##(1996-10#1)(2007-11#1)
persistent chronic##2##2##(1992-11#1)(2006-2#1)
persistent colonization##2##2##(2005-8#1)(2007-6#1)
persistent cough and##2##3##(1995-8#1)(2008-12#1)
persistent cough##3##2##(1995-8#1)(2008-12#1)(2013-8#1)
persistent current##4##2##(2010-7#4)
persistent decreases##2##2##(1993-4#1)(2011-12#1)
persistent deficits##2##2##(2011-1#1)(2012-3#1)
persistent disease##4##2##(1997-6#1)(2009-11#1)(2013-1#2)
persistent ductus arteriosus##3##3##(1994-3#1)(2007-8#2)
persistent effect on the##2##4##(2008-10#1)(2010-7#1)
persistent effect##3##2##(1992-3#1)(2008-10#1)(2010-7#1)
persistent elevation of##3##3##(1992-3#1)(1997-3#1)(2010-1#1)
persistent epithelial defect##2##3##(2011-2#2)
persistent epithelial defects##2##3##(2005-11#1)(2007-1#1)
persistent epithelial##4##2##(2005-11#1)(2007-1#1)(2011-2#2)
persistent even after##2##3##(1997-1#2)
persistent exposure##2##2##(2008-4#1)(2010-9#1)
persistent fever##3##2##(1993-5#1)(2005-12#1)(2008-5#1)
persistent gestational trophoblastic##3##3##(1994-3#1)(2008-7#2)
persistent hepatitis B virus##2##4##(2006-10#1)(2008-8#1)
persistent hepatitis##5##2##(1992-11#1)(1992-9#1)(2006-10#1)(2008-8#1)(2013-1#1)
persistent hole##2##2##(2007-12#2)
persistent hyperparathyroidism##2##2##(1991-5#1)(1993-3#1)
persistent in##7##2##(1990-5#1)(1995-9#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-9#1)
persistent increase in##4##3##(1993-11#1)(1995-2#1)(1996-12#1)(1997-7#1)
persistent increase##5##2##(1993-11#1)(1995-2#1)(1996-12#1)(1997-7#1)(2008-8#1)
persistent infection and##3##3##(2006-10#2)(2008-11#1)
persistent infection in##4##3##(1997-6#4)
persistent infection of##2##3##(1994-10#1)(2008-4#1)
persistent infection with##3##3##(1997-6#1)(2011-2#1)(2012-12#1)
persistent infection##20##2##(1994-10#2)(1994-8#1)(1997-4#1)(1997-6#6)(2005-7#1)(2006-10#2)(2007-10#1)(2008-11#1)(2008-4#2)(2011-2#1)(2012-12#1)(2012-2#1)
persistent infections##6##2##(1997-3#1)(1997-6#1)(2010-1#1)(2010-12#1)(2013-1#2)
persistent inflammation##2##2##(2005-11#1)(2007-8#1)
persistent instability##2##2##(2006-3#1)(2008-8#1)
persistent left superior vena cava##7##5##(2007-8#1)(2010-11#1)(2010-9#2)(2011-2#1)(2012-2#2)
persistent left##8##2##(2007-8#1)(2010-11#1)(2010-9#2)(2011-2#1)(2012-1#1)(2012-2#2)
persistent leptokurtosis##2##2##(2008-8#2)
persistent lesions##3##2##(1991-8#1)(1992-10#1)(2013-1#1)
persistent low back pain##6##4##(2006-12#1)(2006-8#4)(2009-5#1)
persistent neurological##2##2##(1992-6#1)(2007-8#1)
persistent neuropathic pain##2##3##(2008-12#1)(2010-7#1)
persistent neutropenia##2##2##(2012-3#2)
persistent occlusion##2##2##(2007-10#2)
persistent or recurrent cutaneous T-cell lymphoma##2##6##(2010-12#2)
persistent or recurrent##10##3##(1991-2#1)(2006-10#2)(2006-5#1)(2007-2#1)(2008-10#1)(2008-8#1)(2010-12#2)(2012-2#1)
persistent or##16##2##(1991-2#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-12#1)(2007-2#2)(2008-10#2)(2008-8#1)(2009-3#1)(2010-12#2)(2011-1#1)(2012-2#1)
persistent organic pollutants##6##3##(2004-4#2)(2008-10#1)(2008-7#1)(2010-9#1)(2011-12#1)
persistent organochlorine##3##2##(2008-8#3)
persistent otitis media##3##3##(1996-11#2)(2008-9#1)
persistent pain and##3##3##(1996-6#1)(2007-11#1)(2008-7#1)
persistent pain states##3##3##(1996-3#1)(2008-7#2)
persistent pain##30##2##(1990-9#1)(1991-8#1)(1992-6#1)(1996-3#4)(1996-6#1)(2006-12#1)(2006-8#3)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#8)(2011-2#1)(2012-12#1)
persistent pathogen##2##2##(2007-12#1)(2013-1#1)
persistent pigment darkening##2##3##(2008-5#2)
persistent primitive trigeminal artery##2##4##(2008-7#2)
persistent problem##2##2##(2012-2#2)
persistent proteinuria##2##2##(2007-8#1)(2012-2#1)
persistent pulmonary hypertension##4##3##(2007-2#1)(2009-10#1)(2009-6#2)
persistent reduction in##2##3##(1991-9#1)(1994-5#1)
persistent reductions in##2##3##(1997-3#1)(2011-12#1)
persistent reflux##2##2##(2012-11#2)
persistent skin##2##2##(2012-3#1)(2013-8#1)
persistent spectral hole burning of Eu(3+) in sodium##2##8##(2007-12#2)
persistent spectral hole burning##6##4##(2007-12#6)
persistent spectral holes##3##3##(2007-12#3)
persistent spectral##9##2##(2007-12#9)
persistent symptoms##9##2##(1990-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-5#2)(2011-2#1)(2013-1#1)
persistent vegetative state##9##3##(1990-11#1)(1990-9#1)(1991-12#1)(1993-2#1)(1995-4#2)(1997-5#1)(2006-11#1)(2008-2#1)
persistent wheezing##2##2##(1993-12#1)(2010-2#1)
persistent##571##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#4)(1991-10#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#3)(1991-9#3)(1992-1#1)(1992-10#3)(1992-11#3)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#5)(1992-9#4)(1993-1#2)(1993-11#3)(1993-12#1)(1993-2#3)(1993-3#2)(1993-4#2)(1993-5#1)(1994-10#4)(1994-3#8)(1994-5#2)(1994-6#2)(1994-8#1)(1995-10#1)(1995-12#1)(1995-2#3)(1995-4#2)(1995-5#1)(1995-8#1)(1995-9#1)(1996-10#3)(1996-11#4)(1996-12#3)(1996-3#5)(1996-5#2)(1996-6#1)(1996-7#5)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#5)(1997-4#2)(1997-5#2)(1997-6#9)(1997-7#1)(1997-8#2)(2004-10#1)(2004-12#2)(2004-3#1)(2004-4#2)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#4)(2005-12#2)(2005-7#5)(2005-8#5)(2006-10#12)(2006-11#3)(2006-12#11)(2006-2#3)(2006-3#1)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#9)(2007-1#3)(2007-10#7)(2007-11#11)(2007-12#25)(2007-2#6)(2007-3#2)(2007-6#1)(2007-7#4)(2007-8#15)(2007-9#5)(2008-1#5)(2008-10#26)(2008-11#15)(2008-12#6)(2008-2#3)(2008-3#8)(2008-4#4)(2008-5#8)(2008-6#5)(2008-7#19)(2008-8#20)(2008-9#6)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#5)(2009-6#2)(2009-7#2)(2009-8#4)(2010-1#2)(2010-11#1)(2010-12#10)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#2)(2010-7#6)(2010-8#3)(2010-9#4)(2011-1#7)(2011-12#4)(2011-2#17)(2012-1#2)(2012-11#3)(2012-12#10)(2012-2#9)(2012-3#12)(2013-1#20)(2013-8#10)
persistent-estrous##3##1##(1995-9#3)
persistently activated form of##2##4##(1992-9#2)
persistently activated##3##2##(1992-9#2)(2007-1#1)
persistently active##2##2##(1996-1#1)(2007-11#1)
persistently elevated##2##2##(2007-10#1)(2008-5#1)
persistently high##7##2##(1990-5#1)(2006-10#1)(2007-3#1)(2008-1#1)(2008-4#1)(2010-2#1)(2013-1#1)
persistently infected with##2##3##(1997-5#1)(1997-6#1)
persistently infected##5##2##(1995-9#1)(1996-4#1)(1997-5#1)(1997-6#1)(2012-2#1)
persistently normal##4##2##(2009-8#1)(2012-1#2)(2012-2#1)
persistently transmitted##2##2##(2008-10#2)
persistently##48##1##(1990-12#1)(1990-5#1)(1990-6#1)(1992-10#1)(1992-12#1)(1992-9#2)(1994-4#1)(1995-9#1)(1996-1#2)(1996-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-12#1)(2012-1#5)(2012-2#2)(2013-1#3)
persister##2##1##(2012-3#2)
persisting after##2##2##(1996-5#1)(2007-11#1)
persisting at##3##2##(2008-3#1)(2010-6#1)(2013-1#1)
persisting for##6##2##(1991-3#1)(1992-7#1)(1994-6#1)(2006-12#1)(2011-2#1)(2012-1#1)
persisting symptoms##3##2##(1992-9#1)(1996-12#1)(2010-12#1)
persisting##59##1##(1991-3#1)(1991-6#1)(1992-5#1)(1992-7#2)(1992-8#1)(1992-9#2)(1993-3#1)(1993-5#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-5#1)(1997-7#1)(2004-4#1)(2006-10#3)(2006-12#1)(2006-9#1)(2007-11#1)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-12#3)(2010-6#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#4)(2013-1#2)
persists after##7##2##(1993-12#2)(1994-2#1)(1996-10#1)(2007-8#1)(2008-5#1)(2008-8#1)
persists at##2##2##(1992-10#1)(2013-1#1)
persists despite##2##2##(2006-12#1)(2010-10#1)
persists during the##2##3##(1995-2#1)(2008-10#1)
persists even##2##2##(1993-4#1)(2006-8#1)
persists for months##2##3##(2008-4#1)(2008-5#1)
persists for more than 2##2##5##(2005-8#1)(2010-12#1)
persists for##7##2##(1994-2#1)(2005-11#1)(2005-8#1)(2008-4#1)(2008-5#1)(2010-12#1)(2013-1#1)
persists in the##5##3##(1994-12#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-10#1)
persists in##16##2##(1994-12#1)(1994-2#1)(1995-12#1)(1996-5#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-2#1)
persists into##2##2##(2007-3#1)(2008-2#1)
persists throughout the##2##3##(1990-12#1)(1994-2#1)
persists with a period of##2##5##(1996-9#2)
persists##73##1##(1990-10#1)(1990-12#1)(1991-11#1)(1992-10#1)(1992-8#1)(1993-12#2)(1993-4#1)(1993-9#1)(1994-12#2)(1994-2#4)(1994-8#1)(1995-12#1)(1995-2#2)(1996-10#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#2)(2005-11#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#3)(2008-7#1)(2008-8#2)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#2)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#4)
person and the##4##3##(1993-6#1)(1995-8#1)(2006-6#1)(2011-2#1)
person and##14##2##(1993-6#1)(1994-1#1)(1995-6#1)(1995-8#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-7#1)(2010-10#1)(2010-6#1)(2011-2#1)(2013-8#2)
person can##2##2##(2009-4#1)(2009-9#1)
person for##3##2##(1990-12#1)(2008-10#1)(2008-9#1)
person from##5##2##(1994-7#1)(2006-2#1)(2008-11#1)(2008-6#2)
person had##2##2##(1995-8#1)(2006-3#1)
person has a##2##3##(2006-9#1)(2008-11#1)
person having##3##2##(1994-12#1)(2007-11#1)(2012-2#1)
person identification##3##2##(2009-4#1)(2012-1#2)
person in a coma after a car accident##3##8##(2005-4#3)
person in a##4##3##(2005-4#3)(2006-10#1)
person in the##3##3##(1991-9#1)(1992-1#1)(2008-2#1)
person in##10##2##(1991-9#1)(1992-1#1)(1993-4#1)(1996-3#1)(2005-4#3)(2006-10#1)(2008-2#1)(2012-1#1)
person information##2##2##(2008-11#2)
person is##6##2##(1996-5#1)(2009-4#1)(2010-10#2)(2012-12#1)(2012-3#1)
person living##2##2##(2010-12#1)(2011-1#1)
person may##2##2##(1992-4#1)(2012-1#1)
person needs##2##2##(2007-2#1)(2009-4#1)
person of the##2##3##(2007-2#1)(2011-2#1)
person of##6##2##(1991-8#1)(1993-9#1)(2007-2#1)(2008-5#1)(2008-7#1)(2011-2#1)
person on##2##2##(1993-4#1)(2009-3#1)
person or##2##2##(2006-10#1)(2011-2#1)
person perspective##2##2##(2008-11#2)
person recognition##4##2##(2012-1#4)
person through##2##2##(1994-6#1)(2008-9#1)
person to person##7##3##(1990-6#1)(1992-6#1)(1994-6#1)(1996-3#2)(2007-12#2)
person to##18##2##(1990-6#1)(1991-3#1)(1991-4#1)(1992-6#1)(1994-6#1)(1995-1#1)(1995-6#1)(1996-3#2)(1997-5#2)(2007-12#2)(2007-6#1)(2008-10#1)(2008-3#1)(2010-5#1)(2012-12#1)
person was##6##2##(1993-8#1)(1995-6#1)(2006-10#1)(2007-2#2)(2009-4#1)
person who##11##2##(1991-8#1)(1993-5#1)(1997-2#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-2#1)(2009-6#1)(2012-12#1)(2012-2#1)
person will##3##2##(2009-2#1)(2011-1#1)(2013-7#1)
person with a##2##3##(1995-11#1)(1996-8#1)
person with chronic##2##3##(2009-4#2)
person with incomplete SCI##2##4##(2012-1#2)
person with##23##2##(1993-6#1)(1995-11#1)(1996-5#1)(1996-8#1)(2005-10#1)(2005-4#2)(2008-1#1)(2009-4#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#1)
person years##5##2##(1995-9#2)(2005-10#1)(2007-1#1)(2007-8#1)
person##275##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-9#2)(1991-12#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-6#2)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#2)(1993-4#3)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#2)(1994-1#1)(1994-12#1)(1994-2#2)(1994-6#2)(1994-7#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#5)(1995-8#2)(1995-9#2)(1996-11#1)(1996-3#5)(1996-5#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#1)(2004-10#1)(2004-12#1)(2004-9#1)(2005-10#2)(2005-4#5)(2005-8#2)(2006-10#6)(2006-11#1)(2006-2#2)(2006-3#2)(2006-6#2)(2006-7#3)(2006-8#3)(2006-9#1)(2007-1#2)(2007-11#3)(2007-12#12)(2007-2#5)(2007-3#1)(2007-6#1)(2007-8#4)(2008-1#4)(2008-10#4)(2008-11#10)(2008-12#1)(2008-2#5)(2008-3#3)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-2#2)(2009-3#1)(2009-4#11)(2009-6#1)(2009-9#1)(2010-10#6)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#11)(2011-3#2)(2012-1#14)(2012-12#8)(2012-2#7)(2012-3#6)(2013-1#10)(2013-7#1)(2013-8#6)
person's ability to##2##3##(1990-3#1)(1993-5#1)
person's body##2##2##(2005-8#1)(2010-8#1)
person's fitness to drive##2##4##(1993-5#2)
person's perception of##2##3##(2007-10#1)(2007-3#1)
person's##58##1##(1990-3#1)(1991-6#1)(1992-6#1)(1993-5#4)(1995-8#1)(1996-6#1)(1997-6#1)(2005-12#1)(2005-4#1)(2005-8#1)(2006-11#1)(2006-12#1)(2006-2#3)(2006-4#1)(2007-10#2)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#2)(2010-12#1)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#2)(2013-7#3)(2013-8#1)
person-centered caregiving##3##2##(2011-2#3)
person-centered interactions##2##2##(2007-10#2)
person-centered medicine##4##2##(2012-12#2)(2013-8#2)
person-centered##10##1##(2007-10#2)(2010-2#1)(2011-2#3)(2012-12#2)(2013-8#2)
person-centeredness##3##1##(2011-2#3)
person-centred##7##1##(2007-10#1)(2011-2#5)(2013-1#1)
person-oriented##2##1##(2008-11#1)(2009-4#1)
person-years at risk##2##3##(1993-7#1)(1993-9#1)
person-years of exposure in the##2##5##(2010-8#2)
person-years of follow-up##3##3##(2007-8#1)(2008-7#1)(2012-2#1)
person-years of##5##2##(2007-8#1)(2008-7#1)(2010-8#2)(2012-2#1)
person-years##15##1##(1993-7#1)(1993-9#1)(1996-9#1)(2006-10#1)(2006-2#3)(2007-8#1)(2008-7#1)(2009-3#1)(2010-8#2)(2011-1#2)(2012-2#1)
person]##2##1##(2008-12#1)(2012-3#1)
personal accomplishment)##2##2##(1996-2#1)(2008-11#1)
personal account of##5##3##(1995-4#1)(1996-12#1)(2011-2#2)(2013-1#1)
personal account##6##2##(1995-4#1)(1996-12#1)(2006-12#1)(2011-2#2)(2013-1#1)
personal accounts of##2##3##(1995-1#1)(2006-7#1)
personal agency##4##2##(2012-12#2)(2013-1#2)
personal and collective##4##3##(2005-10#1)(2008-9#2)(2011-3#1)
personal and cultural##2##3##(2008-12#1)(2008-2#1)
personal and environmental factors##2##4##(2009-12#1)(2012-2#1)
personal and environmental##5##3##(2008-7#1)(2009-12#1)(2010-12#1)(2012-2#2)
personal and family history##2##4##(2007-11#1)(2010-12#1)
personal and family##3##3##(2007-11#1)(2009-9#1)(2010-12#1)
personal and organizational growth##2##4##(1993-12#1)(1997-1#1)
personal and organizational##3##3##(1993-12#1)(1997-1#1)(2012-1#1)
personal and professional##20##3##(1993-3#1)(1994-1#1)(1994-3#1)(2006-2#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-11#5)(2008-12#1)(2009-11#1)(2009-8#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)
personal and public health##2##4##(1994-3#1)(2013-1#1)
personal and social##4##3##(1995-5#1)(2008-12#1)(2009-8#1)(2012-3#1)
personal and societal##2##3##(2008-12#1)(2011-2#1)
personal and##54##2##(1991-1#1)(1992-4#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-3#2)(1994-6#1)(1995-5#1)(1997-1#1)(2005-10#1)(2006-2#2)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-11#5)(2008-12#5)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#1)(2009-8#2)(2009-9#1)(2010-12#2)(2011-2#2)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#1)
personal appearance##2##2##(2007-7#1)(2010-8#1)
personal as##2##2##(2006-2#1)(2009-4#1)
personal assistance services##2##3##(1996-1#2)
personal attitudes##2##2##(2010-2#1)(2013-1#1)
personal attributes##2##2##(2008-12#1)(2012-12#1)
personal autonomy##5##2##(2005-11#1)(2005-7#2)(2006-7#1)(2009-9#1)
personal bankruptcy filings##2##3##(2008-11#2)
personal bankruptcy##3##2##(2008-11#3)
personal behavior##2##2##(2008-12#1)(2011-2#1)
personal beliefs##3##2##(2007-11#1)(2007-12#1)(2010-11#1)
personal belongings##3##2##(1992-12#1)(2008-10#1)(2008-2#1)
personal care applications##3##3##(2008-5#3)
personal care formulations##2##3##(2008-5#2)
personal care products##5##3##(2007-8#1)(2008-5#4)
personal care services##2##3##(2011-1#2)
personal care##20##2##(1996-2#1)(1997-2#2)(2007-8#1)(2008-5#12)(2011-1#4)
personal case series]##2##3##(1992-6#1)(1993-6#1)
personal case##5##2##(1990-4#1)(1992-6#1)(1993-6#1)(2008-11#1)(2008-4#1)
personal characteristics and##2##3##(2007-6#1)(2010-9#1)
personal characteristics of alcoholics##2##4##(2011-2#2)
personal characteristics of##4##3##(2008-7#1)(2011-2#3)
personal characteristics##19##2##(1995-12#2)(2005-10#2)(2007-1#1)(2007-12#3)(2007-6#1)(2008-7#2)(2009-7#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#1)
personal cleansing products##4##3##(2008-5#4)
personal cleansing##5##2##(2008-5#5)
personal commitments to pay for##2##5##(2010-12#2)
personal communication) and##2##3##(1991-5#1)(1996-5#1)
personal communication)##4##2##(1991-5#1)(1995-12#1)(1996-5#1)(1997-3#1)
personal computer (PC)##2##3##(1994-2#1)(2008-11#1)
personal computer and##2##3##(2007-4#1)(2008-3#1)
personal computer##24##2##(1990-11#1)(1991-1#1)(1991-12#1)(1992-10#1)(1994-2#1)(1996-6#1)(1997-2#1)(2006-8#2)(2007-12#1)(2007-4#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#5)(2010-8#1)
personal computers##8##2##(1993-1#1)(1993-12#1)(1994-3#1)(2007-4#1)(2007-9#1)(2008-3#1)(2008-4#1)(2010-9#1)
personal considerations##3##2##(2008-1#1)(2013-1#2)
personal contact with##3##3##(1991-2#1)(2006-10#1)(2007-3#1)
personal contact##5##2##(1991-2#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-11#1)
personal control##5##2##(2007-7#1)(2009-5#1)(2011-1#2)(2012-12#1)
personal data and##2##3##(2007-1#1)(2007-10#1)
personal data##11##2##(1993-8#1)(2006-10#1)(2007-1#5)(2007-10#1)(2008-4#1)(2010-8#1)(2011-2#1)
personal development##2##2##(2008-11#2)
personal digital assistant (PDA)##3##4##(2008-10#1)(2008-12#1)(2010-2#1)
personal digital assistant##5##3##(2007-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-2#1)
personal digital assistants##3##3##(2006-10#1)(2008-11#1)(2008-12#1)
personal digital##8##2##(2006-10#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2010-2#1)
personal experience and##4##3##(1992-9#1)(1993-9#1)(1997-3#1)(2006-6#1)
personal experience as##2##3##(1994-12#1)(2008-2#1)
personal experience in the##5##4##(1991-5#1)(1991-9#1)(1996-2#1)(2006-6#1)(2007-12#1)
personal experience is##3##3##(1991-3#1)(2007-12#1)(2013-1#1)
personal experience of the##2##4##(1990-3#1)(2008-11#1)
personal experience of##6##3##(1990-3#1)(1990-5#1)(1996-3#1)(2008-11#1)(2012-3#2)
personal experience on the##2##4##(1990-9#1)(2009-6#1)
personal experience on##4##3##(1990-12#1)(1990-9#1)(2008-1#1)(2009-6#1)
personal experience relating to##2##4##(1990-9#1)(1993-10#1)
personal experience with##4##3##(1991-4#1)(2006-7#1)(2007-8#1)(2008-2#1)
personal experience##46##2##(1990-12#1)(1990-3#2)(1990-5#1)(1990-9#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-9#2)(1992-9#1)(1993-10#1)(1993-3#1)(1993-9#1)(1994-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-2#2)(2006-6#2)(2006-7#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-11#2)(2008-2#2)(2008-8#2)(2009-4#2)(2009-6#1)(2010-12#1)(2012-3#2)(2013-1#1)
personal experience]##4##2##(1991-4#1)(1993-3#1)(1996-8#1)(2006-2#1)
personal experiences and##4##3##(2010-3#1)(2010-5#1)(2012-12#1)(2012-3#1)
personal experiences of##3##3##(2004-12#1)(2008-11#1)(2008-12#1)
personal experiences##11##2##(2004-12#1)(2004-3#1)(2007-9#1)(2008-11#1)(2008-12#2)(2010-3#1)(2010-5#2)(2012-12#1)(2012-3#1)
personal exposure assessment##2##3##(2008-6#1)(2010-5#1)
personal exposure to##4##3##(2007-9#1)(2008-11#2)(2010-5#1)
personal exposure##10##2##(2007-9#1)(2008-11#6)(2008-6#1)(2010-5#2)
personal factors##3##2##(1996-4#1)(2008-11#1)(2009-7#1)
personal genomics and##2##3##(2009-5#2)
personal genomics##4##2##(2009-12#1)(2009-5#3)
personal growth##5##2##(1995-1#1)(2007-9#2)(2008-1#1)(2010-4#1)
personal habits##3##2##(1992-3#1)(2007-7#1)(2013-1#1)
personal health care expenditures##2##4##(1996-3#1)(1997-3#1)
personal health care##4##3##(1996-1#1)(1996-3#1)(1997-3#2)
personal health information##5##3##(2007-10#1)(2007-12#1)(2010-5#1)(2013-1#2)
personal health is##2##3##(2008-10#1)(2010-1#1)
personal health##18##2##(1990-12#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#2)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#2)(2010-1#1)(2010-5#1)(2013-1#4)
personal hygiene and##2##3##(2007-7#1)(2010-12#1)
personal hygiene##5##2##(1995-5#2)(2007-7#1)(2010-12#1)(2013-8#1)
personal identification##3##2##(1991-9#1)(1995-6#2)
personal identity##2##2##(2012-12#1)(2013-8#1)
personal income##3##2##(1993-1#1)(1994-2#1)(2008-9#1)
personal information##4##2##(1997-4#1)(2006-10#1)(2007-1#1)(2008-12#1)
personal interview##6##2##(1990-10#1)(1991-9#1)(1993-9#1)(2007-3#1)(2011-2#1)(2012-12#1)
personal interviews##8##2##(2008-12#1)(2008-2#1)(2008-5#1)(2010-10#1)(2011-2#1)(2013-1#3)
personal journey##3##2##(1995-12#1)(2008-11#1)(2013-1#1)
personal life stories##2##3##(2012-12#2)
personal life##4##2##(1992-1#1)(2009-10#1)(2012-12#2)
personal microcomputer##2##2##(1992-10#2)
personal moral dilemmas##3##3##(2008-11#3)
personal moral violations##2##3##(2008-11#2)
personal moral##7##2##(2008-11#7)
personal needs##5##2##(1994-1#1)(1995-3#1)(1996-1#1)(2006-8#2)
personal number##4##2##(2006-10#4)
personal numbers##2##2##(2006-10#2)
personal observations##2##2##(1993-3#1)(2010-8#1)
personal opinion##2##2##(2008-11#1)(2008-2#1)
personal or family history of##2##5##(2007-10#1)(2010-6#1)
personal or##6##2##(1991-2#1)(2007-10#1)(2009-6#1)(2009-7#1)(2010-6#1)(2012-3#1)
personal perspective##8##2##(1993-12#1)(2005-7#1)(2006-5#1)(2008-11#2)(2008-12#1)(2008-4#1)(2013-1#1)
personal physical##2##2##(2007-7#1)(2008-1#1)
personal preferences##3##2##(2006-2#1)(2012-12#1)(2013-1#1)
personal problems##2##2##(2007-10#1)(2007-7#1)
personal professional##2##2##(1992-3#1)(2008-10#1)
personal protective equipment##4##3##(2007-7#1)(2008-12#1)(2008-8#2)
personal protective##8##2##(2007-2#1)(2007-7#1)(2008-12#1)(2008-8#2)(2009-12#1)(2010-3#1)(2010-4#1)
personal qualities required##2##3##(1990-12#1)(2007-10#1)
personal qualities##6##2##(1990-12#3)(1990-4#1)(2007-10#1)(2011-2#1)
personal reflection##6##2##(1996-12#1)(2008-1#1)(2008-11#2)(2008-12#2)
personal resources##4##2##(2007-9#1)(2009-4#1)(2011-3#1)(2012-12#1)
personal responsibility for##4##3##(2005-10#1)(2009-5#1)(2009-9#1)(2012-3#1)
personal responsibility##7##2##(1994-1#1)(2005-10#1)(2008-4#1)(2009-5#1)(2009-9#1)(2012-1#1)(2012-3#1)
personal risk##10##2##(1991-3#1)(1997-5#1)(2005-10#1)(2006-9#1)(2010-2#2)(2011-2#2)(2012-12#1)(2013-1#1)
personal safety##2##2##(2007-11#1)(2007-2#1)
personal sampling##2##2##(1994-6#1)(2008-5#1)
personal satisfaction##2##2##(2007-4#2)
personal self##2##2##(2007-2#2)
personal series of##3##3##(1993-6#1)(2006-12#1)(2008-7#1)
personal series##5##2##(1993-6#1)(2006-12#1)(2007-7#1)(2008-3#1)(2008-7#1)
personal space boundary##2##3##(2007-3#2)
personal space##5##2##(2006-3#1)(2007-3#2)(2010-12#2)
personal stories##2##2##(1994-10#1)(2007-2#1)
personal stressors##2##2##(2008-1#2)
personal supervision##2##2##(1992-6#2)
personal touch##3##2##(1994-3#1)(1995-1#1)(1996-3#1)
personal treatment##2##2##(2006-7#1)(2013-8#1)
personal tutor role##2##3##(2008-11#2)
personal tutor##4##2##(2008-11#4)
personal use##4##2##(1996-11#1)(2010-4#1)(2013-1#2)
personal values##2##2##(2012-2#1)(2013-1#1)
personal variables##2##2##(2008-2#1)(2008-7#1)
personal view of##5##3##(1994-12#1)(1995-12#2)(1996-1#1)(2008-12#1)
personal view##6##2##(1994-12#1)(1995-12#2)(1996-1#1)(2008-12#1)(2010-2#1)
personal##692##1##(1990-10#1)(1990-11#2)(1990-12#6)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#2)(1990-8#1)(1990-9#2)(1991-1#2)(1991-12#3)(1991-2#3)(1991-3#4)(1991-4#2)(1991-5#3)(1991-6#1)(1991-9#4)(1992-1#1)(1992-10#3)(1992-12#2)(1992-3#3)(1992-4#1)(1992-6#3)(1992-9#1)(1993-1#3)(1993-10#1)(1993-12#8)(1993-2#2)(1993-3#5)(1993-6#2)(1993-8#1)(1993-9#2)(1994-1#4)(1994-10#1)(1994-12#5)(1994-2#4)(1994-3#5)(1994-6#4)(1995-1#5)(1995-12#8)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#5)(1995-6#2)(1996-1#9)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#5)(1997-4#1)(1997-5#1)(1997-7#1)(2004-12#2)(2004-3#1)(2005-10#8)(2005-11#3)(2005-5#1)(2005-7#3)(2006-10#13)(2006-12#4)(2006-2#10)(2006-3#3)(2006-4#1)(2006-5#4)(2006-6#4)(2006-7#5)(2006-8#5)(2006-9#1)(2007-1#7)(2007-10#7)(2007-11#6)(2007-12#12)(2007-2#8)(2007-3#4)(2007-4#8)(2007-5#2)(2007-6#1)(2007-7#10)(2007-8#5)(2007-9#6)(2008-1#12)(2008-10#17)(2008-11#54)(2008-12#23)(2008-2#14)(2008-3#10)(2008-4#6)(2008-5#23)(2008-6#1)(2008-7#8)(2008-8#10)(2008-9#5)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#3)(2009-2#1)(2009-4#4)(2009-5#11)(2009-6#3)(2009-7#7)(2009-8#2)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#11)(2010-2#8)(2010-3#2)(2010-4#4)(2010-5#7)(2010-6#2)(2010-8#6)(2010-9#2)(2011-1#8)(2011-12#3)(2011-2#22)(2011-3#2)(2012-1#7)(2012-11#1)(2012-12#17)(2012-2#10)(2012-3#7)(2013-1#29)(2013-8#6)
personal-care##2##1##(2006-12#1)(2008-5#1)
personalised nutrition##7##2##(2008-10#7)
personalised##14##1##(2007-6#1)(2008-10#8)(2012-12#1)(2012-2#2)(2013-1#2)
personalities##10##1##(1990-3#1)(1992-3#1)(1993-11#1)(1996-7#1)(2006-4#1)(2007-2#1)(2008-4#1)(2008-8#1)(2011-1#1)(2012-2#1)
personality and the##3##3##(2006-12#1)(2010-12#1)(2012-12#1)
personality and##29##2##(1991-12#1)(1993-10#1)(1994-2#5)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-2#1)(2008-3#2)(2009-12#1)(2009-8#1)(2010-12#5)(2011-1#3)(2012-1#1)(2012-11#1)(2012-12#1)
personality assessment##2##2##(1990-2#1)(2008-7#1)
personality changes##5##2##(1995-11#1)(1996-2#1)(1996-7#1)(2008-7#1)(2008-9#1)
personality characteristics and##2##3##(2008-1#1)(2009-5#1)
personality characteristics of##2##3##(2009-5#1)(2011-1#1)
personality characteristics##20##2##(2006-6#5)(2006-7#1)(2007-10#1)(2007-12#3)(2008-1#2)(2008-11#3)(2009-5#3)(2010-12#1)(2011-1#1)
personality dimensions##3##2##(2010-12#3)
personality disorder among##2##3##(1994-2#1)(2007-6#1)
personality disorder and##5##3##(1994-2#1)(2005-6#1)(2005-7#2)(2006-7#1)
personality disorder is##2##3##(2009-10#1)(2011-2#1)
personality disorder##62##2##(1991-1#1)(1993-12#1)(1994-2#3)(1995-1#1)(1995-11#3)(1996-7#1)(1996-8#2)(1997-5#2)(2005-10#2)(2005-6#1)(2005-7#4)(2006-6#1)(2006-7#2)(2006-9#3)(2007-3#2)(2007-6#2)(2007-7#4)(2008-1#1)(2008-11#1)(2008-4#1)(2008-9#3)(2009-10#4)(2009-9#2)(2010-12#2)(2010-2#2)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#3)
personality disorders and##2##3##(1990-3#1)(2012-2#1)
personality disorders are##2##3##(2006-9#2)
personality disorders in substance abusers##2##5##(1991-1#2)
personality disorders in##8##3##(1991-1#3)(1996-8#1)(2007-7#1)(2008-11#1)(2009-10#1)(2012-12#1)
personality disorders were##2##3##(1995-4#1)(2007-7#1)
personality disorders##41##2##(1990-3#1)(1991-1#3)(1991-9#1)(1992-1#1)(1992-3#1)(1993-5#1)(1994-2#1)(1995-4#1)(1996-8#2)(1997-5#1)(2005-7#6)(2006-3#1)(2006-8#2)(2006-9#2)(2007-7#5)(2008-11#1)(2008-12#1)(2009-10#1)(2010-12#2)(2011-1#1)(2012-12#1)(2012-2#3)(2013-7#1)(2013-8#1)
personality factors and##2##3##(2008-11#2)
personality factors##5##2##(1994-2#2)(2008-11#2)(2008-5#1)
personality in##4##2##(1995-1#1)(2010-12#1)(2011-2#1)(2013-1#1)
personality inventory##2##2##(2010-1#1)(2011-1#1)
personality is##3##2##(2009-12#1)(2009-9#1)(2011-1#1)
personality of the##4##3##(1994-3#1)(1995-5#1)(2006-3#1)(2008-8#1)
personality of##7##2##(1994-3#2)(1995-5#1)(2006-3#1)(2008-8#1)(2011-1#1)(2012-3#1)
personality on##4##2##(2007-12#1)(2010-8#1)(2012-1#2)
personality or##4##2##(1994-2#1)(2008-9#1)(2009-10#1)(2011-1#1)
personality pathology##3##2##(2006-8#3)
personality profile##3##2##(1994-2#1)(2008-1#1)(2011-1#1)
personality profiles##4##2##(2011-1#3)(2011-12#1)
personality questionnaire##3##2##(1997-8#2)(2012-1#1)
personality structure##2##2##(1995-1#1)(2008-5#1)
personality structures##2##2##(2007-1#1)(2011-1#1)
personality to##3##2##(2004-8#1)(2006-12#1)(2007-1#1)
personality trait##7##2##(2007-8#1)(2008-11#2)(2008-5#1)(2010-6#2)(2011-2#1)
personality traits and##6##3##(2006-8#1)(2008-7#3)(2009-1#1)(2011-1#1)
personality traits are##2##3##(2012-12#2)
personality traits in##2##3##(2007-12#1)(2010-12#1)
personality traits of##3##3##(2007-10#1)(2008-10#1)(2010-12#1)
personality traits were##2##3##(1997-8#1)(2004-11#1)
personality traits##42##2##(1994-2#1)(1997-8#3)(2004-11#4)(2006-8#1)(2006-9#2)(2007-10#3)(2007-12#2)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#3)(2008-9#1)(2009-1#1)(2009-7#1)(2009-8#2)(2010-12#3)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#3)(2013-7#1)
personality variables##4##2##(1994-2#1)(2008-5#1)(2009-12#1)(2012-2#1)
personality##341##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1991-1#4)(1991-12#1)(1991-9#1)(1992-1#1)(1992-3#2)(1992-8#1)(1993-10#2)(1993-11#2)(1993-12#1)(1993-5#3)(1994-2#17)(1994-3#2)(1995-1#4)(1995-11#5)(1995-4#1)(1995-5#1)(1996-2#2)(1996-3#1)(1996-7#3)(1996-8#4)(1997-5#3)(1997-8#7)(2004-11#4)(2004-12#2)(2004-8#2)(2005-10#2)(2005-6#1)(2005-7#10)(2006-12#2)(2006-3#2)(2006-6#6)(2006-7#3)(2006-8#9)(2006-9#9)(2007-1#7)(2007-10#4)(2007-11#4)(2007-12#13)(2007-3#2)(2007-5#1)(2007-6#2)(2007-7#9)(2007-8#3)(2008-1#8)(2008-10#2)(2008-11#11)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#10)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#6)(2009-1#1)(2009-10#8)(2009-12#3)(2009-5#3)(2009-7#1)(2009-8#4)(2009-9#5)(2010-1#1)(2010-12#19)(2010-2#2)(2010-6#3)(2010-8#1)(2011-1#18)(2011-12#1)(2011-2#11)(2012-1#6)(2012-11#1)(2012-12#8)(2012-2#6)(2012-3#1)(2013-1#7)(2013-7#6)(2013-8#2)
personalized FAIME-profiles of GO biological processes are generated from genome-wide expression profiles##2##12##(2013-1#2)
personalized and##2##2##(1995-3#1)(2011-3#1)
personalized approach to##2##3##(2008-10#1)(2010-12#1)
personalized drug##2##2##(2008-8#1)(2010-10#1)
personalized drugs##2##2##(2009-5#1)(2010-4#1)
personalized face##2##2##(2008-6#2)
personalized medicine and##3##3##(2010-10#2)(2010-9#1)
personalized medicine for##2##3##(2008-1#1)(2013-1#1)
personalized medicine##18##2##(2008-1#1)(2008-10#3)(2008-6#1)(2009-3#1)(2010-10#2)(2010-4#2)(2010-5#2)(2010-9#1)(2011-1#2)(2013-1#2)(2013-8#1)
personalized nutrition##5##2##(2008-10#4)(2012-12#1)
personalized treatment##3##2##(2009-4#1)(2009-9#1)(2012-2#1)
personalized##67##1##(1991-8#1)(1992-3#1)(1995-3#1)(1996-11#1)(2006-6#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-6#3)(2008-7#1)(2008-8#3)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-8#1)(2009-9#1)(2010-10#4)(2010-12#1)(2010-3#1)(2010-4#3)(2010-5#3)(2010-9#1)(2011-1#2)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#10)(2013-8#3)
personalizing##3##1##(1992-3#1)(2008-11#1)(2013-8#1)
personally and##4##2##(2006-5#1)(2006-7#1)(2008-10#1)(2012-1#1)
personally familiar faces##4##3##(2008-1#2)(2009-4#2)
personally familiar##6##2##(2008-1#3)(2009-4#3)
personally##35##1##(1990-10#1)(1990-4#1)(1994-3#1)(1995-2#1)(1996-12#1)(2006-10#1)(2006-5#2)(2006-7#2)(2007-2#2)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#1)(2008-11#4)(2008-12#1)(2008-9#1)(2009-4#3)(2010-1#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
personata##4##1##(2007-12#2)(2008-10#2)
personatum##3##1##(2008-10#3)
personhood##7##1##(2005-7#2)(2007-3#1)(2012-11#1)(2012-3#1)(2013-7#2)
personnel about the##2##3##(2007-2#1)(2012-2#1)
personnel and equipment##2##3##(1992-2#1)(1994-3#1)
personnel and patients##2##3##(1994-12#1)(2006-6#1)
personnel and the##7##3##(1990-12#1)(1992-12#1)(1993-3#1)(2006-10#1)(2007-7#1)(2012-12#1)(2013-1#1)
personnel and##37##2##(1990-12#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#2)(1995-2#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-8#1)(2006-1#1)(2006-10#1)(2006-6#2)(2007-1#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-8#1)(2009-2#1)(2010-1#1)(2010-12#1)(2012-12#2)(2012-2#3)(2013-1#1)
personnel are##6##2##(1993-12#1)(2006-10#1)(2007-4#1)(2008-1#1)(2008-10#1)(2010-12#1)
personnel as##5##2##(1991-2#1)(1995-1#1)(2008-12#1)(2008-7#1)(2008-8#1)
personnel at the##2##3##(2007-10#1)(2008-11#1)
personnel at##3##2##(1994-10#1)(2007-10#1)(2008-11#1)
personnel by##2##2##(2008-7#1)(2009-3#1)
personnel costs##5##2##(1990-12#1)(1995-3#1)(2006-10#1)(2008-11#1)(2010-2#1)
personnel employed##2##2##(1991-11#1)(1992-11#1)
personnel for##2##2##(2007-3#1)(2010-2#1)
personnel from##7##2##(1991-12#1)(1991-4#1)(1992-2#1)(2007-2#1)(2008-10#1)(2011-1#1)(2011-2#1)
personnel have##4##2##(2006-10#1)(2007-6#1)(2008-10#1)(2008-7#1)
personnel in the##7##3##(1990-5#1)(1995-2#1)(1996-12#1)(2006-8#1)(2007-6#1)(2008-11#1)(2010-5#1)
personnel in##18##2##(1990-2#1)(1990-5#1)(1993-3#1)(1995-2#1)(1996-12#2)(2005-5#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-5#1)(2012-2#1)
personnel is##8##2##(1991-2#1)(1992-3#1)(1997-8#1)(2007-12#1)(2008-4#1)(2008-8#1)(2011-1#1)(2011-2#1)
personnel management##2##2##(1994-2#1)(2007-4#1)
personnel may##2##2##(1991-2#1)(2006-7#1)
personnel must##3##2##(1994-1#1)(2008-4#1)(2008-8#1)
personnel of the##3##3##(1994-3#1)(1996-3#1)(2010-9#1)
personnel of##9##2##(1994-3#1)(1996-3#1)(2008-10#2)(2010-9#1)(2011-1#2)(2012-3#1)(2013-1#1)
personnel portal##2##2##(2008-10#2)
personnel requirements##2##2##(1990-11#1)(2008-8#1)
personnel resources##2##2##(1995-4#1)(1997-3#1)
personnel satisfaction##2##2##(2006-6#1)(2008-8#1)
personnel shortage##4##2##(1990-12#2)(1994-1#1)(2007-4#1)
personnel should##3##2##(1996-2#1)(2006-7#1)(2007-7#1)
personnel to ensure##2##3##(1990-11#1)(2010-2#1)
personnel to##17##2##(1990-11#1)(1990-4#1)(1992-3#1)(1994-1#1)(2006-1#1)(2007-4#4)(2007-9#1)(2008-10#1)(2009-3#1)(2009-7#1)(2010-2#1)(2011-1#1)(2013-1#2)
personnel towards HIV##2##3##(1994-4#1)(1994-5#1)
personnel training and##2##3##(2008-10#1)(2008-12#1)
personnel training##3##2##(1996-6#1)(2008-10#1)(2008-12#1)
personnel utilization##2##2##(1990-12#2)
personnel was##3##2##(1990-4#1)(2006-6#1)(2007-2#1)
personnel were##8##2##(1990-6#1)(1996-9#1)(2007-10#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-8#1)
personnel when##2##2##(1997-2#1)(2005-7#1)
personnel who have##2##3##(1991-12#1)(2012-12#1)
personnel who may##2##3##(1995-12#1)(2007-12#1)
personnel who##6##2##(1991-12#1)(1993-5#1)(1995-12#1)(2007-12#1)(2012-12#2)
personnel with##3##2##(2007-6#1)(2008-11#1)(2009-2#1)
personnel within the##2##3##(1990-10#1)(2009-4#1)
personnel working##2##2##(1992-9#1)(2008-10#1)
personnel##352##1##(1990-10#1)(1990-11#2)(1990-12#16)(1990-2#3)(1990-4#2)(1990-5#1)(1990-6#1)(1991-1#1)(1991-11#2)(1991-12#5)(1991-2#8)(1991-3#1)(1991-4#1)(1992-1#3)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#4)(1992-9#1)(1993-12#6)(1993-2#2)(1993-3#5)(1993-5#2)(1993-6#1)(1993-8#1)(1994-1#8)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#4)(1994-3#4)(1994-4#3)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#2)(1995-2#3)(1995-3#4)(1995-4#1)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-6#2)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#3)(1997-5#1)(1997-8#2)(2004-9#1)(2005-5#2)(2005-7#1)(2005-8#3)(2006-1#2)(2006-10#5)(2006-12#2)(2006-2#2)(2006-4#1)(2006-6#4)(2006-7#7)(2006-8#1)(2007-1#1)(2007-10#4)(2007-11#2)(2007-12#5)(2007-2#6)(2007-3#2)(2007-4#8)(2007-6#7)(2007-7#9)(2007-9#3)(2008-1#6)(2008-10#19)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#7)(2008-6#2)(2008-7#4)(2008-8#12)(2008-9#1)(2009-10#1)(2009-2#3)(2009-3#7)(2009-4#1)(2009-6#1)(2009-7#1)(2010-1#2)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#2)(2010-8#2)(2010-9#4)(2011-1#10)(2011-2#5)(2012-12#5)(2012-2#11)(2012-3#3)(2013-1#11)
personnel's##2##1##(1996-9#1)(2012-12#1)
personnel]##7##1##(1990-10#1)(1992-2#1)(1992-4#1)(1993-6#1)(1994-4#1)(1996-3#1)(2006-6#1)
persons (24##2##2##(2007-8#1)(2010-10#1)
persons (3)##2##2##(1995-3#1)(2013-8#1)
persons actively##2##2##(2007-11#1)(2007-8#1)
persons age##2##2##(2009-5#1)(2013-1#1)
persons aged 15-24 years##5##4##(2012-12#5)
persons aged##11##2##(1991-6#2)(1995-6#1)(2008-7#1)(2010-4#1)(2012-12#5)(2013-7#1)
persons and the##2##3##(2007-12#1)(2011-2#1)
persons and##18##2##(1990-12#2)(1991-5#1)(1993-5#1)(1993-9#1)(2004-12#1)(2005-8#1)(2006-2#1)(2007-12#2)(2008-10#1)(2008-9#1)(2009-4#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#1)
persons applying##2##2##(1990-12#1)(1996-3#1)
persons are##12##2##(1992-11#1)(1993-8#1)(1997-6#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#3)(2013-8#1)
persons at high risk##5##4##(1993-5#1)(1993-9#2)(1994-11#1)(2007-10#1)
persons at risk##2##3##(2006-6#2)
persons at the##2##3##(1997-3#1)(2012-2#1)
persons at##11##2##(1993-5#1)(1993-9#2)(1994-11#1)(1997-3#2)(2006-6#2)(2007-10#1)(2008-7#1)(2012-2#1)
persons but##2##2##(1990-12#1)(2012-11#1)
persons by##2##2##(2007-7#1)(2010-8#1)
persons can##2##2##(1996-1#1)(2006-2#1)
persons charged with##2##3##(1990-5#1)(1993-5#1)
persons developed##2##2##(1992-11#1)(1994-4#1)
persons diagnosed##2##2##(2007-8#1)(2011-1#1)
persons did##2##2##(2007-9#1)(2009-2#1)
persons experience##2##2##(2006-10#1)(2008-7#1)
persons experiencing##3##2##(1995-11#1)(2007-12#1)(2008-11#1)
persons exposed to##4##3##(1994-11#1)(2007-12#1)(2010-9#1)(2012-12#1)
persons exposed##6##2##(1991-9#1)(1994-11#1)(2007-12#1)(2008-8#1)(2010-9#1)(2012-12#1)
persons for##3##2##(1995-6#1)(2006-10#1)(2007-7#1)
persons from the##3##3##(1996-3#1)(1997-2#1)(2008-5#1)
persons from##11##2##(1995-6#1)(1996-11#1)(1996-3#1)(1997-2#1)(2007-8#1)(2008-5#1)(2009-11#1)(2009-9#1)(2010-8#2)(2012-3#1)
persons had##6##2##(1991-11#1)(1994-11#1)(1994-9#2)(1996-11#1)(2008-11#1)
persons has##4##2##(1990-3#1)(1993-5#1)(2009-11#1)(2011-2#1)
persons have##2##2##(1993-8#1)(1994-6#1)
persons in Norway##4##3##(1994-2#1)(1994-9#1)(1996-11#1)(1996-6#1)
persons in a##3##3##(1992-1#1)(1995-1#1)(2009-9#1)
persons in charge##2##3##(1996-1#1)(2007-12#1)
persons in rehabilitation##2##3##(2007-8#2)
persons in the United States##5##5##(1990-11#2)(1993-9#1)(1996-11#1)(2009-1#1)
persons in the##12##3##(1990-11#2)(1993-8#1)(1993-9#1)(1995-12#1)(1996-11#1)(1997-3#1)(2006-7#1)(2009-1#1)(2011-2#1)(2012-2#2)
persons in their##2##3##(1995-1#1)(2006-11#1)
persons in##43##2##(1990-11#2)(1990-4#1)(1991-4#1)(1992-1#1)(1992-3#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-9#2)(1995-1#2)(1995-12#1)(1996-1#1)(1996-11#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(2005-9#1)(2006-11#1)(2006-7#1)(2007-12#1)(2007-8#2)(2009-1#1)(2009-9#1)(2010-10#2)(2011-2#2)(2012-12#1)(2012-2#2)
persons infected with HIV##2##4##(1995-3#1)(2008-10#1)
persons infected with##4##3##(1992-2#1)(1993-11#1)(1995-3#1)(2008-10#1)
persons involved in##3##3##(1995-8#1)(1997-8#1)(2007-11#1)
persons is##11##2##(1990-11#1)(1990-4#1)(1993-6#1)(1993-9#1)(1995-5#1)(2007-9#1)(2010-5#2)(2012-11#1)(2012-2#2)
persons living in##2##3##(1992-6#1)(1994-3#1)
persons living near##2##3##(1991-3#1)(2008-8#1)
persons living with HIV/AIDS##3##4##(2007-1#1)(2007-12#1)(2009-7#1)
persons living with##6##3##(2007-1#1)(2007-12#1)(2008-6#2)(2009-7#1)(2010-5#1)
persons living##10##2##(1991-3#1)(1992-6#1)(1994-3#1)(2007-1#1)(2007-12#1)(2008-6#2)(2008-8#1)(2009-7#1)(2010-5#1)
persons may be##2##3##(1994-9#1)(2008-10#1)
persons may##4##2##(1994-9#1)(2008-10#1)(2010-8#1)(2013-8#1)
persons must##2##2##(1990-12#1)(1995-8#1)
persons of different##2##3##(1994-12#1)(2010-2#1)
persons of interest##2##3##(2008-10#2)
persons of the same##2##4##(1990-7#1)(2004-11#1)
persons of##16##2##(1990-7#1)(1994-12#2)(1994-2#1)(1995-1#1)(2004-11#1)(2005-10#1)(2008-10#3)(2008-7#2)(2009-2#1)(2010-2#1)(2010-8#1)(2013-1#1)
persons older than 65##2##4##(1995-10#1)(2010-4#1)
persons on##2##2##(2007-12#1)(2009-7#1)
persons over the age of##2##5##(1996-2#1)(1996-3#1)
persons over the##3##3##(1996-2#1)(1996-3#1)(1996-6#1)
persons over##6##2##(1993-8#1)(1995-2#1)(1996-2#1)(1996-3#1)(1996-6#1)(2010-2#1)
persons participated in a##2##4##(2009-2#1)(2010-8#1)
persons participated in##3##3##(2009-2#1)(2010-3#1)(2010-8#1)
persons per year##3##3##(2008-1#1)(2010-12#1)(2010-3#1)
persons per##5##2##(2008-1#1)(2010-12#1)(2010-3#2)(2011-1#1)
persons ranging##2##2##(1992-7#1)(2007-8#1)
persons recovering from##3##3##(2009-10#2)(2013-1#1)
persons reported##3##2##(1991-4#1)(1997-2#1)(1997-5#1)
persons residing in##3##3##(1994-9#1)(1995-12#1)(1996-3#1)
persons residing##4##2##(1991-3#1)(1994-9#1)(1995-12#1)(1996-3#1)
persons returning from##2##3##(1992-2#1)(2012-3#1)
persons should##5##2##(1991-11#1)(1994-6#1)(2006-10#1)(2008-10#1)(2009-6#1)
persons showed##2##2##(1992-4#1)(2008-9#1)
persons suffering from mental health problems##2##6##(1996-1#2)
persons suffering from##6##3##(1991-3#1)(1992-5#1)(1996-1#2)(2007-8#1)(2012-1#1)
persons the##2##2##(1991-3#1)(2006-10#1)
persons to##6##2##(1993-4#1)(2004-12#1)(2007-2#1)(2011-12#1)(2011-2#1)(2012-1#1)
persons using##2##2##(2012-1#1)(2013-8#1)
persons were##16##2##(1990-8#1)(1991-10#2)(1991-6#1)(1992-5#1)(1994-11#1)(1994-2#1)(1995-2#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-7#1)(2010-8#1)(2012-3#1)
persons who are##4##3##(1993-5#1)(2008-1#1)(2010-11#1)(2012-3#1)
persons who had previously##2##4##(1991-10#1)(1993-5#1)
persons who had##3##3##(1991-10#1)(1993-5#1)(2008-1#1)
persons who have##5##3##(1993-2#1)(1993-7#1)(2010-9#1)(2011-2#1)(2012-12#1)
persons who inject drugs##2##4##(2013-1#2)
persons who were##4##3##(1994-11#1)(1995-2#1)(1996-1#1)(2010-10#1)
persons who##39##2##(1990-12#1)(1991-10#2)(1991-5#1)(1991-6#1)(1991-8#1)(1993-2#1)(1993-5#2)(1993-6#1)(1993-7#2)(1994-11#1)(1994-9#1)(1995-2#1)(1996-1#1)(1996-11#1)(1997-8#1)(2007-10#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-10#1)(2010-11#2)(2010-9#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#4)
persons whose##2##2##(2005-7#1)(2012-12#1)
persons will##2##2##(1996-3#1)(2013-8#1)
persons with AIDS##7##3##(1990-11#2)(1991-8#1)(1993-1#1)(1996-1#1)(1996-2#1)(2005-7#1)
persons with Alzheimer's disease##2##4##(1997-6#1)(2010-2#1)
persons with CHB##2##3##(2009-11#2)
persons with CMT##3##3##(2013-7#3)
persons with HIV##3##3##(1995-9#1)(1997-4#1)(2005-7#1)
persons with HIV/AIDS##2##3##(1995-3#1)(2009-7#1)
persons with Parkinson's disease##2##4##(2008-7#2)
persons with SCI##2##3##(2012-1#2)
persons with a mean age of##2##6##(1991-1#1)(1991-4#1)
persons with a##7##3##(1991-1#1)(1991-4#1)(1992-12#1)(2007-10#2)(2008-6#1)(2011-2#1)
persons with advanced##2##3##(1991-12#1)(2008-2#1)
persons with aphasia##4##3##(2012-2#1)(2012-3#3)
persons with brain##2##3##(1991-12#1)(2007-7#1)
persons with chronic HCV##2##4##(2009-4#2)
persons with chronic back pain##2##5##(1994-4#1)(2010-5#1)
persons with chronic hepatitis C##2##5##(2009-4#2)
persons with chronic##12##3##(1993-3#1)(1994-4#1)(1997-1#1)(2007-10#1)(2008-12#1)(2009-11#1)(2009-4#4)(2010-5#1)(2013-1#1)
persons with dementia##9##3##(1991-1#1)(1992-3#1)(2007-11#2)(2010-11#1)(2010-8#3)(2011-2#1)
persons with diabetes are##2##4##(2008-1#1)(2010-4#1)
persons with diabetes##9##3##(1993-6#1)(2007-12#1)(2008-1#3)(2009-11#1)(2010-4#1)(2011-1#1)(2011-2#1)
persons with diagnosed##2##3##(1993-6#1)(2011-2#1)
persons with disabilities in##2##4##(1996-1#1)(1997-2#1)
persons with disabilities##7##3##(1996-1#1)(1997-2#2)(2007-10#1)(2009-6#1)(2010-2#2)
persons with elevated##2##3##(1991-11#1)(1994-11#1)
persons with human immunodeficiency virus##2##5##(1991-8#1)(1995-3#1)
persons with low##2##3##(1994-9#1)(2008-4#1)
persons with mental illness##2##4##(2006-5#1)(2006-9#1)
persons with mental##5##3##(1997-2#1)(2006-5#1)(2006-9#1)(2007-7#1)(2009-7#1)
persons with multiple##2##3##(2008-1#1)(2012-12#1)
persons with psychiatric disabilities in housing programs##2##7##(1997-1#2)
persons with psychiatric disabilities##6##4##(1997-1#3)(2009-6#3)
persons with schizophrenia##5##3##(2008-3#2)(2008-6#2)(2012-12#1)
persons with serious mental##2##4##(1997-3#1)(2004-3#1)
persons with severe##3##3##(2006-5#3)
persons with spinal cord injuries##2##5##(2007-10#1)(2008-11#1)
persons with stroke and their care partners##2##7##(2010-9#2)
persons with stroke##5##3##(2007-10#1)(2010-9#3)(2012-1#1)
persons with tetraplegia##3##3##(2006-3#1)(2012-1#1)(2012-2#1)
persons with##221##2##(1990-11#3)(1990-12#1)(1990-4#2)(1990-5#2)(1990-9#2)(1991-1#2)(1991-11#1)(1991-12#5)(1991-4#2)(1991-8#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-1#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#3)(1994-11#1)(1994-2#1)(1994-4#1)(1994-9#2)(1995-3#3)(1995-4#2)(1995-6#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-8#4)(1997-1#6)(1997-2#6)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-3#1)(2005-7#2)(2006-10#4)(2006-11#1)(2006-2#2)(2006-3#1)(2006-5#4)(2006-7#1)(2006-9#1)(2007-10#7)(2007-11#3)(2007-12#3)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-6#3)(2008-7#5)(2008-9#1)(2009-11#4)(2009-4#4)(2009-6#4)(2009-7#2)(2010-11#2)(2010-12#3)(2010-2#3)(2010-4#2)(2010-5#2)(2010-8#3)(2010-9#3)(2011-1#5)(2011-2#9)(2012-1#7)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#7)(2013-1#6)(2013-7#5)
persons within the##3##3##(1994-1#2)(2009-5#1)
persons without##13##2##(1990-11#1)(1991-9#1)(1994-12#2)(1994-9#2)(2006-10#1)(2006-5#1)(2007-7#2)(2008-1#1)(2011-1#1)(2011-2#1)
persons working##2##2##(2008-10#1)(2011-1#1)
persons worldwide have##2##3##(2006-2#1)(2012-12#1)
persons worldwide##3##2##(1991-5#1)(2006-2#1)(2012-12#1)
persons##846##1##(1990-11#8)(1990-12#21)(1990-3#2)(1990-4#4)(1990-5#3)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#2)(1991-1#3)(1991-10#4)(1991-11#6)(1991-12#7)(1991-2#3)(1991-3#6)(1991-4#6)(1991-5#3)(1991-6#6)(1991-8#3)(1991-9#8)(1992-1#2)(1992-11#3)(1992-12#2)(1992-2#4)(1992-3#4)(1992-4#3)(1992-5#2)(1992-6#4)(1992-7#2)(1992-8#1)(1992-9#1)(1993-1#6)(1993-10#3)(1993-11#1)(1993-12#1)(1993-2#4)(1993-3#1)(1993-4#1)(1993-5#9)(1993-6#5)(1993-7#2)(1993-8#9)(1993-9#15)(1994-1#7)(1994-11#11)(1994-12#7)(1994-2#5)(1994-3#1)(1994-4#3)(1994-5#1)(1994-6#3)(1994-9#16)(1995-1#5)(1995-10#2)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#7)(1995-4#2)(1995-5#2)(1995-6#8)(1995-7#1)(1995-8#6)(1995-9#1)(1996-1#8)(1996-10#2)(1996-11#7)(1996-2#4)(1996-3#7)(1996-4#1)(1996-6#2)(1996-8#4)(1996-9#4)(1997-1#7)(1997-2#12)(1997-3#6)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#3)(2004-11#1)(2004-12#4)(2004-3#1)(2004-9#2)(2005-10#3)(2005-7#4)(2005-8#4)(2005-9#1)(2006-1#2)(2006-10#14)(2006-11#3)(2006-12#1)(2006-2#7)(2006-3#1)(2006-5#5)(2006-6#6)(2006-7#2)(2006-8#5)(2006-9#1)(2007-1#1)(2007-10#12)(2007-11#8)(2007-12#15)(2007-2#6)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#17)(2007-8#17)(2007-9#6)(2008-1#13)(2008-10#18)(2008-11#6)(2008-12#5)(2008-2#3)(2008-3#9)(2008-4#5)(2008-5#3)(2008-6#7)(2008-7#21)(2008-8#3)(2008-9#5)(2009-1#2)(2009-10#3)(2009-11#7)(2009-2#5)(2009-4#7)(2009-5#2)(2009-6#7)(2009-7#5)(2009-9#2)(2010-10#9)(2010-11#4)(2010-12#5)(2010-2#5)(2010-3#4)(2010-4#5)(2010-5#7)(2010-8#13)(2010-9#6)(2011-1#10)(2011-12#3)(2011-2#29)(2012-1#16)(2012-11#5)(2012-12#15)(2012-2#19)(2012-3#12)(2013-1#18)(2013-7#6)(2013-8#8)
persons'##3##1##(1996-3#1)(2010-10#1)(2013-7#1)
persons)##3##1##(1990-12#1)(2004-11#1)(2008-9#1)
persons]##2##1##(1990-2#1)(2013-7#1)
persoonii group 1##3##3##(2008-10#3)
persoonii group##4##2##(2008-10#4)
persoonii##5##1##(2008-10#5)
perspective and research##2##3##(2008-11#1)(2010-12#1)
perspective and##22##2##(1991-12#1)(1993-6#1)(1994-5#1)(1996-4#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-11#3)(2008-6#2)(2008-8#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-7#1)
perspective are##2##2##(1993-3#1)(2009-2#1)
perspective as##2##2##(2005-7#1)(2012-1#1)
perspective attenuation of##2##3##(2011-12#2)
perspective by##2##2##(1993-5#1)(2008-11#1)
perspective for the##5##3##(2006-3#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-3#1)
perspective for##13##2##(1992-2#1)(1997-3#1)(2006-3#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
perspective from an##2##3##(2008-10#1)(2010-11#1)
perspective from the trenches##2##4##(2007-4#2)
perspective from the##5##3##(2007-4#2)(2008-2#1)(2008-6#1)(2009-10#1)
perspective from##12##2##(2007-4#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-11#1)
perspective has##2##2##(1996-3#1)(2007-4#1)
perspective have##2##2##(2011-2#1)(2012-3#1)
perspective in diabetes##2##3##(2009-5#2)
perspective in order to##3##4##(1994-1#2)(1994-2#1)
perspective in##18##2##(1994-1#2)(1994-2#1)(1995-3#1)(1997-8#1)(2006-8#2)(2008-1#1)(2008-12#1)(2008-6#1)(2008-7#3)(2009-10#1)(2009-5#2)(2012-12#1)(2013-1#1)
perspective into##3##2##(1996-4#1)(2008-12#1)(2009-12#1)
perspective is used to##2##4##(2008-3#1)(2010-4#1)
perspective is##12##2##(1992-3#1)(1993-9#1)(1995-12#1)(2006-12#1)(2008-1#1)(2008-3#1)(2010-12#1)(2010-3#1)(2010-4#1)(2013-1#2)(2013-8#1)
perspective may be##3##3##(1990-12#1)(2006-9#1)(2008-11#1)
perspective may##4##2##(1990-12#1)(2006-9#1)(2007-12#1)(2008-11#1)
perspective of a##11##3##(1994-1#1)(1994-12#1)(1994-6#1)(2006-12#1)(2006-5#1)(2007-4#1)(2008-1#2)(2008-2#1)(2008-4#1)(2009-10#1)
perspective of diabetes care##2##4##(2008-7#2)
perspective of health care in the##2##6##(2008-1#2)
perspective of insomnia##2##3##(2008-5#2)
perspective of the##36##3##(1990-12#1)(1991-12#1)(1992-3#1)(1993-12#2)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-10#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)
perspective of this##4##3##(2008-2#1)(2008-7#1)(2009-3#1)(2011-1#1)
perspective of##143##2##(1990-12#1)(1991-1#1)(1991-12#1)(1991-6#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-12#2)(1994-1#1)(1994-12#2)(1994-3#1)(1994-6#1)(1996-1#2)(1996-2#1)(1996-3#2)(1997-3#1)(2004-11#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-5#4)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#3)(2007-5#2)(2007-7#1)(2007-8#2)(2008-1#8)(2008-10#2)(2008-11#6)(2008-12#2)(2008-2#11)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#4)(2009-10#2)(2009-3#1)(2009-4#2)(2009-8#1)(2010-1#1)(2010-10#5)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#8)(2013-1#2)
perspective on clinical##3##3##(1995-5#1)(1997-2#1)(2006-4#1)
perspective on death and dying##3##5##(1994-1#3)
perspective on health##2##3##(1990-12#1)(2009-9#1)
perspective on how##3##3##(1994-3#1)(2010-10#1)(2011-11#1)
perspective on knowledge##2##3##(2009-12#1)(2009-5#1)
perspective on management##3##3##(1994-1#2)(2007-8#1)
perspective on muscle##2##3##(1993-6#1)(2007-12#1)
perspective on the current##2##4##(1994-1#1)(2009-4#1)
perspective on the##34##3##(1992-1#1)(1994-1#2)(1994-12#1)(1995-6#1)(1997-1#1)(2005-11#1)(2005-2#1)(2006-12#1)(2006-8#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#4)(2009-5#2)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
perspective on##97##2##(1990-12#1)(1991-1#1)(1992-1#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-1#7)(1994-12#1)(1994-3#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-5#3)(1995-6#1)(1996-3#1)(1997-1#1)(1997-2#2)(2005-11#1)(2005-2#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#6)(2009-5#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-11#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#1)
perspective projection##2##2##(2008-2#1)(2008-6#1)
perspective regarding the##2##3##(2005-7#1)(2010-5#1)
perspective regarding##3##2##(2005-7#1)(2006-5#1)(2010-5#1)
perspective review##2##2##(2009-3#1)(2012-12#1)
perspective should##2##2##(2007-10#1)(2012-2#1)
perspective so far##2##3##(2007-12#1)(2009-7#1)
perspective taking##2##2##(2008-11#2)
perspective that##8##2##(1994-1#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-3#1)
perspective the##5##2##(1990-11#1)(1990-12#1)(1991-1#1)(2008-2#1)(2008-3#1)
perspective they##2##2##(1993-1#1)(2008-10#1)
perspective through##2##2##(1997-8#1)(2009-11#1)
perspective to explore##2##3##(2009-7#1)(2010-4#1)
perspective to this##2##3##(2008-12#1)(2010-12#1)
perspective to##15##2##(1993-12#1)(1993-5#1)(1995-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-1#2)(2012-2#1)
perspective toward##2##2##(2011-1#1)(2012-1#1)
perspective using##2##2##(2005-11#1)(2009-3#1)
perspective which##2##2##(1996-1#1)(2009-3#1)
perspective with##3##2##(1991-12#1)(2007-5#1)(2008-12#1)
perspective within##3##2##(2008-12#1)(2009-6#1)(2011-2#1)
perspective##884##1##(1990-11#1)(1990-12#6)(1991-1#3)(1991-11#1)(1991-12#9)(1991-2#2)(1991-3#1)(1991-6#2)(1992-1#2)(1992-12#4)(1992-2#4)(1992-3#6)(1993-1#4)(1993-11#1)(1993-12#10)(1993-2#1)(1993-3#2)(1993-5#3)(1993-6#2)(1993-7#1)(1993-9#1)(1994-1#18)(1994-11#1)(1994-12#4)(1994-2#5)(1994-3#10)(1994-5#1)(1994-6#4)(1994-7#2)(1994-8#1)(1995-11#1)(1995-12#6)(1995-2#6)(1995-3#2)(1995-5#3)(1995-6#1)(1995-8#1)(1996-1#5)(1996-12#4)(1996-2#5)(1996-3#8)(1996-4#3)(1997-1#2)(1997-2#7)(1997-3#4)(1997-5#1)(1997-8#3)(2004-11#1)(2004-12#2)(2004-4#1)(2004-7#1)(2005-10#4)(2005-11#2)(2005-2#1)(2005-6#1)(2005-7#5)(2005-8#4)(2006-10#8)(2006-11#2)(2006-12#10)(2006-2#5)(2006-3#3)(2006-4#6)(2006-5#12)(2006-6#4)(2006-7#9)(2006-8#7)(2006-9#7)(2007-10#5)(2007-11#12)(2007-12#10)(2007-2#5)(2007-3#8)(2007-4#15)(2007-5#4)(2007-6#1)(2007-7#11)(2007-8#9)(2008-1#23)(2008-10#19)(2008-11#43)(2008-12#19)(2008-2#20)(2008-3#11)(2008-4#23)(2008-5#7)(2008-6#22)(2008-7#23)(2008-8#14)(2008-9#20)(2009-10#14)(2009-11#4)(2009-12#6)(2009-2#3)(2009-3#4)(2009-4#13)(2009-5#11)(2009-6#3)(2009-7#7)(2009-8#8)(2009-9#2)(2010-1#1)(2010-10#6)(2010-11#5)(2010-12#10)(2010-2#3)(2010-3#10)(2010-4#7)(2010-5#8)(2010-6#2)(2010-7#4)(2010-8#4)(2010-9#2)(2011-1#13)(2011-11#1)(2011-12#5)(2011-2#32)(2011-7#1)(2012-1#5)(2012-11#1)(2012-12#18)(2012-2#17)(2012-3#19)(2013-1#18)(2013-7#5)(2013-8#19)
perspective)##2##1##(2008-12#1)(2008-9#1)
perspective-based##2##1##(2008-2#2)
perspective-taking##2##1##(2006-3#1)(2008-11#1)
perspective]##20##1##(1990-9#1)(1991-5#1)(1992-10#1)(1993-11#1)(1993-3#1)(1993-6#3)(1995-11#1)(1995-4#1)(1996-3#1)(1996-4#2)(2006-4#1)(2008-12#1)(2009-4#1)(2012-12#1)(2012-2#2)(2013-7#1)
perspectively##2##1##(2006-6#1)(2011-1#1)
perspectives about##2##2##(2009-12#1)(2011-1#1)
perspectives and challenges##2##3##(2009-3#1)(2012-2#1)
perspectives and new##2##3##(2007-9#1)(2008-1#1)
perspectives and##20##2##(1995-1#1)(2007-10#1)(2007-9#1)(2008-1#2)(2008-11#2)(2008-12#2)(2008-3#1)(2009-3#1)(2009-4#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-11#3)(2012-2#1)
perspectives are discussed##3##3##(2006-6#1)(2012-12#2)
perspectives are presented##2##3##(2006-2#1)(2008-3#1)
perspectives are##10##2##(1992-1#1)(2006-2#1)(2006-6#1)(2008-3#1)(2008-4#1)(2009-12#1)(2009-4#1)(2009-8#1)(2012-12#2)
perspectives exist##2##2##(2008-7#1)(2011-2#1)
perspectives for further##2##3##(2006-8#1)(2013-1#1)
perspectives for the future##3##4##(2006-10#1)(2008-1#1)(2012-12#1)
perspectives for the##10##3##(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-4#1)(2010-5#1)(2011-1#1)(2012-12#1)
perspectives for##36##2##(1992-3#1)(1994-1#1)(1995-7#1)(1996-1#1)(2004-2#1)(2006-10#3)(2006-5#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-9#1)(2009-3#1)(2009-4#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#5)(2012-3#1)(2013-1#1)(2013-8#1)
perspectives from the##3##3##(1994-1#1)(2007-1#1)(2008-7#1)
perspectives from##5##2##(1994-1#1)(2007-1#1)(2008-7#1)(2009-4#1)(2012-2#1)
perspectives imaging##3##2##(2008-3#3)
perspectives in the field of##2##5##(2010-4#1)(2012-3#1)
perspectives in the study##2##4##(2006-8#1)(2006-9#1)
perspectives in the##10##3##(2005-10#1)(2006-8#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-4#1)(2012-3#1)
perspectives in##25##2##(1991-12#1)(1991-3#1)(1996-5#1)(2005-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-8#1)(2009-12#1)(2009-9#1)(2010-4#1)(2010-5#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
perspectives into##2##2##(1993-12#1)(2009-12#1)
perspectives of a##4##3##(2008-12#1)(2008-6#1)(2011-2#1)(2012-12#1)
perspectives of an##2##3##(2008-11#1)(2009-7#1)
perspectives of the##7##3##(2008-12#1)(2008-6#1)(2009-7#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
perspectives of##61##2##(1990-12#1)(1990-6#1)(1993-1#1)(1993-5#1)(1995-2#1)(1996-2#1)(1997-3#1)(2005-1#1)(2006-5#1)(2006-6#2)(2007-10#3)(2007-2#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#5)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-7#4)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
perspectives on an old##2##4##(1991-2#1)(2006-10#1)
perspectives on an##3##3##(1991-2#1)(2006-10#1)(2008-12#1)
perspectives on health##3##3##(1996-1#1)(2005-10#1)(2011-2#1)
perspectives on hospital##2##3##(1994-1#1)(2008-11#1)
perspectives on the##12##3##(1991-7#1)(1992-12#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-10#1)(2012-11#1)(2012-3#1)(2013-1#2)(2013-8#1)
perspectives on their##2##3##(1997-3#1)(2012-12#1)
perspectives on##56##2##(1991-2#1)(1991-3#1)(1991-7#1)(1992-12#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-3#2)(2005-10#1)(2005-8#1)(2006-10#1)(2006-5#2)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-10#2)(2010-6#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
perspectives regarding##2##2##(2008-12#1)(2013-1#1)
perspectives that##2##2##(1997-3#1)(2012-11#1)
perspectives to##2##2##(2008-12#1)(2012-12#1)
perspectives within##2##2##(2006-7#1)(2012-3#1)
perspectives##383##1##(1990-12#1)(1990-6#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-7#1)(1992-1#1)(1992-12#2)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-7#2)(1993-8#1)(1994-1#3)(1994-10#1)(1994-12#2)(1994-2#2)(1994-4#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-7#1)(1995-9#1)(1996-1#4)(1996-12#2)(1996-2#2)(1996-3#4)(1996-5#1)(1997-1#2)(1997-3#5)(1997-6#1)(2004-2#1)(2004-7#1)(2005-1#1)(2005-10#3)(2005-12#1)(2005-8#3)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#3)(2006-4#1)(2006-5#7)(2006-6#4)(2006-7#3)(2006-8#2)(2006-9#4)(2007-1#2)(2007-10#7)(2007-12#2)(2007-2#4)(2007-3#1)(2007-4#3)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#4)(2008-11#14)(2008-12#19)(2008-2#7)(2008-3#12)(2008-4#7)(2008-5#7)(2008-6#4)(2008-7#9)(2008-8#4)(2008-9#4)(2009-10#1)(2009-12#7)(2009-2#1)(2009-3#4)(2009-4#6)(2009-5#2)(2009-6#2)(2009-7#4)(2009-8#2)(2009-9#2)(2010-10#7)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#7)(2011-12#2)(2011-2#10)(2011-3#1)(2012-1#4)(2012-11#7)(2012-12#24)(2012-2#8)(2012-3#8)(2013-1#14)(2013-7#1)(2013-8#5)
perspectives]##9##1##(1990-6#1)(1994-3#1)(2008-10#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)
perspex can be used to##2##5##(1997-8#2)
perspex can##3##2##(1997-8#3)
perspex describes##2##2##(1997-8#2)
perspex is a##2##3##(1997-8#2)
perspex space##3##2##(1997-8#3)
perspex##15##1##(1997-8#14)(2008-10#1)
perspiration##5##1##(1995-5#1)(2008-5#2)(2008-7#1)(2009-3#1)
perstans filariasis is##3##3##(2008-4#3)
perstans filariasis##6##2##(2008-4#6)
perstans##11##1##(1990-8#2)(2008-4#9)
perstraction system for##2##3##(2008-7#2)
persuade##9##1##(1993-4#2)(1995-6#1)(1996-1#1)(1996-11#1)(1997-8#1)(2007-9#1)(2009-4#1)(2012-12#1)
persuaded to##2##2##(1994-3#1)(1995-8#1)
persuaded##4##1##(1994-3#1)(1995-8#1)(2009-6#1)(2013-7#1)
persuading##5##1##(1996-11#1)(1996-2#1)(2007-7#1)(2008-5#1)(2010-9#1)
persuasion and##3##2##(1997-7#1)(2009-11#1)(2010-9#1)
persuasion probability##2##2##(1997-8#2)
persuasion tactics##2##2##(2010-1#2)
persuasion##16##1##(1996-2#1)(1997-7#1)(1997-8#2)(2007-4#1)(2008-5#1)(2009-11#2)(2010-1#5)(2010-9#2)(2011-2#1)
persuasive##10##1##(1993-12#1)(1995-12#1)(1997-2#1)(2005-8#1)(2008-10#1)(2008-7#1)(2009-11#2)(2012-1#2)
persuasively##3##1##(2008-11#1)(2009-10#1)(2012-1#1)
persufflation##9##1##(2007-8#9)
persulfate and##2##2##(2008-10#1)(2009-3#1)
persulfate oxidation##3##2##(2011-12#3)
persulfate##9##1##(2005-11#2)(2008-10#1)(2009-3#1)(2010-5#1)(2011-12#4)
persulphate##3##1##(2008-10#3)
pertactin##2##1##(1995-5#1)(2007-11#1)
pertain to the##3##3##(1997-3#1)(2006-10#1)(2006-8#1)
pertain to##13##2##(1991-3#1)(1996-6#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-5#1)(2009-8#1)(2010-11#1)(2010-9#1)(2012-12#1)(2012-2#1)
pertain##15##1##(1991-3#1)(1996-2#1)(1996-6#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-5#1)(2009-8#1)(2010-11#1)(2010-9#1)(2012-12#2)(2012-2#1)
pertained to the##5##3##(2007-4#1)(2007-6#2)(2008-6#2)
pertained to##9##2##(1993-8#1)(2006-7#1)(2007-3#1)(2007-4#1)(2007-6#2)(2008-2#1)(2008-6#2)
pertaining to a##2##3##(2008-4#1)(2012-2#1)
pertaining to cell##2##3##(2008-1#1)(2008-11#1)
pertaining to different##3##3##(2005-11#1)(2008-10#1)(2010-8#1)
pertaining to the##30##3##(1993-6#1)(1994-11#1)(1997-2#1)(1997-7#1)(2004-3#1)(2006-10#3)(2006-8#1)(2007-11#1)(2007-12#1)(2007-6#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-11#1)(2013-7#1)(2013-8#2)
pertaining to these##2##3##(2008-11#1)(2013-8#1)
pertaining to this##3##3##(2008-2#1)(2009-3#1)(2009-8#1)
pertaining to##100##2##(1990-7#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-8#1)(1996-1#2)(1996-3#1)(1997-2#2)(1997-7#1)(2004-3#1)(2005-11#2)(2006-10#4)(2006-2#1)(2006-3#1)(2006-8#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#7)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-1#1)(2009-3#3)(2009-8#2)(2009-9#2)(2010-10#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#3)
pertaining##104##1##(1990-7#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-1#2)(1996-3#1)(1997-2#2)(1997-7#1)(2004-3#1)(2005-11#2)(2006-10#4)(2006-2#1)(2006-3#1)(2006-8#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#7)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-1#1)(2009-3#3)(2009-8#2)(2009-9#2)(2010-10#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
pertains to the##5##3##(2007-11#1)(2008-3#1)(2008-6#1)(2010-4#1)(2010-5#1)
pertains to##11##2##(1995-12#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-2#1)
pertains##13##1##(1995-12#1)(2007-11#3)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-2#1)
pertechnetate##2##1##(1990-8#1)(2010-7#1)
pertinence of##3##2##(1994-3#1)(2006-4#1)(2013-8#1)
pertinence##4##1##(1994-3#1)(2006-4#1)(2006-9#1)(2013-8#1)
pertinent because##2##2##(1992-1#1)(1994-5#1)
pertinent information##3##2##(1994-2#1)(1994-3#1)(2008-9#1)
pertinent literature is reviewed##3##4##(2007-12#1)(2007-2#1)(2012-2#1)
pertinent literature is##4##3##(2006-2#1)(2007-12#1)(2007-2#1)(2012-2#1)
pertinent literature##12##2##(2006-10#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-2#1)(2008-6#1)(2010-12#1)(2012-12#1)(2012-2#2)
pertinent medical history##2##3##(2008-7#1)(2010-3#1)
pertinent questions##2##2##(2010-12#1)(2012-3#1)
pertinent to an##2##3##(1991-2#1)(1991-8#1)
pertinent to the##9##3##(2006-7#1)(2006-8#1)(2007-2#1)(2007-4#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-3#1)
pertinent to##31##2##(1991-2#1)(1991-8#1)(1994-2#1)(1995-1#2)(1997-2#1)(2005-8#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-4#3)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
pertinent##104##1##(1990-2#1)(1990-4#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-6#1)(1993-12#1)(1993-7#1)(1994-2#2)(1994-3#1)(1994-5#1)(1995-1#2)(1996-2#1)(1996-6#1)(1997-2#2)(2005-8#1)(2006-10#5)(2006-11#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#3)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#2)(2007-4#4)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2011-7#1)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
pertrochanteric##3##1##(2007-11#2)(2011-2#1)
perturb the##11##2##(1990-2#1)(1992-3#1)(1993-3#1)(1994-5#1)(1995-9#1)(1997-4#1)(1997-7#1)(2008-3#1)(2008-4#1)(2010-4#1)(2012-2#1)
perturb##18##1##(1990-2#2)(1992-3#1)(1992-6#1)(1993-3#1)(1994-5#1)(1995-2#1)(1995-9#1)(1996-7#1)(1997-4#1)(1997-7#1)(2008-3#1)(2008-4#1)(2009-2#1)(2009-5#2)(2010-4#1)(2012-2#1)
perturbants##4##1##(1994-3#4)
perturbation analysis##2##2##(2008-1#1)(2008-3#1)
perturbation and##5##2##(1992-12#1)(1994-12#1)(2007-12#1)(2008-2#1)(2013-8#1)
perturbation approach##3##2##(2005-11#1)(2008-2#1)(2008-3#1)
perturbation by##2##2##(1992-9#1)(2012-2#1)
perturbation caused by different amounts of##2##6##(2008-10#2)
perturbation caused by##3##3##(2008-10#2)(2008-5#1)
perturbation due to##2##3##(1990-2#1)(1997-1#1)
perturbation in the##4##3##(1992-11#1)(1993-6#1)(2008-10#1)(2008-4#1)
perturbation in##7##2##(1992-11#1)(1993-6#2)(1994-8#1)(1996-7#1)(2008-10#1)(2008-4#1)
perturbation is applied##2##3##(2007-11#1)(2007-12#1)
perturbation is##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
perturbation method##6##2##(1995-2#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
perturbation model to predict the effect of scattering and absorbing inhomogeneities on photon migration##2##14##(2008-3#2)
perturbation of a##2##3##(1990-2#1)(2008-6#1)
perturbation of glycolysis##2##3##(1997-6#2)
perturbation of membrane##2##3##(1994-8#1)(1995-12#1)
perturbation of the normal##2##4##(1990-4#1)(2008-4#1)
perturbation of the##19##3##(1990-4#1)(1992-1#2)(1992-11#1)(1993-12#1)(1994-5#3)(1996-1#1)(1996-5#1)(1996-7#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)
perturbation of##47##2##(1990-2#1)(1990-4#1)(1992-1#2)(1992-11#1)(1993-12#1)(1994-12#1)(1994-5#3)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-5#1)(1996-7#1)(1997-4#2)(1997-6#2)(1997-7#2)(2006-6#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-8#2)(2011-2#1)(2013-1#1)
perturbation solution##2##2##(2008-3#2)
perturbation technique##4##2##(2008-10#2)(2008-2#2)
perturbation techniques##4##2##(1994-11#1)(1995-8#1)(2007-9#1)(2009-3#1)
perturbation that##2##2##(2008-4#1)(2012-1#1)
perturbation theories and the##2##4##(2008-2#2)
perturbation theories##3##2##(2007-12#1)(2008-2#2)
perturbation theory for##3##3##(1992-3#1)(2007-12#1)(2008-1#1)
perturbation theory in##2##3##(1990-7#1)(2009-9#1)
perturbation theory to##4##3##(2007-12#1)(2008-2#3)
perturbation theory##25##2##(1990-7#1)(1992-3#1)(1992-8#1)(1995-2#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#6)(2008-1#1)(2008-2#6)(2008-3#2)(2009-8#1)(2009-9#1)(2010-10#1)
perturbation to##5##2##(1995-2#1)(2008-10#1)(2008-3#2)(2012-1#1)
perturbation##196##1##(1990-11#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#4)(1993-11#1)(1993-12#1)(1993-6#2)(1994-11#1)(1994-12#2)(1994-5#4)(1994-6#1)(1994-8#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#5)(1995-5#2)(1995-8#2)(1995-9#1)(1996-1#2)(1996-2#4)(1996-5#1)(1996-7#2)(1997-1#2)(1997-2#1)(1997-4#3)(1997-6#2)(1997-7#3)(2005-11#2)(2006-10#5)(2006-3#1)(2006-6#2)(2006-9#1)(2007-11#5)(2007-12#18)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#2)(2008-2#19)(2008-3#24)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#2)(2009-3#1)(2009-8#3)(2009-9#2)(2010-10#1)(2010-2#1)(2011-1#4)(2011-2#1)(2012-1#3)(2012-2#1)(2013-1#1)(2013-8#1)
perturbations and##9##2##(2006-10#1)(2008-1#1)(2008-10#2)(2008-2#1)(2010-6#1)(2012-1#1)(2012-2#1)(2012-3#1)
perturbations are##5##2##(1996-8#1)(2007-12#1)(2008-1#1)(2008-10#2)
perturbations at the##2##3##(1994-5#1)(1996-4#1)
perturbations in the##9##3##(1993-11#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)
perturbations in their##2##3##(1992-6#1)(1997-7#1)
perturbations in##30##2##(1990-8#1)(1991-12#1)(1992-6#1)(1993-11#1)(1994-10#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-5#1)(1997-7#1)(2004-11#1)(2006-10#2)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-9#1)(2010-11#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
perturbations is##3##2##(2006-10#1)(2007-12#2)
perturbations may##2##2##(2006-11#1)(2008-4#1)
perturbations of the##5##3##(1990-3#1)(1992-7#1)(2008-1#1)(2008-2#1)(2008-9#1)
perturbations of##17##2##(1990-3#1)(1990-4#1)(1992-12#1)(1992-7#1)(1994-10#1)(1995-5#1)(1996-2#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-9#1)(2011-1#1)(2013-1#1)
perturbations on the##2##3##(1991-9#1)(2008-3#1)
perturbations on##3##2##(1991-9#1)(2008-3#1)(2009-9#1)
perturbations produced by##2##3##(2008-2#1)(2013-1#1)
perturbations that##6##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-1#1)
perturbations to the##4##3##(1993-7#1)(2006-12#1)(2007-9#1)(2012-1#1)
perturbations to##6##2##(1991-6#1)(1993-7#1)(2006-12#1)(2007-9#1)(2009-5#1)(2012-1#1)
perturbations were##2##2##(1993-6#1)(1995-10#1)
perturbations##159##1##(1990-10#1)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-12#3)(1992-6#1)(1992-7#1)(1993-11#2)(1993-6#1)(1993-7#1)(1994-10#2)(1994-2#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-5#2)(1996-12#1)(1996-2#2)(1996-4#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-5#1)(1997-7#3)(2004-11#1)(2006-10#15)(2006-11#1)(2006-12#1)(2007-10#1)(2007-12#12)(2007-2#1)(2007-5#1)(2007-9#2)(2008-1#3)(2008-10#13)(2008-11#3)(2008-2#11)(2008-3#14)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#4)(2010-4#1)(2010-6#1)(2011-1#4)(2011-2#1)(2012-1#6)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#8)(2013-8#1)
perturbative effects##2##2##(1991-4#1)(2005-8#1)
perturbative##9##1##(1991-4#1)(1995-5#1)(2005-8#1)(2007-12#4)(2008-3#2)
perturbed by the##2##3##(1990-3#1)(1996-1#1)
perturbed by##13##2##(1990-3#1)(1991-6#1)(1994-10#1)(1995-8#1)(1996-1#1)(1997-4#1)(2007-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2009-12#1)
perturbed in##2##2##(1993-2#1)(2010-11#1)
perturbed pKa##2##2##(1991-5#1)(1991-7#1)
perturbed the##5##2##(1993-9#1)(1994-9#1)(1996-3#1)(2008-3#1)(2011-1#1)
perturbed to a##2##3##(1990-8#1)(1991-7#1)
perturbed wave##2##2##(2008-3#2)
perturbed with##2##2##(2008-10#1)(2008-3#1)
perturbed##64##1##(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#2)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-9#1)(1995-10#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-3#1)(1997-4#1)(2006-10#1)(2007-12#3)(2007-9#1)(2008-10#3)(2008-11#5)(2008-2#1)(2008-3#8)(2008-5#2)(2008-7#1)(2009-12#1)(2009-5#1)(2009-8#2)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#3)
perturber##4##1##(1993-3#3)(2008-10#1)
perturbing effects##2##2##(1994-1#1)(2008-11#1)
perturbing the##4##2##(1994-6#1)(2007-11#1)(2008-11#1)(2012-1#1)
perturbing##16##1##(1993-2#1)(1994-1#1)(1994-6#1)(1994-9#2)(1996-2#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-11#2)(2012-1#1)(2012-2#2)
perturbs the##9##2##(1990-4#1)(1990-8#1)(1993-8#1)(1995-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-10#1)(2010-12#1)
perturbs##15##1##(1990-4#1)(1990-8#1)(1991-11#1)(1992-6#1)(1993-8#1)(1995-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(2008-10#1)(2008-12#1)(2008-2#1)(2009-3#1)(2010-12#1)
pertusa##2##1##(2007-8#1)(2008-10#1)
pertussis and pertussis##2##3##(1994-11#1)(2010-12#1)
pertussis and##8##2##(1990-9#1)(1994-11#1)(2005-11#1)(2007-2#1)(2009-6#1)(2010-12#2)(2010-9#1)
pertussis antigens##3##2##(1992-2#2)(2007-11#1)
pertussis immunization##2##2##(1993-3#1)(2010-12#1)
pertussis toxin (PTX)##3##3##(1991-3#1)(2008-4#2)
pertussis toxin (PTX)-sensitive##3##3##(1990-7#1)(1994-11#1)(1995-3#1)
pertussis toxin and the##2##4##(1996-5#1)(1997-8#1)
pertussis toxin and##4##3##(1990-8#1)(1993-8#1)(1996-5#1)(1997-8#1)
pertussis toxin but##2##3##(1993-8#1)(1994-2#1)
pertussis toxin did not##2##4##(1991-12#1)(1992-3#1)
pertussis toxin insensitive##2##3##(1993-9#1)(1997-7#1)
pertussis toxin pretreatment##2##3##(1993-11#1)(1997-2#1)
pertussis toxin sensitive##2##3##(1993-9#1)(1994-12#1)
pertussis toxin substrates##3##3##(1990-3#1)(1991-9#1)(1992-9#1)
pertussis toxin treatment##4##3##(1991-8#1)(1993-11#1)(1994-5#1)(1994-9#1)
pertussis toxin##65##2##(1990-11#1)(1990-3#4)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-1#2)(1991-12#3)(1991-3#2)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#2)(1993-11#2)(1993-8#3)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-9#1)(1995-10#1)(1995-3#2)(1995-6#1)(1995-7#1)(1996-10#1)(1996-2#1)(1996-5#2)(1996-8#1)(1997-1#3)(1997-2#1)(1997-7#2)(1997-8#1)(2008-4#4)
pertussis toxin-catalyzed ADP-ribosylation of a##2##5##(1990-9#1)(1992-9#1)
pertussis toxin-catalyzed ADP-ribosylation of##3##4##(1990-9#1)(1992-9#2)
pertussis toxin-insensitive##3##2##(1994-3#1)(1995-2#1)(2008-4#1)
pertussis toxin-sensitive G protein##3##4##(1995-2#1)(1997-1#2)
pertussis toxin-sensitive G##4##3##(1995-11#1)(1995-2#1)(1997-1#2)
pertussis toxin-sensitive G-protein##3##3##(1990-12#1)(1991-7#1)(1996-8#1)
pertussis toxin-sensitive GTP-binding protein##3##4##(1990-9#2)(1996-5#1)
pertussis toxin-sensitive GTP-binding##4##3##(1990-7#1)(1990-9#2)(1996-5#1)
pertussis toxin-sensitive##17##2##(1990-12#1)(1990-3#1)(1990-7#2)(1990-9#2)(1991-7#1)(1992-11#2)(1993-11#1)(1995-11#1)(1995-2#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#1)
pertussis toxin-treated##2##2##(1991-12#1)(1994-9#1)
pertussis toxoid##3##2##(1995-5#1)(2007-11#2)
pertussis vaccination##2##2##(1995-5#1)(1997-8#1)
pertussis vaccine##10##2##(1992-2#1)(1993-6#2)(1995-3#1)(1995-5#2)(2007-11#1)(2007-12#1)(2013-1#2)
pertussis vaccines are##5##3##(2007-11#5)
pertussis vaccines with##2##3##(1995-5#1)(1997-8#1)
pertussis vaccines##18##2##(1995-5#4)(1997-8#2)(2007-11#12)
pertussis##191##1##(1990-11#1)(1990-12#1)(1990-3#5)(1990-6#3)(1990-7#5)(1990-8#1)(1990-9#6)(1991-1#2)(1991-12#4)(1991-2#2)(1991-3#2)(1991-5#1)(1991-7#5)(1991-8#1)(1991-9#1)(1992-11#4)(1992-2#7)(1992-3#3)(1992-5#3)(1992-6#1)(1992-9#4)(1993-11#3)(1993-3#1)(1993-6#2)(1993-8#3)(1993-9#2)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#1)(1994-9#3)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#5)(1995-5#11)(1995-6#1)(1995-7#1)(1995-8#2)(1996-10#1)(1996-2#4)(1996-5#3)(1996-8#2)(1997-1#5)(1997-2#2)(1997-7#2)(1997-8#4)(2005-11#1)(2005-7#1)(2007-11#18)(2007-12#3)(2007-2#6)(2008-12#1)(2008-4#6)(2008-7#2)(2009-5#1)(2009-6#1)(2010-12#10)(2010-9#1)(2011-2#2)(2013-1#5)
peru##6##1##(2007-3#4)(2008-3#2)
perutilis##5##1##(2013-7#5)
peruvian##2##1##(2011-2#1)(2013-1#1)
peruviana##4##1##(2012-2#1)(2013-1#3)
peruvianum##2##1##(2005-10#2)
peruvianus##5##1##(2007-12#3)(2008-10#1)(2012-2#1)
pervades##2##1##(2009-4#1)(2012-3#1)
pervanadate##3##1##(1997-6#3)
pervaporation and##2##2##(2008-10#2)
pervaporation flow injection##2##3##(2008-10#2)
pervaporation##8##1##(2008-10#8)
pervasive and##6##2##(2005-7#1)(2006-10#1)(2007-12#1)(2008-5#1)(2010-4#1)(2013-1#1)
pervasive developmental disorders##2##3##(2010-12#1)(2012-12#1)
pervasive developmental##5##2##(2008-1#1)(2010-12#1)(2012-12#1)(2012-2#2)
pervasive in##2##2##(2007-3#1)(2008-8#1)
pervasive throughout##2##2##(2004-10#1)(2013-8#1)
pervasive##39##1##(1995-2#1)(2004-10#1)(2005-7#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
pervasiveness##4##1##(1994-2#1)(1995-3#1)(2007-10#1)(2009-10#1)
perverse##2##1##(2008-7#1)(2010-1#1)
perversum##2##1##(2013-7#2)
perylene##5##1##(2006-10#2)(2008-10#2)(2009-2#1)
pes cavus##2##2##(2008-7#1)(2010-3#1)
pes planovalgus deformity##3##3##(2009-10#3)
pes##6##1##(2008-7#2)(2009-10#3)(2010-3#1)
pessary##3##1##(2006-10#1)(2006-4#1)(2007-8#1)
pessimism##2##1##(2009-3#1)(2012-2#1)
pessimistic##9##1##(1993-5#1)(2006-4#1)(2007-7#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-11#1)(2013-8#2)
pest abundance##2##2##(2008-10#1)(2013-8#1)
pest and disease##2##3##(2008-10#1)(2008-9#1)
pest control in agriculture##2##4##(2006-12#2)
pest control in##3##3##(2006-12#3)
pest control##12##2##(1997-7#1)(2004-11#2)(2006-12#3)(2007-3#1)(2008-11#2)(2009-3#1)(2011-1#1)(2011-12#1)
pest densities##2##2##(2007-6#1)(2008-10#1)
pest density##2##2##(2008-10#1)(2013-8#1)
pest in North America##2##4##(2008-10#1)(2011-2#1)
pest in the##3##3##(2008-10#2)(2008-6#1)
pest in##8##2##(2008-10#3)(2008-6#1)(2011-12#1)(2011-2#3)
pest insect populations##3##3##(2011-2#1)(2012-12#2)
pest management and##2##3##(2008-10#1)(2011-1#1)
pest management in##2##3##(2004-2#1)(2008-10#1)
pest management is##2##3##(2008-10#2)
pest management strategies##4##3##(2008-10#2)(2008-9#1)(2011-2#1)
pest management##36##2##(1997-7#1)(2004-2#1)(2008-10#25)(2008-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2013-7#1)(2013-8#3)
pest of rice##3##3##(2007-6#1)(2013-8#2)
pest of##12##2##(2004-11#1)(2007-6#1)(2008-10#1)(2008-6#2)(2011-12#3)(2011-2#1)(2013-7#1)(2013-8#2)
pest population##7##2##(2004-11#1)(2008-6#1)(2013-8#5)
pest resistance##2##2##(1991-4#1)(2011-2#1)
pest risk##2##2##(2008-10#1)(2012-2#1)
pest should be##2##3##(2008-8#1)(2013-8#1)
pest species##2##2##(2008-10#1)(2008-5#1)
pest##127##1##(1991-4#1)(1997-7#2)(2004-11#5)(2004-2#2)(2006-10#1)(2006-12#3)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#3)(2008-10#46)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#4)(2008-8#4)(2008-9#2)(2009-3#1)(2009-8#1)(2011-1#2)(2011-12#10)(2011-2#14)(2012-12#2)(2012-2#1)(2013-7#2)(2013-8#14)
pesticide and##3##2##(2008-10#2)(2011-2#1)
pesticide are##3##2##(2008-10#3)
pesticide commonly used##3##3##(2008-10#1)(2009-6#1)(2012-2#1)
pesticide dose##3##2##(2008-10#2)(2011-2#1)
pesticide exposure and##2##3##(2005-10#1)(2008-10#1)
pesticide exposure##7##2##(2005-10#1)(2005-11#3)(2008-10#3)
pesticide formulations##7##2##(2008-10#7)
pesticide in##3##2##(2008-10#2)(2013-1#1)
pesticide is##2##2##(2008-10#2)
pesticide legislation##2##2##(1996-3#2)
pesticide mixtures##4##2##(1996-4#2)(2008-8#2)
pesticide rates##2##2##(2011-2#2)
pesticide residue analysis##2##3##(2008-10#1)(2011-1#1)
pesticide residue##4##2##(2005-11#2)(2008-10#1)(2011-1#1)
pesticide residues and PCBs##4##4##(1993-9#4)
pesticide residues in stored pollen##2##5##(2011-2#2)
pesticide residues in vegetables by##2##5##(2008-10#1)(2012-12#1)
pesticide residues in##16##3##(2008-10#4)(2008-11#1)(2011-1#3)(2011-2#2)(2012-12#2)(2013-8#4)
pesticide residues were##2##3##(2008-10#1)(2013-8#1)
pesticide residues##25##2##(1993-9#4)(2008-10#7)(2008-11#1)(2011-1#3)(2011-2#3)(2012-12#2)(2013-8#5)
pesticide resistance##3##2##(1995-6#1)(2008-10#1)(2011-2#1)
pesticide use##6##2##(2005-11#2)(2008-10#2)(2008-12#1)(2009-4#1)
pesticide was found to be##2##5##(2006-2#1)(2007-8#1)
pesticide was##3##2##(2006-2#1)(2007-8#1)(2008-10#1)
pesticide##164##1##(1990-9#1)(1991-3#1)(1993-9#4)(1995-6#1)(1996-3#3)(1996-4#2)(1997-3#3)(2005-10#1)(2005-11#7)(2005-3#1)(2005-7#1)(2005-8#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#7)(2008-10#74)(2008-11#3)(2008-12#3)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-4#2)(2009-6#1)(2010-5#1)(2011-1#5)(2011-2#11)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#5)
pesticide)##3##1##(2007-8#1)(2008-10#1)(2008-6#1)
pesticide-treated##2##1##(2007-10#1)(2008-10#1)
pesticides (4)##2##2##(1990-9#2)
pesticides (OPPs) in##2##3##(2008-10#2)
pesticides (OPPs)##3##2##(2008-10#3)
pesticides and PCBs##2##3##(1993-9#1)(2008-8#1)
pesticides and alkylphenols in##3##4##(2008-10#3)
pesticides and other##2##3##(1994-3#1)(2010-4#1)
pesticides and their##3##3##(2008-10#2)(2008-8#1)
pesticides and##28##2##(1991-7#1)(1993-9#1)(1994-3#1)(1997-2#1)(2004-4#1)(2005-11#1)(2007-5#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-8#3)(2010-4#2)(2010-5#2)(2010-7#1)
pesticides are##8##2##(2004-2#1)(2008-10#3)(2008-11#1)(2008-7#1)(2013-1#2)
pesticides at##4##2##(1996-4#1)(2008-10#3)
pesticides from the##3##3##(2008-10#2)(2011-2#1)
pesticides from##12##2##(1991-8#1)(2007-7#1)(2007-8#1)(2008-10#7)(2011-1#1)(2011-2#1)
pesticides has##2##2##(2008-10#1)(2013-1#1)
pesticides have been##2##3##(1990-9#1)(2008-10#1)
pesticides in soil##3##3##(1990-9#1)(2007-8#1)(2008-10#1)
pesticides in the##8##3##(2007-10#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-6#1)(2010-5#1)(2011-2#1)
pesticides in vegetables##3##3##(2008-10#2)(2012-12#1)
pesticides in water##8##3##(1991-8#1)(2008-10#7)
pesticides in##46##2##(1990-9#2)(1991-8#1)(2005-11#3)(2007-10#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#24)(2008-11#2)(2008-6#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
pesticides into the##2##3##(2007-3#1)(2007-5#1)
pesticides is##4##2##(2007-10#1)(2008-10#2)(2011-1#1)
pesticides may be##2##3##(2007-5#1)(2008-12#1)
pesticides may##4##2##(2007-5#1)(2008-10#1)(2008-12#1)(2010-5#1)
pesticides on##3##2##(2007-12#1)(2008-12#1)(2011-2#1)
pesticides such as##3##3##(2008-10#3)
pesticides using##4##2##(2008-10#3)(2012-2#1)
pesticides was##7##2##(2004-4#1)(2008-10#4)(2008-11#1)(2010-2#1)
pesticides were detected##2##3##(2007-5#1)(2013-8#1)
pesticides were##16##2##(1991-6#1)(2006-2#1)(2007-5#1)(2007-8#1)(2008-10#10)(2008-11#1)(2013-8#1)
pesticides with the##2##3##(2013-8#2)
pesticides with##5##2##(1997-8#1)(2007-8#1)(2008-10#1)(2013-8#2)
pesticides##254##1##(1990-9#8)(1991-6#3)(1991-7#2)(1991-8#3)(1992-2#1)(1993-9#1)(1994-3#2)(1996-4#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-2#1)(2004-4#3)(2005-11#5)(2006-2#1)(2007-10#3)(2007-12#1)(2007-3#2)(2007-5#7)(2007-7#3)(2007-8#10)(2007-9#1)(2008-10#118)(2008-11#13)(2008-12#4)(2008-6#4)(2008-7#1)(2008-8#6)(2008-9#1)(2009-8#1)(2010-1#1)(2010-2#2)(2010-4#2)(2010-5#6)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#11)(2013-8#4)
pesticides]##2##1##(1996-4#1)(2010-12#1)
pestis and##2##2##(2008-4#1)(2013-1#1)
pestis by##2##2##(2004-11#1)(2005-11#1)
pestis per flea)##2##3##(2004-11#2)
pestis phages##2##2##(2013-1#2)
pestis strains##2##2##(2013-1#2)
pestis##22##1##(2004-11#6)(2005-11#2)(2007-2#1)(2008-10#1)(2008-4#1)(2012-2#1)(2013-1#10)
pestivirus-infected heifers##2##2##(2006-5#2)
pestivirus-infected##3##1##(2006-5#3)
pestiviruses##2##1##(2005-7#1)(2012-3#1)
pests and can##2##3##(2008-10#2)
pests and diseases##4##3##(2006-11#1)(2011-2#3)
pests and pathogens##2##3##(1994-2#1)(2008-10#1)
pests and##11##2##(1994-2#1)(1994-3#1)(2006-11#1)(2008-10#4)(2011-2#3)(2013-8#1)
pests by##2##2##(2008-10#2)
pests for##2##2##(2008-10#2)
pests in##6##2##(2008-10#2)(2008-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
pests is##4##2##(2008-10#2)(2008-9#1)(2011-2#1)
pests of soybean (Glycine max (L##2##6##(2012-11#2)
pests of##6##2##(2008-10#1)(2011-2#3)(2012-11#2)
pests on##3##2##(2007-6#1)(2008-10#2)
pests such as##3##3##(1995-6#1)(2006-12#1)(2008-10#1)
pests##88##1##(1990-6#1)(1992-12#1)(1993-7#1)(1994-2#1)(1994-3#1)(1995-6#1)(1997-4#1)(2004-11#1)(2006-11#1)(2006-12#4)(2007-6#1)(2008-10#31)(2008-5#9)(2008-6#1)(2008-8#3)(2008-9#1)(2009-8#2)(2010-1#1)(2010-10#1)(2011-12#1)(2011-2#12)(2012-11#2)(2012-2#1)(2013-8#9)
pet dogs##5##2##(2008-8#3)(2013-1#2)
pet food##6##2##(2007-4#1)(2010-4#5)
pet foods##2##2##(2010-2#2)
pet rabbits##2##2##(1995-9#2)
pet##32##1##(1992-2#1)(1993-2#1)(1995-11#1)(1995-9#2)(2006-10#1)(2007-4#2)(2008-8#3)(2010-2#4)(2010-4#5)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
petB##2##1##(1994-12#2)
petH gene##2##2##(1992-3#2)
petH##3##1##(1992-3#3)
petal expansion##4##2##(2008-10#4)
petal fall##6##2##(2008-10#6)
petal line##2##2##(2006-12#2)
petal senescence##2##2##(2006-12#2)
petal size##2##2##(2008-8#2)
petal##19##1##(2006-12#7)(2008-10#10)(2008-8#2)
petals of Clitoria##2##3##(2006-12#2)
petals of##6##2##(2006-12#3)(2008-10#2)(2010-3#1)
petals##25##1##(2006-12#9)(2007-11#2)(2008-10#11)(2008-12#1)(2008-4#1)(2010-3#1)
petasin and##2##2##(2007-1#2)
petasin##4##1##(2007-1#4)
petaurista##3##1##(2008-5#3)
petchii##2##1##(2012-11#2)
pete1 and##2##2##(2009-10#2)
pete1##4##1##(2009-10#4)
pete2 double##2##2##(2009-10#2)
pete2##4##1##(2009-10#4)
petechiae##5##1##(1995-11#2)(2006-8#1)(2010-9#1)(2013-8#1)
petechial haemorrhages##2##2##(1992-5#1)(2005-7#1)
petechial rashes##2##2##(2008-12#1)(2012-2#1)
petechial##7##1##(1992-5#1)(2005-7#1)(2007-2#1)(2008-12#1)(2010-8#1)(2012-2#2)
pethidine 1##2##2##(1993-7#2)
pethidine and##3##2##(1993-7#1)(2008-10#1)(2010-7#1)
pethidine concentrations##2##2##(1993-7#2)
pethidine for##2##2##(2010-4#1)(2010-7#1)
pethidine in fetal##2##3##(1993-7#2)
pethidine##23##1##(1993-7#9)(1997-5#1)(2006-7#1)(2007-2#1)(2008-10#3)(2008-7#1)(2009-5#1)(2010-4#1)(2010-7#4)(2012-12#1)
petiolaris##3##1##(2008-8#1)(2011-12#2)
petiole debris##2##2##(2008-10#2)
petiole##9##1##(2008-10#9)
petioles and##3##2##(2008-10#3)
petioles of inoculated leaves##3##4##(2008-10#3)
petioles of##6##2##(2008-10#6)
petioles##16##1##(2008-10#15)(2010-12#1)
petite mutant##2##2##(1995-6#1)(1996-7#1)
petite mutants of yeast##4##4##(1996-7#4)
petite mutants of##5##3##(1996-7#5)
petite mutants##6##2##(1996-7#6)
petite##11##1##(1995-6#1)(1996-7#10)
petition##8##1##(1990-11#1)(1991-7#1)(1993-9#1)(1995-6#1)(2006-11#1)(2009-8#3)
petits##3##1##(2008-11#1)(2011-2#2)
petrakii##2##1##(2008-10#2)
petri dish experiments##2##3##(2011-12#2)
petri dish##6##2##(2008-10#2)(2008-6#1)(2011-12#2)(2011-2#1)
petri dishes with##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
petri dishes##10##2##(1992-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)
petri plates containing a selective medium##3##6##(2008-10#3)
petri plates##5##2##(2008-10#5)
petri##22##1##(1992-8#1)(2007-11#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2011-12#2)(2011-2#1)
petro-mastoid##2##1##(2009-10#2)
petrochemical industries##2##2##(1991-12#1)(1993-9#1)
petrochemical##8##1##(1991-12#1)(1993-9#1)(2008-10#4)(2008-7#1)(2010-12#1)
petrochemicals##3##1##(2006-10#1)(2008-5#2)
petroclival dura mater##2##3##(2006-12#2)
petroclival meningioma##3##2##(2006-12#3)
petroclival##14##1##(2005-5#1)(2006-12#11)(2008-7#2)
petrodiesel##2##1##(2009-3#1)(2010-5#1)
petrol station workers##2##3##(2009-6#2)
petrol station##3##2##(2007-8#1)(2009-6#2)
petrol##16##1##(1990-9#1)(1996-3#2)(1997-6#1)(2006-5#3)(2007-8#1)(2008-10#3)(2008-3#1)(2009-6#4)
petrolatum##13##1##(2005-11#1)(2008-5#10)(2012-3#2)
petroleum ether and##2##3##(2008-8#1)(2010-12#1)
petroleum ether portion##2##3##(2011-1#1)(2013-8#1)
petroleum ether##13##2##(1991-12#1)(2005-11#1)(2005-12#1)(2008-12#3)(2008-8#2)(2010-12#1)(2010-5#1)(2011-1#1)(2013-8#2)
petroleum from##2##2##(2007-7#2)
petroleum gas (LPG)##2##3##(2008-10#1)(2013-7#1)
petroleum gas##4##2##(2008-10#2)(2013-7#2)
petroleum hydrocarbons##6##2##(2004-4#1)(2006-12#2)(2007-5#1)(2008-11#1)(2008-6#1)
petroleum liquid##2##2##(2007-10#2)
petroleum products##8##2##(1992-10#1)(1995-5#2)(2006-10#1)(2006-5#1)(2008-10#3)
petroleum reservoirs##2##2##(2005-11#1)(2013-1#1)
petroleum sulfoxide##2##2##(2005-4#2)
petroleum##79##1##(1991-12#1)(1992-10#1)(1992-3#1)(1995-5#2)(2004-4#4)(2005-11#2)(2005-12#1)(2005-4#2)(2006-10#1)(2006-12#2)(2006-5#2)(2007-1#1)(2007-10#2)(2007-5#2)(2007-7#4)(2007-9#2)(2008-10#15)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#1)(2010-12#1)(2010-5#1)(2011-1#4)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#3)(2013-8#2)
petroporphyrins##3##1##(2008-6#3)
petrosal##7##1##(1991-11#1)(1995-12#2)(1997-1#1)(2006-12#3)
petrosectomy##2##1##(2006-12#1)(2008-7#1)
petrous ICA##2##2##(2005-9#2)
petrous apex cholesteatoma##7##3##(2011-2#7)
petrous apex##17##2##(2006-12#5)(2008-7#1)(2009-5#1)(2010-3#1)(2011-2#9)
petrous bone cholesteatoma##4##3##(2011-2#4)
petrous bone##10##2##(2005-5#1)(2008-7#3)(2008-8#1)(2011-2#5)
petrous erosion##2##2##(2006-12#2)
petrous temporal bone##2##3##(2011-2#2)
petrous##44##1##(2005-5#1)(2005-9#3)(2006-12#12)(2008-7#5)(2008-8#1)(2009-10#1)(2009-5#1)(2010-3#2)(2011-2#17)(2012-12#1)
pets##13##1##(1993-6#3)(1995-11#4)(2006-10#1)(2007-2#1)(2008-5#2)(2010-2#1)(2010-4#1)
petty corruption##3##2##(2012-3#3)
petty##4##1##(2005-9#1)(2012-3#3)
petunia##7##1##(1993-6#3)(1995-8#2)(2008-10#2)
peu##3##1##(2008-5#1)(2012-2#2)
peut être##3##2##(2012-2#2)(2013-1#1)
peut##9##1##(2008-5#3)(2012-2#3)(2013-1#3)
peuvent##2##1##(2008-5#1)(2011-2#1)
pf torque##2##2##(1993-12#2)
pfcrt T76 and pfmdr1 Y86##2##5##(2005-8#2)
pfht##3##1##(2010-2#3)
pfu and##2##2##(2008-9#2)
pfu##10##1##(2008-11#2)(2008-9#8)
pfu/cm(2))##2##1##(2012-2#2)
pfu/ml##5##1##(1995-7#4)(1997-1#1)
pg (R##2##2##(2008-10#2)
pg (n=20##2##2##(2008-10#2)
pg (recommended of 20 pg)##2##5##(2008-10#2)
pg (recommended of##4##3##(2008-10#4)
pg (recommended##6##2##(2008-10#6)
pg As ml(-1)##2##3##(2008-10#2)
pg Hg/ml##3##2##(2008-10#3)
pg and 0##2##3##(2008-10#2)
pg and the detection limit##2##5##(1997-3#1)(2008-10#1)
pg and the##4##3##(1997-3#1)(2008-10#3)
pg and##16##2##(1990-8#1)(1997-3#1)(2005-4#1)(2007-8#1)(2008-10#8)(2008-6#4)
pg cell(-1 )h(-1))##2##3##(2008-11#2)
pg cell(-1) h(-1)##2##3##(2008-11#2)
pg for the##2##3##(1997-3#1)(2008-10#1)
pg for##14##2##(1997-3#2)(2005-4#1)(2008-10#7)(2008-6#4)
pg in the##2##3##(1992-11#1)(1995-8#1)
pg in##3##2##(1992-11#1)(1995-5#1)(1995-8#1)
pg mL(-1)##2##2##(2011-3#2)
pg ml(-1) for##2##3##(2008-10#2)
pg ml(-1)##14##2##(2008-10#14)
pg of 1##2##3##(1992-5#2)
pg of DNA##2##3##(2008-10#2)
pg of bismuth##2##3##(2008-10#2)
pg of each##2##3##(1990-11#1)(1994-9#1)
pg of the##3##3##(1994-9#1)(1997-4#1)(2008-10#1)
pg of##26##2##(1990-11#1)(1991-8#1)(1992-11#1)(1992-5#2)(1993-5#1)(1994-9#2)(1996-7#1)(1996-8#1)(1997-4#1)(2008-10#12)(2008-5#3)
pg per##2##2##(1990-8#1)(2008-10#1)
pg x mL(-1) for##2##4##(2011-3#2)
pg x##3##2##(1991-10#1)(2011-3#2)
pg##134##1##(1990-11#1)(1990-2#1)(1990-4#1)(1990-8#4)(1991-10#1)(1991-8#1)(1992-11#2)(1992-5#2)(1993-5#1)(1994-2#1)(1994-9#2)(1995-5#1)(1995-8#1)(1996-12#2)(1996-3#1)(1996-6#1)(1996-7#3)(1996-8#1)(1997-3#3)(1997-4#1)(1997-8#1)(2005-4#2)(2007-6#1)(2007-8#2)(2008-10#75)(2008-11#6)(2008-5#3)(2008-6#8)(2009-12#1)(2011-3#4)
pg) and##2##2##(1997-2#1)(2008-10#1)
pg)##15##1##(1990-8#1)(1997-2#1)(2008-10#12)(2008-7#1)
pg/10(5)##2##1##(1990-4#1)(1994-5#1)
pg/5 microliters##2##2##(1992-1#2)
pg/5##3##1##(1990-4#1)(1992-1#2)
pg/assay##2##1##(1993-11#2)
pg/assay) and linearity was obtained between 0##2##7##(1996-1#2)
pg/assay)##4##1##(1996-1#4)
pg/l##2##1##(2006-12#1)(2008-2#1)
pg/mL and##3##2##(2011-1#3)
pg/mL or over##2##3##(2012-2#2)
pg/mL##14##1##(2007-8#2)(2008-3#3)(2010-5#1)(2011-1#6)(2012-2#2)
pg/mL)##3##1##(2006-8#1)(2012-2#2)
pg/mg creatinine##4##2##(1990-3#1)(1993-2#2)(2007-8#1)
pg/mg creatinine)##2##2##(1990-3#2)
pg/mg##12##1##(1990-3#3)(1990-7#1)(1991-9#1)(1993-2#2)(1996-11#1)(2007-8#2)(2010-4#2)
pg/microU)##3##1##(1992-7#3)
pg/min (delta =##2##3##(1997-8#2)
pg/min##5##1##(1997-8#5)
pg/ml (mean +/-##2##3##(1990-5#1)(1993-2#1)
pg/ml (p&lt##2##2##(2007-8#2)
pg/ml and 10##2##3##(1996-9#1)(2008-8#1)
pg/ml and the mean##2##4##(1990-11#1)(2007-7#1)
pg/ml and##9##2##(1990-11#1)(1992-7#1)(1996-9#1)(2006-6#1)(2007-7#1)(2008-8#2)(2011-11#2)
pg/ml for IL-6 and IL-8 respectively##2##6##(2008-8#2)
pg/ml for patients with one metastatic site##2##7##(2008-8#2)
pg/ml for patients with##3##4##(2008-8#3)
pg/ml for##12##2##(1991-2#1)(1992-9#2)(1996-9#1)(2008-3#1)(2008-5#2)(2008-8#5)
pg/ml in##8##2##(1990-5#2)(1991-2#3)(1994-7#2)(2007-6#1)
pg/ml respectively##2##2##(2011-11#2)
pg/ml##85##1##(1990-11#1)(1990-2#1)(1990-5#3)(1991-10#1)(1991-2#6)(1992-7#3)(1992-9#4)(1993-2#1)(1994-3#2)(1994-7#8)(1994-9#2)(1995-8#5)(1996-5#1)(1996-8#2)(1996-9#2)(1997-3#1)(1997-7#1)(2005-12#2)(2006-6#3)(2007-6#1)(2007-7#1)(2007-8#2)(2008-3#9)(2008-4#1)(2008-5#4)(2008-8#8)(2010-10#2)(2011-11#4)(2011-2#4)
pg/ml) and##7##2##(1991-3#1)(1992-7#1)(1995-6#1)(2008-8#3)(2011-2#1)
pg/ml) for patients and controls respectively and this difference was##2##10##(2008-8#2)
pg/ml) for##3##2##(1992-4#1)(2008-8#2)
pg/ml) versus##2##2##(2008-8#2)
pg/ml)##31##1##(1991-10#1)(1991-3#2)(1991-9#2)(1992-4#1)(1992-7#2)(1994-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-5#1)(1996-8#2)(2006-7#2)(2008-3#3)(2008-8#8)(2011-11#1)(2011-2#2)
pg/mm(2)##2##1##(2008-2#2)
pg/mu##2##1##(1993-9#1)(1995-12#1)
pg/mul##3##1##(2008-10#3)
pg/tube##3##1##(1990-7#2)(1991-9#1)
pg/well##2##1##(1991-2#2)
pgEI##2##1##(2005-11#2)
pgi and##2##2##(2008-10#2)
pgi##4##1##(2008-10#4)
pgsA##2##1##(1995-1#2)
pgsA3##3##1##(1993-8#3)
ph##2##1##(2010-11#1)(2011-12#1)
phBglII400##2##1##(2008-5#2)
pha genes##4##2##(2008-6#4)
pha##5##1##(1992-12#1)(2008-6#4)
phaA##2##1##(2008-6#2)
phaB##2##1##(2008-6#2)
phacoemulsification in##2##2##(2007-1#1)(2010-10#1)
phacoemulsification##8##1##(2007-1#3)(2009-8#1)(2010-10#1)(2011-2#1)(2013-1#1)(2013-7#1)
phacopids##2##1##(2007-12#2)
phacorrhiza##4##1##(2008-10#4)
phaeochromocytoma##3##1##(2011-2#1)(2013-7#2)
phaeohyphomycosis caused by##2##3##(2007-2#1)(2008-10#1)
phaeohyphomycosis due to##2##3##(2007-7#1)(2008-10#1)
phaeohyphomycosis##6##1##(2007-2#1)(2007-7#1)(2008-10#2)(2008-5#2)
phage Cp-1##2##2##(1990-1#1)(1990-9#1)
phage DNA##9##2##(1990-12#1)(1990-9#1)(1991-9#3)(1992-3#1)(1995-8#1)(1996-8#1)(1997-5#1)
phage DNAs##2##2##(1993-11#1)(1994-8#1)
phage M13##3##2##(1994-12#1)(1995-2#2)
phage P22##3##2##(1990-1#1)(1990-3#2)
phage T4 and##2##3##(1990-10#1)(1990-12#1)
phage T4 morphogenetic##2##3##(1990-1#2)
phage T4##8##2##(1990-1#2)(1990-10#2)(1990-12#1)(1995-12#1)(1997-3#1)(2008-10#1)
phage T7##4##2##(1992-2#1)(1993-3#1)(1994-7#1)(1995-2#1)
phage active##2##2##(2007-12#1)(2013-8#1)
phage and##8##2##(1993-8#1)(1995-7#1)(1996-10#1)(2008-11#1)(2008-4#1)(2012-1#1)(2013-1#2)
phage antibodies##4##2##(2008-10#2)(2008-4#1)(2010-12#1)
phage application##2##2##(2012-2#2)
phage assay is##2##3##(2007-7#1)(2011-12#1)
phage assay##4##2##(2007-7#3)(2011-12#1)
phage assembly##2##2##(1995-11#1)(2011-12#1)
phage att##2##2##(1990-9#1)(1994-12#1)
phage attachment site##2##3##(1996-12#1)(2007-12#1)
phage attachment##3##2##(1996-12#1)(1997-1#1)(2007-12#1)
phage biology##2##2##(2008-4#1)(2013-1#1)
phage can##2##2##(2013-1#2)
phage capture##2##2##(1994-12#2)
phage clone containing a##2##4##(1994-8#1)(1997-2#1)
phage clone##5##2##(1991-9#1)(1994-5#1)(1994-8#1)(1997-2#1)(2008-10#1)
phage clones##6##2##(1994-9#1)(1995-5#1)(1996-10#1)(2005-11#1)(2007-3#1)(2012-2#1)
phage concentrations##3##2##(2012-2#2)(2013-1#1)
phage containing##3##2##(1993-11#1)(1993-8#1)(1997-5#1)
phage display antibody##2##3##(2008-10#1)(2008-8#1)
phage display libraries are##2##4##(2008-10#1)(2008-4#1)
phage display libraries##10##3##(2006-10#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-7#1)(2008-9#1)(2010-12#1)
phage display library##7##3##(1994-9#3)(2008-10#2)(2008-7#1)(2012-2#1)
phage display method##3##3##(2008-11#2)(2010-12#1)
phage display peptide##2##3##(2008-10#1)(2008-4#1)
phage display system##3##3##(1994-12#1)(1995-11#1)(2008-10#1)
phage display technique##2##3##(2008-10#1)(2008-8#1)
phage display technology##2##3##(2008-8#1)(2009-5#1)
phage display##52##2##(1993-8#1)(1994-12#2)(1994-9#3)(1995-11#2)(1995-2#2)(1996-10#3)(1997-4#1)(2006-10#2)(2008-10#9)(2008-11#4)(2008-4#6)(2008-7#5)(2008-8#3)(2008-9#1)(2009-5#1)(2009-6#1)(2010-12#3)(2012-2#2)(2013-8#1)
phage displayed##6##2##(2008-10#3)(2008-8#2)(2013-8#1)
phage for##2##2##(2008-4#1)(2011-12#1)
phage gene##2##2##(1994-9#1)(1995-2#1)
phage genes##2##2##(1991-8#1)(1996-6#1)
phage genome was##2##3##(2007-12#2)
phage genome##7##2##(1990-8#1)(1990-9#1)(1991-8#1)(1995-2#1)(1997-1#1)(2007-12#2)
phage genomes and##2##3##(1990-5#1)(2013-1#1)
phage genomes##7##2##(1990-5#1)(2012-2#1)(2013-1#5)
phage genomic##2##2##(1993-12#1)(2013-1#1)
phage growth using the OmniLog(TM) system##2##6##(2013-1#2)
phage growth##3##2##(2013-1#3)
phage in##4##2##(1990-9#1)(1991-8#1)(2011-1#1)(2013-1#1)
phage inactivation##2##2##(1992-2#1)(2008-10#1)
phage infection##4##2##(1990-11#1)(2011-12#1)(2013-1#2)
phage is##3##2##(1992-2#1)(1994-3#1)(1997-1#1)
phage lambda DNA##6##3##(1990-11#2)(1995-2#2)(1995-3#1)(1997-4#1)
phage lambda##25##2##(1990-11#2)(1990-3#5)(1990-5#2)(1990-8#1)(1991-6#2)(1991-9#1)(1992-4#1)(1994-12#2)(1995-2#2)(1995-3#3)(1995-8#1)(1997-2#1)(1997-4#1)(2008-9#1)
phage libraries##5##2##(1991-6#1)(1995-11#1)(2005-7#1)(2008-7#1)(2009-2#1)
phage library was##3##3##(1992-11#1)(1994-12#1)(2007-2#1)
phage library##8##2##(1991-8#1)(1992-11#1)(1993-4#1)(1994-12#1)(2007-2#1)(2008-4#1)(2013-1#2)
phage life##2##2##(1991-10#1)(2006-5#1)
phage monolayer##2##2##(2009-5#2)
phage of##2##2##(1992-3#1)(1997-1#1)
phage on##2##2##(2007-12#1)(2013-1#1)
phage particles containing##2##3##(1993-4#2)
phage particles##7##2##(1992-2#1)(1993-4#3)(1994-12#1)(2006-10#1)(2012-2#1)
phage phi 29##4##3##(1990-11#2)(1990-3#1)(1990-9#1)
phage phi##5##2##(1990-10#1)(1990-11#2)(1990-3#1)(1990-9#1)
phage products##2##2##(2011-12#2)
phage propagation##2##2##(1996-10#1)(2013-1#1)
phage random##2##2##(1997-2#1)(2005-11#1)
phage resistance and##2##3##(2012-1#1)(2013-1#1)
phage resistance##3##2##(2012-1#1)(2013-1#2)
phage resistant bacteria##2##3##(2013-1#2)
phage scFv##3##2##(1993-8#1)(2008-10#2)
phage selection##2##2##(2008-4#1)(2008-7#1)
phage that##2##2##(1994-12#1)(2013-1#1)
phage therapy##9##2##(2008-4#2)(2012-2#6)(2013-1#1)
phage titer##2##2##(1997-1#1)(2008-4#1)
phage type##3##2##(1996-3#2)(2011-2#1)
phage typing##2##2##(2010-4#2)
phage use as##2##3##(2012-2#2)
phage vector##3##2##(1990-2#1)(1990-5#1)(1993-8#1)
phage was##2##2##(1991-8#1)(2011-12#1)
phage##400##1##(1990-1#5)(1990-10#3)(1990-11#6)(1990-12#2)(1990-2#1)(1990-3#11)(1990-5#8)(1990-7#1)(1990-8#2)(1990-9#12)(1991-10#2)(1991-6#3)(1991-8#7)(1991-9#6)(1992-11#1)(1992-2#7)(1992-3#2)(1992-4#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-4#4)(1993-8#5)(1993-9#1)(1994-12#16)(1994-2#1)(1994-3#3)(1994-5#4)(1994-7#1)(1994-8#2)(1994-9#6)(1995-1#1)(1995-11#4)(1995-12#2)(1995-2#14)(1995-3#4)(1995-5#2)(1995-7#1)(1995-8#5)(1996-10#6)(1996-12#1)(1996-3#2)(1996-6#1)(1996-8#1)(1997-1#14)(1997-2#3)(1997-3#2)(1997-4#3)(1997-5#4)(2005-11#4)(2005-7#1)(2006-10#3)(2006-5#1)(2007-12#7)(2007-2#2)(2007-3#1)(2007-7#4)(2008-1#1)(2008-10#29)(2008-11#5)(2008-4#17)(2008-7#9)(2008-8#7)(2008-9#4)(2009-2#3)(2009-5#3)(2009-6#1)(2010-12#4)(2010-4#3)(2011-1#1)(2011-12#19)(2011-2#1)(2012-1#2)(2012-2#24)(2013-1#43)(2013-8#3)
phage-IFN variants##2##2##(2008-8#2)
phage-IFN##4##1##(2008-8#4)
phage-bacterial interactions##2##2##(2013-1#2)
phage-based##2##1##(1997-4#1)(2013-1#1)
phage-derived##3##1##(2009-2#3)
phage-display##4##1##(1994-12#1)(1994-3#1)(2005-11#1)(2010-1#1)
phage-displayed peptide libraries##2##3##(1994-12#1)(1995-5#1)
phage-displayed peptide##3##2##(1994-12#1)(1994-9#1)(1995-5#1)
phage-displayed random peptide libraries##2##4##(1994-9#2)
phage-displayed##7##1##(1994-12#2)(1994-9#3)(1995-5#1)(2008-1#1)
phage-driven microbial loop in##2##4##(2011-1#2)
phage-host##2##1##(1997-1#1)(2013-1#1)
phage-like##2##1##(1990-11#1)(2006-5#1)
phagemid DNA##5##2##(1991-7#4)(1994-8#1)
phagemid and##2##2##(1994-8#1)(1997-4#1)
phagemid vector##2##2##(1997-6#1)(2008-8#1)
phagemid vectors##3##2##(1991-7#1)(1994-12#2)
phagemid##19##1##(1991-7#5)(1994-12#4)(1994-8#3)(1996-10#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#2)(2008-8#1)
phages and##4##2##(2011-12#1)(2012-1#1)(2013-1#2)
phages as##2##2##(1997-6#1)(2011-12#1)
phages can be##2##3##(2008-4#1)(2012-2#1)
phages have##2##2##(2008-4#2)
phages in##3##2##(1991-10#1)(1994-12#1)(2013-1#1)
phages or##2##2##(1990-11#1)(2013-1#1)
phages per millilitre##2##3##(2011-1#2)
phages to##3##2##(1994-12#1)(2012-2#2)
phages was##2##2##(1994-12#1)(2012-2#1)
phages were##7##2##(1991-12#1)(1994-12#1)(2008-4#1)(2012-2#2)(2013-1#2)
phages with##2##2##(1991-10#1)(1994-12#1)
phages##75##1##(1990-11#1)(1990-4#1)(1991-10#2)(1991-12#1)(1992-2#1)(1993-9#1)(1994-12#8)(1994-2#1)(1994-3#1)(1995-2#1)(1996-10#1)(1996-8#1)(1997-1#2)(1997-3#2)(1997-6#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-4#7)(2009-2#3)(2011-1#2)(2011-12#8)(2012-1#2)(2012-2#10)(2013-1#15)
phagocyte functions##2##2##(1994-3#1)(2008-9#1)
phagocyte##10##1##(1991-9#1)(1994-3#1)(1994-5#1)(1995-8#1)(1996-9#1)(2006-10#2)(2008-4#1)(2008-9#1)(2010-12#1)
phagocytes and##4##2##(1990-4#1)(1991-3#1)(1991-9#2)
phagocytes are##2##2##(1992-7#1)(1993-12#1)
phagocytes in##2##2##(1991-11#1)(1992-6#1)
phagocytes to##2##2##(2008-8#1)(2009-6#1)
phagocytes##40##1##(1990-4#1)(1991-11#2)(1991-3#1)(1991-8#2)(1991-9#3)(1992-6#2)(1992-7#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-3#2)(1994-5#2)(1994-8#1)(1995-8#1)(1996-11#1)(1996-9#2)(1997-7#1)(2006-10#4)(2007-11#3)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
phagocytic activity of##5##3##(1995-5#1)(2008-1#1)(2008-10#2)(2010-12#1)
phagocytic activity##8##2##(1994-3#1)(1995-5#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-12#1)
phagocytic and NK##2##3##(1991-8#2)
phagocytic and ependymal cells##2##4##(1991-5#2)
phagocytic and##7##2##(1991-5#2)(1991-8#2)(1995-12#1)(1995-5#1)(2010-2#1)
phagocytic capacity of the##2##4##(1995-5#2)
phagocytic capacity##6##2##(1994-6#1)(1995-5#4)(2008-4#1)
phagocytic cell##2##2##(1996-12#1)(2012-2#1)
phagocytic cells isolated from##3##4##(1997-3#3)
phagocytic cells##21##2##(1990-2#1)(1991-10#1)(1991-11#1)(1992-12#2)(1993-6#1)(1993-7#1)(1994-11#1)(1997-3#5)(1997-4#1)(2006-10#2)(2008-10#1)(2008-5#2)(2008-9#1)(2012-2#1)
phagocytic index of##2##3##(2009-6#2)
phagocytic index##3##2##(2009-6#2)(2012-2#1)
phagocytic response##2##2##(1995-6#2)
phagocytic system##8##2##(1990-12#1)(2007-11#3)(2007-2#2)(2008-10#2)
phagocytic##79##1##(1990-12#3)(1990-2#1)(1991-10#1)(1991-11#1)(1991-5#2)(1991-8#2)(1992-12#3)(1992-5#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-6#2)(1995-12#1)(1995-5#6)(1995-6#2)(1996-12#1)(1997-3#5)(1997-4#1)(2003-11#1)(2006-10#2)(2007-11#4)(2007-2#3)(2007-7#1)(2008-1#3)(2008-10#7)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-6#2)(2009-9#1)(2010-12#1)(2010-2#2)(2012-1#1)(2012-11#1)(2012-2#3)(2013-1#2)(2013-8#1)
phagocytized##3##1##(1994-6#1)(2006-8#1)(2008-8#1)
phagocytophilum is##3##2##(2008-12#1)(2008-9#2)
phagocytophilum##14##1##(2008-12#4)(2008-9#6)(2010-9#1)(2013-1#3)
phagocytose bacteria##2##2##(1991-10#2)
phagocytose##5##1##(1991-10#2)(1991-7#1)(1997-6#1)(2012-12#1)
phagocytosed by##3##2##(1995-5#1)(1995-9#1)(2012-2#1)
phagocytosed##5##1##(1994-3#1)(1995-5#1)(1995-9#1)(1996-5#1)(2012-2#1)
phagocytosis and the##2##3##(1994-3#1)(2008-4#1)
phagocytosis and##7##2##(1991-2#1)(1992-7#1)(1994-3#1)(2008-1#1)(2008-4#1)(2008-5#1)(2012-1#1)
phagocytosis by macrophages##2##3##(1990-4#1)(1993-4#1)
phagocytosis by rat##3##3##(2008-10#2)(2008-8#1)
phagocytosis by the hemocytes##2##4##(2008-6#2)
phagocytosis by the##4##3##(2008-10#2)(2008-6#2)
phagocytosis by##16##2##(1990-4#1)(1991-4#2)(1993-4#1)(1993-6#1)(1997-2#1)(2008-10#5)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)
phagocytosis in vitro##2##3##(2004-12#1)(2007-10#1)
phagocytosis in##7##2##(1993-6#1)(1994-6#3)(2004-12#1)(2006-10#1)(2007-10#1)
phagocytosis is##2##2##(1991-5#1)(2004-12#1)
phagocytosis of C3b/bi and IgG-opsonized yeast particles##2##7##(1991-6#2)
phagocytosis of Candida##2##3##(2006-10#1)(2009-6#1)
phagocytosis of fluorescent##2##3##(1994-3#1)(1997-3#1)
phagocytosis of liposomes by##4##4##(1991-4#1)(1992-6#3)
phagocytosis of liposomes##5##3##(1991-4#1)(1992-6#4)
phagocytosis of the##2##3##(2008-6#1)(2008-9#1)
phagocytosis of virulent S##2##4##(1994-5#2)
phagocytosis of##42##2##(1990-8#1)(1991-10#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#3)(1992-12#1)(1992-5#1)(1992-6#6)(1993-4#1)(1993-6#1)(1994-3#3)(1994-5#3)(1995-2#2)(1995-6#1)(1996-4#1)(1997-3#1)(1997-6#1)(2004-12#1)(2006-10#1)(2007-11#1)(2008-4#2)(2008-6#3)(2008-9#1)(2009-6#1)(2010-2#1)
phagocytosis or##3##2##(1991-12#1)(1991-6#1)(2008-4#1)
phagocytosis was not##2##3##(1990-4#1)(1991-6#1)
phagocytosis was##6##2##(1990-4#1)(1991-4#1)(1991-6#1)(1997-6#2)(2011-2#1)
phagocytosis##135##1##(1990-12#3)(1990-4#4)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#5)(1991-5#3)(1991-6#5)(1991-8#1)(1992-12#1)(1992-5#1)(1992-6#6)(1992-7#1)(1993-4#3)(1993-6#6)(1994-3#5)(1994-5#3)(1994-6#9)(1995-12#1)(1995-2#2)(1995-6#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-6#4)(2004-12#10)(2006-10#3)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-4#6)(2008-5#2)(2008-6#9)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
phagocytosis'##2##1##(1994-3#1)(2005-6#1)
phagocytosis)##2##1##(2008-10#1)(2008-4#1)
phagolysosome##3##1##(1993-11#1)(1994-12#1)(2008-3#1)
phagosomal maturation##2##2##(2008-1#2)
phagosomal##3##1##(2008-1#2)(2011-2#1)
phagosome##4##1##(1990-6#2)(1996-9#1)(2008-1#1)
phagosomes##5##1##(1990-6#1)(1991-10#1)(1996-9#1)(1997-6#1)(2008-7#1)
phakic##6##1##(2011-2#3)(2013-1#2)(2013-7#1)
phalangeal hair was##2##3##(2009-5#2)
phalangeal hair##4##2##(2009-5#4)
phalangeal##17##1##(1991-11#1)(1994-6#2)(2006-10#2)(2006-3#5)(2006-6#1)(2007-11#1)(2009-5#4)(2009-6#1)
phalanges and##2##2##(1997-1#2)
phalanges of##4##2##(2009-5#1)(2011-1#1)(2012-12#2)
phalanges##16##1##(1994-6#1)(1996-12#1)(1997-1#2)(1997-3#1)(2008-9#3)(2009-5#3)(2011-1#1)(2012-12#4)
phalanx of the big##2##4##(1990-9#1)(2008-12#1)
phalanx of the##4##3##(1990-9#1)(1992-3#1)(2008-12#1)(2010-9#1)
phalanx of##6##2##(1990-9#1)(1992-3#1)(1997-5#1)(2008-12#1)(2010-3#1)(2010-9#1)
phalanx##20##1##(1990-9#3)(1992-3#1)(1997-5#1)(2006-3#4)(2008-12#1)(2008-5#1)(2009-10#2)(2009-5#1)(2010-3#3)(2010-9#1)(2012-1#1)(2012-2#1)
phalloides##4##1##(1991-11#3)(1995-7#1)
phalloidin from actin##2##3##(1994-12#2)
phalloidin microinjection##2##2##(2008-11#2)
phalloidin##18##1##(1990-5#5)(1990-6#2)(1993-11#1)(1993-3#1)(1993-9#1)(1994-12#2)(1997-7#1)(2007-12#2)(2008-11#2)(2008-7#1)
phalloidin-treated##2##1##(1990-5#2)
phallus##8##1##(1995-11#1)(2006-7#1)(2008-1#1)(2008-10#5)
phantom and a##2##3##(2009-11#1)(2012-1#1)
phantom and the##2##3##(2009-5#1)(2010-12#1)
phantom and##10##2##(1993-9#1)(2007-12#1)(2008-3#1)(2009-11#1)(2009-5#2)(2009-8#1)(2010-12#1)(2012-1#1)(2012-12#1)
phantom breast pain##2##3##(2010-7#2)
phantom by##3##2##(2007-11#1)(2008-3#2)
phantom experiments##5##2##(2007-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)
phantom for##5##2##(2008-2#1)(2008-3#3)(2011-1#1)
phantom geometry##2##2##(2012-1#2)
phantom images show##2##3##(2009-10#1)(2009-6#1)
phantom images##3##2##(2008-2#1)(2009-10#1)(2009-6#1)
phantom is##3##2##(2008-5#1)(2011-1#1)(2011-2#1)
phantom limb pain as well as##2##6##(2009-12#2)
phantom limb pain##4##3##(2005-8#1)(2006-10#1)(2009-12#2)
phantom limb##7##2##(2005-8#1)(2006-10#1)(2009-12#4)(2010-3#1)
phantom model##2##2##(1997-6#1)(2007-5#1)
phantom of##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
phantom simulating a##2##3##(1997-8#1)(2010-9#1)
phantom studies##4##2##(1995-5#1)(2006-4#1)(2008-10#1)(2011-1#1)
phantom tissue test##2##3##(2009-11#2)
phantom tissue tests##2##3##(2009-11#2)
phantom tissue##5##2##(2009-11#5)
phantom was##8##2##(2007-11#1)(2008-2#1)(2008-3#3)(2009-10#1)(2011-1#1)(2012-1#1)
phantom were##3##2##(2008-3#2)(2012-1#1)
phantom with##5##2##(2007-11#1)(2007-12#1)(2008-3#1)(2010-3#1)(2012-1#1)
phantom##137##1##(1993-9#1)(1994-3#1)(1995-5#1)(1997-6#1)(1997-8#2)(2005-8#1)(2006-10#1)(2006-4#1)(2006-6#2)(2007-11#6)(2007-12#8)(2007-4#1)(2007-5#1)(2007-6#1)(2008-10#2)(2008-2#11)(2008-3#31)(2008-5#4)(2009-10#4)(2009-11#7)(2009-12#4)(2009-5#4)(2009-6#1)(2009-8#1)(2010-12#2)(2010-2#3)(2010-3#2)(2010-4#1)(2010-7#2)(2010-9#2)(2011-1#10)(2011-2#5)(2012-1#10)(2012-12#2)(2012-3#1)
phantoms and in##3##3##(2007-11#1)(2011-1#1)(2013-1#1)
phantoms and##10##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)(2010-2#1)(2011-1#2)(2013-1#1)
phantoms are##4##2##(2007-12#1)(2008-2#1)(2011-1#1)(2011-2#1)
phantoms containing##5##2##(1997-8#1)(2007-12#2)(2008-2#1)(2011-1#1)
phantoms is##2##2##(2008-3#1)(2010-12#1)
phantoms show##2##2##(2008-2#1)(2009-8#1)
phantoms which simulate the##2##4##(2008-3#1)(2011-1#1)
phantoms with##4##2##(2007-10#1)(2008-2#1)(2008-3#2)
phantoms##70##1##(1996-12#1)(1997-8#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#11)(2007-5#1)(2008-11#1)(2008-2#8)(2008-3#19)(2009-10#2)(2009-8#1)(2010-12#2)(2010-2#1)(2010-9#1)(2011-1#6)(2011-2#1)(2012-1#5)(2012-12#1)(2013-1#1)
pharaoh's ant##3##2##(2007-12#3)
pharaonis hR##4##2##(1994-5#4)
pharaonis hRblue##2##2##(1994-5#2)
pharaonis##21##1##(1993-11#2)(1994-2#3)(1994-5#8)(2007-12#3)(2008-6#1)(2013-7#4)
pharma sense and pharma think##3##5##(2004-12#3)
pharma sense and##4##3##(2004-12#4)
pharma sense##6##2##(2004-12#6)
pharma think to##2##3##(2004-12#2)
pharma think##5##2##(2004-12#5)
pharma##14##1##(2004-12#11)(2005-8#1)(2007-8#1)(2009-9#1)
pharmaceutical agents and##3##3##(1996-5#1)(2005-3#1)(2007-11#1)
pharmaceutical agents to##2##3##(2005-8#1)(2012-12#1)
pharmaceutical agents##12##2##(1996-5#1)(2005-3#1)(2005-8#2)(2006-12#1)(2007-11#4)(2007-8#1)(2008-1#1)(2012-12#1)
pharmaceutical aids##2##2##(2010-11#1)(2012-1#1)
pharmaceutical analysis##8##2##(1990-8#1)(1996-5#1)(2008-10#4)(2010-2#1)(2013-8#1)
pharmaceutical and biotech industries##2##4##(2008-11#1)(2011-2#1)
pharmaceutical and biotechnology companies##2##4##(2005-7#1)(2010-7#1)
pharmaceutical and biotechnology##6##3##(2005-7#2)(2008-10#1)(2008-5#1)(2010-7#1)(2011-1#1)
pharmaceutical and chemical##2##3##(2007-9#1)(2012-3#1)
pharmaceutical and medical##3##3##(1990-9#1)(2008-10#1)(2008-11#1)
pharmaceutical and##21##2##(1990-9#1)(2005-7#3)(2006-2#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
pharmaceutical applications##6##2##(1994-3#1)(2005-11#1)(2006-12#1)(2012-12#1)(2012-2#2)
pharmaceutical care##5##2##(2010-3#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#1)
pharmaceutical companies and##3##3##(2008-10#1)(2009-5#1)(2010-8#1)
pharmaceutical companies are##3##3##(1994-11#1)(2008-11#1)(2010-8#1)
pharmaceutical companies have##3##3##(2008-5#1)(2011-1#1)(2012-2#1)
pharmaceutical companies to##4##3##(1996-12#1)(1997-5#1)(2005-8#1)(2007-11#1)
pharmaceutical companies##38##2##(1991-10#1)(1994-11#1)(1996-12#1)(1996-5#1)(1997-5#1)(2004-12#2)(2005-7#1)(2005-8#3)(2005-9#2)(2006-11#1)(2006-5#1)(2007-11#2)(2008-10#5)(2008-11#2)(2008-2#1)(2008-5#5)(2008-8#1)(2009-5#1)(2010-8#3)(2011-1#1)(2012-2#2)
pharmaceutical company##4##2##(1991-2#1)(2005-8#1)(2009-9#1)(2012-2#1)
pharmaceutical compounds##3##2##(2008-10#2)(2008-5#1)
pharmaceutical development##7##2##(2007-8#1)(2008-10#3)(2008-8#2)(2012-2#1)
pharmaceutical dosage form##5##3##(2008-10#4)(2011-2#1)
pharmaceutical dosage forms and##5##4##(2008-10#3)(2010-2#1)(2010-4#1)
pharmaceutical dosage forms with##3##4##(2008-10#3)
pharmaceutical dosage forms##23##3##(1992-1#2)(2008-10#14)(2010-12#1)(2010-2#2)(2010-4#1)(2011-1#2)(2012-11#1)
pharmaceutical dosage##28##2##(1992-1#2)(2008-10#18)(2010-12#1)(2010-2#2)(2010-4#1)(2011-1#2)(2011-2#1)(2012-11#1)
pharmaceutical dosages##2##2##(2008-10#2)
pharmaceutical drug##2##2##(2008-10#2)
pharmaceutical drugs##6##2##(2007-11#1)(2007-8#1)(2008-1#2)(2010-3#1)(2012-2#1)
pharmaceutical efficacy and safety##2##4##(2012-12#2)
pharmaceutical excipients##2##2##(2008-10#1)(2010-5#1)
pharmaceutical forms##4##2##(1991-5#2)(2008-10#2)
pharmaceutical formulation##25##2##(1994-3#1)(2007-8#2)(2008-10#18)(2008-5#2)(2010-12#1)(2013-7#1)
pharmaceutical formulations (tablets##3##3##(2007-8#1)(2008-10#2)
pharmaceutical formulations and##7##3##(2008-10#7)
pharmaceutical formulations are##2##3##(1996-5#1)(2008-10#1)
pharmaceutical formulations by##8##3##(2008-10#8)
pharmaceutical formulations containing##2##3##(2008-10#2)
pharmaceutical formulations has##2##3##(2008-10#1)(2010-5#1)
pharmaceutical formulations of##2##3##(2008-10#1)(2011-1#1)
pharmaceutical formulations using##13##3##(2008-10#13)
pharmaceutical formulations were##2##3##(2008-10#2)
pharmaceutical formulations with##3##3##(2008-10#3)
pharmaceutical formulations##110##2##(1991-12#1)(1996-5#1)(1997-8#1)(2007-8#2)(2008-10#100)(2008-5#1)(2010-5#1)(2011-1#3)
pharmaceutical industries##16##2##(2005-8#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-6#2)(2008-9#3)(2009-3#1)(2009-4#1)(2010-5#1)(2013-1#1)
pharmaceutical industry and the##3##4##(2005-10#1)(2006-10#1)(2009-12#1)
pharmaceutical industry and##9##3##(2005-10#1)(2006-10#2)(2006-2#1)(2008-5#1)(2009-12#1)(2010-11#1)(2011-2#1)(2012-3#1)
pharmaceutical industry for##2##3##(2008-10#1)(2011-2#1)
pharmaceutical industry has##4##3##(1995-5#1)(2007-11#2)(2012-2#1)
pharmaceutical industry in##4##3##(1991-3#1)(2006-5#1)(2008-10#1)(2012-2#1)
pharmaceutical industry is a##2##4##(2008-10#1)(2009-11#1)
pharmaceutical industry is##6##3##(1997-4#1)(2005-9#1)(2006-2#1)(2008-10#2)(2009-11#1)
pharmaceutical industry##78##2##(1991-2#2)(1991-3#1)(1993-2#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#2)(2005-10#1)(2005-7#2)(2005-8#6)(2005-9#3)(2006-10#3)(2006-2#3)(2006-5#3)(2007-11#2)(2008-10#8)(2008-11#6)(2008-4#1)(2008-5#6)(2008-7#1)(2008-9#1)(2009-11#4)(2009-12#1)(2009-5#1)(2010-11#2)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#5)(2012-3#1)
pharmaceutical industry's##2##2##(2005-8#1)(2008-10#1)
pharmaceutical ingredient##3##2##(2007-8#1)(2011-2#1)(2013-8#1)
pharmaceutical ingredients##2##2##(2010-2#2)
pharmaceutical injection samples##2##3##(2008-10#2)
pharmaceutical injections##2##2##(2008-10#2)
pharmaceutical innovation##3##2##(1990-12#1)(2008-7#2)
pharmaceutical intervention##4##2##(2005-8#1)(2008-7#1)(2011-2#1)(2013-7#1)
pharmaceutical interventions##2##2##(2007-3#1)(2008-6#1)
pharmaceutical lead plasters and painting lead mediums##2##7##(2008-10#2)
pharmaceutical manufacturing##2##2##(2007-8#1)(2011-2#1)
pharmaceutical mixtures##2##2##(2007-8#1)(2013-8#1)
pharmaceutical particles##2##2##(2005-11#2)
pharmaceutical performance##2##2##(2012-12#2)
pharmaceutical powders##2##2##(2008-10#2)
pharmaceutical practice##3##2##(2008-10#1)(2009-10#1)(2009-2#1)
pharmaceutical preparation##18##2##(2008-10#18)
pharmaceutical preparations and the results were##2##6##(2008-10#2)
pharmaceutical preparations and the results##3##5##(2008-10#3)
pharmaceutical preparations and##19##3##(2008-10#17)(2010-4#2)
pharmaceutical preparations containing##3##3##(2008-10#2)(2008-11#1)
pharmaceutical preparations in##3##3##(2008-10#3)
pharmaceutical preparations using##7##3##(2008-10#7)
pharmaceutical preparations##120##2##(2006-1#2)(2006-6#1)(2007-10#1)(2008-10#110)(2008-11#1)(2010-2#1)(2010-4#3)(2011-2#1)
pharmaceutical prices##2##2##(2008-1#1)(2008-7#1)
pharmaceutical processes##4##2##(2008-10#1)(2012-2#3)
pharmaceutical product##4##2##(1997-1#1)(2008-10#1)(2011-2#1)(2012-11#1)
pharmaceutical production##2##2##(2012-2#2)
pharmaceutical products and##2##3##(2008-10#1)(2008-7#1)
pharmaceutical products using##2##3##(2008-10#2)
pharmaceutical products##42##2##(1993-10#1)(1995-1#1)(1997-2#1)(2006-11#1)(2007-2#2)(2007-9#1)(2008-10#23)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
pharmaceutical properties##2##2##(2010-2#1)(2011-3#1)
pharmaceutical protein##2##2##(2006-12#1)(2008-11#1)
pharmaceutical proteins in##2##3##(2006-11#1)(2006-12#1)
pharmaceutical proteins##3##2##(1994-5#1)(2006-11#1)(2006-12#1)
pharmaceutical purposes##2##2##(2008-5#2)
pharmaceutical quality of##2##3##(1992-5#1)(2010-12#1)
pharmaceutical quality##4##2##(1992-5#1)(2008-11#1)(2010-12#2)
pharmaceutical reps##3##2##(2006-2#3)
pharmaceutical research and##2##3##(2008-8#1)(2012-11#1)
pharmaceutical research##8##2##(1991-3#1)(2005-7#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-2#1)(2012-11#1)
pharmaceutical residues##5##2##(2008-10#5)
pharmaceutical samples and##2##3##(2008-10#2)
pharmaceutical samples##22##2##(2008-10#20)(2012-2#2)
pharmaceutical sciences##2##2##(2011-1#2)
pharmaceutical scientists##2##2##(2005-8#1)(2011-1#1)
pharmaceutical sector##3##2##(2011-2#1)(2012-1#1)(2012-2#1)
pharmaceutical services at##4##3##(2010-3#3)(2013-8#1)
pharmaceutical services##5##2##(2008-10#1)(2010-3#3)(2013-8#1)
pharmaceutical substances##2##2##(2009-5#1)(2011-1#1)
pharmaceutical tablet##2##2##(2008-10#1)(2013-8#1)
pharmaceutical tablets##4##2##(2008-10#2)(2011-1#2)
pharmaceutical therapy##4##2##(2007-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
pharmaceutical trials##2##2##(2010-5#1)(2012-2#1)
pharmaceutical use##5##2##(1992-3#1)(1994-5#1)(2007-11#2)(2007-8#1)
pharmaceutical vitamin tablets##2##3##(2008-10#2)
pharmaceutical##803##1##(1990-12#1)(1990-8#1)(1990-9#3)(1991-10#1)(1991-12#2)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#1)(1992-1#2)(1992-3#1)(1992-5#1)(1993-10#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-3#2)(1994-5#2)(1994-9#1)(1995-1#3)(1995-11#1)(1995-5#1)(1996-1#2)(1996-12#3)(1996-2#2)(1996-5#10)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#3)(1997-6#1)(1997-8#1)(2004-12#5)(2005-10#3)(2005-11#4)(2005-3#1)(2005-7#10)(2005-8#20)(2005-9#5)(2006-1#3)(2006-10#4)(2006-11#3)(2006-12#4)(2006-2#8)(2006-5#4)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#11)(2007-2#2)(2007-3#3)(2007-6#1)(2007-7#2)(2007-8#11)(2007-9#2)(2008-1#4)(2008-10#390)(2008-11#18)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#26)(2008-6#6)(2008-7#8)(2008-8#9)(2008-9#5)(2009-10#1)(2009-11#4)(2009-12#1)(2009-2#4)(2009-3#3)(2009-4#2)(2009-5#4)(2009-6#4)(2009-9#1)(2010-11#3)(2010-12#8)(2010-2#10)(2010-3#5)(2010-4#4)(2010-5#4)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#18)(2011-12#1)(2011-2#13)(2011-3#3)(2012-1#7)(2012-11#3)(2012-12#10)(2012-2#25)(2012-3#2)(2013-1#2)(2013-7#3)(2013-8#7)
pharmaceutically equivalent##2##2##(2010-2#2)
pharmaceutically important##3##2##(1997-6#1)(2008-10#1)(2013-8#1)
pharmaceutically relevant##4##2##(2007-1#1)(2008-10#1)(2008-7#1)(2013-1#1)
pharmaceutically##12##1##(1997-6#1)(2005-11#1)(2007-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-2#2)(2013-1#1)(2013-8#1)
pharmaceuticals and##11##2##(2008-10#9)(2010-12#1)(2013-1#1)
pharmaceuticals as##2##2##(2010-11#1)(2010-2#1)
pharmaceuticals by##3##2##(2008-10#3)
pharmaceuticals could##2##2##(2008-10#1)(2010-3#1)
pharmaceuticals in wastewater##2##3##(2008-10#2)
pharmaceuticals in##5##2##(2008-10#4)(2013-1#1)
pharmaceuticals is##2##2##(1997-2#1)(2008-10#1)
pharmaceuticals produced excellent results##2##4##(2008-10#2)
pharmaceuticals that##2##2##(2008-10#1)(2008-11#1)
pharmaceuticals to##2##2##(2011-2#1)(2012-11#1)
pharmaceuticals using##5##2##(2008-10#5)
pharmaceuticals were##2##2##(2008-10#1)(2013-1#1)
pharmaceuticals with##5##2##(1996-5#1)(2008-10#3)(2009-12#1)
pharmaceuticals##117##1##(1993-12#1)(1993-3#1)(1994-1#1)(1994-3#1)(1994-5#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(2005-8#3)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#2)(2007-8#1)(2008-10#71)(2008-11#2)(2008-7#3)(2009-12#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-6#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-2#4)(2012-3#1)(2013-1#3)
pharmaceuticals)##2##1##(2011-2#1)(2013-8#1)
pharmaceutics##2##1##(2009-7#1)(2011-1#1)
pharmacies (OR =##3##3##(2013-1#3)
pharmacies and hospitals##2##3##(1990-5#2)
pharmacies and##5##2##(1990-5#2)(1995-1#1)(2008-11#1)(2011-1#1)
pharmacies in the##2##3##(2008-8#1)(2012-12#1)
pharmacies in urban areas##2##4##(1995-1#1)(2011-1#1)
pharmacies in##13##2##(1990-10#1)(1995-1#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
pharmacies since 1985##2##3##(1990-2#2)
pharmacies that##3##2##(2010-8#1)(2011-1#2)
pharmacies to##2##2##(1995-1#1)(2009-6#1)
pharmacies were more##3##3##(2013-1#3)
pharmacies were##4##2##(2013-1#4)
pharmacies##71##1##(1990-10#1)(1990-2#4)(1990-5#2)(1992-3#2)(1994-3#1)(1995-1#6)(1997-7#1)(2004-10#1)(2006-5#1)(2007-7#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-8#2)(2009-10#1)(2009-6#1)(2010-8#2)(2010-9#1)(2011-1#17)(2012-12#4)(2012-2#1)(2013-1#14)
pharmacist SP##2##2##(2011-1#2)
pharmacist education##2##2##(2008-1#2)
pharmacist in##3##2##(2005-1#1)(2008-11#1)(2011-2#1)
pharmacist prescribing##2##2##(2010-3#1)(2011-1#1)
pharmacist would result in improved##2##5##(2011-1#2)
pharmacist##36##1##(1991-3#1)(1991-6#1)(1992-4#1)(1992-5#1)(1994-12#1)(1995-11#1)(2005-1#1)(2006-1#1)(2006-3#1)(2007-6#1)(2008-1#2)(2008-11#4)(2008-4#1)(2008-5#1)(2010-3#4)(2010-5#1)(2011-1#10)(2011-2#2)(2013-1#1)
pharmacist's role in##2##3##(1993-2#2)
pharmacist's##3##1##(1993-2#2)(2010-3#1)
pharmacists and nurses##2##3##(1997-8#1)(2008-3#1)
pharmacists and patients##2##3##(1996-1#2)
pharmacists and physicians##2##3##(2011-1#2)
pharmacists and the##2##3##(1996-3#1)(2009-2#1)
pharmacists and##11##2##(1996-1#2)(1996-3#1)(1997-8#1)(2008-3#1)(2008-8#1)(2009-2#2)(2011-1#2)(2013-8#1)
pharmacists by##2##2##(2011-1#1)(2013-1#1)
pharmacists can##2##2##(1993-2#1)(1994-12#1)
pharmacists in the##3##3##(2010-5#1)(2011-1#2)
pharmacists in##13##2##(2008-11#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#8)(2013-8#1)
pharmacists play##2##2##(2011-1#2)
pharmacists provide##2##2##(2011-1#1)(2013-8#1)
pharmacists to##5##2##(2010-5#2)(2011-1#3)
pharmacists were##2##2##(2011-1#2)
pharmacists who##2##2##(2011-1#2)
pharmacists##106##1##(1993-2#1)(1993-3#1)(1994-12#2)(1995-2#1)(1996-1#3)(1996-3#3)(1997-8#2)(2004-10#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#4)(2008-8#3)(2008-9#2)(2009-10#1)(2009-2#2)(2010-12#1)(2010-3#1)(2010-5#5)(2010-9#3)(2011-1#47)(2011-2#3)(2012-2#1)(2013-1#5)(2013-8#7)
pharmacists' perceptions##2##2##(2011-1#2)
pharmacists' self-efficacy beliefs about communicating with Spanish-speaking patients##2##8##(2011-1#2)
pharmacists' self-efficacy##3##2##(2011-1#3)
pharmacists' views##4##2##(2011-1#4)
pharmacists'##19##1##(2008-3#1)(2010-5#1)(2010-9#1)(2011-1#15)(2013-8#1)
pharmaco- and behavioral therapies for smoking cessation##2##7##(2012-1#2)
pharmacodynamic and pharmacokinetic profiles##2##4##(2007-11#1)(2008-8#1)
pharmacodynamic and pharmacokinetic##7##3##(1990-6#1)(1991-12#1)(1991-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)
pharmacodynamic approach##2##2##(2008-7#1)(2008-8#1)
pharmacodynamic effect##3##2##(1992-8#1)(2008-5#2)
pharmacodynamic effects##3##2##(1992-8#1)(2006-10#1)(2013-1#1)
pharmacodynamic interactions##2##2##(2007-11#2)
pharmacodynamic models##2##2##(2005-7#1)(2006-8#1)
pharmacodynamic parameters##2##2##(2007-11#1)(2008-5#1)
pharmacodynamic response##4##2##(1996-1#1)(2007-9#1)(2008-5#1)(2010-8#1)
pharmacodynamic studies##4##2##(2006-8#1)(2007-11#1)(2008-5#1)(2008-8#1)
pharmacodynamic##58##1##(1990-6#1)(1991-12#2)(1991-2#1)(1991-8#2)(1992-8#2)(1993-12#1)(1996-1#1)(1996-12#1)(1996-6#1)(2004-12#2)(2005-6#1)(2005-7#1)(2005-8#2)(2006-10#6)(2006-6#1)(2006-8#2)(2007-11#5)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#6)(2008-7#2)(2008-8#6)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
pharmacodynamics and##3##2##(2006-10#1)(2009-2#1)(2010-6#1)
pharmacodynamics of##15##2##(1991-1#1)(1991-2#1)(1992-4#1)(1996-6#1)(2005-8#1)(2006-10#1)(2006-8#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#1)(2011-3#1)
pharmacodynamics##41##1##(1991-1#1)(1991-2#1)(1992-4#2)(1993-1#1)(1996-10#1)(1996-6#1)(1997-4#1)(2005-8#2)(2006-1#1)(2006-10#4)(2006-3#1)(2006-8#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#7)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2010-6#2)(2011-3#2)(2013-1#1)(2013-8#1)
pharmacoeconomic analyses##4##2##(2006-5#2)(2007-11#1)(2008-5#1)
pharmacoeconomic evaluations##3##2##(2006-5#2)(2009-11#1)
pharmacoeconomic studies##3##2##(2006-5#2)(2013-1#1)
pharmacoeconomic##19##1##(2005-8#1)(2006-2#1)(2006-5#11)(2007-11#2)(2008-5#1)(2009-11#1)(2011-1#1)(2013-1#1)
pharmacoeconomics and outcomes research##2##4##(2006-2#1)(2006-5#1)
pharmacoeconomics and outcomes##4##3##(2006-2#1)(2006-5#3)
pharmacoeconomics in##2##2##(2006-6#2)
pharmacoeconomics##10##1##(1995-10#1)(2006-2#1)(2006-5#5)(2006-6#2)(2011-1#1)
pharmacoepidemiologic##3##1##(2008-11#2)(2008-8#1)
pharmacoepidemiological##2##1##(2008-11#1)(2012-3#1)
pharmacoepidemiology##3##1##(2008-11#2)(2008-8#1)
pharmacogenetic factors##2##2##(2008-11#1)(2008-4#1)
pharmacogenetic studies##3##2##(1994-10#1)(2005-8#1)(2005-9#1)
pharmacogenetic##15##1##(1994-10#1)(1996-3#1)(2005-8#2)(2005-9#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#2)(2012-12#2)
pharmacogenetically selected##2##2##(1996-4#2)
pharmacogenetics and pharmacogenomics in##3##4##(2008-10#3)
pharmacogenetics and##6##2##(2005-10#1)(2008-10#3)(2008-12#1)(2008-4#1)
pharmacogenetics in##3##2##(2008-10#1)(2008-8#1)(2012-12#1)
pharmacogenetics is##2##2##(2005-10#1)(2008-4#1)
pharmacogenetics##28##1##(2005-10#3)(2005-9#1)(2007-9#3)(2008-10#4)(2008-12#1)(2008-4#4)(2008-7#1)(2008-8#4)(2008-9#2)(2010-7#1)(2012-1#1)(2012-12#3)
pharmacogenomic and##2##2##(2005-8#1)(2009-5#1)
pharmacogenomic approaches##2##2##(2009-5#1)(2012-1#1)
pharmacogenomic biomarker studies##2##3##(2008-8#2)
pharmacogenomic testing##2##2##(2012-1#1)(2013-8#1)
pharmacogenomic##14##1##(2005-8#1)(2006-12#1)(2008-8#3)(2009-2#1)(2009-5#2)(2010-2#1)(2012-1#3)(2013-8#2)
pharmacogenomics (PGx)##2##2##(2008-10#1)(2010-8#1)
pharmacogenomics and##2##2##(2005-9#1)(2011-1#1)
pharmacogenomics in##7##2##(2008-10#5)(2010-8#1)(2010-9#1)
pharmacogenomics##21##1##(2005-9#1)(2007-3#1)(2007-4#1)(2008-10#8)(2008-7#1)(2008-8#3)(2009-5#1)(2010-8#2)(2010-9#1)(2011-1#1)(2013-8#1)
pharmacognostic##4##1##(2005-10#4)
pharmacokinetic (PBPK)##4##2##(2008-4#1)(2010-2#3)
pharmacokinetic analyses##2##2##(1990-6#1)(2013-8#1)
pharmacokinetic and pharmacodynamic modelling##2##4##(2006-10#2)
pharmacokinetic and pharmacodynamic properties##3##4##(2007-2#1)(2008-3#1)(2008-8#1)
pharmacokinetic and pharmacodynamic##10##3##(1993-12#1)(2004-12#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-3#1)(2008-8#2)
pharmacokinetic and##18##2##(1990-12#2)(1993-12#1)(2004-12#1)(2006-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2010-12#1)(2011-1#1)
pharmacokinetic behavior##3##2##(1995-2#1)(1995-3#1)(2005-7#1)
pharmacokinetic behaviour of cytisine##2##4##(2011-1#2)
pharmacokinetic behaviour of##3##3##(2011-1#2)(2012-12#1)
pharmacokinetic changes##2##2##(2008-3#1)(2013-7#1)
pharmacokinetic characteristics##6##2##(1991-12#1)(1992-4#1)(2007-11#1)(2008-1#1)(2008-10#1)(2013-1#1)
pharmacokinetic considerations##2##2##(1992-4#1)(2013-1#1)
pharmacokinetic data##3##2##(1990-12#1)(1996-11#1)(1996-5#1)
pharmacokinetic differences between##2##3##(1991-12#1)(2013-8#1)
pharmacokinetic differences##3##2##(1991-12#1)(1994-3#1)(2013-8#1)
pharmacokinetic drug interaction##2##3##(2007-11#1)(2011-1#1)
pharmacokinetic drug interactions between##2##4##(2007-11#2)
pharmacokinetic drug##4##2##(2007-11#3)(2011-1#1)
pharmacokinetic factors##2##2##(1993-12#1)(2005-8#1)
pharmacokinetic interaction##5##2##(1993-11#1)(1997-5#1)(2008-7#1)(2011-1#1)(2011-2#1)
pharmacokinetic interactions between##2##3##(2007-11#1)(2009-7#1)
pharmacokinetic interactions##6##2##(2007-11#2)(2008-3#1)(2009-6#1)(2009-7#1)(2011-1#1)
pharmacokinetic model##2##2##(2006-10#1)(2008-5#1)
pharmacokinetic modeling##2##2##(2009-4#1)(2013-7#1)
pharmacokinetic models##3##2##(2008-4#1)(2008-5#1)(2010-12#1)
pharmacokinetic or##3##2##(1997-1#1)(2006-10#1)(2011-2#1)
pharmacokinetic parameters between##2##3##(2004-12#2)
pharmacokinetic parameters for##2##3##(1995-3#1)(2008-10#1)
pharmacokinetic parameters obtained from##2##4##(1995-2#1)(1996-3#1)
pharmacokinetic parameters of the##4##4##(2008-10#1)(2008-11#1)(2012-2#2)
pharmacokinetic parameters of##6##3##(2004-12#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-2#2)
pharmacokinetic parameters were determined##2##4##(1991-12#1)(2008-5#1)
pharmacokinetic parameters were##6##3##(1991-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2013-1#1)
pharmacokinetic parameters##25##2##(1991-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-3#1)(2004-12#3)(2008-10#5)(2008-11#2)(2008-5#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)
pharmacokinetic profile of##6##3##(1996-8#1)(1997-5#1)(2004-12#1)(2005-7#1)(2008-10#1)(2013-8#1)
pharmacokinetic profile##14##2##(1993-8#1)(1996-8#1)(1997-5#1)(2004-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2013-8#1)
pharmacokinetic profiles and##2##3##(2005-7#1)(2008-8#1)
pharmacokinetic profiles of##4##3##(2005-7#1)(2007-11#2)(2011-2#1)
pharmacokinetic profiles##10##2##(1994-9#1)(2005-7#2)(2007-11#3)(2008-8#2)(2010-12#1)(2011-2#1)
pharmacokinetic properties of##8##3##(1991-12#2)(1991-2#1)(1994-11#1)(1996-8#1)(2006-10#1)(2007-2#1)(2008-3#1)
pharmacokinetic properties##20##2##(1991-12#4)(1991-2#1)(1994-11#1)(1996-8#1)(2005-7#1)(2006-10#2)(2007-11#1)(2007-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-3#1)(2010-6#1)(2012-2#2)
pharmacokinetic studies have been##2##4##(2009-1#1)(2013-1#1)
pharmacokinetic studies have##3##3##(2008-5#1)(2009-1#1)(2013-1#1)
pharmacokinetic studies of##6##3##(1990-6#1)(1997-3#1)(1997-8#1)(2008-10#2)(2008-5#1)
pharmacokinetic studies##26##2##(1990-11#1)(1990-6#1)(1993-2#1)(1996-3#1)(1997-3#3)(1997-8#3)(2005-12#1)(2006-10#1)(2008-10#4)(2008-11#1)(2008-5#4)(2009-1#1)(2009-5#1)(2010-11#1)(2012-12#1)(2013-1#1)
pharmacokinetic study of##12##3##(1996-8#1)(1997-3#1)(1997-8#1)(2008-10#5)(2008-5#1)(2011-12#1)(2011-3#1)(2012-12#1)
pharmacokinetic study##20##2##(1990-11#1)(1993-2#1)(1996-8#1)(1997-3#1)(1997-8#1)(2008-10#7)(2008-5#2)(2008-6#1)(2008-8#1)(2011-12#1)(2011-3#2)(2012-12#1)
pharmacokinetic variability##2##2##(2008-8#1)(2010-2#1)
pharmacokinetic##231##1##(1990-11#2)(1990-12#3)(1990-6#3)(1991-12#7)(1991-2#2)(1991-8#2)(1992-4#2)(1993-11#1)(1993-12#2)(1993-2#3)(1993-8#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-2#3)(1995-3#2)(1995-4#1)(1996-10#1)(1996-11#4)(1996-3#2)(1996-5#1)(1996-8#3)(1997-1#1)(1997-3#4)(1997-5#2)(1997-8#5)(2004-12#5)(2005-11#1)(2005-12#1)(2005-6#1)(2005-7#6)(2005-8#3)(2006-10#9)(2007-10#1)(2007-11#13)(2007-12#1)(2007-2#2)(2008-1#2)(2008-10#20)(2008-11#4)(2008-12#1)(2008-3#6)(2008-4#3)(2008-5#13)(2008-6#1)(2008-7#4)(2008-8#9)(2009-1#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2010-10#1)(2010-11#4)(2010-12#7)(2010-2#5)(2010-6#1)(2011-1#7)(2011-12#1)(2011-2#4)(2011-3#2)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#5)
pharmacokinetic-pharmacodynamic##2##1##(2006-10#1)(2008-5#1)
pharmacokinetic/pharmacodynamic properties##2##2##(2008-3#1)(2008-8#1)
pharmacokinetic/pharmacodynamic##3##1##(2008-3#1)(2008-8#2)
pharmacokinetically##3##1##(2010-11#3)
pharmacokinetics and dynamics##2##3##(2006-10#1)(2008-3#1)
pharmacokinetics and metabolism of##2##4##(2007-11#1)(2009-4#1)
pharmacokinetics and metabolism##3##3##(1996-10#1)(2007-11#1)(2009-4#1)
pharmacokinetics and pharmacodynamics of levodopa in##2##6##(2008-8#2)
pharmacokinetics and pharmacodynamics of##7##4##(1991-2#1)(1996-6#1)(2006-8#1)(2008-8#3)(2009-2#1)
pharmacokinetics and pharmacodynamics##18##3##(1991-2#1)(1993-1#1)(1996-10#1)(1996-6#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-10#1)(2008-3#1)(2008-5#1)(2008-8#5)(2009-2#1)(2010-6#1)(2013-8#1)
pharmacokinetics and##37##2##(1991-2#2)(1991-8#1)(1993-1#1)(1995-3#1)(1996-10#2)(1996-4#1)(1996-6#1)(2006-10#2)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-3#3)(2008-5#4)(2008-7#2)(2008-8#7)(2009-2#1)(2009-4#1)(2010-12#1)(2010-6#1)(2013-1#1)(2013-8#1)
pharmacokinetics for##2##2##(2012-3#1)(2013-1#1)
pharmacokinetics in##13##2##(1990-11#1)(1995-2#1)(1996-6#1)(1996-8#1)(1997-3#1)(2005-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-4#2)(2012-3#1)(2013-1#1)
pharmacokinetics of YH439 and its metabolites##3##6##(2008-11#3)
pharmacokinetics of metronidazole##2##3##(2011-2#2)
pharmacokinetics of oral##2##3##(1993-11#1)(2008-11#1)
pharmacokinetics of stealth liposomes##2##4##(1991-9#2)
pharmacokinetics of temafloxacin##2##3##(1991-12#2)
pharmacokinetics of the drug##2##4##(1992-7#1)(2006-10#1)
pharmacokinetics of the##4##3##(1992-7#1)(1996-1#1)(2006-10#1)(2007-11#1)
pharmacokinetics of##60##2##(1990-3#1)(1991-12#5)(1991-9#2)(1992-11#1)(1992-2#1)(1992-7#1)(1993-11#1)(1994-11#1)(1994-3#2)(1995-2#1)(1996-1#1)(1996-6#2)(1997-8#1)(2004-12#1)(2005-3#1)(2006-10#3)(2006-11#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#6)(2009-11#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-3#1)
pharmacokinetics studies##2##2##(2008-5#1)(2012-2#1)
pharmacokinetics was##2##2##(2009-4#1)(2012-3#1)
pharmacokinetics were##3##2##(1996-1#1)(1996-4#1)(2010-3#1)
pharmacokinetics##173##1##(1990-1#1)(1990-11#1)(1990-3#3)(1991-1#1)(1991-12#7)(1991-2#2)(1991-8#1)(1991-9#3)(1992-11#1)(1992-2#1)(1992-7#1)(1993-1#1)(1993-11#2)(1994-11#1)(1994-2#1)(1994-3#2)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#2)(1996-10#2)(1996-11#2)(1996-4#2)(1996-6#5)(1996-8#2)(1997-3#1)(1997-4#2)(1997-8#2)(2004-12#2)(2005-3#1)(2005-7#5)(2005-8#3)(2006-10#7)(2006-11#2)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-3#6)(2008-5#9)(2008-6#1)(2008-7#4)(2008-8#17)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-4#6)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-12#4)(2012-2#1)(2012-3#4)(2013-1#5)(2013-8#1)
pharmacologic agents are##2##3##(2006-10#1)(2008-8#1)
pharmacologic agents can##2##3##(2006-10#1)(2006-9#1)
pharmacologic agents on##2##3##(1996-10#1)(2009-4#1)
pharmacologic agents that##2##3##(2006-10#1)(2009-6#1)
pharmacologic agents to##2##3##(2005-10#1)(2008-2#1)
pharmacologic agents##22##2##(1996-10#1)(1996-5#1)(1996-7#1)(2005-10#1)(2006-10#4)(2006-9#1)(2007-10#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-5#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-4#1)
pharmacologic and nonpharmacologic##2##3##(1996-7#1)(2009-7#1)
pharmacologic and##8##2##(1991-12#1)(1993-10#1)(1996-7#1)(2008-1#1)(2008-5#1)(2009-4#1)(2009-7#1)(2012-2#1)
pharmacologic approaches##2##2##(2006-10#1)(2008-4#1)
pharmacologic ascorbate##2##2##(2012-2#2)
pharmacologic challenge##2##2##(2008-12#1)(2008-4#1)
pharmacologic inhibition of##3##3##(1994-3#1)(2007-10#1)(2012-12#1)
pharmacologic intervention##4##2##(1996-7#1)(2004-3#1)(2008-2#1)(2008-3#1)
pharmacologic interventions that##2##3##(2005-10#1)(2007-11#1)
pharmacologic interventions##4##2##(2005-10#2)(2006-10#1)(2007-11#1)
pharmacologic management##3##2##(1997-6#1)(2008-2#1)(2008-3#1)
pharmacologic methods##2##2##(2006-10#1)(2007-12#1)
pharmacologic options for##2##3##(2006-10#1)(2008-7#1)
pharmacologic profile##4##2##(2007-10#1)(2008-8#1)(2012-12#1)(2013-1#1)
pharmacologic properties##7##2##(1990-7#2)(1996-9#1)(2005-7#1)(2007-11#1)(2007-12#1)(2011-1#1)
pharmacologic therapies##7##2##(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-11#1)(2011-2#1)(2013-7#1)
pharmacologic therapy##8##2##(2006-1#1)(2006-10#1)(2006-2#3)(2007-12#1)(2008-1#1)(2008-10#1)
pharmacologic thrombolysis##2##2##(1990-11#2)
pharmacologic treatment of##5##3##(1996-9#1)(2006-10#1)(2010-8#1)(2011-1#1)(2011-2#1)
pharmacologic treatment##14##2##(1991-12#1)(1994-7#1)(1996-9#2)(2004-3#1)(2006-10#1)(2007-11#1)(2007-6#1)(2008-10#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-8#1)
pharmacologic treatments##4##2##(1996-9#1)(2006-10#1)(2007-8#1)(2008-4#1)
pharmacologic##151##1##(1990-11#3)(1990-2#1)(1990-7#2)(1990-8#4)(1990-9#1)(1991-1#1)(1991-12#3)(1991-8#1)(1992-10#1)(1992-8#1)(1993-1#1)(1993-10#2)(1994-3#1)(1994-7#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-10#1)(1996-5#1)(1996-7#5)(1996-9#7)(1997-6#1)(2004-1#1)(2004-3#2)(2005-10#3)(2005-7#2)(2006-1#1)(2006-10#13)(2006-2#3)(2006-9#2)(2007-10#4)(2007-11#3)(2007-12#3)(2007-2#1)(2007-6#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#3)(2009-2#1)(2009-4#4)(2009-6#1)(2009-7#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
pharmacological action##3##2##(2005-3#1)(2008-10#1)(2010-10#1)
pharmacological actions##5##2##(1991-1#1)(1995-12#1)(1996-10#1)(1996-12#1)(2009-8#1)
pharmacological activation of##5##3##(1993-12#1)(1997-5#1)(1997-6#1)(2008-10#1)(2012-2#1)
pharmacological activities##14##2##(1990-5#1)(2005-8#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-3#1)(2012-11#1)(2012-2#1)(2013-1#1)
pharmacological activity in##3##3##(1991-3#1)(2005-7#1)(2006-12#1)
pharmacological activity of##4##3##(1993-11#1)(1994-9#1)(2008-5#1)(2010-1#1)
pharmacological activity##11##2##(1991-3#1)(1991-8#1)(1993-11#1)(1994-9#1)(1997-5#1)(2005-7#1)(2006-12#1)(2008-5#1)(2010-1#1)(2011-1#1)(2013-1#1)
pharmacological agent##4##2##(1992-11#1)(1993-7#1)(2012-12#1)(2012-2#1)
pharmacological agents are##2##3##(2007-9#1)(2008-12#1)
pharmacological agents for the treatment of##2##6##(2008-5#1)(2009-12#1)
pharmacological agents in##3##3##(2008-1#1)(2008-3#1)(2008-5#1)
pharmacological agents on##2##3##(1993-2#1)(1993-7#1)
pharmacological agents with##2##3##(2007-7#1)(2008-1#1)
pharmacological agents##30##2##(1993-2#1)(1993-7#2)(1994-10#2)(1995-3#1)(1995-5#1)(1996-10#1)(1997-1#1)(2006-10#4)(2007-7#1)(2007-9#1)(2008-1#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2009-12#1)(2010-11#1)(2010-6#1)(2011-12#1)(2012-3#1)
pharmacological aids##2##2##(2009-7#2)
pharmacological analyses##4##2##(2007-12#2)(2008-4#2)
pharmacological analysis##2##2##(1994-2#1)(2008-4#1)
pharmacological and clinical##4##3##(2005-7#2)(2007-2#1)(2008-8#1)
pharmacological and molecular approaches##2##4##(2006-1#1)(2006-10#1)
pharmacological and molecular##3##3##(1994-3#1)(2006-1#1)(2006-10#1)
pharmacological and non-pharmacological##5##3##(1993-2#1)(1996-12#1)(2009-6#1)(2009-7#1)(2011-2#1)
pharmacological and nonpharmacological##3##3##(2008-11#2)(2013-8#1)
pharmacological and psychological##2##3##(2007-11#1)(2010-12#1)
pharmacological and psychosocial##4##3##(2009-7#1)(2009-8#2)(2009-9#1)
pharmacological and surgical treatment##2##4##(2007-11#1)(2012-3#1)
pharmacological and surgical##4##3##(1991-1#1)(2007-11#1)(2009-12#1)(2012-3#1)
pharmacological and therapeutic##2##3##(1992-6#1)(2010-9#1)
pharmacological and##40##2##(1991-1#1)(1992-6#2)(1993-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1995-6#1)(1996-12#1)(2005-7#2)(2006-1#1)(2006-10#1)(2006-6#1)(2007-11#3)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-11#2)(2008-4#1)(2008-8#1)(2009-12#2)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
pharmacological applications##2##2##(2006-12#1)(2008-4#1)
pharmacological approach to##3##3##(1996-6#1)(2008-10#1)(2009-7#1)
pharmacological approach##9##2##(1991-4#1)(1996-1#1)(1996-6#1)(1996-8#1)(2008-10#2)(2009-7#1)(2010-11#1)(2012-2#1)
pharmacological approaches in##2##3##(2006-10#1)(2007-11#1)
pharmacological approaches that##2##3##(2007-11#1)(2009-7#1)
pharmacological approaches##12##2##(1992-9#1)(1995-11#1)(2005-11#1)(2006-10#1)(2007-11#2)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-7#1)(2009-8#1)
pharmacological aspects##4##2##(2006-12#1)(2006-8#1)(2010-5#1)(2012-12#1)
pharmacological blockade##2##2##(1995-12#1)(1996-10#1)
pharmacological characteristics and##2##3##(2005-3#1)(2009-7#1)
pharmacological characteristics of the##2##4##(1992-3#1)(1992-7#1)
pharmacological characteristics of##5##3##(1992-3#1)(1992-7#1)(1993-2#1)(1993-9#1)(2009-7#1)
pharmacological characteristics##10##2##(1990-3#1)(1992-3#1)(1992-7#1)(1993-2#1)(1993-9#1)(1994-5#1)(2005-3#1)(2008-8#1)(2009-7#2)
pharmacological characterization of a##3##4##(1992-9#1)(1993-12#1)(1996-12#1)
pharmacological characterization of the##2##4##(1990-2#1)(1996-12#1)
pharmacological characterization of##8##3##(1990-2#1)(1992-9#1)(1993-12#1)(1996-12#2)(1996-2#1)(1997-5#1)(2012-3#1)
pharmacological characterization##9##2##(1990-2#1)(1992-9#1)(1993-12#1)(1996-12#2)(1996-2#1)(1997-5#1)(2005-8#1)(2012-3#1)
pharmacological compounds##2##2##(2008-1#1)(2008-5#1)
pharmacological concentrations##3##2##(1995-1#1)(2012-1#2)
pharmacological data##5##2##(1992-6#1)(1992-7#1)(1994-10#1)(1996-10#1)(2008-8#1)
pharmacological doses##3##2##(1990-9#1)(2008-5#1)(2013-1#1)
pharmacological effect of##3##3##(1992-9#1)(1995-12#1)(2008-8#1)
pharmacological effects of the##2##4##(1994-5#1)(2008-5#1)
pharmacological effects of##7##3##(1991-9#1)(1994-10#1)(1994-3#1)(1994-5#1)(2008-10#1)(2008-5#1)(2008-7#1)
pharmacological effects##13##2##(1991-9#1)(1994-10#1)(1994-3#1)(1994-5#1)(1997-5#1)(2008-10#3)(2008-5#2)(2008-7#1)(2013-1#1)(2013-8#1)
pharmacological evidence for##2##3##(1990-5#1)(2008-12#1)
pharmacological evidence##5##2##(1990-5#1)(1996-8#1)(2006-1#1)(2008-12#1)(2008-4#1)
pharmacological experiments revealed that SA exerts a strong antagonistic effect on JA-responsive genes##2##13##(2009-6#1)(2009-8#1)
pharmacological experiments##3##2##(1990-7#1)(2009-6#1)(2009-8#1)
pharmacological exploitation##2##2##(2008-4#1)(2009-12#1)
pharmacological factors##2##2##(2007-1#1)(2010-7#1)
pharmacological function##2##2##(1997-7#1)(2012-3#1)
pharmacological information##2##2##(2008-12#1)(2010-12#1)
pharmacological inhibition of##6##3##(2008-4#1)(2008-8#2)(2009-4#1)(2011-2#1)(2013-8#1)
pharmacological inhibition##7##2##(2008-4#1)(2008-8#2)(2009-3#1)(2009-4#1)(2011-2#1)(2013-8#1)
pharmacological inhibitors##2##2##(2008-3#1)(2013-1#1)
pharmacological interest##4##2##(1990-8#1)(1995-6#1)(2007-10#1)(2009-8#1)
pharmacological intervention and##2##3##(2008-1#1)(2008-5#1)
pharmacological intervention for##2##3##(2008-11#1)(2013-1#1)
pharmacological intervention##11##2##(1991-2#2)(2004-12#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#2)(2013-1#1)
pharmacological interventions are##3##3##(2008-3#1)(2009-10#1)(2010-4#1)
pharmacological interventions of##2##3##(2007-11#1)(2008-10#1)
pharmacological interventions that##3##3##(1996-9#1)(2011-1#1)(2011-2#1)
pharmacological interventions to##2##3##(2012-12#1)(2013-8#1)
pharmacological interventions##17##2##(1995-3#2)(1996-9#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
pharmacological management of##12##3##(2005-8#1)(2006-2#1)(2008-1#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
pharmacological manipulation of##4##3##(1990-4#1)(1997-1#1)(2007-11#1)(2011-1#1)
pharmacological manipulation##5##2##(1990-4#1)(1997-1#1)(2007-11#1)(2011-1#2)
pharmacological manipulations##3##2##(1990-7#1)(2008-11#1)(2012-2#1)
pharmacological means##3##2##(1997-1#1)(2007-10#1)(2008-7#1)
pharmacological mechanism of##2##3##(2012-3#2)
pharmacological modulation##3##2##(2005-11#1)(2005-7#1)(2008-7#1)
pharmacological or non-pharmacological treatment##2##4##(2006-10#1)(2008-7#1)
pharmacological or##4##2##(2006-10#1)(2006-12#1)(2008-7#1)(2010-12#1)
pharmacological principles and##2##3##(2005-8#2)
pharmacological principles##4##2##(2004-12#1)(2005-8#2)(2009-9#1)
pharmacological profile and##2##3##(1994-3#1)(1995-1#1)
pharmacological profile for##2##3##(1994-6#1)(1994-8#1)
pharmacological profile of the##5##4##(1992-6#1)(1995-11#1)(1995-12#2)(1996-5#1)
pharmacological profile of##9##3##(1992-6#1)(1993-4#1)(1995-11#1)(1995-12#2)(1996-5#1)(2005-8#1)(2008-1#1)(2012-12#1)
pharmacological profile##23##2##(1990-10#1)(1990-3#1)(1992-6#1)(1992-9#1)(1993-4#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-8#1)(1996-5#1)(1997-5#1)(2005-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-6#1)(2012-12#1)
pharmacological profiles of##2##3##(1990-7#1)(1994-3#1)
pharmacological profiles##6##2##(1990-7#1)(1992-3#1)(1994-3#1)(1994-8#1)(1995-3#2)
pharmacological properties and##3##3##(1991-2#1)(2006-12#1)(2007-11#1)
pharmacological properties of the##5##4##(1990-5#1)(1994-9#1)(1995-12#1)(1995-8#1)(2008-1#1)
pharmacological properties of##18##3##(1990-2#1)(1990-5#1)(1991-5#1)(1992-5#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)
pharmacological properties##32##2##(1990-2#1)(1990-3#1)(1990-5#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-5#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-8#1)(1997-5#1)(1997-7#1)(2006-12#1)(2007-11#2)(2008-1#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#2)
pharmacological response##4##2##(1993-8#1)(1994-6#1)(2006-1#1)(2013-8#1)
pharmacological specificity##3##2##(1990-2#1)(1992-10#1)(1994-9#1)
pharmacological stimuli##2##2##(1992-6#1)(2009-9#1)
pharmacological strategies for##3##3##(1994-6#2)(2008-1#1)
pharmacological strategies##5##2##(1994-6#2)(2006-10#1)(2008-1#1)(2008-7#1)
pharmacological stress##2##2##(2006-9#1)(2008-10#1)
pharmacological studies are##2##3##(2006-10#1)(2008-4#1)
pharmacological studies have##3##3##(1996-3#1)(1996-7#1)(2009-4#1)
pharmacological studies##10##2##(1991-2#1)(1992-5#1)(1996-3#1)(1996-7#1)(1997-3#1)(2006-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-4#1)
pharmacological study##3##2##(1990-9#1)(2008-4#2)
pharmacological support##2##2##(2007-9#2)
pharmacological target##2##2##(2006-12#1)(2007-11#1)
pharmacological targeting##2##2##(2009-10#1)(2011-2#1)
pharmacological targets in##2##3##(1992-6#1)(2008-1#1)
pharmacological targets##3##2##(1992-6#1)(2008-1#2)
pharmacological testing of##2##3##(1996-8#1)(2008-5#1)
pharmacological tests##2##2##(2006-9#1)(2007-1#1)
pharmacological therapies for##2##3##(1993-11#1)(2009-4#1)
pharmacological therapies##7##2##(1993-11#1)(2008-3#1)(2009-4#1)(2009-7#1)(2010-10#1)(2011-1#1)(2011-12#1)
pharmacological therapy and##2##3##(2007-11#1)(2010-5#1)
pharmacological therapy for##2##3##(2007-7#1)(2010-12#1)
pharmacological therapy in##2##3##(2005-10#1)(2010-12#1)
pharmacological therapy to##2##3##(2007-1#1)(2008-3#1)
pharmacological therapy##20##2##(1991-4#1)(2005-10#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-7#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2012-12#1)(2013-1#1)(2013-8#2)
pharmacological tool##4##2##(1992-1#1)(1997-2#1)(2008-4#1)(2009-3#1)
pharmacological tools##6##2##(1990-6#1)(2006-10#2)(2008-11#1)(2009-12#1)(2009-2#1)
pharmacological treatment for##2##3##(2006-11#1)(2011-2#1)
pharmacological treatment in##3##3##(1997-5#1)(2010-2#1)(2012-3#1)
pharmacological treatment of##13##3##(1992-3#1)(1992-6#1)(1994-6#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#2)
pharmacological treatment##41##2##(1990-11#1)(1991-2#2)(1992-3#1)(1992-6#1)(1994-6#1)(1996-2#1)(1997-5#1)(2006-11#1)(2006-8#1)(2006-9#1)(2007-11#5)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#1)(2013-8#1)
pharmacological treatments for##4##3##(2004-12#1)(2008-3#1)(2008-6#1)(2009-7#1)
pharmacological treatments in##2##3##(2008-6#1)(2009-7#1)
pharmacological treatments##17##2##(2004-12#1)(2006-10#1)(2008-1#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2009-7#4)(2010-12#1)(2010-6#1)(2011-2#1)(2011-3#1)
pharmacological trials##2##2##(1996-8#1)(2006-9#1)
pharmacological##619##1##(1990-10#2)(1990-11#1)(1990-2#5)(1990-3#3)(1990-4#1)(1990-5#5)(1990-6#1)(1990-7#3)(1990-8#2)(1990-9#3)(1991-1#2)(1991-2#8)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#7)(1992-7#3)(1992-8#1)(1992-9#5)(1993-11#2)(1993-12#2)(1993-2#4)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#4)(1993-8#1)(1993-9#3)(1994-10#4)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#4)(1994-4#1)(1994-5#3)(1994-6#7)(1994-8#5)(1994-9#5)(1995-1#4)(1995-10#1)(1995-11#3)(1995-12#8)(1995-2#1)(1995-3#5)(1995-5#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-10#7)(1996-12#4)(1996-2#2)(1996-3#2)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#4)(1996-9#2)(1997-1#5)(1997-2#1)(1997-3#1)(1997-5#7)(1997-6#1)(1997-7#2)(1997-8#2)(2004-12#4)(2005-10#1)(2005-11#2)(2005-12#1)(2005-3#2)(2005-7#4)(2005-8#9)(2006-1#4)(2006-10#18)(2006-11#1)(2006-12#10)(2006-2#1)(2006-6#2)(2006-7#1)(2006-8#3)(2006-9#5)(2007-1#4)(2007-10#4)(2007-11#18)(2007-12#3)(2007-2#1)(2007-7#7)(2007-8#1)(2007-9#4)(2008-1#23)(2008-10#20)(2008-11#7)(2008-12#5)(2008-2#2)(2008-3#16)(2008-4#25)(2008-5#12)(2008-6#6)(2008-7#17)(2008-8#14)(2008-9#3)(2009-10#3)(2009-12#8)(2009-2#1)(2009-3#3)(2009-4#6)(2009-6#2)(2009-7#15)(2009-8#6)(2009-9#4)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#13)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#2)(2010-6#4)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#9)(2011-12#3)(2011-2#10)(2011-3#2)(2012-1#3)(2012-11#1)(2012-12#7)(2012-2#8)(2012-3#13)(2013-1#8)(2013-7#3)(2013-8#12)
pharmacologically active compounds##3##3##(1992-2#1)(2006-12#1)(2012-2#1)
pharmacologically active##14##2##(1992-2#2)(1992-5#1)(1995-1#1)(1996-12#1)(1997-8#1)(2006-12#2)(2007-7#1)(2008-10#2)(2010-12#1)(2012-2#2)
pharmacologically and biochemically##2##3##(1991-6#1)(2004-12#1)
pharmacologically and##4##2##(1991-6#1)(2004-12#1)(2008-4#1)(2008-5#1)
pharmacologically different##2##2##(1990-5#1)(1995-12#1)
pharmacologically distinct##4##2##(1990-7#1)(1991-3#1)(1994-3#1)(1995-6#1)
pharmacologically from##3##2##(1992-8#1)(2009-7#1)(2011-2#1)
pharmacologically induced##5##2##(1993-11#1)(1995-5#1)(2008-7#1)(2010-4#1)(2012-2#1)
pharmacologically oriented##2##2##(2006-12#2)
pharmacologically relevant##3##2##(1993-2#1)(1994-11#1)(2008-10#1)
pharmacologically similar##2##2##(1995-11#1)(1996-2#1)
pharmacologically##63##1##(1990-5#1)(1990-7#1)(1991-3#1)(1991-6#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#1)(1997-2#2)(1997-5#1)(1997-8#2)(2004-12#1)(2006-12#4)(2006-9#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#3)
pharmacologist##2##1##(1995-2#1)(2007-4#1)
pharmacologists##3##1##(2005-8#3)
pharmacology and clinical##2##3##(2007-11#1)(2010-5#1)
pharmacology and physiology of##3##4##(1991-12#1)(2005-8#1)(2006-10#1)
pharmacology and therapeutic use of##2##5##(1990-11#1)(2007-11#1)
pharmacology and therapeutic##4##3##(1990-11#1)(1991-2#1)(2007-11#1)(2012-2#1)
pharmacology and therapeutics##4##3##(2005-8#1)(2008-11#2)(2008-5#1)
pharmacology and toxicology of##2##4##(1995-3#1)(2007-6#1)
pharmacology and toxicology##3##3##(1995-3#1)(2007-6#1)(2011-1#1)
pharmacology and use in the##2##5##(2006-3#1)(2009-8#1)
pharmacology and##36##2##(1990-11#1)(1991-12#1)(1991-2#1)(1994-3#1)(1995-3#1)(1996-12#1)(2005-8#4)(2006-1#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#3)(2009-4#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-7#1)
pharmacology are##2##2##(1995-5#1)(2013-1#1)
pharmacology education for nurses##2##4##(2008-12#2)
pharmacology education##3##2##(2008-12#3)
pharmacology in##4##2##(1996-12#1)(2006-10#2)(2007-11#1)
pharmacology is##2##2##(1995-12#2)
pharmacology of an angiotensin AT1 receptor antagonist with balanced affinity for AT2 receptors##2##13##(1995-12#2)
pharmacology of the##9##3##(1993-12#1)(1995-11#2)(1995-2#1)(2005-7#1)(2006-8#1)(2008-3#1)(2008-4#1)(2008-7#1)
pharmacology of these##2##3##(2006-10#1)(2012-12#1)
pharmacology of##34##2##(1990-1#1)(1990-7#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-8#1)(1995-11#3)(1995-12#3)(1995-2#1)(1996-1#1)(1996-7#1)(2005-7#3)(2005-8#1)(2006-10#4)(2006-12#1)(2006-8#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-8#1)(2012-12#1)(2012-2#1)
pharmacology or##2##2##(2005-8#1)(2008-12#1)
pharmacology##170##1##(1990-1#1)(1990-11#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-8#2)(1995-11#7)(1995-12#5)(1995-2#1)(1995-3#2)(1995-5#1)(1996-1#2)(1996-12#3)(1996-7#1)(1996-8#3)(1997-2#1)(1997-5#1)(1997-6#1)(2004-12#1)(2005-7#3)(2005-8#14)(2006-1#1)(2006-10#14)(2006-12#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#6)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#3)(2008-1#3)(2008-10#3)(2008-11#3)(2008-12#9)(2008-3#2)(2008-4#4)(2008-5#7)(2008-7#5)(2008-8#5)(2008-9#1)(2009-10#1)(2009-4#3)(2009-8#2)(2010-2#1)(2010-5#2)(2010-6#2)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#8)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
pharmacopeia##3##1##(2008-10#1)(2012-3#1)(2013-8#1)
pharmacophore and##2##2##(2006-12#1)(2008-3#1)
pharmacophore directed##2##2##(1994-5#2)
pharmacophore for##2##2##(1993-4#1)(2010-4#1)
pharmacophore model for##2##3##(1993-4#1)(2010-12#1)
pharmacophore model was##3##3##(1993-4#2)(2013-7#1)
pharmacophore model##13##2##(1993-4#5)(2010-12#1)(2012-2#1)(2012-3#5)(2013-7#1)
pharmacophore modeling##2##2##(2006-12#1)(2012-3#1)
pharmacophore models##3##2##(2006-12#1)(2012-3#1)(2013-1#1)
pharmacophore of##2##2##(1996-9#1)(2007-11#1)
pharmacophore##36##1##(1990-7#1)(1993-4#7)(1994-5#2)(1994-9#1)(1996-9#1)(2006-12#4)(2007-11#1)(2008-3#2)(2010-12#2)(2010-4#1)(2010-5#1)(2011-3#1)(2012-2#2)(2012-3#7)(2013-1#1)(2013-7#2)
pharmacophoric features##2##2##(2012-3#1)(2013-1#1)
pharmacophoric##7##1##(1990-7#1)(1993-8#1)(2007-10#1)(2009-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
pharmacopoeia##4##1##(2008-10#1)(2008-3#2)(2008-5#1)
pharmacopoeial##8##1##(2007-8#3)(2008-10#3)(2008-5#1)(2010-5#1)
pharmacopoeias##4##1##(2008-10#1)(2012-12#1)(2012-2#2)
pharmacotherapeutic agents in##2##3##(2008-1#1)(2008-4#1)
pharmacotherapeutic agents##6##2##(2007-10#1)(2007-9#1)(2008-1#2)(2008-4#2)
pharmacotherapeutic options for##2##3##(2008-4#1)(2013-1#1)
pharmacotherapeutic##19##1##(1991-11#1)(1991-8#1)(1992-2#1)(1993-8#1)(1997-8#1)(2004-3#1)(2005-7#1)(2007-10#1)(2007-6#1)(2007-9#1)(2008-1#2)(2008-2#1)(2008-3#1)(2008-4#3)(2009-4#1)(2013-1#1)
pharmacotherapies for##2##2##(2008-2#1)(2013-1#1)
pharmacotherapies in##2##2##(2008-2#1)(2008-3#1)
pharmacotherapies##20##1##(2005-9#1)(2006-2#1)(2006-9#1)(2008-11#2)(2008-2#6)(2008-3#1)(2009-2#1)(2009-6#1)(2011-2#1)(2011-7#1)(2012-1#2)(2013-1#2)
pharmacotherapy and psychotherapy##2##3##(2011-12#1)(2013-8#1)
pharmacotherapy and##11##2##(2005-7#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-2#1)(2011-1#1)(2011-12#1)(2013-8#2)
pharmacotherapy as a##2##3##(2007-10#1)(2008-4#1)
pharmacotherapy during##2##2##(2013-1#2)
pharmacotherapy for chronic##2##3##(2011-2#1)(2013-1#1)
pharmacotherapy for##8##2##(2006-9#1)(2007-2#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-8#1)(2011-2#1)(2013-1#1)
pharmacotherapy has##2##2##(1993-11#1)(2008-2#1)
pharmacotherapy in the##3##3##(1990-3#1)(2008-4#1)(2011-1#1)
pharmacotherapy in##13##2##(1990-3#1)(1995-10#1)(1997-2#1)(2006-11#1)(2008-2#2)(2008-4#2)(2008-8#1)(2011-1#2)(2012-12#1)(2013-7#1)
pharmacotherapy is##3##2##(2006-10#1)(2012-2#2)
pharmacotherapy of##14##2##(1990-7#1)(1996-12#1)(2006-3#1)(2007-6#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
pharmacotherapy with##3##2##(2005-7#1)(2007-11#1)(2012-2#1)
pharmacotherapy##116##1##(1990-3#1)(1990-6#1)(1990-7#1)(1991-2#1)(1991-9#1)(1992-2#1)(1992-9#1)(1993-11#3)(1995-10#3)(1996-12#2)(1997-2#1)(2004-12#1)(2004-3#3)(2005-7#4)(2006-10#3)(2006-11#1)(2006-12#2)(2006-3#1)(2006-6#1)(2006-9#3)(2007-10#1)(2007-11#3)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-2#5)(2008-3#5)(2008-4#9)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#10)(2013-7#1)(2013-8#3)
pharmacotherapy-assisted quit attempts##2##3##(2013-1#2)
pharmacovigilance in##2##2##(2008-11#1)(2008-8#1)
pharmacovigilance practice##2##2##(2008-11#2)
pharmacovigilance study##3##2##(2010-5#2)(2011-2#1)
pharmacovigilance##28##1##(2007-2#1)(2008-11#13)(2008-8#4)(2009-6#1)(2010-5#2)(2011-2#1)(2013-1#4)(2013-8#2)
pharmacy and##6##2##(2006-5#1)(2007-8#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-12#1)
pharmacy claims of##2##3##(2008-11#1)(2009-6#1)
pharmacy claims##3##2##(2008-11#1)(2009-6#1)(2009-9#1)
pharmacy curriculum##2##2##(2011-1#1)(2011-2#1)
pharmacy department##3##2##(1992-1#1)(2008-1#2)
pharmacy education##8##2##(2008-1#2)(2010-3#1)(2011-1#2)(2011-2#3)
pharmacy faculty##2##2##(2011-1#2)
pharmacy for##2##2##(2010-3#1)(2011-1#1)
pharmacy graduates##3##2##(2008-1#3)
pharmacy in the##2##3##(1995-11#1)(2008-8#1)
pharmacy in##5##2##(1995-11#1)(2004-4#1)(2008-1#1)(2008-8#1)(2010-3#1)
pharmacy practice##8##2##(2009-2#1)(2010-3#2)(2011-1#3)(2011-2#1)(2013-1#1)
pharmacy schools##5##2##(1994-12#1)(2011-1#4)
pharmacy services##6##2##(2008-10#1)(2011-2#4)(2013-1#1)
pharmacy students##3##2##(2009-12#1)(2010-4#1)(2011-1#1)
pharmacy students'##2##2##(2010-3#1)(2011-2#1)
pharmacy technician##2##2##(2008-1#2)
pharmacy##153##1##(1990-9#1)(1991-1#1)(1991-7#1)(1992-1#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#5)(1993-3#2)(1994-12#2)(1995-1#3)(1995-11#1)(1995-2#1)(1997-2#1)(2004-4#1)(2005-4#1)(2005-7#1)(2005-9#1)(2006-3#1)(2006-5#3)(2006-8#2)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#12)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#1)(2008-6#3)(2008-8#4)(2008-9#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#17)(2010-4#1)(2010-5#1)(2010-8#5)(2010-9#2)(2011-1#27)(2011-12#1)(2011-2#19)(2012-12#1)(2013-1#6)
pharmacy's##2##1##(2010-8#2)
pharmacy-based##2##1##(1990-9#1)(2010-3#1)
pharyngeal and laryngeal##3##3##(1990-9#1)(2010-12#1)(2013-8#1)
pharyngeal muscles##3##2##(2010-2#1)(2011-1#2)
pharyngeal or##2##2##(2011-2#1)(2012-2#1)
pharyngeal pumping##2##2##(2007-12#2)
pharyngeal swabs were##2##3##(2008-5#1)(2011-2#1)
pharyngeal swabs##3##2##(2008-5#2)(2011-2#1)
pharyngeal##38##1##(1990-11#1)(1990-6#1)(1990-9#1)(1993-2#1)(1995-6#1)(1996-9#1)(1997-4#2)(1997-6#1)(2005-10#1)(2006-10#1)(2007-12#3)(2007-6#1)(2007-7#1)(2008-4#1)(2008-5#3)(2009-1#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
pharyngitis in##4##2##(2007-7#2)(2012-2#2)
pharyngitis##14##1##(1991-12#1)(1992-2#1)(2006-4#2)(2007-3#2)(2007-7#2)(2008-4#1)(2009-5#1)(2010-2#1)(2012-2#3)
pharyngo-esophageal##2##1##(1992-8#2)
pharyngolaryngeal##3##1##(1991-9#1)(2005-5#1)(2010-7#1)
pharynx and##3##2##(1997-7#1)(2008-12#1)(2008-9#1)
pharynx is##2##2##(2007-12#1)(2009-10#1)
pharynx of##2##2##(2006-7#1)(2011-2#1)
pharynx##32##1##(1990-8#2)(1991-5#2)(1993-8#1)(1995-5#3)(1997-6#1)(1997-7#1)(2005-10#1)(2006-7#1)(2007-12#4)(2007-6#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-9#1)(2009-1#1)(2009-10#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)
phase (0##3##2##(2006-7#2)(2007-11#1)
phase (2##2##2##(2007-10#1)(2008-5#1)
phase (7##2##2##(1994-2#1)(2008-10#1)
phase (L##2##2##(1990-3#2)
phase (mean##2##2##(2008-3#1)(2010-8#1)
phase (the##3##2##(2007-9#1)(2008-3#1)(2012-2#1)
phase 1 and##2##3##(1997-2#1)(2008-5#1)
phase 1##11##2##(1994-3#2)(1997-2#1)(1997-6#2)(2007-10#1)(2007-11#1)(2008-11#1)(2008-5#2)(2009-2#1)
phase 2##15##2##(1993-3#1)(1995-12#1)(1997-2#1)(1997-6#1)(2006-12#1)(2007-10#2)(2007-11#1)(2007-9#1)(2008-3#1)(2009-12#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-1#1)
phase 3 clinical trials##2##4##(2010-12#1)(2012-12#1)
phase 3 trials in##2##4##(2008-3#1)(2011-1#1)
phase 3 trials##3##3##(2008-3#1)(2011-1#1)(2011-2#1)
phase 3##14##2##(1997-6#1)(2007-11#1)(2008-3#4)(2008-9#2)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
phase 3)##2##2##(2008-9#2)
phase C(18) column##5##3##(2008-10#4)(2011-2#1)
phase Doppler anemometry##2##3##(2008-2#1)(2008-3#1)
phase Doppler##3##2##(2008-2#2)(2008-3#1)
phase HPLC and##2##3##(1991-1#1)(1992-1#1)
phase HPLC##15##2##(1990-10#1)(1990-12#2)(1991-1#1)(1991-5#1)(1991-8#1)(1992-1#1)(1995-1#1)(1995-5#2)(2007-1#1)(2007-8#1)(2008-10#2)(2008-8#1)
phase I - II study##2##5##(2006-6#2)
phase I - II##3##4##(2006-6#3)
phase I Coxiella burnetii##2##4##(1995-12#2)
phase I and II clinical trials##2##6##(2004-1#1)(2005-8#1)
phase I and II clinical##4##5##(2004-1#1)(2005-8#1)(2008-5#2)
phase I and II##12##4##(1995-12#2)(1997-8#2)(2004-1#1)(2005-8#1)(2007-10#1)(2008-11#1)(2008-5#2)(2009-4#1)(2011-12#1)
phase I and phase II trials##2##6##(2008-5#2)
phase I and phase II##4##5##(1995-12#1)(2008-5#2)(2008-7#1)
phase I and##16##3##(1995-12#3)(1997-8#2)(2004-1#1)(2005-8#1)(2007-10#1)(2008-11#1)(2008-5#4)(2008-7#1)(2009-4#1)(2011-12#1)
phase I biotransformation parameter##2##4##(2008-7#1)(2009-4#1)
phase I biotransformation##3##3##(2008-7#1)(2009-4#1)(2011-2#1)
phase I clinical trials as##2##5##(2008-5#2)
phase I clinical trials##12##4##(1993-6#2)(1996-8#1)(2005-8#2)(2006-10#1)(2008-11#1)(2008-5#4)(2012-3#1)
phase I clinical##14##3##(1993-6#2)(1996-8#1)(2005-8#2)(2006-10#1)(2008-11#1)(2008-5#5)(2011-2#1)(2012-3#1)
phase I development##2##3##(2005-7#1)(2008-8#1)
phase I human trials##2##4##(2008-5#2)
phase I metabolites##3##3##(1997-8#2)(2011-3#1)
phase I of##2##3##(2006-8#2)
phase I studies##4##3##(1993-6#1)(2005-8#1)(2006-6#1)(2010-12#1)
phase I study of##3##4##(1992-10#1)(2005-8#1)(2008-5#1)
phase I study##12##3##(1991-1#1)(1992-10#1)(2004-1#1)(2005-7#1)(2005-8#1)(2006-6#1)(2007-4#1)(2008-5#4)(2008-7#1)
phase I trial##7##3##(1994-9#1)(2005-10#1)(2008-5#3)(2008-6#1)(2012-1#1)
phase I trials for##2##4##(2005-8#2)
phase I trials in##3##4##(2005-7#1)(2008-5#2)
phase I trials##11##3##(2005-7#2)(2005-8#4)(2005-9#1)(2008-5#3)(2011-2#1)
phase I##107##2##(1991-1#1)(1992-10#1)(1993-10#1)(1993-6#3)(1994-9#1)(1995-11#1)(1995-12#7)(1995-2#1)(1996-8#1)(1997-8#4)(2004-1#2)(2005-10#1)(2005-7#4)(2005-8#11)(2005-9#1)(2006-10#1)(2006-6#5)(2006-8#3)(2007-10#1)(2007-11#1)(2007-2#2)(2007-4#1)(2008-1#2)(2008-11#2)(2008-4#1)(2008-5#24)(2008-6#1)(2008-7#3)(2008-8#1)(2009-4#2)(2010-12#2)(2010-5#2)(2011-12#1)(2011-2#6)(2011-3#2)(2012-1#2)(2012-3#2)
phase I-II study##4##3##(1990-12#1)(1991-3#1)(1993-8#1)(2006-6#1)
phase I-II##5##2##(1990-12#1)(1991-3#1)(1993-8#1)(2006-6#1)(2008-4#1)
phase I/II clinical trial##2##4##(1995-8#1)(2008-5#1)
phase I/II trial##3##3##(2005-7#1)(2006-12#1)(2008-5#1)
phase I/II trials##4##3##(2005-7#1)(2005-8#1)(2007-11#1)(2008-7#1)
phase I/II##11##2##(1995-8#1)(2005-7#2)(2005-8#1)(2006-12#1)(2007-11#1)(2008-5#4)(2008-7#1)
phase II and III clinical trials##2##6##(2009-11#1)(2010-12#1)
phase II and III studies##3##5##(1993-6#1)(2008-5#2)
phase II and III##7##4##(1993-6#1)(2008-5#2)(2009-11#1)(2010-12#1)(2012-2#1)(2012-3#1)
phase II and##8##3##(1993-6#1)(2007-7#1)(2008-5#2)(2009-11#1)(2010-12#1)(2012-2#1)(2012-3#1)
phase II cancer clinical trials##2##5##(1997-8#1)(2012-2#1)
phase II clinical trial##5##4##(1990-12#1)(1997-8#1)(2008-12#1)(2008-5#1)(2009-8#1)
phase II clinical trials by##2##5##(2005-8#1)(2008-5#1)
phase II clinical trials in##3##5##(2005-8#3)
phase II clinical trials##21##4##(2005-7#4)(2005-8#7)(2005-9#1)(2006-10#1)(2008-5#7)(2009-3#1)
phase II clinical##28##3##(1990-12#1)(1997-8#1)(2005-7#4)(2005-8#7)(2005-9#1)(2006-10#1)(2008-12#1)(2008-5#9)(2009-3#1)(2009-8#1)(2013-1#1)
phase II enzymes##2##3##(2008-7#1)(2011-2#1)
phase II multicenter##4##3##(2005-7#1)(2005-8#1)(2008-6#1)(2010-5#1)
phase II studies have##2##4##(2006-6#1)(2007-11#1)
phase II studies in##3##4##(1990-9#1)(2007-11#1)(2008-5#1)
phase II studies##12##3##(1990-9#1)(2005-8#2)(2006-6#1)(2007-11#3)(2008-5#2)(2008-6#1)(2008-8#1)(2011-2#1)
phase II study of##4##4##(1990-10#1)(1993-2#1)(1995-10#1)(2005-8#1)
phase II study was to##2##5##(2007-7#1)(2008-10#1)
phase II study was##4##4##(2007-7#1)(2008-10#2)(2008-6#1)
phase II study##30##3##(1990-10#3)(1991-2#1)(1991-4#1)(1992-2#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-7#1)(1994-8#1)(1995-10#1)(2005-8#1)(2006-6#3)(2007-3#1)(2007-4#2)(2007-7#1)(2008-10#4)(2008-6#4)(2011-12#1)(2011-2#1)
phase II trial in##3##4##(2008-5#2)(2009-3#1)
phase II trial of##7##4##(1992-10#1)(1993-1#1)(2005-8#1)(2007-11#1)(2008-5#1)(2008-6#1)(2009-8#1)
phase II trial##22##3##(1992-10#1)(1993-1#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-6#1)(2007-11#2)(2007-7#2)(2008-5#5)(2008-6#2)(2009-3#1)(2009-8#1)(2010-12#1)(2012-2#1)
phase II trials for the treatment of##2##7##(2005-6#1)(2005-8#1)
phase II trials for the##3##5##(2005-6#1)(2005-8#2)
phase II trials for##11##4##(2005-6#1)(2005-7#3)(2005-8#5)(2008-5#2)
phase II trials have##3##4##(2004-1#2)(2013-1#1)
phase II trials in patients with##3##6##(2005-7#1)(2007-7#1)(2008-5#1)
phase II trials in patients##4##5##(2005-7#1)(2007-7#1)(2008-5#2)
phase II trials in##7##4##(2005-11#1)(2005-7#2)(2007-7#1)(2008-5#3)
phase II trials##35##3##(2004-1#2)(2005-11#1)(2005-6#1)(2005-7#6)(2005-8#10)(2005-9#2)(2006-10#1)(2007-7#2)(2008-5#9)(2013-1#1)
phase II##190##2##(1990-10#3)(1990-12#1)(1990-2#1)(1990-9#1)(1991-2#3)(1991-3#1)(1991-4#1)(1992-10#1)(1992-2#1)(1993-1#1)(1993-2#1)(1993-6#2)(1994-2#1)(1994-7#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#6)(1997-8#2)(2004-1#4)(2005-11#2)(2005-6#1)(2005-7#13)(2005-8#25)(2005-9#3)(2006-10#4)(2006-12#1)(2006-6#5)(2007-11#7)(2007-2#2)(2007-3#1)(2007-4#2)(2007-7#7)(2008-10#5)(2008-12#1)(2008-5#34)(2008-6#8)(2008-7#2)(2008-8#5)(2009-11#2)(2009-3#3)(2009-4#1)(2009-8#2)(2010-12#3)(2010-5#1)(2010-6#1)(2011-12#1)(2011-2#3)(2012-2#6)(2012-3#3)(2013-1#2)
phase II/III clinical##2##3##(2005-8#1)(2012-3#1)
phase II/III design##2##3##(2012-2#2)
phase II/III trial##3##3##(2007-2#1)(2008-5#2)
phase II/III##11##2##(2005-8#1)(2007-2#1)(2008-5#4)(2008-7#1)(2012-2#3)(2012-3#1)
phase IIB##2##2##(2008-8#2)
phase III clinical trial##5##4##(2008-5#1)(2008-7#1)(2010-1#1)(2011-3#1)(2012-2#1)
phase III clinical trials for the treatment of##3##8##(2005-8#1)(2005-9#2)
phase III clinical trials in##3##5##(2005-8#1)(2008-5#2)
phase III clinical trials##18##4##(1994-11#1)(2005-8#2)(2005-9#3)(2007-11#3)(2007-12#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-5#3)(2009-11#1)(2010-1#1)
phase III clinical##23##3##(1994-11#1)(2005-8#2)(2005-9#3)(2007-11#3)(2007-12#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-5#4)(2008-7#1)(2009-11#1)(2010-1#2)(2011-3#1)(2012-2#1)
phase III development##2##3##(2008-1#1)(2008-5#1)
phase III studies##8##3##(2005-9#1)(2006-4#1)(2007-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2010-12#1)
phase III study in##2##4##(2007-11#1)(2008-3#1)
phase III study of##4##4##(2007-11#1)(2008-7#1)(2010-12#1)(2012-12#1)
phase III study##14##3##(1992-12#1)(1997-4#1)(2007-11#3)(2007-7#2)(2008-3#3)(2008-5#1)(2008-7#1)(2010-12#1)(2012-12#1)
phase III trial for##4##4##(2005-8#1)(2005-9#1)(2008-5#2)
phase III trial with a clinical##2##6##(2008-8#2)
phase III trial with##3##4##(2008-8#3)
phase III trial##28##3##(2004-1#1)(2005-11#1)(2005-7#1)(2005-8#3)(2005-9#2)(2006-10#1)(2006-6#1)(2007-12#1)(2007-9#1)(2008-3#1)(2008-5#8)(2008-8#3)(2010-12#3)(2012-12#1)
phase III trials are##5##4##(2004-1#1)(2005-11#1)(2008-5#3)
phase III trials for the##3##5##(2005-8#1)(2005-9#1)(2008-5#1)
phase III trials for##14##4##(2005-6#2)(2005-7#1)(2005-8#6)(2005-9#2)(2008-3#1)(2008-5#2)
phase III trials in##5##4##(2005-8#2)(2008-5#2)(2009-11#1)
phase III trials of##2##4##(2007-9#1)(2010-12#1)
phase III trials##45##3##(2004-1#3)(2005-11#1)(2005-6#3)(2005-7#3)(2005-8#10)(2005-9#3)(2007-11#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-3#2)(2008-5#7)(2008-7#1)(2008-8#1)(2009-11#2)(2009-3#1)(2009-8#1)(2010-12#2)
phase III##145##2##(1992-12#1)(1994-11#1)(1995-11#1)(1995-5#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-1#5)(2005-11#2)(2005-6#3)(2005-7#6)(2005-8#17)(2005-9#9)(2006-10#1)(2006-12#3)(2006-4#1)(2006-6#1)(2007-11#12)(2007-12#2)(2007-2#1)(2007-7#5)(2007-9#3)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#8)(2008-5#24)(2008-6#1)(2008-7#3)(2008-8#6)(2009-11#3)(2009-3#2)(2009-8#1)(2010-1#2)(2010-12#8)(2011-3#1)(2012-12#2)(2012-2#2)
phase IV data##2##3##(2006-10#1)(2007-10#1)
phase IV study##2##3##(2007-7#1)(2013-8#1)
phase IV##6##2##(1997-3#1)(2006-10#1)(2007-10#1)(2007-7#2)(2013-8#1)
phase TFIID fraction##2##3##(1997-6#2)
phase aberration##3##2##(2008-2#3)
phase aberrations##7##2##(2007-12#3)(2008-2#2)(2008-3#2)
phase absorbances at##2##3##(2008-10#2)
phase accumulation##2##2##(2007-12#2)
phase advance of##2##3##(1991-12#1)(2008-5#1)
phase advance##4##2##(1991-12#1)(1992-3#1)(1997-6#1)(2008-5#1)
phase advances##3##2##(1992-3#2)(1997-5#1)
phase after##4##2##(1993-9#1)(1996-12#1)(2008-10#1)(2008-3#1)
phase allows##3##2##(1993-2#1)(2007-10#1)(2008-3#1)
phase analysis of the##2##4##(1994-9#2)
phase analysis of##3##3##(1994-9#3)
phase analysis##6##2##(1994-9#3)(1996-9#1)(2008-3#2)
phase and 0##2##3##(2008-10#2)
phase and a##11##3##(1990-7#1)(1993-12#1)(1994-12#1)(2005-12#1)(2007-12#1)(2008-10#5)(2008-7#1)
phase and amplitude of the##3##5##(2008-2#2)(2008-3#1)
phase and amplitude of##4##4##(2008-2#2)(2008-3#2)
phase and amplitude profile##2##4##(2007-11#1)(2007-12#1)
phase and amplitude spatial##2##4##(2008-2#1)(2008-3#1)
phase and amplitude##21##3##(1997-6#1)(2006-5#2)(2007-11#4)(2007-12#5)(2008-2#4)(2008-3#5)
phase and an##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
phase and are##2##3##(1996-5#1)(2006-10#1)
phase and by##3##3##(1995-1#1)(1996-1#1)(2006-10#1)
phase and concentration of##2##4##(1997-3#1)(2008-10#1)
phase and decreased##2##3##(1997-2#1)(2008-11#1)
phase and frequency##2##3##(2007-12#1)(2008-3#1)
phase and in##4##3##(1992-4#1)(2007-9#1)(2008-10#1)(2008-7#1)
phase and is##2##3##(2003-11#1)(2008-10#1)
phase and solution##2##3##(2005-11#1)(2010-6#1)
phase and the number of##2##5##(1993-6#1)(2008-4#1)
phase and the##36##3##(1990-10#1)(1990-12#2)(1990-7#1)(1991-5#1)(1993-6#1)(1996-8#1)(1997-3#1)(2004-12#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-2#5)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2009-7#1)(2011-1#2)(2011-2#1)
phase and with##2##3##(1990-12#1)(1997-8#1)
phase and##235##2##(1990-10#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-7#2)(1990-8#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#2)(1993-6#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1996-1#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#3)(1997-2#1)(1997-3#3)(1997-5#1)(1997-6#2)(1997-8#3)(2003-11#1)(2004-11#1)(2004-12#1)(2005-11#2)(2005-12#1)(2006-1#1)(2006-10#4)(2006-12#2)(2006-5#2)(2006-6#1)(2007-11#8)(2007-12#24)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#53)(2008-11#8)(2008-2#12)(2008-3#15)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#3)(2009-3#2)(2009-7#2)(2009-8#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#5)(2011-2#5)(2011-3#1)(2013-1#4)
phase angle##7##2##(1993-11#1)(2007-11#2)(2008-3#1)(2011-2#1)(2013-1#1)(2013-7#1)
phase anisotropy##2##2##(2008-3#2)
phase appeared##2##2##(2008-10#1)(2008-8#1)
phase are##8##2##(1991-4#1)(1992-5#1)(1997-4#1)(2006-5#1)(2008-10#1)(2008-3#1)(2012-3#1)(2013-8#1)
phase arrest##2##2##(2010-6#1)(2011-12#1)
phase as a##4##3##(1990-7#1)(2008-10#1)(2008-2#1)(2008-7#1)
phase as an##3##3##(2008-10#3)
phase as the##3##3##(2005-11#1)(2007-11#1)(2008-10#1)
phase as well as amplitude##2##5##(2008-2#1)(2008-3#1)
phase as well as##6##4##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2013-7#1)
phase as##21##2##(1990-7#1)(1992-12#1)(1993-1#1)(1996-8#1)(2005-11#1)(2007-11#2)(2008-10#6)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2012-1#1)(2012-2#1)(2013-7#1)
phase at a##10##3##(1992-2#1)(1996-8#1)(2007-8#1)(2008-10#2)(2008-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
phase at pH 7##2##4##(2008-10#2)
phase at pH##4##3##(2008-10#2)(2008-11#1)(2008-3#1)
phase at temperatures##2##3##(1990-2#1)(2006-10#1)
phase at the##4##3##(1990-9#1)(2007-12#1)(2008-10#1)(2008-2#1)
phase at##36##2##(1990-2#1)(1990-9#1)(1992-10#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-6#1)(1996-1#1)(1996-8#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)
phase based##2##2##(2008-5#1)(2010-5#1)
phase because##2##2##(2008-2#1)(2013-1#1)
phase before##4##2##(2004-12#1)(2008-10#3)
phase behavior and structure of sucrose ester/water/oil systems##2##8##(2005-11#2)
phase behavior and structure##3##4##(2005-11#3)
phase behavior and##5##3##(1990-5#1)(2005-11#3)(2008-10#1)
phase behavior at low CBS concentrations##2##6##(1993-8#2)
phase behavior of a##2##4##(1996-1#1)(2008-12#1)
phase behavior of##16##3##(1990-2#1)(1990-4#1)(1990-7#1)(1991-2#1)(1993-8#2)(1996-1#2)(2005-11#4)(2006-10#2)(2008-12#1)(2010-4#1)
phase behavior##30##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#2)(1991-2#1)(1993-8#5)(1994-5#1)(1996-1#3)(2005-11#7)(2006-10#2)(2008-10#1)(2008-12#2)(2008-8#1)(2010-4#1)(2010-7#1)
phase behaviors##3##2##(2006-10#1)(2008-10#2)
phase behaviour and##2##3##(2006-10#1)(2012-2#1)
phase behaviour of##5##3##(1994-3#2)(2006-10#2)(2012-2#1)
phase behaviour##9##2##(1994-3#2)(2006-10#3)(2008-5#2)(2012-2#2)
phase between the##5##3##(2007-12#2)(2008-3#2)(2009-7#1)
phase between##6##2##(2007-12#2)(2008-1#1)(2008-3#2)(2009-7#1)
phase bias##4##2##(2007-12#1)(2008-3#2)(2012-2#1)
phase binding##5##2##(1993-2#1)(1994-3#1)(1996-12#1)(2008-10#1)(2008-4#1)
phase block##2##2##(1995-11#2)
phase boundaries##3##2##(1990-2#1)(1991-6#2)
phase boundary##7##2##(1990-2#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)
phase but##8##2##(1992-3#1)(1993-6#1)(1993-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-2#1)
phase by a##3##3##(1997-2#1)(2008-10#1)(2012-12#1)
phase by the##2##3##(2008-10#1)(2008-11#1)
phase by##28##2##(1991-3#1)(1991-6#1)(1992-8#1)(1997-2#1)(2006-10#2)(2007-11#2)(2007-12#2)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#1)(2010-4#1)(2012-12#1)(2013-8#1)
phase called##2##2##(2010-9#1)(2011-1#1)
phase callusing##2##2##(2008-12#2)
phase can be used##2##4##(1996-5#1)(2007-12#1)
phase can be##14##3##(1991-11#1)(1996-5#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#1)(2009-3#1)
phase can occur##2##3##(1997-8#1)(2008-10#1)
phase can##19##2##(1991-11#1)(1996-5#2)(1997-8#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2012-12#1)
phase cannot be##2##3##(2008-10#1)(2008-2#1)
phase cartridges##3##2##(1997-8#1)(2008-10#2)
phase causes##2##2##(1997-1#1)(2008-7#1)
phase cell cycle##2##3##(2011-12#1)(2013-8#1)
phase cells##3##2##(2008-11#2)(2008-5#1)
phase change and##2##3##(1994-12#1)(2008-2#1)
phase change in each##2##4##(2007-11#1)(2008-3#1)
phase change in locusts##2##4##(2012-2#2)
phase change in##5##3##(2007-11#1)(2008-2#1)(2008-3#1)(2012-2#2)
phase change of the##2##4##(2007-11#1)(2008-10#1)
phase change of##6##3##(1994-2#1)(2007-11#2)(2008-10#3)
phase change on reflection from##2##5##(2008-2#2)
phase change on reflection in##2##5##(2007-11#2)
phase change on reflection##8##4##(2007-11#2)(2008-2#6)
phase change to be##2##4##(2007-11#1)(2008-3#1)
phase change##40##2##(1991-6#1)(1994-12#1)(1994-2#2)(2006-6#2)(2007-11#8)(2007-12#3)(2008-10#4)(2008-2#9)(2008-3#7)(2012-2#3)
phase changed the landscape of##2##5##(2005-12#2)
phase changes in the##3##4##(2006-5#1)(2007-11#1)(2008-5#1)
phase changes in##8##3##(1995-11#1)(2006-5#1)(2007-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2013-1#1)
phase changes of##4##3##(1994-2#2)(2007-12#1)(2008-2#1)
phase changes on##2##3##(2008-2#2)
phase changes with##2##3##(2007-12#1)(2008-11#1)
phase changes##33##2##(1994-2#2)(1995-11#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-11#2)(2007-12#6)(2008-11#2)(2008-2#11)(2008-3#3)(2008-5#2)(2013-1#1)
phase characteristics##2##2##(1994-12#1)(2007-12#1)
phase chemiluminescence##2##2##(1990-2#1)(2008-10#1)
phase chessboard##2##2##(2008-3#2)
phase chromatographic##4##2##(2008-10#3)(2010-5#1)
phase chromatography (RPC)##2##3##(1996-7#1)(2008-10#1)
phase chromatography##12##2##(1993-9#1)(1994-11#1)(1996-7#1)(1997-4#1)(2008-10#6)(2008-5#1)(2009-4#1)
phase code##4##2##(2007-12#1)(2008-3#3)
phase codes located in the##2##5##(2007-12#1)(2008-3#1)
phase codes##12##2##(2007-12#6)(2008-3#6)
phase coding of place information##2##5##(2008-11#2)
phase coding##8##2##(2007-11#1)(2008-11#7)
phase coherence##8##2##(1991-4#1)(2007-11#4)(2007-12#2)(2008-1#1)
phase column##8##2##(1992-8#1)(1992-9#1)(1996-6#1)(2005-3#1)(2008-10#3)(2008-6#1)
phase compared with##4##3##(2007-8#3)(2008-3#1)
phase compensation in##2##3##(2007-12#2)
phase compensation is##3##3##(2008-3#2)(2013-8#1)
phase compensation##17##2##(2007-12#6)(2008-2#2)(2008-3#5)(2013-8#4)
phase components##3##2##(2007-12#1)(2008-3#2)
phase composed of##5##3##(2008-10#1)(2008-7#1)(2010-12#1)(2010-2#1)(2013-7#1)
phase composition and##2##3##(1997-8#1)(2009-7#1)
phase composition on the##2##4##(2007-12#1)(2008-10#1)
phase composition##22##2##(1996-5#1)(1997-8#1)(2005-12#1)(2007-12#1)(2007-8#3)(2008-10#8)(2008-11#1)(2008-5#1)(2009-7#3)(2009-9#1)(2010-12#1)
phase computer-generated holograms##2##3##(2008-2#1)(2008-3#1)
phase computer-generated##3##2##(2008-2#1)(2008-3#2)
phase concentrations##2##2##(2006-10#1)(2008-10#1)
phase conditions##6##2##(1990-11#1)(1996-11#1)(1996-8#2)(1997-4#1)(2007-12#1)
phase conjugate##3##2##(2007-12#2)(2008-3#1)
phase conjugation by##2##3##(2007-12#1)(2008-1#1)
phase conjugation from##3##3##(2008-2#3)
phase conjugation in a photorefractive crystal##2##6##(2008-2#2)
phase conjugation in a##8##4##(1990-7#1)(2007-12#5)(2008-2#2)
phase conjugation in##11##3##(1990-7#2)(2007-12#5)(2008-2#4)
phase conjugation with##2##3##(2007-12#2)
phase conjugation##29##2##(1990-7#2)(2007-12#11)(2008-1#3)(2008-2#10)(2008-3#3)
phase conjugator to##2##3##(2008-2#2)
phase conjugator##8##2##(2007-12#2)(2008-2#4)(2008-3#2)
phase consisting of##23##3##(1990-11#1)(1990-12#1)(1990-6#1)(1991-5#1)(1996-6#2)(1996-8#1)(1997-3#2)(1997-8#1)(2008-10#6)(2008-6#1)(2010-2#2)(2010-3#1)(2011-1#1)(2012-12#1)(2012-3#1)
phase containing a mixture of##2##5##(2004-12#1)(2010-3#1)
phase containing a##5##3##(2004-12#1)(2008-10#2)(2010-3#1)(2012-12#1)
phase containing an##2##3##(1990-8#1)(2004-12#1)
phase containing##22##2##(1990-8#1)(1991-8#1)(1992-1#1)(1997-3#1)(1997-8#1)(2004-12#3)(2008-10#11)(2008-7#1)(2010-3#1)(2012-12#1)
phase contrast magnetic resonance##2##4##(2012-3#2)
phase contrast microscope##3##3##(2006-5#1)(2008-2#1)(2013-1#1)
phase contrast microscopy##3##3##(1997-7#1)(2008-11#1)(2013-7#1)
phase contrast##16##2##(1992-12#1)(1997-7#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2012-3#2)(2013-1#1)(2013-3#2)(2013-7#1)(2013-8#1)
phase control of##3##3##(2007-12#2)(2008-3#1)
phase control##11##2##(2007-11#2)(2007-12#4)(2008-1#2)(2008-3#3)
phase correction method##2##3##(2013-8#2)
phase correction of##3##3##(2007-11#1)(2007-12#1)(2013-8#1)
phase correction##13##2##(2007-11#1)(2007-12#5)(2008-2#1)(2013-8#6)
phase correlation##4##2##(2007-12#4)
phase corresponding to the##2##4##(2008-3#2)
phase could be##5##3##(1993-5#1)(2008-10#2)(2008-11#1)(2009-11#1)
phase could##6##2##(1993-5#1)(1993-8#1)(2008-10#2)(2008-11#1)(2009-11#1)
phase cyclins) were##2##3##(1997-6#2)
phase data from##2##3##(2007-12#1)(2008-3#1)
phase data##10##2##(2006-5#1)(2007-12#1)(2008-2#2)(2008-3#6)
phase delay is##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
phase delay##11##2##(1994-2#1)(1997-6#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#2)
phase delays##7##2##(1992-3#2)(1997-5#1)(2007-11#1)(2007-12#3)
phase delivery##2##2##(2008-10#2)
phase demodulation##4##2##(2007-12#3)(2008-3#1)
phase depended on##2##3##(1991-12#1)(1996-11#1)
phase dependent##2##2##(2008-11#1)(2008-5#1)
phase depends on##2##3##(2006-9#1)(2007-12#1)
phase derivative##3##2##(2008-10#2)(2012-2#1)
phase detection is##2##3##(2007-11#1)(2008-2#1)
phase detection of##2##3##(1997-2#1)(2008-10#1)
phase detection##11##2##(1991-12#1)(1997-2#2)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)
phase determination##4##2##(1992-8#1)(2008-2#1)(2009-3#1)(2012-3#1)
phase diagnostics##2##2##(1994-9#1)(2008-2#1)
phase diagram for the##2##4##(1995-7#1)(2004-9#1)
phase diagram for##4##3##(1990-2#1)(1995-7#1)(2004-9#1)(2010-9#1)
phase diagram of##7##3##(1993-8#1)(1995-10#1)(2004-9#1)(2006-10#1)(2008-10#1)(2008-3#1)(2012-2#1)
phase diagram##25##2##(1990-2#2)(1993-8#1)(1995-10#1)(1995-7#1)(1996-1#1)(1996-4#1)(2004-9#2)(2005-11#2)(2006-10#2)(2008-10#4)(2008-3#1)(2008-5#3)(2010-9#2)(2012-2#2)
phase diagrams were determined##2##4##(2008-5#2)
phase diagrams were##3##3##(2008-5#2)(2012-12#1)
phase diagrams##9##2##(1990-2#1)(1991-9#1)(1993-8#1)(2008-10#1)(2008-5#3)(2010-1#1)(2012-12#1)
phase did not##2##3##(1995-9#1)(2008-11#1)
phase difference between the two##2##5##(2007-12#1)(2008-3#1)
phase difference between the##7##4##(2007-12#3)(2008-3#4)
phase difference between two##5##4##(2007-12#1)(2008-3#3)(2010-2#1)
phase difference between##17##3##(2007-12#6)(2008-11#1)(2008-3#9)(2010-2#1)
phase difference in##2##3##(2007-11#1)(2008-3#1)
phase difference is##5##3##(2007-11#3)(2007-12#1)(2008-2#1)
phase difference of##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
phase difference##39##2##(2007-11#6)(2007-12#14)(2008-11#1)(2008-2#3)(2008-3#14)(2010-2#1)
phase differences in##3##3##(2008-2#2)(2008-9#1)
phase differences pi/2 and 3pi/2##2##5##(2008-3#2)
phase differences##13##2##(2007-12#3)(2008-2#4)(2008-3#5)(2008-9#1)
phase disequilibrium##5##2##(2008-10#3)(2012-3#2)
phase dislocation##2##2##(2007-12#2)
phase dislocations is##3##3##(2007-12#1)(2008-2#2)
phase dislocations##8##2##(2007-11#2)(2007-12#2)(2008-2#4)
phase dispersion##7##2##(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#1)
phase dissolution##2##2##(2008-10#2)
phase distortion##9##2##(2007-11#2)(2008-2#5)(2008-3#2)
phase distortions from##2##3##(2007-11#1)(2008-3#1)
phase distortions of##2##3##(2008-2#2)
phase distortions##13##2##(2007-11#1)(2007-12#1)(2008-2#5)(2008-3#5)(2013-8#1)
phase distribution for the##2##4##(2008-3#2)
phase distribution for##3##3##(2008-2#1)(2008-3#2)
phase distribution from##2##3##(2007-12#1)(2008-2#1)
phase distribution in the##3##4##(2008-2#2)(2008-3#1)
phase distribution in##5##3##(2008-2#3)(2008-3#2)
phase distribution is##3##3##(2008-2#3)
phase distribution of the##2##4##(2007-9#1)(2008-2#1)
phase distribution of##4##3##(2007-11#1)(2007-9#1)(2008-2#1)(2008-3#1)
phase distribution##31##2##(2007-11#2)(2007-12#3)(2007-9#1)(2008-10#1)(2008-2#17)(2008-3#7)
phase distributions##7##2##(2007-12#1)(2008-2#4)(2008-3#1)(2011-1#1)
phase disturbance##2##2##(2008-2#2)
phase disturbances##2##2##(1997-6#1)(2008-3#1)
phase diversity##6##2##(2007-11#1)(2008-2#1)(2008-3#4)
phase domain##3##2##(2007-12#1)(2008-3#1)(2010-4#1)
phase domains##5##2##(1990-4#2)(2005-11#1)(2008-12#1)(2008-3#1)
phase due to##2##3##(1991-5#1)(2008-10#1)
phase duration was##2##3##(2009-9#1)(2011-2#1)
phase duration##6##2##(1990-4#1)(1997-2#1)(2009-9#2)(2011-2#2)
phase during the##2##3##(1991-12#1)(2008-10#1)
phase during which##2##3##(1994-2#1)(2012-1#1)
phase during##11##2##(1991-12#1)(1994-10#1)(1994-2#2)(2008-10#1)(2008-3#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-1#1)(2013-8#1)
phase dysphagia##3##2##(1993-2#3)
phase effects##2##2##(2007-11#1)(2008-2#1)
phase element with##2##3##(2008-2#1)(2008-3#1)
phase element##6##2##(2007-11#1)(2008-2#1)(2008-3#4)
phase elements for##5##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
phase elements##28##2##(2007-11#5)(2007-12#8)(2008-2#5)(2008-3#10)
phase encoded on the##2##4##(2008-2#1)(2008-3#1)
phase encoded##4##2##(2008-2#1)(2008-3#3)
phase encoding in##2##3##(2007-12#1)(2008-3#1)
phase encoding##7##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#4)
phase encryption technique##2##3##(2007-11#1)(2008-3#1)
phase encryption##5##2##(2007-11#1)(2008-3#4)
phase enhances##2##2##(2008-10#1)(2008-5#1)
phase equilibration##2##2##(1991-7#1)(2008-10#1)
phase equilibrium##3##2##(2008-10#2)(2012-3#1)
phase error is##2##3##(2008-2#1)(2008-3#1)
phase error was##2##3##(2007-12#1)(2013-8#1)
phase error##19##2##(2007-12#1)(2008-2#13)(2008-3#4)(2013-8#1)
phase errors in##3##3##(2008-2#3)
phase errors##14##2##(2007-12#3)(2008-2#6)(2008-3#4)(2011-1#1)
phase estimate##2##2##(2008-2#1)(2008-8#1)
phase estimation##5##2##(2006-5#1)(2007-12#1)(2008-3#1)(2012-2#2)
phase estimator##4##2##(2008-2#2)(2008-3#2)
phase evaluation##3##2##(2008-2#2)(2008-3#1)
phase even##2##2##(1997-6#1)(2007-12#1)
phase evolution##3##2##(2007-11#1)(2008-2#1)(2010-4#1)
phase exchange kinetics##3##3##(2008-10#3)
phase exchange##4##2##(2008-10#4)
phase exists##3##2##(2010-4#1)(2012-12#2)
phase extraction (SPE)##43##3##(2007-8#4)(2008-10#33)(2008-11#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
phase extraction and##10##3##(1990-9#1)(2008-10#9)
phase extraction of##9##3##(2008-10#9)
phase extraction##122##2##(1990-9#1)(1993-11#1)(1996-3#1)(2005-11#1)(2007-11#1)(2007-8#10)(2008-10#92)(2008-11#1)(2008-2#2)(2009-10#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-11#1)(2012-12#3)(2013-1#2)(2013-7#1)(2013-8#1)
phase extractive preconcentration of##6##4##(2008-10#6)
phase extractive preconcentration##9##3##(2008-10#9)
phase factors##2##2##(2008-2#2)
phase fields##4##2##(2007-12#2)(2008-2#2)
phase flow rate##2##3##(2006-12#1)(2008-10#1)
phase fluctuations##4##2##(2007-12#1)(2008-3#3)
phase following##4##2##(1995-12#1)(1995-3#1)(2007-8#1)(2010-7#1)
phase for the##8##3##(1990-8#2)(2005-4#1)(2008-10#4)(2008-5#1)
phase for##31##2##(1990-8#4)(1991-5#2)(1992-8#1)(2005-11#1)(2005-4#1)(2008-10#12)(2008-2#1)(2008-5#1)(2008-7#1)(2012-12#2)(2012-2#1)(2013-8#4)
phase formation##3##2##(1997-7#1)(2008-5#1)(2009-11#1)
phase from 0 to##2##4##(2006-10#1)(2012-12#1)
phase from a##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
phase from the##5##3##(2007-12#2)(2008-2#1)(2008-3#1)(2009-7#1)
phase from two##2##3##(2008-2#1)(2008-5#1)
phase from##23##2##(1990-12#1)(1996-2#2)(2006-10#1)(2007-12#6)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2009-7#1)(2012-12#1)(2012-9#1)
phase front##2##2##(2008-2#1)(2008-3#1)
phase function and##5##3##(2007-12#1)(2008-2#2)(2008-3#1)(2010-4#1)
phase function for##3##3##(2008-2#2)(2008-3#1)
phase function is not##2##4##(2008-2#2)
phase function is##4##3##(2008-2#2)(2008-3#2)
phase function of the##2##4##(2008-2#2)
phase function of##3##3##(2008-2#3)
phase function##52##2##(2006-4#1)(2007-12#6)(2008-2#27)(2008-3#15)(2008-6#2)(2010-4#1)
phase functions are##2##3##(2008-3#2)
phase functions for##2##3##(2008-2#2)
phase functions with##2##3##(2008-2#1)(2008-3#1)
phase functions##14##2##(2007-11#1)(2007-12#1)(2008-2#7)(2008-3#5)
phase gradient##9##2##(1997-8#1)(2008-2#3)(2008-3#4)(2011-1#1)
phase gradients##2##2##(2007-12#1)(2008-3#1)
phase grating inside a##2##4##(2008-3#2)
phase grating that is##2##4##(2007-11#1)(2007-12#1)
phase grating that##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
phase grating##22##2##(2006-4#2)(2007-11#3)(2007-12#2)(2008-2#2)(2008-3#13)
phase gratings and##2##3##(2008-2#1)(2008-3#1)
phase gratings is##2##3##(2007-12#1)(2008-3#1)
phase gratings on##2##3##(2007-12#1)(2008-3#1)
phase gratings that##2##3##(2007-12#1)(2008-3#1)
phase gratings were##2##3##(2007-11#1)(2008-3#1)
phase gratings##21##2##(2006-4#1)(2007-11#1)(2007-12#6)(2008-2#5)(2008-3#8)
phase has been##6##3##(1993-5#1)(1994-12#1)(1996-8#1)(2008-10#1)(2010-2#1)(2013-1#1)
phase has##10##2##(1993-5#1)(1994-12#1)(1995-6#1)(1996-8#1)(2008-10#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
phase have been##2##3##(2008-10#1)(2008-5#1)
phase have##3##2##(2008-10#2)(2008-5#1)
phase high performance liquid chromatography (HPLC)##3##6##(1992-9#1)(1997-3#1)(2011-2#1)
phase high performance liquid chromatography##16##5##(1990-7#1)(1990-8#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-12#1)(1994-6#1)(1997-3#1)(2007-8#1)(2008-10#4)(2008-5#1)(2010-12#1)(2011-2#1)
phase high performance liquid##18##4##(1990-7#1)(1990-8#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-12#1)(1994-6#1)(1997-3#1)(2007-8#1)(2008-10#5)(2008-5#1)(2010-12#1)(2010-2#1)(2011-2#1)
phase high-performance liquid chromatography##5##4##(1990-12#1)(1994-8#1)(1995-2#1)(2007-2#1)(2008-10#1)
phase hologram##2##2##(2007-12#1)(2008-2#1)
phase holograms##4##2##(2007-12#1)(2008-2#3)
phase image##2##2##(2007-11#1)(2007-12#1)
phase images are##3##3##(2005-11#1)(2007-12#1)(2012-2#1)
phase images of##3##3##(1993-8#1)(2007-11#1)(2007-12#1)
phase images##10##2##(1993-8#1)(2005-11#1)(2007-11#1)(2007-12#3)(2008-2#1)(2012-2#3)
phase imaging of##2##3##(2007-11#1)(2012-1#1)
phase imaging##6##2##(2007-11#2)(2008-3#1)(2008-7#1)(2010-4#1)(2012-1#1)
phase in a two-dimensional##2##4##(1992-5#1)(2008-2#1)
phase in a##14##3##(1992-12#1)(1992-5#1)(1995-5#1)(1997-2#1)(2007-12#3)(2007-4#1)(2008-10#1)(2008-2#1)(2009-6#1)(2010-12#1)(2010-4#1)(2012-3#1)
phase in aqueous##2##3##(1991-2#1)(2008-10#1)
phase in space-variant polarization-state manipulations##2##5##(2007-12#2)
phase in the presence of##3##5##(2008-10#1)(2008-5#1)(2008-8#1)
phase in the##34##3##(1990-2#1)(1990-4#1)(1990-6#1)(1990-8#1)(1993-1#1)(1993-8#1)(1996-2#1)(1996-5#1)(2005-11#2)(2005-12#1)(2007-11#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)
phase in which the##3##4##(1993-8#1)(2006-10#1)(2007-5#1)
phase in which##9##3##(1993-1#1)(1993-8#1)(1994-5#1)(2006-10#1)(2007-5#1)(2008-4#1)(2008-6#1)(2011-2#2)
phase in##114##2##(1990-2#2)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-2#1)(1991-5#1)(1992-12#2)(1992-5#1)(1993-1#2)(1993-8#2)(1994-5#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#2)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(2003-11#2)(2005-11#3)(2005-12#1)(2006-10#3)(2006-5#1)(2007-11#2)(2007-12#7)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#25)(2008-11#5)(2008-2#7)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-6#2)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
phase increased##4##2##(1990-10#1)(1996-7#1)(2006-10#1)(2012-1#1)
phase increases with##3##3##(1991-3#1)(2008-10#1)(2009-7#1)
phase increases##4##2##(1991-3#1)(1994-11#1)(2008-10#1)(2009-7#1)
phase information from##2##3##(2007-12#1)(2008-2#1)
phase information is##2##3##(2008-3#2)
phase information of the##2##4##(2008-1#1)(2008-3#1)
phase information##18##2##(2006-5#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#8)(2008-8#1)(2009-10#1)
phase insulin response)##2##3##(1994-12#2)
phase insulin##4##2##(1994-12#2)(2010-11#1)(2011-2#1)
phase interaction##2##2##(2008-10#2)
phase interface##3##2##(2005-11#1)(2008-10#2)
phase interferometer##2##2##(2008-2#2)
phase interferometry for direct electric-field reconstruction##10##6##(2007-12#10)
phase interferometry for direct##12##4##(2007-11#1)(2007-12#11)
phase into the##3##3##(1991-5#1)(1996-1#1)(2008-10#1)
phase into##9##2##(1991-5#1)(1992-11#1)(1996-1#1)(2006-10#2)(2008-10#3)(2010-2#1)
phase inversion morphology##2##3##(2008-10#2)
phase inversion##5##2##(2006-4#1)(2007-11#1)(2008-10#2)(2008-5#1)
phase involving##2##2##(1992-12#1)(2008-11#1)
phase ion-pair##2##2##(2008-10#2)
phase is a##3##3##(2008-10#2)(2008-5#1)
phase is achieved##2##3##(2008-10#1)(2008-7#1)
phase is also##2##3##(2008-10#1)(2010-12#1)
phase is calculated##2##3##(2007-12#1)(2008-3#1)
phase is characterized by##3##4##(2005-8#3)
phase is described##2##3##(2008-10#1)(2008-3#1)
phase is formed at##2##4##(2007-12#1)(2009-7#1)
phase is formed##3##3##(2005-11#1)(2007-12#1)(2009-7#1)
phase is observed##2##3##(1994-8#1)(2008-7#1)
phase is of##2##3##(1990-12#1)(2008-4#1)
phase is related##2##3##(2006-10#1)(2007-12#1)
phase is used##2##3##(2008-1#1)(2008-10#1)
phase is useful##2##3##(2008-10#1)(2010-12#1)
phase is##85##2##(1990-12#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-1#1)(1994-11#1)(1994-8#1)(1997-6#1)(1997-8#1)(2005-11#2)(2005-8#3)(2006-10#3)(2006-9#1)(2007-11#2)(2007-12#8)(2007-7#1)(2008-1#2)(2008-10#19)(2008-11#3)(2008-2#3)(2008-3#8)(2008-4#2)(2008-5#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-7#1)(2010-12#2)(2010-4#1)(2012-3#1)(2013-8#1)
phase jitter in dispersion-managed soliton systems##2##6##(2007-11#2)
phase jitter in##3##3##(2007-11#3)
phase jitter##7##2##(2007-11#3)(2007-12#4)
phase jump can##2##3##(2008-2#2)
phase jump is##3##3##(2008-2#1)(2008-3#2)
phase jump##12##2##(2008-2#6)(2008-3#6)
phase jumps##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
phase key in the Fourier plane##2##6##(2008-3#2)
phase key##5##2##(2008-3#5)
phase lag##7##2##(1992-8#1)(1993-2#2)(1994-8#1)(2005-11#1)(2008-2#1)(2012-2#1)
phase lasting##2##2##(1991-3#1)(2008-5#1)
phase leads to##2##3##(1994-2#1)(2008-10#1)
phase levels##10##2##(1991-8#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#6)
phase lipid##4##2##(1990-4#3)(1992-6#1)
phase liquid chromatography (LC)##2##4##(2008-10#2)
phase liquid chromatography for the##2##5##(2008-10#2)
phase liquid chromatography with##3##4##(2008-10#2)(2010-11#1)
phase liquid chromatography##20##3##(1990-2#1)(2008-10#17)(2010-11#1)(2010-2#1)
phase liquid##24##2##(1990-2#1)(2005-11#2)(2008-10#17)(2010-11#1)(2010-2#2)(2010-3#1)
phase lock##2##2##(2007-12#1)(2008-2#1)
phase locked to##3##3##(1993-12#1)(2007-12#2)
phase locking and##2##3##(2007-11#2)
phase locking of the##2##4##(2007-12#2)
phase locking of three independent##2##5##(2007-11#2)
phase locking of three##4##4##(2007-11#2)(2007-12#2)
phase locking of##7##3##(2007-11#2)(2007-12#5)
phase locking##16##2##(2007-11#4)(2007-12#10)(2008-11#1)(2008-2#1)
phase map that##2##3##(2008-2#1)(2008-3#1)
phase map##12##2##(2007-12#1)(2008-2#7)(2008-3#4)
phase maps are##2##3##(2008-2#1)(2008-3#1)
phase maps is##2##3##(2008-2#1)(2008-3#1)
phase maps that##3##3##(2008-2#2)(2008-3#1)
phase maps##21##2##(2008-2#8)(2008-3#12)(2011-1#1)
phase mask in##4##3##(2007-11#1)(2008-3#3)
phase mask is##4##3##(2008-2#1)(2008-3#3)
phase mask on##2##3##(2008-2#2)
phase mask##31##2##(2007-11#2)(2007-12#4)(2008-1#1)(2008-2#13)(2008-3#10)(2012-2#1)
phase masks are##3##3##(2008-3#3)
phase masks##12##2##(2007-12#2)(2008-2#1)(2008-3#9)
phase matchable for third-harmonic generation##2##5##(2007-12#2)
phase matchable for##4##3##(2007-12#2)(2008-2#2)
phase matchable##6##2##(2007-12#3)(2008-2#2)(2008-3#1)
phase matched##9##2##(2007-11#2)(2007-12#6)(2008-3#1)
phase matching and##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
phase matching by##3##3##(2007-11#1)(2007-12#1)(2008-1#1)
phase matching can be achieved##2##5##(2007-12#1)(2008-3#1)
phase matching for##2##3##(2007-11#1)(2008-3#1)
phase matching in a##3##4##(2007-11#1)(2007-12#2)
phase matching in##9##3##(2007-11#3)(2007-12#5)(2008-3#1)
phase matching of the##2##4##(2007-12#1)(2008-3#1)
phase matching of##5##3##(2007-11#1)(2007-12#3)(2008-3#1)
phase matching that##2##3##(2007-11#1)(2008-1#1)
phase matching##51##2##(2007-11#14)(2007-12#24)(2008-1#2)(2008-2#3)(2008-3#8)
phase matching)##2##2##(2007-12#2)
phase matrix##4##2##(2008-2#2)(2008-3#2)
phase may##2##2##(2009-4#1)(2011-1#1)
phase measurement by##2##3##(2007-11#1)(2008-2#1)
phase measurement with##2##3##(2008-1#1)(2008-2#1)
phase measurement##16##2##(2007-11#2)(2007-12#3)(2008-1#2)(2008-2#6)(2008-3#3)
phase measurements by##2##3##(2007-12#1)(2008-2#1)
phase measurements##9##2##(2007-12#4)(2008-2#4)(2008-3#1)
phase method for the##2##4##(2008-2#1)(2009-3#1)
phase method##3##2##(1991-5#1)(2008-2#1)(2009-3#1)
phase micro extraction##4##3##(2008-10#3)(2009-3#1)
phase micro-extraction (SPME)##2##3##(1996-12#1)(2008-10#1)
phase micro-extraction##5##2##(1996-12#2)(2008-10#3)
phase microextraction (SPME) coupled##2##4##(2008-10#1)(2011-12#1)
phase microextraction (SPME)##13##3##(2007-8#2)(2008-10#8)(2009-8#1)(2011-12#1)(2012-1#1)
phase microextraction and##2##3##(2007-8#2)
phase microextraction coupled with##2##4##(2008-10#2)
phase microextraction coupled##3##3##(2008-10#3)
phase microextraction technique##3##3##(2007-8#1)(2008-10#1)(2008-3#1)
phase microextraction##36##2##(2007-11#1)(2007-8#8)(2008-10#22)(2008-3#1)(2009-8#1)(2011-12#2)(2012-1#1)
phase microscopy##6##2##(1994-11#1)(2007-11#2)(2007-12#2)(2011-1#1)
phase mismatch and##4##3##(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#1)
phase mismatch in##2##3##(2007-12#1)(2008-3#1)
phase mismatch of##2##3##(2007-12#2)
phase mismatch##18##2##(2007-11#2)(2007-12#7)(2008-1#1)(2008-2#3)(2008-3#5)
phase mixing##2##2##(2008-10#1)(2011-1#1)
phase mode##2##2##(2007-8#1)(2008-10#1)
phase model##3##2##(1992-1#1)(1995-2#1)(2007-11#1)
phase modulation and##3##3##(2007-12#2)(2008-3#1)
phase modulation can##2##3##(2008-2#2)
phase modulation in##2##3##(2007-12#1)(2008-3#1)
phase modulation is used##2##4##(2007-12#2)
phase modulation is##8##3##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#2)
phase modulation of the reference##2##5##(2007-12#1)(2008-2#1)
phase modulation of the##11##4##(2007-11#2)(2007-12#4)(2008-2#2)(2008-3#3)
phase modulation of##15##3##(1993-3#1)(2007-11#2)(2007-12#5)(2008-2#4)(2008-3#3)
phase modulation on##2##3##(2007-11#1)(2008-2#1)
phase modulation that is##2##4##(2007-11#1)(2007-12#1)
phase modulation##60##2##(1993-3#1)(2007-11#9)(2007-12#22)(2008-1#3)(2008-2#11)(2008-3#13)(2012-2#1)
phase modulations##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
phase modulator and##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
phase modulator for##2##3##(2007-12#1)(2008-2#1)
phase modulator in the reference arm of##2##7##(2007-12#1)(2008-3#1)
phase modulator in##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
phase modulator is##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
phase modulator to##2##3##(2007-12#1)(2008-3#1)
phase modulator##25##2##(2007-11#3)(2007-12#9)(2008-1#2)(2008-2#2)(2008-3#9)
phase modulators in##2##3##(2007-11#1)(2007-12#1)
phase modulators##5##2##(2007-11#2)(2007-12#2)(2008-2#1)
phase molecular absorption spectrometry##10##4##(2008-10#10)
phase molecular absorption##13##3##(2008-10#13)
phase noise in a##2##4##(2007-12#2)
phase noise of the##2##4##(2007-12#2)
phase noise of##3##3##(2007-12#3)
phase noise to intensity noise conversion##2##6##(2007-12#2)
phase noise to##3##3##(2007-11#1)(2007-12#2)
phase noise##18##2##(2007-11#8)(2007-12#9)(2008-2#1)
phase object is placed##2##4##(2008-3#2)
phase object##7##2##(2008-2#3)(2008-3#4)
phase objects##12##2##(2007-11#3)(2007-12#1)(2008-2#3)(2008-3#5)
phase observed##2##2##(2006-10#1)(2009-11#1)
phase of CML##3##3##(1997-3#1)(2009-3#1)(2011-1#1)
phase of Cdk4 and cyclin D2 expression##2##7##(1994-12#2)
phase of HPLC##2##3##(2008-10#2)
phase of a##27##3##(1990-6#1)(1993-1#1)(1994-9#1)(1995-3#1)(1997-5#4)(2004-12#1)(2006-10#1)(2007-11#1)(2007-12#5)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#4)(2012-11#1)(2012-2#2)
phase of acute##2##3##(1997-3#1)(2011-1#1)
phase of an##8##3##(2007-12#2)(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-11#1)
phase of apoptosis##3##3##(2003-11#1)(2006-12#1)(2013-8#1)
phase of cell cycle##3##4##(1993-3#1)(1996-7#1)(2008-5#1)
phase of cell##5##3##(1991-9#1)(1993-3#1)(1996-7#1)(2008-11#1)(2008-5#1)
phase of development##3##3##(1990-6#1)(2005-9#1)(2008-10#1)
phase of disease##3##3##(2006-2#1)(2008-10#1)(2009-11#1)
phase of each##3##3##(2008-10#1)(2008-3#1)(2012-3#1)
phase of extraction of the##2##5##(1997-3#2)
phase of fast##2##3##(2008-1#1)(2012-2#1)
phase of gait##3##3##(2010-3#1)(2012-1#1)(2013-1#1)
phase of growth were##2##4##(2008-11#2)
phase of growth##9##3##(1990-12#1)(1994-8#1)(1997-2#1)(2006-8#1)(2006-9#1)(2008-11#2)(2008-5#2)
phase of illness##2##3##(1996-1#2)
phase of infection##2##3##(1996-4#1)(2013-1#1)
phase of liver##2##3##(1994-8#1)(2008-12#1)
phase of migraine##2##3##(2004-12#1)(2008-9#1)
phase of p72syk translocation##2##4##(1994-12#2)
phase of rehabilitation##3##3##(2007-8#3)
phase of starvation the##2##4##(2013-1#2)
phase of starvation##5##3##(2013-1#5)
phase of the cell cycle and##3##6##(1994-5#1)(2004-11#1)(2008-11#1)
phase of the cell cycle##26##5##(1991-10#1)(1991-5#2)(1991-9#1)(1992-6#1)(1992-9#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-5#1)(2004-11#1)(2007-9#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-9#1)(2010-4#1)(2011-1#1)(2013-1#1)
phase of the cell##28##4##(1991-10#1)(1991-5#3)(1991-9#1)(1992-6#1)(1992-9#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-5#1)(2004-11#1)(2007-9#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-9#1)(2010-4#1)(2011-1#1)(2013-1#1)
phase of the cycle##4##4##(1990-12#1)(1994-9#2)(1996-4#1)
phase of the disease was##2##5##(1997-5#1)(2005-7#1)
phase of the disease##11##4##(1997-5#1)(2005-7#2)(2007-7#2)(2008-4#1)(2008-5#1)(2009-10#1)(2010-3#1)(2012-12#1)(2013-1#1)
phase of the emulsion##2##4##(1997-8#1)(2008-5#1)
phase of the epidemic##4##4##(2007-9#1)(2008-10#3)
phase of the formalin test##7##5##(1995-12#1)(2006-12#6)
phase of the interference signal##2##5##(2008-2#1)(2008-3#1)
phase of the life cycle##2##5##(2008-10#1)(2008-4#1)
phase of the menstrual cycle##2##5##(2011-2#1)(2012-3#1)
phase of the project##2##4##(2005-12#2)
phase of the pulse##3##4##(2007-11#2)(2007-12#1)
phase of the pure phospholipid##2##5##(2006-10#2)
phase of the signal##2##4##(2007-12#1)(2008-2#1)
phase of the study in##2##5##(1990-9#1)(2010-9#1)
phase of the study##6##4##(1990-9#1)(2008-11#1)(2008-4#1)(2008-6#1)(2010-1#1)(2010-9#1)
phase of the treatment##2##4##(2007-2#1)(2007-8#1)
phase of the##219##3##(1990-11#3)(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-9#1)(1992-3#2)(1992-4#3)(1992-6#1)(1992-8#2)(1992-9#2)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-10#2)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#2)(1997-1#3)(1997-3#1)(1997-4#5)(1997-5#2)(1997-8#1)(2004-11#1)(2005-11#1)(2005-12#2)(2005-7#3)(2006-10#3)(2006-12#7)(2006-4#2)(2006-5#1)(2007-11#10)(2007-12#14)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#1)(2007-9#4)(2008-1#1)(2008-10#13)(2008-11#5)(2008-2#15)(2008-3#14)(2008-4#6)(2008-5#6)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-6#1)(2009-9#2)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#3)(2013-8#1)
phase of their##5##3##(1992-6#2)(1993-6#1)(2012-1#1)(2012-2#1)
phase of this development##2##4##(2006-11#1)(2008-12#1)
phase of this study##2##4##(2006-4#1)(2012-11#1)
phase of this##8##3##(1995-6#1)(2006-11#1)(2006-4#1)(2007-5#1)(2008-12#1)(2009-9#1)(2010-1#1)(2012-11#1)
phase of treatment##3##3##(2007-7#1)(2007-9#1)(2013-8#1)
phase of ultrashort##5##3##(2007-12#4)(2008-3#1)
phase of wound healing##3##4##(2006-9#2)(2007-12#1)
phase of##600##2##(1990-10#2)(1990-11#7)(1990-12#4)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#4)(1990-7#1)(1990-8#4)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#5)(1991-3#3)(1991-4#1)(1991-5#5)(1991-8#1)(1991-9#5)(1992-11#3)(1992-12#2)(1992-3#3)(1992-4#4)(1992-5#1)(1992-6#4)(1992-8#2)(1992-9#7)(1993-1#3)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#3)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#5)(1994-2#2)(1994-3#4)(1994-4#1)(1994-5#2)(1994-6#4)(1994-7#1)(1994-8#5)(1994-9#3)(1995-1#1)(1995-12#6)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#2)(1995-9#2)(1996-1#5)(1996-10#3)(1996-11#2)(1996-2#2)(1996-4#2)(1996-5#6)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#3)(1997-3#9)(1997-4#5)(1997-5#7)(1997-6#1)(1997-8#2)(2003-11#1)(2004-11#1)(2004-12#2)(2005-11#5)(2005-12#5)(2005-7#4)(2005-8#3)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#9)(2006-2#2)(2006-4#3)(2006-5#2)(2006-7#2)(2006-8#1)(2006-9#5)(2007-10#1)(2007-11#17)(2007-12#35)(2007-2#4)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#2)(2007-7#6)(2007-8#8)(2007-9#7)(2008-1#7)(2008-10#41)(2008-11#15)(2008-12#5)(2008-2#23)(2008-3#28)(2008-4#6)(2008-5#18)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#4)(2009-10#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#3)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#14)(2011-12#1)(2011-2#4)(2012-1#4)(2012-11#2)(2012-12#8)(2012-2#9)(2012-3#5)(2012-9#1)(2013-1#18)(2013-7#2)(2013-8#6)
phase on heating##2##3##(2006-10#2)
phase on the##7##3##(1997-1#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2010-11#1)
phase on##20##2##(1991-1#2)(1997-1#1)(2005-11#2)(2006-10#2)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#2)(2010-11#1)
phase optical##7##2##(2007-11#5)(2008-2#1)(2008-3#1)
phase or##4##2##(2007-3#1)(2008-10#1)(2008-2#1)(2008-5#1)
phase out##2##2##(1996-1#2)
phase over##2##2##(1990-3#2)
phase partitioning##6##2##(1990-5#1)(1993-8#3)(1995-5#1)(2008-10#1)
phase patients##2##2##(1993-12#1)(2005-7#1)
phase pattern##2##2##(2008-2#1)(2008-3#1)
phase plate for##2##3##(2007-11#1)(2008-3#1)
phase plate placed##2##3##(2007-12#1)(2008-2#1)
phase plate##13##2##(2007-11#3)(2007-12#2)(2008-2#5)(2008-3#3)
phase plates##10##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#6)
phase power spectrum with a##2##5##(2007-12#2)
phase precession##9##2##(2008-11#9)
phase preconcentration##2##2##(2008-10#2)
phase profile of##2##3##(2007-12#1)(2008-3#1)
phase profile##7##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#2)
phase profiles of##2##3##(2007-12#1)(2011-1#1)
phase profiles##3##2##(2007-12#1)(2011-1#2)
phase progression##2##2##(1992-11#1)(1994-2#1)
phase properties of##2##3##(1990-5#1)(2008-2#1)
phase properties##3##2##(1990-5#1)(2007-11#1)(2008-2#1)
phase protein##9##2##(1992-12#1)(1994-6#1)(1996-12#2)(1997-3#1)(2005-9#1)(2007-11#1)(2008-10#1)(2008-4#1)
phase provides##3##2##(1997-1#1)(2008-3#1)(2008-7#1)
phase pulse##3##2##(2008-3#3)
phase quantization##3##2##(2007-12#1)(2008-3#2)
phase reconstruction from noisy##2##4##(2007-12#2)
phase reconstruction from##4##3##(2007-12#2)(2008-1#1)(2008-10#1)
phase reconstruction##6##2##(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#1)
phase reconstructions##2##2##(2007-12#1)(2008-10#1)
phase recovery##2##2##(2007-11#1)(2008-3#1)
phase relation among subharmonic pulses##2##5##(2007-12#2)
phase relation##5##2##(2007-11#1)(2007-12#2)(2007-2#1)(2011-1#1)
phase relations##4##2##(2007-11#1)(2007-2#1)(2008-2#1)(2008-3#1)
phase relationship##2##2##(2007-12#1)(2008-3#1)
phase resolution##2##2##(2007-11#1)(2008-2#1)
phase response in##3##3##(1992-12#1)(1996-2#1)(2007-12#1)
phase response##34##2##(1991-8#1)(1992-12#1)(1992-9#1)(1993-12#3)(1993-6#1)(1994-3#1)(1994-6#1)(1994-9#4)(1995-12#1)(1995-2#3)(1996-2#3)(1996-5#4)(2007-12#4)(2007-9#2)(2008-2#2)(2008-3#1)(2008-8#1)
phase responses##4##2##(1994-6#1)(2007-12#2)(2008-2#1)
phase resulted in##2##3##(1992-2#1)(1996-7#1)
phase retardance##4##2##(2008-2#1)(2008-3#3)
phase retardation and##2##3##(2009-4#2)
phase retardation of the##3##4##(2007-12#2)(2008-3#1)
phase retardation of##4##3##(2007-12#2)(2008-3#2)
phase retardation##13##2##(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#5)(2009-4#2)
phase retarder##5##2##(2007-11#2)(2008-2#1)(2010-4#2)
phase retarders##4##2##(2006-4#2)(2008-2#2)
phase retrieval by##2##3##(2007-11#1)(2007-12#1)
phase retrieval for##2##3##(2007-11#1)(2007-12#1)
phase retrieval from##2##3##(2007-12#1)(2008-2#1)
phase retrieval##13##2##(2007-11#4)(2007-12#4)(2008-2#2)(2008-3#1)(2008-8#1)(2013-7#1)
phase retrieved##2##2##(2008-2#2)
phase reversal##2##2##(2008-2#1)(2011-2#1)
phase screen##12##2##(2008-2#3)(2008-3#8)(2008-8#1)
phase screens##2##2##(2007-12#1)(2008-3#1)
phase segregation and##2##3##(2010-4#2)
phase sensitivities##2##2##(2007-12#1)(2008-2#1)
phase separated##4##2##(2006-10#2)(2008-10#1)(2008-5#1)
phase separation and##5##3##(1990-2#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-7#1)
phase separation at##3##3##(1991-6#1)(2005-7#1)(2008-7#1)
phase separation during##4##3##(2004-9#2)(2008-7#1)(2010-4#1)
phase separation in a##2##4##(1996-9#1)(2008-3#1)
phase separation in##8##3##(1991-6#1)(1992-6#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-7#1)
phase separation of##7##3##(1992-6#1)(1997-6#1)(2006-12#1)(2008-10#3)(2008-7#1)
phase separation was##4##3##(1994-3#1)(2008-10#3)
phase separation##54##2##(1990-2#1)(1990-3#1)(1991-6#2)(1992-6#3)(1994-3#1)(1994-5#1)(1996-9#1)(1997-6#1)(1997-7#1)(2004-9#2)(2005-11#2)(2005-7#1)(2006-12#2)(2007-12#3)(2008-10#18)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#6)(2010-1#1)(2010-4#2)
phase separations##3##2##(1990-2#1)(2005-11#1)(2008-10#1)
phase separator and##2##3##(2007-8#1)(2008-10#1)
phase separator for##2##3##(2008-10#2)
phase separator with a##2##4##(2008-10#2)
phase separator##11##2##(2007-8#1)(2008-10#10)
phase shift and##7##3##(2007-12#3)(2008-3#2)(2008-5#1)(2011-1#1)
phase shift at##2##3##(2007-12#2)
phase shift between the s- and the p-polarized##2##8##(2008-3#2)
phase shift between the##5##4##(2007-11#1)(2008-1#1)(2008-3#3)
phase shift between##10##3##(2007-11#2)(2008-1#1)(2008-2#2)(2008-3#5)
phase shift in an##2##4##(2007-12#1)(2008-2#1)
phase shift in the##2##4##(2008-3#2)
phase shift in##7##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#3)
phase shift is##7##3##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#1)
phase shift of the fundamental##3##5##(2007-11#1)(2007-12#2)
phase shift of the##10##4##(1994-2#1)(2007-11#1)(2007-12#5)(2008-3#2)(2009-6#1)
phase shift of##20##3##(1994-2#1)(2007-11#2)(2007-12#8)(2008-2#4)(2008-3#4)(2009-6#1)
phase shift on reflection for##2##5##(2008-2#2)
phase shift on reflection##4##4##(2008-2#4)
phase shift on##5##3##(2008-2#5)
phase shift produced by a##2##5##(2007-11#2)
phase shift relative to##2##4##(2007-11#1)(2007-12#1)
phase shift##103##2##(1994-2#2)(2007-11#17)(2007-12#30)(2008-1#2)(2008-2#25)(2008-3#21)(2008-5#1)(2008-8#1)(2009-6#1)(2011-1#1)(2011-2#2)
phase shifter and##2##3##(2007-12#1)(2008-3#1)
phase shifter based on##2##4##(2007-11#1)(2008-2#1)
phase shifter##13##2##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#8)
phase shifters##5##2##(2008-2#3)(2008-3#2)
phase shifting and prediction##2##4##(2008-2#2)
phase shifting and##3##3##(2007-12#1)(2008-2#2)
phase shifting in electronic speckle-pattern interferometry##2##6##(2008-3#2)
phase shifting##17##2##(1997-5#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#5)(2008-3#7)
phase shifts in the##3##4##(1992-3#1)(2007-11#2)
phase shifts induced by##2##4##(2007-12#1)(2008-2#1)
phase shifts induced##3##3##(2007-12#2)(2008-2#1)
phase shifts of##2##3##(1994-2#1)(2008-2#1)
phase shifts produced by##2##4##(2007-12#1)(2008-2#1)
phase shifts produced##3##3##(2007-12#2)(2008-2#1)
phase shifts to##2##3##(2007-12#1)(2008-3#1)
phase shifts were##2##3##(1997-7#1)(2008-3#1)
phase shifts with##2##3##(2007-12#1)(2008-1#1)
phase shifts##44##2##(1992-3#1)(1993-8#1)(1994-2#3)(1995-12#2)(1997-7#1)(2007-11#5)(2007-12#14)(2008-1#2)(2008-10#1)(2008-2#5)(2008-3#9)
phase should##2##2##(1994-2#1)(2008-10#1)
phase showed##2##2##(1992-11#1)(2008-10#1)
phase singularities##6##2##(2007-11#2)(2007-12#1)(2008-1#2)(2008-3#1)
phase singularity##4##2##(1995-7#1)(2008-2#1)(2008-3#2)
phase slope##2##2##(2007-12#1)(2013-8#1)
phase space beam model to##2##5##(2009-11#2)
phase space beam model##4##4##(2009-11#4)
phase space##8##2##(2007-11#1)(2007-12#1)(2008-3#1)(2009-11#4)(2012-2#1)
phase specificity##2##2##(1993-3#1)(1995-2#1)
phase spectrophotometric determination of vanillin##2##5##(2008-10#2)
phase spectrophotometric determination of##3##4##(2008-10#3)
phase spectrophotometric##5##2##(2008-10#5)
phase stability and##2##3##(2007-12#1)(2012-2#1)
phase stability of##2##3##(2010-12#1)(2010-4#1)
phase stability##5##2##(2007-12#1)(2008-10#1)(2010-12#1)(2010-4#1)(2012-2#1)
phase states##3##2##(1996-5#1)(2007-12#2)
phase step##2##2##(2008-2#1)(2008-3#1)
phase stepping##3##2##(2008-2#2)(2008-3#1)
phase steps##4##2##(2008-2#2)(2008-3#2)
phase structure of the##3##4##(1997-2#1)(2007-11#1)(2007-9#1)
phase structure##6##2##(1997-2#1)(2007-11#2)(2007-9#1)(2008-12#1)(2008-3#1)
phase structures##5##2##(1997-2#1)(2008-3#4)
phase studied##2##2##(1990-9#1)(2008-10#1)
phase study##2##2##(2005-11#1)(2011-1#1)
phase surface##3##2##(2008-10#2)(2008-11#1)
phase synchronization in##3##3##(2007-12#1)(2008-8#1)(2011-2#1)
phase synchronization##4##2##(2007-12#1)(2008-8#1)(2011-2#2)
phase synthesis of##3##3##(1996-7#1)(2007-10#2)
phase synthesis##4##2##(1996-7#1)(2007-10#2)(2008-10#1)
phase synthetic##3##2##(2009-12#3)
phase system##2##2##(1997-3#1)(2007-12#1)
phase term##3##2##(2008-2#3)
phase than##3##2##(1993-7#1)(2008-5#1)(2012-1#1)
phase that is##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
phase that##11##2##(1992-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-8#1)(2009-11#1)
phase the##10##2##(1990-10#1)(1990-12#1)(1997-8#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
phase through##4##2##(1990-7#1)(1996-4#1)(2008-7#1)(2010-4#1)
phase to another##2##3##(2005-11#1)(2010-4#1)
phase to be##4##3##(2007-12#1)(2008-11#1)(2008-3#1)(2012-2#1)
phase to the##10##3##(1991-5#1)(1991-7#1)(1993-7#1)(2006-6#1)(2008-10#3)(2008-2#2)(2008-4#1)
phase to##35##2##(1991-5#1)(1991-7#1)(1993-7#1)(1994-12#1)(1994-9#1)(1995-7#1)(1996-6#1)(2005-11#1)(2006-10#2)(2006-6#1)(2007-12#1)(2008-10#9)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
phase tracing method for fringe pattern analysis##2##7##(2008-3#2)
phase tracking##3##2##(2007-12#1)(2008-2#2)
phase transfer catalysis##2##3##(2007-10#1)(2008-5#1)
phase transfer of the silver nanoparticles##2##6##(2005-11#2)
phase transfer of##4##3##(2005-11#3)(2007-8#1)
phase transfer##11##2##(1994-3#1)(2005-11#3)(2007-10#1)(2007-8#2)(2008-3#1)(2008-5#3)
phase transformation in vanadium dioxide##2##5##(2007-11#2)
phase transformation on##2##3##(2007-11#1)(2008-2#1)
phase transformation##8##2##(2005-11#1)(2007-11#4)(2008-2#2)(2008-3#1)
phase transition and##3##3##(1990-3#1)(1994-5#1)(2008-11#1)
phase transition from##2##3##(2007-12#1)(2008-7#1)
phase transition in the##5##4##(1991-2#1)(1991-4#1)(1994-10#1)(1994-11#1)(2007-12#1)
phase transition in##10##3##(1991-2#1)(1991-4#1)(1991-9#1)(1993-8#1)(1994-10#1)(1994-11#2)(1995-5#1)(2007-12#1)(2008-7#1)
phase transition of the##3##4##(1994-3#1)(2005-11#1)(2007-11#1)
phase transition of##13##3##(1990-2#1)(1991-9#2)(1992-6#1)(1993-6#1)(1994-3#1)(1996-5#1)(1997-5#1)(2005-11#1)(2007-11#1)(2008-8#2)(2009-11#1)
phase transition region##5##3##(1990-4#5)
phase transition temperature of##2##4##(1994-12#1)(2009-10#1)
phase transition temperature##11##3##(1990-3#1)(1990-5#1)(1991-2#1)(1994-12#1)(1994-3#1)(1995-5#3)(2006-10#1)(2008-10#1)(2009-10#1)
phase transition temperatures of liquid crystals##2##6##(2008-10#2)
phase transition temperatures##5##3##(1991-2#1)(1994-12#1)(1996-5#1)(2008-10#2)
phase transition was##2##3##(1990-2#1)(2008-8#1)
phase transition##104##2##(1990-2#5)(1990-3#2)(1990-4#6)(1990-5#1)(1990-7#2)(1991-10#1)(1991-11#1)(1991-2#3)(1991-4#1)(1991-5#1)(1991-9#3)(1992-5#1)(1992-6#2)(1992-8#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-10#2)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#2)(1995-11#1)(1995-5#4)(1995-6#1)(1995-7#1)(1996-4#1)(1996-5#2)(1997-5#1)(2005-11#10)(2006-10#2)(2006-12#1)(2007-11#2)(2007-12#3)(2008-10#13)(2008-11#4)(2008-5#1)(2008-7#3)(2008-8#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)
phase transitions from##2##3##(1995-4#1)(2005-11#1)
phase transitions in##9##3##(1991-6#1)(1991-9#3)(1993-4#1)(1993-5#1)(2006-5#2)(2013-8#1)
phase transitions of the##2##4##(1994-3#1)(2005-7#1)
phase transitions of##5##3##(1990-2#1)(1994-3#1)(2005-7#2)(2006-10#1)
phase transitions##29##2##(1990-2#1)(1991-6#2)(1991-9#3)(1993-2#2)(1993-4#1)(1993-5#1)(1994-3#1)(1995-4#1)(1997-2#1)(2005-11#1)(2005-7#2)(2006-10#2)(2006-5#4)(2007-9#1)(2008-10#2)(2009-2#1)(2013-8#3)
phase two##3##2##(1994-3#1)(2010-8#1)(2012-11#1)
phase under controlled##2##3##(2006-3#1)(2008-10#1)
phase under##4##2##(1996-11#1)(2006-3#1)(2008-10#2)
phase unwrapping algorithm##2##3##(2008-2#1)(2008-3#1)
phase unwrapping and##2##3##(2008-2#1)(2008-3#1)
phase unwrapping in##2##3##(2008-3#2)
phase unwrapping is##4##3##(2008-2#3)(2008-3#1)
phase unwrapping##36##2##(2007-11#1)(2007-12#3)(2008-1#2)(2008-2#14)(2008-3#16)
phase upon##2##2##(1994-3#1)(1994-9#1)
phase used was##14##3##(1997-2#1)(2004-12#1)(2008-10#5)(2010-2#4)(2010-5#1)(2012-2#2)
phase using the##2##3##(2008-10#1)(2008-2#1)
phase using##8##2##(2008-10#6)(2008-2#1)(2008-4#1)
phase values##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
phase variance over a pupil##2##5##(2008-2#2)
phase variance##4##2##(2008-1#1)(2008-2#2)(2008-3#1)
phase variation in##2##3##(2008-2#1)(2008-3#1)
phase variation##7##2##(2008-2#1)(2008-3#6)
phase velocities##2##2##(2007-11#1)(2007-12#1)
phase velocity##5##2##(2007-11#4)(2007-12#1)
phase versus##2##2##(2007-11#1)(2008-2#1)
phase volume##4##2##(1990-3#1)(2008-10#2)(2009-3#1)
phase was a##4##3##(1990-12#1)(2007-8#1)(2008-10#1)(2011-1#1)
phase was also##4##3##(1992-7#1)(1997-1#1)(2008-10#2)
phase was compared with##2##4##(2006-10#1)(2008-10#1)
phase was completed##2##3##(2007-5#1)(2008-10#1)
phase was demonstrated##2##3##(2005-11#1)(2008-10#1)
phase was determined to be##2##5##(1997-2#1)(2008-10#1)
phase was determined##5##3##(1997-2#1)(2007-8#1)(2008-10#2)(2009-11#1)
phase was evaluated##2##3##(2008-10#2)
phase was investigated in##2##4##(2008-10#2)
phase was measured at##2##4##(2008-10#2)
phase was studied##2##3##(2008-5#1)(2013-8#1)
phase was used as the##4##5##(2011-1#4)
phase was used as##5##4##(2008-3#1)(2011-1#4)
phase was used##7##3##(2005-3#1)(2008-10#1)(2008-3#1)(2011-1#4)
phase was very##2##3##(1992-9#1)(1993-6#1)
phase was##99##2##(1990-12#3)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-10#1)(1992-7#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#2)(1994-8#1)(1995-6#1)(1996-6#1)(1996-8#2)(1997-1#2)(1997-2#2)(1997-3#2)(1997-8#3)(2004-9#1)(2005-11#3)(2005-12#1)(2005-3#1)(2006-10#1)(2007-5#1)(2007-8#4)(2008-10#33)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-11#1)(2010-3#1)(2011-1#5)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
phase water content##3##3##(2008-10#3)
phase water##4##2##(2008-10#3)(2008-5#1)
phase were optimised##3##3##(2008-10#3)
phase were optimized##2##3##(2008-10#2)
phase were##27##2##(1992-1#1)(1995-12#2)(1997-2#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#13)(2008-11#2)(2008-2#1)(2008-8#1)(2011-2#1)(2013-1#1)
phase when DNA##2##3##(1997-6#2)
phase when the##2##3##(2008-11#1)(2011-2#1)
phase when##10##2##(1991-7#1)(1994-4#1)(1995-8#1)(1997-6#2)(2005-4#1)(2008-11#1)(2009-11#1)(2009-4#1)(2011-2#1)
phase where##3##2##(2008-10#1)(2008-5#1)(2010-2#1)
phase whereby the hand##2##4##(1992-9#2)
phase which##8##2##(1993-8#1)(1994-6#1)(1996-3#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
phase while##2##2##(1991-9#1)(2008-10#1)
phase will##3##2##(1996-4#1)(2008-10#1)(2008-8#1)
phase with 'P' values of P &lt##2##7##(2012-2#2)
phase with a##5##3##(2008-10#1)(2008-3#3)(2009-10#1)
phase with negatively charged lipids##2##5##(2010-5#2)
phase with no negatively charged lipids##2##6##(2010-5#2)
phase with no##3##3##(2010-5#2)(2010-8#1)
phase with the##9##3##(1990-2#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-8#1)(2010-10#1)(2012-12#1)
phase with##51##2##(1990-2#1)(1991-7#1)(1993-11#1)(1996-6#2)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#15)(2008-11#3)(2008-2#2)(2008-3#4)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#4)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#2)(2013-8#1)
phase within##3##2##(2008-10#2)(2008-3#1)
phase without##3##2##(2008-10#2)(2008-3#1)
phase##6137##1##(1990-10#13)(1990-11#12)(1990-12#29)(1990-2#34)(1990-3#21)(1990-4#18)(1990-5#11)(1990-6#10)(1990-7#18)(1990-8#22)(1990-9#7)(1991-1#7)(1991-10#8)(1991-11#7)(1991-12#14)(1991-2#22)(1991-3#13)(1991-4#7)(1991-5#25)(1991-6#12)(1991-7#9)(1991-8#10)(1991-9#16)(1992-1#12)(1992-10#7)(1992-11#13)(1992-12#14)(1992-2#16)(1992-3#15)(1992-4#10)(1992-5#4)(1992-6#13)(1992-7#5)(1992-8#18)(1992-9#21)(1993-1#9)(1993-10#1)(1993-11#9)(1993-12#17)(1993-2#17)(1993-3#15)(1993-4#3)(1993-5#4)(1993-6#20)(1993-7#3)(1993-8#28)(1993-9#15)(1994-10#3)(1994-11#13)(1994-12#17)(1994-2#30)(1994-3#22)(1994-4#3)(1994-5#12)(1994-6#15)(1994-7#2)(1994-8#15)(1994-9#27)(1995-1#6)(1995-10#3)(1995-11#12)(1995-12#30)(1995-2#12)(1995-3#10)(1995-4#1)(1995-5#11)(1995-6#9)(1995-7#6)(1995-8#10)(1995-9#7)(1996-1#18)(1996-10#4)(1996-11#9)(1996-12#6)(1996-2#13)(1996-3#5)(1996-4#11)(1996-5#21)(1996-6#15)(1996-7#9)(1996-8#20)(1996-9#5)(1997-1#11)(1997-2#27)(1997-3#31)(1997-4#10)(1997-5#14)(1997-6#25)(1997-7#10)(1997-8#31)(2003-11#5)(2004-1#11)(2004-11#3)(2004-12#10)(2004-4#1)(2004-9#9)(2005-10#2)(2005-11#87)(2005-12#15)(2005-3#2)(2005-4#4)(2005-6#4)(2005-7#34)(2005-8#64)(2005-9#15)(2006-1#2)(2006-10#83)(2006-11#3)(2006-12#26)(2006-2#8)(2006-3#3)(2006-4#13)(2006-5#23)(2006-6#18)(2006-7#5)(2006-8#7)(2006-9#7)(2007-1#2)(2007-10#14)(2007-11#290)(2007-12#546)(2007-2#16)(2007-3#4)(2007-4#9)(2007-5#10)(2007-6#6)(2007-7#25)(2007-8#69)(2007-9#32)(2008-1#61)(2008-10#956)(2008-11#132)(2008-12#17)(2008-2#492)(2008-3#584)(2008-4#38)(2008-5#225)(2008-6#36)(2008-7#91)(2008-8#61)(2008-9#24)(2009-1#1)(2009-10#8)(2009-11#23)(2009-12#5)(2009-2#4)(2009-3#14)(2009-4#11)(2009-5#3)(2009-6#11)(2009-7#23)(2009-8#13)(2009-9#8)(2010-1#7)(2010-10#2)(2010-11#6)(2010-12#36)(2010-2#25)(2010-3#8)(2010-4#34)(2010-5#24)(2010-6#7)(2010-7#6)(2010-8#15)(2010-9#9)(2011-1#58)(2011-12#8)(2011-2#72)(2011-3#6)(2011-9#1)(2012-1#16)(2012-11#10)(2012-12#38)(2012-2#68)(2012-3#29)(2012-9#2)(2013-1#53)(2013-3#2)(2013-7#13)(2013-8#49)
phase&quot##2##1##(2008-10#2)
phase) and##5##2##(1991-12#1)(1997-5#1)(2008-10#1)(2008-5#1)(2013-1#1)
phase) is##2##2##(2007-12#1)(2010-2#1)
phase) to##2##2##(1996-10#1)(2005-11#1)
phase) was##2##2##(2006-7#1)(2008-10#1)
phase)##41##1##(1991-12#1)(1994-5#1)(1994-8#1)(1996-10#2)(1996-12#2)(1997-5#2)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-7#1)(2007-12#1)(2008-10#16)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2010-2#1)(2012-2#1)(2013-1#1)
phase- and group-delay##2##3##(2008-1#2)
phase- and##10##2##(2007-11#1)(2007-12#2)(2008-1#2)(2008-2#1)(2008-3#4)
phase-##12##1##(1993-3#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-2#1)(2008-3#4)(2008-8#1)
phase-Doppler anemometry##2##2##(2008-3#2)
phase-Doppler interferometry##2##2##(2008-3#2)
phase-Doppler method for##2##3##(2008-3#2)
phase-Doppler##6##1##(2008-3#6)
phase-HPLC##4##1##(1990-6#1)(1994-5#1)(2008-10#1)(2011-2#1)
phase-advanced##3##1##(1992-3#1)(1996-3#1)(1996-6#1)
phase-based##4##1##(2007-11#1)(2008-2#1)(2008-3#2)
phase-boundary model##2##2##(2008-10#2)
phase-boundary potential model##2##3##(2008-10#2)
phase-boundary##4##1##(2008-10#4)
phase-calculation algorithms for phase-shifting interferometry##2##5##(2008-3#2)
phase-calculation##3##1##(2008-2#1)(2008-3#2)
phase-change disk##2##2##(2008-2#1)(2008-3#1)
phase-change disks##4##2##(2008-2#3)(2008-3#1)
phase-change map##2##2##(2008-3#2)
phase-change material##3##2##(2008-7#2)(2009-11#1)
phase-change optical data storage##2##4##(2008-3#2)
phase-change optical disk##3##3##(2007-11#1)(2008-3#2)
phase-change optical disks##2##3##(2008-2#1)(2008-3#1)
phase-change optical recording media##2##4##(2008-3#2)
phase-change optical##9##2##(2007-11#1)(2008-2#1)(2008-3#7)
phase-change readout##3##2##(2008-3#3)
phase-change##37##1##(2007-11#1)(2007-12#3)(2008-2#10)(2008-3#18)(2008-7#3)(2009-11#2)
phase-code multiplexing in##2##3##(2007-12#1)(2008-3#1)
phase-code multiplexing##4##2##(2007-12#3)(2008-3#1)
phase-code##5##1##(2007-12#3)(2008-3#2)
phase-coded##2##1##(2007-11#1)(2007-12#1)
phase-coherent##5##1##(2007-12#2)(2008-1#1)(2008-2#2)
phase-conjugate beam##3##2##(2008-2#2)(2008-3#1)
phase-conjugate diode-pumped Nd##2##3##(2007-12#2)
phase-conjugate feedback##3##2##(2007-12#3)
phase-conjugate light##2##2##(2008-1#2)
phase-conjugate mirror##16##2##(2007-12#4)(2008-2#10)(2008-3#2)
phase-conjugate mirrors during recording##2##4##(2008-2#2)
phase-conjugate mirrors during##3##3##(2008-2#3)
phase-conjugate mirrors##6##2##(2007-12#2)(2008-1#1)(2008-2#3)
phase-conjugate readout##3##2##(2007-12#1)(2008-3#2)
phase-conjugate reflectivity##2##2##(2007-12#1)(2008-2#1)
phase-conjugate##51##1##(2007-12#22)(2008-1#3)(2008-2#17)(2008-3#9)
phase-conjugated readout##2##2##(2007-12#1)(2008-3#1)
phase-conjugated##4##1##(2007-12#2)(2008-2#1)(2008-3#1)
phase-conjugating correlator is##2##3##(2008-2#2)
phase-conjugating correlator##3##2##(2008-2#3)
phase-conjugating##6##1##(2007-12#1)(2008-2#4)(2008-3#1)
phase-conjugation##5##1##(2007-12#2)(2008-2#3)
phase-contrast (PC) magnetic resonance (MR)##2##5##(1995-11#1)(2006-5#1)
phase-contrast filter##2##2##(2007-12#1)(2008-1#1)
phase-contrast imaging##7##2##(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-3#1)(2010-1#1)
phase-contrast method##4##2##(2007-11#2)(2007-12#1)(2008-1#1)
phase-contrast microscopy##4##2##(2007-12#1)(2008-3#1)(2008-8#1)(2009-9#1)
phase-contrast optical coherence##2##3##(2007-11#2)
phase-contrast technique##2##2##(2007-11#1)(2008-3#1)
phase-contrast##38##1##(1995-11#1)(2006-4#1)(2006-5#5)(2006-8#1)(2007-11#8)(2007-12#7)(2007-3#1)(2008-1#2)(2008-12#1)(2008-3#3)(2008-4#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-1#1)(2012-12#2)
phase-control##2##1##(2008-1#1)(2008-3#1)
phase-correlated##2##1##(1991-9#1)(2011-2#1)
phase-delay control##3##2##(2007-12#3)
phase-delay##4##1##(2007-12#4)
phase-demodulation##2##1##(2007-12#1)(2008-3#1)
phase-dependent##10##1##(1991-5#2)(1992-3#1)(1994-10#1)(2007-12#4)(2008-2#2)
phase-detection##2##1##(2008-2#2)
phase-difference amplification##4##2##(2008-3#4)
phase-difference##7##1##(2007-12#1)(2008-2#2)(2008-3#4)
phase-dispersion microscopy##2##2##(2007-12#2)
phase-displacement equation##2##2##(2008-3#2)
phase-distribution##2##1##(2008-2#1)(2009-10#1)
phase-diversity technique##2##2##(2008-2#2)
phase-diversity##5##1##(2008-2#2)(2008-3#3)
phase-encoded images##5##2##(2008-2#5)
phase-encoded joint transform##2##3##(2008-2#1)(2008-3#1)
phase-encoded optical sampling##2##3##(2007-11#2)
phase-encoded##16##1##(2007-11#3)(2008-2#8)(2008-3#5)
phase-encoding geometry##2##2##(2008-2#2)
phase-encoding##5##1##(2008-2#3)(2008-3#2)
phase-error##5##1##(2007-12#2)(2008-2#2)(2008-3#1)
phase-estimation##2##1##(2008-2#1)(2008-3#1)
phase-factor equations for Talbot array##2##5##(2008-2#2)
phase-factor equations##5##2##(2008-2#5)
phase-field##2##1##(2008-2#1)(2008-3#1)
phase-frequency##3##1##(2005-11#2)(2007-12#1)
phase-front##3##1##(2007-12#2)(2008-2#1)
phase-function##3##1##(2008-2#2)(2008-3#1)
phase-gradient##3##1##(2008-2#1)(2008-3#1)(2009-5#1)
phase-high performance liquid chromatography##2##4##(1990-7#1)(2012-12#1)
phase-iterative algorithm##3##2##(2008-2#1)(2008-3#2)
phase-iterative techniques##2##2##(2008-2#2)
phase-iterative##5##1##(2008-2#3)(2008-3#2)
phase-locked laser diode interferometer##2##4##(2008-2#2)
phase-locked loop##11##2##(2007-11#1)(2007-12#4)(2008-1#1)(2008-2#1)(2008-3#4)
phase-locked pulses##2##2##(2007-11#1)(2008-1#1)
phase-locked resonators##2##2##(2008-3#2)
phase-locked to SAM signals with##2##5##(1996-9#2)
phase-locked##30##1##(1995-11#1)(1996-9#2)(2007-11#6)(2007-12#7)(2007-8#1)(2008-1#2)(2008-2#4)(2008-3#7)
phase-locking of##2##2##(1994-2#2)
phase-locking##5##1##(1994-2#2)(2008-11#2)(2013-8#1)
phase-matched KTP crystal##2##3##(2007-11#1)(2008-3#1)
phase-matched KTP##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
phase-matched frequency##2##2##(2007-12#1)(2008-1#1)
phase-matched optical parametric oscillator##3##4##(2007-11#1)(2007-12#2)
phase-matched optical parametric##5##3##(2007-11#1)(2007-12#3)(2008-1#1)
phase-matched optical##6##2##(2007-11#1)(2007-12#4)(2008-1#1)
phase-matched second-harmonic generation##2##3##(2008-1#1)(2008-3#1)
phase-matched third-harmonic generation##2##3##(2007-12#1)(2008-1#1)
phase-matched##48##1##(2007-11#9)(2007-12#27)(2008-1#4)(2008-2#4)(2008-3#3)(2010-12#1)
phase-matching angle##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
phase-matching angles##3##2##(2007-12#2)(2008-3#1)
phase-matching condition##11##2##(2007-11#2)(2007-12#3)(2008-2#3)(2008-3#3)
phase-matching conditions are##3##3##(2007-12#3)
phase-matching conditions for##3##3##(2007-11#1)(2008-1#1)(2008-3#1)
phase-matching conditions##14##2##(2007-11#2)(2007-12#6)(2008-1#2)(2008-2#1)(2008-3#3)
phase-matching geometry##3##2##(2007-12#3)
phase-matching properties of##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
phase-matching temperatures##3##2##(2007-12#1)(2008-3#2)
phase-matching##62##1##(2006-4#1)(2007-11#6)(2007-12#27)(2008-1#5)(2008-2#7)(2008-3#16)
phase-matrix elements##2##2##(2008-3#2)
phase-measurement error##2##2##(2007-12#1)(2008-2#1)
phase-measurement errors##2##2##(2008-3#2)
phase-measurement##7##1##(2007-12#1)(2008-2#2)(2008-3#4)
phase-measuring algorithms##3##2##(2008-2#3)
phase-measuring profilometry##4##2##(2008-3#4)
phase-measuring##12##1##(2007-11#1)(2008-2#6)(2008-3#5)
phase-mismatched second-harmonic generation##2##3##(2007-12#2)
phase-mismatched##3##1##(2007-12#3)
phase-modulated ellipsometry##4##2##(2008-2#2)(2008-3#2)
phase-modulated optical fiber-ring buffer##2##4##(2007-12#2)
phase-modulated optical##3##2##(2007-12#3)
phase-modulated spectroscopic##2##2##(2008-3#2)
phase-modulated spectroscopy##2##2##(1997-6#2)
phase-modulated##28##1##(1997-6#2)(2007-11#2)(2007-12#10)(2008-1#1)(2008-2#5)(2008-3#7)(2012-2#1)
phase-modulation##9##1##(1995-5#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#3)
phase-noise measurement##2##2##(2007-12#2)
phase-noise##7##1##(2007-11#2)(2007-12#4)(2013-1#1)
phase-only computer-generated##2##2##(2008-3#2)
phase-only domains with##2##3##(2008-3#2)
phase-only elements##2##2##(2008-2#1)(2008-3#1)
phase-only filter##12##2##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#7)
phase-only filters##10##2##(2007-11#1)(2007-12#1)(2008-2#6)(2008-3#2)
phase-only liquid-crystal spatial light modulator##4##5##(2007-12#1)(2008-3#3)
phase-only modulators##2##2##(2008-2#1)(2008-3#1)
phase-only optical##2##2##(2007-12#1)(2008-3#1)
phase-only spatial light modulator##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
phase-only spatial light##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
phase-only##60##1##(2007-11#3)(2007-12#6)(2008-1#2)(2008-2#19)(2008-3#30)
phase-reconstruction##2##1##(2008-1#1)(2008-2#1)
phase-resolved OCT angiography with##2##4##(2013-1#2)
phase-resolved OCT angiography##3##3##(2013-1#3)
phase-resolved OCT##4##2##(2013-1#4)
phase-resolved digital data processing##2##4##(2008-3#2)
phase-resolved functional optical coherence tomography##3##5##(2007-11#3)
phase-resolved optical Doppler##2##3##(2007-11#1)(2007-12#1)
phase-resolved##14##1##(2007-11#5)(2007-12#1)(2008-3#2)(2011-1#2)(2013-1#4)
phase-response##2##1##(1995-12#1)(2010-12#1)
phase-retardation##2##1##(2008-2#1)(2009-4#1)
phase-retarding##3##1##(2008-2#1)(2008-3#2)
phase-retrieval algorithm##3##2##(2008-2#2)(2008-3#1)
phase-retrieval procedure##2##2##(2007-12#1)(2008-3#1)
phase-retrieval##11##1##(2007-11#1)(2007-12#3)(2008-2#4)(2008-3#3)
phase-sensitive detection of##2##3##(2007-12#1)(2008-2#1)
phase-sensitive detection##8##2##(2007-12#3)(2008-2#2)(2008-3#3)
phase-sensitive detector##2##2##(2007-12#1)(2010-4#1)
phase-sensitive##16##1##(2007-12#9)(2008-2#3)(2008-3#3)(2010-4#1)
phase-separated PNIPAM##3##2##(2008-10#3)
phase-separated##10##1##(1994-5#1)(2005-11#1)(2007-12#1)(2008-10#4)(2008-3#1)(2010-4#2)
phase-separation process of##2##3##(2008-10#2)
phase-separation process##3##2##(2005-11#1)(2008-10#2)
phase-shift algorithm##2##2##(2007-12#1)(2008-2#1)
phase-shift algorithms##2##2##(2008-2#2)
phase-shift detection##2##2##(2007-12#1)(2008-2#1)
phase-shift keying##3##2##(2007-11#3)
phase-shift map##2##2##(2008-3#2)
phase-shift technique##2##2##(2008-3#2)
phase-shift##38##1##(1993-12#1)(2007-11#6)(2007-12#5)(2008-2#8)(2008-3#18)
phase-shift-keyed##3##1##(2007-11#2)(2007-12#1)
phase-shifted fringe patterns##2##3##(2007-11#1)(2008-3#1)
phase-shifted images##3##2##(2008-3#3)
phase-shifted measurements##2##2##(2008-2#2)
phase-shifted##15##1##(2007-11#1)(2007-12#1)(2008-2#5)(2008-3#8)
phase-shifting Fizeau interferometer##2##3##(2008-3#2)
phase-shifting algorithm##5##2##(2008-2#2)(2008-3#3)
phase-shifting analysis##3##2##(2007-12#1)(2008-3#2)
phase-shifting digital holographic microscopy##2##4##(2011-1#2)
phase-shifting digital holographic##3##3##(2011-1#3)
phase-shifting digital holography##6##3##(2007-11#2)(2007-12#2)(2008-3#2)
phase-shifting digital##9##2##(2007-11#2)(2007-12#2)(2008-3#2)(2011-1#3)
phase-shifting effects##3##2##(1996-6#1)(1997-5#1)(2008-2#1)
phase-shifting element##2##2##(2007-11#1)(2007-12#1)
phase-shifting error##2##2##(2007-11#1)(2008-3#1)
phase-shifting interferometer##9##2##(2007-11#1)(2008-2#3)(2008-3#5)
phase-shifting interferometers##2##2##(2008-3#2)
phase-shifting interferometry algorithms##2##3##(2007-12#1)(2008-2#1)
phase-shifting interferometry with##3##3##(2007-12#2)(2008-3#1)
phase-shifting interferometry##19##2##(2007-12#6)(2008-1#1)(2008-2#1)(2008-3#11)
phase-shifting joint transform##2##3##(2008-2#1)(2008-3#1)
phase-shifting masks##2##2##(2008-2#2)
phase-shifting method##3##2##(2008-2#2)(2008-3#1)
phase-shifting photoelasticity##2##2##(2008-3#2)
phase-shifting point diffraction interferometer##3##4##(2006-4#1)(2008-2#1)(2008-3#1)
phase-shifting point-diffraction interferometer (PS/PDI)##2##4##(2008-3#2)
phase-shifting point-diffraction interferometer##5##3##(2008-3#5)
phase-shifting quantization##3##2##(2008-2#2)(2008-3#1)
phase-shifting shearing interferometer##3##3##(2007-11#2)(2008-2#1)
phase-shifting speckle interferometry##3##3##(2008-3#3)
phase-shifting speckle##5##2##(2008-2#1)(2008-3#4)
phase-shifting technique is##3##3##(2008-2#2)(2008-3#1)
phase-shifting technique##7##2##(2008-2#3)(2008-3#4)
phase-shifting techniques##2##2##(2008-2#1)(2008-3#1)
phase-shifting##117##1##(1994-2#1)(1996-6#1)(1996-8#1)(1997-5#1)(2006-4#1)(2007-11#9)(2007-12#12)(2008-1#1)(2008-2#28)(2008-3#59)(2011-1#3)
phase-shifts##2##1##(1995-12#1)(2007-3#1)
phase-space distributions##2##2##(2007-12#2)
phase-space product##3##2##(2007-11#3)
phase-space##11##1##(2007-11#3)(2007-12#5)(2008-2#2)(2008-3#1)
phase-specific protein##2##2##(1994-12#1)(2011-2#1)
phase-specific##5##1##(1991-8#3)(1994-12#1)(2011-2#1)
phase-step##3##1##(2008-2#1)(2008-3#2)
phase-stepped interferometry##2##2##(2008-3#2)
phase-stepped##8##1##(2007-12#2)(2008-2#3)(2008-3#3)
phase-stepping images##2##2##(2007-12#1)(2008-3#1)
phase-stepping interferometer##2##2##(2008-2#1)(2008-3#1)
phase-stepping interferometry##2##2##(2007-12#1)(2008-2#1)
phase-stepping technique##2##2##(2008-3#2)
phase-stepping##22##1##(2007-11#1)(2007-12#3)(2008-2#9)(2008-3#9)
phase-tracking##11##1##(2008-2#3)(2008-3#8)
phase-transfer catalysts##3##2##(2007-11#2)(2011-2#1)
phase-transfer##5##1##(1994-3#1)(2007-11#2)(2008-3#1)(2011-2#1)
phase-transition##3##1##(1990-4#1)(2006-12#1)(2007-12#1)
phase-unwrapping algorithm based on a##2##5##(2008-2#1)(2008-3#1)
phase-unwrapping algorithm based on##3##4##(2008-2#1)(2008-3#2)
phase-unwrapping algorithm##7##2##(2008-2#2)(2008-3#5)
phase-unwrapping method##3##2##(2008-3#3)
phase-unwrapping problems##2##2##(2008-2#1)(2008-3#1)
phase-unwrapping technique##2##2##(2008-2#1)(2008-3#1)
phase-unwrapping##22##1##(2008-2#9)(2008-3#13)
phase]##5##1##(1990-6#1)(1995-4#1)(1997-4#1)(1997-6#1)(2013-1#1)
phased array##4##2##(1993-4#1)(2007-11#1)(2011-2#2)
phased arrays##3##2##(2008-2#1)(2008-3#2)
phased coil##3##2##(2013-7#3)
phased in##3##2##(1992-1#1)(2008-11#1)(2008-9#1)
phased##31##1##(1991-4#1)(1992-1#1)(1992-12#1)(1993-11#1)(1993-4#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-8#1)(2004-4#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#4)(2008-9#1)(2011-2#2)(2012-3#1)(2013-7#3)
phased-array antenna##5##2##(2008-3#5)
phased-array antennas##7##2##(2007-12#2)(2008-2#1)(2008-3#4)
phased-array##19##1##(2005-12#1)(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#11)
phaseoli and X##4##3##(2008-10#4)
phaseoli and##5##2##(2008-10#5)
phaseoli in##4##2##(2008-10#4)
phaseoli strains were highly pathogenic on##2##6##(2008-10#2)
phaseoli strains##10##2##(2008-10#10)
phaseoli var##15##2##(2008-10#15)
phaseoli was##2##2##(2008-10#2)
phaseoli##47##1##(1990-3#1)(2008-10#46)
phaseolicola and glycinea##3##3##(2008-10#3)
phaseolicola and##4##2##(2008-10#4)
phaseolicola was##2##2##(2008-10#2)
phaseolicola##22##1##(2008-10#19)(2011-1#3)
phaseolin##3##1##(2009-10#3)
phaseolina##4##1##(2008-10#4)
phaseolorum and P##2##3##(2008-10#2)
phaseolorum and##6##2##(2008-10#6)
phaseolorum var##40##2##(2008-10#40)
phaseolorum##51##1##(2008-10#51)
phaseolotoxin##2##1##(2008-10#2)
phases IV and II##2##4##(2008-10#2)
phases and the##5##3##(1991-8#1)(2008-10#3)(2013-8#1)
phases and##27##2##(1990-12#1)(1991-8#1)(1994-10#1)(1994-4#1)(1995-10#1)(1996-5#1)(1997-6#1)(2005-11#1)(2007-12#3)(2007-5#1)(2008-10#7)(2008-2#1)(2008-5#1)(2010-11#1)(2010-2#1)(2010-4#1)(2013-8#3)
phases are not##2##3##(2005-11#1)(2008-10#1)
phases are##17##2##(1990-5#1)(1990-7#1)(1991-11#1)(1991-8#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2009-12#1)(2011-2#1)(2012-2#1)
phases as##2##2##(2005-11#1)(2007-12#1)
phases associated with##2##3##(2005-8#1)(2008-10#1)
phases at##6##2##(1991-4#1)(1993-8#1)(2006-4#1)(2008-1#1)(2010-4#1)(2011-1#1)
phases bound to the##2##4##(1990-8#2)
phases by cell##2##3##(2008-11#1)(2013-1#1)
phases by##9##2##(1992-9#1)(1997-8#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2013-1#1)
phases can be##6##3##(1994-6#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-5#1)
phases consisted of##2##3##(1990-3#1)(1990-8#1)
phases containing##7##2##(1996-5#3)(1997-3#1)(2005-11#1)(2008-10#2)
phases dominated##2##2##(2008-10#1)(2013-1#1)
phases during##2##2##(2008-5#1)(2010-4#1)
phases employed##2##2##(1997-3#1)(2008-10#1)
phases for the##2##3##(2007-12#1)(2008-10#1)
phases for##16##2##(1990-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-5#2)(2009-11#1)(2011-1#1)
phases has been##3##3##(1997-2#1)(2007-6#1)(2008-5#1)
phases have been##2##3##(2008-10#2)
phases in the##13##3##(1992-4#1)(1996-5#1)(2005-11#1)(2006-2#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-8#1)(2009-7#2)
phases in##30##2##(1990-3#1)(1990-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1995-12#1)(1996-5#2)(1996-8#1)(1997-8#1)(2004-12#1)(2005-11#1)(2006-2#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-7#2)
phases involve##3##2##(1996-2#2)(2008-4#1)
phases is##7##2##(1990-7#1)(1996-8#2)(2005-8#1)(2007-12#1)(2008-3#1)(2008-5#1)
phases may be##2##3##(1997-2#1)(2008-9#1)
phases may##3##2##(1993-4#1)(1997-2#1)(2008-9#1)
phases of a##3##3##(2008-10#1)(2008-3#1)(2009-5#1)
phases of all##2##3##(1992-2#1)(2008-3#1)
phases of both##2##3##(1991-2#1)(2012-2#1)
phases of clinical trials##4##4##(2005-7#1)(2012-12#1)(2012-2#2)
phases of contrast##2##3##(2007-5#1)(2010-12#1)
phases of development##3##3##(2008-8#1)(2011-2#1)(2012-3#1)
phases of different##5##3##(2005-12#2)(2008-10#2)(2008-3#1)
phases of infection##2##3##(2008-10#1)(2013-1#1)
phases of memory##3##3##(2007-8#3)
phases of menstrual cycle on physical working capacity##2##8##(2012-2#2)
phases of menstrual cycle##3##4##(2012-2#3)
phases of recovery##2##3##(2006-7#1)(2008-6#1)
phases of surfactant##2##3##(1993-7#1)(2010-11#1)
phases of the cell cycle and##2##6##(1994-3#1)(2008-4#1)
phases of the cell cycle##14##5##(1994-3#2)(2004-11#1)(2008-11#5)(2008-4#3)(2008-7#1)(2010-4#2)
phases of the cell##15##4##(1994-3#2)(1995-3#1)(2004-11#1)(2008-11#5)(2008-4#3)(2008-7#1)(2010-4#2)
phases of the disease##6##4##(1991-5#1)(2007-5#1)(2007-7#1)(2008-10#1)(2012-12#1)(2012-3#1)
phases of the micellar system##3##5##(1990-5#3)
phases of the strategy##3##4##(1996-1#1)(1996-2#1)(2008-11#1)
phases of the study##2##4##(2008-4#1)(2013-8#1)
phases of the two##3##4##(2008-2#1)(2013-1#2)
phases of the##78##3##(1990-2#1)(1990-4#1)(1990-5#3)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-7#1)(1992-9#1)(1993-2#2)(1994-12#2)(1994-3#2)(1994-6#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-1#2)(1996-11#1)(1996-2#3)(2004-11#1)(2006-10#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#9)(2008-2#2)(2008-3#2)(2008-4#4)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-4#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
phases of their##2##3##(1990-5#1)(1992-9#1)
phases of this##2##3##(1991-3#1)(2008-1#1)
phases of treatment##2##3##(1990-3#1)(2005-7#1)
phases of water##2##3##(2008-10#1)(2012-12#1)
phases of##220##2##(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#2)(1990-5#4)(1990-6#2)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#3)(1992-11#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1996-1#2)(1996-11#1)(1996-2#3)(1996-5#1)(1996-7#1)(1997-5#1)(1997-8#1)(2004-11#1)(2005-11#1)(2005-12#2)(2005-7#2)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#4)(2007-12#6)(2007-2#2)(2007-5#3)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#4)(2008-10#15)(2008-11#15)(2008-12#2)(2008-2#6)(2008-3#5)(2008-4#5)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-4#2)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#4)(2012-2#11)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#4)
phases on the##2##3##(2008-10#1)(2008-3#1)
phases on##3##2##(1991-5#1)(2008-10#1)(2008-3#1)
phases or##2##2##(2005-11#1)(2012-2#1)
phases over##2##2##(1990-3#1)(2009-8#1)
phases showed##2##2##(2006-10#1)(2011-2#1)
phases studied##2##2##(1990-12#1)(2008-10#1)
phases such as##2##3##(1992-9#1)(1996-5#1)
phases that##7##2##(1990-7#1)(1996-10#1)(1996-5#1)(2008-10#2)(2012-2#2)
phases through##2##2##(2005-12#1)(2008-10#1)
phases to##5##2##(1992-8#1)(1996-7#1)(2008-10#1)(2008-2#1)(2008-4#1)
phases under##3##2##(1993-7#1)(1997-8#1)(2008-10#1)
phases used were##2##3##(1990-8#1)(2008-10#1)
phases was##11##2##(1991-6#1)(2004-9#1)(2005-12#1)(2006-10#1)(2008-10#3)(2008-8#1)(2010-4#1)(2012-11#1)(2013-8#1)
phases were compared with##2##4##(2008-10#1)(2010-4#1)
phases were investigated##2##3##(1990-3#1)(2008-10#1)
phases were observed##3##3##(2008-5#1)(2008-7#1)(2013-8#1)
phases were obtained##2##3##(2008-5#1)(2013-8#1)
phases were separated in a##3##5##(2008-10#3)
phases were studied##2##3##(2008-10#2)
phases were used##2##3##(1994-3#1)(2008-10#1)
phases were##37##2##(1990-10#1)(1990-3#1)(1991-4#1)(1991-5#1)(1993-12#1)(1994-3#1)(1996-8#1)(2004-11#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-6#1)(2007-8#2)(2008-10#12)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-11#1)(2010-4#1)(2013-8#2)
phases with a##2##3##(1996-2#1)(2010-2#1)
phases with high##2##3##(2008-7#1)(2011-1#1)
phases with the##3##3##(2008-10#2)(2008-5#1)
phases with##12##2##(1996-2#2)(1997-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-2#1)(2011-1#1)(2012-12#1)
phases##760##1##(1990-10#2)(1990-12#14)(1990-2#2)(1990-3#12)(1990-4#2)(1990-5#6)(1990-6#2)(1990-7#3)(1990-8#6)(1990-9#2)(1991-11#2)(1991-2#5)(1991-3#4)(1991-4#2)(1991-5#3)(1991-6#3)(1991-8#4)(1992-1#4)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#5)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-7#3)(1993-8#2)(1993-9#2)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#5)(1994-4#1)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#5)(1995-5#1)(1995-6#1)(1996-1#2)(1996-10#2)(1996-11#1)(1996-2#9)(1996-3#2)(1996-4#1)(1996-5#12)(1996-7#2)(1996-8#6)(1997-1#2)(1997-2#4)(1997-3#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#12)(2004-11#2)(2004-12#5)(2004-9#3)(2005-11#12)(2005-12#5)(2005-5#1)(2005-7#2)(2005-8#6)(2006-10#13)(2006-11#1)(2006-12#2)(2006-2#3)(2006-4#2)(2006-5#4)(2006-7#2)(2006-8#2)(2007-1#2)(2007-11#15)(2007-12#22)(2007-2#2)(2007-3#2)(2007-5#4)(2007-6#2)(2007-7#3)(2007-8#16)(2007-9#3)(2008-1#5)(2008-10#111)(2008-11#32)(2008-12#5)(2008-2#20)(2008-3#13)(2008-4#15)(2008-5#29)(2008-6#3)(2008-7#19)(2008-8#9)(2008-9#7)(2009-10#1)(2009-11#4)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#3)(2010-11#5)(2010-12#7)(2010-2#6)(2010-4#11)(2010-7#2)(2010-8#1)(2011-1#12)(2011-12#1)(2011-2#7)(2012-1#3)(2012-11#2)(2012-12#6)(2012-2#22)(2012-3#3)(2012-9#1)(2013-1#12)(2013-7#2)(2013-8#21)
phases'##2##1##(2008-11#2)
phasic activity##2##2##(1993-5#1)(1997-4#1)
phasic and tonic##4##3##(1991-9#1)(2004-12#1)(2011-2#2)
phasic contraction##2##2##(2004-12#2)
phasic contractions##2##2##(1997-4#1)(2008-4#1)
phasic events##4##2##(1992-1#4)
phasic inhibition##2##2##(2008-11#1)(2011-2#1)
phasic neuronal activity##2##3##(1991-9#2)
phasic signals##2##2##(1995-12#2)
phasic##32##1##(1991-2#1)(1991-5#1)(1991-9#3)(1992-1#4)(1993-5#1)(1995-12#2)(1995-8#2)(1997-4#3)(1997-7#1)(2004-12#4)(2008-11#1)(2008-4#2)(2009-5#2)(2010-8#1)(2011-2#3)(2012-1#1)
phasing of one-wavelength anomalous-scattering data##2##5##(2006-4#2)
phasing of##7##2##(1995-11#1)(2006-4#3)(2007-12#1)(2008-9#1)(2012-3#1)
phasing out of##2##3##(1994-1#1)(2007-11#1)
phasing power##2##2##(2006-4#1)(2009-11#1)
phasing##25##1##(1992-4#1)(1994-1#2)(1995-11#1)(1996-11#1)(2006-4#4)(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#4)(2008-7#1)(2008-9#1)(2009-11#1)(2009-3#1)(2012-3#2)
phasmid##8##1##(1990-11#2)(1990-9#4)(1995-3#2)
phasmids##2##1##(1990-11#1)(1990-9#1)
phasor##3##1##(2008-2#1)(2013-1#2)
phasors##6##1##(2008-2#5)(2013-1#1)
pheasant flocks##2##2##(2007-6#2)
pheasant##5##1##(1990-6#1)(1992-2#1)(2007-6#3)
pheasants##6##1##(1990-9#1)(1993-10#1)(1996-8#1)(2007-6#2)(2008-5#1)
phellopterin##3##1##(1996-11#3)
phen and##3##2##(1996-2#1)(2008-10#2)
phen##8##1##(1996-2#2)(2008-10#3)(2008-5#2)(2010-5#1)
phenacyl ester##2##2##(2008-10#2)
phenacyl##4##1##(2008-10#3)(2008-11#1)
phenamil##4##1##(1992-2#3)(1994-12#1)
phenanthrene and##3##2##(2006-12#1)(2008-10#2)
phenanthrene derivatives##2##2##(1990-8#1)(2008-9#1)
phenanthrene metabolism##2##2##(1994-5#2)
phenanthrene##28##1##(1990-8#1)(1992-7#2)(1994-5#5)(2006-10#1)(2006-12#2)(2008-10#12)(2008-11#4)(2008-9#1)
phenanthrene-9##2##1##(2008-11#2)
phenanthrene-degrading bacterium##2##2##(2012-2#2)
phenanthrenequinone-doped poly(methyl methacrylate)##2##3##(2007-12#2)
phenanthrenes##4##1##(2004-2#2)(2008-10#2)
phenanthridinium##2##1##(1995-6#1)(2008-9#1)
phenanthroindolizidine and##2##2##(2010-2#2)
phenanthroline and##2##2##(1990-10#1)(2008-5#1)
phenanthroline##11##1##(1990-10#3)(1990-2#1)(1991-2#1)(2008-3#1)(2008-5#3)(2012-3#2)
phenazine methosulfate##3##2##(1992-3#2)(2008-11#1)
phenazine methosulphate-linked formate dehydrogenase##2##4##(1992-6#2)
phenazine##6##1##(1992-3#2)(1992-6#2)(2008-10#1)(2008-11#1)
phencyclidine (PCP)##7##2##(1991-1#2)(1991-6#1)(1991-7#1)(1991-9#1)(1995-7#1)(1995-9#1)
phencyclidine##18##1##(1991-1#2)(1991-2#1)(1991-6#2)(1991-7#2)(1991-9#3)(1995-7#1)(1995-9#2)(1996-10#1)(1996-12#2)(2008-1#1)(2012-12#1)
phenelzine##5##1##(1991-5#1)(1996-7#4)
phenethyl alcohol and##4##3##(2008-5#4)
phenethyl alcohol in##2##3##(2008-5#2)
phenethyl alcohol##11##2##(1996-11#1)(2007-1#1)(2008-5#9)
phenethyl ester##3##2##(1992-8#1)(1996-11#2)
phenethyl##15##1##(1992-8#1)(1993-9#1)(1996-11#3)(2007-1#1)(2008-5#9)
phenethylamine class##2##2##(1995-11#2)
phenethylamine##6##1##(1991-5#1)(1993-4#1)(1995-11#2)(2008-10#2)
phenetic analysis##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
phenetic##8##1##(1996-3#1)(2008-10#3)(2008-2#2)(2008-5#1)(2012-2#1)
pheniramine##3##1##(2010-3#2)(2012-1#1)
phenobarbital (PB)##5##2##(1990-7#2)(1993-7#2)(1994-11#1)
phenobarbital N-glucosides##2##2##(1997-3#2)
phenobarbital N-glucuronides##2##2##(1997-3#2)
phenobarbital and dexamethasone##2##3##(1994-8#2)
phenobarbital and phenytoin##3##3##(1996-1#1)(2008-10#2)
phenobarbital and##12##2##(1990-7#1)(1993-11#2)(1994-8#2)(1996-1#1)(1996-10#1)(1997-3#2)(2008-10#2)(2012-12#1)
phenobarbital in human urine##2##4##(1997-3#1)(2007-8#1)
phenobarbital in##4##2##(1997-3#1)(2007-8#3)
phenobarbital induced##2##2##(1991-5#1)(2007-8#1)
phenobarbital##61##1##(1990-7#4)(1991-10#1)(1991-5#1)(1992-9#1)(1993-11#7)(1993-7#3)(1994-11#2)(1994-3#1)(1994-8#2)(1994-9#1)(1995-2#2)(1996-1#1)(1996-10#4)(1996-6#1)(1997-3#9)(1997-5#5)(2007-8#7)(2008-10#5)(2008-6#2)(2008-8#1)(2012-12#1)
phenobarbital)##4##1##(1994-3#1)(2007-8#2)(2008-10#1)
phenobarbital-induced rat liver##2##3##(1990-5#1)(1991-11#1)
phenobarbital-induced##5##1##(1990-5#1)(1991-11#2)(1993-11#2)
phenobarbitone##6##1##(1994-8#1)(1995-3#1)(1996-4#1)(2007-8#1)(2008-10#1)(2008-4#1)
phenocopies##3##1##(1990-11#1)(1994-3#1)(2012-12#1)
phenogram##4##1##(2008-10#2)(2008-5#2)
phenol UDP-glucuronosyltransferase##3##2##(1997-8#3)
phenol and catechol##5##3##(2008-10#5)
phenol and cresols##3##3##(1990-12#2)(1994-12#1)
phenol and nitrophenols##2##3##(1996-11#2)
phenol and##29##2##(1990-12#2)(1992-8#1)(1993-2#1)(1994-12#1)(1996-11#2)(2005-11#2)(2005-4#3)(2008-10#9)(2008-3#3)(2008-8#2)(2012-1#3)
phenol as a##3##3##(1997-2#1)(2008-10#2)
phenol as well as##2##4##(2006-12#1)(2008-10#1)
phenol as##7##2##(1991-7#1)(1997-2#1)(2006-12#1)(2008-10#4)
phenol compounds##4##2##(1990-9#1)(2006-12#1)(2008-10#2)
phenol concentration##6##2##(2007-8#1)(2008-10#3)(2008-3#2)
phenol concentrations##2##2##(1994-10#1)(2008-10#1)
phenol degradation pathway##2##3##(1994-12#1)(2006-8#1)
phenol degradation##5##2##(1991-7#1)(1994-12#1)(2006-8#3)
phenol derivatives##7##2##(1990-8#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-6#1)(2009-12#1)
phenol extraction of##3##3##(1997-7#1)(2008-1#1)(2008-4#1)
phenol extraction##9##2##(1990-11#1)(1994-12#1)(1997-7#1)(2008-1#1)(2008-2#2)(2008-4#3)
phenol for the##2##3##(1994-10#1)(2006-12#1)
phenol hydroxylase##2##2##(1994-12#1)(1995-2#1)
phenol in the##2##3##(2008-10#2)
phenol in this##2##3##(2006-8#1)(2008-10#1)
phenol in##15##2##(1992-2#1)(1995-11#1)(2005-11#1)(2006-8#1)(2008-10#10)(2008-8#1)
phenol insulin##4##2##(1995-11#4)
phenol is##7##2##(1996-2#1)(2005-4#1)(2006-8#2)(2008-10#2)(2010-5#1)
phenol of##2##2##(2007-8#1)(2008-10#1)
phenol oxidase##2##2##(1991-10#1)(1997-2#1)
phenol ring##2##2##(2008-8#2)
phenol solutions##3##2##(2007-8#1)(2008-10#2)
phenol sulfotransferase##6##2##(1995-8#6)
phenol sulphotransferase##3##2##(1994-11#3)
phenol transformation##3##2##(2006-8#3)
phenol was##3##2##(2006-8#1)(2007-8#1)(2008-10#1)
phenol##229##1##(1990-11#1)(1990-12#4)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-7#2)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-10#5)(1994-11#3)(1994-12#5)(1994-2#1)(1994-5#3)(1994-8#1)(1995-11#8)(1995-2#1)(1995-6#1)(1995-8#9)(1996-11#3)(1996-2#2)(1996-6#2)(1997-2#3)(1997-7#1)(1997-8#3)(2005-11#10)(2005-4#4)(2005-7#1)(2006-12#8)(2006-8#20)(2007-8#6)(2008-1#1)(2008-10#77)(2008-11#3)(2008-2#3)(2008-3#5)(2008-4#4)(2008-5#1)(2008-6#1)(2008-8#6)(2009-12#1)(2009-4#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#3)(2013-1#1)
phenol-chloroform##3##1##(1996-7#1)(2008-4#2)
phenol-induced##2##1##(1992-7#1)(2006-12#1)
phenol/chloroform extraction and##2##3##(2005-11#1)(2006-8#1)
phenol/chloroform##3##1##(2005-11#1)(2006-8#1)(2008-4#1)
phenolate ligands are arranged in##2##5##(1996-2#2)
phenolate ligands have##2##3##(1996-2#2)
phenolate ligands##6##2##(1996-2#6)
phenolate##13##1##(1990-5#1)(1996-2#10)(1997-7#1)(2008-10#1)
phenolic OH groups##4##3##(2008-10#4)
phenolic OH##7##2##(2006-12#2)(2008-10#5)
phenolic acid##4##2##(2007-8#1)(2008-10#1)(2008-5#2)
phenolic acids and##3##3##(2008-10#3)
phenolic acids as##2##3##(2007-8#1)(2008-10#1)
phenolic acids by##2##3##(2008-10#1)(2013-8#1)
phenolic acids in##3##3##(2008-6#2)(2009-8#1)
phenolic acids of##2##3##(1996-1#1)(2008-11#1)
phenolic acids##26##2##(1996-1#1)(2006-8#1)(2007-1#1)(2007-8#2)(2008-10#12)(2008-11#1)(2008-5#2)(2008-6#3)(2009-8#1)(2011-2#1)(2013-8#1)
phenolic and##5##2##(2006-8#1)(2008-1#2)(2008-10#1)(2012-2#1)
phenolic antioxidants##4##2##(2008-10#4)
phenolic benzylamines##3##2##(2008-5#3)
phenolic components##3##2##(1995-3#1)(2008-10#2)
phenolic compound##7##2##(2006-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-2#1)
phenolic compounds and##6##3##(2008-10#4)(2008-5#1)(2010-4#1)
phenolic compounds are##2##3##(2011-2#1)(2012-11#1)
phenolic compounds have##2##3##(2008-10#2)
phenolic compounds in the##2##4##(1994-5#1)(2008-10#1)
phenolic compounds in##11##3##(1994-5#1)(2008-10#7)(2011-1#1)(2011-2#2)
phenolic compounds present in##2##4##(2008-10#2)
phenolic compounds was##3##3##(1992-2#1)(2008-10#1)(2011-1#1)
phenolic compounds were##3##3##(2008-10#2)(2009-6#1)
phenolic compounds with##3##3##(2008-10#3)
phenolic compounds##75##2##(1990-12#1)(1991-5#1)(1992-2#1)(1994-5#3)(1996-6#1)(2006-12#2)(2008-1#1)(2008-10#45)(2008-11#1)(2008-5#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-1#4)(2011-2#4)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
phenolic constituents##4##2##(2008-10#1)(2009-3#2)(2010-12#1)
phenolic content in##2##3##(2010-5#1)(2013-1#1)
phenolic content of the##4##4##(2008-10#1)(2008-11#1)(2011-2#1)(2012-11#1)
phenolic content of##6##3##(2008-10#3)(2008-11#1)(2011-2#1)(2012-11#1)
phenolic content was##3##3##(2008-10#1)(2009-6#1)(2013-1#1)
phenolic content##16##2##(2004-2#1)(2008-10#6)(2008-11#1)(2009-6#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#3)
phenolic contents##6##2##(2008-11#1)(2012-2#3)(2013-8#2)
phenolic groups##2##2##(2008-10#2)
phenolic hydroxy##2##2##(2007-1#1)(2008-10#1)
phenolic hydroxyl group##4##3##(1991-7#1)(1992-9#1)(1993-4#1)(2008-10#1)
phenolic hydroxyl##5##2##(1991-7#1)(1992-9#1)(1993-4#1)(2008-10#1)(2008-9#1)
phenolic ligand##2##2##(1996-8#1)(2008-10#1)
phenolic ligands##2##2##(1995-11#1)(2008-10#1)
phenolic monomers##3##2##(2011-1#1)(2011-2#2)
phenolic substance from##2##3##(2008-5#2)
phenolic substance were##2##3##(2007-10#1)(2008-5#1)
phenolic substance##9##2##(2007-10#2)(2008-5#7)
phenolic substances##2##2##(2006-12#1)(2008-10#1)
phenolic##228##1##(1990-12#1)(1990-5#2)(1991-5#1)(1991-7#2)(1992-2#1)(1992-3#3)(1992-9#2)(1993-2#1)(1993-4#1)(1994-3#1)(1994-5#3)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#3)(1995-8#1)(1996-1#1)(1996-5#1)(1996-6#1)(1996-8#1)(2004-2#1)(2005-11#2)(2005-8#1)(2006-12#7)(2006-8#2)(2007-1#4)(2007-10#2)(2007-11#3)(2007-8#3)(2008-1#4)(2008-10#92)(2008-11#6)(2008-4#2)(2008-5#16)(2008-6#3)(2008-7#1)(2008-9#1)(2009-3#3)(2009-6#3)(2009-7#1)(2009-8#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#5)(2011-2#9)(2012-1#3)(2012-11#2)(2012-12#2)(2012-2#6)(2013-1#4)(2013-8#3)
phenolics and##5##2##(1991-11#1)(2008-10#3)(2012-11#1)
phenolics in##3##2##(2008-10#2)(2008-11#1)
phenolics is##2##2##(2008-10#2)
phenolics were##2##2##(2008-10#2)
phenolics##44##1##(1991-11#1)(1995-3#2)(1997-4#1)(2004-2#1)(2004-4#5)(2007-12#1)(2008-10#16)(2008-11#3)(2008-4#1)(2009-11#1)(2011-2#4)(2012-1#1)(2012-11#2)(2012-2#1)(2013-1#4)
phenological##9##1##(2008-10#4)(2008-5#2)(2011-2#1)(2012-6#2)
phenology in##2##2##(2008-10#1)(2012-6#1)
phenology of the##2##3##(2007-3#1)(2008-5#1)
phenology of##8##2##(2007-3#1)(2008-10#3)(2008-5#2)(2010-2#1)(2012-2#1)
phenology##23##1##(1991-11#1)(2007-3#2)(2008-10#10)(2008-5#4)(2008-8#2)(2010-2#1)(2012-2#1)(2012-6#2)
phenoloxidase##2##1##(1990-3#2)
phenolphthalein##9##1##(1996-3#1)(2007-12#1)(2008-10#6)(2008-4#1)
phenols and related compounds##5##4##(2008-10#5)
phenols and##15##2##(1994-9#1)(1996-12#1)(2008-10#13)
phenols are##2##2##(1995-10#1)(2008-10#1)
phenols by##3##2##(2008-10#3)
phenols from##7##2##(2006-12#1)(2006-3#1)(2007-8#1)(2008-10#3)(2008-4#1)
phenols in air##3##3##(2008-10#3)
phenols in the##2##3##(2008-10#2)
phenols in##9##2##(1990-9#1)(2008-10#8)
phenols is##3##2##(1994-5#1)(2008-6#1)(2011-1#1)
phenols on the##3##3##(2006-12#1)(2008-10#2)
phenols to##2##2##(2008-10#1)(2011-1#1)
phenols using##4##2##(2008-10#4)
phenols was##2##2##(2008-10#2)
phenols were##6##2##(1990-8#1)(1990-9#2)(2008-10#2)(2008-6#1)
phenols with##4##2##(2008-10#4)
phenols##114##1##(1990-12#1)(1990-8#1)(1990-9#6)(1994-5#2)(1994-9#3)(1995-10#1)(1996-12#1)(1996-6#1)(2005-12#1)(2006-10#2)(2006-12#7)(2006-3#2)(2007-11#1)(2007-8#1)(2008-10#71)(2008-11#1)(2008-4#1)(2008-6#3)(2010-4#2)(2011-1#4)(2011-2#1)(2013-1#1)
phenome##4##1##(2013-1#4)
phenomena among##2##2##(2008-7#1)(2013-1#1)
phenomena and their##2##3##(2009-12#1)(2013-1#1)
phenomena and##21##2##(1990-10#1)(1995-11#1)(1996-12#1)(1996-4#1)(1997-3#1)(2006-2#1)(2006-3#4)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-9#1)(2009-12#1)(2010-2#1)(2013-1#1)
phenomena are closely##2##3##(2005-11#1)(2008-9#1)
phenomena are involved##2##3##(2008-7#1)(2008-9#1)
phenomena are##21##2##(1992-2#1)(1996-1#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-8#1)(2005-10#1)(2005-11#2)(2006-10#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#2)(2009-7#1)(2010-7#1)(2013-1#2)
phenomena as##3##2##(1993-5#1)(2010-10#1)(2013-8#1)
phenomena associated with##2##3##(1997-8#1)(2008-3#1)
phenomena at##3##2##(1993-4#1)(2009-7#2)
phenomena being studied##2##3##(2008-4#1)(2009-7#1)
phenomena being##3##2##(1991-12#1)(2008-4#1)(2009-7#1)
phenomena between##2##2##(2008-10#1)(2010-12#1)
phenomena by##2##2##(2007-12#1)(2008-2#1)
phenomena can be##10##3##(1997-2#1)(2005-11#2)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-11#1)(2012-11#2)
phenomena can##12##2##(1997-2#1)(2005-11#2)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#1)(2010-11#1)(2012-11#2)
phenomena discovered in##2##3##(2007-8#1)(2009-8#1)
phenomena due to##3##3##(2009-12#1)(2009-8#1)(2011-2#1)
phenomena during##3##2##(1993-9#1)(2006-10#1)(2008-2#1)
phenomena for##2##2##(1996-3#1)(2008-10#1)
phenomena have been##4##3##(1990-3#1)(1991-5#1)(2008-2#1)(2010-4#1)
phenomena have##8##2##(1990-3#1)(1991-5#1)(2005-11#1)(2006-11#1)(2008-2#1)(2008-7#1)(2009-5#1)(2010-4#1)
phenomena in a##7##3##(1990-8#1)(2005-11#2)(2006-10#1)(2008-1#1)(2008-3#1)(2010-4#1)
phenomena in animal##2##3##(1995-2#1)(2009-5#1)
phenomena in the##9##3##(1996-1#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)
phenomena in##51##2##(1990-2#1)(1990-8#2)(1991-10#1)(1994-5#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-4#1)(1997-4#1)(2005-11#3)(2006-10#3)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#6)(2008-5#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-4#1)(2012-1#1)(2012-11#1)(2012-2#1)
phenomena including##3##2##(1996-4#1)(2008-3#1)(2013-8#1)
phenomena induced by##2##3##(1990-4#1)(1997-6#1)
phenomena involve the##2##3##(1990-7#1)(1995-5#1)
phenomena is##6##2##(1995-3#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-3#2)
phenomena like##2##2##(1994-6#1)(2007-9#1)
phenomena observed##2##2##(2008-11#1)(2008-7#1)
phenomena occur##2##2##(1995-9#1)(2008-5#1)
phenomena occurred##3##2##(2007-12#1)(2008-10#2)
phenomena occurring##3##2##(1990-11#1)(1992-6#1)(2005-11#1)
phenomena of##23##2##(1990-11#1)(1993-11#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#3)(2010-10#1)(2010-11#1)(2012-12#1)(2012-2#1)
phenomena on a##2##3##(2007-11#1)(2007-12#1)
phenomena on##4##2##(2007-11#1)(2007-12#1)(2007-8#1)(2008-7#1)
phenomena play##2##2##(2010-12#1)(2011-2#1)
phenomena related to##4##3##(2005-11#1)(2008-10#1)(2008-11#1)(2008-2#1)
phenomena resulting from the##2##4##(2008-7#1)(2009-12#1)
phenomena resulting from##3##3##(2005-10#1)(2008-7#1)(2009-12#1)
phenomena should be considered##2##4##(2009-12#1)(2013-7#1)
phenomena should##5##2##(2009-12#1)(2009-7#1)(2010-11#1)(2012-3#1)(2013-7#1)
phenomena such as aging##2##4##(1996-4#1)(2007-12#1)
phenomena such as the##3##4##(2006-7#1)(2007-12#1)(2007-9#1)
phenomena such as##17##3##(1993-2#1)(1996-4#2)(2006-10#2)(2006-7#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-3#1)(2012-2#1)(2013-1#1)
phenomena that are not##2##4##(2008-3#1)(2008-5#1)
phenomena that are##7##3##(2006-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2012-2#1)
phenomena that the##2##3##(2006-7#1)(2007-8#1)
phenomena that##21##2##(1996-4#1)(2006-11#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2012-1#1)(2012-2#2)(2013-8#1)
phenomena to##3##2##(2005-12#1)(2006-6#1)(2008-10#1)
phenomena was##4##2##(1991-12#1)(2008-10#1)(2008-3#2)
phenomena we##2##2##(2007-11#1)(2008-7#1)
phenomena were observed##5##3##(1991-8#1)(1993-9#1)(2005-11#1)(2008-10#2)
phenomena were##6##2##(1991-8#1)(1992-12#1)(1993-9#1)(2005-11#1)(2008-10#2)
phenomena which##2##2##(1990-11#1)(2008-10#1)
phenomena##479##1##(1990-10#1)(1990-11#5)(1990-12#1)(1990-2#1)(1990-3#3)(1990-4#1)(1990-7#2)(1990-8#5)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#3)(1991-4#1)(1991-5#4)(1991-6#1)(1991-8#2)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-10#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#4)(1995-2#2)(1995-3#3)(1995-5#2)(1995-8#1)(1995-9#1)(1996-1#4)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#10)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#3)(2005-10#2)(2005-11#15)(2005-12#1)(2005-8#1)(2006-10#12)(2006-11#2)(2006-12#3)(2006-2#4)(2006-3#8)(2006-6#2)(2006-7#4)(2006-9#1)(2007-10#4)(2007-11#14)(2007-12#21)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#3)(2007-9#8)(2008-1#2)(2008-10#35)(2008-11#13)(2008-12#1)(2008-2#28)(2008-3#29)(2008-4#3)(2008-5#9)(2008-6#2)(2008-7#27)(2008-8#5)(2008-9#5)(2009-10#1)(2009-11#3)(2009-12#7)(2009-2#5)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#3)(2009-7#5)(2009-8#5)(2010-10#4)(2010-11#3)(2010-12#4)(2010-2#1)(2010-3#3)(2010-4#5)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#3)(2012-11#3)(2012-12#1)(2012-2#10)(2012-3#2)(2013-1#14)(2013-7#4)(2013-8#4)
phenomena)##2##1##(2008-10#1)(2008-7#1)
phenomenal quality of##2##3##(2012-11#2)
phenomenal##6##1##(1991-3#1)(1997-1#1)(2007-4#1)(2008-12#1)(2012-11#2)
phenomenographic##2##1##(2008-12#1)(2012-1#1)
phenomenological and##2##2##(2008-3#1)(2008-6#1)
phenomenological approach and##3##3##(2007-10#1)(2007-11#1)(2007-12#1)
phenomenological approach to##3##3##(2006-9#1)(2007-11#1)(2010-3#1)
phenomenological approach was##2##3##(2007-10#1)(2009-9#1)
phenomenological approach##15##2##(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#1)(2008-2#2)(2009-9#1)(2010-10#1)(2010-3#1)(2011-1#2)(2013-1#1)
phenomenological description of##2##3##(2006-10#1)(2008-3#1)
phenomenological design##2##2##(2007-12#1)(2011-2#1)
phenomenological methodology##2##2##(2007-10#1)(2010-10#1)
phenomenological model for##2##3##(2008-2#1)(2008-3#1)
phenomenological model that##2##3##(2007-12#1)(2008-2#1)
phenomenological model##6##2##(2007-12#1)(2008-2#2)(2008-3#3)
phenomenological models##3##2##(2007-3#1)(2008-2#1)(2009-8#1)
phenomenological study investigated the##2##4##(2008-11#1)(2010-11#1)
phenomenological study of##4##3##(2005-12#1)(2007-10#1)(2007-11#1)(2011-2#1)
phenomenological study was##3##3##(2007-2#1)(2008-11#1)(2009-5#1)
phenomenological study##16##2##(2005-12#1)(2007-10#2)(2007-11#1)(2007-2#1)(2008-11#4)(2008-12#2)(2009-5#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
phenomenological##71##1##(1990-8#1)(1992-1#1)(1995-2#1)(1995-8#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-10#5)(2007-11#4)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-11#6)(2008-12#2)(2008-2#5)(2008-3#6)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#2)(2009-9#2)(2010-10#2)(2010-11#2)(2010-2#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-3#2)(2013-1#2)(2013-8#2)
phenomenological-hermeneutic approach##2##2##(2006-3#1)(2010-10#1)
phenomenological-hermeneutic##4##1##(2006-2#1)(2006-3#1)(2010-10#1)(2013-1#1)
phenomenologically by##2##2##(1991-2#1)(2008-3#1)
phenomenologically##3##1##(1991-2#1)(1997-2#1)(2008-3#1)
phenomenologies of hallucinations and delusions##2##5##(1997-8#2)
phenomenologies of##3##2##(1997-8#3)
phenomenology and##5##2##(1997-3#1)(2006-9#1)(2008-1#1)(2008-12#1)(2010-8#1)
phenomenology of the##3##3##(1996-4#1)(2008-7#1)(2010-6#1)
phenomenology of##7##2##(1996-4#1)(2005-7#1)(2007-10#1)(2008-11#1)(2008-7#1)(2009-3#1)(2010-6#1)
phenomenology##33##1##(1995-12#2)(1996-4#1)(1997-3#1)(2004-3#1)(2005-7#2)(2006-3#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#3)(2008-1#3)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#2)(2012-2#1)(2013-8#1)
phenomenon after##2##2##(1993-12#1)(2007-12#1)
phenomenon also##3##2##(1993-10#1)(1997-2#1)(2008-7#1)
phenomenon among##3##2##(2006-8#1)(2010-2#1)(2010-8#1)
phenomenon and is##3##3##(2009-11#1)(2012-2#2)
phenomenon and the##6##3##(2006-7#1)(2008-7#1)(2010-7#1)(2011-1#1)(2012-12#2)
phenomenon and##30##2##(1991-4#1)(1992-5#1)(1995-5#1)(1997-7#1)(2006-10#4)(2006-4#1)(2006-7#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#2)(2009-10#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-7#1)(2011-1#1)(2012-12#2)(2012-2#3)(2012-3#1)
phenomenon are discussed##4##3##(1997-4#1)(1997-6#1)(2006-10#1)(2009-2#1)
phenomenon are##8##2##(1992-1#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-11#1)(2009-2#1)(2011-12#1)
phenomenon as##6##2##(2006-10#2)(2006-12#1)(2008-10#1)(2012-2#1)(2013-1#1)
phenomenon associated with##2##3##(1990-10#1)(2007-11#1)
phenomenon but rather##2##3##(1993-2#1)(2010-12#1)
phenomenon but##3##2##(1991-6#1)(1993-2#1)(2010-12#1)
phenomenon by##5##2##(1992-9#1)(2006-10#1)(2006-2#1)(2008-11#1)(2008-2#1)
phenomenon called##5##2##(1994-11#1)(2007-12#1)(2008-7#1)(2008-9#1)(2009-10#1)
phenomenon can be##5##3##(1992-8#1)(1994-2#1)(2008-3#1)(2008-7#1)(2012-2#1)
phenomenon can##8##2##(1992-8#1)(1994-2#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-2#2)
phenomenon commonly##2##2##(2008-12#1)(2010-4#1)
phenomenon could##6##2##(1990-8#1)(1992-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-5#1)
phenomenon depends##3##2##(1990-11#1)(2007-11#1)(2008-4#1)
phenomenon during the##2##3##(2008-10#1)(2008-8#1)
phenomenon enables##2##2##(2008-10#1)(2010-4#1)
phenomenon for##4##2##(1990-12#1)(2008-11#1)(2008-3#2)
phenomenon from the perspective of##2##5##(1994-12#1)(2010-7#1)
phenomenon from##4##2##(1994-12#1)(2006-4#1)(2007-12#1)(2010-7#1)
phenomenon has been described in##2##5##(2007-7#1)(2012-2#1)
phenomenon has been##13##3##(1994-8#1)(1995-11#1)(2004-4#1)(2006-12#1)(2006-4#1)(2007-11#2)(2007-7#2)(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#1)
phenomenon has##19##2##(1993-5#1)(1993-7#1)(1994-8#1)(1995-11#1)(2004-4#1)(2006-12#1)(2006-4#1)(2007-11#2)(2007-7#2)(2008-10#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#2)(2012-2#1)
phenomenon in a##3##3##(1996-6#1)(2007-10#1)(2008-7#1)
phenomenon in humans##2##3##(2008-11#1)(2010-4#1)
phenomenon in psoriasis##3##3##(2007-7#3)
phenomenon in the##14##3##(1991-6#1)(1993-1#1)(1995-5#1)(1996-3#1)(1997-4#1)(1997-8#1)(2006-10#1)(2008-12#1)(2008-2#3)(2008-7#1)(2010-10#1)(2013-8#1)
phenomenon in which##10##3##(1995-8#1)(2008-1#2)(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-11#1)(2013-1#2)
phenomenon in##64##2##(1991-6#1)(1992-8#3)(1993-1#1)(1993-11#1)(1994-8#2)(1995-11#1)(1995-5#1)(1995-8#1)(1996-3#1)(1996-6#1)(1997-4#1)(1997-8#1)(2004-4#1)(2005-4#1)(2006-1#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-12#3)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#5)(2008-4#1)(2008-7#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2010-10#2)(2010-4#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#3)
phenomenon is a##4##3##(1994-11#1)(1995-5#1)(2007-11#1)(2012-2#1)
phenomenon is explained##3##3##(1990-5#1)(2007-12#1)(2009-7#1)
phenomenon is not##2##3##(2008-10#1)(2008-4#1)
phenomenon is observed##2##3##(2008-1#1)(2008-3#1)
phenomenon is the##2##3##(1994-9#1)(2006-2#1)
phenomenon is##58##2##(1990-2#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-5#1)(1997-7#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#5)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#2)(2010-10#1)(2010-12#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
phenomenon known as &quot##3##4##(2011-2#1)(2012-12#1)(2012-2#1)
phenomenon known as##9##3##(1996-10#1)(1996-7#1)(2006-10#1)(2008-10#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
phenomenon known##10##2##(1996-10#1)(1996-7#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
phenomenon may be##11##3##(1991-6#1)(1991-9#1)(2005-10#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-5#2)(2008-7#2)
phenomenon may##16##2##(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1995-10#1)(1997-5#1)(2005-10#1)(2006-10#2)(2007-11#1)(2008-10#2)(2008-5#2)(2008-7#2)
phenomenon might##2##2##(2006-10#1)(2012-2#1)
phenomenon observed in the##2##4##(2007-11#1)(2008-2#1)
phenomenon observed in##4##3##(2007-11#1)(2007-12#1)(2007-7#1)(2008-2#1)
phenomenon observed##5##2##(2005-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-2#1)
phenomenon occurring in##3##3##(2004-11#1)(2007-7#1)(2012-2#1)
phenomenon occurs in##2##3##(1997-7#1)(2006-10#1)
phenomenon occurs##5##2##(1997-2#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#1)
phenomenon of late-arising##2##3##(2008-9#2)
phenomenon of multiple##2##3##(2007-12#1)(2009-8#1)
phenomenon of surface plasmon resonance (SPR)##2##6##(2008-4#1)(2008-9#1)
phenomenon of the##7##3##(1994-5#1)(2005-11#1)(2008-10#1)(2008-5#1)(2009-9#1)(2013-1#1)(2013-7#1)
phenomenon of##94##2##(1990-2#1)(1990-8#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-2#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-8#1)(1996-2#2)(1996-4#3)(1997-6#1)(2004-11#2)(2005-11#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#5)(2007-12#2)(2007-4#1)(2007-7#2)(2008-1#2)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#6)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-1#3)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
phenomenon on the##2##3##(2007-6#1)(2009-5#1)
phenomenon or##2##2##(2008-11#1)(2012-3#1)
phenomenon originates from##2##3##(1990-8#1)(2006-10#1)
phenomenon provides a##2##3##(1990-9#1)(2007-12#1)
phenomenon requires##2##2##(2008-12#1)(2013-1#1)
phenomenon requiring##2##2##(2005-8#1)(2008-9#1)
phenomenon that can##2##3##(2008-10#1)(2008-3#1)
phenomenon that has been##2##4##(2006-11#1)(2008-8#1)
phenomenon that has##3##3##(2006-11#1)(2008-8#1)(2012-2#1)
phenomenon that is not##2##4##(2008-5#1)(2011-2#1)
phenomenon that is##4##3##(2008-3#1)(2008-5#1)(2011-2#2)
phenomenon that may##2##3##(1992-12#1)(1997-3#1)
phenomenon that we##2##3##(2008-5#1)(2012-2#1)
phenomenon that##27##2##(1992-12#1)(1996-4#1)(1997-3#1)(2005-10#1)(2006-11#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-6#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)
phenomenon to##6##2##(1990-12#1)(1994-5#1)(1996-1#1)(2007-12#1)(2008-1#1)(2008-7#1)
phenomenon underlying##2##2##(1994-11#1)(2007-9#1)
phenomenon was not##3##3##(1990-5#2)(1996-10#1)
phenomenon was observed for##3##4##(2004-11#1)(2008-10#1)(2008-12#1)
phenomenon was observed##4##3##(2004-11#1)(2008-10#1)(2008-12#1)(2008-3#1)
phenomenon was present in##2##4##(2007-11#1)(2008-8#1)
phenomenon was##28##2##(1990-5#3)(1991-9#1)(1992-5#1)(1993-2#1)(1995-12#2)(1995-2#1)(1996-10#1)(1997-7#1)(2004-11#1)(2005-11#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#2)(2010-3#1)(2011-2#2)(2013-1#1)
phenomenon we##2##2##(1990-11#1)(2006-7#1)
phenomenon which is##3##3##(1990-8#1)(2007-1#1)(2007-8#1)
phenomenon which##9##2##(1990-6#1)(1990-8#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-11#1)(2009-8#1)(2010-12#1)(2010-4#1)
phenomenon whose##2##2##(2006-7#1)(2008-2#1)
phenomenon with##3##2##(1990-11#1)(2007-4#1)(2008-9#1)
phenomenon##785##1##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#4)(1990-3#1)(1990-5#5)(1990-6#1)(1990-8#4)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-6#5)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#5)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#3)(1993-9#2)(1994-11#5)(1994-12#2)(1994-2#2)(1994-3#2)(1994-4#1)(1994-5#2)(1994-6#3)(1994-8#7)(1994-9#3)(1995-10#1)(1995-11#5)(1995-12#4)(1995-2#3)(1995-4#1)(1995-5#4)(1995-6#1)(1995-8#2)(1996-1#1)(1996-10#3)(1996-2#5)(1996-3#2)(1996-4#5)(1996-5#2)(1996-6#1)(1996-7#3)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#5)(1997-7#6)(1997-8#2)(1997-9#1)(2004-10#2)(2004-11#4)(2004-2#1)(2004-4#2)(2005-10#3)(2005-11#7)(2005-4#4)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#27)(2006-11#3)(2006-12#3)(2006-2#4)(2006-4#6)(2006-5#5)(2006-6#1)(2006-7#5)(2006-8#3)(2006-9#3)(2007-1#2)(2007-10#5)(2007-11#23)(2007-12#29)(2007-2#2)(2007-3#1)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#17)(2007-8#8)(2007-9#4)(2008-1#17)(2008-10#41)(2008-11#19)(2008-12#7)(2008-2#25)(2008-3#21)(2008-4#11)(2008-5#15)(2008-6#7)(2008-7#35)(2008-8#11)(2008-9#19)(2009-10#5)(2009-11#5)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#8)(2009-5#3)(2009-6#6)(2009-7#3)(2009-8#10)(2009-9#4)(2010-10#5)(2010-12#6)(2010-2#2)(2010-3#1)(2010-4#7)(2010-5#2)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#7)(2011-12#3)(2011-2#18)(2011-3#1)(2012-1#5)(2012-11#3)(2012-12#11)(2012-2#26)(2012-3#8)(2013-1#22)(2013-7#4)(2013-8#8)
phenomenon)##2##1##(1994-6#1)(2012-12#1)
phenomenon?##2##1##(2007-7#1)(2011-2#1)
phenomenon]##2##1##(1996-8#1)(2011-2#1)
phenophases##4##1##(2008-1#1)(2012-6#3)
phenosane and##2##2##(2012-1#2)
phenoterol##3##1##(1991-4#3)
phenothiazine derivatives in##4##3##(2008-10#4)
phenothiazine derivatives##11##2##(2008-10#10)(2009-7#1)
phenothiazine drugs##2##2##(2008-10#2)
phenothiazine parent molecule##2##3##(2009-7#2)
phenothiazine##22##1##(1992-6#1)(2004-11#1)(2004-12#1)(2008-10#15)(2008-2#1)(2009-7#3)
phenothiazines and##2##2##(1991-8#1)(1996-9#1)
phenothiazines##11##1##(1991-8#1)(1996-9#1)(2008-10#8)(2011-3#1)
phenotype (e##3##2##(1995-3#1)(2006-10#1)(2008-9#1)
phenotype Q1##3##2##(2012-3#3)
phenotype Q2##2##2##(2012-3#2)
phenotype alterations##2##2##(2008-4#2)
phenotype and a##4##3##(2008-4#1)(2008-9#1)(2011-2#1)(2012-3#1)
phenotype and are##2##3##(2008-11#1)(2009-5#1)
phenotype and function##2##3##(1995-2#1)(1997-2#1)
phenotype and genotype##3##3##(1991-1#1)(2008-4#2)
phenotype and poor prognosis##2##4##(2008-5#1)(2011-1#1)
phenotype and poor##3##3##(2008-12#1)(2008-5#1)(2011-1#1)
phenotype and that##2##3##(1991-7#1)(2008-11#1)
phenotype and the##3##3##(2007-7#1)(2008-3#1)(2011-2#1)
phenotype and##73##2##(1990-4#1)(1990-9#1)(1991-1#1)(1991-7#1)(1991-9#2)(1992-9#1)(1993-11#1)(1993-4#1)(1993-9#1)(1994-12#1)(1995-2#3)(1996-12#2)(1996-4#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-2#2)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#6)(2013-1#2)
phenotype are poorly understood##2##4##(1997-1#1)(2012-12#1)
phenotype are##7##2##(1997-1#1)(2008-7#1)(2011-2#1)(2012-12#2)(2013-1#2)
phenotype as##7##2##(1992-3#1)(1992-7#1)(2008-11#1)(2008-8#2)(2009-10#1)(2012-3#1)
phenotype associated with mutations in exons##2##6##(1996-3#2)
phenotype associated with the##2##4##(2008-10#1)(2009-8#1)
phenotype associated with##7##3##(1996-3#2)(2006-2#1)(2007-11#1)(2008-10#1)(2009-8#1)(2013-8#1)
phenotype at the##2##3##(2008-10#1)(2009-8#1)
phenotype between##2##2##(2008-10#1)(2009-8#1)
phenotype but is##2##3##(1995-3#1)(2012-3#1)
phenotype but##4##2##(1995-3#1)(1996-12#1)(2012-3#1)(2013-8#1)
phenotype by##7##2##(1992-9#1)(1994-12#1)(1995-9#1)(1996-7#1)(1997-3#1)(2007-12#1)(2008-5#1)
phenotype can##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
phenotype caused by##3##3##(1997-3#1)(2007-11#1)(2012-12#1)
phenotype change##2##2##(2008-10#1)(2013-1#1)
phenotype changes in##3##3##(2006-10#1)(2007-12#1)(2007-5#1)
phenotype changes##4##2##(1996-3#1)(2006-10#1)(2007-12#1)(2007-5#1)
phenotype characterized by##3##3##(1997-1#1)(2013-1#1)(2013-8#1)
phenotype could be##3##3##(1991-9#1)(2012-12#2)
phenotype data##4##2##(2012-3#2)(2013-1#2)
phenotype definitions represented in QDM##2##5##(2013-1#2)
phenotype definitions##4##2##(2013-1#4)
phenotype determination##3##2##(2008-11#2)(2010-8#1)
phenotype distribution##2##2##(2005-10#1)(2012-3#1)
phenotype during##2##2##(2008-10#1)(2009-8#1)
phenotype dynamics##3##2##(1994-2#3)
phenotype exhibited##2##2##(2008-10#2)
phenotype expression of##2##3##(1996-11#1)(2012-2#1)
phenotype expression##6##2##(1996-11#2)(2012-2#2)(2013-1#2)
phenotype for##5##2##(1995-8#1)(2008-10#1)(2008-11#1)(2010-12#1)(2013-1#1)
phenotype from##4##2##(1996-5#1)(2007-2#1)(2008-10#1)(2012-2#1)
phenotype has been demonstrated##2##4##(1993-2#1)(2008-9#1)
phenotype have##3##2##(2007-8#1)(2008-10#1)(2008-11#1)
phenotype in a##2##3##(1990-11#1)(1993-12#1)
phenotype in all patients##2##4##(1992-9#1)(2012-12#1)
phenotype in an##2##3##(1996-2#1)(2009-5#1)
phenotype in mice##2##3##(1994-3#1)(2009-5#1)
phenotype in the GAW17##2##4##(2012-3#2)
phenotype in the##9##3##(1990-5#1)(1992-8#1)(1995-8#1)(1996-4#1)(1997-2#1)(2008-10#2)(2012-3#2)
phenotype in this##4##3##(1992-3#1)(1992-5#1)(2008-10#1)(2011-1#1)
phenotype in##58##2##(1990-11#1)(1990-12#1)(1990-5#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-8#2)(1992-9#2)(1993-12#2)(1994-3#1)(1995-11#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-7#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-5#2)(2010-12#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)
phenotype including##3##2##(1991-5#1)(1994-3#1)(2012-12#1)
phenotype involves##2##2##(1995-8#1)(2012-12#1)
phenotype is a##2##3##(2009-3#1)(2012-3#1)
phenotype is associated with##3##4##(1991-12#1)(2008-1#1)(2010-7#1)
phenotype is caused by##2##4##(1996-2#1)(2006-2#1)
phenotype is the##2##3##(1991-9#1)(2012-12#1)
phenotype is##38##2##(1990-7#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-9#2)(1994-12#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-2#1)(2006-8#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-9#1)(2009-3#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
phenotype matching##2##2##(2008-8#1)(2012-2#1)
phenotype may be due to##2##5##(1997-3#1)(2010-2#1)
phenotype may be##6##3##(1996-2#1)(1997-3#1)(2006-8#1)(2007-7#1)(2010-2#1)(2011-1#1)
phenotype may##9##2##(1994-11#1)(1996-2#1)(1997-3#1)(2006-8#1)(2007-7#1)(2008-10#1)(2010-2#1)(2011-1#1)(2012-2#1)
phenotype network##3##2##(2011-1#3)
phenotype observed##2##2##(2008-10#2)
phenotype of LS##2##3##(2008-1#1)(2012-3#1)
phenotype of a##8##3##(1994-12#2)(1995-1#1)(1997-1#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)
phenotype of cancer##2##3##(1994-5#1)(2008-11#1)
phenotype of cells##3##3##(1994-11#1)(1996-5#1)(2008-4#1)
phenotype of each##2##3##(1992-6#1)(2008-10#1)
phenotype of human##3##3##(1991-9#1)(2008-5#1)(2012-1#1)
phenotype of interest##3##3##(2012-3#3)
phenotype of the cells##3##4##(1991-12#1)(1993-9#1)(1996-2#1)
phenotype of the mutant##2##4##(1990-10#1)(2008-9#1)
phenotype of the##24##3##(1990-10#1)(1990-11#1)(1990-6#1)(1991-12#1)(1993-9#2)(1994-3#2)(1995-11#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-8#1)(2006-8#2)(2007-11#1)(2007-8#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-2#2)(2013-8#1)
phenotype of their##2##3##(2008-11#1)(2011-1#1)
phenotype of transgenic##3##3##(1995-8#2)(2008-4#1)
phenotype of tumor cells##2##4##(1994-5#1)(2005-10#1)
phenotype of##122##2##(1990-10#1)(1990-11#2)(1990-4#1)(1990-6#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-6#1)(1993-9#3)(1994-11#3)(1994-12#4)(1994-3#4)(1994-5#3)(1995-1#1)(1995-11#1)(1995-2#3)(1995-6#3)(1995-7#1)(1995-8#4)(1996-10#2)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#2)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#4)(1997-5#1)(1997-8#2)(2005-10#1)(2005-7#1)(2006-8#2)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-10#1)(2010-12#3)(2010-2#1)(2010-7#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#1)(2013-8#3)
phenotype on##2##2##(1993-12#1)(2005-11#1)
phenotype or##6##2##(1994-10#1)(1997-4#1)(2006-9#1)(2008-10#1)(2008-4#1)(2010-11#1)
phenotype rather than##2##3##(2008-11#1)(2008-12#1)
phenotype remains##2##2##(2012-3#1)(2013-8#1)
phenotype screening of##2##3##(2008-9#1)(2009-4#1)
phenotype should##2##2##(2008-10#1)(2010-7#1)
phenotype similar to that##2##4##(1993-9#1)(2009-10#1)
phenotype similar to##4##3##(1993-9#1)(1995-4#1)(1996-1#1)(2009-10#1)
phenotype since##2##2##(1997-6#1)(2008-8#1)
phenotype suggests##2##2##(1990-5#1)(1992-9#1)
phenotype than##2##2##(2009-2#1)(2012-3#1)
phenotype that is##4##3##(2005-8#1)(2008-7#1)(2009-6#1)(2012-3#1)
phenotype that##7##2##(1994-12#1)(2005-8#1)(2007-12#1)(2008-7#1)(2009-6#1)(2012-12#1)(2012-3#1)
phenotype through##2##2##(2010-4#1)(2013-1#1)
phenotype to the##3##3##(2005-7#1)(2008-10#1)(2012-2#1)
phenotype to##8##2##(1993-9#1)(1994-11#1)(1995-5#1)(1996-6#1)(1996-8#1)(2005-7#1)(2008-10#1)(2012-2#1)
phenotype was also##2##3##(1995-2#1)(1996-12#1)
phenotype was dependent on the##2##5##(1995-2#1)(1997-7#1)
phenotype was due to##2##4##(1997-4#1)(2008-10#1)
phenotype was more##2##3##(2007-2#1)(2008-10#1)
phenotype was not##2##3##(1997-3#1)(2008-10#1)
phenotype was##32##2##(1990-8#1)(1992-2#1)(1993-12#1)(1995-2#4)(1995-8#1)(1996-12#1)(1996-6#1)(1997-3#2)(1997-4#1)(1997-7#2)(2006-12#1)(2007-2#1)(2008-10#6)(2008-11#1)(2008-3#1)(2009-2#1)(2009-8#1)(2011-1#2)(2012-3#1)(2013-1#2)
phenotype were##9##2##(1990-5#1)(1990-7#1)(1991-6#1)(1992-6#1)(1993-9#1)(1995-8#1)(2008-10#2)(2012-1#1)
phenotype when##2##2##(1994-6#1)(1995-2#1)
phenotype which##3##2##(1991-8#2)(1995-1#1)
phenotype with##8##2##(1992-11#1)(1993-7#1)(2006-12#1)(2008-10#1)(2009-8#1)(2010-9#1)(2011-1#2)
phenotype without##2##2##(1994-2#1)(2010-6#1)
phenotype##960##1##(1990-10#3)(1990-11#3)(1990-12#3)(1990-4#3)(1990-5#7)(1990-6#1)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#4)(1991-10#2)(1991-11#2)(1991-12#4)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#4)(1991-8#3)(1991-9#6)(1992-10#1)(1992-11#1)(1992-2#5)(1992-3#4)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#3)(1992-9#8)(1993-11#2)(1993-12#7)(1993-2#2)(1993-3#2)(1993-4#1)(1993-6#2)(1993-7#3)(1993-9#7)(1994-10#2)(1994-11#5)(1994-12#13)(1994-2#5)(1994-3#11)(1994-5#4)(1994-6#3)(1994-8#1)(1994-9#8)(1995-1#6)(1995-11#7)(1995-12#2)(1995-2#14)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#5)(1995-7#1)(1995-8#19)(1995-9#3)(1996-1#1)(1996-10#6)(1996-11#4)(1996-12#10)(1996-2#7)(1996-3#10)(1996-4#5)(1996-5#9)(1996-6#8)(1996-7#5)(1996-8#2)(1996-9#1)(1997-1#9)(1997-2#5)(1997-3#19)(1997-4#10)(1997-5#6)(1997-6#5)(1997-7#7)(1997-8#2)(2004-11#2)(2005-10#3)(2005-11#4)(2005-7#3)(2005-8#1)(2006-10#5)(2006-11#4)(2006-12#9)(2006-2#3)(2006-4#1)(2006-8#6)(2006-9#1)(2007-10#1)(2007-11#8)(2007-12#4)(2007-2#5)(2007-5#1)(2007-6#2)(2007-7#6)(2007-8#4)(2007-9#6)(2008-1#6)(2008-10#78)(2008-11#35)(2008-12#4)(2008-2#6)(2008-3#7)(2008-4#23)(2008-5#9)(2008-6#6)(2008-7#17)(2008-8#22)(2008-9#19)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#6)(2009-4#1)(2009-5#7)(2009-6#4)(2009-8#14)(2009-9#3)(2010-10#1)(2010-11#4)(2010-12#8)(2010-2#11)(2010-3#3)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#5)(2010-8#3)(2010-9#2)(2011-1#26)(2011-12#2)(2011-2#16)(2012-1#4)(2012-11#2)(2012-12#33)(2012-2#21)(2012-3#56)(2012-7#1)(2013-1#35)(2013-7#1)(2013-8#11)
phenotype) and##2##2##(2008-8#1)(2009-3#1)
phenotype)##10##1##(1990-9#1)(1992-3#1)(1993-11#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-7#1)(2012-3#3)
phenotype-selected for##2##2##(2009-9#2)
phenotype/genotype##2##1##(2008-8#1)(2011-1#1)
phenotyped for##2##2##(1996-3#1)(2008-10#1)
phenotyped##5##1##(1993-2#1)(1994-3#1)(1996-3#1)(2008-10#1)(2009-4#1)
phenotypes Q1 and Q2##2##4##(2012-3#2)
phenotypes across##2##2##(2008-8#1)(2010-5#1)
phenotypes and disease##2##3##(2012-2#1)(2012-3#1)
phenotypes and genotypes##2##3##(1991-1#1)(2008-4#1)
phenotypes and increased##2##3##(1994-9#1)(2006-11#1)
phenotypes and present##2##3##(1995-11#1)(2008-9#1)
phenotypes and the##3##3##(1991-8#1)(1997-6#1)(2008-8#1)
phenotypes and##34##2##(1991-1#1)(1991-8#1)(1992-5#1)(1993-3#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-11#1)(1997-6#1)(2006-11#1)(2006-9#1)(2007-11#1)(2007-2#1)(2008-10#4)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-9#1)(2010-4#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#3)
phenotypes are also##2##3##(2008-11#1)(2009-8#1)
phenotypes are##4##2##(1996-10#1)(1996-8#1)(2008-11#1)(2009-8#1)
phenotypes associated with##4##3##(2007-1#1)(2008-4#1)(2010-2#1)(2011-12#1)
phenotypes by the##2##3##(2008-10#2)
phenotypes by##5##2##(1993-11#1)(2008-1#1)(2008-10#2)(2008-7#1)
phenotypes can be##4##3##(2008-8#1)(2009-5#1)(2011-1#2)
phenotypes can##5##2##(2008-8#2)(2009-5#1)(2011-1#2)
phenotypes exhibited by##2##3##(1994-12#1)(1997-6#1)
phenotypes exhibited##3##2##(1994-12#1)(1996-12#1)(1997-6#1)
phenotypes for the##2##3##(2007-12#1)(2010-1#1)
phenotypes for##9##2##(1995-11#1)(1996-3#1)(2007-12#1)(2008-4#1)(2010-1#1)(2012-2#2)(2012-3#2)
phenotypes from##4##2##(1990-8#1)(1992-9#1)(2008-7#1)(2012-3#1)
phenotypes has##2##2##(2006-12#1)(2013-1#1)
phenotypes in the##5##3##(2007-12#1)(2008-10#1)(2009-8#1)(2010-4#1)(2012-3#1)
phenotypes in their##3##3##(1997-6#1)(2008-8#1)(2008-9#1)
phenotypes in##31##2##(1991-12#1)(1993-9#1)(1997-6#1)(2004-11#1)(2005-10#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-8#7)(2008-9#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2012-2#1)(2012-3#3)(2013-1#1)
phenotypes including##3##2##(1997-6#1)(2008-8#2)
phenotypes is##6##2##(1995-8#1)(2008-8#1)(2009-5#1)(2009-8#1)(2012-3#2)
phenotypes of V##2##3##(2008-10#2)
phenotypes of the protein##2##4##(1996-3#2)
phenotypes of the##13##3##(1991-7#1)(1993-9#1)(1995-8#1)(1996-3#2)(1996-4#2)(1997-4#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-2#1)(2011-1#1)
phenotypes of##53##2##(1990-7#1)(1991-7#1)(1991-9#1)(1993-4#1)(1993-9#1)(1995-8#1)(1996-2#1)(1996-3#2)(1996-4#2)(1997-4#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#5)(2008-11#5)(2008-4#3)(2008-6#3)(2008-8#3)(2008-9#2)(2009-3#1)(2009-4#1)(2009-8#2)(2010-2#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-3#1)(2013-8#1)
phenotypes on##5##2##(1996-3#1)(1996-8#1)(2008-10#3)
phenotypes ranging from##2##3##(1993-9#1)(2012-12#1)
phenotypes remains##2##2##(1992-1#1)(2012-12#1)
phenotypes similar to##2##3##(2008-10#1)(2012-12#1)
phenotypes than##2##2##(2004-11#1)(2008-10#1)
phenotypes that##10##2##(1991-12#1)(1995-8#1)(2006-5#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-4#2)(2011-1#1)(2012-3#1)
phenotypes to##4##2##(2007-9#1)(2008-10#2)(2009-5#1)
phenotypes using##3##2##(1996-6#1)(2008-7#2)
phenotypes was##4##2##(1996-7#1)(1997-8#1)(2008-10#1)(2008-5#1)
phenotypes were observed##2##3##(1990-12#1)(2008-10#1)
phenotypes were##18##2##(1990-12#1)(1992-9#1)(1996-12#1)(1997-8#1)(2008-10#7)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2012-11#1)(2012-12#1)
phenotypes will##3##2##(2009-10#1)(2013-1#1)(2013-8#1)
phenotypes with the##2##3##(1997-4#1)(2007-9#1)
phenotypes with##5##2##(1997-4#1)(2007-9#1)(2008-10#1)(2008-8#1)(2012-2#1)
phenotypes##464##1##(1990-12#1)(1990-4#2)(1990-7#1)(1990-8#1)(1991-1#2)(1991-12#2)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#3)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-9#4)(1994-11#2)(1994-12#3)(1994-2#4)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#4)(1995-12#1)(1995-2#1)(1995-4#1)(1995-8#3)(1996-10#1)(1996-12#4)(1996-2#3)(1996-3#9)(1996-4#2)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#5)(1997-5#1)(1997-6#10)(1997-7#1)(1997-8#3)(2004-11#3)(2005-10#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#2)(2006-6#2)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#3)(2007-12#6)(2007-2#2)(2007-6#1)(2007-7#3)(2007-9#3)(2008-1#6)(2008-10#47)(2008-11#16)(2008-2#2)(2008-3#3)(2008-4#14)(2008-5#5)(2008-6#4)(2008-7#16)(2008-8#40)(2008-9#9)(2009-10#2)(2009-12#2)(2009-3#1)(2009-4#4)(2009-5#4)(2009-8#13)(2009-9#4)(2010-1#2)(2010-10#2)(2010-12#8)(2010-2#3)(2010-3#3)(2010-4#7)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#15)(2011-11#1)(2011-12#1)(2011-2#8)(2012-1#5)(2012-11#1)(2012-12#12)(2012-2#8)(2012-3#29)(2013-1#8)(2013-8#5)
phenotypes) when building prognostic models is usually measured on a whole set of cases##2##14##(2013-1#2)
phenotypes)##5##1##(2008-10#3)(2013-1#2)
phenotypic analyses of##3##3##(2006-11#1)(2008-10#1)(2008-4#1)
phenotypic analyses##5##2##(1997-3#1)(2006-11#1)(2008-10#1)(2008-4#1)(2008-7#1)
phenotypic analysis of the##3##4##(2008-10#1)(2008-5#1)(2008-7#1)
phenotypic analysis of##5##3##(2008-10#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-1#1)
phenotypic analysis##8##2##(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-1#1)
phenotypic and functional properties##2##4##(1996-3#1)(2008-4#1)
phenotypic and functional##5##3##(1990-9#1)(1991-12#1)(1996-3#1)(2008-4#2)
phenotypic and genetic##4##3##(2008-10#1)(2009-5#1)(2009-8#1)(2011-2#1)
phenotypic and genomic data##2##4##(2006-8#1)(2008-11#1)
phenotypic and genotypic characteristics##3##4##(2008-10#1)(2008-5#1)(2012-12#1)
phenotypic and genotypic methods in##2##5##(2008-10#1)(2011-1#1)
phenotypic and genotypic methods##3##4##(2008-10#1)(2010-4#1)(2011-1#1)
phenotypic and genotypic##13##3##(2005-9#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-4#1)(2011-1#1)(2012-12#2)(2012-3#1)
phenotypic and##31##2##(1990-9#1)(1991-12#1)(1992-6#1)(1995-1#1)(1996-3#1)(1997-6#1)(2005-9#1)(2006-8#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-4#3)(2008-5#2)(2008-8#1)(2009-5#1)(2009-8#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)
phenotypic assay for##2##3##(2007-12#1)(2008-10#1)
phenotypic assay##4##2##(2007-12#1)(2008-10#2)(2012-12#1)
phenotypic assays##2##2##(2009-6#1)(2010-2#1)
phenotypic change##2##2##(1997-2#1)(2008-4#1)
phenotypic changes in##6##3##(1991-5#1)(1996-12#1)(2006-6#1)(2008-1#1)(2008-4#1)(2013-1#1)
phenotypic changes##14##2##(1991-5#1)(1995-5#1)(1996-10#1)(1996-12#1)(2006-6#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-4#1)(2012-12#2)(2012-3#1)(2013-1#1)
phenotypic characteristic##2##2##(1992-6#1)(2008-7#1)
phenotypic characteristics of the##2##4##(1994-3#1)(2010-8#1)
phenotypic characteristics of##3##3##(1994-3#1)(2010-8#1)(2013-8#1)
phenotypic characteristics##13##2##(1991-5#1)(1994-3#1)(2007-1#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-8#2)(2012-2#1)(2013-8#1)
phenotypic characterization of a##2##4##(1996-10#1)(2005-8#1)
phenotypic characterization of##8##3##(1996-10#1)(2005-8#1)(2008-10#1)(2008-4#2)(2008-9#1)(2009-6#1)(2012-2#1)
phenotypic characterization##10##2##(1996-10#1)(2005-8#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-6#2)(2012-2#1)
phenotypic characters##4##2##(2008-10#2)(2008-8#1)(2013-7#1)
phenotypic class##2##2##(2008-10#2)
phenotypic consequences of##3##3##(2008-4#1)(2008-8#1)(2010-7#1)
phenotypic consequences##4##2##(2008-4#1)(2008-8#2)(2010-7#1)
phenotypic correlation##2##2##(2008-10#1)(2008-9#1)
phenotypic data##8##2##(2008-4#1)(2008-7#1)(2008-8#3)(2010-2#2)(2012-3#1)
phenotypic difference##2##2##(1994-9#1)(1996-5#1)
phenotypic differences among##2##3##(2007-12#1)(2008-5#1)
phenotypic differences##7##2##(1991-6#1)(2007-12#1)(2008-10#2)(2008-5#1)(2009-5#1)(2010-12#1)
phenotypic differentiation##2##2##(1996-3#1)(1997-4#1)
phenotypic divergence along##2##3##(2012-3#2)
phenotypic divergence##4##2##(2012-3#3)(2013-1#1)
phenotypic diversification##2##2##(2009-8#1)(2012-3#1)
phenotypic diversity and##2##3##(2008-2#1)(2008-7#1)
phenotypic diversity of##2##3##(1995-6#1)(2012-3#1)
phenotypic diversity within a##2##4##(2008-10#1)(2012-2#1)
phenotypic diversity within##4##3##(2006-11#1)(2008-10#2)(2012-2#1)
phenotypic diversity##13##2##(1993-3#1)(1995-6#1)(2006-11#1)(2008-10#2)(2008-2#1)(2008-7#2)(2009-6#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
phenotypic effect of##2##3##(2012-3#1)(2013-1#1)
phenotypic effect##3##2##(1991-12#1)(2012-3#1)(2013-1#1)
phenotypic effects of the mutation in##2##6##(1993-8#1)(1993-9#1)
phenotypic effects of the##3##4##(1993-8#1)(1993-9#1)(1995-5#1)
phenotypic effects of##7##3##(1990-11#1)(1992-2#1)(1993-8#1)(1993-9#1)(1995-5#1)(1996-5#1)(2013-1#1)
phenotypic effects##11##2##(1990-11#1)(1992-2#1)(1993-8#1)(1993-9#1)(1995-5#1)(1996-5#1)(2007-12#1)(2012-12#2)(2012-3#1)(2013-1#1)
phenotypic evidence##2##2##(1995-11#1)(2006-5#1)
phenotypic evolution##5##2##(2009-2#1)(2010-12#1)(2010-4#2)(2013-1#1)
phenotypic expression of a##2##4##(1996-12#1)(2007-7#1)
phenotypic expression of the##2##4##(1991-5#1)(1997-2#1)
phenotypic expression of##10##3##(1991-5#1)(1996-12#1)(1996-5#1)(1997-2#1)(2005-8#1)(2006-10#1)(2007-7#1)(2010-7#1)(2013-1#2)
phenotypic expression##13##2##(1991-5#1)(1993-9#1)(1996-12#1)(1996-5#1)(1997-2#1)(2005-8#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-4#1)(2010-7#1)(2013-1#2)
phenotypic expressions##2##2##(1996-11#1)(2007-7#1)
phenotypic features and##2##3##(2005-10#1)(2008-8#1)
phenotypic features##7##2##(2005-10#1)(2007-7#1)(2008-11#1)(2008-8#1)(2012-3#3)
phenotypic groups##2##2##(2008-10#2)
phenotypic heterogeneity of##4##3##(1992-2#1)(2007-10#1)(2007-7#1)(2013-8#1)
phenotypic heterogeneity##6##2##(1992-2#1)(1993-9#1)(2007-10#1)(2007-7#1)(2012-3#1)(2013-8#1)
phenotypic marker for##2##3##(1996-3#1)(1997-6#1)
phenotypic marker of##2##3##(1990-8#1)(1996-1#1)
phenotypic marker##5##2##(1990-8#1)(1996-1#1)(1996-3#1)(1997-6#1)(2008-10#1)
phenotypic markers##3##2##(1993-2#1)(1995-2#1)(2008-10#1)
phenotypic methods##2##2##(2008-8#1)(2011-2#1)
phenotypic modulation##2##2##(1993-8#1)(2008-10#1)
phenotypic plasticity in##4##3##(2008-8#1)(2008-9#1)(2009-6#1)(2010-3#1)
phenotypic plasticity##18##2##(2008-1#1)(2008-10#1)(2008-8#4)(2008-9#5)(2009-6#2)(2010-3#2)(2012-12#2)(2012-2#1)
phenotypic profile##2##2##(1991-2#1)(2008-7#1)
phenotypic properties of the##2##4##(1995-10#1)(1996-3#1)
phenotypic properties of##3##3##(1995-10#1)(1996-3#1)(2009-3#1)
phenotypic properties##5##2##(1990-3#1)(1995-10#1)(1996-3#1)(2008-11#1)(2009-3#1)
phenotypic property of##2##3##(1994-6#1)(1997-1#1)
phenotypic ratios##3##2##(2008-10#3)
phenotypic response##3##2##(1995-3#1)(2008-10#1)(2008-11#1)
phenotypic selection##6##2##(2008-8#5)(2013-1#1)
phenotypic severity##2##2##(1996-3#1)(1996-8#1)
phenotypic similarity##2##2##(2006-8#1)(2008-8#1)
phenotypic specialization##6##2##(2008-8#5)(2008-9#1)
phenotypic specializations##2##2##(2008-9#2)
phenotypic switching##3##2##(2007-7#1)(2009-9#2)
phenotypic tests##3##2##(2007-12#1)(2011-2#1)(2012-2#1)
phenotypic traits##11##2##(2008-2#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#3)
phenotypic transformation##5##2##(1991-12#3)(1993-2#1)(2009-4#1)
phenotypic uniformity##2##2##(2008-10#2)
phenotypic variability##8##2##(1996-8#1)(2006-8#1)(2008-10#3)(2008-8#1)(2009-9#1)(2013-8#1)
phenotypic variance of##2##3##(2008-10#1)(2012-3#1)
phenotypic variance##18##2##(2008-10#12)(2008-8#2)(2012-3#4)
phenotypic variation compared##2##3##(2008-10#1)(2009-2#1)
phenotypic variation for resistance in##3##5##(2008-10#3)
phenotypic variation for resistance##5##4##(2008-10#5)
phenotypic variation for##9##3##(2008-10#9)
phenotypic variation in the##3##4##(2008-10#1)(2013-1#1)(2013-7#1)
phenotypic variation in##8##3##(1995-2#1)(1996-8#1)(2008-10#2)(2009-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
phenotypic variation within##2##3##(2009-6#1)(2012-3#1)
phenotypic variation##37##2##(1993-9#2)(1995-2#1)(1996-8#1)(2007-7#1)(2008-10#21)(2008-7#1)(2008-8#1)(2009-2#3)(2009-6#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
phenotypic##428##1##(1990-11#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#5)(1991-2#1)(1991-4#1)(1991-5#3)(1991-6#1)(1992-2#3)(1992-6#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-8#2)(1993-9#5)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#2)(1996-3#6)(1996-5#3)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#2)(2004-2#1)(2005-10#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#1)(2006-11#2)(2006-5#1)(2006-6#1)(2006-8#5)(2007-1#1)(2007-10#2)(2007-12#5)(2007-2#1)(2007-5#1)(2007-7#6)(2007-9#1)(2008-1#2)(2008-10#82)(2008-11#4)(2008-12#2)(2008-2#2)(2008-4#16)(2008-5#10)(2008-7#14)(2008-8#40)(2008-9#15)(2009-10#1)(2009-12#2)(2009-2#4)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#7)(2009-8#5)(2009-9#3)(2010-12#4)(2010-2#5)(2010-3#4)(2010-4#4)(2010-7#2)(2010-8#2)(2011-1#5)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#11)(2012-2#9)(2012-3#25)(2013-1#18)(2013-7#2)(2013-8#5)
phenotypical##11##1##(1994-12#1)(1995-8#1)(2006-12#2)(2006-7#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-11#1)(2010-3#1)(2012-1#1)
phenotypically and functionally distinct##2##4##(1991-11#1)(2013-8#1)
phenotypically and genotypically##2##3##(1991-6#1)(2008-12#1)
phenotypically and##9##2##(1991-11#1)(1991-6#1)(2006-8#1)(2008-10#3)(2008-12#1)(2008-5#1)(2013-8#1)
phenotypically as##2##2##(1990-12#1)(2007-6#1)
phenotypically consistent with Trichophyton rubrum var##2##6##(2009-2#2)
phenotypically diverse endothelial cells##2##4##(1993-3#2)
phenotypically diverse##3##2##(1993-3#2)(2011-1#1)
phenotypically from##2##2##(2008-10#1)(2008-9#1)
phenotypically normal and##2##3##(1994-3#1)(2012-2#1)
phenotypically normal##7##2##(1990-10#1)(1994-3#1)(1996-6#1)(1997-1#1)(2008-10#1)(2012-1#1)(2012-2#1)
phenotypically plastic##2##2##(2008-9#1)(2010-8#1)
phenotypically similar to##2##3##(2008-10#2)
phenotypically similar##5##2##(2008-10#2)(2010-4#2)(2010-8#1)
phenotypically##51##1##(1990-10#1)(1990-11#1)(1990-12#1)(1991-11#2)(1991-2#1)(1991-6#1)(1992-6#1)(1993-3#2)(1994-3#1)(1996-10#1)(1996-4#1)(1996-6#2)(1997-1#1)(1997-3#1)(1997-8#1)(2006-5#1)(2006-8#2)(2007-6#1)(2008-10#10)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#4)(2009-2#2)(2010-3#1)(2010-4#2)(2010-8#2)(2011-1#1)(2012-1#1)(2012-2#2)(2013-8#1)
phenotyping algorithms##6##2##(2013-1#6)
phenotyping and##2##2##(1990-7#1)(1996-3#1)
phenotyping of##9##2##(1995-2#1)(2008-4#2)(2008-8#1)(2011-1#1)(2012-1#2)(2013-1#2)
phenotyping test##2##2##(2008-2#1)(2008-4#1)
phenotyping##48##1##(1990-7#1)(1994-3#3)(1995-2#2)(1995-8#1)(1996-3#2)(1996-9#1)(2008-10#3)(2008-2#5)(2008-4#3)(2008-8#2)(2008-9#4)(2010-10#1)(2010-2#2)(2011-1#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-4#1)(2013-1#12)
phenoxodiol##4##1##(2009-9#4)
phenoxy##3##1##(2008-10#3)
phenoxy-propionic acid##2##2##(2008-10#2)
phenoxyl free radicals##2##3##(2008-10#2)
phenoxyl free##3##2##(2008-10#3)
phenoxyl radical##3##2##(1991-9#1)(2008-8#2)
phenoxyl radicals are##2##3##(2008-10#2)
phenoxyl radicals generated in##2##4##(2008-10#2)
phenoxyl radicals##9##2##(2006-10#2)(2008-10#6)(2008-9#1)
phenoxyl##18##1##(1991-9#1)(2006-10#2)(2007-11#2)(2008-10#9)(2008-8#3)(2008-9#1)
phenoxypropionic acid##2##2##(2008-10#2)
phenoxythiocarbonyl##2##1##(1996-5#1)(2008-4#1)
phenprocoumon##5##1##(1991-8#2)(1997-8#1)(2005-11#1)(2007-8#1)
phentolamine##23##1##(1990-4#1)(1990-5#8)(1991-5#1)(1993-3#3)(1995-12#1)(1996-11#1)(1996-12#1)(1997-5#3)(2007-7#3)(2013-1#1)
phenyl &gt##2##2##(1997-1#1)(1997-7#1)
phenyl and##4##2##(1993-4#1)(2008-10#2)(2010-2#1)
phenyl column##5##2##(1990-6#1)(1996-3#1)(1996-8#1)(2008-10#2)
phenyl derivative)##2##2##(2010-12#2)
phenyl ethanol is##2##3##(2005-11#2)
phenyl ethanol##4##2##(2005-11#4)
phenyl glycidyl ether##2##3##(1990-3#2)
phenyl group was##2##3##(1994-9#1)(1996-1#1)
phenyl group##11##2##(1991-4#1)(1994-9#2)(1995-3#1)(1995-8#1)(1996-1#1)(2006-12#1)(2008-10#3)(2008-5#1)
phenyl groups##4##2##(1994-9#1)(2008-10#1)(2008-3#1)(2010-7#1)
phenyl isocyanide##2##2##(2006-12#2)
phenyl isothiocyanate and##2##3##(1990-7#1)(2007-11#1)
phenyl isothiocyanate##4##2##(1990-2#1)(1990-7#1)(2007-11#1)(2008-10#1)
phenyl phosphate##3##2##(1990-7#1)(2007-8#1)(2008-10#1)
phenyl propanoids##2##2##(2007-1#2)
phenyl ring of##4##3##(1995-5#1)(2006-12#1)(2007-12#1)(2008-6#1)
phenyl ring##15##2##(1993-4#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-5#2)(2006-12#1)(2007-10#1)(2007-12#3)(2008-10#1)(2008-6#1)(2010-5#1)(2013-1#1)
phenyl rings##9##2##(1994-9#1)(1997-7#5)(2005-4#1)(2008-8#2)
phenyl##108##1##(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#1)(1990-7#2)(1991-2#3)(1991-4#1)(1993-4#3)(1994-12#1)(1994-9#5)(1995-11#1)(1995-3#2)(1995-5#2)(1995-8#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-7#6)(1997-8#2)(2005-11#5)(2005-4#1)(2005-7#1)(2006-11#1)(2006-12#4)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#3)(2007-8#2)(2008-10#17)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2009-11#2)(2009-12#1)(2010-12#2)(2010-2#3)(2010-5#2)(2010-7#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
phenyl)-1##2##1##(2006-10#1)(2010-2#1)
phenyl-##2##1##(1990-9#1)(2007-8#1)
phenyl-4##2##1##(2011-1#2)
phenyl-Sepharose##13##1##(1990-5#3)(1990-7#2)(1991-11#5)(1991-4#1)(1992-12#1)(1994-6#1)
phenyl-Superose##2##1##(1991-11#2)
phenyl-mercury##2##1##(2008-10#2)
phenyl-urea##2##1##(2007-8#2)
phenyl]##3##1##(2008-10#2)(2010-2#1)
phenylacetaldehyde##2##1##(1995-7#2)
phenylacetamidomethyl##2##1##(1991-10#1)(1995-1#1)
phenylacetic acid and##2##3##(2006-9#1)(2008-5#1)
phenylacetic acid##8##2##(1995-3#1)(1996-5#1)(2006-9#1)(2007-11#1)(2008-5#3)(2008-6#1)
phenylalanine 39##3##2##(1994-12#3)
phenylalanine ammonia lyase (PAL)##3##4##(2008-10#3)
phenylalanine ammonia lyase activity##2##4##(2008-10#2)
phenylalanine ammonia lyase and##2##4##(2008-10#2)
phenylalanine ammonia lyase##12##3##(1992-8#1)(2008-10#11)
phenylalanine ammonia##14##2##(1992-8#1)(2006-12#2)(2008-10#11)
phenylalanine ammonia-lyase##5##2##(1995-8#2)(1997-4#2)(2008-10#1)
phenylalanine and tyrosine##2##3##(1990-4#1)(1994-9#1)
phenylalanine and##11##2##(1990-4#1)(1990-5#1)(1991-2#1)(1994-6#1)(1994-9#1)(1995-1#2)(2006-8#1)(2008-5#1)(2008-7#1)(2010-4#1)
phenylalanine by##2##2##(1991-11#1)(2006-10#1)
phenylalanine hydroxylase##3##2##(1992-12#1)(1995-1#2)
phenylalanine in##4##2##(1992-9#1)(1993-6#1)(1993-9#1)(1995-3#1)
phenylalanine is##2##2##(1993-6#1)(2009-3#1)
phenylalanine levels##2##2##(2010-2#2)
phenylalanine residue##3##2##(1990-8#1)(1994-5#1)(1996-6#1)
phenylalanine residues in##2##3##(1990-3#1)(1994-8#1)
phenylalanine residues##5##2##(1990-3#1)(1990-4#1)(1994-8#1)(1997-4#1)(2009-3#1)
phenylalanine side chains##2##3##(1990-4#2)
phenylalanine to##3##2##(1991-2#1)(1995-3#1)(2008-3#1)
phenylalanine was##2##2##(1995-3#1)(2008-10#1)
phenylalanine##116##1##(1990-11#1)(1990-3#1)(1990-4#5)(1990-5#1)(1990-8#2)(1991-11#2)(1991-2#3)(1991-4#1)(1991-7#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-6#10)(1993-9#1)(1994-12#3)(1994-5#2)(1994-6#4)(1994-8#1)(1994-9#2)(1995-1#8)(1995-11#1)(1995-3#3)(1995-6#1)(1995-8#2)(1996-5#1)(1996-6#1)(1997-4#3)(1997-7#1)(1997-8#1)(2006-10#2)(2006-12#2)(2006-7#1)(2006-8#1)(2007-11#1)(2008-10#20)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#2)(2009-5#1)(2010-2#3)(2010-4#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#2)
phenylalanine-156##2##1##(1995-2#2)
phenylalanine-21 of the calcium pump peptide##2##6##(1992-12#2)
phenylalanine/tyrosine ratio##2##2##(2006-7#2)
phenylalanines##5##1##(1991-4#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-3#1)
phenylalanyl##4##1##(1990-2#1)(1990-7#1)(1993-6#1)(2013-1#1)
phenylalkyl carboxylic acids##3##3##(2011-1#3)
phenylalkylamine derivatives in biological##2##4##(1992-2#2)
phenylalkylamine derivatives in##3##3##(1992-2#3)
phenylalkylamine##4##1##(1992-2#3)(1995-3#1)
phenylanthranilic acids##3##2##(1993-4#3)
phenylanthranilic##4##1##(1993-4#4)
phenylarsine oxide (PhAsO)##2##3##(1994-8#2)
phenylarsine oxide##11##2##(1991-7#5)(1992-11#1)(1993-6#2)(1994-8#2)(1995-5#1)
phenylazide group##2##2##(1993-5#2)
phenylboronate affinity##2##2##(1991-5#1)(2010-2#1)
phenylboronate##3##1##(1991-5#1)(2008-7#1)(2010-2#1)
phenylboronic acid##4##2##(1997-2#1)(2010-6#1)(2012-11#2)
phenylbutazone##2##1##(1990-9#1)(2007-8#1)
phenylene diamine##2##2##(2008-10#1)(2008-5#1)
phenylene##3##1##(1994-10#1)(2008-10#1)(2008-5#1)
phenylenediamine##2##1##(2008-5#1)(2012-3#1)
phenylephrine and##5##2##(1991-6#1)(1994-12#1)(1997-7#1)(2009-5#2)
phenylephrine hydrochloride##6##2##(2005-7#1)(2008-10#4)(2008-7#1)
phenylephrine in##3##2##(1991-6#1)(1994-2#1)(2013-8#1)
phenylephrine or##2##2##(1994-3#1)(2009-5#1)
phenylephrine was##2##2##(1991-3#1)(2011-2#1)
phenylephrine##63##1##(1990-12#1)(1990-7#1)(1991-1#1)(1991-3#4)(1991-6#2)(1991-8#1)(1993-11#3)(1993-2#1)(1994-12#4)(1994-2#4)(1994-3#5)(1994-6#1)(1994-8#1)(1995-12#4)(1995-5#1)(1996-10#1)(1997-5#2)(1997-7#2)(1997-8#1)(2005-7#1)(2007-10#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-5#3)(2010-6#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-8#1)
phenylephrine-induced##7##1##(1990-12#1)(1995-12#1)(1997-5#3)(1997-7#2)
phenylethanolamine N-methyltransferase##5##2##(1991-5#1)(1996-5#1)(1996-8#2)(2013-1#1)
phenylethanolamine##6##1##(1991-5#2)(1996-5#1)(1996-8#2)(2013-1#1)
phenylethanolamine-N-methyl transferase##2##2##(1992-11#1)(1997-3#1)
phenylethyl alcohol##2##2##(2007-12#1)(2008-10#1)
phenylethyl##3##1##(2007-12#1)(2008-10#1)(2008-9#1)
phenylethylamine oxidase##2##2##(1994-3#2)
phenylethylamine##4##1##(1994-3#2)(2007-8#1)(2008-7#1)
phenylglycine##3##1##(1995-12#1)(2008-8#1)(2010-2#1)
phenylglyoxal inactivation##2##2##(1990-3#1)(1993-3#1)
phenylglyoxal##11##1##(1990-11#1)(1990-2#1)(1990-3#4)(1992-12#1)(1993-2#2)(1993-3#1)(1997-1#1)
phenylglyoxal-mediated inactivation of the##2##4##(1990-3#2)
phenylglyoxal-mediated inactivation##4##2##(1990-3#4)
phenylglyoxal-mediated##5##1##(1990-3#5)
phenylhydrazine and##2##2##(2008-10#2)
phenylhydrazine to##2##2##(2008-10#1)(2010-4#1)
phenylhydrazine##17##1##(1991-1#1)(1991-12#1)(2008-10#12)(2008-11#1)(2010-4#1)(2010-8#1)
phenylhydrazone##6##1##(1991-1#1)(1992-6#1)(1993-9#1)(2005-8#1)(2008-10#2)
phenylisothiocyanate##3##1##(1990-6#2)(1996-6#1)
phenylketonuria##8##1##(1990-12#1)(1992-1#1)(2006-1#3)(2012-2#2)(2013-1#1)
phenylmercapturic acid##2##2##(1992-2#2)
phenylmercury##11##1##(2008-10#11)
phenylmethanesulfonyl fluoride##4##2##(1992-8#1)(1994-6#1)(1994-9#1)(1995-5#1)
phenylmethanesulfonyl##5##1##(1992-8#1)(1994-6#1)(1994-9#1)(1995-5#1)(2009-3#1)
phenylmethyl##2##1##(1996-6#1)(2008-5#1)
phenylmethylsulfonyl fluoride (PMSF)##3##3##(1992-11#1)(1996-2#1)(1996-6#1)
phenylmethylsulfonyl fluoride##4##2##(1991-12#1)(1992-11#1)(1996-2#1)(1996-6#1)
phenylmethylsulfonylfluoride##2##1##(1990-8#1)(1991-1#1)
phenylpropanoid glycoside##3##2##(2007-1#1)(2008-9#2)
phenylpropanoid glycosides##4##2##(2006-10#2)(2007-1#2)
phenylpropanoid pathway##3##2##(2008-10#1)(2008-8#2)
phenylpropanoid##18##1##(1990-9#1)(1992-11#1)(2006-10#2)(2007-1#4)(2007-11#1)(2008-10#5)(2008-8#2)(2008-9#2)
phenylpropanoids##3##1##(2007-1#1)(2008-11#2)
phenylpropanolamine and##4##2##(2008-10#4)
phenylpropanolamine##8##1##(2007-9#4)(2008-10#4)
phenylpyrroles##2##1##(2008-10#2)
phenylquinone##2##1##(1994-9#1)(1996-2#1)
phenylthiohydantoin##2##1##(1994-9#1)(2008-10#1)
phenylurea herbicides##3##2##(2008-10#3)
phenylurea##4##1##(2008-10#4)
phenytoin (20 mg/kg)##2##3##(1995-12#1)(2010-3#1)
phenytoin Na emulsion##2##3##(2008-11#2)
phenytoin Na##3##2##(2008-11#3)
phenytoin and carbamazepine##4##3##(1990-12#1)(1997-5#1)(2007-8#1)(2008-8#1)
phenytoin and sodium valproate##2##4##(1995-12#2)
phenytoin and##10##2##(1990-12#1)(1990-7#1)(1995-12#2)(1995-7#2)(1997-5#1)(2007-8#1)(2008-8#1)(2010-12#1)
phenytoin in##9##2##(1990-12#1)(1994-2#1)(1995-7#1)(2007-7#1)(2008-10#4)(2008-11#1)
phenytoin on##3##2##(2008-11#2)(2011-2#1)
phenytoin sodium##3##2##(2007-7#2)(2008-10#1)
phenytoin suspension##3##2##(2008-11#3)
phenytoin therapy##2##2##(2008-7#2)
phenytoin to##2##2##(1995-7#1)(2013-8#1)
phenytoin was##6##2##(1991-3#1)(1994-2#2)(1995-7#3)
phenytoin were##4##2##(1994-2#2)(1996-1#1)(2008-11#1)
phenytoin with##2##2##(1994-2#1)(2008-11#1)
phenytoin##99##1##(1990-12#4)(1990-5#5)(1990-7#1)(1991-3#5)(1994-2#8)(1994-7#1)(1995-12#4)(1995-3#1)(1995-7#11)(1996-1#2)(1997-5#3)(2007-11#1)(2007-12#1)(2007-7#5)(2007-8#2)(2008-10#11)(2008-11#17)(2008-7#7)(2008-8#2)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#1)(2013-8#3)
phenytoin)##2##1##(1994-9#1)(2013-8#1)
pheochromocytoma (PC12) cells##3##3##(1992-12#1)(2008-4#1)(2013-8#1)
pheochromocytoma PC12##5##2##(1992-11#2)(1997-2#1)(1997-6#1)(2008-10#1)
pheochromocytoma and papillary adenocarcinoma of the thyroid in a##2##9##(1992-2#2)
pheochromocytoma and##8##2##(1991-10#3)(1992-2#2)(1995-7#2)(2009-1#1)
pheochromocytoma cell line##12##3##(1990-11#1)(1990-5#1)(1993-8#1)(1994-11#1)(1995-12#1)(1997-2#1)(1997-8#1)(2005-8#1)(2008-11#4)
pheochromocytoma cells##16##2##(1991-5#2)(1992-8#2)(1993-6#1)(1994-6#1)(1995-2#1)(1995-3#1)(1997-2#1)(1997-8#1)(2008-11#2)(2008-4#1)(2010-8#1)(2012-1#1)(2013-8#1)
pheochromocytoma should##2##2##(1996-12#1)(2012-2#1)
pheochromocytoma was##2##2##(1996-12#1)(2009-1#1)
pheochromocytoma with##2##2##(2006-9#2)
pheochromocytoma##82##1##(1990-11#2)(1990-2#1)(1990-5#1)(1991-10#5)(1991-5#2)(1992-11#2)(1992-12#1)(1992-2#3)(1992-8#2)(1993-6#1)(1993-8#1)(1994-11#2)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#3)(1995-7#6)(1996-11#1)(1996-12#3)(1996-8#1)(1997-2#3)(1997-6#1)(1997-8#2)(2005-8#1)(2006-12#1)(2006-8#1)(2006-9#4)(2007-12#4)(2008-10#2)(2008-11#6)(2008-4#2)(2009-1#4)(2010-8#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#2)
pheochromocytomas##3##1##(1990-4#1)(1995-11#1)(2012-2#1)
pheophytin a##3##2##(2008-11#3)
pheophytin##10##1##(1991-7#1)(1995-8#1)(1997-4#1)(2008-11#3)(2008-8#2)(2008-9#2)
pheophytins##2##1##(2008-9#2)
pheromone and##2##2##(1991-5#1)(1993-12#1)
pheromone biosynthesis activating neuropeptide (PBAN)##3##5##(1992-11#1)(2007-12#1)(2008-9#1)
pheromone biosynthesis activating neuropeptide##4##4##(1992-11#2)(2007-12#1)(2008-9#1)
pheromone biosynthesis##10##2##(1990-7#1)(1992-11#2)(2006-12#3)(2006-4#1)(2007-12#2)(2008-9#1)
pheromone blend##4##2##(2006-4#1)(2008-10#3)
pheromone components of##2##3##(2008-10#2)
pheromone components##8##2##(1995-8#3)(2006-4#1)(2008-10#4)
pheromone from##2##2##(1990-11#1)(2008-10#1)
pheromone gene##2##2##(2008-10#1)(2012-12#1)
pheromone gland##5##2##(2006-4#1)(2007-12#1)(2008-10#3)
pheromone in the##2##3##(2008-10#1)(2008-6#1)
pheromone in##7##2##(1991-5#1)(2008-10#1)(2008-3#2)(2008-6#1)(2008-8#1)(2011-2#1)
pheromone is##3##2##(1990-8#1)(2008-6#1)(2013-8#1)
pheromone molecules##2##2##(2008-3#1)(2009-7#1)
pheromone of the##3##3##(1997-2#1)(2007-11#1)(2008-10#1)
pheromone of##5##2##(1993-12#1)(1997-2#1)(2007-11#1)(2008-10#2)
pheromone production##2##2##(1992-1#1)(2006-12#1)
pheromone receptor##3##2##(1992-5#1)(2008-10#1)(2013-8#1)
pheromone to##2##2##(1995-1#1)(2009-7#1)
pheromone##105##1##(1990-11#3)(1990-7#1)(1990-8#3)(1991-12#2)(1991-5#5)(1992-1#2)(1992-11#2)(1992-5#2)(1992-7#1)(1993-12#3)(1994-12#3)(1995-1#10)(1995-8#4)(1996-2#1)(1997-2#1)(1997-4#2)(2004-2#1)(2006-12#4)(2006-4#5)(2007-11#1)(2007-12#7)(2008-10#19)(2008-3#5)(2008-6#5)(2008-8#1)(2008-9#1)(2009-7#3)(2011-2#4)(2012-12#1)(2013-8#3)
pheromone'##2##1##(2006-12#2)
pheromone-baited##2##1##(2011-2#2)
pheromone-binding protein from the silkworm moth##2##6##(2008-10#2)
pheromone-binding protein from##3##3##(2008-10#2)(2009-7#1)
pheromone-binding protein##4##2##(2008-10#3)(2009-7#1)
pheromone-binding##5##1##(2008-10#3)(2009-7#2)
pheromone-detecting##2##1##(2007-12#2)
pheromone-producing##2##1##(1990-11#1)(2007-12#1)
pheromone-responsive OSNs##2##2##(2013-8#2)
pheromone-responsive##3##1##(2013-8#3)
pheromones##20##1##(1990-11#1)(1990-8#2)(1991-8#1)(1994-12#1)(1995-1#1)(2007-12#2)(2008-10#7)(2009-9#1)(2011-1#1)(2012-12#3)
pheromonotropic##3##1##(1992-1#2)(1992-11#1)
phi &gt##3##2##(1996-12#2)(2008-10#1)
phi &lt##5##2##(1995-10#1)(1996-12#2)(2008-3#2)
phi 1 =##2##3##(1991-7#1)(1995-10#1)
phi 12-S##2##2##(1990-4#2)
phi 29 DNA polymerase##3##4##(1990-3#1)(1990-9#2)
phi 29 terminal protein##2##4##(1990-3#2)
phi 29##7##2##(1990-11#2)(1990-3#3)(1990-9#2)
phi 82-W1##2##2##(1990-4#2)
phi = 0##3##3##(1991-11#1)(2008-3#2)
phi =##4##2##(1991-11#1)(1994-3#1)(2008-3#2)
phi C3208##2##2##(1993-9#2)
phi R73##2##2##(1995-8#2)
phi X174 DNA##2##3##(1991-5#2)
phi X174##9##2##(1991-5#7)(1995-2#2)
phi and##2##2##(1997-5#1)(2008-2#1)
phi angle##3##2##(1992-4#2)(2008-3#1)
phi coefficient##2##2##(2008-10#1)(2010-1#1)
phi is##2##2##(1995-3#1)(2007-12#1)
phi of##2##2##(1993-3#1)(2008-3#1)
phi values##6##2##(1996-12#3)(1997-5#1)(2008-11#1)(2008-3#1)
phi was##2##2##(2008-3#2)
phi##100##1##(1990-10#1)(1990-11#3)(1990-3#3)(1990-4#7)(1990-9#2)(1991-10#4)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#7)(1991-7#1)(1992-1#1)(1992-4#3)(1992-9#1)(1993-12#1)(1993-3#2)(1993-9#3)(1994-11#1)(1994-3#1)(1994-5#1)(1995-10#2)(1995-2#2)(1995-3#3)(1995-4#2)(1995-5#1)(1995-8#2)(1996-12#9)(1997-2#1)(1997-5#2)(2005-11#1)(2007-12#4)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#13)(2010-1#1)(2011-2#1)
phi(p)##2##1##(2008-2#1)(2008-3#1)
phi) and Delta(t)V(0)##2##3##(2006-10#2)
phi)##10##1##(1994-11#1)(2006-10#5)(2008-2#3)(2011-2#1)
phi-x174##2##1##(1997-6#2)
phi29 DNA packaging motor##2##4##(2010-5#2)
phi29 DNA replication##5##3##(1997-5#5)
phi29 DNA##7##2##(1997-5#5)(2010-5#2)
phiFC1##2##1##(2007-12#2)
phiNHOH##2##1##(2008-10#2)
philanthotoxin##2##1##(1990-7#1)(2008-8#1)
philanthropic and##2##2##(1995-2#1)(2009-4#1)
philanthropic organizations##2##2##(1992-1#1)(2006-10#1)
philanthropic##8##1##(1992-1#1)(1995-1#1)(1995-2#1)(2006-10#1)(2008-11#1)(2008-8#1)(2009-4#2)
philanthropy##14##1##(1992-12#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-1#3)(1995-3#3)(1996-3#1)(1997-3#1)(2007-4#1)
philippensis##5##1##(1997-4#2)(2008-5#3)
philippinarum##2##1##(2008-5#2)
philomiragia adenitis and##2##3##(2007-12#2)
philomiragia##5##1##(2007-12#5)
philopatric offspring##2##2##(2008-8#2)
philopatric##6##1##(2006-5#1)(2008-8#4)(2012-2#1)
philopatry and altruism##2##3##(2008-8#2)
philopatry and##3##2##(2008-8#3)
philopatry##7##1##(2008-8#7)
philosopher Michel##2##2##(1993-11#1)(2012-3#1)
philosopher##8##1##(1990-8#1)(1993-11#1)(1994-3#1)(1997-4#1)(2006-4#1)(2008-12#1)(2012-12#1)(2012-3#1)
philosophers##13##1##(2005-11#1)(2006-11#1)(2006-3#1)(2008-1#1)(2009-6#1)(2010-12#4)(2011-2#3)(2012-2#1)
philosophic##2##1##(2008-6#1)(2011-2#1)
philosophical and##5##2##(2006-5#1)(2008-10#1)(2008-7#3)
philosophical concerns##2##2##(2008-8#1)(2012-2#1)
philosophical ideas##3##2##(2008-12#1)(2008-4#1)(2011-2#1)
philosophical literature##3##2##(1990-12#1)(2012-2#2)
philosophical reflections##2##2##(1994-6#1)(2013-8#1)
philosophical##51##1##(1990-12#1)(1992-12#1)(1994-3#1)(1994-6#1)(1997-7#1)(2005-11#1)(2005-12#1)(2005-7#4)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-7#5)(2008-8#2)(2010-11#1)(2010-12#3)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#8)(2013-8#1)
philosophies and##2##2##(1992-3#1)(1993-1#1)
philosophies##10##1##(1992-3#1)(1993-1#1)(1995-1#1)(1997-3#1)(2006-7#1)(2006-8#1)(2007-2#2)(2008-10#1)(2012-2#1)
philosophy and ethics##2##3##(2005-12#1)(2008-11#1)
philosophy and##15##2##(1992-2#1)(1994-1#1)(1994-2#1)(1994-3#2)(2005-12#1)(2006-6#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-6#1)(2009-7#1)
philosophy for##4##2##(1995-1#1)(1996-1#1)(2006-3#1)(2008-1#1)
philosophy is##3##2##(1993-2#1)(1993-5#1)(2008-2#1)
philosophy of##22##2##(1990-12#1)(1991-1#1)(1991-12#2)(1993-2#1)(1994-12#1)(1997-3#1)(2006-3#1)(2006-8#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#1)(2009-2#1)(2010-2#1)(2010-9#1)(2012-2#6)
philosophy##105##1##(1990-12#1)(1990-2#1)(1991-1#1)(1991-12#2)(1991-2#1)(1992-1#1)(1992-2#2)(1993-1#1)(1993-2#3)(1993-5#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#5)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#3)(1996-6#1)(1997-2#1)(1997-3#1)(2005-11#1)(2005-12#1)(2006-3#9)(2006-6#2)(2006-8#2)(2007-11#1)(2007-12#1)(2007-2#3)(2007-3#1)(2007-5#1)(2007-7#2)(2008-1#4)(2008-11#5)(2008-12#6)(2008-2#4)(2008-6#3)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#1)(2013-8#2)
philtrum##2##1##(1996-12#1)(1996-3#1)
phimosis in pediatric##2##3##(2006-8#2)
phimosis in##3##2##(2006-8#2)(2008-7#1)
phimosis##8##1##(2006-7#1)(2006-8#2)(2008-1#1)(2008-10#2)(2008-7#2)
phlA'-'lacZ##2##1##(2008-10#2)
phlD##12##1##(2008-10#12)
phlD(+)##3##1##(2008-10#3)
phlD+ pseudomonads in no-till##2##4##(2008-10#2)
phlD+ pseudomonads in##3##3##(2008-10#3)
phlD+ pseudomonads##4##2##(2008-10#4)
phlD+##5##1##(2008-10#5)
phlD-specific PCR-based##2##2##(2008-10#2)
phlD-specific##3##1##(2008-10#3)
phlebectasia is an##2##3##(2011-1#1)(2013-8#1)
phlebectasia is##3##2##(2011-1#1)(2013-8#2)
phlebectasia##5##1##(2011-1#1)(2013-8#4)
phlebitis of the##2##3##(1992-5#1)(2007-7#1)
phlebitis##10##1##(1992-5#1)(2006-8#1)(2007-7#3)(2010-11#1)(2011-2#1)(2013-1#3)
phlebographically##2##1##(1990-10#1)(1990-12#1)
phlebography##2##1##(1990-12#1)(1992-3#1)
phleboliths##3##1##(2012-12#3)
phlebothrombosis of the##2##3##(1993-7#1)(2005-1#1)
phlebothrombosis##4##1##(1993-7#1)(2005-1#1)(2007-8#1)(2008-11#1)
phlebotomine sand flies##3##3##(2012-12#2)(2013-1#1)
phlebotomine sandflies##3##2##(2007-6#3)
phlebotomine##8##1##(2007-6#3)(2008-8#2)(2012-12#2)(2013-1#1)
phlebotomy##5##1##(2006-10#1)(2007-7#1)(2008-10#1)(2009-8#1)(2010-8#1)
phlegm##2##1##(1995-8#1)(2013-1#1)
phlegmon##6##1##(2005-10#1)(2008-1#1)(2008-8#1)(2011-2#1)(2013-1#2)
phlegmona##2##1##(2008-1#1)(2008-9#1)
phlegmonas##3##1##(2008-8#1)(2008-9#2)
phlegmonous gastritis##3##2##(2008-12#3)
phloem and xylem##3##3##(2008-11#1)(2012-8#2)
phloem and##6##2##(2008-10#3)(2008-11#1)(2012-8#2)
phloem cells##6##2##(2008-10#5)(2008-11#1)
phloem in##2##2##(2009-8#1)(2012-8#1)
phloem of##6##2##(2006-12#1)(2008-10#2)(2008-11#1)(2012-8#2)
phloem remained##2##2##(2012-8#2)
phloem tissue##3##2##(2008-10#2)(2008-9#1)
phloem tissues##4##2##(2008-10#4)
phloem##68##1##(1993-6#1)(1997-8#1)(2006-12#1)(2008-10#40)(2008-11#6)(2008-9#1)(2009-8#7)(2011-10#1)(2012-2#2)(2012-8#8)
phloem-feeding##2##1##(2007-12#1)(2008-10#1)
phloem-limited##7##1##(2008-10#6)(2008-9#1)
phloem-mobile signal##2##2##(2009-8#1)(2012-2#1)
phloem-mobile##3##1##(2009-8#2)(2012-2#1)
phloem-restricted##4##1##(2008-10#4)
phloem-specific##3##1##(1993-6#1)(2006-12#1)(2008-9#1)
phloretin##7##1##(1991-2#2)(1997-1#5)
phlorglucinol##2##1##(2008-10#2)
phlorizin##2##1##(1991-4#1)(1994-6#1)
phloroglucinol##6##1##(2006-9#2)(2008-10#4)
pho1##3##1##(1996-10#3)
phoA##8##1##(1990-10#1)(1990-5#1)(1994-12#3)(2008-8#3)
phoA-kan##2##1##(1994-12#2)
phoAIV gene##4##2##(1990-11#4)
phoAIV##8##1##(1990-11#8)
phoB##4##1##(1993-12#1)(2007-12#3)
phoR##3##1##(2007-12#3)
phobia and##6##2##(2004-12#1)(2006-6#1)(2008-4#2)(2013-1#2)
phobia in##2##2##(2006-3#1)(2008-5#1)
phobia is##5##2##(2005-9#3)(2008-4#2)
phobia##71##1##(1996-1#2)(1996-11#1)(2004-11#1)(2004-12#1)(2005-9#5)(2006-12#1)(2006-3#1)(2006-6#6)(2007-2#1)(2007-7#2)(2007-9#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#20)(2008-5#1)(2008-7#1)(2010-2#8)(2011-12#1)(2012-12#1)(2012-2#8)(2013-1#5)
phobia)##2##1##(1995-6#1)(2007-7#1)
phobias##5##1##(1991-2#1)(2005-9#2)(2006-10#1)(2012-2#1)
phobias)##2##1##(2006-11#1)(2011-2#1)
phobic##2##1##(1993-12#1)(2009-11#1)
phocomelia##2##1##(2006-4#1)(2011-1#1)
phoenicis##3##1##(2008-10#1)(2008-6#2)
phoenicoxanthin##2##1##(2008-12#2)
phonation function##2##2##(2007-8#1)(2007-9#1)
phonation##7##1##(2007-8#1)(2007-9#1)(2009-11#2)(2009-2#1)(2011-12#1)(2012-2#1)
phonatory##3##1##(1994-6#3)
phone calls to##2##3##(1991-3#1)(2011-1#1)
phone calls##8##2##(1991-3#1)(2008-3#1)(2008-6#1)(2009-7#1)(2011-1#1)(2012-3#3)
phone cover##3##2##(2012-2#3)
phone usage##2##2##(2011-2#1)(2012-2#1)
phone use##4##2##(2009-9#1)(2010-12#1)(2013-1#2)
phone##46##1##(1991-3#2)(1994-3#1)(1995-2#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-9#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-8#2)(2011-1#6)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-2#5)(2012-3#7)(2013-1#2)
phoneme awareness##2##2##(2008-4#2)
phoneme monitoring##2##2##(2012-12#2)
phoneme##11##1##(2008-4#2)(2008-9#5)(2012-12#4)
phonemes within##2##2##(2012-12#2)
phonemes##4##1##(2012-12#3)(2013-8#1)
phonemic awareness##3##2##(2008-11#1)(2008-9#1)(2010-2#1)
phonemic##7##1##(2007-9#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-2#1)(2012-12#1)(2013-8#1)
phones and##2##2##(2007-9#1)(2011-2#1)
phones##19##1##(2006-9#1)(2007-9#1)(2008-11#1)(2008-12#3)(2009-6#1)(2009-9#1)(2010-12#4)(2011-2#4)(2012-12#1)(2013-1#1)(2013-8#1)
phonetic perception##3##2##(1992-1#3)
phonetic##18##1##(1992-1#3)(2008-3#1)(2008-5#1)(2009-10#3)(2009-8#1)(2010-2#1)(2012-1#3)(2012-12#3)(2013-8#2)
phonics##3##1##(2007-9#1)(2008-12#1)(2010-2#1)
phonologic##3##1##(2010-7#3)
phonological awareness and letter naming-decoding fluency##3##6##(2008-12#3)
phonological awareness and##8##3##(2007-9#2)(2008-12#4)(2011-1#2)
phonological awareness intervention##2##3##(2011-1#2)
phonological awareness##30##2##(2004-10#1)(2007-9#6)(2008-11#1)(2008-12#9)(2008-9#1)(2011-1#10)(2011-12#1)(2011-2#1)
phonological codes##2##2##(2008-4#1)(2013-7#1)
phonological encoding##3##2##(2008-4#3)
phonological information##3##2##(2008-4#2)(2012-1#1)
phonological knowledge##2##2##(2007-10#1)(2010-2#1)
phonological processing##2##2##(2007-9#1)(2008-4#1)
phonological similarity##2##2##(2007-10#2)
phonological words##3##2##(2008-2#3)
phonological##85##1##(1991-2#2)(1992-1#1)(1996-2#1)(2004-10#1)(2006-3#1)(2006-8#1)(2007-10#4)(2007-9#7)(2008-10#1)(2008-11#2)(2008-12#9)(2008-2#4)(2008-4#15)(2008-5#1)(2008-7#1)(2008-9#4)(2009-1#1)(2009-10#1)(2010-1#2)(2010-2#5)(2011-1#11)(2011-12#1)(2011-2#1)(2012-1#4)(2012-12#2)(2013-7#1)(2013-8#1)
phonology and orthography##2##3##(2008-4#1)(2008-9#1)
phonology and##4##2##(2008-4#1)(2008-9#1)(2010-1#1)(2010-4#1)
phonology##7##1##(2008-4#1)(2008-5#1)(2008-9#1)(2010-1#1)(2010-4#2)(2013-8#1)
phonon energies##2##2##(2006-7#1)(2008-2#1)
phonon##19##1##(1993-5#2)(1993-8#1)(2005-11#1)(2005-4#1)(2006-7#1)(2007-12#6)(2008-10#2)(2008-2#3)(2008-3#1)(2012-2#1)
phonons in##4##2##(1990-7#1)(1992-11#1)(1992-8#1)(2012-2#1)
phonons##9##1##(1990-7#1)(1992-11#1)(1992-5#1)(1992-8#1)(2006-10#2)(2007-11#1)(2012-2#2)
phonophoresis##10##1##(2006-3#1)(2007-7#8)(2008-7#1)
phonosurgery##3##1##(2009-2#2)(2011-1#1)
phonotactic probability##6##2##(2008-9#6)
phonotaxis##3##1##(2009-5#1)(2009-9#2)
phorbol 12##6##2##(1990-12#2)(1990-7#1)(1995-11#1)(1995-2#2)
phorbol 12-myristate 13-acetate (PMA) and##3##5##(1991-5#1)(1992-6#1)(1994-3#1)
phorbol 12-myristate 13-acetate (PMA) induced##2##5##(1994-12#1)(1996-5#1)
phorbol 12-myristate 13-acetate (PMA)##26##4##(1990-5#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#2)(1996-5#1)(1996-8#1)(1997-1#1)(2008-11#2)(2008-5#1)
phorbol 12-myristate 13-acetate and##2##4##(1992-5#1)(1996-8#1)
phorbol 12-myristate 13-acetate##45##3##(1990-11#3)(1990-5#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-7#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-4#1)(1996-5#2)(1996-8#2)(1997-1#1)(2008-11#3)(2008-5#1)(2013-1#1)
phorbol 12-myristate##50##2##(1990-11#3)(1990-2#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#3)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-2#2)(1996-4#1)(1996-5#2)(1996-8#2)(1997-1#1)(2008-11#3)(2008-5#1)(2013-1#2)
phorbol dibutyrate treated##2##3##(1990-11#2)
phorbol dibutyrate##13##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-3#4)(1994-8#1)(1995-3#1)
phorbol ester (PDBu)##2##3##(1990-7#1)(1996-9#1)
phorbol ester (TPA)##2##3##(1990-12#1)(1994-9#1)
phorbol ester 12-O-tetradecanoyl phorbol 13-acetate (TPA)##2##6##(1993-12#1)(1995-11#1)
phorbol ester 12-O-tetradecanoyl##3##3##(1992-3#1)(1993-12#1)(1995-11#1)
phorbol ester 12-O-tetradecanoylphorbol 13-acetate (TPA)##2##5##(1990-4#1)(1994-11#1)
phorbol ester 12-O-tetradecanoylphorbol 13-acetate##3##4##(1990-4#1)(1991-8#1)(1994-11#1)
phorbol ester 4##3##3##(1990-2#1)(1994-2#1)(1995-3#1)
phorbol ester and##7##3##(1992-9#1)(1994-11#3)(1994-3#1)(1995-5#1)(1996-1#1)
phorbol ester binding##6##3##(1993-9#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-8#1)
phorbol ester in##5##3##(1991-6#1)(1994-6#1)(1996-2#1)(1996-7#1)(1997-1#1)
phorbol ester induced##2##3##(1992-11#1)(1993-3#1)
phorbol ester is##3##3##(1991-7#1)(1991-9#1)(1997-1#1)
phorbol ester on cell growth##3##5##(1990-8#2)(1994-12#1)
phorbol ester on##6##3##(1990-8#2)(1992-6#1)(1994-12#1)(1995-5#1)(1995-6#1)
phorbol ester or##4##3##(1990-12#1)(1992-6#1)(1993-11#1)(1995-12#1)
phorbol ester response##2##3##(1993-12#1)(1996-8#1)
phorbol ester stimulation##2##3##(1995-6#2)
phorbol ester treatment##2##3##(1993-8#1)(1995-6#1)
phorbol ester were##2##3##(1992-5#1)(1994-3#1)
phorbol ester##105##2##(1990-10#1)(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#5)(1993-11#1)(1993-12#3)(1993-3#1)(1993-4#2)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#7)(1994-12#4)(1994-2#1)(1994-3#5)(1994-5#1)(1994-6#2)(1994-8#5)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#4)(1995-5#2)(1995-6#5)(1995-8#1)(1996-1#1)(1996-2#1)(1996-5#3)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#3)(2008-11#2)
phorbol ester-activated##4##2##(1991-12#1)(1991-9#3)
phorbol ester-dependent##2##2##(1994-2#1)(1995-5#1)
phorbol ester-induced##11##2##(1991-8#2)(1991-9#1)(1992-11#1)(1993-12#1)(1993-4#1)(1994-3#1)(1994-8#2)(1995-5#1)(1995-7#1)
phorbol ester-mediated##2##2##(1991-9#1)(1994-8#1)
phorbol ester-stimulated##4##2##(1991-5#1)(1995-6#1)(1996-12#1)(1996-5#1)
phorbol esters and##3##3##(1992-12#1)(1993-6#1)(1994-8#1)
phorbol esters are##2##3##(1994-11#1)(2008-11#1)
phorbol esters in##4##3##(1990-9#1)(1992-5#1)(1994-12#1)(1994-2#1)
phorbol esters may##2##3##(1994-11#1)(1995-7#1)
phorbol esters on the##2##4##(1990-10#1)(1990-12#1)
phorbol esters on##4##3##(1990-10#1)(1990-12#1)(1992-4#1)(2010-12#1)
phorbol esters that activate##2##4##(1992-4#1)(1994-2#1)
phorbol esters##51##2##(1990-10#5)(1990-12#3)(1990-7#1)(1990-9#2)(1991-12#1)(1991-5#3)(1992-12#1)(1992-4#3)(1992-5#2)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#3)(1994-12#1)(1994-2#4)(1994-8#3)(1994-9#1)(1995-5#1)(1995-6#4)(1995-7#2)(1996-2#3)(2008-11#1)(2008-7#1)(2010-12#2)
phorbol myristate acetate (PMA##2##4##(1994-8#1)(1997-8#1)
phorbol myristate acetate (PMA) and##2##5##(1993-6#1)(2004-12#1)
phorbol myristate acetate (PMA)##10##4##(1990-2#1)(1990-3#1)(1991-4#1)(1991-9#1)(1993-6#1)(1994-2#1)(1994-6#1)(1997-4#1)(2004-12#1)(2006-6#1)
phorbol myristate acetate (PMA)-induced##2##4##(1994-8#1)(1997-7#1)
phorbol myristate acetate##21##3##(1990-2#1)(1990-3#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-7#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#2)(1997-4#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-8#1)(2006-6#1)
phorbol myristate##25##2##(1990-2#1)(1990-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#2)(1997-4#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-8#1)(2006-6#1)(2008-10#1)
phorbol##295##1##(1990-10#7)(1990-11#5)(1990-12#9)(1990-2#4)(1990-3#3)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#5)(1990-8#3)(1990-9#5)(1991-10#1)(1991-12#3)(1991-2#2)(1991-3#5)(1991-4#3)(1991-5#7)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#8)(1992-1#1)(1992-11#3)(1992-12#3)(1992-3#2)(1992-4#3)(1992-5#6)(1992-6#5)(1992-7#2)(1992-8#2)(1992-9#6)(1993-11#2)(1993-12#5)(1993-2#1)(1993-3#2)(1993-4#3)(1993-6#6)(1993-7#3)(1993-8#4)(1993-9#2)(1994-11#13)(1994-12#7)(1994-2#9)(1994-3#9)(1994-5#1)(1994-6#6)(1994-8#17)(1994-9#4)(1995-11#8)(1995-12#1)(1995-2#3)(1995-3#6)(1995-5#7)(1995-6#11)(1995-7#4)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#6)(1996-4#1)(1996-5#6)(1996-7#2)(1996-8#5)(1996-9#1)(1997-1#4)(1997-4#1)(1997-7#2)(1997-8#1)(2004-12#1)(2005-8#1)(2006-6#1)(2008-10#1)(2008-11#6)(2008-5#1)(2008-7#1)(2010-12#2)(2013-1#2)
phorbol-12##2##1##(1990-8#1)(1997-1#1)
phorbol-12-myristate-13-acetate (PMA)##4##2##(1991-9#1)(1995-7#1)(2008-11#2)
phorbol-13-acetate (TPA)##3##2##(1994-12#1)(1994-3#1)(1995-8#1)
phorbol-ester##4##1##(1991-7#1)(1994-12#2)(1994-2#1)
phoretic##4##1##(2008-4#4)
phorids##4##1##(2008-6#4)
phosducin##12##1##(1994-9#12)
phosgene##2##1##(1992-5#1)(2012-2#1)
phosph(on)ate##2##1##(2008-3#1)(2008-5#1)
phosphatase (ALP) was##2##3##(1991-5#1)(2007-8#1)
phosphatase (ALP)##30##2##(1990-12#1)(1991-5#1)(1992-1#2)(1994-2#1)(1994-5#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-5#2)(2008-7#2)(2009-4#1)(2010-4#1)(2011-1#3)(2012-3#1)(2013-1#2)
phosphatase (AP) and##2##3##(2008-10#2)
phosphatase (AP)##14##2##(1991-8#1)(1992-7#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-10#2)(1995-12#1)(2008-10#4)(2008-11#1)(2013-8#1)
phosphatase (MBP)##2##2##(1993-6#1)(1997-7#1)
phosphatase (PP2B)##2##2##(1992-8#2)
phosphatase (PTPase) activity##3##3##(1993-3#1)(1994-5#1)(1995-3#1)
phosphatase (PTPase)##8##2##(1992-10#1)(1992-6#1)(1993-3#1)(1994-5#1)(1995-10#1)(1995-3#1)(1997-7#1)(2008-8#1)
phosphatase 1 and 2A##2##4##(1997-6#1)(2008-10#1)
phosphatase 1##11##2##(1990-12#1)(1993-7#2)(1994-2#1)(1995-6#2)(1995-8#2)(1997-4#1)(1997-6#1)(2008-10#1)
phosphatase 2A catalytic subunit##7##4##(1992-9#7)
phosphatase 2A enzyme##2##3##(1992-9#2)
phosphatase 2A##23##2##(1992-9#12)(1994-9#2)(1995-3#5)(1995-8#1)(1996-5#2)(2008-9#1)
phosphatase X##2##2##(1992-12#2)
phosphatase activating factor##2##3##(1993-6#2)
phosphatase activities in##2##3##(1994-11#1)(2008-10#1)
phosphatase activities of##2##3##(2008-10#1)(2008-9#1)
phosphatase activities produced in vitro##2##5##(2007-3#2)
phosphatase activities##15##2##(1994-11#1)(1995-3#1)(2007-3#4)(2008-10#6)(2008-9#2)(2009-5#1)
phosphatase activity and##8##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-9#1)(2009-4#1)(2012-4#1)
phosphatase activity as a##2##4##(2004-12#1)(2008-10#1)
phosphatase activity in a##2##4##(1993-3#1)(1994-11#1)
phosphatase activity in the##3##4##(1994-11#1)(2008-10#1)(2008-7#1)
phosphatase activity in##11##3##(1991-8#1)(1993-3#1)(1994-11#2)(1995-12#1)(2004-11#2)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
phosphatase activity is##3##3##(1993-11#1)(1993-8#1)(1997-2#1)
phosphatase activity of##6##3##(1995-1#1)(2008-10#2)(2008-9#2)(2012-12#1)
phosphatase activity was inhibited##2##4##(1992-12#1)(1993-12#1)
phosphatase activity was##6##3##(1992-12#2)(1993-12#1)(1993-6#1)(2004-11#1)(2011-12#1)
phosphatase activity were##3##3##(1994-8#1)(1995-3#1)(2008-5#1)
phosphatase activity##78##2##(1990-12#1)(1990-7#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-12#4)(1992-9#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#3)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#3)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#2)(1995-8#2)(1996-2#1)(1997-1#1)(1997-2#2)(1997-6#1)(2004-11#3)(2004-12#1)(2007-3#1)(2008-10#6)(2008-11#6)(2008-5#7)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-4#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-4#1)(2013-1#2)
phosphatase and choline##2##3##(1994-3#1)(2008-10#1)
phosphatase and is##3##3##(1990-6#1)(1991-10#1)(1993-11#1)
phosphatase and##36##2##(1990-4#1)(1990-6#1)(1991-10#1)(1991-4#2)(1991-9#1)(1992-1#1)(1993-11#2)(1993-3#2)(1993-6#2)(1993-7#1)(1994-11#1)(1994-2#1)(1994-3#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2010-12#2)(2010-2#1)(2012-11#2)(2012-2#2)(2012-3#1)(2013-1#1)
phosphatase are##3##2##(1995-2#1)(1997-2#1)(2012-1#1)
phosphatase as a reporter of##2##5##(1992-7#2)
phosphatase as a reporter##3##4##(1992-7#2)(2008-11#1)
phosphatase as a##5##3##(1992-7#2)(1995-2#1)(2008-11#2)
phosphatase as an##2##3##(1992-11#1)(1995-7#1)
phosphatase as##10##2##(1992-11#1)(1992-7#3)(1995-11#1)(1995-2#2)(1995-7#1)(2008-11#2)
phosphatase by##4##2##(1992-3#1)(1994-11#1)(1994-8#1)(2007-8#1)
phosphatase calcineurin##2##2##(1991-9#1)(1993-12#1)
phosphatase conjugated##2##2##(1990-12#1)(1991-8#1)
phosphatase domain##2##2##(1994-8#1)(2009-7#1)
phosphatase family##2##2##(1995-3#1)(2013-1#1)
phosphatase from bovine##2##3##(1992-3#1)(2008-8#1)
phosphatase from##10##2##(1990-4#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-6#1)(1997-7#1)(2008-8#1)
phosphatase fusion proteins##2##3##(2008-10#2)
phosphatase fusion##3##2##(1990-11#1)(2008-10#2)
phosphatase gene##8##2##(1990-12#1)(1990-4#1)(1991-9#2)(1993-11#2)(1997-1#1)(2009-11#1)
phosphatase has##4##2##(1992-12#1)(1993-8#1)(1994-3#1)(1997-7#1)
phosphatase in the##2##3##(1991-4#1)(2007-9#1)
phosphatase in##22##2##(1990-10#1)(1991-12#1)(1991-4#3)(1991-5#1)(1991-9#1)(1992-12#1)(1993-10#1)(1993-11#1)(1993-6#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-3#1)(1997-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-5#1)(2012-2#1)
phosphatase inhibition##4##2##(1990-12#1)(1997-4#2)(2008-8#1)
phosphatase inhibitor okadaic acid##3##4##(1991-3#1)(1993-8#2)
phosphatase inhibitor##14##2##(1991-3#1)(1993-8#2)(1994-11#1)(1994-2#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-5#1)(1996-5#2)(2008-4#1)(2009-6#1)
phosphatase inhibitors calyculin A##2##4##(1992-12#1)(1994-6#1)
phosphatase inhibitors##16##2##(1992-12#3)(1992-8#1)(1993-6#1)(1994-11#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-6#1)(2008-2#2)(2008-4#3)
phosphatase is a##2##3##(1992-7#1)(1994-8#1)
phosphatase is an##3##3##(1993-8#2)(1994-8#1)
phosphatase is##7##2##(1992-12#1)(1992-7#1)(1993-8#2)(1994-8#2)(2008-4#1)
phosphatase isozymes##5##2##(1994-3#4)(2008-4#1)
phosphatase may be##2##3##(1992-12#1)(1993-6#1)
phosphatase of##2##2##(1992-7#1)(1995-2#1)
phosphatase or##2##2##(1994-9#1)(2008-8#1)
phosphatase production##3##2##(1990-11#1)(2007-3#1)(2008-5#1)
phosphatase substrates##2##2##(1990-3#2)
phosphatase that##3##2##(1990-4#1)(1995-1#1)(1995-6#1)
phosphatase to##3##2##(1991-12#1)(1996-9#1)(2008-7#1)
phosphatase treatment##2##2##(1990-3#1)(1994-11#1)
phosphatase was##14##2##(1990-8#1)(1992-7#1)(1993-11#2)(1993-6#1)(1994-9#1)(1997-7#2)(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
phosphatase##685##1##(1990-10#1)(1990-11#5)(1990-12#10)(1990-2#1)(1990-3#5)(1990-4#10)(1990-5#2)(1990-6#3)(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-10#8)(1991-11#1)(1991-12#2)(1991-2#5)(1991-3#5)(1991-4#7)(1991-5#6)(1991-6#1)(1991-7#3)(1991-8#6)(1991-9#6)(1992-1#6)(1992-10#1)(1992-11#1)(1992-12#28)(1992-3#8)(1992-6#4)(1992-7#7)(1992-8#10)(1992-9#13)(1993-10#1)(1993-11#16)(1993-12#3)(1993-2#1)(1993-3#6)(1993-4#3)(1993-6#21)(1993-7#5)(1993-8#14)(1994-11#13)(1994-12#9)(1994-2#9)(1994-3#9)(1994-4#2)(1994-5#3)(1994-6#4)(1994-8#13)(1994-9#11)(1995-1#9)(1995-10#4)(1995-11#2)(1995-12#2)(1995-2#13)(1995-3#18)(1995-5#3)(1995-6#8)(1995-7#3)(1995-8#13)(1995-9#1)(1996-10#1)(1996-11#1)(1996-2#3)(1996-5#12)(1996-6#1)(1996-7#2)(1996-9#5)(1997-1#2)(1997-2#5)(1997-3#1)(1997-4#4)(1997-6#5)(1997-7#8)(1997-8#2)(2004-11#6)(2004-12#1)(2004-4#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-5#3)(2006-6#4)(2007-11#2)(2007-12#2)(2007-3#9)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#37)(2008-11#19)(2008-12#1)(2008-2#6)(2008-4#16)(2008-5#16)(2008-6#3)(2008-7#12)(2008-8#11)(2008-9#8)(2009-10#1)(2009-11#2)(2009-4#4)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-4#1)(2010-7#1)(2011-1#4)(2011-12#1)(2011-2#3)(2012-1#2)(2012-11#2)(2012-12#6)(2012-2#8)(2012-3#5)(2012-4#1)(2013-1#11)(2013-8#3)
phosphatase) and##2##2##(1996-12#1)(2007-8#1)
phosphatase)##3##1##(1996-12#1)(2007-8#1)(2012-1#1)
phosphatase-1##6##1##(1990-8#1)(1995-3#1)(1995-8#2)(1997-6#2)
phosphatase-positive##4##1##(1995-1#1)(2008-5#1)(2009-3#1)(2012-1#1)
phosphatase-resistant##3##1##(1994-5#2)(2011-12#1)
phosphatases 1 and 2A##8##4##(1991-5#1)(1992-12#2)(1992-8#1)(1994-11#1)(1994-2#1)(1997-6#1)(1997-8#1)
phosphatases 1##12##2##(1990-8#1)(1991-10#1)(1991-5#1)(1992-12#2)(1992-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-8#1)(1997-6#1)(1997-8#1)
phosphatases and kinases##2##3##(1996-9#1)(1997-6#1)
phosphatases and##8##2##(1990-4#1)(1994-5#1)(1995-11#1)(1996-9#1)(1997-6#1)(2008-6#1)(2008-7#1)(2012-12#1)
phosphatases are##2##2##(1995-8#2)
phosphatases by##2##2##(1997-6#1)(2008-8#1)
phosphatases in the cell##2##4##(1995-6#1)(1995-8#1)
phosphatases in the regulation of##2##5##(1994-2#1)(1995-3#1)
phosphatases in the##6##3##(1994-10#1)(1994-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(2012-2#1)
phosphatases in##11##2##(1994-10#1)(1994-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-8#1)(2008-4#1)(2008-5#1)(2012-2#1)(2013-7#2)
phosphatases play##2##2##(1997-6#1)(2012-3#1)
phosphatases such as##2##3##(1991-10#1)(2008-10#1)
phosphatases that dephosphorylate##2##3##(1995-3#2)
phosphatases that##4##2##(1992-8#1)(1995-3#2)(1995-8#1)
phosphatases which##2##2##(1990-8#1)(1992-1#1)
phosphatases##125##1##(1990-12#3)(1990-4#2)(1990-8#3)(1991-10#5)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#2)(1992-8#5)(1992-9#1)(1993-6#1)(1993-7#2)(1994-10#2)(1994-11#2)(1994-12#1)(1994-2#3)(1994-5#3)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-3#4)(1995-6#3)(1995-8#7)(1996-4#1)(1996-5#2)(1996-9#1)(1997-6#9)(1997-7#2)(1997-8#3)(2004-12#3)(2005-7#2)(2005-8#1)(2007-12#1)(2007-3#2)(2007-8#1)(2008-10#3)(2008-2#1)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-5#1)(2009-8#2)(2009-9#1)(2011-1#2)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#3)(2013-7#5)(2013-8#1)
phosphate (0##2##2##(1990-12#1)(2008-10#1)
phosphate (P)##2##2##(1995-8#1)(2008-10#1)
phosphate (Pi)##9##2##(1990-11#1)(1991-5#1)(1993-12#2)(1994-3#1)(1995-11#1)(2008-4#1)(2009-8#1)(2010-8#1)
phosphate (TBP)##4##2##(2008-10#4)
phosphate (TOCP)##2##2##(1990-3#1)(1994-11#1)
phosphate (beta-TCP)##5##2##(2004-9#2)(2008-5#3)
phosphate (pH 6##3##3##(1990-11#1)(2007-8#1)(2008-10#1)
phosphate (pH 7##2##3##(1991-11#1)(2008-10#1)
phosphate (pH##6##2##(1990-11#1)(1991-11#1)(2007-8#1)(2008-10#2)(2012-12#1)
phosphate 0##2##2##(2008-10#1)(2012-2#1)
phosphate accumulation in##5##3##(1995-3#1)(1997-2#1)(2008-4#1)(2010-12#1)(2012-12#1)
phosphate accumulation##10##2##(1995-3#2)(1996-8#1)(1997-1#2)(1997-2#1)(2008-4#2)(2010-12#1)(2012-12#1)
phosphate activating group on##2##4##(1994-11#2)
phosphate affinity SDS-PAGE##2##3##(2010-12#2)
phosphate and D-glucose uptake##2##4##(1991-9#2)
phosphate and arsenate##3##3##(1991-8#2)(2005-12#1)
phosphate and silicate##4##3##(2008-10#4)
phosphate and sulfate anions##2##4##(1992-12#1)(1997-1#1)
phosphate and sulphate binding##2##4##(1994-9#2)
phosphate and sulphate##3##3##(1994-9#2)(2008-10#1)
phosphate and the##2##3##(1996-7#1)(2008-5#1)
phosphate and##72##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-9#1)(1991-12#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-12#1)(1992-3#1)(1993-11#1)(1994-8#1)(1994-9#2)(1996-7#2)(1997-1#1)(1997-2#1)(1997-6#2)(2004-9#1)(2005-11#1)(2005-12#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-8#4)(2007-9#1)(2008-10#16)(2008-5#5)(2009-10#2)(2010-12#3)(2010-2#1)(2012-1#2)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#3)
phosphate are##2##2##(2008-10#2)
phosphate as a##2##3##(2008-10#1)(2010-5#1)
phosphate as substrate##3##3##(1990-3#1)(2004-11#1)(2008-10#1)
phosphate as##8##2##(1990-3#2)(2004-11#1)(2007-8#1)(2008-10#3)(2010-5#1)
phosphate at pH##2##3##(1990-8#1)(2012-3#1)
phosphate at##6##2##(1990-8#1)(2008-10#3)(2008-5#1)(2012-3#1)
phosphate binders##7##2##(1996-8#1)(2007-8#4)(2012-12#1)(2013-1#1)
phosphate binding##4##2##(1990-12#1)(1994-9#3)
phosphate buffer (0##5##3##(1992-10#1)(1992-2#1)(1993-12#1)(1996-6#1)(2008-6#1)
phosphate buffer (ionic strength)##2##4##(2008-10#2)
phosphate buffer (pH 2##9##4##(1996-5#2)(1997-1#1)(1997-3#1)(2008-10#4)(2008-6#1)
phosphate buffer (pH 3##4##4##(1991-8#1)(1997-3#1)(2008-10#1)(2010-2#1)
phosphate buffer (pH 4##2##4##(1996-6#1)(2008-10#1)
phosphate buffer (pH 6##6##4##(1992-1#2)(2008-10#2)(2008-4#1)(2008-5#1)
phosphate buffer (pH 7##20##4##(1990-8#1)(1992-1#1)(1995-5#2)(1995-6#1)(1997-4#1)(2007-8#1)(2008-10#13)
phosphate buffer (pH 7)##4##4##(1992-2#1)(2008-10#3)
phosphate buffer (pH 8##2##4##(2008-10#2)
phosphate buffer (pH##50##3##(1990-8#1)(1991-8#1)(1992-1#3)(1992-2#2)(1995-5#2)(1995-6#1)(1996-5#3)(1996-6#1)(1997-1#1)(1997-3#2)(1997-4#1)(2007-8#1)(2008-10#26)(2008-4#1)(2008-5#1)(2008-6#1)(2010-2#1)(2010-4#1)
phosphate buffer and in the presence of##2##7##(1995-5#1)(2008-10#1)
phosphate buffer and##7##3##(1992-10#1)(1995-5#1)(2008-10#4)(2013-7#1)
phosphate buffer as##3##3##(1997-8#1)(2008-10#1)(2008-6#1)
phosphate buffer at pH 3##2##5##(2008-10#2)
phosphate buffer at pH 6##3##5##(2008-10#2)(2008-5#1)
phosphate buffer at pH 7##2##5##(2008-10#2)
phosphate buffer at pH##9##4##(2008-10#8)(2008-5#1)
phosphate buffer at##14##3##(1995-5#1)(2007-9#1)(2008-10#10)(2008-3#1)(2008-5#1)
phosphate buffer concentration##2##3##(2008-10#2)
phosphate buffer containing 20##2##4##(1995-7#1)(1997-8#1)
phosphate buffer containing##4##3##(1995-7#1)(1996-4#1)(1997-8#1)(2008-10#1)
phosphate buffer for##2##3##(2008-10#2)
phosphate buffer of pH 7##2##5##(2007-8#1)(2008-10#1)
phosphate buffer of pH##3##4##(1990-8#1)(2007-8#1)(2008-10#1)
phosphate buffer pH 2##2##4##(1996-5#1)(2008-10#1)
phosphate buffer pH 5##2##4##(2008-10#1)(2011-1#1)
phosphate buffer pH##7##3##(1996-5#1)(1996-8#1)(2007-1#1)(2008-10#3)(2011-1#1)
phosphate buffer saline solution##2##4##(2008-10#2)
phosphate buffer saline##4##3##(1992-3#1)(2008-10#2)(2010-2#1)
phosphate buffer solution (pH 7##3##5##(2008-10#3)
phosphate buffer solution (pH##4##4##(2008-10#3)(2012-12#1)
phosphate buffer solution##15##3##(1996-1#1)(2007-2#1)(2007-8#1)(2008-10#9)(2009-7#1)(2010-12#1)(2012-12#1)
phosphate buffer solutions##4##3##(2008-10#3)(2010-5#1)
phosphate buffer with##3##3##(2004-9#1)(2008-10#2)
phosphate buffer##185##2##(1990-11#1)(1990-12#1)(1990-8#4)(1990-9#1)(1991-8#1)(1992-1#3)(1992-10#2)(1992-2#4)(1992-3#1)(1992-9#1)(1993-12#1)(1994-3#1)(1995-5#4)(1995-6#1)(1995-7#1)(1996-1#1)(1996-4#1)(1996-5#5)(1996-6#2)(1996-8#2)(1997-1#1)(1997-3#2)(1997-4#1)(1997-8#2)(2004-9#2)(2006-10#1)(2007-1#1)(2007-2#1)(2007-8#5)(2007-9#1)(2008-10#97)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#4)(2009-10#1)(2009-6#1)(2009-7#1)(2010-12#3)(2010-2#5)(2010-3#2)(2010-4#3)(2010-5#2)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
phosphate buffer)##6##2##(1996-2#1)(1997-7#1)(2007-8#1)(2008-10#1)(2010-2#1)(2010-3#1)
phosphate buffered saline (PBS)##3##4##(2006-5#1)(2008-10#2)
phosphate buffered saline##10##3##(1997-2#1)(2004-11#1)(2006-5#1)(2008-10#3)(2009-11#1)(2009-9#1)(2010-8#1)(2011-1#1)
phosphate buffered##11##2##(1997-2#1)(2004-11#1)(2006-5#1)(2008-10#3)(2009-11#1)(2009-5#1)(2009-9#1)(2010-8#1)(2011-1#1)
phosphate buffers##8##2##(1990-4#1)(2004-9#1)(2008-10#4)(2010-2#2)
phosphate by##3##2##(1994-8#1)(1995-10#1)(2011-1#1)
phosphate cement##11##2##(2004-9#8)(2008-5#2)(2010-8#1)
phosphate cements##4##2##(2004-9#3)(2009-9#1)
phosphate chain##3##2##(1996-7#1)(2008-4#2)
phosphate composite layer##3##3##(2008-5#3)
phosphate concentration##9##2##(1990-11#1)(1990-2#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-6#1)(2013-1#1)
phosphate concentrations##2##2##(2008-10#1)(2013-1#1)
phosphate concentrations)##2##2##(1992-11#1)(2012-2#1)
phosphate content in the medium##2##5##(1991-3#2)
phosphate content##3##2##(1991-3#2)(1995-10#1)
phosphate crystal##2##2##(2005-11#1)(2007-11#1)
phosphate dehydrogenase##5##2##(1991-8#1)(1994-11#1)(1997-2#1)(2008-10#1)(2009-4#1)
phosphate determination##3##2##(2008-10#3)
phosphate dibasic##3##2##(2008-10#2)(2009-8#1)
phosphate disodium salt##2##3##(1993-2#1)(2008-5#1)
phosphate dissociation##3##2##(1996-7#3)
phosphate donor and##3##3##(1995-11#1)(2008-4#2)
phosphate donor##8##2##(1990-10#1)(1994-9#1)(1995-11#2)(1996-4#1)(1996-7#1)(2008-4#2)
phosphate ester##3##2##(1992-3#1)(1994-5#1)(1995-1#1)
phosphate esters##11##2##(1991-4#2)(1993-8#1)(1994-11#1)(1995-1#2)(2008-10#1)(2008-4#1)(2010-4#3)
phosphate flocs##2##2##(2005-11#2)
phosphate for preconcentration##2##3##(2008-10#2)
phosphate for##6##2##(2008-10#4)(2008-5#1)(2012-3#1)
phosphate formation##4##2##(1990-7#1)(1993-12#1)(1996-7#1)(1997-7#1)
phosphate from the##2##3##(1994-8#1)(2005-9#1)
phosphate from##9##2##(1994-8#1)(1994-9#1)(1995-8#1)(1996-4#1)(2005-9#1)(2006-12#1)(2006-6#1)(2008-4#2)
phosphate glass laser##3##3##(2007-12#3)
phosphate glass##10##2##(2007-11#1)(2007-12#4)(2008-1#1)(2008-2#3)(2008-3#1)
phosphate group in##2##3##(1992-12#1)(2008-5#1)
phosphate group nor##2##3##(1991-3#1)(1994-5#1)
phosphate group per##2##3##(1993-8#1)(1997-1#1)
phosphate group##17##2##(1990-11#1)(1991-3#2)(1992-12#1)(1993-8#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-4#1)(1996-7#2)(1997-1#1)(2006-10#1)(2008-5#4)
phosphate groups of##3##3##(1990-2#1)(1992-6#1)(2008-10#1)
phosphate groups##13##2##(1990-11#1)(1990-2#1)(1990-3#1)(1991-5#1)(1992-6#2)(1992-9#1)(1994-9#1)(1995-1#1)(1996-8#1)(1997-5#1)(2007-11#1)(2008-10#1)
phosphate has been##3##3##(2009-12#1)(2010-2#1)(2011-2#1)
phosphate in a##2##3##(2008-5#2)
phosphate in the presence of##2##5##(1990-11#1)(2008-10#1)
phosphate in the##7##3##(1990-11#1)(1990-5#1)(2007-8#1)(2008-10#3)(2013-1#1)
phosphate in##33##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-7#1)(1993-12#1)(1994-11#1)(1995-11#1)(2006-10#1)(2007-8#1)(2008-10#15)(2008-11#1)(2008-5#2)(2010-2#3)(2010-9#1)(2013-1#1)
phosphate incorporation into guanylate cyclase##2##5##(1993-6#2)
phosphate incorporation was##3##3##(1990-3#1)(1990-7#2)
phosphate incorporation##6##2##(1990-3#1)(1990-7#2)(1993-6#2)(1994-3#1)
phosphate injection##3##2##(1997-8#2)(2008-10#1)
phosphate ion in river water##2##5##(2008-10#2)
phosphate ion in##3##3##(2008-10#3)
phosphate ion##10##2##(2008-10#10)
phosphate ion-selective##2##2##(2008-10#2)
phosphate ions in##2##3##(2006-7#1)(2008-10#1)
phosphate ions##5##2##(2006-3#1)(2006-7#1)(2006-9#1)(2008-10#2)
phosphate is a##2##3##(1991-5#1)(2008-5#1)
phosphate is##8##2##(1991-5#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-1#1)
phosphate isomerase##6##2##(1993-8#1)(1997-6#2)(2006-5#1)(2008-10#1)(2008-5#1)
phosphate levels were##2##3##(2006-10#1)(2011-1#1)
phosphate levels##8##2##(1990-10#1)(1990-5#1)(1995-9#1)(2006-10#2)(2008-1#1)(2011-1#1)(2012-2#1)
phosphate loss##2##2##(2006-10#1)(2008-6#1)
phosphate mediated##2##2##(1990-10#1)(1990-6#1)
phosphate metabolism and##2##3##(1993-5#1)(2007-12#1)
phosphate metabolism in##3##3##(1992-2#1)(1993-5#2)
phosphate metabolism##11##2##(1992-2#1)(1993-5#3)(1994-11#1)(1997-4#1)(2006-4#2)(2007-12#2)(2008-4#1)
phosphate microelectrode##2##2##(2010-2#2)
phosphate monohydrate##3##2##(2004-9#1)(2008-2#2)
phosphate nanoparticles##8##2##(2010-1#8)
phosphate nor##2##2##(1990-5#1)(1990-8#1)
phosphate of##4##2##(1990-11#1)(1990-4#1)(1994-9#1)(2008-5#1)
phosphate on##5##2##(1992-3#1)(2004-9#1)(2007-1#1)(2008-10#1)(2013-1#1)
phosphate or the##2##3##(1995-11#1)(2007-12#1)
phosphate or##11##2##(1990-8#1)(1993-3#1)(1994-3#1)(1995-11#1)(1996-5#1)(1997-6#1)(2004-9#1)(2007-12#1)(2008-4#1)(2008-5#1)(2013-8#1)
phosphate pathway##19##2##(1991-5#1)(1991-6#2)(1992-12#4)(1994-3#1)(1994-6#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#3)(2009-10#1)(2009-5#1)(2010-12#1)
phosphate phosphorus##2##2##(2008-6#2)
phosphate produced##2##2##(1990-3#1)(2008-10#1)
phosphate profiles##2##2##(1990-2#1)(2010-2#1)
phosphate radiolabel specifically to##2##4##(1990-2#2)
phosphate release##4##2##(1995-11#1)(2008-4#1)(2008-7#2)
phosphate rock##3##2##(2008-10#3)
phosphate salts##3##2##(1993-3#1)(2011-2#2)
phosphate solubilizing##3##2##(2008-5#3)
phosphate solution (pH##2##3##(2012-12#2)
phosphate solution##6##2##(1994-3#1)(2008-10#1)(2008-5#1)(2010-5#1)(2012-12#2)
phosphate starvation##5##2##(1990-11#1)(1994-11#2)(2007-12#2)
phosphate synthase##5##2##(1996-10#2)(1997-4#1)(2011-2#2)
phosphate synthetase##6##2##(1990-2#3)(1990-7#3)
phosphate to the##3##3##(2008-10#3)
phosphate to##7##2##(1990-12#1)(1991-8#1)(2004-9#1)(2008-10#4)
phosphate transfection##5##2##(1993-4#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)
phosphate transport system##2##3##(1996-9#1)(2007-12#1)
phosphate transport##8##2##(1990-8#4)(1991-9#1)(1994-3#1)(1996-9#1)(2007-12#1)
phosphate transporter##3##2##(1996-9#2)(2008-4#1)
phosphate uptake##2##2##(1991-9#1)(1996-11#1)
phosphate using##2##2##(2008-10#2)
phosphate was##11##2##(1990-3#1)(1990-9#1)(1991-12#1)(1994-9#1)(2005-11#2)(2008-10#3)(2009-3#1)(2013-8#1)
phosphate wasting##2##2##(1996-11#1)(2006-10#1)
phosphate were##12##2##(1990-4#1)(1991-11#1)(1994-12#1)(1994-5#1)(1996-6#1)(2005-11#2)(2006-10#2)(2008-10#1)(2008-4#1)(2008-5#1)
phosphate which##2##2##(1991-2#1)(1995-1#1)
phosphate with##4##2##(1997-7#1)(2006-10#1)(2008-10#1)(2011-12#1)
phosphate##1202##1##(1990-10#11)(1990-11#18)(1990-12#9)(1990-2#12)(1990-3#21)(1990-4#4)(1990-5#4)(1990-6#3)(1990-7#12)(1990-8#19)(1990-9#3)(1991-1#3)(1991-11#2)(1991-12#2)(1991-2#7)(1991-3#5)(1991-4#2)(1991-5#8)(1991-6#2)(1991-7#7)(1991-8#8)(1991-9#9)(1992-1#8)(1992-10#2)(1992-11#2)(1992-12#10)(1992-2#5)(1992-3#8)(1992-4#2)(1992-5#2)(1992-6#6)(1992-8#3)(1992-9#3)(1993-11#2)(1993-12#5)(1993-2#1)(1993-3#2)(1993-4#2)(1993-5#4)(1993-6#4)(1993-8#5)(1994-11#14)(1994-12#2)(1994-3#9)(1994-5#5)(1994-6#3)(1994-8#7)(1994-9#15)(1995-1#5)(1995-10#2)(1995-11#8)(1995-12#2)(1995-3#5)(1995-5#4)(1995-6#2)(1995-7#1)(1995-8#7)(1995-9#1)(1996-1#1)(1996-10#2)(1996-11#3)(1996-12#1)(1996-2#3)(1996-4#4)(1996-5#10)(1996-6#5)(1996-7#11)(1996-8#11)(1996-9#5)(1997-1#10)(1997-2#5)(1997-3#2)(1997-4#6)(1997-5#3)(1997-6#10)(1997-7#5)(1997-8#7)(2004-11#2)(2004-9#34)(2005-10#1)(2005-11#13)(2005-12#2)(2005-8#1)(2005-9#1)(2006-10#19)(2006-12#4)(2006-3#2)(2006-4#4)(2006-5#4)(2006-6#1)(2006-7#3)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#9)(2007-12#18)(2007-2#3)(2007-3#1)(2007-7#3)(2007-8#20)(2007-9#2)(2008-1#11)(2008-10#284)(2008-11#10)(2008-2#8)(2008-3#8)(2008-4#29)(2008-5#59)(2008-6#10)(2008-7#14)(2008-8#4)(2009-10#5)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#4)(2010-1#12)(2010-10#3)(2010-12#12)(2010-2#20)(2010-3#3)(2010-4#6)(2010-5#4)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#6)(2011-12#2)(2011-2#12)(2011-3#1)(2012-1#8)(2012-11#1)(2012-12#10)(2012-2#6)(2012-3#4)(2013-1#15)(2013-7#2)(2013-8#9)
phosphate)##8##1##(1990-10#1)(1991-12#2)(1991-9#1)(1996-7#1)(2008-10#2)(2008-5#1)
phosphate-activated glutaminase##3##2##(1990-7#1)(1997-1#1)(2007-12#1)
phosphate-based##4##1##(2005-11#1)(2008-1#1)(2008-2#1)(2008-4#1)
phosphate-binding##2##1##(1993-3#1)(2012-12#1)
phosphate-borate##2##1##(1992-12#1)(1996-5#1)
phosphate-buffered saline (PBS) at pH 7##2##6##(1994-8#1)(2010-12#1)
phosphate-buffered saline (PBS)##4##3##(1992-11#1)(1994-8#1)(2005-10#1)(2010-12#1)
phosphate-buffered saline##14##2##(1991-8#1)(1992-11#1)(1993-3#1)(1994-8#1)(1996-6#1)(2005-10#1)(2006-9#1)(2007-9#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)
phosphate-buffered##16##1##(1990-3#1)(1991-8#1)(1992-11#1)(1993-3#1)(1994-8#1)(1996-6#1)(2005-10#1)(2006-9#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)
phosphate-modified##3##1##(1995-1#2)(2005-11#1)
phosphate-solubilizing microbes##2##2##(2013-8#2)
phosphate-solubilizing##5##1##(2006-3#2)(2013-8#3)
phosphate/mol enzyme##2##2##(1990-3#1)(2008-5#1)
phosphate/mol of##2##2##(1996-5#1)(1997-7#1)
phosphate/mol##4##1##(1990-3#1)(1996-5#1)(1997-7#1)(2008-5#1)
phosphate/thiophosphate-protecting group##2##2##(2008-4#2)
phosphated##2##1##(2007-11#2)
phosphates and a##2##3##(1997-7#1)(2008-5#1)
phosphates and##11##2##(1994-2#1)(1995-8#1)(1997-7#1)(2007-5#1)(2008-10#2)(2008-4#1)(2008-5#1)(2011-12#1)(2012-1#1)(2013-1#1)
phosphates are##2##2##(1993-5#1)(1994-3#1)
phosphates at##2##2##(1993-6#2)
phosphates by##3##2##(2008-10#2)(2008-4#1)
phosphates formation##2##2##(1994-2#1)(1994-6#1)
phosphates in##16##2##(1990-9#1)(1992-6#1)(1993-6#2)(1994-11#1)(1995-5#1)(1996-2#1)(1996-6#1)(1996-8#1)(2008-10#5)(2008-4#1)(2008-7#1)
phosphates is##2##2##(1990-2#1)(1990-3#1)
phosphates of the##2##3##(1992-9#1)(1994-9#1)
phosphates to##2##2##(1994-12#1)(1994-2#1)
phosphates was##6##2##(1990-10#1)(1990-12#1)(1993-5#1)(1993-6#1)(1994-12#1)(2008-10#1)
phosphates were##3##2##(1993-6#1)(2008-5#1)(2012-2#1)
phosphates with##3##2##(2007-11#1)(2008-10#2)
phosphates##124##1##(1990-10#3)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#3)(1990-9#1)(1991-2#2)(1991-5#1)(1992-11#1)(1992-4#2)(1992-6#2)(1992-9#3)(1993-5#4)(1993-6#8)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#5)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-2#1)(1995-4#1)(1995-5#1)(1995-8#2)(1996-2#1)(1996-4#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-7#2)(2006-12#2)(2006-5#1)(2007-11#3)(2007-5#1)(2008-10#23)(2008-4#5)(2008-5#6)(2008-7#3)(2010-12#2)(2010-5#2)(2011-12#1)(2012-1#2)(2012-2#1)(2013-1#1)
phosphates)##4##1##(1992-4#1)(1994-9#3)
phosphatic##3##1##(1990-8#1)(1992-5#1)(2011-2#1)
phosphatidic acid (PA)##6##3##(1991-5#1)(1995-8#1)(1997-8#1)(2008-11#1)(2008-8#1)(2009-8#1)
phosphatidic acid and##3##3##(1991-7#2)(1992-6#1)
phosphatidic acid##34##2##(1990-12#1)(1990-4#1)(1990-8#1)(1991-10#4)(1991-5#1)(1991-7#3)(1992-6#1)(1994-3#9)(1994-5#1)(1994-6#1)(1995-8#1)(1997-1#1)(1997-6#1)(1997-8#1)(2005-11#2)(2008-11#1)(2008-8#1)(2009-8#1)(2011-1#2)
phosphatidic acids and##2##3##(1996-5#2)
phosphatidic acids##5##2##(1996-5#4)(2008-8#1)
phosphatidic##39##1##(1990-12#1)(1990-4#1)(1990-8#1)(1991-10#4)(1991-5#1)(1991-7#3)(1992-6#1)(1994-3#9)(1994-5#1)(1994-6#1)(1995-8#1)(1996-5#4)(1997-1#1)(1997-6#1)(1997-8#1)(2005-11#2)(2008-11#1)(2008-8#2)(2009-8#1)(2011-1#2)
phosphatidyl choline##2##2##(1996-2#1)(2012-1#1)
phosphatidyl ethanolamine##2##2##(2010-3#1)(2012-1#1)
phosphatidyl inositol##5##2##(1991-11#1)(1992-12#1)(1993-8#1)(1997-6#1)(2012-1#1)
phosphatidyl serine##4##2##(1991-8#1)(1992-12#1)(1997-6#1)(2006-10#1)
phosphatidyl##17##1##(1991-11#1)(1991-8#1)(1992-12#2)(1993-8#1)(1996-2#1)(1997-1#1)(1997-6#2)(2006-10#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-3#1)(2012-1#3)
phosphatidylbutanol##2##1##(1993-3#1)(1995-3#1)
phosphatidylcholine (PC) and##4##3##(1993-3#1)(1994-12#1)(1995-8#1)(2008-8#1)
phosphatidylcholine (PC) was##3##3##(1990-9#1)(1995-8#1)(2007-12#1)
phosphatidylcholine (PC)##28##2##(1990-11#1)(1990-5#2)(1990-9#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-12#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-12#2)(1995-8#2)(1996-5#2)(1997-1#1)(2006-10#3)(2007-12#1)(2008-10#1)(2008-8#1)(2012-12#1)(2012-2#1)
phosphatidylcholine (PtdCho)##3##2##(1991-2#1)(1995-5#1)(1996-4#1)
phosphatidylcholine (egg PC)##3##3##(1990-6#1)(1995-8#1)(1997-5#1)
phosphatidylcholine and cholesterol##2##3##(1990-2#1)(1991-4#1)
phosphatidylcholine and deoxycholate##2##3##(2012-1#2)
phosphatidylcholine and phosphatidylethanolamine molecular species composition of##2##7##(1990-2#2)
phosphatidylcholine and phosphatidylethanolamine molecular species##3##5##(1990-2#3)
phosphatidylcholine and phosphatidylethanolamine##9##3##(1990-2#5)(1991-9#1)(1992-8#1)(2005-8#1)(2007-11#1)
phosphatidylcholine and phosphatidylglycerol##2##3##(1991-2#1)(1992-4#1)
phosphatidylcholine and##21##2##(1990-11#1)(1990-2#6)(1990-7#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-4#1)(1992-8#1)(1994-6#1)(1994-8#1)(2005-8#1)(2006-2#1)(2006-8#1)(2007-11#1)(2012-1#2)
phosphatidylcholine bilayers##5##2##(1992-1#2)(1992-3#3)
phosphatidylcholine biosynthesis##2##2##(1994-10#1)(1995-3#1)
phosphatidylcholine breakdown##2##2##(1990-12#2)
phosphatidylcholine component##2##2##(1990-2#1)(1992-6#1)
phosphatidylcholine hydrolysis##3##2##(1991-5#1)(1992-11#1)(1996-5#1)
phosphatidylcholine hydroperoxide##4##2##(1992-11#1)(1996-3#2)(1996-5#1)
phosphatidylcholine in##7##2##(1992-2#1)(1992-9#1)(1995-8#1)(1996-2#1)(2008-10#3)
phosphatidylcholine liposomes##3##2##(1991-5#1)(1997-8#1)(2008-8#1)
phosphatidylcholine membranes##2##2##(1997-7#1)(2006-10#1)
phosphatidylcholine molecules##2##2##(1991-2#1)(1993-11#1)
phosphatidylcholine synthesis in##2##3##(1993-9#1)(1995-3#1)
phosphatidylcholine synthesis##7##2##(1993-9#1)(1995-3#6)
phosphatidylcholine to##3##2##(1991-12#1)(1992-8#1)(1997-1#1)
phosphatidylcholine vesicles##9##2##(1990-11#1)(1990-2#1)(1991-4#1)(1992-3#1)(1996-7#1)(1997-7#2)(2008-10#2)
phosphatidylcholine were##2##2##(1993-9#2)
phosphatidylcholine with##3##2##(1990-7#1)(1991-2#1)(1993-3#1)
phosphatidylcholine##183##1##(1990-10#2)(1990-11#5)(1990-12#2)(1990-2#9)(1990-3#1)(1990-4#4)(1990-5#4)(1990-6#1)(1990-7#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#6)(1991-4#5)(1991-5#4)(1991-7#1)(1991-9#3)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#2)(1993-11#5)(1993-3#5)(1993-6#1)(1993-8#2)(1993-9#3)(1994-10#2)(1994-11#2)(1994-12#3)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-3#7)(1995-5#2)(1995-6#1)(1995-8#5)(1996-1#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#5)(1996-7#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#1)(2004-11#1)(2005-8#1)(2006-10#8)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#11)(2008-5#1)(2008-7#1)(2008-8#5)(2009-12#1)(2010-4#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)
phosphatidylcholine)##2##1##(1990-6#1)(1995-10#1)
phosphatidylcholine-selective phospholipase C##2##3##(1997-2#2)
phosphatidylcholine-specific phospholipase##2##2##(1992-3#1)(1997-8#1)
phosphatidylcholine/phosphatidylserine vesicles##2##2##(1990-11#1)(1990-3#1)
phosphatidylcholines and##5##2##(1990-7#1)(1994-12#1)(1996-5#1)(1997-1#1)(1997-2#1)
phosphatidylcholines in the##2##3##(1990-7#1)(1991-2#1)
phosphatidylcholines in##3##2##(1990-7#2)(1991-2#1)
phosphatidylcholines with##2##2##(1990-7#1)(1996-5#1)
phosphatidylcholines##32##1##(1990-7#13)(1991-2#1)(1991-4#3)(1991-5#2)(1993-11#1)(1994-11#2)(1994-12#1)(1996-5#4)(1997-1#1)(1997-2#3)(2009-12#1)
phosphatidylethanol (PEt) in##2##3##(1990-9#1)(1991-5#1)
phosphatidylethanol (PEt)##4##2##(1990-9#1)(1991-2#1)(1991-5#1)(1996-8#1)
phosphatidylethanol formation##3##2##(1995-5#1)(1995-8#2)
phosphatidylethanol##9##1##(1990-9#1)(1991-2#1)(1991-5#1)(1994-3#1)(1995-5#1)(1995-8#2)(1996-4#1)(1996-8#1)
phosphatidylethanolamine (PE) and##2##3##(1995-8#1)(2005-12#1)
phosphatidylethanolamine (PE)##16##2##(1990-3#1)(1990-5#1)(1991-3#1)(1992-10#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-8#1)(1996-5#1)(2005-12#1)(2007-12#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#1)
phosphatidylethanolamine (PEG-PE)##2##2##(1994-12#1)(1996-1#1)
phosphatidylethanolamine (PtdEtn)##3##2##(1995-2#1)(1995-5#1)(1996-4#1)
phosphatidylethanolamine and phosphatidylcholine##2##3##(1990-5#1)(1993-9#1)
phosphatidylethanolamine and##8##2##(1990-4#1)(1990-5#1)(1990-7#2)(1993-9#1)(1994-5#1)(1997-7#1)(2012-2#1)
phosphatidylethanolamine in the##2##3##(1990-2#1)(1995-8#1)
phosphatidylethanolamine in##3##2##(1990-2#1)(1991-3#1)(1995-8#1)
phosphatidylethanolamine metabolism##2##2##(1992-4#2)
phosphatidylethanolamine##77##1##(1990-11#2)(1990-2#8)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#2)(1991-11#1)(1991-3#2)(1991-7#1)(1991-9#1)(1992-10#1)(1992-4#2)(1992-8#2)(1993-11#2)(1993-3#3)(1993-9#2)(1994-12#6)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-5#2)(1995-8#2)(1996-1#2)(1996-3#2)(1996-4#2)(1996-5#1)(1997-7#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-7#1)(2008-8#4)(2009-8#1)(2011-2#1)(2012-2#4)
phosphatidylethanolamine)##2##1##(1993-3#1)(1995-2#1)
phosphatidylethanolamines##2##1##(1990-4#1)(1993-3#1)
phosphatidylglycerol (PG)##5##2##(1993-3#1)(1993-9#1)(2005-12#1)(2008-8#1)(2012-2#1)
phosphatidylglycerol synthesis and##2##3##(1993-8#2)
phosphatidylglycerol vesicles##2##2##(1991-2#1)(1994-11#1)
phosphatidylglycerol##20##1##(1990-4#1)(1991-2#1)(1992-4#2)(1993-3#1)(1993-8#4)(1993-9#2)(1994-11#1)(1994-12#1)(1994-5#1)(1995-8#1)(2005-12#1)(2006-10#1)(2008-8#2)(2012-2#1)
phosphatidylinositol (PI) 3-kinase##2##3##(1993-6#1)(1994-5#1)
phosphatidylinositol (PI) hydrolysis##2##3##(1992-11#1)(1994-12#1)
phosphatidylinositol (PI) or##2##3##(1994-12#1)(1995-10#1)
phosphatidylinositol (PI) turnover##3##3##(1990-10#1)(1991-8#1)(1995-3#1)
phosphatidylinositol (PI)##21##2##(1990-10#1)(1990-11#1)(1990-3#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-6#1)(1993-6#2)(1994-12#2)(1994-5#1)(1995-10#1)(1995-3#1)(1996-5#1)(2008-4#1)(2009-8#1)(2012-2#1)
phosphatidylinositol 3##5##2##(1993-8#2)(1994-12#1)(2009-7#1)(2012-2#1)
phosphatidylinositol 3' kinase##3##3##(1990-11#1)(1996-2#2)
phosphatidylinositol 3'-kinase##5##2##(1992-10#2)(1996-5#2)(2011-2#1)
phosphatidylinositol 3- and 4-kinases##2##4##(1997-8#2)
phosphatidylinositol 3-kinase (PI 3-kinase)##3##4##(1994-11#1)(1995-8#1)(2008-11#1)
phosphatidylinositol 3-kinase (PI##4##3##(1994-11#1)(1995-8#1)(2008-11#1)(2008-7#1)
phosphatidylinositol 3-kinase (PI3K)##3##3##(2008-11#1)(2011-2#1)(2012-12#1)
phosphatidylinositol 3-kinase and##2##3##(2008-3#1)(2008-7#1)
phosphatidylinositol 3-kinase##32##2##(1992-12#3)(1993-6#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-3#1)(1995-6#4)(1995-8#1)(1996-5#2)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-3#3)(2008-7#3)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
phosphatidylinositol 4##20##2##(1990-11#2)(1990-3#1)(1990-9#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#3)(1992-8#1)(1993-3#1)(1993-6#1)(1993-8#2)(1995-10#1)(1995-5#1)(1997-1#1)(2008-7#1)(2008-8#1)
phosphatidylinositol 4-kinase##2##2##(1997-8#2)
phosphatidylinositol 4-phosphate and phosphatidylinositol 4##2##5##(1992-8#1)(1993-8#1)
phosphatidylinositol 4-phosphate##7##2##(1992-8#1)(1993-8#1)(1994-11#1)(1997-6#1)(1997-8#2)(2008-8#1)
phosphatidylinositol and##3##2##(1991-1#1)(1991-4#1)(1994-11#1)
phosphatidylinositol bisphosphate (PIP2)##2##3##(2008-8#2)
phosphatidylinositol degradation##3##2##(2008-11#3)
phosphatidylinositol in##3##2##(1991-7#1)(1991-8#1)(1993-9#1)
phosphatidylinositol kinase##3##2##(1997-8#3)
phosphatidylinositol level##2##2##(1993-6#1)(2008-8#1)
phosphatidylinositol liposomes##2##2##(1992-1#2)
phosphatidylinositol metabolism in##3##3##(1994-2#2)(1995-6#1)
phosphatidylinositol metabolism##4##2##(1994-2#2)(1995-6#2)
phosphatidylinositol on c-myc##2##3##(1992-1#2)
phosphatidylinositol pathway##3##2##(1994-2#1)(1994-6#1)(1995-2#1)
phosphatidylinositol turnover in##4##3##(1990-10#1)(1994-12#3)
phosphatidylinositol turnover##9##2##(1990-10#1)(1992-1#1)(1994-12#4)(1994-3#1)(1994-9#1)(1997-2#1)
phosphatidylinositol was##3##2##(1991-8#2)(1993-9#1)
phosphatidylinositol##183##1##(1990-10#2)(1990-11#4)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#3)(1991-1#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#3)(1991-7#3)(1991-8#8)(1992-1#6)(1992-10#3)(1992-11#1)(1992-12#8)(1992-6#2)(1992-7#1)(1992-8#3)(1993-11#1)(1993-3#1)(1993-6#6)(1993-8#5)(1993-9#3)(1994-11#4)(1994-12#11)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#4)(1994-9#1)(1995-10#3)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#6)(1995-8#1)(1996-2#4)(1996-5#6)(1997-1#1)(1997-2#1)(1997-6#2)(1997-7#1)(1997-8#10)(2006-10#1)(2007-11#2)(2008-1#1)(2008-11#6)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#7)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#3)
phosphatidylinositol-3 kinase##3##2##(1995-3#1)(2008-10#1)(2008-5#1)
phosphatidylinositol-3##5##1##(1995-3#1)(2008-10#1)(2008-3#2)(2008-5#1)
phosphatidylinositol-3-kinase##2##1##(2010-7#1)(2012-2#1)
phosphatidylinositol-4##4##1##(1991-1#1)(1993-6#1)(2009-6#1)(2013-1#1)
phosphatidylinositol-linked##2##1##(1990-9#1)(2008-4#1)
phosphatidylinositol-specific phospholipase C (PI-PLC)##2##4##(1993-8#1)(2008-4#1)
phosphatidylinositol-specific phospholipase C##8##3##(1990-9#1)(1991-7#1)(1992-3#1)(1993-8#2)(1993-9#1)(2008-4#1)(2008-8#1)
phosphatidylinositol-specific phospholipase C-alpha##3##3##(1991-7#3)
phosphatidylinositol-specific phospholipase##11##2##(1990-9#1)(1991-7#4)(1992-3#1)(1993-8#2)(1993-9#1)(2008-4#1)(2008-8#1)
phosphatidylinositol-specific##12##1##(1990-9#1)(1991-7#4)(1992-3#1)(1993-8#2)(1993-9#2)(2008-4#1)(2008-8#1)
phosphatidylinositols##5##1##(1992-4#3)(1993-8#1)(1996-5#1)
phosphatidylinostol 3-kinase##2##2##(1997-7#2)
phosphatidylserine (PS) and##2##3##(1990-9#1)(1995-10#1)
phosphatidylserine (PS)##15##2##(1990-11#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-4#1)(1992-10#1)(1992-12#1)(1995-10#1)(1995-8#1)(1996-5#1)(2008-1#1)(2008-11#2)(2009-8#1)(2011-1#1)
phosphatidylserine (PtdSer)##2##2##(1992-9#1)(1993-3#1)
phosphatidylserine and 1##4##3##(1990-10#2)(1993-3#2)
phosphatidylserine and diacylglycerol##2##3##(1990-11#1)(1990-9#1)
phosphatidylserine and##17##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-4#1)(1992-9#1)(1993-3#2)(1993-8#1)(1995-6#1)(2008-5#1)(2011-1#1)
phosphatidylserine asymmetry##2##2##(2008-8#2)
phosphatidylserine at the##3##3##(2003-11#1)(2008-11#1)(2008-8#1)
phosphatidylserine at##4##2##(1993-11#1)(2003-11#1)(2008-11#1)(2008-8#1)
phosphatidylserine bilayers##4##2##(1990-2#4)
phosphatidylserine exposure##2##2##(2008-8#2)
phosphatidylserine in the##4##3##(1990-8#1)(1991-4#1)(1991-9#1)(1994-8#1)
phosphatidylserine requirement of the##2##4##(1990-5#2)
phosphatidylserine requirement of##3##3##(1990-5#3)
phosphatidylserine vesicles##2##2##(1993-3#1)(1996-7#1)
phosphatidylserine##95##1##(1990-10#2)(1990-11#5)(1990-12#2)(1990-2#4)(1990-5#5)(1990-6#4)(1990-7#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-3#1)(1991-4#6)(1991-7#2)(1991-9#1)(1992-10#2)(1992-12#2)(1992-3#1)(1992-6#1)(1992-9#2)(1993-11#2)(1993-3#5)(1993-8#1)(1994-11#3)(1994-12#1)(1994-5#4)(1994-8#4)(1995-10#2)(1995-2#3)(1995-6#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-6#3)(2003-11#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-5#1)(2008-8#5)(2009-8#1)(2011-1#2)
phosphide##9##1##(2007-12#2)(2008-11#3)(2008-3#3)(2013-1#1)
phosphine concentrations##2##2##(2011-2#2)
phosphine fumigation at##2##3##(2011-2#2)
phosphine in##4##2##(1996-2#1)(2008-11#1)(2008-5#1)(2011-2#1)
phosphine ligand##2##2##(2008-5#1)(2010-5#1)
phosphine ligands##4##2##(1996-2#2)(2008-5#2)
phosphine oxide##3##2##(2008-10#3)
phosphine##44##1##(1990-10#1)(1990-8#2)(1996-2#4)(2006-4#1)(2008-10#6)(2008-11#5)(2008-5#7)(2008-8#1)(2009-3#2)(2009-7#1)(2010-5#6)(2011-2#8)
phosphine-catalyzed##2##1##(2009-7#2)
phosphinegold(I) thiolates##3##2##(2008-3#2)(2008-5#1)
phosphinegold(I)##4##1##(2008-3#3)(2008-5#1)
phosphines##5##1##(1996-2#1)(1997-7#1)(2008-5#1)(2008-8#1)(2010-5#1)
phosphinite- and phosphite-based##2##3##(2008-7#2)
phosphinomethanide##2##1##(2010-5#2)
phosphinothricin##4##1##(1991-7#1)(1997-1#1)(2006-12#2)
phosphite##16##1##(1991-9#1)(1996-2#1)(1996-5#1)(2008-10#8)(2008-4#5)
phosphitylating##2##1##(2008-4#2)
phosphitylation of##2##2##(2008-4#2)
phosphitylation##3##1##(2008-4#3)
phospho tyrosine phosphatases##2##3##(1992-8#2)
phospho##3##1##(1992-8#2)(1994-3#1)
phospho(enol)pyruvate (PEP)##2##2##(1995-3#1)(2008-4#1)
phospho-Spo0A##3##1##(1995-6#3)
phospho-p38##2##1##(2008-9#1)(2013-1#1)
phospho-species##2##1##(2010-12#2)
phospho-specific antibodies##3##2##(2008-1#1)(2008-4#1)(2010-12#1)
phospho-specific##4##1##(2008-1#1)(2008-4#1)(2010-12#1)(2013-1#1)
phosphoacceptor##7##1##(1990-12#1)(1990-7#1)(1992-11#1)(1992-6#1)(1996-11#3)
phosphoamino acid analysis##2##3##(1995-3#1)(1997-6#1)
phosphoamino acid##3##2##(1994-12#1)(1995-3#1)(1997-6#1)
phosphoamino##4##1##(1994-11#1)(1994-12#1)(1995-3#1)(1997-6#1)
phosphoantigens##2##1##(1994-3#1)(2010-7#1)
phosphocarrier protein##2##2##(1991-12#1)(1994-3#1)
phosphocellulose##9##1##(1990-3#1)(1991-1#1)(1991-8#1)(1992-12#1)(1994-12#1)(1995-8#1)(1996-11#1)(1997-1#1)(2008-9#1)
phosphocholine and choline##2##3##(1991-5#1)(1992-12#1)
phosphocholine cytidylyltransferase (CT)##2##3##(1994-5#1)(1995-3#1)
phosphocholine cytidylyltransferase##6##2##(1994-5#2)(1995-3#2)(1996-7#1)(1997-2#1)
phosphocholine##19##1##(1990-12#2)(1991-5#1)(1992-12#2)(1994-12#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#3)(1996-7#1)(1997-2#3)(2004-11#1)
phosphocitrate##3##1##(1990-8#3)
phosphocreatine and##2##2##(1993-4#1)(1994-2#1)
phosphocreatine##14##1##(1990-11#2)(1991-5#1)(1993-11#1)(1993-2#1)(1993-4#1)(1994-2#1)(1994-8#2)(1995-12#1)(2007-10#1)(2013-1#3)
phosphodiester (PDE)##2##2##(1992-4#1)(2008-8#1)
phosphodiester backbone is replaced by##2##5##(2008-4#2)
phosphodiester backbone##6##2##(1991-5#1)(1991-7#2)(1995-1#1)(2008-4#2)
phosphodiester bond formation##3##3##(1990-12#1)(1996-7#2)
phosphodiester bond scission##2##3##(1990-2#1)(1997-5#1)
phosphodiester bond##7##2##(1990-12#1)(1990-2#1)(1992-8#1)(1996-5#1)(1996-7#2)(1997-5#1)
phosphodiester bonds##3##2##(1996-8#1)(1997-5#2)
phosphodiester groups##4##2##(1991-5#1)(1993-8#1)(1997-5#1)(2006-12#1)
phosphodiester in##2##2##(1990-2#1)(1993-8#1)
phosphodiester linkage##2##2##(1996-8#1)(1997-2#1)
phosphodiester linkages##3##2##(1994-9#1)(1996-4#2)
phosphodiester##41##1##(1990-12#1)(1990-2#3)(1991-5#2)(1991-6#1)(1991-7#3)(1991-9#1)(1992-4#2)(1992-8#1)(1993-11#1)(1993-8#3)(1994-9#1)(1995-1#1)(1996-4#2)(1996-5#1)(1996-7#2)(1996-8#2)(1997-2#1)(1997-4#1)(1997-5#4)(2006-12#2)(2008-10#1)(2008-4#4)(2008-8#1)
phosphodiesterase (PDE IV)##2##3##(1993-7#1)(1996-6#1)
phosphodiesterase (PDE) of##2##3##(1990-2#1)(1992-6#1)
phosphodiesterase (PDE)##6##2##(1990-2#1)(1990-7#1)(1991-12#1)(1992-6#1)(2005-8#1)(2008-5#1)
phosphodiesterase 4##2##2##(1997-7#2)
phosphodiesterase IV inhibitor##2##3##(1995-1#1)(2004-12#1)
phosphodiesterase IV##4##2##(1995-1#1)(2004-12#1)(2008-3#2)
phosphodiesterase activity in##3##3##(1990-7#3)
phosphodiesterase activity##8##2##(1990-7#4)(1992-12#3)(1995-1#1)
phosphodiesterase and##2##2##(1990-7#1)(2007-8#1)
phosphodiesterase inhibition##4##2##(1997-2#1)(2007-8#3)
phosphodiesterase inhibitor##13##2##(1991-10#1)(1991-7#1)(1992-3#1)(1993-3#1)(1993-6#1)(1994-6#2)(1995-12#1)(1996-9#1)(1997-5#1)(2008-1#1)(2008-5#2)
phosphodiesterase inhibitors##4##2##(1991-8#1)(1993-6#1)(2005-8#1)(2007-8#1)
phosphodiesterase isozyme##5##2##(1993-6#2)(1997-2#3)
phosphodiesterase type IV##2##3##(2006-10#1)(2012-2#1)
phosphodiesterase type##5##2##(1997-7#1)(2006-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
phosphodiesterase was##2##2##(1994-8#1)(1997-2#1)
phosphodiesterase##104##1##(1990-11#1)(1990-2#3)(1990-5#2)(1990-7#8)(1991-10#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-7#3)(1991-8#1)(1992-12#9)(1992-3#4)(1992-6#2)(1993-3#1)(1993-6#7)(1993-7#1)(1994-12#1)(1994-6#2)(1994-8#2)(1995-1#3)(1995-11#1)(1995-12#1)(1995-6#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#8)(1997-5#1)(1997-7#6)(2004-12#1)(2005-8#4)(2006-10#1)(2007-11#1)(2007-8#6)(2008-1#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#1)(2009-2#1)(2010-10#2)(2011-2#1)(2012-2#1)
phosphodiesterase-5 inhibitors##2##2##(2009-10#1)(2010-6#1)
phosphodiesterase-5##3##1##(2008-11#1)(2009-10#1)(2010-6#1)
phosphodiesterases from##2##2##(1991-5#2)
phosphodiesterases##8##1##(1991-5#3)(1993-12#1)(1993-7#1)(2005-8#1)(2008-4#1)(2013-7#1)
phosphodiesters##4##1##(1990-2#1)(1991-9#1)(1993-11#2)
phosphoenolpyruvate (PEP)##4##2##(1990-4#1)(1995-1#1)(1995-5#1)(2008-6#1)
phosphoenolpyruvate by##2##2##(1992-11#1)(1994-5#1)
phosphoenolpyruvate carboxykinase (PEPCK) activity##2##4##(1993-3#1)(1994-3#1)
phosphoenolpyruvate carboxykinase (PEPCK) gene expression##2##5##(1994-8#1)(1995-6#1)
phosphoenolpyruvate carboxykinase (PEPCK)##7##3##(1992-3#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-6#1)(2010-11#1)
phosphoenolpyruvate carboxykinase gene##2##3##(1991-7#1)(1994-8#1)
phosphoenolpyruvate carboxykinase##20##2##(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#1)(1992-3#1)(1993-3#1)(1994-3#2)(1994-8#3)(1995-3#1)(1995-6#1)(1997-3#1)(2010-11#1)(2010-4#1)(2013-1#1)
phosphoenolpyruvate carboxykinases from##2##3##(1991-4#1)(1995-2#1)
phosphoenolpyruvate carboxykinases##6##2##(1991-4#3)(1995-2#3)
phosphoenolpyruvate carboxylase##8##2##(1990-4#1)(1993-12#2)(1995-2#2)(2006-12#2)(2008-7#1)
phosphoenolpyruvate##55##1##(1990-10#1)(1990-3#1)(1990-4#2)(1990-7#2)(1991-12#1)(1991-3#1)(1991-4#4)(1991-5#2)(1991-6#2)(1991-7#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-3#2)(1994-5#3)(1994-8#4)(1995-1#2)(1995-2#7)(1995-3#1)(1995-5#1)(1995-6#1)(1997-3#1)(2006-12#2)(2008-6#1)(2008-7#3)(2009-9#1)(2010-11#1)(2010-4#1)(2013-1#1)
phosphoenolpyruvate-dependent##2##1##(1990-5#1)(1995-1#1)
phosphoenzyme intermediate##3##2##(1994-10#1)(1994-8#1)(2008-4#1)
phosphoenzyme##17##1##(1990-11#3)(1990-5#3)(1992-11#1)(1994-10#1)(1994-8#2)(1995-1#1)(1995-6#1)(1996-9#4)(2008-4#1)
phosphoenzymes##3##1##(1990-11#3)
phosphoester##2##1##(1990-8#1)(1992-7#1)
phosphoethanolamine##7##1##(1990-7#2)(1991-4#1)(1992-4#1)(1996-1#1)(1997-5#2)
phosphofructokinase (PFK)##4##2##(1990-12#1)(1990-8#1)(1994-6#1)(1995-5#1)
phosphofructokinase at physiological concentration of enzyme##2##6##(1990-3#2)
phosphofructokinase##32##1##(1990-12#1)(1990-3#4)(1990-8#2)(1991-2#6)(1991-7#1)(1992-11#2)(1992-9#2)(1994-3#2)(1994-6#2)(1994-8#1)(1995-2#2)(1995-5#1)(1997-2#5)(2008-7#1)
phosphofructokinases##3##1##(1991-2#1)(1992-11#1)(1995-5#1)
phosphoglucomutase##3##1##(1992-4#3)
phosphoglucose isomerase##5##2##(1990-11#2)(1990-3#1)(1996-11#1)(2008-10#1)
phosphoglycan chains##3##2##(1994-9#3)
phosphoglycan##5##1##(1991-10#2)(1994-9#3)
phosphoglycerate kinase##9##2##(1990-5#2)(1991-2#3)(1992-1#1)(1995-8#1)(2008-5#2)
phosphoglycerate mutase##6##2##(1990-5#1)(1993-3#2)(2010-12#2)(2012-2#1)
phosphoglycerate##18##1##(1990-5#3)(1991-2#3)(1992-1#1)(1992-8#1)(1993-3#3)(1995-8#2)(2008-5#2)(2010-12#2)(2012-2#1)
phosphoglycerides##2##1##(1992-9#1)(1994-8#1)
phosphoglycolate##2##1##(1995-1#2)
phosphohistidine##2##1##(1995-8#2)
phosphohydrolase##5##1##(1994-3#1)(1996-5#1)(1997-7#1)(2004-11#1)(2008-5#1)
phosphoinositidase C beta##2##3##(1992-8#2)
phosphoinositidase C##10##2##(1991-7#2)(1992-4#1)(1992-8#6)(1993-8#1)
phosphoinositide (PI) hydrolysis##5##3##(1990-10#1)(1994-10#1)(1995-10#1)(1997-4#2)
phosphoinositide (PI)##9##2##(1990-10#1)(1990-11#1)(1993-11#1)(1994-10#1)(1994-9#1)(1995-10#1)(1997-4#2)(2009-6#1)
phosphoinositide 3-kinase complex##2##3##(1996-8#2)
phosphoinositide 3-kinase in##2##3##(1997-4#1)(2008-4#1)
phosphoinositide 3-kinase##6##2##(1996-2#1)(1996-8#3)(1997-4#1)(2008-4#1)
phosphoinositide breakdown in the##2##4##(1990-7#1)(1993-12#1)
phosphoinositide breakdown in##3##3##(1990-7#1)(1991-1#1)(1993-12#1)
phosphoinositide breakdown##6##2##(1990-7#1)(1991-1#1)(1993-12#3)(1996-12#1)
phosphoinositide cycle##2##2##(1991-6#1)(1994-8#1)
phosphoinositide hydrolysis in astrocytes##2##4##(1993-7#1)(1994-3#1)
phosphoinositide hydrolysis in##9##3##(1990-3#1)(1990-9#1)(1991-2#1)(1993-7#1)(1994-3#1)(1995-3#1)(1996-12#1)(1996-5#1)(1996-6#1)
phosphoinositide hydrolysis##39##2##(1990-2#4)(1990-3#2)(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#1)(1993-11#4)(1993-3#1)(1993-6#1)(1993-7#2)(1994-10#1)(1994-3#1)(1994-6#5)(1995-12#1)(1995-3#1)(1996-12#1)(1996-2#3)(1996-5#3)(1996-6#1)(1996-8#1)(1997-1#2)
phosphoinositide kinases##2##2##(1996-2#2)
phosphoinositide lipid##2##2##(1997-4#1)(2013-1#1)
phosphoinositide metabolism in##2##3##(1993-12#1)(1994-11#1)
phosphoinositide metabolism##11##2##(1992-4#1)(1993-12#6)(1993-7#1)(1994-11#1)(1994-12#2)
phosphoinositide signaling pathway##2##3##(1990-3#1)(2012-1#1)
phosphoinositide signaling##5##2##(1990-3#1)(1994-3#2)(2012-1#1)(2013-1#1)
phosphoinositide turnover and##2##3##(1991-12#1)(1992-12#1)
phosphoinositide turnover in##3##3##(1992-10#1)(1992-7#1)(1994-8#1)
phosphoinositide turnover system and##2##4##(1992-6#2)
phosphoinositide turnover system##3##3##(1992-6#3)
phosphoinositide turnover##12##2##(1990-9#1)(1991-12#1)(1992-10#1)(1992-12#1)(1992-6#3)(1992-7#1)(1993-11#1)(1994-8#1)(1995-6#1)(1996-6#1)
phosphoinositide##116##1##(1990-10#1)(1990-11#1)(1990-2#5)(1990-3#3)(1990-7#1)(1990-9#3)(1991-1#2)(1991-12#2)(1991-2#1)(1991-6#1)(1991-7#1)(1992-10#2)(1992-12#1)(1992-4#1)(1992-6#3)(1992-7#1)(1992-8#1)(1993-11#6)(1993-12#9)(1993-3#1)(1993-6#3)(1993-7#4)(1994-10#2)(1994-11#2)(1994-12#2)(1994-3#3)(1994-6#6)(1994-8#2)(1994-9#2)(1995-10#3)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#3)(1996-2#7)(1996-5#4)(1996-6#2)(1996-8#4)(1997-1#3)(1997-4#4)(2006-9#1)(2008-4#2)(2008-8#1)(2009-12#1)(2009-6#1)(2012-1#1)(2013-1#2)(2013-8#1)
phosphoinositide-specific phospholipase C##4##3##(1990-11#1)(1990-3#1)(1994-11#1)(1997-4#1)
phosphoinositide-specific phospholipase##5##2##(1990-11#1)(1990-3#1)(1992-12#1)(1994-11#1)(1997-4#1)
phosphoinositide-specific phospholipases C##2##3##(1995-5#1)(1997-4#1)
phosphoinositide-specific##8##1##(1990-11#2)(1990-3#1)(1992-12#1)(1994-11#1)(1995-5#1)(1997-4#2)
phosphoinositides at##2##2##(1992-12#1)(1993-6#1)
phosphoinositides in##2##2##(1991-12#1)(1994-11#1)
phosphoinositides##23##1##(1990-3#1)(1991-11#2)(1991-12#1)(1992-12#2)(1992-4#1)(1992-7#1)(1993-6#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-5#1)(1995-10#1)(1995-8#1)(1996-2#1)(1997-4#1)(2006-10#1)(2008-8#1)(2010-9#1)(2011-2#1)
phosphoinositol##5##1##(1991-5#1)(1994-12#1)(1994-6#1)(1996-5#1)(1997-7#1)
phosphokinase levels##4##2##(2005-12#1)(2008-1#1)(2008-5#1)(2011-2#1)
phosphokinase##27##1##(1990-11#8)(1994-4#1)(1995-12#1)(1996-6#1)(2005-12#1)(2005-7#1)(2006-10#2)(2007-2#2)(2008-1#2)(2008-12#1)(2008-5#1)(2010-12#1)(2011-2#2)(2013-1#3)
phospholamban and##2##2##(1993-3#1)(1994-3#1)
phospholamban##7##1##(1992-11#1)(1993-3#4)(1994-3#2)
phospholipase A activity##2##3##(1993-9#1)(1995-5#1)
phospholipase A##6##2##(1993-1#1)(1993-9#3)(1995-5#1)(2013-7#1)
phospholipase A(2) (PLA(2))##2##3##(2006-10#1)(2011-2#1)
phospholipase A(2) activity and##2##4##(2008-11#1)(2009-12#1)
phospholipase A(2) and##4##3##(2007-11#1)(2008-11#3)
phospholipase A(2)##12##2##(1996-5#2)(2006-10#1)(2007-11#1)(2008-11#6)(2009-12#1)(2011-2#1)
phospholipase A1##2##2##(1993-9#2)
phospholipase A2 (IC50##2##3##(1994-11#2)
phospholipase A2 (PLA2) is##2##4##(1992-11#1)(1993-6#1)
phospholipase A2 (PLA2)##15##3##(1990-11#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-11#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-6#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-8#1)(2011-2#1)(2012-2#1)
phospholipase A2 activation in rabbit platelets was investigated##2##8##(1994-3#1)(1995-11#1)
phospholipase A2 activation in rabbit platelets##3##6##(1994-3#1)(1995-11#2)
phospholipase A2 activation in##5##4##(1994-11#1)(1994-3#1)(1994-6#1)(1995-11#2)
phospholipase A2 activation##7##3##(1990-7#1)(1994-11#1)(1994-3#2)(1994-6#1)(1995-11#2)
phospholipase A2 activity and##2##4##(1994-2#1)(1995-4#1)
phospholipase A2 activity in##3##4##(1991-5#1)(1992-2#1)(1992-5#1)
phospholipase A2 activity##13##3##(1990-2#1)(1991-1#1)(1991-5#1)(1992-2#3)(1992-5#1)(1994-2#1)(1995-1#3)(1995-11#1)(1995-4#1)
phospholipase A2 and##8##3##(1990-3#1)(1990-4#1)(1993-9#1)(1994-12#1)(1996-2#2)(1997-1#1)(2012-2#1)
phospholipase A2 at##2##3##(1991-2#1)(1994-5#1)
phospholipase A2 by rabbit##2##4##(1991-2#1)(1994-2#1)
phospholipase A2 by##4##3##(1991-2#1)(1994-11#2)(1994-2#1)
phospholipase A2 can##2##3##(1990-4#1)(1997-6#1)
phospholipase A2 from##5##3##(1990-7#1)(1992-2#1)(1994-3#1)(2008-8#2)
phospholipase A2 in rheumatoid##2##4##(1992-4#1)(1995-4#1)
phospholipase A2 in##10##3##(1990-2#1)(1990-4#2)(1992-4#1)(1992-5#1)(1992-7#1)(1993-6#1)(1994-3#1)(1995-4#1)(2006-4#1)
phospholipase A2 mRNA##3##3##(1992-2#1)(1993-12#1)(1994-2#1)
phospholipase A2 to##2##3##(1990-2#1)(1995-11#1)
phospholipase A2 which##2##3##(1990-4#1)(1990-5#1)
phospholipase A2##144##2##(1990-11#2)(1990-2#4)(1990-3#3)(1990-4#7)(1990-5#1)(1990-7#2)(1990-8#2)(1991-1#4)(1991-12#1)(1991-2#7)(1991-5#2)(1991-7#1)(1991-8#1)(1992-11#2)(1992-2#7)(1992-4#1)(1992-5#5)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#3)(1993-12#2)(1993-6#4)(1993-9#1)(1994-11#13)(1994-12#2)(1994-2#5)(1994-3#6)(1994-5#5)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#6)(1995-11#6)(1995-12#2)(1995-4#2)(1995-6#1)(1995-7#1)(1995-8#2)(1996-2#3)(1996-5#1)(1996-8#2)(1997-1#2)(1997-6#2)(2006-4#1)(2006-8#2)(2008-8#3)(2011-12#1)(2011-2#2)(2012-2#2)(2013-8#1)
phospholipase A₂##2##2##(2013-1#2)
phospholipase C (PI-PLC)##4##3##(1993-8#1)(1994-11#1)(1995-8#1)(2008-4#1)
phospholipase C (PLC) and##2##4##(1992-11#1)(2011-2#1)
phospholipase C (PLC)##10##3##(1991-1#1)(1991-10#1)(1991-2#2)(1992-11#1)(1994-12#1)(1994-8#1)(1996-5#1)(2008-4#1)(2011-2#1)
phospholipase C activation and##2##4##(1990-10#1)(2008-8#1)
phospholipase C activation in##3##4##(1990-11#1)(1994-9#1)(1995-11#1)
phospholipase C activation##11##3##(1990-10#1)(1990-11#2)(1990-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#2)(2008-8#1)
phospholipase C activity in##4##4##(1990-11#2)(1994-12#1)(1995-5#1)
phospholipase C activity##12##3##(1990-11#2)(1990-3#1)(1991-7#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#2)(1995-5#2)(1995-8#1)
phospholipase C alpha##4##3##(1993-6#4)
phospholipase C and phospholipase D##2##5##(1992-11#1)(1997-6#1)
phospholipase C and##11##3##(1990-7#1)(1990-9#1)(1992-11#1)(1992-2#1)(1994-3#1)(1995-12#1)(1997-6#1)(2008-11#4)
phospholipase C at##2##3##(1993-3#1)(1994-11#1)
phospholipase C by##3##3##(1992-9#1)(1995-5#1)(1997-2#1)
phospholipase C gamma 1##3##4##(1994-12#2)(1994-9#1)
phospholipase C gamma##8##3##(1991-8#1)(1994-12#2)(1994-9#3)(1995-3#2)
phospholipase C in the##2##4##(1990-10#1)(2008-11#1)
phospholipase C in##6##3##(1990-10#1)(1990-9#1)(1991-9#1)(1992-4#1)(1994-11#1)(2008-11#1)
phospholipase C inhibitor U##2##4##(1994-11#1)(1995-5#1)
phospholipase C inhibitor##7##3##(1992-7#1)(1994-11#2)(1994-12#1)(1995-5#1)(1997-5#1)(2008-10#1)
phospholipase C is##2##3##(1990-10#1)(1995-2#1)
phospholipase C was##2##3##(1990-11#1)(1993-6#1)
phospholipase C with##2##3##(1993-8#1)(1994-12#1)
phospholipase C##140##2##(1990-10#4)(1990-11#6)(1990-12#1)(1990-3#5)(1990-5#1)(1990-7#3)(1990-8#1)(1990-9#5)(1991-1#2)(1991-10#1)(1991-2#4)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-7#2)(1992-9#1)(1993-3#2)(1993-6#9)(1993-8#3)(1993-9#1)(1994-11#7)(1994-12#12)(1994-3#2)(1994-8#2)(1994-9#4)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#6)(1995-6#1)(1995-8#5)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(2006-10#1)(2006-5#1)(2006-8#2)(2008-10#2)(2008-11#5)(2008-3#2)(2008-4#3)(2008-8#3)(2011-2#1)(2012-2#1)
phospholipase C-Ca2+ system through a receptor different from the 53-kDa ATP receptor##2##12##(1993-8#2)
phospholipase C-delta 1 (PLC-delta) to##2##5##(1992-12#2)
phospholipase C-delta 1##8##3##(1992-12#4)(1992-9#2)(1994-12#2)
phospholipase C-gamma (PLC-gamma)##2##3##(1995-3#1)(1997-7#1)
phospholipase C-gamma 1##7##3##(1990-11#1)(1993-3#1)(1995-3#1)(1995-6#3)(1997-4#1)
phospholipase C-gamma##12##2##(1990-11#1)(1991-2#1)(1993-3#1)(1994-6#1)(1995-3#3)(1995-6#3)(1997-4#1)(1997-7#1)
phospholipase C-linked agonists##2##3##(1992-5#2)
phospholipase C-mediated hydrolysis of##2##4##(1990-3#1)(1990-9#1)
phospholipase Cgamma and##2##3##(1996-5#2)
phospholipase Cgamma##4##2##(1996-5#3)(2008-10#1)
phospholipase D (PLD) activation##3##4##(1991-2#1)(1993-3#1)(1997-3#1)
phospholipase D (PLD) was##2##4##(1995-8#1)(1996-4#1)
phospholipase D (PLD)##12##3##(1990-7#1)(1990-9#1)(1991-2#2)(1993-3#1)(1995-3#1)(1995-8#1)(1996-4#1)(1996-5#1)(1997-3#1)(1997-8#1)(2011-2#1)
phospholipase D activation in rat##2##5##(1991-2#1)(1993-3#1)
phospholipase D activity##6##3##(1992-12#1)(1993-3#3)(1995-5#1)(1997-8#1)
phospholipase D from Streptomyces##3##4##(1994-3#1)(1996-7#2)
phospholipase D##48##2##(1990-7#3)(1990-9#2)(1991-10#1)(1991-2#4)(1991-6#1)(1992-11#1)(1992-12#2)(1993-3#8)(1994-3#1)(1995-3#2)(1995-5#2)(1995-8#2)(1996-4#2)(1996-5#3)(1996-6#1)(1996-7#3)(1996-9#2)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#2)(2010-9#1)(2011-2#1)
phospholipase activity and serotype distribution##2##5##(2008-5#2)
phospholipase activity and##4##3##(2008-5#3)(2009-2#1)
phospholipase activity##8##2##(1995-8#2)(2008-5#4)(2009-2#1)(2010-6#1)
phospholipase##417##1##(1990-10#4)(1990-11#9)(1990-12#1)(1990-2#4)(1990-3#9)(1990-4#7)(1990-5#2)(1990-7#9)(1990-8#3)(1990-9#8)(1991-1#7)(1991-10#2)(1991-12#1)(1991-2#16)(1991-5#2)(1991-6#1)(1991-7#6)(1991-8#3)(1991-9#3)(1992-1#2)(1992-11#7)(1992-12#6)(1992-2#8)(1992-3#2)(1992-4#2)(1992-5#7)(1992-7#4)(1992-8#2)(1992-9#5)(1993-1#1)(1993-11#3)(1993-12#2)(1993-3#11)(1993-6#13)(1993-8#5)(1993-9#7)(1994-11#20)(1994-12#16)(1994-2#6)(1994-3#13)(1994-5#5)(1994-6#3)(1994-8#3)(1994-9#5)(1995-1#6)(1995-11#7)(1995-12#3)(1995-2#3)(1995-3#7)(1995-4#2)(1995-5#10)(1995-6#5)(1995-7#1)(1995-8#11)(1996-2#5)(1996-4#2)(1996-5#10)(1996-6#2)(1996-7#3)(1996-8#2)(1996-9#2)(1997-1#4)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#2)(2005-7#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-8#4)(2007-11#1)(2007-7#2)(2008-10#3)(2008-11#11)(2008-3#2)(2008-4#3)(2008-5#5)(2008-8#6)(2009-12#1)(2009-2#1)(2010-6#1)(2010-9#1)(2011-12#2)(2011-2#6)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#1)
phospholipase-A2 activity##2##2##(1997-8#2)
phospholipase-C##2##1##(1993-6#1)(1996-8#1)
phospholipases A2 and C##2##4##(1991-8#1)(1994-11#1)
phospholipases A2 and##3##3##(1991-8#1)(1994-11#1)(1994-3#1)
phospholipases A2 from##2##3##(1994-3#2)
phospholipases A2##9##2##(1991-8#1)(1994-11#1)(1994-12#1)(1994-3#5)(2008-8#1)
phospholipases C and##2##3##(1990-9#1)(1991-5#1)
phospholipases C##7##2##(1990-5#1)(1990-9#1)(1991-5#1)(1994-6#1)(1995-5#1)(1996-7#1)(1997-4#1)
phospholipases and##2##2##(1995-8#1)(2008-1#1)
phospholipases##25##1##(1990-5#1)(1990-7#1)(1990-9#1)(1991-5#1)(1991-8#1)(1994-11#1)(1994-12#1)(1994-3#5)(1994-6#1)(1995-5#4)(1995-8#1)(1996-7#1)(1996-8#1)(1997-4#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-8#1)
phospholipid (PL)##5##2##(1990-5#1)(1991-2#1)(1993-8#1)(2007-8#1)(2008-7#1)
phospholipid N-methylation and sphingomyelin synthesis##2##5##(1994-12#2)
phospholipid N-methylation##3##2##(1994-12#3)
phospholipid analogs##2##2##(1992-11#1)(1992-5#1)
phospholipid anchor##2##2##(1992-3#1)(1993-3#1)
phospholipid and energy metabolism of##2##5##(2008-8#2)
phospholipid and protein##3##3##(1990-7#2)(1994-5#1)
phospholipid and##16##2##(1990-11#1)(1990-4#1)(1990-7#2)(1991-4#1)(1992-11#2)(1992-9#2)(1993-6#1)(1994-5#1)(1995-3#1)(1995-6#1)(1996-5#1)(2008-8#2)
phospholipid asymmetry in human##2##4##(1990-3#2)
phospholipid asymmetry##4##2##(1990-3#2)(1992-1#1)(1995-2#1)
phospholipid bilayer##9##2##(1990-12#1)(1991-5#1)(1991-7#1)(1992-3#1)(1993-9#1)(1995-8#1)(2006-10#2)(2007-12#1)
phospholipid bilayers##21##2##(1990-11#2)(1990-2#5)(1990-5#1)(1990-6#1)(1991-4#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#1)(2005-11#1)(2008-11#2)
phospholipid binding proteins##2##3##(1992-7#1)(1993-4#1)
phospholipid binding##5##2##(1990-2#1)(1990-5#1)(1992-7#1)(1993-4#1)(1994-12#1)
phospholipid bound##2##2##(1990-5#1)(1994-12#1)
phospholipid but##2##2##(1990-6#1)(1992-9#1)
phospholipid classes##2##2##(1991-9#1)(1992-10#1)
phospholipid component##3##2##(1990-5#1)(1992-9#1)(1995-8#1)
phospholipid components##3##2##(2004-8#1)(2005-8#1)(2012-2#1)
phospholipid composition of##6##3##(1990-2#1)(1991-1#1)(1994-12#1)(1995-8#1)(2008-8#1)(2012-2#1)
phospholipid composition##14##2##(1990-2#1)(1991-1#2)(1992-1#3)(1992-3#1)(1994-12#1)(1994-3#1)(1995-8#1)(2008-8#2)(2009-8#1)(2012-2#1)
phospholipid content of##2##3##(1991-12#1)(1991-9#1)
phospholipid content##6##2##(1991-12#1)(1991-9#1)(1995-5#2)(2008-5#1)(2008-8#1)
phospholipid did not##2##3##(1992-6#1)(1996-4#1)
phospholipid distribution##2##2##(1990-3#1)(1992-10#1)
phospholipid fatty acid##4##3##(1991-1#1)(1992-12#1)(1992-8#1)(1996-7#1)
phospholipid fatty acids##2##3##(1991-9#1)(1992-3#1)
phospholipid fatty##7##2##(1991-1#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1996-7#1)
phospholipid flip-flop in##3##3##(1994-5#3)
phospholipid flip-flop##5##2##(1994-5#5)
phospholipid hydrolysis##4##2##(1992-9#1)(1995-3#3)
phospholipid hydroperoxide glutathione peroxidase mRNA levels were##2##7##(1993-6#2)
phospholipid hydroperoxide glutathione peroxidase##7##4##(1993-6#3)(1995-5#1)(1997-6#2)(2009-10#1)
phospholipid hydroperoxide##8##2##(1993-6#3)(1995-5#1)(1997-6#2)(2008-7#1)(2009-10#1)
phospholipid in##6##2##(1991-2#2)(1992-6#1)(1994-10#1)(1996-7#1)(2004-11#1)
phospholipid is##3##2##(1990-5#1)(2006-10#1)(2008-7#1)
phospholipid liposomes##4##2##(1990-5#2)(1994-2#1)(1994-8#1)
phospholipid mediator##5##2##(1993-12#1)(1996-2#1)(2007-11#2)(2007-9#1)
phospholipid membrane##3##2##(1994-2#1)(1996-1#1)(2008-10#1)
phospholipid membranes and##2##3##(1997-4#2)
phospholipid membranes##13##2##(1990-2#2)(1990-3#1)(1991-2#1)(1992-1#1)(1994-11#1)(1995-8#1)(1997-4#3)(2004-11#1)(2008-9#2)
phospholipid messengers##2##2##(2006-10#2)
phospholipid metabolism as measured by an##2##6##(1994-11#1)(1994-6#1)
phospholipid metabolism in##3##3##(1991-5#1)(1996-9#1)(1997-5#1)
phospholipid metabolism##12##2##(1991-5#3)(1992-4#1)(1993-5#1)(1994-11#1)(1994-3#1)(1994-6#1)(1996-9#1)(1997-5#1)(2006-10#1)(2006-8#1)
phospholipid metabolites##2##2##(1990-7#1)(1992-4#1)
phospholipid mixture##3##2##(1990-12#1)(1992-6#1)(2005-11#1)
phospholipid mixtures##3##2##(1990-4#1)(1994-3#1)(1994-8#1)
phospholipid model membranes##2##3##(1991-2#1)(1997-2#1)
phospholipid model##3##2##(1991-2#1)(1991-8#1)(1997-2#1)
phospholipid molecules##6##2##(1990-5#1)(1993-4#1)(1993-8#1)(1994-2#1)(2005-11#1)(2008-9#1)
phospholipid monolayers##7##2##(1990-4#2)(1994-3#1)(1994-5#3)(1994-6#1)
phospholipid or##2##2##(1991-7#1)(1997-1#1)
phospholipid organization##2##2##(1991-5#1)(1992-1#1)
phospholipid precursor levels##2##3##(1990-5#2)
phospholipid precursor##3##2##(1990-5#3)
phospholipid precursors##3##2##(1990-5#1)(1991-1#1)(2011-2#1)
phospholipid probe##2##2##(1992-3#1)(1997-3#1)
phospholipid probes##2##2##(1991-7#2)
phospholipid signaling pathways##2##3##(2008-4#1)(2009-10#1)
phospholipid signaling##3##2##(2005-8#1)(2008-4#1)(2009-10#1)
phospholipid surface##4##2##(1990-12#1)(1991-2#1)(1994-8#2)
phospholipid synthesis##8##2##(1993-9#2)(1995-1#1)(1995-6#1)(1997-8#1)(2011-2#3)
phospholipid to##4##2##(1990-11#1)(1990-2#1)(1991-10#1)(2008-4#1)
phospholipid transfer protein##2##3##(1991-10#1)(1995-5#1)
phospholipid translocation in the endoplasmic reticulum##2##6##(1990-2#2)
phospholipid translocation in##3##3##(1990-2#2)(2011-1#1)
phospholipid translocation##4##2##(1990-2#2)(1994-5#1)(2011-1#1)
phospholipid turnover in##2##3##(1992-4#2)
phospholipid turnover##6##2##(1990-5#1)(1992-4#4)(2008-4#1)
phospholipid vesicles and##2##3##(1990-3#1)(1995-1#1)
phospholipid vesicles by##2##3##(1991-2#1)(1995-1#1)
phospholipid vesicles containing##2##3##(1992-12#1)(1995-10#1)
phospholipid vesicles has been##3##4##(1991-9#1)(1993-3#1)(1996-9#1)
phospholipid vesicles was studied by##2##5##(1992-3#1)(1994-2#1)
phospholipid vesicles##38##2##(1990-3#2)(1990-4#1)(1990-7#1)(1991-2#2)(1991-5#1)(1991-8#2)(1991-9#3)(1992-10#2)(1992-12#2)(1992-3#4)(1992-6#1)(1993-3#1)(1994-11#4)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#2)(1995-10#1)(1996-1#2)(1996-7#2)(1996-9#1)(1997-6#1)
phospholipid was##3##2##(1990-5#1)(1994-3#1)(2006-10#1)
phospholipid##427##1##(1990-10#1)(1990-11#8)(1990-12#3)(1990-2#16)(1990-3#9)(1990-4#9)(1990-5#23)(1990-6#5)(1990-7#7)(1990-9#2)(1991-1#4)(1991-10#5)(1991-11#1)(1991-12#1)(1991-2#9)(1991-4#2)(1991-5#10)(1991-7#7)(1991-8#3)(1991-9#7)(1992-1#8)(1992-10#4)(1992-11#5)(1992-12#3)(1992-2#1)(1992-3#12)(1992-4#6)(1992-5#2)(1992-6#7)(1992-7#1)(1992-8#1)(1992-9#10)(1993-10#1)(1993-11#5)(1993-12#1)(1993-3#3)(1993-4#3)(1993-5#1)(1993-6#4)(1993-8#6)(1993-9#5)(1994-10#1)(1994-11#7)(1994-12#10)(1994-2#6)(1994-3#6)(1994-5#19)(1994-6#2)(1994-8#6)(1994-9#2)(1995-1#4)(1995-10#2)(1995-11#1)(1995-2#2)(1995-3#5)(1995-5#5)(1995-6#4)(1995-8#8)(1996-1#4)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#4)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#3)(1997-8#1)(2004-11#3)(2004-8#1)(2005-11#4)(2005-7#1)(2005-8#2)(2006-10#14)(2006-8#2)(2007-11#2)(2007-12#1)(2007-8#5)(2007-9#1)(2008-10#1)(2008-11#4)(2008-4#3)(2008-5#4)(2008-7#6)(2008-8#5)(2008-9#6)(2009-10#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-3#2)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#8)(2012-12#2)(2012-2#2)(2013-1#2)
phospholipid)##2##1##(1994-5#1)(1996-7#1)
phospholipid-binding protein##4##2##(1993-6#1)(2008-9#2)(2009-10#1)
phospholipid-binding proteins##5##2##(1991-2#4)(1995-11#1)
phospholipid-binding##13##1##(1991-2#4)(1992-11#1)(1992-9#1)(1993-6#1)(1995-11#1)(2008-9#2)(2009-10#2)(2010-10#1)
phospholipid-cholesterol##2##1##(1995-10#1)(2007-12#1)
phospholipid-independent##5##1##(1992-9#1)(1993-8#1)(1994-3#1)(1994-5#2)
phospholipidic##4##1##(1992-3#1)(1994-5#1)(2007-8#1)(2008-10#1)
phospholipids (PL)##3##2##(2004-11#1)(2008-10#1)(2013-1#1)
phospholipids (PLs)##2##2##(1996-5#1)(2005-11#1)
phospholipids and a##2##3##(1993-11#1)(2005-11#1)
phospholipids and##33##2##(1990-2#2)(1990-5#1)(1990-7#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-8#2)(1993-11#1)(1993-3#2)(1993-6#1)(1993-9#2)(1994-12#1)(1995-1#1)(1996-11#1)(1996-5#1)(1996-7#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-8#1)(2007-11#2)(2008-7#1)(2009-7#1)(2010-10#1)(2010-2#1)(2011-2#1)(2013-7#1)
phospholipids at##2##2##(2005-11#1)(2008-10#1)
phospholipids by##3##2##(1995-8#1)(2008-4#1)(2011-2#1)
phospholipids can##2##2##(1995-1#1)(1995-6#1)
phospholipids containing##2##2##(1991-4#1)(2008-4#1)
phospholipids extracted##2##2##(1994-12#1)(2008-8#1)
phospholipids from##3##2##(1992-4#1)(1994-2#1)(2008-4#1)
phospholipids have been##2##3##(1991-1#1)(2008-10#1)
phospholipids in a##2##3##(1991-5#1)(2006-8#1)
phospholipids in biological##2##3##(1990-11#1)(1996-6#1)
phospholipids in the presence##2##4##(1990-11#1)(1994-5#1)
phospholipids in the##6##3##(1990-11#1)(1991-5#1)(1992-1#1)(1994-5#1)(2008-10#1)(2012-12#1)
phospholipids in##32##2##(1990-11#2)(1990-4#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-5#2)(1991-8#1)(1992-1#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-12#3)(1994-3#1)(1994-5#1)(1995-1#2)(1995-3#1)(1996-6#1)(1997-5#1)(2005-10#2)(2006-8#1)(2008-10#1)(2008-8#1)(2010-10#1)(2012-12#1)
phospholipids increased##2##2##(1991-2#1)(1993-9#1)
phospholipids is##6##2##(1990-6#1)(1991-1#1)(1991-9#1)(1994-12#1)(1994-3#1)(1995-8#1)
phospholipids may modulate##2##3##(1992-6#1)(1996-7#1)
phospholipids may##3##2##(1990-7#1)(1992-6#1)(1996-7#1)
phospholipids of##7##2##(1991-9#1)(1992-10#1)(2008-11#1)(2008-8#1)(2009-8#1)(2012-12#1)(2013-1#1)
phospholipids on##5##2##(1991-9#1)(1994-3#1)(1995-8#3)
phospholipids or##3##2##(1990-3#2)(2006-2#1)
phospholipids to##6##2##(1992-10#1)(1996-5#1)(1996-7#1)(2008-10#1)(2010-2#1)(2011-2#1)
phospholipids was observed##2##3##(1990-4#1)(2008-11#1)
phospholipids was##9##2##(1990-4#2)(1991-2#1)(1991-7#2)(1992-9#1)(1994-12#1)(1996-6#1)(2008-11#1)
phospholipids were##2##2##(1996-4#1)(2008-3#1)
phospholipids with a high phase transition temperature##3##7##(1995-5#3)
phospholipids with##8##2##(1990-6#1)(1993-11#1)(1994-12#1)(1994-9#1)(1995-5#3)(1996-5#1)
phospholipids##290##1##(1990-10#1)(1990-11#4)(1990-2#10)(1990-3#7)(1990-4#4)(1990-5#5)(1990-6#3)(1990-7#5)(1991-1#6)(1991-12#1)(1991-2#2)(1991-4#8)(1991-5#3)(1991-6#1)(1991-7#7)(1991-8#1)(1991-9#4)(1992-1#3)(1992-10#4)(1992-12#6)(1992-2#1)(1992-3#1)(1992-4#2)(1992-6#2)(1992-8#4)(1992-9#2)(1993-11#3)(1993-12#1)(1993-3#5)(1993-6#1)(1993-8#1)(1993-9#7)(1994-10#1)(1994-11#1)(1994-12#10)(1994-2#3)(1994-3#6)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#5)(1995-11#2)(1995-2#1)(1995-3#4)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#7)(1996-11#1)(1996-2#1)(1996-4#4)(1996-5#7)(1996-6#2)(1996-7#4)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#2)(1997-8#1)(2004-11#1)(2005-10#5)(2005-11#3)(2005-7#1)(2006-2#1)(2006-8#2)(2006-9#1)(2007-11#2)(2007-8#2)(2008-1#2)(2008-10#7)(2008-11#7)(2008-3#3)(2008-4#7)(2008-5#4)(2008-7#3)(2008-8#5)(2009-7#2)(2009-8#3)(2010-10#7)(2010-2#3)(2010-3#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
phospholipids)##2##1##(2007-8#1)(2008-8#1)
phosphomannose##2##1##(1990-5#1)(2008-5#1)
phosphomannosyl residues##2##2##(1990-7#2)
phosphomolybdate with##2##2##(2008-10#2)
phosphomolybdate##7##1##(2008-10#7)
phosphomolybdenum blue complex by##2##4##(2008-10#2)
phosphomolybdenum blue complex is##2##4##(2008-10#2)
phosphomolybdenum blue complex##5##3##(2008-10#5)
phosphomolybdenum blue##10##2##(2008-10#10)
phosphomolybdenum##11##1##(2008-10#11)
phosphomolybdic acid in##2##3##(2008-10#2)
phosphomolybdic acid##11##2##(2007-9#1)(2008-10#10)
phosphomolybdic##13##1##(2007-9#1)(2008-10#12)
phosphomonoester (PME)##2##2##(1992-4#1)(2008-8#1)
phosphomonoester group##2##2##(1992-10#1)(1993-8#1)
phosphomonoester##7##1##(1992-10#1)(1992-4#2)(1993-8#2)(2008-7#1)(2008-8#1)
phosphomutase##5##1##(1990-7#5)
phosphonate (DBBP)##3##2##(2008-10#3)
phosphonate cages##2##2##(2010-5#2)
phosphonate esters##4##2##(1991-2#1)(2008-10#2)(2008-4#1)
phosphonate phenyl ester##2##3##(1991-2#2)
phosphonate##38##1##(1991-2#6)(1992-5#3)(1992-6#2)(1994-5#1)(2005-7#1)(2007-12#1)(2008-10#13)(2008-3#3)(2008-4#3)(2008-5#2)(2010-5#2)(2011-12#1)
phosphonates##9##1##(1991-2#1)(1992-6#1)(2008-3#2)(2008-4#2)(2009-2#1)(2011-12#2)
phosphonic acid##7##2##(2008-10#7)
phosphonic acids in the##2##4##(1995-11#1)(2008-10#1)
phosphonic acids in##4##3##(1995-11#2)(1996-5#1)(2008-10#1)
phosphonic acids##9##2##(1995-11#5)(1996-5#2)(2008-10#2)
phosphonic group##2##2##(2008-10#2)
phosphonic##21##1##(1990-3#1)(1995-11#5)(1996-5#2)(2008-10#13)
phosphonoacetate and##2##2##(2008-4#2)
phosphonoacetate##4##1##(1992-4#1)(2008-4#3)
phosphonodifluoromethyl##2##1##(1994-6#1)(2007-11#1)
phosphonoformate##3##1##(1990-8#3)
phosphonomethyl##3##1##(1994-6#1)(2008-4#2)
phosphonopeptide##6##1##(1992-10#6)
phosphonopyruvate##2##1##(1990-7#2)
phosphonyl group##2##2##(1991-4#1)(2008-5#1)
phosphonyl##3##1##(1991-4#1)(1995-1#1)(2008-5#1)
phosphopeptide analysis##2##2##(1991-3#1)(1995-2#1)
phosphopeptide enrichment##2##2##(2007-8#1)(2012-12#1)
phosphopeptide fragments##2##2##(2007-8#2)
phosphopeptide mapping##5##2##(1990-11#1)(1993-11#1)(1993-8#1)(1995-10#1)(2008-4#1)
phosphopeptide maps##2##2##(1993-11#2)
phosphopeptide##31##1##(1990-11#6)(1991-3#1)(1991-7#2)(1992-10#4)(1992-6#1)(1993-11#3)(1993-8#1)(1994-9#1)(1995-10#1)(1995-2#1)(1996-2#1)(1996-5#1)(2007-8#4)(2008-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
phosphopeptides were##5##2##(1990-7#1)(1994-12#1)(1994-6#1)(1996-9#1)(2013-8#1)
phosphopeptides##32##1##(1990-3#1)(1990-7#1)(1991-3#2)(1991-8#1)(1993-11#2)(1994-12#1)(1994-6#2)(1995-12#1)(1995-6#1)(1996-2#4)(1996-5#1)(1996-9#2)(2009-6#1)(2010-7#2)(2011-1#1)(2012-12#2)(2013-8#7)
phosphophosducin##2##1##(1994-9#2)
phosphoprotein associated with##2##3##(1994-12#1)(1995-3#1)
phosphoprotein is##2##2##(2003-11#1)(2008-4#1)
phosphoprotein of Mr 32##2##4##(1991-10#2)
phosphoprotein of##3##2##(1991-10#2)(1995-11#1)
phosphoprotein phosphatase##2##2##(1996-5#1)(1997-6#1)
phosphoprotein pp58##2##2##(1991-7#2)
phosphoprotein substrates##2##2##(1991-9#1)(1994-9#1)
phosphoprotein that is##2##3##(1991-9#1)(2010-11#1)
phosphoprotein that##5##2##(1991-9#1)(1994-12#1)(1994-9#1)(2010-11#1)(2013-1#1)
phosphoprotein was identified##2##3##(1994-8#1)(1997-6#1)
phosphoprotein was##3##2##(1994-8#1)(1997-6#2)
phosphoprotein with##2##2##(1993-7#1)(1995-3#1)
phosphoprotein##51##1##(1990-11#1)(1990-2#1)(1990-7#2)(1991-10#2)(1991-12#1)(1991-7#3)(1991-9#3)(1992-12#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-7#2)(1993-8#1)(1994-12#3)(1994-5#1)(1994-8#2)(1994-9#4)(1995-11#1)(1995-3#3)(1995-8#1)(1996-2#1)(1996-5#2)(1997-6#5)(2003-11#1)(2008-2#1)(2008-4#2)(2010-11#1)(2012-3#1)(2013-1#1)
phosphoproteins and##3##2##(1994-5#1)(2007-10#1)(2008-8#1)
phosphoproteins from##2##2##(1994-11#1)(1995-3#1)
phosphoproteins in##2##2##(1990-11#1)(1990-12#1)
phosphoproteins involved##3##2##(1992-1#1)(2008-2#1)(2008-4#1)
phosphoproteins of##2##2##(2009-6#2)
phosphoproteins that##3##2##(1992-10#1)(1995-11#1)(1995-6#1)
phosphoproteins were##2##2##(1994-5#1)(1995-11#1)
phosphoproteins##34##1##(1990-10#1)(1990-11#3)(1990-12#2)(1992-1#1)(1992-10#1)(1994-11#2)(1994-5#2)(1994-8#1)(1995-11#3)(1995-3#2)(1995-6#1)(2007-10#1)(2008-1#1)(2008-2#2)(2008-4#3)(2008-7#1)(2008-8#2)(2009-6#2)(2010-9#2)(2011-2#1)
phosphoproteome##2##1##(2012-12#2)
phosphoproteomic##2##1##(2010-5#1)(2011-2#1)
phosphoproteomics##3##1##(2009-6#1)(2012-12#2)
phosphopyridoxylation##2##1##(1994-9#2)
phosphor molecule##2##2##(2008-10#2)
phosphor##17##1##(2007-12#1)(2008-10#6)(2008-3#3)(2008-4#1)(2011-1#1)(2013-8#5)
phosphoramidate linkages##2##2##(1996-4#1)(2006-12#1)
phosphoramidate##4##1##(1996-4#1)(2006-12#1)(2008-4#2)
phosphoramidates##5##1##(1996-4#2)(1997-3#1)(2007-11#1)(2008-4#1)
phosphoramidite and H-phosphonate##2##3##(2008-4#2)
phosphoramidite and##5##2##(2008-4#5)
phosphoramidite building blocks##4##3##(2008-4#3)(2009-3#1)
phosphoramidite chemistry##2##2##(2008-4#2)
phosphoramidite synthesis##2##2##(2008-4#2)
phosphoramidite that contains##2##3##(2008-4#2)
phosphoramidite##28##1##(2007-10#1)(2008-4#25)(2009-3#1)(2012-12#1)
phosphoramidites and their##2##3##(2008-4#2)
phosphoramidites and##4##2##(2008-4#4)
phosphoramidites are##3##2##(2008-4#3)
phosphoramidites for##2##2##(2008-4#2)
phosphoramidites in the##2##3##(2006-12#1)(2008-4#1)
phosphoramidites in##3##2##(2006-12#1)(2008-4#2)
phosphoramidites was##2##2##(2008-4#1)(2012-2#1)
phosphoramidites##30##1##(2005-11#1)(2006-12#3)(2008-4#25)(2012-2#1)
phosphoramidon were##2##2##(1991-1#1)(1995-1#1)
phosphoramidon##30##1##(1990-10#2)(1990-11#1)(1990-9#1)(1991-1#4)(1991-4#1)(1991-6#5)(1991-7#2)(1992-6#2)(1992-7#5)(1993-11#1)(1994-9#1)(1995-1#4)(1995-6#1)
phosphoramidon-sensitive endothelin##2##2##(1991-10#2)
phosphoramidon-sensitive metalloproteinase##2##2##(1991-6#1)(1992-6#1)
phosphoramidon-sensitive##8##1##(1990-10#1)(1991-1#1)(1991-10#2)(1991-4#1)(1991-6#2)(1992-6#1)
phosphorelay##3##1##(1997-4#2)(2011-1#1)
phosphorescence (RTP) emission##3##3##(2008-10#3)
phosphorescence (RTP)##11##2##(2007-8#1)(2008-10#10)
phosphorescence and optical detection of magnetic resonance##2##7##(1993-11#2)
phosphorescence and##5##2##(1991-7#1)(1993-11#2)(2008-10#1)(2008-3#1)
phosphorescence development##2##2##(2008-10#2)
phosphorescence emission##9##2##(2007-8#1)(2008-10#8)
phosphorescence enhancers##2##2##(2008-10#2)
phosphorescence in##3##2##(2008-10#1)(2008-3#2)
phosphorescence intensity##3##2##(2008-10#3)
phosphorescence lifetime of##2##3##(2008-10#2)
phosphorescence lifetime##3##2##(1995-1#1)(2008-10#2)
phosphorescence of the##2##3##(2008-10#1)(2008-3#1)
phosphorescence of##9##2##(2007-8#1)(2008-10#6)(2008-3#1)(2010-4#1)
phosphorescence quenching##2##2##(1992-12#1)(2008-10#1)
phosphorescence signal##2##2##(2007-8#1)(2008-10#1)
phosphorescence was##2##2##(2008-10#2)
phosphorescence##87##1##(1991-7#2)(1991-8#2)(1992-12#3)(1993-11#3)(1994-5#1)(1995-1#2)(2005-4#1)(2007-8#7)(2008-10#57)(2008-3#7)(2010-3#1)(2010-4#1)
phosphorescent emission##2##2##(2008-10#2)
phosphorescent##10##1##(2005-4#2)(2008-10#4)(2008-3#3)(2010-4#1)
phosphoribosyl transferase##5##2##(1992-8#1)(1995-4#1)(1997-3#1)(2008-7#1)(2010-12#1)
phosphoribosyl##6##1##(1992-8#2)(1995-4#1)(1997-3#1)(2008-7#1)(2010-12#1)
phosphoribosyltransferase##12##1##(1990-12#2)(1994-3#1)(1995-1#1)(1995-5#1)(1995-8#6)(1996-10#1)
phosphoribulokinase##2##1##(1992-12#1)(2009-10#1)
phosphoric acid (PA)##2##3##(2004-9#2)
phosphoric acid (pH 1##2##4##(1996-5#2)
phosphoric acid (pH##3##3##(1996-5#2)(2005-12#1)
phosphoric acid and##4##3##(1997-3#2)(2008-10#2)
phosphoric acid as##3##3##(2008-10#3)
phosphoric acid medium##5##3##(2008-10#5)
phosphoric acid##42##2##(1990-2#1)(1990-3#1)(1990-6#2)(1996-5#2)(1997-3#2)(2004-9#3)(2005-11#3)(2005-12#1)(2008-10#22)(2008-11#1)(2008-5#1)(2010-12#2)(2010-2#1)
phosphoric acid)##2##2##(2008-10#1)(2011-1#1)
phosphoric acids##3##2##(2005-11#2)(2008-10#1)
phosphoric##53##1##(1990-2#1)(1990-3#1)(1990-6#2)(1994-11#1)(1996-3#1)(1996-5#2)(1997-3#2)(2004-9#3)(2005-11#5)(2005-12#1)(2008-10#27)(2008-11#1)(2008-5#2)(2010-12#2)(2010-2#1)(2011-1#1)
phosphorimetric determination of##2##3##(2005-4#1)(2008-10#1)
phosphorimetric method for the determination of##2##6##(2007-8#1)(2008-10#1)
phosphorimetric method##4##2##(2007-8#1)(2008-10#3)
phosphorimetric##9##1##(2005-4#1)(2007-8#1)(2008-10#7)
phosphorimetry##6##1##(2007-8#1)(2008-10#5)
phosphorodiesterase##2##1##(2005-8#2)
phosphorolysis of##3##2##(1994-8#2)(2005-11#1)
phosphorolysis##5##1##(1994-8#3)(1997-1#1)(2005-11#1)
phosphorothioate ODNs##2##2##(1994-12#2)
phosphorothioate antisense oligonucleotide##2##3##(2007-11#1)(2008-5#1)
phosphorothioate antisense##4##2##(1995-11#1)(1995-12#1)(2007-11#1)(2008-5#1)
phosphorothioate linkages##3##2##(2008-4#3)
phosphorothioate oligodeoxynucleotides##4##2##(1993-3#2)(1995-3#1)(2008-9#1)
phosphorothioate oligonucleotide##2##2##(1994-5#1)(2008-10#1)
phosphorothioate oligonucleotides##3##2##(1993-3#1)(2007-1#1)(2008-4#1)
phosphorothioate##37##1##(1990-11#1)(1990-12#1)(1991-5#1)(1991-9#2)(1993-3#3)(1994-12#2)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#3)(1996-7#1)(1996-8#1)(2005-11#1)(2007-1#2)(2007-11#1)(2008-10#1)(2008-4#10)(2008-5#2)(2008-9#2)
phosphorothioates##6##1##(1995-3#1)(1995-8#1)(2008-10#1)(2008-4#2)(2008-5#1)
phosphorous acid##2##2##(2008-10#1)(2011-2#1)
phosphorous and##2##2##(2008-10#1)(2008-12#1)
phosphorous in the##2##3##(2008-7#1)(2013-1#1)
phosphorous in##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
phosphorous##26##1##(2004-9#1)(2007-11#4)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
phosphors##4##1##(2005-4#1)(2008-10#1)(2010-5#2)
phosphorus (1##2##2##(1991-11#1)(2007-2#1)
phosphorus (P) in##3##3##(2008-10#2)(2008-5#1)
phosphorus (P)##11##2##(2008-10#4)(2008-5#1)(2011-1#3)(2012-2#1)(2013-8#2)
phosphorus acid##2##2##(2007-11#1)(2008-10#1)
phosphorus amount##2##2##(2008-10#2)
phosphorus and alkaline phosphatase##2##4##(2012-12#2)
phosphorus and calcium balance##2##4##(2008-4#2)
phosphorus and nitrate##3##3##(2007-6#1)(2008-12#2)
phosphorus and nitrogen##2##3##(2008-12#2)
phosphorus and potassium##2##3##(2008-11#1)(2008-12#1)
phosphorus and##24##2##(1991-7#2)(1997-5#1)(2004-9#1)(2007-6#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#5)(2008-4#2)(2008-6#4)(2011-12#1)(2012-12#2)(2013-8#1)
phosphorus availability##3##2##(2007-3#1)(2008-5#1)(2011-10#1)
phosphorus by spectrophotometry##2##3##(2008-10#2)
phosphorus by##7##2##(1997-6#1)(2008-10#5)(2008-9#1)
phosphorus chemical shift tensor##2##4##(1997-7#2)
phosphorus compounds in##2##3##(2008-10#2)
phosphorus compounds##6##2##(1993-4#1)(1994-11#1)(2008-10#4)
phosphorus concentration##3##2##(2005-7#1)(2008-12#1)(2013-1#1)
phosphorus concentrations##4##2##(2005-7#1)(2007-5#1)(2008-10#1)(2008-12#1)
phosphorus content in##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
phosphorus content of##2##3##(2008-10#1)(2013-8#1)
phosphorus content was##3##3##(2013-8#3)
phosphorus content##9##2##(2008-10#3)(2013-1#1)(2013-8#5)
phosphorus contents##4##2##(2008-10#1)(2013-8#3)
phosphorus deficiency##2##2##(2008-10#1)(2013-8#1)
phosphorus determination by##2##3##(2008-10#2)
phosphorus diets##5##2##(2008-4#5)
phosphorus for##2##2##(1995-11#1)(2008-4#1)
phosphorus had##2##2##(2008-10#1)(2013-8#1)
phosphorus homeostasis and##2##3##(2008-10#1)(2009-8#1)
phosphorus homeostasis##3##2##(2008-10#1)(2008-4#1)(2009-8#1)
phosphorus in environmental##2##3##(2007-8#1)(2008-10#1)
phosphorus in soil##5##3##(2007-8#1)(2008-10#4)
phosphorus in soils##2##3##(2008-10#2)
phosphorus in the natural environment##2##5##(2008-10#2)
phosphorus in the##3##3##(2008-10#2)(2013-8#1)
phosphorus in##26##2##(2007-8#3)(2008-10#17)(2008-11#1)(2008-9#1)(2009-7#1)(2013-1#1)(2013-8#2)
phosphorus is##8##2##(1993-8#1)(2004-9#1)(2006-4#1)(2008-10#5)
phosphorus levels##3##2##(2008-3#2)(2009-6#1)
phosphorus magnetic resonance spectroscopy and##2##5##(1994-12#1)(2008-7#1)
phosphorus magnetic resonance spectroscopy##3##4##(1994-12#1)(2007-10#1)(2008-7#1)
phosphorus moiety##2##2##(1991-2#1)(2008-4#1)
phosphorus occurs##2##2##(1992-6#1)(2008-10#1)
phosphorus ratio##2##2##(2008-9#2)
phosphorus ratios should have several trophic levels simultaneously##2##8##(2008-9#2)
phosphorus release##2##2##(2007-6#2)
phosphorus removal##5##2##(2007-6#1)(2009-6#1)(2013-1#3)
phosphorus speciation##2##2##(2008-10#2)
phosphorus species in##4##3##(2008-10#4)
phosphorus species is##2##3##(2008-10#2)
phosphorus species##9##2##(2008-10#9)
phosphorus to##2##2##(1996-2#1)(2013-1#1)
phosphorus was##5##2##(1991-2#1)(1994-2#1)(2004-9#1)(2008-4#1)(2008-5#1)
phosphorus were##5##2##(2008-6#1)(2009-4#2)(2013-1#1)(2013-8#1)
phosphorus with##2##2##(2008-10#2)
phosphorus##309##1##(1990-10#1)(1990-2#1)(1990-5#1)(1991-11#2)(1991-2#3)(1991-7#3)(1992-2#1)(1992-6#3)(1992-9#2)(1993-4#1)(1993-6#1)(1993-8#2)(1994-11#3)(1994-12#1)(1994-2#3)(1994-9#1)(1995-11#2)(1995-12#1)(1995-9#1)(1996-2#1)(1996-5#1)(1997-5#2)(1997-6#2)(1997-7#5)(2004-9#4)(2005-7#3)(2006-10#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#7)(2007-7#1)(2007-8#8)(2007-9#2)(2008-1#1)(2008-10#104)(2008-11#3)(2008-12#10)(2008-3#4)(2008-4#20)(2008-5#6)(2008-6#5)(2008-7#1)(2008-8#2)(2008-9#8)(2009-12#1)(2009-4#2)(2009-6#2)(2009-7#1)(2009-8#1)(2010-4#3)(2010-5#1)(2011-1#3)(2011-10#2)(2011-12#3)(2011-2#1)(2012-12#5)(2012-2#3)(2013-1#10)(2013-8#28)
phosphorus-centered##2##1##(2007-11#2)
phosphorus-containing molecules##2##2##(1995-11#1)(2008-11#1)
phosphorus-containing##7##1##(1992-5#1)(1995-11#1)(2004-9#1)(2008-10#2)(2008-11#1)(2010-7#1)
phosphorus-doped silica fiber##2##3##(2007-12#2)
phosphoryl groups##3##2##(1992-4#1)(1994-3#1)(2008-10#1)
phosphoryl metabolism##2##2##(1995-6#1)(1996-5#1)
phosphoryl transfer and##2##3##(1990-5#1)(1995-2#1)
phosphoryl transfer by##2##3##(1996-5#2)
phosphoryl transfer in##2##3##(1990-5#1)(1996-5#1)
phosphoryl transfer##17##2##(1990-5#6)(1994-9#1)(1995-2#1)(1995-3#5)(1996-5#4)
phosphoryl##33##1##(1990-5#7)(1990-8#1)(1991-4#1)(1991-7#2)(1992-4#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-3#5)(1995-6#1)(1996-5#7)(1996-6#3)(2008-10#1)(2008-5#1)
phosphorylase (TP)##2##2##(2008-1#1)(2008-7#1)
phosphorylase a##3##2##(1994-11#1)(1994-12#2)
phosphorylase activity##3##2##(1990-10#1)(1992-5#1)(1994-6#1)
phosphorylase and##7##2##(1991-1#2)(1992-7#1)(1993-12#1)(1995-1#1)(1996-5#1)(2008-7#1)
phosphorylase b by##3##3##(1991-11#1)(1994-12#1)(1995-3#1)
phosphorylase b##13##2##(1990-8#2)(1991-1#1)(1991-11#1)(1993-1#1)(1994-12#4)(1995-3#4)
phosphorylase from##4##2##(1994-6#1)(1996-6#1)(1997-1#1)(2005-11#1)
phosphorylase in##3##2##(1990-10#1)(1994-12#1)(1995-11#1)
phosphorylase is##2##2##(1991-11#1)(1997-2#1)
phosphorylase kinase gamma-subunit##2##3##(1995-3#2)
phosphorylase kinase is##2##3##(1991-1#1)(1994-9#1)
phosphorylase kinase with IC50 values of##2##6##(1990-8#2)
phosphorylase kinase##19##2##(1990-8#5)(1991-1#4)(1991-10#1)(1994-9#2)(1995-3#3)(1997-7#4)
phosphorylase phosphatase##2##2##(1990-8#1)(1995-12#1)
phosphorylase was##3##2##(1990-10#2)(1994-6#1)
phosphorylase##102##1##(1990-10#4)(1990-8#8)(1991-1#9)(1991-10#1)(1991-11#8)(1991-12#2)(1992-1#1)(1992-5#3)(1992-7#1)(1993-1#1)(1993-12#2)(1994-11#1)(1994-12#8)(1994-6#4)(1994-8#2)(1994-9#2)(1995-1#3)(1995-11#1)(1995-12#1)(1995-3#7)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#4)(1997-1#2)(1997-2#4)(1997-7#4)(2005-11#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#2)(2008-7#3)(2008-9#1)(2010-4#2)(2012-1#1)(2012-3#1)
phosphorylatable sites##3##2##(1990-7#2)(1991-8#1)
phosphorylatable##5##1##(1990-3#1)(1990-7#2)(1991-8#1)(1992-6#1)
phosphorylate and##5##2##(1995-2#1)(1996-5#1)(2010-7#1)(2012-12#2)
phosphorylate tau##2##2##(1993-6#1)(1995-3#1)
phosphorylate the carboxyl-terminal##2##3##(1997-7#2)
phosphorylate the##9##2##(1990-3#1)(1991-10#1)(1993-11#1)(1996-2#1)(1997-7#2)(2010-9#1)(2011-2#2)
phosphorylate##49##1##(1990-3#1)(1990-9#1)(1991-10#1)(1991-2#2)(1991-4#2)(1992-1#1)(1992-2#1)(1992-6#1)(1993-11#2)(1993-2#1)(1993-5#1)(1993-6#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-11#4)(1996-2#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-7#5)(2007-12#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)
phosphorylated AKT##2##2##(2013-1#1)(2013-7#1)
phosphorylated NF##2##2##(1995-5#2)
phosphorylated R*##2##2##(1995-1#2)
phosphorylated Rh*##3##2##(1990-2#3)
phosphorylated STAT3##2##2##(2011-2#1)(2013-1#1)
phosphorylated Tyr-988##2##2##(1995-3#2)
phosphorylated anabolites##3##2##(2008-7#3)
phosphorylated and activated##3##3##(1993-12#1)(1996-5#1)(1997-6#1)
phosphorylated and dephosphorylated##6##3##(1990-8#2)(1996-5#2)(1997-2#2)
phosphorylated and is##2##3##(1994-8#1)(1996-5#1)
phosphorylated and nonphosphorylated##2##3##(1997-7#1)(2008-9#1)
phosphorylated and##25##2##(1990-5#2)(1990-7#1)(1990-8#2)(1991-1#1)(1991-2#1)(1992-3#1)(1993-12#1)(1994-11#1)(1994-8#1)(1994-9#1)(1996-5#4)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(2008-6#1)(2008-9#1)(2009-12#1)(2011-2#1)
phosphorylated at the##4##3##(1994-11#1)(1996-5#2)(1997-4#1)
phosphorylated at##14##2##(1990-11#1)(1990-7#1)(1994-11#2)(1994-3#1)(1994-9#1)(1995-3#1)(1996-5#2)(1997-4#1)(2008-7#1)(2010-12#1)(2010-8#1)(2013-1#1)
phosphorylated both##2##2##(1990-6#1)(1991-10#1)
phosphorylated by PKC##2##3##(1991-10#1)(1991-8#1)
phosphorylated by TPKI##2##3##(1995-12#2)
phosphorylated by a##2##3##(1990-7#1)(2009-8#1)
phosphorylated by both##3##3##(1990-4#1)(1991-7#1)(1995-6#1)
phosphorylated by protein kinase A##2##5##(1990-7#1)(1991-2#1)
phosphorylated by protein kinase C (PKC)##2##6##(1991-8#1)(1995-10#1)
phosphorylated by protein kinase C##8##5##(1990-3#2)(1991-8#1)(1992-11#1)(1993-6#2)(1994-9#1)(1995-10#1)
phosphorylated by protein kinase##10##4##(1990-3#2)(1990-7#1)(1991-2#1)(1991-8#1)(1992-11#1)(1993-6#2)(1994-9#1)(1995-10#1)
phosphorylated by protein##11##3##(1990-3#2)(1990-7#1)(1991-2#1)(1991-8#1)(1992-11#1)(1993-6#2)(1994-9#2)(1995-10#1)
phosphorylated by purified##3##3##(1994-9#1)(1997-6#1)(2010-11#1)
phosphorylated by the##4##3##(1990-8#1)(1992-7#1)(1993-12#1)(1997-6#1)
phosphorylated by##54##2##(1990-10#2)(1990-11#2)(1990-3#2)(1990-4#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-10#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-7#2)(1991-8#2)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-6#3)(1993-8#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-10#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-11#1)(1997-2#1)(1997-6#2)(2008-11#1)(2008-8#1)(2009-8#1)(2010-11#1)
phosphorylated compound##2##2##(1990-7#1)(1994-9#1)
phosphorylated compounds##2##2##(1990-2#1)(1993-11#1)
phosphorylated cytosolic##2##2##(1993-12#1)(2008-7#1)
phosphorylated during##3##2##(1994-9#2)(2011-2#1)
phosphorylated enzyme##3##2##(1990-8#1)(1991-4#1)(1995-1#1)
phosphorylated extracellular signal-regulated##2##3##(2012-3#1)(2013-1#1)
phosphorylated form of Rad21##2##4##(1995-3#2)
phosphorylated form of the##2##4##(1992-12#1)(1992-5#1)
phosphorylated form of##12##3##(1991-2#1)(1991-3#2)(1992-12#1)(1992-3#1)(1992-5#1)(1993-8#1)(1995-3#2)(1996-12#1)(1997-1#1)(2010-2#1)
phosphorylated form##16##2##(1991-2#1)(1991-3#2)(1991-6#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-8#1)(1995-2#1)(1995-3#2)(1996-12#1)(1997-1#1)(2007-8#1)(2008-5#1)(2010-2#1)
phosphorylated forms##4##2##(1991-2#1)(1995-2#1)(1997-2#1)(2012-3#1)
phosphorylated in a##2##3##(1994-9#1)(1995-6#1)
phosphorylated in cells##2##3##(1991-5#1)(1993-3#1)
phosphorylated in response to##2##4##(1994-12#1)(1996-2#1)
phosphorylated in response##3##3##(1994-12#1)(1996-2#1)(2008-6#1)
phosphorylated in the##6##3##(1990-7#3)(1994-9#1)(2008-5#1)(2009-6#1)
phosphorylated in vitro by casein kinase II##2##7##(1990-11#1)(1993-8#1)
phosphorylated in vitro by##7##4##(1990-11#2)(1992-7#1)(1993-8#1)(1994-6#1)(1995-2#1)(1997-2#1)
phosphorylated in vitro##12##3##(1990-11#3)(1992-7#2)(1993-11#1)(1993-8#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1997-2#1)
phosphorylated in vivo at##2##4##(1995-6#1)(1996-5#1)
phosphorylated in vivo##7##3##(1991-2#1)(1992-11#1)(1993-11#1)(1995-6#2)(1996-5#1)(1997-2#1)
phosphorylated in##48##2##(1990-11#3)(1990-3#1)(1990-7#3)(1991-12#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-3#1)(1992-7#2)(1993-11#3)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-6#2)(1994-8#2)(1994-9#3)(1995-2#2)(1995-6#3)(1995-8#1)(1996-10#1)(1996-2#1)(1996-5#1)(1997-2#3)(2008-5#1)(2008-6#1)(2008-8#2)(2009-6#1)(2012-3#1)
phosphorylated mainly at##2##3##(1991-9#1)(1995-3#1)
phosphorylated myosin##4##2##(1990-7#4)
phosphorylated neurofilament##2##2##(1992-3#1)(1996-9#1)
phosphorylated on Ser##2##3##(1996-2#1)(2008-9#1)
phosphorylated on Tyr##2##3##(1996-2#2)
phosphorylated on serine residues in##2##5##(1993-8#1)(1996-8#1)
phosphorylated on serine residues##3##4##(1991-5#1)(1993-8#1)(1996-8#1)
phosphorylated on serine##4##3##(1991-5#1)(1993-8#1)(1996-8#1)(2008-4#1)
phosphorylated on tyrosine residues in##2##5##(1995-12#1)(1995-8#1)
phosphorylated on tyrosine residues##4##4##(1991-5#1)(1995-12#1)(1995-8#1)(1996-2#1)
phosphorylated on tyrosine##6##3##(1991-5#1)(1994-12#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-5#1)
phosphorylated on##17##2##(1991-5#2)(1993-8#1)(1994-12#1)(1995-12#1)(1995-8#1)(1996-2#4)(1996-5#2)(1996-8#1)(1997-6#1)(2008-4#1)(2008-9#2)
phosphorylated or##2##2##(1992-12#1)(1997-2#1)
phosphorylated peptide##3##2##(2008-8#2)(2009-12#1)
phosphorylated peptides were##2##3##(2013-8#2)
phosphorylated peptides with the same amino acid sequence##2##8##(2013-8#2)
phosphorylated peptides##7##2##(2009-12#1)(2013-8#6)
phosphorylated peptides)##2##2##(2008-4#1)(2013-8#1)
phosphorylated protein was##3##3##(1990-7#1)(1991-1#2)
phosphorylated protein##12##2##(1990-7#1)(1990-9#2)(1991-1#3)(1992-2#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-12#1)
phosphorylated proteins in##2##3##(1991-1#1)(2008-5#1)
phosphorylated proteins were##2##3##(1991-10#1)(2012-12#1)
phosphorylated proteins##12##2##(1990-11#1)(1990-7#1)(1991-1#1)(1991-10#1)(1993-6#1)(1995-8#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-6#1)(2012-12#1)
phosphorylated residue##3##2##(1993-11#1)(1994-5#2)
phosphorylated residues##4##2##(1992-6#1)(1994-11#1)(1996-5#1)(2008-10#1)
phosphorylated rhodopsin##3##2##(1990-2#2)(1997-7#1)
phosphorylated sites of##2##3##(1991-3#1)(1994-11#1)
phosphorylated species##2##2##(2010-12#2)
phosphorylated state of##4##3##(1994-9#1)(1996-11#1)(1996-6#1)(2008-1#1)
phosphorylated state##7##2##(1990-7#1)(1994-9#1)(1995-2#1)(1996-11#1)(1996-6#1)(2008-1#1)(2008-4#1)
phosphorylated tau##2##2##(1996-8#1)(2008-3#1)
phosphorylated the##5##2##(1990-3#1)(1993-6#1)(1994-8#1)(1995-6#1)(1996-6#1)
phosphorylated to##8##2##(1990-12#1)(1991-7#1)(1994-3#3)(1994-8#1)(1995-6#1)(2009-5#1)
phosphorylated upon##3##2##(1990-5#1)(1994-6#1)(1995-6#1)
phosphorylated when##3##2##(1991-3#1)(1995-2#2)
phosphorylated with a##2##3##(1994-12#1)(2008-6#1)
phosphorylated with##4##2##(1994-12#1)(1996-2#1)(2007-11#1)(2008-6#1)
phosphorylated##427##1##(1990-10#3)(1990-11#7)(1990-12#1)(1990-2#8)(1990-3#6)(1990-4#1)(1990-5#6)(1990-6#2)(1990-7#17)(1990-8#7)(1990-9#2)(1991-1#5)(1991-10#8)(1991-12#3)(1991-2#8)(1991-3#6)(1991-4#3)(1991-5#4)(1991-6#1)(1991-7#4)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#3)(1992-12#5)(1992-2#1)(1992-3#7)(1992-4#1)(1992-5#2)(1992-6#4)(1992-7#3)(1993-11#6)(1993-12#4)(1993-3#3)(1993-5#1)(1993-6#7)(1993-7#1)(1993-8#8)(1994-10#1)(1994-11#7)(1994-12#6)(1994-2#3)(1994-3#4)(1994-5#4)(1994-6#6)(1994-8#12)(1994-9#21)(1995-1#6)(1995-10#1)(1995-12#4)(1995-2#10)(1995-3#8)(1995-5#4)(1995-6#12)(1995-8#3)(1996-1#1)(1996-10#2)(1996-11#3)(1996-12#2)(1996-2#10)(1996-5#12)(1996-6#2)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#8)(1997-4#2)(1997-6#6)(1997-7#6)(2005-8#1)(2006-12#2)(2007-11#3)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#6)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#7)(2008-9#8)(2009-12#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#7)
phosphorylates and inactivates##2##3##(1996-5#1)(1997-6#1)
phosphorylates and##3##2##(1993-6#1)(1996-5#1)(1997-6#1)
phosphorylates both##2##2##(1990-6#1)(1991-2#1)
phosphorylates c-Jun in vitro##2##4##(1995-2#2)
phosphorylates serine##2##2##(1994-6#1)(1995-3#1)
phosphorylates the##3##2##(1992-11#1)(1994-2#1)(1996-5#1)
phosphorylates##23##1##(1990-6#1)(1991-1#1)(1991-2#1)(1992-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-2#1)(1994-6#1)(1995-2#2)(1995-3#3)(1995-6#1)(1996-5#2)(1997-1#1)(1997-6#1)(2011-1#1)(2011-2#1)(2012-12#1)
phosphorylating activity##5##2##(1990-8#1)(1991-12#1)(1994-8#1)(1995-8#1)(2011-1#1)
phosphorylating protein##2##2##(1990-3#1)(1990-9#1)
phosphorylating systems##2##2##(1994-12#2)
phosphorylating the##3##2##(1990-8#1)(1993-11#1)(1993-12#1)
phosphorylating##32##1##(1990-3#1)(1990-8#2)(1990-9#1)(1991-12#5)(1991-4#2)(1992-6#1)(1993-11#1)(1993-12#2)(1994-12#3)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-3#2)(1995-8#1)(1996-10#1)(1997-6#1)(2008-4#2)(2008-8#1)(2011-1#1)
phosphorylation activity##2##2##(1990-3#1)(2008-2#1)
phosphorylation after##3##2##(1996-5#2)(2007-11#1)
phosphorylation and activation of ERK1 and ERK2##2##7##(1996-5#2)
phosphorylation and activation of the##4##5##(1993-6#1)(1994-12#1)(1996-5#1)(1997-7#1)
phosphorylation and activation of##17##4##(1992-8#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-9#1)(1995-3#3)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#4)(1997-7#1)
phosphorylation and activation##20##3##(1992-8#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-9#1)(1995-3#3)(1995-6#2)(1995-8#1)(1996-2#1)(1996-5#4)(1996-8#1)(1997-1#1)(1997-7#1)
phosphorylation and dephosphorylation reactions##2##4##(1994-9#1)(1996-9#1)
phosphorylation and dephosphorylation##7##3##(1990-4#1)(1991-10#1)(1991-9#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-9#1)
phosphorylation and is##2##3##(1994-3#1)(2012-3#1)
phosphorylation and nuclear exclusion of p53##2##6##(1993-9#2)
phosphorylation and nuclear##3##3##(1993-9#2)(1996-5#1)
phosphorylation and the##8##3##(1990-7#1)(1992-8#1)(1994-12#1)(1994-5#1)(1994-6#1)(1996-9#1)(2008-11#1)(2012-12#1)
phosphorylation and##94##2##(1990-10#1)(1990-4#1)(1990-5#1)(1990-7#2)(1991-10#1)(1991-11#1)(1991-3#2)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-7#1)(1992-8#2)(1993-6#3)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#4)(1994-3#2)(1994-5#2)(1994-6#8)(1994-8#2)(1994-9#2)(1995-10#2)(1995-3#5)(1995-5#1)(1995-6#4)(1995-8#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#9)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#1)(1997-7#2)(2006-10#1)(2008-1#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)
phosphorylation and/or##3##2##(1990-8#1)(1995-11#1)(2008-6#1)
phosphorylation appears##2##2##(1995-11#1)(1995-3#1)
phosphorylation are##4##2##(1991-11#1)(1991-2#1)(1992-7#1)(1996-2#1)
phosphorylation as well as##2##4##(1996-12#1)(2013-1#1)
phosphorylation as##6##2##(1992-11#1)(1994-9#1)(1995-6#1)(1996-12#1)(1997-1#1)(2013-1#1)
phosphorylation assays##3##2##(1991-10#1)(1995-5#1)(1996-8#1)
phosphorylation at a##2##3##(1996-5#1)(2008-8#1)
phosphorylation at##17##2##(1990-8#1)(1994-11#2)(1994-8#1)(1995-3#1)(1996-5#2)(1997-1#1)(2008-11#1)(2008-8#2)(2010-11#1)(2010-8#3)(2012-2#1)(2013-1#1)
phosphorylation but also##2##3##(1993-3#1)(2005-12#1)
phosphorylation but##6##2##(1993-3#1)(1995-10#1)(1996-12#1)(2005-12#1)(2008-2#1)(2008-4#1)
phosphorylation by a##3##3##(1991-12#1)(1996-6#1)(1997-4#1)
phosphorylation by one##2##3##(1990-8#1)(1996-5#1)
phosphorylation by protein kinase A##2##5##(1992-7#1)(1994-9#1)
phosphorylation by protein kinase C and##2##6##(1990-9#1)(1997-2#1)
phosphorylation by protein kinase C##7##5##(1990-11#1)(1990-9#2)(1992-7#1)(1993-6#1)(1994-9#1)(1997-2#1)
phosphorylation by protein kinase##9##4##(1990-11#1)(1990-9#2)(1992-7#2)(1993-6#1)(1994-9#2)(1997-2#1)
phosphorylation by protein kinases##2##4##(1990-8#1)(1995-6#1)
phosphorylation by protein##11##3##(1990-11#1)(1990-8#1)(1990-9#2)(1992-7#2)(1993-6#1)(1994-9#2)(1995-6#1)(1997-2#1)
phosphorylation by several##2##3##(1995-2#1)(1996-2#1)
phosphorylation by the##6##3##(1991-1#1)(1991-10#1)(1995-3#1)(1995-5#1)(1997-1#1)(1997-6#1)
phosphorylation by##56##2##(1990-10#1)(1990-11#2)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#1)(1991-10#2)(1991-12#1)(1991-3#1)(1991-7#1)(1992-7#2)(1992-8#1)(1993-12#1)(1993-4#1)(1993-6#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#4)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1996-2#3)(1996-5#3)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#2)(2005-8#1)(2010-10#2)(2012-12#1)
phosphorylation can##4##2##(1991-3#1)(2005-8#1)(2008-8#2)
phosphorylation capacity##4##2##(1993-8#2)(1994-9#1)(1996-5#1)
phosphorylation caused by##2##3##(1997-2#1)(1997-6#1)
phosphorylation could be##2##3##(1990-7#1)(1997-7#1)
phosphorylation coupled to electron##2##4##(1991-5#2)
phosphorylation dependent##2##2##(1991-12#1)(1994-12#1)
phosphorylation during the##3##3##(1990-9#1)(1993-6#1)(1995-3#1)
phosphorylation during##5##2##(1990-9#1)(1993-6#1)(1994-5#1)(1995-3#1)(1997-7#1)
phosphorylation event and##2##3##(1992-8#1)(1995-8#1)
phosphorylation event##4##2##(1992-8#2)(1995-8#1)(2008-8#1)
phosphorylation events are##2##3##(1991-5#1)(1994-11#1)
phosphorylation events##10##2##(1990-12#1)(1990-4#1)(1991-5#1)(1993-11#1)(1994-11#1)(1995-11#1)(1995-2#1)(2005-11#1)(2008-2#1)(2008-4#1)
phosphorylation experiments##2##2##(1992-8#1)(1995-5#1)
phosphorylation for##6##2##(1990-10#1)(1993-12#1)(1995-10#1)(1995-3#2)(1996-5#1)
phosphorylation from ATP##3##3##(1994-10#2)(1995-1#1)
phosphorylation from P(i)##2##3##(1994-10#2)
phosphorylation from##6##2##(1990-11#1)(1994-10#4)(1995-1#1)
phosphorylation has##2##2##(1991-2#1)(1995-7#1)
phosphorylation in HEK293 and COS-1 cells##2##6##(2008-8#2)
phosphorylation in HEK293##3##3##(2008-8#3)
phosphorylation in a##4##3##(1990-9#2)(1995-1#1)(1995-6#1)
phosphorylation in cells##2##3##(1995-3#1)(1997-1#1)
phosphorylation in intact cells##2##4##(1990-11#1)(1995-6#1)
phosphorylation in mouse##2##3##(1990-5#1)(1992-6#1)
phosphorylation in response to growth factors##3##6##(1991-5#1)(1993-3#1)(2011-2#1)
phosphorylation in response to##5##4##(1991-5#1)(1992-2#1)(1992-3#1)(1993-3#1)(2011-2#1)
phosphorylation in the##11##3##(1990-9#1)(1991-7#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-5#1)(1995-6#1)(1996-5#1)(2010-12#1)(2010-8#1)
phosphorylation in these events##2##4##(1990-3#1)(1996-4#1)
phosphorylation in vivo##2##3##(1990-7#1)(1991-12#1)
phosphorylation in##89##2##(1990-11#2)(1990-12#3)(1990-3#2)(1990-5#1)(1990-7#2)(1990-9#4)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#2)(1993-3#2)(1994-11#2)(1994-12#6)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#2)(1994-9#2)(1995-1#1)(1995-10#2)(1995-3#4)(1995-5#3)(1995-6#3)(1995-8#1)(1996-4#2)(1996-5#3)(1996-9#1)(1997-1#2)(1997-6#1)(1997-7#1)(2003-11#1)(2005-8#1)(2007-10#1)(2008-4#4)(2008-6#1)(2008-8#4)(2009-3#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#1)
phosphorylation induced by##5##3##(1990-3#1)(1990-9#1)(1991-12#1)(1996-5#1)(1997-6#1)
phosphorylation induced##6##2##(1990-3#1)(1990-9#1)(1991-12#1)(1992-8#1)(1996-5#1)(1997-6#1)
phosphorylation is an early##2##4##(1990-3#1)(1991-5#1)
phosphorylation is an important##2##4##(2011-1#1)(2013-8#1)
phosphorylation is an##4##3##(1990-3#1)(1991-5#1)(2011-1#1)(2013-8#1)
phosphorylation is highly##2##3##(1991-2#1)(2008-4#1)
phosphorylation is involved in the##2##5##(1994-2#1)(1995-12#1)
phosphorylation is involved in##3##4##(1993-8#1)(1994-2#1)(1995-12#1)
phosphorylation is##25##2##(1990-11#2)(1990-3#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-5#1)(1993-8#1)(1994-2#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-5#2)(1997-6#1)(2005-8#1)(2008-2#1)(2008-4#3)(2009-5#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
phosphorylation levels of##2##3##(1991-12#1)(2010-4#1)
phosphorylation may be##5##3##(1990-8#1)(1992-3#1)(1995-2#1)(1996-5#1)(1997-1#1)
phosphorylation may##8##2##(1990-8#1)(1992-3#1)(1992-9#1)(1993-11#1)(1994-9#1)(1995-2#1)(1996-5#1)(1997-1#1)
phosphorylation mechanisms##2##2##(1992-11#1)(1994-2#1)
phosphorylation occurred##2##2##(1991-5#1)(1993-11#1)
phosphorylation occurs in##2##3##(1991-7#1)(1994-11#1)
phosphorylation occurs##4##2##(1991-2#1)(1991-7#1)(1994-11#1)(1994-5#1)
phosphorylation of 14-3-3ζ at serine 58##2##6##(2010-12#2)
phosphorylation of ACC##2##3##(1991-12#1)(1996-5#1)
phosphorylation of CREB##2##3##(2008-11#2)
phosphorylation of CheY##3##3##(1994-8#3)
phosphorylation of GR##2##3##(1994-3#2)
phosphorylation of GST-Shc##3##3##(1997-6#3)
phosphorylation of HMG I##3##4##(1990-8#3)
phosphorylation of HSP 28##2##4##(1992-9#2)
phosphorylation of HSP28##2##3##(1992-9#1)(1994-8#1)
phosphorylation of IRS-1##2##3##(1995-8#1)(1997-7#1)
phosphorylation of IRS-I##4##3##(1997-1#4)
phosphorylation of MAP kinase##5##4##(1992-8#1)(1994-3#4)
phosphorylation of PKCalpha##2##3##(1996-5#2)
phosphorylation of PLC-gamma 1##5##4##(1990-11#1)(1992-7#2)(1993-3#1)(1995-6#1)
phosphorylation of PLC-gamma 2##2##4##(1994-6#2)
phosphorylation of PLC-gamma##9##3##(1990-11#1)(1991-2#2)(1992-7#2)(1993-3#1)(1994-6#2)(1995-6#1)
phosphorylation of SHC##4##3##(1995-3#3)(1996-5#1)
phosphorylation of Shc##5##3##(1994-12#1)(1995-8#1)(1997-6#1)(1997-7#2)
phosphorylation of Stat3##2##3##(1995-3#1)(2008-4#1)
phosphorylation of Tir at##2##4##(2011-2#2)
phosphorylation of Tyr in RHL1##2##5##(1994-12#2)
phosphorylation of a number of##3##5##(1991-3#1)(1992-3#1)(1994-12#1)
phosphorylation of a##24##3##(1990-10#1)(1990-12#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#4)(1991-5#1)(1991-8#2)(1991-9#2)(1992-3#1)(1992-7#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-8#2)(1996-5#1)(1997-7#1)(2009-5#1)
phosphorylation of alpha##2##3##(1990-11#2)
phosphorylation of an##3##3##(1990-10#1)(1991-10#1)(1993-12#1)
phosphorylation of both##4##3##(1995-3#1)(1995-6#2)(1997-4#1)
phosphorylation of calponin by protein kinase C was##2##8##(1990-9#1)(1994-9#1)
phosphorylation of calponin##3##3##(1990-9#1)(1994-9#2)
phosphorylation of cellular proteins##5##4##(1992-10#1)(1992-12#1)(1994-12#1)(1996-5#1)(2010-12#1)
phosphorylation of cellular##6##3##(1992-10#1)(1992-12#1)(1994-12#1)(1995-3#1)(1996-5#1)(2010-12#1)
phosphorylation of critical##2##3##(1996-4#1)(2008-4#1)
phosphorylation of eIF-2##4##3##(1991-7#1)(1994-5#2)(1994-6#1)
phosphorylation of endogenous substrates in##2##5##(1992-8#1)(1993-12#1)
phosphorylation of endogenous substrates##4##4##(1992-8#1)(1992-9#1)(1993-12#2)
phosphorylation of endogenous##7##3##(1990-4#1)(1992-8#1)(1992-9#1)(1993-12#3)(2008-8#1)
phosphorylation of epidermal##2##3##(1990-11#1)(2012-3#1)
phosphorylation of exogenous##2##3##(1991-11#1)(1997-6#1)
phosphorylation of histone##4##3##(1990-8#1)(1991-10#1)(1991-6#1)(2009-5#1)
phosphorylation of hsp 28##2##4##(1995-3#2)
phosphorylation of insulin receptor substrate-1##2##5##(1996-5#1)(1997-7#1)
phosphorylation of insulin receptor##4##4##(1994-12#1)(1994-2#1)(1996-5#1)(1997-7#1)
phosphorylation of isolated##3##3##(1990-8#1)(1992-5#2)
phosphorylation of mitogen-activated protein kinase##3##5##(1992-8#1)(1994-3#1)(1994-8#1)
phosphorylation of mitogen-activated protein##4##4##(1992-8#1)(1994-3#1)(1994-8#1)(2013-1#1)
phosphorylation of nuclear##2##3##(1990-3#1)(1992-8#1)
phosphorylation of p125FAK##4##3##(1994-9#4)
phosphorylation of p53##2##3##(1992-12#1)(1993-9#1)
phosphorylation of paxillin##7##3##(1994-9#1)(1996-5#4)(1997-7#2)
phosphorylation of phosphofructokinase##2##3##(1991-2#2)
phosphorylation of phospholipase C-gamma##3##4##(1991-2#1)(1994-6#1)(1995-6#1)
phosphorylation of phosphorylase##3##3##(1994-12#3)
phosphorylation of pp185 and receptor##2##5##(1995-3#2)
phosphorylation of pp64##4##3##(1990-3#4)
phosphorylation of procathepsin L##2##4##(1995-6#2)
phosphorylation of protein kinase Akt##2##5##(2011-1#2)
phosphorylation of protein kinase##4##4##(1992-9#1)(1993-9#1)(2011-1#2)
phosphorylation of proteins in##2##4##(1990-11#1)(1995-2#1)
phosphorylation of proteins##7##3##(1990-11#1)(1992-5#1)(1993-6#1)(1994-3#1)(1995-2#1)(1995-8#1)(2009-5#1)
phosphorylation of purified##2##3##(1993-3#1)(1997-6#1)
phosphorylation of rhodopsin##2##3##(1995-1#2)
phosphorylation of serine##3##3##(1991-12#1)(1991-3#1)(1994-11#1)
phosphorylation of several proteins##2##4##(1994-12#1)(1994-6#1)
phosphorylation of several##6##3##(1991-9#1)(1992-8#1)(1994-12#1)(1994-6#2)(1994-9#1)
phosphorylation of signal##2##3##(2009-3#1)(2011-1#1)
phosphorylation of specific##4##3##(1993-11#1)(1997-6#1)(2008-1#1)(2008-2#1)
phosphorylation of synaptic membranes isolated from##2##6##(1995-12#2)
phosphorylation of tau##4##3##(1995-10#1)(1995-12#2)(2003-11#1)
phosphorylation of the 20 kDa myosin light chain##2##8##(1990-11#1)(1991-3#1)
phosphorylation of the ATP synthase delta subunit##2##7##(2005-8#2)
phosphorylation of the EGFR##2##4##(1996-5#2)
phosphorylation of the IIA domain##2##5##(1995-1#2)
phosphorylation of the adapter protein SHC##2##6##(1996-5#2)
phosphorylation of the cytoplasmic domain##2##5##(1997-6#2)
phosphorylation of the endogenous##2##4##(1992-3#1)(1992-9#1)
phosphorylation of the enzyme##3##4##(1990-5#1)(1995-10#1)(1997-2#1)
phosphorylation of the insulin receptor##3##5##(1990-11#1)(1997-6#1)(2008-4#1)
phosphorylation of the postsynaptic protein kinase##2##6##(1997-2#2)
phosphorylation of the protein##2##4##(1994-8#1)(1996-2#1)
phosphorylation of the receptor##6##4##(1990-11#1)(1992-9#1)(1995-10#1)(1995-12#1)(1995-3#1)(1996-5#1)
phosphorylation of the retinoblastoma##2##4##(1996-2#1)(1997-1#1)
phosphorylation of the sarcoplasmic reticulum##2##5##(1996-9#2)
phosphorylation of the##108##3##(1990-10#1)(1990-11#5)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-11#3)(1992-3#3)(1992-5#1)(1992-6#1)(1992-9#2)(1993-4#1)(1993-6#2)(1994-11#1)(1994-12#2)(1994-3#1)(1994-8#4)(1994-9#2)(1995-1#3)(1995-10#2)(1995-12#1)(1995-2#2)(1995-3#10)(1995-6#2)(1996-2#5)(1996-5#5)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#4)(1997-6#5)(2005-8#4)(2008-4#4)(2008-8#1)(2008-9#1)(2009-6#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
phosphorylation of these proteins##3##4##(1993-8#1)(1994-9#1)(1995-3#1)
phosphorylation of these##9##3##(1992-11#1)(1993-8#2)(1994-9#1)(1995-3#2)(1997-2#1)(2008-8#1)(2012-12#1)
phosphorylation of this site##2##4##(1995-3#1)(1996-8#1)
phosphorylation of this##4##3##(1995-3#1)(1996-8#2)(1997-7#1)
phosphorylation of three##2##3##(1996-8#1)(2008-4#1)
phosphorylation of two##6##3##(1990-11#1)(1990-4#1)(1991-5#1)(1992-6#1)(1994-5#1)(2008-6#1)
phosphorylation of tyrosine-331##2##3##(1997-6#2)
phosphorylation of##534##2##(1990-10#4)(1990-11#12)(1990-12#4)(1990-2#2)(1990-3#9)(1990-4#4)(1990-5#4)(1990-6#1)(1990-7#4)(1990-8#10)(1990-9#2)(1991-1#3)(1991-10#3)(1991-11#2)(1991-12#4)(1991-2#9)(1991-3#9)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#4)(1991-8#6)(1991-9#8)(1992-10#2)(1992-11#5)(1992-12#2)(1992-3#6)(1992-5#5)(1992-6#5)(1992-7#4)(1992-8#8)(1992-9#8)(1993-1#1)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#4)(1993-4#1)(1993-6#5)(1993-8#9)(1993-9#2)(1994-11#4)(1994-12#22)(1994-2#1)(1994-3#9)(1994-5#5)(1994-6#6)(1994-8#18)(1994-9#19)(1995-1#5)(1995-10#4)(1995-12#8)(1995-2#8)(1995-3#36)(1995-6#14)(1995-8#4)(1996-2#8)(1996-4#1)(1996-5#23)(1996-6#1)(1996-7#1)(1996-8#6)(1996-9#2)(1997-1#6)(1997-2#12)(1997-4#1)(1997-6#18)(1997-7#16)(2003-11#2)(2005-11#1)(2005-8#4)(2006-10#3)(2007-10#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#10)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#2)(2009-3#3)(2009-5#4)(2009-6#2)(2010-1#1)(2010-12#5)(2011-1#7)(2011-2#12)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#1)
phosphorylation on the##4##3##(1991-10#1)(1995-7#1)(1997-2#1)(2008-4#1)
phosphorylation on tyrosine and threonine##2##5##(1995-3#1)(1996-2#1)
phosphorylation on tyrosine and##3##4##(1990-11#1)(1995-3#1)(1996-2#1)
phosphorylation on tyrosine##4##3##(1990-11#1)(1992-8#1)(1995-3#1)(1996-2#1)
phosphorylation on##22##2##(1990-11#1)(1991-1#1)(1991-10#2)(1991-2#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-9#1)(1995-3#4)(1995-7#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-1#1)
phosphorylation or##7##2##(1994-3#1)(1994-6#1)(1995-3#1)(1995-8#1)(2005-12#1)(2005-8#1)(2009-5#1)
phosphorylation pathway##2##2##(2008-3#1)(2013-8#1)
phosphorylation plays##2##2##(1992-8#1)(1994-8#1)
phosphorylation promotes##2##2##(2008-1#1)(2008-9#1)
phosphorylation rate with##2##3##(1990-12#2)
phosphorylation rate##4##2##(1990-12#2)(1991-10#1)(1994-12#1)
phosphorylation rates##3##2##(1992-3#1)(1993-3#1)(1995-6#1)
phosphorylation reaction is##2##3##(1993-3#1)(1994-9#1)
phosphorylation reaction##6##2##(1990-11#1)(1993-3#1)(1994-3#2)(1994-9#1)(1996-11#1)
phosphorylation regulates##2##2##(1994-9#1)(2012-3#1)
phosphorylation requires##2##2##(1997-2#1)(1997-7#1)
phosphorylation site in##3##3##(1995-2#1)(1995-3#1)(1996-8#1)
phosphorylation site of the##2##4##(1992-5#1)(1993-8#1)
phosphorylation site of##3##3##(1992-5#1)(1993-8#1)(1994-8#1)
phosphorylation site was##2##3##(1991-7#1)(2008-8#1)
phosphorylation site##27##2##(1990-10#1)(1990-12#1)(1991-2#1)(1991-3#1)(1991-7#2)(1992-5#1)(1993-8#2)(1994-11#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#5)(1995-3#1)(1996-5#1)(1996-8#3)(2008-12#1)(2008-8#1)(2010-12#1)
phosphorylation sites and##4##3##(1995-2#1)(2008-12#1)(2008-8#1)(2008-9#1)
phosphorylation sites are##4##3##(1993-8#1)(1995-10#1)(1997-9#1)(2008-8#1)
phosphorylation sites for casein kinase II##3##6##(1997-1#1)(1997-2#1)(1997-7#1)
phosphorylation sites for##6##3##(1990-6#1)(1994-3#1)(1994-9#1)(1997-1#1)(1997-2#1)(1997-7#1)
phosphorylation sites in##2##3##(1994-11#1)(1994-6#1)
phosphorylation sites of the##2##4##(1990-6#1)(1994-11#1)
phosphorylation sites of##4##3##(1990-6#1)(1994-11#1)(2008-8#2)
phosphorylation sites on##4##3##(1995-2#2)(2005-8#1)(2008-8#1)
phosphorylation sites were##3##3##(1994-12#1)(1995-10#1)(2009-6#1)
phosphorylation sites##56##2##(1990-6#2)(1991-2#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#4)(1995-10#4)(1995-12#2)(1995-2#3)(1995-3#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-9#1)(2005-8#1)(2008-12#5)(2008-5#1)(2008-8#9)(2008-9#2)(2009-6#1)(2010-11#1)(2010-8#1)
phosphorylation state and##4##3##(1991-9#2)(2008-1#1)(2008-2#1)
phosphorylation state of phosducin##3##4##(1994-9#3)
phosphorylation state of the##5##4##(1990-7#1)(1992-4#1)(1996-4#1)(1996-8#1)(1997-2#1)
phosphorylation state of##21##3##(1990-7#1)(1991-12#1)(1991-6#1)(1992-2#1)(1992-4#1)(1994-6#1)(1994-9#3)(1996-4#1)(1996-8#1)(1997-2#2)(1997-6#2)(2003-11#1)(2008-1#1)(2008-4#1)(2010-11#2)(2010-8#1)
phosphorylation state##28##2##(1990-7#1)(1991-12#1)(1991-6#1)(1991-9#3)(1992-2#1)(1992-4#1)(1994-6#1)(1994-9#3)(1996-4#1)(1996-8#2)(1997-2#2)(1997-6#2)(2003-11#1)(2008-1#2)(2008-2#1)(2008-4#1)(2010-11#2)(2010-8#1)(2012-12#1)
phosphorylation states of##2##3##(1994-12#1)(2009-3#1)
phosphorylation status of the##2##4##(1996-5#1)(2008-5#1)
phosphorylation status of##5##3##(1995-11#2)(1996-5#1)(2008-5#1)(2009-2#1)
phosphorylation status##7##2##(1990-8#1)(1995-11#2)(1996-5#1)(2008-5#1)(2009-2#1)(2010-11#1)
phosphorylation system##2##2##(1997-7#1)(2008-7#1)
phosphorylation targets of individual##2##4##(2008-2#2)
phosphorylation targets##4##2##(2008-2#2)(2012-12#2)
phosphorylation that##2##2##(1995-3#1)(1997-1#1)
phosphorylation to##5##2##(1990-11#1)(1994-8#1)(2009-8#1)(2009-9#1)(2011-1#1)
phosphorylation via##2##2##(1993-9#1)(1996-2#1)
phosphorylation was accompanied by a##2##5##(1993-12#1)(1996-5#1)
phosphorylation was also##2##3##(1994-12#1)(1995-6#1)
phosphorylation was inhibited by##2##4##(1990-10#1)(1992-7#1)
phosphorylation was not##3##3##(1992-9#1)(1997-1#1)(1997-2#1)
phosphorylation was observed in##2##4##(1991-12#1)(1995-6#1)
phosphorylation was observed only##2##4##(1992-9#1)(1997-2#1)
phosphorylation was observed##6##3##(1990-7#1)(1991-12#1)(1992-9#1)(1994-5#1)(1995-6#1)(1997-2#1)
phosphorylation was##35##2##(1990-10#1)(1990-11#2)(1990-7#3)(1991-12#1)(1991-5#1)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-3#1)(1995-6#2)(1996-5#4)(1997-1#1)(1997-2#2)(1997-7#2)(2010-12#1)(2012-3#1)
phosphorylation were detected##2##3##(1994-5#1)(2012-3#1)
phosphorylation were##12##2##(1992-11#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-7#1)(1997-6#1)(2008-5#1)(2012-3#1)
phosphorylation which is##2##3##(1991-8#1)(1996-2#1)
phosphorylation which##4##2##(1991-8#1)(1995-8#1)(1996-10#1)(1996-2#1)
phosphorylation with##4##2##(1990-11#1)(1990-12#1)(1993-11#1)(1995-3#1)
phosphorylation##1449##1##(1990-10#9)(1990-11#32)(1990-12#14)(1990-2#6)(1990-3#17)(1990-4#6)(1990-5#8)(1990-6#3)(1990-7#17)(1990-8#27)(1990-9#12)(1991-1#7)(1991-10#14)(1991-11#4)(1991-12#12)(1991-2#25)(1991-3#19)(1991-4#3)(1991-5#13)(1991-6#2)(1991-7#9)(1991-8#13)(1991-9#14)(1992-10#3)(1992-11#10)(1992-12#2)(1992-2#5)(1992-3#17)(1992-4#2)(1992-5#8)(1992-6#10)(1992-7#11)(1992-8#20)(1992-9#16)(1993-1#1)(1993-11#6)(1993-12#8)(1993-2#1)(1993-3#14)(1993-4#3)(1993-5#1)(1993-6#17)(1993-8#24)(1993-9#8)(1994-10#4)(1994-11#23)(1994-12#45)(1994-2#6)(1994-3#17)(1994-5#17)(1994-6#22)(1994-8#34)(1994-9#52)(1995-1#14)(1995-10#18)(1995-11#9)(1995-12#14)(1995-2#22)(1995-3#75)(1995-5#9)(1995-6#34)(1995-7#6)(1995-8#13)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#7)(1996-2#18)(1996-4#5)(1996-5#68)(1996-6#4)(1996-7#1)(1996-8#20)(1996-9#7)(1997-1#20)(1997-2#26)(1997-3#1)(1997-4#2)(1997-6#27)(1997-7#36)(1997-8#3)(1997-9#1)(2003-11#4)(2005-11#2)(2005-12#2)(2005-8#10)(2006-10#4)(2006-12#1)(2006-5#1)(2006-9#2)(2007-10#2)(2007-11#1)(2008-1#9)(2008-10#3)(2008-11#9)(2008-12#6)(2008-2#9)(2008-3#1)(2008-4#34)(2008-5#5)(2008-6#3)(2008-7#7)(2008-8#32)(2008-9#7)(2009-12#1)(2009-2#1)(2009-3#5)(2009-5#6)(2009-6#5)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#5)(2010-11#6)(2010-12#11)(2010-2#1)(2010-4#1)(2010-8#7)(2011-1#12)(2011-2#14)(2012-12#13)(2012-2#8)(2012-3#17)(2013-1#12)(2013-7#2)(2013-8#6)
phosphorylation-dependent antibodies##2##2##(1997-1#1)(2004-12#1)
phosphorylation-dependent inhibitory protein of protein phosphatase-1##2##6##(1997-6#2)
phosphorylation-dependent mechanism##2##2##(1991-1#1)(1996-8#1)
phosphorylation-dependent##13##1##(1991-1#1)(1993-8#1)(1994-2#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-6#2)(2004-12#1)(2008-4#1)
phosphorylation-dephosphorylation##4##1##(1992-11#1)(1994-3#1)(1995-6#1)(2008-1#1)
phosphorylation-independent##3##1##(1994-3#2)(1996-5#1)
phosphorylation-induced##2##1##(1995-6#2)
phosphorylation/dephosphorylation##5##1##(1992-8#1)(1996-4#1)(1997-4#1)(1997-6#1)(2013-1#1)
phosphorylations of##4##2##(1990-12#1)(2008-10#2)(2012-12#1)
phosphorylations##13##1##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#1)(1993-11#1)(1996-5#2)(2005-8#1)(2008-10#2)(2009-8#1)(2012-12#1)
phosphorylative##2##1##(1990-10#1)(1992-9#1)
phosphorylcholine##8##1##(1990-10#1)(1993-11#1)(1994-3#1)(2006-10#1)(2008-11#2)(2010-4#2)
phosphoserine residues##2##2##(1994-9#1)(2008-5#1)
phosphoserine was detected##2##3##(1990-7#1)(1991-7#1)
phosphoserine##10##1##(1990-7#1)(1991-4#1)(1991-7#1)(1994-11#1)(1994-9#1)(1996-8#2)(2008-5#2)(2012-2#1)
phosphoseryl##2##1##(1992-6#2)
phosphosilicate##4##1##(2007-12#4)
phosphosilicate-fiber##2##1##(2007-12#2)
phosphospecific antibody##2##2##(2010-12#1)(2010-3#1)
phosphospecific##3##1##(2008-1#1)(2010-12#1)(2010-3#1)
phosphothreonine containing peptide##2##3##(1994-9#2)
phosphothreonine##5##1##(1991-5#1)(1994-9#2)(1995-2#2)
phosphotransfer##13##1##(1995-3#6)(1996-12#1)(1996-5#2)(1997-4#3)(2009-8#1)
phosphotransferase gene##2##2##(2008-10#2)
phosphotransferase system (PTS)##2##3##(1995-1#1)(2008-7#1)
phosphotransferase system##7##2##(1990-10#1)(1990-5#1)(1991-10#1)(1991-12#1)(1995-1#1)(2007-6#1)(2008-7#1)
phosphotransferase##16##1##(1990-10#2)(1990-5#1)(1991-10#1)(1991-12#1)(1991-2#1)(1993-5#1)(1994-11#1)(1994-12#1)(1995-1#1)(1996-5#1)(1997-4#1)(2007-6#1)(2008-10#2)(2008-7#1)
phosphotriester##2##1##(1991-7#1)(2008-4#1)
phosphotriesterase##4##1##(1991-7#2)(1997-6#2)
phosphotriesters##3##1##(1991-7#1)(2008-4#2)
phosphotungstic acid##3##2##(2006-5#1)(2008-10#2)
phosphotyrosine content of##4##3##(1991-5#1)(1994-9#3)
phosphotyrosine in##4##2##(1992-10#1)(1992-8#1)(1994-6#1)(2005-7#1)
phosphotyrosine motifs##4##2##(1996-5#2)(1996-9#2)
phosphotyrosine phosphatase##4##2##(1992-12#1)(1993-8#1)(1994-6#1)(1994-9#1)
phosphotyrosine residues##2##2##(1993-6#1)(1996-9#1)
phosphotyrosine to##2##2##(2008-4#2)
phosphotyrosine##44##1##(1990-7#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-8#2)(1993-6#1)(1993-8#2)(1994-11#1)(1994-2#2)(1994-6#3)(1994-9#6)(1995-1#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-5#9)(1996-8#1)(1996-9#3)(1997-7#1)(2005-7#1)(2007-12#1)(2008-4#2)(2012-12#1)
phosphotyrosine-binding domain of Shc##2##4##(1997-6#2)
phosphotyrosine-binding##3##1##(1997-6#2)(2012-12#1)
phosphotyrosine-containing proteins##2##2##(1993-6#1)(1996-1#1)
phosphotyrosine-containing##3##1##(1993-6#1)(1995-2#1)(1996-1#1)
phosphotyrosine-dependent##2##1##(1992-8#1)(1995-6#1)
phosphotyrosine-specific##2##1##(1992-12#1)(1994-9#1)
phosphotyrosyl##7##1##(1990-7#2)(1994-5#2)(1994-6#1)(1997-4#1)(2006-12#1)
phosvitin at different pH values##2##5##(1994-11#2)
phosvitin##4##1##(1994-11#2)(1995-8#2)
photic information##4##2##(1994-2#1)(1997-5#2)(2008-5#1)
photic##10##1##(1993-2#1)(1994-2#3)(1997-3#1)(1997-5#2)(2006-1#1)(2008-5#1)(2008-7#1)
photo diode array##4##3##(2008-10#2)(2010-5#1)(2012-3#1)
photo identification system##2##3##(1993-12#1)(2009-4#1)
photo oxidation##2##2##(2008-5#2)
photo standard##5##2##(2008-5#5)
photo##28##1##(1990-3#1)(1991-2#1)(1993-12#1)(1995-2#1)(1996-6#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#7)(2008-6#1)(2008-8#1)(2009-4#1)(2010-5#1)(2012-12#2)(2012-3#1)
photo- and##2##2##(1994-2#1)(2009-8#1)
photo-##4##1##(1994-2#1)(2005-11#1)(2009-8#2)
photo-Fenton##2##1##(2008-10#2)
photo-Fenton's process##2##2##(2010-5#2)
photo-Fenton's##3##1##(2010-5#3)
photo-affinity##2##1##(1991-7#1)(1992-12#1)
photo-assisted electrochemical detection##2##3##(2008-10#2)
photo-crosslinked##4##1##(2012-11#4)
photo-crosslinking PCLTA on micro-fabricated silicon wafers with pre-designed concentric groove patterns##2##11##(2012-11#2)
photo-damaged##2##1##(1991-12#1)(2006-12#1)
photo-degradation product##3##2##(2008-5#3)
photo-electric##3##1##(2008-5#1)(2012-2#2)
photo-induced processes##2##2##(2006-12#2)
photo-induced toxicity of PAHs##3##4##(2004-4#3)
photo-induced toxicity of##4##3##(2004-4#4)
photo-induced toxicity##5##2##(2004-4#5)
photo-induced##15##1##(1992-8#1)(1994-5#3)(2004-4#5)(2006-12#3)(2008-1#1)(2008-11#1)(2012-2#1)
photo-oxidants##2##1##(1992-3#2)
photo-oxidation and##4##2##(2008-10#4)
photo-oxidation##15##1##(2008-10#12)(2008-5#3)
photo-oxidative##2##1##(2008-5#1)(2008-8#1)
photo-physics##2##1##(2013-8#2)
photo-polymerization##2##1##(2008-10#2)
photo-symbiotic clams##6##2##(2008-5#6)
photo-symbiotic##7##1##(2008-5#7)
photoablative surgery##2##2##(2007-3#2)
photoacoustic (PA)##3##2##(2005-4#1)(2007-11#1)(2008-10#1)
photoacoustic and photothermal##2##3##(2007-12#2)
photoacoustic and##4##2##(2007-12#3)(2008-2#1)
photoacoustic cavitation##3##2##(2013-1#3)
photoacoustic cell##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
photoacoustic cells##2##2##(2008-2#2)
photoacoustic detection of##3##3##(2006-3#1)(2007-12#1)(2008-3#1)
photoacoustic detection##4##2##(2006-3#1)(2007-12#1)(2008-3#2)
photoacoustic detector##2##2##(2008-10#1)(2008-2#1)
photoacoustic imaging of##2##3##(2007-12#1)(2008-3#1)
photoacoustic imaging##12##2##(2007-12#1)(2008-3#1)(2009-12#1)(2009-5#2)(2011-1#5)(2011-7#1)(2012-2#1)
photoacoustic microscopy##5##2##(2009-12#2)(2011-1#2)(2011-7#1)
photoacoustic probe##2##2##(2008-2#1)(2011-1#1)
photoacoustic signal##6##2##(2007-11#1)(2008-10#1)(2008-3#3)(2013-8#1)
photoacoustic spectroscopy##10##2##(2007-11#2)(2008-2#1)(2008-3#2)(2013-8#5)
photoacoustic##85##1##(1990-8#2)(1994-11#1)(2005-4#1)(2006-3#1)(2007-11#5)(2007-12#8)(2008-10#4)(2008-2#10)(2008-3#19)(2009-12#3)(2009-5#2)(2010-2#1)(2011-1#13)(2011-7#3)(2012-2#3)(2013-1#3)(2013-8#6)
photoacoustics##6##1##(2006-3#1)(2007-12#1)(2008-2#1)(2008-3#3)
photoactivatable##5##1##(1990-5#1)(1992-8#1)(1994-5#2)(1995-1#1)
photoactivated 8-MOP##2##2##(1991-12#2)
photoactivated by##2##2##(1991-12#1)(2008-10#1)
photoactivated chromotropic acid##2##3##(2008-10#2)
photoactivated##19##1##(1991-12#4)(1993-8#1)(1995-6#1)(1996-5#1)(1997-7#1)(2008-1#2)(2008-10#4)(2009-6#1)(2012-11#2)(2012-2#1)(2012-3#1)
photoactivation of##6##2##(1990-12#1)(1990-5#1)(1991-12#1)(1992-5#1)(1994-5#1)(2008-1#1)
photoactivation##19##1##(1990-12#1)(1990-5#5)(1991-12#1)(1992-5#1)(1992-8#1)(1993-8#1)(1994-5#1)(2008-1#2)(2008-10#2)(2009-2#3)(2010-2#1)
photoactive protochlorophyllide-protein complex##2##3##(1992-8#2)
photoactive yellow protein##2##3##(1994-11#1)(2006-10#1)
photoactive yellow##3##2##(1994-11#2)(2006-10#1)
photoactive##18##1##(1991-12#1)(1992-8#4)(1994-11#3)(2005-11#1)(2006-10#1)(2006-4#1)(2007-12#3)(2008-10#3)(2011-1#1)
photoactivity##3##1##(2012-11#3)
photoadduct##3##1##(1992-8#1)(1994-5#1)(2007-8#1)
photoadducts##2##1##(1991-12#1)(1992-6#1)
photoaffinity analog##2##2##(1992-1#1)(1993-6#1)
photoaffinity cleavage##2##2##(1991-4#2)
photoaffinity cross-linking##2##2##(1992-3#1)(1995-5#1)
photoaffinity label##3##2##(1992-5#2)(1994-6#1)
photoaffinity labeling and##2##3##(1991-7#1)(1993-8#1)
photoaffinity labeling of the##2##4##(1990-12#1)(1992-6#1)
photoaffinity labeling of##5##3##(1990-11#1)(1990-12#1)(1992-6#1)(1995-3#2)
photoaffinity labeling with NAD##2##4##(1990-5#2)
photoaffinity labeling with##8##3##(1990-11#1)(1990-5#2)(1993-11#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-7#1)
photoaffinity labeling##25##2##(1990-11#4)(1990-12#1)(1990-5#2)(1991-7#3)(1991-9#1)(1992-6#1)(1993-11#1)(1993-8#1)(1995-1#2)(1995-11#2)(1995-3#4)(1996-7#3)
photoaffinity labelling##3##2##(1990-8#1)(1993-5#2)
photoaffinity ligands##2##2##(1996-8#2)
photoaffinity probe##6##2##(1992-6#1)(1993-8#1)(1994-5#1)(1994-8#1)(1996-5#2)
photoaffinity##56##1##(1990-11#4)(1990-12#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-4#2)(1991-7#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#2)(1992-6#2)(1993-11#1)(1993-5#2)(1993-6#1)(1993-8#3)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#3)(1995-11#2)(1995-3#5)(1995-5#1)(1996-5#2)(1996-7#4)(1996-8#3)
photoaffinity-labeled with##2##2##(1992-6#2)
photoaffinity-labeled##3##1##(1992-1#1)(1992-6#2)
photoaged skin##5##2##(2006-12#1)(2008-5#2)(2011-2#2)
photoaged##9##1##(2006-12#1)(2008-5#5)(2011-2#2)(2012-2#1)
photoageing and##2##2##(2006-12#1)(2008-5#1)
photoageing##7##1##(2006-12#2)(2008-5#5)
photoaging of human skin##2##4##(1992-6#1)(2008-5#1)
photoaging##16##1##(1991-6#1)(1992-6#5)(2008-5#6)(2011-2#4)
photoallergic contact dermatitis from##2##4##(2010-12#2)
photoallergic contact dermatitis##3##3##(2010-12#3)
photoallergic##5##1##(2005-11#1)(2010-12#4)
photoanode##2##1##(2010-5#2)
photoassimilate##2##1##(2008-12#2)
photoautotrophic growth##2##2##(1994-8#1)(2008-6#1)
photobinding##4##1##(1992-6#4)
photobiological activity of##2##3##(1992-6#2)
photobiological activity##3##2##(1992-6#2)(2007-11#1)
photobiological##4##1##(1992-6#3)(2007-11#1)
photobionts##2##1##(2008-1#1)(2010-6#1)
photobioreactor was##2##2##(2008-6#2)
photobioreactor##4##1##(2008-6#3)(2008-7#1)
photobiostimulation##3##1##(2007-11#3)
photobiotinylated##3##1##(1994-3#3)
photobleached at a##2##3##(2008-1#1)(2008-9#1)
photobleached region is##2##3##(2008-1#2)
photobleached##9##1##(2008-1#6)(2008-2#2)(2008-9#1)
photobleaching and##2##2##(2008-2#1)(2012-3#1)
photobleaching are##2##2##(2008-1#1)(2008-2#1)
photobleaching is##3##2##(2008-1#1)(2008-10#1)(2008-2#1)
photobleaching of##6##2##(2008-10#1)(2008-2#2)(2008-3#1)(2008-9#1)(2011-1#1)
photobleaching rate##3##2##(2008-3#3)
photobleaching recovery##2##2##(1995-12#1)(1995-3#1)
photobleaching##65##1##(1990-2#1)(1993-11#1)(1995-12#2)(1995-3#1)(1997-4#1)(1997-6#1)(2005-11#1)(2007-12#2)(2008-1#14)(2008-10#3)(2008-2#10)(2008-3#8)(2008-4#1)(2008-7#3)(2008-9#7)(2009-8#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-3#1)
photobleaching-induced birefringence in##2##3##(2008-2#2)
photocarcinogenesis and##2##2##(1996-11#1)(2011-2#1)
photocarcinogenesis##7##1##(1996-11#4)(2006-12#1)(2008-5#1)(2011-2#1)
photocarcinogenic##2##1##(1996-11#1)(2011-2#1)
photocatalysis##7##1##(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2011-12#2)(2013-8#1)
photocatalyst and##2##2##(2008-10#1)(2011-12#1)
photocatalyst was##2##2##(2008-10#1)(2009-11#1)
photocatalyst##15##1##(1990-8#1)(1996-2#1)(2005-11#1)(2008-10#6)(2009-11#3)(2010-4#1)(2010-5#1)(2011-12#1)
photocatalysts are##2##2##(2008-10#2)
photocatalysts##3##1##(2008-10#2)(2010-4#1)
photocatalytic activity for##2##3##(2009-11#1)(2010-1#1)
photocatalytic activity of the##3##4##(2005-11#1)(2010-1#1)(2013-8#1)
photocatalytic activity was##3##3##(2005-11#1)(2008-1#1)(2013-8#1)
photocatalytic activity##14##2##(2005-11#4)(2008-1#1)(2009-11#1)(2010-1#3)(2010-4#1)(2013-8#4)
photocatalytic degradation of##2##3##(2008-1#1)(2008-10#1)
photocatalytic degradation##4##2##(2008-1#2)(2008-10#2)
photocatalytic disinfection##2##2##(2013-1#2)
photocatalytic oxidation for##2##3##(2008-10#2)
photocatalytic oxidation##6##2##(2008-10#6)
photocatalytic##44##1##(1991-3#1)(1994-3#3)(1996-2#1)(2005-11#4)(2008-1#3)(2008-10#13)(2009-11#2)(2009-8#4)(2010-1#3)(2010-4#1)(2010-7#1)(2011-12#1)(2013-1#2)(2013-8#5)
photocathode##11##1##(2007-12#1)(2008-1#1)(2008-2#7)(2008-3#2)
photocell cages##4##2##(1990-10#2)(1994-2#2)
photocell##5##1##(1990-10#2)(1993-6#1)(1994-2#2)
photochemical activities##3##2##(1991-12#1)(2008-10#1)(2008-9#1)
photochemical activity##2##2##(1991-12#1)(1991-4#1)
photochemical and photophysical##2##3##(2008-1#1)(2009-7#1)
photochemical and##6##2##(1991-5#1)(1991-7#1)(1994-6#1)(1996-2#1)(2008-1#1)(2009-7#1)
photochemical cortical##2##2##(2008-4#2)
photochemical cross-linking experiments##2##3##(1992-6#1)(1994-12#1)
photochemical degradation of the##2##4##(2008-11#1)(2008-5#1)
photochemical degradation of##3##3##(2008-11#2)(2008-5#1)
photochemical degradation##4##2##(1995-2#1)(2008-11#2)(2008-5#1)
photochemical derivatization##2##2##(2008-10#2)
photochemical effects##3##2##(2008-2#2)(2011-1#1)
photochemical efficiency##3##2##(2007-3#3)
photochemical ozone destruction##3##3##(2012-2#3)
photochemical processes in the##2##4##(2007-11#1)(2008-11#1)
photochemical processes in##3##3##(2007-11#1)(2008-11#2)
photochemical processes##4##2##(2007-11#1)(2008-11#2)(2010-5#1)
photochemical properties of##2##3##(1992-2#1)(2009-8#1)
photochemical properties##3##2##(1992-2#1)(2008-5#1)(2009-8#1)
photochemical reaction of##4##3##(2005-11#1)(2008-10#1)(2008-3#1)(2008-8#1)
photochemical reaction##20##2##(2005-11#1)(2007-8#1)(2008-10#9)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#2)
photochemical reactions of##2##3##(2008-10#2)
photochemical reactions##5##2##(1992-4#1)(1994-5#1)(2006-12#1)(2008-10#2)
photochemical reactivity##2##2##(2006-12#1)(2007-8#1)
photochemical smog##2##2##(1994-3#1)(2008-5#1)
photochemical stability##4##2##(2008-2#1)(2008-5#1)(2008-7#1)(2009-9#1)
photochemical##111##1##(1990-2#1)(1990-7#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-7#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1994-12#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#2)(1995-2#2)(1996-2#2)(1996-5#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-12#3)(2007-10#1)(2007-11#1)(2007-3#3)(2007-8#2)(2008-1#1)(2008-10#24)(2008-11#4)(2008-2#6)(2008-3#7)(2008-4#3)(2008-5#6)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-4#1)(2010-5#2)(2011-1#3)(2011-3#1)(2012-2#3)
photochemically active##3##2##(1994-11#1)(2008-5#2)
photochemically induced dynamic-nuclear-polarization (photo-CIDNP) NMR##2##5##(1991-2#2)
photochemically induced fluorescence##7##3##(2008-10#7)
photochemically induced##12##2##(1991-2#2)(1995-6#2)(1997-3#1)(2008-10#7)
photochemically symmetry-allowed##2##2##(1996-2#2)
photochemically##23##1##(1991-2#2)(1992-8#1)(1994-11#1)(1995-6#2)(1996-2#2)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-5#2)
photochemically-induced fluorescence##3##2##(2008-10#3)
photochemistry of##5##2##(1993-12#1)(2006-3#1)(2008-2#1)(2010-2#2)
photochemistry##15##1##(1992-8#1)(1993-12#1)(1993-6#1)(1994-11#1)(2006-12#1)(2006-3#1)(2007-8#1)(2008-1#1)(2008-2#1)(2010-2#2)(2011-3#1)(2012-1#1)(2012-7#1)(2012-8#1)
photochemotherapy and##3##2##(1992-6#1)(2007-7#2)
photochemotherapy with##2##2##(1992-6#1)(2007-8#1)
photochemotherapy##19##1##(1991-12#3)(1992-6#3)(2007-7#7)(2007-8#4)(2008-1#1)(2010-6#1)
photochromic optical memory##2##3##(2007-12#1)(2008-2#1)
photochromic optical##3##2##(2007-12#2)(2008-2#1)
photochromic properties##2##2##(2008-1#1)(2009-9#1)
photochromic reaction##3##2##(2007-12#1)(2009-8#2)
photochromic##24##1##(2007-11#1)(2007-12#8)(2008-1#2)(2008-2#2)(2008-3#6)(2009-7#1)(2009-8#3)(2009-9#1)
photocleavage##2##1##(1996-5#1)(2007-8#1)
photocoagulation for##2##2##(2008-1#1)(2011-1#1)
photocoagulation##19##1##(1993-1#1)(1993-6#4)(2006-1#1)(2007-3#1)(2008-1#3)(2008-11#2)(2011-1#5)(2011-2#1)(2013-7#1)
photoconducting polymeric layers##2##3##(2008-2#2)
photoconducting##7##1##(2007-11#2)(2007-12#2)(2008-2#3)
photoconductive antennas##4##2##(2008-2#4)
photoconductive sampling##2##2##(2007-12#1)(2008-2#1)
photoconductive switch##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
photoconductive##23##1##(2007-11#1)(2007-12#6)(2008-1#1)(2008-2#7)(2008-3#6)(2009-5#1)(2010-7#1)
photoconductivity of##2##2##(1990-4#1)(2007-11#1)
photoconductivity##8##1##(1990-4#1)(2007-11#1)(2007-12#1)(2008-3#1)(2009-2#4)
photoconductor##6##1##(2007-12#1)(2008-2#2)(2008-3#3)
photoconductors##9##1##(2007-12#3)(2008-2#2)(2008-3#4)
photoconversion in##2##2##(2011-1#2)
photoconversion##6##1##(1990-5#3)(2011-1#3)
photoconverted##2##1##(1990-5#2)
photocount##2##1##(2008-2#2)
photocrosslinkable##4##1##(2013-1#4)
photocrosslinking##2##1##(1993-5#1)(2007-11#1)
photocurable##2##1##(2008-10#1)(2008-9#1)
photocured##2##1##(2008-10#2)
photocurrent and transmittance measurements##2##4##(2008-3#2)
photocurrent for##2##2##(2007-11#1)(2008-2#1)
photocurrent generated by##3##3##(2007-11#1)(2008-10#1)(2010-5#1)
photocurrent in a##2##3##(2007-11#1)(2008-1#1)
photocurrent in##3##2##(2007-11#1)(2008-1#1)(2008-2#1)
photocurrent response##3##2##(2005-4#1)(2008-10#2)
photocurrent##28##1##(2005-4#2)(2007-11#6)(2007-12#5)(2008-1#1)(2008-10#4)(2008-2#5)(2008-3#3)(2010-4#1)(2010-5#1)
photocycle of bacteriorhodopsin##3##3##(1994-5#1)(1997-3#2)
photocycle of##7##2##(1992-11#1)(1994-5#2)(1997-3#2)(1997-4#1)(2006-10#1)
photocycle##20##1##(1990-2#1)(1992-11#3)(1993-11#1)(1994-11#3)(1994-5#2)(1995-11#1)(1995-5#1)(1997-3#5)(1997-4#2)(2006-10#1)
photocycles of##2##2##(1992-11#1)(1997-4#1)
photocycles##3##1##(1992-11#1)(1995-11#1)(1997-4#1)
photodamage in##2##2##(2008-8#1)(2009-4#1)
photodamage to##3##2##(2008-1#1)(2008-3#1)(2008-5#1)
photodamage##19##1##(1991-7#2)(1993-8#1)(1997-1#3)(2006-12#1)(2008-1#1)(2008-3#1)(2008-5#4)(2008-8#2)(2009-12#1)(2009-4#1)(2011-2#1)(2012-2#1)
photodamage/photoaging##2##1##(2012-2#2)
photodamaged skin##3##2##(1993-12#1)(1996-8#1)(2008-5#1)
photodamaged##7##1##(1993-12#1)(1996-8#1)(1997-1#2)(2008-5#2)(2008-8#1)
photodarkening##2##1##(2008-3#2)
photodecomposition##6##1##(1997-6#1)(2007-11#2)(2008-10#2)(2008-8#1)
photodegradation and##2##2##(2008-10#2)
photodegradation in##2##2##(2007-8#1)(2008-1#1)
photodegradation of NM##2##3##(2004-12#2)
photodegradation of the##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
photodegradation of##9##2##(2004-12#3)(2007-12#2)(2008-10#1)(2008-3#1)(2011-1#2)
photodegradation processes##4##2##(2008-10#2)(2011-1#2)
photodegradation products##2##2##(1996-6#1)(1997-6#1)
photodegradation rate##3##2##(2004-12#1)(2007-12#1)(2008-10#1)
photodegradation rates were##2##3##(2008-10#2)
photodegradation rates##3##2##(2008-10#3)
photodegradation reactions##2##2##(1994-3#1)(2008-10#1)
photodegradation were##2##2##(2008-10#1)(2012-3#1)
photodegradation##48##1##(1994-3#1)(1996-6#1)(1997-6#1)(2004-12#4)(2007-11#1)(2007-12#3)(2007-8#2)(2008-1#2)(2008-10#22)(2008-3#1)(2008-5#1)(2010-4#1)(2011-1#7)(2012-3#1)
photodegraded##2##1##(1996-6#2)
photodensitometry##2##1##(2008-5#2)
photoderivatization##2##1##(1990-7#2)
photodermatitis##3##1##(2007-7#3)
photodestruction in a solid-state dye laser##2##6##(2008-2#2)
photodestruction##7##1##(1990-11#2)(2008-10#1)(2008-2#4)
photodestructive##2##1##(1990-11#2)
photodetection##3##1##(2007-11#1)(2008-3#2)
photodetector and##5##2##(2007-12#1)(2008-2#4)
photodetector array##2##2##(2008-2#1)(2008-3#1)
photodetector arrays##2##2##(2007-12#1)(2008-2#1)
photodetector output signal##3##3##(2008-2#3)
photodetector output##4##2##(2008-2#4)
photodetector signal##2##2##(2008-2#2)
photodetector##44##1##(2007-11#3)(2007-12#6)(2008-10#2)(2008-2#15)(2008-3#17)(2011-1#1)
photodetectors and##2##2##(2007-12#1)(2008-3#1)
photodetectors are##2##2##(2008-3#1)(2013-1#1)
photodetectors in##2##2##(2007-11#1)(2007-12#1)
photodetectors is##2##2##(2007-11#1)(2008-2#1)
photodetectors##31##1##(2007-11#4)(2007-12#3)(2008-10#1)(2008-2#12)(2008-3#9)(2012-12#1)(2013-1#1)
photodiagnosis (PD)##3##2##(2009-4#2)(2012-3#1)
photodiode and##3##2##(2007-11#1)(2008-3#2)
photodiode array (PDA) and##2##4##(2007-1#1)(2008-10#1)
photodiode array detector##10##3##(1991-8#1)(2007-12#1)(2008-10#7)(2013-7#1)
photodiode array##19##2##(1991-8#1)(1996-12#2)(1997-2#2)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#10)(2013-7#1)
photodiode as##2##2##(2008-10#1)(2008-3#1)
photodiode detector##2##2##(1997-6#1)(2008-10#1)
photodiode detectors##3##2##(2008-2#1)(2008-3#2)
photodiode instead of##2##3##(2007-11#1)(2008-10#1)
photodiode is used##2##3##(2007-12#2)
photodiode is##3##2##(2007-12#2)(2008-1#1)
photodiode system##2##2##(2008-11#2)
photodiode that is##2##3##(2008-3#2)
photodiode that##3##2##(1997-3#1)(2008-3#2)
photodiode##67##1##(1991-8#1)(1996-12#2)(1997-2#2)(1997-3#1)(1997-6#1)(1997-8#1)(2006-5#1)(2007-1#1)(2007-11#6)(2007-12#5)(2007-8#1)(2008-1#3)(2008-10#15)(2008-11#2)(2008-2#6)(2008-3#18)(2013-7#1)
photodiode-array detection##8##2##(1990-11#1)(1990-12#1)(1990-3#1)(1992-2#4)(1996-8#1)
photodiode-array detector##3##2##(1993-2#1)(1996-8#1)(2008-10#1)
photodiode-array##14##1##(1990-11#1)(1990-12#1)(1990-3#1)(1992-2#4)(1993-2#1)(1996-8#2)(1997-2#1)(2008-10#3)
photodiodes and##4##2##(2007-11#1)(2007-12#2)(2008-10#1)
photodiodes for##3##2##(2008-2#1)(2008-3#2)
photodiodes were##2##2##(1997-3#1)(2008-3#1)
photodiodes##32##1##(1997-3#1)(2007-11#3)(2007-12#4)(2008-10#2)(2008-2#10)(2008-3#10)(2010-4#1)(2010-9#1)
photodissociation and##2##2##(1992-8#1)(2008-3#1)
photodissociation of the##2##3##(1992-12#1)(1995-8#1)
photodissociation of##7##2##(1990-8#1)(1992-12#1)(1995-8#1)(2008-2#1)(2008-3#3)
photodissociation##15##1##(1990-8#1)(1992-12#1)(1992-8#2)(1995-2#1)(1995-8#1)(2008-2#3)(2008-3#6)
photodrug reactions##2##2##(2010-8#2)
photodynamic action of##2##3##(1997-1#2)
photodynamic action##5##2##(1990-11#1)(1992-2#1)(1997-1#2)(2008-5#1)
photodynamic agent##2##2##(2005-7#1)(2008-8#1)
photodynamic agents##3##2##(2005-7#3)
photodynamic dose##2##2##(2008-2#2)
photodynamic effect of##2##3##(2009-3#1)(2012-3#1)
photodynamic effect##3##2##(1992-1#1)(2009-3#1)(2012-3#1)
photodynamic inactivation##3##2##(2012-12#2)(2012-2#1)
photodynamic oxidation rates##3##3##(2008-5#3)
photodynamic oxidation##5##2##(2008-5#5)
photodynamic reactivity##2##2##(2008-5#2)
photodynamic sensitizers##2##2##(1993-8#1)(1994-3#1)
photodynamic therapy (PDT) for##3##4##(2006-12#1)(2008-5#2)
photodynamic therapy (PDT) of##4##4##(1990-11#1)(2006-10#1)(2008-7#1)(2012-12#1)
photodynamic therapy (PDT)##28##3##(1990-11#1)(1990-9#1)(1992-6#1)(1992-9#1)(2005-7#1)(2006-10#1)(2006-12#2)(2007-8#3)(2008-5#8)(2008-7#1)(2009-4#3)(2011-11#1)(2012-12#2)(2012-3#2)
photodynamic therapy and##7##3##(1990-6#1)(1995-4#1)(2007-8#1)(2008-5#1)(2009-4#1)(2011-1#1)(2011-11#1)
photodynamic therapy for##3##3##(1994-1#1)(2008-5#1)(2012-2#1)
photodynamic therapy in the##3##4##(2007-11#1)(2012-12#1)(2012-3#1)
photodynamic therapy in##6##3##(2007-11#1)(2008-5#1)(2011-1#1)(2012-12#1)(2012-3#2)
photodynamic therapy of##7##3##(2005-7#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-3#2)
photodynamic therapy with##3##3##(1992-8#1)(1992-9#1)(1996-8#1)
photodynamic therapy##86##2##(1990-11#1)(1990-6#1)(1990-9#1)(1992-1#2)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-12#1)(1994-1#1)(1995-4#1)(1996-8#1)(2005-7#2)(2006-10#3)(2006-12#3)(2007-11#1)(2007-8#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#13)(2008-7#2)(2008-8#2)(2009-4#5)(2009-5#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-11#2)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#12)(2013-7#1)
photodynamic treatment##5##2##(1992-6#1)(2008-5#4)
photodynamic##132##1##(1990-11#2)(1990-6#1)(1990-9#1)(1991-9#1)(1992-1#3)(1992-2#2)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-8#2)(1994-1#1)(1994-3#1)(1995-4#1)(1996-8#1)(1997-1#2)(2005-7#6)(2006-10#4)(2006-12#3)(2007-11#1)(2007-8#5)(2008-1#1)(2008-12#1)(2008-2#5)(2008-3#1)(2008-5#27)(2008-7#2)(2008-8#3)(2009-3#1)(2009-4#7)(2009-5#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#3)(2011-11#2)(2011-2#1)(2012-1#1)(2012-12#8)(2012-2#4)(2012-3#13)(2013-1#1)(2013-7#1)
photodynamics##3##1##(1990-2#2)(1994-3#1)
photoelastic data##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
photoelastic fringe patterns##4##3##(2008-2#2)(2008-3#2)
photoelastic fringe##6##2##(2008-2#2)(2008-3#4)
photoelastic measurements##2##2##(2008-3#2)
photoelastic tomography##2##2##(2007-11#2)
photoelastic##29##1##(2007-11#2)(2007-12#2)(2008-1#1)(2008-2#7)(2008-3#17)
photoelasticity##14##1##(2007-7#1)(2008-2#4)(2008-3#9)
photoelectric modulation interferometer##3##3##(2013-8#3)
photoelectric##7##1##(2007-12#1)(2008-3#1)(2008-5#2)(2013-8#3)
photoelectrochemical##2##1##(2010-5#2)
photoelectromotive force##4##2##(2007-12#2)(2008-3#2)
photoelectron diffraction##2##2##(1992-11#1)(2006-4#1)
photoelectron spectroscopy (XPS)##20##3##(2004-9#3)(2005-11#6)(2005-4#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-5#1)(2010-8#1)(2013-8#1)
photoelectron spectroscopy##54##2##(1990-2#1)(1996-12#1)(2004-9#4)(2005-11#12)(2005-4#1)(2006-10#1)(2007-12#1)(2007-5#1)(2007-8#2)(2007-9#2)(2008-10#12)(2008-2#7)(2008-5#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-2#2)(2013-8#2)
photoelectron spectroscopy)##2##2##(1993-4#1)(2008-5#1)
photoelectron##74##1##(1990-2#1)(1992-11#1)(1992-9#2)(1993-4#1)(1993-6#1)(1996-12#1)(2004-9#4)(2005-11#16)(2005-4#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-5#1)(2007-8#2)(2007-9#2)(2008-10#17)(2008-2#7)(2008-3#1)(2008-5#2)(2009-11#1)(2010-4#3)(2010-7#1)(2010-8#1)(2011-2#2)(2013-8#3)
photoelectronic spectroscopy##2##2##(2005-11#2)
photoelectronic##3##1##(2005-11#3)
photoellipsometry method##2##2##(2008-2#2)
photoemission from##2##2##(1991-9#1)(1993-5#1)
photoemission spectroscopy##3##2##(2005-11#1)(2009-7#1)(2012-2#1)
photoemission##12##1##(1990-4#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-5#2)(2005-11#1)(2006-5#1)(2009-7#1)(2012-2#2)
photoenhanced##2##1##(2008-11#1)(2010-4#1)
photoerythema##2##1##(2008-5#2)
photoexcitation at##2##2##(2006-4#1)(2007-12#1)
photoexcitation of##4##2##(1990-2#1)(1993-3#1)(2007-11#1)(2010-5#1)
photoexcitation##18##1##(1990-2#1)(1992-2#1)(1993-3#1)(2005-8#1)(2006-4#1)(2007-1#1)(2007-11#3)(2007-12#4)(2008-3#1)(2008-7#1)(2010-5#1)(2010-7#2)
photoexcited azo##2##2##(2007-12#2)
photoexcited##9##1##(1992-12#1)(1992-6#1)(1993-5#1)(2005-11#1)(2007-12#4)(2008-10#1)
photofilters##2##1##(2008-5#2)
photofragmentation##5##1##(2008-2#4)(2008-3#1)
photofragmentation-fragment detection##2##2##(2008-3#2)
photofragments##5##1##(2008-2#2)(2008-3#3)
photogalvanic##3##1##(2007-12#3)
photogenerated##6##1##(1994-3#1)(1994-8#1)(2007-11#1)(2008-10#2)(2009-11#1)
photograding##3##1##(2008-5#3)
photograph##19##1##(1990-1#1)(1990-10#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-2#1)(1992-7#1)(1995-6#1)(1997-2#1)(2007-7#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-12#1)(2012-2#2)
photographed in##2##2##(1990-12#1)(2006-12#1)
photographed##15##1##(1990-12#1)(1995-6#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-8#1)(2008-2#4)(2008-3#3)(2012-12#1)(2013-7#1)
photographic documentation##2##2##(1996-12#1)(2010-9#1)
photographic emulsions##5##2##(2007-11#1)(2008-2#3)(2008-3#1)
photographic methods##2##2##(2007-6#2)
photographic plates##3##2##(2008-3#3)
photographic scale##2##2##(2008-5#1)(2011-2#1)
photographic systems##2##2##(2008-3#2)
photographic##47##1##(1996-12#1)(2005-11#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-6#2)(2007-8#1)(2008-10#12)(2008-11#1)(2008-2#8)(2008-3#9)(2008-4#1)(2008-5#1)(2009-10#1)(2010-9#1)(2011-2#1)(2012-12#3)(2013-1#1)
photographically##2##1##(1996-12#1)(2012-12#1)
photographs and##3##2##(2008-2#1)(2012-11#1)(2013-1#1)
photographs has##2##2##(2007-9#1)(2012-12#1)
photographs of each##2##3##(2008-2#1)(2012-12#1)
photographs of the##3##3##(2007-8#1)(2008-3#1)(2008-5#1)
photographs of##20##2##(1991-11#1)(1993-11#1)(1995-6#1)(1997-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2012-12#1)
photographs taken from different angles##2##5##(1995-6#2)
photographs taken from##3##3##(1995-6#2)(2010-12#1)
photographs taken##4##2##(1995-6#2)(2007-7#1)(2010-12#1)
photographs to##3##2##(2007-7#1)(2008-11#1)(2008-2#1)
photographs using a##2##3##(2008-5#1)(2011-2#1)
photographs were taken##2##3##(2007-7#1)(2008-10#1)
photographs were##5##2##(2006-8#1)(2007-5#1)(2007-7#1)(2008-10#1)(2013-7#1)
photographs##65##1##(1991-11#1)(1993-11#2)(1995-6#3)(1995-9#1)(1997-2#1)(2005-8#1)(2005-9#1)(2006-8#1)(2007-12#2)(2007-4#1)(2007-5#7)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#9)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-4#2)(2009-7#1)(2010-10#1)(2010-12#2)(2010-2#1)(2011-2#2)(2012-11#1)(2012-12#4)(2013-1#1)(2013-7#1)
photography and##7##2##(2005-7#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-7#1)(2011-2#1)(2013-7#1)
photography for##4##2##(2007-12#1)(2008-1#1)(2008-2#1)(2008-4#1)
photography of##5##2##(1991-9#1)(2006-8#1)(2007-3#1)(2008-2#1)(2008-4#1)
photography system##2##2##(2007-12#1)(2009-6#1)
photography to##2##2##(2008-3#2)
photography was used to##2##4##(1995-11#1)(2012-2#1)
photography##63##1##(1991-1#1)(1991-9#1)(1995-11#1)(1995-6#1)(2005-7#1)(2005-8#1)(2006-8#1)(2007-11#2)(2007-12#4)(2007-3#1)(2007-5#1)(2007-6#1)(2008-1#2)(2008-10#2)(2008-2#10)(2008-3#22)(2008-4#3)(2008-5#1)(2008-8#1)(2009-6#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
photoheterotrophic##3##1##(2007-12#2)(2012-2#1)
photoimmunoconjugates##2##1##(2008-2#2)
photoinactivated syngeneic##2##2##(1991-12#2)
photoinactivated##6##1##(1991-12#6)
photoinactivation is##2##2##(1996-7#2)
photoinactivation##7##1##(1992-6#1)(1996-7#4)(2011-2#1)(2012-12#1)
photoinduced birefringence##3##2##(2007-11#1)(2008-2#2)
photoinduced chi((2))##2##2##(2007-12#1)(2008-1#1)
photoinduced current##2##2##(2007-11#1)(2009-2#1)
photoinduced damage##3##2##(2007-12#3)
photoinduced electron transfer (PET)##2##4##(2008-10#2)
photoinduced electron transfer##5##3##(1992-1#1)(2007-8#2)(2008-10#2)
photoinduced refractive-index change##3##3##(2007-12#3)
photoinduced refractive-index changes##2##3##(2007-12#1)(2008-3#1)
photoinduced refractive-index##5##2##(2007-12#4)(2008-3#1)
photoinduced second-harmonic generation##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
photoinduced second-order susceptibility##2##3##(2007-12#2)
photoinduced##69##1##(1990-7#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-6#3)(1994-11#2)(1994-3#1)(1995-11#1)(1995-5#1)(2006-10#1)(2007-11#10)(2007-12#23)(2007-8#2)(2008-1#3)(2008-10#4)(2008-2#4)(2008-3#3)(2009-2#1)(2010-4#2)(2010-5#1)(2012-1#1)(2012-11#2)
photoinduction##2##1##(1994-5#1)(2008-3#1)
photoinhibition and C(4) pathway##2##4##(2008-9#2)
photoinhibition and##4##2##(2008-9#4)
photoinhibition##15##1##(1990-5#2)(1991-7#3)(1995-8#5)(2007-3#1)(2008-9#4)
photoinhibitory##2##1##(1991-12#2)
photoinitiated##2##1##(2008-2#1)(2010-6#1)
photoinitiator system##3##2##(2008-8#1)(2010-2#2)
photoinitiator##6##1##(2007-11#1)(2008-8#1)(2010-2#3)(2010-4#1)
photoionization##10##1##(1991-12#1)(1991-9#1)(1992-3#1)(1992-4#1)(2006-5#3)(2007-12#2)(2008-1#1)
photoirradiation of##4##2##(2008-5#1)(2008-8#3)
photoirradiation##10##1##(1990-4#1)(2005-11#1)(2008-10#1)(2008-5#1)(2008-8#4)(2009-2#1)(2010-4#1)
photoisomerization##6##1##(1992-8#1)(1995-10#3)(1995-6#1)(2008-10#1)
photolabel##3##1##(1991-6#1)(1994-5#1)(1996-8#1)
photolabeled##13##1##(1990-11#2)(1992-11#1)(1992-12#1)(1992-5#1)(1993-8#3)(1996-8#5)
photolabeling of P-glycoprotein##2##3##(1990-12#1)(1997-5#1)
photolabeling##8##1##(1990-12#2)(1993-8#1)(1994-11#1)(1994-5#1)(1995-5#1)(1997-5#1)(2008-1#1)
photolabile protecting group##2##3##(2008-4#2)
photolabile##7##1##(1990-7#1)(1995-3#1)(1997-4#1)(2008-4#4)
photolesions##6##1##(1992-6#4)(1993-8#2)
photolinker##2##1##(2008-10#2)
photolithographic mask##3##2##(2008-2#1)(2008-3#2)
photolithographic procedures##2##2##(2008-10#1)(2008-5#1)
photolithographic technique##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
photolithographic##14##1##(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#6)(2008-5#1)
photolithography and wet etching##2##4##(2008-11#1)(2008-3#1)
photolithography and##5##2##(2008-11#1)(2008-2#1)(2008-3#2)(2009-12#1)
photolithography to##2##2##(2007-11#1)(2008-11#1)
photolithography with##2##2##(2008-3#2)
photolithography##32##1##(2005-11#1)(2007-11#4)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#5)(2008-3#9)(2009-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2012-2#2)
photoluminescence (PL)##3##2##(2008-10#2)(2013-8#1)
photoluminescence excitation spectra##2##3##(2008-7#1)(2009-2#1)
photoluminescence intensity##2##2##(2013-8#2)
photoluminescence of##3##2##(2007-11#1)(2008-11#1)(2010-5#1)
photoluminescence quenching of##2##3##(2008-10#1)(2009-11#1)
photoluminescence spectra##2##2##(2008-10#1)(2010-4#1)
photoluminescence##32##1##(1995-7#1)(2006-12#1)(2007-11#5)(2007-12#2)(2007-9#2)(2008-10#5)(2008-11#1)(2008-2#2)(2008-7#1)(2009-11#2)(2009-2#1)(2010-2#1)(2010-4#3)(2010-5#1)(2013-8#4)
photoluminescent properties##4##2##(2005-11#2)(2008-10#1)(2008-3#1)
photoluminescent##8##1##(2005-11#2)(2006-12#1)(2008-10#3)(2008-3#1)(2009-11#1)
photolyase##4##1##(1994-8#1)(1995-6#3)
photolysed##2##1##(2008-10#2)
photolysis and##7##2##(1992-6#1)(1994-5#1)(1997-2#1)(2008-10#1)(2008-3#2)(2010-2#1)
photolysis at##2##2##(1990-3#1)(1995-8#1)
photolysis errors##2##2##(2008-3#2)
photolysis frequencies in the atmosphere##2##5##(2008-3#2)
photolysis frequencies##4##2##(2008-3#4)
photolysis in##2##2##(1995-11#1)(1995-2#1)
photolysis of H2O2##5##3##(1994-6#2)(2013-8#3)
photolysis of caged ATP##3##4##(1995-2#1)(1997-4#2)
photolysis of caged Ca2+##4##4##(1997-2#4)
photolysis of caged##9##3##(1995-2#1)(1997-2#4)(1997-4#2)(2008-4#1)(2008-7#1)
photolysis of the##2##3##(1991-12#1)(1996-6#1)
photolysis of##28##2##(1990-1#1)(1991-12#1)(1992-2#1)(1992-8#2)(1994-12#1)(1994-6#2)(1995-2#1)(1996-5#3)(1996-6#1)(1997-2#4)(1997-4#2)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-1#1)(2013-8#3)
photolysis technique##2##2##(1995-2#1)(2005-4#1)
photolysis to##3##2##(1996-2#1)(2008-10#1)(2008-5#1)
photolysis was carried out##2##4##(2010-5#2)
photolysis was##4##2##(1992-1#1)(2010-5#3)
photolysis##90##1##(1990-1#1)(1990-11#2)(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-8#3)(1992-9#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-2#4)(1995-3#1)(1995-8#1)(1996-2#1)(1996-5#3)(1996-6#2)(1997-2#5)(1997-4#2)(2005-4#3)(2006-12#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-3#12)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-5#3)(2011-1#2)(2012-12#2)(2013-7#1)(2013-8#3)
photolytic activity##2##2##(2007-1#2)
photolytic and##2##2##(2010-2#2)
photolytic conditions##4##2##(2007-11#1)(2010-12#1)(2010-2#1)(2011-1#1)
photolytic##13##1##(2007-1#2)(2007-11#1)(2008-10#1)(2008-2#2)(2010-12#1)(2010-2#3)(2011-1#1)(2012-12#1)(2013-7#1)
photolyzed rhodopsin##2##2##(1990-10#1)(1992-5#1)
photolyzed##5##1##(1990-10#1)(1992-5#1)(1995-1#2)(2009-12#1)
photomechanical##2##1##(2007-12#1)(2008-2#1)
photometer is##2##2##(2008-10#2)
photometer##16##1##(1992-6#1)(1993-7#1)(2007-10#1)(2007-7#1)(2008-10#7)(2008-2#3)(2008-3#2)
photometers##3##1##(2008-10#2)(2008-5#1)
photometric analysis##2##2##(2008-10#1)(2008-2#1)
photometric and##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
photometric detection at##2##3##(2008-10#2)
photometric detection##16##2##(1993-1#2)(1994-9#1)(1996-11#1)(1997-2#1)(2008-10#11)
photometric detector##4##2##(2008-10#4)
photometric determination of iron(II)/iron(III) and nitrite/nitrate##2##6##(2008-10#2)
photometric determination of##5##3##(1996-11#1)(2008-10#4)
photometric linearity##2##2##(2008-10#2)
photometric measurements##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
photometric method for##2##3##(2008-10#2)
photometric method with##2##3##(2008-10#2)
photometric method##14##2##(1996-9#1)(2005-4#2)(2008-10#11)
photometric system##3##2##(2008-10#3)
photometric tests##2##2##(2008-10#2)
photometric titration##3##2##(2008-10#3)
photometric##87##1##(1990-12#2)(1990-4#1)(1991-9#1)(1993-1#2)(1994-2#1)(1994-9#1)(1995-6#1)(1996-11#2)(1996-9#1)(1997-2#1)(1997-5#1)(2005-4#2)(2007-10#2)(2008-10#54)(2008-2#5)(2008-3#10)
photometrically##5##1##(2008-10#4)(2008-5#1)
photometry and##2##2##(2008-10#1)(2008-3#1)
photometry##11##1##(2007-10#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)
photomorphogenesis##7##1##(1991-9#1)(2008-7#1)(2009-8#5)
photomorphogenic##3##1##(1996-10#2)(2009-8#1)
photomultiplier and##2##2##(2008-1#1)(2008-2#1)
photomultiplier gain modulation##2##3##(2008-2#2)
photomultiplier tube (PMT)##3##3##(2008-10#2)(2010-9#1)
photomultiplier tube##18##2##(2007-11#2)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#6)(2008-7#1)(2010-9#1)(2011-1#1)
photomultiplier tubes##3##2##(2008-3#3)
photomultiplier##37##1##(1996-12#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#6)(2008-2#7)(2008-3#12)(2008-7#1)(2010-9#2)(2011-1#1)
photomultipliers##2##1##(2008-3#2)
photon absorptiometry##5##2##(1991-11#4)(2005-7#1)
photon and proton beam treatment##3##5##(2009-8#3)
photon and##8##2##(2008-3#1)(2008-6#1)(2009-8#3)(2010-7#1)(2012-1#1)(2012-2#1)
photon antibunching##2##2##(2007-12#2)
photon beam##3##2##(1995-8#1)(2008-3#1)(2012-12#1)
photon beams##9##2##(1993-9#1)(1994-7#1)(2006-4#1)(2008-3#1)(2008-6#1)(2009-12#1)(2012-1#3)
photon concentration##2##2##(2008-3#2)
photon conversion efficiency of##3##4##(2007-11#1)(2007-12#2)
photon conversion efficiency##4##3##(2007-11#1)(2007-12#3)
photon correlation and##3##3##(2008-2#2)(2008-3#1)
photon correlation spectroscopy##13##3##(1990-3#1)(2005-11#1)(2006-12#1)(2006-4#1)(2008-2#6)(2008-3#1)(2008-5#1)(2013-1#1)
photon correlation##22##2##(1990-3#1)(2005-11#1)(2006-12#1)(2006-4#1)(2008-2#13)(2008-3#3)(2008-5#1)(2013-1#1)
photon count##2##2##(2009-5#1)(2011-1#1)
photon counting at##2##3##(2007-11#1)(2008-3#1)
photon counting##16##2##(2006-10#1)(2007-11#3)(2008-10#1)(2008-3#4)(2011-1#6)(2013-1#1)
photon counts##3##2##(2007-11#1)(2008-3#2)
photon density in##2##3##(2007-11#1)(2008-2#1)
photon density waves (PDWs)##2##4##(1997-6#1)(2008-3#1)
photon density waves are##2##4##(2007-12#1)(2008-3#1)
photon density waves##11##3##(1997-6#1)(2007-12#2)(2008-2#4)(2008-3#4)
photon density##22##2##(1997-6#1)(2007-11#3)(2007-12#2)(2008-10#2)(2008-2#6)(2008-3#7)(2011-1#1)
photon detection##4##2##(1995-6#1)(2007-12#1)(2008-2#1)(2009-10#1)
photon detector##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
photon diffusion##3##2##(2007-11#2)(2008-3#1)
photon echo##5##2##(2006-4#1)(2007-12#2)(2008-11#1)(2010-2#1)
photon echoes in##2##3##(2007-12#2)
photon echoes##13##2##(2007-11#2)(2007-12#11)
photon emission computed tomography (SPECT)##13##5##(1994-1#1)(1996-12#1)(1996-5#1)(1996-7#1)(2005-1#1)(2005-9#1)(2007-10#1)(2007-9#2)(2008-11#1)(2008-8#1)(2009-12#1)(2009-8#1)
photon emission computed tomography in##3##5##(1994-1#1)(1996-5#1)(2006-2#1)
photon emission computed tomography##24##4##(1994-1#2)(1995-5#1)(1996-12#1)(1996-5#2)(1996-7#2)(2005-1#1)(2005-9#1)(2006-10#1)(2006-2#1)(2007-10#3)(2007-9#3)(2008-11#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-12#1)
photon emission computed##27##3##(1994-1#2)(1995-5#1)(1996-12#1)(1996-5#3)(1996-7#2)(2005-1#1)(2005-9#1)(2006-10#1)(2006-2#1)(2007-10#3)(2007-9#3)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-12#2)
photon emission computerized##3##3##(1995-4#1)(2008-12#1)(2009-2#1)
photon emission tomography##5##3##(1992-10#1)(2005-8#1)(2006-10#1)(2008-2#2)
photon emission##39##2##(1992-10#1)(1994-1#2)(1995-4#1)(1995-5#1)(1996-12#1)(1996-5#3)(1996-7#2)(2005-1#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-2#1)(2007-10#3)(2007-9#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-12#2)(2010-2#1)(2012-2#1)
photon energies above the##2##4##(2008-3#2)
photon energies of##2##3##(2008-2#1)(2008-3#1)
photon energies##11##2##(2006-5#3)(2008-2#4)(2008-3#3)(2013-1#1)
photon energy is##2##3##(2006-5#1)(2008-3#1)
photon energy range from##2##4##(2006-4#1)(2008-2#1)
photon energy##15##2##(1995-6#1)(2006-4#2)(2006-5#3)(2006-6#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-12#1)
photon flight##2##2##(2008-3#2)
photon flux density##4##3##(2008-10#3)(2010-10#1)
photon flux from##2##3##(2006-5#1)(2010-2#1)
photon flux##14##2##(2006-5#2)(2008-10#4)(2008-2#2)(2008-3#3)(2010-10#2)(2010-2#1)
photon in##2##2##(2007-11#1)(2010-11#1)
photon irradiation##4##2##(1993-9#1)(2008-6#3)
photon is##2##2##(2008-2#1)(2008-3#1)
photon lifetimes##2##2##(2007-11#1)(2008-3#1)
photon measurement density##2##3##(1997-6#1)(2008-3#1)
photon migration (FDPM)##4##3##(1997-6#1)(2008-3#3)
photon migration data##2##3##(2008-3#1)(2009-5#1)
photon migration in##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
photon migration is##2##3##(2008-3#2)
photon migration measurements##3##3##(2008-2#1)(2008-3#2)
photon migration##27##2##(1997-6#2)(2007-12#5)(2008-2#5)(2008-3#14)(2009-5#1)
photon noise in the##2##4##(2008-3#2)
photon noise##6##2##(2008-2#1)(2008-3#5)
photon number##2##2##(1992-11#1)(2007-11#1)
photon pairs generated by spontaneous parametric downconversion##2##7##(2007-12#2)
photon pairs##5##2##(2007-11#2)(2007-12#2)(2008-3#1)
photon paths##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
photon per##2##2##(2007-12#2)
photon propagation in##2##3##(2008-3#1)(2010-4#1)
photon propagation##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2010-4#1)
photon radiation##2##2##(1990-11#1)(2008-7#1)
photon scanning tunneling microscope##4##4##(2007-11#1)(2007-12#3)
photon statistics of##2##3##(2007-11#1)(2007-12#1)
photon statistics##6##2##(1993-8#1)(1995-11#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
photon trajectories##2##2##(2007-12#1)(2008-2#1)
photon transport in##2##3##(2007-11#1)(2008-3#1)
photon transport through##2##3##(2007-11#1)(2008-3#1)
photon transport##9##2##(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#2)(2008-6#1)
photon treatment##2##2##(2009-8#2)
photon##361##1##(1990-11#1)(1990-2#1)(1990-3#1)(1991-11#4)(1992-10#1)(1992-11#1)(1993-8#1)(1993-9#2)(1994-1#2)(1994-3#1)(1994-7#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-5#3)(1996-7#2)(1997-6#4)(1997-8#1)(2005-1#1)(2005-11#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#8)(2006-5#9)(2006-6#2)(2007-10#3)(2007-11#31)(2007-12#45)(2007-5#1)(2007-8#4)(2007-9#3)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#54)(2008-3#78)(2008-5#1)(2008-6#8)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-5#2)(2009-8#6)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#5)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#9)(2012-1#4)(2012-12#3)(2012-2#3)(2013-1#3)
photon-conversion efficiency of##2##3##(2007-11#1)(2007-12#1)
photon-conversion efficiency##4##2##(2007-11#1)(2007-12#3)
photon-conversion##6##1##(2007-11#3)(2007-12#3)
photon-correlated beams##2##2##(2008-2#2)
photon-correlation##4##1##(2008-3#4)
photon-counting avalanche##2##2##(2007-11#2)
photon-counting detectors##2##2##(2007-11#1)(2012-2#1)
photon-counting lock-in##3##2##(2007-11#3)
photon-counting mode##2##2##(2007-12#1)(2008-3#1)
photon-counting receivers##2##2##(2008-3#2)
photon-counting##22##1##(2006-4#1)(2007-11#6)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#8)(2012-2#1)
photon-density##3##1##(2007-12#3)
photon-echo process##2##2##(2007-12#2)
photon-echo##9##1##(2007-12#7)(2008-2#2)
photon-gated##2##1##(2007-12#1)(2008-2#1)
photon-migration##3##1##(2007-12#2)(2008-3#1)
photon-number distribution##2##2##(2007-11#1)(2007-12#1)
photon-number statistics of twin beams##2##5##(2007-11#2)
photon-number##7##1##(2007-11#3)(2007-12#4)
photon-pair##4##1##(2007-11#1)(2007-12#1)(2008-3#2)
photon-scanning tunneling##2##2##(2008-2#1)(2008-3#1)
photon-transport##2##1##(2007-12#1)(2008-3#1)
photoneutrons##2##1##(2008-3#2)
photonic analog-to-digital##2##2##(2007-12#1)(2008-3#1)
photonic atoms##2##2##(2007-11#2)
photonic backplane##2##2##(2008-2#2)
photonic band structure of##2##4##(2007-12#1)(2008-2#1)
photonic band structure##5##3##(1992-3#1)(2007-11#1)(2007-12#2)(2008-2#1)
photonic band##10##2##(1992-3#1)(1992-9#1)(2007-11#1)(2007-12#5)(2008-2#1)(2010-4#1)
photonic bandgap structures##10##3##(2007-12#6)(2008-2#2)(2008-3#1)(2008-7#1)
photonic bandgap##27##2##(2007-11#7)(2007-12#14)(2008-2#3)(2008-3#1)(2008-7#1)(2012-3#1)
photonic bandgaps##3##2##(2007-12#3)
photonic circuits##2##2##(2008-3#1)(2012-2#1)
photonic crystal (PC)##5##3##(2007-11#3)(2007-12#2)
photonic crystal and##4##3##(2007-11#2)(2007-12#2)
photonic crystal fiber##13##3##(2007-12#13)
photonic crystal fibers##15##3##(2007-11#5)(2007-12#10)
photonic crystal nanocavities##2##3##(2007-11#2)
photonic crystal slab##3##3##(2007-11#1)(2007-12#2)
photonic crystal structure##2##3##(2007-12#2)
photonic crystal structures##2##3##(2007-11#1)(2007-12#1)
photonic crystal waveguide##4##3##(2007-12#4)
photonic crystal waveguides##7##3##(2007-11#3)(2007-12#4)
photonic crystal##92##2##(2007-11#31)(2007-12#50)(2007-9#1)(2008-3#2)(2008-7#4)(2009-12#3)(2010-4#1)
photonic crystals and##2##3##(2007-11#1)(2012-2#1)
photonic crystals by##2##3##(2007-11#1)(2009-12#1)
photonic crystals is##2##3##(2007-11#1)(2007-12#1)
photonic crystals that##2##3##(2007-11#1)(2008-3#1)
photonic crystals with##3##3##(2007-11#1)(2007-12#2)
photonic crystals##27##2##(2005-11#1)(2007-11#15)(2007-12#7)(2008-3#2)(2009-12#1)(2012-2#1)
photonic delay line for phased-array##2##5##(2008-3#2)
photonic delay line is demonstrated##2##5##(2008-2#2)
photonic delay line##7##3##(2008-2#3)(2008-3#4)
photonic delay##8##2##(2008-2#3)(2008-3#5)
photonic device##3##2##(2007-12#1)(2008-3#1)(2009-2#1)
photonic devices##8##2##(2007-12#1)(2007-9#3)(2008-10#1)(2008-2#1)(2008-7#2)
photonic hydrogels##3##2##(2013-7#3)
photonic integrated circuits##2##3##(2007-9#1)(2008-3#1)
photonic integrated##4##2##(2007-9#1)(2008-3#3)
photonic lattice##2##2##(2007-11#2)
photonic lattices##2##2##(2007-11#1)(2008-3#1)
photonic sensors##3##2##(2007-11#1)(2007-12#2)
photonic stop band##3##3##(2007-12#1)(2008-3#2)
photonic stopgaps##2##2##(2007-11#2)
photonic structures##3##2##(2007-11#1)(2007-12#1)(2012-2#1)
photonic switch##6##2##(2008-2#2)(2008-3#4)
photonic systems##4##2##(2008-2#1)(2008-3#2)(2010-4#1)
photonic##251##1##(1992-3#1)(1992-9#1)(2005-11#1)(2007-11#69)(2007-12#95)(2007-9#5)(2008-10#1)(2008-2#17)(2008-3#35)(2008-7#8)(2009-12#4)(2009-2#2)(2010-4#3)(2010-6#1)(2012-2#4)(2012-3#1)(2013-7#3)
photonic-crystal slab##2##2##(2007-11#1)(2007-12#1)
photonic-crystal waveguide##5##2##(2007-11#5)
photonic-crystal waveguides##2##2##(2007-11#2)
photonic-crystal##22##1##(2007-11#18)(2007-12#2)(2008-2#2)
photonics applications##3##2##(2008-3#2)(2008-7#1)
photonics##8##1##(2007-12#1)(2008-10#1)(2008-3#3)(2008-7#3)
photons and##5##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
photons are##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
photons by##4##2##(2007-12#2)(2008-10#1)(2008-2#1)
photons emitted by##2##3##(1992-6#1)(2008-3#1)
photons emitted from##2##3##(2007-12#1)(2012-12#1)
photons emitted##4##2##(1992-6#1)(2007-12#1)(2008-3#1)(2012-12#1)
photons for##4##2##(2007-12#2)(2008-2#2)
photons from a##3##3##(2006-4#1)(2008-2#2)
photons from##7##2##(1994-10#1)(2006-4#1)(2007-12#1)(2008-2#3)(2009-8#1)
photons in a##2##3##(2008-2#1)(2009-11#1)
photons in the##4##3##(2008-2#2)(2008-3#2)
photons in##13##2##(2006-4#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#4)(2008-3#3)(2008-6#1)(2009-11#1)
photons inside##4##2##(2007-12#2)(2008-3#2)
photons of##2##2##(2008-2#1)(2008-7#1)
photons per##3##2##(2008-2#1)(2008-3#1)(2010-2#1)
photons pixel(-1)##2##2##(2006-5#2)
photons produced##2##2##(2007-12#1)(2008-2#1)
photons scattered##2##2##(2007-11#1)(2007-12#1)
photons that##4##2##(2007-11#1)(2007-8#1)(2008-3#2)
photons to##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
photons traversing a turbid medium##2##5##(2008-2#2)
photons with the##2##3##(2008-3#1)(2008-7#1)
photons with##5##2##(2007-12#2)(2008-3#2)(2008-7#1)
photons##126##1##(1990-6#1)(1991-2#1)(1992-4#1)(1992-6#1)(1994-10#1)(1994-9#1)(1995-4#1)(2006-3#1)(2006-4#5)(2006-5#3)(2007-11#10)(2007-12#20)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#31)(2008-3#22)(2008-4#1)(2008-6#1)(2008-7#2)(2009-11#3)(2009-8#2)(2010-12#1)(2010-2#1)(2011-1#3)(2012-12#3)(2012-2#1)
photons)##3##1##(2008-2#1)(2008-3#2)
photons/(s 4pi##2##2##(2007-11#2)
photooxidation of the##3##3##(1990-5#1)(2007-11#1)(2008-10#1)
photooxidation of##6##2##(1990-5#2)(2006-12#1)(2007-11#2)(2008-10#1)
photooxidation##16##1##(1990-5#2)(1991-4#1)(1992-8#1)(1994-3#1)(1994-8#2)(1996-2#1)(1997-1#1)(2006-10#1)(2006-12#2)(2007-11#2)(2008-10#2)
photooxidative coupling of##2##3##(2008-10#2)
photooxidative stress##2##2##(1991-7#1)(2010-10#1)
photooxidative##5##1##(1991-7#1)(2008-10#2)(2008-5#1)(2010-10#1)
photooxidize##2##1##(1990-5#1)(2008-10#1)
photooxidized##3##1##(1994-8#2)(1997-1#1)
photopatch testing##2##2##(2007-7#1)(2010-12#1)
photopatch##3##1##(2007-7#2)(2010-12#1)
photopeak##3##1##(2006-5#3)
photoperiod and##3##2##(2007-3#1)(2008-5#1)(2008-7#1)
photoperiod on##3##2##(2009-5#2)(2010-8#1)
photoperiod sensitivity##3##2##(1995-6#2)(2012-3#1)
photoperiod##45##1##(1994-5#1)(1994-6#1)(1995-6#2)(1996-3#1)(2007-3#1)(2007-5#2)(2008-10#1)(2008-11#5)(2008-5#3)(2008-7#6)(2009-5#5)(2009-6#3)(2010-8#7)(2011-12#1)(2011-2#3)(2012-11#1)(2012-3#2)
photoperiodic conditions##2##2##(2008-5#1)(2012-2#1)
photoperiodic flowering##3##2##(2009-6#3)
photoperiodic##11##1##(1995-11#1)(1997-5#1)(2008-5#1)(2009-5#1)(2009-6#3)(2009-8#1)(2010-8#2)(2012-2#1)
photoperiods##5##1##(2008-5#1)(2008-7#3)(2009-5#1)
photophase##4##1##(2007-12#1)(2007-3#1)(2008-6#1)(2008-9#1)
photopheresis##10##1##(1991-12#7)(1992-6#1)(2013-8#2)
photophobia##7##1##(2005-11#2)(2006-10#1)(2007-8#1)(2009-2#1)(2009-3#1)(2012-12#1)
photophobic response##2##2##(1994-2#1)(2008-5#1)
photophosphorylation and uncoupled electron transfer##2##5##(1997-7#2)
photophosphorylation and uncoupled electron##3##4##(1997-7#3)
photophosphorylation and##4##2##(1992-3#1)(1997-7#3)
photophosphorylation##9##1##(1992-3#3)(1997-7#4)(2005-10#2)
photophysical and electrochemical properties of##2##5##(2009-7#2)
photophysical and##3##2##(2005-7#1)(2009-7#2)
photophysical dynamics##2##2##(2008-3#2)
photophysical evaluation##2##2##(2008-4#2)
photophysical properties of these##2##4##(2009-9#1)(2010-2#1)
photophysical properties of##9##3##(2005-11#1)(2005-8#2)(2006-10#1)(2006-12#1)(2008-4#1)(2009-9#1)(2010-2#1)(2010-5#1)
photophysical properties##16##2##(2005-11#1)(2005-8#2)(2006-10#1)(2006-12#2)(2007-8#2)(2008-10#2)(2008-4#1)(2008-5#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-5#1)
photophysical##31##1##(1995-1#1)(2005-11#2)(2005-7#1)(2005-8#2)(2006-10#1)(2006-12#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#2)(2009-4#1)(2009-7#3)(2009-9#1)(2010-2#1)(2010-5#1)(2013-8#1)
photophysics##5##1##(1990-4#1)(2008-2#1)(2009-6#1)(2010-2#2)
photopic conditions##2##2##(2010-9#1)(2011-2#1)
photopic luminance##2##2##(2011-2#2)
photopic##6##1##(1997-3#1)(2007-5#1)(2010-9#1)(2011-2#3)
photoplethysmography##6##1##(1990-5#1)(2008-2#2)(2010-7#2)(2010-8#1)
photopolarimeter##4##1##(1995-6#1)(2008-3#3)
photopolymer and##4##2##(2007-8#1)(2008-3#1)(2008-9#2)
photopolymer film##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
photopolymer films##7##2##(2008-1#2)(2008-2#2)(2008-3#3)
photopolymer media##2##2##(2007-12#2)
photopolymer recording##2##2##(2007-12#2)
photopolymer storage##2##2##(2007-12#1)(2008-3#1)
photopolymer systems##2##2##(2007-12#2)
photopolymer##38##1##(2007-12#15)(2007-8#1)(2008-1#2)(2008-2#4)(2008-3#13)(2008-7#1)(2008-9#2)
photopolymerizable##6##1##(2007-11#2)(2008-2#2)(2008-3#1)(2013-1#1)
photopolymerization kinetics##2##2##(2008-2#1)(2009-12#1)
photopolymerization of resins##2##3##(2007-12#2)
photopolymerization of##5##2##(2004-9#1)(2007-12#2)(2007-8#1)(2008-2#1)
photopolymerization##14##1##(2004-9#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-2#5)(2008-3#2)(2008-5#1)(2009-12#1)
photopolymerized##2##1##(2008-5#1)(2009-7#1)
photopolymers##4##1##(2007-12#1)(2008-2#1)(2008-3#2)
photoporation##8##1##(2011-1#8)
photoprobe##2##1##(1990-11#1)(1993-8#1)
photoproduced##2##1##(1994-8#2)
photoproduct is##2##2##(2006-3#2)
photoproduct of##5##2##(1990-5#1)(1991-7#1)(1995-1#2)(2008-10#1)
photoproduct was##2##2##(1995-1#1)(1995-8#1)
photoproduct with##2##2##(1990-2#1)(2006-6#1)
photoproduct##26##1##(1990-2#1)(1990-5#1)(1991-7#4)(1994-9#1)(1995-1#6)(1995-6#1)(1995-8#2)(1997-7#1)(2006-12#1)(2006-3#3)(2006-6#2)(2008-10#1)(2008-2#1)(2008-3#1)
photoproducts after##2##2##(2008-10#2)
photoproducts from##2##2##(2006-12#1)(2008-10#1)
photoproducts in a##2##3##(1996-11#1)(2008-3#1)
photoproducts in##4##2##(1996-11#3)(2008-3#1)
photoproducts of##2##2##(1992-6#1)(1995-1#1)
photoproducts##35##1##(1990-8#2)(1991-7#1)(1992-6#1)(1992-8#3)(1994-7#1)(1994-9#1)(1995-1#5)(1996-11#4)(2006-12#2)(2008-10#10)(2008-3#2)(2009-8#2)(2011-1#1)
photoprotection##12##1##(2008-5#5)(2010-9#1)(2011-2#3)(2012-2#3)
photoprotective agent##2##2##(2008-5#2)
photoprotective effect of##3##3##(2008-5#2)(2010-12#1)
photoprotective substance##2##2##(2008-11#2)
photoprotective##13##1##(1992-2#1)(2006-12#1)(2008-11#3)(2008-5#4)(2008-7#1)(2010-10#1)(2010-12#1)(2013-1#1)
photoprotein##3##1##(1990-8#3)
photoradiation##6##1##(1990-6#4)(2008-5#2)
photoreaction can##2##2##(1996-2#1)(2005-11#1)
photoreaction##8##1##(1991-12#1)(1991-7#1)(1996-2#1)(2005-11#1)(2007-12#2)(2008-3#1)(2008-9#1)
photoreactions##2##1##(1990-2#1)(1992-2#1)
photoreactive group at position##2##4##(1990-5#2)
photoreactive##21##1##(1990-11#2)(1990-5#5)(1991-10#1)(1991-7#1)(1993-11#2)(1993-5#1)(1994-2#1)(1994-8#3)(1995-1#1)(1996-7#3)(2011-2#1)
photoreactivity##4##1##(1992-6#2)(1997-6#2)
photoreactor##3##1##(2008-1#1)(2008-10#2)
photoreception##3##1##(1994-5#1)(2007-12#2)
photoreceptor and##3##2##(1992-8#1)(1994-3#1)(2012-12#1)
photoreceptor cell##7##2##(1991-12#2)(1993-6#1)(1995-10#1)(1996-5#1)(2008-5#1)(2009-10#1)
photoreceptor cells and##5##3##(1993-3#1)(2007-12#4)
photoreceptor cells exist##2##3##(2007-12#2)
photoreceptor cells that##2##3##(1991-12#1)(2008-7#1)
photoreceptor cells##20##2##(1990-11#1)(1990-6#1)(1990-7#1)(1991-12#1)(1993-3#1)(1994-10#2)(1994-12#1)(1994-5#2)(2007-12#7)(2008-7#2)(2008-9#1)
photoreceptor degeneration##5##2##(1990-11#1)(1997-3#1)(2011-1#3)
photoreceptor development in##2##3##(1996-2#1)(2011-1#1)
photoreceptor development##5##2##(1996-2#2)(1997-1#1)(2007-12#1)(2011-1#1)
photoreceptor differentiation##3##2##(1996-2#1)(2012-12#2)
photoreceptor disk##2##2##(1995-10#1)(1996-9#1)
photoreceptor outer segment disk shedding##2##5##(1996-9#2)
photoreceptor outer segment disk##3##4##(1995-10#1)(1996-9#2)
photoreceptor outer segment##4##3##(1995-10#1)(1996-9#2)(2008-7#1)
photoreceptor outer segments by the##2##5##(2008-3#1)(2012-12#1)
photoreceptor outer segments##6##3##(1994-2#1)(1995-9#1)(2008-3#2)(2008-7#1)(2012-12#1)
photoreceptor outer##10##2##(1994-2#1)(1995-10#1)(1995-9#1)(1996-9#2)(2008-3#2)(2008-7#2)(2012-12#1)
photoreceptor regeneration##2##2##(2010-1#2)
photoreceptor signals##2##2##(1995-7#2)
photoreceptor##96##1##(1990-11#4)(1990-6#1)(1990-7#2)(1991-12#3)(1991-6#2)(1991-9#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-3#1)(1993-6#1)(1993-7#2)(1994-10#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#3)(1995-10#4)(1995-7#2)(1995-8#4)(1995-9#1)(1996-2#3)(1996-5#1)(1996-9#3)(1997-1#1)(1997-3#1)(1997-4#1)(2007-12#12)(2007-5#1)(2008-3#3)(2008-5#1)(2008-7#4)(2008-9#2)(2009-10#1)(2009-8#1)(2010-1#4)(2010-12#1)(2011-1#4)(2011-12#1)(2012-12#4)(2012-3#3)
photoreceptors and lateral eyes##2##4##(1993-3#2)
photoreceptors and the##5##3##(1990-6#2)(1994-5#1)(2008-4#1)(2011-2#1)
photoreceptors and##14##2##(1990-6#3)(1993-3#2)(1994-5#1)(1996-6#1)(1997-4#1)(1997-5#3)(2008-4#1)(2011-2#2)
photoreceptors are##5##2##(1994-5#1)(1995-1#1)(2007-11#1)(2012-12#2)
photoreceptors in the##4##3##(1991-10#1)(1996-8#1)(2009-8#1)(2010-1#1)
photoreceptors in##5##2##(1991-10#1)(1992-7#1)(1996-8#1)(2009-8#1)(2010-1#1)
photoreceptors of the##2##3##(2008-9#1)(2011-1#1)
photoreceptors to##3##2##(2008-7#2)(2011-1#1)
photoreceptors were##2##2##(1994-3#1)(2010-1#1)
photoreceptors##67##1##(1990-6#3)(1991-10#1)(1992-7#4)(1993-3#3)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#5)(1995-1#2)(1995-7#1)(1996-2#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-4#2)(1997-5#3)(1997-7#1)(2007-11#1)(2007-12#1)(2007-5#2)(2008-10#1)(2008-4#2)(2008-7#3)(2008-9#3)(2009-10#1)(2009-6#1)(2009-8#2)(2010-1#4)(2011-1#2)(2011-2#2)(2012-12#6)
photoreduced##2##1##(1990-12#1)(1992-12#1)
photoreduction of##6##2##(1992-12#1)(1994-8#2)(2007-12#1)(2008-8#1)(2009-9#1)
photoreduction with ultraviolet light##2##4##(1990-7#1)(2007-8#1)
photoreduction with##3##2##(1990-7#1)(2007-8#1)(2013-7#1)
photoreduction##19##1##(1990-7#1)(1992-11#2)(1992-12#3)(1992-8#1)(1994-8#2)(1996-2#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-8#1)(2009-9#1)(2013-7#1)
photorefraction##4##1##(1992-7#1)(2007-11#1)(2007-12#2)
photorefractive Bragg gratings##2##3##(2007-12#2)
photorefractive KNbO(3)##2##2##(2008-1#2)
photorefractive SBN##2##2##(2008-3#2)
photorefractive and##2##2##(2008-3#2)
photorefractive barium titanate##2##3##(1990-4#1)(2007-12#1)
photorefractive crystal in##2##3##(2008-2#1)(2008-3#1)
photorefractive crystal inside the cavity##2##5##(2007-12#2)
photorefractive crystal is demonstrated##2##4##(2007-12#1)(2008-2#1)
photorefractive crystal is##7##3##(2007-12#2)(2008-2#2)(2008-3#3)
photorefractive crystal with##2##3##(2007-12#2)
photorefractive crystal##39##2##(2007-11#2)(2007-12#16)(2008-2#8)(2008-3#13)
photorefractive crystals with##3##3##(2007-12#3)
photorefractive crystals##16##2##(2007-11#1)(2007-12#10)(2008-2#2)(2008-3#3)
photorefractive damage##5##2##(2007-12#4)(2008-3#1)
photorefractive effect in##5##3##(2007-12#3)(2008-3#2)
photorefractive effect is##3##3##(2007-12#1)(2008-3#2)
photorefractive effect##16##2##(2007-12#9)(2008-2#1)(2008-3#6)
photorefractive four-wave mixing##4##3##(2008-2#3)(2008-3#1)
photorefractive grating##8##2##(2007-11#1)(2007-12#6)(2008-2#1)
photorefractive gratings##3##2##(2007-11#1)(2008-1#1)(2008-3#1)
photorefractive holograms in##2##3##(2007-12#1)(2008-3#1)
photorefractive holograms##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
photorefractive holographic##3##2##(2007-12#2)(2008-3#1)
photorefractive holography##2##2##(2007-11#2)
photorefractive incoherent-to-coherent optical converter##3##4##(2007-12#2)(2008-2#1)
photorefractive keratectomy##2##2##(2008-3#1)(2013-1#1)
photorefractive material##8##2##(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#2)
photorefractive materials##6##2##(2007-12#2)(2008-1#2)(2008-2#1)(2008-3#1)
photorefractive media##8##2##(2007-12#5)(2008-1#2)(2008-2#1)
photorefractive medium##6##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)
photorefractive memory##2##2##(2008-2#2)
photorefractive optical##2##2##(2007-11#1)(2008-2#1)
photorefractive phase-conjugate mirror##2##3##(2008-2#2)
photorefractive polymer composite##2##3##(2007-12#1)(2008-3#1)
photorefractive polymer##13##2##(2007-11#2)(2007-12#6)(2008-2#1)(2008-3#4)
photorefractive polymers##4##2##(2007-12#2)(2008-3#2)
photorefractive properties##5##2##(2007-11#3)(2007-12#2)
photorefractive recording media##2##3##(2008-2#2)
photorefractive response in##4##3##(2007-11#3)(2007-12#1)
photorefractive response of##2##3##(2007-11#1)(2007-12#1)
photorefractive response time of##2##4##(2007-11#2)
photorefractive response##9##2##(2007-11#6)(2007-12#3)
photorefractive screening solitons##2##3##(2007-12#2)
photorefractive screening##3##2##(2007-12#3)
photorefractive solitons##6##2##(2007-12#6)
photorefractive spatial solitons##3##3##(2007-12#3)
photorefractive spatial##5##2##(2007-11#1)(2007-12#4)
photorefractive strontium barium niobate##4##4##(2007-11#2)(2007-12#2)
photorefractive surface waves in BaTiO(3)##2##5##(2007-12#2)
photorefractive surface##3##2##(2007-12#3)
photorefractive two-beam coupling##3##3##(2007-12#2)(2008-3#1)
photorefractive two-wave mixing##2##3##(2008-1#1)(2008-3#1)
photorefractive volume hologram##2##3##(2007-12#2)
photorefractive volume##7##2##(2007-12#5)(2008-1#1)(2008-3#1)
photorefractive##283##1##(1990-4#1)(1992-8#1)(2007-11#31)(2007-12#129)(2008-1#18)(2008-2#45)(2008-3#57)(2013-1#1)
photorefractive-index change##3##2##(2007-11#2)(2007-12#1)
photorefractive-index##4##1##(2007-11#2)(2007-12#1)(2008-3#1)
photorefractives##2##1##(2007-12#1)(2008-2#1)
photorejuvenation##2##1##(2009-4#2)
photorelease of##3##2##(1997-4#2)(2008-4#1)
photorelease##5##1##(1997-4#2)(2008-4#3)
photoresist and##4##2##(2008-1#1)(2008-2#2)(2008-3#1)
photoresist grating##3##2##(2007-12#1)(2008-3#2)
photoresist gratings##2##2##(2008-3#2)
photoresist is##2##2##(2008-2#1)(2008-3#1)
photoresist on silicon##3##3##(2008-10#1)(2008-2#2)
photoresist##47##1##(2007-12#4)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#18)(2008-3#15)(2008-7#3)(2009-11#1)(2010-4#2)
photoresists##3##1##(2008-3#1)(2008-9#2)
photorespiration##6##1##(2008-8#4)(2009-10#1)(2009-8#1)
photoresponse##7##1##(1992-2#3)(1994-2#1)(2005-4#1)(2007-12#2)
photoresponses##2##1##(1992-11#1)(1995-8#1)
photoresponsive##4##1##(1990-4#1)(2007-11#1)(2008-7#1)(2009-5#1)
photoresponsivity##2##1##(2007-11#2)
photorhodopsin##3##1##(2006-3#1)(2006-6#2)
photos of opposite-sex faces##2##4##(2010-2#2)
photos of the##2##3##(2005-10#1)(2007-9#1)
photos of##7##2##(2005-10#1)(2007-9#1)(2008-5#2)(2010-2#2)(2011-2#1)
photos##15##1##(1991-7#1)(2005-10#1)(2007-11#1)(2007-9#1)(2008-2#1)(2008-5#2)(2010-2#4)(2011-2#1)(2013-1#3)
photoselected##2##1##(1997-3#1)(2007-12#1)
photoselection##2##1##(1997-3#1)(2007-12#1)
photosensitiser##9##1##(2007-11#8)(2008-1#1)
photosensitising##3##1##(2008-11#3)
photosensitive damage##5##2##(2008-8#5)
photosensitive films##2##2##(2007-12#1)(2008-2#1)
photosensitive glass##3##2##(2007-12#1)(2008-3#2)
photosensitive##43##1##(1991-2#1)(1993-7#1)(1994-10#1)(1995-6#1)(1997-5#1)(2006-12#1)(2007-11#4)(2007-12#13)(2008-1#2)(2008-10#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#1)(2008-8#6)
photosensitivity and##5##2##(1997-1#1)(2007-12#1)(2007-8#1)(2012-11#1)(2012-12#1)
photosensitivity due to##2##3##(1991-10#2)
photosensitivity in germanosilicate fibers##2##4##(2007-12#2)
photosensitivity in##9##2##(1990-1#1)(2006-9#1)(2007-11#1)(2007-12#4)(2008-2#1)(2011-2#1)
photosensitivity is##7##2##(1990-1#2)(1991-10#1)(2007-12#3)(2008-5#1)
photosensitivity of##5##2##(2007-12#5)
photosensitivity rashes##2##2##(2008-5#2)
photosensitivity was##2##2##(2008-5#1)(2012-3#1)
photosensitivity with##3##2##(2007-11#1)(2008-2#2)
photosensitivity##63##1##(1990-1#3)(1991-10#6)(1993-11#1)(1993-12#5)(1997-1#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#3)(2007-12#22)(2007-7#1)(2007-8#1)(2008-2#4)(2008-5#6)(2010-6#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)
photosensitization and##2##2##(1992-8#1)(2010-5#1)
photosensitization in##3##2##(1991-10#2)(1991-5#1)
photosensitization of##6##2##(1992-1#1)(1992-8#1)(1994-12#1)(1997-1#1)(2008-8#2)
photosensitization using##2##2##(2012-2#2)
photosensitization was investigated##2##3##(1990-1#1)(2012-2#1)
photosensitization##25##1##(1990-1#1)(1991-10#3)(1991-5#1)(1992-1#1)(1992-8#2)(1994-12#3)(1997-1#3)(2007-8#1)(2008-5#1)(2008-8#3)(2010-5#2)(2012-11#1)(2012-2#3)
photosensitized by##2##2##(2008-2#1)(2012-2#1)
photosensitized##9##1##(1993-8#1)(1994-12#1)(2006-12#1)(2007-11#1)(2008-2#3)(2008-8#1)(2012-2#1)
photosensitizer and##2##2##(1992-12#1)(2009-4#1)
photosensitizer concentration##3##2##(1996-7#1)(2008-3#1)(2012-2#1)
photosensitizer fluorescence##2##2##(2008-2#2)
photosensitizer for photodynamic therapy##2##4##(2012-3#2)
photosensitizer for##4##2##(1990-11#1)(2012-3#3)
photosensitizer in##2##2##(2008-2#1)(2012-3#1)
photosensitizer were##2##2##(2009-3#2)
photosensitizer##51##1##(1990-11#1)(1992-1#1)(1992-12#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-12#2)(1996-7#1)(2005-7#1)(2006-10#1)(2007-1#1)(2008-11#1)(2008-2#11)(2008-3#2)(2008-5#3)(2008-8#2)(2009-3#3)(2009-4#4)(2010-4#1)(2010-5#1)(2012-12#2)(2012-2#1)(2012-3#6)
photosensitizers and##3##2##(1992-7#1)(2008-5#1)(2009-3#1)
photosensitizers in##3##2##(1992-7#1)(1993-11#2)
photosensitizers such as##2##3##(1993-12#2)
photosensitizers used##2##2##(1994-3#1)(2009-4#1)
photosensitizers with##2##2##(1994-3#1)(2007-1#1)
photosensitizers##33##1##(1990-1#1)(1991-5#1)(1992-6#1)(1992-7#4)(1993-11#6)(1993-12#2)(1993-8#1)(1994-3#2)(2005-7#1)(2007-1#1)(2007-11#1)(2008-11#1)(2008-5#7)(2009-3#1)(2009-4#1)(2012-11#2)
photosensitizing agents##5##2##(1992-1#1)(1992-6#3)(2008-5#1)
photosensitizing concentration of##2##3##(2012-3#2)
photosensitizing drug##3##2##(1993-8#2)(1997-6#1)
photosensitizing##14##1##(1992-1#1)(1992-6#4)(1992-9#1)(1993-8#2)(1997-6#1)(2008-2#1)(2008-5#2)(2012-3#2)
photosensor##3##1##(2008-3#1)(2008-5#1)(2013-8#1)
photosensory##2##1##(1994-11#1)(2012-3#1)
photospray ionization##2##2##(2008-10#2)
photostabilities of##2##2##(2008-5#2)
photostabilities##3##1##(2007-8#1)(2008-5#2)
photostability of the##3##3##(2008-10#1)(2008-2#1)(2012-12#1)
photostability of##10##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#4)(2009-2#1)(2011-1#1)(2012-12#1)
photostability was##2##2##(2008-5#2)
photostability##22##1##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-5#9)(2009-2#2)(2009-4#1)(2011-1#1)(2012-12#1)
photostable and##2##2##(2011-2#1)(2012-12#1)
photostable##5##1##(2010-2#1)(2011-2#1)(2012-12#3)
photosynthate##2##1##(1997-6#1)(2008-9#1)
photosynthesis (A(max))##2##2##(2004-4#1)(2006-12#1)
photosynthesis and growth##2##3##(2008-10#1)(2009-10#1)
photosynthesis and##5##2##(2004-11#1)(2008-10#2)(2009-10#1)(2009-8#1)
photosynthesis by##2##2##(1993-12#1)(2009-8#1)
photosynthesis in the##2##3##(1993-12#1)(2008-10#1)
photosynthesis in##5##2##(1993-12#1)(2007-9#1)(2008-10#2)(2008-9#1)
photosynthesis is##2##2##(2007-9#1)(2009-2#1)
photosynthesis of##3##2##(1997-6#1)(2008-9#1)(2013-8#1)
photosynthesis to##2##2##(2008-10#1)(2013-8#1)
photosynthesis was##3##2##(2006-12#1)(2008-10#2)
photosynthesis were##2##2##(2012-12#1)(2012-7#1)
photosynthesis##70##1##(1993-12#3)(1995-6#2)(1996-12#2)(1997-6#1)(2004-11#3)(2004-4#1)(2006-12#3)(2007-1#3)(2007-9#2)(2008-10#16)(2008-12#2)(2008-3#1)(2008-6#1)(2008-8#3)(2008-9#3)(2009-10#2)(2009-2#2)(2009-5#1)(2009-6#2)(2009-8#4)(2010-2#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-5#1)(2012-7#2)(2013-1#2)(2013-8#2)
photosynthesis-related##2##1##(1996-12#1)(2008-9#1)
photosynthetic active##2##2##(2008-11#1)(2013-7#1)
photosynthetic and##4##2##(1993-12#1)(2007-12#1)(2009-8#1)(2011-2#1)
photosynthetic antenna##2##2##(1997-6#1)(2006-10#1)
photosynthetic bacteria is##2##3##(1993-8#1)(2009-10#1)
photosynthetic bacteria##7##2##(1991-3#1)(1993-8#1)(1994-12#1)(2008-6#1)(2008-8#2)(2009-10#1)
photosynthetic bacterium Rhodopseudomonas##2##3##(1991-3#1)(1993-8#1)
photosynthetic bacterium##7##2##(1991-3#1)(1991-5#1)(1993-8#1)(1995-1#1)(1996-2#1)(2008-6#1)(2009-10#1)
photosynthetic capacity of##3##3##(1995-8#1)(2008-11#1)(2013-8#1)
photosynthetic capacity##7##2##(1995-8#1)(2006-12#1)(2008-10#3)(2008-11#1)(2013-8#1)
photosynthetic electron flow##2##3##(2009-10#2)
photosynthetic electron transport to photorespiration##3##5##(2008-8#3)
photosynthetic electron transport##7##3##(1994-12#1)(1996-4#1)(2008-8#4)(2011-2#1)
photosynthetic electron##10##2##(1994-12#1)(1994-3#1)(1996-4#1)(2008-8#4)(2009-10#2)(2011-2#1)
photosynthetic function in##2##3##(2008-9#2)
photosynthetic function##3##2##(2008-9#3)
photosynthetic herbicides##3##2##(2008-10#3)
photosynthetic induction##2##2##(2013-8#2)
photosynthetic membrane##2##2##(1994-8#1)(2007-12#1)
photosynthetic membranes##3##2##(1991-3#2)(2008-7#1)
photosynthetic organisms##14##2##(1994-12#1)(2008-7#2)(2009-10#7)(2010-2#2)(2010-6#1)(2012-12#1)
photosynthetic oxygen##2##2##(1997-4#1)(2009-8#1)
photosynthetic oxygen-evolving complex##2##3##(1995-8#1)(2009-2#1)
photosynthetic pigments and##2##3##(2008-12#1)(2011-12#1)
photosynthetic pigments##6##2##(2008-12#2)(2011-1#1)(2011-12#3)
photosynthetic prokaryote##2##2##(1994-12#2)
photosynthetic purple##2##2##(1994-5#2)
photosynthetic rate (Pn)##2##3##(2008-5#1)(2013-8#1)
photosynthetic rate of##4##3##(2008-10#1)(2008-9#1)(2013-8#2)
photosynthetic rate##12##2##(2008-10#5)(2008-5#1)(2008-8#1)(2008-9#1)(2013-8#4)
photosynthetic rates##3##2##(2008-10#2)(2009-8#1)
photosynthetic reaction center##3##3##(1992-6#1)(1993-8#1)(1997-7#1)
photosynthetic reaction centers##3##3##(1991-4#1)(1992-6#1)(2010-4#1)
photosynthetic reaction##7##2##(1991-4#1)(1992-6#2)(1993-8#1)(1997-4#1)(1997-7#1)(2010-4#1)
photosynthetic responses of##2##3##(2012-5#1)(2012-7#1)
photosynthetic symbiosis##2##2##(2012-12#2)
photosynthetic systems##2##2##(2008-10#2)
photosynthetic unit##2##2##(2007-12#1)(2010-2#1)
photosynthetic##153##1##(1990-7#1)(1991-3#6)(1991-4#1)(1991-5#1)(1992-12#1)(1992-6#2)(1993-12#2)(1993-8#3)(1994-12#5)(1994-3#1)(1994-5#3)(1994-8#1)(1995-1#1)(1995-3#1)(1995-8#2)(1996-2#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#3)(1997-6#2)(1997-7#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-12#4)(2007-5#1)(2007-6#1)(2008-10#20)(2008-11#2)(2008-12#2)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#7)(2008-9#9)(2009-10#13)(2009-2#2)(2009-6#2)(2009-8#4)(2010-2#5)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#5)(2011-2#2)(2012-1#1)(2012-12#3)(2012-5#2)(2012-6#1)(2012-7#2)(2013-1#1)(2013-7#1)(2013-8#8)
photosynthetically active radiation (PAR)##2##4##(2006-3#1)(2008-10#1)
photosynthetically active radiation##4##3##(2006-3#1)(2008-10#2)(2008-3#1)
photosynthetically active##6##2##(2006-3#1)(2008-10#2)(2008-2#1)(2008-3#2)
photosystem 2##2##2##(1991-7#2)
photosystem I##10##2##(1991-1#1)(1991-12#1)(1992-11#2)(1994-12#2)(1995-11#2)(1996-7#1)(2008-7#1)
photosystem I-mediated##2##2##(1991-1#2)
photosystem II (PS II)##3##4##(1994-12#1)(1995-8#1)(2008-10#1)
photosystem II (PSII)##6##3##(1991-7#1)(1994-8#1)(1997-6#1)(2008-10#1)(2008-8#1)(2009-2#1)
photosystem II by##2##3##(1994-8#1)(1995-8#1)
photosystem II in##2##3##(1994-12#2)
photosystem II is##2##3##(1990-8#1)(1992-4#1)
photosystem II membranes##4##3##(1990-5#2)(1991-7#1)(1992-3#1)
photosystem II of##2##3##(1997-4#2)
photosystem II reaction center##3##4##(1994-10#1)(1995-8#2)
photosystem II reaction##4##3##(1994-10#1)(1995-8#2)(1997-4#1)
photosystem II##47##2##(1990-5#2)(1990-8#1)(1991-12#1)(1991-7#2)(1992-3#2)(1992-4#3)(1994-10#1)(1994-12#3)(1994-8#5)(1995-8#9)(1996-10#1)(1996-4#1)(1997-4#4)(1997-6#2)(1997-7#1)(2008-10#2)(2008-11#2)(2008-8#3)(2009-2#2)
photosystem##62##1##(1990-5#2)(1990-8#1)(1991-1#3)(1991-12#2)(1991-7#4)(1992-11#2)(1992-3#2)(1992-4#3)(1994-10#1)(1994-12#5)(1994-8#6)(1995-11#2)(1995-8#9)(1996-10#1)(1996-4#1)(1996-7#1)(1997-4#4)(1997-6#2)(1997-7#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#3)(2009-2#2)
photosystem-II##6##1##(1990-5#6)
phototactic##2##1##(1993-3#1)(2009-10#1)
phototherapy for##2##2##(1997-6#1)(2008-12#1)
phototherapy in##3##2##(1994-3#1)(2007-7#1)(2007-8#1)
phototherapy with a##2##3##(2008-3#2)
phototherapy##29##1##(1992-4#2)(1994-12#1)(1994-3#2)(1995-5#1)(1997-6#2)(2005-11#1)(2007-11#1)(2007-7#6)(2007-8#5)(2008-11#1)(2008-12#1)(2008-3#3)(2010-3#1)(2010-7#1)(2012-12#1)
photothermal OCT##3##2##(2011-1#3)
photothermal deflection spectroscopy##3##3##(2008-2#1)(2008-3#2)
photothermal deflection##6##2##(2007-11#1)(2008-2#2)(2008-3#3)
photothermal lens spectroscopy##2##3##(2008-2#2)
photothermal lens##4##2##(2008-2#4)
photothermal method##2##2##(2008-10#1)(2008-3#1)
photothermal radiometry##3##2##(2008-2#2)(2012-1#1)
photothermal signals##2##2##(2008-3#2)
photothermal therapy##5##2##(2008-2#1)(2012-12#3)(2013-1#1)
photothermal##47##1##(1994-3#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-2#15)(2008-3#14)(2010-6#1)(2011-1#4)(2012-1#1)(2012-12#3)(2013-1#1)
photothermorefractive glass##3##2##(2007-12#2)(2008-2#1)
photothermorefractive##4##1##(2007-12#2)(2008-2#2)
phototoxic##10##1##(1994-8#1)(1997-6#1)(2005-11#1)(2006-12#2)(2007-7#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
phototoxicity and##3##2##(1997-6#1)(2008-2#1)(2008-5#1)
phototoxicity##12##1##(1990-9#1)(1993-11#1)(1997-6#1)(2006-12#3)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-7#1)
phototransduction##7##1##(1990-11#1)(1991-9#1)(1993-7#1)(1994-12#1)(1994-5#1)(1997-4#1)(1997-7#1)
phototransformation of##2##2##(1992-8#1)(2008-10#1)
phototrophic##3##1##(1997-2#1)(2008-8#1)(2009-4#1)
phototrophs##4##1##(2009-4#2)(2012-2#2)
phototropic##2##1##(2008-9#1)(2011-1#1)
phototropism of rice root##3##4##(2008-9#3)
phototropism##7##1##(2008-9#7)
phototype##10##1##(2008-5#9)(2011-2#1)
photovoltage##2##1##(2007-11#1)(2008-2#1)
photovoltaic devices##2##2##(2007-9#1)(2009-11#1)
photovoltaic film##3##2##(2008-2#3)
photovoltaic spatial solitons##3##3##(2007-12#3)
photovoltaic spatial##4##2##(2007-12#4)
photovoltaic##20##1##(1996-2#1)(2007-12#7)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#7)(2008-7#1)(2009-11#1)
php##5##1##(2007-6#1)(2009-3#1)(2009-4#1)(2010-5#1)(2010-8#1)
phr probes##2##2##(1993-5#2)
phr##4##1##(1993-5#4)
phrase &quot##4##2##(1996-2#1)(2007-12#1)(2007-2#1)(2013-1#1)
phrase in##3##2##(2007-8#1)(2011-2#1)(2013-1#1)
phrase length##2##2##(2008-4#2)
phrase##30##1##(1991-9#1)(1996-2#1)(2005-8#1)(2007-12#2)(2007-2#1)(2007-8#5)(2008-11#1)(2008-4#5)(2009-2#1)(2010-2#2)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#6)
phrases to##4##2##(2013-1#4)
phrases##29##1##(1991-2#1)(1994-2#2)(2008-2#1)(2008-4#3)(2008-7#1)(2008-8#2)(2011-2#1)(2012-3#1)(2013-1#16)(2013-8#1)
phrenic and##2##2##(1994-10#1)(1997-6#1)
phrenic motoneurons##3##2##(1990-7#2)(1997-8#1)
phrenic nerve paresis##5##3##(2013-1#5)
phrenic nerve##20##2##(1992-8#1)(1994-10#6)(1997-1#1)(1997-4#1)(2008-9#5)(2012-2#1)(2013-1#5)
phrenic##33##1##(1990-7#4)(1992-3#2)(1992-8#1)(1994-10#8)(1997-1#1)(1997-4#3)(1997-6#1)(1997-8#1)(2006-8#1)(2008-9#5)(2012-2#1)(2013-1#5)
phrenic-musculocutaneous nerve transfer##4##3##(2008-9#4)
phthalanilic##2##1##(2005-4#2)
phthalate (BBP)##4##2##(1993-3#1)(2004-9#1)(2008-10#1)(2008-5#1)
phthalate (DBP)##7##2##(2004-9#1)(2008-10#4)(2008-5#1)(2010-5#1)
phthalate (DEHP) and##2##3##(2008-5#1)(2010-7#1)
phthalate (DEHP)##7##2##(2004-9#1)(2007-4#1)(2008-10#2)(2008-5#1)(2010-7#1)(2011-2#1)
phthalate (DEP)##2##2##(2008-10#1)(2008-5#1)
phthalate (DOP)##6##2##(2008-10#6)
phthalate acid esters##2##3##(2008-10#2)
phthalate as the internal##2##4##(2005-12#1)(2005-3#1)
phthalate as##5##2##(2005-12#1)(2005-3#1)(2008-10#3)
phthalate crystals##2##2##(2008-2#2)
phthalate##76##1##(1993-3#2)(2004-9#3)(2005-11#2)(2005-12#1)(2005-3#1)(2005-7#6)(2007-4#4)(2008-10#29)(2008-12#1)(2008-2#3)(2008-5#12)(2008-8#1)(2010-2#1)(2010-5#3)(2010-7#2)(2011-2#3)(2012-2#1)(2013-8#1)
phthalate)##2##1##(2008-10#1)(2008-2#1)
phthalates were##3##2##(2005-7#2)(2008-5#1)
phthalates##14##1##(2004-4#1)(2005-7#2)(2008-10#8)(2008-11#2)(2008-5#1)
phthaleins##3##1##(2008-10#3)
phthalic acid in##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
phthalic acid##10##2##(1994-3#1)(2005-11#4)(2008-10#1)(2008-3#1)(2008-5#3)
phthalic anhydride##2##2##(1995-11#1)(1997-3#1)
phthalic##16##1##(1994-3#1)(1995-11#1)(1997-3#1)(2005-11#4)(2008-10#5)(2008-3#1)(2008-5#3)
phthalide##2##1##(2008-11#2)
phthalides##2##1##(2008-12#2)
phthalocyanine (CoTSPc)##4##2##(2005-4#2)(2008-10#2)
phthalocyanine (FePc)##2##2##(2008-10#2)
phthalocyanine and##4##2##(2008-10#2)(2010-5#2)
phthalocyanine complex##5##2##(2006-12#1)(2008-10#4)
phthalocyanine derivative##2##2##(2007-12#1)(2010-4#1)
phthalocyanine molecules##2##2##(1992-2#1)(2010-4#1)
phthalocyanine tetrasulfonate##2##2##(1990-11#2)
phthalocyanine##54##1##(1990-11#2)(1992-1#1)(1992-2#2)(1992-6#1)(1993-8#2)(1996-7#1)(2005-4#5)(2006-12#2)(2007-12#2)(2008-10#31)(2008-3#1)(2010-4#2)(2010-5#2)
phthalocyanines##5##1##(1993-8#2)(1994-12#1)(2006-12#1)(2008-10#1)
phthaloyl##3##1##(1996-4#1)(1997-1#1)(2009-9#1)
phthirapteran##2##1##(2007-12#2)
phthirapterans##5##1##(2007-12#5)
phycobilisome##4##1##(1990-9#1)(1993-11#1)(2008-8#2)
phycobilisomes##9##1##(1992-3#3)(1993-11#5)(1997-6#1)
phycocyanin 645##2##2##(1994-5#2)
phycocyanin and##2##2##(1997-6#2)
phycocyanin##9##1##(1994-5#2)(1997-6#2)(2008-3#1)(2008-8#4)
phycocyanobilins##3##1##(1994-5#3)
phycoerythrin as a##2##3##(1997-2#1)(2008-4#1)
phycoerythrin fluorescence##4##2##(1997-2#1)(2008-10#1)(2008-2#2)
phycoerythrin spectral##3##2##(2008-2#3)
phycoerythrin##24##1##(1996-12#1)(1997-2#4)(2008-10#1)(2008-2#5)(2008-3#2)(2008-4#3)(2008-8#6)(2008-9#2)
phycoerythrin-streptavidin##2##1##(1990-12#1)(2008-4#1)
phycoerythrobilin##3##1##(2008-2#2)(2008-3#1)
phycoerythrocyanin##3##1##(1990-9#2)(2008-8#1)
phycomycosis##3##1##(2007-7#3)
phycourobilin##4##1##(2008-2#2)(2008-3#1)(2008-8#1)
phyla##14##1##(1991-6#1)(1992-6#1)(2006-8#1)(2007-12#2)(2008-4#2)(2008-9#2)(2009-6#1)(2010-11#1)(2011-2#2)(2012-2#1)
phylactolaemate##2##1##(2011-2#2)
phyletic##3##1##(2009-6#1)(2010-3#1)(2010-6#1)
phylla##2##1##(2008-10#1)(2009-8#1)
phyllanthi##2##1##(2012-11#2)
phyllobacteria##3##1##(2008-10#3)
phyllodes tumor of the breast##4##5##(1994-12#1)(1995-4#3)
phyllodes tumor##11##2##(1992-10#2)(1994-12#1)(1995-4#5)(1996-6#3)
phyllodes tumour of the seminal vesicle##2##6##(2011-2#2)
phyllodes tumour of the##4##4##(2008-6#2)(2011-2#2)
phyllodes tumour##5##2##(2008-6#2)(2011-2#3)
phyllodes##22##1##(1992-10#2)(1994-12#1)(1995-4#5)(1996-6#3)(2008-6#2)(2011-2#4)(2011-3#5)
phyllody##3##1##(2008-10#3)
phylloplane##4##1##(2008-10#4)
phyllosilicates##4##1##(2008-6#4)
phyllosphere##3##1##(2007-12#1)(2008-10#2)
phyllotactic##2##1##(1991-11#1)(2009-8#1)
phyllotaxis##2##1##(2009-8#2)
phylogenetic affinity between Plecoptera and the other orders of Polyneoptera##2##10##(2007-12#2)
phylogenetic analyses of the internal transcribed spacer##2##7##(2008-10#2)
phylogenetic analyses of the##7##4##(2008-10#5)(2008-8#1)(2010-3#1)
phylogenetic analyses of##13##3##(2008-10#8)(2008-8#1)(2010-3#3)(2011-1#1)
phylogenetic analyses were performed##2##4##(2008-10#1)(2013-7#1)
phylogenetic analyses were##3##3##(2007-6#1)(2008-10#1)(2013-7#1)
phylogenetic analyses##30##2##(1995-11#1)(2007-6#1)(2008-10#14)(2008-8#2)(2009-5#1)(2009-6#1)(2010-3#4)(2010-6#1)(2011-1#1)(2012-2#1)(2013-7#1)(2013-8#2)
phylogenetic analysis based on the##2##5##(2008-10#1)(2008-5#1)
phylogenetic analysis based on##3##4##(2008-10#1)(2008-5#1)(2013-7#1)
phylogenetic analysis indicated that##2##4##(2008-10#2)
phylogenetic analysis is##2##3##(2007-12#1)(2008-10#1)
phylogenetic analysis of the##6##4##(1993-11#1)(2008-10#2)(2008-5#1)(2008-8#1)(2011-1#1)
phylogenetic analysis of##21##3##(1993-11#1)(1993-12#1)(1996-12#1)(1996-6#1)(1997-8#1)(2007-12#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-3#1)(2013-8#1)
phylogenetic analysis showed that##3##4##(2005-11#1)(2008-8#1)(2011-2#1)
phylogenetic analysis to##2##3##(2008-10#2)
phylogenetic analysis using##3##3##(1996-5#1)(2008-10#2)
phylogenetic analysis was##2##3##(1994-8#1)(2008-10#1)
phylogenetic analysis##61##2##(1993-11#1)(1993-12#1)(1994-8#1)(1995-3#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-8#1)(2005-11#1)(2007-12#2)(2008-1#1)(2008-10#22)(2008-4#1)(2008-5#5)(2008-8#3)(2008-9#1)(2009-2#1)(2009-5#2)(2010-10#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#2)
phylogenetic and molecular##2##3##(2010-3#1)(2013-8#1)
phylogenetic and##14##2##(1990-11#1)(1995-11#1)(1997-4#1)(2006-5#1)(2008-10#1)(2008-8#1)(2008-9#2)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
phylogenetic approach##5##2##(1996-3#1)(2008-8#1)(2010-3#1)(2010-6#1)(2013-7#1)
phylogenetic associations##2##2##(2008-8#2)
phylogenetic background##2##2##(2008-4#1)(2012-12#1)
phylogenetic branch##2##2##(1997-4#1)(2008-10#1)
phylogenetic characteristics##3##2##(2006-8#2)(2008-9#1)
phylogenetic comparative data##2##3##(2008-8#1)(2012-3#1)
phylogenetic comparative##3##2##(2008-8#1)(2012-3#2)
phylogenetic comparison##3##2##(1991-5#1)(1995-6#1)(2007-6#1)
phylogenetic comparisons##2##2##(1990-11#1)(2011-2#1)
phylogenetic conservation##2##2##(1993-12#1)(1995-3#1)
phylogenetic considerations##2##2##(1990-11#1)(2008-7#1)
phylogenetic correction##2##2##(2008-8#2)
phylogenetic correlation##3##2##(2008-8#3)
phylogenetic coverage##2##2##(2008-10#2)
phylogenetic data##3##2##(2006-10#1)(2008-9#1)(2013-7#1)
phylogenetic dependence##2##2##(2008-8#2)
phylogenetic distribution##2##2##(2008-7#1)(2008-8#1)
phylogenetic estimation of##2##3##(2010-6#2)
phylogenetic estimation##4##2##(1992-1#1)(2010-6#3)
phylogenetic framework##3##2##(2008-7#1)(2008-8#1)(2009-2#1)
phylogenetic group##3##2##(2008-10#1)(2008-4#2)
phylogenetic groups using##2##3##(2008-10#1)(2008-8#1)
phylogenetic groups##5##2##(2008-10#4)(2008-8#1)
phylogenetic history and##2##3##(2006-5#1)(2012-2#1)
phylogenetic history##3##2##(2006-5#1)(2012-2#1)(2012-3#1)
phylogenetic implications of##2##3##(2007-12#2)
phylogenetic implications##6##2##(2007-12#5)(2011-2#1)
phylogenetic inference##5##2##(2008-8#2)(2010-6#1)(2012-12#1)(2013-1#1)
phylogenetic information##6##2##(1995-11#2)(2008-8#1)(2010-6#3)
phylogenetic interest because of the##2##5##(2011-2#2)
phylogenetic interest because of##4##4##(2011-2#4)
phylogenetic interest because##5##3##(2011-2#5)
phylogenetic lineages##3##2##(2008-10#2)(2008-8#1)
phylogenetic methods##3##2##(1995-8#1)(2008-8#1)(2010-3#1)
phylogenetic networks##2##2##(2008-4#1)(2008-8#1)
phylogenetic origin of##2##3##(1996-5#1)(2008-10#1)
phylogenetic origin##4##2##(1990-1#1)(1993-11#1)(1996-5#1)(2008-10#1)
phylogenetic origins##2##2##(1995-12#1)(2010-7#1)
phylogenetic position of##4##3##(2007-12#1)(2008-10#1)(2008-8#1)(2011-2#1)
phylogenetic position within the##2##4##(2011-2#1)(2013-7#1)
phylogenetic position##7##2##(2007-12#1)(2008-10#1)(2008-8#1)(2011-2#3)(2013-7#1)
phylogenetic reconstruction and##2##3##(2008-8#2)
phylogenetic reconstruction##5##2##(2008-8#3)(2008-9#1)(2009-6#1)
phylogenetic reconstructions##2##2##(1991-6#1)(2008-10#1)
phylogenetic relationship of##5##3##(1994-11#1)(1996-12#1)(1996-7#1)(2007-12#1)(2008-8#1)
phylogenetic relationship##10##2##(1994-11#1)(1996-12#1)(1996-7#1)(2007-12#1)(2008-10#2)(2008-8#1)(2009-10#1)(2010-10#1)(2013-1#1)
phylogenetic relationships among##8##3##(1992-4#1)(1996-3#1)(2008-10#3)(2008-5#2)(2008-6#1)
phylogenetic relationships between##2##3##(2008-10#1)(2008-5#1)
phylogenetic relationships of##7##3##(1997-4#1)(2007-12#1)(2008-10#2)(2010-3#1)(2010-6#2)
phylogenetic relationships were detected##2##4##(2008-10#2)
phylogenetic relationships were##3##3##(2008-10#2)(2008-6#1)
phylogenetic relationships within##3##3##(2007-12#1)(2008-10#2)
phylogenetic relationships##30##2##(1992-4#1)(1996-3#1)(1996-4#1)(1997-4#1)(2007-12#3)(2008-10#11)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-3#1)(2010-6#2)
phylogenetic results##2##2##(2006-8#1)(2010-3#1)
phylogenetic species##3##2##(2008-10#3)
phylogenetic studies##8##2##(2006-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-6#2)(2012-12#1)(2013-7#1)
phylogenetic study of##2##3##(2007-12#1)(2010-6#1)
phylogenetic study##7##2##(2007-12#1)(2008-10#1)(2010-6#4)(2013-7#1)
phylogenetic tree and##2##3##(2011-1#1)(2013-8#1)
phylogenetic tree based on##3##4##(2008-10#2)(2013-1#1)
phylogenetic tree obtained##2##3##(1997-2#1)(2008-5#1)
phylogenetic tree of the##2##4##(1997-2#1)(1997-7#1)
phylogenetic tree of##7##3##(1990-4#1)(1991-4#1)(1996-7#1)(1997-2#1)(1997-7#1)(2008-8#2)
phylogenetic tree was constructed##3##4##(1990-8#1)(2013-8#2)
phylogenetic tree was reconstructed##2##4##(2011-1#1)(2013-8#1)
phylogenetic tree was##6##3##(1990-8#1)(2010-7#1)(2011-1#1)(2013-8#3)
phylogenetic tree##44##2##(1990-4#1)(1990-8#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-2#1)(1993-6#1)(1995-3#1)(1996-5#1)(1996-7#1)(1997-2#2)(1997-7#1)(2005-11#1)(2007-1#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-4#5)(2008-5#1)(2008-8#3)(2009-10#1)(2010-6#1)(2010-7#1)(2011-1#2)(2012-2#1)(2013-1#1)(2013-8#5)
phylogenetic trees##20##2##(1991-5#2)(1993-6#2)(1994-6#1)(2008-1#3)(2008-10#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2013-8#2)
phylogenetic##418##1##(1990-1#1)(1990-11#4)(1990-3#1)(1990-4#1)(1990-8#1)(1991-4#1)(1991-5#4)(1991-6#2)(1991-9#2)(1992-1#1)(1992-2#1)(1992-4#1)(1993-11#2)(1993-12#2)(1993-5#1)(1993-6#5)(1993-8#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#4)(1995-12#1)(1995-3#3)(1995-6#1)(1995-8#2)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#2)(1997-2#2)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#2)(2006-10#3)(2006-5#3)(2006-8#4)(2007-1#1)(2007-12#21)(2007-6#2)(2008-1#6)(2008-10#84)(2008-11#1)(2008-12#1)(2008-4#17)(2008-5#13)(2008-6#3)(2008-7#10)(2008-8#41)(2008-9#12)(2009-10#3)(2009-2#2)(2009-5#4)(2009-6#4)(2010-10#2)(2010-12#1)(2010-3#13)(2010-6#22)(2010-7#2)(2010-8#1)(2011-1#6)(2011-2#19)(2011-3#1)(2012-11#1)(2012-12#5)(2012-2#9)(2012-3#4)(2013-1#8)(2013-7#9)(2013-8#12)
phylogenetically and##2##2##(2008-10#1)(2008-5#1)
phylogenetically based statistical##2##3##(2008-9#2)
phylogenetically closely related##3##3##(2008-10#2)(2008-5#1)
phylogenetically conserved##7##2##(1991-2#1)(1992-9#1)(1996-8#3)(2008-4#1)(2012-3#1)
phylogenetically distant species##3##3##(1991-12#1)(1993-3#1)(2008-7#1)
phylogenetically distant##5##2##(1991-12#1)(1993-3#1)(2008-10#1)(2008-7#2)
phylogenetically distinct from the##2##4##(2008-10#1)(2010-3#1)
phylogenetically distinct from##5##3##(2008-10#4)(2010-3#1)
phylogenetically distinct##9##2##(2008-10#8)(2010-3#1)
phylogenetically independent contrasts##3##3##(2008-8#3)
phylogenetically independent##5##2##(2008-8#3)(2009-8#1)(2013-1#1)
phylogenetically informative and##2##3##(2008-10#1)(2008-5#1)
phylogenetically invariant##2##2##(1994-8#1)(1997-7#1)
phylogenetically more##2##2##(1995-8#1)(2009-10#1)
phylogenetically related to##4##3##(1997-2#1)(1997-4#1)(2011-2#1)(2012-12#1)
phylogenetically related##5##2##(1997-2#1)(1997-4#1)(2006-12#1)(2011-2#1)(2012-12#1)
phylogenetically##67##1##(1991-12#1)(1991-2#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-6#2)(1995-8#2)(1996-8#4)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-12#3)(2006-5#1)(2006-7#1)(2007-12#1)(2008-10#15)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-5#1)(2009-8#1)(2010-3#2)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
phylogenetics and##2##2##(2008-8#1)(2010-3#1)
phylogenetics of##2##2##(2008-7#1)(2010-6#1)
phylogenetics##9##1##(1992-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-3#1)(2010-6#3)
phylogenic analysis##3##2##(1994-10#1)(2009-3#1)(2012-11#1)
phylogenic tree##2##2##(2005-11#1)(2012-1#1)
phylogenic##7##1##(1991-12#1)(1994-10#1)(2005-11#1)(2009-3#1)(2012-1#1)(2012-11#2)
phylogenically conserved##2##2##(1991-1#2)
phylogenies and##4##2##(1995-8#1)(2008-8#1)(2010-5#1)(2012-3#1)
phylogenies of##3##2##(2008-10#1)(2008-9#1)(2012-3#1)
phylogenies##28##1##(1991-9#1)(1992-1#1)(1992-12#1)(1995-8#2)(1996-11#2)(2007-12#1)(2008-10#3)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-2#1)(2010-10#2)(2010-5#1)(2011-2#1)(2012-3#5)
phylogenomic analyses of##2##3##(2008-7#1)(2013-8#1)
phylogenomic analyses##4##2##(2008-7#2)(2010-3#1)(2013-8#1)
phylogenomic##14##1##(2008-4#1)(2008-7#5)(2009-10#2)(2010-3#1)(2012-2#1)(2012-3#2)(2013-8#2)
phylogenomics##2##1##(2010-3#2)
phylogeny and##9##2##(1994-8#1)(1995-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-3#2)(2013-8#1)
phylogeny are##2##2##(2009-5#1)(2009-6#1)
phylogeny inferred from##3##3##(1994-12#1)(2008-10#1)(2008-9#1)
phylogeny of the##6##3##(1993-6#2)(2006-10#1)(2008-10#1)(2008-7#1)(2013-7#1)
phylogeny of##21##2##(1993-6#2)(1995-11#2)(1995-2#1)(1996-11#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-6#1)(2013-7#1)
phylogeny was##2##2##(1996-11#1)(2007-12#1)
phylogeny##102##1##(1991-6#2)(1992-1#2)(1993-6#2)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#3)(1995-2#1)(1995-3#1)(1996-11#4)(1997-4#2)(2006-10#1)(2006-5#1)(2007-12#11)(2007-3#1)(2007-7#1)(2008-10#13)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#7)(2008-9#7)(2009-10#1)(2009-5#2)(2009-6#2)(2010-3#5)(2010-4#1)(2010-6#4)(2010-7#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#3)(2013-8#3)
phylogeographic pattern##2##2##(1996-6#2)
phylogeographic##9##1##(1995-8#1)(1996-6#3)(2008-7#1)(2010-8#2)(2013-1#1)(2013-7#1)
phylogeography of##2##2##(1996-6#1)(2008-10#1)
phylogeography##3##1##(1996-6#1)(2008-10#1)(2010-8#1)
phylogram##2##1##(2008-10#1)(2012-2#1)
phylotype I##2##2##(2008-10#2)
phylotype##5##1##(2008-10#2)(2011-1#1)(2011-2#2)
phylotypes##7##1##(2010-6#2)(2011-1#3)(2011-2#1)(2012-12#1)
phylum Planctomycetes##2##2##(2011-1#2)
phylum Synergistetes##3##2##(2011-2#3)
phylum of##2##2##(1994-2#1)(2010-6#1)
phylum##32##1##(1992-6#1)(1994-12#1)(1994-2#1)(1996-5#2)(2006-10#1)(2006-8#1)(2007-12#2)(2008-10#1)(2008-7#3)(2010-6#2)(2011-1#2)(2011-2#9)(2012-2#1)(2013-8#5)
physeal##9##1##(1993-4#1)(2005-7#3)(2009-3#1)(2010-3#3)(2013-1#1)
physes##4##1##(2007-2#3)(2013-1#1)
physical Health Improvement Profile##2##4##(2009-6#2)
physical Health Improvement##3##3##(2009-6#3)
physical UV filter##3##3##(2008-5#3)
physical ability##9##2##(1996-4#1)(2007-8#1)(2011-12#7)
physical abuse by parents##2##4##(2009-7#2)
physical abuse by##3##3##(2009-7#3)
physical abuse##14##2##(1995-11#1)(2006-2#1)(2007-12#1)(2009-4#1)(2009-7#3)(2010-7#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#1)
physical activities and##3##3##(2010-8#1)(2011-2#1)(2012-2#1)
physical activities##15##2##(1993-3#1)(1995-6#2)(1996-6#1)(2005-3#1)(2008-1#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#1)
physical activity (PA)##5##3##(2009-3#2)(2011-2#1)(2012-2#1)(2013-1#1)
physical activity among sedentary##2##4##(2008-4#1)(2010-2#1)
physical activity among##4##3##(2008-4#1)(2010-11#1)(2010-2#1)(2012-12#1)
physical activity and exercise##5##4##(2007-9#1)(2013-1#4)
physical activity and health##2##4##(2010-1#1)(2013-1#1)
physical activity and healthy eating##5##5##(2011-1#1)(2013-1#4)
physical activity and nutrition intervention##4##5##(2007-12#4)
physical activity and nutrition##7##4##(2007-12#4)(2008-7#2)(2010-9#1)
physical activity and other##2##4##(2009-6#1)(2013-7#1)
physical activity and physical##2##4##(2009-6#1)(2013-1#1)
physical activity and the##4##4##(2007-7#1)(2008-4#1)(2009-6#1)(2012-12#1)
physical activity and##55##3##(1993-10#1)(1996-4#1)(2005-10#1)(2006-10#1)(2006-2#2)(2006-8#4)(2006-9#1)(2007-12#4)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#3)(2009-6#4)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#12)(2013-7#1)
physical activity are##3##3##(1996-2#1)(2010-3#1)(2010-5#1)
physical activity as##2##3##(1993-2#1)(2008-10#1)
physical activity at##4##3##(1991-9#1)(2004-10#1)(2010-11#1)(2013-1#1)
physical activity behaviour##2##3##(2010-2#2)
physical activity counseling##4##3##(2008-4#4)
physical activity during##2##3##(2007-2#1)(2009-9#1)
physical activity for##5##3##(1996-6#1)(2008-12#1)(2010-12#1)(2011-2#1)(2012-11#1)
physical activity in an##2##4##(2010-12#1)(2012-12#1)
physical activity in the first half of pregnancy##2##8##(2011-2#2)
physical activity in the##4##4##(2006-12#1)(2011-1#1)(2011-2#2)
physical activity in##16##3##(1995-2#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2013-1#3)
physical activity is a##3##4##(2009-12#2)(2013-1#1)
physical activity is##12##3##(1995-8#1)(2005-10#3)(2008-3#1)(2009-12#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
physical activity level were##2##4##(2012-12#1)(2012-2#1)
physical activity level##4##3##(2008-11#1)(2012-1#1)(2012-12#1)(2012-2#1)
physical activity levels##7##3##(1996-12#1)(2008-11#1)(2008-3#2)(2008-4#1)(2012-12#1)(2012-2#1)
physical activity measurement##2##3##(1991-9#1)(2008-12#1)
physical activity might##2##3##(2013-1#2)
physical activity of healthcare workers##3##5##(2013-1#3)
physical activity on body##2##4##(2007-12#1)(2008-5#1)
physical activity on most days##2##5##(2005-10#1)(2012-12#1)
physical activity on##13##3##(2005-10#2)(2007-12#1)(2008-5#1)(2010-3#1)(2010-9#1)(2012-12#2)(2013-1#4)(2013-8#1)
physical activity or##4##3##(2006-2#1)(2009-3#1)(2013-1#2)
physical activity participation##6##3##(2009-6#1)(2010-2#3)(2012-2#1)(2013-7#1)
physical activity practice##2##3##(2010-11#1)(2013-1#1)
physical activity recommendations in##2##4##(2010-3#1)(2011-2#1)
physical activity recommendations##3##3##(2010-3#1)(2011-2#1)(2012-12#1)
physical activity than subjects##2##4##(2008-4#1)(2010-11#1)
physical activity to##2##3##(1995-3#1)(2006-8#1)
physical activity was##5##3##(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#2)
physical activity which##2##3##(2005-10#1)(2011-2#1)
physical activity##329##2##(1991-12#2)(1991-2#1)(1991-5#1)(1991-9#3)(1993-10#1)(1993-2#1)(1994-11#1)(1994-2#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-12#1)(1996-2#2)(1996-4#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(2004-10#1)(2005-10#7)(2006-10#4)(2006-12#1)(2006-2#5)(2006-8#9)(2006-9#3)(2007-10#4)(2007-11#1)(2007-12#5)(2007-2#1)(2007-6#2)(2007-7#6)(2007-8#1)(2007-9#3)(2008-1#4)(2008-10#2)(2008-11#6)(2008-12#4)(2008-3#10)(2008-4#11)(2008-5#3)(2008-7#4)(2008-9#1)(2009-12#3)(2009-3#3)(2009-5#1)(2009-6#11)(2009-9#1)(2010-1#3)(2010-11#14)(2010-12#7)(2010-2#9)(2010-3#7)(2010-4#1)(2010-5#3)(2010-7#2)(2010-8#4)(2010-9#7)(2011-1#13)(2011-11#1)(2011-2#17)(2012-1#2)(2012-11#4)(2012-12#13)(2012-2#11)(2013-1#54)(2013-7#5)(2013-8#12)
physical adsorption of##3##3##(2005-11#2)(2009-12#1)
physical adsorption##10##2##(2005-11#3)(2008-10#5)(2009-12#1)(2013-8#1)
physical agents##3##2##(1990-6#2)(2007-7#1)
physical aggression and##2##3##(2008-2#1)(2011-2#1)
physical aggression in children with attention-deficit/hyperactivity disorder##2##7##(2008-2#2)
physical aggression##10##2##(2008-2#8)(2010-4#1)(2011-2#1)
physical algorithm##3##2##(2008-3#3)
physical analyses##2##2##(1990-5#1)(2012-2#1)
physical analysis of the##2##4##(2008-10#1)(2008-7#1)
physical and biological##10##3##(1994-5#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-8#1)
physical and chemical characteristics of##2##5##(1990-1#1)(1994-6#1)
physical and chemical characteristics##7##4##(1990-1#1)(1990-2#1)(1994-6#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-7#1)
physical and chemical factors##2##4##(2008-2#1)(2011-1#1)
physical and chemical properties and##3##5##(2010-11#1)(2010-2#1)(2013-8#1)
physical and chemical properties of the##3##6##(2005-11#1)(2007-9#1)(2011-2#1)
physical and chemical properties of##11##5##(1991-2#1)(1992-8#1)(1993-12#1)(2005-11#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#1)(2013-8#2)
physical and chemical properties##31##4##(1990-12#1)(1990-9#1)(1991-2#1)(1992-8#1)(1993-12#1)(1996-12#1)(2005-11#1)(2007-11#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-11#2)(2010-11#1)(2010-2#1)(2011-2#2)(2011-3#1)(2012-1#1)(2013-8#6)
physical and chemical stability##2##4##(2008-7#1)(2011-1#1)
physical and chemical variables##2##4##(2008-10#2)
physical and chemical##66##3##(1990-1#1)(1990-12#1)(1990-2#1)(1990-9#2)(1991-2#1)(1991-3#1)(1992-8#1)(1993-12#1)(1994-6#1)(1996-12#1)(2005-11#2)(2006-12#1)(2007-11#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#11)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#2)(2009-10#2)(2009-11#4)(2009-12#1)(2009-8#2)(2010-11#1)(2010-2#1)(2010-7#1)(2011-1#2)(2011-11#1)(2011-2#2)(2011-3#1)(2012-1#1)(2013-8#6)
physical and cognitive##4##3##(1991-6#1)(1995-3#1)(2012-1#1)(2013-1#1)
physical and cultural##2##3##(2009-7#1)(2009-8#1)
physical and emotional consequences of##2##5##(1997-2#1)(2011-2#1)
physical and emotional health##2##4##(2008-3#1)(2010-8#1)
physical and emotional pain##2##4##(2008-6#1)(2013-1#1)
physical and emotional##14##3##(1991-8#1)(1997-2#1)(2005-8#1)(2006-11#1)(2007-8#1)(2008-3#1)(2008-6#1)(2009-5#1)(2009-8#1)(2010-8#1)(2010-9#1)(2011-2#2)(2013-1#1)
physical and enzymatic##2##3##(1990-2#1)(1995-1#1)
physical and functional##4##3##(1990-12#1)(1994-12#1)(2005-10#1)(2008-11#1)
physical and genetic map of B##2##6##(2006-5#2)
physical and genetic##3##3##(2006-5#2)(2008-5#1)
physical and instrumental##2##3##(1990-6#1)(2008-2#1)
physical and intellectual##3##3##(2007-8#1)(2008-7#1)(2013-8#1)
physical and laboratory##2##3##(1990-12#1)(2006-10#1)
physical and mental component##2##4##(2012-3#1)(2013-1#1)
physical and mental health and##4##5##(2008-10#1)(2011-2#2)(2013-1#1)
physical and mental health needs##2##5##(2010-10#1)(2011-2#1)
physical and mental health##22##4##(1990-12#1)(1991-4#1)(1994-1#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2010-10#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
physical and mental quality of life##2##6##(2012-3#2)
physical and mental training combined##2##5##(2009-11#2)
physical and mental training##3##4##(1995-10#1)(2009-11#2)
physical and mental##46##3##(1990-12#1)(1990-6#1)(1991-3#1)(1991-4#1)(1994-1#1)(1994-3#1)(1995-10#1)(1995-5#1)(1996-3#1)(1996-9#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-11#3)(2009-3#1)(2009-6#1)(2010-10#1)(2010-6#1)(2011-1#4)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#1)
physical and numerical##2##3##(2006-11#2)
physical and psychological abuse##3##4##(2010-2#3)
physical and psychological access##2##4##(2009-4#2)
physical and psychological well-being##2##4##(2007-12#1)(2011-12#1)
physical and psychological##30##3##(1995-2#1)(1997-5#1)(2004-3#1)(2005-11#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#3)(2010-6#2)(2011-12#1)(2012-12#1)(2013-8#1)
physical and psychosocial##6##3##(2006-10#1)(2006-7#1)(2010-11#1)(2010-3#1)(2012-12#1)(2012-2#1)
physical and self-assessment tests##2##4##(2008-9#2)
physical and sexual abuse##5##4##(1995-11#3)(2008-2#1)(2009-7#1)
physical and social##4##3##(1995-4#1)(2008-11#1)(2010-11#1)(2012-3#1)
physical and structural properties of##2##5##(2010-2#2)
physical and structural properties##3##4##(2008-4#1)(2010-2#2)
physical and symbolic isolation##2##4##(2009-7#2)
physical and verbal/emotional abuse##3##4##(2013-1#3)
physical and##262##2##(1990-1#1)(1990-10#1)(1990-12#4)(1990-2#2)(1990-6#2)(1990-8#1)(1990-9#2)(1991-2#2)(1991-3#2)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-1#1)(1995-10#1)(1995-11#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#1)(2004-3#1)(2004-8#1)(2005-1#1)(2005-10#1)(2005-11#4)(2005-7#1)(2005-8#1)(2006-10#3)(2006-11#3)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#3)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#2)(2007-6#2)(2007-8#5)(2007-9#3)(2008-1#3)(2008-10#17)(2008-11#3)(2008-12#1)(2008-2#9)(2008-3#5)(2008-4#4)(2008-5#8)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#2)(2009-11#9)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#7)(2009-8#5)(2009-9#1)(2010-10#1)(2010-11#4)(2010-12#1)(2010-2#6)(2010-3#1)(2010-6#4)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-11#1)(2011-12#1)(2011-2#12)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#12)(2013-8#9)
physical appearance and##2##3##(2006-7#1)(2007-12#1)
physical appearance##8##2##(1993-1#1)(2006-7#1)(2007-12#5)(2009-7#1)
physical area##2##2##(2008-4#1)(2011-2#1)
physical arguments##2##2##(2007-12#1)(2008-2#1)
physical assault##3##2##(1996-12#2)(2008-6#1)
physical assay##2##2##(1995-8#1)(1997-4#1)
physical association between##3##3##(1994-12#2)(1994-9#1)
physical association##5##2##(1994-12#2)(1994-9#2)(2008-4#1)
physical associations##2##2##(2008-11#1)(2008-4#1)
physical attractiveness are##2##3##(2007-12#2)
physical attractiveness in Britain and Malaysia##2##6##(2007-12#2)
physical attractiveness in##4##3##(2006-7#1)(2007-12#3)
physical attractiveness##16##2##(2006-7#1)(2007-12#14)(2009-4#1)
physical attributes##3##2##(2007-12#2)(2008-8#1)
physical barrier that##2##3##(1997-4#1)(2008-5#1)
physical barrier to##2##3##(2008-10#1)(2009-8#1)
physical barrier##4##2##(1997-4#1)(2008-10#1)(2008-5#1)(2009-8#1)
physical basis##3##2##(2006-10#1)(2007-8#1)(2008-10#1)
physical beam##2##2##(2007-12#2)
physical beauty and##2##3##(2006-12#1)(2008-10#1)
physical beauty##3##2##(2006-12#2)(2008-10#1)
physical burden and##2##3##(2008-6#2)
physical burden##3##2##(2008-6#3)
physical capacity##5##2##(1996-1#1)(2007-11#1)(2010-2#1)(2012-2#1)(2013-1#1)
physical care activity##3##3##(1990-8#3)
physical care##5##2##(1990-8#3)(1996-1#1)(2004-3#1)
physical changes##9##2##(2007-12#3)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2011-2#1)
physical characteristics and##2##3##(1990-9#1)(2008-1#1)
physical characteristics of the##11##4##(1990-9#1)(1992-2#1)(1992-4#1)(1994-8#1)(1996-3#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-7#1)(2013-8#1)
physical characteristics of##19##3##(1990-9#1)(1992-2#1)(1992-4#1)(1994-8#1)(1996-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-7#1)(2013-8#1)
physical characteristics##38##2##(1990-12#1)(1990-7#1)(1990-9#2)(1992-2#1)(1992-4#1)(1994-11#1)(1994-8#1)(1996-3#1)(2006-7#1)(2007-12#2)(2007-4#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2012-2#1)(2013-8#1)
physical characterization and##2##3##(1990-2#1)(2008-5#1)
physical characterization of##2##3##(1995-5#1)(2008-3#1)
physical characterization##6##2##(1990-2#1)(1990-8#1)(1995-5#1)(2008-3#1)(2008-5#2)
physical chemical properties##3##3##(1991-4#1)(1995-1#1)(2010-8#1)
physical chemical##5##2##(1991-4#1)(1995-1#1)(1995-8#1)(2010-4#1)(2010-8#1)
physical chemistry and##2##3##(2005-11#1)(2011-1#1)
physical chemistry of the##2##4##(2008-10#1)(2008-5#1)
physical chemistry##10##2##(2005-11#2)(2007-11#1)(2008-10#1)(2008-5#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
physical child##3##2##(2006-3#1)(2007-2#1)(2007-3#1)
physical competence##2##2##(2009-7#2)
physical complaints##2##2##(1991-4#2)
physical component summary (PCS)##2##4##(2007-8#1)(2011-12#1)
physical component##5##2##(2007-8#1)(2008-5#1)(2008-7#2)(2011-12#1)
physical concept##2##2##(2008-3#1)(2012-2#1)
physical concepts##2##2##(1995-5#1)(2009-5#1)
physical condition and##3##3##(1994-12#1)(2008-5#1)(2012-12#1)
physical condition of##2##3##(1991-6#1)(2005-7#1)
physical condition##14##2##(1991-6#1)(1994-12#2)(1995-4#1)(2004-11#1)(2005-7#1)(2008-11#1)(2008-5#1)(2010-2#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)
physical conditioning##3##2##(1993-1#1)(2005-10#1)(2013-7#1)
physical conditions##10##2##(1991-7#2)(1993-12#1)(1997-5#1)(2007-7#1)(2008-10#1)(2009-6#1)(2009-8#1)(2013-1#1)(2013-8#1)
physical connection##2##2##(2007-12#1)(2011-2#1)
physical constraints on##2##3##(1994-8#1)(1997-2#1)
physical constraints##3##2##(1994-8#1)(1997-2#2)
physical contact with the##3##4##(1994-12#1)(1996-8#1)(2009-10#1)
physical contact with##4##3##(1994-12#1)(1996-8#1)(2006-9#1)(2009-10#1)
physical contact##9##2##(1993-3#1)(1994-12#1)(1994-6#1)(1996-8#1)(2006-9#1)(2007-8#1)(2008-9#1)(2009-10#1)(2010-8#1)
physical contig##2##2##(2008-7#1)(2008-9#1)
physical criteria##2##2##(1997-1#1)(2008-3#1)
physical cues##2##2##(1992-2#2)
physical damage##5##2##(1995-5#1)(2008-3#1)(2012-12#3)
physical deformation of##2##3##(2008-3#1)(2009-8#1)
physical demands##2##2##(2011-1#2)
physical dependence in##3##3##(1991-1#3)
physical dependence on nicotine##2##4##(1996-10#2)
physical dependence on##3##3##(1996-10#2)(2008-3#1)
physical dependence##14##2##(1991-1#4)(1991-12#2)(1996-10#2)(1996-12#1)(2007-7#1)(2008-3#1)(2008-8#2)(2009-7#1)
physical development and##2##3##(2007-2#1)(2007-6#1)
physical development##10##2##(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-11#1)(2009-4#1)(2011-1#1)(2013-1#1)
physical differences##3##2##(1995-5#1)(2007-12#1)(2010-8#1)
physical dimensions of##3##3##(1993-2#2)(2007-12#1)
physical dimensions##6##2##(1993-2#2)(2007-12#1)(2008-11#2)(2010-8#1)
physical disabilities##12##2##(1993-9#1)(1995-12#2)(1995-5#2)(2005-8#1)(2006-10#1)(2007-8#1)(2008-7#1)(2010-12#3)
physical disability and##2##3##(1997-1#1)(2010-7#1)
physical disability##12##2##(1992-12#1)(1997-1#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-11#1)(2008-6#2)(2010-7#1)(2012-2#1)
physical discomfort##2##2##(2008-9#1)(2010-6#1)
physical disorder##2##2##(1997-7#1)(2010-12#1)
physical disorders##3##2##(1994-6#1)(1996-7#1)(2013-8#1)
physical distance##4##2##(2008-10#1)(2008-9#2)(2011-2#1)
physical disturbance##3##2##(2006-6#3)
physical education and##2##3##(2007-12#1)(2008-12#1)
physical education##8##2##(1993-6#1)(2006-9#1)(2007-12#1)(2008-12#2)(2009-6#1)(2012-2#1)(2013-7#1)
physical effects of##3##3##(1994-9#1)(2006-6#1)(2007-9#1)
physical effects##4##2##(1991-4#1)(1994-9#1)(2006-6#1)(2007-9#1)
physical entrapment of##2##3##(2006-4#1)(2008-10#1)
physical environment##9##2##(1992-4#2)(1996-12#1)(2007-3#1)(2007-9#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-7#1)
physical environments to##2##3##(2011-2#1)(2012-2#1)
physical environments##5##2##(2006-10#1)(2008-11#1)(2011-2#1)(2012-1#1)(2012-2#1)
physical evidence##5##2##(1992-2#1)(1997-5#1)(2008-10#3)
physical exam##10##2##(2006-10#1)(2007-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-12#1)
physical examination and a##3##4##(1990-6#1)(1993-9#1)(2006-2#1)
physical examination and clinical##2##4##(2005-10#1)(2006-9#1)
physical examination and radiologic##2##4##(2005-12#1)(2011-12#1)
physical examination and##30##3##(1990-12#1)(1990-6#1)(1992-2#1)(1993-9#1)(1995-4#1)(1997-8#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
physical examination are the most##2##5##(2006-10#1)(2013-8#1)
physical examination are the##3##4##(1997-3#1)(2006-10#1)(2013-8#1)
physical examination are##7##3##(1997-3#1)(2006-10#1)(2006-5#1)(2009-9#1)(2010-1#1)(2010-9#1)(2013-8#1)
physical examination can##2##3##(2008-4#1)(2010-12#1)
physical examination findings##3##3##(2006-8#1)(2010-11#1)(2010-2#1)
physical examination is##4##3##(1995-11#1)(2006-12#1)(2008-11#1)(2010-2#1)
physical examination of the neck and cervical spine##2##8##(2006-8#2)
physical examination of the##3##4##(1990-6#1)(2006-8#2)
physical examination or simple tests##2##5##(2007-7#2)
physical examination screening##2##3##(1991-12#1)(2010-8#1)
physical examination that included##2##4##(1993-2#1)(2010-4#1)
physical examination using##2##3##(2007-8#1)(2011-2#1)
physical examination was##3##3##(1997-4#1)(2006-10#1)(2010-9#1)
physical examination with##2##3##(1996-6#1)(2011-2#1)
physical examination##170##2##(1990-10#1)(1990-12#2)(1990-6#2)(1991-12#2)(1991-9#1)(1992-2#4)(1993-2#1)(1993-9#1)(1994-10#1)(1994-4#1)(1994-6#1)(1994-7#1)(1995-11#1)(1995-4#4)(1996-3#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-10#1)(2005-12#1)(2005-8#2)(2006-10#10)(2006-12#3)(2006-2#3)(2006-4#1)(2006-5#2)(2006-8#13)(2006-9#2)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#2)(2007-3#2)(2007-7#6)(2007-8#4)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#3)(2008-3#2)(2008-4#2)(2008-6#5)(2008-7#4)(2008-8#4)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#2)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-12#3)(2011-2#5)(2012-1#3)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#4)
physical examinations and##2##3##(1997-7#1)(2007-8#1)
physical examinations of##2##3##(1992-12#1)(1996-3#1)
physical examinations##9##2##(1992-12#2)(1996-3#1)(1996-6#1)(1997-7#1)(2007-8#1)(2008-3#1)(2012-2#1)(2013-8#1)
physical exercise and##4##3##(1991-4#1)(2006-9#1)(2009-7#1)(2013-8#1)
physical exercise in##4##3##(1996-2#1)(1996-9#1)(2006-6#1)(2010-12#1)
physical exercise may##2##3##(1991-4#1)(2008-6#1)
physical exercise on##3##3##(1993-6#1)(2008-7#2)
physical exercise##42##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-4#2)(1993-2#1)(1993-6#2)(1994-4#2)(1995-1#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-9#1)(2006-12#1)(2006-6#1)(2006-9#2)(2007-9#2)(2008-3#1)(2008-6#1)(2008-7#3)(2009-1#1)(2009-7#1)(2010-12#1)(2010-6#2)(2011-1#5)(2012-12#1)(2013-8#3)
physical exercises and##2##3##(2011-1#2)
physical exercises##4##2##(2007-8#1)(2008-4#1)(2011-1#2)
physical exertion##3##2##(1997-5#1)(2010-10#2)
physical explanation for##2##3##(1996-12#1)(2007-11#1)
physical explanation##3##2##(1996-12#1)(2007-11#1)(2008-3#1)
physical factors affecting the##2##4##(2007-11#1)(2008-3#1)
physical factors##11##2##(1993-1#1)(2006-3#1)(2006-8#2)(2007-11#3)(2008-3#1)(2011-1#1)(2012-1#1)(2013-1#1)
physical features of the##2##4##(1992-6#1)(2008-2#1)
physical features of##3##3##(1992-6#1)(2008-2#1)(2011-2#1)
physical features##5##2##(1992-6#1)(2008-2#1)(2010-6#1)(2011-2#1)(2012-2#1)
physical findings are##3##3##(1990-5#1)(2006-7#1)(2007-7#1)
physical findings may##2##3##(2008-8#1)(2013-8#1)
physical findings of##2##3##(2006-2#1)(2009-9#1)
physical findings##21##2##(1990-2#1)(1990-5#1)(1991-12#1)(1991-4#1)(1997-8#1)(2004-1#1)(2006-10#1)(2006-2#1)(2006-7#1)(2006-8#2)(2007-12#1)(2007-7#1)(2008-8#2)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
physical fitness and##5##3##(2006-10#1)(2007-10#1)(2012-2#3)
physical fitness of##2##3##(1990-8#1)(1996-2#1)
physical fitness##25##2##(1990-8#1)(1991-8#1)(1996-2#4)(2006-10#5)(2007-10#1)(2007-12#1)(2007-8#1)(2010-4#3)(2012-2#5)(2013-1#1)(2013-7#2)
physical force##2##2##(2005-8#1)(2008-11#1)
physical forces##4##2##(2007-3#1)(2008-11#1)(2010-10#1)(2010-9#1)
physical forms##2##2##(2008-6#1)(2010-5#1)
physical function and##2##3##(1996-1#1)(2010-7#1)
physical function in adults##2##4##(2010-12#1)(2013-1#1)
physical function in##4##3##(2006-10#1)(2010-11#1)(2010-12#1)(2013-1#1)
physical function items##2##3##(2010-9#2)
physical function of##2##3##(1994-4#1)(2011-2#1)
physical function##33##2##(1990-5#1)(1994-4#1)(1996-1#2)(2004-1#1)(2006-10#2)(2006-7#1)(2007-10#2)(2007-11#2)(2007-7#2)(2008-3#1)(2008-6#1)(2008-7#1)(2010-11#2)(2010-12#3)(2010-7#1)(2010-8#1)(2010-9#5)(2011-1#1)(2011-2#1)(2013-1#2)
physical functioning and##4##3##(2006-10#1)(2007-11#1)(2008-3#1)(2011-2#1)
physical functioning in##2##3##(2006-10#1)(2010-12#1)
physical functioning##22##2##(1995-3#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#3)(2008-1#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-12#2)(2010-5#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-7#3)
physical growth and##4##3##(2008-11#2)(2011-1#1)(2012-2#1)
physical growth##5##2##(2008-11#2)(2008-8#1)(2011-1#1)(2012-2#1)
physical handicap##2##2##(1990-3#1)(2012-1#1)
physical health and##5##3##(2006-10#1)(2008-1#1)(2010-2#2)(2011-2#1)
physical health care##3##3##(1995-2#1)(1997-2#1)(2012-2#1)
physical health consequences##2##3##(2010-12#1)(2012-2#1)
physical health needs##4##3##(2011-2#4)
physical health of the##3##4##(2008-11#1)(2008-2#1)(2009-6#1)
physical health of##5##3##(1996-9#1)(2008-11#1)(2008-2#1)(2009-6#1)(2012-2#1)
physical health outcomes##2##3##(2009-5#1)(2010-3#1)
physical health problems##3##3##(2008-1#1)(2008-7#1)(2012-2#1)
physical health##50##2##(1991-2#1)(1995-11#1)(1995-2#1)(1996-9#1)(1997-2#1)(2005-11#1)(2006-10#3)(2006-2#1)(2006-8#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-7#1)(2008-9#1)(2009-5#2)(2009-6#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-9#1)(2011-1#3)(2011-2#10)(2012-1#1)(2012-11#1)(2012-2#4)(2013-1#1)(2013-8#1)
physical illness##5##2##(1992-3#1)(1997-5#1)(1997-7#1)(2010-12#1)(2010-2#1)
physical impairments##4##2##(1996-12#1)(2007-7#1)(2008-3#1)(2008-6#1)
physical inactivity during##2##3##(1991-12#2)
physical inactivity##18##2##(1991-12#2)(1996-2#1)(1997-2#2)(2008-11#1)(2008-12#3)(2008-3#1)(2010-11#1)(2010-12#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
physical injuries##3##2##(1996-3#1)(2009-10#1)(2011-1#1)
physical injury and##3##3##(1997-7#1)(2010-12#1)(2011-2#1)
physical injury##7##2##(1995-1#1)(1997-7#1)(2005-8#1)(2010-12#1)(2011-10#1)(2011-2#2)
physical insight into the##2##4##(2007-12#2)
physical interaction between##5##3##(1996-4#1)(1997-2#1)(2006-12#1)(2009-10#1)(2010-8#1)
physical interaction of##2##3##(1992-9#1)(1994-8#1)
physical interaction##11##2##(1992-9#1)(1994-8#1)(1996-4#2)(1997-2#1)(2006-12#1)(2007-12#1)(2007-5#1)(2009-10#1)(2009-8#1)(2010-8#1)
physical interactions between##11##3##(1992-7#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-4#3)(2008-5#1)
physical interactions##14##2##(1992-7#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-4#3)(2008-5#1)(2009-10#1)(2010-2#1)(2013-7#1)
physical interpretation##7##2##(1996-4#1)(2007-12#2)(2008-2#3)(2010-7#1)
physical limit##3##2##(2008-1#2)(2008-7#1)
physical limits on##2##3##(2007-12#1)(2007-9#1)
physical limits##4##2##(2006-12#1)(2007-12#1)(2007-9#1)(2008-2#1)
physical linkage##3##2##(2008-8#2)(2008-9#1)
physical loads and##2##3##(2005-1#1)(2012-1#1)
physical manifestations of##3##3##(2006-12#1)(2006-7#1)(2008-4#1)
physical manipulation of##2##3##(2008-11#1)(2009-2#1)
physical manipulation##3##2##(2008-11#1)(2009-2#1)(2012-12#1)
physical map and##2##3##(1997-6#1)(2008-7#1)
physical map is##2##3##(2008-8#2)
physical map of a##2##4##(1995-6#1)(1996-3#1)
physical map of chromosome##3##4##(1997-6#1)(1997-8#1)(2008-10#1)
physical map of rice chromosome##2##5##(1996-10#2)
physical map of the genome##3##5##(1995-6#1)(2011-2#1)(2012-11#1)
physical map of the##9##4##(1995-6#1)(1997-2#1)(1997-4#1)(1997-8#2)(2008-10#1)(2008-8#1)(2011-2#1)(2012-11#1)
physical map of##20##3##(1995-6#2)(1996-10#2)(1996-3#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-8#3)(2006-12#1)(2008-10#2)(2008-7#1)(2008-8#2)(2011-2#1)(2012-11#1)
physical map will##2##3##(2010-3#1)(2012-11#1)
physical map##34##2##(1995-6#2)(1996-10#4)(1996-3#1)(1997-2#3)(1997-4#1)(1997-6#2)(1997-8#3)(1997-9#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-7#4)(2008-8#4)(2010-3#1)(2011-2#1)(2012-11#2)(2012-3#1)
physical mapping data##3##3##(1997-4#1)(2008-7#1)(2010-3#1)
physical mapping of rice##2##4##(1996-12#1)(1997-4#1)
physical mapping of the##2##4##(2008-10#1)(2012-11#1)
physical mapping of##8##3##(1996-12#1)(1997-4#2)(2008-10#2)(2008-2#1)(2008-5#1)(2012-11#1)
physical mapping using##2##3##(1990-10#1)(1996-4#1)
physical mapping##24##2##(1990-10#2)(1995-6#1)(1996-10#1)(1996-12#1)(1996-4#2)(1997-4#3)(1997-9#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-3#2)(2012-11#2)
physical maps##14##2##(1994-6#1)(1994-9#1)(1995-6#2)(1996-10#1)(1996-4#1)(2008-2#1)(2008-4#3)(2008-7#2)(2010-10#1)(2012-11#1)
physical meaning##2##2##(2005-11#1)(2008-10#1)
physical measurements##3##2##(2006-4#1)(2009-12#1)(2009-5#1)
physical measures##2##2##(2008-12#1)(2011-2#1)
physical mechanism for##2##3##(2007-12#1)(2008-1#1)
physical mechanism of##2##3##(2007-12#1)(2008-1#1)
physical mechanism##7##2##(1996-9#1)(2007-12#2)(2008-1#3)(2012-12#1)
physical mechanisms##4##2##(2006-10#1)(2007-12#1)(2008-7#1)(2009-4#1)
physical medicine and rehabilitation##2##4##(2007-10#1)(2012-2#1)
physical medicine and##3##3##(2007-10#1)(2008-12#1)(2012-2#1)
physical medicine##8##2##(1990-6#1)(1990-7#1)(1996-7#1)(2007-10#1)(2008-12#3)(2012-2#1)
physical method##2##2##(1992-2#1)(2008-5#1)
physical methods that##2##3##(2007-9#1)(2008-2#1)
physical methods##7##2##(1993-6#1)(1995-8#1)(2007-11#1)(2007-9#1)(2008-2#1)(2010-7#2)
physical mixture##3##2##(2004-12#1)(2008-5#2)
physical mixtures were##2##3##(2008-10#2)
physical mixtures##4##2##(2007-11#1)(2008-10#3)
physical mobility##2##2##(2007-11#1)(2010-11#1)
physical model for the##2##4##(2007-12#1)(2008-2#1)
physical model of the##3##4##(2007-1#2)(2011-1#1)
physical model of##4##3##(1996-4#1)(2007-1#2)(2011-1#1)
physical model with##2##3##(2007-1#1)(2008-6#1)
physical model##13##2##(1991-8#1)(1996-4#1)(2007-1#3)(2007-12#2)(2007-9#1)(2008-2#2)(2008-3#1)(2008-6#1)(2011-1#1)
physical models##3##2##(2007-1#2)(2008-10#1)
physical morbidity in the##2##4##(2012-12#2)
physical morbidity in##3##3##(2012-12#3)
physical movement##2##2##(1996-12#1)(2009-8#1)
physical nature##2##2##(2007-12#1)(2009-3#1)
physical needs##2##2##(2010-10#1)(2013-8#1)
physical obstruction##2##2##(1995-11#1)(1995-6#1)
physical ones##2##2##(1997-1#1)(2008-8#1)
physical optics##4##2##(2008-2#4)
physical or chemical##6##3##(2007-11#1)(2008-5#2)(2008-7#1)(2009-2#1)(2013-1#1)
physical or emotional##4##3##(1993-11#1)(2009-6#2)(2011-1#1)
physical or occupational therapists##2##4##(2008-4#2)
physical or occupational##3##3##(2008-4#3)
physical or##19##2##(1993-11#1)(1995-6#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#1)(2009-2#1)(2009-6#2)(2011-1#1)(2011-2#1)(2013-1#1)
physical order of##2##3##(1992-6#2)
physical pain tolerance##4##3##(2011-1#4)
physical pain##8##2##(2010-11#2)(2010-12#1)(2011-1#5)
physical parameter##4##2##(1996-8#1)(2006-6#1)(2008-10#1)(2008-5#1)
physical parameters and##3##3##(2007-11#1)(2007-4#1)(2008-2#1)
physical parameters of the##2##4##(2008-2#2)
physical parameters of##7##3##(2005-11#1)(2008-10#1)(2008-2#3)(2008-3#2)
physical parameters on##2##3##(2007-11#1)(2008-7#1)
physical parameters that##3##3##(1993-5#1)(2008-3#1)(2012-2#1)
physical parameters##34##2##(1990-11#1)(1993-5#1)(2005-11#3)(2006-11#2)(2007-11#2)(2007-4#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#6)(2008-3#4)(2008-5#1)(2008-7#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#2)
physical performance and##2##3##(2008-3#1)(2011-2#1)
physical performance of##2##3##(2008-3#1)(2009-3#1)
physical performance##11##2##(1992-9#1)(1996-3#1)(2006-9#1)(2007-8#1)(2008-3#2)(2009-3#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
physical phenomena##6##2##(2007-11#1)(2008-10#1)(2008-3#2)(2010-9#1)(2012-1#1)
physical picture##4##2##(2005-11#1)(2007-11#1)(2008-3#1)(2010-7#1)
physical plant##3##2##(1991-11#1)(2007-3#1)(2008-8#1)
physical play##2##2##(2006-8#2)
physical pore##2##2##(2008-5#1)(2009-2#1)
physical principles of##3##3##(1994-5#1)(2008-1#1)(2008-4#1)
physical principles##8##2##(1994-5#1)(1996-4#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-9#1)(2011-12#1)(2012-2#1)
physical problems##5##2##(1992-5#1)(2007-11#3)(2011-2#1)
physical procedures##2##2##(2008-1#1)(2008-10#1)
physical processes that are##3##4##(2008-2#3)
physical processes that##4##3##(2008-2#3)(2008-3#1)
physical processes##8##2##(1996-4#1)(1996-5#1)(2007-12#1)(2008-2#4)(2008-3#1)
physical properties and##6##3##(1991-5#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)
physical properties can be##2##4##(2007-11#1)(2008-10#1)
physical properties of human##2##4##(2008-5#2)
physical properties of the##23##4##(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-7#1)(1992-5#1)(1996-8#2)(1997-3#1)(2006-10#1)(2007-6#1)(2008-2#1)(2008-5#5)(2008-7#1)(2009-12#1)(2010-4#1)(2010-6#1)(2012-2#1)(2013-1#1)
physical properties of##51##3##(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-2#1)(1991-7#1)(1992-11#1)(1992-2#2)(1992-5#2)(1993-11#1)(1995-6#1)(1996-1#1)(1996-8#2)(1997-2#1)(1997-3#1)(2006-10#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#10)(2008-7#1)(2009-12#1)(2009-3#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
physical properties that##2##3##(1997-5#1)(2006-10#1)
physical properties##98##2##(1990-2#1)(1990-7#1)(1990-8#4)(1990-9#2)(1991-1#2)(1991-10#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-2#2)(1992-5#3)(1993-11#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-5#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-5#1)(2005-11#2)(2006-10#3)(2006-2#2)(2007-11#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#14)(2008-7#2)(2008-8#1)(2009-12#2)(2009-3#1)(2009-8#1)(2010-4#3)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
physical property of the##3##4##(1992-6#2)(2012-2#1)
physical property##6##2##(1992-6#2)(1996-4#1)(2007-11#1)(2008-12#1)(2012-2#1)
physical proximity##3##2##(2008-10#2)(2008-4#1)
physical quantities##2##2##(2012-2#1)(2013-1#1)
physical rehabilitation##5##2##(1992-3#1)(1994-3#1)(2007-11#1)(2011-2#1)(2013-1#1)
physical relationship##2##2##(2008-4#1)(2012-12#1)
physical removal##2##2##(2010-2#1)(2011-2#1)
physical responses##4##2##(2005-7#1)(2007-11#1)(2007-6#1)(2008-11#1)
physical restraints##4##2##(1996-3#1)(2010-10#3)
physical sciences##4##2##(2006-10#1)(2007-9#1)(2010-5#1)(2012-2#1)
physical security##3##2##(1992-12#1)(2008-9#1)(2010-8#1)
physical self-perceptions##3##2##(2007-12#3)
physical separation of##5##3##(1990-4#1)(1994-9#1)(1997-6#1)(2008-4#1)(2009-12#1)
physical separation##6##2##(1990-4#1)(1994-9#1)(1997-6#1)(2008-4#2)(2009-12#1)
physical signs of##3##3##(1993-5#1)(2006-10#2)
physical signs##8##2##(1992-2#1)(1993-5#1)(2006-10#2)(2006-2#1)(2007-3#1)(2008-6#1)(2011-12#1)
physical size of##2##3##(2008-11#1)(2008-4#1)
physical size##3##2##(2008-11#1)(2008-3#1)(2008-4#1)
physical space##5##2##(2007-12#1)(2008-11#1)(2008-2#2)(2013-1#1)
physical stability of##3##3##(2007-5#1)(2008-5#1)(2013-7#1)
physical stability##9##2##(1991-9#1)(2007-5#1)(2008-5#4)(2010-5#1)(2012-12#1)(2013-7#1)
physical state and##3##3##(1991-4#1)(2005-7#1)(2008-5#1)
physical state of HPV DNA##2##5##(1992-9#2)
physical state of the##4##4##(1991-3#1)(1991-5#1)(1991-7#1)(1994-8#1)
physical state of##10##3##(1990-12#1)(1990-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-9#2)(1993-4#1)(1994-8#1)(2008-4#1)
physical state##15##2##(1990-12#1)(1990-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-9#2)(1993-4#1)(1994-8#1)(2005-7#1)(2008-4#2)(2008-5#1)(2008-8#1)
physical status of##2##3##(1993-1#1)(1997-1#1)
physical status##12##2##(1992-10#1)(1993-1#1)(1997-1#1)(2008-7#1)(2010-7#2)(2011-12#1)(2012-3#1)(2013-8#4)
physical steady state##3##3##(2008-10#3)
physical stimuli##3##2##(1991-5#1)(2005-7#1)(2008-10#1)
physical strain##2##2##(1995-1#1)(2008-6#1)
physical strength##2##2##(2007-8#2)
physical stress##4##2##(2008-5#1)(2008-9#1)(2009-1#1)(2010-2#1)
physical stresses##3##2##(1996-1#1)(2008-10#1)(2011-2#1)
physical structure##3##2##(2008-2#2)(2008-5#1)
physical sunscreen films##2##3##(2008-5#2)
physical sunscreen##3##2##(2008-5#3)
physical support##2##2##(2007-2#1)(2008-4#1)
physical symptoms and##4##3##(1991-4#1)(1992-2#1)(2006-8#1)(2007-5#1)
physical symptoms##13##2##(1991-4#1)(1992-2#1)(1994-12#1)(2006-3#1)(2006-8#1)(2007-5#1)(2008-3#1)(2009-12#4)(2011-1#1)(2011-12#1)
physical systems##6##2##(2007-12#1)(2008-3#1)(2012-2#2)(2013-1#2)
physical techniques##3##2##(1995-4#2)(2008-4#1)
physical test##2##2##(2006-11#1)(2008-5#1)
physical testing##2##2##(2012-2#2)
physical therapies##3##2##(2009-12#1)(2011-1#2)
physical therapist students during##2##4##(2009-9#2)
physical therapist students##3##3##(2009-9#3)
physical therapist##11##2##(1993-12#1)(2006-1#2)(2006-10#1)(2008-12#2)(2008-6#1)(2009-9#3)(2012-1#1)
physical therapists in##5##3##(1992-3#1)(1993-12#2)(2006-1#1)(2006-10#1)
physical therapists to##2##3##(1991-3#1)(2008-8#1)
physical therapists with##2##3##(1993-12#1)(2008-12#1)
physical therapists##23##2##(1991-3#2)(1992-3#3)(1993-12#6)(2006-1#2)(2006-10#1)(2006-3#1)(2008-12#3)(2008-8#2)(2010-7#1)(2011-2#1)(2012-1#1)
physical therapists'##2##2##(2006-10#1)(2008-12#1)
physical therapy (PT)##4##3##(2008-11#1)(2009-9#1)(2010-9#1)(2012-2#1)
physical therapy and##5##3##(2006-12#1)(2006-8#1)(2009-2#1)(2010-3#1)(2013-1#1)
physical therapy education##2##3##(2010-7#2)
physical therapy following surgery##2##4##(1994-3#2)
physical therapy in##4##3##(1993-3#1)(2006-10#1)(2008-12#1)(2008-7#1)
physical therapy intervention##3##3##(2006-10#2)(2008-6#1)
physical therapy management##2##3##(2008-12#2)
physical therapy modalities##3##3##(2008-7#3)
physical therapy on##4##3##(2006-10#2)(2012-2#1)(2013-8#1)
physical therapy practice##3##3##(2008-12#1)(2010-5#2)
physical therapy students##4##3##(1995-3#2)(2009-9#1)(2011-2#1)
physical therapy treatment of##3##4##(1992-3#1)(2008-12#1)(2013-7#1)
physical therapy treatment the weekend following##2##6##(1994-3#2)
physical therapy treatment##8##3##(1992-3#1)(1994-3#3)(2008-12#3)(2013-7#1)
physical therapy with##3##3##(2007-11#2)(2008-12#1)
physical therapy##109##2##(1991-3#1)(1992-3#1)(1993-12#2)(1993-3#1)(1994-3#6)(1995-2#1)(1995-3#3)(1996-1#4)(1997-6#1)(2006-1#1)(2006-10#10)(2006-12#3)(2006-7#1)(2006-8#9)(2007-10#1)(2007-11#2)(2007-2#2)(2007-7#2)(2007-8#1)(2008-11#2)(2008-12#14)(2008-2#1)(2008-6#1)(2008-7#10)(2008-9#1)(2009-2#2)(2009-5#1)(2009-9#2)(2010-1#1)(2010-3#1)(2010-5#4)(2010-6#1)(2010-7#2)(2010-9#1)(2011-2#1)(2012-1#3)(2012-2#5)(2013-1#2)(2013-7#1)(2013-8#1)
physical to##2##2##(1996-1#1)(2008-12#1)
physical training and##2##3##(1990-12#2)
physical training in patients with##2##5##(2005-1#2)
physical training program##2##3##(1990-12#1)(2008-7#1)
physical training##20##2##(1990-12#4)(1996-4#1)(2005-1#3)(2006-2#3)(2007-6#1)(2008-7#1)(2009-11#1)(2013-1#3)(2013-7#1)(2013-8#2)
physical treatment##4##2##(2006-10#1)(2007-8#1)(2008-10#1)(2008-7#1)
physical treatments##3##2##(1990-12#1)(2005-12#1)(2011-1#1)
physical vapor deposition##2##3##(2009-11#1)(2009-7#1)
physical variables##3##2##(2008-10#1)(2008-2#1)(2008-9#1)
physical violence was##2##3##(2007-9#1)(2011-1#1)
physical violence##9##2##(2005-8#1)(2007-9#1)(2009-7#1)(2011-1#3)(2011-12#1)(2012-11#1)(2013-8#1)
physical well-being##3##2##(1994-11#1)(2006-7#1)(2008-7#1)
physical##2565##1##(1990-1#1)(1990-10#6)(1990-11#2)(1990-12#15)(1990-2#7)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#8)(1990-7#4)(1990-8#11)(1990-9#7)(1991-1#6)(1991-10#2)(1991-11#2)(1991-12#9)(1991-2#6)(1991-3#7)(1991-4#10)(1991-5#5)(1991-6#4)(1991-7#5)(1991-8#3)(1991-9#6)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#6)(1992-2#16)(1992-3#10)(1992-4#5)(1992-5#4)(1992-6#7)(1992-7#1)(1992-8#1)(1992-9#4)(1993-1#4)(1993-10#1)(1993-11#2)(1993-12#11)(1993-2#5)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#4)(1993-8#1)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#8)(1994-2#1)(1994-3#8)(1994-4#5)(1994-5#3)(1994-6#7)(1994-7#2)(1994-8#5)(1994-9#6)(1995-1#6)(1995-10#2)(1995-11#9)(1995-12#5)(1995-2#4)(1995-3#8)(1995-4#9)(1995-5#8)(1995-6#12)(1995-8#6)(1996-1#11)(1996-10#9)(1996-11#1)(1996-12#12)(1996-2#8)(1996-3#8)(1996-4#14)(1996-5#5)(1996-6#5)(1996-7#5)(1996-8#4)(1996-9#4)(1997-1#8)(1997-2#15)(1997-3#4)(1997-4#9)(1997-5#7)(1997-6#4)(1997-7#5)(1997-8#7)(1997-9#2)(2004-1#2)(2004-10#1)(2004-11#1)(2004-12#2)(2004-3#2)(2004-4#2)(2004-8#2)(2005-1#5)(2005-10#14)(2005-11#20)(2005-12#4)(2005-3#1)(2005-7#7)(2005-8#7)(2006-1#6)(2006-10#64)(2006-11#7)(2006-12#19)(2006-2#20)(2006-3#6)(2006-4#5)(2006-5#7)(2006-6#11)(2006-7#11)(2006-8#40)(2006-9#10)(2007-1#5)(2007-10#15)(2007-11#51)(2007-12#75)(2007-2#14)(2007-3#9)(2007-4#5)(2007-5#3)(2007-6#9)(2007-7#23)(2007-8#31)(2007-9#20)(2008-1#29)(2008-10#90)(2008-11#41)(2008-12#50)(2008-2#70)(2008-3#77)(2008-4#46)(2008-5#87)(2008-6#25)(2008-7#61)(2008-8#31)(2008-9#24)(2009-1#2)(2009-10#9)(2009-11#15)(2009-12#20)(2009-2#9)(2009-3#9)(2009-4#13)(2009-5#9)(2009-6#22)(2009-7#17)(2009-8#15)(2009-9#10)(2010-1#10)(2010-10#10)(2010-11#30)(2010-12#33)(2010-2#31)(2010-3#16)(2010-4#14)(2010-5#13)(2010-6#10)(2010-7#21)(2010-8#20)(2010-9#20)(2011-1#64)(2011-10#1)(2011-11#2)(2011-12#18)(2011-2#90)(2011-3#1)(2012-1#26)(2012-11#12)(2012-12#38)(2012-2#68)(2012-3#18)(2012-5#1)(2013-1#109)(2013-7#22)(2013-8#57)
physical)##3##1##(1995-12#1)(2008-2#1)(2011-1#1)
physical-##2##1##(2008-5#2)
physical-chemical properties of the##2##4##(2005-4#1)(2011-1#1)
physical-chemical properties of##4##3##(1992-3#1)(1994-11#1)(2005-4#1)(2011-1#1)
physical-chemical properties##5##2##(1992-3#1)(1994-11#1)(2005-4#1)(2010-11#1)(2011-1#1)
physical-chemical##10##1##(1990-2#2)(1992-3#1)(1994-11#1)(2005-4#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-11#1)(2011-1#1)
physical-chemistry##3##1##(2005-6#1)(2011-2#2)
physical/chemical##3##1##(1996-8#1)(2008-10#1)(2008-5#1)
physical/mental health##3##2##(2011-1#3)
physicality##2##1##(2005-10#1)(2010-12#1)
physically active##12##2##(1992-5#1)(1994-3#1)(2006-8#1)(2008-3#2)(2008-5#1)(2009-12#1)(2012-12#1)(2012-3#1)(2013-1#3)
physically adsorbed##5##2##(1990-12#2)(1996-11#1)(2005-11#1)(2008-7#1)
physically aggressive##3##2##(2008-2#1)(2009-9#1)(2012-12#1)
physically and functionally##3##3##(1996-5#1)(2009-12#1)(2013-1#1)
physically and mentally##4##3##(1990-2#1)(1990-3#1)(1995-11#1)(2006-7#1)
physically and##12##2##(1990-2#1)(1990-3#1)(1995-11#1)(1996-5#1)(1997-1#1)(1997-4#1)(2006-7#1)(2007-8#1)(2009-12#1)(2009-8#1)(2012-2#1)(2013-1#1)
physically as##2##2##(1991-8#1)(2007-12#1)
physically assigned P1 clones##2##4##(1997-6#1)(1997-8#1)
physically associated with the##2##4##(1992-12#1)(1992-5#1)
physically associated with##3##3##(1991-8#1)(1992-12#1)(1992-5#1)
physically associated##4##2##(1991-8#1)(1992-12#1)(1992-5#1)(1994-6#1)
physically based##2##2##(2005-11#1)(2008-2#1)
physically by##3##2##(2007-12#2)(2013-7#1)
physically cross-linked##2##2##(2009-12#2)
physically distinct##4##2##(2005-11#1)(2008-1#1)(2008-12#1)(2009-11#1)
physically entrapped##2##2##(2007-8#2)
physically healthy##3##2##(1995-2#1)(1996-5#1)(1996-7#1)
physically ill##3##2##(1992-3#1)(2009-12#2)
physically interact with##2##3##(1996-10#1)(2008-8#1)
physically interact##3##2##(1995-12#1)(1996-10#1)(2008-8#1)
physically interacting with##2##3##(1990-7#1)(1994-9#1)
physically interacts with##4##3##(1995-12#1)(2008-9#1)(2012-12#1)(2013-1#1)
physically interacts##5##2##(1995-12#2)(2008-9#1)(2012-12#1)(2013-1#1)
physically linked to QCR9##2##4##(1995-6#2)
physically linked to##8##3##(1993-6#1)(1995-5#1)(1995-6#3)(1995-7#1)(1996-10#1)(2008-4#1)
physically mapped##3##2##(1990-10#1)(1995-6#1)(1997-7#1)
physically meaningful##2##2##(2008-2#2)
physically realistic##2##2##(1997-2#1)(2008-3#1)
physically reasonable##4##2##(1991-10#1)(1995-8#1)(2006-10#1)(2007-12#1)
physically remove##2##2##(2008-10#1)(2008-8#1)
physically robust##2##2##(2007-11#1)(2008-10#1)
physically separated##4##2##(1995-8#1)(2008-10#1)(2008-7#1)(2008-9#1)
physically weak persons##2##3##(2012-1#2)
physically##190##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-4#1)(1991-8#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#2)(1993-3#1)(1993-6#2)(1993-7#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#5)(1995-7#1)(1995-8#2)(1996-10#2)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#2)(1996-7#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-9#1)(2005-11#4)(2006-10#2)(2006-12#1)(2006-5#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-11#5)(2007-12#7)(2007-3#1)(2007-8#6)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#3)(2008-2#9)(2008-3#7)(2008-4#3)(2008-5#3)(2008-7#4)(2008-8#4)(2008-9#3)(2009-11#1)(2009-12#7)(2009-2#2)(2009-3#1)(2009-5#1)(2009-8#3)(2009-9#2)(2010-10#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-12#2)(2011-2#1)(2012-1#4)(2012-12#6)(2012-2#2)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#1)
physically-based simulation##2##2##(2007-5#2)
physically-based##5##1##(2007-5#2)(2008-6#3)
physician acceptance##3##2##(1996-1#1)(1997-1#1)(2006-8#1)
physician access##2##2##(1996-3#2)
physician alignment##2##2##(2013-7#2)
physician and patient##11##3##(1990-10#1)(1992-11#1)(1993-11#3)(1995-2#1)(2006-5#1)(2007-11#1)(2008-11#1)(2008-8#1)(2012-3#1)
physician and the patient##3##4##(1991-4#1)(1996-6#1)(2008-8#1)
physician and the##13##3##(1990-9#1)(1991-4#1)(1993-1#1)(1993-12#1)(1996-6#1)(1997-3#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-8#2)(2010-8#1)(2013-1#1)
physician and##63##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-4#1)(1992-1#3)(1992-11#1)(1992-4#1)(1993-1#1)(1993-11#3)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-4#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-3#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-6#1)(2010-1#1)(2010-11#1)(2010-7#2)(2010-8#1)(2011-1#1)(2012-3#2)(2013-1#2)(2013-8#2)
physician apologies##2##2##(2012-3#2)
physician are##3##2##(1992-12#1)(1994-3#1)(2007-7#1)
physician arrangements##2##2##(1991-9#1)(1993-3#1)
physician as##11##2##(1992-1#1)(1992-8#1)(1994-12#1)(1995-12#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-6#1)
physician assistant-certified##3##2##(1995-9#3)
physician assistants can##2##3##(2007-4#2)
physician assistants##12##2##(1997-3#1)(2007-4#7)(2008-3#1)(2010-4#1)(2010-5#1)(2013-1#1)
physician at##3##2##(1991-12#1)(1996-9#1)(2008-1#1)
physician attitudes##3##2##(1993-12#1)(2007-9#2)
physician autonomy##3##2##(1994-1#1)(1996-12#2)
physician awareness##2##2##(2007-6#1)(2012-2#1)
physician behavior##4##2##(1995-1#1)(1995-2#1)(2010-10#1)(2010-4#1)
physician care##3##2##(2006-8#2)(2009-4#1)
physician centered##2##2##(1997-1#2)
physician charges##2##2##(1993-12#1)(1994-1#1)
physician claims##2##2##(1993-1#1)(1996-3#1)
physician compensation##5##2##(1993-3#1)(1995-12#1)(1996-1#2)(2013-7#1)
physician diagnosis (100%)##2##3##(2013-1#2)
physician diagnosis##3##2##(1995-12#1)(2013-1#2)
physician education about##2##3##(1994-12#1)(2007-9#1)
physician education##5##2##(1994-12#1)(1997-1#1)(2007-4#1)(2007-9#1)(2008-8#1)
physician executive##2##2##(2006-10#1)(2007-4#1)
physician executives##2##2##(1992-3#1)(2007-9#1)
physician extenders in##2##3##(1991-12#1)(2007-4#1)
physician extenders##4##2##(1991-12#1)(1996-12#1)(2007-4#2)
physician fee##3##2##(1993-12#1)(1993-3#1)(2012-3#1)
physician fees are##2##3##(1994-1#2)
physician fees##7##2##(1992-6#1)(1994-1#4)(1996-3#1)(1997-1#1)
physician for a##2##3##(1993-2#1)(2008-12#1)
physician for##7##2##(1990-6#1)(1991-9#1)(1993-2#1)(1994-3#1)(1997-2#1)(2008-12#1)(2012-2#1)
physician groups##8##2##(1990-5#1)(1994-3#1)(1996-3#1)(1997-1#1)(2007-1#1)(2008-11#1)(2008-4#1)(2013-7#1)
physician has##6##2##(1994-5#1)(1996-7#1)(2006-8#1)(2006-9#1)(2007-9#1)(2008-11#1)
physician health##4##2##(1992-12#2)(1996-12#1)(2007-7#1)
physician hospital##2##2##(1996-2#1)(1997-3#1)
physician house calls##2##3##(1992-5#1)(2011-2#1)
physician house##3##2##(1992-5#1)(2011-2#2)
physician if the##2##3##(1993-12#1)(2008-8#1)
physician in the rational use of##2##6##(1995-2#1)(1995-9#1)
physician in the##5##3##(1994-10#1)(1995-2#2)(1995-9#1)(1996-4#1)
physician in##22##2##(1990-6#1)(1991-11#1)(1991-6#1)(1992-11#1)(1993-11#1)(1993-2#1)(1994-10#1)(1995-11#1)(1995-2#2)(1995-9#1)(1996-1#1)(1996-4#1)(1997-4#1)(2006-8#1)(2007-4#1)(2007-5#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-8#1)
physician income##2##2##(1991-12#1)(2010-10#1)
physician input into##2##3##(2007-4#1)(2012-2#1)
physician involvement##2##2##(1993-12#1)(2008-3#1)
physician is##11##2##(1990-6#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-3#1)(1996-2#1)(2006-3#1)(2007-4#1)(2012-12#2)(2013-1#1)
physician job satisfaction##5##3##(2007-9#5)
physician knowledge and##2##3##(1993-12#1)(2006-7#1)
physician leaders##4##2##(1992-1#1)(1994-1#1)(1996-3#1)(2008-11#1)
physician liability##3##2##(1991-12#1)(1993-2#2)
physician liaison##2##2##(1990-12#1)(2008-1#1)
physician management##2##2##(1997-2#1)(2011-2#1)
physician marketing##2##2##(1993-12#1)(1994-2#1)
physician may be asked##2##4##(1996-2#1)(2007-7#1)
physician may thus##2##3##(1990-10#1)(1993-11#1)
physician may##7##2##(1990-10#2)(1992-1#1)(1993-11#1)(1996-2#1)(1997-1#1)(2007-7#1)
physician must##4##2##(1991-10#1)(1991-3#1)(1992-3#1)(2013-8#1)
physician non-compliance with guidelines occurs when scientific evidence is lacking##2##10##(2013-1#2)
physician non-compliance##4##2##(2013-1#4)
physician of##3##2##(1990-3#1)(2008-8#1)(2010-12#1)
physician office##4##2##(1992-1#1)(1994-3#2)(1996-12#1)
physician on##4##2##(1993-2#1)(1995-9#1)(1996-4#1)(2007-7#1)
physician or facility##2##3##(1995-12#1)(1995-9#1)
physician or##9##2##(1991-2#1)(1991-3#1)(1992-3#1)(1995-12#2)(1995-9#1)(2006-2#1)(2008-11#1)(2008-12#1)
physician order entry and##4##4##(1995-2#1)(2004-10#2)(2010-8#1)
physician order entry systems##3##4##(1995-2#1)(2013-1#2)
physician order entry##12##3##(1995-2#3)(2004-10#2)(2010-8#1)(2013-1#6)
physician order##13##2##(1995-2#3)(2004-10#2)(2008-3#1)(2010-8#1)(2013-1#6)
physician organizations##2##2##(1993-3#1)(1997-2#1)
physician ownership of##2##3##(1993-3#1)(1996-1#1)
physician payment reform##5##3##(1994-1#2)(1995-12#3)
physician payment system##3##3##(1991-12#1)(1992-1#1)(2007-4#1)
physician payment##20##2##(1991-1#2)(1991-12#1)(1992-1#1)(1993-3#1)(1994-1#6)(1994-12#2)(1995-12#4)(2007-10#1)(2007-4#1)(2008-4#1)
physician payments##3##2##(1993-12#1)(1994-1#1)(2006-10#1)
physician perceptions of##2##3##(1993-12#1)(1996-1#1)
physician performance and##4##3##(2007-4#1)(2010-9#1)(2013-1#2)
physician performance information##2##3##(2013-1#2)
physician performance##15##2##(1996-3#1)(2007-4#1)(2007-7#1)(2008-8#1)(2010-11#1)(2010-9#1)(2013-1#9)
physician perspective##2##2##(1994-1#2)
physician practice patterns##2##3##(1992-12#1)(1994-12#1)
physician practice##10##2##(1991-12#1)(1992-12#1)(1994-1#2)(1994-12#2)(1997-3#1)(2006-7#1)(2010-8#1)(2010-9#1)
physician practices must##2##3##(1992-12#1)(2006-7#1)
physician practices##10##2##(1991-12#1)(1992-12#1)(2006-4#1)(2006-7#1)(2006-8#3)(2011-2#1)(2013-1#1)(2013-7#1)
physician prescribing##2##2##(2008-11#1)(2012-11#1)
physician profiling##2##2##(1995-2#1)(1995-3#1)
physician recruitment##2##2##(1996-3#1)(2010-11#1)
physician referral##2##2##(1996-1#1)(2008-12#1)
physician referrals##3##2##(1994-2#1)(1995-1#1)(1995-3#1)
physician reimbursement system##2##3##(2007-4#2)
physician reimbursement##9##2##(1991-3#2)(2006-10#2)(2007-4#4)(2012-2#1)
physician relationships##3##2##(1991-12#1)(1995-3#1)(1996-3#1)
physician reports##2##2##(1993-6#1)(1997-3#1)
physician resource##2##2##(1994-3#1)(2010-5#1)
physician resources##2##2##(1994-12#1)(2008-11#1)
physician satisfaction##6##2##(1993-1#2)(2007-8#1)(2008-8#1)(2009-11#2)
physician service##4##2##(1991-3#1)(1992-8#1)(1995-12#1)(2007-4#1)
physician services##18##2##(1990-12#1)(1992-1#1)(1992-12#1)(1992-2#2)(1993-12#3)(1994-1#2)(1994-3#2)(1995-12#1)(2006-8#1)(2007-4#2)(2010-11#1)(2010-5#1)
physician shortage##4##2##(2007-10#1)(2007-4#1)(2009-3#1)(2011-1#1)
physician should be aware##2##4##(2007-8#1)(2008-7#1)
physician should be##4##3##(1994-3#1)(2007-8#1)(2008-3#1)(2008-7#1)
physician should##8##2##(1993-11#1)(1994-3#1)(2007-8#1)(2008-3#2)(2008-7#1)(2012-1#1)(2012-3#1)
physician specialty##2##2##(2007-4#1)(2007-9#1)
physician staffing##3##2##(1992-8#2)(1993-3#1)
physician supply##8##2##(1993-2#1)(2008-12#1)(2009-4#1)(2010-8#3)(2012-3#1)(2013-1#1)
physician survey##3##2##(2007-4#1)(2007-5#1)(2007-9#1)
physician to##21##2##(1991-1#1)(1991-7#1)(1992-9#1)(1995-2#1)(1996-7#1)(1997-3#1)(2006-3#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
physician towards##2##2##(1993-12#2)
physician turnover##2##2##(2008-9#1)(2010-8#1)
physician visits##6##2##(1995-1#1)(1995-12#1)(1997-2#1)(2006-10#2)(2007-2#1)
physician were##2##2##(2006-8#1)(2010-7#1)
physician who is##3##3##(1997-4#1)(2006-9#1)(2007-2#1)
physician who##7##2##(1992-12#1)(1997-4#1)(2006-9#1)(2007-2#1)(2007-5#1)(2008-12#1)(2012-3#1)
physician with##6##2##(1993-3#1)(1993-8#1)(2006-10#1)(2007-11#1)(2008-8#1)(2011-1#1)
physician work and practice##2##4##(2007-4#2)
physician work##3##2##(2007-4#2)(2007-9#1)
physician workforce##7##2##(2007-3#1)(2008-10#1)(2008-4#1)(2009-4#1)(2010-11#1)(2010-9#2)
physician##818##1##(1990-10#3)(1990-12#5)(1990-3#1)(1990-5#2)(1990-6#5)(1990-9#1)(1991-1#9)(1991-10#1)(1991-11#1)(1991-12#10)(1991-2#4)(1991-3#5)(1991-4#1)(1991-6#4)(1991-7#2)(1991-9#2)(1992-1#12)(1992-11#3)(1992-12#9)(1992-2#5)(1992-3#5)(1992-4#3)(1992-5#1)(1992-6#1)(1992-8#4)(1992-9#1)(1993-1#7)(1993-11#7)(1993-12#19)(1993-2#8)(1993-3#15)(1993-4#1)(1993-5#2)(1993-6#2)(1993-7#2)(1993-8#2)(1994-1#25)(1994-10#1)(1994-12#9)(1994-2#7)(1994-3#19)(1994-4#1)(1994-5#1)(1995-1#5)(1995-11#1)(1995-12#19)(1995-2#11)(1995-3#7)(1995-6#1)(1995-8#1)(1995-9#11)(1996-1#13)(1996-11#1)(1996-12#10)(1996-2#5)(1996-3#12)(1996-4#3)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#12)(1997-2#10)(1997-3#11)(1997-4#6)(1997-7#1)(2004-1#2)(2004-10#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-9#1)(2006-10#14)(2006-12#4)(2006-2#3)(2006-3#5)(2006-4#3)(2006-5#2)(2006-6#1)(2006-7#3)(2006-8#25)(2006-9#2)(2007-1#2)(2007-10#7)(2007-11#6)(2007-12#2)(2007-2#6)(2007-3#2)(2007-4#41)(2007-5#7)(2007-6#2)(2007-7#15)(2007-8#7)(2007-9#21)(2008-1#6)(2008-10#6)(2008-11#13)(2008-12#6)(2008-2#1)(2008-3#13)(2008-4#10)(2008-5#2)(2008-6#5)(2008-7#5)(2008-8#16)(2008-9#1)(2009-11#4)(2009-12#2)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#3)(2009-7#2)(2009-9#2)(2010-1#2)(2010-10#4)(2010-11#11)(2010-12#5)(2010-3#3)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#14)(2010-9#6)(2011-1#7)(2011-12#3)(2011-2#9)(2012-1#5)(2012-11#2)(2012-12#2)(2012-2#9)(2012-3#10)(2013-1#39)(2013-7#7)(2013-8#7)
physician&quot##2##1##(2011-1#1)(2012-12#1)
physician's experience##4##2##(1997-1#1)(2006-8#2)(2007-7#1)
physician's obligation##2##2##(1990-2#1)(2006-10#1)
physician's office##7##2##(1990-11#1)(1994-3#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-3#1)(2010-7#1)
physician's orders##2##2##(1992-3#1)(2004-10#1)
physician's perspective##2##2##(1991-12#1)(1992-12#1)
physician's responsibility##2##2##(1996-4#1)(2011-12#1)
physician's role in##2##3##(1990-12#1)(2007-9#1)
physician's role##5##2##(1990-12#1)(1992-6#2)(1993-3#1)(2007-9#1)
physician's##66##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-4#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-6#1)(1991-7#2)(1992-12#2)(1992-3#1)(1992-6#3)(1993-11#1)(1993-12#3)(1993-3#1)(1993-9#1)(1994-1#2)(1994-12#1)(1994-3#2)(1994-7#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#2)(1997-7#1)(2004-10#1)(2005-12#1)(2006-10#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-7#1)(2007-9#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#2)(2010-11#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2013-1#1)
physician)##3##1##(1992-3#1)(1997-2#1)(2010-1#1)
physician-##2##1##(2006-8#1)(2011-1#1)
physician-assisted death##2##2##(2012-11#2)
physician-assisted suicide##7##2##(1996-6#1)(2006-4#3)(2006-7#3)
physician-assisted##10##1##(1996-6#1)(2006-4#3)(2006-7#4)(2012-11#2)
physician-based##4##1##(1995-12#2)(1996-11#1)(2013-1#1)
physician-driven marketing##2##2##(1991-1#2)
physician-hospital organizations##2##2##(1994-3#1)(1996-2#1)
physician-hospital##9##1##(1994-1#1)(1994-3#5)(1995-1#1)(1996-2#2)
physician-nurse collaboration##2##2##(1992-12#2)
physician-patient communication##2##2##(2007-4#1)(2010-3#1)
physician-patient discussions##2##2##(2009-5#2)
physician-patient relation##2##2##(1991-5#1)(1993-10#1)
physician-patient relationship##10##2##(1995-2#1)(1996-12#1)(2005-12#1)(2006-10#1)(2007-9#2)(2008-3#1)(2008-4#1)(2009-7#1)(2011-2#1)
physician-patient##21##1##(1991-5#1)(1993-10#1)(1994-5#1)(1995-2#1)(1996-12#1)(2005-12#3)(2006-10#2)(2007-4#1)(2007-9#2)(2008-3#1)(2008-4#1)(2009-5#2)(2009-7#1)(2010-3#1)(2011-2#1)(2012-3#1)
physician-related factors##2##2##(1995-3#1)(2008-1#1)
physician-related##3##1##(1993-10#1)(1995-3#1)(2008-1#1)
physician-scientists##3##1##(1990-5#1)(2007-4#1)(2013-1#1)
physician/hospital##2##1##(1993-3#1)(1996-2#1)
physician?##2##1##(1995-9#1)(2008-8#1)
physician]##7##1##(1991-3#1)(1993-6#1)(1995-3#1)(1996-8#1)(1996-9#2)(2007-9#1)
physicians (79##2##2##(2007-7#1)(2013-1#1)
physicians (n =##2##3##(1996-9#2)
physicians a##3##2##(1990-12#1)(2007-10#1)(2013-8#1)
physicians about the##2##3##(2006-10#1)(2011-2#1)
physicians about this##2##3##(1991-6#1)(2007-3#1)
physicians about##9##2##(1991-6#2)(1995-3#1)(1996-7#1)(2006-10#1)(2007-3#1)(2007-9#1)(2008-10#1)(2011-2#1)
physicians according to##3##3##(1992-1#1)(1997-6#1)(2011-2#1)
physicians across Canada##2##3##(2008-11#1)(2008-12#1)
physicians and consumers##2##3##(1995-1#1)(2008-4#1)
physicians and forensic pathologists##2##4##(2005-8#2)
physicians and from##2##3##(2008-8#1)(2011-12#1)
physicians and general practitioners##3##4##(1995-5#1)(2008-10#1)(2010-11#1)
physicians and health care##3##4##(1991-2#1)(1996-3#1)(2007-9#1)
physicians and hospital##4##3##(1992-12#1)(1995-1#1)(1996-9#1)(2007-4#1)
physicians and hospitals for##2##4##(1993-12#1)(2007-4#1)
physicians and hospitals to##3##4##(1992-3#1)(1996-2#2)
physicians and hospitals##12##3##(1991-3#1)(1992-11#1)(1992-12#2)(1992-3#1)(1993-12#1)(1994-1#1)(1996-2#2)(1997-5#1)(2007-2#1)(2007-4#1)
physicians and how##2##3##(1992-1#1)(1996-3#1)
physicians and is##2##3##(2007-4#1)(2010-11#1)
physicians and management##2##3##(1991-3#1)(1997-2#1)
physicians and managers##4##3##(1992-2#1)(1995-1#1)(1997-1#2)
physicians and nurses##9##3##(1992-12#1)(1993-2#1)(1996-3#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2010-11#1)(2013-8#1)
physicians and other health care professionals##2##6##(1994-3#1)(2012-11#1)
physicians and other health care##3##5##(1994-3#1)(2005-10#1)(2012-11#1)
physicians and other healthcare professionals##2##5##(1996-7#1)(2008-5#1)
physicians and other##8##3##(1994-3#1)(1996-2#1)(1996-7#1)(2005-10#1)(2006-8#1)(2008-5#1)(2010-8#1)(2012-11#1)
physicians and patients alike##4##4##(1994-6#1)(2006-10#1)(2006-7#1)(2007-3#1)
physicians and patients##21##3##(1991-2#2)(1992-8#1)(1993-3#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-2#1)(1996-1#1)(2005-3#1)(2005-7#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#1)(2008-6#1)(2012-12#1)
physicians and payors##2##3##(1992-1#2)
physicians and pharmacists##2##3##(1994-12#1)(2011-1#1)
physicians and physician groups##2##4##(1994-3#1)(1996-3#1)
physicians and physician##4##3##(1992-1#1)(1993-3#1)(1994-3#1)(1996-3#1)
physicians and public##3##3##(1997-6#1)(2008-1#1)(2008-8#1)
physicians and researchers##2##3##(2006-3#1)(2008-5#1)
physicians and scientists##2##3##(2005-10#1)(2013-8#1)
physicians and support personnel##2##4##(1992-3#1)(2010-9#1)
physicians and support##3##3##(1992-3#1)(1996-1#1)(2010-9#1)
physicians and surgeons##5##3##(1993-6#1)(2007-8#1)(2008-4#1)(2012-2#1)(2013-8#1)
physicians and the public##2##4##(2007-10#1)(2007-4#1)
physicians and the##5##3##(1994-12#1)(2006-10#1)(2007-10#1)(2007-4#1)(2010-5#1)
physicians and their patients##3##4##(1995-2#1)(2007-8#2)
physicians and their##11##3##(1991-1#1)(1991-2#2)(1992-5#1)(1994-3#1)(1995-2#1)(1996-1#1)(2007-8#2)(2008-11#1)(2011-2#1)
physicians and to##2##3##(1997-8#1)(2007-2#1)
physicians and##185##2##(1990-12#1)(1990-5#1)(1991-1#1)(1991-2#10)(1991-3#4)(1992-1#4)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#4)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#4)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#4)(1995-11#1)(1995-2#2)(1995-5#1)(1996-1#3)(1996-12#1)(1996-2#3)(1996-3#5)(1996-6#2)(1996-7#1)(1996-9#2)(1997-1#3)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-8#1)(2005-10#2)(2005-3#1)(2005-7#1)(2005-8#3)(2006-10#4)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#1)(2007-2#3)(2007-3#1)(2007-4#7)(2007-7#3)(2007-8#4)(2007-9#3)(2008-1#1)(2008-10#3)(2008-11#5)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#4)(2008-7#3)(2008-8#2)(2009-4#1)(2009-9#1)(2010-11#5)(2010-12#2)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#4)
physicians answered##3##2##(1996-1#1)(2007-7#1)(2008-1#1)
physicians are more##2##3##(2007-11#1)(2010-9#1)
physicians are not##2##3##(1991-1#1)(2010-8#1)
physicians are required to treat a hospital's emergency patients##2##9##(1993-1#1)(1993-2#1)
physicians are required to##3##4##(1993-1#1)(1993-2#1)(2006-8#1)
physicians are##36##2##(1991-1#1)(1991-3#3)(1992-1#3)(1992-5#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-4#1)(1995-2#1)(1996-1#1)(1996-11#1)(1997-1#1)(1997-4#1)(2004-3#1)(2006-12#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-4#1)(2008-3#1)(2008-4#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#3)
physicians as##10##2##(1991-2#1)(1993-12#1)(1993-3#1)(1995-2#1)(1997-1#1)(2006-6#1)(2007-4#1)(2007-9#1)(2008-12#1)(2011-2#1)
physicians assume##2##2##(2006-8#1)(2007-1#1)
physicians at risk##2##3##(1990-12#1)(1995-10#1)
physicians at the##2##3##(1996-9#1)(2010-6#1)
physicians at##9##2##(1990-12#1)(1991-4#1)(1991-6#1)(1992-4#1)(1995-10#1)(1996-9#1)(2007-4#1)(2010-5#1)(2010-6#1)
physicians attending##2##2##(1993-6#1)(2008-4#1)
physicians be##2##2##(1994-8#1)(1997-8#1)
physicians become##2##2##(1994-11#1)(2005-10#1)
physicians before##3##2##(2004-3#1)(2009-5#1)(2009-7#1)
physicians better##2##2##(1996-3#1)(2008-11#1)
physicians by##4##2##(1993-12#1)(2007-6#1)(2008-6#1)(2010-9#1)
physicians can be##3##3##(1992-8#1)(1993-12#1)(1996-1#1)
physicians can expect##2##3##(1997-3#1)(2007-3#1)
physicians can##18##2##(1991-3#1)(1992-8#1)(1993-10#1)(1993-12#1)(1996-1#1)(1997-1#1)(1997-3#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-3#2)(2007-4#1)(2008-6#1)(2010-12#1)(2011-2#1)
physicians communicate##2##2##(2006-10#1)(2008-5#1)
physicians completed##2##2##(2007-11#1)(2011-1#1)
physicians connecting to share expertise to improve point of care##2##10##(2013-1#2)
physicians could##2##2##(1997-3#1)(2006-10#1)
physicians did not##4##3##(1990-2#1)(1993-6#1)(1995-5#1)(2012-1#1)
physicians during##2##2##(1990-2#1)(1996-3#1)
physicians educate##2##2##(1993-2#1)(2004-3#1)
physicians expressed##2##2##(1997-8#1)(2013-1#1)
physicians focus more##2##3##(2011-1#2)
physicians for rural##3##3##(1994-1#2)(2008-12#1)
physicians for the##2##3##(1991-12#1)(1994-3#1)
physicians for##18##2##(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#1)(1994-1#2)(1994-3#1)(1995-3#1)(2006-5#1)(2006-8#1)(2007-3#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)
physicians from a##2##3##(2007-9#1)(2013-1#1)
physicians from the##3##3##(2007-10#1)(2009-3#1)(2009-4#1)
physicians from##17##2##(1991-6#1)(1992-1#1)(1994-3#1)(1995-8#1)(1996-3#1)(1997-1#1)(2007-10#1)(2007-3#1)(2007-4#1)(2007-9#2)(2008-1#1)(2008-7#1)(2009-3#1)(2009-4#2)(2013-1#1)
physicians had##7##2##(1990-2#1)(1996-1#1)(1997-6#1)(2008-8#3)(2012-2#1)
physicians has been##2##3##(1990-6#1)(2007-4#1)
physicians has##6##2##(1990-6#1)(1992-6#1)(2007-4#2)(2007-8#1)(2008-10#1)
physicians have a##2##3##(2006-10#1)(2010-9#1)
physicians have an##2##3##(2007-12#1)(2013-8#1)
physicians have not##2##3##(1991-1#1)(2011-2#1)
physicians have to##2##3##(2005-3#1)(2008-8#1)
physicians have##24##2##(1991-1#1)(1991-12#1)(1991-6#1)(1992-2#1)(1994-3#1)(1995-3#1)(2005-3#1)(2006-10#3)(2006-8#1)(2006-9#1)(2007-12#1)(2007-4#2)(2008-2#1)(2008-8#1)(2009-3#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#1)
physicians in Norway##3##3##(1990-6#1)(1993-6#1)(1996-9#1)
physicians in a##5##3##(1994-12#1)(1996-1#1)(1996-9#1)(1997-6#1)(2008-7#1)
physicians in an##3##3##(1995-1#1)(1995-2#1)(2007-4#1)
physicians in clinical practice in##2##5##(2010-11#2)
physicians in clinical practice##4##4##(2010-11#3)(2011-1#1)
physicians in many##2##3##(2005-11#1)(2005-8#1)
physicians in ontario##2##3##(2010-11#2)
physicians in private##2##3##(1996-4#1)(2008-4#1)
physicians in the promotion of##2##5##(2007-3#2)
physicians in the##20##3##(1991-8#2)(1992-6#1)(1993-6#1)(1994-3#1)(1996-12#1)(1996-2#1)(1997-3#1)(2006-1#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-3#2)(2007-7#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-7#1)(2013-1#1)
physicians in##104##2##(1990-6#1)(1991-2#1)(1991-5#1)(1991-8#2)(1992-1#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#3)(1993-6#2)(1994-11#1)(1994-12#1)(1994-3#8)(1994-5#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-11#1)(2005-8#2)(2006-1#1)(2006-10#3)(2006-12#1)(2006-6#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-2#5)(2007-3#3)(2007-4#1)(2007-6#2)(2007-7#5)(2007-9#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#1)(2009-2#1)(2010-11#6)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#4)
physicians into##2##2##(1993-5#1)(1995-1#1)
physicians involved in##3##3##(1994-4#1)(2005-9#1)(2007-1#1)
physicians involved##4##2##(1994-4#1)(2005-9#1)(2006-1#1)(2007-1#1)
physicians is the##3##3##(2004-12#1)(2004-3#1)(2006-2#1)
physicians is##10##2##(1991-3#1)(2004-12#1)(2004-3#1)(2006-10#1)(2006-2#1)(2007-2#1)(2007-4#1)(2007-5#1)(2010-5#1)(2011-2#1)
physicians know about##3##3##(1990-2#1)(1994-2#1)(2011-1#1)
physicians know##5##2##(1990-2#1)(1994-2#1)(2007-7#1)(2010-10#1)(2011-1#1)
physicians make##4##2##(1994-2#1)(2006-10#1)(2007-12#1)(2007-4#1)
physicians may be##2##3##(1996-3#1)(2008-11#1)
physicians may##4##2##(1996-3#1)(1997-1#1)(2006-10#1)(2008-11#1)
physicians might##2##2##(1995-12#1)(2007-10#1)
physicians must be aware of the##2##6##(1994-3#1)(2010-9#1)
physicians must be##4##3##(1994-2#1)(1994-3#1)(2010-9#1)(2011-1#1)
physicians must##12##2##(1991-3#1)(1993-9#1)(1994-2#1)(1994-3#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-8#2)(2010-9#1)(2011-1#1)(2013-8#1)
physicians need to be aware##2##5##(2007-9#1)(2009-6#1)
physicians need to be##5##4##(1993-12#1)(2006-10#1)(2007-9#1)(2009-6#1)(2012-2#1)
physicians need to##8##3##(1993-12#1)(1994-2#1)(2006-10#1)(2007-9#1)(2008-1#1)(2009-6#1)(2012-2#1)(2013-7#1)
physicians not##2##2##(1992-9#1)(1995-4#1)
physicians of the##6##3##(2007-3#1)(2007-8#1)(2008-5#1)(2009-2#1)(2013-1#2)
physicians of##8##2##(2007-11#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-5#1)(2009-2#1)(2013-1#2)
physicians often##2##2##(2009-4#1)(2011-2#1)
physicians on the##2##3##(2009-3#1)(2013-1#1)
physicians on##5##2##(2007-10#1)(2009-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
physicians or other##2##3##(2006-7#1)(2009-5#1)
physicians or##4##2##(1991-3#1)(1994-12#1)(2006-7#1)(2009-5#1)
physicians per capita##2##3##(1996-3#1)(2010-8#1)
physicians per##3##2##(1993-1#1)(1996-3#1)(2010-8#1)
physicians perform##2##2##(1996-12#1)(2007-4#1)
physicians performing##2##2##(1995-12#1)(1996-6#1)
physicians play##2##2##(2007-6#1)(2008-8#1)
physicians prescribe##4##2##(1993-12#1)(1996-11#1)(2011-1#1)(2011-2#1)
physicians rated##2##2##(1990-12#1)(1997-3#1)
physicians regarding##6##2##(2007-4#1)(2009-7#2)(2012-3#1)(2013-1#2)
physicians remain##2##2##(1993-6#1)(2012-12#1)
physicians report##3##2##(2010-9#1)(2011-1#2)
physicians reported##3##2##(2007-3#1)(2010-12#1)(2013-1#1)
physicians responded##2##2##(2007-3#1)(2013-1#1)
physicians see patients in##2##4##(2011-1#2)
physicians should be aware of the##2##6##(1994-7#1)(2011-2#1)
physicians should be aware of##4##5##(1994-7#1)(2007-3#1)(2008-10#1)(2011-2#1)
physicians should be aware##5##4##(1994-7#1)(2006-10#1)(2007-3#1)(2008-10#1)(2011-2#1)
physicians should be##15##3##(1990-6#1)(1991-1#1)(1991-3#2)(1994-7#1)(1996-8#1)(2006-10#2)(2006-8#1)(2007-3#1)(2007-7#1)(2008-10#1)(2009-7#1)(2011-2#1)(2012-11#1)
physicians should consider the possibility of pernicious anemia when patients with diabetes mellitus have cryptogenic anorexia with the finding of significant macrocytosis (MCV &gt##2##23##(2013-1#2)
physicians should consider the possibility of##3##6##(2009-6#1)(2013-1#2)
physicians should consider##4##3##(2009-6#1)(2011-2#1)(2013-1#2)
physicians should do##2##3##(1991-3#1)(2007-8#1)
physicians should##28##2##(1990-6#1)(1991-1#1)(1991-3#3)(1994-3#1)(1994-7#1)(1996-8#1)(2006-10#3)(2006-5#1)(2006-8#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#2)
physicians specializing in##2##3##(1996-1#1)(2008-12#1)
physicians spend##4##2##(2011-1#4)
physicians surveyed##2##2##(2010-10#1)(2013-1#1)
physicians taking##2##2##(2006-1#1)(2007-11#1)
physicians than##2##2##(1993-12#1)(1997-6#1)
physicians that##4##2##(1991-1#1)(1993-10#1)(1993-9#1)(2006-8#1)
physicians the##2##2##(1990-3#1)(1992-12#1)
physicians through the##2##3##(1997-1#1)(2008-1#1)
physicians through##3##2##(1996-3#1)(1997-1#1)(2008-1#1)
physicians to a##2##3##(2006-8#1)(2012-12#1)
physicians to apply##2##3##(2006-8#1)(2013-1#1)
physicians to be##4##3##(1991-7#1)(2005-6#1)(2006-10#1)(2012-2#1)
physicians to improve##2##3##(2008-3#1)(2009-5#1)
physicians to promote##2##3##(1994-7#1)(2008-8#1)
physicians to tailor##2##3##(2008-7#1)(2008-8#1)
physicians to the##2##3##(1997-3#1)(2008-4#1)
physicians to##69##2##(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-1#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-1#2)(1994-2#1)(1994-3#1)(1994-7#1)(1995-1#1)(1996-1#2)(1996-3#1)(1997-3#2)(2005-6#1)(2005-7#1)(2006-10#4)(2006-12#2)(2006-6#1)(2006-8#6)(2007-10#1)(2007-3#1)(2007-4#6)(2007-6#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#4)(2009-5#1)(2010-12#1)(2010-4#2)(2010-9#1)(2011-1#1)(2012-12#3)(2012-2#3)(2013-1#3)(2013-8#2)
physicians toward collaborating with##2##4##(2011-1#2)
physicians toward##3##2##(2006-12#1)(2011-1#2)
physicians towards##3##2##(2006-8#1)(2008-1#1)(2013-1#1)
physicians treating##2##2##(1994-1#1)(2008-5#1)
physicians under Medicare##2##3##(1991-2#1)(1992-2#1)
physicians under##4##2##(1991-2#1)(1992-1#1)(1992-2#1)(1992-3#1)
physicians use##3##2##(2007-5#1)(2007-7#1)(2008-3#1)
physicians using##2##2##(2007-11#1)(2010-8#1)
physicians was##6##2##(1997-3#1)(2007-8#1)(2008-11#2)(2011-1#2)
physicians were asked to##2##4##(2007-3#1)(2009-2#1)
physicians were##15##2##(1993-12#1)(1996-11#1)(1996-3#1)(1997-4#1)(2007-3#2)(2007-6#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-2#1)(2010-10#1)(2011-2#2)
physicians when##4##2##(1993-3#1)(2007-10#1)(2012-12#1)(2012-3#1)
physicians while dealing with##2##4##(2009-5#1)(2013-8#1)
physicians who are##2##3##(2007-10#1)(2011-2#1)
physicians who did not smoke##2##5##(2011-2#2)
physicians who provide##2##3##(1991-2#1)(1993-12#1)
physicians who were##2##3##(2011-2#2)
physicians who work##2##3##(1994-12#1)(2007-7#1)
physicians who##27##2##(1991-2#1)(1993-12#1)(1994-12#1)(1994-7#1)(1995-9#2)(1996-9#1)(2004-3#1)(2007-1#1)(2007-10#1)(2007-4#3)(2007-7#2)(2008-11#1)(2008-3#1)(2009-12#1)(2010-2#1)(2010-9#1)(2011-2#6)(2013-1#1)
physicians whose##2##2##(1993-12#1)(2008-7#1)
physicians will be##2##3##(1997-1#1)(2006-10#1)
physicians will not##2##3##(1994-2#1)(2010-4#1)
physicians will##10##2##(1992-1#1)(1994-2#1)(1995-12#1)(1997-1#1)(2006-10#2)(2007-3#1)(2007-7#1)(2010-4#1)(2012-2#1)
physicians with a##3##3##(1996-11#1)(2007-10#1)(2008-3#1)
physicians with the##3##3##(1994-1#1)(2007-5#2)
physicians with##25##2##(1991-3#1)(1994-1#1)(1994-12#1)(1996-1#1)(1996-11#1)(1997-3#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-9#1)(2008-3#1)(2008-8#2)(2010-11#1)(2010-7#1)(2010-9#1)(2011-2#1)(2013-1#2)
physicians within a##2##3##(1995-3#1)(2008-2#1)
physicians within##3##2##(1995-3#1)(2008-2#1)(2009-7#1)
physicians working in##5##3##(2007-7#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-11#1)
physicians would##3##2##(1992-1#1)(1996-9#1)(2007-10#1)
physicians##1375##1##(1990-10#2)(1990-12#7)(1990-2#8)(1990-3#1)(1990-5#2)(1990-6#3)(1990-8#1)(1991-1#10)(1991-10#2)(1991-12#7)(1991-2#26)(1991-3#24)(1991-4#4)(1991-5#2)(1991-6#8)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#16)(1992-11#1)(1992-12#10)(1992-2#12)(1992-3#8)(1992-4#1)(1992-5#4)(1992-6#3)(1992-8#3)(1992-9#2)(1993-1#9)(1993-10#3)(1993-11#4)(1993-12#16)(1993-2#6)(1993-3#17)(1993-5#9)(1993-6#9)(1993-9#5)(1994-1#16)(1994-11#4)(1994-12#11)(1994-2#13)(1994-3#24)(1994-4#2)(1994-5#1)(1994-6#2)(1994-7#4)(1994-8#4)(1995-1#11)(1995-10#1)(1995-11#4)(1995-12#6)(1995-2#7)(1995-3#6)(1995-4#1)(1995-5#4)(1995-6#3)(1995-8#4)(1995-9#5)(1996-1#20)(1996-11#6)(1996-12#5)(1996-2#9)(1996-3#18)(1996-4#1)(1996-5#1)(1996-6#5)(1996-7#2)(1996-8#2)(1996-9#11)(1997-1#15)(1997-2#6)(1997-3#18)(1997-4#3)(1997-5#1)(1997-6#8)(1997-8#4)(2004-1#1)(2004-10#1)(2004-12#1)(2004-3#8)(2005-1#1)(2005-10#4)(2005-11#1)(2005-2#1)(2005-3#2)(2005-6#1)(2005-7#2)(2005-8#9)(2005-9#2)(2006-1#4)(2006-10#46)(2006-12#7)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#2)(2006-6#7)(2006-7#3)(2006-8#35)(2006-9#2)(2007-1#6)(2007-10#17)(2007-11#11)(2007-12#9)(2007-2#13)(2007-3#26)(2007-4#52)(2007-5#13)(2007-6#9)(2007-7#28)(2007-8#10)(2007-9#21)(2008-1#19)(2008-10#10)(2008-11#25)(2008-12#10)(2008-2#4)(2008-3#17)(2008-4#19)(2008-5#6)(2008-6#10)(2008-7#14)(2008-8#30)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#7)(2009-3#4)(2009-4#8)(2009-5#7)(2009-6#3)(2009-7#6)(2009-8#1)(2009-9#5)(2010-1#3)(2010-10#7)(2010-11#18)(2010-12#11)(2010-2#3)(2010-3#3)(2010-4#6)(2010-5#9)(2010-6#2)(2010-7#3)(2010-8#10)(2010-9#18)(2011-1#35)(2011-12#2)(2011-2#33)(2012-1#8)(2012-11#7)(2012-12#9)(2012-2#22)(2012-3#13)(2013-1#47)(2013-7#5)(2013-8#13)
physicians' attitudes toward##2##3##(1997-1#1)(2007-7#1)
physicians' attitudes##4##2##(1997-1#1)(1997-6#1)(2007-2#1)(2007-7#1)
physicians' compliance with the##2##4##(2006-8#1)(2010-8#1)
physicians' knowledge of##2##3##(2007-5#1)(2011-2#1)
physicians' knowledge##4##2##(2007-5#1)(2008-11#1)(2011-2#2)
physicians' office records and Medicare Part B claims##2##8##(1996-2#2)
physicians' office##3##2##(1992-12#1)(1996-2#2)
physicians' offices##6##2##(1992-1#1)(1994-2#2)(1996-2#1)(2010-11#2)
physicians' perceptions of##8##3##(1990-12#1)(1993-12#1)(1997-3#1)(2011-1#3)(2013-1#2)
physicians' perceptions##9##2##(1990-12#1)(1993-12#1)(1997-3#1)(2011-1#4)(2013-1#2)
physicians' practice##2##2##(1991-4#1)(1994-1#1)
physicians' services##9##2##(1991-2#5)(1993-2#1)(2005-12#1)(2009-3#1)(2010-2#1)
physicians' unawareness of patients'##2##4##(2011-1#2)
physicians' work##2##2##(1995-2#2)
physicians'##96##1##(1990-12#2)(1990-6#1)(1991-12#2)(1991-2#6)(1991-3#3)(1991-4#2)(1992-1#1)(1992-12#2)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#2)(1994-1#2)(1994-2#3)(1994-3#1)(1995-12#1)(1995-2#3)(1995-5#1)(1995-9#1)(1996-1#2)(1996-2#4)(1996-3#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-12#1)(2006-10#2)(2006-8#1)(2007-10#2)(2007-11#1)(2007-2#2)(2007-4#2)(2007-5#1)(2007-7#1)(2007-9#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#3)(2009-3#1)(2010-11#3)(2010-2#1)(2010-8#1)(2010-9#4)(2011-1#7)(2011-2#4)(2012-11#1)(2013-1#2)
physicians-in-training##2##1##(2007-2#1)(2008-1#1)
physicians/nurses##2##1##(2012-3#2)
physicians?##2##1##(1991-9#1)(2008-4#1)
physicians?]##6##1##(1990-6#2)(1993-6#1)(1993-8#1)(1994-3#1)(1995-10#1)
physicians]##20##1##(1990-6#1)(1991-4#1)(1992-6#1)(1993-10#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#1)(1996-3#1)(1996-6#1)(1996-9#2)(2007-9#1)(2008-11#1)(2008-4#1)(2012-2#1)
physicist##5##1##(2007-4#1)(2007-8#2)(2007-9#2)
physicists and technologists##2##3##(2007-4#1)(2008-10#1)
physicists and##4##2##(2007-4#2)(2008-10#2)
physicists are##2##2##(1990-11#1)(2008-3#1)
physicists in##2##2##(2007-4#1)(2007-8#1)
physicists##30##1##(1990-11#1)(1993-2#1)(2007-4#10)(2007-8#4)(2007-9#5)(2008-10#2)(2008-3#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-5#1)(2012-2#2)
physico-chemical and structural##2##3##(2008-10#2)
physico-chemical and##9##2##(1991-6#1)(1991-8#1)(1992-6#1)(2008-10#2)(2008-5#2)(2010-4#1)(2013-1#1)
physico-chemical characteristics of the##2##4##(1994-12#1)(2007-7#1)
physico-chemical characteristics##4##2##(1994-12#1)(2007-7#1)(2008-1#1)(2012-2#1)
physico-chemical conditions##4##2##(1991-7#1)(2004-4#1)(2006-10#1)(2008-10#1)
physico-chemical methods##2##2##(2008-1#1)(2008-4#1)
physico-chemical parameters and##2##3##(2008-5#1)(2013-7#1)
physico-chemical parameters were##3##3##(2007-10#1)(2008-5#1)(2013-7#1)
physico-chemical parameters##19##2##(2006-12#1)(2007-10#3)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#4)(2013-7#2)
physico-chemical properties of the##3##4##(1992-6#2)(2008-5#1)
physico-chemical properties of##13##3##(1990-7#1)(1992-6#2)(1993-9#1)(2004-9#2)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-5#2)(2009-2#1)
physico-chemical properties##35##2##(1990-7#2)(1992-6#2)(1993-9#1)(1994-12#1)(1994-8#1)(1997-1#1)(1997-7#1)(1997-8#1)(2004-9#2)(2006-1#1)(2006-10#1)(2006-12#1)(2007-6#2)(2007-8#1)(2008-10#4)(2008-5#8)(2009-2#2)(2010-8#1)(2012-1#1)(2013-1#1)
physico-chemical stability##2##2##(1992-5#1)(2008-10#1)
physico-chemical techniques##2##2##(1997-2#1)(2008-3#1)
physico-chemical variables##2##2##(2012-2#2)
physico-chemical##103##1##(1990-4#1)(1990-7#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-5#1)(1992-6#3)(1993-9#1)(1994-11#1)(1994-12#2)(1994-8#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-4#1)(2004-9#2)(2005-10#1)(2006-1#1)(2006-10#2)(2006-12#3)(2007-10#3)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#19)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#18)(2008-6#1)(2008-8#1)(2009-2#2)(2009-6#2)(2010-1#1)(2010-12#1)(2010-4#2)(2010-8#1)(2012-1#1)(2012-2#3)(2013-1#2)(2013-7#2)
physico-mechanical properties##2##2##(2012-12#2)
physicochemical and functional##2##3##(2012-2#2)
physicochemical and sensory##2##3##(2010-4#1)(2012-2#1)
physicochemical and##12##2##(1992-7#1)(2005-8#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-4#3)(2012-11#1)(2012-2#3)
physicochemical aspects of##2##3##(2008-10#1)(2009-4#1)
physicochemical characteristics of M##2##4##(2010-4#2)
physicochemical characteristics of the##2##4##(2006-5#1)(2008-5#1)
physicochemical characteristics of##7##3##(2006-12#1)(2006-5#1)(2008-10#1)(2008-5#2)(2010-4#2)
physicochemical characteristics were##2##3##(2010-2#1)(2010-4#1)
physicochemical characteristics##17##2##(2005-7#1)(2006-12#1)(2006-5#1)(2007-11#1)(2008-10#2)(2008-5#6)(2010-2#1)(2010-4#4)
physicochemical characterization of##3##3##(1995-8#1)(2008-10#2)
physicochemical conditions##4##2##(2008-10#1)(2008-11#1)(2013-7#2)
physicochemical descriptors##2##2##(2007-11#1)(2013-1#1)
physicochemical factors##2##2##(2009-6#1)(2012-2#1)
physicochemical parameters and##3##3##(1996-5#1)(2008-10#2)
physicochemical parameters in##2##3##(2008-10#1)(2012-2#1)
physicochemical parameters on the##2##4##(1996-5#1)(2008-10#1)
physicochemical parameters##13##2##(1996-5#2)(2008-10#6)(2008-5#1)(2009-6#1)(2010-7#1)(2011-12#1)(2012-2#1)
physicochemical properties and##4##3##(1996-11#1)(2007-11#1)(2008-10#1)(2011-2#1)
physicochemical properties of a##2##4##(2008-10#1)(2012-11#1)
physicochemical properties of the##13##4##(1992-2#1)(1992-6#1)(1994-9#2)(1996-1#1)(1996-11#1)(1996-8#1)(2008-5#2)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
physicochemical properties of##25##3##(1992-2#1)(1992-6#1)(1993-1#1)(1994-11#1)(1994-9#2)(1996-1#1)(1996-11#1)(1996-8#1)(2004-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-8#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#1)
physicochemical properties were##3##3##(1991-9#1)(2005-11#1)(2008-5#1)
physicochemical properties##58##2##(1990-7#1)(1991-9#1)(1992-2#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#1)(1994-11#1)(1994-2#1)(1994-9#2)(1996-1#1)(1996-11#2)(1996-5#1)(1996-8#1)(2004-12#2)(2004-8#1)(2005-11#3)(2005-7#1)(2007-11#2)(2007-8#1)(2008-10#8)(2008-11#2)(2008-5#6)(2008-8#2)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#2)
physicochemical qualities##2##2##(1996-8#2)
physicochemical stability##3##2##(2010-12#2)(2010-7#1)
physicochemical studies##3##2##(1996-7#1)(2008-5#2)
physicochemical techniques##2##2##(2006-12#1)(2008-4#1)
physicochemical##158##1##(1990-7#1)(1991-9#1)(1992-2#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-1#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-9#2)(1995-11#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-5#3)(1996-7#1)(1996-8#4)(1997-4#1)(1997-6#1)(2004-12#2)(2004-8#1)(2005-11#5)(2005-7#2)(2005-8#1)(2006-10#1)(2006-12#2)(2006-5#1)(2007-1#1)(2007-11#4)(2007-7#1)(2007-8#2)(2008-10#25)(2008-11#4)(2008-4#1)(2008-5#17)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#2)(2009-6#2)(2010-11#1)(2010-12#5)(2010-2#2)(2010-4#12)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-2#8)(2012-3#1)(2013-1#4)(2013-7#2)
physicochemically##2##1##(2008-10#1)(2010-4#1)
physics and chemistry##3##3##(2007-11#1)(2008-7#1)(2012-2#1)
physics and##19##2##(1990-12#3)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-12#1)(2010-9#3)(2011-2#1)(2012-2#2)
physics are##2##2##(2007-9#1)(2008-7#1)
physics experiments##3##2##(2008-2#2)(2009-9#1)
physics is##5##2##(1991-6#1)(1996-4#1)(2007-12#1)(2007-8#1)(2007-9#1)
physics lab##3##2##(2007-8#1)(2012-2#2)
physics of the##3##3##(2006-5#1)(2008-3#1)(2012-2#1)
physics of##10##2##(1996-2#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-2#2)(2008-3#1)(2009-5#1)(2012-2#1)(2013-1#1)
physics services##2##2##(1990-12#1)(2007-4#1)
physics##100##1##(1990-12#5)(1990-2#1)(1991-11#1)(1991-5#1)(1991-6#1)(1992-5#1)(1993-2#1)(1993-4#2)(1994-3#1)(1995-9#2)(1996-2#1)(1996-4#2)(1996-5#1)(1997-6#1)(2005-11#2)(2006-10#3)(2006-12#1)(2006-2#2)(2006-5#3)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#6)(2007-4#6)(2007-6#1)(2007-8#5)(2007-9#6)(2008-1#3)(2008-2#6)(2008-3#3)(2008-5#1)(2008-7#5)(2008-9#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#4)(2010-9#3)(2011-2#1)(2012-2#7)(2013-1#1)
physics-based##2##1##(2008-10#1)(2008-6#1)
physio-chemical parameters##4##2##(2008-10#4)
physio-chemical##5##1##(2008-10#5)
physio-psycho-social status##3##2##(2007-10#3)
physiochemical characteristics##2##2##(2005-11#1)(2008-5#1)
physiochemical properties of the##2##4##(1992-8#1)(2012-2#1)
physiochemical properties of##5##3##(1992-8#1)(1996-11#1)(2005-9#1)(2008-1#1)(2012-2#1)
physiochemical properties##7##2##(1992-8#1)(1996-11#1)(2005-9#2)(2008-1#1)(2012-2#2)
physiochemical##11##1##(1992-8#1)(1996-11#1)(2005-11#1)(2005-9#2)(2008-1#1)(2008-5#1)(2009-8#1)(2011-1#1)(2012-2#2)
physiogenomic##2##1##(2012-3#2)
physiognomic##2##1##(2007-1#2)
physiognomies##2##1##(2007-3#2)
physiognomy##2##1##(2008-11#1)(2008-7#1)
physiologic abnormalities##2##2##(1991-12#1)(1996-7#1)
physiologic actions##2##2##(1991-9#1)(2006-10#1)
physiologic amounts of##2##3##(1990-12#1)(2006-10#1)
physiologic amounts##3##2##(1990-12#1)(2006-10#2)
physiologic and biochemical##2##3##(1996-8#1)(2007-9#1)
physiologic and metabolic##3##3##(1992-9#1)(2006-10#1)(2008-5#1)
physiologic and pathologic##6##3##(1990-3#1)(1993-12#1)(2007-11#1)(2008-9#1)(2010-6#1)(2013-1#1)
physiologic and pathophysiologic##2##3##(1992-7#1)(1995-2#1)
physiologic and##15##2##(1990-3#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-4#1)(1995-2#1)(1996-8#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-9#1)(2010-6#1)(2013-1#1)
physiologic changes occurring##2##3##(1991-10#1)(2007-9#1)
physiologic changes##5##2##(1991-10#1)(1996-7#1)(2006-10#1)(2007-9#1)(2008-5#1)
physiologic concentrations of##2##3##(1991-9#1)(1993-6#1)
physiologic concentrations##3##2##(1991-9#1)(1993-6#1)(1995-3#1)
physiologic conditions##3##2##(1992-7#1)(2009-10#1)(2013-1#1)
physiologic control##2##2##(1995-8#1)(2006-10#1)
physiologic data##6##2##(2013-1#6)
physiologic effects##3##2##(1993-12#1)(2006-10#2)
physiologic factors##2##2##(1991-4#1)(2010-8#1)
physiologic function##2##2##(1992-11#1)(2006-8#1)
physiologic functions##5##2##(1990-11#1)(2006-10#1)(2010-12#1)(2012-1#1)(2013-8#1)
physiologic levels##2##2##(2004-11#1)(2008-4#1)
physiologic mechanism that##2##3##(2006-10#1)(2010-12#1)
physiologic mechanism##4##2##(2006-10#1)(2007-1#1)(2007-2#1)(2010-12#1)
physiologic mechanisms##5##2##(1994-9#1)(1996-4#1)(2006-10#1)(2008-3#1)(2010-8#1)
physiologic or##2##2##(2007-11#1)(2008-2#1)
physiologic parameters##2##2##(1991-1#1)(1994-3#1)
physiologic phenomenon##2##2##(1990-6#1)(2010-12#1)
physiologic processes in##2##3##(2008-5#1)(2012-12#1)
physiologic processes##4##2##(2007-10#1)(2008-10#1)(2008-5#1)(2012-12#1)
physiologic regulation of##2##3##(1994-11#1)(1995-9#1)
physiologic regulation##3##2##(1994-11#1)(1995-9#1)(2008-7#1)
physiologic responses to##3##3##(2006-10#1)(2008-4#1)(2013-8#1)
physiologic responses##4##2##(1996-8#1)(2006-10#1)(2008-4#1)(2013-8#1)
physiologic responsivity##2##2##(1996-7#2)
physiologic role##10##2##(1993-8#1)(1994-12#1)(1995-12#1)(1995-2#1)(1997-4#1)(2006-10#2)(2008-4#2)(2013-7#1)
physiologic roles of##2##3##(1994-12#1)(2008-5#1)
physiologic roles##3##2##(1994-12#1)(1995-7#1)(2008-5#1)
physiologic saline##2##2##(1993-1#1)(2012-3#1)
physiologic significance##3##2##(1990-3#1)(1991-10#1)(2013-8#1)
physiologic state##2##2##(2008-3#1)(2008-8#1)
physiologic stress##2##2##(2011-12#1)(2011-2#1)
physiologic system##2##2##(1996-10#1)(2010-7#1)
physiologic systems##3##2##(1997-1#1)(2010-7#2)
physiologic##194##1##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#2)(1991-1#2)(1991-10#2)(1991-12#1)(1991-3#2)(1991-4#1)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#4)(1992-11#1)(1992-4#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-4#1)(1993-6#2)(1993-8#1)(1994-11#2)(1994-12#2)(1994-3#2)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-3#1)(1996-4#1)(1996-7#4)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#1)(2004-11#3)(2005-10#1)(2006-10#21)(2006-11#1)(2006-2#1)(2006-6#1)(2006-8#2)(2006-9#2)(2007-1#3)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#2)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-6#2)(2010-7#4)(2010-8#2)(2010-9#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#9)(2013-7#2)(2013-8#3)
physiological abnormalities##3##2##(1996-5#1)(2005-8#1)(2006-5#1)
physiological acrosome reaction##2##3##(2006-5#2)
physiological actions##3##2##(1995-6#1)(2007-5#1)(2010-7#1)
physiological activation of##2##3##(1992-9#1)(1997-5#1)
physiological activities##2##2##(1993-8#1)(2007-11#1)
physiological activity of##2##3##(1992-1#1)(2008-10#1)
physiological activity##7##2##(1992-1#2)(1997-6#1)(2007-11#1)(2008-10#1)(2009-8#1)(2013-1#1)
physiological adaptation to##2##3##(1994-11#1)(2010-12#1)
physiological adaptation##4##2##(1994-11#1)(2008-1#1)(2008-11#1)(2010-12#1)
physiological adaptations to##2##3##(2009-7#1)(2011-2#1)
physiological adaptations##5##2##(2009-7#1)(2011-2#1)(2012-3#1)(2013-8#2)
physiological agonists##2##2##(1992-12#1)(2006-6#1)
physiological alterations in##2##3##(1994-3#1)(2013-1#1)
physiological alterations##4##2##(1994-3#1)(2009-11#1)(2012-3#1)(2013-1#1)
physiological amino acids##2##3##(1996-6#1)(2008-4#1)
physiological and anatomical##2##3##(2006-1#1)(2006-5#1)
physiological and behavioral responses##2##4##(1995-5#1)(2013-7#1)
physiological and behavioral##8##3##(1995-5#1)(2008-4#1)(2008-7#1)(2009-8#1)(2011-2#2)(2012-12#1)(2013-7#1)
physiological and biochemical parameters##2##4##(1992-12#1)(2012-2#1)
physiological and biochemical studies##2##4##(2005-11#2)
physiological and biochemical tests##2##4##(2005-11#1)(2012-2#1)
physiological and biochemical##13##3##(1991-2#1)(1992-12#1)(2005-11#3)(2006-9#1)(2008-11#2)(2009-9#1)(2011-12#1)(2012-2#2)(2013-8#1)
physiological and environmental##3##3##(2006-7#1)(2008-2#1)(2008-4#1)
physiological and metabolic##4##3##(2006-10#1)(2010-2#1)(2012-1#1)(2013-1#1)
physiological and molecular##5##3##(2006-10#1)(2009-10#1)(2009-8#2)(2013-7#1)
physiological and morphological##5##3##(1994-3#1)(2008-4#1)(2009-10#1)(2009-8#1)(2011-2#1)
physiological and pathological conditions##8##4##(1992-4#1)(1994-2#1)(1997-2#1)(2005-8#1)(2006-2#1)(2008-4#2)(2008-8#1)
physiological and pathological processes##7##4##(1992-2#1)(1994-2#1)(1995-4#1)(2007-11#1)(2007-2#1)(2007-6#1)(2010-1#1)
physiological and pathological roles##3##4##(2008-8#1)(2012-2#1)(2012-3#1)
physiological and pathological##25##3##(1990-9#1)(1992-2#1)(1992-4#1)(1994-2#2)(1995-4#1)(1997-2#1)(2005-8#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#2)(2010-1#1)(2011-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
physiological and pathophysiological functions of##2##5##(2006-10#1)(2008-5#1)
physiological and pathophysiological processes##2##4##(2007-11#1)(2008-4#1)
physiological and pathophysiological states##2##4##(1994-11#1)(2013-1#1)
physiological and pathophysiological##15##3##(1994-11#1)(2006-10#1)(2006-12#1)(2007-11#2)(2008-1#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-11#1)(2010-7#1)(2011-1#2)(2012-12#1)(2013-1#1)
physiological and pharmacological##4##3##(1992-6#1)(1994-12#1)(2008-1#1)(2008-7#1)
physiological and psychological well-being##2##4##(1992-2#1)(2008-10#1)
physiological and psychological##7##3##(1992-2#1)(1995-10#1)(2007-11#1)(2007-2#2)(2008-10#1)(2012-1#1)
physiological and##120##2##(1990-9#1)(1991-10#1)(1991-2#1)(1991-4#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-10#1)(1995-12#1)(1995-4#1)(1995-5#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#1)(2005-11#3)(2005-8#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-5#1)(2006-7#1)(2006-9#1)(2007-11#5)(2007-2#3)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#4)(2008-2#1)(2008-4#7)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#2)(2009-8#4)(2009-9#2)(2010-1#1)(2010-11#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#2)
physiological and/or##4##2##(1990-12#1)(2008-11#1)(2008-5#1)(2009-9#1)
physiological application##2##2##(2007-8#2)
physiological as well as pathological##2##5##(1990-8#1)(2010-9#1)
physiological as well as##3##4##(1990-8#1)(1994-3#1)(2010-9#1)
physiological aspects of##2##3##(1990-6#1)(1990-8#1)
physiological basis of##3##3##(2007-12#1)(2008-10#1)(2012-1#1)
physiological basis##5##2##(1994-11#1)(2007-12#1)(2008-10#1)(2011-1#1)(2012-1#1)
physiological benefits##3##2##(2010-7#3)
physiological buffer##4##2##(1990-9#1)(1992-1#1)(1997-2#1)(2010-10#1)
physiological calcium##3##2##(1990-11#1)(1991-9#1)(1992-9#1)
physiological cell##2##2##(1994-10#1)(1995-2#1)
physiological change##2##2##(2008-6#1)(2009-5#1)
physiological changes are##2##3##(1990-11#1)(2006-10#1)
physiological changes in##5##3##(1996-10#1)(2008-12#1)(2008-9#1)(2009-3#1)(2011-12#1)
physiological changes that##2##3##(2006-5#1)(2009-5#1)
physiological changes##26##2##(1990-11#1)(1993-7#1)(1995-3#1)(1996-10#1)(1997-1#1)(1997-6#1)(1997-7#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-8#2)(2008-9#2)(2009-1#1)(2009-3#1)(2009-5#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)
physiological characteristics of##3##3##(1991-2#1)(1997-7#1)(2005-8#1)
physiological characteristics##7##2##(1991-2#1)(1994-5#1)(1997-7#1)(2005-8#1)(2008-5#1)(2009-5#1)(2012-2#1)
physiological concentration of##5##3##(1990-3#2)(1994-3#1)(1994-5#1)(2006-10#1)
physiological concentration range##2##3##(1990-11#1)(2008-10#1)
physiological concentration##9##2##(1990-11#1)(1990-3#2)(1993-8#1)(1994-3#1)(1994-5#1)(2006-10#1)(2008-10#1)(2008-3#1)
physiological concentrations of##9##3##(1990-2#1)(1990-4#1)(1991-4#1)(1992-3#1)(1992-9#1)(1993-6#1)(1994-12#1)(1995-1#1)(2013-8#1)
physiological concentrations##19##2##(1990-10#1)(1990-2#1)(1990-4#1)(1991-4#1)(1992-3#1)(1992-9#1)(1993-6#2)(1993-9#1)(1994-12#2)(1995-1#2)(1995-3#1)(1997-4#1)(2008-10#2)(2010-8#1)(2013-8#1)
physiological concepts##2##2##(2005-10#1)(2008-7#1)
physiological condition##3##2##(1996-5#1)(2006-8#1)(2010-2#1)
physiological conditions and after##2##4##(2008-7#2)
physiological conditions and##6##3##(1990-9#1)(1993-4#1)(2008-1#1)(2008-3#1)(2008-7#2)
physiological conditions are##2##3##(1996-6#1)(2008-10#1)
physiological conditions of##2##3##(1997-2#1)(2008-10#1)
physiological conditions with##3##3##(2006-6#1)(2007-2#1)(2008-3#1)
physiological conditions##84##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-4#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-4#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2005-1#1)(2006-12#1)(2006-6#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#1)(2009-2#1)(2009-7#1)(2010-4#2)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#2)
physiological consequences of##2##3##(1995-12#1)(2006-10#1)
physiological consequences##4##2##(1991-2#1)(1995-12#1)(2006-10#1)(2007-2#1)
physiological constraints##9##2##(2008-7#5)(2008-8#1)(2009-8#2)(2010-8#1)
physiological context##2##2##(2008-7#1)(2009-8#1)
physiological data##8##2##(1995-9#1)(1997-7#1)(2006-5#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)
physiological deterioration##2##2##(2008-7#1)(2008-9#1)
physiological differences between##2##3##(1992-4#1)(2008-10#1)
physiological differences##6##2##(1991-11#1)(1992-4#1)(1996-12#1)(1996-9#1)(2006-10#1)(2008-10#1)
physiological doses##2##2##(1997-8#1)(2008-8#1)
physiological effect of##4##3##(1992-8#1)(1994-11#1)(2005-7#1)(2008-10#1)
physiological effects of##9##3##(1992-3#1)(1993-12#1)(1995-3#1)(1997-7#1)(2005-12#1)(2007-10#1)(2008-3#1)(2008-4#1)(2012-3#1)
physiological effects on##2##3##(2005-8#1)(2013-1#1)
physiological effects##18##2##(1992-3#1)(1993-12#1)(1995-3#1)(1996-2#1)(1997-5#1)(1997-7#1)(2005-12#1)(2005-8#1)(2007-10#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-5#1)(2012-3#1)(2013-1#2)
physiological electron##4##2##(1992-6#1)(1994-9#1)(1995-2#1)(2009-10#1)
physiological environment##2##2##(1996-7#1)(2008-1#1)
physiological environments##3##2##(1995-8#1)(2008-9#1)(2012-2#1)
physiological events##7##2##(2006-4#1)(2008-2#2)(2008-4#2)(2008-7#1)(2009-8#1)
physiological evidence for##2##3##(1992-7#1)(1997-5#1)
physiological evidence##4##2##(1992-7#1)(1997-5#1)(2005-8#1)(2013-8#1)
physiological evolution##2##2##(2008-5#1)(2008-7#1)
physiological experiments##2##2##(1995-12#1)(1997-7#1)
physiological expression##2##2##(1996-7#1)(2010-2#1)
physiological factors##9##2##(1995-6#1)(1997-6#1)(2004-2#1)(2005-7#1)(2008-11#1)(2008-5#1)(2009-12#1)(2010-2#1)(2013-8#1)
physiological flow conditions##3##3##(1997-4#1)(2007-7#1)(2008-9#1)
physiological fluid##2##2##(1993-2#1)(2008-10#1)
physiological fluids##6##2##(1993-2#1)(1996-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#1)
physiological function is not##2##4##(1995-1#1)(1995-6#1)
physiological function of NACP##2##4##(1997-2#2)
physiological function of##15##3##(1991-7#1)(1992-12#1)(1992-7#1)(1994-12#1)(1994-2#1)(1997-2#2)(2008-1#1)(2008-4#1)(2008-6#1)(2009-5#1)(2010-10#1)(2010-7#1)(2012-2#1)(2013-8#1)
physiological function##30##2##(1990-11#1)(1991-7#1)(1992-12#1)(1992-7#1)(1994-12#1)(1994-2#1)(1994-4#1)(1995-1#1)(1995-6#1)(1995-8#1)(1997-2#3)(1997-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-10#1)(2009-5#1)(2010-10#2)(2010-7#1)(2011-12#1)(2012-2#2)(2013-8#2)
physiological functions and##3##3##(1992-7#1)(1994-12#1)(2008-7#1)
physiological functions as##2##3##(2008-5#1)(2013-1#1)
physiological functions in##5##3##(1995-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
physiological functions of##7##3##(1990-3#1)(1991-7#1)(1993-12#1)(1995-3#1)(1997-5#1)(2006-6#1)(2012-2#1)
physiological functions##45##2##(1990-3#2)(1991-7#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-5#1)(1997-6#1)(2005-6#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#2)(2010-4#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#2)
physiological glucose##3##2##(1997-4#2)(2012-4#1)
physiological gonadal secretions##2##3##(2008-11#2)
physiological growth##4##2##(2008-12#2)(2008-5#1)(2008-9#1)
physiological immaturity##2##2##(2010-5#1)(2013-1#1)
physiological impact##3##2##(1995-2#1)(2008-10#1)(2008-5#1)
physiological implications of##2##3##(1991-9#1)(2005-7#1)
physiological importance##4##2##(1990-2#1)(1992-3#1)(1992-9#1)(2009-10#1)
physiological information##3##2##(2008-3#1)(2008-7#1)(2012-12#1)
physiological inhibitors of##2##3##(1993-6#1)(1996-2#1)
physiological instability##2##2##(1993-3#1)(2011-1#1)
physiological interactions##2##2##(1996-12#1)(2008-1#1)
physiological ionic strengths##3##3##(1994-8#1)(1995-2#2)
physiological ionic##7##2##(1990-7#1)(1994-5#3)(1994-8#1)(1995-2#2)
physiological leaf spot formation in##2##5##(2008-10#2)
physiological leaf spot##3##3##(2008-10#3)
physiological leaf##4##2##(2008-10#4)
physiological level of##2##3##(1992-12#1)(1997-5#1)
physiological level##5##2##(1992-12#1)(1997-5#1)(2008-10#1)(2008-6#1)(2011-10#1)
physiological levels of##8##3##(1996-5#1)(2004-12#1)(2005-12#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-1#1)(2012-6#1)
physiological levels##14##2##(1990-11#1)(1990-12#1)(1996-5#1)(2004-12#1)(2005-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-8#1)(2010-1#1)(2012-6#1)(2013-1#1)
physiological maturity##3##2##(2008-10#2)(2008-12#1)
physiological meaning of##2##3##(2008-1#1)(2008-7#1)
physiological measurements##5##2##(1997-6#1)(2006-3#1)(2012-12#2)(2012-3#1)
physiological measures##2##2##(2008-10#1)(2008-5#1)
physiological mechanisms of##2##3##(2006-7#1)(2008-12#1)
physiological mechanisms that##8##3##(2007-9#1)(2008-4#1)(2008-9#1)(2012-12#3)(2012-3#1)(2013-1#1)
physiological mechanisms underlying##2##3##(2008-3#1)(2008-5#1)
physiological mechanisms##23##2##(1990-11#1)(1990-2#1)(1990-5#1)(2006-5#1)(2006-7#1)(2007-3#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2012-12#3)(2012-3#1)(2013-1#1)
physiological media##3##2##(2010-4#3)
physiological model##2##2##(2008-7#1)(2009-2#1)
physiological modulation of##2##3##(1996-4#1)(2005-10#1)
physiological motion##2##2##(2011-1#1)(2012-2#1)
physiological observations##2##2##(1996-5#1)(2009-8#1)
physiological or pathological##3##3##(1993-3#1)(1996-6#1)(2012-2#1)
physiological or pharmacological##2##3##(2008-4#1)(2009-9#1)
physiological or##7##2##(1993-3#1)(1996-6#1)(2008-4#2)(2008-9#1)(2009-9#1)(2012-2#1)
physiological outcomes##2##2##(2004-12#1)(2012-1#1)
physiological pH values##4##3##(1994-8#1)(1997-7#1)(2006-10#1)(2008-5#1)
physiological pH##26##2##(1990-12#1)(1990-9#1)(1994-12#1)(1994-8#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-7#1)(2006-10#1)(2006-12#1)(2008-10#6)(2008-3#1)(2008-4#2)(2008-5#1)(2009-11#1)(2010-1#1)(2010-5#1)(2011-1#1)(2012-11#1)
physiological parameters and##2##3##(1994-12#1)(2011-2#1)
physiological parameters in##4##3##(1996-11#1)(2007-12#2)(2008-12#1)
physiological parameters of##4##3##(2007-10#1)(2008-12#2)(2011-1#1)
physiological parameters were##2##3##(2007-9#1)(2008-6#1)
physiological parameters##26##2##(1992-12#1)(1994-12#1)(1994-5#1)(1996-1#1)(1996-11#1)(2005-9#1)(2007-10#4)(2007-12#2)(2007-9#1)(2008-10#1)(2008-12#3)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
physiological partners##4##2##(1994-5#1)(1995-2#3)
physiological peptides##2##2##(1990-11#1)(1992-5#1)
physiological performance##3##2##(2012-3#1)(2013-1#2)
physiological perspective##3##2##(2005-11#1)(2013-1#2)
physiological phenomena##2##2##(1996-5#1)(2008-10#1)
physiological plasminogen##2##2##(1991-4#1)(1993-2#1)
physiological plasticity##2##2##(1996-9#1)(2009-6#1)
physiological pressure##2##2##(1997-5#1)(2007-9#1)
physiological process of##2##3##(1992-1#1)(2007-11#1)
physiological process##7##2##(1992-1#1)(1993-6#1)(2005-1#1)(2007-11#2)(2009-3#1)(2010-6#1)
physiological processes associated with##2##4##(1996-2#1)(2005-7#1)
physiological processes such as cell##2##5##(2009-6#1)(2013-1#1)
physiological processes such as##6##4##(2008-10#1)(2008-8#1)(2009-12#2)(2009-6#1)(2013-1#1)
physiological processes##46##2##(1992-5#1)(1992-8#1)(1993-11#1)(1993-5#1)(1994-8#1)(1995-2#1)(1996-2#1)(2005-7#1)(2005-9#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-8#2)(2008-9#2)(2009-12#2)(2009-4#3)(2009-6#3)(2009-8#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#4)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
physiological profile##2##2##(1997-6#1)(2011-2#1)
physiological properties of these##2##4##(1990-7#1)(2008-7#1)
physiological properties of this##2##4##(1991-8#1)(2008-5#1)
physiological properties of##15##3##(1990-7#1)(1991-3#1)(1991-8#1)(1997-6#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#1)(2012-1#1)(2012-12#2)(2013-8#1)
physiological properties##21##2##(1990-7#2)(1991-3#1)(1991-8#1)(1991-9#1)(1997-6#2)(1997-7#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-5#1)(2009-8#1)(2012-1#1)(2012-12#2)(2013-8#1)
physiological races of D##2##4##(2008-10#2)
physiological races##4##2##(2008-10#4)
physiological range of##5##3##(1993-6#1)(2007-1#1)(2007-11#2)(2008-10#1)
physiological range##13##2##(1990-11#1)(1990-3#1)(1993-6#1)(1995-3#1)(1995-5#1)(2007-1#1)(2007-11#3)(2007-2#1)(2007-9#1)(2008-10#2)
physiological ranges of##2##3##(1994-12#1)(2011-2#1)
physiological ranges##3##2##(1994-12#1)(2008-6#1)(2011-2#1)
physiological reaction##4##2##(1994-5#1)(1995-10#1)(1995-6#1)(2012-1#1)
physiological reactions##3##2##(2007-11#1)(2011-2#1)(2012-12#1)
physiological reasons##2##2##(1991-11#1)(2009-9#1)
physiological redox##2##2##(1994-5#1)(2008-11#1)
physiological regulation of##2##3##(1994-8#1)(1995-11#1)
physiological regulation##4##2##(1994-8#1)(1995-11#1)(2008-9#1)(2012-12#1)
physiological regulatory##3##2##(1991-10#1)(1995-10#1)(2008-11#1)
physiological relevance of the##3##4##(1995-11#1)(2009-12#1)(2009-4#1)
physiological relevance of##6##3##(1994-11#1)(1995-11#1)(2006-11#1)(2007-12#1)(2009-12#1)(2009-4#1)
physiological relevance##11##2##(1991-6#1)(1991-7#1)(1994-11#1)(1995-11#1)(1995-2#1)(2006-11#1)(2007-11#1)(2007-12#1)(2009-12#1)(2009-4#1)(2011-12#1)
physiological response of##5##3##(2007-7#1)(2008-9#1)(2012-12#1)(2013-1#2)
physiological response that##2##3##(2006-8#1)(2010-2#1)
physiological response to##7##3##(1990-11#1)(1995-2#1)(2006-10#1)(2007-9#1)(2010-8#1)(2012-2#2)
physiological response##18##2##(1990-11#1)(1992-1#1)(1993-7#1)(1995-2#1)(2006-10#1)(2006-8#1)(2007-7#1)(2007-9#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)
physiological responses of##6##3##(1994-6#1)(1997-8#1)(2008-10#1)(2008-9#1)(2010-8#1)(2013-7#1)
physiological responses to##4##3##(1990-9#1)(1994-11#1)(1995-8#1)(2012-1#1)
physiological responses##24##2##(1990-9#1)(1991-5#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-8#1)(1997-5#1)(1997-8#1)(2004-4#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#2)(2009-8#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-7#2)(2013-8#2)
physiological role in humans##2##4##(1992-12#1)(2005-8#1)
physiological role in the regulation of##2##6##(2008-1#1)(2008-4#1)
physiological role in the##7##4##(1992-5#1)(1996-5#1)(1997-4#1)(2008-1#1)(2008-4#2)(2012-12#1)
physiological role in##14##3##(1991-9#1)(1992-12#1)(1992-5#1)(1994-8#1)(1996-5#1)(1997-4#1)(2005-8#1)(2008-1#1)(2008-4#2)(2008-6#1)(2009-8#1)(2012-12#2)
physiological role is##2##3##(1997-6#1)(2008-11#1)
physiological role of the##7##4##(1992-3#1)(1994-6#1)(1995-12#2)(1997-4#1)(2008-1#1)(2008-4#1)
physiological role of this##2##4##(1990-11#1)(1994-12#1)
physiological role of##30##3##(1990-11#1)(1992-3#1)(1993-11#2)(1993-3#1)(1993-4#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-12#2)(1996-2#1)(1996-9#1)(1997-2#1)(1997-4#2)(2008-1#3)(2008-10#2)(2008-11#1)(2008-4#2)(2009-8#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
physiological role##65##2##(1990-11#1)(1990-12#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-11#3)(1993-3#1)(1993-4#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#2)(1996-2#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#3)(1997-6#1)(1997-8#1)(2005-8#1)(2008-1#4)(2008-10#2)(2008-11#2)(2008-4#4)(2008-5#1)(2008-6#1)(2009-11#1)(2009-4#1)(2009-8#3)(2010-10#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)
physiological role(s) for##2##3##(1995-3#1)(1995-6#1)
physiological role(s)##3##2##(1995-3#1)(1995-6#1)(1996-9#1)
physiological roles and##3##3##(2005-8#1)(2007-8#1)(2012-12#1)
physiological roles for##2##3##(2008-8#1)(2009-10#1)
physiological roles in##2##3##(2008-4#1)(2013-8#1)
physiological roles of NCKX proteins##2##5##(2008-8#2)
physiological roles of plant##2##4##(1997-4#1)(2009-8#1)
physiological roles of##9##3##(1992-12#1)(1993-11#1)(1997-4#1)(2008-8#2)(2009-8#2)(2010-12#1)(2013-8#1)
physiological roles##27##2##(1992-12#1)(1993-11#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-7#2)(2005-8#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-8#4)(2008-9#1)(2009-10#2)(2009-8#2)(2010-12#1)(2010-2#2)(2012-12#1)(2013-1#1)(2013-8#2)
physiological saline##12##2##(1991-2#1)(1995-12#2)(1996-10#1)(1997-2#1)(1997-4#2)(2005-10#1)(2008-5#2)(2010-12#1)(2011-2#1)
physiological salt solution##7##3##(1996-10#1)(2004-9#1)(2008-5#1)(2009-5#3)(2010-3#1)
physiological salt##10##2##(1991-1#2)(1996-10#1)(2004-9#1)(2008-5#1)(2009-12#1)(2009-5#3)(2010-3#1)
physiological samples##4##2##(1996-6#1)(2008-10#3)
physiological sensors##3##2##(1997-4#1)(2007-5#1)(2008-4#1)
physiological significance of the##6##4##(1991-3#1)(1992-6#1)(1994-5#1)(1994-6#1)(2005-8#1)(2010-3#1)
physiological significance of these##4##4##(1991-10#1)(1993-11#1)(1993-8#1)(1997-7#1)
physiological significance of##15##3##(1990-10#1)(1990-8#1)(1991-10#1)(1991-3#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-6#1)(1997-7#1)(2005-8#1)(2007-8#1)(2010-3#1)(2011-2#1)
physiological significance##17##2##(1990-10#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-3#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-6#1)(1997-7#1)(2005-8#1)(2007-8#1)(2010-3#1)(2011-1#1)(2011-2#1)
physiological situations##2##2##(2009-5#1)(2011-2#1)
physiological solution##5##2##(2004-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2013-1#1)
physiological stability and##3##3##(2008-10#1)(2010-7#1)(2012-2#1)
physiological state and##2##3##(2008-10#1)(2010-2#1)
physiological state of the cell##2##5##(1995-9#1)(2012-3#1)
physiological state of##3##3##(1995-9#1)(1996-5#1)(2012-3#1)
physiological state##11##2##(1995-9#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-2#1)(2012-3#1)
physiological states##9##2##(1992-12#1)(1994-12#1)(2007-5#1)(2008-3#3)(2008-5#1)(2008-7#1)(2012-12#1)
physiological status (e##2##3##(2008-4#1)(2008-9#1)
physiological status##7##2##(1997-3#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-12#2)(2013-1#1)
physiological stimuli##3##2##(2008-2#1)(2008-4#2)
physiological stimulus##2##2##(1994-12#1)(1995-1#1)
physiological strain of##2##3##(2008-6#1)(2013-7#1)
physiological stress##6##2##(2006-10#1)(2007-1#1)(2008-10#1)(2008-8#1)(2010-4#1)(2013-1#1)
physiological stressors##2##2##(2010-12#1)(2010-2#1)
physiological studies of##3##3##(2008-7#1)(2010-2#1)(2011-1#1)
physiological studies##13##2##(1995-11#1)(1996-9#1)(1997-8#1)(2005-10#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-2#1)(2011-1#2)(2013-1#1)
physiological substrate##3##2##(1994-8#1)(1995-1#1)(1995-10#1)
physiological system##3##2##(2007-11#1)(2008-11#1)(2008-9#1)
physiological systems##6##2##(2006-10#1)(2006-12#1)(2006-6#1)(2008-10#1)(2009-12#1)(2011-2#1)
physiological temperature##8##2##(1995-3#3)(2008-10#1)(2012-11#2)(2013-8#2)
physiological temperatures##5##2##(1990-11#1)(1994-3#2)(1997-4#1)(2008-10#1)
physiological traits##6##2##(2008-10#3)(2008-8#1)(2013-7#1)(2013-8#1)
physiological understanding##2##2##(2008-11#1)(2012-1#1)
physiological values##2##2##(1994-12#1)(2007-8#1)
physiological variables##5##2##(1993-11#1)(1996-11#1)(2005-10#1)(2009-11#1)(2010-8#1)
physiological variations of##2##3##(1994-11#1)(2008-5#1)
physiological variations##3##2##(1990-12#1)(1994-11#1)(2008-5#1)
physiological##1437##1##(1990-10#4)(1990-11#17)(1990-12#13)(1990-2#8)(1990-3#7)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#5)(1990-8#3)(1990-9#5)(1991-1#3)(1991-10#5)(1991-11#5)(1991-12#2)(1991-2#5)(1991-3#2)(1991-4#3)(1991-5#2)(1991-6#4)(1991-7#5)(1991-8#2)(1991-9#4)(1992-1#5)(1992-11#2)(1992-12#10)(1992-2#3)(1992-3#5)(1992-4#2)(1992-5#3)(1992-6#3)(1992-7#4)(1992-8#2)(1992-9#7)(1993-1#1)(1993-11#10)(1993-12#2)(1993-2#4)(1993-3#5)(1993-4#3)(1993-5#3)(1993-6#7)(1993-7#3)(1993-8#5)(1993-9#2)(1994-10#1)(1994-11#10)(1994-12#16)(1994-2#6)(1994-3#9)(1994-4#1)(1994-5#13)(1994-6#5)(1994-7#1)(1994-8#9)(1994-9#6)(1995-1#9)(1995-10#4)(1995-11#5)(1995-12#9)(1995-2#13)(1995-3#11)(1995-4#2)(1995-5#4)(1995-6#8)(1995-8#6)(1995-9#2)(1996-1#4)(1996-10#5)(1996-11#5)(1996-12#6)(1996-2#6)(1996-4#5)(1996-5#12)(1996-6#7)(1996-7#2)(1996-9#10)(1997-1#2)(1997-2#10)(1997-3#4)(1997-4#20)(1997-5#8)(1997-6#12)(1997-7#12)(1997-8#6)(2004-12#2)(2004-2#2)(2004-4#1)(2004-9#3)(2005-1#2)(2005-10#6)(2005-11#5)(2005-12#3)(2005-6#1)(2005-7#4)(2005-8#11)(2005-9#3)(2006-1#3)(2006-10#21)(2006-11#1)(2006-12#7)(2006-2#3)(2006-3#2)(2006-4#1)(2006-5#7)(2006-6#6)(2006-7#4)(2006-8#4)(2006-9#2)(2007-1#2)(2007-10#7)(2007-11#23)(2007-12#8)(2007-2#7)(2007-3#1)(2007-4#2)(2007-5#3)(2007-6#2)(2007-7#6)(2007-8#12)(2007-9#6)(2008-1#15)(2008-10#85)(2008-11#37)(2008-12#10)(2008-2#6)(2008-3#12)(2008-4#41)(2008-5#38)(2008-6#13)(2008-7#42)(2008-8#26)(2008-9#29)(2009-1#2)(2009-10#10)(2009-11#5)(2009-12#8)(2009-2#5)(2009-3#2)(2009-4#7)(2009-5#10)(2009-6#6)(2009-7#3)(2009-8#20)(2009-9#7)(2010-1#4)(2010-10#11)(2010-11#3)(2010-12#10)(2010-2#17)(2010-3#3)(2010-4#8)(2010-5#5)(2010-6#1)(2010-7#10)(2010-8#9)(2010-9#2)(2011-1#22)(2011-10#1)(2011-12#10)(2011-2#40)(2012-1#13)(2012-11#4)(2012-12#33)(2012-2#37)(2012-3#14)(2012-4#1)(2012-6#2)(2013-1#35)(2013-7#9)(2013-8#24)
physiological- and product-dependent parameters##2##4##(2008-5#2)
physiologically active compounds##2##3##(2008-10#2)
physiologically active##6##2##(1994-8#1)(2006-12#1)(2006-5#1)(2008-10#3)
physiologically and##4##2##(2004-4#1)(2008-3#1)(2009-7#1)(2012-2#1)
physiologically appropriate##4##2##(1992-8#1)(1995-12#1)(2006-11#1)(2008-7#1)
physiologically as##2##2##(1992-6#1)(1995-5#1)
physiologically based pharmacokinetic (PBPK) models##2##5##(2010-2#2)
physiologically based pharmacokinetic (PBPK)##3##4##(2010-2#3)
physiologically based pharmacokinetic##5##3##(2010-2#4)(2013-7#1)
physiologically based##7##2##(1993-9#1)(2010-2#5)(2013-7#1)
physiologically compatible##3##2##(1990-4#1)(2011-2#2)
physiologically constitutive##2##2##(1990-12#2)
physiologically defined##2##2##(1991-3#1)(1995-12#1)
physiologically distinct##2##2##(1992-5#1)(2008-11#1)
physiologically drug-resistant##2##2##(2006-11#2)
physiologically functional##2##2##(2008-11#1)(2009-7#1)
physiologically important##6##2##(1994-11#1)(1994-8#1)(2007-12#1)(2008-10#1)(2011-2#1)(2012-9#1)
physiologically involved in##2##3##(2010-11#1)(2012-12#1)
physiologically occurring##2##2##(2008-11#1)(2008-5#1)
physiologically or##2##2##(2008-4#1)(2010-1#1)
physiologically relevant concentrations of##2##4##(1992-5#1)(1993-8#1)
physiologically relevant doses of##2##4##(1997-8#2)
physiologically relevant in##2##3##(2006-10#1)(2012-2#1)
physiologically relevant##24##2##(1990-8#1)(1991-6#1)(1992-12#1)(1992-5#1)(1993-8#1)(1994-8#1)(1997-1#1)(1997-8#2)(2006-10#1)(2006-12#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#2)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#2)
physiologically significant##4##2##(1992-8#1)(2008-10#1)(2008-4#1)(2009-4#1)
physiologically to##2##2##(1995-10#1)(2005-12#1)
physiologically##127##1##(1990-12#2)(1990-4#1)(1990-8#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-5#3)(1992-6#2)(1992-7#1)(1992-8#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-8#3)(1995-10#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#1)(1995-9#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-8#2)(2004-4#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-11#4)(2006-12#3)(2006-2#1)(2006-3#1)(2006-5#2)(2007-12#2)(2007-2#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#3)(2009-12#2)(2009-4#1)(2009-6#2)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#5)(2010-3#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2012-9#1)(2013-1#3)(2013-7#1)(2013-8#2)
physiologies##2##1##(2009-5#1)(2011-12#1)
physiologist##4##1##(2008-7#2)(2012-1#1)(2013-8#1)
physiologists##4##1##(1997-6#1)(2005-8#1)(2007-12#1)(2008-4#1)
physiology and behaviour##2##3##(2010-8#1)(2012-12#1)
physiology and biochemistry##2##3##(2005-11#1)(2008-8#1)
physiology and clinical##3##3##(1997-6#1)(2006-4#1)(2010-10#1)
physiology and disease##4##3##(2008-1#1)(2008-10#1)(2008-4#1)(2011-2#1)
physiology and ecology##2##3##(2008-9#1)(2011-1#1)
physiology and its##3##3##(2005-7#1)(2006-2#1)(2011-2#1)
physiology and pathology##3##3##(2008-8#1)(2009-8#1)(2010-10#1)
physiology and pathophysiology of##5##4##(1992-9#1)(2005-9#1)(2006-10#1)(2007-1#1)(2007-11#1)
physiology and pathophysiology##10##3##(1992-9#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-4#1)(2007-1#1)(2007-11#1)(2008-4#1)(2010-2#1)
physiology and pharmacology##3##3##(1995-3#1)(2006-10#1)(2012-2#1)
physiology and physiopathology##2##3##(2009-3#1)(2010-3#1)
physiology and the##2##3##(2008-4#1)(2010-7#1)
physiology and virulence##2##3##(2008-10#1)(2013-1#1)
physiology and##82##2##(1992-9#1)(1993-9#1)(1995-12#1)(1995-3#1)(1996-9#1)(1997-5#1)(1997-6#1)(2005-11#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#2)(2006-10#6)(2006-12#1)(2006-2#1)(2006-4#2)(2007-1#3)(2007-11#2)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-3#2)(2009-4#1)(2009-8#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-11#1)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
physiology are##5##2##(1990-2#1)(2005-10#1)(2006-10#2)(2009-5#1)
physiology as##2##2##(2008-12#1)(2010-7#1)
physiology course##5##2##(2005-10#5)
physiology courses##2##2##(2005-10#2)
physiology have been##2##3##(2006-10#1)(2008-4#1)
physiology have##3##2##(2006-10#1)(2008-2#1)(2008-4#1)
physiology in a##2##3##(2006-10#1)(2008-3#1)
physiology in##9##2##(2005-7#1)(2006-10#1)(2008-3#1)(2008-7#1)(2010-2#1)(2010-3#2)(2012-2#1)(2012-5#1)
physiology is##10##2##(1990-5#1)(1991-9#1)(2005-10#1)(2006-1#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-10#1)(2010-5#1)
physiology of normal##3##3##(2008-4#1)(2008-6#2)
physiology of the gastrointestinal tract##2##5##(2008-7#1)(2011-2#1)
physiology of the human##2##4##(2012-12#1)(2012-2#1)
physiology of the##35##3##(1990-5#1)(1993-2#1)(1994-9#1)(1995-12#1)(1996-2#1)(1997-1#1)(1997-7#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-3#2)(2009-5#1)(2010-9#3)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)
physiology of these##3##3##(1991-12#1)(2008-7#1)(2008-8#1)
physiology of this##3##3##(2009-9#1)(2010-8#1)(2011-1#1)
physiology of##97##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-12#1)(1992-6#1)(1993-2#1)(1993-7#1)(1994-9#1)(1995-12#1)(1996-11#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-7#2)(2004-4#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-8#2)(2007-11#3)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#5)(2008-8#6)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-8#3)(2010-9#3)(2011-1#4)(2011-2#3)(2012-12#1)(2012-2#2)
physiology or##3##2##(1997-6#1)(2005-8#1)(2013-8#1)
physiology research##2##2##(2008-7#1)(2010-5#1)
physiology through##2##2##(2011-2#2)
physiology to the##2##3##(2008-1#2)
physiology to##3##2##(2008-1#2)(2013-8#1)
physiology was##2##2##(1994-2#1)(2010-8#1)
physiology were##2##2##(2008-7#1)(2011-1#1)
physiology will##2##2##(1995-10#1)(2011-2#1)
physiology##403##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#4)(1990-7#1)(1991-10#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-11#3)(1994-2#2)(1994-9#1)(1995-10#2)(1995-12#2)(1995-3#1)(1995-5#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#1)(2004-4#1)(2005-10#18)(2005-11#5)(2005-12#2)(2005-7#3)(2005-8#4)(2005-9#1)(2006-1#3)(2006-10#23)(2006-11#3)(2006-12#2)(2006-2#2)(2006-4#2)(2006-8#4)(2007-1#5)(2007-10#1)(2007-11#7)(2007-12#8)(2007-2#1)(2007-5#1)(2007-8#3)(2008-1#11)(2008-10#13)(2008-11#11)(2008-12#3)(2008-2#4)(2008-3#3)(2008-4#14)(2008-5#12)(2008-6#5)(2008-7#17)(2008-8#13)(2008-9#9)(2009-10#3)(2009-11#6)(2009-12#1)(2009-2#1)(2009-3#6)(2009-4#2)(2009-5#5)(2009-6#1)(2009-8#5)(2009-9#4)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#2)(2010-2#6)(2010-3#5)(2010-5#4)(2010-7#5)(2010-8#5)(2010-9#6)(2011-1#7)(2011-11#1)(2011-2#14)(2012-1#1)(2012-12#7)(2012-2#11)(2012-3#3)(2012-5#2)(2013-1#9)(2013-7#2)(2013-8#6)
physiology)##3##1##(2008-9#1)(2010-3#1)(2010-8#1)
physiome##2##1##(2010-9#2)
physiopathologic mechanisms##2##2##(2006-2#1)(2007-8#1)
physiopathologic##3##1##(2006-2#1)(2007-8#1)(2008-10#1)
physiopathological approach##2##2##(1993-3#1)(2006-2#1)
physiopathological conditions##2##2##(2005-8#1)(2008-5#1)
physiopathological mechanism##2##2##(1992-10#1)(2007-10#1)
physiopathological mechanisms##2##2##(1990-9#1)(1997-3#1)
physiopathological##25##1##(1990-12#1)(1990-6#1)(1990-9#1)(1992-10#2)(1992-3#1)(1992-5#1)(1993-3#1)(1993-6#1)(1997-3#2)(1997-5#1)(2004-12#1)(2005-8#1)(2006-2#1)(2007-10#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-2#1)(2010-6#2)
physiopathology and##4##2##(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
physiopathology of the##3##3##(2008-10#1)(2008-5#1)(2009-3#1)
physiopathology of##19##2##(1990-2#1)(1990-9#2)(1991-6#1)(1992-3#1)(1994-9#1)(1995-3#1)(1997-7#1)(2007-2#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-3#1)(2011-2#1)(2013-1#3)
physiopathology##36##1##(1990-2#1)(1990-9#2)(1991-6#1)(1992-10#1)(1992-3#2)(1992-5#2)(1994-9#1)(1995-3#1)(1996-4#1)(1997-7#1)(2007-2#1)(2008-1#1)(2008-10#5)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-3#1)(2010-3#1)(2010-6#1)(2011-2#4)(2013-1#3)
physiotherapeutic##8##1##(1991-6#1)(1992-3#1)(1993-3#1)(2004-1#1)(2007-7#1)(2012-12#3)
physiotherapist##20##1##(1991-2#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-1#1)(1996-4#1)(2007-7#1)(2007-8#2)(2008-3#1)(2008-9#2)(2009-3#1)(2010-3#2)(2011-12#1)(2012-1#1)(2012-12#1)(2013-1#1)
physiotherapists and##4##2##(1996-1#2)(1996-2#1)(2007-11#1)
physiotherapists can##2##2##(1992-12#1)(2011-2#1)
physiotherapists in##6##2##(1993-1#1)(1994-3#2)(2008-9#1)(2010-9#1)(2011-2#1)
physiotherapists to##2##2##(2009-4#1)(2012-12#1)
physiotherapists were##3##2##(1993-2#1)(1996-6#1)(2012-12#1)
physiotherapists working##2##2##(2010-9#1)(2012-12#1)
physiotherapists##48##1##(1991-2#1)(1992-12#2)(1993-1#4)(1993-2#4)(1994-3#3)(1995-12#1)(1996-1#2)(1996-2#1)(1996-6#1)(2004-1#1)(2007-11#2)(2007-8#2)(2008-3#5)(2008-9#1)(2009-4#1)(2009-7#1)(2010-9#4)(2011-2#4)(2012-12#7)(2012-3#1)
physiotherapists'##3##1##(1991-6#1)(1993-3#2)
physiotherapy and##5##2##(1991-5#1)(1993-1#1)(2007-11#1)(2007-7#1)(2008-5#1)
physiotherapy are##2##2##(1991-2#1)(1993-3#1)
physiotherapy assessment##2##2##(1992-12#1)(2011-2#1)
physiotherapy care##2##2##(1992-2#1)(2011-2#1)
physiotherapy clinics##2##2##(1995-2#1)(2008-10#1)
physiotherapy for##4##2##(1997-3#1)(2008-7#1)(2012-12#2)
physiotherapy in prisons##2##3##(1992-2#2)
physiotherapy in##6##2##(1991-2#1)(1992-2#2)(1993-3#2)(2007-7#1)
physiotherapy intervention##2##2##(2012-12#2)
physiotherapy is##4##2##(1994-2#1)(2005-7#1)(2008-3#1)(2012-12#1)
physiotherapy management##2##2##(2008-3#2)
physiotherapy practice for##2##3##(2012-12#2)
physiotherapy practice in##2##3##(1995-12#1)(2012-12#1)
physiotherapy practice##11##2##(1991-6#1)(1994-4#1)(1995-12#1)(1996-1#1)(2008-10#1)(2012-1#1)(2012-12#5)
physiotherapy students towards##2##3##(2008-1#1)(2012-1#1)
physiotherapy students##13##2##(1996-1#2)(2008-1#1)(2012-1#2)(2012-12#8)
physiotherapy utilization for##2##3##(2012-2#2)
physiotherapy utilization##3##2##(2012-2#3)
physiotherapy were##2##2##(1993-1#1)(2012-3#1)
physiotherapy##129##1##(1990-12#1)(1990-2#1)(1990-6#3)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-5#1)(1993-1#2)(1993-2#2)(1993-3#4)(1994-12#1)(1994-2#2)(1994-4#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#2)(1996-1#3)(1996-12#1)(1996-2#1)(1997-3#3)(2004-1#2)(2005-7#1)(2006-10#6)(2007-11#3)(2007-12#2)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#3)(2008-12#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-9#2)(2011-2#4)(2012-1#5)(2012-12#28)(2012-2#7)(2012-3#3)(2013-1#2)
physique pictures##2##2##(2007-12#2)
physique slides of##2##3##(2006-7#2)
physique slides##4##2##(2006-7#4)
physique##12##1##(2006-7#4)(2007-12#6)(2009-4#1)(2010-4#1)
physiques##3##1##(2007-12#2)(2010-3#1)
physis##7##1##(2006-11#1)(2007-11#1)(2008-8#1)(2010-3#1)(2012-12#2)(2013-1#1)
physisorbed and##2##2##(2008-10#1)(2008-5#1)
physisorbed##7##1##(1991-9#1)(2008-10#2)(2008-5#2)(2010-12#2)
physisorption of##2##2##(2007-8#1)(2008-10#1)
physisorption##3##1##(2007-8#1)(2008-10#2)
physodes##4##1##(2008-10#3)(2011-12#1)
physostigmine and pilocarpine##2##3##(2008-10#2)
physostigmine application##2##2##(1991-12#1)(1995-12#1)
physostigmine or##2##2##(1993-11#1)(1997-2#1)
physostigmine##22##1##(1991-1#3)(1991-12#1)(1992-3#3)(1993-11#6)(1994-10#2)(1995-12#1)(1996-6#1)(1997-2#2)(2008-10#3)
phytanic acid##2##2##(1994-11#1)(1997-4#1)
phytase and acid##2##3##(2008-5#2)
phytase gene##2##2##(1993-8#1)(2006-12#1)
phytase supplementation in##2##3##(2010-2#2)
phytase supplementation##3##2##(2010-2#3)
phytase##32##1##(1992-12#1)(1993-8#2)(1995-3#1)(2006-12#3)(2008-11#2)(2008-4#3)(2008-5#3)(2010-2#15)(2013-1#2)
phytate##5##1##(2006-12#2)(2012-12#1)(2012-2#2)
phytate-phosphorus##2##1##(2010-2#2)
phytic acid (inositol##2##3##(1992-7#2)
phytic acid on the##3##4##(1991-2#2)(2008-10#1)
phytic acid##12##2##(1991-2#4)(1992-7#2)(1993-9#1)(2008-10#4)(2013-1#1)
phyto- and zooplankton##2##3##(2007-9#2)
phytoalexin accumulation##5##2##(1997-4#3)(2008-10#2)
phytoalexin production##2##2##(2008-10#2)
phytoalexin response##4##2##(1990-6#1)(2008-10#3)
phytoalexin synthesis in##2##3##(1992-8#1)(1997-4#1)
phytoalexin synthesis##3##2##(1992-8#1)(1997-4#2)
phytoalexin##23##1##(1990-6#1)(1992-8#2)(1997-4#5)(2008-10#15)
phytoalexins in##4##2##(1990-6#1)(2008-10#3)
phytoalexins##15##1##(1990-6#3)(2008-10#11)(2010-9#1)
phytochelatin##3##1##(1994-8#3)
phytochelatins##3##1##(1994-8#1)(2008-10#2)
phytochemical analysis of##3##3##(2007-1#2)(2010-6#1)
phytochemical analysis##5##2##(2007-1#2)(2010-12#1)(2010-5#1)(2010-6#1)
phytochemical constituents##2##2##(2008-12#1)(2009-11#1)
phytochemical screening of##3##3##(2008-10#2)(2010-12#1)
phytochemical screening##4##2##(2008-10#2)(2008-4#1)(2010-12#1)
phytochemical##24##1##(1992-2#1)(2004-12#1)(2005-11#1)(2006-10#1)(2007-1#3)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-3#1)(2010-12#4)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-7#1)
phytochemicals and##5##2##(2006-10#1)(2006-12#1)(2008-11#1)(2010-1#1)(2013-1#1)
phytochemicals including##2##2##(2008-10#1)(2008-12#1)
phytochemicals##31##1##(1992-5#1)(2006-10#2)(2006-12#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#10)(2008-8#1)(2010-1#2)(2011-1#2)(2012-2#1)(2013-1#4)
phytochemistry##2##1##(2007-8#1)(2010-9#1)
phytochrome and##2##2##(1990-12#1)(1995-2#1)
phytochrome chromophore synthesis##4##3##(1996-8#4)
phytochrome chromophore##5##2##(1996-8#5)
phytochrome##24##1##(1990-12#6)(1990-5#2)(1995-2#3)(1996-8#6)(2006-10#1)(2008-4#1)(2008-7#2)(2009-8#2)(2012-2#1)
phytoconstituents##2##1##(2011-2#1)(2013-1#1)
phytoene desaturase##5##2##(1992-5#1)(1995-2#1)(2006-12#1)(2010-10#2)
phytoene synthase##6##2##(1995-2#2)(2006-12#1)(2009-10#2)(2010-10#1)
phytoene##17##1##(1990-7#2)(1992-5#1)(1995-2#6)(2006-12#2)(2008-12#1)(2009-10#2)(2010-10#3)
phytoestrogenic##2##1##(2012-2#1)(2013-1#1)
phytoestrogens in##2##2##(2008-10#2)
phytoestrogens to##2##2##(2008-10#2)
phytoestrogens##19##1##(2006-8#3)(2008-10#11)(2008-11#2)(2012-2#3)
phytoextraction##14##1##(2004-4#1)(2008-10#1)(2008-2#12)
phytohaemagglutinin##3##1##(1992-9#1)(1993-8#1)(1995-7#1)
phytohaemagglutinin-activated peripheral blood lymphocytes##2##4##(1995-7#2)
phytohemagglutinin (PHA)##3##2##(1990-4#1)(1994-4#1)(2011-2#1)
phytohemagglutinin##14##1##(1990-4#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-6#1)(1994-2#1)(1994-4#1)(1994-9#1)(1995-2#1)(1995-3#1)(1997-1#1)(2008-7#1)(2011-2#1)(2013-1#1)
phytohemagglutinin-stimulated peripheral blood mononuclear cells##4##5##(1995-8#2)(1996-8#2)
phytohemagglutinin-stimulated peripheral blood mononuclear##5##4##(1995-3#1)(1995-8#2)(1996-8#2)
phytohormone##4##1##(1991-11#1)(2006-12#1)(2008-10#1)(2011-1#1)
phytohormones on##3##2##(2005-11#2)(2008-7#1)
phytohormones##18##1##(1993-8#1)(1994-3#1)(2004-2#2)(2005-11#3)(2008-10#5)(2008-7#1)(2009-8#4)(2011-1#1)
phytomedicine##3##1##(2006-10#1)(2011-2#2)
phytomyxean species to##2##3##(2012-2#2)
phytomyxean species##4##2##(2012-2#4)
phytopathogen##2##1##(2009-8#1)(2011-12#1)
phytopathogenic and entomopathogenic##2##3##(2006-10#2)
phytopathogenic bacteria##6##2##(1995-1#1)(2008-10#5)
phytopathogenic fungi and bacteria##2##4##(2006-10#1)(2008-10#1)
phytopathogenic fungi##11##2##(1990-6#1)(1997-4#1)(2006-10#1)(2008-10#4)(2008-11#1)(2008-5#1)(2009-8#1)(2011-10#1)
phytopathogenic fungus##6##2##(1997-2#2)(1997-4#1)(2008-10#2)(2009-8#1)
phytopathogenic##44##1##(1990-4#1)(1990-6#1)(1992-3#1)(1995-1#1)(1997-2#2)(1997-4#2)(2006-10#5)(2007-7#1)(2008-10#24)(2008-11#1)(2008-5#1)(2009-6#1)(2009-8#2)(2011-10#1)
phytopathogens##5##1##(2008-10#2)(2008-7#1)(2009-6#1)(2009-8#1)
phytopathological literature##2##2##(2008-10#2)
phytopathological significance##2##2##(2008-10#2)
phytopathological##25##1##(2008-10#25)
phytophagous bugs##2##2##(2008-7#2)
phytophagous insects##4##2##(2008-5#1)(2008-9#3)
phytophagous##11##1##(1992-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#5)
phytophthora##3##1##(2008-10#3)
phytoplankter##2##1##(1991-11#1)(1992-8#1)
phytoplankters##5##1##(1991-11#1)(2004-4#4)
phytoplanktivorous bighead carp (Aristichthys nobilis)##2##5##(2010-5#2)
phytoplankton absorption coefficient##3##3##(2008-2#2)(2008-3#1)
phytoplankton absorption##6##2##(2008-2#3)(2008-3#3)
phytoplankton and their##2##3##(2006-3#1)(2008-2#1)
phytoplankton and zooplankton species##2##4##(2009-8#2)
phytoplankton and zooplankton##3##3##(2007-9#1)(2009-8#2)
phytoplankton and##9##2##(2006-3#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-8#2)
phytoplankton biomass and turbidity##2##4##(2007-5#2)
phytoplankton biomass was mainly of##2##5##(2013-8#2)
phytoplankton biomass##5##2##(2007-5#3)(2013-8#2)
phytoplankton blooms##5##2##(1992-8#1)(2008-2#1)(2008-3#1)(2008-8#2)
phytoplankton class##2##2##(2008-10#2)
phytoplankton classes##2##2##(2008-10#2)
phytoplankton community##2##2##(2008-8#1)(2013-8#1)
phytoplankton growth##3##2##(2007-3#1)(2013-8#2)
phytoplankton in##2##2##(1994-8#1)(2008-3#1)
phytoplankton populations##2##2##(2008-8#2)
phytoplankton samples##2##2##(2008-10#1)(2012-2#1)
phytoplankton species##7##2##(2007-9#2)(2008-3#1)(2008-8#3)(2009-8#1)
phytoplankton were##4##2##(2008-10#1)(2008-5#1)(2009-8#1)(2012-2#1)
phytoplankton##97##1##(1992-8#1)(1994-8#2)(2006-3#1)(2007-3#1)(2007-5#3)(2007-9#3)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#12)(2008-3#15)(2008-5#8)(2008-8#18)(2008-9#4)(2009-8#8)(2011-2#1)(2012-2#3)(2013-8#8)
phytoplasma and##2##2##(2008-10#2)
phytoplasma concentrations in##2##3##(2008-10#2)
phytoplasma concentrations##3##2##(2008-10#3)
phytoplasma could##2##2##(2008-10#2)
phytoplasma extracts##2##2##(2008-10#2)
phytoplasma from##2##2##(2008-10#2)
phytoplasma groups##2##2##(2008-10#2)
phytoplasma in the##3##3##(2008-10#3)
phytoplasma in##9##2##(2008-10#9)
phytoplasma isolates from##3##3##(2008-10#3)
phytoplasma isolates##5##2##(2008-10#5)
phytoplasma strain##3##2##(2005-11#2)(2008-10#1)
phytoplasma strains from##2##3##(2008-10#2)
phytoplasma strains in##2##3##(2008-10#2)
phytoplasma strains were##2##3##(2008-10#2)
phytoplasma strains##12##2##(2005-11#2)(2008-10#10)
phytoplasma taxa##2##2##(2008-10#2)
phytoplasma was##2##2##(2008-10#2)
phytoplasma were##2##2##(2008-10#2)
phytoplasma##96##1##(2005-11#6)(2008-10#90)
phytoplasma-infected##2##1##(2008-10#2)
phytoplasma-specific##3##1##(2008-10#3)
phytoplasmas and##2##2##(2008-10#2)
phytoplasmas belonging to##2##3##(2008-10#2)
phytoplasmas from##2##2##(2008-10#2)
phytoplasmas in the##3##3##(2008-10#3)
phytoplasmas in##7##2##(2008-10#7)
phytoplasmas involved in##2##3##(2008-10#2)
phytoplasmas present in##2##3##(2008-10#2)
phytoplasmas were detected in##2##4##(2008-10#2)
phytoplasmas were##4##2##(2008-10#4)
phytoplasmas with##2##2##(2008-10#2)
phytoplasmas##53##1##(2008-10#53)
phytoremediation of##3##2##(2004-4#1)(2008-10#1)(2011-1#1)
phytoremediation##13##1##(2004-4#2)(2006-12#3)(2008-10#1)(2008-11#4)(2008-5#1)(2009-8#1)(2011-1#1)
phytoreovirus##2##1##(2008-10#2)
phytosanitary treatments##2##2##(2011-2#2)
phytosanitary##7##1##(2005-5#1)(2008-10#3)(2011-2#3)
phytosphingosine##4##1##(1997-5#1)(2008-5#3)
phytostabilisation of##2##2##(2010-5#2)
phytostabilisation##3##1##(2010-5#3)
phytostanol ester##2##2##(2007-8#2)
phytostanol##5##1##(2007-8#5)
phytosterol##8##1##(2006-12#3)(2007-11#2)(2007-8#2)(2008-12#1)
phytosterols on##3##2##(2007-8#3)
phytosterols##9##1##(2006-10#1)(2006-12#1)(2007-8#4)(2008-10#1)(2008-12#1)(2010-12#1)
phytotherapy (quercetin##2##2##(2008-5#1)(2008-6#1)
phytotherapy and##3##2##(1990-5#2)(2011-1#1)
phytotherapy##8##1##(1990-5#3)(1992-5#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-1#1)
phytotoxic activity##2##2##(2008-10#1)(2008-11#1)
phytotoxic effects##4##2##(2004-2#1)(2008-10#1)(2008-11#1)(2010-5#1)
phytotoxic protein##2##2##(2008-10#2)
phytotoxic strength index##2##3##(2004-2#2)
phytotoxic to sugarcane##2##3##(2008-10#2)
phytotoxic to##6##2##(2008-10#5)(2010-5#1)
phytotoxic##23##1##(2004-2#3)(2008-10#13)(2008-11#2)(2008-12#1)(2008-8#1)(2009-8#1)(2010-5#2)
phytotoxicity of##3##2##(2006-12#1)(2008-12#1)(2011-12#1)
phytotoxicity was##3##2##(2004-2#1)(2008-10#1)(2011-12#1)
phytotoxicity##13##1##(2004-2#5)(2006-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-1#2)(2011-12#2)
phytotoxin produced by##2##3##(2008-10#2)
phytotoxin##7##1##(2008-10#4)(2008-7#1)(2010-10#2)
phytotoxins in##4##2##(2008-10#3)(2009-6#1)
phytotoxins##7##1##(2008-10#5)(2008-11#1)(2009-6#1)
phéochromocytome##3##1##(2011-2#3)
pi +##2##2##(1992-8#1)(1996-7#1)
pi --&gt##2##2##(2008-10#1)(2010-5#1)
pi are##2##2##(1990-2#1)(2005-11#1)
pi as##2##2##(1995-9#1)(2007-12#1)
pi centers##2##2##(1996-2#2)
pi class GSTs##2##3##(1995-1#2)
pi is##2##2##(2005-11#2)
pi phase##4##2##(2007-11#1)(2007-12#1)(2008-2#2)
pi was##2##2##(1994-2#1)(2006-8#1)
pi##78##1##(1990-2#2)(1990-7#2)(1991-1#2)(1991-12#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-6#1)(1992-8#2)(1993-11#1)(1993-8#1)(1994-2#2)(1995-1#2)(1995-10#1)(1995-4#1)(1995-5#3)(1995-9#2)(1996-2#9)(1996-7#1)(1997-2#1)(1997-4#1)(1997-7#4)(2005-11#6)(2006-12#1)(2006-8#1)(2007-11#3)(2007-12#9)(2008-10#1)(2008-2#3)(2008-3#8)(2008-8#1)(2010-5#1)(2011-2#1)
pi)##4##1##(1994-2#1)(2007-11#1)(2007-12#1)(2008-2#1)
pi* transition##2##2##(2008-10#1)(2010-5#1)
pi*##3##1##(2008-10#1)(2010-5#2)
pi*-type orbitals contributed##2##3##(2010-5#2)
pi*-type orbitals##3##2##(2010-5#3)
pi-A isotherms of the mixed films##2##6##(2005-11#2)
pi-A isotherms of##3##3##(1992-6#1)(2005-11#2)
pi-A isotherms##5##2##(1992-6#1)(2005-11#4)
pi-A##7##1##(1992-6#1)(2005-11#6)
pi-Electron##2##1##(1996-5#1)(2008-10#1)
pi-acceptor##2##1##(1996-2#1)(2007-10#1)
pi-acceptors##2##1##(2008-10#2)
pi-bond##3##1##(1996-5#2)(2009-5#1)
pi-cation radical##5##2##(1994-5#1)(1996-2#4)
pi-cation##6##1##(1994-5#2)(1996-2#4)
pi-conjugated##5##1##(1993-11#1)(2007-12#1)(2008-7#1)(2009-11#1)(2010-7#1)
pi-coordinating##4##1##(2008-10#4)
pi-electron conjugation##3##2##(2007-11#2)(2009-9#1)
pi-electron##10##1##(1990-12#1)(1996-5#1)(2005-11#1)(2007-11#4)(2009-9#1)(2010-2#2)
pi-electrons##2##1##(1997-4#1)(2008-10#1)
pi-phase##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
pi-phase-shifted##2##1##(2007-12#2)
pi-pi interaction##3##2##(2007-11#1)(2008-10#2)
pi-pi interactions##4##2##(1997-7#1)(2007-11#2)(2008-5#1)
pi-pi stacking and##2##3##(1994-8#1)(2010-5#1)
pi-pi stacking##10##2##(1994-8#1)(2007-10#4)(2007-11#1)(2008-4#1)(2008-5#1)(2009-11#1)(2010-5#1)
pi-pi##20##1##(1994-8#1)(1997-7#1)(2007-10#4)(2007-11#4)(2008-10#5)(2008-4#1)(2008-5#2)(2009-11#1)(2010-5#1)
pi-polarized##2##1##(2008-3#2)
pi-shifted Sagnac interferometer##2##3##(2007-11#2)
pi-shifted##4##1##(2007-11#2)(2007-12#2)
pi-system##2##1##(1997-7#1)(2010-2#1)
pi-ta allele##2##2##(2008-10#2)
pi/2##5##1##(2007-11#1)(2008-2#1)(2008-3#3)
pi0##2##1##(1994-3#2)
piRNA##2##1##(2009-3#1)(2010-5#1)
piRNAs##9##1##(2007-10#2)(2009-3#7)
pia##2##1##(2006-11#2)
pial artery##6##2##(1992-8#6)
pial##12##1##(1992-8#6)(1995-12#1)(1996-9#1)(1997-5#2)(2006-11#1)(2008-4#1)
piano##3##1##(2008-9#1)(2012-1#1)(2012-2#1)
piascledine is##2##2##(2007-11#2)
piascledine##3##1##(2007-11#3)
piazselenol##2##1##(2008-10#2)
pica##6##1##(1992-4#3)(1993-2#1)(1995-11#1)(1996-11#1)
piceae##6##1##(2008-10#6)
pick of##2##2##(2008-7#2)
pick up##3##2##(2005-7#1)(2012-12#1)(2012-2#1)
pick##12##1##(1992-2#1)(1994-6#1)(1995-12#1)(2005-7#1)(2007-9#1)(2008-7#2)(2008-8#2)(2012-1#1)(2012-12#1)(2012-2#1)
pick-and-place##3##1##(2007-12#2)(2012-1#1)
pick-up of task-specific information##2##4##(2006-10#2)
pick-up##3##1##(2006-10#2)(2009-11#1)
picked from##2##2##(1991-7#1)(2008-10#1)
picked up##10##2##(1995-3#1)(2005-11#1)(2005-4#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-3#1)(2008-4#1)(2009-2#1)(2013-8#1)
picked##21##1##(1991-7#1)(1992-11#1)(1994-3#2)(1995-3#1)(1997-1#1)(1997-3#1)(2005-11#1)(2005-4#1)(2006-12#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#2)(2009-2#1)(2013-8#1)
picket fence##2##2##(2008-3#2)
picket-fence##3##1##(1994-2#1)(2007-12#1)(2008-3#1)
pickettii##7##1##(1991-2#5)(1995-2#2)
picking##5##1##(1990-12#1)(1994-6#1)(2007-8#1)(2008-4#2)
pickle##2##1##(1997-4#1)(2008-10#1)
pickled food##2##2##(2011-2#2)
pickled vegetables##3##2##(1992-5#1)(2011-2#2)
pickled##6##1##(1992-5#2)(2011-2#4)
pickling##7##1##(2007-10#4)(2008-10#2)(2013-1#1)
picks up##3##2##(2007-10#1)(2013-1#2)
picks##5##1##(1991-5#1)(1991-9#1)(2007-10#1)(2013-1#2)
pickup and display##2##3##(2007-11#1)(2008-3#1)
pickup for##2##2##(2008-2#2)
pickup is##2##2##(2008-2#1)(2008-3#1)
pickup system##2##2##(2008-3#2)
pickup##23##1##(1996-1#1)(2006-11#1)(2007-11#1)(2007-12#3)(2008-2#7)(2008-3#9)(2008-7#1)
pickups##4##1##(2007-12#1)(2008-3#3)
picloram##2##1##(2006-12#2)
pico and nanoplankton##2##3##(2012-2#2)
pico##3##1##(2006-10#1)(2012-2#2)
pico- to##2##2##(1994-6#1)(1997-2#1)
picogram##5##1##(1991-2#1)(2008-4#1)(2010-6#1)(2013-7#2)
picograms of##2##2##(1994-9#1)(2008-2#1)
picograms##3##1##(1994-9#1)(2008-10#1)(2008-2#1)
picolinate##3##1##(2005-11#2)(2008-10#1)
picolinic##3##1##(2008-10#1)(2008-5#2)
picoliter##2##1##(2008-1#1)(2008-3#1)
picomolar concentrations of##4##3##(1990-10#1)(1994-12#1)(2008-10#2)
picomolar concentrations##6##2##(1990-10#1)(1990-7#1)(1994-12#1)(2008-10#3)
picomolar doses of##2##3##(1995-5#1)(2009-10#1)
picomolar##15##1##(1990-10#1)(1990-7#3)(1994-12#1)(1994-8#1)(1995-5#1)(1996-11#1)(2008-10#4)(2008-7#2)(2009-10#1)
picomoles/mg/min)##2##1##(1994-11#2)
picornavirus##2##1##(2007-2#1)(2013-1#1)
picornaviruses##2##1##(2008-8#1)(2013-1#1)
picosecond Nd##3##2##(2007-11#2)(2008-1#1)
picosecond Ti##2##2##(2007-11#1)(2007-12#1)
picosecond and##2##2##(1990-8#1)(2007-12#1)
picosecond laser pulses##5##3##(2007-11#2)(2007-12#2)(2008-2#1)
picosecond laser##9##2##(1997-6#1)(2007-11#2)(2007-12#5)(2008-2#1)
picosecond lasers##2##2##(2007-11#1)(2008-3#1)
picosecond optical parametric oscillator based on periodically poled RbTiOAsO(4)##2##9##(2007-12#2)
picosecond optical parametric oscillator based on periodically poled##3##8##(2007-11#1)(2007-12#2)
picosecond optical parametric oscillator##4##4##(2007-11#2)(2007-12#2)
picosecond pulse##7##2##(2007-11#1)(2007-12#5)(2008-1#1)
picosecond pulsed##3##2##(2007-11#3)
picosecond pulses at 1##2##4##(2007-11#1)(2007-12#1)
picosecond pulses at a##2##4##(2007-11#1)(2007-12#1)
picosecond pulses at##7##3##(2007-11#4)(2007-12#3)
picosecond pulses by##2##3##(2007-12#2)
picosecond pulses in##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
picosecond pulses with##2##3##(2007-12#1)(2008-3#1)
picosecond pulses##25##2##(2007-11#8)(2007-12#11)(2007-9#1)(2008-2#2)(2008-3#3)
picosecond temporal resolution##2##3##(2007-11#1)(2007-12#1)
picosecond temporal##3##2##(2007-11#1)(2007-12#2)
picosecond time scale##4##3##(1995-1#2)(2006-3#1)(2007-12#1)
picosecond time##6##2##(1995-1#2)(2006-3#1)(2007-12#2)(2008-2#1)
picosecond time-resolved laser-induced fluorescence##2##4##(2007-12#1)(2008-3#1)
picosecond time-resolved##5##2##(2006-10#1)(2007-12#2)(2008-3#2)
picosecond##112##1##(1990-8#1)(1993-5#1)(1994-5#1)(1995-1#2)(1995-2#2)(1997-6#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-11#30)(2007-12#44)(2007-9#1)(2008-1#8)(2008-2#9)(2008-3#9)
picosecond-time-scale##2##1##(2007-12#1)(2008-10#1)
picoseconds to##4##2##(2006-6#1)(2007-11#1)(2008-2#1)(2008-3#1)
picoseconds##10##1##(1994-5#1)(2006-6#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#4)
picotamide on##2##2##(1990-12#1)(2008-7#1)
picotamide##6##1##(1990-12#2)(1990-5#2)(2008-7#2)
picrate 1##2##2##(2008-10#2)
picrate anion##3##2##(2008-10#3)
picrate concentration##3##2##(2008-10#3)
picrate ion##2##2##(2008-10#2)
picrate##21##1##(2008-10#19)(2008-5#2)
picrates of##2##2##(2008-10#2)
picrates with##6##2##(2008-10#6)
picrates##18##1##(2008-10#18)
picric acid based on##2##4##(2007-8#1)(2008-10#1)
picric acid in##3##3##(2007-8#1)(2008-10#2)
picric acid##14##2##(2006-8#1)(2007-8#5)(2008-10#8)
picroliv##2##1##(2008-8#2)
picrorhizoside##3##1##(2006-12#3)
picrotoxin (PTX)##2##2##(2008-8#1)(2008-9#1)
picrotoxin and pentylenetetrazol##2##3##(1991-5#2)
picrotoxin and##4##2##(1991-10#1)(1991-5#2)(1995-5#1)
picrotoxin##19##1##(1990-10#2)(1990-5#2)(1990-7#2)(1991-10#1)(1991-5#3)(1991-9#1)(1995-12#2)(1995-5#1)(1995-7#1)(2008-8#1)(2008-9#1)(2012-1#2)
picrotoxin-induced##2##1##(2008-4#1)(2012-1#1)
picrotoxinin sensitivity of##2##3##(1995-7#2)
picrotoxinin sensitivity##3##2##(1995-7#3)
picrotoxinin##4##1##(1995-7#4)
pictogram##2##1##(2009-3#2)
pictorial essay##12##2##(1997-8#2)(2009-9#1)(2010-12#1)(2012-2#8)
pictorial review is##4##3##(2012-2#4)
pictorial review##14##2##(2006-1#1)(2010-12#1)(2011-2#1)(2012-2#11)
pictorial##38##1##(1992-3#1)(1997-8#2)(2006-1#1)(2008-10#4)(2008-12#1)(2008-4#1)(2009-11#1)(2009-9#2)(2010-12#2)(2011-2#2)(2012-2#20)(2012-3#1)
picture and##11##2##(1990-1#1)(1991-6#1)(1991-8#1)(1992-2#1)(1995-6#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-3#1)(2008-6#1)(2011-2#1)
picture archiving and communication system (PACS)##3##6##(2004-9#2)(2007-4#1)
picture archiving and communication system##4##5##(2004-9#2)(2007-4#2)
picture archiving and communication systems##2##5##(1997-8#1)(2004-9#1)
picture archiving and communication##6##4##(1997-8#1)(2004-9#3)(2007-4#2)
picture archiving and##7##3##(1996-2#1)(1997-8#1)(2004-9#3)(2007-4#2)
picture are##2##2##(2007-2#1)(2007-8#1)
picture by##2##2##(2008-2#1)(2012-1#1)
picture can be a##3##4##(2011-1#1)(2013-1#2)
picture can be##5##3##(2008-3#1)(2010-7#1)(2011-1#1)(2013-1#2)
picture does not##2##3##(1997-4#1)(2012-2#1)
picture emerges##3##2##(1991-3#1)(1997-1#1)(2007-12#1)
picture has##6##2##(1994-6#1)(2005-11#1)(2007-11#1)(2007-12#1)(2011-1#1)(2011-2#1)
picture improves##2##2##(1993-6#1)(1995-11#1)
picture in the##4##3##(1990-10#2)(2007-11#1)(2008-3#1)
picture in which##2##3##(2008-3#1)(2012-2#1)
picture in##10##2##(1990-10#2)(1990-3#1)(2007-11#1)(2008-3#2)(2008-4#2)(2012-2#1)(2013-1#1)
picture is further complicated by the##2##6##(2008-1#1)(2008-4#1)
picture is made##2##3##(1993-2#1)(2008-3#1)
picture is##14##2##(1990-6#1)(1990-8#2)(1993-1#1)(1993-2#1)(1994-6#1)(1995-11#1)(1997-5#1)(2008-1#1)(2008-3#2)(2008-4#1)(2010-9#1)(2012-3#1)
picture matching##2##2##(2013-7#2)
picture memory##3##2##(2010-2#3)
picture naming##4##2##(1994-3#2)(2009-4#1)(2010-2#1)
picture of a##4##3##(1994-11#1)(1995-4#1)(2006-12#1)(2012-3#1)
picture of acute##2##3##(2006-10#1)(2009-8#1)
picture of chronic pancreatitis##2##4##(2006-6#2)
picture of how these##3##4##(1995-9#1)(2007-10#1)(2008-8#1)
picture of how##6##3##(1990-4#1)(1995-9#1)(2007-10#1)(2007-12#1)(2008-8#1)(2009-2#1)
picture of inflammatory##2##3##(2007-11#1)(2010-6#1)
picture of paraoesophageal lymph nodes##2##5##(2005-1#2)
picture of the quality##2##4##(2008-10#1)(2009-11#1)
picture of the underlying##2##4##(2006-7#1)(2008-7#1)
picture of the##49##3##(1990-10#1)(1992-2#2)(1992-6#1)(1993-8#1)(1994-5#1)(1994-7#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-4#1)(1997-5#1)(2005-1#1)(2005-9#1)(2006-10#2)(2006-4#2)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-11#1)(2009-12#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#2)(2012-5#1)
picture of##127##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-5#2)(1991-8#2)(1992-1#1)(1992-10#1)(1992-2#2)(1992-5#1)(1992-6#1)(1993-1#1)(1993-10#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-4#2)(1995-6#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-4#1)(1997-5#1)(2005-1#5)(2005-11#4)(2005-9#1)(2006-10#4)(2006-12#3)(2006-4#2)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#3)(2007-2#1)(2007-9#2)(2008-1#3)(2008-10#4)(2008-11#4)(2008-12#3)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#5)(2008-8#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#2)(2012-3#2)(2012-5#1)(2013-8#2)
picture quality##2##2##(2008-2#2)
picture should be##2##3##(2008-4#1)(2008-7#1)
picture should##3##2##(2008-4#1)(2008-7#1)(2012-12#1)
picture similar to##2##3##(2009-3#1)(2012-2#1)
picture that##6##2##(2009-6#1)(2009-8#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
picture to##2##2##(2006-8#1)(2012-3#1)
picture was##4##2##(1990-2#1)(2005-12#1)(2009-5#1)(2011-2#1)
picture with##3##2##(1993-10#1)(1996-6#1)(2010-1#1)
picture##358##1##(1990-1#1)(1990-10#4)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#3)(1990-8#5)(1990-9#1)(1991-11#3)(1991-2#1)(1991-3#2)(1991-4#3)(1991-5#2)(1991-6#1)(1991-8#3)(1992-1#2)(1992-10#1)(1992-11#1)(1992-2#3)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#3)(1993-10#2)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#4)(1994-11#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#3)(1994-7#1)(1995-11#2)(1995-2#1)(1995-4#2)(1995-6#2)(1995-7#1)(1995-9#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#2)(1997-1#1)(1997-4#2)(1997-5#3)(1997-6#2)(1997-7#1)(1997-8#2)(2004-9#3)(2005-1#5)(2005-11#6)(2005-12#1)(2005-9#1)(2006-10#7)(2006-11#1)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#2)(2006-6#3)(2006-7#3)(2006-8#3)(2006-9#2)(2007-10#3)(2007-11#13)(2007-12#8)(2007-2#3)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#2)(2007-9#3)(2008-1#6)(2008-10#7)(2008-11#4)(2008-12#4)(2008-2#6)(2008-3#12)(2008-4#10)(2008-5#2)(2008-6#5)(2008-7#14)(2008-8#6)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#4)(2009-3#1)(2009-4#4)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#9)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#5)(2010-3#1)(2010-4#1)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#9)(2012-1#3)(2012-12#5)(2012-2#9)(2012-3#6)(2012-5#1)(2013-1#5)(2013-7#2)(2013-8#4)
picture-location##2##1##(2009-2#2)
picture?##2##1##(1994-12#1)(2011-2#1)
picture]##3##1##(1990-3#1)(2008-7#1)(2012-2#1)
pictures and laboratory diagnosis##2##4##(1993-11#1)(1994-2#1)
pictures and##7##2##(1993-11#1)(1994-2#1)(2006-6#1)(2007-10#1)(2009-8#1)(2011-2#1)(2012-12#1)
pictures as##2##2##(2009-4#1)(2012-2#1)
pictures in##2##2##(2007-12#1)(2010-2#1)
pictures is##2##2##(2008-1#1)(2012-2#1)
pictures may##2##2##(2010-2#2)
pictures of the##5##3##(1993-2#1)(2007-12#1)(2007-8#1)(2008-2#2)
pictures of##16##2##(1993-2#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-2#2)(2008-3#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
pictures on##3##2##(2005-11#1)(2006-3#1)(2008-11#1)
pictures to##5##2##(2006-10#1)(2009-2#1)(2010-2#1)(2013-1#2)
pictures were##2##2##(2008-4#1)(2012-2#1)
pictures with Spanish names from##2##5##(2008-9#2)
pictures with##3##2##(2008-9#2)(2009-4#1)
pictures##90##1##(1990-8#1)(1993-11#1)(1993-2#1)(1994-2#1)(1995-5#1)(1995-7#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-3#1)(2006-6#2)(2006-7#1)(2007-10#2)(2007-11#2)(2007-12#7)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#3)(2009-11#1)(2009-2#6)(2009-4#5)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#6)(2011-2#2)(2012-12#4)(2012-2#6)(2013-1#9)(2013-8#2)
pictures]##2##1##(1992-11#1)(1997-4#1)
piece are##2##2##(2008-3#1)(2008-4#1)
piece in##4##2##(2006-6#1)(2008-3#1)(2008-5#1)(2008-7#1)
piece of equipment##3##3##(2006-5#1)(2008-10#1)(2012-1#1)
piece of information##2##3##(1993-6#1)(2011-2#1)
piece of the##6##3##(1990-7#1)(1991-3#1)(1992-12#1)(1992-3#1)(2008-10#1)(2009-3#1)
piece of tissue##2##3##(1997-8#1)(2004-9#1)
piece of tubing##3##3##(1997-3#3)
piece of##44##2##(1990-7#1)(1991-11#1)(1991-2#1)(1991-3#2)(1992-12#1)(1992-3#1)(1993-6#1)(1995-11#1)(1996-2#1)(1997-3#5)(1997-8#1)(2004-9#1)(2006-5#1)(2006-8#1)(2007-5#1)(2007-8#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
piece to##3##2##(2008-10#2)(2011-2#1)
piece##72##1##(1990-11#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-3#2)(1992-12#1)(1992-3#1)(1993-6#1)(1995-11#1)(1996-2#1)(1997-1#1)(1997-3#5)(1997-8#1)(2004-9#1)(2005-11#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-12#2)(2007-5#1)(2007-8#2)(2008-10#5)(2008-11#4)(2008-12#3)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2009-3#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#1)
piecemeal##4##1##(1997-8#1)(2006-5#1)(2011-2#1)(2013-8#1)
pieces and##2##2##(2008-10#2)
pieces by##2##2##(1990-12#2)
pieces in a##3##3##(1996-3#1)(2008-10#1)(2008-5#1)
pieces in##5##2##(1995-7#1)(1996-3#1)(2008-10#1)(2008-5#1)(2012-11#1)
pieces of information##3##3##(1992-8#1)(2008-2#1)(2008-7#1)
pieces of the##9##3##(1990-12#1)(1997-2#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-6#1)(2010-10#1)(2011-1#1)(2013-1#1)
pieces of##35##2##(1990-12#1)(1992-8#2)(1994-3#1)(1995-3#2)(1996-6#1)(1997-2#1)(1997-7#1)(2006-4#1)(2006-5#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
pieces or##2##2##(2008-10#1)(2008-11#1)
pieces placed##2##2##(2008-10#2)
pieces was##2##2##(2005-11#1)(2012-11#1)
pieces were##6##2##(1995-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-3#1)
pieces##83##1##(1990-12#3)(1990-3#1)(1992-5#1)(1992-8#2)(1994-3#1)(1995-3#2)(1995-7#2)(1996-3#1)(1996-6#1)(1997-2#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#19)(2008-11#4)(2008-12#2)(2008-2#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-5#1)(2009-7#2)(2010-10#1)(2010-4#3)(2010-8#1)(2011-1#3)(2012-11#2)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
pieces)##3##1##(1995-7#1)(2007-8#1)(2008-10#1)
piecewise affine##2##2##(2006-10#2)
piecewise direct standardization (PDS)##3##4##(2008-10#3)
piecewise exponential model with proportional hazards covariate effects##2##8##(1996-1#2)
piecewise exponential model##4##3##(1992-6#1)(1996-1#3)
piecewise linear regression##3##3##(1991-5#1)(1993-11#1)(1994-4#1)
piecewise linear##7##2##(1991-5#1)(1993-11#1)(1994-4#1)(2007-11#1)(2007-9#1)(2008-2#1)(2013-1#1)
piecewise models##2##2##(2007-11#2)
piecewise##28##1##(1991-5#1)(1992-6#1)(1993-1#1)(1993-11#1)(1994-4#1)(1995-12#1)(1996-1#3)(2006-10#2)(2007-11#5)(2007-4#1)(2007-9#1)(2008-10#3)(2008-2#3)(2008-6#2)(2009-5#1)(2013-1#1)
piecewise-linear function##3##2##(2008-2#3)
piecewise-linear##5##1##(1992-2#1)(2008-2#4)
piecewise-polynomial##2##1##(2008-2#2)
pied flycatcher (Ficedula hypoleuca) in##2##5##(2004-4#2)
pier abutment##3##2##(2012-2#3)
pier##7##1##(1994-3#1)(2008-3#2)(2012-2#4)
pierced##2##1##(1996-11#1)(2013-1#1)
piercing the##2##2##(1991-5#1)(2011-2#1)
piercing##8##1##(1991-5#1)(2006-2#2)(2007-1#1)(2007-12#1)(2008-11#1)(2011-2#1)(2013-8#1)
piercings##2##1##(2006-12#1)(2013-8#1)
piericidin A##4##2##(1992-11#3)(1994-8#1)
piericidin##5##1##(1992-11#3)(1994-8#1)(1995-3#1)
pierre##3##1##(1991-11#1)(2008-10#2)
piety##3##1##(2008-11#1)(2008-12#2)
piezoelectric chemical sensor array##2##4##(2008-10#2)
piezoelectric crystal##4##2##(2008-10#4)
piezoelectric crystals##2##2##(2008-10#2)
piezoelectric detection##3##2##(2008-10#3)
piezoelectric immunosensor##3##2##(2008-10#3)
piezoelectric micro-pumps##2##2##(2007-10#2)
piezoelectric quartz crystal (PQC) sensor##2##5##(2007-8#1)(2008-10#1)
piezoelectric quartz crystal (PQC)##6##4##(2007-8#1)(2008-10#5)
piezoelectric quartz crystal impedance (PQCI)##2##5##(2008-10#2)
piezoelectric quartz crystal impedance##3##4##(2008-10#3)
piezoelectric quartz crystal##19##3##(2007-8#1)(2008-10#18)
piezoelectric quartz##22##2##(1990-8#1)(2007-8#1)(2008-10#20)
piezoelectric response model##2##3##(2008-10#2)
piezoelectric response##3##2##(2008-10#2)(2009-12#1)
piezoelectric sensor##4##2##(2008-10#2)(2010-5#2)
piezoelectric transducer and##3##3##(2007-12#2)(2008-3#1)
piezoelectric transducer##12##2##(2007-12#5)(2008-10#1)(2008-2#2)(2008-3#4)
piezoelectric##112##1##(1990-8#5)(1992-3#1)(1992-5#2)(2007-10#3)(2007-11#1)(2007-12#7)(2007-8#1)(2008-1#5)(2008-10#55)(2008-2#5)(2008-3#12)(2008-8#1)(2009-12#1)(2009-5#5)(2010-2#2)(2010-4#2)(2010-5#2)(2012-12#1)(2013-1#1)
piezoresistive##6##1##(2006-6#1)(2007-5#1)(2007-8#2)(2008-7#1)(2010-2#1)
piezosurgery##4##1##(2012-12#4)
pig and cow##3##3##(1990-4#1)(1994-12#1)(1994-5#1)
pig and human CYP17##2##4##(1995-10#2)
pig and human##5##3##(1990-7#1)(1993-11#1)(1995-10#2)(1995-3#1)
pig and rabbit##2##3##(1992-7#1)(2007-11#1)
pig and##23##2##(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#2)(1990-7#1)(1991-9#1)(1992-7#1)(1993-11#1)(1994-12#1)(1994-5#1)(1995-10#3)(1995-3#1)(1996-2#1)(2005-12#1)(2007-11#1)(2008-3#2)(2008-4#1)(2012-2#1)
pig aorta##2##2##(1991-12#1)(1993-3#1)
pig blastocyst cDNA##2##3##(1993-6#2)
pig blood##4##2##(1990-7#1)(1994-9#1)(2006-6#1)(2008-12#1)
pig bone marrow##2##3##(1993-3#2)
pig brain##6##2##(1991-1#2)(1994-2#1)(1996-4#2)(2007-12#1)
pig breeds##3##2##(2008-8#3)
pig farms##3##2##(1997-6#1)(2013-1#2)
pig had##2##2##(2012-3#2)
pig handling##2##2##(2011-1#2)
pig heart and##2##3##(1990-12#1)(1994-9#1)
pig heart##11##2##(1990-12#1)(1990-5#2)(1991-2#2)(1992-2#1)(1992-3#1)(1994-9#1)(1996-9#1)(2008-11#1)(2008-4#1)
pig hepatic##2##2##(1992-5#1)(1993-11#1)
pig herds##3##2##(2005-7#1)(2005-8#1)(2013-1#1)
pig ileum by##2##3##(1991-2#1)(1992-6#1)
pig ileum##19##2##(1990-11#2)(1991-2#3)(1991-5#3)(1992-6#1)(1993-3#1)(1994-11#1)(1995-12#4)(1995-3#1)(1997-2#1)(2008-7#2)
pig industry##6##2##(2005-12#1)(2008-7#2)(2008-8#1)(2011-2#2)
pig insulin##3##2##(1995-11#3)
pig kidney prolidase##2##3##(1991-4#2)
pig kidney##10##2##(1991-4#2)(1991-5#3)(1992-9#1)(1996-10#1)(1996-2#2)(2008-11#1)
pig left##2##2##(1991-2#1)(1994-9#1)
pig liver by##2##3##(1990-2#1)(1992-11#1)
pig liver plasma membranes##2##4##(1992-7#2)
pig liver plasma##3##3##(1992-7#3)
pig liver##25##2##(1990-11#2)(1990-2#2)(1991-10#1)(1991-7#2)(1992-1#1)(1992-11#2)(1992-5#3)(1992-7#3)(1992-8#3)(1992-9#1)(1994-3#2)(1995-2#1)(1995-3#1)(1996-5#1)
pig management in##2##3##(1996-12#2)
pig manure##4##2##(2007-12#1)(2008-10#1)(2013-8#2)
pig meat##5##2##(2008-10#1)(2010-4#2)(2013-1#2)
pig model##3##2##(1995-2#1)(2007-8#2)
pig muscle##3##2##(1994-5#1)(1994-9#1)(2008-11#1)
pig oocytes##2##2##(1990-12#1)(2013-1#1)
pig pancreatic##2##2##(1993-6#1)(1994-11#1)
pig parietal cells##3##3##(1993-6#3)
pig phosphoglucose isomerase##2##3##(1990-11#2)
pig production##3##2##(2008-7#1)(2010-4#2)
pig pulmonary##2##2##(1993-3#2)
pig skin##4##2##(1994-9#1)(2008-3#1)(2011-12#1)(2013-7#1)
pig slurry##2##2##(2008-10#2)
pig small intestine##5##3##(1990-11#4)(2008-5#1)
pig spleen##2##2##(1990-2#2)
pig stomach##4##2##(1992-4#1)(1995-6#3)
pig that##2##2##(2008-3#1)(2012-3#1)
pig to##2##2##(1991-7#1)(1993-3#1)
pig tonsils##2##2##(2010-4#2)
pig was##3##2##(1994-3#1)(1996-3#1)(2010-4#1)
pig##424##1##(1990-11#13)(1990-12#4)(1990-2#6)(1990-3#1)(1990-4#3)(1990-5#4)(1990-7#6)(1990-9#4)(1991-1#10)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#12)(1991-3#2)(1991-4#2)(1991-5#9)(1991-6#3)(1991-7#7)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#5)(1992-12#3)(1992-2#1)(1992-3#6)(1992-4#1)(1992-5#4)(1992-6#5)(1992-7#6)(1992-8#8)(1992-9#6)(1993-11#2)(1993-2#2)(1993-3#12)(1993-4#1)(1993-5#1)(1993-6#6)(1993-7#1)(1993-8#2)(1994-11#2)(1994-12#7)(1994-2#2)(1994-3#5)(1994-5#3)(1994-8#5)(1994-9#8)(1995-10#4)(1995-11#3)(1995-12#6)(1995-2#2)(1995-3#9)(1995-5#6)(1995-6#3)(1995-7#1)(1995-8#7)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#7)(1996-2#4)(1996-3#6)(1996-4#4)(1996-5#3)(1996-6#2)(1996-9#3)(1997-1#1)(1997-2#4)(1997-3#5)(1997-5#2)(1997-6#3)(1997-7#2)(2005-12#2)(2005-7#2)(2005-8#1)(2006-2#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-11#1)(2007-12#4)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#5)(2008-12#4)(2008-3#5)(2008-4#5)(2008-5#4)(2008-7#11)(2008-8#12)(2008-9#2)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-4#11)(2010-6#1)(2010-7#1)(2011-1#4)(2011-12#1)(2011-2#6)(2012-1#4)(2012-2#2)(2012-3#6)(2013-1#8)(2013-7#1)(2013-8#4)
pig) and##2##2##(1995-3#1)(1995-5#1)
pig)##5##1##(1990-2#1)(1994-11#1)(1995-3#1)(1995-5#1)(2008-4#1)
pig-tailed macaques##5##2##(1995-2#4)(1997-3#1)
pigbel and##2##2##(2006-2#2)
pigbel was##3##2##(2006-2#3)
pigbel##12##1##(2006-2#12)
pigeon and pig##3##3##(2010-4#3)
pigeon and##5##2##(1997-6#1)(2010-4#4)
pigeon delta-crystallin##2##2##(1992-12#2)
pigeon lenses##2##2##(1992-12#2)
pigeon pea pollen##2##3##(2008-6#2)
pigeon pea##6##2##(2008-10#2)(2008-6#4)
pigeon##51##1##(1991-2#2)(1991-6#1)(1992-1#1)(1992-12#8)(1993-4#2)(1993-8#2)(1995-11#1)(1995-12#1)(1995-8#1)(1996-7#2)(1997-3#1)(1997-6#1)(2005-7#3)(2005-9#1)(2006-1#1)(2006-5#1)(2006-7#1)(2007-12#1)(2008-10#2)(2008-5#6)(2008-6#4)(2008-8#2)(2009-11#1)(2010-4#5)
pigeonpea (Cajanus##2##2##(2008-10#1)(2010-10#1)
pigeonpea and##3##2##(2008-10#1)(2010-10#2)
pigeonpea plants##5##2##(2008-10#5)
pigeonpea##18##1##(2008-10#9)(2010-10#9)
pigeons (Columba livia)##3##3##(1992-1#1)(1994-2#1)(1995-12#1)
pigeons (Columba##4##2##(1992-1#1)(1994-2#1)(1995-12#1)(2008-5#1)
pigeons and##6##2##(1991-2#2)(1993-5#1)(2005-9#2)(2006-7#1)
pigeons free of##2##3##(2008-5#2)
pigeons in the##2##3##(1990-11#1)(1997-3#1)
pigeons in##3##2##(1990-11#1)(1997-3#1)(2008-5#1)
pigeons to##5##2##(1990-10#1)(1990-11#1)(1991-2#2)(2012-12#1)
pigeons was##2##2##(1990-11#1)(1991-2#1)
pigeons were trained##2##3##(1993-5#1)(2011-2#1)
pigeons were##7##2##(1993-5#1)(1994-2#1)(1997-3#1)(2008-5#2)(2011-2#2)
pigeons with##2##2##(1990-10#1)(1990-11#1)
pigeons##73##1##(1990-10#4)(1990-11#5)(1991-1#1)(1991-2#12)(1992-1#2)(1992-8#1)(1993-5#3)(1994-2#3)(1995-12#1)(1997-3#2)(1997-6#1)(2004-11#2)(2005-9#3)(2006-7#3)(2008-5#16)(2008-8#2)(2009-11#2)(2009-2#1)(2011-2#8)(2012-12#1)
pigeons'##3##1##(1994-2#2)(2012-12#1)
piggy##2##1##(1997-6#1)(2008-8#1)
piglet model##2##2##(2008-5#1)(2011-2#1)
piglet##10##1##(1996-10#2)(2005-11#2)(2006-8#2)(2008-5#1)(2010-2#2)(2011-2#1)
piglets (n = 12)##2##4##(1994-2#2)
piglets (n =##3##3##(1990-5#1)(1994-2#2)
piglets and##3##2##(2011-2#2)(2013-1#1)
piglets as##3##2##(2005-11#1)(2006-8#1)(2010-12#1)
piglets at##2##2##(1994-2#1)(2008-7#1)
piglets from the##2##3##(2005-11#1)(2013-1#1)
piglets from##6##2##(1990-5#2)(1996-8#1)(2005-11#1)(2013-1#2)
piglets in##3##2##(1992-5#1)(2012-1#1)(2013-1#1)
piglets on##2##2##(2005-11#1)(2013-1#1)
piglets##62##1##(1990-11#1)(1990-5#4)(1992-5#1)(1994-2#5)(1995-7#1)(1996-12#4)(1996-3#1)(1996-8#2)(2005-11#7)(2005-12#3)(2006-5#3)(2006-8#4)(2008-7#5)(2008-8#1)(2010-12#6)(2010-2#1)(2011-12#1)(2011-2#3)(2012-1#2)(2013-1#7)
pigment and##5##2##(1990-12#1)(1995-12#1)(1996-1#1)(2005-7#1)(2010-2#1)
pigment cell-specific##2##2##(1992-4#2)
pigment cells##5##2##(1992-2#1)(1992-4#1)(1996-2#1)(2008-5#2)
pigment concentration##5##2##(2007-5#1)(2008-2#2)(2008-3#2)
pigment concentrations##2##2##(2008-10#1)(2008-3#1)
pigment dispersing hormone##2##3##(1992-12#2)
pigment dispersion##3##2##(2008-8#3)
pigment elaboration##2##2##(2008-8#2)
pigment epithelium##24##2##(1990-3#1)(1990-6#1)(1992-2#1)(1995-9#2)(1997-6#1)(2006-4#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-4#1)(2011-7#3)(2012-12#4)(2012-3#1)(2013-1#1)
pigment epithelium-derived factor##4##3##(2008-7#1)(2010-3#2)(2012-5#1)
pigment from the##2##3##(1992-8#1)(2007-11#1)
pigment granules in##2##3##(1992-3#2)
pigment granules##3##2##(1992-3#2)(2007-12#1)
pigment in the##2##3##(2008-9#1)(2010-6#1)
pigment in##4##2##(2008-11#1)(2008-5#1)(2008-9#1)(2010-6#1)
pigment is##3##2##(1991-7#1)(2007-12#2)
pigment layers were found##2##4##(2008-10#2)
pigment levels in##2##3##(2007-11#2)
pigment levels##3##2##(2007-11#2)(2011-1#1)
pigment metals##2##2##(2008-10#2)
pigment molecules##2##2##(1990-4#1)(2007-11#1)
pigment of##2##2##(1991-9#1)(2008-8#1)
pigment particles##3##2##(2008-3#3)
pigment pattern##2##2##(2008-11#2)
pigment production##10##2##(1990-10#5)(1991-5#1)(2007-7#1)(2008-10#3)
pigment substitution##5##2##(2008-8#5)
pigment to##2##2##(2007-12#1)(2010-4#1)
pigment was##2##2##(1990-12#1)(2010-6#1)
pigment##194##1##(1990-10#8)(1990-12#6)(1990-3#1)(1990-4#2)(1990-6#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-9#3)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#4)(1992-4#3)(1992-8#1)(1993-3#8)(1993-6#1)(1994-3#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-6#1)(1995-9#2)(1996-1#1)(1996-2#1)(1996-5#2)(1997-4#1)(1997-6#5)(2004-2#1)(2005-7#1)(2006-11#1)(2006-4#1)(2007-11#5)(2007-12#5)(2007-5#1)(2007-6#1)(2007-7#3)(2008-1#3)(2008-10#20)(2008-11#5)(2008-12#3)(2008-2#3)(2008-3#12)(2008-4#2)(2008-5#9)(2008-7#2)(2008-8#19)(2008-9#1)(2009-4#1)(2010-10#2)(2010-2#1)(2010-3#2)(2010-4#4)(2010-6#2)(2011-1#1)(2011-2#1)(2011-7#3)(2012-12#4)(2012-3#3)(2012-5#1)(2013-1#4)(2013-8#1)
pigment-protein complex##2##2##(1990-8#1)(2010-2#1)
pigment-protein complexes##6##2##(2010-2#6)
pigment-protein##8##1##(1990-8#1)(2010-2#7)
pigment-stimulating properties##2##2##(1992-6#2)
pigment-to-volume concentration##2##2##(2008-3#2)
pigmentary disorders##3##2##(1994-12#1)(2006-12#1)(2008-5#1)
pigmentary##11##1##(1994-12#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-5#2)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#2)
pigmentation and##11##2##(1996-1#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-11#1)
pigmentation are##2##2##(2009-5#1)(2012-11#1)
pigmentation became lighter to grade-I (76##2##6##(2007-7#2)
pigmentation by##2##2##(2005-11#1)(2007-12#1)
pigmentation differences##2##2##(1997-6#1)(2008-7#1)
pigmentation due to##2##3##(2006-12#1)(2009-2#1)
pigmentation in##6##2##(1995-2#1)(1997-3#1)(2006-12#1)(2012-11#3)
pigmentation is##3##2##(1991-6#1)(1992-11#1)(2013-8#1)
pigmentation of the##2##3##(2007-7#1)(2012-3#1)
pigmentation of##3##2##(2007-7#1)(2008-6#1)(2012-3#1)
pigmentation on##2##2##(2007-7#1)(2008-8#1)
pigmentation patterns##2##2##(2007-9#1)(2012-11#1)
pigmentation to##3##2##(2007-7#3)
pigmentation##102##1##(1990-7#1)(1991-6#2)(1991-9#1)(1992-11#1)(1992-2#1)(1995-2#2)(1996-1#1)(1997-3#1)(1997-6#3)(2005-11#2)(2006-11#1)(2006-12#4)(2007-12#2)(2007-4#1)(2007-7#15)(2007-8#2)(2007-9#1)(2008-10#7)(2008-4#1)(2008-5#12)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#6)(2009-2#1)(2009-4#1)(2009-5#3)(2010-8#2)(2011-2#1)(2012-11#9)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#3)(2013-8#1)
pigmented Bowen's disease##2##3##(2010-6#2)
pigmented and##3##2##(2008-10#2)(2008-8#1)
pigmented cells##3##2##(1992-8#1)(2008-1#1)(2008-8#1)
pigmented epidermis##2##2##(2008-5#2)
pigmented epithelium##4##2##(1996-9#1)(2007-3#1)(2008-4#2)
pigmented lesion on the##2##4##(2007-10#1)(2010-6#1)
pigmented lesions##2##2##(2007-11#1)(2007-12#1)
pigmented medaka##4##2##(2008-11#4)
pigmented melanoma cells##3##3##(1992-3#2)(1996-2#1)
pigmented melanoma##4##2##(1992-3#3)(1996-2#1)
pigmented meningioma##2##2##(1992-11#2)
pigmented naevi##3##2##(1991-9#3)
pigmented neurons in##2##3##(1995-3#2)
pigmented skin lesion##3##3##(2007-10#2)(2007-11#1)
pigmented skin lesions##3##3##(2007-10#1)(2011-2#2)
pigmented skin##8##2##(1992-2#1)(1997-5#1)(2007-10#3)(2007-11#1)(2011-2#2)
pigmented villonodular synovitis##2##3##(2011-2#1)(2013-1#1)
pigmented##105##1##(1990-10#1)(1990-4#2)(1990-5#1)(1991-7#1)(1991-9#3)(1992-11#4)(1992-2#3)(1992-3#3)(1992-7#3)(1992-8#1)(1992-9#2)(1995-3#3)(1995-4#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-3#1)(1997-5#1)(2005-5#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-10#4)(2007-11#4)(2007-12#2)(2007-3#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#6)(2008-4#2)(2008-5#8)(2008-8#2)(2010-12#1)(2010-5#1)(2010-6#3)(2011-1#2)(2011-2#5)(2012-12#2)(2012-3#1)(2013-1#3)(2013-7#4)(2013-8#2)
pigmenti and##2##2##(2012-3#2)
pigmenti##4##1##(2007-2#1)(2012-3#3)
pigmentosa (RP)##2##2##(2008-5#1)(2009-12#1)
pigmentosa is a##2##3##(2007-7#1)(2011-1#1)
pigmentosa##21##1##(1991-6#1)(1995-10#1)(2007-7#5)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#1)(2011-1#2)(2011-12#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
pigmentosum is##3##2##(2005-11#3)
pigmentosum##21##1##(1991-3#2)(1991-6#1)(1993-8#1)(1994-7#1)(1997-4#1)(2005-11#10)(2007-8#2)(2008-8#1)(2009-3#1)(2011-2#1)
pigments (chlorophyll a##2##3##(2011-1#1)(2011-12#1)
pigments and antioxidative##2##3##(2011-12#2)
pigments and other##2##3##(2007-3#1)(2008-10#1)
pigments and water##2##3##(2008-10#1)(2008-12#1)
pigments and##14##2##(1991-3#1)(2007-10#1)(2007-3#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-8#1)(2010-4#1)(2011-12#2)
pigments by##2##2##(2008-10#1)(2012-12#1)
pigments from##2##2##(2008-10#2)
pigments have##2##2##(1997-6#1)(2008-10#1)
pigments in a liquid matrix##2##5##(2008-3#2)
pigments in a##3##3##(2008-3#3)
pigments in the##7##3##(1990-7#1)(1992-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2011-12#1)(2012-2#1)
pigments in##14##2##(1990-10#2)(1990-7#1)(1992-2#1)(1996-7#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#3)(2011-12#1)(2012-2#1)
pigments occur##2##2##(2008-12#1)(2008-2#1)
pigments were##6##2##(2008-10#3)(2008-12#1)(2008-5#2)
pigments##104##1##(1990-10#3)(1990-12#3)(1990-7#1)(1991-3#1)(1991-9#1)(1992-2#1)(1993-12#2)(1994-6#1)(1995-11#1)(1996-7#4)(1997-6#1)(2006-11#1)(2007-10#3)(2007-11#4)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#2)(2008-10#26)(2008-12#4)(2008-2#3)(2008-3#12)(2008-5#6)(2008-8#4)(2009-10#2)(2010-4#2)(2011-1#2)(2011-12#6)(2012-12#3)(2012-2#1)(2013-7#1)
pigs after##2##2##(2007-8#1)(2009-4#1)
pigs and##13##2##(1990-3#1)(1992-7#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-12#1)(2007-4#1)(2009-6#1)(2010-4#1)(2011-1#2)
pigs are##2##2##(2012-2#1)(2013-8#1)
pigs at##5##2##(1990-3#2)(2010-4#1)(2011-1#1)(2013-1#1)
pigs by##3##2##(1992-2#1)(1995-12#1)(1997-2#1)
pigs each##2##2##(1997-6#1)(2006-8#1)
pigs fed PE##2##3##(2004-11#2)
pigs fed##5##2##(2004-11#3)(2010-2#1)(2012-2#1)
pigs from##3##2##(1990-3#2)(1997-3#1)
pigs had##3##2##(2010-4#1)(2011-2#1)(2012-3#1)
pigs in the##2##3##(1990-3#1)(2013-1#1)
pigs in vitro##2##3##(1990-7#1)(2011-12#1)
pigs in##11##2##(1990-3#1)(1990-7#1)(1994-11#1)(2009-5#1)(2011-12#1)(2011-2#3)(2013-1#2)(2013-8#1)
pigs is##3##2##(2006-8#1)(2011-1#2)
pigs of##3##2##(2006-5#1)(2010-4#1)(2013-1#1)
pigs per##2##2##(2008-7#1)(2013-8#1)
pigs produced##2##2##(1993-9#1)(1997-3#1)
pigs received##2##2##(2008-5#2)
pigs served as controls##2##4##(1997-6#1)(2012-2#1)
pigs showed##2##2##(1994-9#1)(2011-2#1)
pigs that##6##2##(2006-10#2)(2006-8#2)(2008-12#1)(2010-4#1)
pigs the##2##2##(2006-8#1)(2008-4#1)
pigs to study the##2##4##(2008-11#1)(2010-4#1)
pigs to##3##2##(1996-9#1)(2008-11#1)(2010-4#1)
pigs was##3##2##(2006-10#1)(2010-2#1)(2011-1#1)
pigs were divided into two groups##2##6##(2006-6#1)(2013-1#1)
pigs were fed##2##3##(2004-11#1)(2012-2#1)
pigs were inoculated with##2##4##(2012-3#2)
pigs were used##3##3##(2008-4#1)(2012-2#1)(2013-1#1)
pigs were##20##2##(1990-3#1)(1997-6#1)(2004-11#1)(2006-6#1)(2007-8#3)(2008-4#1)(2008-5#1)(2008-9#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#3)
pigs with HGR##3##3##(2012-2#3)
pigs with polyserositis##2##3##(2013-1#2)
pigs with##23##2##(1990-3#3)(1995-12#1)(1996-9#1)(2006-5#2)(2006-8#1)(2007-8#2)(2008-4#1)(2010-4#1)(2011-2#1)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#1)
pigs##296##1##(1990-10#1)(1990-11#1)(1990-3#10)(1990-7#1)(1990-9#1)(1991-11#3)(1991-12#1)(1991-6#1)(1991-8#2)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-7#2)(1992-8#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#9)(1995-2#3)(1995-8#2)(1996-11#1)(1996-12#8)(1996-3#2)(1996-4#1)(1996-8#1)(1996-9#5)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#6)(1997-7#1)(1997-8#2)(2004-11#8)(2005-12#1)(2006-10#7)(2006-2#1)(2006-5#4)(2006-6#2)(2006-8#13)(2007-11#2)(2007-12#1)(2007-4#2)(2007-5#1)(2007-8#15)(2008-10#1)(2008-11#3)(2008-12#3)(2008-4#8)(2008-5#5)(2008-7#5)(2008-8#1)(2008-9#4)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-2#13)(2010-4#23)(2010-7#1)(2011-1#14)(2011-12#1)(2011-2#13)(2012-12#1)(2012-2#19)(2012-3#9)(2013-1#17)(2013-7#1)(2013-8#7)
pigs)##4##1##(1996-12#1)(2006-8#1)(2012-2#1)(2012-3#1)
pigtail##3##1##(1992-3#2)(2012-2#1)
pigtailed##2##1##(2007-11#1)(2007-12#1)
pigtailing##2##1##(2007-12#1)(2008-2#1)
pigus virgo##2##2##(2008-10#2)
pigweed##2##1##(2011-2#1)(2013-8#1)
pika##3##1##(2008-9#3)
pike##10##1##(1992-4#6)(1997-2#4)
pilE transcription##2##2##(1993-12#2)
pilE##8##1##(1993-12#8)
pile driving and other##3##4##(2010-8#3)
pile of##2##2##(1995-11#1)(2012-12#1)
pile##9##1##(1992-11#1)(1995-11#1)(2004-4#1)(2008-10#1)(2010-8#3)(2012-12#2)
piled##2##1##(1996-11#1)(2008-11#1)
piles##8##1##(2004-4#1)(2007-5#1)(2007-9#1)(2008-10#5)
pileus##3##1##(1995-2#1)(2007-7#1)(2010-3#1)
pilgrimage##3##1##(2007-2#1)(2009-9#2)
pilgrims##7##1##(2007-2#1)(2009-9#6)
pili##12##1##(1990-11#1)(1990-6#1)(1997-1#6)(1997-4#1)(2006-12#1)(2008-8#1)(2011-12#1)
pilin##2##1##(1993-12#2)
piling up##2##2##(1991-6#1)(2008-5#1)
piling##5##1##(1991-6#1)(2007-12#2)(2008-5#1)(2013-8#1)
pill containing##2##2##(2008-5#1)(2013-8#1)
pill smokers##3##2##(1991-8#3)
pill to##2##2##(1993-2#1)(1997-4#1)
pill##40##1##(1991-3#1)(1991-6#2)(1991-8#3)(1992-10#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-2#5)(1995-11#1)(1997-4#1)(1997-6#3)(2006-10#1)(2006-12#1)(2007-12#1)(2007-7#4)(2008-10#1)(2008-5#1)(2010-1#1)(2010-12#1)(2011-1#3)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#3)
pill-induced esophagitis##3##2##(2008-5#3)
pillar cells##3##2##(1993-9#1)(2008-7#2)
pillar of##4##2##(1995-8#1)(2008-1#1)(2010-12#1)(2010-4#1)
pillar##12##1##(1993-9#1)(1995-8#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-4#1)(2012-2#1)
pillars is##2##2##(2007-12#1)(2009-2#1)
pillars of##4##2##(1996-1#1)(2008-4#1)(2009-4#1)(2013-8#1)
pillars##20##1##(1995-8#1)(1996-1#1)(2005-5#1)(2007-12#2)(2007-8#1)(2008-11#2)(2008-2#7)(2008-4#1)(2008-9#1)(2009-2#1)(2009-4#1)(2013-8#1)
pillow##12##1##(2006-9#1)(2007-11#1)(2007-6#1)(2007-8#9)
pillows##2##1##(2006-9#1)(2013-7#1)
pills and##5##2##(2004-10#1)(2004-12#1)(2006-8#1)(2008-10#1)(2011-2#1)
pills for##2##2##(1991-7#1)(1996-9#1)
pills on##2##2##(2008-10#1)(2012-3#1)
pills or##2##2##(1993-2#1)(2006-10#1)
pills##35##1##(1990-11#1)(1990-9#1)(1991-7#1)(1991-8#3)(1992-2#1)(1993-10#1)(1993-2#3)(1994-9#1)(1996-8#1)(1996-9#1)(2004-10#4)(2004-12#1)(2005-11#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#3)(2009-2#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
pills?##2##1##(2009-11#1)(2010-8#1)
pilocarpine (400 mg/kg##3##3##(2010-7#1)(2010-8#2)
pilocarpine group##5##2##(2006-10#2)(2010-7#2)(2010-8#1)
pilocarpine group)##2##2##(2010-8#2)
pilocarpine##39##1##(1990-11#6)(1991-3#3)(1991-7#1)(1993-9#1)(1994-2#1)(1994-6#2)(1997-5#1)(2006-10#4)(2008-10#3)(2008-3#1)(2008-7#2)(2010-7#6)(2010-8#8)
pilocarpine-induced seizures and##2##3##(1994-2#1)(2010-7#1)
pilocarpine-induced seizures##5##2##(1994-2#4)(2010-7#1)
pilocarpine-induced##6##1##(1994-2#5)(2010-7#1)
pilocytic astrocytoma of the##2##4##(2005-10#1)(2008-5#1)
pilocytic astrocytoma##8##2##(2005-10#1)(2006-12#1)(2008-5#2)(2013-1#4)
pilocytic astrocytomas##2##2##(2006-12#1)(2007-12#1)
pilocytic##10##1##(2005-10#1)(2006-12#2)(2007-12#1)(2008-5#2)(2013-1#4)
pilomatrix carcinoma##2##2##(1994-8#2)
pilomatrix##3##1##(1994-8#2)(2013-7#1)
pilomatrixoma##3##1##(1994-8#2)(2013-7#1)
pilon fractures##3##2##(2007-11#1)(2007-8#2)
pilon##4##1##(2007-11#1)(2007-8#3)
pilonidal sinus##4##2##(2009-1#1)(2010-3#2)(2013-8#1)
pilonidal##6##1##(2009-1#1)(2010-11#1)(2010-3#2)(2012-2#1)(2013-8#1)
pilosa##7##1##(2008-10#1)(2008-12#5)(2012-12#1)
pilosebaceous unit##7##2##(1990-6#1)(2008-5#1)(2010-3#4)(2010-7#1)
pilosebaceous units##2##2##(2008-5#1)(2010-3#1)
pilosebaceous##10##1##(1990-6#1)(2008-5#2)(2010-3#5)(2010-5#1)(2010-7#1)
pilosicoli genome##2##2##(2006-5#2)
pilosicoli##12##1##(2006-5#11)(2006-8#1)
pilosula##3##1##(2005-11#2)(2007-1#1)
pilot analysis##2##2##(2004-11#2)
pilot and##3##2##(2007-5#1)(2008-10#1)(2013-1#1)
pilot clinical study##2##3##(2008-4#1)(2010-5#1)
pilot clinical trial##3##3##(1993-10#1)(1994-10#1)(2005-10#1)
pilot clinical##6##2##(1993-10#1)(1994-10#1)(2005-10#1)(2008-4#1)(2010-5#1)(2013-1#1)
pilot data##6##2##(2006-7#1)(2007-2#1)(2010-9#1)(2012-1#1)(2013-1#2)
pilot experience##2##2##(2010-12#2)
pilot experiments##4##2##(2008-4#3)(2011-2#1)
pilot feasibility study##2##3##(2010-6#1)(2010-7#1)
pilot investigation##2##2##(1995-11#1)(2012-12#1)
pilot model##2##2##(2008-4#2)
pilot of##5##2##(1994-3#1)(2007-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
pilot phase of##3##3##(2008-12#1)(2010-9#1)(2012-3#1)
pilot phase##5##2##(1990-12#1)(2007-11#1)(2008-12#1)(2010-9#1)(2012-3#1)
pilot plant##6##2##(1995-3#1)(2005-8#1)(2008-10#2)(2012-2#2)
pilot program##9##2##(1993-9#1)(2007-2#3)(2007-5#3)(2010-12#1)(2012-2#1)
pilot programs##3##2##(1994-12#1)(2007-11#1)(2008-12#1)
pilot project in##2##3##(2007-2#1)(2008-3#1)
pilot project##24##2##(1993-3#1)(1994-1#1)(1996-1#1)(1996-2#1)(1997-2#1)(2005-9#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-2#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#3)
pilot projects##3##2##(1996-3#2)(2006-4#1)
pilot prospective##3##2##(2008-4#1)(2010-10#1)(2011-2#1)
pilot randomised##2##2##(2008-6#1)(2010-12#1)
pilot randomized clinical trial##2##4##(1994-8#1)(2011-2#1)
pilot randomized##4##2##(1994-8#1)(2011-2#1)(2013-1#2)
pilot sample##2##2##(2008-10#2)
pilot scale cultivation##2##3##(1994-5#1)(2012-3#1)
pilot scale##15##2##(1992-5#1)(1994-5#3)(2006-8#1)(2008-11#7)(2008-7#1)(2010-4#1)(2012-3#1)
pilot screening##2##2##(2013-1#2)
pilot series##2##2##(2007-8#2)
pilot site##2##2##(2008-11#1)(2010-9#1)
pilot sites were##2##3##(2008-11#2)
pilot sites##3##2##(2008-11#3)
pilot studies in##2##3##(2005-7#1)(2007-7#1)
pilot studies using##2##3##(2007-11#1)(2012-12#1)
pilot studies##13##2##(1996-7#2)(1996-8#1)(2005-7#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-11#1)(2010-3#1)(2012-12#1)
pilot study and##2##3##(1996-1#1)(2011-1#1)
pilot study are##3##3##(1993-1#1)(1995-1#1)(2008-5#1)
pilot study assessed the##2##4##(2008-7#1)(2011-2#1)
pilot study comparing##3##3##(1990-1#1)(1996-12#1)(2008-6#1)
pilot study has##2##3##(2008-10#1)(2009-5#1)
pilot study in which##2##4##(2006-10#1)(2007-5#1)
pilot study in##13##3##(1994-7#1)(2006-10#1)(2006-12#1)(2007-5#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-3#2)(2011-2#1)(2013-1#2)(2013-8#1)
pilot study of the##3##4##(1996-2#1)(2009-4#1)(2010-9#1)
pilot study of##37##3##(1990-2#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#2)(1993-3#1)(1996-1#1)(1996-2#1)(1996-8#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-5#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-12#1)(2012-1#2)(2012-12#1)(2013-1#3)
pilot study on##6##3##(1990-8#1)(1994-11#1)(1996-3#1)(2008-9#1)(2010-2#1)(2013-8#1)
pilot study provides the first##2##5##(2008-3#1)(2012-1#1)
pilot study results##2##3##(2007-10#1)(2010-7#1)
pilot study suggest that##3##4##(2006-10#1)(2006-9#1)(2008-7#1)
pilot study suggest##4##3##(2006-10#1)(2006-9#1)(2008-7#1)(2010-8#1)
pilot study that##2##3##(2009-10#1)(2011-1#1)
pilot study to evaluate##2##4##(2008-7#2)
pilot study to examine the##2##5##(2006-4#1)(2008-12#1)
pilot study to##11##3##(1990-12#1)(1996-8#1)(2006-10#1)(2006-4#1)(2008-12#1)(2008-7#2)(2009-12#1)(2009-5#1)(2012-3#1)(2013-1#1)
pilot study was conducted in##3##5##(1992-2#1)(2004-2#1)(2012-3#1)
pilot study was conducted##5##4##(1992-2#1)(2004-2#1)(2006-10#1)(2010-5#1)(2012-3#1)
pilot study was designed to##2##5##(2005-5#1)(2008-7#1)
pilot study was to determine the##2##6##(2007-10#1)(2008-12#1)
pilot study was to determine##3##5##(2007-10#1)(2007-2#1)(2008-12#1)
pilot study was to##19##4##(1992-8#1)(1995-3#1)(1996-3#1)(2007-10#1)(2007-2#3)(2008-11#1)(2008-12#4)(2010-3#1)(2010-9#1)(2011-2#2)(2012-1#1)(2013-1#2)
pilot study was##39##3##(1991-12#1)(1992-2#1)(1992-8#1)(1995-3#1)(1996-3#1)(1997-1#1)(2004-2#1)(2005-5#1)(2005-9#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-2#3)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-3#1)(2008-7#2)(2010-10#1)(2010-3#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#2)
pilot study were##3##3##(1990-12#1)(2010-7#1)(2012-12#1)
pilot study##301##2##(1990-1#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#3)(1993-2#1)(1993-3#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-7#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#4)(1996-7#1)(1996-8#2)(1997-1#2)(2004-2#1)(2004-8#1)(2005-1#2)(2005-10#1)(2005-5#1)(2005-8#1)(2005-9#2)(2006-1#5)(2006-10#8)(2006-11#2)(2006-12#1)(2006-4#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#7)(2007-11#1)(2007-12#2)(2007-2#6)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#6)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#12)(2008-3#4)(2008-4#7)(2008-5#9)(2008-6#3)(2008-7#11)(2008-9#5)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#7)(2010-2#2)(2010-3#10)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#5)(2010-9#6)(2011-1#3)(2011-12#4)(2011-2#12)(2012-1#8)(2012-12#6)(2012-2#3)(2012-3#4)(2013-1#19)(2013-7#1)(2013-8#4)
pilot study]##6##2##(1994-8#1)(2005-10#1)(2007-9#1)(2010-12#1)(2013-7#1)(2013-8#1)
pilot survey##2##2##(1993-1#1)(2009-5#1)
pilot test and##2##3##(2010-7#1)(2012-12#1)
pilot test##11##2##(1994-3#1)(1996-2#1)(2007-2#1)(2009-9#1)(2010-4#2)(2010-5#1)(2010-7#2)(2012-12#2)
pilot tested##5##2##(2008-1#1)(2010-10#1)(2012-1#1)(2012-3#1)(2013-1#1)
pilot testing##5##2##(1996-2#1)(2007-10#1)(2009-9#1)(2010-3#1)(2012-1#1)
pilot trial in##2##3##(2007-8#1)(2012-12#1)
pilot trial was##3##3##(1992-12#1)(2008-7#1)(2012-12#1)
pilot trial##12##2##(1992-12#1)(2006-10#1)(2006-11#1)(2007-8#1)(2008-3#1)(2008-7#2)(2008-8#1)(2010-10#1)(2012-12#2)(2012-3#1)
pilot##551##1##(1990-1#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#5)(1993-10#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-1#2)(1994-10#2)(1994-11#3)(1994-12#2)(1994-3#9)(1994-5#3)(1994-7#1)(1994-8#2)(1995-1#2)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-1#4)(1996-12#1)(1996-2#4)(1996-3#6)(1996-7#4)(1996-8#3)(1997-1#2)(1997-2#2)(1997-5#3)(1997-8#1)(2004-11#2)(2004-2#1)(2004-8#1)(2005-1#2)(2005-10#3)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#3)(2005-9#3)(2006-1#5)(2006-10#13)(2006-11#3)(2006-12#1)(2006-2#1)(2006-4#9)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#3)(2006-9#1)(2007-10#10)(2007-11#5)(2007-12#2)(2007-2#13)(2007-3#1)(2007-4#1)(2007-5#6)(2007-7#11)(2007-8#9)(2007-9#3)(2008-1#3)(2008-10#13)(2008-11#25)(2008-12#15)(2008-3#7)(2008-4#16)(2008-5#10)(2008-6#4)(2008-7#19)(2008-8#1)(2008-9#6)(2009-1#1)(2009-10#4)(2009-11#2)(2009-12#2)(2009-2#2)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#4)(2010-11#3)(2010-12#13)(2010-2#4)(2010-3#12)(2010-4#8)(2010-5#3)(2010-6#2)(2010-7#7)(2010-8#6)(2010-9#9)(2011-1#3)(2011-12#5)(2011-2#20)(2011-3#1)(2011-9#1)(2012-1#12)(2012-12#14)(2012-2#10)(2012-3#13)(2013-1#33)(2013-7#2)(2013-8#7)
pilot&quot##2##1##(1994-3#2)
pilot-scale##5##1##(2007-6#1)(2008-11#1)(2008-6#1)(2011-2#2)
pilot-tested##4##1##(2007-7#1)(2010-3#1)(2011-2#1)(2012-12#1)
piloted a##2##2##(2007-8#1)(2010-2#1)
piloted##10##1##(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#2)(2010-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
piloting##5##1##(2008-11#1)(2012-2#1)(2013-1#3)
pilots and##4##2##(2007-2#2)(2012-2#2)
pilots##17##1##(1990-3#3)(1995-1#1)(1997-5#3)(2007-2#3)(2007-4#1)(2011-2#2)(2012-2#2)(2013-1#2)
pilus system##2##2##(1997-4#2)
pilus##6##1##(1997-4#4)(2008-10#1)(2011-12#1)
pim-1##2##1##(1991-5#2)
pim1##3##1##(1995-2#3)
pimaricin##3##1##(2008-10#1)(2009-8#2)
pimecrolimus##4##1##(2006-12#1)(2008-3#2)(2011-2#1)
pimozide##11##1##(1992-9#3)(1995-12#5)(2010-8#1)(2012-12#2)
pin insertion sites##2##3##(2006-12#1)(2009-3#1)
pin insertion##3##2##(2006-12#1)(2007-11#1)(2009-3#1)
pin sites##2##2##(2006-12#2)
pin track##2##2##(2010-12#2)
pin tracts##2##2##(2009-4#2)
pin##23##1##(1993-8#1)(1995-5#1)(2006-12#4)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-12#2)(2008-5#1)(2009-3#1)(2009-4#3)(2010-12#2)(2012-2#1)(2012-3#1)
pin-on-disc##2##1##(2004-9#1)(2009-4#1)
pin-on-disk##2##1##(2009-4#1)(2010-4#1)
pinacidil##4##1##(1991-1#1)(1994-3#2)(2008-8#1)
pinaverium bromure and##2##3##(2013-1#2)
pinch and grasp##3##3##(2006-3#3)
pinch and##4##2##(1993-2#1)(2006-3#3)
pinch in##2##2##(1995-5#1)(1996-12#1)
pinch plasma is##2##3##(2008-3#2)
pinch plasma##3##2##(2007-12#1)(2008-3#2)
pinch pressure##4##2##(2012-1#4)
pinch strength##5##2##(2009-3#3)(2012-1#2)
pinch##32##1##(1991-6#1)(1992-11#1)(1993-2#3)(1995-5#1)(1996-12#1)(2006-3#4)(2007-12#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-9#2)(2009-3#4)(2010-2#1)(2012-1#7)(2012-12#1)
pinch-off##2##1##(2005-11#1)(2009-6#1)
pinched##3##1##(1995-10#1)(2008-5#1)(2011-1#1)
pinches##2##1##(1995-10#1)(2012-1#1)
pinching of##2##2##(1997-2#1)(2010-12#1)
pinching##5##1##(1996-8#1)(1997-2#1)(2006-3#1)(2008-5#1)(2010-12#1)
pindolol and##4##2##(1995-12#1)(1995-6#1)(2008-10#2)
pindolol in##2##2##(1997-5#1)(2008-10#1)
pindolol##22##1##(1992-11#1)(1992-2#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#3)(1997-5#1)(2005-9#1)(2008-10#11)
pine (P##8##2##(2008-10#8)
pine (Pinus nigra##2##3##(2009-3#1)(2011-12#1)
pine (Pinus##19##2##(2004-4#2)(2006-12#1)(2008-10#11)(2009-3#2)(2011-12#2)(2013-1#1)
pine and##6##2##(1990-8#1)(1993-4#1)(2008-10#2)(2009-3#2)
pine bark##4##2##(1995-8#1)(2008-10#3)
pine blister rust in##3##4##(2008-10#3)
pine blister rust##18##3##(2008-10#18)
pine blister##19##2##(2008-10#19)
pine forest##3##2##(2013-8#3)
pine forests##2##2##(2008-10#1)(2008-4#1)
pine in##4##2##(2008-10#3)(2013-1#1)
pine mistletoe##3##2##(2011-12#3)
pine needles combustion emissions in##2##5##(2007-8#2)
pine needles##7##2##(2004-4#2)(2007-8#3)(2008-10#1)(2008-12#1)
pine plantations##3##2##(2008-10#3)
pine seedlings##6##2##(1997-2#1)(2004-4#3)(2008-10#1)(2008-7#1)
pine species##4##2##(2008-10#3)(2008-8#1)
pine stem rusts##2##3##(2008-10#2)
pine stem##3##2##(2008-10#3)
pine trees##3##2##(2008-10#1)(2011-12#1)(2011-2#1)
pine were##3##2##(2008-10#2)(2011-12#1)
pine with##2##2##(2008-10#1)(2008-7#1)
pine##148##1##(1990-8#1)(1993-4#2)(1995-8#2)(1997-2#1)(2004-4#10)(2006-12#3)(2007-8#3)(2008-10#89)(2008-12#1)(2008-4#1)(2008-7#4)(2008-8#3)(2009-3#8)(2011-10#2)(2011-12#8)(2011-2#1)(2013-1#5)(2013-7#1)(2013-8#3)
pineal activity##3##2##(1992-8#2)(1995-12#1)
pineal and serum melatonin##2##4##(1990-5#1)(1992-12#1)
pineal and serum##3##3##(1990-5#1)(1992-12#1)(1997-5#1)
pineal and##5##2##(1990-5#1)(1992-12#1)(1997-5#1)(2006-1#1)(2008-7#1)
pineal cells##4##2##(1994-10#2)(1994-5#1)(1995-9#1)
pineal cysts##4##2##(2012-2#4)
pineal function##3##2##(1992-8#1)(1994-5#1)(1995-9#1)
pineal gland and the##2##4##(2008-10#1)(2013-7#1)
pineal gland and##7##3##(1994-5#1)(1995-9#1)(1997-5#2)(2008-10#2)(2013-7#1)
pineal gland cDNA library##2##4##(2008-7#2)
pineal gland hormone##3##3##(1995-3#1)(2008-12#2)
pineal gland or plasma##2##4##(1994-2#2)
pineal gland##53##2##(1992-1#1)(1993-4#3)(1994-2#6)(1994-5#7)(1994-9#3)(1995-11#1)(1995-12#2)(1995-3#3)(1995-9#4)(1997-5#2)(2008-10#2)(2008-12#3)(2008-5#1)(2008-7#4)(2008-9#1)(2010-4#2)(2012-1#4)(2012-2#1)(2013-1#1)(2013-7#2)
pineal hormone melatonin (MLT)##3##4##(1992-12#1)(1995-9#1)(2013-7#1)
pineal hormone melatonin##9##3##(1990-2#2)(1990-5#1)(1991-6#1)(1992-12#2)(1994-8#1)(1995-9#1)(2013-7#1)
pineal hormone##14##2##(1990-2#3)(1990-5#1)(1991-6#1)(1992-12#2)(1994-8#2)(1995-1#1)(1995-9#1)(2007-8#1)(2008-5#1)(2013-7#1)
pineal melatonin##3##2##(1994-2#1)(1994-5#2)
pineal organ via##2##3##(1994-5#2)
pineal organ##14##2##(1994-5#11)(1995-7#3)
pineal parenchymal tumors##2##3##(2012-2#2)
pineal proteins##3##2##(2010-4#3)
pineal serotonin##2##2##(1990-5#1)(1995-3#1)
pineal##167##1##(1990-2#3)(1990-5#7)(1991-6#1)(1992-1#1)(1992-12#4)(1992-8#3)(1993-4#3)(1994-10#2)(1994-2#8)(1994-5#36)(1994-8#2)(1994-9#8)(1995-1#2)(1995-11#1)(1995-12#8)(1995-3#10)(1995-7#5)(1995-9#7)(1996-4#1)(1997-5#4)(2006-1#1)(2006-5#2)(2007-8#1)(2008-10#2)(2008-12#4)(2008-5#6)(2008-7#9)(2008-9#1)(2010-4#6)(2012-1#4)(2012-12#1)(2012-2#8)(2013-1#1)(2013-7#5)
pinealectomized (Px)##2##2##(1995-1#1)(2008-5#1)
pinealectomized##4##1##(1994-5#1)(1995-1#2)(2008-5#1)
pinealectomy##2##1##(1995-1#2)
pinealocyte##4##1##(1993-4#2)(2012-1#2)
pinealocytes##3##1##(1993-4#1)(1994-5#2)
pineals of##3##2##(1994-5#3)
pineals##5##1##(1994-5#5)
pineapple (Ananas##2##2##(2006-12#1)(2008-10#1)
pineapple fruit##2##2##(2006-12#2)
pineapple mealybug##3##2##(2008-10#3)
pineapple plants##2##2##(2008-10#2)
pineapple skin##2##2##(2012-2#2)
pineapple##24##1##(2006-12#6)(2008-10#13)(2008-8#1)(2012-2#3)(2013-1#1)
pineocytoma##4##1##(1992-8#1)(2012-2#3)
pines and##3##2##(2008-10#2)(2008-12#1)
pines in##2##2##(2008-10#2)
pines##15##1##(1995-8#1)(2008-10#11)(2008-12#1)(2008-7#1)(2008-8#1)
pinewood nematode##2##2##(2008-10#2)
ping pong##2##2##(1993-6#2)
ping##3##1##(1993-6#2)(2008-5#1)
ping-pong##4##1##(1990-3#1)(1992-3#1)(1994-5#1)(2013-7#1)
pinhole array##3##2##(2007-12#1)(2008-3#2)
pinhole camera##7##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-6#1)(2012-12#2)
pinhole of##3##2##(2007-12#1)(2008-2#2)
pinhole size##2##2##(2008-3#2)
pinhole##45##1##(2007-11#2)(2007-12#10)(2007-4#1)(2008-10#1)(2008-12#1)(2008-2#12)(2008-3#11)(2008-6#1)(2009-8#2)(2010-9#1)(2012-12#2)(2012-2#1)
pinholes and##2##2##(2008-3#1)(2012-2#1)
pinholes in##3##2##(2006-4#1)(2008-2#1)(2012-2#1)
pinholes is##2##2##(2008-2#2)
pinholes##16##1##(2006-4#1)(2007-11#1)(2008-2#4)(2008-3#4)(2009-8#1)(2012-2#5)
pini and##3##2##(2008-10#2)(2011-2#1)
pini##11##1##(1995-8#3)(2008-10#5)(2011-2#3)
pink colour##2##2##(2008-10#1)(2008-5#1)
pink coloured##2##2##(2008-10#2)
pink##31##1##(1990-12#1)(1993-8#1)(2007-2#2)(2008-10#16)(2008-4#1)(2008-5#5)(2008-9#1)(2010-10#1)(2010-12#1)(2012-3#1)(2013-1#1)
pink-eyed unstable##2##2##(1997-4#2)
pink-eyed##3##1##(1994-3#1)(1997-4#2)
pinless navigation group##2##3##(2013-1#2)
pinless navigation##3##2##(2013-1#3)
pinless##5##1##(2009-9#1)(2013-1#4)
pinna##3##1##(1993-12#1)(2005-7#1)(2012-2#1)
pinnacle##2##1##(2007-8#1)(2012-3#1)
pinnae##5##1##(2008-5#5)
pinned##5##1##(1991-12#1)(1991-2#1)(2007-9#1)(2008-8#1)(2011-1#1)
pinning and##2##2##(1992-6#1)(2008-9#1)
pinning##9##1##(1992-3#1)(1992-6#2)(2008-8#2)(2008-9#1)(2010-4#2)(2012-5#1)
pinniped lactation##2##2##(2008-9#2)
pinnipeds by##2##2##(2008-9#2)
pinnipeds##8##1##(2008-9#6)(2009-2#1)(2012-3#1)
pinocytosis##2##1##(1990-11#1)(1991-12#1)
pinocytotic vesicles##2##2##(1993-6#1)(2007-12#1)
pinocytotic##4##1##(1993-6#1)(2007-12#2)(2012-1#1)
pinodes##2##1##(2008-10#2)
pinpoint##18##1##(1990-12#1)(1992-6#1)(1996-8#1)(1997-4#1)(2006-10#1)(2006-3#1)(2007-9#1)(2008-10#2)(2008-4#2)(2008-7#1)(2008-9#1)(2009-6#1)(2012-3#2)(2013-1#2)
pinpointed##9##1##(1993-8#1)(1997-2#1)(2006-8#1)(2008-10#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-7#1)
pinpointing the##3##2##(2007-11#1)(2007-9#1)(2009-12#1)
pinpointing##6##1##(2007-11#1)(2007-5#1)(2007-9#1)(2009-10#1)(2009-12#1)(2013-1#1)
pinpoints##5##1##(2008-5#1)(2009-10#1)(2010-8#1)(2012-2#1)(2012-3#1)
pins were##2##2##(2007-4#1)(2010-11#1)
pins##14##1##(1997-3#2)(2005-11#1)(2006-3#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-4#1)(2009-4#1)(2010-11#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
pinto bean##3##2##(2008-10#1)(2010-5#2)
pinto beans##4##2##(2010-5#4)
pinto##7##1##(2008-10#1)(2010-5#6)
pinwheel centers##6##2##(2008-11#2)(2012-2#1)(2013-7#3)
pinwheel##7##1##(2008-11#2)(2012-2#1)(2013-7#4)
pioarachnoidal##2##1##(2011-1#2)
pioglitazone on##2##2##(1993-12#1)(2008-3#1)
pioglitazone to##2##2##(1993-12#1)(2008-3#1)
pioglitazone##17##1##(1993-12#4)(1995-3#1)(2008-1#2)(2008-3#7)(2010-10#1)(2012-3#1)(2013-1#1)
pioneer of##14##2##(1990-3#1)(1993-5#1)(1997-6#1)(2006-8#1)(2007-11#1)(2007-4#2)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#1)(2009-1#1)(2012-2#1)
pioneer##41##1##(1990-3#1)(1991-5#1)(1991-6#1)(1992-9#1)(1993-5#1)(1994-12#1)(1994-6#1)(1995-7#1)(1996-2#1)(1997-6#1)(2006-4#1)(2006-8#2)(2007-1#2)(2007-11#1)(2007-12#6)(2007-3#1)(2007-4#2)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-1#1)(2010-11#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
pioneered by##5##2##(1994-9#1)(2006-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
pioneered in##2##2##(2007-8#1)(2009-9#1)
pioneered the##2##2##(2010-10#1)(2011-7#1)
pioneered##15##1##(1994-9#1)(1996-3#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-8#1)(2009-9#1)(2010-10#1)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
pioneering work in##4##3##(2005-8#1)(2006-10#1)(2007-4#1)(2011-2#1)
pioneering work of##2##3##(2008-2#1)(2010-5#1)
pioneering work##7##2##(2005-8#1)(2006-10#1)(2007-4#1)(2008-2#1)(2010-5#1)(2010-8#1)(2011-2#1)
pioneering##27##1##(1992-12#1)(1994-2#1)(1995-12#1)(1996-11#1)(1997-3#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
pioneers and innovators##2##3##(2006-4#1)(2012-2#1)
pioneers in the##2##3##(1997-4#1)(2008-5#1)
pioneers in##3##2##(1997-4#1)(2007-12#1)(2008-5#1)
pioneers of##3##2##(2007-12#1)(2010-5#1)(2012-2#1)
pioneers##23##1##(1991-4#1)(1993-6#1)(1993-9#1)(1994-2#1)(1997-4#1)(2006-4#1)(2006-7#1)(2007-12#9)(2008-5#1)(2008-9#1)(2010-5#1)(2011-2#2)(2012-2#2)
pious##2##1##(2008-5#1)(2011-1#1)
pipe is##3##2##(2008-2#1)(2008-3#2)
pipe##28##1##(1991-5#2)(2006-4#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#6)(2010-3#1)(2010-6#2)(2011-12#1)(2011-2#1)
pipeline and##3##2##(2008-1#1)(2008-10#1)(2013-1#1)
pipeline for##3##2##(2008-5#2)(2011-1#1)
pipeline model##2##2##(2008-12#2)
pipeline planning##3##2##(2012-3#3)
pipeline programs##3##2##(2012-3#3)
pipeline transport##2##2##(2008-5#2)
pipeline##45##1##(2005-8#1)(2006-12#1)(2007-11#2)(2007-2#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#9)(2013-1#1)(2013-7#1)
pipelined##2##1##(2008-2#1)(2011-1#1)
pipelines##8##1##(2005-7#1)(2008-5#2)(2008-7#3)(2011-1#1)(2011-2#1)
piperacillin in##4##2##(1990-2#1)(1996-6#3)
piperacillin##10##1##(1990-2#2)(1996-6#5)(2008-7#1)(2012-2#1)(2013-8#1)
piperacillin-tazobactam##4##1##(1996-6#1)(2013-8#3)
piperazine##14##1##(1993-4#1)(1995-11#1)(1995-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-5#1)(2012-11#1)(2013-7#1)
piperazine-1##2##1##(2008-10#2)
piperidine treatment##3##2##(1990-3#1)(1993-8#2)
piperidine##22##1##(1990-3#1)(1990-5#1)(1990-8#2)(1991-9#1)(1992-3#1)(1992-8#1)(1993-8#2)(1994-11#1)(1995-1#1)(1995-3#2)(1995-5#1)(1995-6#1)(2007-11#2)(2008-10#2)(2008-11#2)(2010-5#1)
piperidine-2##2##1##(2008-10#2)
piperidinecarboxylic##2##1##(2008-1#2)
piperine##5##1##(1992-1#5)
piperita L##6##2##(2008-10#3)(2013-1#3)
piperita##7##1##(2008-10#3)(2013-1#4)
piperitylmagnolol##2##1##(2006-12#2)
piperonyl butoxide##3##2##(1990-3#1)(1994-5#1)(2008-8#1)
piperonyl##4##1##(1990-3#1)(1994-5#1)(1996-8#1)(2008-8#1)
pipes##14##1##(2006-10#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2010-2#2)(2010-6#1)
pipet geometry##2##2##(2008-4#2)
pipet##11##1##(1990-2#2)(2008-11#3)(2008-4#5)(2013-1#1)
pipets##5##1##(2008-4#5)
pipette solution##4##2##(1994-5#2)(2009-12#2)
pipette tip##3##2##(2008-11#3)
pipette was##5##2##(1992-7#1)(1993-12#1)(1994-5#1)(1995-12#1)(2013-1#1)
pipette##28##1##(1992-7#2)(1993-12#1)(1994-5#3)(1995-11#3)(1995-12#2)(1995-8#1)(1996-1#1)(2007-2#1)(2008-10#2)(2008-11#5)(2008-8#1)(2009-12#3)(2010-4#1)(2013-1#2)
pipetteman##2##1##(2008-11#2)
pipettes##4##1##(1993-12#1)(2008-11#2)(2013-1#1)
pipetting##7##1##(2007-12#1)(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)
pipiens ssp##3##2##(2011-1#3)
pipiens##12##1##(1997-3#2)(2011-1#3)(2012-2#2)(2013-1#5)
pipiens)##4##1##(1992-9#1)(1994-12#1)(1997-3#1)(2008-9#1)
piping##2##1##(1992-11#1)(2013-8#1)
piracetam##2##1##(1995-3#2)
piracy##3##1##(2011-2#1)(2012-2#2)
piranha##3##1##(2008-11#1)(2010-8#2)
pirate##3##1##(2008-2#2)(2012-2#1)
pirenzepine##14##1##(1990-2#1)(1990-7#1)(1991-2#4)(1991-5#1)(1993-9#2)(1994-2#2)(1995-3#1)(1996-1#2)
pirenzepine-insensitive muscarinic receptors##2##3##(1995-7#2)
pirenzepine-insensitive muscarinic##3##2##(1995-11#1)(1995-7#2)
pirica##6##1##(2012-12#6)
piriform and entorhinal cortex##2##4##(1996-9#1)(1997-3#1)
piriform and entorhinal##3##3##(1993-7#1)(1996-9#1)(1997-3#1)
piriform cortex in##2##3##(1990-5#1)(1993-2#1)
piriform cortex##14##2##(1990-5#2)(1991-1#1)(1993-2#1)(1993-4#2)(1994-3#3)(1997-3#1)(2012-1#1)(2013-1#3)
piriform##23##1##(1990-2#1)(1990-5#2)(1991-1#2)(1993-2#1)(1993-4#2)(1993-7#1)(1994-3#3)(1996-12#1)(1996-9#1)(1997-3#3)(1997-5#1)(2012-1#1)(2013-1#3)(2013-7#1)
piriformis##5##1##(1990-2#2)(2006-7#3)
pirimicarb##7##1##(2007-8#6)(2008-10#1)
pirimiphos##3##1##(1996-4#3)
pirina on##2##2##(2008-10#2)
pirina##9##1##(2008-10#9)
piritramide##4##1##(2007-2#4)
piritrexim##7##1##(2005-8#7)
piroctone olamine and salicylic acid##2##5##(2008-5#2)
piroctone olamine and##3##3##(2008-5#3)
piroctone olamine##7##2##(2008-5#7)
piroxicam and##2##2##(1990-11#1)(2008-10#1)
piroxicam in##6##2##(1997-8#3)(2008-10#2)(2012-1#1)
piroxicam##27##1##(1990-11#1)(1990-9#4)(1992-3#4)(1994-2#2)(1997-8#5)(2007-7#1)(2007-9#1)(2008-10#5)(2012-1#4)
piroximone##3##1##(1992-2#3)
piruvate --&gt##2##2##(2011-2#2)
pisi and##2##2##(2008-10#2)
pisi##23##1##(1995-3#1)(2006-9#1)(2008-10#19)(2008-7#2)
pistachio and##5##2##(2008-10#5)
pistachio in##6##2##(2008-10#6)
pistachio isolates##4##2##(2008-10#4)
pistachio orchards##7##2##(2008-10#7)
pistachio##44##1##(2008-10#44)
piston and##2##2##(2007-10#1)(2008-3#1)
piston pump##2##2##(2008-10#2)
piston##12##1##(2007-10#1)(2007-11#2)(2008-10#3)(2008-2#3)(2008-3#2)(2012-1#1)
pisum##9##1##(1996-12#1)(2007-12#1)(2008-10#4)(2008-5#1)(2011-12#2)
pit and fissure##2##3##(2008-5#1)(2012-2#1)
pit and##4##2##(1995-2#1)(2007-7#1)(2008-5#1)(2012-2#1)
pit cell##3##2##(1995-2#1)(1995-6#2)
pit cells##2##2##(1995-6#2)
pit hardening stage##3##3##(2008-10#3)
pit on the##2##3##(2009-3#1)(2011-2#1)
pit viper##2##2##(1994-6#1)(2012-2#1)
pit##41##1##(1994-6#1)(1995-2#3)(1995-3#1)(1995-6#4)(1996-8#1)(2006-5#6)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#3)(2008-7#1)(2009-3#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
pit-and-fissure sealants##3##2##(2007-2#1)(2013-1#2)
pit-and-fissure##4##1##(2007-2#1)(2013-1#3)
pit-lining##2##1##(1997-1#2)
pitch accent##3##2##(2013-8#3)
pitch accents##4##2##(2009-2#2)(2013-8#2)
pitch and##8##2##(1995-8#1)(2008-2#3)(2008-3#1)(2008-9#1)(2011-1#2)
pitch blende##2##2##(2008-10#2)
pitch canker##3##2##(2008-10#3)
pitch change##2##2##(1995-11#1)(2010-6#1)
pitch changes##2##2##(1996-1#1)(2008-9#1)
pitch contour##2##2##(2008-2#1)(2013-8#1)
pitch estimation##3##2##(2008-2#3)
pitch for##4##2##(2008-4#1)(2009-2#1)(2012-11#2)
pitch height##2##2##(2013-8#2)
pitch in##3##2##(1990-5#1)(1997-2#2)
pitch is##2##2##(2007-12#1)(2008-2#1)
pitch of the##7##3##(1994-8#1)(1997-7#1)(2006-12#1)(2008-2#2)(2008-3#2)
pitch of##14##2##(1994-8#1)(1995-11#1)(1997-7#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-2#5)(2008-3#2)(2011-12#1)
pitch on##2##2##(2007-12#1)(2008-3#1)
pitch scaling##2##2##(2013-8#2)
pitch##106##1##(1990-5#1)(1992-9#2)(1993-9#1)(1994-8#1)(1995-11#6)(1995-8#4)(1996-1#2)(1997-2#4)(1997-7#3)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#4)(2008-10#5)(2008-2#21)(2008-3#14)(2008-4#2)(2008-9#4)(2009-2#4)(2009-9#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-11#4)(2012-2#1)(2013-8#11)
pitched##3##1##(2008-2#1)(2008-6#2)
pitcher##2##1##(2004-11#1)(2012-1#1)
pitches of##2##2##(1995-5#1)(2008-3#1)
pitches##7##1##(1991-1#1)(1993-9#1)(1995-5#1)(2008-3#3)(2010-9#1)
pitching of the head##2##4##(2013-8#2)
pitching##14##1##(2005-10#3)(2006-8#4)(2007-12#1)(2009-9#3)(2013-8#3)
pitfall in the##2##3##(2006-8#1)(2009-4#1)
pitfall in##6##2##(1990-7#1)(1991-12#1)(2006-8#1)(2009-4#1)(2011-2#1)(2012-12#1)
pitfall of the##2##3##(1993-5#1)(1994-9#1)
pitfall of##7##2##(1993-5#1)(1994-9#1)(2007-3#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-8#1)
pitfall traps##2##2##(2008-5#2)
pitfall##22##1##(1990-7#1)(1991-12#1)(1993-5#1)(1994-9#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-3#2)(2007-8#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)
pitfalls and the##2##3##(1994-3#1)(2006-5#1)
pitfalls and##13##2##(1994-3#1)(2006-5#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-7#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
pitfalls associated with##2##3##(1993-1#1)(2010-5#1)
pitfalls for the##2##3##(2006-10#1)(2008-1#1)
pitfalls for##3##2##(1992-12#1)(2006-10#1)(2008-1#1)
pitfalls in diagnosis##2##3##(2008-6#1)(2012-12#1)
pitfalls in the##5##3##(2007-10#1)(2007-8#1)(2008-4#1)(2010-11#1)(2011-2#1)
pitfalls in##20##2##(1991-5#1)(1992-1#1)(1993-1#1)(1993-12#1)(1995-2#1)(1996-7#1)(2007-10#1)(2007-8#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-3#2)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#2)
pitfalls of a##2##3##(2007-4#1)(2008-10#1)
pitfalls of##18##2##(1994-6#1)(2007-11#1)(2007-12#1)(2007-4#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-8#1)(2009-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
pitfalls related to##2##3##(2008-5#1)(2009-5#1)
pitfalls such as##3##3##(2008-6#1)(2010-7#1)(2011-2#1)
pitfalls that##3##2##(1992-1#1)(2004-9#1)(2009-8#1)
pitfalls to##3##2##(1992-3#1)(2007-4#1)(2013-7#1)
pitfalls when##2##2##(2008-10#1)(2013-7#1)
pitfalls##105##1##(1991-5#1)(1992-1#2)(1992-12#1)(1992-3#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-6#1)(1994-3#2)(1994-6#1)(1995-2#2)(1996-12#1)(1996-7#1)(1997-2#1)(2004-9#2)(2005-9#1)(2006-10#2)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#4)(2007-8#2)(2008-1#4)(2008-10#2)(2008-11#3)(2008-2#2)(2008-4#7)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-3#6)(2009-4#2)(2009-5#2)(2009-8#1)(2010-11#1)(2010-5#1)(2010-7#3)(2010-8#4)(2011-1#1)(2011-12#1)(2011-2#6)(2012-12#1)(2012-2#8)(2013-1#1)(2013-7#2)(2013-8#1)
pith##3##1##(2008-10#2)(2008-5#1)
pithed rats##2##2##(1991-2#1)(1993-11#1)
pithed##3##1##(1991-2#1)(1993-11#2)
piths##2##1##(1991-11#2)
pitocin##2##1##(2007-2#2)
pits and vesicles##3##3##(1991-9#1)(2007-12#1)(2008-1#1)
pits and##6##2##(1991-9#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-3#1)
pits in##2##2##(2006-12#1)(2007-2#1)
pits or##2##2##(2008-3#2)
pits was##2##2##(2008-10#1)(2013-1#1)
pits##32##1##(1991-9#1)(1994-10#1)(1995-1#1)(1995-3#3)(1995-6#2)(1997-1#1)(1997-3#4)(2006-12#1)(2006-5#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-7#1)(2009-3#1)(2013-1#2)
pitted against the##2##3##(2005-9#1)(2008-11#1)
pitted against##3##2##(2005-9#1)(2008-11#1)(2012-2#1)
pitted##4##1##(2005-9#1)(2008-10#1)(2008-11#1)(2012-2#1)
pitting##12##1##(1994-9#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-8#1)(2009-10#1)(2011-2#1)
pituitaries and##2##2##(1990-12#1)(1990-3#1)
pituitaries##14##1##(1990-12#2)(1990-3#1)(1995-11#1)(1995-12#1)(1995-9#5)(2006-1#3)(2008-4#1)
pituitary ACTH##2##2##(1992-12#1)(1995-12#1)
pituitary GH##2##2##(1990-4#1)(1996-11#1)
pituitary GH4C1 cells##3##3##(1991-10#2)(1991-2#1)
pituitary GnRH receptor##4##3##(1992-11#2)(1993-3#1)(1994-6#1)
pituitary LH##3##2##(1994-10#1)(1995-9#2)
pituitary PRL##2##2##(1994-3#1)(2011-2#1)
pituitary abnormalities##2##2##(1997-3#1)(2008-6#1)
pituitary adenoma##12##2##(1995-12#1)(1996-11#2)(2006-12#1)(2006-5#1)(2007-12#1)(2008-5#1)(2010-10#2)(2013-1#1)(2013-8#2)
pituitary adenoma]##4##2##(1990-6#1)(1991-6#1)(2013-8#2)
pituitary adenomas and##3##3##(2006-12#1)(2011-2#1)(2013-8#1)
pituitary adenomas##22##2##(1990-12#3)(1991-2#1)(1994-5#1)(1995-9#1)(1996-11#3)(2006-12#1)(2006-9#1)(2008-7#1)(2010-2#1)(2011-2#4)(2013-1#2)(2013-8#3)
pituitary adenomas]##2##2##(2005-9#1)(2013-8#1)
pituitary adenylate cyclase activating polypeptide (PACAP)##4##6##(1990-12#2)(1992-9#1)(1997-8#1)
pituitary adenylate cyclase activating polypeptide##6##5##(1990-11#1)(1990-12#2)(1990-7#1)(1992-9#1)(1997-8#1)
pituitary adenylate cyclase##7##3##(1990-11#1)(1990-12#2)(1990-7#2)(1992-9#1)(1997-8#1)
pituitary adenylate cyclase-activating peptide##3##4##(1995-11#1)(2006-10#2)
pituitary adenylate cyclase-activating polypeptide##3##4##(1994-10#1)(1994-3#1)(2006-10#1)
pituitary adenylate cyclase-activating##6##3##(1994-10#1)(1994-3#1)(1995-11#1)(2006-10#3)
pituitary adenylate##13##2##(1990-11#1)(1990-12#2)(1990-7#2)(1992-9#1)(1994-10#1)(1994-3#1)(1995-11#1)(1997-8#1)(2006-10#3)
pituitary adrenal axis##2##3##(1994-2#1)(2011-2#1)
pituitary and a##2##3##(1990-2#1)(1993-3#1)
pituitary and the##2##3##(1993-5#2)
pituitary and##16##2##(1990-2#1)(1990-3#1)(1992-12#1)(1993-3#2)(1993-5#3)(1995-8#1)(1996-8#1)(2006-5#1)(2008-4#1)(2008-5#2)(2011-2#1)(2013-1#1)
pituitary apoplexy##5##2##(1994-5#2)(2011-2#2)(2012-2#1)
pituitary as##2##2##(1991-8#1)(1993-5#1)
pituitary cell line##5##3##(1993-3#1)(1995-10#1)(1996-2#2)(2007-12#1)
pituitary cell lines##2##3##(1996-11#1)(1996-8#1)
pituitary cell##15##2##(1990-7#1)(1990-8#1)(1991-7#1)(1992-9#1)(1993-3#1)(1995-10#1)(1995-9#1)(1996-11#2)(1996-2#2)(1996-8#1)(2006-9#1)(2007-12#2)
pituitary cells and##2##3##(1990-10#1)(2008-4#1)
pituitary cells from##3##3##(1995-10#1)(1996-2#1)(2008-5#1)
pituitary cells in monolayer culture##2##5##(1990-2#1)(1994-3#1)
pituitary cells in##4##3##(1990-10#1)(1990-2#1)(1990-7#1)(1994-3#1)
pituitary cells was##2##3##(1992-6#1)(2008-5#1)
pituitary cells##46##2##(1990-10#3)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#2)(1990-7#2)(1990-9#1)(1991-2#1)(1991-6#1)(1992-6#3)(1992-8#1)(1993-8#1)(1994-11#1)(1994-3#4)(1994-9#2)(1995-10#1)(1995-9#2)(1996-11#1)(1996-2#5)(1996-5#1)(1997-2#1)(1997-5#1)(2008-4#4)(2008-5#2)
pituitary corticotrope tumor##2##3##(1992-12#2)
pituitary corticotrope##4##2##(1991-6#1)(1992-12#2)(1994-11#1)
pituitary extracts##2##2##(1990-12#1)(1992-7#1)
pituitary fragments##3##2##(1990-2#1)(1994-8#2)
pituitary function##5##2##(1993-5#1)(1994-5#1)(2006-9#3)
pituitary functions##2##2##(2007-1#2)
pituitary gland and##6##3##(1990-11#1)(1993-9#1)(1994-11#1)(1995-11#1)(1995-7#1)(2013-8#1)
pituitary gland of##3##3##(1997-2#1)(2006-9#1)(2008-5#1)
pituitary gland using##2##3##(1992-6#1)(1995-11#1)
pituitary gland was##2##3##(1990-10#1)(2007-1#1)
pituitary gland##56##2##(1990-10#3)(1990-11#1)(1990-8#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-3#2)(1992-6#2)(1992-7#2)(1993-3#1)(1993-9#3)(1994-11#1)(1995-10#1)(1995-11#3)(1995-12#2)(1995-7#2)(1996-11#2)(1996-2#1)(1997-1#1)(1997-2#2)(1997-8#1)(2006-12#1)(2006-6#1)(2006-9#4)(2007-1#1)(2008-1#1)(2008-4#1)(2008-5#2)(2009-2#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#2)(2013-8#1)
pituitary glands was##2##3##(1992-7#1)(1997-2#1)
pituitary glands##10##2##(1990-7#1)(1992-7#1)(1997-2#1)(2008-11#1)(2008-5#5)(2011-2#1)
pituitary gonadal hormonal responses##2##4##(2007-7#2)
pituitary gonadal hormonal##3##3##(2007-7#3)
pituitary gonadal##4##2##(2007-7#4)
pituitary gonadotropes##6##2##(1993-11#1)(1995-10#1)(1995-11#1)(1996-8#1)(1997-2#2)
pituitary gonadotrophs##2##2##(1995-10#1)(2006-11#1)
pituitary gonadotropin-releasing hormone##2##3##(1992-12#1)(1994-6#1)
pituitary hormone and##4##3##(1997-4#1)(2007-12#3)
pituitary hormone deficiencies##2##3##(2013-1#2)
pituitary hormone deficiency##2##3##(2006-1#1)(2011-1#1)
pituitary hormone secretion in##2##4##(1992-8#1)(1995-12#1)
pituitary hormone##16##2##(1991-5#1)(1992-8#1)(1993-11#1)(1995-12#1)(1997-4#1)(2006-1#1)(2006-11#1)(2007-12#6)(2011-1#1)(2013-1#2)
pituitary hormones##3##2##(1995-12#2)(2008-5#1)
pituitary insufficiency##3##2##(2006-10#2)(2008-4#1)
pituitary is##3##2##(1992-12#1)(2008-5#1)(2008-7#1)
pituitary isografted##2##2##(1994-3#2)
pituitary level##2##2##(1994-6#1)(1996-2#1)
pituitary macroadenoma##9##2##(1991-6#1)(1994-5#1)(2008-8#3)(2010-10#2)(2011-2#2)
pituitary melanotrophs##4##2##(1993-5#4)
pituitary metastasis##2##2##(1996-3#2)
pituitary of the##3##3##(1993-5#3)
pituitary progenitor##2##2##(1996-11#1)(1996-8#1)
pituitary radiotherapy##2##2##(2006-9#2)
pituitary stalk##4##2##(1997-3#1)(2013-8#3)
pituitary surgery##6##2##(1997-1#2)(2006-5#1)(2006-9#1)(2009-5#1)(2012-1#1)
pituitary tissue##2##2##(2013-1#1)(2013-8#1)
pituitary tissues##2##2##(1990-2#1)(2011-2#1)
pituitary tumor cell growth in serum-free chemically defined##2##8##(1991-7#2)
pituitary tumor cell growth##3##4##(1991-7#2)(2010-2#1)
pituitary tumor cell line##5##4##(1990-12#1)(1993-3#1)(1994-12#1)(1995-10#1)(1997-7#1)
pituitary tumor cell##8##3##(1990-12#1)(1991-7#2)(1993-3#1)(1994-12#1)(1995-10#1)(1997-7#1)(2010-2#1)
pituitary tumor cells to##2##4##(1991-7#1)(1994-12#1)
pituitary tumor cells##3##3##(1991-7#1)(1994-12#1)(1995-10#1)
pituitary tumor##14##2##(1990-12#1)(1991-7#3)(1993-2#1)(1993-3#1)(1994-12#2)(1995-10#2)(1997-7#1)(2005-10#1)(2010-2#2)
pituitary tumoral cells##2##3##(1992-2#2)
pituitary tumoral##3##2##(1992-2#3)
pituitary tumors##9##2##(1992-2#1)(2006-1#1)(2006-12#1)(2006-9#1)(2009-2#2)(2010-2#1)(2011-2#1)(2013-1#1)
pituitary tumours##2##2##(2006-9#1)(2011-2#1)
pituitary was##2##2##(1995-12#1)(2010-5#1)
pituitary##526##1##(1990-10#6)(1990-11#6)(1990-12#14)(1990-2#5)(1990-3#3)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#7)(1990-8#3)(1990-9#5)(1991-1#3)(1991-10#2)(1991-12#5)(1991-2#3)(1991-5#3)(1991-6#4)(1991-7#4)(1991-8#3)(1991-9#3)(1992-1#1)(1992-10#2)(1992-11#4)(1992-12#11)(1992-2#6)(1992-3#4)(1992-6#6)(1992-7#4)(1992-8#2)(1992-9#2)(1993-11#4)(1993-2#1)(1993-3#6)(1993-5#21)(1993-8#2)(1993-9#5)(1994-10#4)(1994-11#4)(1994-12#3)(1994-2#1)(1994-3#11)(1994-5#6)(1994-6#10)(1994-8#5)(1994-9#4)(1995-1#1)(1995-10#10)(1995-11#11)(1995-12#13)(1995-3#3)(1995-5#3)(1995-7#2)(1995-8#4)(1995-9#9)(1996-11#16)(1996-2#9)(1996-3#3)(1996-5#3)(1996-7#1)(1996-8#5)(1997-1#6)(1997-2#8)(1997-3#2)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#5)(2005-10#3)(2005-8#2)(2005-9#1)(2006-1#4)(2006-10#6)(2006-11#4)(2006-12#4)(2006-5#3)(2006-6#1)(2006-8#1)(2006-9#15)(2007-1#3)(2007-10#1)(2007-11#3)(2007-12#9)(2007-7#4)(2008-1#1)(2008-11#1)(2008-3#2)(2008-4#14)(2008-5#19)(2008-6#2)(2008-7#4)(2008-8#4)(2009-1#1)(2009-2#3)(2009-4#1)(2009-5#1)(2010-10#5)(2010-2#10)(2010-5#2)(2011-1#3)(2011-2#18)(2012-1#5)(2012-2#4)(2012-3#3)(2013-1#13)(2013-8#13)
pituitary-adrenal axis##4##2##(1995-12#2)(2006-8#2)
pituitary-adrenal##7##1##(1995-12#2)(1996-4#2)(2006-8#2)(2008-11#1)
pituitary-adrenocortical##3##1##(1995-12#2)(1995-5#1)
pituitary-derived GH##2##2##(1994-9#1)(1996-11#1)
pituitary-derived##3##1##(1994-9#1)(1996-11#1)(1997-5#1)
pituitary-gonadal axis##3##2##(2006-10#1)(2006-9#1)(2008-3#1)
pituitary-isografted mice##2##2##(1994-3#2)
pituitary-reproductive tract##2##2##(2008-3#2)
pituitary-specific##4##1##(1993-8#1)(1996-11#1)(1996-8#1)(2008-3#1)
pityocampa larvae##3##2##(2008-12#3)
pityocampa##5##1##(2008-12#5)
pityriasis alba was observed in##2##5##(2007-7#2)
pityriasis alba##5##2##(2007-7#5)
pityriasis lichenoides et varioliformis acuta##3##5##(2005-11#1)(2007-7#1)(2011-2#1)
pityriasis versicolor and dermatitis seborrhoeica##2##5##(2008-5#2)
pityriasis versicolor##14##2##(2007-7#7)(2008-5#6)(2011-2#1)
pityriasis##23##1##(2005-11#1)(2007-7#13)(2008-5#6)(2011-12#1)(2011-2#2)
pivot point##6##2##(2006-6#1)(2008-2#3)(2008-3#2)
pivot shift in##2##3##(2009-9#2)
pivot shift##7##2##(2009-6#1)(2009-7#1)(2009-9#5)
pivot##23##1##(1992-3#1)(1995-2#1)(2006-6#1)(2008-11#1)(2008-2#4)(2008-3#5)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#5)(2010-12#1)(2013-1#1)
pivotal clinical##4##2##(2005-7#1)(2005-9#1)(2008-8#1)(2010-12#1)
pivotal for##3##2##(2007-8#1)(2012-2#1)(2012-3#1)
pivotal in the##5##3##(2006-10#2)(2008-4#1)(2010-12#1)(2012-12#1)
pivotal in understanding##2##3##(2009-8#1)(2012-1#1)
pivotal in##16##2##(2006-10#4)(2007-10#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-2#1)(2009-8#1)(2010-10#2)(2010-12#1)(2012-1#1)(2012-12#1)
pivotal link##2##2##(1994-3#1)(2009-10#1)
pivotal phase III trial for##2##5##(2005-8#1)(2008-5#1)
pivotal phase III##5##3##(2005-7#1)(2005-8#3)(2008-5#1)
pivotal phase##6##2##(2005-7#1)(2005-8#3)(2008-5#2)
pivotal point##3##2##(1994-1#1)(2006-10#1)(2009-4#1)
pivotal position##4##2##(2006-10#1)(2007-7#1)(2010-10#1)(2010-3#1)
pivotal role for##4##3##(1992-1#1)(1995-2#1)(2005-11#1)(2013-7#1)
pivotal role in##59##3##(1991-12#1)(1991-2#1)(1991-9#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-10#1)(1996-5#1)(1997-7#1)(1997-8#2)(2005-7#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
pivotal role of the##2##4##(2008-10#1)(2008-7#1)
pivotal role of##10##3##(1991-1#1)(2004-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-3#1)(2013-1#1)
pivotal role##84##2##(1991-1#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-9#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1996-10#1)(1996-5#1)(1997-7#1)(1997-8#2)(2004-12#1)(2005-11#1)(2005-7#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-4#1)(2008-1#3)(2008-10#4)(2008-11#4)(2008-3#2)(2008-4#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#2)
pivotal roles in##4##3##(2007-12#1)(2010-2#1)(2010-3#1)(2011-2#1)
pivotal roles of##3##3##(2008-3#1)(2009-10#1)(2009-6#1)
pivotal roles##8##2##(2007-12#1)(2008-3#1)(2009-10#1)(2009-6#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-12#1)
pivotal studies##3##2##(1996-1#1)(2005-7#1)(2013-1#1)
pivotal study##2##2##(2008-3#1)(2012-12#1)
pivotal to##6##2##(1995-11#1)(1995-2#1)(2008-1#1)(2008-8#1)(2009-10#1)(2010-5#1)
pivotal trial for the##2##4##(2008-5#2)
pivotal trial##3##2##(2008-5#2)(2010-4#1)
pivotal trials##3##2##(2007-11#3)
pivotal##196##1##(1990-3#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-10#2)(1996-3#1)(1996-5#2)(1996-8#1)(1997-3#1)(1997-7#2)(1997-8#3)(2004-12#1)(2005-10#1)(2005-11#1)(2005-7#5)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-5#1)(2007-10#2)(2007-11#7)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#9)(2008-10#5)(2008-11#5)(2008-12#3)(2008-3#6)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#4)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#4)(2009-6#4)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#5)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#3)(2010-4#2)(2010-5#2)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#3)(2013-1#3)(2013-7#4)
pivoted##2##1##(1995-6#1)(2008-8#1)
pivots##3##1##(2010-8#2)(2012-2#1)
pixel and##2##2##(2008-1#1)(2008-2#1)
pixel area##2##2##(2008-3#1)(2008-7#1)
pixel array##5##2##(2007-12#1)(2008-2#1)(2008-3#2)(2010-12#1)
pixel being##2##2##(2008-2#2)
pixel by pixel##3##3##(2008-2#1)(2008-3#1)(2011-1#1)
pixel can##2##2##(2007-12#1)(2010-2#1)
pixel classification schemes##2##3##(2008-2#2)
pixel classification##3##2##(2008-2#3)
pixel clusters##2##2##(2008-2#2)
pixel columns##2##2##(2008-3#2)
pixel detector##2##2##(2006-4#2)
pixel for a##2##3##(2008-2#1)(2011-1#1)
pixel geometries##2##2##(2008-2#2)
pixel image##2##2##(2008-2#2)
pixel in the##6##3##(2007-12#1)(2008-2#2)(2008-3#2)(2011-1#1)
pixel intensities##4##2##(2006-5#2)(2010-2#1)(2011-2#1)
pixel intensity##2##2##(2006-5#1)(2008-2#1)
pixel is##4##2##(2008-10#1)(2008-3#3)
pixel misregistration in##2##3##(2007-11#1)(2007-12#1)
pixel misregistration##3##2##(2007-11#2)(2007-12#1)
pixel of the##2##3##(2008-10#1)(2008-3#1)
pixel patterns##2##2##(2008-2#1)(2008-3#1)
pixel pitch and##2##3##(2011-1#2)
pixel pitch of##2##3##(2007-11#1)(2008-3#1)
pixel pitch##5##2##(2007-11#2)(2008-3#1)(2011-1#2)
pixel resolution##4##2##(2004-9#1)(2008-3#1)(2012-12#2)
pixel sensor##2##2##(2008-10#1)(2008-3#1)
pixel size of##4##3##(2007-11#1)(2007-12#2)(2011-1#1)
pixel size##8##2##(2007-11#2)(2007-12#4)(2011-1#1)(2012-1#1)
pixel sizes##2##2##(2007-12#1)(2008-2#1)
pixel to##2##2##(2007-11#1)(2008-2#1)
pixel values##5##2##(2006-5#1)(2008-2#1)(2008-6#1)(2010-9#2)
pixel was##2##2##(2008-1#1)(2012-2#1)
pixel##176##1##(1991-2#1)(2004-9#2)(2006-4#3)(2006-5#4)(2007-11#8)(2007-12#19)(2008-1#5)(2008-10#4)(2008-11#1)(2008-2#48)(2008-3#47)(2008-6#2)(2008-7#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-5#1)(2010-9#6)(2011-1#12)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#1)
pixel's##2##1##(2008-2#1)(2008-3#1)
pixel)##2##1##(2004-9#1)(2008-3#1)
pixel-matched holographic##2##2##(2007-12#2)
pixel-matched volume holographic data storage##2##5##(2008-3#2)
pixel-matched##6##1##(2007-11#2)(2007-12#2)(2008-3#2)
pixel-pitch reflective liquid-crystal display by use of a light-emitting diode reference light##2##12##(2007-11#2)
pixelated lens##4##2##(2008-3#4)
pixelated##17##1##(2007-11#2)(2007-12#1)(2008-2#7)(2008-3#7)
pixels and##8##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#4)
pixels as##2##2##(2008-3#2)
pixels by##2##2##(2007-11#1)(2007-12#1)
pixels for##2##2##(2008-3#2)
pixels from##2##2##(2007-11#1)(2008-2#1)
pixels in a##2##3##(2008-2#1)(2008-3#1)
pixels in the##5##3##(2008-2#1)(2008-3#3)(2008-5#1)
pixels in##8##2##(2008-2#2)(2008-3#4)(2008-5#1)(2012-2#1)
pixels of the##2##3##(2008-10#1)(2013-8#1)
pixels of##6##2##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2013-8#1)
pixels that##6##2##(2007-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)
pixels to be##2##3##(2008-3#1)(2013-8#1)
pixels to##3##2##(2008-2#1)(2008-3#1)(2013-8#1)
pixels with##8##2##(2007-11#1)(2007-12#2)(2008-3#2)(2011-1#2)(2013-7#1)
pixels x##3##2##(2008-2#2)(2008-3#1)
pixels##111##1##(2007-10#1)(2007-11#11)(2007-12#8)(2008-1#2)(2008-10#3)(2008-2#34)(2008-3#38)(2008-5#2)(2008-8#1)(2010-11#1)(2010-4#1)(2011-1#3)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#3)
pixels) in##2##2##(2008-2#2)
pixels)##5##1##(1992-10#1)(2008-10#2)(2008-2#2)
pixon scheme##3##2##(2008-2#3)
pixon-based##2##1##(2008-2#2)
pk(a(1))=2##2##1##(2008-10#2)
pk(a(1))=7##3##1##(2008-10#3)
pk(a(2))=6##2##1##(2008-10#2)
pka1 gene##2##2##(1994-12#2)
pka1##3##1##(1994-12#3)
pkc1##2##1##(1996-6#1)(1997-3#1)
pkn1 is##2##2##(1991-11#2)
pkn1##3##1##(1991-11#3)
pl##5##1##(1991-12#1)(1993-3#1)(2008-7#1)(2008-8#2)
place a high##2##3##(2008-10#1)(2013-1#1)
place a substantial##2##3##(2007-10#2)
place a##13##2##(1990-12#1)(1995-12#2)(2005-8#1)(2006-10#2)(2006-5#1)(2007-10#2)(2007-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
place across##2##2##(1997-8#1)(2008-2#1)
place after##10##2##(1990-8#1)(1993-10#1)(1993-3#1)(1993-5#1)(1993-8#1)(1995-5#1)(2006-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
place all##4##2##(2007-7#1)(2008-1#1)(2008-9#1)(2011-2#1)
place among##3##2##(2008-10#1)(2010-2#1)(2013-1#1)
place an##4##2##(2007-11#2)(2007-5#1)(2008-8#1)
place and head direction##2##4##(2013-8#2)
place and route##2##3##(1996-11#1)(2008-2#1)
place and##20##2##(1990-8#1)(1992-9#1)(1996-11#1)(2004-2#1)(2004-3#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-8#1)(2012-12#1)(2012-2#1)(2013-8#3)
place as a##2##3##(1992-1#1)(2008-10#1)
place as the##3##3##(1993-5#1)(2006-12#1)(2008-2#1)
place as##11##2##(1991-9#1)(1992-1#1)(1993-5#1)(2006-10#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-9#1)(2010-11#1)
place at a##4##3##(1995-1#1)(2006-8#1)(2008-1#1)(2008-10#1)
place at the##16##3##(1991-2#1)(1994-2#1)(1996-1#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-7#1)
place at##37##2##(1990-11#1)(1991-10#1)(1991-2#1)(1992-2#1)(1992-3#1)(1993-12#1)(1994-2#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-8#1)(2010-1#1)(2010-7#1)(2012-12#1)
place aversion in##3##3##(1996-10#1)(1996-12#2)
place aversion##4##2##(1996-10#2)(1996-12#2)
place before##4##2##(1997-2#1)(1997-5#1)(2011-1#1)(2011-2#1)
place between the##2##3##(1997-2#1)(1997-3#1)
place between##10##2##(1997-2#1)(1997-3#1)(1997-4#1)(2006-8#1)(2007-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-3#1)
place but##2##2##(1995-12#1)(2007-11#1)
place by##5##2##(1991-1#1)(1991-5#1)(2008-10#1)(2008-7#1)(2012-2#1)
place cell firing##2##3##(2008-11#2)
place cell##6##2##(1995-12#1)(1996-12#1)(2007-8#1)(2008-11#3)
place cells##5##2##(1996-12#1)(2007-8#3)(2008-11#1)
place during the enzymatic reaction##2##5##(2008-10#2)
place during the##12##3##(1990-2#1)(1991-12#1)(1991-2#1)(1994-3#1)(1997-8#1)(2006-10#2)(2006-6#1)(2008-10#2)(2008-3#1)(2009-9#1)
place during##26##2##(1990-2#1)(1991-12#1)(1991-2#1)(1992-3#1)(1994-3#1)(1995-12#1)(1995-4#1)(1996-4#1)(1997-8#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-12#1)(2007-5#1)(2008-10#4)(2008-12#1)(2008-3#1)(2009-9#1)(2012-12#2)(2012-2#1)
place for a##2##3##(2007-7#1)(2008-6#1)
place for the##2##3##(2008-11#1)(2012-1#1)
place for##44##2##(1991-12#1)(1992-1#2)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#1)(1995-1#1)(1996-2#1)(1996-7#1)(2005-5#1)(2006-12#1)(2006-6#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#2)
place from the##6##3##(1993-10#1)(1994-3#1)(2006-8#1)(2008-1#1)(2008-10#1)(2013-1#1)
place from##18##2##(1991-9#1)(1993-10#1)(1994-3#1)(1996-10#1)(2005-8#1)(2006-12#1)(2006-8#1)(2008-1#1)(2008-10#2)(2009-2#1)(2009-4#1)(2009-6#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
place greater emphasis on##4##4##(1994-2#2)(2008-12#1)(2012-3#1)
place in a##20##3##(1991-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1995-3#1)(1996-11#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-2#1)(2009-10#1)(2010-11#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
place in all##3##3##(2011-12#1)(2011-2#1)(2012-8#1)
place in an##2##3##(2008-11#1)(2010-7#1)
place in basic##2##3##(2008-10#1)(2011-1#1)
place in clinical##2##3##(2008-11#1)(2010-9#1)
place in many##2##3##(2007-11#1)(2009-5#1)
place in response to##2##4##(1993-11#1)(2013-8#1)
place in society##3##3##(2007-8#1)(2010-7#1)(2012-12#1)
place in the algorithm of##2##5##(2008-1#1)(2008-6#1)
place in the field of##2##5##(2006-10#1)(2008-10#1)
place in the history##2##4##(2008-7#1)(2008-8#1)
place in the management of##2##5##(2007-11#1)(2008-3#1)
place in the##88##3##(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-3#1)(1993-3#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-3#1)(1996-9#1)(1997-4#1)(1997-8#1)(2003-11#1)(2004-12#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-7#3)(2007-11#7)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#2)
place in this area##2##4##(2008-2#2)
place in this##3##3##(2007-5#1)(2008-2#2)
place in##198##2##(1990-10#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#2)(1991-6#1)(1992-1#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#2)(1994-10#1)(1994-12#1)(1994-3#2)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2003-11#1)(2004-12#1)(2005-11#3)(2005-7#1)(2005-8#2)(2006-10#6)(2006-7#3)(2007-11#10)(2007-12#5)(2007-2#2)(2007-3#2)(2007-5#2)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#13)(2008-11#10)(2008-12#1)(2008-2#7)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#3)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#5)(2012-1#1)(2012-12#8)(2012-2#7)(2012-3#1)(2012-8#1)(2013-1#3)(2013-7#1)(2013-8#3)
place is##3##2##(1996-3#1)(2008-9#1)(2009-10#1)
place it##4##2##(1996-11#1)(2006-10#1)(2009-7#1)(2012-1#1)
place learning deficits##2##3##(1993-3#2)
place learning##10##2##(1992-9#5)(1993-12#2)(1993-3#3)
place like##2##2##(1997-1#1)(2008-1#1)
place mainly in##2##3##(1996-2#1)(2008-7#1)
place mainly##3##2##(1994-6#1)(1996-2#1)(2008-7#1)
place of a##4##3##(1990-10#1)(1994-8#1)(2007-8#1)(2008-10#1)
place of an##2##3##(1997-1#1)(2008-7#1)
place of birth##8##3##(1990-6#1)(2005-10#1)(2007-2#1)(2008-9#1)(2013-1#4)
place of care##3##3##(2007-10#1)(2008-11#1)(2010-3#1)
place of death##4##3##(1991-12#1)(1991-3#1)(2011-2#2)
place of diagnosis##3##3##(2012-12#3)
place of living##2##3##(2007-11#1)(2008-10#1)
place of mortality causes##2##4##(2005-10#2)
place of origin##8##3##(2007-3#1)(2008-10#1)(2010-12#1)(2012-12#1)(2012-3#4)
place of residence##7##3##(1994-6#1)(2006-10#1)(2007-7#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
place of the##31##3##(1990-4#1)(1990-5#2)(1990-6#1)(1991-10#1)(1992-1#1)(1994-3#1)(1995-2#2)(1996-7#1)(1997-1#1)(2005-1#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2009-12#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
place of treatment##2##3##(2007-5#1)(2009-6#1)
place of##168##2##(1990-10#1)(1990-11#2)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#4)(1991-10#4)(1991-12#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-5#2)(1992-6#2)(1992-7#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#3)(1995-3#1)(1995-6#1)(1996-7#1)(1997-1#2)(2004-8#1)(2005-1#1)(2005-10#5)(2005-11#1)(2005-4#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-10#3)(2007-11#7)(2007-12#1)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#2)(2007-8#5)(2008-1#3)(2008-10#10)(2008-11#6)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#5)(2009-12#1)(2009-6#1)(2009-7#1)(2010-10#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#5)(2012-11#2)(2012-12#4)(2012-2#2)(2012-3#9)(2013-1#5)(2013-8#1)
place on the##8##3##(1992-4#1)(2005-11#1)(2007-11#1)(2008-10#2)(2008-8#1)(2010-8#1)(2013-1#1)
place on##13##2##(1992-4#1)(1995-2#1)(2005-11#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-8#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#1)
place only##2##2##(1996-2#1)(2008-1#1)
place or##2##2##(2008-12#1)(2008-9#1)
place over##2##2##(1994-12#1)(2008-9#1)
place predominantly##2##2##(2005-8#1)(2008-3#1)
place preference in both diabetic and non-diabetic mice##2##8##(1996-12#2)
place preference in both##3##4##(1996-12#2)(2008-4#1)
place preference in##8##3##(1995-10#1)(1995-11#1)(1996-12#5)(2008-4#1)
place preference is##3##3##(1992-9#1)(1993-6#1)(2008-4#1)
place preference may be##2##4##(1995-10#1)(1996-12#1)
place preference paradigm##3##3##(1990-2#2)(1996-10#1)
place preference to cocaine##3##4##(1995-10#3)
place preference##43##2##(1990-2#7)(1992-9#4)(1993-6#2)(1994-2#1)(1995-10#10)(1995-11#2)(1996-10#2)(1996-12#9)(2008-4#2)(2010-3#2)(2012-2#2)
place preferences##3##2##(1992-9#3)
place such##2##2##(2008-7#1)(2009-7#1)
place the patient##2##3##(1992-8#1)(2006-12#1)
place the##21##2##(1990-9#1)(1992-11#1)(1992-8#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-9#1)(2006-12#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-7#2)(2008-8#2)(2012-3#1)(2013-7#1)
place them at risk##2##4##(2007-4#1)(2012-12#1)
place them##6##2##(1993-9#1)(1995-1#1)(2007-4#1)(2008-12#1)(2010-7#1)(2012-12#1)
place these##5##2##(2007-5#1)(2008-10#2)(2008-3#1)(2008-5#1)
place this##4##2##(2005-11#1)(2008-11#1)(2008-7#1)(2009-3#1)
place through the##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
place through##7##2##(1990-11#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-5#2)(2009-6#1)
place to seek##2##3##(2007-6#1)(2008-2#1)
place to the##2##3##(1993-7#1)(2008-2#1)
place to##32##2##(1991-3#1)(1993-7#1)(1993-8#2)(1994-3#1)(1995-8#2)(2006-10#1)(2007-4#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#2)(2008-5#1)(2009-5#1)(2009-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
place under##6##2##(1994-6#1)(2008-10#3)(2011-2#2)
place upon##2##2##(1990-12#1)(2005-8#1)
place was##2##2##(2008-8#1)(2008-9#1)
place were##2##2##(1995-12#1)(2011-1#1)
place when##6##2##(1994-12#1)(1997-1#1)(2008-10#2)(2008-2#1)(2008-7#1)
place where##10##2##(1993-11#1)(1994-3#1)(2006-9#1)(2007-4#1)(2008-10#1)(2010-12#1)(2012-12#1)(2013-1#3)
place with##10##2##(1990-12#1)(1990-5#1)(1992-6#1)(1993-4#1)(1996-7#1)(1997-1#1)(2008-3#1)(2010-12#1)(2011-1#1)(2012-2#1)
place within a##3##3##(1990-3#1)(2013-1#2)
place within the##7##3##(1991-2#1)(1997-1#1)(2006-8#1)(2008-11#1)(2008-5#1)(2010-10#1)(2012-12#1)
place within##17##2##(1990-10#2)(1990-3#1)(1991-11#1)(1991-2#1)(1992-1#1)(1997-1#1)(2005-11#1)(2006-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-10#1)(2012-12#1)(2012-2#1)(2013-1#2)
place without##2##2##(1992-8#1)(2009-12#1)
place##1139##1##(1990-10#5)(1990-11#5)(1990-12#4)(1990-2#10)(1990-3#3)(1990-4#1)(1990-5#5)(1990-6#5)(1990-7#1)(1990-8#4)(1990-9#1)(1991-1#2)(1991-10#7)(1991-11#5)(1991-12#11)(1991-2#5)(1991-3#6)(1991-5#1)(1991-6#2)(1991-9#4)(1992-1#7)(1992-11#4)(1992-12#1)(1992-2#3)(1992-3#4)(1992-4#1)(1992-5#3)(1992-6#6)(1992-7#1)(1992-8#5)(1992-9#19)(1993-1#1)(1993-10#3)(1993-11#2)(1993-12#9)(1993-2#5)(1993-3#8)(1993-4#1)(1993-5#5)(1993-6#8)(1993-7#1)(1993-8#5)(1993-9#4)(1994-1#1)(1994-10#1)(1994-12#6)(1994-2#6)(1994-3#8)(1994-6#4)(1994-8#3)(1994-9#5)(1995-1#6)(1995-10#10)(1995-11#3)(1995-12#9)(1995-2#8)(1995-3#5)(1995-4#1)(1995-5#2)(1995-6#4)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#4)(1996-10#6)(1996-11#4)(1996-12#14)(1996-2#8)(1996-3#4)(1996-4#5)(1996-7#3)(1996-8#1)(1996-9#2)(1997-1#7)(1997-2#4)(1997-3#4)(1997-4#2)(1997-5#2)(1997-6#1)(1997-8#3)(2003-11#1)(2004-12#1)(2004-2#1)(2004-3#1)(2004-4#1)(2004-8#2)(2004-9#1)(2005-1#1)(2005-10#5)(2005-11#12)(2005-4#1)(2005-5#1)(2005-7#1)(2005-8#6)(2005-9#2)(2006-10#20)(2006-12#9)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#6)(2006-7#6)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#6)(2007-11#28)(2007-12#17)(2007-2#8)(2007-3#7)(2007-4#4)(2007-5#9)(2007-6#4)(2007-7#12)(2007-8#22)(2007-9#5)(2008-1#23)(2008-10#72)(2008-11#43)(2008-12#15)(2008-2#27)(2008-3#16)(2008-4#13)(2008-5#23)(2008-6#14)(2008-7#21)(2008-8#14)(2008-9#25)(2009-10#6)(2009-11#4)(2009-12#5)(2009-2#3)(2009-3#4)(2009-4#7)(2009-5#3)(2009-6#6)(2009-7#5)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#5)(2010-11#3)(2010-12#9)(2010-2#4)(2010-3#5)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#7)(2010-8#5)(2010-9#2)(2011-1#10)(2011-12#6)(2011-2#29)(2011-3#1)(2012-1#5)(2012-11#2)(2012-12#30)(2012-2#28)(2012-3#19)(2012-8#1)(2013-1#28)(2013-7#3)(2013-8#12)
place]##2##1##(1991-2#1)(1993-8#1)
placebo (4##4##2##(2008-4#3)(2008-5#1)
placebo (P = 0##3##4##(1992-12#2)(2008-7#1)
placebo (P##5##2##(1992-12#2)(1992-5#1)(1993-1#1)(2008-7#1)
placebo (P)##4##2##(1993-12#1)(2008-5#2)(2010-8#1)
placebo (PL)##2##2##(1994-6#1)(2008-7#1)
placebo (n =##7##3##(1993-11#1)(1997-1#1)(2006-10#2)(2007-11#1)(2008-6#1)(2013-1#1)
placebo (p &lt##4##3##(1993-11#1)(2006-10#1)(2007-7#1)(2008-5#1)
placebo (p##5##2##(1992-4#1)(1993-11#1)(2006-10#1)(2007-7#1)(2008-5#1)
placebo +##2##2##(2007-8#2)
placebo administered once a day##2##5##(2008-7#2)
placebo and##11##2##(1990-12#1)(1991-7#1)(2005-7#1)(2007-11#3)(2008-6#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-12#1)
placebo and/or##2##2##(2007-10#1)(2011-2#1)
placebo as##2##2##(1994-7#1)(2007-10#1)
placebo at##6##2##(1990-12#1)(2005-8#1)(2008-10#1)(2008-5#1)(2012-2#2)
placebo control group##2##3##(2007-11#1)(2010-11#1)
placebo control##4##2##(1995-1#1)(2007-11#1)(2008-5#1)(2010-11#1)
placebo controlled studies##2##3##(2008-11#1)(2008-5#1)
placebo controlled study with##2##4##(1990-3#1)(2008-5#1)
placebo controlled study##7##3##(1990-11#1)(1990-3#1)(2007-7#2)(2007-9#1)(2008-5#1)(2010-4#1)
placebo controlled trial##2##3##(1996-3#1)(2008-11#1)
placebo controlled trials##2##3##(1995-9#1)(2006-9#1)
placebo controlled##21##2##(1990-11#1)(1990-3#1)(1991-8#1)(1993-3#1)(1994-11#1)(1995-4#1)(1995-9#1)(1996-3#1)(1997-8#1)(2006-9#1)(2007-7#2)(2007-9#1)(2008-11#2)(2008-5#4)(2010-4#1)(2012-3#1)
placebo controls##2##2##(2007-9#1)(2013-1#1)
placebo cream##2##2##(2008-5#2)
placebo did not modify the insulin sensitivity##2##7##(2008-3#2)
placebo did not##3##3##(2008-3#2)(2009-3#1)
placebo during the##2##3##(2012-2#1)(2013-8#1)
placebo effect in##2##3##(2006-10#1)(2008-12#1)
placebo effect was##3##3##(2006-10#1)(2008-10#1)(2012-3#1)
placebo effect##11##2##(1990-3#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-12#3)(2008-3#1)(2012-3#2)
placebo effects##3##2##(1990-3#1)(2008-10#2)
placebo for the##4##3##(2005-8#1)(2006-2#1)(2008-3#2)
placebo for##21##2##(1990-5#1)(1992-10#2)(1992-8#1)(2004-12#1)(2005-8#1)(2006-2#1)(2008-10#2)(2008-3#3)(2008-5#5)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
placebo group (P = 0##3##5##(1992-1#1)(2007-8#1)(2010-4#1)
placebo group and##6##3##(1990-8#1)(1991-7#2)(2008-7#1)(2010-4#1)(2012-2#1)
placebo group was##4##3##(2006-10#1)(2008-5#1)(2011-1#2)
placebo group were##5##3##(1990-6#1)(1990-8#1)(2006-10#1)(2011-1#1)(2013-1#1)
placebo group with##2##3##(2007-8#1)(2012-2#1)
placebo group##78##2##(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#4)(1991-11#1)(1991-6#1)(1991-7#2)(1992-1#2)(1992-10#2)(1992-5#1)(1993-11#1)(1995-12#1)(1996-2#1)(1997-5#1)(1997-6#1)(1997-7#2)(2004-1#1)(2004-3#1)(2005-7#1)(2006-10#2)(2007-10#1)(2007-5#2)(2007-8#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#12)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-7#2)(2009-8#1)(2010-4#2)(2010-5#1)(2011-1#4)(2012-12#1)(2012-2#5)(2013-1#3)(2013-7#1)
placebo groups##10##2##(1990-3#1)(1990-6#1)(1995-12#1)(2006-10#1)(2008-5#2)(2008-8#1)(2009-11#1)(2012-2#1)(2013-7#1)
placebo in a##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
placebo in patients with##2##4##(2007-11#1)(2012-12#1)
placebo in short##2##3##(2011-2#1)(2013-1#1)
placebo in the treatment of##2##5##(2006-10#1)(2007-7#1)
placebo in the##8##3##(1990-7#1)(1992-12#1)(2004-3#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-3#1)(2010-1#1)
placebo in##33##2##(1990-7#1)(1990-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(2004-3#1)(2006-10#2)(2007-11#3)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#3)(2010-1#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
placebo is##2##2##(2012-2#1)(2013-8#1)
placebo on##7##2##(1991-2#1)(1997-5#2)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#1)
placebo or no treatment##2##4##(2005-10#1)(2007-11#1)
placebo or##26##2##(1991-7#2)(1992-4#1)(1992-8#1)(1996-2#1)(1996-8#1)(1996-9#1)(2005-10#1)(2007-11#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#3)(2010-1#1)(2010-7#1)(2012-2#1)(2013-1#3)(2013-8#1)
placebo recipients##6##2##(1993-12#1)(2007-11#5)
placebo to##2##2##(2006-10#1)(2008-10#1)
placebo treated##2##2##(2008-5#1)(2009-7#1)
placebo treatment##7##2##(1990-3#2)(1991-11#1)(2013-1#4)
placebo was##10##2##(1990-11#1)(1992-12#1)(1992-5#1)(1993-12#1)(2004-3#2)(2007-11#1)(2007-9#1)(2008-7#1)(2011-1#1)
placebo were##3##2##(1990-5#1)(2008-10#1)(2011-2#1)
placebo with##4##2##(1992-11#1)(2006-12#1)(2007-11#1)(2009-11#1)
placebo##535##1##(1990-10#2)(1990-11#5)(1990-12#7)(1990-3#8)(1990-5#2)(1990-6#5)(1990-7#2)(1990-8#6)(1990-9#1)(1991-11#4)(1991-12#1)(1991-2#2)(1991-3#5)(1991-6#2)(1991-7#6)(1991-8#1)(1992-1#2)(1992-10#5)(1992-11#3)(1992-12#5)(1992-2#1)(1992-3#1)(1992-4#5)(1992-5#5)(1992-8#4)(1993-1#2)(1993-11#3)(1993-12#4)(1993-3#2)(1993-5#1)(1993-9#1)(1994-11#6)(1994-2#1)(1994-6#1)(1994-7#1)(1995-1#2)(1995-12#3)(1995-2#1)(1995-4#1)(1995-5#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-8#1)(1996-9#3)(1997-1#5)(1997-5#3)(1997-6#3)(1997-7#3)(1997-8#1)(2004-1#4)(2004-11#1)(2004-12#3)(2004-3#6)(2005-10#1)(2005-7#6)(2005-8#7)(2005-9#1)(2006-10#24)(2006-12#2)(2006-2#1)(2006-7#2)(2006-9#4)(2007-10#4)(2007-11#23)(2007-12#1)(2007-5#3)(2007-7#5)(2007-8#12)(2007-9#7)(2008-1#1)(2008-10#18)(2008-11#4)(2008-12#4)(2008-2#4)(2008-3#23)(2008-4#4)(2008-5#68)(2008-6#7)(2008-7#21)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#5)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-4#7)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#9)(2012-1#2)(2012-12#5)(2012-2#20)(2012-3#4)(2013-1#19)(2013-7#5)(2013-8#7)
placebo) and##3##2##(2007-11#2)(2013-1#1)
placebo)##16##1##(1992-10#3)(1992-8#1)(1996-2#1)(2007-11#5)(2008-3#1)(2008-5#1)(2008-8#1)(2009-7#1)(2013-1#2)
placebo-##2##1##(1991-7#1)(2007-8#1)
placebo-control##2##1##(1991-1#1)(2008-9#1)
placebo-controlled clinical trial##8##3##(2006-10#3)(2008-3#2)(2010-9#1)(2011-2#1)(2013-7#1)
placebo-controlled clinical trials are##3##4##(2007-11#1)(2008-7#1)(2010-12#1)
placebo-controlled clinical trials##6##3##(1991-9#1)(2007-11#1)(2008-2#1)(2008-7#1)(2010-12#1)(2012-3#1)
placebo-controlled clinical##16##2##(1991-9#1)(2006-10#3)(2007-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-7#1)
placebo-controlled cross-over trial##2##3##(1994-12#1)(1997-6#1)
placebo-controlled crossover study##2##3##(1990-11#1)(1996-2#1)
placebo-controlled crossover##4##2##(1990-11#1)(1996-2#1)(2008-5#1)(2013-7#1)
placebo-controlled double-blind study##2##3##(1992-5#1)(2008-7#1)
placebo-controlled double-blind##3##2##(1992-5#1)(1994-8#1)(2008-7#1)
placebo-controlled multicentre trial##2##3##(1992-1#1)(1992-10#1)
placebo-controlled phase I/II##2##3##(2008-5#2)
placebo-controlled phase III trials##2##4##(2005-8#1)(2009-11#1)
placebo-controlled phase##5##2##(2005-8#2)(2008-5#2)(2009-11#1)
placebo-controlled studies have##2##3##(2006-10#1)(2007-12#1)
placebo-controlled studies in patients with##2##5##(2007-11#1)(2008-3#1)
placebo-controlled studies in##4##3##(2007-11#1)(2008-1#1)(2008-3#1)(2011-2#1)
placebo-controlled studies##13##2##(1997-3#1)(2005-7#2)(2006-10#1)(2007-11#4)(2007-12#1)(2008-1#1)(2008-3#1)(2009-9#1)(2011-2#1)
placebo-controlled study in##2##3##(2006-10#1)(2008-5#1)
placebo-controlled study of##3##3##(1996-3#1)(2006-10#1)(2008-7#1)
placebo-controlled study on the##3##4##(2005-8#1)(2007-1#1)(2007-8#1)
placebo-controlled study on##4##3##(2005-8#1)(2007-1#1)(2007-8#1)(2010-8#1)
placebo-controlled study was conducted##2##4##(2011-1#1)(2011-2#1)
placebo-controlled study was##4##3##(2007-8#1)(2008-5#1)(2011-1#1)(2011-2#1)
placebo-controlled study##22##2##(1992-12#1)(1996-2#1)(1996-3#1)(2005-8#1)(2006-10#3)(2007-1#1)(2007-8#2)(2008-5#4)(2008-7#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
placebo-controlled trial in patients##2##4##(2007-11#1)(2007-8#1)
placebo-controlled trial in##4##3##(2005-8#1)(2007-11#1)(2007-8#1)(2008-5#1)
placebo-controlled trial of a##3##4##(2005-8#1)(2006-10#1)(2007-8#1)
placebo-controlled trial of##12##3##(1991-2#1)(1997-5#1)(2005-8#2)(2006-10#2)(2006-7#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#1)
placebo-controlled trial##32##2##(1991-2#1)(1991-3#1)(1992-1#1)(1997-5#1)(2004-1#1)(2005-8#3)(2006-10#3)(2006-7#1)(2007-11#4)(2007-8#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-10#1)(2012-12#1)(2013-1#3)
placebo-controlled trials and##2##3##(2008-9#1)(2009-8#1)
placebo-controlled trials have##2##3##(1993-11#1)(2011-1#1)
placebo-controlled trials in patients with##3##5##(2008-3#2)(2008-7#1)
placebo-controlled trials of##6##3##(2007-11#1)(2008-2#1)(2008-7#1)(2009-12#1)(2010-2#1)(2013-1#1)
placebo-controlled trials showed that##2##4##(2008-7#1)(2009-6#1)
placebo-controlled trials##26##2##(1993-11#1)(2004-3#1)(2006-12#1)(2007-11#3)(2008-2#2)(2008-3#4)(2008-7#5)(2008-9#2)(2009-12#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-1#1)(2013-1#1)
placebo-controlled##167##1##(1990-11#1)(1990-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#2)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-8#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#1)(2004-1#1)(2004-12#1)(2004-3#2)(2005-7#2)(2005-8#6)(2006-10#13)(2006-12#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#12)(2007-12#1)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#12)(2008-5#16)(2008-6#2)(2008-7#10)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#7)(2013-7#4)(2013-8#1)
placebo-related##2##1##(2006-10#1)(2011-1#1)
placebo-treated patients##5##2##(1990-12#1)(1991-11#1)(1993-12#1)(2008-5#1)(2011-2#1)
placebo-treated##10##1##(1990-12#1)(1990-6#1)(1991-11#1)(1993-12#1)(1997-5#1)(1997-7#1)(2008-5#2)(2011-2#2)
placebos##6##1##(1995-9#1)(1996-2#1)(2007-12#2)(2010-7#1)(2012-3#1)
placed a##6##2##(2007-11#1)(2008-11#1)(2010-5#1)(2012-12#1)(2013-1#2)
placed after the##2##3##(2007-12#1)(2007-9#1)
placed after##4##2##(2007-12#1)(2007-9#1)(2008-2#1)(2011-2#1)
placed all##3##2##(1996-12#1)(2008-10#1)(2009-10#1)
placed along the##2##3##(1995-3#1)(2009-2#1)
placed along##3##2##(1995-3#1)(2008-10#1)(2009-2#1)
placed and in the##2##4##(2007-7#1)(2012-2#1)
placed and##4##2##(2006-6#1)(2007-7#1)(2012-12#1)(2012-2#1)
placed around the##3##3##(1995-12#1)(2008-12#1)(2008-2#1)
placed around##4##2##(1995-12#1)(2007-8#1)(2008-12#1)(2008-2#1)
placed at a##2##3##(2007-12#1)(2008-3#1)
placed at the detection point##2##5##(2008-10#2)
placed at the##17##3##(1993-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)
placed at##37##2##(1991-11#1)(1992-7#1)(1993-3#1)(1996-3#1)(1997-5#1)(2006-10#1)(2006-8#2)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-8#1)(2011-2#1)(2013-1#2)
placed back into##2##3##(2008-11#2)
placed back##3##2##(2008-11#3)
placed before##2##2##(2008-2#1)(2013-1#1)
placed between a##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
placed between crossed polarizers##2##4##(2008-2#1)(2008-3#1)
placed between the##6##3##(1994-4#1)(2006-12#1)(2008-3#2)(2008-5#1)(2009-5#1)
placed between##16##2##(1994-4#1)(2006-12#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#6)(2008-5#1)(2008-9#1)(2009-5#1)(2012-1#1)
placed by##5##2##(1996-7#1)(2006-8#1)(2008-11#1)(2009-2#1)(2010-5#1)
placed directly on the##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)
placed directly on##5##3##(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)
placed directly##7##2##(2008-10#3)(2008-2#2)(2008-3#1)(2008-6#1)
placed either on##2##3##(1994-1#1)(2008-11#1)
placed either##5##2##(1994-1#1)(2005-11#1)(2006-8#1)(2008-11#1)(2008-9#1)
placed for high##2##3##(2007-5#1)(2010-5#1)
placed for##8##2##(2007-5#1)(2008-2#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
placed from##2##2##(2006-11#1)(2008-10#1)
placed in 10##2##3##(2007-8#1)(2008-9#1)
placed in a cage##2##4##(2008-11#1)(2013-8#1)
placed in a cell##2##4##(2008-10#1)(2008-3#1)
placed in a flow##2##4##(2008-10#2)
placed in a large volume##2##5##(2008-10#1)(2008-8#1)
placed in a##46##3##(1990-10#1)(1992-7#1)(1994-6#1)(1996-3#1)(2007-12#2)(2007-8#1)(2008-10#15)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-3#1)(2010-10#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
placed in an##14##3##(1993-9#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2009-3#1)
placed in close##2##3##(2008-10#1)(2009-12#1)
placed in contact with##6##4##(1995-4#1)(2007-11#1)(2008-10#2)(2008-2#1)(2009-5#1)
placed in different##2##3##(2007-3#1)(2008-8#1)
placed in each##2##3##(2008-10#1)(2008-5#1)
placed in front of##2##4##(2007-12#1)(2008-2#1)
placed in immediate function##2##4##(2008-4#2)
placed in nursing homes##2##4##(1990-12#1)(1996-1#1)
placed in one of##3##4##(1992-12#1)(2012-1#1)(2013-7#1)
placed in one##5##3##(1992-12#1)(2007-12#1)(2008-10#1)(2012-1#1)(2013-7#1)
placed in organ##2##3##(1995-8#1)(2010-12#1)
placed in that##2##3##(1997-4#1)(2008-10#1)
placed in the Fourier plane##2##5##(2008-2#2)
placed in the chamber##2##4##(2008-1#1)(2008-10#1)
placed in the iliac artery##2##5##(1996-2#1)(2008-3#1)
placed in the mouth of##2##5##(2006-8#1)(2008-7#1)
placed in the same group##2##5##(1997-6#1)(2008-10#1)
placed in the same##5##4##(1997-6#1)(2008-10#2)(2008-12#1)(2013-1#1)
placed in the sample##2##4##(2008-10#1)(2008-11#1)
placed in the upper##3##4##(1997-5#1)(2006-6#1)(2011-12#1)
placed in the##91##3##(1990-3#1)(1992-2#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-6#1)(1994-7#1)(1995-11#1)(1996-2#2)(1997-4#2)(1997-5#2)(1997-6#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#20)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#7)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-12#2)(2011-1#1)(2011-12#2)(2011-2#1)(2012-11#1)(2013-1#3)(2013-7#1)
placed in their##2##3##(2006-10#1)(2008-7#1)
placed in two##3##3##(2007-12#1)(2008-7#1)(2013-1#1)
placed in water##2##3##(2004-9#1)(2008-10#1)
placed in##264##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-9#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-6#2)(1994-7#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-4#2)(1995-8#2)(1996-1#1)(1996-11#2)(1996-2#2)(1996-3#1)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#1)(2004-11#1)(2004-9#5)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-11#3)(2007-12#7)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#9)(2007-8#7)(2008-1#1)(2008-10#59)(2008-11#11)(2008-12#2)(2008-2#13)(2008-3#11)(2008-4#3)(2008-5#9)(2008-6#4)(2008-7#9)(2008-8#3)(2008-9#3)(2009-12#1)(2009-3#3)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#4)(2010-3#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#3)(2013-8#3)
placed individually##2##2##(1993-4#1)(2008-10#1)
placed inside a##6##3##(2007-12#1)(2008-10#2)(2008-3#2)(2011-2#1)
placed inside##11##2##(1997-6#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#2)(2009-3#1)(2011-2#1)
placed into the##6##3##(1990-10#1)(2007-7#1)(2007-8#1)(2010-12#1)(2011-2#1)(2012-12#1)
placed into##20##2##(1990-10#1)(1993-9#1)(1994-6#1)(1996-4#1)(1996-5#1)(2006-10#1)(2006-5#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)
placed just##4##2##(1996-2#1)(1997-4#1)(2006-11#1)(2008-10#1)
placed more importance on##3##4##(2007-12#2)(2008-12#1)
placed more##4##2##(2007-12#2)(2008-12#1)(2008-3#1)
placed new##2##2##(1991-2#1)(1992-12#1)
placed on a gluten-free diet for##2##6##(2007-5#2)
placed on a##17##3##(1990-2#1)(1996-12#1)(1996-3#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-4#2)(2007-5#2)(2008-10#2)(2008-3#1)(2008-7#2)(2011-1#1)
placed on how these##2##4##(2006-10#1)(2013-8#1)
placed on radiology reports##2##4##(2012-2#2)
placed on the importance of the##2##6##(1996-3#1)(2005-8#1)
placed on the importance of##5##5##(1996-3#1)(2005-8#2)(2006-10#1)(2008-12#1)
placed on the left##2##4##(2005-12#1)(2007-8#1)
placed on the side##2##4##(2007-11#1)(2007-7#1)
placed on the use of##2##5##(2006-10#1)(2008-9#1)
placed on the##71##3##(1990-10#1)(1991-5#1)(1993-2#1)(1993-3#1)(1995-9#1)(1996-3#1)(1997-3#1)(2004-11#1)(2005-10#1)(2005-12#1)(2005-5#1)(2005-7#2)(2005-8#3)(2006-10#3)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#7)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-7#1)
placed on their##2##3##(1994-1#1)(2005-7#1)
placed on top of a##2##5##(2007-8#1)(2008-3#1)
placed on top##3##3##(2007-8#1)(2008-2#1)(2008-3#1)
placed on##170##2##(1990-10#1)(1990-2#1)(1990-4#1)(1991-5#1)(1992-1#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-4#1)(1995-9#2)(1996-12#1)(1996-3#2)(1996-8#1)(1997-3#2)(2004-11#1)(2005-10#2)(2005-12#1)(2005-5#2)(2005-7#3)(2005-8#3)(2006-10#6)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#7)(2007-12#4)(2007-3#2)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#16)(2008-11#7)(2008-12#2)(2008-2#8)(2008-3#4)(2008-4#6)(2008-5#1)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#3)(2009-10#2)(2009-12#2)(2009-3#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#3)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
placed onto##3##2##(2006-12#1)(2007-3#1)(2008-5#1)
placed outside the##2##3##(2006-6#1)(2008-1#1)
placed over the##7##3##(1994-6#1)(2008-11#1)(2008-12#1)(2008-3#1)(2011-1#1)(2012-2#2)
placed over##9##2##(1993-4#1)(1994-6#1)(2008-11#1)(2008-12#1)(2008-3#1)(2011-1#1)(2012-2#3)
placed side by side##2##4##(2008-8#1)(2008-9#1)
placed the##7##2##(1992-3#1)(1995-10#1)(1995-3#1)(1995-9#1)(1996-10#1)(1996-6#1)(2007-4#1)
placed them##3##2##(1992-1#1)(2008-5#1)(2009-3#1)
placed through the##2##3##(2006-3#1)(2006-8#1)
placed through##3##2##(1995-9#1)(2006-3#1)(2006-8#1)
placed to the right##2##4##(1990-3#1)(2008-3#1)
placed to##15##2##(1990-3#1)(2006-12#2)(2006-8#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
placed together##2##2##(2008-10#1)(2008-3#1)
placed under the transcriptional control of##2##6##(1993-12#1)(1995-2#1)
placed under the##11##3##(1993-12#2)(1994-11#1)(1994-2#1)(1995-2#1)(1996-7#1)(1997-4#2)(1997-5#1)(2008-11#1)(2012-2#1)
placed under##18##2##(1993-12#2)(1994-11#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-7#1)(1997-4#2)(1997-5#1)(1997-6#1)(2005-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#1)
placed upon##5##2##(1995-12#1)(2007-8#1)(2008-1#1)(2008-3#1)(2012-12#1)
placed upstream##3##2##(1990-5#1)(1993-3#1)(2008-11#1)
placed using a##2##3##(2006-6#2)
placed using##3##2##(2006-6#2)(2013-1#1)
placed with##5##2##(1994-3#2)(2007-10#1)(2008-8#1)(2013-1#1)
placed within a##5##3##(1993-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2012-2#1)
placed within the##4##3##(2007-12#1)(2008-10#1)(2008-9#1)(2012-2#1)
placed within##10##2##(1993-11#1)(1995-3#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2012-2#2)
placed##793##1##(1990-10#3)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#3)(1990-4#2)(1990-5#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-5#2)(1992-1#2)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#3)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#7)(1993-2#3)(1993-3#4)(1993-4#2)(1993-9#2)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-4#1)(1994-6#5)(1994-7#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#6)(1995-2#3)(1995-3#4)(1995-4#3)(1995-8#3)(1995-9#4)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#4)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#3)(1997-4#7)(1997-5#4)(1997-6#3)(1997-7#2)(2004-11#2)(2004-9#6)(2005-10#4)(2005-11#3)(2005-12#1)(2005-5#2)(2005-7#3)(2005-8#4)(2006-10#10)(2006-11#4)(2006-12#6)(2006-2#1)(2006-3#3)(2006-4#1)(2006-5#4)(2006-6#10)(2006-7#3)(2006-8#15)(2006-9#1)(2007-10#3)(2007-11#12)(2007-12#20)(2007-3#4)(2007-4#6)(2007-5#6)(2007-6#1)(2007-7#19)(2007-8#19)(2007-9#2)(2008-1#4)(2008-10#114)(2008-11#35)(2008-12#7)(2008-2#32)(2008-3#40)(2008-4#13)(2008-5#20)(2008-6#8)(2008-7#19)(2008-8#11)(2008-9#15)(2009-10#4)(2009-11#1)(2009-12#3)(2009-2#3)(2009-3#7)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#3)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#7)(2010-2#3)(2010-3#4)(2010-4#1)(2010-5#5)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-12#5)(2011-2#19)(2012-1#3)(2012-11#2)(2012-12#10)(2012-2#16)(2012-3#4)(2013-1#24)(2013-7#6)(2013-8#8)
placement and is##2##3##(2008-1#1)(2010-7#1)
placement and the##2##3##(2006-11#1)(2009-5#1)
placement and##28##2##(1990-8#1)(1993-3#1)(1995-1#1)(1997-2#1)(2006-10#1)(2006-11#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-7#2)(2012-2#2)
placement are##2##2##(2007-10#1)(2009-2#1)
placement areas##2##2##(2008-11#1)(2013-8#1)
placement at the##2##3##(2012-12#1)(2012-2#1)
placement at##3##2##(2009-6#1)(2012-12#1)(2012-2#1)
placement error##2##2##(2010-12#1)(2013-1#1)
placement experiences##2##2##(2007-8#1)(2008-11#1)
placement for the##2##3##(2008-10#1)(2008-8#1)
placement for##15##2##(2006-11#4)(2006-7#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-12#2)(2013-1#1)
placement in a##4##3##(1995-1#1)(2006-7#1)(2007-7#1)(2011-2#1)
placement in an Irish##2##4##(2008-11#1)(2008-12#1)
placement in an##3##3##(2008-11#1)(2008-12#1)(2009-4#1)
placement in patients with##2##4##(2007-5#1)(2012-12#1)
placement in patients##4##3##(2006-12#1)(2007-5#1)(2007-8#1)(2012-12#1)
placement in the treatment of##2##5##(2009-1#1)(2010-7#1)
placement in the##12##3##(2006-5#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2009-1#1)(2010-7#2)(2012-12#2)(2012-2#1)
placement in##48##2##(1995-1#1)(2005-10#1)(2006-12#1)(2006-5#3)(2006-6#2)(2006-7#1)(2007-12#1)(2007-5#2)(2007-7#6)(2007-8#4)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-7#2)(2011-2#2)(2012-11#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)
placement is a##4##3##(2006-9#1)(2007-7#1)(2007-8#1)(2011-2#1)
placement is##6##2##(2006-5#1)(2006-9#1)(2007-7#2)(2007-8#1)(2011-2#1)
placement of a pacemaker##2##4##(2009-4#1)(2012-2#1)
placement of a shunt##3##4##(2006-10#1)(2006-5#1)(2006-8#1)
placement of a##35##3##(1993-11#1)(1997-5#2)(2006-10#2)(2006-11#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-12#1)(2007-5#1)(2007-7#7)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
placement of an##13##3##(1990-2#1)(1994-4#1)(1994-9#1)(1997-4#1)(2006-6#1)(2007-10#1)(2007-7#1)(2007-8#4)(2008-10#1)(2009-4#1)
placement of anterior instrumentation##2##4##(2006-2#1)(2006-8#1)
placement of automatic implantable cardioverter defibrillator##2##6##(2007-9#2)
placement of central venous catheters##4##5##(2005-10#1)(2007-7#3)
placement of central venous##5##4##(2005-10#1)(2007-7#4)
placement of dental implants##4##4##(1993-2#1)(2007-12#2)(2012-12#1)
placement of dialysis catheters##2##4##(2007-7#2)
placement of electrodes for##2##4##(2007-8#2)
placement of electrodes##3##3##(2007-8#2)(2013-7#1)
placement of the catheter##3##4##(2006-10#1)(2007-7#2)
placement of the electrode##2##4##(2006-3#2)
placement of the##33##3##(1992-6#1)(1994-5#1)(1995-5#1)(1996-5#1)(1996-7#1)(2006-10#1)(2006-3#4)(2006-8#3)(2007-4#2)(2007-5#1)(2007-7#5)(2007-8#3)(2008-2#1)(2008-5#1)(2009-10#1)(2009-2#1)(2009-4#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
placement of these##2##3##(2007-7#1)(2008-10#1)
placement of three##2##3##(2006-11#1)(2009-2#1)
placement of##177##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-4#1)(1994-5#1)(1994-9#1)(1995-5#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-3#2)(1997-4#1)(1997-5#2)(2005-10#1)(2006-10#3)(2006-11#2)(2006-2#2)(2006-3#4)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#10)(2007-10#1)(2007-12#6)(2007-4#2)(2007-5#4)(2007-7#30)(2007-8#15)(2007-9#2)(2008-1#3)(2008-10#8)(2008-11#1)(2008-12#3)(2008-2#2)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#2)(2009-10#3)(2009-2#4)(2009-4#3)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#5)(2012-11#3)(2012-12#6)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
placement on##3##2##(2008-10#1)(2011-12#1)(2013-1#1)
placement or##5##2##(1990-8#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)
placement provided##2##2##(2008-12#1)(2012-12#1)
placement rather than##2##3##(2007-12#1)(2010-7#1)
placement to##2##2##(2006-8#1)(2010-7#1)
placement using##3##2##(2013-1#2)(2013-7#1)
placement was##11##2##(2006-5#1)(2006-7#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2010-7#1)(2011-2#1)
placement were##8##2##(1990-5#1)(2006-10#1)(2006-6#1)(2007-7#4)(2012-3#1)
placement while##2##2##(2008-12#1)(2008-8#1)
placement will be##2##3##(2008-5#1)(2009-10#1)
placement with##2##2##(2006-10#1)(2011-1#1)
placement within the##3##3##(2007-7#1)(2008-4#2)
placement within##4##2##(2007-7#1)(2008-3#1)(2008-4#2)
placement##513##1##(1990-12#1)(1990-2#1)(1990-5#6)(1990-8#3)(1991-1#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-1#2)(1992-6#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-4#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-5#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#2)(2005-10#3)(2005-12#1)(2005-8#1)(2006-10#12)(2006-11#13)(2006-12#5)(2006-2#2)(2006-3#6)(2006-5#8)(2006-6#9)(2006-7#6)(2006-8#17)(2006-9#1)(2007-10#8)(2007-11#1)(2007-12#15)(2007-4#3)(2007-5#9)(2007-7#63)(2007-8#27)(2007-9#2)(2008-1#4)(2008-10#14)(2008-11#31)(2008-12#23)(2008-2#4)(2008-3#3)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#4)(2009-12#1)(2009-2#5)(2009-3#3)(2009-4#6)(2009-5#3)(2009-6#3)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#7)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#11)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#16)(2012-11#5)(2012-12#24)(2012-2#9)(2012-3#6)(2013-1#23)(2013-7#4)(2013-8#2)
placement)##3##1##(2007-11#1)(2007-8#2)
placements and##2##2##(1994-3#1)(2008-12#1)
placements can be##2##3##(2008-11#1)(2013-8#1)
placements in##3##2##(2008-11#1)(2008-12#1)(2013-8#1)
placements of##3##2##(2006-12#1)(2006-3#1)(2012-12#1)
placements to##2##2##(2008-11#2)
placements##59##1##(1991-1#1)(1994-3#2)(1995-3#2)(2006-10#1)(2006-12#1)(2006-3#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-11#21)(2008-12#11)(2010-3#2)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#7)
placenta and fetal##3##3##(1990-5#1)(1992-2#1)(2008-9#1)
placenta and the##2##3##(1993-4#1)(2009-9#1)
placenta and##26##2##(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-10#1)(1992-2#1)(1993-4#1)(1995-5#1)(1995-6#1)(1996-11#2)(1996-12#1)(1996-9#1)(1997-6#1)(2006-10#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-9#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
placenta as##2##2##(1990-11#1)(2010-5#1)
placenta by##4##2##(1992-2#1)(1993-11#1)(1995-12#1)(2006-5#1)
placenta growth factor##2##3##(1995-3#2)
placenta growth##3##2##(1990-5#1)(1995-3#2)
placenta have##2##2##(1991-2#1)(2008-9#1)
placenta in##5##2##(1990-2#1)(1994-6#1)(1995-12#1)(2013-1#1)(2013-7#1)
placenta is##3##2##(1990-2#1)(1996-7#1)(2012-12#1)
placenta membranes##2##2##(1991-10#2)
placenta of##3##2##(1994-9#1)(2009-2#1)(2009-4#1)
placenta praevia##2##2##(2007-2#1)(2009-4#1)
placenta with##2##2##(1990-11#1)(2012-12#1)
placenta##171##1##(1990-10#1)(1990-11#4)(1990-12#2)(1990-2#8)(1990-5#8)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#6)(1991-10#4)(1991-12#3)(1991-2#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#4)(1992-10#2)(1992-11#1)(1992-12#4)(1992-2#2)(1992-4#1)(1992-7#1)(1992-8#3)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#6)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#3)(1996-11#4)(1996-12#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-1#3)(1997-6#1)(2006-10#1)(2006-5#2)(2007-11#1)(2007-2#2)(2007-3#1)(2007-5#2)(2007-7#2)(2008-10#7)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#4)(2008-9#5)(2009-2#2)(2009-4#2)(2009-9#3)(2010-12#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#7)(2013-7#1)
placenta)##2##1##(1990-11#1)(1993-4#1)
placenta-derived multipotent cells##2##3##(2008-9#2)
placentae##4##1##(1992-8#1)(1997-4#1)(2007-7#1)(2011-2#1)
placental AP##4##2##(1992-3#1)(2008-11#3)
placental Cd concentration##2##3##(1993-4#2)
placental Cd##3##2##(1993-4#3)
placental IgG##4##2##(2007-7#4)
placental P-450arom isoform##2##3##(1995-8#2)
placental P-450arom##3##2##(1995-8#3)
placental alkaline phosphatase (PLAP)##2##4##(1994-4#1)(1996-7#1)
placental alkaline phosphatase##8##3##(1994-4#2)(1996-7#1)(2006-6#1)(2008-11#4)
placental and##3##2##(1993-2#1)(1995-8#2)
placental antigen##2##2##(1993-7#2)
placental barrier##4##2##(2007-7#1)(2010-2#1)(2010-5#2)
placental cells##10##2##(1990-3#1)(1993-12#3)(1996-12#1)(1997-8#4)(2008-9#1)
placental development##2##2##(1992-6#1)(1994-9#1)
placental functions##2##2##(1995-12#1)(2012-1#1)
placental glycoprotein##2##2##(1990-4#1)(1992-8#1)
placental growth##2##2##(1994-5#1)(2008-8#1)
placental insufficiency##4##2##(1991-9#1)(1996-11#2)(2013-7#1)
placental lactogen (bPL)##2##3##(1992-6#1)(1995-11#1)
placental lactogen##7##2##(1992-6#2)(1994-11#2)(1995-10#1)(1995-11#1)(1997-6#1)
placental mammals##9##2##(1995-11#1)(2006-5#3)(2008-8#2)(2008-9#2)(2010-4#1)
placental microsomes##3##2##(1990-5#2)(1991-12#1)
placental nutrient transport##2##3##(2013-1#2)
placental nutrient##3##2##(2013-1#3)
placental pathology##2##2##(1996-12#1)(2006-10#1)
placental ribonuclease inhibitor##2##3##(1991-2#2)
placental ribonuclease##3##2##(1991-2#3)
placental steroids##3##2##(1992-1#3)
placental syncytiotrophoblast##4##2##(1990-12#1)(1990-9#2)(2007-6#1)
placental tissue and##2##3##(1992-2#1)(2008-9#1)
placental tissue is##2##3##(1990-12#1)(1992-2#1)
placental tissue##5##2##(1990-12#1)(1992-2#2)(2007-6#1)(2008-9#1)
placental tissues##4##2##(1990-5#1)(2007-6#2)(2008-9#1)
placental type (GST-P)##2##3##(1991-9#1)(2008-4#1)
placental type III##2##3##(1991-4#2)
placental type##4##2##(1991-4#2)(1991-9#1)(2008-4#1)
placental vascular resistance##3##3##(1992-1#3)
placental villi##3##2##(2009-2#3)
placental villous##2##2##(2007-6#2)
placental##202##1##(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#9)(1990-6#1)(1990-7#3)(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#9)(1991-4#5)(1991-5#1)(1991-9#2)(1992-1#6)(1992-12#3)(1992-2#3)(1992-3#2)(1992-6#3)(1992-8#2)(1993-12#7)(1993-2#1)(1993-4#5)(1993-7#3)(1994-11#3)(1994-3#2)(1994-4#2)(1994-5#1)(1994-6#5)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#4)(1995-6#1)(1995-8#8)(1996-11#2)(1996-12#2)(1996-7#1)(1997-6#2)(1997-8#4)(2005-7#2)(2006-10#3)(2006-11#1)(2006-12#2)(2006-5#6)(2006-6#1)(2007-3#1)(2007-6#8)(2007-7#6)(2007-8#1)(2008-10#1)(2008-11#9)(2008-3#1)(2008-4#3)(2008-8#5)(2008-9#5)(2009-10#1)(2009-2#5)(2009-7#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#4)(2012-1#3)(2012-12#1)(2012-3#1)(2013-1#4)(2013-7#3)
placentals##2##1##(2008-8#2)
placentas of##6##2##(1990-5#1)(2011-1#4)(2013-1#1)
placentas##13##1##(1990-5#1)(1994-9#1)(1996-7#1)(2011-1#5)(2012-1#4)(2013-1#1)
places a##7##2##(1992-9#1)(1994-8#1)(2006-10#1)(2007-11#1)(2008-1#1)(2009-11#1)(2011-2#1)
places all##2##2##(1994-3#1)(1995-9#1)
places and##5##2##(1997-8#1)(2005-8#1)(2008-10#1)(2008-2#2)
places by##2##2##(2012-12#1)(2012-2#1)
places emphasis on##2##3##(2009-8#1)(2010-8#1)
places for##3##2##(2007-11#1)(2007-9#1)(2013-8#1)
places greater emphasis on##2##4##(2007-4#1)(2008-3#1)
places high demands##2##3##(2008-10#1)(2008-12#1)
places in the##6##3##(1993-2#1)(1996-12#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-3#1)
places in##12##2##(1993-2#1)(1996-12#1)(2006-12#1)(2007-10#1)(2007-3#1)(2007-7#1)(2008-10#3)(2008-3#1)(2011-12#1)(2013-7#1)
places like##2##2##(2007-10#1)(2008-8#1)
places of origin##5##3##(2012-3#4)(2013-1#1)
places of the world##2##4##(2007-10#1)(2007-3#1)
places of the##3##3##(1991-6#1)(2007-10#1)(2007-3#1)
places of##23##2##(1991-6#2)(1995-6#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-7#1)(2008-10#3)(2010-10#1)(2010-8#1)(2012-3#7)(2013-1#2)
places on##6##2##(1992-8#1)(1996-3#1)(2005-11#1)(2008-11#1)(2008-2#1)(2009-9#1)
places rectangles where they do not overlap each other and where the##2##12##(2008-6#2)
places rectangles##3##2##(2008-6#3)
places that##2##2##(2009-11#1)(2012-12#1)
places the##8##2##(1991-12#1)(1992-12#1)(1992-3#1)(1994-9#1)(2005-11#1)(2008-12#1)(2008-2#1)(2012-11#1)
places them at##2##3##(2008-11#1)(2012-2#1)
places them in##3##3##(1996-6#1)(2006-2#1)(2012-2#1)
places them##5##2##(1996-6#1)(2006-2#1)(2008-11#1)(2012-2#2)
places where##9##2##(1996-1#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-12#2)(2010-12#1)(2012-1#2)
places with##3##2##(2007-2#1)(2008-4#1)(2013-1#1)
places##171##1##(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#3)(1991-7#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-2#2)(1993-3#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-6#1)(1995-9#1)(1996-1#3)(1996-12#1)(1996-3#2)(1996-6#1)(1997-8#1)(2005-11#2)(2005-8#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-7#1)(2007-10#5)(2007-11#3)(2007-12#5)(2007-2#4)(2007-3#3)(2007-4#5)(2007-5#3)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#10)(2008-11#4)(2008-12#4)(2008-2#5)(2008-3#3)(2008-4#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#3)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#9)(2013-1#6)(2013-7#1)(2013-8#3)
placing a stent##2##3##(2009-2#1)(2013-7#1)
placing a##13##2##(1997-5#1)(2006-10#2)(2006-5#1)(2006-6#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#2)(2009-2#1)(2010-3#1)(2013-7#1)
placing an##3##2##(1996-2#1)(1996-8#1)(2008-10#1)
placing and##2##2##(2008-3#1)(2009-10#1)
placing emphasis on##2##3##(2005-10#1)(2010-7#1)
placing emphasis##3##2##(2005-10#1)(2008-7#1)(2010-7#1)
placing it##3##2##(1995-8#1)(2007-11#1)(2008-5#1)
placing of the##2##3##(2007-12#1)(2008-3#1)
placing of##6##2##(1990-1#1)(1990-4#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-8#1)
placing patients##2##2##(1995-12#1)(2012-11#1)
placing the device##2##3##(2008-11#1)(2012-2#1)
placing the##22##2##(1990-4#1)(1992-1#1)(1992-12#1)(1992-5#1)(1993-5#1)(1994-11#1)(1994-12#1)(1995-5#1)(1997-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
placing them##4##2##(1992-3#1)(2008-7#1)(2009-4#1)(2010-8#1)
placing themselves##2##2##(1992-3#1)(2007-4#1)
placing these##3##2##(2005-11#1)(2009-4#1)(2013-1#1)
placing##123##1##(1990-1#1)(1990-4#2)(1991-10#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-12#4)(1992-3#2)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-7#1)(1995-10#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-5#1)(1997-6#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-5#3)(2006-6#3)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#5)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#4)(2009-12#1)(2009-2#1)(2009-4#2)(2009-8#1)(2010-3#3)(2010-7#2)(2010-8#1)(2011-1#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
placode##2##1##(1995-5#1)(1996-3#1)
placodea##5##1##(2007-12#5)
placodes of##2##2##(1994-3#1)(1995-8#1)
placodes##11##1##(1994-3#1)(1995-3#1)(1995-8#9)
placoid chorioretinitis##2##2##(2009-8#2)
placoid##4##1##(2009-2#1)(2009-8#3)
plagiarism##5##1##(2008-12#1)(2012-1#2)(2013-1#2)
plagiarized##5##1##(2008-10#4)(2012-1#1)
plagiarizers##2##1##(2012-1#2)
plagiocephaly##8##1##(2006-7#1)(2007-12#6)(2007-8#1)
plague and##2##2##(2007-5#1)(2011-2#1)
plague in##5##2##(1990-12#1)(1991-11#1)(1996-5#1)(2004-10#1)(2007-2#1)
plague was##2##2##(1990-6#1)(2007-2#1)
plague##37##1##(1990-12#2)(1990-6#4)(1990-9#1)(1991-11#1)(1996-5#1)(1997-6#1)(2004-10#1)(2004-11#2)(2007-1#1)(2007-11#1)(2007-2#3)(2007-3#1)(2007-5#5)(2008-3#1)(2008-8#2)(2010-2#1)(2010-8#1)(2011-2#3)(2013-1#5)
plagued by significant##2##3##(2008-3#1)(2011-2#1)
plagued by##9##2##(1994-3#1)(1995-3#1)(2006-3#1)(2007-2#1)(2007-9#1)(2008-3#3)(2011-2#1)
plagued##13##1##(1994-3#1)(1995-12#1)(1995-3#1)(1995-5#1)(2006-10#1)(2006-3#1)(2007-2#1)(2007-9#1)(2008-3#3)(2010-4#1)(2011-2#1)
plagues##5##1##(1990-6#1)(1994-2#1)(2008-10#1)(2008-2#1)(2010-1#1)
plaguing##2##1##(1991-2#1)(2013-8#1)
plain CT##2##2##(2012-12#2)
plain X-ray of the##2##4##(1990-12#1)(1990-6#1)
plain X-ray##4##2##(1990-12#1)(1990-6#1)(2007-11#1)(2008-1#1)
plain abdominal x-ray##2##3##(1996-2#1)(2007-3#1)
plain abdominal##5##2##(1991-8#1)(1996-2#1)(2007-3#1)(2008-10#1)(2012-2#1)
plain bupivacaine containing##2##3##(1993-4#2)
plain bupivacaine plus##3##3##(1993-4#1)(2011-2#2)
plain bupivacaine##9##2##(1993-4#5)(1993-7#1)(2011-2#3)
plain clindamycin##2##2##(2007-7#2)
plain film arthrography##4##3##(2006-8#4)
plain film##8##2##(2006-8#5)(2007-11#2)(2008-12#1)
plain films##3##2##(1992-10#1)(2006-10#1)(2012-2#1)
plain of##6##2##(2006-12#2)(2008-5#1)(2011-2#2)(2013-1#1)
plain particles##2##2##(2006-5#2)
plain plates##2##2##(2006-10#2)
plain radiograph##3##2##(2007-8#1)(2012-12#1)(2012-3#1)
plain radiographs##11##2##(2007-10#1)(2007-4#1)(2007-7#3)(2008-7#1)(2008-9#1)(2009-3#2)(2009-9#1)(2010-5#1)
plain radiography##5##2##(2007-8#1)(2010-6#1)(2011-2#2)(2012-12#1)
plain scintigraphic##2##2##(2008-7#2)
plain scintigraphy##2##2##(2008-7#2)
plain water##2##2##(1994-2#1)(2013-7#1)
plain x-ray films##2##3##(2006-8#2)
plain x-ray##6##2##(2006-10#1)(2006-8#2)(2007-11#1)(2007-3#1)(2012-2#1)
plain##121##1##(1990-12#2)(1990-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-6#1)(1993-1#2)(1993-4#5)(1993-7#2)(1994-2#1)(1996-2#1)(2005-11#1)(2005-2#1)(2006-1#1)(2006-10#4)(2006-12#2)(2006-5#2)(2006-8#8)(2007-10#1)(2007-11#7)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#11)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#3)(2009-9#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#7)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
plainly##3##1##(2008-4#1)(2008-5#1)(2010-5#1)
plains##9##1##(1993-7#1)(2007-7#2)(2008-10#3)(2012-12#2)(2013-7#1)
plaintiff had received##2##3##(1991-6#1)(1991-7#1)
plaintiff had##4##2##(1991-6#1)(1991-7#3)
plaintiff##21##1##(1991-6#2)(1991-7#6)(1996-11#3)(1996-12#3)(1996-6#2)(1997-5#3)(2004-1#1)(2010-12#1)
plaintiff's##3##1##(1991-7#1)(1996-11#1)(1996-12#1)
plaintiffs are##2##2##(1992-2#1)(1996-6#1)
plaintiffs in the##2##3##(1995-6#2)
plaintiffs in##3##2##(1995-6#2)(1997-1#1)
plaintiffs who##2##2##(1997-5#2)
plaintiffs##16##1##(1992-2#1)(1993-9#1)(1994-1#1)(1995-12#1)(1995-6#3)(1996-11#2)(1996-12#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-5#2)
plakoglobin##9##1##(1991-11#4)(1994-11#1)(1994-8#4)
plan a##3##2##(1992-1#1)(1995-11#1)(2012-3#1)
plan accordingly##2##2##(2005-8#1)(2010-12#1)
plan aims##2##2##(1993-8#1)(2008-7#1)
plan an##3##2##(1997-6#1)(2008-10#1)(2008-9#1)
plan and implement##6##3##(1996-3#1)(1997-1#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-7#1)
plan and provider##2##3##(1991-2#1)(1992-3#1)
plan and the##2##3##(2007-12#1)(2013-8#1)
plan and##34##2##(1990-12#1)(1991-2#2)(1992-1#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-1#4)(1994-2#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-1#2)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-11#3)(2008-12#1)(2008-6#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
plan are##5##2##(1991-2#1)(1992-3#1)(1993-3#1)(1996-7#1)(2008-3#1)
plan as##4##2##(1992-3#1)(2008-2#1)(2008-3#1)(2008-6#1)
plan at##3##2##(2007-3#1)(2008-5#1)(2011-2#1)
plan choice##2##2##(1997-3#1)(2007-2#1)
plan choices##3##2##(1997-3#3)
plan development and##2##3##(1994-2#1)(1994-3#1)
plan development##4##2##(1993-2#1)(1994-2#1)(1994-3#1)(1996-12#1)
plan for a##3##3##(1991-3#1)(2007-2#1)(2008-2#1)
plan for future##2##3##(2010-2#1)(2012-3#1)
plan for health care##2##4##(1992-12#1)(2008-4#1)
plan for neuronal##2##3##(2007-12#2)
plan for the future##2##4##(1992-12#1)(1992-2#1)
plan for the##13##3##(1990-12#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-1#1)(1994-2#1)(1995-2#1)(2005-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2012-2#1)
plan for their##2##3##(1992-1#1)(2008-11#1)
plan for this##2##3##(2008-9#1)(2011-2#1)
plan for##65##2##(1990-11#1)(1990-12#2)(1991-3#2)(1992-1#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-1#1)(1993-2#1)(1994-1#3)(1994-2#2)(1995-2#1)(1995-9#1)(1996-2#1)(1996-3#1)(2005-10#1)(2005-8#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-4#2)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-2#2)(2010-3#1)(2011-1#2)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#1)
plan has##2##2##(1992-1#1)(2007-12#1)
plan in##9##2##(1991-1#1)(1993-12#1)(2006-8#1)(2007-4#1)(2007-9#1)(2008-11#1)(2008-6#1)(2012-11#1)(2013-1#1)
plan included##4##2##(2007-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
plan including##2##2##(2006-8#1)(2008-7#1)
plan is the##2##3##(1996-3#1)(2007-4#1)
plan is to##2##3##(1992-11#1)(2011-2#1)
plan is##21##2##(1991-2#1)(1992-11#1)(1995-2#1)(1996-1#2)(1996-3#1)(2006-7#1)(2007-4#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#2)(2013-1#2)
plan management##2##2##(1992-3#1)(2006-10#1)
plan managers##2##2##(1994-2#1)(1996-12#1)
plan must##2##2##(1993-2#1)(2007-12#1)
plan of action for##2##4##(2008-10#1)(2013-8#1)
plan of action##6##3##(1991-1#1)(1991-3#1)(2008-1#1)(2008-10#1)(2011-2#1)(2013-8#1)
plan of care##8##3##(2006-10#1)(2006-8#2)(2008-11#1)(2008-2#2)(2013-1#2)
plan of the##6##3##(1993-6#1)(1995-8#2)(1996-12#1)(1996-2#1)(2012-11#1)
plan of##25##2##(1991-1#1)(1991-3#1)(1993-6#1)(1993-8#1)(1995-8#2)(1996-12#1)(1996-2#1)(2006-10#1)(2006-8#2)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-8#1)(2011-2#1)(2012-11#1)(2013-1#2)(2013-8#1)
plan on##4##2##(1992-3#1)(1997-2#1)(2010-12#1)(2011-1#1)
plan or##4##2##(1994-3#1)(2004-12#1)(2006-5#1)(2008-11#1)
plan performance##7##2##(1993-12#1)(1994-2#1)(1995-2#1)(1996-3#3)(1997-3#1)
plan report cards##2##3##(1996-3#1)(1997-2#1)
plan selections##2##2##(1997-3#2)
plan that is##2##3##(2010-2#1)(2011-1#1)
plan that##13##2##(1991-2#1)(1993-1#1)(1993-2#1)(1994-12#1)(1995-12#2)(2007-2#1)(2007-4#1)(2007-9#1)(2010-2#2)(2010-3#1)(2011-1#1)
plan the##10##2##(1990-6#1)(2007-11#1)(2007-5#2)(2008-10#1)(2008-7#1)(2009-11#1)(2009-4#1)(2009-9#1)(2013-8#1)
plan their##7##2##(1992-4#1)(1995-12#1)(1997-8#1)(2006-2#1)(2007-2#1)(2011-2#1)(2013-8#1)
plan to be##2##3##(1997-2#1)(2008-6#1)
plan to enhance##2##3##(2008-7#1)(2013-8#1)
plan to improve##2##3##(1993-3#1)(2012-11#1)
plan to increase##2##3##(1990-12#1)(1992-12#1)
plan to the##2##3##(2006-10#1)(2011-1#1)
plan to use##2##3##(1994-5#1)(2007-2#1)
plan to##54##2##(1990-12#2)(1991-1#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-9#2)(1993-3#2)(1993-7#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-2#3)(1995-6#3)(1997-2#1)(1997-6#1)(1997-7#1)(2006-10#2)(2007-1#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-2#1)(2011-1#2)(2012-11#1)(2012-2#1)(2013-1#4)(2013-8#3)
plan was developed##3##3##(2007-3#1)(2008-10#1)(2010-7#1)
plan was to##2##3##(1992-12#1)(2006-5#1)
plan was##11##2##(1990-12#1)(1992-12#1)(1996-3#1)(2006-5#1)(2007-3#1)(2008-10#1)(2009-10#2)(2010-7#1)(2010-9#1)(2012-2#1)
plan which##2##2##(1991-1#1)(1992-1#1)
plan will have##2##3##(2006-8#1)(2013-7#1)
plan will##7##2##(1992-2#1)(1994-3#2)(2006-8#1)(2008-7#1)(2008-9#1)(2013-7#1)
plan with##8##2##(1991-4#1)(1992-3#1)(1993-3#1)(2005-12#1)(2007-7#1)(2008-11#1)(2009-10#1)(2011-1#1)
plan would##3##2##(1991-9#1)(1992-3#1)(2008-10#1)
plan##624##1##(1990-11#1)(1990-12#9)(1990-3#1)(1990-6#2)(1990-7#1)(1991-1#4)(1991-12#3)(1991-2#7)(1991-3#6)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#6)(1992-10#1)(1992-11#2)(1992-12#10)(1992-2#6)(1992-3#12)(1992-4#2)(1992-5#1)(1992-6#4)(1992-9#2)(1993-1#4)(1993-12#3)(1993-2#6)(1993-3#7)(1993-5#2)(1993-6#3)(1993-7#1)(1993-8#3)(1994-1#11)(1994-10#1)(1994-12#4)(1994-2#15)(1994-3#8)(1994-5#2)(1995-1#2)(1995-11#2)(1995-12#9)(1995-2#9)(1995-3#4)(1995-6#8)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#8)(1996-11#1)(1996-12#5)(1996-2#7)(1996-3#18)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#6)(1997-2#6)(1997-3#17)(1997-6#2)(1997-7#1)(1997-8#2)(2003-11#1)(2004-10#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-5#2)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#6)(2006-2#1)(2006-4#2)(2006-5#6)(2006-6#1)(2006-7#1)(2006-8#7)(2007-1#2)(2007-10#3)(2007-11#2)(2007-12#15)(2007-2#21)(2007-3#3)(2007-4#5)(2007-5#6)(2007-6#2)(2007-7#4)(2007-8#1)(2007-9#15)(2008-1#6)(2008-10#9)(2008-11#18)(2008-12#3)(2008-2#11)(2008-3#10)(2008-4#2)(2008-5#4)(2008-6#10)(2008-7#8)(2008-8#5)(2008-9#7)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#4)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#4)(2010-2#6)(2010-3#3)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#5)(2010-8#2)(2010-9#5)(2011-1#15)(2011-2#18)(2012-1#1)(2012-11#5)(2012-12#2)(2012-2#6)(2012-3#8)(2013-1#25)(2013-7#6)(2013-8#11)
plan's##6##1##(1992-9#1)(1993-8#1)(1994-5#1)(1995-12#1)(1995-6#1)(2008-6#1)
plan?##2##1##(2006-10#1)(2007-2#1)
plana vitrectomy and##2##3##(2007-7#1)(2013-1#1)
plana vitrectomy##4##2##(2007-7#2)(2011-2#1)(2013-1#1)
plana##7##1##(2006-8#1)(2007-11#1)(2007-7#2)(2011-1#1)(2011-2#1)(2013-1#1)
planar BLM##4##2##(1997-7#4)
planar and##8##2##(2006-2#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-2#2)(2008-3#2)
planar arrangement##2##2##(2008-3#1)(2008-5#1)
planar bilayer lipid##2##3##(1996-7#1)(1997-1#1)
planar bilayers##5##2##(1990-11#1)(2008-4#4)
planar bone##2##2##(2007-11#1)(2010-12#1)
planar cell polarity (PCP)##4##4##(2007-12#1)(2012-12#3)
planar cell##5##2##(2007-12#2)(2012-12#3)
planar chromatography##3##2##(2004-12#1)(2008-10#1)(2008-6#1)
planar conformation##3##2##(1997-1#1)(2006-12#1)(2007-11#1)
planar dielectric##6##2##(2007-12#1)(2008-2#5)
planar geometry and##2##3##(2008-3#2)
planar geometry##12##2##(1996-2#1)(2008-2#3)(2008-3#4)(2008-5#4)
planar guided-wave##2##2##(2007-12#2)
planar holographic optical elements##2##4##(2008-2#2)
planar holographic##3##2##(2008-2#3)
planar images##2##2##(2006-5#1)(2012-2#1)
planar imaging##6##2##(1992-3#2)(1994-1#1)(2008-2#2)(2009-2#1)
planar laser##2##2##(2008-3#2)
planar laser-induced fluorescence (PLIF)##2##4##(2008-2#1)(2008-3#1)
planar laser-induced fluorescence measurements##2##4##(2008-2#2)
planar laser-induced fluorescence##6##3##(2008-2#4)(2008-3#2)
planar light waveguide-type##2##3##(2007-12#2)
planar lipid bilayer##3##3##(1993-3#1)(1996-9#1)(2008-8#1)
planar lipid bilayers##6##3##(1992-7#4)(1993-3#1)(1993-8#1)
planar lipid##11##2##(1990-3#1)(1991-9#1)(1992-7#4)(1993-3#2)(1993-8#1)(1996-9#1)(2008-8#1)
planar membranes and##2##3##(1990-3#1)(1994-2#1)
planar membranes##5##2##(1990-12#1)(1990-3#1)(1991-9#1)(1994-2#2)
planar micro-optics##2##2##(2007-12#2)
planar microcavities##2##2##(2008-3#2)
planar microlenses##2##2##(2008-3#2)
planar mirror##2##2##(2007-12#1)(2008-6#1)
planar optical waveguide##5##3##(2007-12#3)(2008-10#1)(2008-2#1)
planar optical waveguides##4##3##(2007-12#4)
planar optical##11##2##(2007-12#7)(2008-10#1)(2008-2#2)(2008-3#1)
planar optics##4##2##(2007-12#4)
planar or##2##2##(2008-3#1)(2012-1#1)
planar phenolic##2##2##(1994-3#1)(1994-8#1)
planar phospholipid bilayers##3##3##(1990-11#1)(1990-2#1)(1990-6#1)
planar photonic crystal##2##3##(2007-12#2)
planar quadrupole microelectrode##2##3##(2006-2#2)
planar red blood cell scintigraphy##2##5##(2009-2#2)
planar source##2##2##(2007-11#1)(2008-2#1)
planar strontium barium niobate##2##4##(2007-12#2)
planar structure##5##2##(1992-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
planar structures##3##2##(1991-10#1)(2008-5#1)(2012-2#1)
planar wave##2##2##(2007-12#1)(2008-3#1)
planar waveguide and##2##3##(2007-12#1)(2008-3#1)
planar waveguide gratings##4##3##(2008-3#4)
planar waveguide laser##6##3##(2007-11#3)(2007-12#2)(2008-1#1)
planar waveguide was##2##3##(2007-12#2)
planar waveguide with##3##3##(2007-11#1)(2007-12#1)(2008-1#1)
planar waveguide##44##2##(2006-2#1)(2007-11#11)(2007-12#9)(2008-1#6)(2008-2#8)(2008-3#7)(2010-5#2)
planar waveguides and##2##3##(2007-12#1)(2008-2#1)
planar waveguides by ultraviolet##2##4##(2007-12#1)(2008-3#1)
planar waveguides by##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
planar waveguides in##2##3##(2007-12#1)(2008-3#1)
planar waveguides made##2##3##(2007-12#1)(2008-3#1)
planar waveguides##25##2##(2007-11#3)(2007-12#8)(2008-1#1)(2008-2#3)(2008-3#10)
planar##346##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-9#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#4)(1992-9#1)(1993-3#2)(1993-8#3)(1994-1#1)(1994-11#1)(1994-2#3)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-2#3)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#5)(1997-2#1)(1997-7#7)(2004-12#1)(2005-11#3)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#5)(2006-4#2)(2006-5#2)(2007-11#21)(2007-12#65)(2007-3#2)(2007-5#1)(2007-9#2)(2008-1#9)(2008-10#11)(2008-11#3)(2008-2#50)(2008-3#57)(2008-4#5)(2008-5#8)(2008-6#3)(2008-7#2)(2008-8#1)(2009-2#4)(2010-1#1)(2010-12#1)(2010-4#2)(2010-5#3)(2012-1#6)(2012-11#3)(2012-12#5)(2012-2#5)(2012-3#2)(2013-7#1)(2013-8#1)
planar-apertured probe array##2##3##(2008-3#2)
planar-constrained##2##1##(2008-9#2)
planar-integrated free-space##2##2##(2008-2#1)(2008-3#1)
planar-integrated##8##1##(2007-11#2)(2008-2#2)(2008-3#4)
planar-waveguide##2##1##(2007-12#1)(2008-3#1)
planarian CNS##3##2##(2008-5#3)
planarian##5##1##(2008-5#5)
planarians##2##1##(2008-5#1)(2013-8#1)
planarity##5##1##(1996-5#1)(1997-8#1)(2008-3#2)(2010-2#1)
planarization##4##1##(2008-1#3)(2008-3#1)
planarized##2##1##(2008-1#1)(2008-2#1)
planarizing##2##1##(2008-1#2)
plane and the##4##3##(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)
plane and##23##2##(1993-4#1)(2005-4#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2009-5#1)(2011-2#2)(2013-8#2)
plane are##6##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)
plane as##2##2##(2008-9#1)(2011-2#1)
plane at##3##2##(2008-2#2)(2008-3#1)
plane between the##2##3##(2008-3#1)(2012-12#1)
plane by a##2##3##(2007-12#1)(2008-3#1)
plane by##7##2##(2006-5#2)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2012-1#1)
plane containing the##2##3##(2007-11#1)(2008-2#1)
plane containing##3##2##(1996-5#1)(2007-11#1)(2008-2#1)
plane defined by the##3##4##(1994-9#1)(1997-2#1)(2008-2#1)
plane diffuse##2##2##(2008-1#1)(2008-2#1)
plane during##3##2##(2007-10#2)(2007-5#1)
plane for##6##2##(2004-9#1)(2008-2#3)(2008-3#2)
plane from##4##2##(2007-11#2)(2008-2#1)(2010-12#1)
plane grating##3##2##(2008-2#2)(2008-3#1)
plane gratings##3##2##(2008-2#3)
plane image##2##2##(2008-3#2)
plane in a##2##3##(2008-3#1)(2012-2#1)
plane in the##3##3##(2007-12#1)(2008-3#1)(2012-2#1)
plane in##7##2##(2007-12#1)(2008-3#2)(2009-11#1)(2010-8#1)(2012-2#2)
plane interface##3##2##(2005-11#1)(2008-3#2)
plane interpolation##2##2##(2008-2#2)
plane is presented##2##3##(2008-2#1)(2008-3#1)
plane is proposed##2##3##(2007-11#1)(2007-12#1)
plane is recorded##2##3##(2007-12#1)(2008-2#1)
plane is##22##2##(1994-2#1)(2007-11#1)(2007-12#3)(2008-2#5)(2008-3#7)(2008-4#1)(2008-5#1)(2010-11#1)(2011-1#1)(2012-2#1)
plane located in the Fresnel diffraction region##2##7##(2007-12#1)(2008-3#1)
plane mirror##5##2##(2008-2#4)(2008-3#1)
plane mirrors##6##2##(2008-2#5)(2008-3#1)
plane must be##2##3##(2008-2#2)
plane nonlinear filtering##2##3##(2008-2#2)
plane normolipemic xanthomatosis##2##3##(2007-7#2)
plane of a##13##3##(2007-12#3)(2008-2#5)(2008-3#4)(2008-9#1)
plane of an##2##3##(2008-2#1)(2008-3#1)
plane of incidence##13##3##(2007-12#3)(2008-1#1)(2008-2#3)(2008-3#6)
plane of polarization##2##3##(2007-12#1)(2008-2#1)
plane of the correlator##2##4##(2008-3#2)
plane of the grating##3##4##(2008-3#3)
plane of the##46##3##(1990-4#1)(1991-5#1)(1991-9#1)(1994-12#1)(1994-3#1)(1995-10#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-8#1)(1997-5#1)(2004-7#1)(2005-4#1)(2006-11#1)(2006-12#1)(2006-3#1)(2007-1#1)(2007-11#3)(2007-12#5)(2007-7#1)(2008-2#5)(2008-3#12)(2010-6#1)(2010-8#1)(2013-1#1)
plane of##97##2##(1990-4#1)(1991-5#1)(1991-9#1)(1992-7#1)(1993-4#1)(1994-12#1)(1994-3#1)(1995-10#2)(1995-11#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-5#1)(1997-6#1)(2004-7#1)(2005-4#2)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#14)(2007-7#1)(2008-1#1)(2008-2#16)(2008-3#27)(2008-7#1)(2008-9#1)(2009-8#2)(2010-6#1)(2010-8#1)(2013-1#1)(2013-8#1)
plane on the##2##3##(2006-11#1)(2008-2#1)
plane or##5##2##(1990-3#1)(2007-7#1)(2008-2#1)(2008-3#2)
plane parallel to the##2##4##(2006-3#1)(2007-5#1)
plane perpendicular to the##6##4##(1996-4#1)(2008-2#1)(2008-3#2)(2012-12#1)(2013-8#1)
plane polariscope##2##2##(2008-3#2)
plane surface of a##2##4##(2008-2#1)(2008-3#1)
plane surface of##3##3##(2008-2#1)(2008-3#2)
plane surface##5##2##(2008-2#2)(2008-3#3)
plane that##2##2##(2007-12#1)(2008-3#1)
plane to##3##2##(2008-2#1)(2008-3#2)
plane warts##4##2##(2013-1#4)
plane was##6##2##(2008-2#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
plane wave or##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
plane wave with##2##3##(2008-2#1)(2008-3#1)
plane wave##24##2##(2007-11#3)(2007-12#2)(2008-2#5)(2008-3#14)
plane waves in##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
plane waves with##2##3##(2007-12#2)
plane waves##17##2##(2007-11#4)(2007-12#2)(2007-9#1)(2008-2#2)(2008-3#8)
plane were##6##2##(1996-5#1)(2005-4#1)(2007-12#1)(2008-3#1)(2008-7#1)(2012-3#1)
plane when##3##2##(2005-11#1)(2007-12#1)(2008-3#1)
plane with and without##2##4##(2008-2#1)(2008-3#1)
plane with the##2##3##(2007-12#1)(2008-3#1)
plane with##6##2##(2007-12#1)(2008-2#2)(2008-3#3)
plane without##3##2##(2007-11#2)(2008-2#1)
plane##592##1##(1990-3#1)(1990-4#3)(1990-7#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-7#1)(1993-2#1)(1993-4#3)(1993-6#1)(1993-8#1)(1993-9#5)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-10#2)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#1)(2004-3#1)(2004-7#2)(2004-9#1)(2005-11#7)(2005-4#4)(2006-11#4)(2006-12#4)(2006-3#3)(2006-4#1)(2006-5#2)(2007-1#3)(2007-10#4)(2007-11#27)(2007-12#48)(2007-4#2)(2007-5#2)(2007-7#13)(2007-8#2)(2007-9#1)(2008-1#7)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#118)(2008-3#163)(2008-4#3)(2008-5#2)(2008-6#4)(2008-7#5)(2008-8#15)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#5)(2009-8#3)(2010-10#1)(2010-11#4)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#6)(2010-9#1)(2011-1#3)(2011-2#10)(2012-1#4)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#9)
plane)##3##1##(2007-11#1)(2008-3#1)(2010-5#1)
plane-parallel plate##3##2##(2008-2#3)
plane-parallel resonator##3##2##(2008-3#3)
plane-parallel##20##1##(2005-11#1)(2008-2#10)(2008-3#8)(2012-1#1)
plane-plane##2##1##(2007-12#1)(2008-3#1)
plane-polarized##2##1##(2007-12#1)(2008-4#1)
plane-symmetric##2##1##(2008-3#2)
plane-wave holograms##3##2##(2007-12#3)
plane-wave illumination##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
plane-wave spectrum##2##2##(2007-12#2)
plane-wave##29##1##(1990-3#1)(2006-4#2)(2007-11#1)(2007-12#13)(2008-2#3)(2008-3#7)(2013-1#2)
planed##2##1##(2005-10#1)(2008-4#1)
planes and##5##2##(1990-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-10#1)
planes are##4##2##(2008-2#1)(2008-3#3)
planes for##3##2##(2004-3#1)(2007-12#1)(2008-11#1)
planes from##2##2##(2007-12#1)(2008-3#1)
planes in##10##2##(1992-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#5)
planes is##2##2##(2008-3#2)
planes of incidence##2##3##(2008-2#2)
planes of polarization##2##3##(2007-12#1)(2008-3#1)
planes of the##5##3##(1992-11#1)(2007-5#1)(2007-8#1)(2008-2#1)(2008-6#1)
planes of##19##2##(1992-11#1)(1994-4#1)(1996-4#1)(2006-4#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2010-5#1)(2012-2#1)
planes were##2##2##(1992-1#1)(2013-1#1)
planes with##2##2##(1993-8#1)(2007-5#1)
planes##120##1##(1990-11#2)(1991-10#1)(1992-1#2)(1992-11#1)(1992-8#1)(1993-8#1)(1994-4#1)(1995-5#1)(1996-2#1)(1996-4#2)(1997-2#1)(2004-3#1)(2005-11#2)(2005-12#1)(2006-12#3)(2006-4#2)(2006-5#1)(2007-11#5)(2007-12#10)(2007-5#4)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#14)(2008-3#38)(2008-4#2)(2008-6#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-4#1)(2009-7#1)(2010-11#2)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#2)(2013-1#1)
planet detection##2##2##(2008-3#2)
planet##22##1##(1991-8#1)(1992-10#2)(1992-7#1)(1995-9#1)(1996-6#1)(2004-9#1)(2006-10#1)(2006-7#1)(2007-9#3)(2008-3#3)(2009-3#2)(2010-5#2)(2012-1#1)(2012-12#1)(2013-8#1)
planetary scientists##2##2##(2007-9#2)
planetary##18##1##(1992-1#1)(1992-2#1)(1997-5#1)(2007-9#5)(2008-2#4)(2008-3#6)
planets##14##1##(1993-4#2)(1995-6#1)(1997-5#1)(2006-5#1)(2007-8#1)(2007-9#4)(2008-2#2)(2008-3#1)(2012-2#1)
planimetry##2##1##(1993-2#1)(2009-2#1)
planing##13##1##(1996-1#1)(2006-10#8)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
plankton community##3##2##(2013-8#3)
plankton population##3##2##(2007-9#2)(2009-8#1)
plankton##15##1##(2007-3#1)(2007-9#3)(2008-3#1)(2008-5#1)(2009-8#2)(2010-6#1)(2010-8#1)(2012-2#1)(2013-8#4)
planktonic bacteria##4##2##(1995-12#2)(2006-11#2)
planktonic systems##2##2##(2009-8#2)
planktonic##29##1##(1995-12#2)(2006-11#3)(2007-5#5)(2007-9#1)(2008-11#1)(2008-3#4)(2009-6#3)(2009-8#2)(2010-9#3)(2011-1#1)(2011-12#2)(2012-2#2)
planned a##3##2##(1995-1#1)(2007-2#1)(2008-12#1)
planned action##2##2##(2008-11#1)(2013-1#1)
planned and executed##2##3##(1990-3#1)(2012-12#1)
planned and##21##2##(1990-3#1)(1992-3#2)(1995-1#1)(2006-10#8)(2007-1#1)(2007-11#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-8#1)(2011-2#1)(2012-12#1)
planned as a##4##3##(2008-5#1)(2010-6#1)(2010-7#1)(2013-8#1)
planned as##6##2##(1990-6#1)(2008-5#1)(2010-6#1)(2010-7#1)(2013-8#2)
planned behavior##3##2##(2008-2#1)(2008-3#1)(2010-10#1)
planned but##2##2##(2006-10#1)(2007-6#1)
planned cholecystectomy##2##2##(1997-8#2)
planned dental visits##2##3##(2012-2#2)
planned extubation##2##2##(2010-10#1)(2010-7#1)
planned for 2000##2##3##(2005-6#1)(2006-4#1)
planned for the##3##3##(1991-3#1)(2008-2#1)(2012-3#1)
planned for##13##2##(1991-3#1)(2005-6#1)(2005-9#1)(2006-4#1)(2007-12#1)(2007-7#1)(2008-2#3)(2008-5#1)(2010-12#1)(2011-2#1)(2012-3#1)
planned gifts##4##2##(1991-1#1)(1992-3#1)(1996-3#2)
planned giving program##2##3##(1991-3#1)(1996-3#1)
planned giving##6##2##(1991-3#2)(1992-3#1)(1994-1#2)(1996-3#1)
planned in order to##2##4##(2008-12#1)(2013-1#1)
planned in##15##2##(1991-9#1)(2006-8#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-7#2)(2010-12#1)(2011-12#1)(2012-11#2)(2012-2#2)(2013-1#2)
planned interim analysis##2##3##(2004-1#1)(2007-10#1)
planned interim##3##2##(1993-5#1)(2004-1#1)(2007-10#1)
planned on##2##2##(1996-2#1)(2008-4#1)
planned operation##5##2##(1991-11#1)(1997-8#4)
planned replacement##2##2##(2005-11#2)
planned studies##2##2##(1990-6#1)(2011-1#1)
planned study##2##2##(1996-7#1)(2010-3#1)
planned suicide##3##2##(1992-1#3)
planned surgery##3##2##(1991-8#1)(1994-11#1)(2007-8#1)
planned through##2##2##(2008-1#1)(2008-2#1)
planned to breastfeed##3##3##(2007-2#3)
planned to enhance##2##3##(2008-7#2)
planned to evaluate the##2##4##(2007-10#1)(2011-1#1)
planned to##35##2##(1992-4#1)(1993-1#1)(1994-11#1)(1994-12#2)(1994-3#1)(1996-10#1)(2004-1#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-2#5)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2011-1#1)(2012-3#1)(2013-1#6)(2013-8#3)
planned treatment##5##2##(2007-11#1)(2009-6#1)(2011-2#3)
planned with##3##2##(2008-8#1)(2010-3#1)(2011-1#1)
planned##277##1##(1990-12#1)(1990-3#2)(1990-6#2)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#3)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#3)(1992-11#1)(1992-3#7)(1992-4#1)(1992-9#2)(1993-1#2)(1993-3#1)(1993-5#1)(1994-1#2)(1994-11#2)(1994-12#2)(1994-3#1)(1994-7#1)(1995-1#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#4)(1996-3#4)(1996-7#1)(1996-9#1)(1997-2#1)(1997-8#7)(2004-1#3)(2005-10#1)(2005-11#2)(2005-12#1)(2005-6#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#10)(2006-12#1)(2006-4#1)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#5)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#2)(2007-2#10)(2007-5#1)(2007-6#3)(2007-7#4)(2007-8#7)(2007-9#1)(2008-1#4)(2008-10#4)(2008-11#4)(2008-12#3)(2008-2#5)(2008-3#3)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#11)(2008-8#3)(2008-9#2)(2009-2#2)(2009-4#1)(2009-6#2)(2009-9#1)(2010-10#2)(2010-12#4)(2010-2#3)(2010-3#2)(2010-4#1)(2010-6#2)(2010-7#4)(2011-1#6)(2011-12#3)(2011-2#13)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#9)(2012-3#5)(2013-1#15)(2013-7#3)(2013-8#6)
planner##3##1##(2007-5#1)(2010-11#2)
planner's##2##1##(1994-2#1)(2008-8#1)
planners and##6##2##(2008-1#1)(2008-2#1)(2011-2#2)(2012-3#2)
planners should consider##2##3##(1994-6#1)(2008-10#1)
planners##27##1##(1991-1#1)(1992-2#1)(1992-3#1)(1994-3#1)(1994-6#1)(1996-1#1)(1996-3#2)(2008-1#2)(2008-10#1)(2008-2#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#7)(2013-1#2)
planning a pregnancy##2##3##(2007-2#1)(2011-1#1)
planning a##8##2##(1991-2#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2010-12#1)(2011-1#1)
planning actions##2##2##(2008-9#2)
planning activities##3##2##(1993-8#1)(1996-12#1)(2008-2#1)
planning after##2##2##(1992-2#1)(1992-4#1)
planning among##3##2##(1996-2#1)(2007-2#1)(2008-11#1)
planning an##2##2##(2006-5#1)(2007-7#1)
planning and action##2##3##(2008-10#1)(2012-3#1)
planning and carrying out##2##4##(1991-2#1)(2008-4#1)
planning and conducting##2##3##(2004-4#1)(2005-7#1)
planning and decision making##3##4##(2007-10#1)(2013-1#2)
planning and delivery##2##3##(1992-8#1)(2006-10#1)
planning and design##2##3##(2008-8#1)(2012-12#1)
planning and development##6##3##(1996-3#1)(1997-3#1)(2008-11#1)(2008-12#1)(2011-2#2)
planning and distribution of##2##4##(1990-12#1)(2008-1#1)
planning and evaluation##2##3##(1994-6#1)(1997-8#1)
planning and executing##2##3##(1991-2#1)(2009-11#1)
planning and execution of##3##4##(1994-6#1)(2009-8#1)(2010-11#1)
planning and execution##7##3##(1994-6#1)(1997-2#1)(2005-11#1)(2007-8#1)(2008-2#1)(2009-8#1)(2010-11#1)
planning and implementation of a##2##5##(1991-2#1)(2008-1#1)
planning and implementation of the##2##5##(1993-3#1)(2008-9#1)
planning and implementation of##10##4##(1991-2#1)(1993-3#1)(1995-3#1)(1996-4#1)(2005-10#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-4#1)(2012-12#1)
planning and implementation##14##3##(1991-2#1)(1992-2#1)(1993-3#1)(1994-12#1)(1994-7#1)(1995-3#2)(1996-4#1)(2005-10#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-4#1)(2012-12#1)
planning and implementing##4##3##(1990-12#1)(1994-2#1)(1995-1#1)(2005-10#1)
planning and improving##2##3##(1997-1#1)(2007-11#1)
planning and management of##3##4##(1993-12#1)(2006-2#1)(2011-2#1)
planning and management##6##3##(1993-12#1)(1993-2#1)(1994-1#1)(2006-2#1)(2010-12#1)(2011-2#1)
planning and monitoring##2##3##(1996-2#1)(2012-2#1)
planning and preparation##2##3##(1994-11#1)(2004-7#1)
planning and regular##2##3##(1991-7#1)(2010-11#1)
planning and simulation##2##3##(2006-6#2)
planning and the##6##3##(1990-12#1)(1991-4#1)(1994-2#1)(1996-3#1)(2010-2#1)(2013-1#1)
planning and##167##2##(1990-12#4)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-4#1)(1991-7#1)(1992-12#2)(1992-2#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-6#3)(1994-7#1)(1995-1#3)(1995-12#1)(1995-3#3)(1995-5#1)(1996-2#1)(1996-3#3)(1996-4#1)(1997-1#4)(1997-2#3)(1997-3#3)(1997-6#1)(1997-8#2)(2004-4#1)(2004-7#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-7#1)(2006-10#2)(2006-12#2)(2006-2#2)(2006-3#1)(2006-5#1)(2006-6#3)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#3)(2008-1#3)(2008-10#4)(2008-11#8)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#3)(2009-8#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#5)(2011-7#1)(2012-1#1)(2012-11#3)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#14)(2013-7#1)(2013-8#1)
planning are discussed##3##3##(1994-1#2)(2008-7#1)
planning are##6##2##(1991-12#1)(1993-3#1)(1994-1#2)(1996-2#1)(2008-7#1)
planning at the##2##3##(1991-2#1)(1994-2#1)
planning at##3##2##(1991-2#1)(1994-2#1)(2007-12#1)
planning by##3##2##(2006-2#1)(2008-1#1)(2008-8#1)
planning can##4##2##(1995-2#1)(2006-5#1)(2012-3#2)
planning child##2##2##(1990-12#1)(2009-10#1)
planning complications and surgical miscues##2##5##(2008-11#2)
planning disturbances in children who clutter##2##6##(2011-1#2)
planning document##2##2##(1992-2#1)(2013-8#1)
planning effort##2##2##(1992-1#1)(2012-2#1)
planning efforts##4##2##(1994-1#1)(1997-1#2)(2008-11#1)
planning enable##2##2##(2007-7#1)(2008-6#1)
planning experiments##3##2##(1993-4#1)(2008-6#1)(2013-1#1)
planning for a##2##3##(1991-3#1)(2007-7#1)
planning for cancer##3##3##(1997-1#1)(2008-7#1)(2009-11#1)
planning for data collection##5##4##(1994-12#3)(1995-2#1)(1995-3#1)
planning for intracranial##2##3##(1994-7#1)(2006-2#1)
planning for the future##3##4##(1994-2#1)(2006-6#1)(2008-12#1)
planning for the##10##3##(1992-2#1)(1993-9#1)(1994-2#1)(1997-2#1)(2006-5#1)(2006-6#1)(2007-2#1)(2008-12#1)(2008-7#1)(2008-8#1)
planning for totally endoscopic coronary artery bypass##2##7##(2007-8#2)
planning for##70##2##(1991-2#1)(1991-3#1)(1992-2#2)(1992-3#1)(1992-4#1)(1993-1#1)(1993-11#1)(1993-9#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-7#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-2#1)(1997-1#1)(1997-2#3)(2005-8#1)(2006-10#1)(2006-2#1)(2006-5#2)(2006-6#1)(2007-10#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#3)(2009-11#2)(2010-11#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#2)(2013-7#2)
planning from the##2##3##(1992-4#1)(1994-2#1)
planning from##4##2##(1991-1#1)(1992-4#1)(1993-12#1)(1994-2#1)
planning future##2##2##(1995-1#1)(2008-8#1)
planning has##3##2##(1994-3#1)(2006-6#1)(2010-2#1)
planning have##2##2##(1994-1#1)(1996-12#1)
planning health##2##2##(1992-11#1)(2006-4#1)
planning in Canada##2##3##(1991-1#1)(1994-1#1)
planning in health care##2##4##(1994-2#1)(1995-1#1)
planning in the##7##3##(1994-1#1)(1994-2#1)(1996-12#1)(2008-11#1)(2011-1#1)(2011-2#1)(2011-3#1)
planning in##40##2##(1991-1#1)(1992-1#1)(1992-10#1)(1992-12#1)(1994-1#2)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#1)(1996-12#1)(1997-2#1)(2004-10#1)(2006-10#1)(2006-2#4)(2007-4#1)(2007-7#1)(2008-11#2)(2008-7#1)(2008-9#1)(2010-11#1)(2010-3#2)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#3)(2013-8#1)
planning initiatives##3##2##(1992-1#1)(2007-6#1)(2010-12#1)
planning interventions##2##2##(2007-8#1)(2012-3#1)
planning is a##5##3##(1994-2#1)(1994-7#1)(1997-1#1)(2006-10#1)(2012-3#1)
planning is becoming##2##3##(1993-3#2)
planning is##29##2##(1990-9#1)(1992-2#1)(1993-2#1)(1993-3#2)(1993-8#2)(1994-1#1)(1994-2#1)(1994-7#1)(1996-2#1)(1997-1#2)(1997-2#1)(2004-9#1)(2006-10#1)(2007-8#1)(2008-2#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#1)(2010-2#1)(2012-1#2)(2012-2#1)(2012-3#2)
planning issues##3##2##(2008-11#1)(2013-1#2)
planning method##2##2##(1992-7#1)(2008-10#1)
planning methods##7##2##(1994-2#3)(2007-11#1)(2007-3#1)(2008-7#1)(2011-2#1)
planning model##6##2##(1991-1#2)(1991-3#1)(1993-12#1)(1996-2#1)(2009-3#1)
planning needs##2##2##(1994-3#1)(2012-11#1)
planning new##4##2##(1996-1#1)(1996-6#1)(2006-6#2)
planning of a##4##3##(1992-2#1)(1996-12#1)(2008-2#1)(2008-7#1)
planning of health care##2##4##(1992-12#1)(2008-8#1)
planning of health##5##3##(1990-12#1)(1992-12#1)(1993-11#1)(1993-6#1)(2008-8#1)
planning of surgical##3##3##(2007-5#1)(2009-2#1)(2013-7#1)
planning of the##4##3##(2007-5#1)(2008-1#1)(2008-10#1)(2011-2#1)
planning of various##2##3##(2007-12#1)(2008-1#1)
planning of##49##2##(1990-12#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-8#1)(1996-12#1)(1996-6#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-5#2)(2007-6#1)(2007-7#2)(2008-1#2)(2008-10#3)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#4)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#3)(2013-1#2)(2013-7#1)
planning or##4##2##(1994-3#1)(1997-3#1)(2008-2#1)(2012-12#1)
planning preventive##2##2##(2010-9#1)(2011-2#1)
planning problem##2##2##(2007-5#1)(2009-3#1)
planning process and##4##3##(1992-2#1)(1994-2#1)(1996-1#1)(2008-11#1)
planning process##32##2##(1990-12#1)(1991-2#2)(1991-3#2)(1991-9#1)(1992-2#4)(1993-3#2)(1994-2#8)(1994-3#1)(1995-1#1)(1996-1#3)(1997-1#2)(2007-4#1)(2008-1#1)(2008-11#1)(2008-2#1)(2013-7#1)
planning processes##4##2##(1994-2#1)(1995-2#1)(1996-2#1)(2008-2#1)
planning programs##8##2##(1997-2#2)(2006-4#1)(2007-9#1)(2008-7#2)(2012-11#1)(2013-1#1)
planning should##3##2##(1991-3#1)(2007-12#1)(2012-2#1)
planning software##3##2##(2007-5#1)(2008-11#1)(2008-3#1)
planning stages##4##2##(2007-11#1)(2008-1#1)(2010-8#1)(2013-1#1)
planning strategies##5##2##(1992-1#1)(1993-2#1)(1996-3#2)(2009-4#1)
planning strategy##2##2##(1993-3#1)(2008-9#1)
planning structure##2##2##(1995-4#1)(1996-1#1)
planning surgical##3##2##(2007-11#1)(2007-8#2)
planning system for##2##3##(2007-5#2)
planning system##11##2##(1996-1#2)(2007-5#2)(2008-3#3)(2009-11#2)(2013-1#2)
planning target volume (PTV)##7##4##(2008-2#2)(2008-3#1)(2008-6#1)(2009-10#1)(2009-5#1)(2012-12#1)
planning that leads to##2##4##(2006-2#1)(2010-2#1)
planning that##4##2##(1992-6#1)(2006-2#1)(2008-8#1)(2010-2#1)
planning the##11##2##(1991-4#1)(1994-2#1)(1995-1#1)(1995-2#1)(2006-5#1)(2006-7#1)(2007-11#1)(2008-6#1)(2013-1#1)(2013-8#2)
planning to improve##2##3##(1992-1#1)(2010-4#1)
planning to return##2##3##(1993-1#2)
planning to##19##2##(1990-2#1)(1991-1#1)(1992-1#1)(1993-1#2)(1995-2#1)(1996-1#1)(2005-8#1)(2007-2#2)(2007-7#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-4#1)(2010-9#1)(2013-1#2)
planning tool##5##2##(1991-2#1)(1997-1#1)(1997-3#1)(2007-1#1)(2008-7#1)
planning tools##9##2##(1994-1#2)(1994-2#2)(2007-12#1)(2009-11#1)(2009-5#1)(2013-1#2)
planning treatment strategies##2##3##(2008-9#1)(2013-8#1)
planning treatment##6##2##(2006-7#1)(2008-11#1)(2008-6#1)(2008-9#1)(2013-7#1)(2013-8#1)
planning using##4##2##(1995-9#1)(1997-3#1)(2011-1#1)(2012-2#1)
planning was##9##2##(1992-4#3)(1994-12#1)(1994-2#1)(2008-7#1)(2009-2#2)(2013-1#1)
planning were##3##2##(2005-9#1)(2010-2#1)(2012-11#1)
planning with##7##2##(2007-7#1)(2008-11#1)(2008-2#1)(2008-7#2)(2009-5#1)(2012-3#1)
planning within the##2##3##(2008-11#1)(2010-10#1)
planning work##2##2##(2008-11#1)(2012-3#1)
planning##1052##1##(1990-12#12)(1990-2#1)(1990-3#1)(1990-9#3)(1991-1#13)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#12)(1991-3#8)(1991-4#3)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#6)(1992-10#2)(1992-11#2)(1992-12#7)(1992-2#17)(1992-3#4)(1992-4#9)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-1#6)(1993-11#2)(1993-12#6)(1993-2#8)(1993-3#11)(1993-4#1)(1993-6#3)(1993-8#5)(1993-9#1)(1994-1#18)(1994-10#1)(1994-11#1)(1994-12#8)(1994-2#33)(1994-3#21)(1994-6#4)(1994-7#6)(1994-8#10)(1994-9#3)(1995-1#12)(1995-12#1)(1995-2#7)(1995-3#5)(1995-4#1)(1995-5#1)(1995-8#3)(1995-9#2)(1996-1#12)(1996-12#9)(1996-2#9)(1996-3#8)(1996-4#2)(1996-6#2)(1997-1#17)(1997-2#16)(1997-3#10)(1997-5#1)(1997-6#1)(1997-8#3)(2004-1#1)(2004-10#2)(2004-4#1)(2004-7#1)(2004-9#1)(2005-10#2)(2005-11#3)(2005-12#2)(2005-4#1)(2005-5#1)(2005-6#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#7)(2006-12#3)(2006-2#17)(2006-3#3)(2006-4#8)(2006-5#11)(2006-6#14)(2006-7#3)(2006-8#1)(2007-1#6)(2007-10#5)(2007-11#11)(2007-12#9)(2007-2#10)(2007-3#3)(2007-4#7)(2007-5#9)(2007-6#2)(2007-7#19)(2007-8#13)(2007-9#3)(2008-1#10)(2008-10#10)(2008-11#27)(2008-12#9)(2008-2#24)(2008-3#13)(2008-4#3)(2008-5#2)(2008-6#8)(2008-7#23)(2008-8#17)(2008-9#20)(2009-10#3)(2009-11#14)(2009-12#2)(2009-2#7)(2009-3#4)(2009-4#7)(2009-5#6)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#7)(2010-12#7)(2010-2#12)(2010-3#8)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#12)(2010-9#2)(2011-1#12)(2011-11#1)(2011-12#3)(2011-2#27)(2011-3#1)(2011-7#1)(2012-1#5)(2012-11#17)(2012-12#19)(2012-2#14)(2012-3#22)(2013-1#63)(2013-7#9)(2013-8#8)
planning&quot##2##1##(1992-3#1)(2008-11#1)
planning)##2##1##(2008-9#2)
planning]##2##1##(1994-3#1)(1996-6#1)
plano-concave##2##1##(2008-2#2)
plano-convex lens##2##2##(2007-12#2)
plano-convex##4##1##(2007-12#2)(2008-2#2)
planovalgus deformity##5##2##(2009-10#3)(2009-3#2)
planovalgus##6##1##(2009-10#3)(2009-3#3)
plans among##3##2##(1992-2#1)(2013-1#2)
plans and providers##3##3##(1996-3#2)(2008-6#1)
plans and the##3##3##(1997-2#1)(2005-11#1)(2009-4#1)
plans and##24##2##(1991-2#1)(1991-3#1)(1992-2#1)(1993-1#1)(1993-3#1)(1994-3#2)(1996-12#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-3#1)(2005-11#1)(2006-5#1)(2007-5#1)(2008-1#3)(2008-10#1)(2008-6#2)(2009-4#2)
plans are available##2##3##(1993-3#1)(2007-4#1)
plans are##12##2##(1991-3#1)(1993-3#1)(1997-3#2)(2006-1#1)(2006-11#1)(2006-5#1)(2007-3#1)(2007-4#3)(2008-1#1)
plans based on##4##3##(2007-4#1)(2007-6#1)(2009-5#1)(2011-12#1)
plans by##3##2##(1993-3#1)(2005-3#1)(2006-5#1)
plans can be##2##3##(1997-1#1)(2008-8#1)
plans can##6##2##(1997-1#1)(1997-2#3)(2006-8#1)(2008-8#1)
plans for preventive##2##3##(1990-12#1)(1997-1#1)
plans for the future##3##4##(1990-3#1)(2007-4#1)(2013-7#1)
plans for the##5##3##(1990-3#1)(1995-12#1)(1996-5#1)(2007-4#1)(2013-7#1)
plans for their##2##3##(1993-3#1)(1996-3#1)
plans for##39##2##(1990-12#1)(1990-3#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-2#2)(1994-7#1)(1995-12#3)(1996-1#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-4#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-5#1)(2010-6#1)(2010-8#1)(2012-3#1)(2013-1#2)(2013-7#1)
plans has##3##2##(1994-1#1)(2008-10#1)(2008-11#1)
plans have##7##2##(1996-12#1)(1997-2#1)(2005-12#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-12#1)
plans if##2##2##(1991-3#1)(1992-9#1)
plans in radiology##2##3##(1993-3#1)(2007-4#1)
plans in the##2##3##(1994-3#1)(2008-11#1)
plans in##14##2##(1993-3#1)(1993-5#1)(1994-3#1)(1995-12#2)(1996-12#1)(1996-3#1)(1997-1#2)(1997-2#2)(2007-4#1)(2008-11#1)(2010-9#1)
plans may##3##2##(1992-12#1)(1996-2#1)(2005-9#1)
plans must##3##2##(1996-1#1)(1997-1#1)(2011-2#1)
plans of the##2##3##(2007-11#2)
plans of##8##2##(1992-2#1)(1993-3#1)(2007-11#2)(2008-2#2)(2010-12#1)(2013-7#1)
plans often##2##2##(2007-2#1)(2008-12#1)
plans on##3##2##(1990-12#1)(1994-1#1)(2005-8#1)
plans or##3##2##(1991-2#1)(1994-3#1)(1995-12#1)
plans that##11##2##(1994-1#1)(1995-1#1)(1997-1#2)(1997-3#2)(2007-12#1)(2008-2#1)(2008-5#1)(2009-4#1)(2012-2#1)
plans to build##2##3##(1993-6#1)(2007-9#1)
plans to meet the##2##4##(1994-2#1)(2006-5#1)
plans to meet##3##3##(1994-2#1)(2005-8#1)(2006-5#1)
plans to open##2##3##(1994-3#2)
plans to turn##2##3##(2007-6#1)(2007-9#1)
plans to##42##2##(1990-12#2)(1991-10#1)(1991-11#1)(1991-9#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#4)(1995-1#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-5#1)(2007-4#3)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-2#2)
plans were generated##2##3##(2008-6#1)(2009-5#1)
plans were##13##2##(1997-3#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#2)(2009-5#2)(2012-1#1)(2013-1#3)
plans with##6##2##(1997-2#1)(2008-3#1)(2009-5#2)(2013-1#2)
plans##420##1##(1990-12#5)(1990-3#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#5)(1991-3#7)(1991-9#1)(1992-12#3)(1992-2#6)(1992-3#2)(1992-5#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-12#2)(1993-2#1)(1993-3#8)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-1#9)(1994-12#3)(1994-2#9)(1994-3#14)(1994-5#1)(1994-7#1)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#10)(1995-2#2)(1995-3#3)(1995-5#2)(1995-7#1)(1995-8#1)(1996-1#4)(1996-12#7)(1996-2#12)(1996-3#14)(1996-5#1)(1996-8#1)(1997-1#15)(1997-2#11)(1997-3#13)(1997-5#5)(2005-10#1)(2005-11#5)(2005-12#6)(2005-3#1)(2005-7#1)(2005-8#2)(2005-9#2)(2006-1#4)(2006-11#1)(2006-5#8)(2006-8#6)(2006-9#2)(2007-11#4)(2007-12#1)(2007-2#7)(2007-3#2)(2007-4#16)(2007-5#4)(2007-6#2)(2007-8#1)(2007-9#5)(2008-1#11)(2008-10#8)(2008-11#11)(2008-12#3)(2008-2#3)(2008-3#9)(2008-4#6)(2008-5#1)(2008-6#7)(2008-7#2)(2008-8#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#10)(2009-6#1)(2009-8#3)(2010-10#1)(2010-12#2)(2010-2#3)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#1)(2011-12#4)(2011-2#4)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#18)(2013-7#4)(2013-8#3)
plans&quot##3##1##(1993-12#1)(2012-1#2)
plans)##4##1##(1996-3#1)(2008-3#3)
plant &quot##3##2##(1994-3#1)(2008-11#2)
plant AChEs##3##2##(2009-8#3)
plant Arabidopsis thaliana##10##3##(1994-8#1)(1996-10#1)(1996-5#1)(2008-7#1)(2008-9#3)(2009-3#1)(2011-1#1)(2011-2#1)
plant Arabidopsis##11##2##(1994-8#1)(1996-10#1)(1996-5#1)(2008-7#1)(2008-9#3)(2009-3#1)(2009-8#1)(2011-1#1)(2011-2#1)
plant DNA barcode##2##3##(2009-9#1)(2012-2#1)
plant DNA##12##2##(2008-10#3)(2008-9#1)(2009-9#2)(2010-10#1)(2010-2#3)(2012-2#2)
plant N##2##2##(2009-8#1)(2012-1#1)
plant PKC##3##2##(1994-8#3)
plant RNA##5##2##(1992-1#1)(2008-10#3)(2008-9#1)
plant Senecio##3##2##(1990-7#2)(2012-2#1)
plant activators##6##2##(2007-11#1)(2008-10#5)
plant against##5##2##(2007-12#1)(2008-4#1)(2008-8#2)(2009-8#1)
plant age and##2##3##(2008-10#2)
plant age at##2##3##(2008-10#2)
plant age##12##2##(2006-12#1)(2007-1#1)(2008-10#8)(2011-2#2)
plant alkaloid##4##2##(1992-1#1)(1993-8#1)(1994-8#1)(2011-1#1)
plant and a##3##3##(2008-10#2)(2012-2#1)
plant and algal systems##2##4##(2009-8#2)
plant and algal##3##3##(1990-12#1)(2009-8#2)
plant and animal cells##4##4##(1994-12#1)(1995-8#1)(2008-2#1)(2008-4#1)
plant and animal species##2##4##(1992-4#1)(2009-5#1)
plant and animal viruses##2##4##(1995-8#1)(2005-8#1)
plant and animal##22##3##(1992-4#1)(1992-7#1)(1994-12#1)(1995-8#2)(2005-10#1)(2005-5#1)(2005-8#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#2)(2009-6#1)(2011-2#1)(2012-3#1)
plant and bacterial##2##3##(2008-7#2)
plant and fungal##3##3##(2008-10#2)(2009-8#1)
plant and insect##3##3##(2008-1#1)(2008-10#2)
plant and its##2##3##(1991-12#1)(2009-8#1)
plant and pathogen##2##3##(2011-10#2)
plant and the##4##3##(2008-10#2)(2012-2#2)
plant and to##2##3##(2008-10#1)(2009-10#1)
plant and##70##2##(1990-12#1)(1991-12#1)(1992-1#1)(1992-4#1)(1992-7#1)(1994-12#1)(1994-6#2)(1995-8#2)(2004-2#1)(2005-10#1)(2005-5#1)(2005-8#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#2)(2009-10#1)(2009-5#2)(2009-6#1)(2009-8#4)(2011-10#2)(2011-2#1)(2012-2#4)(2012-3#1)
plant antifungal peptides##2##3##(1994-12#2)
plant architecture##3##2##(2006-12#1)(2008-7#1)(2011-12#1)
plant are##3##2##(1993-3#1)(2007-1#1)(2007-3#1)
plant as a##3##3##(2007-11#1)(2008-10#2)
plant as##5##2##(2007-11#1)(2008-10#2)(2008-11#1)(2008-6#1)
plant assays##2##2##(2008-10#2)
plant associations##2##2##(2008-10#1)(2008-5#1)
plant at##3##2##(2008-10#1)(2008-12#1)(2012-12#1)
plant availability##3##2##(1992-3#2)(2008-10#1)
plant bioinformatics##2##2##(2008-7#2)
plant biology and##2##3##(2008-7#1)(2008-9#1)
plant biology##7##2##(2007-12#1)(2008-7#3)(2008-9#2)(2012-1#1)
plant biomass and##2##3##(2008-11#1)(2012-2#1)
plant biomass reductions were##2##4##(2008-10#2)
plant biomass##12##2##(2008-10#2)(2008-11#1)(2008-8#5)(2010-12#1)(2012-2#2)(2013-8#1)
plant biotechnology##7##2##(1994-6#1)(2006-12#2)(2008-7#1)(2009-6#1)(2009-8#1)(2012-2#1)
plant breeding and##3##3##(2006-12#1)(2008-10#1)(2009-2#1)
plant breeding##10##2##(2006-12#2)(2006-4#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-2#1)(2013-8#1)
plant by##6##2##(2007-1#1)(2008-10#3)(2008-9#1)(2009-8#1)
plant can##3##2##(1995-8#1)(2008-10#1)(2008-11#1)
plant canopy##3##2##(1993-3#1)(2008-10#2)
plant carbon/nitrogen ratio##2##3##(2008-10#2)
plant carbon/nitrogen##3##2##(2008-10#3)
plant cell death##2##3##(2009-8#2)
plant cell is##3##3##(2009-8#2)(2010-3#1)
plant cell wall##4##3##(1994-3#1)(1995-3#1)(2009-10#1)(2010-2#1)
plant cell walls##6##3##(2008-9#1)(2009-10#1)(2012-2#1)(2013-8#3)
plant cell##26##2##(1994-11#1)(1994-3#1)(1995-2#1)(1995-3#1)(1997-4#1)(2008-1#2)(2008-7#1)(2008-9#1)(2009-10#2)(2009-8#7)(2010-2#1)(2010-3#1)(2012-1#1)(2012-2#1)(2013-8#4)
plant cells and tissues##2##4##(2008-4#1)(2010-11#1)
plant cells and##7##3##(2006-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-8#2)(2010-11#1)
plant cells during##3##3##(1992-5#1)(2008-7#1)(2009-8#1)
plant cells is##3##3##(2008-9#1)(2009-8#2)
plant cells may##2##3##(2009-8#2)
plant cells to##3##3##(1997-8#1)(2008-8#1)(2009-8#1)
plant cells using##2##3##(2008-11#1)(2008-9#1)
plant cells##68##2##(1992-11#1)(1992-5#2)(1994-11#2)(1994-8#1)(1995-6#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-12#3)(2008-10#5)(2008-11#5)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#6)(2008-9#4)(2009-10#4)(2009-6#2)(2009-8#20)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
plant chloroplasts##4##2##(1993-6#1)(1994-12#1)(1995-8#1)(1997-6#1)
plant cold responsive##2##3##(2006-12#2)
plant communities in##4##3##(2007-3#1)(2008-5#1)(2008-8#1)(2013-7#1)
plant communities##13##2##(2007-3#1)(2007-9#3)(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#1)(2012-6#1)(2013-7#3)
plant community structure##2##3##(2008-5#1)(2008-8#1)
plant community##7##2##(2008-11#1)(2008-5#1)(2008-8#4)(2013-8#1)
plant compartments##2##2##(2010-11#2)
plant competition##2##2##(2008-10#1)(2008-8#1)
plant complex##7##2##(2008-5#6)(2009-8#1)
plant compounds##2##2##(2009-3#2)
plant constituents##2##2##(2008-10#1)(2009-6#1)
plant cover##5##2##(2006-12#1)(2008-8#4)
plant damage##5##2##(2008-10#2)(2008-8#3)
plant databases##2##2##(2008-7#2)
plant defence##4##2##(2006-5#1)(2011-1#3)
plant defences##2##2##(1991-11#1)(2011-10#1)
plant defense against##5##3##(1990-12#1)(2008-10#3)(2009-8#1)
plant defense mechanisms##2##3##(1994-2#1)(2008-10#1)
plant defense reactions##4##3##(2008-10#4)
plant defense response##2##3##(2008-10#2)
plant defense responses##2##3##(2008-10#1)(2009-8#1)
plant defense##28##2##(1990-12#1)(1994-2#1)(1994-3#1)(1997-4#1)(2008-10#14)(2008-8#3)(2008-9#1)(2009-8#6)
plant defenses##2##2##(2008-9#1)(2009-8#1)
plant density##5##2##(2008-10#3)(2008-8#1)(2008-9#1)
plant derived##4##2##(1990-5#1)(2007-12#1)(2008-10#1)(2011-3#1)
plant development and##7##3##(2008-10#2)(2008-9#1)(2009-6#1)(2009-8#1)(2010-2#1)(2012-3#1)
plant development##22##2##(2006-12#3)(2007-8#1)(2008-10#7)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#6)(2010-2#1)(2012-3#1)
plant digests##2##2##(2008-10#2)
plant disease and##2##3##(2008-10#2)
plant disease control##2##3##(2008-10#2)
plant disease epidemics##7##3##(2007-9#1)(2008-10#6)
plant disease epidemiology##3##3##(2008-10#3)
plant disease forecasting##2##3##(2008-10#2)
plant disease incidence##2##3##(2008-10#2)
plant disease management##2##3##(2008-10#2)
plant disease resistance##6##3##(2008-10#4)(2009-6#1)(2009-8#1)
plant disease suppression##3##3##(2008-10#3)
plant disease##44##2##(2007-9#2)(2008-10#38)(2008-8#1)(2009-6#1)(2009-8#1)(2011-1#1)
plant diseases in##2##3##(2008-10#2)
plant diseases##19##2##(2008-10#17)(2009-8#1)(2012-2#1)
plant diversification##2##2##(2010-5#1)(2012-3#1)
plant diversity##9##2##(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#5)
plant drugs##4##2##(2005-4#3)(2008-11#1)
plant dry##2##2##(2008-10#1)(2013-8#1)
plant during##2##2##(2007-12#1)(2008-10#1)
plant ecology##2##2##(2008-8#2)
plant enzyme##4##2##(1990-10#1)(1993-6#1)(1994-10#1)(1996-5#1)
plant evolution##4##2##(1996-4#1)(2009-6#2)(2009-8#1)
plant expression vectors were constructed##2##5##(2008-9#2)
plant expression vectors##3##3##(2008-8#1)(2008-9#2)
plant expression##5##2##(1997-6#1)(2008-8#1)(2008-9#3)
plant extract##11##2##(1994-6#1)(2007-10#2)(2008-5#1)(2010-12#1)(2011-1#1)(2012-12#2)(2013-1#2)(2013-7#1)
plant extracts and##4##3##(2005-8#1)(2008-10#2)(2008-5#1)
plant extracts for##3##3##(1993-9#1)(2008-5#2)
plant extracts from##2##3##(2008-10#1)(2011-1#1)
plant extracts were##2##3##(2008-5#1)(2011-1#1)
plant extracts with a##2##4##(2008-10#1)(2008-5#1)
plant extracts##50##2##(1992-2#1)(1993-9#1)(2005-8#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-8#2)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#3)(2008-5#13)(2010-12#1)(2010-2#1)(2011-1#4)(2011-2#1)(2012-11#2)(2012-12#1)(2013-1#1)
plant families##8##2##(2006-12#3)(2007-6#1)(2008-10#3)(2008-8#1)
plant family##3##2##(2008-7#1)(2008-8#1)(2012-2#1)
plant fatty acids##2##3##(1991-7#1)(1996-5#1)
plant fitness##4##2##(2008-8#4)
plant folate##2##2##(2011-2#2)
plant food##3##2##(1991-11#1)(1996-4#1)(2008-10#1)
plant foods##8##2##(1990-9#1)(1991-11#4)(2012-12#2)(2013-1#1)
plant for##8##2##(1992-2#1)(1996-12#1)(2007-10#1)(2008-10#1)(2008-8#1)(2010-7#1)(2011-3#1)(2012-11#1)
plant from##5##2##(1994-7#1)(2008-10#2)(2008-11#1)(2008-6#1)
plant functional genomics##2##3##(2008-7#2)
plant functional group richness##5##4##(2008-8#5)
plant functional group##6##3##(2008-8#6)
plant functional##9##2##(2008-7#2)(2008-8#6)(2008-9#1)
plant gene encoding a##2##4##(1993-2#1)(1995-6#1)
plant gene##5##2##(1993-2#1)(1995-2#1)(1995-6#1)(2008-9#1)(2010-10#1)
plant genera##2##2##(2008-10#1)(2008-5#1)
plant generations##2##2##(2006-12#1)(2008-10#1)
plant genes##10##2##(1994-3#1)(1997-6#1)(2006-12#2)(2008-10#3)(2008-7#1)(2012-2#2)
plant genetic##4##2##(2008-10#1)(2008-7#1)(2008-9#1)(2009-8#1)
plant genome##7##2##(2007-6#1)(2008-10#1)(2008-7#3)(2008-9#1)(2011-2#1)
plant genomes##6##2##(2006-12#2)(2009-6#1)(2009-8#1)(2012-3#1)(2013-8#1)
plant genomic##2##2##(1997-7#1)(2008-7#1)
plant genomics##2##2##(2008-7#1)(2010-2#1)
plant genotype##3##2##(2008-10#3)
plant grown in##2##3##(2008-12#1)(2012-12#1)
plant growth and development and##2##5##(2009-6#2)
plant growth and development##6##4##(2008-9#1)(2009-6#2)(2009-8#2)(2011-1#1)
plant growth and nutrient##2##4##(2008-10#1)(2013-8#1)
plant growth and##17##3##(2008-10#5)(2008-9#1)(2009-10#1)(2009-6#2)(2009-8#6)(2011-1#1)(2013-8#1)
plant growth in##2##3##(2008-10#1)(2008-8#1)
plant growth on##2##3##(2007-12#1)(2009-8#1)
plant growth parameters##3##3##(2008-10#3)
plant growth promotion##8##3##(2007-12#1)(2008-10#4)(2013-8#3)
plant growth regulator##2##3##(2008-10#1)(2011-1#1)
plant growth regulators##8##3##(1997-1#2)(2007-7#1)(2008-10#3)(2008-12#1)(2013-1#1)
plant growth stage was##2##4##(2008-10#2)
plant growth stage##4##3##(2008-10#2)(2011-2#2)
plant growth stages##3##3##(2008-10#2)(2011-2#1)
plant growth##86##2##(1997-1#2)(2005-11#1)(2006-9#2)(2007-11#1)(2007-12#4)(2007-7#1)(2008-10#36)(2008-11#1)(2008-12#3)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-6#2)(2009-8#11)(2011-1#2)(2011-2#4)(2012-7#1)(2013-1#1)(2013-8#5)
plant growth-promoting rhizobacteria##6##3##(2007-12#1)(2008-10#5)
plant growth-promoting##7##2##(2007-12#1)(2008-10#6)
plant habit##2##2##(2008-10#1)(2009-10#1)
plant has been##3##3##(2007-10#1)(2008-6#1)(2011-2#1)
plant has##4##2##(2006-9#1)(2007-10#1)(2008-6#1)(2011-2#1)
plant have##2##2##(2004-4#1)(2012-2#1)
plant health##3##2##(2005-5#2)(2008-10#1)
plant height and##3##3##(2008-10#1)(2008-12#2)
plant height was##2##3##(2008-12#2)
plant height##22##2##(2008-10#12)(2008-12#6)(2008-9#1)(2013-7#2)(2013-8#1)
plant homeodomain proteins##2##3##(1997-5#2)
plant hormone auxin##2##3##(2009-6#2)
plant hormone ethylene##2##3##(1992-1#1)(2009-8#1)
plant hormone##12##2##(1992-1#1)(2009-6#4)(2009-8#6)(2011-10#1)
plant hormones##6##2##(1994-8#1)(2008-10#1)(2008-9#1)(2009-8#3)
plant host##11##2##(2005-8#1)(2008-1#1)(2008-10#6)(2008-8#1)(2008-9#1)(2013-1#1)
plant hosts and##2##3##(2008-10#1)(2009-8#1)
plant hosts##9##2##(2008-10#7)(2009-8#2)
plant hydrolysates##4##2##(2008-11#3)(2012-3#1)
plant immune responses##2##3##(2009-8#2)
plant immunity##4##2##(2009-6#1)(2009-8#2)(2011-2#1)
plant in a##2##3##(2008-10#2)
plant in##19##2##(1994-6#1)(2004-2#1)(2004-4#2)(2006-12#1)(2008-10#6)(2008-2#1)(2008-6#1)(2009-8#1)(2010-5#1)(2012-1#1)(2012-11#2)(2012-2#1)
plant increased##2##2##(2008-10#1)(2008-2#1)
plant infected##3##2##(2008-10#2)(2008-9#1)
plant infection by##3##3##(2008-10#3)
plant infection##4##2##(2008-10#4)
plant introduction (PI)##2##3##(2008-10#2)
plant is##13##2##(1997-6#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-8#1)(2009-6#1)(2009-8#1)(2011-2#1)(2013-8#1)
plant isolates##3##2##(2008-10#3)
plant keratin intermediate filaments##3##4##(2008-8#3)
plant keratin intermediate##4##3##(2008-8#4)
plant kingdom##11##2##(1991-8#1)(2007-6#1)(2008-10#1)(2009-12#1)(2009-5#1)(2009-8#2)(2011-2#1)(2012-2#1)(2013-8#2)
plant leaf K concentration##2##4##(2013-8#2)
plant leaf N##5##3##(2013-8#5)
plant leaf##11##2##(2008-10#1)(2013-8#10)
plant leaves##10##2##(2007-6#1)(2008-10#5)(2008-5#1)(2008-8#1)(2008-9#1)(2013-7#1)
plant lectin##2##2##(1991-3#1)(2008-10#1)
plant lectins##2##2##(1990-7#1)(2008-9#1)
plant level##2##2##(2008-10#1)(2009-8#1)
plant life##2##2##(2007-8#1)(2011-2#1)
plant lineage##3##2##(2009-10#1)(2011-2#2)
plant lineages##3##2##(2009-8#2)(2011-2#1)
plant lines##3##2##(2006-12#2)(2008-10#1)
plant lipids##3##2##(1991-2#1)(2008-11#2)
plant litter##2##2##(2005-12#1)(2008-6#1)
plant mass##2##2##(2008-10#1)(2008-9#1)
plant material and##2##3##(2008-10#1)(2008-9#1)
plant material from##2##3##(2008-10#1)(2008-9#1)
plant material is##3##3##(2008-10#2)(2008-11#1)
plant material was##3##3##(2007-1#1)(2007-11#1)(2008-10#1)
plant material##39##2##(2004-2#1)(2004-4#1)(2005-10#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#20)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#5)(2011-12#1)(2012-2#1)
plant materials from##2##3##(2008-10#2)
plant materials in##2##3##(2008-10#1)(2010-5#1)
plant materials##16##2##(1992-2#1)(2005-10#1)(2006-12#1)(2007-1#1)(2008-10#10)(2008-5#1)(2010-5#1)
plant matrices##2##2##(2008-10#2)
plant maturity##3##2##(2008-10#3)
plant may##2##2##(2008-2#1)(2009-8#1)
plant membrane##2##2##(1990-11#1)(2008-7#1)
plant metabolism##5##2##(2008-10#1)(2008-11#1)(2009-8#1)(2012-1#2)
plant metabolites##3##2##(2007-1#1)(2008-10#1)(2012-12#1)
plant mitochondria##4##2##(1992-2#1)(1993-8#1)(1994-2#1)(1995-8#1)
plant molecular##2##2##(2008-7#1)(2012-2#1)
plant morphology##2##2##(2008-9#1)(2012-11#1)
plant mortality##4##2##(2011-1#2)(2013-1#2)
plant names##2##2##(2008-5#1)(2012-2#1)
plant nuclei##2##2##(1995-1#1)(2009-8#1)
plant nutrition##3##2##(2006-12#1)(2009-10#1)(2011-2#1)
plant odors##2##2##(1990-11#1)(2007-12#1)
plant of##5##2##(2006-12#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-12#1)
plant oils##2##2##(2008-7#1)(2009-3#1)
plant on##2##2##(2008-10#2)
plant or##5##2##(2007-11#1)(2008-1#1)(2008-7#2)(2009-5#1)
plant orders##3##2##(2008-10#3)
plant organ/tissue##2##2##(2010-12#2)
plant organs##5##2##(1991-11#1)(1994-11#1)(2008-10#2)(2008-11#1)
plant origin##11##2##(1994-5#1)(1996-1#1)(1997-4#1)(2006-10#2)(2006-9#1)(2008-10#1)(2012-2#1)(2013-8#3)
plant parasites##3##2##(2008-10#1)(2008-8#2)
plant parasitic##2##2##(2008-10#1)(2009-8#1)
plant part##2##2##(2008-10#1)(2013-8#1)
plant parts##16##2##(1991-11#2)(2004-4#1)(2007-11#2)(2008-10#5)(2008-5#3)(2008-7#1)(2008-8#1)(2010-1#1)
plant pathogen that##2##3##(2008-10#2)
plant pathogen##17##2##(2008-10#13)(2008-8#1)(2008-9#1)(2010-10#1)(2011-1#1)
plant pathogenic bacteria##3##3##(2008-10#2)(2009-6#1)
plant pathogenic##8##2##(1997-6#1)(2005-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-6#1)
plant pathogens and##5##3##(2008-10#3)(2009-8#1)(2011-1#1)
plant pathogens by##4##3##(2008-10#4)
plant pathogens in##4##3##(2008-10#4)
plant pathogens is##2##3##(2008-10#2)
plant pathogens##59##2##(1994-3#1)(2008-10#53)(2009-2#1)(2009-8#1)(2010-10#1)(2011-1#2)
plant pathologists##6##2##(2008-10#5)(2011-1#1)
plant pathology##15##2##(1990-9#1)(1992-9#1)(2008-10#13)
plant pattern##2##2##(2009-10#1)(2009-6#1)
plant penetration##2##2##(2007-12#1)(2008-10#1)
plant performance##3##2##(2008-8#1)(2012-5#1)(2012-7#1)
plant peroxidases##2##2##(1990-4#1)(2006-10#1)
plant pheophytin##2##2##(2008-8#1)(2008-9#1)
plant photosynthesis##2##2##(2008-10#1)(2008-8#1)
plant physiological##3##2##(1994-2#1)(2008-10#1)(2008-4#1)
plant physiologist##3##2##(2008-7#2)(2012-1#1)
plant physiology##5##2##(2006-12#1)(2008-10#1)(2008-7#2)(2012-5#1)
plant pigments##3##2##(2007-10#3)
plant polyphenols in##2##3##(1996-1#1)(2009-8#1)
plant polyphenols##3##2##(1996-1#2)(2009-8#1)
plant population can be##2##4##(1995-8#1)(2008-12#1)
plant population##11##2##(1995-8#1)(2008-10#2)(2008-12#7)(2008-9#1)
plant populations##21##2##(1995-8#2)(2007-9#1)(2008-10#2)(2008-12#2)(2008-8#9)(2008-9#5)
plant processes##3##2##(1990-9#2)(2008-10#1)
plant producing##2##2##(2008-12#1)(2012-2#1)
plant production system##2##3##(2008-7#2)
plant production##5##2##(2008-10#2)(2008-7#2)(2008-8#1)
plant productivity##3##2##(2008-8#2)(2013-8#1)
plant products##7##2##(1993-11#1)(2006-9#1)(2007-12#1)(2008-5#1)(2012-1#2)(2012-2#1)
plant profilins##2##2##(1994-2#2)
plant propagation##2##2##(2008-10#1)(2009-8#1)
plant protection##8##2##(2008-10#2)(2008-11#3)(2011-10#1)(2011-2#1)(2013-8#1)
plant protein##4##2##(1997-2#1)(2008-11#1)(2009-8#1)(2011-2#1)
plant proteins##3##2##(1996-2#1)(2008-10#1)(2009-8#1)
plant protoplasts##5##2##(2008-1#1)(2008-2#1)(2008-9#3)
plant quality##2##2##(2009-10#1)(2012-3#1)
plant regeneration##2##2##(2008-12#1)(2013-1#1)
plant regulatory##2##2##(2008-10#1)(2009-8#1)
plant reproduction##2##2##(2008-8#1)(2008-9#1)
plant reproductive##2##2##(1990-6#1)(2008-8#1)
plant research##3##2##(2008-9#1)(2009-10#1)(2013-8#1)
plant resistance (R) genes##2##4##(2008-8#1)(2009-6#1)
plant resistance genes##2##3##(2008-10#2)
plant resistance has##2##3##(2008-9#1)(2012-11#1)
plant resistance to##7##3##(2008-10#5)(2008-8#1)(2011-2#1)
plant resistance##24##2##(2008-10#13)(2008-6#1)(2008-8#5)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-11#1)
plant resources##2##2##(2008-8#2)
plant response to##3##3##(2008-10#2)(2009-8#1)
plant response##7##2##(2004-2#1)(2008-10#3)(2009-8#1)(2010-12#2)
plant responses to herbivory##2##4##(2008-8#2)
plant responses to insect feeding##2##5##(2009-8#2)
plant responses to iron deficiency##2##5##(2009-8#2)
plant responses to##13##3##(2004-2#1)(2008-10#1)(2008-8#3)(2009-6#1)(2009-8#7)
plant responses##15##2##(2004-2#1)(2008-10#2)(2008-8#3)(2009-6#1)(2009-8#8)
plant resulted in##2##3##(1994-3#1)(2008-10#1)
plant revealed##3##2##(1996-3#1)(2008-10#2)
plant richness and##2##3##(2008-8#1)(2013-7#1)
plant richness##3##2##(2008-8#1)(2013-7#2)
plant root##4##2##(1994-6#1)(2008-7#1)(2010-10#1)(2012-1#1)
plant roots##15##2##(1992-3#1)(2004-4#1)(2006-5#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-4#2)(2009-8#1)(2012-1#1)
plant sPLA₂s##2##2##(2013-1#2)
plant samples and##2##3##(2008-10#1)(2008-6#1)
plant samples was##2##3##(2008-10#2)
plant samples##34##2##(2008-10#27)(2008-11#1)(2008-6#2)(2008-9#1)(2013-7#1)(2013-8#2)
plant sap##2##2##(2007-12#1)(2013-8#1)
plant scale##2##2##(1995-3#1)(2008-10#1)
plant scales##2##2##(2008-10#2)
plant sciences##3##2##(1994-11#1)(2008-7#1)(2011-10#1)
plant scientists##3##2##(2007-9#1)(2008-4#1)(2009-6#1)
plant seeds##2##2##(2008-9#1)(2012-2#1)
plant sequences##2##2##(2008-10#1)(2008-7#1)
plant showed##2##2##(2008-10#1)(2008-9#1)
plant signal##2##2##(2006-11#1)(2009-6#1)
plant signaling##2##2##(2008-4#1)(2009-6#1)
plant size##3##2##(2008-5#1)(2008-8#2)
plant source##2##2##(2006-12#1)(2008-10#1)
plant sources##2##2##(2008-10#1)(2008-8#1)
plant spacing##4##2##(2008-12#4)
plant species and##8##3##(1991-11#1)(2004-4#1)(2008-10#3)(2008-11#1)(2009-8#1)(2011-12#1)
plant species are##2##3##(2008-10#1)(2008-8#1)
plant species belonging to##3##4##(2008-10#2)(2013-1#1)
plant species from##2##3##(2006-12#1)(2013-7#1)
plant species in##6##3##(2008-10#2)(2008-8#1)(2010-3#1)(2012-11#1)(2013-8#1)
plant species of##2##3##(2008-2#1)(2009-10#1)
plant species richness and plant functional group richness##2##8##(2008-8#2)
plant species richness and plant functional##3##6##(2008-8#2)(2008-9#1)
plant species richness##7##3##(2008-8#5)(2008-9#2)
plant species tested were##2##4##(2008-10#1)(2008-6#1)
plant species tested##6##3##(2004-4#1)(2008-10#3)(2008-12#1)(2008-6#1)
plant species that##2##3##(2013-7#2)
plant species to##2##3##(2008-8#1)(2009-8#1)
plant species was##3##3##(2008-10#3)
plant species were screened for their##2##6##(2008-10#1)(2008-8#1)
plant species were##3##3##(2008-10#1)(2008-8#1)(2012-6#1)
plant species##138##2##(1991-11#1)(1992-2#1)(1994-3#1)(1995-8#1)(2004-11#1)(2004-4#5)(2006-12#4)(2007-1#1)(2007-6#3)(2008-10#48)(2008-11#2)(2008-12#2)(2008-2#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#20)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#7)(2010-12#1)(2010-3#3)(2010-5#2)(2011-12#1)(2011-2#2)(2012-11#1)(2012-2#2)(2012-6#1)(2013-1#1)(2013-7#4)(2013-8#6)
plant species/cultivars##2##2##(2008-10#2)
plant stages##2##2##(2007-1#1)(2008-10#1)
plant stem##3##2##(2008-10#2)(2012-5#1)
plant stems##2##2##(1995-1#1)(2008-10#1)
plant sterols##6##2##(1992-6#1)(2008-12#1)(2009-4#4)
plant stress##5##2##(2008-9#1)(2009-10#1)(2009-8#2)(2011-2#1)
plant surfaces##7##2##(1992-6#2)(2008-10#3)(2008-6#1)(2009-8#1)
plant survival##3##2##(2008-10#1)(2008-5#1)(2009-8#1)
plant system##7##2##(1997-2#1)(1997-8#1)(2008-10#1)(2008-7#1)(2009-8#2)(2011-2#1)
plant systems##6##2##(1990-4#1)(2006-12#1)(2007-1#1)(2008-11#1)(2008-8#1)(2010-5#1)
plant than##3##2##(2008-10#3)
plant that has##2##3##(2006-4#1)(2007-6#1)
plant that##4##2##(2006-4#1)(2007-6#1)(2008-10#1)(2009-8#1)
plant tissue and##3##3##(2008-10#3)
plant tissue homogenate##2##3##(2008-10#2)
plant tissue in##3##3##(1991-8#1)(2008-10#1)(2011-2#1)
plant tissue##37##2##(1991-8#1)(1996-12#1)(2004-11#2)(2007-1#1)(2007-12#2)(2007-3#1)(2008-10#22)(2008-11#1)(2008-9#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
plant tissues and##5##3##(2006-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-8#1)
plant tissues##32##2##(1990-5#1)(1997-2#2)(2004-11#1)(2006-12#1)(2006-3#1)(2008-10#8)(2008-2#2)(2008-4#1)(2008-5#1)(2008-9#5)(2009-10#2)(2009-5#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-7#1)
plant to the##2##3##(2008-10#2)
plant to##17##2##(2004-4#1)(2005-8#1)(2006-12#1)(2007-12#1)(2008-10#6)(2008-8#1)(2009-6#1)(2009-8#4)(2012-2#1)
plant tolerance to##4##3##(2008-12#1)(2009-8#2)(2011-1#1)
plant total##2##2##(2008-10#1)(2008-5#1)
plant toxin##2##2##(1995-7#1)(2008-5#1)
plant traits at##2##3##(2009-2#1)(2010-10#1)
plant traits##3##2##(2008-10#1)(2009-2#1)(2010-10#1)
plant transformation##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
plant under##4##2##(1995-8#1)(2008-10#1)(2008-8#2)
plant uptake##2##2##(1992-3#1)(2008-9#1)
plant use##2##2##(2006-3#1)(2008-5#1)
plant used in##3##3##(1992-5#1)(2007-7#1)(2008-12#1)
plant used##5##2##(1992-5#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-4#1)
plant vigor##3##2##(2008-10#3)
plant virus disease epidemics##2##4##(2008-10#2)
plant virus##12##2##(2008-10#8)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)
plant viruses by##3##3##(2008-10#3)
plant viruses##32##2##(2005-8#1)(2007-11#1)(2008-10#21)(2008-9#8)(2010-10#1)
plant volatiles##3##2##(2007-12#1)(2007-6#1)(2009-8#1)
plant was significantly##2##3##(2008-10#2)
plant was##20##2##(2004-2#1)(2005-11#1)(2007-1#1)(2008-10#7)(2008-12#3)(2008-4#1)(2008-9#3)(2009-10#1)(2012-1#1)(2013-7#1)
plant weight##3##2##(2008-10#1)(2008-6#2)
plant were##9##2##(1994-5#1)(2007-1#1)(2007-6#1)(2008-10#3)(2008-5#1)(2009-8#1)(2012-12#1)
plant with a##2##3##(2008-11#1)(2008-5#1)
plant with##10##2##(2008-10#3)(2008-11#1)(2008-5#3)(2009-8#1)(2011-2#2)
plant workers##3##2##(2006-10#1)(2008-7#1)(2011-2#1)
plant##2570##1##(1990-10#1)(1990-11#3)(1990-12#4)(1990-4#3)(1990-5#3)(1990-6#1)(1990-7#4)(1990-8#1)(1990-9#4)(1991-11#11)(1991-12#3)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#4)(1991-9#2)(1992-1#5)(1992-11#2)(1992-2#6)(1992-3#7)(1992-4#1)(1992-5#4)(1992-6#6)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#4)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#9)(1994-12#7)(1994-2#8)(1994-3#11)(1994-5#5)(1994-6#10)(1994-7#2)(1994-8#11)(1995-1#4)(1995-2#3)(1995-3#3)(1995-6#3)(1995-7#2)(1995-8#13)(1996-1#3)(1996-10#2)(1996-12#2)(1996-2#1)(1996-3#3)(1996-4#3)(1996-5#4)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#8)(1997-4#11)(1997-5#2)(1997-6#8)(1997-7#1)(1997-8#3)(2004-11#5)(2004-2#11)(2004-4#19)(2005-10#4)(2005-11#7)(2005-12#1)(2005-4#3)(2005-5#3)(2005-7#1)(2005-8#6)(2006-10#9)(2006-11#4)(2006-12#56)(2006-3#4)(2006-4#2)(2006-5#3)(2006-8#2)(2006-9#7)(2007-1#22)(2007-10#9)(2007-11#11)(2007-12#26)(2007-3#9)(2007-4#1)(2007-5#2)(2007-6#12)(2007-7#4)(2007-8#13)(2007-9#11)(2008-1#10)(2008-10#832)(2008-11#54)(2008-12#62)(2008-2#20)(2008-4#20)(2008-5#79)(2008-6#18)(2008-7#70)(2008-8#152)(2008-9#116)(2009-10#27)(2009-12#2)(2009-2#3)(2009-3#6)(2009-4#4)(2009-5#7)(2009-6#37)(2009-8#173)(2009-9#2)(2010-1#1)(2010-10#9)(2010-11#7)(2010-12#11)(2010-2#11)(2010-3#5)(2010-4#2)(2010-5#9)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#31)(2011-10#7)(2011-12#10)(2011-2#52)(2011-3#3)(2012-1#19)(2012-11#9)(2012-12#13)(2012-2#47)(2012-3#7)(2012-5#3)(2012-6#4)(2012-7#3)(2013-1#19)(2013-7#20)(2013-8#52)
plant's##6##1##(2008-10#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-8#2)
plant(-1)##9##1##(2008-12#9)
plant(-1))##2##1##(2008-12#2)
plant)##8##1##(1993-3#1)(2006-12#1)(2008-10#3)(2009-5#1)(2011-2#1)(2013-8#1)
plant- and##2##2##(2007-12#1)(2009-5#1)
plant-1##2##1##(2011-12#2)
plant-associated bacteria##4##2##(1995-1#1)(2008-10#3)
plant-associated microbes##3##2##(2008-10#3)
plant-associated##9##1##(1995-1#1)(2008-10#8)
plant-based##9##1##(2006-10#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-7#1)(2009-6#1)(2010-6#1)(2010-7#1)(2011-1#1)
plant-derived small molecules##2##3##(2008-7#1)(2010-2#1)
plant-derived##15##1##(1996-2#1)(2006-11#2)(2006-12#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-3#1)(2010-2#1)(2011-1#1)(2012-12#2)(2012-2#1)
plant-growth-promoting rhizobacteria##2##2##(2008-10#1)(2012-2#1)
plant-herbivore##4##1##(2008-8#3)(2008-9#1)
plant-made##5##1##(2006-12#4)(2011-2#1)
plant-mediated##2##1##(2008-10#1)(2009-6#1)
plant-microbe##2##1##(2008-10#1)(2012-2#1)
plant-parasitic nematode##3##2##(1994-12#2)(2008-10#1)
plant-parasitic nematodes##4##2##(2008-10#4)
plant-parasitic##7##1##(1994-12#2)(2008-10#5)
plant-pathogen interactions##2##2##(2008-10#1)(2011-10#1)
plant-pathogen##4##1##(2008-10#3)(2011-10#1)
plant-pathogenic fungi##3##2##(2008-10#3)
plant-pathogenic##15##1##(2005-12#1)(2008-10#14)
plant-pollinator interactions##3##2##(2008-8#1)(2009-6#1)(2012-6#1)
plant-pollinator##4##1##(2008-8#2)(2009-6#1)(2012-6#1)
plant-specific##6##1##(1997-4#1)(1997-6#1)(2006-12#2)(2009-10#1)(2009-8#1)
plant-to-plant##3##1##(2008-10#1)(2009-8#2)
planta conditions##2##2##(2011-1#2)
planta growth##2##2##(2008-10#2)
planta##62##1##(1990-3#1)(1997-3#1)(1997-6#1)(2006-12#1)(2008-10#44)(2008-7#1)(2008-9#2)(2009-12#4)(2009-8#1)(2010-10#1)(2010-11#1)(2011-1#3)(2011-2#1)
plantain##7##1##(2008-1#1)(2008-10#1)(2008-4#5)
plantains##2##1##(2008-10#2)
plantar and##3##2##(2009-9#1)(2011-2#2)
plantar fascia##3##2##(2006-10#1)(2009-10#1)(2011-12#1)
plantar fasciitis##3##2##(2010-11#1)(2011-12#1)(2013-8#1)
plantar flexion##5##2##(2007-8#1)(2010-3#1)(2011-1#2)(2013-8#1)
plantar pressure measurements##3##3##(2012-2#3)
plantar pressure##6##2##(2010-3#1)(2011-2#1)(2012-2#4)
plantar pressures and##2##3##(2011-2#2)
plantar pressures##6##2##(2008-1#1)(2011-2#5)
plantar talalgia##2##2##(2006-10#2)
plantar##56##1##(1990-4#1)(1990-8#1)(1993-8#1)(1997-3#1)(1997-6#1)(2006-10#4)(2007-7#1)(2007-8#1)(2008-1#3)(2008-7#2)(2009-10#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-11#4)(2010-3#4)(2010-7#1)(2011-1#2)(2011-12#2)(2011-2#16)(2012-2#4)(2012-3#1)(2013-8#2)
plantarflexion##3##1##(1993-12#2)(2006-11#1)
plantaris muscle##6##2##(1997-6#1)(2012-2#5)
plantaris##10##1##(1997-6#1)(2008-12#1)(2011-2#1)(2012-2#7)
plantarum SM-I##2##2##(2012-11#2)
plantarum TF103##2##2##(2008-6#2)
plantarum##18##1##(1997-2#3)(2005-12#2)(2006-8#1)(2007-12#1)(2008-2#1)(2008-6#4)(2012-11#4)(2012-2#2)
plantation during##2##2##(2007-11#1)(2008-5#1)
plantation of##3##2##(2008-10#2)(2008-5#1)
plantation##25##1##(2005-12#1)(2007-11#1)(2007-6#1)(2008-10#7)(2008-5#5)(2008-6#1)(2008-8#1)(2009-6#1)(2012-2#1)(2013-8#6)
plantations and##6##2##(2008-10#5)(2012-2#1)
plantations in the##3##3##(2008-10#2)(2013-8#1)
plantations in##6##2##(2008-10#4)(2011-2#1)(2013-8#1)
plantations##38##1##(2006-5#1)(2007-11#1)(2007-3#1)(2008-10#25)(2008-5#1)(2011-12#3)(2011-2#1)(2012-2#1)(2013-8#4)
planted at##2##2##(2008-10#1)(2011-2#1)
planted in##21##2##(2004-4#1)(2007-11#1)(2008-10#14)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-2#1)
planted to a##2##3##(2008-10#2)
planted to corn##3##3##(2008-10#1)(2011-2#2)
planted to snap##2##3##(2008-10#2)
planted to##17##2##(2008-10#14)(2011-2#3)
planted with cotton##2##3##(2008-10#2)
planted with##12##2##(2008-10#11)(2008-12#1)
planted##69##1##(2004-4#1)(2007-11#1)(2008-10#53)(2008-12#2)(2008-4#1)(2008-5#1)(2008-9#4)(2010-10#1)(2011-2#4)(2012-2#1)
planthopper##3##1##(2006-12#1)(2008-10#2)
planthoppers##5##1##(2008-10#5)
plantibody##2##1##(2006-12#2)
planting and##2##2##(2008-10#1)(2008-5#1)
planting area##4##2##(2008-10#1)(2008-12#1)(2008-9#1)(2011-2#1)
planting date##2##2##(2008-10#2)
planting densities##2##2##(2008-10#2)
planting density and the##2##4##(2008-10#2)
planting density##9##2##(2008-10#9)
planting in##2##2##(2008-10#2)
planting material##4##2##(2008-10#3)(2010-2#1)
planting of the##2##3##(2008-10#2)
planting of##5##2##(2008-10#5)
planting##68##1##(1995-6#1)(2006-3#2)(2006-4#1)(2007-6#1)(2007-9#1)(2008-10#52)(2008-12#1)(2008-5#1)(2008-9#1)(2010-2#1)(2011-2#5)(2013-8#1)
plantings and##2##2##(2008-10#2)
plantings##12##1##(2008-10#12)
plantlet##4##1##(2007-1#1)(2007-3#1)(2008-10#1)(2011-10#1)
plantlets from##4##2##(2008-10#1)(2008-12#3)
plantlets were##4##2##(2006-12#1)(2008-10#1)(2008-9#1)(2010-2#1)
plantlets##28##1##(1995-3#1)(2006-10#1)(2006-12#4)(2007-1#6)(2008-10#5)(2008-12#4)(2008-9#4)(2009-8#1)(2010-2#1)(2013-1#1)
plants (cv##2##2##(2008-10#2)
plants (plants##2##2##(2008-10#2)
plants -##2##2##(2008-5#2)
plants a##2##2##(2008-10#1)(2008-11#1)
plants accumulated##6##2##(1990-7#1)(2006-12#4)(2008-11#1)
plants after##5##2##(1997-6#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-11#1)
plants against##6##2##(1992-8#1)(1993-8#1)(2007-12#1)(2008-7#1)(2009-10#1)(2009-6#1)
plants also##6##2##(2006-4#1)(2008-10#3)(2010-4#1)(2012-7#1)
plants although##2##2##(2008-10#1)(2012-2#1)
plants analysed##2##2##(2007-1#1)(2011-12#1)
plants and a##3##3##(2007-6#1)(2008-10#1)(2008-8#1)
plants and algae##4##3##(2008-7#1)(2012-2#3)
plants and animals##23##3##(1991-5#1)(1994-8#2)(1995-6#2)(1995-8#1)(1997-2#2)(2006-5#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#4)(2009-3#1)(2009-5#1)(2009-6#2)(2010-4#1)(2010-5#1)(2013-8#1)
plants and bacteria##2##3##(1993-9#1)(1996-7#1)
plants and in the##3##4##(2008-6#1)(2008-8#1)(2012-2#1)
plants and in##14##3##(2008-10#8)(2008-3#2)(2008-6#1)(2008-8#1)(2009-8#1)(2012-2#1)
plants and insect vectors##2##4##(2008-10#2)
plants and insects##6##3##(1994-12#1)(2005-7#1)(2006-12#1)(2007-11#1)(2008-10#1)(2009-8#1)
plants and is##4##3##(2008-10#2)(2009-8#1)(2013-8#1)
plants and microorganisms##2##3##(1993-2#1)(2010-7#1)
plants and resistance to##2##4##(2008-10#1)(2011-10#1)
plants and resistance##3##3##(2008-10#2)(2011-10#1)
plants and some##3##3##(2008-7#1)(2009-8#1)(2010-1#1)
plants and the##14##3##(1992-5#1)(1997-3#1)(2006-12#1)(2008-10#3)(2008-5#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#1)
plants and their##7##3##(1996-1#1)(2008-10#2)(2008-5#1)(2008-8#2)(2013-1#1)
plants and those##3##3##(2007-12#1)(2008-10#2)
plants and to##2##3##(1990-6#1)(2008-9#1)
plants and##178##2##(1990-5#1)(1990-6#1)(1991-5#1)(1992-5#1)(1992-7#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#1)(2004-4#1)(2005-7#1)(2006-10#1)(2006-12#7)(2006-5#2)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#1)(2008-10#59)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#13)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#7)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2011-1#2)(2011-10#2)(2011-2#1)(2012-2#6)(2013-1#1)(2013-8#2)
plants and/or##2##2##(2008-10#1)(2012-3#1)
plants appear##2##2##(2008-10#2)
plants appeared to##2##3##(2008-10#2)
plants are discussed##2##3##(1991-11#1)(2004-4#1)
plants are used##2##3##(2008-4#1)(2011-2#1)
plants are vernalized##2##3##(2009-8#2)
plants are##37##2##(1991-11#1)(1994-3#1)(2004-11#1)(2004-4#1)(2006-10#1)(2007-3#1)(2007-6#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-8#4)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
plants as a##2##3##(2006-12#1)(2013-7#1)
plants as natural##2##3##(2009-8#1)(2012-2#1)
plants as well##3##3##(1991-8#1)(1997-8#1)(2008-10#1)
plants as##15##2##(1991-8#1)(1997-3#1)(1997-8#1)(2006-12#2)(2007-11#1)(2008-10#4)(2008-8#1)(2009-8#1)(2011-12#1)(2012-2#1)(2013-7#1)
plants at 96 h after inoculation##2##6##(2008-10#2)
plants at the##3##3##(2006-12#1)(2008-10#1)(2008-12#1)
plants at various##2##3##(2008-10#2)
plants at##19##2##(2006-12#1)(2007-11#1)(2007-3#1)(2008-10#15)(2008-12#1)
plants became infected with##2##4##(2008-10#2)
plants became infected##3##3##(2008-10#3)
plants became##6##2##(2008-10#6)
plants belonging to##2##3##(2008-10#1)(2008-5#1)
plants between##2##2##(2008-11#1)(2011-2#1)
plants but not in##2##4##(2008-10#2)
plants but##8##2##(1996-6#1)(2008-10#4)(2008-5#1)(2009-8#2)
plants by GC/MS##2##3##(2008-10#2)
plants by Southern blot hybridization##2##5##(2008-10#2)
plants by Southern##3##3##(2008-10#2)(2008-9#1)
plants by##33##2##(1992-6#1)(1994-8#1)(1997-2#1)(2004-4#1)(2006-12#1)(2007-12#1)(2008-10#16)(2008-11#1)(2008-8#1)(2008-9#4)(2009-8#1)(2011-2#2)(2012-11#1)(2013-8#1)
plants can be used##2##4##(2006-11#1)(2009-8#1)
plants can be##7##3##(1994-11#1)(2006-11#1)(2007-1#1)(2008-10#1)(2008-6#1)(2009-8#2)
plants can occur##2##3##(1993-4#1)(2008-10#1)
plants can##17##2##(1993-4#1)(1994-11#1)(2006-11#1)(2006-5#1)(2007-1#1)(2008-10#6)(2008-4#1)(2008-6#1)(2008-9#1)(2009-8#3)
plants carrying cognate resistance proteins##2##5##(2009-8#2)
plants carrying the##2##3##(2010-9#1)(2011-1#1)
plants carrying##10##2##(1997-4#1)(2006-12#2)(2008-10#3)(2009-8#2)(2010-9#1)(2011-1#1)
plants co-inoculated with##2##3##(2008-10#1)(2011-1#1)
plants collected from##2##3##(2008-10#2)
plants collected##3##2##(2008-10#3)
plants colonized by##2##3##(2008-10#1)(2008-12#1)
plants compared with##2##3##(2008-10#2)
plants consists of##2##3##(1990-8#1)(1995-2#1)
plants contained##4##2##(2008-10#3)(2009-8#1)
plants containing the VP6 cDNA under the control of the##3##10##(2006-12#3)
plants containing the##7##3##(2006-12#3)(2008-10#1)(2008-5#1)(2008-9#2)
plants containing##17##2##(1992-6#1)(1993-5#1)(2006-12#3)(2007-1#1)(2008-10#5)(2008-5#2)(2008-9#3)(2009-8#1)
plants could be##4##3##(2008-10#2)(2008-8#1)(2011-10#1)
plants could##5##2##(2008-10#2)(2008-8#1)(2009-6#1)(2011-10#1)
plants cultivated in##2##3##(2008-10#2)
plants decreased##2##2##(2008-10#2)
plants derived from##3##3##(2006-12#1)(2006-3#1)(2008-9#1)
plants developed##3##2##(2008-10#2)(2009-8#1)
plants did not differ##2##4##(2008-10#1)(2013-7#1)
plants did not##8##3##(2008-10#5)(2008-8#1)(2010-10#1)(2013-7#1)
plants display##2##2##(2008-10#1)(2008-11#1)
plants displayed a##2##3##(2004-2#1)(2008-10#1)
plants displayed lower##2##3##(2006-3#1)(2008-10#1)
plants displayed##5##2##(2004-2#1)(2006-3#1)(2008-10#3)
plants displaying##5##2##(2008-10#5)
plants do not##4##3##(1995-2#1)(2008-10#1)(2009-10#1)(2010-10#1)
plants due to the##2##4##(2008-12#1)(2012-2#1)
plants during##5##2##(2008-10#3)(2009-10#1)(2011-12#1)
plants either##2##2##(2008-10#2)
plants emit##2##2##(1991-7#1)(2006-5#1)
plants exhibit##2##2##(1996-2#1)(2008-4#1)
plants exhibited a##3##3##(1995-8#1)(1997-6#1)(2006-11#1)
plants exhibited##7##2##(1995-8#1)(1997-6#1)(2006-11#1)(2008-10#3)(2013-1#1)
plants exhibiting##4##2##(2008-10#4)
plants exposed to##6##3##(2008-10#3)(2008-7#1)(2013-8#2)
plants expressing OC-I##4##3##(2006-12#4)
plants expressing a##8##3##(2006-12#2)(2008-10#4)(2009-8#1)(2012-2#1)
plants expressing the coat protein##2##5##(1997-6#1)(2008-10#1)
plants expressing the##8##3##(1997-6#2)(1997-8#1)(2006-12#1)(2008-10#3)(2011-10#1)
plants expressing##30##2##(1994-3#1)(1995-2#1)(1997-6#2)(1997-8#1)(2006-11#1)(2006-12#7)(2008-10#11)(2008-8#1)(2009-8#2)(2011-10#2)(2012-2#1)
plants following##2##2##(2006-12#1)(2008-5#1)
plants for the treatment of##2##5##(2011-2#1)(2012-12#1)
plants for the##6##3##(2006-11#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-12#1)
plants for##20##2##(2004-2#1)(2004-4#1)(2006-11#1)(2006-12#1)(2008-10#7)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)
plants from five##2##3##(2008-10#2)
plants from powdery mildew##2##4##(2008-10#2)
plants from the same##2##4##(2008-10#2)
plants from the##10##3##(2005-11#1)(2008-10#6)(2012-7#3)
plants from##36##2##(2005-11#1)(2007-1#1)(2007-11#1)(2007-6#1)(2008-10#22)(2008-5#2)(2009-12#1)(2009-2#1)(2010-7#1)(2012-2#1)(2012-7#4)
plants grew##2##2##(2007-8#1)(2008-8#1)
plants growing in field soil##2##5##(2008-10#2)
plants growing in##10##3##(2004-4#1)(2007-12#1)(2008-10#7)(2013-7#1)
plants growing##12##2##(2004-4#1)(2007-12#1)(2007-3#1)(2008-10#7)(2008-8#1)(2013-7#1)
plants grown in either mix##2##5##(2008-10#2)
plants grown in soil##3##4##(2008-10#3)
plants grown in the compost mix##2##6##(2008-10#2)
plants grown in the compost##3##5##(2008-10#3)
plants grown in the##7##4##(2008-10#7)
plants grown in##29##3##(1996-10#1)(2006-12#1)(2008-10#23)(2008-11#1)(2012-7#3)
plants grown##33##2##(1996-10#1)(2006-12#2)(2008-10#24)(2008-11#1)(2008-5#2)(2012-7#3)
plants had##15##2##(2007-1#2)(2007-3#1)(2008-10#7)(2008-8#4)(2008-9#1)
plants has been##3##3##(2007-12#1)(2009-9#1)(2012-2#1)
plants has##7##2##(1992-3#1)(2006-12#1)(2007-12#1)(2008-11#1)(2008-8#1)(2009-9#1)(2012-2#1)
plants have a##2##3##(2008-10#1)(2011-1#1)
plants have been##8##3##(2008-11#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-12#1)(2011-2#2)(2012-2#1)
plants have evolved##2##3##(2011-10#1)(2011-12#1)
plants have on average##2##4##(2008-11#1)(2009-8#1)
plants have the##3##3##(2006-12#1)(2008-10#1)(2009-12#1)
plants have##22##2##(2006-12#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-1#2)(2011-10#1)(2011-12#1)(2011-2#3)(2011-3#1)(2012-2#1)
plants homozygous for the##2##4##(2012-3#2)
plants in F(2)##2##3##(2008-10#1)(2008-8#1)
plants in Iceland showed##2##4##(2006-10#2)
plants in a greenhouse##2##4##(2008-10#2)
plants in a##12##3##(1997-6#1)(2008-10#11)
plants in an area##2##4##(2008-10#2)
plants in an##4##3##(2004-4#1)(2007-8#1)(2008-10#2)
plants in dry##2##3##(2008-5#1)(2012-5#1)
plants in each##4##3##(2008-10#3)(2012-2#1)
plants in greenhouse##2##3##(2008-10#2)
plants in response to##2##4##(2008-10#2)
plants in some families##2##4##(2008-8#2)
plants in terms of##3##4##(1997-4#1)(2008-10#2)
plants in the absence of##2##5##(1997-3#1)(2009-8#1)
plants in the family Brassicaceae##2##5##(2008-10#2)
plants in the field##4##4##(2008-10#2)(2008-11#1)(2008-8#1)
plants in the greenhouse##3##4##(2008-10#3)
plants in the presence of a##2##6##(2006-12#1)(2008-10#1)
plants in the##39##3##(1994-6#1)(1997-3#1)(1997-4#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#22)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#1)(2012-2#1)
plants in which##2##3##(1995-8#1)(2011-1#1)
plants in##123##2##(1994-6#1)(1995-8#1)(1997-3#1)(1997-4#3)(1997-6#1)(2004-11#1)(2004-4#2)(2005-10#1)(2006-10#2)(2006-12#3)(2006-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#67)(2008-11#2)(2008-12#4)(2008-5#2)(2008-7#1)(2008-8#5)(2008-9#2)(2009-10#2)(2009-12#1)(2009-3#1)(2009-8#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-2#2)(2012-5#1)(2012-9#1)(2013-8#1)
plants include a##2##3##(2008-5#1)(2009-6#1)
plants including##2##2##(2008-10#1)(2009-8#1)
plants increased as the##2##4##(2008-10#1)(2008-2#1)
plants increased##5##2##(2008-10#4)(2008-2#1)
plants incubated##2##2##(2008-10#2)
plants indicate that##2##3##(2008-10#2)
plants indicated that##5##3##(2008-10#5)
plants indicated##7##2##(2008-10#7)
plants infected with F##2##4##(2008-10#2)
plants infected with PVX##2##4##(2008-10#2)
plants infected with the##5##4##(2008-10#4)(2011-12#1)
plants infected with##17##3##(2008-10#16)(2011-12#1)
plants infected##19##2##(2008-10#18)(2011-12#1)
plants initially##2##2##(2007-9#1)(2008-10#1)
plants inoculated only with##2##4##(2011-1#2)
plants inoculated with the higher zoospore concentration##2##7##(2008-10#2)
plants inoculated with the##4##4##(2008-10#4)
plants inoculated with##26##3##(2008-10#24)(2008-12#1)(2009-8#1)
plants inoculated##31##2##(2008-10#27)(2008-12#1)(2009-8#1)(2011-1#2)
plants involves##2##2##(1997-8#1)(2013-8#1)
plants is a##2##3##(2008-10#1)(2008-2#1)
plants is also##2##3##(2008-4#1)(2008-8#1)
plants is##22##2##(1992-12#1)(1993-5#1)(1997-4#1)(2006-12#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-6#1)(2009-8#2)(2012-3#1)
plants lack##2##2##(2006-12#1)(2009-8#1)
plants maintained##3##2##(2006-3#1)(2008-10#2)
plants may##5##2##(2006-10#1)(2008-10#3)(2008-11#1)
plants not receiving SA##2##4##(2008-10#2)
plants not##4##2##(2008-10#4)
plants observed##2##2##(2008-10#2)
plants obtained from##2##3##(2008-10#2)
plants occurred##2##2##(2008-10#2)
plants of C##2##3##(2004-2#2)
plants of a##3##3##(1994-8#1)(1997-6#1)(2008-10#1)
plants of both cultivars##2##4##(2008-10#2)
plants of different##2##3##(2008-10#1)(2008-7#1)
plants of each##2##3##(2008-10#2)
plants of the family##2##4##(1996-10#1)(2008-10#1)
plants of the resistant##2##4##(2008-10#2)
plants of the##12##3##(1996-10#1)(2006-12#2)(2007-1#1)(2008-10#6)(2008-11#2)
plants of two##2##3##(2008-10#1)(2013-1#1)
plants of##53##2##(1994-8#1)(1996-10#1)(1996-4#1)(1997-2#1)(1997-6#2)(2004-2#3)(2006-12#2)(2007-1#5)(2008-10#27)(2008-11#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-5#1)(2011-12#1)(2013-1#1)
plants offers an##2##3##(1996-8#1)(2006-12#1)
plants on a##2##3##(2006-12#1)(2008-10#1)
plants on##10##2##(1994-3#1)(2004-2#1)(2004-4#1)(2006-12#1)(2007-6#1)(2008-10#3)(2008-5#1)(2011-2#1)
plants only##2##2##(2008-10#1)(2008-2#1)
plants or in##2##3##(2006-12#1)(2008-10#1)
plants or##16##2##(2006-12#1)(2007-6#1)(2008-10#10)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
plants over time##2##3##(2008-10#1)(2008-9#1)
plants per plot at##2##4##(2008-10#2)
plants per rootstock##2##3##(2010-10#2)
plants per##8##2##(2008-10#5)(2010-10#2)(2013-8#1)
plants possess##3##2##(1995-1#1)(2013-1#1)(2013-8#1)
plants produce##2##2##(1990-9#1)(2012-2#1)
plants produced more##2##3##(2008-10#1)(2008-8#1)
plants produced##5##2##(2006-12#1)(2008-10#2)(2008-8#1)(2013-1#1)
plants protected##2##2##(2008-10#2)
plants remain##2##2##(2008-10#1)(2012-2#1)
plants representing##2##2##(2008-10#1)(2008-5#1)
plants represents a##2##3##(2009-6#2)
plants respond##2##2##(2004-2#1)(2008-4#1)
plants resulted in##2##3##(2008-10#1)(2011-1#1)
plants revealed that the##2##4##(2008-10#2)
plants revealed##4##2##(2008-10#3)(2008-8#1)
plants sampled at##2##3##(2008-10#2)
plants sampled##4##2##(2008-10#4)
plants shed##2##2##(2008-10#2)
plants should##2##2##(2009-6#1)(2011-1#1)
plants show##2##2##(1990-7#1)(2008-3#1)
plants showed a##3##3##(1997-6#1)(2006-12#1)(2008-10#1)
plants showed that##4##3##(2006-10#1)(2008-10#3)
plants showed##16##2##(1997-6#1)(2004-4#1)(2006-10#1)(2006-12#3)(2008-10#8)(2011-1#1)(2013-1#1)
plants showing##8##2##(2005-11#1)(2008-10#5)(2008-5#1)(2009-8#1)
plants significantly##2##2##(2006-9#1)(2008-10#1)
plants species##3##2##(2008-10#1)(2008-12#1)(2010-12#1)
plants suggests that##4##3##(2008-10#4)
plants suggests##5##2##(1996-10#1)(2008-10#4)
plants than in##6##3##(1994-3#1)(2006-12#1)(2008-10#3)(2009-10#1)
plants than on##2##3##(2008-10#1)(2012-2#1)
plants than##13##2##(1991-12#1)(1994-3#1)(1997-3#1)(2006-12#1)(2008-10#7)(2009-10#1)(2012-2#1)
plants that are not##2##4##(2008-10#2)
plants that are##7##3##(1991-11#1)(2006-11#1)(2007-6#1)(2008-10#3)(2009-8#1)
plants that expressed##2##3##(2008-10#2)
plants that had##2##3##(2007-3#1)(2007-6#1)
plants that produce##2##3##(2006-12#1)(2009-3#1)
plants that were##9##3##(2004-4#1)(2008-10#6)(2008-5#1)(2011-1#1)
plants that##36##2##(1991-11#1)(1997-4#1)(2004-4#1)(2006-11#2)(2006-12#1)(2007-11#1)(2007-3#1)(2007-6#2)(2007-9#1)(2008-1#1)(2008-10#15)(2008-5#2)(2008-9#1)(2009-3#1)(2009-8#1)(2011-1#1)(2012-11#1)(2013-7#1)(2013-8#1)
plants through##3##2##(2008-5#1)(2008-7#1)(2008-8#1)
plants to a##3##3##(2008-10#3)
plants to adapt to##3##4##(2008-8#1)(2009-6#1)(2013-8#1)
plants to environmental##2##3##(2009-8#1)(2012-5#1)
plants to the##4##3##(2008-10#2)(2009-6#1)(2011-10#1)
plants to##55##2##(1995-8#2)(2006-12#2)(2007-8#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#2)(2009-8#5)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-5#1)(2013-8#1)
plants transformed with a##2##4##(1990-7#1)(2008-10#1)
plants transformed with##6##3##(1990-7#1)(1997-2#1)(2006-12#1)(2008-10#3)
plants transformed##7##2##(1990-7#1)(1997-2#1)(2006-12#2)(2008-10#3)
plants treated with##6##3##(2006-10#1)(2008-10#5)
plants treated##7##2##(2006-10#1)(2008-10#6)
plants under the control of the##2##6##(1997-4#1)(2008-10#1)
plants under##10##2##(1997-4#1)(2006-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-12#1)(2009-8#1)(2013-8#1)
plants use##2##2##(2008-6#1)(2009-8#1)
plants used in the##2##4##(2008-10#1)(2008-4#1)
plants used in##6##3##(2008-10#2)(2008-4#1)(2010-12#1)(2010-3#1)(2010-5#1)
plants used##8##2##(2006-3#1)(2008-10#2)(2008-4#1)(2010-12#2)(2010-3#1)(2010-5#1)
plants using high-performance liquid chromatography##2##5##(2007-1#1)(2008-10#1)
plants using##13##2##(1991-7#1)(2006-12#1)(2007-1#2)(2008-10#4)(2008-9#3)(2009-8#1)(2010-10#1)
plants was analyzed##2##3##(2008-10#1)(2008-9#1)
plants was demonstrated##2##3##(2008-10#2)
plants was higher##2##3##(2008-10#1)(2008-12#1)
plants was initiated##2##3##(1990-11#1)(2006-12#1)
plants was mainly##2##3##(2008-10#2)
plants was significantly##2##3##(2006-12#2)
plants was studied##2##3##(2008-10#1)(2008-12#1)
plants was##45##2##(1990-11#1)(1991-7#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-8#1)(2006-12#4)(2007-9#1)(2008-10#25)(2008-11#1)(2008-12#3)(2008-6#1)(2008-8#2)(2008-9#1)(2011-2#1)
plants were aggregated##2##3##(2008-10#2)
plants were also##2##3##(2008-10#2)
plants were analyzed##2##3##(1995-2#1)(2008-5#1)
plants were at##2##3##(2008-12#1)(2011-2#1)
plants were challenged with##3##4##(2008-10#3)
plants were characterized##2##3##(2006-12#1)(2008-10#1)
plants were classified##2##3##(2013-7#1)(2013-8#1)
plants were collected##2##3##(2008-10#1)(2008-6#1)
plants were determined##3##3##(2008-10#1)(2008-2#1)(2013-1#1)
plants were evaluated for##3##4##(2008-10#3)
plants were evaluated##6##3##(2008-10#6)
plants were examined by##2##4##(2008-10#2)
plants were examined with##2##4##(2008-10#2)
plants were examined##4##3##(2008-10#4)
plants were exposed to##3##4##(2008-10#1)(2011-1#1)(2011-12#1)
plants were generated##4##3##(2006-12#2)(2008-10#1)(2013-8#1)
plants were grown in##3##4##(2006-12#1)(2008-10#1)(2010-11#1)
plants were grown##5##3##(2006-12#1)(2008-10#2)(2008-12#1)(2010-11#1)
plants were infected with##2##4##(2008-10#2)
plants were infected##4##3##(2008-10#4)
plants were inoculated with##4##4##(1997-6#1)(2008-10#3)
plants were inoculated##9##3##(1997-6#1)(2008-10#7)(2008-5#1)
plants were investigated##2##3##(2008-10#1)(2010-3#1)
plants were kept in##2##4##(2008-10#1)(2008-5#1)
plants were measured##3##3##(2008-10#2)(2008-12#1)
plants were more##3##3##(2008-10#1)(2008-8#2)
plants were not##2##3##(2007-1#1)(2013-1#1)
plants were observed##2##3##(2008-10#2)
plants were obtained##2##3##(2006-12#1)(2013-1#1)
plants were produced##2##3##(2006-11#1)(2008-8#1)
plants were recovered##2##3##(2006-12#1)(2008-8#1)
plants were regenerated##3##3##(2008-9#2)(2013-1#1)
plants were screened for##2##4##(2008-10#1)(2008-5#1)
plants were screened##3##3##(2006-9#1)(2008-10#1)(2008-5#1)
plants were sprayed with##2##4##(2008-10#1)(2008-8#1)
plants were sprayed##3##3##(2008-10#2)(2008-8#1)
plants were subjected to##3##4##(1995-2#1)(2008-12#1)(2012-2#1)
plants were transferred into##2##4##(2004-4#2)
plants were transformed with the##2##5##(2008-10#2)
plants were used as##2##4##(2007-12#1)(2008-10#1)
plants were used##4##3##(2007-12#1)(2008-10#2)(2010-12#1)
plants were##146##2##(1995-2#2)(1996-8#1)(1997-3#1)(1997-6#1)(2004-4#3)(2006-11#1)(2006-12#9)(2006-9#1)(2007-1#2)(2007-12#1)(2008-10#80)(2008-11#1)(2008-12#7)(2008-2#1)(2008-5#5)(2008-6#1)(2008-8#9)(2008-9#2)(2009-3#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#3)
plants when##6##2##(2008-10#2)(2008-9#1)(2009-8#2)(2011-12#1)
plants where##3##2##(1994-6#1)(2008-10#1)(2008-8#1)
plants which were##3##3##(2004-4#1)(2008-10#2)
plants which##6##2##(2004-4#1)(2008-10#3)(2008-12#1)(2013-1#1)
plants while##3##2##(1995-2#1)(2009-8#1)(2010-12#1)
plants with a##9##3##(1995-8#1)(2006-12#1)(2007-2#1)(2007-6#1)(2008-10#2)(2009-10#1)(2009-8#2)
plants with an##2##3##(2008-10#2)
plants with greater##2##3##(2008-10#1)(2008-8#1)
plants with large##2##3##(2006-12#1)(2008-9#1)
plants with the same##2##4##(2008-10#1)(2008-8#1)
plants with the##7##3##(2006-12#1)(2008-10#5)(2008-8#1)
plants with##73##2##(1994-6#2)(1995-8#2)(1997-2#1)(2004-2#1)(2006-12#5)(2007-1#2)(2007-2#1)(2007-6#1)(2008-10#38)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#3)(2008-9#2)(2009-10#2)(2009-12#1)(2009-8#6)(2011-12#1)(2011-2#1)(2012-2#1)
plants within##5##2##(2008-10#4)(2008-5#1)
plants without##4##2##(2006-12#1)(2008-10#3)
plants worldwide##3##2##(2008-10#1)(2010-9#1)(2012-11#1)
plants##2624##1##(1990-11#2)(1990-3#1)(1990-5#5)(1990-6#2)(1990-7#4)(1990-8#1)(1990-9#1)(1991-11#3)(1991-12#1)(1991-2#1)(1991-5#3)(1991-7#6)(1991-8#2)(1991-9#2)(1992-12#1)(1992-3#2)(1992-5#2)(1992-6#2)(1992-7#3)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#2)(1993-4#3)(1993-5#4)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#3)(1994-11#5)(1994-12#4)(1994-3#14)(1994-6#10)(1994-8#7)(1995-1#3)(1995-11#2)(1995-2#13)(1995-3#3)(1995-6#4)(1995-8#13)(1996-1#1)(1996-10#3)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#6)(1997-1#1)(1997-2#10)(1997-3#12)(1997-4#13)(1997-6#18)(1997-8#7)(2004-11#3)(2004-2#11)(2004-4#16)(2005-10#1)(2005-11#2)(2005-7#1)(2005-9#1)(2006-10#13)(2006-11#12)(2006-12#115)(2006-3#7)(2006-4#2)(2006-5#7)(2006-6#1)(2006-9#3)(2007-1#30)(2007-10#2)(2007-11#11)(2007-12#18)(2007-2#2)(2007-3#7)(2007-5#1)(2007-6#11)(2007-7#1)(2007-8#6)(2007-9#3)(2008-1#3)(2008-10#1205)(2008-11#39)(2008-12#46)(2008-2#11)(2008-3#6)(2008-4#15)(2008-5#48)(2008-6#9)(2008-7#40)(2008-8#105)(2008-9#79)(2009-10#33)(2009-11#1)(2009-12#14)(2009-2#6)(2009-3#7)(2009-4#1)(2009-5#4)(2009-6#36)(2009-7#1)(2009-8#116)(2009-9#3)(2010-1#2)(2010-10#11)(2010-11#3)(2010-12#10)(2010-2#4)(2010-3#4)(2010-4#4)(2010-5#11)(2010-6#3)(2010-7#4)(2010-8#3)(2010-9#4)(2011-1#28)(2011-10#8)(2011-12#18)(2011-2#36)(2011-3#1)(2012-1#5)(2012-11#8)(2012-12#2)(2012-2#36)(2012-3#5)(2012-5#2)(2012-7#9)(2012-9#2)(2013-1#25)(2013-7#14)(2013-8#24)
plants'##2##1##(1996-3#1)(2009-8#1)
plants) is##2##2##(2008-10#1)(2008-8#1)
plants) showed##2##2##(2006-12#1)(2008-10#1)
plants)##20##1##(2006-12#1)(2008-10#13)(2008-5#2)(2008-8#1)(2010-3#1)(2010-4#1)(2010-6#1)
plants/m2 in the##2##3##(2006-12#2)
plants/m2##5##1##(2006-12#2)(2008-5#3)
plants]##5##1##(2007-3#3)(2010-11#1)(2011-3#1)
planum temporale##3##2##(2010-2#3)
planum##6##1##(2005-9#1)(2010-2#3)(2011-2#1)(2012-2#1)
planus and##7##2##(1991-2#1)(2006-2#1)(2007-7#1)(2008-4#1)(2009-6#2)(2013-1#1)
planus in##3##2##(2007-7#2)(2011-2#1)
planus is##3##2##(1991-2#2)(2007-7#1)
planus##58##1##(1990-5#1)(1991-2#4)(1991-3#1)(1992-10#1)(1996-2#1)(2005-10#3)(2005-12#1)(2006-2#3)(2007-5#1)(2007-7#13)(2007-8#2)(2008-4#6)(2008-7#1)(2009-6#5)(2010-12#2)(2011-2#3)(2012-1#4)(2012-2#1)(2013-1#5)
plaque accumulation##4##2##(2006-2#2)(2008-1#1)(2008-7#1)
plaque after##3##2##(2007-8#1)(2008-5#2)
plaque and the##2##3##(2008-5#1)(2012-3#1)
plaque and##14##2##(1991-1#1)(1991-3#1)(1997-2#1)(2006-6#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
plaque are##2##2##(2008-10#1)(2008-8#1)
plaque area##3##2##(2006-2#1)(2008-8#2)
plaque assay and##4##3##(1992-1#1)(2006-3#1)(2012-2#1)(2013-8#1)
plaque assay##20##2##(1990-12#1)(1992-1#1)(1993-12#1)(1995-10#1)(1995-12#2)(2006-3#6)(2008-2#1)(2008-4#2)(2012-2#2)(2013-1#1)(2013-8#2)
plaque assays##3##2##(1995-8#1)(2008-4#1)(2008-9#1)
plaque biofilm##2##2##(2011-1#1)(2013-7#1)
plaque burden and##2##3##(2005-7#1)(2012-2#1)
plaque burden complicated by##2##4##(2011-1#2)
plaque burden##13##2##(2003-11#1)(2005-7#1)(2008-7#1)(2011-1#7)(2012-2#3)
plaque characteristics##4##2##(2007-10#1)(2011-1#1)(2012-2#1)(2013-4#1)
plaque composition and##3##3##(2011-1#1)(2012-2#2)
plaque composition##8##2##(2008-7#1)(2010-9#1)(2011-1#4)(2012-2#2)
plaque control##3##2##(2012-12#1)(2012-2#1)(2012-3#1)
plaque creating stenosis &gt##2##4##(2007-10#2)
plaque development and##2##3##(2008-10#1)(2008-5#1)
plaque disruption##7##2##(2007-10#6)(2010-12#1)
plaque erosion##3##2##(2005-10#1)(2007-10#2)
plaque erosions##2##2##(2010-12#1)(2012-2#1)
plaque formation and##2##3##(2008-1#1)(2012-2#1)
plaque formation on##2##3##(2008-9#1)(2012-12#1)
plaque formation##12##2##(1994-12#1)(1994-5#1)(1995-5#1)(1997-4#1)(2006-2#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
plaque forming units (PFU)##2##4##(1997-3#1)(2010-5#1)
plaque forming units##3##3##(1997-3#1)(2008-4#1)(2010-5#1)
plaque forming##6##2##(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-5#1)
plaque hybridization##5##2##(1990-4#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-8#1)
plaque imaging##7##2##(2008-7#3)(2010-9#4)
plaque in##6##2##(2008-1#1)(2008-12#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-3#1)
plaque index and##3##3##(2006-2#1)(2008-8#1)(2010-5#1)
plaque index##9##2##(2006-2#2)(2008-12#1)(2008-8#2)(2010-5#2)(2011-2#1)(2013-1#1)
plaque inflammation##2##2##(2011-12#2)
plaque instability##4##2##(2007-1#1)(2008-4#1)(2010-12#1)(2011-12#1)
plaque is##3##2##(2011-2#2)(2012-3#1)
plaque morphology##4##2##(2007-9#1)(2011-1#2)(2012-2#1)
plaque neurites and neuropil threads##2##5##(1992-3#1)(1996-11#1)
plaque neurites##3##2##(1991-10#1)(1992-3#1)(1996-11#1)
plaque of##3##2##(2008-7#1)(2010-8#1)(2012-3#1)
plaque on the##3##3##(2007-7#2)(2010-6#1)
plaque on##9##2##(1993-9#1)(2005-11#1)(2006-2#1)(2007-2#1)(2007-7#3)(2010-6#1)(2012-2#1)
plaque progression##2##2##(2009-10#1)(2010-9#1)
plaque psoriasis##7##2##(2007-11#1)(2008-1#1)(2008-5#3)(2008-6#1)(2012-2#1)
plaque purification##2##2##(2008-2#1)(2013-8#1)
plaque purified##2##2##(1997-4#1)(2008-5#1)
plaque re-growth##2##2##(2006-2#2)
plaque reduction neutralization test##2##4##(2007-12#2)
plaque rupture and##3##3##(2006-10#1)(2008-3#1)(2012-2#1)
plaque rupture##11##2##(2003-11#1)(2005-10#1)(2005-7#1)(2006-10#1)(2008-10#1)(2008-3#1)(2010-4#1)(2011-1#1)(2012-2#3)
plaque samples from 61 patients##2##5##(2008-12#2)
plaque score##3##2##(2007-10#3)
plaque scores##3##2##(2008-1#1)(2012-12#1)(2012-3#1)
plaque size##3##2##(2010-9#2)(2013-8#1)
plaque sizes##3##2##(2013-8#3)
plaque surface##2##2##(2007-10#1)(2008-8#1)
plaque that##2##2##(2009-8#1)(2010-9#1)
plaque types##3##2##(1992-8#2)(2007-11#1)
plaque ulcerations##2##2##(2007-10#2)
plaque ulcers##2##2##(2007-10#2)
plaque using##2##2##(2008-3#1)(2008-5#1)
plaque volume##4##2##(2008-6#1)(2008-8#1)(2009-1#1)(2011-1#1)
plaque vulnerability##3##2##(2008-8#2)(2012-2#1)
plaque was##3##2##(2007-7#1)(2008-5#1)(2010-12#1)
plaque with##7##2##(2007-7#1)(2008-5#1)(2010-6#2)(2010-9#1)(2012-2#1)(2012-3#1)
plaque##350##1##(1990-10#2)(1990-12#1)(1990-4#1)(1991-1#2)(1991-10#1)(1991-3#1)(1991-7#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-8#4)(1993-11#1)(1993-12#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-10#1)(1995-12#3)(1995-3#2)(1995-4#1)(1995-5#1)(1995-8#1)(1996-11#3)(1996-4#1)(1997-2#1)(1997-3#1)(1997-4#2)(2003-11#2)(2005-1#1)(2005-10#4)(2005-11#1)(2005-7#3)(2006-10#1)(2006-2#14)(2006-3#6)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#22)(2007-11#4)(2007-12#2)(2007-2#1)(2007-7#5)(2007-8#2)(2007-9#1)(2008-1#7)(2008-10#8)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#6)(2008-5#18)(2008-6#2)(2008-7#11)(2008-8#19)(2008-9#3)(2009-1#1)(2009-10#3)(2009-12#1)(2009-5#5)(2009-8#1)(2010-12#6)(2010-4#2)(2010-5#3)(2010-6#3)(2010-8#1)(2010-9#20)(2011-1#27)(2011-12#6)(2011-2#11)(2012-12#3)(2012-2#30)(2012-3#8)(2013-1#5)(2013-4#2)(2013-7#3)(2013-8#8)
plaque-forming cell (PFC) assay##2##4##(2008-10#1)(2008-4#1)
plaque-forming cell (PFC) assays##2##4##(2008-4#2)
plaque-forming cell (PFC)##5##3##(1993-12#1)(2008-10#1)(2008-4#3)
plaque-forming cell##6##2##(1993-12#1)(1995-12#1)(2008-10#1)(2008-4#3)
plaque-forming units of##2##3##(2013-8#2)
plaque-forming units##7##2##(2007-11#1)(2008-11#1)(2008-5#1)(2013-8#4)
plaque-forming##16##1##(1992-1#1)(1993-12#1)(1995-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#2)(2012-3#1)(2013-8#4)
plaque-induced peri-implant inflammatory diseases##2##4##(2012-12#2)
plaque-induced##4##1##(2012-12#4)
plaque-like##2##1##(2007-7#1)(2013-8#1)
plaque-purified##2##1##(1991-6#1)(1997-4#1)
plaque-type psoriasis with##2##3##(2007-8#2)
plaque-type psoriasis##4##2##(1991-1#1)(2007-8#3)
plaques (AP)##2##2##(1996-6#1)(2012-3#1)
plaques also##2##2##(1991-10#1)(2008-8#1)
plaques and cerebrovascular##2##3##(1992-12#1)(1995-10#1)
plaques and neurofibrillary tangles##7##4##(1991-1#1)(1993-11#3)(2004-11#1)(2008-5#1)(2008-7#1)
plaques and##26##2##(1991-1#1)(1991-12#3)(1991-9#1)(1992-12#1)(1993-11#3)(1993-6#1)(1995-10#1)(2004-11#1)(2005-11#1)(2006-6#1)(2007-7#2)(2008-5#2)(2008-7#5)(2012-2#2)(2013-1#1)
plaques are##6##2##(1992-1#1)(2003-11#2)(2007-10#1)(2008-4#1)(2010-12#1)
plaques as##3##2##(2007-10#1)(2012-2#1)(2013-8#1)
plaques found in Alzheimer's disease##2##5##(1990-5#1)(1995-10#1)
plaques grow##2##2##(2008-8#1)(2012-2#1)
plaques in Alzheimer's disease (AD)##3##5##(1994-5#1)(2012-12#1)(2012-2#1)
plaques in the##8##3##(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2013-7#1)
plaques in##26##2##(1990-7#2)(1991-1#2)(1991-11#1)(1991-12#1)(1992-8#2)(1993-3#1)(1994-5#1)(1995-6#1)(1996-1#1)(1997-3#1)(2005-7#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-7#1)
plaques involving the##2##3##(2006-10#1)(2008-4#1)
plaques is##3##2##(1997-8#1)(2008-5#2)
plaques may be##2##3##(1995-6#1)(2008-6#1)
plaques observed in##2##3##(2008-7#1)(2013-1#1)
plaques of all##2##3##(1995-3#2)
plaques of the##2##3##(2007-7#1)(2012-3#1)
plaques of##8##2##(1990-5#1)(1991-5#1)(1995-3#2)(2007-7#3)(2012-3#1)
plaques on the##4##3##(2008-11#1)(2008-4#1)(2008-5#2)
plaques on##7##2##(1994-5#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#2)(2010-6#1)
plaques or##4##2##(2003-11#1)(2007-11#1)(2007-6#1)(2011-2#1)
plaques over##4##2##(2007-7#2)(2013-1#2)
plaques that##2##2##(2010-12#1)(2010-9#1)
plaques was##2##2##(1991-10#1)(2007-10#1)
plaques were more##2##3##(1992-8#2)
plaques were##10##2##(1991-10#1)(1992-11#1)(1992-8#2)(1995-12#1)(2007-12#1)(2008-10#1)(2008-7#1)(2012-12#1)(2013-8#1)
plaques with##7##2##(1991-12#1)(1997-4#1)(2007-7#2)(2010-12#1)(2010-6#1)(2012-3#1)
plaques##241##1##(1990-5#2)(1990-6#1)(1990-7#2)(1991-1#5)(1991-10#6)(1991-11#1)(1991-12#9)(1991-3#2)(1991-5#1)(1991-7#2)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#2)(1992-7#1)(1992-8#5)(1993-11#4)(1993-3#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-5#3)(1994-8#1)(1995-10#4)(1995-12#1)(1995-3#3)(1995-5#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#2)(1997-3#1)(1997-4#4)(1997-7#1)(1997-8#2)(2003-11#4)(2004-11#2)(2005-11#1)(2005-7#4)(2006-10#2)(2006-11#2)(2006-6#2)(2007-10#6)(2007-11#5)(2007-12#1)(2007-6#1)(2007-7#12)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-4#8)(2008-5#14)(2008-6#1)(2008-7#12)(2008-8#5)(2008-9#1)(2009-4#1)(2010-12#7)(2010-4#1)(2010-5#1)(2010-6#5)(2010-8#1)(2010-9#4)(2011-1#3)(2011-2#2)(2012-12#5)(2012-2#13)(2012-3#6)(2013-1#4)(2013-4#2)(2013-7#1)(2013-8#4)
plaques)##2##1##(2008-5#2)
plasm##29##1##(2008-10#27)(2009-3#1)(2009-7#1)
plasma (0##5##2##(1990-6#1)(1997-8#1)(2006-12#1)(2008-10#1)(2011-2#1)
plasma (PRP)##8##2##(1990-1#1)(1997-7#1)(2007-9#2)(2008-7#1)(2012-12#2)(2013-1#1)
plasma 1##2##2##(1994-11#2)
plasma ACTH and corticosterone##3##4##(1995-12#1)(1997-5#2)
plasma ACTH and##4##3##(1995-12#2)(1997-5#2)
plasma ACTH in##2##3##(1992-8#2)
plasma ACTH##13##2##(1992-8#3)(1993-3#2)(1995-12#4)(1997-5#4)
plasma ADAMTS13##2##2##(2009-7#2)
plasma AG##2##2##(1996-3#2)
plasma ANP levels##2##3##(2006-11#2)
plasma ANP##3##2##(2006-11#2)(2008-5#1)
plasma Bragg mirror##2##3##(2007-12#2)
plasma C-peptide values##2##3##(1990-2#2)
plasma C-peptide##5##2##(1990-2#3)(2010-4#1)(2012-3#1)
plasma C-reactive protein (CRP)##2##4##(1990-12#1)(1997-7#1)
plasma C-reactive protein##3##3##(1990-12#1)(1997-7#1)(2006-4#1)
plasma CCK levels##3##3##(1996-4#1)(2008-7#2)
plasma CCK##7##2##(1991-2#2)(1996-4#1)(2008-7#4)
plasma CCK-LI##2##2##(1995-5#2)
plasma CETP activity##2##3##(1997-2#2)
plasma CPB##7##2##(1996-5#7)
plasma Cardiac Troponin I##2##4##(2008-12#2)
plasma Co Q10##2##3##(1992-2#2)
plasma DBH activity##2##3##(1995-11#2)
plasma DBH##3##2##(1995-11#3)
plasma DNA##2##2##(1990-4#2)
plasma ET-1 levels##2##3##(1990-3#2)
plasma FDOPA##2##2##(1997-8#2)
plasma Fb##4##2##(1995-7#4)
plasma GABA levels##2##3##(1995-11#1)(1996-7#1)
plasma GABA##5##2##(1995-11#2)(1996-7#3)
plasma GH##2##2##(1991-12#1)(1997-2#1)
plasma HCY concentration in##2##4##(2007-9#2)
plasma HCY concentration##3##3##(2007-9#3)
plasma HDL##3##2##(1990-5#1)(1995-6#2)
plasma HDL-C concentrations##2##3##(1997-4#2)
plasma HDL-C level for##2##4##(2013-1#2)
plasma HDL-C level##3##3##(2013-1#3)
plasma HDL-C##8##2##(1997-4#5)(2013-1#3)
plasma HDL-cholesterol##2##2##(1993-12#1)(2006-2#1)
plasma HIV##2##2##(2012-12#1)(2012-2#1)
plasma Hp were##2##3##(1995-7#2)
plasma Hp##9##2##(1995-7#9)
plasma IGF1 levels##2##3##(2009-5#2)
plasma IL-6 levels in##2##4##(2011-2#2)
plasma IL-6 levels##4##3##(1997-7#1)(2011-2#3)
plasma IL-6##6##2##(1997-7#2)(1997-8#1)(2011-2#3)
plasma IgM##2##2##(2008-7#2)
plasma LCAT activity##6##3##(1991-7#3)(1995-6#3)
plasma LDL cholesterol##3##3##(1993-9#1)(2009-4#1)(2010-12#1)
plasma LDL##6##2##(1990-11#1)(1991-5#1)(1993-9#1)(2004-12#1)(2009-4#1)(2010-12#1)
plasma LDL-cholesterol##2##2##(1990-11#1)(2006-7#1)
plasma LEP levels were##2##4##(2006-6#2)
plasma LEP levels##5##3##(2006-6#5)
plasma LEP##6##2##(2006-6#6)
plasma Lp(a) levels in##3##4##(1993-12#2)(1997-2#1)
plasma Lp(a)##5##2##(1993-12#3)(1997-2#2)
plasma MDA##3##2##(1992-4#1)(2006-8#1)(2012-2#1)
plasma MTX##2##2##(2004-10#2)
plasma NE##2##2##(1996-1#1)(1996-7#1)
plasma NO##2##2##(2007-10#1)(2010-4#1)
plasma NPY levels##4##3##(1995-12#2)(1996-1#2)
plasma Na ion and corticosterone levels##2##6##(2009-5#2)
plasma PAF acetylhydrolase##2##3##(1997-7#2)
plasma PAI-1 antigen and activity levels##2##6##(2007-9#2)
plasma PAI-1 antigen levels##2##4##(2007-9#2)
plasma PAI-1 antigen##4##3##(2007-9#4)
plasma PAI-1 levels##2##3##(2007-9#1)(2013-1#1)
plasma PAI-1##7##2##(2007-9#6)(2013-1#1)
plasma PC##5##2##(1995-8#5)
plasma SHBG levels##5##3##(2008-3#5)
plasma TAC##4##2##(2007-8#4)
plasma TAG##2##2##(2007-8#2)
plasma TG levels alone##3##4##(2008-3#3)
plasma TSH levels##3##3##(1994-6#2)(2008-5#1)
plasma V level and V loss##3##6##(2011-2#3)
plasma V level and##4##4##(2011-2#4)
plasma V level##5##3##(2011-2#5)
plasma V##6##2##(1993-12#1)(2011-2#5)
plasma VEGF##2##2##(2007-8#1)(2013-8#1)
plasma Zn alpha 2gp##2##4##(1994-6#2)
plasma activities in##2##3##(1993-12#2)
plasma activities##3##2##(1993-12#3)
plasma activity augmenting PMN adherence##2##5##(1993-12#2)
plasma activity##8##2##(1993-11#2)(1993-12#5)(1997-7#1)
plasma adrenocorticotropic##3##2##(1990-2#1)(1997-1#1)(2011-2#1)
plasma after##7##2##(1992-6#1)(1993-1#1)(1993-2#1)(1997-3#1)(2007-11#1)(2008-10#2)
plasma albumin concentration and indices of glycaemic control##2##8##(1992-9#2)
plasma albumin concentration##5##3##(1992-9#5)
plasma albumin was##2##3##(2010-4#2)
plasma albumin##8##2##(1992-9#5)(2008-7#1)(2010-4#2)
plasma aldosterone##5##2##(1992-7#2)(1995-10#2)(2008-1#1)
plasma amino acids##5##3##(1990-4#1)(1992-12#1)(1992-8#1)(1995-5#1)(1996-6#1)
plasma amino##6##2##(1990-4#1)(1992-12#1)(1992-8#1)(1995-5#1)(1996-6#1)(2006-7#1)
plasma aminothiols##2##2##(2004-11#2)
plasma analyses##2##2##(1996-5#1)(2008-10#1)
plasma and CSF##3##3##(1992-9#1)(1994-8#1)(1995-11#1)
plasma and amniotic fluid##2##4##(1990-11#1)(1992-2#1)
plasma and blood##3##3##(1993-9#2)(2008-4#1)
plasma and brain were##2##4##(1993-7#1)(2012-12#1)
plasma and brain##7##3##(1990-11#2)(1990-6#2)(1993-7#1)(2012-12#2)
plasma and cerebrospinal fluid (CSF)##2##5##(1992-9#1)(2008-5#1)
plasma and cerebrospinal fluid##4##4##(1992-9#1)(1995-3#1)(2008-5#1)(2009-10#1)
plasma and cytoplasmic##2##3##(1996-7#2)
plasma and erythrocyte samples##2##4##(1995-1#1)(2008-10#1)
plasma and erythrocyte##7##3##(1992-4#2)(1995-1#2)(2008-10#2)(2013-1#1)
plasma and erythrocytes##8##3##(1990-7#2)(1991-12#1)(1993-2#1)(2007-9#1)(2008-7#1)(2013-1#2)
plasma and for##3##3##(1996-3#1)(1997-8#1)(2007-8#1)
plasma and granule membranes##2##4##(1992-6#2)
plasma and in##8##3##(1990-12#1)(1990-8#1)(1992-1#1)(1992-2#1)(1993-2#1)(1996-8#1)(2008-10#2)
plasma and its##3##3##(1994-12#1)(1997-8#1)(2008-10#1)
plasma and lipoprotein lipid peroxidation in##2##6##(1994-6#2)
plasma and lipoprotein lipid##3##4##(1994-6#2)(2004-11#1)
plasma and liver##5##3##(1993-2#1)(1995-3#1)(2007-8#2)(2010-12#1)
plasma and pineal gland##2##4##(1994-2#2)
plasma and platelet##3##3##(1992-12#1)(2013-1#1)(2013-8#1)
plasma and red cell glutathione##2##5##(1991-9#2)
plasma and saliva##6##3##(1990-10#2)(2008-10#3)(2013-8#1)
plasma and serum##6##3##(1995-1#1)(1996-1#1)(2005-8#3)(2008-8#1)
plasma and spinal cord##2##4##(1991-5#2)
plasma and the##6##3##(1991-9#1)(1992-12#1)(1994-12#2)(2008-1#1)(2009-9#1)
plasma and tissue levels of##2##5##(1997-1#1)(2008-3#1)
plasma and tissue##7##3##(1993-11#1)(1993-12#1)(1996-12#1)(1997-1#1)(2008-3#1)(2008-9#1)(2012-2#1)
plasma and urinary##4##3##(1990-4#1)(1995-2#1)(2010-7#1)(2011-12#1)
plasma and urine by##11##4##(1990-11#3)(1990-6#2)(1993-9#1)(1996-8#1)(1997-3#1)(1997-8#1)(2013-1#2)
plasma and urine samples##6##4##(1990-6#2)(1997-3#1)(2005-12#1)(2008-10#2)
plasma and urine##44##3##(1990-10#1)(1990-11#5)(1990-3#1)(1990-6#8)(1991-10#1)(1991-12#1)(1993-9#1)(1995-2#1)(1996-6#3)(1996-8#5)(1997-3#6)(1997-8#4)(2005-12#2)(2008-10#2)(2008-11#1)(2013-1#2)
plasma and was##2##3##(1990-11#1)(1992-3#1)
plasma and whole blood##2##4##(1990-11#1)(1997-2#1)
plasma and##230##2##(1990-10#3)(1990-11#11)(1990-12#4)(1990-2#2)(1990-3#1)(1990-4#1)(1990-6#12)(1990-7#4)(1990-8#1)(1990-9#2)(1991-10#1)(1991-12#5)(1991-2#1)(1991-3#2)(1991-5#2)(1991-7#1)(1991-9#4)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#2)(1992-6#2)(1992-9#2)(1993-11#2)(1993-12#1)(1993-2#4)(1993-7#1)(1993-9#4)(1994-11#1)(1994-12#4)(1994-2#2)(1994-6#2)(1994-8#5)(1994-9#1)(1995-1#3)(1995-11#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-6#5)(1996-7#2)(1996-8#9)(1997-1#1)(1997-2#1)(1997-3#8)(1997-8#7)(2004-11#2)(2004-9#1)(2005-12#3)(2005-8#4)(2006-5#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#18)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#6)(2008-8#6)(2008-9#2)(2009-10#1)(2009-11#2)(2009-4#3)(2009-9#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#8)(2013-8#3)
plasma androgen levels##2##3##(1997-5#1)(2009-5#1)
plasma antioxidant capacity##2##3##(2007-8#1)(2013-8#1)
plasma antioxidant##4##2##(1997-2#1)(2006-12#1)(2007-8#1)(2013-8#1)
plasma antioxidants##2##2##(1992-11#1)(1997-8#1)
plasma apolipoprotein##2##2##(1991-8#1)(1995-2#1)
plasma apolipoproteins##6##2##(1990-8#1)(1993-9#5)
plasma are often##2##3##(1992-3#1)(2008-8#1)
plasma are##12##2##(1992-3#2)(1993-9#1)(1994-12#1)(1995-1#1)(1995-2#2)(1996-6#2)(2008-2#1)(2008-8#1)(2012-3#1)
plasma as a##4##3##(1996-3#1)(2008-2#1)(2008-8#1)(2013-1#1)
plasma as well as in##2##5##(1990-3#1)(1993-11#1)
plasma as well as##3##4##(1990-3#1)(1993-11#1)(2008-7#1)
plasma as##10##2##(1990-3#1)(1992-3#1)(1993-11#1)(1996-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2013-1#1)
plasma ascorbic acid##2##3##(1993-3#1)(2010-8#1)
plasma ashing##2##2##(2008-10#1)(2010-4#1)
plasma at a##2##3##(1990-12#1)(1994-2#1)
plasma at##9##2##(1990-12#3)(1992-2#1)(1993-2#1)(1994-2#1)(1996-8#1)(2005-4#1)(2008-10#1)
plasma atomic emission spectrometry (ICP-AES)##17##5##(2005-4#1)(2008-10#15)(2009-6#1)
plasma atomic emission spectrometry##61##4##(1992-3#1)(2005-4#2)(2008-10#56)(2009-6#2)
plasma atomic emission spectroscopy##5##4##(2008-10#4)(2008-5#1)
plasma atomic emission##77##3##(1992-3#1)(2005-4#2)(2008-10#69)(2008-5#1)(2009-6#2)(2013-7#2)
plasma atomic##79##2##(1992-3#1)(2005-4#2)(2008-10#71)(2008-5#1)(2009-6#2)(2013-7#2)
plasma balls##2##2##(2008-2#2)
plasma because of##2##3##(1990-2#1)(1996-6#1)
plasma because##3##2##(1990-2#1)(1992-2#1)(1996-6#1)
plasma before##2##2##(1995-12#1)(1996-4#1)
plasma beta2M##2##2##(2008-1#2)
plasma between##2##2##(1994-11#1)(2007-8#1)
plasma biochemical profiles##2##3##(2007-2#2)
plasma biochemical##3##2##(2005-7#1)(2007-2#2)
plasma biochemistry##3##2##(2006-7#1)(2007-2#1)(2009-5#1)
plasma biomarkers of##2##3##(2009-10#1)(2012-2#1)
plasma but not in##2##4##(1997-1#1)(2013-7#1)
plasma but not##3##3##(1990-4#1)(1997-1#1)(2013-7#1)
plasma by a##7##3##(1990-4#1)(1990-8#1)(1992-10#1)(1993-2#1)(1996-3#2)(2011-3#1)
plasma by high-performance liquid chromatography and##3##6##(1997-3#1)(2008-10#2)
plasma by high-performance liquid chromatography with##4##6##(1990-6#1)(1992-2#1)(1996-8#2)
plasma by high-performance liquid chromatography##22##5##(1990-6#2)(1992-2#1)(1993-2#1)(1996-6#1)(1996-8#5)(1997-3#6)(1997-8#2)(2008-10#4)
plasma by high-performance liquid##23##4##(1990-6#2)(1992-2#1)(1993-2#1)(1996-6#1)(1996-8#6)(1997-3#6)(1997-8#2)(2008-10#4)
plasma by reversed-phase##4##3##(1990-6#3)(2008-10#1)
plasma by the##4##3##(1993-9#1)(2007-12#1)(2008-1#1)(2012-12#1)
plasma by using##2##3##(1996-8#1)(2008-10#1)
plasma by##69##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#5)(1990-8#3)(1991-2#1)(1992-10#1)(1992-2#3)(1993-2#2)(1993-9#1)(1995-6#1)(1995-7#1)(1996-3#3)(1996-4#1)(1996-6#1)(1996-8#9)(1997-1#1)(1997-3#6)(1997-8#2)(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-2#1)(2008-9#1)(2011-2#2)(2011-3#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
plasma calcitonin##2##2##(1990-12#1)(1993-6#1)
plasma calcium levels in the chick##2##6##(1990-6#2)
plasma calcium levels##5##3##(1990-6#4)(1991-7#1)
plasma calcium##9##2##(1990-6#5)(1991-7#2)(1994-11#2)
plasma can be used##3##4##(1990-2#1)(2012-12#2)
plasma can be##4##3##(1990-2#1)(1995-3#1)(2012-12#2)
plasma can##7##2##(1990-2#1)(1995-3#2)(1997-2#1)(2008-2#1)(2012-12#2)
plasma carotene concentrations##2##3##(2006-5#2)
plasma catecholamines and heart##2##4##(1994-3#2)
plasma catecholamines##5##2##(1990-11#1)(1992-4#1)(1994-3#2)(2008-7#1)
plasma cell dyscrasia##4##3##(2008-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
plasma cell dyscrasias##2##3##(2009-8#2)
plasma cell granuloma##3##3##(1991-9#2)(2012-2#1)
plasma cell infiltration##3##3##(2007-7#1)(2009-8#2)
plasma cell tumors##7##3##(1995-1#2)(2006-12#4)(2012-12#1)
plasma cell##28##2##(1991-9#2)(1993-8#1)(1995-1#3)(2006-12#4)(2007-7#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#4)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
plasma cells and##4##3##(1997-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
plasma cells in##3##3##(2008-1#1)(2008-9#1)(2009-7#1)
plasma cells of the##2##4##(1992-10#1)(2012-12#1)
plasma cells##31##2##(1992-10#1)(1994-6#1)(1995-1#2)(1995-5#1)(1996-11#1)(1996-4#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-1#2)(2008-5#1)(2008-9#4)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#2)(2012-12#2)(2013-1#2)(2013-8#1)
plasma ceruloplasmin##2##2##(2004-4#1)(2008-9#1)
plasma chemical##4##2##(2006-4#1)(2008-10#1)(2008-2#1)(2008-5#1)
plasma cholesterol and##4##3##(1991-2#1)(1995-8#1)(1997-1#1)(2010-2#1)
plasma cholesterol concentrations##2##3##(2004-11#1)(2010-2#1)
plasma cholesterol in##2##3##(1991-4#1)(1992-5#1)
plasma cholesterol level in##2##4##(1997-1#1)(2008-4#1)
plasma cholesterol level##7##3##(1997-1#4)(1997-2#1)(2008-4#1)(2008-8#1)
plasma cholesterol levels##8##3##(1990-3#1)(1992-11#1)(1994-8#1)(1995-2#1)(1995-4#2)(2005-9#2)
plasma cholesterol lowering##2##3##(1992-5#1)(2004-11#1)
plasma cholesterol##33##2##(1990-3#2)(1991-2#1)(1991-4#1)(1992-11#1)(1992-5#2)(1993-9#1)(1994-8#2)(1995-2#1)(1995-4#2)(1995-8#2)(1996-8#1)(1997-1#5)(1997-2#1)(1997-8#1)(2004-11#2)(2005-9#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#2)
plasma cholesteryl ester transfer protein activity##3##6##(2008-12#3)
plasma cholesteryl ester transfer protein##4##5##(1997-2#1)(2008-12#3)
plasma cholesteryl ester transfer##5##4##(1997-2#2)(2008-12#3)
plasma cholesteryl ester##6##3##(1991-1#1)(1997-2#2)(2008-12#3)
plasma cholinesterase##2##2##(1991-9#1)(1995-1#1)
plasma cleaner##3##2##(2008-11#3)
plasma clearance##5##2##(2005-7#1)(2007-2#1)(2008-5#1)(2009-4#1)(2013-8#1)
plasma clots##3##2##(1990-11#2)(1997-2#1)
plasma coagulation (APC)##4##3##(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#1)
plasma coagulation##12##2##(1992-10#1)(2006-10#1)(2008-3#1)(2008-7#1)(2010-12#3)(2010-8#1)(2012-12#1)(2013-1#2)(2013-7#1)
plasma collected##2##2##(1991-6#1)(1996-1#1)
plasma column##2##2##(2007-11#1)(2007-12#1)
plasma component##2##2##(1990-6#1)(1996-6#1)
plasma components##9##2##(1990-11#2)(1992-7#1)(1996-3#1)(2005-10#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-4#1)
plasma concentration and##3##3##(2007-2#1)(2008-1#1)(2012-2#1)
plasma concentration in the##2##4##(1991-12#1)(1992-9#1)
plasma concentration in##3##3##(1991-1#1)(1991-12#1)(1992-9#1)
plasma concentration is##2##3##(2007-11#1)(2008-12#1)
plasma concentration of endothelin-1##2##4##(1990-5#1)(1993-11#1)
plasma concentration of the##3##4##(1993-1#1)(1994-12#1)(1996-5#1)
plasma concentration of vitamin C##2##5##(1994-10#1)(2008-12#1)
plasma concentration of##33##3##(1990-11#1)(1990-4#1)(1990-5#1)(1990-6#1)(1993-1#1)(1993-11#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-5#1)(1995-9#1)(1996-5#1)(2005-10#1)(2006-7#2)(2007-8#5)(2008-1#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2012-2#1)(2013-8#3)
plasma concentration profiles##2##3##(2008-11#2)
plasma concentration versus time profile##2##5##(2010-11#2)
plasma concentration versus time##4##4##(1991-12#1)(2008-11#1)(2010-11#2)
plasma concentration was##3##3##(1995-6#1)(1997-3#1)(2007-8#1)
plasma concentration##71##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#2)(1991-1#1)(1991-12#2)(1992-9#1)(1993-1#1)(1993-11#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-5#1)(1994-9#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-8#1)(2004-12#3)(2005-10#1)(2006-7#2)(2007-11#1)(2007-2#1)(2007-8#7)(2007-9#1)(2008-1#3)(2008-11#3)(2008-12#2)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2010-11#2)(2010-12#2)(2011-2#1)(2012-12#3)(2012-2#2)(2013-8#3)
plasma concentration-time curve##4##3##(1996-5#1)(2008-5#1)(2008-8#1)(2010-12#1)
plasma concentration-time##7##2##(1994-11#1)(1996-5#1)(2008-5#2)(2008-8#2)(2010-12#1)
plasma concentrations are##2##3##(2008-7#1)(2012-2#1)
plasma concentrations in##2##3##(1990-12#1)(2012-2#1)
plasma concentrations of the##4##4##(1990-12#1)(1995-2#1)(1997-1#1)(2007-8#1)
plasma concentrations of##41##3##(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#2)(1991-1#1)(1991-8#1)(1992-3#1)(1992-5#1)(1993-7#2)(1993-9#3)(1994-8#1)(1995-2#1)(1997-1#1)(1997-4#1)(1997-8#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-8#4)(2007-9#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
plasma concentrations##74##2##(1990-12#3)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1991-1#2)(1991-12#3)(1991-2#1)(1991-8#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-7#2)(1993-9#3)(1994-11#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-8#1)(2004-10#1)(2005-8#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-8#4)(2007-9#2)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2009-4#2)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
plasma contained##2##2##(1991-2#1)(1995-2#1)
plasma containing##4##2##(1990-6#1)(1992-2#2)(1996-8#1)
plasma contains##2##2##(1993-3#1)(1994-2#1)
plasma corticosterone and ACTH##2##4##(1997-5#2)
plasma corticosterone and##4##3##(1994-2#1)(1997-5#2)(2013-7#1)
plasma corticosterone##8##2##(1994-11#1)(1994-2#1)(1994-6#1)(1995-3#1)(1997-5#2)(2013-7#2)
plasma cortisol levels##2##3##(2008-6#2)
plasma cortisol##8##2##(2007-11#1)(2008-6#4)(2010-8#2)(2013-1#1)
plasma creatinine concentrations##2##3##(1997-5#1)(2005-10#1)
plasma creatinine level was##2##4##(2007-6#1)(2008-4#1)
plasma creatinine##6##2##(1996-3#1)(1997-5#1)(2005-10#1)(2007-6#1)(2008-4#1)(2009-12#1)
plasma deficient in##2##3##(1991-8#2)
plasma depleted##2##2##(1994-12#1)(2008-8#1)
plasma did not##3##3##(1990-11#1)(2006-5#1)(2008-10#1)
plasma digoxin level##8##3##(1994-6#8)
plasma during late pregnancy and after delivery was##2##8##(1991-4#2)
plasma during##6##2##(1991-3#1)(1991-4#2)(1992-6#1)(1995-11#1)(1995-12#1)
plasma emission spectrometer##2##3##(2008-10#2)
plasma emission spectrophotometry##2##3##(1990-10#1)(2008-10#1)
plasma emission##8##2##(1990-10#2)(2008-10#4)(2008-3#1)(2008-5#1)
plasma enhanced chemical vapor deposition##3##5##(2005-4#1)(2008-10#1)(2009-11#1)
plasma enzyme activity##2##3##(1997-7#2)
plasma enzyme levels were##2##4##(1993-1#2)
plasma enzyme##9##2##(1991-7#1)(1992-9#1)(1993-1#2)(1995-1#1)(1995-6#1)(1997-7#3)
plasma epinephrine levels##2##3##(1995-12#2)
plasma epinephrine##3##2##(1995-12#3)
plasma exchange and intravenous immunoglobulins##2##5##(2007-11#1)(2012-3#1)
plasma exchange and##4##3##(1993-2#1)(2006-10#1)(2007-11#1)(2012-3#1)
plasma exchange refractory##2##3##(2007-12#2)
plasma exchange##19##2##(1990-12#1)(1993-2#1)(1995-3#1)(1995-5#1)(2006-10#3)(2006-4#1)(2007-11#1)(2007-12#4)(2011-2#4)(2012-3#2)
plasma exchanges synchronized with##2##4##(1993-2#2)
plasma expansion##2##2##(1995-5#1)(2008-5#1)
plasma extraction rate##2##3##(2011-2#2)
plasma extracts##2##2##(1990-3#1)(1996-3#1)
plasma extravasation##4##2##(1996-11#2)(1997-3#1)(2004-3#1)
plasma factor##2##2##(1990-5#1)(1995-8#1)
plasma fatty acids##2##3##(2012-2#2)
plasma fibrinogen concentrations##2##3##(1996-2#1)(1996-6#1)
plasma fibrinogen##11##2##(1995-7#1)(1996-2#1)(1996-6#2)(2008-10#5)(2008-3#1)(2008-7#1)
plasma fibronectin##8##2##(1990-7#2)(1991-4#2)(1995-5#1)(2008-7#3)
plasma for both##2##3##(1997-3#1)(2008-11#1)
plasma for fractionation##2##3##(2007-8#1)(2012-12#1)
plasma for##15##2##(1995-8#1)(1996-3#1)(1997-2#1)(1997-3#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#1)(2012-12#2)
plasma form##2##2##(1990-3#1)(1996-7#1)
plasma formation in##3##3##(2007-12#1)(2008-3#2)
plasma formation##6##2##(2007-12#3)(2008-3#3)
plasma free T4 concentrations##2##4##(1994-6#2)
plasma free fatty acid##2##4##(1997-2#1)(2013-1#1)
plasma free##9##2##(1990-4#1)(1990-5#1)(1994-6#2)(1997-2#1)(2006-9#3)(2013-1#1)
plasma freezing##3##2##(1991-10#1)(2007-8#2)
plasma from a##2##3##(2008-10#1)(2011-2#1)
plasma from healthy individuals##2##4##(2008-10#1)(2010-12#1)
plasma from healthy volunteers##2##4##(1992-3#1)(2007-11#1)
plasma from healthy##5##3##(1992-3#1)(2007-11#1)(2008-10#1)(2008-8#1)(2010-12#1)
plasma from patients##3##3##(1994-12#1)(1995-12#1)(1996-7#1)
plasma from pregnant women##2##4##(1994-10#2)
plasma from the##5##3##(1990-5#2)(2008-2#1)(2010-11#1)(2013-8#1)
plasma from##37##2##(1990-10#1)(1990-5#2)(1991-1#1)(1991-10#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-10#2)(1994-12#2)(1994-6#1)(1995-11#1)(1995-12#1)(1995-6#2)(1996-5#1)(1996-7#1)(1997-8#1)(2005-7#1)(2007-11#2)(2008-10#3)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
plasma fructosamine concentration##3##3##(1992-9#3)
plasma gastrin##2##2##(1997-1#1)(2006-10#1)
plasma gastrins were##2##3##(1992-8#2)
plasma gastrins##3##2##(1992-8#3)
plasma gelsolin##5##2##(1990-4#1)(1992-8#2)(1996-7#2)
plasma generated##2##2##(2007-12#1)(2008-3#1)
plasma generation##3##2##(2007-12#1)(2008-2#2)
plasma glucagon##4##2##(1991-10#1)(1991-8#1)(2010-11#2)
plasma glucose and insulin##2##4##(2008-7#1)(2010-10#1)
plasma glucose and lactate##2##4##(2010-10#1)(2010-8#1)
plasma glucose and##10##3##(1990-8#1)(1996-8#1)(2007-6#1)(2008-7#1)(2009-6#1)(2010-10#2)(2010-8#1)(2012-3#1)(2013-1#1)
plasma glucose concentration in##2##4##(1991-12#1)(1992-9#1)
plasma glucose concentration##10##3##(1991-12#1)(1991-7#1)(1991-8#1)(1992-9#1)(1994-12#1)(1994-2#1)(2007-8#1)(2008-1#1)(2010-10#2)
plasma glucose concentrations##2##3##(1994-7#1)(2010-8#1)
plasma glucose level and##2##4##(2008-4#1)(2011-1#1)
plasma glucose level##4##3##(1997-2#1)(2008-4#1)(2009-6#1)(2011-1#1)
plasma glucose levels without##2##4##(1990-5#1)(1994-4#1)
plasma glucose levels##6##3##(1990-5#1)(1991-12#1)(1994-4#1)(1995-6#1)(2008-7#2)
plasma glucose##65##2##(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#2)(1991-7#1)(1991-8#3)(1992-9#1)(1993-3#3)(1994-12#2)(1994-2#1)(1994-4#2)(1994-7#2)(1995-6#1)(1996-8#1)(1997-2#1)(2005-7#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#2)(2008-3#4)(2008-4#1)(2008-7#4)(2009-3#1)(2009-6#2)(2010-10#4)(2010-4#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#5)(2012-3#1)(2012-7#3)(2013-1#3)
plasma glycoprotein that##2##3##(1991-2#1)(1995-5#1)
plasma glycoprotein##5##2##(1991-2#1)(1994-8#1)(1995-5#1)(2008-11#1)(2010-4#1)
plasma glycosaminoglycans##2##2##(1992-3#2)
plasma half-life and##4##3##(1993-8#1)(1996-12#1)(2007-11#1)(2008-10#1)
plasma half-life of##6##3##(1993-8#1)(1996-12#1)(2005-7#2)(2005-9#1)(2008-3#1)
plasma half-life##14##2##(1993-8#2)(1996-12#2)(2005-7#2)(2005-9#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#3)(2012-2#1)
plasma has been developed##4##4##(1996-3#1)(1997-3#2)(1997-8#1)
plasma has been##5##3##(1996-3#1)(1997-3#2)(1997-8#1)(2009-1#1)
plasma has##7##2##(1992-9#1)(1996-3#1)(1997-3#2)(1997-8#1)(2009-1#1)(2010-12#1)
plasma high density lipoprotein##2##4##(1995-6#1)(1997-4#1)
plasma high density##3##3##(1994-8#1)(1995-6#1)(1997-4#1)
plasma high##4##2##(1994-8#1)(1995-6#1)(1997-4#1)(2010-12#1)
plasma homocyst(e)ine##4##2##(1992-2#1)(1995-2#3)
plasma homocysteine concentration has also been shown to be related to macrovascular disease and death##2##15##(2005-10#1)(2008-3#1)
plasma homocysteine concentrations and##2##4##(2005-10#1)(2008-3#1)
plasma homocysteine concentrations##6##3##(1992-4#1)(2005-10#1)(2008-3#3)(2008-7#1)
plasma homocysteine level##3##3##(2005-10#1)(2008-3#2)
plasma homocysteine levels##2##3##(1992-9#1)(2007-9#1)
plasma homocysteine##22##2##(1991-12#1)(1992-4#1)(1992-9#2)(1996-6#1)(2005-10#3)(2005-12#2)(2007-10#1)(2007-9#1)(2008-1#1)(2008-3#7)(2008-7#2)
plasma hormones and##2##3##(1994-6#1)(2012-12#1)
plasma hormones##5##2##(1993-7#1)(1994-6#2)(2012-12#2)
plasma hypoxanthine##2##2##(1990-11#1)(1991-2#1)
plasma igniter##2##2##(2013-8#2)
plasma in a##2##3##(1994-3#1)(1997-7#1)
plasma in the##5##3##(1995-2#1)(1996-5#1)(2007-12#1)(2008-1#1)(2008-3#1)
plasma in vitro##4##3##(1990-12#1)(1990-4#1)(1991-3#1)(1995-5#1)
plasma in##20##2##(1990-12#2)(1990-4#1)(1991-3#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-3#1)(1996-5#2)(1997-7#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-3#1)(2011-2#1)(2013-8#1)
plasma instead of##2##3##(1993-11#1)(2009-4#1)
plasma insulin and corticosterone##2##4##(1996-12#2)
plasma insulin and##4##3##(1991-2#1)(1996-12#2)(2010-10#1)
plasma insulin concentration##3##3##(2010-10#1)(2010-4#1)(2012-2#1)
plasma insulin level##3##3##(1997-2#1)(2008-4#1)(2011-1#1)
plasma insulin levels were##4##4##(1990-5#2)(2008-3#1)(2008-5#1)
plasma insulin levels##9##3##(1990-5#3)(1991-7#1)(1994-8#1)(1997-7#1)(2008-3#1)(2008-5#2)
plasma insulin##25##2##(1990-5#3)(1991-2#1)(1991-7#1)(1994-8#1)(1996-12#2)(1997-2#1)(1997-7#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-6#1)(2010-10#2)(2010-4#1)(2011-1#2)(2012-1#1)(2012-2#1)
plasma intact parathyroid hormone##2##4##(1991-3#2)
plasma interferograms##2##2##(2008-3#2)
plasma ion concentrations##2##3##(2008-5#1)(2010-8#1)
plasma is described##4##3##(1990-12#1)(1990-6#1)(1993-2#1)(1993-9#1)
plasma is generated##2##3##(2008-10#1)(2008-2#1)
plasma is observed##2##3##(2007-8#1)(2008-1#1)
plasma is presented##3##3##(1996-8#1)(2008-10#1)(2008-3#1)
plasma is reported##2##3##(2008-10#1)(2010-3#1)
plasma is##34##2##(1990-12#3)(1990-4#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-2#2)(1993-9#1)(1994-12#1)(1995-2#1)(1996-8#3)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-2#1)(2008-3#2)(2008-9#1)(2010-3#1)(2013-8#1)
plasma isatin##2##2##(1997-3#2)
plasma jet##8##2##(1992-11#1)(2011-1#4)(2013-8#3)
plasma kallikrein##5##2##(1990-12#1)(1990-9#1)(1995-5#2)(1996-9#1)
plasma kernel##2##2##(2008-2#2)
plasma kinetics and##2##3##(1993-11#1)(2012-1#1)
plasma kinetics##3##2##(1993-11#1)(1996-12#1)(2012-1#1)
plasma lactate##4##2##(1990-3#1)(1991-2#2)(2010-8#1)
plasma leptin and##2##3##(2008-3#1)(2013-1#1)
plasma leptin levels##2##3##(2008-3#1)(2013-1#1)
plasma leptin##7##2##(2006-6#1)(2008-3#2)(2011-2#2)(2013-1#2)
plasma level during##2##3##(1990-9#1)(2008-12#1)
plasma level of##17##3##(1990-11#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-6#1)(1993-5#1)(1995-1#1)(1996-3#1)(1997-4#1)(2006-6#1)(2007-9#2)(2008-12#2)(2008-4#1)(2010-12#1)(2011-2#1)
plasma level##30##2##(1990-11#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-9#1)(1992-2#1)(1992-4#1)(1992-6#1)(1993-2#1)(1993-5#1)(1995-1#1)(1996-3#1)(1996-4#1)(1997-4#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-8#1)(2007-9#3)(2008-12#5)(2008-4#1)(2010-12#1)(2011-2#1)(2012-2#1)
plasma levels and##5##3##(1993-10#1)(2008-6#1)(2008-7#1)(2011-2#2)
plasma levels are##2##3##(1993-10#2)
plasma levels below 400 copies/ml##2##5##(2008-5#2)
plasma levels but##2##3##(1994-12#1)(2007-9#1)
plasma levels in##4##3##(1997-5#1)(2010-6#1)(2011-2#2)
plasma levels of ACTH##2##4##(1995-12#1)(1996-12#1)
plasma levels of antiepileptic drugs##2##5##(1993-11#1)(1997-5#1)
plasma levels of cholesterol##4##4##(1994-8#1)(1995-4#1)(1997-1#1)(2012-2#1)
plasma levels of corticosterone##2##4##(1995-12#1)(1997-2#1)
plasma levels of cortisol##2##4##(1996-8#1)(2008-6#1)
plasma levels of free##2##4##(2008-4#1)(2009-4#1)
plasma levels of glucose and insulin##2##6##(1992-3#1)(1996-11#1)
plasma levels of glucose and##3##5##(1992-3#1)(1996-11#1)(2011-2#1)
plasma levels of lipid##2##4##(1992-11#1)(2004-4#1)
plasma levels of oxidised##2##4##(2005-7#2)
plasma levels of t-PA##2##4##(1990-11#1)(2007-9#1)
plasma levels of the##3##4##(1996-6#1)(2009-4#1)(2012-12#1)
plasma levels of##80##3##(1990-10#1)(1990-11#3)(1990-12#2)(1990-3#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-7#3)(1992-9#1)(1993-11#2)(1993-12#2)(1993-3#1)(1994-10#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-4#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-5#2)(1997-8#2)(2004-4#1)(2005-10#1)(2005-7#2)(2007-10#1)(2007-11#2)(2007-3#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-4#2)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
plasma levels were determined in##2##5##(2006-12#1)(2007-9#1)
plasma levels were found##2##4##(1993-2#1)(2011-2#1)
plasma levels were##10##3##(1990-12#1)(1993-2#1)(1995-12#1)(1996-4#1)(1997-3#1)(2006-12#2)(2007-9#1)(2008-7#1)(2011-2#1)
plasma levels##131##2##(1990-10#1)(1990-11#3)(1990-12#5)(1990-3#1)(1990-8#1)(1991-2#1)(1991-3#2)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#3)(1992-9#1)(1993-10#3)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#4)(1995-4#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-3#3)(1996-4#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-5#4)(1997-8#3)(2004-4#1)(2005-10#1)(2005-7#2)(2006-12#2)(2006-6#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-3#1)(2007-9#4)(2008-1#2)(2008-10#1)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#8)(2009-4#2)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#9)(2012-12#1)(2012-2#4)(2013-1#2)(2013-8#1)
plasma lipid concentrations##2##3##(2012-2#2)
plasma lipid levels##4##3##(1993-9#1)(1997-8#1)(2009-5#1)(2009-8#1)
plasma lipid peroxidation and##2##4##(2008-7#2)
plasma lipid peroxidation##3##3##(1995-1#1)(2008-7#2)
plasma lipid profiles##3##3##(1991-12#1)(2006-7#1)(2011-1#1)
plasma lipid responses##2##3##(2004-11#1)(2012-2#1)
plasma lipid##20##2##(1991-12#1)(1991-2#2)(1993-9#1)(1995-1#1)(1997-8#1)(2004-11#1)(2006-7#1)(2008-10#2)(2008-7#2)(2009-5#1)(2009-8#1)(2011-1#2)(2012-2#4)
plasma lipids and enzymes of lipid metabolism##2##7##(2008-7#2)
plasma lipids and lipoproteins##2##4##(1991-7#1)(2008-7#1)
plasma lipids and other##2##4##(1996-8#1)(2007-2#1)
plasma lipids and##9##3##(1991-7#1)(1993-1#1)(1996-8#1)(2007-2#1)(2008-7#4)(2012-2#1)
plasma lipids##18##2##(1990-2#1)(1991-7#1)(1992-11#1)(1993-1#1)(1996-11#1)(1996-8#2)(1997-2#2)(1997-8#1)(2007-2#1)(2007-8#1)(2008-7#5)(2012-2#1)
plasma lipoprotein metabolism##2##3##(1996-4#1)(2008-7#1)
plasma lipoprotein##8##2##(1995-6#1)(1996-4#1)(1997-2#2)(2007-1#1)(2008-1#1)(2008-7#1)(2012-2#1)
plasma lipoproteins and##4##3##(1993-6#1)(1995-5#1)(1995-8#1)(2012-2#1)
plasma lipoproteins##16##2##(1992-12#1)(1993-6#3)(1995-5#1)(1995-8#1)(1996-4#1)(1997-2#2)(1997-8#1)(2006-10#1)(2008-5#1)(2012-2#4)
plasma low density lipoprotein (LDL) cholesterol##2##6##(1993-9#1)(2010-12#1)
plasma low density lipoprotein (LDL)##3##5##(1993-9#1)(2004-12#1)(2010-12#1)
plasma low density##4##3##(1993-9#1)(1994-3#1)(2004-12#1)(2010-12#1)
plasma low-density lipoproteins##2##3##(1991-9#2)
plasma low-density##3##2##(1991-9#2)(2006-12#1)
plasma malondialdehyde##3##2##(1992-4#1)(2007-8#1)(2009-4#1)
plasma markers of##2##3##(1997-1#1)(2008-10#1)
plasma mass spectrometry and Raman##2##5##(2013-8#2)
plasma mass spectrometry was##2##4##(2008-10#1)(2010-12#1)
plasma mass spectrometry##85##3##(1993-9#1)(2007-8#3)(2008-10#70)(2008-3#2)(2010-11#4)(2010-12#1)(2013-8#4)
plasma mass##94##2##(1993-9#1)(2007-8#4)(2008-10#75)(2008-3#2)(2010-11#5)(2010-12#1)(2013-8#6)
plasma materials##2##2##(2008-10#2)
plasma may##3##2##(1990-12#1)(1997-2#1)(2012-3#1)
plasma melatonin##2##2##(1994-2#1)(1995-1#1)
plasma membrane ATPase##3##3##(1992-11#1)(1993-8#1)(2006-8#1)
plasma membrane Ca(2+)-ATPase##3##3##(1992-11#1)(1992-12#1)(1997-1#1)
plasma membrane H(+)-ATPase in##2##4##(1995-2#1)(1997-3#1)
plasma membrane H(+)-ATPase##10##3##(1990-11#2)(1992-11#1)(1993-6#1)(1994-9#1)(1995-2#1)(1995-4#1)(1997-3#2)(2009-8#1)
plasma membrane NADH##2##3##(1992-11#1)(1994-12#1)
plasma membrane NTPDases##2##3##(2008-4#2)
plasma membrane and the##14##4##(1990-12#1)(1991-5#1)(1991-9#1)(1993-2#1)(1994-9#1)(1995-8#1)(1997-4#2)(2008-1#2)(2008-10#1)(2008-11#1)(2009-2#1)(2009-8#1)
plasma membrane and##45##3##(1990-12#1)(1990-2#1)(1990-8#1)(1991-10#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-3#2)(1992-9#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#2)(1994-9#1)(1995-6#1)(1995-8#1)(1997-1#1)(1997-4#2)(1997-6#3)(2005-8#1)(2006-10#1)(2006-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-4#2)(2009-2#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-3#1)(2011-3#1)
plasma membrane and/or##2##3##(1994-12#1)(2009-8#1)
plasma membrane are##2##3##(1990-5#1)(2008-11#1)
plasma membrane at##2##3##(1995-10#1)(2009-10#1)
plasma membrane caused by##2##4##(1990-2#1)(1990-5#1)
plasma membrane cholesterol##3##3##(1995-10#1)(1996-8#1)(2011-1#1)
plasma membrane depolarization##2##3##(2008-4#1)(2010-11#1)
plasma membrane desialylation##5##3##(1994-6#5)
plasma membrane diacylglycerols##2##3##(1992-1#2)
plasma membrane domains##2##3##(1990-12#1)(1995-11#1)
plasma membrane during##3##3##(1992-1#1)(1994-3#1)(2008-11#1)
plasma membrane electron transport and##2##5##(2009-9#2)
plasma membrane electron transport##4##4##(1994-8#1)(2009-9#3)
plasma membrane fraction##6##3##(1990-2#1)(1990-9#1)(1991-9#1)(1993-8#1)(1994-11#2)
plasma membrane fractions were##2##4##(1991-9#2)
plasma membrane fractions##5##3##(1990-5#1)(1991-9#2)(1994-11#1)(1994-8#1)
plasma membrane from##3##3##(1993-4#1)(1996-8#1)(2008-10#1)
plasma membrane hyperpolarization##2##3##(2008-4#2)
plasma membrane in##14##3##(1990-11#2)(1990-9#1)(1992-12#1)(1992-4#1)(1994-3#3)(1997-6#1)(2007-10#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-6#1)
plasma membrane integrity##3##3##(1991-1#1)(1995-9#1)(2013-1#1)
plasma membrane is divided into##2##5##(2007-8#1)(2008-1#1)
plasma membrane is##4##3##(1992-7#1)(1994-3#1)(2007-8#1)(2008-1#1)
plasma membrane level##2##3##(1990-10#1)(1990-3#1)
plasma membrane localization of##2##4##(2009-10#1)(2010-12#1)
plasma membrane marker##6##3##(1990-11#2)(1990-5#1)(1994-3#1)(1995-11#1)(2008-11#1)
plasma membrane of Mycobacterium tuberculosis##2##5##(2008-7#2)
plasma membrane of cultured##2##4##(2007-10#1)(2011-2#1)
plasma membrane of##52##3##(1990-12#3)(1990-2#1)(1990-5#2)(1990-7#2)(1990-9#1)(1991-2#1)(1992-3#1)(1992-4#3)(1993-11#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#1)(1997-1#3)(1997-4#1)(1997-7#1)(2006-10#2)(2007-10#1)(2008-11#1)(2008-4#1)(2008-7#3)(2008-8#4)(2009-8#3)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#1)
plasma membrane permeability of##2##4##(1994-2#2)
plasma membrane permeability##4##3##(1994-2#2)(2008-9#2)
plasma membrane phospholipid##2##3##(1991-1#1)(1995-2#1)
plasma membrane potential variations##2##4##(2008-4#2)
plasma membrane potential##8##3##(1992-12#1)(1994-12#1)(2008-4#2)(2010-12#4)
plasma membrane preparations of##2##4##(1990-11#1)(1992-12#1)
plasma membrane preparations##4##3##(1990-11#1)(1991-8#1)(1992-12#1)(1995-10#1)
plasma membrane protein##8##3##(1990-11#2)(1995-2#3)(1997-4#1)(2008-11#1)(2008-5#1)
plasma membrane proteins and##2##4##(1995-12#1)(2008-7#1)
plasma membrane proteins by##2##4##(1995-12#1)(2008-11#1)
plasma membrane proteins of##2##4##(1995-12#2)
plasma membrane proteins were##2##4##(1993-8#1)(1995-2#1)
plasma membrane proteins##12##3##(1991-3#1)(1993-8#1)(1995-12#4)(1995-2#1)(1997-1#1)(2008-11#1)(2008-7#1)(2009-4#1)(2010-12#1)
plasma membrane receptors that##2##4##(2008-4#2)
plasma membrane receptors##6##3##(1992-12#1)(1993-6#1)(2006-10#1)(2008-4#3)
plasma membrane redox system##2##4##(1993-4#1)(2005-8#1)
plasma membrane redox##3##3##(1993-4#1)(2005-8#1)(2009-9#1)
plasma membrane sphingomyelin##2##3##(1996-8#2)
plasma membrane to##8##3##(1990-11#1)(1993-6#1)(1994-12#2)(1996-10#1)(2006-10#1)(2009-2#1)(2012-12#1)
plasma membrane vesicles##7##3##(1991-4#2)(1992-1#1)(1994-12#2)(1996-9#2)
plasma membrane was##2##3##(1994-11#1)(2008-11#1)
plasma membrane were##5##3##(1990-10#1)(1991-1#1)(1993-3#1)(1997-6#1)(2012-3#1)
plasma membrane##509##2##(1990-10#4)(1990-11#15)(1990-12#7)(1990-2#8)(1990-3#1)(1990-5#10)(1990-7#4)(1990-8#1)(1990-9#5)(1991-1#5)(1991-10#2)(1991-12#3)(1991-2#7)(1991-3#2)(1991-4#3)(1991-5#1)(1991-8#2)(1991-9#6)(1992-1#7)(1992-11#9)(1992-12#10)(1992-3#10)(1992-4#5)(1992-5#1)(1992-6#2)(1992-7#5)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#4)(1993-2#1)(1993-3#5)(1993-4#6)(1993-6#4)(1993-8#3)(1993-9#4)(1994-10#3)(1994-11#8)(1994-12#15)(1994-2#5)(1994-3#19)(1994-5#3)(1994-6#8)(1994-8#7)(1994-9#6)(1995-10#3)(1995-11#6)(1995-12#5)(1995-2#9)(1995-3#1)(1995-4#1)(1995-6#8)(1995-7#2)(1995-8#3)(1995-9#1)(1996-1#1)(1996-10#1)(1996-3#1)(1996-5#2)(1996-7#2)(1996-8#8)(1996-9#2)(1997-1#11)(1997-3#7)(1997-4#6)(1997-6#12)(1997-7#1)(2003-11#1)(2005-8#2)(2006-10#8)(2006-8#2)(2007-10#8)(2007-12#5)(2007-8#1)(2008-1#5)(2008-10#8)(2008-11#14)(2008-4#21)(2008-5#1)(2008-7#8)(2008-8#8)(2008-9#5)(2009-10#7)(2009-12#1)(2009-2#2)(2009-4#2)(2009-6#2)(2009-7#3)(2009-8#16)(2009-9#8)(2010-11#4)(2010-12#9)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#5)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#4)
plasma membrane-associated##3##2##(1991-2#1)(1995-12#1)(2012-2#1)
plasma membrane-bound##3##2##(1994-3#1)(2009-10#2)
plasma membranes and intracellular membranes##3##5##(1990-10#2)(1990-2#1)
plasma membranes and##7##3##(1990-10#2)(1990-11#1)(1990-2#1)(1991-5#1)(1997-1#1)(1997-6#1)
plasma membranes by##3##3##(1990-11#1)(1997-1#1)(2008-11#1)
plasma membranes from##9##3##(1990-11#1)(1992-1#1)(1992-12#1)(1993-6#1)(1995-11#1)(1995-6#1)(1997-1#1)(1997-4#1)(2008-4#1)
plasma membranes has been##2##4##(1992-7#1)(2008-6#1)
plasma membranes in mouse##2##4##(2008-4#2)
plasma membranes in the##2##4##(1994-5#1)(1995-8#1)
plasma membranes in##11##3##(1990-11#1)(1992-3#1)(1994-5#1)(1995-8#1)(2008-4#2)(2008-7#1)(2012-12#2)(2012-2#1)(2013-1#1)
plasma membranes is##2##3##(1992-7#1)(1995-6#1)
plasma membranes of rat##2##4##(1991-4#1)(1995-2#1)
plasma membranes of##18##3##(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-9#1)(1992-11#1)(1993-6#1)(1993-8#1)(1994-9#1)(1995-2#1)(1997-1#2)(1997-4#1)(1997-6#1)(2008-10#1)(2008-5#1)(2010-10#1)
plasma membranes or##2##3##(1990-7#1)(1995-7#1)
plasma membranes showed##2##3##(1994-9#1)(1995-7#1)
plasma membranes using##2##3##(1995-11#1)(1996-8#1)
plasma membranes was observed##2##4##(1991-4#1)(1994-6#1)
plasma membranes was##7##3##(1991-4#1)(1993-4#1)(1994-12#1)(1994-6#1)(1996-8#1)(1996-9#1)(1997-1#1)
plasma membranes were##2##3##(1992-1#1)(1994-12#1)
plasma membranes##121##2##(1990-10#3)(1990-11#7)(1990-2#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#3)(1991-12#1)(1991-2#3)(1991-4#3)(1991-5#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#3)(1992-7#4)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#6)(1994-2#5)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#3)(1995-11#4)(1995-2#1)(1995-6#4)(1995-7#2)(1995-8#5)(1996-5#1)(1996-8#2)(1996-9#2)(1997-1#10)(1997-3#1)(1997-4#4)(1997-6#2)(2006-10#1)(2008-10#3)(2008-11#4)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2010-10#1)(2012-12#2)(2012-2#1)(2013-1#1)
plasma method##2##2##(1996-8#1)(2007-12#1)
plasma might##2##2##(1991-12#1)(2007-8#1)
plasma milieu##2##2##(1990-11#1)(1997-2#1)
plasma near a high-power antenna##2##5##(2013-8#2)
plasma nifedipine##2##2##(1992-4#2)
plasma non-esterified fatty acids##2##4##(1991-3#1)(1996-5#1)
plasma norepinephrine##9##2##(1991-5#1)(1993-3#1)(1995-12#3)(1995-6#2)(2005-10#1)(2011-2#1)
plasma obtained##2##2##(2008-10#1)(2010-11#1)
plasma of a##4##3##(1993-11#1)(1994-9#2)(1995-5#1)
plasma of healthy##2##3##(1995-3#1)(2008-10#1)
plasma of human##2##3##(1994-9#1)(2005-8#1)
plasma of normal##2##3##(1991-2#1)(1992-7#1)
plasma of patients with##8##4##(1992-9#1)(2006-4#1)(2006-7#1)(2007-1#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-12#1)
plasma of patients##11##3##(1992-9#1)(1995-6#1)(2006-4#1)(2006-7#1)(2007-1#1)(2008-10#1)(2008-8#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-12#1)
plasma of the##6##3##(1992-6#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-5#1)
plasma of##72##2##(1990-12#2)(1990-2#1)(1990-7#1)(1991-2#4)(1991-3#1)(1991-5#1)(1992-6#4)(1992-7#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-12#2)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-9#1)(1996-3#1)(1997-3#2)(1997-8#1)(2005-8#2)(2006-4#1)(2006-7#1)(2007-1#1)(2007-12#1)(2008-10#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-12#3)(2010-6#1)(2010-8#4)(2011-1#1)(2011-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
plasma omega-3 PUFA##2##3##(2007-8#2)
plasma on the##2##3##(2008-10#1)(2012-11#1)
plasma on##3##2##(2008-10#2)(2012-11#1)
plasma or erythrocyte##3##3##(1991-12#1)(2008-7#1)(2013-1#1)
plasma or serum##8##3##(1990-6#1)(1992-8#1)(1996-8#1)(1997-8#2)(2005-8#2)(2008-4#1)
plasma or urine##2##3##(1993-2#1)(1997-3#1)
plasma or##28##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-6#1)(1995-8#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-8#2)(2004-11#1)(2005-11#1)(2005-8#2)(2008-4#1)(2008-7#1)(2010-11#2)(2013-1#1)
plasma oxalate##2##2##(1990-10#2)
plasma oxidation##2##2##(2005-11#2)
plasma paracetamol##2##2##(1990-2#1)(1993-7#1)
plasma peak##2##2##(1992-8#1)(2012-12#1)
plasma phosphatidylcholine (PC)##2##3##(1995-8#1)(1996-5#1)
plasma phosphatidylcholine##3##2##(1995-8#2)(1996-5#1)
plasma phospholipids##2##2##(1994-12#1)(2008-7#1)
plasma plume##2##2##(2006-12#1)(2008-3#1)
plasma plumes##2##2##(2006-12#1)(2008-3#1)
plasma polymerization##2##2##(2007-8#1)(2010-9#1)
plasma potassium concentration##3##3##(1993-1#1)(1995-9#2)
plasma potassium##6##2##(1993-1#3)(1995-9#2)(2008-5#1)
plasma prekallikrein##7##2##(1991-2#3)(1991-8#2)(1993-12#2)
plasma profile##2##2##(1992-4#1)(2012-2#1)
plasma profiles##3##2##(1990-6#3)
plasma progesterone##3##2##(2006-5#2)(2008-6#1)
plasma prolactin levels in##2##4##(1997-8#2)
plasma prolactin levels##4##3##(1997-8#4)
plasma prolactin##6##2##(1996-8#1)(1997-8#5)
plasma protein were##2##3##(2007-8#1)(2011-1#1)
plasma protein##25##2##(1990-3#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-12#1)(1994-3#1)(1995-1#1)(1995-7#1)(1995-8#1)(1996-9#1)(2004-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-7#2)(2009-10#1)(2011-1#3)(2013-1#1)(2013-7#1)
plasma protein-A##4##2##(1995-7#1)(2011-12#3)
plasma proteinase##2##2##(1992-2#1)(1994-10#1)
plasma proteins and##3##3##(1991-8#1)(2007-2#1)(2008-5#1)
plasma proteins in##2##3##(1990-4#1)(1992-9#1)
plasma proteins was##2##3##(1995-6#1)(2004-11#1)
plasma proteins were##2##3##(2004-11#1)(2010-12#1)
plasma proteins##33##2##(1990-11#1)(1990-4#1)(1990-8#2)(1991-8#1)(1992-3#2)(1992-4#1)(1992-9#1)(1993-9#1)(1994-10#1)(1995-1#1)(1995-2#1)(1995-6#1)(1997-8#1)(2004-11#4)(2006-6#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#4)(2010-12#2)(2011-2#1)
plasma proteome of##2##3##(2010-12#2)
plasma proteome##5##2##(2010-12#5)
plasma ratio##2##2##(1993-7#2)
plasma reactor##2##2##(2008-2#1)(2008-6#1)
plasma reduced##2##2##(1995-1#1)(2010-12#1)
plasma renin activity##13##3##(1991-10#1)(1992-4#1)(1992-5#1)(1993-12#1)(1993-3#1)(1995-10#1)(1995-5#1)(1997-3#1)(1997-7#1)(2006-11#1)(2007-8#1)(2008-7#1)(2012-1#1)
plasma renin levels##2##3##(2006-9#1)(2007-8#1)
plasma renin##17##2##(1991-10#1)(1992-4#1)(1992-5#2)(1993-12#1)(1993-3#1)(1995-10#1)(1995-5#1)(1997-3#1)(1997-7#1)(2006-11#1)(2006-9#1)(2007-8#2)(2008-1#1)(2008-7#1)(2012-1#1)
plasma replacement##2##2##(1995-3#1)(2011-2#1)
plasma resonance##3##2##(2007-11#1)(2007-12#2)
plasma responses##2##2##(2008-12#2)
plasma revealed##3##2##(1991-10#1)(1995-5#1)(2012-2#1)
plasma sCD8##2##2##(1997-8#2)
plasma sample was##4##3##(1990-8#2)(1996-8#1)(2008-10#1)
plasma sample##11##2##(1990-8#2)(1993-11#1)(1996-3#1)(1996-8#1)(1997-8#1)(2007-11#1)(2008-10#2)(2012-1#1)(2012-12#1)
plasma samples (n =##2##4##(2012-3#2)
plasma samples and##2##3##(2008-10#2)
plasma samples containing##2##3##(1990-11#1)(1993-2#1)
plasma samples following##2##3##(2008-10#1)(2010-12#1)
plasma samples for##2##3##(1991-12#1)(2010-12#1)
plasma samples from patients##2##4##(1990-11#1)(1996-1#1)
plasma samples from##9##3##(1990-11#1)(1991-1#1)(1992-11#1)(1992-2#1)(1996-1#1)(1996-3#1)(2007-2#1)(2008-10#1)(2008-8#1)
plasma samples in##3##3##(1993-2#1)(1995-2#1)(2011-2#1)
plasma samples obtained from##5##4##(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#1)
plasma samples obtained##6##3##(1994-3#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#1)
plasma samples of##6##3##(1990-11#2)(1994-4#1)(2008-10#2)(2013-1#1)
plasma samples spiked with##2##4##(1993-9#1)(2008-10#1)
plasma samples taken##2##3##(1991-9#1)(1995-7#1)
plasma samples using##3##3##(1996-5#1)(2008-10#2)
plasma samples was##4##3##(1992-8#1)(1995-12#1)(1997-1#1)(2008-10#1)
plasma samples were extracted##3##4##(1990-6#1)(1996-5#1)(2011-3#1)
plasma samples were##12##3##(1990-11#1)(1990-12#1)(1990-6#1)(1995-12#1)(1996-5#1)(1997-1#1)(2008-10#4)(2011-2#1)(2011-3#1)
plasma samples with an##2##4##(1990-12#1)(2008-10#1)
plasma samples with##3##3##(1990-12#1)(1995-3#1)(2008-10#1)
plasma samples##89##2##(1990-11#8)(1990-12#3)(1990-6#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#2)(1992-8#2)(1993-2#3)(1993-9#1)(1994-3#1)(1994-4#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-7#1)(1996-1#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-8#5)(2007-11#1)(2007-2#1)(2008-10#23)(2008-4#1)(2008-8#1)(2010-12#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#2)(2012-3#3)(2013-1#1)(2013-8#1)
plasma selenium##2##2##(1992-4#1)(1995-1#1)
plasma separator##4##2##(2011-1#4)
plasma sex##2##2##(2007-1#1)(2008-3#1)
plasma should be##2##3##(1996-8#1)(2006-5#1)
plasma should##3##2##(1996-8#1)(2006-10#1)(2006-5#1)
plasma showed##2##2##(1992-3#1)(2013-1#1)
plasma shutter##2##2##(2007-12#1)(2008-1#1)
plasma sialoglycoproteins##2##2##(1995-3#2)
plasma sialytransferase##3##2##(1991-3#3)
plasma somatostatin-like immunoreactivity##2##3##(1992-6#2)
plasma source mass spectrometry##3##4##(2008-10#3)
plasma sources##2##2##(2007-12#1)(2008-3#1)
plasma species##2##2##(2008-10#1)(2010-4#1)
plasma specimens##2##2##(1994-2#1)(1996-8#1)
plasma spectrometer##2##2##(2008-10#2)
plasma spectrometric##2##2##(2008-10#2)
plasma spectrometry is##2##3##(1996-3#1)(2008-10#1)
plasma spectrometry##9##2##(1996-3#1)(2007-12#2)(2008-10#5)(2008-7#1)
plasma spiked with##2##3##(2008-10#1)(2012-1#1)
plasma spray##2##2##(2008-11#2)
plasma supplemented##2##2##(1997-8#2)
plasma t-PA antigen was##2##4##(2007-9#2)
plasma t-PA antigen##5##3##(2007-9#5)
plasma t-PA##6##2##(1990-11#1)(2007-9#5)
plasma testosterone levels##2##3##(1992-7#1)(1993-2#1)
plasma than##3##2##(1990-12#1)(1992-7#1)(2012-11#1)
plasma that##2##2##(2008-10#1)(2008-2#1)
plasma the##2##2##(1990-10#1)(1997-8#1)
plasma thiobarbituric##2##2##(1996-3#1)(2011-2#1)
plasma thus##2##2##(1996-5#1)(2008-10#1)
plasma thyroid##4##2##(1997-3#1)(2008-7#2)(2008-8#1)
plasma to##7##2##(1993-3#1)(1994-10#1)(1995-10#1)(1996-5#1)(1997-7#1)(2008-5#1)(2008-9#1)
plasma torch##9##2##(2008-10#9)
plasma total and##2##3##(1993-9#1)(2012-2#1)
plasma total antioxidant capacity (TAC)##2##5##(2007-8#1)(2008-10#1)
plasma total homocysteine##3##3##(1992-4#1)(2008-8#1)(2010-12#1)
plasma total leptin levels##2##4##(2006-9#2)
plasma total leptin##3##3##(2006-9#3)
plasma total protein##2##3##(1993-2#1)(2008-5#1)
plasma total##15##2##(1992-4#1)(1993-2#1)(1993-9#1)(2006-9#3)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
plasma treatment of##3##3##(2005-11#2)(2008-6#1)
plasma treatment##12##2##(2005-11#4)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#1)(2012-11#2)
plasma treatments with##2##3##(2004-9#1)(2005-11#1)
plasma treatments##3##2##(2004-9#2)(2005-11#1)
plasma triacylglycerol and cholesterol##2##4##(1991-2#2)
plasma triacylglycerol##5##2##(1991-2#2)(1995-3#2)(2004-11#1)
plasma triglyceride (TG) levels##3##4##(1995-6#1)(2010-8#2)
plasma triglyceride (TG)##4##3##(1995-6#1)(2008-7#1)(2010-8#2)
plasma triglyceride levels were##2##4##(1992-11#2)
plasma triglyceride levels##4##3##(1992-11#3)(1997-2#1)
plasma triglyceride##14##2##(1992-11#3)(1993-3#1)(1994-11#1)(1995-6#1)(1997-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-8#2)
plasma triglycerides##3##2##(1992-3#1)(1997-2#1)(2005-10#1)
plasma ubiquinol##2##2##(1996-9#2)
plasma ubiquinol-10##3##2##(1997-2#3)
plasma urea##2##2##(1990-3#2)
plasma uric acid concentrations##2##4##(2008-5#1)(2010-4#1)
plasma uric acid##4##3##(2008-5#1)(2008-7#1)(2010-4#1)(2013-1#1)
plasma uridine concentration##3##3##(1996-6#3)
plasma uridine##9##2##(1996-6#9)
plasma using a##3##3##(1991-10#1)(2008-10#1)(2012-12#1)
plasma using high-performance liquid chromatography with##3##6##(1990-11#1)(1996-8#1)(1997-3#1)
plasma using high-performance liquid chromatography##5##5##(1990-11#1)(1996-8#1)(1997-3#2)(1997-8#1)
plasma using##23##2##(1990-11#1)(1990-12#1)(1991-10#1)(1991-5#1)(1993-2#1)(1994-2#1)(1996-8#2)(1997-3#2)(1997-8#1)(2005-12#1)(2008-10#9)(2010-12#1)(2012-12#1)
plasma very long chain fatty##2##5##(1991-10#1)(1992-3#1)
plasma viral load##3##3##(2007-11#1)(2007-7#1)(2011-1#1)
plasma viscosity and##3##3##(1991-12#1)(2007-1#2)
plasma viscosity##4##2##(1991-12#1)(1997-5#1)(2007-1#2)
plasma vitamin E##3##3##(1990-8#2)(2008-7#1)
plasma vitamin##5##2##(1990-8#2)(1993-12#1)(2008-7#2)
plasma volume##5##2##(1992-8#1)(1995-2#1)(2011-1#1)(2011-2#2)
plasma von Willebrand factor##2##4##(2007-10#2)
plasma was determined##5##3##(1990-8#1)(1995-3#1)(1997-8#1)(2007-2#1)(2013-1#1)
plasma was higher##2##3##(1994-6#1)(1996-8#1)
plasma was measured##3##3##(1990-11#1)(1996-4#1)(2008-2#1)
plasma was not##3##3##(1995-2#1)(1996-8#1)(2005-12#1)
plasma was##44##2##(1990-1#1)(1990-11#3)(1990-12#1)(1990-5#1)(1990-8#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#2)(1992-2#3)(1992-4#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-4#1)(1996-8#2)(1997-3#1)(1997-8#3)(2005-12#1)(2006-5#1)(2006-6#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-8#1)(2012-11#1)(2013-1#1)
plasma water##4##2##(1993-2#4)
plasma waves##2##2##(2007-11#2)
plasma were 97##2##3##(1996-8#1)(1997-3#1)
plasma were determined by##3##4##(1990-8#1)(2007-8#1)(2008-1#1)
plasma were measured##2##3##(1997-8#1)(2008-4#1)
plasma were not##2##3##(2004-11#1)(2008-10#1)
plasma were##26##2##(1990-6#1)(1990-8#2)(1996-5#1)(1996-8#2)(1997-3#3)(1997-8#1)(2004-11#1)(2007-8#2)(2008-1#1)(2008-10#10)(2008-4#1)(2009-4#1)
plasma when##2##2##(1992-2#1)(2008-11#1)
plasma which##4##2##(1990-11#1)(1991-2#1)(1995-10#1)(1995-8#1)
plasma with a##4##3##(1992-8#1)(1996-4#1)(2007-12#2)
plasma with high levels of##2##5##(1990-11#1)(1992-2#1)
plasma with high##3##3##(1990-11#1)(1992-2#1)(2008-8#1)
plasma with##23##2##(1990-11#1)(1990-6#1)(1992-2#1)(1992-8#1)(1993-11#1)(1994-10#1)(1994-8#1)(1995-7#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-8#2)(2006-6#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-8#1)
plasma zinc##2##2##(2005-10#1)(2006-5#1)
plasma γ-globulin fraction proteins and their##2##6##(2012-1#2)
plasma##4095##1##(1990-1#4)(1990-10#19)(1990-11#98)(1990-12#60)(1990-2#28)(1990-3#27)(1990-4#18)(1990-5#30)(1990-6#48)(1990-7#16)(1990-8#26)(1990-9#11)(1991-1#18)(1991-10#16)(1991-11#4)(1991-12#27)(1991-2#47)(1991-3#24)(1991-4#12)(1991-5#13)(1991-6#3)(1991-7#11)(1991-8#19)(1991-9#27)(1992-1#11)(1992-10#4)(1992-11#24)(1992-12#26)(1992-2#36)(1992-3#36)(1992-4#23)(1992-5#7)(1992-6#19)(1992-7#23)(1992-8#25)(1992-9#32)(1993-1#14)(1993-10#3)(1993-11#26)(1993-12#26)(1993-2#37)(1993-3#20)(1993-4#7)(1993-5#2)(1993-6#11)(1993-7#13)(1993-8#7)(1993-9#30)(1994-10#12)(1994-11#34)(1994-12#47)(1994-2#25)(1994-3#30)(1994-4#5)(1994-5#9)(1994-6#36)(1994-7#8)(1994-8#27)(1994-9#15)(1995-1#25)(1995-10#9)(1995-11#21)(1995-12#41)(1995-2#34)(1995-3#24)(1995-4#8)(1995-5#24)(1995-6#35)(1995-7#32)(1995-8#27)(1995-9#9)(1996-1#9)(1996-10#1)(1996-11#8)(1996-12#13)(1996-2#1)(1996-3#33)(1996-4#15)(1996-5#42)(1996-6#32)(1996-7#13)(1996-8#69)(1996-9#10)(1997-1#42)(1997-2#45)(1997-3#59)(1997-4#19)(1997-5#17)(1997-6#14)(1997-7#22)(1997-8#72)(2003-11#1)(2004-10#3)(2004-11#18)(2004-12#5)(2004-3#1)(2004-4#2)(2004-9#6)(2005-10#13)(2005-11#10)(2005-12#14)(2005-4#4)(2005-7#10)(2005-8#17)(2005-9#4)(2006-1#1)(2006-10#19)(2006-11#3)(2006-12#13)(2006-2#3)(2006-4#5)(2006-5#12)(2006-6#16)(2006-7#10)(2006-8#3)(2006-9#12)(2007-1#6)(2007-10#24)(2007-11#32)(2007-12#48)(2007-2#17)(2007-3#1)(2007-5#3)(2007-6#2)(2007-7#4)(2007-8#69)(2007-9#30)(2008-1#41)(2008-10#425)(2008-11#44)(2008-12#19)(2008-2#26)(2008-3#59)(2008-4#50)(2008-5#53)(2008-6#18)(2008-7#93)(2008-8#33)(2008-9#27)(2009-1#3)(2009-10#15)(2009-11#3)(2009-12#3)(2009-2#3)(2009-3#2)(2009-4#22)(2009-5#9)(2009-6#10)(2009-7#6)(2009-8#26)(2009-9#9)(2010-10#8)(2010-11#20)(2010-12#53)(2010-2#7)(2010-3#4)(2010-4#19)(2010-5#4)(2010-6#4)(2010-7#3)(2010-8#23)(2010-9#2)(2011-1#34)(2011-12#9)(2011-2#69)(2011-3#6)(2012-1#15)(2012-11#11)(2012-12#47)(2012-2#53)(2012-3#16)(2012-7#3)(2013-1#55)(2013-7#11)(2013-8#38)
plasma&quot##2##1##(2010-12#1)(2012-2#1)
plasma's electron temperature##2##3##(2008-3#2)
plasma) was##2##2##(1990-5#1)(2008-8#1)
plasma)##14##1##(1990-12#1)(1990-5#1)(1992-3#1)(1993-11#1)(1995-1#1)(1995-2#1)(1996-8#1)(1997-3#1)(2008-10#2)(2008-8#1)(2010-6#1)(2010-7#1)(2013-1#1)
plasma-assisted##3##1##(2007-12#2)(2008-10#1)
plasma-atomic emission spectroscopy (ICP-AES)##3##4##(2008-10#3)
plasma-atomic emission spectroscopy##5##3##(1995-2#1)(2008-10#3)(2008-3#1)
plasma-atomic emission##22##2##(1995-2#1)(2005-4#1)(2008-10#19)(2008-3#1)
plasma-based##3##1##(1996-5#1)(2006-2#1)(2008-10#1)
plasma-cell##2##1##(1995-1#1)(2011-2#1)
plasma-deposited##4##1##(2008-2#3)(2008-3#1)
plasma-derived vaccine##5##2##(1991-3#1)(1992-8#1)(2007-11#3)
plasma-derived##13##1##(1990-7#1)(1991-3#1)(1992-2#1)(1992-8#1)(1994-9#2)(1997-7#1)(2007-11#4)(2010-11#1)(2012-12#1)
plasma-enhanced chemical vapor deposition of##3##5##(2008-3#2)(2010-4#1)
plasma-enhanced chemical vapor deposition##11##4##(2008-2#4)(2008-3#5)(2010-4#2)
plasma-enhanced chemical vapor##12##3##(2008-2#5)(2008-3#5)(2010-4#2)
plasma-enhanced##15##1##(2007-11#1)(2007-12#1)(2008-2#5)(2008-3#6)(2010-4#2)
plasma-like##2##1##(1996-7#1)(2011-1#1)
plasma-mass spectrometer (ICP-MS)##2##3##(2008-10#2)
plasma-mass spectrometer##3##2##(2008-10#3)
plasma-mass##25##1##(2004-9#1)(2007-8#1)(2008-10#21)(2012-12#2)
plasma-membrane H(+)-ATPase##2##2##(1990-12#1)(1992-11#1)
plasma-membrane##10##1##(1990-11#4)(1990-12#1)(1991-2#1)(1992-11#1)(1992-6#1)(1995-11#1)(2009-8#1)
plasma-optical emission spectrometry##6##3##(2006-12#1)(2007-8#1)(2008-10#3)(2010-5#1)
plasma-optical emission##10##2##(2006-12#1)(2007-8#1)(2008-10#6)(2008-5#1)(2010-5#1)
plasma-polymerized##2##1##(2008-10#2)
plasma-spraying##2##1##(2004-9#1)(2012-2#1)
plasma-treated fibers##2##2##(2005-11#2)
plasma-treated##6##1##(2004-9#1)(2005-11#4)(2008-6#1)
plasma/serum samples##2##2##(1992-7#1)(1993-1#1)
plasma]##3##1##(1992-5#1)(2011-3#1)(2012-2#1)
plasmacytoid##5##1##(1996-3#1)(2005-12#1)(2007-2#1)(2012-1#1)(2013-1#1)
plasmacytoma cell##2##2##(1996-7#1)(2008-4#1)
plasmacytoma cells and normal fibroblasts##2##5##(1991-9#2)
plasmacytoma of the##3##3##(2009-3#2)(2012-12#1)
plasmacytoma of##4##2##(1994-10#1)(2009-3#2)(2012-12#1)
plasmacytoma##25##1##(1991-9#3)(1994-10#2)(1996-7#1)(2005-5#3)(2006-12#1)(2008-4#1)(2008-5#1)(2009-3#4)(2009-8#1)(2011-2#2)(2012-12#4)(2012-2#2)
plasmacytomas##8##1##(1995-1#3)(1996-7#1)(1997-3#1)(2005-8#1)(2006-12#2)
plasmalemma and cell##2##3##(2007-5#1)(2008-8#1)
plasmalemma and##3##2##(2007-5#1)(2008-7#1)(2008-8#1)
plasmalemma of the##3##3##(2008-10#2)(2008-7#1)
plasmalemma of##6##2##(1995-2#1)(1995-9#1)(2008-10#3)(2008-7#1)
plasmalemma vesicles##3##2##(1990-3#2)(2008-5#1)
plasmalemma##34##1##(1990-3#3)(1990-7#1)(1991-11#1)(1992-1#1)(1993-3#1)(1994-11#1)(1995-2#1)(1995-9#2)(1996-9#2)(1997-4#3)(1997-7#2)(2007-12#1)(2007-5#1)(2008-10#7)(2008-5#2)(2008-7#2)(2008-8#3)
plasmalemmal damage##2##2##(1997-4#2)
plasmalemmal lesions##2##2##(1997-4#2)
plasmalemmal vesicles##2##2##(1994-2#1)(1995-2#1)
plasmalemmal##10##1##(1994-2#1)(1995-2#2)(1996-8#1)(1997-4#6)
plasmalogen##4##1##(1991-10#1)(1994-12#1)(1997-4#2)
plasmalogen-PE##3##1##(1994-12#3)
plasmalogen-deficient##2##1##(1997-4#2)
plasmalogens##5##1##(1996-7#2)(1997-4#3)
plasmapheresis and##2##2##(1995-3#1)(2008-8#1)
plasmapheresis was##2##2##(2006-4#1)(2012-12#1)
plasmapheresis with##2##2##(2008-8#1)(2013-8#1)
plasmapheresis##29##1##(1993-2#1)(1995-3#4)(1997-7#1)(2005-11#1)(2006-10#2)(2006-4#1)(2007-7#1)(2007-8#1)(2008-8#4)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#4)(2013-8#2)
plasmas are diluted##2##3##(2007-8#2)
plasmas are##5##2##(2007-8#2)(2008-2#1)(2008-3#1)(2011-1#1)
plasmas to##2##2##(2008-3#1)(2010-12#1)
plasmas were##3##2##(1990-12#2)(2008-10#1)
plasmas with##3##2##(1990-12#1)(1990-9#1)(2005-11#1)
plasmas##41##1##(1990-12#5)(1990-9#2)(1991-9#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-5#1)(1994-10#1)(1994-5#1)(1995-11#1)(1995-5#1)(1995-7#1)(2004-11#1)(2005-11#2)(2007-11#2)(2007-12#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#5)(2010-12#3)(2010-4#1)(2011-1#1)
plasmatic and##3##2##(1990-9#1)(2008-7#1)(2013-1#1)
plasmatic clearance##3##2##(1990-9#1)(2006-6#2)
plasmatic concentration##3##2##(1991-11#1)(1992-9#2)
plasmatic expansion factor##2##3##(1996-9#2)
plasmatic levels##2##2##(1992-12#1)(1995-7#1)
plasmatic lipids##2##2##(1990-12#2)
plasmatic##23##1##(1990-10#1)(1990-12#2)(1990-9#2)(1991-11#1)(1992-12#1)(1992-9#2)(1995-7#1)(1996-9#2)(2006-6#2)(2008-1#1)(2008-7#1)(2008-8#2)(2010-12#2)(2012-2#1)(2013-1#2)
plasmepsin 2##2##2##(2008-4#2)
plasmepsin##3##1##(2008-4#3)
plasmepsins##3##1##(2008-4#3)
plasmic##3##1##(1991-2#1)(1993-6#2)
plasmid (pI524) DNA##3##3##(1993-12#3)
plasmid DNA (pDNA)##2##3##(2013-1#2)
plasmid DNA and##9##3##(1993-4#1)(1994-9#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2009-10#1)
plasmid DNA carrying##2##3##(1990-7#1)(1994-10#1)
plasmid DNA delivery##2##3##(2010-4#1)(2011-1#1)
plasmid DNA for##2##3##(2008-2#1)(2011-2#1)
plasmid DNA from##5##3##(1990-9#1)(2008-10#1)(2008-11#3)
plasmid DNA has##2##3##(2008-10#1)(2010-8#1)
plasmid DNA in##3##3##(1990-11#1)(1991-8#1)(1996-6#1)
plasmid DNA into the##2##4##(2008-2#1)(2008-4#1)
plasmid DNA into##6##3##(2008-11#2)(2008-2#1)(2008-4#3)
plasmid DNA is introduced to monolayer cell cultures via a precipitate that adheres to the cell surface##3##17##(2008-1#1)(2008-2#1)(2008-4#1)
plasmid DNA is##6##3##(1995-2#1)(1997-8#1)(2008-1#1)(2008-2#1)(2008-4#1)(2013-1#1)
plasmid DNA pBR322##2##3##(2008-5#1)(2008-8#1)
plasmid DNA replication##6##3##(1994-11#3)(1994-3#2)(1994-8#1)
plasmid DNA to##3##3##(2004-12#1)(2008-8#2)
plasmid DNA using##2##3##(1994-9#1)(2008-11#1)
plasmid DNA was##4##3##(1996-6#1)(2007-11#1)(2008-11#1)(2008-5#1)
plasmid DNA##109##2##(1990-11#4)(1990-7#1)(1990-9#3)(1991-6#1)(1991-8#3)(1992-11#1)(1992-2#1)(1993-4#1)(1993-8#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-3#2)(1994-7#1)(1994-8#1)(1994-9#4)(1995-11#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-6#2)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#2)(2004-12#2)(2005-7#1)(2006-3#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#9)(2008-11#14)(2008-2#4)(2008-3#2)(2008-4#10)(2008-5#3)(2008-8#4)(2008-9#1)(2009-10#1)(2010-1#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#4)
plasmid RK2##3##2##(1990-4#1)(1990-9#1)(1991-9#1)
plasmid RP4##2##2##(1996-5#2)
plasmid and chromosomal##4##3##(1996-6#1)(1997-1#1)(2008-10#1)(2008-3#1)
plasmid and phagemid##2##3##(1994-12#1)(1994-8#1)
plasmid and##23##2##(1990-5#1)(1991-4#1)(1991-9#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-10#1)(1996-6#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#2)
plasmid bearing the##2##3##(1993-12#1)(1995-5#1)
plasmid between##2##2##(1990-3#1)(1992-5#1)
plasmid by##4##2##(1991-7#1)(1992-11#1)(2008-10#1)(2008-8#1)
plasmid can##5##2##(1991-8#1)(1991-9#1)(1995-2#1)(1996-10#1)(1997-2#1)
plasmid carrying the##4##3##(1990-3#1)(1990-9#1)(1996-11#1)(1997-4#1)
plasmid carrying##8##2##(1990-3#1)(1990-9#1)(1991-9#1)(1993-8#1)(1996-11#1)(1996-2#1)(1997-4#1)(1997-6#1)
plasmid clone##2##2##(1990-5#1)(1994-12#1)
plasmid clones##2##2##(1990-3#1)(1996-8#1)
plasmid construct##2##2##(2008-11#1)(2008-4#1)
plasmid construction##2##2##(1990-11#1)(2008-5#1)
plasmid constructs##4##2##(1993-12#1)(1993-3#1)(1994-8#1)(1995-8#1)
plasmid containing a construct##2##4##(1990-12#1)(1990-6#1)
plasmid containing a##8##3##(1990-12#1)(1990-5#1)(1990-6#1)(1992-12#1)(1996-12#1)(1997-1#1)(2008-10#1)(2008-11#1)
plasmid containing the coding##2##4##(1993-5#1)(1994-8#1)
plasmid containing the gene##2##4##(1994-2#1)(2008-2#1)
plasmid containing the##15##3##(1990-12#2)(1991-12#1)(1992-8#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1996-2#1)(1996-3#1)(2005-11#1)(2008-2#1)
plasmid containing##29##2##(1990-12#3)(1990-5#1)(1990-6#1)(1991-12#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(2005-11#1)(2005-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#2)
plasmid content##2##2##(2008-7#1)(2012-3#1)
plasmid copy number and##2##4##(1994-12#1)(2008-11#1)
plasmid copy number##5##3##(1994-12#1)(1994-2#2)(2008-11#1)(2008-12#1)
plasmid could be##2##3##(1993-12#1)(2005-10#1)
plasmid delivery##3##2##(2008-11#1)(2010-4#1)(2012-2#1)
plasmid designated##2##2##(2008-10#1)(2008-4#1)
plasmid encoding the##5##3##(1990-5#1)(1993-3#1)(1997-4#1)(2010-6#2)
plasmid encoding##13##2##(1990-5#1)(1991-3#1)(1993-3#1)(1994-8#1)(1997-4#2)(2008-1#1)(2008-2#1)(2010-11#1)(2010-12#1)(2010-6#2)(2012-2#1)
plasmid expressing an##2##3##(1996-8#1)(2008-2#1)
plasmid expressing##6##2##(1996-8#1)(2005-11#1)(2008-11#1)(2008-2#1)(2008-9#2)
plasmid expression vector##3##3##(1991-1#1)(1991-9#1)(1995-2#1)
plasmid expression##4##2##(1991-1#1)(1991-9#1)(1995-2#1)(2007-11#1)
plasmid for##3##2##(1990-9#1)(2008-11#2)
plasmid from##2##2##(1990-5#1)(1990-9#1)
plasmid harboring the##2##3##(1995-6#1)(2008-10#1)
plasmid harboring##4##2##(1992-9#1)(1994-3#1)(1995-6#1)(2008-10#1)
plasmid has##2##2##(1990-9#1)(1997-2#1)
plasmid in the##2##3##(1995-8#1)(2008-10#1)
plasmid in##7##2##(1990-9#1)(1991-7#1)(1991-9#1)(1995-8#1)(1996-10#1)(2008-10#2)
plasmid integration##2##2##(2008-10#2)
plasmid into the host##3##4##(2007-11#2)(2008-8#1)
plasmid is##10##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-9#1)(1991-9#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-8#1)(2011-1#1)
plasmid libraries into##2##3##(2008-4#1)(2011-2#1)
plasmid maintenance##4##2##(1990-4#1)(1990-9#1)(1992-12#1)(1996-10#1)
plasmid mediated##4##2##(2006-10#1)(2007-7#3)
plasmid molecules##2##2##(1990-11#1)(1995-8#1)
plasmid of P##2##3##(1997-2#1)(2008-10#1)
plasmid of approximately 70 kb##2##5##(2008-10#2)
plasmid of approximately##3##3##(2008-10#2)(2008-5#1)
plasmid of the##4##3##(1994-2#1)(1997-3#1)(2005-11#1)(2008-9#1)
plasmid of##15##2##(1992-5#1)(1994-2#1)(1995-6#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(2005-11#2)(2008-10#3)(2008-5#1)(2008-9#2)
plasmid or##7##2##(1994-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)
plasmid origin##3##2##(1993-12#1)(1997-4#2)
plasmid pACYC177##2##2##(1990-9#1)(2008-10#1)
plasmid pBR322##3##2##(1994-9#1)(1995-1#1)(1996-2#1)
plasmid pCIS7##2##2##(1990-9#2)
plasmid pI9789##2##2##(1995-8#2)
plasmid pIJ702##3##2##(1990-1#2)(2008-9#1)
plasmid pKYM is##2##3##(1997-6#2)
plasmid pKYM##4##2##(1997-6#4)
plasmid pRL-rhTNF##2##2##(2008-8#2)
plasmid pSC-O##2##2##(1991-12#2)
plasmid pUCEmDE##2##2##(2005-11#2)
plasmid pcDNA3##2##2##(2005-6#2)
plasmid per cell##2##3##(1991-8#1)(1993-12#1)
plasmid profile##6##2##(1997-8#1)(2007-7#1)(2008-12#4)
plasmid profiles##4##2##(1997-3#1)(2008-10#2)(2008-12#1)
plasmid replication and##2##3##(2008-11#1)(2008-12#1)
plasmid replication##6##2##(1994-11#2)(1995-2#2)(2008-11#1)(2008-12#1)
plasmid series##3##2##(1994-12#3)
plasmid size##2##2##(1990-9#1)(1996-4#1)
plasmid stability and protein##2##4##(2008-7#2)
plasmid stability and##4##3##(1994-2#1)(1994-3#1)(2008-7#2)
plasmid stability##7##2##(1990-9#1)(1994-2#2)(1994-3#1)(1995-4#1)(2008-7#2)
plasmid strand##2##2##(1996-5#1)(2013-1#1)
plasmid subcloning##3##2##(1990-3#3)
plasmid system##5##2##(1990-12#1)(1993-9#2)(1995-8#1)(2011-1#1)
plasmid that carries##2##3##(1995-2#1)(1997-6#1)
plasmid that is##2##3##(1991-9#1)(1995-2#1)
plasmid that##11##2##(1991-9#1)(1993-3#2)(1995-2#2)(1995-8#1)(1997-6#2)(2008-10#1)(2008-11#1)(2008-6#1)
plasmid to##7##2##(1991-9#1)(1993-12#1)(1993-5#1)(1995-1#1)(1996-12#1)(1996-7#1)(2008-5#1)
plasmid transfection##2##2##(1990-11#1)(1992-11#1)
plasmid type##2##2##(2007-2#1)(2008-10#1)
plasmid used##2##2##(1991-6#1)(1997-4#1)
plasmid variants##2##2##(1990-4#1)(2011-1#1)
plasmid vector for##2##3##(1993-11#1)(1996-2#1)
plasmid vector##27##2##(1990-10#1)(1990-12#1)(1990-5#3)(1991-3#1)(1991-7#2)(1991-8#1)(1992-11#1)(1992-3#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-12#1)(1995-2#1)(1996-2#1)(1996-7#1)(2005-11#1)(2006-8#1)(2008-10#3)(2008-11#1)(2008-9#1)(2010-8#1)
plasmid vectors for##3##3##(1990-9#1)(1991-5#1)(2008-2#1)
plasmid vectors##16##2##(1990-3#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-5#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#2)(1995-5#2)(1995-8#1)(2008-11#1)(2008-2#1)(2008-4#1)
plasmid was integrated##3##3##(1997-4#1)(2005-6#1)(2008-10#1)
plasmid was introduced into##5##4##(1990-8#1)(1993-12#1)(1994-8#2)(2005-11#1)
plasmid was stably maintained##2##4##(1994-3#1)(2008-7#1)
plasmid was##29##2##(1990-1#1)(1990-3#1)(1990-8#1)(1991-7#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-8#1)(1997-2#1)(1997-3#1)(1997-4#2)(2005-11#2)(2005-6#2)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-3#2)
plasmid were##4##2##(1991-4#1)(1993-9#1)(1995-8#1)(2011-2#1)
plasmid which##6##2##(1990-9#1)(1992-7#1)(1993-9#1)(1994-6#1)(1996-10#1)(2008-11#1)
plasmid with a##3##3##(1990-1#1)(1993-9#1)(2008-10#1)
plasmid with an##2##3##(1991-7#1)(1993-3#1)
plasmid with##9##2##(1990-1#1)(1991-7#1)(1992-8#1)(1993-3#1)(1993-9#1)(1995-2#2)(2007-6#1)(2008-10#1)
plasmid##792##1##(1990-1#6)(1990-10#8)(1990-11#19)(1990-12#6)(1990-3#15)(1990-4#9)(1990-5#18)(1990-6#1)(1990-7#5)(1990-8#4)(1990-9#28)(1991-1#1)(1991-12#5)(1991-2#1)(1991-3#2)(1991-4#3)(1991-5#3)(1991-6#2)(1991-7#8)(1991-8#9)(1991-9#15)(1992-11#4)(1992-12#5)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#4)(1992-7#2)(1992-8#3)(1992-9#3)(1993-11#16)(1993-12#16)(1993-2#1)(1993-3#7)(1993-4#1)(1993-5#4)(1993-8#4)(1993-9#13)(1994-10#1)(1994-11#6)(1994-12#16)(1994-2#8)(1994-3#8)(1994-6#1)(1994-7#1)(1994-8#12)(1994-9#9)(1995-1#6)(1995-11#2)(1995-2#16)(1995-3#1)(1995-4#2)(1995-5#5)(1995-6#3)(1995-7#1)(1995-8#22)(1996-10#9)(1996-11#2)(1996-12#2)(1996-2#8)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#7)(1996-7#7)(1996-8#3)(1997-1#5)(1997-2#16)(1997-3#8)(1997-4#14)(1997-6#11)(1997-7#1)(1997-8#4)(2004-12#2)(2005-10#1)(2005-11#16)(2005-6#6)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-3#2)(2006-5#1)(2006-8#1)(2007-11#8)(2007-12#2)(2007-2#1)(2007-6#2)(2007-7#7)(2007-9#1)(2008-1#5)(2008-10#45)(2008-11#41)(2008-12#8)(2008-2#12)(2008-3#4)(2008-4#28)(2008-5#14)(2008-6#3)(2008-7#6)(2008-8#24)(2008-9#16)(2009-10#1)(2009-2#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#3)(2010-6#2)(2010-8#3)(2011-1#6)(2011-2#15)(2012-2#5)(2012-3#7)(2013-1#9)
plasmid)##2##1##(2008-10#1)(2008-11#1)
plasmid-based##6##1##(1994-12#2)(1996-10#1)(1996-8#1)(1997-7#1)(2008-4#1)
plasmid-borne cpe-carrying C##2##3##(2011-2#2)
plasmid-borne cpe-carrying##3##2##(2011-2#3)
plasmid-borne##11##1##(1990-3#1)(1990-5#1)(1995-11#1)(1995-2#1)(2008-8#1)(2011-2#4)(2012-3#2)
plasmid-carrying cells##4##2##(2008-7#4)
plasmid-carrying##5##1##(2008-7#5)
plasmid-cured variant##2##2##(2008-4#2)
plasmid-cured##3##1##(2005-9#1)(2008-4#2)
plasmid-derived 23 S rRNA##3##4##(1997-1#3)
plasmid-derived##5##1##(1997-1#5)
plasmid-encoded##9##1##(1991-10#2)(1994-12#1)(1994-5#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-6#1)(2011-2#1)
plasmid-mediated##5##1##(1995-2#1)(2005-8#1)(2008-10#1)(2008-4#2)
plasmid-transfected##2##1##(1994-6#1)(2008-11#1)
plasmid/liposomes and##2##2##(2008-8#2)
plasmid/liposomes##3##1##(2008-8#3)
plasmids F and R6-5##2##4##(1991-7#2)
plasmids also##2##2##(1991-7#1)(1997-3#1)
plasmids and##10##2##(1990-9#1)(1991-8#1)(1993-12#1)(1995-2#1)(1997-3#1)(1997-6#1)(2005-11#1)(2006-11#1)(2008-10#1)(2008-5#1)
plasmids are##5##2##(1991-9#2)(1997-6#1)(2008-5#1)(2011-2#1)
plasmids at##2##2##(1995-8#1)(1996-7#1)
plasmids carrying##6##2##(1993-12#1)(1995-6#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-8#1)
plasmids contained##3##2##(1990-1#1)(1992-12#1)(2008-8#1)
plasmids containing the##6##3##(1993-3#1)(1994-12#1)(1994-9#1)(1995-6#1)(1997-2#1)(2008-8#1)
plasmids containing##16##2##(1990-10#2)(1990-5#1)(1992-2#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(2008-8#1)(2013-8#1)
plasmids efficiently##2##2##(2008-8#2)
plasmids encoding mutant##2##3##(1995-8#1)(1996-11#1)
plasmids encoding the##5##3##(1993-6#1)(1995-2#1)(1996-1#1)(2008-1#1)(2008-2#1)
plasmids encoding##11##2##(1993-6#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-11#1)(1997-4#1)(2005-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2010-12#1)
plasmids expressing##3##2##(1993-2#1)(2008-4#1)(2009-12#1)
plasmids for the expression##2##4##(1991-7#1)(1993-9#1)
plasmids for the##3##3##(1991-7#1)(1993-9#1)(1997-8#1)
plasmids for##4##2##(1991-7#1)(1993-9#1)(1997-8#1)(2008-9#1)
plasmids from##6##2##(1990-11#1)(1991-8#1)(1995-2#1)(1997-3#1)(1997-4#1)(2012-3#1)
plasmids had##2##2##(1995-6#1)(2008-8#1)
plasmids in the##3##3##(1997-2#1)(1997-6#1)(2012-1#1)
plasmids in##14##2##(1990-11#1)(1990-4#1)(1990-9#1)(1994-8#1)(1995-8#1)(1996-10#1)(1997-2#1)(1997-6#2)(1997-7#1)(2006-10#1)(2008-1#1)(2012-1#1)(2012-3#1)
plasmids into##5##2##(1992-11#1)(1994-8#1)(1995-3#1)(2008-11#1)(2012-3#1)
plasmids is##2##2##(1990-4#1)(1991-8#1)
plasmids of size##2##3##(2011-2#2)
plasmids of##8##2##(2006-10#1)(2007-2#1)(2008-10#2)(2008-4#1)(2011-2#3)
plasmids on##2##2##(1990-3#1)(1997-6#1)
plasmids or##3##2##(1996-10#1)(2008-4#1)(2012-3#1)
plasmids resulted in##2##3##(1990-4#1)(1993-8#1)
plasmids that were##2##3##(1991-9#1)(2011-1#1)
plasmids that##5##2##(1991-9#1)(1994-9#1)(1995-8#1)(2008-2#1)(2011-1#1)
plasmids to##3##2##(1991-7#1)(2008-10#1)(2008-5#1)
plasmids under the control of the##2##6##(1990-4#1)(2008-10#1)
plasmids under##3##2##(1990-3#1)(1990-4#1)(2008-10#1)
plasmids was compared##2##3##(1990-11#1)(1997-8#1)
plasmids was##4##2##(1990-11#1)(1995-8#1)(1997-4#1)(1997-8#1)
plasmids were constructed##5##3##(1990-5#1)(1993-12#1)(1993-3#1)(1994-8#1)(2008-8#1)
plasmids were##25##2##(1990-3#1)(1990-5#2)(1993-12#1)(1993-3#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-8#1)(2008-10#2)(2008-11#1)(2008-8#3)(2008-9#3)(2010-1#1)(2010-6#2)(2012-3#1)(2013-1#1)
plasmids which##2##2##(1990-5#1)(1991-5#1)
plasmids with##4##2##(1990-3#1)(1990-5#1)(1991-7#1)(1994-9#1)
plasmids##279##1##(1990-1#2)(1990-10#2)(1990-11#6)(1990-12#1)(1990-3#5)(1990-4#7)(1990-5#8)(1990-9#4)(1991-12#1)(1991-5#1)(1991-7#12)(1991-8#6)(1991-9#6)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-11#5)(1993-12#4)(1993-2#2)(1993-3#3)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#4)(1994-3#1)(1994-8#4)(1994-9#5)(1995-1#2)(1995-2#5)(1995-3#1)(1995-6#3)(1995-8#11)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#1)(1996-5#2)(1996-6#3)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#5)(1997-4#5)(1997-6#6)(1997-7#4)(1997-8#3)(2004-4#1)(2005-10#1)(2005-11#2)(2005-7#1)(2006-10#3)(2006-11#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-1#5)(2008-10#13)(2008-11#5)(2008-2#3)(2008-4#4)(2008-5#8)(2008-8#11)(2008-9#8)(2009-12#1)(2010-1#1)(2010-12#2)(2010-6#2)(2011-1#1)(2011-2#8)(2012-1#3)(2012-11#1)(2012-2#2)(2012-3#14)(2013-1#3)(2013-8#2)
plasmids)##2##1##(1997-4#1)(2011-2#1)
plasmin and MMP-2 activity##2##4##(2011-2#2)
plasmin and a##2##3##(1997-2#1)(2008-5#1)
plasmin and##9##2##(1990-9#1)(1991-9#1)(1993-12#1)(1994-9#1)(1996-9#1)(1997-2#1)(2008-5#1)(2011-2#2)
plasmin generation##4##2##(1990-11#1)(1990-9#1)(1996-8#1)(2011-2#1)
plasmin in##2##2##(1995-2#1)(2013-1#1)
plasmin is##2##2##(1994-3#1)(1996-2#1)
plasmin on fibrinogen##2##3##(1990-11#2)
plasmin to its##2##3##(1990-11#2)
plasmin to##3##2##(1990-11#2)(1991-7#1)
plasmin##54##1##(1990-11#11)(1990-12#1)(1990-5#1)(1990-7#5)(1990-9#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-7#1)(1993-12#1)(1993-8#2)(1994-3#3)(1994-9#1)(1995-2#1)(1995-6#3)(1995-7#2)(1996-2#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#2)(2007-7#1)(2008-5#3)(2008-6#1)(2011-2#4)(2013-1#1)(2013-8#1)
plasmin-mediated##3##1##(1990-11#1)(1996-8#1)(1997-2#1)
plasminogen activating##3##2##(1991-9#1)(1997-2#2)
plasminogen activation and##4##3##(1990-11#1)(1991-2#1)(1996-9#1)(1997-2#1)
plasminogen activation by##4##3##(1997-2#4)
plasminogen activation on the##2##4##(1990-5#2)
plasminogen activation##27##2##(1990-11#3)(1990-5#2)(1991-1#1)(1991-2#3)(1995-6#1)(1996-9#1)(1997-2#16)
plasminogen activator (rt-PA)##5##3##(1990-11#1)(2007-10#2)(2007-9#1)(2008-7#1)
plasminogen activator (t-PA) and##2##4##(1990-11#1)(1992-2#1)
plasminogen activator (t-PA) in##4##4##(1990-11#1)(1995-3#1)(1995-8#1)(2007-9#1)
plasminogen activator (t-PA)##22##3##(1990-11#5)(1990-12#1)(1990-5#1)(1991-1#1)(1992-2#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-8#1)(2007-10#2)(2007-9#3)(2008-11#2)(2010-12#1)
plasminogen activator (tPA)##6##3##(1990-9#1)(1992-12#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-8#1)
plasminogen activator (u-PA)##9##3##(1990-11#2)(1991-1#1)(1991-10#1)(1993-12#1)(1993-3#1)(1994-3#1)(1996-9#1)(2008-11#1)
plasminogen activator (uPA) and its receptor##2##6##(1997-4#1)(1997-7#1)
plasminogen activator (uPA)##8##3##(1990-12#1)(1990-5#1)(1995-5#1)(1996-8#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-11#1)
plasminogen activator activity by##3##4##(1996-9#1)(2008-11#2)
plasminogen activator activity in##6##4##(1991-10#1)(1997-2#1)(2008-11#3)(2010-3#1)
plasminogen activator activity##11##3##(1991-10#1)(1992-4#1)(1996-9#1)(1997-2#1)(2008-11#5)(2008-8#1)(2010-3#1)
plasminogen activator and##6##3##(1990-11#1)(1993-3#1)(1995-5#1)(1995-6#1)(1997-2#1)(1997-7#1)
plasminogen activator antigen##2##3##(1997-2#1)(2005-10#1)
plasminogen activator for##6##3##(2006-12#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-7#1)
plasminogen activator gene##2##3##(1994-3#1)(1995-3#1)
plasminogen activator in##5##3##(1990-11#2)(1992-10#1)(2007-9#1)(2008-7#1)
plasminogen activator inhibitor 1##2##4##(1990-11#1)(1993-4#1)
plasminogen activator inhibitor type##2##4##(1990-5#1)(1992-7#1)
plasminogen activator inhibitor##9##3##(1990-11#2)(1990-5#1)(1990-9#1)(1991-4#1)(1992-7#1)(1993-4#1)(1994-9#1)(2010-6#1)
plasminogen activator inhibitor-1 (PAI-1) were##2##5##(1993-4#1)(2013-1#1)
plasminogen activator inhibitor-1 (PAI-1)##10##4##(1992-12#1)(1992-2#1)(1993-12#1)(1993-4#1)(1994-9#1)(2007-9#1)(2008-3#1)(2008-4#1)(2009-8#1)(2013-1#1)
plasminogen activator inhibitor-1##25##3##(1990-11#1)(1992-12#2)(1992-2#2)(1993-12#1)(1993-4#1)(1994-3#1)(1994-9#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#2)(2005-7#1)(2007-9#2)(2008-3#1)(2008-4#2)(2009-4#1)(2009-8#1)(2011-2#1)(2013-1#2)
plasminogen activator is##4##3##(2006-7#1)(2007-10#1)(2007-9#1)(2013-7#1)
plasminogen activator of bacterial origin##2##5##(2012-2#2)
plasminogen activator of##3##3##(2009-11#1)(2012-2#2)
plasminogen activator therapy##2##3##(2013-7#1)(2013-8#1)
plasminogen activator was##2##3##(1995-6#1)(2008-7#1)
plasminogen activator with##3##3##(2007-11#1)(2007-9#1)(2010-8#1)
plasminogen activator##201##2##(1990-11#22)(1990-12#3)(1990-5#4)(1990-8#1)(1990-9#2)(1991-1#2)(1991-10#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-9#3)(1992-10#1)(1992-12#5)(1992-2#3)(1992-4#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#2)(1994-3#6)(1994-5#2)(1994-6#1)(1994-9#2)(1995-3#4)(1995-5#5)(1995-6#2)(1995-8#1)(1996-2#2)(1996-5#1)(1996-8#2)(1996-9#3)(1997-1#2)(1997-2#8)(1997-4#1)(1997-7#2)(2005-10#1)(2005-7#2)(2006-12#2)(2006-7#1)(2007-10#9)(2007-11#3)(2007-12#1)(2007-5#1)(2007-7#3)(2007-9#21)(2008-11#13)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#7)(2008-8#4)(2008-9#1)(2009-11#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#4)(2013-7#3)(2013-8#1)
plasminogen activators and##2##3##(1992-12#1)(1992-6#1)
plasminogen activators##10##2##(1990-11#1)(1991-1#2)(1992-12#2)(1992-6#2)(1995-6#1)(2007-11#1)(2008-1#1)
plasminogen and the##3##3##(1990-5#1)(1995-3#1)(1996-5#1)
plasminogen and##15##2##(1990-11#1)(1990-5#1)(1992-3#2)(1993-8#1)(1994-11#2)(1995-3#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-2#3)
plasminogen are##3##2##(1994-6#1)(1995-6#1)(1996-2#1)
plasminogen binding##2##2##(1990-11#1)(1992-8#1)
plasminogen by##6##2##(1990-11#1)(1995-3#2)(1997-2#1)(2007-7#1)(2008-10#1)
plasminogen gene##4##2##(1990-12#1)(1992-3#1)(1992-7#1)(1995-6#1)
plasminogen is##3##2##(1995-6#1)(1997-2#1)(2012-12#1)
plasminogen nor##2##2##(1993-2#1)(1996-9#1)
plasminogen to##5##2##(1990-11#3)(1991-7#1)(1995-2#1)
plasminogen##335##1##(1990-11#35)(1990-12#7)(1990-5#10)(1990-8#1)(1990-9#3)(1991-1#6)(1991-10#2)(1991-2#4)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#3)(1991-9#4)(1992-10#1)(1992-12#7)(1992-2#4)(1992-3#6)(1992-4#1)(1992-6#3)(1992-7#5)(1992-8#2)(1993-12#2)(1993-2#4)(1993-3#2)(1993-4#2)(1993-8#5)(1994-11#2)(1994-3#6)(1994-5#3)(1994-6#2)(1994-9#2)(1995-2#3)(1995-3#13)(1995-5#5)(1995-6#10)(1995-8#2)(1996-2#4)(1996-5#4)(1996-8#4)(1996-9#5)(1997-1#2)(1997-2#32)(1997-4#2)(1997-7#5)(2005-10#1)(2005-7#2)(2006-12#2)(2006-7#1)(2007-10#9)(2007-11#4)(2007-12#1)(2007-5#1)(2007-7#4)(2007-9#21)(2008-1#1)(2008-10#1)(2008-11#14)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#7)(2008-8#6)(2008-9#1)(2009-11#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#6)(2013-7#3)(2013-8#2)
plasminogen-activator##2##1##(1994-6#1)(1997-7#1)
plasminogen-binding protein##2##2##(1997-2#1)(1997-7#1)
plasminogen-related gene##2##2##(1992-7#2)
plasminogen-related genes##2##2##(1992-3#2)
plasminogen-related##5##1##(1991-11#1)(1992-3#2)(1992-7#2)
plasmocytoma##3##1##(1991-3#1)(2006-12#1)(2007-11#1)
plasmode##3##1##(2010-2#3)
plasmodesmata formation and function##2##4##(2011-12#2)
plasmodesmata##10##1##(1997-3#1)(2008-10#1)(2009-8#1)(2011-12#7)
plasmodia##3##1##(1991-9#1)(2008-10#2)
plasmodial##3##1##(2007-2#1)(2010-12#1)(2012-12#1)
plasmodic index##2##2##(2006-4#2)
plasmodium##8##1##(1994-11#2)(2006-10#4)(2008-11#1)(2011-12#1)
plasmolysis##2##1##(1991-11#1)(1995-1#1)
plasmon absorbance##2##2##(2009-11#1)(2011-2#1)
plasmon polariton##4##2##(2007-11#1)(2007-12#1)(2008-7#2)
plasmon resonance (SPR)##26##3##(2005-11#1)(2008-10#16)(2008-11#1)(2008-2#2)(2008-4#3)(2008-9#1)(2011-1#1)(2012-11#1)
plasmon resonance immunosensor for##3##4##(2007-8#2)(2008-10#1)
plasmon resonance in##2##3##(2007-11#2)
plasmon resonance##96##2##(1992-11#1)(1994-11#2)(1994-8#1)(1995-12#1)(1996-5#1)(1996-7#1)(1997-4#2)(1997-7#1)(2005-11#1)(2007-11#4)(2007-12#2)(2007-4#2)(2007-8#5)(2007-9#1)(2008-10#39)(2008-11#1)(2008-2#5)(2008-3#5)(2008-4#6)(2008-5#3)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-2#1)(2010-7#1)(2011-1#2)(2012-11#1)(2013-1#2)
plasmon resonances of##2##3##(2008-3#1)(2010-2#1)
plasmon resonances##7##2##(2007-12#1)(2007-4#1)(2008-3#1)(2008-6#2)(2010-2#2)
plasmon##135##1##(1991-12#1)(1992-11#1)(1994-11#2)(1994-8#1)(1995-12#1)(1996-5#1)(1996-7#1)(1997-4#2)(1997-7#1)(2005-11#1)(2007-11#6)(2007-12#13)(2007-4#3)(2007-8#7)(2007-9#1)(2008-1#2)(2008-10#39)(2008-11#1)(2008-2#7)(2008-3#9)(2008-4#7)(2008-5#3)(2008-6#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-9#3)(2010-1#1)(2010-2#3)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-11#1)(2013-1#2)
plasmon-coupled##2##1##(2008-2#1)(2009-11#1)
plasmon-polariton modes##2##2##(2007-12#2)
plasmon-polariton##3##1##(2007-12#3)
plasmonic materials##2##2##(2008-7#2)
plasmonic metamaterials##3##2##(2008-7#3)
plasmonic##13##1##(2006-12#1)(2007-11#1)(2008-7#8)(2012-2#1)(2013-1#2)
plasmons and##3##2##(2007-12#3)
plasmons are##2##2##(2005-11#1)(2007-12#1)
plasmons##23##1##(2005-11#1)(2007-12#11)(2008-11#1)(2008-2#3)(2008-3#1)(2008-7#3)(2012-2#3)
plaster cast##8##2##(1993-3#1)(1996-9#1)(2007-12#2)(2007-8#3)(2012-2#1)
plaster##17##1##(1991-12#1)(1993-3#1)(1996-9#1)(2007-12#3)(2007-3#1)(2007-8#4)(2008-12#2)(2008-2#1)(2009-6#1)(2011-2#1)(2012-2#1)
plasters##5##1##(1990-11#1)(2008-10#2)(2013-8#2)
plastic alterations of##2##3##(2010-8#2)
plastic and reconstructive surgery##3##4##(2008-11#2)(2013-1#1)
plastic and##11##2##(1991-3#1)(1995-9#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#5)(2013-1#1)
plastic bag##6##2##(1991-12#1)(1991-3#2)(2007-12#1)(2007-7#2)
plastic bags##6##2##(1996-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)(2013-1#1)
plastic beads##3##2##(2008-10#2)(2008-8#1)
plastic changes in the##2##4##(1994-8#1)(2008-3#1)
plastic changes in##3##3##(1994-8#1)(1995-12#1)(2008-3#1)
plastic changes##6##2##(1991-6#1)(1994-8#1)(1995-12#1)(1996-11#1)(2008-3#1)(2008-9#1)
plastic chip##2##2##(2007-11#1)(2008-10#1)
plastic containers##2##2##(2007-5#1)(2008-5#1)
plastic corrector##2##2##(2013-1#2)
plastic cover##3##2##(1990-12#1)(2008-10#2)
plastic deformation of a##2##4##(2008-7#1)(2009-5#1)
plastic deformation of##5##3##(1994-7#1)(2008-7#2)(2009-5#1)(2009-7#1)
plastic deformation##10##2##(1994-7#1)(2008-7#7)(2009-5#1)(2009-7#1)
plastic device and ceramic knives##2##5##(2008-10#2)
plastic device##4##2##(1996-12#1)(2008-10#2)(2008-3#1)
plastic embedded##2##2##(1994-10#2)
plastic film##4##2##(2006-2#1)(2008-11#1)(2010-1#1)(2011-12#1)
plastic foils##5##2##(1990-10#1)(1991-12#1)(1997-6#1)(2008-1#2)
plastic graded-index##2##2##(2007-12#2)
plastic insufficiency of cardiomyocytes##2##4##(2010-12#2)
plastic insufficiency##3##2##(2010-12#3)
plastic material##2##2##(2008-3#2)
plastic objective lenses##2##3##(2008-3#2)
plastic objective##4##2##(2008-3#4)
plastic occlusion##2##2##(2006-12#1)(2008-5#1)
plastic optical fibers (POF's)##2##4##(2008-3#2)
plastic optical fibers##4##3##(2008-3#4)
plastic optical##8##2##(2008-2#1)(2008-3#5)(2010-4#2)
plastic or##2##2##(2007-5#1)(2009-10#1)
plastic pattern for##2##3##(2012-2#2)
plastic pattern##3##2##(2012-2#3)
plastic pigments##3##2##(2008-3#3)
plastic pins##2##2##(1997-3#1)(2008-4#1)
plastic plates##2##2##(1990-11#1)(1990-12#1)
plastic products for food use##2##5##(2008-10#2)
plastic products##6##2##(2004-4#3)(2008-10#3)
plastic reserves##2##2##(2009-2#2)
plastic resin##2##2##(2004-9#1)(2008-9#1)
plastic response##2##2##(2008-8#1)(2009-6#1)
plastic responses##2##2##(2009-6#2)
plastic restrainer##4##2##(2008-4#4)
plastic stent##2##2##(2007-5#1)(2010-12#1)
plastic strain was##2##3##(2009-7#2)
plastic strain##7##2##(2009-7#7)
plastic substrates##6##2##(1990-8#1)(2005-11#1)(2008-3#1)(2008-7#2)(2010-2#1)
plastic surface##3##2##(1990-12#1)(1991-7#1)(1994-9#1)
plastic surfaces##2##2##(2005-8#1)(2009-6#1)
plastic surgeon and##2##3##(2009-9#1)(2013-1#1)
plastic surgeon##6##2##(2007-8#1)(2009-9#1)(2011-2#1)(2012-2#2)(2013-1#1)
plastic surgeons to##2##3##(2010-8#2)
plastic surgeons##14##2##(2006-8#2)(2007-12#1)(2008-4#1)(2009-9#1)(2010-8#5)(2010-9#3)(2013-1#1)
plastic surgery for##2##3##(1990-9#1)(2012-1#1)
plastic surgery of the##3##4##(1992-10#1)(2013-1#1)(2013-8#1)
plastic surgery procedures##3##3##(2010-9#2)(2013-1#1)
plastic surgery##37##2##(1990-3#1)(1990-9#2)(1991-4#3)(1992-10#1)(1992-2#1)(1993-9#2)(1996-6#1)(2006-6#1)(2007-12#1)(2008-4#1)(2010-8#3)(2010-9#4)(2011-12#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#9)(2013-8#1)
plastic surgical##3##2##(1990-5#1)(2009-2#1)(2013-1#1)
plastic synapses##2##2##(2008-2#2)
plastic type##4##2##(2008-8#4)
plastic were##2##2##(2008-3#1)(2008-5#1)
plastic workers##5##2##(2010-2#5)
plastic##336##1##(1990-10#3)(1990-11#1)(1990-12#4)(1990-3#1)(1990-5#1)(1990-8#2)(1990-9#2)(1991-12#3)(1991-3#3)(1991-4#3)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-2#3)(1992-3#2)(1992-5#1)(1992-8#2)(1993-6#1)(1993-9#2)(1994-10#2)(1994-7#2)(1994-8#4)(1994-9#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-9#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(2004-12#2)(2004-4#6)(2004-9#1)(2005-11#3)(2005-8#1)(2006-10#1)(2006-12#2)(2006-2#2)(2006-3#1)(2006-6#2)(2006-8#3)(2007-11#2)(2007-12#9)(2007-2#1)(2007-3#1)(2007-5#4)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#31)(2008-11#12)(2008-2#11)(2008-3#21)(2008-4#9)(2008-5#7)(2008-6#1)(2008-7#12)(2008-8#10)(2008-9#4)(2009-10#2)(2009-2#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#5)(2009-7#8)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#4)(2010-2#6)(2010-3#1)(2010-4#2)(2010-8#10)(2010-9#8)(2011-12#3)(2011-2#3)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#10)(2012-4#1)(2013-1#17)(2013-7#1)(2013-8#2)
plastic)##2##1##(2008-4#1)(2008-8#1)
plastica##2##1##(1992-10#1)(2008-5#1)
plastically bent##2##2##(2008-3#2)
plastically##6##1##(2008-3#2)(2008-5#1)(2008-7#2)(2013-1#1)
plasticised PVC##4##2##(2008-10#4)
plasticised##5##1##(2008-10#5)
plasticiser##2##1##(2008-10#2)
plasticising##2##1##(2008-10#1)(2008-5#1)
plasticity after##4##2##(1995-11#1)(1995-3#1)(2008-11#1)(2009-10#1)
plasticity and adaptation##2##3##(1995-12#1)(2013-7#1)
plasticity and cellular resilience##2##4##(2008-7#2)
plasticity and may##2##3##(1996-2#1)(2008-9#1)
plasticity and the##2##3##(2005-8#1)(2012-5#1)
plasticity and their##4##3##(2008-3#1)(2008-4#1)(2008-8#1)(2009-8#1)
plasticity and##42##2##(1991-9#1)(1995-12#1)(1996-2#1)(2005-8#1)(2006-10#1)(2007-10#1)(2008-1#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#4)(2008-8#4)(2008-9#1)(2009-3#1)(2009-6#1)(2009-8#4)(2011-2#1)(2012-12#2)(2012-2#2)(2012-5#1)(2013-7#1)(2013-8#2)
plasticity are##7##2##(1996-3#1)(1996-6#1)(2006-5#1)(2008-11#1)(2008-8#1)(2009-6#1)(2009-9#1)
plasticity as##4##2##(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)
plasticity between##2##2##(2009-6#1)(2012-2#1)
plasticity by##4##2##(1995-12#1)(2009-8#1)(2012-2#1)(2013-1#1)
plasticity can##2##2##(2010-8#1)(2012-2#1)
plasticity from##2##2##(1994-11#1)(2012-2#1)
plasticity has been##3##3##(1991-8#1)(1994-8#1)(2010-3#1)
plasticity has##8##2##(1991-8#1)(1994-8#1)(1996-5#1)(2008-8#2)(2010-3#1)(2012-2#2)
plasticity in hippocampus and##2##4##(1995-2#1)(2013-1#1)
plasticity in maternal selection##2##4##(2008-8#2)
plasticity in response to the##2##5##(2008-9#1)(2010-12#1)
plasticity in response to##3##4##(2008-9#1)(2009-6#1)(2010-12#1)
plasticity in the adult##2##4##(2008-11#1)(2008-7#1)
plasticity in the brain##2##4##(2006-8#2)
plasticity in the cortex##2##4##(2008-11#1)(2009-6#1)
plasticity in the hippocampal##3##4##(1997-7#1)(2008-4#1)(2008-7#1)
plasticity in the hippocampus##2##4##(1993-12#1)(2008-7#1)
plasticity in the##23##3##(1993-12#1)(1995-12#2)(1996-12#2)(1996-7#1)(1997-5#1)(1997-7#1)(2006-8#2)(2007-5#1)(2008-11#3)(2008-4#1)(2008-7#4)(2009-6#1)(2010-12#2)(2012-2#1)
plasticity in their##2##3##(2010-3#2)
plasticity in these##2##3##(1995-12#1)(2008-7#1)
plasticity in##62##2##(1991-8#2)(1993-12#1)(1994-8#2)(1995-12#4)(1995-2#1)(1996-12#2)(1996-7#1)(1997-5#1)(1997-7#3)(2006-11#1)(2006-8#2)(2007-5#1)(2008-11#4)(2008-2#1)(2008-4#3)(2008-7#7)(2008-8#4)(2008-9#3)(2009-10#1)(2009-6#3)(2010-12#3)(2010-3#3)(2011-12#1)(2012-12#1)(2012-2#2)(2012-9#1)(2013-1#2)(2013-7#1)(2013-8#1)
plasticity is##9##2##(1995-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#3)(2011-2#1)
plasticity may##2##2##(2008-8#1)(2009-6#1)
plasticity might##4##2##(2008-7#2)(2012-2#2)
plasticity of nigrostriatal DAergic neurons##2##5##(2013-7#2)
plasticity of the auditory##2##4##(2008-9#1)(2010-12#1)
plasticity of the##8##3##(1993-9#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-7#1)
plasticity of these##2##3##(2008-11#2)
plasticity of this##2##3##(2007-8#1)(2008-9#1)
plasticity of##36##2##(1993-9#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-7#1)(2004-2#1)(2006-11#1)(2006-12#1)(2007-8#2)(2008-1#1)(2008-11#6)(2008-7#1)(2008-9#3)(2009-12#1)(2009-6#2)(2010-12#1)(2010-8#1)(2011-1#2)(2012-12#2)(2012-2#2)(2013-7#3)
plasticity that##3##2##(2008-11#1)(2008-9#1)(2012-1#1)
plasticity to##3##2##(1995-11#1)(2008-8#1)(2012-2#1)
plasticity was##2##2##(1991-8#2)
plasticity within##2##2##(2010-8#1)(2013-8#1)
plasticity##351##1##(1990-9#1)(1991-8#7)(1991-9#1)(1992-3#1)(1993-11#1)(1993-12#4)(1993-9#2)(1994-11#3)(1994-8#3)(1995-11#4)(1995-12#10)(1995-2#2)(1995-3#2)(1995-7#1)(1996-12#3)(1996-2#1)(1996-3#3)(1996-5#3)(1996-6#3)(1996-7#1)(1996-9#1)(1997-4#1)(1997-5#5)(1997-7#7)(2004-2#1)(2005-8#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-5#2)(2006-6#1)(2006-8#3)(2007-10#1)(2007-12#3)(2007-5#2)(2007-8#6)(2008-1#9)(2008-10#2)(2008-11#27)(2008-2#6)(2008-3#2)(2008-4#10)(2008-6#1)(2008-7#25)(2008-8#31)(2008-9#12)(2009-10#5)(2009-12#1)(2009-3#6)(2009-6#17)(2009-7#2)(2009-8#17)(2009-9#2)(2010-12#5)(2010-2#1)(2010-3#5)(2010-7#1)(2010-8#4)(2011-1#4)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#9)(2012-2#25)(2012-5#1)(2012-9#2)(2013-1#6)(2013-7#5)(2013-8#5)
plasticity)##3##1##(1991-8#1)(2008-2#1)(2011-12#1)
plasticity-related##2##1##(2008-11#2)
plasticization##2##1##(2010-4#1)(2012-2#1)
plasticized PVC membranes##5##3##(2008-10#5)
plasticized PVC##10##2##(2008-10#10)
plasticized cellulose triacetate membranes##2##4##(2008-10#2)
plasticized poly (vinyl chloride) (PVC)##2##5##(2008-10#2)
plasticized poly##3##2##(2008-10#3)
plasticized poly(vinyl chloride) (PVC) membrane##2##5##(2008-10#2)
plasticized poly(vinyl chloride) (PVC) membranes##2##5##(2008-10#2)
plasticized poly(vinyl chloride) (PVC)##5##4##(2008-10#5)
plasticized poly(vinyl chloride) membrane##4##4##(2008-10#4)
plasticized poly(vinyl chloride) membranes##2##4##(2007-8#1)(2008-10#1)
plasticized poly(vinyl chloride)##13##3##(2007-8#1)(2008-10#12)
plasticized polymer##2##2##(2008-10#2)
plasticized polymeric##2##2##(2008-10#2)
plasticized with o-NPOE##2##3##(2008-10#2)
plasticized with##10##2##(2008-10#8)(2008-5#2)
plasticized##50##1##(1995-3#1)(2007-8#1)(2008-10#45)(2008-5#2)(2010-2#1)
plasticizer admixtures##5##2##(2008-10#5)
plasticizer and molecular weight of cyanocopolymers##2##6##(2008-10#2)
plasticizer and the##2##3##(2008-10#2)
plasticizer and##12##2##(2008-10#11)(2010-2#1)
plasticizer in##3##2##(2008-10#3)
plasticizer nature##3##2##(2008-10#3)
plasticizer##49##1##(1996-8#2)(2004-12#1)(2008-10#44)(2010-2#1)(2012-2#1)
plasticizers in plastic##2##3##(2008-10#2)
plasticizers in##3##2##(2008-10#2)(2010-7#1)
plasticizers were##2##2##(1996-8#1)(2012-2#1)
plasticizers##29##1##(1996-8#1)(2008-10#17)(2008-5#4)(2010-5#2)(2010-7#2)(2012-2#3)
plastics and##5##2##(1997-8#1)(2008-10#1)(2008-6#1)(2010-9#1)(2012-2#1)
plastics in packaging and disposable products##2##6##(2008-6#2)
plastics in##3##2##(2008-6#2)(2013-1#1)
plastics##25##1##(1991-8#1)(1997-8#1)(2005-11#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-3#2)(2008-6#6)(2008-7#1)(2009-2#1)(2010-9#1)(2011-12#1)(2012-2#1)(2013-1#1)
plastid envelope##2##2##(1997-6#1)(2009-10#1)
plastid evolution##2##2##(1997-4#2)
plastid gene expression##2##3##(2011-2#2)
plastid genome##2##2##(2006-12#1)(2013-1#1)
plastid proteins##2##2##(1994-12#1)(2011-2#1)
plastid##29##1##(1992-12#1)(1994-12#1)(1995-10#1)(1995-8#1)(1997-4#2)(1997-6#4)(2006-12#2)(2007-12#4)(2008-1#1)(2009-10#2)(2009-9#1)(2010-10#1)(2011-2#7)(2013-1#1)
plastidial##2##1##(2009-10#2)
plastidic##4##1##(1995-8#4)
plastids in##3##2##(1997-6#1)(2007-12#1)(2011-2#1)
plastids of##2##2##(2008-9#1)(2009-10#1)
plastids##20##1##(1993-3#1)(1993-4#1)(1994-12#1)(1997-4#2)(1997-6#3)(2007-12#3)(2008-10#1)(2008-9#3)(2009-10#1)(2009-8#1)(2011-2#2)(2012-2#1)
plastocyanin and##2##2##(1990-5#1)(1994-12#1)
plastocyanin has been##3##3##(1994-5#1)(2006-10#1)(2009-10#1)
plastocyanin in##4##2##(2006-10#3)(2009-10#1)
plastocyanin is##2##2##(1994-12#1)(1994-5#1)
plastocyanin isoforms##3##2##(2009-10#3)
plastocyanin##43##1##(1990-5#2)(1993-11#1)(1993-6#1)(1994-12#6)(1994-5#6)(1996-9#7)(1997-1#2)(2006-10#8)(2009-10#10)
plastocyanins##4##1##(1994-5#3)(1996-9#1)
plastoquinone synthesis##2##2##(1994-11#2)
plastoquinone##5##1##(1994-11#3)(1994-8#1)(2010-10#1)
plastron##2##1##(2007-2#1)(2007-3#1)
plasty of the##2##3##(2006-6#1)(2008-10#1)
plasty was##2##2##(2007-9#1)(2009-6#1)
plasty with##2##2##(2007-11#1)(2012-1#1)
plasty##13##1##(1992-3#1)(1993-5#1)(2006-6#1)(2007-11#3)(2007-8#2)(2007-9#2)(2008-10#1)(2009-6#1)(2012-1#1)
platanus leaves##4##2##(2013-8#4)
platanus##5##1##(2013-8#5)
plate -##2##2##(2013-1#2)
plate allows##2##2##(2008-10#1)(2008-3#1)
plate and a##4##3##(2008-12#1)(2008-2#1)(2008-3#1)(2012-3#1)
plate and screw fixation##2##4##(2007-8#1)(2008-9#1)
plate and screw##3##3##(2006-3#1)(2007-8#1)(2008-9#1)
plate and screws##3##3##(2008-9#1)(2011-2#1)(2012-2#1)
plate and the##8##3##(1995-5#1)(2006-5#1)(2008-10#3)(2008-3#3)
plate and##57##2##(1990-2#1)(1991-12#1)(1991-9#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-5#1)(1996-12#1)(2006-10#1)(2006-3#1)(2006-5#1)(2007-11#4)(2007-12#3)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-12#2)(2008-2#2)(2008-3#7)(2008-5#3)(2008-7#1)(2008-9#2)(2009-5#2)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
plate are##5##2##(2005-11#2)(2007-11#1)(2008-1#1)(2008-3#1)
plate as a##3##3##(2008-2#1)(2008-3#2)
plate as##5##2##(2008-2#2)(2008-3#3)
plate assay##2##2##(2008-11#1)(2008-9#1)
plate assays##5##2##(2007-11#2)(2008-10#3)
plate at a##2##3##(1997-4#1)(2006-3#1)
plate at##6##2##(1997-4#1)(1997-6#1)(2006-3#1)(2007-12#1)(2008-10#1)(2008-3#1)
plate by##5##2##(2008-2#2)(2008-3#2)(2008-8#1)
plate can##4##2##(1992-8#1)(2006-10#1)(2013-1#2)
plate coated with##3##3##(1994-6#1)(2008-11#2)
plate containing a##2##3##(2007-12#1)(2008-8#1)
plate containing##3##2##(2007-12#1)(2008-11#1)(2008-8#1)
plate count method and##2##4##(2007-7#1)(2008-10#1)
plate count##10##2##(1997-4#2)(2006-8#2)(2007-2#1)(2007-3#1)(2007-7#2)(2008-10#2)
plate counts##13##2##(2007-3#2)(2007-6#1)(2007-7#3)(2008-10#4)(2010-4#1)(2011-12#2)
plate diagram sheet##6##3##(2013-1#6)
plate diagram##7##2##(2013-1#7)
plate excited by##2##3##(2008-2#2)
plate fixation or##2##3##(2007-7#1)(2013-7#1)
plate fixation##8##2##(2006-4#1)(2007-7#1)(2009-10#3)(2009-3#1)(2011-2#1)(2013-7#1)
plate for the##3##3##(1997-1#1)(2008-2#1)(2011-2#1)
plate for##10##2##(1997-1#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
plate forces##2##2##(2007-4#2)
plate from##3##2##(1993-8#1)(2008-11#1)(2008-2#1)
plate has been##3##3##(2006-3#1)(2007-12#1)(2008-10#1)
plate has##5##2##(1997-4#1)(2006-3#1)(2007-12#1)(2008-10#2)
plate height##4##2##(1997-8#1)(2007-8#1)(2008-10#1)(2013-8#1)
plate imaging##2##2##(2007-11#1)(2007-12#1)
plate in the##4##3##(1990-6#1)(1997-7#1)(2007-11#1)(2008-2#1)
plate in##15##2##(1990-6#1)(1997-7#1)(2006-12#1)(2007-11#5)(2007-4#1)(2007-8#1)(2008-11#1)(2008-2#1)(2009-5#1)(2012-1#1)(2012-12#1)
plate into##2##2##(1994-3#1)(2007-11#1)
plate is a##3##3##(2006-1#1)(2008-7#1)(2010-2#1)
plate is##25##2##(2006-1#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#4)(2008-3#5)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#1)(2010-2#1)(2010-5#1)
plate lysis##2##2##(2009-6#2)
plate mesoderm##4##2##(2008-11#1)(2012-12#3)
plate method for##2##3##(2006-12#1)(2008-10#1)
plate method##8##2##(2006-12#1)(2008-10#3)(2008-5#1)(2010-3#2)(2011-1#1)
plate models##2##2##(2011-2#2)
plate numbers##4##2##(1994-9#1)(2008-10#3)
plate of the##5##3##(1993-9#1)(1997-1#1)(2007-11#2)(2008-3#1)
plate of##10##2##(1993-9#1)(1997-1#1)(2007-11#2)(2008-10#3)(2008-3#1)(2008-8#2)
plate or a##3##3##(2005-11#2)(2007-11#1)
plate or##4##2##(2005-11#2)(2006-12#1)(2007-11#1)
plate osteosynthesis##4##2##(2007-11#1)(2008-9#1)(2009-3#2)
plate painters##4##2##(1994-6#4)
plate procedure##2##2##(1991-2#1)(2013-1#1)
plate provides##2##2##(2007-11#1)(2007-12#1)
plate reader##6##2##(1990-11#1)(2008-10#2)(2008-4#2)(2010-8#1)
plate separation##2##2##(1991-8#1)(2007-11#1)
plate stabilisation##3##2##(2007-11#3)
plate surface##3##2##(2008-10#1)(2008-8#2)
plate technique##3##2##(2006-10#1)(2007-11#2)
plate tectonics##2##2##(2006-5#2)
plate test##18##2##(1990-2#2)(1992-3#1)(1993-9#4)(1994-2#5)(1996-2#2)(2006-12#2)(2011-2#1)(2013-8#1)
plate tests##4##2##(1994-3#1)(2006-11#1)(2008-10#2)
plate that allows##3##3##(2006-3#2)(2007-12#1)
plate that was##3##3##(2006-11#1)(2007-7#1)(2008-3#1)
plate that##13##2##(1994-12#1)(1996-11#1)(2006-11#1)(2006-3#2)(2007-11#1)(2007-12#2)(2007-7#1)(2008-2#3)(2008-3#1)
plate to a##2##3##(2008-2#2)
plate to##6##2##(2007-12#1)(2008-2#3)(2009-5#1)(2010-11#1)
plate using##2##2##(1991-8#1)(2005-10#1)
plate was used to##2##4##(2008-10#1)(2010-9#1)
plate was used##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2010-9#1)
plate was##16##2##(1991-9#1)(1994-2#1)(1996-3#1)(1997-7#1)(2007-1#1)(2007-11#6)(2008-10#1)(2008-11#1)(2008-2#1)(2010-9#1)(2012-1#1)
plate with a##4##3##(1991-8#1)(2008-10#1)(2008-3#2)
plate with the##2##3##(2008-3#2)
plate with##15##2##(1991-8#1)(2007-12#3)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#1)(2009-5#1)
plate##678##1##(1990-11#2)(1990-2#4)(1990-4#2)(1990-6#1)(1991-12#2)(1991-2#2)(1991-6#1)(1991-8#4)(1991-9#5)(1992-3#1)(1992-6#1)(1992-8#4)(1993-12#3)(1993-4#1)(1993-8#1)(1993-9#5)(1994-12#4)(1994-2#8)(1994-3#2)(1994-5#1)(1994-6#8)(1994-8#2)(1994-9#1)(1995-10#2)(1995-5#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-7#1)(1997-1#2)(1997-3#1)(1997-4#4)(1997-6#1)(1997-7#2)(1997-8#1)(2004-4#1)(2005-10#3)(2005-11#8)(2005-12#2)(2006-1#3)(2006-10#4)(2006-11#3)(2006-12#12)(2006-2#1)(2006-3#16)(2006-4#2)(2006-5#4)(2006-8#4)(2007-1#2)(2007-11#54)(2007-12#33)(2007-2#3)(2007-3#3)(2007-4#4)(2007-6#1)(2007-7#11)(2007-8#9)(2007-9#4)(2008-1#5)(2008-10#71)(2008-11#19)(2008-12#4)(2008-2#60)(2008-3#52)(2008-4#5)(2008-5#14)(2008-6#1)(2008-7#14)(2008-8#12)(2008-9#17)(2009-10#10)(2009-12#1)(2009-3#5)(2009-5#12)(2009-6#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#9)(2010-4#1)(2010-5#4)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#17)(2012-1#2)(2012-12#18)(2012-2#9)(2012-3#4)(2013-1#19)(2013-7#1)(2013-8#2)
plate'##2##1##(2005-5#1)(2007-12#1)
plate) and##2##2##(2011-2#2)
plate) of##2##2##(1990-4#1)(2007-7#1)
plate)##15##1##(1990-4#1)(2004-4#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2011-2#5)(2012-11#2)
plate-based##2##1##(1997-6#1)(2011-1#1)
plate-like crystals##2##2##(1994-2#1)(2005-11#1)
plate-like##6##1##(1994-2#1)(2005-11#2)(2005-12#1)(2008-5#1)(2010-7#1)
plate-oriented##3##1##(2008-2#3)
plate-screw combinations##2##2##(2011-2#2)
plate-screw##4##1##(2008-12#1)(2011-2#3)
plate]##2##1##(2008-12#1)(2008-2#1)
plateau after##4##2##(1990-7#1)(1997-5#2)(2005-7#1)
plateau and##5##2##(1997-6#1)(2005-11#1)(2008-10#2)(2010-10#1)
plateau at 25##2##3##(1991-10#1)(2005-11#1)
plateau at##4##2##(1991-10#1)(2005-11#1)(2011-2#1)(2012-2#1)
plateau collapse##2##2##(2013-1#2)
plateau contraction induced by SP (60##2##6##(1996-3#2)
plateau contraction induced by SP##3##5##(1996-3#3)
plateau contraction induced by##4##4##(1996-3#4)
plateau contraction of##2##3##(1996-3#2)
plateau contraction##9##2##(1996-3#8)(1996-5#1)
plateau in the##3##3##(2007-4#1)(2008-10#1)(2010-8#1)
plateau in##10##2##(1991-6#1)(1995-4#1)(2006-11#1)(2007-4#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-3#1)(2010-8#1)
plateau level at##2##3##(1996-7#1)(1997-1#1)
plateau level of##2##3##(1993-9#1)(1994-6#1)
plateau level##7##2##(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#2)(1996-7#1)(1997-1#1)
plateau of##5##2##(1997-5#1)(2005-11#1)(2008-5#1)(2010-3#1)(2011-1#1)
plateau phase of##3##3##(1990-11#1)(1991-2#1)(2010-10#1)
plateau phase##8##2##(1990-11#2)(1990-7#1)(1991-2#1)(1994-6#1)(1997-2#1)(2010-10#2)
plateau region##4##2##(1992-1#1)(2005-11#1)(2008-5#1)(2011-1#1)
plateau stresses and elastic moduli##2##5##(2009-7#2)
plateau value##4##2##(1990-7#1)(1991-9#1)(1995-1#1)(2005-11#1)
plateau##130##1##(1990-11#3)(1990-12#1)(1990-7#3)(1991-10#1)(1991-2#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-3#2)(1992-9#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#5)(1994-8#1)(1995-1#1)(1995-4#1)(1995-6#1)(1996-3#8)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-5#3)(1997-6#2)(1997-7#1)(2005-11#12)(2005-7#3)(2006-11#1)(2006-9#1)(2007-1#2)(2007-4#4)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#1)(2008-9#2)(2009-4#1)(2009-7#2)(2010-10#3)(2010-12#1)(2010-3#4)(2010-8#1)(2011-1#2)(2011-11#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#10)
plateaued and##2##2##(2007-9#1)(2008-4#1)
plateaued##5##1##(1993-7#1)(2007-9#1)(2008-4#1)(2008-6#1)(2010-5#1)
plateauing##3##1##(1996-7#1)(2006-9#1)(2008-10#1)
plateaus##10##1##(1990-7#1)(1993-6#1)(1995-10#1)(2005-11#2)(2007-9#1)(2008-10#1)(2011-11#1)(2012-2#2)
plateaux##2##1##(2008-5#2)
plated in situ##2##3##(2008-10#2)
plated in##10##2##(1991-2#1)(1994-6#1)(1997-4#1)(2008-10#4)(2008-12#1)(2013-1#2)
plated on a##4##3##(2007-12#1)(2008-10#2)(2012-4#1)
plated on capsules extended##2##4##(1997-3#2)
plated on the##3##3##(1991-8#1)(1992-6#1)(2012-4#1)
plated on##17##2##(1991-8#2)(1992-6#1)(1994-6#1)(1997-3#3)(2005-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2012-4#2)
plated with##2##2##(1994-8#1)(2008-10#1)
plated##52##1##(1990-3#1)(1990-4#1)(1991-1#2)(1991-2#1)(1991-8#2)(1992-6#1)(1993-8#1)(1994-6#2)(1994-8#1)(1995-11#1)(1997-3#4)(1997-4#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#1)(2008-10#12)(2008-11#5)(2008-12#1)(2008-5#1)(2010-8#4)(2011-2#1)(2012-4#2)(2013-1#2)
platelet (PLT)##2##2##(2005-10#1)(2009-10#1)
platelet CD36##2##2##(1990-7#2)
platelet GP##3##2##(1990-11#1)(2006-6#1)(2007-11#1)
platelet GPIIbIIIa##2##2##(2006-12#2)
platelet MAO activity##3##3##(1995-11#1)(2008-3#2)
platelet MAO##4##2##(1995-11#2)(2008-3#2)
platelet NOS##2##2##(2008-5#1)(2011-1#1)
platelet actin [beta##2##3##(1990-5#2)
platelet activating factor (PAF) receptor##2##5##(1991-5#1)(1995-3#1)
platelet activating factor (PAF)##6##4##(1991-5#1)(1991-8#1)(1992-11#1)(1995-3#1)(1996-5#1)(2007-1#1)
platelet activating factor##12##3##(1991-5#2)(1991-7#1)(1991-8#1)(1992-11#1)(1994-3#1)(1995-2#2)(1995-3#1)(1996-5#1)(2007-1#1)(2008-1#1)
platelet activation and aggregation##2##4##(2006-6#2)
platelet activation and##6##3##(1992-6#1)(2006-6#2)(2008-7#1)(2008-9#1)(2011-2#1)
platelet activation as##2##3##(2011-2#1)(2012-11#1)
platelet activation by##2##3##(1994-6#1)(2008-9#1)
platelet activation in##2##3##(1990-12#1)(1997-7#1)
platelet activation induced by##2##4##(1990-5#1)(1990-7#1)
platelet activation of##2##3##(2006-6#1)(2008-4#1)
platelet activation was##3##3##(1990-12#1)(1992-12#1)(1994-12#1)
platelet activation##51##2##(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-4#1)(1992-6#3)(1992-8#1)(1994-12#4)(1994-3#1)(1994-6#1)(1995-12#1)(1997-6#1)(1997-7#4)(2005-7#1)(2006-6#5)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#3)(2009-8#2)(2011-2#5)(2012-11#1)
platelet activity and##2##3##(1997-7#1)(2011-2#1)
platelet activity##6##2##(1990-11#1)(1995-12#2)(1997-7#2)(2011-2#1)
platelet adhesion and##2##3##(2005-1#1)(2012-11#1)
platelet adhesion to collagen in##2##5##(1990-12#2)
platelet adhesion to collagen##4##4##(1990-12#4)
platelet adhesion##10##2##(1990-12#4)(1994-12#1)(2004-10#1)(2004-9#1)(2005-1#1)(2006-10#1)(2012-11#1)
platelet aggregability in##2##3##(1991-12#1)(2008-7#1)
platelet aggregability##5##2##(1991-12#3)(2008-7#1)(2011-1#1)
platelet aggregation and release##2##4##(1990-11#2)
platelet aggregation and##23##3##(1990-11#2)(1990-12#3)(1990-8#1)(1991-12#1)(1991-9#3)(1992-4#1)(1992-8#2)(1994-12#1)(1995-3#2)(1996-7#2)(1997-7#1)(2006-10#2)(2006-5#1)(2011-1#1)
platelet aggregation assay##2##3##(1992-5#2)
platelet aggregation but##2##3##(1991-8#1)(2008-8#1)
platelet aggregation by##10##3##(1990-10#1)(1995-12#3)(1996-12#1)(1996-2#1)(1997-7#1)(2008-11#1)(2008-5#2)
platelet aggregation from the##2##4##(1990-12#1)(2008-8#1)
platelet aggregation in response to##3##5##(1992-4#1)(2008-3#1)(2008-5#1)
platelet aggregation in vitro and##4##5##(1995-12#1)(2006-6#3)
platelet aggregation in vitro##6##4##(1990-5#1)(1995-12#1)(2006-6#4)
platelet aggregation in##16##3##(1990-12#1)(1990-5#1)(1991-11#2)(1992-4#1)(1995-12#2)(1995-5#1)(2006-6#4)(2007-7#1)(2008-3#1)(2008-5#1)(2011-2#1)
platelet aggregation induced by arachidonic acid##2##6##(1997-7#1)(2006-12#1)
platelet aggregation induced by##8##4##(1990-11#1)(1992-8#1)(1997-6#2)(1997-7#1)(2006-10#1)(2006-12#1)(2010-6#1)
platelet aggregation induced##10##3##(1990-11#1)(1992-8#2)(1997-6#2)(1997-7#2)(2006-10#1)(2006-12#1)(2010-6#1)
platelet aggregation is##3##3##(1992-8#2)(1994-12#1)
platelet aggregation of##2##3##(1991-12#1)(1991-3#1)
platelet aggregation or calpain activity##2##5##(1994-12#2)
platelet aggregation was##9##3##(1991-10#1)(1991-11#1)(1991-12#1)(1994-5#1)(1995-12#3)(1995-5#1)(1997-2#1)
platelet aggregation which##2##3##(1990-10#1)(2006-8#1)
platelet aggregation with##3##3##(1990-12#1)(1991-10#1)(1992-7#1)
platelet aggregation##153##2##(1990-10#3)(1990-11#3)(1990-12#7)(1990-5#4)(1990-8#1)(1991-10#3)(1991-11#3)(1991-12#6)(1991-3#1)(1991-8#3)(1991-9#5)(1992-4#2)(1992-5#4)(1992-7#1)(1992-8#7)(1993-3#2)(1993-8#1)(1994-12#5)(1994-5#2)(1994-8#1)(1995-1#1)(1995-12#10)(1995-3#4)(1995-5#2)(1995-8#1)(1996-12#1)(1996-2#2)(1996-7#2)(1997-2#1)(1997-5#1)(1997-6#2)(1997-7#4)(2004-12#1)(2005-7#2)(2005-8#1)(2006-10#3)(2006-12#2)(2006-5#1)(2006-6#8)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-7#1)(2008-11#2)(2008-3#3)(2008-4#5)(2008-5#9)(2008-7#2)(2008-8#3)(2009-3#2)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2013-8#1)
platelet aggregatory##2##2##(1990-12#1)(1995-2#1)
platelet alpha-granule protein##2##3##(1991-2#1)(1992-8#1)
platelet alpha-granule##3##2##(1991-2#1)(1992-8#1)(1995-3#1)
platelet alpha-granules##4##2##(1997-7#3)(2010-3#1)
platelet and endothelial##2##3##(1990-7#1)(1991-9#1)
platelet and leukocyte activation##2##4##(2006-6#2)
platelet and##15##2##(1990-7#1)(1991-9#1)(1992-8#1)(1995-3#1)(1996-7#1)(2006-6#2)(2007-10#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-7#2)(2012-11#1)
platelet binding##2##2##(1990-9#1)(2008-9#1)
platelet cAMP##6##2##(1992-9#2)(1993-3#3)(1994-8#1)
platelet cholesterol content##2##3##(1997-7#2)
platelet cholesterol##3##2##(1992-12#1)(1997-7#2)
platelet components##2##2##(2005-10#2)
platelet concentrate##3##2##(1991-8#1)(2011-12#1)(2012-11#1)
platelet count &lt##2##3##(2007-10#1)(2009-8#1)
platelet count (PC)##2##3##(2008-10#1)(2008-7#1)
platelet count above##2##3##(1990-12#1)(2008-4#1)
platelet count and the##2##4##(1991-8#1)(2013-8#1)
platelet count and##7##3##(1991-8#1)(1993-5#1)(2007-10#3)(2008-10#1)(2013-8#1)
platelet count in##3##3##(1990-12#1)(2006-6#1)(2007-10#1)
platelet count##45##2##(1990-12#2)(1990-3#1)(1991-8#1)(1992-2#3)(1993-5#1)(1993-6#1)(1997-6#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-6#2)(2007-10#7)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#3)
platelet counting##3##2##(2008-10#3)
platelet counts and##3##3##(2007-10#1)(2008-10#1)(2010-3#1)
platelet counts at##2##3##(1990-12#1)(2007-11#1)
platelet counts in patients with##2##5##(1990-12#1)(2007-10#1)
platelet counts in##4##3##(1990-12#2)(2007-10#1)(2008-10#1)
platelet counts##23##2##(1990-10#2)(1990-12#4)(2007-10#3)(2007-11#1)(2008-10#4)(2008-7#1)(2008-8#1)(2010-3#3)(2010-5#1)(2011-2#2)(2013-7#1)
platelet cross-matching##4##2##(2011-2#4)
platelet degranulation##3##2##(1992-12#2)(1995-2#1)
platelet deposition in##2##3##(1990-11#2)
platelet deposition##8##2##(1990-11#4)(1992-9#1)(2006-6#3)
platelet derived growth factor (PDGF)##2##5##(1991-12#1)(2008-1#1)
platelet derived growth factor##8##4##(1990-6#2)(1991-12#1)(1994-3#1)(2008-1#1)(2012-2#2)(2013-1#1)
platelet derived##10##2##(1990-6#2)(1991-12#1)(1994-3#1)(2008-1#2)(2008-11#1)(2012-2#2)(2013-1#1)
platelet destruction##2##2##(1993-6#2)
platelet disorder##2##2##(1997-7#1)(2006-6#1)
platelet dysfunction##7##2##(2007-10#4)(2008-10#1)(2009-1#1)(2011-12#1)
platelet factor 4 and##3##4##(1990-10#1)(1995-3#1)(2005-7#1)
platelet factor 4 was##2##4##(1990-5#1)(1992-8#1)
platelet factor 4##12##3##(1990-10#1)(1990-12#1)(1990-5#1)(1992-8#4)(1995-3#3)(2005-7#1)(2013-1#1)
platelet factor##16##2##(1990-10#1)(1990-12#1)(1990-5#2)(1992-8#5)(1995-3#3)(2005-7#1)(2007-12#2)(2013-1#1)
platelet fatty##2##2##(1991-12#2)
platelet fibrinogen receptor##5##3##(1993-8#1)(1997-7#1)(2006-6#3)
platelet free##2##2##(1992-12#1)(1997-7#1)
platelet function and##3##3##(1992-10#1)(2009-1#1)(2009-5#1)
platelet function##33##2##(1990-12#1)(1991-11#2)(1991-12#3)(1992-10#1)(1992-9#1)(1993-8#1)(1996-5#1)(1997-4#1)(1997-6#1)(2004-12#3)(2005-9#1)(2006-10#1)(2006-6#2)(2007-10#3)(2007-8#1)(2008-1#3)(2008-11#1)(2008-3#1)(2008-7#1)(2009-1#1)(2009-5#1)(2010-5#1)(2012-12#1)
platelet glycoprotein (GP)##2##3##(1993-3#1)(2007-11#1)
platelet glycoprotein IIb-IIIa complex##2##4##(1991-10#2)
platelet glycoprotein IIb/IIIa##2##3##(2007-11#1)(2009-12#1)
platelet glycoprotein##9##2##(1990-7#1)(1991-10#2)(1993-3#1)(2004-10#1)(2007-11#2)(2008-11#1)(2009-12#1)
platelet homogenates##2##2##(1994-8#2)
platelet hyperactivity##3##2##(1997-7#2)(2010-12#1)
platelet hyperaggregability##2##2##(1991-11#1)(1997-6#1)
platelet inhibition##8##2##(1990-10#1)(2006-12#1)(2007-11#1)(2008-3#3)(2009-5#2)
platelet inhibitor##2##2##(1991-4#1)(2008-8#1)
platelet integrin alpha IIb beta 3##2##6##(1994-12#2)
platelet integrin##4##2##(1994-12#3)(1997-7#1)
platelet levels##3##2##(1990-12#1)(1991-9#1)(2012-12#1)
platelet loss##2##2##(2008-1#1)(2011-2#1)
platelet lysate medium##2##3##(2008-11#2)
platelet lysate was##3##3##(2008-11#3)
platelet lysate##9##2##(2008-11#9)
platelet lysates##3##2##(1990-10#1)(2012-6#2)
platelet mRNA##3##2##(1990-12#1)(1994-12#1)(2006-6#1)
platelet magnesium##3##2##(2008-7#3)
platelet membrane##8##2##(1990-12#3)(1990-8#1)(1994-12#1)(1995-11#1)(1996-5#1)(2006-6#1)
platelet membranes and##2##3##(1990-12#1)(1992-6#1)
platelet membranes with##2##3##(1992-3#1)(1995-11#1)
platelet membranes##13##2##(1990-12#1)(1992-3#2)(1992-6#3)(1993-6#1)(1995-11#1)(1995-3#1)(1997-7#1)(2007-10#1)(2008-11#1)(2008-6#1)
platelet monoamine oxidase activity##2##4##(1995-1#1)(2008-3#1)
platelet monoamine oxidase##5##3##(1995-1#1)(1995-11#1)(1995-8#1)(2008-3#2)
platelet numbers##3##2##(1990-12#3)
platelet plasma membrane##2##3##(1992-11#1)(1997-3#1)
platelet plasma##3##2##(1990-9#1)(1992-11#1)(1997-3#1)
platelet production##3##2##(2006-6#1)(2008-5#1)(2008-8#1)
platelet protein##2##2##(1990-5#1)(1991-2#1)
platelet reactivity in##2##3##(2008-4#1)(2013-7#1)
platelet reactivity##7##2##(2008-4#1)(2008-9#1)(2009-5#4)(2013-7#1)
platelet recovery##3##2##(2007-11#1)(2010-4#2)
platelet release##3##2##(1990-10#1)(1994-10#1)(2006-6#1)
platelet response and##2##3##(2008-1#1)(2011-2#1)
platelet response##3##2##(1990-5#1)(2008-1#1)(2011-2#1)
platelet rich plasma (PRP)##3##4##(2007-9#2)(2013-1#1)
platelet rich plasma##4##3##(1992-12#1)(2007-9#2)(2013-1#1)
platelet size##3##2##(1990-12#1)(1997-6#1)(2006-6#1)
platelet stimulation with##3##3##(1992-6#2)(2008-9#1)
platelet storage pool disease##2##4##(2007-10#2)
platelet storage pool##3##3##(1997-7#1)(2007-10#2)
platelet substitution##2##2##(1997-6#1)(2007-8#1)
platelet sulphate conjugated NA##2##4##(1997-7#2)
platelet sulphate conjugated##3##3##(1997-7#3)
platelet surface##7##2##(1990-5#1)(1994-12#1)(1996-7#1)(2006-6#1)(2008-9#2)(2010-4#1)
platelet suspensions from##2##3##(1990-12#2)
platelet suspensions##3##2##(1990-12#3)
platelet syndrome##3##2##(1997-6#2)(1997-7#1)
platelet thrombin##2##2##(1991-9#1)(1992-4#1)
platelet thrombospondin 1##3##3##(1996-7#3)
platelet thrombospondin##5##2##(1991-6#1)(1996-7#3)(2006-10#1)
platelet thromboxane##2##2##(1995-12#1)(1995-3#1)
platelet thrombus formation##4##3##(2006-6#4)
platelet to lymphocyte ratio##4##4##(2013-1#4)
platelet transfusion##9##2##(1991-3#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-9#1)(2011-2#3)(2012-2#1)
platelet transfusions associated with##2##4##(2011-2#2)
platelet transfusions##8##2##(2006-10#1)(2008-11#1)(2008-3#1)(2011-2#4)(2013-8#1)
platelet volume##6##2##(1991-12#1)(2005-10#1)(2008-10#1)(2008-7#1)(2013-8#2)
platelet##776##1##(1990-1#1)(1990-10#9)(1990-11#14)(1990-12#50)(1990-2#2)(1990-3#2)(1990-5#12)(1990-6#2)(1990-7#7)(1990-8#3)(1990-9#4)(1991-10#6)(1991-11#8)(1991-12#16)(1991-2#3)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#8)(1991-9#8)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#11)(1992-2#3)(1992-3#2)(1992-4#4)(1992-5#5)(1992-6#9)(1992-7#1)(1992-8#16)(1992-9#4)(1993-11#1)(1993-3#7)(1993-4#1)(1993-5#2)(1993-6#7)(1993-8#3)(1994-10#3)(1994-11#1)(1994-12#18)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#5)(1995-1#2)(1995-11#5)(1995-12#14)(1995-2#5)(1995-3#14)(1995-5#2)(1995-8#2)(1996-12#1)(1996-2#3)(1996-3#2)(1996-5#3)(1996-7#11)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#11)(1997-7#29)(2004-10#2)(2004-12#4)(2004-9#1)(2005-1#1)(2005-10#7)(2005-7#5)(2005-8#3)(2005-9#1)(2006-10#9)(2006-12#7)(2006-2#1)(2006-5#1)(2006-6#43)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#23)(2007-11#15)(2007-12#10)(2007-6#2)(2007-7#1)(2007-8#5)(2007-9#5)(2008-1#10)(2008-10#16)(2008-11#20)(2008-2#1)(2008-3#13)(2008-4#10)(2008-5#13)(2008-6#1)(2008-7#14)(2008-8#10)(2008-9#10)(2009-1#2)(2009-10#1)(2009-12#2)(2009-3#2)(2009-5#8)(2009-7#1)(2009-8#4)(2010-12#10)(2010-3#5)(2010-4#7)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#6)(2011-12#2)(2011-2#32)(2012-11#4)(2012-12#2)(2012-2#5)(2012-6#2)(2013-1#10)(2013-7#3)(2013-8#8)
platelet-activating factor (PAF) and its##2##5##(1990-2#1)(2009-3#1)
platelet-activating factor (PAF) and##3##4##(1990-2#1)(1996-6#1)(2009-3#1)
platelet-activating factor (PAF)##10##3##(1990-2#1)(1991-11#1)(1991-5#1)(1993-10#1)(1993-4#1)(1996-6#1)(1997-7#2)(2007-11#1)(2009-3#1)
platelet-activating factor acetylhydrolase##2##3##(1997-7#1)(2012-12#1)
platelet-activating factor and##4##3##(1990-5#1)(1992-1#1)(1996-6#1)(2006-10#1)
platelet-activating factor antagonist##2##3##(2006-10#1)(2007-11#1)
platelet-activating factor receptor in monocytic and B cell lines##2##9##(1993-12#2)
platelet-activating factor receptor##5##3##(1993-12#4)(1996-2#1)
platelet-activating factor##35##2##(1990-2#4)(1990-5#1)(1990-7#1)(1991-11#1)(1991-5#2)(1992-1#1)(1992-3#1)(1993-10#1)(1993-12#4)(1993-4#1)(1996-2#1)(1996-6#2)(1997-3#1)(1997-7#3)(2006-10#2)(2007-1#1)(2007-11#3)(2007-9#1)(2008-10#1)(2008-3#1)(2009-3#1)(2012-12#1)
platelet-activating factor-induced##2##2##(1991-8#1)(1992-3#1)
platelet-activating##39##1##(1990-2#4)(1990-5#1)(1990-7#1)(1991-11#1)(1991-5#2)(1991-8#1)(1992-1#1)(1992-3#2)(1993-10#1)(1993-12#4)(1993-4#1)(1994-5#1)(1996-2#1)(1996-6#2)(1997-3#1)(1997-7#3)(2006-10#3)(2007-1#1)(2007-11#3)(2007-9#1)(2008-10#1)(2008-3#1)(2009-3#1)(2012-12#1)
platelet-aggregating enzyme##2##2##(1995-5#2)
platelet-aggregating##5##1##(1995-5#4)(2006-12#1)
platelet-dependent##2##1##(1990-12#2)
platelet-derived growth factor (PDGF) and##3##5##(1992-11#1)(1997-6#1)(2007-11#1)
platelet-derived growth factor (PDGF) receptor##2##5##(1996-6#1)(1996-8#1)
platelet-derived growth factor (PDGF)##22##4##(1990-3#2)(1991-7#1)(1991-9#1)(1992-11#1)(1993-7#1)(1994-10#1)(1994-12#1)(1995-11#2)(1995-3#3)(1996-6#1)(1996-8#1)(1997-6#1)(2005-8#1)(2006-1#1)(2007-11#1)(2008-11#1)(2008-3#1)(2009-4#1)
platelet-derived growth factor (PDGF)-induced##2##4##(1995-1#1)(1995-2#1)
platelet-derived growth factor B##2##4##(1991-3#1)(2013-1#1)
platelet-derived growth factor beta-receptor##2##4##(1990-3#1)(1992-2#1)
platelet-derived growth factor receptor (PDGFR)##2##5##(1996-9#1)(2013-1#1)
platelet-derived growth factor receptor tyrosine kinase##2##6##(1996-6#1)(1996-9#1)
platelet-derived growth factor receptor##8##4##(1994-3#1)(1996-6#1)(1996-8#1)(1996-9#2)(2009-3#1)(2013-1#1)(2013-8#1)
platelet-derived growth factor receptors##4##4##(1995-3#1)(1996-8#1)(2006-6#1)(2008-5#1)
platelet-derived growth factor##59##3##(1990-3#4)(1990-7#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-7#1)(1993-7#1)(1993-8#1)(1994-10#2)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#3)(1995-2#1)(1995-3#6)(1995-6#1)(1996-5#3)(1996-6#2)(1996-8#3)(1996-9#2)(1997-6#2)(1997-7#2)(2005-8#1)(2006-1#1)(2006-6#1)(2007-11#2)(2008-11#1)(2008-3#1)(2008-5#1)(2009-3#2)(2009-4#1)(2009-8#1)(2013-1#2)(2013-8#1)
platelet-derived growth factor-A chain and##2##5##(1995-11#1)(1995-2#1)
platelet-derived growth factor-AA##2##3##(1991-12#1)(1995-11#1)
platelet-derived growth factor-stimulated##2##3##(1995-6#2)
platelet-derived growth factors##4##3##(1992-7#1)(1992-8#1)(2007-7#1)(2011-2#1)
platelet-derived growth##72##2##(1990-3#4)(1990-7#1)(1991-12#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-7#2)(1992-8#1)(1993-7#1)(1993-8#1)(1994-10#2)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#5)(1995-2#3)(1995-3#6)(1995-6#3)(1996-10#1)(1996-5#3)(1996-6#2)(1996-8#3)(1996-9#2)(1997-6#2)(1997-7#3)(2005-8#1)(2006-1#1)(2006-6#1)(2007-11#2)(2007-7#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-3#2)(2009-4#1)(2009-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
platelet-derived##83##1##(1990-10#1)(1990-12#1)(1990-3#4)(1990-7#1)(1991-12#1)(1991-3#1)(1991-6#2)(1991-7#1)(1991-9#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-7#2)(1992-8#1)(1993-7#1)(1993-8#1)(1994-10#2)(1994-12#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#5)(1995-2#3)(1995-3#6)(1995-6#3)(1996-10#1)(1996-11#1)(1996-5#3)(1996-6#2)(1996-8#3)(1996-9#2)(1997-6#2)(1997-7#3)(2005-8#1)(2006-1#1)(2006-6#1)(2007-11#2)(2007-7#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-3#2)(2009-4#1)(2009-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
platelet-factor##2##1##(1990-10#2)
platelet-leukocyte conjugate formation in whole blood##3##6##(2006-6#3)
platelet-leukocyte##4##1##(2006-6#4)
platelet-monocyte##2##1##(2006-6#2)
platelet-poor plasma##4##2##(1992-12#1)(1994-10#1)(1995-2#2)
platelet-related##2##1##(1997-4#1)(2011-1#1)
platelet-rich plasma (PRP)##5##3##(1990-1#1)(1997-7#1)(2008-7#1)(2012-12#2)
platelet-rich plasma and##3##3##(1993-11#1)(2008-1#1)(2010-4#1)
platelet-rich plasma can be used in this field for its ability to stimulate tissue regeneration##2##15##(2012-12#2)
platelet-rich plasma concentrate##2##3##(2010-4#2)
platelet-rich plasma##29##2##(1990-1#1)(1990-12#1)(1991-12#1)(1991-9#1)(1993-11#2)(1995-12#1)(1995-5#1)(1996-12#2)(1997-7#1)(2006-6#1)(2008-1#1)(2008-7#1)(2010-12#1)(2010-4#3)(2012-12#10)(2013-8#1)
platelet-rich##31##1##(1990-1#1)(1990-12#1)(1991-12#1)(1991-9#1)(1993-11#2)(1994-10#1)(1995-12#1)(1995-5#1)(1996-12#2)(1997-7#1)(2006-6#1)(2008-1#1)(2008-7#1)(2010-12#1)(2010-4#3)(2012-11#1)(2012-12#10)(2013-8#1)
platelet-sized particles##2##2##(2010-12#2)
platelet-specific##3##1##(1991-2#1)(2008-9#2)
plateletpheresis##4##1##(2007-9#3)(2011-2#1)
platelets activation##3##2##(2008-8#3)
platelets after stimulation with##2##4##(1997-3#1)(1997-6#1)
platelets after##3##2##(1990-8#1)(1997-3#1)(1997-6#1)
platelets aggregate with##2##3##(2008-1#1)(2008-9#1)
platelets also##2##2##(2006-6#2)
platelets and coagulation factors##2##4##(2012-2#1)(2012-3#1)
platelets and endothelial cells##3##4##(1991-12#1)(1993-3#1)(2009-3#1)
platelets and its##4##3##(1990-11#1)(1992-12#1)(1992-6#1)(1995-11#1)
platelets and monocytes##2##3##(2006-6#1)(2008-9#1)
platelets and plasma##2##3##(1995-2#1)(2008-11#1)
platelets and##45##2##(1990-11#1)(1990-12#1)(1990-9#2)(1991-12#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-9#2)(1993-3#1)(1993-8#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-11#1)(1995-2#1)(1996-7#1)(2005-10#1)(2006-6#5)(2007-11#2)(2008-11#1)(2008-4#3)(2008-7#1)(2008-9#2)(2009-3#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
platelets are##6##2##(1990-11#1)(1992-12#1)(2006-6#1)(2007-11#1)(2008-11#1)(2011-2#1)
platelets as##5##2##(1990-12#1)(1990-5#2)(1995-8#1)(2012-2#1)
platelets at##3##2##(1991-8#1)(1992-6#1)(2008-1#1)
platelets by the##2##3##(1990-11#1)(1992-1#1)
platelets by##17##2##(1990-11#1)(1990-12#1)(1990-5#2)(1991-8#2)(1992-1#2)(1992-12#1)(1992-4#1)(1992-6#1)(1996-2#1)(2006-6#2)(2008-7#1)(2008-9#1)(2011-1#1)
platelets can be##2##3##(2008-10#1)(2008-9#1)
platelets can##4##2##(1991-2#1)(2006-6#1)(2008-10#1)(2008-9#1)
platelets contain##2##2##(1990-12#1)(2006-6#1)
platelets from##13##2##(1990-11#2)(1990-12#1)(1991-12#1)(1991-6#4)(1992-12#1)(1992-8#1)(1996-7#1)(2005-8#1)(2006-6#1)
platelets had##2##2##(2006-6#2)
platelets has been##2##3##(1992-12#1)(1994-12#1)
platelets has##3##2##(1992-12#1)(1994-12#1)(2006-6#1)
platelets in plasma##2##3##(1990-5#1)(2008-8#1)
platelets in response to##2##4##(1991-4#1)(2008-8#1)
platelets in the presence of##2##5##(1993-6#1)(1997-4#1)
platelets in the##6##3##(1990-5#1)(1993-6#1)(1997-4#1)(2007-11#1)(2011-2#1)(2012-12#1)
platelets in vitro##2##3##(1990-5#1)(2008-9#1)
platelets in##25##2##(1990-10#1)(1990-5#3)(1991-12#1)(1991-4#2)(1992-12#1)(1992-9#1)(1993-6#1)(1995-11#1)(1997-4#1)(1997-7#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-5#1)(2008-8#3)(2008-9#2)(2010-12#1)(2011-2#1)(2012-12#1)
platelets induced by##2##3##(1990-10#1)(1990-5#1)
platelets into buffer without TMA-DPH##2##5##(1990-5#2)
platelets is##6##2##(1990-11#1)(1991-9#1)(1992-12#1)(1993-8#1)(2006-6#1)(2008-9#1)
platelets may serve as##2##4##(1992-12#1)(2008-3#1)
platelets may##4##2##(1990-12#1)(1992-12#1)(2006-6#1)(2008-3#1)
platelets occurred##2##2##(1990-10#1)(2012-1#1)
platelets of drug-free patients with schizophrenia##2##6##(1996-2#1)(1996-7#1)
platelets of##7##2##(1990-12#1)(1994-10#1)(1995-11#1)(1996-2#1)(1996-7#1)(2008-3#2)
platelets on##5##2##(2006-6#3)(2008-11#1)(2010-3#1)
platelets or##2##2##(1992-12#1)(1992-8#1)
platelets resulted in##2##3##(1990-10#1)(1992-6#1)
platelets stimulated with##3##3##(1992-12#1)(1995-11#1)(1997-7#1)
platelets than##2##2##(2010-9#1)(2011-2#1)
platelets that##3##2##(1993-6#1)(2005-10#1)(2006-6#1)
platelets to fibrinogen##3##3##(1997-7#3)
platelets to##11##2##(1991-12#1)(1996-5#1)(1997-7#6)(2006-6#1)(2008-11#1)(2008-5#1)
platelets using##3##2##(1990-8#1)(1991-4#1)(2007-1#1)
platelets was investigated##3##3##(1990-5#1)(1994-3#1)(1995-11#1)
platelets was##14##2##(1990-5#1)(1991-4#1)(1992-6#2)(1994-10#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-2#1)(2006-6#1)(2008-3#1)(2008-5#1)(2011-1#1)
platelets were examined##2##3##(1991-9#1)(1993-8#1)
platelets were significantly##3##3##(1990-12#2)(1995-11#1)
platelets were treated with##2##4##(1994-3#1)(1995-11#1)
platelets were##19##2##(1990-12#2)(1991-4#2)(1991-9#1)(1992-11#1)(1992-6#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-11#2)(1997-7#1)(2006-6#3)(2006-8#1)(2011-2#1)(2012-12#1)
platelets which##3##2##(1990-12#1)(1991-9#1)(2009-8#1)
platelets will##2##2##(2006-6#1)(2011-12#1)
platelets with##11##2##(1990-12#2)(1990-5#2)(1992-12#1)(1992-8#1)(1993-11#1)(1993-6#1)(1997-7#1)(2008-9#1)(2011-2#1)
platelets##477##1##(1990-1#2)(1990-10#7)(1990-11#9)(1990-12#26)(1990-2#1)(1990-3#1)(1990-5#17)(1990-7#5)(1990-8#8)(1990-9#3)(1991-10#2)(1991-12#5)(1991-2#2)(1991-4#9)(1991-6#6)(1991-7#1)(1991-8#6)(1991-9#7)(1992-1#5)(1992-11#6)(1992-12#19)(1992-2#1)(1992-4#4)(1992-5#4)(1992-6#16)(1992-8#9)(1992-9#6)(1993-11#5)(1993-3#2)(1993-6#5)(1993-8#10)(1994-10#5)(1994-12#14)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#9)(1995-12#1)(1995-2#3)(1995-3#3)(1995-6#3)(1995-8#2)(1996-12#2)(1996-2#4)(1996-5#2)(1996-7#4)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#17)(2005-10#4)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#48)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#2)(2007-9#4)(2008-1#7)(2008-10#1)(2008-11#5)(2008-3#7)(2008-4#7)(2008-5#7)(2008-7#3)(2008-8#8)(2008-9#16)(2009-11#1)(2009-12#1)(2009-3#3)(2009-8#2)(2010-12#3)(2010-3#2)(2010-9#1)(2011-1#4)(2011-12#5)(2011-2#12)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
platelets) and##2##2##(2008-4#2)
platelets)##4##1##(1995-12#1)(2008-4#2)(2013-8#1)
platelike##3##1##(2005-11#1)(2008-3#2)
platensis##5##1##(2008-10#1)(2008-8#4)
plates after##2##2##(1990-5#1)(2010-6#1)
plates and a##3##3##(1990-12#1)(2006-5#1)(2008-10#1)
plates and cultured##2##3##(1994-3#1)(2013-1#1)
plates and photoresists##2##3##(2008-9#2)
plates and##26##2##(1990-12#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-11#1)(2006-5#2)(2007-11#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#3)(2010-8#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-7#1)
plates are also##2##3##(1997-4#1)(2008-2#1)
plates are##11##2##(1990-12#1)(1997-4#1)(2005-11#1)(2006-3#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#1)
plates as##5##2##(1991-3#1)(1992-7#1)(2006-4#1)(2008-10#1)(2008-5#1)
plates at##3##2##(1990-4#1)(2008-3#1)(2008-7#1)
plates by the##2##3##(1991-9#1)(2008-2#1)
plates by##9##2##(1991-9#1)(2006-12#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-2#1)(2011-2#1)
plates coated with##4##3##(1990-12#3)(2007-12#1)
plates containing##6##2##(1997-6#1)(2007-11#1)(2008-10#3)(2008-5#1)
plates for distal radius fractures##2##5##(2008-9#2)
plates for the##2##3##(1994-9#1)(1996-11#1)
plates for##18##2##(1994-9#2)(1996-11#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-4#2)(2008-9#2)(2009-6#1)(2010-11#1)(2010-6#1)(2011-1#1)
plates from##2##2##(1996-11#1)(2008-9#1)
plates have been##2##3##(2007-11#1)(2008-5#1)
plates have##5##2##(1996-11#1)(2007-11#1)(2008-3#2)(2008-5#1)
plates in a##2##3##(2007-8#1)(2008-10#1)
plates in##13##2##(1992-7#1)(2005-10#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-3#1)
plates indicated##2##2##(1997-3#1)(2008-10#1)
plates is##7##2##(1996-5#1)(2007-11#1)(2008-2#1)(2008-3#3)(2011-1#1)
plates of each type were##2##5##(2008-9#2)
plates of the##3##3##(2007-12#1)(2008-11#1)(2008-3#1)
plates of##13##2##(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#2)(2010-10#1)
plates on##3##2##(2008-11#1)(2008-3#1)(2008-4#1)
plates or##9##2##(1997-3#1)(2007-11#1)(2007-7#1)(2008-12#1)(2008-4#4)(2008-7#1)
plates per meter##2##3##(2008-10#2)
plates precoated with##3##3##(2008-10#1)(2008-11#2)
plates showed##3##2##(2008-11#1)(2009-2#1)(2011-2#1)
plates that##5##2##(2006-8#1)(2008-2#2)(2008-3#2)
plates to##5##2##(2006-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
plates under##3##2##(1990-11#1)(1996-11#1)(2008-11#1)
plates used##4##2##(1990-12#1)(1996-11#1)(2008-3#1)(2011-2#1)
plates using##3##2##(1990-5#1)(2010-4#2)
plates was##8##2##(1992-7#1)(1996-11#1)(2007-12#1)(2008-10#4)(2008-3#1)
plates were##12##2##(1990-12#1)(1990-8#1)(1992-7#1)(1993-8#1)(2006-10#1)(2006-8#1)(2007-9#2)(2008-10#1)(2008-11#1)(2010-2#1)(2012-12#1)
plates with a##3##3##(2007-8#1)(2011-2#1)(2012-12#1)
plates with##13##2##(1994-9#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#2)(2010-5#1)(2011-2#2)(2012-12#1)
plates##393##1##(1990-11#2)(1990-12#11)(1990-4#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#4)(1991-9#1)(1992-5#1)(1992-7#5)(1993-12#1)(1993-5#1)(1993-6#1)(1993-7#2)(1993-8#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#5)(1995-12#1)(1995-3#1)(1995-7#1)(1996-1#1)(1996-11#12)(1996-2#1)(1996-5#3)(1996-8#1)(1997-3#3)(1997-4#3)(1997-6#1)(2004-9#1)(2005-10#2)(2005-11#4)(2006-10#4)(2006-12#1)(2006-3#2)(2006-4#1)(2006-5#5)(2006-6#1)(2006-8#4)(2007-11#23)(2007-12#21)(2007-7#2)(2007-8#5)(2007-9#6)(2008-10#50)(2008-11#17)(2008-12#4)(2008-2#18)(2008-3#40)(2008-4#11)(2008-5#9)(2008-7#11)(2008-8#2)(2008-9#14)(2009-2#2)(2009-3#3)(2009-6#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#19)(2012-12#4)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#4)(2013-7#1)(2013-8#1)
plates)##4##1##(1996-11#1)(2006-12#1)(2008-10#1)(2008-11#1)
plates/m##2##1##(2013-8#2)
platform allows##2##2##(2009-12#1)(2009-2#1)
platform and##8##2##(1995-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
platform as a##2##3##(2009-12#1)(2009-7#1)
platform as##3##2##(2008-4#1)(2009-12#1)(2009-7#1)
platform based on##3##3##(2008-10#2)(2011-1#1)
platform can be used to##2##5##(2008-2#1)(2013-1#1)
platform can be used##3##4##(2008-2#1)(2013-1#2)
platform can be##5##3##(2007-8#1)(2008-10#1)(2008-2#1)(2013-1#2)
platform can##6##2##(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2013-1#2)
platform consists of a##2##4##(2008-11#2)
platform consists of##3##3##(2008-11#2)(2010-12#1)
platform for a##2##3##(2008-10#1)(2008-11#1)
platform for evaluating##3##3##(2008-11#2)(2012-3#1)
platform for functional imaging##2##4##(2011-1#2)
platform for future##3##3##(2008-11#1)(2012-2#2)
platform for the##14##3##(1994-12#1)(1996-3#1)(2005-6#1)(2007-12#1)(2008-1#1)(2008-10#3)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
platform for##82##2##(1994-12#2)(1994-6#1)(1996-3#1)(1997-6#1)(2005-10#1)(2005-12#1)(2005-6#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-4#1)(2007-6#1)(2007-8#2)(2008-1#3)(2008-10#7)(2008-11#8)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#3)(2009-10#2)(2009-2#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#2)(2013-7#2)
platform from which##2##3##(2007-6#1)(2008-10#1)
platform has been##2##3##(2008-10#2)
platform has##3##2##(2008-10#2)(2012-2#1)
platform in##7##2##(1993-2#1)(1994-2#1)(1995-5#1)(2005-7#1)(2007-11#1)(2010-5#1)(2012-11#1)
platform is described##3##3##(1996-12#1)(2008-9#1)(2012-11#1)
platform is##5##2##(1996-12#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-11#1)
platform may##3##2##(2008-5#1)(2012-12#2)
platform of##6##2##(1995-12#1)(2008-10#4)(2009-12#1)
platform or##2##2##(1993-9#1)(2008-3#1)
platform provides##2##2##(2012-12#1)(2013-8#1)
platform surface##2##2##(2008-10#2)
platform technologies##2##2##(2008-4#1)(2011-2#1)
platform that##9##2##(1993-6#1)(2008-10#2)(2008-11#1)(2009-12#1)(2011-1#1)(2012-2#1)(2013-1#2)
platform to identify##2##3##(2010-6#1)(2012-2#1)
platform to investigate##2##3##(2008-11#1)(2012-1#1)
platform to study the##2##4##(2008-11#1)(2009-12#1)
platform to the##2##3##(2009-3#1)(2012-3#1)
platform to##24##2##(1994-2#1)(1994-3#1)(2005-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
platform upon which##2##3##(2010-12#1)(2012-2#1)
platform was developed##2##3##(2009-4#1)(2011-1#1)
platform was##8##2##(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-4#1)(2010-2#1)(2011-1#2)
platform which allows##2##3##(2008-7#1)(2012-1#1)
platform which##3##2##(2008-4#1)(2008-7#1)(2012-1#1)
platform with their##2##3##(1993-9#1)(2007-4#1)
platform with##6##2##(1993-9#1)(2007-4#1)(2008-4#1)(2010-5#1)(2012-12#1)(2012-2#1)
platform within##2##2##(2011-1#1)(2012-1#1)
platform##322##1##(1992-6#1)(1992-9#3)(1993-12#1)(1993-2#1)(1993-6#1)(1993-7#1)(1993-9#5)(1994-12#2)(1994-2#4)(1994-3#2)(1994-6#1)(1995-12#2)(1995-5#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-6#1)(2005-10#1)(2005-12#1)(2005-6#1)(2005-7#2)(2005-9#2)(2006-10#2)(2006-12#3)(2007-10#1)(2007-11#4)(2007-12#4)(2007-4#2)(2007-6#2)(2007-8#3)(2008-1#4)(2008-10#40)(2008-11#23)(2008-12#1)(2008-2#7)(2008-3#4)(2008-4#9)(2008-5#11)(2008-7#13)(2008-9#7)(2009-10#2)(2009-12#5)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#5)(2010-12#9)(2010-2#3)(2010-4#1)(2010-5#4)(2010-6#2)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#11)(2011-12#2)(2011-2#5)(2011-3#1)(2012-1#6)(2012-11#6)(2012-12#10)(2012-2#15)(2012-3#6)(2013-1#27)(2013-7#3)(2013-8#3)
platform-independent##2##1##(2008-4#1)(2011-3#1)
platforms and##6##2##(1995-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-7#1)(2013-8#1)
platforms are not##2##3##(2008-4#1)(2008-7#1)
platforms are##5##2##(2008-10#1)(2008-4#1)(2008-7#2)(2010-2#1)
platforms for##11##2##(1994-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-2#2)(2013-1#2)(2013-7#1)
platforms to##3##2##(2008-7#1)(2010-7#1)(2012-2#1)
platforms will##2##2##(2008-7#1)(2010-7#1)
platforms##83##1##(1990-11#2)(1993-7#1)(1994-8#1)(1995-12#1)(2006-6#1)(2007-12#3)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#5)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#9)(2008-8#1)(2009-12#2)(2009-2#3)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#6)(2010-5#2)(2010-7#4)(2011-1#3)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
platforms)##3##1##(2008-4#1)(2012-11#2)
platinated##4##1##(1992-1#1)(1995-11#1)(2008-3#1)(2008-5#1)
platination##6##1##(1990-2#1)(1991-9#1)(1992-11#1)(1993-8#1)(1994-6#1)(2008-5#1)
plating and##3##2##(1994-3#1)(2008-10#2)
plating assay##2##2##(2008-1#1)(2008-10#1)
plating assays##2##2##(2008-10#2)
plating by##2##2##(1990-9#1)(2012-12#1)
plating conditions##2##2##(2009-6#1)(2013-1#1)
plating density##5##2##(1990-7#1)(1993-11#1)(1994-2#1)(1996-5#1)(2008-11#1)
plating efficiencies##2##2##(1990-4#1)(2008-10#1)
plating efficiency##3##2##(1990-4#1)(1992-9#1)(1996-11#1)
plating for##2##2##(2008-9#1)(2010-7#1)
plating of##5##2##(2008-10#1)(2008-11#1)(2008-9#2)(2011-2#1)
plating on##6##2##(1991-12#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-8#1)
plating onto##2##2##(2008-10#2)
plating system##2##2##(2006-3#1)(2006-8#1)
plating systems##3##2##(2006-8#1)(2008-9#1)(2012-2#1)
plating technique for##2##3##(2006-4#1)(2012-12#1)
plating technique##3##2##(2006-3#1)(2006-4#1)(2012-12#1)
plating techniques for##2##3##(2006-10#1)(2008-10#1)
plating techniques##6##2##(2006-10#1)(2006-8#1)(2008-10#1)(2008-3#1)(2011-1#2)
plating##83##1##(1990-4#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-7#1)(1996-11#1)(1996-5#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-3#2)(2006-4#1)(2006-8#4)(2008-1#1)(2008-10#20)(2008-11#6)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#8)(2009-3#1)(2009-6#2)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#1)
platinised carbon##2##2##(2008-10#2)
platinum (Pt)##5##2##(1993-9#1)(2008-10#3)(2008-11#1)
platinum accumulation##2##2##(1994-6#1)(2008-4#1)
platinum and paclitaxel##2##3##(2007-7#2)
platinum and palladium##9##3##(2008-10#9)
platinum and##20##2##(2007-7#2)(2008-10#17)(2008-2#1)
platinum as##2##2##(2007-8#1)(2008-10#1)
platinum based##2##2##(2008-5#2)
platinum black##2##2##(2008-10#2)
platinum coil##2##2##(2008-7#2)
platinum complexes##14##2##(1991-10#2)(1995-11#2)(2008-1#7)(2008-5#1)(2010-11#1)(2013-1#1)
platinum compounds##3##2##(2008-3#1)(2008-4#1)(2008-5#1)
platinum concentrations in##2##3##(1990-5#1)(2008-10#1)
platinum concentrations##4##2##(1990-5#2)(2008-10#2)
platinum coordination##2##2##(2008-5#1)(2010-11#1)
platinum dish##2##2##(2008-10#2)
platinum disk electrode##3##3##(2008-10#3)
platinum disk##4##2##(2008-10#4)
platinum drugs##3##2##(2008-1#2)(2009-4#1)
platinum electrode in the##2##4##(2008-10#2)
platinum electrode in##3##3##(2008-10#3)
platinum electrode were##2##3##(2008-10#2)
platinum electrode##21##2##(1991-5#2)(1993-2#1)(1996-6#1)(2007-8#1)(2008-10#16)
platinum electrodes##8##2##(2008-10#7)(2008-11#1)
platinum group elements (PGEs)##2##4##(2008-10#2)
platinum group elements##7##3##(2008-10#5)(2008-11#2)
platinum group metals##7##3##(2008-10#7)
platinum group##15##2##(2008-10#13)(2008-11#2)
platinum in##4##2##(1994-6#1)(2008-10#2)(2008-11#1)
platinum nanoparticles##5##2##(2008-7#1)(2010-12#1)(2010-4#3)
platinum particles##2##2##(1991-3#1)(2010-4#1)
platinum was##3##2##(1990-5#1)(1991-3#1)(2008-10#1)
platinum wire as the##2##4##(2008-10#2)
platinum wire##5##2##(2008-10#5)
platinum##216##1##(1990-5#5)(1990-6#1)(1991-10#3)(1991-3#2)(1991-5#2)(1991-7#1)(1992-1#1)(1992-10#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-6#4)(1995-11#3)(1996-2#1)(1996-6#1)(1997-3#1)(1997-5#1)(1997-6#1)(2005-11#1)(2005-4#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-7#3)(2007-8#4)(2008-1#9)(2008-10#113)(2008-11#6)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#13)(2008-7#3)(2008-9#1)(2009-11#3)(2009-4#2)(2010-11#3)(2010-12#2)(2010-4#4)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#1)
platinum(II) and palladium(II) chlorido complexes##2##5##(2013-1#2)
platinum(II) complex##3##2##(2008-5#3)
platinum(II) complexes##6##2##(2008-3#1)(2008-5#3)(2012-3#1)(2013-1#1)
platinum(II) with##5##2##(2008-10#4)(2008-5#1)
platinum(II)##26##1##(1992-11#1)(2008-10#11)(2008-3#1)(2008-5#7)(2011-2#1)(2012-3#2)(2013-1#3)
platinum(IV)##9##1##(2008-10#9)
platinum-DNA##3##1##(1990-2#1)(1992-11#1)(1995-5#1)
platinum-based chemotherapy##10##2##(2004-1#2)(2007-10#2)(2008-1#1)(2009-5#1)(2010-8#3)(2012-1#1)
platinum-based##19##1##(1990-6#1)(2004-1#2)(2007-10#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-5#1)(2010-8#3)(2012-1#1)(2012-12#2)
platinum-carbon##2##1##(1994-8#2)
platycephala from Suriname##2##3##(2010-3#2)
platycephala##3##1##(2010-3#3)
platyfish (Xiphophorus##2##2##(2008-12#2)
platyfish##4##1##(2008-12#4)
platyhelminth##3##1##(1993-6#3)
platypnea-orthodeoxya syndrome##2##2##(2007-8#2)
platypus##3##1##(1997-8#1)(2008-8#2)
platyspondylic##2##1##(1996-12#2)
plaunotol##5##1##(2007-1#5)
plausibility of the##4##3##(2008-6#1)(2008-9#1)(2011-12#1)(2012-1#1)
plausibility of##11##2##(2008-2#1)(2008-6#1)(2008-7#2)(2008-9#1)(2011-12#3)(2012-1#1)(2012-2#1)(2013-7#1)
plausibility##18##1##(1991-12#1)(1995-6#1)(2006-2#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2011-12#3)(2012-1#1)(2012-2#1)(2013-7#1)
plausible and##5##2##(1994-3#1)(2006-10#1)(2008-3#1)(2009-2#1)(2012-12#1)
plausible but##2##2##(2007-9#1)(2008-7#1)
plausible by the##2##3##(2008-1#1)(2009-10#1)
plausible candidate##3##2##(1990-12#1)(2008-4#1)(2010-12#1)
plausible explanation for the##3##4##(2006-8#1)(2008-10#1)(2011-2#1)
plausible explanation##4##2##(2006-8#1)(2008-10#1)(2008-3#1)(2011-2#1)
plausible mechanism##5##2##(1991-9#1)(1994-8#1)(2008-10#1)(2008-3#1)(2008-5#1)
plausible mechanisms for the##2##4##(2005-12#1)(2010-7#1)
plausible mechanisms for##4##3##(2005-12#1)(2010-12#1)(2010-4#1)(2010-7#1)
plausible mechanisms##7##2##(1994-3#1)(2005-12#1)(2007-9#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)
plausible mechanistic##3##2##(1997-2#1)(2008-9#2)
plausible model##3##2##(1997-7#1)(2010-5#1)(2012-1#1)
plausible molecular##3##2##(1991-8#2)(2009-10#1)
plausible that##9##2##(1996-5#1)(2008-11#1)(2008-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-5#1)
plausible to##4##2##(2005-10#1)(2006-8#1)(2008-10#1)(2008-2#1)
plausible##117##1##(1990-12#1)(1990-3#1)(1990-8#1)(1991-8#2)(1991-9#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-8#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#2)(2005-12#1)(2006-10#2)(2006-12#3)(2006-4#1)(2006-5#1)(2006-8#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#1)(2007-9#2)(2008-1#5)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#3)(2009-10#2)(2009-2#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-12#3)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#1)(2011-2#1)(2012-1#3)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
plausibly##4##1##(1995-11#1)(2007-11#1)(2011-1#1)(2012-1#1)
play a causal role in##4##5##(1991-12#1)(1995-12#1)(2008-6#1)(2011-1#1)
play a causal role##5##4##(1991-12#1)(1995-12#1)(2008-6#1)(2011-1#2)
play a causative role in the##2##6##(1992-4#1)(2008-7#1)
play a central role in cellular##2##6##(2006-6#1)(2008-7#1)
play a central role in determining##3##6##(2009-10#1)(2013-1#2)
play a central role in regulating##2##6##(1991-7#1)(2006-2#1)
play a central role in the initiation and##3##8##(1994-8#1)(2006-7#1)(2010-2#1)
play a central role in the##7##6##(1991-9#1)(1993-11#1)(1994-8#1)(1996-5#1)(2006-7#1)(2008-10#1)(2010-2#1)
play a central role in this##3##6##(1992-9#1)(1993-4#1)(2007-7#1)
play a central role in##35##5##(1991-5#1)(1991-7#1)(1991-9#1)(1992-9#1)(1993-11#1)(1993-4#1)(1993-7#1)(1994-8#1)(1995-5#1)(1996-5#1)(1996-8#1)(2006-2#1)(2006-6#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
play a central role##37##4##(1991-5#1)(1991-7#1)(1991-9#1)(1992-9#1)(1993-11#1)(1993-4#1)(1993-7#1)(1994-8#2)(1995-5#1)(1996-5#1)(1996-8#1)(2006-2#1)(2006-6#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
play a central##38##3##(1990-12#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-9#1)(1993-11#1)(1993-4#1)(1993-7#1)(1994-8#2)(1995-5#1)(1996-5#1)(1996-8#1)(2006-2#1)(2006-6#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
play a certain role in##4##5##(2007-8#1)(2008-8#3)
play a complementary role##2##4##(2008-10#1)(2010-6#1)
play a critical role in providing##2##6##(1994-2#1)(2010-2#1)
play a critical role in the pathogenesis of##2##8##(2006-9#1)(2008-4#1)
play a critical role in the##12##6##(1990-11#1)(2006-9#2)(2008-11#1)(2008-4#2)(2008-6#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
play a critical role in this##2##6##(2009-6#1)(2011-2#1)
play a critical role in##45##5##(1990-11#1)(1991-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-4#1)(2006-6#1)(2006-9#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-6#2)(2010-12#1)(2010-2#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
play a critical role on the##2##6##(2009-3#1)(2009-4#1)
play a critical role on##3##5##(1996-12#1)(2009-3#1)(2009-4#1)
play a critical role##50##4##(1990-11#1)(1991-6#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-4#1)(2006-6#1)(2006-9#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#2)(2009-6#2)(2010-12#1)(2010-2#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
play a critical##52##3##(1990-11#1)(1991-6#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-4#1)(2006-6#1)(2006-9#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#2)(2009-6#2)(2010-12#1)(2010-2#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
play a crucial role in the pathogenesis of##3##8##(1996-8#1)(2008-1#1)(2011-2#1)
play a crucial role in the##16##6##(1990-3#1)(1991-8#1)(1994-5#1)(1996-4#1)(1996-8#1)(1997-7#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-9#1)(2011-2#1)
play a crucial role in##35##5##(1990-3#1)(1991-8#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-6#1)(1996-4#1)(1996-8#1)(1997-7#1)(2005-11#1)(2007-10#1)(2007-2#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
play a crucial role##38##4##(1990-3#1)(1991-8#1)(1992-10#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-6#1)(1996-4#1)(1996-8#1)(1997-7#1)(2005-11#1)(2007-10#1)(2007-2#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
play a crucial##39##3##(1990-3#1)(1991-8#1)(1992-10#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-6#1)(1996-4#1)(1996-8#1)(1997-7#1)(2005-11#1)(2007-10#1)(2007-2#1)(2008-1#3)(2008-10#2)(2008-11#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
play a decisive role in##2##5##(2008-10#1)(2013-8#1)
play a different role in##2##5##(1990-2#1)(2010-2#1)
play a direct role in##2##5##(2010-2#1)(2012-1#1)
play a dominant role in##4##5##(1990-7#1)(2007-12#1)(2008-1#1)(2011-2#1)
play a dominant role##5##4##(1990-7#1)(2007-12#1)(2008-1#1)(2008-2#1)(2011-2#1)
play a dual role in##3##5##(1990-10#1)(1991-7#1)(2013-1#1)
play a dual role##4##4##(1990-10#1)(1991-7#1)(2005-10#1)(2013-1#1)
play a functional role in##2##5##(1991-4#1)(1997-6#1)
play a functional role##3##4##(1990-7#1)(1991-4#1)(1997-6#1)
play a fundamental role in the##2##6##(2004-12#1)(2008-7#1)
play a fundamental role in##6##5##(1996-10#1)(2004-12#1)(2008-7#1)(2008-8#1)(2012-12#2)
play a fundamental role##8##4##(1996-10#1)(2004-12#1)(2008-1#1)(2008-12#1)(2008-7#1)(2008-8#1)(2012-12#2)
play a greater role in##3##5##(1994-3#1)(2006-6#1)(2008-10#1)
play a key role for##2##5##(1990-2#1)(2010-8#1)
play a key role in atherogenesis##2##6##(1990-2#1)(1995-8#1)
play a key role in the development of##4##8##(1996-1#1)(2006-10#1)(2008-1#1)(2010-11#1)
play a key role in the development##5##7##(1991-12#1)(1996-1#1)(2006-10#1)(2008-1#1)(2010-11#1)
play a key role in the effects of##2##8##(1991-4#1)(1994-3#1)
play a key role in the interaction between the##2##9##(1995-12#1)(1996-12#1)
play a key role in the natural##2##7##(2008-10#2)
play a key role in the pathogenesis of##2##8##(2008-3#1)(2009-8#1)
play a key role in the regulation of##3##8##(1996-4#1)(1997-8#1)(2011-2#1)
play a key role in the##37##6##(1991-12#1)(1991-4#1)(1993-10#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-3#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-4#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#3)
play a key role in##82##5##(1990-2#1)(1991-12#1)(1991-4#1)(1991-8#1)(1993-10#1)(1993-6#3)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#1)(1997-2#2)(1997-3#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-2#2)(2006-4#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#2)(2008-10#6)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)
play a key role##88##4##(1990-2#2)(1991-12#1)(1991-4#1)(1991-8#1)(1993-10#1)(1993-6#3)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-4#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-2#2)(2006-4#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#2)(2008-10#6)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)
play a large role in the##2##6##(2006-5#1)(2008-8#1)
play a larger role in##3##5##(2009-8#1)(2010-11#1)(2013-8#1)
play a leading role##2##4##(1992-9#1)(1997-5#1)
play a major role as##2##5##(2008-5#1)(2009-11#1)
play a major role in determining##4##6##(1997-2#1)(2008-6#1)(2010-8#1)(2011-1#1)
play a major role in mediating##3##6##(2008-5#1)(2008-7#1)(2013-1#1)
play a major role in regulating the##3##7##(1992-12#1)(2007-5#1)(2008-4#1)
play a major role in regulating##5##6##(1992-12#1)(1993-5#1)(2007-5#1)(2008-4#1)(2009-8#1)
play a major role in the pathogenesis of##4##8##(1991-9#1)(2008-1#1)(2008-4#1)(2011-12#1)
play a major role in the regulation of##2##8##(1991-6#1)(1992-8#1)
play a major role in the##22##6##(1991-6#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-5#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-3#1)(2011-12#2)
play a major role in##65##5##(1991-4#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-4#1)(1992-8#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-6#1)(1996-10#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-5#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#2)(2012-11#1)(2012-2#2)(2013-1#2)(2013-7#1)
play a major role##75##4##(1991-4#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-4#1)(1992-8#1)(1993-5#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-6#1)(1995-12#2)(1996-10#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#2)(2013-7#1)
play a major##78##3##(1991-4#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-4#1)(1992-8#1)(1993-5#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-6#1)(1995-12#2)(1996-10#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#2)(2012-11#1)(2012-2#2)(2013-1#2)(2013-7#1)
play a minor role in##4##5##(1995-12#1)(1997-4#1)(2005-11#1)(2008-10#1)
play a minor role##6##4##(1995-12#1)(1997-4#1)(2005-11#1)(2008-10#2)(2010-12#1)
play a more important role in##3##6##(1994-8#1)(1995-1#1)(2006-6#1)
play a more important role##4##5##(1994-8#1)(1995-1#1)(1995-6#1)(2006-6#1)
play a more##8##3##(1992-3#1)(1994-8#1)(1995-1#1)(1995-6#1)(2006-6#1)(2007-11#1)(2008-5#1)(2011-1#1)
play a part in the##5##5##(1990-10#1)(1990-8#1)(1994-2#1)(1997-1#1)(1997-3#1)
play a part in##10##4##(1990-10#1)(1990-8#2)(1993-2#1)(1994-2#1)(1997-1#1)(1997-3#1)(2007-12#1)(2009-4#1)(2013-8#1)
play a part##11##3##(1990-10#1)(1990-8#2)(1993-2#1)(1994-2#1)(1996-11#1)(1997-1#1)(1997-3#1)(2007-12#1)(2009-4#1)(2013-8#1)
play a particular role in##2##5##(1992-3#1)(2012-2#1)
play a physiologic role in##2##5##(1995-2#1)(2006-10#1)
play a physiological role##2##4##(1994-8#1)(2009-11#1)
play a pivotal role in the control of##2##8##(1994-2#1)(2009-5#1)
play a pivotal role in the##8##6##(1994-2#1)(1995-12#1)(1995-2#1)(2008-1#2)(2008-10#1)(2008-11#1)(2009-5#1)
play a pivotal role in##28##5##(1991-12#1)(1991-2#1)(1991-9#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-8#1)(2005-7#1)(2007-10#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-6#1)(2009-12#1)(2009-5#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
play a pivotal role##33##4##(1991-12#1)(1991-2#1)(1991-9#1)(1992-9#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-8#1)(2005-7#1)(2007-10#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#2)(2009-12#1)(2009-5#1)(2009-6#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
play a pivotal##34##3##(1991-12#1)(1991-2#1)(1991-9#1)(1992-9#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-8#1)(2005-7#1)(2007-10#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#1)(2008-6#2)(2009-12#1)(2009-5#1)(2009-6#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
play a positive##2##3##(1995-12#1)(2008-8#1)
play a primary role in##6##5##(1990-9#1)(1997-4#1)(2007-11#1)(2009-3#1)(2009-4#1)(2011-2#1)
play a primary role##7##4##(1990-9#1)(1997-4#1)(2007-10#1)(2007-11#1)(2009-3#1)(2009-4#1)(2011-2#1)
play a primary##9##3##(1990-9#1)(1997-4#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-12#1)(2009-3#1)(2009-4#1)(2011-2#1)
play a prominent role in##3##5##(1990-12#1)(1990-5#1)(1995-3#1)
play a prominent role##5##4##(1990-12#1)(1990-5#1)(1995-3#1)(2007-10#1)(2008-9#1)
play a prominent##7##3##(1990-12#1)(1990-5#1)(1995-3#1)(2007-10#1)(2007-12#1)(2008-8#1)(2008-9#1)
play a protective role against##2##5##(1995-1#1)(2006-8#1)
play a protective role##3##4##(1995-1#1)(1996-12#1)(2006-8#1)
play a regulatory role in##4##5##(1990-9#1)(1991-12#1)(1994-12#1)(2008-4#1)
play a regulatory role##6##4##(1990-9#1)(1991-12#1)(1991-7#1)(1993-3#1)(1994-12#1)(2008-4#1)
play a relevant role in the##2##6##(1993-9#1)(1996-3#1)
play a relevant role in##3##5##(1993-9#1)(1996-3#1)(2009-8#1)
play a relevant##4##3##(1993-9#1)(1996-3#1)(2009-8#1)(2012-8#1)
play a role as a##3##5##(1991-1#1)(1997-5#1)(2006-2#1)
play a role as##5##4##(1991-1#1)(1992-9#1)(1997-5#1)(2006-2#1)(2011-2#1)
play a role during##2##4##(1991-7#1)(1996-4#1)
play a role in a##3##5##(1994-11#1)(1994-6#1)(2007-8#1)
play a role in ammonia##2##5##(2008-10#1)(2008-7#1)
play a role in controlling##2##5##(2008-10#2)
play a role in determining the##4##6##(2007-3#1)(2008-4#1)(2009-7#1)(2009-8#1)
play a role in determining##5##5##(2007-1#1)(2007-3#1)(2008-4#1)(2009-7#1)(2009-8#1)
play a role in disease##3##5##(1995-3#1)(2008-10#1)(2009-8#1)
play a role in early##3##5##(1992-4#1)(1993-3#1)(2006-11#1)
play a role in explaining##2##5##(2007-11#1)(2012-1#1)
play a role in health##2##5##(1994-3#1)(2011-2#1)
play a role in inflammatory##2##5##(1995-12#1)(2007-12#1)
play a role in its pathogenesis##2##6##(2006-10#1)(2010-8#1)
play a role in its##4##5##(1994-8#1)(2006-10#1)(2008-10#1)(2010-8#1)
play a role in learning##2##5##(2008-8#1)(2012-12#1)
play a role in local##2##5##(1992-6#1)(1994-6#1)
play a role in maintaining##3##5##(1994-8#1)(1995-2#1)(2005-12#1)
play a role in mediating##5##5##(1990-9#1)(1994-8#1)(2005-7#1)(2011-2#1)(2013-8#1)
play a role in modulating##4##5##(1990-5#1)(1994-11#1)(1994-5#1)(1995-10#1)
play a role in normal##2##5##(2008-5#1)(2009-10#1)
play a role in pathological##2##5##(1996-8#1)(2008-4#1)
play a role in protection##2##5##(2007-10#1)(2013-1#1)
play a role in receptor##2##5##(1991-3#1)(1992-8#1)
play a role in reducing##2##5##(2010-10#1)(2013-1#1)
play a role in regulating##3##5##(1995-12#1)(2010-2#1)(2010-5#1)
play a role in several##3##5##(2006-8#1)(2012-12#2)
play a role in some##5##5##(1994-12#1)(1995-12#2)(2008-5#1)(2010-7#1)
play a role in stabilizing##2##5##(1994-12#1)(1994-9#1)
play a role in the activity of the##2##8##(1995-6#2)
play a role in the development and progression of##2##9##(2010-3#1)(2012-3#1)
play a role in the development and##3##7##(2008-6#1)(2010-3#1)(2012-3#1)
play a role in the development of##14##7##(1991-5#1)(1991-7#1)(1993-2#1)(1994-2#1)(1995-12#1)(1997-2#1)(2006-8#1)(2007-8#1)(2008-1#1)(2009-1#1)(2010-8#1)(2011-10#1)(2012-12#1)(2013-8#1)
play a role in the development##17##6##(1991-5#1)(1991-7#1)(1993-2#1)(1994-2#1)(1995-12#1)(1997-2#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-6#1)(2009-1#1)(2010-3#1)(2010-8#1)(2011-10#1)(2012-12#1)(2012-3#1)(2013-8#1)
play a role in the early##2##6##(1994-11#1)(1997-3#1)
play a role in the etiology of##4##7##(1992-1#1)(1996-12#1)(2008-5#1)(2012-12#1)
play a role in the etiology##5##6##(1990-11#1)(1992-1#1)(1996-12#1)(2008-5#1)(2012-12#1)
play a role in the evolution of##2##7##(2008-8#1)(2010-3#1)
play a role in the formation of##2##7##(1990-12#1)(1993-11#1)
play a role in the genesis of##2##7##(1995-8#1)(2006-9#1)
play a role in the induction##3##6##(1993-9#1)(1997-6#1)(2012-3#1)
play a role in the modulation of##4##7##(1993-12#1)(1994-9#1)(2012-2#1)(2013-8#1)
play a role in the modulation##5##6##(1993-12#1)(1994-9#1)(2006-10#1)(2012-2#1)(2013-8#1)
play a role in the molecular##3##6##(2007-8#2)(2008-8#1)
play a role in the pathogenesis of##16##7##(1990-11#1)(1991-5#1)(1991-8#1)(1992-6#1)(1992-7#1)(1993-12#1)(1994-2#1)(1994-8#2)(2008-3#2)(2008-4#1)(2009-1#1)(2009-2#1)(2009-7#1)(2010-12#1)
play a role in the pathophysiology of##4##7##(1995-3#1)(2008-4#1)(2010-12#1)(2011-1#1)
play a role in the regulation of##11##7##(1990-5#1)(1991-1#1)(1991-9#1)(1992-12#1)(1992-6#1)(1994-11#1)(1995-8#1)(1997-4#1)(2006-10#1)(2008-1#1)(2008-4#1)
play a role in the survival##2##6##(2008-10#2)
play a role in the##161##5##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-2#1)(1991-5#2)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-6#2)(1992-7#2)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#3)(1994-2#2)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#2)(1995-12#3)(1995-2#1)(1995-3#3)(1995-6#2)(1995-8#2)(1996-10#2)(1996-12#3)(1996-3#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(2003-11#1)(2005-11#1)(2006-10#3)(2006-5#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-8#4)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-1#2)(2009-10#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#3)(2010-8#1)(2011-1#2)(2011-10#1)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#3)
play a role in this process##2##6##(1991-9#1)(2009-7#1)
play a role in this##6##5##(1991-9#1)(1994-11#1)(2008-1#1)(2008-12#1)(2009-7#1)(2012-12#1)
play a role in transcriptional##2##5##(2008-7#1)(2009-9#1)
play a role in##389##4##(1990-10#2)(1990-11#3)(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-2#1)(1991-3#3)(1991-5#6)(1991-7#3)(1991-8#1)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-4#1)(1992-6#5)(1992-7#2)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#3)(1993-4#1)(1993-7#2)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#7)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#4)(1994-6#5)(1994-8#7)(1994-9#5)(1995-1#3)(1995-10#1)(1995-12#9)(1995-2#4)(1995-3#5)(1995-5#1)(1995-6#2)(1995-8#6)(1996-1#2)(1996-10#2)(1996-12#3)(1996-2#4)(1996-3#2)(1996-4#1)(1996-5#5)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#3)(1997-7#3)(2003-11#2)(2004-12#1)(2004-3#1)(2004-4#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#10)(2006-11#2)(2006-2#3)(2006-4#1)(2006-5#1)(2006-8#3)(2006-9#2)(2007-1#3)(2007-10#2)(2007-11#6)(2007-12#4)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#6)(2008-1#4)(2008-10#20)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#7)(2008-5#4)(2008-6#2)(2008-7#9)(2008-8#6)(2008-9#3)(2009-1#2)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#4)(2010-2#2)(2010-3#4)(2010-5#3)(2010-7#4)(2010-8#4)(2011-1#4)(2011-10#2)(2011-12#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#10)(2012-2#7)(2012-3#3)(2012-7#1)(2013-1#4)(2013-8#5)
play a role##428##3##(1990-10#2)(1990-11#3)(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#3)(1991-10#1)(1991-11#2)(1991-2#1)(1991-3#3)(1991-5#6)(1991-7#4)(1991-8#1)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-4#1)(1992-6#5)(1992-7#2)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#3)(1993-4#1)(1993-7#2)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#8)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#4)(1994-6#5)(1994-8#8)(1994-9#5)(1995-1#3)(1995-10#1)(1995-12#9)(1995-2#5)(1995-3#5)(1995-5#1)(1995-6#2)(1995-8#6)(1996-1#2)(1996-10#2)(1996-12#3)(1996-2#5)(1996-3#2)(1996-4#3)(1996-5#5)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#1)(2003-11#2)(2004-12#1)(2004-3#1)(2004-4#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#12)(2006-11#3)(2006-2#4)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#3)(2007-10#2)(2007-11#6)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#6)(2008-1#4)(2008-10#21)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#8)(2008-5#4)(2008-6#2)(2008-7#13)(2008-8#6)(2008-9#3)(2009-1#2)(2009-10#3)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#7)(2010-2#2)(2010-3#4)(2010-5#3)(2010-7#4)(2010-8#4)(2011-1#4)(2011-10#2)(2011-12#1)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#10)(2012-2#7)(2012-3#3)(2012-7#1)(2013-1#6)(2013-8#5)
play a significant role in the pathogenesis of##2##8##(2007-12#1)(2008-5#1)
play a significant role in the##17##6##(1990-7#1)(1995-5#1)(1995-6#1)(2006-8#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-5#1)(2009-8#1)(2011-1#1)(2012-2#4)(2013-8#1)
play a significant role in##41##5##(1990-7#1)(1991-8#1)(1992-1#1)(1993-1#1)(1993-4#1)(1995-5#1)(1995-6#1)(1996-7#1)(1997-1#1)(1997-4#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-12#2)(2007-9#1)(2008-10#8)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-1#1)(2011-1#4)(2012-2#4)(2013-8#2)
play a significant role##44##4##(1990-7#1)(1991-8#1)(1992-1#1)(1993-1#1)(1993-4#1)(1995-5#1)(1995-6#1)(1996-7#1)(1997-1#1)(1997-4#1)(2005-11#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-12#2)(2007-9#1)(2008-10#8)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-1#1)(2011-1#5)(2012-2#4)(2013-8#2)
play a significant##45##3##(1990-7#1)(1991-8#1)(1992-1#1)(1993-1#1)(1993-4#1)(1995-5#1)(1995-6#1)(1996-7#1)(1997-1#1)(1997-4#1)(2005-11#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-12#2)(2007-9#1)(2008-10#8)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-1#1)(2011-1#5)(2012-2#4)(2013-8#2)
play a similar role in##3##5##(1992-9#1)(1997-4#1)(2008-7#1)
play a similar role##4##4##(1992-9#1)(1997-4#1)(1997-7#1)(2008-7#1)
play a small role in##3##5##(2008-9#1)(2009-9#1)(2011-1#1)
play a special role##2##4##(1990-11#1)(1990-3#1)
play a structural role##2##4##(1993-6#1)(1995-10#1)
play a substantial role in##3##5##(1990-2#1)(2008-5#1)(2008-9#1)
play a substantial##4##3##(1990-2#1)(2008-11#1)(2008-5#1)(2008-9#1)
play a synergistic role in##2##5##(1993-3#1)(2010-8#1)
play a useful role in##2##5##(1992-3#1)(2008-6#1)
play a useful role##3##4##(1992-3#1)(2005-7#1)(2008-6#1)
play a valuable role in the##2##6##(2008-11#1)(2008-5#1)
play a very important role in##2##6##(2009-2#1)(2010-5#1)
play a very##4##3##(2007-11#1)(2009-2#1)(2009-6#1)(2010-5#1)
play a vital role in the##3##6##(2008-4#1)(2008-5#1)(2008-7#1)
play a vital role in##12##5##(1990-12#1)(2006-4#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#4)
play a vital role##14##4##(1990-11#1)(1990-12#1)(2006-4#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#4)
play a wide range of##2##5##(2008-7#1)(2010-11#1)
play a##1007##2##(1990-10#4)(1990-11#6)(1990-12#6)(1990-2#5)(1990-3#2)(1990-4#1)(1990-5#3)(1990-7#4)(1990-8#3)(1990-9#3)(1991-1#3)(1991-10#2)(1991-11#2)(1991-12#5)(1991-2#2)(1991-3#3)(1991-4#3)(1991-5#7)(1991-6#2)(1991-7#8)(1991-8#4)(1991-9#7)(1992-1#3)(1992-10#2)(1992-11#2)(1992-12#5)(1992-3#4)(1992-4#3)(1992-5#1)(1992-6#5)(1992-7#2)(1992-8#4)(1992-9#9)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#5)(1993-2#2)(1993-3#5)(1993-4#4)(1993-5#2)(1993-6#5)(1993-7#3)(1993-8#2)(1993-9#5)(1994-1#1)(1994-10#1)(1994-11#10)(1994-12#6)(1994-2#6)(1994-3#5)(1994-5#5)(1994-6#8)(1994-8#13)(1994-9#7)(1995-1#5)(1995-10#2)(1995-11#2)(1995-12#16)(1995-2#9)(1995-3#8)(1995-5#3)(1995-6#6)(1995-8#8)(1996-1#3)(1996-10#5)(1996-11#3)(1996-12#6)(1996-2#5)(1996-3#3)(1996-4#6)(1996-5#8)(1996-6#2)(1996-7#2)(1996-8#6)(1996-9#1)(1997-1#5)(1997-2#4)(1997-3#4)(1997-4#10)(1997-5#3)(1997-6#5)(1997-7#6)(1997-8#3)(2003-11#2)(2004-12#2)(2004-3#1)(2004-4#1)(2005-10#2)(2005-11#5)(2005-12#1)(2005-7#3)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#16)(2006-11#3)(2006-12#1)(2006-2#8)(2006-4#3)(2006-5#4)(2006-6#4)(2006-7#2)(2006-8#8)(2006-9#4)(2007-1#3)(2007-10#6)(2007-11#14)(2007-12#13)(2007-2#3)(2007-3#4)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#7)(2007-9#4)(2008-1#17)(2008-10#49)(2008-11#17)(2008-12#6)(2008-2#6)(2008-3#14)(2008-4#26)(2008-5#19)(2008-6#10)(2008-7#31)(2008-8#20)(2008-9#11)(2009-1#2)(2009-10#4)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#4)(2009-4#7)(2009-5#4)(2009-6#6)(2009-7#7)(2009-8#11)(2009-9#8)(2010-1#2)(2010-10#8)(2010-11#7)(2010-12#14)(2010-2#7)(2010-3#6)(2010-4#2)(2010-5#5)(2010-6#1)(2010-7#5)(2010-8#8)(2010-9#1)(2011-1#24)(2011-10#2)(2011-12#3)(2011-2#27)(2011-3#1)(2012-1#5)(2012-11#2)(2012-12#21)(2012-2#20)(2012-3#7)(2012-7#1)(2012-8#1)(2013-1#17)(2013-7#3)(2013-8#14)
play an active role in##5##5##(1996-3#1)(1996-8#1)(2007-8#1)(2008-5#1)(2010-11#1)
play an active role##8##4##(1996-11#1)(1996-3#1)(1996-8#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-5#1)(2010-11#1)
play an essential role as##2##5##(1995-6#1)(1997-7#1)
play an essential role in the##7##6##(1990-5#1)(1992-11#1)(1996-10#1)(2005-10#1)(2008-1#1)(2008-11#2)
play an essential role in##17##5##(1990-5#1)(1992-11#1)(1992-9#1)(1995-2#1)(1995-5#1)(1996-10#2)(1997-2#1)(1997-6#1)(2005-10#1)(2008-1#1)(2008-11#4)(2009-8#1)(2010-4#1)
play an essential role##21##4##(1990-5#1)(1992-11#1)(1992-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-10#2)(1997-2#1)(1997-6#1)(1997-7#1)(2005-10#1)(2006-2#1)(2008-1#1)(2008-11#4)(2009-8#1)(2010-4#1)(2011-2#1)
play an important and##3##4##(1994-10#1)(1995-12#1)(2006-2#1)
play an important part in the##3##6##(1992-5#1)(1993-9#1)(2012-12#1)
play an important part in##5##5##(1992-5#1)(1993-9#1)(1995-5#2)(2012-12#1)
play an important role during##4##5##(2007-1#1)(2007-11#1)(2008-8#1)(2008-9#1)
play an important role for the##3##6##(1997-6#1)(2008-5#1)(2012-2#1)
play an important role for##8##5##(1994-12#1)(1996-2#1)(1997-1#1)(1997-6#1)(2008-3#1)(2008-5#1)(2010-7#1)(2012-2#1)
play an important role in carcinogenesis##2##6##(1992-8#1)(2004-1#1)
play an important role in cell##3##6##(1992-11#1)(2008-1#1)(2011-2#1)
play an important role in controlling##3##6##(1997-1#1)(2008-10#1)(2008-9#1)
play an important role in determining##4##6##(1993-5#1)(2006-6#1)(2009-2#1)(2011-1#1)
play an important role in host##2##6##(1994-3#1)(2008-4#1)
play an important role in human##4##6##(1996-5#1)(2008-10#1)(2011-1#1)(2011-2#1)
play an important role in immune##2##6##(2008-4#1)(2008-9#1)
play an important role in many##3##6##(1996-6#1)(1997-3#1)(2008-5#1)
play an important role in mediating##6##6##(1990-12#1)(1990-4#1)(1994-2#1)(1995-12#1)(2008-11#1)(2008-4#1)
play an important role in modulating##3##6##(1990-5#1)(1993-12#1)(1993-9#1)
play an important role in promoting##2##6##(2008-4#1)(2011-1#1)
play an important role in providing##2##6##(2008-5#1)(2009-2#1)
play an important role in reducing##3##6##(2009-3#1)(2011-2#1)(2012-2#1)
play an important role in regulating the##5##7##(1991-3#1)(1991-5#1)(1994-11#1)(2008-11#1)(2010-11#1)
play an important role in regulating##6##6##(1991-3#1)(1991-5#1)(1994-11#1)(1996-5#1)(2008-11#1)(2010-11#1)
play an important role in renal##2##6##(1992-9#1)(2011-2#1)
play an important role in resistance##2##6##(2008-10#2)
play an important role in signal transduction##2##7##(1992-11#1)(1997-8#1)
play an important role in the binding of##2##8##(1991-3#1)(2008-10#1)
play an important role in the binding##4##7##(1991-3#1)(1994-12#1)(2008-10#2)
play an important role in the development of the##2##9##(2008-3#1)(2012-1#1)
play an important role in the development of##9##8##(1990-4#1)(1997-7#1)(2006-6#1)(2008-3#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-1#2)
play an important role in the early##2##7##(1994-3#1)(1996-1#1)
play an important role in the evaluation of##2##8##(1993-11#1)(2008-7#1)
play an important role in the formation of##2##8##(1996-6#1)(2009-8#1)
play an important role in the future##2##7##(1996-2#1)(1996-3#1)
play an important role in the genesis of##3##8##(1995-6#1)(1996-11#1)(2011-2#1)
play an important role in the modulation of##2##8##(1995-3#1)(2008-1#1)
play an important role in the molecular##2##7##(2005-11#1)(2010-2#1)
play an important role in the pathogenesis of##15##8##(1992-11#1)(1995-2#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#1)(2008-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
play an important role in the pathogenesis##16##7##(1992-11#1)(1995-2#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#1)(2008-2#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
play an important role in the regulation of##10##8##(1991-5#1)(1993-11#2)(1993-7#1)(1995-2#1)(1995-3#1)(1996-3#1)(2007-12#1)(2008-8#1)(2012-2#1)
play an important role in the treatment of##5##8##(1994-4#1)(1995-11#1)(1996-7#1)(2011-1#1)(2011-3#1)
play an important role in the##137##6##(1990-4#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#2)(1991-5#1)(1992-1#1)(1992-11#2)(1992-4#1)(1993-11#4)(1993-12#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#2)(1994-4#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-6#2)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#7)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#5)(2009-10#1)(2009-8#3)(2010-1#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#3)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#3)
play an important role in their##2##6##(1996-12#1)(2011-1#1)
play an important role in these##2##6##(2007-12#1)(2013-8#1)
play an important role in this##4##6##(1995-3#1)(2008-7#1)(2008-9#1)(2010-8#1)
play an important role in tissue##2##6##(1997-2#1)(2010-1#1)
play an important role in tumor##2##6##(1993-7#1)(1994-5#1)
play an important role in##329##5##(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-3#3)(1991-4#2)(1991-5#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#5)(1992-12#1)(1992-4#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#5)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-7#3)(1993-9#2)(1994-11#5)(1994-12#4)(1994-2#3)(1994-3#4)(1994-4#1)(1994-5#2)(1994-8#2)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#4)(1995-6#1)(1995-7#1)(1995-8#3)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#2)(1996-6#3)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#2)(1997-6#1)(1997-7#4)(1997-8#3)(1997-9#1)(2004-1#1)(2004-11#1)(2005-10#4)(2005-11#1)(2005-7#2)(2006-10#5)(2006-11#1)(2006-2#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#5)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#3)(2007-12#3)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#3)(2008-1#5)(2008-10#16)(2008-11#5)(2008-2#3)(2008-3#6)(2008-4#8)(2008-5#6)(2008-7#7)(2008-8#6)(2008-9#9)(2009-10#4)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#4)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#6)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#2)(2011-1#9)(2011-12#2)(2011-2#14)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#6)(2013-7#3)(2013-8#3)
play an important role on the##2##6##(2008-6#1)(2009-4#1)
play an important role on##3##5##(1992-3#1)(2008-6#1)(2009-4#1)
play an important role##365##4##(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-3#3)(1991-4#2)(1991-5#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#5)(1992-12#1)(1992-3#1)(1992-4#1)(1992-7#2)(1992-8#3)(1992-9#1)(1993-11#5)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-7#3)(1993-9#2)(1994-10#1)(1994-11#5)(1994-12#6)(1994-2#3)(1994-3#4)(1994-4#1)(1994-5#2)(1994-8#2)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#4)(1995-6#1)(1995-7#1)(1995-8#3)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#3)(1996-4#1)(1996-5#2)(1996-6#3)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#2)(1997-6#2)(1997-7#4)(1997-8#4)(1997-9#1)(2004-1#1)(2004-11#1)(2005-10#5)(2005-11#1)(2005-7#2)(2006-1#1)(2006-10#5)(2006-11#1)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#5)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#4)(2007-12#3)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#3)(2008-1#5)(2008-10#16)(2008-11#7)(2008-2#3)(2008-3#8)(2008-4#9)(2008-5#8)(2008-6#1)(2008-7#8)(2008-8#7)(2008-9#10)(2009-10#4)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#8)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#9)(2011-12#2)(2011-2#15)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#8)(2012-3#2)(2013-1#7)(2013-7#3)(2013-8#3)
play an important structural role##2##5##(1991-4#1)(2008-10#1)
play an important##387##3##(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-10#2)(1991-12#2)(1991-3#3)(1991-4#3)(1991-5#3)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#5)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#2)(1992-8#4)(1992-9#1)(1993-11#5)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-7#3)(1993-9#3)(1994-10#2)(1994-11#5)(1994-12#6)(1994-2#3)(1994-3#4)(1994-4#1)(1994-5#2)(1994-8#2)(1995-11#1)(1995-12#6)(1995-2#3)(1995-3#4)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#3)(1996-1#3)(1996-10#2)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#3)(1996-4#1)(1996-5#2)(1996-6#3)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#3)(1997-6#2)(1997-7#4)(1997-8#4)(1997-9#1)(2004-1#1)(2004-11#1)(2005-10#5)(2005-11#1)(2005-7#2)(2006-1#1)(2006-10#5)(2006-11#1)(2006-2#2)(2006-3#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#6)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#5)(2007-12#4)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#4)(2008-1#5)(2008-10#17)(2008-11#7)(2008-2#3)(2008-3#8)(2008-4#9)(2008-5#8)(2008-6#1)(2008-7#9)(2008-8#7)(2008-9#10)(2009-10#4)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#8)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#9)(2011-12#2)(2011-2#15)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#8)(2012-3#2)(2013-1#7)(2013-7#3)(2013-8#3)
play an increasingly important role##2##5##(2008-7#1)(2011-7#1)
play an influential role in##2##5##(2006-7#1)(2009-4#1)
play an integral role in the##2##6##(1992-2#1)(2008-11#1)
play an##440##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#1)(1990-9#1)(1991-10#2)(1991-12#3)(1991-2#1)(1991-3#3)(1991-4#3)(1991-5#3)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#6)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#2)(1992-8#4)(1992-9#3)(1993-11#5)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-7#3)(1993-9#3)(1994-10#2)(1994-11#5)(1994-12#6)(1994-2#3)(1994-3#4)(1994-4#1)(1994-5#2)(1994-8#2)(1995-11#1)(1995-12#6)(1995-2#4)(1995-3#4)(1995-5#3)(1995-6#4)(1995-7#1)(1995-8#3)(1996-1#3)(1996-10#5)(1996-11#2)(1996-12#4)(1996-2#3)(1996-3#4)(1996-4#1)(1996-5#2)(1996-6#3)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#4)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#5)(1997-8#4)(1997-9#1)(2004-1#1)(2004-11#1)(2005-10#6)(2005-11#1)(2005-7#2)(2006-1#1)(2006-10#7)(2006-11#2)(2006-2#3)(2006-3#1)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#6)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#5)(2007-12#4)(2007-2#1)(2007-6#3)(2007-7#3)(2007-8#2)(2007-9#4)(2008-1#6)(2008-10#17)(2008-11#13)(2008-2#3)(2008-3#8)(2008-4#9)(2008-5#9)(2008-6#1)(2008-7#10)(2008-8#7)(2008-9#11)(2009-10#4)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#6)(2010-12#8)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#9)(2011-12#2)(2011-2#16)(2011-3#1)(2011-7#1)(2012-1#3)(2012-12#5)(2012-2#8)(2012-3#3)(2013-1#7)(2013-7#3)(2013-8#3)
play and##9##2##(1991-3#1)(1992-3#3)(2007-11#1)(2007-7#1)(2008-11#1)(2008-9#1)(2009-9#1)
play any role in##3##4##(1993-9#1)(2007-8#1)(2008-2#1)
play any role##4##3##(1993-9#1)(2007-8#1)(2008-10#1)(2008-2#1)
play any##5##2##(1991-11#1)(1993-9#1)(2007-8#1)(2008-10#1)(2008-2#1)
play as a##5##3##(1992-9#1)(1993-6#1)(1994-11#1)(1996-3#1)(2008-9#1)
play as##9##2##(1992-3#1)(1992-9#1)(1993-6#1)(1994-11#1)(1996-3#1)(2006-10#1)(2008-9#2)(2011-12#1)
play back##2##2##(2008-3#2)
play behaviors##4##2##(1993-12#2)(2012-12#2)
play central roles in##5##4##(1996-9#1)(2006-8#1)(2008-11#1)(2008-8#1)(2012-2#1)
play central roles##6##3##(1996-9#1)(2006-8#1)(2008-1#1)(2008-11#1)(2008-8#1)(2012-2#1)
play certain roles in##2##4##(1997-8#1)(2008-4#1)
play critical roles in regulating##2##5##(2004-2#1)(2009-8#1)
play critical roles in the##2##5##(2009-10#1)(2013-1#1)
play critical roles in##13##4##(2004-2#1)(2008-1#2)(2008-10#1)(2009-10#2)(2009-4#1)(2009-8#1)(2009-9#2)(2011-1#2)(2013-1#1)
play critical roles##14##3##(1996-3#1)(2004-2#1)(2008-1#2)(2008-10#1)(2009-10#2)(2009-4#1)(2009-8#1)(2009-9#2)(2011-1#2)(2013-1#1)
play critical##16##2##(1996-3#1)(1997-7#1)(2004-2#1)(2008-1#2)(2008-10#1)(2009-10#2)(2009-4#1)(2009-8#1)(2009-9#2)(2011-1#3)(2013-1#1)
play crucial roles in the##4##5##(2008-10#1)(2008-4#1)(2009-9#1)(2012-12#1)
play crucial roles in##11##4##(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2009-8#1)(2009-9#1)(2010-7#1)(2012-12#3)
play different roles in the##2##5##(1994-8#1)(1995-11#1)
play different roles in##5##4##(1994-8#1)(1995-11#1)(1997-7#1)(2006-6#1)(2008-11#1)
play different roles##6##3##(1994-8#1)(1995-11#1)(1997-7#1)(2006-6#1)(2008-11#1)(2012-2#1)
play different##8##2##(1994-8#1)(1995-11#2)(1997-7#1)(2006-6#1)(2008-11#1)(2012-2#1)(2013-1#1)
play distinct roles in##2##4##(1995-2#1)(1997-7#1)
play distinct##3##2##(1995-2#1)(1997-7#1)(1997-8#1)
play diverse roles##2##3##(2005-10#1)(2005-7#1)
play during##2##2##(1993-12#1)(2006-10#1)
play essential roles in##7##4##(1994-11#1)(1994-2#1)(1994-8#1)(2008-11#1)(2008-2#1)(2008-8#1)(2011-1#1)
play essential roles##9##3##(1994-11#1)(1994-2#1)(1994-8#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-8#1)
play essential##10##2##(1994-11#1)(1994-2#1)(1994-8#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
play fighting##2##2##(1992-9#2)
play for##2##2##(2005-7#1)(2008-10#1)
play fundamental roles in##3##4##(2007-12#1)(2010-10#1)(2010-12#1)
play important regulatory roles##2##4##(1995-8#1)(2011-12#1)
play important role in##2##4##(2013-1#2)
play important role##3##3##(2013-1#2)(2013-8#1)
play important roles during##2##4##(1992-6#1)(2006-8#1)
play important roles in both the formation of flower meristem and the determination of floral organ identity##2##17##(1997-2#1)(1997-8#1)
play important roles in both##3##5##(1997-2#1)(1997-8#1)(2009-6#1)
play important roles in determining##2##5##(2006-10#1)(2009-4#1)
play important roles in many biological processes##2##7##(2009-11#1)(2013-8#1)
play important roles in many biological##3##6##(2007-11#1)(2009-11#1)(2013-8#1)
play important roles in plant development and##2##7##(2008-9#1)(2012-3#1)
play important roles in plant##3##5##(2008-9#2)(2012-3#1)
play important roles in the formation of##2##7##(1991-11#1)(2007-11#1)
play important roles in the growth##2##6##(2008-8#1)(2010-5#1)
play important roles in the pathogenesis of##2##7##(2006-10#1)(2007-8#1)
play important roles in the regulation of##3##7##(2008-1#1)(2009-8#1)(2013-1#1)
play important roles in the##22##5##(1991-11#1)(1994-12#2)(1995-11#1)(1996-10#1)(1997-7#1)(2006-10#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-8#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
play important roles in various##2##5##(2009-8#1)(2012-11#1)
play important roles in##74##4##(1990-8#1)(1991-11#1)(1991-9#1)(1994-11#1)(1994-12#2)(1995-11#1)(1996-10#1)(1997-2#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#3)(2006-6#1)(2007-11#5)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-1#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-11#3)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
play important roles##81##3##(1990-8#1)(1991-11#1)(1991-9#1)(1992-4#1)(1992-6#1)(1994-11#1)(1994-12#2)(1995-11#1)(1996-10#1)(1997-2#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#5)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-1#2)(2010-11#1)(2010-12#5)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-11#3)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
play important##87##2##(1990-8#1)(1991-11#1)(1991-9#1)(1992-4#1)(1992-6#1)(1994-11#1)(1994-12#2)(1995-11#1)(1995-8#1)(1996-10#1)(1997-2#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#5)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-1#2)(2010-11#1)(2010-12#5)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#1)(2012-11#3)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#2)
play in HIV##2##3##(2010-8#1)(2013-1#1)
play in activating##2##3##(2010-2#1)(2013-1#1)
play in determining##5##3##(1994-12#1)(2007-9#1)(2008-9#1)(2012-2#1)(2012-3#1)
play in promoting##2##3##(2007-2#1)(2012-12#1)
play in the development of##3##5##(2006-6#1)(2008-11#1)(2008-5#1)
play in the regulation of##2##5##(1994-8#1)(2007-6#1)
play in the various##2##4##(1994-3#1)(2007-11#1)
play in the##34##3##(1990-5#1)(1992-3#1)(1993-1#1)(1994-3#1)(1994-8#1)(1996-10#1)(1996-2#1)(2005-7#1)(2006-6#1)(2007-11#3)(2007-12#2)(2007-6#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-11#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#3)(2013-7#1)(2013-8#1)
play in their##3##3##(1990-12#1)(1995-6#1)(2008-1#1)
play in this##4##3##(1997-2#1)(2006-10#1)(2007-11#1)(2008-7#1)
play in##95##2##(1990-12#1)(1990-5#1)(1991-5#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-2#1)(1997-2#2)(1997-7#1)(2005-11#2)(2005-7#2)(2006-10#1)(2006-5#1)(2006-6#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-6#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#5)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#5)(2009-11#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#2)
play key roles in the pathogenesis of##2##7##(2007-8#1)(2009-9#1)
play key roles in the##3##5##(2007-8#1)(2008-1#1)(2009-9#1)
play key roles in##14##4##(1996-10#1)(1996-2#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-4#2)(2008-5#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
play key roles##15##3##(1996-10#1)(1996-2#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-4#2)(2008-5#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-2#2)(2013-1#1)
play key##16##2##(1991-9#1)(1996-10#1)(1996-2#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-4#2)(2008-5#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-2#2)(2013-1#1)
play major roles in##3##4##(1994-11#1)(2008-11#1)(2008-7#1)
play major roles##4##3##(1994-11#1)(2008-11#1)(2008-7#2)
play many important##2##3##(2007-10#1)(2013-8#1)
play many##3##2##(1991-3#1)(2007-10#1)(2013-8#1)
play more##2##2##(1992-1#1)(2007-10#1)
play multiple roles in##2##4##(1992-11#1)(2013-8#1)
play multiple roles##3##3##(1992-11#1)(1994-12#1)(2013-8#1)
play no role in##2##4##(2007-12#1)(2007-3#1)
play no##3##2##(1991-1#1)(2007-12#1)(2007-3#1)
play only a minor role in the##2##7##(1997-4#1)(2008-9#1)
play only a minor role##4##5##(1997-4#1)(2008-5#2)(2008-9#1)
play only a##6##3##(1997-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-4#1)
play out##2##2##(2007-8#1)(2008-5#1)
play pivotal roles in##3##4##(2007-12#1)(2010-3#1)(2011-2#1)
play pivotal roles##4##3##(2007-12#1)(2010-3#1)(2011-2#1)(2012-12#1)
play role in##3##3##(2007-1#1)(2007-7#1)(2013-7#1)
play roles as##2##3##(1991-2#1)(1995-6#1)
play roles in both##2##4##(2009-10#1)(2012-2#1)
play roles in mammalian##2##4##(1992-12#1)(2007-12#1)
play roles in the##4##4##(2007-2#2)(2008-8#1)(2010-8#1)
play roles in##21##3##(1992-12#1)(1992-8#1)(1994-8#1)(1996-3#1)(1997-6#1)(2007-12#2)(2007-2#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-8#1)(2010-8#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)
play roles##23##2##(1991-2#1)(1992-12#1)(1992-8#1)(1994-8#1)(1995-6#1)(1996-3#1)(1997-6#1)(2007-12#2)(2007-2#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-8#1)(2010-8#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)
play several roles in##2##4##(2008-1#1)(2009-8#1)
play several##3##2##(2008-1#1)(2009-8#1)(2012-2#1)
play significant roles in the##2##5##(1990-8#1)(2007-7#1)
play significant roles in##7##4##(1990-8#1)(1995-2#1)(1997-6#1)(2007-7#1)(2008-9#1)(2011-1#1)(2012-1#1)
play significant##8##2##(1990-8#1)(1995-2#1)(1997-6#1)(2007-7#1)(2008-9#1)(2011-1#1)(2012-1#1)(2013-8#1)
play some role in##3##4##(2006-4#1)(2008-7#1)(2008-8#1)
play some role##4##3##(2006-4#1)(2007-2#1)(2008-7#1)(2008-8#1)
play some##9##2##(1992-7#1)(1993-8#1)(1994-3#1)(2006-4#1)(2007-2#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-2#1)
play specific roles in##2##4##(1992-12#1)(1995-2#1)
play such##2##2##(1995-2#1)(2007-4#1)
play the major role in##2##5##(1992-11#1)(1997-9#1)
play the most important role##3##5##(1996-5#1)(2007-11#1)(2008-10#1)
play the role of##7##4##(1990-12#1)(1993-10#1)(1993-12#1)(2006-12#1)(2007-9#1)(2008-10#2)
play the##18##2##(1990-12#1)(1992-11#1)(1993-10#1)(1993-12#1)(1995-12#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-9#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-4#1)(2013-8#1)
play their##3##2##(2010-3#1)(2010-8#1)(2012-12#1)
play therapy##2##2##(2009-9#2)
play to##2##2##(1993-12#1)(2006-7#1)
play two##2##2##(2009-10#1)(2010-5#1)
play unique roles in the##2##5##(1991-4#1)(1996-3#1)
play unique roles in##3##4##(1991-4#1)(1992-10#1)(1996-3#1)
play unique roles##4##3##(1991-4#1)(1992-10#1)(1996-3#1)(1996-8#1)
play very important roles##2##4##(1995-9#1)(2008-11#1)
play very important##3##3##(1995-9#1)(2008-11#1)(2008-5#1)
play very##4##2##(1995-9#1)(2008-11#1)(2008-5#1)(2008-8#1)
play vital roles in##3##4##(2010-9#1)(2012-12#2)
play with##5##2##(2008-12#1)(2008-4#1)(2008-7#1)(2009-9#1)(2011-1#1)
play##1976##1##(1990-10#5)(1990-11#7)(1990-12#9)(1990-2#5)(1990-3#3)(1990-4#3)(1990-5#6)(1990-6#2)(1990-7#4)(1990-8#5)(1990-9#4)(1991-1#4)(1991-10#4)(1991-11#4)(1991-12#8)(1991-2#4)(1991-3#10)(1991-4#7)(1991-5#11)(1991-6#2)(1991-7#9)(1991-8#4)(1991-9#11)(1992-1#5)(1992-10#4)(1992-11#10)(1992-12#10)(1992-2#1)(1992-3#12)(1992-4#5)(1992-5#2)(1992-6#6)(1992-7#5)(1992-8#9)(1992-9#20)(1993-1#3)(1993-10#2)(1993-11#7)(1993-12#19)(1993-2#3)(1993-3#6)(1993-4#4)(1993-5#3)(1993-6#6)(1993-7#6)(1993-8#3)(1993-9#9)(1994-1#2)(1994-10#3)(1994-11#19)(1994-12#16)(1994-2#10)(1994-3#11)(1994-4#1)(1994-5#7)(1994-6#8)(1994-8#19)(1994-9#7)(1995-1#6)(1995-10#2)(1995-11#6)(1995-12#24)(1995-2#18)(1995-3#12)(1995-5#6)(1995-6#12)(1995-7#1)(1995-8#12)(1995-9#1)(1996-1#6)(1996-10#13)(1996-11#5)(1996-12#11)(1996-2#10)(1996-3#12)(1996-4#7)(1996-5#11)(1996-6#5)(1996-7#3)(1996-8#10)(1996-9#3)(1997-1#9)(1997-2#12)(1997-3#8)(1997-4#17)(1997-5#5)(1997-6#11)(1997-7#17)(1997-8#11)(1997-9#2)(2003-11#2)(2004-1#1)(2004-11#1)(2004-12#2)(2004-2#1)(2004-3#1)(2004-4#1)(2005-10#9)(2005-11#9)(2005-12#1)(2005-7#9)(2005-8#5)(2005-9#1)(2006-1#2)(2006-10#31)(2006-11#5)(2006-12#3)(2006-2#11)(2006-3#3)(2006-4#4)(2006-5#7)(2006-6#10)(2006-7#9)(2006-8#19)(2006-9#5)(2007-1#7)(2007-10#11)(2007-11#34)(2007-12#26)(2007-2#8)(2007-3#5)(2007-4#2)(2007-5#2)(2007-6#6)(2007-7#11)(2007-8#14)(2007-9#10)(2008-1#32)(2008-10#75)(2008-11#49)(2008-12#11)(2008-2#17)(2008-3#27)(2008-4#48)(2008-5#40)(2008-6#13)(2008-7#56)(2008-8#36)(2008-9#40)(2009-1#2)(2009-10#15)(2009-11#6)(2009-12#1)(2009-2#5)(2009-3#5)(2009-4#14)(2009-5#8)(2009-6#9)(2009-7#9)(2009-8#25)(2009-9#19)(2010-1#6)(2010-10#11)(2010-11#14)(2010-12#32)(2010-2#15)(2010-3#12)(2010-4#5)(2010-5#9)(2010-6#1)(2010-7#8)(2010-8#15)(2010-9#3)(2011-1#43)(2011-10#2)(2011-12#9)(2011-2#52)(2011-3#2)(2011-7#1)(2012-1#12)(2012-11#5)(2012-12#45)(2012-2#42)(2012-3#17)(2012-7#1)(2012-8#1)(2013-1#43)(2013-7#11)(2013-8#27)
playa##3##1##(2007-10#1)(2008-10#1)(2013-7#1)
playable##2##1##(2006-7#2)
playback systems##2##2##(2008-10#1)(2008-3#1)
playback##11##1##(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#4)(2009-8#2)
playbacks of##2##2##(2012-2#1)(2013-8#1)
playbacks##4##1##(2008-8#1)(2012-2#1)(2013-8#2)
played a central role in the##2##6##(1997-1#1)(2008-8#1)
played a central role##3##4##(1997-1#1)(2004-12#1)(2008-8#1)
played a crucial role in##4##5##(2006-7#1)(2007-8#1)(2008-10#1)(2008-8#1)
played a fundamental role in##2##5##(2008-8#1)(2011-1#1)
played a key role in the##3##6##(2008-6#1)(2009-4#1)(2009-6#1)
played a key role in##10##5##(1996-9#1)(2008-10#1)(2008-11#2)(2008-6#1)(2009-4#1)(2009-6#1)(2010-5#1)(2011-12#1)(2013-1#1)
played a major role in the##2##6##(1991-1#1)(1996-12#1)
played a major role in##3##5##(1991-1#1)(1996-12#1)(2009-4#1)
played a major role##4##4##(1991-1#1)(1996-12#1)(2009-4#1)(2011-2#1)
played a minor role in##2##5##(1990-8#1)(1995-6#1)
played a minor role##3##4##(1990-8#1)(1995-6#1)(2008-10#1)
played a more##2##3##(1996-7#1)(2007-9#1)
played a part##2##3##(1990-6#1)(1990-9#1)
played a prominent role in##2##5##(2005-5#1)(2008-9#1)
played a role in the##5##5##(2007-8#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
played a role in##14##4##(2007-8#1)(2008-10#3)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-1#2)
played a significant role in the##2##6##(2006-11#1)(2008-4#1)
played a significant role in##9##5##(2006-11#1)(2006-12#2)(2007-10#1)(2008-4#1)(2009-4#1)(2010-2#1)(2010-3#1)(2011-2#1)
played a significant##10##3##(2006-11#1)(2006-12#2)(2007-10#1)(2008-1#1)(2008-4#1)(2009-4#1)(2010-2#1)(2010-3#1)(2011-2#1)
played a##73##2##(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1994-12#1)(1994-6#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-1#1)(2004-12#1)(2005-10#1)(2005-5#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-7#1)(2007-10#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-11#1)(2009-4#3)(2009-6#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-3#2)(2013-1#4)
played an important part in##2##5##(1991-9#1)(1993-10#1)
played an important role in the##9##6##(1991-12#1)(1993-3#1)(1996-1#1)(2006-10#2)(2006-4#1)(2008-1#1)(2008-8#1)(2012-2#1)
played an important role in##22##5##(1991-12#1)(1991-6#1)(1992-12#1)(1993-3#1)(1996-1#1)(2006-10#2)(2006-4#1)(2007-12#1)(2008-1#2)(2008-3#1)(2008-4#1)(2008-8#3)(2009-11#1)(2010-8#1)(2011-3#1)(2012-2#1)(2013-1#2)
played an important role##23##4##(1991-12#1)(1991-6#1)(1992-12#1)(1993-3#1)(1996-1#1)(2006-10#2)(2006-4#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#3)(2009-11#1)(2010-8#1)(2011-3#1)(2012-2#1)(2013-1#2)
played an important##26##3##(1991-12#1)(1991-6#1)(1991-9#1)(1992-12#1)(1993-10#1)(1993-3#1)(1996-1#1)(2006-10#2)(2006-4#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#3)(2009-11#1)(2010-8#1)(2011-3#1)(2012-2#1)(2013-1#2)
played an##30##2##(1991-12#1)(1991-6#1)(1991-9#1)(1992-12#1)(1993-10#1)(1993-3#1)(1996-1#1)(2006-10#3)(2006-4#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#3)(2009-11#1)(2009-4#1)(2009-6#1)(2010-8#1)(2011-3#1)(2012-2#1)(2013-1#2)
played as##2##2##(2006-7#1)(2007-6#1)
played by nuclear##2##3##(1990-11#1)(2007-9#1)
played by the##20##3##(1991-2#1)(1994-3#1)(1995-5#1)(1996-4#1)(1997-1#1)(2005-11#1)(2006-10#2)(2006-2#1)(2007-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2012-2#1)
played by these##3##3##(1990-10#1)(1997-5#1)(2009-8#1)
played by this##2##3##(1993-12#1)(1997-7#1)
played by##88##2##(1990-10#2)(1990-11#1)(1990-9#1)(1991-2#1)(1992-12#1)(1992-2#1)(1993-12#2)(1993-2#1)(1994-12#2)(1994-3#1)(1995-5#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-5#1)(1997-7#1)(2005-1#1)(2005-11#2)(2006-10#8)(2006-2#1)(2006-6#2)(2007-1#1)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-4#1)(2009-7#2)(2009-8#2)(2010-10#2)(2011-2#1)(2012-2#4)(2013-1#2)(2013-8#1)
played important roles in the##2##5##(1995-4#1)(2008-11#1)
played important roles in##3##4##(1995-4#1)(2008-11#1)(2012-12#1)
played important roles##4##3##(1995-4#1)(2008-11#2)(2012-12#1)
played important##5##2##(1995-4#1)(2008-11#2)(2012-12#2)
played in its##2##3##(2007-11#2)
played in the##4##3##(1993-6#1)(2008-1#1)(2009-2#2)
played in##13##2##(1993-1#1)(1993-6#1)(1995-12#1)(2005-9#1)(2007-11#2)(2008-1#1)(2008-12#1)(2008-6#1)(2009-2#2)(2010-7#1)(2013-1#1)
played key roles##2##3##(2009-12#1)(2010-12#1)
played only a##2##3##(2006-10#1)(2012-1#1)
played out##4##2##(1994-2#1)(2007-8#1)(2010-11#1)(2012-3#1)
played the##3##2##(2008-10#1)(2008-12#1)(2013-1#1)
played##246##1##(1990-10#2)(1990-11#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#2)(1991-2#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-2#2)(1992-6#1)(1992-9#1)(1993-1#6)(1993-10#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#2)(1996-9#2)(1997-1#3)(1997-5#2)(1997-7#1)(2004-12#1)(2005-1#1)(2005-10#1)(2005-11#2)(2005-5#1)(2005-8#1)(2005-9#1)(2006-10#14)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#2)(2006-7#3)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#3)(2008-1#8)(2008-10#17)(2008-11#7)(2008-12#5)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#5)(2008-7#6)(2008-8#8)(2008-9#7)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#3)(2009-4#5)(2009-6#3)(2009-7#2)(2009-8#3)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#10)(2013-8#1)
player classification##2##2##(2007-10#2)
player for##2##2##(2009-3#1)(2013-7#1)
player in the development of##2##5##(2005-8#1)(2010-5#1)
player in the##15##3##(1994-12#1)(1995-12#1)(2005-8#1)(2006-11#1)(2008-11#2)(2009-8#1)(2010-11#1)(2010-12#2)(2010-5#1)(2011-2#2)(2012-12#1)(2013-8#1)
player in##22##2##(1994-12#1)(1995-12#1)(1995-3#1)(1996-2#1)(2005-8#1)(2006-11#1)(2008-1#1)(2008-11#2)(2008-4#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-8#1)
player to##2##2##(2006-3#1)(2008-11#1)
player##46##1##(1992-9#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-2#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-3#5)(2006-7#1)(2007-10#3)(2007-7#1)(2008-1#1)(2008-11#3)(2008-2#2)(2008-4#1)(2008-9#1)(2009-1#2)(2009-3#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#1)(2013-7#1)(2013-8#1)
player's##2##1##(2008-2#1)(2012-1#1)
players and##4##2##(1996-6#1)(2011-2#2)(2013-1#1)
players have##3##2##(2007-4#1)(2007-9#1)(2011-2#1)
players in the process##2##4##(1995-6#1)(2012-12#1)
players in the##16##3##(1995-6#1)(1996-12#1)(1997-2#1)(1997-3#1)(2004-3#1)(2008-4#1)(2009-10#2)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)
players in##34##2##(1993-3#1)(1995-2#1)(1995-6#1)(1996-12#2)(1997-1#1)(1997-2#1)(1997-3#1)(2004-3#1)(2007-12#1)(2008-4#1)(2008-7#2)(2009-10#2)(2009-3#1)(2009-5#2)(2010-3#1)(2010-5#3)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-7#2)
players involved in##3##3##(2007-11#1)(2008-8#1)(2012-3#1)
players involved##5##2##(2007-11#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-3#1)
players of##4##2##(2009-3#1)(2011-2#2)(2012-3#1)
players under##2##2##(2008-5#1)(2011-2#1)
players were##4##2##(2008-5#1)(2011-2#2)(2013-1#1)
players who##2##2##(1997-3#1)(2010-1#1)
players with##2##2##(2009-10#1)(2010-1#1)
players##103##1##(1991-12#1)(1992-9#1)(1993-3#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-12#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#3)(2004-3#1)(2005-7#1)(2006-3#6)(2007-11#3)(2007-12#1)(2007-4#1)(2007-7#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#3)(2009-3#2)(2009-5#2)(2009-6#1)(2010-1#3)(2010-3#2)(2010-5#3)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#14)(2012-12#3)(2012-2#1)(2012-3#7)(2013-1#8)(2013-7#6)
players'##6##1##(2007-4#1)(2008-8#2)(2011-2#2)(2012-3#1)
playful##4##1##(1992-9#3)(2008-11#1)
playfulness##3##1##(1992-9#2)(2008-4#1)
playground##2##1##(2009-10#1)(2012-2#1)
playgrounds##2##1##(2008-11#1)(2012-2#1)
playgroups##2##1##(2008-12#2)
playing a computer##2##3##(1997-7#1)(2007-10#1)
playing a key role in the pathogenesis of CNS manifestations associated with HUS##2##13##(2013-1#2)
playing a key role in the##3##6##(2009-8#1)(2013-1#2)
playing a key role in##6##5##(1994-8#1)(2008-1#1)(2008-5#1)(2009-8#1)(2013-1#2)
playing a major role in##3##5##(1990-11#1)(2008-10#1)(2013-1#1)
playing a role in the##5##5##(1993-11#1)(1993-3#1)(1997-7#1)(2009-3#1)(2010-5#1)
playing a role in##10##4##(1992-8#1)(1993-11#1)(1993-3#2)(1994-12#1)(1997-7#1)(2008-7#1)(2009-1#1)(2009-3#1)(2010-5#1)
playing a role##12##3##(1990-11#1)(1992-8#1)(1993-11#1)(1993-3#2)(1994-12#1)(1997-7#1)(2008-7#1)(2009-1#1)(2009-3#1)(2009-9#1)(2010-5#1)
playing a##41##2##(1990-11#2)(1992-8#1)(1993-11#1)(1993-3#2)(1994-12#1)(1994-8#1)(1994-9#1)(1997-2#1)(1997-7#2)(2007-10#2)(2007-12#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-1#2)(2009-10#2)(2009-3#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#3)
playing an essential role in##2##5##(2007-12#1)(2012-1#1)
playing an important role in the##2##6##(2006-10#1)(2011-2#1)
playing an important role in##9##5##(2006-10#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-2#1)(2013-1#1)
playing an important role##10##4##(2006-10#1)(2007-2#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-2#1)(2013-1#1)
playing an important##11##3##(2006-10#1)(2007-10#1)(2007-2#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-2#1)(2013-1#1)
playing an increasingly important role in the##3##7##(1990-10#1)(2007-7#1)(2009-4#1)
playing an increasingly important role in##6##6##(1990-10#1)(1992-6#1)(2007-7#1)(2009-4#2)(2010-12#1)
playing an increasingly##7##3##(1990-10#1)(1992-6#1)(2007-7#1)(2009-4#2)(2010-12#1)(2010-7#1)
playing an##22##2##(1990-10#1)(1992-6#2)(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#3)(2009-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-1#1)
playing and##2##2##(1992-1#1)(1993-5#1)
playing animal##2##2##(1992-9#2)
playing at##2##2##(1990-6#1)(1993-1#1)
playing field##2##2##(2009-8#1)(2010-7#1)
playing important roles in##2##4##(1996-8#1)(2013-8#1)
playing important##3##2##(1996-8#1)(2005-8#1)(2013-8#1)
playing key roles in##2##4##(2007-8#1)(2008-8#1)
playing key roles##3##3##(1991-5#1)(2007-8#1)(2008-8#1)
playing roles in##2##3##(2009-10#2)
playing such games##2##3##(2006-7#2)
playing surfaces##4##2##(2013-1#4)
playing with thin dolls##2##4##(2011-1#2)
playing with##3##2##(2005-7#1)(2011-1#2)
playing##119##1##(1990-10#1)(1990-11#2)(1990-6#7)(1991-5#1)(1992-1#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-3#2)(1993-5#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-4#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-7#2)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-7#3)(2007-10#3)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#2)(2009-10#5)(2009-11#1)(2009-3#1)(2009-4#3)(2009-7#1)(2009-8#4)(2009-9#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#2)(2012-1#2)(2012-12#5)(2012-3#1)(2013-1#11)(2013-8#1)
plays a central role in the regulation of##2##8##(1990-10#1)(1994-12#1)
plays a central role in the##17##6##(1990-10#1)(1990-11#1)(1990-6#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-6#1)(1996-5#1)(1997-4#1)(2006-3#1)(2007-12#1)(2007-9#1)(2008-4#1)(2009-10#1)(2009-9#1)(2011-2#1)(2013-1#1)
plays a central role in##38##5##(1990-10#1)(1990-11#1)(1990-6#1)(1991-2#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#2)(2006-3#1)(2007-12#2)(2007-9#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-8#1)(2009-10#1)(2009-8#2)(2009-9#1)(2010-11#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
plays a central role##41##4##(1990-10#1)(1990-11#1)(1990-6#1)(1991-2#2)(1992-3#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#2)(2006-3#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-8#1)(2009-10#1)(2009-8#2)(2009-9#1)(2010-11#2)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
plays a critical role in maintaining##2##6##(2007-5#1)(2011-2#1)
plays a critical role in the development of##2##8##(2008-7#1)(2008-9#1)
plays a critical role in the##20##6##(1990-5#1)(1995-3#1)(1995-6#1)(1997-6#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-8#1)(2011-1#1)(2012-2#3)(2013-1#1)
plays a critical role in##49##5##(1990-11#1)(1990-5#1)(1991-7#1)(1994-2#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-7#1)(1997-1#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#6)(2013-1#3)
plays a critical role##55##4##(1990-11#1)(1990-5#1)(1991-7#1)(1994-2#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-7#1)(1997-1#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#4)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#2)(2009-9#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#6)(2013-1#3)
plays a critical##58##3##(1990-11#1)(1990-5#1)(1991-12#1)(1991-7#1)(1994-2#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-7#1)(1997-1#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#4)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#2)(2009-9#1)(2010-11#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#6)(2013-1#3)
plays a crucial role in neuronal##2##6##(1997-6#1)(2013-8#1)
plays a crucial role in the development of the CNS complications##2##11##(2013-1#2)
plays a crucial role in the pathogenesis of##3##8##(2005-7#1)(2010-12#1)(2011-2#1)
plays a crucial role in the##16##6##(1991-10#1)(1994-10#1)(1994-3#1)(1996-11#1)(1997-6#1)(2005-7#1)(2006-10#1)(2008-11#1)(2008-2#1)(2009-7#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#3)
plays a crucial role in##43##5##(1991-10#1)(1994-10#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-4#1)(1997-6#2)(1997-7#3)(2005-7#1)(2006-10#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
plays a crucial role##46##4##(1991-10#2)(1993-6#1)(1994-10#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-4#1)(1997-6#2)(1997-7#3)(2005-7#1)(2006-10#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
plays a crucial##48##3##(1991-10#2)(1993-6#1)(1994-10#1)(1994-3#2)(1995-3#1)(1995-6#1)(1996-11#1)(1996-4#1)(1997-6#2)(1997-7#3)(2005-7#1)(2006-10#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
plays a direct##2##3##(1994-5#1)(2006-11#1)
plays a dominant role in##2##5##(2010-4#1)(2012-1#1)
plays a functional role##2##4##(2008-11#1)(2009-12#1)
plays a fundamental role in the regulation of##2##8##(1995-3#1)(2008-4#1)
plays a fundamental role in the##4##6##(1995-3#1)(2007-5#1)(2008-4#1)(2008-7#1)
plays a fundamental role in##6##5##(1990-11#1)(1995-3#1)(2007-5#1)(2008-4#1)(2008-7#1)(2009-6#1)
plays a greater role than the##2##6##(1991-11#1)(2008-10#1)
plays a key regulatory role in the##2##7##(2006-11#1)(2008-7#1)
plays a key regulatory role in##3##6##(2006-11#1)(2008-7#1)(2013-1#1)
plays a key role in regulating the##2##7##(1996-8#1)(2006-1#1)
plays a key role in regulating##5##6##(1992-5#1)(1996-11#1)(1996-8#1)(2006-1#1)(2011-10#1)
plays a key role in the de novo synthesis of##2##10##(1995-3#1)(2007-11#1)
plays a key role in the development##2##7##(2008-11#1)(2010-12#1)
plays a key role in the regulation of blood pressure##2##10##(2007-1#1)(2008-1#1)
plays a key role in the regulation of##3##8##(2007-1#1)(2007-12#1)(2008-1#1)
plays a key role in the##29##6##(1990-9#1)(1991-5#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-3#1)(2005-8#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#2)(2009-7#1)(2010-12#1)(2011-1#2)(2012-11#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
plays a key role in this##2##6##(1991-5#1)(1997-7#1)
plays a key role in##66##5##(1990-9#1)(1991-5#2)(1992-5#1)(1994-12#1)(1994-2#1)(1994-6#2)(1994-8#2)(1995-1#1)(1995-11#2)(1995-3#1)(1996-11#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-7#2)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-7#1)(2010-12#3)(2011-1#2)(2011-10#1)(2011-2#2)(2012-11#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#2)
plays a key role##71##4##(1990-9#1)(1991-5#2)(1992-5#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#2)(1994-8#2)(1995-1#1)(1995-11#2)(1995-3#1)(1996-11#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-7#2)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-3#1)(2009-7#1)(2010-12#3)(2011-1#2)(2011-10#1)(2011-2#2)(2012-11#3)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#6)(2013-8#2)
plays a key##76##3##(1990-9#1)(1991-5#2)(1992-5#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#2)(1994-8#2)(1995-1#1)(1995-11#2)(1995-3#1)(1996-11#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-7#2)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#2)(2009-3#1)(2009-6#1)(2009-7#1)(2010-12#3)(2011-1#2)(2011-10#1)(2011-2#2)(2012-11#3)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#7)(2013-8#2)
plays a major part in##4##5##(1993-9#1)(2011-2#1)(2012-12#2)
plays a major role in characterizing quasi-monochromatic##3##7##(2007-12#2)(2008-3#1)
plays a major role in determining the##2##7##(1995-10#1)(2008-10#1)
plays a major role in determining##3##6##(1995-10#1)(2008-10#1)(2008-7#1)
plays a major role in regulating##3##6##(1995-8#1)(2012-12#1)(2012-3#1)
plays a major role in the occurrence of##2##8##(2010-4#1)(2012-12#1)
plays a major role in the regulation of##2##8##(1990-7#1)(1995-8#1)
plays a major role in the##18##6##(1990-7#1)(1992-10#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-10#1)(1997-8#1)(2004-12#1)(2006-10#2)(2007-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-1#1)(2010-4#1)(2012-12#1)
plays a major role in##39##5##(1990-7#1)(1991-9#1)(1992-10#1)(1994-11#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-8#1)(1997-1#1)(1997-8#1)(2004-12#1)(2005-11#1)(2006-10#3)(2006-8#1)(2007-10#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-3#1)(2009-8#1)(2010-4#1)(2012-12#2)(2012-3#1)
plays a major role##42##4##(1990-7#1)(1991-9#1)(1992-10#1)(1994-11#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-8#1)(1997-1#1)(1997-8#1)(2004-12#1)(2005-11#1)(2006-10#3)(2006-8#1)(2007-10#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-3#1)(2009-8#1)(2010-4#1)(2012-12#3)(2012-3#1)
plays a major##48##3##(1990-11#1)(1990-7#1)(1991-9#1)(1992-10#1)(1993-9#1)(1994-11#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-8#1)(1997-1#1)(1997-8#1)(2004-12#1)(2005-11#1)(2006-10#3)(2006-8#1)(2007-10#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#5)(2012-3#1)
plays a modulatory##2##3##(1993-6#1)(2008-5#1)
plays a more important role in##2##6##(1991-12#1)(2013-1#1)
plays a more##5##3##(1991-12#1)(2005-10#1)(2010-2#1)(2013-1#1)(2013-8#1)
plays a physiological role in##2##5##(1991-9#1)(2008-4#1)
plays a pivotal role for##2##5##(1995-2#1)(2005-11#1)
plays a pivotal role in the pathogenesis of##2##8##(1996-10#1)(1997-8#1)
plays a pivotal role in the##6##6##(1996-10#1)(1997-8#1)(2006-12#1)(2009-4#1)(2012-2#1)(2013-7#1)
plays a pivotal role in##17##5##(1994-12#1)(1995-1#1)(1995-6#1)(1996-10#1)(1996-5#1)(1997-7#1)(1997-8#1)(2006-12#1)(2008-10#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
plays a pivotal role##22##4##(1994-12#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-5#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
plays a positive role in##3##5##(1991-5#1)(2009-8#1)(2011-2#1)
plays a positive role##4##4##(1991-5#1)(1995-2#1)(2009-8#1)(2011-2#1)
plays a predominant role in##3##5##(1996-12#1)(2008-11#1)(2008-5#1)
plays a primary role in the##3##6##(1993-10#1)(2006-11#1)(2008-7#1)
plays a primary role in##5##5##(1993-10#1)(1995-5#1)(2006-11#1)(2008-7#1)(2008-8#1)
plays a prominent role in##6##5##(1996-5#1)(2006-12#1)(2008-10#1)(2008-11#1)(2010-2#1)(2011-1#1)
plays a regulatory role in##2##5##(1993-3#1)(2010-10#1)
plays a regulatory role##3##4##(1993-3#1)(2010-10#1)(2010-12#1)
plays a relatively minor role in##2##6##(1997-8#1)(2009-9#1)
plays a role as an##2##5##(1994-12#1)(2008-7#1)
plays a role as##3##4##(1994-12#1)(2008-7#1)(2009-8#1)
plays a role in encoding##2##5##(1995-12#1)(1996-5#1)
plays a role in regulating##4##5##(1991-3#1)(1994-9#1)(1995-12#1)(2012-12#1)
plays a role in the development of##5##7##(1994-12#1)(1997-4#1)(2010-12#1)(2011-2#1)(2013-8#1)
plays a role in the maintenance of##2##7##(1996-5#1)(1997-1#1)
plays a role in the neural control of the##2##9##(1992-8#1)(1997-4#1)
plays a role in the pathogenesis of##3##7##(2006-10#1)(2012-12#1)(2013-8#1)
plays a role in the regulation of atypical aPKCζ but not in aPKCι##2##13##(2012-12#2)
plays a role in the regulation of##5##7##(1996-5#1)(2010-12#1)(2012-12#2)(2012-2#1)
plays a role in the##42##5##(1991-8#1)(1992-12#1)(1992-8#2)(1993-3#1)(1994-12#3)(1994-6#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-4#1)(1996-5#2)(1997-1#3)(1997-2#1)(1997-4#2)(2006-10#2)(2006-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-12#2)(2010-7#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-8#3)
plays a role in##101##4##(1991-2#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#2)(1993-11#1)(1993-3#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#5)(1996-8#1)(1997-1#3)(1997-2#2)(1997-4#3)(1997-6#3)(2006-10#2)(2006-12#1)(2006-3#1)(2007-1#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-12#2)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#6)(2012-2#5)(2013-1#3)(2013-8#4)
plays a role not only in the##2##7##(2008-9#1)(2010-3#1)
plays a role##111##3##(1990-8#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#2)(1993-11#1)(1993-3#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-12#5)(1994-2#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#5)(1996-8#1)(1997-1#3)(1997-2#2)(1997-4#3)(1997-6#3)(2005-12#1)(2006-10#3)(2006-12#1)(2006-3#1)(2007-1#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-3#2)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#6)(2012-2#5)(2013-1#3)(2013-8#4)
plays a significant role in regulating##2##6##(2009-10#1)(2012-12#1)
plays a significant role in the regulation of##3##8##(1990-7#1)(1990-8#1)(2008-1#1)
plays a significant role in the##11##6##(1990-7#1)(1990-8#2)(1994-10#1)(2006-10#1)(2006-4#1)(2008-1#1)(2008-4#1)(2008-5#1)(2012-2#1)(2013-1#1)
plays a significant role in##22##5##(1990-7#1)(1990-8#2)(1994-10#1)(1995-2#1)(2006-10#2)(2006-4#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
plays a significant role##25##4##(1990-7#1)(1990-8#2)(1993-4#1)(1994-10#1)(1995-2#1)(2006-10#2)(2006-4#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2009-10#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
plays a significant##27##3##(1990-7#1)(1990-8#2)(1993-4#1)(1993-8#1)(1994-10#1)(1995-2#1)(1996-1#1)(2006-10#2)(2006-4#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2009-10#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
plays a strategic role##2##4##(2008-9#1)(2011-1#1)
plays a substantial role in##2##5##(2007-10#1)(2010-3#1)
plays a substantial##3##3##(2007-10#1)(2010-3#1)(2013-1#1)
plays a very important role in##3##6##(2006-12#1)(2008-9#1)(2012-2#1)
plays a very important##5##4##(2006-12#1)(2008-5#1)(2008-9#1)(2010-11#1)(2012-2#1)
plays a vital role in the##4##6##(2008-1#1)(2010-12#1)(2012-12#2)
plays a vital role in##10##5##(1990-12#1)(2007-7#1)(2008-1#1)(2010-1#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#2)(2013-1#1)
plays a vital##11##3##(1990-12#1)(2007-7#1)(2008-1#1)(2010-1#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#3)(2013-1#1)
plays a##528##2##(1990-10#1)(1990-11#4)(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#3)(1991-7#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-8#3)(1992-9#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#4)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#3)(1994-11#3)(1994-12#8)(1994-2#4)(1994-3#3)(1994-5#1)(1994-6#5)(1994-8#2)(1994-9#1)(1995-1#5)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#6)(1995-3#7)(1995-5#1)(1995-6#6)(1995-7#1)(1995-8#3)(1996-1#1)(1996-10#2)(1996-11#3)(1996-12#3)(1996-3#2)(1996-4#3)(1996-5#9)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#5)(1997-2#2)(1997-4#4)(1997-6#7)(1997-7#7)(1997-8#4)(2004-12#2)(2005-10#2)(2005-11#3)(2005-12#1)(2005-7#3)(2005-8#1)(2006-1#1)(2006-10#15)(2006-11#4)(2006-12#4)(2006-3#2)(2006-4#2)(2006-6#1)(2006-8#2)(2007-1#3)(2007-10#2)(2007-11#2)(2007-12#6)(2007-5#3)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#8)(2008-10#21)(2008-11#13)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#9)(2008-5#17)(2008-7#10)(2008-8#7)(2008-9#7)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#2)(2009-3#5)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#6)(2009-9#5)(2010-1#1)(2010-10#4)(2010-11#5)(2010-12#10)(2010-2#4)(2010-3#4)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#14)(2011-10#1)(2011-2#13)(2012-1#2)(2012-11#3)(2012-12#19)(2012-2#24)(2012-3#4)(2013-1#25)(2013-7#3)(2013-8#10)
plays an active role in##2##5##(1995-2#1)(2008-10#1)
plays an active role##3##4##(1995-2#1)(2006-10#1)(2008-10#1)
plays an essential role in the##7##6##(1994-9#1)(1996-9#1)(2006-2#1)(2007-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
plays an essential role in##19##5##(1992-3#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-9#1)(1997-3#1)(2003-11#1)(2006-10#1)(2006-2#1)(2007-4#1)(2007-9#1)(2008-6#1)(2008-9#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
plays an essential##20##3##(1992-3#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-9#1)(1997-3#1)(2003-11#1)(2006-10#1)(2006-2#1)(2007-4#1)(2007-9#1)(2008-6#1)(2008-9#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
plays an important part in##2##5##(1996-3#1)(1996-8#1)
plays an important part##3##4##(1996-3#1)(1996-8#1)(2005-8#1)
plays an important role as a##3##6##(1991-9#1)(1995-3#1)(2009-8#1)
plays an important role as##4##5##(1991-9#1)(1995-3#1)(2008-4#1)(2009-8#1)
plays an important role during##2##5##(1990-10#1)(2008-5#1)
plays an important role for the##3##6##(1997-6#1)(2008-8#1)(2011-2#1)
plays an important role for##4##5##(1997-6#1)(2008-5#1)(2008-8#1)(2011-2#1)
plays an important role in a##2##6##(1990-2#1)(2008-5#1)
plays an important role in antioxidant defence##2##7##(2010-8#2)
plays an important role in cancer##3##6##(2007-11#1)(2009-8#1)(2012-12#1)
plays an important role in cell proliferation##2##7##(2008-9#1)(2013-1#1)
plays an important role in cell##3##6##(2008-9#1)(2011-2#1)(2013-1#1)
plays an important role in cellular proliferation##2##7##(1995-6#1)(2010-4#1)
plays an important role in chronic##2##6##(2005-7#1)(2011-2#1)
plays an important role in day case surgery##2##8##(2006-10#2)
plays an important role in determining the##2##7##(2008-5#1)(2010-4#1)
plays an important role in determining##3##6##(2004-12#1)(2008-5#1)(2010-4#1)
plays an important role in its##3##6##(2007-5#1)(2008-10#1)(2008-8#1)
plays an important role in pain##2##6##(1996-12#1)(2008-8#1)
plays an important role in regulating##7##6##(1991-12#1)(1995-2#1)(1995-8#1)(1997-4#1)(2008-4#1)(2008-8#1)(2010-2#1)
plays an important role in the assessment of##2##8##(2005-11#1)(2012-2#1)
plays an important role in the binding##2##7##(1994-8#1)(2006-12#1)
plays an important role in the daily##2##7##(1991-12#1)(2008-11#1)
plays an important role in the development and progression of##2##10##(2009-5#1)(2013-1#1)
plays an important role in the development of##7##8##(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-10#1)(2010-4#1)(2012-3#1)
plays an important role in the development##9##7##(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-10#1)(2010-4#1)(2012-3#1)(2013-1#1)
plays an important role in the early development of the##2##10##(1992-12#1)(1992-5#1)
plays an important role in the functioning of##2##8##(2012-12#1)(2013-8#1)
plays an important role in the interaction##2##7##(1995-6#1)(2008-10#1)
plays an important role in the maintenance of##2##8##(1995-1#1)(2008-5#1)
plays an important role in the pathogenesis of##7##8##(1991-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2013-3#1)(2013-7#1)
plays an important role in the pathophysiology of##2##8##(2008-7#1)(2009-8#1)
plays an important role in the process of##2##8##(1996-5#1)(2005-11#1)
plays an important role in the recovery of##2##8##(1992-7#1)(2008-11#1)
plays an important role in the regulation of cellular##2##9##(1991-4#1)(1991-5#1)
plays an important role in the regulation of##7##8##(1991-4#1)(1991-5#1)(1993-12#1)(1995-11#1)(2007-8#1)(2008-4#1)(2008-8#1)
plays an important role in the##103##6##(1990-12#1)(1990-8#2)(1990-9#1)(1991-11#2)(1991-12#3)(1991-4#1)(1991-5#2)(1992-12#1)(1992-5#1)(1992-7#3)(1993-11#2)(1993-12#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-4#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#2)(1996-5#2)(1996-6#1)(1997-4#1)(1997-7#1)(2005-11#2)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#7)(2008-11#4)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#4)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#2)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#1)(2011-12#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#3)(2013-3#1)(2013-7#2)(2013-8#1)
plays an important role in this##6##6##(1992-3#1)(1993-11#1)(2004-9#1)(2007-2#1)(2008-12#1)(2010-2#1)
plays an important role in tumor##2##6##(2008-8#1)(2009-3#1)
plays an important role in tumorigenesis##2##6##(2008-7#1)(2013-1#1)
plays an important role in##217##5##(1990-12#1)(1990-2#2)(1990-8#2)(1990-9#1)(1991-11#2)(1991-12#4)(1991-4#2)(1991-5#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-7#4)(1992-8#1)(1992-9#1)(1993-11#4)(1993-12#2)(1993-2#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-4#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-6#3)(1995-8#4)(1996-1#1)(1996-12#1)(1996-5#2)(1996-6#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-9#2)(2005-10#1)(2005-11#4)(2005-7#2)(2006-10#3)(2006-11#1)(2006-12#3)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#10)(2008-11#5)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#9)(2008-9#2)(2009-10#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#3)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#4)(2010-3#1)(2010-4#3)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#8)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#6)(2013-3#1)(2013-7#4)(2013-8#2)
plays an important role to##3##5##(2008-10#1)(2012-1#1)(2013-7#1)
plays an important role##243##4##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-8#2)(1990-9#1)(1991-11#2)(1991-12#4)(1991-4#2)(1991-5#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-7#4)(1992-8#1)(1992-9#1)(1993-11#4)(1993-12#2)(1993-2#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-4#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#3)(1995-8#4)(1996-1#1)(1996-12#1)(1996-5#2)(1996-6#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(2004-12#1)(2004-9#2)(2005-10#1)(2005-11#5)(2005-7#3)(2006-10#4)(2006-11#1)(2006-12#3)(2006-4#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#12)(2008-11#5)(2008-12#3)(2008-3#2)(2008-4#3)(2008-5#9)(2008-6#1)(2008-7#2)(2008-8#11)(2008-9#2)(2009-10#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#4)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#4)(2010-3#1)(2010-4#3)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#9)(2012-1#3)(2012-12#5)(2012-2#3)(2012-3#3)(2012-7#1)(2013-1#6)(2013-3#1)(2013-7#5)(2013-8#4)
plays an important structural role##2##5##(2009-8#1)(2013-8#1)
plays an important##257##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-8#2)(1990-9#1)(1991-11#2)(1991-12#4)(1991-4#2)(1991-5#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-7#4)(1992-8#1)(1992-9#1)(1993-11#4)(1993-12#2)(1993-2#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-4#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-6#3)(1995-8#4)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(2004-12#1)(2004-9#2)(2005-10#1)(2005-11#5)(2005-7#3)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#3)(2006-4#1)(2006-6#2)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#4)(2008-10#12)(2008-11#5)(2008-12#3)(2008-3#2)(2008-4#3)(2008-5#10)(2008-6#2)(2008-7#2)(2008-8#11)(2008-9#2)(2009-10#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#5)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#4)(2010-3#1)(2010-4#3)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#10)(2012-1#3)(2012-12#5)(2012-2#3)(2012-3#3)(2012-7#1)(2013-1#6)(2013-3#1)(2013-7#5)(2013-8#5)
plays an inhibitory role in the##2##6##(1995-12#1)(1996-11#1)
plays an integral and##2##4##(1996-12#1)(2010-5#1)
plays an integral role in the##2##6##(1993-3#1)(2007-4#1)
plays an integral role in##3##5##(1993-3#1)(2007-4#1)(2010-10#1)
plays an integral##6##3##(1993-3#1)(1996-12#1)(2007-4#1)(2010-10#1)(2010-5#1)(2010-8#1)
plays an##300##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-8#2)(1990-9#1)(1991-11#2)(1991-12#4)(1991-4#2)(1991-5#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-7#4)(1992-8#1)(1992-9#1)(1993-11#4)(1993-12#2)(1993-2#1)(1993-3#2)(1993-7#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#4)(1994-3#1)(1994-4#1)(1994-5#1)(1994-8#1)(1994-9#3)(1995-1#2)(1995-11#1)(1995-12#4)(1995-2#4)(1995-3#2)(1995-6#3)(1995-8#5)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#2)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(2003-11#1)(2004-12#1)(2004-9#2)(2005-10#1)(2005-11#5)(2005-7#3)(2005-8#1)(2006-10#8)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#1)(2006-6#2)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#14)(2008-11#5)(2008-12#3)(2008-3#2)(2008-4#4)(2008-5#10)(2008-6#3)(2008-7#2)(2008-8#11)(2008-9#3)(2009-10#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#5)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#4)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#2)(2010-8#3)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#11)(2012-1#4)(2012-12#7)(2012-2#4)(2012-3#3)(2012-7#1)(2013-1#10)(2013-3#1)(2013-7#5)(2013-8#5)
plays any##2##2##(1990-12#1)(2010-7#1)
plays critical roles in##3##4##(2007-3#1)(2008-1#1)(2013-8#1)
plays crucial role in##3##4##(2007-9#1)(2010-7#1)(2012-2#1)
plays crucial roles in##4##4##(1994-6#1)(2009-6#1)(2009-9#1)(2012-2#1)
plays crucial##7##2##(1994-6#1)(2007-9#1)(2009-6#1)(2009-9#1)(2010-7#1)(2012-2#2)
plays essential##2##2##(1996-10#1)(1996-11#1)
plays for##2##2##(2009-11#1)(2010-7#1)
plays host to a##2##4##(2009-4#1)(2012-1#1)
plays important role in##3##4##(2007-9#1)(2008-4#1)(2011-1#1)
plays important roles as##2##4##(2008-10#1)(2012-2#1)
plays important roles in the##3##5##(2008-10#2)(2008-5#1)
plays important roles in##8##4##(1993-8#1)(1994-9#1)(1995-3#1)(1996-12#1)(2008-10#2)(2008-5#1)(2009-9#1)
plays important roles##10##3##(1993-8#1)(1994-9#1)(1995-3#1)(1996-12#1)(2008-10#3)(2008-5#1)(2009-9#1)(2012-2#1)
plays important##16##2##(1993-8#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-12#1)(2007-9#1)(2008-10#4)(2008-4#1)(2008-5#1)(2009-9#1)(2010-5#1)(2011-1#1)(2012-2#1)
plays in the development and progression of##2##7##(2004-9#1)(2012-12#1)
plays in the development##3##4##(2004-9#1)(2010-7#1)(2012-12#1)
plays in the##17##3##(1993-12#1)(1994-3#1)(1995-8#1)(2004-9#1)(2005-12#1)(2006-10#1)(2007-7#2)(2008-12#1)(2008-3#1)(2008-4#1)(2010-7#1)(2012-12#2)(2013-1#2)(2013-7#1)
plays in##34##2##(1992-10#1)(1992-6#1)(1993-12#2)(1994-3#1)(1995-1#1)(1995-8#1)(1996-3#1)(1996-6#1)(2004-9#1)(2005-12#1)(2006-10#2)(2007-11#1)(2007-7#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#2)(2013-7#1)
plays key roles in##2##4##(2007-10#1)(2012-12#1)
plays key##3##2##(2007-10#1)(2009-6#1)(2012-12#1)
plays major role in##2##4##(1996-6#1)(2011-2#1)
plays many##2##2##(1990-4#1)(2008-11#1)
plays no role in##3##4##(1996-4#1)(2007-8#1)(2010-7#1)
plays no role##5##3##(1996-4#1)(2007-8#1)(2008-7#1)(2010-2#1)(2010-7#1)
plays no##7##2##(1995-8#1)(1996-4#1)(2007-8#1)(2008-6#1)(2008-7#1)(2010-2#1)(2010-7#1)
plays one of the##2##4##(1990-3#1)(2013-1#1)
plays pivotal role in##2##4##(2008-4#1)(2010-5#1)
plays roles in##2##3##(1994-3#1)(2012-3#1)
plays the essential role##2##4##(2008-1#1)(2008-8#1)
plays the##8##2##(1994-8#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-11#1)(2012-2#1)
plays to##2##2##(2008-7#1)(2009-12#1)
plays two##2##2##(2005-11#1)(2009-8#1)
plays very important##2##3##(2007-8#1)(2008-4#1)
plays##958##1##(1990-1#1)(1990-10#2)(1990-11#5)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#5)(1990-9#2)(1991-10#2)(1991-11#3)(1991-12#6)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#5)(1991-7#2)(1991-8#2)(1991-9#3)(1992-10#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#4)(1992-6#2)(1992-7#4)(1992-8#4)(1992-9#2)(1993-10#1)(1993-11#5)(1993-12#4)(1993-2#2)(1993-3#8)(1993-4#1)(1993-6#2)(1993-7#4)(1993-8#2)(1993-9#3)(1994-10#3)(1994-11#4)(1994-12#10)(1994-2#8)(1994-3#7)(1994-4#1)(1994-5#2)(1994-6#6)(1994-8#5)(1994-9#5)(1995-1#8)(1995-10#1)(1995-11#5)(1995-12#7)(1995-2#10)(1995-3#11)(1995-5#1)(1995-6#9)(1995-7#1)(1995-8#10)(1996-1#2)(1996-10#3)(1996-11#5)(1996-12#6)(1996-3#4)(1996-4#4)(1996-5#11)(1996-6#3)(1996-7#2)(1996-8#4)(1996-9#3)(1997-1#6)(1997-2#2)(1997-3#2)(1997-4#7)(1997-6#9)(1997-7#8)(1997-8#5)(2003-11#1)(2004-12#3)(2004-9#3)(2005-10#3)(2005-11#9)(2005-12#2)(2005-7#6)(2005-8#2)(2006-1#1)(2006-10#25)(2006-11#5)(2006-12#7)(2006-2#1)(2006-3#2)(2006-4#3)(2006-6#3)(2006-8#2)(2007-1#4)(2007-10#4)(2007-11#8)(2007-12#9)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#4)(2007-7#6)(2007-8#6)(2007-9#4)(2008-1#15)(2008-10#40)(2008-11#20)(2008-12#7)(2008-2#1)(2008-3#10)(2008-4#19)(2008-5#28)(2008-6#4)(2008-7#14)(2008-8#20)(2008-9#12)(2009-1#1)(2009-10#4)(2009-11#8)(2009-12#3)(2009-3#7)(2009-4#5)(2009-5#2)(2009-6#6)(2009-7#3)(2009-8#12)(2009-9#7)(2010-1#2)(2010-10#7)(2010-11#8)(2010-12#15)(2010-2#9)(2010-3#5)(2010-4#6)(2010-5#5)(2010-6#2)(2010-7#6)(2010-8#7)(2010-9#2)(2011-1#17)(2011-10#1)(2011-12#1)(2011-2#27)(2012-1#7)(2012-11#3)(2012-12#30)(2012-2#32)(2012-3#10)(2012-7#1)(2013-1#38)(2013-3#1)(2013-7#9)(2013-8#17)
plc's##2##1##(2005-8#2)
plc)##6##1##(2005-8#4)(2008-5#2)
ple21##2##1##(1994-3#2)
plea for##7##2##(1990-5#1)(1993-3#1)(2007-8#3)(2010-10#1)(2012-12#1)
plea to##4##2##(1995-1#1)(1996-11#1)(2007-2#1)(2007-6#1)
plea##13##1##(1990-5#1)(1993-3#1)(1995-1#1)(1996-11#2)(2006-7#1)(2007-2#1)(2007-6#1)(2007-8#3)(2010-10#1)(2012-12#1)
plead##2##1##(1995-12#1)(2008-6#1)
pleading for the##2##3##(2005-11#1)(2008-10#1)
pleading##3##1##(2005-11#1)(2008-10#1)(2011-1#1)
pleasant##13##1##(1991-12#1)(1996-6#1)(1997-3#1)(2006-12#2)(2007-9#1)(2008-5#2)(2008-7#1)(2009-5#1)(2011-2#2)(2012-2#1)
pleasantness##13##1##(2007-6#1)(2008-11#1)(2008-5#2)(2012-12#8)(2012-2#1)
please##10##1##(1992-5#1)(1994-3#1)(1995-9#1)(1996-3#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-12#1)(2010-8#1)(2012-3#1)
pleased to see##2##3##(2007-9#1)(2011-12#1)
pleased to##4##2##(1995-3#1)(2007-9#1)(2008-6#1)(2011-12#1)
pleased with the##4##3##(1992-3#1)(2006-4#1)(2006-8#1)(2011-2#1)
pleased with##5##2##(1992-3#1)(1996-11#1)(2006-4#1)(2006-8#1)(2011-2#1)
pleased##10##1##(1991-1#1)(1992-3#1)(1995-3#1)(1996-11#1)(2006-4#1)(2006-8#1)(2007-9#1)(2008-6#1)(2011-12#1)(2011-2#1)
pleasing and##2##2##(2006-10#1)(2007-2#1)
pleasing##8##1##(2004-3#1)(2006-10#1)(2007-1#1)(2007-2#1)(2008-2#1)(2008-6#1)(2009-2#1)(2010-8#1)
pleasurable##6##1##(1992-3#1)(2009-6#1)(2011-2#1)(2012-2#3)
pleasure and##2##2##(1994-6#1)(2008-6#1)
pleasure for##2##2##(2008-7#1)(2009-5#1)
pleasure##20##1##(1990-2#1)(1991-3#1)(1994-6#1)(2006-7#2)(2007-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#2)(2009-6#1)(2010-2#1)(2011-2#4)
pleated##2##1##(1996-6#1)(2006-12#1)
plebejum group##2##2##(2008-5#2)
plebejum##5##1##(2008-5#5)
pleckstrin homology (PH) domain##2##4##(1995-1#1)(2009-7#1)
pleckstrin homology domain of RAC protein kinase##4##7##(1994-12#4)
pleckstrin homology domain of##5##4##(1994-12#4)(1995-1#1)
pleckstrin homology domain##9##3##(1994-11#2)(1994-12#6)(1995-1#1)
pleckstrin homology##13##2##(1994-11#2)(1994-12#7)(1995-1#2)(1996-10#1)(2009-7#1)
plectin gene##5##2##(1996-4#5)
plectin##7##1##(1996-4#7)
pledged##2##1##(1991-9#1)(2007-8#1)
pleiocytosis##2##1##(2007-8#1)(2013-8#1)
pleiotrophic mutations##2##2##(1997-4#2)
pleiotrophic##3##1##(1997-4#2)(2008-9#1)
pleiotrophin##2##1##(1992-5#1)(2007-3#1)
pleiotropic associations##2##2##(1996-6#1)(2010-7#1)
pleiotropic effects of##3##3##(1992-8#1)(1992-9#1)(2008-1#1)
pleiotropic effects on##3##3##(1992-2#1)(1995-2#1)(2010-10#1)
pleiotropic effects##13##2##(1992-2#1)(1992-8#1)(1992-9#1)(1994-3#2)(1995-10#1)(1995-2#1)(1996-2#1)(2008-1#1)(2008-3#1)(2008-4#1)(2010-10#1)(2010-9#1)
pleiotropic phenotypes characteristic for tup1 mutants##2##6##(1990-4#2)
pleiotropic phenotypes of##2##3##(1995-8#1)(2011-2#1)
pleiotropic phenotypes##5##2##(1990-4#2)(1995-8#1)(2009-8#1)(2011-2#1)
pleiotropic##44##1##(1990-2#1)(1990-4#2)(1991-2#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-10#1)(1994-3#2)(1995-10#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-6#1)(2005-11#1)(2005-12#1)(2006-11#1)(2006-8#2)(2007-9#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-8#2)(2010-10#2)(2010-2#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
pleiotropy##8##1##(2007-11#1)(2008-8#1)(2008-9#3)(2009-8#1)(2010-1#2)
pleitropic##2##1##(2009-8#1)(2011-1#1)
plenary and##2##2##(2005-7#1)(2013-7#1)
plenary lectures##4##2##(2005-8#4)
plenary session##3##2##(2005-7#2)(2009-6#1)
plenary sessions##8##2##(2005-7#1)(2005-8#1)(2005-9#1)(2008-5#4)(2010-11#1)
plenary##23##1##(2005-7#4)(2005-8#7)(2005-9#1)(2008-12#1)(2008-5#5)(2008-7#1)(2009-6#1)(2010-11#1)(2013-7#2)
plentiful##7##1##(1992-3#1)(1997-4#1)(2006-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#1)
plenty of room for improvement##2##5##(2008-6#1)(2012-12#1)
plenty of##8##2##(1997-4#1)(2007-7#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-11#1)(2010-5#1)(2012-12#1)
plenty##11##1##(1997-4#1)(2006-1#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#1)
pleocytosis##6##1##(1992-11#1)(1993-7#1)(1997-8#1)(2006-1#1)(2007-12#1)(2009-10#1)
pleomorphic adenoma of the parotid##2##5##(2012-2#2)
pleomorphic adenoma of the##3##4##(2008-8#1)(2012-2#2)
pleomorphic adenoma##7##2##(2007-8#1)(2008-8#1)(2012-2#3)(2013-8#2)
pleomorphic adenomas##4##2##(2007-8#1)(2012-1#3)
pleomorphic carcinoma##2##2##(1991-12#1)(2012-12#1)
pleomorphic liposarcoma##4##2##(2007-2#1)(2008-6#3)
pleomorphic vesicles##2##2##(1992-1#1)(1997-2#1)
pleomorphic xanthoastrocytoma##5##2##(2007-12#1)(2008-7#3)(2013-8#1)
pleomorphic##44##1##(1991-12#2)(1992-1#1)(1997-2#1)(1997-7#1)(2005-7#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#7)(2008-7#3)(2008-8#1)(2009-7#1)(2010-12#1)(2010-6#1)(2012-1#3)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#4)
pleomorphism and##3##2##(2007-12#1)(2008-6#2)
pleomorphism##11##1##(1991-12#1)(1991-4#1)(1993-10#1)(2007-12#2)(2008-11#1)(2008-6#2)(2009-1#1)(2011-12#1)(2011-2#1)
pleotropic##2##1##(2008-3#1)(2009-11#1)
plesiomorphic##4##1##(2007-12#4)
plethora of information##2##3##(2008-4#1)(2008-8#1)
plethora of new##2##3##(2008-1#2)
plethora of##43##2##(1991-1#1)(1993-11#1)(1994-11#1)(1996-12#1)(2004-3#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)
plethysmographic##2##1##(1990-3#1)(2009-5#1)
plethysmography##5##1##(2005-10#2)(2007-8#1)(2013-1#2)
pleura and the##2##3##(1991-12#1)(2007-8#1)
pleura and##4##2##(1991-12#1)(2007-4#1)(2007-8#1)(2010-12#1)
pleura but##2##2##(2007-5#1)(2010-12#1)
pleura of##2##2##(2007-5#1)(2012-2#1)
pleura was##2##2##(1990-12#1)(2012-1#1)
pleura##41##1##(1990-12#1)(1991-12#2)(2007-10#1)(2007-2#1)(2007-4#1)(2007-5#4)(2007-8#10)(2008-6#3)(2010-12#3)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#2)(2012-1#1)(2012-2#5)(2012-3#2)
pleural adhesions##6##2##(2007-8#6)
pleural and diaphragmatic endometriosis##2##4##(2012-12#2)
pleural and peritoneal mesothelioma tissues##2##5##(1991-12#2)
pleural and peritoneal##3##3##(1991-12#2)(1997-7#1)
pleural and##9##2##(1991-12#2)(1997-7#1)(2007-12#2)(2007-8#1)(2010-12#1)(2012-12#2)
pleural biopsy in Iceland##2##4##(2006-7#2)
pleural biopsy##14##2##(1996-12#1)(1997-4#1)(2006-12#2)(2006-7#7)(2007-8#2)(2012-12#1)
pleural catheter##4##2##(2012-12#4)
pleural cavities##3##2##(2007-8#1)(2008-10#2)
pleural cavity##16##2##(1990-10#1)(1990-5#1)(1991-8#1)(1995-6#1)(2007-1#1)(2007-12#2)(2007-8#1)(2010-10#1)(2011-2#1)(2012-1#2)(2012-2#3)(2013-7#1)
pleural disease##4##2##(1991-12#2)(2012-12#2)
pleural diseases##2##2##(1996-2#1)(2010-12#1)
pleural drainage and##2##3##(2007-8#1)(2008-1#1)
pleural drainage##5##2##(2007-8#3)(2008-1#1)(2008-10#1)
pleural effusion and##8##3##(2005-10#1)(2007-12#1)(2007-8#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
pleural effusion are##2##3##(2008-7#1)(2012-12#1)
pleural effusion as a##3##4##(2012-1#1)(2013-1#2)
pleural effusion in four##2##4##(2008-5#2)
pleural effusion in the##2##4##(2012-1#1)(2013-8#1)
pleural effusion in##8##3##(2008-5#2)(2008-7#2)(2010-12#1)(2012-1#1)(2013-8#2)
pleural effusion is##6##3##(1990-10#1)(1991-6#1)(2007-4#1)(2012-12#2)(2013-8#1)
pleural effusion or##2##3##(2007-8#1)(2010-12#1)
pleural effusion were not##2##4##(1996-12#1)(1997-4#1)
pleural effusion were##5##3##(1991-12#1)(1995-6#1)(1996-12#1)(1997-4#1)(2013-1#1)
pleural effusion##84##2##(1990-10#2)(1991-12#4)(1991-6#1)(1992-2#1)(1995-6#1)(1996-12#2)(1997-4#2)(1997-8#1)(2005-10#1)(2005-12#1)(2006-12#1)(2006-4#4)(2006-7#1)(2007-12#3)(2007-4#1)(2007-7#5)(2007-8#4)(2008-1#3)(2008-5#2)(2008-6#2)(2008-7#4)(2009-6#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-5#1)(2011-2#1)(2012-1#3)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#11)(2013-8#7)
pleural effusion]##2##2##(1990-10#1)(1994-3#1)
pleural effusions and##2##3##(2006-6#1)(2007-12#1)
pleural effusions##19##2##(1991-6#2)(1992-1#1)(1996-12#1)(1997-8#2)(2006-10#1)(2006-12#2)(2006-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-9#1)(2009-5#1)(2010-3#1)(2012-1#1)(2012-12#1)(2012-2#1)
pleural empyema and##2##3##(2007-3#1)(2011-2#1)
pleural empyema##9##2##(1990-3#1)(2007-3#1)(2007-8#2)(2011-2#2)(2012-2#3)
pleural fibrosis is##2##3##(1991-12#2)
pleural fibrosis##8##2##(1991-12#5)(2010-12#2)(2010-9#1)
pleural fluid accumulation##2##3##(2012-12#2)
pleural fluid and##6##3##(1991-3#1)(1995-1#1)(1997-8#1)(2007-12#1)(2010-10#2)
pleural fluid cultures##2##3##(1996-12#1)(2007-12#1)
pleural fluid##25##2##(1990-4#1)(1991-3#1)(1995-1#1)(1996-12#3)(1997-8#1)(2005-12#2)(2006-12#1)(2007-12#2)(2007-6#1)(2007-7#1)(2008-1#1)(2010-10#3)(2010-12#1)(2011-2#1)(2012-12#3)(2012-2#2)
pleural invasion and##2##3##(2007-8#2)
pleural invasion##6##2##(2007-8#6)
pleural mesothelioma (MPM)##3##3##(2008-10#1)(2010-9#2)
pleural mesothelioma in##6##3##(1991-12#1)(1995-2#1)(1997-5#1)(2010-9#2)(2011-2#1)
pleural mesothelioma to a hyperplastic##2##5##(2012-2#2)
pleural mesothelioma was##2##3##(1991-12#1)(1997-5#1)
pleural mesothelioma##32##2##(1990-12#2)(1990-3#1)(1991-12#2)(1992-12#3)(1995-2#2)(1997-5#4)(2007-8#7)(2008-10#1)(2008-2#1)(2010-5#1)(2010-9#4)(2011-2#2)(2012-2#2)
pleural plaque##4##2##(2010-9#4)
pleural plaques and diffuse pleural thickening##2##6##(1991-12#2)
pleural plaques and##3##3##(1991-12#3)
pleural plaques##8##2##(1991-12#6)(2010-9#2)
pleural space disease##4##3##(2011-2#4)
pleural space##17##2##(2006-10#1)(2007-7#6)(2007-8#1)(2008-11#1)(2011-2#5)(2012-2#2)(2012-3#1)
pleural thickening##5##2##(1991-12#3)(2010-12#1)(2010-9#1)
pleural tissue##3##2##(1996-12#2)(2013-7#1)
pleural tract##2##2##(2012-12#2)
pleural tuberculosis##4##2##(1991-3#1)(1996-12#2)(1997-3#1)
pleural##341##1##(1990-10#4)(1990-12#2)(1990-3#2)(1990-4#1)(1990-5#2)(1991-12#25)(1991-3#2)(1991-6#3)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#1)(1994-10#1)(1994-3#1)(1995-1#1)(1995-2#2)(1995-6#2)(1996-11#1)(1996-12#12)(1996-2#2)(1997-3#1)(1997-4#3)(1997-5#4)(1997-7#1)(1997-8#6)(2005-10#1)(2005-12#3)(2005-8#1)(2006-10#2)(2006-12#6)(2006-4#4)(2006-6#1)(2006-7#9)(2006-8#1)(2007-1#1)(2007-12#11)(2007-3#1)(2007-4#2)(2007-6#2)(2007-7#16)(2007-8#46)(2008-1#7)(2008-10#5)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#5)(2008-9#1)(2009-5#1)(2009-6#2)(2010-10#5)(2010-11#1)(2010-12#11)(2010-2#1)(2010-3#1)(2010-5#2)(2010-9#15)(2011-2#12)(2012-1#6)(2012-12#22)(2012-2#16)(2012-3#2)(2013-1#12)(2013-7#2)(2013-8#8)
pleural-based##2##1##(2010-12#1)(2010-5#1)
pleural/serum##2##1##(1997-8#2)
pleurectomy for##2##2##(1992-1#1)(2007-8#1)
pleurectomy##6##1##(1991-6#1)(1992-1#1)(2007-8#2)(2008-10#2)
pleurisy and##5##2##(2006-10#1)(2010-12#1)(2011-2#2)(2012-2#1)
pleurisy in cats with##2##4##(2012-1#2)
pleurisy progressed in##2##3##(2012-1#2)
pleurisy##20##1##(1992-7#1)(2006-10#2)(2010-12#2)(2011-2#5)(2012-1#7)(2012-2#1)(2013-1#2)
pleuritic chest pain##4##3##(2006-10#1)(2007-12#1)(2012-1#1)(2012-2#1)
pleuritis or##2##2##(2006-7#1)(2010-1#1)
pleuritis##11##1##(1992-10#1)(1997-4#1)(2005-7#1)(2006-4#1)(2006-7#2)(2007-12#3)(2007-8#1)(2010-1#1)
pleuro-pulmonary##2##1##(2007-8#1)(2012-3#1)
pleurocarpous##2##1##(2004-4#2)
pleurodesis is##2##2##(2005-12#1)(2008-1#1)
pleurodesis using##2##2##(2008-1#2)
pleurodesis with a##3##3##(1990-9#1)(2008-1#2)
pleurodesis with##4##2##(1990-9#1)(2008-1#3)
pleurodesis##22##1##(1990-12#1)(1990-9#1)(2005-12#1)(2006-10#2)(2007-3#1)(2007-8#1)(2008-1#13)(2012-12#2)
pleuroperitoneal##3##1##(2009-7#1)(2012-12#1)(2013-1#1)
pleuropneumoniae##4##1##(1996-12#4)
pleuropneumopathy##2##1##(2010-12#2)
pleuropulmonary infections##2##2##(2007-7#2)
pleuropulmonary##9##1##(1992-11#1)(2006-8#1)(2007-7#2)(2008-5#1)(2008-6#2)(2010-12#2)
pleurotomy during internal mammary artery##2##5##(2007-8#2)
pleurotomy during##3##2##(2007-8#3)
pleurotomy##5##1##(2007-8#5)
plexiform fibrohistiocytic tumor##2##3##(2007-8#2)
plexiform layer##11##2##(1990-12#2)(1990-5#2)(1991-10#1)(1992-7#1)(1995-12#1)(1996-6#1)(1997-5#1)(2008-4#1)(2012-3#1)
plexiform layers##2##2##(1996-5#1)(2013-8#1)
plexiform neurofibroma##2##2##(2012-12#1)(2013-7#1)
plexiform pattern##2##2##(2007-8#1)(2010-9#1)
plexiform##27##1##(1990-12#2)(1990-5#3)(1991-10#1)(1992-3#1)(1992-7#1)(1995-12#2)(1996-5#1)(1996-6#1)(1997-5#1)(2007-8#4)(2008-4#1)(2010-9#2)(2012-12#4)(2012-3#1)(2013-7#1)(2013-8#1)
plexiglass plate##2##2##(1991-12#2)
plexiglass##4##1##(1991-12#3)(1993-4#1)
plexopathy##5##1##(2006-4#1)(2008-12#3)(2012-12#1)
plexus and the##3##3##(1997-8#1)(2006-3#1)(2011-2#1)
plexus and##20##2##(1993-12#2)(1994-10#5)(1995-12#1)(1995-3#1)(1996-12#1)(1997-4#1)(1997-8#1)(2006-1#1)(2006-11#1)(2006-12#1)(2006-3#1)(2008-1#1)(2008-10#1)(2011-2#2)
plexus as a##2##3##(1996-5#1)(2006-8#1)
plexus block for##2##3##(2006-11#1)(2010-7#1)
plexus block is##3##3##(2006-8#3)
plexus block##21##2##(2006-10#5)(2006-11#1)(2006-7#1)(2006-8#4)(2008-7#1)(2009-4#1)(2010-7#2)(2011-12#1)(2012-2#2)(2012-3#1)(2013-7#2)
plexus blocks##3##2##(2006-10#1)(2006-8#1)(2010-7#1)
plexus cyst##3##2##(2006-5#3)
plexus in the##3##3##(1992-3#1)(1996-12#1)(1997-5#1)
plexus in##8##2##(1992-3#1)(1994-2#1)(1996-12#1)(1997-5#1)(2008-9#2)(2009-6#1)(2013-1#1)
plexus injuries in##2##3##(1996-8#1)(2006-4#1)
plexus injuries##11##2##(1996-8#1)(2006-4#1)(2008-8#2)(2008-9#7)
plexus injury##11##2##(2006-3#2)(2007-6#1)(2008-9#2)(2009-3#1)(2009-5#1)(2010-7#1)(2011-2#2)(2013-1#1)
plexus is##4##2##(1992-3#2)(1994-10#1)(2011-12#1)
plexus may##2##2##(1992-10#1)(1996-3#1)
plexus nerve##2##2##(2008-8#1)(2008-9#1)
plexus neuroma##2##2##(2009-3#2)
plexus of the##8##3##(1992-8#1)(1994-9#1)(1996-3#2)(1996-5#1)(1997-1#1)(2008-4#2)
plexus of##17##2##(1990-5#1)(1992-8#2)(1994-2#1)(1994-9#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-1#2)(1997-3#1)(2006-12#1)(2008-4#2)(2011-2#1)(2012-1#1)
plexus on##2##2##(1995-5#1)(1996-5#1)
plexus or##3##2##(1993-12#1)(2006-6#1)(2007-12#1)
plexus preparation##2##2##(1990-5#1)(1995-12#1)
plexus were##2##2##(1996-5#1)(2013-8#1)
plexus whereas##2##2##(1995-5#1)(1997-8#1)
plexus##229##1##(1990-11#1)(1990-4#1)(1990-5#3)(1991-2#1)(1992-10#1)(1992-3#5)(1992-8#4)(1993-11#1)(1993-12#4)(1994-10#8)(1994-12#1)(1994-2#3)(1994-9#3)(1995-12#3)(1995-3#1)(1995-5#4)(1996-12#5)(1996-2#2)(1996-3#7)(1996-5#6)(1996-8#2)(1996-9#3)(1997-1#2)(1997-3#2)(1997-4#1)(1997-5#4)(1997-6#4)(1997-8#3)(2005-8#1)(2006-1#1)(2006-10#10)(2006-11#4)(2006-12#2)(2006-3#5)(2006-4#3)(2006-5#4)(2006-6#1)(2006-7#3)(2006-8#13)(2007-10#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-4#4)(2008-7#4)(2008-8#5)(2008-9#20)(2009-3#8)(2009-4#2)(2009-5#1)(2009-6#2)(2010-12#2)(2010-7#4)(2010-9#1)(2011-12#2)(2011-2#13)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#2)
plexuses and##2##2##(1992-8#1)(2011-2#1)
plexuses of##2##2##(1995-6#1)(2013-8#1)
plexuses##12##1##(1990-5#1)(1992-8#1)(1995-6#1)(1997-5#2)(2006-8#2)(2011-2#3)(2013-8#2)
pliability and##2##2##(2008-5#2)
pliability##3##1##(2008-5#2)(2009-9#1)
pliable##4##1##(2006-3#1)(2007-12#1)(2008-11#1)(2009-9#1)
plica syndrome##2##2##(2007-7#2)
plica##7##1##(2007-7#7)
plicata##3##1##(1991-4#1)(2008-6#2)
plicatilis and##2##2##(2008-5#1)(2008-9#1)
plicatilis##5##1##(2008-5#1)(2008-9#2)(2010-3#2)
plication and##3##2##(2006-10#1)(2010-6#1)(2011-1#1)
plication is##2##2##(1991-10#1)(2013-1#1)
plication of the##4##3##(1991-10#1)(2013-1#3)
plication of##5##2##(1991-10#1)(2006-2#1)(2013-1#3)
plication##18##1##(1991-10#4)(2006-10#1)(2006-2#1)(2008-4#1)(2008-8#1)(2010-6#1)(2011-1#1)(2013-1#8)
plicatus##4##1##(1992-3#1)(1993-11#1)(1994-10#1)(2007-1#1)
plight##2##1##(2006-8#1)(2008-1#1)
plipastatin synthase##2##2##(2012-2#2)
plipastatin##4##1##(2012-2#4)
ploidy analysis##2##2##(2008-6#1)(2008-9#1)
ploidy and##6##2##(1993-1#1)(2007-11#1)(2008-9#3)(2009-8#1)
ploidy in##3##2##(2008-6#1)(2008-9#1)(2009-2#1)
ploidy level##7##2##(2008-11#1)(2008-5#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)
ploidy levels##3##2##(2008-5#1)(2008-7#1)(2010-3#1)
ploidy status##2##2##(1993-1#1)(2008-6#1)
ploidy##48##1##(1991-6#1)(1992-2#1)(1993-1#2)(1994-11#1)(1995-10#1)(1995-4#2)(1996-4#1)(2006-12#1)(2006-6#1)(2007-11#2)(2008-11#1)(2008-5#3)(2008-6#7)(2008-7#1)(2008-8#1)(2008-9#10)(2009-12#1)(2009-2#2)(2009-5#1)(2009-8#2)(2010-3#5)(2011-1#1)
plot 2##3##2##(2008-5#3)
plot analysis showed that the##3##5##(1990-12#1)(1991-1#1)(1996-11#1)
plot analysis showed that##4##4##(1990-12#1)(1991-1#1)(1993-11#1)(1996-11#1)
plot analysis##13##2##(1990-11#1)(1990-12#2)(1991-1#1)(1993-11#1)(1993-7#1)(1994-8#1)(1996-11#1)(1996-12#1)(1997-5#1)(2007-10#1)(2008-10#1)(2008-4#1)
plot and##10##2##(2005-11#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2010-4#1)(2013-8#2)
plot are##2##2##(1995-5#1)(2008-10#1)
plot at##6##2##(2005-11#1)(2008-10#3)(2011-1#1)(2013-7#1)
plot between the##2##3##(2008-10#2)
plot between##3##2##(1993-12#1)(2008-10#2)
plot calibration##3##2##(2008-10#2)(2008-3#1)
plot for##5##2##(1992-11#1)(2007-8#1)(2008-10#2)(2008-6#1)
plot in the fall of##2##5##(2008-10#2)
plot in the##3##3##(2008-10#3)
plot in##7##2##(2008-10#5)(2008-11#1)(2008-9#1)
plot is not##2##3##(1992-5#1)(2008-10#1)
plot is##4##2##(1992-5#1)(2008-10#3)
plot of deltaT versus (1 - RT(-1))##2##7##(2008-3#2)
plot of the##15##3##(1990-3#1)(1993-11#1)(1995-5#1)(1996-9#1)(1997-8#1)(2005-11#2)(2008-10#2)(2008-11#1)(2008-3#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-7#1)
plot of##38##2##(1990-3#1)(1991-5#1)(1992-2#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-11#3)(2007-3#1)(2008-10#9)(2008-11#1)(2008-3#3)(2008-5#1)(2008-8#1)(2009-11#1)(2009-12#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-7#2)
plot produced a best-fit line with slope=0##4##7##(2011-1#4)
plot revealed that##2##3##(1990-2#1)(2008-11#1)
plot revealed##3##2##(1990-2#1)(2008-11#2)
plot showed that##3##3##(1991-7#1)(2011-1#1)(2012-11#1)
plot showed##6##2##(1991-7#1)(2008-10#2)(2011-1#1)(2012-11#1)(2013-8#1)
plot that##2##2##(1996-3#1)(2008-4#1)
plot to##2##2##(2008-10#2)
plot was linear over the range##2##6##(2008-10#2)
plot was linear##4##3##(2008-10#3)(2012-12#1)
plot was##16##2##(1990-9#1)(1996-3#2)(2005-11#1)(2008-10#8)(2008-12#2)(2012-12#1)(2013-7#1)
plot with a##2##3##(1991-5#1)(1997-1#1)
plot with##3##2##(1991-5#1)(1997-1#1)(2008-10#1)
plot##220##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-4#1)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#2)(1992-5#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-7#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-2#1)(1995-5#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#3)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-11#8)(2006-10#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#3)(2007-9#1)(2008-10#82)(2008-11#4)(2008-12#9)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#13)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-7#1)(2013-7#4)(2013-8#5)
plot) for##2##2##(2008-10#2)
plot)##7##1##(1997-8#1)(2008-10#6)
plots also##3##2##(2007-6#1)(2008-10#1)(2008-12#1)
plots amended with##4##3##(2008-10#4)
plots and##19##2##(1992-8#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-3#1)(2007-6#1)(2008-10#7)(2008-12#1)(2008-7#1)(2009-8#1)(2012-1#1)(2012-12#1)(2013-1#1)
plots are presented##3##3##(2008-3#1)(2008-8#1)(2011-1#1)
plots are##9##2##(1992-3#1)(1995-9#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-3#1)(2011-1#1)
plots as a##2##3##(1991-4#1)(2005-11#1)
plots as##3##2##(1991-4#1)(2005-11#1)(2008-10#1)
plots at##4##2##(1990-9#1)(2008-10#2)(2008-12#1)
plots based on##3##3##(2008-7#1)(2008-8#1)(2013-8#1)
plots by##3##2##(2008-10#3)
plots during##2##2##(2008-10#2)
plots expressed as##2##3##(2007-6#1)(2008-10#1)
plots for each##2##3##(1995-3#1)(2008-10#1)
plots for the##2##3##(1995-9#1)(2008-10#1)
plots for##17##2##(1995-3#1)(1995-8#1)(1995-9#2)(1996-12#1)(2007-10#1)(2008-10#9)(2008-3#2)
plots from##2##2##(2007-5#1)(2008-10#1)
plots in the##5##3##(1995-9#1)(2008-10#3)(2008-11#1)
plots in##14##2##(1995-9#1)(2008-10#11)(2008-11#1)(2013-7#1)
plots increased##2##2##(2008-10#2)
plots indicated that the##2##4##(1996-12#1)(1996-6#1)
plots indicated that##3##3##(1996-12#1)(1996-6#1)(2007-6#1)
plots indicated##4##2##(1996-12#1)(1996-6#1)(2007-6#1)(2011-2#1)
plots infected##2##2##(2008-10#2)
plots obtained##3##2##(2008-10#3)
plots of log##2##3##(1995-3#1)(2008-3#1)
plots of the data##2##4##(1990-11#1)(1993-3#1)
plots of the##20##3##(1990-11#1)(1992-12#1)(1993-3#1)(1994-12#1)(1995-9#1)(1996-11#1)(1996-5#1)(1997-1#1)(2006-12#1)(2007-8#1)(2008-10#6)(2008-3#2)(2008-5#1)(2010-12#1)
plots of##58##2##(1990-11#1)(1990-3#1)(1990-8#1)(1991-10#1)(1992-12#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-3#1)(1995-9#1)(1996-11#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-11#1)(2006-12#2)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-3#4)(2008-5#2)(2008-6#1)(2008-8#2)(2009-4#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#1)
plots planted with##3##3##(2008-10#3)
plots protected by##2##3##(2008-10#2)
plots provide##2##2##(2008-10#1)(2010-12#1)
plots ranged from##2##3##(2008-10#1)(2011-2#1)
plots ranging from##2##3##(2008-10#2)
plots received##2##2##(2008-10#1)(2008-9#1)
plots revealed##2##2##(1990-2#1)(1991-5#1)
plots show that##2##3##(1991-7#1)(1994-12#1)
plots showed good##4##3##(2008-10#3)(2011-2#1)
plots showed##6##2##(1990-3#1)(2008-10#3)(2010-11#1)(2011-2#1)
plots sown with##2##3##(2008-10#1)(2008-12#1)
plots than in##2##3##(2008-10#2)
plots than##5##2##(2008-10#3)(2008-9#1)(2013-8#1)
plots that were##2##3##(1990-11#1)(2008-10#1)
plots that##5##2##(1990-11#1)(2006-3#1)(2008-10#3)
plots the##3##2##(2008-2#2)(2010-1#1)
plots to determine the##2##4##(2008-10#2)
plots to##5##2##(2008-10#4)(2011-2#1)
plots was##7##2##(2008-10#5)(2011-12#1)(2011-2#1)
plots were constructed##2##3##(2008-10#1)(2011-1#1)
plots were obtained##3##3##(1993-3#1)(2008-10#2)
plots were##31##2##(1993-3#1)(2004-12#1)(2007-11#1)(2008-10#23)(2008-12#1)(2008-5#2)(2011-1#1)(2011-2#1)
plots when##2##2##(2008-10#2)
plots where##6##2##(2008-10#5)(2008-12#1)
plots with four replications##2##4##(2008-10#1)(2008-12#1)
plots with two##2##3##(2008-10#2)
plots with##15##2##(1990-11#1)(2007-8#1)(2008-10#11)(2008-12#1)(2010-10#1)
plots##421##1##(1990-11#3)(1990-2#1)(1990-3#4)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-4#1)(1991-5#2)(1991-7#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-12#2)(1994-3#1)(1994-6#1)(1995-11#2)(1995-3#3)(1995-7#1)(1995-8#1)(1995-9#7)(1996-11#1)(1996-12#3)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#4)(1997-8#1)(2004-12#1)(2005-11#4)(2006-10#1)(2006-12#6)(2006-3#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-5#1)(2007-6#8)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#231)(2008-11#4)(2008-12#17)(2008-2#4)(2008-3#8)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#3)(2009-3#1)(2009-4#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2011-1#3)(2011-12#2)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#4)
plots)##3##1##(2008-10#3)
plotted against the##6##3##(1990-7#1)(1996-1#1)(1996-11#1)(1996-3#1)(2008-10#1)(2008-11#1)
plotted against##15##2##(1990-7#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(2005-11#2)(2006-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)
plotted as a function of##2##5##(2005-11#1)(2008-2#1)
plotted as a##4##3##(1990-9#1)(1997-6#1)(2005-11#1)(2008-2#1)
plotted by##3##2##(1996-12#1)(2008-10#1)(2013-8#1)
plotted for##2##2##(1995-8#1)(2013-8#1)
plotted in##5##2##(1990-12#1)(1990-4#1)(1996-7#1)(2007-8#1)(2008-4#1)
plotted on a##2##3##(1992-3#1)(2012-12#1)
plotted##43##1##(1990-12#1)(1990-4#1)(1990-7#1)(1990-9#1)(1992-3#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-6#1)(2005-11#3)(2005-12#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
plotting and##3##2##(1995-2#1)(2008-2#1)(2009-11#1)
plotting methods##2##2##(1995-2#1)(2008-3#1)
plotting of##3##2##(2007-11#1)(2008-10#1)(2008-5#1)
plotting the##9##2##(2005-11#1)(2008-10#5)(2010-12#1)(2010-8#1)(2013-1#1)
plotting##24##1##(1990-10#1)(1995-2#2)(1995-7#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#9)(2008-2#1)(2008-3#2)(2008-5#1)(2009-11#1)(2010-12#1)(2010-8#1)(2013-1#1)
plow##5##1##(2008-12#5)
plowing depth##4##2##(2008-12#4)
plowing##8##1##(2008-10#1)(2008-12#7)
ploy##2##1##(1996-11#1)(2011-2#1)
plucked##2##1##(2007-7#1)(2008-5#1)
plucking as##2##2##(1990-3#1)(2008-5#1)
plucking##10##1##(1990-3#1)(1990-9#3)(2006-12#3)(2008-5#3)
plug and##7##2##(1995-5#1)(2007-7#1)(2008-10#2)(2008-3#1)(2009-6#1)(2013-1#1)
plug flow##5##2##(2005-11#1)(2007-10#1)(2008-7#2)(2008-9#1)
plug in##3##2##(1995-5#2)(2009-6#1)
plug length##2##2##(2009-6#2)
plug of##5##2##(2007-8#1)(2008-10#2)(2008-4#1)(2013-1#1)
plug speed decreases##2##3##(2009-6#2)
plug test during anoscopy##2##4##(2013-1#2)
plug test##6##2##(2013-1#6)
plug was##6##2##(1995-5#1)(2008-10#1)(2010-5#1)(2013-1#3)
plug##88##1##(1992-2#1)(1994-3#1)(1994-8#1)(1995-5#8)(1997-4#1)(2005-11#1)(2005-8#1)(2006-4#1)(2006-5#1)(2007-1#2)(2007-10#2)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#16)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-6#16)(2010-5#3)(2010-9#2)(2011-2#2)(2012-2#1)(2013-1#13)
plug-flow##2##1##(2005-11#1)(2008-10#1)
plug-in for##2##2##(2006-10#1)(2008-7#1)
plug-in##4##1##(2006-10#1)(2008-10#1)(2008-7#1)(2009-10#1)
plugging of##3##2##(2008-10#1)(2009-5#1)(2009-8#1)
plugging##10##1##(1990-10#1)(2008-1#1)(2008-10#4)(2008-9#2)(2009-5#1)(2009-8#1)
plugs and##4##2##(2008-10#3)(2008-5#1)
plugs in the##2##3##(1995-5#1)(2007-1#1)
plugs of##2##2##(2008-4#1)(2008-9#1)
plugs were##4##2##(1995-2#1)(1995-5#1)(2006-12#1)(2008-11#1)
plugs##31##1##(1993-2#1)(1995-2#1)(1995-5#2)(1997-1#1)(2005-10#2)(2006-12#2)(2007-1#5)(2007-11#1)(2008-10#6)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-7#2)(2011-2#1)
plugs)##2##1##(2007-10#1)(2008-4#1)
plum and peach##2##3##(2008-10#2)
plum ingredient##2##2##(2010-4#2)
plum juice concentrate##2##3##(2010-4#2)
plum##29##1##(2008-10#16)(2010-4#6)(2011-12#2)(2011-2#5)
plumage##7##1##(1997-3#1)(2008-8#6)
plume from the##2##3##(1994-7#1)(2007-5#1)
plume is##2##2##(2008-3#2)
plume protection problems##2##3##(1993-3#2)
plume spacing and##2##3##(2008-6#2)
plume spacing##3##2##(2008-6#3)
plume with##2##2##(1996-12#1)(2008-2#1)
plume##33##1##(1991-6#2)(1993-2#1)(1993-3#2)(1994-7#1)(1996-12#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-5#2)(2008-2#6)(2008-3#11)(2008-6#3)
plumes are##2##2##(2006-12#1)(2008-3#1)
plumes of##2##2##(2006-12#1)(2008-6#1)
plumes##20##1##(1991-6#2)(2006-10#2)(2006-12#2)(2007-5#1)(2008-11#1)(2008-2#2)(2008-3#8)(2008-6#1)(2009-6#1)
plumierii##2##1##(2013-7#2)
plummeted##2##1##(2007-11#1)(2011-2#1)
plump##3##1##(2008-8#1)(2010-6#2)
plunge##2##1##(1996-7#1)(2008-7#1)
plunging and sweeping##2##3##(2005-10#2)
plunging##4##1##(2005-10#3)(2009-6#1)
plural##3##1##(1994-2#1)(2008-5#1)(2011-2#1)
pluralism##5##1##(2009-8#4)(2012-11#1)
pluralistic##6##1##(1993-3#1)(1994-2#1)(2004-12#1)(2008-7#1)(2012-12#1)(2012-2#1)
plurality of##3##2##(1993-7#1)(2005-11#1)(2011-2#1)
pluripotency and##2##2##(2008-9#1)(2013-1#1)
pluripotency genes##2##2##(2012-12#2)
pluripotency##16##1##(2006-5#1)(2008-1#1)(2008-11#3)(2008-9#3)(2009-4#1)(2010-7#1)(2012-12#5)(2013-1#1)
pluripotent and##4##2##(1991-10#1)(2007-11#1)(2008-9#1)(2010-12#1)
pluripotent cells##8##2##(1993-2#1)(2008-1#1)(2008-11#1)(2010-2#1)(2012-11#2)(2012-12#2)
pluripotent stem cell##4##3##(2008-11#1)(2009-3#1)(2012-12#2)
pluripotent stem cells (iPSCs)##3##4##(2012-12#3)
pluripotent stem cells from##2##4##(2012-12#2)
pluripotent stem cells has##3##4##(2009-3#2)(2012-1#1)
pluripotent stem cells##29##3##(2008-1#1)(2008-9#1)(2009-3#7)(2010-10#1)(2010-7#1)(2011-1#1)(2012-1#2)(2012-12#12)(2012-2#2)(2012-5#1)
pluripotent stem##35##2##(2008-1#1)(2008-11#1)(2008-9#1)(2009-3#8)(2010-10#1)(2010-7#1)(2011-1#2)(2012-1#2)(2012-12#15)(2012-2#2)(2012-5#1)
pluripotent##67##1##(1990-5#1)(1991-10#1)(1992-12#1)(1992-5#1)(1993-2#3)(1995-3#1)(2007-11#1)(2008-1#5)(2008-10#1)(2008-11#4)(2008-4#1)(2008-9#4)(2009-3#8)(2010-10#1)(2010-12#2)(2010-2#1)(2010-7#1)(2011-1#3)(2012-1#2)(2012-11#2)(2012-12#18)(2012-2#2)(2012-5#2)(2013-1#1)
pluripotential differentiation##2##2##(2006-6#2)
pluripotential##3##1##(2006-6#2)(2008-9#1)
pluronic lecithin##3##2##(2010-2#3)
pluronic##5##1##(2005-11#1)(2010-2#3)(2011-2#1)
plus 0##11##2##(1990-2#1)(1995-12#1)(1996-5#1)(2008-10#4)(2008-4#2)(2008-5#1)(2009-3#1)
plus 1##4##2##(1993-1#1)(1997-1#1)(2007-2#1)(2008-10#1)
plus 1% cholesterol##2##3##(1993-9#2)
plus 1%##4##2##(1993-9#2)(2008-10#2)
plus 10##3##2##(1995-9#1)(2008-10#1)(2008-4#1)
plus 10%##2##2##(1994-12#1)(2008-10#1)
plus 100 mg##2##3##(2007-2#1)(2008-10#1)
plus 1000##2##2##(1992-1#1)(2008-5#1)
plus 2##8##2##(1990-5#1)(1995-12#1)(2004-4#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-2#2)
plus 3##2##2##(1990-5#1)(2008-5#1)
plus 300##2##2##(1993-2#1)(2007-11#1)
plus 35##2##2##(1997-8#1)(2011-2#1)
plus 36##2##2##(1992-4#1)(2008-10#1)
plus 4##2##2##(2006-3#1)(2008-10#1)
plus 50##2##2##(1995-5#1)(2008-1#1)
plus 7##2##2##(2008-10#1)(2008-5#1)
plus C##4##2##(2008-6#1)(2013-1#3)
plus CHM##5##2##(2012-2#5)
plus FSK##2##2##(1993-7#2)
plus GM-CSF##2##2##(1991-8#1)(1992-8#1)
plus IBMX##2##2##(1993-6#1)(1995-5#1)
plus LV##2##2##(2009-10#1)(2010-11#1)
plus MPA##4##2##(1995-4#4)
plus P##2##2##(2008-10#2)
plus SCA##2##2##(2007-10#2)
plus a diuretic##2##3##(2006-6#1)(2009-9#1)
plus a signal peptide of##2##5##(1990-2#1)(2008-8#1)
plus a##31##2##(1990-2#1)(1990-6#1)(1991-11#1)(1991-2#1)(1994-11#1)(1996-11#1)(1997-5#1)(2005-7#1)(2006-10#2)(2006-6#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-2#1)(2012-2#2)
plus additional##2##2##(2008-11#1)(2011-1#1)
plus alemtuzumab##3##2##(2008-12#3)
plus alpha##2##2##(1993-6#1)(2008-7#1)
plus amikacin##2##2##(2011-2#2)
plus an additional##2##3##(2008-5#1)(2009-10#1)
plus an##8##2##(1993-8#1)(2008-3#2)(2008-5#1)(2009-10#1)(2009-4#1)(2010-4#1)(2011-2#1)
plus and##3##2##(1990-8#1)(1995-1#1)(2006-3#1)
plus anti-asialo GM1##3##3##(1994-2#3)
plus ascorbate##2##2##(2011-1#2)
plus aspirin##2##2##(2005-12#1)(2011-2#1)
plus canola oil##4##3##(2008-10#4)
plus chemotherapy##4##2##(2005-10#1)(2008-10#1)(2008-11#1)(2009-3#1)
plus cholesterol##2##2##(1993-9#2)
plus cisplatin##4##2##(2005-11#1)(2009-8#2)(2010-12#1)
plus cisplatinum##2##2##(1991-2#1)(2009-8#1)
plus clopidogrel##4##2##(2007-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
plus cyclophosphamide##3##2##(1993-4#1)(2007-11#1)(2012-12#1)
plus dexamethasone##3##2##(1991-11#2)(2007-7#1)
plus different##2##2##(2008-5#1)(2011-2#1)
plus dipyridamole##7##2##(1990-11#3)(1993-7#4)
plus either##3##2##(1995-3#1)(2005-7#1)(2006-9#1)
plus endocervical brush##2##3##(2009-6#2)
plus endotoxin##2##2##(1990-11#2)
plus epirubicin combination##2##3##(2008-6#2)
plus esophagectomy##2##2##(2013-8#2)
plus etoposide##4##2##(1993-8#4)
plus extended-release dipyridamole##5##3##(2007-10#1)(2010-9#4)
plus family##2##2##(1997-8#1)(2008-1#1)
plus fentanyl 3 microg/ml##2##4##(1993-4#2)
plus folinic acid##2##3##(1991-10#1)(2007-10#1)
plus fosfomycin##3##2##(2012-2#3)
plus gemcitabine##5##2##(2004-1#3)(2011-2#2)
plus glucose##4##2##(2008-10#3)(2008-7#1)
plus glyburide##2##2##(2010-4#2)
plus glycerol##2##2##(1991-4#1)(1996-7#1)
plus heparin##5##2##(1992-1#4)(1994-6#1)
plus ifosfamide##2##2##(1992-6#1)(2010-3#1)
plus interferon-alpha##2##2##(1993-12#1)(2009-11#1)
plus ligand##2##2##(1995-12#1)(2005-4#1)
plus medication##2##2##(2008-3#1)(2012-3#1)
plus melatonin##2##2##(1994-12#1)(2008-8#1)
plus monthly##2##2##(1996-5#1)(2006-6#1)
plus necessary analgesics##2##3##(2013-1#2)
plus one##3##2##(1990-12#1)(1996-3#1)(2006-11#1)
plus or minus##2##3##(1997-6#1)(2011-2#1)
plus oral##2##2##(2009-5#1)(2010-12#1)
plus other##7##2##(1990-11#1)(1991-9#1)(1997-5#1)(2008-1#1)(2008-12#1)(2008-6#1)(2012-3#1)
plus oxaliplatin##3##2##(2008-5#3)
plus pilocarpine##2##2##(2010-8#2)
plus placebo##4##2##(1992-2#1)(1994-7#1)(2009-6#1)(2010-4#1)
plus poly I##2##3##(2007-11#2)
plus propranolol##3##2##(1990-5#1)(1993-11#2)
plus radiation therapy##3##3##(1995-10#1)(2007-6#1)(2008-6#1)
plus radiation##4##2##(1994-2#1)(1995-10#1)(2007-6#1)(2008-6#1)
plus radiotherapy in##2##3##(1992-4#1)(1993-8#1)
plus radiotherapy##3##2##(1991-4#1)(1992-4#1)(1993-8#1)
plus ribavirin##9##2##(2006-10#1)(2007-11#2)(2008-3#1)(2009-5#1)(2009-7#1)(2010-11#1)(2012-12#1)(2013-1#1)
plus several##2##2##(1991-8#1)(2008-10#1)
plus standard##3##2##(2008-3#1)(2010-8#1)(2013-1#1)
plus strand DNA##2##3##(1990-11#1)(1997-2#1)
plus strand##4##2##(1990-11#2)(1997-2#2)
plus testosterone (n =##2##4##(1992-4#2)
plus the##21##2##(1991-11#2)(1991-5#1)(1993-12#1)(1993-9#2)(1994-12#1)(1994-5#1)(1995-10#1)(1997-5#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#1)
plus two##3##2##(1995-3#1)(1996-6#1)(2008-6#1)
plus type 2##2##3##(1995-6#1)(2010-3#1)
plus type##3##2##(1995-6#1)(2007-12#1)(2010-3#1)
plus vinorelbine##4##2##(2004-1#3)(2009-5#1)
plus vitamin##2##2##(1993-7#1)(2013-7#1)
plus##818##1##(1990-10#2)(1990-11#9)(1990-12#6)(1990-2#7)(1990-3#1)(1990-4#2)(1990-5#6)(1990-6#3)(1990-8#10)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#6)(1991-2#5)(1991-3#2)(1991-4#4)(1991-5#2)(1991-7#3)(1991-8#4)(1991-9#3)(1992-1#7)(1992-10#2)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-4#6)(1992-5#7)(1992-6#9)(1992-7#1)(1992-8#4)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#5)(1993-12#5)(1993-2#5)(1993-3#3)(1993-4#3)(1993-5#3)(1993-6#4)(1993-7#14)(1993-8#8)(1993-9#9)(1994-10#1)(1994-11#1)(1994-12#7)(1994-2#6)(1994-5#1)(1994-6#4)(1994-7#3)(1994-8#2)(1994-9#1)(1995-1#2)(1995-10#2)(1995-12#6)(1995-2#3)(1995-3#4)(1995-4#8)(1995-5#3)(1995-6#7)(1995-8#4)(1995-9#5)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#4)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#7)(1997-4#1)(1997-5#4)(1997-6#7)(1997-7#5)(1997-8#2)(2004-1#8)(2004-4#3)(2005-10#4)(2005-11#2)(2005-12#4)(2005-4#1)(2005-7#2)(2005-8#3)(2006-10#11)(2006-11#1)(2006-2#2)(2006-3#3)(2006-5#6)(2006-6#6)(2006-7#3)(2006-8#4)(2006-9#2)(2007-10#8)(2007-11#15)(2007-12#11)(2007-2#8)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#5)(2007-8#8)(2008-1#5)(2008-10#80)(2008-11#11)(2008-12#7)(2008-2#4)(2008-3#15)(2008-4#11)(2008-5#34)(2008-6#15)(2008-7#9)(2008-8#7)(2008-9#7)(2009-10#3)(2009-11#3)(2009-2#4)(2009-3#2)(2009-4#3)(2009-5#4)(2009-6#5)(2009-7#1)(2009-8#5)(2009-9#3)(2010-10#1)(2010-11#4)(2010-12#8)(2010-2#3)(2010-3#7)(2010-4#10)(2010-5#1)(2010-7#1)(2010-8#4)(2010-9#4)(2011-1#6)(2011-12#3)(2011-2#31)(2012-11#1)(2012-12#9)(2012-2#22)(2012-3#8)(2012-6#1)(2013-1#18)(2013-7#2)(2013-8#12)
plus&quot##2##1##(2010-12#1)(2011-1#1)
plus- and minus-strand##2##3##(2008-9#2)
plus-maze and##4##2##(1993-3#4)
plus-maze experience##3##2##(1992-7#3)
plus-maze test and##2##3##(1994-2#1)(2013-1#1)
plus-maze test##9##2##(1991-2#1)(1993-3#2)(1993-9#1)(1994-2#1)(2008-11#2)(2013-1#2)
plus-maze##30##1##(1991-2#3)(1992-7#6)(1993-3#7)(1993-7#1)(1993-9#3)(1994-2#1)(2008-11#5)(2008-4#1)(2013-1#2)(2013-7#1)
plus-strand##3##1##(1990-10#1)(2008-8#2)
plusmn##2##1##(1996-5#2)
pluton##3##1##(2013-8#3)
plutonium##4##1##(2008-10#4)
plutonyl(VI)##2##1##(2010-5#2)
pluvialis##3##1##(2010-10#3)
pluviosity##3##1##(2008-5#3)
plymuthica##3##1##(2008-10#3)
plywood##3##1##(2008-7#3)
pm and 6##2##3##(2008-12#1)(2008-5#1)
pm and##3##2##(2008-12#1)(2008-5#2)
pm for##5##2##(1996-2#4)(2007-11#1)
pm##30##1##(1990-2#2)(1996-2#16)(2007-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#3)(2011-2#1)
pm)##5##1##(1991-4#1)(1997-6#1)(2008-5#3)
pm/V was##3##2##(2007-12#3)
pm/V##7##1##(2007-11#1)(2007-12#5)(2008-1#1)
pmMC##2##1##(2013-8#2)
pma+##9##1##(1990-11#9)
pmc in NRS versus##4##4##(2011-2#4)
pmc in RS)##3##3##(2011-2#3)
pmc in##8##2##(2011-2#8)
pmc##9##1##(2011-2#9)
pmi##2##1##(2006-12#2)
pmn-LDL##2##1##(1997-2#2)
pmoA##3##1##(2013-7#3)
pmol 3-hydroxyanthranilic acid formed per mg protein per min##2##9##(1991-5#2)
pmol 32P/min/mg##2##2##(1997-6#2)
pmol L(-1)##2##2##(2010-11#2)
pmol PCOOH and##2##3##(1996-3#2)
pmol PEOOH/ml packed RBC##2##4##(1996-3#2)
pmol and##5##2##(1991-3#1)(1992-7#2)(1994-12#1)(1997-2#1)
pmol cm(-2)##3##2##(2007-8#1)(2008-10#2)
pmol cm-2 s-1##2##3##(1991-5#2)
pmol for##16##2##(1990-7#2)(1990-8#4)(2007-8#1)(2008-10#7)(2009-7#2)
pmol in##2##2##(1990-8#1)(2007-10#1)
pmol l(-1)##4##2##(2008-10#3)(2008-11#1)
pmol of a##2##3##(1991-10#1)(1996-2#1)
pmol of each##2##3##(1997-3#1)(2008-10#1)
pmol of##10##2##(1991-10#1)(1991-8#2)(1992-7#1)(1994-12#1)(1995-8#2)(1996-2#1)(1997-3#1)(2008-10#1)
pmol per 10(9) cells for inositol##2##6##(1992-2#2)
pmol per 10(9) cells##3##4##(1992-2#3)
pmol per##6##2##(1991-5#1)(1992-2#4)(1992-4#1)
pmol x h/10(6) PBMC##2##4##(2008-7#2)
pmol x##4##2##(1996-5#1)(2008-7#2)(2011-3#1)
pmol##104##1##(1990-10#1)(1990-11#1)(1990-4#2)(1990-6#2)(1990-7#2)(1990-8#5)(1990-9#1)(1991-1#1)(1991-10#1)(1991-3#1)(1991-5#6)(1991-8#4)(1992-1#1)(1992-2#4)(1992-4#1)(1992-7#4)(1993-1#1)(1993-11#3)(1993-4#3)(1993-8#1)(1994-10#1)(1994-12#3)(1994-3#1)(1994-9#1)(1995-11#3)(1995-8#2)(1996-2#2)(1996-3#4)(1996-5#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#4)(2005-12#1)(2006-5#1)(2007-10#1)(2007-8#2)(2008-10#16)(2008-11#2)(2008-7#3)(2009-7#2)(2010-11#2)(2010-4#1)(2010-5#1)(2011-3#1)
pmol) induced a##2##3##(1993-4#2)
pmol) injected into the##2##4##(1991-8#1)(1997-8#1)
pmol) into the##2##3##(1992-8#1)(1994-5#1)
pmol) into##3##2##(1992-8#1)(1993-7#1)(1994-5#1)
pmol) or##5##2##(1993-2#1)(1993-4#2)(1993-7#1)(1994-5#1)
pmol)##19##1##(1991-8#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-4#7)(1993-7#2)(1994-11#1)(1994-5#2)(1997-8#1)(2008-10#1)
pmol/10(6) cells##3##2##(1992-3#1)(1994-9#2)
pmol/10(6)##4##1##(1992-3#1)(1993-9#1)(1994-9#2)
pmol/8 x 10(8)##2##3##(2007-11#2)
pmol/A(260)##2##1##(2008-4#2)
pmol/L##8##1##(2004-11#1)(2006-11#2)(2008-1#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-4#1)
pmol/g body wt##2##3##(1994-11#2)
pmol/g wet wt##2##3##(1991-3#2)
pmol/g wet##3##2##(1991-3#3)
pmol/g##9##1##(1990-3#1)(1991-3#3)(1991-5#1)(1991-8#2)(1994-11#2)
pmol/g)##2##1##(1991-2#2)
pmol/injection##2##1##(2008-10#2)
pmol/kg) increased the##2##3##(2004-12#2)
pmol/kg)##4##1##(2004-12#4)
pmol/l (mean##5##2##(1995-6#1)(1996-1#3)(1996-3#1)
pmol/l after##2##2##(1995-6#2)
pmol/l and the##2##3##(1996-1#1)(2008-7#1)
pmol/l and##3##2##(1996-1#1)(2007-6#1)(2008-7#1)
pmol/l for##2##2##(1995-6#1)(1996-4#1)
pmol/l to 1400 pmol/l)##2##4##(1995-2#2)
pmol/l to##4##2##(1995-2#4)
pmol/l##43##1##(1993-12#2)(1995-2#8)(1995-6#9)(1996-1#6)(1996-12#1)(1996-3#9)(1996-4#1)(2005-7#3)(2007-6#2)(2008-7#1)(2013-7#1)
pmol/l) for##3##2##(1996-1#3)
pmol/l)##16##1##(1990-3#1)(1992-8#1)(1995-10#1)(1995-2#2)(1996-1#4)(1996-12#1)(1996-3#2)(2007-8#1)(2012-12#2)(2013-7#1)
pmol/mg in##2##2##(1994-12#2)
pmol/mg of##2##2##(1992-6#1)(1995-10#1)
pmol/mg per h in##2##4##(1991-5#2)
pmol/mg protein and##3##3##(1990-7#1)(1993-7#1)(1995-11#1)
pmol/mg protein per min##2##4##(1992-3#2)
pmol/mg protein per##3##3##(1992-2#1)(1992-3#2)
pmol/mg protein##14##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-12#2)(1992-2#1)(1992-3#2)(1993-7#1)(1994-12#1)(1995-11#2)(1995-7#1)
pmol/mg protein) and##2##3##(1990-3#1)(1993-11#1)
pmol/mg protein)##8##2##(1990-3#4)(1992-9#1)(1993-11#2)(1994-12#1)
pmol/mg##33##1##(1990-12#1)(1990-2#1)(1990-3#5)(1990-7#1)(1991-12#2)(1991-5#2)(1992-2#1)(1992-3#3)(1992-6#1)(1992-9#1)(1993-11#2)(1993-7#1)(1994-12#4)(1995-10#1)(1995-11#2)(1995-7#1)(1997-8#1)(2008-4#1)(2008-8#2)
pmol/mg/30 min in the##2##4##(1990-5#2)
pmol/min per mg##2##3##(1991-3#1)(1994-12#1)
pmol/min per##4##2##(1991-1#2)(1991-3#1)(1994-12#1)
pmol/min##5##1##(1990-2#1)(1991-1#2)(1991-3#1)(1994-12#1)
pmol/min/mg##2##1##(1996-5#1)(2008-8#1)
pmol/ml of##3##2##(1990-8#3)
pmol/ml##5##1##(1990-8#3)(1992-2#1)(1995-12#1)
pmol/well/30 min##2##2##(1994-3#2)
pmole of##3##2##(1991-3#2)(2008-10#1)
pmole##4##1##(1991-3#3)(2008-10#1)
pmole) alone##2##2##(1991-3#2)
pmole) but not##2##3##(1991-3#2)
pmole) into the IML##2##4##(1991-3#2)
pmole)##7##1##(1991-3#7)
pmole/mg protein)##4##2##(2008-11#4)
pmoles of radioligandY mg(-1) protein##2##5##(2008-11#2)
pmoles per mg of membrane protein##2##6##(1990-5#2)
pmoles##5##1##(1990-5#2)(2008-11#2)(2010-12#1)
pmoles/g) and##2##2##(1992-1#2)
pmoles/g)##4##1##(1992-1#4)
pmol·l-1##2##1##(2013-1#2)
pmp##3##1##(2008-4#3)
pms##6##1##(1991-4#6)
pms) in another##2##3##(1991-4#2)
pms) in##3##2##(1991-4#3)
pms)##4##1##(1991-4#4)
pms1##2##1##(1994-8#2)
pms2##2##1##(1994-8#2)
pmtA##3##1##(2007-12#3)
pnbA gene##2##2##(1994-12#2)
pnbA##4##1##(1994-12#4)
pnd##3##1##(1996-4#3)
pneumadin was##2##2##(1995-5#2)
pneumadin##9##1##(1995-5#9)
pneumatic compression devices##3##3##(2010-2#2)(2011-1#1)
pneumatic compression##4##2##(2010-2#2)(2011-1#2)
pneumatic dilatation##2##2##(1992-9#2)
pneumatic nebulization##3##2##(2008-10#3)
pneumatic nebulizer##3##2##(2008-10#3)
pneumatic##35##1##(1992-9#3)(1994-9#2)(1997-4#1)(2006-10#1)(2006-11#2)(2007-4#2)(2008-10#11)(2009-6#1)(2009-8#1)(2010-2#3)(2011-1#2)(2012-1#3)(2012-3#3)
pneumatization in##2##2##(2011-2#2)
pneumatization##5##1##(1996-12#1)(2011-2#4)
pneumatosis intestinalis##5##2##(2007-5#2)(2012-2#3)
pneumatosis##8##1##(2007-5#2)(2008-12#1)(2012-2#5)
pneumocephalus##12##1##(2006-12#4)(2008-7#4)(2008-9#1)(2009-6#2)(2011-2#1)
pneumococcal and##3##2##(2007-3#1)(2008-7#1)(2011-2#1)
pneumococcal bacteraemia##3##2##(1995-3#1)(2007-11#2)
pneumococcal conjugate vaccine (PCV7)##2##4##(2012-12#2)
pneumococcal conjugate vaccine##5##3##(2008-10#1)(2011-2#1)(2012-12#3)
pneumococcal conjugate vaccines##3##3##(2011-2#2)(2012-12#1)
pneumococcal conjugate##9##2##(2008-10#1)(2011-2#3)(2012-12#5)
pneumococcal disease among##2##3##(1994-9#1)(2012-12#1)
pneumococcal disease in##3##3##(2007-12#1)(2008-10#1)(2011-2#1)
pneumococcal disease##11##2##(1994-9#4)(2007-12#1)(2008-10#1)(2011-2#4)(2012-12#1)
pneumococcal diseases##4##2##(2007-12#1)(2011-2#1)(2012-12#2)
pneumococcal endocarditis##4##2##(1997-2#4)
pneumococcal infection in##3##3##(2011-2#3)
pneumococcal infection##7##2##(2007-11#2)(2007-8#2)(2011-2#3)
pneumococcal infections##5##2##(1995-3#1)(1997-2#1)(2007-11#1)(2011-2#1)(2012-12#1)
pneumococcal meningitis and##2##3##(2007-2#1)(2012-12#1)
pneumococcal meningitis in the rat##3##5##(1997-3#3)
pneumococcal meningitis##10##2##(1996-3#1)(1997-3#3)(2007-2#1)(2011-2#4)(2012-12#1)
pneumococcal pneumonia##3##2##(1992-8#1)(2007-11#1)(2007-7#1)
pneumococcal polysaccharide vaccine##5##3##(1994-9#2)(2010-9#1)(2012-12#2)
pneumococcal strains##2##2##(2007-11#1)(2011-2#1)
pneumococcal vaccination##2##2##(1995-3#1)(2008-9#1)
pneumococcal vaccine##11##2##(1990-9#1)(1994-2#1)(1994-9#2)(1997-2#1)(2007-11#4)(2007-8#1)(2012-12#1)
pneumococcal vaccine]##2##2##(1994-9#1)(2007-6#1)
pneumococcal vaccines##2##2##(1991-12#1)(2011-2#1)
pneumococcal##101##1##(1990-1#1)(1990-5#6)(1990-9#1)(1991-12#1)(1991-3#1)(1992-8#1)(1994-2#1)(1994-9#11)(1995-3#4)(1996-11#1)(1996-3#1)(1997-2#6)(1997-3#3)(2007-11#11)(2007-12#3)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-10#3)(2008-7#3)(2008-8#1)(2008-9#1)(2010-9#1)(2011-2#20)(2012-12#13)
pneumococci##10##1##(1990-9#1)(1991-3#1)(1993-5#1)(1994-11#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-1#1)(2009-5#1)(2010-12#1)
pneumococcus##4##1##(1991-2#1)(1993-5#1)(2007-8#1)(2012-12#1)
pneumocoele##3##1##(2012-2#3)
pneumocoeles##9##1##(2012-2#9)
pneumoconiosis and##2##2##(2010-9#1)(2013-8#1)
pneumoconiosis##6##1##(1994-6#3)(1994-8#1)(2010-9#1)(2013-8#1)
pneumoconiosis]##4##1##(2012-2#3)(2013-8#1)
pneumocystis##3##1##(1990-6#1)(2007-8#1)(2013-8#1)
pneumocyte##3##1##(1994-12#1)(2008-10#1)(2013-1#1)
pneumocytes##9##1##(1990-7#2)(1992-11#1)(1993-9#1)(1994-12#1)(1994-5#3)(1996-9#1)
pneumology##3##1##(1994-10#1)(2010-12#1)(2013-7#1)
pneumolysin##5##1##(2008-10#5)
pneumomediastinum##3##1##(2011-2#1)(2013-8#2)
pneumonectomies##3##1##(2007-8#2)(2008-10#1)
pneumonectomy due to##3##3##(2008-5#1)(2012-12#2)
pneumonectomy for##5##2##(2007-10#1)(2007-8#3)(2008-1#1)
pneumonectomy in##2##2##(1990-10#1)(2007-8#1)
pneumonectomy is##3##2##(1995-11#1)(2007-8#2)
pneumonectomy was##3##2##(2008-1#1)(2012-12#2)
pneumonectomy with##2##2##(2007-8#1)(2009-3#1)
pneumonectomy##54##1##(1990-10#1)(1990-8#1)(1995-11#1)(2006-10#1)(2007-10#1)(2007-6#1)(2007-8#26)(2008-1#2)(2008-5#1)(2008-6#1)(2009-3#1)(2009-7#1)(2012-12#16)
pneumonia (CAP)##6##2##(2005-8#1)(2007-12#1)(2008-3#1)(2008-5#1)(2010-11#1)(2010-5#1)
pneumonia (OP)##3##2##(2005-8#1)(2010-12#1)(2011-2#1)
pneumonia (PCP)##2##2##(1996-12#1)(2013-8#1)
pneumonia after##3##2##(2005-9#1)(2012-2#1)(2013-1#1)
pneumonia among##3##2##(2009-1#1)(2013-1#2)
pneumonia and eosinophilic##4##3##(1991-12#2)(2005-8#2)
pneumonia and hemorrhagic##3##3##(2010-6#2)(2013-1#1)
pneumonia and influenza##3##3##(1992-6#1)(2005-8#1)(2012-12#1)
pneumonia and one##2##3##(2008-1#1)(2011-2#1)
pneumonia and other##2##3##(1991-4#1)(2005-8#1)
pneumonia and with##2##3##(2005-11#1)(2013-1#1)
pneumonia and##43##2##(1990-9#1)(1991-12#2)(1991-4#2)(1991-8#1)(1992-6#1)(1997-4#2)(2005-11#2)(2005-8#5)(2006-10#1)(2006-4#2)(2006-8#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-6#2)(2011-2#2)(2012-12#3)(2013-1#5)
pneumonia are##2##2##(2005-11#1)(2005-8#1)
pneumonia as##2##2##(2007-11#1)(2010-7#1)
pneumonia associated with##3##3##(2006-10#2)(2008-5#1)
pneumonia at##2##2##(1997-7#1)(2011-12#1)
pneumonia by##2##2##(1990-6#1)(1991-12#1)
pneumonia can##2##2##(2005-11#1)(2005-7#1)
pneumonia cases##4##2##(2008-1#1)(2009-5#1)(2012-12#2)
pneumonia caused by##7##3##(1992-2#1)(2008-5#2)(2011-2#1)(2012-2#1)(2013-8#2)
pneumonia complicated by##4##3##(2008-1#4)
pneumonia during##2##2##(1991-9#1)(2008-10#1)
pneumonia from##3##2##(2006-10#1)(2007-3#1)(2012-2#1)
pneumonia has##3##2##(1990-12#1)(2006-10#1)(2010-9#1)
pneumonia identification##4##2##(2013-1#4)
pneumonia in a##3##3##(2008-10#1)(2010-12#2)
pneumonia in adults##3##3##(1991-10#1)(2010-5#1)(2013-1#1)
pneumonia in children##2##3##(2007-7#1)(2010-12#1)
pneumonia in patients with##3##4##(1991-12#1)(2006-11#1)(2006-4#1)
pneumonia in patients##4##3##(1991-12#1)(1993-6#1)(2006-11#1)(2006-4#1)
pneumonia in the##3##3##(1992-5#1)(2005-11#1)(2008-3#1)
pneumonia in##37##2##(1991-10#1)(1991-12#1)(1991-3#2)(1992-2#1)(1992-5#1)(1993-6#1)(1996-4#1)(1996-9#1)(2005-11#4)(2006-10#1)(2006-11#1)(2006-4#1)(2006-7#1)(2007-12#2)(2007-7#3)(2008-1#1)(2008-10#2)(2008-3#1)(2009-4#1)(2010-12#5)(2010-5#1)(2012-11#2)(2012-2#1)(2013-1#1)
pneumonia is##4##2##(1991-4#1)(1997-3#1)(2006-10#1)(2010-12#1)
pneumonia of##3##2##(1992-8#1)(2005-7#1)(2013-1#1)
pneumonia or##6##2##(2007-6#1)(2008-3#1)(2011-1#1)(2012-12#2)(2012-2#1)
pneumonia that##2##2##(2007-7#1)(2013-1#1)
pneumonia was associated with##2##4##(2007-7#1)(2012-2#1)
pneumonia was##6##2##(1993-5#1)(2006-10#1)(2007-7#1)(2010-12#1)(2012-12#1)(2012-2#1)
pneumonia were##3##2##(2010-7#1)(2012-2#1)(2013-1#1)
pneumonia with##8##2##(1990-8#1)(1990-9#1)(1993-2#1)(2005-8#1)(2006-10#1)(2010-12#1)(2010-7#1)(2011-2#1)
pneumonia##407##1##(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#5)(1991-10#1)(1991-11#1)(1991-12#5)(1991-3#2)(1991-4#4)(1991-8#2)(1991-9#1)(1992-10#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#1)(1992-8#2)(1993-10#3)(1993-2#2)(1993-5#2)(1993-6#3)(1994-11#1)(1994-3#1)(1994-4#2)(1994-5#1)(1994-6#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-3#2)(1997-4#2)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#12)(2005-7#4)(2005-8#45)(2005-9#1)(2006-10#32)(2006-11#1)(2006-4#4)(2006-7#2)(2006-8#2)(2007-11#3)(2007-12#7)(2007-2#8)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#12)(2007-8#8)(2008-1#12)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#6)(2008-5#10)(2008-6#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-4#2)(2009-5#2)(2009-6#1)(2010-11#4)(2010-12#36)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#4)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#3)(2011-2#13)(2012-11#2)(2012-12#14)(2012-2#11)(2012-3#5)(2013-1#32)(2013-8#9)
pneumonia) and##2##2##(2005-8#1)(2011-2#1)
pneumonia)##11##1##(1990-9#1)(1992-11#1)(2005-8#2)(2010-12#1)(2011-12#1)(2011-2#2)(2011-3#1)(2013-1#1)(2013-8#1)
pneumonia/ARDSs in outpatient X-ray##2##4##(2010-12#2)
pneumonia]##6##1##(1990-2#1)(1992-1#1)(1992-5#1)(1992-6#1)(1996-9#1)(2008-11#1)
pneumoniae BLSE##2##2##(2010-4#2)
pneumoniae MGH 78578##2##3##(2010-10#2)
pneumoniae and Chlamydia##2##3##(2005-11#1)(2013-1#1)
pneumoniae and Escherichia coli##2##4##(1990-5#1)(2005-8#1)
pneumoniae and Legionella##2##3##(1992-5#1)(2006-10#1)
pneumoniae and Streptococcus##2##3##(2012-12#1)(2012-2#1)
pneumoniae and##28##2##(1990-1#1)(1990-5#1)(1991-12#1)(1992-5#2)(1993-2#1)(1995-5#1)(1995-8#1)(1997-4#2)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-12#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
pneumoniae are##2##2##(2005-11#1)(2011-2#1)
pneumoniae as##3##2##(2006-8#1)(2007-8#1)(2011-2#1)
pneumoniae fldA gene##2##3##(1997-7#2)
pneumoniae fldA##3##2##(1997-7#3)
pneumoniae from##3##2##(2007-11#1)(2007-8#1)(2011-2#1)
pneumoniae gene##2##2##(1997-7#2)
pneumoniae has been##7##3##(2006-10#3)(2006-8#1)(2007-10#1)(2007-12#1)(2011-2#1)
pneumoniae has##8##2##(1997-2#1)(2006-10#3)(2006-8#1)(2007-10#1)(2007-12#1)(2011-2#1)
pneumoniae have##3##2##(2006-10#2)(2007-7#1)
pneumoniae in Thailand##2##3##(2011-2#2)
pneumoniae in a##2##3##(2007-7#2)
pneumoniae in the##2##3##(1997-3#1)(2006-10#1)
pneumoniae in##11##2##(1993-2#1)(1997-3#1)(2006-10#1)(2007-7#3)(2011-2#3)(2012-12#2)
pneumoniae infection##8##2##(1992-12#1)(1994-4#1)(2005-7#1)(2007-10#2)(2007-11#1)(2007-12#1)(2013-1#1)
pneumoniae infections##4##2##(1996-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
pneumoniae is a major cause of##2##6##(2012-12#2)
pneumoniae is a##5##3##(2006-8#1)(2007-10#1)(2011-2#1)(2012-12#2)
pneumoniae is##13##2##(1991-7#1)(1997-7#1)(2005-11#1)(2006-8#1)(2007-10#1)(2008-7#1)(2011-2#3)(2012-12#4)
pneumoniae isolated from##3##3##(2006-10#1)(2010-12#1)(2011-1#1)
pneumoniae isolates in##2##3##(1994-8#1)(2011-2#1)
pneumoniae isolates##7##2##(1994-8#1)(2011-2#4)(2012-12#1)(2012-2#1)
pneumoniae or##4##2##(1995-5#1)(2006-8#2)(2007-11#1)
pneumoniae strains##3##2##(2008-4#1)(2012-12#1)(2012-2#1)
pneumoniae to cefepime##2##3##(2008-7#2)
pneumoniae to##7##2##(1991-4#1)(2007-8#1)(2008-7#2)(2009-2#1)(2010-12#1)(2013-8#1)
pneumoniae type##3##2##(1991-9#3)
pneumoniae was significantly##3##3##(2006-8#2)(2007-10#1)
pneumoniae was##7##2##(1995-3#1)(1997-7#1)(2006-8#2)(2007-10#1)(2011-2#1)(2012-12#1)
pneumoniae were##5##2##(1991-3#1)(2008-8#1)(2010-12#1)(2012-12#1)(2012-2#1)
pneumoniae with##2##2##(2005-7#1)(2012-12#1)
pneumoniae##302##1##(1990-1#2)(1990-4#2)(1990-5#2)(1990-9#1)(1991-12#8)(1991-3#3)(1991-4#3)(1991-6#1)(1991-7#3)(1991-9#4)(1992-12#1)(1992-5#5)(1993-11#2)(1993-2#2)(1994-11#1)(1994-4#1)(1994-5#1)(1994-8#1)(1994-9#4)(1995-3#2)(1995-5#5)(1995-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-7#13)(2005-11#3)(2005-12#1)(2005-7#8)(2005-8#4)(2005-9#1)(2006-10#19)(2006-12#2)(2006-8#19)(2007-10#6)(2007-11#6)(2007-12#6)(2007-7#14)(2007-8#7)(2007-9#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#3)(2008-7#11)(2008-8#2)(2008-9#3)(2009-2#1)(2009-5#1)(2009-6#3)(2010-10#3)(2010-11#1)(2010-12#9)(2010-3#2)(2010-4#3)(2010-6#2)(2011-1#3)(2011-2#26)(2012-12#21)(2012-2#14)(2012-3#2)(2013-1#4)(2013-8#11)
pneumoniae) and##3##2##(2005-8#1)(2010-11#1)(2012-2#1)
pneumoniae)##10##1##(2005-11#1)(2005-8#1)(2006-8#1)(2007-7#1)(2010-11#2)(2011-2#2)(2012-2#1)(2012-3#1)
pneumoniae]##2##1##(1992-1#1)(2012-12#1)
pneumonias##18##1##(1993-5#1)(2005-11#6)(2005-8#7)(2007-3#1)(2008-5#1)(2011-2#1)(2013-8#1)
pneumonias]##2##1##(1993-10#1)(2010-12#1)
pneumonic consolidation##2##2##(1997-8#1)(2008-5#1)
pneumonic plague##2##2##(1990-6#2)
pneumonic##9##1##(1990-6#2)(1991-3#1)(1997-8#1)(2005-7#1)(2007-9#1)(2008-5#3)
pneumonie varicelleuse du nouveau-né##2##4##(2013-1#2)
pneumonie varicelleuse##3##2##(2013-1#3)
pneumonitis and##2##2##(1995-10#1)(2006-4#1)
pneumonitis in##2##2##(1990-11#1)(2010-12#1)
pneumonitis##33##1##(1990-11#1)(1991-9#2)(1994-6#4)(1995-10#1)(1995-9#1)(2005-8#6)(2006-4#1)(2006-8#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-6#1)(2010-12#4)(2010-2#3)(2010-4#1)(2011-2#1)(2012-12#1)
pneumonitis]##4##1##(1994-3#3)(1994-6#1)
pneumopathy and##2##2##(1996-3#1)(2006-8#1)
pneumopathy##4##1##(1996-3#1)(2006-8#2)(2010-12#1)
pneumoperitoneum in##3##2##(2006-10#1)(2007-5#1)(2013-7#1)
pneumoperitoneum with##2##2##(1991-12#1)(2009-8#1)
pneumoperitoneum##16##1##(1991-12#1)(1993-6#3)(2006-10#2)(2007-5#3)(2008-3#1)(2009-4#1)(2009-8#1)(2010-5#1)(2011-2#1)(2013-7#2)
pneumorrhachis##3##1##(2008-12#2)(2009-4#1)
pneumostasis##2##1##(2007-8#2)
pneumothoraces and##2##2##(2010-9#1)(2011-2#1)
pneumothoraces##7##1##(2005-8#1)(2006-4#1)(2008-7#1)(2010-9#1)(2011-2#3)
pneumothorax after pneumonectomy##2##3##(2007-8#2)
pneumothorax after##3##2##(2007-7#1)(2007-8#2)
pneumothorax and##6##2##(1990-12#1)(1991-4#1)(1992-2#1)(2007-6#1)(2007-8#1)(2013-1#1)
pneumothorax as a##2##3##(2007-7#1)(2007-8#1)
pneumothorax as##3##2##(2007-7#1)(2007-8#1)(2008-1#1)
pneumothorax in a##2##3##(2007-8#1)(2012-3#1)
pneumothorax in silicosis##2##3##(2008-7#2)
pneumothorax in##8##2##(2006-10#1)(2007-3#1)(2007-8#3)(2008-7#2)(2012-3#1)
pneumothorax is##3##2##(2007-8#2)(2008-7#1)
pneumothorax on##2##2##(2007-8#1)(2010-12#1)
pneumothorax or##3##2##(1992-2#1)(2007-11#1)(2013-1#1)
pneumothorax patients##2##2##(2007-8#1)(2008-5#1)
pneumothorax was##2##2##(2007-8#1)(2013-8#1)
pneumothorax were##2##2##(2007-8#1)(2008-6#1)
pneumothorax##106##1##(1990-12#2)(1990-3#1)(1990-5#2)(1991-3#3)(1991-4#1)(1991-6#3)(1991-9#1)(1992-2#2)(1994-10#1)(2006-10#7)(2007-11#1)(2007-3#1)(2007-6#1)(2007-7#10)(2007-8#28)(2008-1#2)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#11)(2009-6#3)(2010-12#2)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#2)
pneumothorax]##3##1##(1991-3#1)(2008-1#1)(2008-10#1)
pneumotoxicity##5##1##(1993-3#1)(1994-5#3)(1995-3#1)
pneumotropica in##2##2##(2012-2#2)
pneumotropica##6##1##(2012-2#6)
pnp1-1##2##1##(2012-3#2)
po in##2##2##(1993-4#1)(1997-1#1)
po##8##1##(1993-4#3)(1997-1#1)(2005-8#1)(2006-12#1)(2007-3#1)(2008-5#1)
poae isolates from##2##3##(2010-10#2)
poae isolates##4##2##(2010-10#4)
poae##10##1##(2007-7#1)(2008-10#2)(2010-10#7)
pockels##3##1##(2008-2#2)(2008-3#1)
pocket and the##4##3##(1990-8#1)(2007-5#1)(2008-4#1)(2009-3#1)
pocket and##8##2##(1990-7#1)(1990-8#2)(2007-12#1)(2007-5#2)(2008-4#1)(2009-3#1)
pocket can##2##2##(1990-8#1)(2011-1#1)
pocket cards##2##2##(2008-3#2)
pocket depth and##2##3##(2006-2#1)(2013-8#1)
pocket depth##5##2##(2006-2#1)(2008-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
pocket for the##2##3##(2007-11#1)(2008-4#1)
pocket for##6##2##(1991-2#1)(1991-7#1)(1992-1#1)(2007-11#1)(2008-4#1)(2010-7#1)
pocket formed by##2##3##(1991-12#1)(1992-4#1)
pocket in the##2##3##(2007-7#1)(2008-8#1)
pocket in##5##2##(1994-8#1)(1996-5#1)(2007-7#1)(2008-8#1)(2008-9#1)
pocket is##3##2##(1990-8#1)(1994-8#1)(1995-3#1)
pocket of the enzyme##4##4##(1993-3#3)(1997-4#1)
pocket of the##8##3##(1991-12#1)(1993-3#3)(1994-8#1)(1996-5#1)(1997-4#1)(2008-10#1)
pocket of##17##2##(1991-12#1)(1991-8#1)(1993-3#3)(1994-8#1)(1994-9#1)(1995-11#1)(1995-5#2)(1996-4#1)(1996-5#1)(1996-7#1)(1997-4#2)(2008-10#1)(2013-7#1)
pocket region##3##2##(1992-4#1)(2008-8#2)
pocket that is##2##3##(1993-6#1)(2010-10#1)
pocket that##4##2##(1993-6#1)(1995-10#1)(2010-10#1)(2013-1#1)
pocket to##3##2##(1990-8#1)(1992-12#1)(2008-4#1)
pocket was##2##2##(2008-8#1)(2009-12#1)
pocket with##2##2##(1995-11#1)(2012-2#1)
pocket##132##1##(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#8)(1991-12#2)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-12#2)(1992-3#2)(1992-4#3)(1992-8#2)(1992-9#2)(1993-3#4)(1993-6#1)(1994-12#1)(1994-5#4)(1994-8#7)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#3)(1995-2#5)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#1)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#1)(1997-4#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#3)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-4#4)(2008-7#1)(2008-8#6)(2008-9#2)(2009-12#1)(2009-3#4)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-12#1)(2012-12#1)(2012-2#4)(2013-1#3)(2013-7#1)(2013-8#3)
pocket&quot##3##1##(1992-8#1)(1996-8#2)
pocket)##2##1##(1990-8#1)(1992-8#1)
pocket-like##2##1##(2008-5#1)(2008-8#1)
pocket-sized##2##1##(1996-2#1)(2008-11#1)
pockets adjacent to##3##3##(2012-12#3)
pockets and##3##2##(1995-8#1)(2008-10#1)(2013-7#1)
pockets in the##3##3##(1995-8#2)(2008-12#1)
pockets in##4##2##(1995-8#2)(2006-2#1)(2008-12#1)
pockets of the##2##3##(1996-8#1)(2008-3#1)
pockets of##11##2##(1994-3#1)(1994-9#1)(1995-3#2)(1996-8#1)(2006-8#1)(2008-3#1)(2008-5#1)(2009-11#1)(2012-12#1)(2012-2#1)
pockets##46##1##(1990-12#1)(1992-10#1)(1992-4#2)(1994-3#1)(1994-9#1)(1995-3#2)(1995-8#3)(1996-8#2)(1997-4#2)(2005-11#2)(2006-10#2)(2006-2#5)(2006-8#2)(2007-6#2)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2009-11#1)(2012-12#5)(2012-2#1)(2013-7#1)
pod = 27##2##3##(2011-12#2)
pod =##3##2##(2011-12#3)
pod dehiscence##3##2##(2012-11#3)
pod mottle virus (BPMV)##3##4##(1990-5#1)(1992-8#1)(2008-10#1)
pod mottle virus##9##3##(1990-5#2)(1992-8#2)(2008-10#5)
pod mottle##10##2##(1990-5#2)(1992-8#2)(2008-10#6)
pod rot##6##2##(2008-10#6)
pod yields##4##2##(2008-10#2)(2008-12#2)
pod##50##1##(1990-5#2)(1992-8#2)(2008-10#31)(2008-12#4)(2010-11#2)(2011-12#4)(2012-11#3)(2013-1#1)(2013-8#1)
podium##3##1##(2005-9#1)(2008-5#1)(2012-12#1)
podium/poster sessions##2##2##(2012-1#2)
podocyte##9##1##(2007-9#1)(2008-1#2)(2009-8#1)(2011-2#5)
podocytes and##2##2##(2007-9#1)(2009-2#1)
podocytes in##3##2##(2007-9#2)(2008-1#1)
podocytes##20##1##(2007-12#2)(2007-9#8)(2008-1#5)(2008-7#2)(2009-2#2)(2009-3#1)
podophyllotoxin from##4##2##(2007-1#2)(2008-11#2)
podophyllotoxin##23##1##(1991-9#6)(1992-9#1)(1994-9#1)(2005-4#2)(2007-1#8)(2008-11#5)
podophyllum##2##1##(2008-10#2)
podoplanin expression in##2##3##(2011-2#1)(2013-1#1)
podoplanin expression##4##2##(2011-2#1)(2013-1#3)
podoplanin##9##1##(2011-2#1)(2013-1#8)
podospirone##2##1##(2008-11#2)
pods (12##2##2##(2008-12#2)
pods and##3##2##(2008-10#3)
pods ha(-1)##2##2##(2008-12#2)
pods of##4##2##(2008-10#2)(2011-12#1)(2011-2#1)
pods plant(-1)##3##2##(2008-12#3)
pods was##2##2##(2008-10#1)(2008-12#1)
pods were##2##2##(2008-10#2)
pods##31##1##(2007-3#1)(2008-10#17)(2008-12#9)(2011-12#1)(2011-2#2)(2013-8#1)
poet##4##1##(1993-3#1)(2008-1#3)
poetry##2##1##(2006-12#1)(2011-1#1)
poignant##2##1##(1993-2#1)(2012-2#1)
poinsettia##6##1##(2008-10#5)(2011-2#1)
point (7##2##2##(1992-12#1)(2013-8#1)
point (P = 0##2##4##(1996-8#1)(2007-8#1)
point (control##2##2##(2008-7#2)
point (the##2##2##(2008-3#1)(2008-9#1)
point (tsp)##20##2##(1991-12#1)(1991-6#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#3)(1995-2#1)(1995-8#1)(1996-8#2)(1997-2#1)
point 1##2##2##(2008-9#2)
point a##2##2##(1991-3#1)(2009-4#1)
point after##2##2##(2008-10#1)(2013-8#1)
point agarose##2##2##(2005-11#1)(2008-2#1)
point along the##6##3##(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)
point along##8##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)
point and extended sources##2##4##(2008-2#2)
point and interval estimates##3##4##(1994-9#1)(2008-11#1)(2008-4#1)
point and interval##5##3##(1994-9#1)(2008-11#1)(2008-4#1)(2010-2#1)(2012-1#1)
point and the##5##3##(1993-4#1)(2008-10#2)(2008-3#2)
point and##41##2##(1991-5#1)(1991-9#1)(1993-4#1)(1994-2#1)(1994-9#1)(1996-5#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-10#7)(2008-11#2)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#2)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
point are##2##2##(1991-12#1)(2012-12#1)
point as##2##2##(1990-10#1)(1994-11#1)
point at the##2##3##(2007-12#1)(2008-10#1)
point at which##8##3##(1994-11#1)(2005-11#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-1#1)(2012-2#1)
point at##25##2##(1990-3#1)(1993-5#1)(1993-7#1)(1994-11#1)(1994-4#2)(1996-7#1)(1997-8#2)(2005-11#2)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-1#1)(2009-2#1)(2012-2#2)
point between##2##2##(1994-10#1)(2008-10#1)
point by point##2##3##(2008-11#1)(2010-6#1)
point by##7##2##(1995-11#1)(1996-4#1)(2007-8#1)(2008-11#2)(2010-6#1)(2012-12#1)
point can be##4##3##(2007-12#3)(2008-2#1)
point charge##4##2##(1991-9#1)(1996-2#1)(2010-12#2)
point contact##2##2##(1995-10#1)(2005-11#1)
point counting##2##2##(2008-4#1)(2011-2#1)
point defects on the##2##4##(2007-11#1)(2008-10#1)
point defects##3##2##(2007-11#1)(2008-10#1)(2012-2#1)
point diffraction interferometer##5##3##(2006-4#1)(2008-2#1)(2008-3#3)
point during the##2##3##(1990-11#1)(2008-2#1)
point during##7##2##(1990-11#1)(1995-9#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2013-1#1)
point estimate of##4##3##(2008-11#1)(2008-4#1)(2012-3#2)
point estimate##7##2##(2008-11#2)(2008-4#1)(2012-12#2)(2012-3#2)
point estimates of##2##3##(1995-4#1)(2008-4#1)
point estimates##4##2##(1994-2#1)(1994-9#1)(1995-4#1)(2008-4#1)
point extraction (CPE)##3##3##(2008-10#3)
point extraction of lead##2##4##(2008-10#2)
point extraction of##6##3##(2008-10#6)
point extraction was applied##2##4##(2008-10#2)
point extraction was##4##3##(2008-10#4)
point extraction##25##2##(2008-10#25)
point for a##3##3##(1994-9#1)(2012-2#2)
point for the##17##3##(1991-1#1)(1992-4#1)(1994-8#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
point for##72##2##(1990-9#1)(1991-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-1#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-2#1)(1996-12#1)(1997-3#2)(2005-11#1)(2005-8#1)(2006-10#3)(2006-12#3)(2007-10#1)(2007-12#2)(2007-7#2)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#2)(2011-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#2)
point from the##2##3##(1991-9#1)(2007-7#1)
point from##6##2##(1991-6#1)(1991-9#1)(2005-11#1)(2006-3#1)(2007-7#1)(2008-6#1)
point greater##2##2##(1992-6#1)(1995-1#1)
point group##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
point has been##2##3##(1995-4#1)(2008-2#1)
point has##3##2##(1995-4#1)(1996-12#1)(2008-2#1)
point illumination##2##2##(2007-11#1)(2008-3#1)
point image approximation##2##3##(2010-12#2)
point image##3##2##(2010-12#3)
point images##3##2##(2008-3#3)
point in a##2##3##(2008-2#2)
point in determining the##2##4##(2008-10#1)(2009-8#1)
point in human##3##3##(1992-4#1)(2006-10#1)(2012-1#1)
point in the##37##3##(1992-2#1)(1992-4#1)(1992-7#1)(1992-9#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-6#1)(1997-6#1)(2004-9#1)(2005-11#1)(2006-10#3)(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2009-10#1)(2009-6#1)(2012-2#1)(2013-8#1)
point in their##4##3##(2004-9#1)(2008-4#1)(2008-9#1)(2009-5#1)
point in time##13##3##(2007-2#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#1)(2011-1#1)(2011-2#1)
point in##89##2##(1991-6#1)(1992-2#1)(1992-4#2)(1992-7#1)(1992-9#1)(1993-11#2)(1993-5#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-5#1)(1996-6#1)(1997-6#1)(2004-9#2)(2005-11#1)(2006-10#5)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#3)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#4)(2008-5#5)(2008-6#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
point inoculation##3##2##(2008-10#3)
point inside##2##2##(2008-3#1)(2008-7#1)
point into##2##2##(2007-12#1)(2012-2#1)
point is a##3##3##(2006-10#1)(2007-11#1)(2008-6#1)
point is reached##2##3##(2008-10#1)(2009-5#1)
point is that##3##3##(2008-11#2)(2011-1#1)
point is the##5##3##(1996-3#1)(2007-5#1)(2008-11#1)(2008-4#1)(2011-2#1)
point is##40##2##(1992-7#1)(1994-12#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-12#3)(2007-5#1)(2008-10#3)(2008-11#5)(2008-2#3)(2008-3#5)(2008-4#2)(2008-6#2)(2008-7#2)(2009-5#1)(2010-6#1)(2011-1#1)(2011-2#1)
point it##3##2##(1992-2#1)(1994-2#1)(2006-6#1)
point measurements##3##2##(2008-5#2)(2012-2#1)
point models##2##2##(2006-10#1)(2009-2#1)
point more##2##2##(1995-6#1)(2013-7#1)
point mutagenesis##2##2##(1991-8#1)(1997-4#1)
point mutants were##3##3##(1991-10#1)(1993-3#1)(1997-4#1)
point mutants##7##2##(1990-9#1)(1991-10#1)(1993-3#2)(1995-6#1)(1996-7#1)(1997-4#1)
point mutation (H163R)##2##3##(1997-5#2)
point mutation analysis##2##3##(1990-4#1)(2008-4#1)
point mutation and##2##3##(1994-9#1)(2008-2#1)
point mutation associated with##2##4##(1993-6#1)(1994-8#1)
point mutation at##6##3##(1990-11#1)(1990-5#1)(1991-6#1)(1993-3#1)(1995-8#1)(2005-11#1)
point mutation in the##12##4##(1990-12#1)(1991-2#1)(1991-7#1)(1992-3#1)(1992-8#1)(1994-8#1)(1994-9#1)(1995-6#1)(1997-1#1)(1997-6#1)(2008-10#2)
point mutation in##17##3##(1990-11#1)(1990-12#1)(1991-2#1)(1991-7#1)(1992-3#1)(1992-8#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-6#1)(1997-1#2)(1997-6#1)(2008-1#1)(2008-10#3)
point mutation of the##3##4##(1994-12#1)(1995-8#1)(2008-3#1)
point mutation of##5##3##(1992-8#1)(1994-12#1)(1995-8#1)(1996-6#1)(2008-3#1)
point mutation resulting in a substitution of##2##7##(1992-1#1)(1992-8#1)
point mutation was##3##3##(1990-8#1)(1992-8#1)(1996-2#1)
point mutation##68##2##(1990-11#2)(1990-12#3)(1990-4#1)(1990-5#1)(1990-8#1)(1991-2#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-8#5)(1993-11#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#2)(1994-9#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#3)(1996-2#3)(1996-6#2)(1997-1#2)(1997-5#2)(1997-6#1)(2005-11#1)(2005-8#1)(2007-2#2)(2008-1#1)(2008-10#7)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-4#1)
point mutations and 3##2##4##(1993-9#1)(2011-1#1)
point mutations and inversions##2##4##(2011-2#2)
point mutations and##7##3##(1993-9#1)(1994-11#1)(2008-7#1)(2011-1#2)(2011-2#2)
point mutations at##3##3##(1995-8#1)(1997-7#1)(2005-7#1)
point mutations found in##2##4##(1991-5#1)(1997-6#1)
point mutations in the##10##4##(1991-12#1)(1995-2#1)(1996-2#1)(1996-6#1)(1997-4#3)(1997-6#1)(2009-3#1)(2011-2#1)
point mutations in##24##3##(1991-12#1)(1991-4#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-7#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-6#1)(1997-4#3)(1997-6#1)(1997-7#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-7#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
point mutations near the##2##4##(1993-11#1)(1995-8#1)
point mutations of the##3##4##(1994-11#1)(1995-11#1)(2008-10#1)
point mutations of##4##3##(1991-5#1)(1994-11#1)(1995-11#1)(2008-10#1)
point mutations that##2##3##(1993-11#1)(2010-8#1)
point mutations were##2##3##(1995-3#1)(1997-1#1)
point mutations within the##2##4##(2008-5#1)(2010-2#1)
point mutations within##3##3##(1996-5#1)(2008-5#1)(2010-2#1)
point mutations##87##2##(1990-12#1)(1990-3#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-4#2)(1991-5#5)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-11#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-3#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-8#5)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-4#3)(1997-6#3)(1997-7#2)(2005-7#1)(2006-12#2)(2007-10#1)(2007-2#1)(2008-10#3)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#5)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#1)
point near##2##2##(2007-4#1)(2008-5#1)
point of 2##2##3##(1997-2#1)(2012-2#1)
point of 5##2##3##(1991-1#1)(2008-10#1)
point of a##8##3##(1992-12#1)(2007-12#1)(2008-3#3)(2008-6#1)(2011-2#1)(2012-2#1)
point of care##12##3##(1997-2#1)(1997-3#1)(2007-2#1)(2008-11#1)(2008-2#1)(2009-5#1)(2010-10#1)(2010-8#1)(2013-1#4)
point of contact##2##3##(2006-8#1)(2007-7#1)
point of control##2##3##(1992-4#1)(2012-2#1)
point of convenience##2##3##(2011-1#1)(2012-12#1)
point of departure for##5##4##(1991-12#1)(1993-3#1)(2007-7#1)(2008-11#1)(2012-2#1)
point of departure##7##3##(1991-12#1)(1993-3#1)(1993-8#1)(2007-7#1)(2008-11#1)(2008-5#1)(2012-2#1)
point of interest##2##3##(2008-3#2)
point of maximum##2##3##(1997-2#1)(2008-11#1)
point of no return&quot##2##4##(2008-11#2)
point of no##4##3##(1993-9#1)(2008-11#3)
point of origin##2##3##(2007-10#1)(2013-7#1)
point of reference##2##3##(2007-11#1)(2013-8#1)
point of service##2##3##(1996-1#1)(1996-3#1)
point of the test##2##4##(2005-10#1)(2008-10#1)
point of the##59##3##(1990-10#2)(1990-12#1)(1996-12#1)(1996-5#2)(1997-3#1)(1997-6#1)(2005-10#1)(2005-11#3)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#3)(2007-4#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#5)(2008-5#1)(2008-7#2)(2008-8#2)(2009-3#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#4)
point of this##3##3##(1991-2#1)(2007-8#1)(2008-10#1)
point of time##2##3##(1992-4#1)(2008-1#1)
point of view and##8##4##(1992-6#1)(2005-10#1)(2006-8#1)(2007-10#1)(2007-8#2)(2008-9#1)(2010-12#1)
point of view has##2##4##(2007-7#1)(2011-2#1)
point of view in##2##4##(1991-2#1)(2013-1#1)
point of view is##2##4##(2006-12#1)(2010-4#1)
point of view of##38##4##(1990-3#1)(1990-9#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-3#2)(1993-1#1)(1993-3#1)(1994-2#1)(1994-3#2)(1995-11#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-6#1)(2007-10#1)(2007-5#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-9#1)(2012-1#1)(2012-3#1)(2013-8#2)
point of view that##2##4##(2005-12#1)(2010-10#1)
point of view the##4##4##(1994-7#1)(2009-3#2)(2013-8#1)
point of view##178##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#2)(1990-5#2)(1990-9#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#3)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-2#1)(1994-3#3)(1994-7#1)(1995-11#1)(1995-2#1)(1995-4#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(2004-12#1)(2004-9#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#3)(2006-7#1)(2006-8#2)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#16)(2008-11#2)(2008-2#7)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-7#1)(2009-9#2)(2010-10#2)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#5)(2013-8#8)
point of view]##3##3##(1990-5#1)(1991-6#1)(1993-5#1)
point of zero##2##3##(2005-11#1)(2008-10#1)
point of##402##2##(1990-10#3)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#3)(1990-5#4)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#3)(1992-1#1)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#3)(1992-4#3)(1992-6#1)(1992-7#1)(1993-1#1)(1993-10#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-5#1)(1993-8#2)(1993-9#2)(1994-12#2)(1994-2#2)(1994-3#3)(1994-7#1)(1995-11#1)(1995-2#2)(1995-4#1)(1995-7#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#4)(1997-2#3)(1997-3#4)(1997-4#1)(1997-6#1)(2004-12#1)(2004-9#1)(2005-10#3)(2005-11#8)(2005-12#1)(2005-3#1)(2005-4#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#3)(2006-7#3)(2006-8#4)(2006-9#1)(2007-10#4)(2007-11#9)(2007-12#7)(2007-2#3)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#6)(2007-8#5)(2007-9#1)(2008-1#5)(2008-10#37)(2008-11#13)(2008-12#3)(2008-2#19)(2008-3#15)(2008-4#1)(2008-5#7)(2008-6#4)(2008-7#11)(2008-8#4)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#2)(2010-10#3)(2010-12#6)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#5)(2010-7#1)(2010-8#3)(2011-1#6)(2011-2#9)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#6)(2012-2#13)(2012-3#2)(2013-1#11)(2013-7#1)(2013-8#15)
point on the##14##3##(1991-5#1)(1995-12#1)(1995-6#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-2#1)(2008-3#3)(2008-7#2)(2010-4#1)
point on##17##2##(1991-5#1)(1995-12#1)(1995-6#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-2#2)(2008-3#3)(2008-7#2)(2010-4#2)(2011-1#1)
point or a locus of points##2##6##(2008-2#2)
point or##6##2##(1991-12#1)(2008-2#3)(2008-6#1)(2011-2#1)
point out a##2##3##(1990-12#1)(2005-11#1)
point out that the##3##4##(2008-10#1)(2008-2#1)(2012-2#1)
point out that##16##3##(1990-2#1)(1992-5#1)(2006-2#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#3)(2008-5#1)(2008-6#1)(2009-3#1)(2012-2#1)
point out the challenges##2##4##(2007-2#1)(2009-4#1)
point out the need for##2##5##(2007-10#1)(2012-3#1)
point out the need##3##4##(1991-8#1)(2007-10#1)(2012-3#1)
point out the##22##3##(1991-8#1)(1993-10#1)(1993-4#1)(1995-8#1)(1996-12#1)(2006-12#1)(2006-5#1)(2007-10#2)(2007-12#1)(2007-2#2)(2007-7#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-8#1)(2009-4#1)(2012-3#1)(2012-8#1)(2013-1#1)
point out to##3##3##(2008-10#1)(2010-4#1)(2011-1#1)
point out##55##2##(1990-12#1)(1990-2#1)(1991-8#1)(1992-5#1)(1993-10#1)(1993-4#1)(1995-8#1)(1996-12#2)(2005-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-2#2)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-2#5)(2008-5#2)(2008-6#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#1)
point patterns##2##2##(2008-10#2)
point pressure##3##2##(2006-4#1)(2010-12#1)(2011-1#1)
point prevalence of##3##3##(1990-6#1)(2011-1#1)(2013-8#1)
point prevalence##6##2##(1990-6#1)(1997-6#1)(2008-7#1)(2011-1#1)(2013-8#2)
point process##9##2##(1996-12#1)(2008-2#1)(2009-9#2)(2010-11#2)(2010-5#2)(2012-2#1)
point processes##5##2##(1995-7#1)(1996-12#2)(2010-11#2)
point sets##4##2##(2008-2#3)(2009-10#1)
point source and##2##3##(2007-12#1)(2008-3#1)
point source is##3##3##(2008-3#3)
point source##28##2##(2007-11#2)(2007-12#1)(2007-3#1)(2008-10#5)(2008-11#1)(2008-2#6)(2008-3#11)(2011-12#1)
point sources##7##2##(2008-3#3)(2010-2#1)(2010-5#1)(2011-2#2)
point spread function of##2##4##(2007-12#1)(2011-1#1)
point spread function##7##3##(2006-4#1)(2007-12#1)(2008-1#1)(2008-6#1)(2009-4#1)(2011-1#2)
point target##2##2##(2008-2#1)(2008-3#1)
point temperature##5##2##(2005-11#1)(2008-10#3)(2008-2#1)
point that##9##2##(1991-5#1)(2006-10#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-7#1)(2009-8#1)(2012-12#1)(2013-1#1)
point the way to##3##4##(2007-4#1)(2007-9#1)(2010-3#1)
point the way##6##3##(1990-11#1)(2007-4#1)(2007-9#1)(2008-1#1)(2010-3#1)(2011-2#1)
point the##20##2##(1990-11#1)(1996-2#1)(2005-10#1)(2006-10#1)(2006-3#2)(2007-4#1)(2007-9#1)(2008-1#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
point to a correlation between##2##5##(2008-10#1)(2008-7#1)
point to a line##2##4##(2008-2#1)(2008-3#1)
point to a novel##2##4##(2009-2#1)(2011-1#1)
point to a##25##3##(1991-5#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-7#1)(1995-10#1)(1996-10#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-8#1)
point to an##5##3##(1991-11#1)(1991-2#1)(2008-11#1)(2011-2#1)(2013-1#1)
point to be##2##3##(2008-12#1)(2008-2#1)
point to consider##2##3##(1996-4#1)(2010-5#1)
point to improved##2##3##(2006-2#1)(2011-2#1)
point to new##2##3##(2008-6#1)(2012-2#1)
point to potential##2##3##(2012-1#1)(2012-3#1)
point to the importance of##3##5##(1991-6#1)(1995-2#1)(2008-5#1)
point to the necessity of##2##5##(1997-4#1)(2007-12#1)
point to the need for a##2##6##(2008-2#1)(2011-2#1)
point to the need for##6##5##(1991-3#1)(1994-2#1)(2008-10#1)(2008-2#1)(2009-9#1)(2011-2#1)
point to the need##9##4##(1991-3#1)(1994-2#1)(1996-5#1)(2006-3#1)(2008-10#1)(2008-2#1)(2009-9#1)(2011-2#1)(2012-3#1)
point to the possibility of##2##5##(1992-2#1)(2010-3#1)
point to the possibility##3##4##(1992-2#1)(2008-3#1)(2010-3#1)
point to the##37##3##(1990-10#1)(1990-6#1)(1991-3#1)(1991-6#2)(1992-11#1)(1992-2#1)(1993-12#2)(1994-2#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-1#1)(1997-4#1)(2005-11#1)(2006-3#1)(2006-7#1)(2007-1#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-2#3)(2012-3#1)(2013-7#1)
point to##121##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1992-11#1)(1992-2#1)(1992-5#1)(1993-12#3)(1993-3#1)(1993-7#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-3#2)(1996-10#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-3#1)(2006-7#1)(2007-1#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#7)(2008-11#5)(2008-12#2)(2008-2#7)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-8#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#3)(2013-8#1)
point toward##3##2##(2007-12#1)(2007-2#1)(2007-9#1)
point towards the##2##3##(2008-10#1)(2011-2#1)
point towards##4##2##(2006-2#1)(2008-10#1)(2010-9#1)(2011-2#1)
point two##2##2##(2013-1#2)
point was 6##3##3##(1994-8#1)(2009-2#1)(2011-1#1)
point was detected##2##3##(2004-8#1)(2008-11#1)
point was the##3##3##(2007-8#1)(2008-10#1)(2008-2#1)
point was##34##2##(1990-12#2)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-4#1)(1994-8#1)(1995-8#1)(2004-8#1)(2004-9#1)(2005-11#2)(2006-6#1)(2006-8#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2009-11#1)(2009-2#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)
point were##3##2##(2008-3#1)(2008-5#1)(2011-2#1)
point when##4##2##(2007-8#1)(2008-12#1)(2010-12#2)
point where a##2##3##(1992-3#1)(2008-1#1)
point where the##6##3##(1990-12#1)(1992-7#1)(2007-11#1)(2008-10#1)(2008-8#1)(2010-9#1)
point where they##2##3##(2007-12#1)(2010-3#1)
point where##19##2##(1990-12#1)(1991-2#1)(1992-3#1)(1992-7#1)(1994-10#1)(1995-8#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#2)(2010-3#1)(2010-9#1)(2011-1#1)
point which##2##2##(2008-12#1)(2011-2#1)
point will##3##2##(2007-11#1)(2007-12#1)(2008-9#1)
point with the##2##3##(2008-10#1)(2012-2#1)
point with##5##2##(2008-10#2)(2008-3#1)(2012-2#1)(2013-7#1)
point within##4##2##(2008-6#1)(2012-2#1)(2013-1#2)
point without##2##2##(2006-6#1)(2007-8#1)
point would##2##2##(1991-6#1)(2008-8#1)
point##1842##1##(1990-10#5)(1990-11#10)(1990-12#10)(1990-2#2)(1990-3#6)(1990-4#2)(1990-5#9)(1990-6#3)(1990-7#1)(1990-8#1)(1990-9#4)(1991-1#6)(1991-10#3)(1991-11#2)(1991-12#6)(1991-2#9)(1991-3#3)(1991-4#4)(1991-5#10)(1991-6#11)(1991-7#2)(1991-8#8)(1991-9#4)(1992-1#3)(1992-11#2)(1992-12#10)(1992-2#10)(1992-3#7)(1992-4#7)(1992-5#2)(1992-6#4)(1992-7#5)(1992-8#6)(1992-9#1)(1993-1#4)(1993-10#3)(1993-11#9)(1993-12#7)(1993-2#4)(1993-3#12)(1993-4#3)(1993-5#4)(1993-6#3)(1993-7#2)(1993-8#4)(1993-9#5)(1994-1#1)(1994-10#2)(1994-11#6)(1994-12#8)(1994-2#9)(1994-3#7)(1994-4#2)(1994-5#2)(1994-6#5)(1994-7#1)(1994-8#5)(1994-9#10)(1995-1#3)(1995-10#2)(1995-11#5)(1995-12#8)(1995-2#11)(1995-3#9)(1995-4#4)(1995-5#2)(1995-6#11)(1995-7#3)(1995-8#14)(1995-9#2)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#9)(1996-2#11)(1996-3#8)(1996-4#4)(1996-5#9)(1996-6#5)(1996-7#3)(1996-8#4)(1997-1#4)(1997-2#7)(1997-3#8)(1997-4#10)(1997-5#2)(1997-6#9)(1997-7#3)(1997-8#3)(2004-10#1)(2004-12#1)(2004-8#1)(2004-9#6)(2005-10#4)(2005-11#29)(2005-12#1)(2005-3#1)(2005-4#1)(2005-7#4)(2005-8#4)(2005-9#1)(2006-1#3)(2006-10#25)(2006-11#3)(2006-12#11)(2006-2#5)(2006-3#6)(2006-4#10)(2006-5#5)(2006-6#11)(2006-7#6)(2006-8#8)(2006-9#2)(2007-1#2)(2007-10#13)(2007-11#37)(2007-12#42)(2007-2#10)(2007-3#4)(2007-4#8)(2007-5#3)(2007-6#3)(2007-7#13)(2007-8#19)(2007-9#9)(2008-1#20)(2008-10#187)(2008-11#50)(2008-12#13)(2008-2#101)(2008-3#98)(2008-4#21)(2008-5#37)(2008-6#22)(2008-7#35)(2008-8#17)(2008-9#21)(2009-1#1)(2009-10#4)(2009-11#7)(2009-12#4)(2009-2#13)(2009-3#9)(2009-4#8)(2009-5#6)(2009-6#3)(2009-7#4)(2009-8#5)(2009-9#6)(2010-1#2)(2010-10#5)(2010-11#8)(2010-12#23)(2010-2#8)(2010-3#9)(2010-4#9)(2010-5#16)(2010-6#3)(2010-7#1)(2010-8#7)(2010-9#4)(2011-1#31)(2011-10#1)(2011-12#3)(2011-2#46)(2011-3#2)(2012-1#9)(2012-11#4)(2012-12#28)(2012-2#43)(2012-3#13)(2012-8#1)(2013-1#43)(2013-7#9)(2013-8#36)
point&quot##2##1##(1991-4#1)(2008-8#1)
point'##3##1##(1994-6#1)(1995-8#1)(1997-6#1)
point)##8##1##(1997-8#1)(2008-10#2)(2008-2#1)(2009-6#1)(2009-8#1)(2010-5#1)(2011-2#1)
point-by-point##2##1##(2007-12#1)(2008-3#1)
point-diffraction interferometer for##2##3##(2008-2#1)(2008-3#1)
point-diffraction interferometer##12##2##(2007-12#2)(2008-2#2)(2008-3#8)
point-diffraction interferometry##3##2##(2008-3#3)
point-diffraction##15##1##(2007-12#2)(2008-2#2)(2008-3#11)
point-focusing##3##1##(2006-5#2)(2009-5#1)
point-light##3##1##(2008-11#1)(2012-1#1)(2012-11#1)
point-of-care assay##2##2##(2008-3#1)(2013-1#1)
point-of-care diagnostics and##2##3##(2007-8#1)(2008-11#1)
point-of-care testing##2##2##(2008-12#1)(2013-8#1)
point-of-care##18##1##(1996-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#3)(2008-7#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
point-of-service##6##1##(1991-3#1)(1994-2#1)(1995-8#1)(1996-3#1)(1997-2#1)(2006-10#1)
point-prevalence##3##1##(1992-2#1)(2007-2#1)(2013-8#1)
point-source##8##1##(2007-12#1)(2008-2#4)(2008-3#3)
point-spread function (PSF) of##2##4##(2008-3#2)
point-spread function (PSF)##6##3##(2008-2#1)(2008-3#5)
point-spread function and##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
point-spread function by##2##3##(2007-12#1)(2008-2#1)
point-spread function engineering##2##3##(2007-12#2)
point-spread function for##2##3##(2007-12#1)(2008-2#1)
point-spread function in##3##3##(2007-11#1)(2008-3#2)
point-spread function is##6##3##(2008-2#1)(2008-3#5)
point-spread function of##7##3##(2007-12#4)(2008-2#2)(2008-3#1)
point-spread function that##2##3##(2008-2#1)(2008-3#1)
point-spread function##51##2##(2007-11#2)(2007-12#13)(2008-2#16)(2008-3#20)
point-spread functions##11##2##(2007-12#3)(2008-2#3)(2008-3#5)
point-spread##62##1##(2007-11#2)(2007-12#16)(2008-2#19)(2008-3#25)
point-symmetric extension at the##2##4##(2008-2#2)
point-symmetric extension at##3##3##(2008-2#3)
point-to-point##13##1##(1997-3#1)(2007-10#1)(2008-2#1)(2008-3#6)(2008-8#1)(2012-2#1)(2013-1#2)
point?##3##1##(2006-5#1)(2008-8#1)(2013-7#1)
pointed at##5##2##(1993-7#1)(2006-12#1)(2008-10#2)(2008-3#1)
pointed in##3##2##(1990-7#1)(2008-6#1)(2012-1#1)
pointed out and##2##3##(1990-7#1)(1993-12#1)
pointed out as##3##3##(1990-8#1)(2008-10#1)(2008-12#1)
pointed out by##2##3##(2008-9#1)(2010-2#1)
pointed out in##3##3##(1990-4#1)(2006-10#1)(2012-3#1)
pointed out that the##7##4##(1991-7#1)(2006-4#1)(2007-3#1)(2008-10#2)(2008-2#1)(2009-2#1)
pointed out that these##3##4##(1992-3#1)(2005-11#1)(2011-12#1)
pointed out that##21##3##(1991-7#1)(1992-3#1)(1993-9#1)(1995-4#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-5#1)(2009-2#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-12#1)
pointed out the##3##3##(1994-9#1)(2007-11#1)(2007-12#1)
pointed out##72##2##(1990-10#1)(1990-2#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-3#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-9#1)(1995-4#1)(1996-3#1)(2005-10#1)(2005-11#3)(2006-1#1)(2006-10#3)(2006-4#1)(2007-11#4)(2007-12#3)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-2#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#2)(2009-4#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
pointed to a##3##3##(2007-8#1)(2008-2#1)(2009-10#1)
pointed to the##10##3##(1990-5#1)(1992-12#1)(1995-12#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-1#1)
pointed to##18##2##(1990-5#1)(1992-12#1)(1994-1#1)(1995-12#2)(2005-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-10#1)(2011-1#1)(2012-12#1)(2012-2#1)
pointed toward the##2##3##(1996-2#1)(2012-2#1)
pointed towards##2##2##(1990-10#1)(2006-12#1)
pointed##115##1##(1990-10#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-4#1)(1996-2#1)(1996-3#1)(2005-1#1)(2005-10#1)(2005-11#3)(2005-8#1)(2006-1#1)(2006-10#3)(2006-12#2)(2006-4#1)(2007-11#5)(2007-12#4)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#11)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#2)(2009-4#2)(2009-9#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
pointedly##2##1##(2009-2#1)(2013-8#1)
pointer##3##1##(2004-9#1)(2006-6#1)(2007-8#1)
pointers to##2##2##(2004-5#1)(2008-2#1)
pointers##5##1##(2004-5#1)(2004-9#1)(2008-2#1)(2009-12#1)(2010-12#1)
pointing by captive##2##3##(2007-12#2)
pointing by##3##2##(2007-12#3)
pointing errors##3##2##(1990-11#1)(2008-3#2)
pointing into##2##2##(1995-1#1)(1995-8#1)
pointing jitter##3##2##(2008-2#3)
pointing movements in##2##3##(1990-11#1)(1993-5#1)
pointing movements##3##2##(1990-11#1)(1993-5#1)(1993-7#1)
pointing out the##4##3##(1996-9#1)(2006-10#1)(2009-10#1)(2011-2#1)
pointing out##10##2##(1996-9#1)(2006-10#1)(2007-8#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
pointing position##2##2##(1993-5#1)(1993-7#1)
pointing system##4##2##(2008-2#2)(2008-3#2)
pointing task##2##2##(1990-11#1)(2008-4#1)
pointing the##2##2##(2008-3#1)(2010-5#1)
pointing to a role for##2##5##(1991-9#1)(2009-8#1)
pointing to a role##3##4##(1991-9#1)(2008-4#1)(2009-8#1)
pointing to a##10##3##(1991-9#1)(1992-1#1)(2005-11#1)(2007-7#1)(2008-4#1)(2008-8#1)(2009-8#1)(2010-3#1)(2012-1#1)(2012-12#1)
pointing to the##7##3##(1994-5#1)(2006-2#1)(2008-1#1)(2008-10#1)(2009-8#1)(2010-2#1)(2011-12#1)
pointing to##35##2##(1990-8#1)(1991-9#1)(1992-1#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-3#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-4#1)(2004-4#1)(2005-11#1)(2006-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-8#2)(2010-2#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)
pointing toward##2##2##(1994-5#1)(2009-11#1)
pointing towards a##2##3##(2007-8#1)(2012-12#1)
pointing towards##3##2##(1993-3#1)(2007-8#1)(2012-12#1)
pointing##104##1##(1990-11#3)(1990-8#1)(1991-9#1)(1992-1#1)(1992-10#2)(1993-3#1)(1993-5#3)(1993-7#5)(1994-11#1)(1994-3#1)(1994-5#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-8#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-12#6)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-2#11)(2008-3#13)(2008-4#3)(2008-7#1)(2008-8#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-8#2)(2010-2#1)(2010-3#2)(2010-5#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#1)
pointlike source##2##2##(2008-2#1)(2008-3#1)
pointlike##8##1##(2007-12#1)(2008-2#2)(2008-3#5)
points (p##2##2##(2008-3#1)(2008-9#1)
points (range##5##2##(2007-7#2)(2008-4#2)(2008-8#1)
points about the##2##3##(2008-10#1)(2008-3#1)
points according to##2##3##(1997-8#1)(2007-11#1)
points after##5##2##(1995-2#1)(2007-11#1)(2010-2#1)(2011-3#1)(2012-1#1)
points along a##2##3##(2007-11#1)(2008-10#1)
points along the curvature##2##4##(2007-11#1)(2009-2#1)
points along the##6##3##(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2009-2#1)(2011-2#1)
points along##11##2##(2006-10#1)(2007-11#3)(2008-10#2)(2008-2#2)(2009-2#1)(2011-2#2)
points and elementary##2##3##(1992-9#2)
points and in##3##3##(1993-7#1)(1997-3#1)(2011-2#1)
points and the##3##3##(2007-12#1)(2011-1#1)(2011-12#1)
points and##38##2##(1992-9#2)(1993-7#1)(1997-3#2)(2007-11#2)(2007-12#1)(2007-5#2)(2007-6#1)(2007-8#2)(2008-10#4)(2008-2#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-2#3)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#1)(2012-4#1)(2013-1#4)
points are located##2##3##(1996-6#1)(2008-10#1)
points are##23##2##(1990-7#1)(1994-3#1)(1995-3#1)(1996-6#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#3)(2008-6#2)(2009-9#1)(2012-12#2)(2012-2#1)
points as##2##2##(2006-6#1)(2008-10#1)
points at which##3##3##(1990-8#1)(2008-10#1)(2008-2#1)
points at##6##2##(1990-8#1)(2007-3#1)(2008-10#1)(2008-2#1)(2010-8#1)(2011-1#1)
points before##2##2##(2007-11#1)(2007-5#1)
points between the##3##3##(1997-4#1)(2007-8#1)(2008-3#1)
points between##7##2##(1997-4#1)(2006-9#1)(2007-8#1)(2008-11#1)(2008-3#1)(2010-10#1)(2012-2#1)
points by##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
points can be##3##3##(2008-10#1)(2009-11#1)(2009-7#1)
points discussed are##2##3##(1994-6#1)(2013-7#1)
points discussed##4##2##(1993-3#1)(1993-5#1)(1994-6#1)(2013-7#1)
points during the##6##3##(2006-3#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-1#1)(2013-1#1)
points during##11##2##(2006-3#1)(2006-5#1)(2007-2#1)(2008-3#1)(2009-11#1)(2009-9#1)(2010-2#2)(2011-2#1)(2012-1#1)(2013-1#1)
points evaluated##3##2##(2007-11#2)(2008-5#1)
points for a##2##3##(2007-11#1)(2008-4#1)
points for the##6##3##(1990-11#1)(2005-8#1)(2007-12#1)(2007-8#1)(2009-2#1)(2011-2#1)
points for##29##2##(1990-11#1)(1992-9#1)(1997-8#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-2#2)(2009-8#1)(2010-12#2)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)
points from##11##2##(1992-2#2)(1995-2#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-11#1)(2012-1#1)(2013-1#1)
points has##2##2##(1992-6#1)(2008-1#1)
points in a##8##3##(1990-11#1)(1991-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2012-1#1)
points in the phase##3##4##(2007-12#1)(2008-3#1)(2010-9#1)
points in the##35##3##(1992-2#1)(1992-6#1)(1994-12#1)(1995-6#1)(1996-8#2)(1997-3#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#7)(2008-3#4)(2008-7#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2013-1#1)
points in time and##2##4##(1992-1#1)(2008-7#1)
points in time##10##3##(1992-1#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-5#1)(2012-1#1)(2012-12#1)
points in##88##2##(1990-11#1)(1990-7#1)(1991-12#1)(1992-1#1)(1992-2#2)(1992-6#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-8#2)(1997-3#2)(2005-7#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#3)(2008-2#10)(2008-3#5)(2008-5#1)(2008-6#4)(2008-7#4)(2008-8#2)(2009-12#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#3)(2010-9#2)(2011-1#1)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#5)(2013-7#1)
points included##4##2##(2008-6#1)(2010-4#1)(2010-7#1)(2012-3#1)
points is presented##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
points is proposed##2##3##(2007-12#1)(2008-2#1)
points is the##2##3##(1990-8#1)(2008-10#1)
points is##19##2##(1990-8#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#5)(2008-3#3)(2009-11#1)(2010-2#1)(2012-2#1)(2012-3#1)
points may be##2##3##(2007-6#1)(2008-3#1)
points may##3##2##(2007-6#1)(2008-3#1)(2009-10#1)
points more##3##2##(2008-10#1)(2013-1#2)
points of a##2##3##(2007-11#1)(2008-3#1)
points of comparison##2##3##(2008-6#2)
points of contact between##3##4##(2005-11#1)(2010-12#2)
points of contact##4##3##(2005-11#1)(2009-5#1)(2010-12#2)
points of origin##2##3##(1994-4#1)(2008-10#1)
points of reference for##4##4##(2007-4#1)(2008-2#2)(2011-2#1)
points of reference##6##3##(2007-4#1)(2008-2#4)(2011-2#1)
points of the##29##3##(1990-3#1)(1993-6#1)(1995-11#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-5#1)(2007-7#3)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#3)(2008-6#1)(2009-3#1)(2009-8#1)(2012-1#1)(2012-12#2)(2012-2#1)
points of these##3##3##(1990-1#1)(2008-10#1)(2008-9#1)
points of view and##2##4##(2008-7#1)(2011-2#1)
points of view##26##3##(1990-11#1)(1990-2#1)(1991-6#1)(1993-11#1)(1993-2#1)(1996-1#1)(2005-11#2)(2005-5#1)(2005-7#1)(2006-12#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
points of views##2##3##(2012-2#1)(2013-1#1)
points of zero##2##3##(2005-11#1)(2007-12#1)
points of##137##2##(1990-1#1)(1990-11#1)(1990-2#1)(1990-3#1)(1991-10#1)(1991-11#1)(1991-6#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-4#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-2#2)(2004-10#1)(2004-11#1)(2005-11#7)(2005-5#1)(2005-7#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-1#2)(2007-11#6)(2007-12#4)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#2)(2008-10#13)(2008-11#2)(2008-2#13)(2008-3#10)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#8)
points on a##4##3##(2008-2#1)(2008-3#1)(2008-6#2)
points on the ODS) in##2##5##(2007-8#2)
points on the ODS)##3##4##(2007-8#3)
points on the##9##3##(2007-8#3)(2008-12#1)(2008-2#1)(2008-3#3)(2013-1#1)
points on##19##2##(2005-12#1)(2007-8#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-6#2)(2009-11#1)(2009-2#1)(2010-2#1)(2012-12#2)(2013-1#1)
points only##2##2##(2007-12#1)(2009-2#1)
points or higher##2##3##(2010-12#2)
points or##5##2##(2008-1#1)(2008-10#2)(2010-12#2)
points out some##2##3##(1995-2#1)(2007-11#1)
points out that the##3##4##(2008-4#1)(2008-7#1)(2011-2#1)
points out that##10##3##(1994-12#1)(1996-5#1)(2007-2#1)(2007-5#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-7#1)
points out the##13##3##(1991-9#1)(1992-1#1)(1993-10#1)(1993-6#1)(1996-6#1)(1997-5#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-11#1)(2013-7#1)
points out##32##2##(1991-9#1)(1992-1#1)(1992-8#1)(1993-10#1)(1993-6#1)(1994-12#1)(1995-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-5#1)(2005-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2010-8#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-7#2)
points over a##2##3##(1991-9#1)(2011-2#1)
points over##5##2##(1991-9#1)(2008-7#1)(2009-4#1)(2010-12#1)(2011-2#1)
points postoperatively##3##2##(2008-3#1)(2013-1#2)
points raised##2##2##(2007-11#1)(2007-8#1)
points regarding the##2##3##(1995-1#1)(2010-10#1)
points relating to##2##3##(2007-10#1)(2008-8#1)
points separated by##2##3##(1990-7#1)(2010-1#1)
points showed that##2##3##(1997-6#1)(2007-5#1)
points showed##3##2##(1997-6#1)(2007-5#1)(2011-2#1)
points than##2##2##(1996-6#1)(2005-12#1)
points that are##4##3##(1997-8#1)(2008-3#3)
points that##12##2##(1991-2#1)(1997-8#1)(2007-11#1)(2008-11#1)(2008-3#3)(2009-8#1)(2010-2#1)(2012-1#2)(2013-8#1)
points the##2##2##(2007-11#1)(2012-12#1)
points through##2##2##(2008-5#1)(2009-4#1)
points to a role##2##4##(2006-10#1)(2012-1#1)
points to a##17##3##(1990-5#1)(1996-1#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-6#2)(2007-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-11#1)(2012-1#2)
points to an##2##3##(1990-6#1)(2009-9#1)
points to consider in designing preclinical animal studies##2##8##(2012-12#2)
points to consider in##3##4##(2008-4#1)(2012-12#2)
points to consider##4##3##(2008-11#1)(2008-4#1)(2012-12#2)
points to the existence of a##3##6##(1993-9#1)(1994-6#1)(2006-10#1)
points to the existence of##5##5##(1993-9#1)(1994-6#1)(1995-12#1)(2006-10#1)(2009-8#1)
points to the image##2##4##(2008-12#1)(2010-5#1)
points to the importance of##2##5##(2007-11#1)(2008-3#1)
points to the involvement of##5##5##(1994-12#1)(1994-3#1)(2008-11#1)(2008-4#1)(2013-8#1)
points to the need for##4##5##(1991-6#1)(1995-5#1)(2004-10#1)(2006-10#1)
points to the need to##2##5##(1997-2#1)(2007-10#1)
points to the need##6##4##(1991-6#1)(1995-5#1)(1997-2#1)(2004-10#1)(2006-10#1)(2007-10#1)
points to the possibility##2##4##(1996-12#1)(2008-10#1)
points to the##35##3##(1990-5#2)(1991-1#1)(1991-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-2#2)(1997-6#1)(2004-10#1)(2005-10#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-4#1)(2009-8#1)(2010-5#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
points to##89##2##(1990-5#3)(1990-6#1)(1990-8#1)(1991-1#1)(1991-6#1)(1991-7#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-5#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#2)(1997-6#2)(2004-10#1)(2005-10#2)(2006-10#3)(2006-12#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-6#2)(2007-7#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-4#3)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-1#3)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
points towards the##3##3##(1996-6#1)(2006-4#1)(2008-2#1)
points towards##7##2##(1995-12#1)(1996-6#1)(2006-4#1)(2007-7#1)(2008-2#1)(2008-7#1)(2012-3#1)
points was##9##2##(1991-11#1)(1996-7#1)(2008-10#2)(2009-2#1)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
points we##2##2##(2008-2#1)(2012-2#1)
points were achieved##2##3##(2007-7#1)(2009-2#1)
points were compared##2##3##(2008-11#1)(2012-12#1)
points were##26##2##(1991-3#1)(1994-11#1)(1995-2#1)(1995-5#1)(1997-2#1)(2004-9#1)(2006-12#1)(2006-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-2#4)(2010-7#1)(2011-12#1)(2012-12#1)(2013-1#2)(2013-8#1)
points when##2##2##(2010-12#1)(2010-2#1)
points where##3##2##(2008-3#1)(2009-2#1)(2010-4#1)
points which##2##2##(2007-8#1)(2010-8#1)
points with##11##2##(1993-2#1)(1995-11#1)(2008-10#2)(2008-2#1)(2008-9#2)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
points within##2##2##(2007-12#1)(2008-5#1)
points##1052##1##(1990-1#1)(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#3)(1990-6#2)(1990-7#4)(1990-8#3)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#4)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#2)(1991-9#3)(1992-1#2)(1992-12#5)(1992-2#4)(1992-5#1)(1992-6#4)(1992-7#3)(1992-8#2)(1992-9#4)(1993-1#2)(1993-10#1)(1993-11#3)(1993-2#2)(1993-3#1)(1993-5#2)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#3)(1994-3#2)(1994-4#1)(1994-5#2)(1994-6#4)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#3)(1995-2#6)(1995-3#3)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#3)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#2)(1996-6#6)(1996-7#2)(1996-8#3)(1996-9#1)(1997-2#7)(1997-3#5)(1997-4#2)(1997-5#1)(1997-6#4)(1997-8#4)(2004-1#1)(2004-10#2)(2004-11#2)(2004-9#2)(2005-10#3)(2005-11#8)(2005-12#3)(2005-4#1)(2005-5#1)(2005-7#3)(2005-8#1)(2006-1#1)(2006-10#10)(2006-12#9)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#4)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#3)(2007-10#4)(2007-11#43)(2007-12#23)(2007-2#6)(2007-3#2)(2007-4#2)(2007-5#8)(2007-6#7)(2007-7#16)(2007-8#17)(2007-9#3)(2008-1#6)(2008-10#79)(2008-11#18)(2008-12#9)(2008-2#74)(2008-3#62)(2008-4#28)(2008-5#20)(2008-6#21)(2008-7#17)(2008-8#13)(2008-9#7)(2009-1#1)(2009-10#4)(2009-11#6)(2009-12#2)(2009-2#16)(2009-3#4)(2009-4#8)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#6)(2009-9#5)(2010-1#4)(2010-10#4)(2010-11#4)(2010-12#20)(2010-2#15)(2010-3#3)(2010-4#6)(2010-5#5)(2010-6#1)(2010-7#2)(2010-8#6)(2010-9#5)(2011-1#15)(2011-10#1)(2011-12#4)(2011-2#27)(2011-3#1)(2012-1#17)(2012-11#1)(2012-12#23)(2012-2#18)(2012-3#12)(2012-4#2)(2013-1#48)(2013-7#9)(2013-8#10)
points'##4##1##(1993-6#1)(2004-2#1)(2008-10#1)(2009-10#1)
points) and##2##2##(2008-8#1)(2008-9#1)
points) was##2##2##(2008-9#1)(2012-3#1)
points)##29##1##(1993-12#1)(1993-3#1)(1996-12#1)(1996-3#1)(2007-11#1)(2007-6#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#7)(2009-11#1)(2009-2#1)(2012-3#1)
points]##2##1##(1997-8#1)(2013-8#1)
pointwise detector##2##2##(2008-2#2)
pointwise##7##1##(2008-12#1)(2008-2#3)(2009-12#1)(2010-2#2)
poised at##4##2##(1995-8#1)(2007-8#1)(2008-10#2)
poised for##2##2##(2009-4#1)(2013-8#1)
poised to revolutionize##2##3##(2008-1#1)(2008-4#1)
poised to##6##2##(1996-2#1)(2006-2#1)(2007-1#1)(2008-1#1)(2008-4#1)(2008-8#1)
poised##14##1##(1994-12#1)(1995-8#1)(1996-2#1)(1996-3#1)(2006-2#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-4#1)(2013-8#1)
poison control center##2##3##(2007-12#1)(2010-8#1)
poison control##4##2##(2007-12#1)(2009-5#1)(2009-6#1)(2010-8#1)
poison glands##2##2##(2007-12#2)
poison##25##1##(1995-11#1)(1996-11#1)(1997-1#1)(2006-10#1)(2007-12#3)(2007-6#1)(2007-8#2)(2008-10#1)(2008-4#2)(2008-5#1)(2009-5#2)(2009-6#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#2)
poisoned by##3##2##(1991-11#1)(1997-3#1)(2008-10#1)
poisoned patients##2##2##(2008-1#1)(2011-1#1)
poisoned##11##1##(1990-5#1)(1991-11#1)(1993-6#2)(1996-4#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#1)(2011-1#1)(2012-12#1)
poisoning and##8##2##(1992-5#1)(1995-9#1)(1996-4#1)(2005-5#1)(2010-4#1)(2012-2#2)(2013-1#1)
poisoning as a##3##3##(1993-10#1)(1995-3#1)(2010-8#1)
poisoning as##6##2##(1993-10#1)(1995-3#1)(1997-4#1)(2010-5#1)(2010-8#1)(2012-1#1)
poisoning by##8##2##(1990-9#1)(1993-2#1)(1993-4#1)(1995-11#1)(1997-3#1)(2006-4#1)(2008-10#1)(2010-5#1)
poisoning cases in##2##3##(2012-12#1)(2012-3#1)
poisoning cases##8##2##(1995-9#1)(1996-7#1)(2006-2#2)(2008-5#1)(2012-12#1)(2012-2#1)(2012-3#1)
poisoning caused by##2##3##(1996-4#1)(2007-3#1)
poisoning due to##2##3##(1990-9#1)(1996-9#1)
poisoning from##2##2##(1991-3#1)(2012-12#1)
poisoning has been##2##3##(1997-7#1)(2010-2#1)
poisoning in a young##2##4##(2010-2#1)(2011-2#1)
poisoning in a##6##3##(1991-11#1)(1995-11#1)(2005-7#1)(2010-11#1)(2010-2#1)(2011-2#1)
poisoning in children##4##3##(1990-3#1)(1991-8#1)(2007-3#1)(2009-4#1)
poisoning in the emergency department##2##5##(2009-6#1)(2011-12#1)
poisoning in the##4##3##(1997-4#1)(2009-6#1)(2011-12#1)(2011-2#1)
poisoning in young##2##3##(2005-8#1)(2013-1#1)
poisoning in##36##2##(1990-3#1)(1990-5#2)(1991-11#1)(1991-3#1)(1991-6#1)(1991-8#1)(1993-6#1)(1995-11#1)(1995-9#1)(1996-11#1)(1996-4#1)(1996-6#1)(1997-4#1)(2005-7#1)(2005-8#1)(2006-9#1)(2007-3#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-4#1)(2011-12#1)(2011-2#2)(2012-12#5)(2012-2#1)(2013-1#1)
poisoning includes##3##2##(2007-7#1)(2013-1#2)
poisoning is##7##2##(1991-9#2)(1997-6#1)(2007-7#1)(2009-11#1)(2013-1#1)(2013-8#1)
poisoning of the##2##3##(1997-3#1)(2008-10#1)
poisoning of##9##2##(1990-9#1)(1993-10#1)(1997-3#1)(1997-4#2)(2008-10#1)(2008-9#1)(2009-2#1)(2012-2#1)
poisoning or##2##2##(2006-4#1)(2011-1#1)
poisoning presenting##3##2##(2006-4#3)
poisoning the##2##2##(1997-3#1)(2006-9#1)
poisoning treated with##2##3##(2008-1#1)(2012-2#1)
poisoning was##3##2##(1990-4#2)(2012-12#1)
poisoning were##3##2##(1990-5#1)(2005-8#1)(2013-1#1)
poisoning with organophosphate##2##3##(1997-7#1)(2013-1#1)
poisoning with the most common##2##5##(2011-2#2)
poisoning with##12##2##(1991-11#1)(1991-12#1)(1997-5#1)(1997-7#1)(2007-2#1)(2008-1#1)(2010-4#1)(2011-2#2)(2012-1#2)(2013-1#1)
poisoning##229##1##(1990-3#2)(1990-4#2)(1990-5#7)(1990-6#1)(1990-9#3)(1991-11#2)(1991-12#2)(1991-3#4)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-5#1)(1992-6#2)(1993-10#3)(1993-2#1)(1993-4#1)(1993-6#1)(1994-12#2)(1994-6#1)(1995-1#2)(1995-11#2)(1995-3#3)(1995-4#1)(1995-7#1)(1995-9#5)(1996-11#1)(1996-4#4)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#3)(1997-4#6)(1997-5#2)(1997-6#4)(1997-7#3)(2005-11#1)(2005-5#1)(2005-7#5)(2005-8#4)(2006-12#1)(2006-2#4)(2006-4#8)(2006-6#1)(2006-8#2)(2006-9#2)(2007-12#3)(2007-2#1)(2007-3#2)(2007-7#5)(2008-1#4)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-9#2)(2009-11#3)(2009-12#5)(2009-2#2)(2009-4#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#5)(2010-5#4)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#12)(2012-1#5)(2012-12#12)(2012-2#12)(2012-3#1)(2013-1#13)(2013-7#1)(2013-8#2)
poisoning]##13##1##(1990-9#1)(1991-11#1)(1992-2#1)(1992-7#2)(1993-5#1)(1995-7#1)(1996-3#1)(1997-5#1)(2009-5#1)(2010-9#1)(2013-1#1)(2013-8#1)
poisonings are##2##2##(1990-5#1)(2008-5#1)
poisonings associated with##2##3##(1990-11#1)(1996-11#1)
poisonings by##2##2##(2010-4#1)(2010-9#1)
poisonings in##2##2##(1996-11#1)(2011-2#1)
poisonings##16##1##(1990-11#1)(1990-5#1)(1996-11#3)(1996-3#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-5#2)(2010-4#1)(2010-9#1)(2011-2#2)(2013-1#1)
poisonous##11##1##(1996-6#1)(2005-9#1)(2007-3#3)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2011-2#1)
poisons and##2##2##(2008-8#1)(2011-2#1)
poisons in##2##2##(1994-3#1)(2010-4#1)
poisons##9##1##(1990-9#1)(1994-3#1)(1996-2#1)(2008-10#1)(2008-8#1)(2010-4#3)(2011-2#1)
poisson##4##1##(1994-4#1)(1997-8#1)(2008-8#2)
pokeweed antiviral protein (PAP)##2##4##(2008-10#1)(2008-8#1)
pokeweed antiviral protein##7##3##(1992-1#1)(1993-3#1)(1995-8#1)(1997-6#1)(2008-10#1)(2008-8#2)
pokeweed mitogen##2##2##(1997-6#1)(2011-2#1)
pokeweed##11##1##(1992-1#1)(1993-3#1)(1995-8#1)(1997-6#3)(2008-10#2)(2008-8#2)(2011-2#1)
pol I##8##2##(1992-6#1)(1993-3#1)(1997-6#3)(1997-8#2)(2010-2#1)
pol II##2##2##(1990-6#1)(1996-7#1)
pol alpha##10##2##(1993-3#4)(1994-8#1)(1994-9#1)(1995-2#4)
pol beta##5##2##(2006-10#1)(2006-12#4)
pol delta was##2##3##(1994-9#1)(1995-2#1)
pol delta##12##2##(1994-8#4)(1994-9#6)(1995-2#2)
pol peptide##2##2##(1995-8#2)
pol##55##1##(1990-6#1)(1990-9#1)(1991-9#1)(1992-6#1)(1993-3#5)(1994-12#1)(1994-8#6)(1994-9#7)(1995-2#7)(1995-8#5)(1996-11#1)(1996-7#4)(1997-6#3)(1997-8#2)(2006-10#1)(2006-12#4)(2007-3#1)(2008-11#2)(2009-8#1)(2010-2#1)
polA##4##1##(1990-3#1)(1990-5#1)(1996-10#2)
polII assembly##2##2##(1997-1#2)
polII subunit##3##2##(1997-1#3)
polII##5##1##(1997-1#5)
polar I-compounds##2##2##(1992-11#2)
polar NCCs##2##2##(2006-12#2)
polar PIN##3##2##(2009-10#3)
polar and non-polar##2##3##(2008-10#2)
polar and nonpolar##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
polar and##14##2##(1990-12#1)(1992-6#1)(1997-7#1)(2008-10#5)(2008-11#1)(2009-12#1)(2010-4#1)(2010-7#1)(2012-3#1)(2013-8#1)
polar auxin transport##5##3##(2009-10#3)(2009-6#1)(2009-8#1)
polar bear##4##2##(1996-12#1)(2008-2#3)
polar biology##2##2##(2008-7#1)(2012-12#1)
polar cap##2##2##(1990-8#1)(2008-3#1)
polar cave##2##2##(1992-3#2)
polar components##3##2##(2008-10#1)(2012-12#2)
polar compounds and##2##3##(2005-12#1)(2008-10#1)
polar compounds##10##2##(1990-11#1)(1997-3#1)(2005-11#1)(2005-12#1)(2008-10#1)(2008-11#1)(2012-12#2)(2013-8#2)
polar coordinate system##2##3##(2008-3#2)
polar distribution##2##2##(2009-10#2)
polar environment at the##2##4##(1994-11#1)(2012-2#1)
polar environment##9##2##(1992-3#1)(1994-11#1)(1994-5#1)(1995-1#1)(1995-2#1)(1996-7#1)(1996-9#1)(2012-12#1)(2012-2#1)
polar expression##3##2##(2007-12#1)(2009-8#2)
polar extracts##2##2##(2007-1#1)(2013-8#1)
polar groups##6##2##(1992-12#1)(1995-11#1)(2004-12#1)(2005-11#1)(2008-10#1)(2008-5#1)
polar growth##3##2##(2008-10#1)(2009-8#2)
polar head group##7##3##(1990-5#1)(1991-2#1)(1991-7#1)(1996-7#1)(1997-7#1)(2005-11#2)
polar head groups##2##3##(1994-3#1)(2008-11#1)
polar head##12##2##(1990-2#1)(1990-5#1)(1991-2#1)(1991-7#1)(1994-3#1)(1996-6#1)(1996-7#1)(1997-7#1)(2005-11#3)(2008-11#1)
polar headgroups of##2##3##(1991-9#1)(1992-9#1)
polar headgroups##5##2##(1990-11#1)(1990-7#1)(1991-9#1)(1992-9#1)(1994-8#1)
polar heads##3##2##(1991-5#2)(1997-1#1)
polar ice##2##2##(2007-12#1)(2007-9#1)
polar inner-layer##2##2##(2008-10#2)
polar interactions##5##2##(1991-9#1)(1996-8#1)(1997-1#1)(2008-10#2)
polar ligand atom##3##3##(1997-1#3)
polar ligand##4##2##(1997-1#4)
polar lipid##4##2##(1990-11#1)(1992-10#1)(1995-2#1)(2008-5#1)
polar lipids as##2##3##(2008-5#1)(2010-3#1)
polar lipids##12##2##(1992-10#1)(1996-11#3)(2008-11#3)(2008-5#2)(2010-3#1)(2011-2#1)(2013-1#1)
polar molecules##3##2##(1990-2#1)(1994-10#1)(2005-11#1)
polar monomers##2##2##(1995-4#1)(2007-11#1)
polar nature##2##2##(1993-2#1)(2007-12#1)
polar nephelometer##3##2##(2007-11#1)(2008-3#2)
polar nucleus##2##2##(2009-12#2)
polar oils##2##2##(2008-5#2)
polar organic solvents##2##3##(2005-11#1)(2007-11#1)
polar organic##3##2##(2005-11#1)(2007-11#1)(2008-10#1)
polar orientation##2##2##(2007-11#2)
polar phospholipids##2##2##(1992-10#1)(1996-5#1)
polar products##3##2##(1995-7#2)(2005-12#1)
polar regions##2##2##(1996-5#1)(2008-8#1)
polar residues##4##2##(1994-11#1)(1994-9#1)(2006-10#1)(2008-10#1)
polar segment##2##2##(2008-3#2)
polar side##2##2##(1992-9#1)(1997-6#1)
polar solutes##2##2##(1996-5#1)(2012-12#1)
polar solvent##2##2##(1992-1#1)(2005-12#1)
polar solvents##9##2##(1997-7#2)(2005-11#2)(2005-8#1)(2008-10#3)(2010-5#1)
polar stationary##2##2##(2008-10#1)(2008-5#1)
polar stratosphere##4##2##(1991-5#3)(2008-2#1)
polar stratospheric clouds on##2##4##(2008-3#2)
polar stratospheric clouds##5##3##(1991-5#2)(2008-3#3)
polar stratospheric##7##2##(1991-5#2)(2008-2#2)(2008-3#3)
polar surface area##3##3##(1992-5#3)
polar surface##7##2##(1992-5#6)(2008-10#1)
polar targeting##2##2##(2009-10#2)
polar term##2##2##(2005-11#2)
polar to non-polar##3##3##(1993-2#2)(2009-12#1)
polar vortex##2##2##(1991-5#2)
polar##327##1##(1990-11#5)(1990-12#1)(1990-2#5)(1990-5#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-2#1)(1991-5#11)(1991-7#3)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#3)(1992-11#3)(1992-12#1)(1992-3#3)(1992-5#7)(1992-6#4)(1992-9#2)(1993-11#1)(1993-2#3)(1994-10#2)(1994-11#2)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-7#2)(1996-11#3)(1996-12#2)(1996-5#5)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#8)(1997-2#1)(1997-3#1)(1997-6#3)(1997-7#4)(2004-12#1)(2004-8#1)(2005-11#15)(2005-12#3)(2005-7#1)(2005-8#2)(2006-10#1)(2006-12#4)(2006-8#1)(2007-1#1)(2007-11#7)(2007-12#9)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#41)(2008-11#9)(2008-2#10)(2008-3#12)(2008-5#11)(2008-7#6)(2008-8#2)(2008-9#3)(2009-10#14)(2009-12#6)(2009-2#1)(2009-3#1)(2009-6#2)(2009-8#7)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#9)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#6)
polarimeter are##2##2##(2008-3#2)
polarimeter for##3##2##(2008-2#1)(2008-3#2)
polarimeter is##4##2##(2008-2#2)(2008-3#2)
polarimeter was set up##2##4##(2008-2#1)(2008-3#1)
polarimeter was##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
polarimeter with##2##2##(2008-3#2)
polarimeter##37##1##(2007-11#1)(2007-12#7)(2008-2#12)(2008-3#17)
polarimeters##6##1##(2007-12#1)(2008-3#5)
polarimetric detection##2##2##(2008-10#2)
polarimetric fiber laser##2##3##(2007-12#2)
polarimetric images##2##2##(2008-6#2)
polarimetric information##2##2##(2008-3#2)
polarimetric interference##2##2##(2007-12#1)(2008-3#1)
polarimetric pressure##3##2##(2008-2#2)(2010-4#1)
polarimetric strain sensor##2##3##(2007-12#2)
polarimetric temperature sensor and##2##4##(2008-2#2)
polarimetric##38##1##(2007-11#2)(2007-12#5)(2008-10#6)(2008-2#7)(2008-3#12)(2008-6#3)(2009-5#1)(2010-4#2)
polarimetry and##2##2##(2008-2#1)(2008-3#1)
polarimetry with##2##2##(1993-8#1)(2007-12#1)
polarimetry##23##1##(1993-8#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-2#2)(2008-3#14)(2009-4#2)
polarisation##7##1##(1996-1#1)(1996-12#1)(1996-5#2)(2008-10#3)
polariscope##10##1##(2008-2#5)(2008-3#5)
polariscopes##2##1##(2008-3#2)
polarised Ca(2+)-dependence of the paracellular barrier##2##6##(1994-6#2)
polarised##11##1##(1994-6#5)(2005-8#1)(2006-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-5#1)
polarities of the##3##3##(1991-3#1)(2008-10#2)
polarities of##5##2##(1991-3#1)(1995-8#2)(2008-10#2)
polarities##13##1##(1990-8#1)(1991-3#1)(1992-10#2)(1995-8#2)(2005-11#1)(2005-12#1)(2006-12#1)(2008-10#2)(2010-5#1)(2010-7#1)
polariton modes##2##2##(2007-12#2)
polariton##8##1##(2007-11#1)(2007-12#3)(2008-3#2)(2008-7#2)
polarity and##17##2##(1990-2#1)(1990-5#1)(1996-11#1)(2005-11#3)(2005-12#1)(2006-4#1)(2007-12#1)(2008-10#4)(2010-2#1)(2011-2#1)(2012-12#2)
polarity are##2##2##(2008-10#1)(2008-7#1)
polarity at##3##2##(1992-1#1)(1995-7#1)(2012-2#1)
polarity establishment##2##2##(2009-8#2)
polarity in the##6##3##(1994-2#1)(1994-6#1)(1995-1#1)(1995-11#1)(2007-10#1)(2009-8#1)
polarity in##12##2##(1990-5#1)(1990-6#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-11#1)(2007-10#1)(2008-9#1)(2009-10#1)(2009-8#3)
polarity is##4##2##(2007-8#1)(2008-1#1)(2008-9#1)(2009-5#1)
polarity of the solvent##2##4##(1996-2#1)(2008-10#1)
polarity of the##14##3##(1991-5#2)(1995-1#1)(1995-6#1)(1996-2#1)(2005-11#3)(2006-12#1)(2007-12#1)(2008-10#3)(2008-5#1)
polarity of this##2##3##(2008-10#1)(2008-7#1)
polarity of##20##2##(1991-2#1)(1991-5#2)(1995-1#1)(1995-6#1)(1996-2#1)(2004-11#1)(2005-11#3)(2006-12#1)(2007-12#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#1)
polarity proteins##4##2##(1997-4#1)(2008-9#1)(2012-2#2)
polarity to##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
polarity##168##1##(1990-2#1)(1990-4#1)(1990-5#4)(1990-6#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-5#5)(1992-1#2)(1993-12#6)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#3)(1995-1#2)(1995-11#1)(1995-6#1)(1995-7#2)(1996-11#1)(1996-2#2)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#3)(2004-11#1)(2005-11#11)(2005-12#2)(2006-12#2)(2006-4#1)(2007-10#1)(2007-11#3)(2007-12#12)(2007-8#2)(2008-1#1)(2008-10#27)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#6)(2009-10#3)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#9)(2010-2#3)(2010-5#2)(2011-2#2)(2012-1#1)(2012-12#13)(2012-2#4)(2012-3#2)
polarizabilities##2##1##(1992-3#1)(1996-2#1)
polarizability and##3##2##(1994-7#1)(2006-12#1)(2008-10#1)
polarizability of##6##2##(1997-6#1)(2006-12#1)(2007-12#2)(2008-10#1)(2008-3#1)
polarizability##18##1##(1994-7#3)(1997-6#2)(2006-12#2)(2007-11#1)(2007-12#4)(2008-10#3)(2008-3#2)(2010-5#1)
polarizable##7##1##(1990-2#1)(1995-5#1)(2007-6#1)(2008-11#1)(2011-3#1)(2012-1#1)(2012-11#1)
polarization Sagnac interferometer##4##3##(2007-12#4)
polarization amplitude and the phase##2##5##(2008-2#2)
polarization analysis of##2##3##(2008-2#1)(2008-3#1)
polarization analysis##6##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
polarization and anisotropy##4##3##(2008-10#4)
polarization and the##6##3##(2007-12#2)(2008-2#4)
polarization and wavelength-encoding scheme to achieve a##2##7##(2007-12#1)(2008-3#1)
polarization and##38##2##(1995-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#7)(2008-10#4)(2008-11#1)(2008-2#11)(2008-3#5)(2008-4#1)(2008-8#1)(2009-12#1)(2009-8#1)(2011-2#1)(2013-8#1)
polarization angle of the##2##4##(2007-12#1)(2008-3#1)
polarization angle##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
polarization angles##2##2##(2008-3#2)
polarization anisotropy##6##2##(1991-3#1)(1994-11#2)(2007-12#2)(2008-3#1)
polarization are##6##2##(2007-11#1)(2008-2#3)(2008-3#1)(2012-1#1)
polarization as well as##2##4##(2008-3#2)
polarization at a scattering angle of##2##6##(2008-2#1)(2008-3#1)
polarization at the zenith##2##4##(2008-2#2)
polarization at the##6##3##(2007-12#1)(2008-2#5)
polarization at##14##2##(1994-3#1)(1997-6#1)(2007-12#2)(2008-2#8)(2008-3#2)
polarization beam splitter and quarter-wave plates##2##6##(2008-3#2)
polarization beam splitter##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
polarization between##3##2##(2008-2#2)(2009-4#1)
polarization can be##4##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
polarization can##5##2##(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)
polarization changing##3##2##(2008-2#3)
polarization characteristics of a##2##4##(2008-2#1)(2008-3#1)
polarization characteristics of##6##3##(2007-11#1)(2008-2#4)(2008-3#1)
polarization characteristics##7##2##(2007-11#1)(2008-2#5)(2008-3#1)
polarization components of the##2##4##(2007-11#1)(2007-12#1)
polarization components that are##2##4##(2007-12#2)
polarization components##8##2##(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#1)
polarization configurations##4##2##(2007-12#1)(2008-3#1)(2013-8#2)
polarization control##2##2##(2007-12#2)
polarization controller##3##2##(2007-12#2)(2008-3#1)
polarization conversion##2##2##(2007-12#1)(2008-3#1)
polarization converter##4##2##(2008-2#2)(2008-3#2)
polarization correlation##2##2##(2007-12#1)(2008-3#1)
polarization correlations##2##2##(2007-11#1)(2008-3#1)
polarization data on##2##3##(1990-4#1)(2008-2#1)
polarization data##5##2##(1990-4#1)(1995-5#1)(2008-2#1)(2008-3#2)
polarization dependence is##2##3##(2007-12#1)(2008-2#1)
polarization dependence of the##4##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
polarization dependence of##9##3##(2007-11#4)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)
polarization dependence##14##2##(2007-11#5)(2007-12#3)(2008-1#2)(2008-2#2)(2008-3#2)
polarization detection##2##2##(2008-2#1)(2008-4#1)
polarization difference##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2013-8#1)
polarization direction of incident light##2##5##(2008-2#1)(2008-3#1)
polarization direction of the##3##4##(2008-1#1)(2008-2#1)(2008-3#1)
polarization direction of##6##3##(2008-1#1)(2008-2#3)(2008-3#2)
polarization direction##10##2##(2007-12#1)(2008-1#1)(2008-2#4)(2008-3#4)
polarization directions##4##2##(2007-11#2)(2008-2#2)
polarization discrimination##3##2##(2007-12#1)(2008-3#2)
polarization effect##2##2##(2005-11#1)(2008-10#1)
polarization effects in##2##3##(2007-12#1)(2008-2#1)
polarization effects##10##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#5)
polarization eigenmodes##4##2##(2007-12#1)(2008-2#3)
polarization eigenstates in##2##3##(2008-2#1)(2008-3#1)
polarization eigenstates is##2##3##(2008-3#2)
polarization eigenstates##5##2##(2008-2#1)(2008-3#4)
polarization evolution##3##2##(2007-12#3)
polarization extinction ratio##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
polarization for##7##2##(2007-12#2)(2008-2#1)(2008-3#4)
polarization gate and##2##3##(2007-11#1)(2007-12#1)
polarization gate##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
polarization gating##3##2##(2007-11#2)(2008-2#1)
polarization gratings##5##2##(2007-12#3)(2008-3#2)
polarization has##2##2##(1995-1#1)(2008-7#1)
polarization holography##4##2##(2007-11#1)(2008-3#3)
polarization imaging##7##2##(2007-12#1)(2008-3#2)(2009-10#1)(2011-1#3)
polarization in a##3##3##(1995-1#1)(2007-12#1)(2008-2#1)
polarization in spectral##3##3##(2008-3#3)
polarization in##15##2##(1990-4#1)(1994-7#1)(1995-1#1)(2007-12#2)(2008-1#1)(2008-2#3)(2008-3#5)(2008-5#1)
polarization induced##2##2##(2008-2#2)
polarization insensitive##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
polarization instability of##2##3##(2007-12#2)
polarization instability##3##2##(2007-12#3)
polarization interferometer##2##2##(2008-1#1)(2008-2#1)
polarization interferometric##2##2##(2007-11#1)(2008-3#1)
polarization interferometry##5##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
polarization is##20##2##(1995-1#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-2#6)(2008-3#9)
polarization length##2##2##(1997-6#2)
polarization lidar and##2##3##(2008-2#1)(2008-3#1)
polarization lidar measurements##2##3##(2008-2#1)(2008-3#1)
polarization lidar##9##2##(2008-2#4)(2008-3#5)
polarization may##2##2##(2007-12#1)(2011-2#1)
polarization measurement is##2##3##(2007-11#1)(2007-12#1)
polarization measurement##4##2##(2007-11#1)(2007-12#2)(2008-10#1)
polarization measurements##8##2##(1990-4#1)(1991-4#1)(1993-9#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-7#1)
polarization method##2##2##(1996-7#1)(2008-11#1)
polarization microscopy##4##2##(2008-1#1)(2008-3#2)(2012-3#1)
polarization mixing##3##2##(2007-12#1)(2008-2#2)
polarization mode dispersion (PMD)##10##4##(2007-11#5)(2007-12#5)
polarization mode dispersion in##2##4##(2007-12#2)
polarization mode dispersion of##2##4##(2007-11#2)
polarization mode dispersion##29##3##(2007-11#13)(2007-12#16)
polarization mode##31##2##(2007-11#14)(2007-12#17)
polarization modes##6##2##(2007-11#3)(2007-12#2)(2008-3#1)
polarization modulation##6##2##(2007-11#1)(2007-12#3)(2008-1#1)(2008-3#1)
polarization modulators##2##2##(2008-2#1)(2008-3#1)
polarization multiplexing##4##2##(2007-12#1)(2008-3#3)
polarization noise##2##2##(2008-2#2)
polarization of 1##2##3##(1990-4#1)(1991-9#1)
polarization of fluorescence of##2##4##(1990-2#1)(1990-3#1)
polarization of light propagating through scattering media##2##7##(2008-2#2)
polarization of light scattered by##3##5##(2007-12#1)(2008-1#1)(2008-2#1)
polarization of light scattered##5##4##(2007-12#2)(2008-1#1)(2008-2#2)
polarization of light##12##3##(2007-12#3)(2008-1#1)(2008-2#5)(2008-3#3)
polarization of the incident field##2##5##(2007-11#1)(2007-12#1)
polarization of the incident laser beam##2##6##(2008-3#2)
polarization of the incident##5##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
polarization of the light##2##4##(2008-2#1)(2008-3#1)
polarization of the##31##3##(1995-6#1)(2005-11#1)(2007-11#3)(2007-12#1)(2007-5#1)(2008-1#1)(2008-2#11)(2008-3#11)(2008-8#1)
polarization of##78##2##(1990-2#1)(1990-3#2)(1990-4#1)(1991-5#1)(1991-9#1)(1993-3#1)(1993-5#1)(1995-6#1)(1995-8#1)(2005-11#1)(2006-12#1)(2007-11#6)(2007-12#5)(2007-5#1)(2008-1#2)(2008-10#1)(2008-2#21)(2008-3#19)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-8#1)(2010-1#1)(2010-4#1)(2012-2#2)
polarization on the##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
polarization on##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
polarization or##3##2##(1990-9#1)(2008-3#1)(2008-4#1)
polarization orientation of the reference beam##2##6##(2008-3#2)
polarization orientation of the##3##4##(2008-3#3)
polarization orientation)##2##2##(2008-2#2)
polarization over a##2##3##(2008-3#2)
polarization over##3##2##(2008-2#1)(2008-3#2)
polarization parallel##2##2##(2007-12#1)(2008-2#1)
polarization patterns from##2##3##(2008-2#1)(2008-3#1)
polarization patterns##4##2##(2008-2#3)(2008-3#1)
polarization portion of the##2##4##(2008-2#2)
polarization preservation of##2##3##(2008-2#2)
polarization properties of##16##3##(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#4)(2008-3#6)(2011-1#1)
polarization properties##21##2##(2007-11#2)(2007-12#6)(2008-1#1)(2008-2#4)(2008-3#7)(2011-1#1)
polarization pulse shaping##2##3##(2007-11#2)
polarization pulse##4##2##(2007-11#4)
polarization purity##2##2##(2007-11#1)(2008-2#1)
polarization response of##3##3##(2007-12#2)(2008-2#1)
polarization rotation##17##2##(2007-11#4)(2007-12#3)(2008-1#2)(2008-2#5)(2008-3#3)
polarization rotator##5##2##(2007-11#1)(2008-2#3)(2008-3#1)
polarization self-modulation in vertical-cavity surface-emitting lasers##3##6##(2007-11#3)
polarization self-modulation##6##2##(2007-11#5)(2007-12#1)
polarization sensitivity on the##2##4##(2008-2#2)
polarization sensitivity##11##2##(2007-12#6)(2008-2#4)(2008-3#1)
polarization signature##3##2##(2007-11#2)(2008-3#1)
polarization spectroscopy for##2##3##(2006-12#1)(2008-3#1)
polarization spectroscopy of##2##3##(2008-3#2)
polarization spectroscopy##10##2##(1994-6#1)(2006-12#5)(2007-12#1)(2008-3#3)
polarization state and##4##3##(2007-12#3)(2008-2#1)
polarization state in##2##3##(2008-2#1)(2008-3#1)
polarization state is##2##3##(2007-12#1)(2008-3#1)
polarization state of a light beam##2##6##(2007-12#1)(2008-3#1)
polarization state of a##4##4##(2007-11#2)(2007-12#1)(2008-3#1)
polarization state of the incident##4##5##(2007-12#2)(2008-2#1)(2008-3#1)
polarization state of the##9##4##(2007-12#3)(2008-2#2)(2008-3#4)
polarization state of##23##3##(2007-11#3)(2007-12#10)(2008-2#2)(2008-3#8)
polarization state##43##2##(2007-11#4)(2007-12#20)(2008-1#1)(2008-2#8)(2008-3#10)
polarization states and##2##3##(2008-3#2)
polarization states during##2##3##(2007-11#1)(2007-12#1)
polarization states in##5##3##(2007-11#2)(2007-12#2)(2008-3#1)
polarization states is##3##3##(2007-12#1)(2008-3#2)
polarization states of the##4##4##(2007-12#2)(2008-2#2)
polarization states of##8##3##(2007-12#4)(2008-2#3)(2013-7#1)
polarization states##33##2##(2007-11#5)(2007-12#10)(2008-2#8)(2008-3#9)(2013-7#1)
polarization study##2##2##(2008-2#1)(2008-3#1)
polarization switching in##2##3##(2007-12#2)
polarization switching is##2##3##(2007-12#2)
polarization switching##5##2##(2007-12#5)
polarization technique##3##2##(1996-3#1)(2007-12#1)(2008-8#1)
polarization techniques##4##2##(1991-5#1)(2008-10#2)(2008-3#1)
polarization that##3##2##(2007-12#1)(2008-3#2)
polarization the##3##2##(2007-11#2)(2008-3#1)
polarization to##5##2##(1990-12#1)(1997-7#1)(2008-3#3)
polarization was##2##2##(2008-3#1)(2008-7#1)
polarization were##4##2##(1995-8#1)(2007-11#1)(2007-12#1)(2013-1#1)
polarization with##3##2##(2007-12#1)(2008-2#2)
polarization##938##1##(1990-12#1)(1990-2#2)(1990-3#3)(1990-4#4)(1990-9#2)(1991-1#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-8#1)(1991-9#1)(1993-3#1)(1993-5#1)(1993-8#3)(1993-9#1)(1994-11#2)(1994-3#1)(1994-6#1)(1994-7#2)(1995-1#5)(1995-5#3)(1995-6#1)(1995-8#3)(1996-11#1)(1996-2#1)(1996-3#1)(1996-7#3)(1996-8#2)(1996-9#2)(1997-4#2)(1997-6#3)(1997-7#1)(2004-9#2)(2005-11#7)(2006-1#1)(2006-10#1)(2006-12#8)(2006-4#1)(2006-7#1)(2007-11#101)(2007-12#210)(2007-5#1)(2007-8#2)(2007-9#2)(2008-1#19)(2008-10#14)(2008-11#4)(2008-2#215)(2008-3#236)(2008-4#6)(2008-5#3)(2008-7#4)(2008-8#3)(2008-9#4)(2009-10#1)(2009-12#1)(2009-4#2)(2009-8#3)(2010-1#1)(2010-4#2)(2010-7#1)(2011-1#5)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#6)
polarization-based##3##1##(2008-2#2)(2008-3#1)
polarization-channel and the scattering-angle dependence##2##5##(2008-3#2)
polarization-conversion bands##2##2##(2007-11#2)
polarization-conversion##3##1##(2007-11#3)
polarization-coupled##3##1##(2007-11#2)(2007-12#1)
polarization-dependent gain##2##2##(2008-3#2)
polarization-dependent loss of##2##3##(2007-11#1)(2008-3#1)
polarization-dependent loss##6##2##(2007-11#4)(2008-3#2)
polarization-dependent losses##3##2##(2007-11#1)(2007-12#2)
polarization-dependent##25##1##(2007-11#8)(2007-12#4)(2008-1#1)(2008-2#1)(2008-3#11)
polarization-division multiplexing with##2##3##(2007-12#2)
polarization-division multiplexing##3##2##(2007-12#3)
polarization-independent optical quasi-circulator with a simple structure##2##7##(2007-12#2)
polarization-independent##7##1##(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#3)
polarization-insensitive##15##1##(2007-12#4)(2008-1#2)(2008-2#8)(2008-3#1)
polarization-maintaining fiber##3##2##(2007-11#3)
polarization-maintaining fibers##2##2##(2007-11#1)(2008-3#1)
polarization-maintaining##13##1##(2007-11#9)(2008-3#4)
polarization-mode dispersion (PMD)##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
polarization-mode dispersion##14##2##(2007-11#1)(2007-12#8)(2008-2#1)(2008-3#4)
polarization-mode##16##1##(2007-11#1)(2007-12#10)(2008-2#1)(2008-3#4)
polarization-modulated grating##2##2##(2007-12#2)
polarization-modulated##5##1##(2007-12#3)(2008-3#2)
polarization-preserving##4##1##(2007-11#3)(2007-12#1)
polarization-resolved##5##1##(2007-11#1)(2007-12#2)(2008-3#2)
polarization-rotation##2##1##(2007-12#1)(2008-1#1)
polarization-selective diffractive phase elements##5##4##(2008-3#5)
polarization-selective diffractive##6##2##(2008-2#1)(2008-3#5)
polarization-selective##10##1##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#7)
polarization-sensitive detection##2##2##(2007-11#1)(2007-12#1)
polarization-sensitive optical coherence tomography (OCT) system##2##6##(2007-12#1)(2008-3#1)
polarization-sensitive optical coherence tomography##12##4##(2007-11#3)(2007-12#6)(2008-2#1)(2008-3#2)
polarization-sensitive optical coherence##13##3##(2007-11#3)(2007-12#7)(2008-2#1)(2008-3#2)
polarization-sensitive optical##15##2##(2007-11#4)(2007-12#8)(2008-2#1)(2008-3#2)
polarization-sensitive##23##1##(2007-11#5)(2007-12#12)(2008-2#3)(2008-3#2)(2009-4#1)
polarization-state##8##1##(2006-5#1)(2007-11#2)(2007-12#2)(2008-3#3)
polarizations and##3##2##(2007-12#1)(2008-3#2)
polarizations are##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
polarizations in the##2##3##(2007-11#1)(2008-2#1)
polarizations is##2##2##(2008-2#1)(2008-3#1)
polarizations of the##8##3##(2007-11#1)(2007-12#4)(2008-3#2)(2008-4#1)
polarizations of##13##2##(2007-11#2)(2007-12#5)(2008-3#4)(2008-4#1)(2008-9#1)
polarizations##48##1##(2006-5#1)(2006-7#1)(2007-11#6)(2007-12#11)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#8)(2008-3#13)(2008-4#1)(2008-9#1)(2010-4#1)(2011-7#1)
polarize the##3##2##(2008-10#1)(2008-9#1)(2009-10#1)
polarize##5##1##(1993-8#2)(2008-10#1)(2008-9#1)(2009-10#1)
polarized Caco-2 cell monolayers##2##4##(2007-12#2)
polarized Gaussian beam##3##3##(2007-12#2)(2008-3#1)
polarized Gaussian##4##2##(2007-12#2)(2008-3#2)
polarized Raman##3##2##(2007-11#2)(2008-4#1)
polarized XAFS##2##2##(2006-4#2)
polarized absorption spectra##2##3##(2008-10#1)(2008-3#1)
polarized absorption##4##2##(1993-6#1)(1997-4#1)(2008-10#1)(2008-3#1)
polarized along the##2##3##(2007-12#2)
polarized along##4##2##(2007-12#2)(2012-12#2)
polarized and##7##2##(2007-11#3)(2008-2#2)(2010-5#1)(2010-8#1)
polarized at##5##2##(2008-10#4)(2008-3#1)
polarized beam of##3##3##(2007-12#2)(2008-10#1)
polarized beam##6##2##(2007-12#3)(2008-10#1)(2008-3#2)
polarized beams##11##2##(2007-11#3)(2007-12#3)(2008-10#1)(2008-3#4)
polarized by##2##2##(2008-10#1)(2008-3#1)
polarized cells##4##2##(1992-5#1)(1994-8#2)(2008-5#1)
polarized component##2##2##(2007-11#1)(2008-3#1)
polarized components of##3##3##(2007-11#1)(2008-1#1)(2008-2#1)
polarized components##5##2##(2007-11#1)(2008-1#1)(2008-2#2)(2008-3#1)
polarized delivery of##2##3##(1997-6#2)
polarized field##2##2##(2007-12#2)
polarized fluorescence##4##2##(2007-11#3)(2008-3#1)
polarized fundamental##2##2##(2007-12#2)
polarized growth in##2##3##(2009-8#2)
polarized growth##4##2##(2009-8#4)
polarized human##3##2##(2006-10#1)(2008-1#1)(2012-3#1)
polarized in the##2##3##(1995-8#2)
polarized incident light##3##3##(2008-2#2)(2008-3#1)
polarized incident##4##2##(2008-2#3)(2008-3#1)
polarized infrared##2##2##(1991-9#1)(2008-10#1)
polarized irradiance##2##2##(2008-2#2)
polarized laser beam##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
polarized laser##8##2##(2007-12#4)(2008-2#1)(2008-3#3)
polarized lidar technique##2##3##(2008-3#2)
polarized lidar##4##2##(2008-3#4)
polarized light and##3##3##(2007-11#1)(2008-3#2)
polarized light by##2##3##(2007-12#2)
polarized light from##2##3##(2008-2#1)(2008-3#1)
polarized light in##4##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
polarized light is the##2##4##(2008-3#1)(2009-5#1)
polarized light is##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2009-5#1)
polarized light propagation in##2##4##(2008-3#2)
polarized light scattering##3##3##(1991-8#2)(2008-3#1)
polarized light survives##2##3##(2007-12#1)(2008-3#1)
polarized light through##3##3##(2007-12#1)(2008-3#2)
polarized light to##2##3##(2007-11#1)(2008-2#1)
polarized light with##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
polarized light##73##2##(1991-8#3)(2007-11#5)(2007-12#17)(2007-8#1)(2008-1#1)(2008-2#17)(2008-3#24)(2008-5#1)(2009-5#1)(2010-12#2)(2012-2#1)
polarized measurements##2##2##(2008-2#2)
polarized morphology##2##2##(1994-8#1)(2008-1#1)
polarized object beam##2##3##(2007-12#2)
polarized optical##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
polarized or##2##2##(2008-2#1)(2008-7#1)
polarized output##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
polarized perpendicular to##2##3##(2008-2#2)
polarized perpendicular##3##2##(2008-2#2)(2008-3#1)
polarized plane waves##2##3##(2007-11#1)(2008-2#1)
polarized pulses##2##2##(2007-11#1)(2007-12#1)
polarized pump##5##2##(2007-11#2)(2007-12#2)(2008-2#1)
polarized radiance##3##2##(2008-2#1)(2008-3#2)
polarized radiation at##2##3##(2007-11#1)(2007-12#1)
polarized radiation can be##2##4##(2007-12#1)(2008-2#1)
polarized radiation##6##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)
polarized rat##2##2##(1992-3#1)(2008-1#1)
polarized secretion##3##2##(1996-5#1)(2008-10#1)(2008-11#1)
polarized signal##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
polarized sky##2##2##(2008-2#1)(2008-3#1)
polarized technique##2##2##(2008-3#2)
polarized to the##3##3##(2007-11#2)(2008-3#1)
polarized to##4##2##(1997-7#1)(2007-11#2)(2008-3#1)
polarized tweezers##2##2##(2006-12#2)
polarized wave##2##2##(2007-11#1)(2008-2#1)
polarized with the##3##3##(1992-10#1)(2008-2#2)
polarized with##4##2##(1992-10#1)(2007-11#1)(2008-2#2)
polarized##357##1##(1990-11#1)(1991-12#1)(1991-8#3)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-6#1)(1994-8#3)(1994-9#2)(1995-8#2)(1996-5#3)(1996-9#1)(1997-3#1)(1997-4#2)(1997-6#3)(1997-7#2)(2005-4#1)(2006-10#1)(2006-12#2)(2006-4#4)(2006-7#1)(2007-10#3)(2007-11#33)(2007-12#71)(2007-8#3)(2008-1#8)(2008-10#14)(2008-11#1)(2008-2#69)(2008-3#81)(2008-4#2)(2008-5#4)(2008-7#3)(2009-10#2)(2009-12#1)(2009-5#1)(2009-8#5)(2009-9#1)(2010-12#3)(2010-5#1)(2010-8#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-8#1)
polarized-light##3##1##(2007-12#1)(2008-3#2)
polarizer and a##4##3##(2008-2#3)(2008-3#1)
polarizer and analyzer##2##3##(2008-3#2)
polarizer and##8##2##(2008-2#5)(2008-3#3)
polarizer at##3##2##(2007-12#1)(2008-2#2)
polarizer for the##2##3##(2008-2#1)(2008-3#1)
polarizer for##3##2##(2008-2#2)(2008-3#1)
polarizer losses##2##2##(2007-12#1)(2008-2#1)
polarizer that##2##2##(2007-12#1)(2008-1#1)
polarizer##56##1##(2006-4#1)(2007-12#11)(2008-1#3)(2008-2#20)(2008-3#21)
polarizer)##2##1##(2008-3#2)
polarizers and##4##2##(2007-11#2)(2007-12#1)(2008-2#1)
polarizers are##2##2##(2008-3#1)(2011-1#1)
polarizers in##2##2##(2008-2#1)(2008-3#1)
polarizers##25##1##(2007-11#2)(2007-12#5)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#12)(2011-1#1)
polarizing activity##7##2##(1991-5#1)(1993-12#5)(2008-5#1)
polarizing and phase-retarding##2##3##(2008-2#1)(2008-3#1)
polarizing beam splitter (PBS)##2##4##(2008-2#1)(2008-3#1)
polarizing beam splitter##17##3##(2007-12#3)(2008-10#1)(2008-2#7)(2008-3#6)
polarizing beam splitters##3##3##(2007-12#1)(2008-3#2)
polarizing beam##20##2##(2007-12#4)(2008-10#1)(2008-2#7)(2008-3#8)
polarizing elements##2##2##(2008-2#2)
polarizing films##5##2##(2008-3#5)
polarizing glass##2##2##(2007-11#2)
polarizing microscope##2##2##(2008-3#1)(2008-5#1)
polarizing##68##1##(1990-7#1)(1991-5#1)(1993-12#7)(1993-6#1)(2006-10#1)(2007-11#3)(2007-12#7)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#16)(2008-3#23)(2008-5#2)(2009-9#2)
polarogram of##2##2##(2008-10#2)
polarogram##3##1##(2008-10#3)
polarograms and##2##2##(1990-5#1)(2008-10#1)
polarograms##6##1##(1990-5#1)(2008-10#5)
polarographic and amperometric methods##2##4##(2008-5#2)
polarographic and##3##2##(2008-10#1)(2008-5#2)
polarographic determination of##13##3##(2008-10#13)
polarographic determination##14##2##(2008-10#14)
polarographic method for the determination of##2##6##(2008-10#2)
polarographic method##9##2##(2008-10#8)(2010-2#1)
polarographic peak##2##2##(2008-10#2)
polarographic signal##2##2##(2008-10#2)
polarographic studies##2##2##(1990-5#1)(2008-10#1)
polarographic study##2##2##(2008-10#2)
polarographic wave##4##2##(2008-10#4)
polarographic##50##1##(1990-5#1)(2008-10#46)(2008-5#2)(2010-2#1)
polarography##41##1##(2008-10#39)(2010-2#2)
polaronic##3##1##(2008-3#2)(2010-4#1)
pole and##5##2##(1992-3#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-1#1)
pole is##2##2##(2012-1#1)(2013-1#1)
pole of the kidney##4##4##(1992-8#1)(2006-9#1)(2008-7#1)(2011-2#1)
pole of the oocyte##2##4##(2007-12#2)
pole of the##17##3##(1990-9#1)(1992-8#1)(1994-12#1)(1994-5#1)(2006-10#3)(2006-9#1)(2007-12#2)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#2)(2011-2#1)
pole of##20##2##(1990-9#1)(1991-5#1)(1992-8#1)(1994-12#1)(1994-5#1)(2006-10#3)(2006-9#1)(2007-12#2)(2007-3#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#2)(2009-7#1)(2011-2#1)
pole to##2##2##(1996-7#1)(2007-9#1)
pole##82##1##(1990-6#3)(1990-9#1)(1991-11#1)(1991-5#3)(1991-9#2)(1992-3#2)(1992-8#1)(1992-9#1)(1993-9#2)(1994-12#1)(1994-5#1)(1994-8#1)(1996-12#1)(1996-7#1)(1997-4#1)(1997-6#2)(2006-10#5)(2006-3#3)(2006-9#3)(2007-10#1)(2007-12#6)(2007-3#2)(2007-8#1)(2007-9#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-9#3)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-1#3)(2013-1#4)
polecat M##2##2##(2008-6#2)
poled KTiOPO(4) was##2##3##(2007-11#1)(2008-3#1)
poled KTiOPO(4)##22##2##(2007-11#3)(2007-12#18)(2008-3#1)
poled LiNbO(3)##29##2##(2007-11#3)(2007-12#24)(2008-1#1)(2008-2#1)
poled crystal##2##2##(2007-11#1)(2007-12#1)
poled crystals##3##2##(2007-11#2)(2007-12#1)
poled films##2##2##(2008-2#1)(2008-3#1)
poled glass##2##2##(2007-11#1)(2007-12#1)
poled lithium niobate monolithic##2##4##(2007-12#2)
poled lithium niobate optical parametric##8##5##(2007-12#5)(2008-2#1)(2008-3#2)
poled lithium niobate##76##3##(2007-11#15)(2007-12#46)(2008-1#7)(2008-2#2)(2008-3#6)
poled lithium##80##2##(2007-11#15)(2007-12#50)(2008-1#7)(2008-2#2)(2008-3#6)
poled nonlinear##6##2##(2007-11#2)(2007-12#2)(2008-1#1)(2008-2#1)
poled polymer and silica films##2##5##(2008-2#2)
poled polymer films is##2##4##(2007-11#1)(2008-3#1)
poled polymer##7##2##(2007-11#3)(2008-1#1)(2008-2#2)(2008-3#1)
poled potassium##2##2##(2007-12#2)
poled silica##4##2##(2007-12#4)
poled with a##2##3##(2007-11#1)(2008-1#1)
poled##235##1##(2006-4#1)(2007-11#46)(2007-12#142)(2008-1#18)(2008-2#11)(2008-3#17)
poleroviruses##2##1##(2008-10#1)(2009-8#1)
poles in##2##2##(2008-3#1)(2011-2#1)
poles of the##2##3##(1990-4#1)(2008-9#1)
poles of##4##2##(1990-4#1)(1993-2#1)(2008-8#1)(2008-9#1)
poles##26##1##(1990-4#1)(1993-2#1)(1997-4#1)(1997-6#1)(2006-3#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#4)(2010-6#1)(2011-2#5)(2012-1#1)(2012-12#1)
poleward flow##2##2##(1992-7#1)(1996-5#1)
poleward##4##1##(1992-7#1)(1996-5#1)(1997-6#2)
polh or p10##2##3##(1997-4#2)
polh promoter##4##2##(1997-4#4)
polh##10##1##(1997-4#10)
police and the##2##3##(1992-12#1)(2012-3#1)
police and##7##2##(1992-12#1)(1993-2#1)(2005-10#1)(2005-8#1)(2006-5#1)(2009-4#1)(2012-3#1)
police chiefs##2##2##(1993-2#2)
police force personnel##5##3##(2009-3#5)
police force##7##2##(1991-3#1)(2009-3#6)
police forces##2##2##(2009-3#1)(2012-2#1)
police investigation##2##2##(1997-8#1)(2008-10#1)
police of##3##2##(2004-4#2)(2005-8#1)
police officers##12##2##(1993-4#1)(1994-2#1)(2005-9#1)(2007-7#1)(2008-6#7)(2008-7#1)
police reports of##2##3##(1991-8#1)(1993-5#1)
police reports##4##2##(1991-8#1)(1992-11#1)(1993-5#1)(2012-3#1)
police surgeon##2##2##(2005-9#2)
police surgeons##2##2##(2005-9#2)
police##96##1##(1991-3#2)(1991-5#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-2#2)(1993-10#1)(1993-2#4)(1993-3#1)(1993-4#1)(1993-5#2)(1994-2#2)(1994-4#1)(1996-6#1)(1997-2#2)(1997-5#2)(1997-8#4)(2004-4#3)(2005-10#1)(2005-8#6)(2005-9#10)(2006-12#1)(2006-5#2)(2006-8#1)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#7)(2008-7#1)(2009-2#1)(2009-3#7)(2009-4#1)(2009-7#2)(2010-1#4)(2011-2#1)(2012-2#2)(2012-3#5)(2013-7#3)
policemen##3##1##(2008-8#1)(2011-1#2)
policies affect##2##2##(1995-2#1)(2009-8#1)
policies affecting##2##2##(1995-1#1)(1995-3#1)
policies aimed at##4##3##(1993-1#1)(2007-7#1)(2010-5#1)(2011-1#1)
policies and guidelines##5##3##(1996-11#1)(1996-12#1)(2007-3#1)(2010-5#1)(2012-11#1)
policies and laws##2##3##(1991-5#1)(2012-3#1)
policies and practices##4##3##(1991-3#1)(2008-11#1)(2010-11#1)(2010-7#1)
policies and procedures for##3##4##(1993-1#1)(1994-2#1)(2008-12#1)
policies and procedures##11##3##(1993-1#1)(1994-2#2)(1995-12#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-12#2)(2008-2#1)(2009-11#1)
policies and programmes##2##3##(2011-2#1)(2012-3#1)
policies and programs to##2##4##(1997-3#1)(2008-11#1)
policies and programs##9##3##(1993-9#1)(1997-3#1)(2008-11#1)(2008-3#1)(2008-9#3)(2010-8#1)(2013-1#1)
policies and their##3##3##(1995-2#1)(2006-10#1)(2011-1#1)
policies and##66##2##(1991-3#1)(1991-4#1)(1991-5#1)(1992-2#1)(1993-1#1)(1993-9#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#3)(2009-11#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-11#2)(2010-5#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#1)(2013-8#1)
policies appear to##2##3##(1995-1#1)(2009-4#1)
policies are often##2##3##(1997-2#1)(2006-9#1)
policies are##13##2##(1993-3#2)(1994-4#1)(1995-6#1)(1997-2#1)(2006-10#1)(2006-9#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2012-3#1)
policies at the##4##3##(1994-2#1)(2007-6#1)(2008-10#1)(2010-11#1)
policies at##5##2##(1994-2#1)(1996-2#1)(2007-6#1)(2008-10#1)(2010-11#1)
policies based on##3##3##(1997-3#1)(2013-1#2)
policies developed##2##2##(1994-5#1)(2008-7#1)
policies directed at##3##3##(2011-2#1)(2012-2#2)
policies do not##3##3##(1994-8#1)(2008-2#1)(2010-7#1)
policies for controlling##2##3##(1995-1#1)(2013-1#1)
policies for the##3##3##(2007-5#1)(2008-11#1)(2008-9#1)
policies for volunteer programs##2##4##(1994-2#2)
policies for##22##2##(1992-3#1)(1993-3#1)(1994-2#2)(1994-3#1)(1995-1#2)(1995-2#1)(1996-8#1)(2007-2#1)(2007-4#1)(2007-5#2)(2008-11#3)(2008-9#1)(2012-12#1)(2013-1#4)
policies from##2##2##(2012-11#1)(2013-1#1)
policies geared##2##2##(2007-6#1)(2009-7#1)
policies governing##2##2##(2006-12#1)(2008-11#1)
policies have been##2##3##(2008-1#1)(2008-10#1)
policies have##7##2##(1995-1#1)(1996-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)
policies in a##2##3##(1993-2#1)(2011-12#1)
policies in health##2##3##(2008-7#1)(2012-12#1)
policies in place##2##3##(2007-2#1)(2011-2#1)
policies in the areas of##2##5##(2009-8#1)(2011-1#1)
policies in the field##2##4##(1997-7#1)(2010-10#1)
policies in the##6##3##(1997-7#1)(2008-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2011-1#1)
policies in##26##2##(1991-12#1)(1993-2#1)(1994-1#1)(1995-1#1)(1995-6#1)(1996-1#1)(1997-7#1)(2006-10#1)(2007-2#2)(2007-3#1)(2008-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#2)(2013-8#2)
policies may not be##3##4##(2008-10#1)(2013-1#2)
policies may##4##2##(1996-1#1)(2008-10#1)(2013-1#2)
policies need to be##2##4##(2008-8#1)(2012-12#1)
policies of the##2##3##(1995-1#1)(2006-9#1)
policies of##11##2##(1994-1#1)(1995-1#1)(1997-8#1)(2006-9#1)(2007-8#1)(2008-2#1)(2009-11#1)(2010-1#1)(2012-2#2)(2012-3#1)
policies on the##5##3##(1990-9#1)(1995-2#1)(1997-7#1)(2007-2#1)(2008-9#1)
policies on##13##2##(1990-9#1)(1991-11#1)(1995-1#1)(1995-2#1)(1997-7#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-3#2)(2012-2#1)
policies or##4##2##(1992-1#1)(1996-3#1)(2008-12#1)(2012-3#1)
policies relating to##2##3##(1991-12#1)(1993-3#1)
policies resulting in##2##3##(1996-12#1)(2007-6#1)
policies should be##2##3##(1996-3#1)(2007-5#1)
policies should##3##2##(1996-3#1)(2007-5#1)(2008-1#1)
policies that encourage##2##3##(2009-12#1)(2011-2#1)
policies that guide##2##3##(2006-3#1)(2012-12#1)
policies that##22##2##(1990-12#1)(1993-11#1)(1993-3#1)(1995-1#1)(1997-2#1)(2006-1#1)(2006-12#1)(2006-3#1)(2007-2#1)(2008-1#1)(2008-7#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)
policies to prevent##2##3##(2007-12#1)(2010-7#1)
policies to##13##2##(1993-2#2)(1994-3#1)(2007-12#1)(2008-1#1)(2008-11#2)(2009-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
policies was##2##2##(1993-12#1)(1996-12#1)
policies were##3##2##(1990-12#1)(2010-8#1)(2012-12#1)
policies will##4##2##(1993-11#1)(1994-2#1)(1995-1#1)(2008-12#1)
policies with##2##2##(1992-3#1)(1995-1#1)
policies##405##1##(1990-12#6)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-1#3)(1992-2#2)(1992-3#2)(1992-5#1)(1993-1#3)(1993-11#2)(1993-12#2)(1993-2#3)(1993-3#8)(1993-7#1)(1993-9#1)(1994-1#3)(1994-12#4)(1994-2#7)(1994-3#4)(1994-4#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-1#11)(1995-12#1)(1995-2#7)(1995-3#5)(1995-6#3)(1996-1#4)(1996-11#2)(1996-12#3)(1996-2#3)(1996-3#7)(1996-8#1)(1997-1#4)(1997-2#4)(1997-3#6)(1997-7#2)(1997-8#1)(2004-4#1)(2005-10#1)(2005-5#2)(2006-1#1)(2006-10#3)(2006-12#2)(2006-3#2)(2006-4#1)(2006-8#2)(2006-9#3)(2007-1#3)(2007-11#1)(2007-12#2)(2007-2#7)(2007-3#2)(2007-4#2)(2007-5#3)(2007-6#5)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#9)(2008-10#3)(2008-11#14)(2008-12#8)(2008-2#4)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#11)(2008-8#2)(2008-9#13)(2009-10#1)(2009-11#3)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#7)(2009-5#3)(2009-7#3)(2009-8#6)(2009-9#1)(2010-1#5)(2010-10#3)(2010-11#3)(2010-12#1)(2010-2#2)(2010-5#6)(2010-6#2)(2010-7#4)(2010-8#6)(2010-9#1)(2011-1#11)(2011-12#1)(2011-2#10)(2011-7#2)(2012-1#4)(2012-11#3)(2012-12#12)(2012-2#11)(2012-3#11)(2013-1#19)(2013-8#6)
policing and##2##2##(2010-8#1)(2012-3#1)
policing in##2##2##(2008-8#1)(2013-8#1)
policing of male production##2##4##(2008-8#2)
policing of##3##2##(1991-1#1)(2008-8#2)
policing##12##1##(1991-1#1)(2007-8#1)(2008-8#7)(2010-8#1)(2012-3#1)(2013-8#1)
policy advocates##4##2##(1996-11#3)(2008-11#1)
policy against##3##2##(2008-11#1)(2012-2#1)(2013-8#1)
policy agenda##3##2##(1996-3#1)(2008-11#1)(2008-7#1)
policy agendas##2##2##(1997-2#1)(2009-4#1)
policy allowed##3##2##(1996-5#1)(2008-7#1)(2011-2#1)
policy analysis and##2##3##(1997-1#1)(2010-11#1)
policy analysis##8##2##(1990-12#1)(1991-2#1)(1996-2#2)(1996-3#1)(1997-1#1)(2010-11#1)(2010-8#1)
policy analysts##4##2##(1996-2#1)(1996-3#1)(2007-8#1)(2010-5#1)
policy and environmental strategies##3##4##(2011-1#3)
policy and future##2##3##(1992-12#1)(2006-2#1)
policy and health##2##3##(1996-12#1)(2013-1#1)
policy and management##2##3##(1993-12#1)(1994-2#1)
policy and operational##2##3##(1992-1#1)(1992-12#1)
policy and planning##3##3##(1994-3#1)(2010-12#1)(2012-12#1)
policy and politics##2##3##(1995-1#1)(2008-7#1)
policy and practice##11##3##(1993-9#1)(2005-7#1)(2005-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#2)(2011-1#1)(2013-8#1)
policy and procedure manual##2##4##(2013-8#2)
policy and procedure manuals##2##4##(2013-8#2)
policy and procedure##5##3##(2004-4#1)(2013-8#4)
policy and procedures##2##3##(2013-8#2)
policy and the##7##3##(1990-12#1)(1991-1#1)(2007-3#1)(2007-6#1)(2008-2#1)(2010-2#1)(2012-1#1)
policy and to##2##3##(2008-7#1)(2012-12#1)
policy and##85##2##(1990-12#1)(1990-6#1)(1991-1#1)(1991-3#1)(1992-1#2)(1992-12#2)(1993-12#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-10#1)(1994-2#3)(1994-3#1)(1995-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-8#1)(2004-4#1)(2005-7#1)(2005-8#1)(2006-2#1)(2007-10#2)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#2)(2009-2#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#2)(2012-1#3)(2012-12#6)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#8)
policy are discussed##3##3##(1995-1#1)(2012-1#1)(2013-1#1)
policy are##7##2##(1990-12#1)(1995-1#1)(1996-1#1)(2004-12#1)(2007-11#1)(2012-1#1)(2013-1#1)
policy areas##2##2##(1994-4#1)(2008-3#1)
policy as a##3##3##(1997-2#1)(2008-11#2)
policy as well as##2##4##(1993-3#1)(1994-1#1)
policy as##5##2##(1993-3#1)(1994-1#1)(1997-2#1)(2008-11#2)
policy at##3##2##(2009-2#1)(2011-12#1)(2012-2#1)
policy brief##3##2##(2007-7#1)(2008-10#1)(2012-12#1)
policy challenges##3##2##(2009-3#1)(2009-4#1)(2012-1#1)
policy change##2##2##(1991-1#1)(1992-12#1)
policy changes##4##2##(1992-12#1)(1995-3#1)(2011-2#1)(2012-2#1)
policy choices##2##2##(1990-3#1)(2012-1#1)
policy considerations##3##2##(1994-12#1)(2006-10#1)(2008-7#1)
policy context##3##2##(1994-2#1)(2008-11#1)(2008-7#1)
policy criteria##2##2##(1991-1#1)(1991-12#1)
policy debates##2##2##(1995-1#1)(2005-2#1)
policy decisions##14##2##(1990-12#1)(1991-3#1)(1996-1#1)(1997-8#1)(2006-2#1)(2008-5#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-7#1)
policy design and##2##3##(1993-3#1)(2008-7#1)
policy design##3##2##(1993-3#1)(2008-7#2)
policy designers##2##2##(1995-2#2)
policy development and##4##3##(1992-1#1)(1995-2#1)(1996-12#1)(2010-11#1)
policy development##19##2##(1992-1#1)(1994-1#1)(1994-2#3)(1995-2#1)(1996-1#2)(1996-12#1)(1996-3#2)(1997-1#1)(1997-2#1)(2006-5#1)(2007-12#1)(2008-1#1)(2010-11#1)(2012-3#1)(2013-1#1)
policy directives##2##2##(2008-12#2)
policy discussion##2##2##(2010-11#2)
policy documents##2##2##(2008-11#2)
policy for the##4##3##(1991-1#1)(2004-2#1)(2007-5#1)(2010-12#1)
policy for##21##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-1#2)(1991-12#1)(1993-3#1)(1995-3#1)(1996-3#1)(2004-2#1)(2005-11#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
policy formation##3##2##(1994-2#1)(2008-8#1)(2012-3#1)
policy formulation##2##2##(1997-3#1)(2010-1#1)
policy framework##2##2##(1995-1#1)(2011-1#1)
policy goals##3##2##(2007-6#1)(2009-4#1)(2012-1#1)
policy guidelines##2##2##(1995-6#1)(2006-8#1)
policy has been##2##3##(1996-3#1)(2009-4#1)
policy has##5##2##(1994-1#1)(1996-3#2)(2008-7#1)(2009-4#1)
policy implications and##2##3##(1996-2#1)(2012-12#1)
policy implications for the##2##4##(1992-12#1)(1993-12#1)
policy implications for##4##3##(1992-12#1)(1993-12#1)(1994-12#1)(2011-1#1)
policy implications of the##2##4##(1995-12#1)(2007-6#1)
policy implications of##8##3##(1995-12#1)(1996-1#1)(2007-6#1)(2008-11#1)(2008-7#2)(2010-12#1)(2011-1#1)
policy implications that##2##3##(1991-12#1)(1992-1#1)
policy implications##29##2##(1991-1#1)(1991-12#4)(1992-1#1)(1992-12#2)(1993-12#2)(1994-12#1)(1994-2#1)(1995-12#1)(1996-1#1)(1996-2#1)(2007-6#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#3)(2010-12#1)(2010-8#2)(2011-1#2)(2012-12#1)
policy in the United States##2##5##(1990-12#2)
policy in the##8##3##(1990-12#2)(1990-3#1)(1992-1#1)(1993-3#1)(2008-10#1)(2008-9#1)(2010-4#1)
policy in##27##2##(1990-12#3)(1990-3#2)(1991-6#1)(1992-1#3)(1993-10#1)(1993-3#1)(2005-7#1)(2005-9#1)(2008-10#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-4#1)(2011-2#2)(2013-1#1)
policy initiatives in##3##3##(1993-2#1)(2011-1#2)
policy initiatives##5##2##(1992-12#1)(1993-2#1)(2011-1#2)(2012-3#1)
policy instruments##3##2##(1991-1#2)(2009-4#1)
policy interest in##2##3##(1994-12#1)(2012-1#1)
policy interventions to promote physical activity##2##6##(2013-1#2)
policy interventions to##3##3##(2013-1#3)
policy interventions##7##2##(2007-6#1)(2013-1#6)
policy is the##2##3##(1997-5#1)(2012-12#1)
policy is to##2##3##(1992-11#1)(1997-3#1)
policy is##15##2##(1990-10#1)(1990-12#1)(1991-1#1)(1992-11#1)(1993-12#1)(1993-3#1)(1996-11#1)(1997-3#1)(1997-5#1)(2006-7#1)(2009-2#1)(2011-2#1)(2012-12#3)
policy issue##3##2##(1991-12#1)(1994-2#1)(2008-7#1)
policy issues and##2##3##(2010-8#1)(2011-1#1)
policy issues in##2##3##(2010-8#2)
policy issues related to##3##4##(1991-5#1)(1996-12#1)(2005-12#1)
policy issues that##3##3##(1991-1#1)(1994-2#1)(2010-8#1)
policy issues##22##2##(1990-12#1)(1991-1#1)(1991-5#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-1#2)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#1)(2005-12#1)(2010-4#1)(2010-8#4)(2011-1#2)(2012-12#2)
policy makers and program##2##4##(2012-3#1)(2013-1#1)
policy makers and##14##3##(1992-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(2007-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
policy makers can##2##3##(2007-9#1)(2010-8#1)
policy makers must##3##3##(1993-12#1)(2006-4#1)(2011-1#1)
policy makers to##8##3##(2006-10#1)(2008-7#1)(2008-8#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#2)
policy makers##59##2##(1991-1#1)(1992-12#1)(1993-12#1)(1994-1#3)(1994-12#1)(1995-3#1)(1996-2#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-1#1)(2006-10#2)(2006-4#1)(2006-5#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#4)(2008-8#2)(2009-4#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-8#5)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
policy making##5##2##(2005-11#1)(2006-5#1)(2007-10#1)(2008-7#1)(2009-3#1)
policy may##2##2##(1995-12#1)(2009-2#1)
policy measures##3##2##(1996-11#1)(2009-7#1)(2012-12#1)
policy must##2##2##(1997-7#1)(2007-11#1)
policy needs##2##2##(2005-10#1)(2006-10#1)
policy network##2##2##(2008-9#1)(2009-4#1)
policy objectives of##2##3##(2007-3#1)(2008-7#1)
policy objectives##3##2##(2007-3#1)(2008-7#1)(2010-11#1)
policy of free##2##3##(1997-3#1)(2012-3#1)
policy of reducing##2##3##(1993-7#1)(2007-8#1)
policy of##21##2##(1990-10#1)(1990-12#1)(1992-1#1)(1992-10#1)(1993-11#1)(1993-3#1)(1993-7#1)(1993-8#1)(1997-3#1)(2006-6#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
policy on smoking##2##3##(1995-6#1)(2012-1#1)
policy on the##3##3##(2008-6#1)(2012-11#2)
policy on##16##2##(1990-11#2)(1991-12#1)(1992-1#1)(1992-2#2)(1995-6#1)(2006-8#1)(2007-6#1)(2008-11#1)(2008-6#1)(2011-2#1)(2012-1#1)(2012-11#2)(2013-1#1)
policy options##10##2##(1992-3#1)(1994-2#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-12#1)(2011-1#1)(2011-2#2)(2012-12#1)
policy or##4##2##(1992-2#1)(2007-2#1)(2009-4#1)(2012-12#1)
policy outcomes##2##2##(1991-1#1)(2011-1#1)
policy perspective##3##2##(1994-2#1)(2010-4#1)(2011-1#1)
policy planning##4##2##(1991-1#1)(1997-2#1)(2008-1#1)(2008-9#1)
policy preferences##4##2##(1994-12#1)(2006-7#3)
policy process##6##2##(1993-1#1)(1995-1#1)(1995-2#2)(1996-12#1)(2008-7#1)
policy provided##2##2##(1997-1#1)(2006-10#1)
policy recommendations##3##2##(1996-1#1)(1996-3#1)(2009-4#1)
policy reform##4##2##(1994-1#1)(1997-2#2)(1997-3#1)
policy reforms##2##2##(1994-7#1)(2009-6#1)
policy regarding##2##2##(2008-12#1)(2013-1#1)
policy relevant##3##2##(1992-3#1)(1993-3#1)(2012-12#1)
policy research##6##2##(1990-12#1)(1994-1#1)(1995-3#1)(2009-3#1)(2009-4#1)(2010-8#1)
policy review##3##2##(1991-1#1)(1994-12#1)(2009-4#1)
policy should be##3##3##(1992-12#1)(1994-1#1)(2007-7#1)
policy should##4##2##(1990-9#1)(1992-12#1)(1994-1#1)(2007-7#1)
policy statement on##2##3##(1996-3#1)(2005-8#1)
policy statement##5##2##(1996-3#1)(2005-8#2)(2007-4#1)(2008-11#1)
policy statements##2##2##(2006-3#1)(2006-9#1)
policy support##2##2##(2008-2#1)(2012-2#1)
policy that##10##2##(1991-4#1)(1995-3#1)(1996-11#1)(1996-6#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2012-3#1)(2013-1#1)
policy to reduce##2##3##(2007-8#1)(2011-1#1)
policy to##14##2##(1994-11#1)(1997-2#1)(2006-7#1)(2007-8#1)(2008-6#1)(2008-7#1)(2009-11#1)(2010-10#1)(2010-12#1)(2011-1#1)(2013-1#4)
policy toward health##3##3##(1993-1#1)(2013-1#2)
policy toward##6##2##(1993-1#1)(1994-3#1)(1996-5#1)(2008-10#1)(2013-1#2)
policy was to##2##3##(2008-6#1)(2011-12#1)
policy was##5##2##(1996-12#1)(1997-1#1)(2008-6#1)(2011-12#1)(2011-2#1)
policy which##2##2##(1994-12#1)(2007-12#1)
policy will##5##2##(1996-11#1)(1996-12#1)(2009-2#1)(2009-8#1)(2013-8#1)
policy with a##2##3##(1994-2#1)(1995-2#1)
policy with respect to##2##4##(2011-1#1)(2012-3#1)
policy with##5##2##(1993-3#1)(1994-2#1)(1995-2#1)(2011-1#1)(2012-3#1)
policy would##2##2##(1997-1#1)(2012-12#1)
policy##941##1##(1990-10#3)(1990-11#3)(1990-12#23)(1990-2#4)(1990-3#3)(1990-6#2)(1990-9#3)(1991-1#19)(1991-10#1)(1991-12#12)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#2)(1992-1#14)(1992-10#1)(1992-11#2)(1992-12#16)(1992-2#4)(1992-3#12)(1992-5#2)(1992-8#2)(1993-1#4)(1993-10#1)(1993-11#1)(1993-12#9)(1993-2#4)(1993-3#18)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#12)(1994-10#3)(1994-11#1)(1994-12#10)(1994-2#16)(1994-3#2)(1994-4#2)(1994-6#2)(1994-7#4)(1995-1#13)(1995-11#1)(1995-12#2)(1995-2#7)(1995-3#11)(1995-6#4)(1995-8#1)(1996-1#16)(1996-11#8)(1996-12#12)(1996-2#13)(1996-3#23)(1996-4#1)(1996-5#3)(1996-6#4)(1996-8#1)(1997-1#10)(1997-2#11)(1997-3#12)(1997-4#1)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#4)(2004-12#1)(2004-2#1)(2004-4#1)(2004-7#1)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-2#2)(2005-7#3)(2005-8#3)(2005-9#3)(2006-1#1)(2006-10#5)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#7)(2006-6#2)(2006-7#10)(2006-8#4)(2006-9#1)(2007-10#3)(2007-11#2)(2007-12#7)(2007-2#4)(2007-3#6)(2007-4#4)(2007-5#4)(2007-6#9)(2007-7#8)(2007-8#9)(2007-9#4)(2008-1#10)(2008-10#11)(2008-11#29)(2008-12#8)(2008-2#7)(2008-3#5)(2008-4#6)(2008-5#3)(2008-6#10)(2008-7#38)(2008-8#5)(2008-9#6)(2009-10#1)(2009-11#2)(2009-2#6)(2009-3#7)(2009-4#21)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#6)(2010-11#10)(2010-12#11)(2010-2#1)(2010-3#2)(2010-4#5)(2010-5#3)(2010-7#2)(2010-8#17)(2010-9#3)(2011-1#23)(2011-12#3)(2011-2#23)(2012-1#19)(2012-11#2)(2012-12#33)(2012-2#19)(2012-3#14)(2013-1#34)(2013-7#2)(2013-8#11)
policy&quot##2##1##(1995-3#1)(2008-8#1)
policy's##2##1##(1990-12#1)(1992-12#1)
policy-driven##2##1##(2012-1#1)(2013-8#1)
policy-makers and##2##2##(2007-7#1)(2007-9#1)
policy-makers have pursued##2##3##(1996-1#1)(2011-1#1)
policy-makers have##4##2##(1995-3#1)(1996-1#1)(2007-7#1)(2011-1#1)
policy-makers in##2##2##(1996-1#1)(2010-8#1)
policy-makers to##2##2##(2008-11#1)(2012-12#1)
policy-makers would##2##2##(2006-5#1)(2007-8#1)
policy-makers##25##1##(1995-3#2)(1996-1#2)(2006-5#1)(2007-2#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-11#1)(2008-7#2)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#2)
policy-making##10##1##(1994-3#1)(1996-1#1)(1997-2#1)(1997-3#1)(2007-4#1)(2008-7#2)(2011-1#2)(2013-1#1)
policy-relevant##5##1##(1995-1#1)(2008-11#1)(2008-5#1)(2010-11#1)(2011-2#1)
policy]##3##1##(1991-6#1)(1997-6#1)(2008-9#1)
policymakers and##3##2##(2006-10#1)(2007-7#1)(2010-4#1)
policymakers##24##1##(1992-3#1)(1992-5#1)(1993-3#2)(1994-1#1)(1994-2#1)(1995-3#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-7#1)(2008-4#3)(2009-4#2)(2010-4#4)(2010-9#2)(2012-11#1)(2013-8#1)
policymaking and##2##2##(1995-2#1)(1995-3#1)
policymaking##8##1##(1991-1#1)(1995-2#1)(1995-3#1)(1995-4#2)(2007-3#1)(2009-4#1)(2010-4#1)
poling at room temperature##2##4##(2007-11#1)(2008-2#1)
poling at##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
poling direction##2##2##(2007-12#2)
poling duty cycle##2##3##(2007-12#2)
poling in##2##2##(2007-11#1)(2007-12#1)
poling of##8##2##(2007-11#2)(2007-12#6)
poling period##2##2##(2007-11#1)(2007-12#1)
poling technique##2##2##(2007-11#1)(2008-1#1)
poling temperature##4##2##(2007-12#4)
poling time##2##2##(2007-12#2)
poling##50##1##(2007-11#10)(2007-12#36)(2008-1#2)(2008-2#1)(2008-3#1)
polio and##2##2##(1994-3#1)(2006-10#1)
polio eradication##5##2##(1994-9#1)(2004-12#2)(2012-12#2)
polio has##2##2##(1994-9#1)(2008-4#1)
polio in##4##2##(1994-9#3)(2008-8#1)
polio is##2##2##(1994-9#1)(2004-12#1)
polio vaccination in the United States##3##6##(1994-3#1)(2004-12#2)
polio vaccination in##5##3##(1994-3#1)(2004-12#2)(2012-12#2)
polio vaccination uptake##2##3##(2012-12#2)
polio vaccination##11##2##(1994-3#1)(2004-12#2)(2009-7#1)(2012-12#7)
polio vaccine##9##2##(1994-9#2)(2007-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-8#1)
polio vaccines##2##2##(2006-7#1)(2008-11#1)
polio virus##5##2##(1992-6#1)(2007-10#1)(2008-4#1)(2008-8#1)(2011-1#1)
polio##70##1##(1992-6#1)(1994-3#3)(1994-9#14)(1995-3#1)(1997-1#1)(2004-12#7)(2005-7#1)(2006-10#3)(2006-7#1)(2007-10#5)(2007-2#1)(2007-8#3)(2008-11#2)(2008-4#4)(2008-7#1)(2008-8#6)(2009-7#1)(2011-1#1)(2012-1#1)(2012-12#11)(2013-1#1)(2013-8#1)
polio-free countries##2##2##(1994-9#1)(2008-8#1)
polio-vaccine##2##1##(1995-5#1)(2006-7#1)
poliomyelitis and##2##2##(2006-4#1)(2009-5#1)
poliomyelitis eradication program##2##3##(1993-3#2)
poliomyelitis has been##2##3##(2007-2#2)
poliomyelitis has##3##2##(1997-1#1)(2007-2#2)
poliomyelitis immunization##2##2##(1994-3#1)(2006-2#1)
poliomyelitis in##4##2##(1991-11#1)(1997-1#1)(1997-5#1)(2007-2#1)
poliomyelitis is an##2##3##(2009-3#2)
poliomyelitis is##3##2##(2007-2#1)(2009-3#2)
poliomyelitis prevention##2##2##(1994-8#1)(2004-12#1)
poliomyelitis vaccination##2##2##(1995-8#1)(2007-2#1)
poliomyelitis##45##1##(1991-11#1)(1993-12#2)(1993-3#3)(1994-3#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-1#4)(1997-5#1)(2004-12#2)(2006-2#1)(2006-4#1)(2006-8#1)(2007-2#7)(2007-7#1)(2008-11#1)(2008-8#2)(2009-3#6)(2009-4#1)(2009-5#1)(2010-12#2)
poliovirus (PV)##2##2##(2008-11#1)(2008-4#1)
poliovirus in##2##2##(1994-12#1)(2011-1#1)
poliovirus strains##3##2##(2006-10#1)(2008-4#2)
poliovirus vaccination##3##2##(1990-3#1)(1995-5#1)(1997-1#1)
poliovirus vaccine (OPV)##3##3##(1995-3#1)(1997-1#1)(2004-12#1)
poliovirus vaccine and##2##3##(2007-10#1)(2007-11#1)
poliovirus vaccine##11##2##(1995-3#2)(1997-1#2)(2004-12#2)(2006-10#1)(2007-10#2)(2007-11#2)
poliovirus vaccines##2##2##(1995-5#2)
poliovirus##42##1##(1990-3#1)(1993-6#1)(1994-12#1)(1995-3#3)(1995-5#10)(1997-1#5)(2004-12#3)(2006-10#2)(2007-10#2)(2007-11#2)(2007-2#1)(2008-10#2)(2008-11#1)(2008-4#5)(2011-1#3)
polioviruses##4##1##(2006-10#2)(2007-2#1)(2008-7#1)
polish orthopedists##2##2##(2007-8#2)
polish##19##1##(1997-6#3)(2007-8#14)(2008-10#1)(2008-3#1)
polished and##3##2##(2006-5#1)(2009-4#1)(2013-8#1)
polished glass##2##2##(2008-11#1)(2008-2#1)
polished optical##2##2##(2007-11#1)(2008-3#1)
polished surface##4##2##(2008-2#1)(2008-3#2)(2013-1#1)
polished to##2##2##(2008-3#1)(2009-5#1)
polished with##2##2##(2008-2#1)(2013-1#1)
polished##36##1##(2006-12#2)(2006-5#1)(2007-11#3)(2007-12#4)(2007-7#2)(2008-10#1)(2008-11#1)(2008-2#7)(2008-3#5)(2008-8#2)(2009-2#1)(2009-4#2)(2009-5#1)(2013-1#2)(2013-8#2)
polishers##4##1##(1994-6#1)(2008-2#3)
polishing and##5##2##(2007-12#1)(2008-1#1)(2008-10#2)(2013-1#1)
polishing is##2##2##(2008-10#1)(2008-3#1)
polishing methods##2##2##(2008-10#1)(2013-1#1)
polishing of optical surfaces##2##4##(2008-2#1)(2008-3#1)
polishing of the##2##3##(2008-1#2)
polishing of##6##2##(1994-6#1)(2008-1#2)(2008-2#2)(2008-3#1)
polishing on an alumina paper##3##5##(2008-10#3)
polishing on##7##2##(2008-10#7)
polishing procedure##2##2##(2008-10#1)(2010-2#1)
polishing the##2##2##(2008-10#2)
polishing##64##1##(1994-6#2)(2007-12#1)(2008-1#5)(2008-10#21)(2008-11#1)(2008-2#8)(2008-3#10)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#3)(2010-4#1)(2011-1#1)(2011-2#1)(2012-7#1)(2013-1#3)(2013-8#1)
polisomnography##2##1##(2010-8#2)
polistine wasps##2##2##(2008-8#2)
politeness##2##1##(2008-11#1)(2008-12#1)
political activity##3##2##(1996-3#1)(2008-4#1)(2012-2#1)
political and administrative context##2##4##(1993-3#2)
political and administrative##3##3##(1993-3#2)(2011-2#1)
political and economic##5##3##(1995-2#1)(2008-5#2)(2009-4#1)(2010-9#1)
political and economical##2##3##(2005-5#1)(2011-1#1)
political and professional##2##3##(2011-2#1)(2012-2#1)
political and religious##2##3##(2006-2#1)(2008-8#1)
political and scientific##2##3##(2006-4#1)(2009-4#1)
political and social##5##3##(2006-7#1)(2009-7#1)(2010-4#1)(2013-1#2)
political and##34##2##(1993-3#2)(1994-3#1)(1995-2#2)(1996-2#2)(1997-1#1)(2005-5#1)(2005-8#2)(2006-2#1)(2006-4#1)(2006-7#2)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2009-7#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
political arena##2##2##(2008-11#1)(2013-7#1)
political aspects##2##2##(1996-1#1)(2009-10#1)
political asylum##2##2##(1996-6#2)
political at##2##2##(1996-1#1)(2008-1#1)
political climate##2##2##(2008-11#1)(2008-4#1)
political clout##2##2##(2008-11#1)(2008-9#1)
political commitment and##2##3##(2012-12#2)
political commitment to##2##3##(1992-1#1)(2008-11#1)
political commitment##6##2##(1992-1#1)(2008-11#1)(2010-12#1)(2011-1#1)(2012-12#2)
political conflict##2##2##(1996-3#1)(2008-7#1)
political consensus##2##2##(1996-2#1)(2008-10#1)
political culture##6##2##(1995-1#1)(1996-12#1)(2008-11#1)(2008-9#1)(2013-7#2)
political debate##2##2##(2008-11#1)(2009-4#1)
political ecology##2##2##(2008-1#2)
political economy of##3##3##(2008-12#1)(2008-7#1)(2009-2#1)
political economy##4##2##(2008-12#1)(2008-7#1)(2008-9#1)(2009-2#1)
political expediency##2##2##(1993-12#1)(2007-4#1)
political forces##3##2##(1995-12#1)(1997-2#1)(2012-2#1)
political influence of##2##3##(2008-7#1)(2011-1#1)
political influence##3##2##(1995-4#1)(2008-7#1)(2011-1#1)
political leadership##2##2##(2008-7#1)(2012-3#1)
political liberalism##2##2##(1993-1#1)(2006-7#1)
political participation##7##2##(1994-2#1)(2007-7#1)(2010-4#2)(2011-2#2)(2012-2#1)
political parties##2##2##(2008-7#1)(2010-4#1)
political pressure##2##2##(2009-3#1)(2012-3#1)
political process##3##2##(1991-2#1)(1997-1#1)(2006-7#1)
political projects##2##2##(2008-9#1)(2009-4#1)
political realities##2##2##(1995-3#1)(2012-3#1)
political science##4##2##(1995-1#1)(2008-1#1)(2008-2#1)(2011-1#1)
political structure##2##2##(1994-2#1)(1996-12#1)
political support##4##2##(1990-12#1)(1990-3#1)(1996-3#1)(2013-1#1)
political will and##2##3##(1993-6#1)(2007-12#1)
political will to##2##3##(2012-1#1)(2013-8#1)
political will##9##2##(1993-6#1)(1994-7#1)(1997-1#1)(2007-12#1)(2007-7#2)(2010-12#1)(2012-1#1)(2013-8#1)
political##284##1##(1990-12#1)(1990-3#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-1#3)(1992-11#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#1)(1993-3#3)(1993-6#1)(1993-8#1)(1994-1#2)(1994-2#3)(1994-3#4)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#4)(1995-12#2)(1995-2#2)(1995-3#4)(1995-4#4)(1995-6#1)(1995-9#1)(1996-1#4)(1996-11#1)(1996-12#5)(1996-2#5)(1996-3#5)(1996-4#1)(1996-6#2)(1997-1#3)(1997-2#3)(1997-3#2)(1997-5#1)(2004-12#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-8#2)(2006-10#3)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-7#14)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#6)(2007-8#1)(2007-9#5)(2008-1#8)(2008-10#2)(2008-11#15)(2008-12#4)(2008-2#4)(2008-4#3)(2008-5#2)(2008-7#9)(2008-8#3)(2008-9#6)(2009-10#3)(2009-2#3)(2009-3#1)(2009-4#7)(2009-6#1)(2009-7#3)(2010-11#1)(2010-12#5)(2010-2#1)(2010-4#4)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#14)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#8)(2012-3#13)(2013-1#5)(2013-7#3)(2013-8#2)
politically and##2##2##(2010-9#1)(2011-2#1)
politically viable##2##2##(1993-3#1)(1995-3#1)
politically##16##1##(1990-12#1)(1992-5#1)(1993-3#1)(1994-6#1)(1995-12#1)(1995-3#2)(1996-1#1)(1996-2#1)(2005-8#1)(2006-5#1)(2007-6#1)(2007-9#1)(2010-9#1)(2011-2#1)(2013-1#1)
politician##2##1##(1991-8#1)(2011-2#1)
politicians and##3##2##(2008-11#1)(2011-2#1)(2012-2#1)
politicians have##2##2##(1995-6#1)(2007-9#1)
politicians##16##1##(1992-2#1)(1993-11#1)(1993-5#1)(1995-1#1)(1995-6#2)(2005-8#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-11#1)(2010-1#1)(2011-2#1)(2012-2#1)
politicization of sexual violence##2##4##(2006-7#2)
politicization of##4##2##(2006-10#1)(2006-7#3)
politicized##3##1##(1996-12#1)(2006-7#1)(2008-5#1)
politics and policy##3##3##(1990-12#1)(1995-1#2)
politics and the##2##3##(1994-12#1)(2012-3#1)
politics and##18##2##(1990-12#1)(1991-2#1)(1994-12#1)(1994-3#2)(1995-1#4)(2006-7#2)(2006-8#1)(2007-9#1)(2008-7#1)(2009-10#1)(2010-8#1)(2012-2#1)(2012-3#1)
politics in##7##2##(1990-10#1)(1992-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-7#1)
politics of##18##2##(1991-2#1)(1992-1#1)(1993-1#1)(1994-2#1)(1994-9#1)(1996-12#1)(1996-3#1)(2006-7#2)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-11#1)(2012-3#1)(2013-7#1)
politics or##2##2##(1990-10#1)(2008-3#1)
politics to##2##2##(1995-1#1)(2012-2#1)
politics##83##1##(1990-10#2)(1990-12#2)(1991-2#2)(1992-1#1)(1992-10#1)(1992-12#1)(1993-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-1#6)(1995-9#1)(1996-12#1)(1996-3#2)(2005-12#1)(2006-12#1)(2006-2#1)(2006-7#6)(2006-8#2)(2007-10#1)(2007-3#1)(2007-4#1)(2007-7#2)(2007-9#1)(2008-1#5)(2008-10#3)(2008-11#3)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#3)(2009-10#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#2)
poll##12##1##(1991-3#1)(1991-4#1)(1994-1#1)(1994-10#1)(1995-2#1)(1996-1#1)(1997-5#1)(2006-7#1)(2009-4#1)(2011-2#2)(2012-2#1)
polled##4##1##(1996-3#1)(2008-7#3)
pollen abortion##2##2##(2008-8#2)
pollen allergens##7##2##(1996-5#2)(2009-10#2)(2011-2#3)
pollen allergy##3##2##(2011-2#1)(2013-8#2)
pollen and ovule##2##3##(2008-8#2)
pollen and##12##2##(1990-10#1)(1994-2#1)(2008-10#2)(2008-6#1)(2008-8#2)(2009-10#2)(2009-12#1)(2011-2#1)(2013-1#1)
pollen but##3##2##(2008-6#1)(2009-10#1)(2012-12#1)
pollen by##2##2##(2008-10#1)(2010-10#1)
pollen counts##2##2##(2006-12#2)
pollen development##3##2##(1996-5#1)(2006-12#1)(2009-10#1)
pollen discounting and its##2##4##(2008-9#2)
pollen discounting and##3##3##(2008-9#3)
pollen discounting##4##2##(2008-9#4)
pollen dispersal##5##2##(2005-10#1)(2010-10#3)(2011-2#1)
pollen export##2##2##(2008-9#2)
pollen fertility##4##2##(2009-10#3)(2013-1#1)
pollen from##3##2##(2008-10#2)(2011-2#1)
pollen germination and pollen tube##2##5##(2008-8#1)(2009-10#1)
pollen germination and##3##3##(2008-8#1)(2009-10#1)(2009-12#1)
pollen germination##14##2##(2005-10#1)(2008-8#1)(2009-10#6)(2009-12#1)(2012-2#5)
pollen grains and##4##3##(2008-10#1)(2008-5#1)(2008-8#2)
pollen grains were##2##3##(2009-10#1)(2011-12#1)
pollen grains##26##2##(2007-2#2)(2007-3#7)(2007-4#1)(2008-10#5)(2008-2#2)(2008-5#2)(2008-8#2)(2009-10#1)(2009-12#1)(2011-12#1)(2013-1#1)(2013-8#1)
pollen in##5##2##(2007-3#1)(2008-2#1)(2008-6#1)(2012-12#1)(2012-7#1)
pollen mass##2##2##(2007-3#2)
pollen maturation##2##2##(2008-8#1)(2009-8#1)
pollen mediated gene##2##3##(2011-2#2)
pollen mother cells##2##3##(2008-10#1)(2009-12#1)
pollen of##6##2##(1996-5#1)(2008-11#2)(2008-6#1)(2009-12#1)(2012-7#1)
pollen parent##3##2##(2005-10#3)
pollen plus honey##3##3##(2008-6#3)
pollen produced##2##2##(1990-6#1)(2013-8#1)
pollen production has##2##3##(2012-7#2)
pollen production##3##2##(2007-3#1)(2012-7#2)
pollen profilin was##2##3##(1994-2#2)
pollen profilin##4##2##(1994-2#4)
pollen samples##3##2##(2011-2#3)
pollen season##4##2##(2007-9#1)(2012-12#1)(2012-7#2)
pollen species##2##2##(2008-6#2)
pollen sterility##2##2##(2008-8#1)(2011-12#1)
pollen to##4##2##(1992-3#1)(2007-3#1)(2008-10#2)
pollen transfer##5##2##(2008-8#5)
pollen tube growth##5##3##(2008-11#1)(2009-10#1)(2009-12#2)(2009-8#1)
pollen tube##18##2##(2008-10#1)(2008-11#3)(2008-8#1)(2009-10#4)(2009-12#3)(2009-8#6)
pollen tubes##17##2##(1997-2#1)(2008-10#3)(2008-8#3)(2009-10#5)(2009-12#2)(2009-8#3)
pollen viability##2##2##(2011-12#2)
pollen was##5##2##(1997-6#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-7#1)
pollen wasps (Masarinae##2##3##(2007-12#2)
pollen wasps##4##2##(2007-12#4)
pollen were##2##2##(2008-10#1)(2012-7#1)
pollen##300##1##(1990-10#3)(1990-11#1)(1990-6#2)(1992-3#5)(1993-6#1)(1994-2#5)(1996-5#4)(1997-2#1)(1997-6#3)(2005-10#9)(2006-12#4)(2007-11#1)(2007-12#6)(2007-2#8)(2007-3#15)(2007-4#7)(2007-9#1)(2008-10#38)(2008-11#6)(2008-2#3)(2008-5#7)(2008-6#11)(2008-7#1)(2008-8#27)(2008-9#9)(2009-10#36)(2009-12#14)(2009-8#10)(2010-10#5)(2011-12#4)(2011-2#16)(2012-1#1)(2012-12#5)(2012-2#8)(2012-7#14)(2013-1#3)(2013-8#6)
pollen)##4##1##(1990-8#1)(2008-5#1)(2008-6#1)(2011-2#1)
pollen-bearing##2##1##(1990-6#1)(2008-8#1)
pollen-mediated gene flow##2##3##(2011-2#2)
pollen-specific##4##1##(1997-2#3)(2009-10#1)
pollenizer##2##1##(2008-10#2)
pollens and##2##2##(2008-8#1)(2013-1#1)
pollens##16##1##(1991-2#1)(1997-2#1)(2006-12#2)(2007-2#2)(2007-3#2)(2008-5#1)(2008-6#2)(2008-8#1)(2012-12#1)(2012-3#1)(2013-1#2)
pollicis longus tendon##5##3##(2006-3#2)(2008-9#3)
pollicis longus##10##2##(2006-3#3)(2007-11#2)(2008-7#2)(2008-9#3)
pollicis##15##1##(1996-5#1)(1996-9#2)(2006-3#4)(2007-11#2)(2008-7#2)(2008-9#4)
pollicus longus##2##2##(2008-9#2)
pollinating##4##1##(2007-3#1)(2008-2#1)(2008-8#1)(2009-5#1)
pollination and seed dispersal##3##4##(2008-9#3)
pollination and##6##2##(2008-10#2)(2008-9#3)(2009-10#1)
pollination conditions##2##2##(2008-9#2)
pollination experiments##3##2##(2005-10#3)
pollination is##2##2##(2012-7#1)(2013-8#1)
pollination occurs##2##2##(2008-10#1)(2012-7#1)
pollination systems##4##2##(2009-8#3)(2013-8#1)
pollination##54##1##(1994-3#2)(2005-10#4)(2008-10#12)(2008-11#3)(2008-8#1)(2008-9#14)(2009-10#2)(2009-12#3)(2009-6#2)(2009-8#4)(2011-2#2)(2012-7#2)(2013-8#3)
pollinator abundance in crop fields##2##5##(2012-2#2)
pollinator abundance in##3##3##(2008-8#1)(2012-2#2)
pollinator abundance##5##2##(2008-8#1)(2012-2#4)
pollinator visitation##3##2##(2008-8#3)
pollinator##19##1##(2008-10#3)(2008-8#8)(2008-9#1)(2009-8#3)(2012-2#4)
pollinators##11##1##(2007-3#1)(2008-10#2)(2008-5#1)(2008-8#3)(2008-9#3)(2013-8#1)
pollinators' learning##2##2##(2008-9#2)
pollinosis##12##1##(2008-11#2)(2012-12#10)
polls##3##1##(1990-12#1)(1994-1#1)(2006-7#1)
pollutant and##3##2##(1991-4#1)(2008-8#1)(2010-2#1)
pollutant concentrations##2##2##(2007-10#1)(2008-10#1)
pollutant detection##2##2##(2007-11#1)(2008-3#1)
pollutant dispersion##2##2##(2010-9#2)
pollutant exposure and##3##3##(2005-10#1)(2005-11#1)(2010-2#1)
pollutant exposure##8##2##(2005-10#2)(2005-11#1)(2010-2#2)(2012-2#3)
pollutant exposures##2##2##(2005-10#1)(2010-2#1)
pollutant levels##2##2##(2004-4#1)(2007-4#1)
pollutant producers##2##2##(2011-2#2)
pollutant##57##1##(1990-8#2)(1991-4#2)(1991-9#1)(1992-3#1)(1992-4#2)(1993-7#1)(1996-3#1)(2004-4#2)(2005-10#3)(2005-11#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#13)(2008-11#5)(2008-3#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-2#4)(2010-9#2)(2011-2#2)(2012-2#3)(2013-1#3)
pollutants and other##2##3##(2007-5#1)(2008-3#1)
pollutants and##8##2##(1992-9#1)(1994-3#1)(1997-4#1)(2007-5#1)(2008-3#1)(2008-5#1)(2010-7#1)(2010-9#1)
pollutants at##5##2##(2004-4#1)(2008-10#3)(2008-3#1)
pollutants by##3##2##(2008-10#3)
pollutants can##2##2##(2008-11#1)(2010-5#1)
pollutants contained in##2##3##(2008-10#2)
pollutants found##2##2##(2007-10#1)(2008-7#1)
pollutants from the##3##3##(2007-10#3)
pollutants from##6##2##(2007-10#4)(2007-5#1)(2008-10#1)
pollutants have##2##2##(2008-3#1)(2009-6#1)
pollutants in a##4##3##(2008-10#4)
pollutants in soils##2##3##(2008-10#1)(2008-7#1)
pollutants in the##10##3##(2004-4#2)(2007-10#2)(2007-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-1#1)
pollutants in##27##2##(1996-3#1)(2004-4#2)(2006-12#1)(2007-10#3)(2007-5#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#1)(2010-9#1)(2011-1#1)(2011-2#1)
pollutants is##4##2##(2004-4#1)(2008-10#1)(2008-2#1)(2013-1#1)
pollutants sampled##2##2##(2004-4#2)
pollutants such as##4##3##(1994-3#1)(2007-8#1)(2008-10#1)(2008-12#1)
pollutants that are##2##3##(2008-11#1)(2011-12#1)
pollutants that##6##2##(1994-3#1)(2008-10#2)(2008-11#2)(2011-12#1)
pollutants was##2##2##(2007-10#1)(2007-8#1)
pollutants were##3##2##(2005-4#1)(2007-10#1)(2008-10#1)
pollutants with a##2##3##(2005-4#1)(2008-10#1)
pollutants with##4##2##(1992-4#1)(2004-4#1)(2005-4#1)(2008-10#1)
pollutants##185##1##(1991-3#1)(1991-4#2)(1992-3#1)(1992-4#5)(1992-7#1)(1992-9#1)(1993-4#1)(1994-3#3)(1995-11#1)(1996-11#1)(1996-3#2)(1997-4#1)(2004-4#13)(2005-11#2)(2005-4#3)(2006-10#1)(2006-12#1)(2007-10#13)(2007-5#3)(2007-8#6)(2008-10#58)(2008-11#18)(2008-12#1)(2008-2#4)(2008-3#4)(2008-5#4)(2008-7#4)(2009-6#2)(2009-8#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-5#2)(2010-7#1)(2010-9#5)(2011-1#4)(2011-12#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)
polluted air##2##2##(1991-4#1)(2008-3#1)
polluted area##4##2##(1996-3#1)(2004-4#2)(2007-8#1)
polluted areas##2##2##(1992-3#1)(2007-7#1)
polluted by##2##2##(2004-4#1)(2008-10#1)
polluted environment##2##2##(2007-7#1)(2008-1#1)
polluted habitats##6##2##(2008-5#6)
polluted river##3##2##(2008-10#3)
polluted seawater##2##2##(2012-2#2)
polluted site##3##2##(2006-12#1)(2007-8#1)(2010-5#1)
polluted sites in##2##3##(2010-5#1)(2011-1#1)
polluted sites##4##2##(2008-11#1)(2008-4#1)(2010-5#1)(2011-1#1)
polluted soils##4##2##(2004-4#1)(2006-12#2)(2008-2#1)
polluted water##8##2##(2004-4#1)(2008-10#3)(2012-2#4)
polluted waters##3##2##(2008-10#3)
polluted##75##1##(1991-4#1)(1992-3#1)(1996-3#1)(2004-4#9)(2006-10#1)(2006-12#3)(2006-3#1)(2007-10#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#14)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#12)(2008-7#3)(2009-6#1)(2010-5#3)(2011-1#1)(2012-12#2)(2012-2#6)
polluting##3##1##(2008-1#1)(2008-12#1)(2011-2#1)
pollution and health##3##3##(2008-6#1)(2008-7#1)(2010-9#1)
pollution and human health##2##4##(1994-3#1)(2010-9#1)
pollution and its##3##3##(1992-4#1)(1992-9#1)(1993-6#1)
pollution and the##2##3##(2008-11#1)(2010-9#1)
pollution and##34##2##(1992-4#1)(1992-9#1)(1993-6#1)(1994-3#1)(1995-6#1)(1997-1#1)(1997-4#1)(2007-10#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#2)(2010-2#1)(2010-5#1)(2010-9#5)(2011-2#3)(2012-12#1)(2013-1#1)
pollution are##6##2##(1992-5#1)(1993-4#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-5#1)
pollution at##2##2##(2008-12#1)(2010-9#1)
pollution by##4##2##(2007-10#1)(2008-11#1)(2008-12#1)(2013-8#1)
pollution can##2##2##(1994-9#1)(1997-1#1)
pollution events##2##2##(2008-2#1)(2011-1#1)
pollution from##5##2##(1992-6#1)(2004-4#1)(2008-11#2)(2011-2#1)
pollution has##3##2##(2008-2#1)(2010-9#1)(2013-8#1)
pollution have been suggested##2##4##(1994-9#1)(2012-12#1)
pollution have been##4##3##(1994-9#1)(2004-4#1)(2008-10#1)(2012-12#1)
pollution history##2##2##(2006-3#1)(2008-11#1)
pollution in Shizuoka##2##3##(2008-10#2)
pollution in aquatic##2##3##(2004-4#1)(2008-10#1)
pollution in the##10##3##(1992-9#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-11#1)(2010-9#2)(2011-1#1)(2011-2#1)
pollution in##34##2##(1991-12#1)(1992-6#1)(1992-9#2)(1993-3#1)(1994-11#1)(2004-4#1)(2006-12#1)(2007-10#2)(2007-5#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-8#1)(2009-6#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-9#3)(2011-1#1)(2011-12#1)(2011-2#1)(2013-8#2)
pollution is##4##2##(1992-9#1)(2007-10#1)(2008-10#2)
pollution levels and##2##3##(2007-4#1)(2008-11#1)
pollution levels##6##2##(1992-9#1)(2007-10#1)(2007-4#1)(2008-10#1)(2008-11#1)(2012-12#1)
pollution of indoor##2##3##(1994-9#2)
pollution of the operating##2##4##(1990-4#1)(2008-8#1)
pollution of the##3##3##(1990-4#1)(1994-3#1)(2008-8#1)
pollution of##10##2##(1990-4#1)(1994-3#1)(1994-9#2)(2006-10#1)(2008-10#2)(2008-8#1)(2010-5#1)(2012-12#1)
pollution on the##3##3##(2004-4#1)(2006-12#1)(2008-11#1)
pollution on##10##2##(1997-1#1)(2004-4#2)(2006-12#1)(2008-11#1)(2010-5#1)(2010-6#1)(2010-9#3)
pollution source##2##2##(2004-4#1)(2008-10#1)
pollution sources##7##2##(2004-4#1)(2008-10#2)(2013-8#4)
pollution status##2##2##(2007-5#2)
pollution was##2##2##(2008-10#2)
pollution with##4##2##(1992-4#1)(2007-7#1)(2008-11#1)(2011-2#1)
pollution##260##1##(1990-4#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-3#2)(1991-4#2)(1992-3#1)(1992-4#9)(1992-5#1)(1992-6#2)(1992-9#8)(1993-3#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-3#3)(1994-6#1)(1994-9#4)(1995-6#1)(1996-7#1)(1997-1#4)(1997-4#1)(1997-5#1)(1997-6#1)(2004-4#11)(2005-10#2)(2006-10#1)(2006-12#2)(2006-3#2)(2007-10#13)(2007-4#4)(2007-5#11)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#6)(2008-10#32)(2008-11#22)(2008-12#3)(2008-2#4)(2008-3#4)(2008-5#3)(2008-6#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-6#4)(2009-8#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-5#6)(2010-6#1)(2010-7#1)(2010-9#16)(2011-1#5)(2011-12#2)(2011-2#10)(2012-12#5)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#11)
polonica in##2##2##(2008-10#2)
polonica##5##1##(2008-10#5)
polonium-210##2##1##(2008-7#2)
poloxamer 188##2##2##(1994-5#1)(2005-9#1)
poloxamer##9##1##(1994-5#2)(2005-10#1)(2005-11#2)(2005-9#2)(2010-1#2)
poloxamine##2##1##(2010-1#2)
poly (A) sites##2##3##(1992-1#1)(2010-4#1)
poly (A)##5##2##(1992-1#1)(2008-11#1)(2010-4#3)
poly (A)(+) RNA##2##3##(2008-8#1)(2008-9#1)
poly (A)+##2##2##(1992-6#1)(1992-8#1)
poly (POSS-MA)##2##2##(2013-8#2)
poly (lactic-co-glycolic acid) (PLGA)##2##4##(2009-11#1)(2009-7#1)
poly (lactic-co-glycolic acid)##3##3##(2009-11#2)(2009-7#1)
poly (vinyl chloride) (PVC)##3##4##(2008-10#3)
poly (vinyl chloride) carboxylate##2##4##(2008-10#2)
poly (vinyl chloride)##8##3##(1992-6#1)(2008-10#7)
poly (vinyl##11##2##(1992-6#1)(2008-10#10)
poly A tail##2##3##(1992-9#1)(1994-11#1)
poly A##4##2##(1990-12#1)(1992-9#1)(1994-11#1)(1997-2#1)
poly A+##2##2##(1990-12#1)(1994-11#1)
poly I##6##2##(2007-11#6)
poly L-lactic acid##2##3##(2005-11#2)
poly chain reaction##2##3##(2007-7#2)
poly vinyl##2##2##(2008-10#2)
poly##87##1##(1990-10#1)(1990-12#2)(1990-8#2)(1991-10#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-6#2)(1992-8#1)(1992-9#1)(1994-11#4)(1994-6#2)(1994-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(2004-1#1)(2005-11#2)(2007-11#6)(2007-12#1)(2007-7#2)(2008-10#26)(2008-11#3)(2008-12#2)(2008-5#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#3)(2009-7#2)(2010-3#1)(2010-4#3)(2011-2#1)(2012-2#1)(2013-8#3)
poly(-caprolactone)##2##1##(2010-4#2)
poly(1##6##1##(2008-10#5)(2008-3#1)
poly(2-acrylamido-2-methylpropane sulfonate)##3##2##(2008-10#3)
poly(2-hydroxyethyl methacrylate)##4##2##(2004-9#1)(2008-10#2)(2010-4#1)
poly(3##5##1##(2008-10#3)(2009-11#1)(2010-4#1)
poly(3-hydroxyalkanoic##2##1##(2008-6#2)
poly(3-hydroxybutyrate) (PHB)##2##2##(2008-6#1)(2013-1#1)
poly(3-hydroxybutyrate)##3##1##(2008-6#1)(2013-1#2)
poly(3-methylthiophene)##5##1##(2008-10#5)
poly(4-BCMU)##2##1##(2007-12#2)
poly(4-vinylpyridine)##3##1##(2008-10#1)(2008-12#2)
poly(A##2##1##(1991-12#1)(1993-11#1)
poly(A(+))##2##1##(2008-4#2)
poly(A) addition##2##2##(1994-12#1)(1997-1#1)
poly(A) binding##2##2##(1997-5#2)
poly(A) polymerase##4##2##(1997-2#2)(2013-1#2)
poly(A) sites##2##2##(1991-7#1)(1995-5#1)
poly(A) tail of##2##3##(1991-2#1)(2008-4#1)
poly(A) tail##13##2##(1990-3#1)(1990-4#2)(1991-2#1)(1991-9#1)(1996-10#1)(1997-2#1)(1997-5#1)(2008-10#4)(2008-4#1)
poly(A) tail)##2##2##(1994-11#2)
poly(A) tails##3##2##(1997-2#1)(2006-12#1)(2011-1#1)
poly(A)##43##1##(1990-11#1)(1990-3#1)(1990-4#2)(1991-2#2)(1991-7#1)(1991-9#1)(1994-11#4)(1994-12#1)(1995-5#1)(1996-10#1)(1996-11#2)(1996-5#1)(1997-1#1)(1997-2#8)(1997-5#4)(2006-10#2)(2006-12#2)(2008-10#4)(2008-4#1)(2011-1#1)(2013-1#2)
poly(A)+ RNA from##3##3##(1993-4#1)(1994-8#1)(2008-2#1)
poly(A)+ RNA##18##2##(1991-7#1)(1992-5#1)(1992-6#2)(1992-7#3)(1993-4#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-3#4)(1997-1#1)(1997-2#1)(2008-2#1)
poly(A)+ RNAs from##2##3##(1994-9#1)(1995-6#1)
poly(A)+##21##1##(1991-7#1)(1992-5#1)(1992-6#2)(1992-7#3)(1992-8#1)(1993-4#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#4)(1995-6#1)(1997-1#1)(1997-2#1)(2008-2#1)
poly(A)+RNA##5##1##(1991-3#1)(1991-6#1)(1993-4#1)(1994-12#1)(1997-7#1)
poly(A)+mRNA##2##1##(1997-8#2)
poly(A)-binding protein##3##2##(1993-4#1)(1997-5#2)
poly(A)-dependent##2##1##(1996-5#2)
poly(A)-enriched RNA from##2##3##(1995-3#2)
poly(A+)RNA##3##1##(1990-7#1)(1990-8#1)(1993-6#1)
poly(ADP-ribose) polymerase activation##2##3##(1994-3#2)
poly(ADP-ribose) polymerase activity in##3##4##(1990-9#1)(1994-6#1)(1994-9#1)
poly(ADP-ribose) polymerase activity##10##3##(1990-9#5)(1991-10#1)(1994-6#1)(1994-9#3)
poly(ADP-ribose) polymerase##24##2##(1990-9#6)(1991-10#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-10#1)(1994-3#3)(1994-6#2)(1994-9#3)(2008-1#2)(2008-10#1)(2011-2#1)(2012-1#1)
poly(ADP-ribose) polymerase-1 (PARP-1)##2##3##(2006-12#1)(2008-1#1)
poly(ADP-ribose) polymerase-1##3##2##(2006-12#2)(2008-1#1)
poly(ADP-ribose) synthesis##2##2##(2008-1#2)
poly(ADP-ribose) synthetase##6##2##(1991-6#2)(1993-6#4)
poly(ADP-ribose)##39##1##(1990-9#6)(1991-10#1)(1991-6#2)(1992-3#1)(1992-6#1)(1993-12#2)(1993-6#4)(1994-10#1)(1994-3#3)(1994-6#2)(1994-9#3)(2006-12#2)(2008-1#8)(2008-10#1)(2011-2#1)(2012-1#1)
poly(ADP-ribosyl)ated##2##1##(1993-12#2)
poly(ADP-ribosyl)ation##3##1##(1990-7#2)(2006-12#1)
poly(ADP-ribosyl)transferase##2##1##(1993-12#2)
poly(D##3##1##(2004-9#1)(2008-5#1)(2012-2#1)
poly(DHPM-co-EDM) particles##2##2##(2007-8#2)
poly(DL-lactide)##2##1##(1996-6#2)
poly(DL-lactide-co-glycolide)##4##1##(1996-6#1)(2006-9#2)(2010-5#1)
poly(GMA-co-EDM) particles##2##2##(2007-8#2)
poly(HPMA)-DTPA-(99m)Tc##3##1##(2013-7#3)
poly(HPMA)-SPD-DTPA##2##1##(2013-7#2)
poly(HPMA)-SPD-DTPA-(99m)Tc##6##1##(2013-7#6)
poly(I##4##1##(2009-9#4)
poly(L-glutamic##2##1##(1997-8#2)
poly(L-lactide)##5##1##(1996-6#2)(2009-7#1)(2012-11#2)
poly(L-lysine) to##2##2##(1992-6#2)
poly(L-lysine)##9##1##(1991-4#1)(1991-5#1)(1992-6#5)(2008-10#1)(2010-4#1)
poly(N-isopropylacrylamide) (PNIPAAm)##2##2##(2008-10#1)(2008-11#1)
poly(N-isopropylacrylamide)##4##1##(2005-11#1)(2008-10#2)(2008-11#1)
poly(P)##4##1##(1996-7#4)
poly(POSS-MA) monolith##3##2##(2013-8#3)
poly(Pu/Py) sequences##2##2##(1997-4#2)
poly(Pu/Py)##3##1##(1997-4#3)
poly(SMA) hydrogel was##3##3##(2008-5#3)
poly(U)##6##1##(1990-2#1)(1991-4#1)(1997-2#1)(1997-5#1)(2006-10#2)
poly(acrylic acid) (PAA)##4##3##(2008-10#1)(2009-12#1)(2009-2#1)(2010-4#1)
poly(acrylic acid)##8##2##(2004-9#1)(2008-10#1)(2009-12#1)(2009-2#1)(2010-4#2)(2013-1#2)
poly(acrylic acids)##5##2##(2008-10#5)
poly(acrylic##13##1##(2004-9#1)(2008-10#6)(2009-12#1)(2009-2#1)(2010-4#2)(2013-1#2)
poly(alpha-hydroxyacid)s##3##1##(1996-6#3)
poly(amidoamine)##2##1##(2005-11#1)(2008-10#1)
poly(amphiphilic pyrrole)##2##2##(2008-10#2)
poly(beta-hydroxybutyrate)##5##1##(2008-7#5)
poly(butyl methacrylate-g-methoxypoly(ethylene glycol)) and poly(methyl methacrylate-g-methoxypoly(ethylene glycol)) graft copolymers##2##9##(2005-11#2)
poly(butyl##5##1##(2005-11#4)(2010-4#1)
poly(butylene terephthalate)##3##2##(2007-11#2)(2008-10#1)
poly(butylene##4##1##(2007-11#2)(2008-10#2)
poly(d##2##1##(2010-1#1)(2010-4#1)
poly(dA) and poly(dT)##2##3##(2006-10#2)
poly(dA) into##2##2##(2010-5#2)
poly(dA)##10##1##(1991-5#1)(1997-2#2)(2006-10#2)(2006-12#1)(2010-5#4)
poly(dA)poly(dT)##2##1##(2006-10#2)
poly(dA-dT)##7##1##(1992-5#3)(1995-2#2)(1997-7#1)(2008-3#1)
poly(dAdT)##3##1##(1995-2#3)
poly(dC)##2##1##(1992-3#1)(1992-6#1)
poly(dG)##3##1##(1992-3#1)(1992-6#1)(1997-2#1)
poly(dG-dC) and poly(dG-me5dC)##2##3##(2006-10#2)
poly(dG-dC)##11##1##(1995-11#4)(1995-2#2)(1997-7#1)(2006-10#4)
poly(dG-m5dC)##4##1##(1991-5#3)(1995-2#1)
poly(dG-me5dC)##4##1##(2006-10#4)
poly(dGdC)##2##1##(1997-2#2)
poly(dT)##8##1##(1991-2#2)(1995-5#1)(1996-7#1)(1997-2#2)(2006-10#2)
poly(dimethylsiloxane) (PDMS)##7##2##(2005-11#1)(2006-7#1)(2008-11#1)(2009-11#2)(2009-2#1)(2010-4#1)
poly(dimethylsiloxane)##14##1##(2005-11#1)(2006-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2009-11#2)(2009-2#1)(2010-4#3)
poly(epsilon-caprolactone)##2##1##(2005-7#1)(2010-1#1)
poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone)##2##2##(2010-12#2)
poly(ether ether ketone)##2##3##(2010-4#2)
poly(ethylene glycol) (PEG) chains##2##4##(2008-8#1)(2009-9#1)
poly(ethylene glycol) (PEG)##12##3##(1990-3#1)(1991-4#1)(2006-12#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-9#1)(2010-5#1)(2010-7#1)(2013-1#2)
poly(ethylene glycol) and##2##3##(2005-11#1)(2010-9#1)
poly(ethylene glycol) precipitation##2##3##(1991-2#1)(1993-6#1)
poly(ethylene glycol)##38##2##(1990-3#1)(1991-2#1)(1991-4#1)(1993-6#2)(1993-8#1)(1995-2#1)(1996-1#1)(2005-11#2)(2006-12#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#1)(2013-1#4)
poly(ethylene glycol)-based amphiphilic comb-like##2##4##(2005-11#2)
poly(ethylene glycol)-based##3##2##(2005-11#2)(2010-12#1)
poly(ethylene oxide) (PEO)##4##3##(2005-11#2)(2008-10#1)(2008-5#1)
poly(ethylene oxide)##14##2##(1997-1#1)(2005-11#5)(2008-10#4)(2008-5#2)(2010-7#2)
poly(ethylene terephthalate) (PET)##2##3##(2008-10#1)(2010-5#1)
poly(ethylene terephthalate) (PET)-toner##2##3##(2008-10#2)
poly(ethylene terephthalate)##9##2##(2007-11#1)(2007-12#1)(2008-10#5)(2010-5#1)(2010-8#1)
poly(ethylene##75##1##(1990-3#1)(1991-2#1)(1991-4#1)(1993-3#1)(1993-6#2)(1993-8#1)(1995-2#1)(1996-1#1)(1997-1#1)(2005-11#13)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#14)(2008-11#1)(2008-2#1)(2008-5#5)(2008-6#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-2#2)(2013-1#4)
poly(ethyleneglycol) precipitation##2##2##(1990-7#1)(1991-2#1)
poly(ethyleneglycol)##3##1##(1990-7#1)(1991-2#1)(2008-10#1)
poly(ethylenimine)##4##1##(2008-10#4)
poly(gamma-benzyl-L-glutamate) and##3##2##(2008-11#3)
poly(hydromethylsiloxane)##2##1##(2008-10#2)
poly(indenofluorene)##2##1##(2007-12#2)
poly(lactic acid) (PLA)##2##3##(2004-9#1)(2005-7#1)
poly(lactic acid)##4##2##(2004-9#3)(2005-7#1)
poly(lactic-co-glycolic acid) (PLGA)##3##3##(2008-5#1)(2009-11#1)(2009-7#1)
poly(lactic-co-glycolic acid)##5##2##(2008-5#1)(2009-11#1)(2009-7#2)(2010-9#1)
poly(lactide-co-glycolide)##2##1##(1996-6#1)(2010-9#1)
poly(lysine)##4##1##(1994-3#4)
poly(maleic##3##1##(2005-11#1)(2008-10#2)
poly(methyl acrylate)/poly(ethylene##2##2##(2010-4#2)
poly(methyl methacrylate) (PMMA) films##2##4##(2007-12#1)(2010-4#1)
poly(methyl methacrylate) (PMMA) particles##2##4##(2005-11#2)
poly(methyl methacrylate) (PMMA)##13##3##(2004-9#1)(2005-11#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2010-4#2)(2010-5#1)
poly(methyl methacrylate) are##2##3##(2007-12#2)
poly(methyl methacrylate) photopolymer##2##3##(2007-12#2)
poly(methyl methacrylate)##46##2##(2004-9#3)(2005-11#2)(2007-11#4)(2007-12#11)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#10)(2008-3#10)(2010-4#2)(2010-5#1)
poly(methyl##53##1##(2004-9#3)(2005-11#5)(2007-11#4)(2007-12#12)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#10)(2008-3#10)(2008-5#1)(2010-4#4)(2010-5#1)
poly(methylmethacrylate)##2##1##(2005-11#1)(2006-5#1)
poly(oxyethylene) cholesterol ether surfactants##2##4##(2005-11#2)
poly(oxyethylene) cholesterol##3##2##(2005-11#3)
poly(oxyethylene)##4##1##(2005-11#3)(2005-9#1)
poly(p-phenylene##2##1##(2005-11#1)(2008-10#1)
poly(p-phenylenevinylene)##2##1##(1995-3#1)(2007-11#1)
poly(phenolic)sulfonates##2##1##(2008-5#2)
poly(propylene oxide)##2##2##(2005-11#1)(2008-10#1)
poly(propylene##4##1##(2005-11#1)(2006-12#1)(2008-10#2)
poly(pyrrolylalkylammonium) films containing an enzyme##2##5##(2008-10#2)
poly(rA)##3##1##(1990-7#3)
poly(rC) to form a triple helix##2##6##(1992-2#2)
poly(rC)##3##1##(1992-2#3)
poly(sodium 4-styrenesulfonate) (PSS)##2##3##(2008-10#1)(2009-11#1)
poly(sodium 4-styrenesulfonate) coatings##3##3##(2008-10#3)
poly(sodium 4-styrenesulfonate)##6##2##(2005-11#1)(2008-10#4)(2009-11#1)
poly(sodium 4-styrenesulfonate)-coated thin mercury film electrodes##2##6##(2008-10#2)
poly(sodium##8##1##(2005-11#1)(2008-10#6)(2009-11#1)
poly(styrene)-poly(ethylene oxide)##2##2##(2005-11#2)
poly(sulfonylpiperidinylmethylene hydroxide)##2##2##(2008-10#2)
poly(tert-butyl##3##1##(2008-12#1)(2008-5#2)
poly(tetrafluoroethylene) (PTFE)##4##2##(2005-11#1)(2007-11#1)(2008-10#1)(2008-3#1)
poly(tetrafluoroethylene)##5##1##(2005-11#1)(2007-11#2)(2008-10#1)(2008-3#1)
poly(vinyl acetate)##3##2##(2008-3#2)(2010-5#1)
poly(vinyl alcohol) (PVA) and##2##4##(1996-5#1)(2013-7#1)
poly(vinyl alcohol) (PVA)##7##3##(1996-5#1)(2008-10#2)(2008-5#1)(2009-10#1)(2009-12#1)(2013-7#1)
poly(vinyl alcohol)##14##2##(1990-8#1)(1996-5#1)(2007-12#2)(2008-10#4)(2008-3#2)(2008-5#1)(2009-10#1)(2009-12#1)(2013-7#1)
poly(vinyl alcohol)poly(acrylic acid)##2##3##(2005-10#2)
poly(vinyl chloride) (PVC) matrix##2##4##(2008-10#2)
poly(vinyl chloride) (PVC) membrane electrode##2##5##(2008-10#2)
poly(vinyl chloride) (PVC) membrane##5##4##(2008-10#5)
poly(vinyl chloride) (PVC) membranes##4##4##(2008-10#4)
poly(vinyl chloride) (PVC)##13##3##(2008-10#13)
poly(vinyl chloride) (PVC)-based##2##3##(2008-10#2)
poly(vinyl chloride) matrix membrane##2##4##(2008-10#2)
poly(vinyl chloride) membrane electrode##2##4##(2008-10#2)
poly(vinyl chloride) membrane electrodes##3##4##(2008-10#3)
poly(vinyl chloride) membrane##11##3##(2008-10#11)
poly(vinyl chloride)##33##2##(2007-8#1)(2008-10#32)
poly(vinyl##55##1##(1990-8#1)(1996-5#1)(2005-10#2)(2007-12#2)(2007-8#1)(2008-10#38)(2008-3#4)(2008-5#1)(2009-10#1)(2009-12#1)(2010-5#2)(2013-7#1)
poly(vinylchloride)##2##1##(2008-10#2)
poly(vinylidene##2##1##(1992-3#1)(2010-4#1)
poly(vinylpyridine) (PVP)##2##2##(2008-10#1)(2010-4#1)
poly(vinylpyrrolidone)##3##1##(2008-10#1)(2008-5#1)(2010-4#1)
poly(ϵ-caprolactone)##4##1##(2012-11#4)
poly-##3##1##(1993-3#2)(2012-5#1)
poly-(2-thiouridylic acid)##2##2##(1990-2#2)
poly-1-naphthylamine##2##1##(2008-10#2)
poly-3##2##1##(2008-4#1)(2013-1#1)
poly-3-methylthiophene##2##1##(2008-10#2)
poly-A##2##1##(1995-10#1)(2013-8#1)
poly-L-glutamic acid and##2##3##(1993-8#2)
poly-L-lactic acid##3##2##(2008-6#3)
poly-L-lysine (PL)##2##2##(1990-8#1)(2008-8#1)
poly-L-lysine (PLL)##5##2##(1992-8#1)(2005-7#1)(2008-10#1)(2008-11#1)(2011-2#1)
poly-L-lysine and##2##2##(1992-8#1)(2012-12#1)
poly-L-lysine with##3##2##(1992-8#2)(2008-11#1)
poly-L-lysine##27##1##(1990-8#1)(1992-8#8)(1994-8#1)(1995-7#1)(1996-7#1)(2005-11#2)(2005-7#1)(2006-12#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-8#1)(2009-2#1)(2011-2#1)(2012-12#1)
poly-N-acetyllactosamine##3##1##(1990-12#2)(1994-6#1)
poly-alanine lengths##2##2##(2012-2#2)
poly-alanine repeat##2##2##(2012-2#2)
poly-alanine##6##1##(2012-2#6)
poly-alpha-2##2##1##(1990-4#2)
poly-beta-hydroxybutyric acid##2##2##(2008-7#2)
poly-drug users of##2##3##(2013-8#2)
poly-drug users who used##3##4##(2013-8#3)
poly-drug users##5##2##(2013-8#5)
poly-glutamic##2##1##(2008-11#2)
poly-l-aspartic acid##3##2##(2009-8#3)
poly-l-lysine (PLL) film##2##3##(2008-10#2)
poly-l-lysine (PLL)##3##2##(2008-10#3)
poly-l-lysine##5##1##(2008-10#3)(2013-7#2)
poly-lactic-co-glycolic acid##2##2##(2006-5#2)
poly-lysine(5)##2##1##(2008-10#2)
poly-m-aminophenol##2##1##(2008-10#2)
polyA##4##1##(1992-11#1)(1992-3#1)(1993-8#1)(1997-3#1)
polyI##3##1##(2013-1#3)
poly[9##3##1##(2010-4#3)
poly[A]##2##1##(2005-4#2)
polyacetylene##6##1##(1991-6#2)(2009-11#2)(2009-3#2)
polyacetylenes##2##1##(2007-1#1)(2009-3#1)
polyacrilamide##2##1##(2008-10#1)(2010-9#1)
polyacrylamide gel and##2##3##(1996-12#1)(2008-10#1)
polyacrylamide gel electrophoresis (PAGE)##6##4##(1990-11#1)(1995-10#1)(1995-12#1)(2008-4#1)(2009-4#1)(2010-3#1)
polyacrylamide gel electrophoresis (SDS-PAGE)##7##4##(1990-8#1)(1991-1#1)(1991-9#1)(1992-9#1)(2005-8#1)(2009-4#1)(2012-2#1)
polyacrylamide gel electrophoresis and##9##4##(1990-5#1)(1990-7#1)(1991-11#1)(1991-6#1)(1992-1#1)(1992-3#1)(1996-2#1)(2008-10#1)(2012-3#1)
polyacrylamide gel electrophoresis in sodium dodecyl sulfate##2##7##(1990-2#1)(1992-3#1)
polyacrylamide gel electrophoresis in the presence of##2##7##(1990-12#1)(1992-12#1)
polyacrylamide gel electrophoresis in##4##4##(1990-12#1)(1990-2#1)(1992-12#1)(1992-3#1)
polyacrylamide gel electrophoresis of##3##4##(1993-6#1)(1996-5#1)(2012-2#1)
polyacrylamide gel electrophoresis showed that##4##5##(1996-9#1)(1997-1#1)(2008-10#1)(2008-11#1)
polyacrylamide gel electrophoresis showed##5##4##(1996-9#1)(1997-1#1)(2007-6#1)(2008-10#1)(2008-11#1)
polyacrylamide gel electrophoresis was##3##4##(1991-12#1)(1992-2#1)(2008-8#1)
polyacrylamide gel electrophoresis##82##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-12#2)(1995-3#1)(1996-2#1)(1996-5#2)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-8#1)(2006-10#1)(2007-5#1)(2007-6#1)(2008-10#5)(2008-11#2)(2008-2#3)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#2)(2010-2#1)(2010-3#1)(2011-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
polyacrylamide gel electrophoretic##3##3##(1991-12#1)(1992-8#1)(1995-3#1)
polyacrylamide gel##103##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-12#2)(1995-3#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-8#1)(2006-10#1)(2007-5#1)(2007-6#1)(2008-10#6)(2008-11#2)(2008-2#4)(2008-3#1)(2008-4#7)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#2)(2010-2#1)(2010-3#1)(2011-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
polyacrylamide gels and##4##3##(1990-12#1)(1990-7#1)(1992-2#1)(2008-2#1)
polyacrylamide gels##25##2##(1990-10#2)(1990-12#2)(1990-7#1)(1992-2#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(2008-10#2)(2008-2#3)(2008-4#2)
polyacrylamide gradient gel and silver staining##3##6##(1991-10#3)
polyacrylamide gradient gel electrophoresis##2##4##(1991-12#1)(2008-3#1)
polyacrylamide gradient gel##5##3##(1991-10#3)(1991-12#1)(2008-3#1)
polyacrylamide gradient##7##2##(1991-10#3)(1991-12#1)(2008-10#2)(2008-3#1)
polyacrylamide hydrogel##3##2##(2008-10#1)(2010-9#2)
polyacrylamide##160##1##(1990-10#3)(1990-11#3)(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#4)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#4)(1991-4#1)(1991-6#1)(1991-8#3)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#6)(1992-3#3)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#2)(1995-3#2)(1995-6#2)(1995-8#1)(1996-12#2)(1996-2#1)(1996-5#3)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-5#1)(2007-6#1)(2008-10#19)(2008-11#3)(2008-2#7)(2008-3#2)(2008-4#11)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#2)(2009-6#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-9#2)(2011-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
polyacrylamide-gel electrophoresis##4##2##(1993-11#1)(1994-12#1)(1996-8#2)
polyacrylaminoimidazole chelating fiber##2##3##(2008-10#2)
polyacrylate (PA)##2##2##(2007-8#1)(2008-10#1)
polyacrylate hydrogel##2##2##(2007-8#1)(2008-5#1)
polyacrylate nanoparticles##2##2##(2008-8#2)
polyacrylate##16##1##(1996-8#1)(2005-11#3)(2007-8#2)(2008-10#3)(2008-11#2)(2008-5#2)(2008-8#2)(2009-3#1)
polyacrylates##2##1##(2008-10#2)
polyacrylic acid (PAA)##3##3##(2005-11#1)(2008-10#1)(2010-1#1)
polyacrylic acid##15##2##(1996-11#1)(2005-11#4)(2008-10#4)(2008-5#5)(2010-1#1)
polyacrylic##17##1##(1996-11#1)(2005-11#4)(2008-10#6)(2008-5#5)(2010-1#1)
polyacrylonitrile fiber##2##2##(2008-10#2)
polyacrylonitrile##6##1##(2008-10#5)(2010-1#1)
polyactis##4##1##(2011-12#4)
polyadenylate##3##1##(1994-8#1)(1996-11#1)(2008-10#1)
polyadenylated RNA##3##2##(1994-10#1)(2006-12#1)(2008-2#1)
polyadenylated mRNA##2##2##(1993-5#1)(1997-8#1)
polyadenylated##23##1##(1991-10#1)(1991-12#1)(1993-5#1)(1994-10#1)(1994-5#1)(1996-11#2)(1997-2#2)(1997-8#2)(2006-10#1)(2006-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-8#2)(2008-9#1)(2010-4#3)
polyadenylation and##3##2##(1994-9#1)(1997-2#1)(2010-11#1)
polyadenylation at the##2##3##(1997-7#1)(2007-12#1)
polyadenylation at##4##2##(1991-12#1)(1997-4#1)(1997-7#1)(2007-12#1)
polyadenylation factor##2##2##(1996-11#2)
polyadenylation of##5##2##(1995-6#1)(1997-2#1)(1997-7#1)(2010-4#2)
polyadenylation signal was found in the##2##6##(1993-12#1)(1997-2#1)
polyadenylation signal##11##2##(1991-12#1)(1991-2#1)(1992-12#2)(1992-2#1)(1993-12#2)(1994-3#1)(1997-2#2)(2008-8#1)
polyadenylation signals (AATAAA)##2##3##(1994-11#1)(1997-2#1)
polyadenylation signals and##3##3##(1992-11#1)(1997-5#1)(2008-7#1)
polyadenylation signals##8##2##(1992-11#1)(1993-3#1)(1994-11#1)(1995-3#2)(1997-2#1)(1997-5#1)(2008-7#1)
polyadenylation site##8##2##(1990-2#2)(1991-12#1)(1991-9#1)(1992-12#2)(1994-11#1)(1997-2#1)
polyadenylation sites##6##2##(1991-12#1)(1993-2#1)(1997-4#1)(2008-8#1)(2010-4#2)
polyadenylation##62##1##(1990-2#2)(1990-8#1)(1990-9#1)(1991-12#5)(1991-2#1)(1991-9#1)(1992-11#1)(1992-12#4)(1992-2#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#5)(1994-3#1)(1994-9#1)(1995-3#3)(1995-6#1)(1996-11#3)(1997-2#8)(1997-4#3)(1997-5#2)(1997-7#2)(2007-12#1)(2008-7#1)(2008-8#2)(2010-11#1)(2010-4#6)
polyalcohol was##4##2##(1991-12#3)(2006-12#1)
polyalcohol##7##1##(1991-12#6)(2006-12#1)
polyamide membranes##2##2##(2005-11#2)
polyamide##11##1##(2005-11#3)(2006-12#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-1#3)
polyamides are##2##2##(2006-12#1)(2008-7#1)
polyamides##4##1##(2006-12#2)(2008-7#2)
polyamidoamine##3##1##(2008-10#2)(2008-12#1)
polyamine Metalfix-Chelamine resin##2##3##(2008-10#2)
polyamine binding##2##2##(1990-7#1)(2008-8#1)
polyamine biosynthesis##6##2##(1991-10#1)(1991-11#1)(1992-1#1)(1992-9#1)(2008-10#2)
polyamine composition##2##2##(1996-7#2)
polyamine concentrations##4##2##(1994-11#1)(2008-8#1)(2010-4#2)
polyamine conjugates##2##2##(1997-3#2)
polyamine depletion sensitizes cells##2##4##(1994-5#2)
polyamine depletion##7##2##(1991-10#1)(1992-8#2)(1994-5#4)
polyamine inhibition at high concentrations##2##5##(1993-4#2)
polyamine levels##2##2##(1991-7#1)(1996-10#1)
polyamine linkers##2##2##(1997-3#2)
polyamine metabolism and phosphatidylinositol turnover##3##5##(1994-12#3)
polyamine metabolism##6##2##(1991-9#1)(1994-12#3)(2009-8#1)(2013-8#1)
polyamine site on##2##3##(1990-2#1)(1997-3#1)
polyamine site##7##2##(1990-2#1)(1992-3#1)(1996-2#3)(1997-3#1)(2007-9#1)
polyamine stimulation##3##2##(1993-4#2)(1997-3#1)
polyamine synthesis##3##2##(1990-2#1)(1991-10#1)(1993-9#1)
polyamine transport##3##2##(1994-8#3)
polyamine##85##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#3)(1990-7#2)(1991-10#6)(1991-11#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#2)(1992-8#2)(1992-9#1)(1993-4#4)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#4)(1994-5#5)(1994-6#1)(1994-8#4)(1996-10#1)(1996-2#3)(1996-7#2)(1997-3#7)(1997-7#2)(1997-8#2)(2007-9#1)(2008-10#7)(2008-12#2)(2008-8#3)(2009-8#1)(2010-4#3)(2013-8#1)
polyamine-deficient##6##1##(1990-10#1)(1994-8#2)(2009-6#3)
polyamines (putrescine##3##2##(1991-5#1)(1994-9#1)(2009-8#1)
polyamines and methonium ions##2##4##(1991-8#2)
polyamines and##15##2##(1991-10#1)(1991-8#3)(1996-12#1)(2007-8#1)(2008-10#3)(2008-7#1)(2008-8#3)(2010-11#1)(2010-12#1)
polyamines are##7##2##(1997-3#1)(2007-9#1)(2009-10#4)(2009-6#1)
polyamines as##2##2##(1990-9#1)(2008-10#1)
polyamines at##3##2##(1991-7#1)(1993-12#1)(1996-12#1)
polyamines in##7##2##(1994-11#1)(1995-2#1)(1996-12#2)(2007-8#1)(2008-10#1)(2010-4#1)
polyamines may##3##2##(1991-10#2)(2008-10#1)
polyamines on##3##2##(1991-4#1)(1993-4#1)(2008-11#1)
polyamines to##4##2##(1991-4#2)(1995-2#2)
polyamines were##5##2##(1993-3#1)(1994-11#1)(2008-10#3)
polyamines with##2##2##(1991-8#1)(2008-10#1)
polyamines##114##1##(1990-10#2)(1990-9#1)(1991-10#9)(1991-4#5)(1991-5#1)(1991-7#2)(1991-8#6)(1991-9#1)(1992-11#2)(1992-8#1)(1993-12#6)(1993-3#1)(1993-4#1)(1993-8#2)(1994-11#2)(1994-5#1)(1994-9#2)(1995-2#3)(1996-10#1)(1996-12#9)(1996-7#1)(1997-3#3)(2007-8#3)(2007-9#1)(2008-10#14)(2008-11#2)(2008-12#5)(2008-7#2)(2008-8#6)(2009-10#9)(2009-6#2)(2009-8#2)(2010-11#1)(2010-12#2)(2010-4#2)(2011-2#1)
polyamino##2##1##(2008-3#1)(2011-2#1)
polyammonium cation##2##2##(2008-10#2)
polyammonium cations##5##2##(2008-10#5)
polyammonium##8##1##(2008-10#8)
polyamorphic##2##1##(1995-3#2)
polyampholyte##2##1##(2013-7#2)
polyandrous mating##2##2##(2008-8#2)
polyandrous##3##1##(2008-8#3)
polyandry##4##1##(2008-8#1)(2008-9#3)
polyangiitis##9##1##(2006-10#2)(2007-8#2)(2008-4#1)(2012-12#3)(2013-8#1)
polyanhydrides##3##1##(2012-11#2)(2012-2#1)
polyaniline (PANI) films##2##3##(2005-11#1)(2007-9#1)
polyaniline (PANI)##5##2##(2005-11#2)(2007-8#1)(2007-9#1)(2008-10#1)
polyaniline and##5##2##(1991-6#1)(2005-11#1)(2008-10#3)
polyaniline based##2##2##(2007-9#1)(2008-10#1)
polyaniline film##2##2##(2005-11#1)(2008-10#1)
polyaniline films##6##2##(2005-11#3)(2007-8#1)(2007-9#1)(2008-10#1)
polyaniline##44##1##(1990-7#1)(1991-6#3)(2005-11#8)(2007-8#2)(2007-9#3)(2008-10#20)(2008-7#2)(2010-4#1)(2011-2#4)
polyanion complexes##2##2##(2008-10#2)
polyanion##9##1##(1993-6#1)(1996-4#1)(1997-1#1)(2006-10#1)(2008-10#5)
polyanionic compounds##3##2##(1997-1#2)(2005-7#1)
polyanionic##6##1##(1995-1#2)(1997-1#2)(1997-8#1)(2005-7#1)
polyanions and##2##2##(2006-10#1)(2008-10#1)
polyanions by##4##2##(2008-10#4)
polyanions such as sulfated##2##4##(1993-6#2)
polyanions were##2##2##(1997-1#1)(2008-10#1)
polyanions##26##1##(1991-11#2)(1993-6#4)(1997-1#7)(2006-10#2)(2008-10#9)(2010-5#2)
polyaromatic hydrocarbons (PAHs)##5##3##(2008-10#5)
polyaromatic hydrocarbons##10##2##(1991-3#1)(1993-8#1)(2008-10#8)
polyaromatic##14##1##(1991-3#2)(1993-8#1)(1995-1#1)(1995-3#1)(2008-10#9)
polyarteritis nodosa in##2##3##(1990-6#1)(2006-10#1)
polyarteritis nodosa##5##2##(1990-6#1)(1997-8#1)(2006-10#2)(2007-8#1)
polyarteritis##8##1##(1990-6#1)(1990-8#1)(1990-9#1)(1997-8#1)(2006-10#2)(2007-8#1)(2008-11#1)
polyarthritis and##3##2##(2006-10#1)(2007-11#1)(2010-4#1)
polyarthritis##32##1##(1990-6#1)(1991-7#1)(1993-11#6)(1993-6#1)(1996-1#1)(2005-7#4)(2006-10#8)(2007-11#2)(2008-1#1)(2008-7#1)(2010-4#2)(2011-2#1)(2012-2#1)(2012-3#2)
polyarticular##3##1##(2006-10#2)(2013-1#1)
polyatomic interferences##2##2##(2008-10#2)
polyatomic ions##2##2##(2008-10#2)
polyatomic##7##1##(1990-3#1)(2008-1#1)(2008-10#5)
polybrominated diphenyl ethers (PBDEs) in##2##5##(2008-10#2)
polybrominated diphenyl ethers (PBDEs)##4##4##(2008-10#3)(2008-7#1)
polybrominated diphenyl ethers##7##3##(2008-10#6)(2008-7#1)
polybrominated##9##1##(2008-10#8)(2008-7#1)
polybutadiene##4##1##(2008-10#2)(2010-8#2)
polycaprolactone (PCL)##2##2##(2008-5#1)(2010-4#1)
polycaprolactone##4##1##(2006-5#1)(2008-5#1)(2010-4#2)
polycarbonate and##5##2##(2005-11#1)(2006-2#1)(2008-10#1)(2008-3#1)(2008-4#1)
polycarbonate at##2##2##(2008-10#1)(2009-11#1)
polycarbonate filters##2##2##(1990-12#1)(1990-5#1)
polycarbonate surface##3##2##(2008-10#3)
polycarbonate##34##1##(1990-12#1)(1990-5#1)(2004-9#1)(2005-11#4)(2006-2#3)(2008-10#12)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2009-11#2)
polycarboxylate##3##1##(2004-9#3)
polycation and##2##2##(2005-11#1)(2008-10#1)
polycation is##2##2##(2005-11#2)
polycation##15##1##(1994-2#5)(1996-4#1)(2005-11#4)(2006-10#1)(2008-10#1)(2010-2#2)(2010-4#1)
polycationic proteins##3##2##(1994-9#3)
polycationic##12##1##(1993-11#1)(1994-9#6)(1995-11#1)(1996-4#1)(2008-11#1)(2008-8#1)(2009-10#1)
polycations##7##1##(1991-4#2)(2006-10#2)(2008-11#1)(2010-4#2)
polycellular forms##2##2##(2012-1#2)
polycentric evaluation of##2##3##(2007-7#2)
polycentric##4##1##(1990-3#2)(2007-7#2)
polycephalum##8##1##(1991-4#2)(1991-9#3)(1992-12#2)(1997-2#1)
polychaete abundance and species##2##4##(2008-5#2)
polychaete##9##1##(1990-5#1)(1992-6#1)(1994-10#2)(2007-5#1)(2008-5#3)(2010-2#1)
polychaetes##9##1##(2007-5#2)(2008-5#6)(2008-7#1)
polychemotherapy for##2##2##(1990-6#1)(2008-1#1)
polychemotherapy##6##1##(1990-6#1)(1991-3#1)(2007-11#2)(2008-1#1)(2012-12#1)
polychlorinated biphenyl (PCB) congeners##2##4##(1994-10#1)(2008-10#1)
polychlorinated biphenyl (PCB)##3##3##(1994-10#1)(2008-10#1)(2012-1#1)
polychlorinated biphenyl congeners were##2##4##(2004-4#1)(2008-10#1)
polychlorinated biphenyl congeners##4##3##(1994-10#1)(2004-4#2)(2008-10#1)
polychlorinated biphenyl##12##2##(1991-8#1)(1992-12#1)(1994-10#2)(1994-9#1)(1997-5#1)(2004-4#2)(2008-10#3)(2012-1#1)
polychlorinated biphenyls (PCBs) and polychlorinated##4##5##(1997-5#1)(2007-10#1)(2008-10#2)
polychlorinated biphenyls (PCBs) and##5##4##(1994-3#1)(1997-5#1)(2007-10#1)(2008-10#2)
polychlorinated biphenyls (PCBs) from##2##4##(2008-10#2)
polychlorinated biphenyls (PCBs) have##2##4##(1995-3#1)(2008-7#1)
polychlorinated biphenyls (PCBs) in##3##4##(2008-10#3)
polychlorinated biphenyls (PCBs)##14##3##(1993-12#1)(1994-3#1)(1995-3#1)(1997-5#1)(2007-10#1)(2008-10#8)(2008-7#1)
polychlorinated biphenyls in##3##3##(2008-10#3)
polychlorinated biphenyls##28##2##(1993-12#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-5#1)(2007-10#1)(2008-10#14)(2008-11#3)(2008-7#2)(2010-10#1)(2013-1#1)
polychlorinated dibenzo-p-dioxins and dibenzo-furans##2##4##(2008-10#2)
polychlorinated dibenzo-p-dioxins and dibenzofurans##2##4##(2008-10#1)(2008-11#1)
polychlorinated dibenzo-p-dioxins and##5##3##(2008-10#4)(2008-11#1)
polychlorinated dibenzo-p-dioxins##7##2##(2008-10#6)(2008-11#1)
polychlorinated dibenzofurans##5##2##(2008-10#3)(2008-7#1)(2008-8#1)
polychlorinated##60##1##(1990-1#1)(1991-8#1)(1992-12#1)(1993-12#1)(1994-10#2)(1994-3#2)(1994-9#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-5#4)(2004-4#2)(2007-10#2)(2008-10#28)(2008-11#4)(2008-3#1)(2008-7#3)(2008-8#1)(2010-10#1)(2012-1#1)(2013-1#1)
polychondritis with##3##2##(2006-10#3)
polychondritis##10##1##(2006-10#9)(2008-11#1)
polychromatic erythrocytes was##2##3##(2008-8#1)(2008-9#1)
polychromatic erythrocytes##5##2##(1993-8#1)(2008-8#1)(2008-9#2)(2011-2#1)
polychromatic flow cytometry##2##3##(2008-4#1)(2012-11#1)
polychromatic flow##3##2##(2008-4#1)(2008-9#1)(2012-11#1)
polychromatic illumination##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
polychromatic light##2##2##(2007-11#1)(2007-12#1)
polychromatic##23##1##(1993-8#1)(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#4)(2008-4#4)(2008-8#1)(2008-9#3)(2011-2#1)(2012-1#1)(2012-11#1)
polychromator design for##2##3##(2006-5#1)(2008-3#1)
polychromator for energy-dispersive XAFS##2##4##(2006-5#2)
polychromator for##3##2##(2006-5#3)
polychromator##7##1##(2006-5#4)(2008-3#3)
polycistronic##6##1##(1995-8#1)(2007-12#1)(2008-7#1)(2008-8#2)(2012-2#1)
polyclonal B cell##2##3##(1993-4#1)(1995-2#1)
polyclonal T cell##2##3##(1992-6#1)(2008-4#1)
polyclonal and monoclonal antibodies##4##4##(1990-3#1)(1990-5#1)(1993-9#1)(2009-11#1)
polyclonal and monoclonal##8##3##(1990-3#1)(1990-5#1)(1993-9#1)(1994-9#1)(2008-4#3)(2009-11#1)
polyclonal and two monoclonal antibodies##2##5##(1990-10#2)
polyclonal and##13##2##(1990-10#2)(1990-3#1)(1990-5#1)(1991-2#1)(1993-9#1)(1994-9#1)(2008-10#1)(2008-4#4)(2009-11#1)
polyclonal anti-C##2##2##(1994-3#2)
polyclonal anti-e reagents##2##3##(1994-3#2)
polyclonal anti-human##2##2##(1997-7#1)(2008-4#1)
polyclonal antibodies against the##2##4##(1990-5#1)(1991-9#1)
polyclonal antibodies against##12##3##(1990-12#1)(1990-5#2)(1991-9#1)(1992-8#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-8#1)(2008-10#2)(2008-5#1)
polyclonal antibodies and##5##3##(1990-12#1)(1992-6#1)(1995-12#1)(1997-6#1)(2008-4#1)
polyclonal antibodies are##2##3##(2008-10#1)(2008-4#1)
polyclonal antibodies as##2##3##(1995-8#1)(2008-5#1)
polyclonal antibodies directed##2##3##(1996-5#1)(2008-9#1)
polyclonal antibodies for##5##3##(1992-8#1)(1993-2#1)(1995-12#1)(1996-6#1)(2008-1#1)
polyclonal antibodies in##3##3##(1994-3#1)(1996-8#1)(2008-4#1)
polyclonal antibodies raised against human##2##5##(1991-5#1)(1993-12#1)
polyclonal antibodies raised against the##4##5##(1990-3#1)(1992-8#1)(1996-12#1)(1997-3#1)
polyclonal antibodies raised against##14##4##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-5#1)(1992-8#2)(1993-12#1)(1995-5#1)(1996-12#1)(1997-3#1)(2006-8#1)
polyclonal antibodies specific to##2##4##(1992-8#1)(1996-7#1)
polyclonal antibodies to##6##3##(1990-5#1)(1991-8#1)(1992-6#1)(1995-6#1)(1995-8#1)(1997-5#1)
polyclonal antibodies were##3##3##(1995-12#1)(2007-6#1)(2008-10#1)
polyclonal antibodies##86##2##(1990-11#1)(1990-12#3)(1990-3#1)(1990-5#5)(1990-6#1)(1990-7#2)(1990-8#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-4#1)(1992-6#3)(1992-8#5)(1993-12#1)(1993-2#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-3#4)(1994-8#1)(1995-10#1)(1995-12#4)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#4)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#2)(2006-10#1)(2006-8#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-4#4)(2008-5#2)(2008-7#1)(2008-9#2)(2009-2#1)
polyclonal antibody against the##2##4##(1994-3#1)(1996-9#1)
polyclonal antibody against##9##3##(1994-3#1)(1994-6#1)(1994-9#1)(1995-3#1)(1996-2#1)(1996-9#1)(1997-4#1)(2008-10#1)(2010-12#1)
polyclonal antibody directed##2##3##(1995-8#1)(2013-8#1)
polyclonal antibody preparation##2##3##(2008-10#2)
polyclonal antibody raised against a##3##5##(1991-5#1)(1997-5#1)(1997-6#1)
polyclonal antibody raised against the##3##5##(1992-3#1)(2007-12#2)
polyclonal antibody raised against##11##4##(1990-3#1)(1990-4#1)(1991-5#1)(1992-11#1)(1992-3#1)(1994-2#1)(1995-2#1)(1997-5#1)(1997-6#1)(2007-12#2)
polyclonal antibody raised##12##3##(1990-3#1)(1990-4#1)(1990-7#1)(1991-5#1)(1992-11#1)(1992-3#1)(1994-2#1)(1995-2#1)(1997-5#1)(1997-6#1)(2007-12#2)
polyclonal antibody to##8##3##(1990-7#1)(1993-6#1)(1994-9#1)(1995-8#1)(1997-7#1)(2005-12#1)(2008-10#1)(2008-6#1)
polyclonal antibody was produced against##2##5##(2008-10#2)
polyclonal antibody was raised##2##4##(1990-6#1)(1992-9#1)
polyclonal antibody was##11##3##(1990-6#1)(1992-9#1)(1993-12#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-11#1)(2008-10#4)
polyclonal antibody##75##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#3)(1990-8#1)(1991-11#1)(1991-2#1)(1991-5#2)(1991-9#2)(1992-11#2)(1992-3#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-9#2)(1994-2#2)(1994-3#3)(1994-6#1)(1994-9#2)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#3)(1996-1#1)(1996-11#2)(1996-2#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-12#1)(2007-12#2)(2007-8#1)(2008-10#14)(2008-6#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-8#1)
polyclonal antisera against##3##3##(1990-8#1)(1991-2#1)(2008-10#1)
polyclonal antisera in##2##3##(2008-10#2)
polyclonal antisera##20##2##(1990-8#2)(1991-10#1)(1991-2#2)(1992-12#1)(1996-5#1)(1997-4#1)(1997-6#2)(2008-10#7)(2008-4#3)
polyclonal antiserum against##5##3##(1990-3#1)(1993-12#1)(1997-1#1)(2008-10#2)
polyclonal antiserum to the##2##4##(1992-5#1)(1993-9#1)
polyclonal antiserum to##5##3##(1992-5#1)(1993-9#2)(1996-3#1)(2008-10#1)
polyclonal antiserum was raised against the##2##6##(1990-8#1)(1994-8#1)
polyclonal antiserum was##3##3##(1990-8#1)(1994-6#1)(1994-8#1)
polyclonal antiserum##22##2##(1990-3#1)(1990-8#1)(1992-5#1)(1993-12#1)(1993-9#2)(1994-6#1)(1994-8#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-8#2)(2006-8#1)(2008-10#7)
polyclonal antithymoglobulins##3##2##(2007-8#3)
polyclonal human##2##2##(1992-12#1)(2008-11#1)
polyclonal immunoglobulin##5##2##(1990-6#1)(2007-11#1)(2008-4#3)
polyclonal in##2##2##(1994-7#1)(2007-11#1)
polyclonal or monoclonal##5##3##(1991-6#1)(1996-6#1)(2008-2#1)(2008-4#2)
polyclonal rabbit antiserum##2##3##(1990-12#1)(2008-10#1)
polyclonal rabbit##6##2##(1990-12#1)(1992-9#1)(1996-12#1)(2007-5#1)(2008-10#2)
polyclonal sera##3##2##(1990-2#1)(1990-6#1)(1991-7#1)
polyclonal serum##2##2##(2008-4#1)(2008-8#1)
polyclonal##313##1##(1990-10#2)(1990-11#3)(1990-12#5)(1990-2#1)(1990-3#4)(1990-4#1)(1990-5#6)(1990-6#4)(1990-7#5)(1990-8#5)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#4)(1991-5#4)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#3)(1992-11#2)(1992-12#4)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#4)(1992-8#6)(1992-9#3)(1993-12#5)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#3)(1993-9#5)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#14)(1994-6#2)(1994-7#2)(1994-8#2)(1994-9#3)(1995-10#1)(1995-12#5)(1995-2#6)(1995-3#2)(1995-5#2)(1995-6#3)(1995-8#9)(1996-1#1)(1996-11#3)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#5)(1997-7#3)(1997-8#2)(2005-12#1)(2006-10#2)(2006-4#1)(2006-8#2)(2007-11#5)(2007-12#2)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#7)(2008-1#2)(2008-10#41)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#26)(2008-5#9)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2010-12#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
polyclonally##2##1##(1991-9#1)(2006-10#1)
polycomb##2##1##(2008-7#2)
polycondensation##3##1##(1992-12#2)(2007-11#1)
polycrystalline counterpart##2##2##(2007-9#2)
polycrystalline fibers##2##2##(1991-1#1)(2007-12#1)
polycrystalline gold##2##2##(2008-10#1)(2010-4#1)
polycrystalline samples##2##2##(1996-2#1)(2007-12#1)
polycrystalline structure##3##2##(2007-11#1)(2007-12#2)
polycrystalline##30##1##(1991-1#1)(1996-2#2)(1997-4#1)(2004-9#1)(2005-11#1)(2006-4#1)(2007-11#2)(2007-12#8)(2007-9#2)(2008-10#4)(2008-2#2)(2008-3#1)(2008-7#1)(2010-4#1)(2010-7#2)
polycyclic aromatic compounds (PACs) in##2##5##(2008-10#2)
polycyclic aromatic compounds##7##3##(2008-10#6)(2012-2#1)
polycyclic aromatic hydrocarbon (PAH)##4##4##(2004-4#1)(2008-10#1)(2008-2#1)(2011-1#1)
polycyclic aromatic hydrocarbon##13##3##(1991-8#2)(1994-6#1)(1996-3#1)(1997-5#1)(2004-4#1)(2005-11#1)(2008-10#3)(2008-2#1)(2011-1#2)
polycyclic aromatic hydrocarbons (PAH)##2##4##(1995-11#1)(2008-10#1)
polycyclic aromatic hydrocarbons (PAHs) and##2##5##(2004-4#1)(2008-10#1)
polycyclic aromatic hydrocarbons (PAHs) dissolved in aqueous micellar cetyltrimethylammonium chloride##2##10##(2008-10#2)
polycyclic aromatic hydrocarbons (PAHs) in a##2##6##(2008-10#2)
polycyclic aromatic hydrocarbons (PAHs) in##10##5##(2008-10#9)(2010-5#1)
polycyclic aromatic hydrocarbons (PAHs) is##2##5##(2008-10#2)
polycyclic aromatic hydrocarbons (PAHs)##30##4##(1990-7#1)(1992-3#1)(1997-5#1)(2004-4#1)(2008-10#23)(2010-5#3)
polycyclic aromatic hydrocarbons and##7##4##(1993-2#1)(1995-11#1)(2008-10#3)(2008-11#1)(2010-7#1)
polycyclic aromatic hydrocarbons from##3##4##(2008-10#3)
polycyclic aromatic hydrocarbons in olive oil##2##6##(1991-8#2)
polycyclic aromatic hydrocarbons in water samples##5##6##(2008-10#5)
polycyclic aromatic hydrocarbons in water##6##5##(2008-10#6)
polycyclic aromatic hydrocarbons in##14##4##(1991-8#2)(2008-10#11)(2008-2#1)
polycyclic aromatic hydrocarbons were##2##4##(2008-10#2)
polycyclic aromatic hydrocarbons##83##3##(1990-7#2)(1991-8#4)(1992-3#2)(1992-7#1)(1993-2#1)(1993-9#2)(1995-11#2)(1997-5#1)(2004-4#1)(2005-12#1)(2008-10#56)(2008-11#2)(2008-2#1)(2008-3#1)(2009-4#1)(2010-5#3)(2010-7#1)(2011-1#1)
polycyclic aromatic##104##2##(1990-7#2)(1991-8#6)(1992-3#2)(1992-7#1)(1993-2#1)(1993-9#2)(1994-3#1)(1994-6#1)(1995-11#2)(1996-3#1)(1997-5#2)(2004-4#2)(2005-11#1)(2005-12#1)(2008-10#65)(2008-11#2)(2008-2#2)(2008-3#1)(2009-4#1)(2010-5#3)(2010-7#1)(2011-1#3)(2012-2#1)
polycyclic epidemics##2##2##(2008-10#2)
polycyclic systemic##2##2##(2006-10#2)
polycyclic##114##1##(1990-7#2)(1991-6#1)(1991-8#6)(1992-3#2)(1992-7#1)(1993-2#1)(1993-9#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#2)(1996-3#1)(1997-5#2)(2004-4#2)(2005-11#1)(2005-12#1)(2006-10#2)(2008-10#70)(2008-11#2)(2008-2#2)(2008-3#1)(2009-4#1)(2010-5#3)(2010-7#1)(2011-1#3)(2012-2#1)(2013-7#1)
polycylic aromatic hydrocarbons##3##3##(1996-3#1)(2008-10#2)
polycylic aromatic##4##2##(1996-3#1)(2008-10#3)
polycystic kidney disease (ADPKD)##8##4##(1993-12#1)(1997-1#2)(2007-8#2)(2013-1#3)
polycystic kidney disease##25##3##(1992-5#1)(1993-12#2)(1996-5#2)(1997-1#2)(2007-6#2)(2007-7#4)(2007-8#6)(2008-1#1)(2008-4#1)(2010-6#1)(2013-1#3)
polycystic kidney##27##2##(1992-5#1)(1993-12#2)(1996-5#2)(1997-1#2)(2007-6#2)(2007-7#4)(2007-8#6)(2008-1#1)(2008-4#1)(2010-6#1)(2011-1#1)(2013-1#4)
polycystic ovarian disease##2##3##(2007-2#1)(2010-8#1)
polycystic ovarian syndrome (PCOS)##3##4##(2008-3#1)(2013-8#2)
polycystic ovarian syndrome##10##3##(2007-7#1)(2008-1#2)(2008-3#2)(2010-11#1)(2011-1#1)(2012-2#1)(2013-8#2)
polycystic ovarian##14##2##(2007-2#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-3#2)(2010-11#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
polycystic ovary syndrome (PCOS) and##2##5##(2008-1#1)(2013-8#1)
polycystic ovary syndrome (PCOS) is##2##5##(2008-4#2)
polycystic ovary syndrome (PCOS)##16##4##(2006-2#1)(2008-1#1)(2008-3#3)(2008-4#7)(2010-10#1)(2010-12#1)(2011-1#1)(2013-8#1)
polycystic ovary syndrome##38##3##(1993-1#1)(2005-8#1)(2006-2#1)(2007-7#1)(2008-1#2)(2008-3#8)(2008-4#11)(2008-5#1)(2010-10#3)(2010-12#1)(2010-4#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
polycystic ovary syndrome]##2##3##(2005-8#1)(2011-2#1)
polycystic ovary##42##2##(1993-1#1)(2005-8#2)(2006-2#1)(2007-7#2)(2008-1#2)(2008-3#8)(2008-4#11)(2008-5#1)(2009-2#1)(2010-10#3)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
polycystic##90##1##(1992-5#1)(1993-1#1)(1993-12#2)(1995-2#1)(1996-5#2)(1997-1#3)(2005-8#2)(2006-2#1)(2007-2#1)(2007-6#2)(2007-7#7)(2007-8#6)(2008-1#5)(2008-11#1)(2008-3#11)(2008-4#12)(2008-5#2)(2008-7#1)(2009-2#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#4)
polycythemia vera##3##2##(1993-9#1)(2007-9#1)(2009-7#1)
polycythemia##11##1##(1990-12#1)(1993-9#1)(1994-6#1)(1995-6#1)(2007-9#1)(2008-1#1)(2008-10#2)(2009-4#1)(2009-7#1)(2012-2#1)
polycythemic##2##1##(1990-12#2)
polycytidylic##3##1##(2007-11#1)(2008-11#2)
polydactyly##13##1##(1996-3#2)(1996-5#1)(1997-3#1)(2006-11#3)(2006-4#1)(2008-7#1)(2010-4#3)(2013-8#1)
polydentate##2##1##(2005-11#1)(2007-11#1)
polydiacetylene##6##1##(2007-11#1)(2007-12#3)(2008-10#2)
polydimethyl siloxane (PDMS)##2##3##(2008-10#1)(2008-11#1)
polydimethyl siloxane##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#1)
polydimethylsiloxane (PDMS)##9##2##(2005-11#1)(2006-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2010-8#1)(2013-7#1)
polydimethylsiloxane##17##1##(1996-12#1)(1997-8#1)(2005-11#1)(2006-12#1)(2006-4#2)(2007-8#1)(2008-10#6)(2008-11#1)(2009-9#1)(2010-8#1)(2013-7#1)
polydimethylsiloxane/divinylbenzene##3##1##(2007-8#1)(2008-10#2)
polydimethysiloxane##2##1##(2010-9#2)
polydioxanone##3##1##(1992-1#1)(2007-8#1)(2008-5#1)
polydipsia##6##1##(1993-6#2)(1994-2#1)(1996-12#1)(1997-3#2)
polydipsia-hyponatremia##2##1##(1997-8#2)
polydipsic##2##1##(1993-6#1)(1996-7#1)
polydisperse C12E7##2##2##(2005-11#2)
polydisperse LDL##3##2##(1995-6#3)
polydisperse##17##1##(1993-8#1)(1994-9#1)(1995-2#1)(1995-6#4)(2005-11#2)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#2)
polydispersion##2##1##(1995-6#1)(2008-2#1)
polydispersities##2##1##(2009-10#1)(2010-12#1)
polydispersity and##5##2##(2005-11#4)(2008-5#1)
polydispersity of##5##2##(2005-11#1)(2007-12#2)(2013-8#2)
polydispersity##23##1##(1994-12#1)(1995-2#1)(2005-11#9)(2007-12#3)(2007-8#1)(2008-10#1)(2008-12#2)(2008-5#1)(2010-2#1)(2012-11#1)(2013-8#2)
polydithiocarbamate resin##2##2##(2008-10#2)
polydrug use##4##2##(1996-11#1)(2009-11#1)(2013-1#2)
polyelectrolyte adsorption##2##2##(2005-11#1)(2010-4#1)
polyelectrolyte coatings on##2##3##(2008-10#2)
polyelectrolyte coatings##4##2##(2008-10#4)
polyelectrolyte concentration##3##2##(2005-11#3)
polyelectrolyte layer##2##2##(2008-10#2)
polyelectrolyte layers##2##2##(2005-11#1)(2013-1#1)
polyelectrolyte multilayer films##3##3##(2008-10#1)(2008-5#2)
polyelectrolyte multilayer##4##2##(2008-10#2)(2008-5#2)
polyelectrolyte##50##1##(1991-11#1)(1996-4#2)(2005-11#9)(2006-2#1)(2006-5#1)(2008-10#16)(2008-12#1)(2008-5#2)(2008-7#5)(2009-12#2)(2010-4#4)(2010-9#4)(2013-1#2)
polyelectrolyte-ELISA##4##1##(2008-10#4)
polyelectrolytes and##6##2##(2005-11#3)(2006-12#1)(2008-10#1)(2009-11#1)
polyelectrolytes onto##2##2##(2005-11#1)(2009-11#1)
polyelectrolytes such as##3##3##(2008-10#3)
polyelectrolytes using##2##2##(2008-10#2)
polyelectrolytes##33##1##(1997-1#1)(1997-2#1)(2005-11#8)(2006-12#1)(2007-8#2)(2008-10#10)(2008-7#1)(2009-10#1)(2009-11#2)(2010-4#4)(2010-9#2)
polyene chain##2##2##(1995-10#1)(1995-11#1)
polyene##10##1##(1990-5#1)(1995-10#1)(1995-11#1)(1996-1#1)(2006-12#2)(2006-9#2)(2010-2#2)
polyenes##3##1##(2005-7#1)(2008-11#1)(2008-5#1)
polyenoic fatty##3##2##(1991-10#2)(2008-11#1)
polyenoic##4##1##(1991-10#2)(1991-7#1)(2008-11#1)
polyenthesitis##2##1##(1992-11#2)
polyenzyme formulation##2##2##(2008-8#2)
polyenzyme##3##1##(2008-8#3)
polyester and##2##2##(2008-3#1)(2008-9#1)
polyester biomaterials##2##2##(2010-8#2)
polyester patch##3##2##(2006-3#3)
polyester##38##1##(2004-4#2)(2005-11#6)(2005-12#1)(2006-3#3)(2007-12#2)(2008-10#4)(2008-11#3)(2008-3#3)(2008-5#3)(2008-9#1)(2010-4#2)(2010-5#2)(2010-8#6)
polyesters##3##1##(2010-4#1)(2012-11#2)
polyether##8##1##(2007-11#1)(2008-10#6)(2009-10#1)
polyethers##6##1##(2005-8#1)(2008-10#5)
polyethoxylate##2##1##(2008-10#2)
polyethoxylated##3##1##(2008-10#3)
polyethylene (HDPE)##3##2##(2008-3#1)(2009-3#1)(2009-7#1)
polyethylene and titanium##2##3##(2009-3#2)
polyethylene and##3##2##(2007-12#1)(2009-3#2)
polyethylene glycol (PEG##2##3##(1990-9#1)(2004-9#1)
polyethylene glycol (PEG) and##3##4##(1990-1#1)(1992-11#1)(2012-1#1)
polyethylene glycol (PEG)##13##3##(1990-1#1)(1990-12#1)(1992-11#1)(1997-6#1)(2005-11#1)(2008-10#3)(2008-7#2)(2012-1#1)(2012-3#1)(2013-1#1)
polyethylene glycol (PEG)-induced##2##3##(1997-4#1)(2008-5#1)
polyethylene glycol 400##4##3##(1991-12#1)(2005-11#1)(2010-12#1)(2012-12#1)
polyethylene glycol 4000##4##3##(1990-6#1)(1991-12#1)(1992-11#1)(1994-9#1)
polyethylene glycol additives##2##3##(1994-3#2)
polyethylene glycol and##2##3##(2004-9#1)(2011-2#1)
polyethylene glycol##60##2##(1990-1#1)(1990-12#2)(1990-6#2)(1990-9#1)(1991-12#2)(1991-5#2)(1991-9#1)(1992-11#2)(1993-11#2)(1994-3#3)(1994-9#3)(1995-4#1)(1997-4#1)(1997-6#1)(2004-9#2)(2005-11#3)(2005-12#1)(2006-3#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-3#1)(2010-12#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
polyethylene glycol-modified##2##2##(1994-2#1)(2009-10#1)
polyethylene glycols##3##2##(1997-6#1)(2004-12#1)(2008-4#1)
polyethylene liner##2##2##(2008-5#1)(2008-8#1)
polyethylene oxide##2##2##(2008-10#2)
polyethylene wear debris##2##3##(2004-9#1)(2008-8#1)
polyethylene wear##7##2##(2004-9#1)(2007-7#1)(2008-8#5)
polyethylene##135##1##(1990-1#1)(1990-12#2)(1990-4#1)(1990-6#2)(1990-9#1)(1991-12#2)(1991-5#2)(1991-8#3)(1991-9#1)(1992-11#2)(1993-11#2)(1994-2#1)(1994-3#3)(1994-9#3)(1995-4#1)(1996-11#1)(1997-3#2)(1997-4#1)(1997-6#2)(2004-12#1)(2004-9#9)(2005-11#3)(2005-12#2)(2006-3#2)(2006-7#2)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#14)(2008-11#3)(2008-12#3)(2008-3#5)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#9)(2008-9#3)(2009-10#2)(2009-3#9)(2009-4#1)(2009-5#2)(2009-7#1)(2010-12#2)(2010-2#1)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
polyethyleneglycol (PEG) 6000##2##3##(2008-12#2)
polyethyleneglycol (PEG)##3##2##(2008-10#1)(2008-12#2)
polyethyleneglycol##6##1##(1992-12#1)(1994-11#1)(1994-12#1)(2008-10#1)(2008-12#2)
polyethyleneimide and##2##2##(1990-11#2)
polyethyleneimine (PEI)##6##2##(1994-5#1)(1996-5#1)(1997-1#1)(2008-10#2)(2009-11#1)
polyethyleneimine precipitation##2##2##(1992-8#1)(1995-1#1)
polyethyleneimine##14##1##(1992-8#1)(1994-5#1)(1995-1#1)(1996-5#2)(1997-1#2)(1997-3#1)(2008-10#5)(2009-11#1)
polyethyleneimine-cellulose thin-layer chromatography##2##3##(1993-2#2)
polyethyleneimine-cellulose##3##1##(1993-2#2)(1995-7#1)
polyethyleneterephthalate##2##1##(2004-9#2)
polyethylenimine (PEI)##5##2##(2006-5#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-4#1)
polyethylenimine##11##1##(2006-5#2)(2007-12#1)(2008-10#4)(2008-11#2)(2009-10#1)(2010-4#1)
polyfluorene##2##1##(2009-2#2)
polyfluorooctanol as##2##2##(2007-11#2)
polyfunctional##3##1##(2005-11#1)(2008-4#1)(2010-5#1)
polygalacturonase activity##2##2##(2008-10#2)
polygalacturonase##6##1##(1997-2#2)(2008-10#4)
polygalacturonase-inhibiting protein##3##2##(2008-10#3)
polygalacturonase-inhibiting proteins##3##2##(2008-10#1)(2011-10#2)
polygalacturonase-inhibiting##6##1##(2008-10#4)(2011-10#2)
polygalacturonases (PGs)##2##2##(2008-10#1)(2011-10#1)
polygalacturonic##2##1##(2006-12#1)(2008-10#1)
polygamy##3##1##(2007-1#1)(2011-1#1)(2012-2#1)
polygenic and##2##2##(2008-2#1)(2009-12#1)
polygenic disease##4##2##(2006-10#1)(2008-1#1)(2012-12#1)(2013-7#1)
polygenic hypercholesterolemia##2##2##(1991-2#1)(1991-6#1)
polygenic hypercholesterolemic patients##2##3##(1991-2#2)
polygenic##35##1##(1991-2#3)(1991-6#1)(1993-9#1)(1994-9#1)(1995-8#1)(1996-5#2)(2006-10#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-5#2)(2008-7#2)(2009-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#4)(2013-1#1)(2013-7#1)
polyglandular syndrome type 2##2##4##(2006-6#2)
polyglandular syndrome type 3 with##4##5##(2013-1#4)
polyglandular syndrome type##8##3##(2006-6#2)(2009-5#1)(2012-3#1)(2013-1#4)
polyglandular syndrome##10##2##(2006-6#3)(2009-5#1)(2012-2#1)(2012-3#1)(2013-1#4)
polyglandular##14##1##(1997-2#2)(2006-6#3)(2009-5#1)(2012-2#2)(2012-3#2)(2013-1#4)
polyglutamate##2##1##(1991-4#1)(2008-8#1)
polyglutamates##2##1##(1995-7#1)(2006-10#1)
polyglutamine tract##2##2##(1997-1#1)(2011-2#1)
polyglutamine tracts in the##3##4##(1997-1#2)(2006-11#1)
polyglutamine tracts##4##2##(1997-1#2)(2006-11#2)
polyglutamine##8##1##(1997-1#3)(2006-11#2)(2008-6#2)(2011-2#1)
polyglycolic acid (PGA)##2##3##(2008-5#1)(2011-2#1)
polyglycolic acid##3##2##(2008-5#1)(2011-2#2)
polygon##9##1##(1995-8#1)(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#2)
polygonal shape##2##2##(2008-11#1)(2008-7#1)
polygonal##22##1##(1990-5#1)(2004-2#1)(2005-10#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2009-7#1)(2010-6#1)(2012-1#4)
polygonal-shaped##2##1##(2005-11#1)(2007-11#1)
polygoni##2##1##(2012-3#1)(2013-8#1)
polygons##8##1##(1995-8#1)(2008-2#2)(2008-6#2)(2009-12#1)(2012-2#2)
polygraph##2##1##(2007-8#2)
polygynous##10##1##(1995-6#1)(1996-6#1)(2008-5#2)(2008-8#2)(2008-9#3)(2009-2#1)
polygyny and##4##2##(1995-6#1)(2006-10#1)(2006-5#1)(2011-2#1)
polygyny##9##1##(1995-6#1)(2006-10#4)(2006-5#1)(2007-12#1)(2008-6#1)(2011-2#1)
polyhedra or GFP##2##3##(2008-11#2)
polyhedra##11##1##(1993-12#1)(1995-12#1)(2005-11#1)(2006-10#1)(2008-11#6)(2009-12#1)
polyhedral oligomeric##2##2##(2013-8#2)
polyhedral prisms##2##2##(2008-3#2)
polyhedral##12##1##(1996-2#1)(1996-5#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2013-1#1)(2013-7#1)(2013-8#2)
polyhedrin gene##5##2##(1991-1#1)(1995-12#1)(2008-11#2)(2008-8#1)
polyhedrin promoter##8##2##(1994-11#1)(1997-4#3)(2005-11#1)(2008-11#2)(2008-7#1)
polyhedrin##16##1##(1991-1#1)(1993-8#1)(1994-11#1)(1995-12#1)(1997-4#5)(2005-11#1)(2008-11#4)(2008-7#1)(2008-8#1)
polyhedrosis virus##23##2##(1991-1#1)(1993-11#1)(1993-12#2)(1994-11#1)(1995-12#2)(1997-1#1)(1997-3#1)(1997-4#7)(2005-11#1)(2008-11#2)(2008-7#3)(2008-8#1)
polyhexanide##2##1##(2005-11#2)
polyhydramnios with##2##2##(1992-12#1)(2012-3#1)
polyhydramnios##9##1##(1992-12#3)(2009-4#1)(2010-4#1)(2012-12#2)(2012-3#1)(2013-1#1)
polyhydric phenols##3##2##(2008-10#3)
polyhydroxy compounds##2##2##(1992-12#1)(2006-9#1)
polyhydroxy phenols##3##2##(2008-10#3)
polyhydroxy##7##1##(1992-12#1)(2005-7#1)(2006-12#1)(2006-9#1)(2008-10#3)
polyhydroxyalkanoates##4##1##(1994-11#1)(2007-8#1)(2011-1#2)
polyhydroxylbenzenes##2##1##(2008-10#2)
polyimide and poly(vinyl alcohol)##2##4##(2007-12#2)
polyimide waveguide##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
polyimide##19##1##(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#2)(2008-3#5)(2009-7#4)(2010-4#2)
polyimides##5##1##(2008-2#4)(2010-4#1)
polyinosinic and polycytidylic acids##2##4##(2008-11#2)
polyinosinic##3##1##(2007-11#1)(2008-11#2)
polyion##7##1##(1996-4#3)(2006-10#3)(2008-10#1)
polyion-polyion interaction##3##2##(1996-11#3)
polyionic##3##1##(2007-8#2)(2008-10#1)
polyketide synthase gene##2##3##(2008-10#1)(2008-8#1)
polyketide synthase##6##2##(1994-12#2)(2008-10#2)(2008-8#1)(2010-10#1)
polyketide##11##1##(1994-12#2)(2006-12#2)(2008-10#3)(2008-8#1)(2010-10#1)(2013-1#2)
polylactic acid##4##2##(2008-10#3)(2009-6#1)
polylactic##5##1##(2008-10#3)(2009-6#1)(2009-7#1)
polylactide (PLA)##2##2##(2008-5#1)(2008-6#1)
polylactide##4##1##(2008-5#1)(2008-6#2)(2009-12#1)
polylinker##9##1##(1991-7#1)(1991-9#3)(1997-1#1)(1997-2#1)(2008-11#1)(2008-2#1)(2008-4#1)
polylysine##19##1##(1990-11#1)(1992-3#4)(1992-4#1)(1993-3#1)(1994-6#1)(1995-6#4)(2005-11#5)(2008-11#1)(2012-1#1)
polylysines##4##1##(1991-5#2)(2008-10#2)
polymer (CP) films##2##3##(2008-10#2)
polymer (CP)##3##2##(2008-10#3)
polymer (IIP)##3##2##(2008-10#3)
polymer alone##2##2##(2006-9#1)(2010-7#1)
polymer analysis##3##2##(2006-2#1)(2008-10#2)
polymer and its application##2##4##(2008-10#1)(2013-8#1)
polymer and silica films##3##4##(2008-2#3)
polymer and the##8##3##(1995-6#1)(2005-11#1)(2008-10#2)(2008-7#1)(2010-12#1)(2010-8#1)(2012-12#1)
polymer and##35##2##(1995-11#1)(1995-6#1)(2005-11#3)(2005-5#1)(2007-1#1)(2007-8#2)(2008-10#8)(2008-11#1)(2008-2#4)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2012-12#1)(2013-8#1)
polymer as a##3##3##(1996-5#1)(2008-10#2)
polymer at##2##2##(2008-12#1)(2008-3#1)
polymer backbone##6##2##(2005-11#2)(2007-12#1)(2008-10#1)(2009-10#2)
polymer backbones##2##2##(1995-3#1)(2009-9#1)
polymer based##7##2##(2006-2#1)(2007-8#4)(2008-4#1)(2010-5#1)
polymer beads##8##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-7#2)(2011-1#1)
polymer blend microparticles##2##3##(2007-12#2)
polymer blend##6##2##(1992-9#1)(2007-12#2)(2008-3#1)(2008-7#2)
polymer brush##2##2##(2009-5#2)
polymer brushes in##2##3##(2009-10#1)(2010-7#1)
polymer brushes on##2##3##(2010-4#1)(2012-11#1)
polymer brushes with##3##3##(2005-11#3)
polymer brushes##15##2##(2005-11#6)(2009-10#2)(2009-5#1)(2010-4#4)(2010-7#1)(2012-11#1)
polymer by use of##2##4##(2007-11#1)(2007-12#1)
polymer by##6##2##(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
polymer can##3##2##(1995-6#1)(2004-9#1)(2013-7#1)
polymer capsules##7##2##(2006-12#2)(2008-10#2)(2010-7#3)
polymer caused##2##2##(1991-7#1)(2008-5#1)
polymer chain##5##2##(1990-7#1)(2005-11#1)(2008-10#1)(2008-7#1)(2009-9#1)
polymer chains in##2##3##(2005-11#1)(2010-4#1)
polymer chains##14##2##(1994-2#1)(2005-11#5)(2007-11#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-11#1)(2010-4#1)
polymer coated##4##2##(2008-10#4)
polymer coating##6##2##(2006-6#1)(2007-12#1)(2008-10#3)(2010-2#1)
polymer coatings##4##2##(2008-10#2)(2009-11#1)(2010-4#1)
polymer column##2##2##(1991-3#1)(2008-10#1)
polymer compared##2##2##(2008-12#1)(2013-1#1)
polymer complex##2##2##(1991-11#1)(2013-1#1)
polymer composite##7##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#1)(2009-6#2)
polymer composites##3##2##(2008-10#2)(2008-2#1)
polymer composition##5##2##(2008-10#1)(2010-4#1)(2010-5#1)(2013-1#2)
polymer concentration were##2##3##(2004-12#1)(2009-10#1)
polymer concentration##10##2##(1991-10#1)(2004-12#2)(2005-11#1)(2006-10#1)(2007-10#1)(2009-10#2)(2010-4#1)(2010-9#1)
polymer containing##2##2##(1994-2#1)(2008-10#1)
polymer degradation##2##2##(2008-11#1)(2009-12#1)
polymer demixed##2##2##(2006-5#2)
polymer dielectric##2##2##(2007-12#1)(2008-2#1)
polymer dispersion##2##2##(2008-10#2)
polymer dye##2##2##(2007-12#1)(2008-3#1)
polymer electrode##5##2##(1996-6#1)(2008-10#4)
polymer electrodes##2##2##(2008-10#2)
polymer electrolyte##3##2##(2008-10#1)(2010-4#2)
polymer electrolytes by volumetric Karl Fischer##2##6##(2008-10#2)
polymer electrolytes by##3##3##(2008-10#3)
polymer electrolytes##5##2##(2008-10#5)
polymer exhibits##2##2##(1991-10#1)(2010-4#1)
polymer extrusion processes##2##3##(2008-10#2)
polymer extrusion##3##2##(2008-10#3)
polymer fiber##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
polymer fibers##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
polymer film are##2##3##(2008-10#1)(2008-3#1)
polymer film on##2##3##(2005-12#1)(2008-10#1)
polymer film were##2##3##(2008-10#2)
polymer film##34##2##(2005-12#2)(2006-12#1)(2007-12#8)(2007-2#1)(2008-1#1)(2008-10#12)(2008-2#1)(2008-3#2)(2009-10#1)(2009-11#1)(2009-9#1)(2010-2#2)(2010-5#1)
polymer films are##2##3##(2008-10#1)(2008-3#1)
polymer films by the##2##4##(2008-10#1)(2010-4#1)
polymer films by##3##3##(2006-5#1)(2008-10#1)(2010-4#1)
polymer films containing##2##3##(2008-10#1)(2008-2#1)
polymer films for##2##3##(2008-10#2)
polymer films is##5##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-1#1)
polymer films was##2##3##(2008-10#2)
polymer films##45##2##(1990-8#1)(1993-11#1)(2006-12#1)(2006-2#1)(2006-5#3)(2007-11#3)(2007-12#6)(2008-1#3)(2008-10#12)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#1)(2010-2#1)(2010-4#2)(2013-1#2)
polymer for##8##2##(2007-11#2)(2008-10#4)(2010-4#1)(2011-2#1)
polymer formation##2##2##(1994-9#1)(1996-6#1)
polymer forms##2##2##(2008-5#1)(2012-12#1)
polymer fractions##3##2##(1992-5#3)
polymer from##2##2##(2006-10#1)(2007-11#1)
polymer gel electrolyte and triphenylamine-based##2##5##(2010-4#2)
polymer gel electrolyte##3##3##(2010-4#3)
polymer gel##9##2##(1991-11#1)(2005-11#1)(2007-8#2)(2009-10#1)(2010-4#4)
polymer gels##5##2##(2005-10#2)(2005-11#2)(2010-4#1)
polymer has been##3##3##(2005-11#1)(2007-8#1)(2008-10#1)
polymer has##4##2##(2005-11#1)(2007-8#1)(2008-10#1)(2013-1#1)
polymer having##4##2##(1994-2#1)(2004-1#1)(2008-12#1)(2011-1#1)
polymer host##4##2##(2007-12#2)(2008-3#1)(2010-4#1)
polymer impregnation##2##2##(2008-5#1)(2012-2#1)
polymer in a##2##3##(2008-2#1)(2008-3#1)
polymer in the##2##3##(2005-11#1)(2008-10#1)
polymer in##14##2##(1991-7#1)(2005-11#2)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)(2009-2#1)(2011-2#1)(2012-12#1)
polymer into the##2##3##(2005-11#1)(2008-5#1)
polymer is described##2##3##(2008-10#1)(2008-2#1)
polymer is##11##2##(2005-11#2)(2008-1#1)(2008-10#5)(2008-2#1)(2008-5#1)(2013-8#1)
polymer laser dye##3##3##(2007-12#3)
polymer laser##4##2##(2007-12#4)
polymer layer##15##2##(2005-11#4)(2007-12#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-5#1)(2010-2#1)(2010-5#1)
polymer layers##2##2##(2007-6#1)(2010-4#1)
polymer material##3##2##(2008-3#1)(2013-1#2)
polymer materials and##2##3##(1995-3#1)(2010-4#1)
polymer materials##7##2##(1995-3#1)(1996-12#2)(2008-10#2)(2010-10#1)(2010-4#1)
polymer matrices##6##2##(2007-12#1)(2008-3#4)(2010-10#1)
polymer matrix and##7##3##(2006-2#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-11#1)(2009-12#1)(2010-4#1)
polymer matrix during##3##3##(2008-10#2)(2009-12#1)
polymer matrix##27##2##(2005-11#2)(2006-2#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#5)(2008-3#3)(2008-7#4)(2009-11#1)(2009-12#3)(2009-7#1)(2010-4#2)(2012-2#1)
polymer membrane##7##2##(2005-12#1)(2008-10#3)(2008-3#1)(2008-5#2)
polymer membranes##3##2##(2008-10#3)
polymer micelle##3##2##(2005-11#1)(2008-7#1)(2010-2#1)
polymer microlens arrays##3##3##(2008-3#3)
polymer microlens##5##2##(2007-12#2)(2008-3#3)
polymer microring resonators##3##3##(2009-5#3)
polymer microspheres##2##2##(2008-10#1)(2008-3#1)
polymer mixtures##3##2##(2005-11#3)
polymer modified electrode obtained##2##4##(2008-10#2)
polymer modified electrode##5##3##(2008-10#5)
polymer modified electrodes##6##3##(2008-10#6)
polymer modified##13##2##(2005-12#2)(2008-10#11)
polymer molecular weight##2##3##(2004-12#1)(2010-4#1)
polymer molecules##2##2##(2008-10#1)(2008-7#1)
polymer monolith##3##2##(2013-8#3)
polymer nanocomposites##2##2##(2009-11#1)(2011-1#1)
polymer nanoparticles##2##2##(2009-2#2)
polymer network##3##2##(1991-10#1)(2007-12#1)(2008-5#1)
polymer obtained##2##2##(2008-10#1)(2011-1#1)
polymer of##8##2##(1990-2#1)(1992-12#1)(1995-3#1)(2008-10#2)(2009-8#1)(2010-4#1)(2013-1#1)
polymer on the##3##3##(1994-9#1)(2006-10#1)(2008-10#1)
polymer on##7##2##(1994-9#1)(2005-12#1)(2006-10#1)(2006-9#1)(2008-10#2)(2008-12#1)
polymer optical fiber##4##3##(2007-12#4)
polymer optical##6##2##(2006-2#1)(2007-12#4)(2008-2#1)
polymer or##2##2##(1994-9#1)(2008-5#1)
polymer particles##12##2##(2004-9#2)(2007-12#1)(2007-8#1)(2008-10#8)
polymer phase##7##2##(1996-6#3)(2008-10#3)(2009-10#1)
polymer physics##3##2##(2007-9#1)(2008-2#1)(2008-7#1)
polymer properties##3##2##(2008-6#1)(2009-10#1)(2009-12#1)
polymer ratio of##2##3##(2010-12#2)
polymer ratio##3##2##(2010-12#2)(2011-1#1)
polymer resin##2##2##(2008-10#1)(2009-7#1)
polymer sample##3##2##(1996-12#1)(2004-9#1)(2010-5#1)
polymer samples##2##2##(2008-5#1)(2010-5#1)
polymer scaffold##2##2##(2006-2#1)(2008-7#1)
polymer scaffolds##4##2##(2006-6#1)(2008-5#1)(2012-11#2)
polymer shells##2##2##(2005-11#1)(2008-3#1)
polymer skeleton##2##2##(1991-3#1)(2008-10#1)
polymer solar cells##2##3##(2011-2#2)
polymer solution in##2##3##(1997-5#1)(2005-11#1)
polymer solution##13##2##(1997-5#3)(2004-1#1)(2005-11#5)(2006-12#1)(2008-10#1)(2008-5#1)(2010-7#1)
polymer solutions##8##2##(1990-2#1)(2004-12#1)(2005-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-7#1)
polymer structure to##2##3##(2008-8#1)(2009-7#1)
polymer structure##3##2##(2007-12#1)(2008-8#1)(2009-7#1)
polymer substrates with##4##3##(2012-11#4)
polymer substrates##6##2##(2008-2#1)(2010-11#1)(2012-11#4)
polymer such as##2##3##(2008-7#1)(2013-8#1)
polymer support##2##2##(2008-10#1)(2010-1#1)
polymer surface##10##2##(2005-11#2)(2007-8#1)(2008-10#2)(2008-5#1)(2009-11#1)(2010-4#1)(2013-1#2)
polymer surfaces##2##2##(2004-9#1)(2008-10#1)
polymer surfactants##5##2##(2005-11#5)
polymer synthesis##3##2##(1992-11#1)(2009-12#2)
polymer systems##4##2##(2008-3#1)(2010-4#1)(2012-11#2)
polymer that has##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
polymer that##8##2##(2005-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#3)(2009-10#1)
polymer thin film##3##3##(2007-12#2)(2008-7#1)
polymer thin films##3##3##(2007-12#2)(2008-3#1)
polymer thin##6##2##(2007-12#4)(2008-3#1)(2008-7#1)
polymer to a##2##3##(1995-11#1)(2007-12#1)
polymer to drug ratio##3##4##(2011-2#3)
polymer to the##2##3##(2008-11#1)(2009-2#1)
polymer to##13##2##(1995-11#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-11#1)(2009-2#1)(2009-3#1)(2010-4#1)(2011-2#3)
polymer transfer##2##2##(2009-4#2)
polymer volume fraction##2##3##(1996-11#1)(2005-11#1)
polymer was also##2##3##(2007-8#1)(2008-5#1)
polymer was found to##2##4##(2010-4#2)
polymer was prepared##2##3##(2008-10#2)
polymer was synthesized##2##3##(2008-10#1)(2008-3#1)
polymer was used in##2##4##(2008-3#1)(2010-12#1)
polymer was used##3##3##(2008-10#1)(2008-3#1)(2010-12#1)
polymer was##22##2##(1990-3#1)(1991-9#1)(1996-2#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-3#3)(2008-5#1)(2009-3#1)(2010-12#1)(2010-4#2)(2012-11#2)
polymer waveguide##7##2##(2007-11#3)(2007-12#1)(2008-1#1)(2008-3#2)
polymer waveguides##9##2##(2006-2#5)(2007-11#1)(2008-2#3)
polymer were##6##2##(1996-6#1)(2008-10#4)(2012-12#1)
polymer with a##3##3##(1995-6#1)(2012-11#2)
polymer with##14##2##(1995-6#1)(2005-11#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-1#1)(2010-5#1)(2012-11#2)
polymer##1088##1##(1990-2#2)(1990-3#2)(1990-4#1)(1990-7#1)(1990-8#1)(1991-10#5)(1991-11#2)(1991-3#2)(1991-7#3)(1991-8#4)(1991-9#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-5#3)(1992-8#1)(1992-9#1)(1993-11#2)(1993-8#1)(1994-10#1)(1994-2#5)(1994-6#1)(1994-9#8)(1995-11#5)(1995-2#1)(1995-3#4)(1995-6#3)(1996-11#1)(1996-12#3)(1996-2#2)(1996-5#3)(1996-6#9)(1997-3#3)(1997-4#1)(1997-5#3)(1997-7#2)(2004-1#2)(2004-12#5)(2004-9#7)(2005-10#2)(2005-11#71)(2005-12#7)(2005-5#1)(2005-7#1)(2005-9#1)(2006-10#5)(2006-12#7)(2006-2#13)(2006-5#5)(2006-6#2)(2006-8#2)(2006-9#6)(2007-1#1)(2007-10#2)(2007-11#27)(2007-12#74)(2007-2#1)(2007-6#3)(2007-8#21)(2007-9#3)(2008-1#7)(2008-10#253)(2008-11#21)(2008-12#9)(2008-2#35)(2008-3#59)(2008-4#1)(2008-5#34)(2008-6#4)(2008-7#35)(2008-8#3)(2008-9#6)(2009-10#15)(2009-11#10)(2009-12#10)(2009-2#6)(2009-3#7)(2009-4#2)(2009-5#7)(2009-6#2)(2009-7#6)(2009-8#3)(2009-9#4)(2010-1#4)(2010-10#2)(2010-11#3)(2010-12#7)(2010-2#11)(2010-4#48)(2010-5#14)(2010-6#1)(2010-7#10)(2010-8#3)(2010-9#2)(2011-1#8)(2011-2#12)(2011-3#3)(2012-11#13)(2012-12#12)(2012-2#5)(2012-3#1)(2013-1#16)(2013-7#3)(2013-8#10)
polymer's##5##1##(2007-11#1)(2007-12#2)(2008-5#1)(2009-8#1)
polymer)##4##1##(2006-2#1)(2007-8#1)(2008-12#1)(2008-5#1)
polymer-based##16##1##(1990-12#3)(1991-3#4)(2007-12#1)(2007-8#1)(2008-10#1)(2010-10#1)(2010-12#1)(2010-4#1)(2012-11#2)(2012-2#1)
polymer-blend##2##1##(2007-11#2)
polymer-bound##3##1##(1990-3#1)(2008-4#2)
polymer-coated silver hollow-glass waveguide##2##4##(2007-12#2)
polymer-coated silver##3##2##(2007-12#2)(2008-2#1)
polymer-coated##10##1##(1997-3#1)(2007-12#4)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)
polymer-dispersed liquid crystals##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
polymer-dispersed liquid##5##2##(2007-12#2)(2008-2#2)(2008-3#1)
polymer-dispersed liquid-crystal (PDLC)##2##3##(2007-11#1)(2008-3#1)
polymer-dispersed liquid-crystal##8##2##(2007-11#6)(2008-3#2)
polymer-dispersed##13##1##(2007-11#6)(2007-12#2)(2008-2#2)(2008-3#3)
polymer-grafted##2##1##(1997-3#1)(2006-10#1)
polymer-impregnated concrete##2##2##(2008-9#2)
polymer-membrane##2##1##(2007-8#1)(2008-10#1)
polymer-modified electrode##2##2##(2008-10#2)
polymer-modified##4##1##(1996-6#1)(2008-10#3)
polymer-network liquid##3##2##(2008-3#3)
polymer-polymer##2##1##(2006-5#1)(2007-12#1)
polymer-solvent##3##1##(2007-12#3)
polymer-supported chiral##2##2##(2007-11#2)
polymer-supported##7##1##(1997-4#1)(2007-11#3)(2008-10#1)(2008-4#2)
polymerase (PARP)##3##2##(2008-12#1)(2011-2#2)
polymerase I##22##2##(1990-3#1)(1990-5#1)(1991-11#1)(1991-7#2)(1992-9#2)(1993-3#2)(1995-1#4)(1997-4#1)(1997-6#3)(1997-8#1)(2006-10#3)(2008-4#1)
polymerase I)##2##2##(1994-9#1)(1996-10#1)
polymerase II ternary##2##3##(1996-8#2)
polymerase II transcription##4##3##(1990-4#1)(1990-6#2)(1997-4#1)
polymerase II##68##2##(1990-4#1)(1990-6#4)(1991-5#1)(1992-2#2)(1992-5#10)(1993-12#1)(1993-9#1)(1994-3#8)(1994-8#3)(1995-2#2)(1995-6#1)(1995-8#1)(1996-4#5)(1996-8#3)(1997-1#2)(1997-2#3)(1997-4#3)(1997-7#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-11#3)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)
polymerase III##24##2##(1991-3#1)(1991-7#1)(1992-3#3)(1993-9#2)(1994-12#7)(1995-1#1)(1995-2#1)(1995-6#1)(1996-7#2)(1997-5#2)(1997-7#1)(2012-12#2)
polymerase accessory protein##4##3##(1994-9#1)(1997-3#3)
polymerase accessory##5##2##(1992-5#1)(1994-9#1)(1997-3#3)
polymerase activities##4##2##(1991-7#2)(1994-2#1)(2008-5#1)
polymerase activity and##2##3##(1990-9#1)(1996-9#1)
polymerase activity in##5##3##(1990-9#1)(1993-8#1)(1994-6#1)(1994-9#1)(2012-3#1)
polymerase activity##27##2##(1990-9#5)(1991-10#1)(1991-5#1)(1991-7#1)(1993-8#2)(1994-4#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-5#1)(1996-11#1)(1996-9#3)(1997-4#1)(2008-4#1)(2008-5#1)(2012-2#1)(2012-3#1)
polymerase alpha##38##2##(1990-12#2)(1990-7#3)(1991-2#1)(1991-4#2)(1991-7#3)(1993-3#9)(1994-2#4)(1994-8#1)(1994-9#1)(1995-4#5)(1995-6#3)(2008-5#4)
polymerase alpha-primase complex##4##3##(1990-7#2)(1994-2#1)(1994-8#1)
polymerase alpha-primase holoenzyme##2##3##(1994-8#2)
polymerase alpha-primase##7##2##(1990-7#2)(1994-2#1)(1994-8#4)
polymerase and the##2##3##(1991-11#1)(1997-5#1)
polymerase and##21##2##(1990-3#1)(1990-7#2)(1991-11#1)(1991-4#1)(1991-7#1)(1993-8#1)(1994-10#1)(1994-5#1)(1995-1#2)(1995-2#1)(1995-7#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-5#1)(2008-10#1)(2008-5#1)(2012-3#1)
polymerase by##6##2##(1991-4#1)(1993-8#1)(1995-2#1)(1997-5#1)(1997-6#1)(2011-1#1)
polymerase chain reaction (PCR) amplification and##2##6##(2008-10#2)
polymerase chain reaction (PCR) amplification of the##2##7##(2008-10#2)
polymerase chain reaction (PCR) amplification##7##5##(1996-10#1)(2008-10#5)(2013-8#1)
polymerase chain reaction (PCR) amplified##3##5##(1992-5#1)(1995-12#1)(2008-10#1)
polymerase chain reaction (PCR) analysis of##2##6##(2005-7#1)(2006-10#1)
polymerase chain reaction (PCR) analysis##6##5##(1991-9#1)(1997-4#1)(2005-7#1)(2006-10#1)(2008-10#2)
polymerase chain reaction (PCR) and direct##2##6##(1992-7#1)(1993-9#1)
polymerase chain reaction (PCR) and restriction fragment length##2##8##(2008-10#1)(2008-4#1)
polymerase chain reaction (PCR) and##23##5##(1991-3#1)(1991-9#1)(1992-7#1)(1993-9#1)(1994-7#1)(1997-7#1)(2008-10#10)(2008-4#3)(2009-10#1)(2010-6#1)(2011-2#1)(2012-3#1)
polymerase chain reaction (PCR) approach##2##5##(2008-10#2)
polymerase chain reaction (PCR) assay for##2##6##(2008-10#2)
polymerase chain reaction (PCR) assay to##2##6##(2011-2#1)(2013-1#1)
polymerase chain reaction (PCR) assay using a##2##7##(2008-10#2)
polymerase chain reaction (PCR) assay was developed##5##7##(1997-3#1)(2008-10#4)
polymerase chain reaction (PCR) assay##15##5##(1997-3#1)(2005-9#1)(2008-10#11)(2011-2#1)(2013-1#1)
polymerase chain reaction (PCR) assays##8##5##(2008-10#5)(2012-2#2)(2012-3#1)
polymerase chain reaction (PCR) based method##3##6##(1991-5#1)(1997-2#1)(2007-8#1)
polymerase chain reaction (PCR) based##4##5##(1991-5#1)(1997-2#1)(1997-7#1)(2007-8#1)
polymerase chain reaction (PCR) detection method for##2##7##(2008-10#2)
polymerase chain reaction (PCR) followed by##2##6##(1992-10#1)(2008-10#1)
polymerase chain reaction (PCR) for##4##5##(2006-8#1)(2007-3#1)(2007-8#1)(2008-10#1)
polymerase chain reaction (PCR) from##3##5##(1994-8#1)(2008-10#1)(2008-4#1)
polymerase chain reaction (PCR) has become##2##6##(2008-4#1)(2012-3#1)
polymerase chain reaction (PCR) has##3##5##(2008-10#1)(2008-4#1)(2012-3#1)
polymerase chain reaction (PCR) in##4##5##(1994-1#1)(1995-8#1)(2008-10#2)
polymerase chain reaction (PCR) method was##2##6##(1996-12#1)(2008-5#1)
polymerase chain reaction (PCR) method##5##5##(1991-10#1)(1996-12#1)(1997-4#1)(2008-10#1)(2008-5#1)
polymerase chain reaction (PCR) methods##2##5##(2008-10#1)(2011-2#1)
polymerase chain reaction (PCR) of genomic DNA##2##7##(1992-8#2)
polymerase chain reaction (PCR) primers were##2##6##(2008-10#2)
polymerase chain reaction (PCR) primers##4##5##(1993-11#1)(2008-10#3)
polymerase chain reaction (PCR) procedure##3##5##(1992-5#1)(1993-12#1)(1994-9#1)
polymerase chain reaction (PCR) products##2##5##(2006-12#1)(2008-4#1)
polymerase chain reaction (PCR) technique##4##5##(1990-3#1)(1992-9#1)(2008-10#1)(2013-1#1)
polymerase chain reaction (PCR) technology##4##5##(1991-12#1)(1992-2#1)(2008-4#1)(2008-7#1)
polymerase chain reaction (PCR) test for the##2##7##(2008-5#2)
polymerase chain reaction (PCR) testing##3##5##(1991-1#1)(2006-10#1)(2008-10#1)
polymerase chain reaction (PCR) tests##2##5##(1997-6#1)(2008-10#1)
polymerase chain reaction (PCR) to##11##5##(1991-6#1)(1992-1#1)(1992-3#1)(1993-4#1)(1993-5#1)(2008-11#1)(2008-2#2)(2008-4#3)
polymerase chain reaction (PCR) using TaqMan chemistry##2##7##(2008-10#2)
polymerase chain reaction (PCR) using##8##5##(1996-12#1)(1996-8#1)(2006-8#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-3#1)
polymerase chain reaction (PCR) was##3##5##(1993-4#1)(1996-6#1)(2008-10#1)
polymerase chain reaction (PCR) with##3##5##(2008-10#3)
polymerase chain reaction (PCR)##224##4##(1990-11#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#4)(1992-9#2)(1993-11#2)(1993-12#2)(1993-4#2)(1993-5#2)(1993-7#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-8#2)(1996-10#2)(1996-11#1)(1996-12#3)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#2)(2004-11#1)(2005-11#1)(2005-7#2)(2005-9#1)(2006-10#2)(2006-12#1)(2006-8#2)(2007-1#1)(2007-3#1)(2007-8#5)(2008-10#80)(2008-11#3)(2008-2#4)(2008-4#12)(2008-5#3)(2008-7#2)(2008-9#1)(2009-10#1)(2009-6#1)(2010-2#1)(2010-6#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#7)(2013-8#1)
polymerase chain reaction (PCR)-amplified##2##4##(1992-8#1)(2008-10#1)
polymerase chain reaction (PCR)-based assay##4##5##(1997-7#1)(2008-10#2)(2008-5#1)
polymerase chain reaction (PCR)-based detection method##2##6##(2008-1#1)(2008-10#1)
polymerase chain reaction (PCR)-based##13##4##(1997-7#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-10#7)(2008-4#1)(2008-5#1)
polymerase chain reaction (QPCR)##2##4##(2008-2#1)(2012-2#1)
polymerase chain reaction (RT-PCR) and##6##5##(1994-6#1)(2005-11#1)(2008-10#1)(2008-4#1)(2008-8#1)(2012-2#1)
polymerase chain reaction (RT-PCR) in##3##5##(1995-12#1)(2007-10#1)(2008-7#1)
polymerase chain reaction (RT-PCR) method##2##5##(1994-11#1)(2008-5#1)
polymerase chain reaction (RT-PCR) technique##3##5##(1993-7#1)(1996-12#1)(2008-10#1)
polymerase chain reaction (RT-PCR) was performed##2##6##(1994-11#1)(2008-10#1)
polymerase chain reaction (RT-PCR) was##3##5##(1993-8#1)(1994-11#1)(2008-10#1)
polymerase chain reaction (RT-PCR)##39##4##(1992-12#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-12#1)(1996-12#2)(1997-4#1)(1997-6#1)(2005-11#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#7)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#2)(2013-1#1)
polymerase chain reaction (qPCR)##4##4##(2009-6#2)(2012-3#2)
polymerase chain reaction (rep-PCR) and##2##5##(2008-10#2)
polymerase chain reaction (rep-PCR) with##2##5##(2008-10#2)
polymerase chain reaction (rep-PCR)##9##4##(2008-10#9)
polymerase chain reaction amplification and##4##5##(1992-4#1)(1995-3#1)(1995-5#1)(2008-10#1)
polymerase chain reaction amplification of the##2##6##(1993-8#1)(2008-10#1)
polymerase chain reaction amplification of##6##5##(1991-5#1)(1993-8#1)(1996-6#1)(2008-10#3)
polymerase chain reaction amplification##17##4##(1991-5#1)(1991-9#1)(1992-1#1)(1992-4#1)(1993-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-6#1)(2008-10#7)
polymerase chain reaction amplified##3##4##(2008-10#1)(2009-5#1)(2012-3#1)
polymerase chain reaction analysis of##2##5##(2008-10#1)(2012-3#1)
polymerase chain reaction analysis##6##4##(1991-7#1)(1994-9#1)(2008-10#2)(2009-5#1)(2012-3#1)
polymerase chain reaction and Southern blot##2##6##(2008-10#1)(2008-6#1)
polymerase chain reaction and direct DNA sequencing##2##7##(1992-7#1)(2013-7#1)
polymerase chain reaction and oligonucleotide##2##5##(1990-8#1)(1991-1#1)
polymerase chain reaction and the##3##5##(1993-11#1)(1995-2#1)(2007-10#1)
polymerase chain reaction and##50##4##(1990-12#1)(1990-3#1)(1990-8#2)(1991-1#2)(1991-12#1)(1991-5#2)(1991-9#1)(1992-7#1)(1993-11#2)(1994-11#1)(1994-12#2)(1994-9#1)(1995-2#1)(1996-10#1)(1996-5#1)(1997-2#1)(1997-3#1)(2005-12#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)
polymerase chain reaction as##2##4##(2007-7#1)(2009-2#1)
polymerase chain reaction assay for##3##5##(1996-12#1)(1997-3#1)(2012-3#1)
polymerase chain reaction assay was##2##5##(2007-2#1)(2008-10#1)
polymerase chain reaction assay##14##4##(1992-12#2)(1994-8#1)(1996-12#1)(1997-3#1)(2004-11#1)(2007-2#1)(2007-6#1)(2008-10#3)(2011-2#1)(2012-2#1)(2012-3#1)
polymerase chain reaction assays for##4##5##(1991-3#1)(2008-10#3)
polymerase chain reaction assays##11##4##(1991-3#1)(2006-9#1)(2007-11#1)(2008-10#7)(2012-2#1)
polymerase chain reaction detection##3##4##(2007-12#2)(2011-2#1)
polymerase chain reaction employing##2##4##(2008-2#1)(2008-5#1)
polymerase chain reaction followed by restriction##2##6##(1990-12#1)(1994-2#1)
polymerase chain reaction followed by##3##5##(1990-12#1)(1992-2#1)(1994-2#1)
polymerase chain reaction following##2##4##(1992-12#1)(2008-5#1)
polymerase chain reaction for the##4##5##(1996-11#1)(2007-8#1)(2012-3#1)(2013-8#1)
polymerase chain reaction for##11##4##(1996-11#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-12#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
polymerase chain reaction from##8##4##(1994-12#1)(1994-3#1)(1995-12#1)(2008-10#3)(2008-4#1)(2012-3#1)
polymerase chain reaction in peripheral blood##2##6##(1996-2#1)(2006-10#1)
polymerase chain reaction in real-time operation mode##3##7##(2013-1#3)
polymerase chain reaction in##13##4##(1993-12#1)(1994-7#1)(1995-9#1)(1996-2#1)(1996-3#1)(1997-7#1)(2006-10#1)(2008-10#3)(2013-1#3)
polymerase chain reaction is##7##4##(1990-8#1)(1996-2#2)(1997-7#1)(2006-10#2)(2008-6#1)
polymerase chain reaction markers##3##4##(2008-10#1)(2011-2#2)
polymerase chain reaction method##3##4##(1997-6#2)(1997-8#1)
polymerase chain reaction of the##2##5##(2008-10#1)(2011-2#1)
polymerase chain reaction of##10##4##(1993-8#1)(1995-6#1)(2008-10#5)(2011-2#2)(2013-8#1)
polymerase chain reaction on##2##4##(2006-10#1)(2010-5#1)
polymerase chain reaction primers designed##2##5##(2008-10#1)(2008-5#1)
polymerase chain reaction primers##4##4##(2008-10#3)(2008-5#1)
polymerase chain reaction product##3##4##(1995-12#1)(1997-3#1)(2008-10#1)
polymerase chain reaction products##4##4##(1991-9#1)(1996-10#1)(1996-3#1)(2008-5#1)
polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) analysis of##2##10##(2008-10#2)
polymerase chain reaction restriction fragment length polymorphism##3##7##(2008-10#3)
polymerase chain reaction restriction fragment length##4##6##(2008-10#4)
polymerase chain reaction showed##2##4##(2008-10#1)(2009-8#1)
polymerase chain reaction technique##7##4##(1990-12#1)(1990-2#1)(1991-9#1)(1993-2#1)(1993-9#1)(1994-12#1)(2010-4#1)
polymerase chain reaction techniques##5##4##(1991-8#1)(1992-5#1)(2006-10#1)(2006-8#1)(2008-10#1)
polymerase chain reaction to##13##4##(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-12#1)(1993-11#1)(1993-7#1)(2008-11#1)(2008-5#1)(2011-2#2)(2013-1#1)
polymerase chain reaction using primers based on the##2##8##(1993-2#1)(2008-10#1)
polymerase chain reaction using primers##3##5##(1992-6#1)(1993-2#1)(2008-10#1)
polymerase chain reaction using##10##4##(1992-6#1)(1993-2#1)(1993-9#1)(1996-7#1)(1997-6#1)(1997-7#1)(2008-10#2)(2012-12#1)(2013-1#1)
polymerase chain reaction was used to##7##6##(1991-12#1)(1991-7#1)(1992-6#1)(1992-8#1)(1996-5#1)(1997-2#1)(2007-6#1)
polymerase chain reaction was##11##4##(1991-12#1)(1991-7#1)(1991-9#1)(1992-6#1)(1992-8#1)(1994-2#1)(1995-6#1)(1996-5#1)(1997-2#1)(2007-6#1)(2008-10#1)
polymerase chain reaction with degenerate primers##2##6##(1993-2#1)(1997-5#1)
polymerase chain reaction with degenerate##3##5##(1993-2#1)(1997-4#1)(1997-5#1)
polymerase chain reaction with##9##4##(1990-11#1)(1992-11#1)(1992-2#1)(1993-2#1)(1994-11#1)(1994-9#1)(1997-4#1)(1997-5#1)(2008-10#1)
polymerase chain reaction##745##3##(1990-10#2)(1990-11#4)(1990-12#7)(1990-2#4)(1990-3#6)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#5)(1990-8#3)(1991-1#4)(1991-10#3)(1991-11#1)(1991-12#5)(1991-2#2)(1991-3#4)(1991-5#7)(1991-6#7)(1991-7#3)(1991-8#3)(1991-9#13)(1992-1#3)(1992-10#2)(1992-11#3)(1992-12#6)(1992-2#4)(1992-3#1)(1992-4#2)(1992-5#3)(1992-6#4)(1992-7#5)(1992-8#7)(1992-9#5)(1993-10#1)(1993-11#5)(1993-12#5)(1993-2#7)(1993-3#1)(1993-4#3)(1993-5#3)(1993-7#3)(1993-8#4)(1993-9#6)(1994-1#1)(1994-11#4)(1994-12#12)(1994-2#5)(1994-3#3)(1994-6#3)(1994-7#2)(1994-8#3)(1994-9#6)(1995-10#1)(1995-11#3)(1995-12#5)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#2)(1995-9#2)(1996-10#5)(1996-11#5)(1996-12#6)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#4)(1997-4#6)(1997-5#1)(1997-6#10)(1997-7#7)(1997-8#1)(2004-11#3)(2005-10#1)(2005-11#3)(2005-12#1)(2005-7#2)(2005-8#1)(2005-9#2)(2006-10#13)(2006-12#2)(2006-4#1)(2006-5#1)(2006-8#5)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#3)(2007-12#6)(2007-2#4)(2007-3#1)(2007-4#1)(2007-6#3)(2007-7#1)(2007-8#8)(2008-1#3)(2008-10#211)(2008-11#8)(2008-12#2)(2008-2#7)(2008-4#20)(2008-5#17)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#4)(2009-2#1)(2009-5#2)(2009-6#3)(2009-8#4)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#4)(2010-7#2)(2011-1#3)(2011-2#23)(2012-1#2)(2012-12#5)(2012-2#9)(2012-3#15)(2013-1#19)(2013-7#1)(2013-8#5)
polymerase chain reaction)##2##3##(2008-5#1)(2011-2#1)
polymerase chain reaction-allele specific oligonucleotide##2##5##(1997-8#2)
polymerase chain reaction-amplified DNA##2##4##(2008-10#1)(2008-5#1)
polymerase chain reaction-amplified##9##3##(1991-7#1)(1992-1#1)(2008-10#5)(2008-3#1)(2008-5#1)
polymerase chain reaction-based assay##2##4##(2007-2#1)(2008-10#1)
polymerase chain reaction-based diagnostic##2##4##(1994-3#1)(2008-10#1)
polymerase chain reaction-based markers##3##4##(2008-10#3)
polymerase chain reaction-based##18##3##(1991-6#1)(1993-8#1)(1994-3#1)(1994-9#1)(2007-2#2)(2008-10#12)
polymerase chain reaction-restriction fragment length polymorphism##10##6##(1997-8#1)(2005-8#1)(2007-12#1)(2008-10#4)(2009-5#2)(2011-2#1)
polymerase chain reaction-restriction fragment length##11##5##(1997-8#1)(2005-8#1)(2007-12#1)(2008-10#5)(2009-5#2)(2011-2#1)
polymerase chain reaction-sequence-specific##2##3##(1997-8#1)(2012-2#1)
polymerase chain reaction-single##2##3##(1992-2#1)(2009-7#1)
polymerase chain reaction-single-strand conformation polymorphism##2##5##(1993-11#1)(1995-6#1)
polymerase chain reaction]##3##3##(1990-8#1)(1996-8#1)(2011-2#1)
polymerase chain reactions (PCR) with##2##5##(2007-1#1)(2008-10#1)
polymerase chain reactions (PCR)##6##4##(1990-2#1)(1993-8#1)(1997-8#1)(2007-1#2)(2008-10#1)
polymerase chain reactions##11##3##(1990-2#1)(1992-1#1)(1993-8#1)(1996-4#1)(1997-4#1)(1997-8#1)(2007-1#2)(2008-10#2)(2008-3#1)
polymerase chain##814##2##(1990-10#2)(1990-11#4)(1990-12#7)(1990-2#5)(1990-3#6)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#5)(1990-8#4)(1991-1#4)(1991-10#3)(1991-11#1)(1991-12#5)(1991-2#2)(1991-3#4)(1991-5#7)(1991-6#8)(1991-7#4)(1991-8#3)(1991-9#13)(1992-1#5)(1992-10#2)(1992-11#3)(1992-12#6)(1992-2#5)(1992-3#1)(1992-4#2)(1992-5#3)(1992-6#5)(1992-7#5)(1992-8#7)(1992-9#5)(1993-10#1)(1993-11#6)(1993-12#5)(1993-2#7)(1993-3#1)(1993-4#3)(1993-5#3)(1993-7#3)(1993-8#6)(1993-9#6)(1994-1#1)(1994-11#4)(1994-12#12)(1994-2#5)(1994-3#4)(1994-6#3)(1994-7#2)(1994-8#3)(1994-9#8)(1995-10#1)(1995-11#3)(1995-12#5)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#2)(1995-9#2)(1996-10#5)(1996-11#5)(1996-12#7)(1996-2#3)(1996-3#2)(1996-4#2)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#5)(1997-4#7)(1997-5#1)(1997-6#10)(1997-7#7)(1997-8#7)(2004-11#3)(2005-10#1)(2005-11#3)(2005-12#1)(2005-7#2)(2005-8#2)(2005-9#2)(2006-10#13)(2006-12#2)(2006-4#1)(2006-5#1)(2006-8#5)(2006-9#1)(2007-1#4)(2007-10#3)(2007-11#3)(2007-12#7)(2007-2#6)(2007-3#1)(2007-4#1)(2007-6#3)(2007-7#1)(2007-8#8)(2008-1#3)(2008-10#236)(2008-11#8)(2008-12#2)(2008-2#7)(2008-3#2)(2008-4#20)(2008-5#19)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#4)(2009-2#1)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#4)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#4)(2010-7#2)(2011-1#3)(2011-2#26)(2012-1#2)(2012-12#5)(2012-2#10)(2012-3#15)(2013-1#20)(2013-7#1)(2013-8#5)
polymerase complex##2##2##(1996-5#1)(2012-12#1)
polymerase delta##14##2##(1990-12#2)(1991-7#5)(1993-3#1)(1994-12#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-8#1)
polymerase does not##2##3##(1994-9#1)(1997-6#1)
polymerase domain##3##2##(1996-10#2)(2008-10#1)
polymerase enzyme##2##2##(1993-11#1)(2008-7#1)
polymerase from Thermus thermophilus##3##4##(1990-7#1)(1996-4#2)
polymerase from Thermus##5##3##(1990-7#1)(1996-4#2)(1997-6#1)(1997-8#1)
polymerase from the##5##3##(1990-3#1)(1990-7#1)(1990-9#1)(1994-8#1)(1997-6#1)
polymerase from##20##2##(1990-3#1)(1990-7#2)(1990-9#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-9#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-4#2)(1996-9#1)(1997-2#1)(1997-5#1)(1997-6#2)(1997-8#1)(2012-2#1)
polymerase gene##9##2##(1990-4#1)(1991-9#1)(1993-8#2)(1997-4#2)(2008-10#2)(2013-1#1)
polymerase has been##3##3##(1990-5#1)(1993-9#1)(1995-8#1)
polymerase has##6##2##(1990-5#1)(1993-9#1)(1995-8#1)(1997-6#1)(1997-8#1)(2008-1#1)
polymerase holoenzyme##7##2##(1990-5#1)(1994-9#6)
polymerase in a##2##3##(1995-2#1)(2008-4#1)
polymerase in the##2##3##(1994-7#1)(1997-4#1)
polymerase in##10##2##(1990-12#1)(1990-8#1)(1994-11#1)(1994-7#1)(1995-2#1)(1997-4#1)(1997-5#1)(2008-4#1)(2011-1#1)(2012-1#1)
polymerase incorporation of##2##3##(2008-4#2)
polymerase inhibition##2##2##(1991-7#1)(2008-5#1)
polymerase inhibitors##2##2##(1991-7#1)(2010-12#1)
polymerase is##8##2##(1990-7#1)(1990-9#1)(1991-7#1)(1991-9#1)(1994-12#1)(1994-6#1)(1997-6#1)(1997-8#1)
polymerase molecule##2##2##(1994-12#1)(1994-9#1)
polymerase mutations##2##2##(2013-1#2)
polymerase of##4##2##(1991-9#1)(1995-8#1)(2008-10#1)(2012-2#1)
polymerase purified##3##2##(1990-3#1)(1990-4#1)(2008-8#1)
polymerase reaction##3##2##(1990-8#1)(1991-1#1)(1997-8#1)
polymerase that##4##2##(1990-9#1)(1995-2#1)(1995-8#1)(1996-4#1)
polymerase to##7##2##(1990-3#1)(1993-8#1)(1994-9#1)(1995-2#2)(1996-11#1)(1997-6#1)
polymerase was purified##2##3##(1991-11#1)(1997-2#1)
polymerase was##11##2##(1990-7#1)(1991-11#1)(1991-12#1)(1993-12#1)(1993-8#1)(1994-5#1)(1996-4#1)(1997-2#1)(1997-4#2)(1997-6#1)
polymerase with##3##2##(1991-3#1)(1994-9#1)(2008-5#1)
polymerase##1401##1##(1990-10#3)(1990-11#5)(1990-12#14)(1990-2#8)(1990-3#14)(1990-4#7)(1990-5#12)(1990-6#5)(1990-7#23)(1990-8#8)(1990-9#13)(1991-1#6)(1991-10#5)(1991-11#4)(1991-12#7)(1991-2#3)(1991-3#8)(1991-4#7)(1991-5#12)(1991-6#10)(1991-7#25)(1991-8#5)(1991-9#24)(1992-1#5)(1992-10#2)(1992-11#3)(1992-12#7)(1992-2#7)(1992-3#5)(1992-4#4)(1992-5#14)(1992-6#6)(1992-7#5)(1992-8#7)(1992-9#8)(1993-10#1)(1993-11#12)(1993-12#11)(1993-2#7)(1993-3#17)(1993-4#3)(1993-5#4)(1993-7#3)(1993-8#16)(1993-9#12)(1994-1#1)(1994-10#1)(1994-11#5)(1994-12#27)(1994-2#12)(1994-3#15)(1994-4#1)(1994-5#2)(1994-6#7)(1994-7#5)(1994-8#23)(1994-9#30)(1995-1#8)(1995-10#3)(1995-11#3)(1995-12#5)(1995-2#17)(1995-3#3)(1995-4#5)(1995-5#5)(1995-6#13)(1995-7#1)(1995-8#13)(1995-9#2)(1996-10#8)(1996-11#14)(1996-12#7)(1996-2#3)(1996-3#2)(1996-4#17)(1996-5#3)(1996-6#3)(1996-7#6)(1996-8#6)(1996-9#5)(1997-1#5)(1997-2#15)(1997-3#10)(1997-4#26)(1997-5#21)(1997-6#29)(1997-7#10)(1997-8#13)(1997-9#1)(2004-11#3)(2005-10#1)(2005-11#3)(2005-12#1)(2005-7#2)(2005-8#2)(2005-9#2)(2006-10#18)(2006-12#4)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#5)(2006-9#1)(2007-1#4)(2007-10#3)(2007-11#3)(2007-12#7)(2007-2#6)(2007-3#1)(2007-4#1)(2007-6#3)(2007-7#1)(2007-8#9)(2008-1#6)(2008-10#253)(2008-11#9)(2008-12#3)(2008-2#8)(2008-3#3)(2008-4#30)(2008-5#34)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#4)(2009-10#4)(2009-2#1)(2009-5#5)(2009-6#3)(2009-7#1)(2009-8#7)(2010-11#3)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#4)(2010-7#2)(2011-1#7)(2011-2#31)(2012-1#3)(2012-12#9)(2012-2#16)(2012-3#20)(2013-1#27)(2013-7#1)(2013-8#7)
polymerase)##5##1##(1995-8#1)(1996-4#2)(2008-10#1)(2013-1#1)
polymerase-encoding##2##1##(1993-12#1)(1997-4#1)
polymerases are##2##2##(2008-5#1)(2010-7#1)
polymerases by##3##2##(1992-6#1)(2008-1#1)(2010-7#1)
polymerases from calorie restricted##2##4##(1992-1#2)
polymerases from##4##2##(1992-1#3)(1997-1#1)
polymerases in##3##2##(1991-4#1)(2007-8#1)(2008-5#1)
polymerases which##2##2##(1990-3#1)(1997-6#1)
polymerases##89##1##(1990-10#1)(1990-12#3)(1990-3#1)(1990-7#4)(1990-9#1)(1991-1#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#4)(1992-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-5#1)(1995-6#2)(1996-11#1)(1996-4#1)(1996-7#4)(1996-9#1)(1997-1#5)(1997-2#1)(1997-4#3)(1997-5#3)(1997-6#6)(1997-8#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-5#9)(2008-8#1)(2008-9#1)(2010-2#1)(2010-6#1)(2010-7#3)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
polymeric CTA membrane##2##3##(2008-10#2)
polymeric MB##2##2##(2008-10#2)
polymeric RP columns were##2##4##(1991-3#2)
polymeric analogues##2##2##(1990-8#1)(2011-2#1)
polymeric and##4##2##(1996-8#1)(2006-10#1)(2008-5#1)(2012-12#1)
polymeric chains##2##2##(2006-12#1)(2008-10#1)
polymeric coating##2##2##(1996-8#1)(2010-5#1)
polymeric coatings##2##2##(2007-11#1)(2009-11#1)
polymeric composites##2##2##(2010-4#2)
polymeric coupling##2##2##(2005-11#2)
polymeric dye##2##2##(2008-3#1)(2011-1#1)
polymeric emulsifier##2##2##(2008-5#2)
polymeric film coated##2##3##(2008-10#1)(2008-5#1)
polymeric film##12##2##(2007-11#1)(2008-10#7)(2008-5#2)(2012-12#2)
polymeric films##7##2##(2006-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2010-4#1)
polymeric gain medium##3##3##(2008-2#3)
polymeric gel##2##2##(2008-10#1)(2010-7#1)
polymeric gels##2##2##(2008-8#2)
polymeric implant##2##2##(2004-1#2)
polymeric layer##3##2##(1996-8#1)(2008-2#1)(2009-7#1)
polymeric layers##3##2##(2008-2#2)(2013-1#1)
polymeric material##4##2##(1992-2#1)(1997-2#1)(2007-12#1)(2010-4#1)
polymeric materials that are##2##4##(1990-9#1)(2008-10#1)
polymeric materials##14##2##(1990-9#1)(1996-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-4#2)
polymeric matrices##4##2##(2007-12#1)(2008-10#2)(2008-5#1)
polymeric matrix##15##2##(1995-3#1)(1996-2#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-5#1)(2010-4#1)
polymeric membrane electrode based on##2##5##(2008-10#2)
polymeric membrane electrode##5##3##(2008-10#5)
polymeric membrane electrodes based on##2##5##(2008-10#2)
polymeric membrane electrodes##8##3##(2008-10#8)
polymeric membrane sensor##3##3##(2008-10#3)
polymeric membrane##22##2##(2005-11#1)(2008-10#20)(2009-2#1)
polymeric membranes for the effective batch pre-concentration and determination of zinc traces with flame atomic absorption spectrometry##2##17##(2008-10#2)
polymeric membranes##10##2##(2008-10#10)
polymeric microcapsule##2##2##(2011-2#1)(2012-11#1)
polymeric microneedle##2##2##(2011-1#2)
polymeric microspheres##2##2##(2008-10#1)(2010-12#1)
polymeric monoliths in##2##3##(2013-8#2)
polymeric monoliths##3##2##(2013-8#3)
polymeric nanocapsules##2##2##(2010-1#1)(2010-12#1)
polymeric nanoparticles##6##2##(2012-11#2)(2012-2#1)(2013-1#3)
polymeric optical##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
polymeric reagent##2##2##(1990-8#2)
polymeric resin Amberlite##2##3##(1992-4#1)(2008-10#1)
polymeric resin beads##2##3##(2008-10#2)
polymeric resin##12##2##(1992-4#1)(2005-11#1)(2008-1#1)(2008-10#8)(2008-2#1)
polymeric scattering gain media##2##4##(2007-12#1)(2008-3#1)
polymeric sorbent was##2##3##(2008-10#2)
polymeric sorbent##6##2##(2008-10#6)
polymeric stationary phases##2##3##(1996-8#2)
polymeric structure##3##2##(2008-10#1)(2008-5#1)(2010-5#1)
polymeric substances##5##2##(2005-11#2)(2009-4#1)(2011-1#1)(2011-12#1)
polymeric substrate##2##2##(1991-7#1)(2008-10#1)
polymeric support##2##2##(2004-9#1)(2008-10#1)
polymeric supports and##2##3##(1997-4#1)(2008-10#1)
polymeric supports##3##2##(1997-4#1)(2008-10#2)
polymeric surface##2##2##(2009-11#1)(2010-7#1)
polymeric system##3##2##(1991-11#2)(2006-12#1)
polymeric systems##2##2##(2008-11#1)(2010-5#1)
polymeric##307##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-7#1)(1990-8#4)(1990-9#1)(1991-11#2)(1991-3#7)(1991-7#1)(1992-2#1)(1992-4#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#3)(1995-7#1)(1996-12#1)(1996-2#1)(1996-8#7)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(2004-1#2)(2004-9#1)(2005-11#9)(2005-7#1)(2006-10#1)(2006-12#4)(2006-2#1)(2007-11#6)(2007-12#5)(2007-8#4)(2008-1#3)(2008-10#101)(2008-11#5)(2008-2#14)(2008-3#6)(2008-5#16)(2008-6#1)(2008-8#4)(2009-11#2)(2009-2#4)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#3)(2010-4#9)(2010-5#8)(2010-7#2)(2011-1#4)(2011-12#2)(2011-2#5)(2012-1#3)(2012-11#9)(2012-12#4)(2012-2#3)(2013-1#7)(2013-7#1)(2013-8#3)
polymerisation of##4##2##(2007-8#1)(2008-10#2)(2010-5#1)
polymerisation##10##1##(1990-7#1)(1992-12#1)(2007-8#1)(2008-10#3)(2010-5#4)
polymerised##4##1##(2005-7#1)(2008-10#2)(2008-5#1)
polymerizable carbon double bonds##2##4##(2009-7#2)
polymerizable##13##1##(1990-2#2)(1990-5#1)(1991-2#3)(1992-8#1)(1994-8#2)(2007-12#1)(2009-7#2)(2011-2#1)
polymerization (ATRP)##4##2##(2008-10#2)(2010-4#1)(2013-8#1)
polymerization and##22##2##(1990-2#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-9#2)(1997-4#1)(2004-9#2)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-7#2)(2010-4#1)(2011-2#2)(2012-2#1)
polymerization as a##2##3##(2008-10#1)(2012-1#1)
polymerization as##3##2##(1990-5#1)(2008-10#1)(2012-1#1)
polymerization assays##2##2##(2008-1#1)(2008-8#1)
polymerization behavior##2##2##(2009-10#2)
polymerization by##3##2##(1990-11#1)(1996-7#1)(1997-6#1)
polymerization contraction force through##2##4##(2008-12#2)
polymerization contraction force##4##3##(2008-12#4)
polymerization could be##2##3##(1994-5#1)(2005-12#1)
polymerization during##2##2##(2009-10#1)(2009-8#1)
polymerization for##2##2##(2008-10#1)(2010-4#1)
polymerization from##2##2##(2008-10#1)(2008-2#1)
polymerization in tris(hydroxymethyl)-aminomethane##2##3##(2008-10#2)
polymerization in##12##2##(1991-8#1)(1994-9#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-8#1)(2009-10#1)(2009-9#1)
polymerization induced by##2##3##(1995-6#1)(1997-6#1)
polymerization is##3##2##(2005-8#1)(2007-11#1)(2013-8#1)
polymerization kinetics##3##2##(2008-3#2)(2013-1#1)
polymerization method for##2##3##(2010-2#1)(2013-8#1)
polymerization method##6##2##(2007-9#1)(2008-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2013-8#1)
polymerization modes on temperature rise in human dentin of different thicknesses##2##11##(2008-5#2)
polymerization modes##4##2##(2008-5#4)
polymerization of a##2##3##(1996-2#1)(2008-12#1)
polymerization of actin##3##3##(1990-6#1)(1992-4#1)(1993-6#1)
polymerization of hemoglobin##2##3##(1991-8#1)(1994-9#1)
polymerization of phenothiazine derivatives##2##4##(2008-10#2)
polymerization of styrene##3##3##(2005-11#1)(2005-8#1)(2008-12#1)
polymerization of tert-butyl acrylate##2##4##(2008-12#2)
polymerization of the protein##2##4##(1991-7#1)(2008-7#1)
polymerization of the##9##3##(1991-7#1)(1996-2#1)(1997-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2010-4#1)
polymerization of##61##2##(1990-10#1)(1990-6#1)(1990-7#1)(1991-7#1)(1991-8#1)(1992-4#1)(1993-5#1)(1993-6#1)(1994-9#2)(1995-2#2)(1995-3#1)(1996-2#3)(1997-1#1)(1997-8#1)(2005-11#2)(2005-12#2)(2005-8#1)(2007-11#4)(2007-12#1)(2007-9#1)(2008-10#8)(2008-12#6)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2009-10#1)(2010-2#1)(2010-4#3)(2010-9#1)(2011-1#3)(2012-2#1)
polymerization on##2##2##(1993-8#1)(2012-2#1)
polymerization process was##2##3##(2005-11#1)(2008-12#1)
polymerization process were##2##3##(2004-9#1)(2005-11#1)
polymerization process##10##2##(2004-9#1)(2005-11#2)(2007-8#1)(2008-12#1)(2008-3#2)(2009-12#1)(2010-10#1)(2010-4#1)
polymerization rate##5##2##(1990-9#1)(1994-12#1)(2007-11#1)(2008-3#1)(2010-2#1)
polymerization reaction##4##2##(2005-11#1)(2008-2#1)(2010-7#1)(2013-1#1)
polymerization shrinkage##2##2##(2010-4#1)(2013-8#1)
polymerization system##3##2##(2005-12#1)(2008-10#1)(2010-4#1)
polymerization technique##3##2##(2005-11#2)(2008-8#1)
polymerization that##3##2##(2008-7#1)(2012-12#2)
polymerization to##2##2##(2005-11#1)(2013-8#1)
polymerization was##5##2##(1990-7#1)(1997-6#1)(2004-9#1)(2008-10#1)(2010-2#1)
polymerization were##2##2##(2008-10#1)(2009-3#1)
polymerization with##3##2##(1997-8#1)(2007-11#1)(2013-7#1)
polymerization##306##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#4)(1990-7#4)(1990-9#1)(1991-2#1)(1991-7#2)(1991-8#9)(1992-4#1)(1992-9#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#8)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#4)(1996-5#1)(1996-7#2)(1996-8#1)(1997-1#4)(1997-4#1)(1997-6#7)(1997-8#3)(2004-9#5)(2005-11#10)(2005-12#6)(2005-8#3)(2006-8#1)(2007-11#15)(2007-12#1)(2007-8#7)(2007-9#4)(2008-1#1)(2008-10#37)(2008-12#12)(2008-2#4)(2008-3#11)(2008-4#2)(2008-5#12)(2008-7#7)(2008-8#5)(2009-10#12)(2009-11#3)(2009-12#2)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#5)(2010-4#15)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#5)(2011-2#2)(2012-1#2)(2012-12#4)(2012-2#5)(2013-1#5)(2013-7#1)(2013-8#8)
polymerization-induced##2##1##(2008-10#1)(2010-4#1)
polymerizations were##2##2##(2004-9#1)(2008-12#1)
polymerizations##10##1##(1994-9#1)(2004-9#1)(2005-11#2)(2007-11#2)(2008-12#1)(2008-3#2)(2010-2#1)
polymerize##6##1##(1990-6#1)(1995-2#1)(2007-12#1)(2008-3#1)(2012-1#1)(2013-1#1)
polymerized bovine hemoglobin##2##3##(1997-6#2)
polymerized form##2##2##(1990-6#2)
polymerized in the presence of##3##5##(1990-12#1)(1994-3#1)(1994-9#1)
polymerized in##4##2##(1990-12#1)(1994-3#1)(1994-9#1)(2012-2#1)
polymerized to form##2##3##(1991-7#1)(2009-7#1)
polymerized to##3##2##(1991-7#1)(2007-12#1)(2009-7#1)
polymerized with##2##2##(2007-9#1)(2009-3#1)
polymerized##42##1##(1990-12#1)(1990-6#2)(1991-7#1)(1991-9#1)(1993-3#1)(1993-8#1)(1994-3#2)(1994-5#1)(1994-9#3)(1995-2#1)(1996-2#2)(1997-2#1)(1997-4#1)(1997-6#2)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#3)(2009-12#2)(2009-3#1)(2009-7#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
polymerizes##2##1##(1994-5#1)(1994-9#1)
polymerizing##5##1##(1990-7#1)(1991-12#1)(2008-10#2)(2008-7#1)
polymers after##2##2##(1996-1#1)(2008-11#1)
polymers and interfaces for biology and medicine##2##7##(2012-11#2)
polymers and##33##2##(1990-3#1)(1991-7#1)(1996-11#1)(2005-11#1)(2006-2#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#4)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2012-11#6)(2012-2#1)
polymers are##11##2##(2005-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#2)(2009-11#1)(2009-12#2)(2009-7#1)
polymers as well as##2##4##(2005-11#1)(2008-11#1)
polymers as##8##2##(2005-11#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2010-10#1)
polymers based on##2##3##(1994-10#1)(2008-10#1)
polymers by##4##2##(1995-2#1)(2008-10#2)(2008-5#1)
polymers can##2##2##(2008-10#1)(2008-5#1)
polymers containing##3##2##(2007-12#1)(2013-1#2)
polymers could##3##2##(1996-6#1)(1997-7#1)(2011-1#1)
polymers demonstrated##3##2##(2008-10#1)(2010-4#1)(2010-8#1)
polymers do not##2##3##(2008-5#1)(2010-4#1)
polymers for the##3##3##(2007-11#1)(2008-2#1)(2008-7#1)
polymers for##12##2##(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#1)(2011-2#1)
polymers formed##3##2##(1990-7#2)(2008-6#1)
polymers from##3##2##(1995-3#1)(2008-12#1)(2009-9#1)
polymers have been##3##3##(2008-11#1)(2008-2#1)(2009-2#1)
polymers have##6##2##(1995-6#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-12#1)(2009-2#1)
polymers in soil##2##3##(2008-11#2)
polymers in##21##2##(1991-7#1)(1994-3#1)(1996-1#1)(1997-6#1)(1997-8#1)(2005-11#2)(2006-11#1)(2007-12#1)(2007-8#2)(2008-11#3)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#1)(2010-10#1)(2013-1#1)
polymers into the##2##3##(1992-11#1)(2010-2#1)
polymers is##3##2##(2008-2#1)(2008-3#1)(2009-12#1)
polymers like##3##2##(2008-7#1)(2011-1#2)
polymers may##2##2##(2005-11#1)(2008-12#1)
polymers offer##2##2##(2008-10#2)
polymers on the##2##3##(2005-11#1)(2010-12#1)
polymers on##5##2##(1994-9#1)(1995-3#1)(2005-11#1)(2009-12#1)(2010-12#1)
polymers or##3##2##(1993-12#1)(1995-6#1)(2007-12#1)
polymers prepared##2##2##(2008-10#1)(2010-5#1)
polymers show##3##2##(1995-11#1)(2007-9#1)(2008-7#1)
polymers such as##4##3##(1994-9#1)(2008-10#1)(2010-2#1)(2012-2#1)
polymers synthesized so that##2##4##(1990-5#2)
polymers synthesized##3##2##(1990-5#2)(2011-1#1)
polymers that are##3##3##(2007-12#1)(2008-5#1)(2010-5#1)
polymers that##10##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-5#1)(2011-1#1)
polymers the##2##2##(2004-9#1)(2008-10#1)
polymers to##7##2##(1995-11#1)(2005-11#1)(2007-8#1)(2008-7#1)(2008-9#1)(2009-12#1)(2013-1#1)
polymers under##3##2##(2006-12#1)(2008-10#1)(2008-5#1)
polymers used as##2##3##(2007-12#1)(2008-2#1)
polymers used##3##2##(2005-11#1)(2007-12#1)(2008-2#1)
polymers using##2##2##(2004-12#1)(2008-10#1)
polymers was##2##2##(2010-4#1)(2011-2#1)
polymers were constructed##2##3##(2005-11#1)(2008-10#1)
polymers were prepared##3##3##(2005-11#1)(2008-5#1)(2010-5#1)
polymers were##20##2##(1996-11#1)(2005-11#2)(2007-11#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#2)(2010-4#1)(2010-5#2)(2010-9#1)(2011-2#1)
polymers with a##2##3##(2008-10#1)(2008-5#1)
polymers with low##2##3##(2008-1#1)(2011-2#1)
polymers with##16##2##(1990-8#1)(1995-3#1)(2006-5#1)(2007-11#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2010-2#1)(2011-1#1)(2011-2#2)
polymers without the##2##3##(2005-11#1)(2006-12#1)
polymers##424##1##(1990-3#1)(1990-5#2)(1990-7#2)(1990-8#2)(1991-11#2)(1991-2#1)(1991-6#3)(1991-7#2)(1992-11#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-10#1)(1994-11#1)(1994-3#2)(1994-9#5)(1995-11#3)(1995-2#1)(1995-3#7)(1995-5#1)(1995-6#2)(1996-1#2)(1996-11#3)(1996-2#1)(1996-5#1)(1996-6#3)(1997-6#1)(1997-7#2)(1997-8#2)(2004-12#1)(2004-9#4)(2005-11#19)(2005-12#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#5)(2006-2#5)(2006-5#3)(2007-10#1)(2007-11#14)(2007-12#14)(2007-8#9)(2007-9#1)(2008-1#3)(2008-10#79)(2008-11#13)(2008-12#6)(2008-2#15)(2008-3#12)(2008-4#5)(2008-5#35)(2008-6#3)(2008-7#14)(2008-8#1)(2008-9#6)(2009-11#3)(2009-12#7)(2009-2#2)(2009-3#3)(2009-7#4)(2009-9#2)(2010-10#4)(2010-12#3)(2010-2#4)(2010-4#6)(2010-5#8)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#10)(2011-2#7)(2011-3#1)(2012-11#6)(2012-2#6)(2013-1#6)
polymetalates##2##1##(2009-11#2)
polymetallic##5##1##(2008-10#1)(2010-5#2)(2013-8#2)
polymethacrylate##3##1##(2007-11#1)(2009-8#2)
polymethacrylates##3##1##(2008-10#2)(2009-8#1)
polymethacrylic acid##2##2##(1990-12#1)(2008-10#1)
polymethacrylic-acid-co-vinyl-acetate (PMAVA)##2##2##(2008-10#2)
polymethine dyes##5##2##(1994-7#3)(2009-12#2)
polymethine##6##1##(1994-7#3)(2008-10#1)(2009-12#2)
polymethyl methacrylate (PMMA)##2##3##(2008-5#1)(2012-12#1)
polymethyl methacrylate##6##2##(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-12#1)(2013-8#1)
polymethylene chain##2##2##(1990-2#1)(1991-12#1)
polymethylene linker##2##2##(1992-11#1)(2008-10#1)
polymethylene##6##1##(1990-2#2)(1991-12#1)(1992-11#1)(1994-9#1)(2008-10#1)
polymethylmethacrylate (PMMA)##6##2##(2005-12#1)(2006-2#1)(2006-8#2)(2008-5#1)(2009-11#1)
polymethylmethacrylate##13##1##(2005-12#1)(2006-2#2)(2006-8#2)(2007-11#1)(2007-3#2)(2008-5#2)(2008-7#1)(2009-11#1)(2010-6#1)
polymicrobial##10##1##(2007-7#3)(2007-8#1)(2008-10#1)(2010-12#1)(2010-9#1)(2012-12#1)(2012-2#1)(2012-3#1)
polymodal receptors##3##2##(1993-12#1)(1994-2#2)
polymodal##8##1##(1992-3#1)(1993-12#1)(1994-2#2)(1995-12#1)(2007-5#1)(2008-4#1)(2008-8#1)
polymorph##5##1##(1992-7#1)(2005-11#1)(2008-12#1)(2011-3#2)
polymorpha##14##1##(1994-9#2)(1995-8#1)(1995-9#2)(1996-7#3)(1997-2#2)(1997-4#2)(2008-11#1)(2013-1#1)
polymorphic AFLP markers were##2##4##(2008-10#2)
polymorphic AFLP markers##3##3##(2008-10#3)
polymorphic AFLP##4##2##(2008-10#4)
polymorphic DNA fingerprints##2##3##(2008-10#2)
polymorphic DNA markers##12##3##(1994-8#1)(1996-12#1)(2008-10#9)(2008-5#1)
polymorphic DNA##96##2##(1993-12#2)(1994-8#1)(1995-6#1)(1996-10#1)(1996-12#1)(1997-8#1)(2005-10#1)(2005-11#2)(2007-1#3)(2007-10#1)(2007-7#1)(2008-10#73)(2008-5#4)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
polymorphic among##3##2##(1996-8#1)(2008-5#1)(2011-12#1)
polymorphic and##9##2##(1996-12#2)(2007-11#1)(2008-10#3)(2008-4#1)(2008-5#1)(2010-12#1)
polymorphic bands between##2##3##(1990-5#1)(2008-8#1)
polymorphic bands##9##2##(1990-5#1)(1992-5#1)(2005-10#1)(2008-10#3)(2008-12#1)(2008-8#2)
polymorphic di-##2##2##(1996-3#1)(2008-3#1)
polymorphic disease##2##2##(1990-6#1)(2008-4#1)
polymorphic epithelial mucin (PEM) is##2##5##(1990-12#1)(1992-5#1)
polymorphic epithelial mucin##3##3##(1990-12#2)(1992-5#1)
polymorphic for##4##2##(2008-10#2)(2008-5#1)(2008-9#1)
polymorphic fragments##3##2##(1995-6#2)(2008-10#1)
polymorphic genetic##2##2##(2008-9#1)(2011-1#1)
polymorphic in##4##2##(1995-3#1)(1997-5#1)(2008-10#1)(2011-2#1)
polymorphic individuals##2##2##(2008-5#2)
polymorphic layer##2##2##(2010-12#2)
polymorphic light eruption (PLE)##2##4##(2006-12#2)
polymorphic light eruption##4##3##(2006-12#3)(2008-5#1)
polymorphic loci in##4##3##(2008-10#1)(2008-5#1)(2008-9#2)
polymorphic loci on##2##3##(1996-11#1)(2008-5#1)
polymorphic loci were##2##3##(2008-10#1)(2008-5#1)
polymorphic loci##16##2##(1996-11#1)(2006-2#1)(2008-10#7)(2008-12#1)(2008-5#3)(2008-9#3)
polymorphic marker##3##2##(1997-5#1)(2011-1#2)
polymorphic markers associated with##2##4##(2008-10#1)(2008-7#1)
polymorphic markers##19##2##(1994-12#1)(1996-3#1)(1996-5#1)(1997-5#1)(1997-8#1)(2007-2#1)(2007-5#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-7#1)(2011-1#2)(2013-8#1)
polymorphic metabolism##2##2##(1996-3#1)(2008-8#1)
polymorphic metabolizing##2##2##(2008-4#1)(2010-2#1)
polymorphic microsatellite loci##4##3##(2006-5#1)(2008-10#1)(2008-9#1)(2009-2#1)
polymorphic microsatellite##6##2##(2006-5#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-2#1)(2013-8#1)
polymorphic microsatellites##3##2##(1994-3#2)(1994-8#1)
polymorphic minisatellite##3##2##(1995-1#1)(2008-3#2)
polymorphic patterns##2##2##(1990-5#1)(2008-1#1)
polymorphic positions##2##2##(2012-12#2)
polymorphic probes were##3##3##(2008-10#3)
polymorphic promoter##2##2##(2009-10#1)(2010-8#1)
polymorphic psychotic##2##2##(2012-2#2)
polymorphic restriction sites##2##3##(1990-7#1)(1997-4#1)
polymorphic site##5##2##(1996-5#2)(2007-2#1)(2008-4#2)
polymorphic sites in the##4##4##(2009-5#2)(2012-12#1)(2013-8#1)
polymorphic sites##9##2##(1996-11#2)(2008-10#1)(2008-12#1)(2009-5#3)(2012-12#1)(2013-8#1)
polymorphic ventricular tachycardia##6##3##(2006-9#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-5#1)(2013-1#1)
polymorphic ventricular##7##2##(2006-9#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-5#1)(2013-1#2)
polymorphic##336##1##(1990-12#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-5#3)(1992-6#4)(1992-8#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-8#4)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#4)(1995-9#1)(1996-10#1)(1996-11#3)(1996-12#3)(1996-2#1)(1996-3#6)(1996-4#2)(1996-5#4)(1996-8#2)(1997-4#2)(1997-5#4)(1997-8#3)(2005-10#3)(2005-11#3)(2006-12#3)(2006-2#2)(2006-5#1)(2006-6#1)(2006-9#2)(2007-1#5)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#120)(2008-11#1)(2008-12#8)(2008-3#3)(2008-4#9)(2008-5#17)(2008-7#2)(2008-8#6)(2008-9#8)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#6)(2010-12#5)(2010-2#3)(2010-6#1)(2010-8#2)(2011-1#6)(2011-12#2)(2011-2#4)(2012-12#7)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#3)
polymorphism (PCR-SSCP)##3##2##(1995-6#1)(2008-4#1)(2009-7#1)
polymorphism (SNP) and##2##3##(2012-12#1)(2012-3#1)
polymorphism (SNP) chip##2##3##(2013-1#1)(2013-8#1)
polymorphism (SNP) genotyping##2##3##(2008-4#2)
polymorphism (SNP)##22##2##(2008-10#2)(2008-4#2)(2008-7#3)(2009-5#1)(2009-7#1)(2010-2#1)(2012-12#1)(2012-2#2)(2012-3#6)(2012-5#1)(2013-1#1)(2013-8#1)
polymorphism (SSCP) analysis of the##2##5##(1996-6#1)(2008-10#1)
polymorphism (SSCP) analysis of##4##4##(1992-8#1)(1996-6#1)(2008-10#2)
polymorphism (SSCP) analysis##7##3##(1992-8#1)(1994-2#1)(1994-7#1)(1996-6#1)(2008-10#3)
polymorphism (SSCP)##10##2##(1992-8#1)(1994-2#1)(1994-7#1)(1996-6#1)(2005-10#1)(2008-10#3)(2008-4#1)(2008-8#1)
polymorphism among the##3##3##(2008-10#2)(2012-2#1)
polymorphism among##6##2##(1996-7#1)(1996-8#1)(2007-7#1)(2008-10#2)(2012-2#1)
polymorphism analyses of##3##3##(1996-12#1)(2008-10#2)
polymorphism analyses##5##2##(1996-12#1)(2008-10#4)
polymorphism analysis and##3##3##(1991-7#1)(1992-8#1)(2008-4#1)
polymorphism analysis for##2##3##(2008-10#2)
polymorphism analysis of the amplified##2##5##(2008-10#1)(2011-2#1)
polymorphism analysis of the##6##4##(1996-10#1)(2008-10#4)(2011-2#1)
polymorphism analysis of##14##3##(1996-10#1)(1997-4#1)(2005-8#1)(2008-10#10)(2011-2#1)
polymorphism analysis was##2##3##(2008-10#1)(2011-2#1)
polymorphism analysis##43##2##(1991-12#1)(1991-7#2)(1992-2#1)(1992-8#2)(1993-7#1)(1996-10#1)(1996-3#1)(1997-4#1)(2005-8#1)(2006-3#1)(2007-12#1)(2008-10#21)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-11#1)(2011-1#1)(2011-2#2)
polymorphism and risk of##3##4##(2007-5#1)(2011-2#1)(2013-1#1)
polymorphism and risk##4##3##(2007-10#1)(2007-5#1)(2011-2#1)(2013-1#1)
polymorphism and sequence diversity in##3##5##(2010-12#3)
polymorphism and sequence##4##3##(1997-4#1)(2010-12#3)
polymorphism and the##6##3##(1996-11#1)(2007-3#1)(2008-12#1)(2008-8#1)(2011-1#1)(2012-2#1)
polymorphism and##71##2##(1990-12#1)(1992-2#1)(1993-11#2)(1996-11#1)(1996-6#6)(1997-4#2)(1997-7#1)(2006-3#1)(2006-6#1)(2006-9#3)(2007-10#3)(2007-11#4)(2007-3#1)(2007-5#1)(2008-1#2)(2008-10#15)(2008-12#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#4)(2010-2#1)(2010-3#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
polymorphism as a risk factor##2##5##(1996-6#1)(2009-10#1)
polymorphism as a##5##3##(1994-5#1)(1995-6#1)(1996-6#1)(2008-12#1)(2009-10#1)
polymorphism as##7##2##(1994-5#1)(1995-6#1)(1996-6#1)(2005-10#1)(2008-11#1)(2008-12#1)(2009-10#1)
polymorphism assay##2##2##(1990-11#1)(2008-10#1)
polymorphism at both##2##3##(1996-10#1)(2008-9#1)
polymorphism at the##3##3##(1995-11#2)(2011-2#1)
polymorphism at##6##2##(1995-11#2)(1996-10#1)(2006-6#1)(2008-9#1)(2011-2#1)
polymorphism between the##3##3##(2007-10#1)(2008-10#1)(2008-8#1)
polymorphism between##6##2##(2005-11#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-1#1)
polymorphism but##2##2##(2010-10#1)(2010-6#1)
polymorphism by##2##2##(1993-11#1)(2012-12#1)
polymorphism can##3##2##(2008-1#1)(2008-9#2)
polymorphism could be##2##3##(2008-1#1)(2013-1#1)
polymorphism could##4##2##(2008-1#1)(2008-11#1)(2008-12#1)(2013-1#1)
polymorphism data##4##2##(2008-10#1)(2008-7#1)(2012-3#2)
polymorphism database##2##2##(2008-9#1)(2010-2#1)
polymorphism detected in this##2##4##(2008-10#1)(2008-5#1)
polymorphism detected##4##2##(1990-12#1)(2008-10#2)(2008-5#1)
polymorphism for##8##2##(1995-12#1)(1996-3#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-10#1)
polymorphism genetic##2##2##(2007-11#1)(2008-10#1)
polymorphism has been##2##3##(1990-2#1)(2012-1#1)
polymorphism has##6##2##(1990-2#1)(1997-9#1)(2006-6#1)(2010-6#1)(2012-1#2)
polymorphism in a##2##3##(1995-3#1)(2008-9#1)
polymorphism in alternative##2##3##(2007-11#1)(2008-12#1)
polymorphism in dopamine##2##3##(2008-9#1)(2012-1#1)
polymorphism in exon##2##3##(2007-11#1)(2012-2#1)
polymorphism in the promoter region of the plasminogen activator inhibitor-1##2##10##(2007-9#2)
polymorphism in the promoter region of##3##6##(2007-9#2)(2011-2#1)
polymorphism in the promoter##6##4##(1996-5#1)(2006-6#1)(2007-9#2)(2008-7#1)(2011-2#1)
polymorphism in the signal sequence of apolipoprotein B##2##8##(1993-9#2)
polymorphism in the##28##3##(1991-12#1)(1991-6#1)(1991-8#1)(1993-6#1)(1993-9#2)(1995-11#1)(1995-12#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-5#1)(1997-9#1)(2006-6#1)(2006-9#1)(2007-9#3)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#2)
polymorphism in two##2##3##(1993-9#1)(1995-3#1)
polymorphism in##89##2##(1991-10#1)(1991-12#1)(1991-6#1)(1991-8#1)(1991-9#1)(1993-6#1)(1993-9#3)(1995-11#1)(1995-12#3)(1995-3#3)(1995-9#1)(1996-3#4)(1996-5#2)(1996-6#1)(1997-1#3)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(1997-9#1)(2006-6#3)(2006-8#2)(2006-9#1)(2007-11#2)(2007-12#1)(2007-9#3)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#5)(2009-4#1)(2010-12#3)(2010-2#5)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-11#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
polymorphism is associated with##3##4##(2008-6#1)(2010-10#1)(2012-2#1)
polymorphism is not##2##3##(1996-9#1)(1997-7#1)
polymorphism is##13##2##(1995-9#1)(1996-4#1)(1996-9#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2010-10#1)(2011-2#2)(2012-2#1)
polymorphism maintained by##2##3##(1996-8#1)(2008-9#1)
polymorphism markers##15##2##(1997-4#1)(2008-10#13)(2008-8#1)
polymorphism may be##2##3##(1997-2#1)(2005-10#1)
polymorphism may##3##2##(1997-2#1)(2005-10#1)(2010-2#1)
polymorphism of CYP450 2C9 and##2##5##(2011-1#2)
polymorphism of DNA##2##3##(2008-10#1)(2008-5#1)
polymorphism of cholesteryl ester transfer protein gene##2##7##(2008-12#2)
polymorphism of genes##2##3##(2006-2#1)(2013-7#1)
polymorphism of the##19##3##(1990-3#1)(1991-10#1)(1991-5#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#2)(2009-5#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
polymorphism of these##2##3##(2012-12#1)(2013-8#1)
polymorphism of##70##2##(1990-3#1)(1990-5#1)(1991-10#1)(1991-5#1)(1992-3#1)(1993-2#1)(1995-9#1)(1996-11#1)(1996-3#4)(1996-4#1)(1996-5#1)(1996-6#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-6#2)(2007-11#2)(2007-3#1)(2008-10#9)(2008-12#4)(2008-5#2)(2008-8#2)(2009-5#2)(2010-12#2)(2011-1#7)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#1)
polymorphism on the##5##3##(2006-6#1)(2007-11#2)(2012-3#1)(2013-8#1)
polymorphism on##14##2##(1990-4#1)(2006-6#1)(2007-11#2)(2008-10#1)(2008-12#1)(2008-5#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
polymorphism or##3##2##(2008-10#1)(2010-6#1)(2012-2#1)
polymorphism revealed##2##2##(1992-5#1)(2010-6#1)
polymorphism that##4##2##(1992-8#1)(2008-10#2)(2011-2#1)
polymorphism using##2##2##(1996-11#1)(2008-10#1)
polymorphism was associated with##2##4##(2010-8#1)(2013-7#1)
polymorphism was detected##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
polymorphism was found##3##3##(2006-9#1)(2008-10#1)(2008-3#1)
polymorphism was not##2##3##(1997-8#1)(2012-1#1)
polymorphism was observed between##2##4##(1995-12#1)(2008-10#1)
polymorphism was observed##6##3##(1995-12#1)(2006-3#1)(2008-10#2)(2008-12#1)(2011-2#1)
polymorphism was##24##2##(1995-12#1)(1997-8#3)(2006-3#2)(2006-8#1)(2006-9#1)(2007-10#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-7#1)
polymorphism were##4##2##(1991-5#1)(2006-9#1)(2008-12#1)(2008-5#1)
polymorphism with the##2##3##(2008-9#1)(2011-1#1)
polymorphism with##10##2##(2008-10#2)(2008-8#1)(2008-9#3)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
polymorphism within##3##2##(1994-8#1)(1996-1#1)(2008-10#1)
polymorphism##773##1##(1990-11#1)(1990-12#4)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#1)(1991-10#3)(1991-12#2)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#3)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-8#4)(1992-9#1)(1993-10#1)(1993-11#4)(1993-2#2)(1993-6#1)(1993-7#2)(1993-9#3)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-11#5)(1995-12#6)(1995-3#3)(1995-6#4)(1995-9#4)(1996-1#1)(1996-10#4)(1996-11#4)(1996-12#2)(1996-3#14)(1996-4#5)(1996-5#4)(1996-6#13)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#4)(1997-2#2)(1997-3#1)(1997-4#9)(1997-5#4)(1997-7#3)(1997-8#6)(1997-9#2)(2005-10#5)(2005-11#2)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-3#4)(2006-4#1)(2006-6#10)(2006-8#4)(2006-9#6)(2007-10#6)(2007-11#15)(2007-12#10)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#2)(2007-9#3)(2008-1#7)(2008-10#236)(2008-11#3)(2008-12#23)(2008-2#3)(2008-3#2)(2008-4#8)(2008-5#15)(2008-6#3)(2008-7#13)(2008-8#11)(2008-9#19)(2009-10#2)(2009-4#2)(2009-5#8)(2009-6#1)(2009-7#2)(2010-10#4)(2010-11#1)(2010-12#12)(2010-2#13)(2010-3#2)(2010-4#1)(2010-6#7)(2010-8#2)(2010-9#1)(2011-1#19)(2011-12#1)(2011-2#21)(2011-3#2)(2012-1#12)(2012-11#1)(2012-12#9)(2012-2#19)(2012-3#14)(2012-5#1)(2013-1#15)(2013-7#3)(2013-8#8)
polymorphism)##6##1##(1992-8#1)(2006-8#1)(2007-2#1)(2010-10#1)(2012-12#2)
polymorphisms (RFLP)##2##2##(2008-10#2)
polymorphisms (SNPs) in##6##3##(2008-10#1)(2010-6#1)(2012-2#1)(2012-3#3)
polymorphisms (SNPs) on##2##3##(2012-1#1)(2012-3#1)
polymorphisms (SNPs) were detected##2##4##(2008-8#1)(2009-7#1)
polymorphisms (SNPs) were##3##3##(2008-7#1)(2008-8#1)(2009-7#1)
polymorphisms (SNPs)##46##2##(2005-8#1)(2006-12#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-2#2)(2012-3#17)(2013-1#2)
polymorphisms among##6##2##(2008-10#1)(2008-12#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
polymorphisms and mutations##3##3##(2005-8#1)(2008-7#2)
polymorphisms and the##3##3##(2008-1#1)(2011-1#1)(2013-1#1)
polymorphisms and their associations with##2##5##(2010-10#1)(2013-8#1)
polymorphisms and their##4##3##(2008-11#1)(2010-10#1)(2010-2#1)(2013-8#1)
polymorphisms and##43##2##(1990-6#1)(1993-11#1)(1996-4#1)(2005-10#2)(2005-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#3)(2009-4#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#3)(2011-12#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#2)
polymorphisms are associated with##2##4##(2010-2#1)(2012-3#1)
polymorphisms are##13##2##(1993-9#1)(2006-10#1)(2008-10#2)(2008-8#2)(2010-2#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#1)
polymorphisms associated with##3##3##(2008-4#1)(2010-4#1)(2012-12#1)
polymorphisms associated##4##2##(2008-4#1)(2010-4#1)(2012-12#1)(2012-2#1)
polymorphisms at the##4##3##(1996-12#1)(1997-7#1)(2008-10#1)(2012-12#1)
polymorphisms at##6##2##(1996-12#1)(1997-7#1)(2008-10#1)(2011-1#2)(2012-12#1)
polymorphisms between the##2##3##(2008-10#2)
polymorphisms between##6##2##(1991-8#1)(1993-9#1)(2008-10#4)
polymorphisms could##2##2##(1996-4#1)(2004-1#1)
polymorphisms detected in##2##3##(1996-6#1)(2010-3#1)
polymorphisms for##3##2##(2008-5#1)(2008-8#1)(2012-3#1)
polymorphisms has##2##2##(2008-12#1)(2012-12#1)
polymorphisms have been##4##3##(2008-5#1)(2009-5#1)(2010-12#1)(2012-12#1)
polymorphisms have##5##2##(2008-4#1)(2008-5#1)(2009-5#1)(2010-12#1)(2012-12#1)
polymorphisms in Atlantic cod##2##4##(2012-12#2)
polymorphisms in a##5##3##(2005-8#1)(2008-10#2)(2010-12#1)(2012-2#1)
polymorphisms in the IL4##2##4##(2008-7#2)
polymorphisms in the human##3##4##(1997-5#1)(1997-9#1)(2008-7#1)
polymorphisms in the##22##3##(1990-12#1)(1996-5#1)(1997-5#1)(1997-9#1)(2004-10#1)(2005-10#1)(2006-10#1)(2006-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-8#1)(2010-11#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
polymorphisms in these##3##3##(1994-8#1)(2005-11#1)(2010-2#1)
polymorphisms in this region##2##4##(1991-8#1)(2005-8#1)
polymorphisms in this##3##3##(1991-8#1)(2005-8#2)
polymorphisms in##72##2##(1990-12#1)(1991-8#1)(1992-3#2)(1993-11#1)(1994-8#1)(1996-10#1)(1996-5#1)(1997-5#1)(1997-9#1)(2004-10#2)(2005-10#1)(2005-11#1)(2005-8#3)(2006-10#1)(2006-11#1)(2006-8#1)(2007-6#1)(2008-10#11)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#3)(2009-8#1)(2010-11#1)(2010-12#3)(2010-2#3)(2011-2#1)(2012-1#3)(2012-12#5)(2012-2#6)(2012-3#2)(2013-1#2)(2013-8#1)
polymorphisms is##4##2##(1994-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
polymorphisms linked to the##2##4##(1990-3#1)(2011-2#1)
polymorphisms may##3##2##(2006-10#1)(2008-6#1)(2008-8#1)
polymorphisms of Y chromosome at YAP locus##2##7##(2008-9#2)
polymorphisms of the IL-1β gene##2##5##(2010-10#2)
polymorphisms of the##11##3##(1994-8#1)(2005-11#1)(2006-10#2)(2008-2#1)(2010-10#2)(2011-2#1)(2012-12#2)(2012-2#1)
polymorphisms of##40##2##(1994-12#1)(1994-8#1)(1994-9#1)(1997-8#1)(2005-11#1)(2006-10#2)(2007-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#2)(2010-12#2)(2010-6#2)(2010-8#2)(2011-1#5)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)
polymorphisms on##7##2##(1996-9#1)(2008-3#1)(2010-2#2)(2012-1#1)(2012-2#1)(2012-3#1)
polymorphisms rs1410996 CFH and rs10490924 ARMS2##2##6##(2013-1#2)
polymorphisms showed##3##2##(2007-10#1)(2008-5#2)
polymorphisms that##10##2##(1994-8#1)(1997-4#1)(2005-10#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-5#1)(2010-2#1)(2012-1#1)(2012-3#1)
polymorphisms to##3##2##(2007-7#1)(2008-10#1)(2012-3#1)
polymorphisms using##3##2##(2008-10#2)(2008-8#1)
polymorphisms were detected by##2##4##(2008-5#1)(2012-12#1)
polymorphisms were detected##4##3##(2008-10#1)(2008-5#2)(2012-12#1)
polymorphisms were identified in##2##4##(1997-4#1)(2013-7#1)
polymorphisms were identified##3##3##(1996-12#1)(1997-4#1)(2013-7#1)
polymorphisms were observed##2##3##(2008-10#2)
polymorphisms were useful##2##3##(2010-8#2)
polymorphisms were##22##2##(1996-12#1)(1996-3#1)(1997-4#2)(1997-5#1)(2008-10#5)(2008-2#1)(2008-5#2)(2009-12#1)(2010-2#2)(2010-8#4)(2012-12#1)(2013-7#1)
polymorphisms will##3##2##(1991-2#1)(2007-3#1)(2012-2#1)
polymorphisms with the##2##3##(2008-10#1)(2012-12#1)
polymorphisms with##11##2##(1996-12#1)(2005-10#1)(2007-10#1)(2008-10#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-4#1)(2012-12#1)(2012-3#1)(2013-8#1)
polymorphisms within the##2##3##(1997-9#1)(2013-7#1)
polymorphisms within##7##2##(1994-3#1)(1997-9#1)(2008-10#2)(2010-12#1)(2012-3#1)(2013-7#1)
polymorphisms##480##1##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-2#1)(1991-6#1)(1991-8#2)(1992-2#1)(1992-3#2)(1993-11#2)(1993-7#1)(1993-9#2)(1994-11#2)(1994-12#2)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#2)(1995-11#1)(1995-2#1)(1996-10#1)(1996-12#4)(1996-3#2)(1996-4#2)(1996-5#2)(1996-6#3)(1996-9#2)(1997-4#5)(1997-5#3)(1997-7#1)(1997-8#2)(1997-9#3)(2004-1#1)(2004-10#2)(2005-10#5)(2005-11#3)(2005-12#1)(2005-8#5)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#3)(2006-8#1)(2007-10#2)(2007-3#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#78)(2008-11#3)(2008-12#13)(2008-2#4)(2008-3#5)(2008-4#14)(2008-5#14)(2008-6#3)(2008-7#9)(2008-8#13)(2008-9#7)(2009-11#1)(2009-12#2)(2009-4#5)(2009-5#5)(2009-7#2)(2009-8#3)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#10)(2010-2#14)(2010-3#1)(2010-4#3)(2010-6#4)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#17)(2011-12#1)(2011-2#13)(2012-1#12)(2012-11#1)(2012-12#25)(2012-2#16)(2012-3#44)(2013-1#16)(2013-7#4)(2013-8#6)
polymorphonuclear cells (PMNs)##3##3##(2008-12#1)(2008-4#1)(2010-4#1)
polymorphonuclear cells##10##2##(1990-4#3)(1993-4#1)(2007-11#1)(2008-12#1)(2008-4#1)(2009-10#1)(2010-4#2)
polymorphonuclear granulocytes##2##2##(1995-7#1)(2008-10#1)
polymorphonuclear leucocytes and##2##3##(1991-11#1)(1991-8#1)
polymorphonuclear leucocytes##6##2##(1991-11#3)(1991-8#1)(1992-6#1)(1997-2#1)
polymorphonuclear leukocyte##4##2##(1991-7#1)(1992-12#1)(1993-6#1)(1993-8#1)
polymorphonuclear leukocytes (PMN)##5##3##(1993-11#1)(1994-3#1)(2008-4#3)
polymorphonuclear leukocytes (PMNL)##2##3##(1990-10#1)(2006-12#1)
polymorphonuclear leukocytes (PMNLs)##2##3##(1996-9#1)(2010-1#1)
polymorphonuclear leukocytes (PMNs)##7##3##(1991-1#1)(1991-7#1)(1991-9#1)(1993-3#1)(1995-1#1)(1995-6#1)(2008-12#1)
polymorphonuclear leukocytes were##2##3##(1990-3#1)(1992-12#1)
polymorphonuclear leukocytes with##2##3##(1994-9#1)(2006-6#1)
polymorphonuclear leukocytes##45##2##(1990-10#2)(1990-12#1)(1990-3#1)(1990-4#2)(1990-8#1)(1991-1#2)(1991-7#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-11#2)(1993-3#2)(1993-4#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#2)(1995-6#1)(1996-11#1)(1996-12#2)(1996-6#2)(1996-9#2)(1997-1#1)(1997-3#1)(2006-12#1)(2006-6#1)(2008-12#1)(2008-4#4)(2008-8#1)(2010-1#1)
polymorphonuclear neutrophils (PMNs)##3##3##(1993-6#1)(2009-10#1)(2012-12#1)
polymorphonuclear neutrophils##9##2##(1990-12#1)(1990-9#1)(1992-10#1)(1993-6#1)(1994-12#1)(1994-5#1)(2009-10#1)(2011-12#1)(2012-12#1)
polymorphonuclear##82##1##(1990-10#2)(1990-12#3)(1990-3#1)(1990-4#5)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#3)(1991-7#3)(1991-8#2)(1991-9#1)(1992-10#1)(1992-12#2)(1992-5#1)(1992-6#1)(1993-11#2)(1993-3#2)(1993-4#2)(1993-6#3)(1993-8#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#2)(1995-6#1)(1995-7#1)(1996-11#1)(1996-12#2)(1996-6#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-12#2)(2008-4#5)(2008-7#1)(2008-8#1)(2009-10#2)(2010-1#1)(2010-12#1)(2010-4#2)(2011-12#1)(2012-12#1)
polymorphous##6##1##(1997-7#1)(2007-7#1)(2008-11#1)(2008-5#1)(2010-12#1)(2010-6#1)
polymorphs##9##1##(1994-6#1)(2005-11#1)(2007-7#1)(2008-10#2)(2009-11#1)(2011-2#1)(2011-3#2)
polymorphy##2##1##(1990-9#1)(2008-10#1)
polymyalgia rheumatica and temporal arteritis##9##5##(1994-9#2)(1997-8#5)(2006-10#2)
polymyalgia rheumatica##20##2##(1994-11#2)(1994-9#4)(1995-4#1)(1997-8#5)(2006-10#6)(2008-7#2)
polymyalgia##21##1##(1994-11#2)(1994-9#4)(1995-4#1)(1997-8#5)(2006-10#6)(2008-7#3)
polymyositis and##3##2##(1995-5#1)(1996-11#1)(2010-12#1)
polymyositis##12##1##(1993-2#1)(1995-5#1)(1996-11#1)(1997-8#1)(2006-10#1)(2008-7#4)(2009-7#1)(2010-12#1)(2012-2#1)
polymyxin B##7##2##(1992-8#1)(1996-12#1)(2006-8#2)(2008-10#1)(2008-11#1)(2009-9#1)
polymyxins##3##1##(2008-10#3)
polyneuropathies##2##1##(1995-5#1)(2012-3#1)
polyneuropathy after##2##2##(2007-7#1)(2009-4#1)
polyneuropathy and##2##2##(1990-3#1)(2012-3#1)
polyneuropathy in a##2##3##(1992-1#1)(2005-1#1)
polyneuropathy in##6##2##(1990-5#2)(1992-1#1)(1994-6#1)(2005-1#1)(2008-7#1)
polyneuropathy or##2##2##(2013-7#2)
polyneuropathy##50##1##(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#2)(1992-1#2)(1992-12#1)(1992-8#2)(1993-1#1)(1994-6#1)(1995-11#1)(1995-5#1)(2005-1#2)(2006-10#1)(2006-12#2)(2007-11#1)(2007-7#1)(2008-1#5)(2008-2#1)(2008-7#4)(2009-4#1)(2010-11#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#4)(2013-7#2)
polynitroaromatic##3##1##(2008-10#3)
polynomial and##2##2##(1996-11#1)(2008-2#1)
polynomial approximation##3##2##(2007-11#2)(2008-10#1)
polynomial equation##2##2##(2008-3#1)(2011-12#1)
polynomial expansion##2##2##(2007-12#1)(2008-3#1)
polynomial in##4##2##(1990-8#1)(1993-5#1)(2008-2#1)(2008-6#1)
polynomial model##8##2##(2006-8#1)(2008-10#2)(2008-6#3)(2009-9#1)(2010-3#1)
polynomial models##2##2##(2008-10#1)(2009-9#1)
polynomial regression##4##2##(2007-8#1)(2008-3#2)(2012-2#1)
polynomial time##3##2##(2006-10#2)(2010-2#1)
polynomial##67##1##(1990-8#1)(1993-5#1)(1996-11#1)(2006-10#2)(2006-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#12)(2008-2#9)(2008-3#9)(2008-6#8)(2009-3#3)(2009-4#1)(2009-6#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-3#4)(2011-1#2)(2011-12#1)(2012-1#1)(2012-2#1)(2013-8#1)
polynomial-time##2##1##(2006-10#1)(2008-3#1)
polynomially decreasing##2##2##(2008-10#2)
polynomials are##5##2##(2008-2#3)(2008-6#1)(2009-12#1)
polynomials is##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
polynomials##29##1##(1993-5#1)(2007-12#3)(2008-10#1)(2008-2#8)(2008-3#12)(2008-6#2)(2009-12#2)
polynuclear aromatic hydrocarbons (PAH)##2##4##(2008-10#1)(2008-11#1)
polynuclear aromatic hydrocarbons in##3##4##(2008-10#3)
polynuclear aromatic hydrocarbons##10##3##(1994-9#2)(2007-7#1)(2008-10#6)(2008-11#1)
polynuclear complexes##2##2##(2008-10#1)(2008-3#1)
polynuclear species##2##2##(1996-8#1)(2008-10#1)
polynuclear##23##1##(1993-10#1)(1994-9#3)(1996-8#1)(1997-6#1)(2007-11#1)(2007-7#1)(2008-10#13)(2008-11#1)(2008-3#1)
polynucleated##3##1##(1993-8#2)(1994-11#1)
polynucleotide phosphorylase##4##2##(1996-5#1)(1997-2#2)(2012-3#1)
polynucleotide treated##2##2##(1991-2#2)
polynucleotide##12##1##(1991-2#3)(1992-6#1)(1995-1#1)(1996-5#1)(1997-2#2)(2006-12#1)(2007-6#1)(2008-4#1)(2012-3#1)
polynucleotides##13##1##(1993-3#1)(1994-6#1)(1994-8#1)(1995-5#1)(1997-2#1)(2005-4#2)(2006-10#3)(2006-12#1)(2008-10#1)(2008-4#1)
polyol accumulation##2##2##(1992-5#1)(2008-5#1)
polyol pathway and##2##3##(2008-1#2)
polyol pathway##5##2##(1992-3#1)(2004-11#1)(2008-1#2)(2011-2#1)
polyol##14##1##(1992-3#1)(1992-5#1)(2004-11#1)(2005-12#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-5#3)(2011-2#1)(2013-1#1)
polyoma large##2##2##(1995-2#2)
polyoma##12##1##(1991-4#2)(1992-8#1)(1994-8#1)(1994-9#1)(1995-2#6)(2006-7#1)
polyomavirus##10##1##(2008-5#7)(2009-3#1)(2011-2#1)(2013-1#1)
polyomavirus-associated nephropathy##2##2##(2007-8#1)(2011-2#1)
polyorchidism##3##1##(2008-6#3)
polyoxometalate##9##1##(2007-11#1)(2008-10#2)(2008-7#3)(2010-5#3)
polyoxometalates##8##1##(2005-11#2)(2008-10#5)(2010-5#1)
polyoxometallates##2##1##(2007-8#2)
polyoxotungstates##2##1##(2008-5#2)
polyoxyalkylene systems##2##2##(2008-10#2)
polyoxyalkylene##3##1##(2008-10#3)
polyoxyethylene chain##2##2##(2005-11#2)
polyoxyethylene##13##1##(1994-9#1)(2005-11#4)(2005-7#1)(2008-10#5)(2010-1#2)
polyp and##3##2##(2006-10#1)(2010-12#1)(2012-12#1)
polyp has##2##2##(2009-12#2)
polyp in##4##2##(2006-1#2)(2008-3#1)(2013-8#1)
polyp of the esophagus##2##4##(2007-8#1)(2009-7#1)
polyp of the##7##3##(2007-8#1)(2009-5#2)(2009-7#1)(2010-5#2)(2012-2#1)
polyp of##9##2##(2007-8#1)(2009-5#2)(2009-7#1)(2010-2#1)(2010-5#2)(2012-2#1)(2013-8#1)
polyp removal##2##2##(2008-5#2)
polyp was##2##2##(2007-8#1)(2010-12#1)
polyp with a##2##3##(2010-5#1)(2012-12#1)
polyp with##4##2##(1992-2#1)(2010-5#2)(2012-12#1)
polyp##73##1##(1992-2#1)(1993-3#1)(1993-9#3)(1994-2#1)(2006-1#3)(2006-10#1)(2006-6#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-5#3)(2008-7#1)(2009-12#5)(2009-5#4)(2009-7#3)(2009-8#1)(2010-12#5)(2010-2#2)(2010-3#2)(2010-5#6)(2010-6#1)(2011-1#1)(2011-12#2)(2011-2#8)(2012-12#3)(2012-2#4)(2013-8#2)
polyp]##3##1##(1994-3#1)(2011-2#1)(2012-1#1)
polyparasitism and##2##2##(2009-10#1)(2010-12#1)
polyparasitism##5##1##(2009-10#2)(2010-12#1)(2012-12#2)
polypectomy is##3##2##(1997-5#1)(2008-5#1)(2009-12#1)
polypectomy of##2##2##(1990-6#1)(2009-12#1)
polypectomy##23##1##(1990-6#2)(1993-10#1)(1993-9#1)(1994-2#1)(1997-5#4)(2006-2#1)(2007-5#2)(2007-8#1)(2008-5#2)(2009-12#5)(2011-2#3)
polypeptide (PACAP)##7##2##(1990-12#2)(1992-9#1)(1994-10#1)(1994-3#1)(1997-8#1)(2006-10#1)
polypeptide 1##5##2##(1990-7#1)(1995-8#1)(1996-12#3)
polypeptide and##10##2##(1990-2#1)(1990-3#1)(1990-5#1)(1991-1#1)(1992-1#1)(1993-2#1)(1994-11#1)(1994-5#1)(1994-8#1)(1997-8#1)
polypeptide antigen##5##2##(1990-10#2)(1990-8#2)(1992-7#1)
polypeptide are##5##2##(1990-8#1)(1994-12#1)(1994-9#1)(1997-5#1)(2010-7#1)
polypeptide associated##2##2##(1995-2#1)(2011-1#1)
polypeptide backbones of##2##3##(1994-3#1)(1995-3#1)
polypeptide backbones##4##2##(1994-3#1)(1995-3#1)(2008-10#1)(2009-2#1)
polypeptide bands with apparent MW in the range##2##8##(1996-12#2)
polypeptide bands with##3##3##(1996-12#3)
polypeptide chain consisting of##2##4##(1990-5#1)(2008-8#1)
polypeptide chain folds into##2##4##(1994-6#1)(1997-4#1)
polypeptide chain folds##3##3##(1994-6#1)(1994-8#1)(1997-4#1)
polypeptide chain is##2##3##(1992-9#1)(1995-4#1)
polypeptide chain of##12##3##(1990-10#1)(1990-9#1)(1991-4#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-6#1)(1997-1#1)(1997-7#1)
polypeptide chain release factor##2##4##(1994-12#2)
polypeptide chain##49##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-4#3)(1991-8#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#4)(1994-2#2)(1994-3#1)(1994-6#3)(1994-8#2)(1994-9#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-1#1)(1997-4#1)(1997-6#5)(1997-7#1)(2006-10#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#2)(2012-1#1)
polypeptide chains of##2##3##(1990-10#1)(1990-5#1)
polypeptide chains##20##2##(1990-10#1)(1990-5#1)(1990-7#1)(1991-7#1)(1992-6#1)(1992-8#1)(1993-9#1)(1994-11#2)(1995-4#3)(1995-6#2)(1995-8#1)(1996-12#1)(1996-4#3)(2011-1#1)
polypeptide components##2##2##(1990-11#1)(2008-4#1)
polypeptide composition of##2##3##(1991-3#1)(1992-12#1)
polypeptide composition##3##2##(1991-3#1)(1992-12#1)(1992-6#1)
polypeptide consisting of##3##3##(1990-3#1)(1995-8#1)(2011-2#1)
polypeptide containing##4##2##(1990-11#1)(1995-10#1)(1995-2#1)(1997-4#1)
polypeptide deduced from the##4##4##(1990-5#1)(1990-9#1)(1991-7#1)(1997-2#1)
polypeptide deduced from##5##3##(1990-5#1)(1990-9#1)(1991-7#1)(1997-2#1)(2008-10#1)
polypeptide derived##2##2##(1992-7#1)(1995-6#1)
polypeptide designated##3##2##(1991-2#1)(1992-3#1)(1993-11#1)
polypeptide domains##2##2##(1990-7#1)(1995-12#1)
polypeptide folding##2##2##(2005-10#2)
polypeptide folds##2##2##(1994-8#1)(1997-4#1)
polypeptide for##2##2##(1994-5#1)(2008-4#1)
polypeptide fragments##2##2##(1992-1#1)(1993-8#1)
polypeptide from##3##2##(1990-8#1)(1995-4#1)(2008-10#1)
polypeptide gramicidin A##2##3##(1991-5#1)(1995-10#1)
polypeptide growth factor##3##3##(1992-11#1)(1993-5#1)(2008-4#1)
polypeptide growth factors like##2##4##(1991-10#1)(1996-11#1)
polypeptide growth##6##2##(1991-10#2)(1992-11#1)(1993-5#1)(1996-11#1)(2008-4#1)
polypeptide has##6##2##(1990-6#1)(1994-5#2)(1995-5#1)(1995-6#1)(1996-12#1)
polypeptide hormone##3##2##(1991-6#1)(2007-8#1)(2008-4#1)
polypeptide in rat##2##3##(1991-9#1)(1992-1#1)
polypeptide in the##2##3##(1992-6#1)(1993-8#1)
polypeptide in##13##2##(1990-11#1)(1991-7#1)(1991-9#2)(1992-1#2)(1992-6#1)(1992-8#1)(1993-8#1)(1994-12#2)(1995-6#1)(1997-4#1)
polypeptide into##3##2##(1991-7#1)(1992-6#1)(1995-8#1)
polypeptide is homologous##2##3##(1995-1#2)
polypeptide is located##2##3##(1994-12#1)(1996-7#1)
polypeptide is##17##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-1#1)(1992-11#1)(1992-5#1)(1993-12#1)(1993-3#1)(1994-12#2)(1994-8#1)(1995-1#2)(1995-5#1)(1996-10#1)(1996-7#1)(1997-8#1)
polypeptide of 33##3##3##(1992-8#1)(1996-5#1)(2008-10#1)
polypeptide of Mr##5##3##(1990-1#1)(1990-5#1)(1991-1#1)(1991-4#1)(1992-7#1)
polypeptide of approximately##6##3##(1992-10#1)(1996-10#1)(1996-2#1)(1997-7#1)(2008-10#2)
polypeptide of the##3##3##(1990-8#1)(1996-10#1)(2006-12#1)
polypeptide of##64##2##(1990-1#3)(1990-11#2)(1990-3#1)(1990-4#2)(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-4#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-7#2)(1992-8#1)(1993-1#1)(1993-11#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-4#1)(1995-6#1)(1995-8#3)(1996-10#6)(1996-2#1)(1996-5#3)(1996-7#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2006-12#1)(2008-10#3)(2008-8#1)(2008-9#1)(2013-1#1)
polypeptide on##2##2##(1990-8#1)(1991-9#1)
polypeptide or##4##2##(1992-6#1)(1993-3#1)(2006-10#1)(2008-5#1)
polypeptide predicted from the##2##4##(1991-9#1)(1992-8#1)
polypeptide products##2##2##(1990-7#1)(1990-8#1)
polypeptide receptor##3##2##(1994-12#1)(1994-3#1)(1997-8#1)
polypeptide recognized by a monoclonal antibody##2##6##(1995-3#2)
polypeptide segment##3##2##(1990-12#1)(1995-3#1)(1995-8#1)
polypeptide sequence##4##2##(1993-2#1)(1994-11#1)(1994-8#1)(1996-10#1)
polypeptide sequences##2##2##(1994-8#1)(1995-7#1)
polypeptide signal in plants##2##4##(2008-8#2)
polypeptide signal in##3##3##(2008-8#3)
polypeptide subunit of the##2##4##(1996-7#1)(1997-7#1)
polypeptide subunit of##3##3##(1990-7#1)(1996-7#1)(1997-7#1)
polypeptide subunit##4##2##(1990-7#1)(1993-4#1)(1996-7#1)(1997-7#1)
polypeptide synthesis##3##2##(1993-12#1)(1995-5#1)(2008-7#1)
polypeptide that was##2##3##(1991-11#1)(1994-8#1)
polypeptide that##15##2##(1991-11#1)(1991-12#1)(1991-3#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-1#1)(1997-3#1)(1997-7#1)(2010-12#1)
polypeptide to##6##2##(1990-3#1)(1990-5#2)(1993-8#1)(2006-10#1)(2012-1#1)
polypeptide using##2##2##(1992-7#1)(1996-2#1)
polypeptide was##15##2##(1990-3#1)(1990-9#1)(1991-1#3)(1991-10#1)(1993-1#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-9#1)(1997-6#1)(2008-8#2)(2008-9#1)
polypeptide were##2##2##(1994-8#1)(1995-3#1)
polypeptide which##3##2##(1990-11#2)(1993-3#1)
polypeptide whose##3##2##(1990-3#1)(1992-8#1)(1995-5#1)
polypeptide with a##10##3##(1990-9#1)(1991-12#1)(1991-2#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-9#1)(1995-1#1)(1997-2#1)(2008-10#1)
polypeptide with an apparent molecular##2##5##(1990-6#1)(1993-11#1)
polypeptide with an apparent##3##4##(1990-2#1)(1990-6#1)(1993-11#1)
polypeptide with an##4##3##(1990-2#1)(1990-6#1)(1993-11#1)(1995-9#1)
polypeptide with##21##2##(1990-10#1)(1990-2#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-6#1)(1994-9#2)(1995-1#1)(1995-9#1)(1997-2#1)(2008-10#1)
polypeptide##596##1##(1990-1#3)(1990-10#5)(1990-11#13)(1990-12#7)(1990-2#6)(1990-3#8)(1990-4#5)(1990-5#19)(1990-6#2)(1990-7#10)(1990-8#13)(1990-9#5)(1991-1#10)(1991-10#7)(1991-11#2)(1991-12#5)(1991-2#5)(1991-3#4)(1991-4#5)(1991-5#5)(1991-6#1)(1991-7#6)(1991-8#3)(1991-9#7)(1992-1#5)(1992-10#1)(1992-11#7)(1992-12#7)(1992-3#5)(1992-4#3)(1992-5#1)(1992-6#7)(1992-7#6)(1992-8#9)(1992-9#10)(1993-1#2)(1993-11#4)(1993-12#6)(1993-2#4)(1993-3#9)(1993-4#3)(1993-5#3)(1993-6#3)(1993-7#3)(1993-8#8)(1993-9#4)(1994-10#5)(1994-11#10)(1994-12#19)(1994-2#2)(1994-3#8)(1994-5#5)(1994-6#4)(1994-8#13)(1994-9#12)(1995-1#3)(1995-10#6)(1995-11#3)(1995-12#2)(1995-2#9)(1995-3#8)(1995-4#6)(1995-5#7)(1995-6#11)(1995-7#1)(1995-8#13)(1995-9#2)(1996-10#8)(1996-11#2)(1996-12#9)(1996-2#5)(1996-3#3)(1996-4#4)(1996-5#6)(1996-6#2)(1996-7#6)(1996-8#7)(1996-9#2)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#6)(1997-5#3)(1997-6#11)(1997-7#6)(1997-8#9)(2005-10#3)(2005-11#1)(2006-10#7)(2006-12#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#3)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-4#8)(2008-5#2)(2008-7#3)(2008-8#11)(2008-9#3)(2009-2#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#2)(2013-8#1)
polypeptide(s)##2##1##(1991-10#1)(1994-12#1)
polypeptides and##10##2##(1991-1#1)(1991-2#2)(1991-5#1)(1994-12#1)(1995-2#1)(1995-4#1)(1996-8#1)(2008-5#1)(2009-2#1)
polypeptides are also##2##3##(1994-8#1)(1996-11#1)
polypeptides are##15##2##(1990-6#1)(1991-10#1)(1992-1#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-5#2)(1994-8#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-6#1)(2007-12#1)(2012-1#1)
polypeptides as##3##2##(1991-3#1)(1997-2#1)(2008-7#1)
polypeptides by##2##2##(1991-7#1)(1994-5#1)
polypeptides comprising the##2##3##(1993-3#1)(1995-2#1)
polypeptides consisting of##2##3##(1994-12#1)(2008-5#1)
polypeptides containing##3##2##(1994-11#1)(2008-4#1)(2010-7#1)
polypeptides encoded by the##2##4##(1990-8#1)(1997-1#1)
polypeptides expressed##2##2##(1990-3#1)(2007-5#1)
polypeptides from##4##2##(1990-8#1)(1997-4#1)(2008-5#1)(2008-7#1)
polypeptides have been##2##3##(1994-12#1)(1995-2#1)
polypeptides in respiratory washings and to##2##6##(2008-5#2)
polypeptides in the##3##3##(1993-11#1)(2008-5#1)(2008-9#1)
polypeptides in which##2##3##(1995-5#1)(2012-12#1)
polypeptides in##16##2##(1990-6#1)(1991-1#1)(1991-7#1)(1993-11#1)(1993-6#1)(1994-12#1)(1995-5#1)(2008-4#3)(2008-5#3)(2008-9#2)(2012-12#1)
polypeptides is##2##2##(1991-7#1)(2008-1#1)
polypeptides may##2##2##(1991-10#1)(1994-9#1)
polypeptides of M##2##3##(2008-5#2)
polypeptides of Mr##2##3##(1992-1#1)(1992-6#1)
polypeptides of the##5##3##(1990-5#1)(1994-8#1)(1997-4#2)(1997-6#1)
polypeptides of##24##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-10#1)(1997-4#2)(1997-6#1)(2008-5#2)(2008-9#1)
polypeptides reacting with##2##3##(1991-10#2)
polypeptides that have##3##3##(1996-8#1)(2008-5#1)(2009-8#1)
polypeptides that##10##2##(1990-7#1)(1991-3#1)(1993-6#1)(1994-11#1)(1995-5#1)(1996-8#1)(1997-4#1)(2007-11#1)(2008-5#1)(2009-8#1)
polypeptides was##6##2##(1991-12#1)(1993-11#1)(1994-11#1)(1994-12#1)(1995-5#1)(2008-4#1)
polypeptides were the##2##3##(1991-1#1)(1993-11#1)
polypeptides were##12##2##(1991-1#3)(1993-11#3)(1993-9#1)(1994-12#2)(1994-5#1)(1994-9#1)(2008-7#1)
polypeptides which##2##2##(1991-6#1)(2012-12#1)
polypeptides with molecular masses of##2##5##(1990-2#1)(1991-10#1)
polypeptides with molecular weights of##2##5##(1990-12#1)(1990-7#1)
polypeptides with molecular##5##3##(1990-12#1)(1990-2#1)(1990-7#1)(1991-10#1)(2005-11#1)
polypeptides with##13##2##(1990-12#3)(1990-2#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-3#1)(1992-11#1)(1994-2#1)(1995-3#1)(2005-11#1)(2011-2#1)
polypeptides##238##1##(1990-10#1)(1990-11#1)(1990-12#5)(1990-2#2)(1990-3#3)(1990-4#2)(1990-5#2)(1990-6#3)(1990-7#4)(1990-8#4)(1990-9#1)(1991-1#8)(1991-10#10)(1991-12#2)(1991-2#6)(1991-3#7)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#2)(1993-11#10)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#6)(1993-9#3)(1994-11#6)(1994-12#11)(1994-2#2)(1994-5#6)(1994-8#4)(1994-9#5)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#6)(1995-3#4)(1995-4#1)(1995-5#4)(1995-6#3)(1995-8#4)(1996-10#1)(1996-11#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#5)(1997-1#1)(1997-2#2)(1997-4#5)(1997-6#3)(2005-11#1)(2005-7#1)(2006-3#1)(2007-11#5)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-11#2)(2008-4#7)(2008-5#12)(2008-7#3)(2008-8#3)(2008-9#3)(2009-2#1)(2009-6#1)(2009-8#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#2)(2013-8#1)
polypeptidic##3##1##(1993-3#1)(1994-11#1)(2008-5#1)
polyphagous species##2##2##(2007-3#1)(2011-2#1)
polyphagous##9##1##(2004-2#1)(2006-12#1)(2007-3#2)(2008-5#1)(2008-8#1)(2011-12#1)(2011-2#1)(2013-7#1)
polypharmacotherapy strategy##2##2##(2009-4#2)
polypharmacotherapy##3##1##(2009-4#3)
polypharmacy and##2##2##(2006-12#1)(2008-7#1)
polypharmacy in the##2##3##(2005-1#1)(2011-2#1)
polypharmacy is##3##2##(2008-1#1)(2010-4#1)(2011-2#1)
polypharmacy##22##1##(1991-8#1)(2005-1#2)(2005-6#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-4#2)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)
polyphemus##5##1##(2007-12#4)(2009-12#1)
polyphenol in##2##2##(2007-8#2)
polyphenol index##3##2##(2008-10#3)
polyphenol oxidase (PPO)##6##3##(2006-12#1)(2008-10#5)
polyphenol oxidase into##2##3##(2008-10#2)
polyphenol oxidase##16##2##(2006-12#2)(2008-10#14)
polyphenol##39##1##(1995-9#2)(2006-10#1)(2006-12#2)(2007-8#5)(2008-10#19)(2009-12#2)(2009-3#1)(2010-2#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
polyphenol-rich##2##1##(2008-10#2)
polyphenolic compounds in wastewater##2##4##(2008-10#2)
polyphenolic compounds##15##2##(1992-9#3)(1997-8#1)(2005-10#1)(2006-12#1)(2008-10#4)(2008-5#2)(2010-4#1)(2011-2#1)(2013-1#1)
polyphenolic constituents##2##2##(2008-10#1)(2012-2#1)
polyphenolic##25##1##(1992-7#1)(1992-9#3)(1993-9#1)(1997-8#1)(2005-10#1)(2006-12#1)(2008-10#6)(2008-11#1)(2008-5#2)(2009-12#1)(2010-12#2)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#1)
polyphenolics##2##1##(1992-9#1)(2008-10#1)
polyphenoloxidase##3##1##(2008-10#3)
polyphenols and##6##2##(2005-7#1)(2007-8#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
polyphenols are##3##2##(1996-1#1)(2009-12#1)(2012-12#1)
polyphenols can##2##2##(2009-3#2)
polyphenols extraction##2##2##(2009-6#1)(2013-1#1)
polyphenols from##2##2##(2012-12#1)(2013-1#1)
polyphenols have been shown to##2##5##(2012-12#2)
polyphenols have been##3##3##(2008-10#1)(2012-12#2)
polyphenols in##9##2##(1996-1#1)(2008-10#3)(2008-4#1)(2009-12#1)(2009-3#1)(2009-8#2)
polyphenols may##4##2##(2008-7#1)(2009-12#1)(2009-8#1)(2011-2#1)
polyphenols with##2##2##(2008-10#1)(2009-6#1)
polyphenols##70##1##(1993-9#1)(1996-1#5)(2005-7#1)(2007-8#1)(2008-10#14)(2008-4#1)(2008-5#3)(2008-7#2)(2009-12#6)(2009-3#10)(2009-6#2)(2009-8#6)(2010-2#1)(2011-2#2)(2011-3#1)(2012-12#7)(2012-2#2)(2013-1#4)(2013-8#1)
polyphenols-rich foods##2##2##(2012-12#2)
polyphenylalanine synthesis##2##2##(1996-2#2)
polyphosphate##16##1##(1992-2#1)(1993-12#2)(1994-11#3)(1995-3#1)(1996-7#1)(1997-1#1)(2007-6#1)(2008-10#2)(2009-2#4)
polyphosphates in##4##2##(1994-11#2)(1997-4#1)(2008-10#1)
polyphosphates were##2##2##(1992-2#1)(1994-11#1)
polyphosphates##17##1##(1992-2#2)(1994-11#3)(1996-5#1)(1996-7#1)(1997-4#2)(1997-7#2)(2008-10#3)(2008-4#2)(2009-2#1)
polyphosphoinositide##4##1##(1991-5#1)(1995-5#1)(2008-8#1)(2012-2#1)
polyphosphoinositides##9##1##(1990-11#1)(1990-3#1)(1991-5#1)(1993-11#1)(1993-6#1)(1994-12#1)(2009-6#1)(2012-2#2)
polyphyletic##6##1##(1995-11#1)(2007-12#1)(2008-10#4)
polyphylla var##3##2##(2012-3#1)(2013-1#2)
polypill##3##1##(2010-8#1)(2011-1#2)
polyplexes in HT-treated tumors##2##4##(2009-10#2)
polyplexes##6##1##(2009-10#5)(2011-2#1)
polyploid hybrid##2##2##(2008-9#1)(2009-2#1)
polyploid##18##1##(1991-11#1)(1993-3#1)(1995-8#1)(2006-5#1)(2008-10#1)(2008-5#1)(2008-9#3)(2009-12#1)(2009-2#1)(2010-3#2)(2011-1#1)(2011-12#1)(2012-3#2)(2013-1#1)
polyploidization by##2##2##(1994-11#1)(2009-12#1)
polyploidization was##2##2##(1994-11#2)
polyploidization##12##1##(1994-11#5)(2006-10#1)(2007-12#1)(2008-7#2)(2009-12#1)(2013-1#1)(2013-8#1)
polyploids##5##1##(2007-12#2)(2008-9#1)(2009-2#2)
polyploidy##5##1##(2006-5#1)(2007-12#1)(2008-9#2)(2009-2#1)
polypoid granulation##3##2##(2008-1#3)
polypoid lesion##4##2##(1993-9#2)(2009-2#1)(2013-1#1)
polypoid lesions in##5##3##(2008-5#1)(2013-1#4)
polypoid lesions##9##2##(2006-2#1)(2008-5#1)(2013-1#7)
polypoid tumor with##2##3##(1997-8#1)(2008-11#1)
polypoid tumor##6##2##(1991-12#1)(1997-8#1)(2006-1#1)(2007-8#1)(2008-11#1)(2013-8#1)
polypoid##34##1##(1991-12#1)(1992-6#1)(1993-9#2)(1997-8#1)(2006-1#1)(2006-2#2)(2007-8#1)(2008-1#3)(2008-11#1)(2008-5#2)(2009-2#1)(2009-7#1)(2010-12#2)(2010-2#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#8)(2013-7#1)(2013-8#2)
polypoidal lesions in the nasal cavity##3##6##(2013-8#3)
polypoidal lesions in the##4##4##(2013-8#4)
polypoidal lesions##5##2##(2013-8#5)
polypoidal##7##1##(2013-1#1)(2013-8#6)
polyposis (MAP)##2##2##(2009-12#1)(2010-11#1)
polyposis and##7##2##(1990-6#1)(1991-6#1)(1993-4#1)(1996-2#1)(2005-11#1)(2009-2#1)(2012-3#1)
polyposis coli##13##2##(1990-3#1)(1997-5#2)(1997-6#1)(2006-2#1)(2007-4#1)(2009-12#1)(2009-5#1)(2010-12#1)(2012-1#2)(2012-2#2)
polyposis is##2##2##(2009-12#1)(2010-2#1)
polyposis syndromes##3##2##(1995-9#1)(2009-12#1)(2010-11#1)
polyposis##65##1##(1990-3#1)(1990-6#3)(1991-6#1)(1993-10#1)(1993-12#1)(1993-4#1)(1993-5#1)(1995-9#2)(1996-2#1)(1997-5#6)(1997-6#1)(2005-11#1)(2006-10#1)(2006-2#4)(2007-3#1)(2007-4#1)(2008-11#1)(2008-3#1)(2008-4#2)(2009-12#13)(2009-2#1)(2009-5#1)(2010-11#4)(2010-12#2)(2010-2#1)(2011-12#1)(2011-2#4)(2012-1#4)(2012-2#2)(2012-3#1)
polypous##2##1##(2008-5#1)(2012-2#1)
polyprenyl##3##1##(1993-4#2)(2008-11#1)
polypropylene and human hair##3##4##(2012-3#3)
polypropylene and##4##2##(2008-10#1)(2012-3#3)
polypropylene coatings##3##2##(2005-11#3)
polypropylene fiber##3##2##(2012-3#3)
polypropylene glycol##4##2##(2004-9#1)(2008-10#1)(2008-7#1)(2012-3#1)
polypropylene mesh##5##2##(1996-9#1)(2008-12#1)(2008-7#1)(2010-1#1)(2010-4#1)
polypropylene##49##1##(1990-10#1)(1991-8#1)(1992-7#1)(1996-12#1)(1996-9#1)(2004-9#1)(2005-11#4)(2006-6#2)(2007-11#2)(2007-12#3)(2007-8#1)(2008-10#9)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2010-1#1)(2010-4#1)(2010-7#2)(2012-3#9)
polyprotein of 3##2##3##(2008-10#2)
polyprotein of##4##2##(2008-10#3)(2008-8#1)
polyprotein processing##3##2##(2011-1#2)(2012-2#1)
polyprotein substrates##2##2##(1991-9#1)(2011-1#1)
polyprotein##24##1##(1991-9#1)(1992-6#1)(1994-11#2)(2008-10#9)(2008-8#2)(2008-9#2)(2009-7#1)(2011-1#3)(2012-2#2)(2013-8#1)
polyproteins and##2##2##(1993-6#1)(2011-1#1)
polyproteins##5##1##(1993-6#1)(2008-10#1)(2011-1#3)
polyps and allergic##2##3##(2010-6#1)(2012-1#1)
polyps and##16##2##(2006-2#2)(2009-1#1)(2009-12#1)(2009-8#2)(2010-5#1)(2010-6#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
polyps are##8##2##(1997-8#1)(2006-8#1)(2009-12#4)(2011-2#1)(2013-8#1)
polyps at##2##2##(1990-11#1)(1997-8#1)
polyps in the colon##2##4##(2006-2#2)
polyps in the##4##3##(2006-2#2)(2011-2#1)(2012-1#1)
polyps in##9##2##(2006-2#2)(2007-4#1)(2008-11#1)(2008-3#1)(2010-2#1)(2011-2#2)(2012-1#1)
polyps is##2##2##(2006-6#1)(2009-12#1)
polyps of the colon##2##4##(1993-5#1)(1997-5#1)
polyps of the##4##3##(1993-5#1)(1993-9#2)(1997-5#1)
polyps of##5##2##(1993-5#1)(1993-9#2)(1997-5#1)(2010-2#1)
polyps or##4##2##(2005-11#1)(2009-12#1)(2013-1#1)(2013-7#1)
polyps that##2##2##(2006-2#1)(2009-12#1)
polyps the##2##2##(1993-9#1)(1996-12#1)
polyps was##3##2##(1993-9#1)(2010-2#1)(2011-2#1)
polyps were##3##2##(2006-6#1)(2012-1#1)(2013-1#1)
polyps with##2##2##(2006-2#1)(2009-12#1)
polyps##144##1##(1990-11#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-5#1)(1993-5#1)(1993-9#6)(1994-2#2)(1995-9#1)(1996-12#1)(1997-5#1)(1997-8#5)(2004-10#1)(2005-11#1)(2006-10#1)(2006-2#10)(2006-6#2)(2006-8#1)(2007-11#1)(2007-3#2)(2007-4#2)(2007-5#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-3#5)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#2)(2009-1#1)(2009-12#19)(2009-2#1)(2009-5#1)(2009-8#3)(2010-11#1)(2010-12#1)(2010-2#8)(2010-5#2)(2010-6#4)(2011-1#2)(2011-2#13)(2012-1#4)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#4)
polyps?##2##1##(2011-2#1)(2013-1#1)
polypurine sequence##2##2##(1996-4#1)(1996-8#1)
polypurine tract##6##2##(1990-6#2)(1995-8#1)(1996-4#2)(2012-3#1)
polypurine tracts##2##2##(1990-6#1)(1994-2#1)
polypurine##10##1##(1990-6#3)(1994-2#1)(1995-8#1)(1996-4#3)(1996-8#1)(2012-3#1)
polypyridyl complexes##3##2##(2008-5#3)
polypyrimidine target##2##2##(2006-12#2)
polypyrimidine tract binding protein##2##4##(2008-1#1)(2008-9#1)
polypyrimidine##7##1##(1993-6#1)(1997-5#1)(2006-12#3)(2008-1#1)(2008-9#1)
polypyrrole (PPY)##2##2##(2008-10#2)
polypyrrole (PPy)##4##2##(2008-10#3)(2008-4#1)
polypyrrole and##4##2##(2008-10#3)(2010-11#1)
polypyrrole as##2##2##(2007-9#1)(2008-5#1)
polypyrrole electrode modified with a##2##5##(2008-10#2)
polypyrrole electrode modified##3##3##(2008-10#3)
polypyrrole electrode##4##2##(2008-10#4)
polypyrrole film##9##2##(2007-9#2)(2008-10#7)
polypyrrole on##2##2##(2008-10#1)(2009-2#1)
polypyrrole##51##1##(2006-12#1)(2007-9#7)(2008-10#36)(2008-4#1)(2008-5#3)(2009-2#2)(2010-11#1)
polypyrrole/beta-cyclodextrin (Ppy/beta-CD) film##2##3##(2008-10#2)
polyquaternium-1 (PQ)##2##2##(2005-11#2)
polyradiculoneuropathy##11##1##(1995-5#2)(2006-1#2)(2007-8#2)(2008-2#2)(2008-7#1)(2012-12#1)(2013-8#1)
polyradiculopathy##2##1##(1991-2#1)(2011-2#1)
polyreactive##2##1##(1994-11#1)(2008-5#1)
polyrhiza accumulated##2##2##(2011-1#2)
polyrhiza##8##1##(2011-1#8)
polyribonucleotides##2##1##(1990-8#1)(2008-10#1)
polyribosomal distribution of P450IIE1 mRNA##2##5##(1990-10#2)
polyribosomal distribution of##3##3##(1990-10#3)
polyribosomal distribution##4##2##(1990-10#4)
polyribosomal fractions##2##2##(1990-10#2)
polyribosomal##7##1##(1990-10#7)
polyribosomes##3##1##(1990-10#1)(2010-8#1)(2012-2#1)
polyribosylribitol phosphate##2##2##(1991-2#1)(2008-4#1)
polyribosylribitol##3##1##(1991-2#2)(2008-4#1)
polysaccharide and##6##2##(1990-3#1)(1991-2#1)(1991-7#1)(2006-8#1)(2009-2#1)(2012-12#1)
polysaccharide antigens##2##2##(2010-12#1)(2010-4#1)
polysaccharide chains##2##2##(1992-3#1)(2008-5#1)
polysaccharide conjugate vaccine##2##3##(1994-9#1)(1997-3#1)
polysaccharide from a##2##3##(1992-7#1)(1996-4#1)
polysaccharide from##7##2##(1991-12#1)(1991-9#1)(1992-7#1)(1995-11#1)(1995-4#1)(1996-10#1)(1996-4#1)
polysaccharide has##2##2##(1990-3#1)(1995-11#1)
polysaccharide hemospheres##5##2##(2009-3#5)
polysaccharide in##3##2##(1991-7#1)(2007-11#1)(2013-8#1)
polysaccharide is##5##2##(1991-7#1)(1995-11#2)(1996-7#1)(2012-3#1)
polysaccharide of##5##2##(1990-12#1)(1991-9#1)(1995-4#1)(1995-6#1)(2007-10#1)
polysaccharide vaccine for typhoid##2##4##(2010-12#2)
polysaccharide vaccine##10##2##(1994-9#2)(2010-12#4)(2010-9#1)(2012-12#2)(2013-1#1)
polysaccharide was##5##2##(1990-3#3)(1996-4#1)(2012-3#1)
polysaccharide with##2##2##(1991-7#1)(1995-4#1)
polysaccharide##145##1##(1990-12#1)(1990-2#1)(1990-3#7)(1990-4#1)(1991-12#8)(1991-2#1)(1991-3#1)(1991-7#10)(1991-9#3)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-6#1)(1994-3#1)(1994-9#4)(1995-11#6)(1995-2#1)(1995-4#6)(1995-5#1)(1995-6#2)(1995-7#1)(1996-10#2)(1996-4#3)(1996-7#2)(1997-2#1)(1997-3#1)(2005-7#2)(2005-8#2)(2006-12#3)(2006-8#5)(2007-10#2)(2007-11#3)(2007-2#2)(2007-8#2)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#3)(2008-6#1)(2009-10#1)(2009-2#1)(2009-3#6)(2009-9#3)(2010-11#1)(2010-12#6)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#10)(2012-3#5)(2013-1#2)(2013-8#1)
polysaccharide-based##2##1##(2012-12#2)
polysaccharides after##2##2##(2008-5#1)(2011-2#1)
polysaccharides and##5##2##(1991-9#1)(2008-10#1)(2008-2#1)(2012-6#1)(2013-8#1)
polysaccharides are##4##2##(1994-9#1)(1995-6#1)(2006-5#1)(2006-8#1)
polysaccharides as chiral selectors##2##4##(1996-5#2)
polysaccharides as##5##2##(1991-7#1)(1996-12#1)(1996-5#3)
polysaccharides at##2##2##(2008-10#2)
polysaccharides could be obtained##2##4##(1992-3#1)(2007-8#1)
polysaccharides from the##2##3##(1995-11#1)(2008-10#1)
polysaccharides from##4##2##(1994-9#1)(1995-11#1)(2008-10#1)(2012-1#1)
polysaccharides in##5##2##(2007-12#1)(2008-10#2)(2008-5#1)(2011-2#1)
polysaccharides of##3##2##(1992-12#1)(1995-11#1)(1996-5#1)
polysaccharides on##2##2##(1992-11#1)(2012-3#1)
polysaccharides such as##2##3##(1996-5#2)
polysaccharides that##3##2##(1992-12#1)(2008-10#1)(2011-1#1)
polysaccharides were##3##2##(2013-1#3)
polysaccharides with##2##2##(2008-10#2)
polysaccharides##92##1##(1991-7#1)(1991-9#1)(1992-11#2)(1992-12#3)(1992-3#3)(1994-11#1)(1994-9#4)(1995-11#3)(1995-12#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#7)(1997-4#1)(1997-8#1)(2005-12#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-8#3)(2008-10#16)(2008-2#2)(2008-5#8)(2008-6#3)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#5)(2012-3#1)(2012-6#1)(2013-1#4)(2013-8#1)
polysegmental##4##1##(2006-8#1)(2007-8#2)(2008-10#1)
polysemic##2##1##(2009-8#1)(2012-2#1)
polysensory##2##1##(1990-11#1)(1992-5#1)
polyserositis##3##1##(2013-1#3)
polysialic acid##4##2##(1994-11#1)(2005-7#1)(2009-8#2)
polysialic##5##1##(1994-11#1)(2005-7#1)(2009-8#3)
polysilazane nanocoating and##2##3##(2010-5#2)
polysiloxane##10##1##(1990-9#1)(1992-1#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#3)(2008-6#1)
polysomal mRNA##4##2##(1991-12#1)(2012-2#3)
polysomal##8##1##(1991-12#3)(1991-2#1)(2012-2#4)
polysome##2##1##(1990-4#1)(2008-4#1)
polysomes and##3##2##(1994-9#2)(2008-12#1)
polysomes were##3##2##(1990-3#1)(1991-12#1)(2008-7#1)
polysomes##25##1##(1990-11#1)(1990-3#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-3#1)(1992-8#2)(1994-9#3)(1997-7#1)(2007-5#1)(2008-11#3)(2008-12#1)(2008-7#1)(2012-2#6)
polysomnogram##3##1##(2007-6#1)(2010-3#1)(2013-8#1)
polysomnographic##2##1##(2008-7#1)(2008-9#1)
polysomnography (PSG)##2##2##(2012-12#1)(2012-3#1)
polysomnography was##2##2##(1994-2#1)(2010-2#1)
polysomnography##14##1##(1994-2#1)(1996-3#1)(2007-1#1)(2007-6#8)(2010-2#1)(2012-12#1)(2012-3#1)
polysomy 17##3##2##(2010-7#3)
polysomy##8##1##(2010-12#3)(2010-7#5)
polysorbate 80 as##2##3##(2006-4#1)(2008-10#1)
polysorbate 80##6##2##(2006-4#1)(2007-1#2)(2008-10#2)(2008-5#1)
polysorbate##7##1##(2006-4#1)(2007-1#2)(2008-10#2)(2008-5#2)
polyspecific##2##1##(1993-11#1)(1993-9#1)
polyspermy and##2##2##(2006-5#1)(2008-8#1)
polyspermy under sperm-limited conditions##2##4##(2008-8#2)
polyspermy was##2##2##(2006-5#1)(2008-8#1)
polyspermy##14##1##(2006-5#5)(2008-8#9)
polystachion##2##1##(2007-6#2)
polysterism##3##1##(1997-7#3)
polystyrene (PS)##6##2##(1990-12#1)(2004-9#1)(2007-9#1)(2008-10#1)(2009-11#1)(2012-11#1)
polystyrene and glass##2##3##(2008-3#2)
polystyrene and##9##2##(2005-11#3)(2008-11#2)(2008-3#3)(2013-1#1)
polystyrene beads and##4##3##(2005-11#1)(2008-3#1)(2009-5#1)(2011-2#1)
polystyrene beads for##2##3##(2013-1#2)
polystyrene beads loaded with##2##4##(2008-10#2)
polystyrene beads with a##2##4##(2005-11#1)(2008-3#1)
polystyrene beads##21##2##(1990-12#1)(1996-3#1)(2005-11#2)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-3#2)(2009-5#1)(2010-12#1)(2011-2#1)(2013-1#4)
polystyrene dish##2##2##(2008-11#2)
polystyrene divinyl benzene##2##3##(2008-10#2)
polystyrene film##2##2##(2005-11#1)(2008-2#1)
polystyrene latex particles##3##3##(2005-11#1)(2010-6#2)
polystyrene latex sphere##2##3##(2007-12#1)(2008-3#1)
polystyrene latex spheres##7##3##(2007-12#2)(2008-3#5)
polystyrene latex##12##2##(2005-11#1)(2007-12#3)(2008-3#6)(2010-6#2)
polystyrene microbeads##2##2##(2007-11#1)(2008-10#1)
polystyrene microplates##2##2##(1992-8#1)(1993-9#1)
polystyrene microsphere##2##2##(2007-12#1)(2008-3#1)
polystyrene microspheres##14##2##(2007-1#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-10#1)(2008-2#5)(2008-3#1)(2009-6#1)
polystyrene microtiter plates##2##3##(1997-3#1)(2008-10#1)
polystyrene nanoparticles##2##2##(2008-6#2)
polystyrene particles and##2##3##(2008-10#1)(2010-7#1)
polystyrene particles of##2##3##(2005-11#1)(2008-2#1)
polystyrene particles##11##2##(2005-11#2)(2007-12#1)(2008-10#3)(2008-2#3)(2010-4#1)(2010-7#1)
polystyrene plate##4##2##(2008-11#4)
polystyrene plates##3##2##(1995-3#1)(2008-4#1)(2012-5#1)
polystyrene resin##3##2##(2007-12#2)(2008-10#1)
polystyrene spheres are##2##3##(2007-11#1)(2008-3#1)
polystyrene spheres##12##2##(2007-11#2)(2007-12#2)(2008-2#4)(2008-3#4)
polystyrene surfaces##3##2##(2005-11#1)(2008-10#1)(2012-11#1)
polystyrene##179##1##(1990-12#2)(1991-10#1)(1991-9#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-3#1)(2004-9#1)(2005-11#21)(2006-12#1)(2006-2#2)(2007-1#1)(2007-11#6)(2007-12#16)(2007-8#1)(2007-9#2)(2008-10#30)(2008-11#20)(2008-2#16)(2008-3#19)(2008-4#1)(2008-6#2)(2009-11#3)(2009-2#1)(2009-5#1)(2009-6#1)(2010-12#3)(2010-4#4)(2010-6#2)(2010-7#1)(2011-2#1)(2012-11#3)(2012-5#1)(2013-1#6)
polystyrene-based##3##1##(2005-11#1)(2008-11#2)
polystyrene-block-poly(ferrocenylethylmethylsilane)##2##1##(2009-2#2)
polystyrene-divinylbenzene reversed-phase HPLC##2##3##(1997-2#2)
polystyrene-divinylbenzene##7##1##(1990-6#1)(1992-2#1)(1997-2#3)(2008-10#2)
polystyrenesulfonate##3##1##(2008-10#3)
polysulfides##4##1##(2005-11#2)(2008-10#2)
polysulfone membranes##2##2##(2005-11#1)(2010-5#1)
polysulfone##10##1##(2005-11#2)(2007-7#2)(2008-1#2)(2008-5#2)(2008-7#1)(2010-5#1)
polysynaptic EPSPs evoked##2##3##(1992-8#2)
polysynaptic EPSPs##3##2##(1992-8#3)
polysynaptic##11##1##(1991-6#1)(1992-8#5)(1993-12#2)(1996-2#2)(2013-1#1)
polytene chromosomes##3##2##(1994-12#1)(1995-8#1)(2012-12#1)
polytene region##3##2##(1993-9#1)(1995-8#1)(2008-9#1)
polytene##7##1##(1993-9#1)(1994-12#1)(1995-8#2)(1996-6#1)(2008-9#1)(2012-12#1)
polytetrafluoroethylene (PTFE) graft##3##3##(2007-7#2)(2007-8#1)
polytetrafluoroethylene (PTFE) grafts##5##3##(2007-7#4)(2008-1#1)
polytetrafluoroethylene (PTFE) turnings##2##3##(2008-10#2)
polytetrafluoroethylene (PTFE)##19##2##(2007-7#8)(2007-8#1)(2008-1#1)(2008-10#7)(2008-2#1)(2011-2#1)
polytetrafluoroethylene##28##1##(2006-5#1)(2007-10#1)(2007-12#1)(2007-7#10)(2007-8#1)(2008-1#1)(2008-10#10)(2008-2#1)(2011-2#1)(2011-3#1)
polytheonamide B##3##2##(2010-12#3)
polytherapy##2##1##(2008-5#1)(2013-8#1)
polythiophene##3##1##(2008-10#3)
polytomous##2##1##(2010-2#1)(2012-2#1)
polytopic integral membrane protein##2##4##(1990-11#2)
polytopic membrane proteins##2##3##(1990-5#1)(1995-1#1)
polytopic membrane##4##2##(1990-5#1)(1995-1#2)(1996-7#1)
polytopic##8##1##(1990-11#2)(1990-5#1)(1990-6#1)(1995-1#2)(1996-7#1)(2011-2#1)
polytransfused##2##1##(2006-12#1)(2007-11#1)
polytrauma##2##1##(2011-12#1)(2013-8#1)
polytraumatised patients##3##2##(2008-4#3)
polytraumatized patients with##2##3##(1996-9#1)(2013-8#1)
polytraumatized patients##3##2##(1991-10#1)(1996-9#1)(2013-8#1)
polyubiquitin##2##1##(2009-7#1)(2012-3#1)
polyubiquitinated##2##1##(1994-8#1)(2009-7#1)
polyunsaturated FA##2##2##(1994-9#1)(2013-1#1)
polyunsaturated Fatty acids##3##3##(2012-2#1)(2013-1#2)
polyunsaturated Fatty##4##2##(2010-1#1)(2012-2#1)(2013-1#2)
polyunsaturated fat##6##2##(1993-9#1)(1996-11#3)(2010-4#1)(2011-1#1)
polyunsaturated fat)##2##2##(1996-11#2)
polyunsaturated fats##2##2##(2010-4#2)
polyunsaturated fatty acid (PUFA)##3##4##(1996-9#1)(2008-7#1)(2010-4#1)
polyunsaturated fatty acid and##2##4##(1994-3#1)(2010-2#1)
polyunsaturated fatty acid##12##3##(1990-11#1)(1994-3#1)(1995-11#1)(1996-10#1)(1996-9#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-1#1)(2010-2#1)(2010-4#1)
polyunsaturated fatty acids (PUFA) and##2##5##(1997-5#1)(2010-4#1)
polyunsaturated fatty acids (PUFA)##6##4##(1995-8#1)(1997-5#1)(2010-4#2)(2011-2#2)
polyunsaturated fatty acids (PUFAs) and##3##5##(2004-11#1)(2013-1#2)
polyunsaturated fatty acids (PUFAs) in##4##5##(2008-10#1)(2010-4#1)(2010-6#1)(2012-2#1)
polyunsaturated fatty acids (PUFAs)##10##4##(2004-11#2)(2008-10#2)(2008-5#1)(2010-4#1)(2010-6#1)(2012-2#1)(2013-1#2)
polyunsaturated fatty acids and iron##4##5##(2012-2#4)
polyunsaturated fatty acids and##5##4##(2006-2#1)(2012-2#4)
polyunsaturated fatty acids in the##5##5##(1991-2#1)(2004-11#1)(2006-7#1)(2007-8#1)(2011-2#1)
polyunsaturated fatty acids in##11##4##(1991-12#1)(1991-2#1)(1992-3#1)(2004-11#2)(2006-7#3)(2007-8#1)(2008-5#1)(2011-2#1)
polyunsaturated fatty acids##66##3##(1990-2#1)(1990-3#1)(1991-12#2)(1991-2#1)(1992-3#1)(1992-9#1)(1993-9#1)(1994-11#2)(1994-12#1)(1995-2#1)(1995-8#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-5#1)(2004-11#5)(2006-2#2)(2006-6#1)(2006-7#5)(2006-8#1)(2007-8#2)(2008-10#3)(2008-5#4)(2008-7#1)(2010-1#1)(2010-4#5)(2010-6#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#8)(2013-1#4)
polyunsaturated fatty##79##2##(1990-11#1)(1990-2#1)(1990-3#1)(1991-12#2)(1991-2#1)(1992-3#1)(1992-9#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-9#2)(1997-1#1)(1997-4#2)(1997-5#1)(2004-11#5)(2006-2#2)(2006-6#1)(2006-7#5)(2006-8#1)(2007-8#2)(2008-10#3)(2008-3#1)(2008-5#6)(2008-7#2)(2010-1#2)(2010-2#1)(2010-4#6)(2010-6#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#8)(2013-1#4)
polyunsaturated##111##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-12#2)(1991-2#1)(1991-4#2)(1992-3#1)(1992-9#1)(1993-9#3)(1994-11#2)(1994-12#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-11#7)(1996-7#1)(1996-9#2)(1997-1#1)(1997-4#2)(1997-5#1)(1997-7#1)(2004-11#7)(2006-2#2)(2006-6#1)(2006-7#5)(2006-8#1)(2007-8#2)(2008-10#3)(2008-3#1)(2008-5#6)(2008-7#2)(2009-5#1)(2010-1#3)(2010-10#1)(2010-2#1)(2010-4#11)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#9)(2013-1#7)
polyurethane (PU)##2##2##(2008-6#1)(2009-9#1)
polyurethane and##2##2##(2004-9#1)(2008-10#1)
polyurethane coating##5##2##(2013-8#5)
polyurethane film##2##2##(2008-10#1)(2008-9#1)
polyurethane foam (PUF) were##2##4##(2008-10#1)(2008-11#1)
polyurethane foam (PUF)##6##3##(2008-10#4)(2008-11#2)
polyurethane foam and##2##3##(2007-8#1)(2008-10#1)
polyurethane foam column##2##3##(2008-10#2)
polyurethane foam loaded with##4##4##(2008-10#4)
polyurethane foam mini-column##2##3##(2008-10#2)
polyurethane foam##39##2##(2007-8#2)(2008-10#29)(2008-11#3)(2008-6#2)(2008-7#2)(2010-5#1)
polyurethane foams##3##2##(1997-1#1)(2008-10#2)
polyurethane membrane has been investigated##2##5##(2008-10#2)
polyurethane membrane has been##3##4##(2008-10#3)
polyurethane membrane##13##2##(2008-10#13)
polyurethane sheath##2##2##(1997-7#2)
polyurethane##99##1##(1996-12#1)(1996-6#1)(1997-1#1)(1997-7#2)(2004-4#1)(2004-9#5)(2005-12#1)(2006-7#1)(2007-7#3)(2007-8#2)(2008-10#55)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#3)(2008-7#2)(2008-9#1)(2009-7#2)(2009-9#1)(2010-5#1)(2013-8#7)
polyurethane-based##2##1##(2008-5#2)
polyurethanes##5##1##(2005-11#2)(2008-10#1)(2010-4#2)
polyuria with low urine osmolality##2##5##(2013-1#2)
polyuria##6##1##(1997-3#1)(2006-9#1)(2007-7#1)(2009-7#1)(2013-1#2)
polyuric##2##1##(1997-2#1)(2008-8#1)
polyvalent cations##3##2##(1990-7#2)(1993-12#1)
polyvalent##23##1##(1990-7#2)(1993-12#1)(1994-12#1)(1994-9#1)(1995-5#1)(2005-8#1)(2006-10#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-4#2)(2008-5#2)(2009-10#3)(2011-1#1)(2012-12#1)(2012-2#1)
polyvalvular disease with##2##3##(2008-4#2)
polyvalvular disease##4##2##(2008-4#4)
polyvinyl alcohol (PVA)##4##3##(2008-10#1)(2008-5#1)(2009-11#1)(2012-3#1)
polyvinyl alcohol##15##2##(2006-9#1)(2008-10#6)(2008-2#3)(2008-3#1)(2008-5#1)(2009-11#1)(2012-3#2)
polyvinyl chloride (PVC) matrix##2##4##(2008-10#2)
polyvinyl chloride (PVC) membrane##3##4##(2008-10#3)
polyvinyl chloride (PVC)##10##3##(1996-8#1)(2008-10#8)(2012-2#1)
polyvinyl chloride and##2##3##(1996-8#1)(2012-1#1)
polyvinyl chloride##20##2##(1992-7#1)(1996-8#2)(2006-4#1)(2007-4#1)(2008-10#13)(2012-1#1)(2012-2#1)
polyvinyl pyrrolidine##2##2##(2012-2#2)
polyvinyl pyrrolidone##3##2##(1990-12#1)(2008-10#1)(2008-5#1)
polyvinyl##49##1##(1990-12#1)(1991-3#1)(1992-7#1)(1996-11#1)(1996-8#2)(2005-11#1)(2006-4#1)(2006-9#1)(2007-4#1)(2008-10#22)(2008-2#3)(2008-3#1)(2008-5#3)(2008-7#1)(2009-11#1)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#2)
polyvinylalcohol##2##1##(1991-2#1)(2008-10#1)
polyvinylchloride##2##1##(1992-1#1)(2008-10#1)
polyvinylidene difluoride (PVDF) membrane##2##4##(2007-8#1)(2008-11#1)
polyvinylidene difluoride##6##2##(1992-1#1)(1992-8#1)(1993-11#1)(2007-8#1)(2008-11#1)(2012-2#1)
polyvinylidene##7##1##(1992-1#1)(1992-8#1)(1993-11#1)(2007-8#1)(2008-11#1)(2009-5#1)(2012-2#1)
polyvinylpolypyrrolidone (PVPP) to##2##3##(2008-5#1)(2011-2#1)
polyvinylpolypyrrolidone (PVPP)##3##2##(2008-5#2)(2011-2#1)
polyvinylpolypyrrolidone##5##1##(2008-5#4)(2011-2#1)
polyvinylpyrollidone##2##1##(2008-10#1)(2010-5#1)
polyvinylpyrrolidone (PVP) and##2##3##(2006-11#1)(2008-5#1)
polyvinylpyrrolidone (PVP)##4##2##(2005-11#1)(2006-11#1)(2008-10#1)(2008-5#1)
pomaceous flowers##2##2##(2008-10#2)
pomatia agglutinin (HPA)##3##3##(1990-7#1)(2008-4#1)(2011-2#1)
pomatia agglutinin##4##2##(1990-7#1)(2008-4#1)(2011-2#2)
pomatia##8##1##(1990-7#1)(1991-8#1)(1994-10#1)(1996-5#2)(2008-4#1)(2011-2#2)
pombe adenylyl cyclase##2##3##(1990-2#2)
pombe cells##2##2##(2007-9#1)(2008-2#1)
pombe gene##4##2##(1991-5#1)(1994-12#1)(1997-3#1)(1997-4#1)
pombe genomic##2##2##(1993-11#1)(1994-12#1)
pombe is##5##2##(1990-2#2)(1995-3#2)(2008-2#1)
pombe##89##1##(1990-10#1)(1990-2#4)(1991-5#2)(1991-8#2)(1992-6#2)(1992-7#5)(1993-11#2)(1993-3#2)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#7)(1994-2#1)(1994-8#1)(1994-9#3)(1995-2#4)(1995-3#4)(1995-8#3)(1995-9#1)(1996-7#6)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#5)(1997-4#2)(1997-6#1)(2007-9#2)(2008-2#8)(2008-4#1)(2008-7#6)(2008-9#1)(2009-3#1)(2010-11#1)(2012-3#5)
pome fruit##5##2##(2008-10#3)(2011-2#2)
pome##7##1##(2008-10#5)(2011-2#2)
pomegranate antioxidants##2##2##(2013-8#2)
pomegranate##9##1##(2012-12#3)(2013-8#6)
pomi (Fr##2##2##(2011-1#2)
pomiferin administration##2##2##(2011-1#2)
pomiferin##4##1##(2011-1#4)
pomonella##3##1##(2006-5#1)(2011-2#2)
pompholyx##2##1##(2007-8#2)
ponceau 4R##2##2##(2008-10#2)
ponction##2##1##(2011-2#1)(2012-2#1)
pond culture##2##2##(2013-7#2)
pond in##3##2##(2007-3#2)(2010-8#1)
pond of##2##2##(1991-2#1)(2006-8#1)
pond water and##2##3##(2012-3#2)
pond water samples##2##3##(2007-10#1)(2012-3#1)
pond water##13##2##(2007-10#1)(2008-10#2)(2008-5#3)(2012-2#1)(2012-3#6)
pond##51##1##(1990-7#1)(1991-11#1)(1991-2#1)(2004-4#2)(2005-10#3)(2006-8#3)(2007-10#1)(2007-3#3)(2008-10#3)(2008-5#7)(2008-6#1)(2008-8#1)(2009-6#2)(2010-8#1)(2011-12#6)(2011-2#1)(2012-2#5)(2012-3#7)(2013-7#2)
ponder##2##1##(2009-4#1)(2013-1#1)
ponderal index##2##2##(2007-6#2)
pondering##3##1##(2007-9#1)(2012-1#2)
ponderomotive##4##1##(1992-9#1)(2007-11#1)(2008-1#1)(2008-3#1)
ponds of##2##2##(2008-7#1)(2011-12#1)
ponds was##2##2##(2011-12#2)
ponds##15##1##(2007-3#2)(2008-10#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-12#4)(2012-2#1)(2012-3#3)(2013-7#1)
pong##3##1##(1993-6#2)(2008-7#1)
ponies##3##1##(1990-6#2)(2009-6#1)
pons and medulla##4##3##(1997-2#4)
pons and##5##2##(1996-1#1)(1997-2#4)
pons##20##1##(1991-9#1)(1992-1#1)(1992-2#1)(1992-8#2)(1992-9#1)(1993-3#2)(1995-10#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-5#1)(1997-2#4)(2007-10#2)(2011-1#1)
ponticum##5##1##(2008-10#5)
pontine and##3##2##(1995-5#1)(1996-9#1)(2011-2#1)
pontine cholinergic cell column##2##4##(1992-1#2)
pontine cholinergic##3##2##(1992-1#3)
pontine infarction##3##2##(2007-10#1)(2008-7#1)(2013-8#1)
pontine micturition center##2##3##(1992-8#1)(2010-8#1)
pontine myelinolysis##5##2##(1992-2#2)(1997-8#1)(2008-7#2)
pontine nucleus##5##2##(1993-5#4)(2007-5#1)
pontine reticular formation of##2##4##(1990-7#2)
pontine reticular formation##6##3##(1990-7#6)
pontine reticular##7##2##(1990-7#6)(1993-9#1)
pontine##52##1##(1990-12#1)(1990-7#6)(1991-3#1)(1991-6#2)(1992-1#6)(1992-2#3)(1992-8#1)(1993-12#1)(1993-2#1)(1993-5#4)(1993-9#1)(1995-5#3)(1995-7#1)(1996-9#2)(1997-8#1)(2007-10#3)(2007-5#1)(2008-11#6)(2008-7#3)(2008-8#1)(2010-8#1)(2011-2#2)(2013-8#1)
pontis##5##1##(1990-9#1)(1991-3#4)
pontomedullary##3##1##(1990-9#1)(1992-8#1)(1994-2#1)
pontomesencephalic tegmentum##2##2##(1995-12#2)
pontomesencephalic##5##1##(1995-12#2)(1997-3#2)(2008-2#1)
pony##2##1##(2006-5#1)(2009-9#1)
pool and that##2##3##(1995-8#1)(2008-10#1)
pool and##13##2##(1991-3#1)(1992-4#2)(1995-8#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2010-10#1)(2012-12#1)
pool composition##2##2##(1995-6#1)(2008-8#1)
pool depletion##3##2##(1993-12#1)(1996-8#1)(1997-2#1)
pool disease##3##2##(1994-3#1)(2007-10#2)
pool for##5##2##(1992-12#1)(1993-12#1)(1993-3#1)(1995-9#1)(1997-8#1)
pool in the##6##3##(1993-3#1)(2007-10#1)(2008-10#1)(2008-8#1)(2012-1#1)(2012-2#1)
pool in##9##2##(1990-12#1)(1993-3#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-1#1)(2012-2#1)
pool is##9##2##(1990-10#1)(1991-10#2)(1993-12#1)(1993-3#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-11#1)
pool may be##2##3##(1990-7#1)(1992-3#1)
pool may##3##2##(1990-7#1)(1992-3#1)(2011-2#1)
pool of IBV strains##2##4##(1997-6#2)
pool of chromaffin granules##2##4##(2007-10#2)
pool of docked granules##2##4##(1997-7#2)
pool of intracellular##2##3##(1991-6#1)(1994-12#1)
pool of proteins##2##3##(2010-11#1)(2013-7#1)
pool of these##2##3##(1990-4#1)(1990-5#1)
pool of##106##2##(1990-11#2)(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-2#2)(1991-6#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#3)(1994-2#2)(1994-5#1)(1994-8#1)(1995-1#3)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-7#3)(1995-8#1)(1996-1#1)(1996-8#2)(1997-2#2)(1997-6#4)(1997-7#3)(2004-12#1)(2005-11#1)(2005-12#1)(2005-8#1)(2005-9#1)(2006-7#1)(2007-1#1)(2007-10#5)(2007-2#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#2)(2008-4#1)(2008-5#5)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)
pool size##5##2##(1993-11#1)(1995-1#1)(2008-11#3)
pool sizes of the##2##4##(1993-9#1)(2007-11#1)
pool sizes of##3##3##(1990-8#1)(1993-9#1)(2007-11#1)
pool sizes##5##2##(1990-8#1)(1991-10#1)(1993-9#1)(2007-11#1)(2008-11#1)
pool to be##2##3##(2008-4#1)(2008-8#1)
pool to##5##2##(1991-8#1)(1992-8#1)(2008-3#1)(2008-4#1)(2008-8#1)
pool was reduced##2##3##(1990-8#1)(1993-2#1)
pool was##6##2##(1990-8#1)(1992-3#1)(1993-2#1)(1995-6#1)(1996-8#1)(2013-1#1)
pool with##3##2##(1991-12#1)(1993-2#1)(2007-3#1)
pool##311##1##(1990-10#3)(1990-11#2)(1990-12#4)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#2)(1990-7#5)(1990-8#4)(1991-10#3)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#3)(1992-11#2)(1992-12#1)(1992-3#4)(1992-4#6)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#7)(1993-3#4)(1993-4#3)(1993-6#1)(1993-7#1)(1993-9#2)(1994-12#7)(1994-2#2)(1994-3#4)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#6)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#4)(1995-6#3)(1995-7#3)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-8#5)(1996-9#4)(1997-2#3)(1997-6#5)(1997-7#8)(1997-8#2)(2004-12#1)(2005-11#1)(2005-12#4)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-7#1)(2007-1#1)(2007-10#9)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#3)(2007-4#1)(2007-7#4)(2007-9#2)(2008-1#1)(2008-10#23)(2008-11#13)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#5)(2008-5#7)(2008-7#4)(2008-8#12)(2008-9#2)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#3)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#4)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#2)
pooled FC-PRA##2##2##(1995-2#2)
pooled according to##2##3##(1995-8#1)(2008-10#1)
pooled analysis of four##2##4##(1991-5#1)(2012-3#1)
pooled analysis of##5##3##(1991-5#2)(1997-1#1)(2012-3#2)
pooled analysis##10##2##(1991-5#2)(1997-1#1)(2008-10#1)(2009-2#1)(2012-3#4)(2013-8#1)
pooled cell FC##2##3##(1995-2#2)
pooled cell##3##2##(1995-2#3)
pooled data from##4##3##(2004-3#1)(2005-7#1)(2008-10#1)(2008-3#1)
pooled data of##3##3##(1990-11#2)(2009-11#1)
pooled data##10##2##(1990-11#2)(2004-3#1)(2005-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-11#1)(2012-2#1)
pooled estimates##2##2##(2008-8#1)(2010-9#1)
pooled for##2##2##(2008-10#1)(2011-2#1)
pooled from##5##2##(1990-6#1)(1991-12#1)(1993-4#1)(1995-12#1)(2007-11#1)
pooled human##3##2##(1995-3#1)(2007-11#1)(2008-5#1)
pooled normal##3##2##(1990-11#1)(1990-8#2)
pooled plasma##4##2##(1990-12#1)(1996-7#1)(2007-8#1)(2012-2#1)
pooled probes##2##2##(2008-4#2)
pooled samples##2##2##(2012-2#1)(2013-8#1)
pooled sera from##2##3##(1990-7#1)(2007-2#1)
pooled serum##3##2##(1990-12#1)(1992-4#1)(2008-10#1)
pooled##117##1##(1990-11#4)(1990-12#3)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-11#1)(1991-12#2)(1991-5#2)(1991-9#1)(1992-4#3)(1993-12#1)(1993-4#1)(1994-7#1)(1995-12#2)(1995-2#5)(1995-3#1)(1995-8#2)(1996-11#1)(1996-3#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-8#1)(2004-3#1)(2005-12#1)(2005-7#3)(2006-11#1)(2006-6#1)(2007-11#2)(2007-2#2)(2007-8#2)(2008-10#14)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#4)(2009-11#1)(2009-12#1)(2009-2#1)(2010-12#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-2#4)(2012-3#8)(2013-1#4)(2013-8#3)
pooling of the##2##3##(2007-8#1)(2008-7#1)
pooling of##5##2##(1997-8#1)(2007-8#2)(2008-7#1)(2012-2#1)
pooling strategy##2##2##(1994-3#1)(2008-11#1)
pooling##20##1##(1992-2#1)(1994-11#2)(1994-3#1)(1994-9#1)(1995-9#1)(1997-8#4)(2007-8#2)(2008-10#2)(2008-11#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-2#1)
pools and##11##2##(1993-3#1)(1995-6#2)(2007-10#1)(2008-11#2)(2009-4#1)(2009-6#2)(2013-1#2)
pools are##2##2##(1994-3#1)(1995-6#1)
pools as##2##2##(1995-6#1)(2008-7#1)
pools at##2##2##(1990-2#1)(2007-3#1)
pools containing##3##2##(2004-11#1)(2007-11#1)(2008-11#1)
pools for##2##2##(1993-3#1)(2008-11#1)
pools in##7##2##(1991-10#1)(1991-6#1)(1995-1#1)(1995-3#1)(1997-8#1)(2008-11#1)(2010-12#1)
pools is##2##2##(1991-10#1)(2008-9#1)
pools of DNA##3##3##(1990-3#2)(2008-7#1)
pools of precursor##2##3##(1990-5#1)(1994-3#1)
pools of the##2##3##(1990-7#1)(1992-7#1)
pools of##27##2##(1990-3#2)(1990-5#1)(1990-7#1)(1992-7#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-8#1)(2004-11#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-9#2)(2012-3#1)
pools was##2##2##(1993-4#1)(1997-8#1)
pools were##4##2##(1994-12#1)(1995-3#1)(1995-6#1)(2011-2#1)
pools##119##1##(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#1)(1991-10#4)(1991-2#1)(1991-6#3)(1992-1#1)(1992-11#1)(1992-7#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#2)(1994-11#2)(1994-12#2)(1994-3#2)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#3)(1995-6#6)(1996-10#2)(1996-2#1)(1996-5#2)(1996-7#1)(1996-8#3)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#3)(2004-11#6)(2007-10#1)(2007-11#1)(2007-3#1)(2008-10#12)(2008-11#10)(2008-5#3)(2008-7#4)(2008-9#2)(2009-12#2)(2009-4#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-12#1)(2011-2#3)(2012-3#1)(2013-1#2)
pools/h##3##1##(1991-2#3)
poor -##2##2##(2007-11#1)(2007-7#1)
poor PE##2##2##(2008-8#2)
poor QOL##3##2##(2006-11#1)(2010-5#2)
poor adaptation##3##2##(2008-11#2)(2009-12#1)
poor adhesion##2##2##(2005-11#1)(2008-2#1)
poor affinity for the rat##2##5##(1992-10#1)(1995-12#1)
poor and extensive metabolisers##2##4##(1996-3#2)
poor and marginalized women##3##4##(2012-3#3)
poor and the##4##3##(1993-3#1)(2008-1#1)(2008-10#1)(2011-12#1)
poor and##30##2##(1992-10#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-7#1)(1995-12#1)(1996-3#2)(2005-10#1)(2005-7#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-3#3)(2013-1#2)(2013-7#1)
poor appetite and##2##3##(2007-11#1)(2007-12#1)
poor appetite##3##2##(1990-10#1)(2007-11#1)(2007-12#1)
poor aqueous solubility##2##3##(2010-12#2)
poor are not##2##3##(2008-11#2)
poor are##5##2##(1992-5#1)(1995-9#1)(2007-7#1)(2008-11#2)
poor as##3##2##(1992-10#1)(2005-9#1)(2012-2#1)
poor at##3##2##(1994-9#1)(1996-3#1)(2005-7#1)
poor because##4##2##(1993-11#1)(2005-10#1)(2007-2#1)(2013-7#1)
poor binding of##2##3##(1994-12#1)(2008-5#1)
poor bioavailability##3##2##(2009-4#1)(2011-3#1)(2012-2#1)
poor birth outcomes##2##3##(1997-7#1)(2009-5#1)
poor blood##3##2##(1996-10#1)(1996-12#1)(2007-7#1)
poor bone quality##2##3##(1995-9#1)(2011-7#1)
poor candidates for##3##3##(1991-3#1)(2007-7#1)(2008-6#1)
poor cell viability and low##2##5##(2008-11#2)
poor children##4##2##(1992-2#1)(2007-9#1)(2008-11#1)(2010-8#1)
poor clinical condition##3##3##(1990-5#1)(2006-11#1)(2007-10#1)
poor clinical outcome##2##3##(2008-8#1)(2012-12#1)
poor clinical##12##2##(1990-5#1)(1991-3#1)(1995-9#1)(2006-11#1)(2007-10#1)(2008-1#1)(2008-8#1)(2009-3#2)(2009-7#1)(2011-2#1)(2012-12#1)
poor cognitive performance##2##3##(1994-2#1)(2012-1#1)
poor cognitive##3##2##(1994-2#1)(2010-2#1)(2012-1#1)
poor compared with##4##3##(1996-8#1)(2006-5#1)(2008-6#1)(2009-7#1)
poor compliance is##2##3##(1993-1#1)(1993-11#1)
poor compliance with iron-chelating therapy and##2##6##(2013-8#2)
poor compliance with##4##3##(1993-11#1)(2007-4#1)(2013-8#2)
poor compliance##11##2##(1992-5#1)(1993-1#2)(1993-11#2)(2006-5#1)(2007-4#1)(2007-7#1)(2008-3#1)(2013-8#2)
poor concentration##4##2##(1996-5#1)(2004-3#1)(2012-2#1)(2013-8#1)
poor condition##3##2##(2008-10#1)(2008-5#1)(2010-10#1)
poor control##4##2##(2008-7#1)(2010-4#1)(2010-9#1)(2011-2#1)
poor correlation between##4##3##(2006-4#1)(2007-9#1)(2010-4#1)(2012-2#1)
poor correlation##7##2##(1991-9#1)(2006-10#1)(2006-4#1)(2007-9#1)(2008-9#1)(2010-4#1)(2012-2#1)
poor countries##3##2##(2007-8#1)(2008-5#1)(2013-1#1)
poor crop##2##2##(2008-12#1)(2010-10#1)
poor data quality##2##3##(2011-2#1)(2012-12#1)
poor data##3##2##(2008-11#1)(2011-2#1)(2012-12#1)
poor despite##2##2##(2008-7#1)(2011-2#1)
poor development of##4##3##(2007-5#1)(2009-5#1)(2011-1#1)(2012-1#1)
poor diabetic control##2##3##(1996-11#1)(2007-2#1)
poor dietary##3##2##(2007-7#1)(2008-3#1)(2010-12#1)
poor differentiation (P &lt##2##4##(2012-3#2)
poor differentiation##10##2##(1992-2#1)(1992-4#1)(1993-9#1)(2007-8#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-3#3)
poor economic##3##2##(1993-12#1)(2008-1#1)(2013-8#1)
poor efficacy##4##2##(2006-2#1)(2008-1#1)(2009-4#1)(2010-10#1)
poor environments##2##2##(1993-2#1)(2007-4#1)
poor families##2##2##(2008-9#2)
poor family##3##2##(2006-4#1)(2007-9#1)(2013-8#1)
poor for##5##2##(1990-2#1)(2007-4#1)(2008-10#1)(2010-4#1)(2011-1#1)
poor from##2##2##(2004-10#1)(2007-7#1)
poor functional status##2##3##(2008-1#1)(2009-3#1)
poor functional##4##2##(2008-1#1)(2008-5#1)(2008-7#1)(2009-3#1)
poor general condition##3##3##(2006-5#1)(2007-7#1)(2010-3#1)
poor general health##3##3##(2006-2#1)(2008-7#1)(2012-2#1)
poor general##7##2##(2006-2#1)(2006-5#1)(2007-7#1)(2008-7#2)(2010-3#1)(2012-2#1)
poor glycemic control and##2##4##(2007-3#1)(2008-1#1)
poor glycemic control were##2##4##(2007-3#2)
poor glycemic control##12##3##(2007-3#6)(2007-7#1)(2008-1#2)(2008-3#1)(2008-7#1)(2013-7#1)
poor graft##3##2##(1995-2#1)(2005-10#1)(2011-2#1)
poor growth##3##2##(2006-10#1)(2008-5#1)(2008-6#1)
poor healing##4##2##(2006-12#1)(2008-1#1)(2011-12#1)(2012-12#1)
poor health status and##2##4##(2005-10#1)(2010-8#1)
poor health status##5##3##(2005-10#1)(2007-2#1)(2009-5#2)(2010-8#1)
poor health##18##2##(1990-2#1)(1993-12#1)(1997-2#1)(2005-10#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-5#2)(2010-4#1)(2010-8#1)(2011-2#2)
poor hemodynamic##2##2##(1993-10#1)(2007-8#1)
poor households##2##2##(2012-12#2)
poor hygiene of##2##3##(1996-9#1)(2008-2#1)
poor hygiene##8##2##(1991-12#1)(1992-2#1)(1993-3#1)(1994-6#1)(1996-9#1)(2008-2#1)(2010-12#1)(2013-1#1)
poor immunogenicity##2##2##(1991-5#1)(2010-8#1)
poor in 2##3##3##(2007-11#1)(2007-8#1)(2009-2#1)
poor in the##5##3##(1991-6#1)(1993-3#1)(1994-6#1)(1995-6#1)(2008-9#1)
poor in##41##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-6#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-6#1)(1995-6#2)(1996-4#1)(2004-9#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-5#4)(2006-7#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-2#1)(2009-5#1)(2010-7#1)(2011-12#1)(2011-2#2)(2013-8#1)
poor insight##2##2##(1997-8#2)
poor job##3##2##(2007-8#1)(2008-5#1)(2008-9#1)
poor knowledge about##2##3##(2011-2#1)(2013-7#1)
poor knowledge##3##2##(2011-2#1)(2013-1#1)(2013-7#1)
poor left ventricular ejection fraction##2##5##(2007-8#2)
poor left ventricular function##2##4##(1997-6#1)(2007-9#1)
poor left ventricular##5##3##(1997-6#1)(2007-8#3)(2007-9#1)
poor left##6##2##(1997-6#1)(2007-8#4)(2007-9#1)
poor ligand##2##2##(1994-9#1)(1996-6#1)
poor long term##2##3##(2006-2#1)(2013-8#1)
poor long-term results##2##3##(2008-11#1)(2010-12#1)
poor long-term##7##2##(2005-8#2)(2006-2#1)(2008-11#1)(2008-5#1)(2009-11#1)(2010-12#1)
poor lung##2##2##(2006-10#1)(2007-2#1)
poor mechanical properties##3##3##(2007-7#1)(2007-8#1)(2009-7#1)
poor mechanical##4##2##(2007-11#1)(2007-7#1)(2007-8#1)(2009-7#1)
poor medical##3##2##(1995-9#1)(2006-10#1)(2010-1#1)
poor mental health##3##3##(2009-5#2)(2010-11#1)
poor mental##4##2##(2009-5#3)(2010-11#1)
poor metabolic control##3##3##(1991-8#1)(1996-11#1)(1996-9#1)
poor metabolizer##2##2##(1996-3#1)(2008-11#1)
poor metabolizers (PM)##2##3##(2008-10#1)(2010-2#1)
poor metabolizers##3##2##(1996-3#1)(2008-10#1)(2010-2#1)
poor methodological quality##2##3##(2008-11#1)(2010-3#1)
poor methodological##3##2##(1993-3#1)(2008-11#1)(2010-3#1)
poor model##3##2##(1991-2#1)(2012-1#1)(2012-3#1)
poor neurological status##2##3##(2013-1#2)
poor neurological##3##2##(2007-2#1)(2013-1#2)
poor nitrogen##2##2##(1996-7#1)(2004-2#1)
poor nutrient##2##2##(1997-6#1)(2011-12#1)
poor nutrition##3##2##(1991-2#1)(1994-6#1)(2010-6#1)
poor nutritional status##3##3##(1993-1#1)(2007-7#1)(2008-7#1)
poor or##8##2##(1992-2#1)(1993-9#1)(2007-8#1)(2008-1#1)(2009-3#1)(2013-1#3)
poor oral bioavailability of##2##4##(2009-4#2)
poor oral bioavailability##4##3##(2007-8#1)(2008-5#1)(2009-4#2)
poor oral health##3##3##(2008-1#1)(2008-7#1)(2010-7#1)
poor oral hygiene##2##3##(2007-12#1)(2010-12#1)
poor oral##10##2##(2007-12#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-4#2)(2010-12#1)(2010-7#1)(2012-2#1)
poor orientation##2##2##(1990-11#1)(2006-5#1)
poor outcome after ischemic stroke##2##5##(2007-10#2)
poor outcome after##4##3##(2007-10#2)(2008-9#1)(2011-1#1)
poor outcome in##9##3##(2007-10#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-12#1)(2008-7#1)(2011-2#2)(2012-12#1)
poor outcome of##2##3##(2007-12#1)(2010-12#1)
poor outcome##48##2##(1990-9#1)(1991-12#1)(1993-2#1)(1993-5#1)(1994-12#2)(2004-10#2)(2005-10#1)(2006-10#1)(2007-10#4)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#3)(2011-2#5)(2012-12#4)(2012-3#4)(2013-7#1)
poor outcomes of##3##3##(2008-4#1)(2008-8#1)(2011-2#1)
poor outcomes##16##2##(1996-9#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-4#1)(2008-8#2)(2009-1#1)(2009-8#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
poor overall survival##2##3##(2008-6#1)(2013-8#1)
poor overall##3##2##(1995-3#1)(2008-6#1)(2013-8#1)
poor patient compliance##2##3##(1996-11#1)(2011-2#1)
poor patient outcomes##2##3##(2009-11#1)(2011-1#1)
poor patient##4##2##(1996-11#1)(2009-11#1)(2011-1#1)(2011-2#1)
poor pay##2##2##(1992-5#1)(2008-1#1)
poor performance in##3##3##(2007-10#1)(2008-10#1)(2012-12#1)
poor performance on##2##3##(1993-12#1)(2006-9#1)
poor performance when the##2##4##(2008-2#1)(2012-2#1)
poor performance##17##2##(1992-10#1)(1993-12#1)(1996-11#1)(1997-5#1)(2006-9#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
poor physical health##2##3##(2008-11#1)(2011-1#1)
poor physical##4##2##(1991-4#1)(2008-11#1)(2011-1#1)(2011-2#1)
poor practice##2##2##(2011-1#1)(2013-8#1)
poor precision and##2##3##(2008-10#2)
poor precision##3##2##(2008-10#3)
poor predictors of##2##3##(1993-8#1)(1994-3#1)
poor predictors##3##2##(1993-8#1)(1994-3#2)
poor preoperative neurologic status##2##4##(2007-10#2)
poor preoperative##3##2##(2007-10#2)(2007-8#1)
poor prognoses##3##2##(2005-10#1)(2010-12#1)(2011-2#1)
poor prognosis and high##2##4##(2011-1#1)(2013-1#1)
poor prognosis and##9##3##(2007-11#1)(2007-12#1)(2009-5#1)(2009-8#2)(2010-12#1)(2010-6#1)(2011-1#1)(2013-1#1)
poor prognosis because##3##3##(1993-5#1)(1996-11#1)(2012-1#1)
poor prognosis in patients with##2##5##(2011-2#1)(2013-1#1)
poor prognosis in patients##3##4##(2007-10#1)(2011-2#1)(2013-1#1)
poor prognosis in##11##3##(2004-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2009-10#1)(2011-1#1)(2011-2#3)(2013-1#1)
poor prognosis of this##2##4##(1992-6#1)(2009-5#1)
poor prognosis of##8##3##(1991-2#1)(1992-2#1)(1992-6#1)(1996-4#1)(2006-10#1)(2008-8#1)(2009-5#1)(2012-2#1)
poor prognosis##139##2##(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-10#2)(1993-5#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-6#2)(1994-8#1)(1996-11#1)(1996-4#1)(1997-4#1)(1997-5#2)(1997-8#1)(2004-1#1)(2005-10#2)(2006-1#1)(2006-10#3)(2006-2#2)(2006-6#3)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#2)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-3#2)(2009-5#4)(2009-8#4)(2010-1#1)(2010-11#2)(2010-12#5)(2010-5#1)(2010-6#2)(2010-9#1)(2011-1#4)(2011-11#1)(2011-2#11)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#4)(2013-1#8)(2013-7#2)(2013-8#2)
poor prognostic factors##6##3##(2007-11#1)(2007-6#1)(2008-1#1)(2008-6#2)(2013-1#1)
poor prognostic features##2##3##(2010-12#2)
poor prognostic##13##2##(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-6#2)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#1)
poor psychological adjustment##2##3##(2009-11#2)
poor psychological##3##2##(2006-3#1)(2009-11#2)
poor quality of life in##2##5##(2009-7#1)(2011-2#1)
poor quality of life##15##4##(2006-10#2)(2006-4#1)(2007-11#2)(2007-8#1)(2008-12#1)(2009-7#2)(2010-11#1)(2010-5#1)(2011-2#2)(2013-1#2)
poor quality of the##3##4##(1994-3#1)(1995-9#1)(2008-5#1)
poor quality of##22##3##(1991-9#1)(1994-3#1)(1995-9#2)(2006-10#2)(2006-4#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-7#2)(2010-11#1)(2010-5#1)(2011-2#2)(2013-1#2)
poor quality##33##2##(1991-9#1)(1993-12#1)(1994-3#1)(1995-5#1)(1995-9#3)(1997-6#1)(2006-10#2)(2006-4#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2009-3#1)(2009-7#2)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
poor reactivity##2##2##(1995-8#1)(1997-7#1)
poor readability##2##2##(2013-1#2)
poor readers who were##2##4##(2004-10#2)
poor readers##7##2##(2004-10#3)(2007-9#4)
poor recovery of##3##3##(1996-10#1)(2010-7#1)(2012-12#1)
poor recovery##9##2##(1996-10#1)(2007-11#1)(2008-10#2)(2008-6#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-12#1)
poor relief in##2##3##(2008-11#2)
poor representation##2##2##(2008-4#1)(2008-7#1)
poor respiratory##3##2##(2007-8#1)(2010-7#1)(2013-1#1)
poor responders to##2##3##(2010-3#1)(2012-2#1)
poor responders##6##2##(2010-3#2)(2011-1#1)(2012-2#1)(2012-3#2)
poor response of##2##3##(2008-10#1)(2013-1#1)
poor response to##10##3##(1990-10#1)(1993-5#1)(1996-9#1)(2010-11#1)(2010-12#2)(2010-6#2)(2012-12#1)(2013-8#1)
poor response##20##2##(1990-10#1)(1993-5#1)(1996-9#1)(2008-10#3)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#2)(2011-2#3)(2012-12#1)(2013-1#3)(2013-8#1)
poor responsiveness to##2##3##(2010-12#1)(2013-8#1)
poor results after##2##3##(2006-3#1)(2007-11#1)
poor results in 4##2##4##(2007-11#1)(2007-7#1)
poor results in##5##3##(2007-11#3)(2007-7#1)(2008-3#1)
poor results were##2##3##(2007-7#1)(2008-9#1)
poor results##14##2##(1990-10#1)(1990-6#1)(2006-10#1)(2006-3#1)(2007-11#4)(2007-7#3)(2008-3#1)(2008-9#1)(2012-12#1)
poor risk features##2##3##(2010-12#2)
poor risk##3##2##(2008-3#1)(2010-12#2)
poor school performance##3##3##(2008-11#1)(2009-7#1)(2013-1#1)
poor school##4##2##(2008-11#1)(2008-12#1)(2009-7#1)(2013-1#1)
poor self-rated health##2##3##(2011-2#1)(2013-1#1)
poor self-rated##3##2##(2011-2#1)(2013-1#1)(2013-7#1)
poor sense of well-being##3##4##(2008-7#3)
poor sense of##4##3##(2008-7#4)
poor sensitivity and specificity##2##4##(2007-9#1)(2009-9#1)
poor sensitivity of##4##3##(1996-8#1)(2004-1#1)(2008-10#2)
poor sensitivity##11##2##(1993-11#1)(1996-8#1)(2004-1#1)(2006-10#1)(2006-12#1)(2007-9#1)(2008-10#2)(2009-9#1)(2011-2#1)(2012-1#1)
poor sleep##4##2##(2007-2#1)(2012-12#3)
poor solubility of##3##3##(1990-11#1)(2006-10#1)(2010-2#1)
poor solubility##6##2##(1990-11#1)(1994-9#1)(2006-10#1)(2008-10#1)(2010-12#1)(2010-2#1)
poor spatial##2##2##(1994-2#1)(2008-2#1)
poor specificity##4##2##(1992-1#1)(1996-9#1)(2008-6#1)(2011-2#1)
poor stability##2##2##(2008-10#1)(2008-5#1)
poor substrate for##5##3##(1991-5#1)(1992-3#1)(1994-11#1)(1994-9#1)(1997-3#1)
poor substrate##11##2##(1991-5#2)(1991-8#1)(1992-12#1)(1992-3#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-2#1)(1997-3#1)
poor substrates for##3##3##(1993-8#1)(1994-9#1)(1995-8#1)
poor substrates of##3##3##(1991-5#1)(1993-4#1)(1994-9#1)
poor substrates##9##2##(1990-11#1)(1991-4#1)(1991-5#1)(1993-4#1)(1993-8#1)(1994-9#2)(1995-8#1)(1996-5#1)
poor surgical##3##2##(2006-12#1)(2007-8#1)(2011-2#1)
poor survival##8##2##(1991-2#1)(1991-4#1)(1994-6#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-10#1)(2012-2#1)
poor therapeutic##2##2##(1992-10#1)(1993-11#1)
poor tissue##2##2##(2011-2#1)(2012-12#1)
poor tolerance of##2##3##(2009-2#1)(2013-1#1)
poor tolerance##3##2##(2008-9#1)(2009-2#1)(2013-1#1)
poor understanding of the##2##4##(2007-2#1)(2012-2#1)
poor understanding of##3##3##(1993-12#1)(2007-2#1)(2012-2#1)
poor understanding##4##2##(1993-12#1)(2007-2#1)(2010-5#1)(2012-2#1)
poor use##2##2##(2006-2#1)(2006-4#1)
poor vision##2##2##(1993-11#1)(2010-8#1)
poor visualization of##3##3##(2007-10#1)(2010-12#1)(2012-2#1)
poor water##3##2##(2008-10#1)(2009-6#1)(2011-2#1)
poor when##2##2##(2008-5#1)(2009-3#1)
poor with a##2##3##(2008-4#1)(2010-12#1)
poor with##7##2##(1996-9#1)(2006-7#1)(2007-10#1)(2007-5#1)(2008-4#1)(2010-12#1)(2010-5#1)
poor working conditions##3##3##(2006-10#1)(2008-1#1)(2012-3#1)
poor working##4##2##(2006-10#1)(2008-1#1)(2008-11#1)(2012-3#1)
poor wound healing##2##3##(2012-3#2)
poor##1384##1##(1990-1#1)(1990-10#5)(1990-11#3)(1990-12#3)(1990-2#3)(1990-4#1)(1990-5#5)(1990-6#5)(1990-8#1)(1990-9#3)(1991-10#2)(1991-11#3)(1991-12#5)(1991-2#4)(1991-3#4)(1991-4#5)(1991-5#7)(1991-6#3)(1991-7#2)(1991-8#7)(1991-9#3)(1992-1#1)(1992-10#8)(1992-12#1)(1992-2#7)(1992-3#2)(1992-4#2)(1992-5#5)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#3)(1993-1#4)(1993-10#3)(1993-11#8)(1993-12#7)(1993-2#2)(1993-3#6)(1993-4#1)(1993-5#4)(1993-7#1)(1993-8#6)(1993-9#3)(1994-1#2)(1994-11#2)(1994-12#6)(1994-2#5)(1994-3#4)(1994-6#8)(1994-7#2)(1994-8#1)(1994-9#7)(1995-1#1)(1995-11#1)(1995-12#6)(1995-2#3)(1995-3#1)(1995-5#3)(1995-6#2)(1995-7#2)(1995-8#5)(1995-9#9)(1996-1#4)(1996-10#2)(1996-11#5)(1996-12#5)(1996-2#3)(1996-3#8)(1996-4#2)(1996-5#4)(1996-6#3)(1996-7#1)(1996-8#6)(1996-9#7)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#3)(1997-6#5)(1997-7#2)(1997-8#4)(2004-1#2)(2004-10#6)(2004-2#1)(2004-3#1)(2004-9#1)(2005-10#14)(2005-11#3)(2005-7#5)(2005-8#4)(2005-9#1)(2006-1#4)(2006-10#23)(2006-11#3)(2006-12#4)(2006-2#8)(2006-3#3)(2006-4#12)(2006-5#12)(2006-6#5)(2006-7#6)(2006-8#5)(2006-9#2)(2007-1#3)(2007-10#18)(2007-11#30)(2007-12#13)(2007-2#18)(2007-3#8)(2007-4#4)(2007-5#2)(2007-6#8)(2007-7#30)(2007-8#29)(2007-9#20)(2008-1#25)(2008-10#50)(2008-11#30)(2008-12#14)(2008-2#20)(2008-3#28)(2008-4#10)(2008-5#26)(2008-6#25)(2008-7#39)(2008-8#17)(2008-9#24)(2009-1#1)(2009-10#5)(2009-11#5)(2009-12#3)(2009-2#6)(2009-3#11)(2009-4#10)(2009-5#17)(2009-6#5)(2009-7#10)(2009-8#6)(2009-9#2)(2010-1#5)(2010-10#4)(2010-11#6)(2010-12#32)(2010-2#12)(2010-3#14)(2010-4#6)(2010-5#8)(2010-6#6)(2010-7#7)(2010-8#7)(2010-9#3)(2011-1#24)(2011-11#1)(2011-12#5)(2011-2#60)(2011-3#2)(2011-7#1)(2012-1#8)(2012-11#2)(2012-12#28)(2012-2#26)(2012-3#31)(2012-8#1)(2013-1#56)(2013-7#10)(2013-8#28)
poor&quot##3##1##(2007-10#1)(2011-2#2)
poor-quality##3##1##(2008-1#1)(2008-3#1)(2013-1#1)
poor-risk AML##2##2##(2009-8#2)
poor-risk##4##1##(1994-12#1)(2009-8#2)(2010-11#1)
poorer academic achievement##2##3##(2007-8#1)(2012-2#1)
poorer adjustment##3##2##(2007-12#2)(2012-1#1)
poorer body esteem in terms of##2##6##(2007-12#2)
poorer body esteem##3##3##(2007-12#3)
poorer body##5##2##(2007-12#5)
poorer child social development##2##4##(2009-9#2)
poorer countries##2##2##(2006-2#1)(2008-10#1)
poorer disease-free##2##2##(1990-6#1)(1991-8#1)
poorer feed##2##2##(2008-5#2)
poorer health outcomes##2##3##(2007-12#1)(2008-11#1)
poorer health status##2##3##(1996-2#1)(1997-2#1)
poorer health##11##2##(1992-12#1)(1993-1#1)(1995-12#2)(1996-2#1)(1997-2#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2010-5#1)
poorer households##2##2##(1992-2#1)(2008-3#1)
poorer in##2##2##(2008-2#2)
poorer outcome##4##2##(1995-2#1)(2007-12#1)(2007-3#1)(2007-8#1)
poorer outcomes##5##2##(1991-12#1)(2005-7#1)(2008-5#1)(2010-2#1)(2011-1#1)
poorer perceived health##2##3##(2008-6#2)
poorer performance in##4##3##(1996-5#1)(2008-11#1)(2008-12#1)(2012-1#1)
poorer performance##10##2##(1992-6#1)(1996-5#1)(2008-11#2)(2008-12#1)(2008-9#1)(2009-7#1)(2011-2#2)(2012-1#1)
poorer physical health##2##3##(2011-2#1)(2013-8#1)
poorer physical##3##2##(1994-1#1)(2011-2#1)(2013-8#1)
poorer prognosis than those##2##4##(1992-11#1)(1993-9#1)
poorer prognosis##15##2##(1991-10#1)(1991-2#1)(1992-11#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-7#1)(1993-9#1)(1994-12#1)(1997-7#1)(2004-2#1)(2006-2#1)(2008-5#1)(2008-7#1)(2009-2#1)
poorer quality of life##2##4##(2009-11#1)(2011-2#1)
poorer quality of##3##3##(1992-2#1)(2009-11#1)(2011-2#1)
poorer recovery##2##2##(2011-1#1)(2013-1#1)
poorer renal survival##2##3##(2007-2#1)(2013-1#1)
poorer social##2##2##(2009-10#1)(2013-1#1)
poorer spatial##2##2##(1994-3#1)(2008-3#1)
poorer survival##3##2##(1991-8#1)(1995-10#1)(2007-11#1)
poorer than that##3##3##(2006-10#1)(2008-2#1)(2011-2#1)
poorer than those##2##3##(1996-11#1)(2004-9#1)
poorer than##7##2##(1996-11#1)(2004-9#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2011-2#1)
poorer##159##1##(1990-6#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-6#1)(1993-1#2)(1993-11#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-10#1)(1995-12#2)(1995-2#3)(1995-4#1)(1996-11#1)(1996-2#2)(1996-5#2)(1997-2#2)(1997-5#1)(1997-7#1)(2004-2#1)(2004-9#1)(2005-7#2)(2005-9#1)(2006-10#2)(2006-2#3)(2006-7#2)(2006-8#1)(2007-11#5)(2007-12#11)(2007-2#2)(2007-3#1)(2007-4#1)(2007-8#3)(2008-1#3)(2008-10#3)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-7#3)(2009-9#2)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#1)(2010-9#1)(2011-1#6)(2011-2#9)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#1)
poorest among##2##2##(1991-9#1)(1992-2#1)
poorest##30##1##(1990-2#1)(1991-9#1)(1992-2#1)(1992-5#1)(1993-6#1)(1993-7#1)(2006-10#1)(2007-3#1)(2007-4#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-6#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)
poorly absorbed##3##2##(2005-7#1)(2006-5#1)(2010-2#1)
poorly active in##3##3##(1995-2#1)(2007-11#1)(2008-5#1)
poorly active##6##2##(1991-3#1)(1995-2#1)(1995-8#1)(2006-5#1)(2007-11#1)(2008-5#1)
poorly and##5##2##(1995-2#1)(2008-2#1)(2010-12#1)(2013-1#2)
poorly between##2##2##(1996-12#1)(1997-5#1)
poorly by##2##2##(1991-8#1)(2009-10#1)
poorly characterized##9##2##(1991-6#1)(1993-3#1)(1996-8#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-4#1)(2010-12#1)(2013-7#1)
poorly controlled diabetes mellitus##2##4##(2013-1#2)
poorly controlled pain##2##3##(2006-7#1)(2012-12#1)
poorly controlled##14##2##(2006-7#1)(2007-12#2)(2008-1#1)(2008-7#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
poorly correlated with the##3##4##(1991-12#1)(1996-3#1)(2006-2#1)
poorly correlated##4##2##(1991-12#1)(1992-12#1)(1996-3#1)(2006-2#1)
poorly crystalline##4##2##(1996-2#1)(2005-11#2)(2008-5#1)
poorly defined##25##2##(1993-2#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-5#1)(2004-10#1)(2005-11#1)(2005-8#1)(2006-5#1)(2006-8#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#1)
poorly demarcated##2##2##(2007-2#1)(2008-5#1)
poorly demonstrated##2##2##(2008-5#1)(2008-7#1)
poorly described##2##2##(1994-2#1)(2006-12#1)
poorly detected##2##2##(1997-1#1)(2005-9#1)
poorly developed##10##2##(1990-2#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-7#1)(2011-1#1)(2013-1#1)
poorly differentiated adenocarcinoma##3##3##(1990-2#2)(2011-2#1)
poorly differentiated carcinoma##3##3##(1990-3#1)(2007-8#1)(2011-2#1)
poorly differentiated endometrial##2##3##(1990-2#1)(2013-7#1)
poorly differentiated##30##2##(1990-2#5)(1990-3#1)(1991-5#1)(1992-2#1)(1993-9#2)(2006-8#2)(2007-2#1)(2007-8#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#3)(2012-3#3)(2013-7#3)
poorly distributed##2##2##(2006-8#1)(2008-10#1)
poorly documented##8##2##(1990-12#1)(1992-8#1)(1995-5#1)(2007-4#1)(2009-6#1)(2012-1#1)(2012-2#1)(2013-7#1)
poorly explored##3##2##(2007-3#1)(2009-2#1)(2010-12#1)
poorly expressed in##3##3##(1990-5#1)(2011-2#1)(2013-8#1)
poorly expressed##5##2##(1990-5#1)(1992-9#1)(1993-2#1)(2011-2#1)(2013-8#1)
poorly fit##2##2##(1996-2#1)(2005-11#1)
poorly fitted##2##2##(1996-2#2)
poorly immunogenic##6##2##(1993-12#1)(1994-5#1)(1997-4#1)(2005-7#1)(2007-11#1)(2008-4#1)
poorly in##3##2##(1993-7#1)(1996-12#1)(2009-10#1)
poorly induced##2##2##(1995-2#1)(2009-9#1)
poorly informed about##2##3##(1991-6#1)(1995-1#1)
poorly informed##4##2##(1990-12#1)(1991-6#1)(1992-2#1)(1995-1#1)
poorly known##14##2##(1992-2#1)(1997-5#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-5#3)(2013-7#2)
poorly managed##5##2##(2006-8#1)(2008-10#2)(2008-3#1)(2008-5#1)
poorly on the##2##3##(1995-1#1)(1995-11#1)
poorly on##7##2##(1995-1#1)(1995-11#1)(2006-3#1)(2006-8#1)(2009-7#1)(2012-3#2)
poorly or not at all##2##5##(1994-8#1)(1995-4#1)
poorly or##3##2##(1994-8#1)(1995-2#1)(1995-4#1)
poorly ordered##2##2##(1990-2#1)(1995-4#1)
poorly preserved##2##2##(1991-6#1)(2008-6#1)
poorly processed cassava##2##3##(2006-4#2)
poorly protected##2##2##(1997-3#2)
poorly quantified##2##2##(2007-8#1)(2008-10#1)
poorly represented##2##2##(1994-12#1)(2011-2#1)
poorly resolved##5##2##(1997-4#1)(2008-10#2)(2011-1#2)
poorly responsive to##5##3##(2006-4#2)(2008-1#1)(2012-12#1)(2012-2#1)
poorly soluble in water##2##4##(1994-3#1)(2010-3#1)
poorly soluble in##3##3##(1994-3#1)(2008-10#1)(2010-3#1)
poorly soluble##8##2##(1994-3#1)(2008-10#1)(2008-5#3)(2008-7#1)(2010-3#1)(2012-12#1)
poorly studied##12##2##(2006-8#1)(2007-3#1)(2008-5#1)(2008-9#1)(2009-7#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#3)
poorly the##3##2##(1997-7#1)(2008-9#1)(2009-5#1)
poorly to##15##2##(1990-8#1)(1991-11#1)(1992-6#1)(1992-8#1)(1995-1#1)(1995-3#1)(2005-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)
poorly tolerated by##2##3##(2006-2#1)(2008-7#1)
poorly tolerated##5##2##(1995-3#1)(1996-9#1)(2006-2#1)(2006-4#1)(2008-7#1)
poorly translated or##2##3##(1992-12#1)(2011-2#1)
poorly understood and##12##3##(1990-5#1)(1996-1#1)(2006-9#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#1)(2011-1#1)(2013-1#1)(2013-8#2)
poorly understood##154##2##(1990-2#1)(1990-5#3)(1990-6#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-2#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-7#1)(1993-4#1)(1994-1#1)(1994-10#1)(1994-4#1)(1994-7#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-8#1)(1997-1#1)(2004-11#1)(2004-12#2)(2005-10#2)(2005-11#2)(2006-10#4)(2006-11#1)(2006-12#1)(2006-7#2)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-10#3)(2009-11#1)(2009-2#1)(2009-3#4)(2009-5#1)(2009-6#1)(2009-8#3)(2010-11#3)(2010-12#4)(2010-2#1)(2010-3#3)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-10#1)(2011-2#2)(2012-12#6)(2012-2#9)(2012-3#4)(2013-1#8)(2013-7#2)(2013-8#4)
poorly visualized##3##2##(2007-8#1)(2013-1#2)
poorly water-soluble drugs##2##3##(2012-2#2)
poorly water-soluble##5##2##(2008-5#1)(2010-5#1)(2012-12#1)(2012-2#2)
poorly when##2##2##(1990-6#1)(2006-5#1)
poorly with the##3##3##(1992-11#1)(1995-12#1)(2005-7#1)
poorly with##13##2##(1990-10#1)(1992-11#1)(1995-12#1)(1995-2#1)(1997-1#1)(2005-7#1)(2006-12#1)(2007-8#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-3#2)
poorly##528##1##(1990-10#1)(1990-12#3)(1990-2#9)(1990-3#2)(1990-5#5)(1990-6#2)(1990-8#2)(1991-11#3)(1991-12#3)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#3)(1991-8#2)(1991-9#1)(1992-11#2)(1992-12#4)(1992-2#5)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#3)(1994-1#1)(1994-10#1)(1994-12#4)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#6)(1995-11#1)(1995-12#1)(1995-2#6)(1995-3#3)(1995-4#2)(1995-5#2)(1995-6#4)(1995-8#2)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#7)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-3#3)(1997-4#2)(1997-5#2)(1997-7#1)(1997-8#2)(2004-10#1)(2004-11#1)(2004-12#2)(2005-10#3)(2005-11#6)(2005-7#3)(2005-8#3)(2005-9#1)(2006-10#6)(2006-11#1)(2006-12#3)(2006-2#2)(2006-3#1)(2006-4#5)(2006-5#6)(2006-7#3)(2006-8#10)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#8)(2007-2#3)(2007-3#3)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#6)(2008-1#4)(2008-10#22)(2008-11#8)(2008-12#1)(2008-2#3)(2008-3#11)(2008-4#6)(2008-5#27)(2008-6#5)(2008-7#15)(2008-8#4)(2008-9#8)(2009-1#1)(2009-10#5)(2009-11#1)(2009-2#2)(2009-3#4)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#4)(2010-12#12)(2010-2#4)(2010-3#5)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#13)(2011-10#1)(2011-12#1)(2011-2#17)(2012-1#3)(2012-11#2)(2012-12#12)(2012-2#15)(2012-3#13)(2013-1#19)(2013-7#12)(2013-8#8)
poorly-controlled##2##1##(1993-12#1)(2013-7#1)
poorly-differentiated##3##1##(2008-5#3)
pop and##2##2##(2008-9#1)(2009-10#1)
pop##7##1##(2008-12#4)(2008-9#1)(2009-10#1)(2009-2#1)
poplar (Populus##2##2##(2008-5#1)(2011-2#1)
poplar clones##5##2##(2008-10#1)(2011-2#4)
poplar tree##4##2##(2006-11#4)
poplar##35##1##(2006-11#5)(2008-10#16)(2008-5#2)(2008-6#3)(2011-2#6)(2013-1#1)(2013-8#2)
poplar-agriculture system##2##2##(2013-8#2)
popliteal artery and##2##3##(2006-10#1)(2007-11#1)
popliteal artery##14##2##(1990-10#3)(1991-3#4)(2005-10#2)(2006-10#1)(2007-11#1)(2007-8#1)(2008-8#1)(2010-11#1)
popliteal fossa and##2##3##(2010-12#1)(2012-12#1)
popliteal fossa nerve blockade##2##4##(2008-8#2)
popliteal fossa##6##2##(1993-7#1)(2008-8#3)(2010-12#1)(2012-12#1)
popliteal lymph node assay##3##4##(2008-10#3)
popliteal lymph node##7##3##(2008-10#4)(2008-5#1)(2008-9#2)
popliteal lymph##8##2##(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#2)
popliteal vein entrapment##3##3##(2005-10#3)
popliteal vein##4##2##(1990-10#1)(2005-10#3)
popliteal##43##1##(1990-10#5)(1991-3#6)(1993-7#1)(2005-10#7)(2006-10#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-5#1)(2008-8#4)(2008-9#2)(2010-11#1)(2010-12#1)(2012-12#1)
popliteus muscle##3##2##(2010-12#3)
popliteus##5##1##(2010-12#5)
poppy (Papaver somniferum)##3##3##(2008-10#3)
poppy leaves##2##2##(2008-10#2)
poppy##21##1##(2007-12#1)(2008-10#20)
pops##9##1##(2008-12#8)(2008-9#1)
popular among##5##2##(1992-2#1)(2006-9#1)(2007-11#1)(2007-8#1)(2013-1#1)
popular and##7##2##(1995-12#1)(1995-2#1)(1995-3#1)(2006-2#1)(2008-11#1)(2008-5#1)(2011-1#1)
popular as a##2##3##(2005-10#1)(2008-3#1)
popular as##6##2##(2005-10#1)(2006-5#2)(2008-3#1)(2012-2#1)(2012-3#1)
popular belief that##2##3##(2008-5#1)(2008-7#1)
popular belief##7##2##(1993-1#1)(1997-3#1)(2008-5#2)(2008-7#1)(2009-9#1)(2012-3#1)
popular brands of##2##3##(2005-11#1)(2008-5#1)
popular choice for##2##3##(2008-10#1)(2010-8#1)
popular choice##3##2##(2008-10#1)(2008-5#1)(2010-8#1)
popular culture##4##2##(2007-3#1)(2008-11#1)(2008-5#1)(2008-7#1)
popular due to its##2##4##(2007-8#1)(2008-5#1)
popular due to##3##3##(2005-12#1)(2007-8#1)(2008-5#1)
popular due##4##2##(2005-12#1)(2007-8#1)(2008-2#1)(2008-5#1)
popular films##2##2##(2009-4#2)
popular for##8##2##(1994-9#1)(2004-2#1)(2008-2#1)(2008-5#1)(2009-9#1)(2012-1#1)(2012-2#2)
popular free##2##2##(2010-9#1)(2013-8#1)
popular in the##8##3##(1993-1#1)(1997-6#1)(2006-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
popular in##23##2##(1993-1#1)(1995-2#2)(1997-6#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-2#2)(2010-7#1)(2011-2#1)(2012-12#1)
popular magazines##2##2##(2007-12#1)(2008-7#1)
popular method for##4##3##(1994-5#1)(2008-11#2)(2008-6#1)
popular method##8##2##(1994-5#1)(2008-10#1)(2008-11#2)(2008-6#1)(2009-8#1)(2011-2#1)(2012-3#1)
popular methods for##2##3##(2006-10#1)(2008-4#1)
popular methods##3##2##(2006-10#1)(2008-4#1)(2008-6#1)
popular music of today##2##4##(1992-3#2)
popular music##4##2##(1992-3#3)(2007-6#1)
popular romances##2##2##(2011-2#2)
popular sequential##2##2##(1997-2#1)(1997-8#1)
popular strategy##2##2##(1996-3#1)(2012-2#1)
popular technique##3##2##(2006-10#1)(2006-3#1)(2013-1#1)
popular techniques for##3##3##(2008-10#2)(2010-3#1)
popular techniques##4##2##(2008-1#1)(2008-10#2)(2010-3#1)
popular theory that##2##3##(2007-8#1)(2007-9#1)
popular tool for##6##3##(2006-8#1)(2007-8#1)(2008-8#1)(2009-6#1)(2013-1#2)
popular tool##8##2##(1994-2#1)(2006-8#1)(2007-8#1)(2008-8#1)(2009-3#1)(2009-6#1)(2013-1#2)
popular with##3##2##(2006-10#1)(2007-2#1)(2008-10#1)
popular##288##1##(1991-10#1)(1991-2#1)(1991-7#1)(1992-2#1)(1992-3#4)(1992-6#1)(1992-8#2)(1993-1#4)(1993-12#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#4)(1995-3#3)(1996-1#1)(1996-11#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-9#2)(1997-2#2)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#2)(2004-10#1)(2004-11#1)(2004-2#1)(2004-9#3)(2005-10#2)(2005-11#3)(2005-12#1)(2005-9#3)(2006-10#7)(2006-12#4)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#2)(2006-8#2)(2006-9#2)(2007-1#1)(2007-11#7)(2007-12#3)(2007-2#5)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#9)(2007-9#3)(2008-1#4)(2008-10#15)(2008-11#12)(2008-12#1)(2008-2#7)(2008-3#7)(2008-4#9)(2008-5#11)(2008-6#4)(2008-7#9)(2008-8#6)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-12#2)(2010-2#4)(2010-3#1)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#9)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#11)(2012-3#5)(2013-1#5)(2013-7#2)(2013-8#6)
popular&quot##2##1##(2009-7#2)
popularity and##5##2##(2007-5#1)(2009-6#1)(2012-12#1)(2013-1#1)(2013-7#1)
popularity as a##3##3##(2007-8#1)(2012-12#1)(2012-3#1)
popularity as##7##2##(2007-8#1)(2010-12#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
popularity for their##2##3##(1992-11#1)(2007-7#1)
popularity for##4##2##(1992-11#1)(2006-10#1)(2007-7#1)(2008-12#1)
popularity in the##3##3##(1994-2#1)(2006-2#1)(2007-8#1)
popularity in##13##2##(1992-12#1)(1994-2#1)(1996-9#1)(2006-10#1)(2006-2#1)(2007-8#2)(2008-11#1)(2010-1#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)
popularity motivations##3##2##(2009-8#3)
popularity of minimally invasive##2##4##(2006-10#1)(2009-12#1)
popularity of the##3##3##(1993-2#1)(2004-10#1)(2008-1#1)
popularity of##25##2##(1990-8#1)(1993-2#1)(1994-9#1)(2004-10#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-7#2)
popularity over the past##2##4##(2006-3#1)(2011-2#1)
popularity was##2##2##(2010-1#2)
popularity with##3##2##(2007-12#1)(2007-5#1)(2009-11#1)
popularity worldwide##2##2##(2005-11#1)(2011-2#1)
popularity##88##1##(1990-8#1)(1992-11#1)(1992-12#1)(1993-2#1)(1994-2#1)(1994-9#1)(1996-9#2)(2004-10#1)(2004-2#1)(2005-11#1)(2005-7#1)(2006-10#5)(2006-12#1)(2006-2#2)(2006-3#1)(2006-5#1)(2007-11#2)(2007-12#3)(2007-5#2)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#2)(2009-8#4)(2010-1#7)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#4)(2012-3#1)(2013-1#4)(2013-7#3)(2013-8#1)
popularization of##4##2##(1993-2#1)(2006-5#1)(2007-3#1)(2007-5#1)
popularization##7##1##(1993-2#1)(2006-5#1)(2007-3#1)(2007-5#1)(2008-8#1)(2010-7#1)(2013-1#1)
popularize##2##1##(2006-7#1)(2008-7#1)
popularized in##2##2##(2006-10#1)(2010-8#1)
popularized the##2##2##(1995-12#1)(1997-1#1)
popularized##10##1##(1995-1#1)(1995-12#1)(1997-1#1)(2006-10#1)(2006-8#1)(2007-4#1)(2008-2#1)(2010-8#1)(2011-1#1)(2013-1#1)
popularly known as &quot##2##4##(2011-2#1)(2013-7#1)
popularly used##3##2##(2005-4#1)(2008-1#1)(2013-1#1)
popularly##6##1##(2005-4#1)(2008-1#1)(2008-3#1)(2011-2#1)(2013-1#1)(2013-7#1)
populate the##3##2##(1991-6#1)(1992-5#1)(1996-11#1)
populate##11##1##(1991-6#1)(1992-5#1)(1993-6#1)(1995-11#1)(1995-2#1)(1996-11#1)(2006-7#1)(2012-1#1)(2012-2#1)(2013-1#2)
populated areas##5##2##(1991-5#1)(1994-8#1)(2006-4#1)(2008-2#1)(2008-4#1)
populated by##6##2##(1995-1#1)(1995-11#1)(1997-5#1)(2006-5#1)(2008-5#2)
populated in##5##2##(1994-8#1)(1995-9#1)(1996-2#1)(2006-12#1)(2007-11#1)
populated the##2##2##(1991-12#1)(2010-12#1)
populated with##3##2##(1996-11#1)(1996-8#1)(2008-9#1)
populated##42##1##(1990-3#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-9#1)(1993-11#1)(1993-6#1)(1994-8#4)(1995-1#1)(1995-10#1)(1995-11#1)(1995-9#3)(1996-11#1)(1996-2#1)(1996-8#1)(1997-4#2)(1997-5#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2010-12#1)(2011-2#2)(2013-1#1)
populating the##2##2##(2007-11#1)(2010-12#1)
populating##4##1##(2007-11#1)(2008-4#1)(2008-7#1)(2010-12#1)
population (0##2##2##(2007-2#2)
population (44##2##2##(2008-3#1)(2011-1#1)
population (P &gt##2##3##(2008-10#1)(2008-8#1)
population (approximately##2##2##(1992-11#1)(2008-9#1)
population (n =##3##3##(1995-3#1)(2007-10#1)(2013-7#1)
population - are##2##3##(2012-12#1)(2013-1#1)
population 4 years of age and older was##2##8##(2009-4#2)
population 4 years of age and older##3##7##(2009-4#3)
population a##3##2##(2007-7#1)(2010-7#1)(2013-1#1)
population about##3##2##(1990-5#1)(1991-9#1)(2007-3#1)
population abundance##2##2##(2004-11#1)(2008-8#1)
population abundances##2##2##(2012-2#2)
population adapted to##2##3##(2008-8#2)
population affected by##2##3##(2007-9#1)(2008-11#1)
population affected##3##2##(2007-9#1)(2008-11#1)(2011-2#1)
population after##6##2##(1992-2#1)(1992-6#1)(2007-2#1)(2007-5#1)(2008-10#1)(2009-4#1)
population aged 65 or older##2##5##(2007-10#2)
population aged##4##2##(1995-9#1)(2007-10#2)(2008-7#1)
population ageing##2##2##(2008-7#2)
population ages##9##2##(1996-2#1)(2005-7#1)(2006-9#1)(2008-1#1)(2008-3#1)(2008-7#2)(2009-5#1)(2012-3#1)
population aging##4##2##(2008-7#1)(2010-5#2)(2013-1#1)
population also##2##2##(2008-10#2)
population analysis##3##2##(2008-1#1)(2012-12#1)(2012-3#1)
population and a##4##3##(1992-1#1)(1997-6#1)(2007-8#1)(2012-12#1)
population and an##2##3##(1995-12#1)(2007-12#1)
population and are##5##3##(2008-1#1)(2008-6#1)(2010-12#2)(2010-2#1)
population and for##4##3##(1991-1#1)(1993-7#1)(1995-12#1)(2011-2#1)
population and has##2##3##(2006-9#1)(2008-3#1)
population and healthcare##2##3##(2010-11#1)(2013-1#1)
population and in the##2##4##(2007-12#1)(2007-5#1)
population and in women##2##4##(2009-5#1)(2012-2#1)
population and in##9##3##(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-2#1)
population and individual##4##3##(1993-6#1)(1996-7#1)(2008-5#1)(2010-2#1)
population and is the##2##4##(2009-3#1)(2013-8#1)
population and is##5##3##(1992-8#1)(2009-3#1)(2010-8#1)(2011-12#1)(2013-8#1)
population and its##6##3##(1990-3#1)(1991-12#1)(1993-5#1)(2007-9#1)(2008-9#1)(2009-1#1)
population and may be##2##4##(2007-7#1)(2008-10#1)
population and more##4##3##(1997-1#1)(1997-2#1)(2008-2#1)(2008-4#1)
population and reproductive##2##3##(2010-8#1)(2013-7#1)
population and should be##2##4##(1990-6#1)(2012-12#1)
population and should##5##3##(1990-6#1)(2011-2#1)(2012-12#1)(2013-1#2)
population and that may##2##4##(2005-10#1)(2007-12#1)
population and that##5##3##(1992-5#1)(2005-10#1)(2006-10#1)(2007-12#1)(2008-10#1)
population and the use of##2##5##(2007-11#1)(2012-1#1)
population and the##23##3##(1997-1#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-7#1)
population and their##3##3##(1991-3#1)(2011-1#1)(2013-8#1)
population and three##2##3##(2008-10#1)(2009-4#1)
population and to##7##3##(1990-3#1)(1993-1#1)(2006-10#1)(2006-12#1)(2006-8#1)(2008-10#1)(2010-9#1)
population and were##3##3##(1993-2#2)(2010-2#1)
population and##205##2##(1990-10#1)(1990-3#2)(1990-6#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#3)(1992-1#1)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-6#1)(1993-7#1)(1994-2#1)(1994-8#1)(1995-12#3)(1995-9#1)(1996-1#1)(1996-3#2)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-11#2)(2005-1#1)(2005-10#2)(2005-11#1)(2006-1#1)(2006-10#8)(2006-11#2)(2006-12#2)(2006-2#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-5#1)(2007-7#5)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#12)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#4)(2009-1#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#2)(2009-7#1)(2009-9#2)(2010-11#3)(2010-12#2)(2010-2#5)(2010-4#2)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#3)(2011-12#2)(2011-2#15)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#5)
population appears to##3##3##(2008-10#1)(2011-2#1)(2012-1#1)
population appears##4##2##(2008-10#1)(2008-11#1)(2011-2#1)(2012-1#1)
population approach##2##2##(1991-6#1)(2008-10#1)
population are also##2##3##(2005-10#1)(2008-12#1)
population are##24##2##(1996-12#1)(1996-3#1)(2005-10#1)(2006-10#3)(2006-2#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
population as a whole##14##4##(1990-4#1)(1992-4#1)(1993-11#2)(1994-10#1)(2008-11#2)(2008-4#1)(2008-8#2)(2009-5#1)(2010-8#1)(2011-1#1)(2012-12#1)
population as a##17##3##(1990-4#1)(1992-4#1)(1993-11#2)(1994-10#1)(1996-12#1)(2007-9#1)(2008-11#2)(2008-4#1)(2008-8#2)(2009-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)
population as well as the##2##5##(1995-9#1)(2011-1#1)
population as well as to##2##5##(1994-2#1)(2008-10#1)
population as well as##8##4##(1992-2#1)(1994-2#1)(1995-9#1)(2007-12#1)(2008-10#1)(2009-10#1)(2011-1#1)(2011-2#1)
population as##32##2##(1990-4#1)(1992-2#1)(1992-4#1)(1993-11#2)(1993-7#1)(1994-10#1)(1994-2#1)(1995-9#1)(1996-12#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#2)(2009-10#1)(2009-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
population at high risk of##2##5##(1993-11#1)(2008-1#1)
population at high##3##3##(1993-11#1)(2008-1#1)(2008-10#1)
population at large##8##3##(1992-2#2)(2006-10#1)(2006-7#1)(2007-9#1)(2008-4#1)(2011-2#1)(2012-2#1)
population at risk##3##3##(1997-6#1)(2012-12#2)
population at the##4##3##(1992-11#1)(1994-4#1)(2008-10#1)(2013-1#1)
population at##26##2##(1991-1#1)(1992-11#1)(1992-2#2)(1993-11#1)(1994-4#1)(1997-4#1)(1997-6#1)(2004-4#1)(2005-7#1)(2006-10#1)(2006-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#2)(2009-6#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
population balance##4##2##(2005-11#3)(2008-11#1)
population based cancer registries which##2##5##(2011-2#1)(2011-3#1)
population based on##3##3##(2005-10#1)(2009-10#1)(2010-12#1)
population based rates##2##3##(1992-3#2)
population based study##3##3##(1996-11#1)(2004-2#1)(2008-2#1)
population based##18##2##(1992-3#2)(1996-11#1)(1996-2#1)(2004-2#1)(2005-10#1)(2006-4#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#1)(2010-12#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#1)
population before##3##2##(2004-9#1)(2008-10#1)(2010-9#1)
population being##8##2##(1994-9#1)(1997-2#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-12#2)
population between 2000 and 2010##6##5##(2013-8#6)
population between##11##2##(1990-8#1)(1994-6#1)(2008-10#1)(2008-9#1)(2010-2#1)(2013-8#6)
population bioequivalence##4##2##(1993-6#1)(1996-12#2)(1997-2#1)
population biology and##2##3##(2008-6#1)(2008-8#1)
population biology in##2##3##(2008-8#2)
population biology##11##2##(2008-10#3)(2008-6#1)(2008-8#6)(2008-9#1)
population bottleneck##3##2##(2008-10#1)(2008-9#2)
population bottlenecks##3##2##(1995-2#2)(2010-8#1)
population but in##2##3##(2009-11#1)(2010-8#1)
population but##8##2##(1993-9#1)(2006-7#1)(2007-1#1)(2007-7#1)(2008-10#1)(2009-11#2)(2010-8#1)
population by the##3##3##(1993-10#1)(1994-11#1)(2008-11#1)
population by##24##2##(1991-3#1)(1993-10#1)(1993-11#2)(1993-9#1)(1994-11#1)(1996-1#1)(1997-7#1)(2006-2#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-9#2)(2009-8#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
population can be##9##3##(1995-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2010-3#1)(2011-2#1)(2012-3#1)
population can##11##2##(1995-8#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2010-3#1)(2011-2#1)(2012-3#1)
population carrying Rcm##2##3##(2008-10#2)
population census of##2##3##(1994-2#1)(2008-9#1)
population census##5##2##(1991-11#1)(1994-2#1)(2008-9#1)(2010-8#1)(2013-1#1)
population change##2##2##(2008-8#1)(2008-9#1)
population characteristics##5##2##(2006-2#1)(2009-9#1)(2010-11#1)(2010-8#1)(2011-2#1)
population compared##2##2##(1994-4#1)(2007-7#1)
population composition##2##2##(2008-10#2)
population comprising##3##2##(1990-6#1)(2010-2#1)(2011-2#1)
population consisted of 100##2##4##(2006-12#1)(2008-5#1)
population consisted of 248##2##4##(2008-10#1)(2008-6#1)
population consisted of##19##3##(1996-7#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#1)
population consists of##2##3##(1997-6#1)(2008-1#1)
population continues to age##2##4##(2005-3#1)(2008-3#1)
population continues to##3##3##(2005-3#1)(2008-3#1)(2011-1#1)
population control##6##2##(1993-9#1)(1994-8#1)(1994-9#1)(2007-7#1)(2011-2#1)(2012-3#1)
population controls##2##2##(1990-8#1)(2010-2#1)
population could##3##2##(1996-12#1)(2007-2#1)(2008-5#1)
population coverage##3##2##(1990-10#1)(2013-1#2)
population crashes##2##2##(1995-2#1)(1996-6#1)
population cultured##3##2##(2008-11#2)(2008-9#1)
population data from the##4##4##(2011-2#1)(2012-12#1)(2013-1#2)
population data from##7##3##(2008-12#2)(2011-2#2)(2012-12#1)(2013-1#2)
population data##19##2##(1996-12#1)(1996-2#1)(2008-10#3)(2008-12#8)(2008-7#1)(2011-2#2)(2012-12#1)(2013-1#2)
population database##3##2##(2008-12#1)(2009-8#1)(2010-5#1)
population decline##7##2##(1995-3#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-8#2)(2013-1#1)
population declines##3##2##(1995-2#1)(2007-3#1)(2009-2#1)
population demographics##3##2##(1991-3#1)(1992-1#1)(1994-3#1)
population demography##3##2##(2008-8#2)(2010-8#1)
population densities after##2##3##(2008-10#1)(2012-2#1)
population densities at##2##3##(2008-10#2)
population densities in the##2##4##(2008-10#2)
population densities in##3##3##(2008-10#3)
population densities of H##5##4##(2008-10#5)
population densities of the##3##4##(2008-10#2)(2008-7#1)
population densities of##22##3##(2004-11#1)(2004-4#1)(2005-8#1)(2007-5#1)(2008-10#17)(2008-7#1)
population densities than the##2##4##(2008-10#2)
population densities were##2##3##(2008-10#2)
population densities##61##2##(1991-12#1)(2004-11#1)(2004-4#1)(2005-8#1)(2007-5#1)(2008-10#42)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#4)(2009-3#1)(2010-8#1)(2012-2#2)
population density and##13##3##(1993-1#1)(1997-7#1)(2007-3#1)(2008-10#4)(2008-8#2)(2008-9#2)(2013-1#1)(2013-8#1)
population density in the##2##4##(1990-11#1)(2008-10#1)
population density in##3##3##(1990-11#1)(2008-10#1)(2013-8#1)
population density increased##2##3##(2008-8#1)(2012-2#1)
population density of strain##2##4##(2008-10#2)
population density of the##4##4##(2008-10#4)
population density of##17##3##(2006-12#1)(2007-5#1)(2008-10#13)(2008-3#1)(2009-3#1)
population density or##3##3##(2008-8#1)(2010-8#1)(2012-2#1)
population density when##2##3##(2008-8#1)(2008-9#1)
population density##82##2##(1990-11#1)(1992-12#1)(1993-1#1)(1994-5#1)(1995-10#6)(1995-9#1)(1996-3#1)(1996-7#1)(1997-7#1)(2004-11#1)(2006-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2008-10#23)(2008-11#2)(2008-12#2)(2008-3#3)(2008-8#7)(2008-9#9)(2009-3#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#3)(2013-1#3)(2013-8#2)
population derived from a cross between a##2##7##(2012-11#2)
population derived from a cross between##5##6##(2008-10#3)(2012-11#2)
population derived from a cross##6##5##(2008-10#4)(2012-11#2)
population derived from a##7##4##(2008-10#5)(2012-11#2)
population derived from anther culture of##2##6##(2008-4#1)(2008-8#1)
population derived from the cross##2##5##(2008-10#2)
population derived from##15##3##(2008-10#9)(2008-4#1)(2008-8#1)(2009-10#1)(2012-1#1)(2012-11#2)
population development of##3##3##(2008-10#1)(2009-3#2)
population development##6##2##(2008-10#3)(2009-3#3)
population did not##6##3##(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)
population differences##2##2##(2008-10#1)(2008-8#1)
population differentiation and##2##3##(2008-10#1)(2012-11#1)
population differentiation at##3##3##(2012-3#3)
population differentiation was detected##2##4##(2008-10#2)
population differentiation was##4##3##(2008-10#4)
population differentiation##19##2##(2008-10#13)(2008-8#1)(2012-11#1)(2012-3#4)
population distribution of##6##3##(1991-9#1)(2008-1#1)(2010-2#4)
population distribution##14##2##(1991-9#1)(1995-12#1)(1997-1#2)(1997-2#1)(2008-1#1)(2008-2#1)(2010-2#6)(2010-9#1)
population distributions of##3##3##(1993-6#1)(2010-2#2)
population distributions##7##2##(1993-6#1)(2008-8#2)(2008-9#1)(2010-2#3)
population diversity of##2##3##(2008-10#1)(2008-5#1)
population diversity##3##2##(2008-10#2)(2008-5#1)
population does not##2##3##(2008-10#1)(2011-12#1)
population does##3##2##(1997-3#1)(2008-10#1)(2011-12#1)
population doubling##6##2##(1993-6#1)(2008-11#3)(2011-1#2)
population doublings##8##2##(1991-8#1)(1993-11#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-12#2)
population due to##4##3##(2008-11#2)(2008-9#1)(2011-1#1)
population during a##2##3##(2008-10#1)(2008-7#1)
population during the##2##3##(1996-5#1)(2011-2#1)
population during##13##2##(1990-6#1)(1993-6#1)(1996-3#1)(1996-5#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
population dynamic models##2##3##(1995-8#1)(2008-8#1)
population dynamics and##8##3##(2007-9#1)(2008-10#2)(2008-8#1)(2008-9#1)(2011-12#1)(2013-7#1)(2013-8#1)
population dynamics at the##2##4##(2008-5#1)(2013-8#1)
population dynamics in the##2##4##(2008-10#1)(2010-8#1)
population dynamics in##8##3##(2007-3#1)(2007-9#1)(2008-10#3)(2010-8#1)(2012-2#1)(2013-8#1)
population dynamics of each##2##4##(2008-10#2)
population dynamics of the##7##4##(2007-12#1)(2008-10#5)(2008-5#1)
population dynamics of##27##3##(1991-2#1)(1994-8#1)(2007-12#1)(2007-3#1)(2008-10#14)(2008-11#1)(2008-5#2)(2008-8#2)(2008-9#1)(2010-12#1)(2012-3#1)(2013-8#1)
population dynamics##80##2##(1991-2#2)(1994-2#1)(1994-8#2)(1997-6#1)(2005-11#1)(2005-8#1)(2006-5#1)(2007-12#1)(2007-3#2)(2007-6#1)(2007-9#2)(2008-10#23)(2008-11#2)(2008-5#3)(2008-8#13)(2008-9#9)(2010-12#1)(2010-5#1)(2010-8#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#5)
population ecology##3##2##(2008-9#1)(2012-2#1)(2013-8#1)
population effects##2##2##(2008-10#1)(2012-2#1)
population enjoys##2##2##(2012-1#2)
population established##2##2##(2007-3#1)(2008-10#1)
population estimates for##2##3##(2010-11#1)(2011-2#1)
population estimates of##2##3##(1994-2#1)(2004-11#1)
population estimates##7##2##(1994-2#1)(1995-4#1)(2004-11#2)(2010-11#2)(2011-2#1)
population estimation##3##2##(2004-11#2)(2010-11#1)
population excitatory post-synaptic##2##3##(1991-9#1)(1995-12#1)
population excitatory##3##2##(1991-9#1)(1995-12#1)(1997-5#1)
population exhibited##3##2##(2008-10#2)(2013-8#1)
population expansion##3##2##(2010-8#1)(2011-1#1)(2011-2#1)
population experienced a##2##3##(2008-7#1)(2008-8#1)
population exposed to##2##3##(1995-5#1)(2008-7#1)
population exposure##3##2##(2008-7#1)(2010-2#1)(2010-8#1)
population features##2##2##(2008-8#1)(2008-9#1)
population fitness##2##2##(2008-7#1)(2012-1#1)
population for the##2##3##(1995-2#1)(2008-11#1)
population for##21##2##(1994-6#1)(1995-2#1)(1996-12#1)(1997-3#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-8#1)(2012-3#1)(2013-1#1)
population forecasts##2##2##(2007-7#1)(2013-1#1)
population from Iruttupallam##2##3##(2007-6#2)
population from Real de Salinas##3##5##(2008-5#3)
population from a##4##3##(1997-2#1)(2008-10#2)(2012-3#1)
population from the cross##2##4##(2008-10#2)
population from the##14##3##(1991-12#1)(1995-9#1)(2007-2#1)(2007-7#2)(2008-10#2)(2008-3#1)(2009-7#1)(2011-1#3)(2012-12#1)(2013-1#1)
population from##52##2##(1991-11#1)(1991-12#1)(1995-9#1)(1997-2#1)(2005-10#1)(2005-5#1)(2006-10#1)(2007-1#1)(2007-2#1)(2007-6#3)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#15)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#3)(2009-7#1)(2010-11#1)(2010-3#1)(2011-1#4)(2011-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
population genetic models##3##3##(2008-12#1)(2008-8#1)(2008-9#1)
population genetic structure and##2##4##(2010-8#2)
population genetic structure of##8##4##(2008-10#5)(2008-8#1)(2011-2#1)(2013-8#1)
population genetic structure##15##3##(2008-10#7)(2008-8#3)(2010-8#2)(2011-2#1)(2012-3#1)(2013-8#1)
population genetic studies of##2##4##(2008-10#1)(2012-3#1)
population genetic studies##4##3##(1995-11#1)(2008-10#2)(2012-3#1)
population genetic##31##2##(1995-11#1)(2007-12#1)(2008-10#13)(2008-12#3)(2008-3#1)(2008-8#4)(2008-9#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#1)
population genetics and##2##3##(2008-10#1)(2009-2#1)
population genetics of##4##3##(2007-12#1)(2008-10#2)(2013-1#1)
population genetics##20##2##(2007-12#1)(2008-10#6)(2008-12#1)(2008-6#1)(2008-8#4)(2009-2#1)(2009-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
population grating##3##2##(2007-12#3)
population group##2##2##(1994-12#1)(2008-1#1)
population groups and##4##3##(2006-2#1)(2007-7#1)(2011-2#1)(2012-2#1)
population groups for##2##3##(1997-8#1)(2010-2#1)
population groups in##3##3##(1990-12#1)(2006-4#1)(2006-7#1)
population groups##34##2##(1990-12#1)(1993-1#1)(1997-4#1)(1997-8#1)(2005-7#2)(2006-2#2)(2006-4#2)(2006-7#1)(2006-8#1)(2007-12#1)(2007-6#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-2#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-2#1)(2012-3#2)(2013-1#1)
population grows##3##2##(1993-5#1)(2008-5#1)(2012-3#1)
population growth and##4##3##(1994-3#1)(2008-11#2)(2013-8#1)
population growth is##2##3##(2008-9#2)
population growth of##9##3##(2006-12#1)(2008-10#2)(2008-6#1)(2011-2#1)(2012-2#4)
population growth rate##8##3##(1990-9#1)(2008-8#4)(2008-9#2)(2010-8#1)
population growth rates and##3##4##(2008-8#3)
population growth rates##9##3##(2008-8#6)(2008-9#1)(2010-2#1)(2010-8#1)
population growth##61##2##(1990-3#2)(1990-9#1)(1991-3#2)(1994-2#1)(1994-3#1)(1994-7#2)(1994-9#1)(1995-8#1)(2004-11#1)(2006-12#1)(2007-1#1)(2007-3#1)(2008-10#5)(2008-11#5)(2008-5#1)(2008-6#1)(2008-8#12)(2008-9#7)(2009-4#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#6)(2013-8#1)
population had a##5##3##(1992-5#1)(2008-10#2)(2008-5#1)(2008-8#1)
population had##16##2##(1990-2#1)(1990-5#1)(1992-5#1)(1992-8#1)(1994-4#1)(2006-2#1)(2008-10#2)(2008-5#1)(2008-8#2)(2011-2#1)(2012-7#1)(2013-1#1)(2013-8#2)
population has a##6##3##(2006-7#1)(2007-10#1)(2008-1#1)(2008-10#2)(2012-1#1)
population has been##8##3##(1997-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
population has led to##2##4##(1997-2#1)(2012-2#1)
population has not##3##3##(1997-5#1)(2008-3#1)(2012-12#1)
population has##34##2##(1991-2#1)(1992-3#1)(1997-2#1)(1997-5#1)(1997-8#1)(2006-10#3)(2006-2#1)(2006-7#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)
population have been##3##3##(2007-11#1)(2008-10#1)(2009-6#1)
population have##11##2##(1991-8#1)(1994-6#1)(1996-6#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-8#1)
population having the##2##3##(2008-8#1)(2013-1#1)
population having##3##2##(1992-8#1)(2008-8#1)(2013-1#1)
population health in##3##3##(1996-12#1)(2010-2#1)(2011-1#1)
population health status##5##3##(1996-12#1)(2009-4#1)(2010-11#3)
population health##28##2##(1996-12#3)(1997-2#1)(2005-9#1)(2008-1#2)(2008-2#3)(2008-7#1)(2009-4#2)(2009-7#1)(2009-9#1)(2010-11#3)(2010-2#1)(2010-8#3)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
population heterogeneity##2##2##(2008-8#1)(2012-2#1)
population history##2##2##(2006-2#1)(2010-8#1)
population identified##2##2##(2008-10#2)
population in Amsterdam##2##3##(1990-3#1)(2006-4#1)
population in Baghdad##2##3##(2006-4#2)
population in Iceland##2##3##(2006-10#2)
population in Israel##2##3##(2008-1#1)(2008-10#1)
population in Japan##3##3##(2007-1#1)(2012-2#2)
population in Nepal##3##3##(2008-10#1)(2010-5#1)(2012-3#1)
population in Western##2##3##(2008-10#1)(2008-3#1)
population in a##8##3##(1992-2#1)(1997-2#1)(2005-9#1)(2007-9#1)(2008-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
population in developed countries##2##4##(2005-8#1)(2011-2#1)
population in high##2##3##(2008-9#1)(2011-2#1)
population in northern##2##3##(1990-2#1)(2006-2#1)
population in order to##2##4##(2011-1#1)(2013-1#1)
population in particular##2##3##(2006-2#1)(2008-3#1)
population in regards to##2##4##(2007-12#1)(2008-9#1)
population in relation to##2##4##(1993-9#1)(2011-2#1)
population in terms of##2##4##(2006-10#1)(2012-12#1)
population in the North Fiji Basin##2##6##(2008-6#2)
population in the United States##5##5##(2006-11#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
population in the same##2##4##(2004-10#1)(2012-12#1)
population in the##51##3##(1990-7#1)(1992-3#1)(1993-4#1)(1993-8#2)(1996-2#1)(1997-1#1)(2004-10#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-10#1)(2007-12#2)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#2)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2012-7#1)(2013-8#1)
population in this##2##3##(2008-10#2)
population in which##4##3##(2005-12#1)(2008-11#1)(2008-7#1)(2008-8#1)
population in##172##2##(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-12#2)(1992-2#3)(1992-3#1)(1993-10#1)(1993-12#1)(1993-4#1)(1993-8#2)(1993-9#1)(1995-9#3)(1996-2#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(2004-10#1)(2005-10#1)(2005-12#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#5)(2006-11#1)(2006-2#5)(2006-4#4)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-5#2)(2007-7#1)(2007-9#1)(2008-1#4)(2008-10#11)(2008-11#5)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#6)(2008-6#4)(2008-7#6)(2008-8#6)(2008-9#3)(2009-4#1)(2009-6#1)(2010-11#2)(2010-12#3)(2010-5#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#14)(2012-1#1)(2012-12#6)(2012-2#4)(2012-3#4)(2012-7#1)(2013-1#4)(2013-8#4)
population included##4##2##(1996-9#1)(1997-1#1)(2011-2#1)(2012-12#1)
population increase and##2##3##(2008-10#1)(2013-8#1)
population increase##9##2##(2007-6#1)(2008-10#1)(2008-3#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-8#2)
population increased##2##2##(1995-2#1)(2011-2#1)
population increases over time##2##4##(2008-10#1)(2009-3#1)
population increases##7##2##(1991-3#1)(1993-5#1)(2006-9#1)(2008-10#2)(2008-8#1)(2009-3#1)
population indicated that the##2##4##(2008-10#1)(2012-3#1)
population infected##2##2##(2008-2#1)(2013-8#1)
population interactions##2##2##(2008-10#1)(2008-8#1)
population into a##2##3##(1997-6#1)(2008-8#1)
population into##4##2##(1997-6#2)(2008-10#1)(2008-8#1)
population inversion##6##2##(1990-3#1)(2007-12#3)(2008-2#1)(2008-3#1)
population inversions##2##2##(2007-12#1)(2008-3#1)
population investigated##2##2##(1995-8#1)(1996-12#1)
population is a##3##3##(1990-3#1)(2008-10#1)(2010-6#1)
population is affected by##2##4##(2008-9#1)(2012-2#1)
population is affected##3##3##(2008-9#1)(2010-7#1)(2012-2#1)
population is allowed to##2##4##(1991-2#1)(2008-2#1)
population is also##3##3##(2011-2#1)(2012-12#1)(2013-1#1)
population is at##3##3##(2006-2#1)(2012-12#1)(2012-2#1)
population is capable of##2##4##(2008-10#1)(2010-1#1)
population is dependent on##2##4##(2008-7#1)(2011-2#1)
population is estimated##2##3##(2006-10#1)(2011-2#1)
population is growing##2##3##(1991-3#1)(2006-10#1)
population is increasing##2##3##(1992-11#1)(1997-8#1)
population is larger##2##3##(2006-3#1)(2013-1#1)
population is limited##3##3##(1994-9#1)(2011-2#1)(2012-2#1)
population is not##5##3##(2005-10#1)(2008-3#1)(2011-1#1)(2012-1#1)(2012-12#1)
population is uncertain##2##3##(2005-10#1)(2008-10#1)
population is##121##2##(1990-12#1)(1990-3#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-9#1)(1992-11#1)(1993-4#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-1#2)(1996-10#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-8#2)(2005-10#2)(2005-8#1)(2006-10#3)(2006-2#2)(2006-3#1)(2007-10#1)(2007-12#6)(2007-2#1)(2007-3#1)(2007-6#1)(2007-9#1)(2008-10#7)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#7)(2008-9#2)(2009-2#1)(2009-5#2)(2010-1#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#4)(2011-2#7)(2012-1#3)(2012-12#7)(2012-2#5)(2013-1#4)(2013-8#2)
population isolated from##5##3##(2008-10#2)(2008-5#3)
population it is##2##3##(2012-12#1)(2012-2#1)
population it##4##2##(1994-3#1)(2011-1#1)(2012-12#1)(2012-2#1)
population leads##2##2##(2007-10#1)(2012-3#1)
population level##27##2##(1991-2#1)(1994-12#1)(1994-6#1)(2006-10#1)(2006-5#1)(2007-4#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-8#4)(2009-4#2)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
population levels increased in##2##4##(1991-2#1)(2008-10#1)
population levels of##2##3##(2008-10#2)
population levels##13##2##(1991-2#1)(1993-9#1)(2008-10#9)(2010-5#1)(2012-2#1)
population life##2##2##(1993-1#1)(2013-1#1)
population living in the##3##4##(1993-6#1)(2010-9#1)(2012-2#1)
population living in##4##3##(1993-6#1)(2007-12#1)(2010-9#1)(2012-2#1)
population living near##3##3##(2005-12#1)(2011-2#2)
population living##7##2##(1993-6#1)(2005-12#1)(2007-12#1)(2010-9#1)(2011-2#2)(2012-2#1)
population located in##2##3##(2008-10#1)(2008-12#1)
population makes##3##2##(2006-2#1)(2011-2#1)(2013-8#1)
population may be##3##3##(1990-8#1)(2008-10#1)(2010-8#1)
population may##12##2##(1990-8#1)(1995-12#1)(1996-12#1)(2006-4#1)(2008-10#2)(2008-7#1)(2010-8#1)(2011-2#2)(2012-2#2)
population mean##5##2##(1991-3#1)(1992-9#1)(2008-12#1)(2009-12#1)(2010-7#1)
population means##2##2##(1996-7#1)(2010-5#1)
population membership##2##2##(2008-11#1)(2012-3#1)
population might##4##2##(1994-3#1)(2008-10#2)(2008-3#1)
population model##5##2##(2007-9#1)(2008-10#1)(2008-11#2)(2008-8#1)
population models##3##2##(2007-9#1)(2008-9#1)(2010-10#1)
population movements##5##2##(1993-9#1)(2007-2#1)(2008-8#1)(2010-9#1)(2013-1#1)
population must##2##2##(1993-9#1)(1996-12#1)
population needs##4##2##(1994-3#1)(2008-9#1)(2009-4#1)(2012-2#1)
population norms##4##2##(2006-10#1)(2008-6#1)(2010-10#1)(2013-1#1)
population now##2##2##(1994-12#1)(2012-2#1)
population obtained in a##2##4##(2004-11#1)(2006-8#1)
population occurred##2##2##(2007-6#1)(2009-4#1)
population of &gt##2##3##(1995-6#1)(2008-10#1)
population of 1##5##3##(1997-3#1)(1997-6#1)(2007-10#1)(2008-10#1)(2012-2#1)
population of 128##2##3##(2007-9#1)(2008-10#1)
population of 2##2##3##(2008-10#1)(2008-7#1)
population of 20##2##3##(2008-1#1)(2008-10#1)
population of 330##2##3##(1991-11#2)
population of ACS patients admitted to##2##6##(2013-8#2)
population of ACS##3##3##(2013-8#3)
population of B##2##3##(1993-6#1)(2008-4#1)
population of C##2##3##(2008-10#1)(2008-8#1)
population of Colletotrichum##2##3##(2005-11#1)(2008-10#1)
population of Culex##2##3##(2004-11#1)(2006-4#1)
population of India##2##3##(2008-11#1)(2010-12#1)
population of Ixodes##3##3##(1992-12#2)(2004-11#1)
population of Kerala##2##3##(2013-1#2)
population of Nigerian##2##3##(2009-5#2)
population of P##2##3##(2008-10#2)
population of Phytophthora##3##3##(2008-10#3)
population of Poecilia reticulata##2##4##(2007-3#2)
population of Polish##2##3##(2007-9#1)(2013-1#1)
population of R##3##3##(2006-8#1)(2008-10#2)
population of S##2##3##(2007-5#1)(2010-4#1)
population of Soay sheep (Ovis##2##5##(1995-2#1)(1997-7#1)
population of South Siberia##2##4##(2009-8#2)
population of T##2##3##(1991-12#2)
population of a cross##2##4##(2008-10#2)
population of a small##2##4##(2008-9#1)(2011-2#1)
population of a##9##3##(1993-5#1)(1995-9#1)(2007-2#1)(2008-10#2)(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
population of about##4##3##(1996-3#1)(2007-12#1)(2008-10#1)(2012-2#1)
population of adolescent##2##3##(2011-1#2)
population of an##2##3##(2007-12#1)(2007-8#1)
population of any##2##3##(1995-5#1)(2008-5#1)
population of approximately##4##3##(1991-8#1)(1995-11#1)(2008-1#1)(2008-4#1)
population of axon terminals with##2##5##(1997-2#2)
population of bacteria##4##3##(1996-6#1)(2007-10#1)(2008-7#1)(2011-2#1)
population of cells##16##3##(1991-12#2)(1995-11#1)(1995-5#1)(1996-5#1)(2006-5#1)(2008-1#1)(2008-11#4)(2008-4#2)(2008-9#1)(2010-10#1)(2010-11#1)
population of children who##2##4##(1992-1#1)(2008-11#1)
population of children##6##3##(1991-12#1)(1992-1#1)(2006-10#1)(2008-11#1)(2008-2#1)(2009-5#1)
population of dorsal##2##3##(1993-12#1)(1996-3#1)
population of each##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
population of elderly##4##3##(1990-10#1)(2007-12#1)(2008-7#1)(2009-3#1)
population of four##2##3##(1995-11#1)(1995-9#1)
population of free-ranging##2##3##(2007-2#2)
population of heads was##2##4##(1996-2#2)
population of healthy##4##3##(1990-12#1)(2007-1#1)(2008-11#1)(2013-8#1)
population of helical##2##3##(1993-6#1)(1997-4#1)
population of helix##2##3##(1993-6#1)(1997-4#1)
population of immature##3##3##(2008-11#1)(2008-4#1)(2008-5#1)
population of immunocompromised##2##3##(2011-2#2)
population of infants and##2##4##(1991-12#1)(2011-12#1)
population of interest##3##3##(1994-1#1)(2008-6#1)(2008-9#1)
population of ions##2##3##(2006-4#1)(2009-10#1)
population of isolates##2##3##(2008-10#2)
population of its##2##3##(2007-11#1)(2008-10#1)
population of more than##2##4##(2007-7#1)(2008-10#1)
population of more##3##3##(2007-7#1)(2008-10#1)(2009-10#1)
population of mtDNA with##2##4##(1991-10#2)
population of neurons##9##3##(1991-2#2)(1994-10#1)(1994-5#1)(1996-12#2)(1996-9#1)(2007-8#1)(2009-10#1)
population of normal##2##3##(1992-6#1)(2011-2#1)
population of older adults##2##4##(2009-4#1)(2010-4#1)
population of older##5##3##(2009-4#1)(2010-3#1)(2010-4#1)(2013-1#2)
population of patients with##7##4##(1991-2#1)(2006-2#1)(2008-1#1)(2008-5#1)(2009-11#1)(2012-12#1)(2012-2#1)
population of patients##15##3##(1991-2#1)(1995-11#1)(2005-8#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-11#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)
population of persons##2##3##(2009-6#1)(2009-9#1)
population of pituitary cells##2##4##(1994-3#1)(1994-9#1)
population of pluripotent##2##3##(1993-2#1)(2008-11#1)
population of recombinant inbred lines (RILs) was developed from a cross between##2##12##(2008-10#1)(2012-11#1)
population of recombinant inbred lines (RILs) was##3##7##(2008-10#2)(2012-11#1)
population of recombinant inbred lines##4##5##(2008-10#3)(2012-11#1)
population of sequence variants##2##4##(2008-10#2)
population of striatal##2##3##(1990-5#1)(1995-2#1)
population of the United States##3##5##(2008-3#1)(2010-10#1)(2010-8#1)
population of the city of##3##5##(1991-7#1)(2008-7#1)(2013-1#1)
population of the world##2##4##(1991-11#1)(2008-1#1)
population of the##60##3##(1990-12#1)(1990-4#1)(1991-11#1)(1991-2#4)(1991-7#2)(1991-9#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-9#2)(1994-2#1)(1995-1#1)(1995-12#1)(1995-4#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#1)(2008-1#2)(2008-10#5)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#1)(2010-10#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#3)
population of these##3##3##(1990-6#1)(2008-12#1)(2012-1#1)
population of this##5##3##(1995-3#1)(2008-10#2)(2008-8#1)(2011-2#1)
population of three##2##3##(2007-9#1)(2008-4#1)
population of young adults##3##4##(1991-1#1)(2010-5#1)(2012-12#1)
population of young##4##3##(1991-1#1)(2010-5#1)(2012-12#1)(2012-2#1)
population of##624##2##(1990-10#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#2)(1990-7#3)(1990-8#3)(1991-1#3)(1991-10#2)(1991-11#3)(1991-12#11)(1991-2#8)(1991-3#2)(1991-4#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-5#2)(1992-6#3)(1992-7#4)(1992-8#3)(1992-9#2)(1993-10#1)(1993-11#4)(1993-12#2)(1993-2#1)(1993-4#1)(1993-5#2)(1993-6#5)(1993-7#1)(1993-8#1)(1993-9#4)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#5)(1994-3#5)(1994-5#3)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#4)(1995-11#6)(1995-12#7)(1995-2#5)(1995-3#4)(1995-4#1)(1995-5#4)(1995-6#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#5)(1996-4#1)(1996-5#4)(1996-6#4)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#3)(1997-3#3)(1997-4#3)(1997-5#3)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#2)(2004-2#1)(2004-4#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#7)(2006-2#6)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#3)(2007-1#4)(2007-10#6)(2007-11#2)(2007-12#11)(2007-2#9)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#6)(2007-9#5)(2008-1#16)(2008-10#80)(2008-11#20)(2008-12#13)(2008-2#7)(2008-3#11)(2008-4#10)(2008-5#15)(2008-6#2)(2008-7#17)(2008-8#5)(2008-9#11)(2009-10#3)(2009-11#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#6)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#2)(2010-10#5)(2010-11#1)(2010-12#3)(2010-2#5)(2010-3#1)(2010-4#3)(2010-5#2)(2010-8#3)(2011-1#5)(2011-12#1)(2011-2#19)(2012-1#7)(2012-11#3)(2012-12#7)(2012-2#15)(2012-3#9)(2013-1#15)(2013-7#2)(2013-8#13)
population often##3##2##(1996-7#1)(2008-8#1)(2012-12#1)
population on the##4##3##(1991-12#1)(2008-10#1)(2011-2#1)(2012-2#1)
population on##9##2##(1991-12#1)(1995-2#1)(2006-10#1)(2008-10#2)(2008-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
population only##2##2##(2008-10#1)(2008-8#1)
population or##11##2##(1992-11#1)(2006-7#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-8#2)
population over##10##2##(1990-6#1)(1995-10#1)(2007-7#1)(2008-10#2)(2011-1#1)(2011-2#4)
population owing to##2##3##(2009-11#1)(2011-2#1)
population parameters from##2##3##(2007-9#1)(2008-9#1)
population parameters##10##2##(1993-1#1)(2007-5#1)(2007-9#1)(2008-8#3)(2008-9#1)(2012-2#2)(2013-8#1)
population per year##3##3##(1993-2#1)(2008-10#1)(2011-2#1)
population per##5##2##(1993-2#1)(1995-9#1)(2006-1#1)(2008-10#1)(2011-2#1)
population persistence##5##2##(2008-8#5)
population policies##2##2##(2008-5#2)
population policy##2##2##(1991-3#1)(2006-7#1)
population present##3##2##(2008-4#1)(2008-5#1)(2011-1#1)
population presents a unique##2##4##(2007-2#1)(2010-8#1)
population pressure##2##2##(1995-9#1)(2013-8#1)
population pressures##2##2##(2008-10#1)(2008-5#1)
population prevalence##2##2##(1994-3#1)(2013-1#1)
population projections##4##2##(1993-10#2)(2012-12#2)
population provides##2##2##(2008-9#1)(2011-2#1)
population ranged from##2##3##(2008-8#1)(2012-12#1)
population redistribution##4##2##(2011-12#1)(2011-2#3)
population reflect##2##2##(2007-12#1)(2012-2#1)
population reflects##3##2##(2007-2#1)(2007-8#1)(2012-1#1)
population regarding##3##2##(2006-8#1)(2008-3#1)(2008-5#1)
population regulation##5##2##(2008-8#5)
population relaxation##2##2##(2007-11#2)
population remains##3##2##(1994-12#1)(2006-7#1)(2010-9#1)
population replacement##3##2##(2008-11#3)
population requires##3##2##(2008-9#1)(2012-3#1)(2013-1#1)
population requiring##3##2##(2008-3#1)(2009-9#1)(2013-1#1)
population research registry##4##3##(2010-11#4)
population residing in##2##3##(2007-7#1)(2013-8#1)
population risk##8##2##(1996-6#1)(1996-8#6)(2008-1#1)
population risks##2##2##(2008-8#1)(2010-12#1)
population salt intake##4##3##(2013-1#4)
population sample from##5##3##(1996-12#1)(1996-7#1)(2008-12#3)
population sample of##11##3##(1990-12#1)(1990-8#1)(1992-2#1)(1993-11#1)(1993-3#1)(1996-7#1)(2006-3#1)(2008-10#1)(2008-11#2)(2009-4#1)
population sample##29##2##(1990-12#1)(1990-8#1)(1992-2#1)(1993-11#2)(1993-3#1)(1995-12#1)(1996-12#1)(1996-7#4)(1997-2#1)(2006-3#1)(2008-10#1)(2008-11#3)(2008-12#3)(2008-9#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-3#1)(2012-12#1)(2013-1#2)
population samples and##2##3##(2008-12#1)(2012-3#1)
population samples##10##2##(1993-9#1)(1995-12#1)(2005-10#1)(2008-11#1)(2008-12#2)(2009-5#1)(2010-3#1)(2012-12#1)(2012-3#1)
population sampling##2##2##(2008-1#1)(2008-10#1)
population screening##12##2##(1990-12#1)(1990-6#1)(1993-9#1)(1996-8#1)(1997-8#1)(2006-10#3)(2007-6#2)(2007-9#1)(2013-7#1)
population seeking##2##2##(1994-10#1)(2011-1#1)
population segregated##2##2##(2008-10#2)
population sex ratio##2##3##(2008-8#1)(2010-8#1)
population should##3##2##(1990-12#1)(1991-12#1)(2008-1#1)
population showed a##3##3##(2006-3#1)(2008-5#1)(2008-8#1)
population showed that##6##3##(1995-2#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-9#1)
population showed##11##2##(1992-12#1)(1995-2#1)(2006-10#1)(2006-3#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#1)
population size and##9##3##(1991-3#1)(2004-11#1)(2006-8#1)(2008-10#3)(2008-8#1)(2008-9#1)(2011-2#1)
population size at##2##3##(1997-4#1)(2008-1#1)
population size below##3##3##(2008-10#1)(2008-8#2)
population size for##2##3##(1991-11#1)(1995-9#1)
population size in##4##3##(1997-5#1)(2008-1#1)(2008-8#1)(2008-9#1)
population size is##3##3##(2008-8#2)(2010-7#1)
population size of the##4##4##(2008-10#3)(2011-2#1)
population size of##19##3##(1995-11#1)(2004-11#2)(2006-10#1)(2008-10#11)(2008-9#1)(2010-8#1)(2011-2#1)(2012-5#1)
population size was##4##3##(2004-11#1)(2008-10#1)(2008-8#2)
population size##99##2##(1991-11#1)(1991-3#1)(1992-12#1)(1992-2#1)(1995-11#1)(1995-9#1)(1996-3#1)(1996-6#2)(1996-8#1)(1997-4#1)(1997-5#1)(2004-11#5)(2006-10#1)(2006-3#1)(2006-8#1)(2007-3#2)(2008-1#3)(2008-10#24)(2008-11#3)(2008-12#1)(2008-5#2)(2008-8#21)(2008-9#10)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-3#2)(2012-5#1)(2013-1#4)(2013-8#1)
population size/adult population size ratios in wildlife##2##7##(2008-11#2)
population sizes and##3##3##(2008-10#2)(2010-6#1)
population sizes in##3##3##(2008-10#2)(2008-9#1)
population sizes of NPS3136##2##4##(2006-3#2)
population sizes of the##2##4##(2008-10#2)
population sizes of##9##3##(2004-11#1)(2006-3#3)(2008-10#5)
population sizes##30##2##(2004-11#1)(2006-3#4)(2007-9#1)(2008-10#13)(2008-8#7)(2008-9#2)(2010-6#1)(2013-1#1)
population spike (PS) amplitude##2##4##(1991-3#1)(1997-5#1)
population spike (PS)##3##3##(1991-3#1)(1997-5#2)
population spike amplitude of##2##4##(1997-7#1)(2008-7#1)
population spike amplitude##7##3##(1996-5#1)(1996-8#1)(1997-5#1)(1997-7#3)(2008-7#1)
population spike##20##2##(1990-7#1)(1991-12#3)(1991-3#1)(1995-12#4)(1996-5#1)(1996-8#1)(1997-2#1)(1997-5#4)(1997-7#3)(2008-7#1)
population spikes and##2##3##(1996-5#1)(1996-9#1)
population spikes in##2##3##(2008-11#1)(2008-2#1)
population spikes##12##2##(1992-7#1)(1993-2#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-5#1)(1997-8#1)(2008-11#3)(2008-2#1)
population spread##3##2##(2008-8#3)
population strategy##3##2##(1991-6#2)(2006-8#1)
population stratification in##2##3##(2007-10#1)(2012-3#1)
population stratification##9##2##(2007-10#1)(2011-2#1)(2012-3#7)
population structure and its##2##4##(2011-1#1)(2012-3#1)
population structure and##16##3##(1995-8#2)(2008-10#4)(2008-3#1)(2008-5#1)(2008-9#3)(2010-12#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-7#1)
population structure can##2##3##(2008-8#1)(2008-9#1)
population structure in##3##3##(2006-3#1)(2008-10#1)(2008-8#1)
population structure is##2##3##(2008-10#1)(2012-3#1)
population structure of S##2##4##(2008-10#2)
population structure of the##2##4##(2012-3#1)(2013-8#1)
population structure of##26##3##(2006-3#1)(2008-10#15)(2008-5#2)(2011-2#4)(2012-11#1)(2012-3#1)(2013-8#2)
population structure was##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
population structure##88##2##(1995-8#2)(2006-10#2)(2006-3#3)(2008-10#36)(2008-3#1)(2008-5#5)(2008-8#5)(2008-9#6)(2010-12#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#6)(2012-11#2)(2012-12#1)(2012-3#9)(2013-1#1)(2013-7#1)(2013-8#3)
population structuring##2##2##(2010-8#2)
population studied##7##2##(1995-11#1)(1997-4#1)(2007-10#1)(2009-5#1)(2011-2#1)(2013-1#2)
population studies indicate that##2##4##(2008-12#1)(2009-8#1)
population studies of##4##3##(2007-12#1)(2007-4#1)(2008-10#1)(2010-9#1)
population studies should##2##3##(2010-2#1)(2011-2#1)
population studies to##2##3##(2008-10#1)(2008-4#1)
population studies##22##2##(1991-12#3)(2005-8#1)(2006-8#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-9#1)(2011-2#1)(2012-3#1)
population study in##3##3##(1991-4#1)(1993-11#1)(2013-1#1)
population study of##6##3##(1990-4#1)(2004-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)
population study##14##2##(1990-4#1)(1991-4#1)(1993-11#1)(1993-6#1)(1995-12#1)(2004-10#1)(2006-2#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)(2013-1#1)
population subdivision##5##2##(1997-4#1)(2008-10#1)(2008-8#1)(2009-2#2)
population subgroups##5##2##(2009-4#1)(2010-11#1)(2010-9#1)(2011-2#1)(2013-1#1)
population substructure##3##2##(2007-10#2)(2008-12#1)
population suffer from##2##3##(1994-11#1)(1997-2#1)
population surveillance##4##2##(1991-12#2)(1991-3#1)(2009-4#1)
population survey data##2##3##(2006-9#1)(2007-11#1)
population survey##3##2##(2006-9#1)(2007-11#1)(2008-7#1)
population surveys##7##2##(2006-6#1)(2006-8#3)(2008-10#1)(2012-3#2)
population tested##2##2##(2007-7#1)(2008-12#1)
population than in the##2##4##(2008-10#1)(2011-1#1)
population than##3##2##(2008-10#2)(2011-1#1)
population that is##9##3##(1995-1#1)(1996-2#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2011-1#1)
population that might##2##3##(2008-4#1)(2010-10#1)
population that was##4##3##(1997-5#1)(2008-10#3)
population that will##2##3##(1995-2#1)(2008-10#1)
population that would##2##3##(1996-3#1)(2008-4#1)
population that##36##2##(1995-1#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-5#1)(2006-10#1)(2006-11#1)(2007-12#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-4#4)(2008-7#1)(2008-8#2)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)
population the##8##2##(1994-12#1)(2007-6#1)(2007-7#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-12#2)
population through##4##2##(2008-11#1)(2009-2#1)(2011-2#1)(2012-12#1)
population to be##4##3##(1997-2#1)(2008-10#2)(2008-9#1)
population to extinction##2##3##(2008-2#1)(2008-8#1)
population to the##3##3##(2006-2#1)(2007-7#1)(2008-10#1)
population to##34##2##(1991-12#1)(1996-7#2)(1997-2#1)(1997-8#1)(2006-10#1)(2006-2#2)(2006-7#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-2#3)(2008-3#2)(2008-8#2)(2008-9#4)(2009-3#1)(2009-6#1)(2011-2#4)(2013-1#1)(2013-7#1)
population towards##2##2##(1993-8#1)(2006-10#1)
population trapping##7##2##(1993-8#1)(2007-11#3)(2007-12#3)
population trends##4##2##(1997-2#1)(2008-8#1)(2008-9#2)
population turnover##3##2##(2008-8#2)(2008-9#1)
population under study##3##3##(1997-7#1)(1997-8#1)(2008-1#1)
population under##9##2##(1997-3#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-8#1)
population undergoing percutaneous coronary intervention (PCI)##2##6##(2006-10#1)(2010-12#1)
population undergoing##3##2##(2006-10#1)(2007-7#1)(2010-12#1)
population used##2##2##(2008-10#1)(2008-4#1)
population using a##2##3##(2010-10#1)(2012-1#1)
population using both##2##3##(2009-3#1)(2010-11#1)
population using##10##2##(1990-2#1)(1995-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-3#1)(2010-10#1)(2010-11#1)(2012-1#1)
population values##2##2##(2006-10#1)(2012-3#1)
population variability in##5##3##(2010-2#4)(2012-1#1)
population variability##6##2##(2008-9#1)(2010-2#4)(2012-1#1)
population variation of##2##3##(2010-2#1)(2013-7#1)
population viability##3##2##(2008-9#2)(2010-8#1)
population was compared##2##3##(2008-10#1)(2012-3#1)
population was composed of##4##4##(2008-10#2)(2008-3#1)(2010-1#1)
population was composed##5##3##(2008-10#2)(2008-3#1)(2010-1#1)(2011-2#1)
population was consisted of##2##4##(2011-2#1)(2013-1#1)
population was created from##2##4##(2008-10#2)
population was determined##2##3##(2007-1#1)(2011-2#1)
population was divided into##2##4##(1997-2#1)(2008-8#1)
population was evaluated for##2##4##(2008-10#2)
population was evaluated##3##3##(2008-10#2)(2013-8#1)
population was found##3##3##(1996-12#1)(1996-2#1)(2008-7#1)
population was low##2##3##(1992-8#1)(2008-10#1)
population was lower than##2##4##(1996-3#1)(2008-9#1)
population was more##2##3##(2008-10#1)(2010-11#1)
population was not##3##3##(1991-9#1)(2008-10#1)(2008-3#1)
population was observed##2##3##(1995-5#1)(2008-10#1)
population was obtained##2##3##(2006-8#1)(2008-10#1)
population was reduced##2##3##(1995-2#1)(2008-11#1)
population was stratified by##2##4##(2006-12#2)
population was##125##2##(1990-2#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-3#2)(1993-8#1)(1993-9#2)(1995-2#1)(1995-5#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-2#1)(2004-10#1)(2005-11#1)(2006-10#2)(2006-12#3)(2006-8#3)(2007-1#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-7#4)(2007-8#1)(2008-1#3)(2008-10#36)(2008-11#2)(2008-12#2)(2008-3#3)(2008-5#8)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-7#1)(2010-1#2)(2010-11#1)(2010-8#3)(2011-1#3)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#3)
population we found##2##3##(2007-8#1)(2008-8#1)
population we##3##2##(2007-8#1)(2008-8#1)(2011-1#1)
population were associated##2##3##(2006-7#1)(2008-10#1)
population were estimated##2##3##(2007-8#1)(2008-10#1)
population were evaluated##2##3##(2008-10#1)(2008-12#1)
population were significantly##2##3##(2011-1#1)(2012-3#1)
population were studied##3##3##(2008-7#1)(2012-12#1)(2013-8#1)
population were##40##2##(1994-3#1)(1996-12#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-8#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2011-1#6)(2011-2#3)(2012-12#3)(2012-3#1)(2012-4#1)(2013-1#1)(2013-7#2)(2013-8#1)
population when##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
population where##3##2##(1996-3#1)(2008-8#1)(2010-11#1)
population which##8##2##(1990-3#1)(1992-7#1)(1995-12#1)(1996-12#1)(2007-9#1)(2010-3#1)(2011-2#1)(2012-2#1)
population while##3##2##(2008-11#1)(2010-3#1)(2010-9#1)
population who##9##2##(1996-8#1)(1997-1#1)(2006-4#1)(2006-8#1)(2007-10#1)(2008-3#1)(2008-7#1)(2010-9#1)(2013-1#1)
population whose##3##2##(1991-1#1)(2006-12#1)(2006-2#1)
population will be##5##3##(1994-7#1)(1994-9#1)(2006-8#1)(2008-8#1)(2011-2#1)
population will##10##2##(1990-9#1)(1994-7#1)(1994-9#1)(2006-1#1)(2006-8#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#2)
population with a##10##3##(1994-12#1)(1994-2#1)(1995-10#1)(2007-10#1)(2008-10#2)(2009-5#1)(2009-9#2)(2012-2#1)
population with acute##2##3##(2011-2#1)(2013-1#1)
population with diabetes##2##3##(2010-4#2)
population with different##2##3##(2008-2#1)(2012-2#1)
population with no##2##3##(2007-9#1)(2011-2#1)
population with the##2##3##(2007-2#1)(2008-9#1)
population with##53##2##(1990-3#1)(1990-9#1)(1991-10#1)(1992-3#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-4#1)(1995-10#1)(1996-1#1)(1997-2#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-10#2)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-5#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-9#2)(2010-12#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#3)
population within the##2##3##(2006-10#1)(2010-8#1)
population within##6##2##(1992-1#1)(2006-10#1)(2008-10#1)(2008-11#1)(2010-8#2)
population without##5##2##(1996-9#1)(2008-10#2)(2008-2#1)(2008-8#1)
population would be exposed to 3-30 mug/kg body weight/day##2##9##(2005-7#2)
population would be##3##3##(2005-7#2)(2008-4#1)
population##5308##1##(1990-1#1)(1990-10#3)(1990-11#4)(1990-12#22)(1990-2#8)(1990-3#16)(1990-4#5)(1990-5#7)(1990-6#15)(1990-7#7)(1990-8#9)(1990-9#9)(1991-1#11)(1991-10#6)(1991-11#7)(1991-12#39)(1991-2#20)(1991-3#21)(1991-4#4)(1991-5#3)(1991-6#11)(1991-7#2)(1991-8#7)(1991-9#7)(1992-1#6)(1992-10#5)(1992-11#6)(1992-12#10)(1992-2#16)(1992-3#7)(1992-4#4)(1992-5#7)(1992-6#9)(1992-7#9)(1992-8#11)(1992-9#10)(1993-1#12)(1993-10#11)(1993-11#16)(1993-12#16)(1993-2#10)(1993-3#8)(1993-4#3)(1993-5#7)(1993-6#17)(1993-7#4)(1993-8#8)(1993-9#23)(1994-1#1)(1994-10#3)(1994-11#6)(1994-12#11)(1994-2#22)(1994-3#25)(1994-4#7)(1994-5#9)(1994-6#15)(1994-7#8)(1994-8#8)(1994-9#13)(1995-1#16)(1995-10#8)(1995-11#14)(1995-12#30)(1995-2#24)(1995-3#7)(1995-4#4)(1995-5#11)(1995-6#2)(1995-8#7)(1995-9#15)(1996-1#9)(1996-10#4)(1996-11#7)(1996-12#30)(1996-2#12)(1996-3#32)(1996-4#4)(1996-5#12)(1996-6#20)(1996-7#19)(1996-8#13)(1996-9#14)(1997-1#13)(1997-2#27)(1997-3#17)(1997-4#15)(1997-5#19)(1997-6#18)(1997-7#14)(1997-8#22)(2004-10#5)(2004-11#26)(2004-12#1)(2004-2#2)(2004-3#2)(2004-4#5)(2004-9#2)(2005-1#2)(2005-10#20)(2005-11#8)(2005-12#3)(2005-2#1)(2005-3#1)(2005-5#2)(2005-6#2)(2005-7#13)(2005-8#10)(2005-9#4)(2006-1#8)(2006-10#98)(2006-11#11)(2006-12#16)(2006-2#40)(2006-3#13)(2006-4#14)(2006-5#6)(2006-6#5)(2006-7#16)(2006-8#41)(2006-9#10)(2007-1#19)(2007-10#41)(2007-11#29)(2007-12#73)(2007-2#36)(2007-3#28)(2007-4#10)(2007-5#14)(2007-6#16)(2007-7#55)(2007-8#32)(2007-9#38)(2008-1#87)(2008-10#673)(2008-11#135)(2008-12#89)(2008-2#46)(2008-3#76)(2008-4#55)(2008-5#101)(2008-6#31)(2008-7#114)(2008-8#249)(2008-9#169)(2009-1#2)(2009-10#18)(2009-11#13)(2009-12#7)(2009-2#18)(2009-3#20)(2009-4#25)(2009-5#30)(2009-6#14)(2009-7#12)(2009-8#14)(2009-9#16)(2010-1#7)(2010-10#20)(2010-11#36)(2010-12#37)(2010-2#57)(2010-3#15)(2010-4#17)(2010-5#26)(2010-6#19)(2010-7#13)(2010-8#85)(2010-9#23)(2011-1#104)(2011-11#3)(2011-12#14)(2011-2#225)(2011-3#5)(2011-7#1)(2012-1#44)(2012-11#15)(2012-12#123)(2012-2#118)(2012-3#105)(2012-4#2)(2012-5#1)(2012-7#2)(2013-1#184)(2013-3#1)(2013-7#26)(2013-8#122)
population&quot##2##1##(1991-12#1)(2011-2#1)
population's health##2##2##(2010-8#1)(2011-1#1)
population's##15##1##(1994-3#1)(1994-6#1)(1996-1#1)(1997-7#1)(2008-1#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-7#1)
population) and##2##2##(1993-6#1)(2008-12#1)
population) incidence##2##2##(1995-5#1)(2007-8#1)
population) were##2##2##(2006-10#1)(2013-1#1)
population)##25##1##(1990-12#1)(1990-6#1)(1990-9#1)(1993-6#1)(1995-5#2)(1996-12#1)(2006-10#3)(2006-7#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-8#2)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
population- and##2##2##(2008-9#1)(2012-3#1)
population-averaged##3##1##(1995-2#3)
population-based analyses##4##2##(2010-11#2)(2012-12#1)(2013-1#1)
population-based and##5##2##(1994-3#1)(1997-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
population-based approaches##3##2##(2009-12#1)(2010-4#1)(2011-2#1)
population-based cancer##3##2##(1993-9#1)(2007-1#1)(2011-2#1)
population-based case-control studies##2##3##(2007-10#1)(2009-9#1)
population-based case-control study##7##3##(1991-5#1)(1991-9#1)(1992-10#3)(1995-5#2)
population-based case-control##10##2##(1991-5#1)(1991-9#1)(1992-10#3)(1995-5#2)(2007-10#1)(2009-9#1)(2010-12#1)
population-based cohort of##2##3##(2010-4#1)(2010-6#1)
population-based cohort studies##2##3##(2009-12#1)(2013-1#1)
population-based cohort study##3##3##(2007-3#1)(2008-6#1)(2013-1#1)
population-based cohort##9##2##(2007-10#1)(2007-3#1)(2008-6#1)(2009-12#1)(2010-4#1)(2010-6#1)(2013-1#3)
population-based data analysis##4##3##(2013-1#4)
population-based data on##2##3##(2006-10#1)(2008-3#1)
population-based data##11##2##(1996-12#1)(1997-2#1)(2006-10#1)(2007-10#1)(2008-3#1)(2010-11#2)(2013-1#4)
population-based estimates of long-term survival##2##5##(2011-2#2)
population-based estimates of##5##3##(1993-9#1)(2007-11#1)(2011-2#2)(2013-1#1)
population-based health datasets - part##2##5##(2012-2#2)
population-based health##4##2##(2007-10#1)(2008-2#1)(2012-2#2)
population-based information systems to enhance primary healthcare##2##7##(2010-11#2)
population-based information systems##4##3##(2010-11#4)
population-based information##5##2##(2010-11#5)
population-based interventions##2##2##(2008-2#1)(2012-1#1)
population-based model##3##2##(2009-8#3)
population-based prospective##2##2##(2005-10#1)(2010-12#1)
population-based research##2##2##(1997-8#1)(2010-11#1)
population-based screening mammography##2##3##(2008-6#2)
population-based screening##3##2##(1991-6#1)(2008-6#2)
population-based services##2##2##(1995-12#1)(1996-2#1)
population-based stroke##2##2##(2007-10#1)(2008-8#1)
population-based studies of##2##3##(2007-12#1)(2008-1#1)
population-based studies on##2##3##(2008-6#1)(2013-1#1)
population-based studies##13##2##(2005-10#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-6#1)(2008-7#1)(2010-11#1)(2010-12#1)(2013-1#1)(2013-8#1)
population-based study of##7##3##(2006-10#1)(2006-2#1)(2007-12#1)(2007-9#1)(2008-12#1)(2008-7#1)(2010-4#1)
population-based study on##2##3##(2007-7#1)(2008-8#1)
population-based study was to##2##4##(2006-10#2)
population-based study was##4##3##(2006-10#3)(2008-3#1)
population-based study##32##2##(1993-7#1)(1997-7#1)(2006-10#4)(2006-2#1)(2006-7#1)(2007-12#1)(2007-7#1)(2007-9#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
population-based survey##5##2##(1994-8#1)(2006-2#1)(2007-7#1)(2010-8#1)(2013-8#1)
population-based surveys##4##2##(2005-12#1)(2008-12#2)(2010-2#1)
population-based##200##1##(1990-12#1)(1990-4#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#3)(1992-12#1)(1992-2#1)(1992-6#1)(1993-7#1)(1993-9#5)(1994-3#2)(1994-8#1)(1995-12#1)(1995-2#2)(1995-5#2)(1996-12#2)(1996-2#3)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#2)(2005-10#2)(2005-12#1)(2006-1#1)(2006-10#7)(2006-2#2)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#6)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#1)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#5)(2008-7#5)(2008-8#3)(2009-12#2)(2009-6#1)(2009-8#3)(2009-9#1)(2010-11#14)(2010-12#5)(2010-2#2)(2010-3#2)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#5)(2011-1#4)(2011-2#9)(2012-1#1)(2012-12#7)(2012-2#6)(2012-3#6)(2013-1#14)(2013-8#5)
population-genetic structure##2##2##(2008-9#1)(2011-2#1)
population-genetic##3##1##(2008-9#2)(2011-2#1)
population-groups##2##1##(2008-12#2)
population-level and individual-level##2##3##(1994-9#1)(2008-8#1)
population-level and##3##2##(1994-9#1)(2008-8#1)(2013-8#1)
population-level##21##1##(1994-9#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#4)(2009-9#1)(2010-8#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
population-specific##7##1##(1995-6#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-5#1)(2009-9#1)(2012-3#1)
population-wide##9##1##(2005-10#1)(2008-8#3)(2010-12#1)(2011-2#2)(2012-1#1)(2012-12#1)
population?##5##1##(2005-7#1)(2006-5#1)(2008-12#1)(2008-4#1)(2008-8#1)
population]##22##1##(1991-3#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-6#1)(2008-12#3)(2008-4#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
populational##2##1##(2008-6#1)(2008-9#1)
populations (&gt##2##2##(2008-10#2)
populations (P &lt##2##3##(2004-2#1)(2008-10#1)
populations (P##3##2##(1991-1#1)(2004-2#1)(2008-10#1)
populations (as##2##2##(1993-9#1)(2008-8#1)
populations (e##3##2##(1992-5#1)(2008-10#1)(2013-7#1)
populations (from##2##2##(2008-10#2)
populations 881-WT and 882-WT on##2##5##(2008-10#2)
populations 881-WT and 882-WT##3##4##(2008-10#3)
populations adapted to##3##3##(2008-10#1)(2012-3#2)
populations after##4##2##(1991-9#1)(2007-12#1)(2008-10#1)(2008-9#1)
populations almost##2##2##(2008-5#1)(2009-3#1)
populations along the##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
populations along##4##2##(2008-10#1)(2008-5#1)(2012-3#1)(2013-8#1)
populations also##2##2##(2008-10#1)(2010-5#1)
populations among##2##2##(2008-7#1)(2010-5#1)
populations analyzed##2##2##(2008-12#1)(2010-2#1)
populations and 10##2##3##(2008-10#1)(2008-7#1)
populations and are##2##3##(2006-9#1)(2012-12#1)
populations and can##2##3##(2012-1#1)(2012-3#1)
populations and ecosystems##2##3##(2013-8#2)
populations and in the##2##4##(2006-8#1)(2012-3#1)
populations and in##5##3##(1994-1#1)(2006-8#1)(2008-10#1)(2009-4#1)(2012-3#1)
populations and is##2##3##(2008-10#1)(2010-2#1)
populations and may##2##3##(2007-12#1)(2012-7#1)
populations and root##2##3##(2008-10#2)
populations and species##3##3##(2007-1#1)(2008-8#1)(2013-7#1)
populations and suggest that##3##4##(1997-7#1)(2008-10#1)(2009-2#1)
populations and that##3##3##(1992-8#1)(2008-10#1)(2008-8#1)
populations and the##11##3##(1991-12#1)(1995-6#1)(2006-10#1)(2006-9#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-8#2)(2011-2#1)
populations and their##3##3##(1990-5#1)(2007-3#1)(2008-10#1)
populations and to##3##3##(2006-9#1)(2007-11#1)(2007-8#1)
populations and with##2##3##(1994-1#1)(2011-1#1)
populations and##131##2##(1990-5#1)(1991-12#2)(1992-8#1)(1993-12#1)(1993-9#2)(1994-1#2)(1995-12#1)(1995-6#1)(1996-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-1#1)(2006-10#2)(2006-2#3)(2006-5#1)(2006-8#1)(2006-9#4)(2007-1#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-3#1)(2007-5#2)(2007-8#1)(2008-1#2)(2008-10#29)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#8)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#3)(2010-5#2)(2011-1#3)(2011-12#2)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#4)(2012-4#1)(2012-7#1)(2013-1#3)(2013-7#3)(2013-8#3)
populations are at##3##3##(2007-12#1)(2008-7#1)(2012-1#1)
populations are not##2##3##(2008-10#1)(2008-5#1)
populations are often##2##3##(2007-12#1)(2008-8#1)
populations are##52##2##(1992-3#1)(1994-3#1)(1995-12#1)(1995-3#1)(1997-8#1)(2004-11#1)(2004-4#1)(2006-2#1)(2007-11#1)(2007-12#4)(2007-3#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#5)(2010-5#1)(2011-1#2)(2012-1#3)(2013-7#1)
populations as a##2##3##(1995-12#1)(2010-10#1)
populations as well as##3##4##(1996-4#1)(2008-10#1)(2008-8#1)
populations as well##4##3##(1996-4#1)(2005-10#1)(2008-10#1)(2008-8#1)
populations as##11##2##(1995-12#2)(1996-4#1)(2005-10#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-10#1)(2010-2#1)
populations associated with##5##3##(2008-10#2)(2008-4#1)(2013-1#2)
populations at risk##6##3##(1995-3#1)(1997-8#1)(2007-11#1)(2008-12#1)(2008-6#2)
populations at the##5##3##(1997-1#1)(2008-10#1)(2008-12#1)(2009-8#1)(2011-2#1)
populations at##22##2##(1994-3#1)(1995-3#1)(1997-1#2)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-5#1)(2008-6#2)(2008-9#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#2)
populations based on the##2##4##(1993-6#1)(2013-8#1)
populations based on##5##3##(1993-6#1)(1996-6#1)(2008-10#1)(2012-3#1)(2013-8#1)
populations before##2##2##(1995-5#1)(2007-7#1)
populations being##2##2##(1994-7#1)(2008-10#1)
populations belong to##2##3##(2008-10#1)(2013-7#1)
populations between##3##2##(1994-3#1)(2008-10#2)
populations but##3##2##(1994-3#1)(1995-8#1)(2011-2#1)
populations by##17##2##(1990-11#1)(1996-11#1)(1997-6#1)(2007-3#1)(2008-10#4)(2008-4#1)(2008-9#2)(2009-3#1)(2009-8#1)(2009-9#1)(2011-2#2)(2012-2#1)
populations can be identified##2##4##(2008-10#1)(2008-11#1)
populations can be##11##3##(1994-5#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-8#1)(2010-8#1)(2013-1#1)
populations can##19##2##(1994-5#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-8#4)(2008-9#1)(2010-12#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#1)
populations changed##4##2##(2008-10#4)
populations collected from three##2##4##(2008-10#1)(2011-2#1)
populations collected from##12##3##(2007-6#2)(2008-10#9)(2011-2#1)
populations collected##14##2##(2007-6#2)(2008-10#11)(2011-2#1)
populations compared with the##2##4##(2008-10#2)
populations containing##4##2##(1994-11#1)(2008-9#1)(2012-12#1)(2013-1#1)
populations could be##3##3##(2008-10#2)(2010-8#1)
populations could##5##2##(2008-10#3)(2009-8#1)(2010-8#1)
populations decreased##2##2##(2008-10#2)
populations derived from an##2##4##(2008-5#1)(2008-8#1)
populations derived from crosses between##2##5##(2008-10#1)(2012-11#1)
populations derived from crosses##3##4##(2008-10#2)(2012-11#1)
populations derived from##14##3##(2008-10#7)(2008-4#3)(2008-5#1)(2008-8#2)(2012-11#1)
populations did##2##2##(2008-10#1)(2010-8#1)
populations differed##3##2##(1990-8#1)(1994-6#1)(2009-9#1)
populations displayed##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
populations due to##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
populations during the##3##3##(2006-8#1)(2008-10#2)
populations during##8##2##(1994-9#1)(2006-8#1)(2008-10#3)(2008-8#1)(2012-2#1)(2012-3#1)
populations even when##2##3##(2008-7#1)(2008-9#1)
populations even##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)
populations experiencing##3##2##(1995-8#1)(2010-8#1)(2011-2#1)
populations exposed to##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
populations followed##2##2##(2008-10#1)(2013-8#1)
populations following 30 passages##2##4##(2013-1#2)
populations for##12##2##(1992-3#1)(1995-11#1)(1997-5#1)(1997-6#1)(2004-11#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-6#1)(2010-2#1)(2011-2#1)(2012-2#1)
populations found in##2##3##(1991-12#1)(2008-10#1)
populations from P##2##3##(2008-10#2)
populations from a##2##3##(2008-8#1)(2011-2#1)
populations from component pure stands##2##5##(2008-10#2)
populations from cultivated##2##3##(2008-10#2)
populations from different locations##2##4##(2008-10#2)
populations from different##6##3##(2004-11#1)(2008-10#4)(2012-7#1)
populations from four host genotypes##3##5##(2008-10#3)
populations from the##13##3##(1992-12#1)(2004-4#1)(2007-1#1)(2008-10#7)(2008-8#1)(2010-2#1)(2011-2#1)
populations from##88##2##(1991-3#1)(1992-12#1)(1996-7#1)(2004-11#1)(2004-4#1)(2005-10#1)(2005-7#1)(2007-1#2)(2007-6#1)(2008-1#1)(2008-10#48)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#7)(2008-9#1)(2009-3#1)(2009-6#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-7#1)(2013-1#5)
populations generally##2##2##(2008-10#1)(2008-9#1)
populations had##5##2##(2008-10#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-3#1)
populations has##9##2##(1996-3#1)(2004-12#1)(2006-5#1)(2006-7#1)(2009-4#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-1#1)
populations have been##5##3##(1991-11#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
populations have not been##2##4##(2005-10#1)(2008-10#1)
populations have not##3##3##(2005-10#1)(2008-10#1)(2008-8#1)
populations have##14##2##(1991-11#1)(1996-3#1)(2005-10#1)(2007-10#1)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
populations having##2##2##(1996-12#1)(2008-8#1)
populations in China##2##3##(2006-9#1)(2008-10#1)
populations in a##5##3##(1997-4#1)(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#1)
populations in areas##2##3##(2011-2#1)(2012-3#1)
populations in both##2##3##(2008-10#2)
populations in developing countries##2##4##(2005-7#1)(2009-6#1)
populations in developing nations##2##4##(2005-7#2)
populations in developing##5##3##(1994-11#1)(2005-7#3)(2009-6#1)
populations in high##2##3##(2012-3#2)
populations in one##2##3##(2011-2#1)(2013-7#1)
populations in order to##2##4##(2007-11#1)(2008-10#1)
populations in sympatry##2##3##(2008-10#2)
populations in terms of##3##4##(2005-8#1)(2011-12#1)(2013-8#1)
populations in the field##2##4##(2008-10#1)(2008-9#1)
populations in the greenhouse##2##4##(2008-10#2)
populations in the##34##3##(1992-8#1)(1994-10#1)(1997-6#1)(2005-7#1)(2006-10#1)(2007-12#1)(2008-10#15)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-4#1)(2012-1#3)
populations in their##3##3##(2008-10#1)(2008-12#1)(2010-1#1)
populations in vivo##3##3##(2005-8#2)(2008-1#1)
populations in which##4##3##(2008-10#1)(2008-3#1)(2008-8#1)(2011-1#1)
populations in##151##2##(1990-9#1)(1992-2#1)(1992-3#1)(1992-8#1)(1994-10#3)(1994-11#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-3#1)(1997-4#2)(1997-6#1)(2004-11#1)(2005-11#1)(2005-7#4)(2005-8#3)(2005-9#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#2)(2008-1#2)(2008-10#45)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#7)(2008-9#4)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#4)(2012-12#1)(2012-2#4)(2012-3#7)(2013-1#4)(2013-7#2)(2013-8#2)
populations include##2##2##(2008-11#2)
populations including the##2##3##(2010-11#1)(2010-3#1)
populations including##5##2##(2008-10#1)(2008-4#1)(2010-11#1)(2010-3#1)(2012-3#1)
populations increased##2##2##(2008-10#1)(2008-8#1)
populations indicated that##3##3##(2008-10#1)(2010-8#1)(2011-2#1)
populations indicated##4##2##(2008-10#2)(2010-8#1)(2011-2#1)
populations interact with##2##3##(1995-2#1)(2011-2#1)
populations into two##2##3##(2008-10#1)(2013-1#1)
populations into##4##2##(2004-3#1)(2008-10#1)(2008-8#1)(2013-1#1)
populations involved in##2##3##(2008-10#1)(2008-11#1)
populations is a##3##3##(2008-9#2)(2009-2#1)
populations is described##2##3##(2008-5#1)(2010-12#1)
populations is##27##2##(1991-2#1)(1995-2#1)(1997-6#2)(1997-8#1)(2006-6#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#4)(2009-2#1)(2010-12#2)(2010-8#2)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
populations isolated from##2##3##(2008-10#2)
populations isolated##3##2##(1992-8#1)(2008-10#2)
populations living in##6##3##(1994-5#1)(1995-1#1)(2007-5#1)(2008-12#1)(2008-7#1)(2013-7#1)
populations living##11##2##(1991-3#2)(1994-5#1)(1995-1#1)(1996-6#2)(2007-5#1)(2008-12#1)(2008-7#1)(2011-2#1)(2013-7#1)
populations located##2##2##(2008-10#1)(2012-7#1)
populations may be##2##3##(1997-7#1)(2008-8#1)
populations may##8##2##(1997-7#1)(2004-4#1)(2007-5#1)(2008-8#1)(2009-9#1)(2010-2#1)(2010-5#1)(2013-1#1)
populations near##2##2##(2007-3#1)(2008-9#1)
populations occur##2##2##(1996-6#1)(2008-10#1)
populations of 2##2##3##(2008-10#2)
populations of A##2##3##(2008-10#2)
populations of Aedes aegypti##2##4##(2007-10#2)
populations of Avena sterilis##2##4##(2008-10#2)
populations of B##5##3##(2008-10#5)
populations of C##8##3##(2007-12#1)(2008-10#7)
populations of CMV and its satRNA##2##6##(2008-10#2)
populations of CMV##3##3##(2008-10#3)
populations of D##4##3##(2007-5#1)(2008-5#1)(2013-8#2)
populations of Drosophila##2##3##(2008-9#1)(2012-3#1)
populations of Eimeria##2##3##(2008-5#2)
populations of Erwinia amylovora##2##4##(2008-10#2)
populations of F##4##3##(2008-10#4)
populations of Fusarium##2##3##(2008-10#2)
populations of G##6##3##(2008-10#4)(2010-3#1)(2012-11#1)
populations of H##4##3##(2008-10#2)(2011-2#2)
populations of Heterodera glycines##2##4##(2008-10#2)
populations of L##3##3##(2008-10#2)(2010-8#1)
populations of M##6##3##(2008-10#3)(2008-11#1)(2008-5#1)(2011-12#1)
populations of Mycosphaerella graminicola##2##4##(2008-10#2)
populations of P##16##3##(2007-6#1)(2008-10#14)(2009-5#1)
populations of Phytophthora capsici##2##4##(2008-10#2)
populations of Phytophthora infestans in the United States##2##8##(2008-10#2)
populations of Phytophthora parasitica were significantly reduced in##2##8##(2008-10#2)
populations of Phytophthora parasitica##4##4##(2008-10#4)
populations of Phytophthora##9##3##(2008-10#9)
populations of Pseudomonas putida 06909-rif/nal##2##5##(2008-10#2)
populations of Pseudomonas##4##3##(2008-10#4)
populations of R##2##3##(2008-10#2)
populations of S##5##3##(2007-5#1)(2008-10#3)(2011-2#1)
populations of T cells##2##4##(1991-12#1)(2008-4#1)
populations of T##5##3##(1991-12#1)(2008-10#2)(2008-4#1)(2008-9#1)
populations of V##3##3##(2008-10#3)
populations of Venturia inaequalis was##2##5##(2008-10#2)
populations of Venturia inaequalis##3##4##(2008-10#3)
populations of Western##2##3##(2008-10#1)(2011-2#1)
populations of a##9##3##(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#2)(2010-3#1)(2012-3#1)(2012-7#1)
populations of an##3##3##(1995-8#1)(2008-5#1)(2013-1#1)
populations of bacteria##4##3##(2005-11#1)(2008-10#2)(2012-3#1)
populations of birds##2##3##(2008-8#1)(2008-9#1)
populations of both##3##3##(1996-3#1)(1997-4#1)(2007-4#1)
populations of cells from##2##4##(2008-11#1)(2008-4#1)
populations of cells in peripheral blood##2##6##(1995-1#1)(1995-2#1)
populations of cells that##3##4##(1991-1#1)(1992-8#1)(1995-8#1)
populations of cells with##3##4##(1991-12#1)(1995-1#1)(1995-11#1)
populations of cells##16##3##(1991-1#1)(1991-12#1)(1992-7#1)(1992-8#2)(1994-3#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-8#1)(2008-11#1)(2008-4#1)(2009-2#1)(2012-3#1)(2013-1#1)
populations of culturable bacteria##3##4##(2008-10#3)
populations of different sizes##3##4##(2008-9#2)(2011-2#1)
populations of different##4##3##(2008-10#1)(2008-9#2)(2011-2#1)
populations of differently##2##3##(1990-7#1)(2005-11#1)
populations of each##3##3##(2008-10#3)
populations of four##2##3##(2007-2#1)(2011-2#1)
populations of hybrids between##2##4##(2008-9#2)
populations of hybrids##4##3##(2008-10#2)(2008-9#2)
populations of lymphocytes##2##3##(1990-5#1)(1995-11#1)
populations of men##2##3##(2007-12#1)(2008-7#1)
populations of neurons and##2##4##(1993-12#1)(2008-4#1)
populations of neurons in##2##4##(2008-11#1)(2008-4#1)
populations of neurons were##2##4##(1994-5#1)(2013-1#1)
populations of neurons##15##3##(1992-5#1)(1993-12#1)(1993-6#1)(1994-5#1)(1996-3#2)(1996-9#1)(2008-11#2)(2008-4#2)(2008-5#1)(2009-8#1)(2010-12#1)(2013-1#1)
populations of particles##2##3##(1993-9#1)(2008-3#1)
populations of patients##4##3##(1995-12#1)(2005-7#1)(2006-10#1)(2007-2#1)
populations of primary##2##3##(2008-11#1)(2011-12#1)
populations of sensory##2##3##(1996-3#1)(2007-1#1)
populations of single##2##3##(1993-7#1)(2008-8#1)
populations of strain##2##3##(2008-10#2)
populations of sweet corn##2##4##(2008-10#2)
populations of the fungus##2##4##(2008-10#2)
populations of the pathogen##4##4##(2008-10#4)
populations of the rat##2##4##(1991-4#1)(1995-5#1)
populations of the species##2##4##(1996-12#1)(2008-8#1)
populations of the world##4##4##(1997-4#1)(2008-1#1)(2008-12#1)(2011-1#1)
populations of the##54##3##(1990-8#2)(1991-4#1)(1991-8#1)(1992-9#1)(1994-9#1)(1995-5#1)(1996-12#1)(1997-4#1)(1997-7#1)(2005-10#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#20)(2008-12#1)(2008-5#1)(2008-8#6)(2008-9#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#2)
populations of these two##2##4##(2008-10#2)
populations of these##3##3##(2008-10#2)(2011-2#1)
populations of this##3##3##(1992-8#1)(2008-11#2)
populations of three##3##3##(1994-9#1)(2008-10#2)
populations of wild##3##3##(2008-10#1)(2008-5#1)(2013-7#1)
populations of##462##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#3)(1990-7#1)(1990-8#2)(1991-1#2)(1991-11#1)(1991-12#2)(1991-3#2)(1991-4#2)(1991-6#1)(1991-8#2)(1992-11#2)(1992-12#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#4)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#3)(1993-7#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#2)(1995-1#3)(1995-11#4)(1995-12#1)(1995-2#2)(1995-5#1)(1995-8#4)(1996-12#2)(1996-2#1)(1996-3#4)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#2)(1997-7#1)(2004-11#1)(2004-4#1)(2005-10#1)(2005-11#2)(2005-7#2)(2005-8#1)(2006-10#1)(2007-1#3)(2007-10#2)(2007-12#3)(2007-2#3)(2007-3#3)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#181)(2008-11#8)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#6)(2008-5#18)(2008-6#2)(2008-7#1)(2008-8#17)(2008-9#14)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#3)(2010-3#4)(2010-8#3)(2011-1#2)(2011-12#4)(2011-2#15)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#7)(2012-3#8)(2012-7#2)(2013-1#11)(2013-7#1)(2013-8#4)
populations on a##2##3##(2008-10#1)(2008-9#1)
populations on different##2##3##(2008-10#2)
populations on pear##2##3##(2008-10#2)
populations on the##6##3##(1993-6#1)(2007-5#1)(2009-5#1)(2010-8#1)(2011-11#1)(2012-9#1)
populations on##24##2##(1993-6#1)(2007-5#1)(2008-10#14)(2008-4#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-11#1)(2012-9#1)(2013-7#1)
populations or##12##2##(1996-2#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
populations over the##2##3##(2008-10#2)
populations over##3##2##(2008-10#3)
populations present##3##2##(1993-9#1)(2008-10#2)
populations prior to##2##3##(2008-10#1)(2008-11#1)
populations probably##2##2##(2008-10#2)
populations ranged from##4##3##(2007-1#1)(2008-10#3)
populations ranging from##2##3##(2009-4#1)(2012-3#1)
populations remained##2##2##(2008-10#1)(2008-8#1)
populations requires##2##2##(2008-7#1)(2008-9#1)
populations resistant to##2##3##(2008-10#2)
populations respond to##2##3##(2008-8#2)
populations revealed that##4##3##(1993-11#1)(2008-10#2)(2008-8#1)
populations revealed##8##2##(1993-11#1)(2008-10#4)(2008-12#1)(2008-8#1)(2009-6#1)
populations sampled from the##2##4##(2008-10#2)
populations sampled from##4##3##(2008-10#4)
populations sampled in##3##3##(2008-10#3)
populations sampled##10##2##(2008-10#9)(2008-9#1)
populations segregating for##2##3##(2006-12#1)(2010-10#1)
populations separated##2##2##(2008-11#2)
populations should be##4##3##(2008-4#1)(2008-8#1)(2008-9#1)(2011-12#1)
populations show##6##2##(2004-4#1)(2007-3#1)(2007-4#1)(2008-8#1)(2012-2#1)(2013-1#1)
populations showed a##2##3##(2008-9#1)(2011-1#1)
populations showed##8##2##(1990-9#1)(2007-3#1)(2008-5#1)(2008-9#2)(2011-1#1)(2011-12#1)(2011-2#1)
populations significantly##3##2##(2008-2#1)(2008-5#1)(2013-1#1)
populations so##2##2##(2008-10#1)(2008-9#1)
populations studied##16##2##(1992-10#1)(1992-12#1)(1996-12#1)(2006-3#1)(2008-1#1)(2008-10#4)(2008-9#3)(2010-2#1)(2013-7#2)(2013-8#1)
populations such as the##2##4##(2007-1#1)(2012-12#1)
populations such as##6##3##(1997-2#1)(2006-10#1)(2007-1#1)(2008-1#1)(2008-3#1)(2012-12#1)
populations suggests that##2##3##(2008-10#1)(2010-5#1)
populations targeted##2##2##(1993-9#1)(1994-3#1)
populations than##6##2##(1990-3#1)(2008-10#2)(2008-11#1)(2009-3#1)(2009-9#1)
populations that are at risk##2##5##(1996-8#1)(2007-11#1)
populations that are large##2##4##(2008-4#1)(2011-2#1)
populations that are##12##3##(1996-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#2)(2008-9#2)(2009-4#1)(2011-2#1)(2013-7#1)
populations that can be##2##4##(2008-10#1)(2008-4#1)
populations that had been##2##4##(2008-10#1)(2008-8#1)
populations that were##3##3##(1991-8#1)(2008-10#1)(2011-12#1)
populations that##42##2##(1991-6#1)(1991-8#1)(1996-3#1)(1996-8#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#9)(2008-4#2)(2008-6#1)(2008-8#6)(2008-9#4)(2009-12#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-6#1)(2010-8#3)(2011-12#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
populations through##8##2##(2006-10#1)(2008-10#2)(2008-4#1)(2008-8#3)(2010-8#1)
populations throughout the world##2##4##(2007-2#1)(2011-1#1)
populations throughout the##3##3##(2007-2#1)(2008-10#1)(2011-1#1)
populations to be##2##3##(2008-11#1)(2009-6#1)
populations to determine##2##3##(2012-1#1)(2012-12#1)
populations to fully benefit##2##4##(2013-1#2)
populations to the##4##3##(2008-10#2)(2008-8#1)(2010-10#1)
populations to##43##2##(1990-8#1)(1992-6#1)(1995-2#1)(1997-8#1)(2004-4#1)(2007-10#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-6#1)(2009-9#1)(2010-10#1)(2010-8#2)(2011-12#1)(2011-2#2)(2012-1#3)(2012-12#1)(2012-7#1)(2013-1#3)
populations under##5##2##(2007-10#1)(2008-10#1)(2008-8#1)(2010-10#1)(2012-3#1)
populations using the##2##3##(2008-10#2)
populations using##12##2##(1991-12#1)(1996-12#1)(2006-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)(2009-7#1)(2010-12#1)(2012-3#1)
populations varied##3##2##(2008-10#1)(2013-1#2)
populations varies##2##2##(2006-10#2)
populations versus##2##2##(1997-1#1)(2007-1#1)
populations via##2##2##(1992-7#1)(2012-3#1)
populations was 0##3##3##(2005-10#1)(2008-10#2)
populations was assessed##2##3##(2004-4#1)(2008-10#1)
populations was high##2##3##(2005-10#1)(2008-10#1)
populations was observed##2##3##(2008-10#1)(2012-3#1)
populations was significantly##2##3##(2008-10#2)
populations was studied##2##3##(2008-10#2)
populations was##40##2##(1995-2#1)(2004-4#1)(2005-10#3)(2006-9#1)(2008-10#23)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-1#3)(2012-3#1)(2013-1#1)(2013-7#1)
populations were at##2##3##(2008-10#2)
populations were compared##3##3##(1990-6#1)(1995-12#1)(2006-8#1)
populations were developed by crossing##2##5##(2008-10#2)
populations were developed##3##3##(2008-10#3)
populations were evaluated##2##3##(2008-10#2)
populations were found##2##3##(1996-2#1)(2008-4#1)
populations were genotyped##2##3##(2008-10#1)(2013-8#1)
populations were highly diverse##2##4##(2008-10#2)
populations were highly##5##3##(2008-10#5)
populations were maintained##2##3##(1996-4#1)(2013-1#1)
populations were monitored##2##3##(2008-10#2)
populations were more aggressive on##2##5##(2008-10#2)
populations were more##4##3##(2008-10#2)(2008-9#1)(2011-2#1)
populations were not##4##3##(2006-12#1)(2008-10#2)(2011-12#1)
populations were observed##3##3##(1995-12#1)(2007-6#1)(2011-2#1)
populations were reduced##2##3##(2008-10#2)
populations were sampled from##2##4##(2008-10#2)
populations were sampled##3##3##(2008-10#3)
populations were selected##2##3##(2007-1#1)(2008-10#1)
populations were tested##2##3##(2011-2#1)(2013-1#1)
populations were##100##2##(1990-3#1)(1990-6#1)(1992-6#1)(1994-5#1)(1995-11#1)(1995-12#3)(1995-8#2)(1996-11#1)(1996-2#1)(1996-4#2)(1996-7#1)(1997-7#2)(2005-9#1)(2006-12#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-6#1)(2008-10#48)(2008-12#1)(2008-4#1)(2008-5#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-7#1)(2010-8#1)(2011-11#1)(2011-12#2)(2011-2#7)(2013-1#2)(2013-7#1)(2013-8#2)
populations when##4##2##(1990-3#1)(2007-2#1)(2008-8#1)(2012-3#1)
populations where##5##2##(1996-11#1)(1996-7#1)(2008-8#1)(2008-9#1)(2010-2#1)
populations who are##2##3##(1995-12#1)(2008-5#1)
populations who##8##2##(1995-12#1)(2006-2#1)(2006-7#1)(2008-1#1)(2008-5#1)(2010-1#1)(2011-1#1)(2012-3#1)
populations will require##2##3##(2008-10#1)(2010-8#1)
populations will##7##2##(1995-3#1)(2005-7#1)(2008-1#1)(2008-10#1)(2010-2#1)(2010-8#1)(2012-2#1)
populations with a##6##3##(2007-10#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-8#1)(2012-3#1)
populations with different##7##3##(1996-6#1)(2006-8#1)(2007-3#1)(2008-5#1)(2008-8#1)(2013-1#2)
populations with the##3##3##(1994-4#1)(2007-1#1)(2010-5#1)
populations with##52##2##(1990-8#1)(1990-9#1)(1991-8#1)(1991-9#1)(1992-2#1)(1994-11#1)(1994-2#1)(1994-4#1)(1994-6#1)(1994-9#1)(1996-6#1)(1997-8#1)(2005-3#1)(2006-10#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-3#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#3)(2009-4#1)(2009-7#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)
populations within the##7##3##(1990-9#1)(1991-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-9#1)(2013-1#1)
populations within##15##2##(1990-9#1)(1991-12#1)(2008-10#8)(2008-12#1)(2008-5#1)(2008-9#1)(2009-9#1)(2013-1#1)
populations would##2##2##(2009-9#1)(2011-2#1)
populations##2802##1##(1990-1#1)(1990-10#2)(1990-11#5)(1990-12#3)(1990-2#2)(1990-3#3)(1990-5#5)(1990-6#2)(1990-7#3)(1990-8#9)(1990-9#5)(1991-1#6)(1991-10#1)(1991-11#3)(1991-12#19)(1991-2#2)(1991-3#6)(1991-4#2)(1991-5#3)(1991-6#5)(1991-8#6)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#4)(1992-12#4)(1992-2#3)(1992-3#5)(1992-4#1)(1992-5#3)(1992-6#4)(1992-7#4)(1992-8#9)(1992-9#2)(1993-10#1)(1993-11#2)(1993-12#5)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#5)(1993-7#3)(1993-9#7)(1994-1#2)(1994-10#4)(1994-11#6)(1994-2#2)(1994-3#18)(1994-4#1)(1994-5#6)(1994-6#6)(1994-7#1)(1994-9#6)(1995-1#6)(1995-11#8)(1995-12#14)(1995-2#12)(1995-3#7)(1995-4#2)(1995-5#4)(1995-6#5)(1995-8#13)(1995-9#5)(1996-11#6)(1996-12#11)(1996-2#6)(1996-3#16)(1996-4#7)(1996-5#4)(1996-6#9)(1996-7#4)(1996-8#1)(1996-9#3)(1997-1#5)(1997-2#7)(1997-3#4)(1997-4#7)(1997-5#3)(1997-6#12)(1997-7#7)(1997-8#7)(2004-10#1)(2004-11#9)(2004-12#1)(2004-2#2)(2004-3#1)(2004-4#10)(2004-9#1)(2005-10#19)(2005-11#6)(2005-12#1)(2005-3#2)(2005-4#1)(2005-7#9)(2005-8#6)(2005-9#2)(2006-1#2)(2006-10#33)(2006-11#1)(2006-12#5)(2006-2#9)(2006-3#1)(2006-4#5)(2006-5#9)(2006-6#1)(2006-7#2)(2006-8#6)(2006-9#13)(2007-1#20)(2007-10#14)(2007-11#10)(2007-12#23)(2007-2#20)(2007-3#18)(2007-4#3)(2007-5#17)(2007-6#8)(2007-7#5)(2007-8#7)(2007-9#5)(2008-1#34)(2008-10#775)(2008-11#53)(2008-12#37)(2008-2#16)(2008-3#19)(2008-4#41)(2008-5#60)(2008-6#16)(2008-7#32)(2008-8#155)(2008-9#115)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#12)(2009-3#9)(2009-4#14)(2009-5#10)(2009-6#10)(2009-7#8)(2009-8#13)(2009-9#18)(2010-1#5)(2010-10#14)(2010-11#5)(2010-12#15)(2010-2#21)(2010-3#9)(2010-4#4)(2010-5#13)(2010-6#2)(2010-8#50)(2010-9#5)(2011-1#37)(2011-11#5)(2011-12#23)(2011-2#100)(2012-1#32)(2012-10#1)(2012-11#6)(2012-12#29)(2012-2#50)(2012-3#56)(2012-4#1)(2012-7#8)(2012-9#1)(2013-1#82)(2013-7#24)(2013-8#28)
populations'##3##1##(2008-5#1)(2008-8#1)(2009-9#1)
populations) of##2##2##(1994-3#1)(2008-9#1)
populations)##10##1##(1994-3#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-8#2)(2008-9#2)(2011-1#1)(2011-12#1)
populations?##6##1##(1991-11#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-12#1)(2012-1#1)
populations]##3##1##(2011-2#1)(2012-12#1)(2013-8#1)
populus sp##2##2##(2007-7#2)
populus##3##1##(2007-7#2)(2008-10#1)
porA from##2##2##(1993-12#2)
porA##6##1##(1993-12#5)(2008-11#1)
porcelain aorta&quot##3##2##(2012-2#3)
porcelain gallbladder##2##2##(1992-6#1)(1994-6#1)
porcelain##17##1##(1992-6#1)(1994-6#3)(2006-6#2)(2007-3#1)(2008-5#1)(2010-12#1)(2011-1#1)(2012-2#3)(2013-8#4)
porcellus##2##1##(2013-1#2)
porcine AF cells##2##3##(2012-2#2)
porcine CNP##2##2##(1991-3#1)(1991-8#1)
porcine DOs##2##2##(2013-1#2)
porcine FGF-2 mRNA##2##3##(1996-12#2)
porcine FGF-2##3##2##(1996-12#3)
porcine FIXa##3##2##(1995-1#3)
porcine Leydig##2##2##(1992-3#2)
porcine MCP-1##2##2##(1994-11#2)
porcine PMNL##4##2##(1990-10#4)
porcine Serpulina##3##2##(1996-11#3)
porcine Tex11 is##2##3##(2012-2#2)
porcine Tex11##4##2##(2012-2#4)
porcine and human##4##3##(1991-8#1)(1996-2#1)(1996-4#1)(2008-3#1)
porcine and rat##2##3##(1991-8#1)(1992-11#1)
porcine and##11##2##(1991-2#1)(1991-6#1)(1991-8#3)(1992-11#1)(1996-2#1)(1996-4#1)(1996-8#1)(2007-1#1)(2008-3#1)
porcine aorta##4##2##(1997-6#2)(2007-4#1)(2009-7#1)
porcine aortic endothelial cells (PAEC)##2##5##(2004-11#1)(2008-8#1)
porcine aortic endothelial cells##9##4##(1990-2#2)(1991-8#2)(1992-12#1)(1993-3#1)(1995-3#1)(2004-11#1)(2008-8#1)
porcine aortic smooth muscle cells##2##5##(1990-7#1)(1992-8#1)
porcine aortic tissue##2##3##(2009-7#2)
porcine aortic valve##2##3##(2007-8#1)(2010-8#1)
porcine aortic##16##2##(1990-2#2)(1990-7#1)(1991-7#1)(1991-8#2)(1992-12#1)(1992-8#1)(1993-3#1)(1995-3#1)(2004-11#1)(2007-8#1)(2008-8#1)(2009-7#2)(2010-8#1)
porcine big endothelin-1##2##3##(1990-12#2)
porcine big##4##2##(1990-12#2)(1990-2#2)
porcine bone##2##2##(2008-12#1)(2012-3#1)
porcine brain##17##2##(1990-7#5)(1991-2#2)(1991-3#1)(1993-2#1)(1993-9#1)(1994-3#1)(1994-5#2)(1994-8#1)(1996-12#1)(1996-5#1)(2007-4#1)
porcine ciliary##2##2##(1992-8#2)
porcine coronary arterial smooth muscle##2##5##(1994-11#1)(1995-1#1)
porcine coronary arterial##4##3##(1994-11#1)(1995-1#1)(1996-12#2)
porcine coronary arteries and##2##4##(1992-11#1)(1994-11#1)
porcine coronary arteries with##2##4##(1994-11#2)
porcine coronary arteries##9##3##(1990-10#1)(1992-11#2)(1994-11#3)(1997-8#1)(2009-5#1)(2011-1#1)
porcine coronary artery smooth muscle cells##3##6##(1990-10#2)(1990-8#1)
porcine coronary artery##7##3##(1990-10#2)(1990-8#1)(1992-9#2)(2008-11#2)
porcine coronary##20##2##(1990-10#3)(1990-8#1)(1992-11#2)(1992-9#2)(1994-11#4)(1995-1#1)(1996-12#2)(1997-8#1)(2008-11#2)(2009-5#1)(2011-1#1)
porcine endogenous##2##2##(2010-10#1)(2011-2#1)
porcine epidermal growth factor##2##4##(2008-7#2)
porcine erythrocytes##2##2##(1990-2#2)
porcine genomic##2##2##(1994-2#1)(1997-7#1)
porcine granulosa cells##2##3##(1995-12#2)
porcine heart tissue##2##3##(1996-7#2)
porcine heart##7##2##(1991-1#1)(1991-10#2)(1996-7#2)(2008-5#1)(2008-8#1)
porcine hemoglobin##2##2##(2010-4#2)
porcine hepatocyte spheroids##2##3##(2008-11#2)
porcine hepatocyte##3##2##(2008-11#3)
porcine hepatocytes was##2##3##(2008-11#2)
porcine hepatocytes##7##2##(2006-6#1)(2008-11#5)(2011-2#1)
porcine intestinal mucosa##3##3##(1994-12#2)(1995-2#1)
porcine intestinal##5##2##(1994-12#2)(1995-2#1)(2008-10#1)(2012-1#1)
porcine kidney##7##2##(1990-11#1)(1991-2#1)(1992-11#1)(1994-5#1)(1997-3#1)(2008-10#2)
porcine lacrimal gland##2##3##(1997-5#2)
porcine lacrimal##3##2##(1997-5#3)
porcine leukocyte 12-lipoxygenase##2##3##(1994-11#2)
porcine liver in indentation##2##4##(2009-7#2)
porcine liver in##3##3##(2006-6#1)(2009-7#2)
porcine liver##6##2##(1994-12#2)(2006-11#1)(2006-6#1)(2009-7#2)
porcine luteal cells##2##3##(1994-11#2)
porcine model of##3##3##(2007-7#2)(2012-2#1)
porcine model##14##2##(2005-8#1)(2006-6#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-4#1)(2009-2#1)(2011-2#3)(2012-2#1)(2013-1#1)
porcine models##2##2##(2009-2#1)(2012-2#1)
porcine muscle##4##2##(2010-4#4)
porcine myocardium##3##2##(1991-10#1)(2007-12#1)(2008-2#1)
porcine neonatal##2##2##(1992-2#1)(1996-12#1)
porcine oocytes fertilized in vitro##2##5##(2006-5#2)
porcine oocytes##9##2##(2006-5#4)(2013-1#5)
porcine organ##2##2##(2005-7#1)(2006-6#1)
porcine pancreas##4##2##(1990-12#1)(1991-2#1)(2008-10#1)(2010-11#1)
porcine pancreas)##2##2##(2011-12#2)
porcine pancreatic elastase (PPE)##6##4##(1991-3#1)(1992-3#1)(1994-9#1)(2008-5#3)
porcine pancreatic elastase##8##3##(1991-3#2)(1992-3#2)(1994-9#1)(2008-5#3)
porcine pancreatic phospholipase A2##3##4##(1991-2#1)(1992-5#1)(1992-9#1)
porcine pancreatic##25##2##(1990-2#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-2#2)(1991-3#4)(1992-12#2)(1992-2#1)(1992-3#3)(1992-5#1)(1992-9#1)(1994-9#1)(2008-5#3)(2010-11#1)
porcine pepsinogen##3##2##(1995-3#3)
porcine placental##2##2##(1995-8#2)
porcine plasma##3##2##(1990-2#2)(1994-12#1)
porcine platelet lysate##2##3##(2008-11#2)
porcine platelet##3##2##(1996-5#1)(2008-11#2)
porcine platelets##4##2##(1992-6#2)(1993-11#1)(1996-5#1)
porcine polymorphonuclear leukocytes##2##3##(1990-10#2)
porcine renal##2##2##(1991-12#1)(2008-11#1)
porcine serum##4##2##(1991-12#4)
porcine skin model##2##3##(2008-5#2)
porcine skin##7##2##(2008-5#7)
porcine small intestine##3##3##(2004-11#3)
porcine small##4##2##(2004-11#3)(2008-5#1)
porcine somatostatin receptor##2##3##(1994-2#2)
porcine spleen##3##2##(1990-3#2)(1992-12#1)
porcine thyroid gland##4##3##(1993-3#4)
porcine thyroid##5##2##(1991-5#1)(1993-3#4)
porcine tissue and##2##3##(1990-7#1)(2011-1#1)
porcine tissue##5##2##(1990-7#2)(1991-3#1)(1997-3#1)(2011-1#1)
porcine tissues##4##2##(1991-12#1)(1992-9#2)(1997-3#1)
porcine tumor necrosis factor-encoding genes##2##5##(1991-6#2)
porcine uterus##4##2##(1991-8#1)(1992-11#1)(1994-9#2)
porcine zona pellucida glycoproteins##2##4##(1991-2#2)
porcine##409##1##(1990-10#9)(1990-11#3)(1990-12#5)(1990-2#15)(1990-3#2)(1990-7#9)(1990-8#2)(1990-9#2)(1991-1#1)(1991-10#4)(1991-11#1)(1991-12#9)(1991-2#12)(1991-3#9)(1991-4#2)(1991-5#1)(1991-6#4)(1991-7#1)(1991-8#11)(1991-9#2)(1992-11#6)(1992-12#5)(1992-2#3)(1992-3#5)(1992-5#1)(1992-6#4)(1992-8#4)(1992-9#9)(1993-10#1)(1993-11#3)(1993-2#1)(1993-3#6)(1993-5#1)(1993-6#1)(1993-9#2)(1994-11#13)(1994-12#6)(1994-2#3)(1994-3#1)(1994-5#4)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#5)(1995-12#3)(1995-2#1)(1995-3#4)(1995-6#1)(1995-8#4)(1996-10#1)(1996-11#3)(1996-12#8)(1996-2#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#3)(1996-8#6)(1997-3#3)(1997-5#4)(1997-6#4)(1997-7#2)(1997-8#2)(2004-11#6)(2005-11#3)(2005-7#2)(2005-8#1)(2006-10#2)(2006-11#3)(2006-5#5)(2006-6#4)(2007-1#2)(2007-11#1)(2007-12#2)(2007-4#4)(2007-7#2)(2007-8#6)(2008-10#5)(2008-11#15)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#13)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#1)(2009-2#2)(2009-4#2)(2009-5#2)(2009-7#6)(2010-10#1)(2010-11#3)(2010-2#1)(2010-4#9)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#5)(2012-1#2)(2012-2#9)(2012-3#2)(2013-1#16)(2013-7#1)
pore and the##2##3##(2008-10#1)(2011-2#1)
pore and##8##2##(1995-1#1)(2005-11#1)(2007-7#1)(2008-10#1)(2010-11#1)(2011-2#2)(2012-2#1)
pore canals##2##2##(2007-12#1)(2010-7#1)
pore complex##13##2##(1993-6#2)(1994-11#3)(1995-2#2)(1997-6#1)(2007-8#1)(2009-8#1)(2011-2#3)
pore complexes##3##2##(2008-9#1)(2011-2#2)
pore density and##2##3##(2004-9#1)(2010-10#1)
pore diameter of##2##3##(1990-8#1)(2008-10#1)
pore diameter##10##2##(1990-12#1)(1990-8#2)(1994-12#1)(2004-9#1)(2005-12#1)(2008-10#1)(2008-5#1)(2009-2#1)(2010-4#1)
pore diameters##2##2##(1990-8#1)(2008-3#1)
pore distribution##3##2##(2007-12#1)(2009-7#1)(2013-1#1)
pore formation##13##2##(1990-11#1)(1994-2#5)(1994-5#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2011-1#2)
pore forming##5##2##(2006-8#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
pore glass##13##2##(2007-10#1)(2007-8#1)(2008-10#8)(2008-3#2)(2009-2#1)
pore in##2##2##(2008-5#1)(2010-12#1)
pore is##3##2##(1995-8#1)(2005-11#1)(2006-10#1)
pore network##3##2##(2008-6#1)(2009-7#1)(2010-2#1)
pore of Winer##3##3##(2007-7#3)
pore of the##2##3##(1991-9#2)
pore of##8##2##(1991-9#2)(1995-8#1)(2006-10#1)(2007-7#3)(2008-10#1)
pore properties##2##2##(2005-12#1)(2008-8#1)
pore radius##5##2##(2005-11#5)
pore size analysis##2##3##(2005-11#1)(2008-10#1)
pore size and##12##3##(1990-12#2)(2004-9#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-2#1)(2009-7#1)(2010-9#1)
pore size decreases with increasing acrylamide concentration##2##7##(2008-2#1)(2008-4#1)
pore size distribution##8##3##(2005-11#4)(2008-10#1)(2008-7#1)(2009-11#2)
pore size distributions##2##3##(2005-11#2)
pore size of the##4##4##(1994-8#1)(2005-11#1)(2008-5#2)
pore size of##6##3##(1990-12#1)(1994-8#1)(2005-11#1)(2008-10#1)(2008-5#2)
pore size##53##2##(1990-12#4)(1990-3#1)(1990-8#1)(1994-5#3)(1994-8#1)(2004-9#3)(2005-11#13)(2007-8#2)(2008-10#6)(2008-2#2)(2008-4#2)(2008-5#2)(2008-7#3)(2009-11#2)(2009-2#4)(2009-7#3)(2010-9#1)
pore sizes were##2##3##(2008-6#1)(2009-7#1)
pore sizes##14##2##(1994-5#1)(2005-11#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2009-7#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#1)
pore space##2##2##(2005-11#1)(2012-2#1)
pore spaces##2##2##(2005-11#1)(2010-9#1)
pore structure and the##2##4##(2005-11#1)(2009-2#1)
pore structure and##5##3##(2005-11#2)(2009-2#3)
pore structure##10##2##(2005-11#6)(2009-2#3)(2013-8#1)
pore volume of##2##3##(2010-4#2)
pore volume##6##2##(1990-8#1)(1993-12#1)(2005-11#2)(2010-4#2)
pore volumes##5##2##(1990-12#1)(2005-11#3)(2010-2#1)
pore walls##2##2##(2005-11#1)(2008-5#1)
pore water##5##2##(2008-10#3)(2011-1#1)(2013-8#1)
pore waters##4##2##(2008-10#4)
pore with##2##2##(1991-9#1)(1997-6#1)
pore##334##1##(1990-11#3)(1990-12#6)(1990-2#5)(1990-3#1)(1990-8#5)(1991-5#1)(1991-9#3)(1992-6#1)(1993-12#1)(1993-6#3)(1994-11#3)(1994-12#2)(1994-2#7)(1994-5#6)(1994-8#1)(1995-1#3)(1995-11#1)(1995-2#2)(1995-8#4)(1997-2#1)(1997-4#1)(1997-6#6)(2004-9#5)(2005-11#45)(2005-12#2)(2005-8#1)(2006-10#8)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#9)(2007-3#2)(2007-5#1)(2007-7#5)(2007-8#5)(2008-1#1)(2008-10#41)(2008-11#9)(2008-2#2)(2008-3#3)(2008-4#7)(2008-5#10)(2008-6#4)(2008-7#6)(2008-8#16)(2008-9#2)(2009-11#2)(2009-2#11)(2009-3#7)(2009-7#6)(2009-8#2)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#6)(2010-3#2)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#10)(2012-2#7)(2012-3#1)(2013-1#5)(2013-8#2)
pore-forming activity##2##2##(1990-6#1)(1994-3#1)
pore-forming loop##2##2##(2012-12#2)
pore-forming peptide##2##2##(1994-3#2)
pore-forming##24##1##(1990-6#1)(1991-3#1)(1994-2#3)(1994-3#3)(1994-5#1)(1995-8#1)(1997-4#1)(1997-6#2)(2006-10#1)(2006-2#1)(2008-8#4)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)
pore-size distributions##2##2##(2008-3#1)(2008-7#1)
pored##2##1##(2007-12#1)(2013-7#1)
porencephaly##3##1##(1997-3#3)
pores and##7##2##(2005-11#2)(2007-8#1)(2008-10#1)(2008-4#1)(2010-12#1)(2011-2#1)
pores are##5##2##(1994-2#2)(2005-11#1)(2007-12#1)(2009-11#1)
pores by##2##2##(2004-8#1)(2008-10#1)
pores in the ferritin##2##4##(2009-3#2)
pores in the##12##3##(1990-6#1)(1994-2#2)(1997-6#1)(2005-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-3#3)
pores in##23##2##(1990-6#1)(1994-2#2)(1995-1#1)(1997-6#1)(2005-11#1)(2005-12#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#5)(2010-8#1)(2011-1#1)
pores is##7##2##(1990-3#1)(2008-4#1)(2008-7#2)(2011-2#1)(2012-11#2)
pores of the##8##3##(2008-10#4)(2008-5#2)(2010-2#1)(2011-1#1)
pores of##21##2##(2004-9#2)(2005-11#3)(2006-2#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#3)(2008-6#1)(2010-12#1)(2010-2#1)(2011-1#1)
pores or##3##2##(2006-10#1)(2008-10#1)(2009-8#1)
pores size##3##2##(2004-9#1)(2008-5#1)(2013-8#1)
pores that are##2##3##(2008-4#1)(2009-11#1)
pores that##3##2##(2008-4#1)(2008-7#1)(2009-11#1)
pores was##2##2##(2008-10#1)(2008-3#1)
pores with a diameter of##2##5##(1994-2#1)(2008-10#1)
pores with##4##2##(1994-2#1)(2005-11#1)(2008-10#2)
pores##143##1##(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#1)(1991-3#1)(1994-2#8)(1995-1#1)(1997-1#1)(1997-6#1)(2004-8#1)(2004-9#8)(2005-11#15)(2005-12#1)(2006-10#1)(2006-2#2)(2006-5#1)(2007-12#6)(2007-3#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#19)(2008-11#7)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#1)(2009-11#3)(2009-2#1)(2009-3#8)(2009-8#3)(2010-10#1)(2010-12#5)(2010-2#1)(2010-4#2)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#2)(2012-11#2)(2012-2#1)(2013-8#2)
pores)##2##1##(2008-1#1)(2009-2#1)
porewaters of##2##2##(2006-6#1)(2008-10#1)
porfiromycin##2##1##(1995-2#1)(1996-6#1)
porgy##7##1##(1990-6#2)(2008-7#5)
porin in##2##2##(1990-8#1)(1992-7#1)
porin of the##2##3##(1992-7#1)(1996-9#1)
porin of##3##2##(1992-7#1)(1996-9#1)(2006-8#1)
porin##19##1##(1990-8#4)(1992-7#2)(1993-12#1)(1994-8#1)(1996-5#1)(1996-9#2)(2005-7#1)(2006-8#1)(2007-3#1)(2008-8#3)(2012-3#1)(2013-8#1)
porins from##2##2##(2006-8#1)(2008-10#1)
porins##19##1##(1992-12#1)(1994-6#1)(1997-8#2)(2006-8#5)(2008-10#3)(2008-8#2)(2013-1#5)
pork and pork products by##2##5##(1994-5#1)(1997-4#1)
pork and pork products##3##4##(1994-5#1)(1997-4#1)(2010-4#1)
pork and##9##2##(1994-5#1)(1997-2#1)(1997-4#1)(2005-5#1)(2008-10#1)(2010-4#4)
pork backfat##2##2##(2010-4#2)
pork fat##4##2##(2007-6#1)(2010-4#3)
pork freshness using potentiometric##2##4##(2008-10#2)
pork freshness##3##2##(2008-10#3)
pork loin##2##2##(2010-4#2)
pork meat##9##2##(1990-8#1)(1997-4#2)(2010-4#6)
pork or##2##2##(2007-12#1)(2009-3#1)
pork products##4##2##(1994-5#1)(1997-4#1)(2010-4#2)
pork quality##8##2##(2010-4#6)(2011-1#1)(2013-1#1)
pork##88##1##(1990-8#1)(1991-7#1)(1992-2#1)(1994-5#2)(1995-12#1)(1997-2#1)(1997-4#4)(2005-5#1)(2007-12#2)(2007-2#1)(2007-6#2)(2008-10#8)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-2#7)(2010-4#48)(2010-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
pornography##2##1##(1996-6#1)(2008-7#1)
poroelastic##2##1##(2011-2#2)
porogen##4##1##(2007-8#1)(2008-10#1)(2008-7#1)(2010-2#1)
porogenic mixture##3##2##(2005-12#3)
porogenic solvents##3##2##(2005-12#1)(2013-8#2)
porogenic##9##1##(2005-12#6)(2008-10#1)(2013-8#2)
porogens##5##1##(2008-10#4)(2010-2#1)
porokeratosis in a##2##3##(2007-7#1)(2010-6#1)
porokeratosis of Mibelli##3##3##(2007-7#1)(2012-2#2)
porokeratosis##12##1##(2007-7#8)(2010-6#2)(2012-2#2)
porosimetry data##5##2##(2005-11#4)(2007-11#1)
porosimetry##12##1##(2005-11#9)(2007-11#1)(2008-10#1)(2008-5#1)
porosities##3##1##(2009-12#1)(2009-7#2)
porosity and mechanical##2##3##(1993-12#1)(2013-8#1)
porosity and the##2##3##(2009-7#1)(2010-5#1)
porosity and##17##2##(1993-12#1)(2005-11#2)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-12#1)(2009-7#2)(2010-5#3)(2011-1#1)(2013-8#1)
porosity for##2##2##(2009-7#1)(2010-9#1)
porosity graded-layer model##2##3##(2008-2#2)
porosity in the##2##3##(2008-10#1)(2010-7#1)
porosity in##4##2##(1990-3#1)(2008-10#1)(2008-12#1)(2010-7#1)
porosity is##3##2##(1990-3#1)(2005-11#1)(2009-7#1)
porosity may##2##2##(2005-11#1)(2009-7#1)
porosity of the##8##3##(1996-11#1)(2005-11#2)(2006-1#1)(2008-10#2)(2008-2#1)(2010-5#1)
porosity of##11##2##(1996-11#1)(2004-9#1)(2005-11#2)(2006-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2010-5#1)
porosity to##2##2##(2007-8#1)(2008-2#1)
porosity were##2##2##(2005-11#1)(2011-2#1)
porosity##77##1##(1990-3#2)(1993-12#1)(1996-11#1)(2004-9#4)(2005-11#11)(2006-1#1)(2006-12#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#8)(2008-3#1)(2008-5#8)(2008-6#1)(2008-7#2)(2009-12#1)(2009-7#8)(2009-9#1)(2010-12#1)(2010-4#2)(2010-5#4)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#1)(2011-2#1)(2013-8#1)
porosome structures##2##2##(2012-2#2)
porosome##3##1##(2012-2#3)
porosus##2##1##(2010-3#2)
porotic hyperostosis##2##2##(1991-11#2)
porous 3D scaffold##2##3##(2008-5#1)(2009-12#1)
porous 3D##4##2##(2008-5#1)(2009-12#1)(2010-4#1)(2012-11#1)
porous HA ceramic scaffolds##3##4##(2008-5#3)
porous HA##6##2##(2008-5#6)
porous Si oxide##2##3##(2008-5#2)
porous Si##3##2##(2008-5#3)
porous SiO(2)##2##2##(2011-1#2)
porous Vycor glass##2##3##(2008-3#2)
porous alumina##2##2##(2005-10#1)(2007-8#1)
porous and##7##2##(1997-2#1)(2008-5#1)(2009-7#1)(2010-12#1)(2010-8#1)(2012-11#1)(2013-7#1)
porous beads (CPB##2##3##(2008-11#2)
porous beta-TCP scaffolds##3##3##(2008-5#3)
porous beta-TCP##5##2##(2008-5#5)
porous bioceramic##2##2##(2008-5#2)
porous carrier##2##2##(1994-5#1)(2008-11#1)
porous carriers was investigated in order##2##6##(2008-11#2)
porous carriers##5##2##(1994-5#1)(2008-11#4)
porous cellulose##3##2##(1995-2#1)(2008-10#1)(2008-11#1)
porous coating##2##2##(2008-11#1)(2008-5#1)
porous collagen##2##2##(2008-11#1)(2009-7#1)
porous core##4##2##(2008-10#4)
porous crystals##2##2##(2010-12#2)
porous film##2##2##(2008-10#1)(2011-1#1)
porous films##2##2##(2008-1#1)(2009-11#1)
porous glass##5##2##(2008-10#4)(2008-11#1)
porous graphitic carbon##5##3##(1990-8#2)(1995-6#1)(2008-10#2)
porous hydroxyapatite (HA)##2##3##(2008-5#2)
porous hydroxyapatite##3##2##(2008-5#2)(2013-7#1)
porous layer##10##2##(2005-11#8)(2008-10#2)
porous layers##4##2##(2005-11#4)
porous material##4##2##(2008-3#3)(2010-12#1)
porous materials##3##2##(2004-9#1)(2005-11#1)(2008-10#1)
porous matrices##2##2##(2008-10#1)(2010-8#1)
porous media##11##2##(1992-12#1)(2005-11#5)(2007-9#3)(2008-7#1)(2013-1#1)
porous medium##7##2##(2005-11#3)(2008-10#1)(2009-3#1)(2010-9#2)
porous membrane for##4##3##(2012-11#4)
porous membrane##8##2##(2010-2#1)(2012-11#6)(2012-4#1)
porous membranes##3##2##(2004-9#1)(2005-11#2)
porous metal##3##2##(2006-12#1)(2008-11#2)
porous microcarrier Cytopore##2##3##(2008-11#2)
porous microcarrier##3##2##(2008-11#3)
porous microcarriers##2##2##(2008-11#2)
porous microspheres of##2##3##(2010-12#1)(2011-2#1)
porous microspheres##6##2##(2010-12#4)(2011-2#2)
porous network##2##2##(2009-11#1)(2010-4#1)
porous particles##2##2##(1996-8#1)(2008-11#1)
porous poly(glycidyl##2##2##(2007-8#1)(2013-8#1)
porous scaffold##3##2##(2008-5#2)(2012-2#1)
porous scaffolds##2##2##(2009-9#1)(2012-2#1)
porous silica##12##2##(1990-12#1)(1990-8#1)(1991-8#2)(2007-11#1)(2008-10#3)(2008-7#1)(2009-3#1)(2012-12#2)
porous silicon samples##2##3##(2008-10#2)
porous silicon##16##2##(1992-11#1)(2007-11#2)(2008-10#7)(2008-2#4)(2008-3#2)
porous structure##11##2##(2005-11#3)(2008-10#2)(2008-11#1)(2008-5#1)(2009-7#1)(2010-12#1)(2012-11#1)(2013-8#1)
porous substrate and the##2##4##(2005-11#2)
porous substrate##9##2##(2005-11#9)
porous substrates##5##2##(2005-11#4)(2010-7#1)
porous surface##2##2##(2010-4#1)(2012-1#1)
porous tablets##2##2##(2010-12#2)
porous##277##1##(1990-12#1)(1990-6#1)(1990-8#5)(1991-8#4)(1992-11#1)(1992-12#1)(1992-4#2)(1994-5#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-5#2)(1996-6#1)(1996-8#2)(1997-2#1)(1997-5#3)(2004-9#7)(2005-10#1)(2005-11#47)(2006-12#1)(2006-6#1)(2007-11#3)(2007-8#5)(2007-9#5)(2008-1#5)(2008-10#32)(2008-11#23)(2008-12#2)(2008-2#4)(2008-3#7)(2008-5#27)(2008-7#5)(2009-11#3)(2009-12#2)(2009-3#3)(2009-7#3)(2009-9#1)(2010-10#1)(2010-12#14)(2010-2#1)(2010-4#5)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#3)(2011-2#2)(2012-1#1)(2012-11#10)(2012-12#2)(2012-2#7)(2012-4#1)(2013-1#2)(2013-7#2)(2013-8#4)
porphobilinogen and##2##2##(1991-10#1)(1997-7#1)
porphobilinogen##5##1##(1991-10#1)(1992-3#1)(1997-7#3)
porphyria cutanea tarda##6##3##(1990-1#1)(1991-10#2)(2011-2#3)
porphyria##23##1##(1990-1#1)(1990-2#5)(1991-10#2)(1991-2#1)(1991-5#1)(1994-6#1)(1995-1#1)(1996-1#1)(2007-2#2)(2011-2#7)(2013-7#1)
porphyrin (TAPP)##2##2##(2008-10#2)
porphyrin N-oxide##3##2##(1996-2#3)
porphyrin and its##3##3##(2008-10#3)
porphyrin and##11##2##(1992-6#1)(2008-10#8)(2010-5#2)
porphyrin catalysts##2##2##(2008-7#2)
porphyrin complex##3##2##(2010-5#3)
porphyrin compounds##3##2##(1994-5#1)(2008-10#2)
porphyrin derivative##3##2##(2007-11#1)(2010-7#2)
porphyrin derivatives##3##2##(1993-12#1)(2007-12#1)(2010-7#1)
porphyrin film##3##2##(2008-10#3)
porphyrin fluorescence##4##2##(1991-5#2)(1993-11#1)(2008-10#1)
porphyrin in##3##2##(1992-8#1)(2005-4#1)(2008-10#1)
porphyrin is##2##2##(2008-10#2)
porphyrin macrocycle##3##2##(1990-7#1)(1997-6#1)(2010-6#1)
porphyrin metabolism##2##2##(1991-10#2)
porphyrin molecules##2##2##(2008-10#2)
porphyrin pi-cation##2##2##(1994-5#2)
porphyrin radical##2##2##(1990-3#1)(1996-2#1)
porphyrin ring##4##2##(1996-2#2)(2005-4#2)
porphyrin rings##5##2##(2005-4#2)(2008-9#1)(2010-7#2)
porphyrin to##5##2##(1997-7#1)(2008-10#3)(2010-6#1)
porphyrin with##4##2##(2005-4#1)(2008-10#3)
porphyrin##139##1##(1990-1#1)(1990-3#1)(1990-5#1)(1990-7#2)(1991-10#2)(1991-5#3)(1991-7#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#1)(1994-5#3)(1996-2#8)(1996-5#1)(1997-6#3)(1997-7#2)(2005-11#1)(2005-4#13)(2006-12#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#59)(2008-3#2)(2008-7#2)(2008-9#1)(2009-12#1)(2010-5#7)(2010-6#3)(2010-7#5)(2011-2#1)(2012-11#1)
porphyrin-heme metabolism##3##2##(1990-3#3)
porphyrinates##2##1##(2007-12#1)(2008-10#1)
porphyrinic##2##1##(1993-6#1)(1995-3#1)
porphyrinogen##3##1##(1991-5#1)(1996-5#2)
porphyrinogenic drug##2##2##(1991-10#2)
porphyrins and##2##2##(1991-10#1)(2008-6#1)
porphyrins are##2##2##(1990-1#1)(2008-10#1)
porphyrins can##2##2##(2008-10#2)
porphyrins have been##2##3##(1996-2#1)(2009-12#1)
porphyrins in the##2##3##(1992-9#1)(1996-1#1)
porphyrins in##8##2##(1991-5#1)(1992-9#3)(1996-1#1)(1996-5#2)(2006-12#1)
porphyrins was##3##2##(1992-9#2)(2008-10#1)
porphyrins with##3##2##(2005-4#1)(2008-10#2)
porphyrins##45##1##(1990-1#1)(1991-10#1)(1991-5#1)(1992-6#1)(1992-9#8)(1993-12#2)(1993-8#1)(1994-12#1)(1995-4#1)(1996-1#1)(1996-2#4)(1996-5#3)(2005-4#2)(2006-12#1)(2007-2#1)(2008-10#11)(2008-6#1)(2009-12#2)(2010-6#1)(2012-12#1)
porphyrio##2##1##(1997-4#2)
porri##2##1##(2008-10#2)
porridge##7##1##(1991-6#1)(2007-7#1)(2008-2#1)(2008-4#4)
port access surgery##2##3##(2008-11#1)(2012-12#1)
port access##6##2##(2007-7#1)(2007-8#1)(2008-11#2)(2012-12#2)
port and the##2##3##(2007-11#1)(2008-10#1)
port and##4##2##(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)
port area##2##2##(2008-4#1)(2013-8#1)
port city##3##2##(1997-6#2)(2007-10#1)
port for##3##2##(2007-2#1)(2007-7#1)(2007-8#1)
port implantation##3##2##(2007-7#1)(2012-12#2)
port in##2##2##(2007-7#2)
port is##3##2##(2006-6#1)(2007-7#1)(2008-3#1)
port of Djibouti##2##3##(2008-4#2)
port of a##7##3##(1990-8#1)(1997-8#1)(2007-11#1)(2008-10#3)(2008-3#1)
port of the##5##3##(2007-12#2)(2008-1#1)(2008-10#2)
port of##17##2##(1990-8#1)(1997-1#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#2)
port placement in##2##3##(2007-7#1)(2013-1#1)
port placement##4##2##(2007-7#2)(2007-8#1)(2013-1#1)
port position planning##2##3##(2007-8#2)
port position##3##2##(2007-8#3)
port positions##2##2##(2007-8#2)
port site metastases##2##3##(2006-6#2)
port site##7##2##(2006-6#5)(2007-8#1)(2009-9#1)
port sites##3##2##(2006-6#2)(2010-7#1)
port to##2##2##(2008-10#1)(2008-11#1)
port was##5##2##(2006-6#1)(2007-7#2)(2008-10#1)(2011-1#1)
port which##2##2##(2005-1#1)(2011-1#1)
port wine stain##2##3##(2007-11#1)(2009-4#1)
port wine##3##2##(1996-11#1)(2007-11#1)(2009-4#1)
port##133##1##(1990-8#1)(1995-5#1)(1996-11#1)(1997-1#1)(1997-6#2)(1997-8#1)(2005-1#1)(2006-6#10)(2007-10#2)(2007-11#4)(2007-12#4)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#23)(2007-8#13)(2008-1#1)(2008-10#20)(2008-11#5)(2008-2#5)(2008-3#5)(2008-4#4)(2008-5#1)(2008-6#3)(2009-4#1)(2009-9#1)(2010-7#1)(2011-1#3)(2011-2#4)(2012-12#7)(2013-1#3)(2013-8#1)
port-a-cath##3##1##(2006-6#1)(2007-7#1)(2008-5#1)
port-access mitral valve surgery##2##4##(2007-8#2)
port-access mitral valve##3##3##(2007-8#3)
port-site##2##1##(2006-6#2)
port-wine stain (PWS) birthmarks##2##4##(2007-12#1)(2012-12#1)
port-wine stain##3##2##(2007-12#1)(2011-1#1)(2012-12#1)
port-wine##5##1##(1996-3#1)(2007-12#1)(2007-6#1)(2011-1#1)(2012-12#1)
porta##2##1##(2008-10#1)(2010-12#1)
porta-caval anastomosis##5##2##(1993-3#5)
portability and##6##2##(2008-1#1)(2008-10#4)(2010-9#1)
portability of the##3##3##(2007-12#1)(2013-1#2)
portability of##4##2##(2007-12#1)(2011-1#1)(2013-1#2)
portability##15##1##(1996-12#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#6)(2009-12#1)(2010-9#1)(2011-1#1)(2013-1#2)
portable analytical##2##2##(2008-10#2)
portable analyzer for##2##3##(2008-10#2)
portable analyzer##3##2##(2008-10#3)
portable and easily##2##3##(2008-4#1)(2012-12#1)
portable and##10##2##(1997-8#1)(2004-9#1)(2008-10#4)(2008-3#1)(2008-4#1)(2010-7#1)(2012-12#1)
portable device##2##2##(2012-1#2)
portable devices##3##2##(2008-10#2)(2008-11#1)
portable dynamic ECG monitor##2##4##(2013-1#2)
portable equipment##2##2##(2005-10#1)(2008-3#1)
portable gait rhythmogram##2##3##(2013-1#2)
portable gas chromatography-microflame ionization##2##4##(2008-10#2)
portable gas##3##2##(2008-10#3)
portable instrument##2##2##(2008-10#1)(2008-2#1)
portable micro-XRF##2##2##(2008-10#2)
portable optical##3##2##(2007-12#1)(2008-10#2)
portable pumps##3##2##(1992-5#3)
portable system for##3##3##(2007-11#1)(2007-8#1)(2013-8#1)
portable system##4##2##(2007-11#1)(2007-8#1)(2008-10#1)(2013-8#1)
portable ultrasound bladder scanner##2##4##(2006-6#2)
portable ultrasound##4##2##(1992-11#1)(2006-6#2)(2007-6#1)
portable ventilators##3##2##(2011-1#2)(2011-2#1)
portable##132##1##(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#3)(1993-11#1)(1993-6#1)(1993-9#1)(1994-2#2)(1995-5#1)(1996-1#1)(1996-2#1)(1997-4#2)(1997-8#1)(2004-9#1)(2005-10#1)(2006-1#1)(2006-6#2)(2007-10#3)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#4)(2008-10#43)(2008-11#3)(2008-2#6)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#2)(2009-10#4)(2009-2#2)(2009-8#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#2)(2011-7#1)(2012-1#2)(2012-11#1)(2012-12#3)(2013-1#6)(2013-8#5)
portacaval anastomosis##3##2##(1993-3#1)(1997-5#2)
portacaval##4##1##(1991-11#1)(1993-3#1)(1997-5#2)
portal and cardiac##2##3##(1991-5#2)
portal and##6##2##(1991-5#2)(2006-2#1)(2006-6#1)(2010-12#1)(2012-3#1)
portal blood samples##2##3##(1997-7#2)
portal blood##5##2##(1993-3#1)(1997-7#4)
portal for##2##2##(2008-4#1)(2008-9#1)
portal hypertension and hepatic##2##4##(2006-10#1)(2006-2#1)
portal hypertension and##3##3##(2006-10#2)(2006-2#1)
portal hypertension are##2##3##(2006-10#1)(2013-8#1)
portal hypertension##53##2##(1991-11#1)(1991-5#2)(1991-6#1)(1991-9#1)(1996-8#1)(2005-6#1)(2006-10#15)(2006-2#2)(2006-6#1)(2006-8#1)(2009-8#10)(2009-9#3)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#3)(2013-1#5)(2013-8#3)
portal hypertension]##4##2##(1991-11#1)(1995-9#1)(2007-5#1)(2011-12#1)
portal hypertensive colopathy##3##3##(2013-8#3)
portal hypertensive##5##2##(2009-8#2)(2013-8#3)
portal image##2##2##(2009-2#1)(2010-9#1)
portal images##4##2##(1994-9#1)(2007-6#1)(2008-2#1)(2009-2#1)
portal imaging devices##2##3##(2007-6#1)(2008-2#1)
portal imaging##7##2##(1993-9#1)(2007-6#2)(2008-2#1)(2008-3#1)(2009-10#1)(2009-2#1)
portal infusion of hypertonic saline##4##5##(1993-12#4)
portal infusion of##5##3##(1993-12#5)
portal infusion##6##2##(1993-12#5)(2006-6#1)
portal of entry##3##3##(2006-10#2)(2008-5#1)
portal pressure by##2##3##(1991-5#1)(2009-9#1)
portal pressure##5##2##(1991-5#1)(1993-3#1)(2008-12#1)(2009-8#1)(2009-9#1)
portal technology##2##2##(2008-10#2)
portal thrombosis##4##2##(1990-3#1)(1990-8#3)
portal tract##3##2##(2006-10#2)(2008-6#1)
portal vein and##3##3##(2006-10#1)(2008-11#1)(2009-9#1)
portal vein in##3##3##(2005-12#2)(2009-2#1)
portal vein is##2##3##(2008-11#1)(2012-2#1)
portal vein thrombosis##5##3##(1993-5#1)(2008-3#2)(2008-5#1)(2012-2#1)
portal vein##40##2##(1990-4#1)(1991-4#1)(1993-11#2)(1993-12#1)(1993-5#1)(1995-2#1)(1997-1#1)(1997-4#1)(1997-8#1)(2005-12#3)(2006-10#1)(2006-2#1)(2008-11#4)(2008-12#1)(2008-3#4)(2008-5#2)(2009-11#2)(2009-2#1)(2009-8#1)(2009-9#1)(2010-11#1)(2012-2#7)(2012-3#1)
portal veins##2##2##(2006-4#1)(2008-8#1)
portal venous embolization##3##3##(1997-8#2)(2012-12#1)
portal venous gas##3##3##(2006-4#1)(2010-12#1)(2012-2#1)
portal venous##13##2##(1993-5#1)(1994-7#1)(1997-8#2)(2006-10#1)(2006-4#1)(2008-7#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
portal with##2##2##(2008-10#1)(2013-7#1)
portal##204##1##(1990-3#1)(1990-4#1)(1990-8#3)(1991-11#2)(1991-4#1)(1991-5#5)(1991-6#1)(1991-9#1)(1992-12#2)(1993-11#2)(1993-12#6)(1993-3#2)(1993-5#2)(1993-8#1)(1993-9#2)(1994-3#1)(1994-7#2)(1994-9#1)(1995-2#1)(1995-9#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#4)(1997-8#3)(2005-12#3)(2005-6#1)(2006-10#24)(2006-2#5)(2006-4#2)(2006-6#4)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#3)(2008-10#9)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#2)(2009-2#5)(2009-3#1)(2009-8#14)(2009-9#5)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#9)(2012-3#2)(2013-1#5)(2013-7#6)(2013-8#7)
portals in the##2##3##(2004-2#1)(2010-3#1)
portals in##3##2##(1995-8#1)(2004-2#1)(2010-3#1)
portals of##2##2##(2010-7#1)(2011-2#1)
portals##22##1##(1991-8#1)(1995-8#1)(2004-2#1)(2007-9#1)(2008-10#7)(2008-4#1)(2008-9#1)(2009-2#2)(2010-3#1)(2010-7#1)(2011-2#1)(2013-1#2)(2013-7#2)
portend a##2##2##(2007-12#1)(2008-5#1)
portend##4##1##(2007-12#1)(2007-6#1)(2008-5#1)(2009-10#1)
portends##3##1##(1996-2#1)(2012-2#1)(2013-1#1)
portfolio development##3##2##(2008-11#2)(2008-12#1)
portfolio is##4##2##(2006-5#1)(2007-9#1)(2008-12#2)
portfolio learning##2##2##(2008-12#1)(2013-1#1)
portfolio selection##4##2##(2012-12#2)(2013-1#2)
portfolio##40##1##(1996-1#1)(1996-12#1)(2006-5#7)(2007-1#1)(2007-9#1)(2008-11#3)(2008-12#15)(2008-5#1)(2009-9#2)(2010-3#1)(2012-12#3)(2013-1#4)
portfolios in##2##2##(2008-11#2)
portfolios##15##1##(1997-1#1)(2005-9#2)(2006-5#1)(2008-11#6)(2008-12#1)(2009-9#1)(2012-12#1)(2013-1#2)
portion and a##3##3##(1995-8#1)(1997-4#1)(2012-12#1)
portion and##11##2##(1990-10#1)(1994-3#1)(1995-8#1)(1997-4#1)(2005-11#1)(2007-9#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)
portion are##3##2##(1995-8#1)(2007-12#1)(2008-9#1)
portion consists of##2##3##(2008-10#2)
portion containing##2##2##(2007-7#1)(2008-10#1)
portion for##3##2##(1995-6#1)(2007-9#2)
portion from##3##2##(1997-5#1)(2011-1#1)(2013-8#1)
portion has##2##2##(1991-6#1)(2008-5#1)
portion in the##2##3##(1997-1#1)(2011-1#1)
portion in##4##2##(1997-1#1)(2007-11#1)(2009-10#1)(2011-1#1)
portion is##9##2##(1992-12#1)(1994-12#1)(1996-5#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
portion of PPL of both hemispheres in the Simon effect and##2##11##(2008-4#2)
portion of a##11##3##(1991-6#1)(1995-12#1)(1997-7#1)(2004-3#1)(2007-12#2)(2008-10#2)(2008-4#1)(2008-8#1)(2011-1#1)
portion of an##4##3##(1991-9#2)(2007-8#1)(2008-4#1)
portion of antibodies##2##3##(2005-11#1)(2008-4#1)
portion of bacterial##2##3##(1995-6#1)(2005-12#1)
portion of chromosome##2##3##(1995-8#1)(1996-8#1)
portion of dystrophin##2##3##(1990-5#2)
portion of each##2##3##(1991-2#1)(2008-5#1)
portion of it##3##3##(1990-11#1)(2006-7#1)(2008-2#1)
portion of protein##2##3##(1992-3#1)(2008-5#1)
portion of skin##2##3##(2008-5#1)(2013-7#1)
portion of that##2##3##(1994-8#1)(2008-4#1)
portion of the 5'##2##4##(1992-3#1)(1997-7#1)
portion of the Golgi complex##2##5##(2008-7#2)
portion of the active site##2##5##(1994-8#1)(2010-12#1)
portion of the anterior##2##4##(1992-10#1)(1995-6#1)
portion of the beta##2##4##(1995-3#1)(2006-5#1)
portion of the body##2##4##(1992-3#1)(2010-12#1)
portion of the catheter##2##4##(1992-3#1)(2011-2#1)
portion of the defect##2##4##(2008-5#2)
portion of the diaphragm##3##4##(2007-8#1)(2012-1#1)(2013-1#1)
portion of the duodenum##3##4##(1990-10#1)(2008-5#1)(2011-2#1)
portion of the enzyme##2##4##(1997-1#2)
portion of the esophagus##2##4##(1992-6#1)(1995-3#1)
portion of the gene##5##4##(1990-4#1)(1990-8#1)(1994-12#1)(2007-7#1)(2010-5#1)
portion of the genome##3##4##(2008-10#2)(2010-8#1)
portion of the heavy##3##4##(1990-6#2)(1996-4#1)
portion of the human##4##4##(1993-3#1)(1995-10#1)(1995-11#1)(1997-4#1)
portion of the large##2##4##(1993-8#1)(1996-5#1)
portion of the lateral##2##4##(1991-8#1)(2007-12#1)
portion of the left##3##4##(2007-8#1)(2008-5#1)(2011-1#1)
portion of the ligand##2##4##(1995-11#1)(1997-1#1)
portion of the mRNA##2##4##(1993-2#1)(1993-3#1)
portion of the mature##2##4##(1992-3#1)(1994-6#1)
portion of the medial##2##4##(1993-7#1)(2007-12#1)
portion of the middle##2##4##(2006-12#1)(2007-10#1)
portion of the molecule##7##4##(1991-2#3)(1992-3#1)(1992-5#1)(1994-9#1)(1997-2#1)
portion of the nerve##2##4##(1991-2#1)(2008-9#1)
portion of the normal##2##4##(1997-4#1)(2007-1#1)
portion of the nucleus##2##4##(1993-7#1)(2008-7#1)
portion of the population##3##4##(2011-2#1)(2012-11#1)(2013-8#1)
portion of the protein is##2##5##(1990-6#1)(1996-2#1)
portion of the protein##4##4##(1990-6#1)(1993-6#1)(1996-2#1)(1997-2#1)
portion of the receptor##4##4##(1994-12#1)(1997-4#1)(2006-12#1)(2007-12#1)
portion of the response##2##4##(1990-5#1)(1991-6#1)
portion of the spectrum##2##4##(2007-12#1)(2008-2#1)
portion of the##323##3##(1990-10#1)(1990-11#1)(1990-3#2)(1990-4#1)(1990-5#5)(1990-6#5)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#5)(1991-3#1)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#3)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#9)(1992-5#2)(1992-6#3)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#1)(1994-11#3)(1994-12#7)(1994-2#4)(1994-3#3)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#4)(1995-10#2)(1995-11#5)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#3)(1996-11#2)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#4)(1997-2#2)(1997-3#2)(1997-4#4)(1997-6#4)(1997-7#1)(1997-8#3)(1997-9#1)(2004-11#1)(2005-12#1)(2005-9#1)(2006-10#4)(2006-12#5)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-1#4)(2007-10#2)(2007-11#3)(2007-12#13)(2007-2#4)(2007-5#2)(2007-7#3)(2007-8#6)(2007-9#1)(2008-1#3)(2008-10#21)(2008-11#1)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#8)(2008-7#10)(2008-8#1)(2008-9#4)(2009-1#2)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#12)(2012-1#3)(2012-11#1)(2012-2#4)(2012-3#3)(2013-1#3)(2013-8#2)
portion of their##4##3##(1994-4#1)(2012-3#1)(2013-1#2)
portion of these##7##3##(1992-11#1)(1993-9#1)(1995-9#1)(2007-10#1)(2007-4#1)(2007-6#1)(2008-3#1)
portion of this##2##3##(1997-2#1)(2007-6#1)
portion of which##2##3##(1996-12#1)(2004-4#1)
portion of##476##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-3#2)(1990-4#1)(1990-5#7)(1990-6#7)(1990-7#2)(1990-8#1)(1990-9#3)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#8)(1991-3#1)(1991-5#2)(1991-6#5)(1991-7#1)(1991-8#3)(1991-9#6)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#12)(1992-5#3)(1992-6#3)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#3)(1993-7#2)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#7)(1994-2#4)(1994-3#3)(1994-4#1)(1994-6#2)(1994-8#5)(1994-9#1)(1995-1#4)(1995-10#4)(1995-11#6)(1995-12#2)(1995-3#3)(1995-4#1)(1995-5#4)(1995-6#3)(1995-7#1)(1995-8#5)(1995-9#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#5)(1997-1#6)(1997-2#3)(1997-3#3)(1997-4#5)(1997-5#1)(1997-6#5)(1997-7#2)(1997-8#3)(1997-9#2)(2004-11#1)(2004-3#1)(2004-4#1)(2005-11#1)(2005-12#2)(2005-9#1)(2006-10#4)(2006-12#5)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#4)(2007-10#4)(2007-11#3)(2007-12#15)(2007-2#4)(2007-3#1)(2007-4#2)(2007-5#3)(2007-6#3)(2007-7#5)(2007-8#7)(2007-9#1)(2008-1#3)(2008-10#31)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#10)(2008-5#15)(2008-7#14)(2008-8#4)(2008-9#7)(2009-1#2)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#4)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#13)(2012-1#3)(2012-11#1)(2012-2#6)(2012-3#7)(2013-1#6)(2013-7#1)(2013-8#3)
portion size##2##2##(1993-9#1)(2007-8#1)
portion was about##2##3##(2008-10#1)(2010-12#1)
portion was##7##2##(1992-12#1)(1996-11#1)(2007-8#1)(2008-10#2)(2010-12#1)(2012-12#1)
portion##584##1##(1990-10#3)(1990-11#3)(1990-12#4)(1990-3#2)(1990-4#1)(1990-5#8)(1990-6#7)(1990-7#3)(1990-8#1)(1990-9#3)(1991-1#2)(1991-10#3)(1991-11#1)(1991-12#3)(1991-2#8)(1991-3#1)(1991-5#4)(1991-6#6)(1991-7#1)(1991-8#4)(1991-9#7)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#5)(1992-2#2)(1992-3#13)(1992-5#3)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#3)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#3)(1993-7#2)(1993-8#1)(1993-9#2)(1994-11#5)(1994-12#9)(1994-2#4)(1994-3#4)(1994-4#1)(1994-6#2)(1994-8#5)(1994-9#1)(1995-1#4)(1995-10#5)(1995-11#6)(1995-12#2)(1995-3#3)(1995-4#1)(1995-5#4)(1995-6#5)(1995-7#2)(1995-8#8)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#2)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#5)(1997-1#8)(1997-2#4)(1997-3#3)(1997-4#7)(1997-5#2)(1997-6#5)(1997-7#2)(1997-8#4)(1997-9#2)(2004-11#1)(2004-3#1)(2004-4#1)(2005-11#2)(2005-12#2)(2005-9#1)(2006-10#4)(2006-12#7)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#5)(2007-10#4)(2007-11#5)(2007-12#19)(2007-2#4)(2007-3#1)(2007-4#2)(2007-5#3)(2007-6#3)(2007-7#6)(2007-8#9)(2007-9#6)(2008-1#4)(2008-10#41)(2008-11#6)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#11)(2008-5#20)(2008-6#2)(2008-7#19)(2008-8#5)(2008-9#9)(2009-1#2)(2009-10#1)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#6)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#2)(2010-8#3)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#17)(2012-1#4)(2012-11#1)(2012-12#2)(2012-2#7)(2012-3#8)(2013-1#7)(2013-7#2)(2013-8#4)
portion)##2##1##(2008-10#1)(2008-7#1)
portions and the##2##3##(2008-12#1)(2008-5#1)
portions and##5##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)
portions are##2##2##(1990-3#1)(1996-2#1)
portions in##2##2##(2008-12#1)(2010-3#1)
portions of a##3##3##(2007-4#1)(2008-10#1)(2008-4#1)
portions of an injured segment (mean##2##6##(2008-4#2)
portions of an injured segment##4##5##(2008-4#4)
portions of an##6##3##(1996-12#1)(2008-4#4)(2008-5#1)
portions of human##2##3##(1992-2#1)(1993-11#1)
portions of neurites##4##3##(1996-9#4)
portions of the caudal##2##4##(1990-7#1)(1990-9#1)
portions of the facial skin##2##5##(2008-5#2)
portions of the lateral##2##4##(1995-10#1)(1997-6#1)
portions of the protein##2##4##(1990-4#1)(1993-2#1)
portions of the##61##3##(1990-4#2)(1990-5#1)(1990-7#2)(1990-9#1)(1991-11#1)(1991-5#1)(1992-2#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-12#3)(1994-2#2)(1994-6#1)(1994-9#2)(1995-10#1)(1995-11#2)(1995-2#1)(1995-6#2)(1996-12#1)(1996-3#1)(1996-5#2)(1996-7#1)(1997-6#2)(2006-11#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#4)(2008-7#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#1)(2011-2#2)(2012-1#2)(2013-1#1)
portions of their##2##3##(1994-1#1)(1995-6#1)
portions of these proteins##2##4##(1993-2#1)(1995-1#1)
portions of these##3##3##(1993-2#1)(1995-1#1)(2008-6#1)
portions of##131##2##(1990-3#1)(1990-4#2)(1990-5#2)(1990-7#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#5)(1992-6#1)(1993-11#1)(1993-2#3)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-10#1)(1994-12#4)(1994-2#5)(1994-6#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#2)(1995-2#1)(1995-6#3)(1996-12#3)(1996-3#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-9#4)(1997-3#1)(1997-6#2)(2006-11#2)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#3)(2007-7#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#5)(2008-5#8)(2008-6#1)(2008-7#5)(2009-6#1)(2009-7#1)(2009-8#2)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-3#1)(2013-1#1)
portions with##4##2##(1992-11#1)(1993-3#1)(2005-1#1)(2009-6#1)
portions##186##1##(1990-12#1)(1990-3#2)(1990-4#3)(1990-5#2)(1990-7#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#3)(1991-3#1)(1991-5#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#5)(1992-6#1)(1993-11#1)(1993-2#3)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-1#1)(1994-10#1)(1994-12#5)(1994-2#5)(1994-4#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#5)(1995-2#1)(1995-6#5)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-9#4)(1997-1#2)(1997-2#1)(1997-3#1)(1997-6#2)(2005-1#1)(2006-11#2)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#7)(2007-3#1)(2007-4#3)(2007-7#1)(2007-8#1)(2008-10#17)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#6)(2008-5#12)(2008-6#2)(2008-7#5)(2009-6#2)(2009-7#2)(2009-8#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#1)
portions) of##2##2##(1991-9#1)(2007-7#1)
porto-systemic shunt vessels##2##3##(2011-2#2)
porto-systemic shunt##3##2##(2011-2#3)
portocaval##2##1##(1990-3#2)
portoenterostomy##4##1##(1994-6#3)(2013-1#1)
portography##2##1##(1993-7#1)(1996-9#1)
portosystemic encephalopathy##3##2##(2006-10#3)
portosystemic shunt##3##2##(1996-4#1)(2009-8#1)(2009-9#1)
portosystemic shunts##6##2##(1993-7#1)(1996-9#2)(2006-10#1)(2006-8#1)(2009-9#1)
portosystemic##17##1##(1993-7#1)(1996-4#1)(1996-9#2)(2006-10#7)(2006-8#1)(2009-8#2)(2009-9#2)(2010-2#1)
portrait of the##2##3##(2007-9#1)(2010-9#1)
portrait of##12##2##(1992-1#1)(2004-9#1)(2007-5#1)(2007-9#1)(2008-12#1)(2008-2#1)(2009-1#1)(2009-7#2)(2010-9#1)(2012-2#2)
portrait##16##1##(1992-1#1)(2004-9#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-12#2)(2008-2#2)(2009-1#1)(2009-7#2)(2010-9#1)(2012-2#2)
portray a##3##2##(1992-4#1)(1996-3#1)(2007-12#1)
portray the##3##2##(1993-2#1)(2005-11#1)(2009-10#1)
portray##14##1##(1992-4#1)(1993-2#1)(1995-1#1)(1996-3#1)(2005-11#1)(2006-7#1)(2007-12#1)(2007-6#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-10#1)(2012-3#1)
portrayal of the##3##3##(2007-12#1)(2009-9#1)(2012-3#1)
portrayal of##9##2##(2005-12#2)(2007-12#2)(2008-12#1)(2009-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
portrayal##10##1##(2005-12#2)(2007-12#2)(2008-12#1)(2009-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
portrayals of##2##2##(2011-1#1)(2011-2#1)
portrayals##5##1##(2009-4#1)(2011-1#3)(2011-2#1)
portrayed as##2##2##(1996-6#1)(2005-2#1)
portrayed in##3##2##(2006-12#1)(2007-7#1)(2010-9#1)
portrayed##8##1##(1996-6#1)(2005-2#1)(2006-12#1)(2007-7#1)(2008-11#1)(2010-5#1)(2010-9#1)(2011-2#1)
portrays the##3##2##(1995-12#1)(2012-12#1)(2013-1#1)
portrays##7##1##(1995-12#1)(2007-11#1)(2008-4#1)(2011-2#2)(2012-12#1)(2013-1#1)
ports and##6##2##(2007-2#1)(2007-8#1)(2008-11#1)(2008-9#1)(2012-12#2)
ports are##2##2##(2008-3#1)(2012-12#1)
ports in##2##2##(2007-11#1)(2011-2#1)
ports is##3##2##(2007-8#1)(2011-2#1)(2012-12#1)
ports of entry##2##3##(2008-1#1)(2008-4#1)
ports of##3##2##(2008-1#1)(2008-2#1)(2008-4#1)
ports were placed##2##3##(2006-6#1)(2007-7#1)
ports were##3##2##(2006-6#1)(2007-7#1)(2007-8#1)
ports##41##1##(2006-6#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#1)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#2)(2008-9#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#8)(2012-12#4)
portside##2##1##(1995-9#2)
portuguese##3##1##(2011-1#1)(2013-1#2)
posaconazole##10##1##(2008-5#4)(2009-6#1)(2009-9#1)(2010-11#4)
posatirelin##4##1##(2008-7#4)
poschiavinus##2##1##(1995-11#2)
pose a barrier to##2##4##(1996-2#1)(2008-7#1)
pose a challenge to##4##4##(2009-10#1)(2011-1#1)(2013-1#2)
pose a challenge##8##3##(2007-8#1)(2009-10#1)(2010-3#1)(2010-9#1)(2011-1#1)(2013-1#3)
pose a diagnostic challenge##2##4##(2009-3#1)(2013-1#1)
pose a diagnostic##3##3##(2009-3#1)(2011-1#1)(2013-1#1)
pose a difficult##2##3##(2007-11#1)(2007-8#1)
pose a health risk##4##4##(1992-2#1)(1994-6#1)(2007-1#1)(2010-12#1)
pose a major threat##2##4##(2006-10#2)
pose a major##3##3##(1994-7#1)(2006-10#2)
pose a potential##2##3##(2007-2#1)(2008-5#1)
pose a problem##4##3##(1993-11#1)(2008-11#1)(2010-6#1)(2013-7#1)
pose a risk for##2##4##(2008-12#1)(2009-9#1)
pose a risk of##3##4##(2010-3#1)(2010-9#1)(2011-2#1)
pose a risk##5##3##(2008-12#1)(2009-9#1)(2010-3#1)(2010-9#1)(2011-2#1)
pose a serious##5##3##(1991-1#1)(1994-3#1)(2008-1#1)(2009-4#1)(2011-2#1)
pose a significant##4##3##(2005-6#1)(2010-6#1)(2013-7#1)(2013-8#1)
pose a threat##2##3##(2007-8#1)(2010-1#1)
pose a##56##2##(1991-1#1)(1992-2#1)(1993-11#1)(1994-3#1)(1994-6#1)(1994-7#1)(1996-2#1)(1996-3#1)(2005-11#1)(2005-6#1)(2006-10#2)(2006-2#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#2)(2010-6#2)(2010-9#2)(2011-1#3)(2011-2#2)(2012-12#1)(2013-1#5)(2013-7#2)(2013-8#1)
pose an##3##2##(2008-10#2)(2013-1#1)
pose any##6##2##(2007-10#1)(2008-10#1)(2008-7#1)(2009-5#1)(2012-12#1)(2012-3#1)
pose challenges to##2##3##(1993-3#1)(2005-8#1)
pose challenges##3##2##(1993-3#1)(2005-8#1)(2008-11#1)
pose challenging##2##2##(2006-12#1)(2009-3#1)
pose estimation##3##2##(2008-2#2)(2008-6#1)
pose for##3##2##(1991-12#1)(2006-11#1)(2010-6#1)
pose problems##2##2##(1991-12#1)(2007-7#1)
pose significant##4##2##(1996-12#1)(2007-1#1)(2011-12#1)(2013-8#1)
pose special##2##2##(2005-7#1)(2007-10#1)
pose the##6##2##(2005-12#1)(2007-1#1)(2008-9#1)(2009-9#1)(2012-2#1)(2013-1#1)
pose to##3##2##(2007-2#1)(2008-10#1)(2010-6#1)
pose un problème##2##3##(2011-2#1)(2013-1#1)
pose##131##1##(1990-11#1)(1991-1#1)(1991-12#2)(1992-2#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-3#2)(1994-6#1)(1994-7#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2007-1#3)(2007-10#3)(2007-11#3)(2007-12#1)(2007-2#4)(2007-4#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#6)(2008-7#4)(2008-9#2)(2009-10#1)(2009-12#3)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-5#1)(2010-6#5)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#9)(2013-7#3)(2013-8#2)
posed a serious##2##3##(2010-8#1)(2010-9#1)
posed a##9##2##(1990-6#1)(2005-8#1)(2006-11#1)(2007-11#1)(2009-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-8#1)
posed and##2##2##(2008-7#1)(2010-3#1)
posed by a##2##3##(1996-2#1)(2008-10#1)
posed by the##9##3##(1995-11#1)(2004-12#1)(2007-4#1)(2007-8#1)(2008-4#1)(2008-9#1)(2009-9#1)(2010-3#1)(2012-3#1)
posed by##38##2##(1990-2#1)(1990-9#1)(1991-12#1)(1991-3#2)(1992-2#1)(1993-5#1)(1995-1#1)(1995-11#2)(1996-2#1)(2004-12#1)(2005-8#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
posed to the##4##3##(2007-9#1)(2008-11#1)(2008-12#2)
posed to##7##2##(2007-12#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-12#2)
posed##80##1##(1990-2#1)(1990-6#1)(1990-9#1)(1991-12#2)(1991-3#2)(1992-2#2)(1993-2#1)(1993-5#1)(1995-1#1)(1995-11#2)(1995-8#1)(1996-2#1)(2004-12#1)(2005-8#2)(2006-11#1)(2006-12#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#3)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-12#1)(2009-4#3)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-8#1)(2010-9#2)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
poses a challenge for##3##4##(2007-11#1)(2008-9#1)(2010-5#1)
poses a challenge to##6##4##(1994-12#1)(1995-2#1)(2010-12#1)(2010-3#2)(2012-2#1)
poses a challenge##9##3##(1994-12#1)(1995-2#1)(2007-11#1)(2008-9#1)(2010-12#1)(2010-3#2)(2010-5#1)(2012-2#1)
poses a great challenge##3##4##(2008-7#1)(2011-1#1)(2012-12#1)
poses a major public health problem##2##6##(2005-11#1)(2010-12#1)
poses a major public health##3##5##(2005-11#1)(2010-12#1)(2011-2#1)
poses a major##6##3##(2005-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-12#1)(2011-2#1)
poses a potential##2##3##(1996-8#1)(2012-2#1)
poses a risk##2##3##(2012-3#1)(2013-8#1)
poses a serious##2##3##(2008-7#1)(2011-2#1)
poses a significant##2##3##(2005-6#1)(2013-1#1)
poses a##47##2##(1990-2#1)(1992-1#1)(1994-11#1)(1994-12#1)(1995-2#1)(1996-11#1)(1996-8#1)(2005-11#1)(2005-6#1)(2005-8#1)(2006-7#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#2)(2008-9#2)(2009-9#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
poses additional technical challenges##2##4##(2013-1#2)
poses additional##4##2##(2008-3#1)(2008-4#1)(2013-1#2)
poses an##3##2##(2007-12#1)(2008-4#1)(2009-2#1)
poses challenges##4##2##(1994-6#1)(1996-2#1)(2010-6#1)(2013-1#1)
poses considerable##2##2##(2005-11#1)(2010-5#1)
poses difficulties##2##2##(1997-2#1)(2005-7#1)
poses great##4##2##(2007-11#1)(2009-6#1)(2012-11#2)
poses many##2##2##(1990-3#1)(2009-12#1)
poses multiple challenges##2##3##(2012-2#1)(2013-1#1)
poses new##2##2##(2008-10#1)(2008-7#1)
poses particular##2##2##(2005-8#1)(2010-12#1)
poses problems in##2##3##(2006-9#1)(2007-8#1)
poses problems##3##2##(2006-12#1)(2006-9#1)(2007-8#1)
poses several challenges##4##3##(2009-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
poses significant challenges##2##3##(2009-10#1)(2013-1#1)
poses significant##4##2##(2007-8#1)(2009-10#1)(2009-4#1)(2013-1#1)
poses some problems##2##3##(2008-10#1)(2012-2#1)
poses the problem of##2##4##(1996-3#1)(2006-10#1)
poses the question##2##3##(2008-8#1)(2010-12#1)
poses the##5##2##(1996-3#1)(2006-10#1)(2008-11#1)(2008-8#1)(2010-12#1)
poses unique##2##2##(2006-10#1)(2013-1#1)
poses##119##1##(1990-2#1)(1990-3#1)(1991-3#1)(1992-1#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-2#1)(2005-11#2)(2005-6#1)(2005-7#1)(2005-8#3)(2006-10#3)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#4)(2008-10#5)(2008-11#5)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#6)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#8)(2012-3#2)(2013-1#9)(2013-8#2)
posing a risk of shocks##2##5##(2011-1#1)(2011-2#1)
posing a##9##2##(1990-10#1)(1994-1#1)(2006-4#1)(2007-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#1)
posing problems##2##2##(1994-9#1)(2007-11#1)
posing the##3##2##(2008-11#1)(2008-12#1)(2010-9#1)
posing##21##1##(1990-10#1)(1994-1#1)(1994-9#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-12#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#2)
posit that this##2##3##(2011-1#1)(2013-1#1)
posit that##5##2##(1994-12#1)(2009-10#1)(2010-4#1)(2011-1#1)(2013-1#1)
posit##6##1##(1994-12#1)(2008-5#1)(2009-10#1)(2010-4#1)(2011-1#1)(2013-1#1)
posited as##2##2##(2008-10#1)(2010-11#1)
posited that##2##2##(2008-12#1)(2012-12#1)
posited##7##1##(1997-8#1)(2008-10#1)(2008-12#1)(2010-11#1)(2010-2#1)(2012-12#1)(2012-3#1)
position (4 cm to -8 cm)##2##6##(2006-8#2)
position (P &lt##2##3##(1993-10#2)
position -1##4##2##(1991-10#1)(1992-2#1)(1993-3#1)(1996-9#1)
position -11377C &gt##3##3##(2011-1#3)
position 10##3##2##(1995-1#2)(1997-4#1)
position 11 of protein##2##4##(1997-4#2)
position 11##4##2##(1991-2#1)(1994-3#1)(1997-4#2)
position 12##3##2##(1990-2#1)(1990-5#1)(1991-9#1)
position 13 of the##2##4##(1991-7#2)
position 13##4##2##(1990-2#1)(1991-12#1)(1991-7#2)
position 14##2##2##(1992-9#1)(1995-8#1)
position 143##4##2##(2008-10#4)
position 147##2##2##(2008-8#1)(2012-2#1)
position 198##2##2##(2005-11#1)(2008-10#1)
position 2##9##2##(1991-12#1)(1991-2#1)(1992-6#1)(1993-11#1)(1994-3#1)(1994-9#1)(1995-8#1)(1996-5#1)(1996-8#1)
position 205##2##2##(1994-8#1)(1995-2#1)
position 3 increases lipofilicity##2##4##(2005-10#2)
position 3 of the##3##4##(1994-8#1)(1996-10#1)(2007-11#1)
position 3 of##4##3##(1992-9#1)(1994-8#1)(1996-10#1)(2007-11#1)
position 3##12##2##(1991-11#1)(1992-9#2)(1993-6#1)(1994-8#1)(1995-1#1)(1996-10#1)(1997-3#1)(1997-7#1)(2005-10#2)(2007-11#1)
position 30##3##2##(1992-8#3)
position 3271##2##2##(1993-12#2)
position 33##4##2##(1991-11#1)(1991-12#1)(1993-8#1)(1996-5#1)
position 381##2##2##(1990-3#2)
position 383##2##2##(1994-11#1)(2008-3#1)
position 4##6##2##(1990-8#1)(1991-9#1)(1995-3#1)(1996-5#1)(2006-12#1)(2013-8#1)
position 49##3##2##(1995-8#1)(2007-12#1)(2011-2#1)
position 5##2##2##(1991-3#1)(1997-3#1)
position 53##4##2##(1994-8#4)
position 57##4##2##(1991-2#1)(1991-7#2)(2005-10#1)
position 6 of##3##3##(1991-3#1)(1991-7#1)(2008-4#1)
position 6##9##2##(1991-3#1)(1991-7#1)(1994-3#2)(1994-8#1)(1995-3#1)(1995-5#2)(2008-4#1)
position 65##3##2##(1991-7#2)(1997-7#1)
position 7##6##2##(1991-2#1)(1992-2#1)(1994-2#1)(1995-2#1)(1995-3#1)(2006-12#1)
position 80##2##2##(1994-8#1)(2008-11#1)
position B##2##2##(1997-3#1)(1997-8#1)
position a##12##2##(1992-6#3)(1993-3#4)(1994-3#1)(2007-5#3)(2008-2#1)
position accuracy of##2##3##(2008-2#1)(2008-3#1)
position accuracy##3##2##(1994-3#1)(2008-2#1)(2008-3#1)
position after##3##2##(1992-1#1)(2006-6#1)(2008-10#1)
position against##2##2##(2006-8#1)(2007-12#1)
position along the##6##3##(1997-4#1)(2006-3#1)(2007-3#1)(2008-1#1)(2008-2#1)(2008-6#1)
position along##7##2##(1997-4#1)(2006-3#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-6#1)
position among##6##2##(1992-11#1)(1993-3#1)(1995-6#1)(2006-10#1)(2008-11#1)(2009-8#1)
position and extent##2##3##(2008-2#1)(2011-2#1)
position and movement##2##3##(1996-9#1)(2012-1#1)
position and orientation of##2##4##(2006-6#1)(2010-4#1)
position and orientation##7##3##(1993-6#1)(2006-6#1)(2008-1#1)(2008-3#1)(2010-4#2)(2012-1#1)
position and shape of##2##4##(2008-10#1)(2012-1#1)
position and shape##5##3##(2008-10#1)(2008-2#1)(2008-9#1)(2012-1#1)(2013-7#1)
position and the##12##3##(1990-6#1)(1991-2#1)(1996-8#1)(2007-12#1)(2008-2#3)(2008-3#2)(2008-5#1)(2011-1#1)(2012-12#1)
position and then##3##3##(1996-1#1)(2005-10#1)(2008-12#1)
position and velocity##3##3##(1991-3#1)(2008-3#2)
position and width of the##2##5##(1991-5#1)(1992-12#1)
position and##116##2##(1990-12#2)(1990-6#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-11#2)(1992-12#1)(1992-4#3)(1992-8#1)(1993-12#1)(1993-6#2)(1993-7#1)(1994-12#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#3)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(2004-3#1)(2004-7#1)(2005-10#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-11#3)(2007-12#8)(2007-5#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#9)(2008-3#10)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#2)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-7#1)(2011-1#5)(2011-2#2)(2012-1#4)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#2)
position are##8##2##(1993-3#1)(1997-1#1)(2005-8#1)(2007-7#1)(2008-1#1)(2008-2#1)(2013-1#1)(2013-8#1)
position as a##3##3##(2007-9#1)(2009-11#1)(2009-4#1)
position as compared with##3##4##(1992-11#1)(1993-1#1)(2008-6#1)
position as the##4##3##(1996-6#1)(2006-10#1)(2008-5#1)(2010-3#1)
position as##21##2##(1990-2#1)(1990-7#1)(1992-11#2)(1993-1#1)(1993-2#1)(1994-9#1)(1996-3#1)(1996-6#1)(2005-4#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-9#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-4#1)(2010-10#1)(2010-3#1)
position at the##2##3##(2004-3#1)(2010-5#1)
position at##8##2##(1993-8#1)(2004-3#1)(2008-10#3)(2008-6#1)(2010-5#1)(2011-2#1)
position between the##2##3##(1990-3#1)(2008-3#1)
position between##7##2##(1990-3#1)(1991-8#1)(1992-4#1)(1997-6#1)(2007-12#1)(2008-3#2)
position but##2##2##(2012-2#2)
position by a##2##3##(2009-11#1)(2011-1#1)
position by the##2##3##(1993-9#1)(2012-12#1)
position by##10##2##(1992-11#2)(1993-3#1)(1993-9#1)(1997-2#1)(2008-3#1)(2009-11#2)(2011-1#1)(2012-12#1)
position can##5##2##(1996-9#1)(2008-11#1)(2008-2#1)(2009-5#1)(2013-7#1)
position changes##3##2##(1993-1#1)(2007-12#1)(2009-4#1)
position control##7##2##(1994-2#1)(1995-8#1)(2008-1#1)(2010-3#1)(2011-1#1)(2012-1#2)
position corresponding to##6##3##(1990-2#1)(1991-11#1)(1991-12#1)(1991-9#1)(1993-3#1)(1996-5#1)
position cues##2##2##(1993-9#2)
position d##8##2##(1992-6#3)(1993-3#5)
position during##11##2##(1992-11#1)(1993-1#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-2#2)(2013-7#1)(2013-8#1)
position effect##2##2##(2005-6#1)(2011-2#1)
position emission tomography##2##3##(1995-1#1)(2009-5#1)
position for the##4##3##(1995-5#1)(2007-8#1)(2008-4#1)(2011-2#1)
position for##25##2##(1990-5#1)(1992-4#1)(1993-7#1)(1994-5#1)(1995-5#1)(1995-9#1)(1996-3#1)(2007-12#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-4#1)(2008-5#1)(2009-11#1)(2010-9#1)(2011-12#1)(2011-2#3)
position from the##4##3##(1990-2#1)(1992-4#1)(1994-11#1)(2007-8#1)
position from##6##2##(1990-2#1)(1992-4#1)(1994-11#1)(1995-3#1)(2007-8#1)(2012-3#1)
position has##3##2##(1991-2#1)(1994-11#1)(1997-4#1)
position in a##4##3##(2008-2#1)(2008-7#1)(2011-2#1)(2013-7#1)
position in an##2##3##(2007-5#1)(2013-8#1)
position in human##2##3##(1991-2#1)(1997-4#1)
position in relation to the##7##5##(1995-5#2)(2006-8#2)(2008-10#1)(2008-9#1)(2013-7#1)
position in relation to##8##4##(1995-5#2)(2006-8#3)(2008-10#1)(2008-9#1)(2013-7#1)
position in space##2##3##(1997-1#1)(2012-1#1)
position in the##39##3##(1990-8#1)(1991-2#1)(1991-8#1)(1992-4#1)(1993-1#1)(1993-12#2)(1994-12#2)(1995-8#1)(1996-1#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-6#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#4)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-4#1)(2009-5#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
position in this##3##3##(2005-11#1)(2007-11#1)(2011-1#1)
position in##92##2##(1990-2#1)(1990-8#2)(1991-2#2)(1991-3#1)(1991-8#1)(1992-4#1)(1993-1#1)(1993-12#2)(1994-12#2)(1994-3#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-7#1)(2006-8#5)(2007-1#1)(2007-11#5)(2007-12#5)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#2)(2013-7#2)(2013-8#2)
position information##5##2##(1993-9#1)(2006-4#1)(2008-2#1)(2009-10#1)(2012-2#1)
position is determined##2##3##(2007-12#1)(2008-8#1)
position is in##2##3##(1990-6#1)(2010-3#1)
position is##24##2##(1990-11#1)(1990-6#1)(1991-10#1)(1993-1#1)(1993-6#1)(1996-1#1)(1996-10#1)(1996-5#1)(1996-9#1)(1997-1#1)(2006-11#1)(2007-1#1)(2007-12#4)(2007-6#1)(2007-8#1)(2008-3#3)(2008-7#1)(2008-8#1)(2010-3#1)
position may be##4##3##(1992-4#1)(2006-8#1)(2008-12#1)(2008-4#1)
position may##8##2##(1992-4#1)(1996-12#1)(2006-4#1)(2006-8#1)(2007-8#2)(2008-12#1)(2008-4#1)
position measurement of##2##3##(1993-5#1)(2010-4#1)
position measurement##5##2##(1993-5#1)(2007-11#1)(2008-3#1)(2010-4#2)
position of 45##2##3##(2004-9#1)(2013-8#1)
position of a##14##3##(1990-4#1)(1994-12#1)(1994-8#1)(1995-5#1)(1997-7#1)(2005-11#1)(2006-6#1)(2007-7#1)(2008-2#3)(2008-3#2)(2008-4#1)
position of adenosine##3##3##(2008-4#3)
position of amino acid##2##4##(1990-12#1)(2008-8#1)
position of an##2##3##(2006-12#1)(2008-4#1)
position of each of the##2##5##(1991-7#1)(1994-5#1)
position of each##5##3##(1991-7#1)(1994-5#1)(2007-11#1)(2007-12#1)(2009-5#1)
position of free##2##3##(1990-12#1)(2007-1#1)
position of individual myosin heads##2##5##(1997-4#2)
position of individual##3##3##(1997-4#2)(2008-2#1)
position of its##2##3##(2007-4#1)(2008-3#1)
position of nurse cell nuclei##2##5##(2007-12#2)
position of soybean##2##3##(2012-11#2)
position of the catheter tip##4##5##(2007-7#4)
position of the central##2##4##(1992-3#1)(2008-8#1)
position of the edge##2##4##(1994-9#1)(2008-3#1)
position of the family##2##4##(1992-1#1)(2008-6#1)
position of the heterologous domain##2##5##(1996-7#2)
position of the inhibitor##2##4##(1992-11#1)(1995-1#1)
position of the inositol ring##2##5##(1993-6#1)(2010-9#1)
position of the patient##2##4##(2007-5#1)(2013-1#1)
position of the phenyl ring##2##5##(1995-11#1)(2013-1#1)
position of the sun and associated celestial##2##7##(1994-3#2)
position of the target##2##4##(2008-4#2)
position of the tip##3##4##(2007-12#1)(2007-7#2)
position of the##217##3##(1990-12#1)(1991-1#1)(1991-10#1)(1991-3#1)(1991-4#1)(1991-7#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-6#2)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#4)(1993-7#1)(1994-11#2)(1994-2#1)(1994-3#3)(1994-9#3)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#3)(1995-4#1)(1995-6#2)(1995-8#2)(1996-11#1)(1996-12#1)(1996-5#2)(1996-6#3)(1996-7#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(2004-11#1)(2004-9#3)(2005-11#2)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#4)(2006-3#1)(2006-4#1)(2006-5#4)(2006-7#1)(2006-8#1)(2007-11#6)(2007-12#11)(2007-4#3)(2007-5#3)(2007-7#7)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#17)(2008-3#24)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-9#2)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
position of their##2##3##(2007-11#1)(2008-11#1)
position of this##2##3##(2008-5#1)(2009-2#1)
position of which is##2##4##(2007-11#1)(2008-1#1)
position of##379##2##(1990-12#5)(1990-2#1)(1990-4#1)(1990-5#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-6#1)(1991-7#4)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#3)(1992-9#1)(1993-1#1)(1993-11#2)(1993-3#3)(1993-6#6)(1993-7#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#5)(1995-1#3)(1995-10#3)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#3)(1995-8#3)(1996-1#1)(1996-11#2)(1996-12#1)(1996-5#2)(1996-6#3)(1996-7#3)(1996-8#2)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#4)(1997-5#1)(1997-7#5)(2004-11#1)(2004-9#4)(2005-10#1)(2005-11#4)(2005-4#1)(2005-5#2)(2005-7#2)(2005-8#1)(2006-10#4)(2006-12#6)(2006-3#1)(2006-4#1)(2006-5#4)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-11#14)(2007-12#15)(2007-4#4)(2007-5#3)(2007-7#8)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#15)(2008-11#3)(2008-12#2)(2008-2#25)(2008-3#30)(2008-4#12)(2008-5#12)(2008-6#2)(2008-7#3)(2008-8#6)(2008-9#1)(2009-10#2)(2009-2#3)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#3)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#9)(2011-7#1)(2012-1#2)(2012-11#3)(2012-12#6)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#2)
position on body sway##2##4##(2007-4#2)
position on the##20##3##(1991-2#1)(1991-4#1)(1992-11#1)(1995-12#1)(1995-9#1)(1996-8#1)(2006-11#1)(2007-12#1)(2007-4#1)(2007-6#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-9#1)(2012-2#1)(2013-1#1)
position on##38##2##(1991-2#1)(1991-4#1)(1992-11#1)(1993-12#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-6#1)(1996-8#1)(1997-2#1)(2006-11#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-4#3)(2007-6#3)(2007-9#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-9#1)(2012-2#1)(2013-1#2)
position or##8##2##(1995-1#1)(2006-12#1)(2007-4#1)(2008-10#1)(2008-12#1)(2012-12#2)(2012-2#1)
position paper on##2##3##(2013-1#1)(2013-8#1)
position paper##11##2##(1990-12#2)(1996-1#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
position papers##5##2##(1996-1#3)(2007-2#2)
position parameters##2##2##(2008-2#1)(2008-7#1)
position rather than##2##3##(1992-4#1)(2008-2#1)
position relative to the##5##4##(1990-8#1)(2006-6#1)(2006-8#1)(2008-1#1)(2008-4#1)
position relative to##6##3##(1990-8#1)(2006-6#1)(2006-8#1)(2007-5#1)(2008-1#1)(2008-4#1)
position sense in the##3##4##(2012-1#3)
position sense in##5##3##(2006-3#1)(2012-1#4)
position sense of the##2##4##(2012-1#2)
position sense##12##2##(2006-3#1)(2012-1#9)(2012-3#2)
position sensitive detector##3##3##(2008-10#3)
position sensitive##4##2##(2008-10#4)
position sensors##2##2##(2008-3#1)(2009-9#1)
position shifting of##2##3##(2008-2#1)(2008-3#1)
position shifts##2##2##(2007-11#1)(2009-1#1)
position should be##2##3##(2006-10#1)(2006-8#1)
position show##2##2##(1993-5#1)(2013-8#1)
position significantly##2##2##(1991-7#1)(1992-4#1)
position specific##2##2##(1997-7#1)(2008-11#1)
position statement##5##2##(2006-3#1)(2007-12#1)(2007-4#1)(2008-7#1)(2012-12#1)
position statements##2##2##(2005-8#1)(2006-12#1)
position that can be##2##4##(2007-8#1)(2009-5#1)
position that is##3##3##(2007-12#1)(2008-11#1)(2008-9#1)
position that maximizes##2##3##(2007-12#1)(2008-2#1)
position that the##2##3##(1993-3#1)(2008-12#1)
position that##15##2##(1993-3#1)(1994-9#1)(2005-7#1)(2006-2#1)(2006-7#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-5#1)(2010-12#1)(2013-7#1)
position the##11##2##(1990-10#1)(1990-8#1)(1993-8#1)(1995-5#1)(2006-3#1)(2006-8#1)(2007-5#1)(2007-8#1)(2008-9#1)(2009-8#1)(2012-1#1)
position their##3##2##(1994-3#1)(1996-3#1)(1997-1#1)
position themselves##4##2##(1992-6#1)(1994-12#1)(1994-8#1)(1997-1#1)
position to assess##2##3##(2007-12#1)(2011-2#1)
position to detect##3##3##(2007-10#1)(2007-6#1)(2007-9#1)
position to influence##2##3##(2006-10#1)(2006-8#1)
position to play##2##3##(1990-12#1)(2007-2#1)
position to provide##3##3##(1996-1#1)(2007-7#1)(2008-12#1)
position to the##7##3##(1992-9#1)(1993-1#1)(1994-11#1)(1995-3#1)(1996-12#1)(1996-6#2)
position to##57##2##(1990-12#1)(1991-12#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-3#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#2)(1996-8#1)(1997-1#1)(1997-6#2)(2005-8#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-2#4)(2007-3#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-11#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)
position under##2##2##(1995-4#1)(2012-2#1)
position was not##3##3##(2005-11#1)(2007-4#1)(2008-11#1)
position was##24##2##(1991-4#1)(1992-11#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-7#1)(1993-9#1)(1997-4#1)(1997-6#1)(2005-11#1)(2007-4#2)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#3)(2009-11#1)(2009-8#1)(2013-7#1)
position were##8##2##(1990-11#1)(1993-5#1)(1993-6#1)(2006-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)
position when##2##2##(1997-1#1)(2008-2#1)
position which##3##2##(2011-2#1)(2012-12#2)
position while##2##2##(2008-5#1)(2009-3#1)
position with respect to the##5##5##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)
position with the##4##3##(2007-1#1)(2008-10#1)(2008-12#1)(2012-3#1)
position with##14##2##(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#2)(2011-2#1)(2012-3#1)(2013-7#1)
position within the##12##3##(1990-11#1)(1993-11#1)(1993-12#1)(1994-8#1)(1995-11#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-9#1)(2011-2#2)(2013-7#1)
position within##16##2##(1990-11#1)(1993-11#1)(1993-12#1)(1994-8#1)(1995-11#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-3#1)(2011-2#2)(2013-1#1)(2013-7#1)
position##1871##1##(1990-10#4)(1990-11#4)(1990-12#17)(1990-2#11)(1990-3#7)(1990-4#4)(1990-5#11)(1990-6#4)(1990-7#7)(1990-8#9)(1990-9#1)(1991-1#4)(1991-10#4)(1991-11#6)(1991-12#9)(1991-2#18)(1991-3#5)(1991-4#7)(1991-5#3)(1991-6#1)(1991-7#15)(1991-8#3)(1991-9#10)(1992-1#5)(1992-10#2)(1992-11#22)(1992-12#3)(1992-2#3)(1992-3#8)(1992-4#13)(1992-5#1)(1992-6#16)(1992-7#3)(1992-8#8)(1992-9#8)(1993-1#11)(1993-10#6)(1993-11#9)(1993-12#14)(1993-2#3)(1993-3#21)(1993-5#6)(1993-6#14)(1993-7#6)(1993-8#6)(1993-9#7)(1994-1#1)(1994-11#12)(1994-12#10)(1994-2#5)(1994-3#17)(1994-5#9)(1994-6#3)(1994-7#1)(1994-8#26)(1994-9#15)(1995-1#15)(1995-10#3)(1995-11#9)(1995-12#9)(1995-2#13)(1995-3#11)(1995-4#3)(1995-5#11)(1995-6#10)(1995-7#2)(1995-8#21)(1995-9#3)(1996-1#14)(1996-10#5)(1996-11#5)(1996-12#4)(1996-2#6)(1996-3#3)(1996-4#3)(1996-5#13)(1996-6#15)(1996-7#6)(1996-8#8)(1996-9#11)(1997-1#14)(1997-2#10)(1997-3#13)(1997-4#18)(1997-5#3)(1997-6#11)(1997-7#18)(1997-8#6)(2004-11#1)(2004-12#3)(2004-3#2)(2004-7#1)(2004-9#4)(2005-10#7)(2005-11#10)(2005-4#4)(2005-5#3)(2005-6#1)(2005-7#4)(2005-8#4)(2006-1#1)(2006-10#12)(2006-11#8)(2006-12#16)(2006-2#3)(2006-3#6)(2006-4#4)(2006-5#8)(2006-6#8)(2006-7#4)(2006-8#18)(2006-9#1)(2007-1#9)(2007-10#3)(2007-11#35)(2007-12#61)(2007-2#15)(2007-3#6)(2007-4#16)(2007-5#15)(2007-6#10)(2007-7#18)(2007-8#33)(2007-9#9)(2008-1#16)(2008-10#66)(2008-11#29)(2008-12#25)(2008-2#72)(2008-3#85)(2008-4#28)(2008-5#25)(2008-6#14)(2008-7#20)(2008-8#23)(2008-9#19)(2009-1#1)(2009-10#13)(2009-11#8)(2009-12#4)(2009-2#7)(2009-3#14)(2009-4#6)(2009-5#9)(2009-6#1)(2009-7#1)(2009-8#6)(2009-9#4)(2010-10#5)(2010-11#2)(2010-12#7)(2010-2#5)(2010-3#13)(2010-4#8)(2010-5#2)(2010-6#2)(2010-7#4)(2010-8#3)(2010-9#4)(2011-1#20)(2011-12#2)(2011-2#36)(2011-7#2)(2012-1#28)(2012-11#5)(2012-12#18)(2012-2#26)(2012-3#16)(2013-1#20)(2013-7#14)(2013-8#16)
position) and##2##2##(2008-4#1)(2010-11#1)
position)##9##1##(1997-2#1)(2004-11#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-11#1)
position-dependent##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
position-independent##2##1##(1996-10#1)(2008-7#1)
position-sensing##3##1##(2007-12#1)(2008-3#1)(2009-6#1)
position-sensitive detectors##3##2##(2008-3#3)
position-sensitive device##2##2##(2008-2#1)(2008-5#1)
position-sensitive devices##3##2##(2008-2#3)
position-sensitive##16##1##(2006-4#1)(2007-11#2)(2007-12#1)(2008-2#7)(2008-3#4)(2008-5#1)
position]##4##1##(1991-5#1)(1992-11#1)(1992-4#1)(1993-9#1)
positional and##5##2##(2006-10#1)(2008-10#1)(2008-2#1)(2009-2#1)(2009-4#1)
positional atrial##3##2##(2009-4#3)
positional changes##2##2##(2007-7#1)(2013-8#1)
positional cloning approach##2##3##(1995-6#1)(2008-2#1)
positional cloning of the##4##4##(2008-10#2)(2008-7#2)
positional cloning of##6##3##(2008-1#1)(2008-10#3)(2008-7#2)
positional cloning##16##2##(1995-6#1)(1996-5#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)
positional control of the##2##4##(2010-4#1)(2013-8#1)
positional disorder##2##2##(1996-4#1)(2008-10#1)
positional effect##2##2##(1993-3#1)(1996-4#1)
positional effects##4##2##(1993-3#1)(1995-5#1)(2008-3#1)(2008-4#1)
positional enrichment##3##2##(2009-5#3)
positional errors##2##2##(2008-3#1)(2009-5#1)
positional fluctuation##2##2##(2006-10#2)
positional information##6##2##(1993-6#1)(2007-6#2)(2007-8#1)(2008-7#1)(2013-8#1)
positional isomer##2##2##(1990-11#1)(2008-4#1)
positional isomers of##4##3##(1991-2#1)(1992-8#1)(1995-11#1)(1997-2#1)
positional isomers##12##2##(1991-2#1)(1992-3#1)(1992-8#1)(1995-11#1)(1996-8#2)(1997-2#1)(2008-10#4)(2011-1#1)
positional isotope exchange##2##3##(1991-4#2)
positional plagiocephaly##2##2##(2007-12#2)
positional vertigo##11##2##(2008-4#5)(2011-1#1)(2012-12#1)(2012-2#3)(2013-1#1)
positional##117##1##(1990-11#1)(1991-2#1)(1991-3#1)(1991-4#4)(1992-11#1)(1992-3#1)(1992-8#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-4#3)(1996-5#2)(1996-6#1)(1996-8#2)(1997-2#1)(1997-5#1)(1997-6#1)(2005-8#1)(2006-10#3)(2006-6#1)(2007-1#1)(2007-12#5)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#12)(2008-7#5)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#4)(2009-5#4)(2010-4#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#3)
positioned alongside##2##2##(2007-11#1)(2009-4#1)
positioned and##4##2##(2007-7#1)(2007-8#1)(2008-10#1)(2012-12#1)
positioned as##4##2##(2007-7#1)(2008-3#1)(2008-8#1)(2013-1#1)
positioned at a##2##3##(1993-11#1)(2008-3#1)
positioned at the##10##3##(1994-12#1)(1995-8#1)(1997-6#1)(1997-7#1)(2006-6#1)(2008-10#3)(2008-3#1)(2008-5#1)
positioned at##18##2##(1992-8#1)(1993-11#1)(1994-12#1)(1995-8#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-12#1)(2008-10#4)(2008-3#4)(2008-5#1)(2012-11#1)
positioned between##4##2##(1990-3#1)(1994-11#1)(1996-9#1)(1997-7#1)
positioned in a##3##3##(2007-1#1)(2007-11#1)(2011-2#1)
positioned in the left##2##4##(1997-1#1)(2008-10#1)
positioned in the##10##3##(1990-11#1)(1991-2#1)(1997-1#2)(2007-3#1)(2008-10#4)(2013-1#1)
positioned in##18##2##(1990-11#1)(1991-2#1)(1997-1#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#5)(2011-1#2)(2011-2#2)(2013-1#1)
positioned near##2##2##(1995-6#1)(2012-1#1)
positioned on the##6##3##(1996-11#1)(1997-9#1)(2006-3#1)(2006-7#1)(2007-12#1)(2008-10#1)
positioned on##9##2##(1996-11#1)(1996-12#1)(1997-9#1)(2006-3#1)(2006-7#1)(2007-12#1)(2008-10#3)
positioned opposite dC in the##2##5##(1996-7#2)
positioned opposite dT intercalates to the##2##6##(1995-1#2)
positioned opposite dT##3##3##(1995-1#3)
positioned opposite##11##2##(1994-8#1)(1995-1#3)(1995-10#2)(1996-7#2)(2008-10#3)
positioned over##2##2##(1994-9#1)(1996-5#1)
positioned to##14##2##(1992-1#1)(1993-8#1)(1994-12#1)(1996-2#1)(2006-12#1)(2007-4#1)(2007-5#1)(2008-3#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-12#1)
positioned under the##3##3##(1990-2#1)(2012-12#2)
positioned within the##3##3##(2012-12#3)
positioned within##5##2##(1993-8#1)(2008-8#1)(2012-12#3)
positioned##153##1##(1990-11#1)(1990-2#1)(1990-3#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-4#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-8#2)(1994-9#1)(1995-1#3)(1995-10#2)(1995-6#1)(1995-8#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#3)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(1997-9#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-3#1)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#4)(2007-1#2)(2007-11#2)(2007-12#5)(2007-3#2)(2007-4#3)(2007-5#2)(2007-7#3)(2007-8#1)(2008-10#18)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#4)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#8)(2013-1#3)
positioner##2##1##(2008-9#2)
positioners and##2##2##(2010-8#2)
positioners##4##1##(2008-2#1)(2010-8#3)
positioning a##6##2##(1993-11#1)(1993-9#1)(1994-12#1)(2008-6#1)(2013-1#2)
positioning and the##2##3##(1990-4#1)(2007-10#1)
positioning and##21##2##(1990-4#1)(1993-7#1)(1995-10#1)(1996-7#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-7#2)(2007-9#1)(2008-11#1)(2008-7#2)(2009-8#1)(2010-9#2)(2012-12#1)(2013-1#1)
positioning control##2##2##(2007-7#1)(2008-2#1)
positioning for##2##2##(2006-8#1)(2007-6#1)
positioning from##2##2##(2008-3#1)(2008-5#1)
positioning in##5##2##(2006-10#1)(2007-12#1)(2008-3#1)(2010-2#1)(2011-2#1)
positioning is##5##2##(2005-11#1)(2007-5#1)(2008-3#1)(2009-4#1)(2010-3#1)
positioning of a##2##3##(2007-11#1)(2008-2#1)
positioning of the catheter##2##4##(2007-7#1)(2010-8#1)
positioning of the electrodes##2##4##(1997-4#1)(2009-10#1)
positioning of the stimulating electrode##2##5##(2008-9#2)
positioning of the##41##3##(1990-5#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-6#1)(1992-7#1)(1993-6#1)(1996-2#1)(1997-4#1)(2006-11#1)(2006-5#1)(2007-12#2)(2007-4#1)(2007-7#2)(2007-8#3)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-9#3)(2009-10#1)(2009-2#1)(2009-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
positioning of##70##2##(1990-5#1)(1991-12#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-8#3)(1991-9#1)(1992-6#1)(1992-7#1)(1993-6#1)(1995-1#1)(1995-5#1)(1996-2#1)(1997-4#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-7#4)(2007-8#3)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#2)(2009-2#1)(2009-5#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#4)(2013-1#2)
positioning strategies and##2##3##(1993-12#2)
positioning strategies##3##2##(1993-12#3)
positioning system##8##2##(2007-9#1)(2008-10#1)(2008-8#2)(2009-10#1)(2010-5#1)(2010-8#1)(2011-2#1)
positioning systems##2##2##(2008-10#1)(2008-7#1)
positioning the##6##2##(1991-1#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
positioning to##4##2##(1995-8#1)(2006-7#1)(2009-10#1)(2010-2#1)
positioning with##3##2##(1996-11#1)(2008-10#1)(2008-4#1)
positioning##233##1##(1990-4#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-8#3)(1991-9#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-10#1)(1993-11#1)(1993-12#6)(1993-6#1)(1993-7#2)(1993-9#2)(1994-12#1)(1995-1#1)(1995-10#1)(1995-5#1)(1995-8#1)(1996-11#3)(1996-2#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#2)(2004-2#1)(2005-11#2)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#3)(2006-7#2)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-4#2)(2007-5#4)(2007-6#3)(2007-7#12)(2007-8#5)(2007-9#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#13)(2008-3#19)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#8)(2008-9#5)(2009-10#5)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-2#2)(2010-3#9)(2010-4#2)(2010-5#2)(2010-7#3)(2010-8#2)(2010-9#4)(2011-1#4)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#7)
positions +1 and##2##3##(1996-5#1)(1996-9#1)
positions 1##3##2##(1992-1#1)(1994-11#1)(1997-6#1)
positions 12 and##2##3##(1990-3#1)(1991-9#1)
positions 12##4##2##(1990-3#3)(1991-9#1)
positions 2##4##2##(1992-3#1)(1994-3#1)(2006-3#1)(2012-3#1)
positions 22##3##2##(1994-3#2)(2012-12#1)
positions 3 and##2##3##(1991-10#1)(1992-1#1)
positions 3##3##2##(1990-7#1)(1991-10#1)(1992-1#1)
positions 4 and 6##2##4##(1993-11#1)(2007-11#1)
positions 4 and##3##3##(1993-11#1)(2006-12#1)(2007-11#1)
positions 57 and##3##3##(1991-7#2)(1994-5#1)
positions 8##2##2##(1991-7#1)(1993-3#1)
positions a##3##2##(1993-11#1)(1993-3#2)
positions along the##4##3##(2006-10#1)(2008-10#1)(2008-2#1)(2008-6#1)
positions among##2##2##(1992-11#1)(2012-3#1)
positions and for##2##3##(2007-12#1)(2008-3#1)
positions and of##2##3##(1994-1#1)(1996-9#1)
positions and profiles##2##3##(2008-3#2)
positions and the##5##3##(1994-9#1)(2007-4#2)(2009-5#1)(2012-1#1)
positions and##48##2##(1991-11#1)(1992-11#2)(1992-2#1)(1992-7#1)(1993-1#1)(1994-1#2)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-7#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-4#4)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#7)(2008-6#1)(2009-5#1)(2010-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
positions are##9##2##(1990-12#1)(1994-9#1)(1995-2#1)(1995-8#1)(1997-4#1)(2006-12#1)(2007-12#1)(2008-3#1)(2010-6#1)
positions as the##2##3##(1993-6#1)(2007-4#1)
positions as##7##2##(1990-5#1)(1993-6#1)(1994-1#1)(2007-4#1)(2008-8#1)(2009-6#1)(2013-8#1)
positions at##7##2##(1992-11#2)(1995-9#1)(1996-8#1)(2005-8#1)(2007-2#1)(2009-8#1)
positions by##4##2##(1991-7#1)(2008-3#1)(2008-7#1)(2013-8#1)
positions during##4##2##(1991-5#1)(2007-2#1)(2008-1#1)(2008-6#1)
positions for birth that are##2##5##(2007-2#1)(2008-6#1)
positions for birth##5##3##(2007-2#4)(2008-6#1)
positions for junior##2##3##(1995-9#2)
positions for##15##2##(1990-12#1)(1990-6#1)(1991-1#1)(1992-2#1)(1994-8#1)(1995-9#2)(2007-2#4)(2008-3#1)(2008-6#2)(2011-1#1)
positions from##4##2##(1990-2#1)(1990-5#1)(1994-12#1)(1996-7#1)
positions in a##2##3##(2008-10#1)(2008-3#1)
positions in the presence of##2##5##(1997-7#1)(2011-1#1)
positions in the structure##2##4##(1991-4#1)(1992-9#1)
positions in the waveguide##2##4##(2008-3#2)
positions in the##29##3##(1990-5#1)(1991-4#2)(1992-9#1)(1993-11#2)(1993-6#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-7#2)(2007-10#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-6#1)(2011-1#1)
positions in##51##2##(1990-5#1)(1990-6#1)(1990-9#1)(1991-4#2)(1991-6#1)(1992-9#1)(1993-11#2)(1993-6#2)(1993-8#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#2)(1997-7#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-7#1)(2009-11#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#1)
positions is##3##2##(2007-6#1)(2007-8#1)(2008-6#1)
positions of a##3##3##(1995-4#1)(2008-7#1)(2010-2#1)
positions of the bicyclic##2##4##(1996-5#1)(2007-11#1)
positions of the introns##2##4##(1993-11#1)(1993-3#1)
positions of the##53##3##(1990-2#1)(1990-5#2)(1991-4#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#2)(1994-3#1)(1995-3#1)(1995-8#2)(1996-10#1)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-5#2)(2005-11#2)(2006-12#1)(2007-11#4)(2007-12#2)(2008-1#2)(2008-10#4)(2008-2#2)(2008-3#5)(2008-4#3)(2008-8#1)(2009-8#1)(2012-1#3)(2013-1#1)
positions of##114##2##(1990-12#1)(1990-2#2)(1990-5#4)(1991-4#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#2)(1992-6#1)(1993-11#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-3#1)(1995-4#1)(1995-8#3)(1996-10#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#2)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-8#3)(1997-9#1)(2005-11#2)(2005-7#1)(2006-12#1)(2007-11#4)(2007-12#2)(2007-4#1)(2008-1#3)(2008-10#7)(2008-11#1)(2008-2#4)(2008-3#9)(2008-4#6)(2008-5#1)(2008-7#2)(2008-8#2)(2009-4#1)(2009-8#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)
positions on the##4##3##(2007-10#1)(2008-2#2)(2008-5#1)
positions on##8##2##(1990-7#1)(1996-10#1)(2007-10#1)(2008-10#1)(2008-2#2)(2008-5#1)(2009-4#1)
positions only##2##2##(1993-6#1)(1996-11#1)
positions or##2##2##(1993-9#1)(2013-8#1)
positions other than##2##3##(1994-9#1)(2007-8#1)
positions out of##2##3##(1996-1#1)(1996-5#1)
positions probed by incorporation of##2##5##(1991-4#2)
positions probed##3##2##(1991-4#2)(1995-1#1)
positions reported##2##2##(1992-11#1)(1995-2#1)
positions that##3##2##(1995-8#1)(2006-2#1)(2007-2#1)
positions the##3##2##(1991-11#1)(1991-7#1)(2006-6#1)
positions to##5##2##(1990-3#1)(1993-3#1)(2006-10#1)(2006-7#1)(2007-7#1)
positions was##3##2##(1991-11#1)(1993-8#1)(2013-1#1)
positions were tested##2##3##(1991-4#1)(2007-1#1)
positions were##14##2##(1990-6#2)(1991-4#2)(2006-12#1)(2007-1#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-2#1)(2011-2#1)(2012-12#1)
positions where##2##2##(2007-6#1)(2008-9#1)
positions will be##2##3##(1995-8#1)(2006-8#1)
positions will##3##2##(1995-8#1)(1996-2#1)(2006-8#1)
positions with the##2##3##(1992-11#1)(1993-11#1)
positions with##7##2##(1992-11#1)(1993-11#1)(2007-11#2)(2011-1#1)(2011-2#1)(2012-3#1)
positions within the##5##3##(1993-11#1)(1996-7#1)(1997-9#1)(2008-2#1)(2008-3#1)
positions within##8##2##(1993-11#1)(1994-5#1)(1995-5#1)(1996-7#1)(1997-9#1)(2008-2#1)(2008-3#1)(2008-7#1)
positions##675##1##(1990-11#1)(1990-12#6)(1990-2#6)(1990-3#6)(1990-4#1)(1990-5#8)(1990-6#5)(1990-7#5)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#3)(1991-11#4)(1991-12#3)(1991-2#8)(1991-4#10)(1991-5#5)(1991-6#2)(1991-7#8)(1991-8#2)(1991-9#2)(1992-1#2)(1992-11#10)(1992-12#4)(1992-2#4)(1992-3#9)(1992-5#1)(1992-6#4)(1992-7#1)(1992-9#4)(1993-1#2)(1993-10#2)(1993-11#10)(1993-12#2)(1993-2#2)(1993-3#14)(1993-5#1)(1993-6#8)(1993-8#3)(1993-9#2)(1994-1#5)(1994-11#3)(1994-12#5)(1994-3#7)(1994-5#9)(1994-6#1)(1994-8#12)(1994-9#10)(1995-1#4)(1995-10#4)(1995-11#1)(1995-12#3)(1995-2#7)(1995-3#2)(1995-4#2)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#12)(1995-9#3)(1996-1#2)(1996-10#2)(1996-11#2)(1996-12#1)(1996-2#6)(1996-3#3)(1996-4#1)(1996-5#7)(1996-6#2)(1996-7#7)(1996-8#2)(1996-9#6)(1997-1#1)(1997-2#10)(1997-3#3)(1997-4#12)(1997-5#8)(1997-6#5)(1997-7#3)(1997-8#4)(1997-9#4)(2004-3#1)(2005-11#3)(2005-7#2)(2005-8#3)(2006-10#4)(2006-11#3)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#3)(2007-11#10)(2007-12#15)(2007-2#9)(2007-3#1)(2007-4#11)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#13)(2008-1#4)(2008-10#22)(2008-11#5)(2008-12#5)(2008-2#18)(2008-3#37)(2008-4#11)(2008-5#8)(2008-6#8)(2008-7#7)(2008-8#5)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#4)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#5)(2010-12#1)(2010-2#3)(2010-5#1)(2010-6#3)(2010-7#2)(2011-1#5)(2011-2#9)(2012-1#6)(2012-11#1)(2012-12#6)(2012-2#7)(2012-3#5)(2013-1#9)(2013-7#2)(2013-8#5)
positions)##3##1##(1993-12#1)(1997-7#1)(2010-4#1)
positions]##2##1##(1990-6#1)(1996-2#1)
positive (&gt##2##2##(2008-10#1)(2008-5#1)
positive (CD4+##2##2##(1997-7#2)
positive (P##2##2##(2010-4#1)(2010-7#1)
positive (n =##2##3##(1996-2#1)(2010-12#1)
positive BCR-ABL##2##2##(1996-2#1)(2007-12#1)
positive ELISA##2##2##(1996-12#1)(2005-10#1)
positive ERP##2##2##(1995-12#1)(2006-3#1)
positive HBsAg##3##2##(2008-12#1)(2008-4#2)
positive HCV##3##2##(2006-6#1)(2007-7#1)(2008-8#1)
positive HIV status##2##3##(1996-5#1)(2007-7#1)
positive HIV##4##2##(1996-5#1)(2007-7#2)(2008-10#1)
positive IgA antibody titer##2##4##(2007-10#2)
positive IgG##4##2##(2007-10#1)(2007-12#2)(2008-4#1)
positive Kerr##2##2##(2007-12#2)
positive Kleihauer tests##2##3##(2009-3#2)
positive Kleihauer##3##2##(2009-3#3)
positive LLNA##2##2##(2008-10#2)
positive OCT##4##2##(2011-2#4)
positive P##2##2##(2008-10#2)
positive SPT##2##2##(2007-2#1)(2007-3#1)
positive V(P) shift##2##3##(2009-6#2)
positive WOM advocacy##3##3##(2008-8#3)
positive WOM##4##2##(2008-8#4)
positive about the##2##3##(2008-12#1)(2011-2#1)
positive acid fast bacilli##2##4##(2008-1#1)(2008-4#1)
positive action of##3##3##(1994-3#1)(2007-3#2)
positive adjustment##2##2##(2009-7#2)
positive adsorption##2##2##(2005-11#1)(2013-1#1)
positive affect (PA)##2##3##(2008-11#1)(2008-9#1)
positive affect and##4##3##(2006-8#1)(2008-9#2)(2009-2#1)
positive affect than##2##3##(2006-8#2)
positive affect##19##2##(2006-8#5)(2007-8#1)(2008-11#2)(2008-7#1)(2008-9#4)(2009-2#2)(2009-7#1)(2012-1#1)(2012-12#1)(2012-2#1)
positive affectivity##2##2##(2009-2#1)(2009-3#1)
positive after##2##2##(1990-8#1)(1993-11#1)
positive aging##4##2##(2011-2#4)
positive air##2##2##(1993-5#1)(1997-4#1)
positive airway pressure (CPAP)##4##4##(1995-4#1)(2010-7#1)(2011-1#1)(2013-8#1)
positive airway pressure for##3##4##(2007-8#1)(2010-5#1)(2013-1#1)
positive airway pressure##24##3##(1995-4#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#6)(2007-9#1)(2009-2#1)(2009-7#1)(2010-5#2)(2010-7#1)(2011-1#1)(2013-1#3)(2013-8#3)
positive airway##26##2##(1995-4#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#7)(2007-9#1)(2009-2#1)(2009-7#1)(2010-5#2)(2010-7#2)(2011-1#1)(2013-1#3)(2013-8#3)
positive allometric##2##2##(2007-5#1)(2013-7#1)
positive allometry##4##2##(1993-12#1)(2007-3#1)(2011-2#2)
positive allosteric modulators##2##3##(1992-8#1)(2008-1#1)
positive allosteric##5##2##(1992-8#1)(1995-11#2)(2008-1#1)(2012-1#1)
positive among##2##2##(2008-8#1)(2011-1#1)
positive and 7##2##3##(1991-9#1)(2008-7#1)
positive and had##3##3##(1994-4#1)(1996-1#1)(2004-1#1)
positive and negative affect##3##4##(2006-8#1)(2013-8#2)
positive and negative aspects of the##2##6##(2008-11#2)
positive and negative aspects of##5##5##(1990-5#1)(1993-1#1)(2008-11#2)(2009-12#1)
positive and negative aspects##7##4##(1990-5#1)(1993-1#1)(1995-11#1)(2007-11#1)(2008-11#2)(2009-12#1)
positive and negative cases##3##4##(1991-4#1)(2008-10#2)
positive and negative control##3##4##(1990-7#1)(1992-1#1)(2008-8#1)
positive and negative correlations with##2##5##(2008-10#1)(2008-2#1)
positive and negative correlations##4##4##(2008-10#1)(2008-2#1)(2008-7#1)(2010-7#1)
positive and negative effects of##4##5##(2007-12#1)(2007-8#1)(2008-7#1)(2010-9#1)
positive and negative effects##5##4##(2007-11#1)(2007-12#1)(2007-8#1)(2008-7#1)(2010-9#1)
positive and negative factors##2##4##(2008-1#1)(2009-8#1)
positive and negative index changes##2##5##(2008-2#2)
positive and negative index##3##4##(2007-12#1)(2008-2#2)
positive and negative information##2##4##(1993-12#2)
positive and negative predictive value of##3##6##(2007-5#1)(2011-2#1)(2013-1#1)
positive and negative predictive value##4##5##(2007-5#1)(2010-4#1)(2011-2#1)(2013-1#1)
positive and negative predictive values of the##2##7##(2007-1#1)(2013-1#1)
positive and negative predictive values of##6##6##(1991-6#1)(1996-8#1)(2006-1#1)(2007-1#1)(2008-11#1)(2013-1#1)
positive and negative predictive values were##4##6##(1991-4#1)(2006-1#1)(2007-8#1)(2008-12#1)
positive and negative predictive values##12##5##(1991-4#1)(1991-6#1)(1992-2#1)(1996-8#1)(2006-1#2)(2007-1#1)(2007-8#1)(2008-11#1)(2008-12#1)(2012-3#1)(2013-1#1)
positive and negative predictive##18##4##(1991-4#1)(1991-6#1)(1992-2#1)(1992-3#1)(1994-5#1)(1996-8#1)(2006-1#2)(2007-1#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-12#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
positive and negative regulators##4##4##(1995-1#1)(1997-7#1)(2006-11#1)(2007-12#1)
positive and negative self-statements##2##4##(2006-6#2)
positive and negative social events##2##5##(2010-2#1)(2010-4#1)
positive and negative symptoms and##2##5##(2008-12#1)(2008-3#1)
positive and negative symptoms of schizophrenia##3##6##(2004-3#1)(2005-7#1)(2010-6#1)
positive and negative symptoms##8##4##(1997-2#1)(2004-3#1)(2005-7#1)(2008-12#1)(2008-3#1)(2010-6#1)(2011-2#1)(2012-2#1)
positive and negative transcriptional##2##4##(1991-12#1)(1995-8#1)
positive and negative values##2##4##(2008-3#1)(2012-2#1)
positive and negative##131##3##(1990-10#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-12#2)(1991-4#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#3)(1993-1#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-7#1)(2004-3#1)(2005-7#1)(2006-1#2)(2006-11#1)(2006-6#3)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#5)(2007-12#7)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#6)(2008-11#6)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#2)(2010-9#2)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#3)
positive and significant##4##3##(1994-5#1)(1996-3#1)(2006-12#1)(2011-1#1)
positive and the##6##3##(1994-12#1)(1995-5#1)(1996-12#1)(2007-2#1)(2008-11#1)(2013-1#1)
positive and##219##2##(1990-10#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#3)(1991-12#4)(1991-4#4)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#3)(1992-4#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-4#1)(1994-5#3)(1994-6#2)(1994-8#2)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-2#4)(1997-7#1)(2004-1#2)(2004-2#1)(2004-3#1)(2005-7#1)(2006-1#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-6#5)(2006-7#2)(2006-8#3)(2007-1#3)(2007-11#6)(2007-12#7)(2007-2#2)(2007-5#1)(2007-7#3)(2007-8#3)(2008-1#2)(2008-10#7)(2008-11#11)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#2)(2011-1#3)(2011-2#4)(2011-7#1)(2012-1#3)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#8)(2013-8#3)
positive antibody##3##2##(1992-10#1)(2011-2#1)(2013-8#1)
positive antinuclear antibody##2##3##(2006-10#1)(2012-2#1)
positive antinuclear##3##2##(2006-10#2)(2012-2#1)
positive approach##2##2##(1994-12#1)(2008-11#1)
positive area##2##2##(1992-10#1)(2012-3#1)
positive as compared##2##3##(2008-5#1)(2010-4#1)
positive as well as##3##4##(2007-3#1)(2008-8#1)(2009-8#1)
positive as##8##2##(1990-6#1)(1994-8#1)(2007-3#1)(2007-6#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-4#1)
positive aspects of the##2##4##(2007-11#1)(2007-3#1)
positive aspects of##5##3##(1990-9#1)(2007-11#1)(2007-3#1)(2011-2#1)(2012-1#1)
positive aspects##6##2##(1990-9#1)(2007-11#1)(2007-3#1)(2010-3#1)(2011-2#1)(2012-1#1)
positive association between##19##3##(1990-8#1)(1991-4#1)(1991-9#1)(1992-4#1)(1993-12#1)(1994-2#2)(1994-6#1)(2005-10#1)(2008-10#1)(2008-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
positive association of##2##3##(2008-1#1)(2008-7#1)
positive association was##2##3##(1992-8#1)(2013-1#1)
positive association with the intake of##2##6##(1991-5#2)
positive association with the##3##4##(1991-5#2)(2006-8#1)
positive association with##12##3##(1991-5#2)(2006-10#1)(2006-8#2)(2008-8#1)(2012-11#1)(2012-2#2)(2013-1#3)
positive association##37##2##(1990-8#1)(1991-4#1)(1991-5#2)(1991-9#1)(1992-4#1)(1992-8#1)(1993-12#1)(1994-2#3)(1994-6#1)(1995-2#1)(2005-10#1)(2006-10#1)(2006-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-2#3)(2013-1#5)
positive associations between##6##3##(1993-12#1)(2007-12#1)(2007-5#1)(2008-11#1)(2009-2#1)(2011-2#1)
positive associations of##3##3##(1997-8#2)(2009-5#1)
positive associations##16##2##(1991-7#1)(1993-12#1)(1997-8#2)(2007-12#2)(2007-5#1)(2008-10#1)(2008-11#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-3#1)
positive assortment##4##2##(2008-8#4)
positive at low##2##3##(1997-2#1)(2012-3#1)
positive at the##2##3##(2006-10#1)(2008-5#1)
positive at##13##2##(1993-10#1)(1994-7#1)(1997-2#1)(2005-12#1)(2006-10#2)(2007-7#2)(2008-5#2)(2012-2#1)(2012-3#1)(2013-8#1)
positive attitude to##2##3##(2007-3#1)(2007-8#1)
positive attitude toward health##2##4##(2009-5#1)(2012-2#1)
positive attitude toward##3##3##(1996-11#1)(2009-5#1)(2012-2#1)
positive attitude towards##5##3##(1993-3#1)(1993-8#1)(2006-10#1)(2011-2#1)(2013-1#1)
positive attitude##13##2##(1993-3#1)(1993-8#1)(1996-11#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
positive attitudes that##2##3##(1994-3#1)(2010-3#1)
positive attitudes to##3##3##(2007-10#1)(2008-12#1)(2013-1#1)
positive attitudes towards##4##3##(1995-6#1)(2007-8#1)(2008-9#1)(2013-1#1)
positive attitudes##14##2##(1991-3#1)(1993-3#1)(1994-3#1)(1995-6#1)(2007-10#1)(2007-8#1)(2008-12#1)(2008-9#1)(2010-2#1)(2010-3#1)(2010-5#1)(2013-1#3)
positive autoantibodies##2##2##(2006-10#1)(2012-2#1)
positive autoregulatory##2##2##(1992-4#1)(1995-6#1)
positive axillary lymph nodes##2##4##(1993-2#1)(2007-6#1)
positive axillary nodes##3##3##(1994-7#1)(1997-7#1)(2004-1#1)
positive axillary##5##2##(1993-2#1)(1994-7#1)(1997-7#1)(2004-1#1)(2007-6#1)
positive bacteria##16##2##(1997-8#1)(2006-10#1)(2006-8#3)(2007-6#1)(2007-7#1)(2007-8#1)(2008-12#1)(2009-6#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
positive bacterial##2##2##(1993-10#1)(2010-12#1)
positive band##3##2##(1994-6#1)(1994-8#1)(2012-1#1)
positive biopsy##2##2##(1994-12#1)(1994-9#1)
positive birefringence##2##2##(1990-7#1)(2008-3#1)
positive blood culture is##2##4##(2005-12#1)(2010-6#1)
positive blood culture##5##3##(2005-12#1)(2010-12#1)(2010-6#1)(2011-2#2)
positive blood cultures using##2##4##(2011-1#1)(2013-7#1)
positive blood cultures##8##3##(2006-10#1)(2010-12#1)(2010-2#2)(2010-6#1)(2011-1#1)(2012-12#1)(2013-7#1)
positive blood##14##2##(2005-12#1)(2006-10#1)(2010-12#2)(2010-2#2)(2010-6#2)(2011-1#1)(2011-2#3)(2012-12#1)(2013-7#1)
positive body image##3##3##(2007-12#3)
positive breast cancer##4##3##(1994-6#1)(2007-11#1)(2012-3#1)(2013-1#1)
positive breast##7##2##(1994-6#1)(2004-1#1)(2007-11#1)(2011-2#2)(2012-3#1)(2013-1#1)
positive but##7##2##(1992-8#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-3#1)(2009-7#1)(2013-7#1)
positive by PCR for##2##4##(2005-7#1)(2006-6#1)
positive by PCR##8##3##(1991-9#2)(2005-7#1)(2006-6#1)(2008-5#4)
positive by RT-PCR##4##3##(2004-11#1)(2006-3#1)(2008-1#1)(2008-10#1)
positive by culture##2##3##(2008-5#2)
positive by the##7##3##(1992-6#2)(2005-11#1)(2005-8#2)(2007-8#1)(2010-8#1)
positive by##41##2##(1991-6#1)(1991-8#1)(1991-9#2)(1992-6#2)(1995-2#3)(1995-4#1)(2004-11#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-3#2)(2006-6#1)(2007-2#2)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#6)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
positive calcium##2##2##(2005-3#1)(2006-7#1)
positive case##3##2##(2005-12#1)(2011-2#2)
positive cases were##6##3##(2006-1#1)(2006-2#1)(2007-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
positive cases##28##2##(1990-6#1)(1992-12#1)(1992-7#1)(1994-3#1)(2004-11#1)(2006-1#1)(2006-2#1)(2007-10#2)(2007-7#8)(2007-8#2)(2008-10#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-8#4)
positive cavity##2##2##(2007-12#2)
positive cell lines##3##3##(1992-12#1)(1993-3#1)(2008-8#1)
positive cell##9##2##(1991-8#1)(1992-12#1)(1993-3#1)(1995-8#1)(1996-6#2)(1997-4#1)(2008-8#1)(2009-8#1)
positive cells and##4##3##(1992-9#1)(1993-9#1)(2007-10#1)(2008-11#1)
positive cells as##2##3##(1990-8#1)(1992-8#1)
positive cells in the##3##4##(1996-9#1)(2013-1#2)
positive cells in##8##3##(1991-4#1)(1996-9#1)(2007-9#1)(2008-10#1)(2010-12#1)(2013-1#3)
positive cells of##3##3##(1993-12#1)(1995-8#2)
positive cells were seen in the##2##6##(1996-5#1)(2007-10#1)
positive cells were##10##3##(1992-1#1)(1992-7#1)(1996-5#1)(2007-10#3)(2007-8#1)(2010-2#1)(2011-2#1)(2013-8#1)
positive cells##49##2##(1990-12#1)(1990-4#1)(1990-8#1)(1991-4#2)(1991-5#1)(1992-1#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-12#1)(1993-9#1)(1994-7#1)(1995-2#1)(1995-8#3)(1995-9#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(2007-10#5)(2007-8#1)(2007-9#2)(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-2#3)(2013-1#3)(2013-8#1)
positive cells)##2##2##(1990-8#1)(2006-8#1)
positive change in##2##3##(2008-5#1)(2011-2#1)
positive change##3##2##(2007-3#1)(2008-5#1)(2011-2#1)
positive changes in##4##3##(2007-12#1)(2008-5#1)(2011-2#1)(2012-3#1)
positive changes##8##2##(1992-3#1)(2007-12#1)(2008-11#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-7#1)
positive charge of the##4##4##(1990-4#1)(1991-9#1)(1994-10#1)(2008-4#1)
positive charge of##9##3##(1990-4#1)(1991-9#1)(1994-10#1)(1994-3#1)(1994-9#1)(2005-11#1)(2008-10#1)(2008-4#1)(2011-2#1)
positive charge on##5##3##(1993-4#1)(1994-10#1)(1995-5#1)(1996-7#1)(2005-11#1)
positive charge##30##2##(1990-4#1)(1990-5#1)(1990-8#1)(1991-9#1)(1992-3#1)(1993-4#1)(1994-10#2)(1994-3#1)(1994-9#4)(1995-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-11#5)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#1)
positive charges in##2##3##(1993-3#1)(2011-2#1)
positive charges on##2##3##(1994-9#1)(2005-10#1)
positive charges##10##2##(1993-3#1)(1994-2#1)(1994-9#1)(1997-4#1)(2005-10#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-6#1)(2011-2#1)
positive chemical ionization##4##3##(2008-10#3)(2013-8#1)
positive chronic##2##2##(1993-11#1)(2006-2#1)
positive clinical experience##2##3##(2007-8#1)(2008-12#1)
positive clinical outcomes##2##3##(1995-1#1)(2011-2#1)
positive clinical##9##2##(1991-4#1)(1991-5#1)(1995-1#1)(2007-8#1)(2008-11#1)(2008-12#1)(2010-2#1)(2011-2#1)(2012-3#1)
positive clone was##3##3##(1992-7#1)(2008-8#1)(2008-9#1)
positive clone##6##2##(1992-7#1)(1994-12#1)(1997-6#1)(2005-11#1)(2008-8#1)(2008-9#1)
positive clones were isolated from##2##5##(1991-1#1)(2008-8#1)
positive clones were obtained from##2##5##(1990-10#1)(2008-9#1)
positive clones were obtained##3##4##(1990-10#1)(2008-9#2)
positive clones were##8##3##(1990-10#1)(1991-1#1)(1993-4#1)(1997-4#1)(2008-8#2)(2008-9#2)
positive clones##17##2##(1990-10#2)(1990-8#1)(1991-1#1)(1992-7#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-8#1)(1997-4#2)(2008-8#3)(2008-9#2)
positive cocci and##3##3##(2007-12#1)(2007-7#1)(2012-12#1)
positive cocci##7##2##(2007-12#1)(2007-7#1)(2008-4#1)(2010-12#1)(2012-12#2)(2013-8#1)
positive control and##3##3##(2008-10#1)(2012-2#2)
positive control group##5##3##(1992-2#1)(1993-4#1)(2008-10#1)(2010-1#1)(2013-1#1)
positive control in##4##3##(2007-1#1)(2008-10#2)(2008-5#1)
positive control of##2##3##(1992-4#1)(1995-6#1)
positive control##44##2##(1992-12#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-3#1)(1993-4#1)(1994-3#1)(1995-6#1)(1995-8#1)(1997-4#1)(2004-9#1)(2006-12#1)(2007-1#1)(2008-10#11)(2008-11#2)(2008-5#3)(2008-9#1)(2010-1#1)(2010-2#1)(2010-5#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-7#1)
positive controls##11##2##(1990-10#1)(1994-6#1)(2008-10#3)(2008-4#1)(2008-9#4)(2013-1#1)
positive cooperativity in the##3##4##(1995-10#1)(1997-2#2)
positive cooperativity in##5##3##(1995-10#2)(1996-2#1)(1997-2#2)
positive cooperativity of##2##3##(1992-6#1)(1995-10#1)
positive cooperativity##17##2##(1992-6#1)(1994-12#3)(1994-5#2)(1995-10#4)(1995-3#1)(1996-2#1)(1997-2#4)(1997-6#1)
positive coping strategies##2##3##(1995-9#1)(2011-2#1)
positive coping##4##2##(1995-9#1)(2010-3#1)(2011-2#1)(2012-1#1)
positive correlation (r = 0##2##5##(1993-12#1)(1996-7#1)
positive correlation (r =##3##4##(1993-12#1)(1996-7#1)(2008-8#1)
positive correlation between expression##2##4##(2012-3#1)(2013-8#1)
positive correlation between the##19##4##(1990-10#1)(1993-11#1)(1995-4#1)(1995-5#1)(1997-7#1)(2004-11#1)(2005-11#1)(2006-5#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#2)
positive correlation between##56##3##(1990-10#1)(1990-7#1)(1993-11#1)(1995-4#1)(1995-5#1)(1996-3#1)(1997-2#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-6#2)(2007-7#4)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-12#2)(2010-3#1)(2011-1#4)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#4)
positive correlation of##11##3##(1995-12#1)(1995-9#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-9#2)(2011-1#2)
positive correlation to##2##3##(2008-9#1)(2011-1#1)
positive correlation was found between the##6##6##(1990-10#1)(1991-12#1)(1992-10#1)(2006-4#1)(2008-10#1)(2013-8#1)
positive correlation was found between##12##5##(1990-10#1)(1991-12#1)(1992-10#1)(1996-3#1)(2006-4#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#2)(2013-8#1)
positive correlation was observed between the##2##6##(2008-1#1)(2013-8#1)
positive correlation was observed between##4##5##(1995-12#1)(2008-1#1)(2008-7#1)(2013-8#1)
positive correlation was##18##3##(1990-10#1)(1991-12#1)(1992-10#1)(1995-12#1)(1996-3#1)(2006-4#1)(2006-8#1)(2008-1#2)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-8#1)(2011-1#1)(2013-8#2)
positive correlation with the##4##4##(1991-11#1)(1991-12#1)(2004-4#1)(2008-12#1)
positive correlation with##19##3##(1990-8#1)(1991-11#1)(1991-12#1)(1994-6#1)(1996-2#1)(2004-4#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-6#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-12#1)(2012-1#1)(2013-1#2)
positive correlation##122##2##(1990-10#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#2)(1992-10#1)(1993-11#1)(1993-12#1)(1994-6#1)(1995-12#2)(1995-4#2)(1995-5#1)(1995-9#1)(1996-2#1)(1996-3#2)(1996-7#1)(1997-2#1)(1997-7#2)(1997-8#1)(2004-11#1)(2004-4#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#2)(2007-1#1)(2007-11#1)(2007-7#4)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-12#2)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#3)(2009-4#1)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#3)(2010-3#1)(2010-8#1)(2011-1#8)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#6)
positive correlations among##3##3##(2008-10#1)(2008-9#1)(2012-3#1)
positive correlations between size at maturity and asymptotic size##3##9##(2008-9#3)
positive correlations between##13##3##(1990-10#1)(2005-11#1)(2007-1#1)(2007-6#1)(2007-8#1)(2008-5#1)(2008-8#1)(2008-9#4)(2010-8#2)
positive correlations were found between##3##5##(2007-1#1)(2008-10#1)(2013-1#1)
positive correlations were found##5##4##(1994-3#1)(2007-1#1)(2008-10#1)(2008-7#1)(2013-1#1)
positive correlations were##7##3##(1994-3#1)(2007-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-3#1)(2013-1#1)
positive correlations with##6##3##(1996-2#1)(2007-5#1)(2008-8#1)(2010-10#1)(2011-1#2)
positive correlations##32##2##(1990-10#1)(1994-3#1)(1996-2#1)(2005-11#1)(2007-1#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#5)(2009-12#1)(2010-10#1)(2010-2#1)(2010-8#2)(2011-1#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
positive criteria##2##2##(1993-8#1)(2009-7#1)
positive culture for##2##3##(2006-10#1)(2011-2#1)
positive culture##6##2##(2006-10#1)(2006-2#1)(2007-7#1)(2007-8#1)(2011-2#1)(2013-1#1)
positive cultures were##2##3##(2007-8#2)
positive cultures##10##2##(2006-7#1)(2006-8#1)(2007-7#2)(2007-8#2)(2008-4#1)(2010-12#1)(2011-2#1)(2013-8#1)
positive curvature##2##2##(2005-11#2)
positive cytology##2##2##(1994-7#1)(2011-1#1)
positive dependence##2##2##(2013-1#2)
positive despite##2##2##(2006-4#1)(2012-1#1)
positive diagnosis of##5##3##(1990-3#1)(2006-4#1)(2007-2#1)(2008-7#1)(2008-9#1)
positive diagnosis##8##2##(1990-3#1)(1997-2#2)(2006-4#1)(2007-2#1)(2008-7#1)(2008-9#1)(2012-12#1)
positive direct antiglobulin test##4##4##(1992-3#1)(1992-9#1)(1994-3#1)(1994-9#1)
positive direct antiglobulin tests##4##4##(1992-3#3)(1994-6#1)
positive direct antiglobulin##8##3##(1992-3#4)(1992-9#1)(1994-3#1)(1994-6#1)(1994-9#1)
positive direct##10##2##(1992-3#4)(1992-9#1)(1994-3#1)(1994-6#1)(1994-9#1)(2005-8#1)(2008-4#1)
positive direction in##2##3##(2008-10#1)(2012-1#1)
positive direction##4##2##(2008-10#2)(2012-1#2)
positive discography##9##2##(2012-12#9)
positive dispersion##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
positive displacement##3##2##(2007-12#1)(2008-10#2)
positive donors##2##2##(2008-11#1)(2011-2#1)
positive due##2##2##(1995-4#1)(2008-1#1)
positive during the##2##3##(2007-7#1)(2011-2#1)
positive during##3##2##(1996-7#1)(2007-7#1)(2011-2#1)
positive dynamics##2##2##(1996-3#1)(2011-1#1)
positive effect in##2##3##(2011-2#1)(2012-3#1)
positive effect of##11##3##(1994-5#1)(1994-9#1)(1995-4#1)(2004-9#1)(2006-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)
positive effect on the##11##4##(1990-4#1)(1995-1#1)(2006-10#1)(2008-12#1)(2008-2#1)(2009-10#1)(2009-8#1)(2010-8#2)(2013-1#1)(2013-8#1)
positive effect on##39##3##(1990-11#1)(1990-4#1)(1990-9#1)(1991-4#1)(1995-1#1)(1995-4#1)(1995-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-8#1)(2010-8#4)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
positive effect##65##2##(1990-11#1)(1990-4#1)(1990-9#1)(1991-4#1)(1993-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-4#2)(1995-6#1)(1996-2#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-9#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-8#1)(2010-8#4)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
positive effector for##2##3##(1995-1#1)(1997-2#1)
positive effector##3##2##(1992-4#1)(1995-1#1)(1997-2#1)
positive effects for##2##3##(2011-2#1)(2013-8#1)
positive effects in##3##3##(1997-1#1)(2008-10#1)(2010-8#1)
positive effects of##18##3##(1995-8#1)(2004-11#1)(2005-6#1)(2006-10#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-12#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
positive effects on the##3##4##(2005-10#1)(2006-12#1)(2008-5#1)
positive effects on##24##3##(1997-2#1)(1997-7#1)(2005-10#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
positive effects##62##2##(1995-8#1)(1997-1#1)(1997-2#1)(1997-7#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-6#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#4)(2008-7#2)(2008-8#4)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#3)
positive electrode##3##2##(2009-12#1)(2009-5#1)(2013-8#1)
positive electrospray ionization##5##3##(2010-11#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-8#1)
positive electrostatic##2##2##(1996-6#1)(2008-10#1)
positive elements##2##2##(1991-6#1)(1996-2#1)
positive emotion##4##2##(2010-3#4)
positive emotional##4##2##(2008-5#1)(2010-10#2)(2012-12#1)
positive emotions and##3##3##(2008-9#1)(2011-2#1)(2013-1#1)
positive emotions##6##2##(1997-8#1)(2008-6#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
positive end expiratory pressure##2##4##(1993-10#1)(2006-10#1)
positive end##3##2##(1991-6#1)(1993-10#1)(2006-10#1)
positive end-expiratory pressure##4##3##(1993-10#1)(2005-8#1)(2006-10#1)(2009-3#1)
positive entropy##2##2##(1991-4#1)(1993-6#1)
positive errors##2##2##(2008-10#2)
positive estrogen##2##2##(2011-2#1)(2012-2#1)
positive events##2##2##(2008-6#1)(2010-2#1)
positive examination##3##2##(1996-6#1)(2008-1#2)
positive exercise##3##2##(1996-6#1)(2008-6#1)(2009-10#1)
positive experiences of##2##3##(2008-10#1)(2013-1#1)
positive experiences##5##2##(1993-3#1)(2008-10#2)(2013-1#1)(2013-8#1)
positive expiratory pressure##2##3##(1991-2#1)(1997-3#1)
positive expression of##2##3##(2008-3#1)(2012-2#1)
positive expression##6##2##(2007-2#1)(2007-6#1)(2008-3#1)(2009-4#1)(2010-12#1)(2012-2#1)
positive expressiveness##2##2##(2008-12#2)
positive factor##3##2##(1993-6#1)(1993-8#1)(1995-2#1)
positive factors##2##2##(2009-12#1)(2009-8#1)
positive family history for##2##4##(2008-7#1)(2012-3#1)
positive family history of##8##4##(1993-9#1)(1997-6#1)(2006-10#1)(2006-9#1)(2007-2#1)(2008-4#1)(2013-1#1)(2013-8#1)
positive family history##20##3##(1993-5#1)(1993-9#1)(1997-5#1)(1997-6#1)(2006-10#1)(2006-9#2)(2007-2#1)(2007-7#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
positive family##22##2##(1993-5#1)(1993-9#2)(1997-5#1)(1997-6#1)(2006-10#1)(2006-9#2)(2007-2#1)(2007-7#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
positive features##3##2##(2008-2#2)(2008-5#1)
positive feedback and##2##3##(2008-11#1)(2009-9#1)
positive feedback in##2##3##(2009-8#1)(2009-9#1)
positive feedback loop##5##3##(1991-5#2)(1993-6#1)(2008-2#1)(2013-7#1)
positive feedback loops##3##3##(2012-2#1)(2013-7#2)
positive feedback##23##2##(1990-8#1)(1991-5#2)(1991-9#1)(1992-9#1)(1993-6#1)(2006-12#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-8#1)(2009-10#1)(2009-8#1)(2009-9#2)(2010-10#1)(2012-2#1)(2013-1#1)(2013-7#3)
positive feelings##4##2##(2007-7#1)(2009-6#1)(2010-3#1)(2012-3#1)
positive financial impact##2##3##(2006-5#1)(2008-11#1)
positive finding##3##2##(1991-9#1)(1992-5#1)(2005-1#1)
positive findings are##2##3##(1995-1#1)(2008-8#1)
positive findings by##2##3##(2007-10#1)(2008-10#1)
positive findings##11##2##(1990-4#1)(1994-12#1)(1995-1#1)(2007-10#1)(2008-10#1)(2008-8#2)(2012-11#1)(2012-2#3)
positive foci##6##2##(1992-3#2)(1994-6#4)
positive for ACA##2##3##(2011-2#2)
positive for C##2##3##(2008-3#1)(2008-5#1)
positive for CD34##2##3##(2009-11#2)
positive for H##4##3##(2006-8#1)(2008-1#1)(2008-5#1)(2013-1#1)
positive for HBsAg##4##3##(1991-9#1)(2008-7#1)(2011-2#1)(2013-8#1)
positive for HCV-RNA##2##3##(1992-3#1)(2008-3#1)
positive for HIV antibodies##3##4##(1996-5#1)(1996-6#1)(2007-7#1)
positive for HIV##7##3##(1991-6#1)(1995-6#1)(1996-5#1)(1996-6#1)(2007-2#1)(2007-7#2)
positive for HSV-2##2##3##(1991-9#2)
positive for IgG##4##3##(1996-4#1)(2006-10#1)(2007-8#2)
positive for Leptospira##2##3##(2007-2#1)(2007-7#1)
positive for Nocardia##2##3##(1992-5#1)(2010-9#1)
positive for PE##4##3##(2010-8#1)(2011-2#1)(2012-2#2)
positive for Plasmodium falciparum##2##4##(2007-2#1)(2012-3#1)
positive for Plasmodium##3##3##(2007-2#1)(2012-2#1)(2012-3#1)
positive for S-100##2##3##(1993-8#1)(2009-7#1)
positive for S100 protein##2##4##(2009-5#1)(2012-2#1)
positive for Staphylococcus##2##3##(2007-7#1)(2012-12#1)
positive for Y##2##3##(2004-11#2)
positive for ZAP-70##2##3##(2008-8#2)
positive for a##3##3##(2006-8#1)(2007-3#1)(2011-2#1)
positive for all##2##3##(1990-12#1)(1996-9#1)
positive for anti-HCV##6##3##(1991-3#1)(1991-9#3)(2008-1#1)(2013-8#1)
positive for antibody to##2##4##(1991-3#1)(2008-4#1)
positive for at least##2##4##(2005-8#1)(2013-7#1)
positive for both##6##3##(1991-9#1)(1993-12#1)(2011-2#4)
positive for bufotenine##2##3##(1995-11#2)
positive for desmin##2##3##(2004-2#1)(2010-6#1)
positive for drugs in##2##4##(2013-7#2)
positive for epithelial membrane antigen##2##5##(2006-12#1)(2011-2#1)
positive for epithelial##3##3##(2006-12#1)(2010-7#1)(2011-2#1)
positive for estrogen receptor (ER)##2##5##(1995-4#1)(2007-5#1)
positive for hepatitis##2##3##(2008-1#1)(2008-12#1)
positive for high##2##3##(2010-10#1)(2012-3#1)
positive for human immunodeficiency virus (HIV)##2##6##(1990-6#1)(2007-7#1)
positive for human##3##3##(1990-6#1)(1991-1#1)(2007-7#1)
positive for malaria parasites##2##4##(2008-2#1)(2012-12#1)
positive for malaria##3##3##(2008-2#2)(2012-12#1)
positive for neutralizing##2##3##(2008-10#1)(2008-5#1)
positive for oestrogen receptors##2##4##(2007-2#2)
positive for one or more##2##5##(2006-8#1)(2007-7#1)
positive for one##5##3##(1990-12#1)(2006-8#1)(2007-7#1)(2011-2#2)
positive for progesterone##2##3##(2007-2#2)
positive for syphilis##3##3##(2011-2#1)(2013-1#2)
positive for the##18##3##(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-9#1)(1994-12#1)(1997-8#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-5#1)(2011-2#3)(2012-12#2)(2013-8#1)
positive for this##2##3##(2007-6#1)(2008-10#1)
positive for vimentin and smooth muscle actin##2##7##(2008-6#1)(2011-1#1)
positive for vimentin and##3##4##(2008-6#1)(2009-7#1)(2011-1#1)
positive for vimentin##4##3##(2008-6#1)(2008-9#1)(2009-7#1)(2011-1#1)
positive for##299##2##(1990-10#1)(1990-12#2)(1990-3#2)(1990-5#1)(1990-6#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#2)(1991-3#3)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#12)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-4#1)(1995-1#1)(1995-11#2)(1995-4#1)(1995-5#3)(1995-6#1)(1996-1#1)(1996-4#1)(1996-5#1)(1996-6#3)(1996-9#6)(1997-2#1)(1997-7#1)(1997-8#2)(2004-11#4)(2004-2#1)(2005-12#1)(2005-8#2)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#2)(2006-8#7)(2007-11#1)(2007-12#2)(2007-2#12)(2007-3#2)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#18)(2007-8#8)(2008-1#5)(2008-10#11)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#5)(2008-5#8)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-11#2)(2009-5#2)(2009-6#1)(2009-7#2)(2010-10#1)(2010-12#1)(2010-6#4)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#22)(2012-1#3)(2012-12#7)(2012-2#9)(2012-3#5)(2013-1#9)(2013-7#3)(2013-8#12)
positive formal thought disorder##2##4##(1997-2#2)
positive frequency##2##2##(1992-3#1)(2008-8#1)
positive from##4##2##(2005-11#1)(2010-4#2)(2011-2#1)
positive group##6##2##(2004-2#1)(2006-8#1)(2008-1#1)(2008-3#1)(2010-4#1)(2012-2#1)
positive growth##3##2##(1992-12#1)(2007-11#1)(2008-10#1)
positive health##3##2##(2005-10#1)(2008-10#1)(2008-11#1)
positive hepatitis##2##2##(2006-2#1)(2008-1#1)
positive history of##8##3##(1991-4#1)(1992-4#2)(2007-2#2)(2008-12#1)(2008-9#1)(2013-7#1)
positive history##9##2##(1991-4#1)(1992-4#2)(2007-2#2)(2008-12#1)(2008-9#1)(2013-7#1)(2013-8#1)
positive human##2##2##(2008-5#2)
positive hybridization##2##2##(2008-10#1)(2008-4#1)
positive identification##3##2##(1995-3#1)(1995-6#1)(2008-10#1)
positive immuno-reactivity for CD 117##2##5##(2006-6#2)
positive immunoreactivity for myoepithelial##2##4##(1996-3#2)
positive immunoreactivity for##6##3##(1992-6#1)(1996-3#3)(2008-10#1)(2008-6#1)
positive immunoreactivity##8##2##(1992-6#1)(1993-9#1)(1996-3#3)(2008-10#1)(2008-5#1)(2008-6#1)
positive immunostaining##2##2##(1992-3#1)(2008-9#1)
positive impact of##5##3##(2008-11#1)(2008-6#1)(2009-4#1)(2012-2#1)(2013-7#1)
positive impact on the ability of##2##6##(1996-12#1)(2013-8#1)
positive impact on the##13##4##(1995-5#1)(1996-12#1)(2006-7#1)(2007-7#1)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2011-2#1)(2013-8#2)
positive impact on##23##3##(1994-3#1)(1995-5#1)(1996-12#1)(1997-1#1)(2006-6#1)(2006-7#1)(2007-7#1)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-6#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
positive impact##31##2##(1994-3#1)(1995-5#1)(1996-12#1)(1997-1#1)(2006-6#1)(2006-7#1)(2007-2#1)(2007-7#1)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#1)(2008-6#2)(2009-4#1)(2011-2#5)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
positive implicit attitudes##3##3##(2010-2#3)
positive in 30##2##3##(2007-7#1)(2007-8#1)
positive in NLE##2##3##(1993-5#2)
positive in all cases##2##4##(1991-3#1)(1996-2#1)
positive in all##6##3##(1991-3#1)(1995-11#1)(1996-2#1)(1996-8#1)(2008-4#1)(2012-12#1)
positive in both cases##2##4##(1997-7#1)(2005-11#1)
positive in both##6##3##(1991-4#1)(1992-8#1)(1997-7#1)(2005-11#1)(2008-12#1)(2012-1#1)
positive in four##2##3##(2007-2#1)(2012-2#1)
positive in media alone##2##4##(1995-12#2)
positive in the##9##3##(1993-1#1)(1994-7#1)(1996-1#1)(2007-2#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#2)
positive in their##3##3##(1996-3#1)(2004-11#1)(2007-2#1)
positive in##92##2##(1990-2#1)(1990-3#1)(1991-3#1)(1991-4#1)(1992-10#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-5#3)(1994-1#1)(1994-7#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-9#1)(1996-1#2)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#3)(1997-2#1)(1997-7#1)(2004-11#1)(2005-1#1)(2005-11#2)(2006-10#1)(2006-8#4)(2007-11#1)(2007-2#5)(2007-7#8)(2007-8#3)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#2)(2009-6#1)(2010-8#1)(2011-1#5)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#4)
positive individuals##3##2##(1996-6#1)(2006-2#1)(2006-6#1)
positive influence of##8##3##(1990-1#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#1)
positive influence on the##3##4##(2006-12#1)(2008-7#1)(2013-8#1)
positive influence on their##2##4##(2008-11#1)(2009-7#1)
positive influence on##12##3##(1994-3#1)(2006-12#1)(2007-11#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-7#1)(2013-1#1)(2013-8#1)
positive influence##20##2##(1990-1#1)(1994-3#1)(2006-12#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
positive influences##2##2##(1996-2#1)(2009-3#1)
positive inotropic action##4##3##(1997-7#3)(2008-1#1)
positive inotropic effect of##3##4##(1991-2#1)(1995-12#2)
positive inotropic effect##6##3##(1991-2#1)(1993-11#1)(1995-12#2)(2007-9#1)(2008-5#1)
positive inotropic##16##2##(1991-2#1)(1991-8#2)(1993-11#1)(1995-12#2)(1997-7#6)(2007-9#1)(2008-1#2)(2008-5#1)
positive instrumental beliefs##2##3##(2010-3#2)
positive ion mode with##2##4##(2011-3#1)(2012-12#1)
positive ion mode##7##3##(2008-10#2)(2009-12#1)(2011-3#2)(2012-12#1)(2012-3#1)
positive ion##9##2##(1997-3#1)(2008-10#3)(2009-12#1)(2011-3#2)(2012-12#1)(2012-3#1)
positive ionization##2##2##(2008-10#1)(2011-2#1)
positive ions##3##2##(1993-2#1)(1996-6#1)(2008-10#1)
positive isolates##2##2##(2007-8#1)(2012-12#1)
positive levels##2##2##(2006-10#1)(2011-2#1)
positive likelihood ratio##3##3##(2008-12#1)(2010-12#1)(2012-2#1)
positive likelihood##5##2##(2008-11#1)(2008-12#1)(2010-12#1)(2012-2#2)
positive linear correlation between##2##4##(1996-6#1)(2008-3#1)
positive linear correlation##3##3##(1996-6#1)(2008-3#1)(2008-8#1)
positive linear relationship between##2##4##(1994-10#1)(2008-10#1)
positive linear relationship##3##3##(1994-10#1)(2008-10#1)(2011-1#1)
positive linear##7##2##(1994-10#1)(1996-6#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-1#1)
positive local##2##2##(1996-9#1)(2008-9#1)
positive lod scores were##2##4##(1997-5#2)
positive lod scores##3##3##(1997-5#3)
positive long-term##3##2##(1993-1#1)(2011-1#1)(2013-1#1)
positive lymph nodes##7##3##(1990-8#1)(2008-8#2)(2011-12#1)(2011-2#1)(2013-1#2)
positive lymph##8##2##(1990-8#1)(2007-8#1)(2008-8#2)(2011-12#1)(2011-2#1)(2013-1#2)
positive lymphocyte cells were##2##4##(2007-12#2)
positive male##2##2##(2009-5#1)(2013-1#1)
positive manifold##2##2##(2011-12#2)
positive margins##9##2##(2004-2#1)(2006-10#1)(2006-6#1)(2008-6#4)(2012-2#2)
positive membrane potentials##2##3##(1991-8#1)(1991-9#1)
positive mental health##4##3##(2007-12#1)(2011-2#3)
positive messages##3##2##(2007-12#1)(2008-11#1)(2010-11#1)
positive modulation of the NMDA##2##5##(1994-6#1)(1996-12#1)
positive modulation of##3##3##(1994-6#1)(1996-12#1)(1997-5#1)
positive modulators of##2##3##(1996-6#1)(1997-5#1)
positive modulators##6##2##(1992-12#1)(1992-3#3)(1996-6#1)(1997-5#1)
positive mood##3##2##(2009-9#2)(2013-1#1)
positive net##5##2##(1995-3#1)(2004-11#1)(2007-7#1)(2008-10#2)
positive neurones##3##2##(1993-9#2)(1995-12#1)
positive neurons##3##2##(1992-8#1)(1997-8#1)(2012-3#1)
positive node##2##2##(1990-4#1)(2011-2#1)
positive nodes the##2##3##(2004-1#1)(2011-2#1)
positive nodes##7##2##(1992-12#1)(1993-1#1)(2004-1#2)(2006-9#1)(2011-2#1)(2012-3#1)
positive of##4##2##(2005-10#2)(2007-7#1)(2008-10#1)
positive on the##3##3##(2005-10#1)(2008-2#1)(2009-7#1)
positive on##10##2##(1991-9#3)(1997-4#1)(2005-10#1)(2007-7#1)(2008-10#1)(2008-2#1)(2009-7#2)
positive one##2##2##(2008-12#1)(2010-1#1)
positive only in##2##3##(2007-5#1)(2009-7#1)
positive or negative control##2##4##(2008-7#1)(2008-8#1)
positive or negative effects##3##4##(2008-11#1)(2008-8#1)(2008-9#1)
positive or negative selection##2##4##(1990-8#1)(2008-11#1)
positive or negative##38##3##(1990-10#1)(1990-6#1)(1990-8#2)(1993-5#1)(1994-7#1)(1995-11#2)(1995-12#1)(1996-10#1)(2006-6#2)(2007-12#2)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-11#1)(2010-4#1)(2012-2#1)(2013-8#1)
positive or neutral##3##3##(1992-6#1)(1994-1#1)(2009-4#1)
positive or suspicious##3##3##(1995-4#2)(2007-6#1)
positive or##53##2##(1990-10#1)(1990-6#1)(1990-8#2)(1992-6#1)(1993-11#1)(1993-5#1)(1994-1#1)(1994-7#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-4#2)(1996-10#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-6#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-11#1)(2009-4#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
positive outcome was##2##3##(2007-8#1)(2008-12#1)
positive outcome##9##2##(1991-5#1)(2006-8#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-12#1)(2008-6#1)(2010-2#1)
positive outcomes and##2##3##(2006-12#1)(2006-8#1)
positive outcomes for patients with##2##5##(2012-3#1)(2013-8#1)
positive outcomes for patients##3##4##(2011-1#1)(2012-3#1)(2013-8#1)
positive outcomes for##5##3##(2008-11#2)(2011-1#1)(2012-3#1)(2013-8#1)
positive outcomes in a##2##4##(2008-12#1)(2010-6#1)
positive outcomes in##3##3##(2007-2#1)(2008-12#1)(2010-6#1)
positive outcomes##23##2##(1995-1#1)(2005-10#1)(2005-12#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-2#3)(2007-7#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-3#1)(2013-1#3)(2013-8#1)
positive p53##3##2##(2005-5#1)(2009-9#1)(2012-2#1)
positive parenting##2##2##(2007-2#1)(2009-7#1)
positive patient##11##2##(1997-8#1)(2005-12#1)(2006-5#1)(2006-6#1)(2007-7#2)(2008-10#1)(2008-4#1)(2010-12#2)(2010-4#1)
positive patients had##2##3##(1993-11#1)(2008-2#1)
positive patients is##3##3##(2007-7#1)(2008-1#1)(2008-5#1)
positive patients were##4##3##(2007-2#1)(2007-7#1)(2008-10#1)(2013-1#1)
positive patients with##4##3##(1991-4#1)(2007-11#1)(2008-8#1)(2010-12#1)
positive patients##35##2##(1990-8#1)(1991-4#1)(1993-11#1)(1994-10#1)(2004-1#1)(2006-6#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#3)(2008-1#4)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#6)(2008-8#1)(2010-12#4)(2011-2#1)(2013-1#1)
positive percentage##2##2##(1991-2#1)(2005-10#1)
positive percentages##2##2##(2005-10#1)(2008-5#1)
positive perception of##2##3##(2006-2#1)(2010-2#1)
positive perceptions##4##2##(2004-12#2)(2008-12#1)(2010-2#1)
positive performance##2##2##(1997-3#2)
positive persons##5##2##(1990-11#1)(1993-8#1)(2007-12#2)(2010-8#1)
positive physical##3##2##(2007-6#1)(2008-8#1)(2009-11#1)
positive polymerase chain reaction for##2##5##(2008-12#1)(2011-1#1)
positive polymerase chain reaction##4##4##(2008-12#1)(2011-1#1)(2011-2#2)
positive population##4##2##(1995-2#1)(2007-11#1)(2008-8#1)(2008-9#1)
positive potential to##3##3##(2008-10#2)(2008-9#1)
positive potential##11##2##(1993-12#1)(1994-8#1)(2005-11#1)(2008-10#7)(2008-9#1)
positive potentials##5##2##(1990-5#2)(2007-8#1)(2008-10#2)
positive prediction##2##2##(1992-7#1)(2007-9#1)
positive predictive value (PPV) of##2##5##(2007-9#1)(2011-1#1)
positive predictive value (PPV)##5##4##(2006-10#2)(2007-9#1)(2010-12#1)(2011-1#1)
positive predictive value 98% and negative predictive value##2##8##(2009-2#2)
positive predictive value and##3##4##(2011-2#1)(2012-12#1)(2012-3#1)
positive predictive value for##5##4##(1992-6#1)(2005-10#1)(2006-10#1)(2011-1#1)(2012-2#1)
positive predictive value of##19##4##(1992-10#1)(1992-5#1)(1993-2#1)(1993-5#1)(2005-10#1)(2006-10#3)(2006-12#1)(2006-2#4)(2007-3#2)(2007-7#1)(2007-8#2)(2012-2#1)
positive predictive value was##4##4##(1993-1#2)(2007-8#1)(2012-2#1)
positive predictive value##62##3##(1990-4#1)(1992-10#1)(1992-11#1)(1992-5#2)(1992-6#1)(1993-1#2)(1993-2#1)(1993-5#1)(1994-7#1)(1996-4#1)(1997-2#1)(1997-4#1)(2005-10#2)(2006-10#8)(2006-12#2)(2006-2#4)(2007-3#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-10#1)(2009-2#2)(2009-4#1)(2010-12#1)(2011-1#2)(2011-2#6)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)
positive predictive values of##5##4##(2004-2#1)(2005-10#1)(2008-5#2)(2012-12#1)
positive predictive values##9##3##(1994-3#1)(2004-2#1)(2005-10#1)(2007-10#1)(2008-5#2)(2011-1#1)(2012-12#1)(2013-1#1)
positive predictive##75##2##(1990-4#1)(1992-10#1)(1992-11#1)(1992-5#2)(1992-6#1)(1993-1#2)(1993-2#1)(1993-5#1)(1994-3#1)(1994-7#1)(1996-4#1)(1997-2#1)(1997-4#1)(2004-2#1)(2005-10#3)(2006-10#8)(2006-12#2)(2006-2#4)(2007-10#1)(2007-3#2)(2007-7#1)(2007-8#5)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2009-10#1)(2009-2#2)(2009-4#1)(2010-12#1)(2011-1#3)(2011-2#7)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
positive predictors##2##2##(2008-9#1)(2013-1#1)
positive pregnancy##2##2##(2007-2#1)(2013-1#1)
positive pregnant women##4##3##(2006-10#1)(2007-12#2)(2010-12#1)
positive preliminary##2##2##(2007-11#1)(2012-3#1)
positive pressure ventilation (NPPV)##2##4##(2006-9#1)(2008-1#1)
positive pressure ventilation in##3##4##(1997-4#1)(2006-9#1)(2013-7#1)
positive pressure ventilation##19##3##(1995-4#1)(1997-4#7)(2005-8#2)(2006-10#3)(2006-9#2)(2008-1#1)(2008-8#1)(2010-7#1)(2013-7#1)
positive pressure with bilevel pressure##2##5##(2013-1#2)
positive pressure##27##2##(1991-6#1)(1993-10#1)(1995-4#1)(1997-4#9)(2005-8#2)(2006-10#3)(2006-6#1)(2006-9#2)(2008-1#1)(2008-10#1)(2008-8#1)(2010-7#1)(2013-1#2)(2013-7#1)
positive pressures##2##2##(2007-10#2)
positive proliferative responses to##2##4##(2011-2#2)
positive psychological##3##2##(2006-7#1)(2008-12#1)(2011-2#1)
positive quality of life and##3##5##(2009-12#3)
positive quality of life##7##4##(2009-12#7)
positive rate of both SARS-CoV-IgG and -IgM antibodies was##2##9##(2005-10#2)
positive rate of##11##3##(1994-12#1)(2005-10#3)(2006-12#1)(2006-8#4)(2011-1#1)(2012-3#1)
positive rate was 9##2##4##(2011-3#1)(2013-8#1)
positive rate was##6##3##(2006-4#1)(2009-5#1)(2011-1#1)(2011-3#1)(2013-8#2)
positive rate##25##2##(1992-3#1)(1993-1#1)(1994-12#1)(1997-4#1)(2005-10#3)(2006-12#1)(2006-4#3)(2006-8#4)(2009-5#1)(2010-1#2)(2011-1#2)(2011-3#1)(2012-3#1)(2013-8#3)
positive rates for##3##3##(1995-10#1)(1996-12#1)(1997-2#1)
positive rates of##4##3##(1997-2#1)(2005-10#1)(2006-12#1)(2010-12#1)
positive rates were##3##3##(1997-2#1)(2012-2#1)(2012-3#1)
positive rates##14##2##(1995-10#1)(1996-12#1)(1997-2#3)(2005-10#1)(2006-12#1)(2010-1#2)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#2)
positive ratings of##2##3##(2012-2#2)
positive ratings##3##2##(2009-5#1)(2012-2#2)
positive reaction in##2##3##(2007-12#1)(2008-10#1)
positive reaction to##7##3##(1990-6#1)(1997-6#1)(2005-8#1)(2011-2#2)(2012-1#2)
positive reaction##14##2##(1990-6#1)(1996-3#1)(1997-6#1)(2005-8#1)(2006-8#1)(2007-12#1)(2008-10#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#2)
positive reactions for##2##3##(1996-3#1)(2010-12#1)
positive reactions in##2##3##(2006-8#1)(2011-2#1)
positive reactions to##2##3##(2006-12#1)(2012-2#1)
positive reactions##14##2##(1996-3#1)(1997-6#1)(2006-12#1)(2006-8#2)(2007-10#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-5#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-2#1)
positive regulation##3##2##(1993-8#1)(2008-4#1)(2008-8#1)
positive regulator of##10##3##(1990-6#1)(1992-2#1)(1994-8#1)(1995-1#1)(1996-2#1)(2006-12#1)(2010-11#1)(2011-1#1)(2012-12#1)(2013-1#1)
positive regulator##14##2##(1990-10#1)(1990-6#1)(1992-2#1)(1994-8#1)(1995-1#1)(1995-8#1)(1996-2#1)(2006-12#2)(2008-11#1)(2010-11#1)(2011-1#1)(2012-12#1)(2013-1#1)
positive regulators##2##2##(1995-8#1)(2007-4#1)
positive regulatory elements##2##3##(1992-3#1)(1993-3#1)
positive regulatory##8##2##(1992-2#1)(1992-3#1)(1993-3#1)(1996-4#1)(1997-1#1)(1997-7#1)(1997-8#1)(2011-1#1)
positive reinforcement##4##2##(1993-6#1)(1994-2#1)(2008-2#1)(2011-2#1)
positive relation between##3##3##(1990-8#1)(2008-12#1)(2009-10#1)
positive relation##4##2##(1990-8#1)(2008-12#1)(2009-10#1)(2012-2#1)
positive relations##2##2##(2006-8#1)(2008-9#1)
positive relationship between physical activity and##2##6##(2006-8#1)(2010-12#1)
positive relationship between the##2##4##(2008-10#1)(2011-1#1)
positive relationship between##21##3##(1995-3#1)(1996-12#1)(1996-2#1)(2005-10#1)(2006-7#1)(2006-8#1)(2007-6#1)(2008-10#3)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-12#1)(2013-7#2)
positive relationship of##2##3##(2008-1#1)(2013-1#1)
positive relationship with##2##3##(2010-4#1)(2011-12#1)
positive relationship##28##2##(1990-10#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(2005-10#1)(2006-7#1)(2006-8#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#3)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-12#2)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#2)
positive relationships between##2##3##(1991-2#1)(2008-8#1)
positive relationships##4##2##(1991-2#1)(1993-2#1)(2008-8#1)(2010-8#1)
positive religious coping##3##3##(2008-12#2)(2008-4#1)
positive remodelling##3##2##(2012-2#3)
positive replicas of##2##3##(2008-1#1)(2008-10#1)
positive resection margin##2##3##(1995-10#1)(2009-12#1)
positive resection##3##2##(1995-10#1)(2007-8#1)(2009-12#1)
positive residue##2##2##(2008-8#2)
positive residues in##3##3##(2008-8#3)
positive respectively##2##2##(2007-7#1)(2011-2#1)
positive respiratory##2##2##(2011-1#2)
positive response to the##2##4##(2008-6#1)(2010-4#1)
positive response to##6##3##(2006-8#1)(2007-11#2)(2008-4#1)(2008-6#1)(2010-4#1)
positive response##19##2##(1993-12#1)(1993-2#1)(1996-3#1)(1997-3#1)(2004-3#1)(2004-4#1)(2006-8#2)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#3)(2008-4#1)(2008-6#1)(2010-4#1)(2012-12#1)
positive responses to##5##3##(1992-12#1)(2008-10#1)(2011-2#2)(2012-3#1)
positive responses##7##2##(1992-12#1)(2008-10#2)(2008-9#1)(2011-2#2)(2012-3#1)
positive result##9##2##(1990-4#1)(1993-5#1)(2006-6#1)(2007-7#1)(2008-2#1)(2008-6#1)(2010-12#1)(2010-3#1)(2012-3#1)
positive results and##4##3##(1990-3#1)(1993-8#1)(1997-5#1)(2009-5#1)
positive results for##3##3##(1997-2#1)(2011-1#1)(2011-2#1)
positive results from##2##3##(2006-7#1)(2010-4#1)
positive results in the##5##4##(1996-2#2)(1997-4#1)(2006-5#1)(2008-5#1)
positive results in##15##3##(1996-2#2)(1996-8#1)(1997-4#1)(1997-7#2)(2006-5#1)(2007-7#1)(2007-8#1)(2008-5#4)(2011-1#1)(2011-3#1)
positive results is##2##3##(1997-5#1)(2007-2#1)
positive results observed##3##3##(1992-12#1)(1997-4#1)(2007-7#1)
positive results obtained##2##3##(1997-4#1)(2011-2#1)
positive results of the##2##4##(1990-10#1)(1991-12#1)
positive results of##6##3##(1990-10#1)(1991-12#1)(1997-6#1)(2007-8#1)(2011-1#1)(2012-2#1)
positive results on##2##3##(1993-3#1)(2010-8#1)
positive results using##3##3##(2005-10#2)(2007-11#1)
positive results were observed##2##4##(1997-4#1)(2012-2#1)
positive results were##5##3##(1990-12#1)(1993-3#1)(1997-4#1)(1997-7#1)(2012-2#1)
positive results with the##2##4##(2008-9#1)(2011-2#1)
positive results##83##2##(1990-10#1)(1990-12#1)(1990-3#1)(1991-1#1)(1991-12#1)(1991-4#2)(1992-12#2)(1993-3#3)(1993-8#1)(1996-2#2)(1996-8#1)(1996-9#1)(1997-2#2)(1997-4#7)(1997-5#3)(1997-6#1)(1997-7#3)(1997-8#1)(2005-10#2)(2005-5#1)(2005-7#1)(2006-10#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-7#2)(2007-8#4)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#6)(2008-9#2)(2009-5#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#5)(2011-3#1)(2012-2#3)(2013-1#1)
positive returns##2##2##(1997-3#1)(2008-1#1)
positive rods##2##2##(2007-12#1)(2009-6#1)
positive role in##6##3##(1991-5#1)(1993-6#1)(1995-12#1)(2009-8#1)(2010-2#1)(2011-2#1)
positive role##9##2##(1991-5#1)(1993-6#1)(1995-12#1)(1995-2#1)(2008-12#1)(2009-8#1)(2010-2#1)(2011-2#1)(2013-1#1)
positive samples and##2##3##(2008-10#1)(2013-8#1)
positive samples by##2##3##(1991-9#1)(2011-2#1)
positive samples of##2##3##(1996-12#1)(2008-10#1)
positive samples were obtained##2##4##(1993-8#1)(2013-1#1)
positive samples were##9##3##(1991-3#1)(1993-8#1)(2007-1#1)(2007-7#1)(2008-1#1)(2011-1#1)(2013-1#2)(2013-8#1)
positive samples##36##2##(1991-3#1)(1991-6#1)(1991-9#1)(1993-2#1)(1993-8#1)(1996-12#2)(1997-6#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-12#1)(2010-12#1)(2010-6#3)(2011-1#2)(2011-2#3)(2012-12#3)(2013-1#2)(2013-7#1)(2013-8#4)
positive selection of##6##3##(1990-12#1)(1994-6#1)(1995-1#1)(1995-2#1)(2006-12#1)(2008-9#1)
positive selection operates on##2##4##(1994-8#2)
positive selection##24##2##(1990-12#1)(1990-8#1)(1994-6#3)(1994-8#2)(1995-1#1)(1995-2#1)(1995-8#1)(2006-12#1)(2007-2#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-9#1)(2010-7#1)(2012-12#2)(2012-2#1)(2012-3#1)
positive sense##2##2##(2005-11#1)(2007-3#1)
positive sensory phenomena##4##3##(2012-2#4)
positive sensory symptoms##2##3##(2008-7#1)(2012-2#1)
positive sensory##6##2##(2008-7#1)(2012-2#5)
positive sentinel##2##2##(2004-2#1)(2008-12#1)
positive sera (dot-blot##2##3##(1990-8#2)
positive sera##10##2##(1990-8#4)(1992-1#1)(1995-2#1)(1997-5#1)(2006-10#1)(2007-2#1)(2007-7#1)
positive serum samples##3##3##(2008-3#3)
positive serum##7##2##(1995-4#1)(2005-11#1)(2006-10#1)(2006-6#1)(2008-3#3)
positive shift##3##2##(1995-5#1)(2008-8#1)(2012-3#1)
positive shifts##2##2##(1997-4#1)(2007-10#1)
positive side##2##2##(1992-6#1)(2013-7#1)
positive sign##2##2##(1995-4#1)(2007-2#1)
positive signal##4##2##(1994-9#1)(1996-8#1)(1997-4#1)(2008-10#1)
positive signals##4##2##(2005-9#1)(2008-11#1)(2008-5#2)
positive significant##2##2##(2010-1#1)(2011-12#1)
positive single##2##2##(1992-11#1)(2009-12#1)
positive skin##2##2##(2006-7#1)(2013-1#1)
positive social##4##2##(2009-10#1)(2010-10#1)(2010-4#1)(2011-2#1)
positive specific##2##2##(2006-8#1)(2010-10#1)
positive specimens##3##2##(1993-2#1)(2010-4#1)(2011-1#1)
positive spherical##2##2##(2008-10#1)(2009-4#1)
positive staining for CD-117##2##4##(2012-12#2)
positive staining for##5##3##(2005-9#1)(2008-4#1)(2012-12#3)
positive staining of##2##3##(1993-9#1)(2008-8#1)
positive staining##11##2##(1993-9#1)(1997-7#1)(2005-10#1)(2005-9#1)(2008-4#1)(2008-8#1)(2010-6#1)(2012-12#3)(2013-1#1)
positive statements##2##2##(2007-12#1)(2008-5#1)
positive status##3##2##(2010-12#1)(2011-1#1)(2012-3#1)
positive steady state##2##3##(2013-8#2)
positive stool##4##2##(2005-11#1)(2007-12#1)(2012-2#1)(2012-3#1)
positive strains were##2##3##(1992-12#1)(2006-8#1)
positive strains##3##2##(1992-12#1)(2006-8#2)
positive strand##4##2##(1990-11#1)(1994-8#2)(2008-10#1)
positive strands##2##2##(1994-8#2)
positive stress##2##2##(2010-8#1)(2012-2#1)
positive structures in##2##3##(1994-2#1)(2010-2#1)
positive studies##2##2##(1992-8#1)(2008-6#1)
positive subjects##5##2##(1990-6#1)(1991-7#1)(2008-10#1)(2008-4#2)
positive supercoils##2##2##(1996-2#1)(1996-8#1)
positive surgical margins##5##3##(2006-9#1)(2008-6#2)(2011-2#2)
positive surgical##9##2##(2006-9#2)(2007-12#1)(2008-6#3)(2011-2#3)
positive symptoms##12##2##(1995-11#1)(1996-1#1)(1996-7#1)(1997-2#1)(1997-8#2)(2005-7#1)(2006-9#2)(2008-6#1)(2008-8#1)(2010-7#1)
positive test result##5##3##(1990-4#1)(1990-5#1)(1990-6#1)(1996-9#2)
positive test results##3##3##(1996-11#1)(1996-12#1)(2008-10#1)
positive test##17##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-12#1)(1992-9#1)(1994-1#1)(1994-2#1)(1995-4#1)(1996-11#1)(1996-12#1)(1996-9#2)(2007-2#1)(2007-7#1)(2008-10#1)(2011-1#1)
positive tests##3##2##(2006-2#1)(2008-1#1)(2011-2#1)
positive than in##2##3##(2007-9#1)(2009-8#1)
positive than##11##2##(1993-3#1)(1994-7#1)(1996-2#1)(1996-5#1)(1997-2#1)(2004-1#1)(2007-9#1)(2008-10#1)(2009-8#1)(2010-7#1)(2012-12#1)
positive thoughts##2##2##(2007-12#1)(2009-6#1)
positive tits were##2##3##(2008-5#2)
positive to negative##2##3##(1992-6#1)(1996-2#1)
positive to the##4##3##(1996-6#1)(2006-10#1)(2007-11#1)(2007-6#1)
positive to##23##2##(1990-2#1)(1990-3#1)(1991-8#1)(1992-6#1)(1995-5#1)(1996-2#1)(1996-6#1)(2006-10#3)(2007-11#1)(2007-2#1)(2007-6#1)(2008-10#1)(2010-11#1)(2010-2#1)(2011-12#2)(2011-2#1)(2013-1#1)(2013-8#3)
positive transcription##2##2##(2011-1#1)(2012-12#1)
positive treatment##3##2##(2006-5#1)(2008-11#1)(2011-1#1)
positive tuberculin skin##2##3##(2006-2#1)(2012-2#1)
positive tuberculin##4##2##(1990-6#1)(2006-2#1)(2012-2#1)(2013-1#1)
positive tumors##3##2##(1996-11#2)(1996-6#1)
positive tumours##2##2##(1995-9#1)(2004-2#1)
positive urine##2##2##(2006-4#1)(2008-5#1)
positive using##4##2##(1993-10#1)(1996-12#1)(2007-8#1)(2012-12#1)
positive valence##2##2##(2008-5#2)
positive value##6##2##(1995-6#1)(2004-11#1)(2005-11#1)(2006-7#1)(2008-5#1)(2011-2#1)
positive values in the##3##4##(1996-12#1)(2008-10#2)
positive values##11##2##(1990-11#1)(1990-8#1)(1993-12#1)(1996-12#1)(2005-11#2)(2008-10#5)
positive viral##2##2##(1992-11#1)(2013-8#1)
positive was##4##2##(2007-2#1)(2008-4#2)(2011-1#1)
positive well-being##3##2##(2010-6#3)
positive were##5##2##(2007-7#1)(2008-1#1)(2008-3#1)(2010-4#1)(2011-1#1)
positive while##4##2##(2007-12#1)(2007-2#1)(2010-4#1)(2012-2#1)
positive with C##2##3##(2008-10#2)
positive with all##2##3##(1995-12#1)(1997-7#1)
positive with anti-IgG and##2##4##(1992-3#1)(1994-12#1)
positive with##21##2##(1991-2#1)(1991-4#1)(1991-7#1)(1992-3#1)(1993-11#1)(1993-9#1)(1994-12#1)(1995-12#1)(1996-6#2)(1997-7#1)(2006-4#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
positive women##4##2##(2007-12#2)(2011-2#1)(2012-3#1)
positive words (e##2##3##(2007-12#2)
positive words##8##2##(2006-3#2)(2007-12#3)(2008-6#1)(2012-12#2)
positive working##3##2##(1993-1#2)(1994-12#1)
positive##3808##1##(1990-1#1)(1990-10#14)(1990-11#6)(1990-12#8)(1990-2#12)(1990-3#12)(1990-4#11)(1990-5#9)(1990-6#16)(1990-7#4)(1990-8#27)(1990-9#3)(1991-1#5)(1991-10#4)(1991-11#4)(1991-12#11)(1991-2#12)(1991-3#9)(1991-4#20)(1991-5#8)(1991-6#9)(1991-7#5)(1991-8#10)(1991-9#27)(1992-1#7)(1992-10#6)(1992-11#6)(1992-12#15)(1992-2#10)(1992-3#27)(1992-4#10)(1992-5#11)(1992-6#13)(1992-7#6)(1992-8#14)(1992-9#10)(1993-1#17)(1993-10#11)(1993-11#10)(1993-12#17)(1993-2#10)(1993-3#17)(1993-4#5)(1993-5#13)(1993-6#6)(1993-7#5)(1993-8#14)(1993-9#14)(1994-1#4)(1994-10#4)(1994-11#4)(1994-12#21)(1994-2#12)(1994-3#14)(1994-4#2)(1994-5#8)(1994-6#16)(1994-7#10)(1994-8#18)(1994-9#11)(1995-1#9)(1995-10#8)(1995-11#10)(1995-12#14)(1995-2#13)(1995-3#7)(1995-4#16)(1995-5#11)(1995-6#9)(1995-7#1)(1995-8#13)(1995-9#6)(1996-1#8)(1996-10#1)(1996-11#4)(1996-12#19)(1996-2#19)(1996-3#13)(1996-4#6)(1996-5#6)(1996-6#19)(1996-7#5)(1996-8#8)(1996-9#18)(1997-1#5)(1997-2#32)(1997-3#8)(1997-4#32)(1997-5#11)(1997-6#12)(1997-7#30)(1997-8#19)(2004-1#11)(2004-11#15)(2004-12#2)(2004-2#10)(2004-3#3)(2004-4#2)(2004-9#3)(2005-1#3)(2005-10#29)(2005-11#32)(2005-12#8)(2005-3#1)(2005-5#2)(2005-6#1)(2005-7#6)(2005-8#9)(2005-9#8)(2006-1#5)(2006-10#72)(2006-11#4)(2006-12#19)(2006-2#19)(2006-3#7)(2006-4#9)(2006-5#9)(2006-6#27)(2006-7#14)(2006-8#57)(2006-9#14)(2007-1#10)(2007-10#24)(2007-11#40)(2007-12#78)(2007-2#64)(2007-3#20)(2007-4#4)(2007-5#13)(2007-6#13)(2007-7#106)(2007-8#72)(2007-9#10)(2008-1#49)(2008-10#174)(2008-11#67)(2008-12#47)(2008-2#24)(2008-3#38)(2008-4#53)(2008-5#114)(2008-6#32)(2008-7#42)(2008-8#83)(2008-9#52)(2009-1#1)(2009-10#10)(2009-11#10)(2009-12#16)(2009-2#11)(2009-3#11)(2009-4#16)(2009-5#14)(2009-6#13)(2009-7#19)(2009-8#23)(2009-9#16)(2010-1#10)(2010-10#15)(2010-11#15)(2010-12#47)(2010-2#24)(2010-3#18)(2010-4#24)(2010-5#11)(2010-6#17)(2010-7#14)(2010-8#25)(2010-9#8)(2011-1#83)(2011-12#17)(2011-2#167)(2011-3#6)(2011-7#1)(2012-1#31)(2012-11#2)(2012-12#74)(2012-2#94)(2012-3#50)(2013-1#129)(2013-7#20)(2013-8#79)
positive&quot##4##1##(1990-2#1)(1991-8#1)(1992-5#1)(2009-3#1)
positive) and 0##2##3##(1996-12#2)
positive)##14##1##(1991-1#1)(1991-8#1)(1993-9#2)(1996-12#2)(2005-1#1)(2007-11#1)(2008-11#1)(2008-6#2)(2011-1#1)(2012-12#1)(2012-2#1)
positive- and negative-ion##2##3##(1990-9#1)(2008-10#1)
positive- and##4##2##(1990-9#1)(1991-6#1)(2008-10#1)(2008-3#1)
positive-acting##5##1##(1990-10#1)(1991-6#1)(1992-5#1)(1994-9#1)(2009-8#1)
positive-branch unstable##2##2##(2008-3#2)
positive-branch##4##1##(2007-11#1)(2008-3#3)
positive-ion mode##3##2##(2008-10#2)(2011-1#1)
positive-ion##7##1##(2008-10#5)(2009-6#1)(2011-1#1)
positive-negative##3##1##(1990-8#1)(1995-8#1)(2006-5#1)
positive-pressure ventilation##6##2##(2005-8#1)(2008-1#1)(2008-10#1)(2013-1#3)
positive-pressure##7##1##(2005-8#1)(2007-10#1)(2008-1#1)(2008-10#1)(2013-1#3)
positive-selection cloning vectors##2##3##(1995-8#2)
positive-selection##3##1##(1995-8#3)
positive-sense RNA##2##2##(1995-8#1)(2008-9#1)
positive-sense##5##1##(1995-8#2)(2008-10#1)(2008-9#2)
positive-side shift##2##2##(1992-6#2)
positive-strand RNA viruses##2##3##(2008-4#1)(2008-9#1)
positive-strand RNA##3##2##(2008-4#1)(2008-9#2)
positive-strand##4##1##(2008-4#1)(2008-9#3)
positive/negative cooperativity##4##2##(2010-7#4)
positive/negative##7##1##(2005-11#1)(2009-11#1)(2010-7#4)(2011-2#1)
positively affect the##3##3##(1995-12#1)(2007-12#1)(2009-6#1)
positively affect##5##2##(1995-12#1)(2006-3#1)(2007-12#1)(2007-9#1)(2009-6#1)
positively affected##3##2##(1990-11#1)(2008-10#1)(2010-8#1)
positively and negatively##7##3##(2007-11#1)(2007-12#1)(2008-11#1)(2009-12#1)(2011-2#3)
positively and significantly##2##3##(2006-4#1)(2008-7#1)
positively and##16##2##(1996-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#3)(2012-1#2)(2012-3#1)(2013-1#1)
positively associated with age##2##4##(2011-2#1)(2013-1#1)
positively associated with the##9##4##(1995-8#1)(2008-11#1)(2008-8#2)(2009-11#1)(2009-9#2)(2010-12#1)(2013-1#1)
positively associated with##51##3##(1993-12#1)(1993-6#1)(1995-8#1)(1996-3#2)(1996-9#1)(1997-2#1)(2005-11#1)(2006-7#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-7#2)(2009-9#4)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#2)(2012-11#1)(2012-3#1)(2013-1#6)
positively associated##53##2##(1993-12#1)(1993-6#1)(1995-8#1)(1996-3#2)(1996-9#1)(1997-2#1)(2005-11#1)(2006-7#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-7#2)(2009-9#4)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#2)(2012-11#1)(2012-3#1)(2013-1#6)
positively biased##3##2##(1994-5#1)(2008-4#1)(2011-1#1)
positively by the##2##3##(1996-12#1)(2011-2#1)
positively by##3##2##(1996-12#1)(1996-3#1)(2011-2#1)
positively charged amino acids in##2##5##(1990-3#1)(2008-8#1)
positively charged amino acids##7##4##(1990-3#1)(1990-8#1)(1994-12#1)(1995-5#3)(2008-8#1)
positively charged amino##8##3##(1990-3#1)(1990-8#1)(1994-12#1)(1995-5#3)(1996-5#1)(2008-8#1)
positively charged and polar residues##2##5##(1994-9#1)(2006-10#1)
positively charged and##3##3##(1994-9#1)(2006-10#1)(2008-2#1)
positively charged complexes##2##3##(2008-10#2)
positively charged gold##2##3##(2007-8#1)(2008-10#1)
positively charged group##2##3##(1990-5#2)
positively charged histidine##2##3##(1991-8#1)(2008-10#1)
positively charged lipid##2##3##(2009-12#2)
positively charged lysine##2##3##(1991-2#1)(1991-8#1)
positively charged nylon##2##3##(2008-11#1)(2008-4#1)
positively charged protein##2##3##(1990-5#1)(1994-9#1)
positively charged proteins##2##3##(1990-11#1)(1994-9#1)
positively charged residue##3##3##(1992-8#1)(1996-6#1)(1997-7#1)
positively charged residues##9##3##(1992-11#3)(1997-8#2)(2008-8#3)(2011-1#1)
positively charged side chains##2##4##(1992-9#1)(2006-12#1)
positively charged surfaces##2##3##(2008-10#1)(2009-12#1)
positively charged##87##2##(1990-1#2)(1990-11#1)(1990-3#1)(1990-5#4)(1990-8#1)(1991-2#1)(1991-5#1)(1991-8#2)(1992-11#3)(1992-6#1)(1992-8#1)(1992-9#2)(1993-2#1)(1993-3#2)(1994-12#1)(1994-3#1)(1994-9#4)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#3)(1996-5#2)(1996-6#1)(1997-3#2)(1997-7#1)(1997-8#3)(2005-11#7)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#4)(2009-12#3)(2009-2#1)(2009-3#1)(2010-4#1)(2011-1#2)
positively controlled by##3##3##(1990-3#1)(1990-5#2)
positively correlated to host##2##4##(2008-10#2)
positively correlated to##8##3##(2004-12#1)(2006-10#1)(2008-10#3)(2008-7#1)(2011-2#1)(2013-7#1)
positively correlated with a##2##4##(2008-10#1)(2009-6#1)
positively correlated with age##3##4##(1994-6#1)(2007-10#1)(2011-1#1)
positively correlated with children's##3##4##(2010-11#3)
positively correlated with high##2##4##(2008-10#1)(2012-11#1)
positively correlated with primary##2##4##(2008-8#1)(2012-1#1)
positively correlated with the degree of##3##6##(1991-7#1)(2007-7#1)(2008-6#1)
positively correlated with the##27##4##(1990-7#1)(1991-12#1)(1991-7#1)(1993-5#1)(1996-6#1)(1997-6#1)(2004-11#1)(2005-11#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-8#1)(2012-12#2)(2013-8#2)
positively correlated with##111##3##(1990-4#1)(1990-7#1)(1991-12#2)(1991-2#1)(1991-7#1)(1991-8#1)(1993-12#1)(1993-5#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-6#2)(1995-12#2)(1996-6#1)(1997-6#1)(2004-11#2)(2005-11#1)(2006-1#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#30)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-11#3)(2010-12#2)(2010-4#2)(2010-5#1)(2010-8#2)(2011-1#4)(2011-10#2)(2011-2#3)(2012-1#3)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#3)
positively correlated##132##2##(1990-4#2)(1990-7#1)(1991-12#2)(1991-2#1)(1991-7#1)(1991-8#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-6#2)(1995-12#2)(1995-3#1)(1996-6#1)(1997-6#1)(2004-11#2)(2004-12#1)(2005-11#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#34)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-11#3)(2010-12#2)(2010-4#2)(2010-5#1)(2010-8#2)(2011-1#4)(2011-10#2)(2011-2#6)(2012-1#3)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#6)(2013-7#3)(2013-8#4)
positively correlates with##3##3##(2008-4#1)(2009-4#1)(2013-1#1)
positively for##9##2##(1991-5#1)(1991-9#1)(1996-10#1)(1996-11#1)(2005-9#1)(2008-4#1)(2008-7#1)(2010-11#1)(2013-8#1)
positively identified as##4##3##(1994-12#1)(1995-6#1)(2008-10#2)
positively identified##11##2##(1991-2#1)(1994-12#1)(1994-9#2)(1995-11#1)(1995-6#1)(2008-10#5)
positively impact##5##2##(2006-5#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-9#1)
positively in##2##2##(1990-3#1)(1991-7#1)
positively influence the##4##3##(1994-12#1)(2006-10#1)(2007-4#1)(2010-5#1)
positively influence##5##2##(1994-12#1)(1994-2#1)(2006-10#1)(2007-4#1)(2010-5#1)
positively influenced##7##2##(1993-10#1)(1993-12#1)(2007-9#1)(2009-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
positively on##4##2##(1990-2#1)(1992-5#1)(2008-10#1)(2010-3#1)
positively or negatively##8##3##(1994-2#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-9#1)
positively or##9##2##(1994-2#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-9#1)
positively predicted##3##2##(2008-9#1)(2011-2#2)
positively regulated by##3##3##(1994-12#1)(1995-3#1)(2010-12#1)
positively regulates the##2##3##(1994-9#1)(2011-1#1)
positively regulates##6##2##(1992-5#1)(1994-9#1)(1995-11#1)(2009-8#1)(2011-1#1)(2013-1#1)
positively related to adolescents'##2##4##(2009-11#1)(2009-7#1)
positively related to physical##2##4##(2009-4#1)(2009-7#1)
positively related to the amount of##2##6##(2010-12#1)(2011-2#1)
positively related to the likelihood of##2##6##(1992-2#1)(2008-12#1)
positively related to the##8##4##(1992-2#1)(1995-2#1)(1996-12#1)(2008-12#1)(2009-8#2)(2010-12#1)(2011-2#1)
positively related to##47##3##(1990-8#1)(1991-11#1)(1991-12#1)(1992-2#2)(1995-12#1)(1995-2#1)(1995-7#1)(1996-12#1)(2006-10#2)(2006-3#1)(2007-12#2)(2008-10#1)(2008-12#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#1)(2009-4#4)(2009-5#1)(2009-7#3)(2009-8#2)(2010-12#1)(2010-2#2)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#1)
positively related with##3##3##(2010-12#2)(2010-8#1)
positively related##51##2##(1990-8#1)(1991-11#1)(1991-12#1)(1992-2#2)(1995-12#1)(1995-2#1)(1995-7#1)(1996-12#1)(2006-10#2)(2006-3#1)(2007-12#2)(2008-10#1)(2008-12#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#1)(2009-4#4)(2009-5#1)(2009-7#3)(2009-8#2)(2010-12#3)(2010-2#2)(2010-8#1)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#1)
positively selected##7##2##(1990-8#1)(1995-12#1)(2007-3#1)(2008-10#1)(2008-4#1)(2010-8#2)
positively selecting##2##2##(1994-6#2)
positively stained##5##2##(1992-3#2)(1993-12#1)(1995-3#1)(1997-2#1)
positively the##4##2##(2006-6#1)(2010-9#1)(2011-1#1)(2013-1#1)
positively to adult##2##3##(1991-3#2)
positively to the##2##3##(2007-5#1)(2010-7#1)
positively to##17##2##(1991-3#2)(1992-3#1)(1994-12#1)(1997-7#1)(2005-10#2)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-5#1)(2010-7#1)(2013-1#1)
positively with temperature and##2##4##(2005-11#1)(2008-10#1)
positively with the##13##3##(1995-8#1)(2006-12#1)(2006-3#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-8#1)(2010-10#1)(2013-8#2)
positively with##45##2##(1990-2#1)(1991-11#1)(1993-7#1)(1995-1#1)(1995-7#1)(1995-8#2)(1996-5#1)(2004-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#3)(2008-10#6)(2008-11#1)(2008-2#1)(2008-8#2)(2010-10#1)(2010-8#2)(2011-1#2)(2011-10#1)(2011-2#3)(2012-1#1)(2013-1#3)(2013-8#2)
positively##551##1##(1990-1#2)(1990-11#4)(1990-2#2)(1990-3#3)(1990-4#3)(1990-5#6)(1990-7#1)(1990-8#3)(1991-11#2)(1991-12#3)(1991-2#3)(1991-3#2)(1991-5#3)(1991-7#2)(1991-8#3)(1991-9#1)(1992-11#3)(1992-2#2)(1992-3#3)(1992-5#3)(1992-6#1)(1992-8#1)(1992-9#2)(1993-10#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#3)(1993-7#1)(1994-1#1)(1994-12#7)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#4)(1994-9#8)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#5)(1995-2#2)(1995-3#3)(1995-5#3)(1995-6#2)(1995-7#2)(1995-8#4)(1996-10#1)(1996-11#1)(1996-12#3)(1996-3#3)(1996-5#3)(1996-6#2)(1996-9#1)(1997-2#2)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#4)(2004-10#1)(2004-11#2)(2004-12#1)(2005-10#2)(2005-11#10)(2005-9#2)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-3#3)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#4)(2007-11#2)(2007-12#7)(2007-2#3)(2007-3#5)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#4)(2007-9#3)(2008-1#2)(2008-10#66)(2008-11#13)(2008-12#6)(2008-2#3)(2008-3#4)(2008-4#9)(2008-5#8)(2008-6#3)(2008-7#10)(2008-8#18)(2008-9#8)(2009-1#1)(2009-10#3)(2009-11#3)(2009-12#5)(2009-2#1)(2009-3#1)(2009-4#5)(2009-5#5)(2009-6#4)(2009-7#7)(2009-8#4)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#7)(2010-2#4)(2010-3#2)(2010-4#3)(2010-5#3)(2010-7#2)(2010-8#9)(2010-9#3)(2011-1#15)(2011-10#3)(2011-12#1)(2011-2#26)(2012-1#8)(2012-11#2)(2012-12#5)(2012-2#1)(2012-3#6)(2013-1#21)(2013-7#3)(2013-8#8)
positives and false negatives##3##4##(2008-7#1)(2011-2#1)(2012-2#1)
positives and##14##2##(1995-3#1)(1997-2#3)(2004-11#1)(2008-10#3)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#3)
positives cases##3##2##(2011-2#3)
positives##50##1##(1990-12#1)(1991-2#1)(1992-7#1)(1993-10#2)(1994-7#1)(1995-3#1)(1997-2#3)(1997-8#1)(2004-1#1)(2004-11#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-6#1)(2011-2#6)(2012-2#1)(2012-3#9)(2013-1#2)(2013-7#2)
positives) and##3##2##(2012-12#1)(2013-1#2)
positivism##4##1##(1993-2#1)(2012-2#2)(2013-1#1)
positivist##3##1##(2008-11#1)(2009-10#1)(2009-7#1)
positivistic##3##1##(1993-2#2)(1993-6#1)
positivities##2##1##(1997-1#1)(2007-7#1)
positivity among##3##2##(1991-1#1)(2007-7#2)
positivity and##5##2##(1990-6#1)(2007-8#1)(2009-7#1)(2011-1#1)(2011-2#1)
positivity by##3##2##(1994-1#1)(2007-7#1)(2011-2#1)
positivity constraint##5##2##(2008-2#2)(2013-1#3)
positivity for smooth muscle actin##2##5##(2008-7#1)(2010-12#1)
positivity for##22##2##(1990-12#1)(1990-4#1)(1991-12#1)(1992-8#1)(1995-12#1)(1997-7#1)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-12#1)(2008-7#1)(2010-12#3)(2010-6#1)(2012-1#2)(2013-8#1)
positivity in##9##2##(1992-6#1)(1993-5#1)(2006-9#1)(2008-4#2)(2011-1#1)(2011-2#1)(2012-3#2)
positivity is##2##2##(1991-11#1)(2006-12#1)
positivity of the##4##3##(1997-8#1)(2006-8#1)(2008-11#1)(2008-5#1)
positivity of##15##2##(1990-4#1)(1991-8#1)(1991-9#1)(1997-8#1)(2006-8#3)(2006-9#1)(2007-7#3)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
positivity on##2##2##(2008-4#1)(2010-1#1)
positivity rate of##3##3##(2007-7#2)(2013-1#1)
positivity rate was##3##3##(2006-8#1)(2007-7#2)
positivity rate##7##2##(1992-6#1)(2006-8#1)(2007-7#4)(2013-1#1)
positivity was also##2##3##(2004-2#1)(2009-3#1)
positivity was found in##4##4##(1994-10#1)(1994-3#1)(2007-7#1)(2007-8#1)
positivity was seen in##2##4##(2007-7#2)
positivity was##17##2##(1994-10#1)(1994-3#1)(1994-9#1)(1996-12#1)(1996-3#1)(2004-2#1)(2007-7#6)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-3#1)
positivity were##3##2##(1990-4#1)(2011-2#2)
positivity##134##1##(1990-12#1)(1990-4#3)(1990-6#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-4#3)(1991-8#2)(1991-9#1)(1992-6#3)(1992-8#1)(1993-5#1)(1994-1#1)(1994-10#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-3#2)(1996-4#1)(1997-2#2)(1997-7#3)(1997-8#1)(2004-2#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#4)(2006-9#2)(2007-11#1)(2007-2#2)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#21)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#4)(2008-4#4)(2008-5#3)(2008-7#1)(2009-3#3)(2009-7#1)(2010-1#2)(2010-11#1)(2010-12#3)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-1#2)(2012-2#3)(2012-3#3)(2013-1#7)(2013-8#2)
positivity)##3##1##(1990-3#1)(1993-7#1)(2008-12#1)
positron emission tomographic (PET)##4##4##(1992-5#1)(1997-8#1)(2007-10#1)(2010-12#1)
positron emission tomographic##6##3##(1992-5#1)(1995-8#1)(1997-8#1)(2007-10#1)(2009-10#1)(2010-12#1)
positron emission tomography (PET) and##5##5##(1995-12#1)(1996-5#2)(2006-9#1)(2008-8#1)
positron emission tomography (PET) have##2##5##(1995-2#1)(2008-8#1)
positron emission tomography (PET) in##5##5##(1993-9#1)(1996-2#1)(2006-11#1)(2008-7#1)(2010-3#1)
positron emission tomography (PET) studies##2##5##(1994-9#1)(2012-12#1)
positron emission tomography (PET) to##3##5##(1995-11#1)(1995-12#1)(2007-10#1)
positron emission tomography (PET)##30##4##(1990-8#1)(1992-10#1)(1992-3#1)(1993-9#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#1)(1996-2#1)(1996-5#3)(1996-7#1)(1997-6#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-10#1)(2007-4#1)(2008-1#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-3#1)(2012-12#1)(2012-2#1)
positron emission tomography and functional magnetic resonance imaging##2##8##(1994-3#1)(2008-2#1)
positron emission tomography and single photon emission computed tomography##2##9##(2007-9#1)(2010-12#1)
positron emission tomography and##6##4##(1994-3#1)(2005-8#1)(2007-9#1)(2008-2#1)(2010-12#1)(2013-8#1)
positron emission tomography have##2##4##(2007-4#1)(2008-2#1)
positron emission tomography in##5##4##(1995-11#1)(1996-2#1)(2004-1#1)(2008-12#1)(2009-5#1)
positron emission tomography scan##3##4##(2012-2#1)(2013-1#2)
positron emission tomography study##3##4##(1996-3#1)(2006-11#1)(2008-8#1)
positron emission tomography##81##3##(1990-2#1)(1990-8#1)(1992-1#1)(1992-10#1)(1992-3#2)(1992-5#1)(1993-11#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#3)(1995-2#1)(1995-5#1)(1995-9#1)(1996-2#4)(1996-3#1)(1996-5#5)(1996-7#1)(1997-5#1)(1997-6#2)(2004-1#1)(2005-8#1)(2005-9#2)(2006-10#2)(2006-11#2)(2006-2#1)(2006-9#1)(2007-10#1)(2007-4#2)(2007-9#1)(2008-1#3)(2008-12#1)(2008-2#3)(2008-7#2)(2008-8#3)(2009-11#1)(2009-5#1)(2010-12#3)(2010-3#1)(2010-9#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
positron emission tomography/computed tomography##2##4##(2010-12#1)(2012-12#1)
positron emission##94##2##(1990-2#1)(1990-5#1)(1990-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-3#2)(1992-5#2)(1993-11#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#3)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-2#4)(1996-3#1)(1996-5#5)(1996-7#1)(1997-5#1)(1997-6#3)(1997-8#1)(2004-1#1)(2005-8#1)(2005-9#2)(2006-10#2)(2006-11#2)(2006-2#1)(2006-9#1)(2007-10#2)(2007-4#2)(2007-9#1)(2008-1#3)(2008-12#1)(2008-2#3)(2008-7#2)(2008-8#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2010-12#6)(2010-3#1)(2010-9#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
positron emitting##2##2##(1992-5#1)(2010-6#1)
positron tracer##3##2##(2010-12#3)
positron##107##1##(1990-2#2)(1990-5#1)(1990-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-3#2)(1992-5#3)(1993-11#1)(1993-4#1)(1993-9#1)(1994-3#1)(1994-9#3)(1995-1#1)(1995-11#3)(1995-12#3)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-2#4)(1996-3#1)(1996-5#5)(1996-7#1)(1997-5#1)(1997-6#3)(1997-8#1)(2004-1#1)(2005-11#2)(2005-8#1)(2005-9#2)(2006-10#2)(2006-11#2)(2006-2#1)(2006-9#1)(2007-10#2)(2007-4#2)(2007-9#1)(2008-1#3)(2008-12#1)(2008-2#3)(2008-7#2)(2008-8#4)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2010-12#9)(2010-3#1)(2010-6#1)(2010-9#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#2)
positron-emission tomography (PET)##3##3##(2007-9#2)(2011-2#1)
positron-emission tomography##6##2##(1990-5#2)(2007-9#2)(2009-10#1)(2011-2#1)
positron-emission##7##1##(1990-5#2)(2007-9#2)(2009-10#1)(2011-2#2)
positrons##3##1##(1995-7#1)(2006-5#1)(2007-9#1)
posits a##2##2##(1995-1#1)(2009-7#1)
posits that the##3##3##(1994-3#1)(2008-11#2)
posits that##10##2##(1994-3#1)(2007-9#1)(2008-11#2)(2008-8#1)(2009-11#1)(2010-1#1)(2010-2#1)(2011-12#1)(2013-1#1)
posits the##2##2##(2008-12#1)(2012-2#1)
posits##16##1##(1994-3#1)(1995-1#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-2#1)(2011-12#1)(2012-2#1)(2013-1#1)
posses a##3##2##(2008-10#2)(2008-11#1)
posses##12##1##(1994-8#1)(2007-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#1)(2009-8#1)(2010-8#1)(2013-7#1)
posseses##2##1##(2007-12#1)(2008-5#1)
possess a greater##2##3##(1991-6#1)(2007-9#1)
possess a high##2##3##(2008-2#1)(2010-4#1)
possess a low##2##3##(1996-8#1)(2010-4#1)
possess a number of##3##4##(2007-12#1)(2010-5#1)(2013-1#1)
possess a remarkable##2##3##(2007-11#1)(2008-8#1)
possess a similar##2##3##(1996-2#1)(2008-5#1)
possess a unique##3##3##(1995-6#1)(1995-8#1)(2009-8#1)
possess a##69##2##(1990-4#1)(1990-7#1)(1991-6#1)(1991-8#1)(1993-12#1)(1993-5#1)(1993-7#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-8#2)(1997-2#1)(1997-5#1)(1997-6#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#6)(2007-9#1)(2008-1#2)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-8#4)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-4#2)(2010-5#2)(2010-7#1)(2011-1#1)(2011-12#1)(2012-12#1)(2013-1#2)
possess an intrinsic##2##3##(1997-1#1)(2008-7#1)
possess an##21##2##(1990-3#1)(1994-11#1)(1996-9#1)(1997-1#2)(2005-11#2)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-8#1)(2010-10#1)(2010-8#1)(2012-1#2)(2012-11#1)(2013-7#1)
possess anesthetic##2##2##(1991-11#1)(2012-2#1)
possess anxiolytic##2##2##(1991-11#1)(2007-11#1)
possess both##4##2##(1990-5#1)(1993-6#1)(1995-8#1)(2008-10#1)
possess different##3##2##(1994-9#1)(2011-1#1)(2012-1#1)
possess either##2##2##(1994-12#1)(2007-1#1)
possess enormous##2##2##(2009-2#1)(2009-6#1)
possess excellent##3##2##(1997-1#1)(2008-5#1)(2011-1#1)
possess four##2##2##(1995-11#1)(2008-2#1)
possess good##5##2##(2007-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2010-12#1)
possess greater##4##2##(2005-11#1)(2006-9#1)(2009-4#1)(2009-7#1)
possess high##4##2##(1991-1#1)(1993-4#1)(2008-10#1)(2010-12#1)
possess higher##2##2##(2008-7#1)(2009-4#1)
possess immunomodulatory##3##2##(1993-12#1)(2007-11#1)(2012-2#1)
possess in##4##2##(1992-2#1)(1995-11#1)(1997-4#1)(1997-6#1)
possess increased##2##2##(1992-3#1)(2006-12#1)
possess inhibitory##2##2##(2008-11#1)(2008-7#1)
possess intrinsic tyrosine kinase activity##3##5##(1992-7#1)(1995-8#1)(2010-3#1)
possess intrinsic##5##2##(1992-7#1)(1995-8#1)(1997-4#1)(2008-1#1)(2010-3#1)
possess many advantages##2##3##(2004-9#1)(2008-4#1)
possess many##3##2##(2004-9#1)(2008-4#1)(2010-11#1)
possess multiple##2##2##(1990-12#1)(1991-7#1)
possess potent##6##2##(1994-5#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-1#1)(2012-2#1)
possess powerful##2##2##(2012-1#1)(2012-12#1)
possess several##3##2##(1990-5#1)(2007-11#1)(2008-10#1)
possess significant##3##2##(2007-5#1)(2008-3#1)(2008-9#1)
possess similar##5##2##(1991-9#1)(1994-9#1)(1996-10#1)(1997-1#1)(2006-8#1)
possess some##4##2##(2006-9#1)(2007-11#1)(2008-10#1)(2013-7#1)
possess specific##4##2##(1991-2#1)(1992-9#1)(1995-8#1)(2008-7#1)
possess strongly##2##2##(2007-11#1)(2008-10#1)
possess the ability to differentiate into##3##6##(2006-6#1)(2008-9#2)
possess the ability to##8##4##(1992-6#1)(1995-8#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-9#2)
possess the same##4##3##(1993-9#1)(1995-1#1)(2008-10#1)(2008-9#1)
possess the##40##2##(1990-2#1)(1992-6#2)(1992-7#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-8#2)(1995-1#1)(1995-8#1)(2005-11#1)(2005-7#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-9#3)(2009-8#1)(2010-8#1)(2011-2#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-8#1)
possess two types of##2##4##(1992-3#1)(2007-12#1)
possess two##6##2##(1992-3#1)(1994-11#1)(2007-12#1)(2008-11#1)(2010-11#1)(2013-1#1)
possess unique properties##2##3##(2006-10#1)(2008-11#1)
possess unique##3##2##(2006-10#1)(2008-11#1)(2008-3#1)
possess##406##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#1)(1991-1#2)(1991-11#2)(1991-12#3)(1991-2#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#4)(1992-3#7)(1992-4#2)(1992-6#4)(1992-7#5)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#4)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#3)(1993-7#2)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#4)(1994-5#3)(1994-6#1)(1994-8#5)(1994-9#4)(1995-1#6)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#4)(1995-6#2)(1995-8#7)(1996-1#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-8#4)(1996-9#1)(1997-1#4)(1997-2#2)(1997-4#4)(1997-5#1)(1997-6#2)(1997-8#1)(2004-9#1)(2005-11#6)(2005-4#1)(2005-6#1)(2005-7#3)(2005-8#1)(2006-1#1)(2006-10#3)(2006-12#8)(2006-2#1)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#3)(2007-11#9)(2007-12#14)(2007-2#1)(2007-4#1)(2007-5#3)(2007-7#1)(2007-9#1)(2008-1#7)(2008-10#33)(2008-11#10)(2008-12#1)(2008-2#6)(2008-3#7)(2008-4#5)(2008-5#19)(2008-7#11)(2008-8#7)(2008-9#6)(2009-11#1)(2009-12#4)(2009-2#4)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#5)(2010-4#4)(2010-5#5)(2010-7#2)(2010-8#4)(2011-1#4)(2011-12#1)(2011-2#4)(2011-3#1)(2012-1#5)(2012-11#3)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#8)(2013-7#2)(2013-8#2)
possessed a high##2##3##(2005-11#2)
possessed a##20##2##(1990-5#1)(1993-3#1)(1993-9#2)(2005-11#4)(2006-5#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-4#1)(2011-12#1)(2013-1#1)(2013-8#1)
possessed an##4##2##(1993-12#1)(1993-8#1)(1996-5#1)(2005-8#1)
possessed both##3##2##(2005-11#1)(2006-8#1)(2008-5#1)
possessed by the##2##3##(2008-10#1)(2008-8#1)
possessed by##4##2##(2008-10#3)(2008-8#1)
possessed high##4##2##(1991-3#1)(2008-10#1)(2010-6#1)(2013-8#1)
possessed higher##2##2##(1996-8#1)(2008-10#1)
possessed local##2##2##(1995-1#1)(2007-12#1)
possessed low##2##2##(2004-2#2)
possessed only##2##2##(1995-1#1)(2008-10#1)
possessed significant##2##2##(2009-10#1)(2010-12#1)
possessed similar##2##2##(1991-8#1)(1997-4#1)
possessed strong##2##2##(1991-12#1)(2004-2#1)
possessed the highest##3##3##(1993-9#1)(1994-9#1)(2007-10#1)
possessed the lowest##2##3##(1993-9#1)(1995-8#1)
possessed the pharmacological##2##3##(1992-3#1)(1992-5#1)
possessed the##20##2##(1990-12#1)(1992-11#1)(1992-3#1)(1992-5#1)(1993-9#3)(1994-9#1)(1995-8#1)(1997-2#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-6#1)(2013-1#1)(2013-8#1)
possessed##128##1##(1990-12#3)(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#2)(1993-9#5)(1994-12#1)(1994-3#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-3#1)(1995-8#2)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-6#1)(2004-12#1)(2004-2#3)(2005-11#6)(2005-8#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#21)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-6#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-9#1)(2011-12#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#5)
possesses a high##5##3##(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)
possesses a higher##3##3##(1992-8#1)(2008-10#1)(2010-5#1)
possesses a unique##2##3##(1991-8#1)(1993-6#1)
possesses a##55##2##(1990-2#1)(1990-7#1)(1991-4#1)(1991-8#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#2)(1993-6#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-3#1)(1995-6#2)(1996-10#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#2)(2004-7#1)(2006-3#1)(2007-1#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-10#5)(2008-2#2)(2008-3#4)(2008-7#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-5#1)(2012-12#1)
possesses all##2##2##(2007-11#1)(2008-7#1)
possesses an##12##2##(1992-1#1)(1992-7#1)(1992-8#2)(1993-1#1)(1997-4#1)(2004-4#1)(2006-10#2)(2008-4#1)(2008-9#1)(2010-2#1)
possesses both##6##2##(1994-5#1)(1995-6#1)(1996-9#1)(2006-12#1)(2007-11#1)(2008-11#1)
possesses extraordinary##2##2##(2006-4#1)(2009-2#1)
possesses extremely##2##2##(2008-3#1)(2013-1#1)
possesses high##2##2##(2008-3#1)(2013-7#1)
possesses intrinsic##3##2##(1996-11#1)(2009-10#2)
possesses one##2##2##(1994-12#1)(2008-10#1)
possesses several##4##2##(1997-8#1)(2005-7#1)(2007-9#1)(2008-7#1)
possesses significant##3##2##(1994-5#1)(2011-1#1)(2011-2#1)
possesses some##4##2##(1992-6#1)(1995-5#1)(2008-10#1)(2013-1#1)
possesses the ability to##3##4##(1993-11#1)(1996-2#1)(2010-1#1)
possesses the property##2##3##(1997-7#1)(2008-2#1)
possesses the unique##2##3##(1993-11#1)(2007-11#1)
possesses the##24##2##(1992-1#1)(1992-7#1)(1993-11#2)(1994-9#1)(1996-2#2)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-9#1)(2012-1#1)
possesses three##2##2##(2007-12#1)(2011-2#1)
possesses two##5##2##(1991-12#1)(1991-7#1)(1994-12#1)(2007-12#1)(2008-7#1)
possesses unique##2##2##(2007-10#1)(2008-11#1)
possesses valuable##2##2##(2008-1#1)(2008-8#1)
possesses##205##1##(1990-10#1)(1990-2#2)(1990-3#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#3)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#6)(1993-12#2)(1993-4#1)(1993-6#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-5#3)(1994-8#2)(1994-9#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#3)(1995-9#1)(1996-10#1)(1996-11#1)(1996-2#2)(1996-5#2)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#3)(1997-7#1)(1997-8#2)(2004-12#1)(2004-4#1)(2004-7#1)(2005-11#2)(2005-7#1)(2005-9#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-1#3)(2007-10#1)(2007-11#6)(2007-12#8)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#5)(2008-2#5)(2008-3#7)(2008-4#5)(2008-5#3)(2008-7#7)(2008-8#4)(2008-9#3)(2009-10#2)(2009-11#1)(2009-2#1)(2009-5#2)(2009-8#2)(2010-1#2)(2010-11#1)(2010-12#3)(2010-2#2)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#3)(2011-3#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
possessing a 1##2##3##(1992-7#1)(1997-4#1)
possessing a##24##2##(1990-9#1)(1991-7#1)(1992-7#1)(1993-12#1)(1993-4#1)(1994-8#1)(1996-4#1)(1996-9#2)(1997-4#1)(1997-5#1)(2006-1#1)(2006-12#1)(2008-10#2)(2008-7#3)(2009-2#1)(2009-3#1)(2012-2#1)(2012-3#2)(2013-7#1)
possessing an##4##2##(1994-6#1)(1997-2#1)(2011-1#1)(2012-2#1)
possessing and##2##2##(2004-7#1)(2008-10#1)
possessing different##6##2##(1990-8#1)(1993-4#1)(2006-12#1)(2008-10#1)(2013-8#2)
possessing four##2##2##(1994-12#1)(1996-8#1)
possessing high##4##2##(1995-8#1)(2005-8#1)(2008-10#1)(2008-5#1)
possessing inhibition##2##2##(2008-10#1)(2008-7#1)
possessing poly(ethylene oxide) methyl ether##2##5##(2010-7#2)
possessing specific##2##2##(1990-11#1)(2007-2#1)
possessing the ability to##2##4##(2008-5#2)
possessing the protease inhibitor domain##2##5##(1990-8#1)(1994-11#1)
possessing the##12##2##(1990-8#1)(1992-10#1)(1994-11#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-5#2)(2010-4#1)(2012-2#1)
possessing various##3##2##(2008-10#2)(2010-5#1)
possessing very##3##2##(1990-12#1)(2008-4#1)(2008-5#1)
possessing##127##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#5)(1990-9#1)(1991-1#1)(1991-2#1)(1991-7#1)(1992-10#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-12#2)(1993-4#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-5#1)(1995-8#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-7#1)(2005-11#2)(2005-8#1)(2006-1#1)(2006-12#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#21)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#2)(2009-2#1)(2009-3#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-7#1)(2013-8#2)
possession and##2##2##(1992-4#1)(2010-12#1)
possession of a##4##3##(1996-5#1)(2005-7#1)(2006-4#1)(2008-6#1)
possession of##10##2##(1991-12#1)(1991-4#1)(1996-5#1)(2005-7#1)(2006-10#1)(2006-4#1)(2008-1#1)(2008-6#1)(2010-12#2)
possession##19##1##(1991-12#1)(1991-4#1)(1992-4#1)(1996-5#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-10#1)(2009-2#1)(2010-12#3)(2011-1#1)(2012-12#2)
possibilistic##2##1##(2009-10#2)
possibilities and limitations##6##3##(1990-3#1)(1991-11#1)(1992-3#1)(2006-10#1)(2008-3#1)(2013-7#1)
possibilities and limits##2##3##(1997-4#1)(2012-2#1)
possibilities and##23##2##(1990-3#1)(1991-11#1)(1991-9#1)(1992-1#1)(1992-3#1)(1994-2#1)(1994-5#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-7#1)
possibilities are##9##2##(1991-12#1)(1992-2#1)(1994-9#1)(1995-3#1)(1996-6#1)(2004-11#1)(2006-12#1)(2007-12#2)
possibilities by##2##2##(1996-6#1)(2011-2#1)
possibilities for engineering##2##3##(2007-12#2)
possibilities for genetic manipulation##2##4##(1993-12#1)(2008-1#1)
possibilities for its##2##3##(2006-10#1)(2011-2#1)
possibilities for the future##2##4##(2008-5#1)(2009-2#1)
possibilities for the treatment of##3##5##(2006-12#1)(2007-11#1)(2009-9#1)
possibilities for the##18##3##(1990-2#1)(1991-11#1)(1992-8#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-2#1)(2008-5#1)(2009-2#1)(2009-9#1)(2010-2#1)(2010-9#1)(2011-2#1)
possibilities for their##2##3##(1992-5#1)(2008-8#1)
possibilities for therapeutic intervention##2##4##(1992-11#1)(1997-7#1)
possibilities for therapeutic##3##3##(1990-3#1)(1992-11#1)(1997-7#1)
possibilities for##78##2##(1990-2#1)(1990-3#1)(1991-11#1)(1991-5#1)(1992-11#2)(1992-5#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-7#2)(1995-10#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#1)(1997-7#1)(2004-4#1)(2005-5#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#7)(2007-3#1)(2007-7#2)(2007-8#6)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-2#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-11#1)(2013-1#1)
possibilities have##3##2##(1993-11#1)(2006-10#1)(2006-12#1)
possibilities in the field of##2##5##(1997-3#1)(2008-6#1)
possibilities in the field##3##4##(1997-3#1)(2008-6#1)(2010-12#1)
possibilities in the##8##3##(1991-12#1)(1997-3#2)(2005-11#1)(2008-10#1)(2008-6#1)(2010-12#1)(2013-7#1)
possibilities in##28##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-6#2)(1990-9#1)(1991-11#2)(1991-12#1)(1993-10#1)(1993-3#1)(1997-3#2)(1997-7#1)(2005-11#1)(2006-6#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-2#1)(2009-4#1)(2010-12#1)(2013-7#1)
possibilities include##2##2##(1990-11#1)(2012-12#1)
possibilities of cancer##2##3##(2007-3#1)(2012-2#1)
possibilities of controlling##2##3##(1990-11#1)(2007-12#1)
possibilities of inductively coupled plasma##2##5##(2008-10#2)
possibilities of its##4##3##(1991-2#1)(2006-6#2)(2012-3#1)
possibilities of pharmacological##2##3##(2007-11#1)(2010-12#1)
possibilities of restoring##2##3##(2007-11#1)(2011-1#1)
possibilities of the##8##3##(1995-11#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)
possibilities of their##2##3##(1991-11#1)(2011-2#1)
possibilities of these##2##3##(2007-12#1)(2008-10#1)
possibilities of treatment##3##3##(1993-11#1)(1993-5#1)(2012-12#1)
possibilities of##91##2##(1990-10#2)(1990-11#1)(1990-3#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-2#1)(1992-3#2)(1992-4#1)(1993-11#1)(1993-5#1)(1994-4#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-9#1)(1997-4#1)(2006-10#2)(2006-3#1)(2006-6#3)(2006-9#1)(2007-11#10)(2007-12#2)(2007-3#1)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#9)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)
possibilities offered by##4##3##(1992-9#1)(2007-11#1)(2008-10#1)(2008-11#1)
possibilities offered##5##2##(1992-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)
possibilities that##5##2##(1993-11#1)(1996-3#1)(2008-10#1)(2008-5#1)(2012-12#1)
possibilities to##13##2##(1990-12#1)(2007-11#1)(2007-6#1)(2007-9#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-1#1)(2011-1#1)(2012-1#1)
possibilities were##3##2##(1990-9#1)(2006-12#1)(2007-7#1)
possibilities will##2##2##(2009-8#1)(2011-1#1)
possibilities with##2##2##(1993-2#1)(2007-8#1)
possibilities##327##1##(1990-10#2)(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#3)(1990-4#1)(1990-6#3)(1990-8#3)(1990-9#2)(1991-1#2)(1991-11#7)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#5)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#4)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#3)(1994-12#2)(1994-2#2)(1994-4#2)(1994-5#2)(1994-6#1)(1994-7#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-7#2)(2004-11#1)(2004-4#1)(2005-1#1)(2005-11#1)(2005-5#1)(2006-10#8)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#4)(2006-9#2)(2007-11#15)(2007-12#12)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#7)(2007-8#11)(2007-9#2)(2008-1#5)(2008-10#24)(2008-11#5)(2008-12#3)(2008-2#7)(2008-3#10)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#6)(2008-9#2)(2009-1#1)(2009-2#3)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#8)(2011-3#2)(2012-1#3)(2012-11#2)(2012-12#6)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#1)
possibilities]##13##1##(1991-3#2)(1991-8#1)(1992-3#1)(1992-4#1)(1993-6#2)(1995-5#1)(1997-5#1)(2005-1#1)(2006-6#1)(2008-10#1)(2010-12#1)
possibility and the##3##3##(1990-4#1)(2010-7#1)(2011-2#1)
possibility and##4##2##(1990-4#1)(2010-7#1)(2011-2#1)(2012-3#1)
possibility by##4##2##(1990-5#1)(1990-6#1)(2009-4#1)(2012-2#1)
possibility exists that##7##3##(1994-11#1)(1994-8#1)(1995-8#1)(1996-4#1)(1996-5#1)(1996-9#1)(2011-2#1)
possibility for further##2##3##(1990-4#1)(2011-2#1)
possibility for safe##2##3##(2007-7#1)(2007-8#1)
possibility for the##6##3##(1993-12#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-5#1)
possibility for##39##2##(1990-2#1)(1990-4#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-9#1)(1993-12#1)(1994-9#1)(1996-3#1)(1996-6#1)(2004-11#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
possibility has been explored##2##4##(1990-8#1)(2007-8#1)
possibility has been##3##3##(1990-8#1)(1992-5#1)(2007-8#1)
possibility in the##3##3##(1991-3#1)(1992-2#1)(2010-10#1)
possibility in##6##2##(1991-3#1)(1992-2#1)(2008-8#1)(2010-10#1)(2011-2#1)(2013-1#1)
possibility is that##10##3##(1991-11#1)(1993-9#1)(1995-6#1)(1996-6#1)(1997-8#1)(2008-6#2)(2008-9#1)(2010-2#1)(2010-8#1)
possibility is##17##2##(1991-11#1)(1991-3#1)(1991-8#1)(1993-9#1)(1994-12#1)(1995-6#1)(1996-6#1)(1997-8#1)(2008-3#1)(2008-6#2)(2008-9#1)(2009-12#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)
possibility may##2##2##(1994-10#1)(2013-1#1)
possibility of a genetic##2##4##(1995-3#1)(2008-11#1)
possibility of a##51##3##(1990-3#1)(1990-4#1)(1990-6#1)(1991-12#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-2#1)(1993-12#2)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-3#1)(1997-8#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-3#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
possibility of achieving##4##3##(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)
possibility of an##18##3##(1990-12#1)(1990-5#1)(1990-7#1)(1991-2#2)(1996-3#1)(1997-8#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2013-1#1)(2013-8#1)
possibility of applying##5##3##(2008-10#3)(2013-1#1)(2013-7#1)
possibility of biliary##2##3##(2011-2#1)(2012-12#1)
possibility of carrying out##2##4##(2008-2#1)(2008-7#1)
possibility of creating##4##3##(1997-4#1)(2005-9#1)(2006-12#1)(2007-11#1)
possibility of designing##4##3##(1990-5#1)(2010-9#1)(2011-2#1)(2012-2#1)
possibility of determining##3##3##(2008-10#1)(2008-2#2)
possibility of developing##9##3##(1991-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
possibility of different##4##3##(1994-6#1)(2009-2#1)(2011-1#1)(2013-7#1)
possibility of direct##3##3##(1990-5#1)(1992-12#1)(2008-10#1)
possibility of early##4##3##(1991-9#1)(2006-10#1)(2009-2#1)(2010-12#1)
possibility of exploiting##2##3##(1995-1#1)(2008-3#1)
possibility of finding##2##3##(2007-3#1)(2007-6#1)
possibility of further##3##3##(1997-3#1)(2006-9#1)(2008-1#1)
possibility of generating##3##3##(2007-11#1)(2007-12#1)(2008-11#1)
possibility of having##3##3##(2006-10#1)(2007-8#1)(2012-2#1)
possibility of horizontal##3##3##(2006-8#1)(2008-3#1)(2010-12#1)
possibility of improving##5##3##(1990-2#1)(1995-12#1)(1996-6#1)(2006-10#1)(2012-1#1)
possibility of in##2##3##(2007-8#1)(2009-6#1)
possibility of increasing the##2##4##(2007-11#1)(2008-10#1)
possibility of infection##4##3##(2006-10#1)(2008-12#2)(2012-3#1)
possibility of influencing the##2##4##(1994-2#1)(2007-11#1)
possibility of involvement of##2##4##(1992-6#1)(1995-2#1)
possibility of malignancy##3##3##(2008-5#1)(2012-12#1)(2013-1#1)
possibility of measuring the##2##4##(1997-3#1)(2008-7#1)
possibility of measuring##4##3##(1990-8#1)(1997-3#1)(2008-2#1)(2008-7#1)
possibility of multiple##3##3##(2005-11#1)(2007-12#1)(2007-8#1)
possibility of obtaining##6##3##(1990-12#1)(1991-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
possibility of on-line##2##3##(2008-10#2)
possibility of performing##5##3##(1990-10#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-7#1)
possibility of routine##2##3##(2008-10#1)(2009-5#1)
possibility of simultaneously##2##3##(2007-12#1)(2008-2#1)
possibility of the##18##3##(1990-9#2)(1991-4#1)(2004-7#1)(2005-10#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#2)
possibility of these##4##3##(1990-9#1)(1995-12#1)(2007-3#1)(2008-10#1)
possibility of this##5##3##(1990-9#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-5#1)
possibility of using the##7##4##(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-2#1)
possibility of using this##4##4##(1994-6#1)(2008-10#1)(2008-3#1)(2008-5#1)
possibility of using##47##3##(1991-1#1)(1991-5#1)(1991-8#1)(1993-3#1)(1994-6#1)(1995-7#1)(1997-1#1)(2005-11#1)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-8#4)(2009-2#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#3)
possibility of##657##2##(1990-10#2)(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#4)(1990-6#4)(1990-7#2)(1990-8#2)(1990-9#5)(1991-1#2)(1991-10#1)(1991-12#3)(1991-2#3)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#5)(1992-2#4)(1992-3#3)(1992-5#1)(1992-6#2)(1992-7#2)(1993-10#4)(1993-11#2)(1993-12#3)(1993-3#4)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#2)(1995-7#3)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#4)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#3)(2004-2#1)(2004-7#1)(2004-9#2)(2005-10#2)(2005-11#6)(2005-3#1)(2005-7#2)(2005-9#1)(2006-10#19)(2006-11#1)(2006-12#2)(2006-2#4)(2006-4#4)(2006-6#2)(2006-7#1)(2006-8#4)(2006-9#3)(2007-1#1)(2007-10#3)(2007-11#35)(2007-12#21)(2007-2#5)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#7)(2007-8#13)(2007-9#5)(2008-1#10)(2008-10#58)(2008-11#15)(2008-12#7)(2008-2#20)(2008-3#26)(2008-4#11)(2008-5#15)(2008-6#3)(2008-7#17)(2008-8#13)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#5)(2009-3#2)(2009-4#3)(2009-5#3)(2009-6#3)(2009-7#2)(2009-8#2)(2010-1#2)(2010-10#2)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#13)(2011-12#2)(2011-2#23)(2011-3#1)(2012-1#10)(2012-12#8)(2012-2#15)(2012-3#11)(2013-1#23)(2013-7#4)(2013-8#6)
possibility that early##2##3##(1995-8#1)(2011-2#1)
possibility that some##5##3##(1990-7#1)(1994-10#1)(1996-5#1)(2005-7#1)(2008-3#1)
possibility that such##3##3##(1991-4#1)(1994-5#1)(2008-11#1)
possibility that the##50##3##(1990-12#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-2#1)(1992-4#1)(1992-7#1)(1993-3#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-6#1)(1995-9#1)(1996-10#2)(1996-3#1)(1996-4#1)(1997-8#2)(2006-4#1)(2007-10#1)(2008-1#1)(2008-10#4)(2008-5#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
possibility that these##13##3##(1993-5#1)(1995-11#1)(1996-12#1)(1996-7#1)(1997-8#2)(2004-2#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-4#1)(2011-2#1)
possibility that they##3##3##(1995-8#1)(2008-10#1)(2011-2#1)
possibility that this##7##3##(1991-4#1)(1992-9#1)(1994-8#1)(1995-1#1)(1997-4#1)(2008-11#1)(2008-5#1)
possibility that##256##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-3#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#5)(1991-3#5)(1991-4#3)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#5)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-8#1)(1994-10#2)(1994-11#1)(1994-2#1)(1994-3#5)(1994-5#4)(1994-6#1)(1994-8#4)(1994-9#4)(1995-1#5)(1995-11#4)(1995-12#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#3)(1995-9#1)(1996-10#3)(1996-12#1)(1996-3#4)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#5)(1997-1#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#5)(2004-10#1)(2004-2#1)(2005-10#1)(2005-12#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-2#3)(2006-4#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#3)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#14)(2008-11#6)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#8)(2008-7#3)(2008-8#5)(2008-9#8)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#2)(2009-8#6)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-1#3)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#4)
possibility to apply##3##3##(2008-10#1)(2008-11#1)(2009-8#1)
possibility to be##2##3##(2008-10#1)(2012-3#1)
possibility to develop##3##3##(2007-8#1)(2008-11#1)(2011-2#1)
possibility to increase##2##3##(2010-11#1)(2011-1#1)
possibility to make##2##3##(2008-1#1)(2008-2#1)
possibility to perform##3##3##(1993-9#1)(1996-12#1)(2013-1#1)
possibility to use##6##3##(2007-9#1)(2008-10#2)(2008-5#1)(2009-5#1)(2010-12#1)
possibility to##80##2##(1990-10#1)(1990-2#2)(1992-6#1)(1993-9#1)(1994-6#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-6#1)(2005-11#3)(2005-4#1)(2006-10#1)(2006-8#2)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#17)(2008-11#2)(2008-2#3)(2008-3#3)(2008-5#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
possibility##1144##1##(1990-10#4)(1990-11#3)(1990-12#7)(1990-2#4)(1990-3#5)(1990-4#4)(1990-5#6)(1990-6#5)(1990-7#3)(1990-8#4)(1990-9#6)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#5)(1991-2#10)(1991-3#9)(1991-4#4)(1991-5#6)(1991-6#3)(1991-7#1)(1991-8#8)(1991-9#4)(1992-1#3)(1992-10#1)(1992-11#3)(1992-12#7)(1992-2#9)(1992-3#4)(1992-4#1)(1992-5#3)(1992-6#4)(1992-7#3)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#5)(1993-11#2)(1993-12#6)(1993-2#2)(1993-3#5)(1993-5#2)(1993-6#1)(1993-8#3)(1993-9#4)(1994-10#3)(1994-11#3)(1994-12#3)(1994-2#4)(1994-3#7)(1994-5#7)(1994-6#6)(1994-7#1)(1994-8#8)(1994-9#6)(1995-1#9)(1995-11#7)(1995-12#5)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#4)(1995-6#4)(1995-7#4)(1995-8#4)(1995-9#1)(1996-1#3)(1996-10#3)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#10)(1996-4#4)(1996-5#6)(1996-6#5)(1996-7#2)(1996-8#5)(1996-9#3)(1997-1#3)(1997-2#1)(1997-3#4)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#9)(2004-10#1)(2004-11#1)(2004-12#1)(2004-2#2)(2004-7#1)(2004-9#2)(2005-10#3)(2005-11#9)(2005-12#1)(2005-3#1)(2005-4#1)(2005-7#4)(2005-9#2)(2006-1#1)(2006-10#27)(2006-11#1)(2006-12#3)(2006-2#8)(2006-4#5)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#6)(2006-9#4)(2007-1#1)(2007-10#4)(2007-11#39)(2007-12#24)(2007-2#8)(2007-3#4)(2007-4#2)(2007-5#2)(2007-6#5)(2007-7#11)(2007-8#20)(2007-9#7)(2008-1#14)(2008-10#97)(2008-11#24)(2008-12#8)(2008-2#27)(2008-3#34)(2008-4#15)(2008-5#27)(2008-6#6)(2008-7#21)(2008-8#24)(2008-9#18)(2009-1#2)(2009-10#2)(2009-11#2)(2009-12#5)(2009-2#5)(2009-3#3)(2009-4#6)(2009-5#5)(2009-6#5)(2009-7#2)(2009-8#9)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#8)(2010-2#5)(2010-3#2)(2010-4#6)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#5)(2010-9#3)(2011-1#20)(2011-12#3)(2011-2#41)(2011-3#1)(2012-1#12)(2012-11#1)(2012-12#13)(2012-2#22)(2012-3#15)(2013-1#36)(2013-7#5)(2013-8#13)
possibility]##2##1##(1993-10#1)(1997-8#1)
possible &quot##5##2##(1994-11#2)(1994-8#1)(2008-6#1)(2009-3#1)
possible N-glycosylation sites##2##3##(1990-11#2)
possible a##10##2##(1991-3#1)(1993-1#1)(2007-11#1)(2008-10#3)(2008-11#1)(2011-2#3)
possible action##4##2##(1992-3#1)(1993-3#1)(1997-7#1)(2013-1#1)
possible activation of##3##3##(1993-3#1)(2010-10#1)(2012-3#1)
possible active##2##2##(2008-8#1)(2008-9#1)
possible acute##4##2##(2006-4#1)(2007-7#2)(2008-3#1)
possible adaptation##2##2##(2011-2#1)(2012-2#1)
possible additional##4##2##(1993-12#1)(1997-3#1)(2006-10#1)(2012-2#1)
possible adulteration##2##2##(2008-10#1)(2010-4#1)
possible advantages##3##2##(1990-12#1)(1993-2#1)(2011-2#1)
possible adverse effects of##4##4##(2008-4#1)(2008-8#2)(2012-2#1)
possible adverse effects on##2##4##(2012-3#1)(2013-1#1)
possible adverse effects##6##3##(2008-4#1)(2008-8#2)(2012-2#1)(2012-3#1)(2013-1#1)
possible adverse events##2##3##(2010-12#1)(2012-12#1)
possible adverse##13##2##(1991-2#1)(1992-11#1)(1996-3#1)(2006-10#1)(2008-4#1)(2008-8#2)(2010-12#1)(2010-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
possible aetiologic##2##2##(2007-4#1)(2008-5#1)
possible aetiologies##2##2##(2007-8#1)(2009-4#1)
possible after the##2##3##(1991-11#1)(2007-10#1)
possible after##7##2##(1990-12#1)(1991-11#1)(2007-10#1)(2007-11#2)(2007-2#1)(2010-10#1)
possible alterations of##3##3##(2009-4#1)(2010-6#1)(2012-2#1)
possible alterations##4##2##(2008-5#1)(2009-4#1)(2010-6#1)(2012-2#1)
possible alternate##2##2##(1990-5#1)(2007-11#1)
possible alternative for##2##3##(2008-7#1)(2008-9#1)
possible alternative##6##2##(1997-5#1)(2006-10#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)
possible alternatives##2##2##(1992-3#1)(1993-1#1)
possible amino acids##2##3##(1995-5#1)(2005-8#1)
possible an##2##2##(2007-11#1)(2009-8#1)
possible and easy##2##3##(1997-3#1)(2008-10#1)
possible and necessary##2##3##(2004-9#1)(2013-8#1)
possible and safe##3##3##(1990-12#1)(1993-11#1)(2012-3#1)
possible and that##3##3##(1994-2#1)(2008-3#1)(2008-8#1)
possible and the##6##3##(1994-6#1)(2006-3#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)
possible and##47##2##(1990-12#1)(1993-11#2)(1993-3#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-6#1)(1995-10#1)(1995-2#1)(1996-5#1)(1997-3#1)(2004-9#1)(2005-7#1)(2006-3#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#1)(2009-4#1)(2010-10#1)(2010-2#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
possible animal##2##2##(2006-10#2)
possible answer##3##2##(2006-3#1)(2011-1#1)(2012-3#1)
possible antioxidant activities by##2##4##(2008-12#1)(2011-1#1)
possible antioxidant compounds in the fingerprints##2##6##(2011-1#2)
possible antioxidant##6##2##(2007-8#1)(2008-12#1)(2011-1#4)
possible application for##2##3##(1992-4#1)(2006-10#1)
possible application in##4##3##(1994-8#1)(2008-2#1)(2008-3#1)(2008-5#1)
possible application of the##2##4##(1996-4#1)(2006-10#1)
possible application of##7##3##(1991-2#1)(1996-4#1)(2005-3#1)(2006-10#1)(2008-10#1)(2008-2#1)(2009-8#1)
possible application to##5##3##(2007-12#2)(2008-10#1)(2008-11#1)(2009-12#1)
possible application##19##2##(1991-2#1)(1992-4#1)(1994-8#1)(1996-4#1)(2005-3#1)(2006-10#2)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2009-12#1)(2009-8#1)
possible applications are##2##3##(2008-7#2)
possible applications as##2##3##(2008-11#1)(2008-5#1)
possible applications in##3##3##(1993-1#1)(1997-5#1)(2007-12#1)
possible applications of the##3##4##(2006-4#1)(2008-11#1)(2008-2#1)
possible applications of##8##3##(2006-4#1)(2007-12#2)(2008-11#1)(2008-2#3)(2011-1#1)
possible applications##19##2##(1993-1#1)(1997-5#1)(2006-4#2)(2007-12#3)(2008-10#1)(2008-11#2)(2008-2#4)(2008-5#1)(2008-7#2)(2008-8#1)(2011-1#1)
possible approach to##4##3##(1992-5#1)(2008-10#1)(2009-3#1)(2010-5#1)
possible approach##5##2##(1992-5#1)(2008-10#1)(2009-3#1)(2010-5#1)(2011-2#1)
possible approaches are##2##3##(1991-9#1)(1994-3#1)
possible approaches to##2##3##(2008-2#1)(2013-1#1)
possible approaches##6##2##(1991-9#1)(1994-3#1)(1995-2#1)(2007-11#1)(2008-2#1)(2013-1#1)
possible areas of##2##3##(2012-2#1)(2013-1#1)
possible areas##3##2##(1997-2#1)(2012-2#1)(2013-1#1)
possible arrangements##3##2##(1991-3#1)(1996-7#1)(2006-5#1)
possible as##9##2##(1991-12#1)(1992-3#1)(1997-3#1)(2007-11#1)(2008-5#2)(2011-2#2)(2012-2#1)
possible association between##13##3##(1997-8#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-10#1)(2008-11#1)(2008-4#1)(2010-12#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
possible association of##6##3##(1992-12#1)(1997-3#1)(2010-10#1)(2011-2#3)
possible association with##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)
possible association##24##2##(1992-12#1)(1997-3#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2010-10#1)(2010-12#1)(2011-1#2)(2011-2#4)(2012-5#1)(2013-1#1)(2013-8#1)
possible associations between##4##3##(1994-12#1)(2007-5#1)(2008-7#1)(2011-1#1)
possible associations of##2##3##(2005-4#1)(2008-10#1)
possible associations##8##2##(1994-12#1)(2005-4#1)(2007-5#1)(2008-10#1)(2008-7#1)(2011-1#1)(2012-12#2)
possible at the##2##3##(2007-10#1)(2008-2#1)
possible at##8##2##(2007-10#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2011-1#1)
possible avenues##2##2##(2007-4#1)(2009-10#1)
possible bacterial##2##2##(2008-5#1)(2010-11#1)
possible barriers##2##2##(2009-5#1)(2012-2#1)
possible because of a##2##4##(2005-7#1)(2008-10#1)
possible because of the##2##4##(2008-5#1)(2011-1#1)
possible because of##8##3##(1991-11#1)(2005-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#1)
possible because##13##2##(1990-9#1)(1991-11#1)(2005-7#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
possible beneficial##3##2##(2006-12#1)(2008-7#1)(2011-2#1)
possible benefit##3##2##(1993-12#1)(1995-11#1)(2008-12#1)
possible benefits of the##2##4##(2006-10#1)(2013-1#1)
possible benefits of##6##3##(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#1)(2012-1#1)(2013-1#1)
possible benefits##13##2##(2005-11#1)(2006-10#1)(2007-11#3)(2007-2#2)(2008-10#1)(2008-5#1)(2012-1#2)(2012-3#1)(2013-1#1)
possible between##2##2##(2008-10#1)(2008-8#1)
possible bias##3##2##(1994-6#1)(1996-8#2)
possible biases##2##2##(2008-5#1)(2011-1#1)
possible binding##5##2##(1992-8#1)(1995-3#1)(2005-10#1)(2008-5#1)(2008-8#1)
possible biodegradation mechanisms##2##3##(2006-10#2)
possible biological functions##2##3##(1995-6#1)(1997-4#1)
possible biological##5##2##(1991-9#1)(1995-6#1)(1997-4#1)(2007-3#1)(2009-7#1)
possible but##4##2##(1996-1#1)(2010-7#1)(2013-1#2)
possible by a##6##3##(1994-6#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#1)
possible by means of##4##4##(2008-1#1)(2008-10#1)(2013-1#1)(2013-8#1)
possible by the##18##3##(1992-5#1)(1992-7#1)(1994-12#1)(1996-5#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-10#2)(2011-2#2)(2013-1#2)
possible by three##2##3##(1996-5#1)(2007-12#1)
possible by use of a##2##5##(2008-2#1)(2008-3#1)
possible by use of the##3##5##(2008-2#2)(2008-3#1)
possible by use of this##2##5##(2007-11#1)(2008-3#1)
possible by use of##9##4##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#4)
possible by using the##3##4##(1996-7#1)(2006-4#1)(2007-11#1)
possible by using##6##3##(1996-12#1)(1996-7#1)(2006-4#1)(2007-11#1)(2008-10#1)(2009-4#1)
possible by##79##2##(1990-11#1)(1990-6#1)(1990-8#1)(1990-9#1)(1992-5#1)(1992-7#1)(1993-12#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-6#1)(1996-12#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-2#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-11#6)(2007-12#9)(2007-2#1)(2007-8#3)(2008-1#4)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#6)(2008-5#2)(2008-6#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-6#1)(2011-2#3)(2012-2#1)(2013-1#3)(2013-8#2)
possible candidate for##2##3##(1996-12#1)(1997-4#1)
possible candidate##3##2##(1996-12#1)(1997-4#1)(2008-11#1)
possible candidates for the##2##4##(2008-12#1)(2013-1#1)
possible candidates for##5##3##(2006-3#1)(2008-12#1)(2008-3#1)(2008-7#1)(2013-1#1)
possible candidates##6##2##(2006-3#1)(2008-12#1)(2008-3#1)(2008-7#2)(2013-1#1)
possible cardiac##2##2##(1994-6#1)(2008-10#1)
possible cardiovascular##2##2##(2005-10#1)(2008-5#1)
possible carriers of##2##3##(2009-10#1)(2013-8#1)
possible causal relationship between##3##4##(1997-3#1)(2009-4#1)(2010-4#1)
possible causal##4##2##(1992-5#1)(1997-3#1)(2009-4#1)(2010-4#1)
possible causative##4##2##(1997-7#1)(2007-7#1)(2010-10#1)(2012-2#1)
possible cause of the##4##4##(1991-4#1)(1995-6#1)(2008-10#1)(2010-12#1)
possible cause of##15##3##(1990-2#1)(1991-4#1)(1994-11#1)(1995-2#1)(1995-6#1)(1996-1#1)(2006-4#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
possible cause##25##2##(1990-2#1)(1991-4#1)(1992-11#1)(1992-5#1)(1992-8#1)(1993-8#1)(1994-11#1)(1995-2#1)(1995-6#1)(1996-1#1)(2006-4#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-7#2)(2009-5#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
possible causes and##2##3##(2008-5#1)(2010-8#1)
possible causes for the##2##4##(2007-12#1)(2008-10#1)
possible causes for##5##3##(1995-11#1)(2007-10#1)(2007-12#1)(2008-10#1)(2010-12#1)
possible causes of death##2##4##(1996-7#2)
possible causes of this discrepancy##2##5##(1995-11#1)(2012-2#1)
possible causes of this##7##4##(1993-5#1)(1995-11#1)(2005-9#1)(2006-10#1)(2008-9#1)(2010-7#1)(2012-2#1)
possible causes of##19##3##(1990-6#1)(1993-10#1)(1993-5#1)(1995-11#1)(1996-7#2)(2004-11#1)(2005-9#1)(2006-10#1)(2006-5#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-7#1)(2012-2#1)
possible causes##33##2##(1990-6#1)(1993-10#1)(1993-5#1)(1993-9#1)(1994-8#1)(1995-11#2)(1996-7#2)(1997-8#1)(2004-11#1)(2005-9#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-7#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
possible cellular mechanisms##2##3##(2004-11#1)(2009-8#1)
possible cellular##5##2##(2004-11#1)(2008-10#1)(2009-8#2)(2011-2#1)
possible changes in the##3##4##(2006-10#1)(2009-12#1)(2010-8#1)
possible changes in##10##3##(1994-2#1)(1996-12#1)(1996-5#1)(1997-5#1)(2006-10#1)(2008-10#1)(2008-9#1)(2009-12#1)(2010-8#1)(2013-1#1)
possible changes of##2##3##(2008-7#1)(2011-1#1)
possible changes##13##2##(1994-2#1)(1996-12#1)(1996-5#1)(1997-5#1)(2006-10#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-1#1)(2010-8#1)(2011-1#1)(2013-1#1)
possible chemical##2##2##(2005-11#1)(2008-5#1)
possible chiral##2##2##(1990-8#1)(2008-10#1)
possible clinical scenarios##2##3##(2008-3#1)(2012-3#1)
possible clinical##10##2##(1994-6#1)(2005-8#1)(2006-6#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-6#1)(2010-7#1)(2012-3#1)(2013-1#1)
possible codon##2##2##(1993-9#1)(1994-3#1)
possible coexistence of##2##3##(1993-3#1)(2012-2#1)
possible combination of##3##3##(2007-6#1)(2008-10#1)(2012-2#1)
possible combinations of the##2##4##(1996-4#1)(2008-12#1)
possible combinations of##9##3##(1990-3#1)(1991-2#1)(1991-7#1)(1996-4#1)(2008-10#2)(2008-12#1)(2008-3#2)
possible combinations##13##2##(1990-3#1)(1991-2#1)(1991-7#1)(1993-2#1)(1994-8#1)(1996-4#1)(2008-10#4)(2008-12#1)(2008-3#2)
possible common##4##2##(1991-5#1)(2004-11#1)(2008-10#1)(2008-7#1)
possible complication of##2##3##(1993-12#1)(2007-2#1)
possible complication##8##2##(1993-12#1)(2007-2#1)(2007-9#1)(2008-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
possible complications and##2##3##(2007-11#1)(2012-2#1)
possible complications of the##2##4##(2011-1#1)(2012-3#1)
possible complications of##10##3##(1990-11#1)(1993-10#1)(1993-8#1)(1993-9#1)(2006-3#1)(2007-11#1)(2007-8#1)(2010-10#1)(2011-1#1)(2012-3#1)
possible complications related to##2##4##(2006-10#1)(2007-12#1)
possible complications##32##2##(1990-11#1)(1991-6#1)(1993-10#1)(1993-8#1)(1993-9#1)(1994-3#1)(2005-10#1)(2006-10#1)(2006-12#3)(2006-3#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-4#1)(2008-7#2)(2008-9#2)(2010-10#1)(2011-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
possible configurations of##2##3##(2008-2#1)(2008-3#1)
possible configurations##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
possible conformational##2##2##(2006-10#1)(2011-2#1)
possible confounding##2##2##(1991-3#1)(2008-2#1)
possible connection between##4##3##(1992-11#1)(2005-11#1)(2006-10#1)(2011-2#1)
possible connection##5##2##(1992-11#1)(2005-11#1)(2006-10#1)(2008-10#1)(2011-2#1)
possible connections##2##2##(2008-4#1)(2013-8#1)
possible consequence of##4##3##(1996-6#1)(2007-11#1)(2013-1#1)(2013-8#1)
possible consequences of##6##3##(2004-12#1)(2006-10#1)(2008-10#1)(2008-3#1)(2011-2#2)
possible consequences##8##2##(1994-8#1)(2004-12#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-3#1)(2011-2#2)
possible contamination##4##2##(2005-7#1)(2008-4#1)(2008-7#1)(2009-11#1)
possible contributing factors##5##3##(2008-1#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-12#1)
possible contributing##7##2##(2008-1#1)(2008-11#1)(2008-12#1)(2009-6#1)(2010-5#1)(2011-2#1)(2012-12#1)
possible contribution to the##2##4##(1995-7#1)(2009-4#1)
possible contribution to##5##3##(1995-3#1)(1995-7#1)(2005-10#1)(2009-4#1)(2012-2#1)
possible contribution##8##2##(1995-3#1)(1995-7#1)(1997-5#1)(2005-10#1)(2008-1#1)(2009-4#1)(2009-6#1)(2012-2#1)
possible contributions##3##2##(1990-8#1)(1992-6#1)(2004-12#1)
possible control##2##2##(2008-10#1)(2012-1#1)
possible correlation between##8##3##(1997-7#1)(2007-5#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
possible correlation with##2##3##(2007-8#1)(2010-5#1)
possible correlation##11##2##(1994-2#1)(1997-7#1)(2007-5#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
possible correlations##2##2##(1994-6#1)(2008-10#1)
possible cost##3##2##(1990-12#1)(1997-1#1)(2008-11#1)
possible cure##3##2##(1993-5#1)(2006-1#1)(2009-7#1)
possible damage##2##2##(1996-3#1)(2008-10#1)
possible dangers##2##2##(1990-2#1)(2007-9#1)
possible decrease##2##2##(1997-4#1)(2010-12#1)
possible defects of##2##3##(1996-12#1)(2012-3#1)
possible dependence##2##2##(1997-4#1)(2008-8#1)
possible dependencies of##2##3##(1997-1#1)(2008-8#1)
possible detection##4##2##(1990-2#1)(2006-4#1)(2008-10#2)
possible determinants of##2##3##(2008-4#1)(2012-3#1)
possible development of##2##3##(1996-2#1)(2013-1#1)
possible diagnosis##7##2##(1990-8#2)(2007-2#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-12#1)
possible diagnostic##7##2##(1992-5#1)(1996-12#1)(1996-3#1)(2007-2#1)(2007-8#1)(2008-3#1)(2013-1#1)
possible differences between##4##3##(1990-5#1)(1993-5#1)(2007-8#1)(2008-1#1)
possible differences in##5##3##(1997-6#1)(2008-3#1)(2008-4#1)(2010-5#1)(2012-12#1)
possible differences##11##2##(1990-5#1)(1993-5#1)(1996-4#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2010-5#1)(2012-12#1)(2012-3#1)
possible differential##6##2##(1992-3#1)(1995-11#1)(2008-4#1)(2008-5#1)(2012-3#1)(2012-8#1)
possible difficulties##2##2##(2007-8#1)(2009-4#1)
possible disadvantages##2##2##(2008-11#1)(2012-2#1)
possible disease##4##2##(1993-12#1)(2009-10#1)(2010-12#1)(2013-7#1)
possible distance##2##2##(1996-8#1)(2008-2#1)
possible dose##6##2##(1991-8#1)(1992-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)
possible drug interactions##3##3##(1992-8#1)(1994-5#1)(2006-10#1)
possible drug##5##2##(1992-8#1)(1994-5#1)(2006-10#1)(2007-7#1)(2008-5#1)
possible due to##3##3##(2007-8#1)(2009-6#1)(2010-12#1)
possible during the##2##3##(1992-7#1)(2012-12#1)
possible during##6##2##(1992-7#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2012-12#1)
possible early##3##2##(1991-6#1)(2008-5#1)(2009-9#1)
possible effect of##8##3##(1992-2#1)(1994-8#1)(1996-2#1)(2006-10#1)(2008-10#1)(2012-2#1)(2013-1#1)(2013-7#1)
possible effect on##5##3##(1993-1#1)(1995-1#1)(2008-2#1)(2008-3#1)(2009-8#1)
possible effect##15##2##(1992-2#1)(1993-1#1)(1994-8#1)(1995-1#1)(1996-2#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
possible effects of the##3##4##(2006-8#1)(2008-1#1)(2008-10#1)
possible effects of##13##3##(1990-6#1)(1994-4#1)(1995-12#1)(1996-2#1)(2005-7#2)(2006-12#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2013-7#1)
possible effects on##8##3##(1990-10#1)(1991-9#1)(2004-11#1)(2005-11#1)(2006-11#1)(2008-10#1)(2011-1#1)(2013-7#1)
possible effects##25##2##(1990-10#1)(1990-6#1)(1991-9#1)(1994-12#1)(1994-4#1)(1995-12#1)(1996-2#2)(1996-8#1)(2004-11#1)(2005-11#1)(2005-7#2)(2006-11#1)(2006-12#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-8#1)(2011-1#1)(2013-7#2)
possible efficacy##3##2##(2008-8#1)(2009-10#1)(2013-1#1)
possible emergence of##2##3##(2006-10#1)(2007-7#1)
possible endemic area##2##3##(1996-11#2)
possible environmental factors##2##3##(2006-10#1)(2008-5#1)
possible environmental##6##2##(1997-5#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-5#1)
possible errors##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
possible etiological factors##2##3##(2007-2#1)(2008-5#1)
possible etiological##3##2##(1995-1#1)(2007-2#1)(2008-5#1)
possible etiologies##6##2##(2006-10#1)(2006-8#2)(2008-11#1)(2008-8#1)(2011-1#1)
possible etiology##11##2##(1990-2#1)(1991-4#1)(1992-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-9#1)(2011-2#2)(2013-1#2)
possible even##4##2##(1990-11#1)(1992-11#1)(1992-5#1)(2008-10#1)
possible evidence##3##2##(1991-1#1)(2008-2#1)(2010-1#1)
possible evolution towards##3##3##(1994-6#3)
possible evolution##5##2##(1994-6#3)(2005-8#1)(2008-5#1)
possible evolutionary##3##2##(1994-8#1)(1994-9#1)(2007-12#1)
possible existence of##13##3##(1990-2#1)(1990-8#1)(1991-9#1)(1992-3#1)(1992-9#1)(1995-2#1)(1997-1#1)(1997-7#1)(2007-10#1)(2007-8#1)(2008-6#1)(2010-11#1)(2012-2#1)
possible experimental##4##2##(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#1)
possible explanation for the##12##4##(1990-8#1)(1992-3#1)(1993-12#1)(1995-6#1)(1996-6#1)(1997-1#1)(1997-8#1)(2004-12#1)(2007-9#1)(2008-10#1)(2010-4#1)(2012-12#1)
possible explanation for these##3##4##(1995-10#1)(1995-8#1)(2006-8#1)
possible explanation for this##3##4##(1995-9#1)(1997-2#1)(2008-1#1)
possible explanation for##21##3##(1990-8#1)(1992-2#1)(1992-3#1)(1993-12#1)(1995-10#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-8#1)(2004-12#1)(2006-8#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-4#1)(2012-12#1)
possible explanation is that##4##4##(1997-7#1)(2007-11#1)(2009-7#1)(2010-3#1)
possible explanation is##7##3##(1997-7#1)(2007-11#1)(2008-3#1)(2008-7#1)(2009-7#1)(2010-3#1)(2011-2#1)
possible explanation of##2##3##(1993-1#1)(1996-12#1)
possible explanation##34##2##(1990-8#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1995-10#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-1#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#1)
possible explanations for the##4##4##(1992-3#1)(1992-7#1)(1993-11#1)(1993-7#1)
possible explanations for these##4##4##(2009-11#1)(2012-12#1)(2012-2#1)(2013-7#1)
possible explanations for this observation##2##5##(1994-2#1)(2006-5#1)
possible explanations for this##5##4##(1993-11#1)(1994-2#1)(2006-5#1)(2006-8#1)(2008-8#1)
possible explanations for##15##3##(1992-3#1)(1992-7#1)(1993-11#2)(1993-7#1)(1994-2#1)(2004-12#1)(2006-5#1)(2006-8#1)(2008-7#1)(2008-8#1)(2009-11#1)(2012-12#1)(2012-2#1)(2013-7#1)
possible explanations of##2##3##(1991-11#1)(2008-2#1)
possible explanations##18##2##(1991-11#1)(1992-3#1)(1992-7#1)(1993-11#2)(1993-7#1)(1994-2#1)(2004-12#1)(2006-5#1)(2006-8#1)(2007-2#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-11#1)(2012-12#1)(2012-2#1)(2013-7#1)
possible explanatory factors##2##3##(2006-10#2)
possible extension of##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
possible extension##4##2##(1994-12#1)(2007-12#1)(2008-10#1)(2008-3#1)
possible factors##6##2##(1993-12#1)(2009-1#1)(2009-4#1)(2009-5#1)(2013-1#2)
possible for a##5##3##(1994-9#1)(1996-9#1)(2008-12#1)(2008-3#1)(2010-12#1)
possible for some##2##3##(2005-11#1)(2010-12#1)
possible for the first time to##3##6##(1992-9#1)(1994-3#1)(1995-8#1)
possible for the##11##3##(1990-5#1)(1991-12#1)(1992-9#1)(1994-3#1)(1995-8#1)(2006-6#1)(2007-12#1)(2007-8#2)(2012-1#1)(2012-2#1)
possible for these##2##3##(2008-9#2)
possible for us to##3##4##(2008-3#1)(2010-6#1)(2011-2#1)
possible for##60##2##(1990-5#1)(1991-12#2)(1992-3#1)(1992-9#1)(1994-3#2)(1994-9#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-9#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-4#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#6)(2007-4#2)(2007-7#1)(2007-8#3)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-12#2)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
possible formation of##4##3##(1993-11#1)(1994-5#1)(1996-8#1)(2011-2#1)
possible from the##4##3##(1991-12#1)(1994-6#2)(2013-1#1)
possible from##11##2##(1991-12#1)(1994-6#2)(1995-3#1)(2006-10#1)(2007-8#1)(2008-11#2)(2008-2#1)(2009-4#1)(2013-1#1)
possible function for##2##3##(1991-2#1)(1994-10#1)
possible function of##3##3##(1996-7#1)(1997-2#1)(2007-2#1)
possible function##7##2##(1991-2#1)(1993-2#1)(1994-10#1)(1996-4#1)(1996-7#1)(1997-2#1)(2007-2#1)
possible functional differences##2##3##(1992-11#1)(2005-8#1)
possible functional role of##5##4##(1995-1#1)(1997-6#1)(2006-10#1)(2009-10#1)(2013-1#1)
possible functional role##6##3##(1990-8#1)(1995-1#1)(1997-6#1)(2006-10#1)(2009-10#1)(2013-1#1)
possible functional##14##2##(1990-8#1)(1991-2#1)(1992-11#1)(1993-2#1)(1993-7#1)(1995-1#1)(1997-6#1)(2005-8#1)(2006-10#1)(2008-1#1)(2008-7#1)(2009-10#1)(2012-2#1)(2013-1#1)
possible functions of##5##3##(1996-7#1)(2008-6#1)(2010-8#1)(2012-12#2)
possible functions##9##2##(1992-6#1)(1996-7#1)(2008-11#1)(2008-6#1)(2009-10#1)(2010-8#1)(2012-12#2)(2012-3#1)
possible further##3##2##(1995-5#1)(1997-3#1)(2012-11#1)
possible future applications##2##3##(2007-5#1)(2008-1#1)
possible future development of##2##4##(2008-1#2)
possible future directions in##2##4##(2006-4#1)(2009-5#1)
possible future directions##6##3##(1996-12#1)(2005-8#1)(2006-4#1)(2008-11#1)(2009-5#1)(2011-2#1)
possible future research##2##3##(2010-4#1)(2013-8#1)
possible future use in##2##4##(2006-12#1)(2009-3#1)
possible future##22##2##(1993-11#1)(1993-2#1)(1996-12#1)(2005-7#1)(2005-8#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-4#1)(2007-5#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-4#1)(2011-2#1)(2011-7#1)(2013-8#1)
possible genetic##9##2##(1991-1#1)(1993-8#1)(1994-2#1)(2006-9#1)(2008-10#1)(2008-7#1)(2009-4#1)(2011-12#1)(2012-3#1)
possible harmful effect of##2##4##(1994-4#1)(2006-10#1)
possible harmful effects of##2##4##(1994-4#1)(2011-2#1)
possible harmful##5##2##(1994-4#2)(2006-10#1)(2011-2#2)
possible hazards##3##2##(1992-8#1)(1993-9#1)(2013-1#1)
possible health effects of##2##4##(1994-9#1)(2011-2#1)
possible health effects##5##3##(1994-9#1)(2011-2#2)(2013-7#1)(2013-8#1)
possible health##12##2##(1994-12#1)(1994-9#1)(1996-3#1)(2006-10#1)(2007-4#1)(2008-1#1)(2008-11#1)(2011-2#3)(2013-7#1)(2013-8#1)
possible hydrogen##2##2##(1990-2#1)(1991-8#1)
possible if the##6##3##(2008-10#1)(2008-4#2)(2008-8#1)(2008-9#1)(2012-2#1)
possible if##13##2##(2006-10#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-8#3)(2008-9#1)(2012-2#1)(2013-8#1)
possible impact of##6##3##(1991-2#1)(1993-9#1)(1995-12#1)(2008-11#1)(2008-8#1)(2013-8#1)
possible impact on the##2##4##(2011-1#1)(2011-2#1)
possible impact on##6##3##(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-1#1)
possible impact##12##2##(1991-2#1)(1993-9#1)(1995-12#1)(2008-11#1)(2008-3#1)(2008-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2013-8#1)
possible impacts##2##2##(1996-9#1)(2007-12#1)
possible implementation of##2##3##(2006-10#1)(2011-2#1)
possible implementation##3##2##(2006-10#1)(2008-11#1)(2011-2#1)
possible implication##4##2##(1990-3#1)(1990-9#1)(1993-8#1)(2009-3#1)
possible implications are##3##3##(1991-3#1)(2008-2#1)(2008-6#1)
possible implications for##6##3##(2007-2#1)(2008-1#1)(2008-5#1)(2009-9#1)(2010-12#1)(2012-1#1)
possible implications of these findings##2##5##(1991-5#1)(2006-7#1)
possible implications of these##3##4##(1991-5#1)(1991-6#1)(2006-7#1)
possible implications of##6##3##(1991-5#1)(1991-6#1)(1995-7#1)(2006-7#1)(2008-6#1)(2009-8#1)
possible implications##17##2##(1990-8#1)(1991-3#1)(1991-5#1)(1991-6#1)(1995-7#1)(2006-7#1)(2007-2#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-6#2)(2009-8#2)(2009-9#1)(2010-12#1)(2012-1#1)
possible importance##4##2##(2005-8#1)(2008-10#1)(2008-9#1)(2010-8#1)
possible improvement in##2##3##(2006-10#1)(2006-6#1)
possible improvement##3##2##(2004-9#1)(2006-10#1)(2006-6#1)
possible in a##6##3##(1996-5#1)(2007-12#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)
possible in all##3##3##(2008-10#1)(2010-7#1)(2011-2#1)
possible in many##2##3##(2008-6#1)(2008-9#1)
possible in most##3##3##(1992-2#1)(2008-7#1)(2013-8#1)
possible in order to##3##4##(1993-8#1)(2007-9#1)(2009-3#1)
possible in the future to##2##5##(1994-6#1)(2008-1#1)
possible in the##15##3##(1994-6#1)(1995-10#1)(1995-12#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-8#2)(2010-12#1)(2011-2#1)(2013-1#1)
possible in these##2##3##(2004-1#1)(2010-5#1)
possible in this setting##2##4##(2006-10#1)(2010-12#1)
possible in this##4##3##(2006-10#1)(2007-12#1)(2010-10#1)(2010-12#1)
possible in vivo##4##3##(1993-9#1)(1997-2#1)(1997-6#1)(2011-12#1)
possible in##89##2##(1990-12#1)(1991-11#1)(1991-6#2)(1992-12#1)(1992-2#1)(1993-3#1)(1993-5#1)(1993-8#2)(1993-9#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-12#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-6#1)(2004-1#2)(2006-10#2)(2006-8#1)(2007-11#3)(2007-12#3)(2007-5#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-1#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-5#1)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#3)(2013-8#1)
possible incomplete##2##2##(1990-5#1)(2012-12#1)
possible incorporation of##2##3##(2007-11#1)(2008-10#1)
possible indications for##2##3##(2006-10#1)(2011-2#1)
possible indications##4##2##(1993-8#1)(1994-12#1)(2006-10#1)(2011-2#1)
possible induction of##2##3##(2007-11#1)(2009-2#1)
possible infarct##2##2##(1993-12#2)
possible infection##2##2##(2008-10#1)(2008-4#1)
possible infectious##2##2##(1996-6#1)(2008-5#1)
possible influence of##10##3##(1993-9#1)(1997-2#1)(2006-6#2)(2007-3#1)(2008-10#1)(2008-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
possible influence on the##2##4##(2007-2#1)(2008-6#1)
possible influence##15##2##(1990-5#2)(1993-9#1)(1997-2#1)(2006-6#2)(2007-2#1)(2007-3#1)(2008-10#1)(2008-6#1)(2008-7#1)(2012-3#1)(2013-1#1)(2013-8#2)
possible inhibition of##2##3##(1994-9#1)(2008-11#1)
possible inhibition##4##2##(1994-9#1)(1995-11#1)(2008-10#1)(2008-11#1)
possible inhibitory##4##2##(1994-5#1)(1995-11#1)(2008-6#1)(2008-7#1)
possible injury##2##2##(2008-7#1)(2008-9#1)
possible integration##2##2##(2008-3#1)(2008-7#1)
possible interaction between##5##3##(1993-12#1)(2006-7#1)(2008-4#1)(2010-12#1)(2013-7#1)
possible interaction of##7##3##(1993-5#1)(1993-6#1)(1994-11#1)(1994-3#1)(2005-11#1)(2010-4#1)(2012-8#1)
possible interaction##15##2##(1991-9#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(2005-11#1)(2006-7#1)(2008-4#1)(2008-8#1)(2010-12#1)(2010-4#1)(2012-8#1)(2013-7#1)
possible interactions between the##2##4##(1993-9#1)(1996-12#1)
possible interactions between##6##3##(1993-9#1)(1996-12#1)(1996-2#1)(1996-6#1)(2007-9#1)(2012-1#1)
possible interactions in##2##3##(1990-2#1)(2011-1#1)
possible interactions of##3##3##(1997-4#1)(2006-10#1)(2011-1#1)
possible interactions with##3##3##(1993-11#1)(2007-1#1)(2012-3#1)
possible interactions##19##2##(1990-2#1)(1991-3#1)(1993-11#1)(1993-9#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-4#1)(2006-10#2)(2007-1#1)(2007-9#1)(2008-10#1)(2009-8#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-3#1)
possible interference##5##2##(1994-6#1)(1997-7#1)(2007-12#1)(2008-10#1)(2013-8#1)
possible interferences of##3##3##(2008-10#2)(2008-2#1)
possible interferences were##2##3##(2008-10#2)
possible interferences##9##2##(2008-10#8)(2008-2#1)
possible interferents##3##2##(2008-10#3)
possible interfering##5##2##(2008-10#5)
possible intermediate##2##2##(1991-12#1)(1992-6#1)
possible interpretations for##2##3##(1994-8#1)(1997-8#1)
possible interventions##4##2##(2009-5#1)(2011-2#2)(2013-8#1)
possible involvement in these##2##4##(1997-5#1)(2008-5#1)
possible involvement in##7##3##(1991-3#1)(1995-12#1)(1997-5#1)(2006-1#1)(2008-5#1)(2010-10#1)(2012-12#1)
possible involvement of a##3##4##(1992-7#1)(1994-8#1)(1997-1#1)
possible involvement of cAMP##2##4##(1997-2#2)
possible involvement of the##3##4##(1994-2#1)(1996-12#1)(1996-5#1)
possible involvement of##44##3##(1990-3#1)(1990-6#1)(1990-7#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#1)(1994-2#3)(1994-3#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#1)(1996-12#2)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-6#1)(1997-7#1)(2007-10#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)(2009-5#1)(2009-8#2)(2013-1#1)(2013-7#1)(2013-8#1)
possible involvement##52##2##(1990-3#1)(1990-6#1)(1990-7#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#1)(1994-2#3)(1994-3#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#2)(1996-12#2)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-1#1)(2007-10#1)(2008-10#2)(2008-11#3)(2008-5#2)(2008-6#1)(2009-5#1)(2009-8#2)(2010-10#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
possible is##6##2##(1990-3#1)(1997-3#1)(2006-8#1)(2008-2#1)(2008-3#1)(2011-2#1)
possible isomers##2##2##(1990-4#1)(2008-5#1)
possible key##2##2##(2004-12#1)(2008-10#1)
possible lack of##2##3##(2006-9#1)(2009-9#1)
possible late##4##2##(1990-6#1)(1996-6#1)(2007-11#1)(2008-1#1)
possible life##2##2##(2006-10#1)(2007-9#1)
possible limitations##2##2##(1995-1#1)(2009-5#1)
possible link between##6##3##(2006-10#2)(2007-9#1)(2009-12#1)(2013-1#1)(2013-7#1)
possible link of##2##3##(2008-10#1)(2012-2#1)
possible link##8##2##(2006-10#2)(2007-9#1)(2008-10#1)(2009-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
possible linkage##3##2##(1997-5#1)(1997-7#1)(2008-3#1)
possible links between##2##3##(2008-1#2)
possible liver##2##2##(2008-1#1)(2009-4#1)
possible local##2##2##(1991-2#1)(2005-8#1)
possible location##2##2##(1996-1#1)(2013-1#1)
possible locations of##2##3##(1994-4#1)(2012-3#1)
possible locations##5##2##(1990-4#1)(1994-4#1)(2006-10#1)(2010-2#1)(2012-3#1)
possible loss or##2##3##(1994-3#1)(2008-10#1)
possible loss##4##2##(1990-5#1)(1994-3#1)(2008-10#1)(2008-4#1)
possible management strategies##2##3##(2005-11#1)(2007-12#1)
possible matrix##2##2##(2008-10#2)
possible mean##2##2##(2007-12#1)(2008-8#1)
possible means for##2##3##(2008-10#1)(2012-3#1)
possible means##5##2##(2008-10#2)(2008-5#1)(2012-3#1)(2013-1#1)
possible mechanism and##2##3##(2008-8#1)(2010-12#1)
possible mechanism by which##5##4##(1991-5#1)(1993-6#1)(1995-3#1)(2008-5#1)(2011-1#1)
possible mechanism for the##11##4##(1993-6#1)(2008-10#7)(2008-5#2)(2010-6#1)
possible mechanism for##23##3##(1990-3#1)(1991-3#1)(1991-8#1)(1993-6#1)(1994-5#1)(1994-8#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#8)(2008-5#2)(2010-4#2)(2010-6#1)(2011-2#1)
possible mechanism is##3##3##(1992-4#1)(2008-10#1)(2008-7#1)
possible mechanism of action of##3##5##(1990-2#1)(1991-2#1)(1993-7#1)
possible mechanism of extraction##2##4##(2008-10#1)(2008-5#1)
possible mechanism of the##7##4##(1991-1#1)(2008-10#5)(2011-3#1)
possible mechanism of##35##3##(1990-2#1)(1990-4#1)(1991-1#1)(1991-2#1)(1992-8#1)(1993-6#1)(1993-7#1)(1996-5#1)(1997-1#1)(2007-10#1)(2007-7#1)(2008-10#14)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#1)
possible mechanism to##2##3##(1996-3#1)(2012-3#1)
possible mechanism underlying this##2##4##(1997-1#1)(2009-5#1)
possible mechanism underlying##3##3##(1993-12#1)(1997-1#1)(2009-5#1)
possible mechanism##87##2##(1990-2#1)(1990-3#1)(1990-4#1)(1991-1#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-6#4)(1993-7#1)(1994-5#1)(1994-8#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#2)(1997-4#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#25)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#3)(2009-12#1)(2009-5#1)(2010-12#1)(2010-4#3)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)
possible mechanisms and##2##3##(2007-8#1)(2008-3#1)
possible mechanisms by which##4##4##(1993-9#1)(2007-12#1)(2008-10#1)(2010-7#1)
possible mechanisms for the##5##4##(1991-5#1)(1992-8#1)(2006-9#1)(2008-10#1)(2010-3#1)
possible mechanisms for##14##3##(1991-12#1)(1991-5#1)(1992-8#1)(1994-5#1)(2005-10#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-12#1)(2008-10#1)(2009-8#2)(2010-3#1)
possible mechanisms involved in##2##4##(2008-10#1)(2008-9#1)
possible mechanisms of action##4##4##(2007-11#1)(2009-2#1)(2013-1#2)
possible mechanisms of the##3##4##(1991-5#1)(1996-1#1)(2008-10#1)
possible mechanisms of these##2##4##(2007-9#1)(2008-10#1)
possible mechanisms of##25##3##(1991-5#1)(1992-12#1)(1994-12#1)(1996-1#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-2#2)(2006-4#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-1#2)
possible mechanisms responsible for##2##4##(1994-2#1)(2008-10#1)
possible mechanisms underlying##3##3##(1991-9#1)(2008-8#1)(2012-12#1)
possible mechanisms##70##2##(1991-1#1)(1991-12#1)(1991-5#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-7#1)(1996-1#1)(1996-9#1)(1997-4#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-2#2)(2006-4#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#3)(2008-9#1)(2009-2#1)(2009-4#1)(2009-8#4)(2010-12#1)(2010-3#1)(2010-7#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)
possible mediator of##2##3##(2008-6#1)(2013-1#1)
possible mediator##4##2##(1995-3#1)(1996-2#1)(2008-6#1)(2013-1#1)
possible mediators##2##2##(2008-2#1)(2011-1#1)
possible metabolic##3##2##(1990-11#1)(1992-8#1)(2008-10#1)
possible method for##2##3##(1992-2#1)(1996-12#1)
possible method of##3##3##(2009-7#1)(2010-12#1)(2011-2#1)
possible method##5##2##(1992-2#1)(1996-12#1)(2009-7#1)(2010-12#1)(2011-2#1)
possible methods##3##2##(1995-12#1)(2008-1#1)(2008-10#1)
possible misdiagnosis##3##2##(2007-12#1)(2010-12#1)(2010-8#1)
possible misinterpretations##2##2##(1991-12#1)(1994-5#1)
possible mode of##6##3##(1994-9#1)(2006-11#1)(2007-7#1)(2008-3#2)(2013-1#1)
possible mode##7##2##(1994-9#1)(1995-5#1)(2006-11#1)(2007-7#1)(2008-3#2)(2013-1#1)
possible mode(s) of action##2##4##(2008-7#2)
possible model for##2##3##(1990-5#1)(2007-7#1)
possible model##5##2##(1990-5#1)(1997-7#1)(2007-7#1)(2009-10#1)(2012-2#1)
possible models for##2##3##(1993-8#1)(1995-8#1)
possible models##6##2##(1993-8#1)(1995-8#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-4#1)
possible modes of##3##3##(1996-8#1)(2003-11#1)(2010-3#1)
possible modes##4##2##(1996-8#1)(2003-11#1)(2008-4#1)(2010-3#1)
possible molecular mechanisms##3##3##(2008-10#1)(2013-1#2)
possible molecular models##2##3##(1994-3#1)(2006-10#1)
possible molecular##14##2##(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1997-4#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)(2010-7#1)(2013-1#2)
possible monitoring##2##2##(2006-12#1)(2008-7#1)
possible morphological##2##2##(1990-5#1)(2008-9#1)
possible negative##4##2##(1994-12#1)(2004-3#1)(2005-12#1)(2013-8#1)
possible neural##4##2##(1992-11#1)(1992-8#1)(1997-8#1)(2013-1#1)
possible neuroprotective##2##2##(2006-10#1)(2009-10#1)
possible neuropsychological##2##2##(2008-11#1)(2013-8#1)
possible new mechanism of##2##4##(1990-8#1)(2008-10#1)
possible new##17##2##(1990-8#2)(1991-12#1)(1992-4#2)(1992-6#1)(1996-7#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2009-3#1)(2012-1#1)
possible novel##3##2##(2008-10#1)(2008-7#1)(2010-3#1)
possible number of##3##3##(1996-12#1)(2008-3#1)(2012-3#1)
possible occurrence of##4##3##(1994-6#1)(2006-12#1)(2011-2#1)(2012-12#1)
possible occurrence##6##2##(1991-3#1)(1994-6#1)(2006-12#1)(2010-5#1)(2011-2#1)(2012-12#1)
possible on a##2##3##(1991-11#1)(2005-12#1)
possible on##4##2##(1991-11#1)(1994-9#1)(2005-12#1)(2006-8#1)
possible only by##3##3##(1993-6#1)(2008-1#1)(2013-1#1)
possible only if the##2##4##(2006-10#1)(2008-8#1)
possible only if##3##3##(2006-10#1)(2008-10#1)(2008-8#1)
possible only with##3##3##(1991-6#1)(2008-5#1)(2012-12#1)
possible only##12##2##(1991-12#1)(1991-6#1)(1993-6#1)(1995-4#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
possible options##4##2##(1992-3#1)(2007-1#1)(2008-9#1)(2011-2#1)
possible or##5##2##(1994-12#1)(1997-4#1)(2007-8#1)(2008-6#1)(2013-7#1)
possible origin of##2##3##(2008-3#1)(2009-7#1)
possible origin##6##2##(2006-10#1)(2006-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-7#1)
possible outcome##3##2##(2005-9#1)(2007-2#1)(2009-5#1)
possible outcomes##2##2##(2006-3#1)(2009-5#1)
possible pairwise##2##2##(2008-10#2)
possible participation of the##2##4##(1992-12#1)(1994-6#1)
possible participation##3##2##(1992-12#1)(1994-6#1)(2011-2#1)
possible pathogenesis##2##2##(2007-9#1)(2008-7#1)
possible pathogenetic##5##2##(1992-2#1)(2006-2#2)(2007-4#1)(2012-2#1)
possible pathogenic mechanisms##3##3##(2005-10#1)(2006-10#1)(2008-1#1)
possible pathogenic##8##2##(1991-6#1)(1996-8#1)(2005-10#1)(2006-10#1)(2008-1#1)(2008-2#1)(2008-7#1)(2010-11#1)
possible pathological##4##2##(2005-7#1)(2008-7#1)(2009-10#1)(2010-12#1)
possible pathophysiological##2##2##(2006-11#1)(2008-4#1)
possible paths##3##2##(1992-2#1)(2008-7#1)(2010-2#1)
possible pathways for##2##3##(1990-11#1)(2010-7#1)
possible pathways##3##2##(1990-11#1)(1992-11#1)(2010-7#1)
possible perturbations##2##2##(2004-11#1)(2008-3#1)
possible phylogenetic##4##2##(1992-4#1)(1993-6#1)(2007-12#2)
possible physiological roles##3##3##(2008-9#1)(2009-10#1)(2009-8#1)
possible physiological##9##2##(1991-10#1)(1991-7#1)(1992-6#1)(1992-8#1)(1994-11#1)(2008-9#1)(2009-10#1)(2009-8#1)(2011-1#1)
possible pitfalls and##2##3##(2008-4#1)(2009-3#1)
possible pitfalls##5##2##(2004-9#1)(2008-10#1)(2008-4#2)(2009-3#1)
possible points of##2##3##(2008-7#1)(2013-1#1)
possible predictors of##3##3##(2006-5#1)(2009-9#1)(2010-4#1)
possible predictors##4##2##(2006-5#1)(2006-7#1)(2009-9#1)(2010-4#1)
possible predisposing##3##2##(2007-8#1)(2010-12#1)(2012-2#1)
possible presence of##6##3##(1990-9#1)(1992-3#1)(1994-11#1)(1995-1#1)(1997-5#1)(2008-10#1)
possible presence##7##2##(1990-9#1)(1992-3#1)(1994-11#1)(1995-1#1)(1997-5#1)(2008-10#1)(2012-2#1)
possible preventive measures are discussed##2##5##(1990-8#1)(2013-1#1)
possible problems##3##2##(1991-2#1)(2006-10#1)(2008-9#1)
possible prognostic##3##2##(2007-8#1)(2008-7#1)(2013-1#1)
possible progression to##2##3##(2007-9#1)(2008-5#1)
possible promoter##4##2##(1990-7#1)(1991-9#1)(1995-2#1)(1995-5#1)
possible protective role of##2##4##(2008-1#1)(2012-4#1)
possible protective##5##2##(2007-2#1)(2008-1#1)(2011-2#1)(2012-4#1)(2013-1#1)
possible reaction mechanism##6##3##(1990-5#1)(1991-1#1)(2008-10#3)(2009-11#1)
possible reaction##8##2##(1990-5#1)(1991-1#1)(2008-10#4)(2009-11#2)
possible reactive##2##2##(1992-11#1)(2008-10#1)
possible reason for the##3##4##(1990-7#1)(1993-9#1)(2012-12#1)
possible reason for this##2##4##(1996-8#1)(2008-2#1)
possible reason for##7##3##(1990-7#1)(1993-9#1)(1996-8#1)(2008-2#1)(2011-12#1)(2012-12#2)
possible reason##8##2##(1990-7#1)(1993-9#1)(1996-8#1)(2008-2#1)(2008-9#1)(2011-12#1)(2012-12#2)
possible reasons for the##6##4##(1996-12#1)(1996-5#1)(2005-8#2)(2006-10#1)(2011-2#1)
possible reasons for these##2##4##(2008-1#1)(2009-4#1)
possible reasons for##15##3##(1996-12#1)(1996-5#1)(2005-8#2)(2006-10#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-4#1)(2009-5#1)(2011-1#1)(2011-12#1)(2011-2#1)
possible reasons##17##2##(1996-12#1)(1996-5#1)(2005-8#2)(2006-10#2)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-4#1)(2009-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)
possible recurrence##3##2##(1992-6#1)(2007-12#1)(2012-1#1)
possible reflections##2##2##(1991-3#1)(2006-4#1)
possible region##2##2##(1993-9#1)(2007-11#1)
possible regulation of##3##3##(1995-12#1)(1995-2#1)(2008-11#1)
possible regulation##4##2##(1995-12#1)(1995-2#1)(2008-11#1)(2012-2#1)
possible regulator##2##2##(1997-8#1)(2010-12#1)
possible regulatory##3##2##(1991-12#1)(1991-4#1)(1994-10#1)
possible relation between##3##3##(1994-7#1)(1995-9#1)(2013-1#1)
possible relation to##3##3##(1996-8#1)(2007-10#1)(2008-4#1)
possible relation##7##2##(1990-6#1)(1994-7#1)(1995-9#1)(1996-8#1)(2007-10#1)(2008-4#1)(2013-1#1)
possible relationship between##15##3##(1992-2#1)(1993-11#1)(1993-12#1)(1993-2#1)(2004-1#1)(2004-11#1)(2006-12#1)(2007-10#1)(2007-4#1)(2007-7#1)(2008-9#1)(2010-12#1)(2012-2#2)(2013-1#1)
possible relationship of##2##3##(1990-6#1)(2008-10#1)
possible relationship with##3##3##(2008-10#1)(2012-2#1)(2013-1#1)
possible relationship##22##2##(1990-6#1)(1992-2#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-4#1)(2004-1#1)(2004-11#1)(2006-12#1)(2007-10#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-9#1)(2010-12#1)(2012-2#3)(2013-1#2)
possible relationships between fluctuations in##2##5##(2008-7#2)
possible relationships between##6##3##(1995-4#1)(2008-10#1)(2008-4#1)(2008-7#2)(2009-9#1)
possible relationships##7##2##(1995-4#1)(2008-10#2)(2008-4#1)(2008-7#2)(2009-9#1)
possible relevance for##2##3##(1994-8#1)(2005-8#1)
possible relevance of##7##3##(1990-12#1)(1992-12#1)(1992-9#1)(1995-3#1)(1997-5#1)(2008-10#1)(2008-9#1)
possible relevance##11##2##(1990-12#1)(1992-12#1)(1992-9#1)(1994-8#1)(1995-3#1)(1996-1#1)(1997-5#1)(2005-8#1)(2008-10#1)(2008-7#1)(2008-9#1)
possible remedies##3##2##(1992-2#1)(2006-9#1)(2007-4#1)
possible research##2##2##(2007-12#1)(2011-2#1)
possible resistance##2##2##(2007-6#1)(2008-11#1)
possible response mechanism##2##3##(2007-8#1)(2008-10#1)
possible results##2##2##(1995-6#1)(2011-2#1)
possible risk factors for##7##4##(1992-11#1)(2005-10#1)(2006-10#1)(2008-1#1)(2008-4#1)(2012-2#2)
possible risk factors##11##3##(1992-11#2)(2005-10#1)(2006-10#1)(2008-1#2)(2008-4#1)(2011-1#1)(2012-2#2)(2013-7#1)
possible risk of##4##3##(1990-12#1)(1995-8#1)(2006-4#1)(2012-2#1)
possible risk##20##2##(1990-12#1)(1991-2#1)(1992-11#2)(1993-5#1)(1995-8#1)(2005-10#1)(2006-10#2)(2006-4#1)(2008-1#2)(2008-4#2)(2011-1#1)(2011-2#1)(2012-2#3)(2013-7#1)
possible risks associated with##2##4##(2011-2#1)(2011-3#1)
possible risks##3##2##(1994-1#1)(2011-2#1)(2011-3#1)
possible role as##4##3##(1995-7#1)(2007-9#1)(2010-10#1)(2010-8#1)
possible role for##21##3##(1991-1#3)(1992-10#1)(1992-11#1)(1992-3#1)(1992-4#1)(1993-12#1)(1994-8#1)(1995-7#1)(1996-12#1)(1997-5#1)(1997-6#1)(2004-11#1)(2006-12#1)(2008-10#2)(2008-5#1)(2009-12#1)(2011-2#1)(2012-2#1)
possible role in the##6##4##(1993-9#1)(1995-12#1)(1996-3#1)(1997-6#1)(2008-12#1)(2008-7#1)
possible role in##23##3##(1990-3#1)(1990-5#1)(1992-7#1)(1993-12#1)(1993-9#1)(1994-2#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-1#1)(2007-6#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-10#1)(2011-2#1)(2013-1#1)
possible role of genetic##2##4##(1992-3#1)(2009-4#1)
possible role of lipids##2##4##(1991-3#1)(1991-4#1)
possible role of the##12##4##(1991-2#1)(1992-6#2)(1995-11#1)(1995-6#1)(1995-8#1)(1997-4#1)(2007-12#1)(2008-1#1)(2009-4#1)(2011-2#1)(2013-8#1)
possible role of these##5##4##(1992-8#1)(1995-2#1)(2008-10#1)(2011-2#1)(2012-12#1)
possible role of##93##3##(1990-1#1)(1990-10#1)(1990-11#1)(1990-2#1)(1990-6#2)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#2)(1992-8#2)(1993-11#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-5#2)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1995-9#3)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#2)(1997-4#1)(1997-8#1)(2005-9#2)(2007-1#1)(2007-10#3)(2007-12#1)(2007-7#2)(2007-9#1)(2008-1#3)(2008-10#4)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-4#2)(2009-9#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#3)(2011-3#1)(2012-12#1)(2013-7#1)(2013-8#1)
possible role##146##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1991-1#3)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-4#3)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#2)(1993-6#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#2)(1995-9#3)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-9#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#1)(2005-9#2)(2006-1#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#2)(2007-9#2)(2008-1#3)(2008-10#6)(2008-12#2)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#2)(2009-10#1)(2009-12#2)(2009-4#2)(2009-9#1)(2010-10#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
possible role(s)##3##2##(1991-5#1)(1997-4#1)(2008-11#1)
possible roles for##4##3##(1990-6#1)(1995-8#1)(2006-10#1)(2007-12#1)
possible roles in##5##3##(1991-1#1)(1993-12#1)(2005-10#1)(2008-7#1)(2009-6#1)
possible roles of these##3##4##(1991-11#1)(1991-9#1)(2007-12#1)
possible roles of##18##3##(1990-7#1)(1991-11#1)(1991-9#1)(1993-9#1)(1994-8#1)(1996-7#1)(1996-9#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#2)(2009-8#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#1)
possible roles##29##2##(1990-6#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-9#1)(1993-12#1)(1993-9#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-7#1)(1996-9#1)(2005-10#1)(2006-10#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#3)(2009-6#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#1)
possible route##2##2##(2011-1#1)(2012-2#1)
possible routes of##2##3##(2008-11#1)(2008-4#1)
possible scenarios##3##2##(1996-3#1)(2008-10#1)(2012-3#1)
possible secondary##2##2##(1990-12#1)(2011-2#1)
possible selves (and##2##3##(2010-6#2)
possible selves focused on##2##4##(2010-6#2)
possible selves of low-income mothers##2##5##(2010-6#2)
possible selves##8##2##(2010-6#8)
possible sensitivity##3##2##(2008-10#1)(2008-12#1)(2008-3#1)
possible sequence##2##2##(1997-6#1)(2008-12#1)
possible shape##2##2##(2008-10#1)(2008-7#1)
possible side effects##9##3##(1991-6#1)(1993-8#1)(1995-1#1)(2006-10#1)(2007-11#2)(2008-5#1)(2008-8#1)(2010-3#1)
possible side##10##2##(1991-6#1)(1993-8#1)(1995-1#1)(2006-10#1)(2007-11#2)(2008-5#1)(2008-8#1)(2010-3#2)
possible signal##3##2##(1994-12#1)(2010-7#1)(2012-1#1)
possible significance for##2##3##(1997-3#1)(2011-2#1)
possible significance of##3##3##(1994-2#1)(2006-4#1)(2008-10#1)
possible significance##6##2##(1990-10#1)(1994-2#1)(1997-3#1)(2006-4#1)(2008-10#1)(2011-2#1)
possible single##3##2##(1991-9#1)(2009-9#1)(2013-8#1)
possible sites for##2##3##(1990-8#1)(2004-12#1)
possible sites##3##2##(1990-8#1)(1994-5#1)(2004-12#1)
possible situations##4##2##(1990-12#1)(2006-10#1)(2008-8#2)
possible solution to##3##3##(1990-6#1)(1991-9#1)(2008-2#1)
possible solution##12##2##(1990-6#1)(1991-9#1)(1992-1#1)(1993-3#1)(1994-11#1)(1994-8#1)(2005-10#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#1)(2009-10#1)
possible solutions are##2##3##(2012-12#1)(2013-7#1)
possible solutions for##2##3##(2008-6#1)(2008-7#1)
possible solutions presented##2##3##(2005-10#1)(2010-6#1)
possible solutions to##5##3##(2006-2#1)(2008-2#1)(2008-6#1)(2009-6#1)(2013-1#1)
possible solutions##24##2##(1994-12#1)(2005-10#1)(2005-6#1)(2005-7#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#2)(2009-6#1)(2009-7#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
possible source of##5##3##(2006-10#1)(2006-5#1)(2006-6#1)(2011-2#1)(2012-2#1)
possible source##6##2##(2006-10#1)(2006-5#1)(2006-6#1)(2007-9#1)(2011-2#1)(2012-2#1)
possible sources of##7##3##(1995-3#1)(1996-3#1)(2008-10#2)(2008-3#1)(2009-6#1)(2011-12#1)
possible sources##9##2##(1995-3#1)(1996-3#1)(2006-3#1)(2006-8#1)(2008-10#2)(2008-3#1)(2009-6#1)(2011-12#1)
possible species##3##2##(1992-12#1)(1997-7#1)(2010-2#1)
possible specific##2##2##(1990-10#1)(1992-3#1)
possible stereoisomers##2##2##(1991-2#1)(2006-12#1)
possible strategies for##2##3##(2007-6#1)(2012-2#1)
possible strategies##6##2##(2006-10#1)(2006-5#1)(2006-7#1)(2007-6#1)(2008-1#1)(2012-2#1)
possible structural##3##2##(1991-5#1)(1993-2#1)(1996-6#1)
possible studies##2##2##(2005-11#1)(2008-11#1)
possible substitutes##2##2##(2008-7#1)(2013-1#1)
possible substrate##2##2##(1996-9#1)(2011-1#1)
possible suggestions##2##2##(2007-8#2)
possible surgical##3##2##(1990-3#1)(2006-6#1)(2007-8#1)
possible synergistic##3##2##(2008-10#1)(2008-8#1)(2009-3#1)
possible synthesis##2##2##(1996-2#1)(2007-8#1)
possible target of##2##3##(1992-8#1)(1994-8#1)
possible target organ##2##3##(1992-12#1)(1997-3#1)
possible target##6##2##(1992-12#1)(1992-8#1)(1993-9#1)(1994-8#1)(1995-11#1)(1997-3#1)
possible targets for##3##3##(2006-10#1)(2008-11#1)(2012-12#1)
possible targets##4##2##(2006-10#1)(2008-11#1)(2012-12#1)(2013-7#1)
possible techniques for##2##3##(2006-10#1)(2008-2#1)
possible techniques to##2##3##(2008-10#1)(2008-3#1)
possible techniques##5##2##(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-11#1)
possible that different##2##3##(2006-9#1)(2009-4#1)
possible that other##5##3##(1995-11#1)(1996-12#1)(2007-9#1)(2008-1#1)(2013-1#1)
possible that the##22##3##(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-12#1)(1997-6#1)(1997-7#1)(2005-8#1)(2006-8#1)(2008-10#2)(2008-12#1)(2008-5#3)(2008-8#1)(2010-12#1)(2010-2#1)(2011-2#1)(2013-1#3)
possible that they##4##3##(1994-5#1)(2006-7#1)(2008-11#1)(2011-2#1)
possible that this##8##3##(1992-1#1)(1995-5#1)(1995-6#1)(1997-1#1)(1997-5#1)(2007-9#2)(2008-9#1)
possible that##122##2##(1990-2#1)(1991-1#1)(1991-2#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#3)(1994-9#3)(1995-11#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2004-4#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#5)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#6)(2008-7#3)(2008-8#3)(2008-9#1)(2009-1#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
possible the assessment of##2##4##(2006-7#1)(2008-8#1)
possible the determination of##3##4##(2008-10#2)(2008-2#1)
possible the##28##2##(1991-5#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-3#1)
possible therapeutic application##2##3##(1991-1#1)(1991-2#1)
possible therapeutic implications##2##3##(2006-10#1)(2008-7#1)
possible therapeutic options##3##3##(2006-2#1)(2012-12#1)(2012-2#1)
possible therapeutic##20##2##(1990-5#2)(1991-1#1)(1991-2#1)(1991-8#1)(1993-4#1)(1996-2#1)(1997-1#1)(2006-10#3)(2006-2#2)(2008-7#1)(2009-3#1)(2010-10#1)(2012-12#1)(2012-2#2)(2013-8#1)
possible therapies##2##2##(2006-10#1)(2012-3#1)
possible through##8##2##(1994-11#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-11#1)(2008-10#1)(2010-6#1)(2010-9#1)
possible time##5##2##(1997-3#1)(2007-8#1)(2008-10#2)(2013-1#1)
possible to achieve a high##2##5##(2008-2#1)(2008-7#1)
possible to achieve a##4##4##(1996-4#1)(2008-2#2)(2008-7#1)
possible to achieve##14##3##(1996-4#1)(2005-9#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#5)(2008-7#1)
possible to adjust the##2##4##(2007-7#1)(2008-10#1)
possible to administer##2##3##(1992-10#1)(2007-11#1)
possible to adopt a##2##4##(2008-10#2)
possible to affirm that##2##4##(1990-10#1)(2008-1#1)
possible to alter the##2##4##(2007-8#1)(2012-11#1)
possible to analyse##4##3##(1997-3#1)(2008-10#2)(2008-7#1)
possible to analyze the##2##4##(2010-10#1)(2012-2#1)
possible to analyze##5##3##(1994-2#1)(2008-10#1)(2010-10#1)(2012-12#1)(2012-2#1)
possible to anticipate##2##3##(2007-8#1)(2013-1#1)
possible to apply##2##3##(2008-10#1)(2011-1#1)
possible to ascertain##3##3##(1990-5#1)(2007-8#1)(2009-2#1)
possible to assess the##6##4##(1993-6#1)(1997-5#1)(2006-3#1)(2007-7#1)(2008-10#2)
possible to assess##7##3##(1992-1#1)(1993-6#1)(1997-5#1)(2006-3#1)(2007-7#1)(2008-10#2)
possible to avoid the need for##2##6##(2007-11#1)(2008-6#1)
possible to avoid the##4##4##(1992-5#1)(2007-11#1)(2007-7#1)(2008-6#1)
possible to avoid##10##3##(1990-8#1)(1992-5#1)(1996-3#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-6#1)(2012-12#1)
possible to be##2##3##(2005-4#1)(2007-2#1)
possible to better##2##3##(2007-4#1)(2010-12#1)
possible to build##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
possible to calculate##2##3##(1991-11#1)(2006-12#1)
possible to carry out##4##4##(1993-11#1)(1996-3#1)(1997-6#1)(2011-2#1)
possible to characterize the##4##4##(1992-3#1)(2007-12#1)(2008-10#1)(2008-6#1)
possible to clarify the##2##4##(1995-8#1)(2008-10#1)
possible to combine##5##3##(1995-5#1)(2007-12#1)(2008-2#1)(2008-7#1)(2013-1#1)
possible to compare the##6##4##(1994-6#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-2#1)
possible to compare##10##3##(1994-6#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#2)(2009-2#1)
possible to conclude that##5##4##(1991-10#1)(1991-3#1)(1993-9#1)(2008-3#1)(2008-5#1)
possible to conclude##6##3##(1991-10#1)(1991-3#1)(1993-9#1)(2008-3#1)(2008-5#1)(2013-7#1)
possible to conduct##4##3##(2007-11#1)(2010-3#1)(2010-5#1)(2011-2#1)
possible to confirm##4##3##(2008-10#1)(2008-5#1)(2009-2#1)(2011-2#1)
possible to consider##5##3##(1997-2#1)(2006-2#1)(2008-10#1)(2008-3#1)(2008-5#1)
possible to construct a##6##4##(1991-4#1)(2008-2#2)(2008-9#1)(2009-4#1)(2010-2#1)
possible to construct##8##3##(1991-4#1)(2006-12#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-4#1)(2010-2#1)
possible to control the##5##4##(2007-12#1)(2008-2#1)(2008-3#2)(2008-7#1)
possible to control##7##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)
possible to create a##3##4##(2006-10#1)(2009-7#1)(2011-1#1)
possible to create##6##3##(1990-8#1)(2006-10#1)(2007-6#1)(2008-7#1)(2009-7#1)(2011-1#1)
possible to define##5##3##(1990-11#1)(1992-9#1)(1996-11#1)(2007-8#1)(2011-2#1)
possible to deliver##2##3##(1997-4#1)(2010-5#1)
possible to demonstrate##5##3##(1990-4#1)(1991-3#1)(1995-1#1)(2005-11#1)(2006-12#1)
possible to derive the##2##4##(2008-2#2)
possible to derive##5##3##(1997-1#1)(2008-2#2)(2008-3#1)(2008-5#1)
possible to describe##2##3##(2005-11#1)(2008-3#1)
possible to design a##2##4##(1996-10#1)(2007-12#1)
possible to design##14##3##(1992-8#1)(1994-2#1)(1996-10#1)(1996-8#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2012-3#1)
possible to detect and##3##4##(1991-6#1)(2007-11#1)(2008-10#1)
possible to detect the##3##4##(2007-9#1)(2008-10#1)(2010-9#1)
possible to detect##24##3##(1990-11#1)(1990-3#1)(1991-6#1)(1994-10#1)(1994-6#1)(1995-11#1)(1996-6#1)(2006-6#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#1)(2009-3#1)(2010-9#1)(2013-1#2)
possible to determine the##16##4##(1991-8#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-8#1)(1996-6#1)(1997-8#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-9#1)
possible to determine##30##3##(1990-8#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-6#1)(1993-8#1)(1996-6#1)(1997-2#1)(1997-8#1)(2006-10#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-4#2)(2008-9#1)(2013-1#1)
possible to develop##9##3##(1995-6#1)(1997-4#1)(2005-7#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)
possible to diagnose##3##3##(1990-6#1)(2007-11#1)(2008-10#1)
possible to differentiate between##2##4##(1994-9#1)(1996-6#1)
possible to differentiate the##3##4##(2006-12#1)(2007-9#1)(2008-10#1)
possible to differentiate##7##3##(1994-9#1)(1995-4#1)(1996-6#1)(2006-12#1)(2007-9#1)(2008-10#1)(2013-8#1)
possible to discover##2##3##(1993-10#1)(2008-5#1)
possible to discriminate between##2##4##(1992-5#1)(2012-12#1)
possible to distinguish between##2##4##(1996-5#1)(2012-12#1)
possible to distinguish different##2##4##(1996-12#2)
possible to distinguish the##2##4##(2007-12#1)(2008-10#1)
possible to distinguish##10##3##(1990-8#1)(1996-12#2)(1996-5#1)(2007-12#1)(2008-10#2)(2010-4#1)(2012-12#1)(2013-7#1)
possible to do##2##3##(2008-10#1)(2008-4#1)
possible to draw##2##3##(2008-9#1)(2009-7#1)
possible to easily##2##3##(2005-11#1)(2008-11#1)
possible to eliminate##3##3##(2006-6#1)(2008-10#1)(2013-1#1)
possible to employ##5##3##(1990-2#1)(2008-10#1)(2008-8#1)(2013-1#2)
possible to engineer##3##3##(2006-5#1)(2006-6#1)(2007-12#1)
possible to establish a##3##4##(1990-3#1)(2008-10#1)(2008-5#1)
possible to establish##8##3##(1990-3#1)(1995-7#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-5#1)(2013-1#2)
possible to estimate the##5##4##(1996-12#1)(2008-10#2)(2008-3#1)(2010-5#1)
possible to estimate##10##3##(1991-3#1)(1996-12#1)(2007-11#1)(2008-10#3)(2008-3#1)(2009-2#1)(2010-5#1)(2012-12#1)
possible to evaluate the##6##4##(1990-3#1)(2006-6#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-3#1)
possible to evaluate##9##3##(1990-3#1)(2006-6#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)(2012-12#1)
possible to examine the##2##4##(2007-8#1)(2008-9#1)
possible to examine##3##3##(2007-8#1)(2008-9#1)(2013-8#1)
possible to exert##2##3##(2007-11#1)(2008-12#1)
possible to extend the##5##4##(1992-3#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#1)
possible to extract##8##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-9#1)
possible to fabricate##3##3##(2007-11#1)(2007-12#1)(2010-9#1)
possible to find a##2##4##(2005-11#1)(2010-4#1)
possible to follow the##2##4##(1995-9#1)(2008-10#1)
possible to follow##4##3##(1994-6#1)(1995-9#1)(1997-6#1)(2008-10#1)
possible to generate##9##3##(1993-12#1)(1994-12#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-2#1)(2012-3#1)
possible to get##2##3##(2008-10#1)(2010-3#1)
possible to highlight##2##3##(1994-10#1)(2010-5#1)
possible to identify and##2##4##(2006-4#1)(2008-4#1)
possible to identify some##4##4##(1997-7#1)(2007-7#1)(2008-10#2)
possible to identify the##5##4##(1991-5#1)(2008-10#1)(2008-11#2)(2012-3#1)
possible to identify##28##3##(1991-5#1)(1996-1#1)(1996-3#1)(1997-7#1)(2006-12#2)(2006-4#1)(2006-7#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#3)(2008-4#2)(2008-6#1)(2009-11#1)(2010-12#1)(2010-4#1)(2012-12#1)(2012-3#2)(2013-8#1)
possible to improve the##4##4##(2008-11#1)(2008-2#2)(2011-2#1)
possible to improve##6##3##(2007-11#1)(2007-5#1)(2008-11#1)(2008-2#2)(2011-2#1)
possible to incorporate##2##3##(1996-8#1)(2007-2#1)
possible to increase the##7##4##(1997-3#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-4#1)(2009-4#1)(2010-12#1)
possible to increase##10##3##(1991-7#1)(1997-3#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-4#1)(2009-4#1)(2010-12#1)
possible to infer##2##3##(2008-11#1)(2010-7#1)
possible to introduce##5##3##(1993-8#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#1)
possible to investigate the##4##4##(1991-8#1)(1997-8#1)(2007-11#1)(2008-8#1)
possible to investigate##7##3##(1991-8#1)(1997-8#1)(2007-11#1)(2008-7#1)(2008-8#2)(2010-2#1)
possible to isolate##3##3##(2005-9#1)(2008-5#1)(2010-4#1)
possible to keep the##2##4##(2004-8#1)(2008-3#1)
possible to maintain a##2##4##(1990-12#1)(2010-12#1)
possible to maintain##4##3##(1990-12#1)(2008-2#1)(2010-12#1)(2010-2#1)
possible to make a##2##4##(2006-10#1)(2007-11#1)
possible to make##7##3##(2006-10#1)(2007-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-6#1)(2009-7#1)
possible to manipulate##2##3##(1995-5#1)(2008-7#1)
possible to measure changes in##2##5##(2004-9#1)(2008-3#1)
possible to measure the##5##4##(1997-4#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-12#1)
possible to measure##10##3##(1990-12#1)(1997-4#1)(2004-9#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-12#1)
possible to monitor the##3##4##(2008-10#3)
possible to monitor##6##3##(1990-4#1)(2008-10#3)(2008-2#1)(2008-9#1)
possible to observe that##2##4##(1992-6#1)(2013-1#1)
possible to observe the##2##4##(1995-8#1)(2010-12#1)
possible to observe##11##3##(1992-6#1)(1995-2#1)(1995-8#1)(1997-2#1)(2006-1#1)(2007-12#1)(2008-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
possible to obtain a model##3##5##(2008-10#3)
possible to obtain a##8##4##(2007-7#1)(2008-10#4)(2008-5#1)(2010-7#1)(2013-1#1)
possible to obtain the##2##4##(2008-10#1)(2008-3#1)
possible to obtain##40##3##(1990-12#1)(1991-12#1)(1992-6#1)(1997-4#1)(2005-11#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-7#1)(2008-10#13)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#1)(2010-4#2)(2010-7#1)(2011-3#1)(2012-12#1)(2013-1#2)
possible to optimize the##3##4##(2007-12#2)(2011-2#1)
possible to optimize##5##3##(2007-12#2)(2008-2#1)(2008-6#1)(2011-2#1)
possible to overcome##2##3##(1994-6#1)(2008-2#1)
possible to perform a##2##4##(2007-12#1)(2008-10#1)
possible to perform accurate##2##4##(2007-12#1)(2008-5#1)
possible to perform the##2##4##(2008-10#2)
possible to perform##15##3##(1990-4#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-12#2)(2008-10#5)(2008-2#1)(2008-5#1)(2008-7#1)(2012-2#1)
possible to place##5##3##(2006-10#1)(2008-6#1)(2008-7#1)(2010-6#1)(2013-1#1)
possible to plan##2##3##(2007-12#1)(2007-7#1)
possible to precondition##2##3##(1993-7#2)
possible to predict which##2##4##(1994-2#1)(2008-10#1)
possible to predict##7##3##(1994-2#1)(1996-4#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)
possible to prepare##2##3##(1990-12#1)(1995-8#1)
possible to prescribe a##2##4##(1990-5#1)(1994-4#1)
possible to prescribe##3##3##(1990-5#1)(1994-4#1)(1996-8#1)
possible to prevent##4##3##(2004-12#1)(2009-7#1)(2010-9#1)(2013-1#1)
possible to prioritize##2##3##(1994-3#1)(2010-9#1)
possible to produce##10##3##(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2009-11#1)
possible to protect the##3##4##(1994-5#1)(2013-1#2)
possible to provide##5##3##(1992-6#1)(2006-10#1)(2008-10#1)(2012-1#1)(2012-2#1)
possible to purify##2##3##(1992-12#1)(2013-8#1)
possible to quantify the##4##4##(1990-11#1)(2008-7#2)(2010-3#1)
possible to quantitatively##2##3##(1992-6#1)(2008-2#1)
possible to rapidly##2##3##(1992-7#1)(2008-10#1)
possible to reach##3##3##(2006-2#1)(2006-4#1)(2008-10#1)
possible to reconstruct the##2##4##(2009-2#1)(2011-12#1)
possible to reconstruct##4##3##(2009-2#1)(2011-12#1)(2012-12#2)
possible to reduce the##6##4##(1997-8#1)(2006-10#1)(2007-12#1)(2008-3#1)(2012-12#1)(2013-7#1)
possible to reduce##8##3##(1997-8#1)(2006-10#1)(2007-12#1)(2008-3#1)(2012-12#2)(2013-1#1)(2013-7#1)
possible to resolve##5##3##(1990-11#1)(2007-12#1)(2008-10#1)(2008-9#1)(2011-1#1)
possible to see##2##3##(1994-2#1)(2009-8#1)
possible to select##6##3##(1997-2#1)(2004-9#1)(2006-5#1)(2008-10#2)(2012-11#1)
possible to selectively##3##3##(2005-8#1)(2006-12#1)(2008-10#1)
possible to separate the##2##4##(1997-2#1)(2008-2#1)
possible to separate##4##3##(1995-7#1)(1997-2#1)(2008-10#1)(2008-2#1)
possible to show that##2##4##(1993-9#1)(2007-9#1)
possible to show##3##3##(1993-9#1)(2007-9#1)(2008-8#1)
possible to simplify##2##3##(1995-1#1)(2006-10#1)
possible to simultaneously##3##3##(1997-8#1)(2008-10#1)(2013-8#1)
possible to store##2##3##(2008-11#1)(2008-5#1)
possible to study##8##3##(1995-5#1)(2006-12#1)(2007-11#2)(2008-2#2)(2008-9#1)(2013-8#1)
possible to take advantage of##2##5##(1993-12#1)(1996-1#1)
possible to take##3##3##(1993-12#1)(1996-1#1)(2008-10#1)
possible to test for##2##4##(2006-10#1)(2008-9#1)
possible to test the##2##4##(1990-1#1)(1997-2#1)
possible to test##5##3##(1990-1#1)(1997-2#1)(2005-7#1)(2006-10#1)(2008-9#1)
possible to track##2##3##(2008-3#1)(2008-7#1)
possible to transfer##4##3##(1993-9#1)(1996-5#1)(2006-11#1)(2007-12#1)
possible to treat##3##3##(1990-3#1)(1992-10#1)(1997-6#1)
possible to use remote##2##4##(2008-3#1)(2008-4#1)
possible to use the##4##4##(1994-11#1)(1997-4#1)(2007-8#1)(2008-7#1)
possible to use##18##3##(1991-1#1)(1994-11#1)(1997-4#1)(1997-8#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2011-12#1)
possible to##882##2##(1990-1#1)(1990-10#2)(1990-11#4)(1990-12#5)(1990-2#2)(1990-3#5)(1990-4#3)(1990-5#3)(1990-6#1)(1990-8#4)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#3)(1991-4#3)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#2)(1992-10#3)(1992-11#1)(1992-12#1)(1992-3#4)(1992-5#3)(1992-6#5)(1992-7#2)(1992-8#3)(1992-9#4)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#3)(1993-9#4)(1994-10#2)(1994-11#2)(1994-12#2)(1994-2#4)(1994-3#2)(1994-4#1)(1994-5#2)(1994-6#4)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#4)(1995-6#1)(1995-7#2)(1995-8#3)(1995-9#2)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#4)(1996-3#4)(1996-4#3)(1996-5#3)(1996-6#4)(1996-8#3)(1996-9#1)(1997-1#3)(1997-2#6)(1997-3#3)(1997-4#5)(1997-5#2)(1997-6#4)(1997-7#1)(1997-8#7)(2004-12#1)(2004-4#1)(2004-8#1)(2004-9#2)(2005-11#9)(2005-4#1)(2005-5#2)(2005-7#2)(2005-8#1)(2005-9#4)(2006-1#1)(2006-10#15)(2006-11#3)(2006-12#11)(2006-2#6)(2006-3#1)(2006-4#3)(2006-5#4)(2006-6#7)(2006-7#3)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#27)(2007-12#32)(2007-2#3)(2007-3#1)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#12)(2007-8#17)(2007-9#4)(2008-1#11)(2008-10#117)(2008-11#27)(2008-12#4)(2008-2#46)(2008-3#49)(2008-4#20)(2008-5#24)(2008-6#7)(2008-7#25)(2008-8#8)(2008-9#18)(2009-1#1)(2009-11#2)(2009-12#1)(2009-2#6)(2009-3#2)(2009-4#5)(2009-6#3)(2009-7#4)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#7)(2010-2#4)(2010-3#3)(2010-4#7)(2010-5#6)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#4)(2011-1#7)(2011-12#2)(2011-2#10)(2011-3#1)(2012-1#2)(2012-11#3)(2012-12#15)(2012-2#7)(2012-3#7)(2013-1#21)(2013-7#3)(2013-8#8)
possible toxic effects##2##3##(2007-9#1)(2008-2#1)
possible trajectories##2##2##(2005-11#1)(2007-9#1)
possible transient##3##2##(1996-12#1)(2007-12#1)(2008-7#1)
possible treatment of##6##3##(2005-7#3)(2008-11#1)(2008-6#1)(2010-12#1)
possible treatment options##3##3##(1995-12#1)(2008-11#1)(2008-6#1)
possible treatment##17##2##(1990-8#1)(1995-12#1)(1995-8#1)(2005-7#3)(2008-11#2)(2008-6#3)(2008-7#2)(2009-11#1)(2010-12#1)(2011-1#1)(2012-2#1)
possible treatments and##3##3##(2012-11#2)(2012-3#1)
possible treatments##4##2##(2012-11#2)(2012-3#1)(2013-8#1)
possible under##2##2##(2005-5#1)(2006-6#1)
possible underlying cause for##2##4##(2007-10#1)(2007-11#1)
possible underlying mechanisms for##2##4##(2008-11#1)(2013-1#1)
possible underlying mechanisms##4##3##(2008-11#1)(2010-12#1)(2011-12#1)(2013-1#1)
possible underlying##20##2##(1992-8#1)(1995-11#1)(1997-1#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2009-11#1)(2010-12#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-11#1)(2013-1#1)
possible up to##2##3##(2005-11#1)(2010-4#1)
possible use as a##3##4##(2007-11#1)(2008-11#1)(2008-5#1)
possible use as##5##3##(2007-11#1)(2008-11#1)(2008-5#2)(2012-2#1)
possible use for##2##3##(2008-10#1)(2008-5#1)
possible use in##6##3##(2004-9#1)(2007-5#1)(2008-5#2)(2010-11#1)(2013-1#1)
possible use of the##3##4##(2008-10#2)(2012-12#1)
possible use of##25##3##(1991-9#1)(1992-3#1)(1992-9#1)(1994-8#1)(1995-12#1)(1997-6#1)(2005-7#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#3)(2009-8#2)(2010-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
possible use##38##2##(1991-9#1)(1992-3#1)(1992-9#1)(1994-8#1)(1995-12#1)(1997-6#1)(2004-9#1)(2005-7#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#8)(2009-8#2)(2010-1#1)(2010-11#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
possible usefulness of##3##3##(1992-6#1)(2004-10#1)(2010-11#1)
possible usefulness##5##2##(1992-6#1)(1996-3#1)(2004-10#1)(2005-11#1)(2010-11#1)
possible uses of##2##3##(1991-11#1)(2009-2#1)
possible uses##3##2##(1991-11#1)(2008-7#1)(2009-2#1)
possible using a##4##3##(2008-10#3)(2008-5#1)
possible using##15##2##(1990-10#1)(1993-11#1)(2006-5#1)(2007-5#1)(2008-10#7)(2008-2#1)(2008-5#1)(2010-12#1)(2011-1#1)
possible values of##3##3##(1994-8#1)(2008-2#2)
possible values##5##2##(1992-4#1)(1994-8#1)(2008-10#1)(2008-2#2)
possible variants of the##3##4##(1992-6#1)(1996-7#1)(2013-7#1)
possible variation##2##2##(2008-3#2)
possible variations in##2##3##(1994-11#1)(2011-2#1)
possible variations##3##2##(1994-11#1)(2008-2#1)(2011-2#1)
possible way of##2##3##(2006-9#1)(2012-1#1)
possible way to##4##3##(1995-2#1)(2007-11#1)(2008-12#1)(2012-1#1)
possible way##8##2##(1995-2#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-2#1)(2008-12#1)(2012-1#2)
possible ways how to##2##4##(1990-11#1)(2005-1#1)
possible ways in which##2##4##(2008-3#1)(2008-7#1)
possible ways of##5##3##(1992-11#1)(1992-9#1)(1993-3#1)(2008-11#1)(2008-6#1)
possible ways to##6##3##(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-9#1)
possible ways##17##2##(1990-11#1)(1992-11#1)(1992-9#1)(1993-3#1)(2005-1#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-9#1)(2010-2#1)(2013-1#1)
possible when the##2##3##(2008-10#1)(2008-2#1)
possible when they##2##3##(1996-6#1)(2011-2#1)
possible when##12##2##(1996-6#1)(2006-7#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2011-2#1)(2013-8#1)
possible will##2##2##(2008-5#1)(2012-2#1)
possible with a limit of detection of##2##7##(2008-10#2)
possible with a##8##3##(2007-11#2)(2008-10#4)(2008-3#1)(2009-3#1)
possible with other##2##3##(2007-11#1)(2011-2#1)
possible with standard##2##3##(2008-3#1)(2011-1#1)
possible with the##8##3##(1993-3#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)
possible with this##3##3##(1997-8#1)(2007-12#1)(2009-12#1)
possible with##62##2##(1990-9#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-6#1)(1996-7#1)(1997-8#1)(2005-11#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#3)(2008-3#11)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)
possible within##2##2##(2008-10#1)(2010-2#1)
possible without##8##2##(1997-3#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-3#1)(2009-2#1)(2010-12#1)(2011-2#1)
possible##4855##1##(1990-1#2)(1990-10#11)(1990-11#22)(1990-12#18)(1990-2#19)(1990-3#15)(1990-4#8)(1990-5#18)(1990-6#18)(1990-7#8)(1990-8#22)(1990-9#13)(1991-1#15)(1991-10#3)(1991-11#15)(1991-12#18)(1991-2#21)(1991-3#19)(1991-4#9)(1991-5#15)(1991-6#14)(1991-7#8)(1991-8#10)(1991-9#19)(1992-1#9)(1992-10#10)(1992-11#15)(1992-12#14)(1992-2#17)(1992-3#27)(1992-4#16)(1992-5#14)(1992-6#22)(1992-7#10)(1992-8#22)(1992-9#13)(1993-1#7)(1993-10#6)(1993-11#15)(1993-12#25)(1993-2#11)(1993-3#13)(1993-4#2)(1993-5#9)(1993-6#19)(1993-7#7)(1993-8#12)(1993-9#24)(1994-1#3)(1994-10#5)(1994-11#15)(1994-12#19)(1994-2#20)(1994-3#23)(1994-4#6)(1994-5#19)(1994-6#28)(1994-7#2)(1994-8#26)(1994-9#15)(1995-1#15)(1995-10#5)(1995-11#16)(1995-12#13)(1995-2#17)(1995-3#12)(1995-4#8)(1995-5#21)(1995-6#15)(1995-7#10)(1995-8#16)(1995-9#10)(1996-1#12)(1996-10#5)(1996-11#10)(1996-12#29)(1996-2#16)(1996-3#23)(1996-4#8)(1996-5#18)(1996-6#13)(1996-7#14)(1996-8#18)(1996-9#14)(1997-1#17)(1997-2#24)(1997-3#21)(1997-4#20)(1997-5#22)(1997-6#20)(1997-7#21)(1997-8#25)(2003-11#1)(2004-1#3)(2004-10#2)(2004-11#7)(2004-12#7)(2004-2#1)(2004-3#4)(2004-4#4)(2004-8#2)(2004-9#9)(2005-1#4)(2005-10#15)(2005-11#30)(2005-12#2)(2005-3#2)(2005-4#4)(2005-5#4)(2005-6#1)(2005-7#17)(2005-8#16)(2005-9#9)(2006-1#5)(2006-10#125)(2006-11#8)(2006-12#39)(2006-2#21)(2006-3#10)(2006-4#20)(2006-5#14)(2006-6#25)(2006-7#17)(2006-8#19)(2006-9#11)(2007-1#7)(2007-10#31)(2007-11#104)(2007-12#131)(2007-2#33)(2007-3#12)(2007-4#26)(2007-5#16)(2007-6#9)(2007-7#46)(2007-8#69)(2007-9#31)(2008-1#68)(2008-10#434)(2008-11#105)(2008-12#33)(2008-2#134)(2008-3#143)(2008-4#85)(2008-5#116)(2008-6#47)(2008-7#121)(2008-8#76)(2008-9#58)(2009-1#4)(2009-10#16)(2009-11#11)(2009-12#12)(2009-2#14)(2009-3#14)(2009-4#26)(2009-5#16)(2009-6#13)(2009-7#16)(2009-8#27)(2009-9#14)(2010-1#6)(2010-10#15)(2010-11#11)(2010-12#52)(2010-2#21)(2010-3#12)(2010-4#25)(2010-5#17)(2010-6#25)(2010-7#22)(2010-8#17)(2010-9#8)(2011-1#58)(2011-12#12)(2011-2#145)(2011-3#5)(2011-7#1)(2012-1#29)(2012-10#1)(2012-11#15)(2012-12#67)(2012-2#86)(2012-3#48)(2012-4#1)(2012-5#2)(2012-8#2)(2013-1#125)(2013-7#27)(2013-8#56)
possible&quot##2##1##(2008-2#1)(2013-1#1)
possible)##3##1##(1993-12#1)(2006-12#1)(2010-6#1)
possible?##6##1##(2005-8#1)(2007-10#1)(2007-12#1)(2010-12#1)(2010-5#1)(2011-7#1)
possible]##3##1##(1992-3#1)(1992-4#1)(1993-6#1)
possibly a##17##2##(1990-2#1)(1992-1#1)(1993-6#1)(1994-12#2)(1994-8#1)(1996-12#1)(1997-2#1)(1997-8#1)(2004-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2009-5#1)(2010-6#1)(2011-1#1)
possibly acting##2##2##(1994-3#1)(1997-4#1)
possibly also##11##2##(1993-12#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-12#1)(2005-10#1)(2006-8#1)(2008-2#1)(2008-4#1)(2010-2#1)
possibly an##2##2##(1990-12#1)(2006-12#1)
possibly as a consequence of##2##5##(1991-1#1)(1996-3#1)
possibly as a result of##3##5##(2006-12#1)(2008-10#1)(2013-8#1)
possibly as a##6##3##(1991-1#1)(1993-12#1)(1996-3#1)(2006-12#1)(2008-10#1)(2013-8#1)
possibly as##10##2##(1991-1#1)(1993-12#1)(1994-3#1)(1995-10#1)(1995-8#1)(1996-3#1)(2004-3#1)(2006-12#1)(2008-10#1)(2013-8#1)
possibly associated with##4##3##(1990-2#1)(1994-9#1)(1997-7#1)(2010-10#1)
possibly at the##2##3##(1994-6#1)(2011-1#1)
possibly be a##3##3##(1992-7#1)(1997-3#1)(2013-8#1)
possibly be attributed to##2##4##(1995-10#1)(2007-7#1)
possibly be explained by##2##4##(1996-5#1)(2005-11#1)
possibly be used##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
possibly be##26##2##(1990-12#1)(1990-5#1)(1991-1#1)(1992-1#1)(1992-7#2)(1993-11#1)(1994-2#1)(1994-6#1)(1995-10#1)(1996-5#1)(1997-3#1)(1997-4#1)(2004-12#1)(2005-11#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2013-8#1)
possibly because of the##3##4##(1994-2#1)(2007-11#1)(2008-11#1)
possibly because of##7##3##(1994-2#1)(1995-7#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-5#1)
possibly because they are##2##4##(1992-4#1)(2009-4#1)
possibly because##18##2##(1992-4#1)(1993-12#1)(1994-2#1)(1995-2#1)(1995-7#1)(2005-9#1)(2007-1#1)(2007-11#1)(2007-12#3)(2008-11#2)(2008-3#1)(2008-5#2)(2009-4#1)(2012-3#1)
possibly being##2##2##(2008-11#1)(2011-2#1)
possibly by affecting##2##3##(2010-7#2)
possibly by decreasing the##2##4##(1995-5#1)(2008-11#1)
possibly by##21##2##(1990-11#1)(1991-6#1)(1991-9#1)(1992-4#1)(1993-9#1)(1994-12#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-12#1)(1996-5#1)(1997-2#1)(2005-7#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-7#2)(2012-2#1)
possibly caused by the##2##4##(2008-10#1)(2011-1#1)
possibly caused by##6##3##(2005-11#1)(2006-10#1)(2008-10#1)(2011-1#1)(2011-2#2)
possibly contribute to##3##3##(1993-6#1)(1995-11#1)(2008-12#1)
possibly contributing to##2##3##(1993-6#1)(2011-2#1)
possibly contributing##3##2##(1993-6#1)(2009-6#1)(2011-2#1)
possibly decrease##2##2##(1990-12#1)(2008-3#1)
possibly different##3##2##(1995-8#1)(1997-8#1)(2011-1#1)
possibly diffuse##2##2##(2010-2#1)(2012-11#1)
possibly due to a##7##4##(1991-2#1)(1995-5#1)(1996-8#1)(2005-7#1)(2009-4#1)(2013-1#2)
possibly due to an##4##4##(1994-11#1)(2008-10#1)(2008-3#1)(2012-11#1)
possibly due to lack of##2##5##(1993-12#1)(2006-11#1)
possibly due to the presence of##2##6##(1991-2#1)(1997-2#1)
possibly due to the##9##4##(1991-2#1)(1993-6#1)(1995-12#1)(1997-1#1)(1997-2#1)(2008-1#2)(2008-11#1)(2008-5#1)
possibly due to##44##3##(1990-10#1)(1991-2#3)(1992-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-11#1)(1995-12#1)(1995-5#1)(1996-8#2)(1997-1#2)(1997-2#1)(1997-5#1)(1997-7#1)(2005-7#1)(2005-9#1)(2006-11#1)(2006-7#1)(2007-1#1)(2007-2#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#4)
possibly enhance##2##2##(2008-8#1)(2011-2#1)
possibly even##9##2##(1994-6#1)(2007-2#1)(2007-4#2)(2007-9#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
possibly for##8##2##(2006-4#1)(2006-8#1)(2007-2#1)(2007-9#1)(2008-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
possibly gastrointestinal##2##2##(1990-10#1)(1991-12#1)
possibly improving##2##2##(2006-7#1)(2010-5#1)
possibly in combination with##3##4##(1993-6#1)(1997-1#1)(2012-2#1)
possibly in conjunction with##3##4##(1996-10#1)(2006-10#1)(2009-8#1)
possibly in order to##2##4##(2007-12#1)(2008-1#1)
possibly in the##5##3##(1990-12#1)(1995-5#1)(1995-8#1)(2006-12#1)(2008-7#1)
possibly in##17##2##(1990-12#1)(1990-5#1)(1992-10#1)(1992-8#1)(1993-6#1)(1995-5#1)(1995-8#1)(1996-10#1)(1997-1#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-8#1)(2012-2#1)
possibly increase the risk##2##4##(2010-6#1)(2011-1#1)
possibly increase##3##2##(2007-8#1)(2010-6#1)(2011-1#1)
possibly indicating a##3##3##(1997-3#1)(2008-10#1)(2012-5#1)
possibly indicating##8##2##(1996-3#1)(1997-3#1)(1997-5#1)(2008-10#2)(2008-5#2)(2012-5#1)
possibly induced##3##2##(1992-8#1)(2010-6#2)
possibly influencing##2##2##(1995-11#1)(1997-2#1)
possibly involve##2##2##(1991-5#2)
possibly involved in the##6##4##(1990-8#1)(1994-5#1)(2006-10#1)(2008-10#1)(2010-11#1)(2010-12#1)
possibly involved in##12##3##(1990-8#2)(1991-4#1)(1993-9#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-5#1)(2006-10#1)(2008-10#1)(2010-11#1)(2010-12#1)
possibly involved##13##2##(1990-8#2)(1991-4#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-5#1)(2006-10#1)(2008-10#1)(2010-11#1)(2010-12#1)
possibly involving the##2##3##(1997-3#1)(2008-10#1)
possibly involving##4##2##(1996-4#2)(1997-3#1)(2008-10#1)
possibly less than##2##3##(2008-5#1)(2012-3#1)
possibly less##5##2##(1996-8#1)(2006-3#1)(2008-11#1)(2008-5#1)(2012-3#1)
possibly linked##2##2##(2008-9#1)(2011-2#1)
possibly makes##2##2##(1990-11#1)(2007-3#1)
possibly mediated by##3##3##(1994-11#1)(2009-8#1)(2012-2#1)
possibly mediated through##2##3##(2008-11#2)
possibly mediated##6##2##(1994-11#1)(1994-12#1)(2008-11#2)(2009-8#1)(2012-2#1)
possibly more##3##2##(1992-3#1)(2008-9#1)(2009-12#1)
possibly not##2##2##(1992-2#1)(2007-12#1)
possibly occurring##2##2##(1990-3#1)(1995-2#1)
possibly of##4##2##(1990-11#1)(1991-12#1)(1995-10#1)(1995-3#1)
possibly other##17##2##(1990-4#1)(1994-9#1)(1995-12#2)(1995-2#1)(1996-2#1)(1996-4#1)(1996-8#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#1)
possibly owing to the##2##4##(1991-1#1)(1997-5#1)
possibly owing to##5##3##(1991-1#1)(1997-5#1)(2009-3#1)(2009-4#1)(2009-6#1)
possibly permanent##2##2##(2007-7#1)(2012-3#1)
possibly playing a##2##3##(1990-11#2)
possibly playing##4##2##(1990-11#2)(2005-10#1)(2009-7#1)
possibly predict##3##2##(2006-7#2)(2008-10#1)
possibly reducing##2##2##(2007-9#1)(2011-2#1)
possibly reflect##2##2##(1997-8#1)(2007-3#1)
possibly reflecting the##3##3##(1990-8#1)(1997-2#1)(2012-5#1)
possibly reflecting##7##2##(1990-8#1)(1996-2#1)(1997-1#1)(1997-2#1)(2007-2#1)(2010-7#1)(2012-5#1)
possibly related to a##2##4##(1994-3#1)(2010-12#1)
possibly related to the##7##4##(1992-6#1)(1993-9#1)(2009-11#1)(2009-4#1)(2010-12#1)(2011-2#1)(2013-1#1)
possibly related to##22##3##(1992-11#1)(1992-6#1)(1993-9#1)(1994-11#1)(1994-3#1)(2006-1#1)(2006-9#1)(2007-11#1)(2008-10#2)(2008-6#1)(2008-8#1)(2009-1#1)(2009-11#1)(2009-4#1)(2009-9#1)(2010-12#2)(2011-2#1)(2012-2#2)(2013-1#1)
possibly related##23##2##(1992-11#1)(1992-6#1)(1993-9#1)(1994-11#1)(1994-3#1)(1997-4#1)(2006-1#1)(2006-9#1)(2007-11#1)(2008-10#2)(2008-6#1)(2008-8#1)(2009-1#1)(2009-11#1)(2009-4#1)(2009-9#1)(2010-12#2)(2011-2#1)(2012-2#2)(2013-1#1)
possibly relevant##3##2##(1991-6#1)(2008-10#1)(2008-12#1)
possibly represent##2##2##(1990-11#1)(2008-10#1)
possibly representing##2##2##(1991-2#1)(2011-2#1)
possibly responsible for##2##3##(1992-8#1)(2010-5#1)
possibly result from##2##3##(2009-9#1)(2012-3#1)
possibly result##3##2##(2008-5#1)(2009-9#1)(2012-3#1)
possibly resulting in##3##3##(2008-10#1)(2009-5#1)(2010-7#1)
possibly resulting##4##2##(1991-4#1)(2008-10#1)(2009-5#1)(2010-7#1)
possibly several##2##2##(2007-8#1)(2008-10#1)
possibly the main##2##3##(2006-6#1)(2008-5#1)
possibly the##20##2##(1992-12#1)(1993-12#1)(1993-3#1)(1994-9#1)(1997-5#1)(2004-2#1)(2006-10#1)(2006-2#1)(2006-6#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-7#1)
possibly through the##3##3##(1990-5#1)(1993-9#1)(2009-4#1)
possibly through##14##2##(1990-5#1)(1991-4#1)(1993-6#2)(1993-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-6#1)(2008-8#1)(2009-11#1)(2009-4#1)(2012-12#1)
possibly to##6##2##(1990-8#1)(1993-2#1)(2007-2#1)(2010-8#1)(2011-2#1)(2012-2#1)
possibly underlie##2##2##(2012-1#1)(2013-1#1)
possibly using##2##2##(2006-10#1)(2008-10#1)
possibly via a##4##3##(1991-9#1)(1995-12#1)(1997-1#1)(2007-12#1)
possibly via##11##2##(1991-9#1)(1994-9#1)(1995-12#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-6#1)(2013-1#2)
possibly with##6##2##(1990-2#1)(1990-4#1)(1991-12#1)(1993-11#1)(1994-8#1)(2008-7#1)
possibly##701##1##(1990-10#4)(1990-11#7)(1990-12#4)(1990-2#4)(1990-3#2)(1990-4#2)(1990-5#4)(1990-7#2)(1990-8#7)(1990-9#1)(1991-1#4)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#7)(1991-3#1)(1991-4#4)(1991-5#2)(1991-6#3)(1991-7#2)(1991-9#5)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#2)(1992-4#2)(1992-6#5)(1992-7#2)(1992-8#4)(1992-9#3)(1993-1#1)(1993-10#2)(1993-11#4)(1993-12#5)(1993-2#2)(1993-3#3)(1993-4#1)(1993-6#7)(1993-8#2)(1993-9#4)(1994-11#3)(1994-12#7)(1994-2#4)(1994-3#5)(1994-5#2)(1994-6#5)(1994-8#6)(1994-9#8)(1995-1#1)(1995-10#4)(1995-11#2)(1995-12#5)(1995-2#7)(1995-3#3)(1995-5#4)(1995-6#3)(1995-7#3)(1995-8#3)(1995-9#1)(1996-1#1)(1996-10#4)(1996-11#2)(1996-12#5)(1996-2#3)(1996-3#2)(1996-4#4)(1996-5#4)(1996-6#3)(1996-7#2)(1996-8#5)(1997-1#7)(1997-2#6)(1997-3#5)(1997-4#4)(1997-5#6)(1997-6#2)(1997-7#4)(1997-8#6)(2004-11#1)(2004-12#2)(2004-2#1)(2004-3#1)(2005-1#1)(2005-10#2)(2005-11#5)(2005-7#2)(2005-8#1)(2005-9#3)(2006-1#1)(2006-10#8)(2006-11#2)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#5)(2006-7#6)(2006-8#9)(2006-9#3)(2007-1#6)(2007-10#2)(2007-11#9)(2007-12#13)(2007-2#6)(2007-3#5)(2007-4#5)(2007-6#1)(2007-7#4)(2007-8#5)(2007-9#6)(2008-1#8)(2008-10#40)(2008-11#17)(2008-12#3)(2008-2#4)(2008-3#9)(2008-4#5)(2008-5#14)(2008-6#5)(2008-7#8)(2008-8#13)(2008-9#9)(2009-1#1)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#6)(2009-5#4)(2009-6#5)(2009-7#2)(2009-8#4)(2009-9#5)(2010-1#1)(2010-10#2)(2010-11#6)(2010-12#6)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#3)(2010-6#6)(2010-7#6)(2010-8#2)(2011-1#8)(2011-12#2)(2011-2#24)(2012-1#1)(2012-11#2)(2012-12#6)(2012-2#9)(2012-3#9)(2012-5#2)(2013-1#17)(2013-7#1)(2013-8#5)
possum (Trichosurus vulpecula)##2##3##(1997-8#1)(2005-7#1)
possum population##2##2##(2005-7#2)
possum##13##1##(1997-8#6)(2005-7#7)
possums (Trichosurus vulpecula)##7##3##(1997-8#2)(2005-7#5)
possums is##2##2##(2005-7#2)
possums##16##1##(1997-8#3)(2005-7#13)
post MO in##2##3##(1993-4#2)
post arthrogram CT##3##3##(2006-8#3)
post arthrogram##4##2##(2006-8#4)
post bolus##3##2##(2010-12#3)
post cardiac surgery##10##3##(2007-8#9)(2010-12#1)
post cardiac##11##2##(2007-8#10)(2010-12#1)
post dialysis##6##2##(2007-7#1)(2008-12#1)(2008-4#4)
post dose##3##2##(2006-12#1)(2008-8#1)(2010-12#1)
post exercise##6##2##(2007-7#1)(2012-12#2)(2013-1#3)
post exposure prophylaxis##2##3##(2013-1#2)
post exposure##6##2##(1996-12#2)(2007-8#1)(2008-8#1)(2013-1#2)
post genomic##2##2##(2008-7#1)(2010-5#1)
post germinative growth and productivity of##2##6##(2008-12#2)
post had##2##2##(1993-7#2)
post hatch##2##2##(1996-8#1)(2008-7#1)
post hepatectomy##3##2##(1991-5#2)(1991-7#1)
post hoc analysis of##2##4##(1990-12#1)(2007-8#1)
post hoc analysis##7##3##(1990-12#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-9#1)(2010-9#1)(2011-2#1)
post hoc test##4##3##(2009-8#1)(2010-3#1)(2012-2#1)(2013-8#1)
post hoc##16##2##(1990-12#1)(2007-10#1)(2007-8#1)(2007-9#2)(2008-6#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
post immunization##3##2##(2007-2#2)(2012-2#1)
post in##3##2##(1993-7#1)(2013-1#1)(2013-8#1)
post incubation##3##2##(2008-12#3)
post infarction ventricular tachycardia##2##4##(2006-9#2)
post infarction##3##2##(1993-2#1)(2006-9#2)
post infection##14##2##(1995-12#1)(1997-4#2)(2007-7#2)(2008-11#4)(2008-5#1)(2010-4#1)(2011-1#1)(2013-1#2)
post injection and##2##3##(1993-9#1)(2008-2#1)
post injection##11##2##(1992-7#2)(1993-9#1)(1994-5#1)(1996-6#1)(1997-2#1)(2007-11#2)(2008-10#1)(2008-2#1)(2010-10#1)
post injury##4##2##(1996-8#1)(2008-9#1)(2009-10#1)(2009-6#1)
post inoculation##8##2##(1994-5#1)(1997-6#1)(2006-10#1)(2008-10#2)(2008-5#2)(2009-7#1)
post intervention##4##2##(2010-9#1)(2012-11#1)(2013-1#2)
post lumbar laminectomy patients who##2##5##(2006-8#2)
post lumbar laminectomy syndrome##2##4##(2006-8#2)
post lumbar laminectomy##4##3##(2006-8#4)
post marketing surveys##2##3##(2008-8#2)
post menopausal##3##2##(1992-12#1)(2008-11#1)(2013-8#1)
post mortem alteration##3##3##(1996-9#3)
post mortem examination##3##3##(2008-5#1)(2010-10#1)(2011-1#1)
post mortem human cerebral cortex##2##5##(1991-9#1)(1996-8#1)
post mortem human subject##2##4##(2007-4#1)(2009-7#1)
post mortem human##5##3##(1991-9#1)(1996-8#1)(2007-4#2)(2009-7#1)
post mortem lesions##3##3##(2008-5#2)(2011-1#1)
post mortem##34##2##(1991-11#1)(1991-2#1)(1991-9#1)(1993-1#1)(1995-9#1)(1996-11#1)(1996-8#1)(1996-9#8)(1997-3#1)(1997-8#1)(2005-7#2)(2006-1#1)(2007-4#2)(2008-11#1)(2008-5#3)(2008-7#2)(2009-7#1)(2010-10#1)(2010-4#1)(2011-1#2)(2012-3#1)
post natal##3##2##(1990-11#1)(2008-1#1)(2008-4#1)
post op##2##2##(2007-8#1)(2008-10#1)
post operative complication##2##3##(2006-1#1)(2010-12#1)
post operative day##2##3##(2012-2#2)
post operative period##2##3##(2010-7#1)(2012-3#1)
post operative##22##2##(1996-6#1)(2006-1#1)(2006-4#1)(2007-11#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#2)(2010-7#2)(2012-2#3)(2012-3#2)(2013-7#1)
post operatively##9##2##(2007-11#1)(2007-7#3)(2007-8#1)(2009-10#1)(2010-5#1)(2013-1#2)
post parathyroidectomy##2##2##(2011-2#2)
post partum care##2##3##(2008-11#2)
post partum depression]##2##3##(2013-1#1)(2013-8#1)
post partum##20##2##(1990-3#1)(1990-6#2)(1992-12#1)(1993-10#1)(1994-7#1)(2005-7#1)(2006-4#1)(2006-5#2)(2007-7#1)(2008-11#2)(2011-2#3)(2013-1#1)(2013-8#3)
post procedure##6##2##(2006-8#1)(2007-6#4)(2011-2#1)
post processing##2##2##(2008-2#1)(2013-1#1)
post registration##4##2##(2008-11#3)(2008-12#1)
post renal transplant##3##3##(2007-7#1)(2010-9#1)(2013-7#1)
post renal##5##2##(1992-10#1)(2007-7#1)(2010-4#1)(2010-9#1)(2013-7#1)
post stroke##5##2##(2006-7#3)(2011-2#1)(2012-1#1)
post surgery##6##2##(2006-5#1)(2007-7#1)(2007-8#2)(2008-6#1)(2009-9#1)
post surgical##4##2##(1990-5#1)(2006-8#1)(2007-2#1)(2011-1#1)
post therapy##3##2##(2007-7#1)(2011-2#2)
post transfection##2##2##(1992-5#1)(2008-8#1)
post transplant complications##2##3##(2008-1#1)(2010-10#1)
post transplant##15##2##(2006-10#1)(2007-2#1)(2007-8#1)(2008-1#6)(2008-3#1)(2009-2#1)(2010-10#2)(2010-4#2)
post traumatic stress disorder##4##4##(1991-2#1)(2007-12#1)(2012-12#1)(2013-8#1)
post treatment##11##2##(1996-12#1)(2006-5#1)(2007-8#1)(2008-2#1)(2008-4#1)(2010-12#2)(2010-9#1)(2013-1#1)(2013-8#2)
post tubal sterilization##2##3##(2006-4#2)
post vaccination##4##2##(2004-1#1)(2006-10#1)(2008-5#1)(2010-4#1)
post##489##1##(1990-11#1)(1990-12#2)(1990-3#2)(1990-5#3)(1990-6#3)(1991-11#1)(1991-12#1)(1991-2#3)(1991-5#3)(1991-6#2)(1991-7#2)(1991-9#1)(1992-10#1)(1992-12#2)(1992-4#1)(1992-5#1)(1992-7#3)(1992-8#1)(1993-1#1)(1993-10#1)(1993-2#2)(1993-4#3)(1993-7#5)(1993-9#2)(1994-5#5)(1994-7#2)(1995-11#4)(1995-12#1)(1995-2#1)(1995-7#1)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#5)(1996-3#1)(1996-4#2)(1996-6#3)(1996-8#6)(1996-9#11)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#1)(2004-1#1)(2004-10#1)(2005-7#3)(2006-1#3)(2006-10#6)(2006-12#3)(2006-2#1)(2006-4#4)(2006-5#11)(2006-7#4)(2006-8#13)(2006-9#2)(2007-1#2)(2007-10#3)(2007-11#14)(2007-12#2)(2007-2#7)(2007-3#2)(2007-4#3)(2007-6#4)(2007-7#16)(2007-8#25)(2007-9#4)(2008-1#12)(2008-10#12)(2008-11#21)(2008-12#9)(2008-2#6)(2008-3#1)(2008-4#8)(2008-5#12)(2008-6#4)(2008-7#9)(2008-8#6)(2008-9#3)(2009-10#3)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#2)(2010-10#5)(2010-12#14)(2010-3#2)(2010-4#7)(2010-5#2)(2010-7#3)(2010-8#3)(2010-9#6)(2011-1#5)(2011-2#16)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#6)(2012-2#11)(2012-3#5)(2013-1#23)(2013-7#5)(2013-8#15)
post)##2##1##(1996-2#1)(2010-7#1)
post-##11##1##(2006-4#1)(2008-10#1)(2008-11#2)(2012-12#4)(2013-1#2)(2013-7#1)
post-1991##2##1##(2007-7#1)(2009-3#1)
post-CCI##5##1##(2009-10#5)
post-CPB##2##1##(2007-8#1)(2007-9#1)
post-DST cortisol levels##3##3##(1994-11#3)
post-DST##4##1##(1994-11#4)
post-ESD##4##1##(2012-2#4)
post-Golgi##5##1##(1992-11#1)(1992-12#1)(1995-8#1)(1997-6#2)
post-I group##5##2##(2009-3#5)
post-Katrina##5##1##(2012-2#5)
post-LT##4##1##(2011-3#1)(2012-12#3)
post-MI##3##1##(1992-5#1)(2010-12#1)(2012-12#1)
post-NDHS##2##1##(1993-4#2)
post-OLTX##3##1##(1995-2#3)
post-PCI##2##1##(2006-7#1)(2008-3#1)
post-PCR##2##1##(2008-10#2)
post-PTCA##3##1##(1991-3#1)(1992-9#2)
post-Paget##2##1##(1993-10#2)
post-QQc cells compared with##2##4##(2012-12#2)
post-QQc cells##5##2##(2012-12#5)
post-RFD##3##1##(2006-8#3)
post-UL##4##1##(1993-9#1)(1997-7#3)
post-UVD##10##1##(1996-9#10)
post-VX exposure##3##2##(2008-4#3)
post-abortion##3##1##(1991-6#1)(2007-1#1)(2011-2#1)
post-accident##2##1##(2010-5#1)(2012-3#1)
post-acute care##3##2##(1991-1#2)(1994-2#1)
post-acute rehabilitation##4##2##(1991-12#1)(1992-3#1)(1993-3#1)(1995-3#1)
post-acute##10##1##(1991-1#2)(1991-12#1)(1992-3#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-3#1)(2008-10#1)(2008-3#1)
post-administration##2##1##(1995-5#2)
post-adolescent acne##6##2##(2008-5#5)(2010-5#1)
post-adolescent##7##1##(2008-5#6)(2010-5#1)
post-angiography##3##1##(2007-3#2)(2007-8#1)
post-annealing##2##1##(2013-8#2)
post-antibiotic effect##4##2##(2005-7#2)(2005-8#1)(2006-8#1)
post-apartheid##5##1##(2006-7#3)(2007-7#2)
post-application##3##1##(2004-4#1)(2007-7#1)(2007-8#1)
post-array-detectors##2##1##(2008-11#2)
post-awakening##3##1##(2013-7#3)
post-binding##4##1##(1993-11#2)(1994-11#1)(1995-11#1)
post-biopsy##2##1##(1995-2#1)(2006-10#1)
post-boundary##2##1##(2008-4#2)
post-burn##6##1##(1996-4#2)(2006-7#1)(2008-12#2)(2009-6#1)
post-cardiac surgery##7##2##(2007-8#6)(2010-12#1)
post-cardiac##8##1##(2006-10#1)(2007-8#6)(2010-12#1)
post-cataract surgery optical images##2##4##(2010-8#2)
post-cataract surgery##3##2##(2010-8#3)
post-caustic esophageal stenosis##2##3##(2007-9#2)
post-cessation weight gain##3##3##(2013-1#3)
post-cessation weight##4##2##(2013-1#4)
post-cessation##5##1##(2007-12#1)(2013-1#4)
post-challenge##8##1##(1997-3#1)(1997-8#2)(2008-10#1)(2008-5#1)(2009-6#2)(2011-2#1)
post-cholecystectomy syndrome##2##2##(2009-6#2)
post-cholecystectomy##3##1##(1993-8#1)(2009-6#2)
post-chromatographic##2##1##(2008-10#2)
post-column UV##2##2##(1996-6#1)(2013-7#1)
post-column derivatisation##2##2##(2007-8#1)(2008-10#1)
post-column derivatization method##2##3##(2008-10#1)(2012-12#1)
post-column derivatization with##5##3##(1990-8#1)(1991-5#1)(2008-10#2)(2010-12#1)
post-column derivatization##12##2##(1990-8#1)(1991-5#1)(1992-2#1)(1993-11#1)(1996-6#2)(2008-10#3)(2010-12#1)(2012-12#2)
post-column reaction of##2##3##(2006-11#1)(2008-10#1)
post-column reaction##7##2##(1990-6#1)(1990-8#1)(1991-5#1)(2006-11#1)(2008-10#3)
post-column reactor##2##2##(1992-1#1)(1997-3#1)
post-column##48##1##(1990-12#1)(1990-6#1)(1990-8#4)(1991-5#4)(1992-1#1)(1992-2#2)(1993-11#1)(1996-6#5)(1997-3#5)(2006-11#3)(2007-8#1)(2008-10#15)(2008-7#1)(2010-12#1)(2012-12#2)(2013-7#1)
post-confluent##2##1##(1997-7#2)
post-copulation##3##1##(2012-12#2)(2013-8#1)
post-crash##4##1##(1996-12#4)
post-delivery##5##1##(1993-4#1)(2004-10#1)(2007-7#2)(2011-1#1)
post-dialysis##6##1##(2007-7#1)(2008-1#3)(2008-4#1)(2013-1#1)
post-diffusion samples##2##2##(2008-11#2)
post-dilatation##2##1##(2010-5#1)(2011-2#1)
post-disaster consequences##2##2##(2008-2#2)
post-disaster##5##1##(2008-2#3)(2012-2#2)
post-discharge complications##2##2##(2011-2#2)
post-discharge in##2##2##(2013-1#2)
post-discharge##9##1##(1990-12#1)(1996-12#1)(2008-11#1)(2009-6#1)(2011-2#2)(2013-1#3)
post-dispersal agents##3##2##(2008-5#3)
post-dispersal##5##1##(2006-5#1)(2008-5#4)
post-dose##3##1##(1995-11#1)(2008-6#1)(2008-8#1)
post-dosing##2##1##(1990-3#1)(1996-10#1)
post-drug##4##1##(1997-5#1)(1997-8#1)(2004-12#1)(2008-2#1)
post-embedding immunocytochemistry##2##2##(1997-7#2)
post-embedding##7##1##(1990-8#3)(1994-2#1)(1997-7#3)
post-embryonic##6##1##(1990-8#1)(2006-5#1)(2007-12#1)(2007-8#1)(2009-8#1)(2013-1#1)
post-excision##2##1##(1991-9#2)
post-exercise##5##1##(2010-3#1)(2010-9#1)(2012-12#3)
post-experience hour##2##2##(2008-11#2)
post-experience##3##1##(2005-7#1)(2008-11#2)
post-exposure prophylaxis (PEP)##2##3##(2007-2#1)(2007-8#1)
post-exposure prophylaxis##6##2##(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2012-12#1)
post-exposure##15##1##(1993-7#2)(1994-6#1)(1997-1#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2012-12#3)
post-fertilization##4##1##(1996-8#2)(1997-9#1)(2013-1#1)
post-fire##2##1##(2007-3#2)
post-flowering period in##2##3##(2008-12#1)(2012-11#1)
post-flush reagent##2##2##(1993-2#2)
post-genome##5##1##(2008-4#1)(2008-7#4)
post-genomic biology##2##2##(2009-5#1)(2009-7#1)
post-genomic era##9##2##(2008-7#4)(2010-4#1)(2011-2#1)(2012-3#3)
post-genomic##15##1##(2008-10#1)(2008-7#5)(2009-5#1)(2009-7#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-3#4)
post-glucose##2##1##(2010-10#1)(2012-7#1)
post-graduate research##2##2##(1994-12#1)(2007-11#1)
post-graduate##11##1##(1994-12#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-8#1)(2010-2#1)(2013-1#2)
post-graduation##2##1##(1993-2#1)(2011-2#1)
post-harvest senescence##2##2##(2006-12#2)
post-harvest##5##1##(2005-5#1)(2006-12#2)(2008-10#2)
post-hatch and##2##2##(2008-12#1)(2008-7#1)
post-hatch development##2##2##(1990-3#2)
post-hatch##9##1##(1990-3#2)(1995-9#1)(2008-12#1)(2008-7#2)(2010-8#3)
post-hatching##2##1##(2005-9#1)(2007-5#1)
post-hemodialysis##3##1##(2008-10#3)
post-hepatitis##4##1##(1993-10#1)(1993-11#1)(1993-7#1)(1993-9#1)
post-herpetic##2##1##(2008-5#1)(2008-7#1)
post-hoc analysis##2##2##(2009-3#1)(2012-2#1)
post-hoc test (p&lt##2##3##(2008-12#1)(2010-2#1)
post-hoc test##3##2##(2008-11#1)(2008-12#1)(2010-2#1)
post-hoc##12##1##(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-2#1)(2010-7#1)(2012-2#1)(2012-3#1)
post-hospital services##2##2##(1990-12#2)
post-hospital##7##1##(1990-12#4)(1992-3#1)(1995-3#1)(2008-1#1)
post-hospitalization##4##1##(2007-8#1)(2012-2#1)(2013-1#2)
post-hybridization washes and##2##3##(2008-1#2)
post-hybridization washes##3##2##(2008-1#2)(2008-9#1)
post-ictal##5##1##(1995-12#5)
post-immunization##6##1##(2008-10#1)(2008-11#1)(2009-5#4)
post-impact##3##1##(2006-12#1)(2008-7#2)
post-implant##7##1##(2008-9#6)(2012-2#1)
post-implantation loss##3##2##(1995-2#1)(1996-12#2)
post-implantation##17##1##(1995-2#1)(1996-12#2)(2006-11#1)(2008-10#1)(2008-5#8)(2008-9#1)(2011-1#2)(2013-1#1)
post-implementation##8##1##(2008-5#4)(2013-1#4)
post-incident##2##1##(2012-1#2)
post-induction##2##1##(1995-9#1)(2012-12#1)
post-infarction##2##1##(1993-10#1)(2010-8#1)
post-infection (p##3##2##(1997-6#1)(2007-6#1)(2008-5#1)
post-infection and then##2##3##(1991-8#1)(1996-12#1)
post-infection in##4##2##(1996-12#3)(2012-12#1)
post-infection stages##2##2##(2008-10#1)(2011-1#1)
post-infection##38##1##(1991-8#3)(1992-8#1)(1996-12#4)(1997-4#2)(1997-6#1)(2005-9#2)(2006-8#1)(2007-6#1)(2008-10#1)(2008-11#6)(2008-12#1)(2008-5#8)(2008-7#2)(2008-9#1)(2009-6#1)(2011-1#1)(2012-12#2)
post-infectious##3##1##(1992-9#1)(2007-7#1)(2008-1#1)
post-infusion F-DOPA##2##2##(2008-7#2)
post-infusion##3##1##(2008-7#3)
post-initiation##3##1##(1992-5#3)
post-injection and##2##2##(1996-9#1)(2008-10#1)
post-injection##16##1##(1991-1#1)(1991-2#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-8#1)(1994-5#1)(1996-9#2)(1997-5#1)(2008-10#3)(2008-6#1)(2011-1#1)
post-injection)##2##1##(1992-3#1)(1997-3#1)
post-injury##13##1##(1991-11#1)(1993-7#1)(2008-6#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-5#1)(2009-6#1)(2011-2#3)(2012-12#1)
post-inoculation (p##2##2##(1997-6#1)(2008-5#1)
post-inoculation##9##1##(1997-6#1)(2008-5#5)(2010-10#2)(2012-2#1)
post-insertion##3##1##(2010-10#1)(2011-12#1)(2012-2#1)
post-inspiratory neuronal##3##2##(1997-5#3)
post-inspiratory##6##1##(1997-5#6)
post-intervention##17##1##(2005-8#1)(2006-10#1)(2007-12#1)(2008-12#8)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#2)(2013-1#1)
post-irradiation##8##1##(1991-9#1)(1992-6#1)(2008-5#3)(2008-9#1)(2011-2#1)(2013-1#1)
post-ischaemic##2##1##(1996-6#1)(2013-7#1)
post-ischemia##2##1##(1994-2#1)(1996-5#1)
post-ischemic hyperemia##2##2##(2008-4#2)
post-ischemic##9##1##(1994-10#1)(1994-2#1)(1997-7#2)(1997-8#1)(2008-1#1)(2008-4#2)(2009-12#1)
post-lesion training##2##2##(1992-10#2)
post-lesion##11##1##(1991-12#1)(1992-10#3)(1992-8#1)(1993-12#1)(1997-5#5)
post-lingually deaf adults using##2##4##(2008-9#2)
post-lingually deaf adults##4##3##(2008-9#4)
post-lingually deaf##5##2##(2008-9#5)
post-lingually deafened##2##2##(2008-9#2)
post-lingually##7##1##(2008-9#7)
post-market surveillance##2##2##(2010-5#1)(2012-3#1)
post-market##6##1##(2010-10#1)(2010-5#1)(2011-2#3)(2012-3#1)
post-marketing surveillance##3##2##(2007-7#2)(2008-8#1)
post-marketing surveillance]##2##2##(1990-9#1)(2010-11#1)
post-marketing##8##1##(1990-9#1)(2007-7#2)(2008-10#1)(2008-8#2)(2010-11#1)(2011-2#1)
post-meal##3##1##(2007-11#1)(2008-3#1)(2009-2#1)
post-meiotic germ cell development##2##4##(2012-2#2)
post-meiotic##7##1##(1996-8#1)(2008-5#1)(2012-12#3)(2012-2#2)
post-meningitic deafness##3##2##(2008-9#3)
post-meningitic##4##1##(2008-9#4)
post-menopausal bleeding##5##2##(2007-3#5)
post-menopausal breast cancer##3##3##(1993-1#2)(2012-12#1)
post-menopausal woman##2##2##(2006-10#1)(2008-3#1)
post-menopausal women##14##2##(1996-2#1)(2005-12#1)(2008-1#1)(2008-11#3)(2008-5#2)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
post-menopausal##32##1##(1990-4#1)(1993-1#2)(1994-7#1)(1996-2#1)(2005-12#1)(2006-10#1)(2007-3#5)(2008-1#1)(2008-10#1)(2008-11#5)(2008-3#1)(2008-5#2)(2009-4#1)(2010-3#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
post-mitochondrial##2##1##(1996-12#1)(1997-6#1)
post-mitotic neurons##2##2##(1996-6#1)(2008-11#1)
post-mitotic##5##1##(1996-3#1)(1996-6#1)(2008-11#1)(2008-5#1)(2009-8#1)
post-modern##2##1##(2006-10#1)(2007-5#1)
post-monsoon##3##1##(2009-6#3)
post-mortem ageing##3##2##(2010-4#3)
post-mortem and a##2##3##(2010-4#2)
post-mortem and##3##2##(2009-5#1)(2010-4#2)
post-mortem cerebral cortex##2##3##(1996-12#2)
post-mortem examination##5##2##(1997-3#3)(2007-8#1)(2008-7#1)
post-mortem human brain tissue##2##4##(1996-12#2)
post-mortem human subjects##2##3##(2006-11#1)(2007-1#1)
post-mortem human##4##2##(1996-12#2)(2006-11#1)(2007-1#1)
post-mortem interval##5##2##(1993-12#1)(1995-11#1)(2008-6#1)(2008-7#1)(2009-3#1)
post-mortem samples##3##2##(1992-3#1)(2009-12#1)(2010-9#1)
post-mortem tissue##2##2##(1992-1#2)
post-mortem tissues of##2##3##(2008-7#2)
post-mortem with##3##2##(2008-7#3)
post-mortem##72##1##(1991-11#1)(1992-1#2)(1992-12#1)(1992-3#3)(1993-12#1)(1995-11#1)(1996-10#1)(1996-11#2)(1996-12#4)(1997-3#4)(1997-5#1)(1997-7#1)(2005-8#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#13)(2008-9#1)(2009-12#2)(2009-3#5)(2009-5#1)(2010-4#11)(2010-9#2)(2011-2#1)(2012-1#1)(2013-1#2)
post-mortem)##3##1##(2010-4#2)(2013-1#1)
post-myocardial infarction patients##2##3##(2006-10#1)(2008-10#1)
post-natal development##2##2##(1990-5#1)(1994-9#1)
post-natal evaluation##2##2##(2006-8#1)(2008-4#1)
post-natal rat##2##2##(1996-8#2)
post-natal##22##1##(1990-5#1)(1992-12#1)(1994-9#1)(1996-8#2)(2005-11#2)(2006-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2009-3#3)(2009-9#1)(2010-2#1)(2012-2#1)
post-natally##2##1##(2005-11#1)(2007-11#1)
post-neonatal##2##1##(1990-11#1)(2007-1#1)
post-obturation##2##1##(2012-3#2)
post-onset##5##1##(2009-11#1)(2012-1#2)(2012-2#2)
post-op##10##1##(2007-5#1)(2007-8#5)(2011-1#1)(2012-2#1)(2013-1#2)
post-operation##5##1##(2008-1#1)(2008-7#1)(2008-9#1)(2011-2#2)
post-operative AF##2##2##(2007-8#1)(2012-2#1)
post-operative analgesia##3##2##(2010-7#1)(2011-2#1)(2012-12#1)
post-operative atrial fibrillation##2##3##(2007-8#1)(2012-2#1)
post-operative blood loss##2##3##(2007-8#1)(2013-1#1)
post-operative blood##3##2##(2007-8#2)(2013-1#1)
post-operative cardiac surgical patients##2##4##(2008-12#2)
post-operative care##4##2##(2006-12#1)(2007-11#2)(2012-2#1)
post-operative complication##2##2##(2007-8#1)(2013-1#1)
post-operative complications in children##2##4##(2013-1#2)
post-operative complications##10##2##(1990-9#1)(2007-2#1)(2007-7#1)(2007-8#1)(2009-10#1)(2012-2#2)(2013-1#3)
post-operative course of##2##3##(1993-5#1)(2007-8#1)
post-operative course##3##2##(1993-5#1)(2007-8#1)(2011-2#1)
post-operative day and##3##3##(2007-2#1)(2012-12#2)
post-operative day##7##2##(1990-12#1)(2007-2#2)(2008-1#1)(2012-12#2)(2012-2#1)
post-operative follow-up##2##2##(1993-10#1)(2010-12#1)
post-operative gaseous##2##2##(2007-8#2)
post-operative hearing##2##2##(2012-2#1)(2012-8#1)
post-operative hospital##2##2##(2007-7#1)(2007-8#1)
post-operative lung function##3##3##(2007-8#3)
post-operative mortality##2##2##(1992-9#1)(2011-2#1)
post-operative nausea and##2##3##(2008-5#1)(2013-1#1)
post-operative neurological##3##2##(2008-6#3)
post-operative outcome##4##2##(2007-8#3)(2010-11#1)
post-operative pain and fever##2##4##(2011-1#2)
post-operative pain and##3##3##(2006-6#1)(2011-1#2)
post-operative pain management##2##3##(2008-11#1)(2011-1#1)
post-operative pain##11##2##(1996-2#1)(2006-6#1)(2007-2#1)(2008-11#2)(2009-3#2)(2009-5#1)(2011-1#3)
post-operative period and##4##3##(2007-11#1)(2007-8#1)(2009-10#1)(2012-2#1)
post-operative period##15##2##(2006-10#1)(2006-9#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-11#1)(2009-10#1)(2011-2#2)(2012-2#2)(2013-1#3)
post-operative phase##2##2##(2007-8#1)(2010-7#1)
post-operative pulmonary##2##2##(2007-8#2)
post-operative radiotherapy##3##2##(2008-6#3)
post-operative rehabilitation##3##2##(2007-11#2)(2007-7#1)
post-operative##180##1##(1990-12#1)(1990-9#2)(1991-5#2)(1991-9#1)(1992-9#1)(1993-10#1)(1993-2#1)(1993-5#2)(1995-9#1)(1996-2#2)(1997-7#1)(2004-12#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-9#3)(2007-11#12)(2007-2#4)(2007-7#11)(2007-8#35)(2007-9#1)(2008-1#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#9)(2009-10#2)(2009-3#5)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-7#2)(2011-1#4)(2011-2#9)(2012-1#1)(2012-12#3)(2012-2#20)(2012-3#1)(2012-8#1)(2013-1#11)(2013-7#2)(2013-8#1)
post-operatively and remains##2##3##(2008-6#1)(2011-2#1)
post-operatively and##5##2##(2008-6#2)(2011-2#1)(2012-12#1)(2012-2#1)
post-operatively##31##1##(1990-10#1)(1993-5#1)(1996-2#1)(1996-3#1)(2006-6#1)(2007-11#2)(2007-7#6)(2007-8#5)(2008-5#1)(2008-6#6)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
post-orthodontic##2##1##(2011-1#1)(2011-2#1)
post-ovulatory##2##1##(1994-9#1)(2007-3#1)
post-oxidation##2##1##(2012-12#2)
post-partum period##3##2##(1994-3#1)(2007-8#1)(2010-11#1)
post-partum women##2##2##(2008-6#1)(2009-9#1)
post-partum##16##1##(1992-1#1)(1993-10#2)(1993-11#1)(1994-3#3)(1994-6#1)(1996-12#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-11#1)(2012-2#1)
post-penetration##2##1##(2008-10#1)(2012-2#1)
post-pneumonectomy##3##1##(2007-8#3)
post-polio##3##1##(1991-4#1)(1997-4#1)(2013-1#1)
post-polymerization treatments on the flexural strength and Vickers hardness of##2##10##(2008-12#2)
post-polymerization treatments##3##2##(2008-12#3)
post-polymerization##4##1##(2004-9#1)(2008-12#3)
post-polypectomy##2##1##(2006-2#1)(2007-5#1)
post-prandial##10##1##(1994-12#1)(2006-2#1)(2008-1#1)(2008-5#2)(2008-6#5)
post-prandially##4##1##(1991-8#3)(1994-11#1)
post-procedural##2##1##(2007-8#1)(2011-2#1)
post-procedure##3##1##(2006-8#1)(2009-2#1)(2010-5#1)
post-processing for##2##2##(2009-10#1)(2012-3#1)
post-processing of the##2##3##(2012-2#1)(2012-3#1)
post-processing##12##1##(2006-4#1)(2007-8#1)(2008-2#3)(2009-10#1)(2009-5#1)(2010-6#1)(2011-12#1)(2012-2#1)(2012-3#2)
post-prostatectomy##2##1##(2007-11#1)(2013-7#1)
post-pubertal##2##1##(2010-5#1)(2012-12#1)
post-pump##2##1##(1996-9#1)(2006-10#1)
post-radiation##3##1##(1995-5#1)(2006-1#1)(2008-2#1)
post-radioiodine hypothyroidism##2##2##(2008-11#2)
post-rainy##2##1##(2008-3#2)
post-reactivation##2##1##(1993-12#1)(2009-2#1)
post-receptor mechanisms##2##2##(1990-3#1)(2006-5#1)
post-receptor##14##1##(1990-3#3)(1991-2#1)(1991-8#1)(1994-12#3)(1994-2#1)(1994-3#1)(1996-2#1)(2006-5#1)(2008-4#1)(2009-7#1)
post-registration students##2##2##(2008-11#1)(2008-12#1)
post-registration##9##1##(2008-11#8)(2008-12#1)
post-release##2##1##(2009-7#1)(2013-8#1)
post-reproductive phase of the experiment##3##5##(1997-4#3)
post-reproductive##11##1##(1995-6#1)(1997-4#9)(2008-1#1)
post-resection endoprosthesis##2##2##(2007-7#2)
post-resection##5##1##(2007-7#3)(2007-8#1)(2008-5#1)
post-residency##2##1##(2011-2#2)
post-response anticipation of##2##3##(2012-1#2)
post-response##3##1##(2012-1#3)
post-resuscitation##2##1##(2008-7#1)(2012-3#1)
post-revolutionary Mexico##2##2##(2009-7#2)
post-sclerotherapy pigmentation##2##2##(2006-12#2)
post-session##2##1##(2013-1#2)
post-settlement##4##1##(2007-5#3)(2010-8#1)
post-shift##2##1##(1996-10#2)
post-slaughter##3##1##(2010-4#3)
post-slavery British##2##2##(2008-7#2)
post-slavery##3##1##(2008-7#3)
post-spawning##2##1##(2010-5#1)(2010-8#1)
post-spike##3##1##(1990-12#1)(1992-8#1)(1996-2#1)
post-splenectomy##2##1##(1990-9#1)(2010-10#1)
post-stenotic##2##1##(1990-10#1)(2007-8#1)
post-stimulation##3##1##(1994-2#1)(2006-8#1)(2009-4#1)
post-stimulus##9##1##(1990-5#1)(1991-9#1)(1995-12#1)(1996-2#3)(1997-1#1)(1997-6#1)(2006-5#1)
post-stress##2##1##(2010-3#1)(2012-2#1)
post-stressed vowels more than their##2##5##(2009-11#2)
post-stressed vowels##4##2##(2009-11#4)
post-stressed##6##1##(2009-11#6)
post-stroke pain##2##2##(1990-1#1)(2008-9#1)
post-stroke##26##1##(1990-1#1)(2006-8#1)(2007-10#6)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#2)(2010-12#1)(2012-1#5)(2012-2#5)(2012-3#1)
post-surgery##13##1##(2007-11#4)(2007-8#2)(2008-11#2)(2008-12#1)(2011-2#1)(2013-1#1)(2013-7#2)
post-surgical and##2##2##(2005-7#1)(2007-8#1)
post-surgical complications##2##2##(2011-1#1)(2012-12#1)
post-surgical follow up##2##3##(2010-3#1)(2012-11#1)
post-surgical group##2##2##(2006-8#2)
post-surgical pain and##6##3##(2005-8#1)(2008-11#5)
post-surgical pain##7##2##(2005-8#1)(2008-11#6)
post-surgical patients##2##2##(2006-8#1)(2007-8#1)
post-surgical##32##1##(1991-1#1)(1993-12#1)(1993-2#1)(1993-9#1)(1995-10#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-8#3)(2007-11#1)(2007-7#3)(2007-8#3)(2008-11#7)(2010-3#1)(2011-1#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
post-synaptic potentials##3##2##(1993-2#2)(1995-12#1)
post-synaptic##19##1##(1991-1#1)(1991-3#2)(1991-9#1)(1993-2#2)(1993-9#1)(1995-12#2)(1996-2#1)(1996-3#1)(1997-5#1)(2005-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#2)
post-synthesis##3##1##(2008-1#2)(2008-10#1)
post-synthetically modified##2##2##(1994-5#2)
post-target mechanisms##2##2##(2008-11#2)
post-test and the##2##3##(1993-9#1)(2008-12#1)
post-test and##5##2##(1993-9#1)(2008-12#2)(2010-2#2)
post-test counselling##2##2##(2004-10#1)(2007-7#1)
post-test##37##1##(1992-1#1)(1993-1#1)(1993-9#4)(1994-1#3)(1996-1#1)(1996-5#1)(1996-9#1)(2004-10#1)(2007-11#1)(2007-12#2)(2007-6#2)(2007-7#2)(2008-11#1)(2008-12#2)(2008-2#2)(2008-5#1)(2008-9#1)(2010-12#1)(2010-2#2)(2011-2#3)(2012-12#1)(2013-1#3)
post-test)##2##1##(1993-9#2)
post-tetanic potentiation##2##2##(1991-3#1)(1997-1#1)
post-tetanic##4##1##(1991-3#1)(1991-5#1)(1996-9#1)(1997-1#1)
post-thaw motility##2##2##(2006-5#1)(2012-3#1)
post-thaw##3##1##(2006-5#1)(2008-11#1)(2012-3#1)
post-thawing##2##1##(2009-5#1)(2011-2#1)
post-therapeutic##2##1##(2005-8#1)(2008-12#1)
post-thoracotomy##3##1##(2006-10#1)(2006-12#1)(2006-8#1)
post-threshold plasticity##2##2##(2009-10#2)
post-thrombolysis##2##1##(1996-6#1)(1997-8#1)
post-thrombotic syndrome and##2##3##(2011-2#1)(2013-1#1)
post-thrombotic syndrome##6##2##(2011-2#5)(2013-1#1)
post-tracheostomy##4##1##(2007-8#1)(2013-1#3)
post-training administration of##2##3##(1990-7#1)(1996-9#1)
post-training inactivation##2##2##(1993-12#2)
post-training injection of##2##3##(1990-7#1)(1996-9#1)
post-training##18##1##(1990-7#4)(1991-2#2)(1992-8#1)(1993-11#2)(1993-12#2)(1993-9#1)(1996-1#2)(1996-9#2)(2008-12#1)(2008-6#1)
post-transcriptional control of##2##3##(1996-12#1)(2007-12#1)
post-transcriptional events##3##2##(1994-9#1)(1997-2#1)(2008-11#1)
post-transcriptional gene regulation##2##3##(1993-12#1)(2009-2#1)
post-transcriptional gene silencing##2##3##(2008-10#1)(2008-9#1)
post-transcriptional gene##5##2##(1993-12#1)(2008-10#1)(2008-9#1)(2009-2#1)(2013-8#1)
post-transcriptional level##4##2##(2008-1#1)(2008-11#1)(2010-11#1)(2011-2#1)
post-transcriptional mechanisms##6##2##(1990-11#1)(1994-10#1)(1995-3#1)(1995-6#1)(2008-4#1)(2013-8#1)
post-transcriptional processing##2##2##(1993-6#2)
post-transcriptional regulation of##8##3##(1990-3#1)(1991-12#1)(1994-5#1)(1995-5#1)(1996-11#2)(1996-12#1)(2009-2#1)
post-transcriptional regulation##11##2##(1990-3#1)(1991-12#2)(1994-12#1)(1994-5#1)(1995-5#1)(1996-11#3)(1996-12#1)(2009-2#1)
post-transcriptional regulons##2##2##(2013-8#2)
post-transcriptional##57##1##(1990-11#1)(1990-3#1)(1991-10#1)(1991-12#2)(1991-6#1)(1992-1#2)(1992-11#1)(1992-12#2)(1993-12#1)(1993-6#2)(1994-10#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-11#3)(1996-12#2)(1996-8#1)(1997-2#2)(2006-11#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#3)(2008-9#3)(2009-2#3)(2009-8#1)(2010-11#1)(2011-2#1)(2013-8#5)
post-transcriptionally by##2##2##(1994-11#1)(2011-2#1)
post-transcriptionally##8##1##(1994-11#1)(1995-3#1)(2007-12#1)(2008-1#1)(2009-5#1)(2010-7#1)(2011-2#2)
post-transfection##6##1##(1994-9#1)(2006-12#1)(2008-11#2)(2011-2#2)
post-transfusion NANBH##3##2##(1991-3#3)
post-transfusion hepatitis##2##2##(1991-3#1)(2006-2#1)
post-transfusion non-A##2##2##(1991-3#1)(2006-2#1)
post-transfusion##10##1##(1991-11#1)(1991-3#5)(1996-1#1)(2006-2#3)
post-translation##2##1##(2008-11#1)(2011-1#1)
post-translational changes##2##2##(1997-7#1)(2009-5#1)
post-translational incorporation of##2##3##(1995-12#2)
post-translational modification (PTM)##3##3##(2009-6#1)(2012-3#1)(2013-8#1)
post-translational modification of the##2##4##(1994-12#1)(1997-1#1)
post-translational modification of##11##3##(1991-1#1)(1991-7#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-12#1)(1997-1#1)(1997-6#1)(2010-1#1)(2013-1#1)
post-translational modification that##2##3##(2008-4#2)
post-translational modification##32##2##(1990-8#2)(1991-1#1)(1991-7#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-3#1)(1997-1#1)(1997-6#1)(2006-12#1)(2008-1#2)(2008-12#1)(2008-4#3)(2008-5#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#2)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
post-translational modifications (PTMs)##2##3##(2008-7#1)(2009-5#1)
post-translational modifications including##2##3##(1990-9#1)(2007-8#1)
post-translational modifications of Ral and Rac1##2##6##(1997-6#2)
post-translational modifications of the##3##4##(1994-8#1)(2008-11#1)(2008-12#1)
post-translational modifications of##8##3##(1994-8#1)(1997-2#1)(1997-6#2)(2008-11#1)(2008-12#1)(2009-3#1)(2011-2#1)
post-translational modifications on##2##3##(2008-11#1)(2008-4#1)
post-translational modifications##41##2##(1990-8#2)(1990-9#1)(1992-12#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-8#1)(1997-2#1)(1997-6#2)(2007-8#1)(2008-11#5)(2008-12#2)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#2)(2009-3#1)(2009-5#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
post-translational processing and##3##3##(1995-8#2)(2008-4#1)
post-translational processing in##2##3##(1991-5#1)(1991-8#1)
post-translational processing of##2##3##(1991-1#1)(1995-8#1)
post-translational processing##7##2##(1991-1#1)(1991-5#1)(1991-8#1)(1995-8#3)(2008-4#1)
post-translational proteolytic##2##2##(1991-7#1)(2008-4#1)
post-translational##119##1##(1990-8#4)(1990-9#1)(1991-1#2)(1991-5#1)(1991-7#3)(1991-8#2)(1992-12#3)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-5#2)(1993-6#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#2)(1995-3#3)(1995-6#1)(1995-8#3)(1997-1#1)(1997-2#1)(1997-6#3)(1997-7#1)(2006-12#1)(2007-8#1)(2008-1#4)(2008-11#5)(2008-12#3)(2008-2#1)(2008-4#8)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#2)(2009-3#1)(2009-5#4)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#2)
post-translationally modified amino acids##2##4##(1997-6#1)(2008-4#1)
post-translationally modified##14##2##(1993-3#1)(1993-4#1)(1994-5#1)(1994-8#1)(1997-2#2)(1997-6#3)(2008-4#1)(2009-5#1)(2009-7#1)(2010-2#1)(2011-1#1)
post-translationally##24##1##(1990-10#2)(1992-11#2)(1993-3#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1996-12#1)(1997-2#2)(1997-6#3)(2006-11#1)(2008-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-2#1)(2011-1#1)
post-transmission##2##1##(2007-12#1)(2011-12#1)
post-transplant course##2##2##(2004-11#1)(2007-11#1)
post-transplant diabetes mellitus##2##3##(2008-1#2)
post-transplant erythrocytosis##2##2##(2008-4#2)
post-transplant immunosuppression##2##2##(2006-10#1)(2007-11#1)
post-transplant lymphoproliferative disease##2##3##(2007-12#1)(2012-2#1)
post-transplant lymphoproliferative##4##2##(2007-12#1)(2010-9#1)(2011-3#1)(2012-2#1)
post-transplant patient##3##2##(2007-11#3)
post-transplant period##3##2##(1996-3#1)(2007-11#1)(2008-1#1)
post-transplant##44##1##(1996-3#1)(2004-11#1)(2006-10#2)(2007-11#12)(2007-12#2)(2007-8#1)(2008-1#12)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#4)(2010-11#1)(2010-6#1)(2010-9#1)(2011-3#1)(2012-2#1)
post-transplantation##11##1##(1996-10#1)(2007-11#1)(2008-1#1)(2008-4#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#3)
post-trauma##2##1##(1995-12#1)(2006-10#1)
post-traumatic and##3##2##(1990-9#1)(2007-11#2)
post-traumatic arthritis##2##2##(2006-3#1)(2008-8#1)
post-traumatic lesions##2##2##(2007-11#1)(2012-2#1)
post-traumatic spinal cord injury##2##4##(1996-1#1)(2007-11#1)
post-traumatic stress disorder (PTSD)##7##4##(2008-6#2)(2009-7#1)(2012-1#1)(2012-12#2)(2013-8#1)
post-traumatic stress disorder in##2##4##(2009-6#1)(2010-12#1)
post-traumatic stress disorder##18##3##(1996-11#1)(2006-3#1)(2008-6#5)(2009-6#1)(2009-7#1)(2010-12#3)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#2)
post-traumatic stress disorder&quot##2##3##(1993-6#2)
post-traumatic stress symptoms##2##3##(2009-7#1)(2012-12#1)
post-traumatic stress##28##2##(1991-2#1)(1992-9#1)(1993-6#2)(1996-11#2)(2006-3#1)(2008-6#5)(2009-6#1)(2009-7#3)(2010-12#3)(2012-1#2)(2012-12#3)(2012-2#1)(2013-8#3)
post-traumatic therapeutic intervention##2##3##(2006-8#2)
post-traumatic ventricular##2##2##(2007-8#2)
post-traumatic##70##1##(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-9#1)(1993-2#1)(1993-6#2)(1996-1#1)(1996-11#2)(1997-3#1)(1997-7#3)(2006-10#1)(2006-3#3)(2006-8#2)(2007-11#6)(2007-7#2)(2007-8#6)(2008-4#1)(2008-6#5)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-6#1)(2009-7#3)(2010-12#4)(2011-2#2)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#1)(2013-8#3)
post-travel##3##1##(2007-2#2)(2011-2#1)
post-treatment and follow-up##2##3##(2007-12#2)
post-treatment and##4##2##(2007-12#2)(2013-1#2)
post-treatment apical periodontitis##3##3##(2013-1#3)
post-treatment follow-up time##2##3##(2008-6#2)
post-treatment follow-up##3##2##(2008-5#1)(2008-6#2)
post-treatment in##3##2##(2005-11#1)(2008-11#1)(2013-1#1)
post-treatment incubation##3##2##(1990-4#1)(1997-4#2)
post-treatment platelet reactivity##2##3##(2009-5#2)
post-treatment surveillance##3##2##(2006-10#3)
post-treatment with##4##2##(1996-6#1)(2010-12#2)(2012-3#1)
post-treatment##92##1##(1990-4#1)(1991-8#1)(1992-9#2)(1993-9#2)(1994-6#1)(1994-8#1)(1996-12#1)(1996-6#1)(1997-2#2)(1997-4#3)(1997-7#1)(2005-11#1)(2006-10#3)(2006-8#1)(2007-11#1)(2007-12#5)(2007-2#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-9#1)(2009-12#2)(2009-3#1)(2009-5#2)(2009-6#1)(2009-9#3)(2010-12#2)(2010-2#2)(2010-3#1)(2010-7#1)(2010-8#1)(2011-11#1)(2011-2#1)(2012-1#4)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#20)(2013-7#1)
post-trial##2##1##(1993-9#1)(1994-8#1)
post-vaccination##11##1##(1997-6#1)(2005-9#2)(2006-8#1)(2007-2#1)(2008-4#2)(2008-5#1)(2009-12#1)(2012-12#2)
post-vasectomy##2##1##(1994-5#1)(2006-10#1)
post-war##5##1##(1994-11#1)(1996-8#1)(2007-7#1)(2012-2#1)(2013-8#1)
post-weaning diarrhea in swine##2##4##(2013-1#2)
post-weaning individual housing##3##3##(2013-8#3)
post-weaning##11##1##(2004-11#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#6)
post-work##2##1##(2012-1#2)
postablation##2##1##(2008-3#2)
postabortion care##3##2##(2012-11#3)
postabortion##4##1##(1996-3#1)(2012-11#3)
postabsorptive##2##1##(1995-5#2)
postacrosomal##2##1##(2008-4#1)(2008-8#1)
postadministration##4##1##(1996-10#3)(1996-2#1)
postadmission##3##1##(2008-3#2)(2010-11#1)
postal and##2##2##(1996-8#1)(2006-5#1)
postal invitations##3##2##(1997-6#3)
postal mail##2##2##(2010-9#1)(2013-1#1)
postal questionnaire was##3##3##(1995-5#1)(2007-2#1)(2011-1#1)
postal questionnaire##12##2##(1993-10#1)(1993-3#1)(1995-5#2)(2004-10#1)(2005-8#1)(2007-2#2)(2008-1#1)(2008-9#1)(2011-1#1)(2011-2#1)
postal questionnaires and##2##3##(2008-11#1)(2009-6#1)
postal survey of##2##3##(1997-4#1)(2007-11#1)
postal survey was##4##3##(1993-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
postal survey##12##2##(1993-8#2)(1997-4#1)(1997-8#2)(2007-11#1)(2009-6#1)(2010-3#1)(2011-2#1)(2012-12#2)(2012-2#1)
postal##36##1##(1993-10#1)(1993-3#1)(1993-8#2)(1995-5#2)(1996-8#1)(1997-4#1)(1997-6#4)(1997-8#2)(2004-10#1)(2005-8#1)(2006-5#1)(2007-11#1)(2007-2#2)(2007-6#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-6#2)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
postalveolar fricatives##2##2##(2009-12#2)
postalveolar##5##1##(2009-12#5)
postamplifier##2##1##(2008-3#2)
postamplifiers and in-line##2##3##(2008-2#2)
postamplifiers and##3##2##(2008-2#3)
postamplifiers##5##1##(2007-12#2)(2008-2#3)
postanaesthetic##2##1##(2006-10#1)(2010-4#1)
postanesthesia care##3##2##(2006-10#2)(2006-8#1)
postanesthesia##5##1##(1993-1#2)(2006-10#2)(2006-8#1)
postanesthetic care unit##3##3##(2006-10#3)
postanesthetic##4##1##(2006-10#3)(2012-2#1)
postanthesis##2##1##(2008-10#2)
postattack##3##1##(2007-12#3)
postauricular##2##1##(2009-5#1)(2009-6#1)
postaxial limb##2##2##(1996-6#2)
postaxial polydactyly##3##2##(1996-5#1)(2010-4#2)
postaxial##9##1##(1996-5#1)(1996-6#2)(2010-4#2)(2012-12#4)
postbirth##2##1##(2007-2#2)
postbloom##9##1##(2008-10#9)
postburn##4##1##(1994-5#1)(2006-9#1)(2008-8#2)
postcapillary##3##1##(1991-5#1)(2009-4#2)
postcardiac surgery##2##2##(2005-12#1)(2012-2#1)
postcardiac##3##1##(2005-12#1)(2012-1#1)(2012-2#1)
postcardiopulmonary##2##1##(2007-9#1)(2008-3#1)
postcardiotomy phrenic nerve paresis##4##4##(2013-1#4)
postcardiotomy##5##1##(2013-1#5)
postcastration syndrome##2##2##(2008-11#2)
postcentral##3##1##(2006-10#1)(2008-7#1)(2013-8#1)
postchallenge##2##1##(2012-3#1)(2013-8#1)
postchemotherapy nausea##3##2##(2008-7#3)
postcodes##2##1##(1991-6#1)(1995-9#1)
postcoital contraceptive methods##2##3##(1992-10#1)(1993-2#1)
postcoital contraceptive##4##2##(1992-10#2)(1993-2#2)
postcoital##10##1##(1992-10#2)(1993-2#7)(1994-2#1)
postcolumn##2##1##(1990-8#2)
postcompensation##3##1##(2007-12#3)
postconceptional age##4##2##(1992-2#1)(1995-8#1)(2007-11#2)
postconcussion syndrome##3##2##(2008-7#2)(2013-1#1)
postconcussive symptoms##3##2##(2008-6#1)(2013-1#2)
postconcussive syndrome##2##2##(2008-6#2)
postconcussive##6##1##(2008-6#4)(2013-1#2)
postconditioning on##2##2##(2008-12#1)(2013-1#1)
postconditioning##8##1##(2008-12#1)(2010-7#1)(2013-1#3)(2013-7#3)
postcontrast##3##1##(2007-10#1)(2008-7#1)(2013-8#1)
postcoronary##2##1##(2005-12#1)(2007-8#1)
postcourse##2##1##(2007-4#1)(2010-7#1)
postcrash##2##1##(1996-12#2)
postdeposition##3##1##(2008-2#1)(2008-3#1)(2010-4#1)
postdialysis##4##1##(2007-8#3)(2008-12#1)
postdiapause embryos##2##2##(2013-1#2)
postdiapause##3##1##(2013-1#3)
postdischarge##6##1##(2006-2#1)(2006-7#2)(2007-10#1)(2008-11#2)
postdoc##2##1##(2007-9#2)
postdocs##2##1##(2007-9#2)
postdoctoral fellows##3##2##(1997-2#1)(2008-12#1)(2008-5#1)
postdoctoral##4##1##(1994-12#1)(1997-2#1)(2008-12#1)(2008-5#1)
postdonation platelet##2##2##(2011-2#2)
postdose##2##1##(1995-3#1)(2009-4#1)
postdural puncture headache in##2##4##(1993-10#2)
postdural puncture headache##4##3##(1993-10#3)(2006-10#1)
postdural##5##1##(1993-10#3)(1993-7#1)(2006-10#1)
posted for cleft##2##3##(2010-7#1)(2012-12#1)
posted for elective##2##3##(2010-7#1)(2011-12#1)
posted for laparoscopic##2##3##(2010-5#1)(2012-2#1)
posted for##13##2##(1994-1#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-7#3)(2011-12#1)(2012-12#2)(2012-2#1)
posted on the##3##3##(2007-8#1)(2008-2#1)(2012-3#1)
posted on##4##2##(2006-2#1)(2007-8#1)(2008-2#1)(2012-3#1)
posted##19##1##(1994-1#1)(2005-10#1)(2006-2#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-7#3)(2011-12#1)(2012-12#2)(2012-2#1)(2012-3#1)
postembedding##5##1##(1992-1#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)
postembryonic development of##3##3##(1996-5#1)(2007-12#1)(2009-8#1)
postembryonic development##5##2##(1996-5#1)(2007-12#3)(2009-8#1)
postembryonic stages##2##2##(2007-12#2)
postembryonic##9##1##(1996-5#1)(2007-12#7)(2009-8#1)
postemergence##2##1##(2008-10#2)
poster &quot##2##2##(2009-5#2)
poster and##2##2##(2005-8#1)(2006-10#1)
poster discussion sessions##2##3##(2005-8#1)(2008-5#1)
poster presentations##9##2##(2005-8#3)(2005-9#2)(2006-12#1)(2008-5#2)(2013-7#1)
poster session##2##2##(2005-8#1)(2011-2#1)
poster sessions##12##2##(2005-7#1)(2005-8#7)(2008-5#3)(2010-11#1)
poster##38##1##(2005-10#1)(2005-7#1)(2005-8#17)(2005-9#3)(2006-10#1)(2006-12#1)(2006-7#2)(2008-12#1)(2008-5#6)(2009-5#2)(2010-11#1)(2011-2#1)(2013-7#1)
posterior C1-2##2##2##(2006-7#1)(2012-3#1)
posterior VSD##2##2##(2012-1#2)
posterior and anterior##7##3##(1994-8#1)(1997-8#1)(2008-6#1)(2009-4#1)(2009-7#1)(2010-3#1)(2011-7#1)
posterior and lateral##5##3##(1992-8#1)(2006-11#1)(2009-7#1)(2013-7#2)
posterior and##18##2##(1992-8#1)(1994-8#1)(1994-9#1)(1997-8#1)(2006-11#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-12#1)(2008-6#1)(2009-4#1)(2009-7#2)(2010-3#1)(2011-7#1)(2013-7#2)
posterior annulus##2##2##(2007-8#1)(2008-8#1)
posterior approach in##2##3##(2006-8#1)(2007-11#1)
posterior approach was##2##3##(2006-8#1)(2007-11#1)
posterior approach##23##2##(2006-8#5)(2007-11#4)(2007-7#3)(2007-8#4)(2008-9#1)(2009-3#2)(2009-8#1)(2011-2#3)
posterior arch##3##2##(2006-8#1)(2013-1#2)
posterior as##2##2##(1990-10#1)(2008-12#1)
posterior auricular neuralgia##2##3##(2006-8#2)
posterior body##2##2##(1995-8#1)(2010-12#1)
posterior canal benign paroxysmal positional vertigo##2##6##(2012-12#1)(2013-1#1)
posterior canal wall during##2##4##(2008-9#2)
posterior canal wall##5##3##(2008-9#5)
posterior canal##7##2##(2008-9#5)(2012-12#1)(2013-1#1)
posterior capsular##3##2##(2007-10#1)(2008-11#1)(2009-8#1)
posterior capsule##3##2##(2009-8#1)(2011-2#2)
posterior cerebral arteries##3##3##(1997-6#1)(2010-8#1)(2012-12#1)
posterior cerebral artery (PCA)##4##4##(1997-6#1)(2007-9#2)(2008-7#1)
posterior cerebral artery is##3##4##(2011-1#3)
posterior cerebral artery##13##3##(1997-6#1)(2007-9#7)(2008-7#1)(2011-1#4)
posterior cerebral##17##2##(1997-6#2)(2006-11#1)(2007-9#7)(2008-7#1)(2010-8#1)(2011-1#4)(2012-12#1)
posterior cervical space##2##3##(1997-6#2)
posterior cervical##5##2##(1997-6#2)(2011-2#1)(2012-3#2)
posterior chamber intraocular lens##2##4##(2007-3#1)(2009-8#1)
posterior chamber intraocular##3##3##(1991-2#1)(2007-3#1)(2009-8#1)
posterior chamber##6##2##(1991-2#1)(2007-3#1)(2008-4#1)(2009-8#1)(2011-2#1)(2013-7#1)
posterior cingulate cortex##3##3##(1993-12#2)(2011-2#1)
posterior cingulate##16##2##(1992-3#1)(1993-12#2)(1995-12#1)(1995-7#1)(2006-9#1)(2008-11#1)(2008-6#4)(2009-1#1)(2009-4#2)(2011-2#1)(2013-8#1)
posterior circulation##15##2##(1993-3#1)(2006-11#1)(2006-12#1)(2007-9#1)(2008-7#4)(2010-8#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
posterior column##2##2##(1990-3#1)(2008-7#1)
posterior communicating arteries##2##3##(2008-7#1)(2011-1#1)
posterior communicating artery##11##3##(2007-9#3)(2008-7#2)(2011-1#6)
posterior communicating##13##2##(2007-9#3)(2008-7#3)(2011-1#7)
posterior compartment##3##2##(1993-2#1)(2013-1#2)
posterior component of the##2##4##(1996-3#1)(2007-12#1)
posterior composites##6##2##(2009-2#6)
posterior cord##2##2##(2008-7#1)(2009-4#1)
posterior cortex##2##2##(1994-9#1)(2013-7#1)
posterior cortical atrophy##2##3##(2008-11#1)(2011-1#1)
posterior cortical##5##2##(1995-5#1)(2005-10#1)(2008-11#1)(2009-2#1)(2011-1#1)
posterior cranial##3##2##(1994-7#1)(2005-9#2)
posterior cruciate ligament (PCL)##5##4##(2007-1#2)(2008-8#1)(2009-7#1)(2013-1#1)
posterior cruciate ligament retaining##2##4##(2013-1#2)
posterior cruciate ligament##13##3##(2007-1#2)(2007-7#2)(2008-8#1)(2009-3#2)(2009-7#1)(2009-9#1)(2013-1#4)
posterior cruciate##14##2##(2007-1#2)(2007-7#2)(2008-8#2)(2009-3#2)(2009-7#1)(2009-9#1)(2013-1#4)
posterior decompression##2##2##(2006-8#1)(2011-2#1)
posterior decompressive##5##2##(2006-8#1)(2006-9#4)
posterior density for##2##3##(2008-12#2)
posterior density##3##2##(2008-12#2)(2009-5#1)
posterior dislocation of the##3##4##(2008-12#1)(2009-3#1)(2012-12#1)
posterior dislocation of##5##3##(2008-12#1)(2009-3#2)(2012-12#2)
posterior dislocation##7##2##(1997-7#1)(2008-12#1)(2009-3#2)(2010-12#1)(2012-12#2)
posterior dislocations##2##2##(2008-12#1)(2009-3#1)
posterior distribution of the##2##4##(1993-6#1)(1997-2#1)
posterior distribution to##2##3##(1993-6#1)(1995-6#1)
posterior distribution##9##2##(1993-6#2)(1995-6#1)(1996-8#1)(1997-2#1)(2007-9#1)(2010-2#1)(2010-5#1)(2012-1#1)
posterior distributions##2##2##(1993-6#1)(1996-12#1)
posterior diverticulum##2##2##(2007-12#2)
posterior drawer test was grade A in##2##7##(2008-8#2)
posterior drawer##4##2##(2007-1#2)(2008-8#2)
posterior edge##2##2##(2007-12#1)(2008-12#1)
posterior elements of the upper##2##5##(2013-1#2)
posterior elements of the##3##4##(2012-3#1)(2013-1#2)
posterior end of the##2##4##(2007-12#1)(2009-10#1)
posterior end##4##2##(2007-12#2)(2008-4#1)(2009-10#1)
posterior epidural##2##2##(2011-2#2)
posterior epistaxis##2##2##(2008-8#1)(2009-10#1)
posterior epithelium##2##2##(2007-12#2)
posterior facets##2##2##(2011-2#2)
posterior fixation##4##2##(2006-8#2)(2007-11#1)(2011-2#1)
posterior fosa##2##2##(2011-1#2)
posterior fossa and##5##3##(1996-6#1)(2005-5#1)(2006-5#2)(2008-7#1)
posterior fossa approach##3##3##(2006-5#3)
posterior fossa with##2##3##(2008-5#1)(2008-7#1)
posterior fossa##43##2##(1993-1#1)(1996-6#2)(1996-9#1)(2005-5#1)(2006-12#3)(2006-5#12)(2006-7#2)(2006-9#1)(2008-12#2)(2008-5#5)(2008-7#7)(2009-9#1)(2011-2#4)(2012-12#1)
posterior frontal##2##2##(1996-12#1)(2008-12#1)
posterior fusion##8##2##(2006-10#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2008-12#1)(2009-3#1)
posterior group##3##2##(1995-8#2)(2007-12#1)
posterior hippocampus and##4##3##(1993-2#1)(1995-12#1)(2009-2#2)
posterior hippocampus##5##2##(1993-2#2)(1995-12#1)(2009-2#2)
posterior hypothalamic##7##2##(1991-5#1)(1995-12#1)(1996-11#4)(1996-3#1)
posterior hypothalamus and##4##3##(1995-12#1)(2007-1#3)
posterior hypothalamus##12##2##(1991-5#1)(1991-8#1)(1995-12#2)(1996-3#1)(2007-1#5)(2010-12#2)
posterior inferior cerebellar artery (PICA)##4##5##(2006-12#1)(2007-10#1)(2007-9#1)(2008-7#1)
posterior inferior cerebellar artery##9##4##(2006-10#3)(2006-11#1)(2006-12#1)(2007-10#1)(2007-9#1)(2008-7#2)
posterior instability of the##2##4##(2010-12#1)(2012-12#1)
posterior instrumentation to the##2##4##(2008-8#2)
posterior instrumentation##3##2##(2008-8#3)
posterior interbody fusion##3##3##(2007-7#1)(2007-8#2)
posterior interbody##4##2##(2007-7#2)(2007-8#2)
posterior intercondylar##3##2##(2007-1#1)(2013-1#2)
posterior interosseous flaps##2##3##(2006-3#2)
posterior interosseous nerve##2##3##(2006-3#1)(2006-4#1)
posterior interosseous##10##2##(2006-3#5)(2006-4#1)(2008-9#4)
posterior joints##2##2##(2006-7#1)(2006-8#1)
posterior lateral##5##2##(1994-12#2)(1995-12#1)(1995-6#1)(2012-11#1)
posterior leaflet##4##2##(2007-8#3)(2008-10#1)
posterior left##2##2##(2008-11#1)(2009-7#1)
posterior lobe and##2##3##(1991-8#1)(1992-9#1)
posterior lobe##7##2##(1991-5#1)(1991-8#1)(1992-9#2)(1997-8#1)(2012-3#2)
posterior location##2##2##(2009-4#1)(2011-2#1)
posterior longitudinal ligament##4##3##(2006-8#2)(2007-8#1)(2008-12#1)
posterior lumbar interbody fusion##3##4##(2006-8#1)(2008-11#2)
posterior lumbar##4##2##(1993-11#1)(2006-8#1)(2008-11#2)
posterior maxilla##4##2##(2007-12#2)(2010-5#1)(2012-2#1)
posterior maxillary##2##2##(2007-12#1)(2011-2#1)
posterior medial##5##2##(1991-2#1)(1995-11#1)(1997-8#1)(2008-10#1)(2008-6#1)
posterior mediastinal##7##2##(2006-10#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-3#2)(2013-1#1)
posterior mediastinum##7##2##(2007-8#2)(2010-12#2)(2011-2#3)
posterior mitral valve prolapse##2##4##(1997-1#2)
posterior mitral valve##3##3##(1997-1#2)(2007-12#1)
posterior mitral##6##2##(1997-1#2)(2007-12#1)(2007-8#2)(2008-10#1)
posterior neck##2##2##(1990-12#1)(2007-5#1)
posterior nucleus##2##2##(1994-10#1)(1995-5#1)
posterior only##2##2##(2008-8#2)
posterior or anterior##2##3##(2006-8#1)(2011-2#1)
posterior or##3##2##(2006-8#1)(2007-11#1)(2011-2#1)
posterior parietal and##2##3##(1992-9#1)(2007-8#1)
posterior parietal cortex##8##3##(1992-8#2)(1993-2#1)(1994-3#2)(1997-2#2)(2008-1#1)
posterior parietal lobule##2##3##(2008-4#2)
posterior parietal##21##2##(1992-8#2)(1992-9#3)(1993-2#1)(1994-3#3)(1996-2#1)(1997-2#3)(2007-10#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#2)(2009-10#1)(2012-1#1)
posterior part of the##9##4##(1992-10#1)(2006-11#1)(2007-12#1)(2008-2#1)(2009-4#3)(2010-12#1)(2011-2#1)
posterior part of##10##3##(1992-10#1)(2006-11#1)(2007-12#1)(2008-2#1)(2009-4#3)(2010-12#1)(2011-2#2)
posterior pituitary gland##2##3##(1997-8#1)(2013-1#1)
posterior pituitary##12##2##(1993-5#1)(1994-10#2)(1995-12#1)(1997-2#1)(1997-8#4)(2007-10#1)(2008-4#1)(2013-1#1)
posterior portion of##4##3##(1996-7#1)(1997-3#1)(2008-3#1)(2008-4#1)
posterior predictive##2##2##(1995-4#1)(2010-2#1)
posterior probabilities##2##2##(2008-10#1)(2011-2#1)
posterior probability calculations##2##3##(1995-2#2)
posterior probability of##2##3##(1994-4#1)(2008-3#1)
posterior probability that the##2##4##(1994-11#1)(1997-8#1)
posterior probability##8##2##(1994-11#1)(1994-4#1)(1995-2#2)(1997-8#1)(2008-2#1)(2008-3#1)(2010-4#1)
posterior quadrants##3##2##(1996-7#1)(2009-8#2)
posterior region##2##2##(2007-12#2)
posterior regions##6##2##(1996-3#1)(2007-12#1)(2008-11#1)(2008-3#1)(2010-2#1)(2011-7#1)
posterior rerouting##2##2##(2005-5#2)
posterior reversible encephalopathy syndrome##5##4##(2010-12#2)(2012-12#2)(2012-2#1)
posterior reversible encephalopathy##6##3##(2010-12#2)(2012-12#2)(2012-2#2)
posterior sagittal and transabdominal approach##2##5##(2008-9#2)
posterior segment##4##2##(1993-1#1)(1997-2#1)(2009-3#1)(2009-4#1)
posterior segmental##3##2##(2006-10#1)(2006-8#1)(2012-3#1)
posterior shear##2##2##(2007-4#2)
posterior shoulder##4##2##(2007-10#1)(2007-3#2)(2012-12#1)
posterior sigmoid##2##2##(2011-2#2)
posterior skull deformity##2##3##(2006-7#2)
posterior skull##3##2##(2005-5#1)(2006-7#2)
posterior spinal##4##2##(2007-11#1)(2007-2#1)(2009-3#2)
posterior spondylodesis##2##2##(2007-11#1)(2007-7#1)
posterior stabilization##4##2##(2006-8#1)(2007-11#3)
posterior stabilized##3##2##(2007-7#2)(2013-1#1)
posterior sternoclavicular##2##2##(2009-3#2)
posterior superior temporal sulcus##2##4##(2008-11#2)
posterior superior temporal##3##3##(2008-11#3)
posterior superior##5##2##(2006-8#2)(2008-11#3)
posterior surface of the neck were##2##6##(2012-1#2)
posterior surface of the##3##4##(2007-8#1)(2012-1#2)
posterior surface##4##2##(2007-8#1)(2012-1#2)(2013-8#1)
posterior surgery##3##2##(2008-8#2)(2011-2#1)
posterior synechiae##2##2##(1997-3#1)(2013-7#1)
posterior teeth##2##2##(2010-6#2)
posterior temporal##3##2##(1994-2#1)(2009-8#1)(2012-2#1)
posterior temporoparietal##2##2##(2008-9#1)(2010-2#1)
posterior tendon transfer##2##3##(2012-12#2)
posterior thigh##2##2##(2007-11#1)(2008-12#1)
posterior third##4##2##(2006-8#4)
posterior thoracic##2##2##(2008-8#1)(2012-2#1)
posterior tibial arteries##2##3##(1990-11#1)(2008-8#1)
posterior tibial artery##4##3##(2013-1#4)
posterior tibial nerve##2##3##(1991-4#1)(2010-5#1)
posterior tibial tendon##3##3##(1990-9#2)(2008-8#1)
posterior tibial##17##2##(1990-11#1)(1990-9#2)(1991-4#1)(2007-1#1)(2007-2#1)(2008-8#3)(2009-9#1)(2010-11#1)(2010-5#2)(2013-1#4)
posterior tibialis muscle##3##3##(2009-3#3)
posterior to anterior##3##3##(1996-12#1)(2008-5#1)(2008-7#1)
posterior to the##6##3##(1996-12#1)(2005-9#1)(2006-10#1)(2006-12#1)(2008-7#1)(2011-2#1)
posterior to##11##2##(1996-12#2)(1997-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-5#1)(2008-7#2)(2011-2#1)
posterior transarticular##2##2##(2006-7#1)(2008-12#1)
posterior transpedicular##3##2##(2005-2#2)(2006-8#1)
posterior trunk##2##2##(2012-2#2)
posterior tympanotomy##2##2##(2008-9#2)
posterior urethra##4##2##(2008-10#4)
posterior urethral valve##6##3##(2008-10#2)(2011-11#1)(2011-2#3)
posterior urethral valves##10##3##(1991-11#1)(2006-10#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#5)
posterior urethral##18##2##(1991-11#1)(2006-10#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#7)(2011-11#1)(2011-2#3)(2013-8#2)
posterior uterine##2##2##(1993-1#1)(2011-2#1)
posterior vitreous##2##2##(2013-7#1)(2013-8#1)
posterior wall of the##7##4##(1997-8#1)(2006-12#1)(2007-12#1)(2008-5#1)(2008-7#1)(2011-12#1)(2013-8#1)
posterior wall of##8##3##(1997-8#1)(2006-12#1)(2006-6#1)(2007-12#1)(2008-5#1)(2008-7#1)(2011-12#1)(2013-8#1)
posterior wall##13##2##(1993-8#1)(1997-8#1)(2006-12#1)(2006-6#1)(2007-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
posterior walls##3##2##(1991-6#2)(1993-12#1)
posterior##933##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#2)(1990-4#1)(1990-9#2)(1991-11#5)(1991-2#4)(1991-4#1)(1991-5#4)(1991-6#5)(1991-8#2)(1992-10#1)(1992-11#1)(1992-3#1)(1992-8#3)(1992-9#5)(1993-1#3)(1993-11#1)(1993-12#7)(1993-2#6)(1993-3#1)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#1)(1994-10#3)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-4#1)(1994-7#1)(1994-8#2)(1994-9#3)(1995-11#1)(1995-12#10)(1995-2#3)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#2)(1995-8#4)(1996-1#1)(1996-11#5)(1996-12#5)(1996-2#3)(1996-3#6)(1996-4#1)(1996-5#3)(1996-6#2)(1996-7#3)(1996-8#1)(1996-9#6)(1997-1#2)(1997-2#10)(1997-3#9)(1997-4#1)(1997-6#4)(1997-7#3)(1997-8#18)(2003-11#1)(2004-2#1)(2005-10#4)(2005-2#2)(2005-5#4)(2005-9#3)(2006-10#11)(2006-11#7)(2006-12#12)(2006-3#6)(2006-4#2)(2006-5#14)(2006-6#3)(2006-7#10)(2006-8#33)(2006-9#8)(2007-1#16)(2007-10#9)(2007-11#23)(2007-12#37)(2007-2#2)(2007-3#6)(2007-4#2)(2007-5#3)(2007-7#19)(2007-8#30)(2007-9#15)(2008-1#2)(2008-10#20)(2008-11#15)(2008-12#18)(2008-2#4)(2008-3#4)(2008-4#10)(2008-5#10)(2008-6#6)(2008-7#37)(2008-8#29)(2008-9#18)(2009-1#1)(2009-10#7)(2009-11#1)(2009-2#13)(2009-3#19)(2009-4#13)(2009-5#2)(2009-7#4)(2009-8#12)(2009-9#3)(2010-10#1)(2010-11#3)(2010-12#12)(2010-2#7)(2010-3#1)(2010-4#1)(2010-5#5)(2010-6#4)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#15)(2011-11#1)(2011-12#1)(2011-2#50)(2011-7#2)(2012-1#8)(2012-11#1)(2012-12#16)(2012-2#15)(2012-3#15)(2013-1#30)(2013-7#7)(2013-8#9)
posterior-anterior##3##1##(2007-4#1)(2008-3#1)(2012-12#1)
posterior-inferior##2##1##(1993-9#1)(2006-8#1)
posterior-lateral##2##1##(2007-7#1)(2010-12#1)
posterior-only##5##1##(2005-2#1)(2008-8#2)(2009-3#1)(2012-3#1)
posterior-to-anterior##3##1##(2007-1#2)(2008-4#1)
posterioris##3##1##(2008-6#3)
posteriorly and##2##2##(1991-8#1)(2006-12#1)
posteriorly in##3##2##(1991-8#1)(1995-11#1)(2006-11#1)
posteriorly##21##1##(1991-8#2)(1995-11#1)(1995-5#2)(2006-11#2)(2006-12#1)(2006-7#2)(2006-8#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-5#3)(2008-7#1)(2009-3#1)(2012-12#1)(2013-8#1)
postero lateral bundle##3##3##(2009-9#3)
postero-lateral spondylodesis was performed##2##4##(2007-11#2)
postero-lateral spondylodesis##5##2##(2007-11#5)
postero-lateral##9##1##(2007-11#6)(2007-8#1)(2008-12#1)(2009-9#1)
postero-medial##5##1##(1993-6#3)(2008-2#1)(2009-7#1)
posteroanterior##3##1##(1995-6#1)(2007-8#1)(2008-9#1)
posterodorsal##4##1##(1991-3#2)(1993-12#1)(1997-6#1)
posterolateral approach##4##2##(2007-1#2)(2007-11#1)(2013-1#1)
posterolateral corner injuries##2##3##(2012-2#2)
posterolateral corner##4##2##(2011-2#1)(2012-2#3)
posterolateral fusion##5##2##(2007-7#2)(2008-8#1)(2012-12#2)
posterolateral instrumentation##2##2##(2011-2#1)(2012-12#1)
posterolateral knee pain##2##3##(2011-2#2)
posterolateral structures##2##2##(2013-1#2)
posterolateral thalamic##2##2##(2008-7#2)
posterolateral thoracotomy and##2##3##(2007-8#1)(2010-12#1)
posterolateral thoracotomy##8##2##(2007-12#1)(2007-8#6)(2010-12#1)
posterolateral##50##1##(1995-5#1)(1996-6#1)(1997-3#1)(2006-3#1)(2006-7#2)(2006-8#2)(2007-1#2)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#7)(2008-10#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#1)(2009-9#2)(2010-12#1)(2010-3#2)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#5)
posterolateral-subcostal thoracotomy##3##2##(2007-8#3)
posterolateral-subcostal##4##1##(2007-8#4)
posteromedial fragment##2##2##(2013-1#2)
posteromedial nucleus##2##2##(1990-4#1)(1993-2#1)
posteromedial##16##1##(1990-4#1)(1993-2#1)(1997-3#1)(2007-10#2)(2008-2#1)(2008-8#1)(2009-3#1)(2010-3#1)(2011-2#3)(2013-1#4)
posteroventral##2##1##(2008-7#2)
posters and##4##2##(2005-8#1)(2006-7#1)(2008-10#1)(2008-7#1)
posters displayed##2##2##(2005-8#1)(2008-10#1)
posters presented at##10##3##(2005-8#1)(2006-11#7)(2008-10#2)
posters presented##11##2##(1994-6#1)(2005-8#1)(2006-11#7)(2008-10#2)
posters were##6##2##(2006-7#2)(2008-5#3)(2008-7#1)
posters##42##1##(1994-6#1)(1996-2#1)(2005-12#1)(2005-7#1)(2005-8#4)(2005-9#1)(2006-11#8)(2006-7#7)(2008-10#4)(2008-3#1)(2008-5#8)(2008-7#2)(2010-11#1)(2013-1#2)
posteruption##2##1##(2008-2#1)(2011-1#1)
postexercise##6##1##(1992-5#1)(2010-8#1)(2013-1#1)(2013-8#3)
postexposure prophylaxis##2##2##(2012-3#2)
postexposure##8##1##(1992-3#1)(2007-11#1)(2008-2#1)(2008-3#2)(2011-2#1)(2012-3#2)
postextubation laryngeal##3##2##(2010-7#3)
postextubation##4##1##(2010-7#4)
postfibrillatory myocardial dysfunction##2##3##(2006-9#2)
postflame region of##2##3##(2008-2#1)(2008-3#1)
postflame region##4##2##(2008-2#2)(2008-3#2)
postflame##6##1##(2008-2#2)(2008-3#4)
postganglionic neurones##2##2##(1995-12#2)
postganglionic sympathetic##2##2##(1995-12#1)(1996-3#1)
postganglionic##16##1##(1990-7#2)(1993-3#1)(1995-12#4)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-5#1)(1997-8#1)(2006-10#2)(2012-1#1)
postgastrectomic disorders##2##2##(2008-4#2)
postgenomic##4##1##(2005-7#1)(2006-10#1)(2008-7#2)
postgermination##3##1##(2008-10#3)
postgraduate (PG)##2##2##(2012-2#1)(2013-1#1)
postgraduate and##2##2##(2007-11#1)(2008-1#1)
postgraduate dental##3##2##(2013-1#3)
postgraduate education and##2##3##(2011-2#1)(2012-2#1)
postgraduate education##6##2##(1991-2#1)(1993-5#1)(1993-6#1)(1994-12#1)(2011-2#1)(2012-2#1)
postgraduate examinations##2##2##(2006-10#2)
postgraduate medical##2##2##(1994-3#1)(2008-8#1)
postgraduate research##2##2##(2005-8#1)(2009-4#1)
postgraduate students in India##2##4##(2013-1#2)
postgraduate students##6##2##(2005-8#2)(2008-11#1)(2013-1#3)
postgraduate training and##2##3##(1991-2#1)(1993-11#1)
postgraduate training in##2##3##(1992-5#1)(1997-6#1)
postgraduate training##10##2##(1991-2#1)(1992-5#1)(1993-11#1)(1993-8#1)(1994-12#1)(1997-5#1)(1997-6#1)(2006-6#1)(2008-7#1)(2012-1#1)
postgraduate##68##1##(1990-12#1)(1991-2#3)(1992-1#2)(1992-5#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#2)(1994-12#8)(1994-3#1)(1997-5#1)(1997-6#1)(2005-8#4)(2006-10#4)(2006-6#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)(2009-4#1)(2009-7#1)(2010-3#2)(2010-9#1)(2011-2#1)(2012-1#3)(2012-2#3)(2012-3#1)(2013-1#10)(2013-8#1)
postgraduates##2##1##(2009-5#1)(2011-2#1)
postgraduation##3##1##(2013-1#3)
postgrowth##2##1##(2007-11#1)(2008-2#1)
postharvest biocontrol##2##2##(2008-10#2)
postharvest blue mold##2##3##(2008-10#2)
postharvest decay##3##2##(2008-10#3)
postharvest fungal##2##2##(2008-10#2)
postharvest pathogen##4##2##(2008-10#4)
postharvest pathogens##4##2##(2008-10#4)
postharvest##37##1##(2008-10#37)
posthatch##6##1##(1994-2#1)(1996-9#4)(2013-8#1)
posthatched##2##1##(1995-11#2)
posthaustorial##2##1##(2008-10#2)
postheparin plasma##3##2##(1993-11#1)(1993-3#1)(1994-11#1)
postheparin##6##1##(1991-12#1)(1993-11#1)(1993-3#1)(1994-11#1)(1997-2#1)(2008-3#1)
posthepatic##2##1##(1993-3#1)(1994-7#1)
postherpetic neuralgia (PHN)##4##3##(1996-6#1)(2006-12#1)(2008-5#1)(2008-9#1)
postherpetic neuralgia##8##2##(1996-6#2)(2006-12#2)(2006-3#1)(2006-7#1)(2008-5#1)(2008-9#1)
postherpetic##9##1##(1994-3#1)(1996-6#2)(2006-12#2)(2006-3#1)(2006-7#1)(2008-5#1)(2008-9#1)
posthospital adjustment##2##2##(1992-3#1)(1993-1#1)
posthospital##4##1##(1992-3#1)(1993-1#1)(2010-6#1)(2013-1#1)
posthospitalization##2##1##(1991-1#1)(2007-8#1)
posthypoxic period and##2##3##(2012-1#2)
posthypoxic period##3##2##(2012-1#3)
postictal behavioral depression##2##3##(1992-12#2)
postictal##5##1##(1992-11#1)(1992-12#2)(2007-2#1)(2012-12#1)
postimmunization##4##1##(2009-4#2)(2009-5#1)(2013-7#1)
postimplantation##4##1##(1993-12#1)(1995-11#1)(1995-2#1)(2006-9#1)
postinfarct##4##1##(2006-10#1)(2007-8#1)(2009-10#1)(2009-4#1)
postinfarction patients##2##2##(1991-3#1)(1996-3#1)
postinfarction##10##1##(1991-3#1)(1993-12#2)(1996-3#1)(2007-8#4)(2009-10#1)(2012-1#1)
postinfection##21##1##(1993-12#1)(1994-8#1)(2005-12#1)(2006-10#1)(2008-10#7)(2008-5#1)(2009-2#1)(2009-8#2)(2009-9#1)(2012-3#2)(2013-8#3)
postinfectious##9##1##(1993-3#1)(1994-5#1)(2007-8#2)(2008-10#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-2#1)
posting##5##1##(1996-9#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-4#1)
postings##3##1##(2008-2#3)
postinjection##9##1##(1991-9#1)(1992-11#1)(1993-1#1)(1993-2#1)(1994-9#3)(1996-2#1)(2008-5#1)
postinjury##5##1##(1994-12#1)(2005-2#1)(2007-11#1)(2008-7#2)
postinoculation (dpi)##5##2##(2008-10#5)
postinoculation and##3##2##(2008-10#3)
postinoculation using##2##2##(2008-10#2)
postinoculation##33##1##(2008-10#30)(2008-9#1)(2010-10#2)
postinstitutionalized Romanian##2##2##(2008-11#2)
postinstitutionalized##3##1##(2008-11#3)
postintervention##11##1##(2006-3#1)(2007-10#1)(2007-8#1)(2008-3#1)(2010-7#1)(2013-1#6)
postirradiation##6##1##(1995-8#1)(2006-12#3)(2007-6#1)(2011-2#1)
postischemia##3##1##(1997-7#2)(2007-10#1)
postischemic reperfusion##2##2##(1991-9#2)
postischemic##13##1##(1991-9#2)(1993-3#1)(1994-9#1)(1995-12#2)(1996-9#1)(1997-8#1)(2006-10#1)(2010-12#1)(2011-2#1)(2013-1#2)
postjunctional##4##1##(1996-10#1)(1996-12#1)(2013-1#2)
postlabeling assay of AAF modified##2##5##(1991-5#2)
postlabeling assay##3##2##(1991-5#3)
postlabeling##7##1##(1991-5#6)(1994-8#1)
postlarvae##7##1##(2007-3#4)(2007-5#2)(2010-8#1)
postlarval and##2##2##(2007-12#1)(2007-5#1)
postlarval development##3##2##(2007-5#1)(2010-8#2)
postlarval##7##1##(2007-12#1)(2007-5#2)(2008-5#2)(2010-8#2)
postlaser##2##1##(1991-2#1)(2007-12#1)
postlesion##18##1##(1991-9#1)(1993-6#1)(1994-2#1)(1995-7#2)(1997-3#12)(2008-8#1)
postlingual patients with cochlear implants##2##5##(2008-9#2)
postlingual##6##1##(2008-9#5)(2011-1#1)
postlingually and prelingually deafened##2##4##(2008-9#2)
postlingually deaf##2##2##(2007-3#1)(2008-9#1)
postlingually deafened adult##2##3##(2008-9#2)
postlingually deafened adults##3##3##(2008-9#3)
postlingually deafened##7##2##(2008-9#7)
postlingually##11##1##(2007-3#1)(2008-9#10)
postlumbar laminectomy syndrome##3##3##(2006-8#3)
postlumbar laminectomy##4##2##(2006-8#4)
postmarketing studies##2##2##(2007-10#1)(2010-5#1)
postmarketing surveillance##5##2##(1993-12#1)(1993-8#1)(1996-7#1)(2010-12#2)
postmarketing##15##1##(1993-12#1)(1993-8#1)(1996-7#1)(2006-10#3)(2007-10#1)(2008-10#1)(2008-11#3)(2010-12#2)(2010-5#1)(2013-1#1)
postmastectomy##4##1##(2006-12#1)(2009-6#1)(2013-1#2)
postmating barriers##3##2##(2008-6#1)(2012-3#2)
postmating##7##1##(2008-6#1)(2008-9#2)(2012-12#2)(2012-3#2)
postmeiotic##4##1##(1990-11#3)(1992-11#1)
postmeningitis headache##2##2##(2004-12#2)
postmenopausal HRT##2##2##(2008-3#2)
postmenopausal bleeding##4##2##(1990-6#3)(2006-10#1)
postmenopausal hormone##2##2##(2006-3#1)(2008-3#1)
postmenopausal or climacteric bleeding##2##4##(1992-12#2)
postmenopausal osteoporosis##28##2##(1993-11#1)(1995-11#2)(2005-1#1)(2005-3#2)(2007-11#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-3#4)(2008-4#1)(2008-8#3)(2009-6#1)(2012-2#5)(2013-1#3)
postmenopausal patients with##6##3##(1991-4#1)(2004-1#2)(2007-11#2)(2008-5#1)
postmenopausal patients##15##2##(1991-12#1)(1991-4#2)(1993-12#1)(1993-5#1)(1994-12#2)(1994-2#1)(2004-1#2)(2007-11#2)(2007-5#1)(2008-5#1)(2010-7#1)
postmenopausal period##2##2##(2008-3#1)(2013-8#1)
postmenopausal stage##2##2##(2006-10#1)(2008-11#1)
postmenopausal subjects who were and were not on HRT and##2##10##(2008-5#2)
postmenopausal woman##2##2##(2006-10#1)(2013-8#1)
postmenopausal women are##2##3##(2007-9#1)(2012-2#1)
postmenopausal women is##3##3##(2005-3#2)(2008-5#1)
postmenopausal women of##2##3##(2013-7#1)(2013-8#1)
postmenopausal women were##3##3##(1992-1#1)(1992-3#1)(1994-12#1)
postmenopausal women who had##4##4##(1993-2#1)(1996-3#1)(2008-7#2)
postmenopausal women who##6##3##(1993-2#1)(1996-3#1)(2005-11#1)(2008-5#1)(2008-7#2)
postmenopausal women with a##2##4##(2007-4#1)(2008-7#1)
postmenopausal women with knee osteoarthritis##2##5##(2006-10#2)
postmenopausal women with knee##3##4##(2006-10#3)
postmenopausal women with##16##3##(2005-12#1)(2006-10#3)(2006-6#1)(2007-11#1)(2007-4#1)(2008-7#1)(2008-8#2)(2011-1#1)(2011-12#1)(2012-2#2)(2013-1#2)
postmenopausal women without##3##3##(1990-6#1)(2008-7#1)(2010-12#1)
postmenopausal women##97##2##(1990-6#3)(1991-5#1)(1992-1#3)(1992-12#2)(1992-3#4)(1993-2#1)(1993-6#3)(1993-7#1)(1994-12#1)(1994-9#1)(1995-12#1)(1996-3#1)(2005-11#2)(2005-12#2)(2005-3#4)(2006-10#6)(2006-2#2)(2006-3#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-4#1)(2007-9#2)(2008-11#2)(2008-3#6)(2008-5#3)(2008-7#6)(2008-8#3)(2010-10#4)(2010-12#5)(2011-1#5)(2011-12#1)(2011-2#1)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#3)
postmenopausal women]##6##2##(2005-10#2)(2005-11#1)(2006-6#1)(2007-9#1)(2012-3#1)
postmenopausal##201##1##(1990-12#1)(1990-6#6)(1991-12#1)(1991-4#4)(1991-5#1)(1992-1#4)(1992-12#4)(1992-3#4)(1993-11#4)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#4)(1993-7#1)(1994-12#3)(1994-2#1)(1994-4#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1996-3#1)(2004-1#2)(2004-10#1)(2005-1#1)(2005-10#2)(2005-11#3)(2005-12#2)(2005-3#7)(2006-10#11)(2006-2#2)(2006-3#2)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#4)(2007-11#8)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#7)(2008-11#3)(2008-3#14)(2008-4#1)(2008-5#6)(2008-7#7)(2008-8#6)(2009-6#1)(2010-10#4)(2010-12#5)(2010-2#1)(2010-7#1)(2011-1#5)(2011-12#1)(2011-2#2)(2012-2#12)(2012-3#5)(2013-1#7)(2013-7#5)(2013-8#6)
postmenopause##2##1##(1996-4#1)(2012-2#1)
postmenstrual age##2##2##(1992-7#2)
postmenstrual##3##1##(1992-7#2)(1995-8#1)
postmitochondrial fraction of##2##3##(2013-1#2)
postmitochondrial##3##1##(1994-6#1)(2013-1#2)
postmitotic cells##4##2##(1994-5#1)(1996-4#1)(1997-6#1)(2007-12#1)
postmitotic##14##1##(1991-1#1)(1994-5#3)(1995-5#1)(1995-8#1)(1996-4#1)(1997-6#2)(1997-7#2)(2007-12#1)(2010-12#1)(2013-1#1)
postmodern##2##1##(2008-1#1)(2008-12#1)
postmodernist##5##1##(2004-3#4)(2012-11#1)
postmodification reactions##2##2##(2010-4#2)
postmodulated Sagnac interferometer##3##3##(2008-1#3)
postmortem CT examination##2##3##(2010-9#2)
postmortem blood##3##2##(1996-7#3)
postmortem brain##4##2##(1996-1#1)(1996-11#1)(2008-7#1)(2011-1#1)
postmortem cases##2##2##(1996-9#1)(2013-7#1)
postmortem examination of the##2##4##(1997-3#1)(2013-1#1)
postmortem examination of##3##3##(1997-3#1)(2011-1#1)(2013-1#1)
postmortem examination##8##2##(1997-3#1)(2007-10#2)(2011-1#1)(2013-1#2)(2013-8#2)
postmortem human brains##2##3##(1992-8#1)(2011-2#1)
postmortem human##9##2##(1992-8#1)(1993-12#1)(1995-12#1)(2007-4#2)(2008-7#2)(2011-1#1)(2011-2#1)
postmortem interval##2##2##(2006-1#1)(2011-1#1)
postmortem redistribution##3##2##(2013-7#3)
postmortem studies have##2##3##(2008-7#1)(2013-1#1)
postmortem studies##4##2##(2006-9#1)(2008-7#1)(2012-2#1)(2013-1#1)
postmortem##85##1##(1990-11#1)(1991-3#1)(1991-8#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-9#1)(1995-12#1)(1995-3#3)(1996-1#2)(1996-11#1)(1996-12#2)(1996-6#2)(1996-7#8)(1996-9#1)(1997-3#2)(1997-8#2)(2005-8#1)(2006-1#1)(2006-11#1)(2006-9#1)(2007-10#3)(2007-12#1)(2007-2#1)(2007-4#2)(2007-5#2)(2007-7#1)(2008-12#1)(2008-5#1)(2008-7#6)(2008-9#3)(2009-4#1)(2009-6#1)(2010-4#6)(2010-9#2)(2011-1#5)(2011-2#1)(2012-2#3)(2013-1#3)(2013-7#5)(2013-8#2)
postmortem)##2##1##(2010-4#2)
postmyocardial infarction patients##2##3##(1996-4#1)(2009-10#1)
postmyocardial infarction##3##2##(1996-4#1)(2008-3#1)(2009-10#1)
postnasal##2##1##(1990-3#1)(2011-2#1)
postnatal (P)##3##2##(1992-7#1)(1992-9#1)(1995-9#1)
postnatal age##3##2##(1991-8#1)(1993-12#1)(1994-4#1)
postnatal ages##6##2##(1991-9#2)(1996-3#1)(1996-4#2)(2007-10#1)
postnatal and adult mouse##2##4##(1992-6#1)(2008-7#1)
postnatal and adult##3##3##(1992-6#1)(1996-5#1)(2008-7#1)
postnatal brain development##3##3##(1994-6#2)(2008-4#1)
postnatal brain##5##2##(1994-6#2)(2008-11#1)(2008-4#1)(2009-8#1)
postnatal care##5##2##(1993-3#1)(2005-11#1)(2007-2#1)(2010-1#1)(2013-8#1)
postnatal day 1##7##3##(1990-11#1)(1990-4#2)(1990-5#1)(1994-12#1)(1995-9#1)(1996-12#1)
postnatal day 2##4##3##(1993-5#1)(1995-6#1)(1996-3#1)(1996-5#1)
postnatal day 30##2##3##(1996-10#2)
postnatal day 5##2##3##(1991-11#1)(1991-7#1)
postnatal day 7##3##3##(1996-12#1)(1996-3#1)(1996-6#1)
postnatal day 8##2##3##(2008-7#1)(2009-4#1)
postnatal day##46##2##(1990-11#1)(1990-4#3)(1990-5#2)(1991-11#1)(1991-2#1)(1991-7#1)(1993-12#2)(1993-3#2)(1993-5#1)(1994-12#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-10#4)(1996-12#3)(1996-3#3)(1996-4#6)(1996-5#3)(1996-6#1)(1997-7#1)(2005-7#1)(2007-5#1)(2008-10#1)(2008-7#1)(2009-4#1)(2012-12#1)
postnatal days##15##2##(1991-4#2)(1992-3#1)(1992-9#1)(1993-12#1)(1995-8#1)(1996-10#1)(1996-5#2)(1997-2#1)(2007-5#1)(2009-2#2)(2009-4#1)(2012-3#1)
postnatal depression##4##2##(1997-3#1)(2007-9#1)(2011-2#1)(2013-1#1)
postnatal development and##3##3##(1995-12#1)(1996-3#2)
postnatal development of##17##3##(1991-6#1)(1991-9#1)(1992-2#2)(1992-6#1)(1992-9#1)(1993-12#2)(1996-3#1)(1996-5#2)(1997-6#1)(2008-4#1)(2009-2#1)(2009-8#1)(2011-2#2)
postnatal development##40##2##(1990-7#1)(1991-6#1)(1991-9#2)(1992-2#2)(1992-6#2)(1992-9#1)(1993-12#2)(1993-2#1)(1994-5#2)(1995-11#1)(1995-12#1)(1996-1#1)(1996-3#3)(1996-4#2)(1996-5#3)(1997-2#1)(1997-6#1)(1997-7#1)(2006-2#1)(2008-4#4)(2009-2#3)(2009-8#2)(2011-2#2)
postnatal effects##2##2##(2009-9#1)(2013-1#1)
postnatal findings in##2##3##(1990-8#1)(1996-3#1)
postnatal findings##3##2##(1990-8#1)(1996-3#2)
postnatal follow-up##6##2##(1992-2#1)(2007-10#1)(2007-8#1)(2008-4#2)(2008-7#1)
postnatal growth##9##2##(1996-10#1)(1996-12#1)(2005-10#1)(2006-9#1)(2009-3#1)(2009-5#1)(2010-12#2)(2011-1#1)
postnatal life##10##2##(1992-12#1)(1994-11#1)(1994-2#1)(1994-8#1)(1997-6#4)(2008-1#1)(2008-11#1)
postnatal management##2##2##(2012-2#1)(2012-3#1)
postnatal mouse##3##2##(1991-4#2)(2008-11#1)
postnatal ontogeny##4##2##(1993-5#1)(2008-4#2)(2010-12#1)
postnatal period##17##2##(1990-5#1)(1991-1#2)(1991-4#1)(1992-7#2)(1996-12#1)(1996-4#1)(1996-8#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-9#1)(2010-1#1)(2011-1#1)(2012-2#1)
postnatal periods##5##2##(1990-2#1)(1994-11#1)(1996-4#1)(1996-5#1)(2008-1#1)
postnatal rat##2##2##(1993-3#1)(1993-4#1)
postnatal rats##2##2##(1991-9#1)(1995-9#1)
postnatal retina##3##2##(2010-1#1)(2012-12#2)
postnatal sheep##5##2##(1990-5#1)(1997-8#4)
postnatal treatment##3##2##(1996-5#1)(2013-1#2)
postnatal week##10##2##(1991-3#1)(1992-10#1)(1993-12#2)(1995-3#1)(1996-3#1)(1997-2#4)
postnatal weeks##3##2##(1991-9#1)(1992-7#1)(1995-6#1)
postnatal weight##4##2##(2009-5#4)
postnatal##322##1##(1990-11#1)(1990-2#1)(1990-4#3)(1990-5#6)(1990-7#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-2#2)(1991-3#1)(1991-4#5)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#7)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-6#4)(1992-7#7)(1992-9#3)(1993-12#14)(1993-2#3)(1993-3#4)(1993-4#1)(1993-5#2)(1994-10#2)(1994-11#5)(1994-12#1)(1994-2#3)(1994-4#2)(1994-5#2)(1994-6#4)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#2)(1995-6#3)(1995-8#1)(1995-9#6)(1996-1#2)(1996-10#6)(1996-12#6)(1996-3#12)(1996-4#14)(1996-5#14)(1996-6#3)(1996-8#2)(1997-1#1)(1997-2#7)(1997-3#2)(1997-5#2)(1997-6#5)(1997-7#2)(1997-8#4)(2005-10#1)(2005-11#1)(2005-7#1)(2006-2#1)(2006-9#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#1)(2008-4#17)(2008-7#4)(2009-10#1)(2009-2#7)(2009-3#3)(2009-4#5)(2009-5#5)(2009-8#4)(2009-9#3)(2010-1#3)(2010-12#4)(2010-4#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-12#6)(2012-2#13)(2012-3#4)(2013-1#6)(2013-8#2)
postnatally to##2##2##(1996-2#1)(1997-3#1)
postnatally with##2##2##(1992-11#1)(1995-3#1)
postnatally##17##1##(1990-4#1)(1991-10#1)(1992-10#1)(1992-11#1)(1994-10#1)(1995-11#1)(1995-3#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-3#1)(2009-3#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-3#1)
postnonlinearity compensation##2##2##(2007-11#2)
postoperation##6##1##(1990-7#3)(1991-11#2)(2012-1#1)
postoperative CSF leak and wound dehiscence##2##6##(2008-7#2)
postoperative CT##2##2##(2006-12#1)(2012-2#1)
postoperative EC##4##2##(1993-7#4)
postoperative LOS##2##2##(1994-3#2)
postoperative MR##2##2##(2006-12#1)(2008-7#1)
postoperative UGI bleed##5##3##(2007-9#5)
postoperative activity##2##2##(2011-2#1)(2013-8#1)
postoperative acute##4##2##(2006-6#2)(2007-12#1)(2009-6#1)
postoperative adhesion formation or reproductive##2##5##(1992-3#2)
postoperative adhesion formation##4##3##(1992-3#4)
postoperative adhesion##5##2##(1992-3#4)(2010-12#1)
postoperative adhesions in##2##3##(1994-6#1)(2009-2#1)
postoperative adhesions##6##2##(1992-3#2)(1994-6#1)(1995-2#2)(2009-2#1)
postoperative adjuvant therapy##2##3##(1997-7#1)(2013-1#1)
postoperative adjuvant##7##2##(1993-10#1)(1994-7#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-6#1)(2013-1#1)
postoperative analgesia in##3##3##(2007-11#1)(2008-7#1)(2010-7#1)
postoperative analgesia was##2##3##(2007-11#1)(2008-8#1)
postoperative analgesia##31##2##(1993-2#1)(2006-10#8)(2007-11#2)(2007-12#1)(2008-7#1)(2008-8#3)(2009-6#1)(2010-7#4)(2011-12#2)(2013-1#2)(2013-7#4)(2013-8#2)
postoperative analgesic##3##2##(1996-1#1)(1996-8#1)(2005-8#1)
postoperative and##6##2##(2004-10#1)(2007-7#1)(2009-3#1)(2013-1#2)(2013-8#1)
postoperative angiogram##3##2##(1990-4#1)(2007-8#1)(2008-7#1)
postoperative angiographic##2##2##(2007-8#1)(2008-3#1)
postoperative atrial##4##2##(2006-10#1)(2007-8#3)
postoperative bleeding##14##2##(1990-3#1)(1992-3#1)(2006-7#1)(2007-10#1)(2007-8#5)(2007-9#2)(2008-7#1)(2011-3#1)(2012-2#1)
postoperative blood loss after##2##4##(2006-10#1)(2007-8#1)
postoperative blood##4##2##(2006-10#1)(2007-8#1)(2008-7#1)(2009-6#1)
postoperative cardiac##4##2##(2006-10#1)(2007-8#2)(2013-1#1)
postoperative cardiorespiratory##2##2##(2007-8#2)
postoperative care and##3##3##(1990-9#1)(2008-4#1)(2012-2#1)
postoperative care of##4##3##(2007-12#1)(2009-9#1)(2010-7#1)(2012-2#1)
postoperative care##24##2##(1990-9#1)(1991-3#1)(2004-2#1)(2006-10#3)(2006-2#1)(2006-3#1)(2007-11#1)(2007-12#2)(2007-9#2)(2008-4#1)(2009-5#2)(2009-9#1)(2010-5#1)(2010-7#2)(2012-2#3)(2013-1#1)
postoperative chemotherapy##7##2##(1990-12#1)(1990-8#1)(1993-8#1)(1996-6#1)(2004-1#1)(2006-10#1)(2012-12#1)
postoperative chest##2##2##(1990-10#1)(2007-9#1)
postoperative clinical##2##2##(2008-12#1)(2008-7#1)
postoperative collateral vessel formation##2##4##(2006-11#2)
postoperative complication in##2##3##(1994-4#1)(2007-8#1)
postoperative complication occurrence##2##3##(2010-8#2)
postoperative complication##12##2##(1991-3#1)(1994-4#1)(2007-8#3)(2008-9#1)(2009-3#1)(2010-8#2)(2011-1#1)(2011-2#2)
postoperative complications and##9##3##(1992-8#1)(2006-10#1)(2007-8#2)(2008-10#1)(2008-9#1)(2009-2#3)
postoperative complications are described##2##4##(1993-10#1)(2012-3#1)
postoperative complications are##3##3##(1993-10#1)(2006-10#1)(2012-3#1)
postoperative complications in##4##3##(1996-9#1)(2007-8#3)
postoperative complications occurred##2##3##(2007-8#1)(2008-8#1)
postoperative complications of##4##3##(2007-8#1)(2009-5#1)(2011-3#1)(2013-8#1)
postoperative complications was##2##3##(2007-7#1)(2008-8#1)
postoperative complications were observed##4##4##(2007-11#1)(2008-10#1)(2008-6#1)(2011-2#1)
postoperative complications were##10##3##(1994-2#1)(1996-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#2)
postoperative complications##79##2##(1991-10#1)(1992-2#1)(1992-8#2)(1993-10#1)(1994-2#2)(1994-4#1)(1996-12#1)(1996-9#1)(1997-3#1)(2006-10#7)(2006-3#3)(2006-5#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#14)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#2)(2009-2#3)(2009-3#1)(2009-5#1)(2011-1#1)(2011-2#6)(2011-3#2)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
postoperative course of##2##3##(1992-6#1)(2007-8#1)
postoperative course was complicated by##3##5##(1991-8#1)(2006-4#1)(2013-1#1)
postoperative course was uneventful and##3##5##(2008-10#1)(2008-12#1)(2012-3#1)
postoperative course was uneventful##19##4##(1996-8#1)(2005-12#1)(2006-12#1)(2007-8#3)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#1)(2010-12#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
postoperative course was##28##3##(1990-3#1)(1991-8#1)(1992-9#1)(1996-8#1)(2005-12#1)(2006-12#1)(2006-4#1)(2007-8#4)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#1)(2010-12#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
postoperative course##49##2##(1990-3#1)(1991-8#1)(1991-9#1)(1992-6#1)(1992-9#1)(1996-2#1)(1996-8#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-8#10)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2010-12#1)(2010-9#1)(2011-12#2)(2011-2#5)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
postoperative courses##2##2##(1993-2#1)(2006-10#1)
postoperative data##3##2##(2006-8#1)(2007-8#1)(2013-7#1)
postoperative day 2##2##3##(2007-8#1)(2012-12#1)
postoperative day with##2##3##(2008-10#1)(2012-12#1)
postoperative day##55##2##(1990-2#1)(1991-6#1)(1993-1#1)(1994-6#1)(2004-10#1)(2006-6#2)(2006-9#2)(2007-1#1)(2007-10#1)(2007-3#1)(2007-4#1)(2007-8#5)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#3)(2011-1#2)(2011-2#1)(2012-12#9)(2012-2#2)(2013-1#7)(2013-7#1)(2013-8#3)
postoperative days 1##2##3##(2006-9#1)(2013-1#1)
postoperative days 2##4##3##(2006-9#2)(2012-2#2)
postoperative days##11##2##(2006-9#3)(2007-10#1)(2007-8#1)(2010-2#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#1)
postoperative death##5##2##(1992-5#1)(2006-6#1)(2007-7#1)(2007-8#1)(2010-6#1)
postoperative deficit##3##2##(1993-8#1)(2006-12#1)(2007-9#1)
postoperative deficits##2##2##(1991-2#1)(2008-9#1)
postoperative delirium##2##2##(1991-11#1)(2010-12#1)
postoperative deterioration##2##2##(2006-9#1)(2008-7#1)
postoperative discomfort##4##2##(2006-5#2)(2010-2#1)(2013-1#1)
postoperative disorders##2##2##(1994-3#1)(2006-8#1)
postoperative emesis in children##3##4##(2006-12#3)
postoperative emesis##4##2##(2006-12#4)
postoperative evaluation of##3##3##(1994-3#1)(2006-6#1)(2008-7#1)
postoperative evaluation##4##2##(1994-3#1)(2006-6#1)(2008-7#1)(2013-8#1)
postoperative examinations##2##2##(2006-7#1)(2007-11#1)
postoperative external radiotherapy##2##3##(2007-4#1)(2007-5#1)
postoperative external##3##2##(1991-4#1)(2007-4#1)(2007-5#1)
postoperative extubation##3##2##(2007-8#3)
postoperative facial function##4##3##(2005-5#3)(2006-11#1)
postoperative facial##5##2##(2005-5#4)(2006-11#1)
postoperative feeding##2##2##(1993-12#1)(2006-10#1)
postoperative fever##2##2##(2005-12#1)(2007-12#1)
postoperative follow-up of##2##3##(1992-6#1)(2007-9#1)
postoperative follow-up##7##2##(1991-12#1)(1992-6#1)(2007-9#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-2#1)
postoperative functional##2##2##(1993-10#1)(2008-8#1)
postoperative hemoglobin##3##2##(1993-4#2)(1996-2#1)
postoperative histopathological##3##2##(1990-9#1)(1993-5#1)(2007-5#1)
postoperative hospital mortality and morbidity after##2##6##(2011-2#2)
postoperative hospital stay##5##3##(2007-8#3)(2008-5#1)(2009-6#1)
postoperative hospital##7##2##(2007-8#3)(2008-5#1)(2009-6#1)(2011-2#2)
postoperative hour##4##2##(2006-12#4)
postoperative hours##4##2##(1991-2#1)(2007-2#1)(2007-8#2)
postoperative hypoxemia in OSA patients##2##5##(2012-2#2)
postoperative hypoxemia##5##2##(2007-8#3)(2012-2#2)
postoperative ileus##5##2##(2010-2#2)(2010-4#2)(2013-1#1)
postoperative immobilization##3##2##(2009-3#3)
postoperative improvement##2##2##(1997-1#1)(2007-8#1)
postoperative increase##3##2##(1990-6#2)(2012-2#1)
postoperative infection##7##2##(1992-6#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-8#2)(2011-2#1)
postoperative infections##14##2##(1990-11#1)(1991-5#2)(1995-11#3)(1996-12#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-9#1)(2012-1#3)
postoperative intensive care##2##3##(1993-5#1)(2006-10#1)
postoperative irradiation for##3##3##(1994-7#1)(1994-8#1)(2008-6#1)
postoperative irradiation is##2##3##(1990-9#1)(2007-11#1)
postoperative irradiation##11##2##(1990-9#1)(1994-7#1)(1994-8#1)(2004-1#1)(2007-11#1)(2008-3#2)(2008-6#3)(2009-5#1)
postoperative length of stay##2##4##(1994-3#1)(2007-5#1)
postoperative length of##3##3##(1994-3#1)(2007-5#1)(2007-9#1)
postoperative lethality##2##2##(1990-9#1)(2009-2#1)
postoperative management and##3##3##(2007-11#1)(2008-12#1)(2011-3#1)
postoperative management of##6##3##(2007-12#2)(2007-2#1)(2007-6#1)(2010-9#1)(2013-1#1)
postoperative management##11##2##(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#1)(2008-12#1)(2010-9#1)(2011-3#1)(2013-1#2)
postoperative meningitis##2##2##(2008-9#2)
postoperative monitoring##4##2##(1993-1#1)(2006-10#1)(2007-11#1)(2012-2#1)
postoperative month##2##2##(2007-6#1)(2013-1#1)
postoperative morbidity and##3##3##(1996-3#1)(2006-10#1)(2007-8#1)
postoperative morbidity was##3##3##(1994-3#1)(2007-2#1)(2008-10#1)
postoperative morbidity##22##2##(1991-8#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-3#1)(2006-10#2)(2007-1#1)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-7#3)(2011-2#1)(2012-3#1)(2013-1#1)
postoperative mortality rate##2##3##(1993-5#1)(2012-1#1)
postoperative mortality was##4##3##(1992-11#1)(2008-10#1)(2008-7#1)(2011-3#1)
postoperative mortality##11##2##(1990-5#1)(1990-8#1)(1992-11#1)(1993-5#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-7#1)(2011-2#1)(2011-3#1)(2012-1#1)
postoperative mortality/morbidity##2##2##(2008-7#2)
postoperative motor##3##2##(2006-12#3)
postoperative nausea and vomiting (PONV)##2##5##(2008-5#1)(2010-7#1)
postoperative nausea and vomiting and##2##5##(2006-10#2)
postoperative nausea and vomiting in##2##5##(2011-12#1)(2012-12#1)
postoperative nausea and vomiting##29##4##(1995-9#1)(2006-10#21)(2006-12#1)(2008-5#1)(2010-7#1)(2011-12#2)(2012-12#2)
postoperative nausea and##31##3##(1995-9#1)(2006-10#23)(2006-12#1)(2008-5#1)(2010-7#1)(2011-12#2)(2012-12#2)
postoperative neurologic##2##2##(1993-8#1)(2012-3#1)
postoperative neurological deficit##3##3##(2008-7#1)(2011-1#1)(2011-2#1)
postoperative neurological##6##2##(1992-5#1)(2006-10#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)
postoperative of cardiac surgery##2##4##(2013-1#2)
postoperative orthopedic##2##2##(2006-12#1)(2008-8#1)
postoperative outcome and##2##3##(2006-2#1)(2011-2#1)
postoperative outcome##6##2##(1992-8#1)(2005-5#1)(2006-2#1)(2008-9#1)(2011-12#1)(2011-2#1)
postoperative outcomes were##2##3##(2007-7#1)(2013-8#1)
postoperative outcomes##5##2##(2007-7#1)(2009-10#2)(2013-1#1)(2013-8#1)
postoperative oxygen saturation##2##3##(2007-8#2)
postoperative oxygen##3##2##(1993-1#1)(2007-8#2)
postoperative pain after##2##3##(2006-12#1)(2010-7#1)
postoperative pain and shorter##2##4##(2008-9#1)(2009-2#1)
postoperative pain and##14##3##(2005-8#1)(2006-10#3)(2007-7#1)(2008-9#1)(2009-2#1)(2010-3#1)(2010-7#1)(2012-1#1)(2012-12#3)(2013-1#1)
postoperative pain characteristics##2##3##(2010-6#2)
postoperative pain control##3##3##(2007-2#1)(2007-9#1)(2010-2#1)
postoperative pain in patients##2##4##(2007-11#1)(2010-7#1)
postoperative pain in##4##3##(2007-11#1)(2007-2#2)(2010-7#1)
postoperative pain levels##2##3##(1994-3#1)(2012-12#1)
postoperative pain management##11##3##(1992-8#1)(2006-1#1)(2006-10#1)(2007-12#1)(2008-3#2)(2010-6#1)(2010-8#1)(2012-3#1)(2013-1#2)
postoperative pain of##2##3##(2006-12#1)(2006-4#1)
postoperative pain relief after knee surgery##2##6##(2006-12#2)
postoperative pain relief##8##3##(2006-10#1)(2006-12#2)(2007-11#1)(2010-11#2)(2010-7#1)(2011-12#1)
postoperative pain therapy after caesarean##2##5##(2006-10#2)
postoperative pain therapy##3##3##(2006-10#2)(2008-11#1)
postoperative pain##97##2##(1992-12#1)(1992-8#1)(1994-2#1)(1994-3#1)(1995-3#1)(2004-12#1)(2005-8#2)(2006-1#1)(2006-10#15)(2006-12#6)(2006-3#1)(2006-4#1)(2006-6#2)(2006-8#1)(2007-11#4)(2007-12#2)(2007-2#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-11#8)(2010-2#3)(2010-3#1)(2010-6#4)(2010-7#8)(2010-8#2)(2011-12#1)(2012-1#1)(2012-12#4)(2012-3#1)(2013-1#5)(2013-7#1)
postoperative pancreatic juice leakage##2##4##(2008-5#2)
postoperative pancreatitis is##2##3##(2006-6#2)
postoperative patient##4##2##(1993-6#1)(2006-10#1)(2010-2#1)(2012-3#1)
postoperative patients with ARM##2##4##(2011-2#2)
postoperative patients with##4##3##(2006-12#1)(2010-4#1)(2011-2#2)
postoperative patients##15##2##(1993-10#1)(1993-12#2)(1996-8#1)(2006-12#2)(2008-3#1)(2009-3#1)(2010-11#1)(2010-4#1)(2011-2#3)(2012-2#2)
postoperative period after##3##3##(2007-8#3)
postoperative period and##4##3##(1991-2#1)(2007-11#1)(2011-12#1)(2013-1#1)
postoperative period is##2##3##(1991-5#1)(2007-11#1)
postoperative period of##5##3##(1996-8#2)(2009-4#1)(2013-1#2)
postoperative period was##3##3##(1991-11#1)(2008-10#1)(2012-12#1)
postoperative period with##2##3##(2007-8#1)(2011-2#1)
postoperative period##79##2##(1990-12#2)(1990-2#1)(1990-3#2)(1991-11#1)(1991-2#1)(1991-5#2)(1992-10#1)(1993-6#1)(1993-8#1)(1994-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-8#2)(2005-10#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#5)(2007-2#1)(2007-7#3)(2007-8#10)(2007-9#4)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-10#3)(2010-4#1)(2010-6#1)(2011-1#2)(2011-12#2)(2011-2#1)(2011-3#1)(2012-12#2)(2012-3#3)(2013-1#4)(2013-8#1)
postoperative periods##3##2##(2007-12#1)(2007-8#2)
postoperative phase##3##2##(1996-12#1)(2007-12#1)(2011-2#1)
postoperative pulmonary complications##6##3##(1990-10#1)(1997-4#1)(2006-10#3)(2011-2#1)
postoperative pulmonary hypertension after pediatric heart surgery##2##7##(2007-8#2)
postoperative pulmonary venous obstruction##3##4##(2007-8#3)
postoperative pulmonary##14##2##(1990-10#1)(1997-4#1)(2006-10#3)(2007-8#5)(2011-2#1)(2012-12#2)(2012-2#1)
postoperative quality##2##2##(2007-8#1)(2008-9#1)
postoperative radiation therapy in##2##4##(1993-9#1)(1994-10#1)
postoperative radiation therapy##5##3##(1993-4#1)(1993-9#1)(1994-10#1)(2006-10#1)(2008-7#1)
postoperative radiation##8##2##(1993-4#1)(1993-9#1)(1994-10#1)(2006-10#1)(2007-6#1)(2008-7#1)(2010-7#1)(2012-12#1)
postoperative radiotherapy for##2##3##(1994-8#1)(2009-3#1)
postoperative radiotherapy was##2##3##(2007-5#1)(2012-2#1)
postoperative radiotherapy##18##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#1)(1991-4#1)(1994-2#1)(1994-8#1)(2004-1#1)(2007-11#3)(2007-2#1)(2007-4#1)(2007-5#1)(2008-7#1)(2009-3#1)(2012-1#1)(2012-2#1)
postoperative range of motion##2##4##(2008-9#1)(2013-1#1)
postoperative recovery##14##2##(1996-3#1)(2006-10#2)(2007-11#1)(2007-8#2)(2008-7#1)(2008-8#1)(2010-5#1)(2010-9#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
postoperative rehabilitation and##4##3##(2008-8#1)(2013-1#3)
postoperative rehabilitation##9##2##(2006-3#2)(2007-11#1)(2008-6#1)(2008-8#1)(2010-10#1)(2013-1#3)
postoperative relief of##2##3##(1995-5#1)(2009-3#1)
postoperative renal dysfunction##2##3##(2010-7#2)
postoperative renal failure##2##3##(2006-10#1)(2010-3#1)
postoperative renal##4##2##(2006-10#1)(2010-3#1)(2010-7#2)
postoperative residual##2##2##(1996-9#1)(2006-10#1)
postoperative result##3##2##(1990-9#1)(2006-3#1)(2008-8#1)
postoperative results in##2##3##(2007-7#1)(2008-10#1)
postoperative results were##2##3##(1991-4#1)(2011-1#1)
postoperative results##8##2##(1991-4#1)(1992-3#1)(1996-6#1)(2007-7#1)(2008-10#1)(2008-9#1)(2009-10#1)(2011-1#1)
postoperative sanguineous wound drainage##2##4##(1996-9#2)
postoperative scar##5##2##(2007-11#3)(2011-2#2)
postoperative shivering##6##2##(2010-7#6)
postoperative sinonasal##2##2##(2012-1#2)
postoperative speech##2##2##(2008-9#2)
postoperative stage##2##2##(1991-2#1)(2008-5#1)
postoperative state##3##2##(1996-3#1)(1997-1#2)
postoperative steroid##2##2##(2007-8#1)(2012-1#1)
postoperative stress##2##2##(1990-12#1)(2008-3#1)
postoperative surveillance##2##2##(2006-10#1)(2009-3#1)
postoperative survival time##2##3##(1992-9#1)(2007-8#1)
postoperative survival##4##2##(1992-9#1)(1993-5#1)(2007-11#1)(2007-8#1)
postoperative symptoms##2##2##(2009-2#1)(2013-1#1)
postoperative thrombosis with##2##3##(1990-12#1)(1995-5#1)
postoperative thrombosis##3##2##(1990-12#2)(1995-5#1)
postoperative time##6##2##(1990-4#1)(1991-6#1)(2007-8#1)(2008-5#1)(2011-2#2)
postoperative treatment of##3##3##(1993-4#1)(1993-5#1)(2010-12#1)
postoperative treatment##14##2##(1990-12#1)(1990-9#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-4#1)(1993-5#1)(1995-4#1)(2007-11#3)(2009-2#1)(2010-12#1)(2013-1#1)
postoperative ventilatory##2##2##(2007-9#1)(2010-7#1)
postoperative visual acuity##3##3##(2012-12#2)(2013-1#1)
postoperative visual##4##2##(1993-2#1)(2012-12#2)(2013-1#1)
postoperative vomiting##3##2##(2006-10#1)(2008-5#2)
postoperative weeks##3##2##(2006-3#1)(2007-8#1)(2009-3#1)
postoperative wound infection##3##3##(1994-2#2)(2008-5#1)
postoperative wound##5##2##(1994-2#2)(2007-12#1)(2007-8#1)(2008-5#1)
postoperative##1297##1##(1990-10#4)(1990-11#2)(1990-12#11)(1990-2#2)(1990-3#7)(1990-4#3)(1990-5#3)(1990-6#3)(1990-8#2)(1990-9#6)(1991-10#1)(1991-11#4)(1991-12#1)(1991-2#6)(1991-3#4)(1991-4#7)(1991-5#6)(1991-6#4)(1991-8#4)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#11)(1992-4#1)(1992-5#2)(1992-6#5)(1992-8#4)(1992-9#3)(1993-1#3)(1993-10#6)(1993-12#7)(1993-2#3)(1993-4#4)(1993-5#6)(1993-6#3)(1993-7#5)(1993-8#5)(1993-9#2)(1994-10#1)(1994-12#1)(1994-2#7)(1994-3#10)(1994-4#3)(1994-6#2)(1994-7#2)(1994-8#2)(1994-9#1)(1995-10#2)(1995-11#3)(1995-12#1)(1995-2#3)(1995-3#2)(1995-4#3)(1995-5#4)(1995-6#1)(1995-9#2)(1996-1#2)(1996-12#5)(1996-2#3)(1996-3#4)(1996-6#2)(1996-8#5)(1996-9#5)(1997-1#4)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#2)(1997-7#1)(2004-1#3)(2004-10#3)(2004-12#1)(2004-2#1)(2005-10#1)(2005-12#3)(2005-5#6)(2005-8#3)(2006-1#1)(2006-10#96)(2006-11#8)(2006-12#32)(2006-2#3)(2006-3#11)(2006-4#2)(2006-5#6)(2006-6#19)(2006-7#5)(2006-8#6)(2006-9#7)(2007-1#4)(2007-10#3)(2007-11#38)(2007-12#24)(2007-2#11)(2007-3#1)(2007-4#4)(2007-5#7)(2007-6#6)(2007-7#20)(2007-8#127)(2007-9#27)(2008-1#3)(2008-10#16)(2008-11#1)(2008-12#5)(2008-2#1)(2008-3#11)(2008-4#5)(2008-5#16)(2008-6#6)(2008-7#31)(2008-8#24)(2008-9#23)(2009-10#5)(2009-2#12)(2009-3#16)(2009-4#3)(2009-5#8)(2009-6#6)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#4)(2010-11#9)(2010-12#17)(2010-2#10)(2010-3#4)(2010-4#5)(2010-5#4)(2010-6#12)(2010-7#30)(2010-8#12)(2010-9#3)(2011-1#11)(2011-12#12)(2011-2#41)(2011-3#7)(2011-7#1)(2012-1#12)(2012-11#1)(2012-12#40)(2012-2#23)(2012-3#14)(2013-1#66)(2013-7#10)(2013-8#19)
postoperative)##2##1##(2013-1#2)
postoperatively a##2##2##(1992-9#1)(2006-12#1)
postoperatively after##2##2##(1996-2#1)(2007-8#1)
postoperatively and may##2##3##(1997-1#1)(2012-2#1)
postoperatively and##12##2##(1990-6#1)(1990-8#1)(1991-12#1)(1997-1#1)(2006-12#1)(2007-8#3)(2008-9#1)(2009-10#1)(2009-3#1)(2012-2#1)
postoperatively because of##3##3##(2007-7#1)(2011-2#2)
postoperatively but more##2##3##(1993-9#1)(2007-8#1)
postoperatively in##10##2##(1990-4#1)(1993-12#2)(2007-1#1)(2007-7#2)(2007-8#1)(2007-9#1)(2010-12#1)(2011-2#1)
postoperatively is##2##2##(2008-1#1)(2009-3#1)
postoperatively on##2##2##(2007-8#1)(2011-1#1)
postoperatively to##2##2##(2007-6#1)(2009-10#1)
postoperatively using##3##2##(2007-7#1)(2009-10#1)(2013-1#1)
postoperatively was##2##2##(2007-2#1)(2013-1#1)
postoperatively with##2##2##(1993-1#1)(2012-1#1)
postoperatively##183##1##(1990-2#2)(1990-4#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-8#1)(1992-9#1)(1993-1#4)(1993-12#3)(1993-2#2)(1993-3#1)(1993-9#1)(1994-1#1)(1994-2#2)(1994-3#3)(1996-2#1)(1996-8#1)(1997-1#1)(1997-4#2)(1997-8#1)(2004-1#1)(2006-11#1)(2006-12#7)(2006-2#1)(2006-5#2)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-6#1)(2007-7#5)(2007-8#16)(2007-9#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#5)(2008-7#8)(2008-8#3)(2008-9#10)(2009-10#4)(2009-3#7)(2009-5#2)(2009-6#1)(2010-12#2)(2010-4#1)(2010-8#3)(2011-1#4)(2011-12#1)(2011-2#10)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#8)(2013-7#3)(2013-8#3)
postoperatively)##3##1##(2006-8#1)(2007-11#1)(2007-12#1)
postopératoire##2##1##(2011-2#1)(2012-2#1)
postoral##3##1##(2007-12#2)(2007-5#1)
postorbital##2##1##(1990-3#1)(1995-8#1)
postovulatory##4##1##(1996-4#1)(2007-2#2)(2008-12#1)
postpandemic season##2##2##(2013-1#2)
postpandemic##3##1##(2013-1#3)
postpartum Pap smears##2##3##(2006-10#2)
postpartum and##5##2##(2004-10#1)(2004-3#1)(2007-2#1)(2007-9#1)(2008-6#1)
postpartum angiopathy##2##2##(2010-8#2)
postpartum beef cows##2##3##(2006-5#2)
postpartum checkup##4##2##(2013-1#4)
postpartum contraceptive use##2##3##(2013-1#2)
postpartum depression##9##2##(2007-2#2)(2010-1#1)(2010-7#1)(2012-2#1)(2013-1#4)
postpartum depressive##2##2##(2010-6#1)(2013-1#1)
postpartum eclampsia##3##2##(2010-8#3)
postpartum fistula##2##2##(1996-12#2)
postpartum haemorrhage##3##2##(2012-12#1)(2013-1#1)(2013-8#1)
postpartum health##2##2##(2006-2#1)(2007-10#1)
postpartum hemorrhage##6##2##(2006-9#1)(2007-2#1)(2008-3#1)(2012-12#1)(2013-1#2)
postpartum hospital##2##2##(2005-7#1)(2007-2#1)
postpartum hysterectomy##3##2##(1995-12#3)
postpartum is##2##2##(1995-2#1)(2011-1#1)
postpartum length of hospital stay##2##5##(2007-2#2)
postpartum period to##2##3##(1992-7#1)(2007-10#1)
postpartum period##25##2##(1992-7#1)(1992-9#1)(1995-8#1)(1996-3#1)(2004-10#1)(2004-3#2)(2006-4#1)(2007-10#2)(2007-2#4)(2008-3#1)(2009-3#1)(2009-4#1)(2010-8#2)(2011-2#1)(2012-2#3)(2013-8#2)
postpartum sterilisation##2##2##(2004-10#2)
postpartum to##3##2##(2004-3#1)(2006-2#1)(2006-5#1)
postpartum were##3##2##(2007-10#1)(2008-12#1)(2008-9#1)
postpartum women in Thailand##3##4##(2011-1#3)
postpartum women who##2##3##(1996-8#1)(2004-3#1)
postpartum women##13##2##(1996-12#1)(1996-8#1)(2004-3#2)(2005-7#1)(2006-2#1)(2007-10#1)(2007-2#1)(2011-1#4)(2013-1#1)
postpartum##180##1##(1990-12#2)(1991-11#1)(1992-12#3)(1992-2#1)(1992-7#3)(1992-9#1)(1993-6#1)(1995-12#3)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#5)(1996-3#2)(1996-7#2)(1996-8#1)(2004-10#4)(2004-3#10)(2005-7#2)(2006-10#5)(2006-12#1)(2006-2#5)(2006-3#2)(2006-4#3)(2006-5#6)(2006-9#1)(2007-10#12)(2007-11#3)(2007-2#20)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#5)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-6#1)(2010-7#2)(2010-8#8)(2010-9#1)(2011-1#6)(2011-2#3)(2012-12#3)(2012-2#7)(2013-1#19)(2013-8#6)
postpartum-onset obsessive-compulsive disorder##2##3##(2004-3#2)
postpartum-onset##3##1##(2004-3#3)
postperfusion##2##1##(2012-3#2)
postplanting environment##4##2##(2008-10#4)
postpneumonectomy empyema##3##2##(2007-8#3)
postpneumonectomy syndrome##3##2##(2007-8#3)
postpneumonectomy##11##1##(2007-3#1)(2007-8#10)
postpone the##4##2##(1996-11#1)(2007-12#1)(2009-5#1)(2012-2#1)
postpone##14##1##(1990-11#1)(1996-11#1)(1997-7#1)(2007-12#1)(2007-9#1)(2008-6#1)(2009-12#2)(2009-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
postponed due to##2##3##(2012-2#1)(2013-1#1)
postponed##21##1##(1991-11#1)(1994-2#1)(1994-5#1)(1995-6#1)(1996-12#3)(2004-9#1)(2005-10#1)(2006-7#1)(2007-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
postponement of##9##2##(2007-9#1)(2008-11#1)(2008-3#1)(2010-3#2)(2011-1#2)(2011-2#1)(2012-12#1)
postponement##14##1##(1991-6#1)(1992-2#1)(1996-12#1)(2007-9#1)(2008-11#1)(2008-3#1)(2010-3#3)(2011-1#3)(2011-2#1)(2012-12#1)
postpones##2##1##(1995-11#1)(2005-8#1)
postponing the##2##2##(1993-6#1)(2007-8#1)
postponing##4##1##(1993-6#1)(2007-8#1)(2007-9#1)(2010-3#1)
postprandial blood##2##2##(1994-12#1)(2012-3#1)
postprandial glucose##2##2##(1991-10#1)(2010-8#1)
postprandial insulin##3##2##(2006-10#1)(2007-5#1)(2010-10#1)
postprandial lipemia##2##2##(2008-1#1)(2008-12#1)
postprandial lipid##3##2##(1997-2#1)(2004-11#2)
postprandial plasma glucose##2##3##(2007-5#1)(2008-4#1)
postprandial plasma##5##2##(2004-11#1)(2007-5#1)(2008-4#1)(2011-1#1)(2012-3#1)
postprandial response##2##2##(1996-9#2)
postprandial state##4##2##(2004-11#1)(2008-1#1)(2008-3#2)
postprandial##48##1##(1990-11#1)(1991-10#1)(1992-3#1)(1994-12#2)(1996-9#4)(1997-1#1)(1997-2#1)(1997-4#1)(2004-11#7)(2005-10#1)(2006-10#3)(2007-5#2)(2008-1#4)(2008-10#3)(2008-12#1)(2008-3#2)(2008-4#1)(2010-10#1)(2010-12#1)(2010-8#2)(2011-1#3)(2012-12#1)(2012-3#3)(2012-4#1)
postprandially##2##1##(2008-1#1)(2012-1#1)
postpregnancy##2##1##(1995-2#1)(2006-3#1)
postprocedural##4##1##(1992-3#1)(2006-11#1)(2007-11#1)(2009-12#1)
postprocedure##3##1##(2006-11#2)(2007-9#1)
postprocessed##3##1##(2008-1#1)(2008-3#1)(2008-7#1)
postprocessing algorithm##2##2##(2007-11#2)
postprocessing of##2##2##(2006-10#1)(2008-2#1)
postprocessing##25##1##(2006-10#1)(2006-4#1)(2007-11#4)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#6)(2008-3#7)(2011-1#1)
postproduction##2##1##(1993-2#1)(2010-4#1)
postpubertal patient##2##2##(2008-10#2)
postpubertal##4##1##(2008-10#3)(2008-5#1)
postradiation##4##1##(1993-2#1)(2006-6#2)(2007-12#1)
postreduction##2##1##(2010-11#1)(2010-4#1)
postrenal azotemia##3##2##(2010-2#3)
postrenal##5##1##(2010-2#5)
postreproductive lifespan##2##2##(2009-12#2)
postreproductive##4##1##(2009-12#4)
postresection##5##1##(2007-11#1)(2007-6#3)(2011-2#1)
postresectional##2##1##(2007-7#2)
postrhinal##5##1##(1997-7#5)
posts and##3##2##(2008-11#1)(2008-3#1)(2013-8#1)
posts are##3##2##(1994-7#1)(2008-11#2)
posts in##2##2##(2007-9#1)(2010-6#1)
posts##27##1##(1990-7#1)(1991-7#1)(1992-3#1)(1993-3#1)(1993-7#2)(1994-7#1)(1996-11#1)(1996-8#1)(2007-8#1)(2007-9#1)(2008-11#6)(2008-3#1)(2008-4#1)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#4)
postseason##2##1##(2006-3#2)
postsecondary education##5##2##(1992-3#1)(1995-3#1)(2007-12#1)(2007-9#1)(2008-11#1)
postsecondary##8##1##(1992-3#2)(1995-3#1)(2007-12#1)(2007-9#1)(2008-11#1)(2011-2#1)(2012-12#1)
postshock##2##1##(2007-5#2)
postspawning mass##3##2##(2010-8#3)
postspawning##5##1##(2008-5#1)(2010-8#4)
postsplenectomy sepsis##3##2##(2007-3#1)(2008-9#2)
poststernotomy mediastinitis##2##2##(2007-8#2)
poststress##2##1##(2006-3#1)(2010-12#1)
poststroke BP##2##2##(2007-10#2)
poststroke and##2##2##(2007-10#2)
poststroke depression##4##2##(2007-10#2)(2007-9#1)(2008-2#1)
poststroke functional##3##2##(2012-12#2)(2013-1#1)
poststroke is##2##2##(2007-10#2)
poststroke patients##4##2##(2008-2#1)(2013-1#3)
poststroke period##2##2##(2007-10#1)(2007-9#1)
poststroke##38##1##(2007-10#19)(2007-7#2)(2007-9#5)(2008-2#2)(2008-8#1)(2009-11#1)(2012-12#4)(2013-1#4)
postsupplementation##4##1##(2013-8#4)
postsurgery##9##1##(1991-3#1)(1992-12#1)(1993-9#1)(2006-11#1)(2006-5#1)(2006-8#1)(2008-1#1)(2008-12#1)(2013-8#1)
postsurgical adhesions##2##2##(1995-12#1)(2010-1#1)
postsurgical observation##2##2##(2007-7#2)
postsurgical##25##1##(1990-2#1)(1995-10#1)(1995-12#3)(2005-12#1)(2006-10#1)(2006-12#2)(2006-5#1)(2007-12#3)(2007-7#2)(2007-8#1)(2008-4#1)(2008-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-3#1)
postsynaptic 5-HT1B receptors##2##3##(1995-12#1)(1996-12#1)
postsynaptic D3 and D2##2##4##(1994-10#2)
postsynaptic actions##4##2##(1990-12#1)(1990-3#2)(2008-1#1)
postsynaptic adrenergic hyporesponsiveness##2##3##(1993-11#2)
postsynaptic cell##3##2##(1990-11#1)(1991-6#1)(2007-10#1)
postsynaptic cells##6##2##(1996-9#1)(2007-10#1)(2012-12#4)
postsynaptic component##2##2##(1997-5#2)
postsynaptic currents##8##2##(1994-2#2)(1995-11#1)(1995-2#1)(1997-3#2)(1997-5#1)(2009-12#1)
postsynaptic densities##6##2##(1994-2#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-2#1)
postsynaptic density##9##2##(1996-12#3)(2008-11#1)(2008-4#1)(2008-5#1)(2010-3#1)(2012-2#1)(2012-3#1)
postsynaptic differentiation at the##2##4##(2009-8#2)
postsynaptic differentiation##3##2##(2009-8#3)
postsynaptic dopamine##3##2##(1993-11#1)(1995-12#1)(2008-11#1)
postsynaptic electrical##2##2##(1997-7#1)(2008-11#1)
postsynaptic field potentials##2##3##(1994-10#1)(2008-4#1)
postsynaptic inhibition##3##2##(1990-4#1)(1997-3#1)(2008-1#1)
postsynaptic locus##2##2##(1997-2#1)(2008-4#1)
postsynaptic mechanisms##2##2##(1992-8#1)(1996-12#1)
postsynaptic membrane of the neuromuscular junction##2##6##(1996-1#1)(2012-2#1)
postsynaptic membrane of##4##3##(1996-1#1)(1996-8#1)(1997-5#1)(2012-2#1)
postsynaptic membrane##8##2##(1996-1#1)(1996-12#2)(1996-4#1)(1996-8#1)(1997-5#1)(2008-11#1)(2012-2#1)
postsynaptic muscle##2##2##(1997-8#2)
postsynaptic neurons##6##2##(1993-3#1)(2007-10#1)(2008-11#2)(2008-2#1)(2009-8#1)
postsynaptic potential##12##2##(1991-8#1)(1992-3#1)(1992-8#1)(1993-12#1)(1995-3#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-5#1)(1997-8#1)(2011-2#1)
postsynaptic potentials and##2##3##(1991-3#1)(2007-11#1)
postsynaptic potentials##17##2##(1990-11#1)(1991-3#1)(1991-5#1)(1992-8#2)(1993-2#1)(1995-12#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-5#1)(1996-7#1)(1996-9#1)(2007-11#1)(2007-12#1)(2009-5#1)
postsynaptic profiles##2##2##(1991-9#1)(1997-7#1)
postsynaptic proteins##2##2##(1992-8#2)
postsynaptic receptors##2##2##(1992-8#1)(2008-11#1)
postsynaptic targets of##3##3##(1992-3#2)(1995-12#1)
postsynaptic targets##6##2##(1992-3#2)(1995-12#1)(1996-9#1)(1997-7#2)
postsynaptic##181##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#3)(1990-4#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-3#3)(1992-8#9)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#1)(1994-10#3)(1994-2#3)(1994-8#1)(1995-1#1)(1995-11#3)(1995-12#4)(1995-2#3)(1995-3#1)(1995-5#4)(1995-6#4)(1995-7#1)(1995-8#2)(1996-1#3)(1996-10#1)(1996-12#11)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#7)(1997-3#4)(1997-5#6)(1997-7#6)(1997-8#3)(2006-3#2)(2007-10#3)(2007-11#1)(2007-12#2)(2008-1#2)(2008-11#9)(2008-2#1)(2008-4#5)(2008-5#2)(2008-7#2)(2009-12#1)(2009-5#2)(2009-8#6)(2009-9#3)(2010-1#1)(2010-3#1)(2011-2#1)(2012-12#8)(2012-2#2)(2012-3#3)(2013-8#1)
postsynaptically##7##1##(1991-1#1)(1992-3#1)(1992-8#2)(1993-11#1)(1996-10#1)(2012-3#1)
postsynthetic conjugation of##2##3##(2006-12#1)(2008-4#1)
postsynthetic##4##1##(2006-12#1)(2008-4#3)
postterm##2##1##(1995-12#1)(2006-10#1)
posttest##10##1##(2008-12#2)(2008-9#1)(2010-10#1)(2010-4#2)(2011-1#1)(2012-2#2)(2013-1#1)
posttherapy##3##1##(1991-1#1)(2007-11#1)(2012-11#1)
posttraining##12##1##(1990-10#2)(1993-5#5)(1994-5#3)(1994-8#1)(2008-5#1)
posttranscriptional gene silencing (PTGS)##3##4##(2008-10#3)
posttranscriptional gene silencing##5##3##(2008-10#4)(2012-3#1)
posttranscriptional gene##6##2##(2008-10#4)(2012-3#1)(2013-1#1)
posttranscriptional level##4##2##(1994-11#1)(1996-5#1)(2008-7#1)(2008-8#1)
posttranscriptional regulation of##2##3##(1991-5#1)(2005-8#1)
posttranscriptional regulation##3##2##(1991-5#1)(1996-10#1)(2005-8#1)
posttranscriptional##29##1##(1990-11#1)(1991-5#2)(1993-3#1)(1994-11#1)(1994-3#1)(1994-8#2)(1995-2#2)(1996-10#1)(1996-12#1)(1996-5#1)(2005-8#1)(2006-10#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
posttranscriptionally##5##1##(1990-11#2)(1991-5#1)(1994-9#1)(2013-8#1)
posttransfection##2##1##(2008-2#2)
posttransfusion##6##1##(1993-9#2)(1994-9#3)(2011-2#1)
posttranslation##2##1##(1996-9#1)(2008-7#1)
posttranslational modification of##5##3##(1990-5#1)(1992-6#1)(1992-9#1)(1997-7#1)(2008-8#1)
posttranslational modification##11##2##(1990-5#1)(1992-11#1)(1992-6#2)(1992-9#1)(1994-11#1)(1994-3#1)(1997-7#1)(2008-8#1)(2010-4#1)(2012-3#1)
posttranslational modifications in##3##3##(1990-5#1)(2009-4#1)(2013-1#1)
posttranslational modifications of##3##3##(1991-5#1)(1997-7#1)(2011-1#1)
posttranslational modifications that##2##3##(1995-8#1)(2009-4#1)
posttranslational modifications##18##2##(1990-5#1)(1991-5#1)(1991-6#1)(1991-8#1)(1995-2#1)(1995-5#1)(1995-7#1)(1995-8#1)(1997-7#1)(2007-8#1)(2008-2#1)(2009-3#1)(2009-4#2)(2011-1#1)(2012-2#1)(2013-1#2)
posttranslational processing of the##3##4##(1991-7#1)(1993-8#1)(1994-11#1)
posttranslational processing of##8##3##(1991-7#1)(1992-10#1)(1992-11#1)(1992-12#1)(1993-8#1)(1994-11#2)(1996-8#1)
posttranslational processing##11##2##(1991-7#1)(1992-10#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-8#1)(1994-11#2)(1994-3#2)(1996-8#1)
posttranslational translocation##2##2##(2012-1#2)
posttranslational##54##1##(1990-5#2)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-10#2)(1992-11#3)(1992-12#2)(1992-6#2)(1992-9#1)(1993-12#1)(1993-8#1)(1994-11#4)(1994-12#1)(1994-3#3)(1994-8#1)(1995-2#1)(1995-5#1)(1995-7#1)(1995-8#2)(1996-3#1)(1996-8#1)(1997-7#2)(2005-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-3#1)(2009-4#2)(2010-4#1)(2011-1#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#2)
posttranslationally modified##2##2##(1991-2#1)(1995-8#1)
posttranslationally##7##1##(1991-2#1)(1991-7#1)(1992-11#1)(1992-7#1)(1994-11#1)(1995-8#1)(1996-8#1)
posttransplant (median##2##2##(2011-2#2)
posttransplant year##2##2##(1995-2#2)
posttransplant##24##1##(1991-9#1)(1995-2#9)(2004-11#1)(2007-2#2)(2008-10#1)(2009-2#1)(2009-4#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-8#2)
posttransplantation AF##2##2##(2007-8#2)
posttransplantation and##2##2##(1995-2#1)(2007-8#1)
posttransplantation diabetes mellitus##2##3##(2008-1#2)
posttransplantation diabetes##3##2##(2007-8#1)(2008-1#2)
posttransplantation hepatitis B##2##3##(2006-10#1)(2013-8#1)
posttransplantation##19##1##(1995-2#6)(1997-5#1)(2006-10#1)(2007-8#7)(2008-1#2)(2008-7#1)(2013-8#1)
posttraumatic and##2##2##(2007-12#1)(2007-7#1)
posttraumatic arthritis##2##2##(2008-9#1)(2010-3#1)
posttraumatic cerebrospinal fluid##2##3##(2008-12#2)
posttraumatic cubitus##2##2##(2013-8#2)
posttraumatic injuries##3##2##(2007-11#3)
posttraumatic narcolepsy##3##2##(2007-6#3)
posttraumatic period##2##2##(2010-12#1)(2011-2#1)
posttraumatic stress disorder (PTSD) and##3##5##(2008-8#1)(2008-9#1)(2012-12#1)
posttraumatic stress disorder (PTSD)##12##4##(1995-11#1)(2005-10#1)(2007-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
posttraumatic stress disorder and##3##4##(2009-9#1)(2012-12#1)(2013-8#1)
posttraumatic stress disorder##30##3##(1994-11#1)(1995-11#1)(1995-12#1)(1996-5#2)(1996-7#1)(2005-10#1)(2007-7#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-11#3)(2009-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#3)(2013-1#2)(2013-7#2)(2013-8#1)
posttraumatic stress symptoms##3##3##(2009-11#2)(2010-12#1)
posttraumatic stress##37##2##(1994-11#1)(1995-11#1)(1995-12#1)(1996-5#2)(1996-7#1)(2005-10#1)(2005-8#1)(2007-7#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-11#6)(2009-9#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
posttraumatic syringomyelia##2##2##(2006-5#2)
posttraumatic##82##1##(1991-5#1)(1993-10#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-12#1)(1996-5#2)(1996-7#1)(2005-10#2)(2005-8#1)(2006-10#1)(2006-5#2)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-6#3)(2007-7#5)(2007-8#3)(2008-12#3)(2008-6#1)(2008-8#3)(2008-9#4)(2009-11#6)(2009-3#2)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#4)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#3)
posttreatment follow-up##3##2##(1991-1#1)(1995-1#1)(2008-7#1)
posttreatment##25##1##(1991-1#1)(1992-9#1)(1994-11#1)(1994-5#1)(1995-1#1)(1996-5#3)(2006-11#3)(2006-4#4)(2006-8#1)(2008-10#3)(2008-6#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-2#2)
postulate a##2##2##(1990-8#1)(1996-4#1)
postulate that the higher##2##4##(1996-12#1)(2012-11#1)
postulate that the##18##3##(1990-12#1)(1990-2#1)(1991-6#1)(1992-3#1)(1994-10#1)(1994-8#1)(1996-12#1)(1996-4#1)(1996-9#1)(1997-3#1)(2005-12#1)(2006-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-11#1)(2012-2#1)
postulate that##47##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#1)(1991-4#1)(1991-6#1)(1992-12#2)(1992-3#1)(1992-8#1)(1993-6#1)(1994-10#1)(1994-12#2)(1994-8#2)(1995-11#1)(1995-2#1)(1996-12#2)(1996-4#1)(1996-6#1)(1996-9#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#1)(2005-12#1)(2006-8#1)(2007-12#1)(2007-6#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
postulate the##3##2##(1993-6#1)(1995-3#1)(2009-10#1)
postulate##61##1##(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#1)(1990-8#3)(1991-4#1)(1991-6#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-6#2)(1994-10#1)(1994-12#2)(1994-8#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#2)(1996-4#2)(1996-6#1)(1996-9#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#1)(2005-12#1)(2006-11#1)(2006-8#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
postulated a##2##2##(1994-4#1)(2008-6#1)
postulated and##2##2##(2008-8#1)(2010-10#1)
postulated as a##2##3##(2006-11#1)(2008-7#1)
postulated as##6##2##(1990-3#1)(1992-4#1)(2006-11#1)(2008-1#1)(2008-7#1)(2009-5#1)
postulated by##2##2##(2008-8#1)(2009-2#1)
postulated for##4##2##(1990-3#1)(2008-11#1)(2008-7#1)(2009-5#1)
postulated in the##2##3##(1994-8#1)(2005-12#1)
postulated in this##2##3##(1990-7#1)(2009-6#1)
postulated in##8##2##(1990-7#1)(1992-11#1)(1994-8#1)(1995-3#1)(1996-2#1)(2005-12#1)(2008-9#1)(2009-6#1)
postulated mechanism##2##2##(1992-8#1)(2008-3#1)
postulated role##2##2##(1990-1#1)(2012-12#1)
postulated that the##14##3##(1992-2#1)(1995-2#1)(2004-12#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2013-8#1)
postulated that there##2##3##(1991-2#1)(2013-7#1)
postulated that this##3##3##(1994-9#1)(1995-12#1)(2008-11#1)
postulated that##55##2##(1990-5#1)(1990-7#1)(1991-2#1)(1991-4#1)(1992-12#1)(1992-2#2)(1992-5#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-8#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-3#1)(2004-12#1)(2005-7#1)(2006-12#1)(2006-4#1)(2006-8#4)(2007-10#1)(2007-11#2)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-12#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2013-1#1)(2013-7#1)(2013-8#1)
postulated the##2##2##(2008-7#1)(2008-8#1)
postulated to be a##8##4##(1992-12#1)(1994-2#1)(1995-8#1)(2007-12#1)(2008-5#1)(2008-7#2)(2012-2#1)
postulated to be in##2##4##(1994-5#1)(2008-10#1)
postulated to be linked to##2##5##(1991-1#1)(2006-12#1)
postulated to be the##5##4##(1994-11#1)(1994-12#1)(1995-11#1)(2007-2#1)(2008-10#1)
postulated to be##30##3##(1990-10#2)(1991-1#1)(1992-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-8#1)(1997-3#1)(2006-12#1)(2007-1#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-10#4)(2008-5#1)(2008-7#3)(2011-1#1)(2012-12#1)(2012-2#1)
postulated to##46##2##(1990-10#2)(1990-5#1)(1991-1#1)(1992-12#2)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-12#1)(2007-1#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)
postulated##177##1##(1990-1#1)(1990-10#3)(1990-3#2)(1990-5#2)(1990-7#4)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#2)(1991-4#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-4#2)(1992-5#1)(1992-8#2)(1993-3#1)(1993-7#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-4#1)(1994-5#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#3)(1995-8#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#4)(2006-4#1)(2006-8#4)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#4)(2008-10#15)(2008-11#5)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#10)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-10#2)(2010-12#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
postulates a##3##2##(1996-2#1)(2004-2#1)(2007-6#1)
postulates that##3##2##(1994-8#1)(2008-5#1)(2009-9#1)
postulates the##3##2##(1995-11#1)(2007-12#1)(2008-5#1)
postulates##26##1##(1993-12#1)(1994-8#1)(1995-11#1)(1996-2#1)(1996-5#1)(2004-2#1)(2005-10#1)(2007-12#1)(2007-6#1)(2008-10#9)(2008-3#1)(2008-5#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-2#1)
postulating##4##1##(1992-6#1)(1994-5#1)(1995-11#1)(2006-11#1)
postulation##3##1##(1997-3#1)(2006-3#1)(2008-5#1)
postural adjustments##2##2##(1992-9#1)(1994-3#1)
postural and movement##3##3##(2008-12#3)
postural and##7##2##(1991-2#1)(1993-9#1)(2008-12#3)(2008-7#2)
postural balance##2##2##(1990-10#2)
postural changes##5##2##(1995-12#1)(2008-12#2)(2010-12#1)(2011-2#1)
postural control##4##2##(2006-10#1)(2006-3#2)(2012-12#1)
postural drainage##2##2##(1991-2#1)(1992-9#1)
postural headache##2##2##(2006-12#2)
postural hypotension##5##2##(2005-6#1)(2008-1#1)(2008-7#2)(2010-12#1)
postural instability and gait abnormalities##2##5##(2008-7#2)
postural instability and##4##3##(1993-10#1)(2008-11#1)(2008-7#2)
postural instability##7##2##(1993-10#1)(2008-11#2)(2008-7#3)(2013-8#1)
postural perturbations##2##2##(2013-1#2)
postural reflexes##4##2##(1996-7#3)(2008-7#1)
postural responses during feeding##2##4##(1991-6#2)
postural responses##3##2##(1991-6#2)(2008-3#1)
postural righting##2##2##(1992-11#2)
postural stability##6##2##(2006-10#1)(2008-7#2)(2010-12#1)(2010-9#1)(2011-1#1)
postural support reflexes##2##3##(1993-9#2)
postural##89##1##(1990-10#4)(1990-6#1)(1991-2#2)(1991-6#2)(1992-11#2)(1992-9#2)(1993-10#1)(1993-5#1)(1993-9#3)(1994-3#1)(1995-12#1)(1995-8#1)(1996-7#3)(2005-6#1)(2006-10#4)(2006-12#2)(2006-3#2)(2006-8#2)(2007-4#2)(2007-6#1)(2008-1#1)(2008-11#2)(2008-12#7)(2008-3#1)(2008-6#1)(2008-7#12)(2009-11#1)(2010-12#3)(2010-2#4)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#3)(2013-1#6)(2013-8#2)
posture after##3##2##(1991-2#2)(2008-5#1)
posture and gait##2##3##(2007-9#1)(2012-12#1)
posture and locomotion##2##3##(1991-2#1)(2007-12#1)
posture and##12##2##(1991-2#1)(1995-5#3)(2006-11#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-12#1)(2010-12#1)(2012-12#1)
posture assessment##2##2##(2012-1#1)(2013-1#1)
posture defects##5##2##(2007-7#4)(2007-8#1)
posture during##3##2##(1995-12#1)(1996-2#1)(2013-8#1)
posture for##2##2##(2006-11#1)(2006-12#1)
posture in the##3##3##(2010-9#1)(2012-1#1)(2013-8#1)
posture in##7##2##(1993-5#1)(2007-12#1)(2007-7#1)(2008-7#1)(2010-9#1)(2012-1#1)(2013-8#1)
posture is##2##2##(2007-4#1)(2008-5#1)
posture of##4##2##(1995-5#1)(2007-4#1)(2007-8#1)(2008-5#1)
posture on the##3##3##(2006-11#1)(2007-7#1)(2012-3#1)
posture on##6##2##(1991-4#1)(2006-11#2)(2007-7#1)(2010-9#1)(2012-3#1)
posture was##3##2##(1991-2#1)(1993-3#1)(2006-11#1)
posture##120##1##(1991-2#6)(1991-4#2)(1991-6#1)(1992-5#1)(1993-3#1)(1993-5#2)(1993-9#3)(1994-3#2)(1995-12#2)(1995-3#1)(1995-5#4)(1996-2#1)(1996-3#1)(2006-11#12)(2006-12#1)(2006-8#1)(2007-1#4)(2007-11#3)(2007-12#4)(2007-2#1)(2007-4#7)(2007-6#4)(2007-7#11)(2007-8#4)(2007-9#1)(2008-11#1)(2008-12#1)(2008-5#5)(2008-6#2)(2008-7#1)(2009-8#4)(2010-10#1)(2010-12#2)(2010-9#7)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-3#4)(2013-1#1)(2013-8#5)
postures and##2##2##(2008-11#1)(2008-12#1)
postures using##2##2##(2007-1#1)(2012-1#1)
postures##20##1##(1997-3#1)(2006-11#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-6#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-6#3)(2010-12#3)(2011-2#2)(2012-1#2)
posturing##2##1##(2006-8#1)(2008-2#1)
postvaccination##3##1##(1995-12#1)(2013-8#2)
postwar appraisals##6##2##(2013-1#6)
postwar##8##1##(2013-1#8)
postweaning hyperinsulinemia##2##2##(2007-5#2)
postweaning##6##1##(1993-4#1)(1994-2#1)(1994-8#1)(2007-5#2)(2009-5#1)
postzygotic##8##1##(1997-1#1)(2007-7#1)(2008-10#2)(2009-2#1)(2012-3#3)
pot experiments##4##2##(1992-3#1)(2008-10#3)
pot##26##1##(1992-3#1)(1996-12#1)(1996-5#1)(2007-2#2)(2008-10#11)(2009-10#1)(2009-6#4)(2011-12#1)(2012-2#3)(2013-1#1)
pot(-1) and##2##2##(2008-10#1)(2008-12#1)
pot(-1)##4##1##(2008-10#3)(2008-12#1)
pot-grown##2##1##(2008-10#2)
potable water##4##2##(2008-10#4)
potable##6##1##(2008-10#5)(2012-1#1)
potassium (K+)##3##2##(1993-11#1)(1996-4#1)(2008-7#1)
potassium (Kir3) channels##2##3##(2008-8#2)
potassium activation of##2##3##(1992-11#2)
potassium ampoules##2##2##(2007-9#2)
potassium and calcium##7##3##(1991-12#1)(1993-9#1)(1997-5#1)(2005-11#1)(2005-8#1)(2008-10#2)
potassium and chloride##2##3##(2008-8#1)(2012-2#1)
potassium and magnesium##4##3##(1994-9#1)(1997-8#1)(2008-10#1)(2008-5#1)
potassium and silver##2##3##(2008-2#2)
potassium and sodium##5##3##(1991-1#2)(2008-10#2)(2008-5#1)
potassium and##34##2##(1990-11#2)(1991-1#2)(1991-12#1)(1991-3#1)(1992-8#1)(1993-1#2)(1993-9#1)(1994-9#1)(1996-12#1)(1997-5#1)(1997-8#1)(2005-11#1)(2005-8#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#2)(2008-5#2)(2008-8#2)(2010-12#1)(2012-12#1)(2012-2#1)
potassium are##3##2##(2007-12#1)(2008-10#1)(2008-5#1)
potassium bromate##8##2##(2008-10#7)(2008-9#1)
potassium bromide##6##2##(2008-10#6)
potassium carbonate##4##2##(2005-4#1)(2007-10#1)(2007-11#1)(2011-2#1)
potassium channel gene##3##3##(1996-5#1)(1997-8#2)
potassium channel in##2##3##(1990-10#1)(1994-2#1)
potassium channel##45##2##(1990-10#2)(1991-11#1)(1991-9#3)(1992-8#1)(1993-5#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-8#2)(1994-9#2)(1996-10#1)(1996-2#2)(1996-5#3)(1997-2#3)(1997-4#2)(1997-7#1)(1997-8#3)(2006-10#1)(2007-12#1)(2007-7#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-10#1)(2013-7#3)
potassium channels are##3##3##(2007-12#1)(2008-1#1)(2008-8#1)
potassium channels in human##2##4##(1990-8#1)(1996-2#1)
potassium channels in##4##3##(1990-8#1)(1996-2#1)(1997-4#1)(2006-10#1)
potassium channels of##2##3##(1990-10#1)(1994-6#1)
potassium channels##46##2##(1990-10#2)(1990-8#1)(1992-3#1)(1992-6#2)(1993-9#3)(1994-12#1)(1994-6#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-10#2)(1996-2#3)(1996-9#1)(1997-4#1)(2005-7#2)(2006-10#2)(2006-2#1)(2007-10#1)(2007-12#5)(2008-1#3)(2008-11#1)(2008-5#2)(2008-8#3)(2009-8#1)(2010-12#3)(2013-7#1)
potassium chlorate##3##2##(2008-10#3)
potassium chloride and##6##3##(1990-8#1)(1996-6#1)(2008-10#4)
potassium chloride as supporting##2##4##(2008-10#1)(2010-2#1)
potassium chloride solution##2##3##(1992-3#1)(2008-10#1)
potassium chloride##22##2##(1990-2#1)(1990-8#1)(1991-10#1)(1991-9#1)(1992-3#1)(1993-7#1)(1995-12#1)(1996-6#1)(2007-5#1)(2007-9#1)(2008-10#9)(2010-2#1)(2010-4#2)
potassium citrate##4##2##(1992-9#1)(1997-7#1)(2007-7#1)(2013-1#1)
potassium complex##2##2##(1996-2#1)(2010-5#1)
potassium concentration was##2##3##(1995-9#1)(2007-6#1)
potassium concentration##10##2##(1990-11#1)(1991-10#1)(1993-1#1)(1995-11#1)(1995-9#3)(1997-7#1)(2007-6#1)(2009-8#1)
potassium concentrations were##3##3##(1995-8#1)(2007-1#1)(2008-5#1)
potassium concentrations##7##2##(1995-8#2)(1995-9#1)(2006-5#1)(2007-1#1)(2008-10#1)(2008-5#1)
potassium conductance##4##2##(1991-5#1)(1994-2#2)(1995-11#1)
potassium content in##2##3##(1991-1#1)(2013-8#1)
potassium content##4##2##(1991-1#1)(2008-12#1)(2013-8#2)
potassium current in##2##3##(1994-2#1)(1996-5#1)
potassium current##6##2##(1992-8#1)(1994-2#1)(1995-7#1)(1996-3#1)(1996-5#1)(2008-8#1)
potassium currents in##4##3##(1993-3#1)(1993-9#1)(2008-8#1)(2010-12#1)
potassium currents were##2##3##(1990-3#1)(1996-5#1)
potassium currents##10##2##(1990-3#1)(1993-3#1)(1993-9#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#2)(2008-8#1)(2010-12#1)
potassium cyanide (0##2##3##(1996-3#2)
potassium cyanide##9##2##(1996-3#4)(1997-6#1)(2007-10#1)(2008-10#1)(2008-7#1)(2011-1#1)
potassium depletion##2##2##(1997-7#2)
potassium dichromate##4##2##(2007-11#1)(2008-10#3)
potassium diet##3##2##(1991-5#1)(2008-7#2)
potassium dihydrogen phosphate (pH##2##4##(2007-8#1)(2012-12#1)
potassium dihydrogen phosphate buffer (pH##2##5##(2008-10#1)(2010-2#1)
potassium dihydrogen phosphate buffer##3##4##(2008-10#1)(2010-2#1)(2010-3#1)
potassium dihydrogen phosphate##9##3##(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-2#1)(2010-3#1)(2012-12#1)
potassium ferricyanide as##2##3##(2008-10#1)(2008-11#1)
potassium ferricyanide##12##2##(1993-4#1)(2008-10#8)(2008-11#1)(2009-9#1)(2010-2#1)
potassium ferrocyanide##2##2##(2008-10#2)
potassium from the##3##3##(1992-8#1)(2008-10#1)(2010-1#1)
potassium glutamate##2##2##(1995-3#1)(1996-7#1)
potassium had##3##2##(2008-9#2)(2013-8#1)
potassium hexacyanoferrate(III)##6##2##(2008-10#6)
potassium hydrogen phthalate##4##3##(2008-10#4)
potassium hydrogen##5##2##(2008-10#5)
potassium hydrogenphthalate##2##2##(1994-9#1)(2008-10#1)
potassium hydroxide (KOH)##5##3##(2006-10#1)(2007-7#3)(2008-10#1)
potassium hydroxide and##2##3##(2008-10#2)
potassium hydroxide solution##3##3##(2008-10#3)
potassium hydroxide to##2##3##(2007-11#1)(2008-6#1)
potassium hydroxide##19##2##(1996-2#1)(2006-10#1)(2007-11#1)(2007-7#4)(2007-8#1)(2008-10#8)(2008-6#2)(2012-11#1)
potassium in##13##2##(1992-4#1)(2006-8#1)(2007-1#1)(2008-10#4)(2008-12#1)(2008-9#2)(2010-12#1)(2012-2#1)(2013-8#1)
potassium iodate and##2##3##(2008-10#2)
potassium iodate in salt##2##4##(2005-4#2)
potassium iodate in##3##3##(2005-4#3)
potassium iodate##6##2##(2005-4#4)(2008-10#2)
potassium iodide (KI)##2##3##(2008-10#2)
potassium iodide and##3##3##(2008-10#3)
potassium iodide##19##2##(2007-11#1)(2007-7#4)(2007-8#1)(2008-10#11)(2008-2#1)(2010-12#1)
potassium ion and##2##3##(2008-10#1)(2010-5#1)
potassium ion in##3##3##(2008-10#3)
potassium ion sensor##2##3##(1992-4#1)(2008-10#1)
potassium ion##18##2##(1992-4#1)(1994-12#1)(1996-2#1)(1997-1#1)(2008-10#10)(2008-3#1)(2008-6#1)(2010-5#1)(2011-2#1)
potassium ion-exchanged waveguides##2##3##(2008-2#1)(2008-3#1)
potassium ion-exchanged##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
potassium ions in the##2##4##(1994-12#1)(2008-10#1)
potassium ions in##5##3##(1991-9#1)(1994-12#1)(2007-9#1)(2008-10#2)
potassium ions##15##2##(1990-11#1)(1990-7#1)(1991-9#2)(1992-4#1)(1994-12#1)(1995-1#1)(2005-10#1)(2007-1#1)(2007-9#1)(2008-10#5)
potassium is##4##2##(1995-11#1)(2008-2#2)(2008-9#1)
potassium lactate##3##2##(2010-4#3)
potassium level and##3##3##(2006-1#1)(2007-11#1)(2007-5#1)
potassium level##9##2##(1994-6#1)(2006-1#3)(2007-11#1)(2007-5#1)(2008-5#1)(2011-2#1)(2012-12#1)
potassium levels##6##2##(1995-10#1)(1996-1#1)(2006-1#1)(2007-9#1)(2008-2#1)(2010-12#1)
potassium lithium tantalate niobate##2##4##(2007-11#1)(2007-12#1)
potassium loss##2##2##(1990-2#2)
potassium niobate##5##2##(2007-12#4)(2008-3#1)
potassium nitrate##4##2##(2008-10#3)(2008-5#1)
potassium or##2##2##(1990-3#1)(1991-3#1)
potassium oxonate##2##2##(1997-3#2)
potassium periodate##6##2##(2008-10#6)
potassium permanganate and##3##3##(2008-10#3)
potassium permanganate in dilute sulphuric acid##2##6##(2008-10#2)
potassium permanganate in##11##3##(2008-10#10)(2009-5#1)
potassium permanganate##29##2##(1991-4#1)(2007-7#1)(2007-8#1)(2008-10#22)(2008-4#1)(2009-5#3)
potassium permanganate-sodium sulfite##2##3##(2008-10#2)
potassium phosphate buffer (pH##4##4##(1997-1#1)(2008-10#3)
potassium phosphate buffer##9##3##(1994-3#1)(1996-4#1)(1996-8#1)(1997-1#1)(2008-10#5)
potassium phosphate##24##2##(1990-12#1)(1991-11#1)(1991-9#2)(1992-11#1)(1993-3#1)(1994-3#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-8#1)(2007-11#1)(2008-10#9)(2008-5#1)(2008-7#2)
potassium poly (vinyl sulfate) (PVSK)##2##5##(2008-10#2)
potassium salt##4##2##(1995-11#1)(2007-11#1)(2010-5#1)(2012-1#1)
potassium sodium##7##2##(2007-12#1)(2007-5#1)(2008-3#5)
potassium sorbate##2##2##(2010-2#1)(2010-4#1)
potassium tartrate##3##2##(1997-7#2)(2008-10#1)
potassium tetrakis##3##2##(2008-10#3)
potassium tetrakis(4-chlorophenyl)borate as##2##3##(2008-10#2)
potassium tetrakis(4-chlorophenyl)borate##3##2##(2008-10#3)
potassium tetrakis(p-chlorophenyl)borate (KTpClPB)##2##3##(2008-10#2)
potassium tetrakis(p-chlorophenyl)borate##3##2##(2008-10#3)
potassium thiocyanate##2##2##(1996-5#1)(2007-11#1)
potassium titanyl phosphate (KTP) and##2##5##(2007-12#1)(2008-10#1)
potassium titanyl phosphate (KTP)##4##4##(2007-12#1)(2008-10#1)(2008-3#2)
potassium titanyl phosphate##12##3##(2006-4#2)(2007-11#2)(2007-12#4)(2008-10#2)(2008-3#2)
potassium to##3##2##(1990-12#1)(1994-2#1)(1995-8#1)
potassium uptake##3##2##(1997-4#1)(2005-8#2)
potassium vapor##2##2##(2007-11#1)(2008-2#1)
potassium was##6##2##(1993-1#1)(1996-9#1)(2007-6#1)(2008-10#2)(2008-9#1)
potassium were##2##2##(2011-12#2)
potassium with a##2##3##(2008-1#1)(2008-10#1)
potassium##743##1##(1990-1#1)(1990-10#6)(1990-11#4)(1990-12#5)(1990-2#4)(1990-3#3)(1990-5#1)(1990-7#4)(1990-8#2)(1990-9#1)(1991-1#3)(1991-10#4)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#4)(1991-9#11)(1992-1#1)(1992-11#4)(1992-3#3)(1992-4#6)(1992-5#2)(1992-6#5)(1992-8#6)(1992-9#1)(1993-1#5)(1993-11#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#6)(1994-11#3)(1994-12#5)(1994-2#6)(1994-3#1)(1994-6#2)(1994-8#2)(1994-9#6)(1995-1#1)(1995-10#1)(1995-11#5)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#6)(1995-9#6)(1996-1#2)(1996-10#3)(1996-12#3)(1996-2#10)(1996-3#5)(1996-4#2)(1996-5#8)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#6)(1997-3#4)(1997-4#6)(1997-5#3)(1997-6#1)(1997-7#7)(1997-8#7)(2005-10#1)(2005-11#4)(2005-4#6)(2005-7#2)(2005-8#5)(2006-1#4)(2006-10#5)(2006-2#2)(2006-4#2)(2006-5#2)(2006-8#1)(2006-9#1)(2007-1#3)(2007-10#7)(2007-11#14)(2007-12#18)(2007-2#2)(2007-5#4)(2007-6#2)(2007-7#12)(2007-8#6)(2007-9#12)(2008-1#9)(2008-10#215)(2008-11#3)(2008-12#6)(2008-2#9)(2008-3#13)(2008-4#5)(2008-5#14)(2008-6#3)(2008-7#7)(2008-8#11)(2008-9#16)(2009-10#1)(2009-2#1)(2009-5#4)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#16)(2010-2#5)(2010-3#1)(2010-4#7)(2010-5#3)(2010-7#1)(2011-1#1)(2011-12#3)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#6)(2013-1#8)(2013-7#4)(2013-8#8)
potassium)##4##1##(1990-1#1)(2005-7#1)(2008-10#1)(2008-4#1)
potassium-induced##3##1##(1990-2#1)(1990-7#1)(1996-5#1)
potassium-ion##2##1##(1994-12#1)(2007-12#1)
potassium-selective channels##2##2##(1990-10#1)(2005-10#1)
potassium-selective electrode##3##2##(2008-10#3)
potassium-selective##7##1##(1990-10#1)(2005-10#1)(2008-10#5)
potassium-sparing##2##1##(1992-4#1)(1997-8#1)
potassium-stimulated##3##1##(1992-11#1)(1992-8#1)(1996-2#1)
potato (Solanum tuberosum L##2##4##(1994-10#1)(2012-2#1)
potato (Solanum##3##2##(1994-10#1)(2008-10#1)(2012-2#1)
potato and tomato production##2##4##(2008-10#2)
potato and tomato##16##3##(2008-10#16)
potato and##29##2##(1990-7#1)(1996-9#1)(2007-3#1)(2008-10#26)
potato based ready-to-eat food products##3##5##(2011-2#3)
potato brown rot##2##3##(2008-10#2)
potato collected##2##2##(2008-10#2)
potato crops in##2##3##(2008-10#2)
potato crops##8##2##(2008-10#8)
potato cultivar##3##2##(2008-10#3)
potato cultivars##14##2##(2008-10#14)
potato cv##6##2##(2008-10#6)
potato cvs##3##2##(2008-10#3)
potato cyst nematode (Globodera##2##4##(2008-10#1)(2009-3#1)
potato cyst nematode##3##3##(2008-10#2)(2009-3#1)
potato cyst##4##2##(2008-10#3)(2009-3#1)
potato dextrose agar##14##3##(2008-10#14)
potato dextrose broth (PDB)##2##4##(2008-10#1)(2008-5#1)
potato dextrose broth##4##3##(2008-10#3)(2008-5#1)
potato dextrose##18##2##(2008-10#17)(2008-5#1)
potato differentials##4##2##(2008-10#4)
potato feathery mottle##5##3##(2008-10#5)
potato fields in##4##3##(2008-10#4)
potato fields##10##2##(2008-10#10)
potato genotypes##2##2##(2006-12#1)(2008-10#1)
potato growers##2##2##(2008-10#2)
potato had a##2##3##(2008-10#2)
potato in##5##2##(2008-10#4)(2011-2#1)
potato isolate##3##2##(2005-11#1)(2008-10#2)
potato isolates collected in##2##4##(2008-10#2)
potato isolates##7##2##(2008-10#7)
potato late blight epidemics##2##4##(2008-10#2)
potato late blight##15##3##(2008-10#15)
potato leafroll virus##3##3##(2008-10#3)
potato leaves##4##2##(2008-10#4)
potato lipoxygenase##2##2##(1990-7#1)(1991-4#1)
potato mixtures##2##2##(2008-10#2)
potato or tomato##4##3##(2008-10#4)
potato or##6##2##(2008-10#5)(2008-5#1)
potato plants were##2##3##(2008-10#1)(2008-8#1)
potato plants##13##2##(1997-4#1)(2006-11#1)(2006-12#1)(2008-10#8)(2008-8#1)(2009-6#1)
potato production##6##2##(2008-10#5)(2008-12#1)
potato proteins##2##2##(2008-5#1)(2010-4#1)
potato samples##3##2##(2008-10#3)
potato scab##3##2##(2008-10#3)
potato seed tubers##3##3##(2008-10#3)
potato seed##4##2##(2008-10#4)
potato stems##2##2##(2008-10#2)
potato stocks##2##2##(2008-10#2)
potato tissue##2##2##(2008-10#2)
potato tuber discs##2##3##(2008-10#2)
potato tuber##11##2##(1996-9#1)(1997-2#1)(1997-6#1)(2008-10#8)
potato tubers##12##2##(1992-12#2)(2006-11#1)(2008-10#7)(2008-12#2)
potato using##2##2##(2008-10#1)(2008-5#1)
potato virus M##2##3##(2005-11#1)(2008-10#1)
potato virus X (PVX)##4##4##(1995-2#2)(1997-3#1)(2008-10#1)
potato virus X##5##3##(1995-2#2)(1997-3#1)(2008-10#1)(2010-9#1)
potato virus Y##5##3##(2008-10#5)
potato virus##14##2##(1995-2#2)(1997-3#1)(2005-11#1)(2008-10#9)(2010-9#1)
potato was##3##2##(2008-10#2)(2010-12#1)
potato yield##2##2##(2008-10#1)(2008-12#1)
potato##409##1##(1990-7#3)(1991-12#1)(1991-4#5)(1992-12#2)(1993-12#2)(1994-10#2)(1994-12#4)(1994-9#1)(1995-2#2)(1996-9#4)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#2)(2005-11#2)(2006-11#4)(2006-12#9)(2007-3#1)(2008-10#308)(2008-12#6)(2008-5#11)(2008-6#3)(2008-8#4)(2008-9#2)(2009-3#1)(2009-6#4)(2010-12#1)(2010-4#2)(2010-9#1)(2011-12#7)(2011-2#8)(2012-2#1)
potatoes and##6##2##(2008-10#6)
potatoes in the##3##3##(2008-10#3)
potatoes in##6##2##(2008-10#6)
potatoes##22##1##(1990-8#1)(1991-5#1)(2006-4#1)(2008-10#17)(2008-9#1)(2012-1#1)
potencies and##6##2##(1991-5#1)(1993-11#1)(1994-8#1)(1995-2#1)(1997-7#1)(2008-12#1)
potencies as##2##2##(1990-6#1)(1992-8#1)
potencies in##5##2##(1991-6#1)(1992-3#3)(1994-3#1)
potencies of the##4##3##(1991-5#1)(1995-11#1)(2007-11#1)(2010-6#1)
potencies of these##3##3##(1993-3#1)(1995-12#1)(2008-5#1)
potencies of##21##2##(1990-11#1)(1991-3#2)(1991-5#1)(1992-9#1)(1993-3#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#3)(1995-12#1)(1995-3#1)(1996-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2010-6#1)
potencies than##2##2##(1997-2#1)(2006-12#1)
potencies to induce##2##3##(1993-12#1)(1995-5#1)
potencies to##4##2##(1993-12#1)(1995-11#1)(1995-5#1)(1997-7#1)
potencies were##5##2##(1990-5#1)(1991-7#1)(1993-3#1)(1995-8#1)(1996-6#1)
potencies##66##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#2)(1991-10#1)(1991-3#2)(1991-5#2)(1991-6#1)(1991-7#2)(1992-3#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-9#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#5)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-6#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-7#2)(2006-12#2)(2007-11#1)(2008-10#3)(2008-12#1)(2008-5#3)(2009-10#1)(2010-6#1)(2013-1#1)
potency (IC50##3##2##(1990-5#1)(1995-1#2)
potency against##6##2##(1995-3#1)(2008-3#1)(2009-12#1)(2011-1#2)(2013-1#1)
potency and efficacy##2##3##(1993-11#1)(1993-8#1)
potency and selectivity of##4##4##(1993-3#1)(1996-8#1)(2005-8#1)(2008-4#1)
potency and selectivity##5##3##(1993-3#1)(1996-12#1)(1996-8#1)(2005-8#1)(2008-4#1)
potency and the##4##3##(1993-3#1)(1994-9#1)(1996-10#1)(2008-3#1)
potency and##34##2##(1991-1#2)(1991-2#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-8#2)(1994-6#1)(1994-9#1)(1995-3#1)(1996-10#2)(1996-12#2)(1996-8#2)(1997-1#1)(2005-6#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-12#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-2#1)(2010-5#1)(2011-12#1)(2012-11#1)(2012-2#1)
potency are##2##2##(2008-3#1)(2008-5#1)
potency as##6##2##(1990-7#1)(1992-1#1)(1995-1#1)(1997-4#1)(2008-12#1)(2013-1#1)
potency assay##3##2##(2007-2#1)(2007-8#1)(2012-3#1)
potency at##3##2##(1992-3#1)(1994-9#1)(2011-12#1)
potency being##2##2##(1991-8#1)(1993-12#1)
potency but##4##2##(1992-9#1)(1993-11#1)(1995-12#1)(2009-8#1)
potency comparable to that of the##2##6##(1991-3#1)(1995-3#1)
potency comparable to that of##4##5##(1991-3#1)(1995-3#2)(2008-5#1)
potency comparable to##6##3##(1991-3#1)(1995-3#2)(1997-2#1)(1997-8#1)(2008-5#1)
potency followed the order##2##4##(2008-8#1)(2010-4#1)
potency following##2##2##(2006-9#1)(2011-12#1)
potency for the##3##3##(1995-12#2)(1996-1#1)
potency for##18##2##(1991-2#1)(1993-11#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#4)(1995-6#1)(1996-1#1)(1996-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-3#2)
potency in both##2##3##(1994-11#1)(2008-7#1)
potency in human##2##3##(1994-3#1)(1997-4#1)
potency in inhibiting##2##3##(1990-12#1)(1990-5#1)
potency in the aerosol##2##4##(1991-1#2)
potency in the##6##3##(1991-1#3)(1994-5#1)(2008-7#1)(2013-1#1)
potency in##25##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1991-1#3)(1991-3#2)(1991-4#1)(1992-2#1)(1993-6#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-3#1)(1997-4#1)(2008-5#1)(2008-7#3)(2013-1#2)
potency is##4##2##(1994-11#1)(1997-2#1)(2006-10#1)(2007-2#1)
potency may##2##2##(1991-12#1)(2008-10#1)
potency of 5-HT to##2##4##(1993-9#2)
potency of a##2##3##(1991-12#1)(2008-5#1)
potency of all##2##3##(1997-2#1)(2011-12#1)
potency of chemicals##3##3##(2007-9#1)(2008-5#2)
potency of human##2##3##(2008-9#1)(2010-2#1)
potency of iloprost but##2##4##(2008-7#2)
potency of iloprost##3##3##(2008-7#3)
potency of inhibition##2##3##(1990-12#1)(1993-4#1)
potency of oral##2##3##(2007-2#1)(2008-5#1)
potency of the peptides##2##4##(1994-8#1)(1995-12#1)
potency of the##29##3##(1990-4#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#1)(1994-3#1)(1994-8#1)(1995-12#3)(1995-5#2)(1996-12#4)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-5#2)(2009-6#1)(2012-11#1)(2013-1#1)
potency of these compounds##2##4##(1990-12#1)(2008-11#1)
potency of these##12##3##(1990-12#1)(1990-4#1)(1990-8#1)(1992-11#1)(1992-12#1)(1994-9#1)(1995-3#1)(1996-4#1)(1997-2#1)(1997-8#1)(2008-11#1)(2008-7#1)
potency of two##3##3##(1994-11#1)(1996-8#1)(2011-1#1)
potency of##145##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#3)(1990-4#4)(1990-7#2)(1990-8#2)(1991-1#2)(1991-10#1)(1991-12#3)(1991-2#2)(1991-3#4)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#3)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-4#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-3#4)(1994-8#5)(1994-9#1)(1995-11#2)(1995-12#4)(1995-3#4)(1995-5#2)(1996-11#1)(1996-12#4)(1996-4#2)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#2)(2006-5#1)(2007-11#1)(2007-2#2)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-4#3)(2008-5#8)(2008-7#6)(2008-9#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-3#1)(2013-1#4)
potency on##4##2##(1990-4#1)(1991-10#2)(1991-3#1)
potency order of##3##3##(1990-2#1)(1992-9#1)(1993-8#1)
potency order##5##2##(1990-2#1)(1990-5#1)(1991-9#1)(1992-9#1)(1993-8#1)
potency similar to that of##4##5##(1992-12#1)(1993-4#1)(2006-10#1)(2008-5#1)
potency similar to##6##3##(1992-12#2)(1993-3#1)(1993-4#1)(2006-10#1)(2008-5#1)
potency than##4##2##(1990-7#1)(1991-5#1)(1995-10#1)(2008-10#1)
potency to induce##2##3##(1991-2#1)(1993-12#1)
potency to that##3##3##(1990-2#1)(1990-7#1)(1994-8#1)
potency to##18##2##(1990-2#1)(1990-7#2)(1991-2#1)(1992-3#1)(1993-12#1)(1993-9#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-6#1)(1997-2#1)(2006-10#1)(2008-5#1)(2008-9#1)(2009-12#1)(2013-1#2)
potency was##12##2##(1991-3#1)(1991-4#1)(1992-5#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-3#1)(1996-1#1)(1996-10#1)(1997-5#1)(2012-3#1)
potency when##4##2##(1993-12#1)(1996-12#1)(2008-8#1)(2012-3#1)
potency with##6##2##(1993-12#1)(1994-2#1)(1996-12#1)(2005-9#1)(2008-5#1)(2010-10#1)
potency##463##1##(1990-10#2)(1990-11#6)(1990-12#7)(1990-2#6)(1990-4#6)(1990-5#4)(1990-7#8)(1990-8#2)(1991-1#8)(1991-10#4)(1991-12#7)(1991-2#5)(1991-3#11)(1991-4#2)(1991-5#5)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#6)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#4)(1992-9#4)(1993-11#5)(1993-12#6)(1993-3#6)(1993-4#3)(1993-6#2)(1993-8#4)(1993-9#4)(1994-11#5)(1994-12#1)(1994-2#2)(1994-3#8)(1994-5#2)(1994-6#5)(1994-8#7)(1994-9#8)(1995-1#7)(1995-10#1)(1995-11#5)(1995-12#11)(1995-2#1)(1995-3#12)(1995-5#4)(1995-6#3)(1995-7#1)(1995-8#1)(1996-1#3)(1996-10#4)(1996-11#1)(1996-12#14)(1996-2#1)(1996-4#2)(1996-6#2)(1996-7#2)(1996-8#9)(1996-9#3)(1997-1#2)(1997-2#7)(1997-3#2)(1997-4#3)(1997-5#3)(1997-6#2)(1997-7#1)(1997-8#3)(2005-11#1)(2005-6#1)(2005-7#1)(2005-8#3)(2005-9#2)(2006-10#6)(2006-12#2)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#9)(2007-2#4)(2007-7#2)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-3#6)(2008-4#6)(2008-5#22)(2008-7#10)(2008-8#3)(2008-9#2)(2009-10#2)(2009-12#3)(2009-2#1)(2009-3#3)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#6)(2011-12#4)(2011-2#2)(2012-11#2)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#12)
potency)##5##1##(1992-3#1)(2008-10#3)(2010-10#1)
potent (1##2##2##(1997-8#2)
potent CYP26 inhibitors##2##3##(2008-8#2)
potent DNA##2##2##(2005-7#1)(2006-12#1)
potent IL-12##3##2##(1996-10#2)(2008-11#1)
potent ability of##2##3##(1995-6#1)(2008-4#1)
potent acid##2##2##(1993-11#1)(2006-10#1)
potent activator of##6##3##(1990-2#1)(1992-9#1)(1994-11#1)(1995-1#1)(2008-4#1)(2010-6#1)
potent activator##7##2##(1990-2#1)(1992-9#1)(1993-8#1)(1994-11#1)(1995-1#1)(2008-4#1)(2010-6#1)
potent activators of##3##3##(1990-8#1)(1992-5#1)(2005-10#1)
potent activators##4##2##(1990-8#1)(1992-5#1)(1996-4#1)(2005-10#1)
potent activity against the##2##4##(2006-8#1)(2011-2#1)
potent activity against##6##3##(2006-8#2)(2008-3#1)(2008-5#1)(2011-2#1)(2011-3#1)
potent activity in##2##3##(1992-5#1)(2012-12#1)
potent activity with##2##3##(2008-11#1)(2011-2#1)
potent activity##17##2##(1991-2#1)(1992-5#1)(1993-3#1)(1994-12#1)(2006-8#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#2)(2009-3#1)(2011-2#3)(2011-3#1)(2012-12#1)
potent against##3##2##(1994-9#1)(1996-12#1)(2011-3#1)
potent agonist##6##2##(1991-3#1)(1995-11#1)(1995-6#1)(1996-11#1)(1997-7#1)(2010-10#1)
potent alternative##2##2##(2008-4#1)(2013-8#1)
potent analgesic##6##2##(1992-12#1)(1993-11#1)(2006-10#2)(2007-11#1)(2008-12#1)
potent and orally active##2##4##(1994-9#1)(1997-1#1)
potent and selective agonists##2##4##(2008-4#2)
potent and selective antagonist##2##4##(1993-11#1)(2006-2#1)
potent and selective human A(3) adenosine##2##6##(2008-4#2)
potent and selective inhibitor##4##4##(1990-8#1)(1993-12#1)(1995-7#1)(2006-12#1)
potent and selective inhibitors of##3##5##(1995-6#1)(1996-8#1)(1997-2#1)
potent and selective inhibitors##4##4##(1995-6#1)(1996-8#1)(1997-2#1)(2008-5#1)
potent and selective##36##3##(1990-2#1)(1990-8#1)(1991-4#1)(1992-10#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#2)(1994-2#2)(1995-3#2)(1995-6#1)(1995-7#1)(1996-10#1)(1996-8#2)(1997-1#1)(1997-2#2)(2004-12#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-12#1)(2006-2#1)(2008-1#1)(2008-4#4)(2008-5#2)(2010-12#1)
potent and specific##12##3##(1990-10#1)(1991-12#1)(1991-9#2)(1992-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(2005-9#1)(2007-1#1)(2008-1#1)
potent and##77##2##(1990-10#1)(1990-2#2)(1990-8#1)(1990-9#1)(1991-12#3)(1991-4#1)(1991-9#2)(1992-10#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#3)(1993-4#2)(1994-11#1)(1994-2#3)(1994-3#1)(1994-9#3)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-8#2)(1997-1#2)(1997-2#4)(2004-12#1)(2005-11#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-11#1)(2006-12#3)(2006-2#1)(2007-1#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#4)(2008-5#4)(2010-12#1)(2011-2#2)
potent angiogenesis##3##2##(1996-6#1)(2009-7#1)(2012-12#1)
potent angiotensin##2##2##(1991-12#1)(1996-12#1)
potent antagonist at the##3##4##(1996-10#2)(1996-2#1)
potent antagonist of##4##3##(1992-11#2)(1996-9#1)(2008-8#1)
potent antagonist##11##2##(1992-11#2)(1995-3#1)(1996-10#3)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(2008-8#1)
potent antagonistic##2##2##(1992-8#1)(2006-2#1)
potent anti-AIDS virus activity##2##4##(1996-2#2)
potent anti-HIV activities##3##3##(2011-3#3)
potent anti-HIV agent##3##3##(1991-3#1)(1992-5#1)(1992-9#1)
potent anti-HIV##7##2##(1991-3#1)(1992-5#1)(1992-9#1)(2011-3#4)
potent anti-inflammatory activity##2##3##(1996-11#1)(2008-5#1)
potent anti-inflammatory and neuroprotective effects##2##5##(2008-11#2)
potent anti-inflammatory and##5##3##(2007-1#1)(2007-11#1)(2008-11#2)(2013-1#1)
potent anti-inflammatory effects##2##3##(2009-8#1)(2013-1#1)
potent anti-inflammatory##10##2##(1996-11#1)(2007-1#1)(2007-11#1)(2008-11#2)(2008-5#2)(2009-8#1)(2013-1#2)
potent anti-tumor##2##2##(2008-12#1)(2009-12#1)
potent antiarrhythmic##2##2##(1993-6#1)(1996-10#1)
potent antibacterial activity##2##3##(1994-3#1)(2006-12#1)
potent antibacterial##3##2##(1993-6#1)(1994-3#1)(2006-12#1)
potent antibiotic##4##2##(2006-9#1)(2008-5#2)(2011-1#1)
potent anticancer##3##2##(2009-7#1)(2011-2#1)(2012-2#1)
potent anticoagulant##3##2##(1995-5#1)(1995-8#1)(2005-7#1)
potent anticonvulsant##2##2##(1992-3#1)(1996-10#1)
potent antifungal activity##2##3##(1994-12#1)(2008-11#1)
potent antifungal##4##2##(1994-12#2)(2008-11#2)
potent antigen-presenting cells##4##3##(2006-10#1)(2008-4#1)(2008-5#1)(2010-2#1)
potent antihypertensive##2##2##(1991-5#1)(2010-1#1)
potent antimicrobial##2##2##(2007-11#1)(2008-8#1)
potent antimitotic##2##2##(1993-1#1)(1994-9#1)
potent antinociceptive effect##2##3##(1996-12#1)(1997-5#1)
potent antinociceptive##4##2##(1995-7#1)(1996-12#1)(1997-5#1)(2011-1#1)
potent antioxidants##3##2##(1993-11#1)(2012-11#1)(2013-8#1)
potent antiproliferative activity against##2##4##(2006-12#1)(2013-8#1)
potent antiproliferative effects##2##3##(1992-3#1)(1995-12#1)
potent antiproliferative##4##2##(1992-3#1)(1995-12#1)(2006-12#1)(2013-8#1)
potent antitumor activity##4##3##(1994-5#1)(1996-10#1)(2008-5#2)
potent antitumor agents##2##3##(1994-12#1)(2008-1#1)
potent antitumor immunity##2##3##(1997-4#1)(2010-2#1)
potent antitumor##11##2##(1991-7#1)(1994-12#1)(1994-5#1)(1996-10#2)(1997-4#1)(2008-1#1)(2008-5#3)(2010-2#1)
potent antiviral activity against##2##4##(1995-8#1)(2012-2#1)
potent antiviral activity in##2##4##(1994-11#1)(2008-1#1)
potent antiviral activity##4##3##(1994-11#1)(1995-8#1)(2008-1#1)(2012-2#1)
potent antiviral##6##2##(1994-11#1)(1995-8#1)(2008-1#1)(2008-10#1)(2010-12#1)(2012-2#1)
potent arterial##2##2##(1990-12#1)(2008-4#1)
potent as##17##2##(1990-2#1)(1990-9#1)(1991-12#1)(1992-12#2)(1992-7#1)(1993-3#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#2)(2005-8#1)(2007-11#1)(2008-3#1)(2008-5#1)(2012-11#1)
potent at inhibiting##3##3##(1990-7#1)(1993-7#1)(1994-8#1)
potent at##7##2##(1990-7#1)(1991-9#1)(1992-3#1)(1993-7#1)(1994-8#1)(1996-2#1)(1997-2#1)
potent bacterial##2##2##(2008-5#1)(2011-2#1)
potent biological##3##2##(1996-4#1)(2007-11#1)(2011-2#1)
potent but##3##2##(1991-1#1)(2008-5#1)(2012-2#1)
potent carcinogens##3##2##(1992-9#1)(1995-1#1)(2008-10#1)
potent class##2##2##(1996-9#1)(2012-2#1)
potent competitive inhibitors of##2##4##(1991-5#1)(1994-11#1)
potent competitive inhibitors##3##3##(1991-5#1)(1994-11#1)(1996-10#1)
potent competitive##7##2##(1990-10#1)(1990-12#1)(1991-5#1)(1994-11#1)(1994-3#1)(1994-9#1)(1996-10#1)
potent compounds##5##2##(1993-4#3)(1994-9#1)(1997-1#1)
potent cryoprotective activity##2##3##(1992-3#2)
potent cytotoxic activities##2##3##(2011-2#1)(2012-2#1)
potent cytotoxic effect##2##3##(1996-3#1)(2008-4#1)
potent cytotoxic##7##2##(1996-3#1)(2008-4#1)(2008-8#2)(2011-2#2)(2012-2#1)
potent cytotoxicity properties##2##3##(2012-2#2)
potent cytotoxicity##3##2##(2008-3#1)(2012-2#2)
potent diuretic##2##2##(1990-11#1)(2008-11#1)
potent dopamine D2 and##2##4##(1993-11#1)(1997-5#1)
potent dopamine##4##2##(1993-11#1)(1997-2#1)(1997-5#1)(2006-1#1)
potent drug##4##2##(1992-7#1)(1994-10#1)(1994-9#1)(2008-8#1)
potent drugs##4##2##(1995-3#1)(2005-9#1)(2010-7#1)(2011-2#1)
potent effector##2##2##(2006-10#1)(2008-4#1)
potent for##3##2##(1991-2#2)(1991-9#1)
potent free radical scavenger##4##4##(1994-6#1)(1995-8#1)(2012-2#2)
potent free radical##5##3##(1994-6#1)(1995-8#1)(2008-10#1)(2012-2#2)
potent functional##2##2##(1991-3#1)(1995-3#1)
potent growth factor for##2##4##(1991-5#1)(2008-4#1)
potent growth##7##2##(1990-2#1)(1991-5#1)(1995-3#2)(2008-4#1)(2008-5#1)(2010-6#1)
potent hemolytic##2##2##(2006-12#1)(2008-8#1)
potent histamine##2##2##(1995-3#1)(2008-3#1)
potent hypocholesterolemic agent##2##3##(1994-5#2)
potent immunosuppressant##4##2##(1990-3#1)(1993-11#1)(2005-8#1)(2008-5#1)
potent immunosuppressive##8##2##(1992-12#1)(1993-8#1)(1994-5#1)(1995-3#1)(2008-10#1)(2008-11#1)(2009-4#1)(2013-8#1)
potent in inhibiting the tail-flick response evoked by##2##8##(1992-3#2)
potent in inhibiting the##6##4##(1992-3#3)(1996-12#2)(1996-6#1)
potent in inhibiting##9##3##(1992-3#3)(1995-6#1)(1996-12#2)(1996-6#1)(1997-5#1)(2008-4#1)
potent in vitro activity##2##4##(1997-1#1)(2012-12#1)
potent in vitro and in vivo##2##6##(1992-5#1)(1993-11#1)
potent in vitro inhibitors of##2##5##(1992-5#1)(2007-5#1)
potent in vitro##10##3##(1992-5#2)(1993-11#1)(1995-3#1)(1997-1#1)(2007-5#1)(2008-8#1)(2010-2#1)(2010-5#1)(2012-12#1)
potent in##45##2##(1990-12#1)(1990-7#1)(1991-2#1)(1991-5#3)(1992-3#5)(1992-5#3)(1993-1#1)(1993-11#1)(1993-3#1)(1994-10#1)(1994-3#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-12#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-5#1)(1997-8#1)(2007-12#1)(2007-5#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-2#1)(2010-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
potent inactivators of##2##3##(1990-11#1)(1994-6#1)
potent inducer of##17##3##(1990-2#1)(1990-5#1)(1991-10#1)(1991-7#2)(1992-8#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-8#1)(1994-9#1)(1996-10#1)(1997-7#1)(2008-10#1)(2008-11#1)(2009-6#1)(2011-2#1)
potent inhibition of##8##3##(1990-11#1)(1990-7#1)(1992-10#1)(1992-8#1)(1996-8#1)(2005-7#1)(2008-5#1)(2012-3#1)
potent inhibition##9##2##(1990-11#1)(1990-7#1)(1992-10#1)(1992-8#1)(1996-8#1)(2005-7#1)(2008-5#1)(2011-1#1)(2012-3#1)
potent inhibitor of DNA##3##4##(1991-2#1)(1995-1#1)(2008-5#1)
potent inhibitor of ErbB-1 and ErbB-2##2##6##(2008-5#2)
potent inhibitor of insulin##2##4##(1994-11#1)(1995-6#1)
potent inhibitor of nitric oxide##2##5##(1995-12#1)(1995-2#1)
potent inhibitor of the##16##4##(1991-1#1)(1991-3#1)(1991-8#3)(1994-9#2)(1995-1#1)(1995-5#1)(1995-8#2)(1996-6#1)(2008-11#1)(2008-3#1)(2009-12#1)(2012-12#1)
potent inhibitor of##97##3##(1990-10#3)(1990-11#1)(1990-12#3)(1990-5#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-7#1)(1991-8#4)(1992-11#2)(1992-12#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#2)(1993-8#2)(1993-9#1)(1994-11#4)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#5)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-3#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#3)(2008-7#1)(2009-12#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
potent inhibitor##106##2##(1990-10#3)(1990-11#1)(1990-12#3)(1990-5#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#2)(1991-7#2)(1991-8#4)(1992-11#3)(1992-12#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#2)(1993-8#2)(1993-9#1)(1994-11#4)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#7)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-6#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-3#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#3)(2008-7#1)(2009-12#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
potent inhibitors against##2##3##(2012-2#2)
potent inhibitors of cell##2##4##(1990-5#1)(1997-6#1)
potent inhibitors of human##4##4##(1992-5#1)(1994-8#1)(1995-3#1)(2012-2#1)
potent inhibitors of protein##3##4##(1990-9#1)(1993-8#1)(2012-2#1)
potent inhibitors of the enzyme##2##5##(1996-8#1)(2009-9#1)
potent inhibitors of the##15##4##(1990-12#2)(1990-9#1)(1991-3#1)(1992-12#1)(1992-5#1)(1994-11#1)(1996-2#1)(1996-8#1)(2006-10#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-12#1)(2013-1#1)
potent inhibitors of##46##3##(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-3#1)(1991-9#1)(1992-12#1)(1992-5#2)(1992-8#1)(1993-8#1)(1994-11#4)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-3#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-8#2)(1997-6#1)(1997-7#1)(2004-2#1)(2005-3#1)(2006-10#1)(2006-12#1)(2007-11#2)(2008-10#1)(2008-5#1)(2008-8#1)(2009-9#2)(2010-12#1)(2012-2#2)(2013-1#1)
potent inhibitors##54##2##(1990-12#3)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-3#1)(1991-9#1)(1992-12#1)(1992-5#2)(1992-8#1)(1993-8#1)(1994-11#4)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-3#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-8#2)(1997-6#1)(1997-7#1)(2004-2#1)(2005-3#1)(2006-10#1)(2006-12#1)(2007-11#2)(2008-10#2)(2008-5#1)(2008-8#1)(2009-9#2)(2010-12#1)(2010-4#1)(2012-2#4)(2012-3#1)(2013-1#2)
potent inhibitory activity##6##3##(1990-7#1)(1991-1#1)(1995-3#1)(2008-8#1)(2009-3#1)(2011-1#1)
potent inhibitory effects on##3##4##(1991-12#1)(1993-1#1)(1995-7#1)
potent inhibitory##15##2##(1990-7#1)(1991-1#1)(1991-12#1)(1993-1#1)(1993-11#1)(1995-3#1)(1995-7#1)(1997-1#1)(1997-7#1)(2007-1#1)(2008-4#1)(2008-8#1)(2009-3#1)(2011-1#1)(2012-12#1)
potent interaction##2##2##(1996-8#1)(2009-12#1)
potent irritant resiniferatoxin##2##3##(1993-9#2)
potent ligand for##4##3##(1991-2#1)(1991-9#2)(1992-12#1)
potent lipid##4##2##(1991-12#1)(1991-5#1)(1992-8#1)(1993-9#1)
potent mitogen for hepatocytes##2##4##(1992-11#1)(1993-8#1)
potent mitogen for##6##3##(1992-11#1)(1992-7#1)(1993-8#1)(1995-2#1)(1997-1#1)(1997-7#1)
potent mitogen##9##2##(1992-11#1)(1992-7#1)(1993-8#1)(1995-2#1)(1995-6#2)(1997-1#1)(1997-7#1)(2009-2#1)
potent neuroprotection##2##2##(2006-7#1)(2013-8#1)
potent neuroprotective##4##2##(1997-4#1)(2007-10#1)(2008-7#1)(2008-8#1)
potent neurotoxicant##2##2##(1996-8#2)
potent new##4##2##(1990-8#1)(2007-4#2)(2008-3#1)
potent on##3##2##(1993-3#1)(1995-12#1)(2010-12#1)
potent oxidant##2##2##(1992-10#1)(2008-10#1)
potent peptide##2##2##(1992-4#1)(2011-1#1)
potent pro-angiogenic##2##2##(2005-7#1)(2008-10#1)
potent protein##3##2##(1992-10#1)(2008-11#1)(2010-12#1)
potent quenching effect on##2##4##(2008-4#2)
potent regulator of##2##3##(2012-12#1)(2013-8#1)
potent regulator##3##2##(1991-10#1)(2012-12#1)(2013-8#1)
potent selective##3##2##(1990-9#1)(1997-6#1)(2008-10#1)
potent sigma##2##2##(1991-1#1)(1993-11#1)
potent signaling##3##2##(2010-3#1)(2012-11#2)
potent stimulator of##13##3##(1990-9#2)(1991-10#1)(1991-2#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-6#1)(1995-12#1)(1996-10#1)(1996-5#1)(1996-6#1)(2008-6#1)
potent stimulator##15##2##(1990-9#2)(1991-10#1)(1991-2#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-8#2)(1995-12#1)(1996-10#1)(1996-5#1)(1996-6#1)(2008-6#1)
potent stimulus for##3##3##(1997-2#1)(1997-5#1)(2008-3#1)
potent suppression of##2##3##(1995-12#1)(1995-7#1)
potent than either compound##2##4##(1995-6#1)(1996-8#1)
potent than either##3##3##(1991-1#1)(1995-6#1)(1996-8#1)
potent than gamma2-MSH##2##3##(1995-12#1)(1996-12#1)
potent than that##5##3##(1990-7#1)(1991-2#1)(1992-9#1)(1993-11#1)(1995-11#1)
potent than the##9##3##(1990-12#1)(1992-2#1)(1992-4#1)(1993-11#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(2007-10#1)
potent than##91##2##(1990-11#2)(1990-12#2)(1990-4#1)(1990-5#1)(1990-7#3)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-4#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-6#4)(1994-8#2)(1994-9#5)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#6)(1995-3#1)(1995-5#1)(1995-6#3)(1996-12#1)(1996-2#2)(1996-5#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-7#1)(2005-8#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-12#1)
potent therapeutic##3##2##(1995-2#1)(2008-10#1)(2013-1#1)
potent transcription##2##2##(1990-8#1)(2012-3#1)
potent tumor##4##2##(1990-7#1)(1993-8#1)(2008-1#1)(2013-1#1)
potent turn mimic##2##3##(2007-11#2)
potent vasoactive##2##2##(1993-3#1)(2005-8#1)
potent vasoconstrictor peptide##2##3##(1990-3#1)(1993-3#1)
potent vasoconstrictor##6##2##(1990-3#1)(1993-3#2)(1996-9#1)(2009-10#1)(2010-10#1)
potent vasodilator##3##2##(1991-12#1)(1991-3#1)(2008-3#1)
potent vasorelaxant##2##2##(1992-9#1)(1994-5#1)
potent with an##2##3##(1996-3#1)(2013-1#1)
potent with##5##2##(1993-4#1)(1994-6#1)(1996-3#1)(2006-12#1)(2013-1#1)
potent##1263##1##(1990-10#6)(1990-11#8)(1990-12#11)(1990-2#8)(1990-3#2)(1990-4#2)(1990-5#9)(1990-6#2)(1990-7#8)(1990-8#5)(1990-9#12)(1991-1#7)(1991-10#3)(1991-12#17)(1991-2#14)(1991-3#9)(1991-4#7)(1991-5#17)(1991-6#1)(1991-7#7)(1991-8#8)(1991-9#14)(1992-1#1)(1992-10#5)(1992-11#10)(1992-12#12)(1992-2#2)(1992-3#14)(1992-4#5)(1992-5#10)(1992-6#10)(1992-7#4)(1992-8#17)(1992-9#14)(1993-1#3)(1993-11#20)(1993-12#6)(1993-2#2)(1993-3#16)(1993-4#10)(1993-5#2)(1993-6#5)(1993-7#4)(1993-8#12)(1993-9#6)(1994-10#3)(1994-11#25)(1994-12#12)(1994-2#7)(1994-3#8)(1994-5#10)(1994-6#11)(1994-8#16)(1994-9#38)(1995-1#11)(1995-10#3)(1995-11#9)(1995-12#20)(1995-2#5)(1995-3#24)(1995-5#12)(1995-6#12)(1995-7#8)(1995-8#7)(1995-9#2)(1996-1#1)(1996-10#20)(1996-11#7)(1996-12#10)(1996-2#12)(1996-3#4)(1996-4#5)(1996-5#6)(1996-6#5)(1996-8#18)(1996-9#6)(1997-1#15)(1997-2#16)(1997-3#2)(1997-4#8)(1997-5#6)(1997-6#7)(1997-7#9)(1997-8#4)(2003-11#2)(2004-12#2)(2004-2#2)(2005-10#2)(2005-11#3)(2005-3#3)(2005-6#1)(2005-7#10)(2005-8#9)(2005-9#3)(2006-1#2)(2006-10#11)(2006-11#2)(2006-12#17)(2006-2#2)(2006-3#2)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#3)(2006-9#3)(2007-1#4)(2007-10#3)(2007-11#20)(2007-12#2)(2007-4#2)(2007-5#2)(2007-8#1)(2008-1#12)(2008-10#24)(2008-11#18)(2008-12#6)(2008-2#1)(2008-3#18)(2008-4#26)(2008-5#43)(2008-6#3)(2008-7#12)(2008-8#26)(2008-9#1)(2009-10#4)(2009-11#1)(2009-12#6)(2009-2#4)(2009-3#4)(2009-4#1)(2009-6#2)(2009-7#4)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#4)(2010-11#3)(2010-12#7)(2010-2#5)(2010-3#2)(2010-4#3)(2010-5#3)(2010-6#4)(2010-7#3)(2010-8#1)(2011-1#7)(2011-12#2)(2011-2#17)(2011-3#6)(2012-1#1)(2012-11#6)(2012-12#15)(2012-2#20)(2012-3#13)(2013-1#13)(2013-7#3)(2013-8#13)
potential &quot##2##2##(2008-11#1)(2008-5#1)
potential (+0##2##2##(2007-8#1)(2008-10#1)
potential (0##2##2##(2008-10#2)
potential (EPSP)##6##2##(1991-8#1)(1992-8#1)(1993-12#1)(1995-12#1)(1997-1#1)(1997-2#1)
potential (ERP) technique##2##3##(1996-5#1)(2009-11#1)
potential (ERP)##8##2##(1995-12#1)(1995-5#1)(1996-5#1)(1997-1#2)(2009-11#1)(2011-2#1)(2013-8#1)
potential (MEP) monitoring##2##3##(2006-12#1)(2011-2#1)
potential (MEP)##3##2##(2006-12#1)(2008-7#1)(2011-2#1)
potential (delta##2##2##(1991-6#1)(1993-6#1)
potential (the##2##2##(2009-12#1)(2012-3#1)
potential (versus##2##2##(2008-10#2)
potential 0##3##2##(2008-10#2)(2009-10#1)
potential B-cell epitopes##2##3##(2008-10#2)
potential DNA##3##2##(2008-2#1)(2008-5#1)(2011-1#1)
potential E##2##2##(2008-10#2)
potential EF-hand##2##2##(1995-6#2)
potential N-glycosylation site##3##3##(1993-8#1)(1994-5#1)(2008-10#1)
potential N-glycosylation sites##4##3##(1991-12#1)(1991-7#1)(1994-8#1)(1997-8#1)
potential N-glycosylation##7##2##(1991-12#1)(1991-7#1)(1993-8#1)(1994-5#1)(1994-8#1)(1997-8#1)(2008-10#1)
potential N-linked glycosylation##3##3##(1993-2#1)(1994-11#1)(1997-4#1)
potential ORFs##2##2##(1995-8#2)
potential Sp1 binding##2##3##(1991-7#1)(1992-3#1)
potential Sp1##3##2##(1991-7#1)(1992-3#1)(1997-4#1)
potential ability of##4##3##(2007-8#1)(2008-10#2)(2013-1#1)
potential ability##5##2##(2006-12#1)(2007-8#1)(2008-10#2)(2013-1#1)
potential abnormalities##2##2##(2008-2#1)(2009-4#1)
potential across the##4##3##(1990-2#1)(1994-12#1)(2005-10#1)(2008-9#1)
potential across##6##2##(1990-2#1)(1994-12#1)(1994-2#1)(2005-10#1)(2008-7#1)(2008-9#1)
potential active##2##2##(1997-7#1)(2012-2#1)
potential activity of##2##3##(1993-12#1)(1995-1#1)
potential activity##5##2##(1993-12#1)(1995-1#1)(1995-2#1)(2008-5#2)
potential acute##3##2##(2008-3#2)(2008-8#1)
potential adaptation of##2##3##(2008-10#1)(2012-12#1)
potential adaptation##3##2##(2008-10#1)(2008-5#1)(2012-12#1)
potential additional##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-1#1)
potential advantage##4##2##(1993-4#1)(2007-5#1)(2012-1#1)(2013-7#1)
potential advantages and disadvantages##2##4##(2008-3#1)(2010-2#1)
potential advantages of this##3##4##(1995-2#1)(2004-2#1)(2008-3#1)
potential advantages of##16##3##(1995-2#1)(2004-2#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#2)(2008-9#1)(2010-12#2)(2010-2#1)(2012-12#1)(2012-2#1)
potential advantages over##5##3##(2007-12#1)(2008-1#1)(2008-2#1)(2012-12#1)(2013-1#1)
potential advantages##33##2##(1995-2#1)(2004-2#1)(2006-10#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#2)(2008-9#2)(2010-12#2)(2010-2#2)(2010-8#1)(2011-7#1)(2012-12#2)(2012-2#1)(2013-1#3)
potential adverse drug reactions##2##4##(1994-6#1)(2008-8#1)
potential adverse drug##3##3##(1994-6#1)(2008-8#1)(2011-3#1)
potential adverse effect##2##3##(1992-11#1)(2005-7#1)
potential adverse effects of##2##4##(2007-11#2)
potential adverse effects##11##3##(1994-6#1)(2007-11#3)(2008-10#2)(2008-12#1)(2008-8#1)(2009-5#1)(2012-11#1)(2013-1#1)
potential adverse events##2##3##(2009-7#1)(2011-2#1)
potential adverse##21##2##(1992-11#1)(1994-6#2)(2005-7#1)(2006-10#1)(2007-11#3)(2008-10#2)(2008-12#2)(2008-8#2)(2009-5#1)(2009-6#1)(2009-7#1)(2011-2#1)(2011-3#1)(2012-11#1)(2013-1#1)
potential affinity##2##2##(1991-1#1)(2005-12#1)
potential after##4##2##(1990-7#1)(1992-2#1)(1994-6#1)(2008-11#1)
potential against##4##2##(1992-6#1)(2008-10#1)(2008-5#1)(2008-6#1)
potential agent##5##2##(1993-7#1)(2005-11#1)(2008-10#1)(2008-5#1)(2008-7#1)
potential agents##3##2##(1997-2#2)(2008-9#1)
potential along the##4##3##(1991-4#1)(2005-11#1)(2008-2#1)(2009-5#1)
potential along##5##2##(1991-4#1)(2005-11#1)(2008-10#1)(2008-2#1)(2009-5#1)
potential alternative to##4##3##(2006-10#1)(2008-2#1)(2009-5#1)(2013-8#1)
potential alternative##13##2##(1994-9#1)(1996-1#1)(2006-10#1)(2008-10#3)(2008-2#1)(2009-5#1)(2011-2#2)(2012-8#1)(2013-1#1)(2013-8#1)
potential amplitude##5##2##(1991-11#1)(1993-12#1)(2008-4#2)(2012-2#1)
potential analytical##2##2##(2008-10#2)
potential anatomical##2##2##(1995-12#1)(2011-2#1)
potential and a##4##3##(1992-2#1)(1994-12#1)(1994-9#1)(2009-10#1)
potential and challenges##2##3##(2010-8#1)(2012-1#1)
potential and conductance##2##3##(1993-12#1)(2005-11#1)
potential and cytosolic free##2##4##(1997-1#2)
potential and cytosolic##3##3##(1991-1#1)(1997-1#2)
potential and deposition time##3##4##(2008-10#3)
potential and force##2##3##(2005-11#1)(2010-12#1)
potential and in##2##3##(2006-10#1)(2008-9#1)
potential and input##2##3##(1990-2#1)(1993-12#1)
potential and persistence##2##3##(2008-11#2)
potential and plasticity##2##3##(2008-1#1)(2009-3#1)
potential and practical##2##3##(2007-8#1)(2008-10#1)
potential and the##12##3##(1993-11#1)(1996-8#1)(2005-11#1)(2007-10#2)(2008-10#4)(2008-3#1)(2010-2#1)(2011-1#1)
potential and##144##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-1#2)(1991-4#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-8#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-4#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-9#1)(1996-8#2)(1997-1#5)(1997-3#1)(2004-11#1)(2004-9#1)(2005-10#2)(2005-11#8)(2006-10#4)(2007-10#2)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#24)(2008-11#7)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#2)(2009-3#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#6)(2012-1#1)(2012-12#1)(2012-3#2)(2013-8#1)
potential animal model##2##3##(1991-9#1)(1993-12#1)
potential antagonist##3##2##(2008-10#3)
potential anti-inflammatory##3##2##(1994-11#1)(2006-12#1)(2009-1#1)
potential anti-invasive##2##2##(1993-4#1)(2005-7#1)
potential antiatherogenic##2##2##(1997-7#1)(2008-7#1)
potential antibacterial##2##2##(2005-11#1)(2007-11#1)
potential anticancer agents##2##3##(1997-1#1)(2010-7#1)
potential anticancer##10##2##(1991-2#1)(1994-4#1)(1995-3#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-5#1)(2010-7#1)(2013-1#2)
potential antifungal##3##2##(2005-7#1)(2008-5#1)(2012-2#1)
potential antimicrobial##3##2##(1993-4#1)(2007-11#1)(2011-12#1)
potential antioxidant##4##2##(1995-1#1)(2004-11#1)(2010-5#1)(2011-2#1)
potential antipsychotic##2##2##(1995-3#1)(1997-3#1)
potential antitumor##3##2##(1994-12#1)(1997-2#1)(2008-3#1)
potential antiviral##2##2##(2007-11#1)(2009-11#1)
potential applicability##5##2##(2007-12#1)(2008-3#1)(2008-8#1)(2010-6#1)(2011-2#1)
potential application as a##2##4##(2008-10#1)(2013-7#1)
potential application as##7##3##(2005-7#1)(2008-10#3)(2013-1#2)(2013-7#1)
potential application for the diagnosis of##2##6##(2008-3#1)(2008-5#1)
potential application for##5##3##(1994-5#1)(2008-3#2)(2008-5#1)(2010-12#1)
potential application in the fields of##2##6##(2008-7#1)(2013-1#1)
potential application in the##7##4##(2005-7#1)(2006-10#1)(2006-12#1)(2008-7#1)(2010-4#1)(2012-12#1)(2013-1#1)
potential application in##26##3##(1994-6#1)(1996-3#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-1#1)(2007-6#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
potential application of the##7##4##(1990-12#1)(1996-5#1)(2005-11#1)(2006-12#1)(2007-8#1)(2008-10#2)
potential application of this##5##4##(2007-1#1)(2008-10#3)(2012-3#1)
potential application of##22##3##(1990-12#1)(1995-9#1)(1996-5#1)(2005-11#1)(2006-12#1)(2007-1#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
potential application to the##2##4##(2008-7#1)(2012-4#1)
potential application to##9##3##(2007-12#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-11#1)(2011-1#1)(2012-4#1)
potential application##72##2##(1990-12#1)(1994-5#1)(1994-6#1)(1995-9#1)(1996-3#1)(1996-5#1)(2005-11#1)(2005-7#2)(2006-10#2)(2006-12#2)(2006-5#1)(2006-7#1)(2007-1#2)(2007-12#1)(2007-6#2)(2007-8#1)(2008-1#2)(2008-10#14)(2008-11#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#4)(2013-7#2)(2013-8#1)
potential applications are suggested##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
potential applications are##6##3##(2007-12#3)(2008-2#1)(2008-3#1)(2008-4#1)
potential applications as##3##3##(2008-4#1)(2010-4#1)(2011-1#1)
potential applications for the##2##4##(2008-1#1)(2008-7#1)
potential applications for##7##3##(1994-11#1)(1997-2#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)
potential applications in biomedical##2##4##(2005-11#2)
potential applications in biomedicine##2##4##(2009-2#1)(2010-6#1)
potential applications in medicine##3##4##(2007-12#1)(2008-7#1)(2010-4#1)
potential applications in the##2##4##(1995-2#1)(2008-5#1)
potential applications in##31##3##(1994-6#1)(1995-2#1)(1997-4#1)(2005-11#2)(2006-12#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-9#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#2)(2009-2#1)(2009-4#1)(2009-5#1)(2010-4#1)(2010-6#1)(2012-2#1)(2013-1#1)
potential applications of the##3##4##(2007-5#1)(2008-10#1)(2008-7#1)
potential applications of##16##3##(1990-3#1)(2006-11#1)(2006-2#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-7#2)(2009-3#1)(2009-4#1)(2010-11#1)(2010-9#1)(2012-11#2)(2013-1#1)
potential applications such as the##2##5##(2008-2#2)
potential applications to##7##3##(1996-12#1)(2007-11#1)(2007-12#2)(2008-10#1)(2013-1#2)
potential applications##92##2##(1990-3#1)(1994-11#1)(1994-6#1)(1995-2#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-4#1)(2005-11#2)(2005-9#1)(2006-11#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-11#4)(2007-12#9)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#4)(2008-5#4)(2008-7#8)(2008-8#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#1)(2010-11#1)(2010-12#1)(2010-4#3)(2010-6#1)(2010-9#1)(2011-1#1)(2012-11#3)(2012-12#2)(2012-2#1)(2013-1#4)
potential approach##3##2##(1993-11#1)(2007-1#1)(2011-2#1)
potential approaches##2##2##(2008-10#1)(2009-12#1)
potential approximately##2##2##(2009-5#1)(2011-2#1)
potential are##9##2##(1990-3#1)(1993-11#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-9#1)(2008-11#1)(2008-9#2)
potential areas for##2##3##(1994-8#1)(2008-6#1)
potential around##2##2##(1990-3#1)(1991-8#1)
potential as a function of##2##5##(2008-10#1)(2009-9#1)
potential as a new##3##4##(1994-5#1)(2007-11#1)(2008-5#1)
potential as a novel##2##4##(2008-10#1)(2011-1#1)
potential as a rapid##2##4##(1997-4#1)(2008-10#1)
potential as a therapeutic agent for##2##6##(1994-6#1)(2008-1#1)
potential as a therapeutic agent##3##5##(1994-6#1)(1996-8#1)(2008-1#1)
potential as a therapeutic##4##4##(1994-6#1)(1996-8#1)(2008-1#2)
potential as a##39##3##(1994-5#2)(1994-6#1)(1996-8#1)(1997-4#2)(1997-5#1)(2005-7#1)(2007-11#2)(2007-3#1)(2008-1#2)(2008-10#7)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-1#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#1)
potential as an alternative##2##4##(2008-10#1)(2008-12#1)
potential as an effective##2##4##(2008-10#1)(2008-7#1)
potential as an##9##3##(1994-9#1)(1996-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-1#1)
potential as effective##2##3##(2008-1#2)
potential as therapeutic##4##3##(2008-3#1)(2011-2#2)(2013-1#1)
potential as##83##2##(1990-11#1)(1992-3#2)(1994-11#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-1#1)(1996-10#1)(1996-8#1)(1997-1#1)(1997-4#2)(1997-5#1)(2004-4#1)(2005-10#1)(2005-7#4)(2006-12#2)(2007-11#3)(2007-3#2)(2008-1#5)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2009-1#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
potential ascospore dose (PAD)##2##4##(2008-10#2)
potential assay##2##2##(2006-5#1)(2008-10#1)
potential associated with##3##3##(1990-2#1)(1992-9#1)(2007-8#1)
potential association##2##2##(2006-10#1)(2007-10#1)
potential associations between##2##3##(2006-9#1)(2012-2#1)
potential at pH 7##2##4##(1995-6#1)(2008-10#1)
potential at pH##4##3##(1990-5#1)(1990-7#1)(1995-6#1)(2008-10#1)
potential at the##5##3##(1991-6#1)(1991-9#1)(1994-10#1)(1997-6#1)(2005-11#1)
potential at##21##2##(1990-5#1)(1990-7#1)(1991-3#1)(1991-6#1)(1991-9#1)(1993-12#1)(1994-10#1)(1995-6#1)(1997-6#1)(2005-11#2)(2007-11#1)(2008-1#1)(2008-10#7)(2008-8#1)
potential atypical antipsychotic##3##3##(1992-12#2)(1995-3#1)
potential atypical##4##2##(1992-12#2)(1995-3#1)(2005-8#1)
potential barrier to##4##3##(1994-3#1)(2007-12#1)(2009-4#1)(2013-1#1)
potential barriers to##4##3##(2007-9#1)(2008-1#2)(2013-1#1)
potential barriers##9##2##(2006-10#2)(2006-2#1)(2007-9#1)(2008-1#2)(2008-4#1)(2012-11#1)(2013-1#1)
potential based on##2##3##(1995-2#2)
potential basic##2##2##(2008-2#1)(2008-9#1)
potential because##2##2##(2007-5#1)(2008-5#1)
potential being##2##2##(1996-9#1)(2008-10#1)
potential beneficial effects of##5##4##(2008-10#1)(2008-5#1)(2008-7#1)(2010-8#1)(2012-1#1)
potential beneficial effects##7##3##(2006-10#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-8#1)(2012-1#1)
potential beneficial##9##2##(2006-10#2)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-8#1)(2012-1#1)(2013-1#1)
potential benefit for##3##3##(1993-3#1)(2008-3#1)(2013-1#1)
potential benefit from##2##3##(2008-7#1)(2009-4#1)
potential benefit in##4##3##(2005-8#1)(2006-2#1)(2008-1#1)(2008-5#1)
potential benefit of this##3##4##(2007-8#1)(2008-6#1)(2009-11#1)
potential benefit of##13##3##(2006-10#2)(2007-4#1)(2007-8#1)(2008-10#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-8#1)
potential benefit to##3##3##(2008-5#2)(2008-7#1)
potential benefit##28##2##(1993-3#1)(1994-3#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-9#1)(2007-10#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-8#1)(2013-1#1)
potential benefits and harms##2##4##(2006-2#1)(2010-11#1)
potential benefits and limitations of##2##5##(1996-11#1)(2008-7#1)
potential benefits and limitations##3##4##(1996-11#1)(2008-7#1)(2013-1#1)
potential benefits and risks##5##4##(1992-3#1)(1996-2#1)(1997-8#1)(2008-10#1)(2010-4#1)
potential benefits and##12##3##(1992-3#1)(1996-11#1)(1996-2#1)(1997-8#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-11#1)(2010-4#1)(2012-12#1)(2013-1#1)
potential benefits for##5##3##(2006-12#1)(2007-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
potential benefits in##2##3##(1995-12#1)(2010-12#1)
potential benefits of##25##3##(1994-3#1)(1995-12#1)(2005-8#1)(2006-11#1)(2006-4#1)(2006-9#2)(2007-10#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-5#1)(2010-1#1)(2010-12#1)(2012-1#1)(2013-1#2)(2013-7#2)
potential benefits on##2##3##(2005-8#1)(2011-2#1)
potential benefits to##2##3##(2009-11#1)(2010-11#1)
potential benefits##56##2##(1992-3#1)(1994-3#1)(1995-12#2)(1996-11#1)(1996-2#1)(1997-8#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-9#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#2)(2009-4#1)(2009-5#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#4)(2013-7#2)(2013-8#1)
potential between different##3##3##(1994-12#2)(1995-11#1)
potential between##9##2##(1994-12#2)(1995-11#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-12#1)(2010-2#1)
potential bias##3##2##(2008-12#1)(2010-2#1)(2011-2#1)
potential biases##3##2##(2006-10#1)(2010-2#1)(2013-8#1)
potential binding sites for##6##4##(1992-5#1)(1993-2#1)(1994-11#1)(1995-8#1)(1996-7#1)(2008-3#1)
potential binding sites##7##3##(1992-5#1)(1993-2#1)(1994-11#1)(1995-8#1)(1996-7#1)(2006-12#1)(2008-3#1)
potential binding##11##2##(1992-5#2)(1992-8#1)(1993-2#1)(1994-11#1)(1995-8#1)(1996-7#1)(1997-7#1)(2006-12#1)(2008-3#2)
potential bioavailability##3##2##(2007-11#1)(2008-10#1)(2008-11#1)
potential biocontrol agents##2##3##(2008-10#2)
potential biocontrol##3##2##(2008-10#2)(2010-3#1)
potential biological activity##3##3##(2007-11#2)(2008-10#1)
potential biological##11##2##(1991-10#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-4#1)(2009-5#1)(2010-10#1)(2012-3#1)(2013-8#1)
potential biologically##2##2##(2007-10#1)(2008-10#1)
potential biomarker for##3##3##(2007-10#1)(2008-10#2)
potential biomarker##4##2##(2007-10#1)(2008-10#2)(2011-2#1)
potential biomarkers for##3##3##(2010-12#1)(2010-6#1)(2011-2#1)
potential biomarkers##8##2##(2010-12#1)(2010-5#2)(2010-6#1)(2011-2#2)(2013-1#2)
potential biotechnological##2##2##(2011-1#2)
potential bleeding##2##2##(2011-2#1)(2013-1#1)
potential blockers##2##2##(2008-3#2)
potential blood##2##2##(1991-1#1)(2006-4#1)
potential breeding##2##2##(2008-1#1)(2012-2#1)
potential buffer from 10(-3) to 10(-5) M##2##7##(2008-10#2)
potential buffer solution containing##2##4##(2008-10#2)
potential buffer solution##5##3##(2008-10#5)
potential buffer##12##2##(2008-10#12)
potential but there##2##3##(1990-5#1)(2006-10#1)
potential but##4##2##(1990-5#1)(1995-11#1)(2005-11#1)(2006-10#1)
potential by##16##2##(1991-11#1)(1991-4#1)(1992-1#1)(1992-11#1)(1992-4#1)(1994-9#1)(1996-9#1)(1997-7#1)(2006-8#1)(2008-10#2)(2008-9#2)(2009-11#1)(2012-2#1)(2013-1#1)
potential calculations##2##2##(1992-3#1)(2010-12#1)
potential can be##2##3##(1990-12#1)(2013-8#1)
potential cancer##3##2##(1994-12#1)(2009-12#1)(2012-12#1)
potential candidate for##6##3##(1991-4#1)(1994-6#1)(1996-9#1)(2008-2#1)(2008-5#1)(2012-2#1)
potential candidate genes##2##3##(1994-12#1)(2009-4#1)
potential candidate##12##2##(1991-4#1)(1994-12#1)(1994-6#1)(1996-9#1)(1997-5#1)(2006-12#1)(2008-2#1)(2008-5#1)(2009-4#1)(2012-12#2)(2012-2#1)
potential candidates as##3##3##(2008-1#1)(2008-10#1)(2011-1#1)
potential candidates for##12##3##(1997-4#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-5#1)(2008-10#1)(2009-10#2)(2009-4#1)(2010-12#1)(2010-8#1)(2012-3#1)
potential candidates##19##2##(1993-2#1)(1994-1#2)(1997-4#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-5#1)(2008-1#2)(2008-10#2)(2009-10#2)(2009-4#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-3#1)
potential carcinogenicity##3##2##(1994-6#1)(1997-3#1)(2008-10#1)
potential catastrophic##2##2##(2006-10#1)(2008-9#1)
potential causal##2##2##(2012-12#1)(2012-3#1)
potential causative##2##2##(2006-10#2)
potential cause of##8##3##(1995-1#1)(1997-6#1)(2005-8#1)(2006-8#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-7#1)
potential cause##9##2##(1995-1#1)(1997-6#1)(2005-8#1)(2006-8#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-3#1)(2013-7#1)
potential causes of##10##3##(2004-12#1)(2006-10#1)(2008-10#1)(2008-7#2)(2008-9#1)(2010-12#1)(2011-1#1)(2013-1#2)
potential causes##11##2##(2004-12#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-12#1)(2011-1#1)(2013-1#2)
potential cellular##3##2##(2008-10#1)(2008-7#1)(2009-5#1)
potential challenges##4##2##(1996-1#1)(1997-3#1)(2007-12#1)(2009-9#1)
potential change (electro-olfactogram##2##3##(2008-5#1)(2008-6#1)
potential change of the##2##4##(2008-10#2)
potential change was##2##3##(1991-9#1)(2008-10#1)
potential change##15##2##(1991-9#1)(2008-10#12)(2008-5#1)(2008-6#1)
potential changes (OSC)##2##3##(2008-5#1)(2008-6#1)
potential changes in##6##3##(1990-7#1)(1993-3#1)(2006-10#1)(2007-4#1)(2010-6#1)(2013-7#1)
potential changes##13##2##(1990-12#1)(1990-7#1)(1993-3#1)(2005-11#1)(2006-10#1)(2007-4#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-6#1)(2013-7#1)
potential chemical##2##2##(1994-5#1)(2012-2#1)
potential chemotherapeutic##3##2##(1990-7#1)(2007-6#1)(2013-1#1)
potential clinical application of##2##4##(2010-12#1)(2012-11#1)
potential clinical application##4##3##(1993-5#1)(2010-12#1)(2011-2#1)(2012-11#1)
potential clinical applications of##4##4##(1997-4#1)(2008-1#1)(2008-7#1)(2011-1#1)
potential clinical applications##8##3##(1994-11#1)(1997-4#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-7#1)
potential clinical efficacy##2##3##(2006-8#1)(2008-7#1)
potential clinical implications##2##3##(1991-6#1)(2010-4#1)
potential clinical importance##4##3##(1994-3#1)(2006-10#1)(2012-3#1)(2013-7#1)
potential clinical role##2##3##(2007-10#1)(2012-2#1)
potential clinical significance##3##3##(1992-11#1)(2008-7#1)(2008-8#1)
potential clinical use##4##3##(2007-11#1)(2008-1#1)(2008-11#1)(2010-8#1)
potential clinical utility##4##3##(1996-10#1)(2004-12#1)(2007-12#1)(2008-6#1)
potential clinical##43##2##(1991-12#1)(1991-6#1)(1992-11#1)(1993-5#1)(1994-11#1)(1994-3#1)(1995-12#1)(1996-10#1)(1997-4#1)(2004-12#1)(2006-10#3)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#4)(2008-8#2)(2009-4#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
potential coding##2##2##(2008-2#1)(2011-2#1)
potential compared to##3##3##(1995-1#1)(2008-1#1)(2008-5#1)
potential compared##4##2##(1995-1#1)(2008-1#1)(2008-5#2)
potential complication of##5##3##(1993-10#1)(2006-10#3)(2007-9#1)
potential complication##7##2##(1993-10#1)(2006-10#4)(2007-9#1)(2012-12#1)
potential complications and##2##3##(2006-11#1)(2010-2#1)
potential complications associated with##3##4##(2006-2#1)(2007-3#1)(2012-12#1)
potential complications in##2##3##(2008-8#1)(2011-1#1)
potential complications of##5##3##(2004-2#1)(2006-10#2)(2010-12#1)(2012-12#1)
potential complications##28##2##(1991-10#1)(1994-5#1)(2004-2#2)(2005-10#1)(2006-10#3)(2006-11#2)(2006-2#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-4#1)(2008-8#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-12#3)(2013-8#2)
potential conditions##4##2##(2005-11#1)(2008-10#3)
potential conflict of interest##2##4##(2011-1#2)
potential conflict##6##2##(1991-2#1)(2005-5#1)(2006-10#1)(2008-5#1)(2011-1#2)
potential confounders##8##2##(2008-3#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#3)
potential confounding factors##9##3##(2007-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-1#3)(2010-11#1)(2013-1#1)
potential confounding##14##2##(1991-2#1)(2005-10#1)(2007-10#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-6#1)(2010-1#3)(2010-11#1)(2010-8#1)(2013-1#1)
potential confounds##2##2##(2008-5#1)(2009-9#1)
potential consequences of##6##3##(2005-11#1)(2006-10#1)(2009-8#1)(2010-8#1)(2012-12#1)(2012-2#1)
potential consequences on##2##3##(1990-7#1)(2013-1#1)
potential consequences##11##2##(1990-7#1)(2005-11#2)(2006-10#2)(2009-8#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
potential contaminants##2##2##(2008-5#1)(2008-9#1)
potential contamination of##2##3##(2005-8#1)(2006-10#1)
potential contamination##4##2##(2005-8#1)(2006-10#1)(2008-11#1)(2012-2#1)
potential contribution##6##2##(2005-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2012-12#1)
potential contributions of##3##3##(2008-12#1)(2008-5#1)(2009-11#1)
potential contributions to##3##3##(1990-12#1)(1993-6#1)(2012-12#1)
potential contributions##7##2##(1990-12#1)(1993-6#1)(2008-12#1)(2008-5#1)(2009-11#1)(2012-12#1)(2012-2#1)
potential contributors to##2##3##(1993-12#1)(2008-12#1)
potential control of##2##3##(2007-8#1)(2008-10#1)
potential control##4##2##(2007-8#1)(2008-10#2)(2012-12#1)
potential correlates of##2##3##(1995-5#1)(2009-12#1)
potential cosmetic odourants##2##3##(2008-5#2)
potential cosmetic##3##2##(2008-5#3)
potential curative##2##2##(1993-11#1)(1997-8#1)
potential curves##3##2##(2005-4#1)(2008-10#2)
potential customers##2##2##(1994-2#1)(1994-3#1)
potential cycling in##3##3##(2008-10#2)(2010-11#1)
potential cytostatic drug##2##3##(1996-5#2)
potential cytotoxic activity##2##3##(1996-8#1)(2008-11#1)
potential damage to##4##3##(1996-7#1)(2008-2#1)(2008-9#1)(2013-1#1)
potential danger##5##2##(1990-10#1)(2006-10#2)(2008-8#1)(2011-2#1)
potential data##3##2##(2007-9#1)(2013-1#2)
potential deleterious effects##2##3##(2008-10#1)(2008-11#1)
potential delivery##2##2##(1994-3#1)(2005-9#1)
potential dependence##3##2##(1990-3#1)(2007-12#1)(2010-11#1)
potential dermal##2##2##(2008-10#1)(2008-5#1)
potential detrimental effects of##3##4##(2010-1#1)(2011-2#1)(2012-1#1)
potential detrimental effects##4##3##(2006-10#1)(2010-1#1)(2011-2#1)(2012-1#1)
potential detrimental##5##2##(1995-5#1)(2006-10#1)(2010-1#1)(2011-2#1)(2012-1#1)
potential development of##3##3##(2005-7#1)(2005-8#1)(2006-10#1)
potential developments in##2##3##(2012-12#1)(2013-8#1)
potential diagnostic and prognostic##2##4##(2007-7#1)(2012-12#1)
potential diagnostic markers##2##3##(1993-11#1)(2013-8#1)
potential diagnostic##11##2##(1991-10#1)(1992-11#1)(1993-11#1)(2007-7#1)(2008-10#1)(2008-4#2)(2009-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
potential difference (PD) and##2##4##(2008-12#1)(2008-5#1)
potential difference (PD)##3##3##(1996-2#1)(2008-12#1)(2008-5#1)
potential difference between the two electrodes##2##6##(2008-10#2)
potential difference between the##3##4##(1997-1#1)(2008-10#2)
potential difference of##2##3##(1991-2#1)(2008-10#1)
potential difference##17##2##(1991-2#2)(1993-8#1)(1994-11#1)(1996-2#1)(1997-1#2)(2008-10#5)(2008-12#2)(2008-5#1)(2008-6#1)(2008-8#1)
potential differences in##3##3##(1995-3#1)(2006-10#1)(2008-11#1)
potential differences##7##2##(1994-12#1)(1995-3#1)(1996-1#1)(2006-10#1)(2008-11#1)(2008-5#1)(2011-1#1)
potential difficulties##5##2##(2006-4#1)(2008-8#1)(2010-12#1)(2013-1#2)
potential direct effects of##2##4##(2008-7#1)(2013-1#1)
potential directions##2##2##(2010-12#1)(2012-1#1)
potential disadvantage##2##2##(1997-2#1)(2006-2#1)
potential disease##4##2##(2008-10#2)(2008-12#1)(2009-12#1)
potential distinct##2##2##(2008-5#1)(2008-6#1)
potential distribution##12##2##(1996-6#1)(2005-11#7)(2006-2#2)(2008-10#1)(2008-8#1)
potential distributions##2##2##(2005-11#1)(2008-11#1)
potential donor##3##2##(2011-2#2)(2013-1#1)
potential donors##3##2##(1990-11#1)(2008-12#1)(2011-2#1)
potential drawback##2##2##(2008-3#1)(2009-2#1)
potential drawbacks##2##2##(2010-8#1)(2012-3#1)
potential driven##2##2##(1994-9#1)(2008-10#1)
potential drop##3##2##(1996-1#2)(2006-12#1)
potential drug candidates##2##3##(2008-3#1)(2009-4#1)
potential drug interactions##3##3##(1991-12#1)(1994-5#1)(2006-3#1)
potential drug target##5##3##(1991-12#1)(2006-10#1)(2012-2#2)(2013-8#1)
potential drug targets##4##3##(2008-4#1)(2010-3#1)(2012-2#1)(2013-8#1)
potential drug##21##2##(1991-12#2)(1991-2#1)(1994-5#1)(2005-10#1)(2006-10#1)(2006-3#1)(2008-11#1)(2008-3#1)(2008-4#2)(2009-4#1)(2010-11#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#3)(2013-8#2)
potential drugs in##2##3##(2007-2#1)(2008-3#1)
potential drugs##6##2##(1994-8#1)(2005-8#1)(2007-2#1)(2008-10#1)(2008-3#1)(2012-2#1)
potential due to##4##3##(2005-11#1)(2008-10#2)(2008-5#1)
potential during##5##2##(1991-4#1)(1992-5#1)(1993-12#1)(1993-8#1)(2008-10#1)
potential economic##3##2##(1996-1#1)(2006-10#1)(2011-2#1)
potential effect of##8##3##(1996-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#1)
potential effect on##4##3##(2007-7#1)(2008-10#1)(2009-10#1)(2011-2#1)
potential effect##13##2##(1996-1#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
potential effectiveness of##5##3##(2008-11#1)(2010-12#2)(2010-8#1)(2012-1#1)
potential effectiveness##6##2##(1992-12#1)(2008-11#1)(2010-12#2)(2010-8#1)(2012-1#1)
potential effectors##2##2##(1995-3#1)(1996-2#1)
potential effects of the##2##4##(2008-10#1)(2008-11#1)
potential effects of##17##3##(1991-5#1)(1995-5#1)(2006-10#2)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2010-12#1)(2010-8#2)(2011-12#1)(2013-1#2)(2013-8#1)
potential effects on the##2##4##(1991-12#1)(1997-5#1)
potential effects on##8##3##(1991-12#1)(1991-9#1)(1997-5#1)(2007-10#1)(2008-10#1)(2008-3#2)(2009-3#1)
potential effects##29##2##(1991-12#1)(1991-5#1)(1991-9#1)(1995-5#1)(1997-5#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-8#2)(2011-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
potential efficacy and##3##3##(2008-7#1)(2013-1#1)(2013-8#1)
potential efficacy of##6##3##(2007-4#1)(2008-11#1)(2010-5#1)(2012-3#1)(2013-7#1)(2013-8#1)
potential efficacy##13##2##(1995-3#1)(2005-7#1)(2007-4#1)(2008-11#1)(2008-7#1)(2010-5#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
potential endogeneity##2##2##(2006-5#1)(2007-7#1)
potential energy barrier##2##3##(1995-10#1)(2008-10#1)
potential energy function##2##3##(1995-3#1)(2006-10#1)
potential energy of##2##3##(1991-11#1)(1993-4#1)
potential energy surface##4##3##(2006-3#2)(2008-8#1)(2011-1#1)
potential energy surfaces##3##3##(2011-2#1)(2012-12#2)
potential energy##25##2##(1991-11#1)(1991-9#2)(1993-3#1)(1993-4#1)(1995-1#1)(1995-10#1)(1995-3#1)(2006-10#2)(2006-3#2)(2006-8#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-4#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)
potential environmental impact##2##3##(1994-11#1)(2012-12#1)
potential environmental##3##2##(1994-11#1)(2010-10#1)(2012-12#1)
potential estimated##2##2##(1991-7#1)(2005-11#1)
potential estrogenic##2##2##(2008-10#2)
potential ethical and practical##2##4##(2010-3#2)
potential ethical##3##2##(2010-3#2)(2013-8#1)
potential evolutionary##3##2##(1991-11#1)(1995-8#1)(2008-8#1)
potential exists for##2##3##(1995-5#1)(2008-5#1)
potential exists##3##2##(1991-9#1)(1995-5#1)(2008-5#1)
potential explanation for##4##3##(1991-10#1)(2008-5#1)(2008-7#1)(2012-3#1)
potential explanations for the##2##4##(2006-11#1)(2008-8#1)
potential explanations for##4##3##(2006-11#1)(2008-1#1)(2008-8#1)(2012-12#1)
potential explanations##5##2##(2006-11#1)(2008-1#1)(2008-8#1)(2009-6#1)(2012-12#1)
potential exposure to##5##3##(1990-8#1)(1997-4#1)(2007-12#1)(2007-4#1)(2012-12#1)
potential exposure##7##2##(1990-8#1)(1997-4#1)(2007-12#1)(2007-2#1)(2007-4#1)(2012-12#1)(2012-3#1)
potential extension##2##2##(2007-7#1)(2009-4#1)
potential extensions##2##2##(2008-2#1)(2011-1#1)
potential factors##6##2##(2006-10#1)(2006-9#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)
potential flow##3##2##(2008-11#1)(2008-5#2)
potential for a new##2##4##(2006-7#1)(2007-11#1)
potential for a##16##3##(1991-6#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-8#1)(2009-8#1)(2010-10#1)(2010-2#2)(2010-8#1)(2012-1#1)(2013-1#2)
potential for abuse##2##3##(1996-4#1)(1996-7#1)
potential for adaptation##2##3##(1990-2#1)(2010-3#1)
potential for adverse##3##3##(1996-1#1)(2007-9#1)(2008-5#1)
potential for an##3##3##(1996-12#1)(2007-7#1)(2013-1#1)
potential for application in the##2##5##(2008-10#1)(2008-2#1)
potential for application##3##3##(1994-11#1)(2008-10#1)(2008-2#1)
potential for both##3##3##(1993-8#1)(2012-11#2)
potential for causing##3##3##(2006-5#1)(2007-1#1)(2008-11#1)
potential for cell therapy##2##4##(2009-4#1)(2012-12#1)
potential for chemical##2##3##(2008-4#1)(2013-1#1)
potential for clinical application##2##4##(1996-9#1)(2010-11#1)
potential for clinical##6##3##(1995-12#1)(1996-9#1)(2005-11#1)(2007-11#1)(2008-5#1)(2010-11#1)
potential for damage##2##3##(2006-12#1)(2008-10#1)
potential for data##3##3##(2011-2#1)(2013-1#2)
potential for decreasing in##4##4##(2008-10#4)
potential for decreasing##5##3##(2008-10#4)(2013-1#1)
potential for developing##2##3##(2007-8#1)(2008-6#1)
potential for development of##2##4##(2008-10#1)(2010-3#1)
potential for development##4##3##(2005-7#1)(2008-10#1)(2010-3#1)(2013-1#1)
potential for distant##2##3##(1997-7#1)(2008-5#1)
potential for drug-drug interactions##3##4##(2008-12#1)(2008-3#2)
potential for enhanced##2##3##(1990-10#1)(2004-9#1)
potential for enhancing the##2##4##(2007-12#1)(2013-1#1)
potential for enhancing##3##3##(2007-12#1)(2009-1#1)(2013-1#1)
potential for expanded##2##3##(1995-1#1)(2006-10#1)
potential for further development##2##4##(2008-10#1)(2011-2#1)
potential for further##5##3##(2006-12#1)(2007-12#1)(2008-10#1)(2009-8#1)(2011-2#1)
potential for future##7##3##(1992-9#2)(2005-8#1)(2006-10#1)(2007-11#1)(2008-8#1)(2011-2#1)
potential for high##2##3##(2008-11#1)(2010-2#1)
potential for human exposure##2##4##(2007-8#1)(2008-9#1)
potential for human##4##3##(1996-4#1)(2007-11#1)(2007-8#1)(2008-9#1)
potential for improved##8##3##(1994-3#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#2)(2009-10#1)
potential for improvement##3##3##(2006-10#2)(2008-12#1)
potential for improving access##3##4##(1995-1#1)(2013-1#2)
potential for improving the##3##4##(2006-2#1)(2008-3#1)(2012-1#1)
potential for improving##10##3##(1993-12#1)(1995-1#1)(2006-2#1)(2008-10#1)(2008-3#1)(2008-6#1)(2012-1#1)(2012-2#1)(2013-1#2)
potential for integration##2##3##(2006-5#1)(2008-3#1)
potential for malignancy##2##3##(2007-11#1)(2012-11#1)
potential for monitoring##2##3##(2007-7#1)(2010-6#1)
potential for myocardial regeneration##2##4##(2010-10#1)(2010-6#1)
potential for other##3##3##(2008-11#1)(2008-7#1)(2010-12#1)
potential for outcrossing in##2##4##(2008-10#2)
potential for outcrossing##4##3##(2008-10#4)
potential for pharmacological##2##3##(1993-5#1)(2009-12#1)
potential for preventing##2##3##(2008-11#1)(2008-5#1)
potential for prevention##2##3##(1991-5#1)(2006-10#1)
potential for producing##4##3##(1990-8#1)(2004-11#1)(2006-8#1)(2011-1#1)
potential for recovery##2##3##(2008-7#2)
potential for regeneration##2##3##(2008-11#1)(2013-1#1)
potential for sensing applications##2##4##(2008-2#2)
potential for serious##5##3##(2005-8#1)(2006-7#1)(2007-7#1)(2008-3#1)(2011-2#1)
potential for significant##2##3##(1996-7#1)(2011-2#1)
potential for studying##2##3##(2008-8#1)(2010-11#1)
potential for success##2##3##(1993-6#1)(2006-12#1)
potential for successful##2##3##(2007-1#1)(2008-10#1)
potential for systemic adverse##2##4##(2007-11#2)
potential for systemic##3##3##(2007-11#3)
potential for targeting the##2##4##(2005-7#1)(2008-6#1)
potential for the development of novel##2##6##(2008-8#1)(2012-12#1)
potential for the development of##6##5##(1996-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-12#1)(2013-8#1)
potential for the study of the##2##6##(2008-3#1)(2009-10#1)
potential for the treatment of cancer##2##6##(2006-11#1)(2008-5#1)
potential for the treatment of rheumatoid arthritis##2##7##(2008-3#1)(2008-5#1)
potential for the treatment of##8##5##(2005-8#2)(2006-11#1)(2008-3#1)(2008-5#3)(2008-7#1)
potential for the use of##2##5##(1992-1#1)(1997-4#1)
potential for the##49##3##(1991-1#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-7#1)(1993-7#1)(1995-3#1)(1996-6#1)(1996-7#1)(1997-4#2)(1997-6#1)(1997-8#1)(2005-11#2)(2005-8#3)(2006-10#1)(2006-11#2)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#5)(2008-7#1)(2008-8#2)(2009-10#1)(2010-4#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
potential for therapeutic##3##3##(1991-12#1)(2008-5#1)(2009-10#1)
potential for these##2##3##(1996-12#1)(2007-10#1)
potential for this##3##3##(2008-10#1)(2008-2#1)(2011-1#1)
potential for treating##4##3##(1993-2#1)(2008-11#1)(2009-3#1)(2012-12#1)
potential for treatment of##2##4##(1991-12#1)(2007-11#1)
potential for use as an##2##5##(2008-11#1)(2008-5#1)
potential for use as##4##4##(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)
potential for use in##5##4##(1996-8#1)(2006-5#1)(2008-10#2)(2013-7#1)
potential for use of##2##4##(2006-5#1)(2008-5#1)
potential for use##13##3##(1996-8#1)(2004-4#1)(2006-5#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-2#1)(2013-7#1)
potential for using##6##3##(2005-11#1)(2008-11#2)(2009-12#1)(2009-3#1)(2011-1#1)
potential for##575##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-8#1)(1991-1#2)(1991-12#4)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#3)(1993-10#2)(1993-12#1)(1993-2#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#2)(1994-11#2)(1994-2#3)(1994-3#1)(1994-6#3)(1994-8#1)(1995-1#3)(1995-10#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-1#2)(1996-12#3)(1996-2#3)(1996-3#1)(1996-4#2)(1996-6#1)(1996-7#3)(1996-8#2)(1996-9#1)(1997-1#1)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#2)(2004-11#2)(2004-4#2)(2004-9#1)(2005-10#1)(2005-11#4)(2005-6#1)(2005-7#9)(2005-8#7)(2006-10#16)(2006-11#6)(2006-12#7)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#4)(2006-6#1)(2006-7#3)(2006-8#1)(2007-1#4)(2007-10#3)(2007-11#19)(2007-12#11)(2007-2#2)(2007-4#3)(2007-5#3)(2007-6#1)(2007-7#4)(2007-8#5)(2007-9#4)(2008-1#7)(2008-10#44)(2008-11#20)(2008-12#5)(2008-2#10)(2008-3#20)(2008-4#10)(2008-5#32)(2008-6#7)(2008-7#10)(2008-8#13)(2008-9#11)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#6)(2009-2#5)(2009-3#5)(2009-4#2)(2009-5#2)(2009-8#3)(2009-9#1)(2010-1#3)(2010-10#3)(2010-11#2)(2010-12#4)(2010-2#6)(2010-3#2)(2010-4#4)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#9)(2011-2#18)(2012-1#4)(2012-11#6)(2012-12#12)(2012-2#11)(2012-3#6)(2013-1#22)(2013-7#5)(2013-8#5)
potential from the##2##3##(1992-9#1)(2008-10#1)
potential from##10##2##(1992-9#1)(1997-8#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#1)
potential function of##3##3##(1991-4#1)(1992-9#1)(1997-7#1)
potential function##9##2##(1991-4#1)(1992-9#1)(1997-7#1)(2006-10#1)(2008-11#1)(2008-4#2)(2011-2#1)(2012-3#1)
potential functional##6##2##(1990-10#1)(1995-6#1)(2008-11#1)(2008-4#1)(2010-4#1)(2011-2#1)
potential functions of##5##3##(2005-7#1)(2006-12#1)(2008-11#1)(2008-7#1)(2009-8#1)
potential functions##7##2##(2005-7#1)(2006-12#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-8#1)(2013-7#1)
potential future applications##4##3##(2006-12#1)(2010-12#1)(2012-12#1)(2013-8#1)
potential future##13##2##(1997-8#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-11#1)(2009-4#2)(2010-12#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
potential gains and##2##3##(2011-7#1)(2013-1#1)
potential gains##3##2##(2010-8#1)(2011-7#1)(2013-1#1)
potential generation##3##2##(1996-9#1)(2006-8#1)(2008-10#1)
potential genes##3##2##(1997-6#1)(1997-8#1)(2006-10#1)
potential genetic biomarkers##2##3##(2011-2#2)
potential genetic##7##2##(1997-5#1)(2008-7#1)(2011-2#3)(2012-11#1)(2013-1#1)
potential glycosylation sites at##2##4##(1992-12#1)(2013-8#1)
potential glycosylation sites##6##3##(1990-5#1)(1991-2#1)(1992-12#2)(1994-9#1)(2013-8#1)
potential gradients##2##2##(1995-3#1)(1997-7#1)
potential habitats of Oncomelania hupensis##2##5##(2008-8#2)
potential had no##2##3##(1997-5#1)(2008-10#1)
potential had##3##2##(1991-11#1)(1997-5#1)(2008-10#1)
potential harm of##3##3##(2007-4#2)(2008-1#1)
potential harm##4##2##(2007-4#2)(2008-1#1)(2008-3#1)
potential harmful##2##2##(1991-4#1)(2008-10#1)
potential has been##4##3##(1994-12#1)(2005-11#1)(2008-10#1)(2010-12#1)
potential has not##2##3##(1995-6#1)(2008-3#1)
potential has##13##2##(1994-12#1)(1995-6#1)(2005-11#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2009-2#1)(2010-12#1)(2012-12#1)
potential have been##2##3##(2008-11#1)(2010-11#1)
potential have##6##2##(1994-2#1)(2006-10#1)(2006-5#1)(2008-11#1)(2008-9#1)(2010-11#1)
potential hazard of##2##3##(2007-10#1)(2007-7#1)
potential hazard to##2##3##(2007-5#1)(2008-5#1)
potential hazard##7##2##(1994-11#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-5#1)
potential hazards of##4##3##(1993-2#1)(2008-10#1)(2008-9#1)(2013-1#1)
potential hazards##11##2##(1993-2#1)(2005-8#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2010-7#1)(2012-1#1)(2013-1#1)
potential health benefits##2##3##(2007-11#1)(2011-1#1)
potential health effects##4##3##(2007-8#1)(2008-9#2)(2011-1#1)
potential health hazards##2##3##(1994-6#1)(2010-4#1)
potential health threat##2##3##(2008-10#1)(2012-12#1)
potential health##17##2##(1994-6#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#2)(2010-4#1)(2011-1#3)(2012-12#1)
potential high##2##2##(2010-10#1)(2012-12#1)
potential host##2##2##(2008-10#1)(2008-9#1)
potential human and##2##3##(2008-5#1)(2012-11#1)
potential human##5##2##(1997-2#1)(2008-10#1)(2008-5#1)(2012-11#1)(2012-3#1)
potential if##2##2##(2007-7#1)(2009-4#1)
potential imaging agents for##2##4##(1993-4#2)
potential imaging##5##2##(1993-4#2)(1993-5#1)(1994-1#1)(2010-4#1)
potential immunomodulatory##3##2##(2006-10#1)(2008-10#2)
potential immunosuppressive action of##2##4##(2008-8#2)
potential immunotoxicity of chemicals##2##4##(2008-10#2)
potential immunotoxicity##4##2##(2008-10#4)
potential impact of these##2##4##(2008-10#1)(2008-7#1)
potential impact of##25##3##(1994-6#1)(1995-12#1)(1997-2#1)(2006-9#1)(2007-12#2)(2007-2#1)(2007-4#2)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-3#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-7#1)(2013-8#3)
potential impact on##21##3##(1990-12#1)(1993-2#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-11#1)(2009-3#1)(2009-5#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)
potential impact##53##2##(1990-12#1)(1992-3#1)(1993-2#1)(1994-6#1)(1995-12#1)(1997-2#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-12#3)(2007-2#2)(2007-4#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-7#3)(2008-8#2)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#3)
potential impacts of##3##3##(2006-6#1)(2007-4#1)(2011-2#1)
potential impacts##5##2##(2006-6#1)(2007-4#2)(2011-2#1)(2013-8#1)
potential implication of##2##3##(2008-6#1)(2012-12#1)
potential implications for##9##3##(1994-12#1)(1996-2#1)(2005-11#1)(2005-7#1)(2007-10#1)(2008-10#1)(2008-3#1)(2009-4#1)(2010-6#1)
potential implications of##4##3##(2009-5#1)(2010-12#1)(2012-12#1)(2013-1#1)
potential implications##15##2##(1994-12#1)(1996-2#1)(2005-11#1)(2005-7#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-4#1)(2009-5#2)(2010-12#1)(2010-6#1)(2012-12#1)(2013-1#1)
potential importance for##2##3##(2007-11#1)(2008-5#1)
potential importance in##2##3##(2004-11#1)(2010-7#1)
potential importance of##14##3##(1990-2#1)(1991-5#1)(1993-4#1)(1995-11#1)(1995-3#1)(2006-10#2)(2006-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-10#1)(2010-1#1)(2010-2#1)
potential importance##21##2##(1990-2#1)(1991-5#1)(1993-4#1)(1995-11#1)(1995-3#1)(1996-5#1)(1997-8#1)(2004-11#1)(2006-10#2)(2006-11#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-10#1)(2010-1#1)(2010-2#1)(2010-7#1)
potential improvement of##2##3##(2007-9#1)(2012-2#1)
potential improvement##3##2##(1997-1#1)(2007-9#1)(2012-2#1)
potential improvements in##3##3##(2009-4#1)(2011-2#2)
potential improvements##4##2##(2009-4#1)(2010-11#1)(2011-2#2)
potential in a##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
potential in both##2##3##(2005-8#1)(2008-12#1)
potential in comparison to##2##4##(2008-10#2)
potential in developing##2##3##(2008-1#1)(2008-10#1)
potential in human##2##3##(1993-12#1)(2012-12#1)
potential in in##2##3##(1995-5#1)(2010-12#1)
potential in intact##2##3##(1993-11#1)(2008-11#1)
potential in patients with##2##4##(2010-4#1)(2011-1#1)
potential in rat##2##3##(1992-3#1)(1996-5#1)
potential in rats##2##3##(1995-12#1)(1996-1#1)
potential in response to##2##4##(1996-8#1)(2008-10#1)
potential in some human##2##4##(1993-12#1)(1993-9#1)
potential in the course of##2##5##(2007-1#1)(2008-10#1)
potential in the treatment of##8##5##(2005-8#1)(2005-9#1)(2007-11#1)(2008-3#1)(2008-7#1)(2009-4#1)(2009-8#1)(2011-1#1)
potential in the##31##3##(1990-3#1)(1991-11#1)(1995-8#1)(1997-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2011-1#1)(2012-3#1)
potential in tissue##2##3##(2009-4#1)(2009-7#1)
potential in vitro##2##3##(1990-12#1)(2012-3#1)
potential in vivo##2##3##(2012-11#1)(2012-12#1)
potential in##124##2##(1990-12#1)(1990-3#1)(1991-11#1)(1992-10#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-12#2)(1993-9#1)(1994-10#1)(1994-5#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-7#1)(2005-8#3)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#3)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#3)(2008-10#17)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#3)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#1)(2011-1#3)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
potential increases##2##2##(1997-4#1)(2008-10#1)
potential indications##5##2##(1995-4#2)(2006-11#1)(2006-9#1)(2010-12#1)
potential indicator##5##2##(1993-3#1)(2004-4#1)(2008-10#1)(2008-11#1)(2011-1#1)
potential indicators of##3##3##(2005-10#1)(2008-10#1)(2012-3#1)
potential indicators##6##2##(2005-10#1)(2007-10#1)(2008-1#1)(2008-10#1)(2010-4#1)(2012-3#1)
potential industrial##2##2##(2008-11#1)(2013-1#1)
potential infection##3##2##(2008-11#1)(2008-8#1)(2011-2#1)
potential infections##2##2##(2006-7#1)(2012-12#1)
potential influence of the##3##4##(2009-9#1)(2011-1#1)(2012-12#1)
potential influence of##9##3##(1997-8#1)(2005-11#1)(2007-12#1)(2009-9#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
potential information##2##2##(2008-6#1)(2010-11#1)
potential inhibitors of##5##3##(1994-9#1)(2008-11#1)(2008-4#1)(2008-6#1)(2011-2#1)
potential inhibitors##7##2##(1994-9#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2011-2#1)
potential inhibitory##5##2##(1992-12#1)(2008-10#1)(2009-12#1)(2011-3#1)(2012-3#1)
potential initiation##3##2##(1993-12#1)(1994-2#1)(1997-6#1)
potential injury##2##2##(2006-11#2)
potential inoculum sources##2##3##(2008-10#2)
potential inoculum##4##2##(2008-10#4)
potential interaction between##2##3##(1995-11#1)(1997-7#1)
potential interaction##5##2##(1990-6#1)(1995-11#1)(1995-6#1)(1997-7#1)(2009-9#1)
potential interactions between##5##3##(1991-4#1)(1995-3#1)(1995-8#1)(1997-2#1)(2006-10#1)
potential interactions of the##2##4##(1996-8#1)(2007-2#1)
potential interactions with##2##3##(2006-10#1)(2008-8#1)
potential interactions##10##2##(1991-4#1)(1995-3#1)(1995-8#1)(1996-8#1)(1997-2#1)(2006-10#2)(2006-2#1)(2007-2#1)(2008-8#1)
potential interest in##2##3##(2008-5#1)(2010-12#1)
potential interest##6##2##(1996-8#1)(2008-3#1)(2008-5#2)(2010-12#1)(2011-2#1)
potential interference##6##2##(2007-8#1)(2008-10#5)
potential interferences were##2##3##(2008-10#1)(2010-5#1)
potential interferences##7##2##(2008-10#6)(2010-5#1)
potential interferents##4##2##(2008-10#4)
potential interfering species##2##3##(2008-10#2)
potential interfering##8##2##(1992-6#1)(2008-10#7)
potential internal##2##2##(1990-8#1)(1994-8#1)
potential into##2##2##(2007-12#1)(2008-11#1)
potential intracellular##3##2##(1990-9#1)(1991-12#1)(1994-6#1)
potential intraoperative##2##2##(2010-2#1)(2011-2#1)
potential involvement of##8##3##(1992-6#1)(1994-11#1)(1995-12#1)(1996-11#1)(1996-5#1)(2008-10#1)(2010-3#1)(2011-1#1)
potential involvement##9##2##(1992-6#1)(1994-11#1)(1995-12#1)(1996-11#1)(1996-5#1)(2008-10#1)(2010-3#1)(2011-1#1)(2011-2#1)
potential iron##3##2##(1994-8#1)(1996-2#1)(2007-11#1)
potential is a##3##3##(2007-8#1)(2008-11#1)(2010-10#1)
potential is the##3##3##(2007-11#1)(2007-12#1)(2012-2#1)
potential is##44##2##(1991-11#1)(1991-4#1)(1992-3#1)(1994-10#1)(2005-11#6)(2005-7#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#11)(2008-11#2)(2008-3#2)(2009-3#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-2#3)(2013-1#1)
potential issues need to be addressed to ensure that multi-site data and resultant predictive models are useful to non-contributing institutions##2##20##(2013-1#2)
potential issues##4##2##(2006-11#1)(2008-8#1)(2013-1#2)
potential it##2##2##(1996-12#1)(2008-7#1)
potential latency##4##2##(2008-7#3)(2011-2#1)
potential less##2##2##(1990-11#1)(1990-3#1)
potential liability of##3##3##(1991-12#2)(1992-1#1)
potential liability##4##2##(1991-12#2)(1992-1#1)(1993-2#1)
potential ligands for##2##3##(1990-9#1)(1996-5#1)
potential ligands##6##2##(1990-9#1)(1991-12#1)(1991-7#1)(1996-5#1)(2007-12#1)(2008-9#1)
potential limitations of the##2##4##(2008-3#1)(2009-9#1)
potential limitations of##3##3##(1996-5#1)(2008-3#1)(2009-9#1)
potential limitations##4##2##(1996-5#1)(2008-3#1)(2009-7#1)(2009-9#1)
potential limits##2##2##(2007-11#1)(2012-3#1)
potential link between##5##3##(1991-3#1)(1997-7#1)(2008-10#1)(2009-10#1)(2010-9#1)
potential link##6##2##(1991-3#1)(1997-7#1)(2008-10#1)(2009-10#1)(2009-12#1)(2010-9#1)
potential links between##2##3##(2009-7#1)(2012-3#1)
potential links##3##2##(2007-9#1)(2009-7#1)(2012-3#1)
potential long-term complications##2##3##(2013-7#2)
potential long-term##5##2##(2007-3#1)(2008-2#1)(2010-2#1)(2013-7#2)
potential major##3##2##(1994-8#1)(1995-12#1)(2010-12#1)
potential malaria mortality##2##3##(2006-4#2)
potential malaria##3##2##(2006-4#2)(2012-12#1)
potential male##3##2##(1993-9#1)(2008-9#1)(2012-2#1)
potential management##3##2##(2008-10#2)(2008-3#1)
potential mapping##3##2##(2006-9#1)(2008-7#2)
potential markers of##3##3##(2008-4#1)(2008-8#1)(2010-12#1)
potential markers##5##2##(2008-10#1)(2008-4#1)(2008-8#1)(2010-12#1)(2012-3#1)
potential market for##2##3##(2005-9#1)(2008-6#1)
potential market##4##2##(2005-9#1)(2008-10#1)(2008-5#1)(2008-6#1)
potential mates##8##2##(2008-8#8)
potential may be##4##3##(1991-11#1)(2008-10#1)(2012-3#1)(2013-1#1)
potential means##2##2##(2007-11#1)(2008-10#1)
potential measurements of##2##3##(2006-10#1)(2008-10#1)
potential measurements##6##2##(1990-3#1)(1997-1#1)(2005-11#2)(2006-10#1)(2008-10#1)
potential mechanism for##5##3##(1991-3#1)(1993-9#1)(2006-10#1)(2008-10#1)(2010-7#1)
potential mechanism of##7##3##(2007-8#1)(2008-10#3)(2011-2#2)(2012-3#1)
potential mechanism##19##2##(1990-8#1)(1991-3#1)(1993-9#1)(2006-10#1)(2007-8#1)(2008-10#4)(2009-5#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)
potential mechanisms are##3##3##(2003-11#1)(2008-4#1)(2008-7#1)
potential mechanisms by which##6##4##(1994-11#1)(2008-1#1)(2008-7#1)(2009-8#1)(2011-1#1)(2012-2#1)
potential mechanisms for the##2##4##(2006-10#1)(2008-4#1)
potential mechanisms of action of the##2##6##(2008-7#1)(2011-1#1)
potential mechanisms of##10##3##(2005-7#1)(2006-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2011-1#1)(2011-12#1)(2012-2#1)
potential mechanisms underlying##2##3##(2006-10#1)(2008-10#1)
potential mechanisms##33##2##(1994-11#1)(2003-11#1)(2005-7#2)(2005-8#1)(2006-10#4)(2006-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#3)(2008-5#2)(2008-7#3)(2009-4#1)(2009-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#1)
potential mediators of##2##3##(2009-7#1)(2012-2#1)
potential mediators##3##2##(2006-6#1)(2009-7#1)(2012-2#1)
potential medical applications##2##3##(2008-1#1)(2008-3#1)
potential medical##9##2##(1993-3#1)(2005-11#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-2#1)(2013-1#1)(2013-8#1)
potential membrane-spanning##2##2##(1994-9#1)(1996-7#1)
potential method (MPM)##4##3##(2008-10#4)
potential method##10##2##(1997-6#1)(2008-10#8)(2008-5#1)
potential methods##3##2##(2008-11#1)(2012-2#1)(2013-1#1)
potential misclassification of exposure##2##4##(1991-9#1)(2010-8#1)
potential mobility##2##2##(2008-10#1)(2012-2#1)
potential model##7##2##(2007-7#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-9#1)(2013-1#1)
potential moderator##3##2##(2007-12#2)(2008-9#1)
potential moderators of the effect of##2##6##(2008-12#1)(2013-1#1)
potential moderators##3##2##(2008-12#1)(2012-2#1)(2013-1#1)
potential modifiers##3##2##(1991-3#2)(2010-12#1)
potential modulation##2##2##(2006-12#2)
potential molecular mechanisms##4##3##(2008-11#1)(2008-3#1)(2009-10#1)(2012-2#1)
potential molecular target##2##3##(2012-12#1)(2012-3#1)
potential molecular targets##2##3##(2008-7#1)(2009-12#1)
potential molecular##8##2##(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
potential monitoring##4##2##(2006-12#1)(2007-9#1)(2008-9#1)(2011-2#1)
potential morbidity of##2##3##(2008-5#1)(2010-8#1)
potential morbidity##4##2##(2008-5#1)(2008-6#1)(2009-12#1)(2010-8#1)
potential movement##2##2##(1990-9#1)(2008-12#1)
potential multidimensional risk factors for##2##5##(2006-7#2)
potential must be##2##3##(1997-1#1)(2008-4#1)
potential need for##5##3##(1992-1#1)(2006-2#1)(2007-12#1)(2008-6#1)(2008-7#1)
potential need##6##2##(1992-1#1)(2006-2#1)(2006-3#1)(2007-12#1)(2008-6#1)(2008-7#1)
potential negative consequences##2##3##(2006-10#1)(2010-11#1)
potential negative effects##3##3##(2008-10#1)(2013-8#2)
potential negative##8##2##(1995-12#1)(1996-4#1)(2006-10#1)(2008-10#1)(2010-11#1)(2012-2#1)(2013-8#2)
potential neural##3##2##(2006-10#1)(2008-11#1)(2013-1#1)
potential neuroprotective##5##2##(2005-7#1)(2007-10#1)(2008-5#1)(2010-12#1)(2010-2#1)
potential new targets##2##3##(2007-11#1)(2008-9#1)
potential new therapeutic##2##3##(2008-5#1)(2011-2#1)
potential new##18##2##(1991-2#1)(1993-7#1)(2005-7#1)(2005-8#3)(2006-10#1)(2007-11#2)(2008-11#2)(2008-3#1)(2008-5#2)(2008-9#1)(2010-11#1)(2011-2#2)
potential novel##9##2##(1995-6#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-1#1)(2010-5#1)(2011-1#1)(2011-2#1)
potential observed in##2##3##(1990-3#1)(1994-9#1)
potential of +0##7##3##(1990-11#1)(1995-12#1)(2008-10#5)
potential of +1##2##3##(2008-10#2)
potential of -##2##3##(1996-1#1)(2008-10#1)
potential of -0##19##3##(2007-8#1)(2008-10#18)
potential of -1##3##3##(1997-3#1)(2008-10#2)
potential of -300 mV##2##4##(2008-10#2)
potential of -50 mV##2##4##(1994-2#1)(2008-10#1)
potential of 0##11##3##(1997-3#1)(2007-2#1)(2007-8#1)(2008-10#8)
potential of 10V##2##3##(2013-1#2)
potential of AA##3##3##(1993-7#1)(2008-10#2)
potential of Hb##2##3##(2008-10#1)(2008-7#1)
potential of RNA##2##3##(2012-2#1)(2013-8#1)
potential of UCB-derived effector cells##2##5##(2007-11#2)
potential of Uf at##2##4##(1991-8#2)
potential of Uf##5##3##(1991-8#5)
potential of a single##2##4##(1997-7#1)(2007-12#1)
potential of a##29##3##(1992-2#1)(1993-9#1)(1997-7#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2010-5#1)(2011-1#2)(2011-2#1)(2013-8#1)
potential of an##4##3##(2005-11#2)(2008-10#1)(2008-5#1)
potential of approximately##2##3##(1990-7#1)(2006-8#1)
potential of biotechnology##2##3##(2008-11#2)
potential of blocking##2##3##(2005-7#2)
potential of bovine##2##3##(2006-5#1)(2012-12#1)
potential of cancer cells##3##4##(1992-9#1)(2011-2#1)(2012-12#1)
potential of cells##5##3##(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#2)
potential of chemicals##2##3##(2008-10#1)(2011-12#1)
potential of combining solid-phase optosensing and multicommutation principles##2##8##(2008-10#2)
potential of compounds##2##3##(2006-10#1)(2008-10#1)
potential of different##3##3##(2006-11#1)(2008-10#1)(2013-8#1)
potential of drugs##2##3##(2008-10#2)
potential of each##4##3##(1995-8#1)(2008-10#1)(2008-5#2)
potential of fluorescence##2##3##(1994-6#1)(1997-6#1)
potential of genetically##2##3##(1995-2#1)(2011-2#1)
potential of human##10##3##(1990-8#1)(1990-9#1)(1994-9#1)(2007-11#1)(2008-11#1)(2008-9#1)(2009-3#1)(2012-1#1)(2012-12#1)(2013-8#1)
potential of improving##3##3##(2008-10#1)(2008-3#1)(2010-4#1)
potential of local##2##3##(2006-10#1)(2013-1#1)
potential of mass##2##3##(2008-10#1)(2009-6#1)
potential of mean force##6##4##(2005-11#3)(2006-10#1)(2007-3#1)(2008-10#1)
potential of mean##7##3##(2005-11#3)(2006-10#1)(2007-3#1)(2008-10#2)
potential of mesenchymal##2##3##(2012-1#1)(2012-12#1)
potential of molecular##2##3##(2006-2#1)(2007-8#1)
potential of new##4##3##(2005-7#1)(2008-2#1)(2008-4#1)(2012-3#1)
potential of novel##3##3##(2005-7#1)(2006-10#1)(2006-5#1)
potential of our##3##3##(2012-2#1)(2013-1#2)
potential of personal cleansing products##2##5##(2008-5#2)
potential of plant##2##3##(2004-11#1)(2008-7#1)
potential of selected##2##3##(2007-10#1)(2008-8#1)
potential of smooth muscle cells##2##5##(1996-5#1)(2008-7#1)
potential of smooth muscle##3##4##(1996-5#1)(2008-7#1)(2008-8#1)
potential of solid-phase extraction and##2##5##(2008-10#2)
potential of some##4##3##(1994-6#1)(2008-10#1)(2008-8#1)(2011-12#1)
potential of stem cells##3##4##(2008-11#2)(2012-2#1)
potential of stem##4##3##(2008-11#3)(2012-2#1)
potential of such##7##3##(1994-5#1)(2005-7#1)(2006-10#1)(2006-7#1)(2008-5#1)(2011-2#1)(2013-1#1)
potential of sunflower stem##2##4##(2008-10#2)
potential of surfactants##2##3##(1992-11#1)(2008-5#1)
potential of targeting##2##3##(2005-8#1)(2011-1#1)
potential of terahertz imaging##2##4##(2012-12#2)
potential of terahertz##3##3##(2010-5#1)(2012-12#2)
potential of the cell##2##4##(1995-3#1)(2008-2#1)
potential of the device##2##4##(2006-2#1)(2006-6#1)
potential of the different##2##4##(2005-7#1)(2007-9#1)
potential of the early##2##4##(1995-6#1)(2008-11#1)
potential of the human##2##4##(1997-4#1)(2009-12#1)
potential of the proposed##3##4##(2006-10#1)(2008-2#1)(2012-1#1)
potential of the technique##5##4##(2006-4#2)(2007-12#2)(2009-12#1)
potential of the working electrode##2##5##(2008-10#2)
potential of the##121##3##(1991-11#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-7#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-10#3)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-11#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-3#1)(2005-11#8)(2005-7#2)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#2)(2006-4#2)(2006-6#1)(2007-11#1)(2007-12#3)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#24)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-1#4)(2011-2#2)(2012-1#2)(2012-2#2)(2013-8#1)
potential of these cells##2##4##(2007-5#1)(2009-3#1)
potential of these chiral amines to catalyze two organic reactions##2##10##(2009-10#2)
potential of these nanoparticles##2##4##(2011-2#1)(2013-1#1)
potential of these##25##3##(1990-5#1)(1993-5#1)(1995-7#1)(1995-8#1)(1997-3#1)(2004-9#1)(2005-11#1)(2006-8#1)(2007-5#1)(2008-10#4)(2008-7#1)(2008-8#1)(2009-10#2)(2009-3#2)(2010-1#1)(2010-5#1)(2010-7#1)(2011-2#2)(2013-1#1)
potential of this method to##2##5##(2008-1#1)(2008-3#1)
potential of this method##4##4##(1995-8#1)(1996-4#1)(2008-1#1)(2008-3#1)
potential of this new##2##4##(2007-11#2)
potential of this technique for##2##5##(2007-12#1)(2008-3#1)
potential of this technique##8##4##(1991-8#1)(1992-7#1)(1994-5#1)(2006-2#1)(2007-11#1)(2007-12#2)(2008-3#1)
potential of this##38##3##(1991-5#1)(1991-8#1)(1992-1#1)(1992-7#1)(1994-5#1)(1995-12#1)(1995-8#1)(1996-4#1)(2005-9#1)(2006-2#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-5#3)(2010-10#1)(2010-7#1)(2011-1#2)(2012-1#2)(2012-12#2)(2013-1#1)
potential of three##2##3##(1997-3#1)(2007-11#1)
potential of two##3##3##(2008-10#2)(2009-8#1)
potential of using##5##3##(2006-12#1)(2008-10#3)(2012-1#1)
potential of various##3##3##(1993-9#1)(1994-6#1)(1997-2#1)
potential of working electrode##3##4##(2008-10#3)
potential of##832##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#4)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#3)(1991-5#3)(1991-8#7)(1991-9#4)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-7#2)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#3)(1993-5#3)(1993-7#2)(1993-8#2)(1993-9#5)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#5)(1994-3#1)(1994-5#4)(1994-6#4)(1994-8#1)(1994-9#2)(1995-10#7)(1995-11#1)(1995-12#5)(1995-2#5)(1995-3#2)(1995-5#1)(1995-6#4)(1995-7#1)(1995-8#6)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#2)(1996-3#1)(1996-4#2)(1996-5#3)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#5)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#2)(2004-11#1)(2004-3#1)(2004-4#2)(2004-9#1)(2005-10#3)(2005-11#19)(2005-7#13)(2005-8#8)(2005-9#1)(2006-1#2)(2006-10#16)(2006-11#4)(2006-12#5)(2006-2#4)(2006-4#3)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#4)(2007-10#6)(2007-11#22)(2007-12#11)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#7)(2007-9#5)(2008-1#14)(2008-10#160)(2008-11#31)(2008-12#5)(2008-2#12)(2008-3#16)(2008-4#12)(2008-5#35)(2008-6#2)(2008-7#16)(2008-8#17)(2008-9#9)(2009-10#2)(2009-11#1)(2009-12#5)(2009-2#3)(2009-3#7)(2009-4#3)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#5)(2010-3#3)(2010-4#5)(2010-5#6)(2010-6#1)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#17)(2011-12#4)(2011-2#24)(2011-3#1)(2012-1#12)(2012-11#5)(2012-12#13)(2012-2#17)(2012-3#2)(2012-7#1)(2013-1#20)(2013-8#10)
potential on the##5##3##(1990-3#1)(1991-9#1)(1992-5#1)(1994-8#1)(2008-10#1)
potential on##14##2##(1990-3#1)(1990-8#1)(1990-9#1)(1991-9#2)(1992-5#1)(1994-8#1)(1997-8#1)(2008-10#5)(2009-3#1)
potential only##3##2##(1991-9#2)(1994-1#1)
potential open reading frames##4##4##(1996-12#2)(1996-6#1)(1997-4#1)
potential opportunities for##2##3##(2008-11#1)(2012-1#1)
potential opportunities##3##2##(2008-11#1)(2010-11#1)(2012-1#1)
potential or##6##2##(1991-1#1)(1992-8#1)(1995-11#1)(2006-10#1)(2008-10#2)
potential organic##2##2##(2008-3#1)(2013-1#1)
potential oscillations##2##2##(1994-2#1)(1997-1#1)
potential over##2##2##(2008-5#1)(2011-2#1)
potential pain generators##2##3##(2006-8#2)
potential pan-RAR##2##2##(2012-11#2)
potential participants in##2##3##(1995-1#1)(2012-2#1)
potential participants##8##2##(1994-1#1)(1995-1#1)(1996-11#1)(2007-10#1)(2007-7#1)(2009-4#1)(2009-6#1)(2012-2#1)
potential partners##2##2##(1995-12#1)(1996-1#1)
potential pathogenetic##2##2##(2008-7#1)(2011-2#1)
potential pathogenic##3##2##(2007-11#1)(2008-1#1)(2009-8#1)
potential pathogens##6##2##(1994-6#1)(2007-11#1)(2007-12#1)(2007-6#1)(2009-4#1)(2009-6#1)
potential pathophysiological##2##2##(2012-1#1)(2012-12#1)
potential pathways##2##2##(2008-1#1)(2011-2#1)
potential patient##4##2##(2005-9#1)(2006-1#1)(2013-1#2)
potential patients##6##2##(1996-2#2)(2007-12#1)(2008-8#2)(2010-8#1)
potential pharmaceutical##2##2##(2005-7#1)(2006-12#1)
potential pharmacological##4##2##(2006-12#1)(2008-4#1)(2008-5#1)(2009-3#1)
potential pharmacotherapeutic agents##2##3##(2008-4#2)
potential phosphorylation sites for casein kinase II##2##7##(1997-1#1)(1997-7#1)
potential phosphorylation sites##3##3##(1997-1#1)(1997-7#1)(2008-5#1)
potential phosphorylation##4##2##(1990-10#1)(1997-1#1)(1997-7#1)(2008-5#1)
potential physiological##4##2##(1993-3#1)(2008-5#1)(2009-10#1)(2012-12#1)
potential pirate attacks##2##3##(2008-2#2)
potential pitfalls for##2##3##(1992-12#1)(2008-1#1)
potential pitfalls in##2##3##(2008-4#1)(2011-2#1)
potential pitfalls##10##2##(1992-12#1)(1992-3#1)(1994-3#1)(2004-9#1)(2008-1#1)(2008-4#1)(2009-5#1)(2010-7#1)(2011-2#1)(2012-2#1)
potential plant##2##2##(1992-11#1)(2007-11#1)
potential plasticity##2##2##(2008-11#1)(2012-12#1)
potential positive effects of##2##4##(2006-10#1)(2007-12#1)
potential positive##6##2##(1991-5#1)(1995-5#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-5#1)
potential postoperative##2##2##(2007-5#1)(2010-9#1)
potential power##3##2##(1997-3#1)(2006-11#1)(2012-3#1)
potential precursor##2##2##(2008-3#1)(2012-2#1)
potential precursors of##2##3##(2006-12#1)(2007-11#1)
potential predictors##2##2##(2007-10#1)(2007-7#1)
potential prevention##4##2##(2008-10#1)(2008-5#1)(2010-7#1)(2012-1#1)
potential prey##5##2##(2007-9#1)(2008-5#2)(2012-12#1)(2012-3#1)
potential probe##4##2##(1992-6#1)(1992-9#1)(1995-12#1)(1997-1#1)
potential probiotic##4##2##(2010-4#2)(2012-2#2)
potential problem for##2##3##(2007-12#1)(2009-8#1)
potential problem of##3##3##(1992-4#1)(2008-2#1)(2008-4#1)
potential problem##10##2##(1992-4#1)(2006-9#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-8#1)
potential problems and##2##3##(1991-3#1)(2007-12#1)
potential problems of##2##3##(1995-9#1)(2011-2#1)
potential problems##13##2##(1991-3#1)(1993-2#1)(1995-9#1)(1997-2#1)(2007-10#1)(2007-12#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#2)(2011-2#1)
potential produced##2##2##(1992-9#1)(1997-3#1)
potential profile##2##2##(2007-12#1)(2007-8#1)
potential prognostic##3##2##(1995-10#1)(1997-7#1)(2012-3#1)
potential promising##2##2##(2008-10#1)(2009-7#1)
potential promoter##2##2##(1996-10#1)(1996-5#1)
potential protective agent##2##3##(1993-2#1)(2010-8#1)
potential protective##12##2##(1990-12#1)(1993-2#1)(1994-5#1)(2005-8#1)(2008-10#3)(2008-12#1)(2009-11#1)(2010-8#1)(2011-1#2)
potential protein genes##3##3##(1996-6#3)
potential protein##4##2##(1993-3#1)(1996-6#3)
potential protein-coding genes and/or gene segments with known or predicted functions were identified##2##13##(1997-6#1)(1997-8#1)
potential protein-coding regions##3##3##(1996-6#3)
potential protein-coding##5##2##(1996-6#3)(1997-6#1)(1997-8#1)
potential public health##5##3##(1991-3#1)(2011-1#1)(2012-12#2)(2012-3#1)
potential public##6##2##(1991-3#1)(1992-3#1)(2011-1#1)(2012-12#2)(2012-3#1)
potential pulse##4##2##(2008-10#4)
potential pulses##2##2##(1995-6#2)
potential quantitative trait loci (QTL)##2##5##(2008-10#2)
potential range##8##2##(2005-11#1)(2007-12#1)(2008-10#6)
potential reasons for##3##3##(2008-10#1)(2010-9#1)(2012-2#1)
potential reasons##4##2##(2008-10#2)(2010-9#1)(2012-2#1)
potential recipients##2##2##(2008-7#1)(2010-12#1)
potential recorded from##2##3##(1991-9#1)(1992-3#1)
potential recorded##3##2##(1991-9#1)(1992-3#1)(1992-7#1)
potential recruitment##2##2##(2005-11#1)(2013-1#1)
potential reducing##2##2##(1990-4#1)(2008-10#1)
potential region##2##2##(2005-11#1)(2008-10#1)
potential regions of##2##3##(1994-8#1)(2009-10#1)
potential regulation##2##2##(1994-6#1)(1996-9#1)
potential regulator of##4##3##(1995-5#1)(1996-2#1)(2012-12#2)
potential regulator##5##2##(1991-12#1)(1995-5#1)(1996-2#1)(2012-12#2)
potential regulatory elements##2##3##(1991-7#1)(1994-8#1)
potential regulatory##9##2##(1990-3#1)(1990-9#1)(1991-7#1)(1992-9#1)(1993-2#1)(1994-8#1)(1994-9#1)(2008-10#1)(2012-3#1)
potential relationship##5##2##(2006-2#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-3#1)
potential relationships between##3##3##(2008-10#1)(2008-3#1)(2010-3#1)
potential relationships##5##2##(2008-10#1)(2008-3#1)(2010-3#1)(2013-8#2)
potential release##2##2##(2008-10#2)
potential relevance of##2##3##(1990-9#1)(2008-1#1)
potential relevance##4##2##(1990-9#1)(2008-1#1)(2010-3#1)(2013-8#1)
potential renal##2##2##(1991-6#1)(2012-1#1)
potential reproductive##4##2##(2008-8#1)(2012-12#2)(2012-3#1)
potential research participants##2##3##(2007-4#1)(2012-2#1)
potential research##10##2##(1994-12#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-4#1)(2010-2#1)(2012-2#1)
potential resistance of##2##3##(2011-2#1)(2013-8#1)
potential resistance##3##2##(1995-1#1)(2011-2#1)(2013-8#1)
potential response of##5##3##(2008-10#5)
potential response##11##2##(1995-5#1)(1996-3#1)(2008-10#9)
potential responses##2##2##(1991-8#1)(2010-11#1)
potential restriction##2##2##(2010-4#1)(2012-2#1)
potential results##3##2##(1996-1#1)(2006-8#1)(2008-10#1)
potential revealed##2##2##(2008-10#1)(2012-1#1)
potential risk factor##3##3##(2009-10#1)(2011-1#1)(2012-2#1)
potential risk factors for##5##4##(2007-10#1)(2007-8#1)(2011-2#1)(2013-1#2)
potential risk factors##14##3##(1991-7#1)(1994-12#1)(1995-8#1)(1996-12#1)(2005-10#1)(2007-10#1)(2007-8#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-1#3)
potential risk for##4##3##(2008-10#2)(2011-2#1)(2012-12#1)
potential risk of##20##3##(1992-6#1)(1994-7#1)(2004-4#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-5#1)(2009-6#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
potential risk to##3##3##(2007-12#1)(2007-2#1)(2008-1#1)
potential risk##55##2##(1991-7#1)(1992-6#1)(1994-12#2)(1994-7#1)(1995-5#1)(1995-8#1)(1996-12#1)(2004-4#1)(2005-10#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-4#2)(2008-7#1)(2008-8#1)(2009-1#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
potential risks and##5##3##(1993-9#1)(2006-9#1)(2007-2#1)(2008-10#1)(2013-1#1)
potential risks for##3##3##(2006-12#1)(2008-10#1)(2010-9#1)
potential risks of##8##3##(1996-12#1)(2006-9#1)(2008-10#2)(2008-9#1)(2009-4#1)(2013-1#2)
potential risks to##2##3##(1994-3#1)(2008-7#1)
potential risks##31##2##(1993-9#1)(1994-3#1)(1996-12#1)(2006-10#2)(2006-12#1)(2006-9#2)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2010-7#1)(2010-9#1)(2012-12#1)(2013-1#5)
potential role as##3##3##(1997-4#1)(2008-11#1)(2008-5#1)
potential role for##20##3##(1992-3#2)(1993-3#1)(1993-9#1)(1994-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-8#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-4#1)(2008-10#2)(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#1)
potential role in the##6##4##(1996-9#1)(2006-8#1)(2007-11#1)(2007-3#1)(2008-7#1)(2011-2#1)
potential role in##22##3##(1991-12#1)(1995-10#1)(1995-12#1)(1996-9#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-2#1)(2009-6#1)(2011-2#2)(2013-8#1)
potential role of pharmacogenomic##2##4##(2009-5#2)
potential role of the##6##4##(1990-7#1)(1994-11#1)(2007-3#1)(2008-7#1)(2012-12#1)(2013-7#1)
potential role of these##5##4##(1992-12#1)(1993-6#1)(1994-6#1)(2006-10#1)(2011-2#1)
potential role of##83##3##(1990-7#1)(1991-1#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-5#1)(1994-6#2)(1994-9#2)(1995-1#2)(1995-12#1)(1995-6#1)(1996-5#2)(1997-1#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-2#1)(2007-1#1)(2007-11#4)(2007-3#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
potential role##129##2##(1990-7#1)(1991-1#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-3#4)(1992-9#1)(1993-11#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#2)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-12#2)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-4#1)(1997-8#1)(2005-7#1)(2005-9#1)(2006-10#8)(2006-11#2)(2006-2#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-11#6)(2007-3#2)(2008-1#3)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#2)(2009-1#1)(2009-11#1)(2009-2#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#4)
potential roles for##3##3##(2009-10#1)(2010-2#1)(2012-2#1)
potential roles in##4##3##(2008-12#1)(2009-8#1)(2012-12#2)
potential roles of##10##3##(1994-8#1)(2005-7#1)(2006-11#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#1)(2012-1#2)(2013-1#1)
potential roles##19##2##(1994-8#1)(2005-7#1)(2006-11#1)(2006-12#1)(2008-12#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#2)(2010-3#1)(2012-1#2)(2012-12#3)(2012-2#1)(2013-1#1)
potential safety concerns##2##3##(2008-11#2)
potential safety##4##2##(2008-11#2)(2013-1#2)
potential scan rate##2##3##(2008-10#2)
potential scan##4##2##(2008-10#4)
potential scans##2##2##(2008-10#2)
potential secreted##2##2##(1992-9#2)
potential selection pressures##2##3##(2012-3#2)
potential selection##3##2##(2008-5#1)(2012-3#2)
potential separation##2##2##(2007-11#1)(2008-10#1)
potential service##2##2##(1993-12#1)(1995-3#1)
potential severe##2##2##(2008-1#2)
potential shift##6##2##(1995-5#2)(1996-5#2)(2008-10#1)(2009-3#1)
potential shifts to##2##3##(1991-10#1)(2008-10#1)
potential shifts##6##2##(1991-10#1)(1995-5#1)(1996-6#1)(2008-10#3)
potential side effect##2##3##(2008-3#1)(2010-12#1)
potential side effects and##2##4##(2005-11#1)(2006-9#1)
potential side effects##8##3##(1996-3#1)(2005-11#1)(2006-9#1)(2007-12#1)(2010-5#1)(2011-2#1)(2013-1#2)
potential side##11##2##(1996-3#1)(2005-11#1)(2006-9#1)(2007-12#1)(2008-3#1)(2008-4#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#2)
potential side-effects of##2##3##(2010-12#1)(2013-1#1)
potential side-effects##3##2##(2010-12#2)(2013-1#1)
potential signal##4##2##(1990-4#1)(1994-9#1)(1996-8#1)(2008-7#1)
potential signaling##2##2##(2009-6#2)
potential significance##5##2##(2006-9#1)(2008-10#1)(2008-2#1)(2008-9#2)
potential site of##4##3##(1990-12#1)(1996-8#1)(1997-2#1)(2008-10#1)
potential site##6##2##(1990-12#1)(1996-5#1)(1996-8#1)(1997-2#1)(2008-10#1)(2011-1#1)
potential sites for N-glycosylation##3##4##(1990-4#1)(1994-9#1)(1997-4#1)
potential sites for##5##3##(1990-4#1)(1992-1#1)(1993-2#1)(1994-9#1)(1997-4#1)
potential sites of##3##3##(1993-3#1)(1997-6#1)(2008-2#1)
potential sites##8##2##(1990-4#1)(1992-1#1)(1993-2#1)(1993-3#1)(1994-9#1)(1997-4#1)(1997-6#1)(2008-2#1)
potential size##2##2##(1995-7#1)(2012-3#1)
potential solid phase##2##3##(2008-10#2)
potential solution to##2##3##(1990-11#1)(2008-8#1)
potential solution##5##2##(1990-11#1)(1992-12#1)(2008-2#1)(2008-8#2)
potential solutions are##2##3##(2007-4#1)(2008-1#1)
potential solutions##10##2##(1996-12#1)(2005-8#1)(2006-4#1)(2007-4#2)(2007-8#1)(2008-1#1)(2009-6#1)(2010-6#1)(2011-12#1)
potential source of##16##3##(1990-5#1)(1991-12#2)(1995-5#1)(2006-5#1)(2006-8#1)(2008-10#4)(2008-5#3)(2008-9#1)(2012-12#1)(2013-1#1)
potential source##22##2##(1990-5#1)(1990-6#1)(1991-12#2)(1992-2#1)(1995-5#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-6#1)(2008-10#4)(2008-5#3)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
potential sources of contamination##2##4##(2008-10#1)(2012-2#1)
potential sources of inoculum##2##4##(2008-10#2)
potential sources of##26##3##(1991-10#2)(1992-11#1)(1993-6#1)(1996-5#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#2)(2008-9#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
potential sources##27##2##(1991-10#2)(1992-11#1)(1993-11#1)(1993-6#1)(1996-5#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#2)(2008-9#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
potential speed of##2##3##(1996-9#1)(2007-11#1)
potential speed##3##2##(1996-9#1)(2007-11#1)(2007-12#1)
potential stability and reproducibility##2##4##(2008-10#2)
potential stability and##3##3##(2008-10#3)
potential stability##6##2##(2008-10#6)
potential step##2##2##(1994-12#1)(2008-10#1)
potential strategies##2##2##(2006-10#1)(2007-7#1)
potential strength of##2##3##(2008-10#1)(2008-9#1)
potential structural##3##2##(2004-9#1)(2008-9#1)(2011-1#1)
potential study##3##2##(1990-9#1)(2004-11#1)(2008-4#1)
potential subgroups##2##2##(2008-12#2)
potential substance##2##2##(2008-11#1)(2008-3#1)
potential substrates and/or inhibitors of##2##5##(2009-2#2)
potential substrates##8##2##(1994-11#1)(1994-12#1)(1994-5#1)(2007-6#1)(2008-11#2)(2009-2#2)
potential success##2##2##(1994-3#1)(2007-4#1)
potential surface##2##2##(2009-5#1)(2012-11#1)
potential surfaces of the##2##4##(1994-8#1)(1995-1#1)
potential surfaces##3##2##(1994-8#1)(1995-1#1)(2009-5#1)
potential sweep##2##2##(2008-10#2)
potential synergistic##2##2##(2008-10#1)(2008-5#1)
potential systematic##2##2##(2006-7#1)(2008-7#1)
potential target for the##3##4##(1993-8#1)(2008-1#2)
potential target for therapeutic intervention##2##5##(2007-11#1)(2010-3#1)
potential target for therapeutic##3##4##(2007-11#1)(2007-12#1)(2010-3#1)
potential target for##22##3##(1993-8#1)(1994-9#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-11#1)(2004-12#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)
potential target##30##2##(1993-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-4#1)(2004-12#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#4)(2008-10#2)(2008-3#1)(2008-9#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)
potential targeting##2##2##(2008-10#1)(2011-2#1)
potential targets for gene therapy##2##5##(2007-11#1)(2011-1#1)
potential targets for therapy##2##4##(2006-10#1)(2008-4#1)
potential targets for##16##3##(1995-6#1)(1997-7#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-11#3)(2007-6#1)(2008-1#2)(2008-4#2)(2008-6#1)(2011-1#1)(2011-2#1)
potential targets##24##2##(1995-6#1)(1997-7#1)(2005-7#2)(2005-8#1)(2006-10#1)(2007-11#3)(2007-6#1)(2008-1#2)(2008-4#2)(2008-6#1)(2008-7#2)(2009-9#1)(2011-1#2)(2011-2#3)(2012-12#1)
potential technique##2##2##(1990-8#1)(2007-12#1)
potential than the##2##3##(1992-7#1)(2008-5#1)
potential than##7##2##(1992-7#1)(1994-6#1)(1997-1#1)(2008-2#1)(2008-5#2)(2012-7#1)
potential that is##2##3##(2008-1#1)(2009-6#1)
potential that##16##2##(1991-9#1)(1992-12#1)(1995-6#1)(2005-7#1)(2007-11#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-2#1)(2008-5#1)(2009-6#1)(2010-2#1)(2012-2#1)(2012-3#1)
potential therapeutic agents for the##2##5##(1994-12#1)(2009-12#1)
potential therapeutic agents for##4##4##(1994-12#1)(2005-7#1)(2008-4#1)(2009-12#1)
potential therapeutic agents##6##3##(1994-12#1)(2005-7#2)(2008-4#1)(2009-12#1)(2010-5#1)
potential therapeutic applications##8##3##(1995-3#1)(1997-4#1)(2008-1#2)(2008-4#2)(2010-11#1)(2013-1#1)
potential therapeutic approaches##2##3##(1990-7#1)(2006-2#1)
potential therapeutic benefit##4##3##(2005-10#1)(2008-11#1)(2009-4#1)(2010-12#1)
potential therapeutic benefits##2##3##(2005-10#2)
potential therapeutic drugs for cognitive impairments##2##6##(2011-1#2)
potential therapeutic drugs for##3##4##(2011-1#3)
potential therapeutic drugs##4##3##(2008-4#1)(2011-1#3)
potential therapeutic implications##4##3##(1994-6#1)(2006-10#1)(2012-2#1)(2013-1#1)
potential therapeutic interventions##3##3##(2004-11#1)(2006-10#1)(2010-5#1)
potential therapeutic role for##2##4##(2006-10#1)(2013-7#1)
potential therapeutic role of##2##4##(1996-10#1)(2006-10#1)
potential therapeutic role##5##3##(1996-10#1)(2006-10#2)(2008-4#1)(2013-7#1)
potential therapeutic roles##2##3##(2011-2#1)(2012-2#1)
potential therapeutic target for##7##4##(2008-1#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#2)
potential therapeutic target##12##3##(1992-4#1)(2008-1#1)(2008-7#1)(2010-6#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#2)
potential therapeutic targets for##3##4##(2008-1#1)(2008-8#1)(2009-11#1)
potential therapeutic targets to##2##4##(2008-4#1)(2013-7#1)
potential therapeutic targets##15##3##(2005-7#1)(2005-8#1)(2006-10#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-12#3)(2010-4#1)(2011-1#1)(2013-7#1)(2013-8#1)
potential therapeutic use##3##3##(1992-9#1)(1993-8#1)(2012-2#1)
potential therapeutic value##2##3##(1996-2#1)(2008-4#1)
potential therapeutic##96##2##(1990-7#1)(1992-4#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-4#1)(2004-11#1)(2005-10#3)(2005-7#4)(2005-8#2)(2005-9#1)(2006-10#5)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#1)(2008-1#4)(2008-11#1)(2008-4#8)(2008-7#3)(2008-8#2)(2009-11#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#6)(2010-4#1)(2010-5#2)(2010-6#2)(2011-1#4)(2011-2#6)(2012-12#5)(2012-2#7)(2013-1#5)(2013-7#2)(2013-8#1)
potential therapies for##2##3##(2008-5#1)(2012-3#1)
potential therapies##7##2##(2006-10#1)(2007-8#1)(2008-4#2)(2008-5#1)(2010-6#1)(2012-3#1)
potential therapy for##3##3##(1994-5#1)(2007-11#1)(2012-12#1)
potential therapy of##3##3##(1994-5#1)(2006-10#1)(2008-5#1)
potential therapy##6##2##(1994-5#2)(2006-10#1)(2007-11#1)(2008-5#1)(2012-12#1)
potential threat to the##3##4##(1996-8#1)(2008-7#1)(2012-2#1)
potential threat to##4##3##(1996-8#1)(2008-10#1)(2008-7#1)(2012-2#1)
potential threat##9##2##(1990-12#1)(1996-8#1)(2008-10#2)(2008-7#1)(2009-12#1)(2011-12#1)(2011-2#1)(2012-2#1)
potential threshold##3##2##(1990-7#1)(2008-10#2)
potential titration##2##2##(2008-10#2)
potential to affect##7##3##(2007-6#1)(2008-10#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-2#1)(2013-1#1)
potential to alter the##2##4##(2008-10#1)(2012-2#1)
potential to answer##2##3##(2008-8#1)(2010-2#1)
potential to be a useful##2##5##(2006-12#1)(2008-10#1)
potential to be a##4##4##(2006-12#1)(2008-1#1)(2008-10#1)(2012-2#1)
potential to be applied##3##4##(2008-3#1)(2008-8#1)(2010-12#1)
potential to be used as feedstock for##2##7##(2008-5#1)(2009-3#1)
potential to be used as##6##5##(1991-9#1)(2008-5#2)(2009-3#1)(2009-7#1)(2012-12#1)
potential to be used for##3##5##(2006-12#1)(2008-10#1)(2008-2#1)
potential to be used in##5##5##(2008-10#1)(2008-5#2)(2008-6#1)(2012-2#1)
potential to be used##16##4##(1991-9#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#1)(2009-3#1)(2009-7#1)(2012-12#1)(2012-2#1)
potential to be##42##3##(1991-9#1)(1997-7#1)(2006-12#2)(2007-11#2)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#4)(2008-6#1)(2008-8#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-12#2)(2012-12#1)(2012-2#4)
potential to become a##6##4##(2006-12#1)(2007-12#1)(2008-10#1)(2008-9#1)(2010-12#1)(2013-8#1)
potential to become##13##3##(2006-12#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-12#2)(2011-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
potential to catalyze##2##3##(1996-5#1)(2012-2#1)
potential to cause##11##3##(1997-2#1)(2006-12#1)(2008-10#2)(2009-10#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
potential to contribute##3##3##(2006-9#1)(2007-3#1)(2011-2#1)
potential to control##3##3##(1994-6#1)(2008-10#1)(2009-6#1)
potential to damage##3##3##(1996-1#1)(2008-10#1)(2008-5#1)
potential to detect##6##3##(1996-3#1)(1996-4#1)(2008-1#1)(2008-2#1)(2008-7#1)(2011-1#1)
potential to differentiate into##5##4##(1995-1#1)(2008-11#3)(2008-8#1)
potential to differentiate##6##3##(1995-1#1)(2008-11#3)(2008-5#1)(2008-8#1)
potential to discriminate between##2##4##(1995-2#1)(2012-12#1)
potential to elevate##2##3##(1993-9#1)(2009-8#1)
potential to enhance the##2##4##(2008-1#1)(2008-9#1)
potential to enhance##10##3##(2007-10#1)(2008-1#1)(2008-10#2)(2008-9#1)(2010-12#1)(2011-1#1)(2011-12#2)(2012-2#1)
potential to form all types of cells##2##7##(2008-9#2)
potential to form##3##3##(1990-7#1)(2008-9#2)
potential to generate##4##3##(1990-5#1)(2008-6#1)(2010-10#1)(2012-12#1)
potential to help##5##3##(1997-2#1)(2005-8#1)(2009-10#1)(2010-12#1)(2012-2#1)
potential to improve the##7##4##(1993-6#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-8#1)(2013-1#1)
potential to improve##20##3##(1993-6#1)(1994-12#1)(1994-2#1)(2005-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2009-9#1)(2012-2#1)(2013-1#5)
potential to increase the##4##4##(2006-2#1)(2006-4#1)(2008-3#1)(2011-1#1)
potential to increase##10##3##(1995-3#1)(1996-11#2)(2006-2#1)(2006-4#1)(2006-5#1)(2007-9#1)(2008-3#1)(2010-6#1)(2011-1#1)
potential to induce##5##3##(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-2#1)
potential to infect##2##3##(2008-10#2)
potential to influence##3##3##(1996-3#1)(2013-1#2)
potential to inform##2##3##(2010-2#1)(2012-12#1)
potential to interact with##2##4##(2008-3#1)(2009-12#1)
potential to lead to##3##4##(2006-10#1)(2008-5#1)(2010-9#1)
potential to limit##2##3##(2008-3#1)(2012-12#1)
potential to make a##2##4##(1994-11#1)(2013-8#1)
potential to make##4##3##(1994-11#1)(1996-11#1)(2011-1#1)(2013-8#1)
potential to mature##2##3##(2008-5#2)
potential to offer##3##3##(2008-12#1)(2010-12#1)(2012-2#1)
potential to overcome##3##3##(2007-7#1)(2008-1#1)(2012-2#1)
potential to predict##4##3##(2007-4#1)(2008-10#1)(2010-4#2)
potential to produce##8##3##(1993-3#1)(1994-11#1)(1996-11#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-7#1)(2009-5#1)
potential to promote##4##3##(2006-12#1)(2007-10#1)(2008-10#1)(2013-1#1)
potential to provide a##7##4##(1993-10#1)(2007-4#1)(2008-10#2)(2008-11#1)(2011-7#1)(2012-2#1)
potential to provide##19##3##(1991-3#1)(1993-10#1)(1996-1#1)(2005-11#1)(2006-5#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
potential to reach##2##3##(2008-10#1)(2008-2#1)
potential to reduce##15##3##(2006-10#1)(2006-5#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-10#2)(2010-1#1)(2010-12#1)(2010-5#1)(2013-1#2)
potential to regulate##4##3##(1994-11#1)(1994-9#1)(2007-2#1)(2008-11#1)
potential to replace##2##3##(2007-11#1)(2008-3#1)
potential to respond to##2##4##(1995-2#1)(2007-3#1)
potential to revolutionize##6##3##(2006-10#1)(2007-11#1)(2009-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
potential to serve as##3##4##(2004-8#1)(2007-5#1)(2008-5#1)
potential to serve##4##3##(2004-8#1)(2007-5#1)(2008-5#2)
potential to support##3##3##(2008-1#1)(2008-7#1)(2013-1#1)
potential to transmit##2##3##(2006-10#1)(2012-12#1)
potential to trigger##2##3##(2006-7#1)(2012-3#1)
potential to undergo##2##3##(2007-12#1)(2013-7#1)
potential to##458##2##(1990-4#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-3#2)(1991-7#1)(1991-9#2)(1992-12#2)(1993-10#1)(1993-11#2)(1993-3#1)(1993-6#3)(1993-7#1)(1993-9#2)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#2)(1996-11#4)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-7#2)(1997-8#1)(2004-1#2)(2004-2#1)(2004-3#1)(2004-8#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#6)(2006-2#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#1)(2006-9#2)(2007-1#2)(2007-10#3)(2007-11#15)(2007-12#6)(2007-2#1)(2007-3#2)(2007-4#4)(2007-5#4)(2007-6#2)(2007-7#1)(2007-8#7)(2007-9#2)(2008-1#11)(2008-10#44)(2008-11#15)(2008-12#4)(2008-2#12)(2008-3#15)(2008-4#1)(2008-5#17)(2008-6#2)(2008-7#12)(2008-8#10)(2008-9#10)(2009-10#5)(2009-11#1)(2009-12#4)(2009-2#6)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#14)(2010-2#6)(2010-4#3)(2010-5#1)(2010-6#2)(2010-8#2)(2010-9#4)(2011-1#8)(2011-12#4)(2011-2#6)(2011-7#4)(2012-1#4)(2012-12#13)(2012-2#16)(2012-3#9)(2012-6#1)(2013-1#23)(2013-7#2)(2013-8#5)
potential toxic##4##2##(2008-10#3)(2008-4#1)
potential toxicities##3##2##(1995-1#1)(2006-10#1)(2007-6#1)
potential toxicity and##4##3##(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)
potential toxicity##12##2##(2008-10#1)(2008-8#3)(2008-9#1)(2009-10#1)(2010-10#1)(2010-12#3)(2010-3#1)(2013-1#1)
potential transcription##3##2##(1991-11#1)(1993-2#1)(1993-4#1)
potential transmembrane##5##2##(1992-6#1)(1994-12#1)(1994-9#1)(1996-12#1)(1996-6#1)
potential treatment of arthritis##2##4##(2005-8#1)(2008-5#1)
potential treatment of various##3##4##(2005-8#1)(2006-9#1)(2008-5#1)
potential treatment of##36##3##(2005-6#2)(2005-7#9)(2005-8#10)(2005-9#4)(2006-9#1)(2008-5#8)(2008-8#1)(2009-4#1)
potential treatment options##5##3##(2007-6#1)(2008-11#1)(2011-2#2)(2012-2#1)
potential treatment##73##2##(1997-1#1)(2005-6#3)(2005-7#10)(2005-8#16)(2005-9#7)(2006-6#1)(2006-9#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#17)(2008-7#2)(2008-8#1)(2009-4#1)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#1)
potential tumor##3##2##(1996-11#1)(1997-7#1)(2007-11#1)
potential tyrosine sulfation sites##2##4##(1990-3#2)
potential tyrosine##3##2##(1990-3#2)(2005-8#1)
potential under##3##2##(1994-12#1)(1994-3#1)(2005-11#1)
potential usage##3##2##(2009-3#1)(2013-1#2)
potential use as a biodegradable implant material##2##7##(2012-2#2)
potential use as a##6##4##(2006-8#1)(2007-12#1)(2008-8#1)(2009-11#1)(2012-2#2)
potential use as an##4##4##(1990-8#1)(1993-12#1)(1995-2#1)(1996-5#1)
potential use as##13##3##(1990-8#1)(1993-12#1)(1995-2#1)(1996-5#1)(2006-5#1)(2006-8#1)(2007-12#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-8#1)(2012-2#2)
potential use for the##2##4##(2008-11#1)(2008-5#1)
potential use for##8##3##(1995-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2009-8#1)(2011-2#1)
potential use in human gene therapy##2##6##(1993-2#1)(1997-4#1)
potential use in human##3##4##(1993-2#1)(1997-4#1)(2008-5#1)
potential use in the treatment of##3##6##(2006-8#1)(2007-11#1)(2008-5#1)
potential use in the##8##4##(1991-8#1)(2006-10#1)(2006-8#1)(2007-11#2)(2008-3#1)(2008-5#1)(2008-9#1)
potential use in##32##3##(1991-8#1)(1991-9#1)(1992-7#1)(1993-2#1)(1993-4#2)(1994-9#1)(1997-4#1)(2004-12#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#5)(2008-9#1)(2010-4#1)(2011-1#1)(2013-1#1)
potential use of a##3##4##(2007-8#1)(2008-10#1)(2008-6#1)
potential use of the##5##4##(1996-7#1)(2006-10#1)(2008-5#1)(2008-8#1)(2012-12#1)
potential use of##50##3##(1993-6#1)(1994-11#1)(1995-12#1)(1995-8#1)(1996-7#1)(2004-9#1)(2005-10#1)(2005-7#3)(2005-8#2)(2006-10#1)(2006-11#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#3)(2009-2#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
potential use##106##2##(1990-8#1)(1991-8#1)(1991-9#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-4#2)(1993-6#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-4#1)(2004-12#1)(2004-9#1)(2005-10#1)(2005-7#3)(2005-8#3)(2006-10#2)(2006-11#1)(2006-5#1)(2006-8#2)(2007-11#2)(2007-12#3)(2007-8#2)(2008-1#2)(2008-10#9)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#12)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#4)(2009-11#1)(2009-2#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#3)
potential used##2##2##(2007-8#1)(2008-10#1)
potential usefulness for##2##3##(2007-7#1)(2008-10#1)
potential usefulness of these##2##4##(2008-10#2)
potential usefulness of##9##3##(1995-7#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-7#1)(2009-7#1)(2013-7#1)
potential usefulness##16##2##(1990-2#1)(1995-7#1)(2005-4#1)(2007-7#2)(2007-8#2)(2008-10#5)(2008-5#1)(2008-7#1)(2009-7#1)(2013-7#1)
potential users in##2##3##(1990-3#1)(2006-5#1)
potential users##4##2##(1990-3#1)(1991-3#1)(2006-5#1)(2013-8#1)
potential uses of the##3##4##(1991-12#1)(2008-3#1)(2008-4#1)
potential uses of##10##3##(1991-12#1)(1996-3#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2010-11#1)(2010-5#1)
potential uses##13##2##(1991-12#1)(1996-3#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#1)(2010-11#1)(2010-3#1)(2010-5#1)
potential using the##2##3##(1993-11#1)(2008-9#1)
potential using##5##2##(1993-11#1)(2008-9#3)(2012-12#1)
potential utility as a##2##4##(2008-6#1)(2010-8#1)
potential utility as##4##3##(2008-6#1)(2008-7#1)(2010-12#1)(2010-8#1)
potential utility for##3##3##(2008-1#1)(2008-5#1)(2008-9#1)
potential utility in##5##3##(2006-5#1)(2008-5#1)(2010-10#1)(2010-5#1)(2011-1#1)
potential utility of the##7##4##(1995-1#1)(1996-2#1)(2007-12#1)(2008-10#1)(2013-1#3)
potential utility of this##2##4##(2005-7#1)(2007-12#1)
potential utility of##21##3##(1995-1#1)(1995-5#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-3#1)(2005-7#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-10#1)(2009-4#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
potential utility##34##2##(1995-1#1)(1995-5#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-3#1)(2005-7#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
potential vaccine candidates##2##3##(2009-5#1)(2013-1#1)
potential vaccine##4##2##(2008-7#1)(2009-5#1)(2012-3#1)(2013-1#1)
potential vaccines##3##2##(2006-10#1)(2006-8#1)(2006-9#1)
potential value for##6##3##(1997-4#1)(2007-1#1)(2008-10#1)(2012-3#1)(2013-1#2)
potential value in the##2##4##(2008-5#1)(2009-1#1)
potential value in##4##3##(2008-5#1)(2008-6#1)(2009-1#1)(2013-8#1)
potential value of the##2##4##(1995-6#1)(2008-5#1)
potential value of##14##3##(1991-3#1)(1991-7#2)(1995-11#1)(1995-12#1)(1995-6#1)(2006-12#1)(2006-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
potential value##32##2##(1991-3#1)(1991-7#2)(1993-2#1)(1995-11#1)(1995-12#1)(1995-6#1)(1997-4#1)(2006-12#1)(2006-3#1)(2007-1#2)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-1#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
potential values were##2##3##(2004-9#1)(2012-2#1)
potential values##8##2##(1992-3#1)(1995-6#1)(2004-9#1)(2007-11#2)(2008-10#2)(2012-2#1)
potential variations##3##2##(2008-4#2)(2013-1#1)
potential varied##2##2##(2008-10#1)(2012-2#1)
potential versus##3##2##(2008-10#3)
potential vulnerability##2##2##(1997-5#1)(2011-2#1)
potential was +0##2##3##(2008-10#2)
potential was assessed##2##3##(1991-6#1)(2011-1#1)
potential was determined##3##3##(1995-10#1)(2008-5#1)(2012-4#1)
potential was investigated##2##3##(2008-10#1)(2009-6#1)
potential was measured##2##3##(1990-12#1)(2005-11#1)
potential was observed##3##3##(1991-9#1)(1992-8#1)(2008-10#1)
potential was##45##2##(1990-12#1)(1990-3#2)(1990-7#1)(1990-8#2)(1991-6#1)(1991-9#2)(1992-11#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-2#2)(1995-10#1)(1997-2#1)(1997-3#1)(2004-4#1)(2005-11#1)(2006-12#1)(2007-1#1)(2008-10#14)(2008-5#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-12#1)(2011-1#1)(2012-4#1)(2013-7#1)
potential waveform##2##2##(2008-10#2)
potential ways##2##2##(2005-10#1)(2006-5#1)
potential well##3##2##(1996-2#3)
potential were observed##2##3##(1991-5#1)(1994-12#1)
potential were##10##2##(1990-8#1)(1991-5#1)(1994-12#1)(2005-11#2)(2007-11#1)(2008-10#1)(2008-5#1)(2012-12#1)(2012-3#1)
potential when##2##2##(1990-8#1)(1997-4#1)
potential window was##2##3##(2008-10#2)
potential window##5##2##(2008-10#5)
potential with##12##2##(1992-8#1)(1994-8#1)(1995-2#1)(2005-7#1)(2006-4#1)(2007-12#1)(2008-10#3)(2008-11#1)(2010-5#1)(2013-8#1)
potential within the##3##3##(1996-8#1)(2009-5#1)(2012-2#1)
potential within##5##2##(1996-8#1)(2008-10#1)(2008-4#1)(2009-5#1)(2012-2#1)
potential without##2##2##(1990-7#1)(1995-6#1)
potential zinc##2##2##(1991-9#1)(1997-7#1)
potential##7067##1##(1990-10#7)(1990-11#9)(1990-12#14)(1990-2#11)(1990-3#20)(1990-4#6)(1990-5#14)(1990-6#3)(1990-7#18)(1990-8#17)(1990-9#12)(1991-1#13)(1991-10#9)(1991-11#15)(1991-12#23)(1991-2#11)(1991-3#16)(1991-4#12)(1991-5#13)(1991-6#9)(1991-7#14)(1991-8#19)(1991-9#31)(1992-1#9)(1992-10#3)(1992-11#17)(1992-12#22)(1992-2#14)(1992-3#31)(1992-4#3)(1992-5#8)(1992-6#12)(1992-7#11)(1992-8#13)(1992-9#20)(1993-1#5)(1993-10#4)(1993-11#23)(1993-12#32)(1993-2#28)(1993-3#19)(1993-4#15)(1993-5#8)(1993-6#13)(1993-7#9)(1993-8#12)(1993-9#18)(1994-1#10)(1994-10#4)(1994-11#31)(1994-12#34)(1994-2#27)(1994-3#27)(1994-4#2)(1994-5#19)(1994-6#29)(1994-7#3)(1994-8#25)(1994-9#28)(1995-1#21)(1995-10#14)(1995-11#9)(1995-12#31)(1995-2#21)(1995-3#29)(1995-4#2)(1995-5#24)(1995-6#26)(1995-7#4)(1995-8#19)(1995-9#5)(1996-1#25)(1996-10#9)(1996-11#16)(1996-12#24)(1996-2#28)(1996-3#13)(1996-4#14)(1996-5#31)(1996-6#13)(1996-7#10)(1996-8#19)(1996-9#13)(1997-1#39)(1997-2#28)(1997-3#19)(1997-4#28)(1997-5#10)(1997-6#16)(1997-7#27)(1997-8#27)(2003-11#1)(2004-1#2)(2004-11#8)(2004-12#5)(2004-2#5)(2004-3#4)(2004-4#9)(2004-8#1)(2004-9#11)(2005-10#24)(2005-11#112)(2005-12#3)(2005-4#2)(2005-5#1)(2005-6#4)(2005-7#69)(2005-8#67)(2005-9#16)(2006-1#5)(2006-10#162)(2006-11#36)(2006-12#71)(2006-2#23)(2006-3#9)(2006-4#15)(2006-5#24)(2006-6#11)(2006-7#16)(2006-8#25)(2006-9#20)(2007-1#19)(2007-10#43)(2007-11#143)(2007-12#112)(2007-2#20)(2007-3#16)(2007-4#32)(2007-5#24)(2007-6#18)(2007-7#27)(2007-8#70)(2007-9#29)(2008-1#114)(2008-10#896)(2008-11#193)(2008-12#53)(2008-2#86)(2008-3#144)(2008-4#113)(2008-5#262)(2008-6#52)(2008-7#164)(2008-8#147)(2008-9#109)(2009-1#9)(2009-10#33)(2009-11#24)(2009-12#33)(2009-2#30)(2009-3#32)(2009-4#45)(2009-5#42)(2009-6#23)(2009-7#18)(2009-8#32)(2009-9#23)(2010-1#17)(2010-10#19)(2010-11#27)(2010-12#97)(2010-2#45)(2010-3#24)(2010-4#42)(2010-5#34)(2010-6#21)(2010-7#19)(2010-8#38)(2010-9#15)(2011-1#116)(2011-12#25)(2011-2#177)(2011-3#5)(2011-7#7)(2012-1#51)(2012-11#29)(2012-12#156)(2012-2#150)(2012-3#89)(2012-4#2)(2012-6#2)(2012-7#3)(2012-8#1)(2013-1#217)(2013-7#38)(2013-8#92)
potential'##3##1##(1991-11#1)(2008-1#1)(2008-10#1)
potential) were##2##2##(1990-2#1)(2008-5#1)
potential)##13##1##(1990-2#1)(1990-7#1)(1996-12#1)(1997-1#1)(2006-12#1)(2006-2#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-10#1)(2013-1#3)
potential-dependent##5##1##(1997-1#1)(2007-12#3)(2008-10#1)
potential-like responses in B104 cells##3##5##(1996-9#3)
potential-like responses##6##2##(1996-9#6)
potential-sensitive##3##1##(1990-12#1)(1996-1#1)(2008-8#1)
potentialities in the##2##3##(2005-12#1)(2006-10#1)
potentialities of the##4##3##(2008-10#2)(2008-3#1)(2008-7#1)
potentialities of##9##2##(2008-10#4)(2008-3#1)(2008-6#1)(2008-7#3)
potentialities##23##1##(1990-6#2)(1991-11#1)(1994-6#1)(1995-12#1)(1997-4#1)(2005-12#1)(2006-10#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-6#1)(2008-7#3)(2009-10#1)(2009-6#2)(2013-1#1)
potentiality as##2##2##(1991-7#1)(2008-2#1)
potentiality of##9##2##(1997-4#1)(1997-5#1)(2008-10#3)(2008-8#1)(2010-3#1)(2013-1#2)
potentiality to##2##2##(2007-7#1)(2012-2#1)
potentiality##15##1##(1990-10#1)(1991-7#1)(1997-4#1)(1997-5#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-8#1)(2010-3#1)(2012-2#1)(2013-1#2)
potentially a powerful##3##3##(2010-5#1)(2013-1#2)
potentially a useful##2##3##(1992-8#1)(2012-12#1)
potentially a##11##2##(1992-8#1)(1997-5#1)(2007-2#1)(2008-1#1)(2008-2#1)(2010-5#1)(2011-1#1)(2012-12#2)(2013-1#2)
potentially adverse effects##2##3##(2007-2#1)(2008-4#1)
potentially adverse##3##2##(2005-11#1)(2007-2#1)(2008-4#1)
potentially allergenic##2##2##(1997-2#1)(2013-8#1)
potentially allow##2##2##(2011-1#1)(2012-2#1)
potentially amenable to##3##3##(1991-2#1)(2008-3#1)(2008-5#1)
potentially amyloidogenic##2##2##(1992-12#1)(1995-10#1)
potentially anti-atherogenic##2##2##(2008-3#2)
potentially applicable to##2##3##(2007-12#1)(2008-8#1)
potentially applicable##5##2##(2007-12#1)(2008-2#1)(2008-8#1)(2009-9#1)(2013-1#1)
potentially associated with the##2##4##(2012-3#2)
potentially associated with##4##3##(2011-1#1)(2012-3#2)(2013-8#1)
potentially associated##5##2##(2011-1#1)(2012-3#3)(2013-8#1)
potentially at risk of##3##4##(2010-11#1)(2013-1#2)
potentially at risk##6##3##(1991-12#1)(2007-10#1)(2010-11#1)(2013-1#3)
potentially at##7##2##(1991-12#1)(1991-2#1)(2007-10#1)(2010-11#1)(2013-1#3)
potentially be a##2##3##(2007-10#1)(2012-1#1)
potentially be used in##3##4##(2007-12#1)(2008-8#1)(2009-12#1)
potentially be used to##7##4##(1996-3#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-4#1)(2013-1#1)(2013-7#1)
potentially be used##14##3##(1996-3#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#2)(2009-12#1)(2009-4#1)(2011-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
potentially be##39##2##(1994-6#1)(1995-1#1)(1996-3#1)(1997-4#1)(1997-5#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#4)(2009-12#1)(2009-4#1)(2009-5#1)(2010-10#2)(2010-7#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#4)(2013-7#1)
potentially beneficial##9##2##(2007-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-6#1)(2009-9#1)(2010-1#2)
potentially biologically active##2##3##(2007-10#1)(2007-11#1)
potentially can be used in##2##5##(2006-8#1)(2008-10#1)
potentially can be##5##3##(2006-8#1)(2007-11#1)(2008-10#1)(2008-7#1)(2012-12#1)
potentially causal##3##2##(1991-12#1)(2008-7#1)(2011-2#1)
potentially cause##3##2##(2008-12#1)(2008-2#1)(2009-3#1)
potentially causing##3##2##(2007-11#1)(2008-12#1)(2008-8#1)
potentially chemopreventive##2##2##(2010-12#1)(2011-2#1)
potentially compromise the##2##3##(2008-1#1)(2011-2#1)
potentially concerned##2##2##(1994-8#1)(2010-12#1)
potentially confounding##3##2##(1997-4#1)(2006-10#1)(2010-8#1)
potentially contribute to the##2##4##(2008-11#1)(2009-3#1)
potentially contribute to##3##3##(1992-5#1)(2008-11#1)(2009-3#1)
potentially contributing to##3##3##(1991-5#1)(2009-6#1)(2012-12#1)
potentially could##4##2##(2008-10#2)(2008-3#1)(2010-3#1)
potentially critical##3##2##(1994-5#1)(2011-2#1)(2012-12#1)
potentially curable##9##2##(1990-8#1)(1993-10#1)(2006-9#1)(2008-7#2)(2008-9#1)(2009-5#1)(2011-2#1)(2012-3#1)
potentially curative treatment##2##3##(1996-11#1)(2008-7#1)
potentially curative##13##2##(1992-12#1)(1993-9#1)(1996-11#1)(1997-8#1)(2006-10#3)(2008-7#1)(2013-1#1)(2013-8#4)
potentially damaging##2##2##(1995-8#1)(2007-11#1)
potentially dangerous##21##2##(1992-3#1)(1995-3#1)(1995-9#1)(1996-9#1)(1997-7#1)(2005-9#1)(2006-4#1)(2006-6#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
potentially deadly##3##2##(1991-12#1)(1992-2#1)(2008-9#1)
potentially debilitating##2##2##(2006-10#1)(2009-3#1)
potentially decrease##2##2##(1993-1#1)(2009-9#1)
potentially decreasing##2##2##(2005-12#1)(2007-3#1)
potentially deleterious effects##4##3##(2006-10#2)(2006-3#1)(2008-11#1)
potentially deleterious##5##2##(1992-9#1)(2006-10#2)(2006-3#1)(2008-11#1)
potentially devastating##7##2##(2006-10#2)(2007-2#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-12#1)
potentially different##2##2##(1990-10#1)(2007-11#1)
potentially disabling##3##2##(2007-7#1)(2011-2#1)(2012-12#1)
potentially effective##4##2##(1993-11#1)(2006-10#1)(2010-4#1)(2010-8#1)
potentially enabling##2##2##(2008-3#1)(2011-1#1)
potentially encodes a polypeptide##2##4##(1996-6#1)(2008-10#1)
potentially encodes a##3##3##(1990-7#1)(1996-6#1)(2008-10#1)
potentially encodes##4##2##(1990-7#1)(1996-6#1)(2008-10#2)
potentially encoding##2##2##(1992-11#1)(1997-3#1)
potentially enormous##2##2##(2005-11#1)(2007-11#1)
potentially explain the##3##3##(1995-11#1)(2009-8#2)
potentially explains the##2##3##(2010-8#1)(2012-2#1)
potentially exposed##3##2##(1992-4#1)(1994-6#1)(2008-7#1)
potentially extend the##2##3##(1994-9#1)(2009-4#1)
potentially extend##3##2##(1994-9#1)(2008-10#1)(2009-4#1)
potentially fatal complication##4##3##(2007-8#2)(2012-12#1)(2012-3#1)
potentially fatal condition##3##3##(2006-10#1)(2007-3#1)(2009-11#1)
potentially fatal disease that results in the remodeling of the pulmonary vasculature##2##12##(2013-1#2)
potentially fatal##33##2##(1991-8#1)(1996-12#1)(1996-8#1)(2006-10#5)(2006-4#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#5)(2008-1#1)(2009-11#1)(2009-4#1)(2009-9#1)(2010-2#1)(2011-2#3)(2012-12#3)(2012-3#3)(2013-1#2)
potentially forming a##2##3##(1991-5#1)(2008-10#1)
potentially forming##3##2##(1991-5#1)(1997-4#1)(2008-10#1)
potentially from##2##2##(2008-10#1)(2008-3#1)
potentially functional##2##2##(1993-2#1)(2009-8#1)
potentially greater##3##2##(2007-12#1)(2008-11#2)
potentially harmful to##3##3##(1994-3#1)(2007-2#1)(2008-11#1)
potentially harmful##21##2##(1990-8#1)(1992-5#1)(1994-3#1)(1994-6#1)(1996-8#1)(2006-11#1)(2006-7#1)(2007-2#1)(2007-8#1)(2007-9#2)(2008-11#1)(2008-5#3)(2010-1#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
potentially have##4##2##(2006-10#1)(2008-10#1)(2008-6#1)(2009-10#1)
potentially hazardous##7##2##(2007-5#1)(2008-10#3)(2011-2#1)(2012-2#1)(2012-3#1)
potentially help in##2##3##(2009-8#1)(2012-3#1)
potentially help##3##2##(2009-8#1)(2012-2#1)(2012-3#1)
potentially hepatotoxic drugs##2##3##(2008-11#2)
potentially high risk##2##3##(1995-2#1)(2007-9#1)
potentially high##7##2##(1995-2#1)(2006-10#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#1)
potentially hundreds of##2##3##(2007-12#1)(2008-10#1)
potentially ideal##2##2##(2007-8#1)(2012-12#1)
potentially important for the##2##4##(1995-11#1)(2009-9#1)
potentially important functional##2##3##(1997-2#1)(2004-11#1)
potentially important in##2##3##(1997-6#1)(2013-8#1)
potentially important role##2##3##(1996-8#1)(2011-2#1)
potentially important##36##2##(1991-5#1)(1993-11#2)(1993-6#1)(1993-8#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-6#1)(2004-11#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
potentially improve##2##2##(2009-5#1)(2010-2#1)
potentially improved##2##2##(2012-2#2)
potentially in##3##2##(2006-10#1)(2009-10#1)(2012-3#1)
potentially increases##2##2##(2007-9#1)(2008-5#1)
potentially increasing the##2##3##(2008-5#1)(2010-2#1)
potentially infectious##3##2##(1994-3#1)(2012-1#2)
potentially influence##4##2##(1991-6#1)(1996-12#1)(2007-12#1)(2007-3#1)
potentially interactive surfaces##2##3##(2006-10#2)
potentially interactive##3##2##(2006-10#3)
potentially interesting##2##2##(1990-6#1)(2012-3#1)
potentially interfering##4##2##(1996-9#1)(2007-8#1)(2008-10#2)
potentially involved in##10##3##(1990-7#1)(1993-7#1)(1994-3#1)(1997-4#1)(2008-10#2)(2011-1#2)(2011-2#1)(2012-12#1)
potentially involved##11##2##(1990-7#1)(1993-7#1)(1994-3#1)(1997-4#1)(1997-7#1)(2008-10#2)(2011-1#2)(2011-2#1)(2012-12#1)
potentially large##2##2##(2008-9#1)(2010-1#1)
potentially lead to an##2##4##(1996-7#1)(2008-7#1)
potentially lead to##5##3##(1996-7#1)(2008-7#1)(2009-9#2)(2012-2#1)
potentially leading to the##2##4##(2007-11#1)(2012-3#1)
potentially leading to##10##3##(2006-2#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-5#1)(2009-3#1)(2009-9#1)(2012-2#1)(2012-3#1)
potentially lethal complication##4##3##(2007-3#1)(2008-3#1)(2009-10#1)(2012-12#1)
potentially lethal condition##3##3##(2007-8#1)(2008-10#1)(2013-8#1)
potentially lethal infection##2##3##(2006-10#1)(2008-5#1)
potentially lethal ventricular##2##3##(2004-11#1)(2012-2#1)
potentially lethal##29##2##(1993-10#1)(1994-4#2)(1995-12#1)(1995-8#1)(1996-2#1)(2004-11#1)(2006-1#1)(2006-10#1)(2006-11#2)(2006-9#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
potentially life threatening##4##3##(1995-12#1)(2007-8#1)(2012-2#1)(2013-1#1)
potentially life-threatening complication##3##3##(2007-8#1)(2009-7#1)(2011-12#1)
potentially life-threatening condition that##2##4##(2007-3#1)(2013-8#1)
potentially life-threatening condition##10##3##(2005-8#1)(2007-12#1)(2007-3#1)(2009-12#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
potentially life-threatening side##2##3##(2006-8#1)(2008-6#1)
potentially life-threatening##31##2##(1995-8#1)(1997-5#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-12#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-8#1)(2013-1#4)(2013-8#2)
potentially malignant##2##2##(1995-2#1)(2005-9#1)
potentially misleading##2##2##(1992-11#1)(1997-8#1)
potentially modifiable risk factors##2##4##(2008-8#1)(2009-5#1)
potentially modifiable##5##2##(2007-8#1)(2008-10#1)(2008-8#1)(2009-5#1)(2012-3#1)
potentially modulate##4##2##(1994-9#1)(1996-9#1)(2008-10#1)(2013-1#1)
potentially more##6##2##(2006-11#1)(2006-9#1)(2007-4#1)(2008-11#1)(2011-12#1)(2012-2#1)
potentially negative##2##2##(1994-3#1)(2009-12#1)
potentially neurotoxic##2##2##(1994-11#1)(1995-11#1)
potentially new##5##2##(1990-12#1)(1996-12#1)(2005-8#1)(2008-5#1)(2013-1#1)
potentially novel gene##2##3##(2005-11#1)(2005-6#1)
potentially novel##8##2##(1990-2#1)(1993-7#1)(1996-6#1)(1996-8#1)(2005-11#1)(2005-6#1)(2006-12#1)(2008-5#1)
potentially of##2##2##(2005-11#1)(2011-2#1)
potentially offer##2##2##(2008-12#1)(2008-4#1)
potentially open##2##2##(2007-10#1)(2011-1#1)
potentially other##2##2##(1995-6#1)(2011-2#1)
potentially pathogenic##2##2##(2007-6#1)(2012-2#1)
potentially play a role in##2##5##(1992-7#1)(2009-3#1)
potentially play a##3##3##(1992-7#1)(2007-3#1)(2009-3#1)
potentially play##5##2##(1992-7#1)(2007-3#1)(2008-10#1)(2009-3#1)(2012-2#1)
potentially possible##2##2##(2006-4#1)(2011-2#1)
potentially powerful##5##2##(1993-3#1)(2007-11#1)(2007-12#1)(2008-7#1)(2008-9#1)
potentially present##2##2##(2007-6#1)(2008-10#1)
potentially preventable##4##2##(1992-5#1)(2007-7#2)(2011-2#1)
potentially promising##2##2##(1991-9#1)(2004-4#1)
potentially provide a##3##3##(2006-8#1)(2008-10#1)(2012-3#1)
potentially provide##4##2##(2006-8#1)(2008-10#1)(2009-9#1)(2012-3#1)
potentially providing a##2##3##(1995-3#1)(2008-10#1)
potentially providing##3##2##(1995-3#1)(1997-3#1)(2008-10#1)
potentially reduce##3##2##(2007-10#1)(2010-12#1)(2012-12#1)
potentially reduces##2##2##(2008-12#1)(2011-12#1)
potentially related to##4##3##(1992-6#1)(1996-1#1)(2008-4#1)(2012-12#1)
potentially related##6##2##(1992-6#1)(1996-1#1)(2007-11#1)(2008-4#1)(2011-2#1)(2012-12#1)
potentially relevant##5##2##(2005-12#1)(2012-12#2)(2013-1#1)(2013-8#1)
potentially remediable##2##2##(2008-2#1)(2012-1#1)
potentially represent##2##2##(1997-7#1)(2008-1#1)
potentially resectable##3##2##(1990-10#2)(2008-2#1)
potentially resistant##2##2##(2008-7#1)(2011-2#1)
potentially responsible for##3##3##(2009-3#1)(2009-8#1)(2010-12#1)
potentially responsive to##2##3##(1993-9#1)(2011-2#1)
potentially responsive##3##2##(1993-9#1)(1994-1#1)(2011-2#1)
potentially result in##2##3##(2007-12#1)(2008-5#1)
potentially resulting in##4##3##(2008-9#1)(2010-9#1)(2011-2#1)(2012-2#1)
potentially reversible##10##2##(1991-8#1)(1992-3#1)(1997-8#1)(2005-8#2)(2008-1#1)(2008-7#2)(2011-2#1)(2012-2#1)
potentially risky##2##2##(2007-12#1)(2012-2#1)
potentially safe##3##2##(1992-5#1)(1997-4#1)(2008-10#1)
potentially safer##2##2##(1991-6#1)(2006-10#1)
potentially salvageable##2##2##(2007-9#2)
potentially serious##19##2##(1991-12#1)(1993-4#1)(2004-10#1)(2006-10#1)(2006-7#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-1#1)(2010-11#1)(2010-8#1)(2011-12#1)(2011-2#3)(2012-3#2)
potentially serve as##4##3##(1991-12#1)(2008-5#1)(2009-7#1)(2011-1#1)
potentially severe complications##2##3##(2006-10#1)(2011-3#1)
potentially severe##7##2##(1995-3#1)(2006-10#1)(2006-2#1)(2008-11#1)(2010-1#1)(2011-3#1)(2013-7#1)
potentially significant##5##2##(1994-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-4#1)
potentially successful##2##2##(1991-12#1)(2008-1#1)
potentially suitable##4##2##(1992-5#1)(1994-8#1)(2006-10#1)(2011-2#1)
potentially susceptible to##3##3##(2008-7#1)(2009-4#1)(2011-1#1)
potentially susceptible##4##2##(2008-7#2)(2009-4#1)(2011-1#1)
potentially the most##2##3##(2008-2#1)(2008-9#1)
potentially the##6##2##(1995-3#1)(1996-1#1)(2006-2#1)(2008-2#1)(2008-7#1)(2008-9#1)
potentially therapeutic##6##2##(1994-5#1)(1995-11#1)(1995-12#2)(2007-10#1)(2010-12#1)
potentially toxic accumulation of##2##4##(1990-5#1)(2008-4#1)
potentially toxic##10##2##(1990-5#1)(1997-2#1)(2005-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2011-2#1)(2013-8#1)
potentially treatable##4##2##(1995-8#1)(2006-7#1)(2007-11#1)(2012-2#1)
potentially unique##2##2##(2008-11#1)(2012-1#1)
potentially unnecessary##2##2##(2012-2#1)(2012-3#1)
potentially unstable##2##2##(2009-5#1)(2012-1#1)
potentially useful agents for##2##4##(1992-2#1)(2010-1#1)
potentially useful applications##2##3##(2007-12#1)(2012-2#1)
potentially useful as##2##3##(2007-10#1)(2009-5#1)
potentially useful diagnostic##2##3##(1997-4#1)(2008-12#1)
potentially useful for studying##2##4##(1993-9#1)(1995-11#1)
potentially useful for##22##3##(1991-11#1)(1992-2#1)(1992-6#1)(1993-9#2)(1995-11#1)(1996-9#1)(2006-2#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
potentially useful in##9##3##(1990-8#1)(1992-12#1)(1992-2#1)(1994-11#1)(2007-3#1)(2009-8#1)(2010-3#1)(2013-1#1)(2013-7#1)
potentially useful information##2##3##(2009-12#1)(2009-7#1)
potentially useful tools for##2##4##(1990-9#1)(2006-12#1)
potentially useful##74##2##(1990-8#2)(1990-9#1)(1991-11#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-6#1)(1993-3#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1995-11#1)(1996-8#1)(1996-9#1)(1997-4#1)(2005-8#2)(2006-12#2)(2006-2#2)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-3#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#1)(2009-12#2)(2009-5#1)(2009-7#3)(2009-8#2)(2010-1#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#3)(2013-1#2)(2013-7#1)
potentially valuable in##2##3##(1996-2#1)(2007-11#1)
potentially valuable##8##2##(1992-8#1)(1996-2#1)(2007-11#1)(2007-6#1)(2008-4#1)(2008-9#1)(2009-12#1)(2012-2#1)
potentially very##2##2##(2006-10#1)(2007-2#1)
potentially violent##2##2##(2008-7#2)
potentially vulnerable##4##2##(2007-7#1)(2009-4#1)(2012-1#2)
potentially without##2##2##(1997-2#1)(2007-4#1)
potentially##1092##1##(1990-10#3)(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#4)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#7)(1991-2#2)(1991-4#2)(1991-5#3)(1991-6#2)(1991-8#3)(1991-9#3)(1992-1#1)(1992-11#3)(1992-12#3)(1992-2#6)(1992-3#4)(1992-4#2)(1992-5#5)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#3)(1993-11#4)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#2)(1993-7#3)(1993-8#1)(1993-9#6)(1994-1#1)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#5)(1994-4#2)(1994-5#4)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#3)(1995-10#1)(1995-11#5)(1995-12#4)(1995-2#3)(1995-3#5)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#6)(1995-9#1)(1996-1#3)(1996-11#2)(1996-12#5)(1996-2#3)(1996-3#1)(1996-6#3)(1996-7#2)(1996-8#6)(1996-9#5)(1997-1#1)(1997-2#7)(1997-3#2)(1997-4#7)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#5)(2004-10#1)(2004-11#2)(2004-4#1)(2005-10#1)(2005-11#4)(2005-12#2)(2005-6#1)(2005-7#2)(2005-8#9)(2005-9#2)(2006-1#1)(2006-10#36)(2006-11#5)(2006-12#7)(2006-2#6)(2006-3#2)(2006-4#3)(2006-5#2)(2006-6#3)(2006-7#4)(2006-8#4)(2006-9#4)(2007-10#14)(2007-11#22)(2007-12#21)(2007-2#7)(2007-3#8)(2007-4#7)(2007-5#4)(2007-6#6)(2007-7#14)(2007-8#26)(2007-9#6)(2008-1#11)(2008-10#61)(2008-11#27)(2008-12#14)(2008-2#16)(2008-3#21)(2008-4#17)(2008-5#26)(2008-6#6)(2008-7#31)(2008-8#15)(2008-9#17)(2009-10#7)(2009-11#7)(2009-12#6)(2009-2#3)(2009-3#7)(2009-4#7)(2009-5#6)(2009-6#5)(2009-7#6)(2009-8#9)(2009-9#10)(2010-1#8)(2010-10#2)(2010-11#3)(2010-12#9)(2010-2#10)(2010-3#4)(2010-4#5)(2010-5#3)(2010-6#1)(2010-7#4)(2010-8#8)(2010-9#6)(2011-1#18)(2011-12#7)(2011-2#48)(2011-3#1)(2012-1#12)(2012-11#2)(2012-12#28)(2012-2#31)(2012-3#24)(2012-8#1)(2013-1#44)(2013-7#5)(2013-8#14)
potentials (-0##2##2##(1990-5#1)(2005-11#1)
potentials (0##2##2##(2008-10#2)
potentials (EPPs)##2##2##(1992-8#1)(2008-4#1)
potentials (EPSPs)##6##2##(1992-8#2)(1993-2#2)(1995-5#1)(1996-5#1)
potentials (ERP)##3##2##(2004-11#1)(2008-11#1)(2009-10#1)
potentials (ERPs) were recorded in##3##5##(1993-2#1)(1996-1#2)
potentials (ERPs) were##4##3##(1993-2#1)(1996-1#2)(2008-8#1)
potentials (ERPs)##8##2##(1993-2#1)(1995-2#1)(1996-1#2)(1996-6#1)(2006-3#1)(2008-11#1)(2008-8#1)
potentials (IPSPs) were##2##3##(1993-2#1)(1995-6#1)
potentials (MEPs)##3##2##(2010-2#1)(2010-7#1)(2011-2#1)
potentials (fEPSPs)##3##2##(1995-12#1)(2008-4#1)(2009-5#1)
potentials after##3##2##(1996-4#2)(2012-1#1)
potentials and the##3##3##(1993-6#1)(1996-4#1)(2008-10#1)
potentials and##42##2##(1990-7#1)(1991-1#1)(1991-10#1)(1991-3#1)(1991-4#2)(1991-8#1)(1992-8#1)(1992-9#1)(1993-5#1)(1993-6#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-8#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-2#1)(2011-1#1)(2013-8#1)
potentials and/or##2##2##(1991-10#1)(2008-11#1)
potentials are##12##2##(1991-6#1)(1992-2#1)(1996-1#1)(1996-4#1)(2006-10#1)(2006-4#1)(2006-8#1)(2008-10#1)(2008-8#1)(2009-10#1)(2009-3#1)(2011-2#1)
potentials as##6##2##(1993-8#1)(1994-12#1)(2007-9#1)(2008-1#2)(2013-8#1)
potentials at##2##2##(1991-11#1)(2009-9#1)
potentials before##2##2##(2007-11#1)(2007-9#1)
potentials between##2##2##(1993-12#1)(2008-10#1)
potentials but##2##2##(1991-12#1)(1995-1#1)
potentials by##4##2##(1991-10#1)(1996-10#1)(1997-5#1)(2008-8#1)
potentials can##2##2##(1996-7#1)(2008-11#1)
potentials could be##2##3##(1995-6#1)(1996-6#1)
potentials during##4##2##(1991-11#1)(1991-4#1)(2005-10#1)(2008-11#1)
potentials evoked by##5##3##(1991-11#1)(1991-5#1)(1994-2#1)(2008-11#1)(2008-7#1)
potentials evoked##7##2##(1991-11#1)(1991-5#1)(1992-8#1)(1994-2#1)(1996-9#1)(2008-11#1)(2008-7#1)
potentials for further##2##3##(2008-10#2)
potentials for the##3##3##(2008-10#1)(2008-9#2)
potentials for##12##2##(1991-11#1)(1995-8#1)(2007-5#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-9#3)
potentials from the##2##3##(2007-8#1)(2013-1#1)
potentials from##5##2##(1990-2#1)(1997-3#1)(2007-8#1)(2008-7#1)(2013-1#1)
potentials generated##2##2##(2009-2#1)(2012-2#1)
potentials has##3##2##(1992-2#1)(2006-10#1)(2008-10#1)
potentials have been determined##3##4##(1995-6#1)(2005-11#1)(2008-10#1)
potentials have##4##2##(1995-6#1)(2005-11#1)(2008-10#1)(2013-1#1)
potentials in a##3##3##(2007-10#1)(2008-10#1)(2012-3#1)
potentials in response to##3##4##(1991-4#1)(2011-2#1)(2013-1#1)
potentials in the dentate##2##4##(1992-7#1)(1995-7#1)
potentials in the##17##3##(1991-6#1)(1992-12#1)(1992-7#2)(1992-8#1)(1993-9#1)(1994-10#1)(1995-7#1)(1996-9#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-12#1)(2013-1#1)
potentials in##49##2##(1991-1#1)(1991-4#1)(1991-6#1)(1992-12#1)(1992-7#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#2)(1995-12#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-5#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#2)
potentials induced by##3##3##(1991-3#1)(1991-5#2)
potentials is##5##2##(1996-4#1)(1996-7#1)(2006-9#1)(2008-4#2)
potentials measured##3##2##(1990-3#1)(1991-3#1)(1995-5#1)
potentials mediated by##2##3##(2008-7#2)
potentials more negative than -60 mV##2##6##(1994-2#1)(1996-5#1)
potentials more negative than##4##4##(1993-3#1)(1994-2#1)(1996-5#1)(1997-2#1)
potentials more positive than##3##4##(1993-3#1)(1996-5#1)(1997-2#1)
potentials more##8##2##(1993-3#2)(1994-2#1)(1996-5#2)(1997-2#2)(2012-2#1)
potentials obtained##2##2##(2008-10#1)(2012-1#1)
potentials of -1##2##3##(2008-10#1)(2012-7#1)
potentials of hMSCs##3##3##(2008-11#3)
potentials of the##17##3##(1990-7#1)(1991-10#1)(1991-4#1)(1992-3#1)(1995-7#2)(1995-8#1)(1997-4#1)(2005-11#1)(2006-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-8#1)
potentials of these##2##3##(2010-11#1)(2010-5#1)
potentials of##72##2##(1990-7#1)(1991-10#1)(1991-11#1)(1991-4#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-2#1)(1994-3#1)(1995-10#1)(1995-6#1)(1995-7#3)(1995-8#1)(1996-10#1)(1997-4#1)(1997-8#2)(2005-10#1)(2005-11#2)(2006-11#1)(2007-12#1)(2008-1#1)(2008-10#14)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-8#2)(2009-10#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-5#1)(2012-3#1)(2012-7#1)(2013-1#2)(2013-8#1)
potentials on##6##2##(1992-12#1)(2005-11#1)(2008-10#3)(2013-8#1)
potentials or##3##2##(1997-6#1)(2008-10#1)(2009-12#1)
potentials recorded in##2##3##(1993-12#1)(2008-9#1)
potentials recorded##6##2##(1991-3#1)(1993-12#1)(1996-6#1)(2008-4#1)(2008-9#1)(2011-1#1)
potentials recording##2##2##(2006-10#1)(2013-1#1)
potentials revealed that##2##3##(1996-6#1)(2008-11#1)
potentials showed##2##2##(1993-5#1)(2007-9#1)
potentials similar to those##2##4##(1992-4#1)(2007-12#1)
potentials suggest that##2##3##(2008-11#1)(2009-2#1)
potentials than##2##2##(1994-3#1)(2008-10#1)
potentials that##10##2##(1990-5#1)(1990-7#1)(1994-2#1)(2007-8#1)(2008-11#1)(2008-4#1)(2009-12#1)(2010-2#1)(2012-1#1)(2012-2#1)
potentials to##10##2##(1990-4#1)(1995-8#1)(1996-5#1)(1996-6#1)(2008-10#1)(2008-4#1)(2009-12#2)(2010-2#1)(2013-7#1)
potentials was##6##2##(1990-11#1)(1991-8#1)(1994-3#1)(1995-6#1)(2012-1#1)(2013-1#1)
potentials were determined##3##3##(1995-10#1)(2005-11#1)(2008-10#1)
potentials were not##2##3##(1996-2#1)(2007-9#1)
potentials were recorded from##2##4##(1996-12#1)(1996-6#1)
potentials were recorded using the##2##5##(1991-1#1)(2008-11#1)
potentials were recorded##5##3##(1991-1#1)(1996-12#1)(1996-6#1)(2008-11#1)(2008-7#1)
potentials were##29##2##(1990-2#2)(1990-9#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-2#1)(1995-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(2005-11#1)(2007-9#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#2)
potentials when##2##2##(1992-9#1)(2008-10#1)
potentials where##2##2##(2005-11#1)(2008-10#1)
potentials which##4##2##(1992-11#1)(1997-5#1)(2008-7#1)(2012-2#1)
potentials with##8##2##(1994-10#1)(1995-2#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-12#1)(2010-7#1)
potentials without##2##2##(2007-8#1)(2008-10#1)
potentials##604##1##(1990-11#2)(1990-2#5)(1990-3#3)(1990-4#1)(1990-5#6)(1990-7#4)(1990-8#1)(1990-9#1)(1991-1#6)(1991-10#6)(1991-11#5)(1991-12#3)(1991-2#3)(1991-3#8)(1991-4#5)(1991-5#5)(1991-6#4)(1991-8#6)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#5)(1992-3#5)(1992-4#2)(1992-6#1)(1992-7#3)(1992-8#11)(1992-9#4)(1993-12#5)(1993-2#9)(1993-3#3)(1993-5#2)(1993-6#1)(1993-8#2)(1993-9#3)(1994-10#4)(1994-11#1)(1994-12#3)(1994-2#8)(1994-3#5)(1994-5#3)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#2)(1995-12#8)(1995-2#3)(1995-3#1)(1995-5#4)(1995-6#11)(1995-7#4)(1995-8#5)(1996-1#7)(1996-10#3)(1996-12#1)(1996-2#2)(1996-3#3)(1996-4#7)(1996-5#7)(1996-6#8)(1996-7#4)(1996-8#2)(1996-9#3)(1997-1#3)(1997-2#3)(1997-3#3)(1997-4#3)(1997-5#9)(1997-6#2)(1997-7#4)(1997-8#3)(2004-11#1)(2005-10#5)(2005-11#12)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#6)(2006-11#1)(2006-3#2)(2006-4#3)(2006-6#2)(2006-8#3)(2006-9#1)(2007-10#4)(2007-11#4)(2007-12#3)(2007-2#2)(2007-5#1)(2007-8#8)(2007-9#8)(2008-1#5)(2008-10#88)(2008-11#34)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#16)(2008-5#4)(2008-6#2)(2008-7#12)(2008-8#8)(2008-9#10)(2009-10#4)(2009-12#6)(2009-2#3)(2009-3#2)(2009-5#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#5)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#4)(2012-1#4)(2012-11#2)(2012-2#6)(2012-3#2)(2012-7#1)(2013-1#9)(2013-7#1)(2013-8#5)
potentiate AII-induced##2##2##(1991-6#2)
potentiate antitumour##2##2##(2005-12#1)(2006-10#1)
potentiate diacylglycerol-activated protein kinase C##2##5##(1990-5#2)
potentiate excitatory##2##2##(1990-7#1)(1992-8#1)
potentiate its##2##2##(2006-6#1)(2010-3#1)
potentiate the effect of##3##4##(1996-12#1)(1996-2#1)(1996-5#1)
potentiate the effects of##6##4##(1996-2#1)(2005-7#1)(2006-10#1)(2006-12#1)(2008-5#1)(2010-4#1)
potentiate the##29##2##(1990-12#2)(1990-7#1)(1990-8#2)(1991-4#1)(1991-7#2)(1992-3#1)(1993-3#1)(1993-6#1)(1995-12#1)(1996-11#1)(1996-12#3)(1996-2#3)(1996-5#1)(2005-7#1)(2006-10#1)(2006-12#1)(2008-11#1)(2008-5#1)(2010-4#1)(2012-1#2)(2012-12#1)
potentiate##73##1##(1990-10#2)(1990-12#2)(1990-5#2)(1990-7#2)(1990-8#2)(1991-3#1)(1991-4#1)(1991-6#2)(1991-7#3)(1992-12#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#3)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-7#1)(1996-11#1)(1996-12#4)(1996-2#3)(1996-5#1)(1997-4#1)(1997-7#1)(2005-12#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2010-12#1)(2010-3#2)(2010-4#1)(2011-12#1)(2012-1#2)(2012-12#2)(2012-6#1)
potentiated by 1##2##3##(1996-12#1)(2008-11#1)
potentiated by adenosine##2##3##(1994-11#1)(2008-5#1)
potentiated by an##2##3##(1997-5#1)(2008-8#1)
potentiated by the##6##3##(1990-7#1)(1993-6#2)(1995-12#1)(2007-10#1)(2008-4#1)
potentiated by##39##2##(1990-10#1)(1990-11#1)(1990-5#1)(1990-7#2)(1991-3#1)(1991-9#1)(1992-11#1)(1992-8#1)(1993-6#4)(1994-11#1)(1994-12#1)(1994-5#2)(1994-6#1)(1995-12#1)(1995-8#1)(1996-12#2)(1996-5#1)(1997-2#2)(1997-5#2)(2007-10#2)(2008-11#2)(2008-4#2)(2008-5#2)(2008-8#1)(2012-12#1)(2013-1#2)
potentiated carbachol-stimulated##2##2##(1994-10#1)(1997-1#1)
potentiated fear##2##2##(2008-11#2)
potentiated in a##2##3##(1996-1#1)(1996-2#1)
potentiated in vitro##2##3##(2007-1#2)
potentiated in##7##2##(1990-5#1)(1990-8#1)(1996-1#1)(1996-2#2)(2007-1#2)
potentiated insulin secretion in##2##4##(1990-8#1)(1995-8#1)
potentiated insulin##3##2##(1990-8#2)(1995-8#1)
potentiated its##2##2##(1995-3#1)(2008-5#1)
potentiated the anticonvulsive##2##3##(1993-11#1)(1997-5#1)
potentiated the effect of##2##4##(1991-3#1)(1992-6#1)
potentiated the effect##3##3##(1991-3#1)(1992-12#1)(1992-6#1)
potentiated the effects of the##2##5##(1991-6#1)(1996-12#1)
potentiated the effects of##4##4##(1991-6#1)(1996-12#1)(1997-7#1)(2012-1#1)
potentiated the growth##2##3##(1992-3#1)(2008-8#1)
potentiated the response to##3##4##(1993-12#1)(1995-11#1)(2007-10#1)
potentiated the responses##3##3##(1990-10#1)(1990-7#1)(2008-8#1)
potentiated the##52##2##(1990-10#2)(1990-2#2)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-6#2)(1994-2#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-7#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2004-12#1)(2007-10#1)(2008-11#1)(2008-4#2)(2008-8#3)(2012-1#1)
potentiated##161##1##(1990-10#3)(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#3)(1990-7#4)(1990-8#3)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#4)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#2)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#2)(1993-11#3)(1993-12#2)(1993-3#1)(1993-6#6)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#4)(1994-6#2)(1995-11#4)(1995-12#4)(1995-3#2)(1995-7#3)(1995-8#2)(1996-1#3)(1996-12#3)(1996-2#6)(1996-5#1)(1996-8#3)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#4)(1997-6#1)(1997-7#2)(2004-12#3)(2005-1#1)(2007-1#3)(2007-10#3)(2008-10#2)(2008-11#6)(2008-4#7)(2008-5#3)(2008-8#4)(2009-4#2)(2010-12#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#1)
potentiates its##3##2##(1991-5#1)(1994-9#1)(2008-5#1)
potentiates the##15##2##(1990-2#1)(1991-7#1)(1993-11#2)(1993-3#2)(1995-8#1)(1996-10#1)(1997-2#1)(1997-4#1)(1997-5#1)(2008-4#1)(2008-5#1)(2010-12#2)
potentiates##57##1##(1990-12#1)(1990-2#2)(1990-7#2)(1990-8#1)(1991-1#1)(1991-3#1)(1991-5#1)(1991-7#1)(1993-11#2)(1993-3#2)(1994-10#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(2004-12#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-12#2)(2012-12#3)(2013-1#1)
potentiating effect of CGRP##3##4##(1997-4#3)
potentiating effect of##13##3##(1990-5#1)(1993-4#1)(1994-5#2)(1996-12#2)(1997-3#1)(1997-4#4)(2008-4#2)
potentiating effect on the##2##4##(1991-7#1)(2008-8#1)
potentiating effect on##3##3##(1991-7#1)(1991-8#1)(2008-8#1)
potentiating effect##18##2##(1990-5#1)(1991-7#1)(1991-8#1)(1993-4#1)(1994-5#2)(1995-11#1)(1996-12#3)(1997-3#1)(1997-4#4)(2008-4#2)(2008-8#1)
potentiating effects##2##2##(1995-11#2)
potentiating or##2##2##(1995-5#1)(2012-2#1)
potentiating the##10##2##(1993-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(2006-6#1)(2008-1#1)(2012-1#1)(2012-12#1)(2013-7#1)
potentiating##38##1##(1990-5#1)(1991-7#1)(1991-8#1)(1992-3#1)(1993-12#1)(1993-4#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-11#4)(1995-12#1)(1995-3#1)(1995-5#1)(1996-12#4)(1997-3#1)(1997-4#4)(2006-10#1)(2006-6#1)(2008-1#2)(2008-4#2)(2008-8#1)(2010-11#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
potentiation (LTP) is##2##3##(1990-4#1)(1997-2#1)
potentiation (LTP) of##2##3##(1991-3#1)(1993-2#1)
potentiation (LTP) was##4##3##(1991-9#1)(1995-12#2)(2008-7#1)
potentiation (LTP)##44##2##(1990-4#1)(1990-5#1)(1990-9#1)(1991-3#4)(1991-6#2)(1991-9#1)(1992-12#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-5#1)(1994-10#1)(1994-11#1)(1994-2#1)(1995-12#3)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-11#2)(2008-7#3)(2008-9#1)(2009-5#1)(2009-8#2)(2011-2#1)(2012-3#1)
potentiation and depression in the##2##5##(2008-2#1)(2009-6#1)
potentiation and depression##3##3##(2008-2#1)(2008-7#1)(2009-6#1)
potentiation and##8##2##(1991-3#2)(1995-12#1)(2008-2#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-3#1)
potentiation by methamphetamine##2##3##(1995-3#2)
potentiation by##7##2##(1991-6#1)(1993-2#1)(1993-6#1)(1995-3#2)(1995-8#1)(2008-7#1)
potentiation in the dentate gyrus##3##5##(1995-12#2)(1997-5#1)
potentiation in the hippocampus##2##4##(1995-12#1)(2008-11#1)
potentiation in the rat##3##4##(1990-5#1)(1991-9#1)(1994-2#1)
potentiation in the##17##3##(1990-4#1)(1990-5#1)(1991-3#1)(1991-8#1)(1991-9#1)(1994-2#1)(1995-12#5)(1996-8#1)(1997-1#1)(1997-5#1)(1997-7#1)(2008-11#1)(2008-7#1)
potentiation in##28##2##(1990-4#1)(1990-5#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-12#1)(1994-2#1)(1994-5#1)(1995-12#5)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)
potentiation is##2##2##(1995-12#1)(1995-3#1)
potentiation of AII-induced drinking##2##4##(1991-6#2)
potentiation of carbon tetrachloride hepatotoxicity##3##5##(1995-3#3)
potentiation of carbon##4##3##(1995-3#4)
potentiation of field##2##3##(1995-12#2)
potentiation of ileal contractions##2##4##(1992-8#2)
potentiation of insulin secretion##2##4##(1990-12#1)(1996-5#1)
potentiation of phagocytosis##4##3##(1993-6#4)
potentiation of synaptic transmission##3##4##(1994-2#1)(1995-2#1)(1996-5#1)
potentiation of the field excitatory postsynaptic##2##6##(1991-8#1)(1995-12#1)
potentiation of the population spike##3##5##(1991-12#2)(1995-12#1)
potentiation of the##29##3##(1990-5#1)(1990-7#1)(1991-12#2)(1991-6#1)(1991-8#2)(1992-10#1)(1993-11#1)(1993-12#1)(1993-6#2)(1994-2#3)(1994-5#1)(1995-11#1)(1995-12#2)(1995-8#1)(1996-1#1)(1996-12#1)(1997-4#2)(1997-7#1)(2007-7#1)(2008-10#1)(2008-5#1)(2012-1#1)
potentiation of##92##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#3)(1991-3#1)(1991-6#3)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-11#2)(1993-12#1)(1993-5#1)(1993-6#7)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#4)(1994-5#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#4)(1995-5#1)(1995-8#2)(1996-1#2)(1996-10#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#3)(1997-7#2)(2005-8#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-11#1)(2010-5#1)(2012-1#1)(2012-2#1)
potentiation was##5##2##(1993-6#1)(1995-12#1)(1995-3#1)(1997-7#1)(2009-5#1)
potentiation were##2##2##(1991-12#1)(1991-6#1)
potentiation##247##1##(1990-12#1)(1990-4#2)(1990-5#4)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#7)(1991-3#10)(1991-6#9)(1991-8#4)(1991-9#4)(1992-1#2)(1992-10#1)(1992-12#3)(1992-3#5)(1992-5#1)(1992-6#1)(1992-8#2)(1993-11#3)(1993-12#6)(1993-2#2)(1993-5#2)(1993-6#9)(1993-8#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#8)(1994-5#2)(1995-11#1)(1995-12#23)(1995-2#2)(1995-3#10)(1995-5#1)(1995-7#1)(1995-8#3)(1996-1#5)(1996-10#2)(1996-12#2)(1996-2#4)(1996-3#2)(1996-4#1)(1996-5#5)(1996-6#3)(1996-8#2)(1996-9#3)(1997-1#4)(1997-2#2)(1997-3#2)(1997-4#6)(1997-5#1)(1997-7#4)(1997-8#2)(2005-8#1)(2006-6#1)(2007-10#2)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#4)(2008-5#2)(2008-7#10)(2008-8#2)(2008-9#2)(2009-1#2)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#4)(2010-11#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#1)
potentiations##2##1##(1994-2#1)(1995-2#1)
potentiators##3##1##(1994-2#1)(2008-1#2)
potentiometer##5##1##(2007-1#1)(2008-10#4)
potentiometric and spectrophotometric##2##3##(2008-10#2)
potentiometric and spectroscopic##2##3##(2008-3#1)(2010-5#1)
potentiometric and##11##2##(2008-10#8)(2008-3#2)(2010-5#1)
potentiometric anion##2##2##(2008-10#2)
potentiometric back-titration##2##2##(2008-10#2)
potentiometric biosensor for##2##3##(2008-10#2)
potentiometric biosensor##3##2##(2008-10#3)
potentiometric clinical analyser##2##3##(2008-10#2)
potentiometric data##2##2##(2008-10#1)(2008-5#1)
potentiometric detection in##2##3##(2008-10#1)(2010-5#1)
potentiometric detection of##6##3##(2008-10#3)(2010-5#3)
potentiometric detection##11##2##(2008-10#7)(2010-5#4)
potentiometric detector##2##2##(2008-10#2)
potentiometric detectors##2##2##(2008-10#2)
potentiometric determination of nitrite ion##2##5##(2008-10#2)
potentiometric determination of##22##3##(2007-8#1)(2008-10#21)
potentiometric electronic tongue##2##3##(2008-10#2)
potentiometric end-point detection##2##3##(2008-10#2)
potentiometric flow injection determination##3##4##(2008-10#3)
potentiometric flow injection##6##3##(2008-10#6)
potentiometric flow titration##2##3##(2008-10#2)
potentiometric flow##9##2##(2008-10#9)
potentiometric indicator##3##2##(2008-10#3)
potentiometric ion##2##2##(2008-10#2)
potentiometric measurements and##2##3##(2008-10#2)
potentiometric measurements##5##2##(2008-10#5)
potentiometric membrane electrode##2##3##(2008-10#2)
potentiometric membrane electrodes (EPMEs) based on##3##6##(2008-10#3)
potentiometric membrane electrodes based on alpha-##2##6##(2008-10#2)
potentiometric membrane electrodes based on maltodextrins##2##6##(2008-10#2)
potentiometric membrane electrodes based on##8##5##(2008-10#8)
potentiometric membrane electrodes for the##2##5##(2008-10#2)
potentiometric membrane electrodes##15##3##(2008-10#15)
potentiometric membrane##18##2##(2008-10#18)
potentiometric method based on##2##4##(2008-10#2)
potentiometric method for the##2##4##(2008-10#2)
potentiometric method for##3##3##(2008-10#3)
potentiometric method##13##2##(2008-10#13)
potentiometric pH-sensitive field-effect transistors##2##4##(2008-10#2)
potentiometric response characteristics of##4##4##(2008-10#4)
potentiometric response characteristics##7##3##(2007-8#1)(2008-10#6)
potentiometric response was##2##3##(2008-10#2)
potentiometric response##20##2##(2007-8#1)(2008-10#19)
potentiometric responses##3##2##(2008-10#3)
potentiometric selectivity coefficient##4##3##(2008-10#4)
potentiometric selectivity coefficients of ion-selective##2##5##(2008-10#2)
potentiometric selectivity coefficients of##4##4##(2008-10#4)
potentiometric selectivity coefficients##6##3##(2008-10#6)
potentiometric selectivity##20##2##(2008-10#20)
potentiometric sensor based on##3##4##(2008-10#3)
potentiometric sensor for ascorbic acid based on cobalt phthalocyanine nanoparticles##2##10##(2008-10#2)
potentiometric sensor for##7##3##(2008-10#7)
potentiometric sensor##24##2##(2008-10#24)
potentiometric sensors based on##2##4##(2008-10#2)
potentiometric sensors for##4##3##(2008-10#4)
potentiometric sensors##14##2##(2008-10#14)
potentiometric stripping analysis##2##3##(2008-10#2)
potentiometric studies##2##2##(1996-8#1)(2008-10#1)
potentiometric study##3##2##(2008-10#3)
potentiometric technique##2##2##(2008-10#2)
potentiometric titration data##2##3##(2005-11#1)(2008-10#1)
potentiometric titration is##2##3##(2008-10#2)
potentiometric titration method##4##3##(2008-10#4)
potentiometric titration of Mg(2+)##2##4##(2008-10#2)
potentiometric titration of##32##3##(2008-10#32)
potentiometric titration was##2##3##(2008-10#2)
potentiometric titration with##2##3##(2008-10#2)
potentiometric titration##57##2##(2005-11#2)(2008-10#55)
potentiometric titrations and##2##3##(2008-10#1)(2008-3#1)
potentiometric titrations in##2##3##(2005-11#1)(2008-3#1)
potentiometric titrations of##5##3##(2008-10#5)
potentiometric titrations##24##2##(1997-3#1)(2005-11#2)(2008-10#19)(2008-3#2)
potentiometric##337##1##(1991-3#1)(1996-2#1)(1996-8#1)(1997-3#1)(2005-11#4)(2007-8#5)(2008-10#305)(2008-3#6)(2008-5#4)(2010-5#9)
potentiometrically in##5##2##(2008-10#5)
potentiometrically using a##2##3##(2008-10#1)(2008-11#1)
potentiometrically with##4##2##(2007-11#2)(2008-10#2)
potentiometrically##23##1##(2006-12#1)(2007-11#2)(2008-10#19)(2008-11#1)
potentiometry and##6##2##(2008-10#6)
potentiometry as##2##2##(2008-10#2)
potentiometry by##3##2##(2008-10#3)
potentiometry for##2##2##(2008-10#2)
potentiometry in##2##2##(2008-10#2)
potentiometry with##2##2##(2008-10#1)(2008-5#1)
potentiometry##44##1##(1991-3#1)(1997-2#1)(2005-11#1)(2008-10#38)(2008-5#1)(2010-5#1)(2013-7#1)
potentiostat and##2##2##(2008-10#2)
potentiostat##4##1##(2008-10#4)
potentiostatic##5##1##(2004-9#1)(2008-10#2)(2008-5#1)(2010-4#1)
potently and selectively##2##3##(1993-7#1)(2007-11#1)
potently inhibit##3##2##(1994-8#1)(2006-10#1)(2008-3#1)
potently inhibited by##5##3##(1990-10#1)(1993-11#1)(1994-8#1)(1995-8#1)(1996-10#1)
potently inhibited the##7##3##(1990-2#1)(1992-4#1)(1992-7#1)(1995-10#1)(1995-12#1)(1997-7#1)(2011-12#1)
potently inhibited##18##2##(1990-10#1)(1990-2#1)(1992-4#1)(1992-7#2)(1993-11#1)(1993-3#1)(1994-8#2)(1995-10#1)(1995-12#1)(1995-8#1)(1996-10#2)(1996-4#1)(1997-7#1)(2011-12#1)(2011-2#1)
potently inhibits the##4##3##(1991-12#1)(1993-3#1)(1995-11#1)(2009-7#1)
potently inhibits##9##2##(1991-12#1)(1993-3#2)(1995-11#1)(1995-12#1)(2005-3#1)(2008-8#1)(2009-3#1)(2009-7#1)
potently stimulates##2##2##(1992-3#1)(1995-12#1)
potently suppress##2##2##(1994-6#1)(2010-7#1)
potently##61##1##(1990-10#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-7#2)(1992-8#1)(1993-11#2)(1993-2#1)(1993-3#8)(1993-6#1)(1993-7#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-10#1)(1995-11#1)(1995-12#3)(1995-6#1)(1995-8#2)(1996-10#2)(1996-2#1)(1996-4#2)(1996-5#1)(1997-5#1)(1997-7#1)(2005-3#1)(2005-6#1)(2006-10#1)(2007-11#1)(2008-3#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
potexviruses##2##1##(1997-2#1)(2008-10#1)
potocytosis and##2##2##(1995-2#1)(1995-6#1)
potocytosis##5##1##(1994-6#1)(1995-2#2)(1995-6#2)
potomac division meeting##7##3##(2008-11#7)
potomac##9##1##(2008-11#9)
potometry##2##1##(2008-5#2)
pots and##2##2##(2008-10#2)
pots containing##3##2##(2008-10#2)(2009-3#1)
pots##14##1##(1994-4#1)(2008-10#9)(2008-12#1)(2009-3#3)
potted plants##4##2##(2008-10#3)(2008-12#1)
potted##13##1##(2008-10#10)(2008-12#2)(2010-12#1)
pottery##6##1##(1994-6#1)(2007-8#3)(2008-10#2)
potting compounds##5##2##(2004-9#5)
potting media##3##2##(2008-10#3)
potting medium##4##2##(2008-10#4)
potting mix was##2##3##(2008-10#2)
potting mix were##2##3##(2008-10#2)
potting mix##23##2##(2008-10#22)(2013-1#1)
potting mixes##3##2##(2008-10#3)
potting mixture##2##2##(2008-10#2)
potting mixtures##3##2##(2008-10#3)
potting##47##1##(2004-9#6)(2008-10#40)(2013-1#1)
potyvirus HC-Pro##4##2##(2008-10#4)
potyvirus##28##1##(2008-10#27)(2008-9#1)
potyviruses##17##1##(2008-10#16)(2008-9#1)
pouch II##2##2##(1996-3#2)
pouch colon##4##2##(2010-2#4)
pouch in##3##2##(2007-12#1)(2012-12#2)
pouch is##2##2##(2006-10#1)(2009-12#1)
pouch of##3##2##(1994-9#1)(2008-5#1)(2011-1#1)
pouch or##2##2##(1993-4#1)(2008-10#1)
pouch polyps##2##2##(2009-12#2)
pouch young##2##2##(1995-11#2)
pouch##64##1##(1990-4#2)(1991-6#1)(1992-3#1)(1992-5#1)(1993-4#1)(1994-9#1)(1995-11#2)(1995-12#1)(1996-3#2)(1997-1#1)(2006-10#3)(2007-12#8)(2008-10#5)(2008-2#1)(2008-5#3)(2008-8#5)(2009-12#7)(2010-12#3)(2010-2#6)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#5)(2012-3#1)
pouch-anal anastomosis is the##2##4##(1997-5#1)(2009-12#1)
pouch-anal anastomosis##5##2##(1997-5#1)(2006-10#3)(2009-12#1)
pouches in the##2##3##(1995-11#1)(2008-5#1)
pouches in##3##2##(1995-11#1)(2008-10#1)(2008-5#1)
pouches##9##1##(1994-3#1)(1995-11#1)(2007-7#1)(2008-10#2)(2008-5#2)(2012-12#2)
pouchitis and##2##2##(1993-10#1)(2012-1#1)
pouchitis##6##1##(1993-10#1)(2006-10#3)(2007-11#1)(2012-1#1)
poultry Veillonella##2##2##(2006-8#2)
poultry and##4##2##(1994-3#1)(2008-5#3)
poultry dust##2##2##(2013-8#2)
poultry farmers##2##2##(2011-2#2)
poultry farms in##2##3##(2011-2#1)(2011-3#1)
poultry farms##4##2##(1997-5#1)(2008-8#1)(2011-2#1)(2011-3#1)
poultry flocks##3##2##(2008-5#1)(2013-8#2)
poultry house##2##2##(2007-6#1)(2013-8#1)
poultry houses##4##2##(2007-6#2)(2008-10#1)(2011-12#1)
poultry in Denmark##2##3##(2008-5#2)
poultry in##7##2##(1996-3#1)(2005-7#1)(2007-3#1)(2008-5#3)(2011-2#1)
poultry industry##5##2##(1996-3#1)(2007-6#1)(2012-2#1)(2013-8#2)
poultry intake##2##2##(2011-2#2)
poultry isolate##6##2##(2006-8#6)
poultry manure with##2##3##(2011-12#2)
poultry manure##8##2##(2008-5#6)(2011-12#2)
poultry meat##3##2##(1996-3#1)(2005-5#1)(2008-3#1)
poultry patties packaged in##2##4##(2010-4#2)
poultry patties##3##2##(2010-4#3)
poultry production##2##2##(1990-3#1)(2011-3#1)
poultry products##3##2##(1990-3#1)(1990-6#1)(2008-5#1)
poultry sheds##3##2##(2006-12#3)
poultry##118##1##(1990-3#2)(1990-6#1)(1990-8#1)(1991-5#1)(1993-10#1)(1994-11#1)(1994-3#6)(1995-8#1)(1995-9#1)(1996-3#3)(1997-5#3)(2005-5#1)(2005-7#1)(2005-9#4)(2006-12#5)(2006-8#9)(2007-3#1)(2007-6#4)(2007-8#1)(2008-10#4)(2008-3#3)(2008-5#24)(2008-6#1)(2008-8#4)(2008-9#1)(2010-2#1)(2010-4#5)(2010-7#1)(2011-12#4)(2011-2#8)(2011-3#2)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#10)
poultry)##2##1##(2008-10#1)(2011-2#1)
poultry-processing workers in##2##3##(2006-12#2)
poults and##3##2##(1997-6#1)(2008-5#2)
poults from flock A##2##4##(1997-3#2)
poults from##4##2##(1997-3#2)(2008-5#2)
poults were##4##2##(1997-3#1)(1997-6#2)(2008-5#1)
poults with##2##2##(1997-6#1)(2008-5#1)
poults##42##1##(1990-6#1)(1992-2#1)(1997-3#6)(1997-6#10)(2004-11#1)(2005-9#2)(2008-5#21)
poumons##2##1##(2011-2#1)(2013-1#1)
pound 13 billion##2##3##(2012-12#2)
pound of##3##2##(1995-9#1)(1997-3#1)(2006-8#1)
pound sterling##3##2##(2004-2#1)(2005-9#2)
pound##16##1##(1995-11#1)(1995-9#1)(1997-3#1)(2004-1#2)(2004-2#1)(2005-9#2)(2006-8#1)(2007-8#2)(2007-9#1)(2010-4#1)(2012-12#2)(2013-1#1)
pound25##2##1##(2006-10#1)(2008-4#1)
pound30##3##1##(2006-10#2)(2008-4#1)
pound60##3##1##(2006-10#3)
pounded yam##5##2##(2008-4#5)
pounds sterling##7##2##(2005-8#4)(2006-12#3)
pounds##14##1##(1992-8#1)(1996-3#2)(1996-8#1)(2005-10#1)(2005-8#4)(2005-9#1)(2006-12#3)(2008-1#1)
pour des##3##2##(2008-5#1)(2012-2#1)(2013-1#1)
pour l'Observation de la Terre##2##5##(2008-2#1)(2008-3#1)
pour la##4##2##(2007-12#1)(2008-5#1)(2008-7#1)(2012-2#1)
pour le##2##2##(2008-11#1)(2012-2#1)
pour les##3##2##(2008-5#1)(2011-2#1)(2012-2#1)
pour plate##3##2##(2006-10#1)(2008-10#1)(2008-5#1)
pour un##2##2##(2012-2#1)(2013-1#1)
pour une##3##2##(2011-2#1)(2012-2#2)
pour##43##1##(2006-10#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#11)(2008-7#1)(2009-7#1)(2011-2#3)(2012-2#13)(2013-1#5)
pour-on##5##1##(1996-12#3)(2007-8#2)
pour-ons##3##1##(2006-10#2)(2007-8#1)
poured into##2##2##(2007-11#1)(2008-11#1)
poured##7##1##(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-12#1)(2012-10#1)
pouring##5##1##(1992-8#1)(2008-4#2)(2009-7#1)(2012-1#1)
pourrait##2##1##(2011-2#1)(2013-1#1)
pouvant##2##1##(2011-2#1)(2012-2#1)
poverty and HIV/AIDS##2##3##(2007-7#2)
poverty and health##2##3##(1993-1#1)(2008-9#1)
poverty and inequality##2##3##(2008-9#2)
poverty and social##2##3##(2008-9#2)
poverty and##28##2##(1993-1#1)(1994-3#1)(2006-2#1)(2006-3#1)(2007-12#1)(2007-6#2)(2007-7#3)(2008-1#1)(2008-11#3)(2008-4#1)(2008-9#7)(2009-8#1)(2010-8#1)(2012-12#2)(2012-2#1)(2012-3#1)
poverty approach##3##2##(2010-3#1)(2010-8#2)
poverty for##2##2##(2008-11#1)(2008-9#1)
poverty in##6##2##(2006-4#1)(2007-12#1)(2007-7#1)(2008-11#2)(2008-9#1)
poverty is##3##2##(2008-11#2)(2013-7#1)
poverty level were##2##3##(2010-11#1)(2011-2#1)
poverty line##3##2##(2005-10#1)(2007-12#1)(2007-7#1)
poverty measurement##2##2##(2010-3#1)(2010-8#1)
poverty on the##2##3##(2008-11#1)(2009-8#1)
poverty on##3##2##(2008-11#2)(2009-8#1)
poverty rates##2##2##(2008-11#1)(2013-8#1)
poverty reduction##5##2##(2006-4#1)(2007-7#2)(2008-9#1)(2009-4#1)
poverty strategy##2##2##(2008-11#1)(2013-1#1)
poverty##152##1##(1990-6#2)(1992-1#1)(1992-5#1)(1993-1#2)(1993-10#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-9#1)(1997-2#1)(1997-6#1)(2005-10#1)(2005-7#1)(2006-2#1)(2006-3#2)(2006-4#3)(2006-8#1)(2007-12#3)(2007-6#2)(2007-7#13)(2008-1#3)(2008-10#1)(2008-11#39)(2008-12#1)(2008-4#3)(2008-7#5)(2008-8#1)(2008-9#18)(2009-10#1)(2009-11#1)(2009-4#2)(2009-8#4)(2010-11#1)(2010-3#5)(2010-8#8)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
poverty-reduction strategy##2##2##(2008-11#2)
povidone iodine solution##2##3##(2007-7#1)(2010-6#1)
povidone iodine##7##2##(1990-3#1)(2007-1#1)(2007-7#2)(2010-6#3)
povidone##8##1##(1990-3#1)(2007-1#1)(2007-7#2)(2008-10#1)(2010-6#3)
povidone-iodine##2##1##(2006-4#1)(2011-2#1)
powder X-ray diffraction (XRD)##2##4##(2005-11#1)(2013-8#1)
powder X-ray diffraction##9##3##(1996-2#1)(1997-7#1)(2005-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-7#1)(2013-8#1)
powder XRD##2##2##(2005-11#1)(2008-10#1)
powder and infant##2##3##(2008-10#2)
powder and then##2##3##(2008-10#1)(2013-1#1)
powder and##19##2##(1991-2#1)(1992-2#1)(1996-2#1)(1997-7#1)(2004-11#1)(2005-11#1)(2007-8#1)(2008-10#7)(2009-9#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
powder as##3##2##(1994-11#1)(2011-2#2)
powder by##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
powder catalysts##3##2##(2008-10#3)
powder characteristics##5##2##(2004-9#4)(2005-11#1)
powder cocaine##2##2##(2007-8#2)
powder containing##2##2##(2008-12#1)(2011-2#1)
powder diet##2##2##(2008-12#2)
powder diffraction (XRD)##3##3##(2008-10#2)(2012-2#1)
powder diffraction data##2##3##(1997-7#1)(2006-4#1)
powder diffraction##13##2##(1996-2#1)(1997-7#1)(2004-9#1)(2006-12#1)(2006-4#1)(2007-11#1)(2008-10#2)(2008-6#1)(2009-5#1)(2011-3#1)(2012-2#1)(2012-3#1)
powder does not##2##3##(1992-8#1)(2004-9#1)
powder for##4##2##(2007-11#1)(2009-7#1)(2011-3#2)
powder form##7##2##(1994-6#1)(2004-9#1)(2008-10#2)(2011-2#2)(2012-2#1)
powder formulations##2##2##(2008-10#1)(2010-8#1)
powder from dormant##2##3##(2008-5#2)
powder from##4##2##(2008-5#3)(2009-6#1)
powder fruit drink has been##2##5##(2006-10#2)
powder fruit drink##3##3##(2006-10#3)
powder had##2##2##(2004-11#1)(2004-9#1)
powder has##2##2##(2008-10#1)(2011-2#1)
powder in##7##2##(2008-10#3)(2008-5#1)(2009-7#1)(2010-4#1)(2013-1#1)
powder inhalation##2##2##(1992-3#1)(2010-1#1)
powder inhaler (DPI)##3##3##(1997-1#1)(1997-2#2)
powder inhaler##11##2##(1994-2#3)(1996-2#5)(1997-1#1)(1997-2#2)
powder inhalers (DPI's)##2##3##(1992-3#2)
powder inhalers##8##2##(1992-3#4)(1996-1#2)(2007-11#2)
powder is##3##2##(1991-2#1)(2007-11#1)(2008-2#1)
powder metallurgy##3##2##(2009-7#3)
powder of##4##2##(2008-10#1)(2008-12#1)(2008-5#1)(2009-8#1)
powder on##4##2##(1994-6#1)(1995-3#1)(2006-4#2)
powder or##3##2##(1992-3#1)(2007-1#1)(2013-7#1)
powder particle##2##2##(2004-9#2)
powder pattern##3##2##(1995-10#1)(1997-7#1)(2008-10#1)
powder patterns##3##2##(1991-4#1)(1997-7#2)
powder samples##7##2##(2006-5#1)(2008-10#2)(2012-2#2)(2013-8#2)
powder spray containing##2##3##(2008-5#2)
powder spray##3##2##(2008-5#3)
powder that##2##2##(2008-5#1)(2011-2#1)
powder to##4##2##(2010-5#2)(2011-2#1)(2012-2#1)
powder used##2##2##(2006-10#1)(2008-10#1)
powder was##10##2##(1990-8#1)(2007-10#1)(2007-8#1)(2008-10#5)(2008-5#1)(2013-8#1)
powder with##2##2##(2004-9#1)(2008-10#1)
powder x-ray##2##2##(1991-5#1)(2008-5#1)
powder##305##1##(1990-8#1)(1991-11#1)(1991-2#2)(1991-4#1)(1991-5#1)(1992-2#1)(1992-3#6)(1992-8#1)(1994-11#1)(1994-2#3)(1994-5#1)(1994-6#5)(1995-10#1)(1995-11#2)(1995-3#2)(1996-1#2)(1996-2#11)(1996-9#1)(1997-1#2)(1997-2#2)(1997-7#6)(2004-11#2)(2004-9#20)(2005-10#1)(2005-11#9)(2005-4#1)(2005-8#1)(2006-10#7)(2006-12#2)(2006-4#4)(2006-5#2)(2007-1#2)(2007-10#3)(2007-11#10)(2007-3#2)(2007-6#3)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#71)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#15)(2008-6#3)(2008-7#1)(2009-5#2)(2009-6#2)(2009-7#9)(2009-8#3)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#6)(2010-5#3)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#16)(2011-3#3)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#9)
powder's##2##1##(2008-10#1)(2012-12#1)
powder)##6##1##(2008-10#6)
powder-type 2H NMR spectra##2##4##(1991-4#2)
powdered corn cobs##2##3##(2007-10#2)
powdered form##2##2##(2004-9#1)(2006-1#1)
powdered infant formula##6##3##(2007-12#6)
powdered milk##4##2##(2008-10#1)(2009-8#2)(2011-2#1)
powdered samples##3##2##(2005-11#1)(2005-12#1)(2008-10#1)
powdered##39##1##(1990-3#1)(1993-9#1)(2004-9#1)(2005-11#3)(2005-12#1)(2006-1#1)(2007-1#1)(2007-10#2)(2007-12#6)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#4)(2009-4#1)(2009-8#2)(2010-12#1)(2011-2#1)(2013-1#1)
powders and##2##2##(2005-11#1)(2008-10#1)
powders are##2##2##(2010-5#1)(2010-8#1)
powders in##3##2##(1994-6#1)(2005-11#1)(2009-7#1)
powders may##2##2##(1995-3#1)(2008-10#1)
powders of##2##2##(2008-10#1)(2010-4#1)
powders was##3##2##(2004-9#1)(2005-11#1)(2007-6#1)
powders were##3##2##(2004-9#2)(2010-4#1)
powders with##2##2##(2008-10#2)
powders##64##1##(1994-6#4)(1995-3#3)(2004-9#17)(2005-11#6)(2006-12#1)(2007-1#1)(2007-6#2)(2008-10#17)(2008-3#1)(2008-5#2)(2009-7#1)(2010-4#3)(2010-5#1)(2010-8#5)
powdery and downy##2##3##(2008-10#2)
powdery mildew (Podosphaera##2##3##(2008-10#2)
powdery mildew (Uncinula##2##3##(2008-10#2)
powdery mildew and##4##3##(2008-10#4)
powdery mildew development on##2##4##(2008-10#2)
powdery mildew fungi##2##3##(2008-10#2)
powdery mildew fungus##3##3##(2008-10#3)
powdery mildew in the##2##4##(2008-10#2)
powdery mildew in##7##3##(2008-10#7)
powdery mildew of##2##3##(2008-10#2)
powdery mildew resistance gene in Suwon 92##2##7##(2008-10#2)
powdery mildew resistance gene in##3##5##(2008-10#3)
powdery mildew resistance gene##4##4##(2006-9#1)(2008-10#3)
powdery mildew resistance in NC96BGTA5##2##5##(2008-10#2)
powdery mildew resistance in Suwon 92##2##6##(2008-10#2)
powdery mildew resistance in the##2##5##(2008-10#2)
powdery mildew resistance in##9##4##(2006-9#1)(2008-10#8)
powdery mildew resistance##19##3##(2006-9#4)(2008-10#15)
powdery mildew was evaluated##2##4##(2008-10#2)
powdery mildew was##4##3##(2008-10#4)
powdery mildew were##2##3##(2008-10#2)
powdery mildew##98##2##(2006-9#4)(2008-10#93)(2009-8#1)
powdery mildews##3##2##(2008-10#3)
powdery##108##1##(2006-9#4)(2007-7#2)(2008-10#99)(2008-5#1)(2009-8#1)(2010-4#1)
power (1##2##2##(2008-1#1)(2008-3#1)
power (relative##2##2##(2008-7#1)(2009-7#1)
power Doppler imaging##2##3##(2006-10#2)
power Doppler##6##2##(2006-10#4)(2007-11#1)(2010-12#1)
power absorption in##2##3##(1992-3#2)
power absorption##4##2##(1992-3#2)(1992-8#1)(2008-3#1)
power abuse##2##2##(2010-1#2)
power among##2##2##(1991-12#1)(2009-4#1)
power amplifier system##2##3##(2007-12#2)
power amplifier##15##2##(2007-11#2)(2007-12#8)(2008-2#3)(2008-3#1)(2009-10#1)
power analysis##8##2##(2007-7#3)(2008-11#1)(2008-2#1)(2008-9#1)(2010-8#1)(2013-1#1)
power and a##5##3##(1995-3#1)(2007-11#2)(2007-12#1)(2008-10#1)
power and an##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
power and as##2##3##(1991-5#1)(2007-12#1)
power and efficiency##4##3##(2007-8#1)(2008-3#1)(2008-7#1)(2012-1#1)
power and flexibility##2##3##(1992-12#1)(2005-7#1)
power and high##2##3##(2007-12#1)(2008-3#1)
power and in##2##3##(2008-11#1)(2008-3#1)
power and potential of##2##4##(2008-11#1)(2010-7#1)
power and precision##2##3##(2008-9#1)(2009-11#1)
power and resolution##3##3##(2008-10#2)(2012-3#1)
power and small##2##3##(2007-12#1)(2008-10#1)
power and the##17##3##(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#5)(2008-8#1)(2010-4#1)(2012-1#1)(2012-3#1)
power and thus##2##3##(2006-10#1)(2008-3#1)
power and type I error rates##2##6##(1993-4#1)(2010-2#1)
power and wavelength tuning##2##4##(2007-11#1)(2008-9#1)
power and wavelength##4##3##(2007-11#1)(2007-12#2)(2008-9#1)
power and##148##2##(1990-3#1)(1991-1#1)(1991-5#1)(1992-1#1)(1992-12#1)(1993-2#1)(1993-4#1)(1994-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-5#1)(2005-7#1)(2006-10#2)(2006-4#2)(2007-11#8)(2007-12#20)(2007-2#2)(2007-4#1)(2007-8#1)(2008-1#4)(2008-10#15)(2008-11#3)(2008-2#12)(2008-3#19)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#5)(2009-11#2)(2009-7#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#2)(2012-1#4)(2012-2#2)(2012-3#6)(2013-1#2)(2013-7#2)(2013-8#4)
power are compared##2##3##(2008-2#1)(2009-3#1)
power are##10##2##(1995-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-3#1)(2009-4#1)(2012-3#1)
power as a function of##3##5##(1993-4#1)(1996-3#1)(2008-2#1)
power as##11##2##(1993-4#1)(1996-3#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2009-4#1)(2011-1#1)(2011-2#1)
power at 1##2##3##(2007-11#1)(2008-2#1)
power at 532 nm##3##4##(2007-12#2)(2008-2#1)
power at a pulse repetition##2##5##(2007-12#2)
power at a wavelength of##2##5##(2007-12#2)
power at a##11##3##(2007-12#11)
power at the##7##3##(2007-12#3)(2008-2#1)(2008-3#1)(2008-9#1)(2010-3#1)
power at##51##2##(1993-8#1)(2007-11#4)(2007-12#27)(2008-1#2)(2008-10#1)(2008-2#7)(2008-3#5)(2008-8#1)(2008-9#1)(2010-3#1)(2013-8#1)
power between##4##2##(1993-4#1)(1997-3#1)(2007-12#1)(2011-2#1)
power budget##2##2##(2007-11#1)(2008-2#1)
power buildup##2##2##(2008-3#2)
power by use of##2##4##(2007-12#2)
power by using##2##3##(2007-12#1)(2012-3#1)
power by##14##2##(2007-11#2)(2007-12#5)(2008-3#3)(2012-1#2)(2012-3#2)
power calculations for##2##3##(1997-2#2)
power calculations##5##2##(1993-4#1)(1996-3#1)(1997-2#2)(2008-8#1)
power can be##3##3##(1995-12#1)(2007-12#1)(2012-12#1)
power can##9##2##(1991-12#1)(1992-9#1)(1995-12#1)(2007-12#1)(2008-3#3)(2010-9#1)(2012-12#1)
power carried##2##2##(2008-3#2)
power characteristics##2##2##(2008-2#2)
power collected by the antenna##2##5##(2008-2#2)
power compared with##2##3##(2007-12#1)(2011-1#1)
power compared##3##2##(2007-12#1)(2011-1#1)(2012-3#1)
power confirmed##2##2##(2007-11#1)(2007-12#1)
power consumption and##4##3##(2008-2#1)(2009-5#1)(2010-11#1)(2011-1#1)
power consumption is##2##3##(2006-6#1)(2008-3#1)
power consumption of the##2##4##(2008-2#1)(2013-7#1)
power consumption of##3##3##(2008-2#2)(2013-7#1)
power consumption##25##2##(2006-6#1)(2007-9#1)(2008-10#1)(2008-2#12)(2008-3#1)(2008-7#2)(2009-5#1)(2010-11#2)(2010-12#1)(2011-1#1)(2013-1#1)(2013-7#1)
power conversion efficiencies##2##3##(2008-3#1)(2011-2#1)
power conversion efficiency##4##3##(2007-12#1)(2008-1#1)(2008-2#1)(2010-4#1)
power conversion##6##2##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2010-4#1)(2011-2#1)
power cords from service##2##4##(2011-1#1)(2011-2#1)
power cords from##3##3##(2011-1#1)(2011-2#2)
power cords##7##2##(2011-1#2)(2011-2#5)
power corresponding to##3##3##(2008-2#2)(2008-3#1)
power coupling to##2##3##(2008-2#2)
power coupling##6##2##(2008-2#5)(2008-3#1)
power decreases with##2##3##(2007-12#1)(2008-10#1)
power delivery##2##2##(2007-12#1)(2008-3#1)
power densities of##2##3##(2008-1#1)(2008-2#1)
power densities##6##2##(2008-1#2)(2008-2#3)(2013-7#1)
power density at the##2##4##(1992-12#2)
power density at##3##3##(1992-12#2)(1995-2#1)
power density of##3##3##(2007-12#1)(2008-12#1)(2008-2#1)
power density##18##2##(1992-1#1)(1992-12#2)(1995-2#1)(2007-12#3)(2008-1#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#1)(2012-2#1)
power dependence of##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
power dependence##4##2##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
power deposition in##2##3##(1992-3#1)(2008-2#1)
power deposition##5##2##(1992-3#1)(2007-11#1)(2008-2#3)
power dissipation##3##2##(2010-8#2)(2011-1#1)
power distribution##4##2##(1992-7#1)(2008-2#1)(2008-3#1)(2011-1#1)
power distributions##2##2##(2008-2#2)
power efficiency of##3##3##(1995-3#1)(2007-12#2)
power efficiency##7##2##(1995-3#1)(2007-12#3)(2008-2#2)(2008-3#1)
power emitted by##2##3##(2007-12#2)
power enhancement and##3##3##(2007-12#2)(2008-1#1)
power enhancement##4##2##(2007-12#3)(2008-1#1)
power exceeding##2##2##(2007-12#1)(2008-3#1)
power extraction##3##2##(2008-2#1)(2008-3#2)
power fluctuation##2##2##(2008-2#1)(2008-3#1)
power fluctuations##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
power for a##5##3##(1996-8#1)(2007-12#1)(2008-10#1)(2008-3#2)
power for detecting a##2##4##(1995-2#2)
power for detecting##4##3##(1994-2#1)(1995-2#2)(2012-3#1)
power for self-focusing in##3##4##(2007-12#3)
power for self-focusing##5##3##(2007-12#5)
power for the##9##3##(1995-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-4#1)(2010-3#1)
power for##48##2##(1993-4#1)(1994-2#1)(1994-4#1)(1995-2#2)(1995-4#1)(1995-8#1)(1996-8#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-11#4)(2007-12#9)(2008-10#5)(2008-11#1)(2008-2#5)(2008-3#4)(2009-4#1)(2010-12#1)(2010-3#2)(2012-3#4)(2013-8#1)
power frequency##3##2##(2010-12#1)(2012-2#2)
power from a##6##3##(2007-11#3)(2007-12#2)(2008-3#1)
power from an##2##3##(2007-11#1)(2007-12#1)
power from the##3##3##(2006-7#1)(2007-12#1)(2008-3#1)
power from##19##2##(2006-7#1)(2007-11#5)(2007-12#6)(2008-3#3)(2008-5#2)(2013-1#2)
power function##10##2##(1992-6#3)(1994-8#1)(1995-8#1)(1997-7#1)(2005-4#2)(2008-6#1)(2008-7#1)
power has been obtained##3##4##(2007-12#2)(2008-2#1)
power has been##10##3##(2007-11#2)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#3)(2008-5#1)
power has##14##2##(1992-3#1)(1993-2#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#3)(2008-5#1)(2010-5#1)(2012-1#1)
power imbalance##2##2##(2006-11#1)(2011-2#1)
power imbalances##2##2##(1997-3#2)
power in a diffraction-limited beam##2##5##(2007-12#2)
power in a diffraction-limited##3##4##(2007-12#3)
power in a##11##3##(2006-5#1)(2007-11#1)(2007-12#6)(2008-1#1)(2008-2#1)(2008-3#1)
power in health##2##3##(1993-2#1)(1997-2#1)
power in predicting##2##3##(1995-8#1)(2006-5#1)
power in the##25##3##(1991-3#1)(1995-2#1)(1995-8#2)(1997-1#2)(1997-7#1)(2007-10#1)(2007-11#4)(2007-12#4)(2008-3#5)(2008-7#1)(2009-4#1)(2009-5#1)(2009-7#1)
power in this##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2010-8#1)
power in##73##2##(1991-3#1)(1991-5#1)(1992-3#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-12#1)(1995-2#1)(1995-8#3)(1997-1#2)(1997-2#1)(1997-7#1)(2006-5#2)(2007-10#1)(2007-11#7)(2007-12#18)(2008-1#1)(2008-2#2)(2008-3#7)(2008-7#4)(2008-9#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#3)(2013-1#1)
power increased##3##2##(1995-3#1)(2007-11#1)(2008-2#1)
power index##2##2##(2007-4#1)(2013-7#1)
power indices##2##2##(2013-7#2)
power input##2##2##(2007-4#1)(2008-8#1)
power into the##3##3##(2007-12#1)(2008-3#2)
power into##7##2##(1997-1#1)(2007-12#1)(2008-2#2)(2008-3#3)
power is a##2##3##(1997-3#1)(2009-11#1)
power is increased##3##3##(1992-12#1)(2007-12#2)
power is presented##2##3##(2007-11#1)(2008-3#1)
power is the##2##3##(2008-2#1)(2008-3#1)
power is to##2##3##(2007-12#1)(2008-7#1)
power is##47##2##(1992-1#1)(1992-12#1)(1997-3#1)(2006-2#1)(2006-4#1)(2007-11#5)(2007-12#14)(2008-1#2)(2008-11#1)(2008-2#4)(2008-3#7)(2008-5#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-3#1)
power law and##2##3##(2008-10#2)
power law dependence##2##3##(2007-10#1)(2009-12#1)
power law was used to##2##5##(2008-10#2)
power law was##3##3##(2008-10#2)(2011-12#1)
power law with##3##3##(2008-10#2)(2008-8#1)
power law##46##2##(1994-3#1)(2005-11#2)(2006-12#1)(2006-7#2)(2007-10#1)(2007-12#2)(2007-6#1)(2008-10#23)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-12#2)(2010-5#1)(2011-12#2)(2011-2#1)
power level of##3##3##(2007-12#2)(2008-1#1)
power level##6##2##(2007-12#4)(2008-1#1)(2008-3#1)
power levels are##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
power levels##16##2##(2006-4#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#8)(2012-11#1)
power limiter is##2##3##(2007-12#2)
power limiter##4##2##(2007-12#4)
power lines##2##2##(1992-2#1)(1994-4#1)
power loss##4##2##(1992-12#1)(2008-2#2)(2008-3#1)
power losses##2##2##(2008-3#1)(2008-5#1)
power maps##4##2##(1996-6#2)(2008-2#1)(2009-7#1)
power measurements##2##2##(1992-12#1)(2008-10#1)
power microwave##2##2##(2008-10#1)(2011-2#1)
power model##2##2##(2007-5#1)(2008-8#1)
power monitoring##2##2##(2007-9#2)
power near##3##2##(2008-2#1)(2008-3#2)
power needed##2##2##(2008-1#2)
power not##2##2##(2007-4#1)(2012-3#1)
power obtained from##3##3##(1995-8#1)(2008-1#1)(2008-7#1)
power obtained##4##2##(1995-8#1)(2007-12#1)(2008-1#1)(2008-7#1)
power of &gt##6##3##(2007-11#1)(2007-12#3)(2008-2#1)(2010-4#1)
power of &quot##2##3##(2009-10#1)(2009-3#1)
power of 0##9##3##(2006-10#1)(2007-11#2)(2007-12#5)(2008-2#1)
power of 1 W##9##4##(2007-11#1)(2007-12#5)(2008-2#1)(2008-3#2)
power of 1 mW##2##4##(2008-3#2)
power of 1##23##3##(2005-4#1)(2007-11#2)(2007-12#8)(2008-1#1)(2008-2#4)(2008-3#7)
power of 10 mW and a##2##6##(2008-2#1)(2008-3#1)
power of 10 mW##4##4##(2008-2#3)(2008-3#1)
power of 10##5##3##(1996-12#1)(2008-2#3)(2008-3#1)
power of 11##2##3##(2007-12#1)(2008-3#1)
power of 2##8##3##(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#2)(2011-1#1)
power of 200 mW##3##4##(2007-12#2)(2008-3#1)
power of 3##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
power of 400##2##3##(2007-12#1)(2008-2#1)
power of 5##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
power of 60 mW##2##4##(2007-11#1)(2007-12#1)
power of 60##3##3##(1991-3#1)(2007-11#1)(2007-12#1)
power of 68##2##3##(2007-12#1)(2008-2#1)
power of 7##2##3##(2007-11#1)(2008-3#1)
power of IMT##2##3##(2012-3#2)
power of UV lamp##2##4##(2007-10#1)(2008-10#1)
power of a single##2##4##(2007-12#1)(2012-3#1)
power of a##20##3##(1993-5#1)(1995-9#1)(1997-4#2)(2007-12#4)(2008-10#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-8#1)(2012-2#2)(2012-3#1)
power of an##4##3##(2007-12#1)(2008-10#1)(2012-2#1)(2012-3#1)
power of approximately 100##2##4##(2008-10#1)(2008-2#1)
power of approximately##7##3##(1996-8#1)(2006-4#1)(2008-10#1)(2008-2#2)(2008-3#1)(2012-3#1)
power of as much as##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
power of attorney##4##3##(1992-1#1)(1997-1#1)(2010-8#2)
power of discrimination##2##3##(2008-12#2)
power of each##2##3##(2011-1#1)(2011-2#1)
power of flow cytometry##2##4##(2008-9#2)
power of irradiation##2##3##(2008-10#2)
power of large##2##3##(1997-1#1)(2010-12#1)
power of less than##2##4##(2008-1#1)(2008-3#1)
power of linkage##2##3##(2010-2#1)(2011-2#1)
power of only##4##3##(2007-12#2)(2008-2#2)
power of several##2##3##(2006-10#1)(2007-12#1)
power of some##2##3##(1992-2#1)(2008-11#1)
power of special##2##3##(1996-2#1)(2008-5#1)
power of the input##3##4##(2007-11#2)(2007-12#1)
power of the laser##3##4##(2006-12#1)(2008-2#1)(2008-3#1)
power of the method##2##4##(2008-3#1)(2012-12#1)
power of the model##2##4##(2008-10#1)(2010-12#1)
power of the models##4##4##(2005-12#1)(2008-10#1)(2008-5#1)(2009-8#1)
power of the proposed##2##4##(2010-11#1)(2012-3#1)
power of the system##2##4##(1995-11#1)(2008-11#1)
power of the test##3##4##(1992-9#1)(1996-3#1)(2012-3#1)
power of the##86##3##(1990-12#1)(1992-2#1)(1992-9#3)(1993-12#1)(1994-2#1)(1994-9#2)(1995-11#1)(1996-3#3)(1997-3#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-12#1)(2006-12#1)(2007-11#4)(2007-12#9)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#11)(2008-3#14)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#4)
power of these##7##3##(2005-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-3#1)(2013-1#1)
power of this methodology##2##4##(2008-2#1)(2012-2#1)
power of this##7##3##(2005-8#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-2#2)(2012-2#1)
power of up to##3##4##(2007-11#1)(2007-12#2)
power of##422##2##(1990-12#1)(1991-3#2)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-9#3)(1993-12#1)(1993-3#2)(1993-5#1)(1994-2#2)(1994-3#1)(1994-9#2)(1995-11#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#4)(1996-3#4)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-12#1)(2005-4#1)(2005-8#2)(2005-9#1)(2006-10#3)(2006-12#1)(2006-4#3)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#29)(2007-12#86)(2007-2#3)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#21)(2008-11#4)(2008-12#6)(2008-2#50)(2008-3#45)(2008-4#5)(2008-5#6)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#3)(2009-10#2)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#4)(2010-2#4)(2010-4#2)(2010-5#1)(2010-8#3)(2010-9#4)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#9)(2012-3#18)(2013-1#2)(2013-8#3)
power on a##3##3##(1993-3#1)(1994-6#1)(2011-1#1)
power on the##6##3##(2007-11#1)(2007-12#2)(2008-3#2)(2008-9#1)
power on##12##2##(1993-3#1)(1994-6#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-9#1)(2011-1#1)
power or##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
power oscillator with##2##3##(2007-12#2)
power oscillator##3##2##(2007-11#1)(2007-12#2)
power output##6##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)
power over the range##3##4##(2007-11#1)(2008-3#2)
power over the##7##3##(2006-2#1)(2007-10#1)(2007-11#1)(2008-3#3)(2011-2#1)
power over##13##2##(1995-4#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-5#2)(2008-11#1)(2008-3#3)(2011-2#1)(2012-11#1)(2013-1#1)
power penalty##4##2##(2007-11#1)(2007-12#1)(2008-2#2)
power per##3##2##(2008-2#1)(2008-3#2)
power performance reported to date from##2##6##(2008-2#2)
power performance##5##2##(2007-12#1)(2008-2#4)
power plant##19##2##(2004-4#6)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#2)(2010-8#1)(2011-2#1)(2012-2#4)
power poles##2##2##(2011-2#2)
power produced##2##2##(1997-1#1)(2007-12#1)
power production from##2##3##(1994-5#1)(2008-5#1)
power range##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
power ratio##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
power relative to the##2##4##(1995-8#1)(2007-11#1)
power required for##2##3##(2006-4#1)(2007-12#1)
power required to##2##3##(2008-3#2)
power required##6##2##(2006-4#1)(2007-12#1)(2008-2#1)(2008-3#2)(2013-1#1)
power requirements##8##2##(2006-7#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#1)
power scaling##3##2##(2008-2#1)(2008-3#2)
power series##5##2##(2008-2#3)(2008-3#2)
power source##4##2##(1996-1#1)(2007-5#1)(2008-1#1)(2008-4#1)
power spectra and##2##3##(2007-9#1)(2008-8#1)
power spectra of the##2##4##(2008-3#2)
power spectra of##3##3##(2007-12#1)(2008-3#2)
power spectra were##3##3##(1997-1#2)(2008-2#1)
power spectra##18##2##(1995-8#1)(1996-5#1)(1997-1#3)(2007-11#1)(2007-12#1)(2007-9#1)(2008-2#3)(2008-3#5)(2008-8#1)(2008-9#1)
power spectral densities##3##3##(2007-12#1)(2008-3#2)
power spectral density (PSD)##3##4##(2008-3#1)(2010-8#1)(2012-1#1)
power spectral density functions##2##4##(2008-2#2)
power spectral density of##3##4##(2007-12#1)(2008-3#2)
power spectral density##14##3##(2007-12#2)(2008-2#4)(2008-3#5)(2010-8#1)(2012-1#1)(2012-2#1)
power spectral##21##2##(1991-8#1)(1997-1#1)(2006-11#1)(2007-12#3)(2008-2#5)(2008-3#7)(2010-8#1)(2012-1#1)(2012-2#1)
power spectrum as a##2##4##(2007-12#1)(2008-3#1)
power spectrum broadens##2##3##(2008-3#2)
power spectrum from##2##3##(2007-12#1)(2008-3#1)
power spectrum is##6##3##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)
power spectrum of the spontaneous Brillouin backscattered light##2##8##(2008-3#2)
power spectrum of the spontaneous##3##5##(2008-3#3)
power spectrum of the##12##4##(2007-12#1)(2008-2#5)(2008-3#6)
power spectrum of##15##3##(1990-4#1)(2007-12#1)(2008-2#5)(2008-3#8)
power spectrum that##2##3##(2008-3#2)
power spectrum with##3##3##(2007-12#2)(2008-3#1)
power spectrum##52##2##(1990-4#1)(1990-8#1)(1997-1#1)(1997-6#1)(2007-11#2)(2007-12#10)(2008-10#1)(2008-11#1)(2008-2#11)(2008-3#21)(2009-2#1)(2010-12#1)
power stability of##2##3##(2008-3#2)
power stabilization##2##2##(2008-3#2)
power station##3##2##(1990-12#1)(2008-10#1)(2012-2#1)
power stations##7##2##(2008-10#6)(2008-3#1)
power supplies##2##2##(2007-8#1)(2008-2#1)
power supply and##2##3##(2006-6#1)(2012-1#1)
power supply##18##2##(2006-6#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#7)(2008-3#2)(2009-10#1)(2011-1#1)(2011-2#1)(2012-1#1)
power system##3##2##(2008-2#2)(2012-1#1)
power than the##2##3##(1997-7#1)(2008-10#1)
power than##10##2##(1993-11#1)(1997-1#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-4#1)(2012-3#2)
power that is##3##3##(2008-2#2)(2008-4#1)
power that##10##2##(1997-3#1)(2007-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2009-3#1)(2010-4#1)
power the##2##2##(2007-12#1)(2012-1#1)
power threshold of##5##3##(2007-11#1)(2007-12#2)(2008-1#2)
power threshold##7##2##(2007-11#2)(2007-12#2)(2008-1#3)
power to a prosthetic knee##2##5##(2013-1#2)
power to a##3##3##(2007-12#1)(2013-1#2)
power to demonstrate##2##3##(2007-11#1)(2012-3#1)
power to detect associations##2##4##(2012-3#2)
power to detect genes with##2##5##(2008-4#1)(2012-3#1)
power to detect rare variants##3##5##(2012-3#3)
power to detect##17##3##(1996-2#1)(1997-5#1)(2004-1#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-3#10)
power to the##9##3##(2006-4#1)(2007-11#1)(2008-2#1)(2008-3#2)(2009-4#1)(2010-12#1)(2012-2#1)(2013-7#1)
power to##60##2##(1991-6#1)(1992-1#1)(1992-2#1)(1993-10#1)(1993-3#1)(1994-9#1)(1996-2#1)(1997-1#1)(1997-5#1)(2004-1#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#5)(2009-4#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-8#2)(2011-1#1)(2012-2#2)(2012-3#13)(2013-1#3)(2013-7#1)
power transfer efficiency##5##3##(2010-10#3)(2013-7#2)
power transfer##11##2##(2007-11#1)(2007-12#2)(2008-3#2)(2010-10#3)(2013-7#3)
power transmission and thermal##2##4##(2008-3#2)
power transmission and##4##3##(2008-3#3)(2008-5#1)
power transmission##13##2##(2008-10#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2010-10#1)(2010-12#2)
power under##4##2##(1992-2#1)(1994-9#1)(1995-2#1)(2007-12#1)
power up to##2##3##(2007-12#1)(2008-3#1)
power using the##3##3##(2006-3#1)(2012-3#2)
power using##4##2##(2006-3#1)(2012-3#3)
power variation##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
power variations##4##2##(2007-11#1)(2008-2#3)
power was also##2##3##(2007-11#1)(2008-2#1)
power was generated with##2##4##(2008-2#2)
power was measured##5##3##(2007-11#1)(2008-2#1)(2008-3#2)(2013-8#1)
power was obtained##2##3##(2007-12#1)(2008-2#1)
power was reduced by##2##4##(2008-2#1)(2008-3#1)
power was##36##2##(1991-10#1)(2007-11#5)(2007-12#3)(2008-1#2)(2008-10#3)(2008-2#8)(2008-3#7)(2008-7#1)(2009-7#1)(2011-2#2)(2012-3#2)(2013-8#1)
power we##3##2##(1993-6#1)(2007-12#2)
power were generated##2##3##(2008-10#1)(2008-3#1)
power were obtained##2##3##(2007-12#1)(2008-2#1)
power were##10##2##(1997-1#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-2#1)
power when##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
power while##2##2##(1997-6#1)(2007-12#1)
power with a##3##3##(2007-12#1)(2008-3#1)(2011-1#1)
power with an##2##3##(2007-12#1)(2008-2#1)
power with respect to the##2##5##(2008-2#1)(2008-5#1)
power with respect to##3##4##(1992-10#1)(2008-2#1)(2008-5#1)
power with the##3##3##(2007-12#1)(2008-3#1)(2013-8#1)
power with##19##2##(1992-10#1)(1996-3#1)(2006-10#1)(2007-11#3)(2007-12#4)(2008-2#4)(2008-3#2)(2008-5#1)(2011-1#1)(2013-8#1)
power within a##2##3##(2007-11#1)(2008-1#1)
power within the##2##3##(2008-2#1)(2008-3#1)
power within##5##2##(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#1)(2010-8#1)
power##2201##1##(1990-10#1)(1990-12#3)(1990-3#2)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-1#2)(1991-10#1)(1991-12#2)(1991-3#3)(1991-5#2)(1991-6#1)(1991-8#1)(1992-1#7)(1992-10#1)(1992-12#10)(1992-2#6)(1992-3#6)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#6)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#5)(1993-3#4)(1993-4#5)(1993-5#2)(1993-6#3)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#4)(1994-3#3)(1994-4#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#5)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#6)(1995-3#5)(1995-4#4)(1995-5#1)(1995-6#2)(1995-8#14)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#7)(1996-3#8)(1996-5#4)(1996-6#3)(1996-7#1)(1996-8#3)(1997-1#18)(1997-2#7)(1997-3#15)(1997-4#4)(1997-5#2)(1997-6#4)(1997-7#4)(2004-1#1)(2004-4#6)(2005-11#5)(2005-12#1)(2005-4#4)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#14)(2006-11#3)(2006-12#3)(2006-2#5)(2006-3#1)(2006-4#12)(2006-5#3)(2006-6#4)(2006-7#8)(2006-8#2)(2006-9#3)(2007-1#1)(2007-10#9)(2007-11#143)(2007-12#379)(2007-2#6)(2007-4#6)(2007-5#7)(2007-6#1)(2007-7#4)(2007-8#6)(2007-9#8)(2008-1#43)(2008-10#138)(2008-11#25)(2008-12#9)(2008-2#284)(2008-3#288)(2008-4#15)(2008-5#28)(2008-6#8)(2008-7#36)(2008-8#20)(2008-9#20)(2009-1#1)(2009-10#6)(2009-11#4)(2009-12#4)(2009-2#1)(2009-3#5)(2009-4#9)(2009-5#8)(2009-6#2)(2009-7#10)(2009-8#1)(2009-9#2)(2010-1#5)(2010-10#5)(2010-11#5)(2010-12#17)(2010-2#11)(2010-3#4)(2010-4#9)(2010-5#6)(2010-7#3)(2010-8#15)(2010-9#10)(2011-1#26)(2011-12#3)(2011-2#38)(2012-1#19)(2012-11#2)(2012-12#5)(2012-2#37)(2012-3#74)(2013-1#24)(2013-7#17)(2013-8#12)
power&quot##2##1##(2008-12#1)(2008-4#1)
power)##13##1##(1990-12#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-6#1)(2012-12#1)
power-amplifier system##5##2##(2007-12#4)(2008-2#1)
power-amplifier##7##1##(2007-12#5)(2008-2#1)(2008-3#1)
power-assist##3##1##(2012-1#3)
power-conversion efficiency##3##2##(2007-12#2)(2008-10#1)
power-delivery system##2##2##(2008-3#2)
power-delivery##4##1##(2008-3#4)
power-dependent lens##2##2##(2008-2#2)
power-dependent##4##1##(2007-12#1)(2008-2#2)(2008-3#1)
power-efficient##2##1##(2008-2#1)(2009-5#1)
power-gap law##2##2##(2008-2#2)
power-law distributions##2##2##(2007-12#1)(2008-2#1)
power-law exponent##4##2##(2007-12#3)(2008-3#1)
power-law model##2##2##(2008-10#2)
power-law##29##1##(1990-4#1)(1991-12#1)(2005-11#1)(2006-7#1)(2007-12#5)(2008-10#5)(2008-2#6)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2012-11#1)(2012-2#2)
power-limiting function##2##2##(2007-12#2)
power-limiting##4##1##(2007-11#2)(2007-12#2)
power-recycled Michelson interferometer with Fabry-Perot##2##5##(2008-2#2)
power-recycled##4##1##(2008-2#3)(2008-3#1)
power-scaling possibilities are discussed##2##4##(2007-12#2)
power-series method##2##2##(2008-3#2)
power-spectrum##2##1##(2008-2#2)
power-to-weight##2##1##(2007-9#1)(2012-1#1)
power?##2##1##(2008-7#2)
power]##2##1##(1997-8#1)(2012-12#1)
powered by a##3##3##(2007-8#1)(2008-8#1)(2012-1#1)
powered by pneumatic##2##3##(2012-1#2)
powered by the##2##3##(1996-12#1)(2008-7#1)
powered by##8##2##(1996-12#1)(2007-8#1)(2008-7#2)(2008-8#1)(2012-1#3)
powered orthoses##2##2##(2012-1#2)
powered orthosis is##4##3##(2012-1#4)
powered orthosis##6##2##(2012-1#6)
powered orthotics##2##2##(2012-1#2)
powered prosthesis##2##2##(2012-1#2)
powered to detect##2##3##(2010-10#1)(2012-3#1)
powered to##5##2##(2007-8#1)(2008-5#1)(2010-10#1)(2012-3#2)
powered toothbrush##2##2##(2006-2#2)
powered toothbrushes##3##2##(2006-2#3)
powered##51##1##(1996-12#1)(2006-2#5)(2006-6#1)(2007-10#1)(2007-12#1)(2007-8#2)(2007-9#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-10#2)(2009-12#1)(2009-4#1)(2010-10#3)(2012-1#22)(2012-3#2)(2013-1#1)
powerful actions##3##2##(1994-10#2)(1995-11#1)
powerful alternative##5##2##(1991-5#1)(2008-10#2)(2008-3#2)
powerful analytical tool##5##3##(2008-10#3)(2008-7#1)(2011-1#1)
powerful analytical tools##4##3##(2008-10#2)(2008-4#1)(2008-5#1)
powerful analytical##10##2##(1993-4#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)
powerful and flexible##4##3##(2008-3#1)(2009-4#1)(2010-3#1)(2012-3#1)
powerful and##21##2##(1994-2#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-3#2)
powerful anti-oxidants##2##2##(2008-5#2)
powerful approach for the##2##4##(1991-12#1)(2005-7#1)
powerful approach for##3##3##(1991-12#1)(2005-7#1)(2008-9#1)
powerful approach to##5##3##(1994-9#1)(1996-12#1)(2008-1#1)(2008-10#1)(2009-12#1)
powerful approach##8##2##(1991-12#1)(1994-9#1)(1996-12#1)(2005-7#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-12#1)
powerful approaches##2##2##(2010-6#1)(2011-2#1)
powerful are##2##2##(2009-7#1)(2012-1#1)
powerful but##4##2##(1995-4#1)(2008-12#1)(2008-2#1)(2008-3#1)
powerful computers##4##2##(1993-12#1)(2007-4#1)(2010-2#1)(2013-1#1)
powerful effect##2##2##(2008-8#1)(2012-3#1)
powerful enough to##2##3##(2008-7#1)(2009-4#1)
powerful enough##4##2##(1991-5#1)(2007-5#1)(2008-7#1)(2009-4#1)
powerful evolutionary##2##2##(2010-4#1)(2013-1#1)
powerful experimental##2##2##(2007-11#1)(2012-3#1)
powerful for##6##2##(2007-5#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-7#1)
powerful genetic techniques##2##3##(1990-7#1)(2011-1#1)
powerful genetic##4##2##(1990-7#1)(1996-10#1)(2007-12#1)(2011-1#1)
powerful imaging##2##2##(2008-1#1)(2008-7#1)
powerful in##5##2##(1992-2#1)(2006-9#1)(2008-10#2)(2012-3#1)
powerful influence##5##2##(1991-5#1)(1993-7#1)(1994-4#1)(2007-4#1)(2012-1#1)
powerful inhibitor of##5##3##(1990-8#1)(1993-9#1)(1994-6#1)(2006-5#1)(2008-5#1)
powerful inhibitors of##2##3##(1994-8#1)(1995-1#1)
powerful inhibitors##3##2##(1992-12#1)(1994-8#1)(1995-1#1)
powerful means for##4##3##(1996-5#1)(2008-11#1)(2008-3#1)(2008-8#1)
powerful means##5##2##(1996-5#1)(2008-11#2)(2008-3#1)(2008-8#1)
powerful method for##5##3##(1990-10#1)(1993-8#1)(1995-2#1)(2008-3#1)(2009-10#1)
powerful method of##2##3##(1990-11#1)(2008-3#1)
powerful method to##2##3##(2008-2#1)(2013-1#1)
powerful method##11##2##(1990-10#1)(1990-11#1)(1991-8#1)(1993-8#1)(1995-2#2)(2008-2#1)(2008-3#2)(2009-10#1)(2013-1#1)
powerful methodology##5##2##(1993-9#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-7#1)
powerful methods for##2##3##(2008-10#1)(2008-4#1)
powerful methods##3##2##(1995-3#1)(2008-10#1)(2008-4#1)
powerful model for##2##3##(2007-12#1)(2008-2#1)
powerful model##3##2##(2007-12#1)(2008-2#1)(2008-4#1)
powerful multidimensional##2##2##(2008-3#1)(2008-4#1)
powerful new##6##2##(1996-12#1)(2007-9#1)(2008-10#2)(2008-8#1)(2009-12#1)
powerful of##2##2##(2007-11#1)(2008-7#1)
powerful predictor of##6##3##(1994-2#1)(2008-1#1)(2008-12#1)(2008-3#1)(2009-5#1)(2010-5#1)
powerful predictor##8##2##(1994-2#1)(2008-1#1)(2008-12#1)(2008-3#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-2#1)
powerful predictors of##2##3##(2009-10#1)(2012-12#1)
powerful predictors##3##2##(1992-12#1)(2009-10#1)(2012-12#1)
powerful role##2##2##(2007-12#1)(2008-7#1)
powerful roles##2##2##(1995-2#1)(2012-2#1)
powerful scavengers of##2##3##(1995-1#2)
powerful strategy##3##2##(1994-8#1)(2008-4#1)(2010-12#1)
powerful technique for##13##3##(1990-10#1)(1990-4#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-8#1)(2007-11#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#1)(2012-1#1)
powerful technique that##2##3##(2008-2#1)(2011-1#1)
powerful technique##23##2##(1990-10#1)(1990-4#1)(1991-5#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-8#1)(2007-11#2)(2008-10#2)(2008-2#4)(2008-4#1)(2008-6#1)(2008-7#1)(2011-1#2)(2012-1#1)(2012-2#1)(2013-1#1)
powerful techniques##3##2##(2006-5#1)(2008-10#2)
powerful technologies##2##2##(2009-4#1)(2010-7#1)
powerful test##2##2##(2007-12#1)(2012-3#1)
powerful to##3##2##(1995-12#1)(1997-5#1)(2012-1#1)
powerful tool for analyzing##3##4##(1997-3#1)(2007-11#2)
powerful tool for structural##2##4##(2006-5#1)(2008-9#1)
powerful tool for##70##3##(1990-7#1)(1991-2#1)(1991-8#2)(1993-2#1)(1995-8#1)(1996-10#2)(1996-12#1)(1997-3#1)(2006-12#1)(2006-5#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#7)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-2#3)(2011-1#1)(2011-12#1)(2012-12#3)(2012-3#1)(2013-1#2)
powerful tool in the##10##4##(1993-11#1)(1994-6#1)(1994-9#1)(1995-5#1)(1995-6#1)(2008-1#1)(2008-10#2)(2008-3#1)(2009-5#1)
powerful tool in##24##3##(1993-11#1)(1994-6#1)(1994-9#1)(1995-5#1)(1995-6#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-4#1)(2010-6#1)(2010-8#1)(2013-8#2)
powerful tool to##25##3##(1993-2#1)(1995-12#1)(1996-8#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2010-12#1)(2011-1#3)(2012-2#1)(2012-3#1)
powerful tool##132##2##(1990-7#1)(1991-2#1)(1991-8#2)(1993-11#1)(1993-12#1)(1993-2#3)(1994-6#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#2)(1996-12#1)(1996-8#1)(1997-3#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#3)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#3)(2007-3#1)(2007-4#3)(2007-8#3)(2008-1#4)(2008-10#12)(2008-11#7)(2008-12#2)(2008-2#5)(2008-3#3)(2008-4#9)(2008-5#3)(2008-7#5)(2008-8#3)(2008-9#3)(2009-12#2)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-2#3)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#5)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
powerful tools available##2##3##(1997-5#1)(2007-12#1)
powerful tools for the##4##4##(2008-1#1)(2008-4#1)(2009-2#1)(2011-2#1)
powerful tools for##11##3##(1994-3#1)(1997-6#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-9#1)(2009-2#1)(2010-12#2)(2011-2#1)
powerful tools in##3##3##(1993-3#1)(2007-11#1)(2012-3#1)
powerful tools that can##2##4##(2008-10#1)(2008-4#1)
powerful tools that##3##3##(1996-2#1)(2008-10#1)(2008-4#1)
powerful tools to##3##3##(1995-2#1)(2007-8#1)(2008-4#1)
powerful tools##23##2##(1993-3#1)(1994-3#1)(1995-2#1)(1996-2#1)(1997-5#1)(1997-6#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#3)(2008-9#1)(2009-2#1)(2010-12#2)(2011-2#1)(2012-3#1)
powerful ultrashort laser pulses##3##4##(2008-1#2)(2008-2#1)
powerful way##4##2##(2008-10#1)(2008-7#1)(2012-11#1)(2012-12#1)
powerful##571##1##(1990-10#2)(1990-11#1)(1990-12#2)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#4)(1991-8#3)(1992-10#1)(1992-12#2)(1992-2#2)(1992-8#1)(1993-11#4)(1993-12#2)(1993-2#6)(1993-3#3)(1993-4#3)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#2)(1994-10#2)(1994-2#3)(1994-3#2)(1994-4#1)(1994-6#2)(1994-8#2)(1994-9#4)(1995-1#4)(1995-11#1)(1995-12#2)(1995-2#6)(1995-3#3)(1995-4#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#5)(1996-12#6)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#1)(2005-10#2)(2005-11#3)(2005-6#1)(2005-7#3)(2006-10#2)(2006-12#4)(2006-3#1)(2006-4#1)(2006-5#5)(2006-6#3)(2006-7#1)(2006-9#1)(2007-1#2)(2007-10#4)(2007-11#15)(2007-12#17)(2007-2#2)(2007-3#2)(2007-4#6)(2007-5#3)(2007-7#2)(2007-8#6)(2007-9#4)(2008-1#18)(2008-10#39)(2008-11#15)(2008-12#6)(2008-2#23)(2008-3#15)(2008-4#36)(2008-5#11)(2008-6#2)(2008-7#20)(2008-8#12)(2008-9#14)(2009-10#3)(2009-11#1)(2009-12#6)(2009-2#2)(2009-3#2)(2009-4#6)(2009-5#4)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-12#9)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#4)(2010-6#3)(2010-7#3)(2010-8#8)(2011-1#13)(2011-12#2)(2011-2#13)(2012-1#10)(2012-11#1)(2012-12#7)(2012-2#7)(2012-3#16)(2013-1#15)(2013-4#1)(2013-8#3)
powerfully and##2##2##(1996-5#1)(1997-8#1)
powerfully inhibited##3##2##(1990-11#1)(1991-12#1)(1996-12#1)
powerfully##12##1##(1990-11#1)(1990-4#1)(1991-12#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-2#1)(2010-12#1)
powering##2##1##(2008-4#1)(2010-12#1)
powerless##3##1##(1995-1#1)(2007-2#1)(2008-1#1)
powerlessness##4##1##(2007-8#1)(2008-2#1)(2009-4#1)(2012-12#1)
powers and a##2##3##(2007-12#1)(2008-3#1)
powers and##9##2##(2007-12#5)(2008-2#3)(2008-3#1)
powers are##7##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)(2009-3#1)
powers as great as##3##4##(2007-12#3)
powers as high as 1##2##5##(2007-12#1)(2008-3#1)
powers as high as##6##4##(2007-12#3)(2008-2#1)(2008-3#2)
powers as##10##2##(2007-12#6)(2008-1#1)(2008-2#1)(2008-3#2)
powers at##3##2##(1996-8#1)(2007-12#1)(2008-2#1)
powers exceeding##2##2##(2007-11#1)(2007-12#1)
powers for##2##2##(2007-12#1)(2008-3#1)
powers from##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
powers greater than##2##3##(2007-12#2)
powers in excess of##6##4##(2007-11#1)(2007-12#3)(2008-1#1)(2008-3#1)
powers in##8##2##(1997-6#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#1)
powers of 1##3##3##(2007-11#2)(2007-12#1)
powers of 600##2##3##(2007-11#1)(2007-12#1)
powers of approximately##2##3##(2007-12#1)(2008-2#1)
powers of as much as##4##5##(2007-11#2)(2007-12#2)
powers of several##3##3##(2007-11#3)
powers of the##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-7#1)
powers of up to##3##4##(2007-11#1)(2007-12#2)
powers of##44##2##(1994-1#1)(2006-5#1)(2007-11#14)(2007-12#16)(2008-10#2)(2008-2#3)(2008-3#1)(2008-8#1)(2008-9#2)(2010-7#1)(2011-1#1)(2012-3#1)
powers over public health##2##4##(2008-2#2)
powers that##2##2##(2008-2#2)
powers to##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
powers were##3##2##(1992-2#1)(2008-1#1)(2012-3#1)
powers##148##1##(1992-2#1)(1992-6#1)(1993-8#1)(1994-1#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-6#1)(2006-5#1)(2007-11#27)(2007-12#48)(2007-5#1)(2008-1#5)(2008-10#3)(2008-2#26)(2008-3#16)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#3)
pox potyvirus##2##2##(2008-10#2)
pox virus Strain##2##3##(2008-10#2)
pox virus##12##2##(1997-6#1)(2008-10#11)
pox##20##1##(1992-2#1)(1997-3#2)(1997-6#1)(2007-2#1)(2008-10#14)(2008-4#1)
poxvirus and##3##2##(2007-2#2)(2013-8#1)
poxvirus infection##3##2##(1997-3#1)(2007-2#1)(2008-5#1)
poxvirus##10##1##(1997-3#2)(2007-2#3)(2008-11#1)(2008-5#2)(2009-9#1)(2013-8#1)
poxviruses##4##1##(1995-5#1)(2008-1#1)(2008-11#2)
pp##52##1##(1990-11#6)(1990-3#4)(1990-6#4)(1990-8#4)(1990-9#3)(1991-9#1)(1993-8#4)(1994-9#1)(1997-6#4)(2006-10#1)(2006-11#1)(2008-11#2)(2008-12#3)(2008-2#2)(2008-5#3)(2008-7#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
pp1 cDNA##2##2##(1993-7#2)
pp1##4##1##(1993-7#4)
pp105 phosphorylation##2##2##(1991-3#2)
pp105##5##1##(1991-3#5)
pp125FAK and##3##2##(1997-7#3)
pp125FAK tyrosine phosphorylation##2##3##(1997-7#2)
pp125FAK##7##1##(1995-1#1)(1997-7#6)
pp14##4##1##(2013-8#4)
pp140trk##2##1##(1994-3#2)
pp15##3##1##(1991-5#3)
pp180 was##3##2##(1991-10#3)
pp185##8##1##(1991-12#1)(1992-10#5)(1995-3#2)
pp33 and pp15##2##3##(1991-5#2)
pp38##6##1##(2013-8#6)
pp58##4##1##(1991-7#4)
pp60c-src from##4##2##(1991-7#4)
pp60c-src kinase##2##2##(1995-6#2)
pp60c-src##17##1##(1990-12#4)(1991-7#5)(1992-11#1)(1994-6#3)(1995-6#4)
pp60src##2##1##(1990-7#2)
pp60v-src##2##1##(1994-8#2)
pp64 is phosphorylated##2##3##(1990-3#2)
pp64##10##1##(1990-3#10)
pp65##3##1##(1991-12#1)(2006-10#1)(2007-11#1)
pp76##7##1##(1995-3#7)
ppANP mRNA##4##2##(1995-5#4)
ppANP##8##1##(1995-5#8)
ppb (parts in##2##3##(2008-3#2)
ppb (parts##3##2##(2008-10#1)(2008-3#2)
ppb (signal to noise ratio##2##5##(2008-10#2)
ppb aflatoxin##3##2##(2008-12#3)
ppb and higher##3##3##(2008-10#1)(2008-12#2)
ppb and##6##2##(2007-8#1)(2008-10#3)(2008-12#2)
ppb at##2##2##(2008-10#2)
ppb for the##2##3##(2008-10#2)
ppb for##12##2##(2008-10#10)(2008-2#1)(2008-3#1)
ppb in dimethylformamide solution##2##4##(2008-10#2)
ppb in the##3##3##(2008-10#2)(2008-5#1)
ppb in##8##2##(2006-2#1)(2008-10#5)(2008-5#1)(2013-8#1)
ppb is##2##2##(2008-10#2)
ppb level##6##2##(1997-8#1)(2007-8#1)(2008-10#4)
ppb levels##7##2##(2008-10#7)
ppb of##3##2##(2008-10#2)(2008-5#1)
ppb were##2##2##(2008-10#1)(2008-5#1)
ppb with##2##2##(2007-8#1)(2008-10#1)
ppb##108##1##(1990-4#1)(1996-5#1)(1997-8#2)(2006-2#1)(2007-8#3)(2008-10#71)(2008-12#5)(2008-2#4)(2008-3#7)(2008-5#3)(2008-8#1)(2013-1#1)(2013-8#8)
ppb) were##2##2##(2008-10#2)
ppb)##13##1##(2007-8#2)(2008-10#8)(2008-5#2)(2008-6#1)
ppbV for##2##2##(2008-10#2)
ppbV##4##1##(2006-12#1)(2008-10#3)
ppbV)##2##1##(2006-12#2)
ppbv##7##1##(2007-12#1)(2007-8#2)(2008-2#2)(2008-3#2)
ppcecDHFR##3##1##(1994-2#3)
pph(3) and the##2##3##(2013-1#2)
pph(3)##6##1##(2013-1#6)
ppk##6##1##(1993-12#6)
ppm (5##2##2##(1997-7#1)(2008-3#1)
ppm (parts in 10(6))##2##4##(2008-3#2)
ppm F)##3##2##(2006-2#3)
ppm and 500##2##3##(1990-5#1)(2006-9#1)
ppm and##14##2##(1990-5#3)(1991-8#1)(1996-11#1)(1996-12#1)(2006-9#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-12#2)
ppm at household level and##2##5##(2007-2#2)
ppm at retail##2##3##(2007-2#2)
ppm at##9##2##(1990-9#1)(1996-2#1)(2007-2#4)(2008-10#3)
ppm benzene##5##2##(1997-3#5)
ppm detection##2##2##(2008-10#2)
ppm enrofloxacin##2##2##(2008-5#2)
ppm exposure##2##2##(1990-5#1)(1997-8#1)
ppm fluoride-containing toothpaste##4##3##(2012-2#4)
ppm for SDZ##2##3##(1991-8#2)
ppm for both##2##3##(1990-9#1)(2008-10#1)
ppm for molybdenum##2##3##(2008-10#2)
ppm for##24##2##(1990-5#1)(1990-8#1)(1990-9#1)(1991-8#4)(1995-5#1)(2008-10#14)(2008-3#2)
ppm from##2##2##(1995-10#1)(2012-12#1)
ppm group##3##2##(1996-11#2)(2008-8#1)
ppm had##2##2##(1997-4#1)(2008-5#1)
ppm in the##4##3##(1995-11#1)(2007-2#1)(2008-10#1)(2011-12#1)
ppm in##10##2##(1993-8#1)(1995-11#2)(2007-2#1)(2008-10#2)(2008-3#1)(2010-1#2)(2011-12#1)
ppm level was##3##3##(2008-10#3)
ppm level##4##2##(2008-10#4)
ppm levels of##2##3##(2008-10#2)
ppm levels##3##2##(2008-10#3)
ppm m##2##2##(2008-3#2)
ppm monensin##2##2##(2008-5#2)
ppm of gold##3##3##(2008-10#3)
ppm of##26##2##(1990-5#1)(1991-9#2)(1997-2#1)(2005-11#1)(2008-10#18)(2008-3#1)(2008-7#1)(2011-12#1)
ppm or 0##2##3##(2008-10#2)
ppm or##3##2##(2008-10#3)
ppm per unit IND and##2##5##(2008-10#2)
ppm per unit IND##3##4##(2008-10#3)
ppm respectively##3##2##(2008-5#1)(2013-8#2)
ppm than##3##2##(1990-5#2)(2008-10#1)
ppm to##6##2##(1995-11#1)(1996-11#1)(2007-2#2)(2008-10#2)
ppm was##5##2##(2008-10#4)(2008-5#1)
ppm with a correlation coefficient##2##5##(2008-10#2)
ppm with a##5##3##(2008-10#5)
ppm with##10##2##(2008-10#10)
ppm##333##1##(1990-3#2)(1990-5#13)(1990-8#5)(1990-9#2)(1991-8#9)(1991-9#2)(1993-1#2)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#1)(1994-5#1)(1995-10#1)(1995-11#3)(1995-5#2)(1996-11#10)(1996-12#3)(1996-2#2)(1997-2#3)(1997-3#5)(1997-4#9)(1997-6#1)(1997-7#4)(1997-8#2)(2004-4#3)(2004-8#1)(2005-10#1)(2005-11#6)(2006-1#1)(2006-12#5)(2006-2#3)(2006-8#1)(2006-9#5)(2007-1#2)(2007-11#1)(2007-12#1)(2007-2#11)(2007-8#1)(2008-1#2)(2008-10#127)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#16)(2008-7#3)(2008-8#9)(2009-10#1)(2009-12#1)(2010-1#3)(2011-1#2)(2011-12#6)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#4)(2013-8#2)
ppm) and the##4##3##(1992-9#1)(2008-10#3)
ppm) and##8##2##(1992-9#1)(2007-2#1)(2008-10#5)(2009-3#1)
ppm) for##3##2##(1992-9#1)(2008-8#1)(2013-1#1)
ppm) or##2##2##(1991-2#1)(2008-10#1)
ppm) were##4##2##(2008-10#4)
ppm)##53##1##(1991-2#2)(1991-7#1)(1992-9#4)(1993-11#1)(1993-4#1)(1993-6#1)(1996-2#1)(2006-9#1)(2007-12#1)(2007-2#3)(2008-10#22)(2008-5#3)(2008-7#1)(2008-8#3)(2009-3#1)(2011-12#6)(2013-1#1)
ppm-hr##2##1##(1993-1#2)
ppm/yr for##2##2##(2008-3#2)
ppmv##2##1##(2008-3#2)
ppnC7##2##1##(2007-12#2)
ppnK-expressing strain##2##2##(2013-1#2)
ppoFEV1 calculated##2##2##(2007-8#2)
ppoFEV1##5##1##(2007-8#5)
pps##4##1##(2008-9#4)
ppt##4##1##(2007-8#1)(2008-10#3)
ppt)##2##1##(1996-8#1)(2007-8#1)
pptv##3##1##(2008-11#1)(2008-2#2)
pr actice##2##2##(2008-11#2)
pr-10##2##1##(2008-10#2)
prC4##4##1##(1997-8#4)
prUprUprU##2##1##(1992-2#2)
pra1##3##1##(2008-10#3)
practicability in##2##2##(2008-10#1)(2008-2#1)
practicability of the##2##3##(1992-2#1)(2008-10#1)
practicability of##4##2##(1992-2#1)(2008-10#2)(2012-12#1)
practicability##10##1##(1992-2#1)(2008-10#5)(2008-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
practicable and##2##2##(1994-7#1)(2012-2#1)
practicable for##2##2##(2011-2#1)(2012-2#1)
practicable##16##1##(1990-5#1)(1994-7#1)(1995-12#1)(2008-10#1)(2008-2#3)(2008-3#2)(2009-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
practical advantages##9##2##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2010-4#1)
practical advice and##2##3##(2008-12#1)(2012-2#1)
practical advice on the##2##4##(1996-9#1)(2012-3#1)
practical advice##7##2##(1992-12#1)(1996-9#1)(2008-1#1)(2008-12#1)(2009-5#1)(2012-2#1)(2012-3#1)
practical alternative##4##2##(2007-2#1)(2007-7#1)(2008-10#1)(2010-9#1)
practical analysis of##2##3##(1996-7#1)(1996-8#1)
practical analysis##4##2##(1994-3#1)(1996-7#1)(1996-8#1)(1997-2#1)
practical analytical##3##2##(1997-2#1)(2008-10#2)
practical and accurate##2##3##(2007-12#1)(2008-10#1)
practical and cost-effective##2##3##(2007-6#1)(2007-8#1)
practical and economic##4##3##(1997-2#1)(2007-8#1)(2008-8#1)(2013-1#1)
practical and economical##3##3##(2006-5#1)(2008-7#1)(2013-1#1)
practical and effective##2##3##(2008-2#1)(2011-1#1)
practical and ethical##2##3##(1991-11#1)(2008-11#1)
practical and handy##2##3##(2008-10#1)(2011-1#1)
practical and highly##2##3##(2006-10#1)(2007-11#1)
practical and political##2##3##(2007-7#1)(2010-2#1)
practical and reliable##2##3##(1993-8#1)(2005-12#1)
practical and theoretical importance in##2##5##(2006-10#1)(2007-6#1)
practical and theoretical##4##3##(2006-10#1)(2007-6#1)(2008-11#1)(2008-5#1)
practical and useful##2##3##(2008-12#1)(2008-9#1)
practical and##56##2##(1991-11#1)(1992-3#1)(1993-8#1)(1994-3#1)(1995-3#1)(1996-3#1)(1997-2#1)(2005-12#1)(2005-5#1)(2005-7#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-12#2)(2007-6#2)(2007-7#2)(2007-8#2)(2008-10#2)(2008-11#6)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2012-3#1)(2013-1#5)
practical applicability of the developed resin##2##6##(2008-10#2)
practical applicability of the##6##4##(1996-11#1)(2008-10#5)
practical applicability of##9##3##(1996-11#1)(2007-8#1)(2008-10#6)(2008-2#1)
practical application are##2##3##(2010-12#1)(2010-9#1)
practical application for##3##3##(2006-5#1)(2010-2#1)(2010-9#1)
practical application in##3##3##(1991-11#1)(1993-1#1)(1994-12#1)
practical application is##2##3##(1995-6#1)(2008-3#1)
practical application of the##2##4##(1992-3#1)(2008-3#1)
practical application of##11##3##(1992-3#1)(1996-8#1)(2004-3#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#2)(2011-2#1)(2012-12#1)
practical application##33##2##(1991-11#1)(1992-3#1)(1993-1#1)(1994-12#1)(1994-6#1)(1995-6#1)(1996-8#1)(1997-2#1)(2004-3#1)(2005-6#1)(2006-5#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#2)(2010-12#1)(2010-2#1)(2010-9#2)(2011-2#1)(2012-12#1)(2012-3#1)
practical applications for##3##3##(1997-7#1)(2008-2#1)(2008-5#1)
practical applications in##3##3##(2008-10#1)(2010-7#1)(2011-1#1)
practical applications of##6##3##(1997-2#1)(2008-10#3)(2009-3#1)(2012-2#1)
practical applications##39##2##(1995-3#1)(1997-2#1)(1997-7#1)(2006-12#2)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#6)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
practical approach for##5##3##(1990-5#1)(2008-11#1)(2008-2#1)(2009-4#1)(2012-2#1)
practical approach to the##2##4##(1993-9#1)(2007-3#1)
practical approach to##14##3##(1993-9#1)(1997-2#1)(2006-9#1)(2007-3#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-12#1)(2012-12#2)(2012-2#1)
practical approach using##2##3##(1997-2#1)(2010-8#1)
practical approach##26##2##(1990-5#1)(1993-9#1)(1997-2#2)(1997-3#1)(2005-10#1)(2006-9#2)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2010-12#1)(2010-8#1)(2012-12#2)(2012-2#2)
practical approaches for##3##3##(2008-10#1)(2009-8#1)(2011-2#1)
practical approaches to the##2##4##(2008-2#1)(2009-3#1)
practical approaches##5##2##(2008-10#1)(2008-2#1)(2009-3#1)(2009-8#1)(2011-2#1)
practical aspects of the##3##4##(2007-7#1)(2008-11#1)(2010-5#1)
practical aspects of##13##3##(1991-12#1)(1993-12#1)(1994-12#1)(1995-4#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-9#2)(2010-3#1)(2010-5#1)(2012-2#1)
practical aspects##19##2##(1991-12#1)(1993-12#1)(1994-12#1)(1995-4#1)(1997-4#1)(1997-5#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#2)(2010-3#1)(2010-5#1)(2012-2#2)
practical assessment##2##2##(2008-11#2)
practical benefits##2##2##(1997-7#1)(2008-11#1)
practical case##4##2##(2008-2#2)(2013-1#1)(2013-7#1)
practical cases##3##2##(1995-2#1)(1995-6#1)(2007-11#1)
practical clinical application of##2##4##(1991-6#1)(2007-11#1)
practical clinical skills##2##3##(1995-6#2)
practical clinical##9##2##(1991-6#1)(1992-3#1)(1995-6#2)(2005-6#1)(2007-11#1)(2007-5#1)(2008-4#1)(2008-6#1)
practical concentrators##2##2##(2008-2#1)(2008-3#1)
practical conditions##2##2##(1993-2#1)(2011-1#1)
practical consequences##2##2##(1991-11#1)(1991-6#1)
practical consideration##2##2##(2007-9#1)(2008-3#1)
practical considerations for##4##3##(2006-8#2)(2008-1#1)(2008-4#1)
practical considerations in##2##3##(1994-6#1)(2008-6#1)
practical considerations##17##2##(1993-1#1)(1993-6#1)(1994-6#1)(1995-5#1)(2006-8#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-6#1)(2009-12#1)(2010-2#1)(2010-6#1)
practical design##3##2##(2005-11#1)(2008-1#1)(2008-3#1)
practical detection##5##2##(2008-10#1)(2008-11#1)(2008-3#2)(2008-9#1)
practical determination of##2##3##(2008-10#1)(2008-2#1)
practical device##2##2##(2008-4#1)(2011-1#1)
practical diagnostic##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
practical dielectric holograms are evaluated with##2##6##(2008-2#2)
practical difficulties of##2##3##(2008-11#2)
practical difficulties##8##2##(1991-7#1)(1992-3#1)(2007-12#1)(2008-11#2)(2008-4#1)(2009-2#1)(2011-2#1)
practical examples from##2##3##(1997-8#1)(2009-4#1)
practical examples of##4##3##(1993-2#1)(1996-5#1)(2008-2#1)(2013-1#1)
practical examples##10##2##(1993-2#1)(1993-4#1)(1996-5#1)(1997-8#1)(2008-10#1)(2008-2#1)(2009-4#1)(2009-7#1)(2012-12#1)(2013-1#1)
practical experience in##3##3##(2006-6#1)(2007-10#1)(2007-2#1)
practical experience of##2##3##(1991-3#1)(2012-3#1)
practical experience to##2##3##(1994-3#1)(2008-10#1)
practical experience##9##2##(1991-3#1)(1994-3#1)(1997-2#1)(2006-6#2)(2007-10#1)(2007-2#1)(2008-10#1)(2012-3#1)
practical experiences##4##2##(1995-12#1)(1995-6#1)(2007-10#1)(2012-1#1)
practical features##2##2##(2007-7#1)(2008-9#1)
practical for##14##2##(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-9#1)(2009-7#1)(2012-12#2)(2013-1#1)
practical framework##2##2##(1996-3#1)(2008-12#1)
practical guidance for##2##3##(1992-2#1)(2011-2#1)
practical guidance##6##2##(1992-2#1)(1995-12#1)(2007-7#1)(2008-10#1)(2011-2#1)(2013-8#1)
practical guide for##6##3##(1991-2#1)(1993-12#1)(1993-6#1)(2008-10#2)(2012-12#1)
practical guide to the##2##4##(1994-3#1)(2008-4#1)
practical guide to##4##3##(1994-3#1)(2007-11#1)(2008-3#1)(2008-4#1)
practical guide##14##2##(1991-2#1)(1993-12#1)(1993-6#1)(1994-3#1)(2007-11#3)(2007-2#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2012-12#1)
practical guidelines for the##2##4##(1990-12#1)(1996-8#1)
practical guidelines for##7##3##(1990-12#2)(1996-8#1)(2006-12#1)(2008-9#1)(2012-3#1)(2013-8#1)
practical guidelines##11##2##(1990-12#2)(1996-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-8#1)(2008-9#1)(2010-12#1)(2012-3#1)(2013-8#1)
practical implementation of##3##3##(2007-12#2)(2007-4#1)
practical implementation##12##2##(1994-11#1)(2007-12#3)(2007-4#1)(2007-9#1)(2008-2#2)(2008-3#2)(2010-2#1)(2013-1#1)
practical implications are##2##3##(1993-5#1)(2010-10#1)
practical implications for##6##3##(1992-7#1)(1996-7#1)(2008-8#1)(2009-7#1)(2010-3#1)(2010-5#1)
practical implications of these##2##4##(1990-9#1)(2007-4#1)
practical implications of##10##3##(1990-9#1)(1992-3#1)(2006-10#1)(2007-4#1)(2008-11#2)(2008-4#1)(2013-1#2)(2013-7#1)
practical implications##24##2##(1990-9#1)(1991-12#1)(1992-3#1)(1992-7#1)(1993-5#1)(1996-7#1)(2006-10#1)(2006-9#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-7#1)(2010-10#1)(2010-3#1)(2010-5#1)(2013-1#3)(2013-7#1)
practical importance for the##3##4##(2007-12#1)(2008-7#1)(2009-9#1)
practical importance for##5##3##(2007-12#1)(2008-7#1)(2009-9#1)(2013-1#2)
practical importance to##2##3##(1990-12#1)(2013-1#1)
practical importance##14##2##(1990-12#1)(1992-5#1)(1995-11#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-7#1)(2013-1#3)
practical in##2##2##(2008-11#1)(2008-3#1)
practical information for##2##3##(1995-3#1)(2006-8#1)
practical information on##3##3##(2006-10#1)(2008-10#1)(2008-7#1)
practical information##8##2##(1995-3#1)(2006-10#1)(2006-8#2)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)
practical insights##2##2##(1995-1#1)(2007-4#1)
practical interest for##3##3##(2008-10#1)(2008-3#1)(2009-3#1)
practical interest##7##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2009-3#1)
practical issues in##2##3##(1992-9#1)(2009-9#1)
practical issues##12##2##(1992-9#1)(1996-6#1)(2005-10#1)(2008-10#1)(2008-3#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-7#1)(2011-2#1)(2013-1#2)
practical knowledge##2##2##(1992-3#1)(2007-5#1)
practical limitations of##2##3##(1996-2#1)(2008-2#1)
practical limitations##4##2##(1994-5#1)(1996-2#1)(2008-2#1)(2012-3#1)
practical means to##2##3##(1994-9#1)(2007-10#1)
practical means##3##2##(1994-9#1)(2007-10#1)(2008-7#1)
practical measurements##2##2##(2008-2#1)(2008-3#1)
practical measures##4##2##(1993-9#1)(1994-3#1)(2008-3#1)(2009-9#1)
practical method for the determination of the##2##7##(2008-10#1)(2008-3#1)
practical method for the determination of##3##6##(2005-12#1)(2008-10#1)(2008-3#1)
practical method for the##5##4##(2005-12#1)(2008-10#2)(2008-3#2)
practical method for##13##3##(1992-12#1)(1993-8#1)(2005-12#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#3)(2009-1#1)(2009-2#1)
practical method is developed to##2##5##(2008-3#2)
practical method of measuring##2##4##(1991-12#1)(2011-1#1)
practical method of##3##3##(1991-12#1)(2008-10#1)(2011-1#1)
practical method to##3##3##(2008-11#1)(2008-5#1)(2011-1#1)
practical method##23##2##(1991-12#1)(1992-12#1)(1993-8#1)(1996-7#1)(2005-12#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-3#5)(2008-4#1)(2008-5#1)(2009-1#1)(2009-2#1)(2011-1#2)
practical methods##2##2##(1995-1#1)(2006-7#1)
practical modeling##2##2##(2008-2#1)(2008-3#1)
practical nurses##2##2##(2006-7#2)
practical optical##3##2##(2007-12#1)(2008-1#1)(2008-2#1)
practical or##3##2##(2007-12#1)(2008-4#1)(2009-10#1)
practical perspective##4##2##(1993-1#1)(1994-2#1)(2007-11#1)(2008-11#1)
practical piety##2##2##(2008-12#2)
practical problem of##2##3##(1997-7#1)(2008-12#1)
practical problem##5##2##(1993-3#1)(1997-2#1)(1997-7#1)(2008-12#1)(2010-12#1)
practical problems encountered##2##3##(1994-2#1)(2008-2#1)
practical problems##9##2##(1994-2#1)(1994-4#1)(2008-2#2)(2008-3#1)(2008-7#2)(2010-3#1)(2012-2#1)
practical procedure##2##2##(1997-5#1)(1997-8#1)
practical procedures##2##2##(1994-6#1)(2008-7#1)
practical purposes##5##2##(1996-6#1)(2006-3#1)(2008-1#1)(2008-10#1)(2008-3#1)
practical realities of##3##3##(2007-4#1)(2008-10#1)(2009-2#1)
practical reasons##5##2##(1992-12#1)(2008-12#1)(2008-3#1)(2012-2#2)
practical recommendations for the##2##4##(2009-11#1)(2010-12#1)
practical recommendations for##3##3##(1994-12#1)(2009-11#1)(2010-12#1)
practical recommendations##8##2##(1992-9#1)(1994-12#1)(2006-12#1)(2007-4#1)(2009-11#1)(2010-12#1)(2011-2#1)(2012-12#1)
practical requirements##4##2##(2007-9#1)(2008-10#1)(2008-3#1)(2011-1#1)
practical research##2##2##(1997-3#1)(2010-3#1)
practical route##3##2##(1990-11#1)(2007-11#1)(2007-8#1)
practical samples##5##2##(2008-10#5)
practical scheme for##2##3##(2007-12#1)(2008-2#1)
practical significance of##3##3##(2005-11#1)(2007-11#1)(2008-2#1)
practical significance##7##2##(2005-11#2)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
practical situation##2##2##(2008-3#2)
practical situations##3##2##(1995-8#1)(2008-2#1)(2008-3#1)
practical skills and performance indicators##2##5##(2008-11#2)
practical skills and##3##3##(1992-11#1)(2008-11#2)
practical skills of##2##3##(1997-4#1)(2008-11#1)
practical skills##9##2##(1992-11#1)(1995-6#1)(1996-1#1)(1997-4#1)(2008-11#4)(2008-12#1)
practical solution to##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
practical solution##5##2##(1994-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-3#1)
practical solutions to the##2##4##(1996-1#1)(2009-7#1)
practical solutions to##4##3##(1996-1#1)(2009-7#1)(2013-1#2)
practical solutions##6##2##(1996-1#1)(2008-11#1)(2008-2#1)(2009-7#1)(2013-1#2)
practical steps##2##2##(1994-6#1)(1995-12#1)
practical strategies##7##2##(1994-12#2)(2007-1#1)(2009-5#1)(2013-1#3)
practical suggestions for##4##3##(1992-2#1)(1993-1#1)(2007-2#1)(2008-12#1)
practical suggestions##6##2##(1992-2#1)(1993-1#1)(2007-2#1)(2007-4#1)(2008-12#1)(2011-12#1)
practical technique##2##2##(2007-12#1)(2008-10#1)
practical techniques##2##2##(1990-12#1)(2010-12#1)
practical test##2##2##(2008-5#1)(2008-9#1)
practical thought##2##2##(2008-7#1)(2008-8#1)
practical tips##2##2##(1995-2#1)(2008-6#1)
practical to##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
practical tool##2##2##(2006-7#1)(2010-9#1)
practical training##5##2##(1994-12#3)(2008-4#1)(2012-1#1)
practical usage##2##2##(1993-3#1)(1997-4#1)
practical use and##3##3##(1996-5#1)(2008-4#1)(2010-3#1)
practical use in##2##3##(2005-11#1)(2010-4#1)
practical use of the##5##4##(2006-11#1)(2007-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
practical use of##11##3##(2006-11#1)(2007-1#1)(2008-10#2)(2008-2#2)(2008-3#3)(2011-1#1)(2012-1#1)
practical use##26##2##(1991-4#1)(1992-5#1)(1996-5#1)(2005-11#1)(2006-11#1)(2007-1#1)(2007-4#1)(2008-10#4)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-1#1)
practical usefulness in##2##3##(1997-2#1)(2007-6#1)
practical usefulness##3##2##(1996-7#1)(1997-2#1)(2007-6#1)
practical utility of the##5##4##(1991-2#1)(2008-10#3)(2008-7#1)
practical utility##8##2##(1991-2#1)(2004-2#1)(2008-10#4)(2008-7#1)(2011-1#1)
practical value##5##2##(2006-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-6#1)
practical way to##3##3##(1991-4#1)(2005-11#1)(2007-12#1)
practical way##10##2##(1991-4#1)(2005-11#1)(2006-9#1)(2007-12#1)(2008-10#3)(2012-3#1)(2013-1#1)(2013-8#1)
practical ways to##3##3##(2007-11#1)(2008-1#1)(2008-10#1)
practical work##2##2##(1995-5#1)(2006-7#1)
practical##956##1##(1990-11#2)(1990-12#4)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#3)(1991-11#3)(1991-12#5)(1991-2#4)(1991-3#1)(1991-4#2)(1991-6#2)(1991-7#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#6)(1992-5#2)(1992-7#1)(1992-9#2)(1993-1#4)(1993-12#3)(1993-2#3)(1993-3#3)(1993-4#2)(1993-5#2)(1993-6#2)(1993-8#2)(1993-9#4)(1994-1#3)(1994-11#1)(1994-12#11)(1994-2#2)(1994-3#5)(1994-4#1)(1994-5#1)(1994-6#4)(1994-8#1)(1994-9#1)(1995-1#4)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#5)(1995-4#3)(1995-5#2)(1995-6#7)(1995-8#2)(1995-9#1)(1996-1#4)(1996-11#1)(1996-2#2)(1996-3#3)(1996-5#3)(1996-6#2)(1996-7#4)(1996-8#6)(1996-9#1)(1997-1#1)(1997-2#11)(1997-3#2)(1997-4#4)(1997-5#2)(1997-6#1)(1997-7#4)(1997-8#2)(2004-12#1)(2004-2#1)(2004-3#1)(2005-10#2)(2005-11#6)(2005-12#3)(2005-4#4)(2005-5#1)(2005-6#2)(2005-7#2)(2005-9#1)(2006-10#7)(2006-11#2)(2006-12#6)(2006-3#1)(2006-4#2)(2006-5#5)(2006-6#2)(2006-7#6)(2006-8#6)(2006-9#5)(2007-1#2)(2007-10#4)(2007-11#22)(2007-12#38)(2007-2#6)(2007-3#1)(2007-4#8)(2007-5#2)(2007-6#3)(2007-7#10)(2007-8#12)(2007-9#5)(2008-1#15)(2008-10#89)(2008-11#41)(2008-12#16)(2008-2#65)(2008-3#75)(2008-4#18)(2008-5#12)(2008-6#9)(2008-7#26)(2008-8#9)(2008-9#16)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#4)(2009-2#7)(2009-3#4)(2009-4#3)(2009-5#3)(2009-6#1)(2009-7#6)(2009-8#1)(2009-9#5)(2010-10#1)(2010-11#1)(2010-12#10)(2010-2#5)(2010-3#6)(2010-4#3)(2010-5#8)(2010-6#1)(2010-7#3)(2010-8#5)(2010-9#4)(2011-1#12)(2011-12#2)(2011-2#8)(2012-1#5)(2012-11#1)(2012-12#12)(2012-2#19)(2012-3#14)(2012-5#1)(2013-1#30)(2013-7#3)(2013-8#6)
practicalities##3##1##(2006-10#2)(2010-2#1)
practicality of the##5##3##(1990-2#1)(2007-11#1)(2007-12#1)(2008-3#1)(2011-2#1)
practicality of using##2##3##(2008-1#1)(2011-12#1)
practicality of##11##2##(1990-2#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#1)(2011-12#1)(2011-2#1)
practicality##18##1##(1990-2#1)(2005-5#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2011-12#1)(2011-2#1)
practically absent##4##2##(1990-7#1)(1996-5#1)(2008-7#1)(2011-1#1)
practically all##6##2##(1990-6#1)(1991-11#1)(2008-11#1)(2008-3#1)(2010-9#1)(2012-12#1)
practically as##3##2##(1997-6#1)(2008-10#1)(2008-2#1)
practically constant##4##2##(2005-11#1)(2008-10#2)(2008-6#1)
practically every##2##2##(2010-7#1)(2013-7#1)
practically identical##3##2##(1995-2#1)(1997-2#1)(2008-3#1)
practically important##2##2##(1995-9#1)(2009-12#1)
practically in##2##2##(2006-10#1)(2008-10#1)
practically independent of the##4##4##(2005-11#2)(2008-10#2)
practically insoluble##2##2##(2008-4#1)(2012-2#1)
practically linear function of##2##4##(2008-3#2)
practically no##6##2##(1996-4#1)(2005-11#1)(2007-8#1)(2008-10#2)(2012-2#1)
practically non-existent##3##2##(1991-8#1)(2008-10#1)(2011-1#1)
practically relevant##5##2##(1994-12#1)(2008-10#3)(2008-5#1)
practically the same##2##3##(2004-8#1)(2005-11#1)
practically the##4##2##(1990-12#1)(2004-8#1)(2005-11#1)(2010-8#1)
practically useful##2##2##(1995-8#1)(2008-10#1)
practically##106##1##(1990-12#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-11#1)(1991-8#1)(1992-4#1)(1993-11#1)(1993-3#1)(1994-12#3)(1995-2#2)(1995-5#1)(1995-8#1)(1995-9#2)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-8#1)(2004-8#1)(2005-11#6)(2006-10#1)(2006-7#2)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#21)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2009-12#1)(2009-2#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2012-1#1)(2012-12#2)(2012-2#2)(2013-7#1)
practice (n =##2##3##(1992-4#1)(1996-9#1)
practice -##5##2##(2005-8#1)(2008-11#2)(2011-2#1)(2012-3#1)
practice BSE##2##2##(1990-6#2)
practice a##3##2##(2008-10#2)(2008-12#1)
practice about##2##2##(2008-8#1)(2013-1#1)
practice across##4##2##(2008-11#1)(2010-3#1)(2011-1#1)(2012-1#1)
practice activity##4##2##(1990-3#3)(2006-1#1)
practice allows##2##2##(1993-12#1)(2006-7#1)
practice alone##2##2##(2008-1#1)(2012-1#1)
practice among##9##2##(1991-6#1)(1992-3#1)(1996-11#1)(2004-10#1)(2007-7#1)(2008-11#1)(2008-8#1)(2010-11#1)(2013-1#1)
practice amongst##3##2##(2008-1#1)(2008-10#1)(2012-1#1)
practice an##2##2##(2008-2#1)(2009-3#1)
practice analysis##2##2##(2006-10#1)(2008-4#1)
practice and a##4##3##(1991-3#1)(2008-11#1)(2008-7#1)(2012-3#1)
practice and academia##2##3##(1993-2#1)(2012-3#1)
practice and academic##2##3##(2007-4#1)(2008-1#1)
practice and attitude##3##3##(2013-1#3)
practice and by##2##3##(1993-3#1)(2004-3#1)
practice and education##3##3##(2008-11#3)
practice and educational##2##3##(2007-12#1)(2008-3#1)
practice and evaluate##2##3##(1996-9#1)(2007-9#1)
practice and further##2##3##(2007-4#1)(2012-2#1)
practice and future research##3##4##(2007-12#1)(2009-12#1)(2010-3#1)
practice and future##5##3##(2007-12#1)(2009-12#1)(2010-3#1)(2011-2#1)(2013-1#1)
practice and health care##2##4##(2008-11#1)(2009-4#1)
practice and health##3##3##(2008-11#1)(2009-4#1)(2013-1#1)
practice and higher education##3##4##(1991-1#1)(2008-12#2)
practice and highlight##2##3##(2010-12#1)(2011-1#1)
practice and in##4##3##(1992-3#1)(1995-11#1)(2006-10#1)(2006-9#1)
practice and its##2##3##(1995-1#1)(2008-11#1)
practice and may##3##3##(2011-2#2)(2013-7#1)
practice and performance##2##3##(2008-8#2)
practice and policy##2##3##(2010-2#1)(2012-1#1)
practice and presents##2##3##(2008-10#1)(2008-11#1)
practice and provides##2##3##(2008-11#1)(2008-6#1)
practice and public health##2##4##(1996-1#1)(2008-3#1)
practice and research in the##2##5##(2008-7#1)(2010-10#1)
practice and research##15##3##(2006-3#2)(2006-4#1)(2008-6#3)(2008-7#1)(2009-7#1)(2010-10#1)(2010-11#1)(2011-2#3)(2012-12#1)(2012-2#1)
practice and that##2##3##(2008-12#1)(2011-2#1)
practice and the effect##2##4##(2006-10#1)(2007-10#1)
practice and the##14##3##(1997-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-2#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#2)(2013-1#1)
practice and theory##5##3##(1996-2#1)(2008-11#3)(2008-8#1)
practice and to##5##3##(1994-7#1)(1996-12#1)(1996-3#1)(1997-2#1)(2010-10#1)
practice and##197##2##(1990-10#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-3#3)(1992-4#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-6#2)(1994-7#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-1#3)(1996-12#1)(1996-2#2)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(2004-10#1)(2004-12#1)(2004-3#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#3)(2006-4#1)(2006-6#3)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#5)(2007-7#1)(2007-9#2)(2008-1#3)(2008-10#1)(2008-11#16)(2008-12#10)(2008-3#3)(2008-5#1)(2008-6#6)(2008-7#6)(2008-8#5)(2008-9#2)(2009-11#2)(2009-12#1)(2009-4#6)(2009-7#1)(2009-8#2)(2010-10#3)(2010-11#3)(2010-12#3)(2010-2#2)(2010-3#1)(2010-5#2)(2010-9#1)(2011-1#5)(2011-2#10)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#16)(2013-7#1)(2013-8#1)
practice approach##2##2##(2008-3#1)(2008-4#1)
practice are discussed##10##3##(1992-9#1)(1994-12#1)(1994-3#1)(2006-7#1)(2007-9#1)(2008-11#1)(2008-12#1)(2009-8#1)(2013-1#2)
practice are largely##2##3##(2007-11#1)(2010-12#1)
practice are likely to##2##4##(1993-7#1)(2008-10#1)
practice are now##2##3##(2008-2#1)(2012-12#1)
practice are the##2##3##(2007-4#1)(2008-11#1)
practice are##35##2##(1992-1#1)(1992-9#1)(1993-7#1)(1994-12#1)(1994-3#1)(1995-5#1)(1997-2#1)(2006-7#1)(2007-11#1)(2007-2#2)(2007-4#2)(2007-9#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#1)(2009-4#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
practice area##3##2##(2008-11#1)(2008-8#1)(2011-1#1)
practice areas##3##2##(2008-1#1)(2008-11#2)
practice as a##6##3##(1991-4#1)(1992-3#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)
practice as much as possible##2##5##(2008-4#1)(2008-7#1)
practice as the##2##3##(2008-11#1)(2010-4#1)
practice as they##2##3##(2006-5#1)(2007-10#1)
practice as well as##5##4##(2006-1#1)(2006-10#1)(2010-1#1)(2010-5#1)(2012-11#1)
practice as well##6##3##(2006-1#1)(2006-10#2)(2010-1#1)(2010-5#1)(2012-11#1)
practice as##33##2##(1991-4#1)(1992-3#1)(1992-7#1)(1994-11#1)(1996-1#1)(2006-1#1)(2006-10#2)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2010-1#1)(2010-4#1)(2010-5#1)(2011-2#3)(2012-11#1)(2012-2#1)(2013-1#5)
practice assessment##2##2##(2007-10#1)(2008-11#1)
practice association##4##2##(1993-12#1)(1993-2#1)(1996-3#1)(1997-3#1)
practice at a##2##3##(2007-4#1)(2011-2#1)
practice at the##2##3##(2008-11#1)(2008-2#1)
practice at##10##2##(1990-6#2)(1996-1#1)(2007-4#2)(2008-1#1)(2008-11#2)(2008-2#1)(2011-2#1)
practice based##3##2##(2011-2#1)(2013-1#1)(2013-8#1)
practice be##2##2##(1994-5#1)(2012-3#1)
practice but##4##2##(2006-6#1)(2006-8#1)(2011-2#1)(2013-1#1)
practice by doctors##2##3##(2013-1#2)
practice by physicians##2##3##(2007-4#1)(2012-1#1)
practice by the##2##3##(2011-1#1)(2012-12#1)
practice by##15##2##(2007-10#1)(2007-4#2)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
practice can be defined##2##4##(1995-12#1)(1996-2#1)
practice can be##3##3##(1995-12#1)(1996-2#1)(2008-12#1)
practice can##6##2##(1995-12#1)(1996-2#1)(2006-7#1)(2008-11#1)(2008-12#1)(2011-2#1)
practice change and##2##3##(2008-11#1)(2010-11#1)
practice change##5##2##(2007-10#1)(2008-11#3)(2010-11#1)
practice characteristics##4##2##(1994-1#1)(2007-9#1)(2011-1#2)
practice combined with##2##3##(1995-1#1)(2012-1#1)
practice conditions##4##2##(2010-11#1)(2010-9#1)(2012-12#2)
practice context##4##2##(1993-1#1)(2008-11#2)(2010-9#1)
practice cost##2##2##(1994-1#2)
practice could##2##2##(1990-2#1)(2008-8#1)
practice development##5##2##(2005-12#1)(2008-11#4)
practice during##3##2##(2008-10#1)(2012-12#2)
practice education##3##2##(1991-8#1)(1994-7#1)(2008-4#1)
practice effects##3##2##(2007-1#1)(2007-9#1)(2012-12#1)
practice environment of##2##3##(2008-12#1)(2012-2#1)
practice environment##6##2##(1992-2#1)(1996-3#1)(2007-4#1)(2007-9#1)(2008-12#1)(2012-2#1)
practice especially##2##2##(2008-6#1)(2009-11#1)
practice evaluation at##2##3##(1997-2#2)
practice evaluation##4##2##(1996-7#1)(1997-2#3)
practice expense component##2##3##(1996-1#2)
practice expense##7##2##(1994-1#4)(1996-1#2)(2007-4#1)
practice expenses##3##2##(1994-1#2)(2007-4#1)
practice experience##2##2##(2008-11#1)(2008-12#1)
practice experiences##2##2##(1996-3#1)(2011-2#1)
practice for children with##2##4##(2009-4#1)(2012-12#1)
practice for the##4##3##(2008-1#1)(2008-11#1)(2011-2#1)(2013-1#1)
practice for this##2##3##(2008-7#1)(2012-12#1)
practice for##37##2##(1991-4#1)(1992-4#1)(1993-10#1)(1995-1#1)(1997-8#2)(2006-6#1)(2006-7#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#1)(2009-4#1)(2010-10#1)(2010-4#2)(2011-1#3)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#2)
practice from a##3##3##(1996-12#1)(1996-3#1)(2011-12#1)
practice from the##2##3##(2009-2#1)(2013-7#1)
practice from##8##2##(1996-12#1)(1996-3#1)(2006-10#1)(2007-5#1)(2008-11#1)(2009-2#1)(2011-12#1)(2013-7#1)
practice function costs##2##3##(1996-1#2)
practice group##3##2##(2005-7#1)(2008-12#1)(2008-9#1)
practice guideline##15##2##(1992-8#1)(1996-2#1)(2007-6#1)(2007-9#1)(2008-6#5)(2009-7#1)(2010-10#2)(2010-8#1)(2012-11#1)(2012-3#1)
practice guidelines and##5##3##(2006-9#1)(2007-4#2)(2009-6#1)(2010-4#1)
practice guidelines for the management of##2##6##(2006-9#1)(2009-11#1)
practice guidelines for the##4##4##(2006-9#1)(2007-4#1)(2008-9#1)(2009-11#1)
practice guidelines for##11##3##(1993-12#1)(1994-3#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-9#2)(2009-11#1)(2013-8#1)
practice guidelines in##3##3##(1996-2#1)(2008-8#1)(2009-7#1)
practice guidelines that##2##3##(1993-12#1)(2007-12#1)
practice guidelines##71##2##(1992-8#1)(1993-12#5)(1993-7#1)(1994-12#1)(1994-3#6)(1995-1#1)(1995-2#1)(1996-1#1)(1996-2#2)(1996-3#1)(1997-1#2)(1997-2#1)(2006-10#1)(2006-2#1)(2006-8#1)(2006-9#3)(2007-12#2)(2007-4#9)(2007-7#1)(2008-10#1)(2008-3#6)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-4#3)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
practice has been##9##3##(2006-10#1)(2006-9#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-3#1)(2009-3#1)
practice has changed##2##3##(2006-2#1)(2008-9#1)
practice has##22##2##(1996-3#1)(1997-4#1)(2006-10#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-3#1)(2007-9#2)(2008-1#1)(2008-11#3)(2008-3#1)(2008-9#1)(2009-3#1)(2011-2#2)(2013-1#2)(2013-8#2)
practice have been##2##3##(1990-5#1)(2011-1#1)
practice have demonstrated##3##3##(2008-11#2)(2008-12#1)
practice have##8##2##(1990-5#1)(2006-10#1)(2007-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2011-1#1)
practice improvement##6##2##(1996-1#2)(1996-12#1)(1997-3#1)(2010-8#1)(2011-1#1)
practice in Australia##2##3##(2007-11#1)(2008-7#1)
practice in Canada##5##3##(1990-12#1)(2006-2#1)(2008-7#1)(2009-4#1)(2010-5#1)
practice in Europe##3##3##(2006-2#3)
practice in a##9##3##(1993-3#1)(1997-4#1)(2005-12#1)(2006-8#1)(2008-11#1)(2008-12#1)(2011-11#1)(2012-12#2)
practice in all##3##3##(2009-7#1)(2010-9#1)(2012-12#1)
practice in an##6##3##(2007-9#1)(2008-8#1)(2009-7#1)(2012-12#2)(2012-3#1)
practice in caring for##2##4##(2006-10#1)(2008-11#1)
practice in clinical##3##3##(2006-6#1)(2008-11#1)(2008-8#1)
practice in healthcare##3##3##(2006-1#1)(2008-12#1)(2011-2#1)
practice in many countries##2##4##(2009-10#1)(2012-12#1)
practice in many##4##3##(2007-12#1)(2009-10#1)(2011-1#1)(2012-12#1)
practice in order to##6##4##(1992-3#1)(1996-3#1)(2007-3#1)(2008-11#1)(2010-11#1)(2011-2#1)
practice in patients with##2##4##(1997-8#1)(2010-12#1)
practice in patients##3##3##(1997-8#1)(2008-1#1)(2010-12#1)
practice in relation to##3##4##(2004-10#1)(2008-11#1)(2013-1#1)
practice in relation##4##3##(1996-10#1)(2004-10#1)(2008-11#1)(2013-1#1)
practice in supporting##2##3##(2006-9#1)(2012-12#1)
practice in the Czech##2##4##(2006-6#1)(2010-6#1)
practice in the UK##3##4##(2005-8#1)(2008-10#1)(2013-1#1)
practice in the United Kingdom##3##5##(1996-11#1)(2004-10#1)(2007-8#1)
practice in the United States in##2##6##(2006-10#1)(2007-4#1)
practice in the United States##3##5##(1997-3#1)(2006-10#1)(2007-4#1)
practice in the United##6##4##(1996-11#1)(1997-3#1)(2004-10#1)(2006-10#1)(2007-4#1)(2007-8#1)
practice in the field of##2##5##(2008-11#1)(2012-12#1)
practice in the field##3##4##(2006-10#1)(2008-11#1)(2012-12#1)
practice in the future##2##4##(2007-10#1)(2010-11#1)
practice in the##48##3##(1991-3#1)(1992-1#2)(1992-3#1)(1993-5#1)(1993-7#1)(1995-12#1)(1996-11#1)(1997-3#1)(2004-10#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-6#2)(2007-1#1)(2007-10#3)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#2)(2009-10#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-6#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
practice in this##6##3##(1993-3#1)(2005-7#1)(2007-11#1)(2008-10#1)(2008-12#1)(2010-1#1)
practice in##197##2##(1990-12#1)(1990-4#1)(1990-5#1)(1991-1#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#3)(1992-3#3)(1992-8#1)(1993-3#2)(1993-5#1)(1993-7#1)(1994-9#1)(1995-12#2)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-10#2)(2004-3#1)(2005-12#3)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-12#2)(2006-2#5)(2006-6#4)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#5)(2007-11#3)(2007-12#1)(2007-2#2)(2007-3#2)(2007-4#2)(2007-5#1)(2007-8#3)(2007-9#2)(2008-1#5)(2008-10#4)(2008-11#18)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#3)(2008-8#4)(2008-9#4)(2009-10#5)(2009-11#1)(2009-4#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#2)(2011-1#4)(2011-11#1)(2011-2#9)(2012-1#1)(2012-11#1)(2012-12#10)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#4)
practice including##2##2##(2006-10#1)(2008-11#1)
practice information##2##2##(1997-3#1)(2011-1#1)
practice into##3##2##(2008-11#2)(2010-10#1)
practice is a##4##3##(2006-8#1)(2010-10#1)(2010-11#1)(2010-12#1)
practice is an##2##3##(2008-12#1)(2008-4#1)
practice is associated with##2##4##(2008-11#1)(2010-12#1)
practice is at##2##3##(1996-8#1)(2008-9#1)
practice is based##2##3##(2008-8#1)(2012-12#1)
practice is discussed##2##3##(2008-1#1)(2012-2#1)
practice is in##2##3##(2008-1#1)(2013-1#1)
practice is inadequate and##2##4##(2012-2#1)(2013-8#1)
practice is largely##2##3##(2008-12#1)(2008-3#1)
practice is likely to##2##4##(2005-7#1)(2011-2#1)
practice is not##4##3##(1993-2#1)(1996-3#1)(1997-8#1)(2007-2#1)
practice is often##2##3##(1997-3#1)(2008-12#1)
practice is presented##3##3##(2007-2#1)(2008-11#1)(2008-12#1)
practice is the##5##3##(1992-3#1)(2006-5#1)(2007-3#1)(2008-11#1)(2011-2#1)
practice is##76##2##(1992-3#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-7#1)(1995-3#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-10#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-2#2)(2007-3#1)(2007-4#1)(2008-1#2)(2008-11#10)(2008-12#9)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
practice issues##4##2##(2005-12#1)(2006-11#1)(2008-11#1)(2008-9#1)
practice it is##5##3##(1992-9#1)(1996-9#1)(2006-2#1)(2008-3#1)(2010-2#1)
practice it##11##2##(1991-12#1)(1992-9#1)(1996-9#1)(1997-8#2)(2006-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-2#1)(2011-2#1)
practice knowledge##2##2##(2008-12#1)(2010-10#1)
practice learning in##2##3##(2008-11#2)
practice learning##8##2##(2008-11#8)
practice led##2##2##(1991-6#1)(2012-1#1)
practice level##3##2##(2008-8#1)(2010-10#1)(2011-2#1)
practice location##4##2##(1994-3#1)(2007-6#1)(2008-12#1)(2009-4#1)
practice management skills##2##3##(1993-1#1)(1994-3#1)
practice management##10##2##(1991-12#1)(1993-1#1)(1994-12#1)(1994-3#2)(1997-3#1)(2004-3#1)(2007-4#1)(2008-1#1)(2011-2#1)
practice may be##2##3##(1997-4#1)(2008-11#1)
practice may##5##2##(1993-7#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-3#1)
practice medical##2##2##(2008-10#1)(2008-8#1)
practice model##5##2##(1991-1#3)(1993-1#1)(1997-3#1)
practice module##2##2##(2008-11#2)
practice more##2##2##(2008-12#2)
practice moves##2##2##(1997-4#1)(2008-11#1)
practice must##3##2##(1991-11#1)(1996-2#1)(2007-9#1)
practice nurse##2##2##(1997-4#1)(2012-3#1)
practice nurses##8##2##(2007-12#3)(2008-12#2)(2011-2#1)(2012-2#1)(2012-3#1)
practice of TCD##2##3##(2007-9#2)
practice of a##4##3##(1991-6#1)(2008-11#1)(2008-9#1)(2013-1#1)
practice of anesthesia##3##3##(2006-10#1)(2008-8#1)(2010-5#1)
practice of assertive community treatment##2##5##(2008-2#2)
practice of blood##2##3##(2011-12#1)(2013-8#1)
practice of clinical##3##3##(2007-4#1)(2012-1#1)(2013-1#1)
practice of community involvement in health programmes##2##7##(2010-3#2)
practice of community##4##3##(1994-3#1)(2008-2#1)(2010-3#2)
practice of dental hygiene##3##4##(2006-2#3)
practice of dermatology##2##3##(2006-12#1)(2010-9#1)
practice of dietetics##2##3##(1992-2#1)(1994-2#1)
practice of emergency##3##3##(2007-7#1)(2012-2#2)
practice of family##3##3##(2008-7#1)(2012-2#1)(2013-1#1)
practice of health##3##3##(1993-2#1)(2004-10#1)(2012-3#1)
practice of hemodialysis##2##3##(2007-8#1)(2008-1#1)
practice of interventional pain##3##4##(2006-8#3)
practice of interventional##4##3##(2006-8#3)(2007-4#1)
practice of medical##4##3##(1991-6#1)(1992-9#1)(2007-12#1)(2009-12#1)
practice of medicine##15##3##(1991-12#1)(1991-2#1)(1992-1#1)(1992-2#1)(1993-12#1)(1993-3#1)(1995-1#1)(2004-11#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-4#3)(2012-1#1)
practice of modern##2##3##(1994-5#1)(2006-7#1)
practice of nursing##2##3##(2008-1#1)(2008-12#1)
practice of oral##2##3##(2006-8#1)(2013-7#1)
practice of physical activity##5##4##(2010-11#5)
practice of primary##2##3##(1990-9#1)(1997-3#1)
practice of public health##5##4##(1996-2#1)(1997-3#1)(2005-3#1)(2010-8#1)(2013-1#1)
practice of public##6##3##(1996-2#1)(1997-3#1)(2005-3#1)(2008-12#1)(2010-8#1)(2013-1#1)
practice of sedation##3##3##(2008-8#3)
practice of the##11##3##(1993-11#1)(1994-6#1)(2008-11#1)(2008-8#1)(2009-4#2)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#2)
practice of this##3##3##(1994-12#1)(2007-3#1)(2008-2#1)
practice of treating##2##3##(2007-3#1)(2007-9#1)
practice of treatment##2##3##(2008-3#1)(2009-11#1)
practice of use of##2##4##(2006-12#1)(2012-12#1)
practice of using##2##3##(2007-8#1)(2008-3#1)
practice of##266##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#4)(1992-1#1)(1992-2#2)(1992-3#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#2)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-1#2)(1995-3#2)(1995-6#1)(1995-7#1)(1996-1#1)(1996-2#2)(1997-3#6)(2004-10#1)(2004-11#1)(2004-12#1)(2005-12#2)(2005-2#1)(2005-3#1)(2006-1#1)(2006-10#5)(2006-12#3)(2006-2#4)(2006-7#2)(2006-8#7)(2006-9#2)(2007-10#2)(2007-12#6)(2007-2#6)(2007-3#2)(2007-4#12)(2007-7#3)(2007-8#3)(2007-9#3)(2008-1#5)(2008-10#9)(2008-11#9)(2008-12#4)(2008-2#7)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#6)(2008-9#3)(2009-11#1)(2009-12#2)(2009-2#2)(2009-4#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#7)(2010-12#2)(2010-2#1)(2010-3#3)(2010-5#1)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#11)(2011-3#1)(2011-7#1)(2012-1#5)(2012-11#3)(2012-12#5)(2012-2#9)(2012-3#5)(2013-1#13)(2013-7#1)(2013-8#2)
practice often##2##2##(1996-1#1)(2011-2#1)
practice on the##2##3##(1996-2#1)(2006-6#1)
practice on##8##2##(1996-2#1)(2006-6#1)(2007-12#1)(2007-4#1)(2008-12#1)(2008-7#1)(2013-1#2)
practice opportunities##2##2##(2008-11#1)(2012-1#1)
practice or##8##2##(1992-11#1)(1994-3#1)(1995-1#1)(2006-10#1)(2009-10#1)(2010-9#1)(2012-12#1)(2013-8#1)
practice outcomes##2##2##(2008-11#1)(2008-8#1)
practice outside##2##2##(2008-11#1)(2008-8#1)
practice over the past##3##4##(1996-8#1)(2010-8#1)(2012-2#1)
practice over##6##2##(1990-9#1)(1996-8#1)(2007-1#1)(2008-4#1)(2010-8#1)(2012-2#1)
practice parameter##2##2##(1996-2#1)(2009-12#1)
practice parameters##9##2##(1993-3#5)(1994-3#2)(1995-1#1)(2006-12#1)
practice pattern##4##2##(1994-12#2)(1995-12#1)(2013-1#1)
practice patterns and##3##3##(1993-2#1)(2007-5#1)(2010-9#1)
practice patterns are##2##3##(1994-12#1)(2008-11#1)
practice patterns for##3##3##(2005-6#1)(2006-10#1)(2012-2#1)
practice patterns in##2##3##(2007-12#1)(2009-4#1)
practice patterns of##6##3##(2006-5#1)(2007-4#1)(2007-6#1)(2009-9#1)(2011-2#1)(2012-1#1)
practice patterns##37##2##(1990-6#2)(1991-4#2)(1992-12#1)(1993-2#1)(1994-1#1)(1994-12#4)(1994-2#1)(1995-12#1)(1997-1#1)(2005-6#1)(2006-10#1)(2006-5#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-6#1)(2008-11#1)(2008-7#1)(2009-4#1)(2009-9#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
practice performance##5##2##(1993-12#1)(1996-2#3)(2007-4#1)
practice placement##10##2##(2008-11#10)
practice placements##5##2##(2008-11#5)
practice places##2##2##(2008-12#1)(2009-5#1)
practice policies##2##2##(1991-12#1)(1996-12#1)
practice profiles##2##2##(1995-2#1)(2007-6#1)
practice recommendations for##2##3##(2006-8#1)(2010-9#1)
practice recommendations##6##2##(2006-8#1)(2007-6#1)(2010-9#1)(2011-2#1)(2013-1#2)
practice relating to care of the older person##2##8##(2010-10#2)
practice relevant to##2##3##(2008-12#1)(2010-10#1)
practice relevant##3##2##(2007-3#1)(2008-12#1)(2010-10#1)
practice remains a##2##3##(2008-3#1)(2010-10#1)
practice remains##4##2##(2008-3#1)(2010-10#1)(2010-5#1)(2012-3#1)
practice represents a##2##3##(1990-4#1)(2008-1#1)
practice research network##2##3##(2006-4#2)
practice research##3##2##(2006-4#2)(2011-1#1)
practice revenues##3##2##(1994-1#1)(2007-4#2)
practice roles##3##2##(1996-3#1)(2004-3#1)(2007-9#1)
practice safe sex##2##3##(2007-3#1)(2012-3#1)
practice safe##3##2##(1991-6#1)(2007-3#1)(2012-3#1)
practice setting##19##2##(1993-2#1)(1994-3#2)(1995-3#1)(1996-1#1)(1996-3#1)(2004-3#1)(2005-7#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2011-1#1)(2011-12#1)
practice settings and##3##3##(2006-8#1)(2007-8#1)(2008-11#1)
practice settings##24##2##(1992-1#1)(1996-7#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-4#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#1)(2009-1#1)(2010-12#1)(2010-7#1)(2010-8#1)(2012-1#1)
practice should be##4##3##(1993-3#1)(2006-10#1)(2007-8#1)(2010-8#1)
practice should##7##2##(1993-3#1)(1994-12#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-4#1)(2010-8#1)
practice since##3##2##(2007-7#1)(2008-11#1)(2011-12#1)
practice sites##3##2##(2004-3#2)(2012-3#1)
practice skills##2##2##(2008-11#1)(2008-12#1)
practice staff and##2##3##(2007-2#1)(2011-2#1)
practice staff##5##2##(2007-2#4)(2011-2#1)
practice standards for##2##3##(1997-7#1)(2007-12#1)
practice standards##4##2##(1993-2#1)(1997-7#1)(2007-12#1)(2011-2#1)
practice style##2##2##(1993-12#1)(2010-12#1)
practice survey##2##2##(2007-9#1)(2008-9#1)
practice than##4##2##(1993-8#1)(1994-12#1)(2009-11#1)(2013-1#1)
practice that can be##2##4##(2005-12#1)(2007-4#1)
practice that can##3##3##(2005-12#1)(2007-4#1)(2008-7#1)
practice that have##2##3##(2006-10#1)(2007-4#1)
practice that helps promote##6##4##(2007-2#6)
practice that##27##2##(1996-2#1)(2004-3#1)(2005-12#1)(2006-10#1)(2006-3#1)(2007-2#7)(2007-4#3)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#2)(2009-9#1)(2010-10#1)(2013-1#1)(2013-8#2)
practice the##9##2##(1993-10#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-4#1)(2012-1#1)(2012-3#1)(2013-1#1)
practice this##2##2##(1994-7#1)(2009-2#1)
practice through the##2##3##(2008-11#1)(2011-12#1)
practice through##12##2##(1991-3#1)(1997-2#1)(2004-3#1)(2008-11#3)(2008-12#3)(2010-9#1)(2011-12#1)(2012-1#1)
practice to ensure##2##3##(2006-8#1)(2012-2#1)
practice to improve the##2##4##(1993-3#1)(2012-1#1)
practice to improve##3##3##(1993-3#1)(2007-9#1)(2012-1#1)
practice to the##2##3##(2006-10#1)(2008-4#1)
practice to their##2##3##(2008-11#1)(2011-1#1)
practice to##46##2##(1992-9#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-4#1)(2006-10#3)(2006-7#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2009-10#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
practice today##2##2##(1997-4#1)(2006-12#1)
practice type##3##2##(1997-2#1)(2007-10#1)(2007-4#1)
practice using##6##2##(1992-8#1)(2007-11#1)(2008-11#1)(2009-6#1)(2012-2#1)(2013-1#1)
practice utilizing##2##2##(2006-8#1)(2008-11#1)
practice vary##2##2##(1990-9#1)(1996-12#1)
practice volume and##2##3##(2005-9#1)(2006-10#1)
practice volume##3##2##(2005-9#1)(2006-10#1)(2012-3#1)
practice was##13##2##(1990-5#1)(1995-12#1)(1995-4#1)(1996-1#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-12#1)(2010-1#1)(2012-1#1)(2013-8#1)
practice we##4##2##(1990-3#1)(2008-1#1)(2008-5#1)(2009-2#1)
practice were found to##2##4##(2008-11#1)(2012-11#1)
practice were investigated##2##3##(1991-11#1)(1995-4#1)
practice were##13##2##(1991-11#1)(1994-6#1)(1995-4#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)
practice when##2##2##(2008-11#1)(2013-1#1)
practice which##4##2##(2007-7#1)(2008-11#1)(2008-3#1)(2008-5#1)
practice whilst##2##2##(2007-5#1)(2008-11#1)
practice who had##2##3##(1996-2#1)(2008-12#1)
practice who##5##2##(1996-2#1)(2006-10#1)(2006-8#2)(2008-12#1)
practice will be##2##3##(2006-8#1)(2010-10#1)
practice will##5##2##(2006-8#1)(2007-4#1)(2007-9#1)(2008-10#1)(2010-10#1)
practice with the##2##3##(2008-11#1)(2008-9#1)
practice with##25##2##(1991-3#1)(1993-2#1)(1993-3#1)(1996-12#1)(2005-9#1)(2006-6#1)(2007-10#1)(2007-6#1)(2007-9#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-9#2)(2009-2#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
practice within##5##2##(1996-8#1)(2007-10#1)(2008-10#1)(2010-10#1)(2013-8#1)
practice would be##2##3##(2008-10#1)(2008-11#1)
practice##3237##1##(1990-10#5)(1990-12#4)(1990-2#7)(1990-3#13)(1990-4#5)(1990-5#9)(1990-6#11)(1990-8#2)(1990-9#7)(1991-1#10)(1991-11#4)(1991-12#6)(1991-2#7)(1991-3#14)(1991-4#6)(1991-5#1)(1991-6#20)(1991-7#2)(1991-8#4)(1991-9#3)(1992-1#8)(1992-10#3)(1992-11#1)(1992-12#5)(1992-2#10)(1992-3#15)(1992-4#4)(1992-5#4)(1992-6#5)(1992-7#1)(1992-8#7)(1992-9#7)(1993-1#9)(1993-10#5)(1993-11#5)(1993-12#25)(1993-2#19)(1993-3#19)(1993-4#2)(1993-5#4)(1993-6#2)(1993-7#8)(1993-8#8)(1993-9#5)(1994-1#23)(1994-11#2)(1994-12#17)(1994-2#7)(1994-3#21)(1994-4#2)(1994-5#5)(1994-6#7)(1994-7#6)(1994-8#2)(1994-9#3)(1995-1#13)(1995-11#3)(1995-12#11)(1995-2#6)(1995-3#6)(1995-4#5)(1995-5#3)(1995-6#4)(1995-7#2)(1995-8#2)(1995-9#7)(1996-1#30)(1996-10#1)(1996-11#9)(1996-12#17)(1996-2#30)(1996-3#21)(1996-4#1)(1996-6#6)(1996-7#4)(1996-8#8)(1996-9#10)(1997-1#7)(1997-2#13)(1997-3#28)(1997-4#12)(1997-5#8)(1997-6#2)(1997-7#6)(1997-8#12)(2004-1#1)(2004-10#9)(2004-11#2)(2004-12#3)(2004-3#13)(2004-7#1)(2005-1#2)(2005-10#7)(2005-11#8)(2005-12#18)(2005-2#2)(2005-3#1)(2005-5#1)(2005-6#5)(2005-7#10)(2005-8#8)(2005-9#7)(2006-1#8)(2006-10#77)(2006-11#5)(2006-12#11)(2006-2#23)(2006-3#6)(2006-4#7)(2006-5#13)(2006-6#20)(2006-7#13)(2006-8#41)(2006-9#24)(2007-1#10)(2007-10#40)(2007-11#36)(2007-12#35)(2007-2#41)(2007-3#22)(2007-4#85)(2007-5#14)(2007-6#13)(2007-7#24)(2007-8#28)(2007-9#40)(2008-1#43)(2008-10#61)(2008-11#297)(2008-12#105)(2008-2#24)(2008-3#67)(2008-4#30)(2008-5#15)(2008-6#29)(2008-7#46)(2008-8#44)(2008-9#36)(2009-1#3)(2009-10#21)(2009-11#14)(2009-12#11)(2009-2#13)(2009-3#4)(2009-4#28)(2009-5#7)(2009-6#10)(2009-7#7)(2009-8#13)(2009-9#10)(2010-1#6)(2010-10#51)(2010-11#34)(2010-12#31)(2010-2#12)(2010-3#15)(2010-4#15)(2010-5#13)(2010-6#3)(2010-7#13)(2010-8#22)(2010-9#26)(2011-1#67)(2011-11#1)(2011-12#25)(2011-2#107)(2011-3#2)(2011-7#1)(2012-1#43)(2012-11#10)(2012-12#63)(2012-2#62)(2012-3#47)(2013-1#135)(2013-7#16)(2013-8#42)
practice&quot##5##1##(1991-12#1)(1995-1#1)(1995-5#1)(2008-10#2)
practice'##9##1##(2007-10#1)(2007-8#1)(2008-11#4)(2008-12#2)(2012-12#1)
practice's##7##1##(1995-1#1)(1996-12#1)(2006-8#1)(2007-4#2)(2008-4#1)(2010-11#1)
practice)##4##1##(1992-5#1)(2006-7#1)(2006-8#1)(2012-3#1)
practice--a##3##1##(1992-3#1)(1993-2#1)(1995-4#1)
practice--an##2##1##(1994-6#1)(2007-7#1)
practice-based research in clinical nutrition##2##5##(1993-2#2)
practice-based research##4##2##(1993-2#3)(2007-12#1)
practice-based teaching##4##2##(2008-11#4)
practice-based##16##1##(1993-2#3)(2007-12#2)(2008-11#7)(2008-12#2)(2008-7#1)(2011-2#1)
practice-related##2##1##(2007-1#2)
practice?##13##1##(1992-12#1)(1997-3#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-3#1)(2007-4#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-3#1)
practice?]##5##1##(1991-6#1)(1994-11#1)(1994-5#1)(1995-8#2)
practice]##72##1##(1990-11#2)(1990-3#1)(1990-4#1)(1991-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-2#2)(1993-3#2)(1993-5#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-2#1)(1994-6#2)(1994-8#3)(1995-11#1)(1995-3#1)(1995-4#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-4#2)(1996-6#1)(1996-9#2)(1997-3#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2005-7#1)(2006-6#3)(2007-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#3)(2009-4#1)(2009-5#1)(2010-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
practiced by the##2##3##(1994-12#1)(2008-7#1)
practiced by##5##2##(1994-12#1)(1995-1#1)(2008-10#1)(2008-7#1)(2012-11#1)
practiced in the##3##3##(1991-8#1)(1994-3#1)(2008-2#1)
practiced in##7##2##(1991-8#1)(1994-3#1)(2008-2#1)(2008-3#1)(2009-6#1)(2012-2#2)
practiced on a##2##3##(2012-1#1)(2013-8#1)
practiced on##3##2##(2012-1#1)(2013-8#2)
practiced##56##1##(1990-2#1)(1991-2#1)(1991-8#1)(1992-4#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-1#1)(1997-8#1)(2004-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-5#4)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-6#2)(2009-9#2)(2010-7#2)(2011-1#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#3)
practices after the##2##3##(1992-5#1)(2008-9#1)
practices among##16##2##(1993-12#1)(2006-1#1)(2006-12#1)(2007-1#1)(2007-2#2)(2008-11#1)(2008-2#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
practices and a##2##3##(1992-2#1)(2008-10#1)
practices and health##2##3##(2007-9#1)(2008-5#1)
practices and outcomes##4##3##(1994-12#1)(2006-12#1)(2007-2#2)
practices and perceptions of##2##4##(2008-7#2)
practices and policies##5##3##(1996-12#1)(2006-3#1)(2007-9#1)(2010-1#1)(2012-12#1)
practices and resources##3##3##(2005-10#1)(2013-1#2)
practices and social##2##3##(2008-12#1)(2013-1#1)
practices and the##7##3##(2007-10#1)(2008-11#1)(2008-6#1)(2010-7#1)(2011-2#1)(2013-1#2)
practices and to##2##3##(2008-4#1)(2008-7#1)
practices and training##2##3##(2008-11#1)(2011-2#1)
practices and##110##2##(1991-12#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-2#1)(1996-12#3)(1996-2#1)(1997-2#1)(1997-3#1)(2005-10#3)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#2)(2006-7#1)(2007-10#2)(2007-12#1)(2007-2#2)(2007-5#1)(2007-7#2)(2007-9#5)(2008-10#1)(2008-11#5)(2008-12#6)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#2)(2010-1#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#4)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#1)
practices are described##2##3##(2008-4#1)(2010-11#1)
practices are discussed##2##3##(1995-2#1)(2007-12#1)
practices are##19##2##(1993-12#1)(1995-2#1)(1996-2#1)(1997-3#1)(2006-2#1)(2007-12#1)(2007-2#2)(2008-11#1)(2008-4#1)(2008-5#1)(2010-10#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-3#1)(2013-1#2)
practices as##6##2##(1992-2#1)(1995-6#1)(2007-2#1)(2008-6#1)(2010-2#1)(2011-1#1)
practices associated with##5##3##(1996-3#1)(1996-9#1)(2008-9#1)(2010-8#1)(2010-9#1)
practices at##5##2##(1995-11#1)(2010-5#1)(2011-2#2)(2013-1#1)
practices based on##2##3##(1992-2#1)(2012-3#1)
practices between##3##2##(1990-2#1)(1996-1#1)(2013-8#1)
practices by##3##2##(2007-2#1)(2008-5#1)(2011-2#1)
practices can be##2##3##(1994-2#1)(2007-2#1)
practices can##8##2##(1992-12#1)(1994-2#1)(2006-2#1)(2007-2#1)(2007-4#1)(2008-10#1)(2009-10#1)(2010-5#1)
practices designed to##4##3##(2008-7#1)(2008-9#1)(2010-4#1)(2012-3#1)
practices during##4##2##(1994-5#1)(2005-11#1)(2007-12#1)(2008-2#1)
practices for the##5##3##(1994-3#1)(2007-10#1)(2009-5#1)(2010-11#1)(2011-2#1)
practices for##39##2##(1993-5#1)(1994-3#1)(1994-6#1)(1996-8#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
practices from##2##2##(1992-6#1)(2011-2#1)
practices had##3##2##(1993-3#2)(2008-9#1)
practices have a##2##3##(1992-3#1)(2013-1#1)
practices have been##3##3##(1991-12#1)(2008-10#1)(2013-7#1)
practices have##12##2##(1991-12#1)(1992-3#1)(1993-3#1)(1994-4#1)(2008-10#2)(2008-11#1)(2010-9#1)(2012-3#2)(2013-1#1)(2013-7#1)
practices in a##8##3##(1993-3#1)(2007-2#1)(2007-7#1)(2010-11#1)(2011-2#1)(2012-12#2)(2012-3#1)
practices in an urban##2##4##(2008-8#1)(2011-1#1)
practices in an##3##3##(2008-3#1)(2008-8#1)(2011-1#1)
practices in different##2##3##(2008-11#1)(2012-3#1)
practices in the United States##3##5##(1993-3#1)(2008-3#1)(2012-2#1)
practices in the United##4##4##(1993-3#1)(2008-11#1)(2008-3#1)(2012-2#1)
practices in the county##2##4##(1993-3#2)
practices in the field##2##4##(2008-12#1)(2011-2#1)
practices in the home##2##4##(2012-2#2)
practices in the##28##3##(1993-3#3)(1994-1#1)(1996-5#1)(1997-7#1)(2005-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#1)
practices in this##3##3##(1991-11#1)(2008-12#1)(2011-2#1)
practices in##109##2##(1990-2#1)(1991-11#1)(1991-12#1)(1993-3#4)(1994-1#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-5#1)(1997-7#2)(2005-10#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#6)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-4#1)(2009-5#1)(2009-7#2)(2010-11#2)(2010-5#1)(2010-7#1)(2010-9#2)(2011-1#3)(2011-2#10)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#4)(2013-7#2)(2013-8#4)
practices include##3##2##(2008-12#1)(2011-2#2)
practices into the##2##3##(2007-1#1)(2008-6#1)
practices involved##2##2##(2008-12#1)(2008-4#1)
practices is needed##2##3##(2009-11#1)(2010-11#1)
practices is##9##2##(1997-3#1)(2007-12#1)(2008-4#3)(2008-9#1)(2009-11#1)(2009-9#1)(2010-11#1)
practices may##2##2##(2010-12#1)(2013-7#1)
practices must be##2##3##(1992-12#1)(2008-10#1)
practices must##5##2##(1992-12#1)(2006-7#1)(2008-10#1)(2008-7#1)(2012-12#1)
practices of health care##4##4##(1993-12#1)(2008-1#1)(2012-11#1)(2013-7#1)
practices of medical##3##3##(2008-2#1)(2008-5#1)(2011-2#1)
practices of the##4##3##(2008-1#1)(2008-11#1)(2009-8#1)(2011-1#1)
practices of##78##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1993-12#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-4#1)(1995-9#1)(1996-11#1)(1997-8#1)(2005-10#1)(2005-9#1)(2006-10#1)(2007-2#2)(2007-3#2)(2007-4#2)(2007-7#2)(2007-9#2)(2008-1#3)(2008-10#2)(2008-11#3)(2008-2#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-4#2)(2010-5#1)(2011-1#4)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#5)(2013-7#2)
practices often##3##2##(1991-3#1)(1997-7#1)(2007-12#1)
practices on the##4##3##(2008-10#2)(2012-12#1)(2013-1#1)
practices on##11##2##(2008-10#4)(2008-2#3)(2008-5#1)(2009-6#1)(2012-12#1)(2013-1#1)
practices or##3##2##(1993-1#1)(2006-11#1)(2007-4#1)
practices rather than##2##3##(2005-10#1)(2007-8#1)
practices regarding##7##2##(1997-1#1)(2008-2#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-6#1)(2011-2#1)
practices related to##4##3##(1994-6#2)(2010-7#1)(2011-2#1)
practices such as##6##3##(1994-2#1)(2006-4#1)(2008-10#3)(2012-12#1)
practices that may##3##3##(1995-3#1)(2008-5#1)(2008-9#1)
practices that promote##3##3##(2007-2#1)(2008-6#2)
practices that reduce##3##3##(2008-10#3)
practices that##31##2##(1993-1#1)(1995-3#2)(1997-1#1)(2005-7#1)(2006-7#1)(2007-2#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#3)(2010-2#1)(2010-4#2)(2010-7#1)(2012-11#1)
practices the##2##2##(1993-12#1)(2010-11#1)
practices throughout##2##2##(2006-10#1)(2006-12#1)
practices to avoid##2##3##(2008-10#1)(2009-3#1)
practices to be##3##3##(1990-9#1)(2007-5#1)(2013-8#1)
practices to children's perceptions and##2##5##(2008-12#2)
practices to the##3##3##(2005-5#1)(2008-12#1)(2012-3#1)
practices to##21##2##(1990-9#1)(1993-3#2)(2005-5#1)(2007-5#1)(2008-10#1)(2008-12#4)(2008-4#1)(2008-6#2)(2009-3#1)(2010-5#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
practices used##3##2##(1991-12#1)(2008-10#1)(2010-11#1)
practices vary##3##2##(2006-10#1)(2012-2#1)(2013-1#1)
practices was##5##2##(1994-12#1)(2005-11#1)(2008-12#1)(2011-1#2)
practices were associated with##2##4##(2009-10#1)(2013-1#1)
practices were##7##2##(2008-4#2)(2008-7#1)(2009-10#1)(2010-4#1)(2010-7#1)(2013-1#1)
practices which have##2##3##(2008-3#1)(2011-1#1)
practices which##4##2##(2004-12#1)(2007-2#1)(2008-3#1)(2011-1#1)
practices will be##2##3##(2006-8#1)(2007-4#1)
practices will##3##2##(2006-8#1)(2007-2#1)(2007-4#1)
practices with regard to##2##4##(2007-10#1)(2007-9#1)
practices with##8##2##(1990-12#1)(1991-12#1)(1993-3#1)(2007-10#1)(2007-9#1)(2008-6#1)(2012-12#1)(2012-3#1)
practices within##3##2##(1994-2#1)(1996-12#1)(2007-5#1)
practices##1008##1##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#9)(1991-2#1)(1991-3#3)(1991-6#2)(1992-1#2)(1992-12#5)(1992-2#3)(1992-3#4)(1992-5#1)(1992-6#1)(1993-1#3)(1993-12#14)(1993-2#1)(1993-3#20)(1993-5#2)(1993-8#2)(1994-1#2)(1994-12#7)(1994-2#8)(1994-3#5)(1994-4#1)(1994-5#1)(1994-6#5)(1994-8#1)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#5)(1995-4#1)(1995-6#3)(1995-9#1)(1996-1#4)(1996-11#1)(1996-12#4)(1996-2#4)(1996-3#7)(1996-5#2)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#5)(1997-3#5)(1997-6#2)(1997-7#7)(1997-8#2)(2004-12#1)(2004-5#1)(2004-9#2)(2005-10#10)(2005-11#3)(2005-12#1)(2005-2#2)(2005-5#2)(2005-7#3)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#10)(2006-11#2)(2006-12#6)(2006-2#8)(2006-3#3)(2006-4#4)(2006-5#2)(2006-7#9)(2006-8#15)(2006-9#2)(2007-1#2)(2007-10#8)(2007-11#4)(2007-12#18)(2007-2#20)(2007-3#6)(2007-4#24)(2007-5#4)(2007-7#10)(2007-8#6)(2007-9#12)(2008-1#11)(2008-10#44)(2008-11#30)(2008-12#28)(2008-2#22)(2008-3#10)(2008-4#27)(2008-5#17)(2008-6#13)(2008-7#24)(2008-8#7)(2008-9#28)(2009-10#6)(2009-11#2)(2009-2#5)(2009-3#1)(2009-4#7)(2009-5#3)(2009-6#4)(2009-7#9)(2009-8#2)(2009-9#3)(2010-1#3)(2010-10#4)(2010-11#18)(2010-12#4)(2010-2#5)(2010-3#2)(2010-4#9)(2010-5#9)(2010-6#6)(2010-7#9)(2010-8#4)(2010-9#11)(2011-1#29)(2011-12#1)(2011-2#44)(2012-1#6)(2012-11#4)(2012-12#21)(2012-2#19)(2012-3#26)(2013-1#51)(2013-7#12)(2013-8#20)
practices&quot##3##1##(2007-1#1)(2007-12#1)(2008-6#1)
practices--the##2##1##(1996-5#1)(2008-1#1)
practices?##3##1##(1997-1#1)(2006-4#1)(2009-2#1)
practices]##2##1##(1993-6#1)(2008-9#1)
practicing cardiothoracic surgeons##2##3##(2007-8#2)
practicing community pharmacists##3##3##(2010-5#3)
practicing community##4##2##(2007-4#1)(2010-5#3)
practicing health care##2##3##(1995-2#1)(1996-1#1)
practicing in the##3##3##(1993-1#1)(2008-9#1)(2013-7#1)
practicing in##7##2##(1993-1#1)(2006-10#1)(2006-11#1)(2008-9#1)(2012-12#1)(2013-7#1)(2013-8#1)
practicing medicine##2##2##(2008-1#1)(2013-1#1)
practicing physician##3##2##(1996-3#1)(2006-6#1)(2010-9#1)
practicing physicians to##3##3##(2008-3#1)(2012-12#2)
practicing physicians##13##2##(1992-12#1)(1996-1#1)(2006-10#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-3#4)(2008-6#1)(2012-12#2)
practicing radiologists to##2##3##(2007-4#2)
practicing radiologists##4##2##(2007-4#4)
practicing##92##1##(1990-6#1)(1992-1#2)(1992-12#1)(1993-1#1)(1993-12#1)(1993-5#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-1#2)(1996-2#1)(1996-3#1)(2004-12#1)(2005-7#1)(2006-10#12)(2006-11#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-12#1)(2007-3#1)(2007-4#6)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-3#5)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#4)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
practicum experience##2##2##(1996-1#1)(2010-6#1)
practicum in##2##2##(1992-2#1)(2007-3#1)
practicum##12##1##(1992-2#2)(1995-12#2)(1996-1#5)(2006-10#1)(2007-3#1)(2010-6#1)
practicums##3##1##(1995-12#1)(1997-3#1)(2008-12#1)
practioners##2##1##(1990-12#1)(2006-4#1)
practise##21##1##(1990-4#1)(1991-2#1)(1994-12#1)(1994-2#1)(1996-4#1)(1997-5#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-8#1)(2011-2#4)(2013-8#2)
practised by##3##2##(1994-12#2)(2013-1#1)
practised in##4##2##(1993-9#1)(2007-6#1)(2009-10#1)(2013-8#1)
practised##23##1##(1991-8#2)(1993-11#1)(1993-9#1)(1994-12#2)(1997-6#1)(2005-2#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-3#2)(2009-10#1)(2009-6#1)(2010-6#1)(2011-12#1)(2013-1#2)(2013-8#1)
practises##3##1##(1996-1#2)(2010-6#1)
practising in##4##2##(2007-6#1)(2007-8#1)(2010-11#2)
practising physicians##2##2##(1995-11#1)(1996-9#1)
practising##29##1##(1993-1#5)(1993-12#1)(1995-11#1)(1996-6#1)(1996-9#1)(2005-9#1)(2006-8#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-12#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-11#4)(2010-5#1)(2012-1#1)(2013-1#3)
practitioner and a##2##3##(1996-4#1)(2008-11#1)
practitioner and patient##4##3##(2006-8#1)(2007-6#1)(2013-1#2)
practitioner and the##6##3##(1995-3#1)(1996-3#1)(1997-6#2)(2006-10#1)(2011-2#1)
practitioner and##22##2##(1991-1#1)(1992-3#1)(1995-3#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-4#1)(1997-6#2)(2006-10#1)(2006-8#1)(2007-6#1)(2008-1#2)(2008-11#4)(2008-12#1)(2011-2#1)(2013-1#2)
practitioner as##2##2##(1996-4#1)(1996-9#1)
practitioner by##2##2##(1990-10#1)(1992-5#1)
practitioner development##2##2##(2007-12#1)(2008-12#1)
practitioner had##2##2##(1993-8#1)(2008-10#1)
practitioner has##2##2##(1995-11#1)(2008-7#1)
practitioner in the##4##3##(1991-7#1)(1997-7#1)(2007-11#1)(2008-3#1)
practitioner in##15##2##(1990-2#1)(1991-7#1)(1992-12#1)(1993-11#1)(1993-2#1)(1997-7#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#1)(2009-9#1)(2010-10#1)(2013-1#1)
practitioner is##7##2##(1994-1#1)(1995-11#1)(1995-8#1)(2006-10#1)(2008-1#1)(2008-11#1)(2010-7#1)
practitioner more##2##2##(1992-5#1)(2008-7#1)
practitioner on##2##2##(1990-3#1)(2012-2#1)
practitioner to##5##2##(1993-8#1)(1994-2#1)(1995-9#1)(2008-11#1)(2012-2#1)
practitioner who is##9##3##(2006-10#7)(2006-8#1)(2008-11#1)
practitioner##175##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#4)(1990-6#1)(1990-9#2)(1991-1#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#4)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-6#1)(1993-8#5)(1994-1#2)(1994-11#1)(1994-2#1)(1994-5#3)(1994-6#1)(1995-11#2)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#4)(1996-1#1)(1996-11#1)(1996-3#4)(1996-4#3)(1996-8#2)(1996-9#1)(1997-3#1)(1997-4#5)(1997-6#3)(1997-7#1)(2004-3#4)(2005-11#2)(2006-10#9)(2006-8#2)(2007-11#5)(2007-12#2)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#1)(2008-1#7)(2008-10#2)(2008-11#17)(2008-12#9)(2008-3#1)(2008-4#1)(2008-7#2)(2009-11#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#6)(2013-8#1)
practitioner's perspective of##2##3##(1991-1#1)(2008-7#1)
practitioner's perspective##4##2##(1991-1#1)(1996-3#1)(2006-8#1)(2008-7#1)
practitioner's role##3##2##(1990-10#1)(1997-1#1)(2008-1#1)
practitioner's##21##1##(1990-10#1)(1990-9#1)(1991-1#2)(1991-4#1)(1992-12#1)(1993-8#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-4#1)(2006-8#1)(2007-11#1)(2008-1#2)(2008-11#1)(2008-7#1)(2012-11#2)(2012-12#2)
practitioner-teacher model##3##2##(1991-12#3)
practitioner?]##2##1##(1997-3#1)(2008-4#1)
practitioner]##3##1##(1994-12#1)(1994-7#1)(1997-6#1)
practitioners (GPs)##9##2##(2006-5#1)(2007-2#3)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2013-8#1)
practitioners -##2##2##(2007-4#1)(2009-10#1)
practitioners about##4##2##(1995-5#1)(2010-12#1)(2010-2#1)(2011-12#1)
practitioners and a##3##3##(1997-4#2)(2013-8#1)
practitioners and educationalists##3##3##(2008-11#3)
practitioners and family##2##3##(2008-12#1)(2010-8#1)
practitioners and health##2##3##(1992-10#1)(2006-10#1)
practitioners and medical##2##3##(2008-1#1)(2011-1#1)
practitioners and other##3##3##(2007-12#1)(2010-12#1)(2010-7#1)
practitioners and patients##2##3##(2008-5#1)(2012-12#1)
practitioners and scientists##3##3##(2004-12#1)(2008-2#1)(2011-1#1)
practitioners and specialists##3##3##(1990-10#1)(2008-1#1)(2008-4#1)
practitioners and the##4##3##(1991-8#1)(1997-4#1)(2007-12#1)(2010-10#1)
practitioners and those##2##3##(2008-7#1)(2010-10#1)
practitioners and users of CER##2##5##(2012-12#2)
practitioners and##66##2##(1990-10#1)(1991-1#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-10#1)(1993-11#1)(1993-2#2)(1993-9#1)(1994-11#1)(1994-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-4#4)(2004-10#1)(2004-12#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-7#2)(2007-12#2)(2008-1#2)(2008-10#1)(2008-11#5)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#3)(2012-3#1)(2013-8#1)
practitioners are required##2##3##(1993-3#1)(2010-8#1)
practitioners are##16##2##(1991-2#1)(1993-12#1)(1993-3#1)(1995-1#1)(1995-12#1)(2005-12#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
practitioners as##3##2##(1991-9#1)(1992-9#1)(1993-11#1)
practitioners can##5##2##(1991-12#1)(1995-9#1)(2005-11#1)(2007-2#1)(2008-11#1)
practitioners consider##2##2##(1993-2#1)(2008-10#1)
practitioners do not have##2##4##(1990-8#1)(2008-12#1)
practitioners do not##3##3##(1990-8#1)(2008-12#1)(2008-7#1)
practitioners do##4##2##(1990-8#1)(1994-6#1)(2008-12#1)(2008-7#1)
practitioners during##2##2##(1991-12#1)(2008-11#1)
practitioners for##4##2##(2007-2#2)(2008-9#1)(2009-6#1)
practitioners from##4##2##(1993-3#1)(1994-6#1)(2008-1#1)(2008-9#1)
practitioners had##3##2##(1993-2#1)(2008-10#1)(2011-1#1)
practitioners have##4##2##(2008-10#1)(2012-12#1)(2013-1#2)
practitioners having##2##2##(1993-5#1)(2007-6#1)
practitioners identify##2##2##(1997-2#1)(2006-7#1)
practitioners in the health##2##4##(1994-3#1)(2008-12#1)
practitioners in the primary##2##4##(2009-5#1)(2013-1#1)
practitioners in the region##2##4##(1991-4#1)(2008-4#1)
practitioners in the##19##3##(1991-4#1)(1993-8#1)(1994-2#1)(1994-3#1)(1997-4#1)(2007-3#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2009-5#1)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#1)
practitioners in##57##2##(1990-12#1)(1991-4#1)(1991-9#2)(1993-1#1)(1993-2#1)(1993-8#2)(1994-2#1)(1994-3#4)(1994-6#1)(1995-11#1)(1996-1#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-6#1)(2005-10#1)(2007-12#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-12#1)(2009-5#1)(2011-1#3)(2011-12#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)
practitioners involved##3##2##(1995-8#1)(2008-9#1)(2013-8#1)
practitioners is##3##2##(1991-3#1)(1993-1#1)(2006-10#1)
practitioners managing##2##2##(1995-1#1)(2005-11#1)
practitioners may be##4##3##(2008-5#1)(2011-1#1)(2013-1#2)
practitioners may encounter##2##3##(2013-1#2)
practitioners may##7##2##(2008-5#1)(2009-4#1)(2011-1#1)(2013-1#4)
practitioners must##4##2##(2008-11#1)(2008-12#1)(2008-7#1)(2010-5#1)
practitioners need to##4##3##(2004-3#2)(2010-8#2)
practitioners of##14##2##(1995-5#1)(1996-3#1)(1997-6#2)(2006-2#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2010-3#1)(2012-12#2)
practitioners often##2##2##(2006-8#1)(2012-2#1)
practitioners on the##5##3##(1993-5#1)(1994-11#1)(2007-2#1)(2008-9#1)(2012-2#1)
practitioners on##9##2##(1993-5#1)(1994-11#1)(2004-12#1)(2005-9#1)(2007-2#1)(2008-9#2)(2012-2#2)
practitioners play##2##2##(1995-11#1)(2013-1#1)
practitioners regarding##2##2##(2010-5#1)(2011-2#1)
practitioners responded##2##2##(1991-4#1)(2008-10#1)
practitioners should##4##2##(1994-7#1)(1995-9#1)(2012-3#1)(2013-8#1)
practitioners to be##3##3##(2006-10#1)(2007-2#1)(2008-7#1)
practitioners to develop##2##3##(2008-12#1)(2010-9#1)
practitioners to understand##3##3##(2009-9#1)(2010-10#1)(2010-4#1)
practitioners to use##2##3##(2007-11#1)(2008-10#1)
practitioners to##40##2##(1992-4#1)(1993-12#1)(1993-8#1)(1996-1#1)(1996-3#1)(1997-4#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-11#2)(2007-2#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-9#2)(2011-2#1)(2013-1#3)(2013-8#1)
practitioners towards##4##2##(1991-2#1)(1996-4#1)(1997-5#1)(2010-8#1)
practitioners were willing to##2##4##(2008-1#1)(2008-8#1)
practitioners were##13##2##(1991-5#1)(1993-10#1)(1993-2#1)(1993-8#2)(2006-7#1)(2008-1#1)(2008-11#1)(2008-8#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-2#1)
practitioners who are##2##3##(2008-11#1)(2010-2#1)
practitioners who treat##2##3##(1997-8#1)(2007-8#1)
practitioners who work with##2##4##(2005-6#1)(2006-7#1)
practitioners who##11##2##(1992-3#1)(1993-5#1)(1996-9#1)(1997-8#1)(2005-6#1)(2006-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2010-12#1)(2010-2#1)
practitioners will be##2##3##(2006-10#1)(2007-12#1)
practitioners will##3##2##(1993-1#1)(2006-10#1)(2007-12#1)
practitioners with the##2##3##(2008-1#1)(2011-2#1)
practitioners with##8##2##(1990-3#1)(1993-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#2)
practitioners working in##2##3##(1994-4#1)(2012-12#1)
practitioners working within LGBT communities##2##5##(2006-11#2)
practitioners working##4##2##(1994-4#1)(2006-11#2)(2012-12#1)
practitioners##564##1##(1990-10#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#4)(1991-3#1)(1991-4#3)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#3)(1992-9#1)(1993-1#6)(1993-10#2)(1993-11#3)(1993-12#3)(1993-2#14)(1993-3#2)(1993-5#3)(1993-6#1)(1993-8#6)(1993-9#1)(1994-11#4)(1994-12#1)(1994-2#3)(1994-3#5)(1994-4#1)(1994-6#4)(1994-7#1)(1995-1#3)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#5)(1995-8#1)(1995-9#4)(1996-1#5)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#2)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#7)(1997-1#1)(1997-2#7)(1997-3#3)(1997-4#10)(1997-5#2)(1997-6#4)(1997-8#2)(2004-10#2)(2004-12#3)(2004-3#5)(2005-10#1)(2005-11#4)(2005-12#2)(2005-2#1)(2005-6#1)(2005-7#2)(2005-8#4)(2005-9#4)(2006-10#9)(2006-11#2)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#6)(2006-8#4)(2007-10#2)(2007-11#11)(2007-12#8)(2007-2#12)(2007-3#2)(2007-4#9)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#16)(2008-10#19)(2008-11#34)(2008-12#25)(2008-2#2)(2008-3#10)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#10)(2009-10#3)(2009-11#1)(2009-12#1)(2009-4#3)(2009-5#1)(2009-6#3)(2009-8#1)(2009-9#2)(2010-10#3)(2010-11#4)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#8)(2010-9#3)(2011-1#11)(2011-12#3)(2011-2#15)(2012-1#4)(2012-11#3)(2012-12#12)(2012-2#9)(2012-3#7)(2013-1#26)(2013-7#1)(2013-8#5)
practitioners' assessment##2##2##(1993-10#1)(2009-6#1)
practitioners' knowledge##2##2##(2008-8#1)(2009-6#1)
practitioners'##25##1##(1990-11#1)(1990-8#1)(1991-2#1)(1993-10#1)(1993-7#1)(1995-5#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-8#3)(2005-7#1)(2006-12#1)(2006-2#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-6#2)(2010-6#1)
practitioners?##2##1##(1991-11#1)(2013-1#1)
practitioners]##3##1##(1991-4#1)(1993-5#1)(1997-6#1)
practolol##4##1##(2005-4#4)
praecordial early repolarization pattern##2##4##(1995-6#2)
praecox##4##1##(2005-9#1)(2006-12#1)(2008-5#1)(2011-2#1)
praevia##4##1##(1992-12#1)(2007-2#1)(2009-4#1)(2011-2#1)
pragmatic and explanatory##2##3##(2008-7#1)(2009-3#1)
pragmatic and##3##2##(2008-7#1)(2009-3#1)(2010-1#1)
pragmatic approach to##4##3##(1994-2#1)(2006-10#1)(2012-3#1)(2013-8#1)
pragmatic approach##7##2##(1994-2#1)(2006-10#1)(2006-6#1)(2007-2#1)(2011-2#1)(2012-3#1)(2013-8#1)
pragmatic considerations##2##2##(2009-12#1)(2013-1#1)
pragmatic trials##3##2##(2010-12#1)(2012-3#2)
pragmatic view of##2##3##(2008-2#1)(2009-4#1)
pragmatic way##3##2##(2008-3#1)(2008-6#1)(2012-3#1)
pragmatic##45##1##(1993-3#1)(1994-2#1)(1995-1#1)(2004-12#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-2#1)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-4#2)(2011-2#4)(2012-2#1)(2012-3#6)(2013-1#2)(2013-7#1)(2013-8#1)
pragmatically##2##1##(1996-6#1)(2012-2#1)
pragmatics##3##1##(2008-11#1)(2008-9#1)(2010-4#1)
pragmatism##3##1##(1993-10#1)(1994-12#1)(2005-5#1)
prairie and aspen forest##2##4##(2008-9#2)
prairie and forest##3##3##(2008-8#1)(2008-9#2)
prairie and##6##2##(2008-8#2)(2008-9#4)
prairie voles did##2##3##(2008-9#2)
prairie voles##6##2##(1995-12#2)(2008-9#4)
prairie##20##1##(1995-12#2)(2008-5#1)(2008-8#3)(2008-9#14)
praise for##4##2##(1991-3#1)(1992-5#1)(2008-9#1)(2010-8#1)
praise##9##1##(1991-3#1)(1992-12#1)(1992-5#1)(1992-9#1)(2007-6#1)(2008-7#1)(2008-9#1)(2010-8#1)(2013-8#1)
praised##2##1##(2008-11#1)(2013-1#1)
prajmaline##3##1##(1996-3#3)
pramipexole and BHT-920 (internal standard)##2##5##(1996-8#2)
pramipexole and internal standard##3##4##(1996-8#3)
pramipexole and##5##2##(1996-8#5)
pramipexole in##3##2##(1996-8#2)(2013-8#1)
pramipexole##13##1##(1996-8#9)(2013-8#4)
prandial##2##1##(1994-12#1)(2008-10#1)
praseodymium (Pr)##2##2##(2007-12#1)(2012-2#1)
praseodymium in the##2##3##(2008-10#2)
praseodymium in##4##2##(2008-10#4)
praseodymium##13##1##(1992-4#1)(1996-5#1)(2007-12#1)(2008-10#8)(2008-2#1)(2012-2#1)
prasinoviruses##3##1##(2013-1#3)
pratense##4##1##(1996-5#1)(2013-1#3)
pratense) pollen profilin##2##3##(1994-2#2)
pratense)##4##1##(1994-2#2)(2004-4#1)(2012-2#1)
pratensis##5##1##(2007-1#1)(2008-5#4)
pratissolii##6##1##(2008-6#6)
pravastatin and gemfibrozil##2##3##(2011-1#2)
pravastatin and##5##2##(1990-7#1)(1991-6#1)(2007-11#1)(2011-1#2)
pravastatin sodium##3##2##(1993-4#2)(2011-1#1)
pravastatin##22##1##(1990-7#2)(1991-6#1)(1992-5#2)(1993-4#3)(1993-9#1)(2005-12#1)(2006-5#4)(2007-11#2)(2008-5#2)(2009-12#1)(2011-1#3)
pravastatin-sensitive process##2##2##(1991-5#2)
prawn (Macrobrachium rosenbergii)##2##3##(2007-3#2)
prawn Macrobrachium##2##2##(2011-12#1)(2012-3#1)
prawn##9##1##(2007-10#1)(2007-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2011-12#2)(2012-3#1)
prawns were##2##2##(2011-12#2)
prawns##9##1##(2007-3#2)(2008-5#1)(2008-8#1)(2011-12#5)
praxis of##2##2##(2008-11#2)
praxis##10##1##(1993-3#1)(2008-11#2)(2009-6#1)(2010-9#1)(2011-1#1)(2011-3#1)(2012-3#2)(2013-1#1)
pray##5##1##(2010-2#5)
prayer##10##1##(1996-1#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-12#3)(2008-4#1)(2010-10#1)(2010-2#1)
prayers##2##1##(2006-12#1)(2013-1#1)
praying##6##1##(2008-12#4)(2009-12#1)(2010-2#1)
prazepam##5##1##(2008-10#5)
praziquantel and##2##2##(2006-10#1)(2007-2#1)
praziquantel in##3##2##(1997-8#1)(2005-8#1)(2012-1#1)
praziquantel is##2##2##(2006-10#1)(2012-3#1)
praziquantel or oxamniquine##4##3##(2010-12#4)
praziquantel##27##1##(1992-2#1)(1995-12#1)(1996-12#2)(1997-8#2)(2005-8#1)(2006-10#6)(2007-2#1)(2008-4#1)(2010-12#5)(2012-1#1)(2012-3#6)
prazosin (50 pmole)##2##3##(1991-3#2)
prazosin and##5##2##(1990-12#1)(1996-12#1)(2006-12#1)(2008-4#1)(2013-1#1)
prazosin##27##1##(1990-12#9)(1990-5#1)(1991-3#3)(1991-5#2)(1991-6#1)(1992-11#1)(1993-11#1)(1993-3#1)(1995-5#1)(1996-12#3)(1996-3#1)(2006-12#1)(2008-4#1)(2013-1#1)
pre and post##11##3##(2007-11#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-3#1)(2012-3#1)
pre and postmenopausal##2##3##(1994-12#1)(2013-1#1)
pre and postoperative##2##3##(2007-8#1)(2009-4#1)
pre and##21##2##(1994-12#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
pre go-live training##4##3##(2013-1#4)
pre malignant##2##2##(2008-7#1)(2009-6#1)
pre operatively##2##2##(2007-7#2)
pre or##3##2##(1992-2#1)(2007-5#1)(2012-3#1)
pre##45##1##(1990-8#1)(1992-2#1)(1994-12#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-3#2)(2013-1#5)(2013-8#1)
pre- and perioperative##2##3##(2004-2#1)(2012-12#1)
pre- and post##2##3##(1990-5#1)(1996-3#1)
pre- and post-dialysis##3##3##(2008-1#3)
pre- and post-emergence##3##3##(2008-10#2)(2013-8#1)
pre- and post-exercise##2##3##(2010-9#1)(2012-12#1)
pre- and post-intervention##7##3##(2007-12#1)(2008-12#3)(2011-1#1)(2011-2#1)(2013-1#1)
pre- and post-maximal##3##3##(2010-9#2)(2013-7#1)
pre- and post-natal##4##3##(1992-12#1)(2008-4#1)(2009-9#1)(2012-2#1)
pre- and post-operative##7##3##(1990-9#1)(1991-5#1)(1996-2#1)(2007-11#2)(2007-8#1)(2008-3#1)
pre- and post-operatively##2##3##(2006-6#1)(2008-5#1)
pre- and post-synaptic##6##3##(1991-1#1)(1993-9#1)(2005-7#1)(2007-12#1)(2012-12#2)
pre- and post-test##5##3##(1993-1#1)(1994-1#1)(1996-5#1)(2008-2#1)(2013-1#1)
pre- and post-treatment##6##3##(1996-6#1)(1997-4#1)(2008-10#1)(2008-3#1)(2013-1#1)(2013-7#1)
pre- and postadaptation##2##3##(1992-10#2)
pre- and postintervention##4##3##(2010-7#1)(2013-1#3)
pre- and postnatal findings##2##4##(1996-3#2)
pre- and postnatal sheep##3##4##(1997-8#3)
pre- and postnatal##15##3##(1991-9#1)(1992-7#1)(1993-3#1)(1994-11#1)(1996-3#2)(1996-5#1)(1997-6#1)(1997-8#3)(2008-2#1)(2010-12#1)(2012-2#2)
pre- and postoperative motor status##2##5##(2006-12#2)
pre- and postoperative##18##3##(1990-10#1)(1994-2#1)(1997-1#1)(2006-12#2)(2006-5#1)(2006-8#1)(2007-1#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-7#2)(2009-2#1)(2010-2#1)(2012-12#2)
pre- and postoperatively##4##3##(2007-7#2)(2007-8#1)(2008-9#1)
pre- and postsynaptic actions##2##4##(1990-12#1)(2008-1#1)
pre- and postsynaptic neurons##2##4##(2008-2#1)(2009-8#1)
pre- and postsynaptic##13##3##(1990-12#1)(1990-2#1)(1995-12#1)(1995-8#1)(2008-1#1)(2008-2#1)(2009-5#1)(2009-8#2)(2009-9#2)(2012-12#2)
pre- and postsynaptically##2##3##(1992-3#1)(1993-11#1)
pre- and posttreatment##2##3##(1992-9#1)(2012-2#1)
pre- and##175##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-12#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-3#3)(1996-5#2)(1996-6#3)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-8#3)(2004-2#1)(2005-10#2)(2005-7#1)(2006-10#3)(2006-12#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#4)(2007-8#5)(2007-9#3)(2008-1#5)(2008-10#7)(2008-11#1)(2008-12#6)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#3)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#4)(2010-10#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#3)(2010-8#1)(2010-9#3)(2011-1#2)(2011-2#3)(2012-12#14)(2012-2#6)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#3)
pre- and/or##3##2##(1990-6#1)(1996-6#1)(2008-6#1)
pre- or post-QQc cells##2##4##(2012-12#2)
pre- or##8##2##(1993-11#1)(1993-5#1)(1995-3#1)(1997-7#1)(2006-10#1)(2008-4#1)(2012-12#2)
pre- to post-intervention##3##3##(2008-12#3)
pre- to##13##2##(1992-12#1)(1994-2#1)(2007-8#1)(2008-12#6)(2008-8#1)(2010-2#1)(2012-1#1)(2012-2#1)
pre-##215##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-12#2)(1992-3#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-5#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-9#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-3#3)(1996-5#2)(1996-6#4)(1996-9#2)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-2#1)(2005-10#2)(2005-7#1)(2006-10#4)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#4)(2007-8#6)(2007-9#3)(2008-1#5)(2008-10#7)(2008-11#1)(2008-12#12)(2008-2#4)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#4)(2010-10#2)(2010-12#2)(2010-2#2)(2010-5#1)(2010-7#3)(2010-8#1)(2010-9#3)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#20)(2012-2#7)(2012-3#3)(2013-1#9)(2013-7#2)(2013-8#3)
pre-B cell stage##2##3##(1991-2#1)(1992-5#1)
pre-B cell##4##2##(1991-2#1)(1991-5#1)(1992-5#1)(2008-4#1)
pre-B cells##3##2##(1993-7#1)(1994-10#1)(1995-5#1)
pre-B##10##1##(1991-2#2)(1991-5#1)(1992-5#1)(1993-7#2)(1994-10#1)(1995-5#1)(2008-4#1)(2009-9#1)
pre-B-cell##2##1##(1990-5#1)(1995-2#1)
pre-Chernobyl##2##1##(1992-4#1)(1992-6#1)
pre-Columbian##2##1##(2008-7#1)(2012-3#1)
pre-E2##2##1##(1991-2#2)
pre-E3##2##1##(1991-2#2)
pre-ETOH control##2##2##(1995-7#2)
pre-ETOH##3##1##(1995-7#3)
pre-EVAR iliac artery embolisation##2##4##(2012-2#2)
pre-Golgi##5##1##(1992-11#1)(1995-1#1)(1996-2#3)
pre-I group##3##2##(2009-3#3)
pre-LT##4##1##(2011-3#3)(2013-8#1)
pre-OLTX##2##1##(1995-2#2)
pre-PPS##2##1##(1991-2#1)(1992-2#1)
pre-QQc cells##2##2##(2012-12#2)
pre-S##2##1##(2007-11#1)(2008-12#1)
pre-Tx##2##1##(2011-2#2)
pre-World War##2##2##(2006-3#1)(2012-2#1)
pre-activated##3##1##(2008-10#2)(2008-8#1)
pre-adjusted##2##1##(1997-8#1)(2012-2#1)
pre-adjustment##2##1##(2008-10#1)(2009-4#1)
pre-admission##3##1##(1994-2#2)(2006-4#1)
pre-adolescents##4##1##(2007-12#3)(2008-11#1)
pre-aligned with the##2##3##(2008-10#2)
pre-aligned##5##1##(2008-10#4)(2008-5#1)
pre-anaesthetic##2##1##(1990-11#1)(2012-2#1)
pre-analytical##6##1##(1996-8#2)(2007-7#1)(2008-5#1)(2010-9#1)(2013-1#1)
pre-and post-treatment regimens##2##3##(2013-1#2)
pre-and##5##1##(2007-9#2)(2008-2#1)(2013-1#2)
pre-antibiotic era##3##2##(2007-11#1)(2010-2#1)(2012-12#1)
pre-antibiotic##4##1##(1996-6#1)(2007-11#1)(2010-2#1)(2012-12#1)
pre-approvals##2##1##(2010-8#2)
pre-aquated CP##2##2##(1994-6#2)
pre-arthritic deformities##2##2##(1997-6#2)
pre-attentive##3##1##(1997-7#2)(2006-3#1)
pre-beta##2##1##(1990-1#1)(1995-2#1)
pre-beta-lactamase##4##1##(1992-3#4)
pre-booking surgery dates##2##3##(2009-4#2)
pre-booking##3##1##(2009-4#3)
pre-cancerised##2##1##(2012-12#2)
pre-cardiopulmonary bypass value of##2##4##(2007-9#2)
pre-case biosurveillance##2##2##(2010-8#2)
pre-cast gels##2##2##(2008-11#2)
pre-cast##3##1##(2008-11#3)
pre-certification##2##1##(1991-2#1)(2009-4#1)
pre-clinical and clinical##6##3##(2008-8#3)(2010-4#1)(2013-1#1)(2013-8#1)
pre-clinical and early clinical##2##4##(2008-11#1)(2008-3#1)
pre-clinical and##8##2##(2008-11#1)(2008-3#1)(2008-8#3)(2010-4#1)(2013-1#1)(2013-8#1)
pre-clinical models of##3##3##(2008-8#1)(2009-4#2)
pre-clinical models##4##2##(2008-8#1)(2009-4#2)(2011-2#1)
pre-clinical studies have##2##3##(2008-5#1)(2009-3#1)
pre-clinical studies##7##2##(1994-11#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-3#1)(2011-2#1)
pre-clinical validation##2##2##(2009-7#2)
pre-clinical##46##1##(1990-10#2)(1994-11#2)(1996-12#2)(1996-3#2)(2007-11#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#5)(2008-9#1)(2009-3#1)(2009-4#3)(2009-7#2)(2009-9#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
pre-clinically##2##1##(2008-5#1)(2010-12#1)
pre-coating##3##1##(2008-10#1)(2013-1#2)
pre-coded##2##1##(2006-2#1)(2007-3#1)
pre-column and##3##2##(1997-3#1)(2008-10#2)
pre-column chelating reagent for##2##4##(2008-10#2)
pre-column chelating##3##2##(2008-10#3)
pre-column derivatization of##2##3##(1991-1#1)(2008-10#1)
pre-column derivatization with o-phthalaldehyde##2##4##(1993-2#2)
pre-column derivatization with##10##3##(1990-6#1)(1993-2#2)(1996-6#1)(1997-8#1)(2008-10#1)(2008-3#1)(2011-1#1)(2012-12#2)
pre-column derivatization##20##2##(1990-6#2)(1991-1#1)(1993-2#2)(1996-6#2)(1997-8#1)(2007-1#1)(2008-10#6)(2008-3#1)(2011-1#2)(2012-12#2)
pre-column extraction##2##2##(1993-2#2)
pre-column fluorescence derivatization with##2##4##(1993-2#1)(2008-10#1)
pre-column fluorescence derivatization##5##3##(1993-2#2)(1997-2#1)(2008-10#2)
pre-column##51##1##(1990-6#2)(1991-1#1)(1992-2#2)(1993-2#11)(1996-6#2)(1997-2#1)(1997-3#5)(1997-8#1)(2007-1#1)(2007-8#1)(2008-10#19)(2008-3#1)(2011-1#2)(2012-12#2)
pre-competitive season##2##2##(2008-5#2)
pre-concentrated##3##1##(2007-8#1)(2008-10#2)
pre-concentrating##3##1##(2008-10#3)
pre-concentration and determination of##3##4##(2008-10#2)(2008-3#1)
pre-concentration and##13##2##(2008-10#12)(2008-3#1)
pre-concentration factor of##3##3##(2008-10#3)
pre-concentration factor##7##2##(2008-10#7)
pre-concentration in##4##2##(1997-3#1)(2008-10#3)
pre-concentration is##2##2##(2006-6#1)(2008-10#1)
pre-concentration of mercury##2##3##(2008-10#2)
pre-concentration of selenite##2##3##(2008-10#2)
pre-concentration of the##3##3##(2008-10#3)
pre-concentration of##21##2##(2007-8#2)(2008-10#19)
pre-concentration procedure for##2##3##(2007-8#1)(2008-10#1)
pre-concentration procedure##6##2##(2007-8#3)(2008-10#3)
pre-concentration step##3##2##(2008-10#3)
pre-concentration system for##2##3##(2008-10#1)(2008-3#1)
pre-concentration time##2##2##(2008-10#2)
pre-concentration with sodium diethyldithiocarbamate##3##4##(2008-10#1)(2009-6#2)
pre-concentration with##4##2##(2008-10#2)(2009-6#2)
pre-concentration##88##1##(1997-3#1)(2006-6#1)(2007-8#7)(2008-10#73)(2008-3#2)(2009-6#2)(2010-5#1)(2012-12#1)
pre-condition for##3##2##(2006-12#1)(2007-8#1)(2012-2#1)
pre-confluent##2##1##(2011-12#2)
pre-contact##2##1##(2009-9#2)
pre-contracted with##2##2##(1995-12#1)(2009-11#1)
pre-contracted##3##1##(1995-12#1)(1997-5#1)(2009-11#1)
pre-contrast##2##1##(1997-8#1)(2012-2#1)
pre-cultured##3##1##(1991-12#1)(2012-11#2)
pre-curved elastic tubes##2##3##(2012-1#1)(2012-2#1)
pre-debut depressive symptoms##2##3##(2009-10#2)
pre-defined##8##1##(2008-3#1)(2008-5#1)(2010-2#2)(2011-2#1)(2012-1#2)(2012-2#1)
pre-denuded group##3##2##(2013-1#3)
pre-denuded##4##1##(2013-1#4)
pre-departure##2##1##(2007-2#1)(2011-2#1)
pre-designed##5##1##(1996-12#1)(2008-5#1)(2010-9#1)(2012-11#2)
pre-determined target##2##2##(2007-6#1)(2007-8#1)
pre-determined##9##1##(1995-6#1)(1995-9#1)(2006-4#1)(2007-6#1)(2007-8#1)(2008-5#1)(2010-5#1)(2010-6#1)(2011-2#1)
pre-diabetes##2##1##(1996-9#1)(2013-8#1)
pre-diabetic##3##1##(2007-5#1)(2008-1#1)(2008-5#1)
pre-dialysis##5##1##(2007-7#2)(2008-3#1)(2011-2#2)
pre-dialytic##4##1##(2011-2#4)
pre-ecdysis##4##1##(2008-7#4)
pre-eclampsia and##4##2##(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
pre-eclampsia is##4##2##(2008-4#1)(2008-6#1)(2011-1#1)(2011-2#1)
pre-eclampsia were##4##2##(1992-2#1)(2006-10#1)(2011-2#2)
pre-eclampsia with##2##2##(2006-11#1)(2011-2#1)
pre-eclampsia##50##1##(1992-1#4)(1992-2#2)(1995-1#1)(1995-2#1)(1997-3#1)(2004-10#2)(2006-10#3)(2006-11#1)(2006-12#1)(2008-4#1)(2008-6#1)(2010-3#1)(2011-1#5)(2011-12#1)(2011-2#18)(2012-2#2)(2013-1#3)(2013-8#2)
pre-eclamptic toxaemia##2##2##(1996-3#1)(2004-10#1)
pre-eclamptic##4##1##(1992-1#1)(1996-3#1)(2004-10#1)(2012-2#1)
pre-education##3##1##(2007-9#2)(2010-8#1)
pre-embedding##4##1##(1990-8#2)(1994-2#1)(2008-4#1)
pre-emergence##2##1##(2008-10#1)(2013-8#1)
pre-eminent in##2##2##(1992-4#2)
pre-eminent##4##1##(1992-4#2)(2005-7#1)(2007-12#1)
pre-employment medical##2##2##(2008-4#1)(2011-2#1)
pre-employment testing##3##2##(1996-2#1)(1997-1#2)
pre-employment##6##1##(1996-2#1)(1997-1#2)(2007-2#1)(2008-4#1)(2011-2#1)
pre-emptive culling##2##2##(2011-3#2)
pre-emptive services that##2##3##(2009-6#2)
pre-emptive treatment with##2##3##(1993-12#1)(2009-7#1)
pre-emptive##17##1##(1993-12#1)(2006-10#2)(2007-11#1)(2007-5#1)(2008-7#1)(2009-12#1)(2009-6#2)(2009-7#1)(2010-2#1)(2011-2#2)(2011-3#2)(2012-2#2)
pre-emptively##3##1##(2006-10#1)(2008-1#1)(2008-5#1)
pre-end stage renal disease##3##4##(2008-1#3)
pre-end stage renal##4##3##(2008-1#4)
pre-enrichment step##2##2##(2006-10#2)
pre-enrichment##3##1##(2006-10#2)(2008-9#1)
pre-established##3##1##(2008-11#1)(2009-1#1)(2013-1#1)
pre-exercise glucose drink##2##3##(2007-1#2)
pre-exercise##11##1##(1991-12#1)(2007-1#2)(2008-10#1)(2008-5#1)(2010-8#1)(2012-12#5)
pre-existent##6##1##(1991-4#1)(1991-5#1)(2006-11#1)(2007-11#1)(2011-2#1)(2012-2#1)
pre-existing abnormalities##2##2##(2007-7#1)(2007-8#1)
pre-existing and##3##2##(1996-3#1)(2007-11#1)(2011-2#1)
pre-existing cardiac##2##2##(1990-2#1)(2006-10#1)
pre-existing conditions##2##2##(1993-12#1)(2006-10#1)
pre-existing heart##2##2##(2007-2#1)(2008-4#1)
pre-existing liver##2##2##(2007-9#1)(2008-8#1)
pre-existing muscularity concerns##2##3##(2007-12#2)
pre-existing renal lesion##2##3##(2007-7#2)
pre-existing renal##3##2##(2007-7#2)(2008-8#1)
pre-existing risk factors##2##3##(2007-2#1)(2012-2#1)
pre-existing##104##1##(1990-2#1)(1990-7#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#2)(1992-4#4)(1992-5#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-4#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#3)(2005-10#1)(2005-7#1)(2006-10#5)(2006-2#1)(2006-8#1)(2007-10#3)(2007-11#4)(2007-12#4)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#2)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-11#3)(2010-12#2)(2010-5#1)(2010-6#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-5#1)(2013-1#2)(2013-8#3)
pre-experimental values##2##2##(2011-2#2)
pre-experimental##5##1##(2009-10#1)(2011-2#3)(2012-2#1)
pre-exponential factor##2##2##(2005-11#1)(2008-4#1)
pre-exponential##3##1##(1996-7#1)(2005-11#1)(2008-4#1)
pre-exposed to##2##2##(1995-12#1)(2008-1#1)
pre-exposed##5##1##(1995-12#1)(1996-5#1)(1997-4#1)(1997-7#1)(2008-1#1)
pre-exposure prophylaxis##3##2##(2012-2#1)(2013-1#2)
pre-exposure to##3##2##(1994-2#1)(1996-2#1)(2012-12#1)
pre-exposure##14##1##(1990-7#1)(1992-11#1)(1993-4#2)(1994-2#1)(1996-2#1)(1997-7#2)(2007-12#2)(2012-12#1)(2012-2#1)(2013-1#2)
pre-extraction##3##1##(1996-12#1)(2006-12#1)(2008-10#1)
pre-fixation##3##1##(1994-9#2)(2008-9#1)
pre-formed##4##1##(1991-7#1)(1992-4#1)(1994-9#1)(2011-1#1)
pre-harvest application of##2##3##(2011-2#2)
pre-harvest##3##1##(2005-5#1)(2011-2#2)
pre-heated##3##1##(2008-10#1)(2008-5#1)(2010-4#1)
pre-heating treatments##2##2##(2010-4#2)
pre-heating##7##1##(2010-4#7)
pre-high##2##1##(2007-2#2)
pre-hospital care##5##2##(2006-10#2)(2008-1#1)(2011-1#2)
pre-hospital##19##1##(1990-12#1)(1991-2#1)(1991-9#2)(2006-10#9)(2008-1#2)(2011-1#3)(2012-2#1)
pre-hypertension##5##1##(2012-12#5)
pre-immune IgG##3##2##(1994-8#1)(1995-10#2)
pre-implant##3##1##(2008-9#2)(2012-2#1)
pre-implantation##5##1##(1996-12#1)(2006-6#1)(2007-11#1)(2008-8#1)(2008-9#1)
pre-implementation##2##1##(2008-5#2)
pre-incubated for##2##2##(2008-5#2)
pre-incubated with##3##2##(1990-12#1)(1992-12#1)(1994-10#1)
pre-incubated##9##1##(1990-12#1)(1992-12#1)(1993-7#1)(1994-10#1)(2008-4#1)(2008-5#3)(2009-7#1)
pre-incubation of the cells with##2##5##(1993-9#2)
pre-incubation of##4##2##(1993-9#2)(1996-5#1)(2008-12#1)
pre-incubation with##5##2##(1992-4#1)(1993-9#1)(2007-10#1)(2008-4#2)
pre-incubation##12##1##(1992-4#1)(1993-4#1)(1993-9#3)(1995-11#1)(1996-5#1)(2007-10#1)(2008-12#1)(2008-4#2)(2010-2#1)
pre-induction##3##1##(1992-1#1)(2005-9#1)(2007-9#1)
pre-infection##2##1##(2008-10#1)(2008-11#1)
pre-infusion##2##1##(1992-7#1)(2008-7#1)
pre-injection baseline##2##2##(1995-12#1)(1995-5#1)
pre-injection##4##1##(1995-12#1)(1995-5#1)(2010-12#2)
pre-injury##3##1##(1996-1#1)(2006-11#1)(2009-5#1)
pre-intervention AROM##2##2##(2008-12#2)
pre-intervention instructions##2##2##(2010-3#2)
pre-intervention##6##1##(2007-11#1)(2008-12#2)(2010-3#3)
pre-ischemic##2##1##(2008-12#1)(2009-12#1)
pre-karyote##7##1##(2009-6#7)
pre-karyotes##2##1##(2009-6#2)
pre-lingual##2##1##(2008-9#2)
pre-lingually deaf children##2##3##(2008-9#2)
pre-lingually##3##1##(2008-9#3)
pre-load##2##1##(1991-5#1)(2012-2#1)
pre-loaded##4##1##(1994-12#2)(1996-2#1)(2008-8#1)
pre-loading##2##1##(1995-8#1)(2010-2#1)
pre-mRNA at##2##2##(1990-6#1)(1997-4#1)
pre-mRNA cleavage##2##2##(1996-8#2)
pre-mRNA introns##2##2##(1991-12#1)(1995-2#1)
pre-mRNA molecule##2##2##(1991-9#2)
pre-mRNA processing##2##2##(1991-4#1)(2012-12#1)
pre-mRNA splicing##11##2##(1990-11#1)(1991-9#3)(1997-4#2)(2008-4#1)(2008-8#1)(2009-7#1)(2010-11#1)(2011-1#1)
pre-mRNA##46##1##(1990-11#1)(1990-6#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-9#9)(1992-12#1)(1992-7#4)(1993-8#3)(1995-2#1)(1995-6#2)(1996-11#2)(1996-4#1)(1996-8#3)(1996-9#1)(1997-4#5)(2007-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#2)(2011-1#1)(2012-12#1)
pre-mRNAs are##2##2##(1994-8#1)(2007-12#1)
pre-mRNAs containing##2##2##(1993-6#2)
pre-mRNAs##7##1##(1993-6#2)(1994-8#1)(1995-5#1)(1996-7#1)(2007-12#2)
pre-malignant and malignant##2##3##(1991-5#1)(1993-7#1)
pre-malignant and##3##2##(1991-5#1)(1993-7#1)(2004-10#1)
pre-malignant##10##1##(1991-5#1)(1991-9#1)(1993-7#1)(1994-2#3)(2004-10#1)(2008-2#1)(2011-2#2)
pre-matured F-component##2##2##(1992-4#2)
pre-maxilla##2##1##(2013-1#2)
pre-meeting##2##1##(2005-8#1)(2009-6#1)
pre-menopausal women##2##2##(2009-3#1)(2010-9#1)
pre-menopausal##6##1##(1990-4#1)(1992-12#1)(2004-2#1)(2009-3#1)(2010-9#1)(2013-8#1)
pre-messenger RNA##4##2##(1990-4#1)(1990-6#1)(1991-6#1)(2008-8#1)
pre-migration environmental stress##2##3##(2011-2#2)
pre-migration##3##1##(2005-10#1)(2011-2#2)
pre-mix##3##1##(2008-10#3)
pre-mixed##2##1##(2012-2#1)(2013-8#1)
pre-modern##3##1##(2008-10#1)(2008-7#2)
pre-monsoon##6##1##(2007-10#1)(2008-7#2)(2009-6#2)(2013-7#1)
pre-morbid##3##1##(2008-7#1)(2009-2#2)
pre-natal care##2##2##(2007-7#2)
pre-natal##6##1##(2007-7#2)(2008-1#2)(2011-2#1)(2012-3#1)
pre-neoplastic lesions##3##2##(1991-9#2)(2008-10#1)
pre-neoplastic##6##1##(1991-9#2)(2008-10#3)(2012-2#1)
pre-neurula##2##1##(1996-7#2)
pre-normative research##2##2##(2008-10#2)
pre-op discharge planning and pre-emptive pain and nausea management##2##9##(2012-2#2)
pre-op##4##1##(2007-5#1)(2007-8#1)(2012-2#2)
pre-operative brain natriuretic##2##3##(2012-2#2)
pre-operative chemotherapy##3##2##(2008-6#1)(2008-8#1)(2013-1#1)
pre-operative diagnosis of##2##3##(2007-6#1)(2012-2#1)
pre-operative diagnosis##5##2##(1991-9#1)(2007-6#1)(2012-2#1)(2013-8#2)
pre-operative natriuretic##3##2##(2012-2#3)
pre-operative radiotherapy and##2##3##(2008-12#2)
pre-operative serum##2##2##(1991-7#1)(2007-7#1)
pre-operative visits##2##2##(1996-2#2)
pre-operative##72##1##(1990-10#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-8#1)(1993-2#1)(1993-4#1)(1995-12#1)(1996-2#3)(1997-6#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-5#3)(2007-6#1)(2007-7#7)(2007-8#5)(2008-11#1)(2008-12#2)(2008-6#2)(2008-8#2)(2008-9#2)(2009-2#1)(2009-6#1)(2009-9#1)(2010-12#3)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#7)(2013-1#7)(2013-8#3)
pre-operatively and on##2##3##(2006-9#1)(2008-1#1)
pre-operatively and##4##2##(1996-3#1)(2006-9#1)(2008-1#1)(2009-6#1)
pre-operatively by##2##2##(2008-2#1)(2008-7#1)
pre-operatively##16##1##(1990-10#1)(1993-2#1)(1996-3#1)(2006-9#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-6#1)(2012-2#1)(2013-1#1)
pre-ovulatory##5##1##(1991-9#3)(1994-3#1)(2011-1#1)
pre-oxidized##2##1##(2008-10#2)
pre-packaging##7##1##(2008-4#7)
pre-parietal##5##1##(1995-6#5)
pre-peritoneal##7##1##(1992-5#2)(1993-9#1)(2012-12#4)
pre-planned##2##1##(2010-12#1)(2012-2#1)
pre-plant##5##1##(2008-10#5)
pre-positioning##3##1##(2007-4#2)(2011-1#1)
pre-post##7##1##(2007-11#1)(2008-6#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-1#2)
pre-prandial##2##1##(1992-4#1)(2009-2#1)
pre-pregnancy##4##1##(1990-9#1)(1997-7#1)(2004-10#1)(2011-1#1)
pre-prepared##2##1##(2007-7#1)(2008-7#1)
pre-procedure##5##1##(1993-3#1)(2006-8#2)(2007-8#1)(2011-2#1)
pre-processed##2##1##(1992-8#1)(2011-2#1)
pre-processing step##3##2##(2008-2#1)(2013-1#2)
pre-processing##12##1##(2008-10#2)(2008-2#2)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#1)
pre-production##3##1##(2007-1#1)(2007-4#1)(2008-12#1)
pre-programmed##2##1##(2008-7#1)(2009-11#1)
pre-prosthetic##3##1##(1990-5#1)(2013-1#2)
pre-protein##2##1##(1990-5#1)(1996-9#1)
pre-pubertal##4##1##(2006-9#3)(2010-4#1)
pre-purification##3##1##(1996-3#1)(2008-10#1)(2010-12#1)
pre-purified##2##1##(2007-8#1)(2008-11#1)
pre-pyloric site gastric cancer after PPG##2##6##(2008-12#2)
pre-qualification##2##1##(2008-11#2)
pre-rRNA##3##1##(1995-6#2)(2009-7#1)
pre-reduced##4##1##(2008-10#4)
pre-reducing##4##1##(2008-10#4)
pre-reduction coil##2##2##(2008-10#1)(2009-6#1)
pre-reduction of pentavalent arsenicals##3##4##(2009-6#3)
pre-reduction of##7##2##(2008-10#4)(2009-6#3)
pre-reduction step##2##2##(2008-10#2)
pre-reduction##18##1##(2007-7#1)(2008-10#10)(2009-6#7)
pre-reflective self##5##2##(2008-11#5)
pre-registration diploma##2##2##(2008-11#1)(2008-12#1)
pre-registration education##2##2##(2008-11#2)
pre-registration nursing programmes##2##3##(2008-11#2)
pre-registration nursing student##2##3##(2008-11#1)(2008-12#1)
pre-registration nursing students##3##3##(2008-11#3)
pre-registration nursing students'##4##3##(2008-11#3)(2008-12#1)
pre-registration nursing##15##2##(2008-11#13)(2008-12#2)
pre-registration programmes##2##2##(2008-11#2)
pre-registration student##3##2##(2008-11#2)(2011-2#1)
pre-registration##38##1##(2008-11#31)(2008-12#5)(2011-2#1)(2012-3#1)
pre-reproductive##2##1##(2008-10#1)(2009-10#1)
pre-requisite for##3##2##(2007-2#1)(2008-1#1)(2009-3#1)
pre-requisite##5##1##(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2009-3#1)
pre-retirement##3##1##(2009-12#3)
pre-ruminant##2##1##(2012-2#2)
pre-school and elementary school children##2##5##(2008-1#1)(2010-9#1)
pre-school children living in austral latitudes##2##6##(2013-8#2)
pre-school children living in##3##4##(2013-8#3)
pre-school children##10##2##(2005-11#2)(2006-10#1)(2008-4#1)(2008-9#1)(2011-2#2)(2013-8#3)
pre-school##15##1##(1991-10#1)(1996-1#1)(2005-11#2)(2006-10#1)(2008-1#1)(2008-4#1)(2008-9#1)(2010-9#1)(2011-2#2)(2013-8#4)
pre-selected##6##1##(1992-1#1)(1997-3#1)(2007-5#1)(2008-10#1)(2008-5#1)(2010-4#1)
pre-separation##7##1##(1996-5#1)(2008-10#5)(2012-12#1)
pre-shift##2##1##(1996-10#2)
pre-slaughter handling##2##2##(2011-1#2)
pre-slaughter##4##1##(2010-4#1)(2011-1#3)
pre-specified##5##1##(1996-12#1)(2005-10#1)(2007-3#1)(2009-12#1)(2009-7#1)
pre-stage salivary##2##2##(2013-8#2)
pre-steady-state kinetic##3##2##(1995-1#1)(1995-6#1)(1996-7#1)
pre-steady-state##5##1##(1990-5#1)(1995-1#2)(1995-6#1)(1996-7#1)
pre-stimulated with##3##2##(2008-11#2)(2009-11#1)
pre-stimulated##4##1##(1990-12#1)(2008-11#2)(2009-11#1)
pre-surgical distress##4##2##(2008-11#4)
pre-surgical##9##1##(2008-11#6)(2010-2#1)(2011-2#1)(2013-1#1)
pre-tensioners##2##1##(2006-11#2)
pre-term birth in##5##3##(2007-1#5)
pre-term birth##6##2##(2007-1#6)
pre-term delivery##10##2##(2005-11#1)(2006-10#3)(2007-1#3)(2007-3#1)(2008-5#2)
pre-term infants could##2##3##(1995-8#2)
pre-term infants##6##2##(1995-8#6)
pre-term##24##1##(1995-8#6)(2005-11#2)(2006-10#3)(2007-1#9)(2007-3#1)(2008-5#2)(2011-1#1)
pre-test and post-test##3##3##(1996-1#1)(2011-2#1)(2012-12#1)
pre-test and##4##2##(1996-1#1)(2008-11#1)(2011-2#1)(2012-12#1)
pre-test probability##2##2##(2007-7#1)(2008-6#1)
pre-test##18##1##(1993-2#1)(1996-1#2)(1996-5#1)(2006-8#2)(2007-7#1)(2008-11#1)(2008-6#1)(2010-2#3)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
pre-tested questionnaire##2##2##(2008-1#1)(2013-8#1)
pre-tested##8##1##(1993-2#1)(2008-1#1)(2008-11#1)(2008-3#1)(2011-1#2)(2012-12#1)(2013-8#1)
pre-testing##2##1##(2006-8#1)(2010-4#1)
pre-therapeutic##2##1##(2007-12#1)(2008-8#1)
pre-training injection##2##2##(1996-9#2)
pre-training##5##1##(1996-9#2)(2008-6#1)(2010-8#2)
pre-transfusion##2##1##(2009-4#1)(2012-2#1)
pre-transition##3##1##(2006-10#3)
pre-translational##3##1##(1995-3#2)(2006-12#1)
pre-transplant##8##1##(2008-1#2)(2008-10#1)(2008-3#1)(2011-1#1)(2012-12#1)(2012-2#2)
pre-travel##7##1##(2007-2#5)(2011-2#2)
pre-treated tumours##2##2##(2008-7#2)
pre-treated with 2##2##3##(2008-10#2)
pre-treated with##22##2##(1990-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1995-5#1)(1997-5#1)(2006-6#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-7#3)(2009-12#1)(2009-4#1)(2012-2#1)
pre-treated##32##1##(1990-3#1)(1990-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1995-11#1)(1995-5#1)(1996-5#1)(1997-5#1)(1997-8#1)(2006-6#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#5)(2009-12#1)(2009-4#1)(2012-2#1)(2013-1#1)
pre-treatment and##8##2##(1992-3#1)(2008-10#5)(2008-7#1)(2013-1#1)
pre-treatment at##2##2##(1995-5#2)
pre-treatment baseline##2##2##(2010-9#1)(2012-3#1)
pre-treatment by##3##2##(2007-8#1)(2008-10#2)
pre-treatment for##2##2##(2008-10#1)(2010-5#1)
pre-treatment hCG ratio##2##3##(2011-2#2)
pre-treatment measurements##3##2##(2012-1#3)
pre-treatment methods for##2##3##(2008-10#1)(2013-8#1)
pre-treatment methods##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
pre-treatment of cells with##2##4##(1993-7#1)(2008-4#1)
pre-treatment of the sample##3##4##(2008-10#3)
pre-treatment of the samples##2##4##(2008-10#2)
pre-treatment of the##8##3##(1996-12#1)(2008-10#6)(2009-8#1)
pre-treatment of##16##2##(1993-11#1)(1993-2#1)(1993-7#1)(1996-12#1)(1996-8#1)(2008-10#6)(2008-4#1)(2009-4#1)(2009-8#1)(2011-1#2)
pre-treatment or##2##2##(2008-10#2)
pre-treatment process##2##2##(2008-10#1)(2008-6#1)
pre-treatment regimen##2##2##(2008-7#1)(2013-1#1)
pre-treatment was##3##2##(1993-12#1)(2008-10#1)(2013-1#1)
pre-treatment with ozone##2##3##(2008-10#2)
pre-treatment with the##3##3##(1993-11#1)(1993-9#1)(2008-10#1)
pre-treatment with##21##2##(1991-9#1)(1993-11#1)(1993-7#2)(1993-9#1)(1994-2#2)(1995-5#1)(1996-12#1)(1997-5#1)(2007-8#1)(2008-10#7)(2009-6#1)(2011-2#2)
pre-treatment##135##1##(1990-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-3#2)(1992-9#2)(1993-11#3)(1993-12#1)(1993-2#1)(1993-7#3)(1993-9#2)(1994-2#2)(1994-9#1)(1995-5#4)(1996-12#2)(1996-8#1)(1997-5#2)(1997-7#2)(1997-8#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-8#6)(2008-1#1)(2008-10#44)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-10#1)(2009-3#1)(2009-4#3)(2009-6#1)(2009-8#1)(2010-5#2)(2010-9#1)(2011-1#5)(2011-2#8)(2012-1#4)(2012-3#1)(2013-1#9)(2013-8#1)
pre-treatments of##2##2##(2008-10#1)(2013-1#1)
pre-treatments##7##1##(2008-10#4)(2013-1#3)
pre-warmed##2##1##(2008-8#2)
pre-weaning##3##1##(2006-8#1)(2008-3#2)
pre-zymogenic##2##1##(1995-6#2)
preAD##3##1##(2009-10#3)
preMBP species##2##2##(1993-12#2)
preMBP##7##1##(1993-12#7)
preQ1##2##1##(1995-11#2)
preS##2##1##(1993-8#2)
preS1 peptide##3##2##(1994-8#3)
preS1##8##1##(1993-8#3)(1994-8#4)(2008-8#1)
preS2##9##1##(1993-8#3)(1997-6#4)(2008-8#2)
preZad##4##1##(1991-10#4)
preabsorbed with##2##2##(1995-12#1)(1996-12#1)
preabsorbed##3##1##(1995-12#1)(1996-12#1)(2008-4#1)
preabsorption##2##1##(1991-12#1)(1996-6#1)
preactivated conidia##2##2##(2008-10#2)
preactivated##6##1##(1990-5#1)(2008-10#4)(2008-4#1)
preadapted##3##1##(2008-11#3)
preadipocyte differentiation##2##2##(1990-11#1)(2008-3#1)
preadipocyte##5##1##(1990-11#1)(1990-12#1)(1994-12#1)(2008-11#1)(2008-3#1)
preadipocytes and adipocytes##3##3##(1993-6#2)(2008-3#1)
preadipocytes and##5##2##(1993-6#2)(2008-3#1)(2008-5#2)
preadipocytes are##2##2##(1994-12#1)(2008-5#1)
preadipocytes is##3##2##(1992-6#1)(2008-3#2)
preadipocytes##35##1##(1990-11#2)(1990-12#1)(1992-6#2)(1992-9#1)(1993-6#3)(1994-12#7)(1997-4#8)(2008-11#1)(2008-3#3)(2008-5#7)
preadipose cells##6##2##(1992-9#2)(1993-6#1)(1994-2#2)(1997-4#1)
preadipose##9##1##(1992-9#4)(1993-6#1)(1994-2#3)(1997-4#1)
preadministration of##2##2##(1994-5#1)(1996-3#1)
preadministration##5##1##(1994-5#1)(1996-10#3)(1996-3#1)
preadmission nursing home assessment##2##4##(2006-7#2)
preadmission telephone call on the day before surgery to initiate##2##10##(2008-8#2)
preadmission telephone call on the day before surgery##3##8##(2008-8#3)
preadmission telephone call##4##3##(2008-8#4)
preadmission##8##1##(1997-2#1)(2006-7#2)(2008-5#1)(2008-8#4)
preadolescent##2##1##(2007-12#1)(2008-10#1)
preadsorbed on the##2##3##(2005-11#1)(2008-10#1)
preadult##6##1##(2008-8#1)(2008-9#1)(2011-12#4)
prealbumin##4##1##(1993-12#1)(2008-5#2)(2011-2#1)
prealignment##2##1##(2007-12#1)(2008-2#1)
preamplification (PEP)##2##2##(2008-4#2)
preamplification##4##1##(2007-12#2)(2008-4#2)
preamplifier has##2##2##(2006-5#1)(2008-2#1)
preamplifier##7##1##(2006-5#1)(2007-12#2)(2008-2#1)(2010-8#2)(2013-1#1)
preamplifiers##2##1##(2007-11#1)(2010-8#1)
preanalytical##2##1##(2009-8#1)(2013-1#1)
preantral and antral follicles##2##4##(2008-8#2)
preantral and##3##2##(2008-8#3)
preantral##4##1##(2008-8#3)(2008-9#1)
preapheresis##2##1##(1994-12#1)(2011-2#1)
prearthritic##2##1##(2007-8#1)(2011-12#1)
preassembled##2##1##(1995-8#1)(2011-2#1)
preattentive##2##1##(1992-7#1)(1995-12#1)
preauricular surgical approach##2##3##(2005-9#2)
preauricular##6##1##(1994-8#1)(1996-3#1)(2005-9#3)(2009-4#1)
prebinding##5##1##(1990-2#5)
prebiotic ingredients##2##2##(2012-2#2)
prebiotic synthesis of##4##3##(1995-11#1)(1995-8#1)(2006-12#2)
prebiotic##19##1##(1995-11#2)(1995-8#2)(2006-10#1)(2006-12#5)(2006-5#1)(2006-8#6)(2012-2#2)
prebiotically##2##1##(1991-3#1)(2006-12#1)
prebiotics and##4##2##(2006-10#1)(2006-5#1)(2009-3#1)(2011-2#1)
prebiotics##16##1##(2006-10#2)(2006-2#1)(2006-5#1)(2006-8#5)(2007-12#1)(2008-8#1)(2009-3#3)(2011-2#1)(2012-12#1)
prebirth body weight##2##3##(2006-6#2)
prebirth##3##1##(2006-6#3)
prebleaching##2##1##(2008-6#2)
prebloom##6##1##(2008-10#6)
prebottleneck##2##1##(2008-9#2)
prebypass##3##1##(1990-2#1)(2007-8#2)
precancer and cancer of the##2##5##(2008-11#2)
precancer and##3##2##(2008-11#2)(2011-1#1)
precancer##5##1##(2008-11#2)(2011-1#2)(2013-1#1)
precancerous and cancerous lesions##4##4##(1990-6#1)(2007-12#1)(2011-2#2)
precancerous and cancerous##6##3##(1990-6#1)(1991-5#1)(2007-12#1)(2008-5#1)(2011-2#2)
precancerous cervical lesions##2##3##(2008-4#1)(2012-2#1)
precancerous lesions and##3##3##(2011-2#2)(2012-3#1)
precancerous lesions by##2##3##(2008-2#1)(2012-12#1)
precancerous lesions were##2##3##(1992-4#1)(2011-2#1)
precancerous lesions##22##2##(1992-4#2)(1994-5#1)(2008-2#1)(2011-2#9)(2011-3#7)(2012-12#1)(2012-3#1)
precancerous##40##1##(1990-6#1)(1991-5#1)(1992-4#2)(1992-8#2)(1993-5#1)(1994-2#1)(1994-5#1)(2005-11#2)(2007-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#12)(2011-3#7)(2012-12#1)(2012-2#1)(2012-3#1)
precapillary##3##1##(1996-9#1)(2012-12#2)
precarious position##2##2##(2006-9#1)(2007-4#1)
precarious##17##1##(1991-12#1)(2006-7#1)(2006-9#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-6#1)(2008-9#1)(2010-4#1)(2011-2#4)(2012-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
precariousness##2##1##(2013-1#2)
precaution##5##1##(1996-3#1)(2007-8#1)(2008-4#1)(2011-1#1)(2012-3#1)
precautionary measures##8##2##(1991-1#1)(1992-2#1)(2007-1#2)(2008-4#1)(2010-12#1)(2012-3#1)(2013-1#1)
precautionary principle##3##2##(2006-7#1)(2013-8#2)
precautionary##13##1##(1991-1#1)(1992-2#1)(1996-11#1)(2006-7#1)(2007-1#2)(2008-11#1)(2008-4#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
precautions against##2##2##(2007-12#1)(2010-3#1)
precautions and##9##2##(1992-3#1)(1994-7#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)
precautions are important##2##3##(1995-2#1)(2007-2#1)
precautions are taken##4##3##(1990-9#1)(2008-10#1)(2009-11#1)(2013-1#1)
precautions are##10##2##(1990-9#1)(1992-2#1)(1993-2#1)(1995-2#1)(2007-2#1)(2008-10#1)(2009-11#1)(2010-3#1)(2012-2#1)(2013-1#1)
precautions as##2##2##(2007-2#1)(2010-4#1)
precautions during##2##2##(2005-8#1)(2007-7#1)
precautions for##7##2##(1993-7#2)(2007-11#1)(2007-2#1)(2009-10#1)(2009-5#1)(2010-8#1)
precautions have##2##2##(1991-12#1)(1996-6#1)
precautions in##2##2##(2008-1#1)(2012-1#1)
precautions including##2##2##(2006-8#1)(2010-4#1)
precautions is##3##2##(2012-11#2)(2012-2#1)
precautions must be taken to##3##5##(1992-3#1)(2008-4#1)(2008-9#1)
precautions must be taken##4##4##(1992-3#1)(2008-4#1)(2008-9#1)(2009-6#1)
precautions must be##5##3##(1992-3#1)(2008-4#1)(2008-9#1)(2009-6#1)(2010-3#1)
precautions needed to##2##3##(2008-10#1)(2008-12#1)
precautions on the##3##3##(2011-2#1)(2012-11#2)
precautions should be##2##3##(1993-2#1)(2008-4#1)
precautions should##3##2##(1992-2#1)(1993-2#1)(2008-4#1)
precautions taken##2##2##(1995-7#1)(2008-4#1)
precautions to##3##2##(1996-5#1)(1996-7#1)(2006-9#1)
precautions when##4##2##(2008-4#1)(2008-8#2)(2008-9#1)
precautions with##3##2##(1991-10#1)(2007-2#1)(2008-3#1)
precautions##116##1##(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#3)(1991-5#2)(1991-8#1)(1992-10#1)(1992-2#2)(1992-3#2)(1993-2#2)(1993-7#2)(1994-7#2)(1995-2#1)(1995-3#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#1)(2005-8#3)(2006-10#1)(2006-5#1)(2006-8#2)(2006-9#2)(2007-11#1)(2007-12#4)(2007-2#7)(2007-7#6)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#2)(2009-6#1)(2010-12#2)(2010-3#7)(2010-4#3)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#7)(2012-11#8)(2012-2#2)(2012-3#1)(2013-1#2)
precede and##2##2##(2006-2#1)(2008-3#1)
precede or##2##2##(2006-9#1)(2007-3#1)
precede the development of##3##4##(2008-1#1)(2008-10#2)
precede the onset of##2##4##(2006-10#1)(2013-8#1)
precede the##13##2##(1990-9#1)(1994-11#1)(1994-3#1)(2005-11#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)(2012-1#1)(2013-8#1)
precede##50##1##(1990-2#1)(1990-4#1)(1990-9#2)(1991-5#1)(1992-5#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-5#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-11#2)(2006-2#1)(2006-5#1)(2006-9#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2010-11#1)(2010-12#1)(2011-12#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
preceded a##2##2##(1991-6#1)(2008-10#1)
preceded and accompanied##2##3##(1993-9#1)(2008-7#1)
preceded and##3##2##(1990-4#1)(1993-9#1)(2008-7#1)
preceded by a period of##2##5##(2008-10#1)(2010-8#1)
preceded by a##30##3##(1990-11#1)(1990-2#1)(1990-3#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-2#1)(1993-12#1)(1993-9#1)(1994-12#2)(1994-2#1)(1996-1#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-7#2)(2005-7#1)(2006-10#1)(2007-11#1)(2008-10#4)(2008-12#1)(2010-8#1)(2011-2#1)
preceded by an##7##3##(1990-9#1)(1991-9#1)(1992-8#1)(1995-8#1)(2006-8#1)(2011-2#1)(2013-1#1)
preceded by changes in##2##4##(1992-9#1)(1996-4#1)
preceded by the##5##3##(1991-9#1)(1994-5#1)(1995-8#1)(2008-10#1)(2008-8#1)
preceded by##86##2##(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-7#2)(1991-8#1)(1991-9#3)(1992-10#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-9#2)(1994-12#2)(1994-2#1)(1994-5#1)(1994-9#1)(1995-8#2)(1996-1#4)(1996-4#2)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-7#2)(2005-10#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-11#7)(2007-7#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
preceded clinical##2##2##(1991-4#1)(2012-1#1)
preceded or##2##2##(1996-1#1)(2013-8#1)
preceded the acquisition of##2##4##(1995-3#1)(2012-12#1)
preceded the admission of##2##4##(1991-2#2)
preceded the appearance of##3##4##(1991-3#1)(1994-9#1)(2006-7#1)
preceded the increase in##2##4##(1990-6#1)(1996-2#1)
preceded the increase##3##3##(1990-6#1)(1992-11#1)(1996-2#1)
preceded the onset of##2##4##(1994-5#1)(1995-1#1)
preceded the period##2##3##(1994-12#1)(2006-12#1)
preceded the rise in##2##4##(1990-7#1)(1991-1#1)
preceded the##33##2##(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-8#1)(1992-11#2)(1992-9#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#1)(1996-2#1)(1997-4#1)(2005-7#1)(2006-12#2)(2006-4#1)(2006-7#1)(2007-10#1)(2008-1#1)(2008-11#2)(2008-7#1)(2009-3#1)(2009-8#1)(2012-12#1)(2013-1#1)
preceded those##2##2##(1991-5#1)(2008-11#1)
preceded##150##1##(1990-11#2)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#2)(1990-7#2)(1990-9#3)(1991-1#1)(1991-11#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#3)(1992-10#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-12#1)(1993-2#1)(1993-9#4)(1994-12#3)(1994-2#1)(1994-5#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-1#6)(1996-2#1)(1996-4#3)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-7#2)(2005-10#1)(2005-7#2)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#7)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#3)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#3)
precedence##10##1##(1994-1#1)(2004-7#1)(2006-12#1)(2008-5#1)(2008-8#2)(2008-9#1)(2011-1#1)(2012-12#2)
precedent##8##1##(1994-12#1)(1995-12#1)(1995-5#1)(1996-6#2)(2008-12#1)(2010-7#1)(2013-1#1)
precedents##5##1##(1996-11#1)(1996-3#1)(2007-10#1)(2007-11#1)(2012-12#1)
precedes DNA##2##2##(1995-5#1)(1996-10#1)
precedes and##2##2##(2008-10#1)(2008-7#1)
precedes the onset of overt##2##5##(1997-8#1)(2009-11#1)
precedes the onset of##3##4##(1995-2#1)(1997-8#1)(2009-11#1)
precedes the##17##2##(1990-11#1)(1990-12#1)(1990-9#2)(1992-11#1)(1993-2#1)(1995-2#1)(1995-3#1)(1995-4#1)(1997-4#1)(1997-8#1)(2008-2#1)(2008-5#1)(2009-11#1)(2009-8#1)(2011-2#2)
precedes##43##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-9#2)(1991-2#1)(1992-11#2)(1992-12#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-10#1)(1996-2#1)(1997-4#1)(1997-8#1)(2005-10#1)(2007-11#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-11#1)(2009-8#1)(2011-2#4)(2012-12#1)(2012-3#1)
preceding a##4##2##(1993-12#1)(2008-10#1)(2009-12#1)(2012-12#1)
preceding and following##7##3##(1993-5#1)(1997-4#1)(2007-7#1)(2008-2#1)(2008-4#2)(2008-5#1)
preceding and##9##2##(1992-6#1)(1993-5#1)(1997-4#1)(2006-10#1)(2007-7#1)(2008-2#1)(2008-4#2)(2008-5#1)
preceding article##4##2##(1991-4#1)(1992-1#2)(1992-3#1)
preceding event##2##2##(1995-5#1)(2011-2#1)
preceding paper in this##2##4##(1990-12#1)(1990-3#1)
preceding paper##9##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#1)(1991-7#1)(1993-12#1)(1995-11#2)
preceding results##2##2##(1992-8#1)(2008-3#1)
preceding that of the##2##4##(1991-2#1)(1992-6#1)
preceding the onset of##3##4##(1990-3#1)(2006-10#1)(2008-1#1)
preceding the posttreatment PET study##2##5##(1996-5#2)
preceding the study##2##3##(2007-2#1)(2011-1#1)
preceding the##35##2##(1990-11#1)(1990-3#2)(1990-9#1)(1991-2#1)(1991-6#1)(1991-9#2)(1992-2#1)(1992-5#2)(1995-1#1)(1995-11#1)(1995-5#1)(1995-6#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-5#1)(2005-12#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-6#1)(2011-1#1)(2012-12#1)(2013-8#1)
preceding##163##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#5)(1990-6#1)(1990-7#1)(1990-9#1)(1991-2#4)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#3)(1992-1#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#3)(1992-6#4)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#2)(1993-2#2)(1993-4#1)(1993-5#1)(1994-7#1)(1994-9#1)(1995-1#2)(1995-11#4)(1995-2#1)(1995-5#2)(1995-6#2)(1995-9#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#5)(1996-6#3)(1996-8#1)(1997-4#3)(1997-5#2)(1997-6#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-5#2)(2006-7#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#10)(2012-1#2)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
preceeding##4##1##(1993-3#1)(1994-12#1)(1996-1#1)(2006-10#1)
preceeds##3##1##(1996-2#1)(1996-5#1)(2006-10#1)
precentral gyrus##2##2##(1992-12#1)(2008-12#1)
precentral motor cortex##2##3##(1993-9#1)(1997-8#1)
precentral##7##1##(1992-12#1)(1993-9#3)(1997-8#2)(2008-12#1)
preceptors##4##1##(1994-12#1)(2008-11#1)(2008-12#1)(2011-2#1)
preceptors'##2##1##(2008-9#1)(2011-2#1)
preceptorship within the workplace##2##4##(2008-11#2)
preceptorship##4##1##(2008-11#4)
precerebral##2##1##(1990-8#1)(2007-10#1)
precertification##3##1##(1992-1#1)(2007-4#2)
precession##15##1##(1992-1#2)(2007-12#1)(2007-8#1)(2008-11#9)(2008-3#1)(2010-8#1)
prechecklist##2##1##(2013-1#2)
prechemotherapy##2##1##(2008-7#1)(2010-3#1)
prechirped##3##1##(2007-11#1)(2007-12#2)
prechordal plate and##2##3##(2012-12#2)
prechordal plate##4##2##(2012-12#4)
precious metal ions##2##3##(2008-10#2)
precious metal##8##2##(2007-8#2)(2008-10#6)
precious metals in##2##3##(2008-10#2)
precious metals##6##2##(2007-8#1)(2008-10#5)
precious stones##2##2##(1994-3#1)(2008-1#1)
precious##32##1##(1990-6#1)(1994-3#1)(1994-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-8#4)(2008-1#1)(2008-10#14)(2008-2#1)(2008-6#1)(2009-2#1)(2011-1#1)(2012-11#1)
precipitable##6##1##(1990-1#1)(1990-2#1)(1994-6#1)(1995-6#1)(2008-2#2)
precipitant##13##1##(1996-6#1)(1996-9#1)(1997-6#1)(1997-7#1)(2008-10#3)(2008-3#2)(2008-8#2)(2009-5#1)(2011-1#1)
precipitate and the##2##3##(2005-11#1)(2008-10#1)
precipitate and##5##2##(2005-11#2)(2008-10#1)(2008-5#1)(2008-9#1)
precipitate by##2##2##(2008-10#1)(2013-1#1)
precipitate formation##2##2##(2008-10#2)
precipitate from solution##2##3##(1992-4#1)(2010-12#1)
precipitate is dissolved with##2##4##(2007-8#1)(2008-10#1)
precipitate is##9##2##(2007-10#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-4#2)
precipitate of##4##2##(2008-10#3)(2008-11#1)
precipitate that##6##2##(2008-1#2)(2008-2#2)(2008-4#2)
precipitate the##8##2##(1993-8#1)(1996-6#1)(2004-9#1)(2008-2#1)(2008-4#2)(2009-2#1)(2013-8#1)
precipitate to##4##2##(2005-11#1)(2008-1#1)(2008-2#1)(2008-4#1)
precipitate was##8##2##(2008-10#7)(2008-5#1)
precipitate with##3##2##(2008-10#3)
precipitate##114##1##(1990-10#1)(1990-11#1)(1990-12#1)(1991-11#1)(1992-12#1)(1992-4#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-9#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#1)(2004-9#1)(2005-10#3)(2005-11#8)(2006-10#2)(2006-12#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#36)(2008-11#2)(2008-2#5)(2008-4#12)(2008-5#5)(2008-6#1)(2008-9#2)(2009-2#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
precipitated a##2##2##(1992-1#1)(2008-1#1)
precipitated and##4##2##(2004-12#1)(2008-10#2)(2008-6#1)
precipitated at##2##2##(1997-4#1)(2008-10#1)
precipitated by a##3##3##(1993-6#1)(2008-5#1)(2013-8#1)
precipitated by the##3##3##(1990-11#1)(1996-12#1)(2008-9#1)
precipitated by##22##2##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#1)(1991-3#1)(1993-6#1)(1994-1#2)(1995-10#1)(1996-12#1)(1996-5#1)(2006-4#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-4#2)(2009-9#1)(2012-11#1)(2012-2#1)(2013-7#1)(2013-8#1)
precipitated fraction##2##2##(1994-8#1)(2008-7#1)
precipitated from the##4##3##(1997-1#1)(2008-10#1)(2008-2#1)(2008-4#1)
precipitated from##7##2##(1990-11#1)(1993-9#1)(1997-1#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-4#1)
precipitated in the form of##2##5##(2007-10#1)(2008-10#1)
precipitated in the##3##3##(1990-11#1)(2007-10#1)(2008-10#1)
precipitated in##6##2##(1990-11#1)(2007-10#1)(2008-10#2)(2008-3#1)(2013-1#1)
precipitated is##2##2##(1990-11#1)(2008-4#1)
precipitated polysaccharides##2##2##(2013-1#2)
precipitated proteins##2##2##(2008-10#1)(2008-4#1)
precipitated the##4##2##(1991-2#1)(1994-8#1)(2005-7#1)(2006-6#1)
precipitated with##10##2##(1990-11#1)(1991-5#1)(1992-5#1)(1995-6#1)(1996-8#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-11#1)
precipitated withdrawal##2##2##(2007-11#1)(2007-2#1)
precipitated##103##1##(1990-1#1)(1990-11#8)(1990-12#1)(1990-2#3)(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-5#1)(1993-6#1)(1993-9#1)(1994-1#2)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#2)(1996-12#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-8#1)(2004-12#1)(2004-9#1)(2005-11#4)(2005-7#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-2#2)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#3)(2008-9#1)(2009-11#1)(2009-4#2)(2009-9#1)(2012-11#1)(2012-2#1)(2013-1#6)(2013-7#1)(2013-8#1)
precipitates and##5##2##(2005-11#1)(2008-10#2)(2009-5#1)(2013-8#1)
precipitates at##2##2##(1996-12#1)(2005-11#1)
precipitates formed##2##2##(2005-11#1)(2008-10#1)
precipitates of##2##2##(1994-11#1)(2009-5#1)
precipitates on the##2##3##(2008-10#1)(2009-5#1)
precipitates were##7##2##(2005-11#2)(2008-10#5)
precipitates with##3##2##(2008-10#1)(2009-5#2)
precipitates##64##1##(1990-11#1)(1994-11#1)(1995-3#1)(1996-12#1)(1996-5#1)(2005-10#1)(2005-11#7)(2006-10#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-10#26)(2008-5#3)(2009-12#4)(2009-5#9)(2010-12#1)(2012-1#1)(2013-1#1)(2013-8#1)
precipitating agent##3##2##(1991-7#2)(2010-12#1)
precipitating agents##3##2##(1992-6#1)(2008-6#2)
precipitating factor by##2##3##(1991-4#1)(1993-5#1)
precipitating factor##5##2##(1991-4#1)(1993-5#1)(2007-8#1)(2009-11#1)(2012-3#1)
precipitating factors##9##2##(1990-11#1)(2006-12#1)(2008-1#1)(2010-10#3)(2011-2#3)
precipitating life##2##2##(1991-12#1)(2009-10#1)
precipitating the##3##2##(1994-11#1)(2008-10#1)(2008-4#1)
precipitating##48##1##(1990-11#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-7#2)(1992-6#1)(1993-5#1)(1994-11#1)(2004-11#1)(2006-11#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-2#1)(2008-4#4)(2008-6#3)(2008-9#1)(2009-10#1)(2009-11#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-3#1)
precipitation F(ab')2 anti-C3 ELISA##2##4##(1990-12#2)
precipitation and##29##2##(1991-2#1)(1991-9#1)(1992-11#1)(1993-3#1)(1996-7#1)(2004-11#1)(2006-10#1)(2006-7#1)(2008-10#10)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#4)(2010-4#1)(2011-3#1)(2013-8#1)
precipitation at##3##2##(2006-11#1)(2007-7#1)(2008-10#1)
precipitation by##2##2##(1990-12#1)(2008-9#1)
precipitation days##4##2##(2013-8#4)
precipitation events##9##2##(2008-10#5)(2011-12#2)(2013-8#2)
precipitation followed by##2##3##(2008-4#2)
precipitation from##4##2##(1991-11#1)(1997-6#1)(2008-10#2)
precipitation in the##4##3##(1995-7#1)(2013-8#3)
precipitation in##6##2##(1995-7#1)(2013-1#1)(2013-8#4)
precipitation is##4##2##(1997-6#1)(2008-10#2)(2008-7#1)
precipitation method##5##2##(1990-7#1)(1992-5#1)(1993-11#1)(1993-6#1)(2004-9#1)
precipitation of DM particles##2##4##(2004-9#2)
precipitation of alpha-lactalbumin##2##3##(2008-7#2)
precipitation of proteins##3##3##(1993-2#1)(1996-11#1)(2008-5#1)
precipitation of the##9##3##(1990-2#1)(1994-11#1)(1994-6#1)(2006-9#1)(2008-10#3)(2008-2#1)(2008-5#1)
precipitation of these##2##3##(2005-11#1)(2008-6#1)
precipitation of##56##2##(1990-2#2)(1991-12#1)(1991-7#1)(1993-2#1)(1994-11#2)(1994-6#1)(1995-5#2)(1996-10#1)(1996-11#2)(1996-2#1)(2004-9#2)(2005-11#3)(2006-9#1)(2008-1#1)(2008-10#18)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-5#1)(2009-7#1)(2010-5#2)(2010-7#1)(2011-1#1)(2012-5#1)(2013-1#1)(2013-7#1)
precipitation on##2##2##(1990-2#1)(2011-2#1)
precipitation or##3##2##(1996-3#1)(2006-12#1)(2008-4#1)
precipitation patterns##2##2##(2008-10#1)(2012-5#1)
precipitation polymerization##2##2##(2007-8#1)(2008-8#1)
precipitation process##2##2##(2005-11#1)(2007-6#1)
precipitation reaction of##3##3##(2008-10#3)
precipitation reaction##4##2##(2008-10#4)
precipitation step##3##2##(1994-11#1)(1994-6#1)(2008-7#1)
precipitation to##4##2##(1995-1#1)(2008-11#1)(2008-9#1)(2013-8#1)
precipitation using ethanol##2##3##(2008-6#1)(2008-8#1)
precipitation using##4##2##(2008-10#2)(2008-6#1)(2008-8#1)
precipitation was##4##2##(1996-11#1)(2005-11#1)(2008-10#1)(2008-11#1)
precipitation were##4##2##(2008-10#3)(2009-7#1)
precipitation with ammonium##2##3##(1990-11#1)(1992-8#1)
precipitation with##13##2##(1990-11#1)(1990-2#1)(1992-8#1)(1993-11#1)(1994-12#1)(1994-6#1)(1995-6#1)(1996-11#1)(1996-8#1)(2008-10#2)(2008-8#1)(2011-2#1)
precipitation##307##1##(1990-11#1)(1990-12#4)(1990-2#5)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#3)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-4#2)(1992-5#1)(1992-8#3)(1993-11#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#4)(1994-12#3)(1994-6#3)(1994-9#2)(1995-1#1)(1995-10#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-7#1)(1996-10#1)(1996-11#5)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#2)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(2004-11#1)(2004-9#3)(2005-11#9)(2006-10#1)(2006-11#1)(2006-12#2)(2006-7#3)(2006-9#2)(2007-1#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#90)(2008-11#4)(2008-2#2)(2008-3#3)(2008-4#13)(2008-5#7)(2008-6#6)(2008-7#9)(2008-8#10)(2008-9#2)(2009-11#2)(2009-4#1)(2009-5#1)(2009-7#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#2)(2010-7#1)(2011-1#2)(2011-12#5)(2011-2#2)(2011-3#1)(2012-2#2)(2012-5#2)(2013-1#4)(2013-7#2)(2013-8#22)
precipitation-dissolution##4##1##(2008-10#4)
precipitation/dissolution##4##1##(2008-10#4)
precipitations##4##1##(1992-12#1)(2007-2#1)(2008-10#1)(2008-6#1)
precipitator with##3##2##(2008-10#1)(2011-1#2)
precipitator##7##1##(2008-10#5)(2011-1#2)
precipitous decrease in##2##3##(1995-2#1)(2007-9#1)
precipitous fall##2##2##(1995-2#1)(1996-6#1)
precipitous##5##1##(1995-2#2)(1996-6#1)(2007-9#1)(2013-1#1)
precise alignment##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2012-1#1)
precise analysis##3##2##(2007-11#1)(2008-2#1)(2009-3#1)
precise anatomical##2##2##(1997-6#1)(2009-5#1)
precise and accurate determination of##2##5##(2007-6#1)(2008-10#1)
precise and accurate##17##3##(1993-2#1)(2007-6#1)(2007-8#1)(2008-10#11)(2010-12#1)(2011-1#1)(2012-2#1)
precise and fast##2##3##(2006-6#1)(2008-10#1)
precise and rapid##3##3##(1990-11#1)(2008-10#1)(2010-5#1)
precise and reproducible##4##3##(1994-2#1)(2008-10#1)(2010-5#1)(2010-9#1)
precise and specific##2##3##(1992-2#1)(1995-4#1)
precise and##54##2##(1990-11#1)(1992-12#1)(1992-2#1)(1993-2#1)(1994-2#1)(1995-2#1)(1995-4#1)(1997-5#1)(1997-7#1)(2005-10#1)(2006-3#1)(2006-6#1)(2007-6#1)(2007-8#1)(2008-10#25)(2008-11#1)(2008-2#1)(2008-3#1)(2009-12#1)(2010-12#2)(2010-2#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
precise assessment of the##2##4##(1994-2#1)(1996-10#1)
precise assessment of##3##3##(1994-2#1)(1996-10#1)(2008-10#1)
precise cause of##2##3##(2006-8#1)(2011-2#1)
precise characterization of##2##3##(1994-9#1)(2012-2#1)
precise chemical##2##2##(1993-12#1)(2007-9#1)
precise clinical##3##2##(2007-11#1)(2007-8#1)(2008-7#1)
precise conformation##2##2##(2005-8#1)(2008-2#1)
precise contribution##3##2##(1995-12#1)(1996-5#1)(2005-11#1)
precise control of the##3##4##(2008-2#1)(2008-7#1)(2008-9#1)
precise control of##8##3##(1995-1#1)(1996-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-2#1)(2012-12#2)
precise control##12##2##(1995-1#1)(1996-10#1)(2008-2#1)(2008-7#4)(2008-9#1)(2010-2#1)(2010-5#1)(2012-12#2)
precise criteria##2##2##(2008-2#1)(2008-9#1)
precise cutting##2##2##(1995-4#1)(2004-2#1)
precise definition##3##2##(1996-12#1)(2009-6#1)(2013-1#1)
precise delivery##4##2##(2008-10#2)(2009-5#1)(2010-5#1)
precise description of##2##3##(2008-10#1)(2013-8#1)
precise determination of the##5##4##(1997-3#1)(2007-11#1)(2008-10#1)(2008-2#2)
precise determination of##15##3##(1990-8#1)(1997-3#1)(2006-10#1)(2007-11#2)(2008-10#6)(2008-2#3)(2010-2#1)
precise determination##16##2##(1990-8#1)(1997-3#1)(2006-10#1)(2007-11#2)(2008-10#6)(2008-2#3)(2010-2#1)(2012-3#1)
precise diagnosis and##4##3##(1992-5#1)(1995-9#1)(2007-11#1)(2013-1#1)
precise diagnosis of##4##3##(1990-2#1)(1992-10#1)(2008-3#1)(2008-9#1)
precise diagnosis##15##2##(1990-2#1)(1991-10#1)(1991-5#1)(1992-10#1)(1992-5#1)(1993-9#1)(1995-9#1)(2007-11#1)(2007-7#1)(2008-3#1)(2008-9#1)(2009-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
precise diagnostic##2##2##(1993-8#1)(2006-8#1)
precise dose##2##2##(1996-2#1)(2010-12#1)
precise elimination##2##2##(2006-12#1)(2012-3#1)
precise enough##2##2##(2007-11#1)(2007-9#1)
precise estimates of the##2##4##(1991-2#1)(2012-3#1)
precise estimates##3##2##(1991-2#1)(1994-11#1)(2012-3#1)
precise etiology of##2##3##(2008-7#1)(2009-12#1)
precise etiology##4##2##(2005-8#1)(2008-7#1)(2009-12#1)(2012-3#1)
precise evaluation of##5##3##(1991-10#1)(1994-12#1)(2007-11#1)(2008-2#1)(2011-7#1)
precise evaluation##6##2##(1991-10#1)(1994-12#1)(2007-11#1)(2008-1#1)(2008-2#1)(2011-7#1)
precise excision##2##2##(1997-4#1)(2009-8#1)
precise features##2##2##(2008-11#1)(2008-9#1)
precise for##3##2##(2008-10#1)(2010-2#1)(2012-2#1)
precise function##4##2##(1994-5#1)(1995-8#1)(1997-3#2)
precise functional role##2##3##(1994-8#1)(2012-2#1)
precise identification##2##2##(2007-8#1)(2010-7#1)
precise identity##2##2##(1990-3#1)(2008-11#1)
precise imaging in regions where the##2##6##(2008-3#2)
precise imaging##4##2##(2008-3#3)(2012-2#1)
precise incidence##2##2##(2007-9#1)(2008-7#1)
precise individual##3##2##(1996-2#1)(2008-10#2)
precise information on the##2##4##(2006-10#2)
precise information on##3##3##(2006-10#2)(2006-3#1)
precise information##5##2##(2006-10#3)(2006-3#1)(2010-4#1)
precise integration of##2##3##(2006-12#2)
precise intraoperative##2##2##(2005-5#1)(2011-12#1)
precise knowledge of the##3##4##(2005-11#1)(2008-2#1)(2008-3#1)
precise knowledge of##4##3##(2005-11#1)(2006-2#1)(2008-2#1)(2008-3#1)
precise localisation##2##2##(1991-3#1)(2011-2#1)
precise localization of##6##3##(2006-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-8#1)
precise localization##7##2##(1993-6#1)(2006-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-8#1)
precise location of##2##3##(1993-12#1)(1997-4#1)
precise location##3##2##(1993-12#1)(1997-4#1)(2008-7#1)
precise manner##2##2##(2008-11#1)(2008-3#1)
precise map##2##2##(1993-9#2)
precise measurement of the##5##4##(2007-11#2)(2007-12#1)(2008-3#2)
precise measurement of##9##3##(1990-6#1)(1991-8#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2008-3#2)
precise measurement##11##2##(1990-6#1)(1991-8#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-3#2)(2010-7#1)
precise measurements of##3##3##(1996-2#1)(1996-5#1)(2008-3#1)
precise measurements##6##2##(1990-11#1)(1996-2#1)(1996-5#1)(2008-11#1)(2008-3#1)(2008-6#1)
precise mechanism by which##2##4##(1996-4#1)(2009-5#1)
precise mechanism of action is unknown##2##6##(2006-8#1)(2007-11#1)
precise mechanism of action##4##4##(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#1)
precise mechanism of##7##3##(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2010-8#1)(2011-1#2)
precise mechanism##13##2##(1992-5#1)(1996-4#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-9#2)(2009-12#1)(2009-5#1)(2010-8#1)(2011-1#2)
precise mechanisms by which##2##4##(1995-12#1)(2005-7#1)
precise mechanisms##13##2##(1994-10#1)(1995-12#1)(2005-7#1)(2006-10#2)(2008-1#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-7#1)(2012-12#2)
precise metabolic##2##2##(1993-12#1)(1994-8#1)
precise method for##3##3##(2007-9#1)(2008-10#1)(2008-2#1)
precise method is##2##3##(1996-3#1)(2008-10#1)
precise method##7##2##(1995-7#1)(1996-3#1)(2007-9#1)(2008-10#2)(2008-2#2)
precise methods of##2##3##(2010-12#1)(2013-8#1)
precise methods##3##2##(2008-10#1)(2010-12#1)(2013-8#1)
precise molecular mechanisms##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
precise molecular##9##2##(1996-7#1)(2005-11#1)(2005-7#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-7#1)(2011-2#1)
precise nature and##2##3##(2006-10#1)(2006-12#1)
precise nature##7##2##(1994-1#1)(1995-12#1)(2006-10#1)(2006-12#1)(2008-11#1)(2008-2#1)(2008-4#1)
precise navigation##2##2##(2007-7#1)(2010-2#1)
precise phase compensation formulas##2##4##(2008-2#1)(2008-3#1)
precise physical##2##2##(1995-12#1)(2010-12#1)
precise placement of##2##3##(2008-5#1)(2013-7#1)
precise positioning of the negatively charged carboxylate##2##7##(1991-8#2)
precise positioning of##4##3##(1991-8#3)(2006-5#1)
precise positioning##5##2##(1991-8#3)(2006-5#1)(2008-3#1)
precise quantification of##2##3##(1993-2#1)(2008-10#1)
precise quantification##3##2##(1993-2#1)(2008-10#2)
precise quantitation##2##2##(2008-4#1)(2009-10#1)
precise results##8##2##(2008-10#7)(2010-3#1)
precise role of##11##3##(1990-5#1)(1993-6#1)(1994-2#1)(1994-8#1)(2005-7#1)(2007-11#2)(2010-2#1)(2010-5#1)(2012-12#2)
precise role##13##2##(1990-5#1)(1993-6#1)(1994-2#1)(1994-8#1)(2005-7#1)(2006-10#1)(2007-11#2)(2008-3#1)(2010-2#1)(2010-5#1)(2012-12#2)
precise spatial and temporal##3##4##(2006-4#1)(2008-11#1)(2013-8#1)
precise spatial##5##2##(1991-11#1)(2006-4#1)(2008-11#1)(2010-9#1)(2013-8#1)
precise structural##2##2##(1990-10#1)(2007-9#1)
precise submicrometer##2##2##(2007-11#1)(2008-2#1)
precise surgical technique##2##3##(1991-5#1)(2006-3#1)
precise surgical##6##2##(1991-5#1)(2006-3#2)(2006-6#1)(2007-12#1)(2009-4#1)
precise three-dimensional##3##2##(2006-10#1)(2007-11#1)(2008-10#1)
precise timing and##3##3##(2007-8#1)(2008-7#2)
precise timing##7##2##(1994-9#1)(2007-8#1)(2008-10#1)(2008-7#2)(2009-12#1)(2012-12#1)
precise tuning##2##2##(2007-12#1)(2011-2#1)
precise use##2##2##(1990-1#1)(1995-12#1)
precise values of##2##3##(2008-11#1)(2008-3#1)
precise values##3##2##(1996-3#1)(2008-11#1)(2008-3#1)
precise when##2##2##(2007-6#1)(2008-10#1)
precise with a##2##3##(1992-2#1)(1996-11#1)
precise##659##1##(1990-1#1)(1990-10#2)(1990-11#4)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#2)(1991-10#2)(1991-11#3)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#5)(1991-9#2)(1992-1#1)(1992-10#2)(1992-12#4)(1992-2#2)(1992-4#1)(1992-5#2)(1992-9#3)(1993-12#3)(1993-2#3)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#3)(1994-1#1)(1994-10#2)(1994-11#1)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#3)(1994-7#1)(1994-8#3)(1994-9#4)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#5)(1995-2#1)(1995-3#1)(1995-4#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-10#2)(1996-11#2)(1996-12#4)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#3)(1996-7#1)(1997-2#2)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#2)(2003-11#1)(2004-11#1)(2004-2#1)(2005-10#2)(2005-11#3)(2005-3#1)(2005-4#1)(2005-5#1)(2005-7#4)(2005-8#2)(2006-10#11)(2006-11#1)(2006-12#7)(2006-2#3)(2006-3#4)(2006-4#4)(2006-5#1)(2006-6#5)(2006-7#3)(2006-8#6)(2006-9#2)(2007-11#17)(2007-12#14)(2007-2#3)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#3)(2007-7#6)(2007-8#9)(2007-9#6)(2008-1#5)(2008-10#118)(2008-11#16)(2008-2#22)(2008-3#25)(2008-4#8)(2008-5#3)(2008-6#4)(2008-7#22)(2008-8#2)(2008-9#9)(2009-10#2)(2009-12#4)(2009-2#1)(2009-3#3)(2009-4#4)(2009-5#6)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#2)(2010-11#1)(2010-12#13)(2010-2#14)(2010-3#5)(2010-4#2)(2010-5#6)(2010-6#1)(2010-7#4)(2010-8#2)(2010-9#2)(2011-1#5)(2011-12#2)(2011-2#10)(2011-7#1)(2012-1#5)(2012-11#1)(2012-12#11)(2012-2#16)(2012-3#7)(2013-1#5)(2013-7#5)(2013-8#7)
precisely address##2##2##(2008-10#1)(2008-7#1)
precisely analyzed by##2##3##(1997-2#1)(2008-10#1)
precisely and##2##2##(2008-11#1)(2010-6#1)
precisely at the##4##3##(1996-10#1)(1997-2#1)(2005-11#1)(2008-10#1)
precisely at##5##2##(1996-10#1)(1997-2#1)(2005-11#1)(2008-10#2)
precisely control##2##2##(2008-2#1)(2009-8#1)
precisely controlled##5##2##(1995-8#1)(2006-6#1)(2008-10#1)(2008-7#1)(2011-1#1)
precisely define the##3##3##(1994-12#1)(2010-6#1)(2012-12#1)
precisely defined##9##2##(1990-5#1)(1994-4#1)(1995-5#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)
precisely designed##2##2##(2007-2#1)(2008-7#1)
precisely determined by##2##3##(2008-10#1)(2008-5#1)
precisely determined without##2##3##(1993-1#1)(2008-10#1)
precisely determined##6##2##(1992-2#1)(1993-1#1)(2008-10#2)(2008-5#1)(2008-9#1)
precisely distinguish##2##2##(2009-4#1)(2009-5#1)
precisely in the##3##3##(2005-6#1)(2010-12#1)(2012-2#1)
precisely in##6##2##(2005-6#1)(2008-3#1)(2009-9#1)(2010-12#1)(2010-8#1)(2012-2#1)
precisely known##6##2##(1991-8#1)(1993-6#1)(1994-5#1)(1997-8#1)(2008-7#1)(2010-6#1)
precisely located##3##2##(1996-8#1)(1997-6#1)(1997-8#1)
precisely mapped##2##2##(1997-3#1)(2012-3#1)
precisely measured##2##2##(2007-12#1)(2008-3#1)
precisely on##2##2##(2009-11#1)(2009-4#1)
precisely performed##2##2##(2006-3#1)(2008-10#1)
precisely predict the##2##3##(2008-10#1)(2008-2#1)
precisely predict##3##2##(2004-2#1)(2008-10#1)(2008-2#1)
precisely reproduced##2##2##(2010-12#1)(2011-2#1)
precisely the same##3##3##(1990-6#1)(2008-10#1)(2009-11#1)
precisely the time##2##3##(1996-5#1)(2008-5#1)
precisely the##21##2##(1990-3#1)(1990-6#1)(1990-8#1)(1993-2#1)(1996-2#1)(1996-5#1)(2005-11#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-11#2)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
precisely to the##3##3##(1991-10#1)(1991-5#1)(2007-12#1)
precisely to##4##2##(1991-10#1)(1991-5#1)(2007-12#1)(2012-12#1)
precisely with##2##2##(1992-6#1)(2005-11#1)
precisely##195##1##(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-2#2)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-4#1)(1994-5#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-6#1)(1997-8#2)(2004-1#1)(2004-2#1)(2005-10#1)(2005-11#6)(2005-6#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#3)(2007-12#4)(2007-2#3)(2007-4#1)(2007-5#2)(2007-8#4)(2007-9#2)(2008-1#5)(2008-10#20)(2008-11#6)(2008-12#2)(2008-2#7)(2008-3#9)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#3)(2009-12#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#4)(2010-5#1)(2010-6#3)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#4)(2012-12#3)(2012-2#7)(2012-3#2)(2013-1#5)(2013-7#3)
precision (CV##4##2##(1997-8#1)(2008-10#3)
precision (R##22##2##(1992-11#1)(2007-8#4)(2008-10#17)
precision (RSD values##2##3##(2007-8#1)(2008-10#1)
precision (RSD##6##2##(2007-8#1)(2008-10#5)
precision (assessed as the relative standard deviation)##2##7##(2008-10#2)
precision (n=8)##2##2##(2008-10#2)
precision (relative standard deviation)##2##4##(2008-10#2)
precision (relative standard##3##3##(2008-10#2)(2013-1#1)
precision and accuracy as##2##4##(1993-11#1)(2008-10#1)
precision and accuracy compared##2##4##(2007-10#1)(2008-10#1)
precision and accuracy of the method##3##6##(1996-6#1)(2008-10#2)
precision and accuracy of the##12##5##(1991-5#1)(1996-6#1)(2008-10#9)(2008-3#1)
precision and accuracy of##20##4##(1991-5#1)(1996-6#1)(1996-8#1)(2008-10#13)(2008-3#2)(2009-8#1)(2010-11#1)
precision and accuracy were within##2##5##(2010-12#2)
precision and accuracy were##3##4##(2008-10#1)(2010-12#2)
precision and accuracy##51##3##(1990-1#1)(1991-5#1)(1992-2#1)(1993-11#1)(1996-6#2)(1996-8#1)(1997-2#1)(2005-4#3)(2007-10#1)(2008-10#32)(2008-3#2)(2009-8#1)(2010-11#1)(2010-12#2)(2011-1#1)
precision and efficiency##2##3##(2008-10#1)(2008-3#1)
precision and linearity##3##3##(2008-10#3)
precision and recall##3##3##(2008-7#1)(2013-1#2)
precision and reproducibility##4##3##(2008-10#3)(2013-8#1)
precision and selectivity##2##3##(2008-10#2)
precision and sensitivity##5##3##(2008-10#4)(2008-5#1)
precision and specificity##5##3##(2006-8#1)(2008-10#1)(2010-2#2)(2012-2#1)
precision and system suitability##2##4##(1996-3#1)(2008-3#1)
precision and the##3##3##(2005-4#1)(2008-3#1)(2011-2#1)
precision and with##2##3##(2008-10#1)(2008-3#1)
precision and##119##2##(1990-1#1)(1991-5#1)(1992-2#1)(1993-11#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-6#2)(1996-8#1)(1997-2#1)(2005-4#5)(2006-8#1)(2007-10#1)(2007-11#1)(2007-5#2)(2007-8#1)(2008-10#59)(2008-11#1)(2008-3#11)(2008-5#1)(2008-7#1)(2009-11#2)(2009-8#1)(2010-11#1)(2010-12#3)(2010-2#3)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#6)(2013-7#1)(2013-8#1)
precision are##9##2##(1992-2#1)(2005-4#3)(2008-10#2)(2008-3#1)(2008-7#1)(2011-1#1)
precision as##5##2##(2006-10#1)(2007-1#1)(2008-10#2)(2008-3#1)
precision at the##3##3##(2008-10#3)
precision at##6##2##(2008-10#4)(2013-1#2)
precision better than##4##3##(1992-8#1)(2008-10#2)(2008-2#1)
precision between##4##2##(1990-6#1)(2008-10#3)
precision by##4##2##(2007-8#1)(2008-10#2)(2008-2#1)
precision calculated##2##2##(1996-8#1)(2008-10#1)
precision characteristics##3##2##(2008-10#3)
precision compared with##2##3##(2007-8#1)(2008-4#1)
precision expressed as relative standard deviation (RSD)##2##7##(2008-10#1)(2009-8#1)
precision expressed as relative standard deviation was##2##7##(2008-10#2)
precision expressed as relative standard deviation##8##6##(2008-10#7)(2009-8#1)
precision expressed as##10##3##(2008-10#8)(2009-4#1)(2009-8#1)
precision filter radiometer##2##3##(2008-3#2)
precision for all##3##3##(2008-10#2)(2010-2#1)
precision for the determination of##2##5##(2008-10#1)(2010-8#1)
precision for the##8##3##(1993-1#1)(2008-10#3)(2008-2#2)(2010-8#1)(2011-2#1)
precision for##35##2##(1993-1#2)(2006-5#1)(2007-8#2)(2008-10#15)(2008-2#2)(2008-3#3)(2008-9#1)(2010-2#2)(2010-8#3)(2011-12#1)(2011-2#2)(2013-7#1)
precision grip between the index finger and thumb##2##8##(1992-9#1)(1996-2#1)
precision grip movements showed##2##4##(1993-7#2)
precision grip##9##2##(1992-9#1)(1993-7#6)(1996-2#2)
precision in the##10##3##(1993-9#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-3#1)(2011-2#1)
precision in##30##2##(1993-9#1)(1994-9#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#9)(2008-3#5)(2008-7#2)(2008-8#2)(2010-9#2)(2011-2#2)(2013-1#1)
precision is##14##2##(1990-2#1)(1997-2#1)(2005-4#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)(2010-4#1)(2012-2#1)(2013-1#2)
precision laser##2##2##(2008-2#2)
precision measurement of##2##3##(1995-11#1)(2008-2#1)
precision method for##2##3##(2006-12#2)
precision metrology##2##2##(2008-2#1)(2008-3#1)
precision obtained##4##2##(2007-11#1)(2008-10#3)
precision of &lt##2##3##(2007-12#1)(2008-10#1)
precision of 0##7##3##(1990-3#1)(2008-10#1)(2008-3#1)(2013-1#4)
precision of 1##9##3##(2008-10#7)(2008-2#2)
precision of a##2##3##(2008-11#1)(2008-2#1)
precision of approximately##5##3##(2006-10#1)(2008-3#4)
precision of direct analyses##2##4##(2008-10#2)
precision of less than##2##4##(2008-10#2)
precision of measurement##3##3##(2008-10#2)(2008-3#1)
precision of the assay##2##4##(1997-3#1)(2011-2#1)
precision of the calibrator##2##4##(2008-10#2)
precision of the determination##3##4##(2008-10#3)
precision of the measurement##2##4##(2008-10#2)
precision of the method was estimated by##2##7##(2008-10#2)
precision of the method was estimated##3##6##(2008-10#3)
precision of the method was##8##5##(2008-10#8)
precision of the method were##2##5##(1990-8#1)(2008-10#1)
precision of the method##28##4##(1990-8#1)(1991-5#1)(1993-2#1)(2008-10#25)
precision of the proposed method was##3##6##(2008-10#3)
precision of the proposed method##5##5##(2008-10#5)
precision of the proposed##6##4##(2008-10#6)
precision of the reference##2##4##(2008-10#1)(2010-4#1)
precision of the results##4##4##(2005-4#1)(2008-10#2)(2008-2#1)
precision of the technique##3##4##(2008-10#2)(2008-7#1)
precision of the##87##3##(1990-8#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-2#1)(1994-2#1)(1996-12#1)(1996-5#1)(1997-3#2)(2005-4#1)(2006-12#1)(2007-12#1)(2008-10#55)(2008-2#2)(2008-3#4)(2008-6#1)(2008-7#2)(2009-5#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-7#1)
precision of these##4##3##(2008-10#2)(2008-7#1)(2011-1#1)
precision of this method##5##4##(2008-10#1)(2008-2#1)(2011-1#1)(2012-12#1)(2013-1#1)
precision of this##8##3##(2008-10#2)(2008-2#3)(2011-1#1)(2012-12#1)(2013-1#1)
precision of##217##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-2#1)(1995-1#2)(1996-12#1)(1996-5#1)(1996-8#1)(1997-3#2)(2005-10#1)(2005-4#1)(2006-10#2)(2006-12#3)(2006-6#1)(2007-11#2)(2007-12#4)(2007-3#1)(2007-6#1)(2007-8#4)(2008-10#101)(2008-11#1)(2008-2#14)(2008-3#19)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-5#3)(2010-4#1)(2010-5#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#14)(2013-7#1)
precision on the##2##3##(2008-10#2)
precision on##4##2##(1990-2#1)(2008-10#2)(2008-3#1)
precision or##3##2##(2008-10#3)
precision ranged from 2##3##4##(1997-8#2)(2008-10#1)
precision ranged##4##2##(1997-8#2)(2008-10#2)
precision ranges from##2##3##(2008-10#2)
precision required##2##2##(2008-2#1)(2009-4#1)
precision spectral pyranometer##2##3##(2008-3#2)
precision spectral##3##2##(2007-11#1)(2008-3#2)
precision studies are##3##3##(2008-10#2)(2010-12#1)
precision studies##5##2##(2008-10#2)(2010-12#2)(2012-12#1)
precision than##3##2##(2008-10#2)(2009-12#1)
precision that##3##2##(2008-2#1)(2008-3#1)(2009-5#1)
precision to the##4##3##(2008-10#1)(2008-2#2)(2008-5#1)
precision to##6##2##(2008-10#1)(2008-2#3)(2008-5#1)(2012-3#1)
precision values##2##2##(2008-10#2)
precision was 0##2##3##(2005-4#1)(2008-10#1)
precision was 1##2##3##(1996-8#1)(2008-10#1)
precision was better##2##3##(1995-2#1)(2008-10#1)
precision was between##2##3##(1990-2#1)(2008-10#1)
precision was found to be##4##5##(1997-3#1)(2008-10#2)(2010-12#1)
precision was less than##2##4##(2008-10#1)(2011-3#1)
precision was obtained##2##3##(2008-10#2)
precision was studied##2##3##(2008-10#2)
precision was##38##2##(1990-2#1)(1990-8#1)(1992-2#1)(1993-2#1)(1995-2#1)(1996-8#1)(1997-3#1)(2005-4#1)(2007-8#1)(2008-10#24)(2008-3#1)(2010-12#1)(2011-3#1)(2012-11#1)(2012-12#1)
precision were also##2##3##(2008-10#1)(2009-8#1)
precision were studied##2##3##(2008-10#2)
precision were##16##2##(1990-12#1)(1990-2#1)(1997-3#2)(2008-1#1)(2008-10#5)(2009-8#1)(2010-12#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-3#1)
precision with##5##2##(1990-6#1)(1996-7#1)(1996-8#2)(2008-10#1)
precision within##2##2##(1990-12#1)(2008-10#1)
precision without##2##2##(1997-2#1)(2007-12#1)
precision##931##1##(1990-1#1)(1990-12#4)(1990-2#4)(1990-3#2)(1990-5#1)(1990-6#4)(1990-8#2)(1990-9#1)(1991-3#3)(1991-5#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#3)(1992-4#1)(1992-8#1)(1992-9#1)(1993-1#3)(1993-11#3)(1993-12#2)(1993-2#2)(1993-7#6)(1993-9#1)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#3)(1996-6#2)(1996-7#2)(1996-8#7)(1997-2#3)(1997-3#10)(1997-8#4)(2004-2#2)(2005-10#2)(2005-12#2)(2005-4#12)(2006-10#3)(2006-12#5)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#9)(2007-12#14)(2007-2#1)(2007-3#2)(2007-5#4)(2007-6#1)(2007-8#21)(2008-1#3)(2008-10#430)(2008-11#4)(2008-12#1)(2008-2#53)(2008-3#65)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#11)(2008-8#5)(2008-9#3)(2009-11#3)(2009-12#2)(2009-2#2)(2009-4#3)(2009-5#6)(2009-7#2)(2009-8#3)(2010-11#2)(2010-12#10)(2010-2#9)(2010-3#3)(2010-4#5)(2010-5#1)(2010-8#4)(2010-9#5)(2011-1#7)(2011-12#4)(2011-2#9)(2011-3#2)(2012-1#1)(2012-11#3)(2012-12#7)(2012-2#9)(2012-3#4)(2013-1#37)(2013-7#7)(2013-8#6)
precision) of##2##2##(1995-7#1)(2008-3#1)
precision)##6##1##(1995-7#1)(2008-10#3)(2008-3#1)(2013-7#1)
precisions (RSD##2##2##(2008-10#2)
precisions and##5##2##(2008-10#2)(2008-2#1)(2013-1#2)
precisions of##8##2##(1993-2#1)(2005-12#1)(2008-10#4)(2013-1#2)
precisions were##3##2##(1990-8#1)(2008-10#1)(2012-12#1)
precisions##27##1##(1990-8#1)(1993-2#1)(2005-12#1)(2008-10#17)(2008-2#1)(2008-3#1)(2012-12#1)(2013-1#4)
preclamping##2##1##(1993-12#1)(2007-9#1)
preclinical AD##2##2##(2011-2#2)
preclinical CS##2##2##(2011-2#2)
preclinical and clinical data##2##4##(2009-9#1)(2010-12#1)
preclinical and clinical research##3##4##(1995-5#1)(2008-5#1)(2008-7#1)
preclinical and clinical stages of##2##5##(2012-1#2)
preclinical and clinical studies##10##4##(1995-12#1)(2005-7#2)(2008-1#1)(2008-3#1)(2009-11#1)(2012-12#2)(2012-2#1)(2013-8#1)
preclinical and clinical trials##3##4##(2008-5#1)(2011-12#1)(2012-3#1)
preclinical and clinical##34##3##(1991-10#1)(1993-11#2)(1995-12#1)(1995-5#1)(2005-7#3)(2005-9#1)(2006-10#1)(2007-11#2)(2008-1#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-12#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#1)
preclinical and early clinical trials##2##5##(2008-8#1)(2009-3#1)
preclinical and early clinical##4##4##(2008-5#1)(2008-8#1)(2009-3#1)(2011-2#1)
preclinical and early##5##3##(2008-5#1)(2008-8#1)(2009-3#1)(2011-2#1)(2013-1#1)
preclinical and##45##2##(1990-2#1)(1991-10#1)(1993-11#2)(1995-12#1)(1995-5#1)(2005-7#3)(2005-9#1)(2006-10#1)(2007-11#3)(2007-4#1)(2008-1#2)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
preclinical animal models##2##3##(2008-1#1)(2008-5#1)
preclinical animal studies##5##3##(2005-2#1)(2012-12#4)
preclinical animal##7##2##(2005-2#1)(2008-1#1)(2008-5#1)(2012-12#4)
preclinical data##9##2##(1996-10#1)(2005-9#1)(2007-9#1)(2008-7#1)(2008-8#2)(2009-3#1)(2010-2#1)(2010-4#1)
preclinical development for##2##3##(2005-7#1)(2011-2#1)
preclinical development of##3##3##(2005-7#1)(2008-4#2)
preclinical development##13##2##(1997-3#1)(2005-7#2)(2005-8#1)(2007-11#2)(2008-11#1)(2008-3#1)(2008-4#2)(2011-2#1)(2012-12#2)
preclinical drug development##2##3##(1994-12#1)(2008-10#1)
preclinical drug##4##2##(1994-12#1)(2008-10#1)(2008-5#1)(2010-3#1)
preclinical evaluation of##5##3##(1991-12#1)(1991-9#1)(1996-6#1)(2006-10#1)(2008-10#1)
preclinical evaluation##8##2##(1991-12#1)(1991-9#1)(1992-5#1)(1996-6#1)(2005-9#1)(2006-10#1)(2007-11#1)(2008-10#1)
preclinical evidence for##3##3##(2008-6#1)(2012-12#2)
preclinical evidence of##2##3##(2008-1#1)(2008-11#1)
preclinical evidence##6##2##(2008-1#1)(2008-11#1)(2008-6#1)(2009-3#1)(2012-12#2)
preclinical findings##5##2##(1997-5#1)(2005-7#1)(2005-9#1)(2007-5#1)(2008-1#1)
preclinical investigations##4##2##(1991-3#1)(2005-8#1)(2008-5#1)(2008-6#1)
preclinical models##15##2##(1996-9#1)(2005-7#4)(2005-8#2)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-3#2)(2010-11#1)(2010-12#1)
preclinical or clinical##2##3##(1990-5#1)(2008-5#1)
preclinical phase##2##2##(2008-10#2)
preclinical research and##4##3##(2005-7#1)(2008-5#1)(2010-12#1)(2012-3#1)
preclinical research##7##2##(2005-7#1)(2005-8#1)(2008-5#1)(2008-7#2)(2010-12#1)(2012-3#1)
preclinical results##6##2##(2005-7#1)(2005-9#1)(2008-5#1)(2010-2#1)(2012-12#1)(2013-8#1)
preclinical students##2##2##(2008-7#1)(2012-2#1)
preclinical studies are##2##3##(2007-10#1)(2011-2#1)
preclinical studies for##3##3##(2012-12#2)(2012-2#1)
preclinical studies have##4##3##(2005-11#1)(2008-1#1)(2008-6#1)(2012-2#1)
preclinical studies on the##2##4##(2005-7#1)(2009-3#1)
preclinical studies on##3##3##(2005-7#1)(2007-11#1)(2009-3#1)
preclinical studies that##4##3##(1996-1#1)(2007-9#1)(2012-12#2)
preclinical studies to##2##3##(2005-7#1)(2012-12#1)
preclinical studies with##4##3##(2005-7#1)(2006-10#1)(2007-11#1)(2008-7#1)
preclinical studies##43##2##(1996-1#1)(1997-6#1)(2005-11#1)(2005-6#1)(2005-7#3)(2005-8#1)(2005-9#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#5)(2007-9#1)(2008-1#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-11#1)(2009-3#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-11#2)(2012-12#7)(2012-2#3)
preclinical study of##2##3##(2005-8#1)(2009-4#1)
preclinical study##6##2##(2005-8#1)(2006-7#1)(2008-8#1)(2009-4#2)(2012-11#1)
preclinical testing of##2##3##(2008-9#1)(2010-6#1)
preclinical testing##3##2##(2008-9#1)(2010-6#1)(2013-1#1)
preclinical##243##1##(1990-2#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-5#1)(1993-11#3)(1994-12#1)(1994-3#2)(1994-4#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-6#1)(1996-9#2)(1997-3#1)(1997-5#1)(1997-6#1)(2005-11#1)(2005-2#1)(2005-6#1)(2005-7#16)(2005-8#12)(2005-9#6)(2006-10#4)(2006-11#1)(2006-2#1)(2006-7#1)(2007-10#2)(2007-11#13)(2007-3#1)(2007-4#1)(2007-5#2)(2007-9#2)(2008-1#9)(2008-10#6)(2008-11#4)(2008-12#2)(2008-3#3)(2008-4#4)(2008-5#15)(2008-6#7)(2008-7#6)(2008-8#6)(2008-9#1)(2009-10#1)(2009-11#2)(2009-3#6)(2009-4#2)(2009-8#1)(2009-9#1)(2010-10#3)(2010-11#3)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#3)(2011-1#2)(2011-12#1)(2011-2#10)(2012-1#4)(2012-11#3)(2012-12#19)(2012-2#9)(2012-3#3)(2013-1#2)(2013-8#2)
preclinically and clinically##2##3##(2008-11#2)
preclinically##4##1##(2008-1#1)(2008-11#2)(2010-10#1)
preclude a##2##2##(2006-10#1)(2008-10#1)
preclude its##3##2##(2005-8#1)(2008-5#1)(2012-12#1)
preclude the##9##2##(1995-7#1)(1996-3#1)(1997-5#1)(2005-7#1)(2006-10#1)(2007-7#1)(2008-10#1)(2010-12#1)(2013-8#1)
preclude##37##1##(1991-12#1)(1992-11#1)(1993-9#1)(1994-3#1)(1995-7#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-5#1)(2005-7#1)(2005-8#2)(2006-10#2)(2007-11#1)(2007-4#1)(2007-7#2)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-8#1)
precluded a##3##2##(1991-6#1)(1995-1#1)(2010-10#1)
precluded by##2##2##(1995-12#1)(2009-2#1)
precluded the##3##2##(1995-3#1)(1997-3#1)(2010-12#1)
precluded##20##1##(1990-12#1)(1991-6#1)(1991-7#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-7#1)(1997-2#1)(1997-3#1)(2005-7#1)(2007-9#1)(2008-10#3)(2008-11#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-12#1)
precludes its use##2##3##(1990-3#1)(1990-6#1)
precludes the use of##3##4##(1993-4#2)(1995-5#1)
precludes the##5##2##(1991-6#1)(1993-4#2)(1995-5#1)(1996-8#1)
precludes their##3##2##(2008-4#1)(2008-7#1)(2008-8#1)
precludes##22##1##(1990-3#1)(1990-6#1)(1991-6#1)(1993-4#2)(1994-8#1)(1995-5#1)(1996-8#1)(2006-9#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-3#1)(2010-5#1)(2011-2#1)(2013-1#3)
precluding the##5##2##(1991-5#1)(1992-9#1)(2008-2#1)(2009-9#1)(2010-12#1)
precluding##16##1##(1991-5#1)(1992-9#1)(1994-11#1)(2005-7#1)(2006-12#1)(2006-5#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-9#1)(2010-12#1)(2011-2#1)(2013-1#2)
precoated with##7##2##(1992-6#1)(1992-8#1)(2008-10#2)(2008-11#3)
precoated##10##1##(1992-6#1)(1992-8#1)(2008-10#3)(2008-11#3)(2010-2#2)
precoating with poly-L-lysine##2##3##(1992-8#2)
precoating##3##1##(1992-8#3)
precocene II##2##2##(1997-3#2)
precocious puberty##7##2##(1991-2#1)(1994-11#1)(2009-3#1)(2011-1#2)(2012-12#1)(2012-2#1)
precocious sexual intercourse##2##3##(2010-12#2)
precocious##16##1##(1991-2#1)(1993-11#1)(1994-11#1)(2007-12#2)(2008-1#1)(2009-3#1)(2010-12#2)(2010-5#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#2)
precociously##2##1##(1992-2#1)(2010-7#1)
precolumn and##2##2##(1990-8#1)(1991-8#1)
precolumn derivatisation##2##2##(1990-12#1)(1996-5#1)
precolumn derivatization of##3##3##(1990-11#1)(1992-7#1)(2008-10#1)
precolumn derivatization with##4##3##(1990-8#1)(1991-12#1)(1992-2#1)(2008-5#1)
precolumn derivatization##8##2##(1990-11#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-2#1)(1992-7#1)(2008-10#1)(2008-5#1)
precolumn enzymatic##2##2##(2008-10#2)
precolumn packed with##2##3##(1990-6#1)(2008-10#1)
precolumn system##2##2##(2008-10#2)
precolumn with##3##2##(1990-8#2)(2008-10#1)
precolumn##47##1##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#6)(1991-12#1)(1991-5#1)(1991-8#3)(1992-2#1)(1992-7#1)(1996-11#1)(1996-5#2)(1996-6#1)(2008-10#26)(2008-5#1)
precolumns##2##1##(1992-11#1)(2008-10#1)
precompensation##4##1##(2007-11#1)(2007-12#3)
precompetitive distribution##2##2##(2008-8#2)
precompetitive distributions##3##2##(2008-8#3)
precompetitive##5##1##(2008-8#5)
preconceived##2##1##(1996-6#1)(2004-3#1)
preconcentrate the##2##2##(2008-10#2)
preconcentrate##10##1##(2008-10#10)
preconcentrated and##3##2##(2008-10#3)
preconcentrated by##4##2##(2008-10#4)
preconcentrated from##2##2##(2008-10#2)
preconcentrated in a membrane cell and##2##6##(2008-10#2)
preconcentrated in a membrane cell using##2##6##(2008-10#2)
preconcentrated in a membrane cell##4##5##(2008-10#4)
preconcentrated in a##6##3##(2008-10#6)
preconcentrated in the##2##3##(2008-10#2)
preconcentrated in##10##2##(2008-10#10)
preconcentrated on a##3##3##(2008-10#3)
preconcentrated on the##5##3##(2008-10#5)
preconcentrated on##12##2##(2008-10#12)
preconcentrated onto the##4##3##(2008-10#4)
preconcentrated onto##6##2##(2008-10#6)
preconcentrated with##3##2##(2008-10#3)
preconcentrated##55##1##(1991-8#1)(2007-8#1)(2008-10#52)(2009-8#1)
preconcentrates the##3##2##(2008-10#3)
preconcentrating##8##1##(2008-10#8)
preconcentration and determination by##3##4##(2008-10#3)
preconcentration and determination in##3##4##(2008-10#3)
preconcentration and determination of 1-naphthylamine##2##5##(2007-8#2)
preconcentration and determination of Cr(III)##2##5##(2008-10#2)
preconcentration and determination of cobalt##2##5##(2008-10#2)
preconcentration and determination of copper by flame##2##7##(2008-10#2)
preconcentration and determination of copper##7##5##(2008-10#7)
preconcentration and determination of lead in##2##6##(2008-10#2)
preconcentration and determination of lead##4##5##(2008-10#4)
preconcentration and determination of trace amounts of##2##7##(2008-10#2)
preconcentration and determination of trace##3##5##(2008-10#3)
preconcentration and determination of##28##4##(2007-8#2)(2008-10#26)
preconcentration and determination system implemented with##2##6##(2008-10#2)
preconcentration and determination##39##3##(2007-8#2)(2008-10#37)
preconcentration and elution##2##3##(2008-10#2)
preconcentration and separation of trace##4##5##(2008-10#4)
preconcentration and separation of##10##4##(2008-10#9)(2009-6#1)
preconcentration and separation##16##3##(2007-8#1)(2008-10#14)(2009-6#1)
preconcentration and speciation of chromium##2##5##(2008-10#2)
preconcentration and speciation of inorganic##2##5##(2008-10#1)(2008-3#1)
preconcentration and speciation of##6##4##(2008-10#5)(2008-3#1)
preconcentration and speciation##8##3##(2008-10#6)(2008-3#2)
preconcentration and spectrophotometric##3##3##(2008-10#3)
preconcentration and##103##2##(2007-8#7)(2008-10#93)(2008-3#2)(2009-6#1)
preconcentration at##2##2##(2008-10#2)
preconcentration by complexation##2##3##(2008-10#2)
preconcentration by using##2##3##(2006-12#1)(2008-10#1)
preconcentration by##11##2##(2006-12#1)(2008-10#10)
preconcentration column##4##2##(2008-10#4)
preconcentration coupled with##2##3##(2008-10#2)
preconcentration efficiency##2##2##(2008-10#2)
preconcentration factor of##11##3##(2008-10#11)
preconcentration factor was 100##2##4##(2008-10#2)
preconcentration factor was##5##3##(2008-10#5)
preconcentration factor##28##2##(2008-10#28)
preconcentration factors of##4##3##(2007-8#1)(2008-10#3)
preconcentration factors##10##2##(2007-8#1)(2008-10#9)
preconcentration followed by##3##3##(2007-8#1)(2008-10#2)
preconcentration for##4##2##(2008-10#4)
preconcentration from##2##2##(2008-10#2)
preconcentration in a##4##3##(2008-10#4)
preconcentration in##7##2##(2008-10#7)
preconcentration is##2##2##(2008-10#2)
preconcentration method and##2##3##(2008-10#2)
preconcentration method for the determination of trace##2##7##(2008-10#2)
preconcentration method for the determination of##4##6##(2008-10#4)
preconcentration method for##7##3##(2008-10#7)
preconcentration method in conjunction with##2##5##(2008-10#2)
preconcentration method in##3##3##(2007-8#1)(2008-10#2)
preconcentration method is described for the determination of##2##8##(2008-10#2)
preconcentration method is##4##3##(2008-10#4)
preconcentration method was##3##3##(2008-10#3)
preconcentration method##26##2##(2007-8#1)(2008-10#25)
preconcentration of 100 ml of##2##5##(2008-10#2)
preconcentration of Cd##3##3##(2008-10#3)
preconcentration of Cd(II)##2##3##(2008-10#2)
preconcentration of U(VI)##5##3##(2008-10#5)
preconcentration of both##2##3##(2008-10#2)
preconcentration of cadmium and lead from##2##6##(2008-10#2)
preconcentration of cadmium and##3##4##(2008-10#3)
preconcentration of cobalt and nickel##2##5##(2008-10#2)
preconcentration of cobalt##5##3##(2008-10#5)
preconcentration of copper##4##3##(2008-10#4)
preconcentration of fulvic and humic acids##2##6##(2008-10#2)
preconcentration of inorganic and##2##4##(2008-10#2)
preconcentration of inorganic##4##3##(2008-10#4)
preconcentration of iron##3##3##(2008-10#3)
preconcentration of its##4##3##(2008-10#4)
preconcentration of lead and##2##4##(2008-10#2)
preconcentration of lead by##2##4##(2008-10#1)(2013-8#1)
preconcentration of lead##6##3##(2008-10#5)(2013-8#1)
preconcentration of mercury##2##3##(2008-10#2)
preconcentration of metal ions##4##4##(2008-10#4)
preconcentration of metal##6##3##(2008-10#6)
preconcentration of palladium(II)##2##3##(2008-10#2)
preconcentration of platinum##2##3##(2008-10#2)
preconcentration of the##7##3##(1997-1#1)(2008-10#5)(2008-5#1)
preconcentration of thorium##3##3##(2008-10#3)
preconcentration of trace amounts of##3##5##(2008-10#3)
preconcentration of trace and ultratrace amounts of lanthanides##2##8##(2008-10#2)
preconcentration of trace and ultratrace amounts of##3##7##(2008-10#3)
preconcentration of trace elements##2##4##(2008-10#2)
preconcentration of trace mercury##2##4##(2008-10#2)
preconcentration of trace##19##3##(2008-10#19)
preconcentration of ultra trace##2##4##(2008-10#2)
preconcentration of uranium(VI)##4##3##(2008-10#4)
preconcentration of##155##2##(1997-1#2)(2007-8#3)(2008-10#148)(2008-5#1)(2013-8#1)
preconcentration on a##5##3##(2008-10#5)
preconcentration on##11##2##(2006-12#1)(2008-10#10)
preconcentration onto the##2##3##(2008-10#2)
preconcentration onto##5##2##(2008-10#5)
preconcentration procedure based on##2##4##(2008-10#2)
preconcentration procedure for lead determination##2##5##(2008-10#2)
preconcentration procedure for##4##3##(2008-10#4)
preconcentration procedure##11##2##(2008-10#10)(2009-6#1)
preconcentration procedures for##2##3##(2008-10#2)
preconcentration procedures##5##2##(2008-10#5)
preconcentration step by##2##3##(2008-10#2)
preconcentration step##16##2##(1996-11#1)(2008-10#15)
preconcentration system for bismuth##2##4##(2008-10#2)
preconcentration system for palladium##2##4##(2008-10#2)
preconcentration system for the##2##4##(2008-10#2)
preconcentration system for##15##3##(2008-10#15)
preconcentration system using##2##3##(2008-10#2)
preconcentration system##32##2##(2008-10#32)
preconcentration systems##3##2##(2008-10#3)
preconcentration technique was examined##2##4##(2008-10#2)
preconcentration technique was##3##3##(2007-8#1)(2008-10#2)
preconcentration technique##6##2##(2007-8#1)(2008-10#4)(2013-1#1)
preconcentration techniques##5##2##(2008-10#4)(2010-7#1)
preconcentration time and sample##2##4##(2007-8#1)(2008-10#1)
preconcentration time and##3##3##(2007-8#1)(2008-10#2)
preconcentration time of 120 s and a sample flow rate of##2##11##(2008-10#2)
preconcentration time of 120 s##5##5##(2008-10#5)
preconcentration time of 5 min##2##5##(2008-10#2)
preconcentration time of##21##3##(2008-10#21)
preconcentration time##51##2##(2007-8#2)(2008-10#49)
preconcentration time)##3##2##(2008-10#3)
preconcentration using the##2##3##(2008-10#2)
preconcentration using##9##2##(2008-10#9)
preconcentration was 0##2##3##(2008-10#1)(2008-5#1)
preconcentration was##9##2##(2008-10#8)(2008-5#1)
preconcentration were##3##2##(2008-10#3)
preconcentration with APDC at pH=8##2##5##(2007-8#2)
preconcentration with the##3##3##(2008-10#3)
preconcentration with##15##2##(2007-8#4)(2008-10#11)
preconcentration##627##1##(1996-11#1)(1997-1#2)(2004-12#1)(2006-12#2)(2007-8#22)(2008-10#588)(2008-11#1)(2008-3#2)(2008-5#2)(2009-6#2)(2010-7#2)(2013-1#1)(2013-8#1)
preconcentration)##4##1##(2008-10#4)
preconcentration/separation of##2##2##(2008-10#2)
preconcentration/separation##9##1##(2008-10#9)
preconcentrative separation of##2##3##(2008-10#2)
preconception care##2##2##(2008-1#2)
preconception##5##1##(2006-1#1)(2007-9#1)(2008-1#2)(2012-12#1)
preconceptional##2##1##(1996-12#1)(2004-10#1)
precondition for##4##2##(1993-2#1)(1994-3#1)(2008-4#1)(2012-1#1)
precondition the##3##2##(1993-7#1)(1996-9#1)(2007-8#1)
precondition##11##1##(1993-2#1)(1993-7#2)(1994-3#1)(1996-9#1)(1997-3#1)(2006-7#2)(2007-8#1)(2008-4#1)(2012-1#1)
preconditioned in##2##2##(1996-9#1)(2009-12#1)
preconditioned with##5##2##(1994-2#1)(1996-9#1)(2008-10#2)(2013-1#1)
preconditioned##28##1##(1994-2#1)(1996-9#7)(2006-2#1)(2007-1#1)(2007-8#1)(2007-9#2)(2008-10#3)(2008-2#3)(2008-3#3)(2008-7#2)(2009-12#1)(2013-1#1)(2013-7#2)
preconditioning (IPC)##2##2##(2007-8#1)(2013-7#1)
preconditioning against stunning##3##3##(2010-2#3)
preconditioning against##5##2##(2010-2#4)(2013-8#1)
preconditioning and adenosine##2##3##(1996-9#1)(2007-9#1)
preconditioning and##7##2##(1996-9#2)(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2010-12#1)
preconditioning before##2##2##(1996-9#1)(2007-8#1)
preconditioning by##2##2##(2007-11#1)(2008-8#1)
preconditioning causes##2##2##(2007-8#1)(2007-9#1)
preconditioning in rat hearts##2##4##(2007-8#1)(2013-7#1)
preconditioning in the##5##3##(1994-2#1)(1996-9#1)(2006-10#2)(2013-7#1)
preconditioning in##10##2##(1994-2#1)(1996-9#3)(2006-10#2)(2007-8#1)(2010-12#1)(2013-7#2)
preconditioning is##4##2##(1993-7#1)(1994-11#1)(1996-9#1)(2006-10#1)
preconditioning of##5##2##(2007-8#1)(2009-4#2)(2010-8#1)(2011-1#1)
preconditioning or##2##2##(2007-8#2)
preconditioning stimulus##2##2##(2010-2#2)
preconditioning##94##1##(1993-7#3)(1994-11#1)(1994-2#2)(1996-5#1)(1996-9#26)(2006-10#12)(2007-11#1)(2007-8#12)(2007-9#2)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-12#1)(2009-4#2)(2009-6#1)(2010-12#4)(2010-2#7)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-7#3)(2013-8#1)
preconditioning]##2##1##(2010-12#1)(2012-3#1)
preconditions are##2##2##(1990-2#1)(2008-8#1)
preconditions for the##2##3##(2007-11#1)(2008-4#1)
preconditions for##4##2##(2007-11#1)(2008-4#1)(2008-8#1)(2011-1#1)
preconditions##9##1##(1990-2#1)(1992-5#1)(1994-7#1)(2006-9#1)(2007-11#1)(2008-4#1)(2008-8#2)(2011-1#1)
preconstricted##2##1##(1993-6#1)(2010-4#1)
preconstriction with##2##2##(2007-9#2)
preconstriction##4##1##(2007-9#4)
precontemplation##3##1##(2006-10#1)(2008-4#1)(2010-2#1)
precontracted with norepinephrine##2##3##(1992-1#1)(2008-11#1)
precontracted with phenylephrine##2##3##(1996-10#1)(2010-6#1)
precontracted with##8##2##(1990-11#1)(1992-1#1)(1996-10#4)(2008-11#1)(2010-6#1)
precontracted##11##1##(1990-11#1)(1990-5#1)(1992-1#1)(1996-10#4)(1996-12#1)(2007-10#1)(2008-11#1)(2010-6#1)
precontrast##2##1##(2007-10#1)(2011-2#1)
precooked corn and white wheat flours##2##6##(2006-4#2)
precooled##3##1##(2008-9#3)
precooling##4##1##(1992-3#4)
precopulatory expenditure##2##2##(2013-1#2)
precopulatory male-male##2##2##(2013-1#2)
precopulatory##5##1##(2013-1#5)
precordial T-negativity##2##2##(1993-8#2)
precordial pain##4##2##(2008-10#1)(2008-7#3)
precordial##10##1##(1993-12#1)(1993-8#2)(2006-4#1)(2006-9#1)(2008-10#1)(2008-7#3)(2012-12#1)
precore mutants##2##2##(2006-10#2)
precore##6##1##(1990-9#1)(2006-10#2)(2008-12#1)(2009-11#1)(2013-1#1)
precorneous layers##2##2##(2011-2#2)
precovalent##2##1##(1995-2#2)
precue##3##1##(2008-7#3)
precued##3##1##(1993-2#2)(2008-1#1)
precuneus and##3##2##(2008-11#1)(2009-1#1)(2010-2#1)
precuneus##7##1##(2008-11#3)(2009-1#2)(2009-4#1)(2010-2#1)
precursor (A beta PP)##2##4##(1992-7#1)(1995-12#1)
precursor (APP)##12##2##(1990-8#1)(1991-2#1)(1991-9#2)(1992-12#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-9#1)
precursor B-cell##3##2##(2007-12#1)(2011-1#1)(2011-2#1)
precursor and the##4##3##(1993-12#2)(1994-11#2)
precursor and##25##2##(1990-12#1)(1990-4#1)(1990-5#1)(1992-6#1)(1993-12#3)(1994-11#2)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(2005-1#1)(2007-8#1)(2008-5#3)(2008-6#1)
precursor as##2##2##(1992-12#1)(1995-6#1)
precursor at##2##2##(1994-11#1)(1995-6#1)
precursor by##2##2##(1995-2#1)(2008-4#1)
precursor cDNA##2##2##(2010-5#2)
precursor can be##2##3##(1994-2#1)(2008-3#1)
precursor cell line##3##3##(1990-11#1)(1990-8#1)(1994-6#1)
precursor cell lines##4##3##(1995-2#1)(2008-11#3)
precursor cell##16##2##(1990-11#1)(1990-8#1)(1991-12#2)(1992-6#1)(1992-9#1)(1994-12#1)(1994-6#1)(1995-2#1)(2007-12#3)(2007-9#1)(2008-11#3)
precursor cells and##3##3##(1995-8#1)(2009-3#1)(2013-8#1)
precursor cells are##2##3##(2008-4#1)(2008-9#1)
precursor cells by##2##3##(2008-7#1)(2012-1#1)
precursor cells from##4##3##(1992-12#1)(2005-10#1)(2007-12#1)(2008-11#1)
precursor cells in the bone marrow##3##6##(2008-4#2)(2012-1#1)
precursor cells in the##5##4##(2006-11#1)(2008-4#3)(2012-1#1)
precursor cells in##6##3##(2006-11#1)(2008-4#4)(2012-1#1)
precursor cells into##3##3##(1995-8#2)(2009-3#1)
precursor cells of the##2##4##(2007-12#1)(2009-2#1)
precursor cells of##3##3##(1996-2#1)(2007-12#1)(2009-2#1)
precursor cells that##2##3##(1995-1#1)(1995-11#1)
precursor cells to the##3##4##(1991-12#1)(1995-8#1)(2012-1#1)
precursor cells to##6##3##(1991-12#1)(1995-8#2)(2007-12#1)(2010-8#1)(2012-1#1)
precursor cells##80##2##(1990-11#3)(1990-5#1)(1991-12#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-6#1)(1995-1#1)(1995-11#3)(1995-12#1)(1995-8#6)(1996-1#1)(1996-2#1)(2005-10#1)(2006-11#1)(2007-12#5)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#14)(2008-4#6)(2008-5#2)(2008-7#3)(2008-9#2)(2009-2#1)(2009-3#2)(2010-8#1)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
precursor chemicals##2##2##(2013-8#2)
precursor cleavage##3##2##(2008-11#3)
precursor delta-aminolevulinic acid##2##3##(1993-8#1)(1995-3#1)
precursor domain##2##2##(2007-12#2)
precursor film thickness##2##3##(2009-6#2)
precursor film##6##2##(2005-11#1)(2009-6#5)
precursor for the synthesis of##2##5##(1992-12#1)(2010-11#1)
precursor for the##7##3##(1990-3#1)(1992-12#1)(1993-3#1)(1994-12#1)(1997-1#1)(2005-11#1)(2010-11#1)
precursor for##27##2##(1990-3#1)(1990-7#1)(1991-2#1)(1991-4#1)(1992-12#2)(1993-12#1)(1993-3#1)(1994-12#2)(1994-3#1)(1994-9#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-11#1)(2006-12#1)(2006-7#1)(2007-10#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-7#1)(2012-1#2)
precursor form of##2##3##(1993-11#1)(1996-5#1)
precursor form##7##2##(1990-12#1)(1990-3#1)(1991-9#1)(1993-11#1)(1996-2#1)(1996-5#1)(2008-4#1)
precursor from##3##2##(1991-8#1)(2008-7#1)(2008-8#1)
precursor gene##5##2##(1990-5#2)(1990-8#1)(1991-6#1)(1992-3#1)
precursor in the##7##3##(1991-9#1)(1992-8#1)(1995-1#2)(2004-11#1)(2006-4#1)(2008-6#1)
precursor in##14##2##(1990-12#1)(1991-2#1)(1991-9#2)(1992-8#1)(1992-9#1)(1994-9#1)(1995-1#2)(1996-2#1)(1996-6#1)(2004-11#1)(2006-4#1)(2008-6#1)
precursor ion survival yield as the##2##6##(2008-9#2)
precursor ion survival yield as##3##5##(2008-9#3)
precursor ion##7##2##(2008-10#1)(2008-9#3)(2009-10#2)(2010-4#1)
precursor is##12##2##(1991-2#1)(1991-3#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-10#1)(1994-2#2)(1995-11#1)(1996-5#1)(2008-4#1)
precursor lesion of colorectal cancer##2##5##(1997-8#1)(2010-12#1)
precursor lesion of##3##3##(1997-8#1)(2010-12#1)(2013-8#1)
precursor lesion##4##2##(1997-8#1)(2010-12#1)(2011-2#1)(2013-8#1)
precursor lesions##5##2##(1992-4#1)(2006-12#1)(2011-2#3)
precursor levels##3##2##(1990-5#2)(1994-6#1)
precursor mRNA in the##3##4##(1990-2#2)(1996-2#1)
precursor mRNA in##4##3##(1990-2#3)(1996-2#1)
precursor mRNA##11##2##(1990-2#3)(1991-7#1)(1992-7#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-8#1)(2009-2#2)
precursor mRNAs in##3##3##(1990-2#1)(1995-5#1)(1995-7#1)
precursor mRNAs##4##2##(1990-2#1)(1995-5#1)(1995-7#2)
precursor maltose-binding protein##2##3##(1993-12#2)
precursor molecule##5##2##(1991-9#1)(1992-12#1)(1994-8#1)(1995-2#1)(1997-2#1)
precursor molecules by##2##3##(1993-11#1)(2008-11#1)
precursor molecules##5##2##(1992-12#1)(1993-11#1)(1995-8#1)(2008-10#1)(2008-11#1)
precursor occurs##2##2##(1991-1#1)(1992-11#1)
precursor of 23-kDa polypeptide of##2##5##(1996-10#2)
precursor of 9-O-acetyl##2##3##(1994-10#2)
precursor of DNA##2##3##(1997-2#1)(2007-3#1)
precursor of a##3##3##(1991-9#1)(1992-12#1)(1995-12#1)
precursor of active##2##3##(1991-2#1)(1994-11#1)
precursor of dehydroalanine in the active site of##2##8##(1994-5#2)
precursor of human sperm protamines HP2 and HP3##2##8##(1990-7#2)
precursor of human##3##3##(1990-7#2)(1991-7#1)
precursor of the##19##3##(1990-11#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#1)(1994-11#1)(1994-5#1)(1994-8#1)(1996-10#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-3#1)
precursor of##108##2##(1990-1#1)(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#5)(1990-7#2)(1990-8#1)(1990-9#4)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#4)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#7)(1991-9#1)(1992-11#2)(1992-12#3)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#1)(1994-10#2)(1994-11#3)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-10#3)(1996-11#1)(1996-2#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-8#1)(2005-11#1)(2006-2#1)(2007-1#1)(2007-11#2)(2007-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#4)(2008-8#1)(2009-3#1)(2009-5#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-8#1)
precursor on##2##2##(1995-1#1)(2008-10#1)
precursor polypeptide##2##2##(1990-9#1)(1995-8#1)
precursor processing##5##2##(1993-6#1)(1994-8#3)(2008-11#1)
precursor produced##2##2##(1994-11#1)(2008-3#1)
precursor protein (APP) and##3##4##(1996-12#1)(1997-1#1)(1997-8#1)
precursor protein (APP) by##4##4##(1994-8#1)(1995-10#1)(2008-8#1)(2012-12#1)
precursor protein (APP) is##4##4##(1990-12#1)(1990-3#1)(1994-12#1)(1996-12#1)
precursor protein (APP)##33##3##(1990-12#1)(1990-3#1)(1991-5#1)(1991-9#1)(1992-12#2)(1992-3#1)(1993-11#2)(1993-8#1)(1994-12#1)(1994-2#2)(1994-8#1)(1994-9#2)(1995-10#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-12#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-8#1)(2012-12#2)
precursor protein (beta APP)##3##4##(1991-10#1)(1991-11#1)(1992-8#1)
precursor protein are##2##3##(1992-12#1)(2012-12#1)
precursor protein expression in##2##4##(1991-10#1)(2009-12#1)
precursor protein gene##8##3##(1991-10#3)(1992-1#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-8#1)
precursor protein in the cytoplasm##2##5##(1990-3#1)(1997-4#1)
precursor protein in the##4##4##(1990-3#1)(1993-11#1)(1994-2#1)(1997-4#1)
precursor protein in##10##3##(1990-3#2)(1991-1#1)(1993-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-3#1)(1997-4#1)(2008-11#1)
precursor protein is##3##3##(1990-9#1)(1995-2#1)(2008-5#1)
precursor protein mRNA##3##3##(1991-11#1)(1994-9#2)
precursor protein of##6##3##(1990-9#1)(1996-7#1)(1996-9#1)(1997-2#2)(2008-5#1)
precursor protein secretion in##2##4##(1993-8#1)(1995-12#1)
precursor protein secretion##3##3##(1993-8#1)(1994-8#1)(1995-12#1)
precursor protein##124##2##(1990-12#3)(1990-3#3)(1990-9#2)(1991-1#1)(1991-10#5)(1991-11#3)(1991-4#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-12#10)(1992-2#1)(1992-3#5)(1992-6#1)(1992-8#2)(1993-11#7)(1993-3#1)(1993-8#4)(1994-12#2)(1994-2#6)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#4)(1995-10#1)(1995-12#3)(1995-2#3)(1995-3#2)(1995-6#3)(1996-12#3)(1996-2#2)(1996-5#5)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2005-7#1)(2005-9#2)(2006-11#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-4#1)(2012-12#3)(2012-3#1)
precursor proteins are##2##3##(1994-5#1)(1997-1#1)
precursor proteins of the##2##4##(1992-6#1)(1996-5#1)
precursor proteins of##3##3##(1990-6#1)(1992-6#1)(1996-5#1)
precursor proteins##18##2##(1990-6#1)(1991-11#1)(1991-2#2)(1992-12#1)(1992-2#1)(1992-6#2)(1993-11#1)(1994-11#1)(1994-5#2)(1994-8#1)(1994-9#1)(1996-5#1)(1997-1#2)(2008-1#1)
precursor species of##2##3##(1992-10#1)(1992-4#1)
precursor that##3##2##(1993-12#1)(2007-8#1)(2008-4#1)
precursor to a##3##3##(1996-4#1)(2010-4#1)(2011-2#1)
precursor to mature##2##3##(1990-7#1)(1992-4#1)
precursor to product##2##3##(2008-11#1)(2009-10#1)
precursor to the##12##3##(1990-9#1)(1992-6#1)(1994-11#1)(1994-3#1)(1995-3#1)(1996-5#1)(1996-9#1)(2007-12#1)(2008-3#1)(2009-8#1)(2012-12#1)(2013-1#1)
precursor to##40##2##(1990-7#1)(1990-9#1)(1991-10#1)(1992-4#1)(1992-6#1)(1994-11#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-3#2)(1995-8#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-7#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-10#2)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
precursor used##2##2##(2005-11#1)(2007-9#1)
precursor was observed##2##3##(1994-8#1)(1995-2#1)
precursor was##8##2##(1990-12#2)(1990-2#1)(1991-9#1)(1994-12#1)(1994-8#1)(1995-2#1)(2008-5#1)
precursor were##3##2##(1992-12#1)(1994-8#1)(1996-6#1)
precursor which##4##2##(1991-3#1)(1991-9#1)(1992-11#1)(1992-5#1)
precursor with##4##2##(1991-12#1)(1992-6#1)(2008-7#1)(2010-4#1)
precursor##850##1##(1990-1#1)(1990-11#8)(1990-12#9)(1990-2#7)(1990-3#6)(1990-4#1)(1990-5#12)(1990-6#1)(1990-7#7)(1990-8#6)(1990-9#10)(1991-1#7)(1991-10#6)(1991-11#8)(1991-12#6)(1991-2#16)(1991-3#4)(1991-4#4)(1991-5#2)(1991-6#2)(1991-7#11)(1991-8#4)(1991-9#15)(1992-1#4)(1992-10#2)(1992-11#7)(1992-12#29)(1992-2#3)(1992-3#8)(1992-4#3)(1992-5#3)(1992-6#14)(1992-7#8)(1992-8#12)(1992-9#9)(1993-11#14)(1993-12#11)(1993-2#2)(1993-3#8)(1993-4#1)(1993-5#2)(1993-6#2)(1993-8#5)(1994-10#5)(1994-11#13)(1994-12#17)(1994-2#15)(1994-3#9)(1994-5#7)(1994-6#7)(1994-8#15)(1994-9#15)(1995-1#11)(1995-10#1)(1995-11#5)(1995-12#6)(1995-2#9)(1995-3#8)(1995-4#1)(1995-5#2)(1995-6#10)(1995-7#4)(1995-8#12)(1995-9#1)(1996-1#3)(1996-10#3)(1996-11#2)(1996-12#6)(1996-2#13)(1996-3#1)(1996-4#4)(1996-5#12)(1996-6#5)(1996-7#1)(1996-8#3)(1996-9#3)(1997-1#10)(1997-2#7)(1997-4#3)(1997-6#3)(1997-7#7)(1997-8#4)(2004-11#2)(2005-1#1)(2005-10#1)(2005-11#5)(2005-7#1)(2005-9#2)(2006-11#2)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-7#1)(2007-1#3)(2007-10#2)(2007-11#7)(2007-12#15)(2007-3#1)(2007-5#1)(2007-8#5)(2007-9#4)(2008-1#3)(2008-10#17)(2008-11#27)(2008-12#3)(2008-2#1)(2008-3#9)(2008-4#19)(2008-5#15)(2008-6#7)(2008-7#10)(2008-8#4)(2008-9#7)(2009-10#5)(2009-11#2)(2009-12#1)(2009-2#4)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#6)(2009-8#1)(2010-10#2)(2010-11#2)(2010-12#4)(2010-3#1)(2010-4#8)(2010-5#5)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#12)(2011-3#1)(2012-1#5)(2012-12#8)(2012-2#6)(2012-3#4)(2013-1#5)(2013-7#2)(2013-8#6)
precursor)##2##1##(1990-10#1)(1996-2#1)
precursor-derived peptides##2##2##(1994-8#2)
precursor-like##3##1##(1996-12#2)(1996-5#1)
precursor-product##2##1##(1991-5#1)(2008-4#1)
precursors and##22##2##(1990-5#1)(1991-11#2)(1994-11#1)(1996-2#1)(1996-4#1)(2004-9#1)(2006-12#1)(2007-3#1)(2008-10#2)(2008-4#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
precursors are##5##2##(1995-12#1)(1996-10#1)(2006-12#1)(2007-11#1)(2008-4#1)
precursors as well as##2##4##(1994-12#1)(2007-12#1)
precursors as##3##2##(1992-2#1)(1994-12#1)(2007-12#1)
precursors by##5##2##(1995-12#1)(2006-12#1)(2006-5#1)(2011-1#1)(2012-12#1)
precursors can##3##2##(1995-1#2)(2008-8#1)
precursors dibutylamine and sodium nitrite##3##5##(1991-10#3)
precursors for the##5##3##(1992-11#1)(2006-12#1)(2008-10#1)(2010-12#1)(2010-5#1)
precursors for##13##2##(1991-2#1)(1992-11#1)(1995-3#1)(2006-12#2)(2007-11#1)(2008-10#1)(2008-4#1)(2010-12#1)(2010-5#1)(2012-11#2)(2013-1#1)
precursors from##2##2##(2007-12#1)(2008-11#1)
precursors have##2##2##(1993-12#1)(2010-4#1)
precursors in a##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
precursors in the##4##3##(1994-11#1)(2008-12#1)(2010-12#1)(2013-1#1)
precursors in vitro##2##3##(2008-5#1)(2012-12#1)
precursors in##16##2##(1990-5#1)(1991-12#1)(1994-11#1)(1995-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
precursors into##3##2##(1991-6#1)(1994-9#1)(2007-12#1)
precursors may##2##2##(2008-12#1)(2012-12#1)
precursors of the##6##3##(1991-9#1)(1992-6#1)(1994-8#1)(1997-6#1)(2007-12#1)(2008-5#1)
precursors of tissue macrophages##2##4##(2012-12#2)
precursors of##49##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-9#1)(1992-12#2)(1992-5#2)(1992-6#1)(1993-12#2)(1993-6#1)(1994-11#2)(1994-8#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-6#1)(2006-10#1)(2006-12#2)(2007-1#1)(2007-11#2)(2007-12#3)(2007-9#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-8#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#1)
precursors present in##2##3##(2008-5#2)
precursors to the##2##3##(1995-11#1)(2007-3#1)
precursors to##16##2##(1992-5#1)(1992-6#1)(1993-12#1)(1993-4#1)(1995-11#1)(1996-4#1)(2007-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)
precursors used##2##2##(2009-3#1)(2010-4#1)
precursors was##3##2##(1990-5#1)(2007-1#1)(2012-12#1)
precursors were##6##2##(1994-3#1)(1994-9#1)(1995-1#1)(2005-7#1)(2008-5#1)(2008-7#1)
precursors which##2##2##(1991-2#1)(1994-12#1)
precursors with##8##2##(1991-9#1)(1992-9#1)(2006-12#1)(2007-10#1)(2007-12#1)(2008-4#1)(2010-4#1)(2010-7#1)
precursors##300##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#5)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#3)(1991-11#4)(1991-12#2)(1991-2#4)(1991-4#1)(1991-6#1)(1991-7#2)(1991-9#3)(1992-11#1)(1992-12#4)(1992-2#2)(1992-5#4)(1992-6#4)(1992-8#4)(1992-9#7)(1993-12#4)(1993-2#1)(1993-4#2)(1993-6#2)(1994-1#1)(1994-11#4)(1994-12#5)(1994-2#1)(1994-3#3)(1994-8#2)(1994-9#3)(1995-1#4)(1995-11#3)(1995-12#3)(1995-2#4)(1995-3#2)(1995-6#1)(1996-10#1)(1996-2#1)(1996-4#3)(1996-5#1)(1996-7#2)(1996-8#3)(1996-9#1)(1997-2#2)(1997-4#1)(1997-6#2)(1997-7#3)(2004-9#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#13)(2006-3#1)(2006-5#1)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#12)(2007-3#2)(2007-5#2)(2007-8#1)(2007-9#1)(2008-10#12)(2008-11#6)(2008-12#3)(2008-2#1)(2008-4#11)(2008-5#8)(2008-7#8)(2008-8#6)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#7)(2010-2#1)(2010-4#7)(2010-5#5)(2010-7#2)(2011-1#1)(2011-2#4)(2011-3#3)(2012-1#4)(2012-11#2)(2012-12#13)(2012-2#7)(2012-3#1)(2013-1#5)(2013-8#1)
precursors)##2##1##(2008-10#1)(2008-3#1)
precursory changes##2##2##(1996-4#2)
precursory seismicity##2##2##(1996-4#2)
precursory##7##1##(1996-4#7)
pred##2##1##(1993-2#2)
predate##5##1##(1994-2#1)(2007-12#1)(2012-12#2)(2012-3#1)
predated the##2##2##(1996-2#1)(2010-2#1)
predated##3##1##(1996-2#1)(2010-2#1)(2010-6#1)
predates the##2##2##(1997-4#1)(2009-6#1)
predates##3##1##(1997-1#1)(1997-4#1)(2009-6#1)
predation and##8##2##(1995-3#1)(2007-7#1)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#2)
predation as##2##2##(2007-7#1)(2008-9#1)
predation by##5##2##(2007-3#2)(2008-5#1)(2011-12#2)
predation increased##2##2##(2008-9#1)(2013-1#1)
predation is##3##2##(2007-3#1)(2008-9#2)
predation on##7##2##(1995-8#1)(2008-8#3)(2008-9#3)
predation pressure##2##2##(2007-12#1)(2008-9#1)
predation risk is##3##3##(2008-8#1)(2012-12#2)
predation risk##11##2##(1991-11#1)(2008-8#1)(2008-9#3)(2010-8#2)(2012-12#2)(2012-3#2)
predation##93##1##(1991-11#1)(1995-3#1)(1995-8#1)(2006-5#1)(2007-12#1)(2007-2#2)(2007-3#4)(2007-7#3)(2008-3#1)(2008-5#4)(2008-6#1)(2008-8#20)(2008-9#24)(2010-8#5)(2011-12#9)(2012-1#1)(2012-12#6)(2012-2#1)(2012-3#5)(2013-1#1)(2013-8#1)
predation)##3##1##(2008-3#1)(2008-9#1)(2012-3#1)
predator and##6##2##(2007-9#1)(2008-8#2)(2009-8#1)(2010-8#1)(2012-3#1)
predator cues##2##2##(2012-3#2)
predator density##2##2##(2012-3#2)
predator effectiveness##2##2##(2008-6#2)
predator feeding strategy##2##3##(2008-5#2)
predator in##4##2##(2008-8#1)(2008-9#1)(2010-8#2)
predator is##2##2##(2008-6#1)(2008-8#1)
predator odors##6##2##(2008-4#6)
predator of##2##2##(1995-8#1)(2008-8#1)
predator population##2##2##(2007-9#1)(2008-8#1)
predator species##6##2##(2005-7#1)(2007-9#1)(2008-8#1)(2008-9#2)(2011-12#1)
predator##92##1##(1994-8#1)(1995-8#1)(2005-7#1)(2007-3#5)(2007-9#5)(2008-12#1)(2008-4#8)(2008-5#4)(2008-6#7)(2008-8#21)(2008-9#12)(2009-10#1)(2009-8#1)(2010-8#7)(2011-12#6)(2012-12#1)(2012-2#1)(2012-3#8)(2013-1#1)
predator-induced##6##1##(2008-4#1)(2008-8#3)(2012-12#2)
predator-prey system##3##2##(2008-8#2)(2008-9#1)
predator-prey##11##1##(1997-6#1)(2007-9#1)(2008-10#1)(2008-8#5)(2008-9#3)
predators and parasitoids##2##3##(2009-8#1)(2013-8#1)
predators and prey##4##3##(2008-8#3)(2012-2#1)
predators and##13##2##(1997-7#1)(2005-7#1)(2008-4#2)(2008-8#5)(2009-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
predators but##4##2##(2008-8#1)(2008-9#1)(2010-8#1)(2011-12#1)
predators in the##2##3##(2007-3#1)(2008-6#1)
predators in##6##2##(2007-3#1)(2008-6#1)(2008-8#3)(2013-1#1)
predators may##2##2##(2008-6#1)(2008-8#1)
predators of##5##2##(2007-5#2)(2008-9#1)(2011-12#1)(2013-1#1)
predators such as##3##3##(2005-7#2)(2008-5#1)
predators through##2##2##(2004-2#1)(2008-9#1)
predators with##2##2##(2008-8#1)(2012-2#1)
predators##94##1##(1997-7#1)(2004-2#1)(2005-7#4)(2007-3#2)(2007-5#3)(2008-4#3)(2008-5#4)(2008-6#3)(2008-8#32)(2008-9#9)(2009-10#1)(2009-2#1)(2009-8#1)(2010-8#2)(2011-12#9)(2011-2#1)(2012-2#4)(2012-3#6)(2013-1#6)(2013-8#1)
predatory behaviour##2##2##(2012-2#2)
predatory mite##4##2##(2007-6#2)(2011-2#2)
predatory mites##4##2##(2007-6#4)
predatory##28##1##(2004-11#1)(2007-12#1)(2007-6#6)(2008-5#4)(2008-6#4)(2008-8#1)(2010-8#1)(2011-12#3)(2011-2#3)(2012-2#4)
predecessors##7##1##(2005-7#1)(2007-4#1)(2009-9#1)(2010-2#1)(2013-1#3)
predefined criteria##5##2##(2007-9#1)(2008-10#1)(2009-11#1)(2011-2#1)(2013-8#1)
predefined joint trajectories##2##3##(2012-1#2)
predefined##37##1##(1993-1#1)(1993-3#1)(1995-4#1)(1996-2#1)(1997-6#1)(2007-12#1)(2007-5#1)(2007-9#2)(2008-1#2)(2008-10#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2010-4#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#1)
predeposit##3##1##(1996-9#2)(2007-4#1)
predesigned##6##1##(2006-12#3)(2008-2#1)(2013-1#1)(2013-8#1)
predestined##3##1##(2006-10#1)(2008-1#1)(2008-8#1)
predetermined##33##1##(1993-12#2)(1993-5#1)(1994-3#1)(1996-3#1)(1996-7#1)(1997-1#1)(2007-11#2)(2008-10#3)(2008-11#3)(2008-3#4)(2008-4#1)(2009-1#1)(2009-5#1)(2009-7#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)
prediabetes##3##1##(2008-4#1)(2008-5#1)(2011-2#1)
prediabetic NOD##2##2##(2008-4#1)(2010-11#1)
prediabetic##8##1##(1991-2#1)(2007-5#4)(2008-4#1)(2010-10#1)(2010-11#1)
predialysis and##2##2##(2008-1#2)
predialysis patients##6##2##(2008-1#3)(2010-12#3)
predialysis systolic BP##3##3##(2007-8#3)
predialysis##21##1##(1994-5#1)(2007-12#1)(2007-8#5)(2008-1#5)(2008-12#2)(2008-4#1)(2008-7#3)(2010-12#3)
predicament##3##1##(1994-2#1)(2009-11#1)(2013-1#1)
predicaments##2##1##(1996-2#1)(2011-2#1)
predicate type##4##2##(2013-1#4)
predicate##7##1##(2008-11#1)(2013-1#6)
predicated on the##2##3##(2005-10#1)(2013-8#1)
predicated on##9##2##(1997-1#1)(2005-10#1)(2006-10#1)(2008-11#1)(2008-2#1)(2009-4#1)(2010-4#1)(2010-5#1)(2013-8#1)
predicated##13##1##(1997-1#1)(2005-10#1)(2005-4#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-4#1)(2010-4#1)(2010-5#1)(2013-8#1)
predicates##3##1##(2008-11#1)(2013-1#2)
predication##3##1##(2006-1#1)(2006-11#1)(2008-9#1)
predict a sharp##2##3##(2004-4#1)(2008-3#1)
predict a##25##2##(1990-8#3)(1993-8#1)(1994-10#1)(1994-9#1)(1997-7#1)(2004-4#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-4#1)(2010-2#2)(2011-2#1)(2012-2#1)(2013-8#2)
predict an##6##2##(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)
predict and decrease bleeding and blood and blood product requirements in adult patients undergoing cardiac##2##15##(2007-8#2)
predict and##13##2##(1996-1#1)(2007-8#2)(2008-3#1)(2008-7#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
predict average##2##2##(1997-1#1)(2007-12#1)
predict behavior##2##2##(2007-1#2)
predict better##2##2##(1994-9#1)(2006-7#1)
predict binding##3##2##(1992-9#1)(2006-12#1)(2010-7#1)
predict blood flow##2##3##(2008-7#1)(2009-4#1)
predict changes##3##2##(1996-1#1)(2008-2#1)(2008-8#1)
predict clinical##3##2##(2005-8#1)(2007-7#1)(2012-12#1)
predict creatinine clearance##2##3##(2006-10#2)
predict different##2##2##(2007-9#1)(2010-4#1)
predict disease severity##3##3##(2008-10#2)(2013-1#1)
predict disease##8##2##(2005-8#1)(2008-10#2)(2008-6#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
predict either##3##2##(1997-8#1)(2008-6#1)(2008-9#1)
predict for##3##2##(2008-6#1)(2010-5#2)
predict future##6##2##(1990-11#1)(1991-2#1)(2008-1#1)(2008-11#1)(2012-2#1)(2013-7#1)
predict growth##2##2##(2005-7#1)(2010-8#1)
predict hospitalization##2##2##(1991-12#1)(2007-8#1)
predict how##6##2##(2006-10#1)(2007-3#1)(2008-5#2)(2011-2#1)(2012-2#1)
predict in vivo##4##3##(1995-7#1)(2004-3#1)(2008-11#1)(2008-5#1)
predict in##6##2##(1995-7#1)(2004-3#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-8#1)
predict increased##2##2##(2008-4#1)(2009-10#1)
predict internal conversion rates roughly double those of the all-trans species##2##11##(2010-2#2)
predict its##2##2##(1996-2#1)(1997-2#1)
predict long-term##4##2##(1994-7#1)(1995-11#1)(2007-11#1)(2012-3#1)
predict mortality##4##2##(2006-10#1)(2008-3#1)(2009-4#1)(2013-1#1)
predict myocardial##2##2##(2008-6#1)(2010-9#1)
predict nodal malignancy##2##3##(2007-3#2)
predict outcome##5##2##(1994-7#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-10#1)
predict outcomes##3##2##(1996-2#1)(2005-11#1)(2007-10#1)
predict patients##3##2##(2006-10#1)(2013-1#2)
predict patterns##2##2##(2008-10#1)(2010-2#1)
predict postoperative##3##2##(2007-8#1)(2010-8#1)(2012-2#1)
predict protein##3##2##(2008-7#2)(2013-8#1)
predict readmission##2##2##(2011-2#2)
predict response to therapy##2##4##(2008-7#1)(2012-12#1)
predict response to##3##3##(2008-7#1)(2012-12#1)(2012-2#1)
predict response##6##2##(1992-3#1)(1995-10#1)(2004-2#1)(2008-7#1)(2012-12#1)(2012-2#1)
predict risk##4##2##(2009-12#1)(2010-7#1)(2012-1#1)(2013-1#1)
predict significant##2##2##(2011-1#1)(2011-2#1)
predict stem cell##2##3##(2008-11#2)
predict stroke recurrence##2##3##(2007-10#1)(2007-9#1)
predict such##2##2##(2008-1#1)(2008-7#1)
predict survival##5##2##(2006-7#3)(2010-3#1)(2012-3#1)
predict that a##4##3##(1996-1#1)(2007-9#1)(2008-2#1)(2009-5#1)
predict that it##2##3##(2008-10#1)(2008-5#1)
predict that the##13##3##(1991-5#1)(1992-11#1)(1994-8#1)(1995-3#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-5#1)(2010-10#1)(2010-4#1)(2010-5#1)(2013-8#1)
predict that##51##2##(1990-12#1)(1991-5#1)(1992-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-5#1)(1997-4#1)(2004-1#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#7)(2008-9#4)(2009-11#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
predict the adverse##2##3##(2007-4#1)(2008-3#1)
predict the binding##2##3##(1992-9#1)(2013-7#1)
predict the biological##2##3##(1993-6#1)(2007-11#1)
predict the effects of##3##4##(2007-12#1)(2008-2#1)(2010-9#1)
predict the efficacy of##3##4##(1996-12#1)(2008-4#1)(2008-5#1)
predict the enantiomeric composition##2##4##(2008-10#2)
predict the existence of a##2##5##(1997-9#1)(2007-12#1)
predict the existence of##6##4##(1997-9#1)(2007-11#1)(2007-12#2)(2008-3#1)(2008-8#1)
predict the failure##2##3##(2008-8#1)(2011-1#1)
predict the formation of##2##4##(2007-12#1)(2008-7#1)
predict the function of newly discovered proteins##2##7##(2009-5#1)(2011-2#1)
predict the function of newly##3##5##(2008-4#1)(2009-5#1)(2011-2#1)
predict the function of##5##4##(2008-4#1)(2008-7#1)(2009-5#1)(2010-2#1)(2011-2#1)
predict the future##3##3##(1993-2#1)(1997-1#1)(2007-11#1)
predict the level of##2##4##(2011-2#1)(2013-1#1)
predict the likelihood of##5##4##(2007-9#1)(2009-6#2)(2011-2#1)(2012-12#1)
predict the need for##2##4##(2007-8#1)(2009-10#1)
predict the number of##2##4##(2008-6#1)(2012-12#1)
predict the number##3##3##(2008-11#1)(2008-6#1)(2012-12#1)
predict the outcome of##6##4##(1990-8#1)(1994-2#1)(2005-11#1)(2007-7#1)(2008-7#1)(2012-3#1)
predict the outcome##7##3##(1990-8#1)(1994-2#1)(2005-11#1)(2007-7#1)(2008-7#1)(2012-1#1)(2012-3#1)
predict the outcomes of##2##4##(2006-3#1)(2007-8#1)
predict the potential##4##3##(1996-3#1)(1996-6#1)(2011-3#1)(2013-8#1)
predict the probability that##2##4##(2008-11#1)(2012-3#1)
predict the prognosis of##3##4##(2010-6#1)(2010-8#1)(2011-2#1)
predict the rate of##2##4##(2007-12#1)(2008-3#1)
predict the results of##2##4##(2008-2#1)(2008-7#1)
predict the risk of##4##4##(1995-6#1)(2006-9#1)(2011-2#1)(2013-1#1)
predict the risk##5##3##(1995-6#1)(2006-9#1)(2007-8#1)(2011-2#1)(2013-1#1)
predict the same##2##3##(2007-12#1)(2012-2#1)
predict the stability of##3##4##(1996-4#1)(2007-11#1)(2008-6#1)
predict the success##2##3##(2005-8#1)(2009-5#1)
predict the##277##2##(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-4#1)(1995-6#2)(1995-8#2)(1996-12#3)(1996-3#1)(1996-4#5)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#1)(1997-9#1)(2005-10#1)(2005-11#7)(2005-8#1)(2006-10#2)(2006-11#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-9#2)(2007-10#2)(2007-11#6)(2007-12#13)(2007-2#1)(2007-4#4)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#28)(2008-11#5)(2008-2#16)(2008-3#16)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#15)(2008-8#12)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#2)(2009-5#2)(2009-6#2)(2009-7#2)(2009-9#1)(2010-1#1)(2010-12#3)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#2)(2011-2#8)(2011-3#1)(2012-1#3)(2012-11#4)(2012-12#4)(2012-2#3)(2012-3#6)(2013-1#6)(2013-7#2)(2013-8#3)
predict their##8##2##(1991-11#1)(2005-10#1)(2007-11#1)(2008-11#1)(2009-9#1)(2011-12#1)(2012-3#1)(2013-1#1)
predict this##5##2##(1995-4#1)(2007-11#1)(2007-4#1)(2010-10#1)(2012-1#1)
predict when##2##2##(2008-9#1)(2011-2#1)
predict which##7##2##(1994-2#1)(2007-11#1)(2008-10#1)(2010-12#1)(2012-1#1)(2013-1#2)
predict who##3##2##(2007-10#1)(2008-3#1)(2008-7#1)
predict will##2##2##(1995-12#1)(2007-9#1)
predict with##2##2##(2008-7#1)(2010-3#1)
predict##882##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-7#1)(1990-8#4)(1990-9#2)(1991-11#1)(1991-12#4)(1991-2#3)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#3)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#2)(1992-9#3)(1993-11#1)(1993-2#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#4)(1994-3#2)(1994-4#1)(1994-5#1)(1994-7#2)(1994-8#1)(1994-9#2)(1995-1#3)(1995-10#2)(1995-11#2)(1995-12#5)(1995-2#1)(1995-3#3)(1995-4#2)(1995-5#2)(1995-6#6)(1995-7#1)(1995-8#5)(1995-9#1)(1996-1#4)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#2)(1996-4#7)(1996-5#2)(1996-6#1)(1996-8#4)(1997-1#5)(1997-2#8)(1997-3#3)(1997-4#4)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#3)(1997-9#1)(2004-1#1)(2004-10#1)(2004-12#3)(2004-2#2)(2004-3#1)(2004-4#1)(2005-10#4)(2005-11#9)(2005-7#2)(2005-8#4)(2005-9#1)(2006-10#14)(2006-11#5)(2006-12#4)(2006-2#2)(2006-3#1)(2006-5#1)(2006-6#2)(2006-7#5)(2006-8#1)(2006-9#3)(2007-1#4)(2007-10#11)(2007-11#19)(2007-12#35)(2007-2#1)(2007-3#3)(2007-4#10)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#12)(2007-9#8)(2008-1#7)(2008-10#67)(2008-11#16)(2008-12#6)(2008-2#30)(2008-3#33)(2008-4#8)(2008-5#15)(2008-6#8)(2008-7#33)(2008-8#41)(2008-9#14)(2009-10#3)(2009-11#3)(2009-12#4)(2009-3#4)(2009-4#8)(2009-5#6)(2009-6#5)(2009-7#4)(2009-8#2)(2009-9#3)(2010-1#3)(2010-10#4)(2010-12#12)(2010-2#12)(2010-3#5)(2010-4#14)(2010-5#10)(2010-6#1)(2010-7#6)(2010-8#11)(2010-9#4)(2011-1#8)(2011-12#3)(2011-2#27)(2011-3#1)(2012-1#7)(2012-11#5)(2012-12#13)(2012-2#19)(2012-3#15)(2013-1#30)(2013-7#6)(2013-8#14)
predictability of the##2##3##(2007-12#1)(2012-2#1)
predictability of##14##2##(1995-12#1)(1997-1#1)(2005-8#1)(2006-12#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#2)(2011-7#1)(2012-2#1)(2013-7#1)
predictability##30##1##(1992-12#1)(1994-3#2)(1995-12#1)(1995-3#1)(1997-1#1)(1997-8#1)(2005-8#1)(2006-12#3)(2006-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#2)(2011-2#2)(2011-7#1)(2012-2#2)(2013-1#1)(2013-7#2)
predictable and##11##2##(2005-10#1)(2008-11#2)(2008-3#1)(2008-8#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-3#1)(2012-12#1)(2013-1#1)
predictable anticoagulant effect##2##3##(2005-7#1)(2007-10#1)
predictable by##3##2##(2004-2#1)(2008-11#1)(2008-2#1)
predictable from the##2##3##(1991-2#1)(2009-2#1)
predictable from##5##2##(1991-2#1)(1995-3#1)(2007-12#1)(2008-9#1)(2009-2#1)
predictable or##2##2##(1994-3#1)(2008-3#1)
predictable success##2##2##(2007-12#1)(2012-12#1)
predictable##103##1##(1991-2#1)(1991-5#1)(1992-7#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-3#2)(1994-9#1)(1995-12#1)(1995-3#2)(1995-5#1)(1997-1#1)(1997-5#1)(2004-2#1)(2004-3#1)(2005-10#1)(2005-7#1)(2006-10#3)(2006-3#2)(2006-5#2)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#8)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-2#2)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#2)(2011-7#1)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#2)(2013-7#3)
predictably at##2##2##(1996-9#1)(2008-2#1)
predictably##10##1##(1994-3#1)(1996-9#1)(1997-1#1)(2006-8#1)(2007-12#2)(2008-2#1)(2010-4#1)(2010-9#1)(2012-12#1)
predicted M(r)##4##2##(1994-12#2)(1994-8#2)
predicted SWB##3##2##(2013-1#3)
predicted a significant##2##3##(2006-6#1)(2008-11#1)
predicted a##15##2##(1990-2#1)(1995-1#1)(1996-12#1)(1996-6#1)(1997-2#1)(2004-10#1)(2005-8#1)(2006-3#1)(2006-6#1)(2008-11#1)(2008-7#4)(2008-9#1)
predicted aa sequence##4##3##(1991-7#1)(1993-2#1)(1995-2#2)
predicted aa##5##2##(1991-7#1)(1991-9#1)(1993-2#1)(1995-2#2)
predicted amino acid (aa) sequence of##2##6##(1990-9#1)(1993-5#1)
predicted amino acid (aa) sequence##3##5##(1990-9#2)(1993-5#1)
predicted amino acid (aa) sequences##3##5##(1991-9#1)(1993-6#1)(1993-9#1)
predicted amino acid (aa)##6##4##(1990-9#2)(1991-9#1)(1993-5#1)(1993-6#1)(1993-9#1)
predicted amino acid sequence from RT-PCR amplified cDNA and its expression##2##11##(1993-11#1)(1993-9#1)
predicted amino acid sequence of the##6##6##(1991-7#1)(1991-9#1)(1993-7#1)(1993-8#1)(1994-6#1)(1996-7#1)
predicted amino acid sequence of##17##5##(1990-12#1)(1991-2#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-6#1)(1996-7#1)
predicted amino acid sequence##36##4##(1990-12#1)(1991-2#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-6#2)(1994-8#4)(1994-9#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-7#1)(1997-2#2)(1997-4#1)(2008-10#1)(2008-9#1)
predicted amino acid sequences of##6##5##(1990-3#1)(1991-7#1)(1991-9#1)(1996-7#1)(1997-2#1)(2008-7#1)
predicted amino acid sequences##7##4##(1990-3#1)(1991-7#1)(1991-9#1)(1996-7#1)(1997-2#1)(2008-10#1)(2008-7#1)
predicted amino acid##51##3##(1990-12#1)(1990-3#1)(1990-9#2)(1991-2#1)(1991-7#2)(1991-8#1)(1991-9#5)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-6#2)(1994-8#4)(1994-9#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-7#2)(1997-2#3)(1997-4#1)(2008-10#3)(2008-7#1)(2008-9#1)
predicted amino acids##2##3##(1993-12#1)(2008-10#1)
predicted amino##53##2##(1990-12#1)(1990-3#1)(1990-9#2)(1991-2#1)(1991-7#2)(1991-8#1)(1991-9#5)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-6#2)(1994-8#4)(1994-9#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-7#2)(1997-2#3)(1997-4#1)(2008-10#4)(2008-7#1)(2008-9#1)
predicted and experimental##3##3##(2008-10#3)
predicted and measured##2##3##(2007-4#1)(2008-3#1)
predicted and observed##7##3##(1990-2#1)(1992-2#1)(1993-9#1)(1996-5#1)(2008-10#1)(2008-3#1)(2009-7#1)
predicted and the measured##4##4##(2007-12#1)(2008-3#2)(2013-1#1)
predicted and the##7##3##(2007-12#1)(2008-10#1)(2008-3#2)(2010-6#1)(2013-1#1)(2013-8#1)
predicted and##28##2##(1990-2#1)(1990-5#1)(1992-2#1)(1993-9#1)(1996-5#1)(2007-12#2)(2007-4#1)(2008-10#7)(2008-3#6)(2008-8#1)(2009-5#2)(2009-7#1)(2010-6#1)(2013-1#1)(2013-8#1)
predicted anisotropy##2##2##(2009-12#2)
predicted as##8##2##(1990-12#1)(1990-7#1)(2008-10#2)(2008-8#1)(2010-2#1)(2013-1#1)(2013-8#1)
predicted at the##2##3##(2005-11#1)(2008-3#1)
predicted at##3##2##(2005-11#1)(2008-3#1)(2010-8#1)
predicted based on##3##3##(1993-6#1)(2008-10#1)(2013-1#1)
predicted better##3##2##(2006-7#1)(2013-7#2)
predicted body dissatisfaction##2##3##(2006-7#1)(2007-12#1)
predicted body##4##2##(2006-7#2)(2007-12#2)
predicted both##2##2##(2007-12#1)(2013-1#1)
predicted by a recently##2##4##(1997-7#1)(2008-2#1)
predicted by a simple##2##4##(1995-6#1)(2008-2#1)
predicted by a##10##3##(1990-7#1)(1991-5#1)(1995-11#1)(1995-6#1)(1997-7#1)(2008-10#1)(2008-2#3)(2013-8#1)
predicted by classical##3##3##(2005-11#1)(2007-12#1)(2008-7#1)
predicted by computer##2##3##(2007-12#2)
predicted by high##2##3##(2007-12#2)
predicted by homology modeling##2##4##(1994-5#1)(2012-2#1)
predicted by means of##3##4##(2006-10#2)(2006-4#1)
predicted by model##2##3##(2008-10#2)
predicted by models of##3##4##(2008-8#2)(2008-9#1)
predicted by the model##9##4##(2007-4#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2012-1#1)
predicted by the standard##2##4##(2006-4#1)(2008-8#1)
predicted by the##70##3##(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-4#1)(1993-3#1)(1993-5#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-11#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#3)(2008-2#6)(2008-3#10)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-3#1)
predicted by theoretical##2##3##(2006-12#1)(2008-8#1)
predicted by theory##9##3##(1995-2#1)(2006-12#1)(2007-12#6)(2008-9#1)
predicted by these##2##3##(1991-11#1)(2012-2#1)
predicted by this model##2##4##(1995-4#1)(2008-3#1)
predicted by this##4##3##(1995-4#1)(2008-2#1)(2008-3#2)
predicted by use of##2##4##(2007-12#1)(2008-3#1)
predicted by##188##2##(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-7#1)(1992-1#1)(1992-4#1)(1992-7#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-5#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-3#1)(2005-10#1)(2005-11#3)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#3)(2007-10#1)(2007-11#1)(2007-12#19)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#13)(2008-3#13)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#13)(2008-9#3)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-2#1)(2010-4#3)(2010-8#1)(2011-1#2)(2011-2#9)(2012-1#3)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#2)
predicted change in##4##3##(1992-3#1)(2005-11#1)(2007-12#2)
predicted children's##2##2##(2007-12#1)(2011-2#1)
predicted concentration##3##2##(2008-10#2)(2013-7#1)
predicted concentrations##3##2##(2008-10#2)(2008-3#1)
predicted coronary death (age-adjusted##2##4##(1997-8#2)
predicted coronary death##3##3##(1997-6#1)(1997-8#2)
predicted depression##2##2##(2008-12#1)(2010-4#1)
predicted difference##2##2##(1991-1#1)(2005-10#1)
predicted distribution##2##2##(1996-4#1)(2008-10#1)
predicted exercise##2##2##(2010-3#2)
predicted for a##4##3##(1991-7#1)(2007-11#1)(2007-12#1)(2008-7#1)
predicted for different##2##3##(2008-3#1)(2008-9#1)
predicted for the##7##3##(1990-5#1)(1993-11#1)(2007-12#2)(2008-10#2)(2012-5#1)
predicted for##35##2##(1990-12#1)(1990-4#1)(1990-5#2)(1991-2#1)(1991-4#1)(1991-7#1)(1992-2#1)(1993-11#1)(1993-2#1)(1994-5#1)(1995-1#1)(1995-5#1)(1997-4#1)(2005-8#1)(2007-11#3)(2007-12#3)(2007-5#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2012-5#1)(2013-1#2)
predicted from a##2##3##(1996-2#1)(2008-3#1)
predicted from its amino acid sequence##2##6##(1994-3#1)(2008-4#1)
predicted from its##5##3##(1990-12#1)(1990-2#1)(1994-3#1)(1994-9#1)(2008-4#1)
predicted from the amino acid sequence##3##6##(1990-6#1)(1993-12#2)
predicted from the cDNA sequence##2##5##(1991-2#1)(1992-8#1)
predicted from the cDNA##4##4##(1991-2#2)(1992-8#1)(1994-8#1)
predicted from the nucleotide sequence of the##2##7##(1991-5#1)(1991-9#1)
predicted from the##27##3##(1990-6#1)(1990-7#1)(1991-2#2)(1991-5#1)(1991-9#2)(1992-11#1)(1992-7#1)(1992-8#1)(1993-12#2)(1994-8#2)(1995-1#1)(1995-2#1)(1995-8#1)(1996-4#1)(1997-2#1)(2005-11#1)(2006-8#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)(2010-5#1)
predicted from their##3##3##(1993-12#1)(1993-6#1)(1994-11#1)
predicted from##59##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-2#3)(1991-5#1)(1991-9#2)(1992-11#1)(1992-7#1)(1992-8#1)(1993-12#3)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-8#1)(1996-2#2)(1996-4#1)(1996-8#1)(1997-2#2)(1997-8#1)(2005-11#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-1#1)
predicted generally##2##2##(2008-10#1)(2008-3#1)
predicted genes##4##2##(1997-6#1)(1997-8#1)(2008-10#1)(2012-11#1)
predicted goals##2##2##(2008-11#1)(2011-1#1)
predicted growth##2##2##(2011-1#1)(2011-2#1)
predicted higher##4##2##(2007-10#1)(2009-7#1)(2011-2#1)(2013-7#1)
predicted in an##2##3##(2006-10#1)(2007-12#1)
predicted in the##6##3##(1992-9#1)(1996-4#1)(1997-6#1)(2008-12#1)(2008-3#1)(2008-8#1)
predicted in##21##2##(1992-3#1)(1992-9#1)(1994-6#1)(1996-4#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-12#4)(2007-4#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-5#1)(2011-2#1)
predicted increase in##2##3##(1992-3#1)(2008-3#1)
predicted increase##3##2##(1991-2#1)(1992-3#1)(2008-3#1)
predicted increases in##3##3##(2005-7#1)(2006-9#1)(2012-2#1)
predicted initial levels##2##3##(2009-7#1)(2011-2#1)
predicted injury##3##2##(2006-11#2)(2012-12#1)
predicted lower levels of##4##4##(2009-2#1)(2009-7#2)(2011-2#1)
predicted lower##7##2##(2006-3#1)(2007-10#2)(2009-2#1)(2009-7#2)(2011-2#1)
predicted model##3##2##(1993-8#1)(1994-6#1)(2008-6#1)
predicted molecular mass of##12##4##(1990-12#1)(1994-12#1)(1994-2#1)(1996-10#1)(1997-1#3)(1997-3#1)(1997-6#1)(2006-8#1)(2008-10#2)
predicted molecular mass##14##3##(1990-12#1)(1992-3#1)(1994-12#2)(1994-2#1)(1996-10#1)(1997-1#3)(1997-3#1)(1997-6#1)(2006-8#1)(2008-10#2)
predicted molecular weights of##2##4##(1995-3#1)(2008-8#1)
predicted molecular##19##2##(1990-12#1)(1992-12#1)(1992-3#1)(1994-12#2)(1994-2#1)(1995-3#1)(1996-10#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-6#1)(2006-8#1)(2008-10#3)(2008-8#1)
predicted more##3##2##(2007-12#3)
predicted mortality##3##2##(2006-10#2)(2007-8#1)
predicted most##3##2##(2008-10#1)(2008-3#1)(2009-9#1)
predicted number of##3##3##(2006-10#1)(2008-8#1)(2010-5#1)
predicted on the basis of##6##5##(1992-12#1)(1993-2#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-7#1)
predicted on the##7##3##(1992-12#1)(1993-2#1)(1994-2#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-7#1)
predicted only##3##2##(2008-10#2)(2012-3#1)
predicted open reading frames (ORFs)##2##5##(2008-10#1)(2012-2#1)
predicted open reading frames##3##4##(1994-11#1)(2008-10#1)(2012-2#1)
predicted open reading##4##3##(1994-11#2)(2008-10#1)(2012-2#1)
predicted optical##2##2##(2008-2#1)(2008-3#1)
predicted optimal##2##2##(2008-7#1)(2013-1#1)
predicted or##2##2##(1991-12#1)(1994-9#1)
predicted outcome##5##2##(1991-2#1)(2007-12#1)(2007-8#2)(2008-7#1)
predicted pattern of##2##3##(1995-8#1)(2008-9#1)
predicted peptide sequence##3##3##(1991-2#1)(1994-5#1)(1995-10#1)
predicted polypeptide##4##2##(1990-5#1)(1995-6#1)(1996-10#1)(2008-10#1)
predicted postoperative forced expiratory##3##4##(2007-8#3)
predicted postoperative##4##2##(2007-8#4)
predicted primary structure##3##3##(1990-9#1)(1992-3#1)(1994-11#1)
predicted primary##5##2##(1990-9#1)(1992-3#1)(1994-11#1)(1994-9#1)(2012-1#1)
predicted probabilities of being a twin##2##6##(1993-9#2)
predicted probability of##2##3##(2007-8#1)(2011-2#1)
predicted product##4##2##(1997-2#1)(1997-7#1)(2008-10#1)(2008-9#1)
predicted products of##2##3##(1991-5#1)(1995-2#1)
predicted products##3##2##(1991-5#1)(1994-12#1)(1995-2#1)
predicted protein of##7##3##(1992-11#1)(1993-2#1)(1995-3#1)(1996-11#1)(1996-6#1)(1997-4#1)(2005-11#1)
predicted protein sequence##4##3##(1990-6#1)(1991-4#1)(1992-5#1)(1996-12#1)
predicted protein##27##2##(1990-6#1)(1991-4#1)(1992-11#1)(1992-5#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-3#1)(1995-4#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-4#5)(1997-6#1)(1997-7#1)(2005-11#1)(2008-10#1)(2008-7#1)
predicted proteins##3##2##(1991-4#1)(1992-12#1)(2009-8#1)
predicted rates##2##2##(2008-7#2)
predicted response##4##2##(2008-10#1)(2008-7#1)(2012-2#2)
predicted results##3##2##(2008-10#2)(2008-8#1)
predicted risk of##2##3##(2007-8#1)(2010-12#1)
predicted risk##3##2##(2006-11#1)(2007-8#1)(2010-12#1)
predicted sales of##7##3##(2005-8#7)
predicted secondary structure##8##3##(1990-4#1)(1992-1#1)(1994-8#1)(1996-8#1)(1996-9#1)(2008-7#1)(2010-7#2)
predicted secondary##11##2##(1990-4#1)(1992-1#1)(1993-3#1)(1994-8#1)(1996-8#1)(1996-9#1)(2007-11#1)(2008-7#1)(2010-7#2)(2012-1#1)
predicted sequence of##3##3##(1990-11#1)(1990-4#1)(1994-12#1)
predicted sequence##6##2##(1990-11#1)(1990-4#2)(1991-11#1)(1993-12#1)(1994-12#1)
predicted sites##2##2##(2006-12#1)(2007-11#1)
predicted size##2##2##(1991-8#1)(2008-10#1)
predicted slopes of##3##3##(2008-8#3)
predicted smoking status at age##2##5##(2010-3#2)
predicted smoking##5##2##(2007-12#1)(2010-3#4)
predicted snail##3##2##(2008-8#3)
predicted solely from##3##3##(1991-8#1)(1994-8#1)(2011-2#1)
predicted spectral##2##2##(2007-12#1)(2012-11#1)
predicted structural##2##2##(1991-4#1)(1995-1#1)
predicted structure##3##2##(1991-12#1)(2011-1#1)(2012-2#1)
predicted subsequent##2##2##(2008-8#1)(2009-9#1)
predicted survival##2##2##(1993-1#1)(1996-2#1)
predicted that a##5##3##(1993-4#1)(1995-12#1)(2008-7#1)(2008-9#1)(2010-7#1)
predicted that the##17##3##(1994-12#1)(1994-9#1)(1995-12#1)(2005-10#1)(2005-9#1)(2006-3#1)(2007-1#1)(2007-12#1)(2007-2#1)(2008-5#1)(2008-7#2)(2008-8#2)(2010-7#1)(2011-1#1)(2011-12#1)
predicted that##49##2##(1990-11#1)(1990-2#1)(1990-3#1)(1991-8#1)(1992-6#1)(1993-4#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-12#2)(1995-3#1)(1996-2#1)(1996-5#1)(1996-8#1)(2005-10#1)(2005-6#1)(2005-8#2)(2005-9#1)(2006-3#1)(2006-6#1)(2007-1#2)(2007-12#1)(2007-2#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-1#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-2#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-12#1)
predicted the presence of##3##4##(1991-9#1)(1992-3#1)(2005-12#1)
predicted the presence##4##3##(1991-9#1)(1992-3#1)(2005-12#1)(2008-10#1)
predicted the severity of##2##4##(1996-5#1)(2011-2#1)
predicted the##36##2##(1991-5#1)(1991-9#1)(1992-1#1)(1992-3#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-5#1)(1997-1#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-11#1)(2006-12#1)(2007-12#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-7#1)(2008-8#2)(2009-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
predicted their##3##2##(2009-9#1)(2010-2#1)(2012-12#1)
predicted theoretical##2##2##(2005-11#1)(2007-12#1)
predicted theoretically##12##2##(1994-12#1)(2007-12#4)(2008-2#4)(2008-3#1)(2008-8#1)(2009-10#1)
predicted those##2##2##(1995-3#1)(2007-8#1)
predicted time##2##2##(2008-3#1)(2013-1#1)
predicted titration##2##2##(2008-4#2)
predicted to be a##5##4##(1991-4#1)(1992-1#1)(1994-11#1)(1996-4#1)(2008-8#1)
predicted to be in the##2##5##(1993-11#1)(2010-5#1)
predicted to be in##3##4##(1993-11#1)(1995-6#1)(2010-5#1)
predicted to be##44##3##(1990-11#1)(1990-12#1)(1991-2#1)(1991-4#1)(1992-1#1)(1992-11#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-9#1)(1995-6#2)(1995-8#1)(1996-4#1)(1997-1#2)(1997-4#1)(1997-5#1)(2005-8#2)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#3)(2008-5#3)(2008-8#3)(2008-9#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-2#1)
predicted to bind to##2##4##(1994-5#1)(2007-12#1)
predicted to bind##4##3##(1992-11#1)(1994-5#1)(2007-12#2)
predicted to encode a protein of##3##6##(1990-8#1)(1995-8#1)(1996-6#1)
predicted to encode a##10##4##(1990-8#1)(1995-8#1)(1996-3#1)(1996-6#1)(1997-4#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)
predicted to encode##14##3##(1990-8#1)(1994-9#1)(1995-8#1)(1996-3#1)(1996-6#1)(1997-4#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-2#1)
predicted to form a##2##4##(1991-12#1)(1994-12#1)
predicted to form##3##3##(1991-12#1)(1994-12#1)(2008-8#1)
predicted to have a##3##4##(2008-9#1)(2010-12#1)(2010-5#1)
predicted to have##5##3##(2006-7#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-5#1)
predicted to increase##4##3##(1995-12#1)(1995-3#1)(2008-7#1)(2008-9#1)
predicted to lead to##2##4##(1991-11#1)(1994-3#1)
predicted to occur##4##3##(1992-12#1)(2006-5#1)(2007-4#1)(2013-8#1)
predicted to produce##2##3##(2008-9#1)(2011-2#1)
predicted to##115##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-4#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#2)(1993-11#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-9#2)(1995-12#2)(1995-3#4)(1995-6#2)(1995-8#2)(1996-3#1)(1996-4#1)(1996-6#1)(1997-1#2)(1997-4#3)(1997-5#1)(2005-10#1)(2005-7#1)(2005-8#3)(2006-12#3)(2006-5#1)(2006-7#1)(2007-11#2)(2007-12#3)(2007-4#1)(2008-10#7)(2008-11#1)(2008-2#4)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#5)(2009-12#1)(2009-5#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
predicted translation product##2##3##(1991-5#1)(1997-8#1)
predicted transmembrane segment##2##3##(1994-11#2)
predicted transmembrane##7##2##(1992-12#1)(1994-11#2)(1994-3#1)(1995-2#1)(1996-3#1)(2012-12#1)
predicted under##2##2##(2007-12#1)(2010-3#1)
predicted using a##5##3##(2006-11#1)(2007-12#1)(2008-10#2)(2009-9#1)
predicted using an##2##3##(2008-10#2)
predicted using the##3##3##(2005-11#1)(2008-7#1)(2009-12#1)
predicted using##19##2##(2005-11#1)(2006-11#1)(2007-12#1)(2007-4#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
predicted value for##2##3##(2008-3#1)(2009-12#1)
predicted value##3##2##(2008-3#1)(2009-12#1)(2010-12#1)
predicted values of##2##3##(2007-11#1)(2010-9#1)
predicted values were##2##3##(2008-10#1)(2009-4#1)
predicted values##10##2##(1992-3#1)(2004-12#1)(2007-11#1)(2008-10#4)(2009-4#1)(2010-9#1)(2013-8#1)
predicted versus##2##2##(1994-3#2)
predicted with a high##2##4##(2006-12#1)(2008-10#1)
predicted with a##4##3##(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
predicted with##11##2##(1994-8#1)(2006-10#2)(2006-12#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2011-1#1)
predicted worse##2##2##(2007-7#1)(2013-7#1)
predicted##1326##1##(1990-1#2)(1990-11#3)(1990-12#7)(1990-2#4)(1990-3#2)(1990-4#8)(1990-5#11)(1990-6#2)(1990-7#4)(1990-8#1)(1990-9#3)(1991-1#2)(1991-10#2)(1991-11#4)(1991-12#4)(1991-2#12)(1991-3#1)(1991-4#5)(1991-5#8)(1991-6#1)(1991-7#7)(1991-8#5)(1991-9#12)(1992-1#6)(1992-11#7)(1992-12#7)(1992-2#4)(1992-3#11)(1992-4#5)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#2)(1992-9#3)(1993-1#3)(1993-11#3)(1993-12#12)(1993-2#4)(1993-3#4)(1993-4#2)(1993-5#3)(1993-6#4)(1993-7#1)(1993-8#3)(1993-9#8)(1994-11#10)(1994-12#12)(1994-2#2)(1994-3#8)(1994-5#5)(1994-6#4)(1994-8#11)(1994-9#9)(1995-1#7)(1995-10#3)(1995-11#3)(1995-12#7)(1995-2#6)(1995-3#13)(1995-4#2)(1995-5#3)(1995-6#8)(1995-8#11)(1996-1#3)(1996-10#6)(1996-11#2)(1996-12#5)(1996-2#5)(1996-3#2)(1996-4#6)(1996-5#6)(1996-6#5)(1996-7#7)(1996-8#9)(1996-9#1)(1997-1#8)(1997-2#11)(1997-3#2)(1997-4#13)(1997-5#4)(1997-6#9)(1997-7#6)(1997-8#9)(2004-10#1)(2004-12#1)(2004-3#1)(2005-10#6)(2005-11#11)(2005-12#1)(2005-6#1)(2005-7#4)(2005-8#20)(2005-9#3)(2006-10#10)(2006-11#14)(2006-12#11)(2006-2#1)(2006-3#5)(2006-4#3)(2006-5#5)(2006-6#3)(2006-7#6)(2006-8#3)(2006-9#3)(2007-1#2)(2007-10#6)(2007-11#19)(2007-12#74)(2007-2#2)(2007-3#2)(2007-4#6)(2007-5#1)(2007-7#2)(2007-8#19)(2007-9#4)(2008-1#4)(2008-10#111)(2008-11#13)(2008-12#11)(2008-2#33)(2008-3#49)(2008-4#9)(2008-5#13)(2008-6#6)(2008-7#34)(2008-8#53)(2008-9#24)(2009-1#1)(2009-10#4)(2009-12#8)(2009-2#2)(2009-3#1)(2009-4#4)(2009-5#10)(2009-6#3)(2009-7#12)(2009-8#10)(2009-9#12)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#6)(2010-2#5)(2010-3#9)(2010-4#10)(2010-5#5)(2010-6#1)(2010-7#5)(2010-8#8)(2010-9#1)(2011-1#15)(2011-12#1)(2011-2#31)(2011-3#2)(2012-1#12)(2012-11#3)(2012-12#7)(2012-2#17)(2012-3#8)(2012-5#1)(2012-7#1)(2013-1#23)(2013-7#5)(2013-8#15)
predicted)##6##1##(2006-9#1)(2007-2#1)(2007-8#2)(2008-3#1)(2008-8#1)
predicting HIV##2##2##(2010-8#1)(2012-2#1)
predicting RNA##4##2##(1992-3#1)(2008-4#2)(2011-3#1)
predicting a##7##2##(1994-11#1)(1994-9#1)(1997-6#1)(2007-9#1)(2008-6#1)(2009-5#1)(2012-11#1)
predicting an##3##2##(2005-8#1)(2008-10#1)(2012-3#1)
predicting and##3##2##(2007-12#1)(2008-12#1)(2010-1#1)
predicting clinical##3##2##(2004-12#1)(2006-11#1)(2009-3#1)
predicting consequences##2##2##(2007-10#1)(2008-11#1)
predicting death##2##2##(2009-10#1)(2011-2#1)
predicting future##5##2##(1992-3#1)(1996-6#1)(2007-7#1)(2008-8#1)(2011-12#1)
predicting hospital mortality##5##3##(2013-1#4)(2013-8#1)
predicting hospital##7##2##(2013-1#6)(2013-8#1)
predicting how##3##2##(2008-8#1)(2009-2#1)(2012-1#1)
predicting intrinsic##2##2##(2006-12#1)(2009-7#1)
predicting mortality in##2##3##(2007-8#1)(2011-2#1)
predicting mortality##3##2##(2007-8#1)(2011-2#1)(2013-8#1)
predicting new##2##2##(2007-12#1)(2008-2#1)
predicting outcome##6##2##(1994-10#1)(2004-4#1)(2006-10#2)(2006-9#1)(2007-10#1)
predicting outcomes##4##2##(2008-9#1)(2010-8#1)(2013-1#2)
predicting poor##2##2##(1996-9#1)(2013-1#1)
predicting potential##2##2##(2007-7#1)(2008-8#1)
predicting prognosis in##2##3##(2011-12#1)(2013-1#1)
predicting prognosis##4##2##(2007-2#1)(2011-12#2)(2013-1#1)
predicting protein##2##2##(2008-7#1)(2013-1#1)
predicting response to##3##3##(2008-8#1)(2009-2#1)(2009-8#1)
predicting secondary##2##2##(2008-4#1)(2009-11#1)
predicting significant##2##2##(2011-1#1)(2011-2#1)
predicting substitution of##2##3##(1991-12#1)(1995-1#1)
predicting survival##3##2##(1994-12#1)(2008-1#1)(2013-1#1)
predicting the behavior of##3##4##(2007-1#1)(2008-3#1)(2013-1#1)
predicting the likelihood of##2##4##(2008-5#1)(2011-2#1)
predicting the likely##2##3##(1996-1#1)(2007-2#1)
predicting the onset of##2##4##(2010-8#1)(2013-8#1)
predicting the outcome of##3##4##(2007-7#1)(2008-1#1)(2012-3#1)
predicting the outcome##4##3##(2007-7#1)(2008-1#1)(2008-9#1)(2012-3#1)
predicting the overall##2##3##(2005-11#1)(2009-8#1)
predicting the performance of##2##4##(2005-10#1)(2011-2#1)
predicting the potential##2##3##(2008-10#1)(2010-7#1)
predicting the prognosis of##2##4##(2008-12#1)(2008-4#1)
predicting the prognosis##4##3##(2008-12#1)(2008-4#1)(2011-3#1)(2013-1#1)
predicting the results of##2##4##(2007-12#1)(2008-4#1)
predicting the risk of##5##4##(1994-3#1)(1996-4#1)(2008-5#1)(2011-2#1)(2012-12#1)
predicting the severity of##3##4##(2006-10#1)(2011-2#1)(2013-1#1)
predicting the structure of simple transmembrane##2##6##(2008-4#2)
predicting the##108##2##(1990-9#1)(1991-4#1)(1993-2#1)(1993-6#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-4#1)(1997-4#1)(1997-7#1)(2004-4#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-11#1)(2006-3#1)(2006-5#2)(2007-1#2)(2007-11#2)(2007-12#5)(2007-2#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#7)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-2#6)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#5)(2013-8#2)
predicting these##2##2##(2008-11#1)(2008-2#1)
predicting treatment##3##2##(2008-6#1)(2010-12#1)(2013-1#1)
predicting which patients##3##3##(2006-10#1)(2013-1#2)
predicting which##5##2##(2006-10#1)(2006-2#1)(2007-9#1)(2013-1#2)
predicting who will##2##3##(2007-4#1)(2008-4#1)
predicting##391##1##(1990-4#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-2#3)(1992-3#3)(1992-9#1)(1993-2#1)(1993-4#1)(1993-6#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#3)(1994-9#3)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#3)(1995-8#3)(1996-1#1)(1996-12#1)(1996-4#2)(1996-6#1)(1996-9#1)(1997-1#4)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-10#1)(2004-12#1)(2004-2#2)(2004-4#2)(2005-10#3)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#2)(2006-10#8)(2006-11#2)(2006-12#1)(2006-2#3)(2006-3#1)(2006-5#4)(2006-7#2)(2006-9#3)(2007-1#3)(2007-10#6)(2007-11#3)(2007-12#10)(2007-2#2)(2007-3#4)(2007-4#4)(2007-6#1)(2007-7#4)(2007-8#9)(2007-9#5)(2008-1#3)(2008-10#38)(2008-11#8)(2008-12#8)(2008-2#7)(2008-3#10)(2008-4#13)(2008-5#5)(2008-6#6)(2008-7#6)(2008-8#8)(2008-9#5)(2009-10#3)(2009-11#5)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#3)(2010-10#2)(2010-12#4)(2010-2#2)(2010-3#5)(2010-4#1)(2010-7#5)(2010-8#8)(2010-9#1)(2011-1#4)(2011-12#5)(2011-2#14)(2011-3#2)(2012-1#2)(2012-11#1)(2012-12#9)(2012-2#3)(2012-3#3)(2013-1#25)(2013-7#2)(2013-8#6)
prediction (RMSEP) of the##2##4##(2008-10#1)(2010-4#1)
prediction (RMSEP)##4##2##(2008-10#3)(2010-4#1)
prediction (SEP)##2##2##(2008-10#1)(2008-7#1)
prediction ability and its##2##4##(2008-10#1)(2013-8#1)
prediction ability and##3##3##(2008-10#2)(2013-8#1)
prediction ability##12##2##(2008-10#10)(2010-4#1)(2013-8#1)
prediction accuracy and##2##3##(2012-3#2)
prediction accuracy##17##2##(2006-10#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2010-2#1)(2010-7#1)(2011-1#2)(2012-12#1)(2012-3#2)(2013-1#2)
prediction algorithm is##2##3##(2011-1#1)(2012-3#1)
prediction algorithm##3##2##(2011-1#1)(2012-2#1)(2012-3#1)
prediction algorithms##3##2##(2008-2#1)(2009-3#1)(2010-7#1)
prediction and analysis##2##3##(2008-4#1)(2008-7#1)
prediction and experimental##2##3##(1993-6#1)(2008-7#1)
prediction and prediction##2##3##(1994-12#1)(2008-4#1)
prediction and principal component analysis##2##5##(2010-8#2)
prediction and real samples data##2##5##(2008-10#2)
prediction and the##3##3##(2009-7#1)(2010-5#1)(2013-8#1)
prediction and##32##2##(1992-7#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#4)(2008-6#1)(2008-7#4)(2008-8#1)(2009-7#1)(2010-5#1)(2010-8#2)(2012-1#1)(2012-11#1)(2012-3#1)(2013-8#2)
prediction are##7##2##(2008-10#1)(2008-11#2)(2013-1#4)
prediction as##4##2##(1996-4#1)(2012-3#1)(2013-1#2)
prediction based##2##2##(2004-4#1)(2011-1#1)
prediction by the##3##3##(1990-8#1)(2005-11#1)(2008-11#1)
prediction by##10##2##(1990-8#1)(1994-9#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-8#3)(2009-2#1)(2010-12#1)
prediction equation and##2##3##(2009-7#2)
prediction equation##6##2##(2009-7#3)(2012-1#1)(2012-2#2)
prediction equations##3##2##(2007-9#1)(2010-8#1)(2012-2#1)
prediction error of the##2##4##(2008-10#1)(2008-3#1)
prediction error of##3##3##(2008-10#2)(2008-3#1)
prediction error rate##2##3##(2008-10#1)(2012-3#1)
prediction error##17##2##(2008-10#7)(2008-11#3)(2008-3#2)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
prediction errors and##2##3##(2008-10#1)(2010-4#1)
prediction errors of the##2##4##(2008-10#2)
prediction errors of##3##3##(2008-10#2)(2008-3#1)
prediction errors##10##2##(2006-7#1)(2008-10#5)(2008-2#1)(2008-3#1)(2010-4#1)(2011-1#1)
prediction for the##2##3##(2005-11#1)(2007-12#1)
prediction for##15##2##(1990-4#1)(1995-8#1)(2005-11#1)(2007-12#3)(2008-1#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#1)(2012-2#1)
prediction from##3##2##(1991-6#1)(2008-10#1)(2013-8#1)
prediction has been##2##3##(2008-2#1)(2008-3#1)
prediction has##4##2##(1990-10#1)(1994-10#1)(2008-2#1)(2008-3#1)
prediction have been developed##2##4##(2008-4#1)(2012-3#1)
prediction in##9##2##(1991-12#1)(1996-4#1)(2008-11#1)(2010-10#1)(2010-12#3)(2012-3#1)(2013-1#1)
prediction is the##2##3##(2008-11#1)(2008-7#1)
prediction is to##2##3##(1996-4#1)(2008-4#1)
prediction is##19##2##(1990-12#1)(1996-4#2)(2007-12#2)(2007-9#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-4#2)(2008-7#3)(2008-9#1)(2012-2#1)(2012-3#1)
prediction method##7##2##(2006-10#1)(2008-5#1)(2008-6#1)(2010-6#1)(2011-1#2)(2012-3#1)
prediction methods##10##2##(1994-10#2)(1996-4#2)(2008-10#1)(2008-4#2)(2012-3#3)
prediction model for##3##3##(2008-10#2)(2012-2#1)
prediction model of retention values of anions with sodium carbonate-sodium bicarbonate as##2##12##(2005-12#2)
prediction model##15##2##(2005-12#3)(2007-11#1)(2007-5#1)(2008-10#4)(2008-11#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#2)
prediction models were##2##3##(2008-10#2)
prediction models##12##2##(1992-2#2)(2008-10#3)(2008-8#1)(2010-5#1)(2012-12#3)(2012-3#2)
prediction obtained##2##2##(2008-10#1)(2010-8#1)
prediction of a##6##3##(1996-4#1)(1997-6#1)(2007-11#1)(2008-2#1)(2008-7#1)(2009-8#1)
prediction of adverse##2##3##(1993-2#1)(2009-12#1)
prediction of all-cause mortality##2##4##(2008-7#2)
prediction of an##2##3##(2008-10#1)(2008-8#1)
prediction of cardiovascular##2##3##(2005-10#1)(2011-1#1)
prediction of clinical outcomes##3##4##(2008-5#2)(2009-6#1)
prediction of disease##5##3##(2007-7#1)(2008-10#1)(2009-4#1)(2009-8#1)(2013-1#1)
prediction of drug##3##3##(2008-10#1)(2008-6#1)(2012-2#1)
prediction of future##3##3##(1995-4#1)(2007-6#1)(2010-5#1)
prediction of gene##2##3##(1997-8#1)(2012-2#1)
prediction of gray leaf spot of##2##6##(2008-10#2)
prediction of human drug##2##4##(2008-8#2)
prediction of human##4##3##(2008-8#4)
prediction of light##2##3##(2008-3#2)
prediction of long term##2##4##(2013-1#2)
prediction of long-term##2##3##(1992-12#1)(2008-9#1)
prediction of moisture##2##3##(2008-10#2)
prediction of outcome##5##3##(1990-9#1)(2006-10#2)(2009-4#1)(2013-1#1)
prediction of outcomes##3##3##(2006-3#1)(2009-2#1)(2010-12#1)
prediction of polymers##2##3##(2008-9#2)
prediction of postoperative##2##3##(1997-1#1)(2007-8#1)
prediction of pregnancy-induced hypertension##2##4##(1994-3#1)(2012-2#1)
prediction of protein##4##3##(2008-4#1)(2008-7#1)(2010-7#1)(2012-3#1)
prediction of response##2##3##(2008-12#1)(2013-1#1)
prediction of risk##4##3##(1990-5#1)(1993-11#1)(2007-8#1)(2010-8#1)
prediction of survival##2##3##(2009-10#1)(2009-5#1)
prediction of the concentration##2##4##(2006-7#1)(2010-4#1)
prediction of the retention##2##4##(2008-10#2)
prediction of the##46##3##(1990-5#1)(1993-2#1)(1996-6#1)(1997-3#1)(1997-6#2)(2005-11#1)(2006-11#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-6#2)(2010-4#3)(2010-8#2)(2012-3#1)(2013-8#1)
prediction of their##4##3##(2008-10#1)(2008-6#1)(2012-3#2)
prediction of therapeutic##2##3##(1995-11#1)(1996-7#1)
prediction of transmembrane proteins##2##4##(2012-2#2)
prediction of tumor##2##3##(2008-12#1)(2008-5#1)
prediction of##278##2##(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-9#1)(1991-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#3)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-4#2)(1995-5#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#4)(1997-8#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#7)(2006-11#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#6)(2007-12#7)(2007-4#1)(2007-6#3)(2007-7#1)(2007-8#8)(2007-9#1)(2008-10#35)(2008-11#5)(2008-12#2)(2008-2#5)(2008-3#9)(2008-4#8)(2008-5#11)(2008-6#2)(2008-7#9)(2008-8#8)(2008-9#7)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#7)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#3)(2010-5#3)(2010-7#3)(2010-8#3)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#10)(2012-3#4)(2012-7#1)(2013-1#7)(2013-8#2)
prediction on##3##2##(2008-10#1)(2008-2#1)(2012-2#1)
prediction performance of the##2##4##(2008-10#1)(2013-1#1)
prediction performance##5##2##(2008-10#3)(2008-4#1)(2013-1#1)
prediction power##2##2##(2008-10#1)(2012-3#1)
prediction problem##4##2##(1993-6#1)(2008-4#1)(2010-7#1)(2012-3#1)
prediction programs##2##2##(2008-8#1)(2008-9#1)
prediction rate of##2##3##(1997-6#1)(2010-8#1)
prediction rate##3##2##(1997-6#1)(2010-8#2)
prediction research has##2##3##(1996-4#1)(2012-3#1)
prediction research##4##2##(1996-4#1)(2012-3#3)
prediction results were##2##3##(2007-8#1)(2008-10#1)
prediction results##9##2##(2007-8#1)(2008-10#4)(2011-1#2)(2012-2#2)
prediction rule##3##2##(2007-7#1)(2008-3#1)(2013-1#1)
prediction rules##7##2##(1993-12#1)(1996-2#1)(2007-6#2)(2007-7#2)(2008-12#1)
prediction samples##2##2##(2008-10#2)
prediction score##2##2##(2010-12#2)
prediction server##3##2##(2007-6#3)
prediction task##3##2##(2009-8#1)(2013-1#2)
prediction than##2##2##(2008-10#1)(2008-5#1)
prediction that##9##2##(1990-7#1)(2008-5#1)(2008-8#3)(2008-9#1)(2012-3#2)(2013-1#1)
prediction tool##2##2##(2009-10#1)(2012-2#1)
prediction tools##2##2##(2005-11#1)(2006-10#1)
prediction using##4##2##(2008-2#1)(2008-4#2)(2008-7#1)
prediction value##3##2##(2007-1#1)(2007-9#2)
prediction variability##2##2##(1991-2#2)
prediction was##12##2##(1991-9#1)(1995-6#1)(2005-8#1)(2006-10#1)(2006-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-4#1)(2011-1#2)
prediction with##2##2##(2007-11#1)(2012-3#1)
prediction##797##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#3)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#3)(1992-7#2)(1992-9#2)(1993-11#2)(1993-12#4)(1993-2#3)(1993-4#1)(1993-5#1)(1993-6#2)(1993-9#2)(1994-10#3)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-4#2)(1995-5#3)(1995-6#1)(1995-7#2)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#3)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#24)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#6)(1997-8#1)(2004-4#1)(2005-10#2)(2005-11#6)(2005-12#3)(2005-7#1)(2005-8#1)(2006-10#11)(2006-11#5)(2006-12#1)(2006-2#1)(2006-3#3)(2006-4#1)(2006-5#1)(2006-7#3)(2006-8#1)(2006-9#2)(2007-1#3)(2007-10#1)(2007-11#13)(2007-12#16)(2007-4#4)(2007-5#2)(2007-6#9)(2007-7#4)(2007-8#14)(2007-9#5)(2008-1#2)(2008-10#129)(2008-11#17)(2008-12#5)(2008-2#27)(2008-3#23)(2008-4#29)(2008-5#15)(2008-6#5)(2008-7#25)(2008-8#25)(2008-9#14)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#5)(2009-4#8)(2009-5#2)(2009-6#3)(2009-7#7)(2009-8#3)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#9)(2010-2#5)(2010-3#2)(2010-4#8)(2010-5#7)(2010-6#2)(2010-7#7)(2010-8#10)(2010-9#1)(2011-1#14)(2011-2#4)(2011-3#1)(2012-1#5)(2012-11#2)(2012-12#9)(2012-2#31)(2012-3#34)(2012-7#1)(2013-1#37)(2013-8#12)
prediction)##3##1##(1992-9#1)(2007-12#1)(2013-1#1)
predictions about the##4##3##(2006-5#1)(2008-11#1)(2008-8#1)(2008-9#1)
predictions about##14##2##(1992-1#1)(1994-3#1)(2006-5#1)(2008-11#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-3#1)(2009-7#2)(2010-2#1)
predictions agree well with##2##4##(2007-11#1)(2007-12#1)
predictions and show##2##3##(2007-12#2)
predictions and##18##2##(1991-5#1)(1994-3#2)(2006-1#1)(2007-12#5)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#2)
predictions are based on##4##4##(2007-11#1)(2008-8#1)(2009-5#2)
predictions are compared with experimental##2##5##(1994-3#1)(2008-10#1)
predictions are compared with##3##4##(1994-3#1)(2008-10#1)(2008-2#1)
predictions are consistent with##2##4##(1995-2#1)(2007-11#1)
predictions are given##2##3##(1991-12#1)(2008-8#1)
predictions are presented##3##3##(1992-5#1)(2007-9#1)(2008-2#1)
predictions are shown to##2##4##(2007-9#1)(2008-3#1)
predictions are##37##2##(1991-12#1)(1992-5#1)(1994-11#1)(1994-3#1)(1995-2#1)(1996-1#1)(1997-2#1)(2005-11#1)(2007-11#3)(2007-12#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-2#4)(2008-3#2)(2008-7#2)(2008-8#4)(2009-11#1)(2009-5#2)(2012-2#1)(2013-8#2)
predictions as to##2##3##(1991-1#1)(2012-3#1)
predictions as##3##2##(1991-1#1)(2008-7#1)(2012-3#1)
predictions at##2##2##(1992-6#1)(2010-6#1)
predictions based on the##4##4##(1992-1#1)(2007-11#1)(2008-2#1)(2010-12#1)
predictions based on##10##3##(1991-9#1)(1992-1#1)(1997-7#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)
predictions based upon##2##3##(1992-6#1)(1995-9#1)
predictions based##12##2##(1991-9#1)(1992-1#1)(1992-6#1)(1995-9#1)(1997-7#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)
predictions by##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
predictions calculated##2##2##(2005-11#1)(2007-11#1)
predictions for a##2##3##(1991-9#1)(2011-1#1)
predictions for the##7##3##(1990-12#1)(2006-6#1)(2007-12#3)(2008-11#1)(2009-3#1)
predictions for##32##2##(1990-12#1)(1991-9#1)(1992-6#1)(1992-9#1)(1995-1#1)(1996-5#1)(1997-5#1)(2006-6#1)(2006-7#1)(2007-12#4)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
predictions from the model##3##4##(1991-7#1)(2007-12#1)(2008-11#1)
predictions from the##6##3##(1991-7#1)(2007-1#1)(2007-12#1)(2008-11#1)(2008-9#1)(2010-6#1)
predictions from##16##2##(1991-7#1)(2007-1#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-6#1)(2013-1#3)
predictions have been made on##2##5##(2008-11#1)(2008-3#1)
predictions have been##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
predictions in a##3##3##(1996-2#1)(2007-4#1)(2010-2#1)
predictions in the light of##2##5##(2008-8#1)(2008-9#1)
predictions in the##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
predictions in##12##2##(1993-12#1)(1993-4#1)(1996-2#1)(1997-3#1)(2007-4#1)(2008-10#2)(2008-3#1)(2008-8#2)(2008-9#1)(2010-2#1)
predictions made##4##2##(1994-3#1)(2008-1#1)(2008-3#1)(2008-8#1)
predictions match##2##2##(2008-11#1)(2008-8#1)
predictions obtained##3##2##(2008-2#3)
predictions of Mie theory##3##4##(2005-11#1)(2008-2#2)
predictions of RNA##2##3##(1991-11#1)(1995-6#1)
predictions of a##10##3##(1994-8#1)(1995-3#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)(2009-2#1)(2012-3#1)
predictions of future##5##3##(1995-4#1)(1997-7#1)(2007-9#1)(2008-11#1)(2009-9#1)
predictions of the model##7##4##(1990-8#1)(1992-3#1)(1995-8#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-2#1)
predictions of the observed times of##2##6##(1995-8#2)
predictions of the##43##3##(1990-8#1)(1992-2#1)(1992-3#2)(1994-11#2)(1995-8#3)(2004-2#1)(2006-7#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#6)(2008-9#3)(2009-5#2)(2009-7#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)
predictions of this##3##3##(2007-11#1)(2008-2#1)(2011-1#1)
predictions of##122##2##(1990-8#1)(1991-11#1)(1992-1#1)(1992-2#1)(1992-3#2)(1993-6#1)(1993-7#1)(1994-11#2)(1994-3#2)(1994-7#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#3)(1996-3#1)(1996-4#1)(1997-7#1)(2004-2#2)(2005-11#1)(2006-10#2)(2006-7#2)(2007-11#7)(2007-12#6)(2007-4#1)(2007-9#3)(2008-10#10)(2008-11#2)(2008-2#9)(2008-3#10)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#9)(2008-9#7)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#3)(2009-7#1)(2009-9#1)(2010-2#2)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
predictions on the##2##3##(2007-5#1)(2008-8#1)
predictions over##2##2##(2007-4#1)(2008-7#1)
predictions provide##3##2##(2008-3#1)(2008-8#1)(2013-1#1)
predictions regarding the##2##3##(2008-8#1)(2013-1#1)
predictions regarding##3##2##(2006-10#1)(2008-8#1)(2013-1#1)
predictions that can be##2##4##(1997-2#1)(2008-8#1)
predictions that the##2##3##(1995-2#1)(2007-12#1)
predictions that##11##2##(1992-2#1)(1995-2#1)(1995-6#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#3)(2013-8#1)
predictions to##2##2##(1992-9#1)(2005-6#1)
predictions using##6##2##(2006-12#1)(2008-10#1)(2008-11#1)(2008-8#3)
predictions was found##2##3##(2005-11#1)(2008-3#1)
predictions was##5##2##(2005-11#1)(2008-10#1)(2008-11#1)(2008-3#2)
predictions were compared with##2##4##(1994-3#1)(2008-8#1)
predictions were made##2##3##(2008-10#1)(2008-7#1)
predictions were then##2##3##(2008-7#2)
predictions were##18##2##(1990-2#1)(1993-12#1)(1994-3#2)(2008-10#5)(2008-7#3)(2008-8#3)(2009-5#1)(2009-7#1)(2013-1#1)
predictions with the##2##3##(2008-5#1)(2008-7#1)
predictions with##5##2##(1996-4#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)
predictions##532##1##(1990-12#1)(1990-2#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-1#3)(1992-2#3)(1992-3#3)(1992-5#1)(1992-6#4)(1992-9#2)(1993-12#2)(1993-2#1)(1993-4#1)(1993-6#1)(1993-7#2)(1994-10#1)(1994-11#4)(1994-3#9)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#6)(1995-9#1)(1996-1#1)(1996-2#2)(1996-3#1)(1996-4#5)(1996-5#1)(1996-9#1)(1997-2#2)(1997-3#3)(1997-5#1)(1997-7#4)(2004-2#2)(2005-11#8)(2005-6#1)(2006-1#1)(2006-10#3)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#5)(2007-1#1)(2007-11#18)(2007-12#40)(2007-3#1)(2007-4#4)(2007-5#2)(2007-8#4)(2007-9#6)(2008-1#4)(2008-10#38)(2008-11#16)(2008-12#1)(2008-2#35)(2008-3#50)(2008-4#4)(2008-5#3)(2008-6#4)(2008-7#24)(2008-8#45)(2008-9#19)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#5)(2009-4#1)(2009-5#7)(2009-6#1)(2009-7#7)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#9)(2010-3#1)(2010-4#2)(2010-6#4)(2010-7#2)(2010-8#3)(2011-1#4)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#10)(2012-3#4)(2013-1#16)(2013-8#8)
predictive abilities##2##2##(2010-4#1)(2011-1#1)
predictive ability of the##8##4##(2008-10#5)(2008-8#1)(2009-3#1)(2012-3#1)
predictive ability of##15##3##(1990-12#1)(2005-11#1)(2008-10#8)(2008-8#1)(2009-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
predictive ability was##2##3##(2011-1#1)(2012-3#1)
predictive ability##25##2##(1990-12#1)(1996-8#1)(1997-6#1)(2005-11#1)(2007-11#1)(2008-10#11)(2008-8#1)(2009-3#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#3)
predictive accuracy for##3##3##(1992-2#1)(2012-3#2)
predictive accuracy of##3##3##(1993-3#1)(1993-9#1)(2012-12#1)
predictive accuracy##12##2##(1992-2#1)(1993-3#1)(1993-9#1)(1996-2#2)(2006-9#1)(2008-9#1)(2012-12#1)(2012-3#3)(2013-1#1)
predictive and prognostic##2##3##(2008-7#1)(2011-3#1)
predictive and##7##2##(2008-10#1)(2008-7#1)(2009-11#1)(2009-3#1)(2011-2#1)(2011-3#1)(2012-2#1)
predictive biomarkers of##2##3##(2006-10#1)(2012-12#1)
predictive biomarkers##7##2##(2006-10#1)(2008-11#1)(2009-2#1)(2010-5#1)(2012-1#1)(2012-12#1)(2012-3#1)
predictive combinations##2##2##(2008-4#2)
predictive control##4##2##(2007-12#2)(2008-2#1)(2013-1#1)
predictive controller##3##2##(2008-1#1)(2008-2#2)
predictive error##3##2##(2008-10#2)(2010-2#1)
predictive factor of##2##3##(1994-3#1)(1994-4#1)
predictive factor##4##2##(1992-10#1)(1994-2#1)(1994-3#1)(1994-4#1)
predictive factors for##5##3##(2007-7#1)(2009-11#1)(2009-5#1)(2009-6#1)(2012-3#1)
predictive factors of recurrent bleeding##3##5##(2007-8#3)
predictive factors of##5##3##(2007-8#3)(2008-10#1)(2010-7#1)
predictive factors that##2##3##(1995-10#1)(2013-8#1)
predictive factors##21##2##(1995-10#2)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#3)(2008-10#1)(2008-7#1)(2009-11#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-8#2)
predictive for a substitution of##2##5##(1994-11#2)
predictive for##8##2##(1994-11#2)(2006-10#1)(2008-7#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
predictive genetic##2##2##(1993-9#1)(2007-12#1)
predictive in##2##2##(1993-11#1)(2007-2#1)
predictive information to##2##3##(2012-2#1)(2012-3#1)
predictive information##6##2##(2004-11#1)(2007-10#1)(2008-10#1)(2012-2#2)(2012-3#1)
predictive marker of##2##3##(2007-10#1)(2010-8#1)
predictive marker##5##2##(2007-10#1)(2008-8#1)(2010-12#2)(2010-8#1)
predictive markers##3##2##(2008-1#1)(2013-1#2)
predictive microbiology##3##2##(2008-5#1)(2011-2#2)
predictive model for##5##3##(1993-9#1)(2008-10#3)(2008-5#1)
predictive model with##2##3##(2010-8#1)(2012-12#1)
predictive model##14##2##(1993-9#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-5#1)(2009-3#2)(2010-7#1)(2010-8#1)(2012-12#1)
predictive models and##3##3##(2010-11#1)(2013-1#2)
predictive models for##3##3##(2012-12#1)(2013-1#2)
predictive models of##9##3##(2007-11#2)(2008-11#1)(2008-7#1)(2010-4#2)(2012-2#1)(2013-1#2)
predictive models##29##2##(2006-9#1)(2007-11#2)(2008-11#1)(2008-7#2)(2008-8#2)(2009-4#1)(2010-11#1)(2010-4#2)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#12)
predictive of PTD##2##3##(2007-8#2)
predictive of a##5##3##(1993-12#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#1)
predictive of better##2##3##(2008-6#1)(2010-8#1)
predictive of clinical##2##3##(2008-5#1)(2010-11#1)
predictive of early##2##3##(2008-8#1)(2012-12#1)
predictive of greater##2##3##(2008-9#1)(2009-7#1)
predictive of increased##3##3##(2008-10#1)(2012-3#2)
predictive of more##2##3##(2007-12#1)(2009-11#1)
predictive of poor outcome##2##4##(2012-12#1)(2012-3#1)
predictive of reporting##2##3##(2009-5#2)
predictive of response to##2##4##(2006-10#1)(2007-8#1)
predictive of response##3##3##(2006-10#2)(2007-8#1)
predictive of the response to##2##5##(2008-8#1)(2010-5#1)
predictive of the##6##3##(1996-6#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-5#1)
predictive of##99##2##(1992-10#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-10#1)(1996-3#1)(1996-6#1)(1996-9#1)(2005-12#1)(2005-5#1)(2006-10#4)(2006-12#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#5)(2007-2#1)(2007-7#1)(2007-8#8)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#4)(2008-6#4)(2008-7#1)(2008-8#5)(2008-9#3)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#3)(2009-7#5)(2010-10#1)(2010-11#2)(2010-12#2)(2010-5#2)(2010-8#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)
predictive performance##6##2##(2008-10#1)(2008-7#2)(2009-7#1)(2012-3#2)
predictive power and##2##3##(2008-8#1)(2013-8#1)
predictive power of the models##3##5##(2005-12#1)(2008-5#1)(2009-8#1)
predictive power of the##7##4##(1990-12#1)(2005-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-2#1)
predictive power of##18##3##(1990-12#1)(1992-12#1)(1992-2#1)(1995-6#1)(2005-12#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-2#1)(2012-2#2)(2013-1#1)
predictive power##25##2##(1990-12#1)(1992-10#1)(1992-12#1)(1992-2#1)(1995-6#1)(2005-12#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-2#2)(2012-2#2)(2013-1#3)(2013-8#1)
predictive process models for##2##4##(2009-9#2)
predictive process##3##2##(2009-9#3)
predictive risk##2##2##(2008-10#1)(2008-11#1)
predictive role in the##2##4##(2008-3#1)(2011-2#1)
predictive role##3##2##(2008-3#1)(2011-2#1)(2012-3#1)
predictive rules##4##2##(2013-1#4)
predictive strategies##2##2##(1993-2#1)(2011-2#1)
predictive studies##2##2##(2008-10#1)(2011-12#1)
predictive test##3##2##(1992-3#1)(1997-6#1)(2013-8#1)
predictive tools for##2##3##(1990-7#1)(2007-11#1)
predictive tools##3##2##(1990-7#1)(2007-11#2)
predictive validity and effects of using the##2##7##(2013-1#2)
predictive validity of##7##3##(1992-2#1)(1994-2#2)(1994-3#1)(2006-3#1)(2008-4#1)(2008-8#1)
predictive validity##16##2##(1992-2#1)(1994-2#3)(1994-3#1)(2006-3#1)(2008-4#1)(2008-6#2)(2008-8#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-7#1)
predictive value (PPV) and negative##2##5##(2007-2#1)(2010-12#1)
predictive value (PPV)##6##3##(2006-10#2)(2007-2#1)(2007-9#1)(2010-12#1)(2011-1#1)
predictive value =##3##3##(2007-10#1)(2009-4#2)
predictive value and##7##3##(2007-8#2)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
predictive value are##2##3##(2006-9#1)(2008-11#1)
predictive value as##4##3##(1991-4#2)(1994-2#1)(2012-2#1)
predictive value but##2##3##(2007-8#1)(2009-4#1)
predictive value for the##3##4##(1994-2#1)(1997-8#1)(2006-10#1)
predictive value for##17##3##(1992-6#1)(1993-12#1)(1993-2#1)(1994-2#1)(1997-8#1)(2004-12#1)(2005-10#1)(2006-10#2)(2006-9#1)(2008-10#1)(2008-4#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
predictive value in the##2##4##(2008-5#1)(2012-12#1)
predictive value in##5##3##(1994-2#1)(2008-5#1)(2010-8#1)(2012-12#1)(2012-2#1)
predictive value of 0##3##4##(1993-2#2)(2008-5#1)
predictive value of 84##2##4##(1994-7#1)(2006-2#1)
predictive value of a positive##4##5##(1990-3#1)(1992-5#1)(1994-2#1)(1997-1#1)
predictive value of a##8##4##(1990-3#1)(1992-10#1)(1992-5#2)(1994-2#1)(1997-1#1)(2009-10#1)(2011-2#1)
predictive value of provisional clinical diagnosis in the evaluation of##2##10##(2007-3#2)
predictive value of the test##2##5##(1991-12#2)
predictive value of the##10##4##(1990-2#1)(1991-12#2)(1992-10#1)(2006-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2009-7#1)(2013-1#1)
predictive value of##78##3##(1990-10#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-12#3)(1992-10#2)(1992-5#5)(1993-2#4)(1993-5#1)(1994-2#1)(1994-7#1)(1995-3#2)(1996-1#1)(1997-1#1)(2005-10#3)(2006-1#1)(2006-10#6)(2006-12#2)(2006-2#8)(2006-7#1)(2007-3#4)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-3#1)(2008-5#1)(2009-10#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)
predictive value was 95%##2##4##(1993-1#1)(2006-7#1)
predictive value was##7##3##(1993-1#3)(2006-7#1)(2007-8#1)(2012-12#1)(2012-2#1)
predictive value##191##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-7#1)(1991-12#4)(1991-2#1)(1991-4#2)(1992-10#2)(1992-11#2)(1992-5#6)(1992-6#1)(1993-1#3)(1993-12#1)(1993-2#5)(1993-5#1)(1994-2#4)(1994-7#3)(1995-3#2)(1996-1#1)(1996-4#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-12#1)(2005-10#5)(2006-1#1)(2006-10#15)(2006-12#3)(2006-2#8)(2006-6#1)(2006-7#2)(2006-9#2)(2007-10#1)(2007-12#1)(2007-2#2)(2007-3#5)(2007-5#1)(2007-7#1)(2007-8#11)(2007-9#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#2)(2009-2#4)(2009-4#3)(2009-6#1)(2009-7#1)(2010-12#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#17)(2012-12#6)(2012-2#6)(2012-3#4)(2013-1#9)(2013-8#1)
predictive values for the##3##4##(1992-5#1)(2007-10#1)(2013-1#1)
predictive values for##6##3##(1992-5#1)(1993-1#1)(1993-2#1)(2007-10#1)(2007-12#1)(2013-1#1)
predictive values of##13##3##(1991-6#1)(1996-8#1)(2004-2#1)(2005-10#1)(2006-1#1)(2007-1#1)(2008-11#1)(2008-5#3)(2012-12#1)(2013-1#2)
predictive values were##7##3##(1991-4#1)(1992-4#1)(1994-3#1)(2006-1#1)(2007-8#1)(2008-12#1)(2008-3#1)
predictive values##35##2##(1991-4#1)(1991-5#1)(1991-6#1)(1992-2#1)(1992-4#1)(1992-5#1)(1993-1#1)(1993-2#1)(1994-3#1)(1996-8#1)(2004-2#1)(2005-10#1)(2006-1#2)(2006-10#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2011-1#2)(2012-12#2)(2012-3#1)(2013-1#3)
predictive variables##5##2##(1996-8#1)(2008-10#1)(2010-4#1)(2012-12#1)(2013-8#1)
predictive##665##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#2)(1990-7#2)(1991-12#4)(1991-2#1)(1991-4#3)(1991-5#1)(1991-6#1)(1991-7#1)(1992-10#5)(1992-11#2)(1992-12#2)(1992-2#5)(1992-3#1)(1992-4#1)(1992-5#7)(1992-6#1)(1993-1#4)(1993-11#2)(1993-12#2)(1993-2#9)(1993-3#1)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#4)(1994-11#2)(1994-2#8)(1994-3#3)(1994-4#1)(1994-5#1)(1994-7#3)(1994-8#1)(1995-1#1)(1995-10#2)(1995-2#1)(1995-3#3)(1995-4#1)(1995-6#1)(1995-8#1)(1996-1#3)(1996-10#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#3)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#3)(2004-11#1)(2004-12#1)(2004-2#2)(2005-10#8)(2005-11#2)(2005-12#2)(2005-5#1)(2005-9#1)(2006-1#3)(2006-10#24)(2006-11#1)(2006-12#4)(2006-2#8)(2006-3#1)(2006-4#1)(2006-6#2)(2006-7#2)(2006-9#5)(2007-1#1)(2007-10#11)(2007-11#10)(2007-12#13)(2007-2#4)(2007-3#5)(2007-5#1)(2007-7#4)(2007-8#26)(2007-9#2)(2008-1#5)(2008-10#47)(2008-11#9)(2008-12#3)(2008-2#7)(2008-3#5)(2008-4#5)(2008-5#12)(2008-6#6)(2008-7#15)(2008-8#13)(2008-9#5)(2009-10#4)(2009-11#5)(2009-2#5)(2009-3#4)(2009-4#8)(2009-5#5)(2009-6#2)(2009-7#9)(2009-8#1)(2009-9#5)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#8)(2010-2#3)(2010-3#3)(2010-4#6)(2010-5#5)(2010-7#5)(2010-8#6)(2011-1#13)(2011-12#2)(2011-2#30)(2011-3#1)(2012-1#4)(2012-12#19)(2012-2#15)(2012-3#24)(2013-1#50)(2013-7#1)(2013-8#11)
predictive/prognostic##2##1##(2009-4#1)(2010-12#1)
predictor electrode##3##2##(2007-8#3)
predictor for disease##2##3##(2008-10#1)(2012-2#1)
predictor for mortality##2##3##(2010-11#1)(2011-2#1)
predictor for survival##2##3##(2007-10#1)(2008-6#1)
predictor for the presence of##2##5##(1997-1#1)(2009-8#1)
predictor for the##7##3##(1997-1#1)(2008-6#2)(2009-2#1)(2009-8#1)(2011-1#1)(2013-1#1)
predictor for##33##2##(1994-11#1)(1997-1#2)(2007-10#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#2)(2009-2#1)(2009-6#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#3)(2013-7#2)
predictor in##5##2##(1991-2#1)(1995-4#1)(1995-6#1)(2010-8#1)(2012-1#1)
predictor is##3##2##(1991-6#1)(2008-10#1)(2008-6#1)
predictor of a##11##3##(1990-12#2)(1997-5#1)(2006-10#1)(2007-10#1)(2007-7#1)(2011-2#1)(2013-1#4)
predictor of acute coronary##2##4##(2008-3#2)
predictor of acute##3##3##(2008-3#2)(2013-1#1)
predictor of adverse##2##3##(2010-12#1)(2012-2#1)
predictor of clinical outcome in##2##5##(2012-2#1)(2013-1#1)
predictor of clinical outcome##3##4##(2010-8#1)(2012-2#1)(2013-1#1)
predictor of clinical##4##3##(1997-1#1)(2010-8#1)(2012-2#1)(2013-1#1)
predictor of cognitive##2##3##(2005-8#1)(2007-10#1)
predictor of coronary##3##3##(1997-8#1)(2005-12#1)(2013-4#1)
predictor of death##2##3##(2007-10#1)(2007-8#1)
predictor of depression##2##3##(2007-12#1)(2013-1#1)
predictor of future##3##3##(2008-9#1)(2010-11#1)(2013-7#1)
predictor of later##3##3##(2008-12#1)(2012-2#1)(2013-7#1)
predictor of long-term##4##3##(2008-5#1)(2009-8#1)(2010-3#1)(2012-2#1)
predictor of mortality##2##3##(2009-6#1)(2011-1#1)
predictor of neurological dysfunction after##2##5##(2013-1#2)
predictor of outcome##8##3##(1993-2#1)(2006-2#1)(2007-10#4)(2008-4#1)(2009-11#1)
predictor of overall##3##3##(2007-8#1)(2011-2#1)(2013-1#1)
predictor of poor outcome##2##4##(2008-3#1)(2012-12#1)
predictor of poor##3##3##(1994-6#1)(2008-3#1)(2012-12#1)
predictor of prognosis##3##3##(1995-10#1)(2007-12#1)(2009-5#1)
predictor of prostate##3##3##(2009-2#1)(2012-12#2)
predictor of renal##2##3##(2008-1#1)(2012-3#1)
predictor of response to##2##4##(2006-9#1)(2008-7#1)
predictor of success##2##3##(2005-11#1)(2008-8#1)
predictor of sympathy than##2##4##(2008-10#2)
predictor of the##17##3##(1990-4#1)(1995-2#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-10#2)(2008-10#3)(2008-4#1)(2008-7#1)(2008-9#2)(2012-3#1)(2013-8#2)
predictor of weight gain##2##4##(2004-3#1)(2006-10#1)
predictor of##203##2##(1990-12#2)(1990-2#1)(1990-4#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-4#1)(1993-1#2)(1993-11#1)(1993-2#2)(1993-9#1)(1994-2#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-3#3)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-5#1)(1997-8#2)(2004-3#1)(2005-10#3)(2005-11#1)(2005-12#1)(2005-6#1)(2005-8#2)(2006-10#5)(2006-11#1)(2006-2#2)(2006-5#1)(2006-6#2)(2006-9#1)(2007-1#1)(2007-10#13)(2007-11#1)(2007-12#4)(2007-4#1)(2007-6#3)(2007-7#4)(2007-8#4)(2008-1#2)(2008-10#5)(2008-12#5)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#9)(2009-11#1)(2009-2#2)(2009-5#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#6)(2012-3#6)(2013-1#18)(2013-4#1)(2013-7#3)(2013-8#3)
predictor to##2##2##(2008-2#1)(2008-6#1)
predictor variable##3##2##(1991-12#1)(1992-2#1)(2010-12#1)
predictor variables for##2##3##(1993-9#1)(2012-2#1)
predictor variables were##5##3##(2007-10#1)(2008-10#2)(2008-9#1)(2010-3#1)
predictor variables##19##2##(1993-9#2)(1997-6#1)(2007-10#1)(2008-10#6)(2008-2#1)(2008-9#1)(2009-7#1)(2010-3#1)(2012-12#2)(2012-2#1)(2012-3#2)
predictor##307##1##(1990-12#2)(1990-2#1)(1990-4#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-1#3)(1993-11#1)(1993-2#2)(1993-6#1)(1993-7#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#4)(1996-3#3)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-5#1)(1997-6#1)(1997-8#2)(2004-3#1)(2005-10#3)(2005-11#1)(2005-12#1)(2005-6#1)(2005-8#2)(2006-10#5)(2006-11#1)(2006-2#2)(2006-5#1)(2006-6#2)(2006-7#1)(2006-9#1)(2007-1#2)(2007-10#16)(2007-11#1)(2007-12#5)(2007-4#3)(2007-6#3)(2007-7#5)(2007-8#8)(2007-9#3)(2008-1#3)(2008-10#14)(2008-11#1)(2008-12#5)(2008-2#4)(2008-3#4)(2008-4#4)(2008-5#2)(2008-6#7)(2008-7#9)(2008-8#6)(2008-9#11)(2009-11#1)(2009-2#3)(2009-3#1)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#3)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#3)(2011-1#6)(2011-12#1)(2011-2#13)(2012-1#2)(2012-11#1)(2012-12#8)(2012-2#9)(2012-3#10)(2013-1#23)(2013-4#1)(2013-7#6)(2013-8#3)
predictors among##3##2##(2006-7#1)(2009-4#1)(2010-8#1)
predictors and##5##2##(2007-7#1)(2008-6#1)(2011-2#2)(2012-12#1)
predictors are##6##2##(1992-12#1)(1993-6#1)(1996-4#1)(2007-12#1)(2010-12#1)(2010-2#1)
predictors associated with##2##3##(1997-8#1)(2013-1#1)
predictors for increased##2##3##(2007-8#1)(2013-1#1)
predictors for the##2##3##(2008-3#1)(2011-2#1)
predictors for##29##2##(1992-12#2)(1994-3#1)(2004-10#1)(2004-2#1)(2006-10#2)(2006-6#1)(2007-10#2)(2007-11#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-3#2)(2008-5#1)(2009-6#1)(2010-10#2)(2010-5#1)(2011-2#2)(2012-2#3)(2013-1#3)
predictors in the model##2##4##(2007-12#1)(2009-3#1)
predictors in the##7##3##(2007-12#1)(2008-6#1)(2009-3#1)(2010-12#1)(2012-2#1)(2013-1#2)
predictors in##8##2##(2007-10#1)(2007-12#1)(2008-6#1)(2009-3#1)(2010-12#1)(2012-2#1)(2013-1#2)
predictors included##2##2##(2007-9#1)(2011-2#1)
predictors of FL##2##3##(2007-9#2)
predictors of PSE##3##3##(2007-10#3)
predictors of a##4##3##(2008-6#1)(2011-2#2)(2012-2#1)
predictors of acculturative stress in##2##5##(2005-10#2)
predictors of adherence##2##3##(2008-2#2)
predictors of adverse##2##3##(2012-12#1)(2012-2#1)
predictors of and##2##3##(2012-3#1)(2013-1#1)
predictors of apple scab##2##4##(2008-10#2)
predictors of atrial fibrillation##2##4##(1995-6#1)(2007-8#1)
predictors of between-individual differences in offending##2##6##(2009-7#2)
predictors of body dissatisfaction##3##4##(2007-12#3)
predictors of body##4##3##(2007-12#4)
predictors of children's##2##3##(1993-1#1)(2008-2#1)
predictors of depression##4##3##(2007-10#1)(2009-5#1)(2011-2#2)
predictors of disease class##2##4##(2008-7#2)
predictors of disease##4##3##(2008-7#2)(2008-8#1)(2012-2#1)
predictors of early##4##3##(2007-7#1)(2007-8#1)(2010-4#2)
predictors of eating##2##3##(2006-7#1)(2012-2#1)
predictors of end-stage##2##3##(2013-1#2)
predictors of engagement##2##3##(2006-5#1)(2009-9#1)
predictors of faster##3##3##(2013-1#3)
predictors of future##2##3##(2005-10#1)(2006-10#1)
predictors of having sex while symptomatic##2##6##(2007-7#2)
predictors of having##3##3##(2007-7#2)(2013-1#1)
predictors of higher##2##3##(2010-8#1)(2011-2#1)
predictors of hypertension##3##3##(2008-11#3)
predictors of increased##2##3##(2007-8#1)(2013-1#1)
predictors of local##2##3##(2006-9#1)(2007-5#1)
predictors of low##2##3##(1995-12#1)(2012-2#1)
predictors of memory performance in##2##5##(2008-12#1)(2008-7#1)
predictors of mortality in##5##4##(1993-9#1)(2011-2#4)
predictors of mortality##9##3##(1993-9#1)(2008-7#3)(2011-2#5)
predictors of nonadherence##2##3##(1994-3#1)(2012-1#1)
predictors of outcome in##3##4##(2007-7#1)(2007-8#1)(2009-10#1)
predictors of outcome##6##3##(1993-8#1)(1995-4#1)(2006-10#1)(2007-7#1)(2007-8#1)(2009-10#1)
predictors of overall##2##3##(1996-3#1)(2007-12#1)
predictors of pain##3##3##(1996-12#1)(2006-10#1)(2008-9#1)
predictors of patient##2##3##(1994-2#1)(2010-12#1)
predictors of peripheral neuropathy occurrence in HIV-1 infected##2##8##(2008-11#2)
predictors of poor##2##3##(2008-3#1)(2011-2#1)
predictors of postoperative##2##3##(2007-8#2)
predictors of progression##3##3##(2006-8#1)(2007-8#1)(2009-11#1)
predictors of readmission##2##3##(2009-7#1)(2011-2#1)
predictors of recovery##2##3##(2007-9#1)(2010-3#1)
predictors of response to##5##4##(2006-7#1)(2008-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
predictors of response##6##3##(2006-7#1)(2008-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
predictors of services use##2##4##(2009-7#2)
predictors of smoking##2##3##(2008-11#1)(2012-1#1)
predictors of stroke##3##3##(2007-10#3)
predictors of success##4##3##(2006-12#3)(2009-12#1)
predictors of successful##2##3##(1991-12#1)(2013-1#1)
predictors of survival##5##3##(2007-8#1)(2008-7#1)(2010-10#1)(2010-5#1)(2011-1#1)
predictors of the##12##3##(1992-4#1)(1997-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#1)
predictors of these##3##3##(2008-11#1)(2012-3#1)(2013-1#1)
predictors of thoracic injury##2##4##(2006-11#2)
predictors of treatment response##3##4##(2006-9#2)(2007-2#1)
predictors of treatment##4##3##(2006-7#1)(2006-9#2)(2007-2#1)
predictors of##279##2##(1991-12#1)(1992-3#1)(1992-4#2)(1993-1#2)(1993-12#1)(1993-8#1)(1993-9#1)(1994-2#2)(1994-3#1)(1995-12#2)(1995-4#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-8#1)(2005-10#4)(2006-1#1)(2006-10#9)(2006-11#2)(2006-12#3)(2006-2#2)(2006-4#1)(2006-5#1)(2006-7#6)(2006-8#1)(2006-9#4)(2007-1#1)(2007-10#13)(2007-11#3)(2007-12#8)(2007-2#2)(2007-3#2)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#9)(2007-9#7)(2008-10#6)(2008-11#9)(2008-12#3)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#11)(2008-8#5)(2008-9#3)(2009-10#2)(2009-11#3)(2009-12#2)(2009-5#3)(2009-7#7)(2009-8#1)(2009-9#4)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#5)(2010-5#2)(2010-6#1)(2010-8#3)(2011-1#7)(2011-2#18)(2011-3#1)(2012-1#2)(2012-12#9)(2012-2#14)(2012-3#5)(2012-5#1)(2013-1#18)(2013-3#1)(2013-7#1)(2013-8#3)
predictors on##3##2##(2006-11#1)(2008-11#1)(2011-1#1)
predictors or##2##2##(1994-6#1)(2005-10#1)
predictors that##2##2##(1994-3#1)(2008-11#1)
predictors to##2##2##(2008-3#1)(2011-1#1)
predictors were##7##2##(2006-2#1)(2007-10#1)(2008-10#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#1)
predictors within##2##2##(1994-6#1)(2008-2#1)
predictors##415##1##(1990-12#1)(1991-12#1)(1991-8#1)(1992-12#4)(1992-3#2)(1992-4#2)(1993-1#2)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#2)(1994-3#3)(1994-6#2)(1995-12#4)(1995-4#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#2)(1996-8#2)(1997-2#1)(1997-8#3)(2004-10#1)(2004-2#1)(2005-10#5)(2006-1#1)(2006-10#11)(2006-11#3)(2006-12#3)(2006-2#3)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#7)(2006-8#1)(2006-9#4)(2007-1#2)(2007-10#20)(2007-11#5)(2007-12#11)(2007-2#2)(2007-3#4)(2007-5#1)(2007-6#2)(2007-7#6)(2007-8#12)(2007-9#12)(2008-1#1)(2008-10#8)(2008-11#16)(2008-12#5)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#6)(2008-7#12)(2008-8#5)(2008-9#3)(2009-10#3)(2009-11#3)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#5)(2009-6#1)(2009-7#9)(2009-8#1)(2009-9#8)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#6)(2010-2#5)(2010-3#2)(2010-4#7)(2010-5#3)(2010-6#1)(2010-8#4)(2011-1#9)(2011-2#28)(2011-3#1)(2012-1#2)(2012-12#13)(2012-2#19)(2012-3#7)(2012-5#1)(2013-1#31)(2013-3#1)(2013-7#1)(2013-8#4)
predicts a polypeptide of##2##4##(1992-12#1)(1996-5#1)
predicts a protein of##3##4##(1994-2#1)(1995-4#1)(2008-5#1)
predicts a protein with##2##4##(1995-3#1)(1995-4#1)
predicts a protein##6##3##(1990-5#1)(1994-2#1)(1995-3#1)(1995-4#2)(2008-5#1)
predicts a##35##2##(1990-1#1)(1990-5#2)(1992-12#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-7#1)(1994-2#1)(1994-8#1)(1994-9#3)(1995-3#1)(1995-4#2)(1995-6#1)(1995-8#1)(1996-5#1)(2005-11#1)(2005-9#1)(2006-11#1)(2007-1#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2012-1#1)
predicts an increase##2##3##(2013-8#2)
predicts an##5##2##(1995-9#1)(2008-1#1)(2008-3#1)(2013-8#2)
predicts clinical##2##2##(2007-8#1)(2011-1#1)
predicts high##2##2##(2007-12#1)(2010-12#1)
predicts long-term##2##2##(2007-9#1)(2012-2#1)
predicts mortality##2##2##(1990-5#1)(1997-7#1)
predicts other##2##2##(2007-11#1)(2010-7#1)
predicts outcomes in##3##3##(2006-7#1)(2013-1#2)
predicts some##2##2##(2008-11#1)(2008-3#1)
predicts that a##3##3##(1997-6#1)(2008-8#1)(2010-8#1)
predicts that cooperation can##2##4##(2008-8#2)
predicts that the##20##3##(1990-3#1)(1991-10#1)(1992-12#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-11#1)(1996-10#1)(1996-4#2)(1997-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#4)(2010-10#1)(2012-3#1)
predicts that this##3##3##(1995-8#1)(2007-12#1)(2008-10#1)
predicts that##76##2##(1990-3#1)(1991-10#2)(1992-12#1)(1992-6#1)(1993-12#2)(1993-3#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-9#2)(1995-11#2)(1995-4#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-4#3)(1996-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#1)(2008-7#5)(2008-8#14)(2008-9#8)(2009-2#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
predicts the correct##2##3##(2005-11#1)(2007-11#1)
predicts the degree of##2##4##(2010-5#1)(2013-1#1)
predicts the existence of##2##4##(1991-5#1)(1992-7#1)
predicts the##53##2##(1991-5#2)(1992-7#1)(1993-9#2)(1994-5#1)(1994-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1997-6#1)(2005-11#4)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#7)(2008-3#9)(2008-4#1)(2008-7#3)(2008-8#2)(2009-8#1)(2010-2#2)(2010-5#1)(2013-1#1)
predicts their##2##2##(2006-2#1)(2010-6#1)
predicts two##2##2##(1991-12#1)(1995-6#1)
predicts well the##2##3##(1997-2#1)(2008-9#1)
predicts well##3##2##(1992-5#1)(1997-2#1)(2008-9#1)
predicts##283##1##(1990-1#1)(1990-3#2)(1990-5#4)(1991-10#2)(1991-12#1)(1991-5#2)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-4#1)(1992-5#2)(1992-6#3)(1992-7#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-6#2)(1993-7#1)(1993-9#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#5)(1995-11#3)(1995-2#1)(1995-3#1)(1995-4#5)(1995-6#3)(1995-8#6)(1995-9#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-4#4)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-11#7)(2005-9#2)(2006-10#3)(2006-11#2)(2006-2#1)(2006-7#4)(2007-1#1)(2007-10#6)(2007-11#5)(2007-12#8)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#10)(2008-11#12)(2008-12#1)(2008-2#15)(2008-3#16)(2008-4#2)(2008-5#3)(2008-7#9)(2008-8#23)(2008-9#11)(2009-10#1)(2009-12#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#4)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#2)(2011-1#3)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#9)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#4)
predilection for the head and neck##2##6##(2008-7#1)(2013-1#1)
predilection for the##8##3##(2004-1#1)(2008-7#1)(2009-9#1)(2012-12#1)(2013-1#4)
predilection for##17##2##(1991-8#1)(1994-2#1)(1997-1#1)(2004-1#1)(2006-12#1)(2006-6#1)(2007-10#1)(2008-7#1)(2009-5#1)(2009-9#1)(2011-2#1)(2012-12#2)(2013-1#4)
predilection in##2##2##(2006-10#1)(2011-12#1)
predilection##22##1##(1991-8#1)(1994-2#1)(1997-1#1)(2004-1#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-2#1)(2008-7#1)(2009-11#1)(2009-5#1)(2009-9#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#4)
predispose for##2##2##(1993-2#1)(1997-4#1)
predispose individuals to##5##3##(2006-10#1)(2007-6#2)(2008-1#1)(2012-3#1)
predispose patients to##4##3##(1993-10#1)(2006-11#1)(2007-11#1)(2007-9#1)
predispose some##2##2##(2008-10#1)(2009-12#1)
predispose the##7##2##(1997-1#1)(2005-8#1)(2006-3#1)(2007-6#1)(2007-8#1)(2008-12#1)(2008-4#1)
predispose them to##2##3##(2007-9#1)(2011-2#1)
predispose these##2##2##(2006-1#1)(2008-1#1)
predispose to breast##2##3##(1992-2#1)(1993-10#1)
predispose to platelet aggregation##2##4##(1991-8#1)(1991-9#1)
predispose to the development of##7##5##(2006-10#2)(2007-8#1)(2008-11#1)(2011-2#2)(2012-2#1)
predispose to the##8##3##(1991-9#1)(2006-10#2)(2007-8#1)(2008-11#1)(2011-2#2)(2012-2#1)
predispose to them##2##3##(2008-4#1)(2008-8#1)
predispose to##42##2##(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-2#2)(1992-8#2)(1993-10#3)(1996-1#1)(1997-8#1)(2006-10#4)(2006-4#1)(2006-7#1)(2007-1#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#2)(2009-10#1)(2011-2#3)(2012-2#3)(2013-1#1)
predispose towards##2##2##(1992-2#1)(2013-8#1)
predispose young##2##2##(2007-12#1)(2012-12#1)
predispose##84##1##(1990-9#2)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-2#3)(1992-8#2)(1993-10#4)(1993-2#1)(1995-7#1)(1996-1#1)(1997-1#1)(1997-4#1)(1997-8#1)(2005-8#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#3)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#3)(2008-7#2)(2008-8#2)(2009-1#1)(2009-10#1)(2009-12#1)(2010-11#1)(2010-2#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#2)
predisposed the##2##2##(2007-2#1)(2008-10#1)
predisposed to memorize##2##3##(2008-6#2)
predisposed to##16##2##(1992-6#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-8#1)
predisposed##34##1##(1992-6#1)(1994-3#2)(1994-5#1)(1996-3#1)(1997-4#1)(2006-10#2)(2006-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#2)(2010-6#2)(2011-1#1)(2011-12#1)(2011-2#5)(2012-2#1)(2013-1#1)(2013-8#1)
predisposes affected##3##2##(1996-12#1)(2008-2#1)(2011-12#1)
predisposes for##2##2##(1992-12#1)(2010-4#1)
predisposes patients##2##2##(2007-12#1)(2012-1#1)
predisposes to##12##2##(1990-2#1)(1995-12#1)(1996-8#1)(1997-7#1)(2006-6#1)(2008-4#2)(2008-7#1)(2010-2#1)(2011-12#1)(2012-1#1)(2013-1#1)
predisposes##25##1##(1990-2#1)(1992-12#1)(1993-10#1)(1995-12#1)(1996-12#1)(1996-8#1)(1997-7#1)(2005-10#1)(2005-9#1)(2006-6#1)(2007-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2009-10#1)(2009-12#1)(2010-2#1)(2010-4#1)(2011-12#2)(2012-1#2)(2012-12#1)(2013-1#1)
predisposing cardiac##2##2##(2007-3#1)(2012-12#1)
predisposing cause##3##2##(1991-2#1)(1995-3#1)(2007-8#1)
predisposing causes##2##2##(1991-8#1)(2007-7#1)
predisposing factor for##9##3##(1991-8#1)(1994-4#1)(1996-1#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-12#1)
predisposing factor in the development of##2##6##(1994-5#1)(2007-2#1)
predisposing factor in##4##3##(1994-5#1)(2007-2#1)(2007-7#2)
predisposing factor##22##2##(1991-8#1)(1992-4#1)(1994-4#1)(1994-5#1)(1996-1#1)(2006-10#1)(2007-2#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-5#1)(2008-7#1)(2009-6#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-2#1)
predisposing factors and##5##3##(2006-8#1)(2008-1#1)(2008-5#1)(2010-12#1)(2012-3#1)
predisposing factors are##2##3##(2006-1#1)(2006-4#1)
predisposing factors for HIV infection##2##5##(2008-5#1)(2012-12#1)
predisposing factors for##5##3##(1996-9#1)(2007-8#1)(2008-5#1)(2012-12#1)(2012-2#1)
predisposing factors in##3##3##(1997-9#1)(2007-6#1)(2007-7#1)
predisposing factors leading##2##3##(2009-3#1)(2012-3#1)
predisposing factors like##2##3##(2007-7#1)(2012-12#1)
predisposing factors such as##2##4##(2011-1#1)(2011-2#1)
predisposing factors to##3##3##(2006-3#1)(2007-2#1)(2008-4#1)
predisposing factors##47##2##(1990-11#1)(1992-1#1)(1996-9#1)(1997-3#1)(1997-9#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-3#1)(2006-4#1)(2006-8#1)(2007-2#1)(2007-4#1)(2007-6#2)(2007-7#2)(2007-8#4)(2008-1#2)(2008-4#1)(2008-5#4)(2008-7#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-7#1)(2013-8#1)
predisposing gene is##2##3##(1993-1#1)(1993-10#1)
predisposing gene##3##2##(1993-1#1)(1993-10#1)(2008-8#1)
predisposing genetic##2##2##(2006-12#1)(2008-11#1)
predisposing lung conditions##2##3##(2007-12#2)
predisposing patients to##3##3##(2006-10#1)(2008-10#1)(2008-3#1)
predisposing risk##2##2##(1994-2#1)(2009-5#1)
predisposing them to##2##3##(2008-1#1)(2008-4#1)
predisposing them##3##2##(2004-10#1)(2008-1#1)(2008-4#1)
predisposing to##17##2##(1992-2#1)(1993-10#1)(1995-9#1)(1996-8#1)(1997-5#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-7#1)(2008-12#1)(2008-5#1)(2009-1#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
predisposing##136##1##(1990-11#2)(1991-10#2)(1991-2#1)(1991-8#2)(1992-1#1)(1992-2#1)(1992-4#1)(1993-1#1)(1993-10#4)(1994-11#1)(1994-2#1)(1994-4#1)(1994-5#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-8#1)(1997-9#1)(2004-10#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#8)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#7)(2007-8#7)(2008-1#5)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#7)(2008-7#2)(2008-8#1)(2009-1#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-6#2)(2011-1#4)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#6)(2013-7#1)(2013-8#1)
predisposition and environmental influences##2##4##(1995-2#1)(2008-10#1)
predisposition and environmental##4##3##(1995-2#1)(2008-10#1)(2008-3#1)(2012-2#1)
predisposition and##7##2##(1995-2#1)(2005-8#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2012-2#1)
predisposition for the##2##3##(2008-6#1)(2012-1#1)
predisposition for##6##2##(2008-3#2)(2008-6#1)(2012-1#1)(2013-1#2)
predisposition in##2##2##(2010-7#1)(2011-2#1)
predisposition is##5##2##(1997-3#1)(2008-11#1)(2008-5#1)(2009-10#1)(2011-2#1)
predisposition may have a##2##4##(2006-1#1)(2008-5#1)
predisposition may##6##2##(1997-8#1)(2006-1#1)(2006-10#1)(2008-1#1)(2008-5#1)(2011-2#1)
predisposition of##6##2##(1991-12#1)(1994-5#1)(2007-7#1)(2008-4#2)(2012-12#1)
predisposition or##2##2##(1996-12#1)(2007-2#1)
predisposition to LDL oxidation during copper-catalyzed oxidative modification##2##8##(1991-12#2)
predisposition to catalepsy##3##3##(2010-12#1)(2013-1#2)
predisposition to develop##3##3##(1993-6#1)(2006-2#1)(2007-11#1)
predisposition to the##3##3##(1990-5#1)(1992-9#1)(2012-11#1)
predisposition to##54##2##(1990-5#1)(1991-12#2)(1992-9#1)(1993-2#1)(1993-6#1)(1995-1#1)(1995-11#1)(1996-11#1)(1996-9#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#3)(2006-2#1)(2006-4#1)(2007-10#2)(2007-11#2)(2007-2#1)(2008-1#2)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-6#1)(2011-2#1)(2012-1#2)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#4)
predisposition##114##1##(1990-5#2)(1991-12#3)(1992-9#1)(1993-2#1)(1993-6#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2005-8#1)(2006-1#1)(2006-10#5)(2006-2#2)(2006-4#1)(2007-10#3)(2007-11#4)(2007-2#3)(2007-7#2)(2008-1#5)(2008-10#1)(2008-11#4)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#1)(2009-10#4)(2009-3#1)(2009-5#1)(2009-8#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-1#3)(2012-11#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#1)
predispositions and##2##2##(2008-10#1)(2009-7#1)
predispositions shape##2##2##(2013-7#2)
predispositions to##3##2##(1997-7#1)(2008-12#1)(2011-2#1)
predispositions##12##1##(1995-1#1)(1997-7#1)(2006-12#1)(2006-9#1)(2008-10#1)(2008-12#1)(2009-7#2)(2011-1#1)(2011-2#1)(2013-7#2)
predissociated##2##1##(2007-12#1)(2008-2#1)
predistortion technique##2##2##(2007-12#2)
prednisolone (40##2##2##(1990-10#1)(2012-12#1)
prednisolone (PSL)##2##2##(2006-4#2)
prednisolone 1##2##2##(2007-7#1)(2013-8#1)
prednisolone 30 mg daily##2##4##(2006-9#1)(2013-8#1)
prednisolone acetate##4##2##(2007-11#1)(2010-2#3)
prednisolone alone##3##2##(2007-8#3)
prednisolone and chlorambucil##3##3##(2010-4#3)
prednisolone and##10##2##(1991-12#1)(2006-10#1)(2008-1#1)(2008-4#1)(2010-4#3)(2010-7#1)(2013-1#1)(2013-8#1)
prednisolone dose##2##2##(2006-4#1)(2008-1#1)
prednisolone for treatment of##2##4##(1992-5#1)(1994-3#1)
prednisolone for##4##2##(1992-5#1)(1994-3#1)(2007-11#1)(2008-1#1)
prednisolone in##4##2##(1995-5#1)(2006-9#1)(2007-7#1)(2011-1#1)
prednisolone is##2##2##(2007-2#1)(2007-7#1)
prednisolone was##4##2##(1990-4#1)(1991-6#1)(2007-7#2)
prednisolone##87##1##(1990-10#1)(1990-4#1)(1991-12#1)(1991-5#1)(1991-6#2)(1992-2#2)(1992-5#1)(1993-11#2)(1994-3#1)(1995-5#2)(1997-8#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-4#6)(2006-9#5)(2007-11#5)(2007-12#1)(2007-2#2)(2007-7#11)(2007-8#8)(2008-1#7)(2008-10#1)(2008-4#1)(2009-8#1)(2010-12#1)(2010-2#3)(2010-4#3)(2010-7#1)(2011-1#3)(2011-12#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#4)
prednisolone)##2##1##(1990-10#1)(1995-8#1)
prednisone (CHOP)##2##2##(2005-10#1)(2011-2#1)
prednisone + cyclosporine +##2##4##(2007-8#2)
prednisone +##4##2##(1992-2#1)(2007-8#3)
prednisone 60 mg/m2##2##3##(1990-10#1)(2007-8#1)
prednisone and##5##2##(1991-5#1)(1994-12#1)(2007-8#1)(2010-6#1)(2013-1#1)
prednisone for##3##2##(1993-9#1)(1997-3#1)(2013-8#1)
prednisone in##6##2##(1990-10#1)(1993-6#1)(2007-8#1)(2008-1#2)(2009-8#1)
prednisone therapy##3##2##(2005-12#1)(2005-8#1)(2006-10#1)
prednisone##76##1##(1990-10#3)(1990-11#4)(1990-12#1)(1991-5#1)(1992-2#1)(1992-5#3)(1993-6#1)(1993-9#1)(1994-12#1)(1995-2#1)(1997-3#1)(1997-8#1)(2004-1#2)(2004-3#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-10#13)(2007-11#3)(2007-7#2)(2007-8#8)(2008-1#4)(2008-12#1)(2008-7#3)(2009-3#2)(2009-8#1)(2010-12#4)(2010-2#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
prednisone)##3##1##(1992-1#1)(2012-12#1)(2012-2#1)
predominance in the##3##3##(1994-12#2)(2013-8#1)
predominance in##9##2##(1991-9#1)(1993-1#1)(1994-12#2)(2006-10#1)(2008-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
predominance is##2##2##(1991-9#1)(1996-2#1)
predominance of a##4##3##(1990-12#1)(1993-2#1)(2010-9#1)(2013-8#1)
predominance of the##8##3##(1995-6#1)(2005-11#1)(2008-1#1)(2008-10#2)(2011-2#1)(2012-3#2)
predominance of##71##2##(1990-12#3)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-2#2)(1993-5#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-11#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#5)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-2#1)(2010-12#1)(2010-9#1)(2011-2#4)(2012-3#7)(2013-1#2)(2013-8#2)
predominance was##2##2##(2006-4#1)(2008-7#1)
predominance##107##1##(1990-12#3)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-9#3)(1992-6#1)(1992-9#1)(1993-1#2)(1993-2#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-9#1)(1995-2#1)(1995-6#1)(1995-7#1)(1996-11#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-10#2)(2005-11#1)(2005-8#2)(2006-1#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#2)(2007-7#3)(2007-8#2)(2008-1#5)(2008-10#8)(2008-12#2)(2008-3#2)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-2#1)(2009-9#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-3#8)(2013-1#3)(2013-8#3)
predominant action of##2##3##(1990-3#1)(2008-2#1)
predominant aerobic isolates##2##3##(2007-7#2)
predominant amino acids##2##3##(1994-8#1)(1997-8#1)
predominant amino##3##2##(1994-8#1)(1997-6#1)(1997-8#1)
predominant among the##2##3##(2007-8#2)
predominant among##4##2##(2007-8#2)(2008-10#1)(2008-11#1)
predominant anaerobic##2##2##(2006-8#1)(2011-1#1)
predominant and##2##2##(1994-2#1)(2013-8#1)
predominant bacteria##2##2##(2008-10#1)(2008-5#1)
predominant cause of##4##3##(1992-2#1)(1994-10#1)(1996-1#1)(2010-4#1)
predominant cell type in##2##4##(1995-6#1)(2011-1#1)
predominant cell##3##2##(1995-6#1)(2008-1#1)(2011-1#1)
predominant cells##2##2##(2009-8#1)(2013-1#1)
predominant clinical##6##2##(2007-10#1)(2007-8#1)(2008-9#2)(2009-6#1)(2011-2#1)
predominant component##2##2##(2008-10#1)(2008-12#1)
predominant conformation##3##2##(1993-3#1)(1995-1#1)(2005-7#1)
predominant expression of##4##3##(1991-1#1)(1991-12#1)(1996-7#1)(2005-10#1)
predominant expression##6##2##(1991-1#1)(1991-12#1)(1996-12#1)(1996-7#1)(2005-10#1)(2009-6#1)
predominant for##3##2##(1992-11#1)(1997-1#1)(2007-11#1)
predominant genotype in##3##3##(2009-3#1)(2010-12#1)(2013-8#1)
predominant genotype##4##2##(2008-10#1)(2009-3#1)(2010-12#1)(2013-8#1)
predominant glucose transporter##2##3##(1993-6#2)
predominant hepatic##3##2##(2008-3#1)(2013-1#2)
predominant in the##11##3##(1990-5#2)(1997-7#1)(2005-8#1)(2007-5#1)(2007-6#1)(2008-5#1)(2009-10#1)(2009-12#1)(2010-8#1)(2012-2#1)
predominant in##33##2##(1990-5#2)(1991-4#2)(1991-9#1)(1994-2#3)(1995-3#1)(1996-6#1)(1997-7#1)(2005-10#1)(2005-8#1)(2006-4#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#5)(2008-5#3)(2008-7#1)(2009-10#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
predominant initial##2##2##(1990-5#1)(2006-10#1)
predominant mode of##3##3##(2008-10#2)(2011-2#1)
predominant mode##5##2##(2008-10#4)(2011-2#1)
predominant molecular##2##2##(1992-12#1)(2008-8#1)
predominant mutations##2##2##(2008-4#2)
predominant organisms##4##2##(2007-12#1)(2007-3#1)(2007-8#2)
predominant pathogens##3##2##(2008-10#1)(2008-6#1)(2010-12#1)
predominant pattern##2##2##(2011-2#1)(2012-3#1)
predominant protein##4##2##(1991-8#1)(1994-2#1)(1995-3#1)(1996-8#1)
predominant reason for##2##3##(2005-8#1)(2006-10#1)
predominant role of##2##3##(1994-12#1)(2010-12#1)
predominant role##7##2##(1994-12#1)(1996-12#1)(2008-11#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-3#1)
predominant serotype##2##2##(2008-5#1)(2013-8#1)
predominant site of##2##3##(2005-8#1)(2008-10#1)
predominant species was##2##3##(2008-5#1)(2013-8#1)
predominant species##12##2##(1990-3#1)(1994-11#1)(1996-12#1)(2005-4#1)(2007-8#1)(2008-10#4)(2008-5#1)(2013-8#2)
predominant structure of the protonated trimers consisting of the two##2##10##(2006-3#2)
predominant throughout the##2##3##(1995-12#1)(2007-5#1)
predominant variant##2##2##(1994-8#1)(2012-1#1)
predominant##406##1##(1990-11#2)(1990-3#6)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#1)(1991-4#3)(1991-7#2)(1991-8#3)(1991-9#2)(1992-11#2)(1992-12#5)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#1)(1993-2#4)(1993-3#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#6)(1994-3#3)(1994-6#1)(1994-8#6)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-4#3)(1995-6#1)(1995-7#1)(1995-9#2)(1996-1#2)(1996-11#1)(1996-12#7)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#3)(1997-1#1)(1997-2#3)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-2#2)(2004-4#1)(2004-9#1)(2005-10#2)(2005-11#3)(2005-12#1)(2005-4#1)(2005-7#1)(2005-8#5)(2006-1#1)(2006-10#7)(2006-12#2)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#2)(2006-8#6)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#5)(2007-2#1)(2007-3#4)(2007-4#1)(2007-5#4)(2007-6#2)(2007-7#9)(2007-8#8)(2008-1#8)(2008-10#43)(2008-11#9)(2008-12#3)(2008-2#2)(2008-3#8)(2008-4#6)(2008-5#13)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#2)(2009-8#1)(2010-11#2)(2010-12#7)(2010-2#2)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#7)(2011-12#2)(2011-2#10)(2012-1#3)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#18)
predominantly CD4+##2##2##(2006-10#1)(2007-11#1)
predominantly a##6##2##(1991-2#1)(1992-12#1)(1997-4#1)(2006-10#1)(2008-7#1)(2009-7#1)
predominantly affects##2##2##(1990-5#1)(2012-2#1)
predominantly as##3##2##(1993-6#1)(1995-6#1)(2008-2#1)
predominantly associated with##3##3##(1997-1#1)(2010-2#1)(2012-2#1)
predominantly at the##3##3##(1991-7#1)(2008-10#1)(2008-3#1)
predominantly at##7##2##(1991-7#1)(1993-11#1)(1997-4#2)(2007-8#1)(2008-10#1)(2008-3#1)
predominantly based on##2##3##(2007-7#1)(2008-5#1)
predominantly been##2##2##(2008-3#1)(2011-1#1)
predominantly bound##2##2##(1992-12#1)(2010-6#1)
predominantly by a##3##3##(1993-7#1)(1993-9#1)(2013-8#1)
predominantly by the##4##3##(1990-11#1)(1992-6#1)(1995-5#1)(2007-1#1)
predominantly by##18##2##(1990-11#1)(1992-6#1)(1993-7#1)(1993-9#1)(1994-9#1)(1995-3#1)(1995-5#1)(1997-5#1)(2005-11#1)(2005-4#1)(2007-1#1)(2007-3#1)(2008-10#1)(2008-8#1)(2009-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
predominantly composed of##3##3##(1995-5#1)(2007-12#1)(2008-5#1)
predominantly consisted of##2##3##(1992-8#1)(2008-5#1)
predominantly cortical##2##2##(1993-11#1)(2007-8#1)
predominantly cytoplasmic##2##2##(1992-8#1)(2008-4#1)
predominantly detected in##2##3##(2008-10#2)
predominantly detected##3##2##(1992-3#1)(2008-10#2)
predominantly determined by##2##3##(1993-9#1)(2006-12#1)
predominantly driven by##2##3##(1992-7#1)(2008-9#1)
predominantly due to##5##3##(1991-8#1)(1996-10#1)(2007-5#1)(2008-6#1)(2009-7#1)
predominantly during##2##2##(1994-8#1)(1995-8#1)
predominantly express the##2##3##(1991-12#1)(2011-2#1)
predominantly expressed in the liver##2##5##(1995-8#1)(1997-5#1)
predominantly expressed in the nervous system##2##6##(1997-4#1)(2007-12#1)
predominantly expressed in the##11##4##(1992-11#1)(1994-2#1)(1995-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2007-12#1)(2008-7#1)(2013-8#2)
predominantly expressed in##18##3##(1992-11#1)(1992-8#1)(1994-2#1)(1995-10#1)(1995-8#2)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-8#1)(2013-8#2)
predominantly expressed##22##2##(1990-12#1)(1991-12#1)(1991-9#1)(1992-11#1)(1992-8#1)(1994-2#1)(1995-10#1)(1995-8#2)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-8#1)(2011-1#1)(2013-8#2)
predominantly extracellular##2##2##(1992-8#1)(1996-12#1)
predominantly facilitatory##2##2##(1991-10#2)
predominantly found in##4##3##(2008-10#1)(2008-7#3)
predominantly found##5##2##(1995-10#1)(2008-10#1)(2008-7#3)
predominantly from the##6##3##(1992-8#1)(1994-10#1)(2006-10#1)(2007-1#1)(2009-8#1)(2012-3#1)
predominantly from##9##2##(1992-8#1)(1993-2#1)(1994-10#1)(1995-8#1)(2006-10#1)(2007-1#1)(2008-10#1)(2009-8#1)(2012-3#1)
predominantly in the dimeric##2##4##(1990-4#1)(2008-9#1)
predominantly in the nucleus##3##4##(1990-6#1)(1995-7#1)(1996-1#1)
predominantly in the posterior fossa##2##5##(2008-7#2)
predominantly in the##47##3##(1990-4#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-2#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-7#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-2#1)(2005-8#2)(2006-10#2)(2007-12#1)(2007-3#1)(2007-9#2)(2008-1#2)(2008-10#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
predominantly in young##2##3##(1996-8#1)(2007-9#1)
predominantly in##81##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#3)(1990-6#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-7#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-2#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-4#2)(1997-5#1)(2005-8#2)(2006-10#3)(2006-12#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-9#3)(2008-1#2)(2008-10#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
predominantly localized in##3##3##(1992-7#1)(1994-12#1)(2008-10#1)
predominantly localized##4##2##(1992-7#1)(1994-12#1)(2008-10#1)(2008-3#1)
predominantly located in##3##3##(1992-1#1)(1992-11#1)(2008-9#1)
predominantly low##2##2##(2010-1#1)(2011-2#1)
predominantly male##4##2##(2006-10#1)(2009-10#1)(2012-12#1)(2012-2#1)
predominantly mediated by##3##3##(1992-3#1)(1992-8#1)(2008-8#1)
predominantly nuclear localization##2##3##(1990-2#1)(1991-5#1)
predominantly nuclear##4##2##(1990-2#1)(1991-5#1)(2009-7#1)(2012-12#1)
predominantly observed##2##2##(1993-9#1)(2010-5#1)
predominantly occurs in##2##3##(2007-11#1)(2009-10#1)
predominantly of##7##2##(1990-4#1)(1995-2#1)(1996-8#1)(2007-2#1)(2008-5#1)(2009-9#1)(2012-2#1)
predominantly on the##6##3##(1994-6#1)(1994-9#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-5#1)
predominantly on##16##2##(1992-12#1)(1993-8#1)(1994-6#1)(1994-9#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2009-2#1)(2010-11#1)(2012-2#1)
predominantly or exclusively##2##3##(2005-8#1)(2008-10#1)
predominantly positive##4##2##(2007-12#1)(2011-1#1)(2013-1#2)
predominantly round##2##2##(1991-9#1)(2008-6#1)
predominantly seen in##2##3##(1995-8#1)(2012-3#1)
predominantly simple##2##2##(1997-2#1)(2011-1#1)
predominantly somatic##2##2##(1990-10#1)(2006-6#1)
predominantly the##11##2##(1991-12#2)(1993-11#1)(1994-3#1)(1994-8#2)(1995-3#1)(2005-4#1)(2007-11#1)(2007-7#1)(2012-11#1)
predominantly through##2##2##(1993-11#1)(2008-10#1)
predominantly to one##2##3##(1991-2#1)(1996-2#1)
predominantly to the##2##3##(1992-1#1)(2006-12#1)
predominantly to##13##2##(1990-7#1)(1991-2#1)(1992-1#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-2#1)(1996-7#1)(1997-5#1)(2006-12#1)(2008-10#1)(2008-4#1)(2012-2#1)
predominantly under##2##2##(2005-10#1)(2006-10#1)
predominantly used##3##2##(2008-4#1)(2008-7#1)(2009-9#1)
predominantly via##3##2##(1993-6#1)(2007-12#1)(2011-2#1)
predominantly were##2##2##(2007-8#1)(2008-10#1)
predominantly with the##2##3##(1994-12#1)(1995-1#1)
predominantly with##3##2##(1994-10#1)(1994-12#1)(1995-1#1)
predominantly women##3##2##(1994-3#1)(2006-10#1)(2006-8#1)
predominantly##540##1##(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#5)(1990-6#1)(1990-7#3)(1990-9#1)(1991-1#1)(1991-10#3)(1991-12#7)(1991-2#3)(1991-3#3)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#3)(1992-1#4)(1992-10#1)(1992-11#4)(1992-12#6)(1992-3#4)(1992-4#3)(1992-6#3)(1992-7#4)(1992-8#8)(1992-9#2)(1993-11#4)(1993-12#2)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#4)(1994-1#1)(1994-10#2)(1994-11#3)(1994-12#7)(1994-2#3)(1994-3#4)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#7)(1994-9#3)(1995-1#2)(1995-10#3)(1995-12#4)(1995-2#6)(1995-3#3)(1995-5#3)(1995-6#2)(1995-7#1)(1995-8#8)(1996-1#3)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#5)(1996-7#2)(1996-8#2)(1997-1#2)(1997-2#4)(1997-4#8)(1997-5#6)(1997-6#2)(1997-7#2)(1997-8#2)(2004-11#1)(2004-2#1)(2004-9#1)(2005-10#2)(2005-11#1)(2005-4#2)(2005-7#1)(2005-8#5)(2005-9#2)(2006-10#15)(2006-12#7)(2006-2#3)(2006-5#1)(2006-6#1)(2006-8#4)(2007-1#3)(2007-10#1)(2007-11#10)(2007-12#13)(2007-2#3)(2007-3#2)(2007-5#2)(2007-7#6)(2007-8#6)(2007-9#4)(2008-1#6)(2008-10#24)(2008-11#4)(2008-12#3)(2008-2#8)(2008-3#6)(2008-4#9)(2008-5#12)(2008-6#4)(2008-7#10)(2008-8#5)(2008-9#6)(2009-10#3)(2009-11#4)(2009-2#4)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#6)(2009-8#3)(2009-9#4)(2010-1#2)(2010-11#2)(2010-12#5)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#8)(2011-2#12)(2012-1#3)(2012-11#2)(2012-12#8)(2012-2#12)(2012-3#9)(2013-1#14)(2013-7#2)(2013-8#4)
predominate in the##5##3##(1997-3#1)(2006-5#1)(2008-10#1)(2010-12#1)(2013-7#1)
predominate in##15##2##(1996-11#1)(1997-3#1)(2006-10#1)(2006-5#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-7#1)
predominate over##2##2##(1995-12#1)(1996-4#1)
predominate##43##1##(1990-11#1)(1991-6#1)(1993-4#1)(1994-9#1)(1995-12#2)(1995-4#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-3#1)(2005-10#1)(2006-10#4)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-6#1)(2011-2#1)(2013-1#2)(2013-7#1)
predominated at##2##2##(1994-11#1)(2013-1#1)
predominated by##2##2##(2009-8#1)(2010-9#1)
predominated in the##4##3##(2006-8#2)(2008-10#1)(2011-2#1)
predominated in##18##2##(1991-11#2)(1991-8#1)(1992-2#1)(1994-3#1)(1995-5#1)(2006-8#3)(2007-11#1)(2007-8#1)(2008-10#5)(2011-2#1)(2013-1#1)
predominated over the other##2##4##(2008-10#2)
predominated over##5##2##(2007-3#1)(2008-10#2)(2012-12#2)
predominated##59##1##(1990-11#1)(1990-12#1)(1990-6#1)(1991-11#2)(1991-5#1)(1991-8#1)(1992-2#1)(1993-6#1)(1994-11#2)(1994-3#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-5#1)(1995-8#1)(1996-6#1)(2006-8#4)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-4#1)(2008-5#4)(2008-8#1)(2009-8#2)(2010-1#1)(2010-12#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#3)(2013-1#2)(2013-7#1)
predominately in##3##2##(1995-11#1)(2008-10#1)(2008-8#1)
predominately of##3##2##(1992-7#1)(2007-12#1)(2009-10#1)
predominately##28##1##(1992-7#1)(1993-2#1)(1994-3#1)(1995-11#1)(1995-3#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-8#1)(2004-11#1)(2007-11#1)(2007-12#3)(2007-6#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-9#1)(2012-12#1)(2012-2#1)(2012-3#2)
predominates in##7##2##(1992-12#1)(1992-6#1)(1993-5#1)(1995-12#1)(2008-11#1)(2008-5#1)(2011-2#1)
predominates over the##3##3##(1991-5#1)(2008-12#1)(2008-4#1)
predominates over##4##2##(1991-5#1)(1993-9#1)(2008-12#1)(2008-4#1)
predominates##24##1##(1990-6#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-6#1)(1993-5#1)(1993-9#1)(1994-11#1)(1995-12#1)(1997-1#2)(1997-4#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
predominating above pH##2##3##(1992-12#1)(1995-10#1)
predominating in the##2##3##(1991-7#1)(2008-5#1)
predominating in##3##2##(1991-7#1)(2008-5#1)(2013-1#1)
predominating##19##1##(1990-11#1)(1991-2#1)(1991-7#1)(1992-12#2)(1995-10#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
predonation hemoglobin##2##2##(1996-9#2)
predonation##6##1##(1996-9#3)(2007-11#1)(2010-12#1)(2011-2#1)
predorsal##2##1##(1993-3#1)(2013-7#1)
predrawn##2##1##(1991-2#2)
preeclampsia and##7##2##(1996-11#1)(2007-10#2)(2008-10#1)(2008-11#2)(2010-8#1)
preeclampsia complicated with HELLP##2##4##(2008-4#2)
preeclampsia or hypertension##2##3##(2006-10#2)
preeclampsia or##3##2##(2006-10#2)(2008-3#1)
preeclampsia##50##1##(1993-10#1)(1993-4#2)(1995-2#1)(1996-11#1)(1996-12#1)(1997-8#1)(2004-10#1)(2006-10#3)(2007-10#3)(2007-9#2)(2008-10#1)(2008-11#7)(2008-3#1)(2008-4#3)(2009-1#1)(2009-8#3)(2010-8#1)(2011-2#7)(2012-12#3)(2012-2#6)(2013-1#1)
preeclampsia]##5##1##(1995-11#1)(2008-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
preeclamptic women##3##2##(2007-9#1)(2008-10#1)(2012-12#1)
preeclamptic##6##1##(2007-9#1)(2008-10#2)(2009-8#1)(2012-12#2)
preemption##2##1##(2006-8#1)(2008-5#1)
preemptive analgesia is##3##3##(2006-10#3)
preemptive analgesia##9##2##(2006-10#7)(2007-11#2)
preemptive transplant##2##2##(2011-2#2)
preemptive##22##1##(2006-10#8)(2006-9#1)(2007-11#3)(2007-4#1)(2008-10#2)(2008-8#1)(2010-2#1)(2011-2#4)(2012-1#1)
preemptively##2##1##(2006-8#1)(2008-7#1)
preening##3##1##(2011-2#3)
preestablished##3##1##(1993-9#1)(1994-3#1)(2012-1#1)
preexcitation syndrome##2##2##(2006-4#1)(2009-10#1)
preexcitation##4##1##(2006-4#3)(2009-10#1)
preexecution processes##2##2##(2012-3#2)
preexisting conditions##3##2##(1994-2#1)(2006-10#1)(2008-7#1)
preexisting pigmented skin lesion##2##4##(2007-10#2)
preexisting pigmented skin##3##3##(2007-10#3)
preexisting##54##1##(1990-11#1)(1992-3#1)(1992-8#1)(1993-11#1)(1994-2#1)(1995-1#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-9#2)(1997-3#1)(1997-6#1)(2004-1#1)(2006-10#2)(2006-2#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#2)(2007-7#1)(2007-9#3)(2008-1#2)(2008-10#2)(2008-6#3)(2008-7#1)(2008-8#2)(2009-11#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
preexponential##2##1##(2005-11#1)(2006-4#1)
preexposure on##3##2##(1991-5#2)(2008-4#1)
preexposure to##3##2##(1992-1#1)(1994-6#1)(2008-10#1)
preexposure##10##1##(1991-5#3)(1992-1#1)(1994-6#1)(2007-12#1)(2008-10#3)(2008-4#1)
prefabricated##8##1##(2007-10#1)(2007-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#1)
preface##4##1##(1994-3#1)(2009-11#1)(2009-4#1)(2010-5#1)
prefactor##3##1##(1995-11#1)(2005-11#1)(2006-10#1)
prefatigue values##2##2##(2013-8#2)
prefatory##2##1##(2008-10#1)(2010-7#1)
prefecture compared with##3##3##(1994-6#3)
prefecture##12##1##(1994-6#5)(2008-10#2)(2012-2#2)(2013-1#3)
prefecture)##2##1##(2010-1#1)(2012-2#1)
prefectures##5##1##(1994-6#2)(1997-3#1)(2008-10#1)(2011-2#1)
prefer a##2##2##(2004-10#1)(2012-3#1)
prefer it##2##2##(2007-7#1)(2010-5#1)
prefer males with##2##3##(2008-8#1)(2008-9#1)
prefer the term##2##3##(1992-5#1)(2006-10#1)
prefer the##4##2##(1992-5#1)(2006-10#1)(2007-4#1)(2008-4#1)
prefer to know the fetal sex as part of invasive##2##10##(2013-1#2)
prefer to seek##2##3##(2005-8#1)(2011-12#1)
prefer to##13##2##(1996-2#1)(1997-3#1)(2004-4#1)(2005-8#1)(2006-10#1)(2006-7#1)(2008-10#1)(2008-11#1)(2009-11#1)(2011-12#1)(2012-2#1)(2013-1#2)
prefer##47##1##(1992-5#2)(1993-10#1)(1993-3#1)(1993-6#1)(1996-2#1)(1997-3#1)(2004-10#1)(2004-4#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-6#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-5#2)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
preferable as##2##2##(1997-7#1)(2012-1#1)
preferable because of##3##3##(1991-12#1)(1997-8#1)(2011-2#1)
preferable for the##3##3##(2007-8#1)(2008-10#2)
preferable for##7##2##(1990-9#1)(2006-12#1)(2006-2#1)(2007-8#1)(2008-10#3)
preferable in##4##2##(1992-8#1)(1994-2#1)(2005-11#1)(2010-5#1)
preferable over##2##2##(1991-8#1)(1991-9#1)
preferable to the##2##3##(2008-3#1)(2012-12#1)
preferable to use##5##3##(2004-11#1)(2007-8#1)(2008-10#2)(2011-2#1)
preferable to##35##2##(1990-11#1)(1990-6#1)(1992-3#1)(1993-3#2)(1994-8#1)(1996-2#1)(1996-5#1)(2004-11#1)(2005-12#1)(2006-10#4)(2006-12#1)(2007-12#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-7#2)(2009-5#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)
preferable##85##1##(1990-11#1)(1990-6#1)(1990-9#1)(1991-12#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-8#2)(1993-3#3)(1994-12#1)(1994-2#1)(1994-8#1)(1995-6#1)(1996-2#2)(1996-5#1)(1996-7#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#2)(2005-12#1)(2006-10#5)(2006-12#2)(2006-2#1)(2007-1#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#3)(2007-9#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-3#5)(2008-5#1)(2008-7#4)(2008-8#1)(2009-2#1)(2009-5#2)(2010-11#1)(2010-5#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2013-1#4)(2013-8#1)
preferably after##2##2##(1994-8#1)(2005-12#1)
preferably be##6##2##(1991-5#1)(1991-6#1)(1991-7#1)(1993-2#1)(1993-6#1)(2008-4#1)
preferably by the##2##3##(1990-12#1)(2007-7#1)
preferably by##6##2##(1990-12#1)(1990-9#2)(1993-1#1)(2006-6#1)(2007-7#1)
preferably in##6##2##(2005-1#1)(2007-12#1)(2008-11#2)(2011-1#1)(2011-12#1)
preferably with a##2##3##(1990-3#1)(2006-2#1)
preferably with##4##2##(1990-3#1)(1990-5#1)(2006-2#1)(2008-2#1)
preferably##66##1##(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#2)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-7#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-5#1)(1996-6#1)(1997-3#1)(2005-1#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#6)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-8#2)(2009-12#3)(2009-8#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
prefered##3##1##(2007-3#3)
preference &quot##2##2##(1996-3#1)(2008-9#1)
preference after##2##2##(1992-12#1)(2008-5#1)
preference and the##3##3##(2008-2#1)(2008-8#1)(2011-2#1)
preference and##28##2##(1991-5#1)(1992-11#1)(1993-9#1)(1994-3#1)(1996-6#1)(1997-8#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-2#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-11#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#3)(2013-1#1)
preference are##2##2##(2005-11#1)(2007-12#1)
preference becomes more##2##3##(2007-4#1)(2008-9#1)
preference between##4##2##(1993-6#1)(1997-8#1)(2010-2#1)(2012-1#1)
preference did not change##2##4##(2008-11#1)(2010-3#1)
preference for Spanish language were associated with##2##7##(2009-5#2)
preference for a##4##3##(1992-7#1)(2008-11#1)(2010-2#1)(2010-9#1)
preference for an##2##3##(1996-12#1)(2007-2#1)
preference for each##2##3##(2008-2#1)(2008-8#1)
preference for female##4##3##(2009-1#1)(2009-4#3)
preference for the benzoyl peroxide foaming cloth##2##7##(2010-8#2)
preference for the formation of##2##5##(1992-3#1)(1994-9#1)
preference for the##18##3##(1990-11#1)(1991-2#1)(1992-3#2)(1992-7#1)(1994-6#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-8#1)(2005-11#1)(2007-11#1)(2008-4#1)(2008-9#1)(2010-8#2)
preference for thinness##2##3##(2006-7#1)(2007-12#1)
preference for##116##2##(1990-11#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-11#2)(1991-2#2)(1991-5#2)(1992-11#1)(1992-3#3)(1992-5#2)(1992-6#1)(1992-7#5)(1992-8#1)(1993-11#1)(1993-6#1)(1993-7#1)(1994-12#4)(1994-6#1)(1994-9#1)(1995-11#2)(1995-3#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-7#1)(1996-8#2)(1997-4#1)(1997-5#2)(1997-7#1)(2005-11#1)(2006-3#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-5#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#5)(2008-5#2)(2008-6#1)(2008-8#4)(2008-9#1)(2009-1#1)(2009-3#1)(2009-4#5)(2009-5#3)(2009-9#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
preference from##2##2##(1992-9#1)(1995-5#1)
preference given to##2##3##(1993-6#1)(2008-8#1)
preference given##3##2##(1993-6#1)(2005-7#1)(2008-8#1)
preference in a##3##3##(1992-9#1)(1994-8#1)(2012-2#1)
preference in mice##3##3##(1996-12#2)(2008-4#1)
preference in##28##2##(1990-11#2)(1991-1#1)(1992-6#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-11#1)(1996-1#1)(1996-12#6)(1997-5#1)(2007-12#1)(2008-1#1)(2008-4#2)(2009-12#2)(2009-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
preference is##10##2##(1992-3#1)(1992-6#1)(1992-9#1)(1993-6#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-3#1)
preference nor##2##2##(1992-9#1)(1996-12#1)
preference occurs##3##2##(2008-8#1)(2012-12#2)
preference of child objects was##2##5##(1991-3#2)
preference of glucose##2##3##(1990-11#1)(1991-10#1)
preference of the##8##3##(1991-4#1)(1991-6#1)(1992-11#1)(1995-1#1)(1997-7#1)(2008-4#1)(2010-10#1)(2012-3#1)
preference of##36##2##(1990-11#1)(1990-7#1)(1991-10#3)(1991-3#2)(1991-4#2)(1991-6#1)(1992-11#2)(1992-9#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-5#1)(1997-7#1)(2006-12#1)(2006-6#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-4#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-8#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#1)
preference on##5##2##(1994-3#1)(2009-11#2)(2009-12#2)
preference or##3##2##(1992-9#1)(2008-8#1)(2011-2#1)
preference test and operant conditioning##2##5##(2010-2#2)
preference test and##3##3##(1994-8#1)(2010-2#2)
preference test in##2##3##(1997-2#1)(2008-4#1)
preference test##6##2##(1992-3#1)(1994-8#1)(1997-2#1)(2008-4#1)(2010-2#2)
preference tests##4##2##(2008-10#1)(2008-11#1)(2008-5#2)
preference to be##2##3##(2009-1#1)(2009-12#1)
preference to##22##2##(1991-11#1)(1991-2#1)(1992-8#1)(1993-12#1)(1995-10#3)(2005-8#1)(2006-12#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-9#4)(2009-1#1)(2009-12#1)(2011-2#1)(2012-12#2)
preference was also##2##3##(1992-7#1)(1996-12#1)
preference was##12##2##(1991-1#1)(1991-10#1)(1992-11#2)(1992-7#1)(1995-5#1)(1996-12#1)(1997-2#1)(2008-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
preference were##5##2##(1991-10#1)(1992-3#1)(1996-12#1)(2007-12#2)
preference with##2##2##(1992-7#1)(2008-10#1)
preference##435##1##(1990-11#4)(1990-2#7)(1990-4#1)(1990-7#3)(1990-9#1)(1991-1#4)(1991-10#5)(1991-11#3)(1991-2#3)(1991-3#2)(1991-4#2)(1991-5#4)(1991-6#1)(1991-7#1)(1992-10#1)(1992-11#7)(1992-12#1)(1992-3#8)(1992-5#2)(1992-6#5)(1992-7#8)(1992-8#3)(1992-9#12)(1993-11#2)(1993-12#1)(1993-4#1)(1993-6#5)(1993-7#1)(1993-9#4)(1994-12#6)(1994-2#3)(1994-3#2)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#10)(1995-11#4)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#2)(1995-8#1)(1996-1#2)(1996-10#4)(1996-12#14)(1996-2#3)(1996-3#1)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#3)(1997-7#2)(1997-8#2)(2004-12#1)(2005-11#3)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-5#3)(2006-6#1)(2006-7#2)(2007-10#1)(2007-11#3)(2007-12#12)(2007-2#2)(2007-4#1)(2007-5#2)(2007-6#3)(2007-7#1)(2007-8#3)(2007-9#3)(2008-1#3)(2008-10#15)(2008-11#12)(2008-2#5)(2008-3#1)(2008-4#13)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#19)(2008-9#11)(2009-1#2)(2009-11#4)(2009-12#10)(2009-3#2)(2009-4#5)(2009-5#3)(2009-7#1)(2009-8#5)(2009-9#4)(2010-10#2)(2010-12#3)(2010-2#8)(2010-3#4)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#2)(2011-2#7)(2012-1#4)(2012-11#1)(2012-12#11)(2012-2#11)(2012-3#4)(2013-1#6)(2013-7#2)(2013-8#3)
preference)##2##1##(2008-8#2)
preferences among##2##2##(2008-2#1)(2011-2#1)
preferences and##23##2##(1992-2#1)(1992-9#1)(1995-5#1)(1995-6#1)(2006-5#1)(2006-7#2)(2007-12#4)(2007-5#1)(2008-10#1)(2008-12#1)(2009-8#1)(2010-2#1)(2010-9#2)(2012-2#3)(2013-1#2)
preferences are##6##2##(2006-10#1)(2008-8#1)(2008-9#1)(2009-9#2)(2010-11#1)
preferences at##2##2##(1993-3#1)(2012-3#1)
preferences between##3##2##(2007-12#1)(2008-9#1)(2011-2#1)
preferences by##4##2##(2008-10#1)(2008-8#1)(2008-9#1)(2012-12#1)
preferences can be##2##3##(2007-12#1)(2008-8#1)
preferences for body##3##3##(2007-12#3)
preferences for different##3##3##(2008-5#1)(2009-9#1)(2010-8#1)
preferences for involvement in##2##4##(1993-12#1)(2008-7#1)
preferences for substance abuse treatment##2##5##(2008-3#2)
preferences for the##5##3##(1992-3#1)(1992-9#1)(2008-8#2)(2013-1#1)
preferences for##56##2##(1990-3#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-3#2)(1996-11#1)(2005-10#1)(2006-5#1)(2007-1#1)(2007-12#6)(2007-2#1)(2007-6#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#6)(2008-9#3)(2009-11#2)(2009-9#6)(2010-1#2)(2010-8#1)(2011-1#2)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#4)(2013-7#1)
preferences have##3##2##(2008-8#1)(2008-9#1)(2011-2#1)
preferences in a##2##3##(2008-11#1)(2011-2#1)
preferences in the##5##3##(1990-2#1)(1990-9#1)(1996-11#1)(2009-6#1)(2010-8#1)
preferences in##25##2##(1990-2#1)(1990-9#1)(1994-8#1)(1995-11#1)(1996-11#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-11#2)(2009-6#1)(2009-9#3)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-7#1)
preferences of the##2##3##(1990-10#1)(2008-5#1)
preferences of these##5##3##(1990-10#1)(1993-6#1)(1996-5#1)(2008-7#1)(2011-2#1)
preferences of##33##2##(1990-10#2)(1991-11#1)(1993-6#1)(1995-2#1)(1995-5#1)(1996-5#1)(2006-7#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#2)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
preferences on##3##2##(2007-12#1)(2008-5#1)(2010-3#1)
preferences regarding##5##2##(2010-4#2)(2012-11#1)(2012-12#1)(2012-2#1)
preferences than##2##2##(2012-12#1)(2012-3#1)
preferences to##5##2##(2007-4#1)(2008-8#2)(2010-1#1)(2012-12#1)
preferences using##2##2##(2008-11#1)(2013-7#1)
preferences were##4##2##(1993-12#1)(2008-7#1)(2010-3#1)(2012-12#1)
preferences##261##1##(1990-10#2)(1990-2#1)(1990-3#1)(1990-9#1)(1991-11#1)(1991-7#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-9#4)(1993-11#2)(1993-12#3)(1993-3#1)(1993-6#4)(1994-12#1)(1994-3#2)(1994-6#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-5#3)(1995-6#1)(1995-8#1)(1996-11#2)(1996-2#1)(1996-5#1)(1997-2#2)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#4)(2006-2#1)(2006-4#1)(2006-5#5)(2006-7#4)(2006-8#4)(2007-1#1)(2007-11#1)(2007-12#16)(2007-2#1)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#4)(2008-7#9)(2008-8#17)(2008-9#11)(2009-11#5)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#11)(2010-1#3)(2010-11#3)(2010-12#1)(2010-2#3)(2010-3#2)(2010-4#4)(2010-7#1)(2010-8#5)(2010-9#3)(2011-1#5)(2011-10#1)(2011-2#8)(2012-1#1)(2012-11#2)(2012-12#11)(2012-2#7)(2012-3#5)(2013-1#9)(2013-7#3)(2013-8#3)
preferences)##2##1##(2008-11#1)(2012-1#1)
preferential accumulation of##4##3##(1995-3#1)(1996-5#1)(2008-11#1)(2012-2#1)
preferential action##2##2##(1990-3#1)(1990-4#1)
preferential activation of##3##3##(1994-8#1)(2005-10#1)(2008-10#1)
preferential activation to objects##2##4##(1995-8#2)
preferential activation to##3##3##(1995-8#3)
preferential activation##7##2##(1994-8#1)(1995-8#3)(2005-10#1)(2008-10#1)(2010-12#1)
preferential activity##2##2##(1990-2#1)(1995-2#1)
preferential affinity##3##2##(1991-2#2)(1995-12#1)
preferential binding of##4##3##(1991-4#1)(1994-12#1)(1996-11#1)(2009-3#1)
preferential binding to##2##3##(1995-8#1)(1997-2#1)
preferential binding##9##2##(1991-4#1)(1993-9#1)(1994-12#1)(1995-8#1)(1996-11#1)(1997-2#2)(2009-3#2)
preferential coupling of##2##3##(1994-3#1)(2008-3#1)
preferential degradation of##2##3##(2006-10#2)
preferential detection of##2##3##(2008-2#2)
preferential distribution##2##2##(2009-12#2)
preferential expansion of##2##3##(1996-10#2)
preferential expression in##2##3##(1997-4#1)(1997-6#1)
preferential expression##3##2##(1996-2#1)(1997-4#1)(1997-6#1)
preferential induction of##2##3##(1991-12#1)(1997-7#1)
preferential inhibition of##2##3##(1991-4#1)(1995-11#1)
preferential interaction of##2##3##(1995-5#1)(1997-7#1)
preferential interaction##3##2##(1995-5#1)(1997-2#1)(1997-7#1)
preferential localization of##3##3##(1990-2#1)(1994-2#1)(1995-12#1)
preferential looking##3##2##(1992-7#3)
preferential loss of##2##3##(2007-11#2)
preferential participation of##2##3##(1993-11#1)(1995-12#1)
preferential site of##3##3##(1992-3#1)(1993-8#1)(1997-2#1)
preferential solvation of lysozyme##2##4##(1997-7#2)
preferential solvation##7##2##(1997-7#5)(2008-10#1)(2010-7#1)
preferential uptake of##2##3##(1997-1#1)(2008-10#1)
preferential##149##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#2)(1990-7#1)(1991-12#1)(1991-2#4)(1991-4#3)(1991-5#3)(1991-6#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-7#3)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#2)(1995-8#4)(1996-10#2)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#6)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#8)(2005-10#1)(2005-11#3)(2005-12#1)(2005-8#1)(2006-10#3)(2006-2#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#2)(2009-6#1)(2009-7#1)(2010-12#1)(2010-2#2)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
preferential-order volume grating waveguide##2##4##(2008-3#2)
preferential-order##4##1##(2007-12#1)(2008-2#1)(2008-3#2)
preferentially accumulated##3##2##(1990-12#1)(1995-3#1)(1997-1#1)
preferentially activated by##2##3##(2008-11#1)(2008-4#1)
preferentially active##3##2##(1991-9#1)(1995-11#1)(2006-8#1)
preferentially affect##2##2##(2005-8#1)(2012-1#1)
preferentially associated with##2##3##(1992-9#1)(1995-3#1)
preferentially at the##2##3##(2010-2#1)(2011-1#1)
preferentially at##3##2##(2008-4#1)(2010-2#1)(2011-1#1)
preferentially attached##2##2##(1994-6#1)(2008-1#1)
preferentially attend to##3##3##(2008-9#1)(2009-11#1)(2012-1#1)
preferentially bind to##3##3##(1995-1#1)(1995-10#1)(2010-7#1)
preferentially bind##4##2##(1991-4#1)(1995-1#1)(1995-10#1)(2010-7#1)
preferentially binds the##3##3##(1994-8#1)(1995-10#1)(1995-11#1)
preferentially binds to##2##3##(1993-8#1)(2007-11#1)
preferentially binds##6##2##(1993-8#1)(1994-8#1)(1995-10#1)(1995-11#1)(2007-11#1)(2008-11#1)
preferentially by##5##2##(1990-12#1)(1990-5#1)(1991-7#1)(1993-11#1)(2005-8#1)
preferentially cleaved##2##2##(1992-12#1)(1993-3#1)
preferentially cleaves##2##2##(1990-10#1)(1993-3#1)
preferentially coupled to##2##3##(1994-3#1)(1994-6#1)
preferentially during the night##2##4##(1994-6#1)(2010-8#1)
preferentially expressed in the##2##4##(1997-2#1)(2008-2#1)
preferentially expressed in##9##3##(1991-12#1)(1994-8#1)(1997-2#1)(2008-2#2)(2008-8#1)(2009-10#1)(2009-4#1)(2010-1#1)
preferentially expressed##11##2##(1991-12#1)(1994-8#1)(1995-8#1)(1997-2#1)(1997-4#1)(2008-2#2)(2008-8#1)(2009-10#1)(2009-4#1)(2010-1#1)
preferentially hydrolyzed##2##2##(1992-8#1)(2012-2#1)
preferentially in the##6##3##(1990-5#1)(1991-2#1)(1994-12#1)(1994-3#1)(1997-2#1)(2010-8#1)
preferentially in##14##2##(1990-5#1)(1991-2#1)(1992-11#1)(1994-12#1)(1994-3#1)(1995-5#1)(1997-2#3)(2005-10#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-8#1)
preferentially induced##3##2##(1996-12#1)(2008-10#1)(2008-5#1)
preferentially inhibit##2##2##(1990-2#1)(2013-1#1)
preferentially inhibited##3##2##(1995-2#1)(2008-10#1)(2008-5#1)
preferentially into the##2##3##(1991-2#1)(2007-12#1)
preferentially into##4##2##(1990-4#2)(1991-2#1)(2007-12#1)
preferentially located on##2##3##(1990-5#1)(1994-9#1)
preferentially on##2##2##(1995-4#1)(2007-7#1)
preferentially oriented##2##2##(2008-2#1)(2008-3#1)
preferentially over##3##2##(2007-12#1)(2007-8#1)(2008-3#1)
preferentially reacted with##2##3##(1990-3#1)(1994-6#1)
preferentially removed by##2##3##(2007-5#1)(2008-5#1)
preferentially stimulated in##2##3##(1991-12#1)(2005-10#1)
preferentially the##2##2##(1990-3#1)(1993-11#1)
preferentially those##2##2##(2005-11#1)(2008-5#1)
preferentially to a##2##3##(1992-12#1)(1992-4#1)
preferentially to the##10##3##(1992-3#1)(1992-5#1)(1993-9#1)(1994-12#1)(1994-5#2)(1996-2#1)(1997-2#1)(2008-8#1)(2009-8#1)
preferentially to##25##2##(1990-12#2)(1991-8#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-11#1)(1993-9#2)(1994-12#2)(1994-5#2)(1995-5#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#2)(2006-10#1)(2007-11#1)(2008-8#1)(2009-4#1)(2009-8#1)
preferentially used##3##2##(1990-10#1)(1996-4#1)(1997-1#1)
preferentially with the##2##3##(1990-5#1)(1995-5#1)
preferentially with##4##2##(1990-5#1)(1995-5#1)(1997-4#1)(2008-10#1)
preferentially##252##1##(1990-10#2)(1990-11#2)(1990-12#5)(1990-2#2)(1990-3#2)(1990-4#2)(1990-5#4)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#3)(1992-3#3)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#2)(1993-11#3)(1993-12#1)(1993-3#4)(1993-6#3)(1993-7#2)(1993-8#1)(1993-9#4)(1994-12#4)(1994-3#4)(1994-5#4)(1994-6#6)(1994-8#3)(1994-9#5)(1995-1#1)(1995-10#2)(1995-11#3)(1995-12#2)(1995-2#2)(1995-3#2)(1995-4#2)(1995-5#7)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#6)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-10#2)(2005-11#2)(2005-8#2)(2006-10#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-3#2)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#3)(2008-2#5)(2008-3#4)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#2)(2009-11#2)(2009-12#2)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#3)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#2)(2012-1#3)(2012-12#6)(2012-2#3)(2013-1#1)(2013-8#2)
preferred a##3##2##(2007-12#1)(2007-7#1)(2008-7#1)
preferred alternative to##2##3##(2008-2#1)(2013-1#1)
preferred alternative##4##2##(1997-6#1)(2008-2#1)(2011-1#1)(2013-1#1)
preferred an average-length call over##2##5##(2009-9#2)
preferred and##3##2##(2008-3#1)(2008-9#1)(2013-7#1)
preferred as##2##2##(2007-12#1)(2008-5#1)
preferred because##2##2##(1991-10#1)(2008-4#1)
preferred by the##2##3##(2007-11#1)(2011-2#1)
preferred by##7##2##(1992-12#1)(1996-8#1)(1997-7#1)(2007-11#1)(2008-10#1)(2009-3#1)(2011-2#1)
preferred cleavage##2##2##(1994-12#2)
preferred conformations of##3##3##(1990-12#1)(1991-7#2)
preferred drug##2##2##(2011-10#1)(2013-1#1)
preferred for patients##2##3##(2006-10#1)(2008-3#1)
preferred for##10##2##(1992-8#1)(2005-12#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)
preferred form of##2##3##(1993-12#1)(2007-7#1)
preferred host##2##2##(2008-9#1)(2011-2#1)
preferred if##2##2##(2007-10#1)(2008-4#1)
preferred in all##2##3##(1991-6#1)(1996-12#1)
preferred in terms of##2##4##(2005-11#1)(2007-11#1)
preferred in the##3##3##(1992-4#1)(2008-3#1)(2010-12#1)
preferred in##15##2##(1991-6#1)(1992-4#1)(1996-12#1)(1997-3#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-3#3)(2009-4#1)(2010-12#1)(2010-5#1)(2011-12#1)(2011-2#1)
preferred initial##2##2##(1996-9#2)
preferred method for##7##3##(2005-10#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-4#1)(2009-12#1)(2011-1#1)
preferred method of##6##3##(1994-1#1)(2005-10#1)(2007-2#1)(2007-7#1)(2008-7#1)(2010-7#1)
preferred method##15##2##(1994-1#1)(2005-10#2)(2006-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-7#1)(2011-1#1)
preferred more##2##2##(2008-7#2)
preferred music##3##2##(2007-6#2)(2010-8#1)
preferred orientation in##2##3##(2010-4#1)(2013-7#1)
preferred orientation##16##2##(1995-10#1)(1995-3#1)(1995-6#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-8#1)(2010-4#1)(2013-7#7)
preferred over the##2##3##(2010-8#1)(2013-1#1)
preferred over##14##2##(1991-11#1)(1991-4#2)(1995-2#2)(2007-2#1)(2008-6#1)(2010-11#2)(2010-8#2)(2011-2#1)(2012-12#1)(2013-1#1)
preferred pathway##2##2##(1995-1#1)(2005-11#1)
preferred private##2##2##(2012-2#1)(2012-3#1)
preferred procedure for##2##3##(2011-2#2)
preferred provider organizations (PPOs)##2##4##(1991-3#1)(1994-1#1)
preferred provider organizations##4##3##(1991-3#1)(1992-2#1)(1993-12#1)(1994-1#1)
preferred provider##6##2##(1991-3#2)(1992-2#1)(1993-12#1)(1994-1#1)(2008-4#1)
preferred resources##2##2##(2008-9#2)
preferred shared##2##2##(2008-7#2)
preferred stimuli)##2##2##(2008-1#2)
preferred strategy for##2##3##(1996-12#1)(2012-3#1)
preferred strategy##5##2##(1996-12#1)(2008-5#1)(2012-3#3)
preferred substrate for##2##3##(1990-7#1)(1991-5#1)
preferred substrate##5##2##(1990-7#1)(1991-4#2)(1991-5#1)(1995-10#1)
preferred surgical##3##2##(2008-5#1)(2011-2#1)(2013-8#1)
preferred target##3##2##(1991-5#1)(2010-12#1)(2011-2#1)
preferred teaching##2##2##(2012-2#1)(2013-8#1)
preferred technique for##3##3##(2004-2#1)(2007-8#1)(2008-7#1)
preferred technique##8##2##(1996-6#1)(2004-2#1)(2006-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)
preferred temperature##2##2##(2011-2#2)
preferred the m-OSCE to the##2##5##(2012-1#2)
preferred the##14##2##(1992-3#1)(1995-12#1)(1995-5#1)(1995-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-3#1)(2011-2#1)(2012-1#2)(2013-1#1)(2013-8#1)
preferred to the##5##3##(1990-8#1)(1991-4#1)(1996-12#1)(1996-3#1)(2012-1#1)
preferred to use##2##3##(1993-12#1)(2013-8#1)
preferred to visit##2##3##(2008-8#2)
preferred to##30##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-4#1)(1993-12#1)(1994-6#1)(1995-4#1)(1996-1#1)(1996-12#2)(1996-3#1)(2006-10#1)(2006-12#1)(2006-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#2)(2009-5#1)(2009-9#1)(2012-1#1)(2012-12#1)(2013-1#3)(2013-8#2)
preferred treatment##11##2##(1996-3#1)(2005-12#2)(2006-10#1)(2006-5#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-3#1)(2010-3#1)
preferred using##2##2##(1993-2#1)(2013-8#1)
preferred walking##2##2##(1996-6#1)(2011-1#1)
preferred##415##1##(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-3#3)(1991-4#5)(1991-5#2)(1991-6#2)(1991-7#4)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#3)(1993-10#1)(1993-11#3)(1993-12#7)(1993-2#4)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-6#2)(1994-7#2)(1994-9#2)(1995-1#4)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#2)(1996-12#4)(1996-2#1)(1996-3#3)(1996-5#3)(1996-6#2)(1996-8#2)(1996-9#3)(1997-2#2)(1997-3#3)(1997-4#2)(1997-6#3)(1997-7#1)(1997-8#1)(2004-11#2)(2004-2#1)(2005-10#3)(2005-11#3)(2005-12#3)(2005-8#3)(2006-10#10)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#4)(2006-7#1)(2007-10#2)(2007-11#3)(2007-12#8)(2007-2#3)(2007-5#1)(2007-6#7)(2007-7#8)(2007-8#7)(2008-1#10)(2008-10#15)(2008-11#7)(2008-2#6)(2008-3#9)(2008-4#7)(2008-5#13)(2008-6#4)(2008-7#12)(2008-8#8)(2008-9#10)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#2)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#5)(2010-10#2)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#6)(2011-10#1)(2011-12#1)(2011-2#15)(2012-1#3)(2012-12#4)(2012-2#6)(2012-3#4)(2012-5#1)(2013-1#12)(2013-7#10)(2013-8#17)
preferring##14##1##(1994-5#2)(1995-6#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-9#1)(2009-9#5)(2010-12#1)
prefers the##4##2##(1994-5#1)(1996-8#1)(2008-8#1)(2009-10#1)
prefers to##4##2##(1994-11#1)(1996-8#1)(1997-4#1)(2008-4#1)
prefers##11##1##(1991-8#1)(1993-6#1)(1994-11#1)(1994-5#1)(1996-8#2)(1997-4#1)(1997-7#1)(2008-4#1)(2008-8#1)(2009-10#1)
prefiguring the##2##2##(2008-7#1)(2009-8#1)
prefiltering##2##1##(2008-2#1)(2012-3#1)
prefixes##2##1##(1993-12#1)(2008-9#1)
preflexion##3##1##(2008-5#3)
preflight##3##1##(2008-2#1)(2008-3#2)
preform was##2##2##(1990-8#1)(2008-2#1)
preform##8##1##(1990-8#1)(2007-12#2)(2008-2#3)(2008-3#2)
preformed DAPs in##2##3##(2010-5#2)
preformed DAPs##4##2##(2010-5#4)
preformed GroEL##2##2##(1996-4#2)
preformed antifungal diene##2##3##(2008-10#2)
preformed antifungal##3##2##(2008-10#3)
preformed in the##2##3##(1990-12#1)(2008-10#1)
preformed in##5##2##(1990-12#1)(1995-6#1)(2008-10#2)(2008-11#1)
preformed metal##3##2##(2011-1#1)(2013-1#2)
preformed plasma##2##2##(2008-1#2)
preformed##58##1##(1990-11#3)(1990-12#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-8#1)(1995-2#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-4#2)(2004-4#1)(2005-11#1)(2007-11#3)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-4#1)(2008-5#5)(2009-12#1)(2009-2#2)(2009-5#1)(2010-12#1)(2010-5#4)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#2)
preformulated##2##1##(2007-10#1)(2008-4#1)
preformulation studies##2##2##(2004-12#1)(2011-2#1)
prefractionation is##2##2##(2008-4#2)
prefractionation##6##1##(2008-4#4)(2008-7#2)
prefrontal activation##2##2##(2008-11#1)(2008-9#1)
prefrontal activity##2##2##(2008-11#2)
prefrontal and parietal##2##3##(1994-2#2)
prefrontal and##9##2##(1993-12#1)(1994-2#2)(1994-5#1)(1997-2#1)(1997-6#1)(2008-11#1)(2009-10#1)(2010-2#1)
prefrontal area of the##2##4##(1994-8#1)(2010-2#1)
prefrontal area##4##2##(1994-8#1)(1996-2#1)(2010-2#1)(2011-2#1)
prefrontal cortex (DLPFC)##5##3##(2006-9#1)(2008-10#2)(2008-11#1)(2011-2#1)
prefrontal cortex (PFC)##6##3##(1996-5#1)(1997-2#1)(2008-11#1)(2008-7#1)(2013-8#2)
prefrontal cortex and the##4##4##(1994-8#1)(1997-6#1)(2008-11#1)(2008-7#1)
prefrontal cortex and##12##3##(1991-12#1)(1991-6#1)(1994-3#1)(1994-8#1)(1997-6#1)(2008-11#4)(2008-7#1)(2012-2#1)(2013-8#1)
prefrontal cortex in the##2##4##(1996-10#1)(2008-11#1)
prefrontal cortex in##8##3##(1993-5#1)(1995-1#1)(1995-11#1)(1996-10#1)(1997-2#1)(2006-9#1)(2008-11#1)(2010-7#1)
prefrontal cortex induced by##2##4##(1994-8#1)(1997-2#1)
prefrontal cortex is##4##3##(2008-11#1)(2008-6#2)(2009-10#1)
prefrontal cortex lesions##2##3##(1991-1#1)(1993-9#1)
prefrontal cortex may##2##3##(2008-12#1)(2009-10#1)
prefrontal cortex of the rat##2##5##(1994-3#1)(1996-10#1)
prefrontal cortex of the##3##4##(1993-2#1)(1994-3#1)(1996-10#1)
prefrontal cortex of##10##3##(1993-2#1)(1994-3#1)(1995-12#1)(1996-10#1)(1997-5#2)(2008-10#1)(2009-12#2)(2010-2#1)
prefrontal cortex that##2##3##(1995-1#1)(2007-8#1)
prefrontal cortex with##2##3##(2010-2#1)(2013-8#1)
prefrontal cortex##131##2##(1991-1#2)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#2)(1993-2#3)(1993-5#4)(1993-6#1)(1993-9#2)(1994-12#1)(1994-2#2)(1994-3#4)(1994-6#2)(1994-8#5)(1995-1#2)(1995-11#3)(1995-12#3)(1996-10#6)(1996-2#4)(1996-4#1)(1996-5#3)(1997-2#3)(1997-5#2)(1997-6#2)(1997-8#1)(2004-11#2)(2006-9#2)(2007-8#3)(2007-9#2)(2008-10#4)(2008-11#20)(2008-12#1)(2008-6#4)(2008-7#3)(2008-9#2)(2009-1#1)(2009-10#3)(2009-12#2)(2009-2#2)(2010-12#1)(2010-2#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#2)(2013-8#4)
prefrontal cortical##9##2##(1991-2#2)(1995-11#1)(1995-12#1)(2006-4#1)(2008-6#1)(2010-2#2)(2011-2#1)
prefrontal cortices##5##2##(1992-9#1)(1995-11#2)(2009-4#1)(2013-8#1)
prefrontal lesions##3##2##(1993-3#3)
prefrontal lobe##3##2##(2008-11#1)(2012-1#1)(2012-12#1)
prefrontal regions##4##2##(1995-11#1)(1995-6#1)(2008-11#2)
prefrontal sulcal prominence##5##3##(1996-7#5)
prefrontal##208##1##(1990-2#1)(1991-1#2)(1991-12#1)(1991-2#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-9#1)(1993-12#1)(1993-2#3)(1993-3#4)(1993-5#4)(1993-6#1)(1993-9#2)(1994-12#1)(1994-2#4)(1994-3#4)(1994-5#1)(1994-6#2)(1994-8#7)(1995-1#3)(1995-11#7)(1995-12#5)(1995-6#3)(1996-10#6)(1996-2#5)(1996-4#1)(1996-5#4)(1996-7#5)(1997-2#6)(1997-5#6)(1997-6#4)(1997-8#4)(2004-11#2)(2006-4#2)(2006-9#3)(2007-8#4)(2007-9#2)(2008-10#4)(2008-11#31)(2008-12#2)(2008-6#5)(2008-7#3)(2008-9#3)(2009-1#1)(2009-10#4)(2009-12#2)(2009-2#2)(2009-4#1)(2010-12#1)(2010-2#6)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#5)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#5)
prefrontal-striatal##2##1##(2008-2#1)(2009-7#1)
pregabalin##5##1##(2008-9#1)(2011-1#4)
preganglionic neurones##3##2##(1995-12#3)
preganglionic neurons in the##3##4##(1992-1#3)
preganglionic neurons were##3##3##(1992-1#1)(1993-7#2)
preganglionic neurons##14##2##(1991-6#1)(1992-1#5)(1993-12#1)(1993-7#4)(1995-7#2)(1996-12#1)
preganglionic neuropils##3##2##(1992-1#3)
preganglionic perikarya and##2##3##(1992-1#2)
preganglionic somas##2##2##(1992-1#2)
preganglionic sympathetic neurones##2##3##(1995-12#2)
preganglionic##32##1##(1991-6#1)(1992-1#15)(1993-12#1)(1993-7#4)(1993-9#1)(1995-12#5)(1995-7#2)(1996-12#1)(2008-9#2)
pregastric##2##1##(1996-9#2)
pregenual##2##1##(2009-10#1)(2009-2#1)
pregestational##3##1##(2008-1#2)(2011-2#1)
preglobular##2##1##(2011-2#2)
pregnacy##2##1##(2007-11#1)(2013-1#1)
pregnancies after in vitro fertilization##2##5##(1995-6#2)
pregnancies after surgery##2##3##(1994-12#1)(2011-2#1)
pregnancies after##4##2##(1994-12#1)(1995-6#2)(2011-2#1)
pregnancies and lactations##2##3##(1992-5#2)
pregnancies and##23##2##(1991-3#1)(1992-4#1)(1992-5#2)(1993-3#1)(1994-4#1)(1996-8#1)(1997-2#1)(2004-10#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-1#1)(2009-3#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-3#2)
pregnancies are more##2##3##(1993-1#1)(2008-7#1)
pregnancies are##6##2##(1991-6#1)(1993-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
pregnancies by##2##2##(1992-6#1)(2013-1#1)
pregnancies can be##2##3##(1992-1#1)(2008-7#1)
pregnancies complicated by##6##3##(1996-12#1)(2006-10#1)(2006-11#1)(2011-2#1)(2013-1#2)
pregnancies from##2##2##(1990-9#1)(2008-7#1)
pregnancies has doubled##2##3##(1992-4#1)(1992-8#1)
pregnancies has##3##2##(1992-4#1)(1992-8#1)(2008-11#1)
pregnancies have##2##2##(1991-1#1)(1993-1#1)
pregnancies in Haitian##2##3##(2008-2#2)
pregnancies in the##2##3##(1990-9#1)(1992-2#1)
pregnancies in this##2##3##(1994-6#1)(2011-1#1)
pregnancies in which at least one##2##6##(1992-12#2)
pregnancies in which##3##3##(1991-3#1)(1992-12#2)
pregnancies in##22##2##(1990-5#1)(1990-9#1)(1991-3#2)(1992-12#2)(1992-2#1)(1992-4#1)(1993-7#1)(1994-3#1)(1994-6#1)(1995-2#2)(2004-10#1)(2007-6#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-1#1)
pregnancies is##5##2##(1992-8#1)(1994-2#1)(2007-11#1)(2010-8#1)(2013-1#1)
pregnancies occurred##4##2##(1992-1#1)(1992-10#3)
pregnancies of##3##2##(1994-9#1)(1996-6#1)(1997-3#1)
pregnancies on the##2##3##(2011-1#2)
pregnancies on##5##2##(1992-12#1)(2011-1#2)(2011-2#2)
pregnancies resulted in##3##3##(2006-8#1)(2008-3#1)(2013-1#1)
pregnancies was##2##2##(1996-6#1)(2006-2#1)
pregnancies were##11##2##(1990-10#1)(1990-8#1)(1991-4#1)(1992-10#1)(2004-10#1)(2007-7#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
pregnancies with fetal##2##3##(1995-8#1)(2008-3#1)
pregnancies with##7##2##(1995-1#1)(1995-8#1)(1996-12#2)(2008-3#1)(2012-12#2)
pregnancies within##2##2##(1996-12#1)(2007-3#1)
pregnancies without##2##2##(2006-10#1)(2012-3#1)
pregnancies##243##1##(1990-10#1)(1990-5#2)(1990-8#1)(1990-9#4)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#4)(1991-4#2)(1991-6#2)(1991-9#1)(1992-1#5)(1992-10#8)(1992-12#11)(1992-2#1)(1992-4#4)(1992-5#2)(1992-6#2)(1992-8#2)(1993-1#4)(1993-12#1)(1993-3#1)(1993-7#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-4#3)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-4#2)(1995-5#1)(1995-6#4)(1995-8#2)(1996-11#1)(1996-12#11)(1996-3#2)(1996-6#2)(1996-8#1)(1997-2#3)(1997-3#1)(2004-10#7)(2004-3#1)(2005-10#3)(2006-10#4)(2006-11#1)(2006-2#2)(2006-4#1)(2006-8#4)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#4)(2007-3#5)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#5)(2008-11#9)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-11#2)(2010-12#4)(2010-3#1)(2010-8#2)(2011-1#8)(2011-2#16)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#5)(2013-1#10)
pregnancies]##2##1##(1990-8#1)(1996-11#1)
pregnancy (17##2##2##(2012-1#1)(2013-1#1)
pregnancy (P &lt##2##3##(1994-3#1)(2007-2#1)
pregnancy (P##3##2##(1994-3#1)(2006-5#1)(2007-2#1)
pregnancy -##2##2##(2007-5#1)(2010-9#1)
pregnancy a##3##2##(1990-6#1)(2007-11#1)(2013-1#1)
pregnancy after the##3##3##(2004-10#2)(2013-1#1)
pregnancy after##12##2##(1992-10#1)(1992-2#1)(1992-7#1)(1995-2#1)(1996-12#1)(2004-10#2)(2006-5#1)(2007-2#1)(2010-12#1)(2011-2#1)(2013-1#1)
pregnancy among adolescents##2##3##(2007-2#1)(2012-11#1)
pregnancy among unmarried##2##3##(2007-3#2)
pregnancy among##7##2##(1995-4#1)(2007-2#1)(2007-3#2)(2007-4#1)(2012-11#1)(2013-8#1)
pregnancy and HIV##2##3##(1997-7#1)(2011-1#1)
pregnancy and STDs##2##3##(1992-2#1)(1996-9#1)
pregnancy and a##2##3##(1992-10#1)(1997-7#1)
pregnancy and after delivery##3##4##(1991-4#2)(2004-10#1)
pregnancy and after##5##3##(1991-4#2)(2004-10#1)(2012-1#1)(2012-2#1)
pregnancy and at##2##3##(1990-11#1)(1993-11#1)
pregnancy and birth of##2##4##(2007-6#1)(2009-10#1)
pregnancy and birth outcomes##2##4##(1997-7#1)(2013-1#1)
pregnancy and birth rate was##2##5##(1994-9#2)
pregnancy and birth##9##3##(1990-4#1)(1994-9#2)(1997-7#1)(2007-2#1)(2007-6#1)(2008-9#1)(2009-10#1)(2013-1#1)
pregnancy and breastfeeding##2##3##(2010-12#1)(2011-2#1)
pregnancy and childbearing##4##3##(1991-9#1)(1995-1#1)(2007-7#1)(2012-12#1)
pregnancy and childbirth##5##3##(1993-3#1)(2004-10#1)(2006-1#1)(2009-4#1)(2012-3#1)
pregnancy and delivery in##2##4##(1991-6#1)(2007-7#1)
pregnancy and delivery##4##3##(1991-6#1)(2006-8#1)(2007-7#1)(2012-3#1)
pregnancy and early##4##3##(2007-2#1)(2008-7#2)(2013-1#1)
pregnancy and end-stage renal##2##4##(2008-10#1)(2008-3#1)
pregnancy and fecundity rates##2##4##(2008-12#2)
pregnancy and in pregnancy##2##4##(1990-9#1)(2009-2#1)
pregnancy and in##11##3##(1990-9#1)(1993-12#1)(1995-12#1)(2006-10#1)(2007-4#1)(2007-6#1)(2009-2#1)(2009-9#1)(2010-5#1)(2012-2#1)(2013-7#1)
pregnancy and its effect on perinatal##2##6##(2012-3#2)
pregnancy and its##4##3##(1995-12#1)(2012-3#3)
pregnancy and labor##5##3##(2009-2#1)(2010-9#1)(2012-3#3)
pregnancy and labour##2##3##(1990-11#1)(1992-4#1)
pregnancy and lactation are##2##4##(1992-2#1)(2012-12#1)
pregnancy and lactation##12##3##(1992-2#1)(1994-2#1)(1996-3#1)(2006-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#1)(2012-12#2)
pregnancy and lactation]##2##3##(1991-6#1)(2008-11#1)
pregnancy and postpartum##5##3##(2007-2#1)(2007-8#1)(2008-9#3)
pregnancy and pregnancy##2##3##(1994-9#1)(1996-12#1)
pregnancy and puerperium##3##3##(1991-3#1)(2007-9#1)(2011-1#1)
pregnancy and the postpartum period##3##5##(2007-2#1)(2010-8#1)(2013-8#1)
pregnancy and the##14##3##(1993-10#1)(1997-7#2)(2006-10#1)(2006-8#1)(2007-2#2)(2007-3#1)(2008-8#1)(2009-2#1)(2009-9#1)(2010-8#1)(2012-2#1)(2013-8#1)
pregnancy and their##2##3##(2011-2#1)(2012-2#1)
pregnancy and to##4##3##(1990-6#1)(2007-2#1)(2008-8#1)(2013-8#1)
pregnancy and was##2##3##(2004-10#1)(2007-7#1)
pregnancy and##186##2##(1990-11#2)(1990-4#1)(1990-6#3)(1990-9#1)(1991-11#1)(1991-3#1)(1991-4#2)(1991-6#2)(1991-9#1)(1992-10#1)(1992-2#3)(1992-4#1)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-12#3)(1995-2#2)(1995-4#1)(1995-8#1)(1996-12#2)(1996-3#1)(1996-9#1)(1997-7#5)(2004-10#5)(2006-1#1)(2006-10#4)(2006-5#1)(2006-8#2)(2007-1#2)(2007-11#2)(2007-2#9)(2007-3#3)(2007-4#1)(2007-6#2)(2007-7#3)(2007-8#2)(2007-9#2)(2008-10#2)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#3)(2008-7#3)(2008-8#4)(2008-9#5)(2009-1#2)(2009-10#1)(2009-2#3)(2009-4#2)(2009-5#2)(2009-6#1)(2009-9#2)(2010-11#1)(2010-12#3)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#2)(2012-12#8)(2012-2#7)(2012-3#9)(2013-1#4)(2013-7#1)(2013-8#2)
pregnancy appeared to##2##3##(1994-6#1)(2007-3#1)
pregnancy are all##2##3##(2004-10#1)(2012-3#1)
pregnancy are discussed##2##3##(1995-6#1)(2008-4#1)
pregnancy are not##3##3##(1994-11#1)(2010-5#1)(2010-6#1)
pregnancy are##18##2##(1990-2#1)(1991-3#1)(1992-2#1)(1994-11#1)(1994-6#2)(1995-6#1)(2004-10#1)(2008-11#1)(2008-4#1)(2009-3#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
pregnancy as a##2##3##(1995-6#1)(2007-2#1)
pregnancy as##4##2##(1995-6#1)(1996-9#1)(2007-2#1)(2009-5#1)
pregnancy at the##2##3##(1990-8#1)(1995-8#1)
pregnancy at##5##2##(1990-8#1)(1994-8#1)(1995-8#1)(2004-10#1)(2013-1#1)
pregnancy because##2##2##(2009-1#1)(2013-1#1)
pregnancy before##2##2##(2004-10#1)(2007-2#1)
pregnancy but##3##2##(1994-9#1)(2008-7#1)(2010-6#1)
pregnancy by##4##2##(1995-4#1)(2005-8#1)(2007-1#1)(2011-1#1)
pregnancy can be##2##3##(1990-3#1)(1992-5#1)
pregnancy can##10##2##(1990-3#1)(1992-5#1)(1996-12#1)(2007-2#3)(2008-2#1)(2008-4#1)(2009-1#1)(2009-3#1)
pregnancy cases##2##2##(1995-2#2)
pregnancy causes##2##2##(1991-12#1)(2013-8#1)
pregnancy complicated by fetal##2##4##(1990-9#1)(2012-3#1)
pregnancy complicated by##6##3##(1990-9#1)(2004-10#1)(2006-10#1)(2012-3#1)(2013-1#2)
pregnancy complicated##7##2##(1990-9#1)(1996-12#1)(2004-10#1)(2006-10#1)(2012-3#1)(2013-1#2)
pregnancy complications and##2##3##(2007-3#1)(2013-1#1)
pregnancy complications##10##2##(1994-12#1)(2007-3#4)(2008-11#2)(2012-3#1)(2013-1#2)
pregnancy continues##2##2##(2005-8#1)(2012-2#1)
pregnancy could be##2##3##(2008-8#1)(2011-1#1)
pregnancy could##3##2##(1995-10#1)(2008-8#1)(2011-1#1)
pregnancy despite##2##2##(1990-8#1)(2004-10#1)
pregnancy did not##3##3##(1995-2#1)(2004-10#1)(2008-3#1)
pregnancy does##2##2##(2009-5#1)(2010-12#1)
pregnancy due to the##2##4##(2009-1#1)(2009-5#1)
pregnancy during##2##2##(1992-7#1)(2007-2#1)
pregnancy failure##2##2##(1996-12#2)
pregnancy following##2##2##(2007-2#1)(2012-2#1)
pregnancy for##6##2##(2004-10#1)(2008-7#1)(2009-4#1)(2010-12#1)(2011-12#1)(2011-2#1)
pregnancy had a##3##3##(1994-12#1)(1995-2#1)(2010-11#1)
pregnancy had##6##2##(1991-7#1)(1992-6#1)(1994-12#1)(1995-2#1)(2006-8#1)(2010-11#1)
pregnancy has been reported in##2##5##(1990-6#1)(1994-3#1)
pregnancy has been##5##3##(1990-6#1)(1994-3#1)(1995-6#1)(2009-1#1)(2009-5#1)
pregnancy has increased##2##3##(1992-8#1)(2008-11#1)
pregnancy has to be##2##4##(1990-9#1)(2008-7#1)
pregnancy has##13##2##(1990-6#1)(1990-9#1)(1992-5#1)(1992-8#1)(1994-3#1)(1995-6#1)(1996-12#1)(2007-2#1)(2008-11#1)(2008-7#2)(2009-1#1)(2009-5#1)
pregnancy have been##4##3##(1992-1#1)(1993-3#1)(2007-2#1)(2011-1#1)
pregnancy have##5##2##(1992-1#1)(1993-3#1)(2007-2#2)(2011-1#1)
pregnancy in a patient with##2##5##(2006-10#1)(2009-6#1)
pregnancy in a rural community##2##5##(2008-5#1)(2010-6#1)
pregnancy in a woman with##3##5##(2004-10#1)(2013-1#2)
pregnancy in a##13##3##(1992-12#1)(1996-12#1)(2004-10#2)(2006-10#1)(2008-5#1)(2009-6#1)(2010-6#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
pregnancy in group##2##3##(1991-3#1)(2012-2#1)
pregnancy in patients with##2##4##(2009-2#1)(2011-2#1)
pregnancy in patients##3##3##(2008-10#1)(2009-2#1)(2011-2#1)
pregnancy in the next year##2##5##(2011-1#2)
pregnancy in the##16##3##(1990-11#1)(1990-2#1)(1992-6#1)(1992-8#1)(1996-6#1)(2005-10#1)(2007-11#1)(2007-3#1)(2008-11#1)(2008-9#1)(2009-6#1)(2011-1#2)(2011-2#2)(2013-1#1)
pregnancy in women##2##3##(1994-8#1)(2008-9#1)
pregnancy in##68##2##(1990-11#1)(1990-2#2)(1990-3#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-8#1)(1995-3#1)(1996-12#4)(1996-6#2)(1996-7#1)(2004-10#3)(2005-10#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-2#1)(2009-6#2)(2009-7#1)(2010-10#3)(2010-12#1)(2010-6#1)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
pregnancy including##3##2##(2006-10#1)(2008-8#1)(2009-5#1)
pregnancy induced hypertension##5##3##(2008-4#2)(2010-3#1)(2012-2#2)
pregnancy induced##7##2##(2007-7#1)(2008-1#1)(2008-4#2)(2010-3#1)(2012-2#2)
pregnancy is a common##2##4##(1997-2#1)(2008-3#1)
pregnancy is a##9##3##(1997-2#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-6#1)(2011-1#1)(2012-12#1)(2013-1#2)
pregnancy is not##5##3##(1992-1#1)(2010-12#2)(2010-2#1)(2012-2#1)
pregnancy is rare##3##3##(1992-10#1)(2009-3#1)(2009-6#1)
pregnancy is reported##3##3##(1993-10#1)(2012-2#2)
pregnancy is##44##2##(1990-9#1)(1992-1#1)(1992-10#1)(1993-10#2)(1993-11#1)(1994-3#1)(1994-7#2)(1995-2#1)(1996-12#1)(1997-2#2)(2007-8#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-7#1)(2009-10#1)(2009-3#1)(2009-6#2)(2010-12#2)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#8)
pregnancy leads to##2##3##(2009-11#1)(2012-3#1)
pregnancy loss and##3##3##(2006-12#1)(2011-2#1)(2012-2#1)
pregnancy loss in##2##3##(1994-9#1)(2012-3#1)
pregnancy loss##15##2##(1994-9#3)(2006-12#1)(2007-3#1)(2009-6#2)(2011-1#2)(2011-2#3)(2012-2#2)(2012-3#1)
pregnancy losses##2##2##(2004-10#2)
pregnancy may be##2##3##(1994-8#1)(2012-3#1)
pregnancy may##8##2##(1992-4#1)(1994-8#1)(2009-3#1)(2010-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
pregnancy might be##2##3##(1992-2#1)(2008-11#1)
pregnancy occurred in##2##3##(1991-12#1)(1991-3#1)
pregnancy occurred##3##2##(1991-12#1)(1991-3#1)(2006-10#1)
pregnancy occurs##2##2##(2007-9#1)(2008-10#1)
pregnancy of the##2##3##(2011-1#1)(2011-2#1)
pregnancy of##6##2##(1994-9#1)(1995-8#1)(2007-2#1)(2010-11#1)(2011-1#1)(2011-2#1)
pregnancy on the##5##3##(1995-12#1)(2011-2#1)(2012-2#2)(2013-7#1)
pregnancy on##13##2##(1995-12#1)(1995-2#1)(1996-12#1)(1996-7#1)(1997-7#2)(2008-3#1)(2010-3#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)
pregnancy or in the##3##4##(1996-7#1)(2004-10#1)(2009-3#1)
pregnancy or##18##2##(1991-3#1)(1992-5#1)(1996-7#1)(2004-10#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-3#1)(2009-9#1)(2010-12#3)(2010-8#1)(2012-3#1)(2013-8#1)
pregnancy outcome in##7##3##(1991-12#1)(1992-2#1)(2004-10#1)(2007-3#1)(2009-6#1)(2011-1#2)
pregnancy outcome with##2##3##(2007-2#1)(2010-8#1)
pregnancy outcome##27##2##(1991-11#1)(1991-12#1)(1992-2#2)(1992-9#1)(1996-12#1)(2004-10#2)(2005-10#1)(2007-2#1)(2007-3#1)(2008-11#2)(2008-3#1)(2009-6#2)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#4)(2011-2#2)(2013-1#2)
pregnancy outcomes##14##2##(2005-10#1)(2006-10#1)(2007-12#2)(2008-11#1)(2009-11#1)(2009-5#1)(2009-9#2)(2011-2#2)(2013-1#2)(2013-8#1)
pregnancy proceeded##2##2##(1994-2#1)(2011-1#1)
pregnancy rate in##5##3##(2005-7#1)(2006-5#2)(2007-10#2)
pregnancy rate was##2##3##(1994-12#1)(1995-7#1)
pregnancy rate##25##2##(1991-11#1)(1992-1#1)(1992-12#2)(1992-7#1)(1994-12#1)(1995-7#3)(2005-7#1)(2006-5#10)(2007-10#2)(2008-10#1)(2009-5#1)(2012-12#1)
pregnancy rates of##5##3##(1992-2#1)(1995-7#2)(2006-5#2)
pregnancy rates to those##2##4##(1991-3#1)(1992-2#1)
pregnancy rates##23##2##(1991-12#2)(1991-3#3)(1992-2#3)(1994-12#2)(1995-7#3)(1996-9#1)(2004-10#1)(2006-5#3)(2008-3#1)(2011-1#4)
pregnancy reached##2##2##(1996-11#1)(2008-9#1)
pregnancy resulted in an##2##4##(1995-12#1)(2007-2#1)
pregnancy sera##2##2##(1992-12#1)(1992-4#1)
pregnancy serum##2##2##(1991-6#1)(2008-10#1)
pregnancy should##2##2##(1991-2#1)(2008-3#1)
pregnancy significantly##2##2##(2008-9#1)(2009-9#1)
pregnancy symptoms and##2##3##(2012-11#1)(2013-7#1)
pregnancy termination##7##2##(1995-4#1)(1996-12#1)(2006-10#1)(2011-1#1)(2011-2#2)(2013-1#1)
pregnancy testing##2##2##(2005-7#1)(2012-12#1)
pregnancy tests##3##2##(2007-7#1)(2011-2#1)(2013-1#1)
pregnancy than##2##2##(2007-10#1)(2007-2#1)
pregnancy that##4##2##(1992-7#1)(1994-2#1)(2007-3#1)(2009-12#1)
pregnancy the##4##2##(1990-12#1)(1991-12#1)(1992-2#1)(1994-8#1)
pregnancy to term##2##3##(2010-8#1)(2011-1#1)
pregnancy to##11##2##(1990-8#1)(1994-2#1)(1995-8#1)(1996-11#1)(2007-2#1)(2008-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
pregnancy was confirmed##2##3##(1993-7#1)(2013-8#1)
pregnancy was found##2##3##(2011-1#1)(2012-11#1)
pregnancy was terminated##3##3##(1993-1#1)(1993-10#1)(2008-4#1)
pregnancy was##28##2##(1991-4#1)(1992-11#1)(1993-1#1)(1993-10#1)(1993-3#2)(1993-7#1)(1995-6#1)(2004-10#2)(2006-5#1)(2006-8#2)(2007-2#1)(2008-4#1)(2009-5#1)(2009-9#2)(2011-1#3)(2011-2#2)(2012-11#1)(2012-3#1)(2013-1#2)(2013-8#1)
pregnancy were included as##2##4##(2008-10#1)(2011-2#1)
pregnancy were##14##2##(1990-9#1)(1992-2#1)(1994-8#1)(1995-12#3)(2004-10#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
pregnancy when##5##2##(1992-12#1)(1993-12#1)(1994-3#1)(2006-10#1)(2007-2#1)
pregnancy which##2##2##(2008-12#1)(2012-2#1)
pregnancy will be##2##3##(1994-6#1)(2008-1#1)
pregnancy with##18##2##(1993-5#1)(1993-8#1)(1996-12#1)(2004-10#2)(2006-1#1)(2006-10#1)(2008-1#1)(2008-3#1)(2009-1#1)(2010-2#1)(2010-8#2)(2011-2#1)(2012-2#3)(2012-3#1)
pregnancy zone protein##3##3##(1990-12#1)(1996-5#2)
pregnancy##1540##1##(1990-11#5)(1990-12#10)(1990-2#5)(1990-3#3)(1990-4#1)(1990-5#4)(1990-6#13)(1990-8#6)(1990-9#9)(1991-1#1)(1991-10#2)(1991-11#7)(1991-12#13)(1991-2#6)(1991-3#14)(1991-4#6)(1991-5#2)(1991-6#6)(1991-7#3)(1991-8#4)(1991-9#3)(1992-1#8)(1992-10#7)(1992-11#3)(1992-12#14)(1992-2#26)(1992-3#2)(1992-4#5)(1992-5#10)(1992-6#2)(1992-7#7)(1992-8#3)(1992-9#3)(1993-1#1)(1993-10#5)(1993-11#6)(1993-12#9)(1993-2#3)(1993-3#5)(1993-4#1)(1993-5#4)(1993-7#3)(1993-8#4)(1994-10#2)(1994-11#3)(1994-12#9)(1994-2#10)(1994-3#13)(1994-4#1)(1994-5#2)(1994-6#13)(1994-7#2)(1994-8#10)(1994-9#15)(1995-1#3)(1995-10#4)(1995-12#12)(1995-2#20)(1995-3#1)(1995-4#5)(1995-5#2)(1995-6#13)(1995-7#6)(1995-8#12)(1995-9#3)(1996-11#8)(1996-12#31)(1996-3#4)(1996-4#6)(1996-5#2)(1996-6#3)(1996-7#6)(1996-8#4)(1996-9#6)(1997-2#4)(1997-4#3)(1997-5#2)(1997-7#8)(1997-8#1)(2004-10#56)(2005-10#6)(2005-11#1)(2005-7#2)(2005-8#2)(2006-1#2)(2006-10#42)(2006-11#1)(2006-12#5)(2006-3#2)(2006-4#2)(2006-5#21)(2006-6#4)(2006-7#2)(2006-8#18)(2007-1#6)(2007-10#4)(2007-11#13)(2007-12#9)(2007-2#59)(2007-3#26)(2007-4#4)(2007-5#1)(2007-6#4)(2007-7#19)(2007-8#14)(2007-9#12)(2008-1#11)(2008-10#12)(2008-11#24)(2008-12#9)(2008-2#9)(2008-3#31)(2008-4#30)(2008-5#7)(2008-7#20)(2008-8#20)(2008-9#15)(2009-1#11)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#8)(2009-3#13)(2009-4#4)(2009-5#16)(2009-6#15)(2009-7#1)(2009-8#1)(2009-9#12)(2010-10#8)(2010-11#3)(2010-12#20)(2010-2#10)(2010-3#7)(2010-4#1)(2010-5#4)(2010-6#6)(2010-7#1)(2010-8#10)(2010-9#5)(2011-1#49)(2011-12#3)(2011-2#49)(2012-1#13)(2012-11#11)(2012-12#32)(2012-2#42)(2012-3#49)(2012-8#3)(2013-1#73)(2013-7#8)(2013-8#17)
pregnancy)##2##1##(2006-3#1)(2008-3#1)
pregnancy--a##3##1##(1997-5#1)(2008-3#1)(2009-6#1)
pregnancy-associated diseases with abnormal fetal growth##2##6##(2008-10#2)
pregnancy-associated plasma##3##2##(1994-6#1)(1995-7#2)
pregnancy-associated##14##1##(1994-6#2)(1994-8#1)(1994-9#1)(1995-7#2)(2008-10#2)(2012-3#1)(2013-1#5)
pregnancy-induced hypertension##19##2##(1990-3#5)(1990-6#3)(1992-2#2)(1994-3#1)(2010-10#1)(2011-2#4)(2012-2#2)(2013-1#1)
pregnancy-induced hypertensive##2##2##(1994-3#1)(2011-2#1)
pregnancy-induced##23##1##(1990-3#5)(1990-6#3)(1992-2#2)(1994-3#2)(1997-7#1)(2007-9#1)(2010-10#1)(2011-2#5)(2012-2#2)(2013-1#1)
pregnancy-related##3##1##(1996-3#1)(2006-1#1)(2007-6#1)
pregnancy?##4##1##(1995-6#1)(2008-11#1)(2008-3#1)(2013-1#1)
pregnancy]##29##1##(1990-2#1)(1991-11#1)(1991-3#1)(1992-4#1)(1992-5#2)(1992-8#1)(1993-10#1)(1993-9#1)(1994-6#1)(1995-9#1)(1996-11#4)(1996-9#1)(1997-2#1)(1997-8#1)(2008-8#1)(2009-1#1)(2010-6#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
pregnane steroids##3##2##(1991-11#3)
pregnane##5##1##(1991-11#3)(2007-1#1)(2008-8#1)
pregnanediol##2##1##(1990-2#1)(1990-8#1)
pregnanes##2##1##(1990-9#1)(2007-1#1)
pregnanolone##5##1##(1990-7#1)(1997-5#4)
pregnant Wistar rats##2##3##(1996-10#1)(2008-7#1)
pregnant abdomen##4##2##(2007-4#4)
pregnant adolescents##6##2##(2007-2#5)(2007-3#1)
pregnant after##3##2##(1990-6#1)(1992-10#1)(2011-1#1)
pregnant and female##2##3##(2007-2#2)
pregnant and lactating women##2##4##(2006-10#2)
pregnant and lactating##6##3##(1990-11#2)(1993-2#1)(2006-10#2)(2011-2#1)
pregnant and non-pregnant mice##5##4##(2008-4#5)
pregnant and non-pregnant women##4##4##(1992-1#1)(2007-2#1)(2010-6#1)(2012-12#1)
pregnant and non-pregnant##13##3##(1992-1#1)(1994-8#1)(2007-2#1)(2007-7#1)(2008-4#6)(2010-2#1)(2010-6#1)(2012-12#1)
pregnant and puerperal women##3##4##(1995-6#3)
pregnant and##38##2##(1990-11#2)(1992-1#1)(1993-2#1)(1994-8#1)(1995-6#3)(1996-4#1)(1996-7#1)(1996-8#1)(2006-10#3)(2006-2#1)(2007-2#3)(2007-7#2)(2008-3#1)(2008-4#6)(2009-9#1)(2010-2#1)(2010-6#2)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#2)
pregnant body##2##2##(2007-2#2)
pregnant cardiac##2##2##(2006-10#2)
pregnant cows##2##2##(1991-3#2)
pregnant female##5##2##(1990-11#1)(1991-11#1)(2008-7#1)(2009-4#1)(2012-1#1)
pregnant females in##2##3##(2013-7#2)
pregnant females##9##2##(2007-2#1)(2008-10#2)(2008-7#1)(2010-11#1)(2011-1#1)(2013-7#3)
pregnant group##2##2##(1990-11#1)(1990-3#1)
pregnant groups##3##2##(2009-5#3)
pregnant in##2##2##(1994-9#1)(2008-3#1)
pregnant lady##3##2##(2011-1#3)
pregnant mare serum##2##3##(2008-5#1)(2008-8#1)
pregnant mice##6##2##(1991-12#1)(1993-4#1)(1994-2#1)(1996-5#1)(2005-7#1)(2008-9#1)
pregnant mother##3##2##(1990-9#1)(1992-2#1)(2012-3#1)
pregnant mothers and##2##3##(2007-7#1)(2008-4#1)
pregnant mothers##13##2##(2007-3#1)(2007-7#2)(2008-10#1)(2008-4#1)(2008-5#6)(2011-12#1)(2012-2#1)
pregnant or##3##2##(2007-2#1)(2008-3#1)(2009-2#1)
pregnant patient##7##2##(2006-10#1)(2009-10#3)(2009-6#1)(2013-1#1)(2013-7#1)
pregnant patients were##3##3##(1993-10#2)(2008-11#1)
pregnant patients with##2##3##(2009-1#1)(2010-2#1)
pregnant patients##15##2##(1990-12#1)(1993-10#4)(1993-12#1)(1996-12#1)(2006-2#1)(2007-7#1)(2008-11#1)(2009-1#1)(2010-2#3)(2013-1#1)
pregnant personnel##2##2##(1993-12#2)
pregnant population with##2##3##(2006-10#1)(2013-1#1)
pregnant population##3##2##(2006-10#2)(2013-1#1)
pregnant rats were treated##2##4##(1993-12#1)(2005-7#1)
pregnant rats were##3##3##(1993-12#1)(1996-10#1)(2005-7#1)
pregnant rats with##2##3##(1991-9#1)(2010-12#1)
pregnant rats##25##2##(1990-11#2)(1991-9#1)(1993-12#1)(1993-2#1)(1994-11#2)(1995-10#3)(1996-10#1)(1996-4#1)(2005-7#1)(2007-1#2)(2008-11#1)(2008-3#3)(2008-4#1)(2010-10#1)(2010-12#2)(2012-1#1)(2013-1#1)
pregnant sheep##2##2##(1993-12#2)
pregnant subjects##2##2##(1994-10#1)(2012-12#1)
pregnant teens##2##2##(2007-2#2)
pregnant uterus##4##2##(2008-7#2)(2008-8#2)
pregnant within##4##2##(1992-7#1)(1997-5#2)(2007-2#1)
pregnant woman has##2##3##(1994-4#1)(2010-8#1)
pregnant woman##22##2##(1990-6#1)(1991-9#1)(1992-9#1)(1993-10#1)(1994-4#1)(1996-12#1)(1996-6#2)(1997-7#1)(1997-8#1)(2005-12#2)(2006-7#1)(2006-8#1)(2007-2#2)(2008-7#1)(2009-1#1)(2009-10#1)(2009-5#1)(2010-8#1)(2011-2#1)
pregnant woman's##3##2##(1991-4#1)(2007-7#1)(2008-2#1)
pregnant women aged##3##3##(2004-10#1)(2011-1#1)(2011-2#1)
pregnant women and that##2##4##(2007-2#1)(2011-2#1)
pregnant women and the##2##4##(1994-6#1)(2011-1#1)
pregnant women and their neonates##4##5##(2007-8#3)(2012-1#1)
pregnant women and their newborn infants##2##6##(2007-12#1)(2007-8#1)
pregnant women and their##11##4##(2005-10#1)(2007-12#1)(2007-8#4)(2008-6#1)(2009-6#1)(2011-1#1)(2012-1#1)(2012-2#1)
pregnant women and women with##2##5##(1992-12#1)(2013-1#1)
pregnant women and##29##3##(1990-11#1)(1992-12#1)(1994-3#1)(1994-6#1)(1996-8#1)(2005-10#1)(2006-12#1)(2007-12#1)(2007-2#3)(2007-8#4)(2008-4#1)(2008-6#1)(2008-9#1)(2009-1#1)(2009-6#1)(2010-12#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
pregnant women are##7##3##(1993-3#1)(2006-10#1)(2006-2#1)(2008-12#1)(2008-8#1)(2009-4#1)(2012-3#1)
pregnant women at##6##3##(1990-3#1)(1990-9#1)(2006-10#1)(2006-2#1)(2010-8#2)
pregnant women attending the##2##4##(2006-7#1)(2013-1#1)
pregnant women attending##8##3##(2006-7#1)(2006-8#1)(2008-8#2)(2009-5#1)(2010-12#1)(2010-8#1)(2013-1#1)
pregnant women born##2##3##(1994-6#1)(2006-7#1)
pregnant women but##2##3##(1994-10#1)(2007-2#1)
pregnant women by##2##3##(2007-3#1)(2007-7#1)
pregnant women during the##2##4##(1992-3#1)(1995-12#1)
pregnant women for##2##3##(1996-12#1)(2007-8#1)
pregnant women from##7##3##(1993-1#1)(1995-8#1)(2007-12#1)(2008-7#1)(2009-9#1)(2010-6#1)(2011-2#1)
pregnant women had##3##3##(1990-8#1)(1997-4#1)(2012-12#1)
pregnant women has##2##3##(2009-9#1)(2011-1#1)
pregnant women have##3##3##(1992-2#1)(2009-4#1)(2011-2#1)
pregnant women in Enugu##2##4##(2009-5#2)
pregnant women in Iceland and##2##5##(2006-7#2)
pregnant women in Iceland##4##4##(2006-7#4)
pregnant women in a##2##4##(2010-6#1)(2010-9#1)
pregnant women in southern China##3##5##(2011-1#3)
pregnant women in the##6##4##(1994-6#1)(1996-5#1)(2007-12#1)(2011-1#1)(2012-2#1)(2013-8#1)
pregnant women in##42##3##(1990-2#1)(1990-6#3)(1994-6#2)(1995-2#1)(1996-5#1)(1997-6#1)(2006-10#3)(2006-7#4)(2006-9#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-9#1)(2009-5#2)(2009-7#1)(2009-9#2)(2010-6#3)(2010-9#1)(2011-1#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
pregnant women is##6##3##(1992-11#1)(1996-3#1)(2007-7#1)(2008-9#1)(2010-8#1)(2013-1#1)
pregnant women living in##3##4##(1991-8#1)(2012-12#1)(2013-8#1)
pregnant women of##4##3##(2011-1#2)(2012-2#2)
pregnant women on##2##3##(1994-6#1)(2012-1#1)
pregnant women prior to##2##4##(2006-8#1)(2008-8#1)
pregnant women referred##2##3##(2006-10#1)(2008-11#1)
pregnant women screened for##2##4##(2007-8#1)(2010-2#1)
pregnant women should##2##3##(1995-4#1)(2013-1#1)
pregnant women still##2##3##(1991-11#1)(1995-6#1)
pregnant women to##5##3##(1992-4#1)(2007-2#2)(2007-9#1)(2012-1#1)
pregnant women was##2##3##(1994-6#1)(2011-1#1)
pregnant women were studied##4##4##(2006-10#1)(2007-2#1)(2007-8#1)(2012-3#1)
pregnant women were##12##3##(1992-5#1)(2006-10#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-10#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-3#1)
pregnant women who are##2##4##(1995-6#1)(2006-10#1)
pregnant women who##8##3##(1990-6#1)(1995-6#1)(2005-10#1)(2006-10#1)(2008-3#1)(2010-8#1)(2011-2#1)(2012-2#1)
pregnant women whose##2##3##(2008-10#1)(2011-1#1)
pregnant women with risk factors##2##5##(2012-2#2)
pregnant women with symptoms of##2##5##(2008-11#2)
pregnant women with##27##3##(1990-12#1)(1992-1#2)(1993-1#1)(1996-11#1)(2007-2#2)(2008-1#1)(2008-11#3)(2008-4#1)(2009-1#2)(2009-10#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#3)(2012-2#2)(2013-8#1)
pregnant women would be##2##4##(2007-7#1)(2009-1#1)
pregnant women##323##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#6)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-8#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-10#2)(1994-3#1)(1994-6#9)(1995-1#1)(1995-12#2)(1995-2#2)(1995-4#2)(1995-6#6)(1995-8#3)(1996-1#1)(1996-11#3)(1996-12#1)(1996-3#4)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1997-3#3)(1997-4#3)(1997-6#1)(2004-10#2)(2005-10#4)(2006-10#11)(2006-12#1)(2006-2#2)(2006-7#6)(2006-8#2)(2006-9#1)(2007-12#10)(2007-2#22)(2007-3#1)(2007-4#1)(2007-7#5)(2007-8#7)(2007-9#4)(2008-1#1)(2008-10#2)(2008-11#7)(2008-12#4)(2008-3#2)(2008-4#4)(2008-6#1)(2008-7#2)(2008-8#8)(2008-9#2)(2009-1#5)(2009-10#1)(2009-4#5)(2009-5#4)(2009-6#2)(2009-7#1)(2009-9#4)(2010-12#3)(2010-2#1)(2010-4#2)(2010-6#5)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#22)(2011-12#1)(2011-2#13)(2012-1#3)(2012-11#4)(2012-12#7)(2012-2#11)(2012-3#7)(2013-1#12)(2013-7#1)(2013-8#3)
pregnant women's##9##2##(1995-6#2)(2006-1#2)(2007-7#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-2#1)
pregnant women]##4##2##(1991-9#1)(1992-4#1)(1995-4#1)(2006-6#1)
pregnant##626##1##(1990-10#1)(1990-11#8)(1990-12#2)(1990-2#4)(1990-3#2)(1990-5#1)(1990-6#8)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#3)(1991-3#2)(1991-4#3)(1991-8#1)(1991-9#3)(1992-1#5)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#3)(1992-5#1)(1992-7#1)(1992-9#1)(1993-1#2)(1993-10#5)(1993-11#2)(1993-12#9)(1993-2#3)(1993-3#1)(1993-4#2)(1993-7#1)(1993-9#1)(1994-10#3)(1994-11#4)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#11)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#4)(1995-12#2)(1995-2#3)(1995-4#3)(1995-6#13)(1995-8#3)(1996-1#1)(1996-10#2)(1996-11#3)(1996-12#3)(1996-3#4)(1996-4#2)(1996-5#2)(1996-6#3)(1996-7#3)(1996-8#2)(1997-3#3)(1997-4#3)(1997-5#4)(1997-6#2)(1997-7#1)(1997-8#1)(2004-10#3)(2005-10#4)(2005-12#2)(2005-7#5)(2005-8#1)(2006-1#2)(2006-10#22)(2006-12#1)(2006-2#4)(2006-5#4)(2006-6#1)(2006-7#7)(2006-8#4)(2006-9#1)(2007-1#2)(2007-12#10)(2007-2#45)(2007-3#4)(2007-4#6)(2007-6#1)(2007-7#12)(2007-8#9)(2007-9#5)(2008-1#1)(2008-10#9)(2008-11#11)(2008-12#4)(2008-2#3)(2008-3#10)(2008-4#14)(2008-5#7)(2008-6#1)(2008-7#9)(2008-8#15)(2008-9#3)(2009-1#7)(2009-10#6)(2009-2#3)(2009-4#6)(2009-5#9)(2009-6#4)(2009-7#1)(2009-9#5)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#6)(2010-4#2)(2010-6#7)(2010-7#1)(2010-8#8)(2010-9#1)(2011-1#30)(2011-12#2)(2011-2#27)(2012-1#5)(2012-11#4)(2012-12#10)(2012-2#12)(2012-3#8)(2013-1#18)(2013-7#6)(2013-8#3)
pregnenolone and##3##2##(1990-11#1)(1990-3#1)(1994-11#1)
pregnenolone fatty acid esters##2##4##(1991-9#2)
pregnenolone production##4##2##(2012-2#4)
pregnenolone production&quot##5##2##(2012-2#5)
pregnenolone sulfate and##2##3##(1996-2#1)(1997-1#1)
pregnenolone sulfate is##2##3##(1997-1#2)
pregnenolone sulfate on the##2##4##(1997-1#2)
pregnenolone sulfate to##2##3##(1990-10#2)
pregnenolone sulfate##20##2##(1990-10#6)(1996-2#7)(1997-1#7)
pregnenolone was##3##2##(1990-3#1)(1995-10#2)
pregnenolone##43##1##(1990-10#6)(1990-11#1)(1990-3#3)(1991-10#1)(1991-9#3)(1994-11#1)(1995-10#3)(1996-2#9)(1997-1#7)(2012-2#9)
pregomisin##2##1##(2008-11#2)
preharvest##6##1##(2008-10#5)(2012-1#1)
prehaustorial resistance to P##2##4##(2008-10#2)
prehaustorial resistance to##3##3##(2008-10#3)
prehaustorial resistance##4##2##(2008-10#4)
prehaustorial##8##1##(2008-10#8)
preheated glassy carbon electrode modified with##2##6##(2008-10#2)
preheated glassy carbon electrode##3##4##(2008-10#3)
preheated##6##1##(1994-11#1)(2008-10#3)(2008-2#1)(2011-2#1)
prehensile movement##2##2##(1992-9#1)(1996-3#1)
prehensile##4##1##(1992-9#2)(1996-3#1)(2011-2#1)
prehension movements##2##2##(1993-7#1)(2008-7#1)
prehension##12##1##(1992-9#1)(1993-7#3)(1996-2#4)(1996-3#1)(2008-7#2)(2012-1#1)
prehistoric##4##1##(2007-9#1)(2008-9#1)(2013-1#1)(2013-7#1)
prehistory##3##1##(2006-2#1)(2006-7#1)(2011-12#1)
prehospital adjustment##3##2##(1993-1#3)
prehospital cardiac arrest##2##3##(1990-12#2)
prehospital decision-making process##2##3##(2008-3#2)
prehospital phase of##3##3##(2007-9#2)(2008-3#1)
prehospital setting##3##2##(2006-10#1)(2007-5#1)(2007-7#1)
prehospital##40##1##(1990-12#2)(1991-2#2)(1993-1#3)(1994-3#1)(1994-4#1)(1996-9#2)(2005-9#1)(2006-10#2)(2007-5#3)(2007-7#6)(2007-9#5)(2008-3#9)(2008-7#1)(2008-9#1)(2009-6#1)
prehospitalization##3##1##(1993-1#1)(2008-7#2)
prehydrolysate##2##1##(2008-6#2)
prehydrolysates##4##1##(2008-5#4)
prehydrolysis##4##1##(2008-5#4)
prehydrolyzate##4##1##(2008-5#4)
prehypertensive##2##1##(1992-2#1)(2010-12#1)
preillumination##4##1##(2007-12#1)(2008-1#3)
preimaginal densities##3##2##(2007-6#3)
preimmune serum and##2##3##(1991-9#1)(1996-12#1)
preimmune serum##5##2##(1990-11#1)(1991-9#2)(1994-9#1)(1996-12#1)
preimplantation development##9##2##(1994-3#3)(1995-1#2)(1995-11#1)(2010-12#1)(2012-2#1)(2013-1#1)
preimplantation embryo##2##2##(2008-4#1)(2008-5#1)
preimplantation embryos##4##2##(1994-3#1)(1995-2#2)(2005-8#1)
preimplantation genetic diagnosis##3##3##(2008-4#2)(2012-3#1)
preimplantation mouse blastocysts##2##3##(1991-9#2)
preimplantation mouse##4##2##(1991-9#2)(1994-3#1)(2008-5#1)
preimplantation##30##1##(1991-2#1)(1991-9#2)(1994-3#6)(1995-1#2)(1995-11#3)(1995-2#3)(2005-8#1)(2008-4#3)(2008-5#4)(2008-8#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
preincision##2##1##(1994-7#1)(2005-12#1)
preincubated for##3##2##(1990-3#1)(1994-2#1)(1994-3#1)
preincubated in##5##2##(1990-11#1)(1991-10#1)(1994-2#1)(1994-3#1)(2008-8#1)
preincubated with the##2##3##(1991-7#1)(1992-1#1)
preincubated with##19##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-7#2)(1992-1#1)(1992-12#1)(1993-6#1)(1994-12#1)(1994-8#4)(1994-9#1)(1995-12#1)(1995-6#2)(1997-5#1)(2009-9#1)
preincubated##29##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-7#2)(1992-1#1)(1992-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-8#5)(1994-9#1)(1995-12#1)(1995-6#2)(1997-5#1)(2008-8#1)(2009-9#1)
preincubating the##3##2##(1993-8#1)(1994-6#1)(1997-1#1)
preincubating##5##1##(1993-8#1)(1994-3#1)(1994-6#1)(1997-1#1)(2008-8#1)
preincubation of cells with##4##4##(1991-12#1)(1991-7#1)(1992-9#1)(1994-6#1)
preincubation of the Latex beads with##2##6##(2008-6#2)
preincubation of the enzyme with##3##5##(1990-2#1)(1991-2#1)(1992-5#1)
preincubation of the enzyme##4##4##(1990-2#1)(1990-4#1)(1991-2#1)(1992-5#1)
preincubation of the##14##3##(1990-2#1)(1990-4#1)(1991-2#1)(1992-1#1)(1992-5#1)(1992-8#1)(1995-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-5#1)(2008-6#2)
preincubation of##28##2##(1990-2#1)(1990-4#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-5#1)(2008-6#2)(2008-9#1)
preincubation pH##2##2##(1991-9#1)(1993-6#1)
preincubation time##2##2##(1991-8#1)(1992-12#1)
preincubation with 5FU##3##3##(1993-11#3)
preincubation with the##4##3##(1990-10#1)(1991-10#1)(1991-9#1)(1994-8#1)
preincubation with##22##2##(1990-10#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-5#1)(1993-11#3)(1993-9#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-5#1)(2008-4#1)
preincubation##66##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#2)(1990-9#2)(1991-10#2)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#5)(1992-1#1)(1992-12#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#3)(1993-6#1)(1993-9#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-12#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#1)
preinduction##2##1##(2007-8#1)(2013-7#1)
preindustrial##2##1##(2008-9#1)(2011-2#1)
preinjury##4##1##(2008-8#1)(2011-2#2)(2013-1#1)
preinoculated with##2##2##(2008-10#2)
preinoculated##5##1##(2008-10#5)
preinoculation with##2##2##(2008-10#2)
preinoculation##4##1##(2008-10#4)
preintegration complex##2##2##(1997-3#1)(2009-11#1)
preintensification time##2##2##(2008-10#2)
preinvasive lesions were##2##3##(2008-5#2)
preinvasive lesions##3##2##(2008-5#3)
preinvasive neoplastic##2##2##(2008-5#2)
preinvasive##8##1##(2006-10#1)(2008-5#6)(2012-2#1)
preirradiated##2##1##(1994-3#2)
preirradiation##4##1##(1994-3#1)(2006-12#1)(2007-12#2)
preirrigated with##2##2##(2008-10#2)
preischemic##4##1##(1996-10#1)(1996-9#1)(2007-9#2)
prejudice against##3##2##(1996-12#1)(2007-12#1)(2008-4#1)
prejudice and hate crimes##2##4##(2008-12#2)
prejudice##20##1##(1991-1#1)(1994-3#1)(1996-12#1)(2007-12#1)(2008-11#2)(2008-12#7)(2008-2#1)(2008-4#1)(2008-6#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
prejudice&quot##2##1##(2012-11#2)
prejudiced##3##1##(1991-2#1)(1993-11#1)(1997-7#1)
prejudices against##2##2##(1994-4#1)(2013-1#1)
prejudices and##2##2##(1992-6#1)(2011-2#1)
prejudices##11##1##(1992-6#1)(1994-1#1)(1994-4#2)(2006-9#1)(2008-5#1)(2009-7#1)(2010-12#1)(2011-2#1)(2013-1#2)
prejudicial##2##1##(1990-2#1)(2008-9#1)
prejunctional##5##1##(1990-11#1)(1996-12#1)(2008-2#1)(2013-1#2)
prekallikrein in plasma##2##3##(1990-11#1)(1991-8#1)
prekallikrein is##2##2##(1991-8#1)(1996-5#1)
prekallikrein##16##1##(1990-11#1)(1991-2#3)(1991-8#4)(1993-12#2)(1996-5#5)(1997-5#1)
prekininogens##4##1##(1997-5#4)
prelabeled LA-N-2 cells were exposed to varying concentrations of##2##9##(1995-5#2)
prelabeled LA-N-2 cells##3##3##(1995-5#3)
prelabeled with##9##2##(1990-11#1)(1990-12#1)(1991-12#1)(1991-8#1)(1992-4#1)(1994-12#1)(1997-2#1)(2006-8#1)(2008-7#1)
prelabeled##14##1##(1990-11#1)(1990-12#1)(1990-3#1)(1991-12#1)(1991-8#1)(1992-4#1)(1994-12#1)(1995-5#3)(1996-2#1)(1997-2#1)(2006-8#1)(2008-7#1)
prelabelled with##4##2##(1990-12#3)(1990-2#1)
prelabelled##8##1##(1990-12#4)(1990-2#1)(1991-8#1)(1993-11#1)(1993-6#1)
prelamin A##6##2##(2011-2#2)(2012-12#4)
prelamin##7##1##(2011-2#2)(2012-12#5)
prelaunch calibration##2##2##(2008-3#2)
prelaunch##5##1##(2008-3#5)
preleptotene spermatocytes##4##2##(2008-5#1)(2012-2#3)
preleptotene##6##1##(2008-5#1)(2009-10#2)(2012-2#3)
prelicensure##2##1##(2008-10#2)
prelimbic area##2##2##(1995-12#1)(1997-5#1)
prelimbic cortex##2##2##(1993-6#2)
prelimbic##5##1##(1993-6#2)(1995-12#1)(1996-10#1)(1997-5#1)
preliminarily##11##1##(1990-11#1)(2005-4#1)(2007-8#1)(2008-6#1)(2008-9#1)(2011-1#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
preliminary acute##2##2##(1992-5#1)(2007-8#1)
preliminary advances in##2##3##(2009-2#2)
preliminary analysis of##3##3##(1991-2#1)(2005-8#1)(2012-2#1)
preliminary analysis##13##2##(1991-2#1)(1996-6#1)(2005-8#1)(2008-3#2)(2008-5#1)(2009-4#1)(2009-5#1)(2010-2#1)(2010-7#1)(2010-9#1)(2012-2#1)(2013-8#1)
preliminary application##2##2##(2008-8#1)(2011-12#1)
preliminary approach##3##2##(2006-12#1)(2008-10#1)(2008-8#1)
preliminary assessment of##6##3##(1992-2#1)(1993-9#1)(2007-4#2)(2008-3#1)(2009-12#1)
preliminary assessment##7##2##(1992-2#1)(1993-9#1)(2007-4#2)(2008-3#1)(2009-12#1)(2013-1#1)
preliminary characterization of##8##3##(1990-4#1)(1992-8#1)(1995-8#1)(1997-6#1)(2007-12#2)(2009-10#1)(2012-1#1)
preliminary clinical data##2##3##(2007-11#1)(2008-1#1)
preliminary clinical experience##3##3##(2006-11#2)(2006-6#1)
preliminary clinical results##3##3##(2007-7#1)(2008-5#1)(2013-8#1)
preliminary clinical studies##2##3##(2008-2#1)(2010-12#1)
preliminary clinical trials##2##3##(2007-1#1)(2007-11#1)
preliminary clinical##16##2##(2006-11#2)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-1#1)(2013-8#1)
preliminary conclusion##2##2##(2008-5#1)(2009-6#1)
preliminary conclusions##2##2##(2005-8#1)(2008-10#1)
preliminary crystallographic##4##2##(1994-9#1)(1997-7#1)(2008-8#1)(2009-3#1)
preliminary data also##2##3##(2007-10#1)(2007-11#1)
preliminary data are promising##2##4##(2007-7#1)(2012-2#1)
preliminary data from the##3##4##(1994-1#1)(2004-11#1)(2008-4#1)
preliminary data from##6##3##(1994-1#1)(2004-11#1)(2008-11#1)(2008-4#1)(2010-12#1)(2013-1#1)
preliminary data indicate that##4##4##(1992-12#1)(2007-11#1)(2008-4#1)(2008-7#1)
preliminary data indicate##5##3##(1992-12#1)(2007-11#2)(2008-4#1)(2008-7#1)
preliminary data on the##3##4##(1995-12#1)(2008-9#1)(2009-5#1)
preliminary data on##7##3##(1993-12#1)(1995-12#1)(2006-10#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-5#1)
preliminary data suggest that the##2##5##(1996-6#1)(2006-9#1)
preliminary data suggest that##6##4##(1996-1#2)(1996-6#1)(2006-10#1)(2006-9#1)(2007-8#1)
preliminary data that##2##3##(2008-7#1)(2008-8#1)
preliminary data which##2##3##(1992-12#1)(2004-9#1)
preliminary data##52##2##(1992-12#2)(1993-12#1)(1994-1#1)(1995-12#1)(1996-1#2)(1996-3#1)(1996-6#1)(2004-11#1)(2004-9#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-6#1)(2006-9#1)(2007-10#3)(2007-11#3)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#2)(2010-2#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
preliminary definitions##2##2##(2011-1#2)
preliminary diagnosis##5##2##(1992-4#1)(1995-11#1)(2008-6#1)(2012-3#1)(2013-8#1)
preliminary evaluation of Grade I Level 1 courses by trainees##2##10##(2012-12#2)
preliminary evaluation of the##5##4##(2007-8#1)(2008-10#2)(2013-1#2)
preliminary evaluation of##11##3##(1990-5#1)(1991-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2010-12#1)(2012-12#2)(2013-1#2)
preliminary evaluation##13##2##(1990-5#1)(1991-12#1)(1993-1#1)(2007-8#1)(2008-10#3)(2008-12#1)(2010-12#1)(2012-12#2)(2013-1#2)
preliminary evaluations##2##2##(1991-2#1)(1996-12#1)
preliminary evidence for the##4##4##(2008-12#2)(2010-8#1)(2012-2#1)
preliminary evidence of##3##3##(1995-3#1)(1995-5#1)(2012-1#1)
preliminary evidence suggests that##2##4##(1993-3#1)(2010-9#1)
preliminary evidence that##6##3##(1992-7#1)(2008-12#2)(2008-3#1)(2011-2#1)(2012-1#1)
preliminary evidence##19##2##(1992-1#1)(1992-7#1)(1993-3#1)(1995-3#1)(1995-5#1)(2007-2#1)(2008-12#4)(2008-3#1)(2008-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-2#1)
preliminary examination##2##2##(2007-11#1)(2009-12#1)
preliminary examinations##2##2##(2003-11#1)(2007-9#1)
preliminary experience in##2##3##(2006-2#1)(2007-8#1)
preliminary experience##8##2##(1990-8#1)(2006-11#1)(2006-2#1)(2006-5#1)(2007-8#4)
preliminary experiment##6##2##(2007-12#1)(2008-2#1)(2008-5#1)(2012-1#2)(2012-12#1)
preliminary experimental results##4##3##(2007-11#1)(2008-3#1)(2012-12#1)(2013-1#1)
preliminary experimental##9##2##(2006-12#1)(2007-11#1)(2007-12#1)(2008-3#2)(2012-1#2)(2012-12#1)(2013-1#1)
preliminary experiments in##2##3##(2007-11#1)(2008-11#1)
preliminary experiments were##2##3##(2008-10#1)(2008-3#1)
preliminary experiments with##3##3##(1997-7#1)(2006-4#1)(2007-12#1)
preliminary experiments##16##2##(1997-3#1)(1997-7#1)(2006-4#1)(2006-5#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)
preliminary findings from##5##3##(1992-5#1)(2005-6#1)(2012-2#1)(2013-1#2)
preliminary findings of an##3##4##(1995-6#1)(1996-6#1)(1997-1#1)
preliminary findings of the##2##4##(1991-8#1)(2011-2#1)
preliminary findings of##6##3##(1990-3#1)(1991-8#1)(1995-6#1)(1996-6#1)(1997-1#1)(2011-2#1)
preliminary findings on##2##3##(1991-1#1)(2009-1#1)
preliminary findings suggest that##2##4##(1994-11#1)(2013-1#1)
preliminary findings##28##2##(1990-3#1)(1991-1#3)(1991-8#1)(1992-1#1)(1992-3#1)(1992-5#1)(1994-11#1)(1995-2#1)(1995-6#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-5#1)(2004-2#1)(2005-11#1)(2005-6#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-1#2)(2011-2#1)(2012-2#1)(2013-1#3)
preliminary genetic##2##2##(2008-10#1)(2011-2#1)
preliminary identification of##3##3##(2008-8#1)(2009-7#1)(2013-8#1)
preliminary in nature##3##3##(2007-8#1)(2008-6#1)(2010-11#1)
preliminary in##6##2##(1995-7#1)(2007-8#1)(2008-5#1)(2008-6#1)(2010-11#1)(2013-8#1)
preliminary information about##2##3##(2007-2#1)(2011-2#1)
preliminary investigation##16##2##(1990-2#1)(1990-6#1)(1991-1#1)(1995-2#1)(2006-3#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-9#4)(2010-3#1)(2011-2#1)(2013-1#2)
preliminary investigations##3##2##(1990-6#1)(2008-12#1)(2008-9#1)
preliminary model##3##2##(1990-9#1)(2007-6#1)(2010-8#1)
preliminary molecular##2##2##(2008-11#1)(2013-7#1)
preliminary multivariate##2##2##(1994-6#1)(2008-10#1)
preliminary nutrient##2##2##(2008-10#1)(2008-8#1)
preliminary observation suggests that##2##4##(2007-8#1)(2009-11#1)
preliminary observation##3##2##(2004-11#1)(2007-8#1)(2009-11#1)
preliminary observations##2##2##(2006-10#1)(2008-6#1)
preliminary pharmacophore model was##2##4##(1993-4#2)
preliminary pharmacophore model##3##3##(1993-4#3)
preliminary report from##2##3##(1994-3#1)(2007-7#1)
preliminary report of##3##3##(1996-2#1)(2005-10#1)(2006-8#1)
preliminary report on##4##3##(1991-2#1)(1993-2#1)(2007-7#2)
preliminary report##36##2##(1990-12#1)(1991-2#1)(1992-12#1)(1993-12#1)(1993-2#1)(1994-3#1)(1996-1#1)(1996-2#1)(1997-5#1)(2005-10#1)(2006-2#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#11)(2007-8#1)(2008-10#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2011-2#1)
preliminary reports##2##2##(1992-11#1)(2007-11#1)
preliminary research on the##2##4##(2010-3#1)(2013-8#1)
preliminary research##3##2##(2006-12#1)(2010-3#1)(2013-8#1)
preliminary result##4##2##(2004-11#1)(2010-12#1)(2011-2#1)(2013-7#1)
preliminary results and##4##3##(1992-8#1)(2009-3#1)(2010-12#1)(2010-5#1)
preliminary results are##6##3##(2005-5#1)(2005-7#1)(2006-4#1)(2007-11#1)(2008-2#1)(2009-5#1)
preliminary results demonstrated the##2##4##(2008-8#1)(2010-12#1)
preliminary results from the##2##4##(2007-8#1)(2012-3#1)
preliminary results from##7##3##(1997-3#1)(2005-7#1)(2006-11#1)(2007-5#1)(2007-8#1)(2012-1#1)(2012-3#1)
preliminary results have##2##3##(2007-11#1)(2008-6#1)
preliminary results indicate that the concept hierarchy used for generalization may influence the associations found##2##15##(2013-1#2)
preliminary results indicate that##9##4##(1990-11#1)(2006-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2013-1#2)
preliminary results of a randomized##2##5##(2007-7#1)(2008-6#1)
preliminary results of a##7##4##(1995-8#1)(2006-3#1)(2006-6#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-6#1)
preliminary results of an##2##4##(2008-2#1)(2013-8#1)
preliminary results of our##3##4##(2006-6#1)(2008-7#1)(2011-1#1)
preliminary results of the##4##4##(2005-8#1)(2006-2#1)(2007-11#1)(2007-8#1)
preliminary results of##30##3##(1995-8#1)(1996-4#1)(1997-6#1)(2005-8#1)(2006-11#1)(2006-2#1)(2006-3#1)(2006-6#3)(2006-7#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
preliminary results on the##3##4##(2008-2#1)(2008-3#1)(2008-8#1)
preliminary results on##5##3##(1991-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2013-1#1)
preliminary results show that the##2##5##(2006-5#1)(2008-10#1)
preliminary results show that##4##4##(1990-2#1)(2006-5#1)(2007-8#1)(2008-10#1)
preliminary results show##5##3##(1990-2#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-5#1)
preliminary results showed##3##3##(2007-2#1)(2007-8#1)(2008-4#1)
preliminary results suggest that this##2##5##(1990-5#1)(1992-4#1)
preliminary results suggest that##10##4##(1990-12#1)(1990-5#1)(1992-12#1)(1992-4#1)(1995-4#1)(1997-4#1)(2006-6#1)(2011-2#2)(2013-1#1)
preliminary results suggest##13##3##(1990-12#1)(1990-5#1)(1992-12#1)(1992-4#1)(1995-4#1)(1997-4#1)(2006-6#1)(2009-4#1)(2011-2#3)(2012-2#1)(2013-1#1)
preliminary results support the##2##4##(1992-6#1)(2010-10#1)
preliminary results that##3##3##(1995-12#1)(2006-11#1)(2008-3#1)
preliminary results##132##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#1)(1991-12#1)(1991-3#1)(1992-10#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-8#1)(1994-4#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-4#1)(1995-8#1)(1996-1#1)(1996-4#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-5#1)(2005-7#2)(2005-8#1)(2006-10#3)(2006-11#3)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#2)(2006-6#4)(2006-7#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#8)(2008-1#3)(2008-10#6)(2008-2#5)(2008-3#6)(2008-4#5)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#3)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-1#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#1)
preliminary results]##3##2##(1993-6#1)(2007-8#1)(2011-2#1)
preliminary review##2##2##(1996-2#1)(2007-7#1)
preliminary screening of##2##3##(2008-10#1)(2009-10#1)
preliminary screening##3##2##(1990-11#1)(2008-10#1)(2009-10#1)
preliminary stage of development##2##4##(2008-10#1)(2010-2#1)
preliminary stage of##3##3##(2008-10#1)(2010-2#1)(2012-3#1)
preliminary stage##4##2##(1997-5#1)(2008-10#1)(2010-2#1)(2012-3#1)
preliminary stages##2##2##(2007-12#2)
preliminary studies have##3##3##(2006-10#2)(2011-2#1)
preliminary studies in##3##3##(2007-4#1)(2007-9#1)(2008-10#1)
preliminary studies using##2##3##(2012-11#1)(2012-12#1)
preliminary studies with##2##3##(1996-5#1)(2006-10#1)
preliminary studies##18##2##(1990-6#1)(1996-3#1)(1996-5#1)(2006-10#3)(2006-8#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-3#1)(2010-11#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-3#1)
preliminary study of##8##3##(1991-4#1)(1992-8#1)(2008-2#1)(2010-10#1)(2010-7#1)(2013-7#1)(2013-8#2)
preliminary study on the##6##4##(1990-7#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
preliminary study on##8##3##(1990-7#1)(2008-8#1)(2008-9#1)(2012-2#3)(2012-3#1)(2013-1#1)
preliminary study suggest##2##3##(1996-5#1)(2006-6#1)
preliminary study was conducted##2##4##(2007-7#1)(2011-2#1)
preliminary study was##6##3##(1993-12#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-5#1)(2011-2#1)
preliminary study with##3##3##(2005-7#1)(2012-1#2)
preliminary study##87##2##(1990-7#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#1)(1995-12#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(2004-10#2)(2004-11#1)(2004-2#1)(2005-7#1)(2006-10#1)(2006-4#2)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#2)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#9)(2013-7#2)(2013-8#2)
preliminary survey##5##2##(2007-10#1)(2008-10#2)(2008-7#1)(2011-1#1)
preliminary targets##2##2##(1991-2#2)
preliminary testing of##2##3##(2008-10#1)(2010-12#1)
preliminary testing##5##2##(1993-4#1)(2008-10#1)(2010-12#1)(2010-8#1)(2010-9#1)
preliminary tests##5##2##(2008-10#4)(2012-1#1)
preliminary theoretical##2##2##(2008-2#1)(2008-3#1)
preliminary trials with##2##3##(2012-1#1)(2012-11#1)
preliminary trials##3##2##(1991-12#1)(2012-1#1)(2012-11#1)
preliminary validation of a##2##4##(2008-12#1)(2012-1#1)
preliminary validation of##4##3##(2006-1#1)(2008-12#1)(2012-1#1)(2013-1#1)
preliminary validation##5##2##(2006-1#1)(2008-12#1)(2010-6#1)(2012-1#1)(2013-1#1)
preliminary work##5##2##(1997-3#1)(2008-10#1)(2008-11#1)(2010-10#1)(2012-1#1)
preliminary##788##1##(1990-10#1)(1990-11#4)(1990-12#5)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#3)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#6)(1991-11#1)(1991-12#6)(1991-2#5)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#5)(1992-2#2)(1992-3#3)(1992-4#3)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#3)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#4)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#4)(1996-12#1)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#2)(1996-6#3)(1996-7#2)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#3)(1997-4#2)(1997-5#3)(1997-6#4)(1997-7#3)(2003-11#1)(2004-10#2)(2004-11#4)(2004-2#2)(2004-9#1)(2005-10#2)(2005-11#3)(2005-12#1)(2005-5#1)(2005-6#1)(2005-7#6)(2005-8#3)(2006-1#1)(2006-10#13)(2006-11#6)(2006-12#4)(2006-2#3)(2006-3#5)(2006-4#5)(2006-5#4)(2006-6#11)(2006-7#1)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#23)(2007-12#20)(2007-2#5)(2007-3#1)(2007-4#6)(2007-5#2)(2007-6#6)(2007-7#18)(2007-8#24)(2007-9#4)(2008-1#6)(2008-10#61)(2008-11#9)(2008-12#11)(2008-2#16)(2008-3#25)(2008-4#15)(2008-5#14)(2008-6#9)(2008-7#10)(2008-8#12)(2008-9#13)(2009-1#2)(2009-10#5)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#4)(2009-4#5)(2009-5#5)(2009-6#2)(2009-7#4)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#11)(2010-2#6)(2010-3#6)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#4)(2010-8#3)(2010-9#4)(2011-1#7)(2011-12#1)(2011-2#23)(2011-3#1)(2012-1#19)(2012-11#2)(2012-12#14)(2012-2#15)(2012-3#11)(2013-1#27)(2013-7#6)(2013-8#11)
preliminary-testing##2##1##(1993-4#2)
prelingual##4##1##(1992-10#1)(2008-9#2)(2011-1#1)
prelingually deaf##2##2##(2008-9#2)
prelingually deafened##7##2##(2008-9#7)
prelingually##12##1##(2007-3#1)(2008-9#11)
preload by##2##2##(1993-12#1)(1997-4#1)
preload##17##1##(1993-12#1)(1996-3#1)(1997-4#4)(2006-10#1)(2006-11#6)(2007-4#1)(2011-2#3)
preloaded##6##1##(1990-2#1)(1991-1#1)(1992-5#1)(1995-12#1)(2006-11#1)(2011-2#1)
preloading##3##1##(2011-1#1)(2011-12#2)
prelude to the##2##3##(2008-9#1)(2012-3#1)
prelude to##8##2##(1991-11#1)(1996-9#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-3#1)
prelude##9##1##(1991-11#1)(1996-9#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
premalignancy##2##1##(2006-10#1)(2009-11#1)
premalignant and malignant lesions of the##2##6##(2007-2#1)(2009-8#1)
premalignant and malignant lesions##5##4##(2006-10#2)(2007-11#1)(2007-2#1)(2009-8#1)
premalignant and malignant##8##3##(2006-10#3)(2007-11#1)(2007-12#1)(2007-2#1)(2008-5#1)(2009-8#1)
premalignant disease##2##2##(2004-10#1)(2006-10#1)
premalignant lesion##3##2##(2006-10#3)
premalignant lesions and##2##3##(2006-9#1)(2011-1#1)
premalignant lesions##5##2##(2006-9#1)(2007-12#1)(2008-2#1)(2011-1#1)(2011-2#1)
premalignant phase##2##2##(1992-12#1)(2013-1#1)
premalignant##34##1##(1992-12#1)(1992-3#1)(1993-2#1)(1993-5#1)(2004-10#1)(2006-10#9)(2006-2#2)(2006-9#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-2#1)(2008-5#3)(2009-12#1)(2009-8#1)(2011-1#1)(2011-2#3)(2013-1#2)
premammillary nucleus##4##2##(1994-2#2)(1997-3#2)
premammillary##6##1##(1994-2#4)(1997-3#2)
premarital childbearing##3##2##(2012-1#3)
premarital first##2##2##(2010-8#1)(2012-1#1)
premarital##6##1##(2006-4#1)(2010-8#1)(2012-1#4)
premating barriers##4##2##(2008-8#2)(2012-3#2)
premating isolation##7##2##(2008-8#3)(2008-9#4)
premating reproductive isolation##3##3##(2008-9#3)
premating##19##1##(2008-8#7)(2008-9#8)(2012-3#4)
premature activation of HIV-1##2##4##(2011-3#2)
premature adrenarche##6##2##(2008-4#6)
premature ageing##3##2##(2008-5#1)(2009-12#2)
premature aging and##3##3##(1994-12#1)(1996-4#1)(2008-11#1)
premature aging disorder##2##3##(2010-2#2)
premature aging syndromes##2##3##(2007-7#1)(2011-2#1)
premature aging##14##2##(1992-9#1)(1994-12#1)(1994-5#1)(1995-12#1)(1996-4#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-8#2)(2010-2#3)(2011-2#1)
premature and low birth weight##2##5##(1991-12#1)(2008-10#1)
premature and newborn##2##3##(1990-8#2)
premature and##7##2##(1990-8#2)(1991-12#1)(2006-7#1)(2008-10#1)(2010-10#1)(2013-1#1)
premature apoptosis##2##2##(2010-11#1)(2011-1#1)
premature atherosclerosis and##2##3##(1991-12#1)(1991-8#1)
premature atherosclerosis##11##2##(1991-12#1)(1991-8#1)(1993-9#1)(1994-8#1)(1995-4#1)(1997-2#3)(2007-10#1)(2008-11#2)
premature atherosclerotic##2##2##(1992-9#1)(2008-1#1)
premature babies##4##2##(1994-3#1)(1994-6#1)(1996-11#1)(2006-8#1)
premature beats##3##2##(1996-3#1)(2007-9#2)
premature birth##4##2##(2011-2#1)(2012-12#2)(2013-1#1)
premature cardiovascular disease##5##3##(1992-9#1)(2006-12#1)(2008-10#1)(2009-11#2)
premature cardiovascular##8##2##(1992-9#1)(1997-2#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-11#2)
premature centromere separation##2##3##(2006-5#2)
premature children##3##2##(1996-4#1)(2011-2#2)
premature coronary artery disease##3##4##(1993-9#3)
premature coronary heart disease##2##4##(1993-10#1)(2011-2#1)
premature coronary##5##2##(1993-10#1)(1993-9#3)(2011-2#1)
premature death and##2##3##(2005-7#1)(2008-5#1)
premature death from##2##3##(1995-7#1)(2012-12#1)
premature death in##4##3##(1990-7#1)(2007-11#1)(2011-2#1)(2012-12#1)
premature death##17##2##(1990-7#1)(1995-10#1)(1995-7#1)(2005-10#1)(2005-7#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#5)
premature deliveries##2##2##(1993-5#1)(1997-3#1)
premature delivery##8##2##(1996-2#1)(2005-11#1)(2006-6#1)(2007-2#1)(2008-11#1)(2011-1#1)(2012-3#2)
premature development of##2##3##(1993-9#1)(1995-6#1)
premature discharge##2##2##(1991-12#1)(1996-1#1)
premature ejaculation##4##2##(2007-7#1)(2008-5#1)(2010-10#1)(2013-7#1)
premature infant##9##2##(1994-3#1)(1997-2#1)(2006-7#1)(2007-12#2)(2007-2#1)(2007-9#1)(2011-2#2)
premature infant]##2##2##(2007-10#1)(2007-12#1)
premature infants and##5##3##(2006-10#1)(2007-10#1)(2010-10#1)(2012-2#1)(2013-1#1)
premature infants are##2##3##(1996-11#1)(2007-11#1)
premature infants during##2##3##(2010-10#1)(2011-2#1)
premature infants in##2##3##(1990-11#1)(2012-12#1)
premature infants may##2##3##(2006-7#1)(2007-11#1)
premature infants with##6##3##(1990-11#1)(1991-9#1)(1996-6#1)(2012-2#3)
premature infants##47##2##(1990-11#4)(1991-9#1)(1993-5#2)(1994-3#1)(1994-4#1)(1995-8#2)(1996-11#1)(1996-6#1)(1996-8#1)(2006-10#2)(2006-7#2)(2007-10#3)(2007-11#9)(2008-11#1)(2008-6#1)(2008-9#1)(2010-10#2)(2011-2#3)(2012-12#2)(2012-2#5)(2013-1#1)(2013-7#1)
premature infants' physiological parameters##2##4##(2007-10#2)
premature infants]##7##2##(1990-11#1)(1991-4#1)(1993-5#1)(1996-11#1)(2012-2#1)(2013-1#2)
premature labor and##2##3##(1994-6#1)(1996-9#1)
premature labor##3##2##(1994-6#1)(1996-9#2)
premature loss of##2##3##(2005-11#1)(2012-2#1)
premature mortality##5##2##(1990-9#1)(1993-10#1)(1995-9#1)(1997-8#1)(2008-1#1)
premature mother-child skin-to-skin contact##6##4##(2011-2#6)
premature myocardial infarction##3##3##(1991-6#2)(2009-12#1)
premature neonate##2##2##(2010-2#1)(2011-2#1)
premature neonates##2##2##(2006-6#2)
premature newborn##4##2##(1996-11#1)(2009-9#1)(2011-2#1)(2013-1#1)
premature newborns##5##2##(2008-11#1)(2009-5#3)(2009-9#1)
premature ovarian failure##7##3##(1996-2#2)(2008-1#1)(2008-4#1)(2008-7#1)(2012-3#1)(2013-8#1)
premature ovarian##8##2##(1996-2#2)(2008-1#1)(2008-4#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
premature rupture of membrane##2##4##(2009-3#1)(2011-12#1)
premature rupture of membranes##2##4##(1993-4#1)(2013-1#1)
premature rupture of the##3##4##(1993-5#1)(1996-12#1)(2008-10#1)
premature rupture of##9##3##(1993-4#1)(1993-5#1)(1996-12#1)(2008-10#1)(2009-3#1)(2011-1#1)(2011-12#1)(2012-3#1)(2013-1#1)
premature senescence##4##2##(2008-11#3)(2009-8#1)
premature stop codon##7##3##(1991-10#1)(1994-11#1)(1995-8#2)(1997-7#1)(2007-2#1)(2008-4#1)
premature termination of the protein##3##5##(1993-6#1)(1994-12#1)(2006-12#1)
premature termination of##9##3##(1990-3#1)(1991-11#1)(1992-2#1)(1993-6#1)(1994-12#1)(1997-1#1)(2006-12#1)(2007-11#1)(2008-1#1)
premature termination##17##2##(1990-3#1)(1990-4#1)(1990-8#1)(1991-11#1)(1992-2#1)(1993-6#1)(1994-12#1)(1995-1#1)(1997-1#1)(1997-6#1)(2006-12#2)(2007-11#1)(2008-1#1)(2008-10#1)(2012-1#1)(2012-2#1)
premature to##9##2##(1994-2#1)(2006-11#1)(2006-12#1)(2006-3#2)(2007-5#1)(2008-11#1)(2008-6#1)(2013-1#1)
premature vascular disease##2##3##(1992-4#1)(2010-5#1)
premature vascular##3##2##(1992-4#1)(1993-9#1)(2010-5#1)
premature ventricular contraction##2##3##(2007-8#2)
premature ventricular##4##2##(1993-1#1)(2007-8#2)(2013-8#1)
premature##349##1##(1990-11#6)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-9#3)(1993-1#1)(1993-10#2)(1993-4#1)(1993-5#5)(1993-6#2)(1993-9#6)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#3)(1995-2#1)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#4)(1995-9#1)(1996-1#1)(1996-11#4)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#3)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#4)(2005-11#2)(2005-7#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#5)(2006-3#2)(2006-5#2)(2006-6#5)(2006-7#4)(2006-8#1)(2006-9#1)(2007-10#8)(2007-11#11)(2007-12#3)(2007-2#3)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#6)(2007-9#4)(2008-1#5)(2008-10#8)(2008-11#15)(2008-3#1)(2008-4#10)(2008-5#6)(2008-6#4)(2008-7#1)(2008-8#2)(2008-9#6)(2009-11#5)(2009-12#3)(2009-3#1)(2009-5#4)(2009-8#2)(2009-9#3)(2010-10#4)(2010-11#1)(2010-2#4)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#9)(2011-12#3)(2011-2#21)(2011-3#3)(2012-1#1)(2012-12#12)(2012-2#12)(2012-3#4)(2013-1#9)(2013-7#2)(2013-8#4)
prematurely and##3##2##(1994-1#1)(1995-2#1)(2013-8#1)
prematurely born children)##2##3##(2008-3#2)
prematurely born infants##2##3##(1996-4#1)(2012-3#1)
prematurely born##7##2##(1996-4#2)(2008-3#3)(2010-12#1)(2012-3#1)
prematurely terminated##2##2##(1996-11#1)(2004-1#1)
prematurely##43##1##(1990-8#1)(1991-11#1)(1992-1#1)(1992-7#1)(1993-1#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-11#2)(1996-4#2)(1996-9#1)(1997-4#3)(2004-1#2)(2005-9#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-3#3)(2008-9#1)(2009-6#1)(2010-12#1)(2010-9#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
prematures##2##1##(2007-12#2)
prematurity and##5##2##(1992-7#1)(1994-6#1)(2004-10#1)(2008-11#1)(2011-12#1)
prematurity is##2##2##(2011-1#1)(2012-2#1)
prematurity was##4##2##(1992-1#1)(1992-2#1)(2007-12#1)(2007-7#1)
prematurity##41##1##(1991-9#2)(1992-1#1)(1992-2#1)(1992-7#2)(1993-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(2004-10#2)(2006-2#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-11#2)(2011-1#8)(2011-12#3)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
premedicated##5##1##(1990-3#2)(1996-6#1)(2012-2#1)(2012-3#1)
premedication for##2##2##(1996-12#1)(2007-3#1)
premedication in##2##2##(2007-2#1)(2012-2#1)
premedication were##2##2##(1992-6#1)(2007-3#1)
premedication with##7##2##(1996-12#1)(1997-6#1)(2007-10#2)(2007-2#1)(2007-9#1)(2011-2#1)
premedication##25##1##(1990-3#1)(1990-8#1)(1992-6#1)(1993-4#2)(1996-12#3)(1997-6#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-10#2)(2007-2#3)(2007-3#2)(2007-9#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)
premeiotic and meiotic periods##2##4##(2008-7#2)
premeiotic##4##1##(1997-1#1)(2008-5#1)(2008-7#2)
premenopausal and postmenopausal patients##2##4##(1993-12#1)(1994-2#1)
premenopausal and postmenopausal##3##3##(1993-12#1)(1994-2#1)(2008-3#1)
premenopausal and##6##2##(1993-12#1)(1994-12#1)(1994-2#1)(2007-1#1)(2008-3#1)(2008-7#1)
premenopausal breast cancer patients##4##4##(1992-12#1)(2006-9#1)(2007-5#1)(2008-7#1)
premenopausal breast cancer##8##3##(1991-4#2)(1992-12#1)(1994-4#1)(1995-8#1)(2006-9#1)(2007-5#1)(2008-7#1)
premenopausal levels##2##2##(1994-6#1)(2008-3#1)
premenopausal patients with##2##3##(1991-4#1)(2006-10#1)
premenopausal patients##5##2##(1991-4#1)(1997-7#1)(2006-10#1)(2007-5#1)(2010-7#1)
premenopausal women with##4##3##(1991-4#1)(2004-2#1)(2008-3#1)(2011-12#1)
premenopausal women##21##2##(1990-12#2)(1991-4#1)(1993-12#1)(1994-4#1)(1994-9#1)(2004-1#1)(2004-2#2)(2007-11#1)(2007-9#1)(2008-1#1)(2008-3#3)(2008-7#1)(2008-9#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-12#1)
premenopausal##56##1##(1990-12#2)(1991-4#4)(1991-8#1)(1991-9#1)(1992-12#1)(1993-12#2)(1993-5#1)(1994-12#2)(1994-2#2)(1994-4#2)(1994-6#1)(1994-9#1)(1995-8#1)(1997-7#1)(2004-1#1)(2004-2#2)(2006-10#2)(2006-9#1)(2007-1#2)(2007-11#1)(2007-5#3)(2007-9#2)(2008-1#2)(2008-3#5)(2008-7#3)(2008-9#1)(2009-8#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
premenstrual dysphoric disorder (PMDD)##2##4##(2008-5#1)(2009-10#1)
premenstrual dysphoric##3##2##(2008-5#1)(2009-10#2)
premenstrual syndrome (PMS)##2##3##(2008-5#1)(2009-6#1)
premenstrual syndrome##7##2##(2006-7#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-6#2)
premenstrual##18##1##(1994-9#1)(2004-3#2)(2006-10#1)(2006-4#1)(2006-7#1)(2007-7#1)(2008-10#2)(2008-5#2)(2008-8#1)(2009-10#2)(2009-6#4)
premetamorphic larvae##2##2##(2008-5#2)
premetamorphic##4##1##(1994-9#1)(2008-12#1)(2008-5#2)
premicellar aggregates##3##2##(2008-10#3)
premicellar aggregation##2##2##(2005-11#2)
premicellar association##3##2##(2005-11#3)
premicellar##10##1##(2005-11#7)(2008-10#3)
premicelles##5##1##(2005-11#4)(2008-10#1)
premier##6##1##(2008-4#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
premise for the##2##3##(2008-12#1)(2013-8#1)
premise for##3##2##(2007-9#1)(2008-12#1)(2013-8#1)
premise is that the##2##4##(1991-3#1)(1994-12#1)
premise is that##4##3##(1991-3#1)(1994-12#1)(2008-1#1)(2008-4#1)
premise of the##2##3##(2007-9#1)(2008-7#1)
premise of##4##2##(1996-8#1)(1997-3#1)(2007-9#1)(2008-7#1)
premise that the##5##3##(1990-8#1)(1994-3#1)(2006-10#1)(2006-8#1)(2008-9#1)
premise that##24##2##(1990-8#1)(1992-3#1)(1992-6#1)(1994-3#1)(1996-11#1)(1996-9#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-8#1)(2013-1#1)
premise##46##1##(1990-8#1)(1991-3#1)(1992-3#2)(1992-6#1)(1994-12#1)(1994-3#1)(1996-11#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#2)(2006-10#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#4)(2008-7#4)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-8#1)(2013-1#1)(2013-8#1)
premises and##3##2##(1990-2#1)(2007-8#1)(2010-4#1)
premises of the##2##3##(2007-11#1)(2008-1#1)
premises of##4##2##(1990-3#1)(2007-11#1)(2008-1#1)(2010-9#1)
premises that##2##2##(2007-4#1)(2008-8#1)
premises##34##1##(1990-2#1)(1990-3#1)(1991-1#1)(1991-10#1)(1991-12#1)(1992-4#1)(1993-1#2)(1995-12#1)(1995-3#1)(1996-3#2)(2006-10#2)(2007-10#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-6#1)(2010-4#2)(2010-9#2)(2012-12#5)(2012-2#1)
premium and##2##2##(1997-1#1)(2008-7#1)
premium costs##2##2##(1996-3#1)(1997-2#1)
premium in##2##2##(1995-12#1)(2010-2#1)
premium increases##2##2##(2007-3#1)(2008-11#1)
premium rate restrictions and open enrolment##2##6##(2008-7#2)
premium##26##1##(1992-9#1)(1993-3#1)(1994-12#2)(1995-12#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-8#2)(2007-3#2)(2008-11#2)(2008-12#1)(2008-7#5)(2009-11#2)(2010-2#3)
premiums for##2##2##(1992-12#1)(1996-3#1)
premiums may##2##2##(1992-12#1)(1993-3#1)
premiums##27##1##(1991-12#1)(1991-3#1)(1992-12#2)(1993-3#3)(1994-12#1)(1994-3#2)(1996-1#1)(1996-3#3)(1996-5#1)(1997-1#5)(1997-3#1)(1997-8#1)(2008-12#1)(2008-7#4)
premix##2##1##(2011-12#2)
premixed ethylene-air##2##2##(2008-3#2)
premixed flames##3##2##(2008-3#3)
premixed twin flames stabilized in##2##5##(2008-2#1)(2008-3#1)
premixed with##2##2##(2009-10#2)
premixed##20##1##(2006-12#1)(2008-10#1)(2008-2#7)(2008-3#9)(2009-10#2)
premolar extractions##5##2##(2010-3#1)(2013-8#4)
premolar##13##1##(2004-9#1)(2006-7#1)(2008-12#1)(2010-10#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-8#6)
premolars in##2##2##(2010-3#1)(2011-12#1)
premolars##9##1##(2009-2#3)(2010-3#1)(2011-12#1)(2013-1#4)
premolt##4##1##(2007-5#2)(2008-6#2)
premonitory##2##1##(1993-12#1)(1996-4#1)
premorbid conditions##2##2##(2007-6#2)
premorbid social adaptation##2##3##(2012-2#2)
premorbid##15##1##(1995-2#1)(2004-11#1)(2004-3#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-6#2)(2007-7#1)(2007-9#1)(2012-2#3)(2013-8#2)
premotoneurons##2##1##(1990-9#1)(1997-7#1)
premotor and##2##2##(2008-11#1)(2010-2#1)
premotor area##3##2##(1995-12#1)(1995-5#1)(1996-2#1)
premotor cortex and##3##3##(1995-12#2)(1995-8#1)
premotor cortex##14##2##(1993-2#1)(1995-12#4)(1995-5#1)(1995-8#1)(1996-1#1)(2007-10#1)(2008-11#1)(2010-7#2)(2013-1#1)(2013-8#1)
premotor neurons##3##2##(1990-7#1)(1996-9#1)(1997-7#1)
premotor##30##1##(1990-7#1)(1993-2#2)(1995-12#5)(1995-5#2)(1995-8#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-7#1)(2006-3#1)(2007-10#1)(2008-11#5)(2010-2#2)(2010-7#2)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
premutation##3##1##(2006-12#2)(2009-5#1)
premyelinating##3##1##(2006-1#3)
prenalterol##4##1##(2008-10#4)
prenatal DES-exposure##2##2##(2008-10#2)
prenatal DEX##2##2##(1995-12#2)
prenatal GC##2##2##(1995-12#2)
prenatal WIC##3##2##(1993-3#3)
prenatal alcohol and##2##3##(2006-10#1)(2006-3#1)
prenatal alcohol consumption##2##3##(2008-11#2)
prenatal alcohol use##3##3##(2008-11#3)
prenatal alcohol##11##2##(1991-1#1)(2006-10#1)(2006-3#2)(2008-11#6)(2011-2#1)
prenatal and neonatal##2##3##(2008-10#1)(2008-12#1)
prenatal and postnatal care##3##4##(1993-3#1)(2005-11#1)(2007-2#1)
prenatal and postnatal##9##3##(1993-3#1)(1995-1#1)(2005-10#1)(2005-11#1)(2007-2#1)(2008-4#2)(2009-9#1)(2012-3#1)
prenatal and##16##2##(1993-3#1)(1995-1#1)(1995-3#1)(2005-10#1)(2005-11#1)(2007-2#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-4#2)(2009-2#1)(2009-9#1)(2010-9#1)(2012-3#1)
prenatal care adequacy##2##3##(2005-10#1)(2008-1#1)
prenatal care and birth##4##4##(1992-2#1)(1995-2#2)(2005-10#1)
prenatal care and##13##3##(1992-2#2)(1993-3#1)(1993-6#1)(1994-3#1)(1995-2#2)(2005-10#2)(2007-2#2)(2008-11#1)(2011-1#1)
prenatal care at a##3##4##(1993-10#1)(1993-3#1)(1995-12#1)
prenatal care in the##3##4##(1994-3#1)(2008-10#1)(2011-2#1)
prenatal care in##6##3##(1994-3#2)(2008-10#2)(2011-2#2)
prenatal care was associated with##2##5##(1993-3#2)
prenatal care was##4##3##(1993-3#2)(1995-2#1)(2008-1#1)
prenatal care##65##2##(1991-2#1)(1992-2#3)(1993-10#1)(1993-3#6)(1993-6#2)(1994-3#8)(1995-12#2)(1995-2#5)(1996-12#1)(1996-8#1)(2005-10#4)(2007-2#3)(2008-1#10)(2008-10#4)(2008-11#2)(2008-9#1)(2009-7#2)(2011-1#1)(2011-2#6)(2013-1#2)
prenatal classes##2##2##(1995-1#1)(2007-2#1)
prenatal clinic##2##2##(2007-2#1)(2008-1#1)
prenatal cocaine##5##2##(1996-10#4)(1996-4#1)
prenatal consultation##2##2##(1993-3#1)(2012-12#1)
prenatal counselling##2##2##(2006-8#1)(2012-2#1)
prenatal cytogenetic diagnosis##3##3##(2008-11#1)(2012-3#2)
prenatal detection of##2##3##(1993-12#1)(2012-3#1)
prenatal development of##3##3##(2007-11#1)(2012-3#2)
prenatal development##8##2##(1996-4#1)(2007-11#2)(2011-12#1)(2012-1#1)(2012-3#3)
prenatal diagnosis and##3##3##(1997-3#1)(2008-1#1)(2011-2#1)
prenatal diagnosis for##2##3##(1996-12#1)(1996-6#1)
prenatal diagnosis in##2##3##(2011-2#1)(2012-3#1)
prenatal diagnosis is##5##3##(1990-9#1)(2006-8#1)(2008-4#1)(2013-1#2)
prenatal diagnosis of fetal##3##4##(1996-12#2)(2012-3#1)
prenatal diagnosis of##14##3##(1991-9#1)(1992-6#1)(1995-4#1)(1996-12#2)(1996-3#1)(1996-6#1)(2006-8#1)(2008-4#1)(2012-2#2)(2012-3#3)
prenatal diagnosis##39##2##(1990-9#1)(1991-9#1)(1992-6#2)(1995-4#1)(1996-12#4)(1996-3#2)(1996-6#3)(1997-3#1)(2006-10#1)(2006-4#2)(2006-8#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-4#3)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#3)
prenatal education##3##2##(2007-2#3)
prenatal events##2##2##(1997-5#1)(2008-2#1)
prenatal exposure of##2##3##(2010-12#2)
prenatal exposure to DEX##2##4##(1995-12#2)
prenatal exposure to alcohol##2##4##(1991-1#1)(1995-3#1)
prenatal exposure to##13##3##(1991-1#1)(1995-12#2)(1995-3#1)(1996-10#2)(2004-11#1)(2008-10#1)(2010-9#2)(2011-2#3)
prenatal exposure##15##2##(1991-1#1)(1995-12#2)(1995-3#1)(1996-10#2)(2004-11#1)(2008-10#1)(2010-12#2)(2010-9#2)(2011-2#3)
prenatal famine and adult##2##4##(2011-1#2)
prenatal famine and##3##3##(2011-1#3)
prenatal findings##2##2##(2008-7#1)(2011-2#1)
prenatal genetic##2##2##(1990-12#1)(2007-2#1)
prenatal growth##2##2##(1996-12#1)(2007-11#1)
prenatal intervention##2##2##(1991-12#1)(2008-7#1)
prenatal life##4##2##(1993-12#1)(2007-7#1)(2008-10#1)(2008-2#1)
prenatal malnutrition and##2##3##(1994-10#1)(2008-11#1)
prenatal malnutrition##3##2##(1994-10#1)(2008-11#2)
prenatal morphine##3##2##(1994-10#3)
prenatal or##2##2##(1995-6#1)(2008-4#1)
prenatal period##9##2##(1995-5#1)(1996-5#1)(2005-11#2)(2007-2#1)(2010-5#1)(2011-12#1)(2012-2#1)(2013-7#1)
prenatal programming##2##2##(2013-1#2)
prenatal protein malnutrition##3##3##(1994-10#2)(2008-11#1)
prenatal screening##3##2##(1996-12#1)(2007-3#1)(2009-4#1)
prenatal smoking on the##2##4##(2007-2#2)
prenatal smoking on##3##3##(2007-2#3)
prenatal stress##5##2##(1996-5#1)(2008-2#3)(2013-7#1)
prenatal testing##3##2##(1992-9#1)(2008-1#1)(2013-1#1)
prenatal treatment of congenital##2##4##(1990-3#1)(2008-4#1)
prenatal treatment with##2##3##(1992-2#1)(2011-2#1)
prenatal treatment##7##2##(1990-3#1)(1991-1#1)(1992-10#1)(1992-2#1)(1996-10#1)(2008-4#1)(2011-2#1)
prenatal vascular disruptions##3##3##(1997-3#3)
prenatal visits##3##2##(2005-10#1)(2008-10#1)(2011-1#1)
prenatal##336##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-1#4)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#7)(1992-6#2)(1992-7#1)(1992-9#1)(1993-10#1)(1993-12#2)(1993-3#11)(1993-6#2)(1994-10#6)(1994-12#1)(1994-3#8)(1995-1#2)(1995-12#8)(1995-2#5)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#1)(1996-10#7)(1996-12#8)(1996-2#1)(1996-3#3)(1996-4#2)(1996-5#4)(1996-6#4)(1996-8#1)(1997-3#4)(1997-5#1)(2004-11#2)(2005-10#7)(2005-11#3)(2006-1#1)(2006-10#3)(2006-2#1)(2006-3#2)(2006-4#3)(2006-7#1)(2006-8#4)(2006-9#1)(2007-11#3)(2007-2#22)(2007-3#2)(2007-7#2)(2007-9#1)(2008-1#13)(2008-10#14)(2008-11#13)(2008-12#3)(2008-2#7)(2008-3#2)(2008-4#9)(2008-7#4)(2008-9#1)(2009-2#1)(2009-4#1)(2009-7#2)(2009-9#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#3)(2011-1#7)(2011-12#2)(2011-2#19)(2011-5#1)(2012-1#2)(2012-12#5)(2012-2#9)(2012-3#16)(2013-1#15)(2013-7#2)
prenatally and##3##2##(1990-5#1)(1990-8#1)(2006-1#1)
prenatally androgenized female rhesus monkeys##2##5##(2008-4#2)
prenatally detected##2##2##(2008-10#1)(2008-7#1)
prenatally diagnosed##3##2##(1990-8#1)(1997-3#1)(2008-4#1)
prenatally exposed to DES##2##4##(2008-10#2)
prenatally exposed to##7##3##(1995-3#1)(1996-10#1)(2008-10#3)(2013-1#2)
prenatally stressed##2##2##(2013-7#2)
prenatally to##6##2##(1990-8#1)(1994-10#1)(1995-12#1)(1996-10#1)(2006-3#2)
prenatally##39##1##(1990-5#2)(1990-8#3)(1991-4#1)(1994-10#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-10#4)(1996-5#1)(1997-3#1)(2006-1#1)(2006-3#2)(2007-2#1)(2008-10#5)(2008-11#2)(2008-4#3)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#4)(2013-7#2)
preneoplastic lesions in##3##3##(1991-6#1)(1991-9#1)(1992-4#1)
preneoplastic lesions##6##2##(1991-6#1)(1991-9#1)(1992-4#2)(1992-9#1)(2011-2#1)
preneoplastic transformation##2##2##(1991-12#1)(1995-9#1)
preneoplastic##18##1##(1991-12#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-4#2)(1992-9#4)(1995-9#1)(2007-6#1)(2008-6#1)(2009-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-7#1)
prenols and sterols##2##3##(1994-11#2)
prenyl acceptor##2##2##(1995-1#2)
prenyl donor##2##2##(1995-1#2)
prenyl group##3##2##(1995-1#1)(2009-11#2)
prenyl##12##1##(1993-3#2)(1994-8#1)(1995-1#5)(2009-11#4)
prenylamine in##2##2##(1993-7#2)
prenylamine##6##1##(1993-7#6)
prenylated proteins##2##2##(1995-3#1)(2008-5#1)
prenylated xanthones##2##2##(2009-3#2)
prenylated##11##1##(1995-3#1)(2007-11#2)(2008-5#1)(2008-9#2)(2009-3#2)(2011-2#3)
prenylation of##4##2##(1996-4#3)(2005-7#1)
prenylation##10##1##(1992-5#3)(1995-1#1)(1996-4#4)(2005-7#2)
prenyltransferase##3##1##(2011-2#3)
prenyltransferases##6##1##(1993-4#1)(1997-7#2)(2008-8#1)(2011-2#1)(2012-2#1)
preoccupation of the##3##3##(1991-2#1)(1994-3#1)(2008-5#1)
preoccupation of##4##2##(1991-2#1)(1994-3#1)(2008-12#1)(2008-5#1)
preoccupation with##2##2##(1993-6#1)(2010-6#1)
preoccupation##11##1##(1991-2#1)(1993-2#1)(1993-6#1)(1994-3#1)(2007-12#4)(2008-12#1)(2008-5#1)(2010-6#1)
preoccupations##3##1##(2008-5#1)(2011-1#1)(2013-8#1)
preoccupied with##3##2##(2007-7#1)(2008-11#1)(2008-7#1)
preoccupied##4##1##(2007-7#2)(2008-11#1)(2008-7#1)
preoperative PDT##2##2##(2008-5#2)
preoperative RVSP##2##2##(2007-8#2)
preoperative activity##2##2##(2006-7#1)(2011-2#1)
preoperative and postoperative##13##3##(1993-7#1)(1994-3#1)(1996-2#1)(2004-2#1)(2007-11#1)(2007-8#1)(2008-8#1)(2009-10#1)(2011-7#1)(2012-12#3)(2013-8#1)
preoperative and##21##2##(1992-3#1)(1993-7#1)(1994-3#1)(1996-2#1)(2004-2#1)(2005-12#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-12#3)(2012-3#1)(2013-7#1)(2013-8#1)
preoperative angiography and##2##3##(2005-5#1)(2012-3#1)
preoperative angiography##4##2##(1996-9#1)(2005-5#1)(2008-12#1)(2012-3#1)
preoperative assessment and##2##3##(2010-11#1)(2012-2#1)
preoperative assessment of the##3##4##(2006-10#2)(2012-3#1)
preoperative assessment of##7##3##(1990-10#1)(2006-10#2)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
preoperative assessment##17##2##(1990-10#1)(2006-10#5)(2007-12#1)(2007-8#1)(2009-3#1)(2010-11#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
preoperative autologous##2##2##(2006-10#1)(2009-3#1)
preoperative biliary##2##2##(2006-10#1)(2006-2#1)
preoperative characteristics##2##2##(2008-9#1)(2012-3#1)
preoperative chemotherapy and##2##3##(1994-8#1)(2006-10#1)
preoperative chemotherapy was##4##3##(2008-1#1)(2010-3#3)
preoperative chemotherapy##13##2##(1992-6#2)(1994-8#1)(2006-10#2)(2007-2#1)(2008-1#1)(2010-3#4)(2012-3#2)
preoperative clinical and##3##3##(1997-2#1)(2006-8#1)(2012-12#1)
preoperative clinical##7##2##(1993-5#1)(1997-2#1)(2006-8#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
preoperative condition##2##2##(1994-11#1)(1996-12#1)
preoperative considerations##2##2##(2006-7#1)(2007-12#1)
preoperative counseling##3##2##(2011-2#1)(2012-12#2)
preoperative diagnosis and##4##3##(1996-8#1)(2006-6#1)(2007-8#1)(2011-2#1)
preoperative diagnosis has been made##2##5##(1993-8#1)(2006-6#1)
preoperative diagnosis is##4##3##(1992-9#1)(2007-9#1)(2008-3#1)(2011-2#1)
preoperative diagnosis of##3##3##(1991-3#1)(2008-7#1)(2013-8#1)
preoperative diagnosis was##2##3##(2008-5#1)(2011-2#1)
preoperative diagnosis##26##2##(1991-3#1)(1992-9#2)(1993-8#1)(1996-8#1)(1997-8#1)(2005-12#1)(2006-6#2)(2006-9#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-7#2)(2010-12#1)(2011-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
preoperative differentiation##2##2##(1993-9#1)(2008-12#1)
preoperative disinfection of hands##2##4##(1994-11#2)
preoperative disinfection of##3##3##(1994-11#3)
preoperative disinfection##4##2##(1994-11#3)(2007-4#1)
preoperative embolization of##2##3##(2008-7#2)
preoperative embolization to##2##3##(2006-12#1)(2008-7#1)
preoperative embolization##13##2##(2006-12#1)(2007-8#2)(2008-7#8)(2012-12#1)(2012-3#1)
preoperative endoscopic##2##2##(2008-3#1)(2008-5#1)
preoperative evaluation and##3##3##(1992-8#1)(2005-10#1)(2009-5#1)
preoperative evaluation clinics##3##3##(2006-10#3)
preoperative evaluation is##3##3##(1991-8#1)(2007-12#1)(2009-6#1)
preoperative evaluation of the patient with##2##6##(1996-2#1)(2006-10#1)
preoperative evaluation of the##5##4##(1992-10#1)(1992-2#1)(1996-2#1)(2006-10#2)
preoperative evaluation of##6##3##(1990-9#1)(1992-10#1)(1992-2#1)(1996-2#1)(2006-10#2)
preoperative evaluation that##2##3##(2010-12#1)(2012-12#1)
preoperative evaluation##29##2##(1990-9#1)(1991-8#1)(1992-10#1)(1992-2#1)(1992-8#1)(1996-2#1)(2005-10#1)(2006-10#8)(2006-2#1)(2007-12#1)(2007-7#1)(2008-12#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-12#1)(2012-12#1)(2013-1#2)
preoperative examination##5##2##(1994-12#1)(2006-3#1)(2007-12#1)(2011-1#1)(2012-2#1)
preoperative examinations##4##2##(2006-7#1)(2010-8#1)(2012-12#2)
preoperative fasting time##3##3##(2010-12#3)
preoperative fasting##4##2##(2010-12#4)
preoperative feeding##3##2##(2011-2#3)
preoperative grading scheme to assess##2##5##(2006-12#2)
preoperative hemoglobin##2##2##(1994-3#1)(2009-3#1)
preoperative imaging##9##2##(1992-9#1)(1993-5#1)(2006-12#1)(2006-6#1)(2007-12#1)(2008-3#1)(2010-12#1)(2012-1#1)(2013-8#1)
preoperative investigation##2##2##(1990-11#2)
preoperative investigations##2##2##(1990-4#1)(2008-5#1)
preoperative levels by 6##2##4##(2013-1#2)
preoperative levels##5##2##(1990-9#1)(2006-8#1)(2007-8#1)(2013-1#2)
preoperative magnetic resonance##3##3##(2007-12#1)(2008-9#1)(2011-2#1)
preoperative model##2##2##(2007-5#1)(2011-2#1)
preoperative neoadjuvant##2##2##(2006-10#1)(2013-1#1)
preoperative neuroimaging##2##2##(2006-5#1)(2006-9#1)
preoperative neurologic##3##2##(2007-10#3)
preoperative neurological status##2##3##(2006-12#1)(2011-1#1)
preoperative neurological##3##2##(2006-12#1)(2008-7#1)(2011-1#1)
preoperative patient##2##2##(2007-8#1)(2010-7#1)
preoperative period of##3##3##(2009-3#1)(2012-3#1)(2013-8#1)
preoperative period##8##2##(2007-9#1)(2008-2#1)(2009-3#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
preoperative planning and##5##3##(1997-6#1)(2006-7#1)(2007-11#1)(2007-12#2)
preoperative planning of##2##3##(2007-5#1)(2007-7#1)
preoperative planning using##2##3##(2011-1#1)(2012-2#1)
preoperative planning##17##2##(1997-6#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#2)(2008-7#2)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
preoperative preparation##7##2##(1992-9#1)(2006-10#1)(2008-10#1)(2009-3#1)(2011-2#2)(2013-7#1)
preoperative pulmonary##2##2##(2006-10#1)(2010-6#1)
preoperative radiation##5##2##(1992-11#1)(2006-6#2)(2010-3#1)(2013-1#1)
preoperative radiotherapy and##2##3##(1993-5#1)(2007-4#1)
preoperative radiotherapy##7##2##(1992-3#1)(1993-5#1)(2006-10#2)(2006-8#1)(2007-4#1)(2008-8#1)
preoperative reducibility##2##2##(2009-3#2)
preoperative risk factors##2##3##(2007-8#1)(2010-7#1)
preoperative risk##4##2##(2007-8#3)(2010-7#1)
preoperative selection##2##2##(1995-7#1)(1995-9#1)
preoperative selective embolization##2##3##(1996-8#2)
preoperative serum##3##2##(2010-7#1)(2011-2#2)
preoperative stage##2##2##(2006-10#1)(2012-3#1)
preoperative staging of##2##3##(1993-5#1)(2006-10#1)
preoperative staging##12##2##(1990-9#2)(1992-4#1)(1993-5#2)(2006-10#3)(2007-4#1)(2008-5#3)
preoperative status##2##2##(2011-2#1)(2013-1#1)
preoperative steps##4##2##(1996-6#1)(2010-9#3)
preoperative symptoms##5##2##(2005-5#1)(2006-12#1)(2006-7#1)(2007-11#1)(2011-2#1)
preoperative teaching program##2##3##(1995-1#2)
preoperative teaching##3##2##(1995-1#3)
preoperative therapy##2##2##(2006-10#1)(2010-3#1)
preoperative traction##2##2##(2006-9#1)(2009-4#1)
preoperative treatment##7##2##(1990-12#1)(1993-8#1)(1996-1#1)(2006-10#1)(2006-2#1)(2006-9#1)(2010-7#1)
preoperative tumor##2##2##(2006-6#1)(2008-2#1)
preoperative values##9##2##(1991-2#2)(2006-5#1)(2006-6#1)(2007-7#1)(2007-8#1)(2009-10#1)(2011-1#1)(2013-1#1)
preoperative volume##2##2##(1992-9#1)(2007-9#1)
preoperative weight##4##2##(2010-8#3)(2013-1#1)
preoperative workup##3##2##(1991-6#1)(2006-10#1)(2010-11#1)
preoperative##554##1##(1990-10#1)(1990-11#4)(1990-12#1)(1990-4#1)(1990-6#1)(1990-8#1)(1990-9#8)(1991-11#1)(1991-2#3)(1991-3#1)(1991-6#1)(1991-8#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#3)(1992-8#2)(1992-9#6)(1993-1#1)(1993-12#1)(1993-5#7)(1993-7#2)(1993-8#3)(1993-9#2)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#3)(1994-4#1)(1994-7#1)(1994-8#2)(1995-1#3)(1995-4#2)(1995-7#1)(1995-9#2)(1996-1#2)(1996-12#1)(1996-2#2)(1996-6#1)(1996-8#4)(1996-9#2)(1997-1#8)(1997-2#1)(1997-6#1)(1997-8#1)(2004-1#1)(2004-10#1)(2004-12#1)(2004-2#1)(2005-10#1)(2005-12#2)(2005-5#2)(2005-9#1)(2006-10#41)(2006-12#12)(2006-2#5)(2006-3#1)(2006-5#4)(2006-6#11)(2006-7#6)(2006-8#3)(2006-9#4)(2007-10#3)(2007-11#7)(2007-12#9)(2007-2#2)(2007-3#2)(2007-4#3)(2007-5#3)(2007-6#2)(2007-7#7)(2007-8#39)(2007-9#7)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#14)(2008-6#2)(2008-7#23)(2008-8#4)(2008-9#8)(2009-10#6)(2009-12#1)(2009-2#2)(2009-3#11)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#3)(2010-11#3)(2010-12#9)(2010-2#3)(2010-3#7)(2010-6#1)(2010-7#7)(2010-8#4)(2010-9#4)(2011-1#9)(2011-2#34)(2011-7#1)(2012-1#5)(2012-11#1)(2012-12#12)(2012-2#9)(2012-3#16)(2013-1#34)(2013-7#7)(2013-8#8)
preoperatively acquired##2##2##(1992-9#1)(1993-7#1)
preoperatively and at 6-month follow-up##3##5##(2008-9#3)
preoperatively and at##5##3##(2007-7#1)(2008-9#4)
preoperatively and postoperatively##5##3##(2008-1#1)(2009-10#2)(2011-1#1)(2013-7#1)
preoperatively and##19##2##(1991-12#1)(1993-9#1)(2006-12#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-4#1)(2008-9#4)(2009-10#2)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
preoperatively by##6##2##(1990-3#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-8#1)(2013-7#1)
preoperatively in##3##2##(1990-5#1)(2006-10#1)(2007-7#1)
preoperatively to 4##2##3##(2009-3#1)(2013-1#1)
preoperatively to##8##2##(1994-9#1)(1997-6#1)(2005-12#1)(2007-11#1)(2008-3#1)(2009-3#1)(2013-1#2)
preoperatively using##2##2##(1991-5#1)(2006-12#1)
preoperatively with##3##2##(2006-5#1)(2008-7#1)(2011-2#1)
preoperatively##125##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1991-12#2)(1991-5#1)(1991-9#1)(1992-10#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#2)(1993-5#1)(1993-7#2)(1993-9#1)(1994-9#1)(1995-10#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-6#1)(1997-8#1)(2005-12#2)(2006-10#1)(2006-12#3)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#3)(2007-5#2)(2007-7#4)(2007-8#9)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#6)(2009-10#3)(2009-2#1)(2009-3#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-8#4)(2011-1#2)(2011-12#1)(2011-2#5)(2012-2#2)(2013-1#7)(2013-7#4)(2013-8#2)
preoptic and##2##2##(1991-5#1)(1993-12#1)
preoptic area (POA)##5##3##(1991-5#1)(1994-10#1)(1995-10#1)(1997-3#1)(2008-8#1)
preoptic area and##4##3##(1990-4#2)(1996-1#1)(1997-5#1)
preoptic area of the##3##4##(1991-4#1)(1992-3#1)(1994-2#1)
preoptic area of##6##3##(1991-4#1)(1992-3#1)(1994-2#1)(1996-4#1)(1996-9#1)(1997-5#1)
preoptic area##36##2##(1990-4#2)(1990-5#1)(1991-11#1)(1991-4#1)(1991-5#2)(1992-1#1)(1992-12#1)(1992-3#2)(1992-5#2)(1992-7#1)(1992-8#1)(1994-10#1)(1994-2#4)(1995-10#1)(1996-1#2)(1996-4#2)(1996-9#2)(1997-3#3)(1997-5#2)(1997-8#2)(2008-8#1)(2008-9#1)
preoptic nuclei##3##2##(1990-4#2)(1992-9#1)
preoptic nucleus and##2##3##(1991-8#1)(1995-5#1)
preoptic nucleus##9##2##(1990-4#3)(1990-5#1)(1991-8#1)(1995-5#1)(1997-8#1)(2008-9#1)(2009-2#1)
preoptic##61##1##(1990-4#7)(1990-5#2)(1991-11#1)(1991-4#1)(1991-5#4)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-5#3)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#1)(1994-10#1)(1994-12#1)(1994-2#5)(1995-10#1)(1995-5#2)(1996-1#2)(1996-4#2)(1996-9#2)(1997-3#4)(1997-5#2)(1997-8#6)(2008-8#2)(2008-9#2)(2009-2#1)
preopticus##4##1##(1990-4#2)(2008-6#2)
preordained##2##1##(1997-5#1)(2008-11#1)
preorganization of##2##2##(1996-2#1)(2006-12#1)
preorganization##4##1##(1996-2#1)(1996-8#1)(2006-12#2)
preosteoblastic cells##3##2##(2008-8#2)(2010-4#1)
preovulatory follicles##8##2##(1994-7#1)(2008-12#4)(2008-8#3)
preovulatory##10##1##(1994-7#1)(2006-5#2)(2008-12#4)(2008-8#3)
preowned imaging equipment##2##3##(1995-1#2)
preowned##3##1##(1995-1#3)
prepaid health plans##2##3##(1994-2#2)
prepaid health##3##2##(1994-2#2)(2006-10#1)
prepaid plans##3##2##(1991-2#2)(1994-2#1)
prepaid##9##1##(1991-2#2)(1991-3#1)(1994-2#3)(1994-3#1)(1997-1#1)(2006-10#1)
preparation (e##2##2##(1994-12#1)(2010-4#1)
preparation against##2##2##(2008-11#1)(2008-4#1)
preparation along with##2##3##(2008-5#1)(2010-11#1)
preparation also##2##2##(2009-9#1)(2013-1#1)
preparation and analysis##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
preparation and application times##2##4##(2012-3#2)
preparation and application##3##3##(2008-5#1)(2012-3#2)
preparation and bacteriological tools##2##4##(2008-2#1)(2008-9#1)
preparation and handling##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
preparation and storage of##2##4##(2008-4#1)(2008-9#1)
preparation and storage##6##3##(1996-5#1)(2008-3#1)(2008-4#1)(2008-9#1)(2012-2#1)(2013-7#1)
preparation and use of##5##4##(1991-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)
preparation and##106##2##(1990-8#1)(1991-12#1)(1991-5#2)(1991-8#1)(1991-9#1)(1993-12#1)(1993-2#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(2005-11#2)(2006-10#1)(2006-6#1)(2006-7#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-9#4)(2008-1#3)(2008-10#18)(2008-11#6)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#12)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#11)(2009-9#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
preparation are discussed##2##3##(2007-12#1)(2008-10#1)
preparation are##9##2##(1990-12#1)(1991-7#1)(1994-2#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-10#1)
preparation as##8##2##(1990-5#1)(1990-7#1)(1990-8#1)(1992-9#1)(2008-10#1)(2008-5#1)(2010-4#1)(2012-2#1)
preparation at##2##2##(2008-10#1)(2012-2#1)
preparation before##5##2##(1990-5#1)(2011-2#1)(2012-1#1)(2012-3#2)
preparation but##3##2##(1990-8#1)(1995-11#1)(2012-2#1)
preparation by##11##2##(1990-12#1)(1990-3#1)(2007-12#1)(2008-10#3)(2008-4#1)(2009-3#1)(2010-11#1)(2012-12#1)(2013-1#1)
preparation can be##3##3##(1995-7#1)(2007-12#1)(2008-11#1)
preparation can##4##2##(1995-7#1)(2007-12#1)(2008-11#1)(2012-2#1)
preparation conditions##3##2##(1994-11#1)(2008-10#2)
preparation contained##4##2##(1992-3#1)(1995-7#1)(1997-2#1)(2006-10#1)
preparation containing##2##2##(2008-5#1)(2012-12#1)
preparation derived from##2##3##(1993-12#1)(1994-3#1)
preparation design##2##2##(2004-9#1)(2008-7#1)
preparation did not##3##3##(1990-7#1)(2008-10#2)
preparation does not affect##2##4##(1997-8#2)
preparation does not##3##3##(1990-7#1)(1997-8#2)
preparation during##3##2##(2006-2#1)(2008-11#2)
preparation for a##4##3##(1994-12#1)(2007-12#1)(2007-8#1)(2008-11#1)
preparation for colonoscopy##2##3##(2011-2#2)
preparation for future##2##3##(1997-6#1)(2012-1#1)
preparation for the##19##3##(1990-12#1)(1990-4#2)(1993-3#1)(1994-1#1)(1994-2#1)(1995-4#1)(1997-2#1)(1997-5#1)(1997-8#1)(2006-10#1)(2006-5#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-4#2)(2009-5#1)(2011-2#1)
preparation for their##2##3##(2008-12#1)(2011-2#1)
preparation for##75##2##(1990-12#1)(1990-4#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#3)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#5)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#2)(2009-4#2)(2009-5#1)(2009-8#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#6)(2012-1#1)(2012-2#3)(2013-1#2)
preparation from the##5##3##(1992-12#1)(1994-12#1)(2006-12#1)(2006-8#1)(2008-10#1)
preparation from##19##2##(1991-5#2)(1992-12#2)(1992-3#1)(1992-8#1)(1994-12#2)(1994-2#1)(1995-7#1)(2006-12#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-4#3)(2008-7#1)(2008-9#1)
preparation had a##2##3##(1991-12#1)(2011-1#1)
preparation had##3##2##(1991-12#1)(1997-8#1)(2011-1#1)
preparation has been evaluated##2##4##(1990-11#1)(1994-6#1)
preparation has been##5##3##(1990-11#1)(1994-6#1)(1996-1#1)(2008-3#1)(2008-8#1)
preparation has##9##2##(1990-11#1)(1990-4#1)(1994-6#1)(1996-1#1)(2008-3#2)(2008-8#1)(2010-5#1)(2011-2#1)
preparation have been##2##3##(2007-6#1)(2008-10#1)
preparation have##8##2##(1990-2#1)(1992-3#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-12#1)(2013-8#1)
preparation in a wide##2##4##(2008-10#1)(2012-1#1)
preparation in a##4##3##(2006-10#1)(2008-10#1)(2012-1#1)(2012-2#1)
preparation in the##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
preparation in vitro##3##3##(1990-7#1)(1990-9#1)(1994-2#1)
preparation in##22##2##(1990-12#1)(1990-7#1)(1990-9#1)(1991-3#1)(1992-5#1)(1993-1#1)(1993-8#1)(1994-2#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#2)(2012-1#1)(2012-2#1)(2013-1#1)
preparation including##2##2##(2007-8#1)(2008-10#1)
preparation into##3##2##(1991-4#1)(2008-10#1)(2013-1#1)
preparation is based on##2##4##(2005-11#1)(2008-10#1)
preparation is rapid and simple##2##5##(2008-10#2)
preparation is##24##2##(1990-11#1)(1991-3#1)(1991-8#1)(1993-10#1)(1994-12#1)(1995-5#2)(2005-11#1)(2008-10#8)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2012-10#2)
preparation isolated##2##2##(1990-2#1)(1992-11#1)
preparation may be##2##3##(2007-9#1)(2008-1#1)
preparation method based on##4##4##(2008-10#3)(2010-5#1)
preparation method for the##2##4##(1994-12#1)(2008-10#1)
preparation method is##2##3##(2008-10#1)(2008-9#1)
preparation method with##3##3##(2006-12#1)(2012-12#1)(2012-2#1)
preparation method##16##2##(1994-11#1)(1994-12#1)(2006-12#1)(2007-8#1)(2008-10#8)(2008-9#1)(2010-5#1)(2012-12#1)(2012-2#1)
preparation methods##14##2##(1990-4#1)(1994-3#1)(2006-12#1)(2007-8#2)(2008-10#4)(2008-11#2)(2008-5#1)(2010-7#1)(2012-12#1)
preparation must##3##2##(1992-5#1)(1997-2#1)(2009-4#1)
preparation of ISCOMs containing##2##4##(2008-4#2)
preparation of T##2##3##(2008-4#2)
preparation of a large##2##4##(1992-2#1)(2008-4#1)
preparation of a new##2##4##(2008-10#2)
preparation of a number of##2##5##(1997-3#1)(2007-11#1)
preparation of a##35##3##(1990-12#1)(1991-7#1)(1992-2#1)(1993-4#1)(1994-2#1)(1995-12#1)(1996-2#1)(1996-7#1)(1997-3#1)(2005-8#1)(2006-11#1)(2006-12#1)(2007-11#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#6)(2008-9#2)(2009-3#1)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#1)(2012-1#1)
preparation of activated##2##3##(2007-11#1)(2008-4#1)
preparation of alpha##2##3##(1997-8#1)(2007-11#1)
preparation of an##6##3##(1994-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2010-12#1)
preparation of both##3##3##(2008-4#2)(2008-7#1)
preparation of bovine##2##3##(1992-6#1)(2008-7#1)
preparation of chromosome##2##3##(2008-4#1)(2008-9#1)
preparation of conjugates##2##3##(2007-8#1)(2008-4#1)
preparation of deoxyribonucleoside phosphoramidites##2##4##(2008-4#2)
preparation of genomic DNA##2##4##(2008-4#1)(2010-2#1)
preparation of heroin##2##3##(2006-8#2)
preparation of human##4##3##(1996-7#1)(1997-8#1)(2008-9#2)
preparation of intact##2##3##(2008-4#1)(2008-9#1)
preparation of large amounts of##2##5##(1995-8#1)(2008-4#1)
preparation of large##3##3##(1995-8#1)(1996-5#1)(2008-4#1)
preparation of liver##2##3##(1990-2#1)(2007-5#1)
preparation of lysosulfatide##2##3##(1991-9#2)
preparation of mAb##3##3##(2005-10#3)
preparation of monoclonal antibody##2##4##(2005-10#2)
preparation of mouse##3##3##(2008-4#2)(2008-9#1)
preparation of new##4##3##(2007-11#1)(2007-9#1)(2008-10#1)(2008-7#1)
preparation of nuclear##3##3##(1992-11#1)(2008-2#1)(2008-8#1)
preparation of nucleoside##2##3##(2008-4#2)
preparation of other##2##3##(2008-4#1)(2010-12#1)
preparation of phage##2##3##(1995-12#1)(2008-9#1)
preparation of phosphoramidites##2##3##(2008-4#2)
preparation of plasma##2##3##(2005-8#1)(2008-4#1)
preparation of plasmid DNA##2##4##(1997-6#1)(2008-11#1)
preparation of plasmid##3##3##(1997-6#1)(2008-11#1)(2008-2#1)
preparation of platelet-rich plasma##2##4##(2012-12#2)
preparation of primary##2##3##(2008-11#1)(2008-9#1)
preparation of purified##2##3##(2008-11#1)(2008-4#1)
preparation of samples##2##3##(2005-8#1)(2008-4#1)
preparation of solid##2##3##(2008-10#2)
preparation of soluble##2##3##(1995-3#1)(2008-4#1)
preparation of staff##2##3##(2008-11#1)(2008-12#1)
preparation of suitable##2##3##(2008-4#2)
preparation of the retina##3##4##(2008-8#3)
preparation of the sample##2##4##(1997-2#1)(2012-12#1)
preparation of the samples##3##4##(2008-10#1)(2008-3#1)(2008-7#1)
preparation of the##53##3##(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-8#1)(1994-11#1)(1996-2#1)(1997-2#1)(2006-3#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#7)(2008-7#1)(2008-8#4)(2009-5#2)(2011-2#3)(2012-12#2)(2013-8#1)
preparation of tissue##3##3##(2008-2#1)(2008-4#1)(2010-10#1)
preparation of total##2##3##(2008-4#1)(2008-9#1)
preparation of two##4##3##(2008-1#1)(2008-4#2)(2011-1#1)
preparation of##484##2##(1990-11#1)(1990-12#5)(1990-2#6)(1990-3#2)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#3)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#2)(1992-6#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#2)(1993-9#3)(1994-11#2)(1994-2#4)(1994-3#2)(1994-5#4)(1994-6#2)(1994-9#1)(1995-11#1)(1995-12#2)(1995-3#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#4)(1996-7#2)(1997-1#1)(1997-2#3)(1997-3#2)(1997-6#1)(1997-8#2)(2004-12#2)(2004-9#1)(2005-10#5)(2005-11#3)(2005-12#1)(2005-8#3)(2006-10#4)(2006-11#1)(2006-12#5)(2006-3#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-11#23)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#6)(2007-9#2)(2008-1#6)(2008-10#46)(2008-11#17)(2008-12#4)(2008-2#13)(2008-3#4)(2008-4#102)(2008-5#7)(2008-6#1)(2008-7#9)(2008-8#7)(2008-9#23)(2009-12#1)(2009-2#2)(2009-3#3)(2009-5#2)(2009-6#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-12#6)(2010-2#5)(2010-4#8)(2010-5#4)(2010-6#1)(2010-7#3)(2011-1#3)(2011-2#9)(2012-1#4)(2012-12#6)(2012-2#1)(2012-3#6)(2013-1#5)(2013-7#1)(2013-8#3)
preparation on the##4##3##(2008-10#2)(2009-4#1)(2011-2#1)
preparation on##7##2##(1991-11#1)(2008-10#2)(2009-4#1)(2011-1#1)(2011-2#1)(2012-3#1)
preparation or##4##2##(1990-12#1)(1993-2#1)(1997-6#1)(2008-10#1)
preparation prior to analysis##3##4##(2008-10#2)(2010-5#1)
preparation procedure for##5##3##(2007-8#1)(2008-10#4)
preparation procedure##17##2##(1990-2#1)(2007-8#2)(2007-9#1)(2008-10#12)(2010-4#1)
preparation procedures were##2##3##(2008-10#2)
preparation procedures##4##2##(2008-10#4)
preparation process and##2##3##(2007-8#1)(2008-10#1)
preparation process was##2##3##(2008-10#1)(2008-11#1)
preparation process##6##2##(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2013-8#1)
preparation processes##2##2##(2008-10#1)(2008-7#1)
preparation programs##2##2##(1992-1#1)(1994-2#1)
preparation protocols##2##2##(1995-7#1)(2008-10#1)
preparation recipes##2##2##(2008-10#2)
preparation required##2##2##(1994-6#1)(2008-10#1)
preparation shows##2##2##(1991-1#1)(1992-2#1)
preparation significantly##3##2##(2013-1#3)
preparation steps##3##2##(2008-10#3)
preparation technique for the##2##4##(2008-10#2)
preparation technique##5##2##(2008-10#3)(2008-9#1)(2012-12#1)
preparation techniques##7##2##(2005-11#1)(2008-3#1)(2008-9#1)(2012-12#2)(2013-1#2)
preparation that##7##2##(1993-1#1)(1993-12#1)(2007-8#1)(2008-4#2)(2009-9#2)
preparation time##2##2##(2008-10#1)(2012-3#1)
preparation to the##3##3##(1990-5#1)(1991-3#1)(2008-7#1)
preparation to##20##2##(1990-4#1)(1990-5#3)(1990-7#1)(1991-3#1)(1991-9#1)(1993-12#1)(1994-9#1)(1996-2#1)(1997-8#1)(2007-5#1)(2007-6#1)(2008-10#2)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#2)
preparation used in##2##3##(1990-3#1)(2007-12#1)
preparation used##4##2##(1990-3#1)(2007-12#1)(2007-7#1)(2008-12#1)
preparation using##6##2##(1991-2#1)(1991-8#1)(1994-12#1)(1995-5#1)(2008-9#1)(2011-2#1)
preparation was compared##2##3##(1995-12#1)(2012-1#1)
preparation was developed##2##3##(2008-10#2)
preparation was not##2##3##(1990-2#1)(2008-10#1)
preparation was performed by##2##4##(1991-5#1)(2008-10#1)
preparation was shown to##2##4##(2006-10#1)(2010-12#1)
preparation was##35##2##(1990-2#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-8#1)(1993-6#1)(1994-11#1)(1995-12#1)(1995-3#1)(1995-7#1)(1997-6#1)(1997-8#1)(2006-10#2)(2006-12#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-7#1)(2010-12#2)(2010-4#1)(2012-1#1)(2012-3#1)(2013-8#1)
preparation were##9##2##(1990-11#1)(1992-2#1)(1993-4#1)(1996-1#1)(1997-8#1)(2007-12#1)(2008-10#2)(2010-12#1)
preparation which##3##2##(1990-4#1)(2008-11#1)(2008-4#1)
preparation will##2##2##(1997-2#1)(2008-9#1)
preparation with a##2##3##(1996-2#1)(2006-1#1)
preparation with##15##2##(1991-1#1)(1991-3#1)(1993-2#1)(1994-10#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-7#1)(2005-11#1)(2006-1#1)(2006-9#1)(2007-9#1)(2011-12#1)
preparation##1423##1##(1990-1#1)(1990-10#2)(1990-11#11)(1990-12#13)(1990-2#12)(1990-3#7)(1990-4#10)(1990-5#12)(1990-6#2)(1990-7#11)(1990-8#5)(1990-9#3)(1991-1#3)(1991-11#4)(1991-12#5)(1991-2#5)(1991-3#6)(1991-4#3)(1991-5#11)(1991-6#1)(1991-7#2)(1991-8#8)(1991-9#6)(1992-1#11)(1992-11#3)(1992-12#5)(1992-2#10)(1992-3#8)(1992-5#5)(1992-6#3)(1992-7#1)(1992-8#3)(1992-9#4)(1993-1#2)(1993-10#2)(1993-11#2)(1993-12#6)(1993-2#6)(1993-3#5)(1993-4#4)(1993-6#2)(1993-8#2)(1993-9#5)(1994-1#1)(1994-10#1)(1994-11#6)(1994-12#12)(1994-2#14)(1994-3#5)(1994-5#6)(1994-6#4)(1994-7#2)(1994-8#5)(1994-9#8)(1995-1#2)(1995-10#1)(1995-11#5)(1995-12#5)(1995-2#3)(1995-3#4)(1995-4#1)(1995-5#7)(1995-6#4)(1995-7#6)(1995-8#1)(1996-1#8)(1996-11#1)(1996-12#2)(1996-2#5)(1996-3#3)(1996-5#7)(1996-6#1)(1996-7#5)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#12)(1997-3#5)(1997-5#1)(1997-6#5)(1997-7#1)(1997-8#12)(2004-12#3)(2004-7#1)(2004-9#2)(2005-10#6)(2005-11#13)(2005-12#1)(2005-8#6)(2006-1#1)(2006-10#14)(2006-11#1)(2006-12#10)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#5)(2006-7#4)(2006-8#5)(2006-9#2)(2007-1#4)(2007-10#2)(2007-11#32)(2007-12#16)(2007-2#3)(2007-5#2)(2007-6#3)(2007-7#10)(2007-8#20)(2007-9#13)(2008-1#17)(2008-10#222)(2008-11#48)(2008-12#13)(2008-2#22)(2008-3#13)(2008-4#146)(2008-5#27)(2008-6#1)(2008-7#29)(2008-8#12)(2008-9#48)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#5)(2009-3#4)(2009-4#6)(2009-5#4)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#5)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#10)(2010-2#9)(2010-4#15)(2010-5#7)(2010-6#2)(2010-7#7)(2010-8#1)(2011-1#7)(2011-12#1)(2011-2#26)(2011-3#1)(2012-1#11)(2012-10#2)(2012-11#1)(2012-12#20)(2012-2#17)(2012-3#17)(2013-1#29)(2013-7#5)(2013-8#9)
preparation)##7##1##(1990-2#1)(1994-9#1)(1995-2#1)(2005-11#2)(2008-10#1)(2008-6#1)
preparations (e##2##2##(1990-5#1)(1995-1#1)
preparations agreed with those##2##4##(2008-10#2)
preparations and in##2##3##(1990-7#1)(1996-12#1)
preparations and the results##4##4##(2008-10#4)
preparations and the##9##3##(1990-2#1)(1991-5#1)(1994-9#1)(2007-11#1)(2008-10#4)(2009-2#1)
preparations and##62##2##(1990-10#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-2#2)(1994-9#2)(1996-11#2)(1996-12#1)(1996-5#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-11#4)(2007-2#1)(2008-1#2)(2008-10#21)(2008-5#1)(2008-7#1)(2009-2#2)(2010-2#1)(2010-4#2)(2012-3#1)(2013-1#1)
preparations are also##2##3##(2008-1#1)(2008-9#1)
preparations are not##2##3##(2006-9#1)(2010-2#1)
preparations are used##2##3##(1995-10#1)(2008-4#1)
preparations are##26##2##(1990-4#1)(1991-8#1)(1992-8#1)(1994-2#1)(1995-10#1)(1995-5#1)(2005-1#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-11#5)(2008-1#2)(2008-4#2)(2008-5#1)(2008-9#2)(2010-11#1)(2010-2#1)(2011-2#1)(2012-12#1)
preparations at##2##2##(1992-12#1)(2007-2#1)
preparations available##3##2##(2005-10#1)(2008-5#2)
preparations based on##2##3##(2007-11#1)(2008-4#1)
preparations but##2##2##(1995-1#1)(1996-9#1)
preparations by capillary electrophoresis##2##4##(2008-10#2)
preparations by high-performance liquid##2##4##(1992-2#1)(2008-10#1)
preparations by using##2##3##(2008-10#2)
preparations by##19##2##(1990-12#1)(1992-2#1)(1994-3#1)(1997-4#1)(2008-10#15)
preparations can be##7##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#4)
preparations can##9##2##(1997-6#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-4#4)
preparations caused##2##2##(1991-11#1)(1994-6#1)
preparations contained##3##2##(1990-12#1)(2008-10#1)(2008-5#1)
preparations containing##12##2##(1990-2#1)(1993-3#1)(1994-12#1)(2005-11#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-9#1)(2013-1#1)
preparations could be##3##3##(1990-7#1)(1991-11#1)(2007-8#1)
preparations could##5##2##(1990-7#1)(1991-11#1)(1992-12#1)(1993-11#1)(2007-8#1)
preparations derived from##2##3##(1991-4#1)(2007-11#1)
preparations for##12##2##(1994-11#1)(1994-3#2)(2004-12#1)(2007-11#2)(2008-10#1)(2008-11#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-8#1)
preparations from adult##2##3##(1990-7#1)(1997-8#1)
preparations from both##4##3##(1990-5#1)(1994-8#1)(1997-4#1)(2008-10#1)
preparations from control##2##3##(1996-10#1)(1996-11#1)
preparations from different sources##2##4##(1990-5#1)(1994-3#1)
preparations from rabbit##2##3##(1991-1#1)(2008-10#1)
preparations from rat##2##3##(1990-2#1)(1995-1#1)
preparations from the##3##3##(1993-12#1)(1994-11#2)
preparations from##45##2##(1990-11#2)(1990-2#2)(1990-3#1)(1990-5#2)(1990-7#2)(1990-8#1)(1991-1#2)(1991-4#1)(1991-5#1)(1992-1#1)(1993-1#1)(1993-12#1)(1994-11#2)(1994-3#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-7#1)(1996-10#2)(1996-11#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-9#1)(2009-7#1)
preparations has been##2##3##(2008-10#1)(2011-2#1)
preparations has##4##2##(1992-11#1)(1994-12#1)(2008-10#1)(2011-2#1)
preparations have a##2##3##(2005-10#1)(2007-11#1)
preparations have been##2##3##(2007-11#1)(2008-4#1)
preparations have##5##2##(2005-10#1)(2007-11#2)(2008-10#1)(2008-4#1)
preparations in the##9##3##(1992-3#1)(1996-10#1)(2007-8#1)(2008-10#2)(2011-1#1)(2012-12#3)
preparations in vitro##3##3##(1990-12#1)(1994-8#1)(2008-7#1)
preparations in##25##2##(1990-12#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-2#1)(1994-6#1)(1994-8#1)(1996-10#1)(1997-7#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-1#1)(2012-12#4)(2013-1#1)
preparations include##2##2##(2004-12#1)(2007-11#1)
preparations induced##2##2##(1990-10#1)(2007-10#1)
preparations is##7##2##(1997-8#1)(2005-11#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#1)
preparations isolated from hyperthyroid##2##4##(1991-9#2)
preparations made##2##2##(1993-7#1)(2007-1#1)
preparations may##2##2##(1993-4#1)(2007-6#1)
preparations obtained from##2##3##(1993-11#1)(1996-3#1)
preparations obtained##5##2##(1991-11#1)(1993-11#1)(1993-4#1)(1996-3#1)(2005-12#1)
preparations of both##3##3##(1990-2#1)(1991-7#1)(2008-5#1)
preparations of cytochrome##2##3##(1990-7#1)(1991-7#1)
preparations of different##2##3##(1995-1#1)(1997-8#1)
preparations of human##5##3##(1992-12#1)(1994-3#1)(1996-4#1)(1997-4#1)(2007-8#1)
preparations of recombinant##3##3##(1992-9#1)(1994-3#1)(1996-7#1)
preparations of the##9##3##(1991-8#1)(1992-8#3)(1996-8#1)(1997-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
preparations of this##2##3##(1996-1#1)(2009-8#1)
preparations of##100##2##(1990-10#1)(1990-11#4)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#2)(1991-12#1)(1991-5#5)(1991-6#1)(1991-7#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#3)(1992-9#1)(1994-12#1)(1994-3#5)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-1#1)(1996-4#2)(1996-7#3)(1996-8#1)(1997-4#1)(1997-6#1)(1997-8#4)(2006-1#1)(2006-10#3)(2006-12#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-4#5)(2008-5#4)(2009-8#1)(2009-9#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#1)
preparations on##5##2##(1993-12#1)(1997-7#1)(2006-2#1)(2008-10#1)(2008-5#1)
preparations or##4##2##(1991-2#1)(1994-4#1)(1996-12#1)(2008-1#1)
preparations presented##2##2##(2008-5#1)(2012-12#1)
preparations ranging##2##2##(1992-9#1)(1994-12#1)
preparations should be##2##3##(2005-11#1)(2010-11#1)
preparations showed that##2##3##(1997-2#1)(2008-8#1)
preparations showed##4##2##(1997-2#2)(2008-5#1)(2008-8#1)
preparations studied##2##2##(1995-7#1)(2004-12#1)
preparations such##2##2##(2007-11#1)(2007-12#1)
preparations that##7##2##(1991-1#1)(1992-2#1)(2006-12#1)(2007-11#1)(2008-4#1)(2008-8#1)(2010-8#1)
preparations to protect##2##3##(2004-12#2)
preparations to##7##2##(2004-12#2)(2007-6#1)(2007-9#1)(2008-4#2)(2008-5#1)
preparations using 1##2##3##(2008-10#2)
preparations using##11##2##(2008-10#9)(2008-4#1)(2011-2#1)
preparations was also##2##3##(1990-4#1)(1997-8#1)
preparations was significantly##2##3##(1990-3#1)(2009-2#1)
preparations was##12##2##(1990-3#1)(1990-4#1)(1992-1#1)(1993-9#1)(1994-9#1)(1997-8#1)(2005-4#1)(2007-1#1)(2008-10#1)(2009-2#1)(2012-1#2)
preparations were characterized##2##3##(1991-11#1)(1991-3#1)
preparations were incubated with##2##4##(1994-9#1)(1995-6#1)
preparations were investigated##2##3##(1991-9#1)(1995-6#1)
preparations were used to produce##2##5##(2008-10#2)
preparations were used##3##3##(1995-1#1)(2008-10#2)
preparations were##30##2##(1990-7#1)(1991-11#1)(1991-3#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-7#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-6#2)(1996-2#1)(2004-12#2)(2005-10#1)(2005-8#1)(2007-6#1)(2007-9#2)(2008-10#5)(2010-12#1)(2011-1#1)
preparations which were##2##3##(1991-12#1)(1992-11#1)
preparations which##3##2##(1991-12#1)(1992-11#1)(1996-3#1)
preparations will be##2##3##(2007-11#1)(2012-2#1)
preparations with 8##2##3##(2004-9#2)
preparations with##20##2##(1990-12#1)(1990-5#1)(1991-12#1)(1992-2#1)(1993-5#1)(1994-12#1)(1995-5#1)(2004-9#2)(2005-1#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-10#3)(2009-8#1)(2011-2#1)(2012-3#1)
preparations without##2##2##(2007-7#1)(2008-10#1)
preparations##820##1##(1990-10#4)(1990-11#8)(1990-12#7)(1990-2#7)(1990-3#7)(1990-4#4)(1990-5#11)(1990-7#10)(1990-8#2)(1990-9#1)(1991-1#3)(1991-10#1)(1991-11#6)(1991-12#3)(1991-2#2)(1991-3#5)(1991-4#2)(1991-5#7)(1991-6#2)(1991-7#3)(1991-8#5)(1991-9#5)(1992-1#3)(1992-11#4)(1992-12#4)(1992-2#7)(1992-3#1)(1992-5#3)(1992-6#2)(1992-7#2)(1992-8#6)(1992-9#3)(1993-1#2)(1993-11#2)(1993-12#5)(1993-3#6)(1993-4#4)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#5)(1994-12#6)(1994-2#15)(1994-3#15)(1994-4#1)(1994-5#3)(1994-6#2)(1994-8#5)(1994-9#10)(1995-1#8)(1995-10#4)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#6)(1995-6#4)(1995-7#6)(1995-8#1)(1996-1#1)(1996-10#3)(1996-11#5)(1996-12#4)(1996-2#2)(1996-3#3)(1996-4#4)(1996-5#6)(1996-6#1)(1996-7#3)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#3)(1997-3#5)(1997-4#3)(1997-6#6)(1997-7#3)(1997-8#9)(2004-11#1)(2004-12#12)(2004-8#1)(2004-9#2)(2005-1#2)(2005-10#5)(2005-11#6)(2005-12#1)(2005-4#1)(2005-8#3)(2006-1#3)(2006-10#9)(2006-12#5)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#5)(2007-1#4)(2007-10#2)(2007-11#34)(2007-12#2)(2007-2#2)(2007-4#1)(2007-6#8)(2007-7#1)(2007-8#8)(2007-9#4)(2008-1#13)(2008-10#169)(2008-11#11)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#33)(2008-5#35)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#7)(2009-2#5)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-11#4)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#4)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#5)(2011-2#9)(2012-1#2)(2012-12#7)(2012-2#6)(2012-3#5)(2013-1#5)(2013-8#1)
preparations)##4##1##(1993-3#1)(2005-10#1)(2008-10#2)
preparations]##6##1##(1991-2#1)(1992-2#1)(1995-8#1)(1996-2#1)(2012-12#2)
preparative HPLC##4##2##(1992-8#1)(2006-12#2)(2010-12#1)
preparative SDS-PAGE##2##2##(1990-8#1)(1993-4#1)
preparative SEC##2##2##(1997-2#2)
preparative anion-exchange high-performance liquid chromatography##2##5##(1991-5#1)(1994-12#1)
preparative chromatography##2##2##(1994-11#1)(2007-8#1)
preparative column##2##2##(2008-10#2)
preparative gel electrophoresis##3##3##(1990-2#1)(1991-9#1)(1995-6#1)
preparative gel##4##2##(1990-2#1)(1991-9#1)(1994-6#1)(1995-6#1)
preparative high-performance liquid chromatography##2##4##(1990-11#1)(2008-10#1)
preparative polyacrylamide gel electrophoresis##2##4##(1990-4#1)(1995-12#1)
preparative procedures##2##2##(2008-9#2)
preparative scale##5##2##(1990-3#1)(2007-11#1)(2008-10#1)(2011-1#2)
preparative techniques##3##2##(1990-7#1)(2008-9#2)
preparative thin layer chromatography and##2##5##(2008-10#1)(2012-2#1)
preparative thin layer chromatography##3##4##(2008-10#1)(2008-5#1)(2012-2#1)
preparative##67##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#2)(1991-11#4)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-4#1)(1994-11#2)(1994-12#1)(1994-5#2)(1994-6#1)(1995-12#1)(1995-6#3)(1996-12#1)(1996-7#1)(1997-2#2)(1997-6#1)(1997-7#1)(2006-10#1)(2006-12#3)(2006-3#1)(2007-11#1)(2007-4#1)(2007-8#2)(2008-10#7)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-9#4)(2010-12#1)(2011-1#2)(2012-2#1)
preparatory activity##2##2##(1993-2#1)(2013-8#1)
preparatory grief##4##2##(2010-2#4)
preparatory work##4##2##(2010-12#3)(2010-7#1)
preparatory##34##1##(1993-2#3)(1995-12#2)(1996-12#1)(1996-2#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-12#3)(2010-2#4)(2010-6#2)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
prepare a##27##2##(1990-11#1)(1993-12#1)(1993-3#1)(1993-7#1)(1995-2#1)(2005-5#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#2)(2008-9#1)(2010-7#1)(2012-12#2)(2013-7#1)(2013-8#2)
prepare all##2##2##(2007-2#1)(2010-6#1)
prepare and##12##2##(1993-11#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-12#1)
prepare for a##4##3##(1993-7#1)(1996-2#1)(2012-2#2)
prepare for future##2##3##(2007-2#1)(2008-11#1)
prepare for the future should##2##5##(2007-12#1)(2008-11#1)
prepare for the##6##3##(2006-4#1)(2007-12#1)(2008-11#2)(2010-4#1)(2012-3#1)
prepare for##19##2##(1993-2#1)(1993-7#1)(1996-2#1)(1997-1#1)(2005-9#1)(2006-4#1)(2007-12#1)(2007-2#2)(2008-11#3)(2009-8#1)(2010-4#1)(2012-2#4)(2012-3#1)
prepare nurses to##2##3##(2008-11#1)(2008-12#1)
prepare nurses##4##2##(2005-12#1)(2008-11#2)(2008-12#1)
prepare students for##2##3##(2005-12#1)(2008-12#1)
prepare the data for##3##4##(2008-2#1)(2008-4#2)
prepare the##31##2##(1990-8#1)(1991-12#1)(1994-9#1)(1995-8#1)(1997-2#1)(2005-11#2)(2005-12#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#2)(2009-4#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-7#1)
prepare them for##5##3##(2008-12#2)(2009-9#1)(2010-3#1)(2013-1#1)
prepare them to##2##3##(1993-3#1)(2008-2#1)
prepare them##9##2##(1991-11#1)(1993-3#1)(2008-12#2)(2008-2#1)(2008-4#1)(2009-9#1)(2010-3#1)(2013-1#1)
prepare two##2##2##(2007-12#1)(2008-6#1)
prepare##229##1##(1990-11#1)(1990-12#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-8#1)(1992-12#2)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-7#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#4)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#2)(1996-3#2)(1997-1#3)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#4)(2005-12#3)(2005-5#1)(2005-7#1)(2005-9#1)(2006-10#3)(2006-12#3)(2006-4#1)(2006-5#1)(2006-7#1)(2007-11#3)(2007-12#5)(2007-2#5)(2007-3#1)(2007-6#1)(2007-8#3)(2007-9#3)(2008-1#3)(2008-10#27)(2008-11#13)(2008-12#9)(2008-2#6)(2008-3#1)(2008-4#8)(2008-5#8)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#3)(2009-4#2)(2009-5#3)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#5)(2010-3#1)(2010-4#5)(2010-5#2)(2010-6#1)(2010-7#5)(2011-1#3)(2011-2#1)(2011-3#2)(2012-1#1)(2012-10#1)(2012-12#4)(2012-2#7)(2012-3#4)(2013-1#1)(2013-7#2)(2013-8#3)
prepared MnO2##2##2##(2010-4#2)
prepared a set of##2##4##(1996-2#1)(2013-8#1)
prepared a##19##2##(1991-11#1)(1991-9#1)(1992-1#1)(1993-11#1)(1993-5#1)(1993-6#2)(1994-8#1)(1995-11#1)(1996-10#1)(1996-2#1)(2004-9#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-9#1)(2010-2#1)(2013-8#1)
prepared according to##2##3##(2008-2#1)(2009-3#1)
prepared after##2##2##(1991-2#1)(1993-12#1)
prepared against the##5##3##(1993-11#1)(1996-1#2)(1996-5#1)(2008-4#1)
prepared against##16##2##(1990-11#1)(1990-8#1)(1991-3#1)(1992-2#1)(1993-11#1)(1993-6#2)(1994-11#1)(1995-5#1)(1996-1#2)(1996-2#2)(1996-5#1)(2008-4#1)(2008-5#1)
prepared an##7##2##(1991-2#1)(1992-7#1)(1993-9#1)(1994-12#1)(2004-12#1)(2008-11#1)(2008-2#1)
prepared and analyzed##3##3##(1990-10#1)(2007-11#1)(2013-7#1)
prepared and assessed##2##3##(2009-11#1)(2011-2#1)
prepared and characterised by##2##4##(2007-10#1)(2008-5#1)
prepared and characterised##6##3##(2007-10#1)(2007-11#1)(2008-3#1)(2008-5#3)
prepared and characterized by##5##4##(2008-5#5)
prepared and characterized##14##3##(1992-9#1)(1995-1#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-5#6)(2008-6#1)(2009-11#1)
prepared and demonstrated##2##3##(2008-10#2)
prepared and employed##2##3##(2008-5#1)(2013-7#1)
prepared and evaluated for##5##4##(1992-5#1)(1994-9#1)(1995-3#1)(1997-2#1)(2007-10#1)
prepared and evaluated##13##3##(1992-12#1)(1992-5#1)(1993-9#1)(1994-9#2)(1995-3#1)(1997-2#1)(2007-10#1)(2008-10#2)(2008-5#2)(2009-6#1)
prepared and fully##2##3##(2008-12#1)(2010-5#1)
prepared and investigated as##5##4##(2008-10#5)
prepared and investigated##7##3##(2007-12#1)(2008-10#5)(2008-5#1)
prepared and its##7##3##(2008-10#4)(2008-4#1)(2008-5#1)(2013-1#1)
prepared and studied##2##3##(2008-10#1)(2009-9#1)
prepared and tested for##7##4##(1992-5#1)(1993-11#1)(1996-8#1)(2007-10#1)(2007-11#1)(2008-10#1)(2010-8#1)
prepared and tested##9##3##(1992-5#1)(1993-11#1)(1993-4#1)(1996-8#1)(2007-10#1)(2007-11#2)(2008-10#1)(2010-8#1)
prepared and the##4##3##(1995-4#1)(2008-10#1)(2011-1#1)(2012-12#1)
prepared and used as an##2##5##(1992-3#1)(2008-10#1)
prepared and used as##3##4##(1992-3#1)(2008-10#2)
prepared and used for##3##4##(2007-8#1)(2008-10#2)
prepared and used##13##3##(1992-3#1)(1994-10#1)(1995-8#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-6#1)
prepared and##137##2##(1990-10#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-9#1)(1993-11#2)(1993-4#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-5#1)(1994-9#2)(1995-1#2)(1995-3#1)(1995-4#1)(1995-8#2)(1996-3#1)(1996-8#2)(1997-2#2)(2005-10#1)(2005-11#1)(2007-10#4)(2007-11#6)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#38)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#17)(2008-6#2)(2008-8#2)(2008-9#1)(2009-11#2)(2009-12#1)(2009-6#1)(2009-9#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-8#1)(2013-1#1)(2013-7#3)
prepared as a continuation of##2##5##(1997-2#1)(2012-2#1)
prepared as a##9##3##(1990-12#1)(1992-3#1)(1997-2#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-2#1)(2013-1#1)
prepared as described in the##2##5##(2008-4#2)
prepared as described##3##3##(2008-4#3)
prepared as##29##2##(1990-12#2)(1991-12#1)(1991-8#1)(1992-3#1)(1994-9#1)(1995-3#1)(1997-2#1)(1997-6#1)(2004-9#1)(2005-11#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#3)(2008-5#1)(2008-9#1)(2012-2#1)(2013-1#2)
prepared at pH##3##3##(2008-5#2)(2009-11#1)
prepared at the##2##3##(2008-10#1)(2010-12#1)
prepared at##13##2##(1996-8#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-5#2)(2009-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
prepared batches##4##2##(2010-2#1)(2010-3#2)(2012-2#1)
prepared blood##2##2##(1993-3#1)(2012-2#1)
prepared by PCR##2##3##(1990-11#1)(1992-8#1)
prepared by a simple##2##4##(2008-10#1)(2010-3#1)
prepared by a sol-gel method##2##5##(2008-10#1)(2010-1#1)
prepared by a sol-gel##3##4##(2008-10#1)(2008-5#1)(2010-1#1)
prepared by a##25##3##(1990-2#1)(1994-2#1)(1994-9#1)(1996-7#1)(2004-9#1)(2005-11#2)(2007-11#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-7#1)(2010-1#2)(2010-3#1)(2010-7#1)(2013-1#1)
prepared by adding a##2##4##(1991-6#1)(2013-1#1)
prepared by adding##4##3##(1991-6#1)(1991-7#1)(2009-3#1)(2013-1#1)
prepared by an##2##3##(2008-10#2)
prepared by attaching##2##3##(2007-8#1)(2010-5#1)
prepared by blending##2##3##(2008-1#1)(2009-7#1)
prepared by chemical##5##3##(1990-12#1)(1995-1#1)(1995-3#1)(1995-8#1)(2007-11#1)
prepared by coupling Amberlite XAD-2 with##2##6##(2008-10#2)
prepared by coupling##6##3##(1990-2#1)(1997-2#1)(2007-8#1)(2008-10#3)
prepared by covalent##2##3##(1997-6#1)(2008-10#1)
prepared by different methods##2##4##(1990-7#1)(2008-11#1)
prepared by different##3##3##(1990-7#1)(2008-11#1)(2008-3#1)
prepared by diluting##2##3##(1996-7#1)(2008-5#1)
prepared by direct compression##3##4##(2008-5#2)(2010-5#1)
prepared by direct##4##3##(2008-10#1)(2008-5#2)(2010-5#1)
prepared by dissolving in##2##4##(2008-10#1)(2008-5#1)
prepared by dissolving##7##3##(2005-11#1)(2008-10#4)(2008-5#1)(2010-4#1)
prepared by electropolymerization of##2##4##(2008-10#2)
prepared by electrospinning##2##3##(2010-12#1)(2012-1#1)
prepared by entrapping##3##3##(2007-8#1)(2008-10#2)
prepared by enzymatic##2##3##(2005-7#1)(2006-8#1)
prepared by first##5##3##(1991-3#1)(1996-4#1)(2007-8#1)(2008-10#1)(2010-4#1)
prepared by fusing##2##3##(1994-12#1)(1994-2#1)
prepared by heating##2##3##(2005-11#1)(2008-10#1)
prepared by immobilizing##2##3##(2008-10#2)
prepared by in situ##2##4##(2008-10#2)
prepared by in-situ polymerization##2##4##(2005-12#1)(2013-8#1)
prepared by incorporating##3##3##(2008-10#3)
prepared by incubation of##2##4##(1996-7#1)(2013-1#1)
prepared by layer-by-layer##2##3##(2005-11#1)(2008-10#1)
prepared by mixing##11##3##(2004-9#1)(2005-11#1)(2008-10#6)(2008-2#1)(2008-5#1)(2011-2#1)
prepared by nucleophilic substitution of##2##5##(1994-9#1)(2007-11#1)
prepared by packing##2##3##(2008-10#2)
prepared by peptization of the niobic acid precipitate##3##8##(2005-11#3)
prepared by polymerization##2##3##(1997-1#1)(2010-4#1)
prepared by reacting##7##3##(2005-11#2)(2007-10#1)(2008-10#2)(2008-5#1)(2008-8#1)
prepared by reaction of##5##4##(1990-2#1)(1996-2#1)(1997-7#1)(2008-5#1)(2010-5#1)
prepared by reactive ion-assisted##2##4##(2008-3#2)
prepared by site-directed mutagenesis##3##4##(1991-10#1)(1996-7#1)(1997-6#1)
prepared by sol-gel method and##2##5##(2008-10#2)
prepared by sol-gel method##3##4##(2008-10#3)
prepared by sol-gel##5##3##(2008-10#5)
prepared by solid##2##3##(2008-10#1)(2010-5#1)
prepared by solid-phase synthesis##2##4##(1993-11#1)(2008-4#1)
prepared by solid-phase##3##3##(1992-5#1)(1993-11#1)(2008-4#1)
prepared by spray##2##3##(2004-12#1)(2010-1#1)
prepared by the hydrothermal method##2##5##(2010-4#1)(2013-8#1)
prepared by the reaction of##3##5##(1992-9#1)(1996-5#1)(2008-5#1)
prepared by the template##2##4##(2008-5#2)
prepared by the##54##3##(1990-12#1)(1990-2#1)(1990-7#1)(1991-7#1)(1992-11#1)(1992-6#2)(1992-9#1)(1994-7#1)(1996-4#1)(1996-5#2)(1997-2#1)(2005-11#4)(2007-11#3)(2007-4#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#8)(2008-6#1)(2008-9#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-8#1)
prepared by thermal##2##3##(2005-11#1)(2008-10#1)
prepared by this method##2##4##(1990-4#1)(1997-1#1)
prepared by this##5##3##(1990-4#1)(1997-1#1)(2007-11#1)(2008-6#1)(2009-9#1)
prepared by two-step##2##3##(2008-10#1)(2013-8#1)
prepared by ultracentrifugation##2##3##(1995-3#1)(1995-7#1)
prepared by use of##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
prepared by using hydrogel##2##4##(2007-11#1)(2010-5#1)
prepared by using##16##3##(2007-11#1)(2008-10#7)(2008-2#1)(2008-5#1)(2008-9#1)(2010-2#1)(2010-5#1)(2013-7#1)(2013-8#2)
prepared by weighing##3##3##(2008-10#3)
prepared by##408##2##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#4)(1990-4#1)(1990-5#1)(1990-7#2)(1991-10#1)(1991-11#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#2)(1991-9#2)(1992-11#3)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#5)(1992-8#3)(1992-9#1)(1993-11#2)(1993-3#2)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-7#1)(1994-9#6)(1995-1#2)(1995-10#1)(1995-3#2)(1995-5#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-2#2)(1996-4#2)(1996-5#2)(1996-7#4)(1996-9#1)(1997-1#3)(1997-2#2)(1997-6#4)(1997-7#2)(1997-9#1)(2004-11#1)(2004-12#1)(2004-9#4)(2005-11#29)(2005-12#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-12#4)(2006-8#1)(2007-10#1)(2007-11#14)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#7)(2008-1#1)(2008-10#97)(2008-11#8)(2008-12#3)(2008-2#5)(2008-3#9)(2008-4#4)(2008-5#31)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#5)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-9#2)(2010-1#7)(2010-11#1)(2010-12#5)(2010-2#6)(2010-3#2)(2010-4#6)(2010-5#7)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#7)
prepared can##2##2##(2008-10#2)
prepared complexes##4##2##(2007-11#1)(2008-5#3)
prepared compounds were##3##3##(2007-11#1)(2008-11#1)(2008-5#1)
prepared compounds##6##2##(2007-10#1)(2007-11#2)(2008-11#1)(2008-5#2)
prepared directly from##4##3##(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)
prepared for a##2##3##(2007-1#1)(2008-11#1)
prepared for analysis##3##3##(1990-11#1)(2008-10#1)(2008-12#1)
prepared for or##2##3##(1992-2#2)
prepared for the##8##3##(1992-1#1)(1996-1#1)(1997-1#1)(2005-12#1)(2005-9#1)(2008-10#1)(2008-11#1)(2013-1#1)
prepared for use in##2##4##(1995-2#1)(2010-4#1)
prepared for use##3##3##(1995-2#1)(2008-2#1)(2010-4#1)
prepared for##57##2##(1990-11#1)(1992-1#1)(1992-2#3)(1993-4#2)(1993-7#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-8#1)(2005-10#1)(2005-12#1)(2005-9#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-2#2)(2007-4#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-7#1)(2010-2#1)(2010-4#2)(2011-7#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
prepared formulations were##2##3##(2008-10#1)(2012-12#1)
prepared from 1##2##3##(2007-11#1)(2008-5#1)
prepared from 14##2##3##(1990-5#1)(2011-2#1)
prepared from a##8##3##(1990-7#1)(1991-5#1)(2005-4#1)(2008-10#3)(2008-5#2)
prepared from an##2##3##(1996-5#1)(1996-7#1)
prepared from bovine##3##3##(1991-10#1)(1992-12#1)(1994-3#1)
prepared from cells grown in the##2##6##(1993-3#1)(1994-12#1)
prepared from cells grown##3##4##(1993-3#1)(1994-12#1)(1995-6#1)
prepared from cells##9##3##(1990-3#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-3#1)(1995-6#1)(1996-3#1)(1997-8#1)(2008-10#1)
prepared from control##2##3##(2008-11#1)(2008-5#1)
prepared from cultured##2##3##(1990-7#1)(1995-11#1)
prepared from either##4##3##(1990-5#1)(1996-5#2)(2007-1#1)
prepared from embryonic day##3##4##(1994-2#1)(1995-12#1)(2008-7#1)
prepared from embryonic##5##3##(1994-2#1)(1995-12#1)(1996-12#1)(2008-4#1)(2008-7#1)
prepared from etiolated##2##3##(1997-2#1)(2006-12#1)
prepared from fetal##2##3##(1994-12#1)(1995-5#1)
prepared from human##5##3##(1990-2#1)(1990-5#1)(1994-2#1)(1994-5#1)(2006-9#1)
prepared from normal##2##3##(1994-9#2)
prepared from postnatal##2##3##(1992-6#1)(1995-9#1)
prepared from purified##3##3##(1990-11#1)(1991-5#1)(2008-10#1)
prepared from rat brain##3##4##(1991-5#1)(1996-8#1)(2008-7#1)
prepared from rat##9##3##(1990-9#1)(1991-5#3)(1995-7#1)(1996-11#1)(1996-8#1)(1997-1#1)(2008-7#1)
prepared from rats##2##3##(1990-5#1)(1993-7#1)
prepared from several##2##3##(1994-6#1)(2008-10#1)
prepared from the isolated##2##4##(2008-11#1)(2008-2#1)
prepared from the same##4##4##(1991-12#1)(1994-6#1)(1995-2#1)(2008-1#1)
prepared from the##48##3##(1990-1#1)(1990-7#3)(1991-12#2)(1992-7#2)(1992-9#1)(1993-12#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-5#4)(1996-9#1)(1997-2#1)(1997-8#1)(2005-11#2)(2006-6#1)(2007-11#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-11#1)
prepared from these##4##3##(1993-6#1)(1995-8#1)(1996-11#1)(2005-8#1)
prepared from this##2##3##(1991-7#1)(2005-8#1)
prepared from tumor##2##3##(2008-4#1)(2008-9#1)
prepared from various##3##3##(1990-12#1)(2008-5#1)(2010-4#1)
prepared from##300##2##(1990-1#1)(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#5)(1990-6#1)(1990-7#7)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#5)(1991-3#4)(1991-4#1)(1991-5#8)(1991-6#1)(1991-7#3)(1991-8#3)(1991-9#4)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#4)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-4#1)(1993-6#2)(1993-7#2)(1994-10#1)(1994-11#4)(1994-12#6)(1994-2#3)(1994-3#2)(1994-5#3)(1994-6#5)(1994-8#2)(1994-9#6)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#5)(1995-5#2)(1995-6#3)(1995-7#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#12)(1996-7#2)(1996-8#2)(1996-9#3)(1997-1#3)(1997-2#3)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#4)(2004-9#2)(2005-11#4)(2005-4#1)(2005-6#1)(2005-8#3)(2006-12#4)(2006-5#2)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#11)(2007-8#3)(2008-1#3)(2008-10#17)(2008-11#8)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#10)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#2)(2009-9#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#4)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#2)
prepared having##2##2##(2008-5#1)(2009-9#1)
prepared in a synthetic study on##2##6##(2004-7#2)
prepared in a##15##3##(1991-3#1)(1992-11#1)(1993-3#1)(2004-7#2)(2005-11#2)(2007-8#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-6#1)(2010-4#1)
prepared in acetonitrile##2##3##(2008-10#1)(2013-1#1)
prepared in an effort to##2##5##(1997-2#1)(1997-7#1)
prepared in an##6##3##(1992-3#1)(1997-2#1)(1997-7#1)(2004-9#1)(2005-11#1)(2006-12#1)
prepared in aqueous phase##3##4##(2008-10#3)
prepared in aqueous solutions##2##4##(2008-10#2)
prepared in aqueous##6##3##(2008-10#6)
prepared in excellent yields##2##4##(2007-11#2)
prepared in good##4##3##(1996-5#1)(2005-8#1)(2007-10#1)(2009-5#1)
prepared in high yields##2##4##(2006-12#1)(2008-4#1)
prepared in high##3##3##(2006-12#1)(2008-4#1)(2009-7#1)
prepared in order to##5##4##(1996-2#2)(2005-8#1)(2007-11#1)(2008-10#1)
prepared in situ##4##3##(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#1)
prepared in the laboratory##3##4##(2008-10#2)(2008-4#1)
prepared in the presence of##4##5##(1990-11#1)(1990-8#1)(1996-7#1)(2005-11#1)
prepared in the presence##5##4##(1990-11#1)(1990-3#1)(1990-8#1)(1996-7#1)(2005-11#1)
prepared in the same##2##4##(2005-12#1)(2006-2#1)
prepared in the##16##3##(1990-11#1)(1990-3#2)(1990-8#1)(1993-4#1)(1996-7#1)(2005-11#1)(2005-12#1)(2006-12#1)(2006-2#1)(2007-7#1)(2008-10#4)(2008-4#1)
prepared in this study##3##4##(2008-10#2)(2010-4#1)
prepared in this##5##3##(1994-12#1)(2008-10#2)(2008-9#1)(2010-4#1)
prepared in tissue culture##2##4##(2008-9#1)(2011-2#1)
prepared in two different##2##4##(1992-11#1)(2008-10#1)
prepared in water##4##3##(2007-10#1)(2008-10#3)
prepared in##129##2##(1990-11#1)(1990-12#1)(1990-3#2)(1990-8#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-11#3)(1992-2#1)(1992-3#1)(1993-3#1)(1993-4#1)(1994-12#1)(1994-9#1)(1995-3#1)(1996-2#5)(1996-5#2)(1996-7#2)(1996-8#2)(1997-1#1)(1997-2#1)(1997-7#1)(2004-7#2)(2004-9#1)(2005-11#4)(2005-12#1)(2005-8#2)(2006-10#1)(2006-12#4)(2006-2#1)(2006-6#1)(2007-10#2)(2007-11#7)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#34)(2008-11#6)(2008-2#1)(2008-4#5)(2008-5#1)(2008-6#2)(2008-9#3)(2009-5#1)(2009-7#1)(2010-1#1)(2010-4#3)(2010-5#2)(2011-2#1)(2013-1#2)(2013-8#1)
prepared is##2##2##(1990-8#1)(2008-10#1)
prepared n-alkyl esters of glucuronic acid##2##6##(2005-11#2)
prepared of##3##2##(1991-3#1)(2008-5#1)(2011-1#1)
prepared on Au##2##3##(2005-11#1)(2008-10#1)
prepared on a##2##3##(1993-1#1)(2007-12#1)
prepared on the basis of a##2##6##(2008-10#1)(2010-12#1)
prepared on the basis of the##2##6##(1992-9#1)(2012-12#1)
prepared on the basis of##5##5##(1992-9#1)(2008-10#1)(2010-12#1)(2011-2#1)(2012-12#1)
prepared on the##10##3##(1990-6#1)(1992-9#1)(1996-12#1)(1997-3#1)(2005-4#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-12#1)
prepared on##21##2##(1990-6#1)(1992-9#1)(1993-1#1)(1996-12#1)(1997-3#1)(2005-11#2)(2005-4#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-5#1)(2010-1#1)(2010-12#1)(2010-4#2)(2011-2#1)(2012-12#1)
prepared only by##2##3##(2005-12#1)(2011-1#1)
prepared only in##2##3##(2008-10#1)(2012-12#1)
prepared only##4##2##(2005-12#1)(2008-10#1)(2011-1#1)(2012-12#1)
prepared over##2##2##(1991-10#1)(2008-10#1)
prepared prior##2##2##(2008-10#1)(2010-11#1)
prepared resin##2##2##(2008-10#2)
prepared samples##2##2##(1997-2#1)(2008-10#1)
prepared separately##2##2##(2005-11#1)(2008-10#1)
prepared serum group was##2##4##(2008-10#2)
prepared serum group##3##3##(2008-10#3)
prepared surface##2##2##(2008-2#1)(2010-4#1)
prepared tablets were##3##3##(2012-2#3)
prepared that##3##2##(1991-4#1)(2008-8#1)(2009-12#1)
prepared the##4##2##(1994-11#1)(2008-1#1)(2008-8#1)(2010-1#1)
prepared three##2##2##(2008-11#1)(2008-9#1)
prepared through a##4##3##(2005-11#1)(2007-11#1)(2010-2#1)(2010-4#1)
prepared through##11##2##(2005-11#1)(2007-11#2)(2008-11#2)(2008-5#1)(2009-4#1)(2010-2#1)(2010-4#1)(2012-11#2)
prepared to address##2##3##(2007-5#1)(2010-2#1)
prepared to care for##2##4##(2008-11#1)(2008-2#1)
prepared to deal with##2##4##(2006-10#1)(2013-8#1)
prepared to meet the##2##4##(1994-1#1)(2011-1#1)
prepared to meet##3##3##(1994-1#1)(1994-11#1)(2011-1#1)
prepared to study the##3##4##(1997-2#1)(1997-3#1)(2007-11#1)
prepared to study##4##3##(1996-8#1)(1997-2#1)(1997-3#1)(2007-11#1)
prepared to##45##2##(1991-1#1)(1991-8#1)(1993-2#1)(1993-3#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2011-1#1)(2013-7#1)(2013-8#1)
prepared total##2##2##(1994-11#1)(2008-5#1)
prepared two##4##2##(1991-5#1)(1992-11#1)(1992-3#1)(1994-11#1)
prepared under different conditions##2##4##(2008-2#1)(2008-5#1)
prepared under##10##2##(2004-12#1)(2005-11#1)(2008-10#2)(2008-2#2)(2008-4#2)(2008-5#1)(2009-12#1)
prepared using a##10##3##(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-12#1)(2010-4#1)(2012-12#1)
prepared using an##3##3##(1995-7#1)(2008-5#1)(2011-2#1)
prepared using the following##2##4##(2008-5#2)
prepared using the##10##3##(1994-3#1)(1995-2#1)(1996-2#1)(2005-11#1)(2008-5#4)(2008-6#1)(2011-2#1)
prepared using these##2##3##(2008-10#1)(2008-4#1)
prepared using various##2##3##(2008-7#1)(2011-2#1)
prepared using##73##2##(1990-11#1)(1990-2#1)(1992-8#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-7#1)(1996-2#2)(1996-8#1)(2004-9#1)(2005-11#4)(2006-1#1)(2007-10#1)(2007-4#1)(2007-8#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#12)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#2)(2009-8#1)(2009-9#1)(2010-12#4)(2010-3#1)(2010-4#2)(2010-7#1)(2010-9#1)(2011-2#3)(2012-12#2)(2012-2#2)
prepared via a##3##3##(1996-5#1)(2008-10#1)(2009-2#1)
prepared via the##2##3##(1997-2#1)(2007-11#1)
prepared via##16##2##(1996-5#1)(1997-2#2)(2005-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-2#2)(2010-5#1)(2013-7#1)(2013-8#1)
prepared were##7##2##(2005-11#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)
prepared with a##8##3##(2006-5#1)(2008-10#4)(2008-3#1)(2008-5#1)(2009-9#1)
prepared with an##3##3##(1993-4#1)(1997-8#1)(2008-4#1)
prepared with and without##2##4##(2008-5#1)(2012-2#1)
prepared with different##4##3##(2005-11#1)(2008-10#2)(2009-3#1)
prepared with iodoacetamide##3##3##(1994-6#3)
prepared with the same##2##4##(2008-10#1)(2008-4#1)
prepared with the##9##3##(2005-8#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-4#1)(2011-3#1)(2013-8#1)
prepared with##86##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-10#1)(1992-9#1)(1993-4#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-2#2)(1994-5#1)(1994-6#3)(1995-3#1)(1996-6#1)(1997-8#1)(2005-11#3)(2005-8#1)(2006-10#1)(2006-5#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#30)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#3)
prepared within##2##2##(2008-10#2)
prepared without##6##2##(1994-6#2)(1995-3#1)(1996-2#1)(2008-10#1)(2009-3#1)
prepared##1787##1##(1990-1#1)(1990-10#3)(1990-11#9)(1990-12#13)(1990-2#7)(1990-3#6)(1990-4#2)(1990-5#8)(1990-6#3)(1990-7#9)(1990-8#3)(1990-9#2)(1991-1#2)(1991-10#5)(1991-11#4)(1991-12#9)(1991-2#4)(1991-3#9)(1991-4#2)(1991-5#11)(1991-6#3)(1991-7#6)(1991-8#5)(1991-9#9)(1992-1#4)(1992-11#7)(1992-12#5)(1992-2#7)(1992-3#10)(1992-4#1)(1992-5#7)(1992-6#9)(1992-7#3)(1992-8#5)(1992-9#6)(1993-1#1)(1993-11#10)(1993-12#3)(1993-2#1)(1993-3#8)(1993-4#7)(1993-5#1)(1993-6#9)(1993-7#4)(1993-8#3)(1993-9#7)(1994-1#2)(1994-10#2)(1994-11#12)(1994-12#10)(1994-2#9)(1994-3#4)(1994-5#7)(1994-6#11)(1994-7#1)(1994-8#5)(1994-9#22)(1995-1#5)(1995-10#2)(1995-11#6)(1995-12#3)(1995-2#8)(1995-3#16)(1995-4#1)(1995-5#6)(1995-6#4)(1995-7#4)(1995-8#7)(1995-9#3)(1996-1#5)(1996-10#3)(1996-11#3)(1996-12#3)(1996-2#18)(1996-3#3)(1996-4#4)(1996-5#19)(1996-6#1)(1996-7#10)(1996-8#11)(1996-9#4)(1997-1#12)(1997-2#16)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#7)(1997-7#6)(1997-8#7)(1997-9#1)(2004-11#1)(2004-12#3)(2004-7#2)(2004-8#1)(2004-9#11)(2005-10#2)(2005-11#63)(2005-12#6)(2005-4#3)(2005-6#1)(2005-7#1)(2005-8#8)(2005-9#1)(2006-1#1)(2006-10#4)(2006-12#20)(2006-2#1)(2006-4#1)(2006-5#3)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#4)(2007-10#18)(2007-11#56)(2007-12#12)(2007-2#8)(2007-3#2)(2007-4#3)(2007-5#4)(2007-6#2)(2007-7#4)(2007-8#22)(2007-9#5)(2008-1#10)(2008-10#337)(2008-11#51)(2008-12#13)(2008-2#21)(2008-3#26)(2008-4#32)(2008-5#115)(2008-6#11)(2008-7#13)(2008-8#18)(2008-9#22)(2009-10#2)(2009-11#9)(2009-12#4)(2009-2#3)(2009-3#7)(2009-4#8)(2009-5#3)(2009-6#1)(2009-7#4)(2009-8#2)(2009-9#8)(2010-1#13)(2010-11#2)(2010-12#16)(2010-2#18)(2010-3#8)(2010-4#28)(2010-5#17)(2010-7#6)(2010-8#5)(2010-9#2)(2011-1#11)(2011-2#14)(2011-3#2)(2011-7#1)(2012-1#3)(2012-11#3)(2012-12#17)(2012-2#22)(2012-3#5)(2012-8#1)(2013-1#20)(2013-7#8)(2013-8#23)
prepared?##2##1##(1991-1#1)(2012-12#1)
preparedness and response to##3##4##(2012-2#3)
preparedness and response##4##3##(2012-12#1)(2012-2#3)
preparedness and##9##2##(2007-3#1)(2008-8#1)(2009-12#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#3)
preparedness for##6##2##(2008-11#1)(2008-8#1)(2012-1#2)(2012-2#1)(2013-1#1)
preparedness in##2##2##(2008-9#1)(2010-9#1)
preparedness is##4##2##(1992-1#1)(2008-8#1)(2010-8#1)(2012-2#1)
preparedness of##3##2##(1996-1#1)(1997-4#1)(2008-10#1)
preparedness planning##4##2##(2008-8#4)
preparedness to manage##2##3##(2007-12#1)(2007-2#1)
preparedness to##3##2##(2007-12#1)(2007-2#1)(2007-3#1)
preparedness##60##1##(1990-2#2)(1992-1#1)(1995-2#1)(1996-1#1)(1997-4#1)(2006-10#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#3)(2008-8#8)(2008-9#2)(2009-12#1)(2009-4#6)(2010-8#5)(2010-9#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#5)(2013-1#4)
prepares the##2##2##(1993-2#1)(2007-12#1)
prepares them for##2##3##(2008-1#1)(2010-8#1)
prepares to##2##2##(1992-8#1)(1996-4#1)
prepares##11##1##(1992-8#1)(1993-2#1)(1996-2#1)(1996-4#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-8#1)
preparing DNA##2##2##(1994-11#1)(2008-9#1)
preparing a##13##2##(2007-3#1)(2008-10#3)(2008-12#1)(2008-4#4)(2008-9#2)(2010-12#1)(2011-1#1)
preparing an abstract##2##3##(2010-4#2)
preparing an##3##2##(1991-5#1)(2010-4#2)
preparing and##7##2##(1993-12#1)(1994-1#1)(2008-11#1)(2008-4#2)(2008-9#1)(2011-2#1)
preparing for a##4##3##(1995-3#1)(2007-9#1)(2008-2#1)(2009-6#1)
preparing for future##2##3##(2006-5#1)(2012-3#1)
preparing for the##7##3##(1992-1#1)(1992-2#1)(1996-12#1)(1996-5#1)(2007-2#2)(2011-1#1)
preparing for##22##2##(1992-1#1)(1992-2#1)(1995-3#1)(1996-12#1)(1996-5#1)(1996-6#1)(2006-5#1)(2007-10#1)(2007-2#3)(2007-4#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-3#1)
preparing microinjection needles##2##3##(2008-11#2)
preparing purified cardiac myosin##2##4##(2008-4#2)
preparing serum##2##2##(2008-4#2)
preparing the##30##2##(1995-4#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-5#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#5)(2008-5#3)(2009-4#1)(2009-6#1)(2010-5#1)(2011-2#2)(2013-1#1)
preparing to##3##2##(1995-1#1)(2004-3#1)(2011-2#1)
preparing##187##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-2#3)(1993-12#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#2)(1995-4#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(2004-12#1)(2004-3#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-5#2)(2007-10#1)(2007-12#2)(2007-2#3)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#11)(2008-12#6)(2008-2#7)(2008-4#48)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#13)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#2)(2010-12#2)(2010-4#2)(2010-5#2)(2010-9#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
preparturient myometrial activity##2##3##(1994-6#2)
prepatellar##3##1##(2013-1#3)
prepayment and##2##2##(1994-2#2)
prepayment##4##1##(1994-2#2)(1997-1#1)(2006-8#1)
prepenetration development##2##2##(2008-10#2)
prepenetration morphogenesis in C##2##4##(2008-10#2)
prepenetration morphogenesis##3##2##(2008-10#3)
prepenetration##5##1##(2008-10#5)
preperitoneal##4##1##(1992-5#1)(1993-9#1)(1996-9#1)(2011-2#1)
preplanned##2##1##(1995-5#1)(2013-1#1)
preplant##3##1##(2008-10#3)
preplanting##2##1##(2008-10#2)
preplated##4##1##(2008-10#4)
prepolymer##2##1##(2008-2#1)(2010-9#1)
preponderance in##2##2##(1995-5#1)(2011-2#1)
preponderance of any##2##3##(1993-8#1)(2007-8#1)
preponderance of males##2##3##(1990-2#1)(2007-7#1)
preponderance of##26##2##(1990-2#1)(1992-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1995-10#1)(1996-11#1)(1996-5#1)(1997-2#2)(2005-8#1)(2006-10#3)(2007-11#1)(2007-7#1)(2007-8#2)(2008-6#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-12#1)(2011-2#2)(2012-2#1)
preponderance##34##1##(1990-2#1)(1990-4#1)(1992-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1995-10#1)(1995-5#1)(1996-11#1)(1996-5#1)(1996-9#1)(1997-2#2)(2005-8#1)(2006-10#4)(2007-11#1)(2007-7#1)(2007-8#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-12#1)(2011-2#3)(2012-2#2)
preponderant##5##1##(1991-9#1)(2007-12#1)(2007-4#1)(2008-8#1)(2008-9#1)
prepontine##4##1##(2005-5#1)(2006-12#2)(2012-3#1)
prepositions##3##1##(2008-10#1)(2008-4#2)
prepositus hypoglossal##3##2##(1991-12#1)(1993-12#1)(1995-5#1)
prepositus##4##1##(1991-12#1)(1993-12#1)(1995-5#1)(1997-6#1)
prepotent##2##1##(2006-4#2)
prepregnancy BMI##3##2##(2011-1#2)(2013-1#1)
prepregnancy body mass index (BMI)##3##5##(2011-1#2)(2013-1#1)
prepregnancy weight##3##2##(2010-4#1)(2013-1#2)
prepregnancy##10##1##(1995-2#1)(2010-4#1)(2011-1#4)(2013-1#4)
prepro sequence##2##2##(1992-2#1)(1994-12#1)
prepro##6##1##(1991-8#2)(1992-2#1)(1994-12#1)(1995-3#1)(1995-6#1)
prepro-EGF##2##1##(1991-12#2)
prepro-alpha-factor##4##1##(1992-2#1)(1992-7#2)(1993-3#1)
prepro-neurotensin/neuromedin N##2##2##(1991-3#2)
prepro-orexin and##2##2##(2010-10#2)
preproET-1##6##1##(1991-2#3)(1992-7#2)(1994-9#1)
preproET-2##2##1##(1993-6#2)
preproPYY##2##1##(1992-11#2)
preproacrosin##4##1##(1990-5#4)
preprocarboxypeptidase A##3##2##(1991-2#3)
preprocarboxypeptidase##4##1##(1991-2#4)
preprocecropinA##2##1##(1994-11#2)
preprocess the##2##2##(2007-12#1)(2008-4#1)
preprocess##3##1##(2007-12#2)(2008-4#1)
preprocessed joint transform correlation##3##4##(2008-3#3)
preprocessed##9##1##(2007-12#1)(2008-2#1)(2008-3#5)(2008-7#1)(2010-8#1)
preprocessing and##3##2##(2008-2#1)(2008-3#2)
preprocessing for##2##2##(2007-12#1)(2008-2#1)
preprocessing method for partial least squares##2##6##(2008-10#2)
preprocessing method##3##2##(2007-12#1)(2008-10#2)
preprocessing of##2##2##(2007-12#1)(2008-2#1)
preprocessing step##4##2##(2006-10#1)(2007-8#1)(2008-2#2)
preprocessing##31##1##(1996-12#1)(2006-10#1)(2007-12#6)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#12)(2008-3#2)(2008-6#2)(2008-7#1)
preprocholecystokinin##2##1##(1992-8#2)
preprodynorphin (PPD)##2##2##(1996-12#2)
preprodynorphin##5##1##(1996-12#3)(1996-2#1)(2012-12#1)
preproendothelin-1 (preproET-1)##2##2##(1991-2#1)(1992-7#1)
preproendothelin-1##4##1##(1991-2#2)(1992-7#2)
preproenkephalin (PPE)##2##2##(1996-12#2)
preproenkephalin and preprodynorphin##2##3##(1996-12#1)(2012-12#1)
preproenkephalin##5##1##(1996-12#3)(2012-12#1)(2013-8#1)
preproenzyme##4##1##(1990-5#2)(1991-11#2)
preprogrammed##3##1##(1992-4#1)(2007-11#1)(2007-12#1)
preprohormone##4##1##(1992-6#1)(1995-8#1)(2008-4#2)
preproinsulin II##3##2##(2007-5#3)
preproinsulin##7##1##(1990-5#1)(2007-5#3)(2008-11#2)(2010-11#1)
preprolactin##2##1##(1996-4#2)
prepromelittin##2##1##(1994-11#2)
preproparathyroid hormone signal sequence##2##4##(1994-12#2)
preproparathyroid hormone##3##2##(1994-12#2)(1997-5#1)
prepropeptide##2##1##(1990-5#1)(2008-9#1)
prepropeptides##5##1##(1992-11#2)(1994-11#1)(1997-6#2)
preprosequence##3##1##(1990-5#1)(1993-3#1)(1995-6#1)
preprosthetic##3##1##(2007-12#2)(2007-9#1)
preprotachykinin##4##1##(1992-9#2)(1993-8#1)(1995-5#1)
preprotein translocation##5##2##(1995-6#1)(1997-7#4)
preprotein##11##1##(1990-6#1)(1991-2#1)(1992-12#1)(1995-6#2)(1996-5#1)(1997-7#5)
preproteins##4##1##(1995-6#1)(1996-10#1)(2008-1#2)
prepubertal and##2##2##(2006-9#1)(2011-1#1)
prepubertal male calves##3##3##(2013-1#3)
prepubertal##28##1##(1991-1#1)(1996-4#2)(2006-10#1)(2006-5#3)(2006-9#1)(2007-11#2)(2007-6#1)(2008-10#1)(2008-4#2)(2008-6#1)(2010-12#1)(2010-2#1)(2011-1#4)(2012-2#2)(2012-3#1)(2013-1#4)
prepubescent Latino children##2##3##(2009-9#2)
prepubescent##8##1##(1993-2#1)(1993-4#1)(2006-10#1)(2009-9#2)(2010-4#1)(2012-1#1)(2013-8#1)
prepuce##3##1##(2006-7#1)(2009-5#1)(2013-1#1)
prepulse inhibition of##2##3##(1991-1#2)
prepulse inhibition##6##2##(1991-1#3)(2008-4#3)
prepulse##15##1##(1991-1#3)(1992-12#1)(1996-1#1)(1996-9#1)(1997-7#1)(2007-11#1)(2007-12#3)(2008-2#1)(2008-4#3)
prepupa##3##1##(2007-12#2)(2011-12#1)
prepupae##3##1##(2008-11#1)(2011-12#2)
prepupal##2##1##(2009-5#1)(2011-12#1)
prepurified by##2##2##(1993-11#1)(1996-3#1)
preputial samples##2##2##(2011-1#1)(2013-1#1)
preputial washings##3##2##(2006-10#3)
preputial##12##1##(2006-10#4)(2008-10#4)(2011-1#2)(2013-1#2)
preputialectomised pups##2##2##(1992-9#2)
prerecorded##2##1##(2007-11#1)(2008-3#1)
prereduced##2##1##(2008-10#1)(2008-5#1)
prereduction##3##1##(2007-10#1)(2008-10#2)
preregistration house officers##3##3##(1995-6#3)
preregistration internship consists of 12 months##2##6##(1995-6#2)
preregistration internship##3##2##(1995-6#3)
preregistration##8##1##(1995-6#6)(1996-12#1)(2013-8#1)
prerenal##2##1##(2010-2#1)(2010-4#1)
prerequisite for a##4##3##(1992-1#1)(1996-6#1)(2008-10#1)(2012-3#1)
prerequisite for the##17##3##(1990-2#1)(1991-2#1)(1993-12#1)(1994-10#1)(1994-2#1)(1996-2#1)(1996-5#1)(1997-5#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-8#2)(2010-11#1)(2012-11#1)(2013-8#1)
prerequisite for##80##2##(1990-10#1)(1990-11#2)(1990-2#1)(1990-3#1)(1991-11#1)(1991-2#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#2)(1993-12#1)(1993-4#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-3#2)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#3)(1997-5#1)(2004-9#1)(2005-11#1)(2005-5#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-7#1)(2009-8#3)(2010-11#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
prerequisite knowledge##2##2##(2005-10#2)
prerequisite of the##3##3##(2008-8#1)(2009-2#1)(2013-8#1)
prerequisite of##9##2##(1991-2#1)(1991-9#1)(1996-8#1)(2005-11#1)(2006-12#1)(2008-8#1)(2009-2#1)(2013-7#1)(2013-8#1)
prerequisite to the##4##3##(1990-8#1)(1991-3#1)(1992-1#1)(2008-11#1)
prerequisite to##15##2##(1990-5#1)(1990-8#1)(1991-3#1)(1992-1#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-6#1)(2008-11#2)(2008-5#2)(2013-7#1)(2013-8#1)
prerequisite##113##1##(1990-10#1)(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-2#3)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#2)(1992-1#2)(1992-12#1)(1992-3#1)(1992-5#2)(1993-12#1)(1993-4#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#3)(1997-5#1)(2004-9#1)(2005-10#2)(2005-11#2)(2005-5#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-8#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-2#1)(2009-7#1)(2009-8#3)(2010-11#1)(2010-9#2)(2011-1#1)(2011-2#3)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#4)
prerequisites for a##4##3##(1995-4#2)(2006-6#1)(2010-10#1)
prerequisites for the##3##3##(1991-3#1)(1995-5#1)(2008-4#1)
prerequisites for##16##2##(1991-3#1)(1994-1#1)(1995-4#3)(1995-5#1)(1997-5#1)(2006-10#1)(2006-6#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-4#3)(2010-10#1)
prerequisites of##2##2##(1995-5#1)(2010-10#1)
prerequisites##26##1##(1991-2#1)(1991-3#1)(1994-1#1)(1995-4#3)(1995-5#3)(1997-5#2)(2005-10#2)(2006-10#2)(2006-6#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#3)(2008-9#1)(2010-10#2)
preruminant calf##3##2##(1992-2#2)(1993-12#1)
presacral mass##2##2##(2008-9#2)
presacral neurectomy##4##2##(1994-3#4)
presacral tumors##3##2##(2010-5#3)
presacral##14##1##(1994-3#6)(2006-8#1)(2008-9#2)(2009-3#1)(2010-5#3)(2013-7#1)
presampled MTF##2##2##(2010-12#1)(2011-1#1)
presampled##3##1##(2008-10#1)(2010-12#1)(2011-1#1)
presbyopia treatment##3##2##(2011-2#3)
presbyopia##4##1##(2011-2#4)
preschool age##3##2##(1993-8#1)(2006-10#1)(2007-12#1)
preschool child##2##2##(2010-7#1)(2010-9#1)
preschool children aged##2##3##(2010-7#1)(2013-7#1)
preschool children in the##2##4##(2007-1#1)(2011-1#1)
preschool children in##7##3##(2005-9#1)(2007-1#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
preschool children##36##2##(1992-4#1)(1993-3#1)(1996-12#1)(2005-9#1)(2006-10#1)(2006-4#4)(2007-1#1)(2007-11#1)(2007-4#2)(2008-11#2)(2008-4#1)(2009-9#1)(2010-7#2)(2011-1#3)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#5)(2013-7#4)
preschool children's##3##2##(2009-9#1)(2011-12#1)(2012-12#1)
preschool years##3##2##(2006-3#1)(2006-7#1)(2008-2#1)
preschool##64##1##(1992-4#1)(1993-3#1)(1993-8#1)(1996-12#1)(2005-9#1)(2006-10#3)(2006-3#3)(2006-4#4)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#2)(2008-11#4)(2008-2#1)(2008-4#2)(2009-9#2)(2010-6#1)(2010-7#3)(2010-9#1)(2011-1#4)(2011-12#4)(2011-2#1)(2012-1#2)(2012-12#5)(2012-2#1)(2013-1#6)(2013-7#5)
preschool-age children##3##2##(1996-12#1)(2009-12#1)(2009-2#1)
preschool-aged children##2##2##(1996-1#1)(2006-10#1)
preschoolers who##2##2##(2006-2#1)(2013-1#1)
preschoolers##12##1##(1992-9#1)(2006-2#2)(2006-4#1)(2009-9#3)(2010-6#1)(2013-1#1)(2013-7#2)(2013-8#1)
preschools##5##1##(2010-12#1)(2012-2#1)(2013-7#3)
prescreening##2##1##(2008-10#1)(2010-2#1)
prescribe a##4##2##(1990-5#1)(1994-4#1)(1996-11#1)(2011-2#1)
prescribe the##3##2##(1991-6#1)(2008-11#1)(2008-5#1)
prescribe##45##1##(1990-12#1)(1990-2#1)(1990-5#1)(1991-6#1)(1991-7#1)(1992-2#1)(1993-12#1)(1993-2#2)(1993-5#1)(1994-4#1)(1996-11#2)(1996-3#1)(1996-8#1)(1997-2#1)(1997-4#2)(2004-3#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-7#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-8#2)
prescribe?##2##1##(2006-12#1)(2009-12#1)
prescribed ACTs##3##2##(2012-12#3)
prescribed a reduction of the horizontal##2##6##(1992-10#2)
prescribed a##8##2##(1992-10#3)(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-1#1)
prescribed and##4##2##(1996-4#1)(2008-7#1)(2010-4#1)(2010-5#1)
prescribed antibiotic##2##2##(2006-10#1)(2008-9#1)
prescribed antidepressants##4##2##(2007-11#1)(2008-8#1)(2012-3#2)
prescribed as##5##2##(1991-6#1)(1992-7#1)(1996-8#1)(2004-9#1)(2008-10#1)
prescribed at##4##2##(1996-9#1)(2008-11#1)(2008-3#1)(2010-5#1)
prescribed by a##3##3##(1996-4#1)(2009-9#1)(2011-1#1)
prescribed by the##5##3##(1997-6#1)(2006-11#2)(2008-1#1)(2012-2#1)
prescribed by##15##2##(1990-5#1)(1995-10#1)(1996-4#1)(1997-6#1)(2006-11#2)(2006-12#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-11#1)(2009-5#1)(2009-9#1)(2011-1#1)(2012-2#1)
prescribed classes of drugs##2##4##(1990-4#1)(1996-3#1)
prescribed drug##4##2##(2008-11#1)(2008-4#1)(2010-12#1)(2010-5#1)
prescribed drugs in##3##3##(2007-11#1)(2008-11#1)(2012-2#1)
prescribed drugs##12##2##(2006-8#1)(2007-11#2)(2007-2#1)(2008-11#4)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#1)
prescribed during##3##2##(2006-3#1)(2007-7#1)(2009-2#1)
prescribed for a##2##3##(1991-12#1)(2012-2#1)
prescribed for the##2##3##(2008-10#1)(2012-12#1)
prescribed for##15##2##(1990-5#1)(1991-12#1)(1996-7#1)(2005-3#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-12#2)(2010-9#1)(2012-12#2)(2012-2#2)
prescribed in about##2##3##(2010-12#2)
prescribed in the##5##3##(1994-3#1)(2008-10#1)(2009-9#1)(2011-1#1)(2011-2#1)
prescribed in##23##2##(1990-5#1)(1990-9#1)(1991-11#2)(1991-4#1)(1994-3#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-9#2)(2009-9#1)(2010-12#2)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)
prescribed medication##8##2##(1993-11#1)(1993-9#1)(1995-2#1)(2006-10#1)(2008-11#1)(2008-4#1)(2010-1#2)
prescribed medications##5##2##(2007-2#1)(2008-8#1)(2010-12#2)(2011-1#1)
prescribed to a##3##3##(1990-4#1)(2008-11#1)(2010-3#1)
prescribed to patients##2##3##(2007-11#1)(2013-8#1)
prescribed to treat##3##3##(2006-12#1)(2007-11#1)(2010-2#1)
prescribed to##26##2##(1990-12#1)(1990-4#2)(1991-2#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-8#1)(2007-11#3)(2008-11#3)(2008-8#1)(2009-5#2)(2010-2#2)(2010-3#1)(2011-2#3)(2013-8#2)
prescribed was##2##2##(2008-11#1)(2010-5#1)
prescribed##300##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#3)(1990-5#3)(1990-6#2)(1990-9#1)(1991-11#3)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-10#5)(1992-7#1)(1993-11#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-4#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#4)(1996-3#2)(1996-4#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-6#2)(1997-8#1)(2004-10#2)(2004-11#1)(2004-9#1)(2005-12#2)(2005-3#1)(2006-10#4)(2006-11#3)(2006-12#2)(2006-2#2)(2006-3#2)(2006-4#1)(2006-7#4)(2006-8#4)(2006-9#2)(2007-10#5)(2007-11#12)(2007-12#6)(2007-2#4)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#8)(2008-11#23)(2008-12#1)(2008-2#3)(2008-3#8)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#7)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#3)(2009-6#2)(2009-8#1)(2009-9#3)(2010-1#3)(2010-11#1)(2010-12#16)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#9)(2010-6#2)(2010-7#1)(2010-9#2)(2011-1#5)(2011-2#9)(2012-1#4)(2012-12#6)(2012-2#8)(2012-3#6)(2013-1#13)(2013-7#1)(2013-8#10)
prescriber##7##1##(1997-6#1)(2008-11#1)(2010-5#1)(2010-9#1)(2011-1#2)(2013-1#1)
prescribers and##2##2##(2008-4#1)(2009-3#1)
prescribers in##3##2##(2008-11#1)(2008-8#1)(2012-12#1)
prescribers of##2##2##(2008-8#2)
prescribers##18##1##(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#2)(2008-8#4)(2009-3#1)(2010-3#1)(2011-1#2)(2012-12#1)(2013-8#2)
prescribers'##2##1##(2011-1#2)
prescribes##2##1##(1993-11#1)(1993-7#1)
prescribing a##2##2##(2007-12#1)(2008-3#1)
prescribing and administration##2##3##(1990-5#1)(2009-3#1)
prescribing and dispensing##2##3##(2008-7#1)(2011-2#1)
prescribing and##11##2##(1990-5#1)(1992-2#1)(2006-8#1)(2008-11#2)(2008-3#1)(2008-7#1)(2009-3#1)(2011-2#1)(2013-1#2)
prescribing antibiotics##3##2##(1997-5#1)(2007-4#1)(2012-2#1)
prescribing appropriate##2##2##(1996-7#1)(2006-10#1)
prescribing conditions##2##2##(2006-10#2)
prescribing drugs##4##2##(1992-2#1)(2008-10#1)(2008-8#1)(2009-10#1)
prescribing errors##2##2##(2010-12#2)
prescribing for##3##2##(2008-11#1)(2010-4#1)(2013-1#1)
prescribing habits##5##2##(1990-6#1)(1995-11#1)(1996-11#1)(1996-3#2)
prescribing has##3##2##(2008-11#2)(2011-2#1)
prescribing in##11##2##(1996-11#1)(1996-6#6)(2006-5#1)(2008-11#2)(2012-2#1)
prescribing it##3##2##(1995-8#1)(2013-1#2)
prescribing of cotrimoxazole##2##3##(2008-11#2)
prescribing of##13##2##(1990-4#1)(1993-12#1)(2006-6#1)(2008-11#3)(2008-4#1)(2008-7#1)(2009-3#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)
prescribing pattern##3##2##(2007-2#1)(2008-4#1)(2010-5#1)
prescribing patterns in##2##3##(2007-2#1)(2013-1#1)
prescribing patterns##8##2##(2007-2#1)(2008-11#5)(2008-6#1)(2013-1#1)
prescribing pharmacologic##2##2##(2005-10#1)(2009-2#1)
prescribing physicians##3##2##(2007-2#1)(2007-9#1)(2008-8#1)
prescribing practices##8##2##(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-3#1)
prescribing preventive medication##2##3##(2008-11#2)
prescribing rates for##2##3##(2008-11#1)(2008-3#1)
prescribing rates##3##2##(2008-11#2)(2008-3#1)
prescribing should be##2##3##(2008-11#1)(2011-12#1)
prescribing the##2##2##(1995-6#1)(2007-7#1)
prescribing these##3##2##(2010-12#1)(2011-2#1)(2013-7#1)
prescribing with##2##2##(2008-11#1)(2011-2#1)
prescribing##170##1##(1990-4#1)(1990-5#1)(1990-6#1)(1991-2#2)(1992-2#2)(1993-1#1)(1993-12#2)(1993-8#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-6#1)(1995-8#2)(1996-11#2)(1996-2#2)(1996-3#3)(1996-6#7)(1996-7#1)(1996-8#1)(1997-5#2)(2004-10#1)(2005-10#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-2#4)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#36)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#7)(2009-10#1)(2009-2#1)(2009-3#3)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#6)(2011-12#3)(2011-2#9)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#3)
prescription IT##4##2##(2013-1#4)
prescription analgesic##2##2##(2008-3#1)(2010-2#1)
prescription and##18##2##(1991-1#1)(1993-1#1)(2005-10#2)(2005-7#1)(2007-12#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-12#1)(2013-1#2)
prescription at##2##2##(1995-12#1)(2012-1#1)
prescription audit##2##2##(2010-12#2)
prescription contraception##3##2##(2006-1#3)
prescription data##4##2##(2008-11#1)(2008-3#1)(2008-8#2)
prescription databases##2##2##(2008-3#2)
prescription drug benefit##5##3##(1995-1#2)(2007-9#1)(2008-11#1)(2011-2#1)
prescription drug benefits##3##3##(1995-1#3)
prescription drug coverage##3##3##(1992-1#1)(1995-1#1)(2009-9#1)
prescription drug expenditures in##2##4##(1995-1#1)(2009-4#1)
prescription drug expenditures##4##3##(1995-1#2)(1997-1#1)(2009-4#1)
prescription drug plan##2##3##(1995-6#1)(2008-11#1)
prescription drug spending##2##3##(1995-1#2)
prescription drug use##5##3##(1992-1#1)(1995-1#1)(2005-8#1)(2013-1#2)
prescription drug##40##2##(1992-1#2)(1993-1#1)(1995-1#13)(1995-6#1)(1997-1#3)(2005-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2009-4#2)(2009-9#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2013-1#4)(2013-8#3)
prescription drugs and##4##3##(1993-1#2)(2009-4#1)(2013-1#1)
prescription drugs in##3##3##(1997-1#1)(2006-10#1)(2008-11#1)
prescription drugs##32##2##(1992-5#1)(1993-1#3)(1993-3#1)(1994-3#1)(1995-1#3)(1996-1#1)(1997-1#2)(1997-2#1)(2006-1#1)(2006-10#2)(2006-8#2)(2008-11#3)(2008-12#3)(2008-4#1)(2008-8#1)(2009-4#1)(2010-4#1)(2010-5#1)(2013-1#2)(2013-8#1)
prescription for##19##2##(1990-5#1)(1991-3#2)(1993-12#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-3#1)(2005-10#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-4#1)(2009-6#1)(2010-1#1)(2010-12#2)(2010-8#1)
prescription in the##2##3##(1996-4#1)(2010-12#1)
prescription in##10##2##(1994-3#1)(1996-11#1)(1996-4#1)(1997-5#1)(2007-11#1)(2007-7#2)(2007-8#1)(2010-12#2)
prescription is##3##2##(2004-4#1)(2007-5#1)(2008-4#1)
prescription labels##2##2##(2011-1#2)
prescription medication##2##2##(1993-9#1)(2013-1#1)
prescription medications##6##2##(1993-9#1)(1996-1#1)(2006-5#1)(2008-12#1)(2008-3#1)(2011-1#1)
prescription of a##2##3##(1996-9#1)(2013-1#1)
prescription of antibiotics##2##3##(2006-10#1)(2010-12#1)
prescription of antidepressants##3##3##(1997-5#1)(2008-8#1)(2012-3#1)
prescription of drugs##2##3##(2007-2#1)(2008-8#1)
prescription of##39##2##(1991-11#1)(1993-2#1)(1993-5#1)(1993-8#1)(1995-11#2)(1995-4#1)(1996-1#1)(1996-4#3)(1996-9#2)(1997-5#2)(2006-10#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-11#2)(2008-4#1)(2008-8#3)(2009-3#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
prescription or##2##2##(1994-6#2)
prescription pads##2##2##(1996-2#1)(2008-3#1)
prescription patterns##2##2##(2008-11#1)(2013-8#1)
prescription principles##4##2##(2013-1#4)
prescription process##3##2##(2008-9#1)(2013-1#2)
prescription was##3##2##(1995-1#1)(2010-12#1)(2012-12#1)
prescription were##2##2##(2004-10#1)(2010-5#1)
prescription writing##2##2##(2008-3#1)(2008-8#1)
prescription##302##1##(1990-2#2)(1990-5#1)(1991-1#1)(1991-11#1)(1991-3#2)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-5#1)(1993-1#5)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-6#2)(1995-1#21)(1995-11#5)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-1#3)(1996-11#4)(1996-12#1)(1996-2#1)(1996-4#5)(1996-6#1)(1996-9#3)(1997-1#5)(1997-2#2)(1997-4#2)(1997-5#3)(2004-1#1)(2004-10#1)(2004-4#1)(2005-10#3)(2005-7#1)(2005-8#1)(2006-1#4)(2006-10#4)(2006-11#1)(2006-4#1)(2006-5#1)(2006-8#7)(2007-10#8)(2007-11#3)(2007-12#7)(2007-2#3)(2007-5#3)(2007-7#6)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#18)(2008-12#5)(2008-2#1)(2008-3#8)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#12)(2008-9#2)(2009-10#3)(2009-2#1)(2009-3#1)(2009-4#3)(2009-6#1)(2009-7#1)(2009-9#3)(2010-1#1)(2010-12#11)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#6)(2012-1#3)(2012-11#2)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#27)(2013-8#7)
prescription]##6##1##(1990-9#1)(1993-11#1)(1995-5#1)(1996-10#1)(1997-6#1)(2011-1#1)
prescriptions and##3##2##(1991-4#1)(1995-6#1)(2013-1#1)
prescriptions are##2##2##(1996-1#1)(1996-3#1)
prescriptions for##16##2##(1991-1#1)(1991-2#1)(1992-2#1)(1993-11#1)(1995-10#1)(1995-11#1)(1996-3#1)(1996-5#1)(2004-3#1)(2007-10#1)(2008-8#2)(2009-9#2)(2010-12#1)(2012-12#1)
prescriptions from##2##2##(2011-1#1)(2012-12#1)
prescriptions in general##3##3##(1995-10#1)(1995-3#1)(1996-9#1)
prescriptions in##10##2##(1990-10#1)(1995-10#2)(1995-11#1)(1995-3#1)(1995-8#1)(1996-9#1)(2008-11#1)(2008-8#1)(2010-9#1)
prescriptions issued##2##2##(1995-11#1)(2007-12#1)
prescriptions of##4##2##(1995-9#1)(2008-3#1)(2012-12#1)(2013-8#1)
prescriptions referred##2##2##(1990-4#1)(1994-9#1)
prescriptions were##10##2##(1995-8#1)(1996-9#1)(2007-2#1)(2008-11#3)(2008-4#2)(2009-9#1)(2010-12#1)
prescriptions##104##1##(1990-10#2)(1990-4#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-1#1)(1992-2#1)(1993-11#2)(1993-12#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-10#4)(1995-11#4)(1995-3#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-5#1)(1996-9#3)(2004-3#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-2#4)(2007-9#1)(2008-10#2)(2008-11#8)(2008-3#1)(2008-4#6)(2008-8#3)(2009-9#7)(2010-12#7)(2010-5#8)(2010-9#1)(2011-1#1)(2012-12#4)(2012-2#2)(2013-1#1)(2013-8#2)
prescriptions]##4##1##(1991-6#1)(1993-11#1)(1993-6#1)(1995-4#1)
prescriptive incrementalism##2##2##(1996-12#2)
prescriptive##6##1##(1996-12#2)(2006-7#1)(2007-2#1)(2008-3#1)(2012-2#1)
presecretory protein##4##2##(1993-9#1)(1994-11#1)(1994-2#2)
presecretory proteins##3##2##(1994-11#3)
presecretory##7##1##(1993-9#1)(1994-11#4)(1994-2#2)
preseizure##4##1##(2013-8#4)
preselected sequence##2##2##(1990-6#2)
preselected##11##1##(1990-6#2)(1991-5#1)(1994-3#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)
preselection##3##1##(1992-7#1)(2008-10#1)(2008-5#1)
presence and absence of##83##4##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#3)(1990-5#2)(1990-6#1)(1990-7#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-6#2)(1992-3#2)(1992-4#2)(1992-6#2)(1992-8#2)(1993-3#2)(1993-6#1)(1993-7#2)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-7#2)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#12)(2008-11#4)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2010-11#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)
presence and location of##4##4##(1991-7#1)(1992-12#1)(2008-10#1)(2013-7#1)
presence and severity of##9##4##(1991-8#1)(1993-12#1)(1997-1#1)(1997-8#1)(2004-1#1)(2006-2#1)(2007-2#1)(2008-3#1)(2009-3#1)
presence and shape of the##2##5##(2008-3#1)(2008-5#1)
presence and the##8##3##(2005-11#1)(2007-5#1)(2008-10#3)(2011-2#1)(2012-12#1)(2013-8#1)
presence and type of##3##4##(2006-10#1)(2011-2#1)(2012-2#1)
presence and##171##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#3)(1990-5#2)(1990-6#1)(1990-7#1)(1991-1#2)(1991-12#1)(1991-3#2)(1991-4#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#2)(1992-6#3)(1992-8#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-7#2)(1994-10#1)(1994-11#6)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#3)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#1)(2004-1#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-6#2)(2007-8#2)(2008-1#1)(2008-10#20)(2008-11#5)(2008-2#1)(2008-3#5)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-8#1)(2011-1#3)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#2)
presence are##2##2##(2008-8#2)
presence as##2##2##(2008-10#1)(2011-1#1)
presence at##3##2##(2007-9#1)(2008-10#1)(2013-1#1)
presence can be##2##3##(2007-3#1)(2008-10#1)
presence can##3##2##(1994-3#1)(2007-3#1)(2008-10#1)
presence does not##2##3##(1997-8#1)(2006-10#1)
presence during the##2##3##(2007-4#1)(2008-9#1)
presence during##7##2##(1996-2#1)(2006-10#1)(2007-2#1)(2007-4#1)(2008-9#1)(2011-2#1)(2013-1#1)
presence has been##3##3##(2008-10#1)(2012-1#1)(2012-2#1)
presence in human##3##3##(1993-2#1)(2008-2#1)(2011-2#1)
presence in some##3##3##(1996-7#1)(2008-10#1)(2008-11#1)
presence in the##15##3##(1990-11#1)(1991-5#1)(1993-8#1)(1994-12#2)(1994-9#1)(1995-11#1)(2008-10#2)(2008-5#1)(2009-10#1)(2009-4#1)(2010-4#1)(2012-2#1)(2013-8#1)
presence in##73##2##(1990-11#1)(1990-3#1)(1990-5#1)(1991-5#1)(1991-8#3)(1992-12#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1996-1#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-4#2)(2008-10#12)(2008-11#1)(2008-12#3)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-4#2)(2009-5#1)(2010-4#1)(2010-5#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#1)
presence is##8##2##(1997-7#1)(2008-1#1)(2008-10#3)(2011-12#1)(2012-2#1)(2013-8#1)
presence may##4##2##(2007-12#1)(2007-9#1)(2008-7#1)(2013-8#1)
presence near the##2##3##(1990-7#1)(2010-4#1)
presence of &gt##2##3##(2004-4#1)(2010-2#1)
presence of &quot##5##3##(1990-3#1)(2007-5#1)(2008-10#1)(2008-5#1)(2009-7#1)
presence of 0##45##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-3#1)(1991-7#2)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-8#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-6#1)(1997-2#1)(1997-5#1)(2005-11#3)(2006-5#1)(2006-9#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-8#1)(2010-2#1)(2010-5#1)(2011-2#2)
presence of 1 mM##8##4##(1991-4#1)(1992-12#1)(1993-6#1)(1995-12#1)(1996-1#1)(1997-4#1)(2005-11#1)(2008-5#1)
presence of 1##37##3##(1990-10#1)(1990-12#1)(1990-3#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-12#1)(1992-8#1)(1993-6#1)(1994-10#1)(1994-11#2)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(2005-11#1)(2006-8#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-5#1)(2009-12#1)(2009-2#1)
presence of 1%##4##3##(2007-8#1)(2008-10#3)
presence of 10 mM##10##4##(1990-10#1)(1990-2#1)(1990-4#1)(1990-8#1)(1991-11#1)(1995-11#1)(1997-2#1)(2005-11#1)(2008-11#1)(2008-5#1)
presence of 10##22##3##(1990-10#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-4#1)(1992-2#1)(1995-11#1)(1996-10#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-5#2)(2008-11#1)(2008-5#2)(2010-11#1)(2012-12#1)(2012-2#1)
presence of 10% fetal##3##4##(1991-10#1)(1995-3#1)(1997-1#1)
presence of 10%##6##3##(1991-10#1)(1991-5#1)(1995-3#1)(1997-1#1)(2008-10#1)(2008-11#1)
presence of 10(-3) M##2##4##(2008-10#2)
presence of 11##3##3##(2007-6#1)(2007-7#1)(2008-10#1)
presence of 18-crown-6##2##3##(2008-10#2)
presence of 2##17##3##(1990-10#1)(1990-8#3)(1992-6#1)(1992-9#1)(1993-8#1)(1995-8#1)(1996-2#1)(2006-10#1)(2008-10#4)(2008-8#1)(2013-1#2)
presence of 22##2##3##(1991-2#1)(2008-4#1)
presence of 3##2##3##(1992-9#1)(2008-10#1)
presence of 4 allele of##2##5##(2011-1#2)
presence of 4##6##3##(1992-1#1)(1992-5#2)(1994-9#1)(2011-1#2)
presence of 5 mM##6##4##(1991-6#1)(1992-11#1)(1996-1#1)(1997-1#1)(1997-2#1)(2005-11#1)
presence of 5 microM##3##4##(1994-11#1)(1995-11#1)(1995-12#1)
presence of 5##15##3##(1991-2#1)(1991-6#1)(1992-11#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-1#1)(1997-2#1)(2005-11#1)(2008-10#1)(2008-7#1)(2008-8#1)
presence of 5%##2##3##(2006-8#1)(2008-12#1)
presence of 50 and 100 mM glucose##2##7##(2007-2#2)
presence of 50##12##3##(1990-7#2)(1990-8#1)(1997-4#2)(2006-12#1)(2007-2#2)(2008-10#2)(2008-11#1)(2008-7#1)
presence of AFP##2##3##(1991-10#1)(2008-10#1)
presence of B##5##3##(1992-3#1)(2007-2#1)(2008-10#2)(2013-7#1)
presence of BSA##2##3##(2007-8#1)(2008-3#1)
presence of CHAPS##2##3##(1990-9#2)
presence of Co(2+)##2##3##(2008-10#1)(2008-5#1)
presence of Co(III)##2##3##(2008-10#2)
presence of DM##2##3##(2007-8#1)(2008-7#1)
presence of DNA##15##3##(1990-11#1)(1994-2#1)(1994-3#1)(1995-2#1)(1997-4#1)(1997-7#2)(2008-10#6)(2008-9#1)(2009-3#1)
presence of DS##2##3##(1995-5#1)(2008-5#1)
presence of E2##2##3##(1997-6#1)(2008-11#1)
presence of EBV in the##3##5##(1997-7#3)
presence of EBV in##5##4##(1997-7#5)
presence of EDTA##9##3##(1990-2#1)(1992-8#1)(1995-6#1)(1996-1#1)(1996-7#1)(2008-10#4)
presence of EGTA##9##3##(1990-10#2)(1990-2#1)(1990-3#1)(1990-8#1)(1991-8#1)(1992-4#1)(1994-6#1)(1995-8#1)
presence of Fusarium##4##3##(2008-10#3)(2010-10#1)
presence of GAP-43##2##3##(2008-9#2)
presence of H(2)##3##3##(2006-4#2)(2010-2#1)
presence of HB-GAM in##2##4##(1996-1#2)
presence of HBV##3##3##(1997-4#1)(2007-8#1)(2009-3#1)
presence of HNO(3)##2##3##(2008-10#2)
presence of HP##4##3##(1991-12#1)(1993-5#1)(2007-3#2)
presence of K+##4##3##(1990-7#1)(1991-7#1)(1992-11#1)(1992-6#1)
presence of L-histidine##2##3##(1995-8#2)
presence of Mn(II)##5##3##(1995-8#2)(2005-11#2)(2008-10#1)
presence of N##4##3##(2006-12#2)(2008-10#1)(2008-3#1)
presence of NO##6##3##(1995-11#1)(1996-2#1)(2008-10#3)(2010-4#1)
presence of Na(+)##3##3##(2008-10#1)(2008-6#1)(2013-1#1)
presence of Na+##6##3##(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-3#1)(1992-6#1)
presence of O2##4##3##(1990-10#1)(1995-6#2)(2006-12#1)
presence of P##4##3##(2008-10#4)
presence of PAF##2##3##(1991-8#1)(1993-10#1)
presence of PAP in##2##4##(2008-12#2)
presence of Rickettsia##2##3##(2012-12#2)
presence of S##3##3##(1992-7#1)(2007-5#1)(2008-10#1)
presence of S9##2##3##(1996-2#1)(1997-4#1)
presence of T##5##3##(1997-8#1)(2006-10#1)(2008-10#1)(2008-8#2)
presence of T22##3##3##(2008-10#3)
presence of TGF##3##3##(1990-3#1)(1991-12#1)(1992-8#1)
presence of TiO(2) colloids##2##4##(2005-11#2)
presence of UV##4##3##(2008-10#1)(2008-11#2)(2010-2#1)
presence of VHb##2##3##(2006-12#2)
presence of Zn2+##2##3##(1997-4#2)
presence of a cationic surfactant##3##5##(2008-10#3)
presence of a central##2##4##(2007-11#1)(2011-2#1)
presence of a common##2##4##(1991-9#1)(1995-5#1)
presence of a conserved##3##4##(1993-11#1)(1994-2#1)(2008-10#1)
presence of a metabolic syndrome##2##5##(2008-10#2)
presence of a neutral surfactant##2##5##(2008-10#2)
presence of a new##2##4##(1996-10#1)(2008-10#1)
presence of a non-ionic##2##4##(1997-7#1)(2008-10#1)
presence of a number attractor##2##5##(2010-2#2)
presence of a number of##2##5##(1990-2#1)(1992-12#1)
presence of a number##4##4##(1990-2#1)(1992-12#1)(2010-2#2)
presence of a relatively##2##4##(1992-6#1)(2008-9#1)
presence of a selective##2##4##(1995-1#1)(2008-9#1)
presence of a significant##2##4##(1997-7#1)(2008-10#1)
presence of a single##24##4##(1990-10#1)(1990-11#1)(1990-2#1)(1991-4#2)(1991-5#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-11#1)(1997-2#1)(1997-5#1)(2006-4#1)(2008-10#2)(2008-6#1)(2009-5#1)(2010-2#1)(2010-3#1)(2012-3#1)
presence of a small##8##4##(1992-12#1)(1993-3#1)(1993-8#1)(1994-8#1)(2007-12#1)(2007-3#1)(2008-10#1)(2011-2#1)
presence of a specific##5##4##(1990-4#1)(2008-7#1)(2012-11#2)(2013-1#1)
presence of a stable##2##4##(1990-2#1)(1991-2#1)
presence of a surfactant##3##4##(2005-11#2)(2008-10#1)
presence of a susceptibility locus##2##5##(1997-5#2)
presence of a transcription##2##4##(1990-11#1)(1997-7#1)
presence of a tumour##3##4##(1992-1#1)(1995-12#1)(2008-7#1)
presence of a##513##3##(1990-1#1)(1990-10#2)(1990-11#4)(1990-12#4)(1990-2#5)(1990-3#4)(1990-4#3)(1990-5#5)(1990-8#1)(1991-1#1)(1991-10#3)(1991-11#2)(1991-12#2)(1991-2#7)(1991-3#1)(1991-4#6)(1991-5#6)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#5)(1992-3#3)(1992-4#2)(1992-6#3)(1992-7#2)(1992-8#4)(1992-9#1)(1993-11#5)(1993-12#3)(1993-2#2)(1993-3#5)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#3)(1994-11#6)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#3)(1994-6#3)(1994-8#6)(1994-9#5)(1995-1#6)(1995-11#5)(1995-12#4)(1995-2#8)(1995-3#4)(1995-5#4)(1995-6#4)(1995-8#3)(1996-10#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#5)(1996-6#3)(1996-7#4)(1996-8#4)(1996-9#2)(1997-1#6)(1997-2#6)(1997-4#2)(1997-5#5)(1997-6#4)(1997-7#7)(1997-8#4)(2004-9#1)(2005-10#3)(2005-11#11)(2005-12#1)(2005-8#2)(2006-1#1)(2006-10#6)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#20)(2007-2#5)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#56)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#9)(2008-5#11)(2008-6#4)(2008-7#5)(2008-8#6)(2008-9#2)(2009-11#2)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#5)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#3)(2010-8#1)(2011-1#6)(2011-2#9)(2012-1#1)(2012-11#3)(2012-12#5)(2012-2#4)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#1)
presence of abnormal##6##3##(1990-12#1)(1995-10#1)(2006-9#1)(2008-10#1)(2009-12#1)(2011-2#1)
presence of abnormalities##2##3##(2008-6#1)(2010-8#1)
presence of acanthosis##2##3##(2013-1#2)
presence of active##12##3##(1990-12#1)(1990-2#1)(1993-12#1)(1994-5#1)(1994-6#1)(1995-10#1)(1996-12#1)(1997-6#1)(2008-11#2)(2008-7#1)(2008-8#1)
presence of acute##3##3##(2006-7#1)(2008-2#1)(2008-3#1)
presence of added##4##3##(1991-5#1)(1992-11#1)(1994-5#1)(1996-5#1)
presence of additional##11##3##(1993-7#1)(1994-12#1)(1994-8#1)(1997-3#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-5#2)(2008-6#1)(2009-3#1)
presence of aerosols##2##3##(2008-3#2)
presence of affective disorders in##2##5##(2009-12#1)(2009-4#1)
presence of agonists##2##3##(1992-11#1)(2012-2#1)
presence of air##7##3##(1991-3#1)(1997-4#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-6#1)(2013-1#1)
presence of albumin##3##3##(1994-12#1)(1996-5#1)(2008-10#1)
presence of alkyl##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
presence of alpha##3##3##(1990-8#1)(1994-2#1)(2008-5#1)
presence of an additional##5##4##(1992-11#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-12#1)
presence of an amine##2##4##(1995-1#1)(2005-11#1)
presence of an electron##2##4##(2008-10#2)
presence of an endogenous##2##4##(2004-12#1)(2006-12#1)
presence of an enzyme##2##4##(1992-7#1)(2007-9#1)
presence of an##156##3##(1990-11#2)(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#4)(1992-10#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#2)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-12#2)(2005-11#3)(2006-10#4)(2006-12#1)(2006-2#1)(2006-3#1)(2006-8#2)(2007-11#1)(2007-12#5)(2007-4#1)(2007-8#2)(2007-9#3)(2008-10#20)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
presence of angina pectoris##2##4##(2008-7#2)
presence of another##9##3##(1990-9#1)(1992-6#1)(1993-9#1)(1995-1#1)(1996-10#1)(2008-5#2)(2008-7#1)(2008-8#1)
presence of antibodies against##3##4##(1990-6#1)(2007-11#2)
presence of antibodies to##4##4##(2007-2#1)(2008-4#1)(2008-5#1)(2010-12#1)
presence of antibodies##9##3##(1990-6#1)(2007-11#2)(2007-2#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-12#1)
presence of antigen##3##3##(1991-5#1)(1992-8#1)(1994-2#1)
presence of antigenic##2##3##(2004-12#1)(2005-12#1)
presence of any##12##3##(2008-10#3)(2008-11#1)(2008-5#3)(2008-8#1)(2010-12#1)(2010-6#1)(2012-12#1)(2013-1#1)
presence of aphasia##2##3##(1990-8#1)(2007-10#1)
presence of apoptosis##2##3##(1994-11#1)(2007-8#1)
presence of apoptotic##2##3##(2003-11#1)(2007-10#1)
presence of ascorbic acid (AA)##2##5##(2008-10#2)
presence of ascorbic acid##14##4##(1995-10#1)(1996-6#2)(2008-10#9)(2011-1#1)(2011-12#1)
presence of at least four##2##5##(1993-11#1)(1995-6#1)
presence of at least one##4##5##(1996-3#1)(2006-5#1)(2010-2#1)(2012-3#1)
presence of at least##13##4##(1990-11#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-3#1)(1993-11#1)(1993-2#1)(1994-8#1)(1995-6#1)(1996-3#1)(2006-5#1)(2010-2#1)(2012-3#1)
presence of atmospheric##2##3##(2007-12#1)(2008-3#1)
presence of atropine##6##3##(1990-11#1)(1996-12#1)(1997-4#2)(1997-5#1)(2011-2#1)
presence of autoantibodies against##2##4##(1990-5#1)(1991-4#1)
presence of autoantibodies##5##3##(1990-5#1)(1991-4#1)(2006-10#1)(2007-11#1)(2011-2#1)
presence of axillary lymph node##2##5##(1990-6#1)(2008-4#1)
presence of axillary##3##3##(1990-10#1)(1990-6#1)(2008-4#1)
presence of bacteria##4##3##(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)
presence of bacterial##3##3##(1991-12#1)(2006-10#1)(2008-10#1)
presence of beta-CD##8##3##(1994-3#2)(2007-11#1)(2008-10#5)
presence of bilateral##5##3##(2006-12#1)(2012-12#1)(2013-1#3)
presence of blood##3##3##(1995-3#1)(2007-7#1)(2012-2#1)
presence of bone metastases##2##4##(1991-8#2)
presence of bone##4##3##(1991-8#2)(2011-1#2)
presence of both##52##3##(1990-5#2)(1991-12#2)(1991-2#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-7#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-7#1)(1997-1#1)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-7#1)(2012-12#1)
presence of bovine serum albumin##8##5##(1993-4#1)(1993-8#1)(1995-12#4)(2008-10#2)
presence of bovine##9##3##(1993-4#1)(1993-8#1)(1995-12#4)(1997-2#1)(2008-10#2)
presence of breast symptoms##2##4##(2007-2#2)
presence of cagA##2##3##(1997-8#2)
presence of calcification##3##3##(1993-4#1)(2012-2#1)(2013-1#1)
presence of calcium##33##3##(1990-3#6)(1990-8#1)(1991-11#1)(1991-3#1)(1991-8#3)(1991-9#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-6#2)(1994-3#1)(1994-5#1)(1995-3#1)(1995-8#1)(1996-1#2)(1996-11#1)(1997-4#1)(1997-6#1)(2005-11#1)(2008-10#2)(2010-8#1)(2011-2#1)(2013-1#1)
presence of cancer##3##3##(2007-3#1)(2012-12#1)(2013-1#1)
presence of carbonate##2##3##(2008-10#2)
presence of carcinoma in##2##4##(1991-9#1)(2007-7#1)
presence of catalase in##2##4##(2008-10#2)
presence of catalase##4##3##(1991-9#1)(2006-10#1)(2008-10#2)
presence of cellular##3##3##(1992-5#1)(2007-8#1)(2013-1#1)
presence of central##2##3##(1997-8#1)(2008-1#1)
presence of cetyltrimethylammonium bromide (CTAB)##3##5##(2008-10#2)(2010-4#1)
presence of cetyltrimethylammonium bromide##4##4##(2008-10#2)(2008-3#1)(2010-4#1)
presence of charged##2##3##(1997-4#1)(2008-10#1)
presence of chloride ions##4##4##(1990-4#1)(1991-9#1)(2008-10#2)
presence of chloride##5##3##(1990-4#1)(1991-9#1)(2008-10#3)
presence of cholesterol##5##3##(1991-5#1)(1993-3#1)(1994-5#1)(2006-10#1)(2006-2#1)
presence of chronic##4##3##(1992-5#1)(2008-1#1)(2008-4#1)(2008-7#1)
presence of circulating##7##3##(1991-2#1)(1992-3#1)(2006-6#1)(2007-11#2)(2007-9#1)(2008-10#1)
presence of closely##2##3##(1991-11#1)(2007-8#1)
presence of clue cells##4##4##(2006-10#4)
presence of communicable diseases##2##4##(2011-2#2)
presence of comorbid##4##3##(2005-7#1)(2008-5#1)(2008-8#1)(2012-2#1)
presence of comorbidities##3##3##(2006-10#1)(2011-2#1)(2013-8#1)
presence of concomitant##5##3##(2008-10#1)(2008-2#2)(2009-9#1)(2012-12#1)
presence of copper(II)##2##3##(2008-10#2)
presence of depressive symptoms was##2##5##(2010-12#2)
presence of depressive symptoms##4##4##(2010-12#3)(2013-1#1)
presence of diabetes##5##3##(2006-10#1)(2006-6#1)(2008-1#2)(2008-3#1)
presence of different percentages of##2##5##(2008-10#2)
presence of different##21##3##(1990-10#1)(1990-5#1)(1991-5#1)(1992-5#1)(1993-3#1)(1994-10#1)(1994-11#1)(2005-11#1)(2007-2#1)(2008-10#6)(2008-2#1)(2008-5#2)(2008-7#1)(2010-10#1)(2010-4#1)
presence of disease in##2##4##(2007-11#1)(2008-10#1)
presence of disease##8##3##(1994-11#1)(1996-2#1)(2007-11#1)(2008-10#3)(2012-2#1)(2013-8#1)
presence of distant metastases##2##4##(1991-8#1)(2011-2#1)
presence of distant##4##3##(1991-8#1)(1994-6#1)(2006-2#1)(2011-2#1)
presence of distracters##2##3##(2009-2#2)
presence of double-stranded##2##3##(2008-10#2)
presence of drugs##3##3##(1990-5#1)(2011-2#1)(2013-8#1)
presence of each of the##3##5##(1994-12#1)(1996-5#1)(2011-2#1)
presence of each##8##3##(1994-12#1)(1996-5#2)(1997-4#1)(2007-2#1)(2008-10#1)(2008-5#1)(2011-2#1)
presence of either##17##3##(1991-2#1)(1991-8#2)(1992-4#1)(1994-6#1)(1995-11#1)(1995-9#1)(1996-1#1)(1996-5#1)(1997-3#1)(1997-6#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-5#1)
presence of elevated##3##3##(1991-10#1)(2008-11#1)(2012-3#1)
presence of endogenous##4##3##(1996-12#1)(2007-6#1)(2008-10#1)(2010-11#1)
presence of equimolar##2##3##(1992-4#1)(1993-6#1)
presence of estrogen##6##3##(1994-3#1)(1996-8#1)(1996-9#1)(2006-5#1)(2008-4#1)(2010-5#1)
presence of ethanol##8##3##(1991-5#1)(1991-6#1)(1996-4#1)(2008-10#3)(2008-5#1)(2011-1#1)
presence of exogenous LDL##2##4##(1996-7#2)
presence of exogenous##10##3##(1992-1#2)(1992-9#1)(1994-12#1)(1994-9#1)(1995-1#1)(1996-2#1)(1996-5#1)(1996-7#2)
presence of extensive##4##3##(1994-12#1)(1995-10#1)(2010-8#1)(2011-2#1)
presence of fibroblasts##4##3##(1990-12#1)(1991-11#1)(1991-5#1)(1995-5#1)
presence of fish##2##3##(2008-2#1)(2008-9#1)
presence of four##8##3##(1991-2#1)(1992-11#1)(1997-7#1)(2008-10#2)(2008-4#1)(2010-3#1)(2012-12#1)
presence of free##6##3##(1993-8#1)(1997-4#1)(1997-8#1)(2008-10#2)(2011-2#1)
presence of fructose 6-phosphate##3##4##(1990-7#3)
presence of functional##6##3##(1990-7#1)(1993-9#2)(1994-2#1)(1996-4#1)(2008-7#1)
presence of gas##2##3##(2012-12#1)(2012-2#1)
presence of genes##2##3##(2005-12#1)(2008-10#1)
presence of glial##2##3##(1993-11#1)(1997-4#1)
presence of glucose oxidase##2##4##(2008-10#2)
presence of glucose##11##3##(1990-2#1)(1991-9#1)(1994-11#1)(1995-1#2)(1995-8#2)(2008-10#3)(2009-10#1)
presence of glycine##2##3##(1990-2#1)(1996-9#1)
presence of great##2##3##(2008-10#2)
presence of growth##2##3##(1991-9#1)(2006-2#1)
presence of guanidine hydrochloride##3##4##(1992-6#1)(1993-3#1)(1995-5#1)
presence of guanidine##4##3##(1992-6#1)(1993-3#1)(1995-5#1)(2008-4#1)
presence of guanine##2##3##(1993-6#1)(2008-10#1)
presence of hemorrhage##4##3##(1996-9#1)(2007-10#1)(2007-9#1)(2009-8#1)
presence of heparin##10##3##(1990-12#1)(1992-5#1)(1994-10#1)(1994-3#1)(1995-10#2)(2008-4#1)(2009-4#2)(2010-8#1)
presence of hepatic##4##3##(1991-10#2)(2006-10#1)(2008-1#1)
presence of high concentrations of##8##5##(1990-12#2)(1994-3#1)(1994-9#1)(2008-10#2)(2008-11#1)(2008-4#1)
presence of high glucose##3##4##(1991-4#1)(1994-3#1)(2012-5#1)
presence of high##36##3##(1990-10#2)(1990-12#3)(1990-2#2)(1990-8#1)(1991-2#1)(1991-4#1)(1991-8#2)(1991-9#1)(1992-9#1)(1994-11#1)(1994-3#2)(1994-9#1)(1997-1#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-5#1)
presence of higher levels of##2##5##(1993-11#1)(1996-6#1)
presence of higher##7##3##(1993-11#1)(1996-6#1)(2008-10#1)(2009-9#1)(2010-8#1)(2011-1#1)(2012-2#1)
presence of higher-order##3##3##(1994-8#1)(2007-12#1)(2008-2#1)
presence of highly##4##3##(1990-9#1)(1991-10#1)(2007-11#1)(2008-10#1)
presence of histone H2B##2##4##(1995-7#2)
presence of human serum##2##4##(2008-10#1)(2010-12#1)
presence of human##13##3##(1990-12#1)(1991-2#1)(1991-8#1)(1992-7#1)(1992-9#1)(1994-2#1)(2005-10#1)(2008-10#1)(2009-4#1)(2009-9#1)(2010-12#1)(2011-2#2)
presence of hydrogen peroxide catalyses the oxidation of hydroquinone to##2##10##(2008-10#2)
presence of hydrogen peroxide catalyses the oxidation of##3##8##(2008-10#3)
presence of hydrogen peroxide##11##4##(1994-2#1)(2008-10#10)
presence of hydrogen##14##3##(1994-2#1)(2007-12#2)(2008-10#11)
presence of hypertension##2##3##(2006-6#1)(2012-2#1)
presence of imidazole##3##3##(1994-5#2)(2008-10#1)
presence of increasing##6##3##(1991-7#1)(1992-12#1)(1993-4#1)(1995-3#1)(1995-6#1)(1997-6#1)
presence of infection##5##3##(1995-2#1)(2007-3#1)(2008-12#1)(2010-8#1)(2012-2#1)
presence of inflammation in##2##4##(2006-12#1)(2008-7#1)
presence of inflammation##3##3##(2006-12#1)(2008-7#1)(2013-1#1)
presence of inflammatory cells##2##4##(2008-5#1)(2012-2#1)
presence of inflammatory##3##3##(2007-2#1)(2008-5#1)(2012-2#1)
presence of inhibitor##2##3##(1995-1#1)(2008-3#1)
presence of insulin##8##3##(1991-12#1)(1994-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-12#1)
presence of interfering ions##3##4##(2008-10#3)
presence of interfering##5##3##(2008-10#4)(2013-1#1)
presence of internal##2##3##(2010-4#1)(2013-1#1)
presence of intussusception or##2##4##(1990-10#1)(2008-8#1)
presence of ions and##2##4##(2008-10#1)(2010-5#1)
presence of ions##3##3##(2005-11#1)(2008-10#1)(2010-5#1)
presence of iron##10##3##(1991-5#1)(1992-4#1)(1995-3#1)(2006-2#1)(2008-10#3)(2009-2#1)(2013-1#1)(2013-8#1)
presence of its##12##3##(1990-11#1)(1993-8#1)(1995-5#1)(2008-10#4)(2008-4#1)(2010-4#1)(2011-2#1)(2013-7#2)
presence of known##4##3##(2007-2#1)(2008-1#1)(2008-10#1)(2013-7#1)
presence of kraft##2##3##(2005-11#2)
presence of large amounts of##4##5##(1990-2#1)(2008-10#3)
presence of large number of cations and anions##2##8##(2008-10#2)
presence of large##24##3##(1990-2#1)(1996-5#1)(2004-11#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#2)(2008-10#9)(2008-2#1)(2011-2#1)(2012-12#1)(2012-3#1)
presence of late potentials##2##4##(2006-9#1)(2010-12#1)
presence of lead##3##3##(1996-3#1)(1997-2#1)(2008-10#1)
presence of left atrial thrombus##2##5##(1997-1#2)
presence of left##4##3##(1997-1#2)(2009-1#1)(2010-12#1)
presence of lesions##2##3##(2007-8#1)(2008-5#1)
presence of ligand##4##3##(1992-12#1)(1994-11#1)(2008-10#1)(2008-4#1)
presence of liver##2##3##(2008-8#1)(2013-1#1)
presence of low##20##3##(1991-2#1)(1991-7#1)(1994-11#2)(1994-2#1)(1994-5#1)(1994-9#1)(1995-3#1)(1996-5#2)(2005-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
presence of magnesium and##2##4##(1992-7#1)(2007-11#1)
presence of magnesium##6##3##(1990-11#1)(1992-7#1)(1996-8#1)(1997-3#1)(2007-11#1)(2008-4#1)
presence of major##2##3##(2005-8#1)(2008-10#1)
presence of mature##2##3##(2008-5#2)
presence of metabolic syndrome##2##4##(2008-1#1)(2012-12#1)
presence of metastases at##2##4##(2007-8#1)(2010-3#1)
presence of metastases##6##3##(1990-12#1)(1990-6#1)(1996-3#1)(2007-8#1)(2010-3#2)
presence of metastatic##4##3##(1991-10#1)(2005-11#1)(2008-1#1)(2010-11#1)
presence of methanol##2##3##(1995-3#1)(2005-11#1)
presence of microorganisms##2##3##(2008-11#2)
presence of molybdate##5##3##(1990-11#1)(1992-3#1)(2006-8#2)(2008-10#1)
presence of more than one##6##5##(1990-11#1)(1991-9#1)(2008-10#1)(2008-5#2)(2013-8#1)
presence of more than##9##4##(1990-11#1)(1990-12#1)(1991-9#1)(2006-5#1)(2007-7#1)(2008-10#1)(2008-5#2)(2013-8#1)
presence of more##12##3##(1990-11#1)(1990-12#1)(1991-3#1)(1991-9#1)(2006-5#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#2)(2013-8#1)
presence of multiple forms of##2##5##(1990-7#1)(1991-5#1)
presence of multiple nodules##3##4##(2006-6#3)
presence of multiple##31##3##(1990-7#1)(1990-8#1)(1991-10#1)(1991-5#1)(1991-6#1)(1992-6#1)(1993-5#1)(1994-3#1)(1995-8#1)(1996-1#1)(1996-9#1)(1997-5#1)(2005-12#1)(2006-10#1)(2006-6#3)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2009-4#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
presence of necrosis and##2##4##(2006-10#1)(2011-2#1)
presence of necrosis##5##3##(2006-10#1)(2007-11#1)(2011-2#2)(2012-3#1)
presence of negative##3##3##(1990-3#1)(1995-1#1)(2012-2#1)
presence of negatively charged##3##4##(1992-12#1)(1995-8#1)(2008-1#1)
presence of nine##2##3##(1992-12#1)(2008-10#1)
presence of nitrate##5##3##(1992-6#1)(2008-10#2)(2008-11#2)
presence of nitrite and##2##4##(2006-10#1)(2008-10#1)
presence of normal##8##3##(1991-3#1)(1992-7#1)(2006-10#1)(2006-5#1)(2006-6#1)(2008-1#1)(2011-12#1)(2011-2#1)
presence of numerous##2##3##(2008-10#1)(2008-2#1)
presence of occult micrometastases##3##4##(1990-6#1)(2004-2#1)(2008-10#1)
presence of occult##4##3##(1990-6#1)(2004-2#1)(2008-10#1)(2010-12#1)
presence of one##10##3##(1991-9#2)(1993-3#1)(1994-6#1)(2008-10#4)(2008-8#1)(2012-12#1)
presence of open##3##3##(1992-3#1)(2007-12#1)(2008-3#1)
presence of organic solvents##2##4##(2007-6#1)(2008-10#1)
presence of organic##5##3##(2005-11#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-3#1)
presence of osteophytes##2##3##(1994-11#1)(2007-11#1)
presence of other metals##2##4##(1996-7#1)(2008-10#1)
presence of other##38##3##(1990-9#1)(1991-5#1)(1991-8#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-4#1)(1996-7#1)(1997-4#1)(1997-8#1)(2007-10#1)(2007-11#1)(2008-10#13)(2008-4#2)(2008-7#1)(2009-12#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-8#3)
presence of ouabain##2##3##(1995-1#1)(1997-1#1)
presence of oxygen##15##3##(1990-12#1)(1991-10#1)(1991-2#1)(1991-9#1)(1993-6#1)(1994-10#1)(1995-2#1)(1997-1#1)(1997-4#1)(2008-10#4)(2008-9#1)(2009-3#1)
presence of pain##3##3##(2009-4#1)(2009-8#1)(2012-12#1)
presence of penicillins##2##3##(1992-2#2)
presence of peptide##2##3##(1992-12#1)(2006-8#1)
presence of peroxidase##2##3##(1991-8#1)(2008-10#1)
presence of phospholipid vesicles##2##4##(1991-2#1)(1991-8#1)
presence of phospholipid##4##3##(1991-2#1)(1991-8#1)(1992-2#1)(1993-8#1)
presence of phospholipids with a high phase transition temperature and##2##10##(1995-5#2)
presence of phospholipids##5##3##(1990-5#1)(1995-5#2)(1997-4#1)(2013-7#1)
presence of phytoplasma in##2##4##(2008-10#2)
presence of plaques##2##3##(2013-4#1)(2013-8#1)
presence of possible##2##3##(2007-11#1)(2008-7#1)
presence of predators##3##3##(2008-8#3)
presence of preformed##2##3##(2007-11#1)(2010-5#1)
presence of previous##2##3##(1993-11#1)(2008-8#1)
presence of protein kinase C##2##5##(1990-7#1)(2008-4#1)
presence of protein kinase##3##4##(1990-7#1)(1994-11#1)(2008-4#1)
presence of protein##5##3##(1990-7#1)(1994-11#1)(2008-3#1)(2008-4#1)(2010-4#1)
presence of proteins##7##3##(1990-12#1)(1992-12#1)(2006-10#1)(2008-10#1)(2008-6#1)(2008-7#1)(2013-8#1)
presence of psychotic symptoms in##2##5##(2007-7#2)
presence of putative##2##3##(1992-8#1)(2008-7#1)
presence of rat plasma##2##4##(1993-11#1)(2013-1#1)
presence of rat##4##3##(1992-7#1)(1993-11#1)(2008-9#1)(2013-1#1)
presence of regional##4##3##(2006-10#1)(2008-7#1)(2010-12#1)(2010-2#1)
presence of relatively##4##3##(1990-12#1)(1991-9#1)(2008-10#2)
presence of renal##3##3##(2004-11#1)(2008-3#1)(2008-4#1)
presence of residual##8##3##(1992-10#1)(2007-2#1)(2008-10#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-7#1)(2013-8#1)
presence of reticuloendotheliosis virus (REV)##2##5##(2008-5#1)(2013-8#1)
presence of risk factors##3##4##(1991-12#1)(1991-9#1)(2011-2#1)
presence of secondary##6##3##(2005-11#1)(2006-10#1)(2008-10#1)(2010-11#1)(2011-2#1)(2013-1#1)
presence of selected##2##3##(1994-3#1)(2008-10#1)
presence of selenium##2##3##(2008-10#2)
presence of serum in##4##4##(1991-5#1)(1992-6#1)(1996-2#1)(2008-11#1)
presence of serum##19##3##(1991-3#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-12#1)(1995-1#1)(1996-2#1)(1997-7#1)(2007-2#1)(2008-10#1)(2008-11#4)(2011-2#1)(2013-1#1)
presence of several cations##2##4##(2008-10#2)
presence of several##26##3##(1991-6#1)(1991-9#1)(1994-9#1)(1995-4#1)(1996-5#1)(1997-2#1)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#13)(2008-12#1)(2008-3#1)(2008-8#1)
presence of severe##6##3##(2006-10#1)(2007-11#3)(2010-7#1)(2012-2#1)
presence of shock##4##3##(2006-10#2)(2007-5#1)(2013-1#1)
presence of signal##3##3##(1995-6#2)(2008-3#1)
presence of skin##3##3##(2006-2#1)(2007-8#1)(2010-4#1)
presence of small##11##3##(1992-9#1)(1993-11#1)(1994-11#1)(1997-6#1)(2005-11#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-12#1)
presence of sodium dodecyl sulfate (SDS)##5##6##(1990-11#1)(2005-11#1)(2007-8#1)(2008-2#1)(2008-4#1)
presence of sodium dodecyl sulfate##9##5##(1990-11#1)(1991-2#1)(1991-9#1)(1996-12#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)
presence of sodium##36##3##(1990-11#1)(1991-2#1)(1991-9#1)(1992-5#2)(1994-12#1)(1994-8#1)(1995-11#1)(1996-12#1)(2005-11#1)(2007-11#3)(2007-8#1)(2008-10#16)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)
presence of soluble##4##3##(1990-3#1)(1994-8#1)(2008-11#2)
presence of specific binding sites for##3##6##(1990-3#1)(1990-5#1)(1992-7#1)
presence of specific binding sites##4##5##(1990-3#1)(1990-5#1)(1992-12#1)(1992-7#1)
presence of specific##12##3##(1990-3#2)(1990-5#1)(1991-7#1)(1992-12#1)(1992-7#1)(1997-2#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-9#1)(2012-12#1)
presence of squamous##2##3##(1991-2#1)(2011-2#1)
presence of stoichiometric##4##3##(1994-9#1)(1995-8#1)(1996-2#1)(2010-6#1)
presence of substantial amounts of##2##5##(1991-12#1)(1992-11#1)
presence of such##14##3##(1991-12#1)(1991-6#1)(1995-7#1)(1997-4#1)(2005-8#1)(2006-5#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-2#1)(2013-1#1)
presence of superficial##2##3##(2007-10#2)
presence of surface charges##4##4##(2005-11#3)(2007-9#1)
presence of surface##5##3##(1996-5#1)(2005-11#3)(2007-9#1)
presence of surfactant##4##3##(1990-10#1)(2008-10#3)
presence of systemic##2##3##(2006-2#1)(2007-9#1)
presence of testosterone##3##3##(1995-2#2)(2012-2#1)
presence of the above##2##4##(2008-10#2)
presence of the additional##2##4##(2006-12#1)(2008-10#1)
presence of the other##8##4##(1990-2#1)(1992-9#1)(1994-2#2)(1996-4#1)(2008-10#2)(2008-12#1)
presence of the pathogen##3##4##(2008-10#3)
presence of the peptide##2##4##(1991-5#1)(1991-9#1)
presence of the polymer##3##4##(1995-2#1)(2008-10#1)(2008-12#1)
presence of the protein##2##4##(1990-5#1)(1994-3#1)
presence of the staphylokinase##2##4##(2012-2#2)
presence of the two##6##4##(1990-7#1)(1994-11#2)(1997-8#1)(2007-7#1)(2008-11#1)
presence of the##382##3##(1990-1#1)(1990-10#2)(1990-11#4)(1990-12#3)(1990-2#3)(1990-4#1)(1990-5#5)(1990-7#2)(1990-8#1)(1991-10#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#5)(1991-7#1)(1991-8#4)(1991-9#4)(1992-11#1)(1992-12#5)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#1)(1992-9#3)(1993-11#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#5)(1993-9#1)(1994-10#1)(1994-11#5)(1994-12#7)(1994-2#7)(1994-3#4)(1994-5#3)(1994-6#6)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#4)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#2)(1995-5#4)(1995-6#4)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#5)(1996-6#2)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#2)(1997-5#6)(1997-7#4)(1997-8#2)(2004-12#1)(2005-11#4)(2005-12#1)(2006-10#2)(2006-12#7)(2006-3#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-6#2)(2007-7#4)(2007-8#3)(2008-10#62)(2008-11#4)(2008-12#6)(2008-2#5)(2008-3#9)(2008-4#9)(2008-5#11)(2008-6#3)(2008-7#5)(2008-8#9)(2009-11#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#5)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#4)
presence of these receptors##2##4##(1991-5#1)(1995-12#1)
presence of these##32##3##(1990-10#1)(1991-1#1)(1991-5#1)(1991-8#1)(1993-11#1)(1994-10#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1997-5#1)(2005-11#1)(2006-5#1)(2006-9#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#1)
presence of thiol##2##3##(1992-11#1)(2010-11#1)
presence of this enzyme##2##4##(1991-5#1)(2008-1#1)
presence of this##38##3##(1990-12#1)(1990-5#1)(1991-3#1)(1991-5#1)(1991-8#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-8#1)(1997-2#1)(1997-6#2)(1997-7#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-9#1)(2009-9#1)(2010-1#1)(2010-10#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)(2013-7#1)
presence of toxic##5##3##(1992-6#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-1#1)
presence of trace amounts of##2##5##(1990-9#1)(1992-7#1)
presence of trace##4##3##(1990-9#1)(1992-7#1)(2008-10#2)
presence of transferable##2##3##(2009-3#1)(2011-2#1)
presence of tremor##2##3##(2008-7#2)
presence of tumor##3##3##(1994-11#1)(2006-6#1)(2007-7#1)
presence of two GH in the tilapia genome is##2##9##(1993-3#2)
presence of two different##7##4##(1990-7#1)(1992-7#1)(1996-2#1)(2006-1#1)(2008-10#2)(2008-4#1)
presence of two distinct##4##4##(1992-3#1)(1995-5#1)(2008-10#1)(2009-4#1)
presence of two introns##2##4##(1991-5#1)(1993-2#1)
presence of two##88##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#2)(1991-12#1)(1991-2#3)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-11#2)(1994-3#2)(1994-8#3)(1995-11#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-10#1)(1996-2#2)(1997-2#2)(1997-3#1)(1997-4#1)(2006-1#2)(2006-10#1)(2006-12#2)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#11)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
presence of type I##3##4##(1991-1#1)(1991-10#1)(1993-11#1)
presence of type##5##3##(1990-8#1)(1991-1#1)(1991-10#1)(1993-11#1)(2008-1#1)
presence of underlying##2##3##(2011-2#1)(2012-12#1)
presence of unique##2##3##(2008-10#1)(2013-8#1)
presence of urea##3##3##(1995-5#1)(2008-10#2)
presence of urinary##2##3##(2007-10#1)(2008-1#1)
presence of various##23##3##(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-6#1)(1992-9#1)(1994-3#1)(1996-5#2)(1997-2#1)(1997-4#1)(1997-7#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#2)(2012-3#1)(2013-8#1)
presence of vascular invasion##2##4##(1990-6#1)(2007-8#1)
presence of vascular##3##3##(1990-6#1)(1993-10#1)(2007-8#1)
presence of viable##2##3##(2007-8#2)
presence of vimentin##2##3##(1990-4#1)(2012-2#1)
presence of viral DNA##2##4##(1993-8#1)(2008-5#1)
presence of viral##4##3##(1993-8#1)(2008-11#1)(2008-5#1)(2012-3#1)
presence of visual##2##3##(2011-2#1)(2013-8#1)
presence of water##8##3##(1990-2#1)(1990-7#1)(1995-6#1)(2004-9#1)(2005-11#1)(2007-9#1)(2008-10#1)(2008-5#1)
presence of##6097##2##(1990-1#5)(1990-10#29)(1990-11#41)(1990-12#46)(1990-2#50)(1990-3#35)(1990-4#13)(1990-5#56)(1990-6#13)(1990-7#42)(1990-8#31)(1990-9#17)(1991-1#15)(1991-10#23)(1991-11#15)(1991-12#37)(1991-2#54)(1991-3#28)(1991-4#35)(1991-5#47)(1991-6#17)(1991-7#19)(1991-8#38)(1991-9#48)(1992-1#18)(1992-10#5)(1992-11#34)(1992-12#38)(1992-2#21)(1992-3#35)(1992-4#16)(1992-5#22)(1992-6#36)(1992-7#25)(1992-8#35)(1992-9#33)(1993-1#1)(1993-10#4)(1993-11#33)(1993-12#25)(1993-2#12)(1993-3#30)(1993-4#17)(1993-5#7)(1993-6#35)(1993-7#11)(1993-8#35)(1993-9#26)(1994-1#1)(1994-10#11)(1994-11#52)(1994-12#61)(1994-2#34)(1994-3#49)(1994-5#33)(1994-6#35)(1994-7#7)(1994-8#54)(1994-9#43)(1995-1#45)(1995-10#25)(1995-11#32)(1995-12#29)(1995-2#45)(1995-3#38)(1995-4#9)(1995-5#35)(1995-6#32)(1995-7#9)(1995-8#52)(1995-9#5)(1996-1#23)(1996-10#15)(1996-11#10)(1996-12#26)(1996-2#32)(1996-3#17)(1996-4#16)(1996-5#53)(1996-6#19)(1996-7#25)(1996-8#19)(1996-9#17)(1997-1#27)(1997-2#42)(1997-3#18)(1997-4#57)(1997-5#31)(1997-6#26)(1997-7#49)(1997-8#28)(2003-11#1)(2004-1#1)(2004-10#1)(2004-11#8)(2004-12#8)(2004-2#2)(2004-4#4)(2004-9#5)(2005-1#2)(2005-10#12)(2005-11#89)(2005-12#15)(2005-3#1)(2005-4#8)(2005-7#3)(2005-8#11)(2005-9#2)(2006-1#4)(2006-10#77)(2006-11#8)(2006-12#40)(2006-2#12)(2006-3#6)(2006-4#9)(2006-5#19)(2006-6#20)(2006-7#5)(2006-8#34)(2006-9#14)(2007-1#12)(2007-10#30)(2007-11#90)(2007-12#84)(2007-2#32)(2007-3#20)(2007-4#5)(2007-5#13)(2007-6#20)(2007-7#37)(2007-8#56)(2007-9#23)(2008-1#38)(2008-10#944)(2008-11#110)(2008-12#35)(2008-2#69)(2008-3#108)(2008-4#82)(2008-5#140)(2008-6#41)(2008-7#81)(2008-8#68)(2008-9#39)(2009-1#2)(2009-10#9)(2009-11#10)(2009-12#6)(2009-2#9)(2009-3#15)(2009-4#14)(2009-5#9)(2009-6#14)(2009-7#10)(2009-8#22)(2009-9#17)(2010-1#5)(2010-10#9)(2010-11#14)(2010-12#37)(2010-2#25)(2010-3#12)(2010-4#30)(2010-5#24)(2010-6#18)(2010-7#10)(2010-8#19)(2010-9#7)(2011-1#47)(2011-12#15)(2011-2#124)(2011-3#1)(2011-7#1)(2012-1#12)(2012-11#8)(2012-12#66)(2012-2#65)(2012-3#46)(2012-5#1)(2013-1#94)(2013-4#1)(2013-7#20)(2013-8#57)
presence on the surface##2##4##(2008-10#1)(2009-8#1)
presence on the##4##3##(1994-5#1)(2008-10#1)(2008-8#1)(2009-8#1)
presence on##7##2##(1994-5#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-8#1)(2013-1#1)
presence or absence of a##15##5##(1990-7#1)(1991-8#1)(1994-3#1)(1996-12#1)(1996-4#1)(2005-8#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#2)(2011-2#1)(2012-12#1)
presence or absence of light##2##5##(1991-9#1)(2008-10#1)
presence or absence of the##20##5##(1991-5#2)(1994-6#1)(1995-11#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-7#1)(1996-9#1)(2006-12#1)(2008-10#5)(2008-5#1)(2008-6#1)(2008-7#1)(2010-9#1)(2013-8#1)
presence or absence of##155##4##(1990-11#1)(1990-3#2)(1990-5#1)(1990-7#2)(1990-9#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#3)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#3)(1993-8#1)(1994-11#1)(1994-3#1)(1994-6#2)(1995-11#2)(1995-3#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-4#2)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-5#3)(1997-7#1)(1997-8#1)(2005-11#1)(2005-12#2)(2005-8#3)(2006-12#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#5)(2007-7#1)(2007-9#3)(2008-10#28)(2008-11#1)(2008-12#4)(2008-2#3)(2008-4#5)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#4)(2009-11#1)(2009-2#1)(2009-5#1)(2010-10#2)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#3)(2013-8#1)
presence or absence##163##3##(1990-11#1)(1990-3#2)(1990-5#1)(1990-7#2)(1990-9#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#3)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#2)(1992-3#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#3)(1993-8#1)(1994-11#1)(1994-3#1)(1994-6#2)(1995-11#2)(1995-3#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-4#2)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-4#2)(1997-5#3)(1997-7#1)(1997-8#1)(2005-11#1)(2005-12#2)(2005-4#2)(2005-8#3)(2006-12#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#5)(2007-7#1)(2007-9#3)(2008-1#1)(2008-10#28)(2008-11#2)(2008-12#4)(2008-2#3)(2008-4#5)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#4)(2009-11#1)(2009-2#1)(2009-5#1)(2010-10#2)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#3)(2013-8#1)
presence or not##4##3##(2006-10#1)(2008-10#1)(2008-2#1)(2011-1#1)
presence or##176##2##(1990-11#1)(1990-3#2)(1990-5#1)(1990-7#2)(1990-9#1)(1991-11#1)(1991-2#1)(1991-4#2)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-12#2)(1992-3#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#3)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#2)(1995-11#2)(1995-3#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-4#2)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-4#2)(1997-5#3)(1997-7#1)(1997-8#1)(2005-11#1)(2005-12#2)(2005-4#2)(2005-8#3)(2006-10#1)(2006-12#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#5)(2007-7#1)(2007-9#3)(2008-1#2)(2008-10#29)(2008-11#3)(2008-12#4)(2008-2#4)(2008-4#6)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#4)(2009-11#1)(2009-2#1)(2009-5#1)(2010-10#2)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#3)(2013-8#1)
presence suggests##2##2##(1994-2#1)(2013-1#1)
presence using##2##2##(2008-10#1)(2012-12#1)
presence versus absence##2##3##(1996-2#1)(2011-2#1)
presence was##7##2##(1991-3#1)(2008-5#1)(2009-9#1)(2011-1#2)(2011-2#2)
presence##6678##1##(1990-1#5)(1990-10#29)(1990-11#44)(1990-12#47)(1990-2#51)(1990-3#42)(1990-4#13)(1990-5#61)(1990-6#14)(1990-7#48)(1990-8#31)(1990-9#18)(1991-1#17)(1991-10#23)(1991-11#16)(1991-12#39)(1991-2#55)(1991-3#32)(1991-4#38)(1991-5#51)(1991-6#19)(1991-7#21)(1991-8#44)(1991-9#50)(1992-1#20)(1992-10#6)(1992-11#35)(1992-12#42)(1992-2#21)(1992-3#39)(1992-4#18)(1992-5#23)(1992-6#39)(1992-7#26)(1992-8#38)(1992-9#35)(1993-1#2)(1993-10#4)(1993-11#35)(1993-12#29)(1993-2#15)(1993-3#35)(1993-4#18)(1993-5#7)(1993-6#38)(1993-7#14)(1993-8#38)(1993-9#26)(1994-1#1)(1994-10#12)(1994-11#61)(1994-12#66)(1994-2#38)(1994-3#53)(1994-5#36)(1994-6#39)(1994-7#7)(1994-8#57)(1994-9#45)(1995-1#47)(1995-10#25)(1995-11#36)(1995-12#29)(1995-2#46)(1995-3#41)(1995-4#9)(1995-5#36)(1995-6#34)(1995-7#10)(1995-8#54)(1995-9#6)(1996-1#25)(1996-10#17)(1996-11#12)(1996-12#27)(1996-2#34)(1996-3#17)(1996-4#19)(1996-5#56)(1996-6#20)(1996-7#28)(1996-8#21)(1996-9#20)(1997-1#34)(1997-2#44)(1997-3#19)(1997-4#61)(1997-5#34)(1997-6#28)(1997-7#54)(1997-8#31)(2003-11#1)(2004-1#2)(2004-10#1)(2004-11#9)(2004-12#8)(2004-2#2)(2004-4#4)(2004-9#5)(2005-1#2)(2005-10#13)(2005-11#91)(2005-12#17)(2005-3#1)(2005-4#10)(2005-7#3)(2005-8#16)(2005-9#3)(2006-1#4)(2006-10#86)(2006-11#8)(2006-12#43)(2006-2#14)(2006-3#6)(2006-4#10)(2006-5#21)(2006-6#21)(2006-7#6)(2006-8#35)(2006-9#14)(2007-1#12)(2007-10#31)(2007-11#96)(2007-12#88)(2007-2#34)(2007-3#22)(2007-4#8)(2007-5#20)(2007-6#22)(2007-7#38)(2007-8#58)(2007-9#28)(2008-1#43)(2008-10#1021)(2008-11#125)(2008-12#43)(2008-2#75)(2008-3#116)(2008-4#90)(2008-5#160)(2008-6#45)(2008-7#95)(2008-8#82)(2008-9#41)(2009-1#2)(2009-10#12)(2009-11#11)(2009-12#6)(2009-2#10)(2009-3#16)(2009-4#17)(2009-5#12)(2009-6#15)(2009-7#10)(2009-8#24)(2009-9#21)(2010-1#5)(2010-10#11)(2010-11#15)(2010-12#39)(2010-2#26)(2010-3#15)(2010-4#32)(2010-5#26)(2010-6#19)(2010-7#11)(2010-8#21)(2010-9#8)(2011-1#58)(2011-12#16)(2011-2#145)(2011-3#1)(2011-7#1)(2012-1#13)(2012-11#8)(2012-12#72)(2012-2#79)(2012-3#50)(2012-5#1)(2013-1#109)(2013-4#1)(2013-7#24)(2013-8#67)
presence/absence data##2##2##(2008-10#1)(2013-7#1)
presence/absence of the##2##3##(1993-2#1)(2010-4#1)
presence/absence of##7##2##(1993-2#1)(2008-11#1)(2009-6#1)(2010-10#1)(2010-4#1)(2012-3#1)(2013-1#1)
presence/absence##10##1##(1993-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#1)(2010-10#1)(2010-4#1)(2012-3#1)(2013-1#1)(2013-7#1)
presences##2##1##(2008-10#1)(2008-8#1)
presenile##5##1##(1990-5#1)(1992-1#2)(1992-8#2)
presenilin 1 (PS-1)##2##3##(1997-5#2)
presenilin 1 gene##3##3##(1996-2#3)
presenilin 1##7##2##(1996-2#3)(1997-5#4)
presenilin 2##3##2##(1997-5#2)(2005-9#1)
presenilin gene##2##2##(1996-2#1)(1996-6#1)
presenilin##14##1##(1996-2#4)(1996-6#1)(1997-5#7)(2005-9#1)(2010-8#1)
presenilin-1##3##1##(1995-12#2)(1997-7#1)
presenilins##3##1##(1997-5#2)(2005-7#1)
presensitized##6##1##(1991-3#1)(2007-12#5)
present 2 cases of##5##4##(2009-1#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-3#1)
present 25##2##2##(2008-10#1)(2008-8#1)
present 3 cases of##3##4##(2007-10#1)(2011-2#1)(2012-12#1)
present 3 cases##4##3##(2007-10#1)(2007-4#1)(2011-2#1)(2012-12#1)
present 3##6##2##(2007-10#1)(2007-4#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-12#1)
present 3D##2##2##(2008-11#1)(2008-3#1)
present 7##2##2##(2007-10#1)(2008-9#1)
present SPE/LC method##2##3##(2008-10#2)
present X-ray##2##2##(1996-6#1)(2007-6#1)
present a 68-year-old##2##3##(1996-12#1)(2010-2#1)
present a basic##2##3##(2008-4#1)(2011-2#1)
present a brief overview of##4##5##(2006-10#1)(2010-11#1)(2010-9#1)(2011-1#1)
present a brief review of the##2##6##(1994-6#1)(2012-3#1)
present a brief##11##3##(1994-6#1)(2006-10#1)(2006-3#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-3#1)
present a broad##2##3##(2008-11#1)(2010-2#1)
present a case in which a##2##6##(2007-6#1)(2010-9#1)
present a case in which the##3##6##(2006-5#1)(2012-12#2)
present a case in which##10##5##(2006-10#1)(2006-5#1)(2007-6#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-7#1)(2010-9#1)(2012-12#2)
present a case of a 38-year-old##3##6##(2009-4#1)(2013-1#2)
present a case of a giant##2##6##(2008-12#1)(2012-12#1)
present a case of a##53##5##(2006-10#2)(2006-12#1)(2006-6#1)(2007-12#1)(2007-3#1)(2007-5#2)(2007-6#1)(2007-8#6)(2007-9#1)(2008-10#2)(2008-12#2)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-1#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#7)
present a case of acute##4##5##(2006-7#1)(2007-9#1)(2010-12#1)(2011-12#1)
present a case of an##10##5##(2006-10#1)(2007-8#1)(2010-9#1)(2012-1#1)(2012-2#2)(2013-1#3)(2013-8#1)
present a case of cutaneous##2##5##(2010-6#1)(2012-3#1)
present a case of giant##2##5##(1991-6#1)(2008-6#1)
present a case of isolated##2##5##(2005-10#1)(2008-12#1)
present a case of multiple##2##5##(2008-10#1)(2013-1#1)
present a case of secondary##2##5##(2008-12#1)(2010-3#1)
present a case of##197##4##(1991-3#1)(1991-6#2)(1992-12#1)(1993-5#1)(1995-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-5#4)(2007-6#1)(2007-7#6)(2007-8#10)(2007-9#2)(2008-10#4)(2008-11#1)(2008-12#7)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#3)(2009-1#2)(2009-10#1)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#5)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#4)(2011-1#2)(2011-12#2)(2011-2#14)(2012-1#1)(2012-11#1)(2012-12#17)(2012-2#9)(2012-3#5)(2013-1#26)(2013-7#4)(2013-8#3)
present a case report about##2##5##(1990-3#1)(1993-5#1)
present a case report of a patient##3##7##(2007-2#1)(2012-12#2)
present a case report of a##12##6##(2007-10#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)
present a case report of##14##5##(2007-10#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-2#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#2)
present a case report##20##4##(1990-3#1)(1993-5#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#2)
present a case study of a##4##6##(2010-6#1)(2012-12#1)(2013-1#2)
present a case study of##5##5##(2010-6#1)(2012-12#1)(2013-1#3)
present a case study##11##4##(2006-11#1)(2008-6#1)(2008-7#1)(2010-6#1)(2010-8#1)(2012-12#1)(2013-1#5)
present a case that##2##4##(2008-7#1)(2010-5#1)
present a case where##5##4##(2006-9#1)(2007-8#2)(2009-9#1)(2012-12#1)
present a case with##4##4##(2008-12#1)(2009-4#1)(2011-1#1)(2011-2#1)
present a case##257##3##(1990-3#1)(1991-3#1)(1991-6#2)(1992-12#1)(1993-5#2)(1995-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#2)(2007-12#2)(2007-2#2)(2007-3#2)(2007-5#4)(2007-6#2)(2007-7#7)(2007-8#13)(2007-9#2)(2008-10#4)(2008-11#2)(2008-12#9)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#5)(2008-7#12)(2008-8#3)(2008-9#3)(2009-1#2)(2009-10#1)(2009-3#1)(2009-4#5)(2009-5#1)(2009-6#2)(2009-8#2)(2009-9#3)(2010-11#1)(2010-12#6)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#4)(2010-6#3)(2010-7#4)(2010-8#3)(2010-9#5)(2011-1#4)(2011-12#3)(2011-2#16)(2012-1#1)(2012-11#1)(2012-12#25)(2012-2#13)(2012-3#6)(2013-1#32)(2013-7#4)(2013-8#3)
present a challenge to##3##4##(2005-11#1)(2009-5#1)(2012-2#1)
present a challenge##6##3##(2005-11#1)(2006-10#1)(2009-5#1)(2009-6#1)(2012-2#1)(2013-1#1)
present a clinical case of##3##5##(2007-9#1)(2010-12#1)(2013-1#1)
present a clinical##6##3##(2006-2#1)(2007-11#1)(2007-9#1)(2008-6#1)(2010-12#1)(2013-1#1)
present a comparative study of##3##5##(2008-3#1)(2010-2#2)
present a comparative##4##3##(2007-9#1)(2008-3#1)(2010-2#2)
present a comparison between##2##4##(2006-11#1)(2008-2#1)
present a comparison##5##3##(2006-11#1)(2008-2#3)(2010-2#1)
present a comprehensive##7##3##(2005-8#1)(2008-3#2)(2010-2#1)(2011-1#1)(2012-1#1)(2012-2#1)
present a computer##2##3##(2008-10#1)(2008-2#1)
present a conceptual##5##3##(1993-3#1)(2008-2#1)(2009-12#1)(2013-1#2)
present a concise review of##2##5##(1997-4#1)(2013-1#1)
present a critical##2##3##(2008-3#1)(2012-3#1)
present a demonstration of##2##4##(2007-12#1)(2008-9#1)
present a design##5##3##(2007-12#2)(2008-2#1)(2008-3#1)(2012-2#1)
present a detailed analysis of the##2##6##(1996-12#1)(2006-7#1)
present a detailed##15##3##(1996-12#1)(1996-4#1)(2006-7#1)(2008-1#1)(2008-2#3)(2008-3#5)(2010-3#1)(2011-1#2)
present a diagnostic##2##3##(2008-3#1)(2009-6#1)
present a difficult##4##3##(1992-2#1)(2006-10#1)(2006-3#1)(2008-12#1)
present a digital##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
present a discretized##2##3##(2008-2#2)
present a discussion of##2##4##(1994-3#1)(2007-12#1)
present a dynamic##2##3##(2006-10#1)(2012-1#1)
present a few examples##2##4##(2005-3#1)(2008-10#1)
present a framework for##3##4##(1993-12#1)(2013-1#2)
present a framework##4##3##(1993-12#1)(1995-6#1)(2013-1#2)
present a general##7##3##(1990-8#1)(1995-2#1)(2006-5#1)(2007-12#1)(2008-2#2)(2008-3#1)
present a generic##2##3##(2008-6#1)(2008-9#1)
present a greater##2##3##(1994-6#1)(2008-10#1)
present a high##2##3##(2009-7#1)(2013-7#1)
present a higher##2##3##(2007-7#1)(2011-1#1)
present a major##3##3##(2007-12#1)(2008-10#1)(2010-1#1)
present a market##2##3##(1994-2#1)(2008-5#1)
present a mathematical model to##2##5##(1991-11#1)(2013-7#1)
present a mathematical model##4##4##(1991-11#1)(2008-2#1)(2008-7#1)(2013-7#1)
present a mathematical##6##3##(1991-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2013-7#1)
present a method for the##7##5##(1997-2#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#2)(2008-3#1)
present a method for##25##4##(1992-6#1)(1995-4#1)(1997-2#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#5)(2007-5#1)(2008-10#1)(2008-2#6)(2008-3#3)(2008-8#1)(2011-2#1)(2012-12#1)
present a method of##14##4##(1992-2#1)(1992-8#1)(2006-3#1)(2007-11#5)(2007-12#2)(2008-2#1)(2008-3#2)(2009-11#1)
present a method that##5##4##(2007-12#1)(2008-2#1)(2008-7#1)(2013-1#2)
present a method to##3##4##(2008-3#1)(2009-3#1)(2012-3#1)
present a method##54##3##(1992-2#1)(1992-6#1)(1992-8#1)(1993-1#1)(1995-4#1)(1997-2#1)(2006-10#1)(2006-2#1)(2006-3#1)(2007-11#6)(2007-12#11)(2007-5#1)(2008-1#1)(2008-10#1)(2008-2#8)(2008-3#7)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
present a methodology##4##3##(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)
present a model for##9##4##(1994-3#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-2#2)(2008-8#1)(2008-9#1)
present a model of##4##4##(1996-9#1)(2007-11#1)(2007-12#2)
present a model##21##3##(1994-3#1)(1995-6#1)(1996-9#1)(1997-2#1)(2006-10#1)(2007-11#2)(2007-12#4)(2007-9#1)(2008-2#3)(2008-8#2)(2008-9#3)(2012-2#1)
present a modified##4##3##(1994-6#1)(2007-11#1)(2007-8#1)(2013-7#1)
present a more##3##3##(2008-3#1)(2012-7#1)(2013-7#1)
present a new algorithm##2##4##(2008-2#1)(2008-3#1)
present a new analytical method##2##5##(2008-10#1)(2008-3#1)
present a new concept##3##4##(2006-3#1)(2006-6#1)(2007-12#1)
present a new method for##7##5##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)
present a new method to##3##5##(2008-5#1)(2013-1#2)
present a new method##17##4##(1994-9#1)(1995-4#1)(2007-11#2)(2007-12#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-12#1)(2013-1#2)
present a new technique to##3##5##(1997-3#1)(2008-3#1)(2008-5#1)
present a new technique##11##4##(1997-3#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-2#2)(2008-3#3)(2008-5#1)
present a new##95##3##(1990-12#1)(1993-8#1)(1994-9#1)(1995-4#1)(1997-3#1)(2005-11#1)(2006-10#2)(2006-3#1)(2006-6#1)(2006-9#1)(2007-11#8)(2007-12#15)(2007-6#1)(2008-10#3)(2008-11#1)(2008-2#12)(2008-3#18)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-9#1)(2010-12#1)(2010-8#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
present a newly developed##2##4##(1992-8#1)(2008-5#1)
present a novel family of##2##5##(2007-12#1)(2008-6#1)
present a novel method for##2##5##(2007-11#1)(2008-5#1)
present a novel method##5##4##(2007-11#1)(2007-12#1)(2008-2#2)(2008-5#1)
present a novel##52##3##(1992-3#1)(1994-12#1)(2006-3#1)(2007-1#1)(2007-11#13)(2007-12#13)(2008-1#1)(2008-11#1)(2008-2#6)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-12#1)(2012-1#1)
present a number of##3##4##(1990-3#1)(2008-1#1)(2008-7#1)
present a particular##2##3##(1990-7#1)(2010-9#1)
present a patient who developed##3##5##(2006-7#1)(2008-1#1)(2011-1#1)
present a patient who##6##4##(1990-9#1)(2006-7#1)(2008-1#1)(2011-1#1)(2013-1#2)
present a patient with a##4##5##(2007-8#1)(2009-11#1)(2009-8#1)(2012-12#1)
present a patient with##23##4##(1993-8#1)(1996-12#1)(2005-11#1)(2006-10#1)(2007-8#4)(2007-9#1)(2008-12#3)(2008-9#2)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#1)(2012-12#1)(2013-1#3)(2013-7#1)
present a patient##30##3##(1990-9#1)(1993-8#1)(1996-12#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-12#3)(2008-6#1)(2008-9#2)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#1)(2011-1#1)(2012-12#1)(2013-1#5)(2013-7#1)
present a perspective##3##3##(2008-12#1)(2011-2#1)(2012-2#1)
present a preliminary##3##3##(2011-1#1)(2012-2#1)(2013-8#1)
present a problem for##2##4##(2008-10#1)(2011-2#1)
present a problem in##2##4##(1997-2#1)(2008-8#1)
present a problem##4##3##(1997-2#1)(2008-10#1)(2008-8#1)(2011-2#1)
present a procedure##4##3##(2007-12#2)(2008-3#1)(2009-12#1)
present a project##2##3##(1990-3#1)(2012-12#1)
present a quantitative##3##3##(2008-2#1)(2008-8#1)(2012-2#1)
present a rare case of##9##5##(2008-10#2)(2008-6#1)(2008-9#2)(2011-2#2)(2012-12#1)(2013-1#1)
present a rare##11##3##(2008-10#2)(2008-6#1)(2008-9#2)(2009-3#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
present a regularized##2##3##(2008-2#1)(2010-1#1)
present a relatively##2##3##(1992-10#1)(2007-11#1)
present a review of the literature and##2##7##(2008-4#1)(2008-9#1)
present a review of the literature on##3##7##(2007-3#1)(2007-4#1)(2008-2#1)
present a review of the literature##8##6##(1996-3#1)(2007-3#1)(2007-4#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-6#1)(2012-2#1)
present a review of the##10##5##(1996-3#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-6#1)(2012-12#1)(2012-2#1)
present a review of##13##4##(1996-3#1)(2007-3#1)(2007-4#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)(2009-5#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-2#1)
present a review##15##3##(1996-3#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)(2009-5#2)(2010-6#1)(2012-1#1)(2012-12#1)(2012-2#1)
present a series of##13##4##(1990-9#1)(1997-2#1)(2006-12#2)(2007-3#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-9#1)(2010-4#1)(2012-12#1)(2012-2#1)
present a serious##5##3##(1997-3#1)(2007-5#1)(2008-11#1)(2008-7#1)(2012-2#1)
present a set of##4##4##(2006-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
present a short##2##3##(2006-4#1)(2007-11#1)
present a simple and##4##4##(2008-8#1)(2009-5#1)(2010-12#1)(2010-4#1)
present a simple approach##2##4##(2008-9#1)(2011-1#1)
present a simple method##2##4##(2008-3#1)(2010-9#1)
present a simple technique for##2##5##(2007-11#1)(2008-3#1)
present a simple technique##3##4##(2006-3#1)(2007-11#1)(2008-3#1)
present a simple##29##3##(2006-3#1)(2007-11#4)(2007-12#3)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#5)(2008-7#1)(2008-8#1)(2008-9#3)(2009-5#2)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
present a simulation study of##2##5##(1993-4#1)(2010-8#1)
present a simulation##3##3##(1993-4#1)(2008-2#1)(2010-8#1)
present a single##2##3##(2008-1#1)(2011-1#1)
present a statistical##3##3##(1993-1#1)(2008-12#1)(2008-2#1)
present a strategy##5##3##(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#1)
present a study of##2##4##(1994-5#1)(2007-7#1)
present a study##8##3##(1990-3#1)(1994-5#1)(2007-7#1)(2008-8#1)(2012-3#2)(2013-1#2)
present a summary of the##3##5##(1992-6#1)(1993-6#1)(2009-12#1)
present a survey of##2##4##(2008-1#1)(2012-1#1)
present a synthetic##2##3##(2008-7#1)(2013-1#1)
present a systematic##10##3##(2007-5#1)(2008-2#4)(2008-7#1)(2009-10#1)(2011-2#1)(2012-11#2)
present a technique for measuring##2##5##(2007-11#2)
present a technique for##9##4##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2013-1#1)
present a technique##11##3##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#3)(2013-1#1)
present a thorough##2##3##(1993-1#1)(2008-2#1)
present a two-step##2##3##(2008-2#1)(2009-5#1)
present a typology##2##3##(2010-12#1)(2012-12#1)
present a unified##2##3##(2008-3#1)(2009-5#1)
present a unique surgical challenge##2##5##(2006-5#1)(2007-12#1)
present a unique##6##3##(2006-4#1)(2006-5#2)(2007-12#1)(2007-2#1)(2008-3#1)
present a variety of##2##4##(2008-7#1)(2010-11#1)
present a##1131##2##(1990-1#1)(1990-12#1)(1990-3#5)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#3)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-6#3)(1992-8#2)(1993-1#3)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#1)(1993-8#3)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#5)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#2)(1995-6#3)(1996-1#1)(1996-11#2)(1996-12#5)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-9#3)(1997-2#4)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#3)(2005-10#2)(2005-11#4)(2005-12#1)(2005-3#1)(2005-8#1)(2006-1#2)(2006-10#16)(2006-11#2)(2006-12#5)(2006-2#4)(2006-3#7)(2006-4#2)(2006-5#5)(2006-6#2)(2006-7#4)(2006-8#2)(2006-9#3)(2007-1#1)(2007-10#4)(2007-11#57)(2007-12#97)(2007-2#3)(2007-3#5)(2007-4#2)(2007-5#10)(2007-6#3)(2007-7#14)(2007-8#32)(2007-9#9)(2008-1#13)(2008-10#27)(2008-11#15)(2008-12#18)(2008-2#87)(2008-3#102)(2008-4#5)(2008-5#11)(2008-6#18)(2008-7#33)(2008-8#19)(2008-9#22)(2009-1#2)(2009-10#3)(2009-11#3)(2009-12#3)(2009-3#4)(2009-4#6)(2009-5#9)(2009-6#7)(2009-7#2)(2009-8#4)(2009-9#10)(2010-1#2)(2010-10#2)(2010-11#4)(2010-12#14)(2010-2#10)(2010-3#3)(2010-4#5)(2010-5#6)(2010-6#5)(2010-7#5)(2010-8#7)(2010-9#10)(2011-1#17)(2011-12#4)(2011-2#30)(2012-1#6)(2012-11#4)(2012-12#37)(2012-2#31)(2012-3#16)(2012-7#1)(2013-1#69)(2013-7#15)(2013-8#10)
present account##3##2##(2006-9#1)(2007-12#2)
present added##2##2##(2007-1#1)(2012-12#1)
present after the##3##3##(1991-11#1)(1992-7#1)(2013-1#1)
present after##11##2##(1990-7#1)(1991-11#2)(1992-3#1)(1992-6#1)(1992-7#1)(1993-12#1)(1997-5#1)(2006-5#1)(2007-12#1)(2013-1#1)
present algorithms for##2##3##(2008-6#1)(2009-12#1)
present alone##2##2##(2008-10#2)
present along the##2##3##(1990-8#1)(2009-2#1)
present along with##2##3##(2006-9#1)(2013-7#1)
present along##5##2##(1990-8#2)(2006-9#1)(2009-2#1)(2013-7#1)
present also in##3##3##(1990-11#1)(1991-9#1)(1994-8#1)
present also##6##2##(1990-11#1)(1991-9#1)(1994-8#1)(2006-6#1)(2008-1#1)(2008-4#1)
present among the##2##3##(2005-11#1)(2008-10#1)
present among##9##2##(2005-11#1)(2008-10#3)(2008-5#1)(2008-9#1)(2009-5#1)(2012-1#1)(2012-12#1)
present an account##2##3##(1990-3#1)(2012-2#1)
present an adult##2##3##(2012-12#1)(2013-1#1)
present an algorithm for##7##4##(2007-12#1)(2008-2#4)(2008-3#1)(2013-1#1)
present an algorithm##11##3##(2007-12#1)(2008-2#6)(2008-3#3)(2013-1#1)
present an alternative derivation##2##4##(2008-2#1)(2008-3#1)
present an alternative method##2##4##(2007-11#1)(2008-9#1)
present an alternative##5##3##(2007-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-4#1)
present an analysis of the##4##5##(1995-8#1)(2008-2#1)(2008-3#1)(2008-7#1)
present an analysis of##10##4##(1995-8#1)(2007-7#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#1)(2009-5#1)(2010-9#1)
present an analysis##12##3##(1995-8#2)(2006-8#1)(2007-7#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#1)(2009-5#1)(2010-9#1)
present an analytical method for##2##5##(2007-12#1)(2008-2#1)
present an analytical##5##3##(2007-11#1)(2007-12#1)(2008-2#3)
present an application##2##3##(2008-2#1)(2013-1#1)
present an approach##9##3##(1996-8#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#3)(2011-1#1)
present an argument for##2##4##(2006-7#1)(2012-1#1)
present an efficient##4##3##(2007-11#1)(2007-12#1)(2008-6#1)(2013-7#1)
present an evaluation of the##5##5##(2008-3#1)(2013-1#4)
present an evaluation of##6##4##(2008-3#1)(2012-3#1)(2013-1#4)
present an example of##4##4##(2007-12#1)(2008-10#1)(2008-8#1)(2010-3#1)
present an experimental##10##3##(2007-11#1)(2007-12#4)(2008-2#3)(2009-8#1)(2012-2#1)
present an extremely##3##3##(1993-8#1)(2006-10#1)(2013-1#1)
present an imaging##2##3##(2006-10#1)(2008-3#1)
present an improved##2##3##(2008-2#1)(2008-3#1)
present an increased##2##3##(1996-11#1)(2007-7#1)
present an integrated##2##3##(2009-6#1)(2010-2#1)
present an interesting case of##3##5##(2008-10#1)(2011-1#1)(2012-2#1)
present an interferometric##2##3##(2007-11#1)(2008-2#1)
present an inversion##2##3##(2008-3#2)
present an investigation of the##2##5##(2008-2#1)(2009-5#1)
present an investigation of##3##4##(2008-2#1)(2009-5#1)(2011-12#1)
present an investigation##4##3##(2007-11#1)(2008-2#1)(2009-5#1)(2011-12#1)
present an opportunity to##2##4##(2006-10#1)(2011-12#1)
present an optical##7##3##(2007-12#1)(2008-2#3)(2008-3#3)
present an overview of the current##2##6##(2006-10#1)(2010-2#1)
present an overview of the##21##5##(2005-7#1)(2006-10#1)(2007-1#1)(2008-11#1)(2008-3#2)(2008-4#3)(2008-5#1)(2009-6#1)(2010-1#1)(2010-2#1)(2010-8#1)(2012-3#2)(2013-1#5)
present an overview of this##2##5##(2010-5#1)(2011-2#1)
present an overview of##31##4##(2005-7#1)(2006-10#1)(2007-1#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#3)(2008-5#2)(2009-11#1)(2009-6#1)(2010-1#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-3#2)(2013-1#5)
present an overview##33##3##(2005-7#1)(2006-10#1)(2007-1#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#3)(2008-5#2)(2009-11#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-3#2)(2013-1#5)
present an unusual case of##9##5##(2006-8#1)(2008-10#1)(2008-9#1)(2010-3#1)(2010-6#1)(2011-1#2)(2012-11#1)(2013-1#1)
present an unusual case##11##4##(2006-8#1)(2008-10#1)(2008-9#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#3)(2012-11#1)(2013-1#1)
present an unusual##12##3##(2006-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#3)(2012-11#1)(2013-1#1)
present an updated##2##3##(2007-3#1)(2012-12#1)
present an##235##2##(1990-3#1)(1990-7#1)(1991-8#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-12#1)(1995-8#2)(1996-11#1)(1996-8#1)(1997-1#1)(1997-3#3)(2005-11#3)(2005-7#1)(2006-10#6)(2006-7#1)(2006-8#2)(2007-1#2)(2007-10#1)(2007-11#9)(2007-12#18)(2007-3#3)(2007-5#2)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#32)(2008-3#29)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#5)(2008-9#2)(2009-10#2)(2009-11#2)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#5)(2010-9#3)(2011-1#8)(2011-12#3)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#16)(2013-7#2)
present analysis is##2##3##(1991-5#1)(2012-3#1)
present analysis##9##2##(1991-5#1)(1993-12#1)(1997-6#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-4#1)(2012-3#1)
present analytical##5##2##(2007-12#2)(2008-10#1)(2008-2#2)
present and analyse##3##3##(2007-9#1)(2008-10#1)(2008-11#1)
present and discuss results from##2##5##(2008-3#1)(2010-4#1)
present and discuss the##4##4##(2005-7#1)(2007-4#1)(2008-3#1)(2008-5#1)
present and discuss##7##3##(2005-7#1)(2007-4#1)(2008-3#2)(2008-5#1)(2010-4#1)(2013-1#1)
present and future of##5##4##(1995-12#1)(2008-10#1)(2009-9#1)(2011-2#1)(2013-7#1)
present and future##37##3##(1992-12#1)(1994-2#1)(1995-12#1)(1997-1#1)(2005-5#1)(2005-8#2)(2005-9#1)(2006-10#1)(2006-2#1)(2007-2#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
present and in##2##3##(2008-4#1)(2008-5#1)
present and previous##2##3##(1996-5#1)(2010-8#1)
present and##103##2##(1990-10#1)(1990-12#1)(1991-11#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-4#1)(1996-4#1)(1996-5#1)(1997-1#1)(2005-5#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-2#2)(2007-4#4)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
present another##4##2##(2007-12#1)(2008-5#1)(2008-7#1)(2012-2#1)
present antigens to T cells##2##5##(1991-11#1)(2006-6#1)
present antigens to##3##3##(1991-11#1)(1995-12#1)(2006-6#1)
present apparatus##2##2##(2008-10#1)(2008-2#1)
present application##2##2##(2008-10#2)
present approach##8##2##(1993-11#1)(1995-8#1)(2006-5#1)(2007-11#1)(2008-10#3)(2010-7#1)
present are##4##2##(1992-12#1)(2006-2#1)(2008-10#2)
present article examines##3##3##(2008-10#1)(2009-3#1)(2009-4#1)
present article highlights##3##3##(2008-10#1)(2008-11#2)
present article is##8##3##(1994-6#1)(2008-11#2)(2010-12#1)(2012-12#1)(2012-2#3)
present article provides a##3##4##(2007-11#1)(2008-11#1)(2013-8#1)
present article provides##7##3##(2007-11#1)(2008-11#2)(2009-2#1)(2011-2#2)(2013-8#1)
present article reports##6##3##(1992-1#1)(1995-8#1)(1996-7#1)(2006-7#1)(2007-12#1)(2008-7#1)
present article##109##2##(1990-12#1)(1990-6#1)(1990-8#1)(1991-5#1)(1991-9#1)(1992-1#1)(1994-10#1)(1994-6#1)(1995-8#2)(1996-7#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#4)(2007-12#5)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#4)(2008-11#22)(2008-12#1)(2008-4#3)(2008-5#2)(2008-7#4)(2008-8#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-6#2)(2010-7#1)(2010-9#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#1)(2013-8#1)
present as a minor##2##4##(2008-10#1)(2012-1#1)
present as a single copy##4##5##(1990-10#1)(1993-2#1)(1997-4#1)(2008-8#1)
present as a##27##3##(1990-10#2)(1992-11#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-12#1)(1995-2#1)(1997-4#1)(1997-6#1)(2007-6#2)(2008-10#3)(2008-2#1)(2008-6#1)(2008-8#1)(2009-10#1)(2011-12#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
present as an##7##3##(1992-2#1)(2007-1#1)(2007-8#2)(2012-12#1)(2013-1#2)
present as multiple##4##3##(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
present as well##3##3##(1995-10#1)(2008-1#1)(2008-4#1)
present as##89##2##(1990-10#2)(1990-12#1)(1990-2#1)(1990-8#1)(1991-10#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-2#4)(1992-4#1)(1992-9#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-10#1)(1995-2#1)(1996-2#4)(1997-4#1)(1997-6#1)(2005-10#1)(2006-10#3)(2006-12#1)(2007-1#1)(2007-6#2)(2007-7#3)(2007-8#3)(2008-1#2)(2008-10#10)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#2)(2008-8#2)(2009-10#1)(2009-8#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#4)
present at a concentration##2##4##(1996-5#1)(2008-2#1)
present at a frequency of##2##5##(2008-10#1)(2011-2#1)
present at a higher##2##4##(1996-11#1)(2006-12#1)
present at a level##3##4##(1991-12#1)(1994-7#1)(2008-10#1)
present at a##16##3##(1990-5#1)(1991-12#1)(1993-8#1)(1994-3#1)(1994-7#1)(1996-11#1)(1996-5#1)(2006-12#1)(2008-10#4)(2008-12#1)(2008-2#1)(2010-7#1)(2011-2#1)
present at all##3##3##(1993-9#1)(2006-10#1)(2008-3#1)
present at approximately##2##3##(1990-10#1)(2011-3#1)
present at birth##4##3##(2008-1#1)(2008-11#1)(2011-1#1)(2012-3#1)
present at both##2##3##(1995-1#1)(1996-5#1)
present at concentrations##2##3##(2008-10#1)(2012-12#1)
present at detectable levels##2##4##(1990-10#1)(2008-10#1)
present at diagnosis##2##3##(2004-1#1)(2011-2#1)
present at different##2##3##(2005-11#1)(2012-3#1)
present at high concentration in##2##5##(1996-8#1)(1997-3#1)
present at high concentrations in##2##5##(1991-8#1)(2008-10#1)
present at high concentrations##3##4##(1991-8#1)(2008-10#1)(2008-8#1)
present at high##6##3##(1991-8#1)(1995-10#1)(1996-8#1)(1997-3#1)(2008-10#1)(2008-8#1)
present at levels##2##3##(2004-11#1)(2008-10#1)
present at low concentration##2##4##(2004-2#1)(2008-10#1)
present at low concentrations##2##4##(1991-9#1)(2007-12#1)
present at low##9##3##(1991-9#1)(1993-9#1)(1994-8#1)(1995-11#1)(2004-2#1)(2007-12#1)(2008-10#1)(2008-9#1)(2010-6#1)
present at only##2##3##(1994-9#1)(1997-4#1)
present at position##2##3##(2008-4#1)(2009-3#1)
present at the cell surface and##2##6##(1993-6#1)(2010-4#1)
present at the ends of##2##5##(1991-8#1)(2008-4#1)
present at the highest##2##4##(1996-6#1)(2008-10#1)
present at the periphery##2##4##(2013-1#1)(2013-8#1)
present at the##39##3##(1991-5#1)(1991-8#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-8#1)(1995-9#1)(1996-5#1)(1996-6#2)(1996-8#2)(1997-2#1)(2006-12#1)(2006-6#2)(2006-9#1)(2007-12#1)(2008-10#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
present at##161##2##(1990-10#4)(1990-12#1)(1990-4#1)(1990-5#2)(1990-7#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-5#3)(1991-8#2)(1991-9#2)(1992-1#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-3#4)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#2)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-11#2)(1996-4#1)(1996-5#3)(1996-6#2)(1996-8#3)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#2)(2004-1#1)(2004-11#1)(2004-2#1)(2004-4#2)(2005-11#1)(2006-10#2)(2006-12#2)(2006-6#2)(2006-9#1)(2007-11#1)(2007-12#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#24)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#1)(2009-3#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#1)
present author##2##2##(2008-3#1)(2012-2#1)
present because##2##2##(2008-3#2)
present before the##3##3##(1990-2#1)(1990-8#1)(2004-1#1)
present before##9##2##(1990-2#1)(1990-8#1)(1995-11#1)(1996-9#1)(1997-5#1)(2004-1#1)(2008-3#1)(2009-3#1)(2010-12#1)
present between the##4##3##(1990-12#1)(1990-4#1)(2008-5#1)(2008-7#1)
present between##7##2##(1990-12#1)(1990-4#1)(1996-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-1#1)
present biological##2##2##(2008-9#1)(2012-1#1)
present both in##4##3##(1992-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
present both##18##2##(1992-2#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-6#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)
present but##6##2##(1991-12#1)(1994-8#1)(2007-12#1)(2008-11#1)(2011-1#1)(2013-7#1)
present by##2##2##(2006-1#1)(2008-1#1)
present can##2##2##(1994-11#1)(2012-2#1)
present case report##16##3##(1990-8#1)(1993-1#1)(1994-7#1)(1997-7#1)(2007-12#4)(2008-7#1)(2009-8#1)(2009-9#1)(2012-2#2)(2013-1#2)(2013-8#1)
present case reports of three patients who successfully underwent##2##9##(2008-11#2)
present case studies##2##3##(1994-2#1)(2013-1#1)
present case was##4##3##(1997-7#1)(2007-12#1)(2007-7#1)(2008-5#1)
present case##65##2##(1990-10#1)(1990-5#1)(1990-8#1)(1993-1#1)(1994-2#1)(1994-7#1)(1995-4#1)(1996-2#1)(1997-7#2)(2004-12#1)(2005-10#1)(2006-4#2)(2007-10#1)(2007-11#1)(2007-12#7)(2007-2#1)(2007-7#3)(2007-8#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
present cases##3##2##(1993-6#1)(1994-6#1)(1997-3#1)
present challenges##4##2##(2008-10#1)(2010-5#1)(2011-1#2)
present classification systems##2##3##(2013-7#2)
present clear evidence##2##3##(2007-12#1)(2013-1#1)
present clinical##8##2##(1990-10#1)(1990-5#1)(1997-4#1)(2006-3#1)(2007-12#1)(2007-8#1)(2011-2#1)(2013-1#1)
present clinically##2##2##(2008-11#1)(2012-2#1)
present clinicians with##2##3##(2006-12#1)(2008-7#1)
present commentary discusses##2##3##(2008-10#1)(2010-9#1)
present commentary##5##2##(1996-6#1)(2008-10#1)(2008-11#1)(2010-9#1)(2012-2#1)
present communication##6##2##(1990-12#1)(1991-12#1)(1993-8#1)(2008-8#1)(2012-12#1)(2012-3#1)
present contribution##3##2##(2006-6#1)(2008-5#1)(2008-6#1)
present current##3##2##(2006-10#1)(2010-12#1)(2012-2#1)
present data and##2##3##(1991-1#1)(2008-7#1)
present data are##3##3##(1990-10#1)(1995-5#1)(1995-7#1)
present data demonstrate that##4##4##(1991-10#1)(1996-6#1)(1997-5#1)(2008-5#1)
present data demonstrate##5##3##(1991-10#1)(1996-6#1)(1997-5#1)(2008-10#1)(2008-5#1)
present data from##4##3##(1992-11#1)(2005-11#1)(2008-7#1)(2013-8#1)
present data indicate that##6##4##(1991-2#1)(1993-8#1)(1995-1#1)(1995-12#1)(1995-7#1)(1997-5#1)
present data indicate##9##3##(1990-7#1)(1990-8#1)(1991-2#1)(1993-8#1)(1995-1#1)(1995-12#1)(1995-7#1)(1997-5#1)(2008-8#1)
present data on##4##3##(1994-9#1)(2008-6#1)(2009-10#1)(2011-2#1)
present data regarding##2##3##(2011-2#1)(2012-3#1)
present data showing that##2##4##(1991-9#1)(2008-5#1)
present data suggest that##5##4##(1994-3#1)(1995-12#1)(1996-6#1)(2007-9#1)(2008-12#1)
present data suggest##8##3##(1991-1#1)(1992-3#1)(1994-3#1)(1995-12#1)(1996-6#1)(2007-9#1)(2008-12#1)(2008-7#1)
present data suggesting that##2##4##(2005-12#1)(2009-8#1)
present data that##6##3##(1992-7#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-2#1)
present data##75##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-7#2)(1990-8#1)(1991-1#2)(1991-10#1)(1991-2#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-3#2)(1992-7#1)(1993-1#1)(1993-3#1)(1993-8#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-5#1)(1995-7#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#3)(1997-2#2)(1997-4#1)(1997-5#2)(2005-11#1)(2005-12#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-2#1)(2009-8#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
present day##13##2##(1990-4#1)(1992-3#1)(2006-8#2)(2007-5#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-6#1)(2010-3#1)(2010-7#2)(2012-3#1)
present design##2##2##(2008-2#1)(2009-10#1)
present detailed##3##2##(1994-3#1)(2008-2#1)(2008-6#1)
present device##2##2##(2006-6#1)(2008-2#1)
present diagnostic##2##2##(1994-6#1)(1997-8#1)
present different##7##2##(1992-11#1)(2006-6#1)(2007-11#1)(2007-3#1)(2008-5#1)(2009-8#1)(2010-12#1)
present difficult##2##2##(2005-7#1)(2008-10#1)
present difficulties in##3##3##(1993-9#1)(2005-11#1)(2010-8#1)
present difficulties##4##2##(1993-9#1)(2005-11#1)(2008-4#1)(2010-8#1)
present discussion##3##2##(1996-8#1)(2006-7#1)(2007-8#1)
present during the##6##3##(1994-2#1)(2006-4#1)(2006-5#2)(2007-12#1)(2008-10#1)
present during##27##2##(1990-11#1)(1990-7#1)(1991-5#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-5#1)(1994-6#2)(2006-4#1)(2006-5#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-2#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
present early##4##2##(1993-2#1)(2008-3#1)(2011-2#1)(2013-1#1)
present either##4##2##(1994-6#1)(2006-8#1)(2008-3#1)(2011-2#1)
present electrochemical##2##2##(1996-11#1)(2008-10#1)
present epidemiological##3##2##(1990-6#1)(1992-5#1)(2009-5#1)
present estimates##2##2##(1992-12#1)(2010-11#1)
present even in the##2##4##(1990-2#1)(2008-4#1)
present even in##4##3##(1990-2#1)(2005-8#1)(2006-2#1)(2008-4#1)
present even##6##2##(1990-2#1)(1991-9#1)(2005-8#1)(2006-2#1)(2008-4#1)(2011-2#1)
present evidence for the##4##4##(1992-4#1)(1993-2#1)(1996-5#1)(2007-8#1)
present evidence for##8##3##(1992-4#1)(1993-2#1)(1994-8#1)(1996-5#1)(2007-8#1)(2008-6#1)(2008-7#1)(2008-9#1)
present evidence suggesting that##2##4##(2008-10#1)(2011-1#1)
present evidence supporting the##2##4##(2007-3#1)(2009-7#1)
present evidence that the##5##4##(1990-11#1)(1994-11#1)(2006-11#1)(2008-6#1)(2011-1#1)
present evidence that this##2##4##(2006-7#1)(2008-2#1)
present evidence that##24##3##(1990-11#1)(1991-5#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-1#1)(1996-5#2)(1996-9#1)(1997-6#1)(2006-11#1)(2006-7#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-2#2)(2011-1#2)(2012-1#1)(2012-12#1)
present evidence##51##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-5#1)(1991-9#1)(1992-4#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1996-11#1)(1996-5#3)(1996-9#1)(1997-6#1)(2006-10#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-10#1)(2009-7#1)(2010-2#2)(2011-1#3)(2012-1#1)(2012-12#1)
present examples of##8##3##(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-5#1)
present examples which##2##3##(1990-8#1)(2006-9#1)
present examples##10##2##(1990-8#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-5#1)
present exclusively in##2##3##(1995-3#1)(1995-9#1)
present experience##2##2##(1991-6#1)(2005-9#1)
present experiment is to##2##4##(1995-5#1)(2010-10#1)
present experiment showed that##2##4##(2008-12#1)(2008-9#1)
present experiment was##4##3##(1992-7#1)(1997-8#1)(2008-11#1)(2008-8#1)
present experiment##23##2##(1990-2#1)(1992-10#2)(1992-7#2)(1992-9#1)(1993-11#1)(1994-3#1)(1995-12#1)(1995-5#1)(1997-2#1)(1997-5#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-11#1)(2010-10#1)(2011-2#2)
present experimental and##3##3##(2006-12#1)(2007-11#1)(2008-3#1)
present experimental data on the##2##5##(2008-2#1)(2009-3#1)
present experimental data##6##3##(1990-8#1)(1995-3#1)(2008-2#2)(2008-3#1)(2009-3#1)
present experimental evidence that##4##4##(1995-8#1)(2005-11#1)(2008-2#1)(2008-9#1)
present experimental evidence##9##3##(1995-8#1)(2005-11#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#2)(2008-9#1)
present experimental results for##2##4##(2008-2#1)(2008-3#1)
present experimental results from##2##4##(2007-12#1)(2008-3#1)
present experimental results obtained with##2##5##(2008-2#1)(2008-3#1)
present experimental results of##5##4##(2007-11#2)(2007-12#2)(2008-2#1)
present experimental results that demonstrate the##2##6##(2008-2#1)(2008-3#1)
present experimental results##21##3##(2007-11#2)(2007-12#5)(2008-2#4)(2008-3#8)(2008-6#1)(2013-1#1)
present experimental##51##2##(1990-8#1)(1993-1#1)(1995-3#1)(1995-8#1)(1997-8#1)(2005-11#1)(2006-12#1)(2007-11#4)(2007-12#10)(2008-1#1)(2008-10#1)(2008-2#8)(2008-3#12)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-4#1)(2010-9#1)(2013-1#1)
present experimentally##2##2##(2008-3#1)(2013-8#1)
present experiments in##2##3##(2007-11#1)(2008-2#1)
present experiments we##2##3##(1996-9#1)(1997-4#1)
present experiments were designed to##2##5##(1993-3#1)(1993-6#1)
present experiments were##6##3##(1991-1#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-7#1)
present experiments##29##2##(1990-5#1)(1991-1#1)(1992-11#2)(1992-3#1)(1992-8#1)(1993-2#2)(1993-3#2)(1993-6#1)(1994-10#2)(1994-2#1)(1995-3#1)(1995-7#1)(1996-12#1)(1996-9#1)(1997-4#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#2)(2009-4#1)
present finding##2##2##(1994-11#1)(1996-7#1)
present findings demonstrate##2##3##(1993-3#1)(2008-5#1)
present findings from##2##3##(2010-2#1)(2012-3#1)
present findings of##2##3##(1990-3#1)(2010-3#1)
present findings suggest that##9##4##(1991-11#1)(1994-2#1)(1994-5#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#2)
present findings suggest##10##3##(1991-11#1)(1994-2#1)(1994-5#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#2)(2007-12#1)
present findings##30##2##(1990-3#1)(1990-9#1)(1991-11#1)(1991-5#1)(1992-8#1)(1992-9#1)(1993-3#2)(1994-2#1)(1994-5#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#3)(1997-7#1)(1997-8#2)(2007-12#1)(2008-5#1)(2008-9#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)
present first##2##2##(2007-11#1)(2008-10#1)
present five##2##2##(2011-12#1)(2011-2#1)
present focus##2##2##(2007-2#1)(2013-1#1)
present follow-up##2##2##(2008-9#1)(2012-1#1)
present for a##2##3##(1990-3#1)(2011-2#1)
present for approximately##2##3##(2005-10#1)(2007-10#1)
present for the first time##2##5##(1996-9#1)(2008-10#1)
present for the##8##3##(1996-9#1)(1997-2#1)(2005-11#1)(2008-10#2)(2010-6#1)(2011-2#1)(2013-1#1)
present for##40##2##(1990-3#1)(1990-9#1)(1992-2#1)(1992-6#1)(1995-2#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-10#1)(2005-11#3)(2006-10#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-2#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
present form##5##2##(2006-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
present formulation##2##2##(1990-8#1)(2011-2#1)
present four##9##2##(1994-6#1)(1996-1#1)(1997-3#1)(2008-2#1)(2008-3#1)(2012-11#1)(2012-12#1)(2012-2#2)
present from early##2##3##(1996-12#1)(2006-8#1)
present from the##2##3##(1992-7#1)(2008-9#1)
present from##7##2##(1991-10#1)(1992-7#1)(1996-12#1)(2006-8#1)(2008-9#1)(2009-2#1)(2009-4#1)
present fundamental##2##2##(2007-11#1)(2013-1#1)
present further##4##2##(1991-7#1)(2010-7#1)(2012-12#2)
present future##2##2##(2008-9#1)(2009-12#1)
present general##3##2##(2007-12#1)(2008-1#1)(2010-8#1)
present genetic##2##2##(2008-8#1)(2011-2#1)
present guidelines for##2##3##(1996-9#1)(2005-7#1)
present guidelines##5##2##(1996-9#1)(2005-7#1)(2007-11#1)(2008-1#1)(2008-10#1)
present here an overview of##2##5##(2008-7#1)(2011-2#1)
present here the##19##3##(1990-3#1)(1990-4#1)(1990-9#1)(1993-12#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-8#1)(2009-11#1)(2009-7#1)(2010-4#1)(2013-1#2)
present here##56##2##(1990-11#2)(1990-3#1)(1990-4#1)(1990-9#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-12#1)(1995-5#1)(1997-2#1)(1997-3#1)(1997-4#2)(2006-10#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
present higher##3##2##(2008-10#2)(2008-5#1)
present hypothesis##2##2##(1991-11#1)(2006-12#1)
present if##2##2##(1994-12#1)(2010-4#1)
present immunocytochemical##3##2##(1991-1#1)(1994-10#1)(2007-9#1)
present in 1##4##3##(2007-2#1)(2008-10#2)(2008-12#1)
present in 11##2##3##(2011-1#2)
present in 12##3##3##(1992-12#1)(1997-8#1)(2006-10#1)
present in 25##2##3##(2005-8#1)(2008-5#1)
present in 25%##3##3##(2007-10#1)(2009-5#1)(2010-12#1)
present in 26##2##3##(1990-9#1)(1995-6#1)
present in 3 cases##2##4##(1991-3#1)(1993-2#1)
present in 3##4##3##(1991-3#1)(1993-2#1)(1997-4#1)(2006-8#1)
present in 40##2##3##(2007-8#2)
present in 46%##3##3##(1990-9#1)(2006-10#1)(2010-4#1)
present in 50##3##3##(2005-8#1)(2007-7#1)(2007-8#1)
present in 58##2##3##(1993-5#1)(1994-7#1)
present in 60% of##2##4##(1993-12#1)(1993-9#1)
present in 60%##3##3##(1993-12#1)(1993-9#1)(2012-3#1)
present in 75% of##2##4##(1993-12#1)(2010-12#1)
present in 8 of##2##4##(1992-12#1)(2008-11#1)
present in 8##3##3##(1991-5#1)(1992-12#1)(2008-11#1)
present in Africa##3##3##(1990-12#1)(2008-4#2)
present in Alzheimer's##2##3##(1991-11#1)(1996-1#1)
present in C##3##3##(1991-9#1)(2008-10#1)(2008-8#1)
present in Drosophila##3##3##(1990-12#1)(1991-5#1)(1997-6#1)
present in Europe##2##3##(2007-8#1)(2008-10#1)
present in GenBank##2##3##(2006-8#1)(2008-10#1)
present in L1##3##3##(1993-12#2)(2008-10#1)
present in S##2##3##(1995-6#1)(2008-11#1)
present in a cell##4##4##(2008-4#2)(2008-9#1)(2013-7#1)
present in a complex##2##4##(1992-11#1)(1994-8#1)
present in a high##4##4##(1990-4#1)(1992-3#1)(2008-10#1)(2009-5#1)
present in a large##3##4##(2008-10#1)(2009-5#1)(2012-11#1)
present in a low##3##4##(1992-3#1)(1994-9#1)(2012-2#1)
present in a number of##5##5##(1995-2#1)(1995-5#1)(1996-12#1)(1997-1#1)(2008-5#1)
present in a range of##2##5##(1991-12#1)(1994-2#1)
present in a sample##2##4##(2008-10#1)(2008-4#1)
present in a single copy##2##5##(1992-11#1)(1993-6#1)
present in a single##4##4##(1992-11#1)(1993-6#1)(2010-1#1)(2012-12#1)
present in a small##2##4##(1990-4#1)(2008-4#1)
present in a variety of##5##5##(1991-2#1)(1992-6#1)(2006-10#1)(2008-4#1)(2012-3#1)
present in a wide variety of##2##6##(2007-12#1)(2009-3#1)
present in a##90##3##(1990-11#1)(1990-4#2)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-11#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-3#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-2#3)(2008-4#9)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#2)(2010-1#1)(2010-11#1)(2010-4#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-7#1)
present in about 50% of##2##5##(1996-1#1)(2011-2#1)
present in about##7##3##(1991-11#1)(1996-1#1)(2008-1#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#1)
present in adult##3##3##(1995-5#1)(1997-7#1)(2006-9#1)
present in all known##2##4##(1995-2#1)(2008-10#1)
present in all patients##2##4##(2007-2#1)(2007-8#1)
present in all the##6##4##(1990-11#1)(1996-7#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-7#1)
present in all three##3##4##(2006-10#1)(2007-12#1)(2008-10#1)
present in all##58##3##(1990-11#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-4#1)(1992-11#1)(1992-12#1)(1992-8#2)(1993-8#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-7#1)(2005-10#2)(2005-7#1)(2005-8#1)(2006-10#1)(2006-8#2)(2007-10#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#3)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
present in almost##3##3##(1990-9#1)(1993-4#1)(1993-5#1)
present in an##8##3##(1993-8#1)(1994-8#1)(1996-11#1)(2006-10#1)(2007-12#1)(2010-7#1)(2011-1#1)(2011-2#1)
present in approximately##2##3##(1990-7#1)(2012-2#1)
present in aqueous solution##2##4##(2005-11#1)(2008-10#1)
present in aqueous##5##3##(1992-9#1)(2005-11#1)(2007-8#1)(2008-10#2)
present in as##2##3##(1996-4#1)(2004-3#1)
present in at least one##2##5##(2004-9#1)(2009-4#1)
present in at least##5##4##(1990-10#1)(1996-5#1)(2004-9#1)(2009-4#1)(2010-3#1)
present in atherosclerotic##2##3##(1992-5#1)(2006-6#1)
present in biological fluids##4##4##(1996-12#1)(1997-7#1)(2008-10#1)(2010-11#1)
present in biological##6##3##(1996-12#1)(1997-7#1)(2007-6#1)(2008-10#2)(2010-11#1)
present in blood##2##3##(2007-11#1)(2008-10#1)
present in body fluids##2##4##(1990-12#1)(1995-5#1)
present in both groups##2##4##(2006-8#1)(2007-2#1)
present in both the##9##4##(1990-8#1)(1995-3#1)(1995-8#1)(1997-4#2)(2010-4#1)(2010-5#1)(2012-3#1)(2013-7#1)
present in both##28##3##(1990-10#1)(1990-8#1)(1991-6#1)(1992-8#1)(1993-4#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-8#1)(1997-4#3)(1997-5#1)(2005-8#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-2#1)(2008-10#2)(2010-4#1)(2010-5#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-7#1)
present in bovine brain##3##4##(1990-5#1)(1993-4#1)(1994-9#1)
present in bovine##4##3##(1990-5#1)(1992-4#1)(1993-4#1)(1994-9#1)
present in brain and##2##4##(1990-7#1)(1996-12#1)
present in brain##4##3##(1990-7#1)(1991-6#1)(1992-8#1)(1996-12#1)
present in carrot##2##3##(2008-10#1)(2008-9#1)
present in cell extracts##2##4##(1994-11#1)(2008-4#1)
present in cell##3##3##(1994-11#1)(1996-5#1)(2008-4#1)
present in cells in which##2##5##(1990-11#1)(1997-6#1)
present in cells of the##2##5##(1995-12#1)(1997-7#1)
present in cells of##3##4##(1992-5#1)(1995-12#1)(1997-7#1)
present in cells##7##3##(1990-11#1)(1991-5#1)(1992-5#1)(1995-12#1)(1997-6#1)(1997-7#1)(2008-1#1)
present in childhood##3##3##(2005-10#1)(2008-4#1)(2013-1#1)
present in cholinergic##2##3##(1992-6#1)(1994-3#1)
present in chromatin of##2##4##(1991-2#2)
present in columns##2##3##(2013-1#2)
present in cornea##2##3##(2008-4#2)
present in cultured##2##3##(1991-2#1)(1992-8#1)
present in cytosol##4##3##(1990-3#1)(1994-6#1)(2012-12#1)(2013-1#1)
present in databases##2##3##(1997-3#2)
present in detail##3##3##(1991-4#1)(2006-3#1)(2008-3#1)
present in different##6##3##(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2013-1#1)
present in each case##2##4##(1996-5#1)(2005-11#1)
present in each of the##3##5##(1991-2#1)(2007-6#1)(2008-10#1)
present in each##11##3##(1990-2#1)(1991-2#2)(1992-2#1)(1996-2#1)(1996-5#1)(2005-11#1)(2007-6#1)(2008-10#1)(2008-12#1)(2012-3#1)
present in early infancy##2##4##(1996-6#1)(2010-6#1)
present in early##4##3##(1991-8#1)(1996-6#1)(2008-7#1)(2010-6#1)
present in either##2##3##(2008-10#1)(2008-5#1)
present in environmental##2##3##(1997-1#1)(2008-10#1)
present in equal amounts##2##4##(1990-11#1)(2008-11#1)
present in equal##5##3##(1990-11#1)(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#1)
present in excess##3##3##(1992-6#1)(1994-11#1)(2008-10#1)
present in fish##2##3##(1994-6#1)(2008-10#1)
present in five##3##3##(1995-1#1)(2008-10#1)(2008-5#1)
present in food##2##3##(2010-5#1)(2011-2#1)
present in foods##2##3##(2008-10#1)(2012-2#1)
present in healthy##2##3##(1991-12#1)(1995-12#1)
present in high concentration in##2##5##(1991-5#1)(2004-2#1)
present in high##7##3##(1991-2#1)(1991-5#1)(1992-6#1)(1994-9#1)(2004-2#1)(2008-10#1)(2008-7#1)
present in higher##3##3##(1995-12#1)(2007-11#1)(2008-7#1)
present in hippocampal##2##3##(1991-10#1)(1993-2#1)
present in human liver and##2##5##(1993-11#1)(1995-12#1)
present in human plasma##4##4##(1990-11#2)(1997-1#1)(1997-3#1)
present in human semen##2##4##(1997-6#1)(1997-8#1)
present in human serum##3##4##(1995-2#2)(2006-10#1)
present in human urine##2##4##(1992-3#1)(1997-3#1)
present in human##27##3##(1990-11#2)(1992-3#2)(1993-11#1)(1993-4#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(1997-1#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-6#1)(2009-4#1)(2011-1#1)(2013-1#2)(2013-8#1)
present in hypothalamic##2##3##(1995-5#1)(1997-6#1)
present in individuals##2##3##(2008-10#1)(2008-8#1)
present in infancy or early childhood with##2##7##(2008-11#1)(2011-1#1)
present in infancy##3##3##(1995-11#1)(2008-11#1)(2011-1#1)
present in inhibitory##2##3##(1994-2#1)(2007-10#1)
present in irrigation water##2##4##(2008-10#2)
present in isolates##2##3##(2008-10#2)
present in large amount in##2##5##(1992-2#1)(2008-10#1)
present in large amounts##2##4##(1992-6#1)(2010-8#1)
present in large quantities##2##4##(1994-8#1)(2004-2#1)
present in large##6##3##(1992-2#1)(1992-6#1)(1994-8#1)(2004-2#1)(2008-10#1)(2010-8#1)
present in layers II##2##4##(1994-2#2)
present in leaves and##2##4##(2008-10#2)
present in leaves##3##3##(2008-10#2)(2013-1#1)
present in less##2##3##(1997-8#1)(2011-1#1)
present in liquid##2##3##(2007-12#1)(2008-10#1)
present in liver##2##3##(1990-2#1)(1992-6#1)
present in low numbers##2##4##(2007-12#1)(2008-10#1)
present in low##5##3##(1990-12#1)(1994-2#1)(1995-2#1)(2007-12#1)(2008-10#1)
present in lower##2##3##(1994-2#1)(1996-9#1)
present in mammalian##2##3##(1991-3#1)(1992-6#1)
present in many##13##3##(1991-4#1)(1992-6#1)(1993-3#1)(1993-9#1)(1996-8#1)(1997-2#1)(2005-7#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-12#1)
present in microsomes from rats fed a fat-free diet##2##9##(1991-2#2)
present in microsomes from##3##4##(1990-12#1)(1991-2#2)
present in more than half of the##2##7##(2008-3#1)(2010-12#1)
present in more than##6##4##(1993-10#1)(1994-7#1)(1997-6#1)(2008-3#1)(2010-12#1)(2011-2#1)
present in more##8##3##(1993-10#1)(1994-7#1)(1997-6#1)(2007-12#1)(2008-3#1)(2010-12#1)(2010-8#1)(2011-2#1)
present in most of##2##4##(2008-10#1)(2011-2#1)
present in most##15##3##(1990-6#1)(1991-3#1)(1992-1#1)(1992-12#1)(1993-11#1)(1995-11#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-2#1)(2010-6#1)(2011-2#1)
present in multiple##3##3##(2008-10#1)(2009-10#1)(2009-4#1)
present in native##2##3##(1993-8#1)(2008-8#1)
present in natural waters##4##4##(2008-10#4)
present in natural##7##3##(1991-5#1)(2008-10#5)(2008-5#1)
present in nearly all##3##4##(1997-2#1)(2008-10#1)(2008-2#1)
present in nearly##7##3##(1990-11#1)(1997-2#1)(2008-10#1)(2008-2#2)(2008-9#1)(2010-12#1)
present in necrotic##2##3##(2008-10#1)(2008-7#1)
present in neuronal##2##3##(1992-8#1)(1994-11#1)
present in normal##6##3##(1992-12#1)(1994-2#1)(1995-6#1)(1996-8#1)(2006-5#1)(2008-7#1)
present in nuclear extracts##2##4##(1994-2#1)(1996-8#1)
present in nuclear##3##3##(1992-12#1)(1994-2#1)(1996-8#1)
present in numerous##3##3##(1993-11#1)(1997-5#1)(2008-10#1)
present in one##5##3##(2006-1#1)(2007-6#1)(2008-2#1)(2010-10#1)(2011-12#1)
present in only one##2##4##(2008-10#1)(2010-4#1)
present in only##5##3##(1990-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-4#1)
present in other##15##3##(1990-3#1)(1991-9#1)(1992-8#1)(1993-4#1)(1994-12#1)(1995-8#1)(1996-11#1)(1997-5#1)(2006-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-5#1)(2011-2#1)
present in our##3##3##(1997-6#1)(2008-5#1)(2009-3#1)
present in patients with##7##4##(1995-2#1)(1996-5#1)(2007-11#1)(2008-5#1)(2011-2#1)(2013-8#2)
present in patients##13##3##(1995-2#1)(1995-6#1)(1996-5#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#2)(2013-8#2)
present in peripheral blood##2##4##(2008-11#2)
present in petrochemical##2##3##(2008-10#2)
present in pharmaceutical##2##3##(2008-10#1)(2012-2#1)
present in plant##4##3##(1997-5#1)(2008-10#1)(2008-7#1)(2013-1#1)
present in plants##4##3##(1991-8#1)(2008-10#2)(2011-2#1)
present in plasma##3##3##(1993-1#1)(1995-2#1)(2004-11#1)
present in primary##3##3##(1996-12#1)(2008-4#1)(2009-9#1)
present in rat brain##2##4##(1994-2#1)(1995-1#1)
present in rat##8##3##(1990-5#1)(1991-8#1)(1992-8#1)(1993-8#1)(1994-2#1)(1995-1#1)(1995-10#1)(1996-4#1)
present in real samples##4##4##(2008-10#4)
present in recombinant##2##3##(1992-12#1)(2007-3#1)
present in samples##2##3##(2008-10#2)
present in secretory##3##3##(1991-1#1)(1995-8#1)(2008-11#1)
present in sensory neurons##2##4##(1996-3#1)(2008-8#1)
present in serum##4##3##(1991-8#1)(1992-12#1)(1996-12#1)(2009-4#1)
present in several other##2##4##(1990-9#1)(1992-9#1)
present in several##8##3##(1990-9#1)(1992-9#1)(1994-10#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-7#1)
present in skeletal and cardiac##2##5##(1991-3#1)(1992-2#1)
present in small##4##3##(1991-6#1)(1996-2#1)(2004-2#1)(2010-4#1)
present in soil##2##3##(2006-10#1)(2008-10#1)
present in solution##6##3##(1994-11#1)(1994-8#1)(2006-12#1)(2008-10#3)
present in some##11##3##(1990-5#1)(1991-11#1)(1992-6#1)(1994-9#1)(2005-7#1)(2006-12#1)(2008-10#2)(2008-7#1)(2011-2#1)(2013-8#1)
present in spleen##2##3##(1991-6#1)(1992-11#1)
present in such##2##3##(1992-4#1)(2008-10#1)
present in sufficient##2##3##(1993-12#1)(2008-3#1)
present in surrounding##2##3##(1992-12#1)(2012-12#1)
present in tandem##2##3##(2008-7#1)(2013-1#1)
present in test##2##3##(2008-10#1)(2008-4#1)
present in the C##3##4##(1990-5#1)(1993-9#1)(1996-3#1)
present in the CA3##2##4##(1992-8#1)(2010-12#1)
present in the active site##2##5##(1994-5#1)(1995-10#1)
present in the adult##2##4##(1997-5#1)(2007-9#1)
present in the atmosphere##2##4##(2008-2#1)(2008-3#1)
present in the brain##2##4##(1992-9#1)(1994-2#1)
present in the cell##7##4##(1990-11#1)(1992-9#1)(1996-2#1)(1997-1#2)(2008-7#1)(2013-8#1)
present in the central nervous system##2##6##(1992-12#1)(1997-8#1)
present in the central##5##4##(1992-12#1)(1995-12#1)(1996-5#1)(1997-8#1)(2008-10#1)
present in the coding##2##4##(1993-2#1)(1997-7#1)
present in the cytoplasm as##2##5##(1994-11#1)(2008-11#1)
present in the data##2##4##(2008-10#1)(2008-2#1)
present in the diet##2##4##(1992-8#1)(1993-9#1)
present in the different##2##4##(2008-10#1)(2013-7#1)
present in the dorsal##2##4##(1991-5#1)(1993-7#1)
present in the dust that##2##5##(2008-10#2)
present in the dust##3##4##(2008-10#3)
present in the environment##3##4##(2005-9#1)(2009-10#1)(2011-1#1)
present in the environmental##2##4##(2008-10#2)
present in the extracts##2##4##(2007-1#1)(2008-5#1)
present in the fat##2##4##(1991-10#1)(1995-2#1)
present in the female##2##4##(1996-12#1)(2008-7#1)
present in the first##3##4##(1993-9#1)(1994-6#1)(2008-10#1)
present in the following##2##4##(2007-9#1)(2008-7#1)
present in the food##2##4##(1992-8#1)(2011-1#1)
present in the form of##6##5##(1992-5#1)(1994-9#1)(2006-12#1)(2008-10#2)(2013-1#1)
present in the heart##2##4##(1993-11#1)(1994-7#1)
present in the host##2##4##(1993-6#1)(2008-10#1)
present in the human genome##2##5##(1991-6#1)(2012-2#1)
present in the human##9##4##(1990-11#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-2#1)(1993-11#1)(1993-9#1)(2008-5#1)(2012-2#1)
present in the inner##3##4##(1991-9#1)(1996-6#1)(2010-8#1)
present in the intracellular##2##4##(2008-4#1)(2008-7#1)
present in the laser##3##4##(2008-3#3)
present in the literature and##2##5##(2008-7#1)(2008-8#1)
present in the literature##3##4##(2008-7#1)(2008-8#1)(2011-12#1)
present in the liver##3##4##(1992-12#1)(2005-7#1)(2008-11#1)
present in the lungs of##2##5##(1994-7#1)(2008-8#1)
present in the main##2##4##(1991-7#1)(2007-12#1)
present in the majority of##4##5##(1994-12#1)(1995-12#1)(2010-3#1)(2011-1#1)
present in the material##2##4##(2008-10#1)(2009-7#1)
present in the medium##9##4##(1992-12#1)(1993-8#1)(1995-3#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-4#1)(2012-7#1)
present in the membrane##5##4##(1990-4#1)(1991-9#1)(1993-11#1)(1995-1#1)(2006-8#1)
present in the midgut##2##4##(1994-3#1)(2008-10#1)
present in the nucleus##3##4##(1994-8#1)(2010-12#1)(2013-1#1)
present in the outer##3##4##(1991-9#1)(2007-12#1)(2009-8#1)
present in the parents##2##4##(2008-10#2)
present in the patient's##2##4##(1990-11#1)(1992-6#1)
present in the pePOA of the male##2##7##(1992-3#2)
present in the pharmaceutical##2##4##(2008-10#1)(2012-11#1)
present in the plant##2##4##(1991-8#1)(2004-2#1)
present in the plasma##4##4##(1990-11#1)(1994-6#1)(2007-1#1)(2008-10#1)
present in the preparation##2##4##(1995-6#1)(1996-1#1)
present in the previous##2##4##(2007-12#1)(2008-10#1)
present in the protein##2##4##(1994-8#1)(1995-11#1)
present in the rat##4##4##(1991-12#1)(1992-12#2)(1993-12#1)
present in the reaction medium##2##5##(1995-1#1)(2008-10#1)
present in the reaction mixture##2##5##(1991-2#1)(1991-3#1)
present in the reaction##6##4##(1991-2#1)(1991-3#1)(1995-1#1)(2008-10#3)
present in the right##2##4##(2006-8#1)(2010-12#1)
present in the same##5##4##(1991-2#1)(2008-10#3)(2010-7#1)
present in the sample solution##2##5##(2008-10#2)
present in the sample##14##4##(2008-10#11)(2008-4#2)(2010-8#1)
present in the samples##6##4##(2008-10#5)(2012-2#1)
present in the second##3##4##(1994-5#1)(2006-2#1)(2013-8#1)
present in the sediments##2##4##(2008-10#1)(2008-5#1)
present in the serum of##2##5##(2008-4#1)(2009-8#1)
present in the serum##3##4##(1994-8#1)(2008-4#1)(2009-8#1)
present in the skin##2##4##(2006-10#1)(2008-5#1)
present in the solution##6##4##(1990-2#1)(1994-2#1)(1996-11#1)(2008-10#2)(2008-5#1)
present in the structures##2##4##(1992-12#1)(1994-8#1)
present in the supernatant##3##4##(1994-12#1)(2008-10#1)(2009-10#1)
present in the system##4##4##(1992-11#2)(2008-10#1)(2008-2#1)
present in the three##2##4##(1993-8#1)(2010-4#1)
present in the tissue##2##4##(1993-8#1)(1997-4#1)
present in the tissues##2##4##(1992-9#1)(2009-5#1)
present in the type 1 repeats of##2##7##(1995-3#2)
present in the type##3##4##(1995-1#1)(1995-3#2)
present in the urine##3##4##(1990-12#2)(2006-10#1)
present in the vast majority of##2##6##(1997-6#1)(2008-6#1)
present in the water##2##4##(2008-10#1)(2008-3#1)
present in the wine##2##4##(2008-10#2)
present in the##613##3##(1990-11#6)(1990-12#7)(1990-2#1)(1990-4#4)(1990-5#3)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#7)(1991-2#4)(1991-3#3)(1991-4#1)(1991-5#4)(1991-6#3)(1991-7#4)(1991-8#4)(1991-9#8)(1992-1#2)(1992-10#1)(1992-11#5)(1992-12#8)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#3)(1992-6#4)(1992-7#4)(1992-8#4)(1992-9#4)(1993-11#4)(1993-12#4)(1993-2#1)(1993-3#4)(1993-4#1)(1993-6#7)(1993-7#2)(1993-8#6)(1993-9#5)(1994-11#4)(1994-12#9)(1994-2#3)(1994-3#7)(1994-5#3)(1994-6#3)(1994-7#3)(1994-8#8)(1994-9#6)(1995-1#5)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#7)(1995-4#2)(1995-5#5)(1995-6#1)(1995-8#4)(1995-9#3)(1996-1#2)(1996-11#2)(1996-12#5)(1996-2#1)(1996-3#4)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#5)(1997-2#3)(1997-3#4)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#3)(1997-8#1)(2004-2#3)(2004-3#1)(2004-4#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-7#4)(2005-9#1)(2006-1#1)(2006-10#7)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-8#2)(2006-9#1)(2007-1#4)(2007-10#1)(2007-11#2)(2007-12#10)(2007-2#1)(2007-3#3)(2007-5#2)(2007-8#6)(2007-9#2)(2008-1#6)(2008-10#103)(2008-11#10)(2008-12#3)(2008-2#5)(2008-3#12)(2008-4#8)(2008-5#18)(2008-6#9)(2008-7#10)(2008-8#7)(2008-9#5)(2009-10#4)(2009-12#2)(2009-2#2)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#3)(2010-7#1)(2010-8#6)(2011-1#5)(2011-12#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#6)(2012-7#1)(2012-9#1)(2013-1#6)(2013-7#4)(2013-8#2)
present in their##2##3##(2008-2#1)(2011-2#1)
present in these cells##6##4##(1990-10#1)(1990-2#1)(1994-12#1)(1994-9#1)(2009-12#1)(2010-2#1)
present in these patients##2##4##(1991-5#1)(2006-9#1)
present in these##32##3##(1990-10#1)(1990-2#1)(1990-7#2)(1991-5#1)(1992-12#1)(1992-8#1)(1993-4#1)(1994-12#1)(1994-9#2)(1995-5#1)(1997-2#1)(1997-4#1)(2006-9#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-10#1)(2009-12#1)(2010-2#1)(2010-4#1)(2010-7#1)
present in this region##2##4##(1990-5#1)(2008-10#1)
present in this##18##3##(1990-12#1)(1990-5#1)(1991-10#1)(1992-12#1)(1993-3#1)(1995-2#2)(2007-1#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-2#1)
present in those##2##3##(1993-8#1)(2009-8#1)
present in three##4##3##(1990-3#1)(1992-11#1)(1997-2#1)(2011-12#1)
present in ticks##2##3##(2004-11#1)(2008-10#1)
present in trace amounts##2##4##(2008-11#1)(2008-5#1)
present in two patients##3##4##(1991-1#1)(2006-10#1)(2006-8#1)
present in two##7##3##(1990-11#1)(1991-1#1)(1997-4#1)(2006-10#1)(2006-8#1)(2008-5#1)(2011-2#1)
present in up to##2##4##(2007-5#1)(2012-12#1)
present in urine##2##3##(1990-12#1)(2008-12#1)
present in various##5##3##(1993-8#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-7#1)
present in vitro model##2##4##(1994-2#1)(1995-9#1)
present in vitro##5##3##(1990-11#1)(1993-2#1)(1994-2#1)(1995-9#1)(2008-3#1)
present in water##2##3##(1994-3#1)(2008-10#1)
present in women##2##3##(2008-7#1)(2012-12#1)
present in##1886##2##(1990-1#1)(1990-10#5)(1990-11#20)(1990-12#21)(1990-2#5)(1990-3#6)(1990-4#9)(1990-5#9)(1990-6#1)(1990-7#9)(1990-8#6)(1990-9#6)(1991-1#4)(1991-10#7)(1991-11#9)(1991-12#13)(1991-2#16)(1991-3#12)(1991-4#4)(1991-5#15)(1991-6#9)(1991-7#7)(1991-8#8)(1991-9#15)(1992-1#6)(1992-10#1)(1992-11#14)(1992-12#23)(1992-2#10)(1992-3#12)(1992-4#6)(1992-5#6)(1992-6#17)(1992-7#5)(1992-8#17)(1992-9#9)(1993-1#1)(1993-10#1)(1993-11#9)(1993-12#13)(1993-2#4)(1993-3#14)(1993-4#7)(1993-5#3)(1993-6#11)(1993-7#2)(1993-8#14)(1993-9#13)(1994-1#1)(1994-10#3)(1994-11#9)(1994-12#16)(1994-2#18)(1994-3#13)(1994-5#6)(1994-6#9)(1994-7#7)(1994-8#23)(1994-9#17)(1995-1#10)(1995-10#4)(1995-11#7)(1995-12#11)(1995-2#15)(1995-3#13)(1995-4#3)(1995-5#15)(1995-6#9)(1995-8#15)(1995-9#4)(1996-1#4)(1996-10#1)(1996-11#7)(1996-12#16)(1996-2#3)(1996-3#6)(1996-4#7)(1996-5#11)(1996-6#2)(1996-7#5)(1996-8#8)(1996-9#4)(1997-1#13)(1997-2#9)(1997-3#14)(1997-4#18)(1997-5#8)(1997-6#13)(1997-7#10)(1997-8#8)(2004-1#1)(2004-11#3)(2004-12#1)(2004-2#6)(2004-3#2)(2004-4#1)(2004-8#2)(2004-9#1)(2005-10#7)(2005-11#9)(2005-12#2)(2005-6#1)(2005-7#9)(2005-8#7)(2005-9#1)(2006-1#3)(2006-10#24)(2006-11#3)(2006-12#13)(2006-2#3)(2006-3#2)(2006-5#2)(2006-6#3)(2006-8#14)(2006-9#7)(2007-1#5)(2007-10#8)(2007-11#11)(2007-12#27)(2007-2#5)(2007-3#8)(2007-4#1)(2007-5#3)(2007-6#3)(2007-7#9)(2007-8#27)(2007-9#3)(2008-1#14)(2008-10#281)(2008-11#29)(2008-12#16)(2008-2#18)(2008-3#20)(2008-4#37)(2008-5#48)(2008-6#15)(2008-7#39)(2008-8#17)(2008-9#14)(2009-1#1)(2009-10#6)(2009-12#3)(2009-2#4)(2009-3#4)(2009-4#7)(2009-5#4)(2009-6#1)(2009-7#3)(2009-8#14)(2009-9#4)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#8)(2010-2#4)(2010-3#5)(2010-4#13)(2010-5#8)(2010-6#2)(2010-7#3)(2010-8#9)(2011-1#13)(2011-11#1)(2011-12#6)(2011-2#32)(2012-1#3)(2012-11#3)(2012-12#15)(2012-2#19)(2012-3#17)(2012-7#1)(2012-9#1)(2013-1#28)(2013-7#7)(2013-8#15)
present indications##2##2##(2007-8#1)(2011-2#1)
present initial results##2##3##(2008-3#1)(2010-2#1)
present initial##4##2##(2007-12#1)(2008-12#1)(2008-3#1)(2010-2#1)
present initially##2##2##(1992-3#1)(2011-1#1)
present inside##2##2##(2006-12#1)(2008-7#1)
present investigation is to##2##4##(2011-1#1)(2013-1#1)
present investigation is##6##3##(1990-4#1)(2007-10#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
present investigation was to##9##4##(1997-8#1)(2008-2#1)(2008-4#2)(2010-1#1)(2010-12#2)(2011-2#1)(2013-7#1)
present investigation was##18##3##(1992-3#1)(1995-12#1)(1996-1#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-4#2)(2010-1#1)(2010-12#3)(2011-2#2)(2012-12#2)(2013-7#1)
present investigation##69##2##(1990-11#1)(1990-12#1)(1990-4#2)(1991-12#1)(1992-3#1)(1993-12#2)(1994-10#1)(1994-6#2)(1995-11#2)(1995-12#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-4#1)(1997-7#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-4#3)(2008-5#4)(2009-3#1)(2009-4#1)(2010-1#1)(2010-12#4)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#4)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#1)
present investigations were##2##3##(1995-2#1)(2008-7#1)
present investigations##5##2##(1995-2#1)(2006-12#1)(2008-6#1)(2008-7#1)(2011-2#1)
present is##10##2##(1990-8#1)(1997-8#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-10#1)(2010-8#1)
present it as##2##3##(2009-3#1)(2013-7#1)
present it##6##2##(2006-6#1)(2007-5#1)(2008-10#1)(2008-4#1)(2009-3#1)(2013-7#1)
present its performance in##2##4##(2007-4#1)(2008-7#1)
present its##4##2##(2007-4#1)(2008-2#2)(2008-7#1)
present itself##2##2##(2007-10#1)(2007-9#1)
present knowledge about##4##3##(1990-10#1)(1993-11#1)(1993-5#1)(1995-2#1)
present knowledge of the##3##4##(2008-10#2)(2008-4#1)
present knowledge of##4##3##(2008-10#2)(2008-11#1)(2008-4#1)
present knowledge##12##2##(1990-10#1)(1991-4#1)(1991-6#1)(1993-11#1)(1993-5#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)
present laboratory##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
present late for##2##3##(2008-1#1)(2013-1#1)
present late##4##2##(2007-7#1)(2007-8#1)(2008-1#1)(2013-1#1)
present limitations##3##2##(2007-8#2)(2008-3#1)
present literature##4##2##(2008-1#1)(2008-10#1)(2010-9#1)(2012-12#1)
present little##3##2##(1991-2#1)(2006-8#1)(2007-11#1)
present low##3##2##(2004-9#1)(2007-7#1)(2008-7#1)
present magnetoencephalographic##2##2##(1996-8#1)(2012-12#1)
present mainly as a##2##4##(2008-5#1)(2009-3#1)
present mainly as##5##3##(1991-8#1)(1993-11#1)(2008-10#1)(2008-5#1)(2009-3#1)
present mainly in the##3##4##(1991-5#1)(1997-3#1)(2008-10#1)
present mainly in##5##3##(1991-5#1)(1997-3#1)(2008-10#2)(2008-4#1)
present mainly##10##2##(1991-5#1)(1991-8#1)(1993-11#1)(1997-3#1)(2008-10#3)(2008-4#1)(2008-5#1)(2009-3#1)
present management##3##2##(2008-1#1)(2008-5#1)(2008-8#1)
present manuscript##5##2##(1993-2#1)(2008-11#1)(2009-6#1)(2010-12#1)(2012-12#1)
present many##2##2##(2007-12#1)(2010-12#1)
present matrix##2##2##(2008-10#2)
present maximum##2##2##(2007-3#1)(2008-10#1)
present may##2##2##(1993-8#1)(2007-2#1)
present meta-analysis##4##2##(2007-4#1)(2008-12#2)(2008-2#1)
present method could be##2##4##(1994-3#1)(2008-10#1)
present method has##3##3##(2007-8#1)(2008-10#2)
present method is##7##3##(1990-7#1)(1991-8#1)(1997-1#1)(2008-10#3)(2010-9#1)
present method showed a##2##4##(2008-10#2)
present method was##9##3##(1997-3#1)(2008-10#8)
present method will##2##3##(1995-3#1)(1997-1#1)
present method##75##2##(1990-2#1)(1990-7#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-6#1)(1993-8#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-11#1)(1996-3#1)(1996-5#2)(1997-1#2)(1997-3#1)(2007-8#2)(2008-10#48)(2008-4#2)(2009-9#1)(2010-9#1)(2011-2#1)(2012-2#1)
present methodology##3##2##(2007-11#1)(2008-10#1)(2008-4#1)
present methods for##10##3##(1997-3#1)(1997-7#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-9#1)(2010-1#1)(2010-2#1)
present methods##16##2##(1996-5#1)(1997-3#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#3)(2008-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)
present modeling##2##2##(2008-3#1)(2008-9#1)
present models##3##2##(1992-4#1)(2008-2#2)
present molecular##3##2##(1996-6#1)(2008-8#1)(2008-9#1)
present moment##2##2##(1996-2#1)(2008-11#1)
present more##7##2##(1992-1#1)(2006-5#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)
present near##2##2##(1994-2#1)(2012-2#1)
present new data showing that##2##5##(2009-5#1)(2009-8#1)
present new data##6##3##(1994-11#1)(2006-3#1)(2008-11#1)(2008-9#1)(2009-5#1)(2009-8#1)
present new##16##2##(1990-8#1)(1994-11#1)(2006-3#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#2)(2009-9#1)(2012-2#1)
present not only##2##3##(2007-5#1)(2011-2#1)
present not##4##2##(1991-12#1)(2004-4#1)(2007-5#1)(2011-2#1)
present novel##5##2##(1996-12#1)(2008-1#1)(2008-2#1)(2011-12#1)(2012-2#1)
present numerical simulations##7##3##(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2011-1#1)
present numerical##10##2##(1992-2#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#2)(2008-3#2)(2011-1#1)
present observations suggest that##2##4##(1991-3#1)(1995-3#1)
present observations##4##2##(1991-3#1)(1995-3#1)(2008-3#1)(2013-8#1)
present on a##4##3##(1993-12#1)(1993-9#1)(1995-8#1)(2011-12#1)
present on all##5##3##(1997-8#1)(2007-2#1)(2008-11#2)(2008-4#1)
present on cell surfaces##2##4##(1990-12#1)(2012-11#1)
present on each##2##3##(1990-2#1)(2008-2#1)
present on only one side of the membrane##2##8##(1990-11#1)(1991-5#1)
present on only one##3##4##(1990-11#1)(1991-5#1)(1993-9#1)
present on such##2##3##(1990-3#1)(2005-11#1)
present on the front seats##3##5##(2010-5#3)
present on the surface of##7##5##(1992-5#1)(1994-11#1)(1994-12#1)(1996-5#1)(1996-9#1)(2007-11#1)(2010-12#1)
present on the surface##10##4##(1992-5#1)(1994-11#1)(1994-12#1)(1996-5#1)(1996-9#1)(2005-11#1)(2007-11#1)(2010-12#1)(2012-11#1)(2013-8#1)
present on the##47##3##(1990-5#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-7#1)(1996-11#1)(1996-5#2)(1996-9#1)(2005-11#2)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#3)(2008-9#1)(2010-12#2)(2010-5#3)(2012-11#2)(2012-2#1)(2012-3#1)(2013-8#1)
present on##111##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#3)(1994-11#2)(1994-12#1)(1994-2#2)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-5#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2005-11#3)(2006-10#2)(2007-1#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#5)(2008-7#3)(2008-9#2)(2009-2#1)(2010-12#2)(2010-4#1)(2010-5#3)(2011-12#1)(2011-2#1)(2012-11#3)(2012-2#1)(2012-3#1)(2013-8#1)
present one of the##2##4##(2009-2#1)(2009-5#1)
present one such##2##3##(2011-1#1)(2012-3#1)
present one##9##2##(1992-4#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-2#1)(2009-5#1)(2011-1#1)(2012-3#1)
present only in a##3##4##(1993-12#1)(1997-6#1)(1997-7#1)
present only in the##2##4##(2006-11#1)(2008-4#1)
present only in##20##3##(1991-12#1)(1991-9#1)(1993-12#1)(1993-3#1)(1995-8#1)(1996-8#1)(1997-6#1)(1997-7#3)(2006-11#1)(2008-10#4)(2008-4#1)(2008-6#2)(2008-7#1)(2009-3#1)
present only on the##2##4##(2007-12#1)(2008-11#1)
present only on##3##3##(2007-12#1)(2008-11#1)(2009-8#1)
present only##28##2##(1990-4#1)(1990-7#1)(1991-12#1)(1991-9#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-8#1)(1996-8#1)(1997-6#1)(1997-7#3)(2006-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-6#3)(2008-7#1)(2009-3#1)(2009-8#1)
present or absent##2##3##(1991-11#1)(2008-3#1)
present or past##2##3##(1992-2#1)(2006-6#1)
present or when##2##3##(1992-8#1)(2009-4#1)
present or##16##2##(1990-6#1)(1991-11#1)(1991-7#1)(1992-1#1)(1992-2#1)(1992-8#1)(1994-12#1)(1994-8#1)(2006-6#2)(2007-7#2)(2008-10#1)(2008-11#1)(2008-3#1)(2009-4#1)
present orientation##2##2##(2010-3#2)
present our approach##2##3##(2007-5#1)(2008-11#1)
present our experience of##4##4##(2007-8#2)(2008-10#1)(2012-2#1)
present our experience with a##4##5##(2008-4#1)(2011-12#1)(2012-2#1)(2013-8#1)
present our experience with##9##4##(2006-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-4#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
present our experience##16##3##(2006-12#1)(2007-5#1)(2007-7#2)(2007-8#3)(2008-10#1)(2008-4#1)(2011-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
present our experimental##2##3##(2007-11#1)(2011-1#1)
present our initial experience##3##4##(2006-6#1)(2012-12#2)
present our preliminary results##2##4##(2008-3#1)(2010-4#1)
present our preliminary##3##3##(2007-8#1)(2008-3#1)(2010-4#1)
present our protocol##2##3##(1992-6#1)(2008-8#1)
present our results##4##3##(1992-8#1)(2008-2#1)(2008-3#1)(2012-1#1)
present our##52##2##(1992-6#1)(1992-8#1)(1996-10#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-5#2)(2007-7#2)(2007-8#6)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
present over the##4##3##(1995-1#1)(2007-7#1)(2008-2#1)(2011-1#1)
present over##5##2##(1992-4#1)(1995-1#1)(2007-7#1)(2008-2#1)(2011-1#1)
present paper aims at##2##4##(1991-6#1)(2007-10#1)
present paper aims##5##3##(1991-6#1)(1993-3#1)(2007-10#1)(2009-7#1)(2012-3#1)
present paper is##10##3##(1990-7#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-12#1)(2009-6#1)
present paper outlines##2##3##(2007-12#1)(2009-6#1)
present paper reflects##2##3##(2007-4#1)(2010-10#1)
present paper##173##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-12#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-12#2)(1996-4#2)(1996-8#1)(2005-11#2)(2005-8#3)(2006-10#5)(2006-12#1)(2006-2#2)(2006-6#3)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#7)(2007-4#1)(2007-6#3)(2007-8#1)(2008-10#36)(2008-11#10)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#5)(2008-7#4)(2008-8#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-5#1)(2009-6#2)(2009-7#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#5)(2013-8#8)
present pathogenetic##2##2##(2010-5#1)(2011-1#1)
present population##2##2##(1994-2#1)(2013-7#1)
present predominantly in##2##3##(1995-2#1)(2008-10#1)
present predominantly##3##2##(1995-2#1)(2008-10#2)
present preliminary data##4##3##(2007-10#1)(2008-4#1)(2008-6#1)(2008-7#1)
present preliminary results of##3##4##(1997-6#1)(2007-8#1)(2008-7#1)
present preliminary results##4##3##(1997-6#1)(2007-8#1)(2008-7#1)(2010-5#1)
present preliminary##11##2##(1990-6#1)(1997-6#1)(2007-10#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2010-5#1)(2011-2#1)
present prior to##2##3##(1997-7#1)(2009-10#1)
present problems in##2##3##(1992-7#1)(1993-9#1)
present problems##3##2##(1992-7#1)(1993-9#1)(2007-11#1)
present recent results##2##3##(2008-3#2)
present recent##7##2##(2008-10#2)(2008-3#2)(2009-1#1)(2009-9#1)(2012-3#1)
present recommendations##2##2##(2008-3#1)(2012-2#1)
present report describes the##10##4##(1990-2#1)(1991-8#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
present report describes##28##3##(1990-12#1)(1990-2#1)(1991-8#1)(1994-12#1)(2007-12#3)(2007-5#1)(2007-7#2)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-11#1)(2011-2#2)(2012-12#1)(2013-1#3)
present report is##5##3##(2007-12#1)(2007-7#1)(2008-8#1)(2008-9#1)(2011-1#1)
present report we discuss##2##4##(2007-11#1)(2008-5#1)
present report we##7##3##(1992-7#1)(1994-9#1)(1995-10#1)(1997-3#1)(2007-11#1)(2008-5#1)(2011-2#1)
present report##72##2##(1990-12#1)(1990-2#1)(1991-8#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-5#1)(1994-12#2)(1994-3#1)(1994-9#2)(1995-10#1)(1995-5#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-5#1)(2007-7#3)(2008-10#5)(2008-11#5)(2008-2#2)(2008-4#4)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#3)(2009-4#1)(2010-10#1)(2010-11#2)(2011-1#2)(2011-2#6)(2012-12#1)(2013-1#3)(2013-7#1)
present research demonstrated that the##2##5##(2009-3#1)(2013-8#1)
present research tested the##2##4##(2009-1#1)(2010-8#1)
present research was to##2##4##(2007-2#1)(2008-12#1)
present research was##4##3##(2007-2#1)(2008-12#1)(2013-8#2)
present research##32##2##(1996-12#1)(2005-8#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#4)(2008-2#3)(2008-3#2)(2008-5#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-9#1)(2010-8#1)(2012-1#3)(2013-7#1)(2013-8#4)
present result of##2##3##(2007-11#2)
present result##4##2##(1994-2#1)(2007-11#2)(2008-8#1)
present results and##4##3##(1990-2#1)(1991-5#1)(1994-11#1)(2008-7#1)
present results demonstrate that##6##4##(1990-5#1)(1991-12#1)(1995-11#1)(1995-7#1)(2008-8#1)(2013-1#1)
present results demonstrate##9##3##(1990-5#1)(1991-12#1)(1991-6#1)(1995-11#1)(1995-7#1)(1997-4#1)(2008-8#1)(2010-8#1)(2013-1#1)
present results do not##2##4##(1997-7#1)(2011-2#1)
present results for##3##3##(1996-8#1)(2007-12#1)(2008-3#1)
present results from a##5##4##(1995-6#1)(2006-12#1)(2008-3#2)(2008-8#1)
present results from##11##3##(1990-11#1)(1995-5#1)(1995-6#2)(2006-12#1)(2008-1#1)(2008-12#1)(2008-3#3)(2008-8#1)
present results in##4##3##(2006-5#1)(2007-11#1)(2007-12#2)
present results indicate that the##3##5##(1990-7#1)(1992-6#1)(1997-3#1)
present results indicate that##12##4##(1990-7#1)(1990-8#1)(1991-5#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-11#1)(1997-3#1)(2004-1#1)(2005-9#1)(2008-5#1)(2010-1#1)
present results indicate##14##3##(1990-7#1)(1990-8#1)(1991-5#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-11#1)(1997-3#1)(2004-1#1)(2005-9#1)(2008-5#1)(2010-1#1)(2013-8#2)
present results of a simulation##2##5##(1996-3#1)(2008-3#1)
present results of a##6##4##(1996-3#1)(2007-9#1)(2008-3#1)(2008-5#1)(2009-11#1)(2010-8#1)
present results of measurements##2##4##(2008-2#1)(2011-2#1)
present results of the##3##4##(1995-5#1)(2008-10#1)(2008-3#1)
present results of##22##3##(1995-5#1)(1996-3#1)(2007-1#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-6#1)(2009-11#1)(2009-4#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)
present results on##3##3##(1997-5#1)(2007-11#1)(2008-3#1)
present results provide##5##3##(1991-6#1)(1993-12#1)(1993-6#2)(2007-9#1)
present results show that the##4##5##(1994-8#1)(1996-12#1)(2006-6#1)(2007-12#1)
present results show that##9##4##(1993-12#1)(1993-3#1)(1993-4#1)(1994-2#1)(1994-8#1)(1995-12#1)(1996-12#1)(2006-6#1)(2007-12#1)
present results strongly suggest that##4##5##(1991-5#1)(2009-2#1)(2012-12#2)
present results strongly suggest##5##4##(1991-2#1)(1991-5#1)(2009-2#1)(2012-12#2)
present results strongly##6##3##(1991-2#1)(1991-5#1)(2006-12#1)(2009-2#1)(2012-12#2)
present results suggest that the##7##5##(1990-2#1)(1991-7#1)(1995-12#1)(1997-2#1)(2008-10#2)(2008-6#1)
present results suggest that##29##4##(1990-2#1)(1991-12#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-5#2)(1995-12#2)(1995-7#1)(1996-3#1)(1997-2#1)(1997-7#1)(2004-11#1)(2006-5#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)(2011-2#1)
present results suggest##33##3##(1990-2#1)(1991-12#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#2)(1995-12#2)(1995-7#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-7#1)(2004-11#1)(2006-5#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)(2011-2#1)
present results that demonstrate##3##4##(2008-2#1)(2008-3#2)
present results that##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
present results##180##2##(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-12#2)(1991-2#3)(1991-4#1)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#4)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-5#2)(1994-8#1)(1995-11#1)(1995-12#5)(1995-3#1)(1995-5#2)(1995-6#2)(1995-7#4)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#3)(1997-7#3)(2004-1#1)(2004-11#1)(2004-4#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-12#2)(2006-5#3)(2006-6#2)(2007-1#1)(2007-11#2)(2007-12#9)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#4)(2008-2#5)(2008-3#11)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#3)(2009-11#1)(2009-2#1)(2009-4#1)(2010-1#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#3)(2012-12#3)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#3)
present review article##3##3##(1993-12#1)(2008-3#1)(2012-12#1)
present review is##13##3##(1992-6#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-4#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-9#1)(2011-2#1)(2012-2#1)
present review of##2##3##(1995-4#1)(2006-10#1)
present review##119##2##(1992-6#1)(1993-11#1)(1993-12#1)(1994-6#1)(1994-8#1)(1995-4#1)(1995-8#1)(1997-1#1)(2005-7#1)(2006-10#22)(2007-1#1)(2007-12#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#12)(2008-10#3)(2008-11#4)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#3)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#5)(2012-12#4)(2012-2#7)(2012-3#1)(2013-1#4)(2013-8#2)
present role##4##2##(1992-12#1)(1997-7#1)(2008-5#1)(2012-12#1)
present sample##5##2##(1992-9#1)(1996-5#1)(2008-10#1)(2008-8#1)(2011-12#1)
present series of experiments##2##4##(1996-2#1)(2011-2#1)
present series##6##2##(1990-12#1)(1991-4#1)(1996-2#1)(2007-8#1)(2008-7#1)(2011-2#1)
present serious##3##2##(1992-9#1)(2007-11#1)(2011-2#1)
present several##10##2##(1992-12#1)(1997-2#1)(2006-9#1)(2008-10#1)(2008-5#1)(2008-8#2)(2009-8#1)(2010-6#1)(2011-3#1)
present short review##2##3##(2008-10#1)(2008-7#1)
present short##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
present significant differences##2##3##(2008-10#1)(2008-3#1)
present significant##5##2##(1997-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-12#1)
present similarly##2##2##(2006-12#1)(2011-2#1)
present simple##2##2##(1992-6#1)(2008-2#1)
present simulated##2##2##(2008-2#1)(2008-3#1)
present simultaneously##3##2##(1992-3#1)(2008-10#1)(2011-1#1)
present single-molecule fluorescence data##2##4##(2007-12#1)(2009-4#1)
present situation##7##2##(1991-3#1)(1991-6#1)(2006-6#1)(2008-1#1)(2008-10#2)(2008-11#1)
present some cases##2##3##(1990-2#1)(2009-4#1)
present some examples of##3##4##(2008-8#1)(2009-4#1)(2010-8#1)
present some of the##7##4##(1990-5#1)(2006-2#1)(2008-12#1)(2008-7#1)(2010-12#1)(2012-1#1)(2013-1#1)
present some##24##2##(1990-2#1)(1990-5#1)(1994-6#1)(1994-8#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-6#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#3)(2010-12#1)(2010-8#1)(2012-1#1)(2013-1#2)
present special##2##2##(1992-2#1)(2008-4#1)
present species##3##2##(1997-4#1)(2008-5#1)(2011-2#1)
present specific##2##2##(2009-8#1)(2013-1#1)
present sporadically##2##2##(1997-4#1)(2006-4#1)
present standard##3##2##(1992-3#1)(1992-5#1)(1995-4#1)
present state of knowledge##3##4##(1990-8#1)(1991-3#1)(2006-10#1)
present state of##13##3##(1990-8#1)(1991-3#1)(1994-6#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-6#1)(2008-11#1)(2009-12#1)(2009-2#1)(2011-1#1)(2011-3#1)(2013-8#1)
present state##16##2##(1990-8#1)(1991-3#1)(1994-6#1)(1997-7#1)(2005-7#2)(2006-10#1)(2006-4#1)(2006-6#1)(2007-6#1)(2008-11#1)(2009-12#1)(2009-2#1)(2011-1#1)(2011-3#1)(2013-8#1)
present statement##4##2##(2008-11#1)(2010-10#1)(2010-11#2)
present status and future##2##4##(2008-11#1)(2013-1#1)
present status and##4##3##(2008-11#1)(2010-2#1)(2012-1#1)(2013-1#1)
present status of##7##3##(1990-11#1)(1993-3#1)(1997-4#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-11#1)
present status##11##2##(1990-11#1)(1993-3#1)(1997-4#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#1)
present strategies for##2##3##(2008-7#1)(2008-9#1)
present strong##2##2##(2007-11#1)(2008-3#1)
present structure##2##2##(1997-1#1)(2008-8#1)
present studies of##2##3##(2007-12#1)(2008-7#1)
present studies show that##3##4##(1991-12#1)(1994-9#1)(1996-2#1)
present studies were designed to##2##5##(1990-7#1)(1991-3#1)
present studies were##6##3##(1990-7#1)(1991-3#1)(1994-6#1)(1995-11#1)(1997-7#1)(2007-11#1)
present studies##36##2##(1990-11#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-4#1)(1993-12#1)(1994-10#1)(1994-6#2)(1994-9#2)(1995-11#1)(1996-10#2)(1996-2#1)(1996-5#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-2#1)(2010-2#1)(2013-1#1)
present study a##9##3##(1990-12#1)(1990-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2010-3#1)(2013-1#2)
present study and##3##3##(1995-9#1)(1996-2#1)(2010-4#1)
present study are to##2##4##(2012-12#1)(2012-2#1)
present study are##5##3##(1992-8#1)(1997-4#1)(1997-5#1)(2012-12#1)(2012-2#1)
present study assessed##6##3##(1993-2#1)(1996-7#1)(2008-10#1)(2008-8#1)(2010-4#1)(2013-1#1)
present study attempts to##3##4##(1993-12#1)(1994-6#1)(1996-3#1)
present study can be##2##4##(2008-2#1)(2009-6#1)
present study clearly##2##3##(1992-9#1)(2012-2#1)
present study concluded that##2##4##(1997-4#1)(2012-12#1)
present study confirmed that##3##4##(1993-12#1)(2010-10#2)
present study demonstrated that##5##4##(1994-3#1)(2008-5#1)(2009-4#1)(2010-4#1)(2010-5#1)
present study demonstrated##6##3##(1994-3#1)(2004-11#1)(2008-5#1)(2009-4#1)(2010-4#1)(2010-5#1)
present study demonstrates that the##5##5##(1991-8#2)(1994-11#1)(2007-11#1)(2011-12#1)
present study demonstrates that##14##4##(1991-12#1)(1991-8#2)(1992-6#1)(1992-7#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#1)(1997-6#1)(2007-11#1)(2011-1#1)(2011-12#1)
present study demonstrates##23##3##(1990-5#1)(1991-12#1)(1991-8#3)(1992-6#1)(1992-7#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-6#1)(2007-11#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)
present study developed##2##3##(2007-7#1)(2010-2#1)
present study different##2##3##(2007-2#1)(2009-7#1)
present study employed a##2##4##(2008-12#1)(2008-9#1)
present study employed##4##3##(1995-11#1)(1995-5#1)(2008-12#1)(2008-9#1)
present study evaluated the##12##4##(1991-2#1)(1993-1#1)(1997-5#2)(2007-4#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
present study evaluated##15##3##(1991-2#1)(1993-1#1)(1993-4#1)(1997-5#2)(2007-4#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2009-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
present study examined the influence of##3##6##(1994-3#1)(1994-8#1)(2007-11#1)
present study examined the##33##4##(1990-4#1)(1990-7#1)(1991-1#1)(1991-6#2)(1991-8#2)(1992-9#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-12#2)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-1#2)(2010-10#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
present study examined##55##3##(1990-4#1)(1990-7#1)(1991-1#1)(1991-5#1)(1991-6#2)(1991-8#2)(1992-12#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-10#2)(1996-12#2)(1996-2#1)(1996-5#1)(1997-6#2)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)
present study examines##17##3##(1990-2#1)(1991-5#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-7#1)(2006-7#1)(2007-12#2)(2008-5#1)(2008-7#1)(2010-3#1)(2010-4#1)(2012-2#1)
present study focused on##2##4##(2008-2#1)(2011-1#1)
present study focuses on the##4##5##(1990-6#1)(2008-3#1)(2011-12#1)(2011-2#1)
present study focuses on##6##4##(1990-6#1)(2008-3#1)(2011-12#1)(2011-2#2)(2012-12#1)
present study had##3##3##(1995-3#1)(2008-2#1)(2013-1#1)
present study has##17##3##(1990-10#1)(1990-2#1)(1993-2#1)(1995-1#1)(1997-8#1)(2006-1#1)(2007-10#3)(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-6#1)(2013-1#2)
present study in##3##3##(2008-11#1)(2011-12#1)(2011-2#1)
present study indicated that the##2##5##(2008-10#1)(2008-9#1)
present study indicated that##4##4##(2004-4#1)(2008-10#1)(2008-5#1)(2008-9#1)
present study indicates that the##3##5##(1994-5#1)(2008-5#1)(2008-7#1)
present study indicates that##9##4##(1993-9#1)(1994-5#1)(1996-6#1)(1996-9#1)(2004-11#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)
present study indicates##10##3##(1993-9#1)(1994-5#1)(1996-6#1)(1996-9#1)(2004-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-2#1)
present study investigated the role of##2##6##(2008-4#1)(2013-8#1)
present study investigated the##17##4##(1991-9#1)(1995-12#2)(2004-9#1)(2007-12#2)(2007-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2010-10#1)(2010-3#1)(2011-2#1)(2013-1#3)(2013-8#1)
present study investigated##25##3##(1991-7#1)(1991-9#1)(1994-6#1)(1995-12#2)(1996-12#2)(2004-9#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#3)(2013-8#1)
present study is the first to##4##6##(2009-12#2)(2010-4#1)(2013-3#1)
present study is the first##5##5##(1997-7#1)(2009-12#2)(2010-4#1)(2013-3#1)
present study is the##7##4##(1997-7#1)(2007-7#1)(2009-12#2)(2010-4#1)(2012-5#1)(2013-3#1)
present study is to assess the##5##6##(2006-1#1)(2006-2#1)(2007-2#1)(2008-11#1)(2012-3#1)
present study is to assess##7##5##(2006-1#1)(2006-10#1)(2006-2#1)(2007-2#1)(2008-11#1)(2011-2#1)(2012-3#1)
present study is to discuss##2##5##(2008-12#1)(2011-2#1)
present study is to##34##4##(1993-9#1)(1996-3#1)(2006-1#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#2)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
present study is##68##3##(1990-7#1)(1990-8#1)(1993-9#2)(1996-3#1)(1997-5#1)(1997-7#1)(2005-10#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#4)(2007-8#2)(2007-9#2)(2008-10#5)(2008-11#2)(2008-12#2)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#2)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#3)(2013-3#1)(2013-7#1)(2013-8#2)
present study may##6##3##(1994-2#1)(1994-5#1)(2008-10#1)(2010-9#1)(2012-12#1)(2013-1#1)
present study of##3##3##(1995-9#1)(2007-12#1)(2011-2#1)
present study on##4##3##(1994-11#1)(1995-7#1)(2008-12#1)(2013-1#1)
present study provides an##2##4##(2010-12#2)
present study provides##6##3##(2006-12#1)(2010-12#2)(2010-4#1)(2011-2#1)(2012-1#1)
present study represents##2##3##(1995-12#1)(2008-3#1)
present study revealed that##5##4##(1991-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)
present study revealed##9##3##(1991-2#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-3#1)(2012-2#1)(2013-7#1)
present study reveals that##3##4##(1997-5#1)(2012-2#1)(2013-1#1)
present study reveals##5##3##(1997-5#1)(2007-7#1)(2010-10#1)(2012-2#1)(2013-1#1)
present study showed that##7##4##(1992-1#1)(1992-12#1)(2008-1#1)(2008-5#1)(2009-5#1)(2012-12#1)(2013-1#1)
present study showed##11##3##(1992-1#1)(1992-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-5#1)(2009-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
present study shows significant##2##4##(2006-4#1)(2011-1#1)
present study shows that the##3##5##(1996-3#1)(1997-2#1)(2008-5#1)
present study shows that##8##4##(1991-10#1)(1992-3#1)(1993-2#1)(1995-7#1)(1996-3#1)(1997-2#1)(2006-8#1)(2008-5#1)
present study shows##14##3##(1991-10#1)(1992-3#2)(1993-2#1)(1995-7#1)(1996-3#1)(1997-2#1)(2006-10#1)(2006-4#1)(2006-8#1)(2008-5#2)(2011-1#1)(2013-7#1)
present study sought to##4##4##(2008-11#1)(2008-7#1)(2008-9#1)(2010-9#1)
present study suggested that##2##4##(1990-12#1)(1995-8#1)
present study suggests that##14##4##(1990-4#1)(1992-8#1)(1992-9#2)(1995-12#2)(1996-10#1)(2006-4#1)(2007-9#1)(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#2)
present study suggests##15##3##(1990-4#1)(1992-12#1)(1992-8#1)(1992-9#2)(1995-12#2)(1996-10#1)(2006-4#1)(2007-9#1)(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#2)
present study the##20##3##(1990-1#1)(1990-10#1)(1991-6#2)(1991-8#1)(1993-11#1)(1993-7#1)(1994-10#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-2#1)(2006-8#1)(2008-10#2)(2008-6#3)(2009-3#1)(2011-2#1)
present study used a##2##4##(1993-12#1)(2009-4#1)
present study used##6##3##(1991-6#1)(1993-12#1)(2008-12#1)(2009-2#1)(2009-4#1)(2011-1#1)
present study using##3##3##(1994-2#1)(2006-12#1)(2013-8#1)
present study was aimed at investigating the##2##7##(2012-12#2)
present study was aimed at investigating##3##6##(1990-6#1)(2012-12#2)
present study was aimed at##5##5##(1990-6#1)(1994-2#1)(1995-5#1)(2012-12#2)
present study was aimed to##7##5##(2008-12#1)(2008-5#1)(2009-12#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-3#1)
present study was aimed##12##4##(1990-6#1)(1994-2#1)(1995-5#1)(2008-12#1)(2008-5#1)(2009-12#1)(2010-12#1)(2010-5#1)(2012-12#3)(2012-3#1)
present study was carried out to find the##3##8##(1995-12#1)(2007-8#1)(2008-3#1)
present study was carried out to investigate##5##7##(1990-3#1)(1991-6#1)(1997-5#1)(2008-11#1)(2012-11#1)
present study was carried out to##14##6##(1990-3#1)(1990-7#1)(1991-6#1)(1992-4#1)(1993-7#1)(1995-12#1)(1997-5#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2012-11#1)
present study was carried out##22##5##(1990-10#1)(1990-3#1)(1990-7#1)(1991-6#1)(1992-10#1)(1992-4#1)(1993-7#1)(1994-6#1)(1995-12#1)(1997-5#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
present study was carried##23##4##(1990-10#1)(1990-3#1)(1990-7#1)(1991-6#1)(1992-10#1)(1992-4#1)(1993-7#1)(1994-6#1)(1995-12#1)(1997-5#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
present study was conducted to determine the##3##7##(1997-6#1)(2008-11#1)(2011-2#1)
present study was conducted to determine##6##6##(1995-8#1)(1997-6#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
present study was conducted to##20##5##(1990-4#1)(1995-10#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-6#1)(2004-11#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-6#1)(2009-9#1)(2010-5#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
present study was conducted##29##4##(1990-4#1)(1995-10#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-6#1)(2004-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#2)(2009-6#2)(2009-9#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#2)
present study was designed to evaluate the##6##7##(2008-5#1)(2008-6#1)(2009-10#1)(2009-12#1)(2011-1#1)(2011-12#1)
present study was designed to evaluate##9##6##(1993-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-12#1)(2011-1#1)(2011-12#1)(2013-1#1)
present study was designed to examine the##4##7##(1992-8#1)(1993-12#1)(1994-11#1)(2012-2#1)
present study was designed to examine##5##6##(1992-8#1)(1993-12#2)(1994-11#1)(2012-2#1)
present study was designed to investigate the role of##2##9##(1993-11#1)(2009-5#1)
present study was designed to investigate the##11##7##(1993-11#2)(1997-6#1)(1997-8#1)(2008-4#1)(2009-5#2)(2009-8#1)(2010-5#1)(2011-2#1)(2012-12#1)
present study was designed to investigate##14##6##(1993-11#2)(1997-6#1)(1997-7#1)(1997-8#1)(2008-11#1)(2008-4#1)(2009-5#3)(2009-8#1)(2010-5#1)(2011-2#1)(2012-12#1)
present study was designed to study##2##6##(2010-4#1)(2012-3#1)
present study was designed to##52##5##(1990-5#1)(1991-1#1)(1991-9#1)(1992-8#1)(1993-11#2)(1993-12#3)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(1996-7#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-10#2)(2007-2#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#3)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
present study was designed##53##4##(1990-5#1)(1991-1#1)(1991-9#1)(1992-8#1)(1993-11#2)(1993-12#3)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(1996-12#1)(1996-7#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-10#2)(2007-2#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#3)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
present study was planned to##2##5##(1994-11#1)(1994-12#1)
present study was to determine the##14##6##(1993-7#1)(1995-7#1)(2005-12#1)(2006-10#1)(2006-4#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-2#1)
present study was to determine##25##5##(1993-7#2)(1995-12#1)(1995-7#1)(1996-5#1)(2005-12#1)(2006-10#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-10#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-10#1)(2011-1#2)(2011-2#3)(2012-2#1)
present study was to estimate the##3##6##(2008-12#1)(2008-6#1)(2013-8#1)
present study was to identify the##4##6##(1994-5#1)(2011-2#3)
present study was to identify##5##5##(1994-5#1)(2011-2#4)
present study was to investigate the relationship between##3##8##(2008-8#1)(2013-8#2)
present study was to investigate the##23##6##(1990-9#1)(1995-12#1)(1996-7#1)(1997-2#1)(2007-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-1#1)(2009-6#2)(2010-2#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#3)
present study was to investigate##36##5##(1990-9#1)(1995-12#1)(1996-7#1)(1997-2#1)(2006-6#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-1#2)(2009-6#2)(2010-10#1)(2010-2#2)(2010-5#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#3)
present study was to##201##4##(1990-10#1)(1990-8#1)(1990-9#1)(1991-10#1)(1992-12#1)(1992-2#2)(1993-1#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-7#2)(1994-10#1)(1994-12#1)(1994-2#2)(1994-5#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-12#2)(2004-2#1)(2004-9#1)(2005-12#1)(2006-10#1)(2006-4#3)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#5)(2007-11#3)(2007-2#1)(2007-7#3)(2007-8#6)(2007-9#5)(2008-10#9)(2008-11#2)(2008-12#5)(2008-3#2)(2008-4#1)(2008-5#9)(2008-6#2)(2008-7#5)(2008-8#2)(2009-1#2)(2009-10#1)(2009-2#3)(2009-4#1)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-12#2)(2010-2#3)(2010-3#1)(2010-5#3)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#15)(2012-1#2)(2012-12#5)(2012-2#8)(2012-3#1)(2013-1#10)(2013-7#5)(2013-8#9)
present study was undertaken to assess the##3##7##(1997-2#1)(2013-7#1)(2013-8#1)
present study was undertaken to find out##2##7##(2007-8#1)(2009-6#1)
present study was undertaken to##41##5##(1991-10#1)(1992-11#1)(1992-3#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-12#2)(1995-10#1)(1995-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(2006-1#2)(2006-9#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-6#1)(2010-2#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#3)(2013-7#1)(2013-8#3)
present study was undertaken##46##4##(1991-10#1)(1991-5#1)(1992-11#1)(1992-3#2)(1993-2#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-12#2)(1995-10#1)(1995-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(2006-1#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-6#1)(2010-2#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#3)(2013-7#1)(2013-8#5)
present study was##409##3##(1990-10#2)(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#2)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-8#2)(1993-1#1)(1993-11#2)(1993-12#4)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#4)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#5)(1994-2#5)(1994-5#2)(1994-6#2)(1994-9#2)(1995-10#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#3)(1996-6#1)(1996-7#2)(1997-2#2)(1997-3#1)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#3)(2004-11#2)(2004-12#2)(2004-2#1)(2004-9#1)(2005-12#1)(2006-1#2)(2006-10#2)(2006-4#3)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#3)(2006-9#2)(2007-10#8)(2007-11#5)(2007-12#3)(2007-2#6)(2007-7#8)(2007-8#9)(2007-9#7)(2008-10#12)(2008-11#5)(2008-12#9)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#16)(2008-6#5)(2008-7#11)(2008-8#3)(2009-1#2)(2009-10#2)(2009-12#2)(2009-2#4)(2009-4#1)(2009-5#3)(2009-6#7)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#3)(2010-12#4)(2010-2#4)(2010-3#2)(2010-4#2)(2010-5#7)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#3)(2011-2#24)(2012-1#2)(2012-11#1)(2012-12#13)(2012-2#19)(2012-3#4)(2013-1#16)(2013-7#7)(2013-8#18)
present study we have##29##4##(1991-11#1)(1991-2#1)(1991-7#1)(1992-12#1)(1993-12#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#2)(1995-12#2)(1995-3#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-7#1)(2009-7#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
present study we##108##3##(1990-7#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-7#2)(1992-12#2)(1992-5#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#5)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#4)(1994-9#4)(1995-10#2)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#2)(1995-7#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-6#2)(1997-7#2)(1997-8#3)(2006-10#2)(2006-8#2)(2007-10#2)(2007-12#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#4)
present study were to##11##4##(1990-10#1)(1996-3#1)(1996-4#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#1)(2010-2#1)(2010-8#1)(2011-12#1)(2012-2#1)
present study were##20##3##(1990-10#1)(1993-3#1)(1996-3#1)(1996-4#1)(1997-2#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-12#1)(2012-1#1)(2012-2#1)
present study##1718##2##(1990-1#1)(1990-10#8)(1990-11#5)(1990-12#5)(1990-2#7)(1990-3#3)(1990-4#4)(1990-5#7)(1990-6#5)(1990-7#8)(1990-8#2)(1990-9#3)(1991-1#5)(1991-10#6)(1991-11#2)(1991-12#4)(1991-2#6)(1991-3#1)(1991-4#1)(1991-5#5)(1991-6#7)(1991-7#5)(1991-8#10)(1991-9#7)(1992-1#4)(1992-10#3)(1992-11#2)(1992-12#11)(1992-2#2)(1992-3#7)(1992-4#2)(1992-5#2)(1992-6#2)(1992-7#4)(1992-8#11)(1992-9#8)(1993-1#5)(1993-11#6)(1993-12#19)(1993-2#5)(1993-3#6)(1993-4#7)(1993-5#2)(1993-6#10)(1993-7#9)(1993-8#2)(1993-9#11)(1994-10#7)(1994-11#11)(1994-12#11)(1994-2#24)(1994-3#12)(1994-5#8)(1994-6#15)(1994-8#14)(1994-9#9)(1995-1#7)(1995-10#8)(1995-11#7)(1995-12#22)(1995-2#8)(1995-3#13)(1995-4#1)(1995-5#5)(1995-7#5)(1995-8#8)(1995-9#2)(1996-1#10)(1996-10#5)(1996-11#2)(1996-12#12)(1996-2#10)(1996-3#7)(1996-4#3)(1996-5#12)(1996-6#8)(1996-7#8)(1996-8#5)(1996-9#5)(1997-1#5)(1997-2#15)(1997-3#8)(1997-4#11)(1997-5#10)(1997-6#11)(1997-7#13)(1997-8#12)(2003-11#1)(2004-11#7)(2004-12#4)(2004-2#1)(2004-4#2)(2004-9#4)(2005-10#4)(2005-11#3)(2005-12#2)(2006-1#5)(2006-10#13)(2006-11#2)(2006-12#3)(2006-2#2)(2006-3#1)(2006-4#6)(2006-5#3)(2006-6#5)(2006-7#3)(2006-8#15)(2006-9#3)(2007-1#3)(2007-10#24)(2007-11#13)(2007-12#19)(2007-2#12)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#27)(2007-8#23)(2007-9#15)(2008-1#4)(2008-10#77)(2008-11#36)(2008-12#32)(2008-2#8)(2008-3#10)(2008-4#14)(2008-5#57)(2008-6#18)(2008-7#31)(2008-8#17)(2008-9#17)(2009-1#3)(2009-10#4)(2009-11#4)(2009-12#8)(2009-2#8)(2009-3#4)(2009-4#6)(2009-5#5)(2009-6#14)(2009-7#8)(2009-8#6)(2009-9#6)(2010-1#3)(2010-10#8)(2010-11#3)(2010-12#20)(2010-2#13)(2010-3#10)(2010-4#12)(2010-5#11)(2010-6#1)(2010-7#5)(2010-8#12)(2010-9#7)(2011-1#21)(2011-12#12)(2011-2#70)(2011-3#1)(2011-7#1)(2012-1#16)(2012-11#1)(2012-12#35)(2012-2#53)(2012-3#18)(2012-5#4)(2012-6#1)(2013-1#63)(2013-3#1)(2013-7#19)(2013-8#43)
present such a##2##3##(2006-7#1)(2008-11#1)
present such##5##2##(1990-8#1)(1992-3#1)(2006-7#1)(2008-11#1)(2012-2#1)
present survey##3##2##(1994-1#1)(2013-1#1)(2013-8#1)
present system##18##2##(1992-4#1)(1992-9#1)(1994-1#1)(1995-6#1)(1996-10#1)(2006-6#2)(2007-7#1)(2008-10#7)(2008-2#1)(2008-8#2)
present systematic##2##2##(1996-11#1)(2009-11#1)
present techniques##2##2##(1993-9#1)(2008-5#1)
present tense/agreement morphology##2##3##(2012-1#2)
present tense/agreement##4##2##(2012-1#4)
present text##2##2##(2007-3#1)(2013-8#1)
present that##2##2##(1991-6#1)(2008-4#1)
present the analysis of##3##4##(2006-10#1)(2008-10#1)(2012-1#1)
present the application of##3##4##(2008-3#2)(2010-7#1)
present the basic##2##3##(2008-1#1)(2008-10#1)
present the best##3##3##(2005-8#1)(2011-2#1)(2013-1#1)
present the case of a man##3##6##(2006-6#1)(2008-11#1)(2008-8#1)
present the case of a patient who##3##7##(2005-10#1)(2008-10#1)(2008-5#1)
present the case of a patient with##6##7##(2005-12#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#1)(2013-1#1)
present the case of a patient##9##6##(2005-10#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#1)(2008-10#1)(2008-5#1)(2013-1#1)
present the case of a##64##5##(1991-6#1)(2005-10#1)(2005-12#2)(2006-10#2)(2006-12#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-8#4)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#6)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#4)
present the case of an##6##5##(2007-11#1)(2008-5#1)(2008-7#1)(2010-12#1)(2013-1#2)
present the case of##76##4##(1991-6#1)(2005-10#1)(2005-12#2)(2006-10#2)(2006-12#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-8#4)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#7)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#2)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#6)
present the case report of a##3##6##(2010-6#1)(2013-1#2)
present the case report of##4##5##(2010-6#1)(2012-2#1)(2013-1#2)
present the case##83##3##(1991-6#1)(2005-10#1)(2005-12#2)(2006-10#2)(2006-12#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-8#4)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#7)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#7)
present the clinical##5##3##(1995-10#1)(2007-8#1)(2008-7#1)(2009-12#1)(2012-12#1)
present the complete nucleotide sequence of the##2##7##(1992-11#1)(1994-12#1)
present the complete nucleotide sequence##3##5##(1992-11#1)(1994-12#1)(1995-2#1)
present the complete##5##3##(1991-12#1)(1992-11#1)(1994-12#1)(1995-2#1)(2008-10#1)
present the concept of##3##4##(2006-12#1)(2007-11#1)(2008-3#1)
present the construction of##3##4##(1994-12#1)(2013-1#2)
present the current knowledge##2##4##(2008-1#1)(2010-12#1)
present the current state of##2##5##(2007-11#1)(2007-8#1)
present the current##5##3##(2007-11#1)(2007-8#1)(2008-1#1)(2008-5#1)(2010-12#1)
present the design and##5##4##(2007-11#1)(2007-12#1)(2007-6#1)(2008-2#1)(2008-3#1)
present the design of##5##4##(2007-4#1)(2008-2#1)(2008-3#2)(2012-1#1)
present the design##12##3##(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-2#3)(2008-3#3)(2012-1#1)(2013-1#1)
present the development of a##5##5##(2008-11#1)(2012-2#1)(2013-1#2)(2013-8#1)
present the development##6##3##(2008-11#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
present the diagnostic##2##3##(1993-8#1)(2007-11#1)
present the evidence##2##3##(2005-10#1)(2011-1#1)
present the first case of##3##5##(2006-12#1)(2010-12#1)(2012-2#1)
present the first case##4##4##(2006-12#1)(2008-10#1)(2010-12#1)(2012-2#1)
present the first experimental##2##4##(2007-12#1)(2008-7#1)
present the first in vivo##2##5##(2009-5#1)(2011-1#1)
present the first report##2##4##(1993-9#1)(2007-12#1)
present the first study##2##4##(2009-4#1)(2010-9#1)
present the first##33##3##(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1995-5#1)(2006-12#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#3)(2008-8#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
present the history of##2##4##(1993-1#1)(2007-8#1)
present the history##3##3##(1993-1#1)(2007-8#1)(2008-2#1)
present the identification of##2##4##(1991-5#1)(2011-1#1)
present the major##3##3##(2007-5#1)(2008-3#1)(2012-3#1)
present the method##2##3##(1996-3#1)(2008-2#1)
present the most recently##2##4##(1993-2#1)(2008-1#1)
present the most##11##3##(1993-2#1)(2005-10#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
present the possibility that##2##4##(2008-11#1)(2008-9#1)
present the possibility##3##3##(1992-2#1)(2008-11#1)(2008-9#1)
present the possible##2##3##(2007-4#1)(2011-2#1)
present the problems##2##3##(2007-7#1)(2007-8#1)
present the results obtained##3##4##(1995-11#1)(2008-10#1)(2013-8#1)
present the results of a study of##2##7##(1996-12#1)(2007-12#1)
present the results of a study##4##6##(1991-9#1)(1996-12#1)(2007-12#1)(2009-6#1)
present the results of a##16##5##(1990-5#1)(1991-12#1)(1991-9#1)(1993-5#1)(1996-12#1)(1996-4#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)
present the results of an##6##5##(1991-7#1)(1993-2#1)(2007-11#1)(2008-2#1)(2008-3#2)
present the results of research##2##5##(2007-11#1)(2008-2#1)
present the results of the##4##5##(2007-3#1)(2008-2#1)(2008-3#1)(2010-9#1)
present the results of##53##4##(1990-5#1)(1990-6#1)(1991-12#1)(1991-7#1)(1991-9#1)(1993-2#1)(1993-5#1)(1994-3#1)(1996-1#1)(1996-12#1)(1996-4#1)(2004-9#1)(2007-11#5)(2007-12#7)(2007-3#1)(2008-10#1)(2008-2#8)(2008-3#7)(2008-4#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#1)(2010-12#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-1#1)
present the results##60##3##(1990-5#1)(1990-6#1)(1991-12#1)(1991-7#1)(1991-9#1)(1993-2#1)(1993-5#1)(1994-3#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-4#1)(1997-7#1)(2004-9#1)(2007-11#5)(2007-12#7)(2007-3#1)(2008-10#2)(2008-2#9)(2008-3#7)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#1)(2010-12#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-1#1)(2013-8#1)
present the successful##2##3##(2007-7#1)(2010-7#1)
present the technique of##4##4##(2007-8#1)(2008-3#2)(2012-2#1)
present the technique##6##3##(2006-6#1)(2007-8#1)(2008-10#1)(2008-3#2)(2012-2#1)
present the theoretical##2##3##(2007-11#1)(2008-2#1)
present the treatment results of##2##5##(2007-11#1)(2011-2#1)
present the use of##3##4##(2008-10#1)(2008-2#1)(2008-4#1)
present the##435##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1993-1#1)(1993-2#3)(1993-3#1)(1993-5#5)(1993-6#5)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#3)(1994-3#2)(1995-10#2)(1995-11#1)(1995-2#1)(1995-5#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-3#2)(1997-6#2)(1997-7#2)(1997-9#1)(2004-9#1)(2005-10#4)(2005-11#1)(2005-12#2)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#3)(2006-4#1)(2006-5#1)(2006-6#2)(2006-9#1)(2007-10#2)(2007-11#18)(2007-12#21)(2007-2#4)(2007-3#3)(2007-4#5)(2007-5#3)(2007-6#1)(2007-7#7)(2007-8#12)(2008-1#5)(2008-10#18)(2008-11#8)(2008-12#1)(2008-2#26)(2008-3#31)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#11)(2008-8#5)(2008-9#6)(2009-10#2)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#2)(2010-10#2)(2010-11#1)(2010-12#13)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#1)(2010-9#8)(2011-1#13)(2011-12#2)(2011-2#19)(2012-1#9)(2012-12#6)(2012-2#9)(2012-3#7)(2013-1#18)(2013-7#5)(2013-8#13)
present their experience##2##3##(2008-6#1)(2011-2#1)
present their own##5##3##(1991-4#1)(1995-5#1)(2007-11#1)(2007-8#2)
present their##23##2##(1990-5#1)(1991-4#1)(1993-3#1)(1995-5#1)(2005-9#1)(2006-11#2)(2006-3#1)(2006-7#1)(2007-11#1)(2007-8#3)(2008-6#1)(2008-7#2)(2008-9#2)(2009-12#1)(2009-4#2)(2011-2#1)(2012-2#1)
present theoretical##4##2##(1991-2#1)(2007-11#1)(2007-12#1)(2008-3#1)
present theory##2##2##(2006-10#1)(2008-10#1)
present therapeutic##4##2##(1991-11#1)(1995-5#1)(2007-8#1)(2009-8#1)
present there are only##2##4##(2008-11#1)(2011-2#1)
present there are##4##3##(1992-2#1)(2005-7#1)(2008-11#1)(2011-2#1)
present there is no##4##4##(1990-4#1)(1992-2#1)(1996-12#1)(2011-1#1)
present there is##5##3##(1990-4#1)(1992-2#1)(1996-12#1)(2011-1#1)(2013-8#1)
present there##12##2##(1990-4#1)(1991-12#1)(1992-2#2)(1996-12#1)(1997-6#1)(2005-7#1)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
present these##4##2##(2007-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
present they##2##2##(2006-2#1)(2008-8#1)
present this case##8##3##(2006-10#1)(2007-4#1)(2007-8#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-12#1)(2012-3#1)
present this##19##2##(1992-10#1)(1992-3#2)(2005-7#1)(2006-10#1)(2006-5#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-3#1)(2009-6#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
present three cases of##4##4##(1997-8#1)(2006-10#1)(2007-8#1)(2011-1#1)
present three cases##6##3##(1997-8#1)(2006-10#1)(2007-8#1)(2008-4#1)(2011-1#2)
present three##16##2##(1991-11#1)(1992-2#1)(1992-7#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-11#1)(2009-12#1)(2011-1#2)
present throughout the year##3##4##(1993-9#1)(2008-10#1)(2008-3#1)
present throughout the##10##3##(1991-5#1)(1993-9#1)(2004-2#2)(2006-11#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#1)
present throughout##13##2##(1991-5#1)(1993-9#1)(1994-2#1)(1997-2#2)(2004-2#2)(2006-11#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#1)
present time##43##2##(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-3#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-9#1)(1996-12#1)(1996-3#2)(1997-3#1)(1997-4#1)(1997-8#1)(2006-1#1)(2006-10#3)(2006-5#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-3#2)
present to a##5##3##(1991-8#1)(2006-8#1)(2007-11#1)(2007-6#1)(2008-10#1)
present to different degrees##2##4##(1993-7#1)(1994-5#1)
present to the emergency department##2##5##(2007-5#1)(2007-7#1)
present to the##10##3##(2006-11#1)(2006-7#1)(2007-5#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-9#1)(2013-1#2)
present to##39##2##(1991-8#1)(1992-12#1)(1993-5#1)(1993-7#1)(1994-5#1)(1996-6#1)(1997-6#1)(1997-8#1)(2004-3#1)(2005-11#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-9#2)(2010-10#1)(2010-12#2)(2010-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#3)
present together in##2##3##(1994-5#1)(2012-7#1)
present together with##2##3##(1995-1#1)(2011-2#1)
present together##6##2##(1993-6#1)(1994-5#1)(1995-1#1)(2008-10#1)(2011-2#1)(2012-7#1)
present treatment##3##2##(2006-12#1)(2007-7#1)(2012-12#1)
present tumor##2##2##(2006-10#1)(2012-1#1)
present two case##2##3##(2008-6#1)(2009-6#1)
present two cases of##25##4##(2005-7#1)(2007-2#1)(2007-4#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2012-3#3)(2013-1#3)(2013-8#1)
present two cases##29##3##(2005-7#1)(2007-2#1)(2007-4#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-3#3)(2013-1#4)(2013-8#1)
present two examples##2##3##(1992-9#1)(2008-1#1)
present two new##2##3##(2007-12#1)(2008-2#1)
present two novel##2##3##(2008-2#1)(2008-3#1)
present two patients##4##3##(1993-5#1)(2006-10#1)(2006-12#1)(2011-2#1)
present two##62##2##(1992-9#1)(1993-5#1)(1995-8#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-3#3)(2013-1#5)(2013-8#2)
present typical##2##2##(2007-7#1)(2008-3#1)
present ubiquitously##2##2##(1995-11#1)(1997-2#1)
present under##4##2##(1991-9#1)(2008-10#1)(2008-8#1)(2012-2#1)
present understanding of the##2##4##(2006-10#1)(2008-10#1)
present understanding##4##2##(1990-12#1)(2006-10#2)(2008-10#1)
present unique challenges##2##3##(1997-2#1)(2010-9#1)
present unique##3##2##(1997-2#1)(2009-10#1)(2010-9#1)
present upstream of##2##3##(1997-2#1)(2008-7#1)
present upstream##3##2##(1991-7#1)(1997-2#1)(2008-7#1)
present using##2##2##(1991-12#1)(1992-1#1)
present various##5##2##(1997-6#1)(2007-11#1)(2007-8#1)(2008-2#1)(2013-1#1)
present very##2##2##(1997-6#1)(2008-10#1)
present was##5##2##(1995-2#1)(1996-3#1)(2007-12#1)(2008-10#1)(2012-12#1)
present we##3##2##(1990-5#1)(1995-6#1)(2010-8#1)
present were##5##2##(1994-2#1)(2008-10#2)(2011-2#1)(2013-8#1)
present what to our knowledge is a novel##2##8##(2008-2#1)(2008-3#1)
present what to our knowledge is a##4##7##(2008-2#2)(2008-3#2)
present what we believe is##4##5##(2008-3#4)
present what we believe to be the first##3##8##(2007-11#1)(2007-12#1)(2008-1#1)
present what we believe to be##5##6##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#2)
present what we believe##10##4##(2007-11#1)(2007-12#2)(2008-1#1)(2008-3#6)
present what##28##2##(2007-11#4)(2007-12#8)(2008-1#2)(2008-2#4)(2008-3#10)
present when the Reveal test scores##2##6##(2006-10#2)
present when the##6##3##(1991-12#1)(1992-10#1)(1994-2#1)(1995-4#1)(2006-10#2)
present when there##2##3##(1991-3#1)(2011-2#1)
present when##15##2##(1991-11#1)(1991-12#1)(1991-3#1)(1992-10#1)(1994-2#1)(1995-4#1)(1997-7#1)(2006-10#2)(2006-5#1)(2008-1#1)(2008-10#3)(2011-2#1)
present which##6##2##(1991-3#1)(1995-2#1)(1996-3#1)(2008-10#1)(2010-12#1)(2012-12#1)
present with a##16##3##(1990-8#1)(1991-7#1)(2005-2#1)(2007-12#1)(2007-2#2)(2008-10#1)(2008-7#2)(2009-3#2)(2010-9#2)(2011-1#2)(2012-2#1)
present with abdominal pain##2##4##(2010-12#1)(2013-1#1)
present with abdominal##3##3##(2010-12#1)(2013-1#2)
present with advanced disease##2##4##(2010-12#1)(2010-2#1)
present with advanced stage##2##4##(2010-12#1)(2012-1#1)
present with advanced##6##3##(2005-10#1)(2010-12#2)(2010-2#1)(2012-1#1)(2012-12#1)
present with atypical##3##3##(2006-10#1)(2012-12#1)(2013-1#1)
present with chronic##6##3##(2005-12#1)(2006-1#1)(2006-8#1)(2009-6#1)(2011-11#1)(2013-7#1)
present with clinical manifestations##2##4##(2006-10#1)(2010-2#1)
present with clinical##3##3##(2006-10#1)(2008-3#1)(2010-2#1)
present with dyspnea and##2##4##(2009-1#1)(2009-6#1)
present with high##2##3##(2008-1#1)(2012-2#1)
present with multiple##2##3##(2006-10#1)(2013-1#1)
present with pain##2##3##(1990-12#1)(1993-5#1)
present with secondary##2##3##(1997-2#1)(2011-1#1)
present with severe##5##3##(2006-7#1)(2009-6#1)(2010-1#1)(2010-12#1)(2011-2#1)
present with short##2##3##(2009-9#1)(2012-2#1)
present with symptoms##5##3##(2007-2#1)(2008-11#1)(2008-4#1)(2008-9#1)(2013-8#1)
present with the##2##3##(2009-3#1)(2010-6#1)
present with this##3##3##(2007-6#1)(2008-10#1)(2008-5#1)
present with unilateral##2##3##(2011-2#1)(2012-1#1)
present with vague##2##3##(2006-2#1)(2011-1#1)
present with various##2##3##(2008-11#1)(2008-2#1)
present with##168##2##(1990-12#1)(1990-8#1)(1990-9#1)(1991-6#1)(1991-7#1)(1993-10#1)(1993-5#1)(1996-12#1)(1997-2#1)(2004-3#1)(2005-10#1)(2005-12#2)(2005-2#1)(2005-6#1)(2005-8#1)(2006-1#2)(2006-10#11)(2006-12#4)(2006-2#3)(2006-3#1)(2006-7#2)(2006-8#2)(2007-11#4)(2007-12#3)(2007-2#3)(2007-4#2)(2007-6#1)(2007-7#4)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#5)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#5)(2009-6#5)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#7)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#9)(2011-11#1)(2011-2#7)(2012-1#2)(2012-12#2)(2012-2#8)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#3)
present within a##3##3##(1996-5#1)(2007-7#1)(2008-3#1)
present within the##14##3##(1991-9#1)(1992-12#1)(1992-3#1)(1994-6#1)(1995-5#1)(1997-7#1)(2007-2#1)(2007-3#1)(2008-10#2)(2008-5#2)(2010-3#1)(2010-9#1)
present within##27##2##(1990-7#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1994-12#1)(1994-6#1)(1995-10#1)(1995-5#1)(1996-5#1)(1997-4#1)(1997-7#1)(2006-6#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-5#2)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#1)
present without mating##2##3##(2009-4#2)
present without##4##2##(2008-2#1)(2009-4#2)(2012-1#1)
present work examined##2##3##(2008-11#1)(2009-7#1)
present work is##13##3##(1995-2#1)(1995-6#1)(1996-12#1)(1997-2#1)(2004-2#1)(2005-1#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-8#1)(2009-12#1)(2011-2#1)
present work shows the##3##4##(1996-5#1)(2008-10#1)(2008-5#1)
present work was##23##3##(1990-12#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-3#1)(1994-9#1)(1996-5#1)(1996-8#1)(1997-8#1)(2005-11#1)(2007-3#1)(2008-10#3)(2008-5#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#3)
present work##201##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-7#2)(1991-1#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#2)(1992-5#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-6#1)(1995-8#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-8#2)(1996-9#1)(1997-2#2)(1997-4#3)(1997-5#1)(1997-7#2)(1997-8#1)(2004-2#1)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#4)(2006-10#5)(2006-4#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#56)(2008-11#5)(2008-12#1)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#3)(2009-11#1)(2009-12#2)(2009-5#1)(2009-7#2)(2009-8#2)(2010-1#1)(2010-11#1)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#3)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#4)
present would##2##2##(2006-8#1)(2008-12#1)
present##9987##1##(1990-1#3)(1990-10#28)(1990-11#42)(1990-12#54)(1990-2#25)(1990-3#27)(1990-4#23)(1990-5#37)(1990-6#15)(1990-7#40)(1990-8#30)(1990-9#21)(1991-1#16)(1991-10#21)(1991-11#24)(1991-12#39)(1991-2#34)(1991-3#29)(1991-4#16)(1991-5#45)(1991-6#33)(1991-7#26)(1991-8#34)(1991-9#44)(1992-1#17)(1992-10#12)(1992-11#27)(1992-12#51)(1992-2#35)(1992-3#50)(1992-4#24)(1992-5#17)(1992-6#40)(1992-7#28)(1992-8#47)(1992-9#34)(1993-1#15)(1993-10#3)(1993-11#34)(1993-12#52)(1993-2#27)(1993-3#42)(1993-4#20)(1993-5#20)(1993-6#43)(1993-7#15)(1993-8#33)(1993-9#46)(1994-1#4)(1994-10#18)(1994-11#30)(1994-12#55)(1994-2#68)(1994-3#46)(1994-4#2)(1994-5#27)(1994-6#53)(1994-7#9)(1994-8#56)(1994-9#44)(1995-1#28)(1995-10#19)(1995-11#29)(1995-12#49)(1995-2#45)(1995-3#48)(1995-4#13)(1995-5#37)(1995-6#24)(1995-7#15)(1995-8#43)(1995-9#11)(1996-1#23)(1996-10#13)(1996-11#20)(1996-12#59)(1996-2#32)(1996-3#29)(1996-4#20)(1996-5#45)(1996-6#24)(1996-7#21)(1996-8#28)(1996-9#24)(1997-1#31)(1997-2#56)(1997-3#47)(1997-4#55)(1997-5#31)(1997-6#43)(1997-7#51)(1997-8#40)(1997-9#1)(2003-11#1)(2004-1#6)(2004-11#12)(2004-12#6)(2004-2#11)(2004-3#4)(2004-4#8)(2004-8#2)(2004-9#8)(2005-1#3)(2005-10#26)(2005-11#52)(2005-12#12)(2005-2#1)(2005-3#1)(2005-5#2)(2005-6#2)(2005-7#26)(2005-8#20)(2005-9#5)(2006-1#19)(2006-10#169)(2006-11#15)(2006-12#58)(2006-2#27)(2006-3#18)(2006-4#21)(2006-5#26)(2006-6#39)(2006-7#19)(2006-8#52)(2006-9#25)(2007-1#18)(2007-10#56)(2007-11#191)(2007-12#308)(2007-2#47)(2007-3#31)(2007-4#29)(2007-5#33)(2007-6#23)(2007-7#116)(2007-8#166)(2007-9#43)(2008-1#94)(2008-10#831)(2008-11#208)(2008-12#108)(2008-2#285)(2008-3#337)(2008-4#136)(2008-5#230)(2008-6#102)(2008-7#225)(2008-8#133)(2008-9#121)(2009-1#12)(2009-10#41)(2009-11#21)(2009-12#33)(2009-2#33)(2009-3#37)(2009-4#49)(2009-5#37)(2009-6#46)(2009-7#33)(2009-8#54)(2009-9#35)(2010-1#20)(2010-10#26)(2010-11#26)(2010-12#102)(2010-2#49)(2010-3#39)(2010-4#53)(2010-5#47)(2010-6#31)(2010-7#31)(2010-8#58)(2010-9#47)(2011-1#139)(2011-10#2)(2011-11#2)(2011-12#42)(2011-2#276)(2011-3#4)(2011-7#2)(2012-1#73)(2012-11#20)(2012-12#158)(2012-2#202)(2012-3#108)(2012-5#4)(2012-6#1)(2012-7#4)(2012-9#3)(2013-1#302)(2013-3#1)(2013-7#69)(2013-8#144)
present)##10##1##(1990-12#2)(1995-2#1)(1996-10#1)(2004-2#1)(2005-11#1)(2008-10#2)(2008-8#1)(2010-12#1)
present-day##15##1##(1990-11#1)(1997-4#1)(2005-7#1)(2006-12#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-7#1)(2008-8#2)
present]##2##1##(1993-3#1)(2008-3#1)
presentation after##5##2##(2007-10#1)(2008-1#1)(2013-1#3)
presentation and a##3##3##(2005-10#1)(2007-9#1)(2010-5#1)
presentation and advanced HIV disease were##2##6##(2013-1#2)
presentation and diagnosis##2##3##(2006-4#1)(2009-5#1)
presentation and diagnostic##3##3##(1991-8#1)(2008-7#1)(2010-8#1)
presentation and discussion##4##3##(1991-6#1)(2005-8#1)(2008-5#1)(2012-2#1)
presentation and is##2##3##(1996-2#1)(2012-2#1)
presentation and its##2##3##(1995-11#1)(2006-9#1)
presentation and management of##2##4##(2007-3#1)(2008-7#1)
presentation and management##5##3##(2007-3#1)(2008-4#1)(2008-7#1)(2010-3#1)(2011-2#1)
presentation and method of delivery on neonatal mortality and##2##9##(1992-12#2)
presentation and outcome##4##3##(1993-5#1)(2006-9#1)(2007-2#1)(2009-4#1)
presentation and rapid##2##3##(2005-11#1)(2009-3#1)
presentation and response to##2##4##(2006-10#1)(2010-12#1)
presentation and the##6##3##(2006-10#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-9#1)(2012-3#1)
presentation and treatment##3##3##(2009-6#1)(2010-8#1)(2011-1#1)
presentation and##115##2##(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-8#1)(1993-5#1)(1995-10#1)(1995-11#2)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(2004-10#1)(2004-11#1)(2005-10#2)(2005-11#1)(2005-8#2)(2006-10#3)(2006-12#1)(2006-4#1)(2006-6#1)(2006-9#2)(2007-11#1)(2007-12#1)(2007-2#5)(2007-3#2)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-12#4)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#8)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
presentation as##5##2##(1997-6#1)(2008-8#1)(2009-9#1)(2010-4#1)(2011-2#1)
presentation at a conference##2##4##(2008-10#1)(2008-12#1)
presentation at##4##2##(1990-12#1)(2008-10#1)(2008-12#1)(2009-10#1)
presentation because of##2##3##(2008-11#1)(2012-3#1)
presentation but##2##2##(2006-10#1)(2012-12#1)
presentation by##10##2##(1991-12#1)(1992-8#1)(1995-5#1)(1995-8#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-3#1)
presentation can be##3##3##(2010-8#1)(2010-9#1)(2012-3#1)
presentation can##5##2##(2005-7#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-3#1)
presentation despite##2##2##(1995-8#1)(2011-2#1)
presentation died##2##2##(2008-6#2)
presentation focuses on##4##3##(2008-1#1)(2008-10#1)(2009-9#1)(2012-12#1)
presentation for##7##2##(1994-2#1)(1995-5#1)(2008-10#1)(2010-10#1)(2010-6#1)(2013-1#2)
presentation from##4##2##(2006-9#1)(2007-7#1)(2008-10#1)(2008-7#1)
presentation has##3##2##(1992-12#1)(2006-2#1)(2012-2#1)
presentation in a##5##3##(2008-5#1)(2009-3#1)(2010-11#1)(2010-4#1)(2012-3#1)
presentation in order to##2##4##(1993-8#1)(2011-2#1)
presentation in the form of##2##5##(2007-7#1)(2008-7#1)
presentation in the##5##3##(1991-12#1)(2007-7#2)(2008-7#1)(2009-4#1)
presentation in these##2##3##(1995-8#1)(2007-7#1)
presentation in##32##2##(1991-11#1)(1991-12#1)(1992-3#1)(1993-8#1)(1995-8#1)(1997-2#1)(2005-8#1)(2007-2#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-3#1)(2009-4#4)(2009-8#1)(2010-11#1)(2010-4#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
presentation included##2##2##(2008-1#1)(2008-8#1)
presentation includes##2##2##(2010-9#1)(2012-12#1)
presentation involves##2##2##(2006-8#1)(2007-1#1)
presentation is usually associated with##2##5##(2008-11#1)(2012-2#1)
presentation is usually##4##3##(2008-11#1)(2009-6#1)(2011-11#1)(2012-2#1)
presentation is variable##2##3##(2005-8#1)(2009-9#1)
presentation is very##2##3##(1997-8#1)(2008-9#1)
presentation is##35##2##(1995-1#1)(1996-1#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-11#1)(2011-12#1)(2012-12#4)(2012-2#3)(2013-1#1)
presentation may be##7##3##(2007-4#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-8#1)(2012-12#1)(2012-3#1)
presentation may##13##2##(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-8#1)(2009-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
presentation methods##4##2##(2008-1#2)(2008-9#1)(2012-12#1)
presentation mimicked##2##2##(2006-10#1)(2007-2#1)
presentation of a case##3##4##(2006-9#1)(2007-11#1)(2010-10#1)
presentation of a patient with a##2##6##(2007-3#1)(2008-5#1)
presentation of a patient with##3##5##(2007-3#1)(2008-5#1)(2009-3#1)
presentation of a rare##3##4##(1997-3#1)(2012-3#1)(2013-1#1)
presentation of a##29##3##(1990-3#1)(1996-12#1)(1996-9#1)(1997-3#1)(2006-3#1)(2006-4#1)(2006-9#1)(2007-11#2)(2007-3#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
presentation of acute myeloid leukemia##2##5##(1990-8#1)(2007-11#1)
presentation of acute##5##3##(1990-8#1)(2007-1#1)(2007-11#1)(2009-3#1)(2012-2#1)
presentation of an##3##3##(2007-4#1)(2008-7#1)(2009-4#1)
presentation of antigen##3##3##(1994-11#1)(2006-10#1)(2007-11#1)
presentation of cervical##2##3##(2004-10#1)(2006-10#1)
presentation of choriocarcinoma##2##3##(2007-7#2)
presentation of chronic##2##3##(2009-11#1)(2010-11#1)
presentation of cutaneous##2##3##(2007-11#1)(2007-7#1)
presentation of hypertensive##2##3##(2006-10#1)(2012-2#1)
presentation of information##3##3##(1996-2#1)(2008-8#1)(2011-1#1)
presentation of malignant##2##3##(2005-10#1)(2008-1#1)
presentation of metastatic##4##3##(1990-12#1)(2006-8#1)(2007-10#1)(2009-3#1)
presentation of pellucid marginal degeneration##2##5##(2007-3#2)
presentation of primary hyperparathyroidism##2##4##(2008-12#1)(2012-12#1)
presentation of primary##3##3##(2008-12#1)(2012-12#1)(2012-2#1)
presentation of such##2##3##(2007-3#1)(2008-8#1)
presentation of systemic lupus erythematosus##2##5##(1994-2#1)(2007-7#1)
presentation of the disease and##2##5##(2010-12#1)(2010-9#1)
presentation of the disease##5##4##(2006-10#1)(2007-4#1)(2010-12#1)(2010-9#1)(2013-1#1)
presentation of the##36##3##(1990-10#1)(1992-11#1)(1992-7#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1997-2#1)(1997-6#1)(2006-10#4)(2006-2#1)(2007-11#3)(2007-4#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-6#1)(2010-12#1)(2010-9#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
presentation of their##2##3##(2006-2#1)(2007-7#1)
presentation of these##3##3##(2006-10#1)(2012-12#1)(2012-2#1)
presentation of this##11##3##(1990-6#1)(1990-9#1)(2005-7#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-6#1)(2010-12#1)(2011-2#1)(2012-3#1)
presentation of tuberculosis##3##3##(2010-4#1)(2011-2#2)
presentation of two cases##3##4##(2006-2#1)(2008-4#1)(2011-2#1)
presentation of two clinical##2##4##(1992-6#1)(2013-8#1)
presentation of two##9##3##(1992-6#1)(1997-7#1)(2005-9#1)(2006-2#1)(2008-4#2)(2011-2#1)(2012-11#1)(2013-8#1)
presentation of type 2 diabetes##3##5##(2006-2#1)(2008-11#1)(2008-3#1)
presentation of type##4##3##(2006-2#1)(2007-2#1)(2008-11#1)(2008-3#1)
presentation of words##2##3##(1990-8#2)
presentation of##335##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-6#1)(1994-11#2)(1994-2#2)(1994-8#1)(1995-10#1)(1995-12#1)(1995-2#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-10#1)(2004-7#2)(2005-10#1)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#18)(2006-2#7)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#3)(2006-9#5)(2007-1#2)(2007-10#2)(2007-11#16)(2007-12#2)(2007-2#3)(2007-3#8)(2007-4#4)(2007-5#2)(2007-6#1)(2007-7#12)(2007-8#3)(2007-9#2)(2008-1#6)(2008-10#3)(2008-11#10)(2008-12#4)(2008-2#3)(2008-3#3)(2008-4#7)(2008-5#7)(2008-6#9)(2008-7#4)(2008-8#6)(2008-9#4)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#7)(2009-4#2)(2009-6#2)(2009-8#3)(2010-10#1)(2010-11#2)(2010-12#10)(2010-2#2)(2010-3#3)(2010-4#2)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#13)(2012-1#4)(2012-11#3)(2012-12#10)(2012-2#14)(2012-3#4)(2013-1#6)(2013-7#4)(2013-8#3)
presentation on##3##2##(1992-12#1)(2008-10#1)(2008-4#1)
presentation or##5##2##(1997-8#1)(2008-6#4)
presentation order##2##2##(2008-12#2)
presentation skills##3##2##(1995-12#1)(1997-4#1)(2008-11#1)
presentation status##3##2##(2008-6#1)(2013-1#2)
presentation that##5##2##(1993-2#1)(2004-3#1)(2009-8#1)(2011-2#1)(2013-1#1)
presentation the##2##2##(2009-3#1)(2010-3#1)
presentation to the emergency department##2##5##(2007-10#1)(2012-2#1)
presentation to the##5##3##(2007-10#2)(2008-10#1)(2009-8#1)(2012-2#1)
presentation to##12##2##(1990-12#1)(1990-6#1)(2007-10#2)(2008-10#1)(2008-11#1)(2008-6#1)(2009-8#1)(2010-5#1)(2011-12#1)(2012-2#1)(2012-3#1)
presentation was by##2##3##(2007-3#1)(2008-1#1)
presentation was most consistent with##2##5##(2007-12#1)(2007-3#1)
presentation was##23##2##(1993-12#1)(1996-3#1)(2004-10#1)(2005-8#1)(2007-12#1)(2007-2#1)(2007-3#5)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-7#1)(2011-11#1)(2012-12#1)(2012-2#1)(2013-1#2)
presentation were##5##2##(1992-6#1)(2006-11#1)(2006-8#1)(2011-12#1)(2013-1#1)
presentation which might##2##3##(2007-2#1)(2012-2#1)
presentation will##9##2##(2007-11#1)(2008-10#1)(2008-7#2)(2013-1#5)
presentation with a##4##3##(1997-3#1)(2008-5#1)(2008-7#1)(2009-8#1)
presentation with the##3##3##(2005-8#1)(2008-4#1)(2012-2#1)
presentation with##20##2##(1997-3#1)(2005-8#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-7#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#3)
presentation##1119##1##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#4)(1990-7#1)(1990-8#4)(1990-9#3)(1991-1#1)(1991-11#3)(1991-12#5)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-10#1)(1992-11#1)(1992-12#7)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-12#5)(1993-2#5)(1993-3#1)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-4#1)(1994-6#3)(1994-7#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#3)(1995-2#2)(1995-5#3)(1995-8#7)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#4)(1996-6#2)(1996-9#1)(1997-2#3)(1997-3#4)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#8)(2004-1#1)(2004-10#11)(2004-11#1)(2004-3#1)(2004-7#2)(2005-10#7)(2005-11#3)(2005-12#2)(2005-2#1)(2005-7#5)(2005-8#11)(2005-9#2)(2006-10#45)(2006-11#2)(2006-12#7)(2006-2#13)(2006-3#2)(2006-4#5)(2006-5#3)(2006-6#2)(2006-7#3)(2006-8#10)(2006-9#10)(2007-1#3)(2007-10#8)(2007-11#22)(2007-12#13)(2007-2#20)(2007-3#24)(2007-4#9)(2007-5#6)(2007-6#7)(2007-7#33)(2007-8#18)(2007-9#8)(2008-1#24)(2008-10#28)(2008-11#27)(2008-12#15)(2008-2#5)(2008-3#12)(2008-4#20)(2008-5#16)(2008-6#35)(2008-7#25)(2008-8#18)(2008-9#11)(2009-1#1)(2009-10#8)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#14)(2009-4#9)(2009-5#3)(2009-6#8)(2009-7#1)(2009-8#16)(2009-9#4)(2010-1#1)(2010-10#3)(2010-11#5)(2010-12#19)(2010-2#4)(2010-3#7)(2010-4#7)(2010-5#6)(2010-6#2)(2010-7#7)(2010-8#5)(2010-9#10)(2011-1#23)(2011-11#3)(2011-12#11)(2011-2#39)(2012-1#8)(2012-11#6)(2012-12#30)(2012-2#46)(2012-3#18)(2013-1#49)(2013-7#11)(2013-8#16)
presentation)##4##1##(1996-9#1)(2007-12#2)(2013-1#1)
presentation]##2##1##(1991-11#1)(2010-12#1)
presentational##2##1##(2007-12#1)(2008-8#1)
presentations and a##3##3##(2013-1#2)(2013-7#1)
presentations and##27##2##(1991-12#1)(1991-4#1)(1992-2#1)(1994-7#1)(1996-9#1)(2005-8#2)(2005-9#2)(2006-10#1)(2006-2#1)(2008-3#1)(2008-5#4)(2008-7#2)(2009-8#1)(2010-11#1)(2010-6#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
presentations are##4##2##(2007-12#1)(2008-12#1)(2008-5#1)(2010-9#1)
presentations at the 2003##7##4##(2008-11#6)(2008-7#1)
presentations at the##51##3##(2005-8#1)(2008-11#45)(2008-5#1)(2008-7#1)(2009-10#1)(2010-11#1)(2012-12#1)
presentations at##53##2##(2005-8#1)(2008-11#45)(2008-5#2)(2008-7#1)(2009-10#1)(2010-11#1)(2010-4#1)(2012-12#1)
presentations by##2##2##(2005-7#1)(2008-3#1)
presentations during the##2##3##(2007-8#1)(2010-4#1)
presentations during##4##2##(1994-9#1)(2007-8#1)(2008-4#1)(2010-4#1)
presentations focused on##2##3##(2005-8#1)(2008-5#1)
presentations for##2##2##(2006-10#1)(2007-10#1)
presentations from##5##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#1)
presentations given##4##2##(2005-8#1)(2006-11#2)(2008-5#1)
presentations have been##3##3##(2006-10#1)(2010-12#1)(2011-2#1)
presentations in the##2##3##(2008-1#1)(2008-7#1)
presentations in##7##2##(2005-7#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2013-7#2)
presentations including##2##2##(2005-10#1)(2005-8#1)
presentations is##2##2##(1995-9#1)(2007-10#1)
presentations of the##2##3##(2008-10#1)(2009-3#1)
presentations of this##2##3##(2008-4#1)(2012-3#1)
presentations of tropical diseases in travelers##2##6##(2011-2#2)
presentations of##26##2##(1991-3#1)(1994-11#2)(1997-8#1)(2006-10#3)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-8#1)(2009-3#1)(2010-12#2)(2011-1#1)(2011-2#3)(2012-3#1)
presentations on the##2##3##(2005-8#1)(2011-2#1)
presentations on topics##2##3##(1995-9#1)(2005-8#1)
presentations on##7##2##(1995-9#1)(1996-3#1)(2005-7#1)(2005-8#3)(2011-2#1)
presentations that##5##2##(2007-7#1)(2008-12#1)(2008-6#1)(2008-7#1)(2010-6#1)
presentations were also##2##3##(2005-8#1)(2008-10#1)
presentations were##13##2##(2005-7#1)(2005-8#3)(2007-11#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-5#1)(2009-10#2)(2011-11#1)
presentations with##2##2##(2006-2#1)(2008-3#1)
presentations##263##1##(1991-12#1)(1991-3#1)(1991-4#1)(1992-2#1)(1993-1#1)(1993-7#1)(1994-11#2)(1994-7#1)(1994-9#1)(1995-1#1)(1995-9#2)(1996-2#1)(1996-3#1)(1996-9#1)(1997-7#1)(1997-8#2)(2005-10#2)(2005-11#1)(2005-7#5)(2005-8#20)(2005-9#4)(2006-1#1)(2006-10#9)(2006-11#5)(2006-12#2)(2006-2#2)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#5)(2007-2#2)(2007-4#5)(2007-6#1)(2007-7#5)(2007-8#1)(2008-1#5)(2008-10#4)(2008-11#49)(2008-12#5)(2008-2#3)(2008-3#5)(2008-4#5)(2008-5#18)(2008-6#5)(2008-7#8)(2008-8#1)(2009-10#6)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#2)(2010-6#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-11#1)(2011-2#12)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#5)(2013-8#3)
presented a case of##4##4##(1990-12#1)(2007-8#1)(2011-12#1)(2011-2#1)
presented a case##5##3##(1990-12#1)(2007-8#1)(2011-12#1)(2011-2#1)(2013-8#1)
presented a good##3##3##(2008-10#3)
presented a high##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
presented a higher##2##3##(2008-12#1)(2008-5#1)
presented a large##2##3##(2005-8#1)(2011-2#1)
presented a more##2##3##(1992-4#1)(2011-2#1)
presented a rapidly##2##3##(1994-8#1)(2013-7#1)
presented a significant##2##3##(2006-12#1)(2013-8#1)
presented a spontaneous##2##3##(1991-4#1)(2007-8#1)
presented a##95##2##(1990-12#1)(1990-8#1)(1991-10#1)(1991-2#2)(1991-4#1)(1991-6#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-5#1)(1994-11#1)(1994-6#1)(1994-8#1)(1996-10#1)(1996-11#1)(1997-4#1)(1997-8#1)(2004-3#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#6)(2007-9#1)(2008-10#11)(2008-12#2)(2008-2#2)(2008-5#6)(2008-7#1)(2008-8#1)(2010-11#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#7)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#7)
presented according to##2##3##(1993-6#1)(2009-4#1)
presented acutely##2##2##(2008-3#1)(2008-8#1)
presented after##4##2##(2006-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
presented again##2##2##(2007-10#1)(2008-6#1)
presented all##2##2##(1991-4#1)(2009-5#1)
presented along with a##3##4##(2006-12#1)(2007-5#1)(2008-2#1)
presented along with the##2##4##(2007-12#1)(2008-10#1)
presented along with##13##3##(1993-9#1)(2006-12#2)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2012-1#1)
presented alteration##2##2##(2008-10#1)(2013-1#1)
presented an analytical##4##3##(2008-10#3)(2008-3#1)
presented an increased##2##3##(1991-3#1)(2008-10#1)
presented an overview of##2##4##(1997-5#1)(2008-10#1)
presented an##26##2##(1990-8#1)(1991-3#1)(1994-5#1)(1996-8#1)(1997-5#1)(2006-8#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-3#1)(2008-6#2)(2008-9#1)(2009-10#1)(2011-2#2)(2013-7#1)(2013-8#1)
presented analysis##2##2##(2007-12#1)(2011-2#1)
presented and a##6##3##(1991-12#1)(1995-12#1)(2008-10#1)(2008-8#1)(2009-2#1)(2011-1#1)
presented and analyzed##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
presented and compared to##2##4##(1993-6#1)(2008-11#1)
presented and compared with experimental data##2##6##(2006-5#1)(2008-2#1)
presented and compared with other##2##5##(1992-2#1)(2008-3#1)
presented and compared with##13##4##(1990-4#1)(1991-12#1)(1991-2#1)(1992-2#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2013-1#1)
presented and compared##15##3##(1990-4#1)(1991-12#1)(1991-2#1)(1992-2#1)(1993-6#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2013-1#1)
presented and discussed in terms of##2##6##(2006-6#1)(2007-5#1)
presented and discussed in##5##4##(2005-7#1)(2006-6#1)(2007-5#1)(2007-8#1)(2008-5#1)
presented and discussed##47##3##(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1994-12#1)(1995-5#1)(1996-1#1)(1996-2#1)(2005-11#3)(2005-7#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-5#1)(2007-6#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#6)(2008-5#3)(2008-6#1)(2008-7#1)(2009-3#1)(2012-12#1)
presented and explained##3##3##(2007-12#1)(2008-10#2)
presented and shows##3##3##(1990-4#1)(2007-12#1)(2013-8#1)
presented and the##15##3##(1990-12#2)(1995-6#1)(2006-10#1)(2008-10#2)(2008-2#2)(2008-3#1)(2009-11#1)(2009-9#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-7#1)
presented and their##3##3##(2008-1#1)(2008-10#1)(2008-2#1)
presented and used to##3##4##(1993-3#1)(1994-5#1)(2008-12#1)
presented and used##4##3##(1993-3#1)(1994-5#1)(2008-12#1)(2008-2#1)
presented and##150##2##(1990-12#2)(1990-3#1)(1990-4#2)(1990-5#1)(1990-8#1)(1991-12#3)(1991-2#2)(1992-11#2)(1992-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#2)(1994-5#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-8#1)(1997-3#1)(1997-7#1)(2004-12#1)(2005-11#3)(2005-4#1)(2005-6#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#7)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#4)(2008-12#1)(2008-2#14)(2008-3#20)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#4)(2011-7#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
presented are##13##2##(1995-6#1)(1996-5#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#5)(2008-9#1)
presented as a function of##2##5##(2007-10#1)(2008-3#1)
presented as a means##3##4##(1997-3#1)(2008-3#1)(2010-4#1)
presented as a new##5##4##(2007-12#2)(2008-10#2)(2012-2#1)
presented as a working hypothesis in Part 1##2##8##(2008-12#2)
presented as a##50##3##(1991-12#2)(1993-1#1)(1993-12#1)(1996-12#1)(1996-5#1)(1997-3#1)(2004-2#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-7#1)(2008-10#4)(2008-12#2)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-2#3)
presented as an alternative to##2##5##(1990-8#1)(2008-10#1)
presented as an alternative##3##4##(1990-8#1)(2008-10#1)(2008-3#1)
presented as an example##5##4##(1994-4#1)(1997-8#1)(2008-2#1)(2009-8#1)(2013-8#1)
presented as an##31##3##(1990-8#1)(1993-9#2)(1994-2#1)(1994-4#1)(1997-8#1)(2005-10#1)(2007-2#6)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#3)(2009-11#1)(2009-8#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
presented as fever of unknown origin##2##6##(2007-11#1)(2008-1#1)
presented as mean##2##3##(2008-5#1)(2011-2#1)
presented as multiple##2##3##(2010-6#2)
presented as powerful analytical tools for##2##6##(2008-10#2)
presented as the##4##3##(1993-6#1)(2008-10#1)(2009-7#1)(2011-2#1)
presented as well as##5##4##(2005-10#1)(2008-2#1)(2008-6#1)(2008-9#2)
presented as well##8##3##(2005-1#1)(2005-10#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-9#2)
presented as##131##2##(1990-8#1)(1991-12#2)(1992-3#1)(1993-1#1)(1993-12#1)(1993-6#1)(1993-9#2)(1994-2#1)(1994-4#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-3#1)(1997-8#1)(2004-2#1)(2005-1#1)(2005-10#2)(2005-11#2)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#6)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#17)(2008-12#4)(2008-2#8)(2008-3#12)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#2)(2010-8#2)(2010-9#1)(2011-2#4)(2012-1#1)(2012-2#7)(2013-1#4)(2013-8#1)
presented at a different##2##4##(1996-6#1)(2007-9#1)
presented at a##7##3##(1996-6#1)(2006-6#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-6#1)
presented at advanced##3##3##(2011-11#1)(2011-2#2)
presented at different##2##3##(1992-9#1)(1994-6#1)
presented at least one##3##4##(1993-8#1)(2007-10#1)(2013-1#1)
presented at least##4##3##(1993-8#1)(2007-10#1)(2008-7#1)(2013-1#1)
presented at the American##3##4##(1995-2#1)(2008-5#1)(2009-10#1)
presented at the European##2##4##(2005-8#1)(2012-3#1)
presented at the Optical Society of America Topical Meeting on##3##10##(2008-2#2)(2008-3#1)
presented at the age of##4##5##(2007-7#2)(2008-7#2)
presented at the annual##2##4##(2005-7#1)(2009-8#1)
presented at the meeting##11##4##(2004-12#1)(2005-7#2)(2006-11#7)(2008-10#1)
presented at the same##2##4##(1996-6#2)
presented at the symposium##3##4##(2005-8#1)(2008-5#2)
presented at the##66##3##(1992-1#1)(1995-2#1)(1995-8#1)(1996-6#2)(2004-12#1)(2005-10#1)(2005-7#3)(2005-8#4)(2006-11#7)(2006-12#1)(2007-5#2)(2007-7#2)(2007-8#1)(2008-10#14)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#7)(2008-6#1)(2008-7#4)(2009-10#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-8#2)
presented at this meeting##2##4##(2005-9#2)
presented at##105##2##(1992-1#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-6#2)(1995-2#1)(1995-8#1)(1996-12#1)(1996-6#3)(2004-12#1)(2005-10#1)(2005-7#3)(2005-8#5)(2005-9#2)(2006-11#7)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#17)(2008-11#1)(2008-12#3)(2008-2#3)(2008-3#3)(2008-5#7)(2008-6#2)(2008-7#6)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-11#1)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
presented based on the##3##4##(1993-7#1)(2008-10#1)(2008-4#1)
presented based on##7##3##(1993-7#1)(1995-5#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)
presented because##2##2##(2007-11#1)(2008-7#1)
presented better performance##2##3##(2008-10#2)
presented better##3##2##(2008-10#2)(2013-1#1)
presented between##2##2##(2007-9#1)(2010-2#1)
presented both##4##2##(1994-6#1)(2007-4#1)(2007-6#1)(2012-2#1)
presented briefly##3##2##(1991-2#1)(1994-6#1)(2010-5#1)
presented by a##2##3##(2005-1#1)(2012-12#1)
presented by an##2##3##(1992-1#1)(2010-12#1)
presented by human MHC class II##2##6##(2009-9#2)
presented by patients with##2##4##(2010-5#1)(2012-3#1)
presented by self##2##3##(1995-2#2)
presented by the##11##3##(1991-6#1)(1997-4#1)(1997-7#1)(2005-8#1)(2007-1#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#2)(2011-2#1)
presented by##63##2##(1991-12#2)(1991-6#1)(1992-1#1)(1992-12#1)(1992-6#2)(1993-2#1)(1994-12#1)(1994-6#1)(1995-2#3)(1995-5#1)(1996-10#1)(1996-3#1)(1997-4#1)(1997-7#1)(2004-10#1)(2005-1#1)(2005-10#1)(2005-8#1)(2005-9#2)(2007-1#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-8#3)(2007-9#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-9#3)(2010-12#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
presented can be##3##3##(2008-3#2)(2008-7#1)
presented case report##2##3##(2008-10#1)(2011-12#1)
presented case##12##2##(1990-9#1)(2006-6#1)(2007-2#1)(2007-9#1)(2008-10#1)(2009-4#1)(2011-12#1)(2012-12#4)(2013-8#1)
presented characteristics of##2##3##(2007-11#1)(2008-10#1)
presented clinical##2##2##(1990-4#1)(2013-1#1)
presented data on##3##3##(1990-9#1)(2005-8#1)(2009-6#1)
presented data##8##2##(1990-9#1)(1991-12#1)(1994-11#1)(1995-10#1)(2005-7#1)(2005-8#1)(2008-5#1)(2009-6#1)
presented decreased##2##2##(2011-1#1)(2011-2#1)
presented different##5##2##(1996-12#1)(2008-10#2)(2013-1#2)
presented during the meeting##2##4##(2008-3#1)(2010-11#1)
presented during the##3##3##(2007-3#1)(2008-3#1)(2010-11#1)
presented during this##2##3##(2005-9#1)(2008-12#1)
presented during##15##2##(1992-4#1)(1994-6#1)(1994-9#1)(1995-8#1)(2004-3#1)(2005-9#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-12#1)(2008-3#1)(2008-4#1)(2010-11#1)(2011-12#1)(2013-8#1)
presented earlier##3##2##(2008-2#1)(2010-7#1)(2012-3#1)
presented either##2##2##(1997-1#1)(2009-10#1)
presented elsewhere in##2##3##(1995-12#1)(2008-4#1)
presented elsewhere##3##2##(1995-12#1)(2008-4#1)(2008-8#1)
presented evidence that##2##3##(2008-10#1)(2011-2#1)
presented evidence to##2##3##(2007-10#1)(2008-11#1)
presented evidence##6##2##(1992-3#1)(2007-10#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
presented following##2##2##(2006-8#1)(2008-7#1)
presented for a##14##3##(1994-6#1)(1994-8#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-3#3)(2009-10#1)(2010-1#1)(2011-1#2)(2011-2#1)
presented for both##5##3##(2007-12#1)(2008-2#3)(2008-3#1)
presented for calculating the##2##4##(2008-2#2)
presented for calculating##3##3##(2007-12#1)(2008-2#2)
presented for determination of##3##4##(2008-10#3)
presented for different##2##3##(2008-2#1)(2009-3#1)
presented for each##2##3##(1993-3#1)(2008-3#1)
presented for necropsy##2##3##(2007-2#1)(2008-5#1)
presented for several##2##3##(2007-12#1)(2008-3#1)
presented for the analysis of##5##5##(1992-1#1)(1992-8#1)(2007-12#1)(2008-10#2)
presented for the case##3##4##(2006-10#1)(2008-2#1)(2008-3#1)
presented for the detection##3##4##(1997-3#1)(2008-10#1)(2008-3#1)
presented for the determination of the##2##6##(2008-10#2)
presented for the determination of##9##5##(2008-10#8)(2008-3#1)
presented for the existence of##2##5##(1990-11#1)(1993-8#1)
presented for the first time in##2##6##(2008-4#1)(2011-2#1)
presented for the first time to our knowledge##2##8##(2008-3#2)
presented for the first time##7##5##(1993-3#1)(2008-3#2)(2008-4#1)(2009-9#1)(2011-2#1)(2013-7#1)
presented for the first##8##4##(1993-3#1)(2008-3#2)(2008-4#1)(2009-9#1)(2010-2#1)(2011-2#1)(2013-7#1)
presented for the##88##3##(1990-11#1)(1990-8#1)(1990-9#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#20)(2008-2#9)(2008-3#15)(2008-4#4)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-2#1)(2011-2#2)(2012-1#1)(2013-7#1)
presented for three##3##3##(2007-11#2)(2008-2#1)
presented for treatment##3##3##(2006-8#1)(2007-11#1)(2012-3#1)
presented for two##3##3##(2005-9#1)(2007-12#1)(2008-3#1)
presented for various##3##3##(2007-12#1)(2007-9#1)(2008-11#1)
presented for##260##2##(1990-11#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-6#1)(1994-7#1)(1994-8#1)(1996-4#1)(1996-8#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(2005-10#1)(2005-11#1)(2005-6#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-2#2)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#7)(2007-12#15)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#34)(2008-11#3)(2008-12#3)(2008-2#29)(2008-3#42)(2008-4#17)(2008-5#4)(2008-7#4)(2008-9#3)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#4)(2009-5#2)(2009-7#3)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
presented from a##5##3##(2007-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)
presented from the##3##3##(1990-12#1)(1993-6#1)(1994-6#1)
presented from##17##2##(1990-12#1)(1993-6#1)(1994-6#1)(1996-12#1)(2005-10#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
presented good##4##2##(2008-10#3)(2012-3#1)
presented here and##2##3##(1994-2#1)(2011-2#1)
presented here are##16##3##(1993-6#1)(1994-6#1)(1996-1#1)(2005-11#1)(2005-8#1)(2005-9#1)(2007-11#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-9#1)(2013-8#1)
presented here as##2##3##(2008-2#1)(2008-4#1)
presented here can also be##2##5##(2008-11#1)(2008-4#1)
presented here can be used##2##5##(2007-8#1)(2008-7#1)
presented here can##6##3##(1994-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
presented here demonstrate##3##3##(1991-7#1)(1994-12#1)(1995-3#1)
presented here for##6##3##(1990-8#1)(1992-2#1)(2008-1#1)(2008-3#1)(2010-12#1)(2011-3#1)
presented here has been##2##4##(2008-3#1)(2008-4#1)
presented here illustrate the##3##4##(1994-2#1)(2005-9#1)(2008-7#1)
presented here in##2##3##(2007-5#1)(2012-2#1)
presented here indicate that##2##4##(1996-12#1)(2006-10#1)
presented here is a##2##4##(2008-3#2)
presented here is based on##3##5##(2008-2#2)(2008-7#1)
presented here is capable of##2##5##(2008-10#1)(2008-11#1)
presented here is##22##3##(2007-10#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
presented here may##2##3##(1991-3#1)(1996-2#1)
presented here provide the##2##4##(1992-11#1)(2009-10#1)
presented here provide##5##3##(1992-11#1)(1995-3#1)(2008-11#1)(2009-10#1)(2012-1#1)
presented here provides a new##2##5##(2008-6#1)(2013-8#1)
presented here provides a##6##4##(1997-1#1)(2008-12#1)(2008-4#1)(2008-6#1)(2010-4#1)(2013-8#1)
presented here should be useful for the##2##7##(1996-8#1)(2008-5#1)
presented here should be useful for##3##6##(1996-2#1)(1996-8#1)(2008-5#1)
presented here should##4##3##(1996-2#1)(1996-8#1)(2006-2#1)(2008-5#1)
presented here show that##4##4##(1991-5#1)(2008-10#1)(2008-11#1)(2008-3#1)
presented here show##5##3##(1991-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
presented here suggest that##5##4##(1996-4#1)(1996-6#1)(2008-10#1)(2008-7#1)(2010-8#1)
presented here suggests that differential##2##5##(2008-7#1)(2008-8#1)
presented here support a##2##4##(2008-10#1)(2010-8#1)
presented here support##3##3##(2008-10#1)(2010-8#1)(2012-3#1)
presented here to##2##3##(1990-5#1)(2006-10#1)
presented here##194##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-8#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#2)(1996-4#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-5#1)(2005-10#1)(2005-11#2)(2005-8#1)(2005-9#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#5)(2008-1#2)(2008-10#12)(2008-11#10)(2008-12#2)(2008-2#6)(2008-3#14)(2008-4#13)(2008-5#5)(2008-6#1)(2008-7#10)(2008-8#5)(2008-9#3)(2009-10#2)(2009-2#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#4)
presented herein show that##2##4##(1997-2#1)(2012-2#1)
presented herein##17##2##(1994-9#1)(1995-11#1)(1996-4#1)(1997-2#1)(2006-12#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)
presented high##3##2##(2008-5#1)(2011-2#1)(2012-11#1)
presented higher##8##2##(1990-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2010-9#1)(2013-1#1)
presented illustrating##4##2##(1991-9#1)(2006-12#1)(2007-12#1)(2009-4#1)
presented in Part I##2##4##(1993-2#1)(2008-3#1)
presented in Part##3##3##(1993-2#1)(2008-3#1)(2012-12#1)
presented in a##23##3##(1990-9#1)(1991-2#1)(1992-11#1)(1993-3#1)(1994-2#1)(1996-12#1)(2006-12#1)(2006-7#1)(2007-1#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-2#1)(2009-8#1)(2012-11#1)(2013-1#1)(2013-7#1)
presented in addition to##2##4##(2008-3#1)(2010-8#1)
presented in an##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
presented in detail##11##3##(1992-2#1)(1993-3#1)(2004-3#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-9#1)
presented in either##2##3##(1995-2#1)(2012-2#1)
presented in our##2##3##(1996-2#1)(2012-2#1)
presented in part##2##3##(2008-3#2)
presented in previous##2##3##(2008-3#1)(2009-3#1)
presented in terms of##6##4##(1995-2#1)(2005-11#1)(2006-6#1)(2007-12#1)(2008-10#1)(2009-7#1)
presented in the article##3##4##(2008-6#1)(2010-11#1)(2012-3#1)
presented in the current##2##4##(2009-2#1)(2010-7#1)
presented in the first##2##4##(2006-7#1)(2008-4#1)
presented in the form of a##3##6##(1992-8#1)(1997-8#1)(2008-4#1)
presented in the form of##6##5##(1992-8#1)(1995-8#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-4#1)
presented in the light of##3##5##(1990-3#1)(2004-12#1)(2008-5#1)
presented in the literature and##2##5##(2008-11#1)(2010-9#1)
presented in the literature##5##4##(2007-4#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-9#1)
presented in the main theme##3##5##(2010-10#3)
presented in the paper##2##4##(2004-7#1)(2008-10#1)
presented in the same##2##4##(1996-5#1)(2007-5#1)
presented in the##64##3##(1990-3#1)(1991-3#1)(1992-3#1)(1992-8#1)(1993-12#1)(1995-12#1)(1995-8#2)(1996-3#1)(1996-5#2)(1997-8#2)(2004-12#1)(2004-7#1)(2006-10#2)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#5)(2008-11#1)(2008-2#2)(2008-4#4)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#2)(2009-2#1)(2010-10#3)(2010-11#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2012-12#2)(2012-3#1)
presented in their##2##3##(2007-11#1)(2008-10#1)
presented in these##2##3##(2008-10#1)(2008-5#1)
presented in this appendix##3##4##(2008-4#2)(2008-9#1)
presented in this article##28##4##(1990-12#1)(1991-2#1)(1992-2#1)(1992-3#1)(1995-3#1)(1996-2#1)(1997-2#1)(2006-1#1)(2006-12#1)(2006-2#2)(2006-6#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#1)(2012-12#3)(2012-3#1)(2013-1#2)
presented in this issue##3##4##(1995-1#2)(1997-3#1)
presented in this paper show that##2##6##(1991-9#1)(1993-3#1)
presented in this paper##52##4##(1991-12#1)(1991-6#1)(1991-9#1)(1993-3#1)(1993-6#1)(1996-5#1)(1997-8#1)(2005-11#2)(2005-2#1)(2005-4#2)(2006-11#2)(2006-6#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-4#2)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2009-10#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#2)
presented in this report##7##4##(1993-3#1)(2006-8#1)(2007-3#1)(2008-10#1)(2010-7#1)(2010-8#1)(2011-2#1)
presented in this review##7##4##(1993-9#1)(2005-11#1)(2006-10#1)(2006-2#1)(2008-11#1)(2008-3#1)(2008-8#1)
presented in this study##11##4##(1994-12#1)(2006-12#1)(2007-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-3#1)(2010-1#1)(2010-3#1)(2012-2#1)
presented in this unit##15##4##(2008-4#9)(2008-9#6)
presented in this work are##2##5##(2005-11#1)(2008-5#1)
presented in this work##11##4##(1995-1#1)(2005-11#1)(2006-12#2)(2008-10#3)(2008-2#1)(2008-5#1)(2009-5#1)(2010-10#1)
presented in this##153##3##(1990-12#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-12#1)(1995-1#3)(1995-3#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-8#2)(2005-11#4)(2005-2#1)(2005-4#2)(2006-1#1)(2006-10#1)(2006-11#2)(2006-12#4)(2006-2#3)(2006-5#1)(2006-6#2)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#2)(2007-8#2)(2008-1#1)(2008-10#18)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#14)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#8)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-5#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
presented in three##2##3##(1994-3#1)(2008-10#1)
presented in various##3##3##(1994-8#1)(2008-3#1)(2009-4#1)
presented in vivo##2##3##(1991-5#1)(2005-12#1)
presented in which the##6##4##(2008-10#1)(2008-2#2)(2008-3#1)(2011-12#1)(2012-1#1)
presented in which##21##3##(1990-2#1)(1991-2#1)(1996-2#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-10#1)(2008-2#4)(2008-3#3)(2008-5#1)(2008-7#2)(2011-12#1)(2012-1#1)
presented in##375##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-9#1)(1991-12#1)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#3)(1992-3#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-6#2)(1993-9#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-8#1)(1995-1#4)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#3)(1997-2#2)(1997-3#1)(1997-8#4)(2004-12#1)(2004-3#1)(2004-7#1)(2005-10#2)(2005-11#6)(2005-12#3)(2005-2#1)(2005-4#2)(2005-7#1)(2005-8#3)(2005-9#2)(2006-1#1)(2006-10#3)(2006-11#2)(2006-12#6)(2006-2#3)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#3)(2006-8#3)(2007-1#3)(2007-10#3)(2007-11#7)(2007-12#7)(2007-2#3)(2007-3#2)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#36)(2008-11#7)(2008-12#5)(2008-2#13)(2008-3#19)(2008-4#22)(2008-5#8)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#12)(2009-10#2)(2009-11#1)(2009-2#4)(2009-3#3)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#4)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#3)(2010-8#5)(2010-9#1)(2011-1#9)(2011-12#1)(2011-2#3)(2012-1#4)(2012-11#1)(2012-12#7)(2012-2#7)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#5)
presented include##2##2##(2008-10#1)(2012-1#1)
presented including##3##2##(2005-9#1)(2008-2#1)(2013-8#1)
presented indicate that the##2##4##(1990-12#1)(1996-7#1)
presented indicate that##4##3##(1990-12#1)(1996-7#1)(2007-12#1)(2008-10#1)
presented indicate##5##2##(1990-12#1)(1996-7#1)(2006-12#1)(2007-12#1)(2008-10#1)
presented indicates that##2##3##(1990-7#1)(1991-1#1)
presented indicating that##2##3##(1993-9#1)(1995-3#1)
presented indicating##3##2##(1993-9#1)(1995-3#1)(2012-1#1)
presented individually##2##2##(2008-3#1)(2010-7#1)
presented information##3##2##(1995-3#1)(2005-9#1)(2013-1#1)
presented infrequently##2##2##(2006-5#2)
presented initially with##4##3##(2006-1#1)(2007-10#1)(2008-8#1)(2009-10#1)
presented initially##6##2##(2006-1#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-8#1)(2009-10#1)
presented intermediary##2##2##(2007-7#1)(2013-1#1)
presented is a##4##3##(1990-8#1)(2008-4#1)(2010-11#1)(2013-1#1)
presented is the use of##2##5##(2008-4#2)
presented is the##4##3##(2008-10#1)(2008-4#2)(2008-7#1)
presented is##17##2##(1990-8#1)(2006-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2013-1#1)
presented it##2##2##(1990-7#1)(2007-11#1)
presented itself##2##2##(1990-9#1)(2008-8#1)
presented late##2##2##(2007-8#1)(2013-1#1)
presented low##3##2##(2008-5#2)(2011-1#1)
presented lower##2##2##(2008-10#1)(2010-4#1)
presented mainly##2##2##(2005-9#1)(2008-5#1)
presented method of##2##3##(2008-11#2)
presented method was##2##3##(2007-8#1)(2011-2#1)
presented method##13##2##(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2011-2#2)(2012-12#2)
presented methods##3##2##(2008-2#1)(2008-3#1)(2008-5#1)
presented more##5##2##(1997-8#1)(2004-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
presented negative##2##2##(2007-5#1)(2008-5#1)
presented new challenges##2##3##(2008-10#1)(2008-7#1)
presented new##5##2##(2005-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-8#1)
presented no##4##2##(1995-7#1)(2004-11#1)(2007-3#1)(2012-2#1)
presented of an##5##3##(1996-7#1)(1997-7#1)(2005-8#1)(2007-3#1)(2010-3#1)
presented of the##5##3##(1992-3#1)(2007-12#1)(2008-2#3)
presented of##31##2##(1990-8#1)(1990-9#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-2#1)(1996-4#1)(1996-7#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-8#1)(2006-11#1)(2006-4#2)(2006-6#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#1)(2009-9#1)(2010-3#1)(2013-1#1)(2013-7#1)
presented on a##3##3##(1992-10#1)(2007-11#1)(2010-9#1)
presented on the basis of the##3##6##(2007-11#1)(2007-7#1)(2007-8#1)
presented on the basis of##4##5##(2007-11#1)(2007-7#1)(2007-8#1)(2008-2#1)
presented on the surface of##2##5##(2008-4#2)
presented on the##22##3##(1992-1#1)(1994-8#1)(1996-8#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#2)(2009-3#1)(2010-2#1)(2011-1#1)
presented on##38##2##(1991-3#1)(1992-1#1)(1992-10#1)(1993-2#2)(1994-8#1)(1996-11#1)(1996-8#1)(1997-3#1)(2004-12#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#3)(2009-3#1)(2010-2#2)(2010-9#1)(2011-1#1)(2012-12#1)
presented one##4##2##(1994-9#1)(2008-7#1)(2009-5#1)(2013-7#1)
presented only##4##2##(2005-11#1)(2006-6#1)(2009-9#2)
presented paper##3##2##(2007-8#1)(2008-10#2)
presented positive##2##2##(2008-5#1)(2008-6#1)
presented preliminary##3##2##(2008-12#1)(2013-1#2)
presented provides an##2##3##(2008-2#1)(2008-7#1)
presented provides##3##2##(2008-10#1)(2008-2#1)(2008-7#1)
presented recoveries##2##2##(2008-10#2)
presented regarding the##4##3##(1993-2#1)(2005-8#1)(2007-5#1)(2012-2#1)
presented regarding##6##2##(1993-2#1)(1996-12#1)(2005-7#1)(2005-8#1)(2007-5#1)(2012-2#1)
presented resistance##2##2##(2007-1#1)(2007-9#1)
presented results of##2##3##(2007-7#1)(2011-1#1)
presented results##6##2##(1991-2#1)(1997-6#1)(2007-11#1)(2007-7#1)(2008-10#1)(2011-1#1)
presented severe##5##2##(1996-3#1)(2007-9#1)(2008-9#1)(2010-9#1)(2013-1#1)
presented shortly##2##2##(1991-12#1)(1992-10#1)
presented should##2##2##(1990-12#1)(2008-7#1)
presented show that the##2##4##(1995-3#1)(2007-12#1)
presented show that##4##3##(1995-3#1)(2007-12#1)(2011-2#1)(2012-2#1)
presented show##6##2##(1992-2#1)(1992-3#1)(1995-3#1)(2007-12#1)(2011-2#1)(2012-2#1)
presented showing that the##2##4##(1992-9#1)(2008-2#1)
presented showing that##7##3##(1992-9#1)(1995-6#1)(2005-8#1)(2005-9#1)(2008-1#1)(2008-2#1)(2008-9#1)
presented showing the##5##3##(1996-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2012-1#1)
presented showing##14##2##(1992-9#1)(1995-6#1)(1996-10#1)(2005-8#1)(2005-9#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-9#1)(2012-1#1)
presented significant##3##2##(2006-11#1)(2008-7#1)(2012-2#1)
presented significantly higher##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
presented significantly##4##2##(2008-10#1)(2008-5#1)(2013-1#1)(2013-8#1)
presented similar##3##2##(2008-10#1)(2013-1#2)
presented simultaneously##2##2##(2006-12#1)(2007-5#1)
presented six##2##2##(2008-4#1)(2012-12#1)
presented some##5##2##(1997-3#1)(1997-5#1)(2008-10#2)(2013-1#1)
presented stimuli##2##2##(1990-10#1)(2010-5#1)
presented study##2##2##(2007-8#1)(2012-12#1)
presented such##4##2##(2007-8#1)(2008-10#1)(2008-2#1)(2012-3#1)
presented suggesting that##3##3##(2007-5#1)(2008-11#1)(2013-1#1)
presented symptoms##3##2##(1991-11#1)(1992-4#1)(2007-8#1)
presented system##3##2##(2007-12#1)(2008-10#2)
presented that can be##5##4##(1992-5#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
presented that can##9##3##(1992-5#1)(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#1)
presented that have##3##3##(1996-8#1)(2007-11#1)(2010-11#1)
presented that relate##2##3##(2008-3#2)
presented that the##7##3##(1991-3#1)(1992-12#1)(1994-12#1)(1995-10#1)(1995-6#1)(1996-8#1)(1997-7#1)
presented that uses##3##3##(2007-5#1)(2008-2#1)(2008-3#1)
presented that##126##2##(1990-2#1)(1990-5#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-12#2)(1992-2#1)(1992-4#2)(1992-5#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#2)(1994-12#1)(1994-5#1)(1995-1#2)(1995-10#1)(1995-2#1)(1995-6#2)(1995-8#2)(1996-8#2)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-9#1)(2005-11#1)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#15)(2007-5#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-2#21)(2008-3#25)(2008-4#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#2)(2009-4#1)(2010-11#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
presented the best evidence to answer the clinical question##35##9##(2007-8#35)
presented the best evidence to answer the##36##7##(2007-8#36)
presented the best##38##3##(2007-8#36)(2010-4#2)
presented the experience of##2##4##(2007-3#1)(2011-2#1)
presented the highest##8##3##(2008-5#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-1#4)
presented the same##5##3##(1990-7#1)(2007-10#1)(2008-10#2)(2012-1#1)
presented the##85##2##(1990-12#1)(1990-7#1)(2005-8#1)(2006-10#2)(2006-8#1)(2007-10#2)(2007-11#3)(2007-2#1)(2007-3#2)(2007-8#37)(2007-9#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-2#2)(2009-7#2)(2010-11#1)(2010-4#2)(2010-8#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
presented three##3##2##(1997-2#1)(2008-12#1)(2012-12#1)
presented to a chiropractic clinic##2##5##(2007-6#2)
presented to a##6##3##(2007-2#1)(2007-6#2)(2008-3#1)(2008-5#1)(2013-8#1)
presented to address##2##3##(2010-8#1)(2012-3#1)
presented to allow##2##3##(2008-3#1)(2008-6#1)
presented to an##2##3##(2006-5#1)(2008-4#1)
presented to attendees##2##3##(2008-10#1)(2010-5#1)
presented to characterize##4##3##(2006-10#1)(2008-2#2)(2008-3#1)
presented to demonstrate that##3##4##(2005-8#1)(2008-2#1)(2012-2#1)
presented to demonstrate the##8##4##(1995-2#1)(2006-2#1)(2006-4#1)(2007-4#1)(2007-9#1)(2008-3#1)(2009-12#1)(2011-2#1)
presented to demonstrate##15##3##(1990-8#1)(1995-2#1)(2005-8#1)(2006-2#1)(2006-4#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-12#1)(2011-2#1)(2012-2#1)
presented to describe the##3##4##(2008-10#1)(2008-2#1)(2008-7#1)
presented to describe##4##3##(2008-10#1)(2008-2#1)(2008-7#1)(2010-11#1)
presented to detect##2##3##(2008-4#1)(2011-1#1)
presented to determine##3##3##(1990-9#1)(2008-2#1)(2008-3#1)
presented to elucidate the##2##4##(2007-4#1)(2008-7#1)
presented to emergency##2##3##(2011-1#2)
presented to explain##3##3##(2008-2#1)(2008-3#1)(2009-2#1)
presented to females##3##3##(2007-12#1)(2008-4#2)
presented to her##2##3##(2006-10#1)(2012-2#1)
presented to his##2##3##(1996-2#1)(2011-1#1)
presented to hospital with##2##4##(2011-2#1)(2012-12#1)
presented to illustrate the proposed##2##5##(1996-12#1)(2008-3#1)
presented to illustrate the##11##4##(1992-6#1)(1996-12#2)(1996-9#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#3)(2012-2#1)
presented to illustrate##15##3##(1992-6#1)(1996-12#2)(1996-9#1)(1997-2#1)(2006-10#1)(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#3)(2012-2#1)
presented to our OPD##2##4##(2007-7#1)(2013-1#1)
presented to our facility with##2##5##(1992-6#1)(2013-8#1)
presented to our hospital with##2##5##(2006-10#1)(2012-12#1)
presented to our hospital##3##4##(2006-10#1)(2011-2#1)(2012-12#1)
presented to our institution with##5##5##(2006-10#1)(2007-9#1)(2008-8#1)(2013-1#2)
presented to our institution##6##4##(2006-10#1)(2006-12#1)(2007-9#1)(2008-8#1)(2013-1#2)
presented to our##19##3##(1992-6#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#2)
presented to provide##2##3##(2007-2#1)(2008-3#1)
presented to show that##3##4##(1992-2#1)(1996-5#1)(2008-3#1)
presented to show the##7##4##(1992-1#1)(2005-11#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
presented to show##12##3##(1992-1#1)(1992-2#1)(1996-5#1)(2005-11#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)(2013-1#1)
presented to suggest that##3##4##(1991-2#1)(2010-3#1)(2011-1#1)
presented to support the##3##4##(1997-3#1)(2006-4#1)(2008-2#1)
presented to support##4##3##(1997-3#1)(2006-4#1)(2008-2#1)(2008-3#1)
presented to the Emergency##2##4##(2007-2#1)(2009-10#1)
presented to the Radiation Oncology and##2##6##(2008-10#2)
presented to the emergency department with acute##2##7##(2009-6#1)(2013-1#1)
presented to the emergency department with an acute##2##8##(2006-4#1)(2007-3#1)
presented to the emergency department with##8##6##(2006-4#1)(2007-3#1)(2007-5#1)(2009-6#1)(2010-7#1)(2013-1#3)
presented to the emergency department##10##5##(2006-4#1)(2007-10#1)(2007-3#1)(2007-5#1)(2007-7#1)(2009-6#1)(2010-7#1)(2013-1#3)
presented to the emergency room##3##5##(2007-12#2)(2009-3#1)
presented to the emergency##14##4##(2006-4#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#1)(2009-3#1)(2009-6#1)(2010-7#1)(2011-2#1)(2013-1#3)
presented to the hospital##2##4##(1993-6#1)(2008-8#1)
presented to the subjects##2##4##(1995-5#1)(2010-2#1)
presented to the##46##3##(1993-12#2)(1993-3#1)(1993-4#1)(1993-6#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-8#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-12#3)(2007-2#2)(2007-3#2)(2007-5#2)(2007-7#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-6#2)(2009-9#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#5)
presented to them##2##3##(1991-2#1)(1996-9#1)
presented to us with##12##4##(2007-7#3)(2008-9#1)(2011-1#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
presented to us##16##3##(2007-7#3)(2007-8#1)(2008-1#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-1#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
presented to verify the##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
presented to##247##2##(1990-12#1)(1990-8#1)(1990-9#1)(1991-2#2)(1991-8#1)(1992-1#1)(1992-2#1)(1992-6#2)(1993-12#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-6#1)(1995-2#2)(1995-5#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-5#2)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-10#6)(2006-12#2)(2006-2#1)(2006-4#3)(2006-5#3)(2006-8#3)(2007-10#3)(2007-12#11)(2007-2#5)(2007-3#3)(2007-4#3)(2007-5#2)(2007-6#2)(2007-7#7)(2007-8#1)(2007-9#3)(2008-1#4)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#20)(2008-3#23)(2008-4#7)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#3)(2010-7#2)(2010-8#1)(2011-1#8)(2011-2#7)(2012-12#6)(2012-2#7)(2012-3#2)(2013-1#15)(2013-7#1)(2013-8#4)
presented together with a##4##4##(2008-2#1)(2008-3#1)(2011-2#1)(2013-7#1)
presented together with##12##3##(1990-2#1)(1997-2#1)(2008-10#2)(2008-2#2)(2008-3#4)(2011-2#1)(2013-7#1)
presented together##14##2##(1990-2#1)(1997-2#1)(2008-10#3)(2008-2#2)(2008-3#4)(2011-2#1)(2013-1#1)(2013-7#1)
presented two##6##2##(1997-2#1)(2008-10#1)(2010-10#1)(2010-12#2)(2011-12#1)
presented upside down##2##3##(1993-2#1)(2007-8#1)
presented using##11##2##(1990-4#1)(1991-5#1)(1992-2#1)(1993-3#1)(1996-12#1)(2007-11#1)(2008-4#2)(2008-6#1)(2008-7#1)(2013-7#1)
presented via##2##2##(1996-6#1)(2008-6#1)
presented visual##3##2##(1995-5#1)(2006-5#2)
presented was##6##2##(1994-8#1)(1997-8#1)(2005-11#1)(2005-8#1)(2008-3#1)(2008-7#1)
presented were##5##2##(1997-8#1)(2005-8#2)(2006-10#1)(2013-1#1)
presented where the##2##3##(2006-4#1)(2008-9#1)
presented where##4##2##(1994-11#1)(2006-4#1)(2008-9#1)(2012-12#1)
presented which##25##2##(1990-7#1)(1990-8#1)(1991-5#1)(1992-6#1)(1993-1#1)(1994-3#1)(1994-8#1)(1997-4#1)(1997-6#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-3#1)(2006-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-8#1)(2011-1#1)(2012-2#1)
presented while##2##2##(2011-1#1)(2013-7#1)
presented who##3##2##(2006-7#1)(2011-12#1)(2012-12#1)
presented will##2##2##(1997-2#1)(1997-4#1)
presented with a 2-year history of##2##6##(2008-5#1)(2008-6#1)
presented with a 4-year history of a##2##7##(2010-6#1)(2012-3#1)
presented with a 4-year history of##3##6##(2006-2#1)(2010-6#1)(2012-3#1)
presented with a complaint of swelling##2##6##(2012-12#2)
presented with a complaint of##3##5##(1996-7#1)(2012-12#2)
presented with a giant##2##4##(2006-12#1)(2010-6#1)
presented with a history of intermittent##2##6##(2011-2#1)(2012-2#1)
presented with a history of##13##5##(2006-6#1)(2007-2#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-8#1)(2013-7#1)
presented with a history##14##4##(2006-10#1)(2006-6#1)(2007-2#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-8#1)(2013-7#1)
presented with a large##5##4##(2008-8#1)(2009-5#1)(2010-5#1)(2012-2#1)(2012-3#1)
presented with a left sided##2##5##(2006-4#1)(2010-12#1)
presented with a left##3##4##(2006-4#1)(2007-9#1)(2010-12#1)
presented with a mass##2##4##(2007-5#1)(2010-12#1)
presented with a neurological##2##4##(1996-8#1)(2010-12#1)
presented with a one year history of##2##7##(2008-12#1)(2008-7#1)
presented with a one##3##4##(1996-9#1)(2008-12#1)(2008-7#1)
presented with a painful##3##4##(2007-7#1)(2009-3#2)
presented with a painless##6##4##(2007-7#1)(2008-7#2)(2009-4#1)(2011-2#1)(2012-3#1)
presented with a palpable##2##4##(2007-6#1)(2013-1#1)
presented with a rapidly##2##4##(2009-3#1)(2011-1#1)
presented with a right##3##4##(2007-12#2)(2007-8#1)
presented with a similar##2##4##(2007-2#1)(2008-7#1)
presented with a single##4##4##(2007-2#1)(2011-2#2)(2012-11#1)
presented with a solitary##3##4##(2008-6#1)(2010-6#2)
presented with a subarachnoid haemorrhage##2##5##(1996-9#1)(2008-7#1)
presented with a subarachnoid##3##4##(1996-9#1)(2008-7#1)(2013-8#1)
presented with a swelling of the##2##6##(2008-6#1)(2009-9#1)
presented with a swelling##4##4##(2007-7#1)(2008-6#1)(2008-7#1)(2009-9#1)
presented with a very##2##4##(2009-4#1)(2010-5#1)
presented with a##171##3##(1990-2#1)(1991-12#1)(1991-8#2)(1992-10#1)(1992-3#1)(1993-12#1)(1993-3#1)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#3)(1997-5#1)(1997-7#1)(2004-12#1)(2005-10#2)(2005-11#2)(2006-10#6)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#2)(2007-11#2)(2007-12#2)(2007-2#8)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#8)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-2#1)(2008-4#2)(2008-5#4)(2008-6#5)(2008-7#12)(2008-8#1)(2008-9#2)(2009-3#3)(2009-4#2)(2009-5#2)(2009-8#1)(2009-9#3)(2010-10#1)(2010-12#4)(2010-3#1)(2010-5#2)(2010-6#8)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#7)(2012-8#1)(2013-1#7)(2013-7#2)(2013-8#6)
presented with abdominal pain##7##4##(1997-8#1)(2005-10#1)(2009-10#1)(2009-7#1)(2012-2#1)(2013-1#2)
presented with abdominal##8##3##(1997-8#1)(2005-10#1)(2009-10#1)(2009-7#1)(2010-9#1)(2012-2#1)(2013-1#2)
presented with acute onset of##2##5##(1997-3#1)(2012-2#1)
presented with acute onset##3##4##(1997-3#1)(2010-8#1)(2012-2#1)
presented with acute##16##3##(1997-3#1)(2006-10#1)(2006-9#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-3#1)(2010-8#2)(2012-2#1)(2013-1#2)
presented with advanced##2##3##(2012-12#1)(2013-1#1)
presented with an acute abdomen##3##5##(2006-4#1)(2008-6#1)(2009-9#1)
presented with an acute##7##4##(2006-4#1)(2008-6#2)(2009-5#1)(2009-9#1)(2011-1#1)(2013-8#1)
presented with an asymptomatic##2##4##(2007-7#1)(2008-5#1)
presented with an impalpable right testis##2##6##(2008-10#2)
presented with an##32##3##(1991-8#1)(1992-2#1)(2006-10#2)(2006-4#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-12#1)(2008-5#2)(2008-6#2)(2008-9#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#1)(2011-1#3)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
presented with and without##3##4##(2005-8#2)(2009-11#1)
presented with arthritis##2##3##(2006-10#1)(2008-1#1)
presented with asymptomatic nodules and plaques##2##6##(2007-7#1)(2007-8#1)
presented with asymptomatic##6##3##(1994-12#1)(2007-7#3)(2007-8#1)(2008-3#1)
presented with bilateral##13##3##(2006-10#2)(2007-5#1)(2007-7#2)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-5#1)(2013-1#2)(2013-8#1)
presented with both##2##3##(2007-9#1)(2012-2#1)
presented with chest pain and##3##5##(2006-10#1)(2006-12#1)(2007-8#1)
presented with chest##4##3##(2006-10#1)(2006-12#1)(2007-8#2)
presented with chyluria##2##3##(2008-1#1)(2008-4#1)
presented with clinical signs of##2##5##(2008-5#1)(2011-2#1)
presented with complaint of##2##4##(2007-3#1)(2008-9#1)
presented with complaints of##5##4##(2007-7#1)(2010-6#1)(2012-11#1)(2013-7#1)(2013-8#1)
presented with complex##2##3##(2008-6#1)(2009-5#1)
presented with cough##2##3##(2007-12#1)(2007-8#1)
presented with different##2##3##(1997-3#1)(2008-11#1)
presented with diffuse##4##3##(2005-7#1)(2007-7#1)(2008-9#1)(2012-12#1)
presented with diplopia##2##3##(1996-9#1)(2011-1#1)
presented with dyspnoea and##3##4##(2009-4#1)(2011-2#2)
presented with dyspnoea##4##3##(2008-1#1)(2009-4#1)(2011-2#2)
presented with epistaxis##2##3##(2007-7#1)(2011-12#1)
presented with erythematous plaques##2##4##(2006-10#1)(2010-6#1)
presented with erythematous##5##3##(2005-11#1)(2006-10#1)(2007-7#1)(2007-8#1)(2010-6#1)
presented with extensive and##2##4##(2007-7#1)(2007-8#1)
presented with extensive local##2##4##(2006-12#1)(2012-1#1)
presented with extensive##5##3##(2006-12#1)(2007-7#1)(2007-8#1)(2009-7#1)(2012-1#1)
presented with features##7##3##(2007-7#1)(2009-10#1)(2009-5#1)(2010-4#1)(2010-7#1)(2012-2#1)(2012-3#1)
presented with fever and##5##4##(2006-10#1)(2007-3#1)(2009-10#1)(2011-1#1)(2013-1#1)
presented with fever of##2##4##(2006-10#1)(2012-2#1)
presented with fever##14##3##(2006-10#3)(2007-11#1)(2007-3#1)(2009-10#1)(2009-11#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
presented with frequent##2##3##(2006-9#1)(2008-12#1)
presented with generalized##3##3##(2005-11#1)(2007-7#1)(2012-2#1)
presented with gross##2##3##(2008-10#1)(2013-8#1)
presented with headache and##3##4##(2006-12#1)(2008-12#1)(2008-5#1)
presented with headache##4##3##(2006-12#1)(2008-12#1)(2008-5#1)(2012-12#1)
presented with headaches and##3##4##(2006-10#1)(2009-1#1)(2011-2#1)
presented with headaches##5##3##(2006-10#1)(2009-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
presented with hearing loss##2##4##(2008-1#1)(2011-2#1)
presented with hemoptysis##2##3##(2007-8#1)(2012-12#1)
presented with hemorrhage##2##3##(2008-12#1)(2008-7#1)
presented with history of##3##4##(2007-12#1)(2008-1#1)(2011-1#1)
presented with hyperpigmented##2##3##(2007-7#1)(2011-1#1)
presented with increased abdominal##2##4##(2008-5#1)(2012-2#1)
presented with increased##4##3##(2008-12#1)(2008-5#1)(2011-2#1)(2012-2#1)
presented with intermittent##2##3##(2008-10#1)(2012-2#1)
presented with invasive pulmonary aspergillosis##2##5##(2007-7#1)(2010-12#1)
presented with left##2##3##(2011-2#1)(2012-2#1)
presented with left-sided##2##3##(2010-5#1)(2012-2#1)
presented with long##3##3##(2008-7#1)(2012-2#2)
presented with low##2##3##(2010-1#1)(2010-12#1)
presented with lower abdominal##2##4##(2007-12#1)(2011-2#1)
presented with lower##3##3##(2007-12#1)(2008-8#1)(2011-2#1)
presented with massive##3##3##(2010-2#1)(2011-12#1)(2013-8#1)
presented with multiple hypopigmented##2##4##(2007-8#2)
presented with multiple##12##3##(2005-11#1)(2007-12#1)(2007-7#4)(2007-8#3)(2010-6#1)(2012-12#1)(2013-1#1)
presented with neck pain##2##4##(2009-3#1)(2009-9#1)
presented with neck##3##3##(1991-8#1)(2009-3#1)(2009-9#1)
presented with oedema##2##3##(2011-1#1)(2013-1#1)
presented with orbital swelling##4##4##(2013-1#4)
presented with pain and swelling##2##5##(2006-8#1)(2012-2#1)
presented with pain and##5##4##(2006-8#1)(2007-7#1)(2009-3#1)(2011-1#1)(2012-2#1)
presented with pain on##2##4##(2006-10#1)(2006-7#1)
presented with pain##8##3##(2006-10#1)(2006-7#1)(2006-8#1)(2007-7#1)(2009-3#2)(2011-1#1)(2012-2#1)
presented with painless##4##3##(2010-11#1)(2010-3#1)(2012-12#1)(2012-2#1)
presented with palpitations##2##3##(2006-9#1)(2008-7#1)
presented with paraparesis##2##3##(2008-6#1)(2013-1#1)
presented with paroxysmal##2##3##(2006-9#1)(2009-10#1)
presented with persistent##5##3##(2005-10#1)(2007-7#1)(2008-12#1)(2012-3#1)(2013-8#1)
presented with progressive##6##3##(2006-8#1)(2007-10#1)(2007-7#1)(2008-7#1)(2011-2#1)(2012-12#1)
presented with recurrent episodes of##2##5##(2007-2#1)(2012-12#1)
presented with recurrent urinary tract infections##2##6##(2008-10#1)(2013-1#1)
presented with recurrent##18##3##(2005-11#1)(2006-12#1)(2007-2#1)(2007-8#3)(2008-10#2)(2008-11#1)(2008-6#1)(2010-6#1)(2011-1#2)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
presented with refractory##2##3##(2011-1#1)(2012-12#1)
presented with right##2##3##(2007-8#1)(2010-2#1)
presented with secondary##3##3##(1996-3#1)(2011-1#1)(2013-8#1)
presented with several##2##3##(2006-10#1)(2008-7#1)
presented with severe##24##3##(1990-9#1)(1991-2#1)(1996-6#1)(2005-12#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-5#1)(2008-7#2)(2009-1#1)(2009-3#1)(2010-2#1)(2010-4#1)(2010-5#2)(2011-2#2)(2012-2#3)(2013-1#3)
presented with short##2##3##(1994-2#1)(2010-12#1)
presented with signs and symptoms of##2##6##(2008-4#1)(2011-12#1)
presented with signs and symptoms##3##5##(2006-5#1)(2008-4#1)(2011-12#1)
presented with skin lesions##2##4##(2007-12#2)
presented with subarachnoid haemorrhage (SAH)##2##5##(2008-7#2)
presented with subarachnoid haemorrhage##5##4##(1997-3#1)(2008-7#4)
presented with subarachnoid hemorrhage##4##4##(2005-9#1)(2007-9#2)(2012-12#1)
presented with subarachnoid##10##3##(1997-3#1)(2005-9#1)(2007-9#2)(2008-7#4)(2011-2#1)(2012-12#1)
presented with sudden onset of coma##2##6##(2008-7#2)
presented with sudden onset of##4##5##(2008-10#1)(2008-7#3)
presented with sudden onset##6##4##(2008-10#1)(2008-7#3)(2013-1#2)
presented with sudden##11##3##(2007-10#1)(2008-10#1)(2008-12#1)(2008-7#3)(2009-8#1)(2010-10#1)(2011-2#1)(2013-1#2)
presented with swelling and##2##4##(2008-7#1)(2010-9#1)
presented with swelling##4##3##(2008-7#1)(2010-9#1)(2013-1#2)
presented with symptomatic##3##3##(2006-8#1)(2007-8#1)(2008-4#1)
presented with symptoms and##2##4##(2007-7#1)(2008-12#1)
presented with symptoms of##4##4##(2008-6#1)(2008-7#2)(2012-12#1)
presented with symptoms##8##3##(2006-10#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2012-12#1)
presented with the##17##3##(1990-6#2)(1992-8#1)(1994-6#1)(2006-10#2)(2006-7#1)(2007-7#1)(2008-10#2)(2008-3#1)(2009-11#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
presented with this##2##3##(2008-12#1)(2012-12#1)
presented with three##2##3##(2012-1#1)(2013-1#1)
presented with transient ischemic##2##4##(2006-11#1)(2007-10#1)
presented with tumor bleeding onset##2##5##(2007-12#2)
presented with two##3##3##(2007-10#1)(2010-11#1)(2011-2#1)
presented with unstable##2##3##(2007-7#1)(2013-1#1)
presented with upper##2##3##(2006-10#1)(2013-1#1)
presented with vague##2##3##(2007-11#1)(2008-1#1)
presented with visual##4##3##(2005-10#1)(2009-10#1)(2010-9#1)(2013-8#1)
presented with##852##2##(1990-2#1)(1990-6#3)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#5)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#2)(1993-3#2)(1993-5#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-11#1)(1995-6#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#3)(1996-7#1)(1996-8#3)(1996-9#4)(1997-1#1)(1997-3#6)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-12#1)(2004-2#1)(2005-10#8)(2005-11#8)(2005-12#1)(2005-7#2)(2005-8#4)(2005-9#2)(2006-1#2)(2006-10#41)(2006-11#2)(2006-12#11)(2006-2#2)(2006-4#2)(2006-5#4)(2006-6#2)(2006-7#2)(2006-8#13)(2006-9#7)(2007-1#1)(2007-10#6)(2007-11#11)(2007-12#13)(2007-2#13)(2007-3#3)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#47)(2007-8#41)(2007-9#12)(2008-1#10)(2008-10#24)(2008-11#8)(2008-12#18)(2008-2#3)(2008-3#15)(2008-4#10)(2008-5#14)(2008-6#21)(2008-7#37)(2008-8#6)(2008-9#7)(2009-1#2)(2009-10#6)(2009-11#4)(2009-2#2)(2009-3#11)(2009-4#6)(2009-5#7)(2009-6#3)(2009-7#4)(2009-8#2)(2009-9#5)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#12)(2010-2#3)(2010-3#4)(2010-4#2)(2010-5#12)(2010-6#14)(2010-7#3)(2010-8#3)(2010-9#4)(2011-1#19)(2011-12#8)(2011-2#34)(2012-1#6)(2012-11#3)(2012-12#28)(2012-2#38)(2012-3#16)(2012-8#1)(2013-1#52)(2013-7#8)(2013-8#22)
presented within the##5##3##(1991-10#1)(1992-1#1)(2007-9#1)(2008-6#1)(2008-7#1)
presented within##10##2##(1991-10#1)(1992-1#1)(2006-12#1)(2007-10#1)(2007-2#1)(2007-9#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-11#1)
presented without##4##2##(1990-3#1)(1994-3#1)(1996-1#1)(2008-10#1)
presented work##3##2##(2005-1#1)(2008-3#1)(2011-3#1)
presented##5482##1##(1990-1#2)(1990-10#2)(1990-11#5)(1990-12#13)(1990-2#7)(1990-3#9)(1990-4#8)(1990-5#10)(1990-6#8)(1990-7#7)(1990-8#15)(1990-9#15)(1991-1#4)(1991-10#4)(1991-11#5)(1991-12#12)(1991-2#24)(1991-3#12)(1991-4#5)(1991-5#12)(1991-6#5)(1991-7#5)(1991-8#9)(1991-9#9)(1992-1#15)(1992-10#6)(1992-11#8)(1992-12#14)(1992-2#26)(1992-3#12)(1992-4#7)(1992-5#3)(1992-6#13)(1992-7#2)(1992-8#7)(1992-9#9)(1993-1#7)(1993-10#3)(1993-11#4)(1993-12#11)(1993-2#13)(1993-3#15)(1993-4#5)(1993-5#8)(1993-6#15)(1993-7#3)(1993-8#6)(1993-9#6)(1994-1#3)(1994-10#1)(1994-11#7)(1994-12#18)(1994-2#11)(1994-3#5)(1994-4#3)(1994-5#7)(1994-6#22)(1994-7#1)(1994-8#10)(1994-9#6)(1995-1#13)(1995-10#4)(1995-11#8)(1995-12#8)(1995-2#17)(1995-3#10)(1995-4#2)(1995-5#10)(1995-6#9)(1995-7#3)(1995-8#10)(1995-9#2)(1996-1#7)(1996-10#3)(1996-11#3)(1996-12#12)(1996-2#16)(1996-3#12)(1996-4#7)(1996-5#11)(1996-6#18)(1996-7#11)(1996-8#15)(1996-9#9)(1997-1#7)(1997-2#16)(1997-3#17)(1997-4#8)(1997-5#8)(1997-6#9)(1997-7#12)(1997-8#18)(2004-10#1)(2004-11#3)(2004-12#8)(2004-2#4)(2004-3#3)(2004-4#1)(2004-7#2)(2004-8#2)(2004-9#3)(2005-1#3)(2005-10#21)(2005-11#35)(2005-12#12)(2005-2#1)(2005-3#1)(2005-4#5)(2005-6#4)(2005-7#14)(2005-8#36)(2005-9#22)(2006-1#8)(2006-10#88)(2006-11#20)(2006-12#51)(2006-2#25)(2006-3#5)(2006-4#16)(2006-5#27)(2006-6#20)(2006-7#10)(2006-8#34)(2006-9#12)(2007-1#10)(2007-10#30)(2007-11#144)(2007-12#212)(2007-2#46)(2007-3#23)(2007-4#15)(2007-5#32)(2007-6#17)(2007-7#83)(2007-8#152)(2007-9#47)(2008-1#48)(2008-10#442)(2008-11#79)(2008-12#62)(2008-2#403)(2008-3#521)(2008-4#157)(2008-5#118)(2008-6#65)(2008-7#125)(2008-8#46)(2008-9#53)(2009-1#2)(2009-10#22)(2009-11#12)(2009-12#4)(2009-2#19)(2009-3#29)(2009-4#18)(2009-5#20)(2009-6#12)(2009-7#18)(2009-8#10)(2009-9#32)(2010-1#8)(2010-10#15)(2010-11#18)(2010-12#31)(2010-2#24)(2010-3#16)(2010-4#20)(2010-5#24)(2010-6#21)(2010-7#14)(2010-8#22)(2010-9#24)(2011-1#67)(2011-10#1)(2011-11#1)(2011-12#21)(2011-2#134)(2011-3#2)(2011-7#1)(2012-1#37)(2012-11#10)(2012-12#81)(2012-2#111)(2012-3#44)(2012-8#2)(2013-1#164)(2013-7#37)(2013-8#73)
presented)##2##1##(1995-5#1)(2008-4#1)
presenters##6##1##(2005-8#1)(2009-9#2)(2013-1#3)
presenting 4##2##2##(2007-10#1)(2012-12#1)
presenting a diagnostic challenge##2##4##(2006-8#1)(2008-9#1)
presenting a high##2##3##(2008-10#1)(2009-1#1)
presenting a method##2##3##(1992-11#1)(2008-3#1)
presenting a##33##2##(1991-6#1)(1992-11#1)(1993-2#1)(1996-1#1)(1996-7#1)(1997-8#1)(2004-9#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-1#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#2)
presenting acute##2##2##(2008-12#1)(2012-2#1)
presenting after##2##2##(2007-7#1)(2009-3#1)
presenting an##9##2##(1992-3#1)(1995-10#1)(1995-3#1)(1997-7#1)(2007-1#1)(2008-8#1)(2011-1#1)(2013-1#2)
presenting and##4##2##(1995-11#1)(2006-7#1)(2007-7#1)(2008-1#1)
presenting antigens to##2##3##(2005-12#1)(2008-4#1)
presenting as a large##2##4##(2006-9#1)(2011-1#1)
presenting as a pelvic##2##4##(2004-10#1)(2009-9#1)
presenting as a##29##3##(1990-2#1)(1992-9#1)(2004-10#1)(2006-4#1)(2006-9#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-11#1)(2011-1#2)(2012-12#4)(2012-2#4)(2012-3#2)
presenting as acute pancreatitis##2##4##(2008-3#1)(2010-6#1)
presenting as acute##8##3##(2007-10#1)(2008-11#1)(2008-3#1)(2009-9#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-12#1)
presenting as an acute##2##4##(2008-11#1)(2013-1#1)
presenting as an isolated##2##4##(2008-7#2)
presenting as an obstructive colon mass##2##6##(2008-11#2)
presenting as an##11##3##(2006-10#1)(2007-8#1)(2008-11#3)(2008-7#2)(2009-4#1)(2012-1#1)(2013-1#2)
presenting as massive##2##3##(2008-12#2)
presenting as multiple##4##3##(1990-2#1)(2008-1#1)(2008-3#1)(2010-6#1)
presenting as primary##2##3##(2006-10#1)(2009-6#1)
presenting as sudden##2##3##(2007-12#1)(2012-1#1)
presenting as unilateral##2##3##(2010-6#1)(2012-1#1)
presenting as##148##2##(1990-2#2)(1990-6#1)(1991-10#1)(1991-4#1)(1992-5#1)(1992-9#1)(1995-11#1)(1995-6#1)(2004-1#1)(2004-10#3)(2006-1#1)(2006-10#7)(2006-12#1)(2006-4#1)(2006-7#1)(2006-9#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#4)(2007-3#2)(2007-7#6)(2007-8#7)(2008-1#3)(2008-10#1)(2008-11#6)(2008-12#5)(2008-3#4)(2008-4#2)(2008-7#10)(2008-8#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#4)(2010-10#2)(2010-11#1)(2010-2#2)(2010-4#1)(2010-5#4)(2010-6#4)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#4)(2012-1#6)(2012-12#7)(2012-2#8)(2012-3#3)(2013-1#2)(2013-7#2)(2013-8#1)
presenting at a##4##3##(2005-8#1)(2008-3#1)(2012-12#1)(2013-8#1)
presenting at birth##2##3##(2007-7#1)(2012-12#1)
presenting at the##2##3##(2006-8#1)(2007-2#1)
presenting at##11##2##(2005-8#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-3#1)(2008-6#1)(2009-4#1)(2012-12#2)(2013-8#1)
presenting cells##23##2##(1991-5#1)(1992-7#2)(1992-8#1)(1993-3#2)(1993-8#1)(1994-11#1)(1995-5#1)(1996-12#1)(1997-4#1)(2006-10#1)(2006-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
presenting clinical features were##2##4##(2008-1#1)(2008-4#1)
presenting clinical features##4##3##(2007-2#1)(2007-9#1)(2008-1#1)(2008-4#1)
presenting clinical##6##2##(2007-2#1)(2007-9#1)(2008-1#1)(2008-4#1)(2009-10#1)(2013-1#1)
presenting complaints##5##2##(2006-8#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
presenting data on##2##3##(1996-3#1)(2011-2#1)
presenting feature of acute lymphoblastic##2##5##(2008-11#1)(2012-2#1)
presenting feature of##10##3##(2007-5#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-9#2)(2010-6#1)(2012-2#2)
presenting feature##15##2##(1996-3#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-9#2)(2010-6#1)(2011-1#1)(2012-11#1)(2012-2#2)
presenting features of##3##3##(2007-11#1)(2007-2#1)(2013-1#1)
presenting features##7##2##(2006-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-3#1)(2011-2#1)(2013-1#1)
presenting for##21##2##(1991-12#1)(1991-5#1)(1993-4#1)(1995-11#1)(2006-10#3)(2007-2#2)(2007-9#1)(2008-1#1)(2008-3#1)(2008-6#1)(2009-10#1)(2010-8#2)(2012-2#2)(2012-3#1)(2013-1#2)
presenting fractures##3##2##(2013-1#1)(2013-8#2)
presenting in a##4##3##(2007-12#1)(2008-10#1)(2008-7#1)(2009-1#1)
presenting in adulthood##3##3##(2005-2#1)(2012-2#2)
presenting in association with##3##4##(2007-7#1)(2008-6#1)(2009-10#1)
presenting in infancy##2##3##(2008-6#1)(2010-5#1)
presenting in the##4##3##(2010-12#1)(2010-9#1)(2012-2#1)(2013-8#1)
presenting in utero##2##3##(1996-4#2)
presenting in##23##2##(1996-4#2)(2005-2#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-6#2)(2008-7#1)(2009-1#1)(2009-10#2)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-2#3)(2013-8#1)
presenting information##3##2##(1992-3#1)(2008-10#1)(2010-9#1)
presenting injury##2##2##(1997-8#1)(2007-12#1)
presenting manifestation of acute##2##4##(2006-10#1)(2010-4#1)
presenting manifestation of##5##3##(2006-10#3)(2007-11#1)(2010-4#1)
presenting metabolism in the context of##2##6##(2008-3#2)
presenting more##3##2##(2008-9#1)(2009-1#1)(2010-12#1)
presenting much higher peak currents than those##2##7##(2008-10#2)
presenting new challenges##2##3##(2013-7#1)(2013-8#1)
presenting on the##3##3##(2007-9#1)(2010-6#1)(2013-7#1)
presenting relative##2##2##(2008-10#2)
presenting sign of##8##3##(2007-2#1)(2008-1#1)(2009-7#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
presenting sign##9##2##(2007-2#1)(2008-1#1)(2009-7#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-12#2)(2012-2#1)
presenting signs and symptoms##2##4##(1991-12#1)(2010-5#1)
presenting signs of##2##3##(2006-8#1)(2008-8#1)
presenting signs were##2##3##(1993-2#1)(2012-3#1)
presenting signs##6##2##(1991-12#1)(1993-2#1)(2006-8#1)(2008-8#1)(2010-5#1)(2012-3#1)
presenting some##2##2##(2005-11#1)(2008-11#1)
presenting symptom of##2##3##(2006-1#1)(2007-2#1)
presenting symptom or##2##3##(2006-8#1)(2007-3#1)
presenting symptom##13##2##(1993-6#1)(1995-10#1)(2006-1#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-7#1)(2013-7#1)
presenting symptoms and##3##3##(1991-9#1)(2007-8#1)(2010-10#1)
presenting symptoms included##2##3##(2006-9#1)(2008-7#1)
presenting symptoms were##2##3##(2011-2#1)(2012-3#1)
presenting symptoms##21##2##(1990-6#1)(1991-11#1)(1991-9#1)(1992-2#1)(2006-11#2)(2006-2#1)(2006-9#3)(2007-11#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
presenting syndrome of HIV disease##2##5##(2011-2#2)
presenting syndrome##4##2##(1991-2#1)(1995-1#1)(2011-2#2)
presenting the first case of##2##5##(2011-1#1)(2013-1#1)
presenting the problem##2##3##(2009-6#1)(2012-2#1)
presenting the results of##2##4##(2008-6#1)(2009-2#1)
presenting the risk##2##3##(2011-2#2)
presenting the##30##2##(1990-9#1)(1992-8#1)(1995-12#1)(1997-3#1)(2006-6#1)(2007-1#1)(2007-2#1)(2007-4#1)(2007-8#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-9#1)(2009-2#2)(2009-6#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#3)
presenting these##2##2##(2007-10#1)(2008-5#1)
presenting this##3##2##(2007-7#1)(2008-12#2)
presenting to a##11##3##(1993-2#1)(2006-8#1)(2007-2#2)(2007-3#1)(2007-6#1)(2008-4#1)(2012-2#4)
presenting to an##3##3##(2006-8#1)(2008-3#1)(2013-8#1)
presenting to our##2##3##(2007-8#1)(2013-8#1)
presenting to the emergency department with chest pain##3##8##(2008-3#3)
presenting to the emergency department with##7##6##(2007-10#1)(2008-3#3)(2009-9#2)(2011-2#1)
presenting to the emergency department##13##5##(2007-10#2)(2007-7#2)(2008-11#1)(2008-3#4)(2009-9#2)(2011-2#1)(2012-3#1)
presenting to the emergency room##2##5##(2007-3#1)(2013-1#1)
presenting to the emergency##15##4##(2007-10#2)(2007-3#1)(2007-7#2)(2008-11#1)(2008-3#4)(2009-9#2)(2011-2#1)(2012-3#1)(2013-1#1)
presenting to the##25##3##(2004-10#1)(2006-10#1)(2006-2#2)(2007-10#2)(2007-12#1)(2007-3#1)(2007-7#3)(2008-1#1)(2008-11#1)(2008-3#5)(2009-6#1)(2009-8#1)(2009-9#2)(2011-2#1)(2012-3#1)(2013-1#1)
presenting to##57##2##(1993-2#1)(1995-8#1)(2004-10#1)(2006-10#1)(2006-2#4)(2006-5#1)(2006-8#4)(2007-10#2)(2007-12#2)(2007-2#2)(2007-3#2)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#6)(2008-4#1)(2008-7#2)(2009-6#1)(2009-8#1)(2009-9#2)(2011-1#5)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
presenting two##2##2##(2008-2#1)(2010-7#1)
presenting under##2##2##(1993-12#1)(2007-9#1)
presenting unique##2##2##(2008-5#1)(2013-8#1)
presenting visual acuity##4##3##(2007-2#1)(2011-1#3)
presenting visual##5##2##(2007-2#2)(2011-1#3)
presenting with ALI due to##2##5##(2011-2#2)
presenting with a history of##2##5##(2012-1#1)(2013-1#1)
presenting with a large##2##4##(2006-9#1)(2008-10#1)
presenting with a palpable##2##4##(2013-1#1)(2013-7#1)
presenting with a##31##3##(1990-6#1)(1992-9#1)(1997-7#1)(2006-10#3)(2006-6#2)(2006-9#1)(2007-3#2)(2007-6#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#1)(2009-9#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-1#4)(2013-7#1)(2013-8#1)
presenting with abdominal pain##5##4##(2008-3#1)(2011-2#1)(2013-1#3)
presenting with acute coronary syndrome##2##5##(2008-11#1)(2008-7#1)
presenting with acute hepatitis##2##4##(2005-12#2)
presenting with acute onset##2##4##(2008-7#1)(2013-1#1)
presenting with acute##22##3##(2005-12#2)(2006-12#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-7#3)(2008-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)
presenting with an acute##2##4##(2007-11#1)(2008-11#1)
presenting with an##8##3##(2006-10#1)(2007-11#1)(2008-11#1)(2008-4#1)(2010-10#1)(2013-1#2)(2013-8#1)
presenting with aortic##2##3##(1991-10#1)(2008-4#1)
presenting with atypical##3##3##(2008-10#1)(2008-12#1)(2012-3#1)
presenting with cervical##2##3##(2006-8#1)(2007-11#1)
presenting with chronic##4##3##(1993-10#1)(2006-8#3)
presenting with clinical signs##2##4##(2007-7#1)(2007-8#1)
presenting with clinical##5##3##(1993-11#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#1)
presenting with dyspnea##3##3##(2008-3#1)(2009-10#1)(2011-1#1)
presenting with features of##3##4##(2008-6#1)(2010-4#1)(2013-1#1)
presenting with fever##3##3##(2007-7#2)(2013-8#1)
presenting with gross hematuria##3##4##(2008-11#3)
presenting with hematuria##2##3##(2008-1#1)(2008-10#1)
presenting with hepatic##2##3##(2004-7#1)(2006-4#1)
presenting with increasing##2##3##(2007-8#1)(2008-6#1)
presenting with ischemic##2##3##(2007-7#1)(2010-8#1)
presenting with lung##2##3##(2007-8#1)(2008-6#1)
presenting with metastatic##3##3##(1997-8#1)(2007-11#1)(2010-3#1)
presenting with multiple##5##3##(2007-2#1)(2008-12#1)(2009-4#1)(2010-12#1)(2012-12#1)
presenting with obstructive jaundice and##2##5##(2007-4#1)(2008-3#1)
presenting with obstructive jaundice##4##4##(2007-4#1)(2008-12#1)(2008-3#1)(2010-9#1)
presenting with progressive##4##3##(2007-1#1)(2007-7#1)(2007-8#1)(2009-6#1)
presenting with prolonged##3##3##(2006-4#1)(2011-1#1)(2011-2#1)
presenting with recurrent##8##3##(2007-11#1)(2007-8#1)(2008-1#1)(2008-6#1)(2009-9#1)(2010-2#1)(2011-2#1)(2013-7#1)
presenting with right##2##3##(2006-1#1)(2008-7#1)
presenting with severe##8##3##(2006-4#3)(2007-12#2)(2007-8#1)(2009-4#1)(2013-8#1)
presenting with spontaneous pneumothorax##3##4##(2008-1#1)(2008-7#1)(2012-11#1)
presenting with spontaneous##4##3##(2008-1#1)(2008-7#1)(2011-2#1)(2012-11#1)
presenting with subarachnoid haemorrhage##2##4##(1996-9#1)(2008-7#1)
presenting with subarachnoid hemorrhage##2##4##(2013-8#2)
presenting with subarachnoid##4##3##(1996-9#1)(2008-7#1)(2013-8#2)
presenting with sudden##4##3##(1995-1#1)(2008-10#1)(2008-12#1)(2008-7#1)
presenting with symptoms of##5##4##(1995-5#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-4#1)
presenting with symptoms##6##3##(1995-5#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-4#1)(2011-1#1)
presenting with the##7##3##(1990-7#1)(2006-6#3)(2006-8#1)(2007-7#2)
presenting with this condition##3##4##(1991-7#1)(2008-10#1)(2008-12#1)
presenting with vertebral##2##3##(2005-10#1)(2006-8#1)
presenting with##328##2##(1990-12#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-7#1)(1992-1#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-8#3)(1994-12#1)(1995-1#1)(1995-10#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-7#2)(1997-8#4)(2004-10#2)(2004-2#1)(2004-7#1)(2005-10#2)(2005-12#2)(2006-1#2)(2006-10#12)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#8)(2006-6#7)(2006-8#10)(2006-9#3)(2007-1#1)(2007-10#5)(2007-11#6)(2007-12#5)(2007-2#6)(2007-3#6)(2007-4#1)(2007-6#1)(2007-7#11)(2007-8#14)(2007-9#2)(2008-1#5)(2008-10#8)(2008-11#6)(2008-12#6)(2008-3#7)(2008-4#5)(2008-5#3)(2008-6#12)(2008-7#19)(2008-8#3)(2008-9#2)(2009-10#2)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#3)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#3)(2010-8#2)(2010-9#3)(2011-1#5)(2011-2#16)(2012-1#3)(2012-11#1)(2012-12#6)(2012-2#12)(2012-3#3)(2013-1#21)(2013-7#5)(2013-8#9)
presenting within##3##2##(2007-10#3)
presenting##955##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-6#3)(1990-7#1)(1990-9#1)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#4)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#4)(1993-3#2)(1993-4#1)(1993-6#2)(1993-8#4)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#3)(1995-10#3)(1995-11#4)(1995-12#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-4#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#3)(1997-8#7)(2004-1#1)(2004-10#9)(2004-2#2)(2004-7#1)(2004-9#1)(2005-10#3)(2005-11#1)(2005-12#3)(2005-2#1)(2005-8#3)(2006-1#4)(2006-10#31)(2006-11#4)(2006-12#3)(2006-2#11)(2006-3#1)(2006-4#9)(2006-5#2)(2006-6#8)(2006-7#2)(2006-8#21)(2006-9#9)(2007-1#4)(2007-10#18)(2007-11#12)(2007-12#10)(2007-2#22)(2007-3#12)(2007-4#2)(2007-5#3)(2007-6#2)(2007-7#31)(2007-8#30)(2007-9#7)(2008-1#16)(2008-10#25)(2008-11#22)(2008-12#17)(2008-2#5)(2008-3#25)(2008-4#18)(2008-5#10)(2008-6#20)(2008-7#37)(2008-8#8)(2008-9#8)(2009-1#3)(2009-10#7)(2009-11#1)(2009-2#3)(2009-3#2)(2009-4#6)(2009-5#4)(2009-6#6)(2009-7#2)(2009-8#4)(2009-9#10)(2010-1#1)(2010-10#8)(2010-11#1)(2010-12#8)(2010-2#6)(2010-3#3)(2010-4#5)(2010-5#9)(2010-6#6)(2010-7#7)(2010-8#7)(2010-9#5)(2011-1#23)(2011-2#38)(2012-1#10)(2012-11#3)(2012-12#25)(2012-2#41)(2012-3#13)(2013-1#47)(2013-7#11)(2013-8#28)
presently available in##2##3##(1990-3#1)(2008-8#1)
presently available##11##2##(1990-3#1)(1991-2#1)(1996-11#1)(2005-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-8#1)
presently being##9##2##(1993-2#1)(1996-5#1)(1997-1#1)(2004-9#1)(2007-11#1)(2008-11#1)(2008-3#1)(2009-3#1)(2010-12#1)
presently described##2##2##(1994-3#1)(1995-12#1)
presently in##2##2##(1997-3#1)(2008-10#1)
presently investigated##2##2##(1995-9#1)(2010-12#1)
presently known##2##2##(1992-2#1)(2013-8#1)
presently unclear##5##2##(1993-11#1)(1993-6#1)(1995-8#1)(2006-10#1)(2008-8#1)
presently under##7##2##(1992-2#1)(1992-6#1)(1995-3#1)(1997-3#1)(2008-9#1)(2010-6#1)(2012-2#1)
presently used##4##2##(1990-12#1)(1991-2#1)(1994-6#1)(2008-10#1)
presently##103##1##(1990-12#2)(1990-3#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-4#1)(1991-8#1)(1992-1#1)(1992-2#2)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-4#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#3)(2007-1#1)(2007-11#1)(2007-4#1)(2007-7#2)(2007-8#5)(2008-1#1)(2008-10#8)(2008-11#4)(2008-3#5)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#3)(2010-3#2)(2010-6#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#3)
presents 10##2##2##(1994-5#1)(2006-12#1)
presents a basic##2##3##(2006-8#1)(2008-4#1)
presents a brief historical##2##4##(1992-1#1)(2006-6#1)
presents a brief history of##2##5##(1991-9#1)(2008-4#1)
presents a brief overview of##3##5##(2006-10#2)(2008-9#1)
presents a brief overview##4##4##(2006-10#3)(2008-9#1)
presents a brief review of the##2##6##(1990-12#1)(2008-5#1)
presents a brief##12##3##(1990-12#1)(1991-9#1)(1992-1#1)(2006-10#3)(2006-4#1)(2006-6#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)
presents a case of a##10##5##(2007-4#1)(2009-3#7)(2010-12#1)(2013-1#1)
presents a case of##23##4##(2007-4#1)(2007-8#1)(2008-11#1)(2009-10#1)(2009-3#14)(2010-12#1)(2011-2#1)(2012-12#2)(2013-1#1)
presents a case study in##3##5##(1993-12#1)(1996-2#1)(2012-2#1)
presents a case study of##2##5##(1997-2#2)
presents a case study##6##4##(1993-12#1)(1996-2#1)(1997-2#2)(2009-5#1)(2012-2#1)
presents a case##33##3##(1993-12#1)(1996-2#1)(1997-2#2)(2007-4#1)(2007-8#1)(2008-11#1)(2009-10#1)(2009-3#14)(2009-5#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#2)
presents a challenge for##2##4##(2009-6#1)(2010-5#1)
presents a challenge to##3##4##(1993-3#1)(2008-10#1)(2008-8#1)
presents a challenge##8##3##(1993-3#1)(2008-10#1)(2008-8#1)(2009-6#1)(2010-5#1)(2012-12#2)(2013-8#1)
presents a complex##2##3##(2007-5#1)(2011-1#1)
presents a comprehensive overview of the##3##6##(1992-12#1)(1993-12#1)(2013-1#1)
presents a comprehensive overview of##4##5##(1992-12#1)(1993-12#1)(2007-12#1)(2013-1#1)
presents a detailed analysis of##2##5##(1994-1#1)(1994-11#1)
presents a detailed description of##2##5##(1996-1#1)(2010-3#1)
presents a detailed##6##3##(1994-1#1)(1994-11#1)(1996-1#1)(2010-12#1)(2010-3#1)(2010-5#1)
presents a different##2##3##(2007-11#1)(2008-5#1)
presents a discussion of the##2##5##(2008-2#2)
presents a discussion of##5##4##(2008-2#2)(2008-4#1)(2008-9#1)(2010-10#1)
presents a flow injection##2##4##(2008-10#2)
presents a general overview of the##2##6##(2005-7#1)(2008-11#1)
presents a general##6##3##(1995-5#1)(2005-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2012-2#1)
presents a high degree of##2##5##(1994-3#1)(2007-3#1)
presents a high##5##3##(1994-3#1)(2007-3#1)(2007-5#1)(2008-10#1)(2012-12#1)
presents a historical overview of##2##5##(2004-12#1)(2011-2#1)
presents a historical##3##3##(2004-12#1)(2010-7#1)(2011-2#1)
presents a large##2##3##(1995-1#1)(2007-5#1)
presents a low##2##3##(2007-12#1)(2007-7#1)
presents a major challenge##2##4##(1996-7#1)(2008-10#1)
presents a major##5##3##(1996-7#1)(2006-9#1)(2008-1#1)(2008-10#1)(2010-6#1)
presents a method for preparing##2##5##(2008-4#2)
presents a method for##7##4##(1993-4#1)(2007-11#1)(2008-10#2)(2008-4#2)(2008-6#1)
presents a method##12##3##(1993-4#1)(2007-11#1)(2008-10#4)(2008-4#3)(2008-6#1)(2008-9#1)(2009-7#1)
presents a methodology for##3##4##(1992-3#1)(1995-12#2)
presents a methodology##5##3##(1992-3#1)(1993-2#1)(1995-12#2)(2008-10#1)
presents a model##3##3##(1992-1#1)(1995-2#1)(2005-11#1)
presents a much##2##3##(2005-11#1)(2008-5#1)
presents a new and##2##4##(2009-3#1)(2012-3#1)
presents a new approach for##2##5##(2008-1#1)(2008-2#1)
presents a new approach##3##4##(2008-1#1)(2008-2#1)(2009-9#1)
presents a new##17##3##(1990-9#1)(1996-12#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-6#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-5#1)(2012-3#1)(2013-1#3)
presents a novel##10##3##(1995-11#1)(2005-11#1)(2006-4#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-5#2)(2012-1#1)(2012-3#1)
presents a number of##3##4##(1995-12#1)(2008-7#1)(2009-3#1)
presents a particular##2##3##(2007-5#1)(2008-12#1)
presents a patient##3##3##(2006-10#1)(2006-7#1)(2007-3#1)
presents a practical##3##3##(1993-6#1)(2012-12#2)
presents a problem in##2##4##(1995-11#1)(2011-2#1)
presents a problem##4##3##(1993-6#1)(1995-11#1)(2008-9#1)(2011-2#1)
presents a procedure##3##3##(2009-8#1)(2010-8#1)(2013-1#1)
presents a protocol in which##2##5##(2008-4#2)
presents a protocol##12##3##(2008-2#2)(2008-4#9)(2008-9#1)
presents a qualitative##2##3##(2006-7#1)(2010-12#1)
presents a range of##2##4##(2008-7#1)(2008-9#1)
presents a research##3##3##(2008-8#1)(2010-2#1)(2012-2#1)
presents a retrospective##4##3##(1993-8#1)(2008-11#1)(2008-9#1)(2013-1#1)
presents a review of the literature##3##6##(2007-8#1)(2008-1#1)(2013-8#1)
presents a review of the##6##5##(2007-11#1)(2007-8#1)(2008-1#1)(2010-1#1)(2010-12#1)(2013-8#1)
presents a review of##13##4##(2007-11#2)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-2#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-7#1)(2013-8#1)
presents a review##15##3##(1996-1#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-2#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-7#1)(2013-8#1)
presents a set of##4##4##(1996-5#1)(2008-2#1)(2008-4#1)(2008-9#1)
presents a short##4##3##(2008-7#1)(2008-9#1)(2012-2#2)
presents a significant challenge##2##4##(2007-12#1)(2013-7#1)
presents a significant##3##3##(2007-12#1)(2012-2#1)(2013-7#1)
presents a simple and##2##4##(2008-4#2)
presents a simple method##2##4##(1997-3#1)(2008-11#1)
presents a simple##11##3##(1994-6#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2009-8#1)
presents a solution to these##2##5##(2008-6#1)(2008-9#1)
presents a special##2##3##(2010-2#1)(2011-2#1)
presents a strategy##2##3##(2007-6#1)(2011-1#1)
presents a study of##3##4##(2008-10#2)(2009-8#1)
presents a study##5##3##(2006-1#1)(2008-10#2)(2009-8#1)(2010-8#1)
presents a substantial##2##3##(2008-10#2)
presents a summary of the##3##5##(2009-10#1)(2011-3#1)(2013-1#1)
presents a summary of##5##4##(2008-7#1)(2009-10#1)(2011-3#1)(2012-11#1)(2013-1#1)
presents a survey of the##2##5##(2007-11#1)(2013-1#1)
presents a survey of##3##4##(1994-3#1)(2007-11#1)(2013-1#1)
presents a synthesis of##2##4##(2008-10#1)(2008-2#1)
presents a system##2##3##(1994-12#1)(2008-6#1)
presents a systematic review of the##2##6##(2007-7#1)(2007-8#1)
presents a systematic##3##3##(1995-1#1)(2007-7#1)(2007-8#1)
presents a technique##3##3##(2008-5#1)(2008-6#1)(2008-9#1)
presents a template##2##3##(1996-1#1)(2008-2#1)
presents a thorough##2##3##(2008-10#1)(2008-4#1)
presents a unique challenge to##3##5##(1997-2#1)(2008-10#1)(2010-8#1)
presents a unique set of##2##5##(2004-12#1)(2007-12#1)
presents a unique##10##3##(1997-2#1)(2004-12#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-4#1)(2010-8#1)(2012-1#1)(2013-1#1)
presents a variety of##4##4##(1991-3#1)(2010-6#1)(2011-2#1)(2012-2#1)
presents a##413##2##(1990-12#2)(1990-3#1)(1990-7#1)(1990-9#1)(1991-2#3)(1991-3#2)(1991-9#1)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#3)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#2)(1993-6#3)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#5)(1994-6#1)(1995-1#2)(1995-11#2)(1995-12#4)(1995-2#2)(1995-5#1)(1996-1#4)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#2)(1997-7#1)(2004-12#2)(2005-10#1)(2005-11#4)(2005-12#1)(2005-7#1)(2006-1#1)(2006-10#8)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#8)(2007-12#7)(2007-2#3)(2007-3#3)(2007-4#2)(2007-5#5)(2007-6#1)(2007-7#3)(2007-8#7)(2007-9#1)(2008-1#6)(2008-10#34)(2008-11#7)(2008-12#1)(2008-2#18)(2008-3#3)(2008-4#31)(2008-5#5)(2008-6#6)(2008-7#7)(2008-8#3)(2008-9#16)(2009-10#5)(2009-11#1)(2009-12#1)(2009-3#16)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#8)(2010-2#5)(2010-3#1)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#7)(2011-1#3)(2011-2#9)(2011-3#1)(2011-7#1)(2012-1#7)(2012-11#1)(2012-12#10)(2012-2#13)(2012-3#4)(2013-1#16)(2013-7#2)(2013-8#2)
presents an account##2##3##(1991-11#1)(2007-8#1)
presents an algorithm for##2##4##(2009-4#1)(2011-10#1)
presents an algorithm##3##3##(2008-2#1)(2009-4#1)(2011-10#1)
presents an alternative##6##3##(2006-10#1)(2008-2#4)(2008-7#1)
presents an analysis of the##2##5##(2005-11#1)(2006-10#1)
presents an analysis of##11##4##(1993-6#1)(1996-2#1)(2005-11#1)(2006-10#1)(2007-8#2)(2008-11#1)(2009-2#1)(2011-1#1)(2012-12#1)(2012-2#1)
presents an application of##2##4##(2008-12#1)(2010-9#1)
presents an approach for##2##4##(2008-9#1)(2012-1#1)
presents an approach to##3##4##(2006-10#1)(2008-1#1)(2008-2#1)
presents an approach##5##3##(2006-10#1)(2008-1#1)(2008-2#1)(2008-9#1)(2012-1#1)
presents an assay##2##3##(1997-8#1)(2008-4#1)
presents an assessment##2##3##(2008-3#1)(2012-3#1)
presents an evaluation of the##3##5##(2008-10#1)(2009-2#1)(2010-5#1)
presents an evaluation of##4##4##(1992-12#1)(2008-10#1)(2009-2#1)(2010-5#1)
presents an interesting##3##3##(2009-2#1)(2010-11#1)(2010-12#1)
presents an introduction to##2##4##(1997-2#1)(2008-4#1)
presents an investigation on##2##4##(2008-10#2)
presents an investigation##3##3##(2008-10#2)(2008-7#1)
presents an outline##2##3##(2005-1#1)(2008-9#1)
presents an overview of the clinical##2##6##(2007-11#1)(2008-2#1)
presents an overview of the##11##5##(1997-2#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
presents an overview of##25##4##(1991-12#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-12#1)(2008-2#2)(2008-4#4)(2008-5#3)(2008-7#1)(2008-9#2)(2009-4#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
presents an overview##26##3##(1991-12#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-12#1)(2008-2#2)(2008-4#4)(2008-5#4)(2008-7#1)(2008-9#2)(2009-4#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
presents an update of##2##4##(2008-11#1)(2008-9#1)
presents an##119##2##(1991-11#1)(1991-12#2)(1992-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-9#2)(1996-11#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#1)(2005-1#1)(2005-11#1)(2006-1#1)(2006-10#4)(2006-2#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-8#3)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#4)(2008-2#8)(2008-3#3)(2008-4#8)(2008-5#7)(2008-6#1)(2008-7#6)(2008-9#5)(2009-2#3)(2009-4#2)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-10#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
presents and##6##2##(1991-9#1)(2009-3#1)(2010-9#1)(2011-1#1)(2013-1#2)
presents as a firm##2##4##(2012-3#1)(2013-1#1)
presents as a solitary##2##4##(2006-1#1)(2012-3#1)
presents as a##16##3##(1990-9#1)(2006-1#1)(2007-2#1)(2007-6#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-9#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
presents as an##4##3##(2005-11#1)(2008-4#1)(2011-2#1)(2012-12#1)
presents as##31##2##(1990-6#1)(1990-9#1)(2005-11#1)(2006-1#1)(2006-10#1)(2007-2#1)(2007-4#1)(2007-6#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-1#1)(2010-8#1)(2010-9#1)(2011-12#2)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#2)(2013-7#1)
presents basic##4##2##(2008-2#1)(2008-4#1)(2008-9#1)(2010-4#1)
presents both##3##2##(1996-6#1)(2008-10#1)(2008-7#1)
presents certain##2##2##(2008-10#1)(2008-5#1)
presents challenges##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)
presents clear##2##2##(1991-3#1)(2013-7#1)
presents clinical##2##2##(1993-1#1)(2008-4#1)
presents concise##2##2##(2008-9#1)(2010-5#1)
presents considerable##2##2##(1993-10#1)(2008-10#1)
presents current##2##2##(2007-7#1)(2008-11#1)
presents data about##2##3##(1992-12#1)(1992-7#1)
presents data of##2##3##(2006-12#1)(2010-8#1)
presents data on##8##3##(1991-6#1)(1994-2#1)(1995-3#1)(1997-1#1)(1997-3#1)(2007-8#1)(2008-10#1)(2011-2#1)
presents data that##2##3##(2008-3#1)(2008-4#1)
presents data##19##2##(1991-6#1)(1992-12#1)(1992-7#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-1#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-8#1)(2011-2#1)
presents diagnostic##5##2##(2007-11#1)(2008-11#1)(2010-11#1)(2013-1#2)
presents different##2##2##(1991-6#1)(2009-8#1)
presents difficulties for the##2##4##(1995-4#1)(2008-2#1)
presents difficulties##3##2##(1995-4#1)(2008-2#1)(2011-2#1)
presents either##2##2##(2006-10#1)(2013-1#1)
presents enormous##2##2##(2005-6#1)(2010-3#1)
presents epidemiology##2##2##(2007-11#1)(2008-2#1)
presents evidence that##5##3##(1991-12#1)(1992-10#1)(1995-11#1)(2007-11#1)(2010-12#1)
presents evidence##8##2##(1991-12#1)(1992-10#1)(1992-4#1)(1994-8#1)(1995-11#1)(2007-11#1)(2007-2#1)(2010-12#1)
presents examples of##4##3##(1995-6#1)(1996-5#1)(2008-8#1)(2009-4#1)
presents extensive##2##2##(2008-9#2)
presents findings from##2##3##(1994-1#1)(2008-11#1)
presents findings##4##2##(1994-1#1)(2007-7#1)(2008-11#1)(2008-12#1)
presents for the first time##2##5##(2007-8#1)(2008-7#1)
presents for##3##2##(2007-8#1)(2008-7#1)(2009-9#1)
presents guidelines##2##2##(1997-2#1)(2008-4#1)
presents high##2##2##(1990-2#1)(2008-10#1)
presents his##5##2##(1995-1#1)(1997-2#1)(2007-11#1)(2008-2#2)
presents in a##3##3##(2008-1#1)(2013-1#2)
presents in the##2##3##(2006-4#1)(2010-1#1)
presents in##16##2##(1993-8#1)(1997-3#1)(2005-12#1)(2006-4#1)(2006-5#1)(2008-1#1)(2008-10#2)(2008-6#1)(2009-1#2)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
presents information on##2##3##(1991-12#1)(2008-9#1)
presents information##4##2##(1991-12#1)(1995-3#1)(2008-2#1)(2008-9#1)
presents interesting##2##2##(2006-10#1)(2007-12#1)
presents issues##2##2##(2006-5#1)(2008-4#1)
presents itself as a##2##4##(1994-2#1)(2008-11#1)
presents itself##6##2##(1994-2#1)(2008-11#1)(2008-2#1)(2010-6#1)(2012-1#1)(2012-3#1)
presents key##3##2##(1992-2#1)(1994-2#1)(2006-4#1)
presents many challenges to##3##4##(2006-12#1)(2008-12#1)(2008-5#1)
presents many challenges##8##3##(2006-12#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#1)
presents many##15##2##(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-7#1)(2011-1#1)(2012-2#1)
presents methods for##9##3##(1994-6#1)(2008-4#5)(2008-9#3)
presents methods##11##2##(1994-6#1)(2007-11#1)(2008-4#5)(2008-9#4)
presents new challenges##2##3##(2007-4#1)(2008-12#1)
presents new##5##2##(2006-10#2)(2007-4#1)(2008-12#1)(2009-8#1)
presents no##4##2##(1990-6#1)(1994-8#1)(2005-11#1)(2008-3#1)
presents numerous##3##2##(1992-3#1)(2008-10#1)(2008-4#1)
presents observations##2##2##(1993-2#1)(2013-1#1)
presents one of##2##3##(2007-2#1)(2010-8#1)
presents one##3##2##(2007-2#1)(2008-2#1)(2010-8#1)
presents only##2##2##(1992-7#1)(1996-2#1)
presents our##3##2##(2007-8#1)(2009-8#1)(2010-7#1)
presents outcomes##2##2##(2007-4#1)(2007-7#1)
presents practical##4##2##(1996-8#1)(2007-12#1)(2008-9#1)(2012-2#1)
presents predominantly in##2##3##(2007-11#1)(2007-9#1)
presents problems##2##2##(1992-3#1)(2008-7#1)
presents procedures for##5##3##(2008-4#3)(2008-9#1)(2010-2#1)
presents protocols for##20##3##(2008-2#2)(2008-4#8)(2008-9#10)
presents protocols##23##2##(2008-2#3)(2008-4#9)(2008-9#11)
presents recent findings##2##3##(1997-7#1)(2006-10#1)
presents recent research##2##3##(1991-2#1)(2008-10#1)
presents recent##4##2##(1991-2#1)(1997-7#1)(2006-10#1)(2008-10#1)
presents results of a##4##4##(1997-3#1)(2008-2#2)(2008-9#1)
presents results of##9##3##(1997-3#1)(2007-11#2)(2007-8#1)(2008-2#2)(2008-4#1)(2008-9#1)(2009-8#1)
presents results##13##2##(1992-5#1)(1997-2#1)(1997-3#1)(2007-11#2)(2007-3#1)(2007-8#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-8#1)
presents serious##2##2##(2008-9#1)(2012-11#1)
presents several advantages over##2##4##(2008-11#1)(2010-4#1)
presents several##6##2##(1997-8#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-4#1)
presents significant challenges##2##3##(2007-12#1)(2007-8#1)
presents significant##4##2##(1997-2#1)(2007-12#1)(2007-8#1)(2009-10#1)
presents some of the##6##4##(1994-8#1)(1995-11#1)(2007-12#1)(2008-12#1)(2008-5#1)(2010-7#1)
presents some of##7##3##(1994-8#1)(1995-11#1)(2006-6#1)(2007-12#1)(2008-12#1)(2008-5#1)(2010-7#1)
presents some##20##2##(1991-12#1)(1993-2#1)(1994-8#1)(1995-11#1)(1996-7#1)(1996-8#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-12#2)(2013-1#1)
presents special challenges##3##3##(1996-12#1)(2006-10#1)(2006-4#1)
presents strategies##2##2##(2006-5#1)(2008-9#1)
presents studies on##2##3##(1995-5#1)(2006-5#1)
presents substantial##2##2##(2012-2#1)(2013-8#1)
presents tables of##2##3##(2008-2#1)(2008-9#1)
presents the authorized translation##2##4##(2007-11#2)
presents the basic##2##3##(2006-10#1)(2011-12#1)
presents the case of a patient##3##6##(2006-10#1)(2010-8#1)(2012-3#1)
presents the case of a##9##5##(2006-10#1)(2007-7#1)(2010-8#1)(2011-12#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
presents the case of##13##4##(1992-1#1)(2006-10#1)(2007-7#2)(2010-8#1)(2011-12#2)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
presents the case##14##3##(1992-1#1)(2006-10#1)(2007-7#2)(2010-5#1)(2010-8#1)(2011-12#2)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
presents the current state of knowledge on the##2##8##(1995-11#1)(2007-11#1)
presents the current##4##3##(1995-11#1)(2007-11#2)(2007-3#1)
presents the development of##5##4##(2008-3#1)(2008-6#1)(2012-1#3)
presents the development##6##3##(2008-3#1)(2008-6#1)(2011-2#1)(2012-1#3)
presents the evaluation of##2##4##(2007-8#1)(2012-1#1)
presents the evidence for the benefits of allowing##2##8##(2008-6#2)
presents the evidence for the benefits of##5##7##(2008-6#5)
presents the evidence for##6##4##(2008-6#6)
presents the findings of a##4##5##(1991-12#1)(1997-7#1)(2008-12#1)(2013-8#1)
presents the findings of##6##4##(1991-12#1)(1994-2#1)(1996-2#1)(1997-7#1)(2008-12#1)(2013-8#1)
presents the findings##7##3##(1991-12#1)(1994-2#1)(1996-2#1)(1997-7#1)(2008-11#1)(2008-12#1)(2013-8#1)
presents the first##7##3##(1990-6#1)(1992-12#1)(1994-5#1)(1996-2#1)(2005-5#1)(2009-3#1)(2012-1#1)
presents the historical background##2##4##(2004-7#1)(2008-9#1)
presents the historical##3##3##(1996-2#1)(2004-7#1)(2008-9#1)
presents the history of the##2##5##(2007-7#1)(2009-10#1)
presents the history of##4##4##(2007-7#2)(2007-8#1)(2009-10#1)
presents the indications and##2##4##(2007-11#1)(2007-8#1)
presents the main##3##3##(1991-2#1)(1991-6#1)(2008-10#1)
presents the most common##2##4##(2008-1#1)(2008-9#1)
presents the most commonly used##2##5##(2007-8#1)(2013-8#1)
presents the most##9##3##(2007-8#1)(2008-1#2)(2008-9#3)(2011-1#1)(2011-2#1)(2013-8#1)
presents the possibilities##3##3##(2007-11#2)(2007-8#1)
presents the principles##3##3##(2007-11#2)(2007-8#1)
presents the results of a study##3##6##(2006-7#1)(2007-8#1)(2009-4#1)
presents the results of a survey##2##6##(1994-3#1)(2008-11#1)
presents the results of a##15##5##(1993-1#1)(1994-3#1)(1995-1#1)(1995-2#1)(1997-3#1)(2006-7#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-4#1)(2011-2#1)(2013-1#1)
presents the results of the first##2##6##(1995-3#1)(2013-8#1)
presents the results of the##5##5##(1994-4#1)(1995-3#1)(2007-4#1)(2008-10#1)(2013-8#1)
presents the results of##33##4##(1993-1#1)(1994-1#1)(1994-3#1)(1994-4#1)(1995-1#1)(1995-2#1)(1995-3#1)(1997-3#1)(2006-11#1)(2006-7#1)(2007-11#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-7#1)(2009-10#1)(2009-4#2)(2010-2#1)(2011-2#3)(2013-1#2)(2013-8#1)
presents the results##35##3##(1993-1#1)(1994-1#1)(1994-3#1)(1994-4#1)(1995-1#1)(1995-2#1)(1995-3#1)(1997-3#1)(2006-11#1)(2006-7#1)(2007-11#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-4#2)(2010-2#1)(2010-8#1)(2011-2#3)(2013-1#2)(2013-8#1)
presents the treatment##2##3##(1993-8#1)(2011-2#1)
presents the use of a##2##5##(2007-12#1)(2012-12#1)
presents the use of##5##4##(2007-10#1)(2007-12#1)(2010-8#2)(2012-12#1)
presents the validation##2##3##(2008-10#1)(2008-5#1)
presents the##247##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-2#1)(1993-7#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#3)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#1)(2004-4#1)(2004-7#1)(2005-5#1)(2006-10#3)(2006-11#3)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#23)(2007-12#4)(2007-3#3)(2007-4#2)(2007-5#1)(2007-7#6)(2007-8#15)(2008-1#2)(2008-10#10)(2008-11#6)(2008-12#3)(2008-2#4)(2008-3#1)(2008-4#5)(2008-5#2)(2008-6#9)(2008-7#1)(2008-9#10)(2009-10#3)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-7#1)(2010-10#2)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#5)(2011-1#5)(2011-12#4)(2011-2#8)(2011-7#2)(2011-9#1)(2012-1#11)(2012-12#6)(2012-2#4)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#8)
presents those##2##2##(2007-11#1)(2007-7#1)
presents three##8##2##(1990-10#1)(1991-1#1)(1994-1#1)(2007-2#2)(2008-2#1)(2010-7#1)(2012-2#1)
presents to the emergency room with##2##6##(2008-3#1)(2009-3#1)
presents two cases##2##3##(1990-10#1)(2008-1#1)
presents two##24##2##(1990-10#1)(1990-4#1)(1994-5#1)(2007-11#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-4#6)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2012-2#1)
presents unique challenges to the##2##5##(2011-2#1)(2013-1#1)
presents unique challenges##5##3##(1991-3#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
presents unique opportunities##2##3##(1995-1#1)(2007-2#1)
presents unique##7##2##(1991-3#1)(1995-1#1)(2007-2#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
presents various##2##2##(2007-11#1)(2008-12#1)
presents with a##11##3##(1997-3#1)(2005-12#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2010-2#1)(2012-12#1)(2012-2#1)
presents with abdominal##2##3##(2004-12#1)(2011-1#1)
presents with acute##3##3##(2006-10#2)(2007-7#1)
presents with an##2##3##(2007-3#1)(2013-7#1)
presents with fever##2##3##(2006-5#1)(2006-7#1)
presents with multiple##3##3##(1997-1#1)(2006-2#1)(2008-10#1)
presents with severe##2##3##(1993-8#1)(2010-6#1)
presents with##59##2##(1993-8#1)(1997-1#2)(1997-3#1)(2004-12#1)(2005-12#1)(2006-10#4)(2006-2#1)(2006-5#4)(2006-7#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#2)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
presents##1368##1##(1990-10#2)(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#4)(1990-7#1)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#6)(1991-2#7)(1991-3#6)(1991-4#3)(1991-6#3)(1991-9#4)(1992-1#4)(1992-10#1)(1992-12#5)(1992-2#3)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#4)(1993-1#2)(1993-10#2)(1993-12#3)(1993-2#7)(1993-3#2)(1993-4#2)(1993-6#4)(1993-7#1)(1993-8#4)(1994-1#6)(1994-11#1)(1994-12#2)(1994-2#8)(1994-3#7)(1994-4#1)(1994-5#3)(1994-6#3)(1994-8#3)(1995-1#5)(1995-11#5)(1995-12#4)(1995-2#4)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#6)(1996-11#3)(1996-12#3)(1996-2#6)(1996-3#2)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#4)(1997-2#16)(1997-3#10)(1997-4#2)(1997-6#1)(1997-7#4)(1997-8#3)(2004-12#3)(2004-4#1)(2004-7#1)(2005-1#1)(2005-10#2)(2005-11#8)(2005-12#4)(2005-5#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-1#3)(2006-10#29)(2006-11#4)(2006-12#5)(2006-2#3)(2006-3#1)(2006-4#6)(2006-5#11)(2006-6#4)(2006-7#6)(2006-8#2)(2006-9#2)(2007-1#2)(2007-10#7)(2007-11#54)(2007-12#22)(2007-2#12)(2007-3#11)(2007-4#9)(2007-5#12)(2007-6#2)(2007-7#20)(2007-8#36)(2007-9#5)(2008-1#15)(2008-10#76)(2008-11#31)(2008-12#15)(2008-2#56)(2008-3#13)(2008-4#94)(2008-5#21)(2008-6#23)(2008-7#27)(2008-8#9)(2008-9#70)(2009-1#3)(2009-10#11)(2009-11#3)(2009-12#2)(2009-2#6)(2009-3#20)(2009-4#11)(2009-5#5)(2009-6#5)(2009-7#5)(2009-8#8)(2009-9#3)(2010-1#3)(2010-10#3)(2010-11#4)(2010-12#16)(2010-2#9)(2010-3#2)(2010-4#3)(2010-5#7)(2010-6#6)(2010-7#7)(2010-8#17)(2010-9#3)(2011-1#16)(2011-10#1)(2011-12#7)(2011-2#31)(2011-3#1)(2011-7#3)(2011-9#1)(2012-1#24)(2012-11#2)(2012-12#30)(2012-2#31)(2012-3#11)(2013-1#43)(2013-7#10)(2013-8#14)
preseparation##2##1##(1993-12#1)(2008-10#1)
preseptal##2##1##(2010-12#1)(2011-1#1)
presequence of the precursor of##2##5##(1991-12#1)(1994-11#1)
presequence of the##4##3##(1991-12#2)(1991-9#1)(1994-11#1)
presequence of##10##2##(1990-5#1)(1990-9#1)(1991-12#4)(1991-7#1)(1991-9#1)(1992-7#1)(1994-11#1)
presequence to##4##2##(1992-6#3)(1997-2#1)
presequence##35##1##(1990-5#1)(1990-9#1)(1991-12#5)(1991-2#1)(1991-4#1)(1991-7#1)(1991-9#3)(1992-6#10)(1992-7#1)(1992-9#1)(1993-3#2)(1994-11#3)(1994-12#2)(1995-11#1)(1996-10#1)(1997-2#1)
presequences of##3##2##(1995-11#1)(1995-2#1)(1996-10#1)
presequences##9##1##(1992-6#2)(1995-11#2)(1995-2#1)(1996-10#2)(1997-2#2)
preservation and restoration of##2##4##(1995-3#1)(2008-1#1)
preservation and##24##2##(1991-3#1)(1991-9#1)(1995-3#1)(1996-12#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
preservation are##2##2##(1991-9#1)(2009-5#1)
preservation at##2##2##(2008-10#1)(2008-11#1)
preservation during##2##2##(2012-12#1)(2013-1#1)
preservation following##2##2##(2007-12#2)
preservation for women##2##3##(2009-5#1)(2009-6#1)
preservation for##3##2##(2009-5#1)(2009-6#1)(2011-2#1)
preservation in the##5##3##(1997-2#2)(2005-10#1)(2008-10#1)(2013-1#1)
preservation in##13##2##(1996-3#1)(1997-2#2)(2005-10#1)(2006-10#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-5#1)(2010-4#2)(2012-2#1)(2013-1#1)
preservation is##9##2##(1996-3#1)(2006-12#1)(2006-2#1)(2008-10#1)(2008-5#1)(2009-4#1)(2010-4#2)(2011-2#1)
preservation medium was##2##3##(2008-10#2)
preservation medium##3##2##(2008-10#3)
preservation method##3##2##(2008-10#2)(2008-5#1)
preservation of a##6##3##(2006-10#1)(2007-11#1)(2008-10#1)(2008-5#1)(2011-2#2)
preservation of arsenic species in##2##5##(2008-10#2)
preservation of bone##2##3##(1993-11#1)(2008-3#1)
preservation of bronchial##2##3##(2010-8#2)
preservation of fertility##2##3##(1994-6#1)(2009-5#1)
preservation of mammalian##3##3##(2008-5#3)
preservation of neurological function##3##4##(2006-11#1)(2006-2#1)(2007-11#1)
preservation of normal tissue##3##4##(2007-12#2)(2010-8#1)
preservation of normal##4##3##(2007-12#2)(2007-5#1)(2010-8#1)
preservation of renal function##3##4##(2008-3#1)(2011-2#1)(2012-2#1)
preservation of renal##5##3##(1992-8#1)(2006-9#1)(2008-3#1)(2011-2#1)(2012-2#1)
preservation of residual##3##3##(2007-12#1)(2007-5#1)(2008-9#1)
preservation of soft tissue##2##4##(2008-12#2)
preservation of the##35##3##(1990-5#1)(1990-6#2)(1990-9#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-9#1)(1993-4#1)(1995-12#1)(1996-5#1)(1997-6#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-3#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
preservation of these##2##3##(2008-10#1)(2011-2#1)
preservation of##136##2##(1990-12#1)(1990-4#1)(1990-5#2)(1990-6#2)(1990-9#2)(1991-9#1)(1992-10#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#1)(1994-11#1)(1994-12#2)(1994-6#2)(1995-1#1)(1995-12#3)(1996-1#2)(1996-5#1)(1996-9#2)(1997-4#1)(1997-6#1)(1997-7#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#4)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#3)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-9#2)(2009-1#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-8#4)(2010-9#3)(2011-1#1)(2011-2#7)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#8)(2013-8#1)
preservation procedures##2##2##(2006-2#1)(2008-10#1)
preservation time##2##2##(2007-8#2)
preservation with 5%##2##3##(1996-12#1)(2012-2#1)
preservation with##6##2##(1996-12#1)(2005-10#2)(2006-5#1)(2008-7#1)(2012-2#1)
preservation##268##1##(1990-12#1)(1990-4#1)(1990-5#2)(1990-6#2)(1990-9#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#6)(1992-10#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#2)(1994-11#1)(1994-12#3)(1994-6#2)(1995-1#1)(1995-12#3)(1995-3#1)(1995-7#2)(1996-1#2)(1996-12#2)(1996-3#2)(1996-5#1)(1996-9#3)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(2005-10#3)(2005-7#2)(2005-8#1)(2006-10#8)(2006-11#3)(2006-12#3)(2006-2#4)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#7)(2007-12#8)(2007-5#3)(2007-7#1)(2007-8#8)(2007-9#1)(2008-1#6)(2008-10#25)(2008-11#8)(2008-12#6)(2008-2#7)(2008-3#7)(2008-4#1)(2008-5#9)(2008-6#4)(2008-7#3)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#5)(2009-6#1)(2009-7#1)(2010-4#5)(2010-7#2)(2010-8#5)(2010-9#4)(2011-1#3)(2011-2#12)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#13)(2013-7#1)(2013-8#1)
preservation)##3##1##(1990-5#1)(2007-8#1)(2008-2#1)
preservative efficacy##3##2##(2008-5#3)
preservative in##5##2##(1990-11#1)(1990-2#1)(1995-1#1)(1995-5#1)(2008-5#1)
preservative system##7##2##(2008-5#7)
preservative was##2##2##(2008-5#1)(2008-8#1)
preservative##39##1##(1990-11#4)(1990-2#1)(1995-1#1)(1995-5#1)(2006-11#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#15)(2008-6#1)(2008-8#4)(2010-12#2)(2011-1#1)(2011-2#3)
preservative-free##3##1##(1990-12#1)(2008-5#1)(2011-2#1)
preservatives and##2##2##(2008-1#1)(2008-5#1)
preservatives has##2##2##(1990-10#1)(2008-8#1)
preservatives in cosmetic##3##3##(2008-10#2)(2008-5#1)
preservatives in##5##2##(1990-10#1)(2008-10#2)(2008-5#1)(2011-1#1)
preservatives used in##2##3##(2008-1#1)(2008-5#1)
preservatives##33##1##(1990-10#8)(1996-2#1)(2008-1#3)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#12)(2008-8#1)(2010-4#1)(2011-1#2)
preserve a##5##2##(1996-8#1)(2008-2#1)(2008-3#1)(2009-10#1)(2009-8#1)
preserve bone##2##2##(1993-11#1)(2008-9#1)
preserve important##3##2##(2010-3#1)(2013-1#2)
preserve its##2##2##(2007-12#1)(2008-5#1)
preserve joint##2##2##(2009-7#1)(2010-5#1)
preserve life##2##2##(1995-12#1)(2007-12#1)
preserve or##4##2##(1993-3#1)(2004-10#1)(2008-5#1)(2010-7#1)
preserve renal function##3##3##(1996-9#1)(2008-10#1)(2011-2#1)
preserve renal##4##2##(1996-9#1)(2007-7#1)(2008-10#1)(2011-2#1)
preserve the quality of##2##4##(2006-10#1)(2012-3#1)
preserve the##48##2##(1991-9#1)(1993-2#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-3#1)(1996-9#1)(1997-3#1)(1997-5#1)(2006-10#1)(2006-6#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-4#1)(2010-1#1)(2010-8#1)(2011-2#3)(2012-11#1)(2012-2#1)(2012-3#2)(2013-8#1)
preserve their##10##2##(1992-1#1)(2007-11#2)(2008-3#1)(2008-9#1)(2009-7#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
preserve these##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)
preserve##151##1##(1990-12#1)(1990-3#1)(1990-5#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-4#1)(1996-12#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-5#1)(1997-8#1)(2004-10#1)(2005-1#1)(2006-10#4)(2006-6#1)(2006-7#2)(2007-11#2)(2007-12#9)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-10#8)(2008-11#1)(2008-2#11)(2008-3#8)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-12#2)(2010-3#3)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-2#8)(2012-11#2)(2012-12#5)(2012-2#2)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#3)
preserved LVEF##3##2##(2010-11#3)
preserved after##4##2##(1994-3#1)(2007-1#1)(2008-9#1)(2012-3#1)
preserved and##5##2##(1991-10#1)(2007-8#1)(2008-10#1)(2012-12#1)(2012-3#1)
preserved at##2##2##(1993-2#2)
preserved by##7##2##(1994-11#1)(1995-8#1)(1996-3#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-7#1)
preserved cells##3##2##(2008-11#3)
preserved corneas##2##2##(1997-6#2)
preserved during##5##2##(1992-10#1)(2004-12#1)(2007-12#1)(2008-10#1)(2012-2#1)
preserved enzymatic##2##2##(1997-8#1)(2012-1#1)
preserved for##5##2##(2007-6#1)(2007-7#1)(2008-10#2)(2008-3#1)
preserved from##3##2##(1990-12#1)(1994-6#1)(2007-6#1)
preserved in the##16##3##(1990-7#1)(1992-4#2)(1992-7#1)(1994-3#2)(2005-12#1)(2007-10#1)(2008-11#2)(2008-2#3)(2008-4#1)(2008-7#1)(2009-4#1)
preserved in##47##2##(1990-7#1)(1991-5#1)(1992-4#2)(1992-7#1)(1993-12#1)(1994-12#2)(1994-3#2)(1995-8#1)(1996-12#1)(1997-1#1)(1997-4#1)(2005-12#1)(2006-11#2)(2006-12#2)(2007-10#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-1#1)(2009-4#1)(2009-9#1)(2010-11#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2012-9#1)(2013-1#2)(2013-7#1)
preserved left ventricular ejection fraction##2##5##(2008-11#1)(2010-11#1)
preserved left ventricular##3##3##(2007-8#1)(2008-11#1)(2010-11#1)
preserved or##2##2##(2008-6#1)(2010-12#1)
preserved over the##2##3##(1996-8#1)(2008-2#1)
preserved performances##2##2##(2009-2#2)
preserved remote myocardial microvascular##2##4##(2012-2#2)
preserved remote##3##2##(2012-2#3)
preserved renal function##2##3##(1992-8#1)(2007-8#1)
preserved systolic function##3##3##(2007-1#1)(2008-10#1)(2012-2#1)
preserved the##5##2##(1990-5#1)(1995-6#1)(2008-11#1)(2011-12#1)(2012-6#1)
preserved through the##2##3##(1997-6#1)(2009-12#1)
preserved when##2##2##(2008-9#1)(2010-7#1)
preserved with the##2##3##(2008-10#2)
preserved with thymol##2##3##(1997-2#1)(2008-10#1)
preserved with##12##2##(1996-12#1)(1997-2#1)(2008-10#4)(2008-3#2)(2008-5#3)(2009-4#1)
preserved##241##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#1)(1991-10#1)(1991-2#2)(1991-5#1)(1991-6#1)(1992-10#1)(1992-4#2)(1992-7#2)(1992-8#1)(1993-12#1)(1993-2#3)(1993-4#1)(1994-11#1)(1994-12#2)(1994-3#4)(1994-6#2)(1995-11#2)(1995-12#1)(1995-5#1)(1995-6#3)(1995-8#4)(1996-12#3)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#4)(1997-6#4)(1997-7#1)(1997-8#3)(2004-12#1)(2005-11#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-11#2)(2006-12#6)(2006-2#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-1#3)(2007-10#2)(2007-11#2)(2007-12#7)(2007-6#2)(2007-7#3)(2007-8#5)(2007-9#2)(2008-10#15)(2008-11#9)(2008-2#9)(2008-3#5)(2008-4#4)(2008-5#8)(2008-6#3)(2008-7#7)(2008-8#1)(2008-9#3)(2009-1#2)(2009-10#3)(2009-12#1)(2009-2#2)(2009-4#3)(2009-8#1)(2009-9#2)(2010-11#6)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#2)(2011-2#6)(2012-1#6)(2012-12#3)(2012-2#7)(2012-3#6)(2012-6#1)(2012-9#1)(2013-1#6)(2013-7#2)(2013-8#2)
preserves both##2##2##(2007-12#1)(2008-1#1)
preserves continence and##2##3##(2010-5#2)
preserves the##17##2##(1997-8#1)(2006-6#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-6#1)(2008-9#1)(2009-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
preserves##44##1##(1993-3#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-3#1)(1997-8#2)(2006-6#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#5)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2009-9#1)(2010-5#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
preserving a##3##2##(2006-2#1)(2007-8#1)(2008-3#1)
preserving and##2##2##(1991-3#1)(2012-11#1)
preserving both##2##2##(2010-7#1)(2011-2#1)
preserving function##2##2##(2008-7#1)(2008-8#1)
preserving normal##3##2##(2005-11#1)(2006-9#1)(2007-8#1)
preserving procedures##2##2##(2007-4#1)(2011-1#1)
preserving the integrity of the##2##5##(2006-10#1)(2007-8#1)
preserving the original##3##3##(2006-12#1)(2007-12#1)(2009-2#1)
preserving the##41##2##(1991-10#1)(1991-3#1)(1993-3#2)(1993-5#1)(1994-12#1)(1994-9#1)(1995-3#1)(1996-12#1)(1996-7#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#1)(2008-7#2)(2009-2#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)
preserving treatment##2##2##(2011-1#1)(2012-3#1)
preserving##126##1##(1990-12#1)(1991-1#1)(1991-10#1)(1991-3#2)(1992-12#1)(1992-2#1)(1992-7#1)(1993-1#1)(1993-3#2)(1993-5#2)(1994-12#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-4#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#2)(2008-2#5)(2008-3#4)(2008-4#1)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#3)(2009-2#1)(2009-5#1)(2009-6#1)(2010-11#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#6)(2012-1#4)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#4)
preset##14##1##(1995-3#1)(2007-12#3)(2007-5#1)(2008-10#4)(2008-3#1)(2008-6#1)(2012-1#1)(2012-3#1)(2013-8#1)
presided over the##2##3##(2008-2#1)(2009-5#1)
presided over##3##2##(2005-8#1)(2008-2#1)(2009-5#1)
presidency##5##1##(1995-1#1)(2006-7#1)(2007-6#2)(2012-2#1)
president and##5##2##(1996-6#1)(2006-5#1)(2006-7#2)(2008-1#1)
president of the##5##3##(1993-12#1)(2005-12#1)(2005-8#1)(2008-2#1)(2010-12#1)
president of##10##2##(1993-12#1)(1994-1#1)(1994-9#1)(1995-5#1)(1996-6#1)(2005-12#1)(2005-8#1)(2008-2#1)(2008-5#1)(2010-12#1)
president to##2##2##(2006-7#1)(2007-8#1)
president##40##1##(1991-3#1)(1992-3#1)(1993-12#1)(1994-1#1)(1994-8#1)(1994-9#1)(1995-5#1)(1996-6#2)(2004-12#1)(2005-12#1)(2005-8#1)(2006-4#1)(2006-5#1)(2006-7#6)(2007-10#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-12#1)(2010-7#1)(2011-12#1)(2011-2#1)
president's##6##1##(1991-12#1)(1992-3#1)(1995-6#1)(2006-7#2)(2007-1#1)
presidential address##2##2##(1994-7#1)(2008-4#1)
presidential disability##2##2##(2006-7#2)
presidential election in##2##3##(1992-9#1)(2007-9#1)
presidential##16##1##(1991-3#1)(1992-9#1)(1994-7#1)(1996-2#1)(1997-2#1)(2004-12#1)(2006-7#3)(2007-9#2)(2008-4#1)(2009-4#1)(2009-8#1)(2012-1#1)(2012-2#1)
presidents##10##1##(1991-4#2)(1994-12#2)(1995-3#2)(1996-11#1)(1997-3#1)(2006-5#1)(2007-5#1)
presiding##2##1##(2008-2#1)(2009-10#1)
prespawning##3##1##(2008-5#1)(2010-8#2)
prespecified##12##1##(1995-2#1)(1995-5#1)(1996-9#1)(2007-8#1)(2008-3#5)(2008-7#1)(2009-9#1)(2012-3#1)
prespore##4##1##(1993-6#3)(1995-8#1)
press 1 RM##2##3##(2008-5#2)
press and the##2##3##(2007-9#1)(2009-4#1)
press and##6##2##(2007-9#1)(2008-5#3)(2009-4#2)
press for##2##2##(1993-6#1)(2006-7#1)
press in##7##2##(1990-12#1)(1991-3#1)(2006-10#1)(2008-1#1)(2009-1#1)(2009-10#2)
press is##2##2##(2007-12#1)(2007-9#1)
press releases##5##2##(1996-2#1)(2007-2#2)(2008-7#1)(2009-4#1)
press reports##2##2##(1994-1#1)(2007-7#1)
press##81##1##(1990-10#2)(1990-12#3)(1990-5#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-3#2)(1992-9#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-2#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-6#2)(2005-12#1)(2005-8#1)(2006-10#2)(2006-2#2)(2006-7#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-7#1)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#10)(2008-7#1)(2008-8#2)(2009-1#1)(2009-10#4)(2009-2#1)(2009-4#5)(2009-7#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
press)##9##1##(1991-9#1)(1992-8#1)(1993-12#1)(1994-12#1)(1996-9#1)(2009-2#1)(2010-2#1)(2010-9#1)(2013-8#1)
press]##5##1##(1990-5#1)(1995-2#1)(2006-4#1)(2008-10#2)
pressed into##2##2##(2008-2#1)(2013-8#1)
pressed onto the##2##3##(2008-2#1)(2008-5#1)
pressed##17##1##(1991-10#1)(1991-3#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#2)(2009-3#1)(2010-12#1)(2013-8#2)
presses in##2##2##(1993-5#1)(2008-5#1)
presses##5##1##(1993-5#3)(2008-5#1)(2013-8#1)
pressing and##2##2##(2008-5#1)(2010-12#1)
pressing health##2##2##(2009-12#1)(2009-4#1)
pressing issues##2##2##(1996-3#1)(2009-4#1)
pressing need for the##2##4##(2008-7#1)(2010-12#1)
pressing need for##6##3##(2007-11#1)(2007-2#1)(2008-12#1)(2008-7#1)(2010-12#1)(2013-1#1)
pressing need##11##2##(1990-9#1)(1995-1#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-12#1)(2008-7#2)(2008-8#1)(2010-12#1)(2013-1#1)
pressing##38##1##(1990-9#1)(1993-8#1)(1994-2#1)(1995-1#1)(1996-3#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2009-11#1)(2009-12#1)(2009-4#2)(2010-12#2)(2010-4#1)(2010-8#2)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
pressor action##3##2##(1991-6#2)(1993-4#1)
pressor and bradycardic responses to##2##5##(1991-12#1)(1997-2#1)
pressor and bradycardic responses##5##4##(1991-12#3)(1997-2#1)(1997-5#1)
pressor and tachycardiac##5##3##(1993-11#2)(1995-12#1)(1996-12#2)
pressor and##12##2##(1990-10#1)(1991-12#3)(1993-11#2)(1995-12#1)(1996-12#3)(1997-2#1)(1997-5#1)
pressor effect of##4##3##(1990-7#1)(1993-11#1)(1993-4#1)(1995-1#1)
pressor effect##6##2##(1990-7#1)(1993-11#1)(1993-4#1)(1995-1#1)(1996-12#1)(1997-2#1)
pressor effects##3##2##(1991-1#1)(1993-11#1)(1995-11#1)
pressor response to i##2##4##(1992-8#2)
pressor response to static contraction##3##5##(1991-5#3)
pressor response to static##4##4##(1991-5#4)
pressor response to##17##3##(1991-5#5)(1991-6#1)(1992-7#1)(1992-8#3)(1994-3#1)(1995-1#2)(1995-12#1)(1997-2#2)(2012-1#1)
pressor response was##3##3##(1991-6#1)(1992-7#1)(1997-2#1)
pressor response with##2##3##(1993-4#2)
pressor response##30##2##(1990-7#1)(1991-2#1)(1991-5#5)(1991-6#2)(1992-7#2)(1992-8#5)(1993-4#2)(1994-3#1)(1995-1#2)(1995-12#1)(1997-2#7)(2012-1#1)
pressor responses induced by##2##4##(1992-8#1)(1997-8#1)
pressor responses to##3##3##(1991-5#1)(1992-8#1)(1997-8#1)
pressor responses##7##2##(1991-5#2)(1992-8#3)(1997-8#2)
pressor##72##1##(1990-10#2)(1990-5#2)(1990-7#3)(1991-1#1)(1991-12#3)(1991-2#1)(1991-5#8)(1991-6#4)(1992-7#2)(1992-8#8)(1993-11#4)(1993-4#4)(1994-3#1)(1995-1#3)(1995-11#1)(1995-12#2)(1996-12#4)(1997-2#9)(1997-5#1)(1997-8#2)(2005-10#1)(2007-9#1)(2008-4#1)(2009-6#2)(2012-1#1)(2012-2#1)
pressure &gt##3##2##(2008-1#1)(2008-7#2)
pressure &lt##3##2##(2008-1#2)(2008-3#1)
pressure (&gt##3##2##(1997-8#2)(2008-10#1)
pressure (1##2##2##(1997-5#1)(2008-10#1)
pressure (25##2##2##(2010-7#1)(2012-3#1)
pressure (27##2##2##(1994-11#1)(2007-3#1)
pressure (BP) is##4##3##(1991-3#1)(2007-10#1)(2008-8#1)(2011-1#1)
pressure (BP)##40##2##(1990-5#1)(1991-3#2)(1991-4#1)(1992-6#1)(1993-4#2)(1996-11#1)(2005-10#1)(2007-1#5)(2007-10#3)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#2)(2009-11#1)(2010-12#1)(2010-4#3)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
pressure (CPAP)##5##2##(1993-5#1)(1995-4#1)(2010-7#1)(2011-1#1)(2013-8#1)
pressure (ICP)##14##2##(1990-9#1)(1992-1#1)(1993-1#1)(1996-9#1)(2005-10#1)(2006-11#1)(2006-7#1)(2007-8#1)(2008-12#1)(2008-7#3)(2010-5#1)(2011-2#1)
pressure (IOP)##19##2##(2007-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-8#1)(2011-12#2)(2011-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
pressure (MAP)##17##2##(1991-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1996-9#1)(2006-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-6#1)(2009-8#1)(2011-2#1)(2013-8#2)
pressure (PAP)##3##2##(2007-8#1)(2008-11#1)(2010-8#1)
pressure (PP)##4##2##(2007-10#1)(2008-4#1)(2009-8#1)(2011-1#1)
pressure (PPA##2##2##(1991-6#2)
pressure (e##2##2##(2005-10#1)(2008-11#1)
pressure (odds ratio##2##3##(1994-3#2)
pressure (p##3##2##(2006-4#1)(2006-6#1)(2008-10#1)
pressure (p&lt##3##2##(2007-9#2)(2008-10#1)
pressure above##2##2##(1992-6#1)(2008-7#1)
pressure after##9##2##(1991-5#1)(1995-11#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-3#1)(2010-10#1)
pressure and a significant##2##4##(2007-9#1)(2008-7#1)
pressure and a##3##3##(2006-10#1)(2007-9#1)(2008-7#1)
pressure and arterial blood pressure of normotensive young##2##8##(2008-4#2)
pressure and arterial blood pressure##3##5##(2008-4#3)
pressure and can##2##3##(2006-2#1)(2008-1#1)
pressure and cerebral blood flow##2##5##(1996-5#1)(2007-10#1)
pressure and coronary heart disease##2##5##(2005-10#2)
pressure and coronary##3##3##(2005-10#2)(2007-8#1)
pressure and fetal heart rate##2##5##(1992-1#1)(1993-10#1)
pressure and flow signals##2##4##(2008-3#2)
pressure and flow##4##3##(1997-1#1)(1997-4#1)(2008-3#2)
pressure and heart rate responses to##2##6##(1991-12#1)(2012-12#1)
pressure and heart rate were##6##5##(1991-2#1)(1993-4#1)(1994-2#1)(2006-6#1)(2010-7#1)(2011-12#1)
pressure and heart rate##26##4##(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#3)(1991-8#3)(1993-11#1)(1993-4#3)(1994-2#1)(1995-12#2)(1996-12#4)(1996-2#1)(2005-11#1)(2006-6#1)(2010-7#1)(2011-12#1)(2012-12#1)
pressure and heart##28##3##(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#3)(1991-8#3)(1993-11#1)(1993-4#3)(1994-2#1)(1995-12#2)(1996-12#4)(1996-2#2)(1997-8#1)(2005-11#1)(2006-6#1)(2010-7#1)(2011-12#1)(2012-12#1)
pressure and high##4##3##(1995-6#1)(1997-8#1)(2005-11#1)(2008-2#1)
pressure and in##3##3##(1990-12#1)(1990-3#1)(1991-8#1)
pressure and its##2##3##(1990-2#1)(2009-6#1)
pressure and low##2##3##(2008-10#1)(2013-8#1)
pressure and of##2##3##(1990-9#1)(2008-3#1)
pressure and pressure##2##3##(1993-10#1)(1995-11#1)
pressure and systemic##2##3##(1993-12#1)(1993-2#1)
pressure and temperature measurements##2##4##(2008-3#2)
pressure and temperature##14##3##(1992-1#1)(1995-6#1)(2008-10#1)(2008-2#4)(2008-3#5)(2009-11#1)(2012-2#1)
pressure and that##3##3##(2008-10#1)(2012-1#1)(2013-1#1)
pressure and the##22##3##(1990-5#1)(1991-12#1)(1992-9#1)(1996-12#1)(1997-8#1)(2005-12#1)(2005-6#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#3)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)
pressure and umbilical venous pressure##2##5##(1992-1#2)
pressure and umbilical##3##3##(1992-1#3)
pressure and venous##2##3##(1990-5#1)(2007-7#1)
pressure and##266##2##(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#3)(1991-12#2)(1991-2#3)(1991-3#1)(1991-6#2)(1991-8#8)(1992-1#7)(1992-11#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-1#3)(1993-10#3)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#4)(1993-5#1)(1994-2#1)(1994-4#1)(1994-6#1)(1995-1#2)(1995-11#2)(1995-12#3)(1995-2#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#5)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#2)(1996-9#1)(1997-1#2)(1997-3#4)(1997-4#2)(1997-8#3)(2005-10#7)(2005-11#6)(2005-12#2)(2005-6#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-6#1)(2007-1#1)(2007-10#4)(2007-11#1)(2007-12#1)(2007-2#2)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#2)(2007-9#5)(2008-1#3)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#9)(2008-3#13)(2008-4#4)(2008-5#2)(2008-7#9)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#2)(2009-6#3)(2009-8#2)(2010-12#2)(2010-2#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#4)(2011-11#1)(2011-12#1)(2011-2#5)(2012-1#3)(2012-12#6)(2012-2#6)(2012-3#3)(2012-4#1)(2012-6#1)(2013-1#5)(2013-7#1)(2013-8#6)
pressure application of##2##3##(1991-8#1)(1992-7#1)
pressure application##3##2##(1991-8#1)(1992-7#1)(2007-4#1)
pressure applied to##2##3##(1990-4#1)(2011-1#1)
pressure are##13##2##(1991-4#1)(1992-11#1)(1993-12#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-6#1)(2008-2#1)(2008-3#3)(2008-7#1)(2012-2#1)
pressure as##9##2##(1997-2#1)(2005-11#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-6#1)(2012-12#1)
pressure associated with##2##3##(1990-7#1)(1997-7#1)
pressure at a##4##3##(1992-4#1)(1993-4#2)(2008-10#1)
pressure at rest##3##3##(1994-4#1)(2008-3#2)
pressure at room temperature##3##4##(1990-3#1)(1995-1#2)
pressure at the##6##3##(1992-12#1)(2005-11#2)(2008-10#1)(2012-1#1)(2012-3#1)
pressure at which the##2##4##(1994-6#1)(2007-11#1)
pressure at##31##2##(1990-3#1)(1992-12#2)(1992-3#1)(1992-4#1)(1993-4#2)(1994-4#1)(1994-6#1)(1995-1#2)(2005-11#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#3)(2008-7#2)(2011-2#1)(2012-1#2)(2012-3#2)(2013-7#1)
pressure autoregulation##4##2##(2006-10#4)
pressure bandage##2##2##(1992-2#1)(2006-4#1)
pressure before##4##2##(1992-12#1)(2006-7#1)(2007-7#1)(2008-11#1)
pressure below##3##2##(1990-11#1)(2005-11#1)(2008-1#1)
pressure between##3##2##(2008-1#1)(2008-3#1)(2008-7#1)
pressure beyond##2##2##(2006-7#1)(2008-3#1)
pressure but##4##2##(1991-5#1)(1996-9#1)(2008-4#1)(2008-7#1)
pressure by the##2##3##(2007-12#1)(2013-8#1)
pressure by##27##2##(1990-3#1)(1990-5#1)(1991-5#2)(1993-12#1)(1993-2#2)(1993-9#1)(1995-12#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-11#2)(2013-8#1)
pressure can be##3##3##(2007-11#1)(2008-2#1)(2012-2#1)
pressure can##9##2##(1991-4#1)(2006-10#4)(2007-11#1)(2008-10#1)(2008-2#1)(2012-2#1)
pressure cannot##2##2##(1995-2#1)(2007-12#1)
pressure caused by##5##3##(1991-2#2)(2006-5#1)(2007-9#1)(2008-12#1)
pressure causes##2##2##(1995-1#1)(2008-10#1)
pressure chamber##3##2##(1995-11#1)(2007-6#1)(2008-5#1)
pressure changes in##3##3##(2008-8#1)(2009-4#1)(2011-2#1)
pressure changes##14##2##(1991-8#2)(1993-3#1)(1995-12#2)(2006-4#1)(2006-8#1)(2007-4#2)(2007-8#1)(2008-3#1)(2008-8#1)(2009-4#1)(2011-2#1)
pressure chemical ionization##13##3##(1996-3#1)(1996-8#6)(1997-3#1)(2007-1#1)(2007-8#1)(2008-10#1)(2010-9#1)(2012-2#1)
pressure chemical ionization-mass spectrometry##2##4##(2007-8#1)(2008-10#1)
pressure chemical##16##2##(1996-3#1)(1996-8#6)(1997-3#1)(2007-1#1)(2007-8#2)(2008-10#2)(2008-2#1)(2010-9#1)(2012-2#1)
pressure chromatographic##2##2##(2008-10#2)
pressure conditions is##2##3##(2008-10#1)(2008-2#1)
pressure conditions##7##2##(1997-8#1)(2008-10#1)(2008-11#3)(2008-2#1)(2011-1#1)
pressure control in##3##3##(1996-10#1)(2007-10#1)(2013-8#1)
pressure control##34##2##(1991-4#1)(1991-6#3)(1992-8#1)(1996-10#1)(1996-2#1)(1996-9#1)(2005-10#2)(2006-10#2)(2007-1#2)(2007-10#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-6#1)(2010-9#1)(2013-1#2)(2013-8#2)
pressure controlled##2##2##(2006-10#1)(2007-8#1)
pressure data##5##2##(1992-4#1)(1993-9#1)(2007-4#1)(2007-8#1)(2008-10#1)
pressure decreased##7##2##(1990-11#1)(1991-6#1)(1992-12#1)(1992-8#1)(2009-6#1)(2010-4#1)(2010-9#1)
pressure denaturation##3##2##(1995-2#1)(1997-7#2)
pressure dependence of##6##3##(1991-2#1)(1992-1#2)(2008-2#2)(2008-3#1)
pressure determination##2##2##(1994-8#1)(2008-2#1)
pressure device and##2##3##(2006-12#1)(2008-10#1)
pressure device##5##2##(2006-12#1)(2007-9#1)(2008-10#3)
pressure did not##3##3##(2005-11#1)(2007-7#1)(2008-11#1)
pressure difference##9##2##(1994-9#1)(2005-10#1)(2008-11#1)(2008-5#1)(2008-8#3)(2009-10#1)(2010-10#1)
pressure differences between##2##3##(1994-8#1)(2008-5#1)
pressure differences##5##2##(1994-8#1)(1994-9#1)(2007-12#1)(2008-5#2)
pressure distributions##4##2##(2007-7#1)(2008-3#2)(2009-9#1)
pressure drop across the plug##2##5##(2009-6#2)
pressure drop pattern##2##3##(2010-11#2)
pressure drop##13##2##(1990-11#1)(1994-11#1)(1994-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-6#2)(2010-11#2)(2013-1#1)
pressure dropped##2##2##(2007-7#1)(2008-2#1)
pressure due to##4##3##(2006-10#1)(2007-8#1)(2008-10#1)(2008-6#1)
pressure during deposition##2##3##(2008-2#1)(2009-11#1)
pressure during the##4##3##(1995-9#1)(2006-12#1)(2008-10#1)(2013-1#1)
pressure during##26##2##(1990-6#1)(1990-8#1)(1993-1#1)(1993-10#1)(1994-3#1)(1994-4#1)(1995-9#1)(2006-12#1)(2006-4#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-7#2)(2009-11#1)(2009-12#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#2)
pressure effect##2##2##(2006-12#1)(2008-2#1)
pressure ejection##3##2##(1990-2#1)(1992-1#1)(1992-7#1)
pressure elevation in##2##3##(1992-9#1)(2007-8#1)
pressure elevation##9##2##(1992-8#1)(1992-9#1)(2007-8#2)(2008-5#1)(2009-5#3)(2010-2#1)
pressure environment##2##2##(1995-11#1)(2005-8#1)
pressure exerted by##4##3##(1991-12#1)(2008-10#1)(2008-5#1)(2010-2#1)
pressure exerted##5##2##(1991-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-2#1)
pressure falls##2##2##(1991-6#1)(2005-11#1)
pressure fell##5##2##(1991-5#1)(1992-2#2)(1992-5#1)(1995-12#1)
pressure flow##2##2##(2008-10#2)
pressure following##3##2##(2007-7#1)(2008-11#1)(2008-7#1)
pressure for a##2##3##(1994-8#1)(2007-1#1)
pressure for both##2##3##(2005-11#1)(2010-7#1)
pressure for the##8##3##(1990-12#1)(1991-7#1)(2006-8#1)(2008-10#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-7#1)
pressure for##30##2##(1990-12#1)(1990-3#1)(1991-3#1)(1991-7#1)(1993-12#1)(1994-8#1)(1995-9#1)(1996-3#1)(1997-2#1)(2005-11#1)(2006-8#1)(2007-1#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-7#2)(2013-1#1)(2013-8#1)
pressure forces##3##2##(2007-6#1)(2008-2#1)(2008-3#1)
pressure from the##8##3##(1995-4#1)(2006-8#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)
pressure from##24##2##(1990-11#1)(1990-9#1)(1993-10#1)(1993-2#1)(1995-4#1)(1997-6#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-6#1)(2007-9#3)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)
pressure gauge##2##2##(2006-12#2)
pressure generated by the##2##4##(2008-10#2)
pressure gradient##17##2##(1991-5#2)(1992-5#2)(2006-2#1)(2006-5#1)(2007-3#2)(2007-5#1)(2007-8#5)(2009-6#2)(2011-2#1)
pressure gradients##4##2##(1992-9#1)(1997-4#1)(2008-7#1)(2010-9#1)
pressure group##2##2##(2009-2#1)(2013-8#1)
pressure guide wire##2##3##(2013-8#2)
pressure has been##3##3##(1994-3#1)(1995-1#1)(2009-11#1)
pressure has##10##2##(1991-10#1)(1992-4#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-1#1)(2008-10#1)(2009-11#1)(2010-4#1)(2012-3#1)
pressure have been##3##3##(1995-11#1)(2008-9#1)(2011-2#1)
pressure have##5##2##(1995-11#1)(1995-5#1)(1996-9#1)(2008-9#1)(2011-2#1)
pressure impulses##2##2##(2008-2#2)
pressure in New Zealand##2##4##(1993-1#1)(1996-6#1)
pressure in a##9##3##(1990-3#1)(1991-2#1)(1992-8#1)(1992-9#1)(1995-12#1)(1996-4#1)(2007-10#1)(2008-7#1)(2012-3#1)
pressure in acute##4##3##(2007-10#3)(2008-8#1)
pressure in an##2##3##(2007-5#1)(2008-2#1)
pressure in healthy##2##3##(2006-10#1)(2012-2#1)
pressure in men##5##3##(1991-6#1)(1997-8#2)(2008-3#1)(2013-1#1)
pressure in one##3##3##(1990-12#1)(2012-12#2)
pressure in order to##2##4##(1995-1#1)(2005-8#1)
pressure in patients with##7##4##(1992-8#1)(1996-9#1)(1997-4#1)(2007-3#1)(2008-7#1)(2013-1#1)(2013-8#1)
pressure in patients##8##3##(1992-8#1)(1996-9#1)(1997-4#1)(2007-3#1)(2008-7#1)(2012-1#1)(2013-1#1)(2013-8#1)
pressure in the absence##2##4##(1990-3#2)
pressure in the left##2##4##(1993-10#1)(2009-12#1)
pressure in the##33##3##(1990-3#2)(1990-4#1)(1992-9#1)(1993-10#1)(1993-11#1)(1996-4#1)(1997-5#5)(2005-1#1)(2005-11#3)(2006-7#1)(2007-3#1)(2007-6#2)(2007-8#2)(2008-1#1)(2008-10#3)(2008-6#1)(2009-12#1)(2009-6#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
pressure in##126##2##(1990-12#2)(1990-3#3)(1990-4#1)(1990-8#4)(1991-2#1)(1991-6#1)(1992-12#1)(1992-5#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-10#2)(1993-11#1)(1993-12#1)(1994-3#1)(1994-4#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-3#1)(1996-4#2)(1996-6#1)(1996-9#3)(1997-4#1)(1997-5#6)(1997-8#4)(2005-1#1)(2005-11#4)(2005-12#2)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-7#2)(2007-10#4)(2007-2#2)(2007-3#3)(2007-5#1)(2007-6#2)(2007-8#4)(2008-1#4)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-5#2)(2010-7#1)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
pressure increase##5##2##(1997-7#3)(2006-10#2)
pressure increased##4##2##(1993-3#1)(1997-2#1)(1997-8#1)(2007-7#1)
pressure increases##3##2##(1995-5#1)(2006-10#1)(2010-9#1)
pressure increasing##2##2##(2009-4#1)(2013-8#1)
pressure index##9##2##(1990-6#1)(1993-12#4)(2005-10#2)(2007-10#1)(2008-8#1)
pressure indices##2##2##(1991-4#1)(2007-1#1)
pressure induced by##5##3##(1992-7#2)(1993-11#1)(1997-8#1)(2007-12#1)
pressure induces##2##2##(2006-10#1)(2008-10#1)
pressure inside the##4##3##(2005-11#1)(2008-10#2)(2012-2#1)
pressure inside##5##2##(2005-11#1)(2008-10#2)(2008-3#1)(2012-2#1)
pressure is a##3##3##(1996-2#1)(1996-9#1)(2008-11#1)
pressure is applied##2##3##(1991-12#1)(2008-5#1)
pressure is being##2##3##(1993-2#1)(2006-8#1)
pressure is raised##3##3##(1995-10#1)(2006-12#1)(2006-8#1)
pressure is usually##2##3##(1997-5#1)(2013-7#1)
pressure is##47##2##(1991-12#1)(1991-3#1)(1992-4#1)(1993-11#1)(1993-2#1)(1993-4#1)(1995-10#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-9#2)(1997-2#1)(1997-5#3)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-8#3)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-6#2)(2009-8#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-7#1)
pressure isotherms of##2##3##(2005-11#2)
pressure level##7##2##(1991-2#1)(1995-12#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-7#1)(2013-7#1)
pressure liquid chromatography (HPLC)##5##4##(1995-12#1)(2008-10#3)(2011-1#1)
pressure liquid chromatography##18##3##(1991-10#1)(1991-2#1)(1992-11#1)(1993-7#1)(1993-9#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-8#1)(2008-10#3)(2008-5#1)(2008-6#3)(2011-1#2)
pressure liquid##25##2##(1991-10#1)(1991-2#1)(1992-11#1)(1993-7#1)(1993-9#1)(1994-6#2)(1995-12#1)(1995-3#1)(1996-8#2)(2005-8#1)(2007-1#1)(2008-10#6)(2008-5#1)(2008-6#3)(2011-1#2)
pressure loss##2##2##(2010-4#2)
pressure losses##2##2##(2010-4#2)
pressure lowering##10##2##(1991-9#2)(1996-9#1)(2005-10#4)(2008-5#1)(2009-4#1)(2010-2#1)
pressure management##6##2##(2007-10#1)(2007-11#2)(2007-9#1)(2008-8#1)(2010-8#1)
pressure may be##2##3##(1997-5#1)(2006-10#1)
pressure may##6##2##(1992-8#1)(1997-5#2)(2006-10#2)(2008-7#1)
pressure measured##2##2##(1995-8#1)(2008-7#1)
pressure measurement and the##2##4##(1990-8#1)(2013-8#1)
pressure measurement and##4##3##(1990-8#1)(1996-6#1)(2008-7#1)(2013-8#1)
pressure measurement is##3##3##(2007-7#1)(2008-2#1)(2010-11#1)
pressure measurement##23##2##(1990-8#1)(1991-6#1)(1992-4#1)(1994-3#1)(1996-6#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-7#1)(2008-8#1)(2010-11#4)(2010-4#1)(2010-8#2)(2012-1#1)(2013-8#1)
pressure measurements and##3##3##(1991-10#1)(1992-8#1)(2012-2#1)
pressure measurements##25##2##(1990-11#1)(1991-10#1)(1991-4#1)(1992-4#1)(1992-8#1)(1995-10#1)(2005-11#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#1)(2009-7#2)(2009-8#1)(2012-1#1)(2012-2#3)
pressure might##3##2##(1996-11#1)(2007-10#1)(2013-8#1)
pressure monitoring and##2##3##(2008-7#1)(2013-1#1)
pressure monitoring in##6##3##(1994-9#1)(2005-10#1)(2008-1#1)(2009-11#1)(2010-1#2)
pressure monitoring is##2##3##(2008-9#1)(2009-11#1)
pressure monitoring##28##2##(1990-11#2)(1991-3#1)(1992-8#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-2#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-10#1)(2007-10#1)(2008-1#4)(2008-7#1)(2008-9#1)(2009-11#3)(2010-1#3)(2012-3#1)(2013-1#2)
pressure occurred##2##2##(1994-3#1)(2012-2#1)
pressure of &lt##4##3##(1997-5#2)(2007-10#1)(2008-3#1)
pressure of 0##2##3##(2009-5#1)(2011-2#1)
pressure of 10##2##3##(2007-12#1)(2008-6#1)
pressure of 17##2##3##(1996-9#1)(2011-2#1)
pressure of 30##3##3##(1997-2#1)(2006-8#1)(2007-8#1)
pressure of 40##2##3##(2007-8#1)(2008-3#1)
pressure of a##5##3##(1991-12#1)(2007-12#2)(2008-2#1)(2008-5#1)
pressure of the##19##3##(1991-12#1)(1991-6#1)(1992-10#1)(1992-12#1)(2005-11#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#3)(2009-11#1)(2010-7#1)
pressure of##119##2##(1990-1#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#2)(1991-6#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#3)(1993-3#1)(1994-12#1)(1995-12#1)(1995-6#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#2)(2004-9#1)(2005-11#4)(2005-7#1)(2006-3#1)(2006-7#1)(2006-8#4)(2007-10#2)(2007-11#1)(2007-12#7)(2007-2#3)(2007-5#1)(2007-7#3)(2007-8#7)(2007-9#2)(2008-1#6)(2008-10#10)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-7#2)(2011-12#1)(2011-2#4)(2012-12#1)(2013-1#1)(2013-8#3)
pressure on physicians and hospitals to##2##6##(1992-3#1)(1996-2#1)
pressure on the##25##3##(1990-2#1)(1991-10#2)(1991-2#1)(1992-6#1)(1992-9#1)(1996-6#1)(1996-8#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-12#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-1#1)(2009-9#1)(2010-4#1)
pressure on##64##2##(1990-2#1)(1990-4#1)(1990-6#1)(1991-10#3)(1991-2#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-2#1)(1994-6#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#2)(2005-12#3)(2006-10#2)(2006-12#1)(2007-10#2)(2007-11#1)(2007-6#2)(2007-7#2)(2007-9#2)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-1#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-7#2)
pressure or##20##2##(1990-4#1)(1992-5#1)(1992-8#1)(1993-1#1)(1995-4#1)(1996-3#1)(1996-8#1)(2006-10#2)(2006-8#2)(2007-5#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)
pressure over##4##2##(2006-6#1)(2007-11#1)(2007-6#1)(2010-2#1)
pressure overload##3##2##(1997-4#2)(2007-8#1)
pressure oxygen##2##2##(2008-10#1)(2012-2#1)
pressure pain threshold##2##3##(2010-12#2)
pressure pain##6##2##(2007-7#1)(2009-7#1)(2010-12#2)(2012-12#2)
pressure parameters##3##2##(2007-1#2)(2012-2#1)
pressure patterns##2##2##(1994-6#1)(2011-2#1)
pressure per se##2##3##(2005-6#1)(2005-8#1)
pressure phosphene tonometer##9##3##(2010-8#9)
pressure points&quot##2##2##(2006-5#1)(2009-10#1)
pressure produced by##3##3##(1990-2#1)(1990-7#2)
pressure produced##4##2##(1990-2#1)(1990-7#2)(2008-11#1)
pressure product##2##2##(2006-6#1)(2007-10#1)
pressure profile is##2##3##(2008-3#2)
pressure profile##7##2##(1992-8#3)(1994-6#1)(2008-3#2)(2010-1#1)
pressure profiles##5##2##(1992-8#2)(2008-3#2)(2008-8#1)
pressure range from##3##3##(2008-10#1)(2008-3#2)
pressure range of##2##3##(2007-1#1)(2008-3#1)
pressure range##10##2##(1993-12#1)(2007-1#1)(2008-10#3)(2008-3#4)(2008-7#1)
pressure ratio##3##2##(2007-7#3)
pressure reduction##12##2##(1992-2#1)(1992-4#1)(1992-8#1)(1996-9#1)(2005-10#3)(2006-6#1)(2007-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
pressure reductions##9##2##(1992-4#1)(1992-8#1)(1996-9#2)(2005-10#1)(2005-7#2)(2008-3#1)(2009-4#1)
pressure reference##2##2##(2006-8#2)
pressure release##4##2##(2006-7#2)(2010-12#1)(2012-2#1)
pressure relief##2##2##(1991-3#1)(2010-11#1)
pressure required##2##2##(1990-2#1)(2006-8#1)
pressure reservoir##2##2##(1990-9#1)(1996-3#1)
pressure resistance##3##2##(2005-8#2)(2007-9#1)
pressure response during##2##3##(1990-5#2)
pressure response##10##2##(1990-2#1)(1990-5#2)(1990-7#1)(2006-11#1)(2008-1#2)(2008-4#1)(2008-7#2)
pressure rise##3##2##(1990-11#1)(1991-3#1)(2009-8#1)
pressure secondary to##2##3##(2008-7#1)(2010-10#1)
pressure sensing##2##2##(2008-2#2)
pressure sensitive##2##2##(1991-10#1)(2007-12#1)
pressure sensitivity of##3##3##(1991-10#1)(2008-3#1)(2010-9#1)
pressure sensitivity##8##2##(1991-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2010-9#1)(2012-2#1)
pressure sensor with##2##3##(2008-2#2)
pressure sensor##9##2##(2007-10#1)(2007-6#1)(2008-10#1)(2008-2#5)(2008-3#1)
pressure sensors##4##2##(2008-3#2)(2009-1#1)(2010-2#1)
pressure should be##6##3##(1993-2#1)(1996-6#2)(2006-7#1)(2007-7#1)(2013-1#1)
pressure should##9##2##(1990-3#1)(1992-6#1)(1993-2#1)(1994-6#1)(1996-6#2)(2006-7#1)(2007-7#1)(2013-1#1)
pressure signal is##2##3##(2007-7#1)(2008-10#1)
pressure signal##9##2##(1993-2#1)(2007-12#1)(2007-7#2)(2008-10#4)(2012-3#1)
pressure signals##4##2##(2008-10#2)(2009-12#1)(2013-1#1)
pressure significantly##4##2##(1992-4#1)(1994-11#1)(2010-2#1)(2010-3#1)
pressure sore##6##2##(1996-1#2)(2006-10#1)(2007-8#1)(2007-9#1)(2008-12#1)
pressure sores##10##2##(1990-6#1)(1996-1#2)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#3)(2012-2#1)
pressure stability and##2##3##(2008-5#1)(2011-2#1)
pressure stability##5##2##(1995-1#2)(2008-5#1)(2011-2#2)
pressure support##3##2##(1993-10#1)(2006-9#1)(2012-2#1)
pressure symptoms##4##2##(2008-6#1)(2010-2#2)(2011-2#1)
pressure tactics##4##2##(2010-1#4)
pressure than##2##2##(1992-1#1)(2013-1#1)
pressure that##4##2##(1995-11#1)(2007-11#1)(2008-1#1)(2010-2#1)
pressure the##6##2##(1990-7#1)(1992-1#1)(1995-1#1)(1995-3#1)(2006-10#1)(2012-3#1)
pressure therapy##2##2##(2007-8#1)(2012-2#1)
pressure thresholds##3##2##(2006-8#1)(2011-2#1)(2013-1#1)
pressure throughout the##2##3##(1992-8#1)(2006-11#1)
pressure time##2##2##(2007-4#1)(2008-5#1)
pressure to a##4##3##(2008-11#1)(2008-5#1)(2009-6#1)(2009-7#1)
pressure to be##2##3##(2007-12#1)(2009-7#1)
pressure to maintain##3##3##(1991-2#1)(1996-5#1)(2008-9#1)
pressure to reduce the##3##4##(1994-3#1)(2006-10#1)(2008-9#1)
pressure to reduce##4##3##(1994-3#1)(2006-10#1)(2008-9#1)(2011-2#1)
pressure to the##4##3##(1991-3#1)(2005-12#1)(2006-7#1)(2013-8#1)
pressure to##53##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-9#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-5#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-6#1)(2009-7#2)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
pressure transducer##3##2##(2008-2#1)(2010-2#2)
pressure treatment##4##2##(2005-12#3)(2012-2#1)
pressure ulcer##5##2##(2007-7#1)(2012-11#1)(2012-3#3)
pressure ulcers##9##2##(1992-8#1)(2006-7#1)(2007-11#2)(2007-5#1)(2007-7#1)(2008-4#1)(2012-2#1)(2013-8#1)
pressure up to##4##3##(1990-2#1)(1996-2#1)(2008-12#1)(2008-6#1)
pressure upon##2##2##(1996-10#1)(2006-10#1)
pressure using##4##2##(1992-3#1)(2008-10#2)(2009-5#1)
pressure values were##2##3##(2007-2#1)(2009-6#1)
pressure values##17##2##(1991-4#1)(1992-8#1)(1995-10#1)(1995-11#2)(1996-10#1)(2007-2#3)(2007-9#1)(2008-5#1)(2008-7#2)(2009-6#1)(2013-8#3)
pressure ventilation via##2##3##(1997-4#2)
pressure ventilation was##2##3##(1994-4#1)(1997-4#1)
pressure ventilation##21##2##(1994-4#1)(1995-4#1)(1997-4#8)(2005-8#2)(2006-10#3)(2006-9#2)(2008-1#1)(2008-8#1)(2010-7#1)(2013-7#1)
pressure volume##3##2##(1993-12#1)(2005-11#1)(2007-8#1)
pressure was achieved##3##3##(1991-4#1)(2007-12#1)(2008-1#1)
pressure was examined in##2##4##(1990-7#1)(2006-5#1)
pressure was increased to##3##4##(1995-3#1)(2007-11#1)(2008-11#1)
pressure was increased##6##3##(1995-1#1)(1995-3#1)(2005-12#2)(2007-11#1)(2008-11#1)
pressure was low##2##3##(1997-7#1)(2008-10#1)
pressure was maintained##3##3##(1995-12#1)(2012-12#2)
pressure was measured##8##3##(1991-4#1)(1992-8#1)(1993-10#2)(2007-7#1)(2008-11#1)(2008-4#1)(2013-7#1)
pressure was not##4##3##(1991-5#1)(1991-8#1)(1993-10#1)(1993-4#1)
pressure was observed in##3##4##(1991-12#1)(2010-4#1)(2012-12#1)
pressure was observed##4##3##(1990-7#1)(1991-12#1)(2010-4#1)(2012-12#1)
pressure was set at##2##4##(2006-8#2)
pressure was significantly higher##5##4##(1991-12#1)(1997-8#1)(2006-6#2)(2008-3#1)
pressure was significantly##7##3##(1991-12#1)(1997-8#1)(2006-6#2)(2007-10#1)(2008-3#1)(2008-7#1)
pressure was##89##2##(1990-5#2)(1990-7#2)(1990-8#1)(1991-12#2)(1991-3#2)(1991-4#2)(1991-5#1)(1991-8#2)(1992-12#1)(1992-4#1)(1992-7#2)(1992-8#1)(1993-10#5)(1993-2#1)(1993-3#1)(1993-4#1)(1994-4#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#1)(1997-7#1)(1997-8#3)(2005-12#3)(2006-5#1)(2006-6#2)(2006-8#5)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-10#1)(2010-4#2)(2010-7#1)(2011-12#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#2)
pressure wave by a rigid body##2##6##(2009-10#2)
pressure wave##5##2##(1996-3#1)(2008-1#1)(2009-1#1)(2009-10#2)
pressure waves##2##2##(2008-3#1)(2008-8#1)
pressure were determined##2##3##(1993-3#1)(2005-11#1)
pressure were measured##5##3##(1994-7#1)(2006-4#1)(2008-3#1)(2008-5#1)(2013-1#1)
pressure were monitored##3##3##(1993-2#2)(2008-7#1)
pressure were observed##4##3##(1992-8#1)(2008-10#1)(2010-7#1)(2011-2#1)
pressure were##32##2##(1990-4#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-7#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-10#2)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-5#2)(2008-7#1)(2010-7#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
pressure when##4##2##(1992-8#1)(1993-3#1)(1997-2#1)(2006-12#1)
pressure which was##2##3##(1992-7#1)(2008-1#1)
pressure which##7##2##(1991-11#1)(1992-3#1)(1992-7#1)(1994-2#1)(1997-3#1)(2005-9#1)(2008-1#1)
pressure while##2##2##(1993-9#1)(2010-7#1)
pressure with a##4##3##(1990-9#1)(1997-4#1)(2008-2#1)(2008-4#1)
pressure with low##2##3##(1990-5#1)(1997-3#1)
pressure with##20##2##(1990-5#1)(1990-9#1)(1992-2#1)(1992-4#1)(1994-3#1)(1996-10#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2012-3#1)(2013-1#2)
pressure within a##2##3##(2009-3#1)(2009-6#1)
pressure within the##4##3##(2005-11#1)(2006-5#1)(2007-4#1)(2008-10#1)
pressure within##7##2##(2005-11#1)(2006-5#1)(2007-4#1)(2008-1#1)(2008-10#1)(2009-3#1)(2009-6#1)
pressure without alerting##2##3##(2011-2#2)
pressure without##7##2##(1993-8#1)(1996-2#2)(2007-10#2)(2011-2#2)
pressure wound therapy##2##3##(2010-3#1)(2012-10#1)
pressure##3061##1##(1990-1#1)(1990-11#11)(1990-12#11)(1990-2#13)(1990-3#22)(1990-4#5)(1990-5#11)(1990-6#8)(1990-7#13)(1990-8#19)(1990-9#10)(1991-10#14)(1991-11#2)(1991-12#12)(1991-2#21)(1991-3#13)(1991-4#10)(1991-5#11)(1991-6#25)(1991-7#1)(1991-8#17)(1991-9#8)(1992-1#22)(1992-10#1)(1992-11#4)(1992-12#16)(1992-2#10)(1992-3#8)(1992-4#19)(1992-5#7)(1992-6#9)(1992-7#9)(1992-8#33)(1992-9#10)(1993-1#12)(1993-10#18)(1993-11#8)(1993-12#27)(1993-2#21)(1993-3#14)(1993-4#14)(1993-5#2)(1993-6#1)(1993-7#3)(1993-8#2)(1993-9#5)(1994-11#4)(1994-12#4)(1994-2#4)(1994-3#14)(1994-4#8)(1994-6#11)(1994-7#2)(1994-8#7)(1994-9#4)(1995-1#14)(1995-10#4)(1995-11#11)(1995-12#18)(1995-2#10)(1995-3#7)(1995-4#5)(1995-5#7)(1995-6#5)(1995-8#4)(1995-9#6)(1996-1#7)(1996-10#7)(1996-11#3)(1996-12#9)(1996-2#16)(1996-3#11)(1996-4#4)(1996-5#6)(1996-6#9)(1996-8#13)(1996-9#26)(1997-1#4)(1997-2#9)(1997-3#15)(1997-4#21)(1997-5#25)(1997-6#5)(1997-7#16)(1997-8#19)(2004-12#1)(2004-9#3)(2005-1#1)(2005-10#35)(2005-11#64)(2005-12#20)(2005-4#1)(2005-6#2)(2005-7#4)(2005-8#17)(2005-9#1)(2006-1#1)(2006-10#81)(2006-11#6)(2006-12#16)(2006-2#9)(2006-3#2)(2006-4#18)(2006-5#8)(2006-6#14)(2006-7#24)(2006-8#35)(2006-9#4)(2007-1#23)(2007-10#41)(2007-11#20)(2007-12#36)(2007-2#14)(2007-3#10)(2007-4#9)(2007-5#14)(2007-6#14)(2007-7#52)(2007-8#82)(2007-9#52)(2008-1#74)(2008-10#184)(2008-11#62)(2008-12#16)(2008-2#70)(2008-3#115)(2008-4#27)(2008-5#47)(2008-6#16)(2008-7#94)(2008-8#29)(2008-9#17)(2009-1#16)(2009-10#7)(2009-11#12)(2009-12#6)(2009-2#6)(2009-3#5)(2009-4#7)(2009-5#11)(2009-6#24)(2009-7#13)(2009-8#12)(2009-9#8)(2010-1#10)(2010-10#6)(2010-11#11)(2010-12#15)(2010-2#20)(2010-3#6)(2010-4#28)(2010-5#17)(2010-6#4)(2010-7#25)(2010-8#22)(2010-9#8)(2011-1#34)(2011-11#4)(2011-12#8)(2011-2#57)(2012-1#19)(2012-10#1)(2012-11#2)(2012-12#29)(2012-2#54)(2012-3#33)(2012-4#1)(2012-6#1)(2013-1#58)(2013-7#19)(2013-8#50)
pressure&quot##2##1##(1994-6#1)(2009-6#1)
pressure) and##2##2##(1993-3#1)(1994-11#1)
pressure) to##2##2##(2007-11#1)(2008-3#1)
pressure)##23##1##(1990-3#1)(1990-7#1)(1991-6#1)(1993-3#2)(1994-11#1)(1994-8#1)(1996-2#1)(1997-4#1)(2005-1#1)(2005-11#1)(2006-8#1)(2007-11#2)(2007-7#1)(2007-9#1)(2008-3#2)(2008-5#1)(2008-6#1)(2010-7#1)(2012-3#2)
pressure-area isotherm##3##2##(1991-3#1)(2005-11#2)
pressure-assisted spinning##2##2##(2008-5#2)
pressure-assisted##3##1##(2008-5#2)(2010-9#1)
pressure-broadened wings of strong O(3) lines##2##6##(2008-2#2)
pressure-broadening coefficients for##2##3##(2008-2#1)(2008-3#1)
pressure-broadening coefficients##3##2##(2008-2#2)(2008-3#1)
pressure-controlled##3##1##(2006-10#1)(2006-12#1)(2011-2#1)
pressure-dependent##4##1##(1991-2#1)(2006-10#1)(2008-3#1)(2008-7#1)
pressure-driven flow in##2##3##(2007-8#1)(2008-12#1)
pressure-driven##4##1##(2007-8#2)(2008-12#1)(2013-1#1)
pressure-independent##3##1##(1991-2#1)(1992-8#1)(2009-7#1)
pressure-induced changes##2##2##(1990-3#1)(2006-10#1)
pressure-induced##11##1##(1990-2#1)(1990-3#3)(1997-5#1)(2005-12#1)(2006-10#3)(2008-3#1)(2010-1#1)
pressure-overloaded##2##1##(1994-3#1)(2008-7#1)
pressure-related##4##1##(1993-11#1)(1996-9#1)(2010-4#1)(2012-12#1)
pressure-sensitive##2##1##(1997-5#1)(2010-4#1)
pressure-temperature##3##1##(1993-4#1)(2008-10#1)(2012-2#1)
pressure-volume##2##1##(1996-9#1)(2005-11#1)
pressure/displacement curves##2##2##(2008-5#2)
pressure?##2##1##(1994-7#1)(1996-2#1)
pressure]##11##1##(1990-8#1)(1990-9#1)(1991-11#1)(1991-9#1)(1996-9#1)(1997-6#2)(2008-10#1)(2010-12#2)(2011-1#1)
pressured to participate##2##3##(2008-8#1)(2012-1#1)
pressured to##3##2##(2008-8#1)(2009-4#1)(2012-1#1)
pressured##4##1##(2008-8#1)(2009-4#1)(2011-1#1)(2012-1#1)
pressures (up to##2##3##(1993-12#1)(2008-10#1)
pressures and##29##2##(1990-10#1)(1991-2#1)(1992-4#1)(1995-2#1)(1995-8#2)(1996-3#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#2)(2009-1#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#1)
pressures are##7##2##(1990-9#1)(2007-8#1)(2007-9#1)(2008-10#2)(2010-3#1)(2011-2#1)
pressures as##5##2##(1990-2#1)(2007-7#1)(2008-2#1)(2008-3#1)(2011-2#1)
pressures at rest##2##3##(2005-8#1)(2006-10#1)
pressures at the##3##3##(1990-8#1)(2008-2#1)(2011-2#1)
pressures at##7##2##(1990-8#1)(1993-4#1)(2005-8#1)(2006-10#1)(2008-2#1)(2010-4#1)(2011-2#1)
pressures between##3##2##(2005-11#1)(2008-2#1)(2010-11#1)
pressures during##6##2##(1997-4#1)(2005-11#1)(2007-10#2)(2013-7#2)
pressures exerted##2##2##(2005-8#1)(2009-2#1)
pressures for##9##2##(1990-8#1)(1993-3#2)(1995-1#1)(1996-3#1)(1997-3#1)(2007-12#2)(2008-2#1)
pressures from##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
pressures have##5##2##(1995-3#1)(2005-7#1)(2006-10#1)(2008-5#2)
pressures in a##2##3##(1993-3#1)(2006-11#1)
pressures in the##2##3##(1997-9#1)(2010-4#1)
pressures in##9##2##(1993-3#1)(1997-9#1)(2005-9#1)(2006-11#1)(2008-10#1)(2008-4#1)(2010-4#1)(2010-8#1)(2013-1#1)
pressures is##3##2##(2007-12#1)(2008-2#1)(2010-8#1)
pressures of &lt##2##3##(2006-10#1)(2008-2#1)
pressures of oxygen and carbon dioxide##2##6##(1990-10#1)(2005-10#1)
pressures of phenethyl alcohol and limonene in##2##7##(2008-5#2)
pressures of the##4##3##(1990-12#1)(2007-9#1)(2008-3#1)(2008-5#1)
pressures of##29##2##(1990-10#1)(1990-12#1)(1990-2#1)(1995-12#1)(1996-5#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-2#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#4)(2010-2#1)(2012-1#1)
pressures on the##3##3##(2006-8#1)(2007-11#1)(2011-7#1)
pressures on traditional##2##3##(2012-3#2)
pressures on##16##2##(1992-12#1)(2004-12#1)(2006-8#1)(2007-11#1)(2007-3#2)(2007-7#1)(2007-8#1)(2008-3#2)(2010-12#1)(2011-7#1)(2012-1#1)(2012-3#3)
pressures ranging from##2##3##(2007-12#1)(2008-10#1)
pressures seen during##2##3##(2007-10#2)
pressures significantly##2##2##(1991-8#1)(2007-12#1)
pressures that may##3##3##(2008-8#1)(2010-8#1)(2012-3#1)
pressures that promote##2##3##(2007-12#2)
pressures that##9##2##(2007-12#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-2#1)(2012-3#1)
pressures to##5##2##(1992-2#1)(2007-8#1)(2008-11#1)(2008-3#1)(2010-4#1)
pressures toward##2##2##(2005-11#1)(2006-7#1)
pressures up to##5##3##(1993-3#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-2#1)
pressures was##2##2##(2008-7#1)(2013-8#1)
pressures were higher##2##3##(1991-12#1)(2008-10#1)
pressures were monitored##2##3##(1996-5#1)(2013-1#1)
pressures were##17##2##(1991-12#1)(1996-5#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
pressures with##2##2##(1994-6#1)(2008-2#1)
pressures within the##2##3##(2006-8#1)(2011-2#1)
pressures##329##1##(1990-10#3)(1990-12#2)(1990-2#3)(1990-8#4)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-1#3)(1993-12#3)(1993-2#2)(1993-3#5)(1993-4#2)(1994-10#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-8#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-7#2)(1997-8#1)(1997-9#1)(2004-12#1)(2005-10#1)(2005-11#7)(2005-12#2)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#10)(2006-11#2)(2006-12#1)(2006-2#1)(2006-4#4)(2006-5#1)(2006-7#5)(2006-8#3)(2007-1#3)(2007-10#9)(2007-11#1)(2007-12#8)(2007-2#1)(2007-3#2)(2007-4#5)(2007-5#1)(2007-7#6)(2007-8#14)(2007-9#6)(2008-1#2)(2008-10#18)(2008-11#5)(2008-2#14)(2008-3#21)(2008-4#6)(2008-5#11)(2008-6#1)(2008-7#5)(2008-8#10)(2008-9#2)(2009-1#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#3)(2010-4#3)(2010-5#3)(2010-6#1)(2010-8#3)(2011-2#10)(2011-7#1)(2012-1#4)(2012-2#3)(2012-3#6)(2013-1#7)(2013-7#2)(2013-8#2)
pressures) were##2##2##(2010-7#1)(2010-8#1)
pressures)##3##1##(2008-11#1)(2010-7#1)(2010-8#1)
pressuring##2##1##(2007-9#1)(2008-8#1)
pressurised##5##1##(1997-1#1)(2006-10#1)(2007-11#1)(2008-10#1)(2012-1#1)
pressurized capillary electrochromatography##2##3##(2008-10#1)(2011-1#1)
pressurized hot water extraction##2##4##(2008-10#2)
pressurized liquid extraction (PLE)##3##4##(2008-10#3)
pressurized liquid extraction##4##3##(2008-10#4)
pressurized metered dose inhaler##2##4##(1996-2#1)(2005-8#1)
pressurized metered dose##4##3##(1992-3#2)(1996-2#1)(2005-8#1)
pressurized metered-dose inhaler##2##3##(2004-12#1)(2008-3#1)
pressurized metered-dose##3##2##(2004-12#2)(2008-3#1)
pressurized microwave digestion##2##3##(2008-10#2)
pressurized##30##1##(1992-3#4)(1996-12#1)(1996-2#1)(2004-12#2)(2005-8#2)(2007-12#2)(2008-10#13)(2008-3#1)(2008-4#1)(2008-9#1)(2011-1#2)
pressurizing##2##1##(1992-3#1)(2008-10#1)
prestalk##7##1##(1993-6#3)(1995-8#3)(2008-8#1)
presternal catheters##3##2##(2011-2#3)
presternal##4##1##(2011-2#4)
prestige of diseases and##3##4##(1991-11#1)(1991-6#2)
prestige##14##1##(1991-11#1)(1991-2#1)(1991-6#6)(1993-6#1)(1995-1#1)(2007-12#1)(2008-10#2)(2009-4#1)
prestigious##6##1##(2006-9#1)(2007-10#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-12#1)
prestimulation##2##1##(1991-1#1)(1995-8#1)
prestimulatory levels##2##2##(1993-3#2)
prestimulus##3##1##(1991-1#1)(1993-12#1)(2013-7#1)
prestress##3##1##(2009-7#3)
prestriate cortex in##2##3##(1993-12#1)(1993-9#1)
prestriate cortex##5##2##(1993-12#3)(1993-9#2)
prestriate##7##1##(1993-12#3)(1993-9#4)
prestroke and poststroke##2##3##(2007-10#2)
prestroke##5##1##(2007-10#3)(2007-9#1)(2013-1#1)
prestructured##3##1##(2006-2#1)(2009-7#1)(2013-1#1)
presumably a##6##2##(1994-3#1)(1994-8#1)(1996-5#1)(2011-1#1)(2012-1#2)
presumably also##3##2##(1996-1#1)(1997-4#1)(1997-7#1)
presumably as a result of the##2##6##(1995-4#1)(2008-10#1)
presumably as a result of##4##5##(1990-3#1)(1992-9#1)(1995-4#1)(2008-10#1)
presumably as a##5##3##(1990-3#1)(1992-9#1)(1995-4#1)(1996-3#1)(2008-10#1)
presumably as##6##2##(1990-3#1)(1992-9#1)(1995-4#1)(1996-3#1)(1997-3#1)(2008-10#1)
presumably associated##2##2##(2012-2#1)(2013-7#1)
presumably because of the##2##4##(2008-3#1)(2013-1#1)
presumably because##5##2##(2007-7#1)(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#1)
presumably by regulating##2##3##(1990-11#1)(2007-12#1)
presumably by##18##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-2#1)(1993-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-6#1)(1997-7#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-5#1)(2009-10#1)
presumably caused by##3##3##(1991-3#1)(1992-5#1)(2009-7#1)
presumably caused##4##2##(1991-3#1)(1991-9#1)(1992-5#1)(2009-7#1)
presumably connected##2##2##(2007-12#1)(2009-5#1)
presumably due to an increase in##2##6##(1994-6#1)(1997-1#1)
presumably due to an##3##4##(1993-5#1)(1994-6#1)(1997-1#1)
presumably due to differences in the##2##6##(1997-2#1)(2009-12#1)
presumably due to the##10##4##(1991-3#1)(1996-6#1)(1997-7#1)(1997-8#1)(2005-11#2)(2008-10#2)(2008-7#1)(2011-1#1)
presumably due to##23##3##(1991-3#1)(1991-7#1)(1993-5#1)(1993-6#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-11#2)(2008-10#3)(2008-6#1)(2008-7#1)(2009-12#1)(2011-1#2)
presumably explained by##2##3##(2006-1#1)(2010-12#1)
presumably from##2##2##(2005-9#1)(2008-7#1)
presumably healthier##2##2##(2010-4#1)(2013-1#1)
presumably in the##3##3##(1990-10#1)(1991-2#1)(1991-5#1)
presumably in##4##2##(1990-10#1)(1991-1#1)(1991-2#1)(1991-5#1)
presumably involve##2##2##(1994-12#1)(2007-11#1)
presumably involved in##6##3##(1990-8#1)(1992-4#1)(1993-6#1)(1994-8#1)(1995-6#1)(1997-5#1)
presumably involved##7##2##(1990-8#1)(1992-4#1)(1993-6#1)(1994-8#1)(1995-6#1)(1997-5#1)(2008-7#1)
presumably involving##3##2##(1996-4#1)(1996-5#1)(2007-11#1)
presumably of##3##2##(1994-3#1)(1995-5#1)(2008-9#1)
presumably protein##2##2##(1991-3#1)(1994-11#1)
presumably reflecting##6##2##(1991-7#1)(1991-9#1)(1992-8#1)(1993-2#1)(1994-2#1)(2010-3#1)
presumably reflects##2##2##(1997-5#1)(2008-11#1)
presumably the##8##2##(1992-11#1)(1992-12#1)(1993-5#1)(1995-12#1)(1995-6#1)(1996-7#1)(2006-10#1)(2011-12#1)
presumably these patients had##2##4##(2007-9#2)
presumably through##5##2##(1992-5#1)(1995-2#1)(1997-4#1)(2006-8#1)(2008-10#1)
presumably to##3##2##(1997-5#1)(2008-11#1)(2009-8#1)
presumably via the##2##3##(1991-10#1)(1991-12#1)
presumably via##8##2##(1991-10#1)(1991-12#1)(1994-8#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-7#1)(2013-1#1)
presumably##223##1##(1990-10#1)(1990-11#4)(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#4)(1991-3#3)(1991-5#2)(1991-7#2)(1991-8#1)(1991-9#2)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-5#2)(1993-6#4)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#4)(1994-3#5)(1994-6#1)(1994-8#3)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#5)(1995-8#1)(1996-1#3)(1996-12#3)(1996-3#2)(1996-4#2)(1996-5#3)(1996-6#2)(1996-7#2)(1997-1#2)(1997-2#2)(1997-3#4)(1997-4#3)(1997-5#3)(1997-7#4)(1997-8#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-12#2)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#15)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#3)(2011-12#2)(2011-2#3)(2012-1#3)(2012-2#2)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
presume that the##2##3##(1996-12#1)(2008-7#1)
presume that##7##2##(1991-9#1)(1996-12#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#1)
presume##11##1##(1991-9#1)(1996-12#1)(2008-5#3)(2008-7#1)(2009-6#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
presumed Sertoli-cell-only syndrome in testis biopsy##2##6##(2012-12#2)
presumed bacterial##2##2##(2007-3#1)(2010-6#1)
presumed consent##3##2##(1991-3#1)(1997-6#1)(2006-2#1)
presumed dopamine##2##2##(1991-8#1)(1997-7#1)
presumed risk##2##2##(2007-11#1)(2012-3#1)
presumed that the##8##3##(1990-2#1)(1992-12#1)(1995-8#1)(1997-4#1)(2004-11#1)(2008-10#1)(2008-11#1)(2012-2#1)
presumed that##12##2##(1990-2#1)(1992-12#1)(1993-8#1)(1995-8#1)(1997-4#1)(2004-11#1)(2007-9#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#1)
presumed to arise from##2##4##(1990-7#1)(2006-1#1)
presumed to be due to##2##5##(2007-1#1)(2008-4#1)
presumed to be##23##3##(1991-3#1)(1991-4#1)(1991-8#2)(1991-9#1)(1992-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-6#1)(1996-2#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-9#1)(2010-5#1)(2012-2#1)
presumed to have a##2##4##(1993-6#1)(2007-10#1)
presumed to have##6##3##(1991-10#1)(1993-6#1)(2005-7#1)(2006-7#1)(2007-10#1)(2009-10#1)
presumed to work##2##3##(2009-9#1)(2012-1#1)
presumed to##48##2##(1990-7#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-9#2)(1997-2#1)(1997-6#1)(2005-7#1)(2006-1#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-5#1)(2012-1#2)(2012-2#1)
presumed vascular##2##2##(1997-3#1)(2008-4#1)
presumed##156##1##(1990-12#1)(1990-2#1)(1990-7#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#2)(1991-8#3)(1991-9#2)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-6#2)(1993-8#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-1#2)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#3)(1996-12#1)(1996-2#2)(1996-4#1)(1996-6#1)(1996-7#1)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(2004-11#1)(2005-11#1)(2005-5#1)(2005-7#1)(2006-1#1)(2006-10#6)(2006-2#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-10#5)(2007-11#3)(2007-12#3)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#6)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#3)
presumes that##3##2##(2006-10#1)(2007-4#1)(2012-12#1)
presumes##4##1##(2006-10#1)(2007-4#1)(2012-12#1)(2012-3#1)
presumptions##2##1##(2006-7#1)(2007-11#1)
presumptive diagnosis of##5##3##(1993-5#1)(2005-8#1)(2007-10#1)(2010-10#1)(2013-8#1)
presumptive diagnosis##7##2##(1993-5#1)(1997-7#1)(2005-8#1)(2007-10#1)(2008-7#1)(2010-10#1)(2013-8#1)
presumptive efferent##2##2##(1991-9#2)
presumptive p53-dependent##2##2##(2008-7#2)
presumptive##50##1##(1990-6#1)(1991-5#1)(1991-9#2)(1992-12#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-12#3)(1994-8#1)(1995-11#1)(1995-6#1)(1995-8#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-5#2)(2006-7#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-5#2)(2008-7#6)(2009-8#1)(2010-10#1)(2010-6#1)(2011-12#1)(2012-12#2)(2013-8#1)
presupplementation resting##2##2##(2013-8#2)
presuppose a##2##2##(1991-11#1)(2012-12#1)
presupposes that##2##2##(2006-7#1)(2008-4#1)
presupposes##6##1##(2006-7#1)(2008-11#1)(2008-4#1)(2009-10#1)(2010-10#1)(2012-2#1)
presupposing##2##1##(2008-1#1)(2010-5#1)
presuppositions##2##1##(2008-10#2)
presurgical assessment##2##2##(1990-10#1)(2008-7#1)
presurgical evaluation##4##2##(1990-3#1)(1990-9#1)(1994-2#1)(2009-9#1)
presurgical##19##1##(1990-10#1)(1990-3#1)(1990-9#1)(1991-1#1)(1994-2#1)(1994-3#1)(1997-3#1)(2006-10#1)(2006-5#1)(2007-12#2)(2007-9#3)(2008-7#1)(2009-11#1)(2009-9#1)(2010-8#1)(2013-1#1)
presymptomatic diagnosis and##3##3##(1991-8#1)(2004-12#1)(2008-11#1)
presymptomatic##9##1##(1990-6#1)(1991-8#1)(1997-3#1)(2004-12#1)(2007-10#1)(2008-10#1)(2008-11#1)(2011-12#1)(2013-7#1)
presynapsis##3##1##(1990-10#3)
presynaptic 5-HT1A receptors as##2##4##(1996-12#1)(1997-7#1)
presynaptic PKC subspecies##2##3##(1996-1#2)
presynaptic action##2##2##(1990-12#1)(1996-10#1)
presynaptic and postsynaptic##4##3##(1995-11#1)(2008-11#2)(2008-7#1)
presynaptic boutons##3##2##(1990-2#1)(1997-7#2)
presynaptic dopamine##4##2##(1996-1#1)(1996-12#1)(2007-11#1)(2008-11#1)
presynaptic dopaminergic##3##2##(1996-2#2)(2013-8#1)
presynaptic elements##2##2##(1992-9#1)(1997-2#1)
presynaptic function##3##2##(1995-11#1)(1997-7#1)(2012-2#1)
presynaptic gain control mechanism##2##4##(2013-8#2)
presynaptic histamine##2##2##(1992-5#2)
presynaptic inhibition##8##2##(1995-11#4)(1995-12#4)
presynaptic markers of##2##3##(1993-3#1)(1995-7#1)
presynaptic markers##5##2##(1990-2#2)(1993-3#1)(1995-7#1)(2007-11#1)
presynaptic membrane##5##2##(1990-11#1)(1995-8#1)(1997-7#1)(2008-7#1)(2012-2#1)
presynaptic nerve terminal protein##2##4##(1995-6#1)(1996-12#1)
presynaptic nerve terminal##4##3##(1991-11#1)(1993-3#1)(1995-6#1)(1996-12#1)
presynaptic nerve terminals##5##3##(1991-5#1)(1993-12#1)(1997-2#1)(1997-7#2)
presynaptic nerve##10##2##(1991-11#1)(1991-5#1)(1993-12#1)(1993-3#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-7#2)(2013-1#1)
presynaptic plasma membrane##2##3##(1995-2#1)(2008-7#1)
presynaptic plasma##3##2##(1995-12#1)(1995-2#1)(2008-7#1)
presynaptic receptors##2##2##(1990-2#1)(1992-8#1)
presynaptic terminal##4##2##(1994-8#1)(1995-12#1)(2008-11#1)(2008-5#1)
presynaptic terminals in##2##3##(1990-2#1)(2007-10#1)
presynaptic terminals of##2##3##(1992-12#1)(2007-10#1)
presynaptic terminals##14##2##(1990-2#4)(1990-4#1)(1992-12#1)(1992-8#1)(2007-10#3)(2007-12#1)(2008-4#1)(2012-2#2)
presynaptic to##4##2##(1992-1#1)(1992-11#1)(1995-11#1)(1997-7#1)
presynaptic##153##1##(1990-11#2)(1990-12#1)(1990-2#9)(1990-4#1)(1991-11#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-5#2)(1992-8#4)(1992-9#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-12#2)(1994-8#3)(1995-11#7)(1995-12#9)(1995-2#1)(1995-5#2)(1995-6#3)(1995-7#2)(1995-8#2)(1996-1#6)(1996-10#1)(1996-12#7)(1996-2#2)(1996-5#1)(1996-9#2)(1997-1#1)(1997-2#5)(1997-5#2)(1997-7#13)(1997-8#2)(2005-10#1)(2007-10#6)(2007-11#2)(2007-12#2)(2007-9#1)(2008-11#6)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#4)(2008-8#2)(2009-5#1)(2009-9#1)(2011-1#1)(2012-2#4)(2013-1#1)(2013-8#3)
presynaptically##3##1##(1991-1#1)(1995-11#1)(1997-3#1)
presynaptically-acting phospholipase A2 neurotoxins##3##4##(1995-1#3)
pretargeting##2##1##(2008-3#2)
pretectal GABAergic##2##2##(1992-3#2)
pretectal##7##1##(1992-3#3)(1992-8#2)(2008-8#2)
pretectalis##2##1##(1992-8#2)
preteen and##4##2##(2013-1#4)
pretends to##2##2##(2008-10#2)
pretends##3##1##(2008-10#2)(2013-1#1)
pretension##6##1##(2006-11#5)(2007-4#1)
pretensioner##2##1##(2007-4#2)
pretensioners##6##1##(2007-4#6)
preterm and low birth weight##2##5##(1991-12#1)(2008-12#1)
preterm and low##3##3##(1991-12#1)(2007-2#1)(2008-12#1)
preterm and##9##2##(1991-12#1)(1993-12#1)(2006-2#1)(2007-2#1)(2008-12#2)(2011-2#2)(2013-1#1)
preterm babies with respiratory distress syndrome##2##6##(1990-12#2)
preterm babies with##3##3##(1990-12#2)(2009-9#1)
preterm babies##9##2##(1990-11#1)(1990-12#3)(1997-5#1)(2006-8#2)(2009-9#1)(2011-2#1)
preterm birth and cerebral palsy##2##5##(2011-2#2)
preterm birth in##2##3##(2007-2#1)(2013-8#1)
preterm birth##32##2##(1995-6#1)(2006-10#1)(2006-6#1)(2007-2#4)(2007-8#1)(2008-11#1)(2008-9#2)(2010-12#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#5)(2013-1#8)(2013-8#1)
preterm children##3##2##(2011-2#3)
preterm deliveries##3##2##(2006-8#1)(2011-2#1)(2013-1#1)
preterm delivery (PTD)##2##3##(2008-9#1)(2013-1#1)
preterm delivery and##4##3##(1994-3#1)(2006-8#1)(2007-12#1)(2012-12#1)
preterm delivery##24##2##(1992-2#1)(1994-3#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-9#4)(2006-8#4)(2007-12#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#3)
preterm groups##2##2##(1992-7#1)(2009-12#1)
preterm infant is##2##3##(1993-12#1)(2012-2#1)
preterm infant##15##2##(1993-12#3)(1993-3#1)(1994-3#2)(2007-9#1)(2008-11#3)(2010-11#2)(2011-12#1)(2012-2#2)
preterm infants and##3##3##(1990-3#1)(2006-7#1)(2010-12#1)
preterm infants with##7##3##(1990-12#1)(1992-7#1)(2006-8#1)(2009-2#1)(2010-5#2)(2013-1#1)
preterm infants##40##2##(1990-12#1)(1990-3#1)(1991-1#1)(1991-4#1)(1992-2#1)(1992-7#3)(1993-12#4)(1993-2#3)(1994-1#1)(1997-2#1)(2006-10#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-11#1)(2008-12#2)(2009-12#3)(2009-2#3)(2009-6#1)(2010-12#1)(2010-5#2)(2011-2#2)(2012-12#1)(2013-1#1)
preterm labor and##2##3##(2006-8#1)(2011-2#1)
preterm labor##10##2##(1993-4#1)(1994-9#1)(2006-8#1)(2010-11#1)(2011-2#4)(2012-12#1)(2012-3#1)
preterm labour and##2##3##(1992-2#1)(1994-3#1)
preterm labour##16##2##(1991-4#1)(1992-2#4)(1994-3#2)(2004-10#3)(2006-1#3)(2006-10#1)(2007-11#2)
preterm neonates##7##2##(2007-11#4)(2012-2#1)(2013-1#2)
preterm newborn##4##2##(2008-11#2)(2011-2#1)(2012-12#1)
preterm or##2##2##(2008-11#1)(2013-1#1)
preterm##216##1##(1990-11#1)(1990-12#5)(1990-3#1)(1990-9#2)(1991-1#1)(1991-12#1)(1991-4#2)(1992-2#6)(1992-4#1)(1992-7#8)(1993-12#8)(1993-2#3)(1993-3#2)(1993-4#2)(1994-1#1)(1994-12#1)(1994-3#6)(1994-6#2)(1994-9#1)(1995-6#1)(1995-8#1)(1996-11#2)(1996-2#1)(1996-9#4)(1997-2#1)(1997-5#1)(2004-10#3)(2006-1#3)(2006-10#5)(2006-2#1)(2006-6#2)(2006-7#2)(2006-8#12)(2006-9#1)(2007-11#9)(2007-12#1)(2007-2#6)(2007-8#2)(2007-9#1)(2008-11#7)(2008-12#4)(2008-9#3)(2009-12#4)(2009-2#3)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#3)(2010-12#2)(2010-5#2)(2011-1#3)(2011-12#2)(2011-2#25)(2012-1#1)(2012-12#6)(2012-2#12)(2012-3#3)(2013-1#17)(2013-7#1)(2013-8#2)
preterminally differentiated##2##2##(1994-12#1)(1994-6#1)
preterms##3##1##(1992-7#1)(2006-10#1)(2008-12#1)
pretest##13##1##(1993-2#1)(1996-6#1)(2006-12#1)(2006-2#1)(2007-12#1)(2007-6#1)(2008-10#1)(2010-10#2)(2010-2#1)(2010-8#1)(2011-1#1)(2012-2#1)
pretest-posttest design study##2##3##(2010-7#2)
pretest-posttest design##3##2##(2010-7#2)(2013-1#1)
pretest-posttest##5##1##(2006-12#1)(2010-7#2)(2013-1#2)
pretested questionnaire##2##2##(2006-10#1)(2011-12#1)
pretested##4##1##(2006-10#1)(2006-7#1)(2011-12#2)
pretesting##2##1##(2007-12#1)(2008-6#1)
pretherapeutic##3##1##(1990-9#1)(2007-6#1)(2008-7#1)
pretherapy##2##1##(1993-5#1)(2006-10#1)
pretibial mucinosis##2##2##(2012-3#2)
pretibial myxedema##3##2##(2007-8#1)(2012-3#2)
pretibial##8##1##(2007-7#1)(2007-8#1)(2012-3#6)
pretraining##4##1##(1992-9#1)(1994-10#1)(1994-5#1)(2008-9#1)
pretransfusion testing during the##2##4##(2011-1#2)
pretransfusion testing##6##2##(1992-3#1)(1993-9#1)(2011-1#4)
pretransfusion tests (with##2##3##(2011-1#2)
pretransfusion##10##1##(1992-3#1)(1992-6#1)(1993-9#1)(1994-9#1)(2011-1#6)
pretransition##2##1##(1990-3#2)
pretranslational regulation of##2##3##(1990-12#1)(1994-6#1)
pretranslational regulation##3##2##(1990-12#1)(1992-5#1)(1994-6#1)
pretranslational##5##1##(1990-12#1)(1992-5#1)(1994-6#1)(1995-3#1)(2006-12#1)
pretransplant biopsies##2##2##(2011-2#2)
pretransplant##14##1##(1994-5#1)(1995-2#3)(2007-11#1)(2007-12#1)(2009-2#1)(2010-11#1)(2011-2#5)(2012-12#1)
pretransplantation##5##1##(1995-2#3)(2007-8#2)
pretreated BALB/c mice##2##3##(1991-12#2)
pretreated advanced breast cancer##3##4##(1992-2#1)(1993-2#1)(1994-8#1)
pretreated and##2##2##(1990-4#1)(2008-5#1)
pretreated animals##2##2##(1990-10#1)(2011-2#1)
pretreated at 200°C##2##3##(2013-1#2)
pretreated at##5##2##(2008-5#1)(2013-1#4)
pretreated breast cancer##2##3##(1992-2#1)(1992-8#1)
pretreated by a##3##3##(1991-3#1)(2011-12#1)(2013-1#1)
pretreated by##9##2##(1990-7#1)(1991-3#1)(2008-10#2)(2008-5#1)(2011-12#1)(2013-1#3)
pretreated corn##2##2##(2004-8#1)(2008-5#1)
pretreated for 2##2##3##(1991-3#1)(1995-8#1)
pretreated for##4##2##(1990-11#1)(1991-3#1)(1995-8#1)(2011-12#1)
pretreated in##2##2##(1991-12#1)(1992-8#1)
pretreated materials##2##2##(2008-6#1)(2013-1#1)
pretreated metastatic breast cancer##3##4##(1991-6#1)(1993-8#1)(2009-8#1)
pretreated patients with advanced breast cancer##2##6##(1992-2#1)(1994-8#1)
pretreated patients##4##2##(1990-6#1)(1992-2#1)(1994-8#1)(2007-12#1)
pretreated plants##2##2##(2008-10#2)
pretreated platinum electrode##2##3##(2008-10#2)
pretreated rats##2##2##(1993-12#1)(1993-3#1)
pretreated samples##3##2##(1993-2#1)(2008-10#2)
pretreated straw was##2##3##(2013-1#2)
pretreated teflon membrane served as##2##5##(2008-10#2)
pretreated teflon membrane##3##3##(2008-10#3)
pretreated with 1##2##3##(2010-7#2)
pretreated with ASM##3##3##(2008-10#3)
pretreated with a##4##3##(1995-3#1)(1997-3#1)(2005-12#1)(2008-5#1)
pretreated with aDON the##2##4##(1995-12#2)
pretreated with an##3##3##(1992-6#1)(2013-1#2)
pretreated with chemotherapy##3##3##(1991-6#1)(2013-7#2)
pretreated with doxifluridine##2##3##(1992-8#2)
pretreated with either##2##3##(1991-5#1)(1993-6#1)
pretreated with fluorouracil##2##3##(1992-8#1)(1994-4#1)
pretreated with indomethacin##2##3##(1993-11#1)(1994-8#1)
pretreated with pertussis toxin##2##4##(1993-8#1)(1996-10#1)
pretreated with phorbol##2##3##(1990-10#1)(1991-5#1)
pretreated with saline##3##3##(1993-3#1)(1994-8#1)(1994-9#1)
pretreated with the##11##3##(1991-9#1)(1992-3#1)(1993-12#1)(1995-11#1)(1995-12#2)(1996-12#1)(1996-9#1)(2007-9#1)(2008-10#1)(2010-7#1)
pretreated with##107##2##(1990-10#1)(1990-11#3)(1990-4#1)(1990-7#1)(1991-12#1)(1991-5#2)(1991-6#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#3)(1992-6#2)(1992-8#4)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#2)(1993-8#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-4#1)(1994-8#5)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#5)(1995-3#1)(1995-7#1)(1995-8#1)(1996-10#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#1)(2004-8#1)(2005-12#1)(2005-4#1)(2007-9#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#3)(2011-1#3)(2011-2#1)(2013-1#2)(2013-7#2)
pretreated##201##1##(1990-10#2)(1990-11#4)(1990-4#2)(1990-6#1)(1990-7#2)(1991-12#6)(1991-3#3)(1991-5#2)(1991-6#3)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#3)(1992-6#2)(1992-8#6)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#5)(1993-3#4)(1993-6#2)(1993-8#2)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-4#1)(1994-8#7)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#6)(1995-3#2)(1995-7#1)(1995-8#2)(1996-10#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#1)(1996-8#1)(1996-9#4)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#1)(2004-8#2)(2004-9#1)(2005-12#2)(2005-4#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#20)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#19)(2008-6#6)(2008-7#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#3)(2011-1#3)(2011-12#2)(2011-2#3)(2012-12#1)(2013-1#14)(2013-7#2)
pretreating the cells with##2##4##(1992-6#1)(1996-5#1)
pretreating the##4##2##(1992-6#1)(1995-12#1)(1996-5#1)(2008-5#1)
pretreating##7##1##(1992-6#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-5#2)(2008-5#1)
pretreatment (i##2##2##(1996-12#1)(2008-10#1)
pretreatment and enzymatic hydrolysis##3##4##(2008-5#2)(2013-1#1)
pretreatment and enzymatic##4##3##(2004-8#1)(2008-5#2)(2013-1#1)
pretreatment and##20##2##(1995-3#1)(1996-5#1)(2004-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#2)(2008-9#1)(2011-2#1)(2013-1#6)(2013-8#1)
pretreatment before##2##2##(1996-5#1)(1996-9#1)
pretreatment by##3##2##(1990-12#1)(2008-10#2)
pretreatment conditions##7##2##(2008-5#5)(2013-1#2)
pretreatment control group##2##3##(2013-8#2)
pretreatment did not##5##3##(1990-11#1)(1993-11#1)(1994-3#1)(1995-3#1)(1997-7#1)
pretreatment evaluation##2##2##(2010-11#1)(2011-2#1)
pretreatment factors on##2##3##(2013-1#2)
pretreatment followed by##2##3##(2008-11#1)(2013-1#1)
pretreatment for the##4##3##(2005-4#2)(2008-10#2)
pretreatment for##12##2##(1990-2#1)(1990-4#1)(1994-3#1)(2005-4#2)(2008-10#4)(2008-5#2)(2012-2#1)
pretreatment glassy carbon electrode##2##4##(2008-10#2)
pretreatment in acute##2##3##(1992-6#1)(2011-1#1)
pretreatment in the##3##3##(1996-2#1)(2007-8#1)(2008-10#1)
pretreatment in##11##2##(1992-6#1)(1995-10#1)(1996-2#1)(2007-11#1)(2007-8#1)(2008-10#4)(2011-1#1)(2012-3#1)
pretreatment increased myocardial##2##3##(1991-9#2)
pretreatment increased##3##2##(1991-9#2)(2013-1#1)
pretreatment is effective in##2##4##(2008-10#1)(2009-10#1)
pretreatment is##4##2##(1994-9#1)(2008-10#1)(2008-5#1)(2009-10#1)
pretreatment led to##2##3##(1996-9#1)(2008-6#1)
pretreatment levels##5##2##(1993-12#1)(1995-12#1)(1996-2#1)(2007-10#1)(2008-8#1)
pretreatment method##4##2##(2005-12#1)(2008-10#2)(2008-5#1)
pretreatment methods for the##3##4##(2008-10#2)(2013-1#1)
pretreatment of a lignocellulosic biomass##2##5##(2013-1#2)
pretreatment of a##4##3##(1991-8#1)(2008-8#1)(2013-1#2)
pretreatment of cells with##6##4##(1994-12#1)(2007-10#1)(2008-11#1)(2008-4#1)(2011-2#2)
pretreatment of cells##7##3##(1990-11#1)(1994-12#1)(2007-10#1)(2008-11#1)(2008-4#1)(2011-2#2)
pretreatment of corn##2##3##(2004-8#1)(2013-1#1)
pretreatment of olive tree pruning residues##2##6##(2008-5#2)
pretreatment of rat##2##3##(1990-2#1)(1993-12#1)
pretreatment of rats with##2##4##(1991-2#1)(1997-4#1)
pretreatment of sugarcane##2##3##(2013-1#2)
pretreatment of the samples##2##4##(2008-10#1)(2008-11#1)
pretreatment of the##19##3##(1993-3#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-2#1)(1997-1#2)(2005-11#1)(2007-8#1)(2008-10#7)(2008-11#1)(2012-2#1)(2013-8#1)
pretreatment of##84##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-9#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-8#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#2)(1994-2#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-2#1)(1997-1#2)(1997-4#2)(2004-8#1)(2005-11#2)(2007-10#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#4)(2008-4#2)(2008-5#7)(2008-6#1)(2008-8#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#7)(2013-8#2)
pretreatment on the##2##3##(1993-11#1)(2010-12#1)
pretreatment on##12##2##(1991-6#1)(1993-11#1)(1993-12#3)(1993-2#1)(2007-12#1)(2008-10#1)(2009-10#1)(2010-12#1)(2012-12#1)(2013-8#1)
pretreatment procedure##4##2##(2008-10#4)
pretreatment process##2##2##(1996-8#1)(2008-6#1)
pretreatment regimen##2##2##(1995-3#1)(2011-2#1)
pretreatment resulted in##2##3##(2008-11#1)(2013-1#1)
pretreatment results in##2##3##(1993-3#1)(1996-12#1)
pretreatment significantly##2##2##(1995-8#1)(2008-5#1)
pretreatment temperatures##2##2##(1993-9#1)(2013-1#1)
pretreatment time##4##2##(1993-11#1)(2008-5#1)(2011-12#1)(2013-1#1)
pretreatment to##3##2##(1995-1#1)(2008-10#1)(2013-8#1)
pretreatment using a##2##3##(2008-10#1)(2013-1#1)
pretreatment using##4##2##(2008-10#2)(2009-6#1)(2013-1#1)
pretreatment was##7##2##(1995-1#1)(1997-7#1)(2008-10#1)(2008-6#1)(2013-1#3)
pretreatment were investigated##2##3##(2010-12#1)(2013-1#1)
pretreatment were##5##2##(1995-12#1)(1996-5#1)(2008-10#1)(2010-12#1)(2013-1#1)
pretreatment with 0##2##3##(1995-3#1)(2008-5#1)
pretreatment with 3##2##3##(1990-3#1)(2008-4#1)
pretreatment with TPA##4##3##(1990-2#1)(1990-9#1)(1994-12#2)
pretreatment with a##5##3##(1990-3#2)(1993-2#1)(1997-7#1)(2008-1#1)
pretreatment with atropine##3##3##(1991-5#1)(1993-9#1)(1994-8#1)
pretreatment with diazomethane##2##3##(2005-12#2)
pretreatment with oxiracetam##2##3##(1992-8#2)
pretreatment with rimalkalim##3##3##(1997-7#3)
pretreatment with the##15##3##(1990-5#1)(1991-5#1)(1991-6#1)(1993-12#1)(1993-7#1)(1994-10#2)(1994-9#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-8#1)(2011-12#1)(2013-1#2)
pretreatment with##130##2##(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#3)(1990-5#1)(1990-7#1)(1990-9#2)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#3)(1991-6#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#5)(1993-4#2)(1993-6#1)(1993-7#1)(1993-9#2)(1994-10#2)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#1)(1994-8#2)(1994-9#2)(1995-1#3)(1995-12#5)(1995-3#2)(1995-7#3)(1996-10#1)(1996-12#4)(1996-2#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#4)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#4)(1997-8#5)(2005-12#2)(2005-8#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2009-3#1)(2010-7#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
pretreatment##530##1##(1990-11#6)(1990-12#3)(1990-2#5)(1990-3#4)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#2)(1990-9#4)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-4#1)(1991-5#6)(1991-6#6)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#1)(1992-2#4)(1992-3#2)(1992-4#1)(1992-6#4)(1992-7#2)(1992-8#3)(1992-9#1)(1993-11#6)(1993-12#10)(1993-2#5)(1993-3#9)(1993-4#4)(1993-6#1)(1993-7#1)(1993-9#3)(1994-10#3)(1994-11#2)(1994-12#7)(1994-2#4)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#4)(1995-1#6)(1995-10#2)(1995-11#2)(1995-12#10)(1995-2#1)(1995-3#8)(1995-4#1)(1995-6#1)(1995-7#3)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#8)(1996-2#4)(1996-3#1)(1996-4#2)(1996-5#7)(1996-6#2)(1996-8#6)(1996-9#8)(1997-1#4)(1997-2#4)(1997-4#3)(1997-6#2)(1997-7#7)(1997-8#5)(2004-8#4)(2005-11#2)(2005-12#4)(2005-4#3)(2005-8#1)(2006-11#1)(2007-10#4)(2007-11#5)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#84)(2008-11#11)(2008-12#1)(2008-3#1)(2008-4#6)(2008-5#35)(2008-6#8)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#4)(2009-3#1)(2009-5#2)(2009-6#1)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-12#4)(2011-2#9)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#2)(2012-4#1)(2013-1#44)(2013-8#10)
pretreatment)##3##1##(1995-12#1)(1997-7#1)(2008-10#1)
pretreatments led to##2##3##(2008-10#1)(2013-1#1)
pretreatments with##2##2##(1991-4#1)(2008-5#1)
pretreatments##16##1##(1991-4#1)(1993-2#1)(2004-8#1)(2007-10#1)(2008-10#5)(2008-5#1)(2013-1#6)
pretty##6##1##(1991-1#1)(1993-2#1)(1996-8#1)(2008-7#1)(2009-4#1)(2010-12#1)
preuroporphyrinogen##4##1##(1997-7#4)
prevacuolar compartment##3##2##(1997-6#2)(2009-10#1)
prevacuolar##5##1##(1997-6#4)(2009-10#1)
prevail in##4##2##(1997-1#1)(2008-9#1)(2009-2#1)(2009-8#1)
prevail on the##2##3##(2005-11#1)(2013-1#1)
prevail over the##2##3##(1991-3#1)(1993-7#1)
prevail over##3##2##(1991-3#1)(1991-8#1)(1993-7#1)
prevail##19##1##(1991-3#1)(1991-8#1)(1993-7#1)(1994-7#1)(1995-3#1)(1997-1#1)(1997-8#1)(2005-11#1)(2006-2#1)(2007-1#1)(2007-10#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-2#1)(2013-1#1)
prevailed in the##2##3##(2011-1#1)(2012-12#1)
prevailed in##9##2##(1991-8#1)(1994-3#1)(1996-1#1)(2008-12#2)(2011-1#2)(2011-2#1)(2012-12#1)
prevailed over##2##2##(2007-12#1)(2009-7#1)
prevailed under##2##2##(1990-7#1)(2009-7#1)
prevailed##30##1##(1990-7#1)(1991-8#1)(1992-3#1)(1994-3#1)(1994-6#1)(1996-1#1)(1997-5#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-9#3)(2008-1#1)(2008-11#1)(2008-12#2)(2008-5#1)(2009-7#2)(2009-8#1)(2011-1#4)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)
prevailing environmental conditions##2##3##(2007-12#1)(2009-8#1)
prevailing hypothesis suggests##2##3##(1996-4#1)(2007-12#1)
prevailing hypothesis##3##2##(1996-4#1)(2007-12#1)(2009-9#1)
prevailing in the##4##3##(1991-12#1)(1993-11#1)(2008-11#1)(2013-1#1)
prevailing in##9##2##(1991-12#1)(1993-11#1)(1996-2#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2013-1#1)
prevailing situation##2##2##(1996-12#1)(2007-7#1)
prevailing wind##4##2##(2007-12#1)(2008-10#2)(2011-12#1)
prevailing##69##1##(1991-1#1)(1991-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-6#1)(1994-7#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-8#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-12#3)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#2)(2010-2#1)(2010-5#1)(2011-1#2)(2011-12#2)(2011-2#4)(2011-9#1)(2012-2#5)(2013-1#1)(2013-8#1)
prevails over##2##2##(1994-2#1)(2008-10#1)
prevails##12##1##(1994-2#1)(1995-8#1)(1997-1#1)(2005-11#1)(2006-7#1)(2008-10#3)(2008-3#1)(2008-9#1)(2012-3#1)(2013-1#1)
prevalance of##2##2##(2006-6#1)(2007-7#1)
prevalant in##2##2##(2008-1#1)(2008-3#1)
prevalence &gt##2##2##(2007-6#1)(2011-2#1)
prevalence =##2##2##(2008-6#2)
prevalence achieved##2##2##(1997-1#1)(2007-3#1)
prevalence across##2##2##(2005-11#1)(2008-10#1)
prevalence among the##3##3##(1990-2#1)(2007-3#1)(2012-3#1)
prevalence among women##2##3##(2007-11#1)(2012-3#1)
prevalence among young##2##3##(1995-9#1)(2008-5#1)
prevalence among##23##2##(1990-2#1)(1990-6#1)(1993-6#1)(1995-9#1)(1996-12#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-6#1)(2008-1#1)(2008-4#2)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#5)(2013-7#1)
prevalence amongst children##2##3##(2011-2#1)(2012-12#1)
prevalence amongst men##2##3##(2011-2#2)
prevalence amongst women of##2##4##(2011-2#2)
prevalence amongst women##3##3##(2011-2#3)
prevalence amongst##7##2##(2011-2#6)(2012-12#1)
prevalence and associated factors##2##4##(2010-7#1)(2012-12#1)
prevalence and characteristics of##3##4##(2006-10#1)(2008-3#1)(2012-2#1)
prevalence and clinical features##2##4##(2007-9#1)(2008-9#1)
prevalence and clinical significance of##2##5##(1997-1#1)(2007-2#1)
prevalence and clinical##9##3##(1997-1#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-5#1)(2008-9#1)(2009-10#1)(2013-8#1)
prevalence and co-occurrence of##2##4##(2008-9#2)
prevalence and consequences##3##3##(1992-2#1)(2006-10#1)(2012-2#1)
prevalence and correlates of##2##4##(2007-3#1)(2013-8#1)
prevalence and determinants of##2##4##(1995-9#1)(2011-1#1)
prevalence and distribution of##3##4##(2006-8#1)(2012-12#1)(2013-8#1)
prevalence and frequency##4##3##(2009-11#1)(2013-1#3)
prevalence and human cysticercosis seroprevalence in##2##6##(2011-2#2)
prevalence and incidence of##4##4##(2006-11#1)(2006-6#1)(2007-12#1)(2009-5#1)
prevalence and incidence##8##3##(1994-6#1)(2006-11#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-7#1)(2009-5#1)(2011-2#1)
prevalence and management of##2##4##(1993-10#1)(2009-2#1)
prevalence and mean##2##3##(1993-7#1)(2012-2#1)
prevalence and patterns##2##3##(1994-6#1)(2013-1#1)
prevalence and predictors of##3##4##(2011-1#2)(2012-2#1)
prevalence and prognostic##2##3##(2006-10#1)(2010-12#1)
prevalence and risk factors for##2##5##(2010-4#1)(2011-2#1)
prevalence and risk factors in##2##5##(2012-12#1)(2013-8#1)
prevalence and risk factors##8##4##(2006-2#1)(2007-8#2)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
prevalence and severity of these##2##5##(2006-10#1)(2006-4#1)
prevalence and severity of##11##4##(2006-10#2)(2006-4#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)
prevalence and severness of##2##4##(2008-8#2)
prevalence and the number of##3##5##(1992-2#1)(2008-6#1)(2011-2#1)
prevalence and the##11##3##(1992-2#2)(1994-8#1)(2006-10#2)(2006-2#1)(2007-7#1)(2008-6#1)(2010-12#1)(2011-2#1)(2011-7#1)
prevalence and to##3##3##(1990-11#1)(1991-9#1)(2013-7#1)
prevalence and##167##2##(1990-11#1)(1991-1#1)(1991-9#1)(1992-1#1)(1992-2#3)(1992-9#2)(1993-10#1)(1993-7#1)(1994-11#2)(1994-6#2)(1994-8#1)(1995-3#3)(1995-9#1)(1997-1#1)(1997-4#1)(2006-10#14)(2006-11#1)(2006-2#4)(2006-4#1)(2006-6#1)(2006-8#2)(2007-1#2)(2007-12#4)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#8)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#12)(2011-7#1)(2012-1#4)(2012-12#4)(2012-2#9)(2013-1#6)(2013-4#1)(2013-7#2)(2013-8#8)
prevalence appears to##2##3##(2007-7#1)(2011-1#1)
prevalence areas##2##2##(2012-3#2)
prevalence as##2##2##(2008-1#1)(2011-1#1)
prevalence at##2##2##(1996-7#1)(2011-2#1)
prevalence between##8##2##(1994-6#1)(2005-11#1)(2006-2#1)(2008-10#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
prevalence data##6##2##(2007-7#1)(2008-10#1)(2008-8#1)(2010-9#1)(2011-1#1)(2011-2#1)
prevalence decreased##3##2##(2006-8#2)(2012-3#1)
prevalence differences##2##2##(1990-6#1)(2013-1#1)
prevalence estimates##4##2##(1990-11#1)(2007-4#1)(2011-2#1)(2012-12#1)
prevalence for##5##2##(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
prevalence has increased##3##3##(1992-2#1)(2009-4#1)(2011-2#1)
prevalence has##8##2##(1992-2#1)(2005-10#1)(2007-10#1)(2007-8#1)(2008-11#1)(2009-4#1)(2011-2#2)
prevalence in Iranian##2##3##(2008-12#1)(2012-12#1)
prevalence in South##3##3##(2010-8#2)(2012-3#1)
prevalence in a##6##3##(1997-6#1)(2008-7#1)(2009-4#1)(2012-12#1)(2012-3#2)
prevalence in different##3##3##(2007-8#1)(2008-10#1)(2013-8#1)
prevalence in females##2##3##(2008-3#1)(2010-8#1)
prevalence in men##2##3##(1996-3#1)(2006-8#1)
prevalence in patients with##2##4##(2006-7#1)(2007-7#1)
prevalence in pregnant women##2##4##(1990-6#1)(2008-8#1)
prevalence in the north-central region of the United States##2##9##(2008-10#2)
prevalence in the population##2##4##(1990-6#1)(2012-2#1)
prevalence in the##22##3##(1990-10#1)(1990-6#1)(1994-11#1)(1996-2#1)(2006-8#1)(2007-8#1)(2008-10#3)(2008-8#3)(2009-11#1)(2009-7#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
prevalence in women is##2##4##(2007-6#1)(2009-10#1)
prevalence in women##4##3##(2007-6#1)(2009-10#1)(2009-4#1)(2013-8#1)
prevalence in##89##2##(1990-10#1)(1990-6#3)(1991-6#1)(1992-2#1)(1994-11#2)(1994-6#3)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-6#1)(2006-10#2)(2006-12#1)(2006-7#1)(2006-8#5)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#5)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#5)(2009-10#1)(2009-11#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-4#2)(2010-8#3)(2011-1#3)(2011-2#4)(2012-12#5)(2012-2#2)(2012-3#4)(2013-1#5)(2013-8#5)
prevalence increased with age##2##4##(2008-3#1)(2008-7#1)
prevalence increased##3##2##(2008-3#1)(2008-7#1)(2012-3#1)
prevalence is estimated##2##3##(2006-10#2)
prevalence is high##3##3##(2006-1#1)(2010-12#1)(2011-2#1)
prevalence is in##2##3##(1996-7#1)(2012-12#1)
prevalence is low##2##3##(1997-3#1)(2011-2#1)
prevalence is##26##2##(1990-7#1)(1991-12#1)(1996-7#1)(1997-2#1)(1997-3#1)(2006-1#1)(2006-10#3)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-1#1)(2009-11#2)(2010-12#2)(2011-2#4)(2012-12#2)
prevalence observed##2##2##(1997-2#1)(2006-4#1)
prevalence occurred##3##2##(1995-2#1)(1996-12#1)(2008-7#1)
prevalence of 0##2##3##(2006-9#1)(2012-12#1)
prevalence of 26##2##3##(1990-6#1)(1994-6#1)
prevalence of 5##4##3##(1997-3#3)(2008-8#1)
prevalence of 6##2##3##(1995-11#1)(2008-12#1)
prevalence of AB in children##2##5##(1996-7#2)
prevalence of AB##3##3##(1996-7#3)
prevalence of AD##2##3##(2008-7#1)(2012-2#1)
prevalence of ADHD##3##3##(2006-9#3)
prevalence of C##3##3##(2007-7#2)(2008-12#1)
prevalence of CCSVI##2##3##(2012-3#2)
prevalence of CD in##2##4##(2011-1#1)(2011-2#1)
prevalence of CSDS##3##3##(2013-8#3)
prevalence of CVD risks##2##4##(2011-1#2)
prevalence of CVD##3##3##(2010-12#1)(2011-1#2)
prevalence of Candida##4##3##(2007-2#1)(2008-5#2)(2012-2#1)
prevalence of Chlamydia trachomatis##2##4##(2007-7#1)(2008-12#1)
prevalence of Chlamydia##3##3##(2007-7#1)(2008-12#2)
prevalence of EIB was##2##4##(2012-12#2)
prevalence of EIB##3##3##(2012-12#3)
prevalence of ESRD##2##3##(2006-5#1)(2007-7#1)
prevalence of GDM##2##3##(2009-3#1)(2011-2#1)
prevalence of GERD is##2##4##(2006-10#1)(2006-2#1)
prevalence of H##8##3##(2006-8#1)(2007-8#4)(2008-1#1)(2008-8#1)(2011-1#1)
prevalence of HBV##3##3##(2008-10#2)(2009-11#1)
prevalence of HBsAg##2##3##(2008-10#1)(2013-1#1)
prevalence of HC (&gt##2##4##(1997-1#2)
prevalence of HC##6##3##(1997-1#6)
prevalence of HCV infection##3##4##(2008-1#1)(2009-8#1)(2013-1#1)
prevalence of HCV##5##3##(2006-2#1)(2008-1#2)(2009-8#1)(2013-1#1)
prevalence of HIV and##3##4##(2012-3#3)
prevalence of HIV in##2##4##(2010-2#1)(2012-3#1)
prevalence of HIV infection among the drug addicts##2##8##(2007-7#2)
prevalence of HIV infection among##4##5##(2007-7#2)(2010-12#1)(2011-2#1)
prevalence of HIV infection in a##2##6##(1993-11#1)(1995-9#1)
prevalence of HIV infection in the##2##6##(1996-11#1)(2007-12#1)
prevalence of HIV infection in##5##5##(1993-1#1)(1993-11#1)(1995-9#1)(1996-11#1)(2007-12#1)
prevalence of HIV infection##10##4##(1993-1#1)(1993-11#1)(1995-9#1)(1996-11#1)(2007-12#1)(2007-7#2)(2010-12#1)(2011-2#2)
prevalence of HIV seropositivity##2##4##(2007-7#2)
prevalence of HIV##24##3##(1993-1#1)(1993-11#1)(1995-9#1)(1996-1#1)(1996-11#1)(2007-12#2)(2007-7#4)(2010-12#1)(2010-2#1)(2010-8#2)(2011-2#2)(2012-3#7)
prevalence of HP##3##3##(2007-3#3)
prevalence of HPV infection##3##4##(2011-2#1)(2013-1#2)
prevalence of HSV-2 infection##4##4##(2011-1#4)
prevalence of Helicobacter pylori##5##4##(1997-8#1)(2006-8#1)(2007-7#1)(2008-5#1)(2011-2#1)
prevalence of Helicobacter##6##3##(1990-2#1)(1997-8#1)(2006-8#1)(2007-7#1)(2008-5#1)(2011-2#1)
prevalence of IgG##2##3##(1990-2#1)(2007-2#1)
prevalence of MDD##2##3##(2011-1#1)(2013-8#1)
prevalence of MS than##2##4##(2008-3#2)
prevalence of MS##5##3##(2008-3#5)
prevalence of Marek's disease##2##4##(2013-8#2)
prevalence of OSA in##2##4##(2009-3#2)
prevalence of PAD was##3##4##(2008-8#2)(2010-4#1)
prevalence of PAD##5##3##(2008-8#2)(2010-4#3)
prevalence of PHP in##2##4##(2007-2#2)
prevalence of PNE##2##3##(2007-7#2)
prevalence of PTD##2##3##(2007-8#2)
prevalence of S##4##3##(1997-3#1)(2008-8#2)(2011-2#1)
prevalence of T(2)##2##3##(2010-8#2)
prevalence of TB in##2##4##(2008-1#1)(2012-2#1)
prevalence of Toxoplasma gondii##2##4##(2011-1#1)(2013-8#1)
prevalence of Toxoplasma##3##3##(2007-7#1)(2011-1#1)(2013-8#1)
prevalence of a##8##3##(1997-7#1)(2006-10#1)(2006-8#1)(2007-2#1)(2008-7#1)(2010-5#1)(2012-1#1)(2012-2#1)
prevalence of abdominal obesity##3##4##(2006-1#1)(2008-3#1)(2013-8#1)
prevalence of abdominal##4##3##(1992-5#1)(2006-1#1)(2008-3#1)(2013-8#1)
prevalence of abnormal##6##3##(1991-12#1)(1994-6#1)(2007-2#1)(2011-2#1)(2012-12#2)
prevalence of about##3##3##(2008-11#1)(2008-3#1)(2008-6#1)
prevalence of active##3##3##(1995-3#1)(2008-12#1)(2009-12#1)
prevalence of acute##2##3##(2008-3#1)(2013-8#1)
prevalence of allergens##2##3##(1993-6#2)
prevalence of allergic##4##3##(2006-8#1)(2007-2#2)(2012-12#1)
prevalence of allergy and##2##4##(2006-10#1)(2006-8#1)
prevalence of and risk factors for##2##6##(2009-2#1)(2009-8#1)
prevalence of and##5##3##(2008-6#1)(2009-2#1)(2009-8#1)(2010-4#1)(2011-2#1)
prevalence of anemia among##2##4##(2012-2#2)
prevalence of anemia##10##3##(2006-4#4)(2007-11#1)(2011-2#2)(2012-2#3)
prevalence of anti A1 antibody and##2##6##(2012-2#2)
prevalence of anti-HCV antibodies##2##4##(2008-1#2)
prevalence of anti-HCV##4##3##(2007-7#2)(2008-1#2)
prevalence of antibodies to B##3##5##(1991-11#2)(2012-2#1)
prevalence of antibodies to##4##4##(1991-11#2)(2008-12#1)(2012-2#1)
prevalence of antibodies##6##3##(1991-11#2)(1994-7#1)(2008-12#1)(2012-2#1)(2013-8#1)
prevalence of anxiety disorders##2##4##(2010-2#2)
prevalence of anxiety##5##3##(2009-10#2)(2010-2#2)(2012-11#1)
prevalence of appropriate##2##3##(2012-2#2)
prevalence of approximately##2##3##(2008-6#1)(2013-8#1)
prevalence of asthma and##5##4##(2006-10#1)(2007-2#1)(2009-1#1)(2012-3#2)
prevalence of asthma has increased##2##5##(2005-8#1)(2011-2#1)
prevalence of asthma is##3##4##(2007-2#1)(2008-3#1)(2013-7#1)
prevalence of asthma was##3##4##(2007-2#2)(2011-1#1)
prevalence of asthma##19##3##(2005-11#1)(2005-8#1)(2006-10#3)(2006-8#1)(2007-2#5)(2008-3#1)(2009-1#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-7#1)
prevalence of asymptomatic bacteriuria##4##4##(2008-12#1)(2008-5#1)(2010-12#2)
prevalence of asymptomatic##5##3##(2007-9#1)(2008-12#1)(2008-5#1)(2010-12#2)
prevalence of atherosclerotic##2##3##(2007-10#1)(2012-2#1)
prevalence of atopy##2##3##(2006-8#2)
prevalence of autoimmune diseases##2##4##(2008-10#1)(2011-2#1)
prevalence of autoimmune##4##3##(2006-10#1)(2008-10#1)(2011-2#2)
prevalence of bacterial##3##3##(2005-7#1)(2010-4#1)(2013-8#1)
prevalence of between##2##3##(2006-12#1)(2006-2#1)
prevalence of bipolar##2##3##(2007-8#1)(2008-8#1)
prevalence of both##4##3##(2006-10#1)(2008-4#1)(2013-8#2)
prevalence of bronchial asthma##4##4##(1996-7#2)(2011-1#2)
prevalence of brown stem rot##4##5##(2008-10#4)
prevalence of cardiovascular disease##2##4##(2008-3#1)(2009-11#1)
prevalence of cardiovascular risk factors and##2##6##(2007-7#1)(2009-9#1)
prevalence of cardiovascular risk factors##3##5##(2006-2#1)(2007-7#1)(2009-9#1)
prevalence of cardiovascular##7##3##(2006-2#1)(2007-7#1)(2008-3#1)(2009-11#2)(2009-9#1)(2012-2#1)
prevalence of cavities##3##3##(2008-9#3)
prevalence of cervical##2##3##(2006-8#1)(2008-4#1)
prevalence of child abuse##2##4##(1994-3#2)
prevalence of chronic##12##3##(1990-12#1)(1997-4#1)(2006-11#1)(2006-8#1)(2007-2#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-8#1)
prevalence of cigarette smoking##2##4##(1996-6#1)(2013-8#1)
prevalence of cigarette##4##3##(1996-6#1)(2013-1#1)(2013-8#2)
prevalence of circumportal pancreas##3##4##(2012-2#3)
prevalence of clinical manifestations##2##4##(2006-10#1)(2006-12#1)
prevalence of comorbid##2##3##(2007-7#1)(2007-8#1)
prevalence of congenital##3##3##(2011-1#2)(2013-8#1)
prevalence of continuing##2##3##(2004-10#2)
prevalence of coronary heart disease##3##5##(1993-12#2)(1997-6#1)
prevalence of coronary##4##3##(1993-12#2)(1997-6#1)(2008-12#1)
prevalence of cryoglobulinemia##2##3##(2011-1#2)
prevalence of curable STIs##4##4##(2012-3#4)
prevalence of delirium in##2##4##(2010-10#1)(2012-12#1)
prevalence of dementia##5##3##(1991-11#1)(1991-9#1)(2008-7#3)
prevalence of dental caries##4##4##(1991-6#1)(1992-5#2)(2011-1#1)
prevalence of dental##6##3##(1991-6#1)(1992-5#2)(2008-8#1)(2011-1#1)(2012-11#1)
prevalence of depression among##2##4##(2007-12#1)(2009-10#1)
prevalence of depression##10##3##(1996-12#1)(2006-4#1)(2007-10#3)(2007-12#1)(2009-10#1)(2010-11#1)(2011-2#1)(2013-8#1)
prevalence of depressive symptoms in Brazil##2##6##(2013-8#2)
prevalence of depressive symptoms in##4##5##(2006-9#1)(2013-8#3)
prevalence of depressive symptoms was found##2##6##(2011-2#1)(2013-1#1)
prevalence of depressive symptoms was##4##5##(2011-2#2)(2013-1#1)(2013-8#1)
prevalence of depressive symptoms##10##4##(2006-9#1)(2011-2#3)(2013-1#2)(2013-8#4)
prevalence of depressive##13##3##(2006-9#1)(2009-10#1)(2011-2#3)(2013-1#2)(2013-8#6)
prevalence of diabetes among##2##4##(2008-7#1)(2013-8#1)
prevalence of diabetes and##2##4##(2008-7#1)(2010-10#1)
prevalence of diabetes in##2##4##(2008-1#1)(2010-10#1)
prevalence of diabetes is##2##4##(2008-1#2)
prevalence of diabetes mellitus is##2##5##(2008-7#1)(2011-2#1)
prevalence of diabetes mellitus##6##4##(2007-12#1)(2007-2#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
prevalence of diabetes was##2##4##(2006-8#1)(2008-7#1)
prevalence of diabetes##22##3##(2006-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#3)(2008-5#1)(2008-7#5)(2010-10#3)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#2)
prevalence of diabetic retinopathy and associated factors in type##2##9##(2007-8#2)
prevalence of diabetic##5##3##(2006-6#1)(2007-12#1)(2007-8#2)(2008-7#1)
prevalence of different##5##3##(2006-10#2)(2006-5#1)(2010-12#1)(2013-8#1)
prevalence of diffuse##2##3##(2005-9#1)(2008-3#1)
prevalence of disturbed eating attitudes in##2##6##(2007-7#2)
prevalence of drug##2##3##(2012-3#1)(2013-8#1)
prevalence of drunk driving##2##4##(2013-7#2)
prevalence of elevated blood lead (PbB) levels in##2##8##(1997-4#2)
prevalence of elevated blood##3##4##(1997-4#2)(2008-5#1)
prevalence of elevated##4##3##(1997-4#2)(2007-7#1)(2008-5#1)
prevalence of end-stage renal disease##2##5##(2007-7#1)(2008-1#1)
prevalence of ergot##2##3##(2008-10#2)
prevalence of facet joint mediated pain##4##6##(2006-12#1)(2006-8#3)
prevalence of facet joint##7##4##(2006-12#1)(2006-8#6)
prevalence of facet##8##3##(2006-12#1)(2006-7#1)(2006-8#6)
prevalence of female##2##3##(1992-2#1)(2006-4#1)
prevalence of genital##2##3##(2007-12#2)
prevalence of goiter##4##3##(2006-4#2)(2007-4#1)(2011-1#1)
prevalence of hepatic cysts##2##4##(2007-8#2)
prevalence of hepatitis A##2##4##(2007-12#2)
prevalence of hepatitis B virus##2##5##(1996-3#1)(2013-1#1)
prevalence of hepatitis B##3##4##(1996-3#2)(2013-1#1)
prevalence of hepatitis C##2##4##(2008-1#2)
prevalence of hepatitis##7##3##(1996-3#2)(2007-12#2)(2008-1#2)(2013-1#1)
prevalence of high blood pressure and##2##6##(2008-3#1)(2008-4#1)
prevalence of high blood pressure##3##5##(2008-3#2)(2008-4#1)
prevalence of high##4##3##(2008-3#2)(2008-4#1)(2011-2#1)
prevalence of hock burn lesions##2##5##(2008-5#2)
prevalence of hospital##2##3##(1995-9#1)(2006-10#1)
prevalence of human##4##3##(2008-10#1)(2010-12#1)(2011-2#1)(2012-12#1)
prevalence of hypertension and##2##4##(1996-8#1)(2008-1#1)
prevalence of hypertension in##3##4##(2008-1#3)
prevalence of hypertension is##3##4##(1993-12#1)(2008-11#1)(2013-1#1)
prevalence of hypertension was##4##4##(2008-11#1)(2008-7#1)(2013-1#2)
prevalence of hypertension##22##3##(1993-12#1)(1996-8#1)(2007-8#1)(2008-1#7)(2008-11#5)(2008-7#2)(2010-9#1)(2013-1#4)
prevalence of illicit drug use by patients in##2##8##(2006-8#2)
prevalence of illicit drug##3##4##(2006-8#3)
prevalence of impaired fasting glycemia##2##5##(2011-2#2)
prevalence of impaired##3##3##(2011-2#2)(2012-3#1)
prevalence of infection in##2##4##(1991-6#1)(2007-12#1)
prevalence of infection##11##3##(1990-9#1)(1991-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-1#1)(2012-12#3)(2012-2#1)
prevalence of infectious##3##3##(2007-2#1)(2007-7#1)(2008-10#1)
prevalence of influenza##2##3##(2011-2#2)
prevalence of insulin resistance##3##4##(2006-1#2)(2008-3#1)
prevalence of insulin##4##3##(2006-1#2)(2006-10#1)(2008-3#1)
prevalence of intestinal parasitism in##2##5##(2012-12#2)
prevalence of intestinal##4##3##(2009-10#1)(2012-12#2)(2012-3#1)
prevalence of involvement of##2##4##(2006-8#1)(2007-6#1)
prevalence of isolated ANAs##2##4##(2006-10#2)
prevalence of low vision##2##4##(2010-8#2)
prevalence of low##9##3##(1997-5#1)(2006-8#1)(2009-4#3)(2010-1#1)(2010-8#2)(2011-2#1)
prevalence of lumbar facet joint mediated pain##2##7##(2006-8#2)
prevalence of lumbar facet joint##4##5##(2006-8#4)
prevalence of lung##2##3##(2007-7#1)(2012-3#1)
prevalence of lymphadenopathy##2##3##(2011-1#2)
prevalence of major depressive##2##4##(2011-1#1)(2013-8#1)
prevalence of major##3##3##(2011-1#2)(2013-8#1)
prevalence of malarial##2##3##(2006-2#1)(2013-1#1)
prevalence of malnutrition##2##3##(2007-7#2)
prevalence of marijuana##2##3##(2008-1#1)(2013-8#1)
prevalence of mental##4##3##(1992-2#1)(1993-5#1)(2008-11#1)(2008-12#1)
prevalence of metabolic syndrome (MS)##2##5##(2008-3#2)
prevalence of metabolic syndrome in Japanese male patients with##2##9##(2008-3#2)
prevalence of metabolic syndrome in Japanese##3##6##(2008-3#3)
prevalence of metabolic syndrome in##6##5##(2008-3#5)(2009-6#1)
prevalence of metabolic syndrome was##3##5##(2008-3#2)(2012-12#1)
prevalence of metabolic syndrome##19##4##(2008-3#14)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2012-12#1)
prevalence of metabolic##21##3##(2007-12#1)(2008-3#15)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2012-12#1)
prevalence of microalbuminuria##2##3##(2010-4#2)
prevalence of microscopic##2##3##(1991-3#1)(2007-8#1)
prevalence of migraine headache among depressed##2##6##(2010-2#2)
prevalence of migraine is##2##4##(2008-9#1)(2012-2#1)
prevalence of migraine##8##3##(2008-9#1)(2010-2#5)(2012-2#2)
prevalence of moderate##2##3##(1993-6#1)(2007-2#1)
prevalence of morbidity##3##3##(2007-2#1)(2009-12#1)(2011-1#1)
prevalence of multiple##2##3##(2007-6#1)(2008-11#1)
prevalence of musculoskeletal pain and discomfort##2##6##(2008-12#2)
prevalence of musculoskeletal symptoms##6##4##(2006-10#6)
prevalence of musculoskeletal##8##3##(2006-10#6)(2008-12#2)
prevalence of myocardial##3##3##(2007-8#1)(2009-9#2)
prevalence of nephropathy##2##3##(1996-12#1)(2008-1#1)
prevalence of neuropathy##3##3##(1991-10#1)(2012-12#1)(2012-2#1)
prevalence of obesity and its##2##5##(2010-9#1)(2012-2#1)
prevalence of obesity and##6##4##(2006-12#1)(2008-3#1)(2008-6#1)(2010-8#1)(2010-9#1)(2012-2#1)
prevalence of obesity has##5##4##(2009-5#1)(2010-6#1)(2011-1#2)(2012-1#1)
prevalence of obesity in the##3##5##(1993-11#1)(2006-10#1)(2006-2#1)
prevalence of obesity in##5##4##(1993-11#1)(2006-10#1)(2006-2#1)(2007-11#1)(2013-1#1)
prevalence of obesity is##2##4##(1996-3#1)(2011-2#1)
prevalence of obesity was##4##4##(1997-1#1)(2007-11#1)(2012-2#1)(2013-7#1)
prevalence of obesity##39##3##(1993-11#1)(1996-3#1)(1997-1#2)(2006-1#1)(2006-10#3)(2006-12#1)(2006-2#2)(2007-11#3)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-4#1)(2009-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#4)(2012-2#5)(2013-1#2)(2013-7#1)
prevalence of occult##2##3##(1990-6#2)
prevalence of one##4##3##(2006-2#1)(2008-11#1)(2011-2#1)(2013-7#1)
prevalence of oocysts##2##3##(1996-12#2)
prevalence of oral Candida##2##4##(2008-5#1)(2012-2#1)
prevalence of oral##4##3##(2008-1#1)(2008-5#2)(2012-2#1)
prevalence of osteoporosis##8##3##(1992-2#1)(1996-11#1)(2005-3#2)(2010-3#4)
prevalence of overweight and obesity among##4##6##(2006-1#2)(2011-1#1)(2012-12#1)
prevalence of overweight and obesity in##4##6##(2006-1#1)(2006-10#1)(2008-3#1)(2012-12#1)
prevalence of overweight and obesity##12##5##(2006-1#4)(2006-10#2)(2008-3#1)(2011-1#1)(2012-12#4)
prevalence of overweight and##17##4##(2006-1#4)(2006-10#2)(2008-3#3)(2009-9#1)(2011-1#1)(2012-12#4)(2012-2#1)(2013-8#1)
prevalence of overweight##21##3##(2006-1#5)(2006-10#2)(2008-3#4)(2009-9#3)(2011-1#1)(2012-12#4)(2012-2#1)(2013-8#1)
prevalence of pain in##3##4##(2007-12#1)(2008-5#1)(2010-12#1)
prevalence of pain##5##3##(2007-12#1)(2008-12#1)(2008-5#1)(2010-12#1)(2012-12#1)
prevalence of pediatric##2##3##(2008-10#1)(2008-11#1)
prevalence of peripheral##2##3##(2008-8#2)
prevalence of persistent low back pain##2##6##(2006-12#1)(2006-8#1)
prevalence of physical##2##3##(2012-3#1)(2013-1#1)
prevalence of positive##5##3##(2006-2#2)(2007-7#1)(2008-12#1)(2013-1#1)
prevalence of pre-hypertension and hypertension in##2##6##(2012-12#2)
prevalence of pre-hypertension##3##3##(2012-12#3)
prevalence of primary##2##3##(2007-7#1)(2008-5#1)
prevalence of psychiatric##2##3##(1993-5#1)(2011-1#1)
prevalence of radiographic##2##3##(1991-12#1)(2012-3#1)
prevalence of recognized##2##3##(2005-10#1)(2012-12#1)
prevalence of reflux##2##3##(2007-3#1)(2011-2#1)
prevalence of resistance##3##3##(2006-8#1)(2012-12#2)
prevalence of respiratory symptoms##2##4##(1995-8#2)
prevalence of respiratory##5##3##(1995-8#2)(2005-11#1)(2006-8#1)(2012-3#1)
prevalence of rheumatoid factor##2##4##(2011-2#2)
prevalence of risk factors##5##4##(1993-2#1)(2006-9#1)(2008-12#1)(2010-12#1)(2013-8#1)
prevalence of schistosomiasis##4##3##(2006-10#1)(2007-7#1)(2008-8#1)(2012-1#1)
prevalence of secondary##2##3##(2008-1#1)(2008-12#1)
prevalence of self-reported##3##3##(1990-9#1)(2010-12#1)(2013-1#1)
prevalence of several##2##3##(2006-5#1)(2009-12#1)
prevalence of severe food insecurity##2##5##(2011-1#2)
prevalence of severe##4##3##(2008-8#1)(2011-1#2)(2012-11#1)
prevalence of sicca symptoms in##2##5##(2006-10#2)
prevalence of skin reactivity to##2##5##(2007-2#2)
prevalence of skin##4##3##(2007-12#1)(2007-2#2)(2011-2#1)
prevalence of smokers##2##3##(1991-5#1)(1994-11#1)
prevalence of smoking among##4##4##(1991-11#1)(1991-4#1)(2007-3#1)(2009-7#1)
prevalence of smoking##10##3##(1991-11#1)(1991-4#1)(1994-6#1)(2006-1#1)(2007-3#1)(2009-5#1)(2009-7#1)(2011-2#1)(2012-1#1)(2013-1#1)
prevalence of soybean##2##3##(2008-10#2)
prevalence of stress##3##3##(2008-10#1)(2012-2#2)
prevalence of subclinical##2##3##(1990-11#1)(1995-2#1)
prevalence of suicidal##2##3##(1992-1#1)(2013-1#1)
prevalence of suicide attempts among##2##5##(2006-7#2)
prevalence of suicide attempts##3##4##(1990-12#1)(2006-7#2)
prevalence of symptoms of the upper limbs##3##7##(2006-10#3)
prevalence of syphilis##3##3##(2009-2#1)(2012-3#2)
prevalence of systemic##2##3##(2006-10#1)(2007-12#1)
prevalence of systolic hypertension##2##4##(2008-4#1)(2011-1#1)
prevalence of systolic##3##3##(2008-4#1)(2011-1#1)(2012-12#1)
prevalence of the MS is##2##5##(2008-3#2)
prevalence of the MS##4##4##(2008-3#4)
prevalence of the disease was##4##5##(2007-3#1)(2007-6#1)(2008-10#2)
prevalence of the disease##10##4##(2006-10#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-6#1)(2008-10#3)(2008-5#1)(2008-9#1)
prevalence of the disorder##2##4##(2006-10#1)(2008-6#1)
prevalence of the illness##2##4##(1990-9#1)(2008-7#1)
prevalence of the infection in##2##5##(1990-9#1)(2008-1#1)
prevalence of the metabolic syndrome##6##5##(2008-1#1)(2008-3#3)(2010-4#2)
prevalence of the most##2##4##(2007-7#1)(2011-1#1)
prevalence of the##57##3##(1990-9#2)(1993-10#1)(1993-2#1)(1993-6#1)(1996-11#2)(2006-10#2)(2006-8#2)(2006-9#1)(2007-11#1)(2007-3#1)(2007-6#1)(2007-7#3)(2008-1#3)(2008-10#3)(2008-3#9)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-9#1)(2010-12#1)(2010-4#2)(2011-1#3)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)
prevalence of these##8##3##(1990-9#1)(2006-6#1)(2007-7#1)(2008-2#1)(2008-5#1)(2010-5#1)(2012-12#1)(2013-1#1)
prevalence of this condition##2##4##(2004-11#1)(2008-12#1)
prevalence of this disease##3##4##(2007-2#1)(2010-5#1)(2013-8#1)
prevalence of this mutation##3##4##(1991-8#1)(2008-2#2)
prevalence of this##16##3##(1991-8#1)(1991-9#1)(1996-12#1)(2004-11#1)(2006-10#1)(2006-9#1)(2007-2#2)(2007-8#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#1)(2010-5#1)(2013-8#1)
prevalence of thrombocytosis##4##3##(1990-12#4)
prevalence of thyroid cancer##2##4##(2013-8#2)
prevalence of thyroid##4##3##(2008-7#2)(2013-8#2)
prevalence of toxoplasmosis##2##3##(2007-7#2)
prevalence of transmitted##2##3##(2013-1#2)
prevalence of treatment##2##3##(1992-9#1)(2008-11#1)
prevalence of tuberculosis##6##3##(1995-10#1)(2006-10#1)(2007-4#1)(2011-1#2)(2012-3#1)
prevalence of type 2 diabetes mellitus##2##6##(2008-1#1)(2008-5#1)
prevalence of type 2 diabetes##5##5##(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#2)
prevalence of type##7##3##(2007-2#2)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#2)
prevalence of use of##2##4##(1991-12#1)(2006-8#1)
prevalence of use##5##3##(1991-12#1)(2006-8#2)(2006-9#1)(2008-1#1)
prevalence of uveitis##3##3##(2006-10#3)
prevalence of valvular##2##3##(1990-6#2)
prevalence of vascular##2##3##(2007-10#1)(2007-8#1)
prevalence of vertebral##2##3##(2010-10#2)
prevalence of vertigo##2##3##(2012-2#2)
prevalence of viral##4##3##(2006-10#1)(2006-6#1)(2008-1#1)(2008-10#1)
prevalence of vitamin D deficiency##2##5##(2012-1#1)(2012-3#1)
prevalence of##1430##2##(1990-11#4)(1990-12#9)(1990-2#3)(1990-3#2)(1990-6#10)(1990-9#5)(1991-10#1)(1991-11#6)(1991-12#5)(1991-3#1)(1991-4#3)(1991-5#2)(1991-6#3)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#4)(1992-3#1)(1992-4#2)(1992-5#6)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#6)(1993-2#3)(1993-3#1)(1993-5#2)(1993-6#6)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-4#1)(1994-6#9)(1994-7#3)(1994-9#2)(1995-1#1)(1995-10#3)(1995-11#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#4)(1995-9#4)(1996-1#3)(1996-11#5)(1996-12#7)(1996-2#1)(1996-3#4)(1996-6#1)(1996-7#5)(1996-8#1)(1996-9#2)(1997-1#10)(1997-2#3)(1997-3#8)(1997-4#3)(1997-5#3)(1997-6#1)(1997-7#3)(1997-8#3)(2004-1#1)(2004-10#3)(2004-11#2)(2005-1#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-3#2)(2005-7#3)(2005-8#3)(2005-9#2)(2006-1#10)(2006-10#56)(2006-11#1)(2006-12#8)(2006-2#21)(2006-4#12)(2006-5#3)(2006-6#4)(2006-7#8)(2006-8#46)(2006-9#9)(2007-1#3)(2007-10#11)(2007-11#6)(2007-12#23)(2007-2#38)(2007-3#12)(2007-4#3)(2007-6#7)(2007-7#53)(2007-8#31)(2007-9#5)(2008-1#46)(2008-10#32)(2008-11#17)(2008-12#28)(2008-2#5)(2008-3#50)(2008-4#6)(2008-5#26)(2008-6#9)(2008-7#24)(2008-8#25)(2008-9#10)(2009-1#2)(2009-10#8)(2009-11#5)(2009-12#5)(2009-2#4)(2009-3#4)(2009-4#5)(2009-5#7)(2009-6#3)(2009-7#4)(2009-8#5)(2009-9#10)(2010-1#2)(2010-10#7)(2010-11#3)(2010-12#20)(2010-2#11)(2010-3#4)(2010-4#11)(2010-5#7)(2010-6#5)(2010-7#1)(2010-8#13)(2010-9#6)(2011-1#57)(2011-12#4)(2011-2#76)(2011-7#1)(2012-1#11)(2012-11#4)(2012-12#47)(2012-2#47)(2012-3#42)(2012-5#1)(2013-1#54)(2013-4#1)(2013-7#10)(2013-8#47)
prevalence on##2##2##(2008-10#1)(2013-1#1)
prevalence or##4##2##(1994-3#1)(2007-2#1)(2013-1#2)
prevalence over##2##2##(2006-8#1)(2010-11#1)
prevalence ranging from##2##3##(2008-1#2)
prevalence rate for##3##3##(2006-8#1)(2008-7#1)(2013-8#1)
prevalence rate of##35##3##(1991-5#2)(1993-3#1)(1994-6#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#4)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-12#1)(2008-3#3)(2008-7#2)(2009-4#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#4)
prevalence rate##53##2##(1990-6#1)(1991-12#2)(1991-5#2)(1993-3#1)(1994-4#1)(1994-6#1)(2006-10#2)(2006-4#1)(2006-8#2)(2007-11#1)(2007-2#5)(2007-3#4)(2007-4#1)(2007-7#3)(2007-8#2)(2008-1#4)(2008-12#1)(2008-3#3)(2008-7#4)(2009-4#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-7#1)(2013-8#5)
prevalence rates for##4##3##(2007-2#1)(2008-1#2)(2011-1#1)
prevalence rates in##3##3##(2008-3#1)(2008-4#1)(2012-12#1)
prevalence rates of probable##2##4##(2012-1#2)
prevalence rates of this##2##4##(2005-10#1)(2008-3#1)
prevalence rates of##23##3##(1991-2#1)(1997-3#2)(1997-8#1)(2004-12#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-7#3)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-1#4)(2012-1#2)
prevalence rates were##3##3##(2007-7#1)(2011-1#1)(2012-3#1)
prevalence rates##50##2##(1991-2#1)(1997-3#2)(1997-8#1)(2004-12#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-12#2)(2007-2#3)(2007-7#4)(2008-1#4)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#2)(2009-8#1)(2011-1#9)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#3)
prevalence ratio##2##2##(2010-12#1)(2011-1#1)
prevalence states##3##2##(2008-3#2)(2011-12#1)
prevalence studies##3##2##(2007-1#1)(2008-1#1)(2011-2#1)
prevalence study of##2##3##(1990-6#1)(1993-4#1)
prevalence study##7##2##(1990-6#1)(1993-4#1)(1993-6#1)(2006-12#1)(2008-7#1)(2009-7#1)(2013-1#1)
prevalence surveillance project##2##3##(2007-12#2)
prevalence survey##5##2##(2006-4#1)(2007-4#1)(2008-12#1)(2013-8#2)
prevalence surveys##2##2##(1996-7#1)(2013-8#1)
prevalence that##2##2##(2008-7#1)(2012-2#1)
prevalence to be##2##3##(2011-2#1)(2013-8#1)
prevalence to##5##2##(2004-12#1)(2006-7#1)(2007-7#1)(2011-2#1)(2013-8#1)
prevalence values##4##2##(2006-8#2)(2008-5#1)(2010-2#1)
prevalence varied from##2##3##(2006-2#1)(2007-2#1)
prevalence varies from##2##3##(2007-8#1)(2008-1#1)
prevalence varies##4##2##(2005-8#1)(2007-8#1)(2008-1#1)(2013-1#1)
prevalence was 0##2##3##(2008-10#1)(2013-1#1)
prevalence was 1##2##3##(2011-1#1)(2012-3#1)
prevalence was 21##2##3##(2007-3#1)(2011-1#1)
prevalence was 4##2##3##(2006-1#1)(2012-12#1)
prevalence was higher in##4##4##(2006-9#2)(2007-2#1)(2011-2#1)
prevalence was higher##5##3##(2006-9#2)(2007-2#1)(2010-3#1)(2011-2#1)
prevalence was observed##3##3##(1990-2#1)(2006-4#1)(2007-8#1)
prevalence was related to##2##4##(2008-5#1)(2008-8#1)
prevalence was related##3##3##(2007-8#1)(2008-5#1)(2008-8#1)
prevalence was significantly higher in##2##5##(1996-12#1)(2008-3#1)
prevalence was significantly higher##3##4##(1996-12#1)(2008-3#1)(2008-5#1)
prevalence was significantly##4##3##(1996-12#1)(2008-3#1)(2008-5#1)(2012-3#1)
prevalence was##53##2##(1990-2#1)(1990-3#1)(1990-6#1)(1992-2#1)(1993-1#1)(1996-12#1)(2006-1#1)(2006-10#1)(2006-2#2)(2006-4#2)(2006-8#3)(2006-9#2)(2007-2#3)(2007-3#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#2)(2008-8#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#3)(2011-2#3)(2012-12#4)(2012-3#2)(2013-1#3)(2013-8#1)
prevalence were##11##2##(1990-3#1)(1991-2#1)(1994-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-4#1)(2010-8#1)(2012-12#1)(2013-1#1)
prevalence with##5##2##(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#2)
prevalence worldwide##3##2##(2008-8#1)(2010-11#1)(2011-2#1)
prevalence##2247##1##(1990-10#1)(1990-11#7)(1990-12#9)(1990-2#5)(1990-3#4)(1990-6#18)(1990-7#1)(1990-9#5)(1991-1#1)(1991-10#1)(1991-11#6)(1991-12#9)(1991-2#2)(1991-3#1)(1991-4#3)(1991-5#4)(1991-6#4)(1991-8#1)(1991-9#3)(1992-1#2)(1992-11#2)(1992-12#1)(1992-2#10)(1992-3#1)(1992-4#2)(1992-5#6)(1992-7#1)(1992-8#2)(1992-9#6)(1993-1#2)(1993-10#2)(1993-11#2)(1993-12#6)(1993-2#3)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#9)(1993-7#2)(1993-8#1)(1993-9#2)(1994-11#6)(1994-12#1)(1994-2#2)(1994-3#4)(1994-4#2)(1994-5#1)(1994-6#18)(1994-7#3)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#4)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-7#1)(1995-8#4)(1995-9#8)(1996-1#3)(1996-11#5)(1996-12#12)(1996-2#2)(1996-3#8)(1996-6#1)(1996-7#8)(1996-8#1)(1996-9#2)(1997-1#12)(1997-2#7)(1997-3#11)(1997-4#5)(1997-5#3)(1997-6#3)(1997-7#5)(1997-8#5)(2004-1#1)(2004-10#3)(2004-11#2)(2004-12#2)(2004-3#1)(2005-1#1)(2005-10#3)(2005-11#5)(2005-12#2)(2005-3#2)(2005-7#3)(2005-8#8)(2005-9#2)(2006-1#13)(2006-10#87)(2006-11#3)(2006-12#14)(2006-2#31)(2006-4#22)(2006-5#3)(2006-6#5)(2006-7#12)(2006-8#68)(2006-9#15)(2007-1#7)(2007-10#12)(2007-11#9)(2007-12#34)(2007-2#59)(2007-3#21)(2007-4#7)(2007-5#1)(2007-6#11)(2007-7#87)(2007-8#47)(2007-9#8)(2008-1#76)(2008-10#56)(2008-11#23)(2008-12#36)(2008-2#9)(2008-3#68)(2008-4#14)(2008-5#44)(2008-6#15)(2008-7#40)(2008-8#44)(2008-9#16)(2009-1#3)(2009-10#10)(2009-11#10)(2009-12#6)(2009-2#5)(2009-3#4)(2009-4#12)(2009-5#9)(2009-6#3)(2009-7#6)(2009-8#7)(2009-9#10)(2010-1#3)(2010-10#8)(2010-11#5)(2010-12#33)(2010-2#12)(2010-3#6)(2010-4#18)(2010-5#13)(2010-6#8)(2010-7#4)(2010-8#21)(2010-9#8)(2011-1#91)(2011-12#6)(2011-2#131)(2011-7#2)(2012-1#19)(2012-11#6)(2012-12#73)(2012-2#68)(2012-3#73)(2012-5#1)(2013-1#94)(2013-4#2)(2013-7#16)(2013-8#78)
prevalence)##3##1##(2007-11#1)(2007-2#1)(2008-4#1)
prevalence--United States##2##2##(1990-12#1)(1997-2#1)
prevalence-based##3##1##(2011-2#2)(2012-2#1)
prevalences of##11##2##(1990-12#1)(1991-12#1)(1995-11#1)(1995-9#1)(2005-8#1)(2006-1#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-3#1)(2011-2#1)
prevalences##18##1##(1990-12#1)(1990-6#1)(1991-12#1)(1995-11#1)(1995-9#1)(2005-8#1)(2006-1#2)(2006-12#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-3#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)
prevalent HD patients##3##3##(2007-7#2)(2007-8#1)
prevalent age##2##2##(2011-2#1)(2012-12#1)
prevalent among T##2##3##(2012-3#2)
prevalent among the general population##2##5##(2012-12#1)(2012-3#1)
prevalent among the##7##3##(1993-10#1)(2008-1#1)(2010-7#1)(2012-12#3)(2012-3#1)
prevalent among##19##2##(1993-10#1)(1996-9#1)(2005-3#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-9#1)(2010-7#1)(2011-1#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#1)
prevalent and##14##2##(1991-2#1)(2005-7#1)(2006-7#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-8#1)(2009-5#1)(2012-12#1)(2012-3#1)
prevalent as the##2##3##(2006-8#1)(2008-2#1)
prevalent as##4##2##(2005-12#1)(2006-8#1)(2007-3#1)(2008-2#1)
prevalent cases of##2##3##(2011-2#2)
prevalent cases##3##2##(2007-3#1)(2011-2#2)
prevalent chronic##2##2##(2008-1#1)(2011-1#1)
prevalent condition##2##2##(2006-7#1)(2013-8#1)
prevalent disease##5##2##(2005-10#1)(2006-6#1)(2009-5#1)(2012-3#1)(2013-8#1)
prevalent disorder##3##2##(2008-3#1)(2008-9#1)(2010-2#1)
prevalent forms of##4##3##(1992-1#1)(1994-12#1)(2004-11#1)(2006-10#1)
prevalent genetic##2##2##(2009-8#1)(2012-12#1)
prevalent human##2##2##(2006-10#1)(2010-3#1)
prevalent in Western##2##3##(2007-12#1)(2007-5#1)
prevalent in adults##2##3##(1991-4#1)(2008-3#1)
prevalent in both##2##3##(1991-1#1)(2009-11#1)
prevalent in cattle##2##3##(2012-3#1)(2013-1#1)
prevalent in elderly##2##3##(2007-7#1)(2010-2#1)
prevalent in many##2##3##(2008-10#1)(2013-8#1)
prevalent in our##2##3##(2007-7#1)(2010-8#1)
prevalent in patients with##3##4##(1992-9#1)(2008-7#1)(2010-6#1)
prevalent in recent years##2##4##(2008-7#1)(2013-1#1)
prevalent in the United States##2##5##(2007-2#1)(2013-8#1)
prevalent in the##25##3##(2005-7#1)(2007-10#1)(2007-2#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
prevalent in##100##2##(1991-1#1)(1991-2#1)(1991-4#1)(1992-9#1)(1993-6#1)(1994-3#1)(1996-12#2)(1996-4#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#3)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#3)
prevalent infection in the##2##4##(1994-2#1)(2008-1#1)
prevalent infection##3##2##(1991-4#1)(1994-2#1)(2008-1#1)
prevalent is##2##2##(2007-12#1)(2012-3#1)
prevalent metabolic##2##2##(2008-3#1)(2010-10#1)
prevalent of##3##2##(2008-12#1)(2008-5#1)(2013-8#1)
prevalent on##2##2##(1990-5#1)(2008-10#1)
prevalent or##2##2##(2007-11#1)(2009-2#1)
prevalent species##2##2##(2007-3#1)(2008-10#1)
prevalent than##5##2##(2005-6#1)(2005-8#1)(2008-7#1)(2011-2#1)(2012-2#1)
prevalent throughout##2##2##(2008-10#1)(2011-2#1)
prevalent vertebral##2##2##(2010-10#2)
prevalent when##2##2##(2008-10#2)
prevalent wind##3##2##(2008-5#3)
prevalent##398##1##(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-1#1)(1991-2#2)(1991-4#3)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-11#1)(1995-6#1)(1996-12#3)(1996-4#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#2)(2004-11#1)(2005-10#1)(2005-12#1)(2005-3#1)(2005-6#1)(2005-7#2)(2005-8#4)(2006-10#7)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#4)(2006-9#3)(2007-10#1)(2007-11#6)(2007-12#4)(2007-2#7)(2007-3#6)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#10)(2007-8#10)(2007-9#2)(2008-1#17)(2008-10#36)(2008-11#5)(2008-12#5)(2008-2#4)(2008-3#8)(2008-4#3)(2008-5#13)(2008-6#3)(2008-7#9)(2008-8#6)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#5)(2009-6#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#9)(2011-12#1)(2011-2#24)(2012-1#1)(2012-11#3)(2012-12#13)(2012-2#8)(2012-3#14)(2013-1#21)(2013-7#2)(2013-8#11)
prevalently##5##1##(2008-10#2)(2008-8#1)(2010-8#1)(2013-1#1)
prevalidation##2##1##(2008-10#1)(2008-5#1)
preveneered crown##2##2##(2012-12#2)
preveneered##5##1##(2012-12#5)
prevent HIV infection##4##3##(1991-12#1)(1996-6#1)(2007-7#1)(2008-10#1)
prevent HIV transmission##3##3##(1996-8#1)(2008-10#1)(2013-8#1)
prevent HIV##10##2##(1991-12#1)(1996-11#1)(1996-6#1)(1996-8#1)(1997-6#1)(2007-7#1)(2008-10#2)(2012-3#1)(2013-8#1)
prevent a##21##2##(1990-6#1)(1991-1#1)(1993-1#1)(1993-2#1)(1995-2#1)(1996-6#1)(1997-5#2)(2005-4#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)(2010-12#1)(2011-2#1)(2013-8#1)
prevent accumulation of##2##3##(1993-6#1)(2008-10#1)
prevent acute##4##2##(1993-11#1)(2007-8#1)(2013-1#2)
prevent adsorption of##2##3##(2008-10#1)(2008-4#1)
prevent advanced##2##2##(1991-7#1)(1996-6#1)
prevent adverse events from##2##4##(2010-7#1)(2012-3#1)
prevent adverse##5##2##(2006-2#1)(2008-4#1)(2010-7#1)(2011-2#1)(2012-3#1)
prevent against##3##2##(2009-8#2)(2010-2#1)
prevent age-related##3##2##(2008-5#1)(2009-5#1)(2009-8#1)
prevent amyloid##2##2##(1992-9#1)(1994-8#1)
prevent and control##8##3##(2006-2#1)(2007-12#1)(2008-1#1)(2008-9#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
prevent and manage##4##3##(2007-12#1)(2012-1#1)(2012-3#1)(2013-1#1)
prevent and reverse the##2##4##(1993-9#1)(2012-12#1)
prevent and reverse##4##3##(1993-9#1)(2012-12#1)(2012-2#2)
prevent and treat##18##3##(1993-5#1)(2006-10#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-6#1)(2009-12#1)(2009-5#1)(2010-3#1)(2010-4#1)(2013-1#2)(2013-8#2)
prevent and##52##2##(1992-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(2004-12#1)(2006-1#1)(2006-10#2)(2006-2#1)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#2)(2009-3#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#4)
prevent another##2##2##(2007-4#1)(2010-12#1)
prevent any##4##2##(2008-11#1)(2008-4#1)(2011-12#1)(2013-8#1)
prevent apoptosis##6##2##(1993-6#1)(1994-10#1)(1994-11#1)(1995-2#1)(1995-3#1)(1996-10#1)
prevent bacterial##4##2##(2004-9#1)(2006-2#1)(2008-4#1)(2012-1#1)
prevent biofilm formation##3##3##(2008-1#1)(2011-12#1)(2013-1#1)
prevent bleeding in##2##3##(1992-11#1)(2011-2#1)
prevent bleeding##4##2##(1992-11#1)(2007-8#1)(2009-8#1)(2011-2#1)
prevent body##2##2##(2006-9#1)(2007-12#1)
prevent bone loss##2##3##(2008-7#1)(2008-8#1)
prevent bone##4##2##(2008-5#1)(2008-7#1)(2008-8#1)(2012-3#1)
prevent both##4##2##(2006-10#1)(2008-4#1)(2008-8#1)(2012-12#1)
prevent cancer##7##2##(1997-1#1)(2005-10#1)(2006-10#1)(2006-2#1)(2009-3#1)(2011-12#1)(2013-7#1)
prevent cardiovascular##5##2##(1993-2#1)(2008-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
prevent cell death##2##3##(1994-10#1)(2008-11#1)
prevent cell##3##2##(1994-10#1)(1994-9#1)(2008-11#1)
prevent chronic disease and##2##4##(2010-1#1)(2011-2#1)
prevent chronic disease##3##3##(2010-1#1)(2011-2#1)(2012-1#1)
prevent chronic##5##2##(2009-11#1)(2009-5#1)(2010-1#1)(2011-2#1)(2012-1#1)
prevent clinical##2##2##(2008-8#1)(2012-3#1)
prevent complete##2##2##(1992-1#1)(2008-8#1)
prevent complications of##2##3##(2011-2#2)
prevent complications##10##2##(1991-2#1)(2007-12#2)(2007-8#1)(2008-5#1)(2011-1#1)(2011-2#3)(2012-12#1)
prevent conversion##2##2##(2008-6#1)(2011-1#1)
prevent damage to the##3##4##(2008-1#1)(2008-11#1)(2008-3#1)
prevent damage to##4##3##(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#1)
prevent damage##6##2##(1992-9#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2013-8#1)
prevent development of##5##3##(1991-6#1)(1994-11#1)(1996-3#1)(1996-7#1)(1997-7#1)
prevent disease##9##2##(2006-10#1)(2006-2#2)(2008-10#1)(2008-7#1)(2009-8#1)(2012-2#1)(2013-7#2)
prevent diseases##2##2##(2006-5#1)(2008-10#1)
prevent early##6##2##(1993-1#1)(1994-3#1)(2007-12#1)(2009-7#1)(2013-1#1)(2013-8#1)
prevent end-to-end##2##2##(1990-8#1)(2008-9#1)
prevent free##2##2##(2006-12#1)(2008-8#1)
prevent further bone loss##2##4##(1993-11#1)(2012-2#1)
prevent further bone##3##3##(1993-11#1)(2008-10#1)(2012-2#1)
prevent further damage##2##3##(2008-1#2)
prevent further##17##2##(1993-11#1)(1994-12#1)(1995-12#1)(2005-11#1)(2007-12#1)(2007-7#1)(2008-1#4)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-12#1)(2012-2#1)
prevent future##2##2##(2007-12#1)(2008-10#1)
prevent growth##3##2##(1990-12#1)(1992-11#1)(2011-2#1)
prevent hypoglycemia##2##2##(1997-2#1)(2010-2#1)
prevent induction##2##2##(1996-10#1)(2006-9#1)
prevent infection with##2##3##(2006-4#1)(2010-12#1)
prevent infection##10##2##(1993-3#1)(2006-4#1)(2006-6#1)(2008-10#1)(2008-5#1)(2010-12#2)(2013-1#1)(2013-8#2)
prevent infections##11##2##(2007-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-1#1)(2011-2#6)
prevent injury##3##2##(1997-3#1)(2007-6#1)(2009-5#1)
prevent interference from##3##3##(2008-10#2)(2008-3#1)
prevent interference##4##2##(2008-10#3)(2008-3#1)
prevent invasive##3##2##(2007-8#1)(2013-1#1)(2013-8#1)
prevent irreversible##3##2##(2007-2#1)(2008-1#1)(2008-10#1)
prevent it from##2##3##(2008-11#2)
prevent it##10##2##(1995-5#1)(1996-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2012-2#2)
prevent its progression##2##3##(2005-7#1)(2006-6#1)
prevent its##14##2##(1990-11#1)(1995-12#1)(2005-7#2)(2006-10#1)(2006-6#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-3#1)(2009-5#1)(2011-2#1)(2012-12#2)
prevent leakage##2##2##(2008-3#1)(2008-5#1)
prevent life-threatening##2##2##(1991-8#1)(2010-8#1)
prevent long-term##5##2##(1993-2#1)(2008-1#2)(2010-2#1)(2013-1#1)
prevent loss of##3##3##(2008-3#1)(2008-7#1)(2013-1#1)
prevent morbidity##3##2##(2006-10#1)(2008-1#1)(2008-7#1)
prevent myocardial##2##2##(1993-2#1)(2008-12#1)
prevent neurodegenerative##2##2##(2009-3#1)(2013-1#1)
prevent neuronal death##3##3##(1994-5#1)(1995-5#1)(2013-8#1)
prevent non-specific##2##2##(1996-11#1)(1996-6#1)
prevent not only##3##3##(1991-6#1)(2008-5#1)(2008-9#1)
prevent obesity##3##2##(2007-12#1)(2011-2#1)(2012-2#1)
prevent or delay##9##3##(2005-11#1)(2007-11#1)(2008-1#3)(2009-11#1)(2010-10#2)(2011-1#1)
prevent or lessen##2##3##(1993-12#1)(2008-7#1)
prevent or limit##2##3##(2006-10#1)(2006-9#1)
prevent or reverse##6##3##(1991-9#1)(1994-2#1)(2005-8#1)(2006-8#1)(2008-3#1)(2011-1#1)
prevent or treat##7##3##(1993-11#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-7#1)(2013-8#1)
prevent or##48##2##(1991-9#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-4#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-8#1)(2006-9#1)(2007-11#3)(2008-1#5)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-10#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
prevent overfitting##2##2##(1995-9#1)(2008-10#1)
prevent pathogen ingress##2##3##(2008-10#2)
prevent patient##3##2##(1994-1#1)(2009-6#1)(2011-2#1)
prevent people from seeking##2##4##(2006-10#1)(2010-1#1)
prevent poor##2##2##(2012-3#1)(2013-1#1)
prevent postoperative##7##2##(1990-12#1)(1992-3#1)(2005-12#1)(2006-10#3)(2010-7#1)
prevent potential##3##2##(2008-3#1)(2010-11#1)(2012-1#1)
prevent progression of##2##3##(2007-2#1)(2011-2#1)
prevent progression##4##2##(2007-2#1)(2010-12#1)(2011-12#1)(2011-2#1)
prevent recurrence##9##2##(1991-11#1)(1995-4#1)(2006-11#1)(2007-11#1)(2007-8#2)(2008-3#1)(2010-7#1)(2012-2#1)
prevent recurrent stroke##2##3##(1991-11#1)(2010-9#1)
prevent recurrent##8##2##(1991-11#1)(1991-3#1)(2006-10#2)(2007-10#1)(2007-11#1)(2010-9#1)(2012-1#1)
prevent relapse##4##2##(1991-1#1)(2006-10#1)(2010-2#1)(2012-12#1)
prevent relapses##2##2##(1996-11#1)(2007-11#1)
prevent renal failure##2##3##(2006-4#1)(2010-7#1)
prevent renal##4##2##(2006-4#1)(2007-8#1)(2009-5#1)(2010-7#1)
prevent repetitive##2##2##(2009-3#1)(2011-1#1)
prevent restenosis##2##2##(1992-9#1)(1996-8#1)
prevent rotation##2##2##(2006-3#1)(2012-3#1)
prevent secondary##7##2##(1993-9#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-4#1)(2012-2#1)(2013-7#1)
prevent serious##4##2##(1995-7#1)(2008-10#1)(2010-1#1)(2010-10#1)
prevent severe##6##2##(2006-10#1)(2007-11#1)(2007-8#1)(2008-3#1)(2010-1#1)(2011-2#1)
prevent sexually transmitted##2##3##(2007-11#1)(2008-11#1)
prevent significant morbidity##3##3##(2006-10#1)(2006-4#1)(2008-6#1)
prevent significant##4##2##(2006-10#1)(2006-4#1)(2008-3#1)(2008-6#1)
prevent skin cancer in##2##4##(1991-11#1)(2008-8#1)
prevent skin cancer##3##3##(1991-11#1)(2008-8#1)(2010-9#1)
prevent skin##4##2##(1991-11#1)(2008-5#1)(2008-8#1)(2010-9#1)
prevent some##2##2##(2007-11#1)(2008-1#1)
prevent such##8##2##(1991-2#1)(2006-10#1)(2006-7#1)(2007-12#1)(2008-5#1)(2009-3#1)(2011-1#1)(2013-8#1)
prevent sudden##3##2##(2006-7#1)(2008-12#1)(2012-2#1)
prevent symptoms##2##2##(2010-12#1)(2010-4#1)
prevent the cell##2##3##(2009-8#1)(2013-1#1)
prevent the decrease in##2##4##(2004-12#2)
prevent the development of##22##4##(1991-7#1)(1991-9#1)(1993-11#1)(1993-2#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-9#1)(2012-11#1)
prevent the development##23##3##(1991-7#1)(1991-9#1)(1993-11#1)(1993-2#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-9#1)(2012-11#1)
prevent the disease##3##3##(1994-9#1)(1996-6#1)(2008-4#1)
prevent the emergence of##2##4##(1993-9#1)(2008-10#1)
prevent the formation of##7##4##(1991-4#1)(1995-8#1)(1997-8#2)(2006-3#1)(2010-8#1)(2011-2#1)
prevent the generation of##2##4##(1990-1#1)(1994-12#1)
prevent the growth of##3##4##(2007-7#1)(2008-12#1)(2012-1#1)
prevent the growth##4##3##(2007-7#1)(2008-1#1)(2008-12#1)(2012-1#1)
prevent the in##2##3##(1991-9#1)(2008-10#1)
prevent the increase in##3##4##(1994-2#1)(2008-1#1)(2008-10#1)
prevent the infection##2##3##(1990-9#1)(2008-3#1)
prevent the need for##2##4##(2008-4#1)(2009-7#1)
prevent the occurrence of##4##4##(1992-12#1)(1993-12#1)(2007-11#1)(2007-7#1)
prevent the onset of##5##4##(2008-1#1)(2008-3#1)(2008-7#1)(2012-1#1)(2013-1#1)
prevent the onset##6##3##(2008-1#1)(2008-3#1)(2008-7#1)(2009-7#1)(2012-1#1)(2013-1#1)
prevent the patient from##3##4##(1992-1#1)(1994-11#1)(2006-10#1)
prevent the progression of##3##4##(2006-10#1)(2008-7#1)(2010-12#1)
prevent the progression##5##3##(2006-10#1)(2006-2#1)(2008-7#1)(2010-12#1)(2013-1#1)
prevent the progressive##2##3##(1994-2#1)(2006-10#1)
prevent the recurrence of##2##4##(2010-6#1)(2012-2#1)
prevent the spread of infection##2##5##(2010-12#1)(2010-3#1)
prevent the spread of##9##4##(1993-8#1)(1997-6#2)(2007-7#2)(2008-10#1)(2010-12#1)(2010-3#1)(2011-1#1)
prevent the subsequent##2##3##(1994-9#1)(2006-9#1)
prevent the##208##2##(1990-1#1)(1990-11#2)(1990-12#3)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-3#2)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#1)(1993-2#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#2)(1994-9#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-6#3)(1997-7#1)(1997-8#3)(2004-12#2)(2005-10#1)(2005-11#1)(2005-3#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#6)(2006-11#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#3)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#5)(2007-9#2)(2008-1#8)(2008-10#13)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-11#1)(2009-12#3)(2009-3#2)(2009-4#1)(2009-7#2)(2009-8#3)(2010-12#4)(2010-3#1)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#1)
prevent their recurrence##2##3##(2008-1#1)(2013-1#1)
prevent their release##2##3##(1996-8#1)(2008-9#1)
prevent their##11##2##(1991-5#1)(1996-8#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
prevent them from##3##3##(2010-11#1)(2011-1#1)(2013-7#1)
prevent them##9##2##(2007-11#1)(2007-9#1)(2008-11#1)(2010-11#1)(2011-1#1)(2013-1#3)(2013-7#1)
prevent these##12##2##(1990-11#1)(1992-8#1)(2006-10#2)(2006-7#1)(2007-11#1)(2007-7#1)(2008-5#2)(2008-7#1)(2010-9#1)(2013-8#1)
prevent this complication##4##3##(2004-11#1)(2007-8#2)(2009-9#1)
prevent this##18##2##(1992-1#1)(1993-11#1)(1994-7#1)(1995-6#1)(1995-8#1)(1996-3#1)(2004-11#1)(2006-10#1)(2006-6#1)(2007-8#3)(2008-5#1)(2009-10#1)(2009-9#1)(2010-9#1)(2012-2#1)(2013-1#1)
prevent toxin##2##2##(1994-9#1)(2009-2#1)
prevent trabecular bone loss##2##4##(1993-11#2)
prevent tumor##2##2##(2011-1#1)(2013-1#1)
prevent unnecessary##7##2##(1995-10#1)(2005-7#1)(2006-10#1)(2008-1#1)(2008-10#1)(2011-12#1)(2011-2#1)
prevent urinary##2##2##(1990-11#1)(2010-11#1)
prevent##1301##1##(1990-1#1)(1990-11#10)(1990-12#7)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#3)(1990-8#2)(1990-9#2)(1991-1#4)(1991-10#4)(1991-11#6)(1991-12#4)(1991-2#5)(1991-3#5)(1991-4#2)(1991-5#2)(1991-6#5)(1991-7#5)(1991-8#4)(1991-9#7)(1992-1#4)(1992-10#2)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#4)(1992-9#7)(1993-1#4)(1993-10#2)(1993-11#11)(1993-12#8)(1993-2#7)(1993-3#5)(1993-5#1)(1993-6#5)(1993-7#1)(1993-8#2)(1993-9#6)(1994-1#2)(1994-10#3)(1994-11#7)(1994-12#4)(1994-2#6)(1994-3#4)(1994-4#1)(1994-5#6)(1994-6#2)(1994-7#1)(1994-8#5)(1994-9#9)(1995-10#2)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#8)(1995-6#4)(1995-7#2)(1995-8#8)(1995-9#3)(1996-1#1)(1996-10#5)(1996-11#8)(1996-12#3)(1996-2#1)(1996-3#3)(1996-4#2)(1996-5#2)(1996-6#6)(1996-7#1)(1996-8#4)(1996-9#3)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#5)(1997-5#5)(1997-6#5)(1997-7#7)(1997-8#3)(2004-11#2)(2004-12#3)(2004-9#2)(2005-10#3)(2005-11#7)(2005-12#3)(2005-3#2)(2005-4#1)(2005-5#1)(2005-7#6)(2005-8#5)(2005-9#1)(2006-1#1)(2006-10#47)(2006-11#3)(2006-12#2)(2006-2#13)(2006-3#4)(2006-4#4)(2006-5#2)(2006-6#12)(2006-7#6)(2006-8#8)(2006-9#6)(2007-1#1)(2007-10#6)(2007-11#29)(2007-12#22)(2007-2#2)(2007-3#2)(2007-4#2)(2007-5#3)(2007-6#7)(2007-7#13)(2007-8#40)(2007-9#7)(2008-1#37)(2008-10#67)(2008-11#28)(2008-12#9)(2008-2#5)(2008-3#29)(2008-4#21)(2008-5#30)(2008-6#9)(2008-7#25)(2008-8#22)(2008-9#11)(2009-1#2)(2009-10#5)(2009-11#6)(2009-12#8)(2009-2#3)(2009-3#11)(2009-4#1)(2009-5#9)(2009-6#5)(2009-7#5)(2009-8#10)(2009-9#3)(2010-1#5)(2010-10#5)(2010-11#3)(2010-12#17)(2010-2#8)(2010-3#3)(2010-4#4)(2010-5#7)(2010-6#4)(2010-7#10)(2010-8#12)(2010-9#8)(2011-1#20)(2011-12#10)(2011-2#53)(2011-3#2)(2012-1#11)(2012-11#4)(2012-12#25)(2012-2#29)(2012-3#14)(2013-1#48)(2013-7#10)(2013-8#24)
preventability##2##1##(2008-11#1)(2012-1#1)
preventable adverse##2##2##(2010-12#1)(2010-8#1)
preventable and##3##2##(1996-11#1)(2006-4#1)(2013-8#1)
preventable by##7##2##(1991-4#1)(1996-5#1)(2006-2#1)(2007-6#1)(2008-7#1)(2010-12#1)(2011-2#1)
preventable cause of##4##3##(2007-12#1)(2008-1#1)(2008-8#1)(2012-2#1)
preventable causes of##3##3##(2010-4#1)(2011-1#1)(2011-2#1)
preventable causes##5##2##(1990-2#1)(1997-2#1)(2010-4#1)(2011-1#1)(2011-2#1)
preventable disease##5##2##(1995-3#1)(2006-10#1)(2006-12#1)(2009-11#1)(2010-9#1)
preventable diseases##4##2##(1994-9#1)(2007-2#1)(2008-7#1)(2013-1#1)
preventable in##3##2##(1992-2#1)(1993-2#1)(2013-8#1)
preventable##75##1##(1990-2#1)(1991-12#1)(1991-4#1)(1992-2#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#3)(2006-4#1)(2007-12#1)(2007-2#3)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#4)(2008-7#4)(2008-8#1)(2009-11#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-8#2)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#5)(2011-3#1)(2011-9#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#4)
preventative measures are##2##3##(1995-9#1)(2008-7#1)
preventative measures##7##2##(1995-9#1)(2007-2#3)(2008-7#1)(2011-2#1)(2012-3#1)
preventative strategies##2##2##(2007-2#2)
preventative therapy##2##2##(2007-10#1)(2009-9#1)
preventative##31##1##(1995-9#1)(2005-12#1)(2006-11#1)(2007-10#1)(2007-12#4)(2007-2#6)(2007-6#1)(2008-10#2)(2008-11#1)(2008-7#2)(2009-11#1)(2009-9#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#1)
preventatives##2##1##(2006-9#1)(2010-1#1)
prevented (range##2##2##(2009-8#2)
prevented activation of##2##3##(1993-12#1)(1997-6#1)
prevented and##4##2##(1990-11#1)(1994-8#1)(2008-1#1)(2011-2#1)
prevented axotomy-induced##2##2##(1995-1#2)
prevented both##2##2##(1994-3#1)(1995-5#1)
prevented by GroE##2##3##(1992-3#2)
prevented by S##2##3##(2006-9#2)
prevented by a##10##3##(1991-3#1)(1992-8#1)(1993-3#1)(1994-3#2)(1997-2#1)(1997-3#1)(2006-9#1)(2007-7#1)(2007-8#1)
prevented by coadministration of##2##4##(1992-8#1)(2008-5#1)
prevented by cycloheximide##2##3##(1990-10#1)(1996-11#1)
prevented by preincubation of##2##4##(1992-5#1)(1995-8#1)
prevented by pretreatment with##6##4##(1992-8#1)(1993-12#1)(1993-3#1)(1995-1#2)(1995-3#1)
prevented by surgical##2##3##(2006-10#1)(2013-1#1)
prevented by the addition of##4##5##(1997-1#2)(1997-4#1)(2008-5#1)
prevented by the presence of##2##5##(1994-7#1)(2006-10#1)
prevented by the protease inhibitor N alpha-p-tosyl-L-lysine chloromethylketone##2##8##(1994-8#2)
prevented by the##26##3##(1990-10#1)(1990-11#1)(1990-6#1)(1991-2#1)(1993-5#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-7#1)(1994-8#3)(1995-5#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#1)(2006-10#1)(2008-11#1)(2008-5#1)(2012-12#1)
prevented by treatment with##2##4##(1990-9#1)(2013-8#1)
prevented by##161##2##(1990-10#4)(1990-11#3)(1990-12#2)(1990-2#3)(1990-3#3)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#3)(1991-4#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-3#3)(1992-5#2)(1992-8#4)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-5#1)(1993-8#1)(1993-9#2)(1994-2#5)(1994-3#6)(1994-5#1)(1994-7#2)(1994-8#5)(1995-1#2)(1995-12#3)(1995-3#2)(1995-5#3)(1995-8#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#3)(1997-1#4)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#4)(2005-7#1)(2005-8#2)(2006-10#3)(2006-11#1)(2006-4#1)(2006-5#1)(2006-9#3)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#6)(2013-8#1)
prevented cell death##2##3##(1994-9#1)(1997-4#1)
prevented cell##4##2##(1990-9#1)(1994-9#1)(1997-4#1)(2008-4#1)
prevented completely##2##2##(1992-3#1)(2013-1#1)
prevented cytotoxicity##2##2##(1994-8#2)
prevented disease##3##2##(1994-12#1)(2008-10#2)
prevented from##13##2##(1990-12#1)(1990-7#1)(1994-3#1)(1995-2#1)(2005-7#1)(2007-5#1)(2007-8#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-12#1)(2012-12#2)
prevented if##3##2##(1992-4#1)(1992-8#1)(2007-10#1)
prevented in a##2##3##(1994-2#1)(1997-2#1)
prevented in cirrhotics##2##3##(2009-8#2)
prevented in the##6##3##(1990-6#1)(1995-2#1)(1996-6#1)(1996-9#1)(1997-1#1)(2008-5#1)
prevented in##17##2##(1990-6#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-12#1)(1994-2#1)(1995-2#2)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#1)(2008-5#1)(2009-8#2)(2013-8#1)
prevented increases in the urinary excretion of protein##3##8##(1994-5#2)(1995-3#1)
prevented increases in##4##3##(1994-5#2)(1995-3#1)(2005-8#1)
prevented infection##4##2##(1996-12#1)(2006-10#1)(2008-10#2)
prevented ischemic##2##2##(2005-12#1)(2009-12#1)
prevented it##2##2##(1991-1#1)(1995-6#1)
prevented its##7##2##(1994-5#1)(1994-9#1)(1995-12#1)(1995-8#1)(2008-5#1)(2012-12#2)
prevented or reversed##2##3##(1996-4#1)(2008-7#1)
prevented or treated##3##3##(2006-10#1)(2008-12#1)(2008-9#1)
prevented or##10##2##(1996-12#1)(1996-4#1)(2006-10#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)
prevented spontaneous##2##2##(1995-5#1)(2013-1#1)
prevented such##2##2##(1997-5#1)(2009-6#1)
prevented the APO-induced MMR depression##2##5##(1996-1#2)
prevented the activation of##3##4##(1990-2#1)(1990-6#1)(1995-5#1)
prevented the appearance##2##3##(1991-7#1)(1995-2#1)
prevented the detrimental effects of##2##5##(1994-3#1)(2010-10#1)
prevented the development of experimental allergic encephalomyelitis##2##7##(2008-4#2)
prevented the development of##5##4##(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#2)
prevented the formation of##5##4##(1990-12#1)(1993-8#1)(1995-3#1)(2005-11#1)(2006-10#1)
prevented the generation of##3##4##(1991-8#1)(2008-11#2)
prevented the growth##2##3##(1991-12#1)(2008-7#1)
prevented the impairment##2##3##(1993-3#1)(1994-5#1)
prevented the increase in##5##4##(1994-3#1)(1995-3#1)(1997-2#1)(2007-11#1)(2013-1#1)
prevented the increase##6##3##(1992-12#1)(1994-3#1)(1995-3#1)(1997-2#1)(2007-11#1)(2013-1#1)
prevented the inhibitory##2##3##(1994-2#1)(1994-8#1)
prevented the loss of##2##4##(1994-5#1)(1997-5#1)
prevented the observed##2##3##(1995-12#1)(1997-3#1)
prevented the occurrence of##3##4##(1995-12#1)(2004-9#1)(2013-1#1)
prevented the reduction##2##3##(1990-2#1)(2011-2#1)
prevented the rise in##4##4##(1990-12#1)(1991-2#1)(1991-6#1)(1995-12#1)
prevented the use of##2##4##(2008-10#1)(2011-10#1)
prevented the##117##2##(1990-10#1)(1990-12#2)(1990-2#2)(1990-6#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-8#4)(1992-9#1)(1993-12#1)(1993-3#3)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#3)(1994-8#1)(1995-10#1)(1995-12#5)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#1)(1996-1#4)(1996-2#3)(1996-4#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#2)(1997-7#2)(1997-8#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#1)(2009-12#1)(2009-6#1)(2010-10#3)(2010-12#2)(2011-10#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)
prevented these##4##2##(1995-3#1)(1997-6#1)(2008-10#1)(2009-8#1)
prevented this effect##3##3##(1995-2#1)(1996-9#1)(2006-9#1)
prevented this##10##2##(1991-1#1)(1992-3#1)(1994-6#1)(1995-2#1)(1996-9#1)(2004-12#1)(2006-10#1)(2006-9#1)(2007-12#1)(2008-3#1)
prevented under##2##2##(1995-1#1)(1995-4#1)
prevented when##6##2##(1990-7#1)(1993-12#1)(1994-12#1)(1994-5#2)(1996-10#1)
prevented with##3##2##(1994-2#1)(2006-10#1)(2008-7#1)
prevented without##2##2##(1992-2#1)(1997-3#1)
prevented##580##1##(1990-10#5)(1990-11#4)(1990-12#6)(1990-2#6)(1990-3#4)(1990-4#2)(1990-5#3)(1990-6#4)(1990-7#4)(1990-8#1)(1990-9#2)(1991-1#4)(1991-10#3)(1991-12#4)(1991-2#4)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#4)(1991-8#3)(1991-9#3)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#8)(1992-4#2)(1992-5#4)(1992-8#9)(1992-9#2)(1993-1#1)(1993-11#3)(1993-12#7)(1993-3#5)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#4)(1994-11#5)(1994-12#4)(1994-2#9)(1994-3#12)(1994-5#11)(1994-6#3)(1994-7#2)(1994-8#11)(1994-9#4)(1995-1#6)(1995-10#3)(1995-11#1)(1995-12#13)(1995-2#7)(1995-3#10)(1995-4#1)(1995-5#6)(1995-6#2)(1995-7#1)(1995-8#4)(1996-1#4)(1996-10#4)(1996-11#2)(1996-12#7)(1996-2#6)(1996-3#4)(1996-4#3)(1996-5#2)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#8)(1997-1#8)(1997-2#6)(1997-3#3)(1997-4#6)(1997-5#5)(1997-6#3)(1997-7#6)(1997-8#5)(2004-10#1)(2004-11#1)(2004-12#1)(2004-9#3)(2005-1#1)(2005-11#1)(2005-12#1)(2005-4#1)(2005-7#2)(2005-8#9)(2006-10#11)(2006-11#2)(2006-12#2)(2006-4#2)(2006-5#2)(2006-6#2)(2006-8#2)(2006-9#4)(2007-10#3)(2007-11#5)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#9)(2007-9#1)(2008-1#8)(2008-10#26)(2008-11#12)(2008-12#2)(2008-3#9)(2008-4#10)(2008-5#11)(2008-7#7)(2008-8#3)(2008-9#3)(2009-12#5)(2009-2#1)(2009-3#2)(2009-6#2)(2009-8#6)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#5)(2010-2#1)(2010-4#2)(2010-5#2)(2010-8#1)(2011-1#4)(2011-10#1)(2011-12#1)(2011-2#9)(2012-1#1)(2012-11#1)(2012-12#8)(2012-2#3)(2012-3#2)(2013-1#19)(2013-8#2)
preventer medication##3##2##(2008-3#3)
preventer##4##1##(2008-3#4)
preventing HIV transmission##2##3##(1992-12#1)(2007-12#1)
preventing HIV##3##2##(1992-12#1)(2007-12#1)(2012-2#1)
preventing a##3##2##(1992-3#1)(2008-10#1)(2009-5#1)
preventing accidents##2##2##(1990-10#1)(2009-10#1)
preventing acute##3##2##(1990-6#1)(2008-12#1)(2008-3#1)
preventing adverse##4##2##(2006-9#1)(2007-8#1)(2011-1#1)(2012-2#1)
preventing an##3##2##(2005-1#1)(2013-1#2)
preventing and controlling##2##3##(2006-10#1)(2008-1#1)
preventing and treating##11##3##(2004-11#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-5#3)(2013-1#2)(2013-7#1)
preventing and##25##2##(1994-2#1)(2004-11#1)(2005-10#2)(2006-10#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-5#5)(2009-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#3)(2013-7#2)(2013-8#1)
preventing any##4##2##(2004-4#1)(2008-10#1)(2008-11#1)(2012-1#1)
preventing apoptosis##2##2##(1995-10#1)(2012-2#1)
preventing cancer##2##2##(2008-7#1)(2008-8#1)
preventing cardiovascular##3##2##(1993-2#1)(2008-8#1)(2011-2#1)
preventing cell##2##2##(2011-2#1)(2012-1#1)
preventing chronic##2##2##(1991-3#1)(2011-2#1)
preventing complications##4##2##(1992-12#1)(2007-12#1)(2008-10#1)(2008-8#1)
preventing damage to##2##3##(2006-8#1)(2007-11#1)
preventing damage##5##2##(2006-8#1)(2007-11#2)(2008-7#1)(2012-1#1)
preventing development of##4##3##(1993-12#1)(2009-11#1)(2013-1#1)(2013-8#1)
preventing disease##4##2##(1990-8#1)(2009-2#1)(2009-4#1)(2013-1#1)
preventing efficient##2##2##(1996-2#1)(2013-8#1)
preventing further##3##2##(2007-11#1)(2012-2#1)(2013-1#1)
preventing harm##2##2##(2008-9#1)(2009-11#1)
preventing in##2##2##(2010-4#1)(2012-2#1)
preventing infection##3##2##(2007-2#1)(2008-10#1)(2010-2#1)
preventing its##4##2##(1990-7#1)(2008-12#1)(2008-9#1)(2010-11#1)
preventing malaria##2##2##(2006-10#1)(2007-12#1)
preventing new##2##2##(1990-6#1)(2007-12#1)
preventing nosocomial##2##2##(1991-7#1)(1992-10#1)
preventing or delaying##3##3##(2007-11#1)(2008-10#1)(2010-6#1)
preventing or limiting##2##3##(2005-7#1)(2007-2#1)
preventing or##17##2##(1993-1#1)(1997-4#1)(2005-7#2)(2006-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-3#2)(2010-6#1)(2013-1#2)
preventing osteoporosis##2##2##(1993-5#1)(2005-3#1)
preventing physical##2##2##(1996-2#1)(2007-3#1)
preventing premature##2##2##(1990-11#1)(1994-12#1)
preventing progression of##4##3##(1993-7#1)(1997-3#1)(2006-10#1)(2008-2#1)
preventing progression##6##2##(1993-7#1)(1994-8#1)(1997-3#1)(2006-10#1)(2007-7#1)(2008-2#1)
preventing recurrent stroke##3##3##(2010-9#3)
preventing recurrent##5##2##(2007-10#2)(2010-9#3)
preventing relapses of##2##3##(2007-11#1)(2009-6#1)
preventing relapses##3##2##(2007-11#2)(2009-6#1)
preventing restenosis##2##2##(1996-8#1)(2007-11#1)
preventing secondary##2##2##(1993-9#1)(1997-5#1)
preventing some##2##2##(2005-9#1)(2008-8#1)
preventing stroke##2##2##(2007-10#1)(2007-7#1)
preventing subsequent##2##2##(2005-6#1)(2010-12#1)
preventing such##3##2##(2006-10#1)(2008-7#1)(2010-12#1)
preventing the accumulation of##2##4##(1991-12#1)(2013-1#1)
preventing the degradation of##2##4##(1992-12#1)(1993-9#1)
preventing the formation of##2##4##(1990-7#1)(1991-9#1)
preventing the interaction##2##3##(2010-12#1)(2010-5#1)
preventing the##72##2##(1990-7#1)(1991-12#2)(1991-9#2)(1992-12#2)(1992-2#1)(1992-7#1)(1993-12#1)(1993-9#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-3#1)(1997-5#2)(2005-10#1)(2005-3#1)(2005-7#1)(2005-8#1)(2006-5#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#3)(2009-3#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
preventing their##6##2##(1991-9#1)(1994-9#1)(1995-3#1)(2008-10#1)(2010-12#1)(2013-1#1)
preventing them##3##2##(1993-7#1)(2006-3#1)(2012-2#1)
preventing these##3##2##(2006-10#1)(2008-4#1)(2009-10#1)
preventing this##4##2##(2005-7#1)(2006-12#1)(2006-6#1)(2012-11#1)
preventing thrombus##2##2##(2007-11#1)(2007-8#1)
preventing transmission##2##2##(2013-8#2)
preventing violence##2##2##(2007-2#1)(2013-1#1)
preventing##502##1##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#2)(1990-6#3)(1990-7#2)(1990-8#1)(1991-10#1)(1991-12#5)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#2)(1991-7#2)(1991-9#3)(1992-10#1)(1992-12#5)(1992-2#2)(1992-3#2)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#6)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#2)(1993-2#3)(1993-5#1)(1993-7#4)(1993-9#4)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#3)(1994-8#2)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-5#1)(1996-1#1)(1996-10#2)(1996-11#1)(1996-2#3)(1996-3#3)(1996-5#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#4)(1997-5#3)(1997-6#3)(1997-8#1)(2004-11#1)(2004-4#1)(2005-1#1)(2005-10#6)(2005-11#1)(2005-12#2)(2005-3#3)(2005-6#1)(2005-7#5)(2005-8#2)(2005-9#1)(2006-10#9)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#4)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#8)(2007-11#22)(2007-12#6)(2007-2#5)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#9)(2007-8#10)(2007-9#2)(2008-1#3)(2008-10#24)(2008-11#11)(2008-12#4)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#15)(2008-6#1)(2008-7#10)(2008-8#10)(2008-9#11)(2009-10#3)(2009-11#5)(2009-12#5)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#12)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#6)(2010-8#4)(2010-9#4)(2011-1#7)(2011-12#1)(2011-2#12)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#4)(2012-2#15)(2012-3#7)(2013-1#34)(2013-7#4)(2013-8#8)
prevention activities##2##2##(1997-8#1)(2008-10#1)
prevention among##4##2##(1990-2#1)(2008-12#1)(2009-5#1)(2013-8#1)
prevention and adequate treatment of##2##5##(1996-12#1)(2011-2#1)
prevention and adequate##3##3##(1994-12#1)(1996-12#1)(2011-2#1)
prevention and attenuation##2##3##(2009-12#1)(2010-8#1)
prevention and awareness##2##3##(2007-2#1)(2007-7#1)
prevention and care##4##3##(1997-3#1)(2007-7#1)(2008-4#1)(2012-1#1)
prevention and control efforts##2##4##(2007-7#1)(2012-1#1)
prevention and control in##2##4##(2010-5#1)(2011-1#1)
prevention and control measures##3##4##(1996-1#1)(2005-8#1)(2008-10#1)
prevention and control of##24##4##(1991-5#1)(1991-8#1)(1993-7#1)(2004-10#3)(2006-2#2)(2007-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2010-4#1)(2010-5#2)(2011-2#4)(2012-2#1)(2012-3#1)(2013-8#2)
prevention and control programme##2##4##(2006-2#1)(2012-11#1)
prevention and control##56##3##(1991-5#1)(1991-8#1)(1993-7#1)(1996-1#1)(1996-2#1)(1997-1#4)(2004-10#3)(2005-8#1)(2006-2#3)(2007-12#2)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-4#1)(2010-4#2)(2010-5#3)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#9)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-8#3)
prevention and early detection##2##4##(1993-2#1)(2007-9#1)
prevention and early treatment of##2##5##(2007-11#1)(2007-8#1)
prevention and early treatment##3##4##(2007-11#1)(2007-8#1)(2010-11#1)
prevention and early##7##3##(1993-2#1)(1996-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2010-11#1)
prevention and health promotion##2##4##(1990-10#1)(1996-3#1)
prevention and health##7##3##(1990-10#1)(1995-3#1)(1996-3#1)(2005-10#4)
prevention and intervention efforts##3##4##(2008-11#1)(2009-7#1)(2010-2#1)
prevention and intervention##9##3##(2008-11#1)(2008-3#1)(2008-9#1)(2009-11#1)(2009-7#2)(2010-12#2)(2010-2#1)
prevention and management of##12##4##(1990-2#1)(1996-1#1)(2005-7#1)(2006-10#1)(2007-12#1)(2008-7#2)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
prevention and management##19##3##(1990-2#1)(1995-12#1)(1996-1#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-7#2)(2009-4#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#2)
prevention and proper management of OP poisoning##2##7##(2013-1#2)
prevention and protection##2##3##(2010-12#1)(2011-1#1)
prevention and quarantine##3##3##(2012-2#3)
prevention and rehabilitation for patients with##2##6##(2012-3#2)
prevention and response##3##3##(1996-12#2)(2013-7#1)
prevention and screening##2##3##(1994-12#1)(1994-3#1)
prevention and the treatment of##2##5##(1993-11#1)(2007-11#1)
prevention and the##6##3##(1993-11#1)(2007-11#1)(2007-8#1)(2009-3#1)(2009-6#1)(2011-1#1)
prevention and therapy of##8##4##(1990-5#1)(1991-9#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-7#1)(2009-9#1)(2013-1#1)
prevention and therapy##16##3##(1990-5#1)(1991-12#1)(1991-9#1)(1997-2#1)(2005-11#1)(2006-10#3)(2006-2#2)(2007-10#1)(2007-11#1)(2008-7#1)(2009-9#1)(2010-12#1)(2013-1#1)
prevention and to##3##3##(2007-9#1)(2008-6#1)(2011-1#1)
prevention and transmission##3##3##(2011-2#1)(2012-12#2)
prevention and treatment for##2##4##(1990-12#1)(2007-1#1)
prevention and treatment in##2##4##(2006-10#1)(2007-7#1)
prevention and treatment of cancer##2##5##(1994-4#1)(2008-1#1)
prevention and treatment of complications##2##5##(2006-10#1)(2006-6#1)
prevention and treatment of human##2##5##(2007-11#1)(2013-1#1)
prevention and treatment of osteoporosis##10##5##(1993-11#4)(1997-6#2)(2005-1#1)(2007-11#1)(2008-3#1)(2008-7#1)
prevention and treatment of postmenopausal osteoporosis##3##6##(2005-3#1)(2007-11#1)(2012-2#1)
prevention and treatment of the##3##5##(1993-12#1)(2005-7#1)(2007-11#1)
prevention and treatment of various##2##5##(1997-2#1)(2013-7#1)
prevention and treatment of##85##4##(1992-7#1)(1993-11#4)(1993-12#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-4#2)(1996-8#1)(1997-2#1)(1997-6#2)(1997-8#1)(2004-12#1)(2005-1#1)(2005-10#1)(2005-3#1)(2005-7#2)(2005-8#2)(2006-10#6)(2006-6#1)(2006-9#1)(2007-11#9)(2007-2#1)(2007-5#1)(2007-7#2)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#5)(2008-8#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
prevention and treatment programs##2##4##(2006-7#1)(2010-2#1)
prevention and treatment strategies##3##4##(2007-9#1)(2009-4#1)(2012-12#1)
prevention and treatment##123##3##(1990-12#1)(1992-5#1)(1992-7#1)(1993-11#5)(1993-12#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-4#2)(1995-1#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#3)(1997-8#1)(2004-12#1)(2005-1#1)(2005-10#1)(2005-3#1)(2005-7#2)(2005-8#2)(2006-10#7)(2006-2#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#10)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#3)(2007-9#3)(2008-1#4)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#3)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#2)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#3)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#3)
prevention and treatment]##3##3##(1993-5#1)(2007-2#1)(2012-2#1)
prevention and##328##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-5#1)(1992-7#1)(1993-11#7)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#2)(1993-7#1)(1993-9#1)(1994-12#3)(1994-3#1)(1994-4#3)(1995-1#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-1#2)(1996-12#4)(1996-2#1)(1996-3#3)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#3)(1997-8#1)(2004-10#3)(2004-12#1)(2004-9#1)(2005-1#1)(2005-10#5)(2005-11#1)(2005-3#2)(2005-7#4)(2005-8#4)(2005-9#1)(2006-10#11)(2006-12#1)(2006-2#7)(2006-4#1)(2006-6#1)(2006-7#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#14)(2007-12#10)(2007-2#3)(2007-5#1)(2007-6#2)(2007-7#8)(2007-8#3)(2007-9#5)(2008-1#6)(2008-10#4)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#15)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#4)(2009-3#2)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#8)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#3)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#12)(2011-12#1)(2011-2#16)(2011-3#1)(2012-1#2)(2012-11#2)(2012-12#8)(2012-2#12)(2012-3#4)(2013-1#10)(2013-7#2)(2013-8#6)
prevention approaches##2##2##(2009-4#1)(2012-2#1)
prevention are addressed##2##3##(2007-1#1)(2010-3#1)
prevention are being##2##3##(2007-11#1)(2008-1#1)
prevention are discussed##3##3##(2007-7#1)(2008-10#1)(2011-1#1)
prevention are examined##2##3##(1991-5#1)(2012-2#1)
prevention are presented##2##3##(2007-11#1)(2012-2#1)
prevention are reviewed##2##3##(2006-9#1)(2007-4#1)
prevention are##19##2##(1991-5#1)(1996-12#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-2#2)
prevention as well as treatment of##2##6##(2008-12#1)(2010-12#1)
prevention awareness##2##2##(1995-2#1)(2009-6#1)
prevention behavior##2##2##(2008-1#2)
prevention by##7##2##(1990-11#1)(1991-9#1)(1993-12#1)(2006-5#1)(2008-5#1)(2010-1#1)(2010-6#1)
prevention campaign##3##2##(1990-3#1)(2008-1#1)(2008-9#1)
prevention can be##2##3##(1993-11#1)(2008-4#1)
prevention can##3##2##(1993-11#1)(2008-4#1)(2011-2#1)
prevention concentrations##2##2##(2011-2#2)
prevention curriculum##2##2##(2006-6#1)(2010-11#1)
prevention during care##2##3##(2011-1#2)
prevention during##3##2##(2006-1#1)(2011-1#2)
prevention education##7##2##(2008-10#2)(2008-3#1)(2009-5#3)(2010-7#1)
prevention efforts and##5##3##(2008-3#1)(2008-8#1)(2009-4#1)(2010-11#1)(2012-2#1)
prevention efforts for##2##3##(2007-10#1)(2008-12#1)
prevention efforts in##2##3##(1990-10#1)(1996-9#1)
prevention efforts##25##2##(1990-10#2)(1996-11#1)(1996-9#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-10#2)(2008-11#1)(2008-12#2)(2008-3#2)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#1)(2011-1#1)(2012-2#2)(2013-1#1)
prevention for cardiovascular disease##2##4##(1992-5#1)(2006-5#1)
prevention for##8##2##(1992-5#1)(2006-11#1)(2006-5#2)(2008-7#1)(2012-3#1)(2013-7#1)(2013-8#1)
prevention from##2##2##(1990-9#1)(2010-2#1)
prevention guidelines##2##2##(2007-10#1)(2007-2#1)
prevention has##3##2##(2006-5#1)(2008-5#1)(2011-2#1)
prevention have been##2##3##(1994-2#1)(2008-3#1)
prevention have##4##2##(1994-2#1)(2007-9#1)(2008-3#1)(2011-2#1)
prevention in atrial fibrillation##2##4##(1997-5#1)(2008-1#1)
prevention in other##2##3##(1993-9#1)(2007-11#1)
prevention in the##7##3##(1993-9#1)(1996-4#1)(2004-12#1)(2007-3#1)(2009-11#1)(2011-2#1)(2012-1#1)
prevention in##40##2##(1990-6#1)(1991-1#1)(1993-12#1)(1993-9#4)(1994-9#1)(1996-11#1)(1996-3#1)(1996-4#2)(1997-5#1)(2004-12#1)(2005-8#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#2)(2009-11#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
prevention initiative##4##2##(1995-12#1)(1995-3#1)(2008-7#1)(2012-3#1)
prevention initiatives##4##2##(1995-12#1)(1995-3#1)(2006-7#1)(2009-5#1)
prevention intervention for college women at low- or high-risk for##2##10##(2007-12#2)
prevention intervention for##4##3##(2007-12#3)(2008-11#1)
prevention intervention##8##2##(2007-12#3)(2008-11#1)(2008-3#1)(2012-3#1)(2013-1#2)
prevention interventions in##2##3##(2007-12#1)(2012-3#1)
prevention interventions##19##2##(2006-7#1)(2007-12#2)(2007-7#2)(2008-12#1)(2008-3#1)(2008-4#1)(2010-10#1)(2011-12#1)(2012-1#2)(2012-3#7)
prevention is better than cure##2##5##(2008-3#1)(2013-7#1)
prevention is not##2##3##(2006-6#1)(2009-8#1)
prevention is the##2##3##(1996-6#1)(2008-1#1)
prevention is##24##2##(1993-12#1)(1993-6#1)(1994-8#1)(1996-6#1)(2006-1#1)(2006-6#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-7#1)
prevention knowledge among##2##3##(2007-9#1)(2012-12#1)
prevention knowledge##3##2##(2007-7#1)(2007-9#1)(2012-12#1)
prevention measures for##2##3##(1993-7#1)(2011-2#1)
prevention measures##10##2##(1993-7#1)(1994-6#2)(2007-12#2)(2011-2#4)(2013-1#1)
prevention messages##2##2##(2008-3#1)(2011-2#1)
prevention methods##2##2##(2007-1#1)(2008-11#1)
prevention more##2##2##(2008-1#1)(2008-12#1)
prevention of A-CVD##3##3##(2008-3#3)
prevention of AMD##2##3##(2011-2#2)
prevention of CHD in##2##4##(2005-12#1)(2006-5#1)
prevention of CHD##4##3##(2005-10#1)(2005-12#1)(2006-5#1)(2008-3#1)
prevention of CVD##2##3##(2009-4#1)(2011-1#1)
prevention of HIV##2##3##(1990-5#1)(2008-7#1)
prevention of HIV/AIDS##3##3##(2005-7#1)(2007-6#1)(2007-7#1)
prevention of IPD##2##3##(2012-12#2)
prevention of OM##3##3##(2008-7#3)
prevention of Pneumocystis carinii pneumonia##2##5##(1992-10#1)(1993-2#1)
prevention of TB##4##3##(2007-2#1)(2009-4#1)(2010-5#1)(2013-1#1)
prevention of acute##8##3##(1990-5#1)(1996-4#1)(2005-12#1)(2007-11#2)(2007-2#1)(2007-8#1)(2008-5#1)
prevention of adverse##2##3##(2009-3#1)(2010-10#1)
prevention of allergic##2##3##(2006-10#1)(2007-11#1)
prevention of atherosclerosis##4##3##(1991-11#1)(2005-7#1)(2008-1#1)(2008-3#1)
prevention of atrial##2##3##(2006-9#1)(2007-8#1)
prevention of autoimmune##2##3##(1996-11#1)(2012-3#1)
prevention of both##3##3##(2006-10#1)(2007-7#1)(2012-1#1)
prevention of breast cancer##2##4##(1994-12#1)(2008-1#1)
prevention of cancer##7##3##(1993-10#2)(1994-3#1)(2009-4#2)(2010-12#1)(2011-2#1)
prevention of cardiac##3##3##(2008-8#1)(2010-8#1)(2013-8#1)
prevention of cardiovascular disease (CVD)##3##5##(2006-2#1)(2011-1#1)(2013-1#1)
prevention of cardiovascular disease in##2##5##(2008-1#1)(2011-2#1)
prevention of cardiovascular disease##10##4##(1993-12#1)(2005-10#1)(2006-2#1)(2006-5#1)(2008-1#1)(2009-4#1)(2011-1#1)(2011-2#1)(2013-1#2)
prevention of cardiovascular diseases##2##4##(1990-2#1)(2008-7#1)
prevention of cardiovascular events##3##4##(1995-11#1)(2008-10#1)(2010-1#1)
prevention of cardiovascular##17##3##(1990-2#1)(1990-4#1)(1993-12#1)(1995-11#1)(2005-10#1)(2006-2#1)(2006-5#2)(2008-1#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-1#1)(2011-1#1)(2011-2#1)(2013-1#2)
prevention of certain##2##3##(2006-8#1)(2012-12#1)
prevention of cervical cancer##5##4##(2008-11#1)(2010-8#1)(2011-1#3)
prevention of chemotherapy-induced##3##3##(2008-7#2)(2010-12#1)
prevention of childhood##3##3##(2004-12#1)(2008-2#1)(2012-2#1)
prevention of chronic disease##3##4##(2007-9#1)(2008-3#2)
prevention of chronic##7##3##(1991-3#1)(1993-7#1)(1997-2#1)(2006-2#1)(2007-9#1)(2008-3#2)
prevention of coronary artery disease##6##5##(1993-9#1)(1996-1#1)(2006-10#1)(2006-5#1)(2007-8#1)(2010-2#1)
prevention of coronary disease##2##4##(1993-9#2)
prevention of coronary heart disease in##5##6##(1993-9#1)(1995-11#1)(1995-6#1)(1996-8#1)(2006-12#1)
prevention of coronary heart disease is##2##6##(1991-6#1)(1996-3#1)
prevention of coronary heart disease##10##5##(1991-6#1)(1993-9#1)(1995-11#1)(1995-6#1)(1996-3#1)(1996-8#1)(2005-10#1)(2006-12#2)(2010-6#1)
prevention of coronary##19##3##(1991-6#1)(1993-9#4)(1995-11#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-8#1)(2005-10#1)(2006-10#1)(2006-12#2)(2006-5#1)(2007-8#1)(2010-2#1)(2010-6#1)
prevention of dental caries##3##4##(2008-7#2)(2013-7#1)
prevention of dental##5##3##(2006-2#1)(2008-5#1)(2008-7#2)(2013-7#1)
prevention of depression##3##3##(2008-12#1)(2011-2#2)
prevention of development##3##3##(2005-3#1)(2005-7#1)(2008-9#1)
prevention of diabetes in##2##4##(2006-10#1)(2010-4#1)
prevention of diabetes##5##3##(1993-11#1)(1996-6#1)(2006-10#1)(2008-1#1)(2010-4#1)
prevention of diabetic##2##3##(1991-5#1)(2008-1#1)
prevention of disease##7##3##(1991-11#1)(1996-10#1)(2005-7#1)(2007-4#1)(2008-1#1)(2008-9#1)(2010-12#1)
prevention of falls##2##3##(1993-11#1)(2007-11#1)
prevention of further##2##3##(2007-11#1)(2008-10#1)
prevention of future##3##3##(2007-4#1)(2008-7#1)(2010-12#1)
prevention of hepatitis##3##3##(1994-8#1)(2007-11#1)(2007-12#1)
prevention of heterotopic ossification##3##4##(1994-8#2)(2007-11#1)
prevention of hip fractures in##2##5##(1993-11#1)(2005-3#1)
prevention of hip fractures##3##4##(1993-11#2)(2005-3#1)
prevention of hip##5##3##(1993-11#2)(2005-3#2)(2007-7#1)
prevention of human##3##3##(1992-2#1)(2008-5#1)(2011-2#1)
prevention of in##2##3##(2005-7#1)(2007-11#1)
prevention of infection of##2##4##(2008-10#1)(2009-6#1)
prevention of infection with##2##4##(1992-10#1)(2008-12#1)
prevention of infection##8##3##(1991-2#1)(1992-10#1)(2005-8#1)(2007-2#1)(2008-10#1)(2008-12#1)(2009-6#1)(2011-2#1)
prevention of infectious diseases##2##4##(2008-4#1)(2011-3#1)
prevention of influenza##4##3##(2006-10#1)(2008-5#2)(2011-2#1)
prevention of invasive##2##3##(2012-12#2)
prevention of ischemic stroke##2##4##(2007-10#1)(2010-8#1)
prevention of ischemic##8##3##(1995-11#1)(2005-10#1)(2006-6#1)(2007-10#2)(2010-8#1)(2011-2#2)
prevention of its##3##3##(1990-12#1)(2008-8#1)(2012-2#1)
prevention of later##2##3##(2006-10#1)(2006-8#1)
prevention of left##3##3##(2006-10#1)(2006-6#2)
prevention of low##2##3##(2007-9#1)(2010-10#1)
prevention of many##2##3##(2008-10#1)(2012-11#1)
prevention of mother to child##2##5##(2008-2#1)(2008-8#1)
prevention of mother-to-child transmission of HIV (PMTCT)##2##7##(2007-2#1)(2012-2#1)
prevention of mother-to-child transmission of HIV in##2##7##(2009-4#1)(2012-2#1)
prevention of mother-to-child transmission of HIV##7##6##(2007-2#1)(2009-4#3)(2009-7#1)(2012-2#2)
prevention of mother-to-child transmission of##8##5##(2007-2#1)(2009-4#4)(2009-7#1)(2012-2#2)
prevention of mother-to-child transmission##11##4##(2007-2#1)(2007-7#1)(2009-4#6)(2009-7#1)(2012-2#2)
prevention of myocardial##2##3##(1991-6#1)(2006-2#1)
prevention of neural tube defects##4##5##(1993-2#1)(2004-10#1)(2010-12#1)(2012-1#1)
prevention of new infections##2##4##(1995-9#1)(2009-4#1)
prevention of new##3##3##(1995-9#1)(2008-10#1)(2009-4#1)
prevention of nosocomial infection##2##4##(2006-10#1)(2007-7#1)
prevention of nosocomial##3##3##(1993-10#1)(2006-10#1)(2007-7#1)
prevention of obesity and##2##4##(2008-5#1)(2012-2#1)
prevention of obesity in##3##4##(2006-1#1)(2011-2#2)
prevention of obesity##9##3##(2006-1#1)(2008-10#3)(2008-5#1)(2011-2#2)(2012-12#1)(2012-2#1)
prevention of occupational##3##3##(2007-3#1)(2007-4#1)(2013-1#1)
prevention of oral cancer##2##4##(1992-9#1)(2007-9#1)
prevention of oral##3##3##(1992-9#1)(2007-9#1)(2012-2#1)
prevention of parent to child transmission (PPTCT)##2##7##(2012-2#2)
prevention of postmenopausal##2##3##(1994-8#1)(2008-3#1)
prevention of postoperative nausea and vomiting##3##6##(2006-10#1)(2011-12#2)
prevention of postoperative##13##3##(1994-6#1)(2006-10#1)(2007-12#3)(2008-4#1)(2008-5#1)(2010-7#1)(2011-12#3)(2012-3#2)
prevention of postpartum##2##3##(1996-12#1)(2007-11#1)
prevention of pregnancy##2##3##(1992-2#1)(1995-3#1)
prevention of primary AVF failure##2##5##(2010-4#2)
prevention of primary##4##3##(2004-10#1)(2007-11#1)(2010-4#2)
prevention of pulmonary##3##3##(1997-3#1)(2010-9#2)
prevention of recurrence##2##3##(2009-7#1)(2010-12#1)
prevention of recurrences and##2##4##(2008-7#1)(2009-10#1)
prevention of recurrences##5##3##(1996-12#1)(2007-7#1)(2008-1#1)(2008-7#1)(2009-10#1)
prevention of recurrent stroke##5##4##(2007-10#1)(2007-9#1)(2010-9#3)
prevention of recurrent##11##3##(2007-10#2)(2007-8#1)(2007-9#1)(2008-3#2)(2008-5#1)(2010-9#3)(2012-2#1)
prevention of respiratory infections##2##4##(2006-10#1)(2007-11#1)
prevention of respiratory##5##3##(1993-5#1)(2006-10#1)(2006-8#2)(2007-11#1)
prevention of restenosis##5##3##(1995-8#1)(1996-12#1)(2005-7#1)(2007-11#1)(2008-12#1)
prevention of retained foreign bodies after surgery##2##7##(2008-4#2)
prevention of rheumatic##2##3##(2005-12#2)
prevention of schizophrenia##2##3##(2006-9#1)(2009-7#1)
prevention of secondary##3##3##(2006-10#2)(2008-5#1)
prevention of sexually##2##3##(1996-8#1)(2013-8#1)
prevention of skin cancer##2##4##(1994-7#1)(2007-11#1)
prevention of skin damage##2##4##(2006-12#1)(2008-5#1)
prevention of skin##5##3##(1994-7#1)(1997-4#1)(2006-12#1)(2007-11#1)(2008-5#1)
prevention of spinal##2##3##(2006-10#1)(2007-11#1)
prevention of spontaneous##2##3##(2008-4#1)(2009-8#1)
prevention of stroke and##2##4##(1991-11#1)(2006-10#1)
prevention of stroke##9##3##(1991-11#1)(1995-5#1)(2006-10#1)(2007-10#3)(2008-1#2)(2012-12#1)
prevention of such##2##3##(2007-10#1)(2008-11#1)
prevention of sudden cardiac death##3##5##(2006-7#1)(2006-9#1)(2008-10#1)
prevention of sudden infant##2##4##(2005-6#1)(2007-12#1)
prevention of sudden##5##3##(2005-6#1)(2006-7#1)(2006-9#1)(2007-12#1)(2008-10#1)
prevention of suicide##2##3##(1992-8#1)(2009-7#1)
prevention of the disease##2##4##(1994-5#1)(2007-8#1)
prevention of the metabolic##2##4##(2008-3#1)(2009-10#1)
prevention of the##23##3##(1991-9#1)(1992-6#1)(1993-11#1)(1994-5#1)(1995-5#1)(1995-9#1)(1996-3#1)(1996-6#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-4#1)(2011-2#2)(2012-12#1)
prevention of these diseases##2##4##(2009-4#1)(2010-4#1)
prevention of these##8##3##(1995-3#1)(1995-8#1)(1996-7#1)(2008-6#1)(2008-7#2)(2009-4#1)(2010-4#1)
prevention of this disease##3##4##(1994-3#1)(1996-6#1)(2009-5#1)
prevention of this##12##3##(1990-3#1)(1991-3#1)(1994-3#1)(1995-5#1)(1996-6#1)(2007-10#1)(2007-2#1)(2007-4#1)(2008-3#2)(2009-4#1)(2009-5#1)
prevention of thromboembolism in##2##4##(2007-8#2)
prevention of thromboembolism##4##3##(2007-8#4)
prevention of transmission##3##3##(1993-3#1)(2008-10#1)(2010-5#1)
prevention of type##3##3##(1993-11#1)(2008-1#1)(2008-7#1)
prevention of unwanted##2##3##(2008-3#1)(2010-6#1)
prevention of venous##4##3##(1994-9#1)(2006-2#1)(2007-10#1)(2010-11#1)
prevention of##696##2##(1990-11#1)(1990-12#4)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#4)(1990-6#4)(1990-7#2)(1990-9#2)(1991-1#2)(1991-11#5)(1991-2#6)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-10#3)(1992-11#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#3)(1993-11#11)(1993-12#1)(1993-2#4)(1993-3#1)(1993-5#2)(1993-7#3)(1993-9#5)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-4#1)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#5)(1994-9#2)(1995-11#3)(1995-2#2)(1995-3#3)(1995-4#2)(1995-5#4)(1995-6#1)(1995-8#2)(1995-9#2)(1996-1#2)(1996-10#2)(1996-11#2)(1996-12#5)(1996-3#2)(1996-4#2)(1996-6#3)(1996-7#1)(1996-8#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#4)(2004-10#2)(2004-12#1)(2004-2#1)(2004-9#1)(2005-10#6)(2005-12#4)(2005-2#1)(2005-3#4)(2005-6#1)(2005-7#8)(2005-8#4)(2006-1#2)(2006-10#26)(2006-11#3)(2006-12#7)(2006-2#8)(2006-3#1)(2006-5#4)(2006-6#5)(2006-7#4)(2006-8#7)(2006-9#3)(2007-1#4)(2007-10#18)(2007-11#34)(2007-12#11)(2007-2#11)(2007-3#3)(2007-4#4)(2007-5#2)(2007-6#2)(2007-7#12)(2007-8#18)(2007-9#5)(2008-1#20)(2008-10#15)(2008-11#11)(2008-12#4)(2008-2#5)(2008-3#17)(2008-4#8)(2008-5#16)(2008-6#1)(2008-7#27)(2008-8#6)(2008-9#2)(2009-10#6)(2009-2#1)(2009-3#4)(2009-4#15)(2009-5#5)(2009-6#1)(2009-7#4)(2009-8#3)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#13)(2010-2#1)(2010-4#6)(2010-5#2)(2010-6#3)(2010-7#4)(2010-8#3)(2010-9#6)(2011-1#10)(2011-12#7)(2011-2#25)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#18)(2012-2#13)(2012-3#6)(2013-1#10)(2013-7#3)(2013-8#5)
prevention or cure##2##3##(1993-11#1)(2009-6#1)
prevention or treatment of##5##4##(2006-10#1)(2007-11#1)(2007-5#1)(2008-7#1)(2010-2#1)
prevention or treatment##7##3##(1990-9#1)(2006-10#1)(2007-11#1)(2007-5#1)(2008-7#1)(2010-2#1)(2013-8#1)
prevention or##17##2##(1990-9#1)(1991-2#1)(1991-9#1)(1993-11#1)(1997-1#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-11#1)(2007-5#2)(2008-7#1)(2009-6#1)(2010-12#1)(2010-2#1)(2013-8#1)
prevention policy##4##2##(1995-3#1)(2008-11#1)(2012-1#2)
prevention practices##2##2##(2007-9#1)(2010-7#1)
prevention program among##2##3##(2006-7#1)(2008-8#1)
prevention program for##4##3##(1995-3#1)(2008-1#1)(2008-12#1)(2012-3#1)
prevention program in##2##3##(2005-11#2)
prevention program on##3##3##(1990-3#1)(2010-7#2)
prevention program that##2##3##(1990-3#1)(2006-7#1)
prevention program##30##2##(1990-12#1)(1990-3#2)(1991-1#2)(1992-2#1)(1993-2#1)(1994-2#1)(1995-3#2)(2005-11#2)(2006-7#5)(2007-1#1)(2007-10#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-8#2)(2009-5#1)(2010-7#2)(2012-3#3)
prevention programme in##2##3##(2008-7#1)(2013-8#1)
prevention programme##8##2##(1991-6#2)(2006-2#1)(2008-1#1)(2008-7#1)(2012-3#2)(2013-8#1)
prevention programmes##8##2##(2006-2#2)(2007-7#1)(2007-8#1)(2008-10#1)(2009-7#1)(2010-12#1)(2012-12#1)
prevention programs and##3##3##(1993-3#1)(2009-9#1)(2012-3#1)
prevention programs are##2##3##(1997-2#1)(2013-1#1)
prevention programs for##5##3##(1995-12#1)(1996-6#1)(2005-10#1)(2008-11#1)(2013-1#1)
prevention programs may##2##3##(2008-12#1)(2012-12#1)
prevention programs that##4##3##(1997-1#1)(2009-6#1)(2009-7#1)(2012-3#1)
prevention programs to##4##3##(2007-11#1)(2007-12#1)(2013-1#2)
prevention programs##56##2##(1991-10#1)(1993-3#1)(1995-1#1)(1995-12#1)(1995-3#4)(1996-10#1)(1996-3#1)(1996-5#1)(1996-6#2)(1997-1#1)(1997-2#2)(1997-3#2)(2005-10#1)(2006-10#1)(2006-7#5)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-11#2)(2008-12#1)(2008-2#3)(2008-8#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#5)
prevention project##4##2##(1995-3#3)(2012-3#1)
prevention rather than##2##3##(2008-10#1)(2012-3#1)
prevention recommendations##2##2##(2008-11#1)(2010-4#1)
prevention remains##3##2##(2007-7#1)(2012-2#1)(2013-7#1)
prevention requires##3##2##(1992-12#1)(2008-3#1)(2008-4#1)
prevention services for##2##3##(2007-5#1)(2012-3#1)
prevention services to##2##3##(2008-6#1)(2012-3#1)
prevention services##11##2##(2007-5#3)(2008-6#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-3#4)
prevention should be based##2##4##(1990-1#1)(2007-9#1)
prevention should be##5##3##(1990-1#1)(1993-6#1)(1997-8#1)(2006-8#1)(2007-9#1)
prevention should##6##2##(1990-1#1)(1993-6#1)(1997-8#1)(2006-8#1)(2007-9#1)(2010-10#1)
prevention still##2##2##(2006-8#1)(2008-4#1)
prevention strategies and##3##3##(1991-6#1)(2005-8#1)(2009-5#1)
prevention strategies for the##2##4##(2008-3#1)(2012-1#1)
prevention strategies for##5##3##(2008-10#1)(2008-3#1)(2009-5#1)(2009-8#1)(2012-1#1)
prevention strategies in##2##3##(2008-12#1)(2012-1#1)
prevention strategies that##4##3##(2005-7#1)(2008-8#1)(2009-5#1)(2012-11#1)
prevention strategies##35##2##(1991-6#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#3)(2009-8#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)
prevention strategy##12##2##(1995-10#1)(1995-12#1)(1996-6#1)(2008-2#3)(2008-3#1)(2008-8#1)(2009-6#1)(2011-1#2)(2012-1#1)
prevention studies##2##2##(2010-4#1)(2012-3#1)
prevention study##5##2##(1997-3#1)(2007-9#2)(2008-4#2)
prevention that##3##2##(2007-11#1)(2007-12#1)(2011-2#1)
prevention through##3##2##(1995-12#1)(2008-3#1)(2013-1#1)
prevention to##7##2##(1993-12#1)(1997-4#1)(2006-10#1)(2007-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
prevention trial##4##2##(1993-2#1)(1997-8#1)(2008-8#1)(2009-7#1)
prevention trials as##3##3##(1993-2#1)(2013-1#2)
prevention trials of##2##3##(1994-9#1)(2013-8#1)
prevention trials##10##2##(1993-2#2)(1994-9#2)(2008-8#1)(2010-4#1)(2013-1#2)(2013-8#2)
prevention using##2##2##(2006-11#1)(2008-3#1)
prevention were##3##2##(2005-10#1)(2007-8#1)(2010-1#1)
prevention will##2##2##(2004-10#1)(2007-7#1)
prevention with##10##2##(1991-9#1)(1993-10#1)(1993-2#1)(1995-12#1)(2007-10#1)(2008-8#1)(2009-5#1)(2012-12#2)(2012-2#1)
prevention##1946##1##(1990-1#1)(1990-10#4)(1990-11#2)(1990-12#9)(1990-2#4)(1990-3#6)(1990-4#1)(1990-5#6)(1990-6#6)(1990-7#2)(1990-8#3)(1990-9#4)(1991-1#5)(1991-10#1)(1991-11#5)(1991-12#5)(1991-2#8)(1991-3#5)(1991-4#1)(1991-5#4)(1991-6#7)(1991-8#3)(1991-9#5)(1992-1#1)(1992-10#3)(1992-11#1)(1992-12#7)(1992-2#4)(1992-5#4)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-10#4)(1993-11#21)(1993-12#8)(1993-2#10)(1993-3#4)(1993-4#1)(1993-5#5)(1993-6#6)(1993-7#5)(1993-9#11)(1994-1#3)(1994-10#1)(1994-11#1)(1994-12#7)(1994-2#4)(1994-3#4)(1994-4#4)(1994-5#2)(1994-6#5)(1994-7#1)(1994-8#7)(1994-9#6)(1995-1#5)(1995-10#2)(1995-11#3)(1995-12#13)(1995-2#3)(1995-3#18)(1995-4#2)(1995-5#6)(1995-6#3)(1995-8#2)(1995-9#6)(1996-1#5)(1996-10#6)(1996-11#7)(1996-12#13)(1996-2#5)(1996-3#11)(1996-4#5)(1996-5#2)(1996-6#9)(1996-7#1)(1996-8#4)(1996-9#3)(1997-1#10)(1997-2#13)(1997-3#7)(1997-4#5)(1997-5#4)(1997-6#3)(1997-8#9)(2004-10#6)(2004-12#4)(2004-2#1)(2004-9#2)(2005-1#1)(2005-10#18)(2005-11#4)(2005-12#4)(2005-2#1)(2005-3#6)(2005-6#3)(2005-7#14)(2005-8#11)(2005-9#1)(2006-1#5)(2006-10#55)(2006-11#11)(2006-12#8)(2006-2#26)(2006-3#2)(2006-4#5)(2006-5#10)(2006-6#10)(2006-7#28)(2006-8#14)(2006-9#9)(2007-1#11)(2007-10#36)(2007-11#60)(2007-12#36)(2007-2#18)(2007-3#4)(2007-4#5)(2007-5#8)(2007-6#5)(2007-7#40)(2007-8#30)(2007-9#21)(2008-1#41)(2008-10#33)(2008-11#31)(2008-12#22)(2008-2#18)(2008-3#48)(2008-4#19)(2008-5#29)(2008-6#9)(2008-7#57)(2008-8#28)(2008-9#11)(2009-10#8)(2009-11#6)(2009-12#4)(2009-2#1)(2009-3#12)(2009-4#29)(2009-5#25)(2009-6#8)(2009-7#12)(2009-8#8)(2009-9#5)(2010-1#9)(2010-10#6)(2010-11#10)(2010-12#34)(2010-2#12)(2010-3#2)(2010-4#17)(2010-5#7)(2010-6#7)(2010-7#9)(2010-8#9)(2010-9#10)(2011-1#40)(2011-11#1)(2011-12#9)(2011-2#90)(2011-3#4)(2012-1#19)(2012-11#7)(2012-12#51)(2012-2#47)(2012-3#43)(2013-1#46)(2013-7#10)(2013-8#21)
prevention)##4##1##(1990-2#1)(2008-7#1)(2010-6#1)(2010-9#1)
prevention-related events##3##2##(2007-7#3)
prevention?##2##1##(2009-4#1)(2012-2#1)
prevention?]##3##1##(1990-6#1)(1993-5#1)(2011-2#1)
prevention]##15##1##(1992-11#1)(1992-12#1)(1992-2#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-6#1)(1996-6#1)(1997-8#1)(2006-2#1)(2008-11#1)(2008-2#1)(2009-5#1)(2010-2#1)(2010-4#1)
preventive action of##3##3##(1993-7#1)(1995-12#1)(2010-12#1)
preventive action##7##2##(1993-7#1)(1994-6#2)(1995-12#1)(2010-12#2)(2010-9#1)
preventive actions##2##2##(2008-1#1)(2010-9#1)
preventive activities##5##2##(1993-11#1)(1993-3#1)(1995-10#1)(1997-3#1)(2006-7#1)
preventive and control measures##3##4##(2011-2#1)(2012-12#1)(2013-1#1)
preventive and educational interventions##3##4##(2012-2#3)
preventive and primary care for children with chronic##2##8##(1997-2#2)
preventive and therapeutic effects of##2##5##(2008-4#2)
preventive and therapeutic effects##3##4##(2008-11#1)(2008-4#2)
preventive and therapeutic interventions##2##4##(2007-6#1)(2010-9#1)
preventive and therapeutic##13##3##(1990-6#1)(1996-9#1)(2005-1#1)(2006-8#1)(2007-6#1)(2008-11#3)(2008-4#2)(2009-3#1)(2010-9#1)(2011-2#1)
preventive and##30##2##(1990-6#1)(1990-9#1)(1994-11#1)(1996-2#1)(1996-9#1)(1997-2#2)(2005-1#1)(2006-8#1)(2007-12#2)(2007-6#2)(2007-7#1)(2008-11#3)(2008-4#2)(2009-3#1)(2009-9#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#1)
preventive antituberculous chemotherapy##2##3##(1994-4#2)
preventive applications##2##2##(2008-10#1)(2008-5#1)
preventive approach##2##2##(2007-11#1)(2008-7#1)
preventive attitudes (aOR =##3##4##(1992-4#3)
preventive attitudes##4##2##(1992-4#4)
preventive behaviour##2##2##(2007-7#2)
preventive care and##3##3##(1994-2#1)(1996-1#1)(2006-2#1)
preventive care as##3##3##(1996-3#1)(2013-1#2)
preventive care for##2##3##(2010-9#1)(2011-2#1)
preventive care##30##2##(1990-12#1)(1994-12#1)(1994-2#5)(1994-3#1)(1994-8#1)(1996-1#2)(1996-12#1)(1996-3#1)(2006-2#4)(2007-2#1)(2007-7#1)(2008-11#2)(2009-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2013-1#2)
preventive commitment as##2##3##(2006-5#2)
preventive commitment##5##2##(2006-5#5)
preventive dental##3##2##(1995-12#1)(2006-2#1)(2012-2#1)
preventive effect in##2##3##(2009-3#1)(2012-1#1)
preventive effect of black tea##2##5##(2009-8#2)
preventive effect of##12##3##(1992-10#1)(1996-11#1)(2008-5#2)(2008-7#1)(2009-6#1)(2009-8#2)(2010-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
preventive effect##21##2##(1992-10#1)(1993-3#1)(1996-11#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-6#1)(2009-8#3)(2010-1#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
preventive effects##3##2##(2008-6#1)(2009-3#1)(2011-2#1)
preventive efforts##4##2##(1990-10#1)(1996-6#1)(2011-1#1)(2012-2#1)
preventive health care##11##3##(1995-2#1)(2008-11#2)(2008-4#2)(2009-5#1)(2010-8#5)
preventive health services##2##3##(1993-12#1)(1995-12#1)
preventive health##20##2##(1991-4#1)(1993-1#1)(1993-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1997-1#1)(2008-11#2)(2008-4#3)(2009-5#2)(2010-8#5)(2011-1#1)
preventive in##2##2##(1992-5#1)(2008-11#1)
preventive ingredients##2##2##(2008-5#2)
preventive intervention and##2##3##(2012-2#1)(2012-3#1)
preventive intervention##8##2##(2006-3#1)(2008-1#1)(2008-12#2)(2010-2#1)(2012-2#1)(2012-3#2)
preventive interventions in##2##3##(2007-7#1)(2012-2#1)
preventive interventions##9##2##(1992-3#1)(2006-7#1)(2007-7#2)(2007-9#1)(2008-5#1)(2011-1#1)(2012-2#1)(2012-3#1)
preventive management##2##2##(2008-10#1)(2008-9#1)
preventive measure##6##2##(1994-9#1)(1996-4#1)(2006-12#1)(2007-12#1)(2008-4#1)(2008-7#1)
preventive measures against##7##3##(1992-3#1)(2007-1#1)(2007-11#1)(2007-4#1)(2008-1#1)(2009-10#1)(2009-3#1)
preventive measures aimed##2##3##(2008-10#1)(2013-8#1)
preventive measures and##6##3##(1993-9#1)(1994-4#1)(1995-9#1)(2006-2#1)(2007-8#1)(2010-1#1)
preventive measures are##5##3##(1990-8#1)(1992-2#1)(1994-4#1)(1994-5#1)(2013-1#1)
preventive measures as##5##3##(1990-10#1)(1994-7#1)(2007-2#1)(2012-12#1)(2012-2#1)
preventive measures in patients##2##4##(2006-10#1)(2007-10#1)
preventive measures in##5##3##(1992-9#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-8#1)
preventive measures of##3##3##(2007-2#1)(2013-1#1)(2013-8#1)
preventive measures to be##2##4##(1995-3#1)(2011-1#1)
preventive measures to##5##3##(1995-3#1)(2010-5#1)(2011-1#2)(2013-8#1)
preventive measures##77##2##(1990-10#1)(1990-12#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-4#2)(1994-5#1)(1994-7#2)(1995-3#1)(1995-9#1)(1996-3#1)(1997-6#1)(2006-10#2)(2006-11#1)(2006-2#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#5)(2007-4#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-1#1)(2009-10#2)(2009-3#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#4)
preventive medical##3##2##(2007-10#1)(2007-5#1)(2012-2#1)
preventive medication was##2##3##(2008-11#2)
preventive medication##3##2##(2008-11#3)
preventive medications##4##2##(2008-10#1)(2008-11#2)(2010-9#1)
preventive medicine##3##2##(1995-6#1)(2006-8#1)(2008-3#1)
preventive medicine]##2##2##(1991-11#1)(2007-1#1)
preventive methods##2##2##(2006-2#1)(2007-5#1)
preventive or therapeutic measures##2##4##(2006-10#1)(2009-10#1)
preventive or therapeutic##3##3##(2006-10#1)(2008-8#1)(2009-10#1)
preventive or##5##2##(2006-10#1)(2007-12#1)(2008-8#1)(2009-10#1)(2011-2#1)
preventive oral##3##2##(1991-6#1)(2005-11#1)(2006-2#1)
preventive outpatient commitment##6##3##(2006-5#6)
preventive outpatient##7##2##(2006-5#7)
preventive programmes##2##2##(2005-11#1)(2010-9#1)
preventive programs##3##2##(2006-10#1)(2006-2#1)(2011-2#1)
preventive role##2##2##(2006-7#1)(2013-1#1)
preventive schistosomiasis interventions##2##3##(2007-7#2)
preventive screening##2##2##(1993-3#1)(1993-5#1)
preventive services for##3##3##(1995-2#1)(2007-5#1)(2008-1#1)
preventive services to##2##3##(1995-12#2)
preventive services##26##2##(1994-2#8)(1995-12#4)(1995-2#2)(1996-12#1)(1996-2#1)(2005-10#1)(2005-9#1)(2006-2#1)(2007-5#2)(2008-1#3)(2009-5#1)(2010-8#1)
preventive strategies against##2##3##(2007-12#1)(2010-9#1)
preventive strategies and##2##3##(2007-6#1)(2012-3#1)
preventive strategies for##2##3##(2012-11#1)(2012-2#1)
preventive strategies have##2##3##(1993-11#1)(2006-7#1)
preventive strategies in##4##3##(2004-12#1)(2006-10#2)(2008-10#1)
preventive strategies to##2##3##(1996-12#1)(2006-10#1)
preventive strategies##28##2##(1993-11#2)(1996-12#1)(1997-3#1)(2004-12#1)(2005-8#1)(2006-10#5)(2006-7#1)(2006-8#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-7#2)(2010-9#1)(2011-2#3)(2012-11#1)(2012-2#2)(2012-3#1)
preventive strategy##3##2##(2007-7#1)(2008-1#1)(2012-3#1)
preventive therapies##3##2##(2006-10#1)(2009-10#1)(2009-6#1)
preventive therapy of##2##3##(1990-3#1)(1995-11#1)
preventive therapy##13##2##(1990-12#1)(1990-3#1)(1995-11#1)(1996-3#1)(1997-2#4)(2007-10#1)(2007-2#2)(2011-1#1)(2011-2#1)
preventive tool##2##2##(1991-5#1)(1996-12#1)
preventive tools##2##2##(1996-12#1)(2006-10#1)
preventive treatment for##2##3##(2005-10#1)(2007-7#1)
preventive treatment is##2##3##(2007-10#1)(2008-8#1)
preventive treatment##11##2##(1990-6#1)(1994-5#1)(1997-2#1)(2005-10#1)(2007-10#1)(2007-7#1)(2008-8#1)(2011-2#2)(2012-3#1)(2013-8#1)
preventive treatments##2##2##(2006-10#1)(2013-1#1)
preventive vaccines##3##2##(1996-12#1)(2007-11#1)(2012-12#1)
preventive##463##1##(1990-10#2)(1990-12#3)(1990-3#1)(1990-6#5)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#2)(1992-4#4)(1992-5#3)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#3)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#15)(1994-3#2)(1994-4#4)(1994-5#3)(1994-6#2)(1994-7#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#8)(1995-2#5)(1995-3#1)(1995-6#1)(1995-9#2)(1996-1#2)(1996-11#1)(1996-12#6)(1996-2#3)(1996-3#3)(1996-4#2)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#8)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-12#1)(2005-1#1)(2005-10#2)(2005-11#3)(2005-8#1)(2005-9#1)(2006-10#12)(2006-11#1)(2006-12#1)(2006-2#11)(2006-3#2)(2006-5#12)(2006-7#4)(2006-8#6)(2007-1#2)(2007-10#4)(2007-11#7)(2007-12#8)(2007-2#8)(2007-4#1)(2007-5#4)(2007-6#3)(2007-7#13)(2007-8#3)(2007-9#1)(2008-1#8)(2008-10#11)(2008-11#16)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#6)(2008-5#7)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#4)(2009-2#2)(2009-3#4)(2009-4#1)(2009-5#6)(2009-6#2)(2009-8#3)(2009-9#2)(2010-1#3)(2010-12#4)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#7)(2010-9#7)(2011-1#7)(2011-12#1)(2011-2#25)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#8)(2012-2#11)(2012-3#8)(2013-1#16)(2013-7#2)(2013-8#8)
prevents accurate##2##2##(2008-10#1)(2008-2#1)
prevents activation of##3##3##(1994-5#1)(1997-4#1)(2008-1#1)
prevents adequate##2##2##(1992-7#1)(2005-9#1)
prevents an##5##2##(1994-8#1)(1997-5#1)(2007-8#1)(2008-10#1)(2010-10#1)
prevents binding##2##2##(1995-8#1)(2009-8#1)
prevents both##2##2##(1991-5#1)(1994-3#1)
prevents cancer##2##2##(2008-1#1)(2010-12#1)
prevents catheter-related bacterial invasion##2##4##(2007-8#2)
prevents development of##5##3##(1993-12#1)(2007-11#1)(2008-12#1)(2008-7#1)(2009-8#1)
prevents exaggerated##2##2##(2008-11#1)(2009-8#1)
prevents it from##3##3##(1990-4#1)(1997-5#1)(2008-8#1)
prevents memory dysfunctions##2##3##(1993-3#2)
prevents neither##2##2##(1994-6#1)(1995-6#1)
prevents oxidation of##2##3##(1991-5#1)(1991-9#1)
prevents pregnancy##3##2##(1994-8#1)(1996-9#2)
prevents progression of##2##3##(2006-6#1)(2010-7#1)
prevents relapse##2##2##(2006-10#1)(2007-7#1)
prevents the application of##2##4##(2007-7#1)(2009-12#1)
prevents the binding of##2##4##(1990-5#1)(1995-1#1)
prevents the degeneration of##2##4##(1990-5#2)
prevents the development of##3##4##(1992-9#1)(1995-3#1)(2009-2#1)
prevents the establishment of##2##4##(2011-10#1)(2012-2#1)
prevents the expression of airway hyperresponsiveness##2##6##(1996-12#2)
prevents the formation of the##2##5##(1991-6#1)(1997-7#1)
prevents the formation of##5##4##(1990-5#1)(1991-6#1)(1994-8#1)(1995-5#1)(1997-7#1)
prevents the normal##3##3##(1997-2#1)(2007-1#1)(2010-2#1)
prevents the occurrence of##2##4##(2006-10#1)(2010-7#1)
prevents the use of##3##4##(1994-5#1)(2007-5#1)(2008-7#1)
prevents the##84##2##(1990-11#1)(1990-3#1)(1990-5#4)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-3#2)(1992-8#3)(1992-9#1)(1993-6#3)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#2)(1996-12#2)(1996-8#1)(1997-2#1)(1997-7#2)(2005-10#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-1#1)(2007-11#5)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#2)(2009-2#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-10#1)(2012-1#1)(2012-2#3)(2013-1#2)
prevents their##3##2##(1990-6#2)(2008-4#1)
prevents them from##3##3##(1996-2#1)(1997-7#1)(2013-1#1)
prevents this##7##2##(1991-9#1)(1995-5#1)(1995-6#1)(1996-5#1)(2005-9#1)(2006-8#1)(2007-7#1)
prevents transformation##2##2##(2008-10#1)(2008-11#1)
prevents tumor##2##2##(2013-1#2)
prevents unnecessary##2##2##(2008-11#1)(2010-11#1)
prevents water##2##2##(1996-11#1)(2008-5#1)
prevents##289##1##(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-5#3)(1991-6#1)(1991-9#3)(1992-3#6)(1992-5#1)(1992-7#2)(1992-8#3)(1992-9#2)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#5)(1993-7#1)(1994-11#1)(1994-12#2)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#6)(1994-9#3)(1995-1#1)(1995-10#3)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#5)(1995-7#2)(1995-8#4)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-5#1)(1996-6#3)(1996-8#1)(1996-9#2)(1997-2#3)(1997-4#3)(1997-5#3)(1997-6#2)(1997-7#5)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-8#1)(2005-9#2)(2006-10#4)(2006-11#1)(2006-5#1)(2006-6#3)(2006-8#1)(2006-9#3)(2007-1#3)(2007-11#8)(2007-12#2)(2007-5#2)(2007-7#3)(2007-8#8)(2008-1#6)(2008-10#15)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#5)(2008-7#6)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#2)(2009-8#5)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-10#1)(2011-12#1)(2011-2#8)(2012-1#3)(2012-12#4)(2012-2#5)(2013-1#8)(2013-7#2)(2013-8#3)
preverbal child##2##2##(2008-9#2)
preverbal children##3##2##(2008-9#3)
preverbal##5##1##(2008-9#5)
prevertebral##2##1##(1995-12#1)(2012-12#1)
preview##11##1##(1992-2#1)(2008-1#5)(2009-5#3)(2011-1#2)
previews##3##1##(2009-5#2)(2011-12#1)
previous &quot##3##2##(2007-5#1)(2008-6#1)(2008-8#1)
previous BCG##2##2##(2008-10#1)(2010-12#1)
previous Caesarean##2##2##(1991-9#1)(2011-1#1)
previous HIV##2##2##(2006-8#1)(2007-12#1)
previous Italian##2##2##(2010-9#2)
previous MAP##3##2##(1996-10#2)(1996-7#1)
previous accounts##2##2##(2007-12#1)(2008-6#1)
previous activities##2##2##(2006-10#1)(2008-4#1)
previous adenovirus (pre-Ad)##2##3##(2008-9#2)
previous aggressive##2##2##(1992-10#1)(2008-8#1)
previous analyses of##3##3##(2004-10#1)(2008-9#1)(2010-3#1)
previous analyses##7##2##(1995-2#1)(2004-10#1)(2008-7#1)(2008-9#2)(2009-7#1)(2010-3#1)
previous analysis of##2##3##(2006-11#1)(2009-7#1)
previous analysis##8##2##(1991-1#1)(2006-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2011-2#1)
previous and ongoing##2##3##(2005-9#1)(2008-10#1)
previous and##8##2##(1994-6#1)(2004-4#1)(2005-9#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-6#1)(2010-7#1)
previous antibiotic therapy##2##3##(1993-5#1)(2011-2#1)
previous aortic valve##2##3##(2007-8#2)
previous application of##2##3##(1990-8#1)(1992-8#1)
previous approach##3##2##(2006-10#1)(2008-2#2)
previous approaches to##4##3##(2008-2#2)(2008-6#1)(2013-1#1)
previous approaches##11##2##(2008-2#3)(2008-6#1)(2008-8#1)(2009-7#1)(2010-12#1)(2011-3#1)(2013-1#3)
previous article in this##2##4##(2007-10#1)(2007-4#1)
previous article##8##2##(1992-3#1)(1996-12#1)(2005-8#1)(2007-10#1)(2007-4#2)(2008-11#1)(2012-12#1)
previous assignment##2##2##(2007-1#1)(2008-5#1)
previous assumptions##2##2##(1993-5#1)(2010-8#1)
previous attempts##3##2##(2007-12#1)(2009-6#1)(2010-6#1)
previous autoradiographic##2##2##(1994-10#2)
previous bad##2##2##(2007-7#1)(2009-6#1)
previous bilateral##2##2##(2006-2#1)(2008-10#1)
previous blood##3##2##(1991-3#1)(2008-1#1)(2011-12#1)
previous breast cancer##2##3##(2008-4#2)
previous caesarean section##3##3##(1992-8#1)(2004-10#1)(2009-1#1)
previous calculations##2##2##(1996-4#1)(2008-2#1)
previous cardiac surgery##3##3##(2007-10#2)(2007-8#1)
previous cardiac##5##2##(2007-10#3)(2007-8#1)(2013-8#1)
previous case##5##2##(2008-6#2)(2009-1#1)(2012-2#1)(2013-8#1)
previous cases of##3##3##(1996-12#1)(2008-10#1)(2010-2#1)
previous cases##8##2##(1996-12#2)(2008-10#1)(2010-2#1)(2011-2#3)(2012-2#1)
previous cellular##2##2##(1990-9#1)(2008-10#1)
previous cesarean##3##2##(1995-12#1)(2010-9#1)(2011-1#1)
previous characterization##2##2##(1993-7#1)(2007-1#1)
previous chemotherapy##5##2##(1991-2#1)(1992-10#1)(2007-10#1)(2008-1#1)(2008-6#1)
previous children##2##2##(2006-4#1)(2013-1#1)
previous claims##2##2##(1991-2#1)(2012-1#1)
previous clinical##4##2##(1993-11#1)(2007-11#1)(2008-6#1)(2009-10#1)
previous comparisons##2##2##(1994-9#1)(2011-2#1)
previous conclusions##3##2##(1993-2#1)(2006-10#1)(2008-8#1)
previous conditioning##2##2##(2013-8#2)
previous contact with##3##3##(1996-9#2)(2005-8#1)
previous coronary##2##2##(2006-8#1)(2008-3#1)
previous data on##3##3##(2005-8#1)(2008-10#1)(2009-8#1)
previous data##14##2##(1990-2#1)(1990-8#1)(1992-10#1)(2005-8#1)(2008-10#3)(2008-2#2)(2008-5#2)(2009-8#1)(2010-11#1)(2011-1#1)
previous decade##5##2##(2008-11#1)(2008-5#1)(2013-1#3)
previous derivatization##3##2##(2008-10#3)
previous descriptions of the##2##4##(1991-11#1)(2007-12#1)
previous descriptions of##3##3##(1991-11#1)(2007-12#1)(2008-10#1)
previous designs##4##2##(2007-4#1)(2008-2#2)(2008-3#1)
previous devices##2##2##(2007-12#2)
previous diabetes##2##2##(2011-2#1)(2012-3#1)
previous diagnosis of##5##3##(2007-3#1)(2007-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
previous educational and##2##3##(2008-11#1)(2011-2#1)
previous educational##3##2##(2008-11#2)(2011-2#1)
previous electrophysiological##2##2##(1993-12#1)(1997-7#1)
previous established##2##2##(2011-2#1)(2013-7#1)
previous estimates##7##2##(1993-3#1)(1996-12#1)(2008-10#3)(2008-2#1)(2008-9#1)
previous evaluation##2##2##(1995-1#2)
previous evidence that##2##3##(2008-3#1)(2011-1#1)
previous evidence##5##2##(1991-1#1)(1995-11#1)(2008-3#1)(2009-4#1)(2011-1#1)
previous experience with the##2##4##(2008-11#1)(2008-12#1)
previous experience with##5##3##(2005-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)
previous experience##10##2##(1996-2#1)(2005-8#1)(2006-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-1#1)
previous experimental and##2##3##(2006-10#1)(2013-1#1)
previous experimental observations of##2##4##(2008-3#2)
previous experimental observations##3##3##(2008-3#2)(2009-9#1)
previous experimental studies##2##3##(2006-11#1)(2008-7#1)
previous experimental##11##2##(2005-11#1)(2006-10#1)(2006-11#1)(2007-4#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-9#1)(2011-2#1)(2013-1#1)
previous experiments it was##2##4##(1992-3#1)(1995-12#1)
previous experiments##8##2##(1991-1#1)(1992-3#1)(1994-5#1)(1995-12#1)(2008-10#2)(2008-7#1)(2011-1#1)
previous exposure to##9##3##(1992-10#1)(1992-7#1)(1995-2#1)(1997-3#1)(2005-8#1)(2007-12#1)(2009-8#1)(2010-9#1)(2013-1#1)
previous exposure##10##2##(1992-10#1)(1992-7#1)(1995-2#1)(1996-12#1)(1997-3#1)(2005-8#1)(2007-12#1)(2009-8#1)(2010-9#1)(2013-1#1)
previous expressions##2##2##(2006-8#1)(2008-2#1)
previous extraction##5##2##(1990-12#1)(2007-12#1)(2008-10#3)
previous fMRI##2##2##(2011-1#1)(2012-1#1)
previous field##4##2##(2004-4#1)(2008-10#1)(2008-9#1)(2011-10#1)
previous finding in##2##3##(1992-10#1)(1995-7#1)
previous finding that the##2##4##(1996-6#1)(1997-5#1)
previous finding that##5##3##(1990-8#1)(1993-7#1)(1996-12#1)(1996-6#1)(1997-5#1)
previous finding##10##2##(1990-8#1)(1992-10#1)(1993-7#1)(1993-8#1)(1995-7#1)(1996-12#1)(1996-6#1)(1997-5#1)(2006-3#1)(2008-9#1)
previous findings for##2##3##(1994-8#1)(1996-5#1)
previous findings from##2##3##(1991-11#1)(2009-7#1)
previous findings in chick##2##4##(1992-5#1)(1995-12#1)
previous findings in##5##3##(1992-5#1)(1993-5#1)(1995-12#1)(2008-7#1)(2013-8#1)
previous findings of##8##3##(1992-9#1)(1993-7#1)(2006-7#1)(2008-10#2)(2008-6#1)(2009-3#1)(2009-5#1)
previous findings on the##3##4##(1993-9#1)(1994-8#1)(2009-10#1)
previous findings on##4##3##(1991-11#1)(1993-9#1)(1994-8#1)(2009-10#1)
previous findings that the##2##4##(1997-5#1)(2008-8#1)
previous findings that##11##3##(1990-6#1)(1991-10#1)(1994-2#1)(1994-5#1)(1996-12#1)(1996-5#1)(1997-5#1)(2006-7#1)(2007-4#1)(2008-7#1)(2008-8#1)
previous findings with##2##3##(1997-1#1)(1997-6#1)
previous findings##64##2##(1990-6#1)(1991-10#1)(1991-11#2)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#4)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-5#4)(1997-1#1)(1997-5#1)(1997-6#2)(2006-6#1)(2006-7#2)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-6#2)(2008-7#3)(2008-8#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
previous generation##2##2##(2010-6#1)(2011-2#1)
previous generations##3##2##(2007-4#1)(2008-9#1)(2013-8#1)
previous history of##29##3##(1993-3#1)(1995-9#1)(2006-10#3)(2006-7#1)(2007-10#2)(2007-11#2)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#3)(2010-12#2)(2010-2#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#2)
previous history or##2##3##(2007-12#1)(2013-1#1)
previous history##33##2##(1992-11#1)(1993-3#1)(1995-9#1)(2006-10#4)(2006-7#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#3)(2010-12#2)(2010-2#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#2)
previous hospitalization##4##2##(1992-2#1)(1995-1#1)(2010-10#1)(2013-8#1)
previous hospitalizations##3##2##(1991-2#2)(1992-2#1)
previous hysterectomy##2##2##(1997-7#1)(2012-3#1)
previous imaging##2##2##(2006-11#1)(2008-1#1)
previous implementations##3##2##(2005-11#1)(2008-2#1)(2009-10#1)
previous in vitro##4##3##(1993-4#1)(1996-11#1)(2012-2#2)
previous in##6##2##(1990-7#1)(1993-4#1)(1995-8#1)(1996-11#1)(2012-2#2)
previous indications##2##2##(1990-1#1)(1990-12#1)
previous infection##4##2##(2005-12#1)(2005-8#1)(2011-1#1)(2013-1#1)
previous invasive##2##2##(2006-10#1)(2010-11#1)
previous investigation##6##2##(1991-4#1)(1997-5#1)(2007-12#1)(2007-7#1)(2009-5#1)(2012-2#1)
previous investigations of##3##3##(1994-3#1)(2007-6#1)(2008-7#1)
previous investigations##14##2##(1990-8#1)(1993-11#1)(1994-3#1)(1995-1#1)(1997-1#1)(1997-8#1)(2005-7#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-3#2)(2008-7#1)(2011-1#1)
previous irradiation##2##2##(1992-10#1)(2006-12#1)
previous isolation##2##2##(1992-7#1)(2007-11#1)
previous issue of##2##3##(2005-7#1)(2008-9#1)
previous knowledge##3##2##(2008-11#1)(2009-1#1)(2012-12#1)
previous laparotomy##2##2##(1992-8#1)(1996-3#1)
previous learning##2##2##(2008-11#1)(2008-5#1)
previous level##4##2##(1990-2#1)(1992-2#1)(2008-5#1)(2013-1#1)
previous limitations##2##2##(1996-12#1)(2011-12#1)
previous literature##5##2##(2007-11#1)(2008-11#1)(2008-6#1)(2011-2#1)(2013-2#1)
previous lower##2##2##(2011-1#1)(2013-1#1)
previous management##2##2##(2007-12#1)(2008-10#1)
previous measurements of##4##3##(2007-12#2)(2008-2#1)(2008-8#1)
previous measurements##8##2##(1993-11#1)(1995-1#1)(2007-12#2)(2008-11#1)(2008-2#2)(2008-8#1)
previous medication##3##2##(1993-2#1)(2008-3#1)(2011-2#1)
previous medications##2##2##(2007-2#1)(2007-7#1)
previous method of##2##3##(1995-2#1)(2008-3#1)
previous method##10##2##(1990-9#1)(1995-2#1)(1996-5#1)(2007-12#1)(2007-8#2)(2008-11#1)(2008-2#2)(2008-3#1)
previous methodology##3##2##(2006-9#1)(2007-8#2)
previous methods of##2##3##(2008-2#1)(2010-12#1)
previous methods##7##2##(1990-8#1)(2007-12#1)(2008-10#2)(2008-2#1)(2010-12#2)
previous model##5##2##(1991-2#1)(1992-3#1)(2007-4#1)(2008-10#1)(2008-5#1)
previous models of##2##3##(2008-8#1)(2008-9#1)
previous models##8##2##(1997-7#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2013-1#2)
previous myocardial infarction##10##3##(1990-11#1)(2005-1#1)(2005-10#1)(2005-8#2)(2007-10#1)(2007-8#1)(2008-11#1)(2008-4#1)(2010-11#1)
previous myocardial##11##2##(1990-11#1)(1997-6#1)(2005-1#1)(2005-10#1)(2005-8#2)(2007-10#1)(2007-8#1)(2008-11#1)(2008-4#1)(2010-11#1)
previous national##2##2##(2012-1#1)(2013-1#1)
previous neuroanatomical##2##2##(1995-11#1)(2007-12#1)
previous normal##2##2##(2008-3#1)(2008-9#1)
previous observation that##4##3##(1991-9#1)(1993-11#1)(1994-9#1)(2008-5#1)
previous observation##6##2##(1991-9#1)(1993-11#1)(1994-9#1)(2008-10#1)(2008-5#1)(2010-8#1)
previous observations and##2##3##(1995-12#1)(2008-5#1)
previous observations of##4##3##(1990-7#1)(1996-11#1)(2008-6#1)(2008-7#1)
previous observations on##2##3##(1997-5#1)(2008-11#1)
previous observations that the##2##4##(1990-2#1)(1993-12#1)
previous observations that##7##3##(1990-2#1)(1991-12#1)(1991-6#1)(1993-12#1)(1995-2#1)(2008-10#1)(2010-8#1)
previous observations with##2##3##(1992-6#1)(1997-2#1)
previous observations##26##2##(1990-2#1)(1990-7#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-8#1)
previous ones##2##2##(1990-7#1)(2008-10#1)
previous operation##3##2##(2008-3#1)(2008-6#1)(2010-12#1)
previous operations##3##2##(2005-10#1)(2006-12#1)(2008-4#1)
previous or##4##2##(1991-12#1)(2006-10#1)(2007-11#1)(2012-2#1)
previous paper##16##2##(1990-12#1)(1990-9#1)(1991-12#1)(1993-2#1)(1994-3#2)(1994-5#1)(2008-10#4)(2008-2#4)(2008-3#1)
previous papers we##4##3##(1993-4#1)(1994-6#1)(1997-6#1)(2008-2#1)
previous papers##14##2##(1993-4#1)(1994-6#1)(1997-6#1)(2006-4#2)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-12#1)(2013-1#1)
previous pelvic surgery##2##3##(2011-2#2)
previous pelvic##3##2##(1990-6#1)(2011-2#2)
previous percutaneous transluminal coronary angioplasty##2##5##(2007-8#1)(2008-7#1)
previous percutaneous##3##2##(2007-10#1)(2007-8#1)(2008-7#1)
previous period##3##2##(1990-8#1)(1996-11#1)(2011-1#1)
previous placement of##2##3##(2006-6#1)(2008-10#1)
previous preconcentration##3##2##(2008-10#3)
previous pregnancies##2##2##(1991-2#1)(2007-7#1)
previous pregnancy##3##2##(1992-12#1)(2011-1#1)(2011-2#1)
previous procedures##4##2##(1990-11#1)(1997-6#1)(2008-8#1)(2009-9#1)
previous psychiatric##2##2##(2005-9#1)(2013-1#1)
previous publication##3##2##(1994-12#1)(2007-11#1)(2008-5#1)
previous published##3##2##(2008-10#2)(2008-5#1)
previous recommendations##2##2##(1996-2#1)(2008-4#1)
previous report of this##2##4##(1996-9#1)(2012-12#1)
previous report of##6##3##(1996-9#1)(2006-10#1)(2008-6#1)(2008-7#1)(2009-5#1)(2012-12#1)
previous report that the##2##4##(1990-1#1)(2010-4#1)
previous report that##5##3##(1990-1#1)(1994-3#1)(1996-6#1)(2010-4#1)(2011-2#1)
previous report##35##2##(1990-1#1)(1990-4#2)(1990-5#1)(1990-7#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-8#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#2)(1996-6#1)(1996-9#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2009-5#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#4)(2012-3#1)(2013-1#1)(2013-8#1)
previous reports have##3##3##(1991-3#1)(1994-2#1)(2011-2#1)
previous reports in the literature##2##5##(2008-12#1)(2011-2#1)
previous reports of##11##3##(1991-8#1)(1994-3#1)(1995-12#1)(1995-8#1)(1997-5#1)(1997-6#1)(2006-2#1)(2008-10#2)(2008-8#1)(2009-3#1)
previous reports on the##3##4##(1991-9#1)(2007-8#1)(2008-10#1)
previous reports on##8##3##(1991-9#1)(1992-2#1)(1993-6#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-5#1)
previous reports that##5##3##(1992-9#1)(1994-8#1)(1997-7#1)(2008-10#1)(2010-3#1)
previous reports##78##2##(1990-11#1)(1990-6#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-6#2)(1994-2#2)(1994-3#2)(1994-8#1)(1994-9#1)(1995-12#3)(1995-7#1)(1995-8#1)(1996-9#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-1#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-9#1)(2007-1#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#2)(2008-5#5)(2008-8#1)(2008-9#2)(2009-3#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-3#2)(2013-7#1)(2013-8#1)
previous research and##2##3##(2010-12#1)(2011-1#1)
previous research by demonstrating that##2##5##(2009-4#1)(2009-7#1)
previous research examining##2##3##(1996-2#1)(2013-1#1)
previous research has##5##3##(1991-3#1)(2005-10#1)(2006-3#1)(2007-1#1)(2007-12#1)
previous research in##4##3##(1996-11#1)(2008-12#1)(2009-5#1)(2013-8#1)
previous research of the##2##4##(1994-3#1)(2012-3#1)
previous research of##4##3##(1994-3#1)(2008-2#1)(2011-2#1)(2012-3#1)
previous research on##4##3##(1993-11#1)(2008-2#1)(2011-1#1)(2012-2#1)
previous research that##4##3##(1992-3#1)(2008-10#1)(2008-2#1)(2008-3#1)
previous research##59##2##(1991-3#1)(1992-3#1)(1993-11#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-11#1)(1996-2#1)(2005-10#1)(2006-3#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#4)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#4)(2009-9#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
previous researches##2##2##(2008-6#1)(2012-1#1)
previous results for##4##3##(1991-8#1)(1993-3#1)(1997-5#1)(2007-11#1)
previous results in##2##3##(1996-10#1)(2008-9#1)
previous results indicating that##3##4##(1994-11#1)(1997-8#1)(2008-11#1)
previous results obtained with##3##4##(1991-4#1)(1992-1#1)(1992-12#1)
previous results obtained##5##3##(1991-4#1)(1992-1#1)(1992-12#1)(1994-2#1)(1997-7#1)
previous results on the##2##4##(1992-3#1)(1992-4#1)
previous results on##4##3##(1990-8#1)(1992-3#1)(1992-4#1)(2008-12#1)
previous results suggest that##2##4##(1995-11#1)(1996-2#1)
previous results using##2##3##(1997-6#1)(2005-11#1)
previous results with##2##3##(2008-6#1)(2009-4#1)
previous results##48##2##(1990-4#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-4#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-3#2)(1994-11#1)(1994-2#1)(1995-11#1)(1995-7#1)(1996-10#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2005-11#2)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
previous review##4##2##(2007-2#1)(2009-3#1)(2011-1#1)(2012-1#1)
previous reviews##3##2##(2010-2#1)(2012-12#1)(2012-3#1)
previous sample##4##2##(2008-10#3)(2010-10#1)
previous screening##2##2##(1992-7#1)(2007-1#1)
previous separation##8##2##(2005-4#1)(2008-10#7)
previous separations##3##2##(2008-10#3)
previous silicone##2##2##(2009-3#1)(2010-8#1)
previous similar##2##2##(2008-3#1)(2008-7#1)
previous spectroscopic and##2##3##(1991-8#1)(2008-5#1)
previous spectroscopic##3##2##(1991-8#1)(1992-3#1)(2008-5#1)
previous spontaneous abortion##2##3##(1992-6#1)(2007-1#1)
previous stage##3##2##(2008-10#1)(2008-2#1)(2009-3#1)
previous step##3##2##(1992-3#1)(1995-3#1)(2008-10#1)
previous strategies##2##2##(2008-3#1)(2008-4#1)
previous stroke##2##2##(2007-10#1)(2009-4#1)
previous structural studies##2##3##(1994-2#1)(2013-8#1)
previous studies and##4##3##(1994-12#1)(2008-1#1)(2008-10#1)(2012-3#1)
previous studies by##3##3##(1994-12#1)(2008-3#1)(2008-5#1)
previous studies from this laboratory##3##5##(1990-11#1)(1995-6#1)(1996-11#1)
previous studies from##4##3##(1990-11#1)(1995-6#1)(1996-11#1)(2006-10#1)
previous studies have indicated##3##4##(1994-5#1)(2006-10#1)(2009-8#1)
previous studies have investigated##2##4##(2009-9#1)(2010-6#1)
previous studies have reported##2##4##(2008-11#1)(2008-3#1)
previous studies have shown that##6##5##(1993-6#1)(1994-5#1)(1995-8#1)(1996-10#1)(1997-2#1)(2013-1#1)
previous studies have shown##7##4##(1992-9#1)(1993-6#1)(1994-5#1)(1995-8#1)(1996-10#1)(1997-2#1)(2013-1#1)
previous studies have##27##3##(1992-8#1)(1992-9#1)(1993-6#1)(1994-5#2)(1995-12#1)(1995-8#1)(1996-10#1)(1997-2#1)(2006-10#1)(2006-3#1)(2007-8#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-9#2)(2009-8#1)(2009-9#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#2)(2013-1#1)
previous studies in which##2##4##(1992-6#1)(2008-10#1)
previous studies in##9##3##(1992-6#1)(1997-7#1)(2008-10#1)(2008-9#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-2#1)
previous studies indicating that##4##4##(1994-2#1)(1994-5#1)(1995-6#1)(2006-10#1)
previous studies is the##2##4##(2008-10#1)(2010-5#1)
previous studies is##3##3##(1993-7#1)(2008-10#1)(2010-5#1)
previous studies of the##2##4##(1990-4#1)(1995-11#1)
previous studies of##17##3##(1990-4#1)(1991-7#1)(1995-11#1)(1996-11#1)(1996-4#1)(1997-5#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-2#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
previous studies on the##7##4##(1994-12#1)(1995-12#1)(1996-5#1)(1996-7#1)(1997-2#1)(2008-11#1)(2008-9#1)
previous studies on##14##3##(1992-9#1)(1994-12#1)(1995-12#1)(1996-5#1)(1996-7#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-4#1)(2013-1#1)
previous studies showing##2##3##(2007-7#1)(2008-5#1)
previous studies that##5##3##(1990-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-11#1)
previous studies using##5##3##(1994-3#1)(1995-11#1)(1996-10#1)(2006-6#1)(2007-11#1)
previous studies with##8##3##(1993-12#1)(1994-9#1)(2005-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-3#1)(2009-8#1)
previous studies##218##2##(1990-11#1)(1990-12#1)(1990-4#2)(1990-8#2)(1991-10#2)(1991-11#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-12#2)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#1)(1994-12#6)(1994-2#2)(1994-3#2)(1994-5#3)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-10#3)(1996-11#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#3)(1997-2#3)(1997-4#1)(1997-5#1)(1997-7#3)(2005-11#1)(2006-10#7)(2006-11#1)(2006-3#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#15)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#5)(2008-7#5)(2008-8#6)(2008-9#7)(2009-1#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-6#2)(2009-8#3)(2009-9#2)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#3)(2010-6#2)(2010-8#4)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#9)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#1)
previous study has shown that##2##5##(1995-6#1)(2008-5#1)
previous study has##3##3##(1995-6#1)(2008-5#1)(2008-8#1)
previous study of the##3##4##(1991-4#1)(2007-2#1)(2007-8#1)
previous study of##10##3##(1991-4#1)(1991-8#1)(1992-6#1)(1996-3#1)(2007-2#1)(2007-8#1)(2008-10#2)(2010-5#1)(2011-1#1)
previous study on the##2##4##(1990-2#1)(1993-7#1)
previous study on##5##3##(1990-2#1)(1991-2#1)(1993-7#1)(2004-9#1)(2010-8#1)
previous study showed that##3##4##(1994-2#1)(2009-6#1)(2013-7#1)
previous study suggested that##2##4##(1992-12#1)(2009-2#1)
previous study that##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
previous study to##3##3##(1996-8#1)(2008-10#1)(2010-8#1)
previous study with##3##3##(1991-2#1)(1993-12#1)(1994-5#1)
previous study##98##2##(1990-2#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-8#2)(1992-12#1)(1992-6#1)(1993-11#1)(1993-12#3)(1993-5#2)(1993-6#2)(1993-7#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-2#2)(1997-6#1)(2004-9#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#5)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
previous study)##3##2##(2008-10#1)(2008-9#2)
previous successful PTCA##2##3##(2007-8#2)
previous successful##3##2##(2007-8#3)
previous suggestions that##3##3##(1990-10#1)(1997-3#1)(2006-10#1)
previous suggestions##4##2##(1990-10#1)(1997-2#1)(1997-3#1)(2006-10#1)
previous suicide attempts##3##3##(2012-2#1)(2013-1#2)
previous surgery and##3##3##(2006-8#2)(2013-1#1)
previous surgery##9##2##(1990-8#1)(2006-2#1)(2006-8#5)(2010-6#1)(2013-1#1)
previous surgical##4##2##(1994-5#1)(2006-5#1)(2009-3#1)(2012-2#1)
previous survey##2##2##(2008-10#1)(2013-1#1)
previous surveys##4##2##(1992-2#1)(1992-6#1)(2008-10#2)
previous system##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2012-1#1)
previous systemic##2##2##(2012-1#1)(2012-12#1)
previous techniques##3##2##(1997-7#1)(2008-3#2)
previous theoretical##6##2##(2008-11#1)(2008-3#3)(2008-9#1)(2010-2#1)
previous theory##3##2##(2008-3#1)(2008-8#2)
previous therapy##3##2##(1995-10#1)(2008-6#1)(2012-12#1)
previous thoracic##2##2##(2007-12#1)(2012-2#1)
previous to the##5##3##(1991-6#1)(2008-10#1)(2008-7#1)(2010-2#1)(2011-2#1)
previous to##8##2##(1991-6#1)(1993-11#1)(1997-7#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-2#1)(2011-2#1)
previous transfection##2##2##(1996-5#1)(2008-11#1)
previous trauma##3##2##(1992-2#1)(2011-12#1)(2011-2#1)
previous treatment declined from##2##4##(2013-8#2)
previous treatment of the##2##4##(2008-10#2)
previous treatment of##5##3##(2006-10#1)(2008-10#2)(2010-10#2)
previous treatment with##4##3##(1992-2#1)(1993-5#1)(1995-12#1)(2007-8#1)
previous treatment##25##2##(1990-4#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-5#1)(1995-12#1)(2006-10#1)(2007-11#2)(2007-8#1)(2008-10#5)(2008-7#1)(2010-10#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
previous treatments##5##2##(1991-12#1)(1993-2#1)(2008-7#1)(2008-9#1)(2011-2#1)
previous trials of##2##3##(2006-10#1)(2012-1#1)
previous trials##9##2##(1996-6#1)(2006-10#1)(2008-7#1)(2008-8#1)(2009-10#2)(2011-1#1)(2012-1#1)(2013-8#1)
previous use of##3##3##(2006-10#1)(2007-8#1)(2008-8#1)
previous view##2##2##(1993-6#1)(2008-5#1)
previous work and##2##3##(2008-10#1)(2008-12#1)
previous work has suggested that##2##5##(2005-11#1)(2012-11#1)
previous work has##8##3##(1991-2#1)(1993-6#1)(2005-11#2)(2008-7#1)(2011-2#1)(2012-1#1)(2012-11#1)
previous work in##6##3##(1995-11#1)(2005-4#1)(2009-2#1)(2010-5#1)(2010-8#1)(2013-8#1)
previous work indicating##2##3##(1992-9#2)
previous work on the##2##4##(1990-4#1)(2008-2#1)
previous work on##10##3##(1990-4#1)(1993-2#1)(1994-2#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-7#2)
previous work that##3##3##(1996-3#1)(2008-10#2)
previous work to##4##3##(1991-1#1)(1992-10#1)(2008-10#1)(2008-12#1)
previous work using##2##3##(2008-7#1)(2012-11#1)
previous work we##3##3##(1990-8#1)(1997-5#1)(2008-5#1)
previous work with##2##3##(2005-11#1)(2010-10#1)
previous work##87##2##(1990-3#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-2#1)(1992-10#1)(1992-2#1)(1992-9#2)(1993-11#1)(1993-2#2)(1993-6#1)(1994-10#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-11#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-5#1)(2005-10#1)(2005-11#4)(2005-4#1)(2005-9#1)(2006-12#2)(2006-8#1)(2007-12#3)(2007-9#1)(2008-10#10)(2008-11#1)(2008-12#3)(2008-2#3)(2008-5#1)(2008-7#6)(2008-9#2)(2009-2#1)(2009-6#1)(2009-7#1)(2010-10#2)(2010-11#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
previous works##9##2##(1992-10#1)(2007-11#3)(2008-10#1)(2009-3#1)(2010-8#1)(2011-1#1)(2013-7#1)
previous year's##4##2##(2008-10#3)(2011-2#1)
previous years##15##2##(1990-12#1)(1991-11#1)(1995-6#1)(1996-3#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-2#2)(2008-7#1)(2008-8#1)(2011-1#2)(2012-2#2)
previous##2068##1##(1990-1#2)(1990-10#1)(1990-11#7)(1990-12#6)(1990-2#7)(1990-3#7)(1990-4#8)(1990-5#5)(1990-6#5)(1990-7#4)(1990-8#11)(1990-9#5)(1991-1#5)(1991-10#3)(1991-11#5)(1991-12#8)(1991-2#14)(1991-3#6)(1991-4#6)(1991-5#4)(1991-6#4)(1991-7#4)(1991-8#5)(1991-9#8)(1992-1#1)(1992-10#9)(1992-11#2)(1992-12#13)(1992-2#9)(1992-3#14)(1992-4#1)(1992-5#3)(1992-6#6)(1992-7#4)(1992-8#8)(1992-9#8)(1993-1#1)(1993-10#1)(1993-11#10)(1993-12#10)(1993-2#6)(1993-3#6)(1993-4#2)(1993-5#11)(1993-6#7)(1993-7#8)(1993-8#3)(1993-9#3)(1994-10#6)(1994-11#4)(1994-12#11)(1994-2#18)(1994-3#14)(1994-5#11)(1994-6#4)(1994-8#10)(1994-9#11)(1995-1#8)(1995-10#1)(1995-11#11)(1995-12#12)(1995-2#9)(1995-3#6)(1995-4#1)(1995-5#2)(1995-6#6)(1995-7#4)(1995-8#3)(1995-9#2)(1996-1#1)(1996-10#8)(1996-11#8)(1996-12#18)(1996-2#8)(1996-3#8)(1996-4#2)(1996-5#15)(1996-6#5)(1996-7#7)(1996-8#2)(1996-9#5)(1997-1#5)(1997-2#12)(1997-3#5)(1997-4#3)(1997-5#8)(1997-6#11)(1997-7#14)(1997-8#7)(2004-1#1)(2004-10#2)(2004-3#1)(2004-4#2)(2004-9#2)(2005-1#2)(2005-10#6)(2005-11#10)(2005-12#1)(2005-4#2)(2005-7#4)(2005-8#11)(2005-9#3)(2006-1#2)(2006-10#38)(2006-11#8)(2006-12#11)(2006-2#6)(2006-3#5)(2006-4#4)(2006-5#4)(2006-6#5)(2006-7#4)(2006-8#17)(2006-9#5)(2007-1#9)(2007-10#21)(2007-11#23)(2007-12#48)(2007-2#12)(2007-3#7)(2007-4#9)(2007-5#7)(2007-6#4)(2007-7#13)(2007-8#32)(2007-9#7)(2008-1#19)(2008-10#168)(2008-11#42)(2008-12#26)(2008-2#64)(2008-3#55)(2008-4#13)(2008-5#43)(2008-6#30)(2008-7#51)(2008-8#42)(2008-9#41)(2009-1#5)(2009-10#9)(2009-12#3)(2009-2#6)(2009-3#12)(2009-4#8)(2009-5#8)(2009-6#6)(2009-7#9)(2009-8#8)(2009-9#13)(2010-10#10)(2010-11#8)(2010-12#20)(2010-2#14)(2010-3#4)(2010-4#8)(2010-5#8)(2010-6#8)(2010-7#3)(2010-8#23)(2010-9#8)(2011-1#41)(2011-10#1)(2011-12#8)(2011-2#72)(2011-3#4)(2012-1#22)(2012-11#3)(2012-12#32)(2012-2#36)(2012-3#22)(2012-7#1)(2013-1#54)(2013-2#1)(2013-7#8)(2013-8#28)
previously [Appl##2##2##(2008-2#1)(2008-3#1)
previously a##3##2##(1992-8#1)(1997-6#1)(2006-4#1)
previously accepted##3##2##(2006-10#2)(2007-12#1)
previously accessible##2##2##(2007-11#1)(2008-2#1)
previously acidified##3##2##(2007-10#1)(2008-10#2)
previously acquired##2##2##(2008-11#1)(2009-6#1)
previously adsorbed##2##2##(2005-11#1)(2008-10#1)
previously affected by##2##3##(1990-8#1)(2013-1#1)
previously affected##4##2##(1990-8#1)(2007-7#1)(2008-10#1)(2013-1#1)
previously amplified##2##2##(2008-10#1)(2011-2#1)
previously analyzed##2##2##(1990-4#1)(2013-8#1)
previously and##12##2##(1990-2#1)(1991-8#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-6#1)(2013-1#3)(2013-8#1)
previously applied to##3##3##(1997-3#1)(2008-2#2)
previously applied##4##2##(1997-3#1)(2005-8#1)(2008-2#2)
previously appreciated##3##2##(1991-6#1)(1995-5#1)(2006-7#1)
previously are reviewed##2##3##(2007-2#1)(2008-10#1)
previously are##3##2##(2007-2#1)(2008-10#1)(2008-4#1)
previously as a##4##3##(1992-12#1)(1993-3#1)(1996-5#1)(2008-7#1)
previously as##11##2##(1990-7#1)(1992-12#1)(1993-3#1)(1995-8#1)(1996-11#1)(1996-5#1)(2006-3#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#1)
previously ascertained##2##2##(1994-6#1)(1995-11#1)
previously ascribed to##2##3##(2008-10#1)(2011-1#1)
previously assessed##3##2##(1993-3#1)(2008-10#1)(2013-1#1)
previously assigned ORFs##2##3##(1995-12#2)
previously assigned##5##2##(1995-12#4)(1995-6#1)
previously associated with##6##3##(1991-5#1)(1992-4#1)(2008-10#1)(2008-7#1)(2009-4#1)(2009-8#1)
previously assumed and##2##3##(1995-11#1)(2007-5#1)
previously assumed##6##2##(1995-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2012-1#1)(2012-2#1)
previously at##2##2##(1994-3#1)(2010-12#1)
previously attributed to##2##3##(2007-12#1)(2008-4#1)
previously available##2##2##(1991-5#1)(1995-10#1)
previously baited hole##2##3##(1992-8#2)
previously been demonstrated that##4##4##(1991-3#1)(1991-4#1)(2005-11#1)(2012-2#1)
previously been demonstrated##9##3##(1991-3#1)(1991-4#1)(1991-9#2)(1993-1#1)(1997-2#1)(2005-11#1)(2005-7#1)(2012-2#1)
previously been described in##4##4##(1992-6#1)(2008-10#1)(2009-3#1)(2011-12#1)
previously been described##10##3##(1990-6#1)(1992-10#1)(1992-6#1)(2007-8#1)(2008-10#2)(2008-12#1)(2009-3#1)(2010-6#1)(2011-12#1)
previously been determined##3##3##(1991-12#1)(1992-7#1)(1996-5#1)
previously been established##3##3##(1993-8#1)(1994-3#1)(2006-2#1)
previously been found to##6##4##(1995-3#1)(2008-11#2)(2008-8#1)(2012-12#1)(2013-7#1)
previously been found##7##3##(1995-3#1)(2008-11#2)(2008-5#1)(2008-8#1)(2012-12#1)(2013-7#1)
previously been identified as##4##4##(1990-10#1)(1990-4#1)(1992-4#1)(1996-3#1)
previously been identified in##3##4##(1993-5#1)(1997-7#1)(2008-10#1)
previously been identified##9##3##(1990-10#1)(1990-4#1)(1991-5#1)(1992-4#1)(1993-5#1)(1994-12#1)(1996-3#1)(1997-7#1)(2008-10#1)
previously been implicated in the##2##5##(1994-5#1)(1996-4#1)
previously been implicated in##4##4##(1993-12#1)(1994-5#1)(1996-4#1)(1996-8#1)
previously been observed in##2##4##(1991-12#1)(2008-6#1)
previously been observed##3##3##(1991-12#1)(1995-8#1)(2008-6#1)
previously been reported as##2##4##(1992-5#1)(2004-10#1)
previously been reported in##6##4##(1993-8#1)(1996-5#1)(2010-7#1)(2012-2#1)(2012-8#1)(2013-8#1)
previously been reported to##5##4##(1996-9#2)(2008-11#1)(2012-12#1)(2013-1#1)
previously been reported##30##3##(1990-11#1)(1990-7#1)(1992-5#1)(1993-8#2)(1995-5#1)(1996-11#1)(1996-5#1)(1996-9#2)(2004-10#1)(2004-11#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-8#1)(2013-1#1)(2013-8#2)
previously been shown to be##8##5##(1991-6#1)(1993-12#1)(1994-9#1)(2008-10#1)(2008-6#1)(2010-2#1)(2010-8#2)
previously been shown to exhibit##2##5##(1990-5#1)(1993-4#1)
previously been shown to interact with the##2##7##(1993-8#1)(2009-7#1)
previously been shown to interact with##3##6##(1993-8#1)(1997-4#1)(2009-7#1)
previously been shown to participate in neurodegenerative processes including Alzheimer's disease##2##11##(1995-11#1)(1995-12#1)
previously been shown to##37##4##(1990-10#1)(1990-12#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-6#1)(1992-10#2)(1992-5#1)(1993-12#3)(1993-4#1)(1993-8#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1997-4#1)(2004-9#1)(2006-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2009-7#1)(2010-2#1)(2010-8#2)(2011-1#1)(2013-1#2)
previously been shown##43##3##(1990-10#1)(1990-12#1)(1990-5#2)(1990-7#1)(1991-10#1)(1991-6#1)(1992-10#2)(1992-5#1)(1993-12#3)(1993-4#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-4#1)(1997-6#1)(2004-9#1)(2006-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-7#1)(2010-2#1)(2010-8#2)(2011-1#1)(2013-1#3)
previously been used for##2##4##(1997-3#1)(2008-6#1)
previously been used to##3##4##(1990-8#1)(2008-10#1)(2009-4#1)
previously been used##7##3##(1990-8#1)(1997-3#1)(2008-10#2)(2008-4#1)(2008-6#1)(2009-4#1)
previously been##190##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#2)(1991-10#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-9#3)(1992-10#3)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-12#5)(1993-3#1)(1993-4#1)(1993-5#1)(1993-8#4)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#2)(1996-5#5)(1996-6#1)(1996-8#2)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(2004-10#1)(2004-11#1)(2004-9#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-11#2)(2006-2#1)(2007-10#2)(2007-11#1)(2007-12#5)(2007-8#3)(2008-10#10)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#4)(2008-8#3)(2008-9#1)(2009-2#1)(2009-3#3)(2009-4#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#1)(2012-8#2)(2013-1#5)(2013-7#1)(2013-8#3)
previously believed to be##2##4##(2005-7#1)(2009-9#1)
previously believed to##3##3##(1995-4#1)(2005-7#1)(2009-9#1)
previously believed##12##2##(1995-4#1)(2005-6#1)(2005-7#1)(2006-2#1)(2007-7#1)(2007-9#2)(2008-10#1)(2009-9#1)(2012-2#3)
previously bound##3##2##(1990-4#1)(1992-12#1)(1995-5#1)
previously by other##2##3##(1993-12#1)(1993-9#1)
previously by##16##2##(1991-12#1)(1991-2#1)(1993-12#1)(1993-9#1)(1994-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2006-9#1)(2007-12#1)(2008-10#3)(2008-3#1)(2009-4#1)
previously called##4##2##(1993-12#1)(1996-7#1)(2006-5#1)(2008-10#1)
previously characterised##3##2##(1992-11#1)(1994-12#1)(1996-12#1)
previously characterized by##2##3##(2007-1#1)(2008-10#1)
previously characterized field##2##3##(2008-10#2)
previously characterized in##4##3##(1993-3#1)(1997-3#1)(2006-12#1)(2008-10#1)
previously characterized the##2##3##(1994-8#1)(1997-5#1)
previously characterized##38##2##(1990-12#1)(1990-5#1)(1991-9#1)(1993-3#1)(1994-12#2)(1994-8#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-12#1)(2007-1#1)(2008-10#12)(2008-11#1)(2008-7#1)(2010-10#1)(2012-12#1)(2013-1#2)
previously checked for the absence of##3##6##(2008-10#3)
previously chloride-depleted animals##2##3##(1995-10#2)
previously chloride-depleted##3##2##(1995-10#3)
previously classified##3##2##(1991-2#1)(2007-1#1)(2008-10#1)
previously cloned G-protein receptors##2##4##(1991-9#2)
previously cloned from##2##3##(1995-11#1)(1997-2#1)
previously cloned##18##2##(1990-11#1)(1991-3#1)(1991-7#2)(1991-9#4)(1992-11#1)(1992-3#1)(1992-5#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-11#2)(1997-2#1)(2008-6#1)
previously collected data##2##3##(2010-6#1)(2013-1#1)
previously collected##6##2##(1996-5#1)(2007-11#1)(2008-10#2)(2010-6#1)(2013-1#1)
previously conducted##4##2##(2006-11#1)(2007-1#1)(2008-5#1)(2013-8#1)
previously considered as##2##3##(2007-12#1)(2013-1#1)
previously considered to be##2##4##(1990-11#1)(2008-10#1)
previously considered to##4##3##(1990-11#1)(2005-9#1)(2008-10#1)(2008-4#1)
previously considered##19##2##(1990-11#1)(1990-12#1)(1992-6#1)(1993-9#1)(1997-3#1)(2005-9#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#1)(2011-1#2)(2012-12#1)(2013-1#1)
previously constructed##5##2##(1995-3#1)(1995-6#1)(1996-12#1)(2008-10#1)(2008-7#1)
previously contributed to##2##3##(2007-6#1)(2011-1#1)
previously created##2##2##(1994-2#1)(2007-8#1)
previously defined##11##2##(1990-11#1)(1993-1#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-6#1)(2008-10#2)(2009-7#1)(2009-8#1)
previously demonstrated a##2##3##(2010-6#1)(2013-1#1)
previously demonstrated for##3##3##(1991-5#1)(1995-3#1)(2007-5#1)
previously demonstrated in##3##3##(1990-10#1)(1993-9#1)(1997-2#1)
previously demonstrated that the##10##4##(1992-12#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-9#1)(1996-2#1)(2008-11#1)(2008-8#1)
previously demonstrated that##40##3##(1990-12#1)(1990-7#1)(1991-4#1)(1992-12#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-2#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#2)
previously demonstrated the##2##3##(1993-11#1)(2009-3#1)
previously demonstrated to be##2##4##(1991-12#1)(2013-8#1)
previously demonstrated to reduce##2##4##(1994-8#1)(2008-3#1)
previously demonstrated to##6##3##(1991-12#1)(1993-9#1)(1994-8#1)(2008-3#1)(2008-8#1)(2013-8#1)
previously demonstrated##74##2##(1990-10#1)(1990-12#2)(1990-4#1)(1990-7#1)(1991-12#1)(1991-4#1)(1991-5#3)(1992-12#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-9#3)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-10#1)(1996-2#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-7#1)(2007-11#2)(2007-5#1)(2007-8#2)(2008-1#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#4)(2009-12#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
previously derived##7##2##(1996-5#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)
previously described EC-2##3##3##(2008-10#3)
previously described and##3##3##(1992-10#1)(1994-2#1)(2008-10#1)
previously described as a##6##4##(1993-12#2)(1994-2#1)(2008-10#1)(2008-12#1)(2008-7#1)
previously described as##11##3##(1990-4#1)(1993-12#2)(1994-2#1)(1996-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)
previously described by##4##3##(1991-7#1)(2005-11#1)(2007-1#1)(2012-3#1)
previously described for the##3##4##(1991-9#1)(2008-10#1)(2008-2#1)
previously described for this##2##4##(1997-3#1)(2007-12#1)
previously described for##16##3##(1991-11#1)(1991-9#1)(1993-9#1)(1995-3#2)(1996-5#1)(1997-3#1)(2005-9#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-2#1)(2010-6#1)(2011-1#1)
previously described gene##3##3##(1991-5#1)(1996-6#2)
previously described genes##2##3##(1995-9#1)(1996-3#1)
previously described in several##2##4##(1995-5#1)(2007-12#1)
previously described in the##3##4##(1990-4#1)(1995-9#1)(2007-1#1)
previously described in these cells##2##5##(1991-3#1)(1997-7#1)
previously described in##21##3##(1990-4#2)(1991-3#2)(1991-5#1)(1991-6#1)(1992-12#1)(1992-8#1)(1995-5#1)(1995-9#1)(1997-2#1)(1997-5#1)(1997-7#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#2)(2012-3#1)
previously described methods for##2##4##(1994-8#1)(2008-10#1)
previously described methods##5##3##(1994-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2012-3#1)
previously described procedure##2##3##(1990-12#1)(1992-2#1)
previously described that##4##3##(1995-3#1)(2008-10#2)(2009-9#1)
previously described##219##2##(1990-11#4)(1990-12#2)(1990-4#5)(1990-5#2)(1990-6#3)(1990-7#1)(1991-10#1)(1991-11#3)(1991-2#1)(1991-3#3)(1991-5#4)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-4#2)(1993-6#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#5)(1995-5#1)(1995-9#3)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-9#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#1)(2004-12#1)(2005-11#2)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#3)(2006-12#2)(2006-5#1)(2006-8#1)(2007-1#5)(2007-11#1)(2007-12#4)(2007-4#1)(2007-8#2)(2008-10#35)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#4)(2013-7#1)
previously designated##3##2##(1991-8#1)(1991-9#1)(2008-10#1)
previously designed##3##2##(2008-5#1)(2008-7#1)(2013-8#1)
previously detected in the##2##4##(1990-10#1)(2013-7#1)
previously detected in##3##3##(1990-10#1)(2012-2#1)(2013-7#1)
previously detected##9##2##(1990-10#1)(1996-7#1)(1997-2#1)(2007-5#1)(2008-10#3)(2012-2#1)(2013-7#1)
previously determined by##3##3##(1992-12#1)(2007-12#1)(2008-10#1)
previously determined for the##2##4##(1991-4#1)(2008-8#1)
previously determined for##3##3##(1990-9#1)(1991-4#1)(2008-8#1)
previously determined in##2##3##(1997-4#1)(2007-11#1)
previously determined##25##2##(1990-9#1)(1991-11#1)(1991-4#1)(1992-1#1)(1992-12#2)(1993-8#1)(1994-2#1)(1994-6#1)(1995-4#1)(1996-10#1)(1997-2#1)(1997-4#2)(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#2)(2008-8#3)
previously developed an##3##3##(1997-2#1)(1997-4#1)(2008-11#1)
previously developed by##2##3##(2008-10#1)(2012-1#1)
previously developed for##8##3##(1990-9#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2011-1#1)
previously developed mathematical##2##3##(2007-9#2)
previously developed##47##2##(1990-8#1)(1990-9#1)(1996-2#1)(1997-2#1)(1997-4#1)(2004-9#1)(2005-7#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-9#2)(2008-1#2)(2008-10#9)(2008-11#3)(2008-2#3)(2008-3#2)(2009-11#2)(2010-7#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
previously diagnosed as##2##3##(2005-10#1)(2006-12#1)
previously diagnosed with breast cancer##2##5##(2006-10#2)
previously diagnosed with##6##3##(2006-10#2)(2007-10#1)(2007-5#1)(2011-2#1)(2013-8#1)
previously diagnosed##11##2##(2005-10#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-10#1)(2007-5#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
previously discussed##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
previously diseased plants##2##3##(2008-10#2)
previously documented##11##2##(1991-7#1)(1993-12#1)(1994-11#1)(1995-2#1)(2005-10#1)(2006-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-5#1)(2012-2#1)
previously dominant##3##2##(2008-10#2)(2008-8#1)
previously employed##2##2##(1995-5#1)(2009-2#1)
previously established by##3##3##(1990-9#1)(1996-1#1)(2007-4#1)
previously established in##2##3##(1996-1#1)(2007-12#1)
previously established##26##2##(1990-9#1)(1991-6#1)(1994-8#1)(1996-1#2)(1996-2#1)(2005-12#1)(2007-1#1)(2007-10#1)(2007-12#3)(2007-4#2)(2008-10#3)(2008-11#4)(2008-12#2)(2008-5#2)(2012-3#1)
previously estimated##7##2##(1993-7#1)(1996-5#1)(1996-8#1)(2006-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
previously evaluated by##2##3##(1990-10#1)(1991-2#1)
previously evaluated##5##2##(1990-10#1)(1991-2#1)(2007-7#1)(2008-11#1)(2008-9#1)
previously examined##5##2##(1991-9#1)(2007-11#1)(2008-10#1)(2008-7#1)(2012-2#1)
previously existing##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
previously exposed to##6##3##(1991-10#1)(1991-8#1)(1993-7#1)(1996-8#1)(2008-10#1)(2008-5#1)
previously exposed##7##2##(1991-10#1)(1991-8#1)(1992-6#1)(1993-7#1)(1996-8#1)(2008-10#1)(2008-5#1)
previously expressed##2##2##(2008-8#1)(2011-2#1)
previously failed conventional##2##3##(2008-6#1)(2010-12#1)
previously failed##5##2##(2006-6#1)(2007-11#1)(2008-6#1)(2010-12#2)
previously for a##2##3##(1994-3#1)(1995-2#1)
previously for other##2##3##(2008-10#1)(2012-12#1)
previously for the##6##3##(1990-10#1)(1992-3#1)(1995-3#1)(2007-12#1)(2008-1#1)(2008-10#1)
previously for##31##2##(1990-10#1)(1990-12#2)(1990-3#2)(1992-3#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-12#1)
previously found in the##3##4##(1990-5#1)(1993-3#1)(1994-11#1)
previously found in##16##3##(1990-5#1)(1991-1#1)(1991-12#1)(1992-8#1)(1993-3#2)(1994-11#2)(1994-12#1)(1995-11#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-9#1)(2010-2#1)(2012-2#1)
previously found only in##2##4##(1994-11#1)(1997-4#1)
previously found that##7##3##(1990-3#1)(1991-12#1)(1994-8#1)(1995-11#1)(1996-1#1)(1996-9#1)(2012-2#1)
previously found to be associated with##2##6##(2008-10#1)(2013-1#1)
previously found to be##8##4##(1994-11#1)(1995-5#1)(1997-6#1)(2006-3#1)(2008-10#1)(2008-4#1)(2008-7#1)(2013-1#1)
previously found to##10##3##(1993-3#1)(1993-9#1)(1994-11#1)(1995-5#1)(1997-6#1)(2006-3#1)(2008-10#1)(2008-4#1)(2008-7#1)(2013-1#1)
previously found with##2##3##(1993-11#1)(1996-2#1)
previously found##43##2##(1990-3#2)(1990-5#1)(1991-1#1)(1991-12#2)(1992-8#1)(1993-11#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-11#4)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#2)(1995-5#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-4#1)(1997-6#1)(2006-12#2)(2006-3#1)(2007-2#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-2#1)(2012-2#2)(2013-1#1)
previously free of the##2##4##(2008-10#1)(2008-8#1)
previously from##6##2##(1990-9#1)(1991-12#1)(1996-11#1)(1997-6#1)(2006-12#1)(2010-8#1)
previously frozen##2##2##(2010-4#2)
previously generated##3##2##(1995-6#1)(2011-1#1)(2011-2#1)
previously genetically##2##2##(2008-10#1)(2008-3#1)
previously had the##2##3##(2008-10#1)(2008-5#1)
previously had##7##2##(1990-3#1)(1992-8#1)(1993-5#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)
previously has been##4##3##(1992-12#1)(1994-9#1)(2005-11#1)(2008-10#1)
previously has not been##2##4##(1992-11#1)(2008-10#1)
previously has##6##2##(1992-11#1)(1992-12#1)(1994-9#1)(2005-11#1)(2008-10#2)
previously have##4##2##(2006-10#1)(2008-10#1)(2008-12#1)(2008-3#1)
previously having##2##2##(1996-12#1)(2007-12#1)
previously healthy male##2##3##(2007-7#1)(2009-8#1)
previously healthy man##2##3##(1992-8#1)(2006-8#1)
previously healthy patients##3##3##(2006-8#1)(2007-3#1)(2011-2#1)
previously healthy##27##2##(1991-12#1)(1992-8#1)(1993-7#1)(1997-8#1)(2005-11#1)(2006-8#3)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-3#2)(2009-8#3)(2010-12#1)(2011-2#2)(2012-2#3)(2013-1#1)
previously heated##2##2##(2008-10#2)
previously hypothesized##2##2##(1993-3#1)(2008-4#1)
previously identified a##6##3##(1990-8#1)(1991-8#2)(1994-11#1)(1994-9#1)(1996-4#1)
previously identified an##3##3##(1994-9#1)(1995-2#1)(2010-11#1)
previously identified and##2##3##(1993-6#1)(1996-8#1)
previously identified as C##2##4##(2010-3#1)(2012-11#1)
previously identified as the##3##4##(1997-4#1)(2008-10#1)(2008-4#1)
previously identified as##13##3##(1991-8#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-11#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2008-10#1)(2008-4#1)(2010-3#1)(2012-11#1)
previously identified by##6##3##(1991-8#1)(1992-9#1)(1994-12#1)(1995-2#1)(1997-6#1)(2010-3#1)
previously identified for##2##3##(1997-6#1)(2012-2#1)
previously identified genes##6##3##(1990-10#1)(1992-2#1)(1995-4#1)(1996-3#1)(1997-8#1)(2008-10#1)
previously identified in human##2##4##(1991-8#1)(1997-8#1)
previously identified in rat##2##4##(1990-12#1)(1991-11#1)
previously identified in the##3##4##(1990-7#1)(1994-8#1)(1995-1#1)
previously identified in##15##3##(1990-12#1)(1990-7#1)(1991-11#1)(1991-8#1)(1992-8#1)(1993-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-6#1)(1996-7#1)(1997-7#1)(1997-8#1)(2008-10#1)
previously identified resistance##2##3##(2008-10#1)(2008-9#1)
previously identified to##2##3##(1995-8#1)(2012-2#1)
previously identified##114##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#5)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#2)(1992-9#3)(1993-11#1)(1993-6#3)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-8#4)(1994-9#5)(1995-1#1)(1995-10#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#2)(1995-8#1)(1996-10#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#2)(1996-7#1)(1996-8#3)(1997-3#1)(1997-4#5)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#2)(2007-11#1)(2007-12#1)(2008-10#12)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#2)(2010-11#1)(2010-3#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#2)
previously immunized with##2##3##(1995-5#2)
previously implanted##6##2##(1993-12#1)(1994-6#1)(2007-7#1)(2008-10#2)(2009-12#1)
previously implicated as##2##3##(1991-10#1)(1994-12#1)
previously implicated in the##4##4##(1991-9#1)(1995-8#1)(2008-10#1)(2008-11#1)
previously implicated in##13##3##(1990-7#1)(1991-9#1)(1993-12#1)(1993-7#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-4#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-12#1)(2010-2#1)
previously implicated##16##2##(1990-7#1)(1991-10#1)(1991-9#1)(1993-12#1)(1993-7#1)(1994-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-4#1)(1997-5#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-12#1)(2010-2#1)
previously impossible##2##2##(1992-10#1)(2013-1#1)
previously in a##2##3##(2007-12#1)(2008-9#1)
previously in association with##2##4##(2006-10#1)(2007-8#1)
previously in other##3##3##(1991-10#1)(1994-8#1)(2007-12#1)
previously in the literature##5##4##(2007-11#1)(2007-8#1)(2008-3#1)(2009-3#1)(2010-2#1)
previously in the##13##3##(1990-10#1)(1992-12#1)(1993-2#1)(1993-9#1)(1996-2#1)(1997-4#2)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-3#1)(2010-2#1)
previously in##43##2##(1990-10#1)(1990-12#1)(1991-10#1)(1992-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-8#1)(1995-12#2)(1995-2#1)(1996-2#1)(1996-3#1)(1997-4#2)(1997-8#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-11#3)(2007-12#3)(2007-8#2)(2008-10#8)(2008-3#1)(2008-9#1)(2009-3#1)(2010-2#1)(2011-1#2)(2012-2#1)
previously inaccessible##4##2##(2007-12#1)(2007-8#1)(2008-6#1)(2010-12#1)
previously incorporated##3##2##(1995-3#1)(2008-4#1)(2008-5#1)
previously infected with##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
previously infected##7##2##(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2011-2#1)
previously inoculated with highly virulent infectious bursal disease virus##2##9##(2008-5#2)
previously inoculated with##4##3##(2008-5#2)(2009-6#1)(2011-1#1)
previously interpreted as##2##3##(2008-7#1)(2008-8#1)
previously interpreted##3##2##(2006-4#1)(2008-7#1)(2008-8#1)
previously intractable##2##2##(1997-8#1)(2006-10#1)
previously introduced##4##2##(1996-2#1)(2008-2#2)(2008-6#1)
previously investigated in##2##3##(2004-11#1)(2006-10#1)
previously investigated##8##2##(1990-11#1)(1996-7#1)(2004-11#1)(2006-10#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-8#1)
previously involved##3##2##(1997-6#1)(2012-12#2)
previously irradiated##3##2##(2008-9#1)(2011-2#2)
previously isolated a##2##3##(1991-1#1)(1992-11#1)
previously isolated by##2##3##(1995-4#1)(2008-10#1)
previously isolated from A##2##4##(2007-1#2)
previously isolated from a##2##4##(1995-2#1)(2006-12#1)
previously isolated from human##2##4##(1990-2#1)(1991-12#1)
previously isolated from rat##2##4##(1991-12#1)(1993-8#1)
previously isolated from the##3##4##(1995-2#1)(2008-5#1)(2011-2#1)
previously isolated from##20##3##(1990-12#1)(1990-2#1)(1991-12#2)(1991-2#1)(1992-8#1)(1993-8#1)(1994-5#2)(1995-2#3)(2006-12#1)(2007-1#3)(2008-10#1)(2008-5#1)(2011-2#2)
previously isolated##42##2##(1990-12#2)(1990-2#2)(1991-1#1)(1991-12#3)(1991-2#1)(1992-11#2)(1992-12#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-5#2)(1995-2#5)(1995-4#1)(1996-10#2)(1996-11#1)(1996-4#1)(1996-9#1)(1997-8#1)(2006-12#1)(2007-1#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2011-1#1)(2011-2#2)
previously known as##3##3##(2007-3#1)(2008-7#1)(2012-2#1)
previously known genes##2##3##(1996-6#1)(1997-3#1)
previously known only##2##3##(2007-11#1)(2008-10#1)
previously known to be##3##4##(1993-12#1)(1995-8#1)(2013-1#1)
previously known to##6##3##(1993-12#1)(1994-11#1)(1995-8#1)(2006-3#1)(2008-10#1)(2013-1#1)
previously known##39##2##(1990-3#1)(1990-6#1)(1990-9#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-11#1)(1995-8#2)(1996-6#1)(1997-3#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-3#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
previously learned##7##2##(1990-10#1)(1993-5#1)(1994-8#2)(1996-10#1)(2005-10#1)(2007-8#1)
previously linked##4##2##(1992-3#1)(2008-5#1)(2012-2#2)
previously loaded with##3##3##(1990-3#1)(2008-10#2)
previously mapped to##3##3##(1991-7#1)(1995-5#1)(2008-10#1)
previously mapped##10##2##(1991-7#1)(1993-12#1)(1994-12#1)(1995-5#1)(2008-10#3)(2009-9#1)(2012-3#2)
previously modified##2##2##(1994-11#1)(2008-10#1)
previously non-endemic##2##2##(2007-7#1)(2008-8#1)
previously not been##2##3##(1993-2#1)(2009-6#1)
previously not##9##2##(1993-12#1)(1993-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-4#1)(2009-6#1)(2010-10#1)(2011-1#1)
previously noted##4##2##(1994-3#1)(1995-3#1)(2006-10#1)(2012-3#1)
previously observed an##2##3##(1994-9#1)(1996-3#1)
previously observed during##2##3##(1991-9#1)(1993-8#1)
previously observed for##2##3##(1996-5#1)(2013-8#1)
previously observed in cells##2##4##(1992-9#1)(2012-2#1)
previously observed in the##3##4##(1994-3#1)(1995-3#1)(2008-3#1)
previously observed in##13##3##(1991-7#1)(1992-3#1)(1992-9#2)(1993-4#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-3#1)(2007-9#1)(2008-3#1)(2010-8#1)(2012-2#1)
previously observed##35##2##(1991-1#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-9#3)(1993-12#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#1)(1997-1#1)(1997-7#1)(2006-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
previously obtained by##3##3##(2007-4#1)(2008-10#2)
previously obtained for##2##3##(1990-2#1)(2006-10#1)
previously obtained from##3##3##(1994-8#1)(2008-10#1)(2008-2#1)
previously obtained in the##2##4##(2007-12#1)(2008-10#1)
previously obtained in##4##3##(2007-12#1)(2008-10#1)(2008-4#1)(2010-6#1)
previously obtained##18##2##(1990-2#2)(1992-7#1)(1994-8#1)(1995-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#4)(2008-2#2)(2008-4#1)(2010-6#1)(2013-1#1)
previously of##2##2##(1995-12#1)(2008-4#1)
previously on##4##2##(1995-2#1)(2008-10#2)(2011-2#1)
previously only##3##2##(1993-5#1)(2008-11#1)(2010-12#1)
previously operated##4##2##(1992-9#1)(1993-7#1)(2008-10#1)(2008-11#1)
previously partially characterized##2##3##(2008-10#2)
previously partially##3##2##(1990-8#1)(2008-10#2)
previously performed##3##2##(2007-4#1)(2007-6#1)(2008-10#1)
previously placed##2##2##(2006-12#1)(2013-1#1)
previously possible##3##2##(2010-10#1)(2010-4#1)(2012-2#1)
previously postulated##5##2##(1990-1#1)(1992-8#1)(1995-8#1)(2008-7#1)(2012-3#1)
previously predicted##3##2##(1996-12#1)(2006-11#1)(2007-11#1)
previously prepared##3##2##(1997-1#1)(2007-11#1)(2007-2#1)
previously presented by##2##3##(1991-6#1)(2008-12#1)
previously presented##10##2##(1991-6#1)(1995-5#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-2#1)
previously proposed for##3##3##(1992-5#1)(2013-1#2)
previously proposed models for##2##4##(1992-4#1)(1994-9#1)
previously proposed models##3##3##(1992-4#1)(1992-6#1)(1994-9#1)
previously proposed that##3##3##(1991-4#1)(2008-10#1)(2008-5#1)
previously proposed to##4##3##(2007-9#1)(2008-2#2)(2011-2#1)
previously proposed##44##2##(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-4#1)(1992-5#1)(1992-6#1)(1994-3#1)(1994-9#1)(1995-6#1)(1996-11#1)(1996-7#1)(1996-8#1)(1997-7#1)(2006-11#1)(2007-12#2)(2007-8#1)(2007-9#2)(2008-10#4)(2008-2#9)(2008-3#3)(2008-5#1)(2009-10#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-1#3)
previously provided by##2##3##(2007-11#1)(2008-10#1)
previously published PCR##2##3##(1997-3#1)(2011-1#1)
previously published case##2##3##(1992-11#1)(2007-10#1)
previously published cases##2##3##(2008-10#1)(2013-8#1)
previously published data and##3##4##(1991-9#1)(2008-5#1)(2012-11#1)
previously published data##11##3##(1990-4#1)(1991-7#1)(1991-9#1)(1993-11#1)(1996-5#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-11#1)
previously published findings in##2##4##(2007-12#2)
previously published findings##3##3##(2007-12#3)
previously published for##2##3##(2005-11#1)(2008-10#1)
previously published methods##3##3##(2005-11#1)(2008-2#1)(2012-1#1)
previously published models##2##3##(2008-10#1)(2008-2#1)
previously published report##3##3##(1990-12#1)(1992-11#1)(2008-9#1)
previously published reports##4##3##(2007-5#2)(2008-2#1)(2010-2#1)
previously published research##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
previously published results##7##3##(1993-8#1)(1995-4#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-3#2)
previously published studies##3##3##(1993-11#1)(2008-9#1)(2012-2#1)
previously published study##2##3##(2008-5#1)(2008-8#1)
previously published##107##2##(1990-12#1)(1990-4#3)(1991-1#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-11#2)(1992-6#1)(1992-9#1)(1993-11#2)(1993-8#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-3#1)(1997-8#1)(2004-9#1)(2005-11#3)(2005-8#2)(2006-10#2)(2006-11#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-4#2)(2007-5#2)(2008-1#1)(2008-10#13)(2008-11#3)(2008-2#6)(2008-3#7)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-5#1)(2010-10#1)(2010-2#3)(2010-7#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
previously purified from##4##3##(1991-1#1)(1994-3#1)(1994-9#1)(1995-5#1)
previously purified##7##2##(1990-11#1)(1990-4#1)(1991-1#1)(1994-3#1)(1994-9#1)(1995-5#1)(2009-8#1)
previously rare##2##2##(1997-3#1)(2006-10#1)
previously realized##2##2##(2006-10#1)(2006-5#1)
previously received##5##2##(1992-11#1)(2006-2#1)(2008-7#1)(2010-12#1)(2011-2#1)
previously recognized that##2##3##(1996-2#1)(2011-2#1)
previously recognized##14##2##(1990-8#1)(1992-5#1)(1994-3#1)(1995-8#1)(1996-2#1)(1997-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-6#1)(2011-2#1)(2013-1#2)
previously regarded as##3##3##(1996-12#1)(2007-12#1)(2009-6#1)
previously reported a##5##3##(1992-6#1)(1996-12#1)(1997-3#1)(2010-8#1)(2011-1#1)
previously reported affinities##2##3##(1995-12#1)(1997-2#1)
previously reported and##4##3##(1991-7#1)(1994-11#1)(2004-12#1)(2006-11#1)
previously reported as a##2##4##(1995-8#1)(2007-12#1)
previously reported as##8##3##(1992-7#1)(1995-8#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-8#1)
previously reported by other##2##4##(1991-2#1)(1996-1#1)
previously reported by##4##3##(1990-12#1)(1991-2#1)(1994-9#1)(1996-1#1)
previously reported case of##2##4##(2013-1#2)
previously reported case##4##3##(2012-3#2)(2013-1#2)
previously reported cases of##5##4##(1990-6#1)(1996-3#1)(2006-10#2)(2008-4#1)
previously reported cases##14##3##(1990-6#1)(1993-8#1)(1996-3#1)(2006-10#3)(2006-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-1#1)(2010-6#1)(2011-2#1)(2013-1#1)
previously reported data##6##3##(1991-1#1)(1991-9#1)(1996-7#1)(2008-10#1)(2008-4#1)(2012-2#1)
previously reported experimental results##2##4##(2008-10#1)(2008-2#1)
previously reported for the##2##4##(1990-1#1)(1990-2#1)
previously reported for##18##3##(1990-1#1)(1990-2#1)(1991-2#1)(1991-4#1)(1991-5#1)(1993-11#1)(1993-7#1)(1994-6#1)(1995-5#1)(1996-12#1)(1996-2#1)(2006-5#1)(2007-1#1)(2008-10#1)(2008-8#2)(2009-9#1)(2012-1#1)
previously reported human##2##3##(1992-10#1)(1993-8#1)
previously reported in Caucasian populations##2##5##(1991-1#2)
previously reported in the literature##17##5##(1994-11#1)(1995-7#1)(1995-9#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-9#1)(2009-5#2)(2009-7#1)(2010-3#1)(2010-7#2)(2011-2#1)(2012-12#1)
previously reported in the##21##4##(1994-11#1)(1995-7#1)(1995-9#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-5#2)(2009-7#2)(2010-3#1)(2010-6#1)(2010-7#2)(2011-2#2)(2012-12#1)
previously reported in vitro effects of##2##6##(1992-5#1)(1995-12#1)
previously reported in vitro##3##4##(1992-5#1)(1995-12#1)(2008-9#1)
previously reported in##47##3##(1991-1#2)(1991-3#1)(1991-8#1)(1992-5#1)(1994-10#1)(1994-11#1)(1995-10#1)(1995-12#2)(1995-7#1)(1995-9#1)(1996-5#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-5#2)(2008-7#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-5#2)(2009-7#3)(2009-9#1)(2010-3#1)(2010-6#1)(2010-7#2)(2011-2#2)(2012-12#1)(2012-3#1)
previously reported lack of##2##4##(1991-2#1)(2008-6#1)
previously reported methods##3##3##(1990-12#1)(2008-10#1)(2008-2#1)
previously reported ones##2##3##(2008-10#1)(2008-9#1)
previously reported procedures##2##3##(1991-5#1)(2009-12#1)
previously reported results##7##3##(1990-12#1)(1993-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2012-2#1)
previously reported structures##2##3##(2006-2#1)(2007-11#1)
previously reported studies##3##3##(1997-4#1)(2008-3#1)(2008-7#1)
previously reported that a##2##4##(1994-3#2)
previously reported that##46##3##(1990-11#1)(1990-7#1)(1991-12#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-2#3)(1994-3#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-12#2)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-12#2)(2008-10#1)(2008-12#1)(2008-4#2)(2009-12#2)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
previously reported the presence of##2##5##(1990-5#1)(1997-5#1)
previously reported the##9##3##(1990-5#1)(1990-8#1)(1994-8#1)(1994-9#1)(1997-5#1)(1997-8#1)(2008-10#2)(2010-3#1)
previously reported to be##4##4##(1990-7#1)(1992-6#1)(1996-4#1)(2008-10#1)
previously reported to have a##2##5##(1997-7#1)(2008-5#1)
previously reported to##13##3##(1990-7#1)(1992-6#1)(1994-10#1)(1994-12#2)(1996-4#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-12#1)(2011-2#1)(2012-3#1)
previously reported values##5##3##(1991-7#1)(1997-7#1)(2007-11#1)(2008-10#2)
previously reported with##3##3##(1993-1#1)(2008-10#1)(2013-1#1)
previously reported##449##2##(1990-1#2)(1990-11#2)(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#3)(1990-8#1)(1991-1#5)(1991-12#2)(1991-2#4)(1991-3#1)(1991-4#4)(1991-5#4)(1991-6#2)(1991-7#4)(1991-8#3)(1991-9#5)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#2)(1993-2#3)(1993-3#1)(1993-6#3)(1993-7#2)(1993-8#2)(1993-9#1)(1994-10#3)(1994-11#5)(1994-12#8)(1994-2#3)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#4)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#2)(1995-5#3)(1995-7#1)(1995-8#4)(1995-9#2)(1996-1#1)(1996-12#8)(1996-2#5)(1996-3#3)(1996-4#3)(1996-5#5)(1996-6#1)(1996-7#4)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#6)(1997-3#2)(1997-4#3)(1997-5#2)(1997-7#3)(1997-8#3)(2004-12#3)(2005-11#2)(2006-10#8)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-8#4)(2007-1#3)(2007-11#12)(2007-12#5)(2007-2#2)(2007-5#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#54)(2008-11#1)(2008-12#2)(2008-2#13)(2008-3#8)(2008-4#6)(2008-5#10)(2008-6#3)(2008-7#10)(2008-8#3)(2008-9#4)(2009-1#2)(2009-10#1)(2009-12#4)(2009-4#1)(2009-5#3)(2009-7#5)(2009-8#3)(2009-9#3)(2010-12#2)(2010-2#2)(2010-3#3)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#5)(2011-11#1)(2011-12#1)(2011-2#9)(2012-1#1)(2012-12#8)(2012-2#3)(2012-3#7)(2013-1#7)(2013-7#1)(2013-8#5)
previously required##3##2##(2006-10#2)(2008-3#1)
previously revealed##2##2##(1990-5#1)(1995-5#1)
previously seen##6##2##(1991-2#1)(1995-12#1)(1997-8#1)(2008-8#1)(2009-10#1)(2010-2#1)
previously selected##4##2##(2008-10#2)(2008-6#1)(2010-4#1)
previously sequenced##11##2##(1991-2#1)(1991-6#1)(1992-12#1)(1993-12#1)(1994-12#1)(1995-11#1)(1995-2#1)(1996-5#1)(1996-6#1)(1997-8#1)(2008-10#1)
previously shocked animals##2##3##(2008-6#2)
previously showed##11##2##(1992-3#2)(1994-5#1)(1995-3#1)(1996-8#1)(1996-9#1)(2006-6#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
previously shown for##2##3##(1990-11#1)(1994-3#1)
previously shown in##2##3##(2009-5#1)(2010-3#1)
previously shown that the##15##4##(1990-9#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-8#2)(1997-6#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)
previously shown that this##3##4##(1991-12#1)(1994-3#1)(2009-7#1)
previously shown that##63##3##(1990-10#1)(1990-12#1)(1990-9#3)(1991-11#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-8#3)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-6#2)(1997-8#1)(2003-11#1)(2006-8#1)(2006-9#1)(2007-11#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
previously shown to be essential for##2##6##(1993-12#1)(2008-11#1)
previously shown to be involved in##2##6##(1994-2#1)(1997-4#1)
previously shown to be related to##2##6##(1991-8#1)(2011-1#1)
previously shown to be##28##4##(1991-5#2)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-12#2)(1993-9#2)(1994-2#1)(1996-2#1)(1996-5#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-4#2)(2010-4#1)(2011-1#1)(2012-1#1)
previously shown to encode##2##4##(1997-6#1)(2008-11#1)
previously shown to enhance##2##4##(1991-8#1)(1995-3#1)
previously shown to have##2##4##(1991-4#1)(1996-8#1)
previously shown to increase the##2##5##(1994-8#1)(2008-7#1)
previously shown to increase##4##4##(1994-8#1)(1996-12#1)(1996-8#1)(2008-7#1)
previously shown to inhibit##2##4##(1995-5#1)(2010-12#1)
previously shown to reflect##2##4##(1991-3#1)(2012-12#1)
previously shown to##72##3##(1990-12#2)(1990-9#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#2)(1991-8#2)(1992-12#1)(1992-3#1)(1993-12#2)(1993-3#1)(1993-9#3)(1994-2#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#2)(1996-8#4)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#1)(2005-9#1)(2006-12#1)(2006-6#1)(2007-12#1)(2007-9#1)(2008-10#9)(2008-11#2)(2008-7#2)(2008-9#1)(2009-4#2)(2009-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#5)(2012-2#1)
previously shown##151##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-3#1)(1990-9#4)(1991-11#2)(1991-12#1)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#2)(1991-8#3)(1992-12#3)(1992-3#1)(1992-8#3)(1993-11#1)(1993-12#4)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-4#2)(1996-5#3)(1996-8#4)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#3)(1997-8#2)(2003-11#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
previously spiked with different amounts of##2##6##(2008-10#2)
previously standardized##2##2##(1992-1#1)(2008-10#1)
previously stored##3##2##(1996-12#1)(2007-12#1)(2008-3#1)
previously studied in##2##3##(1997-5#1)(2004-12#1)
previously studied##32##2##(1992-4#1)(1993-4#2)(1993-7#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-5#1)(1996-7#1)(1997-5#1)(2004-12#1)(2005-10#1)(2006-10#1)(2007-1#1)(2007-11#2)(2007-12#2)(2008-10#4)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-4#1)(2010-8#1)(2013-1#2)
previously suggested for##2##3##(1995-1#1)(2008-10#1)
previously suggested that##3##3##(1990-11#1)(1994-3#1)(1995-3#1)
previously suggested to be##3##4##(1996-4#1)(2012-12#2)
previously suggested to##4##3##(1995-5#1)(1996-4#1)(2012-12#2)
previously suggested##26##2##(1990-11#1)(1990-3#1)(1990-7#1)(1991-7#1)(1992-6#1)(1993-11#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-5#2)(1996-4#1)(1997-1#1)(1997-6#1)(2008-10#5)(2008-2#1)(2008-9#1)(2010-3#1)(2012-12#3)
previously suspected to be a##2##5##(1991-12#2)
previously suspected##4##2##(1991-12#2)(1993-9#1)(2008-5#1)
previously synthesized##5##2##(1994-9#1)(1995-11#2)(2007-11#1)(2008-10#1)
previously taken##2##2##(1991-9#1)(1995-9#1)
previously tested##6##2##(1992-5#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-7#1)
previously that a##4##3##(1992-11#1)(1996-5#1)(1997-7#1)(2009-8#1)
previously that the##8##3##(1991-5#1)(1992-10#1)(1994-8#1)(1995-5#1)(1997-4#1)(2008-2#1)(2008-5#1)(2008-7#1)
previously that##41##2##(1990-11#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#1)(1994-10#1)(1994-11#2)(1994-8#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1996-10#1)(1996-5#4)(1996-7#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-8#2)(2012-12#1)
previously thought to be##7##4##(1992-1#2)(1996-11#1)(1996-2#1)(2007-9#1)(2008-10#1)(2008-5#1)
previously thought to##10##3##(1992-1#2)(1993-8#1)(1995-6#1)(1996-11#1)(1996-2#1)(2007-9#1)(2008-10#1)(2008-5#1)(2010-12#1)
previously thought##31##2##(1990-5#1)(1992-1#2)(1993-3#1)(1993-8#2)(1995-11#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-2#1)(2004-9#1)(2005-11#1)(2006-10#3)(2007-10#1)(2007-9#2)(2008-10#2)(2008-11#1)(2008-5#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
previously to be##6##3##(1991-2#1)(1992-7#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-9#1)
previously to inhibit##3##3##(1994-10#1)(1994-3#1)(1994-8#1)
previously to occur##2##3##(1995-3#1)(2009-3#1)
previously to##33##2##(1990-11#1)(1990-6#1)(1990-8#1)(1991-2#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-8#1)(1994-10#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-9#1)(2005-1#1)(2006-11#1)(2006-4#1)(2007-6#1)(2007-7#1)(2008-10#1)(2009-10#1)(2009-3#1)(2009-4#1)
previously trained##2##2##(1995-10#1)(2007-2#1)
previously transferred to##2##3##(2008-10#2)
previously treated by##3##3##(2004-9#1)(2007-8#1)(2013-1#1)
previously treated patients##5##3##(1991-6#1)(1993-6#1)(2006-9#1)(2007-11#1)(2012-2#1)
previously treated with a##2##4##(1995-9#1)(2008-10#1)
previously treated with chemotherapy##3##4##(1991-4#1)(1991-6#1)(1992-8#1)
previously treated with tamoxifen##3##4##(2004-1#3)
previously treated with the##2##4##(1994-6#1)(2008-10#1)
previously treated with##21##3##(1991-4#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-8#1)(1994-6#1)(1995-9#1)(2004-1#3)(2006-6#1)(2008-10#4)(2008-3#1)(2008-6#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
previously treated##35##2##(1991-4#1)(1991-6#2)(1992-10#1)(1992-12#1)(1992-8#1)(1993-6#1)(1994-6#1)(1995-9#1)(2004-1#3)(2004-9#1)(2006-6#2)(2006-7#1)(2006-9#1)(2007-11#2)(2007-4#1)(2007-8#1)(2008-10#6)(2008-3#1)(2008-6#1)(2010-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
previously unappreciated##3##2##(1996-4#1)(2012-12#1)(2013-1#1)
previously unavailable##4##2##(2006-4#1)(2007-11#1)(2007-4#1)(2011-1#1)
previously uncharacterized##12##2##(1991-12#1)(1993-6#1)(1994-6#1)(1995-1#1)(1996-10#1)(2008-10#3)(2009-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
previously undefined##4##2##(1994-8#1)(1995-3#1)(2008-10#1)(2008-12#1)
previously underappreciated##2##2##(2011-2#1)(2012-3#1)
previously undescribed species of##2##4##(2008-10#2)
previously undescribed species##3##3##(2008-10#2)(2012-11#1)
previously undescribed##19##2##(1990-7#1)(2006-8#3)(2007-11#1)(2008-10#7)(2009-5#1)(2011-1#2)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)
previously undetected##4##2##(1997-7#1)(2008-10#2)(2013-7#1)
previously undiagnosed sickle cell##3##4##(2013-8#3)
previously undiagnosed##7##2##(1992-7#1)(2006-10#1)(2006-4#1)(2010-5#1)(2013-8#3)
previously unexplained##4##2##(1990-2#1)(1994-3#1)(1995-7#1)(2007-12#1)
previously unexplored##2##2##(2010-1#1)(2013-1#1)
previously unidentified##11##2##(1990-8#1)(1992-4#1)(1993-8#1)(1994-3#1)(1994-8#1)(1997-4#1)(1997-7#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-12#1)
previously unknown function##2##3##(1995-5#1)(2008-7#1)
previously unknown or##2##3##(1996-1#1)(2008-10#1)
previously unknown##34##2##(1990-2#1)(1991-12#1)(1992-11#1)(1992-8#1)(1993-2#1)(1993-6#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-4#1)(1997-7#2)(2007-11#1)(2007-3#1)(2008-10#5)(2008-3#2)(2008-5#2)(2008-7#2)(2009-10#2)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
previously unrecognised adverse drug reactions##2##5##(2008-8#2)
previously unrecognised adverse##3##3##(2008-8#3)
previously unrecognised##7##2##(1994-3#1)(1996-6#2)(2008-8#4)
previously unrecognized and##2##3##(2008-8#1)(2012-3#1)
previously unrecognized roles for##2##4##(2009-9#1)(2010-2#1)
previously unrecognized##28##2##(1991-3#1)(1991-5#1)(1994-9#2)(1995-2#1)(1995-5#2)(1996-2#2)(2006-10#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-8#2)(2009-12#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2012-2#2)(2012-3#1)
previously unreported##32##2##(1990-9#1)(1992-1#1)(1993-4#1)(1994-12#2)(1996-3#2)(1997-2#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2012-2#2)(2013-8#1)
previously unseen##3##2##(2008-7#1)(2013-1#2)
previously unsuspected##7##2##(1990-6#1)(1992-3#1)(1994-3#1)(2006-10#1)(2007-8#1)(2012-2#1)(2012-3#1)
previously untapped##2##2##(1996-4#1)(2012-3#1)
previously untreated patients with##5##4##(1990-12#1)(1991-4#1)(1991-9#1)(2007-11#1)(2008-7#1)
previously untreated patients##9##3##(1990-12#1)(1990-6#2)(1991-4#1)(1991-9#1)(2007-11#1)(2007-7#1)(2008-7#1)(2009-6#1)
previously untreated##19##2##(1990-12#1)(1990-6#2)(1991-4#1)(1991-8#1)(1991-9#1)(2007-11#2)(2007-3#1)(2007-7#1)(2008-10#1)(2008-7#3)(2009-6#1)(2009-8#1)(2010-11#1)(2011-2#1)(2013-1#1)
previously used as a##2##4##(1990-11#1)(2011-2#1)
previously used for##3##3##(2007-7#1)(2008-3#1)(2008-8#1)
previously used in##3##3##(2006-11#1)(2008-7#1)(2010-4#1)
previously used to##6##3##(1993-11#1)(2008-10#3)(2008-3#1)(2009-10#1)
previously used##32##2##(1990-11#1)(1990-4#1)(1991-5#1)(1993-11#1)(1993-4#1)(1993-9#1)(1997-4#2)(2006-10#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
previously using other##2##3##(2007-8#1)(2008-10#1)
previously using##4##2##(2007-8#1)(2008-10#3)
previously validated##12##2##(1993-12#1)(2006-11#1)(2006-7#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-4#1)(2012-1#1)(2012-2#1)(2013-1#1)
previously was thought##2##3##(2008-10#2)
previously was##6##2##(2008-10#6)
previously well##4##2##(2009-5#1)(2010-9#1)(2011-1#1)(2012-2#1)
previously well-characterized##2##2##(1990-7#1)(1994-8#1)
previously were##7##2##(2006-11#1)(2007-10#1)(2008-10#4)(2008-3#1)
previously with##12##2##(1991-2#1)(1991-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-2#1)(1997-3#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-5#1)
previously##3305##1##(1990-1#3)(1990-10#10)(1990-11#21)(1990-12#28)(1990-2#11)(1990-3#10)(1990-4#20)(1990-5#14)(1990-6#10)(1990-7#14)(1990-8#12)(1990-9#11)(1991-1#12)(1991-10#7)(1991-11#10)(1991-12#20)(1991-2#19)(1991-3#12)(1991-4#15)(1991-5#26)(1991-6#18)(1991-7#15)(1991-8#20)(1991-9#27)(1992-1#10)(1992-10#10)(1992-11#13)(1992-12#24)(1992-2#5)(1992-3#16)(1992-4#9)(1992-5#9)(1992-6#11)(1992-7#7)(1992-8#26)(1992-9#13)(1993-1#5)(1993-10#1)(1993-11#15)(1993-12#34)(1993-2#9)(1993-3#16)(1993-4#9)(1993-5#7)(1993-6#16)(1993-7#8)(1993-8#16)(1993-9#19)(1994-1#1)(1994-10#9)(1994-11#24)(1994-12#32)(1994-2#19)(1994-3#25)(1994-5#11)(1994-6#11)(1994-8#33)(1994-9#24)(1995-1#12)(1995-10#10)(1995-11#20)(1995-12#20)(1995-2#30)(1995-3#29)(1995-4#5)(1995-5#27)(1995-6#19)(1995-7#3)(1995-8#20)(1995-9#8)(1996-1#9)(1996-10#13)(1996-11#11)(1996-12#23)(1996-2#21)(1996-3#13)(1996-4#21)(1996-5#32)(1996-6#13)(1996-7#13)(1996-8#16)(1996-9#10)(1997-1#12)(1997-2#22)(1997-3#18)(1997-4#26)(1997-5#16)(1997-6#18)(1997-7#21)(1997-8#16)(2003-11#1)(2004-1#4)(2004-10#1)(2004-11#5)(2004-12#6)(2004-2#1)(2004-4#1)(2004-9#6)(2005-1#2)(2005-10#5)(2005-11#22)(2005-12#2)(2005-6#1)(2005-7#6)(2005-8#7)(2005-9#3)(2006-1#3)(2006-10#58)(2006-11#14)(2006-12#18)(2006-2#5)(2006-3#6)(2006-4#8)(2006-5#7)(2006-6#7)(2006-7#5)(2006-8#18)(2006-9#8)(2007-1#18)(2007-10#13)(2007-11#53)(2007-12#55)(2007-2#8)(2007-3#8)(2007-4#10)(2007-5#9)(2007-6#5)(2007-7#10)(2007-8#34)(2007-9#12)(2008-1#9)(2008-10#399)(2008-11#42)(2008-12#16)(2008-2#60)(2008-3#62)(2008-4#34)(2008-5#66)(2008-6#23)(2008-7#58)(2008-8#43)(2008-9#24)(2009-1#2)(2009-10#10)(2009-11#3)(2009-12#7)(2009-2#5)(2009-3#11)(2009-4#11)(2009-5#11)(2009-6#8)(2009-7#8)(2009-8#23)(2009-9#10)(2010-1#4)(2010-10#6)(2010-11#5)(2010-12#26)(2010-2#15)(2010-3#10)(2010-4#17)(2010-5#5)(2010-6#16)(2010-7#9)(2010-8#14)(2010-9#5)(2011-1#41)(2011-11#1)(2011-12#5)(2011-2#52)(2011-3#1)(2012-1#12)(2012-11#5)(2012-12#42)(2012-2#52)(2012-3#40)(2012-7#1)(2012-8#2)(2013-1#62)(2013-7#8)(2013-8#30)
previously)##2##1##(1995-12#1)(2008-3#1)
previously-published##2##1##(1996-11#1)(2006-10#1)
previtellogenesis##5##1##(2007-12#4)(2008-7#1)
previtellogenic growth the##2##3##(2007-12#2)
previtellogenic oocytes (phase I oocytes)##2##5##(2008-8#2)
previtellogenic oocytes##5##2##(2007-12#2)(2008-8#3)
previtellogenic##9##1##(2007-12#4)(2008-8#4)(2010-5#1)
prevocational##2##1##(2008-2#2)
prewarmed##2##1##(1990-2#1)(1994-9#1)
prewarming and##2##2##(1994-9#2)
prewarming##3##1##(1994-9#3)
preweaning and##2##2##(1992-11#1)(1994-8#1)
preweaning##5##1##(1991-4#1)(1992-11#1)(1992-9#1)(1994-8#1)(2008-7#1)
preweanling##2##1##(1992-3#1)(2008-4#1)
prey and##8##2##(2007-2#1)(2007-3#1)(2008-2#1)(2008-8#2)(2008-9#2)(2012-12#1)
prey are##4##2##(1991-11#1)(2004-2#1)(2007-9#1)(2008-6#1)
prey as##3##2##(2008-5#2)(2012-3#1)
prey availability##2##2##(2007-3#1)(2008-9#1)
prey by##3##2##(2007-12#1)(2008-8#1)(2008-9#1)
prey can##3##2##(2008-8#1)(2008-9#1)(2012-2#1)
prey capture##4##2##(2006-12#3)(2012-2#1)
prey consumption##3##2##(2008-8#2)(2009-4#1)
prey density##4##2##(2008-12#1)(2008-8#2)(2008-9#1)
prey for##3##2##(2008-5#2)(2012-2#1)
prey in a##2##3##(2007-12#1)(2010-8#1)
prey in the##3##3##(2008-9#1)(2010-8#1)(2013-8#1)
prey in##7##2##(1991-11#1)(2007-12#1)(2008-9#1)(2010-8#2)(2012-2#1)(2013-8#1)
prey item##3##2##(2008-5#3)
prey items##5##2##(2007-3#4)(2010-8#1)
prey preference##2##2##(2010-8#1)(2012-2#1)
prey productivity##2##2##(2008-9#2)
prey resource##2##2##(2008-9#2)
prey selection of##2##3##(2010-8#2)
prey selection##6##2##(2010-8#6)
prey size##5##2##(2007-3#2)(2010-8#3)
prey species on##4##3##(2009-4#4)
prey species##17##2##(2008-5#1)(2008-8#7)(2008-9#1)(2009-4#5)(2012-12#2)(2012-3#1)
prey to##5##2##(2007-4#1)(2008-8#2)(2010-8#1)(2012-3#1)
prey were##3##2##(2007-3#1)(2008-8#1)(2010-8#1)
prey##178##1##(1991-11#3)(1994-6#1)(1995-11#1)(1995-12#2)(2004-2#2)(2006-12#5)(2007-12#5)(2007-2#2)(2007-3#16)(2007-4#1)(2007-5#1)(2007-9#4)(2008-10#2)(2008-12#2)(2008-2#2)(2008-5#17)(2008-6#1)(2008-8#37)(2008-9#25)(2009-4#6)(2010-8#26)(2012-12#5)(2012-2#7)(2012-3#4)(2013-8#1)
preying mainly on chlorophitic algae##2##5##(2007-3#2)
preying mainly on##3##3##(2007-3#3)
preying##4##1##(2007-3#3)(2012-2#1)
preys##9##1##(2006-12#3)(2007-3#3)(2008-12#2)(2008-5#1)
prezygotic isolation##2##2##(2008-8#2)
prezygotic##5##1##(2008-10#1)(2008-8#3)(2012-3#1)
prg##12##1##(2008-10#12)
priB##2##1##(1991-7#2)
priapism in a##3##3##(2008-10#2)(2009-4#1)
priapism in##5##2##(2008-10#4)(2009-4#1)
priapism##13##1##(2008-10#7)(2009-2#1)(2009-4#1)(2011-1#3)(2013-8#1)
price and##5##2##(1995-1#1)(1996-3#1)(2011-2#2)(2013-1#1)
price changes##2##2##(1994-1#1)(1994-12#1)
price competition among providers##2##4##(1994-1#1)(1994-12#1)
price competition##3##2##(1994-1#1)(1994-12#1)(1994-3#1)
price controls##5##2##(1994-12#4)(1994-2#1)
price for##2##2##(1991-1#1)(2006-8#1)
price increases##5##2##(1991-10#4)(1992-1#1)
price index##5##2##(1992-2#1)(1993-1#3)(1993-3#1)
price indexes##2##2##(1992-1#1)(1993-3#1)
price is##3##2##(1994-12#1)(2007-2#1)(2012-12#1)
price of anarchy in##2##4##(2013-8#2)
price of the##5##3##(1990-9#1)(1991-4#1)(1996-2#1)(2008-12#1)(2008-2#1)
price of these##2##3##(1994-2#1)(2008-10#1)
price of##38##2##(1990-9#1)(1991-1#1)(1991-4#3)(1993-1#1)(1993-11#1)(1994-1#1)(1994-2#1)(1994-7#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-7#2)(2006-11#1)(2006-8#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
price setting##4##2##(1993-2#4)
price spikes##3##2##(2006-4#3)
price to##3##2##(2008-11#1)(2008-12#1)(2013-8#1)
price trends##2##2##(1993-3#2)
price volatility is##2##3##(2012-12#2)
price volatility##5##2##(2012-12#5)
price without##2##2##(1992-1#1)(1993-2#1)
price##148##1##(1990-12#1)(1990-9#1)(1991-1#2)(1991-10#4)(1991-12#1)(1991-4#3)(1992-1#4)(1992-12#1)(1992-2#1)(1993-1#4)(1993-11#1)(1993-12#1)(1993-2#5)(1993-3#4)(1993-8#1)(1994-1#4)(1994-12#7)(1994-2#3)(1994-3#1)(1994-7#1)(1995-1#3)(1995-10#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#3)(1997-8#1)(2005-12#2)(2006-10#1)(2006-11#1)(2006-4#3)(2006-7#1)(2006-8#2)(2007-2#4)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-5#1)(2011-1#2)(2011-2#9)(2012-1#2)(2012-12#8)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#3)
price-competitive##2##1##(1990-12#1)(1996-2#1)
price-fixing##2##1##(1991-1#2)
price/performance##2##1##(1993-2#1)(2006-12#1)
priced##3##1##(1992-5#1)(2007-8#1)(2008-11#1)
prices and##2##2##(2008-11#1)(2008-7#1)
prices are##2##2##(1992-2#1)(1993-1#1)
prices for##7##2##(1990-12#1)(1992-1#1)(1992-2#1)(1993-1#1)(1994-12#1)(1994-2#1)(1995-6#1)
prices in##2##2##(1992-5#1)(1994-12#1)
prices of##4##2##(1997-6#1)(2006-12#1)(2008-11#1)(2013-8#1)
prices on##2##2##(1991-10#1)(2011-2#1)
prices to##2##2##(1991-10#1)(2008-7#1)
prices##66##1##(1990-12#2)(1991-1#1)(1991-10#2)(1991-12#3)(1991-2#2)(1992-1#2)(1992-11#1)(1992-2#3)(1992-5#2)(1993-1#2)(1993-2#1)(1993-3#2)(1994-1#4)(1994-12#4)(1994-2#1)(1994-3#1)(1995-1#2)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-6#1)(2006-12#1)(2006-4#2)(2006-5#1)(2007-11#1)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#3)(2008-7#4)(2010-6#1)(2011-2#3)(2012-12#2)(2013-8#1)
pricing and fair##2##3##(2008-11#2)
pricing and##6##2##(1995-12#1)(2008-11#3)(2008-12#1)(2008-7#1)
pricing to##2##2##(1990-5#1)(2008-11#1)
pricing##37##1##(1990-4#1)(1990-5#1)(1991-3#1)(1992-12#1)(1993-1#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-5#1)(1997-6#2)(2006-5#1)(2007-1#1)(2008-11#8)(2008-12#1)(2008-7#3)(2010-6#1)(2011-1#2)(2011-2#1)
prick test##11##2##(1992-9#1)(1993-5#2)(2007-2#6)(2008-10#1)(2012-3#1)
prick testing##7##2##(1996-8#1)(2006-8#1)(2007-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
prick tests (SPT) were conducted##2##5##(2007-3#1)(2008-10#1)
prick tests##7##2##(1992-9#1)(1993-5#1)(2006-10#1)(2007-3#1)(2007-9#1)(2008-10#1)(2012-3#1)
prick##33##1##(1990-11#1)(1992-9#2)(1993-5#3)(1996-8#1)(1997-6#1)(2006-10#2)(2006-3#1)(2006-8#1)(2007-2#9)(2007-3#1)(2007-9#1)(2008-10#3)(2008-2#1)(2012-12#1)(2012-3#3)(2013-1#2)
pricking##2##1##(2008-10#1)(2011-12#1)
prickle trichomes of##3##3##(2007-3#2)(2008-5#1)
prickle trichomes##5##2##(2007-3#2)(2008-5#3)
prickles##2##1##(1994-3#2)
prickly##3##1##(2007-1#1)(2008-10#1)(2010-12#1)
pride and##2##2##(1996-1#1)(2004-4#1)
pride##11##1##(1996-1#1)(1997-1#1)(2004-3#1)(2004-4#1)(2009-10#1)(2009-4#1)(2009-7#2)(2013-1#1)(2013-8#2)
priest##4##1##(1991-11#1)(1993-3#1)(1995-5#2)
prilocaine##4##1##(1993-1#1)(1995-11#1)(2005-7#1)(2008-10#1)
prima facie##2##2##(1997-7#1)(2008-10#1)
primacy of the##3##3##(2006-9#1)(2007-4#1)(2011-1#1)
primacy of##10##2##(2005-7#1)(2005-8#1)(2006-9#1)(2007-4#1)(2009-4#1)(2009-8#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
primacy##11##1##(2005-7#1)(2005-8#1)(2006-9#1)(2007-4#1)(2009-10#1)(2009-4#1)(2009-8#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
primaquine##9##1##(1993-8#1)(2005-8#1)(2006-10#1)(2006-4#2)(2008-2#2)(2008-4#1)(2008-8#1)
primaries##4##1##(1993-5#1)(2008-5#2)(2012-2#1)
primarily a##12##2##(1990-2#1)(1992-3#1)(1993-3#1)(1993-8#1)(1997-2#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-1#1)(2012-12#1)
primarily about##2##2##(1995-2#1)(2008-11#1)
primarily affecting the##2##3##(2006-10#1)(2013-1#1)
primarily affecting##3##2##(2006-10#1)(2010-12#1)(2013-1#1)
primarily affects the##6##3##(1993-7#1)(1995-3#1)(2007-7#2)(2008-1#1)(2012-2#1)
primarily affects##10##2##(1993-7#1)(1995-3#1)(2006-10#1)(2006-8#1)(2007-7#2)(2008-1#1)(2010-8#1)(2011-1#1)(2012-2#1)
primarily among##3##2##(1992-6#1)(1994-2#1)(2011-2#1)
primarily an##3##2##(1993-12#1)(1996-5#1)(2009-9#1)
primarily as a##8##3##(1995-10#1)(1995-3#1)(2007-7#1)(2007-9#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-1#1)
primarily as an##2##3##(1996-8#1)(2009-9#1)
primarily as##15##2##(1995-10#1)(1995-3#1)(1996-8#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#1)(2012-1#1)
primarily associated with the##3##4##(1994-10#1)(1995-9#1)(1997-7#1)
primarily associated with##4##3##(1994-10#1)(1995-9#1)(1997-7#1)(2008-9#1)
primarily at the##7##3##(1990-12#1)(1990-5#1)(1995-11#1)(2006-3#1)(2008-3#1)(2008-8#1)(2012-2#1)
primarily at##11##2##(1990-12#1)(1990-5#2)(1994-12#1)(1995-11#1)(2006-3#1)(2007-12#1)(2008-3#1)(2008-8#1)(2010-9#1)(2012-2#1)
primarily based on##5##3##(2008-8#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#1)
primarily be##3##2##(1992-2#1)(2006-7#1)(2008-10#1)
primarily because of slow##2##4##(1991-3#1)(1997-3#1)
primarily because of##8##3##(1991-12#1)(1991-3#1)(1994-3#1)(1997-3#1)(2007-2#1)(2010-7#1)(2013-1#2)
primarily because##13##2##(1991-11#1)(1991-12#1)(1991-3#1)(1992-6#1)(1994-3#1)(1997-3#1)(2006-4#1)(2007-2#1)(2007-4#1)(2008-5#1)(2010-7#1)(2013-1#2)
primarily by a##2##3##(1995-3#1)(2008-3#1)
primarily by its##2##3##(1990-12#1)(2008-8#1)
primarily by oxidation##2##3##(2008-8#1)(2013-7#1)
primarily by the##18##3##(1990-3#1)(1991-2#1)(1993-11#1)(1994-3#1)(1994-5#1)(1995-10#1)(1995-11#1)(1996-5#1)(1996-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#2)(2009-9#1)
primarily by##84##2##(1990-12#1)(1990-3#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-3#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(2004-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#15)(2008-11#3)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#3)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)
primarily caused by##5##3##(1994-11#1)(2007-9#3)(2008-8#1)
primarily characterized by##5##3##(1994-8#1)(2008-10#2)(2010-6#1)(2011-1#1)
primarily complicated gastric and intestinal ulcers##2##6##(2006-10#2)
primarily composed of##2##3##(1997-2#1)(2007-5#1)
primarily concerned with##2##3##(2007-11#1)(2013-1#1)
primarily consists of##2##3##(2008-3#1)(2011-2#1)
primarily contain##2##2##(1990-6#1)(2008-10#1)
primarily cultured scar##2##3##(2008-9#2)
primarily cultured##3##2##(2008-2#1)(2008-9#2)
primarily depend##2##2##(1990-9#1)(1994-9#1)
primarily dependent on##3##3##(1997-2#1)(2007-11#1)(2008-11#1)
primarily designed to##2##3##(1994-6#1)(2012-11#1)
primarily determined by##3##3##(2007-11#1)(2009-12#1)(2009-7#1)
primarily determined##5##2##(2007-11#1)(2009-12#1)(2009-7#1)(2013-1#2)
primarily diagnosed##2##2##(2012-12#1)(2013-1#1)
primarily driven by##4##3##(2005-10#1)(2008-10#1)(2011-1#1)(2012-2#1)
primarily due to an increase in##2##6##(1992-12#1)(2010-8#1)
primarily due to the##10##4##(1993-3#1)(1997-7#1)(1997-8#1)(2006-11#1)(2008-4#1)(2009-10#1)(2011-1#1)(2012-12#2)(2013-1#1)
primarily due to##25##3##(1991-12#1)(1992-12#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-3#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-11#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-3#2)(2008-4#1)(2009-10#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-12#2)(2013-1#2)
primarily during the##2##3##(2006-10#1)(2008-10#1)
primarily during##4##2##(1994-8#1)(2006-10#1)(2008-10#1)(2008-9#1)
primarily explained by##2##3##(2010-2#1)(2011-1#1)
primarily expressed in##3##3##(1990-6#1)(1992-5#1)(2007-11#1)
primarily female##2##2##(2010-11#1)(2011-2#1)
primarily focus##2##2##(2006-12#1)(2010-11#1)
primarily focused on the##3##4##(2011-1#1)(2011-2#1)(2012-3#1)
primarily focused on##6##3##(2008-3#1)(2008-4#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
primarily for the##2##3##(2008-7#1)(2009-3#1)
primarily for##11##2##(1997-3#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-3#1)(2012-3#2)
primarily form##2##2##(2008-10#1)(2008-6#1)
primarily found in##2##3##(1992-12#1)(2008-9#1)
primarily found##3##2##(1992-12#1)(2008-9#1)(2010-7#1)
primarily from an##2##3##(1990-5#1)(2011-2#1)
primarily from the##8##3##(1994-3#1)(1994-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-5#1)(2011-2#1)
primarily from##25##2##(1990-5#1)(1994-10#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-4#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-2#1)(2011-1#1)(2011-2#2)(2013-8#1)
primarily in patients with##2##4##(2004-1#1)(2005-10#1)
primarily in terms of##2##4##(2007-11#1)(2010-7#1)
primarily in the form of##3##5##(1995-3#1)(1996-10#1)(2008-7#1)
primarily in the##33##3##(1991-5#1)(1991-9#1)(1992-10#1)(1993-3#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-4#2)(1997-1#2)(1997-8#2)(2006-10#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-11#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#1)
primarily in those##2##3##(2006-8#1)(2007-7#1)
primarily in##65##2##(1990-2#1)(1991-5#1)(1991-9#1)(1992-10#1)(1993-3#2)(1994-9#1)(1995-3#2)(1995-5#3)(1995-6#1)(1996-1#1)(1996-10#1)(1996-4#2)(1996-5#1)(1997-1#2)(1997-4#1)(1997-6#1)(1997-8#4)(2004-1#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-11#2)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)(2010-11#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#1)
primarily indicated##2##2##(1996-11#1)(2012-3#1)
primarily influenced by the##2##4##(2008-3#1)(2010-8#1)
primarily influenced by##4##3##(2008-10#1)(2008-3#1)(2008-9#1)(2010-8#1)
primarily into##3##2##(1994-9#1)(2008-10#1)(2009-5#1)
primarily involve##4##2##(2006-10#1)(2007-10#1)(2008-11#1)(2008-5#1)
primarily involved in##5##3##(1997-8#1)(2007-12#1)(2008-4#1)(2012-12#1)(2013-1#1)
primarily involved##6##2##(1997-8#1)(2007-12#1)(2008-4#1)(2012-1#1)(2012-12#1)(2013-1#1)
primarily involving the##3##3##(1993-9#1)(1995-2#1)(1997-8#1)
primarily involving##4##2##(1993-9#1)(1995-1#1)(1995-2#1)(1997-8#1)
primarily localized in the##2##4##(1991-4#1)(1995-5#1)
primarily localized to the##3##4##(2005-8#1)(2008-10#1)(2008-5#1)
primarily localized##5##2##(1991-4#1)(1995-5#1)(2005-8#1)(2008-10#1)(2008-5#1)
primarily located in the##3##4##(1991-6#1)(2013-1#2)
primarily located##4##2##(1991-6#1)(2013-1#2)(2013-7#1)
primarily mediated##2##2##(2006-2#1)(2010-7#1)
primarily of the##2##3##(1996-2#1)(2009-7#1)
primarily of##19##2##(1992-12#1)(1992-5#1)(1994-3#1)(1995-10#1)(1996-2#1)(1997-5#1)(2004-1#1)(2004-3#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-1#1)(2009-11#1)(2009-7#1)(2012-2#1)(2012-3#1)
primarily on a##2##3##(1992-12#1)(2008-2#1)
primarily on the##23##3##(1991-11#1)(1992-6#1)(1995-12#1)(1996-1#1)(1997-5#1)(2005-7#1)(2006-7#2)(2007-10#1)(2007-11#1)(2007-2#2)(2007-5#1)(2007-7#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-3#1)
primarily on their##4##3##(1990-12#1)(2008-7#2)(2011-2#1)
primarily on##61##2##(1990-11#1)(1990-12#1)(1991-11#1)(1991-3#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-12#1)(1994-1#2)(1994-10#1)(1995-12#2)(1996-1#1)(1996-10#1)(1996-2#1)(1997-5#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-7#2)(2007-10#1)(2007-11#1)(2007-2#2)(2007-5#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-6#1)(2009-8#1)(2010-12#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
primarily or##3##2##(1990-2#1)(1992-8#1)(1993-6#1)
primarily palliative##2##2##(2005-9#1)(2007-8#1)
primarily predicted by##2##3##(2007-12#2)
primarily provider expertise##2##3##(1994-1#2)
primarily recognized##2##2##(1995-2#1)(2007-7#1)
primarily related to##3##3##(2008-1#1)(2011-2#1)(2012-1#1)
primarily responsible for the##9##4##(1990-12#1)(1995-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-12#1)(2012-1#1)
primarily responsible for##19##3##(1990-12#1)(1992-4#1)(1993-6#1)(1995-10#1)(1995-11#1)(1995-3#1)(1996-11#1)(1997-5#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-12#1)(2009-6#1)(2012-1#1)
primarily restricted to##2##3##(2005-7#1)(2008-10#1)
primarily still##2##2##(1995-12#1)(2010-10#1)
primarily the result of##4##4##(1991-1#1)(1993-7#1)(1994-3#1)(2010-8#1)
primarily the##15##2##(1990-4#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-8#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-8#1)(1996-4#1)(1996-5#1)(2006-9#1)(2010-8#1)(2012-2#1)
primarily their##2##2##(2010-12#1)(2011-2#1)
primarily through a##2##3##(2009-8#1)(2012-3#1)
primarily through an##2##3##(1996-11#1)(2008-4#1)
primarily through the##3##3##(1993-12#1)(1997-6#1)(2010-5#1)
primarily through##17##2##(1991-7#1)(1993-12#1)(1993-2#1)(1996-11#1)(1997-6#1)(2005-10#1)(2008-2#1)(2008-4#3)(2008-9#1)(2009-10#1)(2009-8#1)(2010-5#1)(2011-2#2)(2012-3#1)
primarily to determine##2##3##(2007-8#1)(2008-10#1)
primarily to the##10##3##(1994-5#1)(1995-2#1)(1996-8#1)(1996-9#1)(1997-5#1)(2006-7#1)(2008-10#1)(2008-4#1)(2008-8#1)(2012-1#1)
primarily to##59##2##(1990-12#1)(1991-6#1)(1991-7#1)(1992-6#1)(1993-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-5#2)(1997-7#1)(2006-10#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#7)(2008-3#5)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-3#2)(2009-7#1)(2010-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
primarily treated with##2##3##(1991-6#1)(2008-11#1)
primarily treated##3##2##(1991-6#1)(1997-1#1)(2008-11#1)
primarily upon##3##2##(1990-11#1)(1993-6#1)(2008-10#1)
primarily used for##2##3##(2008-4#2)
primarily used in##2##3##(2005-9#1)(2010-12#1)
primarily used##8##2##(2005-11#1)(2005-9#1)(2008-11#1)(2008-4#3)(2010-12#1)(2013-8#1)
primarily via##4##2##(2005-10#1)(2008-7#1)(2008-9#1)(2011-1#1)
primarily when these##2##3##(1991-12#1)(2008-2#1)
primarily with respect to the##3##5##(1991-10#1)(1996-5#1)(2011-1#1)
primarily with the##2##3##(1994-10#1)(2008-6#1)
primarily with##18##2##(1991-10#1)(1991-11#1)(1992-3#1)(1993-7#1)(1994-10#1)(1994-8#1)(1996-5#1)(1996-7#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-3#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-3#1)
primarily within the##2##3##(2006-12#1)(2010-9#1)
primarily within##3##2##(1995-10#1)(2006-12#1)(2010-9#1)
primarily##883##1##(1990-11#2)(1990-12#8)(1990-2#4)(1990-3#4)(1990-4#2)(1990-5#5)(1990-6#4)(1990-7#1)(1990-9#1)(1991-1#3)(1991-10#1)(1991-11#5)(1991-12#3)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#4)(1991-7#4)(1991-8#3)(1991-9#2)(1992-1#2)(1992-10#2)(1992-12#4)(1992-2#1)(1992-3#4)(1992-4#2)(1992-5#2)(1992-6#6)(1992-8#2)(1993-11#6)(1993-12#6)(1993-2#4)(1993-3#5)(1993-5#1)(1993-6#5)(1993-7#4)(1993-8#2)(1993-9#2)(1994-1#4)(1994-10#4)(1994-11#3)(1994-12#3)(1994-2#5)(1994-3#9)(1994-5#5)(1994-6#2)(1994-8#4)(1994-9#5)(1995-1#5)(1995-10#5)(1995-11#3)(1995-12#3)(1995-2#6)(1995-3#11)(1995-4#2)(1995-5#7)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#5)(1996-10#5)(1996-11#3)(1996-12#2)(1996-2#5)(1996-3#4)(1996-4#4)(1996-5#8)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#3)(1997-2#6)(1997-3#3)(1997-4#4)(1997-5#9)(1997-6#5)(1997-7#5)(1997-8#7)(2004-1#2)(2004-11#1)(2004-2#1)(2004-3#1)(2004-9#1)(2005-10#8)(2005-11#2)(2005-3#1)(2005-7#3)(2005-8#3)(2005-9#2)(2006-10#18)(2006-11#3)(2006-12#6)(2006-2#4)(2006-3#3)(2006-4#3)(2006-5#1)(2006-6#1)(2006-7#6)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#18)(2007-12#14)(2007-2#3)(2007-3#4)(2007-4#7)(2007-5#4)(2007-6#1)(2007-7#9)(2007-8#9)(2007-9#9)(2008-1#6)(2008-10#55)(2008-11#19)(2008-12#2)(2008-2#17)(2008-3#26)(2008-4#24)(2008-5#16)(2008-6#4)(2008-7#16)(2008-8#22)(2008-9#24)(2009-1#1)(2009-10#5)(2009-11#3)(2009-12#2)(2009-3#4)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#2)(2009-9#4)(2010-10#2)(2010-11#5)(2010-12#6)(2010-2#8)(2010-3#1)(2010-4#4)(2010-5#1)(2010-6#2)(2010-7#6)(2010-8#6)(2010-9#4)(2011-1#19)(2011-12#1)(2011-2#22)(2011-3#1)(2012-1#9)(2012-11#1)(2012-12#17)(2012-2#15)(2012-3#12)(2013-1#17)(2013-7#2)(2013-8#5)
primarly##2##1##(2008-8#1)(2011-2#1)
primary ACC of the##2##4##(2010-5#1)(2013-8#1)
primary ACC##3##2##(2010-5#1)(2013-8#2)
primary ACL reconstructions##2##3##(2008-4#1)(2012-2#1)
primary APS sera##2##3##(2006-10#2)
primary APS##3##2##(2006-10#3)
primary AVF##4##2##(2010-4#4)
primary B cells##3##3##(1991-2#1)(1995-2#1)(1996-11#1)
primary B##6##2##(1991-2#3)(1995-2#1)(1996-11#1)(2008-9#1)
primary CNS##3##2##(1996-4#1)(2006-12#1)(2008-2#1)
primary EL ERs in##4##4##(1993-9#4)
primary EPR signals##2##3##(1997-7#2)
primary EPR##3##2##(1997-7#3)
primary GN##4##2##(2007-7#3)(2008-1#1)
primary HIV infection##2##3##(1992-4#2)
primary HIV##3##2##(1992-4#2)(2005-6#1)
primary IgA nephropathy##2##3##(2007-11#2)
primary IgA##4##2##(2006-10#2)(2007-11#2)
primary IgM##2##2##(2008-10#2)
primary PCI##5##2##(2008-3#4)(2008-6#1)
primary SS##3##2##(2006-10#3)
primary Schwann cells##2##3##(1997-4#2)
primary Sjögren's syndrome##6##3##(1990-2#2)(2006-10#4)
primary T cells##2##3##(1994-9#1)(2008-4#1)
primary T##5##2##(1994-9#2)(1997-4#1)(2008-4#2)
primary THA cases with##2##4##(2013-1#2)
primary THA##4##2##(2009-3#1)(2013-1#3)
primary access##4##2##(2007-7#3)(2008-1#1)
primary active##3##2##(1990-12#2)(1990-6#1)
primary activities##2##2##(1995-12#1)(2006-7#1)
primary acute##2##2##(2006-1#1)(2008-4#1)
primary adrenal##4##2##(1991-10#1)(2007-9#1)(2013-1#2)
primary adult rat##2##3##(1992-2#1)(1995-8#1)
primary adult##4##2##(1992-2#1)(1995-8#1)(2011-2#1)(2013-1#1)
primary afferent axons##2##3##(1994-5#1)(1995-5#1)
primary afferent fibers in##3##4##(1996-3#1)(1997-2#2)
primary afferent fibers##10##3##(1990-7#1)(1991-5#1)(1994-8#1)(1995-12#1)(1996-3#3)(1997-2#2)(2008-4#1)
primary afferent fibres##3##3##(1991-8#1)(1997-3#1)(2008-7#1)
primary afferent neurons##7##3##(1990-4#1)(1995-12#2)(1996-5#1)(2006-10#2)(2008-4#1)
primary afferent terminal##2##3##(1990-5#1)(1994-8#1)
primary afferent terminals of##2##4##(1990-5#1)(1993-12#1)
primary afferent terminals##5##3##(1990-5#2)(1993-12#1)(1997-3#1)(2008-8#1)
primary afferent##47##2##(1990-4#1)(1990-5#3)(1990-7#2)(1991-5#1)(1991-8#1)(1993-12#1)(1993-2#1)(1994-5#1)(1994-8#2)(1995-12#5)(1995-5#4)(1996-3#3)(1996-5#2)(1996-6#1)(1996-7#1)(1997-2#2)(1997-3#3)(1997-4#1)(2006-10#3)(2006-12#1)(2008-4#2)(2008-7#2)(2008-8#1)(2010-12#2)(2011-2#1)
primary afferents and##3##3##(1995-5#2)(1995-7#1)
primary afferents are##2##3##(1990-7#1)(1997-3#1)
primary afferents in##2##3##(1991-9#1)(1992-8#1)
primary afferents may##2##3##(1992-6#1)(1994-12#1)
primary afferents##23##2##(1990-7#5)(1991-9#1)(1992-6#1)(1992-8#1)(1993-12#2)(1994-12#1)(1995-5#3)(1995-7#3)(1996-3#1)(1997-3#4)(2006-10#1)
primary aim of this##5##4##(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-2#1)
primary aim of##11##3##(2007-1#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-7#2)(2009-12#1)(2010-2#1)(2012-12#1)(2013-8#1)
primary aim was to##4##4##(2007-12#1)(2008-3#1)(2011-12#1)(2013-1#1)
primary aim##15##2##(2007-1#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-3#2)(2008-7#2)(2009-12#1)(2010-2#1)(2011-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
primary alcohol##2##2##(1992-2#1)(2006-12#1)
primary alcohols##5##2##(1992-2#1)(1995-11#1)(2006-12#1)(2007-11#1)(2010-5#1)
primary aldosteronism##8##2##(1990-11#3)(2006-9#3)(2008-4#2)
primary aliphatic##4##2##(2008-10#3)(2008-4#1)
primary amenorrhea##2##2##(2006-10#1)(2009-6#1)
primary amenorrhoea##2##2##(2007-7#1)(2012-3#1)
primary amine##11##2##(1997-8#1)(2007-8#1)(2008-10#7)(2010-12#1)(2011-1#1)
primary amines##6##2##(1996-2#1)(1996-5#1)(2007-11#1)(2010-8#1)(2012-11#1)(2012-3#1)
primary amino acid sequence of##2##5##(1990-11#1)(2012-2#1)
primary amino acid sequence##3##4##(1990-11#1)(1996-12#1)(2012-2#1)
primary amino acid sequences of##2##5##(1990-11#1)(1994-9#1)
primary amino acid##7##3##(1990-11#2)(1991-7#1)(1994-9#1)(1996-12#1)(2009-4#1)(2012-2#1)
primary amino acids##2##3##(1995-2#1)(1996-6#1)
primary amino group of##3##4##(1993-5#1)(2008-10#1)(2010-2#1)
primary amino group##9##3##(1993-5#1)(1996-8#4)(1997-8#1)(2008-10#1)(2008-4#1)(2010-2#1)
primary amino groups##5##3##(1990-11#1)(1995-2#1)(2008-10#1)(2008-5#1)(2010-4#1)
primary amino##26##2##(1990-11#3)(1991-7#1)(1993-1#1)(1993-5#1)(1994-9#2)(1995-2#2)(1996-12#1)(1996-6#1)(1996-8#4)(1997-8#1)(2008-10#3)(2008-4#1)(2008-5#1)(2009-4#1)(2010-2#1)(2010-4#1)(2012-2#1)
primary analysis of##2##3##(1997-4#1)(2008-8#1)
primary analysis##3##2##(1995-4#1)(1997-4#1)(2008-8#1)
primary anastomosis##2##2##(2007-9#1)(2009-2#1)
primary and a##2##3##(1990-6#1)(2008-9#1)
primary and alpha-secondary##2##3##(1991-2#2)
primary and interfering ions##2##4##(2008-10#2)
primary and interfering##3##3##(2008-10#3)
primary and metastatic liver##2##4##(2006-6#1)(2008-3#1)
primary and metastatic lung##2##4##(2012-2#1)(2012-3#1)
primary and metastatic sites##2##4##(1994-7#1)(2008-3#1)
primary and metastatic tumors in##2##5##(1997-7#1)(2009-9#1)
primary and metastatic tumors##4##4##(1997-7#1)(2005-7#1)(2009-9#1)(2010-9#1)
primary and metastatic##19##3##(1992-6#3)(1994-7#1)(1996-2#1)(1997-7#1)(2005-7#1)(2006-6#1)(2006-7#1)(2007-7#1)(2008-3#2)(2009-9#1)(2010-1#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
primary and permanent dentitions##4##4##(2008-12#1)(2008-5#1)(2012-2#2)
primary and permanent##7##3##(2008-12#1)(2008-5#2)(2008-9#1)(2012-2#3)
primary and preventive care##3##4##(1994-12#1)(2013-1#2)
primary and recurrent bladder##2##4##(1991-6#2)
primary and recurrent##10##3##(1990-9#1)(1991-10#1)(1991-6#4)(1996-2#1)(2007-11#1)(2008-6#1)(2012-1#1)
primary and secondary 18O isotope effects##3##6##(1991-7#3)
primary and secondary amines##2##4##(1996-5#1)(2008-10#1)
primary and secondary auditory cortex##3##5##(1994-5#1)(1997-7#1)(2010-7#1)
primary and secondary care##6##4##(1992-10#1)(1993-1#2)(2005-11#1)(2006-9#1)(2010-5#1)
primary and secondary dengue infection##2##5##(2012-2#1)(2012-3#1)
primary and secondary education##2##4##(2009-10#1)(2011-2#1)
primary and secondary foci##2##4##(2007-11#1)(2008-10#1)
primary and secondary infection##12##4##(2005-10#1)(2008-10#11)
primary and secondary patency of pedal bypasses##2##7##(2011-3#2)
primary and secondary patency##4##4##(2007-7#2)(2011-3#2)
primary and secondary prevention have##2##5##(1994-2#1)(2011-2#1)
primary and secondary prevention of coronary artery disease##2##8##(2006-5#1)(2010-2#1)
primary and secondary prevention of coronary##3##6##(2005-10#1)(2006-5#1)(2010-2#1)
primary and secondary prevention of##9##5##(2005-10#2)(2006-5#2)(2008-1#1)(2008-11#1)(2010-2#1)(2010-8#1)(2011-1#1)
primary and secondary prevention trials as studies on antiarrhythmic effects and meta-analyses are summarized##2##14##(2013-1#2)
primary and secondary prevention trials##3##5##(2013-1#2)(2013-8#1)
primary and secondary prevention##23##4##(1990-12#1)(1994-2#1)(1995-10#2)(1996-12#1)(2005-10#2)(2006-2#1)(2006-5#3)(2008-1#1)(2008-11#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
primary and secondary schools##2##4##(2007-1#1)(2007-12#1)
primary and secondary sexual characters##2##5##(1995-2#2)
primary and secondary structures of##2##5##(1993-9#1)(2008-5#1)
primary and secondary##139##3##(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-4#1)(1991-7#4)(1992-10#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-1#3)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-7#1)(1994-8#1)(1995-10#3)(1995-2#4)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-7#1)(2004-12#1)(2005-10#3)(2005-11#2)(2006-10#1)(2006-12#2)(2006-2#1)(2006-5#3)(2006-7#2)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#4)(2008-1#1)(2008-10#17)(2008-11#3)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#3)(2009-7#1)(2009-9#2)(2010-11#2)(2010-2#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#7)(2011-3#2)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#2)
primary and specialty care##2##4##(1990-12#1)(1997-1#1)
primary and tertiary##3##3##(1992-9#1)(2008-9#1)(2012-1#1)
primary and##247##2##(1990-12#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-6#4)(1991-7#4)(1991-8#1)(1992-10#1)(1992-11#1)(1992-3#2)(1992-6#6)(1992-9#2)(1993-1#4)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#4)(1994-7#2)(1994-8#1)(1995-10#3)(1995-2#5)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-5#1)(1996-7#1)(1997-1#2)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#2)(2004-12#1)(2005-10#3)(2005-11#2)(2005-7#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-5#3)(2006-6#1)(2006-7#3)(2006-8#1)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-4#2)(2007-5#1)(2007-7#5)(2007-8#1)(2008-1#1)(2008-10#20)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#5)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#3)(2009-7#1)(2009-9#3)(2010-1#1)(2010-11#2)(2010-12#1)(2010-2#3)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#7)(2011-3#2)(2012-1#2)(2012-12#1)(2012-2#7)(2012-3#4)(2013-1#8)(2013-7#4)(2013-8#3)
primary angioplasty for##2##3##(2008-3#1)(2008-4#1)
primary angioplasty in##2##3##(2007-5#1)(2008-3#1)
primary angioplasty##7##2##(2007-5#1)(2008-3#4)(2008-4#2)
primary angiosarcoma##3##2##(2008-11#2)(2008-6#1)
primary antibodies##3##2##(1990-12#1)(2007-12#1)(2008-8#1)
primary antibody and##3##3##(2008-11#2)(2008-2#1)
primary antibody followed by##2##4##(2008-9#1)(2012-3#1)
primary antibody##25##2##(1992-8#3)(2004-1#1)(2007-2#5)(2008-10#5)(2008-11#4)(2008-2#1)(2008-4#3)(2008-5#1)(2008-9#1)(2012-3#1)
primary antifungal##2##2##(2007-11#1)(2010-11#1)
primary antiphospholipid syndrome (PAPS)##2##4##(2006-10#1)(2011-2#1)
primary antiphospholipid syndrome##7##3##(2006-10#5)(2011-2#2)
primary application##2##2##(2007-7#1)(2008-7#1)
primary applications##2##2##(2007-8#1)(2012-12#1)
primary appraisals##2##2##(2012-1#2)
primary approaches to##2##3##(2008-1#1)(2010-8#1)
primary aromatic amines##3##3##(2007-12#2)(2011-1#1)
primary arthroplasty group##2##3##(2009-3#1)(2013-1#1)
primary arthroplasty##5##2##(2007-12#1)(2009-3#1)(2011-2#1)(2013-1#2)
primary as well as##2##4##(2006-8#1)(2009-10#1)
primary astrocyte cultures from##2##4##(1996-1#1)(1996-6#1)
primary astrocyte cultures##6##3##(1993-7#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-6#1)(2008-11#1)
primary auditory cortex##8##3##(1991-3#1)(1996-2#2)(2008-11#3)(2012-2#1)(2013-8#1)
primary auditory##9##2##(1991-3#1)(1995-5#1)(1996-2#2)(2008-11#3)(2012-2#1)(2013-8#1)
primary autoimmune##2##2##(2006-6#1)(2008-12#1)
primary axon scaffold of the##2##5##(2007-12#2)
primary beam##6##2##(2007-2#1)(2008-2#2)(2009-11#1)(2010-2#2)
primary benign##5##2##(1997-8#1)(2007-10#1)(2007-4#1)(2007-8#1)(2010-7#1)
primary biliary cirrhosis (PBC) and##2##5##(1992-6#1)(2008-12#1)
primary biliary cirrhosis (PBC) or##2##5##(2007-11#1)(2012-2#1)
primary biliary cirrhosis (PBC)##6##4##(1992-6#1)(1992-8#1)(2004-11#1)(2007-11#1)(2008-12#1)(2012-2#1)
primary biliary cirrhosis and autoimmune##2##5##(2004-11#2)
primary biliary cirrhosis and primary sclerosing cholangitis##3##7##(2004-11#2)(2005-8#1)
primary biliary cirrhosis and##10##4##(1990-3#1)(1991-1#1)(2004-11#4)(2005-8#1)(2006-10#1)(2012-12#1)(2012-2#1)
primary biliary cirrhosis with##2##4##(1996-11#1)(2004-11#1)
primary biliary cirrhosis##55##3##(1990-3#1)(1990-9#1)(1991-1#3)(1991-5#1)(1992-12#3)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-5#1)(1993-8#1)(1994-2#1)(1996-11#1)(1996-4#1)(2004-11#19)(2005-8#2)(2006-10#7)(2006-2#1)(2007-11#3)(2008-12#1)(2012-12#1)(2012-2#2)
primary biliary##56##2##(1990-3#1)(1990-9#1)(1991-1#3)(1991-5#1)(1992-12#4)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-5#1)(1993-8#1)(1994-2#1)(1996-11#1)(1996-4#1)(2004-11#19)(2005-8#2)(2006-10#7)(2006-2#1)(2007-11#3)(2008-12#1)(2012-12#1)(2012-2#2)
primary binding site of##2##4##(1992-1#1)(2008-3#1)
primary binding site##4##3##(1992-1#1)(1997-3#1)(2008-10#1)(2008-3#1)
primary binding##5##2##(1992-1#1)(1994-12#1)(1997-3#1)(2008-10#1)(2008-3#1)
primary biodiversity data are##2##4##(2012-3#2)
primary biodiversity data##8##3##(2012-3#8)
primary biological##3##2##(1995-2#1)(2005-8#1)(2008-3#1)
primary blood##3##2##(2011-2#2)(2012-12#1)
primary bone lymphoma##3##3##(2007-5#3)
primary bone tumors##6##3##(2007-7#1)(2008-2#3)(2009-3#1)(2012-12#1)
primary bone##17##2##(1990-11#1)(2007-5#3)(2007-7#2)(2008-2#3)(2008-6#3)(2008-7#1)(2009-3#1)(2010-3#1)(2012-12#1)(2012-2#1)
primary brain tumor##4##3##(2006-10#1)(2007-10#1)(2008-11#1)(2008-5#1)
primary brain tumors##6##3##(1991-12#1)(2005-10#1)(2008-8#1)(2010-12#1)(2013-7#1)(2013-8#1)
primary brain tumours##4##3##(2007-10#1)(2007-11#1)(2013-1#2)
primary brain##14##2##(1991-12#1)(2005-10#1)(2006-10#1)(2007-10#2)(2007-11#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
primary breast cancer (n =##2##5##(1993-1#2)
primary breast cancer patients##2##4##(1994-12#1)(1996-4#1)
primary breast cancer##22##3##(1990-8#3)(1991-12#2)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#1)(1993-1#2)(1993-5#1)(1994-12#1)(1994-7#1)(1995-10#2)(1996-3#1)(1996-4#1)(1997-7#1)(2007-5#2)(2013-1#1)
primary breast cancers##2##3##(1990-10#1)(2007-6#1)
primary breast carcinoma and##2##4##(1990-5#1)(2004-1#1)
primary breast carcinoma##4##3##(1990-5#1)(1993-9#1)(1994-8#1)(2004-1#1)
primary breast carcinomas##2##3##(1997-7#1)(2004-1#1)
primary breast tumor##2##3##(2011-1#1)(2011-12#1)
primary breast##41##2##(1990-10#1)(1990-5#1)(1990-8#3)(1991-12#2)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#1)(1993-1#2)(1993-5#1)(1993-9#1)(1994-12#1)(1994-7#1)(1994-8#1)(1995-10#3)(1996-3#1)(1996-4#1)(1997-7#2)(2004-1#2)(2007-4#2)(2007-5#2)(2007-6#2)(2009-2#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-7#1)
primary breast-cancer patients##2##3##(1993-9#2)
primary cancer site##2##3##(2008-7#1)(2013-8#1)
primary cancer##19##2##(1990-12#1)(1993-1#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-5#1)(1995-4#1)(1996-4#1)(2006-2#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2011-1#1)(2012-12#1)(2013-8#1)
primary cancers##6##2##(1991-6#1)(2008-4#1)(2009-10#1)(2009-9#1)(2012-12#1)(2013-1#1)
primary canines##4##2##(2008-5#1)(2010-3#3)
primary carbon##3##2##(1994-5#1)(2008-3#1)(2008-7#1)
primary carcinoma of the##5##4##(1992-9#1)(1993-8#1)(2007-8#2)(2012-12#1)
primary carcinoma of##6##3##(1992-9#1)(1993-8#1)(2007-8#2)(2011-1#1)(2012-12#1)
primary carcinoma##10##2##(1992-9#1)(1993-8#1)(1994-6#1)(2004-1#1)(2006-2#1)(2007-8#2)(2011-1#2)(2012-12#1)
primary cardiac##10##2##(1994-6#1)(2005-1#1)(2005-9#2)(2007-12#2)(2007-8#2)(2009-4#1)(2010-9#1)
primary cardiomyopathies##2##2##(1995-12#2)
primary care and##13##3##(1993-2#1)(1993-5#1)(1993-9#1)(1996-12#1)(1997-3#2)(2007-11#1)(2007-5#1)(2008-7#1)(2009-11#1)(2012-1#2)(2012-12#1)
primary care appointment##3##3##(2006-10#3)
primary care are##2##3##(1994-8#1)(2006-8#1)
primary care as##4##3##(1995-4#1)(1996-9#1)(2006-8#1)(2011-12#1)
primary care case##2##3##(1991-2#1)(1994-3#1)
primary care clinic##6##3##(1993-12#1)(1996-3#1)(2008-8#1)(2010-8#1)(2011-1#1)(2013-1#1)
primary care clinics##3##3##(2009-9#1)(2010-8#1)(2011-1#1)
primary care for##4##3##(1996-4#1)(1997-2#2)(2006-9#1)
primary care givers##2##3##(1990-10#1)(2005-12#1)
primary care health##4##3##(1993-6#1)(1994-9#1)(2006-7#1)(2011-2#1)
primary care hospital##2##3##(1993-12#1)(2006-12#1)
primary care in the##6##4##(1995-3#1)(1996-9#1)(1997-5#1)(2006-8#3)
primary care in##11##3##(1995-3#1)(1996-9#1)(1997-5#1)(2006-10#1)(2006-8#3)(2006-9#2)(2010-12#1)(2013-1#1)
primary care is##2##3##(1996-8#1)(2006-9#1)
primary care management##8##3##(1994-6#2)(1995-6#1)(1996-3#1)(2006-5#4)
primary care medical practices##3##4##(2007-9#1)(2008-4#2)
primary care medical##4##3##(2007-9#1)(2008-4#2)(2012-2#1)
primary care nurse##2##3##(1996-3#1)(2010-9#1)
primary care physician as##3##4##(1996-4#1)(1997-2#1)(2008-10#1)
primary care physician in##3##4##(1994-10#1)(1995-2#1)(2010-8#1)
primary care physician##17##3##(1994-10#1)(1995-2#1)(1995-9#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-2#2)(2008-10#1)(2008-12#2)(2008-8#1)(2009-9#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
primary care physician's##2##3##(1996-4#1)(2008-7#1)
primary care physicians (PCPs)##2##4##(1995-3#1)(2006-10#1)
primary care physicians and##9##4##(1994-11#1)(1994-8#1)(2007-4#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#1)
primary care physicians in##2##4##(1994-11#1)(1996-9#1)
primary care physicians on##2##4##(2007-10#1)(2011-2#1)
primary care physicians to##2##4##(2006-10#1)(2007-10#1)
primary care physicians##47##3##(1994-11#2)(1994-12#1)(1994-8#1)(1995-3#2)(1996-11#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(2004-3#2)(2006-10#3)(2006-9#1)(2007-10#5)(2007-12#1)(2007-4#1)(2007-9#2)(2008-12#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-9#4)(2010-12#1)(2010-3#3)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
primary care practice##4##3##(1993-10#1)(1995-2#1)(2004-3#1)(2011-2#1)
primary care practices##2##3##(2008-11#1)(2013-1#1)
primary care practitioners need to##2##5##(2004-3#1)(2010-8#1)
primary care practitioners##8##3##(1996-1#1)(2004-3#3)(2008-7#1)(2010-8#1)(2011-1#2)
primary care prevention##2##3##(1993-12#1)(2007-5#1)
primary care professionals##2##3##(2013-1#2)
primary care provider##3##3##(1993-1#1)(1995-3#1)(2007-10#1)
primary care providers to##3##4##(1994-2#1)(2011-1#1)(2011-2#1)
primary care providers##19##3##(1993-9#1)(1994-2#1)(1996-1#1)(2006-2#1)(2006-7#3)(2007-6#1)(2008-2#1)(2008-7#1)(2009-11#2)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-8#1)
primary care quality##2##3##(2008-11#1)(2011-2#1)
primary care reform##3##3##(2010-11#3)
primary care services in the##2##5##(1995-12#1)(2008-12#1)
primary care services in##3##4##(1995-12#1)(2007-1#1)(2008-12#1)
primary care services##12##3##(1995-12#1)(1997-8#1)(2007-1#1)(2008-12#1)(2008-2#2)(2010-8#2)(2011-2#1)(2012-11#3)
primary care setting##29##3##(1996-12#5)(2004-3#1)(2006-2#1)(2006-5#3)(2006-7#1)(2007-5#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-8#4)(2009-5#1)(2009-9#1)(2010-1#2)(2010-2#1)(2013-1#2)
primary care settings##10##3##(1996-12#1)(2006-1#1)(2006-5#2)(2008-11#2)(2008-2#1)(2009-12#2)(2009-9#1)
primary care sites)##2##3##(1996-2#2)
primary care teams##3##3##(1993-10#1)(1995-6#1)(2006-5#1)
primary care to##5##3##(1994-10#1)(1995-12#1)(1995-4#1)(1996-9#1)(2008-11#1)
primary care training##5##3##(1995-2#1)(1996-1#3)(2008-1#1)
primary care treatment##2##3##(1995-6#1)(2010-7#1)
primary care##439##2##(1990-10#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-2#2)(1992-7#1)(1992-8#2)(1993-1#4)(1993-10#3)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-4#2)(1993-5#2)(1993-6#3)(1993-9#4)(1994-10#2)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#5)(1994-8#4)(1994-9#3)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#5)(1995-3#5)(1995-4#3)(1995-5#1)(1995-6#4)(1995-9#2)(1996-1#8)(1996-10#2)(1996-11#5)(1996-12#16)(1996-2#10)(1996-3#6)(1996-4#5)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#5)(1997-1#2)(1997-2#6)(1997-3#11)(1997-5#4)(1997-8#4)(2004-1#1)(2004-3#11)(2005-11#1)(2005-12#2)(2006-1#1)(2006-10#8)(2006-12#1)(2006-2#3)(2006-5#14)(2006-7#6)(2006-8#6)(2006-9#8)(2007-1#1)(2007-10#6)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#5)(2007-6#1)(2007-7#2)(2007-9#3)(2008-1#1)(2008-10#1)(2008-11#13)(2008-12#9)(2008-2#6)(2008-3#1)(2008-4#3)(2008-6#4)(2008-7#15)(2008-8#6)(2008-9#2)(2009-1#1)(2009-11#3)(2009-12#2)(2009-2#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#11)(2010-1#2)(2010-11#4)(2010-12#3)(2010-2#1)(2010-3#4)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#12)(2010-9#1)(2011-1#14)(2011-12#1)(2011-2#17)(2012-1#3)(2012-11#6)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#12)(2013-7#1)(2013-8#5)
primary care?]##4##2##(1993-4#1)(1995-5#1)(1996-11#1)(1997-6#1)
primary care]##45##2##(1992-1#1)(1993-10#1)(1993-11#2)(1993-2#4)(1993-3#1)(1993-4#3)(1993-5#1)(1993-6#2)(1993-9#1)(1994-10#2)(1994-11#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-10#1)(1995-11#2)(1995-3#2)(1995-6#2)(1996-11#1)(1996-3#3)(1996-4#1)(1996-5#2)(1996-6#2)(1996-9#2)(1997-3#1)(1997-5#1)
primary caregiver##4##2##(2006-1#1)(2009-4#2)(2009-5#1)
primary caregivers##6##2##(1991-3#1)(1995-12#1)(2007-11#2)(2010-7#1)(2010-8#1)
primary cataract##2##2##(2008-5#2)
primary cause for##4##3##(2008-1#1)(2008-10#1)(2008-3#1)(2011-1#1)
primary cause of##15##3##(1994-9#1)(1996-12#1)(2005-7#1)(2005-8#1)(2006-4#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-3#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
primary cause##24##2##(1994-9#1)(1996-1#1)(1996-12#1)(2005-7#1)(2005-8#1)(2006-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#2)(2013-1#1)(2013-8#1)
primary cell culture##2##3##(2008-9#1)(2009-3#1)
primary cell cultures from Indian water snake (Natrix piscator) and Indian mugger (Crocodylus palustris) embryos##2##15##(2010-3#2)
primary cell cultures from##3##4##(2008-11#1)(2010-3#2)
primary cell cultures of rat##3##5##(1990-5#1)(2008-10#1)(2008-7#1)
primary cell cultures of##4##4##(1990-5#1)(1997-2#1)(2008-10#1)(2008-7#1)
primary cell cultures##12##3##(1990-5#2)(1996-1#1)(1996-11#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-3#2)
primary cell##18##2##(1990-5#2)(1996-1#1)(1996-11#1)(1996-12#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-3#3)
primary cells and##2##3##(2008-11#1)(2008-4#1)
primary cells in##2##3##(1996-4#1)(2008-11#1)
primary cells to##2##3##(2008-4#1)(2009-4#1)
primary cells##20##2##(1994-3#1)(1996-4#1)(1997-2#1)(1997-4#1)(2008-11#6)(2008-4#4)(2008-5#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-3#1)(2011-2#1)
primary central nervous system lymphoma (PCNSL)##2##6##(2005-10#1)(2008-7#1)
primary central nervous system lymphoma##7##5##(1991-6#1)(1996-11#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-7#1)
primary central nervous system##10##4##(1991-6#1)(1996-11#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-10#1)(2007-12#2)(2008-7#1)(2010-5#1)
primary central##12##2##(1991-6#1)(1996-11#1)(1996-4#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-10#1)(2007-12#2)(2008-7#1)(2010-5#1)(2012-12#1)
primary cerebral##2##2##(1991-6#1)(2009-3#1)
primary changes in##2##3##(1994-4#1)(2007-9#1)
primary charge separation##2##3##(1991-7#2)
primary chemotherapy##5##2##(1992-6#1)(1993-2#1)(1996-4#1)(2008-9#1)(2010-2#1)
primary chicken##4##2##(1991-3#1)(1994-8#1)(2008-11#1)(2013-8#1)
primary choice##4##2##(2006-6#1)(2007-12#1)(2007-7#2)
primary ciliary dyskinesia and##2##4##(2005-11#1)(2007-9#1)
primary ciliary dyskinesia##4##3##(2005-11#1)(2007-9#2)(2008-4#1)
primary cilium##4##2##(2012-12#1)(2013-1#3)
primary clinical manifestation of##2##4##(2008-3#1)(2010-5#1)
primary clinical##5##2##(2008-3#1)(2008-5#1)(2008-7#1)(2010-5#1)(2013-8#1)
primary closure of##2##3##(2008-7#1)(2011-12#1)
primary closure##8##2##(2006-12#1)(2007-12#1)(2008-6#1)(2008-7#1)(2011-12#2)(2012-3#1)(2013-1#1)
primary colorectal##3##2##(1991-7#1)(2008-11#1)(2013-7#1)
primary component##4##2##(2006-9#1)(2007-12#1)(2008-10#1)(2009-4#1)
primary components##3##2##(1992-9#1)(2008-9#1)(2013-8#1)
primary concern of##3##3##(2004-3#1)(2005-7#1)(2012-1#1)
primary concern was##2##3##(1997-2#1)(2011-2#1)
primary concern##10##2##(1992-8#1)(1994-2#1)(1997-2#1)(2004-3#1)(2005-10#1)(2005-7#1)(2008-11#1)(2010-8#1)(2011-2#1)(2012-1#1)
primary consideration##2##2##(2012-12#1)(2013-1#1)
primary contact site with##2##4##(1991-4#2)
primary contact##5##2##(1991-4#2)(1993-8#1)(2007-11#1)(2008-3#1)
primary control##3##2##(1993-4#1)(2012-1#2)
primary coronary angioplasty with stent implantation##2##6##(2007-9#2)
primary coronary intervention##2##3##(2008-3#1)(2009-5#1)
primary coronary##5##2##(2007-9#2)(2008-11#1)(2008-3#1)(2009-5#1)
primary cortical##5##2##(1995-5#1)(2008-4#2)(2008-7#1)(2010-12#1)
primary culture and##4##3##(1990-12#1)(1990-7#1)(1993-8#1)(2012-12#1)
primary culture of rat##2##4##(1992-3#2)
primary culture of##11##3##(1990-10#2)(1992-3#2)(1993-4#1)(1993-8#2)(2008-11#1)(2012-1#1)(2013-1#2)
primary culture##47##2##(1990-10#5)(1990-12#1)(1990-7#1)(1991-10#2)(1991-2#1)(1991-5#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-8#2)(1993-3#1)(1993-4#1)(1993-8#3)(1993-9#2)(1994-12#1)(1994-3#1)(1994-8#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1996-4#1)(1997-2#2)(1997-7#1)(2008-11#2)(2008-6#1)(2009-6#2)(2012-1#1)(2012-12#1)(2013-1#3)
primary cultured cerebral cortical neurons##2##5##(1994-2#1)(1996-2#1)
primary cultured cerebral cortical##3##4##(1994-2#1)(1996-2#2)
primary cultured hepatocytes##3##3##(1991-1#1)(1991-5#1)(1996-11#1)
primary cultured human##4##3##(1991-5#1)(2008-5#3)
primary cultured neurons##3##3##(1990-10#1)(1994-2#1)(1994-5#1)
primary cultured rat hepatocytes##8##4##(1990-9#3)(1991-1#1)(1991-4#1)(1991-7#1)(1993-6#2)
primary cultured rat##9##3##(1990-9#3)(1991-1#1)(1991-4#1)(1991-7#1)(1992-1#1)(1993-6#2)
primary cultured##32##2##(1990-10#1)(1990-9#3)(1991-1#2)(1991-2#2)(1991-4#1)(1991-5#3)(1991-7#1)(1992-1#1)(1993-6#2)(1994-2#4)(1994-5#1)(1996-10#1)(1996-11#1)(1996-2#2)(2007-11#1)(2008-5#4)(2010-3#1)(2010-7#1)
primary cultures derived from the##2##5##(1992-11#1)(1996-11#1)
primary cultures derived from##3##4##(1991-5#1)(1992-11#1)(1996-11#1)
primary cultures from##3##3##(1991-12#1)(1996-5#1)(1997-8#1)
primary cultures of fetal##2##4##(1994-3#1)(1996-5#1)
primary cultures of hepatocytes##3##4##(1991-5#1)(1994-11#2)
primary cultures of human pancreatic##2##5##(2010-11#2)
primary cultures of human##5##4##(1993-3#2)(2008-11#1)(2010-11#2)
primary cultures of mesencephalic##2##4##(1993-6#1)(1996-10#1)
primary cultures of mouse##5##4##(1990-5#1)(1993-6#1)(1994-2#2)(1996-1#1)
primary cultures of rat hepatocytes##7##5##(1990-7#1)(1994-11#2)(1994-5#1)(2004-11#2)(2008-11#1)
primary cultures of rat hippocampal##2##5##(1993-4#1)(2008-4#1)
primary cultures of rat##14##4##(1990-7#2)(1993-4#1)(1994-11#2)(1994-5#1)(1995-11#1)(1997-6#2)(2004-11#2)(2008-11#1)(2008-4#2)
primary cultures of the##4##4##(1990-7#1)(1995-11#1)(1996-2#1)(2011-2#1)
primary cultures of##63##3##(1990-12#1)(1990-5#1)(1990-7#3)(1991-5#3)(1992-11#3)(1992-5#1)(1992-9#1)(1993-3#2)(1993-4#1)(1993-6#2)(1994-10#1)(1994-11#4)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#4)(1995-12#3)(1995-3#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-2#1)(1996-5#2)(1997-6#2)(2004-11#2)(2008-11#2)(2008-4#3)(2009-9#1)(2010-10#2)(2010-11#3)(2011-2#1)(2012-12#2)(2012-3#1)
primary cultures##83##2##(1990-12#1)(1990-5#1)(1990-7#3)(1991-12#1)(1991-2#3)(1991-5#4)(1992-11#4)(1992-2#1)(1992-5#1)(1992-9#1)(1993-3#2)(1993-4#1)(1993-6#2)(1994-10#1)(1994-11#4)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#4)(1995-12#5)(1995-3#1)(1995-7#1)(1995-8#1)(1996-1#3)(1996-10#2)(1996-11#2)(1996-2#1)(1996-5#3)(1996-6#1)(1996-9#1)(1997-6#2)(1997-8#1)(2004-11#2)(2007-10#1)(2008-1#1)(2008-11#3)(2008-4#3)(2009-9#1)(2010-10#2)(2010-11#3)(2011-2#1)(2012-12#2)(2012-3#1)
primary cutaneous histoplasmosis##2##3##(2007-7#2)
primary cutaneous##14##2##(1991-6#1)(1992-4#1)(2007-7#6)(2009-4#2)(2010-12#1)(2010-8#2)(2011-1#1)
primary cytoreductive surgery##2##3##(2011-2#2)
primary data source##2##3##(2008-1#1)(2008-9#1)
primary data##4##2##(1995-8#1)(2008-1#1)(2008-10#1)(2008-9#1)
primary decision##3##2##(1990-11#1)(2005-7#1)(2013-1#1)
primary defect in##4##3##(1994-11#1)(1994-5#1)(2008-1#1)(2008-10#1)
primary defect##9##2##(1992-2#1)(1994-11#2)(1994-3#1)(1994-5#1)(1995-4#1)(2006-5#1)(2008-1#1)(2008-10#1)
primary defense##3##2##(1997-2#2)(2008-7#1)
primary deficit in##2##3##(2008-11#1)(2008-2#1)
primary deficit##3##2##(2007-8#1)(2008-11#1)(2008-2#1)
primary degenerative##3##2##(2008-4#2)(2008-6#1)
primary degradation##4##2##(1990-4#1)(2007-8#1)(2008-10#2)
primary dendrites##2##2##(1996-9#1)(2007-12#1)
primary dengue##2##2##(2012-2#1)(2013-8#1)
primary dentition##5##2##(2008-5#2)(2011-2#1)(2012-12#2)
primary deuterium isotope effect##2##4##(1994-11#1)(1994-8#1)
primary diagnosis in a##2##4##(2004-9#1)(2010-3#1)
primary diagnosis in##5##3##(1992-1#2)(2004-9#1)(2006-8#1)(2010-3#1)
primary diagnosis of##7##3##(1991-9#1)(2006-8#1)(2007-10#1)(2007-3#2)(2008-1#1)(2008-3#1)
primary diagnosis##25##2##(1991-1#1)(1991-9#1)(1992-1#2)(1994-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(2004-9#2)(2006-8#4)(2007-10#1)(2007-3#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-3#2)(2012-2#1)
primary diagnostic tool##2##3##(2006-8#1)(2008-2#1)
primary diagnostic##6##2##(1990-6#1)(2005-9#1)(2006-8#1)(2008-2#1)(2008-6#1)(2012-12#1)
primary disc related##3##3##(2006-11#1)(2006-12#2)
primary disease gradients##2##3##(2008-10#2)
primary disease##11##2##(1991-3#1)(1997-4#1)(2007-12#1)(2008-10#4)(2008-6#1)(2009-8#1)(2011-1#1)(2013-1#1)
primary diseases of##2##3##(1997-6#1)(2012-3#1)
primary diseases##3##2##(1997-6#1)(2012-12#1)(2012-3#1)
primary disorder##4##2##(1993-10#1)(1996-12#1)(2007-1#1)(2007-6#1)
primary doctor##2##2##(2007-10#1)(2011-12#1)
primary drug resistance##2##3##(1996-11#1)(2006-11#1)
primary drug##3##2##(1996-11#1)(2005-8#1)(2006-11#1)
primary dysmenorrhea##2##2##(1994-3#1)(2008-3#1)
primary dysmenorrhoea##2##2##(1994-9#2)
primary education##3##2##(2013-1#3)
primary effect of##7##3##(1990-7#1)(1992-2#1)(1994-2#1)(1994-8#1)(2007-8#1)(2008-11#1)(2010-1#1)
primary effector of##2##3##(2008-4#1)(2010-7#1)
primary efficacy endpoint##2##3##(2008-7#2)
primary efficacy measure##2##3##(2008-7#1)(2012-2#1)
primary efficacy##8##2##(2007-10#1)(2007-9#1)(2008-7#4)(2012-2#2)
primary electron acceptor##2##3##(1995-11#2)
primary electron donor is##3##4##(2008-8#3)
primary electron donor##9##3##(1991-7#1)(1992-6#2)(1993-11#2)(2008-8#4)
primary electron##14##2##(1991-7#2)(1992-6#2)(1993-11#2)(1995-11#3)(2007-5#1)(2008-8#4)
primary emulsifier##3##2##(2008-5#3)
primary end point##10##3##(2006-6#1)(2007-8#3)(2007-9#1)(2008-3#1)(2009-11#3)(2012-2#1)
primary end##13##2##(2006-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-3#1)(2009-11#3)(2010-7#1)(2010-9#1)(2012-2#1)
primary end-point was##3##3##(2007-11#1)(2011-1#1)(2012-2#1)
primary end-point##4##2##(2007-11#1)(2008-8#1)(2011-1#1)(2012-2#1)
primary endometrial##3##2##(1990-2#1)(1994-9#2)
primary endosperm##5##2##(2008-9#5)
primary endpoint for this trial##2##5##(2005-8#2)
primary endpoint for##3##3##(2005-8#2)(2007-9#1)
primary endpoint of##4##3##(1997-4#1)(2008-5#1)(2009-8#1)(2010-4#1)
primary endpoint##15##2##(1997-2#1)(1997-4#1)(2005-8#2)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-8#1)(2010-4#1)(2010-8#1)
primary endpoints##2##2##(2008-1#1)(2012-1#1)
primary esophageal carcinomas##2##3##(1992-8#2)
primary esophageal##6##2##(1992-8#2)(2007-8#1)(2010-12#1)(2011-1#1)(2012-2#1)
primary etiological##2##2##(2008-12#1)(2011-12#1)
primary event##3##2##(1995-1#1)(2008-3#1)(2010-11#1)
primary events##2##2##(1995-3#1)(2008-7#1)
primary experimental##4##2##(1995-8#1)(2007-11#1)(2008-2#1)(2012-1#1)
primary extremity sarcoma##2##3##(2008-6#2)
primary factor responsible for##2##4##(2008-3#1)(2010-3#1)
primary factor##9##2##(2007-8#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-9#1)(2009-5#1)(2010-3#1)
primary failure##2##2##(1993-2#1)(2012-3#1)
primary fibroblasts##4##2##(1991-10#1)(2012-12#1)(2013-8#2)
primary findings##2##2##(2008-11#1)(2009-5#1)
primary focus of the##3##4##(2007-11#2)(2008-4#1)
primary focus of this##3##4##(2008-1#1)(2008-11#1)(2008-7#1)
primary focus of##10##3##(2006-6#1)(2007-11#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)
primary focus##16##2##(1990-3#1)(1994-2#1)(2006-6#1)(2007-11#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2013-1#2)
primary follicles are##2##3##(2008-1#2)
primary follicles##6##2##(1995-12#2)(2008-1#4)
primary forms##2##2##(1992-11#1)(1996-11#1)
primary frequency##2##2##(2008-2#2)
primary function of the##4##4##(1997-1#1)(2008-2#1)(2008-5#1)(2008-9#1)
primary function of##9##3##(1997-1#1)(2007-12#1)(2008-11#1)(2008-2#3)(2008-5#2)(2008-9#1)
primary gastric carcinoma##2##3##(2008-9#1)(2012-2#1)
primary gastric lymphoma##3##3##(1995-11#1)(2013-1#2)
primary gastric lymphomas##2##3##(1992-8#1)(2009-8#1)
primary gastric##11##2##(1992-8#2)(1994-10#1)(1995-11#2)(2006-9#1)(2008-9#1)(2009-8#1)(2012-2#1)(2013-1#2)
primary gastrointestinal##2##2##(1990-2#1)(1997-3#1)
primary generated##3##2##(1995-3#2)(2010-5#1)
primary genetic##2##2##(1991-3#1)(1994-12#1)
primary germinoma originating in the basal ganglia##2##7##(2008-7#2)
primary glial##2##2##(1995-5#1)(2012-2#1)
primary glomerular disease##2##3##(2007-7#2)
primary glomerular diseases##3##3##(2008-1#3)
primary glomerular##5##2##(2007-7#2)(2008-1#3)
primary glomerulonephritidis##2##2##(2008-1#2)
primary glomerulonephritis##6##2##(2006-7#1)(2007-11#1)(2007-7#2)(2008-1#1)(2010-4#1)
primary goal in##5##3##(2007-11#1)(2008-3#1)(2008-6#1)(2008-9#2)
primary goal of the##2##4##(1995-2#1)(2008-7#1)
primary goal of this##7##4##(2006-10#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-4#1)(2011-2#1)(2012-1#1)
primary goal of##16##3##(1995-2#1)(2006-10#2)(2006-5#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-1#1)(2013-1#1)
primary goal##27##2##(1995-2#1)(2004-3#1)(2006-10#3)(2006-5#1)(2007-1#1)(2007-11#2)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-2#1)(2010-6#1)(2011-2#1)(2012-1#1)(2013-1#2)
primary graft failure?##2##3##(2007-8#2)
primary graft##5##2##(2007-11#1)(2007-2#1)(2007-8#2)(2011-3#1)
primary gustatory##2##2##(1996-1#1)(2010-2#1)
primary headache##5##2##(2008-4#1)(2008-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
primary headaches##4##2##(2008-4#1)(2013-1#3)
primary health care (PHC) physicians in Riyadh##2##7##(2007-2#2)
primary health care (PHC) physicians##3##5##(2007-2#2)(2007-3#1)
primary health care (PHC)##6##4##(1994-3#1)(2006-2#1)(2007-2#2)(2007-3#1)(2007-7#1)
primary health care and##5##4##(1991-6#1)(1992-1#1)(1995-11#1)(2008-6#1)(2012-3#1)
primary health care centers in##3##5##(2007-8#1)(2011-2#2)
primary health care centers##8##4##(1995-8#1)(2007-2#1)(2007-8#1)(2008-8#1)(2011-2#4)
primary health care for##4##4##(1996-12#1)(2010-10#3)
primary health care in the##2##5##(1990-9#1)(2011-1#1)
primary health care physicians##2##4##(1993-6#1)(2007-3#1)
primary health care programme##2##4##(2008-1#2)
primary health care services##8##4##(1991-4#2)(1991-6#1)(1991-8#1)(1993-6#1)(2007-3#1)(2008-1#1)(2010-8#1)
primary health care setting in##2##5##(2005-8#1)(2011-2#1)
primary health care setting##4##4##(2005-8#1)(2007-11#1)(2011-2#1)(2013-8#1)
primary health care staff##2##4##(2011-2#2)
primary health care system##3##4##(1995-9#2)(2007-7#1)
primary health care team##2##4##(1996-2#1)(1996-3#1)
primary health care##103##3##(1990-4#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-4#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#5)(1993-11#1)(1993-4#1)(1993-6#2)(1994-10#1)(1994-3#3)(1994-5#1)(1995-11#2)(1995-4#1)(1995-5#2)(1995-8#2)(1995-9#4)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#2)(2005-8#3)(2006-2#2)(2007-10#1)(2007-11#1)(2007-2#7)(2007-3#4)(2007-7#2)(2007-8#2)(2008-1#5)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#3)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#10)(2012-12#2)(2012-3#2)(2013-7#2)(2013-8#1)
primary health care]##15##3##(1991-9#1)(1992-11#1)(1993-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-2#2)(1995-3#1)(1995-4#2)(1995-9#1)(1997-5#1)(1997-8#1)
primary health centres##3##3##(2013-1#2)(2013-8#1)
primary health clinics##3##3##(2011-1#3)
primary health services##6##3##(1991-6#1)(1992-11#3)(1994-6#1)(1995-6#1)
primary health##143##2##(1990-10#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-4#2)(1991-5#2)(1991-6#3)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#9)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#2)(1994-10#1)(1994-3#4)(1994-4#2)(1994-5#2)(1994-6#2)(1995-10#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-4#3)(1995-5#2)(1995-6#1)(1995-8#2)(1995-9#6)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-8#1)(2005-8#3)(2006-2#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#7)(2007-3#5)(2007-7#2)(2007-8#2)(2008-1#6)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#3)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#6)(2011-2#10)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#2)
primary health-care centres##2##3##(2008-10#2)
primary health-care##3##2##(2008-10#2)(2012-12#1)
primary healthcare (PHC)##5##3##(2010-11#4)(2011-2#1)
primary healthcare facility##2##3##(2007-12#1)(2012-2#1)
primary healthcare services##2##3##(2011-1#1)(2011-2#1)
primary healthcare##29##2##(1994-6#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-3#3)(2009-6#2)(2010-11#12)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)
primary heath care services##2##4##(2008-8#2)
primary heath care##3##3##(2008-8#3)
primary hepatic##3##2##(1992-4#1)(2007-2#1)(2010-2#1)
primary hepatocellular carcinoma##5##3##(2006-10#1)(2008-8#1)(2010-12#1)(2010-7#1)(2012-11#1)
primary hepatocyte cultures##3##3##(1990-5#1)(1992-11#1)(1995-3#1)
primary hepatocyte##5##2##(1990-5#1)(1992-11#1)(1995-3#1)(2008-11#2)
primary hepatocytes##12##2##(1994-11#2)(1995-3#2)(2004-11#3)(2008-11#4)(2008-9#1)
primary hip##3##2##(1996-9#1)(2011-2#1)(2013-1#1)
primary hippocampal neurons##2##3##(1997-4#1)(2009-8#1)
primary hippocampal##4##2##(1991-5#1)(1995-12#1)(1997-4#1)(2009-8#1)
primary host##2##2##(2008-10#2)
primary human breast##2##3##(1994-6#1)(2009-12#1)
primary human cells##4##3##(2008-11#4)
primary human immunodeficiency virus##2##4##(1996-4#2)
primary human intestinal epithelial cells##2##5##(1995-8#2)
primary human osteoblasts##6##3##(1992-12#1)(2006-5#2)(2010-10#2)(2013-1#1)
primary human##38##2##(1991-6#1)(1992-12#1)(1992-3#1)(1992-8#1)(1994-11#1)(1994-5#2)(1994-6#1)(1995-1#1)(1995-2#1)(1995-8#2)(1996-4#2)(1997-4#1)(1997-7#1)(2006-5#2)(2008-1#1)(2008-11#8)(2008-9#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-10#2)(2010-2#1)(2012-12#1)(2012-5#1)(2013-1#2)
primary hydrolysis##2##2##(2008-5#2)
primary hydroxyl groups##4##3##(1990-9#2)(1996-5#1)(2008-7#1)
primary hydroxyl side##2##3##(1991-12#2)
primary hydroxyl##6##2##(1990-9#2)(1991-12#2)(1996-5#1)(2008-7#1)
primary hypercholesterolaemia##2##2##(1992-11#2)
primary hypercholesterolemia##6##2##(1991-6#2)(1991-7#2)(1992-11#1)(2008-3#1)
primary hyperoxaluria type 1##4##4##(1993-9#2)(2007-12#1)(2009-3#1)
primary hyperoxaluria type##6##3##(1993-9#2)(1995-12#2)(2007-12#1)(2009-3#1)
primary hyperoxaluria##13##2##(1990-10#3)(1991-1#1)(1992-6#1)(1993-9#3)(1995-12#2)(2007-12#1)(2009-3#1)(2011-2#1)
primary hyperparathyroidism and##4##3##(1990-2#2)(1996-1#1)(2010-2#1)
primary hyperparathyroidism can##2##3##(2008-12#1)(2010-2#1)
primary hyperparathyroidism is##2##3##(2007-3#1)(2013-1#1)
primary hyperparathyroidism##41##2##(1990-2#5)(1991-12#1)(1991-5#1)(1994-7#4)(1995-11#1)(1996-1#1)(1996-9#1)(2005-9#1)(2007-2#2)(2007-3#3)(2007-8#1)(2008-10#2)(2008-12#2)(2009-9#1)(2010-2#3)(2010-7#3)(2011-1#1)(2011-2#1)(2012-12#3)(2013-1#3)(2013-8#1)
primary hyperparathyroidism]##5##2##(1990-9#1)(1994-7#1)(1995-11#1)(1996-1#1)(2013-8#1)
primary hypertension##2##2##(2004-10#1)(2008-1#1)
primary hypertriglyceridemia##2##2##(2008-12#2)
primary hypertriglyceridemic##2##2##(2008-12#2)
primary hyphae##4##2##(2008-10#4)
primary hypothyroidism##8##2##(1991-2#1)(1997-3#1)(2007-8#1)(2008-1#1)(2010-10#1)(2012-2#3)
primary immune response##6##3##(2007-11#2)(2008-10#1)(2008-11#1)(2008-2#2)
primary immune responses##5##3##(2005-11#1)(2007-2#1)(2008-10#1)(2008-4#1)(2010-2#1)
primary immune##13##2##(2005-11#1)(2006-10#1)(2007-11#2)(2007-2#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#1)(2010-2#1)
primary immunisation##2##2##(1996-3#1)(2013-8#1)
primary immunodeficiencies##8##2##(1996-12#2)(2006-10#1)(2006-2#1)(2007-2#4)
primary immunodeficiency diseases##3##3##(2007-2#1)(2012-12#2)
primary immunodeficiency disorders##2##3##(2007-2#2)
primary immunodeficiency syndrome##2##3##(1990-10#1)(2006-5#1)
primary immunodeficiency##16##2##(1990-10#1)(2006-5#1)(2007-2#8)(2008-10#1)(2012-12#3)(2012-3#1)(2013-1#1)
primary immunosuppression##3##2##(2005-7#1)(2008-1#2)
primary importance##9##2##(1990-5#1)(1991-2#1)(1992-3#1)(1994-11#1)(2006-5#1)(2008-2#1)(2008-9#1)(2009-5#1)(2012-3#1)
primary in##4##2##(1992-8#1)(2008-12#1)(2010-2#1)(2013-1#1)
primary incisors##5##2##(2008-5#1)(2012-12#2)(2012-2#1)(2013-1#1)
primary infection by##4##3##(1991-7#1)(2006-10#1)(2008-10#2)
primary infection in##2##3##(1997-5#1)(2006-10#1)
primary infection of##2##3##(2008-10#1)(2010-4#1)
primary infection##31##2##(1990-3#1)(1991-7#1)(1992-11#2)(1996-4#2)(1997-5#1)(2006-10#4)(2007-10#1)(2008-10#14)(2008-8#1)(2010-1#1)(2010-10#1)(2010-4#1)(2011-1#1)
primary infections##5##2##(1992-10#1)(2007-2#1)(2008-10#3)
primary infertility##5##2##(2006-10#2)(2009-6#1)(2012-2#2)
primary infiltrating##2##2##(1990-12#1)(2008-4#1)
primary influence##2##2##(1990-2#1)(1993-11#1)
primary information##3##2##(1991-2#1)(1996-1#1)(2013-1#1)
primary injury##2##2##(2006-10#1)(2009-6#1)
primary inoculum in##2##3##(2008-10#2)
primary inoculum##23##2##(2008-10#21)(2008-12#1)(2011-1#1)
primary interaction##2##2##(1993-7#1)(2008-10#1)
primary intracerebral hemorrhage (PICH)##2##4##(2007-10#2)
primary intracerebral hemorrhage##5##3##(2007-10#5)
primary intracerebral##7##2##(2006-7#1)(2007-10#5)(2008-8#1)
primary intracranial##4##2##(2007-12#3)(2010-2#1)
primary invasive##2##2##(1991-6#1)(1994-6#1)
primary ion##2##2##(2007-8#1)(2008-10#1)
primary isolation##5##2##(1992-2#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-9#1)
primary isotope##2##2##(1994-11#1)(1995-10#1)
primary issues##2##2##(1996-3#1)(2009-9#1)
primary keratinocyte##2##2##(2008-4#2)
primary kernel percent hull##2##4##(2008-5#2)
primary kernel##3##2##(2008-5#3)
primary kidney##2##2##(2011-2#1)(2012-12#1)
primary kinetic##2##2##(1991-8#1)(2006-12#1)
primary knee##3##2##(2011-1#1)(2011-2#2)
primary leiomyoma of the ureter##2##5##(2013-7#2)
primary leiomyoma of the##3##4##(2013-7#2)(2013-8#1)
primary leiomyosarcoma of##2##3##(2008-6#1)(2012-2#1)
primary lesion in##2##3##(1997-7#1)(2013-8#1)
primary lesion##10##2##(1991-5#1)(1992-2#1)(1997-7#1)(2004-1#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-6#1)(2013-8#2)
primary lesions##3##2##(2008-10#2)(2011-1#1)
primary leukemic cells##2##3##(2005-8#1)(2008-9#1)
primary level##2##2##(2007-5#1)(2010-8#1)
primary ligand and##2##3##(2008-10#2)
primary ligand##3##2##(1996-10#1)(2008-10#2)
primary literature##3##2##(2008-4#1)(2008-7#1)(2009-8#1)
primary liver cancer##5##3##(1991-11#1)(1992-9#2)(2008-4#1)(2013-1#1)
primary liver##7##2##(1991-11#1)(1992-9#2)(2007-11#1)(2008-4#1)(2011-1#1)(2013-1#1)
primary localised cutaneous amyloidosis##3##4##(2007-7#3)
primary localization of##3##3##(2006-10#1)(2007-11#2)
primary lung cancer in##2##4##(1992-3#1)(2013-7#1)
primary lung cancer##10##3##(1991-9#1)(1992-3#1)(1993-8#1)(1996-12#2)(2007-6#1)(2007-8#1)(2008-11#1)(2008-2#1)(2013-7#1)
primary lung cancers##2##3##(1992-3#1)(2011-1#1)
primary lung##20##2##(1991-9#1)(1992-3#2)(1993-1#1)(1993-2#1)(1993-8#1)(1996-12#2)(2007-6#1)(2007-8#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2011-1#1)(2013-1#3)(2013-7#1)
primary lymphocytes##2##2##(2008-2#1)(2011-3#1)
primary lymphoid tissues##2##3##(1997-9#1)(2008-4#1)
primary lymphoid##3##2##(1997-9#1)(2005-10#1)(2008-4#1)
primary malignancies and##2##3##(1990-12#1)(2011-2#1)
primary malignancies of##2##3##(2011-2#2)
primary malignancies##12##2##(1990-12#3)(1991-8#3)(2007-4#1)(2011-2#5)
primary malignancy was##3##3##(2008-1#1)(2010-9#1)(2011-1#1)
primary malignancy##5##2##(1990-12#1)(2006-2#1)(2008-1#1)(2010-9#1)(2011-1#1)
primary malignant bone tumour##2##4##(1993-10#1)(2008-6#1)
primary malignant bone##4##3##(1993-10#1)(2008-6#1)(2010-3#1)(2011-2#1)
primary malignant brain##2##3##(2006-12#1)(2007-10#1)
primary malignant lung##2##3##(1993-1#1)(2008-10#1)
primary malignant neoplasm##2##3##(2008-3#1)(2012-2#1)
primary malignant tumor of the bone##2##6##(2008-6#1)(2010-3#1)
primary malignant tumors##2##3##(1993-1#1)(2007-12#1)
primary malignant tumours##2##3##(1990-12#1)(2012-2#1)
primary malignant##23##2##(1990-12#1)(1992-11#1)(1993-1#2)(1993-10#2)(2006-12#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-6#3)(2010-3#3)(2011-2#1)(2012-2#3)(2013-1#1)
primary mammalian##2##2##(1993-12#1)(2008-11#1)
primary management##2##2##(2006-12#1)(2008-10#1)
primary manifestation##2##2##(1990-9#1)(2007-5#1)
primary maternal##2##2##(1990-9#1)(2009-10#1)
primary maxillary##2##2##(2008-12#2)
primary means for##2##3##(2008-10#1)(2012-12#1)
primary means of##4##3##(2006-5#1)(2008-10#2)(2008-5#1)
primary means##8##2##(2006-5#1)(2007-4#1)(2008-10#3)(2008-5#1)(2009-9#1)(2012-12#1)
primary mechanism of##5##3##(1994-2#1)(2007-7#1)(2008-10#2)(2009-11#1)
primary mechanism##8##2##(1994-2#1)(1997-3#1)(2007-7#1)(2008-10#2)(2009-11#1)(2011-2#1)(2012-12#1)
primary mediastinal##4##2##(2007-8#2)(2009-5#1)(2010-12#1)
primary mediator##3##2##(1993-12#1)(1994-12#1)(2012-3#1)
primary medical care##2##3##(1993-11#1)(1997-4#1)
primary medical##4##2##(1993-11#1)(1997-2#1)(1997-4#1)(2009-9#1)
primary melanoma cells##2##3##(1996-2#2)
primary melanoma##15##2##(1991-9#1)(1996-2#5)(2007-8#1)(2008-9#1)(2009-4#1)(2011-2#5)(2013-8#1)
primary melanomas##9##2##(1991-7#2)(1993-8#1)(2007-8#3)(2008-9#1)(2011-2#2)
primary mesangial cells##2##3##(2011-2#2)
primary messenger##2##2##(1990-10#1)(1997-7#1)
primary metabolism##3##2##(2006-3#1)(2009-10#1)(2012-2#1)
primary metabolite of##2##3##(1993-8#1)(1994-11#1)
primary metabolite##3##2##(1990-12#1)(1993-8#1)(1994-11#1)
primary metabolites##2##2##(2008-10#1)(2012-1#1)
primary method for##2##3##(2008-11#1)(2011-2#1)
primary method##4##2##(2008-11#1)(2008-2#1)(2008-4#1)(2011-2#1)
primary methods of##2##3##(2008-10#1)(2008-4#1)
primary methods##3##2##(1997-3#1)(2008-10#1)(2008-4#1)
primary mirror##11##2##(2008-2#4)(2008-3#7)
primary mixed-valent##2##2##(1997-7#2)
primary mode of therapy##2##4##(2006-5#1)(2007-12#1)
primary mode of##4##3##(2006-5#1)(2007-12#1)(2007-4#1)(2008-11#1)
primary model##4##2##(1991-6#1)(1995-8#1)(2008-5#1)(2008-7#1)
primary molar##4##2##(2007-8#1)(2008-5#1)(2012-12#1)(2013-8#1)
primary molars##13##2##(2007-2#4)(2008-12#3)(2008-5#4)(2012-12#1)(2012-2#1)
primary monolayer##2##2##(1990-4#1)(1990-5#1)
primary motor area##5##3##(1996-1#1)(2008-11#2)(2008-9#1)(2009-6#1)
primary motor cortex (M1)##2##4##(1997-8#1)(2012-2#1)
primary motor cortex##5##3##(1997-8#2)(2010-7#1)(2011-2#1)(2012-2#1)
primary motor##13##2##(1993-2#1)(1995-11#1)(1996-1#1)(1997-8#2)(2008-11#2)(2008-9#1)(2009-6#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-2#1)
primary mouse mammary epithelial cells##2##5##(1991-2#1)(1991-7#1)
primary mouse renal tubular epithelial cells##2##6##(2009-10#2)
primary mouse##10##2##(1990-7#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-2#1)(1995-9#1)(2008-8#1)(2009-10#2)
primary musical cues##2##3##(2013-8#2)
primary mycelium##4##2##(2008-10#4)
primary myelofibrosis##2##2##(2009-2#1)(2012-12#1)
primary neoplasm##6##2##(1991-6#1)(2006-2#1)(2007-7#1)(2009-3#1)(2009-5#1)(2013-1#1)
primary neoplasms##2##2##(2007-7#2)
primary nephropathies##2##2##(2008-1#2)
primary nephrotic syndrome##3##3##(2007-11#2)(2008-1#1)
primary neurological##2##2##(2008-4#1)(2009-12#1)
primary neuronal cultures from##2##4##(2008-11#2)
primary neuronal cultures##5##3##(1995-12#1)(1995-5#1)(2008-11#2)(2008-3#1)
primary neuronal##6##2##(1990-2#1)(1995-12#1)(1995-5#1)(2008-11#2)(2008-3#1)
primary neurotransmitter##4##2##(1992-8#1)(1997-3#1)(1997-5#1)(2009-12#1)
primary nevoid melanoma##2##3##(2011-2#2)
primary nocturnal enuresis##2##3##(2007-7#1)(2008-8#1)
primary nocturnal enuresis?##2##3##(1994-8#1)(2008-10#1)
primary nocturnal##4##2##(1994-8#1)(2007-7#1)(2008-10#1)(2008-8#1)
primary non-Hodgkin's lymphoma of the##3##5##(2006-4#2)(2007-10#1)
primary objective in##2##3##(2008-1#1)(2010-2#1)
primary objective of this study##7##5##(1991-2#1)(2004-1#1)(2007-10#1)(2007-12#1)(2008-10#2)(2010-4#1)
primary objective of this##9##4##(1991-2#1)(2004-1#1)(2007-10#1)(2007-12#1)(2008-10#2)(2010-4#2)(2011-1#1)
primary objective of##15##3##(1991-2#1)(1996-9#1)(2004-1#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-9#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-12#1)
primary objective##22##2##(1991-2#1)(1992-1#1)(1996-9#1)(2004-1#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-12#2)
primary objectives of##3##3##(2005-3#1)(2005-8#1)(2008-10#1)
primary ocular##4##2##(2007-4#1)(2012-3#3)
primary olfactory pathway##2##3##(2007-12#2)
primary olfactory##7##2##(1996-9#1)(2007-12#6)
primary ones##2##2##(1990-8#1)(2008-5#1)
primary open angle glaucoma (POAG)##3##5##(2011-2#1)(2012-2#1)(2013-1#1)
primary open angle glaucoma##10##4##(2010-3#1)(2011-2#2)(2012-2#3)(2013-1#1)(2013-8#3)
primary open angle##12##3##(2010-3#1)(2011-2#3)(2012-2#3)(2013-1#1)(2013-8#4)
primary open-angle glaucoma##4##3##(2009-8#1)(2011-1#1)(2011-12#1)(2011-2#1)
primary operable breast cancer##3##4##(1991-8#1)(1996-4#1)(2007-5#1)
primary operation##6##2##(1993-5#2)(1994-6#1)(2007-8#2)(2008-6#1)
primary or metastatic##3##3##(1993-8#1)(2006-6#1)(2006-7#1)
primary or recurrent##4##3##(1990-9#1)(1991-10#1)(1993-6#1)(2006-9#1)
primary or secondary infection##2##4##(1993-5#1)(2012-2#1)
primary or secondary to##3##4##(1991-12#1)(2010-12#1)(2011-2#1)
primary or secondary##32##3##(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#1)(1993-5#1)(1993-6#1)(1994-2#1)(1995-10#1)(1996-12#1)(1996-9#1)(2005-9#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#2)(2012-3#1)
primary or##51##2##(1990-12#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1993-5#1)(1993-6#2)(1993-8#2)(1994-2#1)(1995-10#1)(1995-9#1)(1996-12#1)(1996-9#1)(1997-4#1)(2004-1#1)(2005-9#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-9#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#2)(2012-3#1)
primary oral##2##2##(1991-5#1)(2012-12#1)
primary orbital##2##2##(2010-11#2)
primary origin of##2##3##(2007-11#1)(2008-10#1)
primary osteogenic sarcoma of the breast##2##6##(1992-2#2)
primary osteoporosis##2##2##(2005-3#1)(2009-5#1)
primary osteosarcoma##3##2##(2008-6#2)(2010-3#1)
primary outcome measure was##2##4##(2006-7#1)(2011-2#1)
primary outcome measure##7##3##(2006-12#2)(2006-7#1)(2008-4#1)(2008-8#1)(2011-2#1)(2013-1#1)
primary outcome was##6##3##(2007-10#2)(2008-11#1)(2008-9#1)(2010-4#1)(2013-1#1)
primary outcome##20##2##(1991-11#1)(1996-7#1)(2005-9#1)(2006-12#2)(2006-7#1)(2007-10#2)(2007-9#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-4#1)(2011-2#1)(2013-1#2)
primary outcomes##5##2##(2008-7#1)(2010-1#1)(2010-4#1)(2011-2#1)(2013-8#1)
primary outpatient care##2##3##(2011-1#2)
primary ovarian##4##2##(1996-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
primary oxalosis##2##2##(1991-11#2)
primary ozonides##3##2##(1996-5#3)
primary pancreatic##2##2##(2006-8#1)(2011-2#1)
primary parenchymatous##2##2##(1997-8#2)
primary particle size##4##3##(2008-2#2)(2008-3#1)(2008-5#1)
primary particle##5##2##(2008-2#2)(2008-3#2)(2008-5#1)
primary particles and##2##3##(2005-11#1)(2008-5#1)
primary particles##10##2##(2005-11#2)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#1)(2010-4#1)
primary patency rate##2##3##(2007-7#2)
primary patency##7##2##(2007-7#7)
primary pathogen for##2##3##(2012-2#2)
primary pathogen of##2##3##(2007-5#1)(2012-2#1)
primary pathogen##6##2##(2007-5#1)(2008-10#1)(2012-2#4)
primary patients in##3##3##(2010-12#1)(2013-1#2)
primary patients##7##2##(1995-2#1)(2008-4#2)(2010-12#1)(2012-3#1)(2013-1#2)
primary pattern##2##2##(2008-2#1)(2008-6#1)
primary percutaneous coronary intervention (PCI)##2##5##(2008-3#2)
primary percutaneous coronary intervention for##2##5##(2008-3#1)(2009-5#1)
primary percutaneous coronary intervention##12##4##(2008-3#6)(2009-12#1)(2009-5#1)(2010-7#1)(2013-1#2)(2013-8#1)
primary percutaneous coronary##13##3##(2008-3#6)(2008-6#1)(2009-12#1)(2009-5#1)(2010-7#1)(2013-1#2)(2013-8#1)
primary percutaneous##14##2##(2008-3#6)(2008-6#2)(2009-12#1)(2009-5#1)(2010-7#1)(2013-1#2)(2013-8#1)
primary peritonitis##2##2##(1990-8#1)(2007-8#1)
primary pests##2##2##(2008-5#2)
primary photochemical##3##2##(1991-12#1)(2008-8#1)(2011-1#1)
primary photoproduct##5##2##(1991-7#3)(1995-1#1)(1995-8#1)
primary placental cells##2##3##(1997-8#2)
primary porcine hepatocytes##4##3##(2008-11#3)(2011-2#1)
primary practice##2##2##(1991-1#1)(2007-10#1)
primary predecessors##3##2##(2013-1#3)
primary predictor for the maintenance of BE##2##7##(2008-6#2)
primary predictor of##2##3##(2007-12#1)(2007-6#1)
primary predictor##4##2##(2007-12#1)(2007-6#1)(2008-6#2)
primary prevention and##5##3##(1990-10#1)(2007-8#1)(2008-12#1)(2009-4#1)(2013-1#1)
primary prevention groups that##2##4##(2010-12#2)
primary prevention groups##3##3##(2010-12#3)
primary prevention in##5##3##(1993-9#3)(1996-3#1)(2013-8#1)
primary prevention measures##2##3##(1994-6#2)
primary prevention of cardiovascular disease##4##5##(2006-5#1)(2009-4#1)(2011-2#1)(2013-1#1)
primary prevention of cardiovascular##5##4##(1995-11#1)(2006-5#1)(2009-4#1)(2011-2#1)(2013-1#1)
primary prevention of coronary heart disease in##3##7##(1993-9#1)(1995-6#1)(2006-12#1)
primary prevention of coronary heart disease##4##6##(1993-9#1)(1995-6#1)(2006-12#1)(2010-6#1)
primary prevention of coronary##5##4##(1993-9#1)(1995-4#1)(1995-6#1)(2006-12#1)(2010-6#1)
primary prevention of##24##3##(1993-9#1)(1995-11#1)(1995-4#1)(1995-5#1)(1995-6#1)(2005-12#1)(2006-12#1)(2006-5#2)(2007-10#3)(2007-8#2)(2008-3#2)(2009-4#2)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-1#1)
primary prevention program##2##3##(2006-7#2)
primary prevention programs##4##3##(1995-3#2)(2006-7#1)(2007-1#1)
primary prevention strategies##3##3##(2007-11#1)(2008-3#1)(2011-2#1)
primary prevention##77##2##(1990-10#1)(1992-12#1)(1992-5#1)(1993-9#4)(1994-6#2)(1995-11#1)(1995-3#7)(1995-4#1)(1995-5#2)(1995-6#1)(1996-12#2)(1996-3#2)(1996-6#1)(1997-1#1)(1997-8#1)(2005-10#1)(2005-12#1)(2006-12#1)(2006-5#2)(2006-7#3)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-8#3)(2008-11#1)(2008-12#1)(2008-3#6)(2009-11#1)(2009-4#3)(2010-1#1)(2010-12#4)(2010-4#4)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#2)(2013-1#2)(2013-8#3)
primary preventive##2##2##(1996-12#2)
primary procedure##6##2##(1990-11#1)(1990-12#1)(1990-2#1)(1996-8#1)(2006-5#1)(2007-7#1)
primary process##2##2##(2007-11#1)(2011-2#1)
primary processes##3##2##(2007-9#1)(2008-10#1)(2008-8#1)
primary producer##3##2##(1991-11#1)(2007-1#1)(2013-8#1)
primary producers##4##2##(2008-8#1)(2009-4#1)(2011-12#1)(2012-2#1)
primary production in##2##3##(2008-8#1)(2012-2#1)
primary production##9##2##(1991-11#2)(2008-3#1)(2008-8#3)(2009-8#1)(2011-1#1)(2012-2#1)
primary productivity##4##2##(2008-5#1)(2008-8#2)(2011-2#1)
primary progressive aphasia##3##3##(2008-9#1)(2012-11#2)
primary progressive##6##2##(1995-6#1)(2008-9#1)(2010-12#1)(2012-11#2)(2012-3#1)
primary prophylaxis##4##2##(2005-10#2)(2008-4#1)(2009-8#1)
primary prostate cancer##2##3##(1992-8#2)
primary prostate##4##2##(1992-8#2)(2008-4#1)(2008-7#1)
primary psychiatric##2##2##(1995-1#1)(2007-7#1)
primary pulmonary hypertension##6##3##(1991-2#3)(1997-5#1)(2005-11#1)(2006-10#1)
primary pulmonary vasculitides##2##3##(2005-8#2)
primary pulmonary##11##2##(1991-2#3)(1996-9#1)(1997-5#1)(2005-11#2)(2005-8#2)(2006-10#1)(2007-8#1)
primary purpose of##8##3##(1990-12#1)(1992-11#1)(2005-8#1)(2007-7#1)(2009-5#1)(2010-3#1)(2013-1#2)
primary radiation damage##2##3##(2006-4#2)
primary radiation##4##2##(2006-4#2)(2007-11#1)(2009-7#1)
primary radical##4##2##(1991-7#2)(1996-7#1)(2006-10#1)
primary radiotherapy##8##2##(1990-10#1)(1992-3#1)(1993-11#2)(2005-5#1)(2006-12#1)(2007-2#1)(2011-1#1)
primary rainbow##2##2##(2008-2#1)(2008-3#1)
primary rat cortical##2##3##(1996-12#1)(2013-8#1)
primary rat hepatocyte cultures##3##4##(1991-10#1)(1993-3#1)(2008-4#1)
primary rat hepatocyte##4##3##(1991-10#2)(1993-3#1)(2008-4#1)
primary rat hepatocytes##12##3##(1990-7#1)(1992-2#2)(1993-8#2)(1995-6#2)(2008-11#2)(2008-9#3)
primary rat##24##2##(1990-7#1)(1991-10#2)(1992-2#2)(1992-3#1)(1993-2#1)(1993-3#1)(1993-7#1)(1993-8#2)(1995-6#2)(1996-12#1)(1996-2#1)(1996-9#1)(2008-11#2)(2008-4#1)(2008-9#3)(2013-1#1)(2013-8#1)
primary reaction##4##2##(2008-8#3)(2010-8#1)
primary reason for the##2##4##(1997-7#1)(2006-10#1)
primary reason for##5##3##(1997-4#1)(1997-7#1)(2006-10#1)(2007-12#2)
primary reasons for##3##3##(2007-11#1)(2007-12#1)(2012-1#1)
primary reasons##4##2##(1994-5#1)(2007-11#1)(2007-12#1)(2012-1#1)
primary rectal cancer##3##3##(1990-9#1)(1995-4#1)(2006-6#1)
primary refractory##2##2##(2008-1#1)(2008-5#1)
primary renal vasculitis##2##3##(2007-8#2)
primary renal##7##2##(1996-6#1)(1997-7#1)(2007-8#2)(2013-1#1)(2013-7#2)
primary repair of##3##3##(2009-6#2)(2011-2#1)
primary repair##9##2##(1994-2#1)(2009-6#2)(2010-12#2)(2010-8#1)(2011-2#2)(2013-7#1)
primary research##5##2##(1993-2#3)(2008-9#1)(2013-8#1)
primary resection##2##2##(1990-9#1)(2008-11#1)
primary resistance to HER2-targeted therapies##2##5##(2013-1#2)
primary resistance##5##2##(2008-5#1)(2010-2#1)(2010-5#1)(2013-1#2)
primary resistant##3##2##(1990-10#1)(1990-12#1)(2010-4#1)
primary response gene##3##3##(1992-12#1)(1992-7#1)(1995-2#1)
primary response##6##2##(1992-12#1)(1992-7#1)(1994-2#1)(1995-2#2)(2009-2#1)
primary responses##2##2##(1995-12#1)(2009-8#1)
primary responsibility##2##2##(1993-3#1)(1995-1#1)
primary retroperitoneal##9##2##(2008-10#2)(2008-6#2)(2008-8#2)(2009-5#3)
primary risk factor##3##3##(2006-10#1)(2006-12#1)(2007-8#1)
primary risk factors##2##3##(1995-8#1)(2008-12#1)
primary risk##5##2##(1995-8#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-12#1)
primary rodent##2##2##(2008-10#1)(2008-7#1)
primary role of##5##3##(1990-11#1)(2006-10#1)(2007-3#1)(2008-5#1)(2008-7#1)
primary role##25##2##(1990-11#2)(1990-9#1)(1993-10#1)(1995-12#1)(1995-5#1)(1996-11#1)(1997-4#1)(2006-10#2)(2006-11#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-3#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2011-2#1)
primary root##3##2##(2008-5#2)(2013-8#1)
primary route of##2##3##(1990-3#1)(2011-2#1)
primary sarcoma##2##2##(2008-1#1)(2008-6#1)
primary sarcomas##2##2##(1993-10#2)
primary scattering approximation##2##3##(2008-3#2)
primary school aged children with ASNs##3##6##(2012-12#3)
primary school children##10##3##(2006-8#1)(2007-7#2)(2008-10#2)(2008-12#1)(2010-8#1)(2012-2#3)
primary school##28##2##(1991-10#2)(1993-6#1)(2006-8#4)(2007-2#1)(2007-5#1)(2007-7#2)(2007-9#2)(2008-10#2)(2008-12#2)(2009-1#1)(2009-12#1)(2010-8#1)(2012-12#4)(2012-2#3)(2013-8#1)
primary schoolchildren##3##2##(2012-2#3)
primary schools in##9##3##(1991-10#1)(2005-9#1)(2007-3#1)(2007-7#3)(2008-10#1)(2012-2#1)(2013-7#1)
primary schools of the##2##4##(2007-2#1)(2008-3#1)
primary schools##20##2##(1991-10#1)(1996-3#1)(2005-9#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-5#2)(2007-7#3)(2008-10#3)(2008-3#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
primary sclerosing cholangitis (PSC)##3##4##(2006-10#1)(2007-11#1)(2008-12#1)
primary sclerosing cholangitis and##2##4##(2004-11#1)(2006-2#1)
primary sclerosing cholangitis is##3##4##(2004-11#1)(2006-10#2)
primary sclerosing cholangitis##37##3##(1993-3#1)(2004-11#16)(2005-12#1)(2005-8#2)(2006-10#9)(2006-2#1)(2007-11#1)(2008-12#1)(2009-8#1)(2010-12#1)(2012-11#1)(2012-2#2)
primary sclerosing cholangitis)##2##3##(1996-4#1)(2004-11#1)
primary sclerosing##39##2##(1993-3#1)(1996-4#1)(2004-11#17)(2005-12#1)(2005-8#2)(2006-10#9)(2006-2#1)(2007-11#1)(2008-12#1)(2009-8#1)(2010-12#1)(2012-11#1)(2012-2#2)
primary screen##2##2##(2007-7#1)(2009-10#1)
primary screening##4##2##(1997-2#1)(2005-11#1)(2007-6#1)(2012-2#1)
primary secondary amine (PSA)##2##4##(2012-12#1)(2013-8#1)
primary sensory neurons in##2##4##(1996-8#1)(2008-6#1)
primary sensory neurons##8##3##(1991-10#1)(1996-3#3)(1996-8#1)(2008-4#1)(2008-5#1)(2008-6#1)
primary sensory##18##2##(1991-10#1)(1994-2#1)(1995-8#1)(1996-3#3)(1996-8#2)(1997-8#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#3)
primary sequence homology##3##3##(1992-3#1)(1994-8#1)(1997-5#1)
primary sequence information##2##3##(1992-12#1)(1995-3#1)
primary sequence of##5##3##(1991-8#1)(1992-2#1)(1993-5#1)(1993-9#1)(2006-12#1)
primary sequence##29##2##(1990-3#1)(1991-2#1)(1991-8#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-6#2)(1993-2#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-6#1)(1994-8#3)(1995-1#1)(1995-3#1)(1996-7#1)(1996-8#1)(1997-5#1)(1997-9#1)(2006-12#2)(2008-9#1)
primary sequences and the##2##4##(1995-5#1)(2008-5#1)
primary sequences##5##2##(1992-12#1)(1993-9#1)(1995-5#1)(2006-8#1)(2008-5#1)
primary shape##2##2##(2011-1#2)
primary signaling##2##2##(1995-3#1)(2006-10#1)
primary site and##3##3##(1990-8#1)(1993-4#1)(1995-8#1)
primary site of cancer##3##4##(1997-8#1)(2007-11#2)
primary site of##15##3##(1991-2#1)(1993-1#1)(1997-6#1)(1997-8#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
primary site was##2##3##(2013-8#2)
primary site with##2##3##(1992-12#1)(1992-2#1)
primary site##37##2##(1990-7#2)(1990-8#1)(1991-2#1)(1992-12#1)(1992-2#2)(1993-1#1)(1993-10#1)(1993-4#1)(1995-8#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#4)
primary sites##13##2##(1990-8#1)(1993-3#1)(1994-7#3)(1995-10#1)(2006-12#1)(2008-10#1)(2008-6#2)(2010-12#1)(2011-2#2)
primary skin##2##2##(1993-3#1)(1997-2#1)
primary sleep disorders##3##3##(2008-8#1)(2012-2#1)(2013-7#1)
primary sleep##4##2##(2008-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
primary somatosensory cortex (SI)##2##4##(1991-11#1)(1996-2#1)
primary somatosensory cortex##10##3##(1990-4#1)(1990-7#1)(1991-11#2)(1995-11#2)(1995-12#1)(1996-1#2)(1996-2#1)
primary somatosensory##12##2##(1990-4#1)(1990-7#1)(1991-11#2)(1992-2#1)(1995-11#2)(1995-12#2)(1996-1#2)(1996-2#1)
primary source of##16##3##(1994-9#2)(1995-1#1)(1997-8#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2010-12#1)(2010-2#1)(2013-1#2)
primary source##19##2##(1994-9#2)(1995-1#1)(1997-8#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-2#1)(2013-1#2)
primary sources##7##2##(1992-6#1)(2008-2#1)(2008-3#1)(2010-5#1)(2012-2#2)(2013-1#1)
primary specialization courses##2##3##(1994-12#2)
primary specificity##5##2##(1992-12#1)(1994-11#1)(1994-8#1)(1995-3#1)(1997-2#1)
primary spermatocytes##6##2##(2006-5#1)(2008-3#1)(2008-4#1)(2010-5#1)(2012-12#2)
primary spherical aberration##2##3##(2007-12#1)(2008-2#1)
primary spontaneous pneumothorax##4##3##(2007-8#2)(2008-10#1)(2008-7#1)
primary spontaneous##6##2##(2007-8#3)(2008-10#2)(2008-7#1)
primary squamous cell##2##3##(2011-1#1)(2013-7#1)
primary stage##3##2##(1997-3#1)(2007-11#1)(2013-1#1)
primary standard##2##2##(1996-12#1)(2008-10#1)
primary stem##2##2##(2009-6#1)(2010-11#1)
primary step in##3##3##(2008-12#1)(2008-5#1)(2009-10#1)
primary step##4##2##(2008-12#1)(2008-5#1)(2008-6#1)(2009-10#1)
primary strategic##2##2##(2008-4#1)(2010-9#1)
primary stroke##2##2##(2007-10#1)(2013-8#1)
primary structural information##2##3##(1991-7#1)(1995-8#1)
primary structural##3##2##(1991-7#1)(1995-8#1)(1997-4#1)
primary structure and##7##3##(1991-7#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-5#1)(1995-3#1)(2008-4#1)
primary structure as##2##3##(2006-5#1)(2007-11#1)
primary structure exhibits##2##3##(1991-1#1)(1995-6#1)
primary structure is##2##3##(1990-2#1)(1992-3#1)
primary structure of African catfish GnRH##2##6##(1992-8#2)
primary structure of a novel##2##5##(1992-1#1)(1995-5#1)
primary structure of a##5##4##(1992-1#1)(1992-11#1)(1993-9#1)(1995-5#1)(2008-10#1)
primary structure of goat Mb##3##5##(2010-4#3)
primary structure of proteins##2##4##(2008-11#1)(2013-1#1)
primary structure of the peptide##3##5##(1991-7#1)(1992-1#1)(1994-2#1)
primary structure of the protein was##2##6##(1990-3#1)(1991-9#1)
primary structure of the protein##4##5##(1990-3#1)(1991-9#1)(1996-7#1)(2008-10#1)
primary structure of the##28##4##(1990-12#1)(1990-3#2)(1990-5#1)(1990-7#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-1#3)(1992-3#3)(1993-6#1)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#2)(1996-7#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)
primary structure of this##2##4##(1991-9#1)(1992-3#1)
primary structure of##70##3##(1990-11#1)(1990-12#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#2)(1991-9#2)(1992-1#4)(1992-11#1)(1992-2#1)(1992-3#5)(1992-5#1)(1992-8#3)(1992-9#1)(1993-4#3)(1993-6#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#2)(1994-9#2)(1995-3#1)(1995-4#1)(1995-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-8#2)(2007-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-4#3)(2011-2#2)(2012-2#1)(2013-1#1)
primary structure to##2##3##(1993-3#1)(1994-12#1)
primary structure was determined##2##4##(1990-2#1)(1992-8#1)
primary structure was##3##3##(1990-2#1)(1992-11#1)(1992-8#1)
primary structure with##2##3##(1995-5#1)(1997-7#1)
primary structure##116##2##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#3)(1990-4#2)(1990-5#1)(1990-7#2)(1990-9#1)(1991-1#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#3)(1991-9#2)(1992-1#4)(1992-11#4)(1992-2#3)(1992-3#7)(1992-5#1)(1992-6#2)(1992-8#5)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#4)(1993-5#1)(1993-6#2)(1993-9#1)(1994-11#3)(1994-12#3)(1994-2#2)(1994-5#2)(1994-8#4)(1994-9#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#2)(1996-7#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#4)(2006-5#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#1)(2010-4#3)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
primary structures of the##2##4##(1992-1#1)(1994-12#1)
primary structures of##7##3##(1990-5#1)(1991-6#1)(1992-1#1)(1992-3#1)(1993-12#1)(1994-12#1)(1994-5#1)
primary structures##15##2##(1990-5#1)(1990-7#1)(1991-6#1)(1992-1#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-5#3)(1995-3#1)(1995-8#1)(1997-2#1)
primary study group##2##3##(2005-8#1)(2007-9#1)
primary study##4##2##(2005-8#1)(2007-9#1)(2008-8#1)(2011-1#1)
primary subtests of the T##2##5##(2006-10#2)
primary subtests of##3##3##(2006-10#3)
primary success of##2##3##(2006-7#1)(2006-8#1)
primary success rate of##2##4##(1991-3#1)(2008-11#1)
primary success rate##7##3##(1991-3#1)(2006-7#2)(2006-8#1)(2008-11#1)(2008-12#2)
primary success##10##2##(1991-3#1)(2006-7#4)(2006-8#2)(2008-11#1)(2008-12#2)
primary supernumerary tooth##3##3##(2008-5#3)
primary supernumerary##5##2##(2008-5#5)
primary surgery##8##2##(1990-6#1)(1991-8#1)(1993-9#1)(2007-11#1)(2007-8#1)(2008-6#1)(2008-9#2)
primary surgical treatment##3##3##(1990-4#1)(1990-5#1)(2008-8#1)
primary surgical##6##2##(1990-4#1)(1990-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-8#1)
primary suture repair##2##3##(2011-2#2)
primary symptom##2##2##(2007-7#1)(2007-8#1)
primary synovial sarcoma of the thyroid##2##6##(2012-1#2)
primary synovial sarcoma of the##3##5##(2012-1#2)(2013-1#1)
primary synovial##4##2##(2010-5#1)(2012-1#2)(2013-1#1)
primary system##2##2##(2006-10#1)(2008-11#1)
primary systemic amyloidosis##2##3##(2011-2#1)(2012-12#1)
primary systemic##4##2##(1990-5#1)(1995-5#1)(2011-2#1)(2012-12#1)
primary target cell##2##3##(1992-11#1)(2012-2#1)
primary target for##2##3##(2005-12#1)(2013-1#1)
primary target of##6##3##(1995-2#1)(1996-5#1)(2005-8#1)(2008-1#1)(2008-10#1)(2011-1#1)
primary target##15##2##(1991-12#1)(1992-11#1)(1993-12#1)(1995-2#1)(1996-5#1)(2005-12#1)(2005-7#1)(2005-8#1)(2007-1#1)(2008-1#1)(2008-10#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
primary targets for##2##3##(2008-7#1)(2013-8#1)
primary targets##4##2##(1992-12#1)(2008-7#1)(2011-2#1)(2013-8#1)
primary teaching##2##2##(2008-11#2)
primary teeth enamel##2##3##(2012-2#2)
primary teeth in##2##3##(2006-8#1)(2008-5#1)
primary teeth with##2##3##(2011-2#2)
primary teeth##22##2##(2005-9#1)(2006-8#1)(2008-5#4)(2008-9#1)(2009-11#1)(2010-3#3)(2011-1#1)(2011-2#6)(2012-2#2)(2013-1#1)(2013-8#1)
primary telescope##2##2##(2008-3#2)
primary teratoma of the penis##2##5##(2008-10#2)
primary testicular##2##2##(2006-9#1)(2007-6#1)
primary therapeutic##2##2##(1994-11#1)(2006-2#1)
primary therapies##2##2##(2006-2#1)(2007-7#1)
primary therapy for##6##3##(2004-10#1)(2006-10#2)(2006-9#1)(2011-2#2)
primary therapy or##2##3##(1991-8#1)(2008-1#1)
primary therapy##14##2##(1990-11#1)(1991-8#1)(1991-9#1)(2004-10#1)(2006-10#2)(2006-9#1)(2007-11#1)(2008-1#2)(2010-12#1)(2011-2#2)(2012-2#1)
primary thymic##2##2##(2007-8#2)
primary thyroid##3##2##(2008-6#1)(2009-5#1)(2012-1#1)
primary tissue##3##2##(1994-3#2)(2007-8#1)
primary to##2##2##(2004-3#1)(2008-10#1)
primary torsion##2##2##(2005-12#1)(2008-11#1)
primary total hip arthroplasty##7##4##(2008-8#5)(2010-11#1)(2011-2#1)
primary total hip##12##3##(1996-11#1)(1996-9#1)(2008-8#5)(2010-11#1)(2010-9#1)(2011-2#2)(2013-1#1)
primary total knee##3##3##(2008-8#1)(2011-1#1)(2011-2#1)
primary total##16##2##(1996-11#1)(1996-9#1)(2007-1#1)(2008-8#6)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#3)(2013-1#1)
primary toxic##2##2##(1992-8#1)(2010-8#1)
primary transcript##4##2##(1990-5#1)(1991-6#1)(1993-6#1)(1997-7#1)
primary transcripts##2##2##(1994-12#1)(2007-5#1)
primary translation##2##2##(1992-2#1)(2011-1#1)
primary treatment and##2##3##(2005-7#1)(2010-12#1)
primary treatment for##8##3##(2005-7#1)(2006-10#1)(2006-5#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
primary treatment in##3##3##(1995-8#1)(1997-5#1)(2006-8#1)
primary treatment modality for##2##4##(2006-12#1)(2010-11#1)
primary treatment modality##3##3##(2006-12#1)(2007-11#1)(2010-11#1)
primary treatment of##9##3##(1992-3#1)(1994-2#1)(1997-3#1)(2006-10#2)(2007-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
primary treatment##42##2##(1991-5#1)(1991-6#1)(1991-9#2)(1992-3#1)(1993-8#1)(1994-2#1)(1995-8#1)(1997-3#2)(1997-5#1)(2004-1#1)(2005-7#2)(2006-10#3)(2006-12#2)(2006-5#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#1)(2008-7#2)(2008-9#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
primary trisomics##4##2##(2009-12#4)
primary tuberculosis##3##2##(2008-1#1)(2008-10#1)(2010-4#1)
primary tumor and##10##3##(1992-6#1)(1993-1#1)(1995-10#1)(2008-10#1)(2010-12#2)(2010-3#2)(2011-12#1)(2012-2#1)
primary tumor cell##2##3##(2009-6#2)
primary tumor growth##2##3##(1996-6#1)(2009-6#1)
primary tumor in the##3##4##(2008-1#1)(2008-4#1)(2011-2#1)
primary tumor in##5##3##(1995-10#1)(2008-1#1)(2008-4#1)(2010-3#1)(2011-2#1)
primary tumor is##4##3##(1991-9#1)(1992-6#1)(2008-4#1)(2011-12#1)
primary tumor of##2##3##(2013-1#1)(2013-8#1)
primary tumor was##8##3##(1990-6#1)(1992-6#2)(1992-8#1)(1995-10#1)(2007-6#1)(2008-6#2)
primary tumor##99##2##(1990-12#1)(1990-4#1)(1990-6#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-6#4)(1992-8#3)(1992-9#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-12#1)(1995-10#4)(1996-3#1)(1996-6#1)(1997-6#1)(2006-10#1)(2007-11#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#3)(2008-4#5)(2008-6#4)(2008-9#2)(2009-10#1)(2009-3#2)(2009-5#2)(2009-6#3)(2010-12#4)(2010-3#8)(2010-6#2)(2010-8#1)(2011-1#1)(2011-12#3)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#3)
primary tumors and##7##3##(1992-12#1)(1993-8#1)(1994-12#1)(2007-7#1)(2008-11#1)(2011-2#1)(2012-12#1)
primary tumors in##3##3##(1992-8#1)(2010-7#1)(2012-2#1)
primary tumors of the heart##2##5##(2007-11#1)(2012-12#1)
primary tumors of the##4##4##(1996-4#1)(2006-6#1)(2007-11#1)(2012-12#1)
primary tumors##38##2##(1991-7#1)(1991-9#4)(1992-12#1)(1992-8#1)(1993-8#3)(1994-12#2)(1995-10#1)(1995-8#1)(1996-4#1)(1997-7#1)(2006-6#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-11#1)(2008-6#2)(2008-8#1)(2009-3#1)(2010-3#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
primary tumour in##4##3##(2006-10#1)(2007-11#1)(2013-7#2)
primary tumour##30##2##(1990-1#1)(1990-5#1)(1991-6#1)(1993-1#1)(1995-8#3)(1997-3#1)(2004-2#4)(2006-10#4)(2007-11#2)(2008-1#1)(2008-6#3)(2009-2#1)(2009-3#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-7#2)(2013-8#1)
primary tumours are##2##3##(2008-6#1)(2009-10#1)
primary tumours of the##7##4##(1990-9#1)(1996-4#1)(2006-8#1)(2008-6#3)(2012-2#1)
primary tumours of##8##3##(1990-9#1)(1996-4#1)(2006-8#1)(2008-6#4)(2012-2#1)
primary tumours were##2##3##(2006-10#1)(2007-8#1)
primary tumours##18##2##(1990-9#2)(1991-8#1)(1996-4#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-4#1)(2008-6#7)(2009-10#1)(2012-2#1)
primary type##5##2##(1994-2#1)(1994-5#1)(2007-8#1)(2008-11#1)(2010-6#1)
primary types of##2##3##(2008-2#1)(2009-5#1)
primary uncomplicated##2##2##(2011-1#2)
primary vaccination##2##2##(2013-1#1)(2013-8#1)
primary value##2##2##(2008-1#1)(2013-1#1)
primary varicella infection##2##3##(2008-5#1)(2010-8#1)
primary varicella zoster infection##3##4##(2008-7#2)(2010-8#1)
primary varicella##5##2##(2008-5#1)(2008-7#2)(2010-8#2)
primary vector##2##2##(1997-4#1)(2004-11#1)
primary vectors of##2##3##(2004-11#1)(2008-10#1)
primary venous insufficiency##2##3##(1990-3#1)(2005-10#1)
primary versus secondary##2##3##(1994-2#1)(2012-2#1)
primary vesicoureteral reflux##2##3##(1991-5#1)(2008-10#1)
primary viral##2##2##(2007-3#1)(2008-7#1)
primary visual cortex (V1)##7##4##(1995-11#1)(1995-12#1)(1997-8#1)(2008-11#2)(2008-8#1)(2012-2#1)
primary visual cortex of##4##4##(1992-10#1)(1993-12#1)(2008-11#1)(2008-8#1)
primary visual cortex##24##3##(1992-10#1)(1993-12#1)(1995-1#1)(1995-11#3)(1995-12#4)(1997-7#1)(1997-8#2)(2007-9#1)(2008-1#1)(2008-11#3)(2008-7#2)(2008-8#2)(2012-2#1)(2013-7#1)
primary visual##29##2##(1992-10#1)(1993-12#1)(1995-1#1)(1995-11#3)(1995-12#4)(1996-1#1)(1997-7#1)(1997-8#2)(2006-3#1)(2007-9#1)(2008-1#2)(2008-11#3)(2008-7#2)(2008-8#3)(2012-2#1)(2013-7#2)
primary weapons##2##2##(2010-6#1)(2011-12#1)
primary##5116##1##(1990-1#1)(1990-10#18)(1990-11#18)(1990-12#28)(1990-2#18)(1990-3#9)(1990-4#10)(1990-5#30)(1990-6#7)(1990-7#20)(1990-8#12)(1990-9#22)(1991-1#15)(1991-10#12)(1991-11#13)(1991-12#14)(1991-2#27)(1991-3#9)(1991-4#10)(1991-5#21)(1991-6#28)(1991-7#29)(1991-8#17)(1991-9#20)(1992-1#13)(1992-10#5)(1992-11#30)(1992-12#20)(1992-2#30)(1992-3#23)(1992-4#6)(1992-5#6)(1992-6#25)(1992-7#5)(1992-8#34)(1992-9#13)(1993-1#21)(1993-10#12)(1993-11#14)(1993-12#19)(1993-2#24)(1993-3#17)(1993-4#15)(1993-5#12)(1993-6#27)(1993-7#4)(1993-8#20)(1993-9#34)(1994-10#9)(1994-11#24)(1994-12#22)(1994-2#31)(1994-3#19)(1994-4#5)(1994-5#25)(1994-6#18)(1994-7#12)(1994-8#24)(1994-9#21)(1995-1#11)(1995-10#19)(1995-11#27)(1995-12#38)(1995-2#28)(1995-3#33)(1995-4#12)(1995-5#25)(1995-6#18)(1995-7#4)(1995-8#22)(1995-9#14)(1996-1#27)(1996-10#7)(1996-11#23)(1996-12#40)(1996-2#33)(1996-3#27)(1996-4#24)(1996-5#24)(1996-6#13)(1996-7#8)(1996-8#12)(1996-9#21)(1997-1#8)(1997-2#26)(1997-3#35)(1997-4#28)(1997-5#12)(1997-6#11)(1997-7#26)(1997-8#30)(1997-9#2)(2004-1#9)(2004-10#3)(2004-11#43)(2004-12#1)(2004-2#4)(2004-3#15)(2004-7#1)(2004-9#2)(2005-1#2)(2005-10#14)(2005-11#13)(2005-12#10)(2005-3#2)(2005-5#3)(2005-6#2)(2005-7#9)(2005-8#24)(2005-9#10)(2006-1#3)(2006-10#102)(2006-11#4)(2006-12#27)(2006-2#20)(2006-3#7)(2006-4#6)(2006-5#39)(2006-6#11)(2006-7#24)(2006-8#30)(2006-9#22)(2007-1#16)(2007-10#39)(2007-11#74)(2007-12#61)(2007-2#47)(2007-3#16)(2007-4#15)(2007-5#27)(2007-6#14)(2007-7#92)(2007-8#83)(2007-9#25)(2008-1#71)(2008-10#238)(2008-11#120)(2008-12#42)(2008-2#59)(2008-3#88)(2008-4#88)(2008-5#100)(2008-6#70)(2008-7#90)(2008-8#69)(2008-9#60)(2009-1#2)(2009-10#24)(2009-11#16)(2009-12#17)(2009-2#11)(2009-3#26)(2009-4#21)(2009-5#27)(2009-6#15)(2009-7#6)(2009-8#21)(2009-9#32)(2010-1#7)(2010-10#11)(2010-11#35)(2010-12#45)(2010-2#28)(2010-3#39)(2010-4#29)(2010-5#17)(2010-6#11)(2010-7#19)(2010-8#35)(2010-9#13)(2011-1#89)(2011-12#23)(2011-2#159)(2011-3#6)(2012-1#27)(2012-11#14)(2012-12#70)(2012-2#112)(2012-3#51)(2012-5#1)(2013-1#145)(2013-7#29)(2013-8#82)
primary&quot##2##1##(2006-10#1)(2008-5#1)
primary)##2##1##(2007-9#1)(2012-1#1)
primary-care providers##2##2##(1992-8#1)(1996-3#1)
primary-care##12##1##(1992-8#2)(1996-2#2)(1996-3#2)(1997-2#4)(2011-2#2)
primary-cultured##4##1##(1992-4#1)(2008-11#3)
primary-growth##2##1##(2008-10#2)
primary-secondary wavelengths##2##2##(2005-4#2)
primary-secondary##3##1##(2005-4#2)(2011-1#1)
primary-tertiary##3##1##(2008-10#3)
primase activity##2##2##(1993-3#1)(2011-1#1)
primase##28##1##(1990-12#1)(1991-2#1)(1992-3#1)(1993-3#9)(1994-12#3)(1994-2#1)(1995-2#2)(1995-6#5)(1996-8#2)(2011-1#3)
primase-synthesized##2##1##(1995-2#2)
primate ES cells##2##3##(2008-9#2)
primate and##3##2##(1990-8#1)(1991-11#1)(1994-12#1)
primate biscuits##2##2##(2007-2#2)
primate bone marrow stromal##2##4##(1994-12#2)
primate brain##4##2##(1992-12#1)(1997-2#2)(2012-3#1)
primate cerebral cortex##2##3##(1992-2#1)(1995-11#1)
primate embryonic stem cells##2##4##(2008-1#1)(2008-9#1)
primate embryonic stem##3##3##(2008-1#1)(2008-9#1)(2009-12#1)
primate genome##2##2##(1995-8#1)(2008-8#1)
primate model of##4##3##(1993-11#1)(1993-6#1)(2007-10#2)
primate models of##3##3##(1993-5#1)(1997-1#1)(2008-9#1)
primate models##5##2##(1993-3#1)(1993-5#1)(1997-1#1)(2007-11#1)(2008-9#1)
primate pregnancy##2##2##(1994-6#2)
primate species##9##2##(1991-9#2)(1994-12#1)(1995-5#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-8#1)(2012-2#1)
primate visual##3##2##(1992-2#1)(1995-5#2)
primate##105##1##(1990-12#2)(1990-3#3)(1990-8#1)(1991-11#1)(1991-3#1)(1991-9#2)(1992-12#1)(1992-2#3)(1992-9#2)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#4)(1994-2#2)(1994-6#3)(1995-11#3)(1995-2#3)(1995-3#1)(1995-5#8)(1995-8#1)(1996-1#1)(1996-10#1)(1996-6#1)(1997-1#1)(1997-2#3)(1997-4#3)(1997-8#3)(2005-7#1)(2006-1#1)(2006-7#1)(2007-10#3)(2007-11#1)(2007-2#5)(2007-9#1)(2008-1#5)(2008-11#2)(2008-4#1)(2008-8#8)(2008-9#4)(2009-12#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-2#4)(2012-3#2)
primates and##11##2##(1991-11#1)(1991-7#1)(1992-11#1)(1994-6#1)(1996-3#1)(1996-6#1)(1997-4#1)(2007-11#1)(2008-10#1)(2012-2#1)(2013-8#1)
primates are##2##2##(1991-2#1)(2008-9#1)
primates at the Afi Mountain##2##5##(2012-2#2)
primates do not##3##3##(1991-11#1)(1994-2#1)(2010-4#1)
primates has##4##2##(2006-2#1)(2008-4#1)(2011-12#1)(2012-3#1)
primates have##2##2##(1991-11#1)(2007-11#1)
primates is##2##2##(2006-8#1)(2012-2#1)
primates that##4##2##(1995-1#1)(1995-8#1)(2007-10#1)(2009-8#1)
primates were##3##2##(1996-12#1)(2012-2#1)(2013-1#1)
primates with##3##2##(1990-11#1)(1993-8#1)(1993-9#1)
primates##147##1##(1990-10#1)(1990-11#1)(1990-3#2)(1990-5#1)(1991-11#11)(1991-12#1)(1991-2#3)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-8#2)(1993-12#1)(1993-5#1)(1993-8#3)(1993-9#1)(1994-2#2)(1994-6#1)(1994-8#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#3)(1996-3#2)(1996-4#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-2#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-2#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-3#1)(2007-6#4)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#5)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#1)(2009-3#2)(2009-4#2)(2009-8#1)(2010-3#2)(2010-4#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#11)(2012-3#6)(2013-1#2)(2013-7#1)(2013-8#2)
primatologists##2##1##(1990-9#1)(2013-8#1)
primaurelia##4##1##(2008-12#4)
prime and##5##2##(2008-2#1)(2008-4#3)(2010-8#1)
prime candidate for##2##3##(1991-9#1)(2008-7#1)
prime candidate##3##2##(1991-9#1)(2008-7#2)
prime candidates for##2##3##(2006-10#1)(2011-2#1)
prime code##3##2##(2008-3#3)
prime importance##7##2##(1992-12#1)(1993-10#1)(2006-12#1)(2008-10#1)(2008-7#1)(2008-9#2)
prime in##2##2##(2007-9#2)
prime naïve CD4(+) T cells##2##5##(2008-11#2)
prime reason for##3##3##(2007-2#1)(2008-1#1)(2010-2#1)
prime site##2##2##(1990-5#1)(2011-2#1)
prime suspect##2##2##(2008-11#1)(2009-5#1)
prime the##4##2##(1992-7#1)(1993-9#1)(1994-11#1)(2008-11#1)
prime time##7##2##(2007-9#1)(2008-8#1)(2009-10#2)(2009-12#1)(2010-4#1)(2011-2#1)
prime volume##2##2##(2010-12#2)
prime word and##2##3##(2008-10#2)
prime##108##1##(1990-4#1)(1990-5#1)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-7#1)(1993-10#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#2)(1997-5#1)(2006-1#2)(2006-10#2)(2006-12#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#3)(2008-1#4)(2008-10#5)(2008-11#5)(2008-12#1)(2008-2#7)(2008-3#5)(2008-4#5)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#2)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#3)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
prime-to-behavior effects##5##2##(2008-5#5)
primed and##2##2##(2005-11#1)(2013-1#1)
primed by##3##2##(1990-3#1)(1994-6#1)(1997-2#1)
primed cells##4##2##(1990-3#2)(1996-5#1)(2012-3#1)
primed for apoptosis##2##3##(1995-2#2)
primed for##3##2##(1995-2#2)(2007-12#1)
primed in situ labeling (PRINS) has traditionally been used to detect tandemly repeated target sequences in chromosomes and nuclei##2##19##(2008-4#1)(2008-9#1)
primed in##3##2##(1995-2#1)(2008-4#1)(2008-9#1)
primed neutrophils to##2##3##(1990-8#1)(1996-2#1)
primed neutrophils##3##2##(1990-7#1)(1990-8#1)(1996-2#1)
primed polymerase chain reaction##7##4##(2007-1#1)(2008-10#5)(2008-11#1)
primed splenocytes##2##2##(1992-8#2)
primed with interferon-gamma##2##3##(1994-11#1)(1994-5#1)
primed with##12##2##(1992-1#1)(1992-11#1)(1994-11#2)(1994-5#1)(1995-2#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-4#2)(2010-8#1)
primed##65##1##(1990-11#1)(1990-3#4)(1990-7#3)(1990-8#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-8#3)(1994-11#2)(1994-12#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#6)(1995-8#1)(1996-2#2)(1996-5#1)(1997-2#2)(1997-4#1)(1997-7#1)(2005-11#1)(2007-1#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-11#4)(2008-2#1)(2008-4#4)(2008-5#1)(2008-9#1)(2009-3#2)(2010-8#1)(2012-3#1)(2013-1#3)
primed-PCR##2##1##(2008-10#1)(2008-5#1)
primer RNA##3##2##(1991-8#1)(1995-6#1)(2011-1#1)
primer analysis##3##2##(2008-10#3)
primer and probe##2##3##(2008-10#1)(2008-2#1)
primer and the##3##3##(1993-12#1)(1994-12#1)(1997-7#1)
primer and##16##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#2)(1992-6#1)(1993-12#1)(1994-12#1)(1997-7#1)(2008-10#3)(2008-2#1)(2008-8#1)(2008-9#1)(2012-2#1)
primer binding site##4##3##(1995-8#1)(1996-11#1)(2008-12#1)(2012-3#1)
primer binding##7##2##(1992-3#1)(1995-8#1)(1996-11#1)(1997-2#1)(2008-10#1)(2008-12#1)(2012-3#1)
primer by##2##2##(1992-4#1)(2008-8#1)
primer coating##2##2##(2010-4#2)
primer combination##2##2##(2008-10#2)
primer combinations##2##2##(1990-2#1)(2008-10#1)
primer complementary to##2##3##(1997-7#1)(2008-5#1)
primer complementary##3##2##(1997-7#1)(2008-4#1)(2008-5#1)
primer concentration##3##2##(1994-12#1)(2006-12#1)(2008-10#1)
primer designed##3##2##(1997-6#1)(2007-6#1)(2008-4#1)
primer extension analysis of##3##4##(1993-2#1)(1993-8#1)(2008-10#1)
primer extension analysis##13##3##(1990-11#1)(1990-5#1)(1990-9#1)(1991-5#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-8#1)(1995-4#1)(1996-10#1)(1997-1#1)(1997-5#1)(2008-10#1)
primer extension and##5##3##(1990-11#1)(1990-12#1)(1991-9#1)(1996-2#1)(2008-4#1)
primer extension assay##2##3##(2008-4#2)
primer extension experiments##3##3##(1990-9#1)(1991-8#1)(1995-8#1)
primer extension reaction##2##3##(2008-3#1)(2008-4#1)
primer extension we##2##3##(1990-11#1)(1993-9#1)
primer extension##46##2##(1990-11#4)(1990-12#1)(1990-5#1)(1990-9#2)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-3#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-4#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#7)(2008-9#1)
primer for##10##2##(1994-9#1)(1996-11#1)(1996-2#1)(2007-5#1)(2008-11#1)(2008-4#2)(2008-6#1)(2009-8#1)(2010-1#1)
primer have##2##2##(2008-10#1)(2008-8#1)
primer hybridization##2##2##(2008-2#2)
primer in a##2##3##(1997-2#1)(2009-3#1)
primer in##5##2##(1997-2#1)(2008-5#1)(2008-7#1)(2009-3#1)(2013-1#1)
primer is##7##2##(1990-12#1)(1994-12#1)(2008-11#1)(2008-2#1)(2008-4#2)(2009-7#1)
primer layer##4##2##(2010-4#4)
primer loop of##3##3##(2009-7#3)
primer loop##4##2##(2009-7#4)
primer of##4##2##(2005-11#1)(2007-11#1)(2008-11#1)(2008-8#1)
primer on##9##2##(1993-12#2)(1994-3#1)(1996-3#1)(2007-12#1)(2007-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
primer pair amplified##3##3##(1992-2#1)(1993-12#1)(2008-10#1)
primer pair specific##2##3##(1992-2#1)(2007-8#1)
primer pair was##2##3##(1993-12#1)(2008-10#1)
primer pair##26##2##(1992-2#2)(1993-12#2)(1995-12#1)(2007-12#1)(2007-8#1)(2008-10#18)(2008-5#1)
primer pairs amplified##2##3##(2008-10#1)(2008-5#1)
primer pairs and##3##3##(1995-6#1)(2008-11#1)(2008-5#1)
primer pairs derived from##2##4##(1995-12#1)(2008-10#1)
primer pairs for##2##3##(2008-10#1)(2013-8#1)
primer pairs previously##2##3##(2008-5#1)(2012-2#1)
primer pairs specific for##3##4##(2007-2#1)(2008-5#1)(2012-3#1)
primer pairs used##2##3##(2008-10#2)
primer pairs were used##2##4##(2008-10#2)
primer pairs were##4##3##(1993-12#1)(2008-10#3)
primer pairs##41##2##(1991-9#1)(1993-12#1)(1995-12#1)(1995-6#1)(2007-1#2)(2007-12#1)(2007-2#1)(2008-10#21)(2008-11#1)(2008-5#5)(2011-12#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
primer recognition##2##2##(1990-5#2)
primer sequences##2##2##(2006-5#1)(2008-10#1)
primer set is##2##3##(2008-10#2)
primer set was##3##3##(2008-10#3)
primer set##20##2##(1994-2#1)(1995-2#1)(2006-5#1)(2008-10#13)(2008-4#2)(2011-1#1)(2013-1#1)
primer sets for##2##3##(2008-10#2)
primer sets##17##2##(1997-2#1)(1997-4#2)(2006-5#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-9#1)(2011-2#1)
primer site##4##2##(1990-9#1)(1991-10#2)(1996-4#1)
primer synthesis##2##2##(1993-3#1)(1996-8#1)
primer tRNA(Lys##2##2##(1991-10#2)
primer walking##3##2##(1995-7#2)(1997-4#1)
primer was##2##2##(2008-10#1)(2012-2#1)
primer##347##1##(1990-10#1)(1990-11#5)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#7)(1990-9#3)(1991-10#4)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#4)(1992-2#2)(1992-3#3)(1992-4#3)(1992-6#3)(1993-11#1)(1993-12#7)(1993-2#2)(1993-3#7)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#7)(1994-2#2)(1994-3#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#2)(1995-8#3)(1996-10#1)(1996-11#3)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#4)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#5)(1997-4#3)(1997-5#3)(1997-6#2)(1997-7#4)(2005-10#1)(2005-11#1)(2006-12#1)(2006-4#1)(2006-5#4)(2006-8#3)(2007-1#2)(2007-11#1)(2007-12#3)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#95)(2008-11#4)(2008-12#3)(2008-2#7)(2008-3#1)(2008-4#17)(2008-5#12)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#6)(2009-3#1)(2009-7#5)(2009-8#1)(2010-1#1)(2010-4#6)(2011-1#5)(2011-12#2)(2011-2#4)(2012-2#5)(2012-3#2)(2013-1#3)(2013-8#1)
primer-extension##3##1##(1993-4#1)(1996-7#1)(2008-4#1)
primer-probe systems##2##2##(2008-10#1)(2010-4#1)
primer-probe##5##1##(2008-10#3)(2010-4#2)
primer-template##4##1##(1993-3#1)(1994-12#1)(1994-9#1)(2008-4#1)
primer/probe sets were##3##3##(2008-10#3)
primer/probe sets##4##2##(2008-10#4)
primer/probe##6##1##(2008-10#6)
primers also were##2##3##(2008-10#2)
primers also##3##2##(2008-10#3)
primers amplified the##2##3##(2008-10#2)
primers amplified##8##2##(2006-2#1)(2008-10#7)
primers and TaqMan probes##3##4##(2008-10#2)(2010-4#1)
primers and a##3##3##(2008-10#2)(2013-1#1)
primers and probes##2##3##(2008-10#2)
primers and the polymerase chain reaction##3##6##(1994-12#3)
primers and the##5##3##(1994-12#3)(2004-11#1)(2008-8#1)
primers and##32##2##(1991-12#1)(1992-3#1)(1993-3#1)(1993-9#1)(1994-12#3)(1994-8#1)(1994-9#1)(1996-7#1)(2004-11#1)(2006-12#1)(2008-10#14)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
primers are##4##2##(2007-8#2)(2008-4#1)(2008-9#1)
primers at least 7 nucleotides long##2##6##(1993-3#2)
primers at##3##2##(1993-3#2)(2007-3#1)
primers based on the##5##4##(1993-2#1)(1996-7#1)(2007-12#1)(2008-10#2)
primers based on##8##3##(1993-2#1)(1993-3#1)(1996-7#1)(2007-12#1)(2008-10#3)(2008-5#1)
primers can##2##2##(1994-12#1)(2007-1#1)
primers chosen##2##2##(1992-11#1)(2004-11#1)
primers complementary to##2##3##(1996-8#1)(1997-4#1)
primers confirmed##2##2##(2008-10#1)(2012-12#1)
primers corresponding to##3##3##(1992-11#1)(1992-6#1)(1997-2#1)
primers could##4##2##(1997-2#1)(2005-11#1)(2008-10#1)(2008-8#1)
primers derived from##6##3##(1992-12#1)(1992-5#1)(1995-8#1)(1997-6#1)(2008-10#2)
primers designed according to##2##4##(2008-8#1)(2008-9#1)
primers designed for##2##3##(2008-10#1)(2008-5#1)
primers designed from the##5##4##(1997-7#1)(2005-11#1)(2008-10#3)
primers designed from##7##3##(1994-12#1)(1994-5#1)(1997-7#1)(2005-11#1)(2008-10#3)
primers designed in this##2##4##(2008-10#1)(2010-4#1)
primers designed to##6##3##(1993-11#1)(1995-11#1)(2008-10#2)(2013-8#2)
primers designed##21##2##(1993-11#1)(1994-12#1)(1994-5#1)(1995-11#1)(1997-7#1)(2005-11#2)(2007-6#1)(2008-10#7)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#1)(2013-8#2)
primers detected##3##2##(2008-10#2)(2013-8#1)
primers developed in##2##3##(2006-5#1)(2008-10#1)
primers directed##3##2##(1991-9#1)(1994-12#1)(2011-2#1)
primers flanking the##9##3##(1990-11#1)(1990-7#1)(1991-12#1)(1997-7#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-4#1)
primers flanking##10##2##(1990-11#1)(1990-7#1)(1991-12#1)(1997-7#1)(2006-12#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-4#1)
primers for C##2##3##(2008-10#2)
primers for amplification##2##3##(1995-2#1)(2006-4#1)
primers for each of##2##4##(2005-9#1)(2008-4#1)
primers for polymerase chain reaction##2##5##(2008-10#2)
primers for the detection and##2##5##(2005-9#1)(2008-10#1)
primers for the##6##3##(1991-6#1)(1993-7#1)(2005-9#1)(2008-10#2)(2008-5#1)
primers for##31##2##(1990-11#1)(1991-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1995-10#1)(1995-2#2)(1995-6#1)(1996-2#1)(2005-9#2)(2006-4#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)
primers from##7##2##(1994-11#1)(2008-10#4)(2008-9#1)(2011-2#1)
primers identified##2##2##(2008-10#1)(2008-5#1)
primers in a##2##3##(2008-10#2)
primers in##9##2##(1990-7#1)(1991-10#1)(2008-10#5)(2008-12#1)(2009-5#1)
primers is##4##2##(1996-11#1)(2008-10#3)
primers on##3##2##(1993-3#1)(2008-10#1)(2011-2#1)
primers or##2##2##(2006-3#1)(2011-1#1)
primers produced##2##2##(1997-4#1)(2013-7#1)
primers resulted in##2##3##(2008-10#2)
primers revealed##3##2##(1997-6#1)(2008-10#1)(2011-2#1)
primers showed##2##2##(2004-11#1)(2011-2#1)
primers specific for the long terminal##2##6##(2008-5#2)
primers specific for the##7##4##(1992-3#1)(1996-11#1)(2006-3#1)(2008-10#2)(2008-5#2)
primers specific for##15##3##(1991-9#1)(1992-3#1)(1992-9#1)(1995-12#1)(1996-11#1)(2006-3#1)(2007-12#1)(2008-10#5)(2008-5#3)
primers specific##16##2##(1991-9#1)(1992-3#1)(1992-9#1)(1995-12#1)(1996-11#1)(2006-3#1)(2007-12#1)(2008-10#6)(2008-5#3)
primers targeting the conserved##2##4##(2008-10#2)
primers that amplified##2##3##(1993-12#1)(2008-10#1)
primers that amplify##4##3##(2008-10#3)(2010-5#1)
primers that specifically amplified##2##4##(1993-12#1)(2008-10#1)
primers that were##2##3##(2008-10#2)
primers that##16##2##(1993-12#2)(1993-3#1)(1993-6#1)(1996-3#1)(2006-5#1)(2008-10#8)(2008-5#1)(2010-5#1)
primers to amplify##2##3##(2006-4#1)(2008-10#1)
primers to##13##2##(1991-5#1)(1993-11#1)(1993-3#1)(1996-2#1)(1997-5#1)(2006-4#1)(2008-10#6)(2008-5#1)
primers used##5##2##(1997-7#1)(2008-10#2)(2008-5#2)
primers was able to amplify##2##5##(1995-2#1)(2008-10#1)
primers was found to be##2##5##(2008-10#1)(2008-12#1)
primers was##12##2##(1993-2#1)(1993-3#1)(1995-2#1)(1997-4#1)(2005-11#1)(2007-1#1)(2007-2#1)(2008-10#4)(2008-12#1)
primers were designed and used to##2##6##(2008-10#2)
primers were designed and##5##4##(2008-10#3)(2008-8#1)(2010-4#1)
primers were designed for##2##4##(2008-10#2)
primers were designed from##2##4##(2008-10#1)(2008-7#1)
primers were designed to##3##4##(2005-11#1)(2008-10#1)(2012-12#1)
primers were designed##17##3##(2005-11#2)(2008-10#8)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-8#2)
primers were developed##2##3##(2008-10#2)
primers were screened##5##3##(2007-1#2)(2008-10#3)
primers were synthesized for##2##4##(2005-11#1)(2008-10#1)
primers were synthesized##3##3##(1990-2#1)(2005-11#1)(2008-10#1)
primers were used for##2##4##(2008-10#1)(2009-5#1)
primers were used in##2##4##(2008-10#2)
primers were used to amplify##2##5##(2007-6#1)(2008-10#1)
primers were used to##7##4##(1993-6#1)(1993-9#1)(2007-6#1)(2008-10#3)(2008-8#1)
primers were used##11##3##(1993-6#1)(1993-9#1)(2007-6#1)(2008-10#6)(2008-8#1)(2009-5#1)
primers were##54##2##(1990-2#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-8#1)(1994-9#1)(1997-2#1)(1997-6#1)(2005-11#3)(2006-12#1)(2007-1#3)(2007-6#1)(2008-10#29)(2008-7#1)(2008-8#2)(2009-5#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-8#2)
primers which##3##2##(1993-9#1)(1994-8#1)(2011-2#1)
primers with sequences##2##3##(1994-12#1)(2008-10#1)
primers with##3##2##(1994-12#1)(2008-10#1)(2010-4#1)
primers##494##1##(1990-11#4)(1990-12#2)(1990-2#3)(1990-5#2)(1990-7#2)(1990-8#1)(1991-10#1)(1991-12#3)(1991-5#4)(1991-6#2)(1991-9#3)(1992-11#2)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#2)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#10)(1993-6#2)(1993-7#1)(1993-9#5)(1994-11#2)(1994-12#11)(1994-5#1)(1994-8#7)(1994-9#7)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#5)(1995-6#2)(1995-7#2)(1995-8#2)(1996-11#7)(1996-12#1)(1996-2#4)(1996-3#2)(1996-4#2)(1996-7#2)(1996-8#2)(1997-2#4)(1997-4#6)(1997-5#1)(1997-6#4)(1997-7#7)(1997-8#1)(2004-11#4)(2005-11#11)(2005-9#2)(2006-10#1)(2006-12#6)(2006-2#1)(2006-3#2)(2006-4#2)(2006-5#4)(2006-6#1)(2006-8#1)(2007-1#9)(2007-12#3)(2007-2#1)(2007-3#1)(2007-6#2)(2007-8#2)(2008-10#193)(2008-11#6)(2008-12#9)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#21)(2008-7#3)(2008-8#7)(2008-9#7)(2009-5#2)(2010-4#5)(2010-5#1)(2011-1#1)(2011-2#11)(2012-12#5)(2012-2#2)(2013-1#3)(2013-7#2)(2013-8#8)
primes##16##1##(1990-7#1)(1992-3#1)(1992-5#1)(1992-8#2)(1993-11#1)(1995-2#1)(1995-5#1)(1997-4#1)(2008-5#2)(2009-8#1)(2009-9#3)(2012-3#1)
primexine##2##1##(2011-2#2)
primidone##2##1##(1994-7#1)(2008-10#1)
primigravid##4##1##(1992-5#2)(2004-10#2)
primigravida with##2##2##(2012-1#1)(2012-2#1)
primigravida##3##1##(2009-10#1)(2012-1#1)(2012-2#1)
primigravidae patients who##2##3##(2004-10#2)
primigravidae##9##1##(1992-2#1)(2004-10#5)(2009-5#2)(2011-12#1)
priming activity##3##2##(1990-3#3)
priming and##3##2##(1992-6#1)(1993-9#1)(1994-8#1)
priming at##2##2##(1992-3#1)(1995-12#1)
priming by##2##2##(1990-8#1)(1996-11#1)
priming doses##2##2##(2008-7#2)
priming effect of extracellular##2##4##(2008-4#2)
priming effect of##3##3##(2007-12#1)(2008-4#2)
priming effect##5##2##(2007-12#1)(2008-2#1)(2008-4#3)
priming effects##2##2##(2008-4#1)(2008-5#1)
priming for##4##2##(1990-9#1)(2008-10#1)(2008-2#1)(2013-1#1)
priming in##6##2##(1992-7#1)(2006-5#1)(2008-4#2)(2009-9#1)(2010-7#1)
priming is##2##2##(1992-3#1)(2013-8#1)
priming may##4##2##(2013-8#4)
priming of alveolar macrophages##2##4##(1992-8#2)
priming of##16##2##(1990-8#1)(1992-8#3)(1996-10#1)(1996-9#1)(2006-5#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2012-2#1)(2013-1#1)
priming period##2##2##(1990-9#1)(1992-8#1)
priming sites##2##2##(1997-4#1)(2008-10#1)
priming to##4##2##(1993-2#1)(2009-11#1)(2010-7#2)
priming volume##2##2##(2007-8#2)
priming was##2##2##(1994-11#1)(2008-4#1)
priming with 1 nM neuropeptide##2##5##(1995-12#2)
priming with##3##2##(1992-3#1)(1995-12#2)
priming##139##1##(1990-11#2)(1990-3#4)(1990-8#2)(1990-9#2)(1991-12#1)(1992-3#4)(1992-6#1)(1992-7#1)(1992-8#6)(1993-2#5)(1993-9#2)(1994-11#1)(1994-8#2)(1994-9#1)(1995-12#7)(1995-2#3)(1995-5#2)(1996-10#1)(1996-11#1)(1996-9#1)(1997-4#2)(1997-8#1)(2006-3#1)(2006-5#4)(2007-12#4)(2007-7#1)(2007-8#2)(2007-9#3)(2008-10#11)(2008-11#1)(2008-2#5)(2008-4#10)(2008-5#8)(2008-7#5)(2009-11#2)(2009-9#3)(2010-12#1)(2010-7#4)(2011-2#1)(2012-12#2)(2012-2#6)(2013-1#4)(2013-8#9)
priming&quot##2##1##(1992-3#2)
primipara##7##1##(2007-3#1)(2008-11#1)(2008-4#1)(2011-1#1)(2011-2#1)(2013-1#2)
primiparas##7##1##(1996-12#1)(2004-10#1)(2007-10#1)(2008-4#1)(2011-2#3)
primiparous mothers##4##2##(1992-5#3)(1994-7#1)
primiparous women##2##2##(2011-1#1)(2012-11#1)
primiparous##11##1##(1991-1#1)(1992-5#3)(1994-7#1)(2007-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-3#1)
primitive adenocarcinoma of the duodenum##2##5##(2006-2#2)
primitive and definitive erythroid##2##4##(1997-4#2)
primitive and definitive##3##3##(1997-4#3)
primitive and##6##2##(1992-2#1)(1995-8#1)(1997-4#3)(2007-2#1)
primitive cells##2##2##(2008-1#1)(2011-1#1)
primitive endoderm##2##2##(2008-1#2)
primitive erythroid##2##2##(1997-4#2)
primitive genetic##2##2##(1995-6#1)(2008-1#1)
primitive hematopoietic##2##2##(1993-2#1)(1993-8#1)
primitive hemopoietic##2##2##(1995-1#1)(2008-5#1)
primitive human hematopoietic##2##3##(1997-4#2)
primitive neuroectodermal tumor##5##3##(2006-8#1)(2007-12#1)(2009-1#3)
primitive neuroectodermal tumors##4##3##(2006-8#2)(2007-12#1)(2012-12#1)
primitive neuroectodermal tumour of the chest wall##2##7##(2008-6#2)
primitive neuroectodermal tumour##3##3##(2008-6#2)(2008-7#1)
primitive neuroectodermal##15##2##(1996-4#1)(2006-8#3)(2007-12#2)(2008-6#3)(2008-7#1)(2009-1#3)(2012-12#2)
primitive stem##2##2##(2008-9#1)(2010-11#1)
primitive##113##1##(1990-10#1)(1990-3#1)(1990-5#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-6#1)(1995-8#4)(1996-4#1)(1996-6#2)(1996-7#1)(1997-4#9)(1997-5#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-2#3)(2006-7#1)(2006-8#5)(2007-11#1)(2007-12#5)(2007-2#2)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#5)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#5)(2008-7#4)(2008-8#3)(2008-9#4)(2009-1#3)(2009-10#2)(2009-12#1)(2010-11#3)(2010-3#2)(2011-1#3)(2012-1#1)(2012-12#5)(2012-2#2)(2013-1#4)(2013-8#1)
primitive&quot##3##1##(2005-11#1)(2010-11#2)
primitively##3##1##(2007-12#1)(2007-9#1)(2010-8#1)
primitives##8##1##(1997-8#1)(2008-11#2)(2008-3#2)(2008-6#2)(2012-1#1)
primordia of##2##2##(1994-3#1)(2007-12#1)
primordia##16##1##(1991-3#1)(1994-3#2)(1995-8#1)(2007-12#1)(2007-3#1)(2008-8#2)(2009-8#6)(2012-12#2)
primordial and primary follicles##2##4##(1995-12#2)
primordial cells##3##2##(2007-12#3)
primordial endoblast##2##2##(2007-12#2)
primordial germ cell##2##3##(2007-12#2)
primordial germ cells (PGCs)##2##4##(2008-11#2)
primordial germ cells between chicken##2##5##(2008-11#2)
primordial germ cells##11##3##(2006-6#1)(2008-11#4)(2010-12#1)(2010-5#5)
primordial germ##14##2##(2006-6#1)(2007-12#2)(2008-11#4)(2008-12#1)(2010-12#1)(2010-5#5)
primordial mesoteloblast##2##2##(2007-12#2)
primordial##41##1##(1994-6#1)(1994-8#1)(1995-12#2)(1996-2#1)(2006-6#1)(2007-12#12)(2008-11#5)(2008-12#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-5#5)(2011-1#1)(2012-12#1)(2013-1#2)
primordium##8##1##(1991-8#1)(1995-11#2)(1996-4#2)(2007-12#1)(2008-5#1)(2008-8#1)
primosome##5##1##(1991-7#1)(1992-3#1)(1994-12#3)
princeps##2##1##(2010-12#1)(2012-2#1)
princes##2##1##(2008-10#1)(2008-6#1)
principal A beta##2##3##(1994-8#2)
principal activity##2##2##(2007-11#1)(2010-3#1)
principal aim of##2##3##(2009-4#1)(2009-6#1)
principal and##2##2##(1990-9#1)(2007-9#1)
principal axes of the##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
principal axes##7##2##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#1)
principal axis of##3##3##(2007-12#1)(2009-5#1)(2012-1#1)
principal axis##6##2##(1997-4#1)(2007-12#1)(2008-3#1)(2008-6#1)(2009-5#1)(2012-1#1)
principal cause of##5##3##(2006-10#1)(2006-8#1)(2007-10#1)(2008-2#1)(2009-2#1)
principal cause##7##2##(2006-10#1)(2006-8#1)(2007-10#1)(2008-2#1)(2008-7#1)(2009-2#1)(2013-8#1)
principal causes##4##2##(1994-4#1)(2007-9#1)(2008-10#1)(2012-2#1)
principal cell##2##2##(2007-9#1)(2008-10#1)
principal cells##4##2##(2007-10#1)(2013-8#3)
principal clinical##2##2##(2006-12#1)(2008-9#1)
principal component adjustment model##2##4##(2012-3#2)
principal component adjustment##3##3##(2012-3#3)
principal component analysis (PCA) and linear discriminant analysis (LDA)##2##9##(2006-7#1)(2008-2#1)
principal component analysis (PCA) and partial least##2##7##(2008-10#2)
principal component analysis (PCA) and##14##5##(2006-10#1)(2006-7#1)(2008-10#11)(2008-2#1)
principal component analysis (PCA) for##2##5##(2008-10#1)(2010-5#1)
principal component analysis (PCA) method##2##5##(2008-10#1)(2013-8#1)
principal component analysis (PCA) of##3##5##(1996-5#1)(2008-10#1)(2011-2#1)
principal component analysis (PCA) were##2##5##(2008-10#1)(2012-12#1)
principal component analysis (PCA)##44##4##(1996-5#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-10#28)(2008-2#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
principal component analysis and cluster analysis##2##6##(2008-10#2)
principal component analysis and improved BP##2##6##(2013-8#2)
principal component analysis and##7##4##(2008-10#4)(2011-2#1)(2013-8#2)
principal component analysis is##2##4##(2013-1#2)
principal component analysis of##2##4##(2008-3#1)(2008-5#1)
principal component analysis on the##2##5##(2010-8#1)(2011-2#1)
principal component analysis or##2##4##(2008-2#1)(2010-10#1)
principal component analysis to##3##4##(2008-10#1)(2008-2#1)(2010-8#1)
principal component analysis was##2##4##(2008-1#1)(2010-5#1)
principal component analysis##99##3##(1993-9#1)(1996-5#2)(2006-10#1)(2006-7#1)(2007-8#2)(2008-1#2)(2008-10#46)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#4)(2010-7#2)(2010-8#3)(2011-1#4)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#2)(2013-8#5)
principal component and##2##3##(2008-10#2)
principal component artificial neural network##2##5##(2008-10#2)
principal component factor analysis##2##4##(1995-8#1)(2008-11#1)
principal component of##7##3##(1993-11#2)(1995-12#2)(1995-2#1)(1995-6#1)(2008-10#1)
principal component regression (PCR) and partial least square##2##8##(2010-4#1)(2011-2#1)
principal component regression (PCR) and partial least squares (PLS)##2##9##(2008-10#1)(2013-8#1)
principal component regression (PCR) and partial least##4##7##(2008-10#1)(2010-4#1)(2011-2#1)(2013-8#1)
principal component regression (PCR) and partial##5##6##(2008-10#2)(2010-4#1)(2011-2#1)(2013-8#1)
principal component regression (PCR)##13##4##(2008-10#10)(2010-4#1)(2011-2#1)(2013-8#1)
principal component regression##18##3##(2008-10#15)(2010-4#1)(2011-2#1)(2013-8#1)
principal component scores##2##3##(2008-10#1)(2012-3#1)
principal component##144##2##(1993-11#2)(1993-9#1)(1994-5#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-5#3)(2006-10#1)(2006-7#1)(2007-8#2)(2008-1#3)(2008-10#71)(2008-11#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-4#2)(2010-5#4)(2010-7#3)(2010-8#3)(2011-1#4)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#5)(2013-7#2)(2013-8#6)
principal components (PCs)##5##3##(2008-10#5)
principal components analysis (PCA)##7##4##(2008-10#5)(2008-6#1)(2013-1#1)
principal components analysis and##6##4##(1992-2#1)(2008-10#1)(2010-8#1)(2012-3#3)
principal components analysis revealed##2##4##(2007-8#1)(2007-9#1)
principal components analysis##27##3##(1992-2#1)(1992-6#2)(1993-6#1)(2007-8#1)(2007-9#1)(2008-10#11)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)(2012-3#3)(2013-1#1)
principal components and cluster##2##4##(2008-10#2)
principal components and##3##3##(2008-10#2)(2012-3#1)
principal components of the##6##4##(1993-11#1)(1997-7#1)(2008-2#1)(2008-9#1)(2012-1#1)(2012-3#1)
principal components of##7##3##(1993-11#1)(1997-7#1)(2008-2#1)(2008-6#1)(2008-9#1)(2012-1#1)(2012-3#1)
principal components scores##2##3##(2008-10#1)(2010-7#1)
principal components to account for##2##5##(2012-3#2)
principal components to##3##3##(2012-3#3)
principal components##65##2##(1992-2#1)(1992-6#2)(1993-11#1)(1993-6#1)(1997-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#24)(2008-2#1)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#2)(2010-12#2)(2010-7#1)(2010-8#3)(2012-1#2)(2012-2#1)(2012-3#10)(2013-1#2)(2013-7#1)(2013-8#2)
principal confounding factors##2##3##(1991-12#1)(2008-6#1)
principal cortical##2##2##(1991-3#1)(2008-11#1)
principal curve algorithm##2##3##(2009-12#2)
principal determinants##2##2##(1990-7#1)(2009-11#1)
principal diagnosis of##3##3##(2008-3#1)(2011-2#1)(2013-8#1)
principal direction##2##2##(2008-6#2)
principal directions##2##2##(2008-2#1)(2008-6#1)
principal domains##2##2##(1995-8#1)(1997-3#1)
principal factors##2##2##(2006-4#1)(2009-6#1)
principal findings of##3##3##(1992-8#1)(2008-7#1)(2011-1#1)
principal findings were as follows##2##5##(1997-2#1)(2008-7#1)
principal findings##6##2##(1992-8#1)(1994-8#1)(1997-2#1)(2008-7#2)(2011-1#1)
principal food##2##2##(2008-1#1)(2008-5#1)
principal frequency##2##2##(2008-8#1)(2008-9#1)
principal goal##4##2##(1993-9#1)(2007-3#1)(2010-8#1)(2011-1#1)
principal indications for the##2##4##(1991-3#1)(2006-12#1)
principal ingredient##2##2##(1991-1#1)(2013-1#1)
principal investigator##3##2##(2007-4#1)(2010-11#1)(2012-3#1)
principal investigators##3##2##(2008-7#1)(2010-11#1)(2012-12#1)
principal map##2##2##(2008-11#2)
principal means##2##2##(2005-11#1)(2008-9#1)
principal mechanisms##2##2##(2007-10#1)(2008-10#1)
principal neurons##2##2##(1992-7#1)(2012-2#1)
principal new##2##2##(2005-7#1)(2007-11#1)
principal parts##3##2##(2007-10#1)(2008-3#1)(2013-8#1)
principal peak##2##2##(1992-12#2)
principal plane##5##2##(2008-2#1)(2008-3#4)
principal planes##2##2##(2008-2#2)
principal polarization states of##2##4##(2008-2#2)
principal purpose of##2##3##(1996-2#1)(2010-12#1)
principal reason for##2##3##(2011-1#1)(2013-1#1)
principal refractive indices and##4##4##(2008-2#4)
principal refractive indices##7##3##(2008-2#5)(2008-3#2)
principal regulator of##2##3##(2005-12#1)(2009-9#1)
principal results##2##2##(1997-2#1)(2011-2#1)
principal sections##3##2##(2008-3#3)
principal source of##4##3##(1991-8#1)(1996-4#1)(2007-12#1)(2008-10#1)
principal states of polarization##5##4##(2007-11#1)(2007-12#4)
principal strain##10##2##(2006-11#1)(2007-1#2)(2007-4#5)(2013-1#2)
principal stratification##4##2##(2009-9#4)
principal transmittance##2##2##(2007-11#2)
principal types of##3##3##(2009-10#2)(2011-2#1)
principal##573##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#3)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#3)(1991-4#1)(1991-8#2)(1991-9#1)(1992-1#3)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#2)(1993-10#1)(1993-11#5)(1993-12#2)(1993-2#3)(1993-6#1)(1993-9#4)(1994-1#1)(1994-12#2)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#4)(1994-9#3)(1995-1#3)(1995-12#2)(1995-2#1)(1995-4#2)(1995-5#2)(1995-6#1)(1995-8#4)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#1)(1996-9#2)(1997-2#2)(1997-3#4)(1997-4#2)(1997-6#3)(1997-7#2)(2004-11#2)(2005-11#3)(2005-12#1)(2005-4#1)(2005-7#3)(2005-8#2)(2006-10#7)(2006-11#3)(2006-12#3)(2006-2#1)(2006-4#2)(2006-5#2)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#6)(2007-11#12)(2007-12#13)(2007-2#1)(2007-3#1)(2007-4#8)(2007-7#2)(2007-8#4)(2007-9#5)(2008-1#8)(2008-10#114)(2008-11#9)(2008-12#2)(2008-2#24)(2008-3#27)(2008-4#5)(2008-5#8)(2008-6#7)(2008-7#13)(2008-8#2)(2008-9#11)(2009-10#4)(2009-11#1)(2009-12#3)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#3)(2009-9#6)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#5)(2010-7#5)(2010-8#10)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#13)(2011-3#1)(2012-1#5)(2012-12#3)(2012-2#4)(2012-3#16)(2013-1#14)(2013-7#3)(2013-8#15)
principal-component analysis##5##2##(2007-12#1)(2008-10#3)(2008-2#1)
principal-component##9##1##(2007-12#3)(2008-10#3)(2008-2#3)
principalement##2##1##(2008-5#1)(2011-2#1)
principalis##3##1##(1991-11#2)(1992-1#1)
principally affecting the##2##3##(1997-1#1)(2011-2#1)
principally at the##2##3##(1993-2#1)(1997-8#1)
principally based on##3##3##(2006-2#1)(2011-1#1)(2013-7#1)
principally by##5##2##(1996-11#1)(2005-8#1)(2006-7#1)(2008-7#1)(2011-2#1)
principally concerned with##2##3##(2007-5#1)(2008-7#1)
principally determined by##2##3##(2007-12#1)(2007-8#1)
principally due to##3##3##(1991-12#1)(2008-7#1)(2013-1#1)
principally from the##2##3##(1995-11#1)(2013-7#1)
principally from##3##2##(1993-2#1)(1995-11#1)(2013-7#1)
principally in the##5##3##(1994-2#1)(1996-12#1)(2006-8#1)(2008-10#1)(2008-12#1)
principally in##12##2##(1993-7#1)(1994-2#1)(1996-12#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-6#1)
principally on the##2##3##(2005-11#1)(2007-12#1)
principally on##8##2##(2005-11#1)(2005-5#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-3#1)(2010-4#1)
principally responsible for##3##3##(1995-9#1)(1996-12#1)(1996-2#1)
principally the##2##2##(1995-5#1)(2006-10#1)
principally through##3##2##(2008-10#2)(2008-4#1)
principally to##5##2##(1990-2#1)(1991-2#1)(2005-8#1)(2006-10#1)(2007-8#1)
principally##91##1##(1990-11#1)(1990-2#4)(1990-4#1)(1991-12#1)(1991-2#2)(1992-6#1)(1993-2#2)(1993-7#1)(1994-2#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-1#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-5#1)(2005-8#2)(2006-10#5)(2006-12#2)(2006-2#1)(2006-7#1)(2006-8#1)(2007-12#4)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#5)(2009-2#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-6#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#3)(2013-8#1)
principals of##3##2##(2010-2#2)(2012-2#1)
principals##7##1##(2006-7#1)(2007-7#1)(2010-2#2)(2012-2#3)
principle and the##3##3##(2007-11#1)(2008-2#1)(2009-5#1)
principle and##20##2##(1992-3#1)(1993-9#1)(1994-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
principle applicable to reflected##2##4##(2008-3#2)
principle are##6##2##(2008-2#2)(2008-3#1)(2009-5#1)(2010-7#1)(2012-2#1)
principle as##2##2##(2007-9#1)(2012-1#1)
principle behind##5##2##(2006-6#1)(2007-9#1)(2008-2#1)(2008-9#1)(2011-7#1)
principle by##2##2##(2008-10#1)(2008-2#1)
principle can##2##2##(2008-11#1)(2012-2#1)
principle component analysis##2##3##(2008-10#2)
principle component##4##2##(2007-12#1)(2008-10#3)
principle features of##3##3##(2007-11#1)(2008-10#1)(2008-5#1)
principle for the##5##3##(1994-4#1)(1995-8#1)(2007-11#1)(2008-3#1)(2008-8#1)
principle for##27##2##(1992-4#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-4#1)(1995-8#2)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#1)(2010-4#1)(2010-5#1)(2013-1#1)(2013-7#1)
principle from##3##2##(1990-4#1)(1992-9#1)(1993-3#1)
principle in massage##2##3##(2009-3#2)
principle in the##4##3##(1992-1#1)(2006-6#1)(2007-7#1)(2008-7#1)
principle in##14##2##(1992-1#1)(1995-8#1)(1996-4#1)(1997-6#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-7#2)(2009-3#2)(2010-2#1)(2012-2#1)
principle involves##2##2##(2008-10#1)(2012-2#1)
principle is based on the##2##5##(2008-10#1)(2010-7#1)
principle is based on##4##4##(2008-10#1)(2008-2#1)(2010-7#1)(2011-1#1)
principle is described##2##3##(2007-12#1)(2008-2#1)
principle is presented##3##3##(2008-2#1)(2008-3#2)
principle is to##3##3##(2007-12#1)(2008-10#1)(2008-4#1)
principle is used to##3##4##(2008-2#2)(2009-12#1)
principle is##34##2##(1992-3#1)(1995-3#1)(1995-4#1)(2005-10#1)(2005-7#1)(2007-12#5)(2008-10#3)(2008-2#9)(2008-3#5)(2008-4#1)(2008-5#1)(2009-12#1)(2010-7#2)(2011-1#1)(2012-2#1)
principle may##2##2##(1993-7#1)(2008-10#1)
principle of a##4##3##(2005-4#1)(2008-10#1)(2008-3#1)(2012-1#1)
principle of autonomy##2##3##(1995-9#1)(2008-9#1)
principle of beneficence##2##3##(1995-9#1)(2008-5#1)
principle of confidentiality##2##3##(1995-9#1)(2008-5#1)
principle of cost-effectiveness##2##3##(2008-7#2)
principle of early##2##3##(2008-11#2)
principle of operation of##2##4##(2007-12#1)(2008-3#1)
principle of operation##4##3##(2007-11#1)(2007-12#1)(2007-8#1)(2008-3#1)
principle of optical##2##3##(2007-12#2)
principle of patient##2##3##(1992-3#1)(2006-4#1)
principle of respect for persons##2##5##(1992-3#1)(2007-11#1)
principle of respect for##3##4##(1992-3#1)(2005-7#1)(2007-11#1)
principle of the method##3##4##(2008-10#1)(2008-2#2)
principle of the technique##2##4##(2008-2#1)(2008-3#1)
principle of the##17##3##(1997-6#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)
principle of this method is##2##5##(2007-12#1)(2007-8#1)
principle of this##6##3##(2007-12#2)(2007-8#1)(2008-10#2)(2008-3#1)
principle of treatment##2##3##(2007-11#1)(2013-8#1)
principle of##143##2##(1991-2#1)(1991-8#1)(1992-1#1)(1992-3#4)(1992-4#1)(1993-3#1)(1993-9#1)(1995-3#1)(1995-8#1)(1995-9#3)(1996-1#2)(1996-3#1)(1997-6#3)(1997-8#2)(2004-11#1)(2005-12#1)(2005-4#1)(2005-6#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-11#4)(2007-12#9)(2007-4#1)(2007-8#3)(2008-1#1)(2008-10#19)(2008-11#5)(2008-12#1)(2008-2#9)(2008-3#17)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-4#3)(2009-5#1)(2009-6#1)(2010-5#1)(2011-1#5)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
principle or##3##2##(2006-11#1)(2008-8#1)(2010-2#1)
principle requires##2##2##(1995-6#1)(2008-3#1)
principle that the##4##3##(1992-2#1)(1994-9#1)(2008-3#1)(2011-2#1)
principle that##14##2##(1992-2#1)(1994-2#1)(1994-9#1)(2007-12#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-10#1)(2013-1#1)
principle to emulsions##2##3##(2008-5#2)
principle to estimate the##2##4##(2007-11#1)(2008-3#1)
principle to##7##2##(2006-6#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#2)
principle using a##2##3##(2008-10#2)
principle using##4##2##(2008-10#4)
principle was discovered##2##3##(1993-10#1)(2008-10#1)
principle was used to##2##4##(2008-12#1)(2008-9#1)
principle was##6##2##(1993-10#1)(2008-10#3)(2008-12#1)(2008-9#1)
principle with##4##2##(1996-3#1)(2008-10#1)(2008-3#1)(2009-12#1)
principle##512##1##(1990-11#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#2)(1992-1#3)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#10)(1992-4#2)(1992-9#2)(1993-10#2)(1993-11#1)(1993-3#2)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-4#1)(1994-6#2)(1994-8#1)(1994-9#5)(1995-12#1)(1995-2#1)(1995-3#4)(1995-4#1)(1995-6#2)(1995-8#4)(1995-9#3)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#2)(1997-1#1)(1997-4#1)(1997-5#2)(1997-6#5)(1997-7#1)(1997-8#3)(2004-10#1)(2004-11#1)(2004-4#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-4#1)(2005-5#1)(2005-6#1)(2005-7#4)(2006-10#4)(2006-11#2)(2006-12#2)(2006-3#1)(2006-4#1)(2006-6#6)(2006-7#3)(2007-10#1)(2007-11#13)(2007-12#27)(2007-4#2)(2007-5#2)(2007-7#3)(2007-8#10)(2007-9#7)(2008-1#3)(2008-10#63)(2008-11#9)(2008-12#5)(2008-2#40)(2008-3#53)(2008-4#9)(2008-5#13)(2008-6#5)(2008-7#11)(2008-8#8)(2008-9#9)(2009-12#3)(2009-2#1)(2009-3#5)(2009-4#5)(2009-5#5)(2009-6#1)(2009-8#3)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#3)(2010-7#3)(2011-1#11)(2011-2#3)(2011-7#2)(2012-1#4)(2012-10#1)(2012-12#2)(2012-2#17)(2012-3#4)(2013-1#6)(2013-7#3)(2013-8#8)
principle)##3##1##(1992-8#1)(2008-10#1)(2008-5#1)
principled##4##1##(1993-12#1)(2008-5#1)(2008-7#1)(2013-8#1)
principles and a##2##3##(1996-2#1)(2008-3#1)
principles and applications##4##3##(2006-3#1)(2008-10#2)(2013-8#1)
principles and clinical applications##2##4##(2008-6#1)(2013-8#1)
principles and clinical##3##3##(2008-6#1)(2009-11#1)(2013-8#1)
principles and concepts##2##3##(1995-3#1)(2004-12#1)
principles and constraints##2##3##(1996-4#1)(2011-12#1)
principles and criteria##2##3##(2008-12#1)(2009-3#1)
principles and methods##3##3##(1995-3#1)(2006-6#1)(2010-8#1)
principles and models##2##3##(2008-2#1)(2008-9#1)
principles and practice of##3##4##(1993-12#1)(1994-5#1)(1997-3#1)
principles and practice##8##3##(1993-12#1)(1994-5#1)(1997-3#1)(2007-3#1)(2008-4#3)(2008-5#1)
principles and practices##4##3##(2006-5#1)(2008-6#1)(2008-9#2)
principles and strategies##3##3##(2005-8#1)(2010-1#1)(2013-1#1)
principles and techniques of##3##4##(1995-1#1)(2007-12#1)(2010-11#1)
principles and techniques##6##3##(1990-12#1)(1995-1#1)(1997-3#1)(2006-3#1)(2007-12#1)(2010-11#1)
principles and the##3##3##(2005-8#1)(2008-11#1)(2008-2#1)
principles and##95##2##(1990-12#1)(1992-3#1)(1993-11#1)(1993-12#2)(1994-3#1)(1994-5#1)(1995-1#2)(1995-2#1)(1995-3#4)(1995-6#2)(1996-2#3)(1996-4#1)(1997-3#3)(2004-12#1)(2005-8#4)(2006-10#2)(2006-3#3)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#5)(2007-3#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#2)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#7)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#5)
principles are addressed##2##3##(2008-12#1)(2010-8#1)
principles are applicable##2##3##(2007-12#1)(2008-12#1)
principles are discussed##2##3##(2008-2#1)(2008-3#1)
principles are presented##2##3##(2005-6#1)(2011-1#1)
principles are##26##2##(1993-2#1)(1993-3#1)(1997-4#1)(2005-6#1)(2005-7#2)(2006-10#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#2)(2010-7#1)(2010-8#1)(2011-1#2)(2012-2#1)
principles as##3##2##(2008-1#1)(2008-10#1)(2008-5#1)
principles based on##4##3##(2005-11#1)(2008-1#1)(2008-5#1)(2008-8#1)
principles behind##2##2##(2007-11#1)(2009-5#1)
principles by##2##2##(1994-3#1)(2008-8#1)
principles can##4##2##(1993-3#1)(2006-10#1)(2009-11#1)(2009-9#1)
principles described##2##2##(1996-8#1)(2008-9#1)
principles discussed##3##2##(2007-5#1)(2008-4#1)(2010-8#1)
principles for clinical##2##3##(1996-2#1)(2012-2#1)
principles for the##12##3##(1991-9#1)(1994-1#1)(1995-5#1)(1997-2#1)(1997-6#1)(2005-7#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-4#1)
principles for treating##4##3##(1993-6#1)(2005-6#1)(2007-11#1)(2007-8#1)
principles for##42##2##(1991-9#1)(1992-11#1)(1992-3#1)(1993-6#1)(1994-1#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-2#1)(1997-6#1)(2005-6#1)(2005-7#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#3)(2008-10#1)(2008-11#1)(2008-4#3)(2009-4#1)(2010-6#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
principles from the##2##3##(2008-10#1)(2008-12#1)
principles from##6##2##(1992-3#1)(2006-12#1)(2007-1#1)(2008-10#1)(2008-12#1)(2011-2#1)
principles governing radiological##2##3##(2007-11#2)
principles governing##8##2##(1994-2#1)(2007-11#4)(2008-11#1)(2011-1#2)
principles have been##4##3##(2006-10#1)(2008-10#1)(2008-3#1)(2011-12#1)
principles have##7##2##(1992-2#1)(2006-10#1)(2008-10#1)(2008-3#1)(2009-4#1)(2011-12#1)(2013-1#1)
principles identified##2##2##(1997-1#1)(2013-1#1)
principles in order to##2##4##(2008-2#1)(2011-2#1)
principles in the management of##2##5##(2009-9#1)(2011-2#1)
principles in the##6##3##(1995-6#1)(2008-11#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
principles in##24##2##(1992-1#1)(1992-2#1)(1994-3#1)(1995-6#1)(1996-3#1)(1996-7#1)(2005-6#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-12#2)(2008-11#2)(2008-2#1)(2008-7#1)(2009-9#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-8#1)
principles into##2##2##(1997-7#1)(2011-12#1)
principles involved in##3##3##(1996-11#1)(2006-9#1)(2008-4#1)
principles involved##5##2##(1992-2#1)(1996-11#1)(2006-9#1)(2008-4#1)(2013-1#1)
principles is##5##2##(1993-2#1)(2006-7#1)(2008-7#1)(2008-9#1)(2011-2#1)
principles leads to the##2##4##(2007-11#1)(2012-2#1)
principles of Paulo Freire##2##4##(2012-12#2)
principles of a##3##3##(1992-6#1)(2006-7#1)(2007-12#1)
principles of action##2##3##(2010-6#1)(2010-7#1)
principles of adult learning##2##4##(1992-1#1)(2007-5#1)
principles of adult##4##3##(1992-1#1)(2007-5#1)(2008-12#1)(2011-2#1)
principles of an##4##3##(1995-7#1)(2008-3#2)(2008-9#1)
principles of beneficence and##2##4##(1991-2#1)(2007-11#1)
principles of beneficence##3##3##(1991-2#1)(2007-11#1)(2008-1#1)
principles of care##2##3##(2008-11#1)(2008-8#1)
principles of conduct##2##3##(2004-10#2)
principles of conservative treatment##2##4##(2006-6#1)(2007-7#1)
principles of continuous quality improvement##2##5##(1992-12#1)(1993-2#1)
principles of diagnosis and##2##4##(2007-7#1)(2011-2#1)
principles of diagnosis##3##3##(2007-7#1)(2007-8#1)(2011-2#1)
principles of diagnostic##2##3##(1990-4#1)(1993-10#1)
principles of different##2##3##(2007-11#1)(2008-10#1)
principles of general##2##3##(2008-10#1)(2008-11#1)
principles of its##2##3##(1996-12#1)(2008-7#1)
principles of justice##2##3##(2009-6#1)(2011-2#1)
principles of laparoscopic##2##3##(1993-12#1)(2012-12#1)
principles of management are##2##4##(2006-2#1)(2008-7#1)
principles of management of##4##4##(1991-4#1)(2011-2#1)(2012-2#2)
principles of management##7##3##(1991-4#1)(2006-2#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-2#2)
principles of medical##2##3##(2010-8#1)(2011-12#1)
principles of optical design and linear measurement##2##7##(2008-3#2)
principles of optical##4##3##(2008-1#1)(2008-3#2)(2012-2#1)
principles of pharmacology and therapeutics##2##5##(2008-11#2)
principles of protein dimer interactions are##2##6##(2007-6#2)
principles of protein##3##3##(2007-6#2)(2008-4#1)
principles of rehabilitation##3##3##(2006-4#1)(2007-11#2)
principles of respect##2##3##(2007-12#1)(2007-2#1)
principles of self-organization##2##3##(2006-3#2)
principles of statistical##4##3##(2008-10#1)(2008-3#1)(2013-1#2)
principles of surgical##4##3##(1990-4#1)(2005-12#1)(2006-7#1)(2008-10#1)
principles of telemedicine##2##3##(2005-10#1)(2012-2#1)
principles of the##22##3##(1994-5#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-4#1)(2008-9#2)(2009-6#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-7#1)(2013-8#1)
principles of this##6##3##(1992-2#1)(1993-6#1)(1997-4#1)(2006-2#1)(2007-12#1)(2008-3#1)
principles of treatment##4##3##(1992-4#1)(1996-3#1)(2010-10#1)(2011-1#1)
principles of treatment]##2##3##(1991-1#1)(2011-2#1)
principles of##290##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#2)(1990-5#2)(1991-1#1)(1991-2#2)(1991-4#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-4#2)(1992-6#3)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-7#1)(1994-1#2)(1994-2#1)(1994-5#2)(1994-6#1)(1995-12#1)(1995-6#1)(1995-7#1)(1996-12#2)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#1)(2004-10#2)(2004-12#1)(2005-10#2)(2005-12#1)(2005-5#1)(2006-12#1)(2006-2#4)(2006-3#3)(2006-4#1)(2006-6#3)(2006-7#3)(2007-1#1)(2007-10#4)(2007-11#9)(2007-12#11)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#5)(2008-10#11)(2008-11#13)(2008-12#2)(2008-2#9)(2008-3#13)(2008-4#14)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#7)(2008-9#14)(2009-1#1)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#3)(2009-6#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#4)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#11)(2011-7#1)(2012-1#2)(2012-12#4)(2012-2#8)(2012-3#1)(2013-1#8)(2013-8#5)
principles rather than##2##3##(2006-10#1)(2009-6#1)
principles regarding##2##2##(2006-10#1)(2008-10#1)
principles that are##2##3##(2008-5#1)(2008-7#1)
principles that govern##2##3##(1993-6#1)(2008-8#1)
principles that underlie##2##3##(2008-3#1)(2012-12#1)
principles that##18##2##(1993-6#1)(2005-6#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
principles to avoid##2##3##(1991-1#1)(2007-12#1)
principles to guide##2##3##(1994-3#1)(2007-3#1)
principles to the##5##3##(1992-1#1)(1996-2#1)(2005-2#1)(2007-6#1)(2008-10#1)
principles to##23##2##(1991-1#1)(1992-1#1)(1992-2#1)(1994-3#1)(1996-2#1)(2005-2#1)(2006-1#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-6#1)(2011-2#2)(2012-2#1)
principles underlying the##8##3##(1992-12#1)(2006-11#1)(2007-12#1)(2007-4#1)(2008-9#1)(2010-8#1)(2012-2#2)
principles underlying##16##2##(1992-12#1)(1995-1#1)(2006-11#1)(2006-7#1)(2007-12#2)(2007-4#1)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-8#1)(2012-2#2)
principles used##4##2##(2008-7#1)(2011-1#2)(2013-8#1)
principles was##2##2##(1993-3#1)(1997-1#1)
principles were##3##2##(2008-10#1)(2010-9#1)(2012-3#1)
principles which##4##2##(1993-7#1)(2005-10#1)(2008-11#1)(2008-7#1)
principles will##2##2##(1991-9#1)(2011-2#1)
principles with##2##2##(1994-11#1)(2008-10#1)
principles##781##1##(1990-11#1)(1990-12#4)(1990-3#1)(1990-4#2)(1990-5#2)(1991-1#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-9#2)(1992-1#4)(1992-11#1)(1992-12#5)(1992-2#9)(1992-3#5)(1992-4#2)(1992-6#3)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#6)(1993-6#3)(1993-7#3)(1994-1#5)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#5)(1994-5#3)(1994-6#2)(1995-1#4)(1995-12#1)(1995-2#2)(1995-3#6)(1995-5#1)(1995-6#4)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#6)(1996-3#2)(1996-4#1)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#6)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#2)(2004-10#2)(2004-12#2)(2005-10#5)(2005-11#1)(2005-12#1)(2005-2#2)(2005-5#5)(2005-6#4)(2005-7#5)(2005-8#6)(2006-1#1)(2006-10#17)(2006-11#1)(2006-12#4)(2006-2#4)(2006-3#6)(2006-4#2)(2006-5#2)(2006-6#8)(2006-7#7)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#6)(2007-11#28)(2007-12#29)(2007-2#3)(2007-3#4)(2007-4#4)(2007-5#5)(2007-6#3)(2007-7#2)(2007-8#6)(2007-9#4)(2008-1#14)(2008-10#33)(2008-11#24)(2008-12#10)(2008-2#17)(2008-3#25)(2008-4#29)(2008-5#15)(2008-6#7)(2008-7#17)(2008-8#17)(2008-9#34)(2009-1#2)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#13)(2009-5#5)(2009-6#6)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#4)(2010-2#2)(2010-3#5)(2010-5#1)(2010-6#5)(2010-7#4)(2010-8#6)(2010-9#3)(2011-1#13)(2011-12#6)(2011-2#25)(2011-7#1)(2012-1#6)(2012-11#1)(2012-12#6)(2012-2#29)(2012-3#3)(2013-1#26)(2013-8#16)
principles]##3##1##(1994-8#1)(1994-9#1)(1995-2#1)
print awareness##2##2##(2009-9#2)
print media##2##2##(1991-3#1)(2006-4#1)
print##34##1##(1991-12#1)(1991-3#1)(1993-1#1)(1996-6#1)(1997-2#1)(2004-9#1)(2006-4#2)(2007-4#1)(2008-10#2)(2008-2#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-9#3)(2010-12#1)(2010-8#3)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
printed as##2##2##(1991-5#1)(1992-8#1)
printed circuit board##2##3##(2008-3#1)(2013-7#1)
printed circuit boards##3##3##(2008-10#1)(2008-2#2)
printed circuit##5##2##(2008-10#1)(2008-2#2)(2008-3#1)(2013-7#1)
printed electrodes##3##2##(2006-2#1)(2010-2#2)
printed in Portugal##2##3##(2007-5#2)
printed in##5##2##(2007-5#2)(2008-10#1)(2008-2#1)(2009-4#1)
printed on##5##2##(2006-5#1)(2008-10#1)(2008-3#2)(2008-7#1)
printed onto##2##2##(2005-11#2)
printed standards of care##2##4##(2008-3#2)
printed text##4##2##(2005-7#2)(2006-10#1)(2006-12#1)
printed upon##2##2##(2008-2#2)
printed##63##1##(1990-4#1)(1990-9#1)(1991-1#1)(1991-5#2)(1992-3#1)(1992-8#1)(1994-3#2)(1996-1#1)(2005-11#4)(2005-7#2)(2006-10#1)(2006-12#2)(2006-2#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-4#2)(2007-5#3)(2008-1#2)(2008-10#4)(2008-2#6)(2008-3#11)(2008-7#2)(2009-4#1)(2009-8#1)(2010-2#2)(2010-9#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-7#1)
printer##10##1##(1995-9#1)(2007-1#1)(2007-5#1)(2008-10#2)(2008-2#2)(2008-3#3)
printers##6##1##(2007-5#1)(2008-2#4)(2010-9#1)
printing and dip-pen nanolithography##2##4##(2006-12#2)
printing and##5##2##(2006-12#2)(2008-10#1)(2008-7#1)(2009-4#1)
printing of a##2##3##(2005-11#1)(2008-2#1)
printing of##9##2##(2005-11#2)(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-2#1)(2010-4#2)
printing parameters and scaffold biopolymer properties##2##6##(2010-9#2)
printing plates##2##2##(2008-7#1)(2008-9#1)
printing##48##1##(1995-9#1)(2005-11#2)(2006-12#6)(2006-2#2)(2007-10#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#5)(2008-9#4)(2009-2#2)(2009-4#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#1)(2010-9#5)(2012-1#1)
prints##4##1##(2006-3#1)(2008-8#1)(2010-8#1)(2012-2#1)
prion disease##6##2##(1993-1#1)(1996-12#1)(2007-9#1)(2010-12#3)
prion diseases in animals and man##2##6##(1996-3#2)
prion diseases##9##2##(1993-2#2)(1995-12#1)(1996-3#2)(1997-3#1)(2006-10#2)(2009-3#1)
prion pre-mRNA##3##2##(1992-7#3)
prion protein (PrP)##2##3##(1995-11#1)(2008-11#1)
prion protein and##2##3##(1995-12#1)(2010-11#1)
prion protein by##2##3##(1996-5#1)(1996-6#1)
prion protein##21##2##(1993-2#2)(1995-11#2)(1995-12#2)(1996-5#2)(1996-6#1)(1997-3#1)(1997-5#1)(1997-7#1)(2006-10#4)(2008-11#2)(2008-5#2)(2010-11#1)
prion research##2##2##(2007-9#1)(2008-11#1)
prion transmission##2##2##(2008-10#1)(2010-11#1)
prion##58##1##(1992-7#4)(1993-1#1)(1993-2#6)(1995-11#2)(1995-12#3)(1996-12#1)(1996-3#5)(1996-5#2)(1996-6#1)(1997-3#2)(1997-5#1)(1997-7#3)(2006-10#7)(2007-9#2)(2008-10#1)(2008-11#6)(2008-5#2)(2009-3#1)(2010-11#2)(2010-12#4)(2011-1#1)(2012-11#1)
prions and##2##2##(1997-7#1)(2010-4#1)
prions##5##1##(1995-5#1)(1997-7#1)(2010-4#3)
prior DNA##2##2##(1991-2#1)(2009-5#1)
prior MI##2##2##(2008-10#2)
prior PDF##3##2##(2008-2#3)
prior abdominal aortic reconstruction##2##4##(2012-12#2)
prior activation##2##2##(1990-11#1)(1992-8#1)
prior addition of the##2##4##(1993-3#1)(2005-11#1)
prior addition of##4##3##(1993-3#2)(1994-12#1)(2005-11#1)
prior administration of##3##3##(1992-6#1)(1996-12#1)(2007-7#1)
prior administration##4##2##(1992-6#1)(1995-2#1)(1996-12#1)(2007-7#1)
prior and##5##2##(1991-6#1)(1997-8#1)(2009-2#1)(2012-2#1)(2013-7#1)
prior antigenic exposure##2##3##(2008-4#1)(2012-2#1)
prior appointment##2##2##(1993-3#1)(1993-4#1)
prior beliefs##2##2##(2009-11#1)(2011-2#1)
prior can##2##2##(2008-6#1)(2011-1#1)
prior chemotherapy##6##2##(1990-12#1)(1990-6#1)(1991-3#1)(1991-4#1)(2004-1#1)(2010-12#1)
prior conditions##2##2##(2010-11#2)
prior depression##3##2##(2013-1#3)
prior diagnosis of##2##3##(1997-3#1)(2008-12#1)
prior distribution for the parameters of interest##2##7##(1995-6#1)(1996-7#1)
prior distribution for the##3##4##(1995-6#1)(1996-12#1)(1996-7#1)
prior distribution##5##2##(1995-4#1)(1995-6#2)(1996-12#1)(1996-7#1)
prior distributions on##2##3##(2009-10#1)(2009-4#1)
prior distributions##7##2##(1993-9#1)(1995-12#1)(1995-6#1)(2009-10#3)(2009-4#1)
prior drug##2##2##(1992-9#1)(1996-9#1)
prior evidence##2##2##(1997-6#1)(2009-5#1)
prior experience with##2##3##(1992-12#1)(2006-5#1)
prior experience##9##2##(1992-12#1)(1993-2#1)(2006-5#1)(2010-3#1)(2010-8#2)(2011-2#1)(2013-1#1)(2013-7#1)
prior exposure to##9##3##(1991-1#1)(1993-12#1)(1994-9#1)(1997-1#1)(2006-10#1)(2008-10#1)(2008-8#1)(2010-8#1)(2013-8#1)
prior exposure##11##2##(1991-1#1)(1993-12#2)(1994-12#1)(1994-9#1)(1997-1#1)(2006-10#1)(2008-10#1)(2008-8#1)(2010-8#1)(2013-8#1)
prior extensive##2##2##(2006-10#1)(2008-11#1)
prior extraction##5##2##(1990-8#1)(1996-9#1)(2008-10#3)
prior findings##5##2##(1996-5#1)(2007-1#1)(2007-9#1)(2008-9#1)(2009-11#1)
prior for the##2##3##(2010-5#1)(2012-3#1)
prior for##3##2##(2008-6#1)(2010-5#1)(2012-3#1)
prior history of sustained VT or VF##2##7##(2006-9#2)
prior history of##14##3##(1996-12#1)(2006-2#1)(2006-8#2)(2006-9#2)(2007-7#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-8#1)(2013-1#1)(2013-8#1)
prior history##16##2##(1992-7#1)(1996-12#1)(2006-2#1)(2006-8#2)(2006-9#2)(2007-7#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-8#1)(2013-1#1)(2013-8#1)
prior hypotheses of##2##3##(2010-6#1)(2013-7#1)
prior i##3##2##(1990-11#1)(1996-2#1)(1997-4#1)
prior immunity##2##2##(2009-12#1)(2011-2#1)
prior incubation with##3##3##(1992-3#1)(1994-8#1)(2011-2#1)
prior incubation##5##2##(1992-3#1)(1994-8#1)(1995-3#1)(1995-5#1)(2011-2#1)
prior induction of##2##3##(1994-11#1)(1995-2#1)
prior information about the##4##4##(1995-4#2)(2008-2#1)(2012-2#1)
prior information on the##2##4##(2008-10#1)(2008-3#1)
prior information on##3##3##(2008-10#1)(2008-3#1)(2010-2#1)
prior information##14##2##(1992-3#1)(1992-7#1)(1995-12#1)(1995-4#3)(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-2#1)(2012-2#1)
prior knowledge about the structure of##3##6##(2010-11#1)(2013-1#2)
prior knowledge about the##6##4##(1997-8#1)(2008-2#1)(2008-4#1)(2010-11#1)(2013-1#2)
prior knowledge about##12##3##(1997-8#2)(2007-7#1)(2008-2#1)(2008-4#1)(2010-11#1)(2010-12#1)(2012-1#1)(2013-1#4)
prior knowledge of the##6##4##(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-3#1)
prior knowledge of##9##3##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-7#1)(2008-8#1)(2010-3#1)
prior knowledge##33##2##(1997-8#7)(2006-5#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#4)
prior learning##2##2##(2008-11#1)(2013-7#1)
prior myocardial infarction##3##3##(2007-10#1)(2008-3#1)(2011-2#1)
prior myocardial##4##2##(2005-1#1)(2007-10#1)(2008-3#1)(2011-2#1)
prior removal of##2##3##(1995-2#1)(2008-10#1)
prior reports of##5##3##(1996-1#1)(2008-1#2)(2008-6#2)
prior reports##8##2##(1996-1#1)(2007-10#1)(2008-1#2)(2008-6#2)(2008-7#1)(2011-2#1)
prior research##10##2##(2008-10#1)(2008-9#2)(2009-11#1)(2009-4#2)(2013-1#2)(2013-7#2)
prior results##2##2##(2008-12#1)(2009-3#1)
prior reviews##3##2##(2006-10#1)(2008-10#2)
prior sample##5##2##(1996-5#1)(2008-10#3)(2008-5#1)
prior separation##9##2##(2008-10#9)
prior specification##2##2##(2009-4#1)(2010-2#1)
prior stimulation of##2##3##(2008-11#2)
prior stimulation##3##2##(2008-11#3)
prior studies have##4##3##(2006-10#1)(2006-2#1)(2006-4#1)(2011-2#1)
prior studies of##2##3##(2006-2#1)(2012-3#1)
prior studies##13##2##(1991-2#1)(1993-1#1)(1996-5#1)(2006-10#1)(2006-2#2)(2006-4#1)(2007-10#1)(2007-2#1)(2009-10#1)(2010-9#1)(2011-2#1)(2012-3#1)
prior surgical##2##2##(2006-8#1)(2007-7#1)
prior that##2##2##(1993-9#1)(2008-2#1)
prior the##2##2##(2008-10#1)(2011-2#1)
prior to 1990/91##2##3##(2008-5#2)
prior to 37##2##3##(2011-2#2)
prior to AIDS##2##3##(1993-11#2)
prior to DNA##2##3##(1991-3#1)(2008-8#1)
prior to FAST##2##3##(2012-12#2)
prior to HSG##2##3##(2011-2#2)
prior to PCR##2##3##(1996-12#1)(2008-10#1)
prior to a##19##3##(1990-12#1)(1991-6#2)(1993-12#1)(1993-4#1)(1996-9#1)(1997-4#1)(2006-11#1)(2006-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-7#1)
prior to activity##2##3##(1993-6#1)(2013-1#1)
prior to addition of##3##4##(1993-12#1)(1994-6#1)(2008-11#1)
prior to addition##4##3##(1993-12#1)(1994-6#1)(1996-6#1)(2008-11#1)
prior to admission##5##3##(1997-8#1)(2007-7#1)(2008-5#1)(2010-12#2)
prior to an##2##3##(2008-12#1)(2008-3#1)
prior to analysis by##3##4##(2008-10#3)
prior to analysis of##2##4##(1993-12#1)(2008-4#1)
prior to analysis##23##3##(1993-12#1)(1997-5#1)(2005-12#1)(2006-5#1)(2008-10#12)(2008-4#3)(2010-4#1)(2010-5#1)(2011-1#1)(2012-12#1)
prior to and after the##2##5##(1990-2#1)(1997-2#1)
prior to and after##7##4##(1990-2#1)(1995-12#1)(1995-5#1)(1997-2#2)(2006-12#1)(2008-5#1)
prior to and at##2##4##(1996-3#1)(2010-5#1)
prior to and during pregnancy##2##5##(1995-6#1)(2006-8#1)
prior to and during##3##4##(1995-6#1)(2006-8#1)(2009-9#1)
prior to and following the##2##5##(2007-11#1)(2010-5#1)
prior to and following##5##4##(1990-11#1)(1992-3#1)(2007-11#1)(2007-12#1)(2010-5#1)
prior to and##20##3##(1990-11#1)(1990-2#1)(1992-3#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-3#1)(1997-2#2)(2004-11#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-5#2)
prior to any##9##3##(1990-11#1)(1991-4#1)(1993-12#1)(2006-8#1)(2007-4#1)(2007-8#2)(2008-11#1)(2008-4#1)
prior to application of the##2##5##(1990-7#1)(2008-10#1)
prior to application of##4##4##(1990-7#1)(2006-8#1)(2008-10#2)
prior to application##5##3##(1990-7#1)(2006-8#1)(2008-10#3)
prior to assay##3##3##(1992-12#1)(1995-1#1)(2008-4#1)
prior to attendance at a health care facility##2##8##(2005-8#2)
prior to being##4##3##(1992-3#1)(2005-10#1)(2006-8#1)(2008-11#1)
prior to biopsy and##2##4##(1996-9#1)(2008-5#1)
prior to birth##2##3##(1997-5#1)(2012-12#1)
prior to bone##2##3##(1994-3#1)(2007-4#1)
prior to cell transfer##2##4##(1991-12#2)
prior to cell##3##3##(1991-12#2)(2008-1#1)
prior to challenge with##2##4##(1993-9#1)(2008-10#1)
prior to challenge##3##3##(1993-9#1)(2008-10#2)
prior to chromosome##2##3##(1993-11#1)(2012-3#1)
prior to coating##2##3##(1994-9#1)(2004-9#1)
prior to commitment##2##3##(1994-12#2)
prior to completion of##2##4##(2007-8#1)(2008-6#1)
prior to completion##3##3##(2005-11#1)(2007-8#1)(2008-6#1)
prior to contact with##3##4##(2008-10#2)(2008-8#1)
prior to death and##2##4##(1995-1#1)(2011-2#1)
prior to death##4##3##(1991-12#1)(1995-1#1)(2011-2#2)
prior to delivery##4##3##(1996-12#1)(1997-6#1)(2006-1#1)(2008-8#1)
prior to derivatization##2##3##(1991-8#1)(1993-2#1)
prior to detection##2##3##(2008-10#2)
prior to determination##2##3##(2008-10#2)
prior to development of##2##4##(2008-3#1)(2008-6#1)
prior to diagnosis##5##3##(1990-6#1)(1992-8#1)(2008-1#1)(2010-3#1)(2011-2#1)
prior to diagnostic##2##3##(1997-6#1)(2006-8#1)
prior to differentiation##2##3##(2011-2#2)
prior to discharge##4##3##(1994-2#1)(2007-10#2)(2008-1#1)
prior to disease##2##3##(2008-10#2)
prior to drug administration##2##4##(2008-8#1)(2012-2#1)
prior to drug##4##3##(1992-8#1)(2008-4#1)(2008-8#1)(2012-2#1)
prior to each##8##3##(1990-12#1)(1994-2#1)(1994-6#1)(1997-2#1)(2007-1#1)(2007-8#1)(2008-10#2)
prior to entering into##2##4##(1994-3#1)(2006-5#1)
prior to entering##6##3##(1993-1#1)(1994-12#1)(1994-3#1)(2006-5#1)(2008-11#1)(2011-1#1)
prior to entry into the##2##5##(1995-3#1)(2009-4#1)
prior to entry##4##3##(1990-12#1)(1995-3#1)(2006-12#1)(2009-4#1)
prior to exercise##2##3##(2007-1#1)(2008-5#1)
prior to exposure to##3##4##(1992-9#1)(2008-10#2)
prior to exposure##4##3##(1992-9#1)(2008-10#2)(2008-11#1)
prior to extraction##3##3##(2007-8#1)(2008-10#1)(2013-8#1)
prior to final##2##3##(1992-9#1)(1997-4#1)
prior to fixation##4##3##(2004-9#1)(2007-11#1)(2007-9#1)(2009-5#1)
prior to flame atomic absorption##2##5##(2008-10#2)
prior to formation of##2##4##(1996-7#1)(1997-3#1)
prior to gastric##2##3##(1996-12#1)(2012-5#1)
prior to graduation##2##3##(2006-8#2)
prior to grafting##3##3##(1995-7#1)(2005-10#1)(2008-4#1)
prior to harvest##5##3##(1992-11#1)(2007-8#1)(2008-10#3)
prior to heading##2##3##(2008-10#2)
prior to her##2##3##(1994-6#1)(1995-12#1)
prior to high##3##3##(2008-10#2)(2008-11#1)
prior to his##3##3##(1992-6#1)(2006-4#1)(2009-3#1)
prior to hospitalization##3##3##(1992-10#1)(1995-5#1)(2012-2#1)
prior to hysterectomy##3##3##(1994-6#1)(1994-9#1)(2013-1#1)
prior to illumination##2##3##(1995-8#2)
prior to implantation##5##3##(1995-7#1)(2005-10#2)(2008-9#1)(2012-1#1)
prior to implementation##2##3##(1994-3#1)(2008-6#1)
prior to incubation with the##2##5##(1990-12#1)(1994-8#1)
prior to incubation##3##3##(1990-12#1)(1994-8#1)(2008-5#1)
prior to induction of##5##4##(1992-6#2)(1993-12#1)(2008-10#1)(2013-7#1)
prior to infection##2##3##(2008-10#1)(2011-2#1)
prior to infestation with##2##4##(2008-10#2)
prior to initiating##4##3##(1997-2#1)(2008-7#1)(2012-12#1)(2013-1#1)
prior to initiation of##5##4##(2008-10#1)(2008-11#1)(2008-4#1)(2010-2#1)(2011-1#1)
prior to injection of##3##4##(2006-8#1)(2007-11#1)(2010-12#1)
prior to injection##5##3##(1995-5#1)(2006-8#1)(2007-11#1)(2009-5#1)(2010-12#1)
prior to injury##4##3##(1991-9#1)(1992-9#1)(1994-12#1)(2005-10#1)
prior to inoculation with the pathogen##2##6##(2008-10#2)
prior to inoculation with the##3##5##(2008-10#3)
prior to inoculation with##6##4##(2008-10#6)
prior to inoculation##13##3##(1991-12#1)(2008-10#12)
prior to insertion##4##3##(1996-10#1)(2006-10#1)(2007-1#1)(2008-5#1)
prior to introduction of vaccination##2##5##(1990-2#2)
prior to introduction##4##3##(1990-2#2)(2009-2#1)(2011-1#1)
prior to ion##3##3##(1991-2#1)(2008-10#1)(2009-3#1)
prior to irradiation##4##3##(1994-12#1)(1997-4#1)(2007-9#1)(2008-7#1)
prior to ischemia##6##3##(1991-11#1)(1991-6#1)(1996-9#3)(2011-2#1)
prior to its determination by inductively coupled plasma##2##8##(2008-10#2)
prior to its determination by##3##5##(2008-10#3)
prior to its use##2##4##(2006-12#1)(2008-10#1)
prior to its##12##3##(1996-5#1)(2005-7#1)(2006-12#1)(2007-12#1)(2008-10#6)(2008-11#1)(2013-8#1)
prior to joining##2##3##(1993-6#1)(2005-7#1)
prior to joint injection##3##4##(2009-5#3)
prior to kainic acid##2##4##(1993-2#1)(2010-10#1)
prior to light##2##3##(1992-6#1)(1996-9#1)
prior to liver##2##3##(1995-1#1)(1995-4#1)
prior to making##2##3##(2008-11#1)(2011-2#1)
prior to mass##2##3##(2008-4#1)(2012-3#1)
prior to necropsy##2##3##(1995-2#1)(1996-11#1)
prior to obliteration##2##3##(2008-7#2)
prior to onset of##3##4##(1997-2#1)(2007-7#1)(2008-10#1)
prior to operation##3##3##(1990-4#1)(1996-2#1)(2008-7#1)
prior to or##6##3##(1991-10#1)(1993-11#1)(1993-4#1)(2005-9#1)(2008-1#1)(2012-12#1)
prior to passing##2##3##(1993-12#1)(2008-10#1)
prior to pathogen##2##3##(2008-10#2)
prior to performing##2##3##(1992-8#1)(2011-12#1)
prior to permanent access##2##4##(2007-7#2)
prior to petal expansion##2##4##(2008-10#2)
prior to photoaffinity labeling##2##4##(1990-11#2)
prior to placement of##2##4##(2007-7#1)(2010-10#1)
prior to placement##5##3##(1994-6#1)(2007-7#2)(2008-10#1)(2010-10#1)
prior to planting of##2##4##(2008-10#2)
prior to planting##5##3##(2008-10#5)
prior to pregnancy##2##3##(2007-12#1)(2008-10#1)
prior to preparation of##2##4##(2006-8#1)(2008-4#1)
prior to presentation##5##3##(2005-8#1)(2007-10#1)(2007-7#1)(2009-3#1)(2012-11#1)
prior to radial artery harvest for##2##6##(2007-8#2)
prior to radial artery harvest##3##5##(2007-8#3)
prior to rapid##2##3##(1995-11#1)(2012-1#1)
prior to re-exposure to the Meth-paired chamber##2##7##(2012-2#2)
prior to receiving a##2##4##(2008-9#1)(2009-4#1)
prior to referral##2##3##(2006-10#1)(2008-6#1)
prior to release##2##3##(2007-8#1)(2010-8#1)
prior to resection##2##3##(2008-5#2)
prior to sacrifice by##2##4##(2004-9#1)(2008-10#1)
prior to sacrifice##6##3##(1992-11#1)(1995-2#1)(1995-7#1)(1996-2#1)(2004-9#1)(2008-10#1)
prior to sampling##4##3##(1996-12#2)(2008-10#2)
prior to separation##3##3##(1997-2#1)(2007-8#1)(2010-5#1)
prior to staining##2##3##(1990-12#1)(2008-4#1)
prior to stimulation##4##3##(1992-12#1)(1994-3#1)(1997-8#1)(2008-7#1)
prior to structural##3##3##(1997-2#1)(2008-4#1)(2009-9#1)
prior to superovulation##4##3##(2006-5#4)
prior to surgery and##2##4##(1991-2#1)(1997-2#1)
prior to surgery in##2##4##(1991-10#1)(2004-1#1)
prior to surgery or radiosurgery##2##5##(2008-7#2)
prior to surgery or##3##4##(2008-10#1)(2008-7#2)
prior to surgery##23##3##(1991-10#1)(1991-2#1)(1991-3#1)(1992-10#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#1)(2012-12#2)
prior to surgical intervention##4##4##(2006-10#1)(2011-1#1)(2011-12#1)(2012-12#1)
prior to surgical interventions##2##4##(2009-5#2)
prior to surgical##9##3##(1997-6#1)(2005-12#1)(2006-10#1)(2009-5#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)
prior to target##2##3##(1991-6#1)(2010-5#1)
prior to testing##9##3##(1993-7#1)(1994-2#1)(1996-12#1)(2004-9#1)(2006-11#1)(2008-10#1)(2008-5#2)(2012-2#1)
prior to the acquisition of##2##5##(1991-1#1)(2008-5#1)
prior to the acquisition##3##4##(1991-1#1)(1994-8#1)(2008-5#1)
prior to the actual##2##4##(2010-3#1)(2011-12#1)
prior to the addition of##6##5##(1990-1#1)(1993-9#1)(1996-1#1)(1996-3#1)(1996-9#1)(2008-10#1)
prior to the administration of##2##5##(1995-12#1)(2007-10#1)
prior to the age of 50 years##2##7##(1990-4#1)(1992-3#1)
prior to the analysis##4##4##(1994-6#1)(2008-10#3)
prior to the appearance of##3##5##(1992-12#1)(2010-2#1)(2012-3#1)
prior to the determination by##2##5##(2008-10#2)
prior to the determination of##5##5##(2008-10#4)(2008-2#1)
prior to the determination##7##4##(2008-10#6)(2008-2#1)
prior to the development of##5##5##(2008-10#1)(2008-5#1)(2009-3#1)(2010-1#1)(2011-2#1)
prior to the diagnosis of##4##5##(1991-9#1)(1994-7#1)(1997-7#1)(2008-10#1)
prior to the divergence of##2##5##(1994-11#1)(2011-1#1)
prior to the end of##4##5##(2008-1#1)(2008-9#3)
prior to the entry into##2##5##(1993-11#1)(2012-1#1)
prior to the experiment##2##4##(1996-10#1)(2007-8#1)
prior to the extraction##2##4##(2008-10#1)(2012-1#1)
prior to the formation of a##2##6##(2008-10#1)(2010-2#1)
prior to the formation of##3##5##(2008-10#2)(2010-2#1)
prior to the initiation of##5##5##(1997-4#1)(2006-5#1)(2008-1#1)(2010-3#1)(2012-12#1)
prior to the interview##2##4##(2007-9#1)(2008-5#1)
prior to the introduction of CsA##2##6##(2007-7#2)
prior to the introduction of##3##5##(2007-7#2)(2010-3#1)
prior to the onset of symptoms##2##6##(2004-11#1)(2006-8#1)
prior to the onset of##11##5##(1991-1#1)(1994-2#1)(2004-11#2)(2006-8#1)(2007-11#1)(2008-10#1)(2009-10#1)(2010-10#1)(2010-9#1)(2012-2#1)
prior to the pathogen##2##4##(2008-10#2)
prior to the radiation##2##4##(2007-12#1)(2008-3#1)
prior to the retention##2##4##(1994-8#1)(1995-12#1)
prior to the start of the##2##6##(2008-10#1)(2010-11#1)
prior to the start of##4##5##(2005-8#1)(2008-10#1)(2010-11#1)(2013-8#1)
prior to the study was##2##5##(2006-10#2)
prior to the study##4##4##(2006-10#2)(2007-7#1)(2011-2#1)
prior to the survey##2##4##(2010-1#1)(2011-1#1)
prior to the third injection##2##5##(2013-8#2)
prior to the third##3##4##(2009-11#1)(2013-8#2)
prior to the##202##3##(1990-1#1)(1990-4#1)(1990-7#1)(1991-1#2)(1991-3#2)(1991-7#2)(1991-9#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-5#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#7)(1994-9#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-7#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#2)(1996-8#1)(1996-9#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-11#2)(2005-11#2)(2005-8#1)(2006-10#3)(2006-5#2)(2006-6#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#30)(2008-11#3)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-2#2)(2010-3#4)(2010-4#2)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#2)(2012-11#3)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#4)
prior to their baby's discharge##2##5##(1994-2#2)
prior to their determination by flame atomic absorption spectrometry##5##9##(2008-10#5)
prior to their determination by graphite furnace atomic absorption spectrometry##2##10##(2008-10#2)
prior to their determination by inductively coupled plasma atomic emission spectrometry##2##11##(2008-10#2)
prior to their determination by inductively coupled##3##7##(2008-10#3)
prior to their determination by##13##5##(2008-10#13)
prior to their##36##3##(1990-11#1)(1990-2#1)(1991-2#1)(1994-2#2)(1995-1#1)(1997-4#1)(2006-10#1)(2008-10#23)(2008-4#2)(2011-1#1)(2012-3#1)(2013-1#1)
prior to therapy##2##3##(2008-7#1)(2012-2#1)
prior to thermal##2##3##(1997-4#1)(2008-4#1)
prior to this##5##3##(1992-6#1)(2006-6#1)(2007-8#1)(2008-10#2)
prior to transfection##2##3##(2008-11#2)
prior to transfer##2##3##(2006-4#1)(2006-5#1)
prior to transplantation##2##3##(1995-7#1)(2007-11#1)
prior to treatment with##4##4##(1992-6#2)(1997-8#1)(2008-6#1)
prior to treatment##20##3##(1990-6#1)(1991-3#1)(1991-7#1)(1992-6#2)(1994-4#1)(1996-12#1)(1996-9#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-4#1)(2007-7#1)(2008-5#2)(2008-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
prior to tumor##3##3##(1995-1#1)(1997-7#1)(2006-8#1)
prior to vaccination##2##3##(2005-9#1)(2011-1#1)
prior to wound closure##3##4##(2008-7#3)
prior to##1150##2##(1990-1#1)(1990-11#6)(1990-12#7)(1990-2#6)(1990-3#2)(1990-4#3)(1990-5#1)(1990-6#3)(1990-7#4)(1990-8#1)(1991-1#2)(1991-10#4)(1991-11#2)(1991-12#7)(1991-2#8)(1991-3#8)(1991-4#1)(1991-6#7)(1991-7#3)(1991-8#2)(1991-9#6)(1992-10#3)(1992-11#2)(1992-12#5)(1992-2#2)(1992-3#11)(1992-4#1)(1992-5#2)(1992-6#9)(1992-8#4)(1992-9#5)(1993-1#2)(1993-11#7)(1993-12#9)(1993-2#5)(1993-3#4)(1993-4#3)(1993-5#2)(1993-6#3)(1993-7#1)(1993-9#3)(1994-11#2)(1994-12#10)(1994-2#9)(1994-3#8)(1994-4#1)(1994-5#1)(1994-6#9)(1994-7#2)(1994-8#10)(1994-9#8)(1995-1#8)(1995-11#5)(1995-12#9)(1995-2#4)(1995-3#2)(1995-4#3)(1995-5#4)(1995-6#3)(1995-7#5)(1995-8#3)(1995-9#1)(1996-1#2)(1996-10#2)(1996-11#2)(1996-12#14)(1996-2#6)(1996-3#4)(1996-4#3)(1996-5#4)(1996-6#3)(1996-7#5)(1996-8#2)(1996-9#11)(1997-1#1)(1997-2#9)(1997-3#5)(1997-4#9)(1997-5#2)(1997-6#7)(1997-7#4)(1997-8#5)(2004-1#2)(2004-11#4)(2004-9#4)(2005-10#7)(2005-11#6)(2005-12#4)(2005-7#2)(2005-8#5)(2005-9#3)(2006-1#1)(2006-10#9)(2006-11#3)(2006-12#5)(2006-2#2)(2006-4#3)(2006-5#12)(2006-6#5)(2006-8#18)(2006-9#2)(2007-1#5)(2007-10#6)(2007-11#13)(2007-12#10)(2007-2#4)(2007-3#2)(2007-4#3)(2007-5#1)(2007-6#3)(2007-7#18)(2007-8#26)(2007-9#5)(2008-1#9)(2008-10#193)(2008-11#21)(2008-12#4)(2008-2#8)(2008-3#6)(2008-4#24)(2008-5#27)(2008-6#13)(2008-7#26)(2008-8#12)(2008-9#14)(2009-10#3)(2009-11#4)(2009-2#4)(2009-3#7)(2009-4#3)(2009-5#10)(2009-6#1)(2009-7#4)(2009-8#1)(2009-9#4)(2010-1#3)(2010-10#4)(2010-11#2)(2010-12#4)(2010-2#4)(2010-3#7)(2010-4#6)(2010-5#6)(2010-6#2)(2010-7#1)(2010-8#12)(2010-9#1)(2011-1#21)(2011-12#4)(2011-2#26)(2012-1#6)(2012-11#4)(2012-12#21)(2012-2#13)(2012-3#6)(2012-5#2)(2013-1#16)(2013-7#7)(2013-8#7)
prior training##2##2##(2008-10#2)
prior treatment of the##3##4##(1993-9#1)(1997-1#1)(2008-10#1)
prior treatment of##5##3##(1991-3#1)(1993-9#1)(1996-9#1)(1997-1#1)(2008-10#1)
prior treatment with##2##3##(1991-4#1)(2009-8#1)
prior treatment##17##2##(1990-10#2)(1991-2#1)(1991-3#1)(1991-4#1)(1993-9#1)(1996-9#1)(1997-1#1)(2005-11#1)(2006-10#1)(2007-8#1)(2008-10#3)(2009-8#1)(2012-3#2)
prior trials##3##2##(1993-2#2)(2009-9#1)
prior use of##3##3##(2007-9#1)(2008-12#1)(2008-5#1)
prior use##4##2##(1994-3#1)(2007-9#1)(2008-12#1)(2008-5#1)
prior work in##2##3##(2008-10#1)(2013-8#1)
prior work##4##2##(2008-10#2)(2009-9#1)(2013-8#1)
prior##1675##1##(1990-1#1)(1990-10#2)(1990-11#10)(1990-12#10)(1990-2#6)(1990-3#2)(1990-4#3)(1990-5#2)(1990-6#4)(1990-7#5)(1990-8#3)(1991-1#3)(1991-10#4)(1991-11#2)(1991-12#10)(1991-2#11)(1991-3#12)(1991-4#3)(1991-5#1)(1991-6#9)(1991-7#4)(1991-8#2)(1991-9#7)(1992-10#5)(1992-11#2)(1992-12#8)(1992-2#2)(1992-3#15)(1992-4#1)(1992-5#2)(1992-6#10)(1992-7#7)(1992-8#5)(1992-9#7)(1993-1#3)(1993-11#7)(1993-12#12)(1993-2#10)(1993-3#8)(1993-4#4)(1993-5#2)(1993-6#5)(1993-7#1)(1993-8#2)(1993-9#10)(1994-1#1)(1994-11#6)(1994-12#13)(1994-2#11)(1994-3#10)(1994-4#1)(1994-5#1)(1994-6#9)(1994-7#2)(1994-8#11)(1994-9#9)(1995-1#9)(1995-11#5)(1995-12#14)(1995-2#10)(1995-3#4)(1995-4#7)(1995-5#6)(1995-6#8)(1995-7#6)(1995-8#5)(1995-9#1)(1996-1#5)(1996-10#2)(1996-11#2)(1996-12#18)(1996-2#7)(1996-3#6)(1996-4#4)(1996-5#9)(1996-6#4)(1996-7#7)(1996-8#3)(1996-9#15)(1997-1#4)(1997-2#11)(1997-3#7)(1997-4#12)(1997-5#2)(1997-6#9)(1997-7#4)(1997-8#15)(2004-1#3)(2004-11#4)(2004-9#4)(2005-1#1)(2005-10#8)(2005-11#8)(2005-12#4)(2005-7#4)(2005-8#5)(2005-9#4)(2006-1#1)(2006-10#18)(2006-11#6)(2006-12#6)(2006-2#5)(2006-3#1)(2006-4#4)(2006-5#15)(2006-6#7)(2006-7#1)(2006-8#23)(2006-9#5)(2007-1#6)(2007-10#14)(2007-11#14)(2007-12#14)(2007-2#5)(2007-3#2)(2007-4#4)(2007-5#2)(2007-6#3)(2007-7#24)(2007-8#29)(2007-9#9)(2008-1#13)(2008-10#248)(2008-11#30)(2008-12#10)(2008-2#27)(2008-3#15)(2008-4#32)(2008-5#33)(2008-6#19)(2008-7#31)(2008-8#18)(2008-9#20)(2009-10#9)(2009-11#8)(2009-12#1)(2009-2#7)(2009-3#10)(2009-4#7)(2009-5#12)(2009-6#3)(2009-7#5)(2009-8#3)(2009-9#7)(2010-1#4)(2010-10#4)(2010-11#6)(2010-12#14)(2010-2#9)(2010-3#11)(2010-4#7)(2010-5#10)(2010-6#7)(2010-7#1)(2010-8#16)(2010-9#2)(2011-1#25)(2011-12#5)(2011-2#41)(2012-1#8)(2012-11#4)(2012-12#29)(2012-2#17)(2012-3#14)(2012-5#2)(2013-1#38)(2013-7#17)(2013-8#14)
priori knowledge about##2##3##(2008-2#1)(2010-6#1)
priori knowledge##18##2##(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-2#6)(2008-3#6)(2010-6#1)(2012-12#1)
priori##94##1##(1990-8#2)(1991-12#1)(1991-2#1)(1994-12#1)(1994-9#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-6#2)(1997-8#1)(2005-5#1)(2006-10#3)(2006-11#1)(2007-11#3)(2007-12#6)(2007-5#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-2#21)(2008-3#18)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#2)(2009-6#1)(2010-1#1)(2010-10#1)(2010-6#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)
priorities 25-90##3##2##(2008-3#3)
priorities and##12##2##(1991-12#1)(1994-3#1)(1995-12#1)(1996-2#1)(1997-3#1)(2006-9#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-4#1)(2012-3#1)(2013-1#1)
priorities are##4##2##(1994-2#1)(2008-2#1)(2010-8#1)(2013-1#1)
priorities for Australian critical care nurses##3##6##(2007-11#3)
priorities for information##2##3##(2010-11#2)
priorities for the##4##3##(1992-2#1)(1997-1#1)(2008-10#1)(2008-5#1)
priorities for##26##2##(1992-2#1)(1994-2#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-3#1)(2006-3#1)(2007-11#6)(2007-12#1)(2007-2#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-11#2)(2010-12#1)
priorities in##8##2##(1991-1#1)(1991-6#1)(1992-2#1)(1994-2#1)(2006-2#1)(2007-9#1)(2008-10#1)(2010-10#1)
priorities include##2##2##(1994-2#1)(2011-1#1)
priorities of calls and##2##4##(2010-3#2)
priorities of calls##3##3##(2010-3#3)
priorities of the##3##3##(1996-1#1)(2005-10#1)(2008-7#1)
priorities of##10##2##(1993-3#1)(1996-1#1)(2005-10#1)(2006-8#1)(2008-7#2)(2010-3#3)(2011-2#1)
priorities were##2##2##(1992-6#1)(2007-11#1)
priorities##121##1##(1991-1#1)(1991-12#1)(1991-2#3)(1991-5#2)(1991-6#1)(1992-1#1)(1992-2#2)(1992-6#1)(1992-8#1)(1993-3#2)(1994-2#5)(1994-3#2)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#2)(1997-3#6)(1997-7#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#10)(2007-12#1)(2007-2#1)(2007-4#1)(2007-9#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#4)(2008-9#1)(2009-3#1)(2009-4#5)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-3#3)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-3#3)(2013-1#3)(2013-8#1)
priorities)##2##1##(1993-12#1)(2008-1#1)
prioritisation##2##1##(2008-5#1)(2011-2#1)
prioritised by the##2##3##(2011-2#2)
prioritised##3##1##(2009-4#1)(2011-2#2)
prioritising##4##1##(1992-10#1)(2007-7#1)(2010-12#1)(2012-12#1)
prioritization in##2##2##(1996-12#1)(2013-7#1)
prioritization of##6##2##(1992-11#1)(1995-8#1)(1996-2#1)(2005-7#1)(2013-1#2)
prioritization##22##1##(1990-12#1)(1992-11#1)(1994-9#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1997-2#1)(2005-7#1)(2006-7#1)(2007-12#1)(2010-8#3)(2011-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
prioritize the##6##2##(2010-8#2)(2013-1#4)
prioritize##31##1##(1994-3#1)(2005-12#1)(2006-10#1)(2007-10#1)(2007-4#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-12#1)(2010-8#3)(2010-9#2)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#6)(2013-8#2)
prioritized for##2##2##(2005-8#1)(2006-7#1)
prioritized##22##1##(1994-3#1)(1996-1#1)(2005-8#1)(2006-7#2)(2008-10#1)(2008-12#1)(2008-2#2)(2008-7#1)(2009-12#1)(2009-6#1)(2009-8#2)(2010-7#1)(2011-2#1)(2012-12#2)(2013-7#1)(2013-8#3)
prioritizing##18##1##(1990-12#1)(1994-12#1)(1994-9#1)(2007-10#1)(2007-12#1)(2008-11#2)(2008-4#1)(2009-9#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
priority among##2##2##(2009-5#1)(2010-7#1)
priority and##3##2##(1992-5#1)(2012-12#2)
priority area##3##2##(2004-4#1)(2008-1#1)(2008-7#1)
priority by##3##2##(2007-6#1)(2009-2#1)(2009-5#1)
priority for the##5##3##(1994-2#1)(2006-10#2)(2008-1#1)(2013-7#1)
priority for##19##2##(1994-2#1)(1994-3#1)(1996-2#1)(2006-10#2)(2007-3#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2010-5#1)(2010-6#1)(2012-2#1)(2013-1#2)(2013-7#1)
priority given to##2##3##(1992-5#1)(2008-4#1)
priority in both##2##3##(2007-8#1)(2009-3#1)
priority in the##6##3##(1992-2#1)(1996-12#1)(1997-8#1)(2006-6#1)(2008-7#1)(2008-8#1)
priority in##23##2##(1992-12#1)(1992-2#1)(1993-11#1)(1994-3#1)(1996-12#2)(1996-2#1)(1997-8#1)(2005-8#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2011-7#1)(2012-1#1)
priority is##3##2##(1994-6#1)(2007-12#1)(2008-8#1)
priority issues and problems to be addressed for the administrative##3##10##(2013-8#3)
priority issues and problems##4##4##(2013-8#4)
priority issues and##5##3##(2013-8#5)
priority issues##7##2##(1994-10#1)(2007-11#1)(2013-8#5)
priority list##2##2##(2007-9#1)(2009-4#1)
priority of the##2##3##(2008-12#1)(2008-7#1)
priority of##9##2##(1991-11#1)(1993-3#1)(2006-7#1)(2007-3#1)(2008-12#1)(2008-7#1)(2010-3#1)(2011-1#1)(2013-7#1)
priority on##5##2##(1996-1#1)(2008-8#1)(2010-10#1)(2013-1#2)
priority over##2##2##(2006-2#1)(2007-6#1)
priority pollutant##2##2##(1996-3#1)(2008-10#1)
priority pollutants##2##2##(2008-10#2)
priority setting##9##2##(1992-2#1)(1993-7#1)(1997-3#1)(2006-2#1)(2007-11#2)(2008-5#2)(2008-7#1)
priority should be given##2##4##(1997-8#1)(2007-9#1)
priority to##11##2##(1990-12#1)(1993-1#1)(1997-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-9#1)(2009-3#1)(2010-12#2)(2013-7#1)
priority##200##1##(1990-12#1)(1990-3#2)(1990-5#1)(1991-11#1)(1991-2#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-5#2)(1992-8#1)(1993-1#1)(1993-11#2)(1993-3#2)(1993-7#1)(1994-10#1)(1994-2#2)(1994-3#3)(1994-6#1)(1994-7#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-9#2)(1997-1#2)(1997-3#2)(1997-4#2)(1997-8#3)(2004-4#1)(2005-11#1)(2005-12#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-2#3)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-3#2)(2007-4#1)(2007-6#3)(2007-7#4)(2007-8#2)(2007-9#4)(2008-1#3)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#3)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#4)(2009-7#1)(2009-9#1)(2010-10#2)(2010-12#3)(2010-2#4)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#3)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#17)(2013-7#6)(2013-8#5)
priority-setting##8##1##(1992-2#1)(2008-10#1)(2008-5#2)(2008-7#4)
priority]##2##1##(1994-3#1)(1994-5#1)
priors and##2##2##(1993-6#1)(1995-2#1)
priors for##2##2##(2008-2#1)(2008-6#1)
priors##12##1##(1993-6#1)(1994-4#1)(1995-2#1)(1996-12#1)(1997-6#1)(2008-2#2)(2008-6#1)(2011-1#3)(2013-1#1)
prise en charge##8##3##(2011-2#2)(2012-2#2)(2013-1#4)
prism and a##4##3##(2008-2#3)(2008-3#1)
prism and##12##2##(2007-11#1)(2008-2#4)(2008-3#7)
prism as##2##2##(2008-2#1)(2008-3#1)
prism assembly is##2##3##(2008-2#1)(2008-3#1)
prism assembly##4##2##(2008-2#1)(2008-3#3)
prism can be##2##3##(2008-2#1)(2008-3#1)
prism can##3##2##(2008-2#1)(2008-3#2)
prism compressor##2##2##(2007-11#1)(2009-4#1)
prism coupler##4##2##(2008-2#2)(2008-3#2)
prism faces##2##2##(2008-2#1)(2008-3#1)
prism for##3##2##(2007-12#1)(2008-3#2)
prism in##2##2##(2007-12#1)(2008-3#1)
prism is used##2##3##(2007-12#1)(2008-3#1)
prism is##6##2##(2007-12#3)(2008-3#3)
prism light guides##3##3##(2008-2#3)
prism light##5##2##(2008-2#5)
prism of the##2##3##(1994-11#1)(2008-7#1)
prism pair##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
prism sequence##2##2##(2007-12#2)
prism with##2##2##(2007-12#1)(2008-3#1)
prism##111##1##(1994-11#1)(1996-2#1)(2007-11#6)(2007-12#16)(2007-5#3)(2008-1#2)(2008-10#1)(2008-2#31)(2008-3#43)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2013-8#3)
prism-coupling technique##2##2##(2007-11#1)(2008-2#1)
prismatic or##2##2##(2007-12#1)(2008-10#1)
prismatic##12##1##(2007-12#3)(2008-10#1)(2008-2#5)(2008-3#2)(2013-1#1)
prismless##2##1##(2007-12#1)(2008-1#1)
prisms after the crystal##2##4##(2007-12#1)(2008-3#1)
prisms after the##3##3##(2007-12#1)(2008-3#2)
prisms and##3##2##(2007-12#1)(2008-2#2)
prisms that##2##2##(2007-11#1)(2008-3#1)
prisms to##2##2##(2007-11#1)(2008-2#1)
prisms##31##1##(2007-11#3)(2007-12#5)(2008-11#1)(2008-2#3)(2008-3#18)(2013-8#1)
prison and##5##2##(2004-9#1)(2008-7#1)(2009-11#1)(2012-1#1)(2012-2#1)
prison for##5##2##(1991-2#1)(1996-5#1)(1997-5#3)
prison health care##3##3##(1992-2#1)(2012-11#2)
prison health##4##2##(1992-2#1)(1993-7#1)(2012-11#2)
prison inmates are##2##3##(1992-2#1)(2009-11#1)
prison is##2##2##(2009-11#1)(2012-2#1)
prison officials##3##2##(1990-2#2)(1996-12#1)
prison population##4##2##(1991-3#2)(1993-10#1)(2012-11#1)
prison sentences##3##2##(1991-3#1)(1992-10#1)(2012-1#1)
prison##58##1##(1990-2#3)(1991-2#1)(1991-3#5)(1992-10#1)(1992-2#4)(1993-10#1)(1993-7#1)(1994-12#1)(1996-12#1)(1996-5#4)(1996-6#1)(1997-5#3)(2004-9#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-7#1)(2008-7#1)(2009-11#7)(2009-5#1)(2010-12#1)(2011-1#1)(2012-1#3)(2012-11#10)(2012-2#2)
prisoner##7##1##(1990-2#2)(1995-4#1)(1996-11#1)(1996-12#3)
prisoner's dilemma##6##2##(1995-2#1)(2008-8#5)
prisoner's##7##1##(1995-2#1)(1996-12#1)(2008-8#5)
prisoners in the##2##3##(2008-12#1)(2012-11#1)
prisoners of##2##2##(1990-12#1)(2008-12#1)
prisoners with##2##2##(2007-1#1)(2008-12#1)
prisoners##17##1##(1990-12#1)(1991-3#1)(1996-2#1)(1996-7#1)(1997-5#3)(2007-1#1)(2008-12#4)(2010-12#1)(2012-11#3)(2013-1#1)
prisoners]##2##1##(1996-6#1)(1996-9#1)
prisons are##2##2##(1992-2#1)(2012-11#1)
prisons##14##1##(1991-3#1)(1992-2#2)(1994-3#1)(1995-4#1)(2006-4#1)(2007-1#1)(2009-7#1)(2010-5#1)(2012-11#5)
pristanic acid oxidase activity##2##4##(1990-10#2)
pristanic acid##7##2##(1990-10#5)(1994-11#1)(1997-7#1)
pristinamycin resistance##2##2##(2010-2#2)
pristinamycin##5##1##(2007-12#1)(2010-2#4)
pristine##19##1##(2005-11#1)(2005-5#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-5#1)(2009-11#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#1)(2012-2#1)
privacy and confidentiality##2##3##(2007-11#1)(2010-11#1)
privacy and##5##2##(1996-3#1)(2006-8#1)(2007-11#1)(2007-3#1)(2010-11#1)
privacy concerns##3##2##(2013-1#3)
privacy in the hospital##2##4##(2012-12#2)
privacy in the##5##3##(1996-9#1)(2008-6#1)(2012-12#3)
privacy in##9##2##(1996-9#1)(1997-5#1)(2007-2#1)(2008-6#1)(2012-12#3)(2013-1#2)
privacy interest##3##2##(1991-7#2)(1995-12#1)
privacy is##2##2##(1997-5#1)(2012-12#1)
privacy issues##2##2##(2008-10#1)(2010-5#1)
privacy of individuals and##3##4##(1993-9#1)(2013-1#2)
privacy of##10##2##(1993-9#1)(1996-5#1)(1997-5#2)(2007-11#1)(2010-8#1)(2013-1#4)
privacy regulations##6##2##(2006-8#5)(2007-12#1)
privacy rights##3##2##(1991-10#1)(2006-8#1)(2010-5#1)
privacy rule and##2##3##(2007-12#1)(2010-9#1)
privacy rule requirements##3##3##(2007-12#3)
privacy rule##10##2##(2005-8#1)(2006-7#1)(2006-8#1)(2007-12#6)(2010-9#1)
privacy was##2##2##(1995-6#1)(1996-12#1)
privacy##120##1##(1990-5#1)(1991-10#1)(1991-7#3)(1992-3#2)(1992-4#1)(1993-9#1)(1994-3#1)(1995-12#3)(1995-2#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#3)(1996-7#1)(1996-9#1)(1997-5#4)(1997-6#1)(2005-11#3)(2005-8#4)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#9)(2007-11#2)(2007-12#9)(2007-2#2)(2007-3#1)(2007-4#3)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2011-9#1)(2012-12#9)(2012-3#2)(2013-1#19)
privacy-insensitive&quot##2##1##(2013-1#2)
privacy-preserving##6##1##(2013-1#6)
private accreditation##2##2##(1995-3#2)
private and government##3##3##(2007-8#1)(2008-3#1)(2011-1#1)
private and public health##2##4##(1997-3#1)(1997-4#1)
private and public hospitals##2##4##(1994-3#1)(2013-8#1)
private and public##15##3##(1991-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-1#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-4#1)(2008-1#1)(2010-11#1)(2011-2#1)(2013-8#1)
private and##24##2##(1991-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-1#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-3#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
private enterprise##2##2##(1995-12#1)(1997-5#1)
private fee-for-service##3##2##(2006-10#2)(2009-8#1)
private fees##5##2##(1994-1#5)
private funders##2##2##(1994-12#1)(1997-5#1)
private funding##2##2##(1997-3#1)(2010-9#1)
private group practices##2##3##(2007-4#2)
private health care providers##2##4##(1996-2#1)(1996-3#1)
private health care##5##3##(1990-6#1)(1996-2#1)(1996-3#1)(2005-7#1)(2012-1#1)
private health insurance##17##3##(1992-2#1)(1993-1#1)(1993-3#3)(1994-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-10#1)(2006-1#2)(2008-1#1)(2008-11#1)(2008-7#1)(2009-2#1)(2013-1#1)
private health services##2##3##(2012-3#2)
private health##32##2##(1990-12#1)(1990-6#1)(1991-2#1)(1992-2#2)(1993-1#1)(1993-3#4)(1994-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-10#1)(2005-7#1)(2006-1#2)(2008-1#1)(2008-11#1)(2008-7#2)(2009-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
private healthcare##5##2##(2006-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2013-8#1)
private high school students##4##4##(2006-7#3)(2008-10#1)
private home##2##2##(2008-9#1)(2012-2#1)
private hospital employees##2##3##(2011-1#2)
private hospital##3##2##(2010-8#1)(2011-1#2)
private hospitals in##4##3##(2007-2#1)(2008-12#1)(2012-2#1)(2013-8#1)
private hospitals##11##2##(1992-2#1)(1994-3#1)(2007-2#1)(2007-7#3)(2008-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
private houses##2##2##(2008-6#2)
private industry##3##2##(1995-3#1)(2007-9#1)(2008-10#1)
private institutions##3##2##(1990-5#1)(2010-1#1)(2013-8#1)
private insurance and##2##3##(1997-2#1)(2012-2#1)
private insurance coverage##3##3##(1991-12#1)(1992-2#1)(1994-3#1)
private insurance for##3##3##(1990-12#1)(1992-2#1)(2010-12#1)
private insurance##17##2##(1990-12#1)(1991-12#1)(1992-2#2)(1994-1#1)(1994-3#1)(1995-12#1)(1996-12#2)(1996-3#2)(1997-2#1)(1997-8#1)(2007-4#1)(2010-12#1)(2012-2#2)
private insurers##4##2##(1993-1#1)(1994-1#1)(1994-2#1)(1997-5#1)
private laboratories##4##2##(1991-6#1)(1997-4#2)(1997-5#1)
private laboratory##5##2##(1994-12#1)(1997-4#2)(2010-4#1)(2012-12#1)
private long-term care insurance##3##4##(1996-1#1)(2010-1#2)
private medical##6##2##(1992-3#1)(1996-1#1)(2005-9#1)(2010-4#1)(2012-2#1)(2013-7#1)
private or##4##2##(1992-3#1)(1993-2#1)(2007-4#1)(2008-11#1)
private pain management practice##2##4##(2006-8#2)
private payers##3##2##(1997-1#1)(2008-12#1)(2008-7#1)
private pharmaceutical##2##2##(2006-5#2)
private physician##3##2##(1990-6#1)(1995-12#1)(2007-5#1)
private practice and##2##3##(2007-4#1)(2013-1#1)
private practice by##2##3##(2012-1#1)(2013-1#1)
private practice in##2##3##(2010-7#1)(2010-9#1)
private practice or##2##3##(1994-3#1)(2009-10#1)
private practice##43##2##(1992-10#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-3#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-5#1)(2005-7#2)(2006-8#2)(2007-10#1)(2007-11#1)(2007-4#7)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#2)(2009-10#1)(2010-1#1)(2010-7#1)(2010-9#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#3)
private practitioners##2##2##(1993-2#1)(1995-12#1)
private providers##4##2##(2011-1#1)(2012-1#1)(2013-7#2)
private psychiatric hospital##3##3##(1991-2#1)(1992-3#1)(1993-12#1)
private psychiatric hospitals##5##3##(1992-1#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#1)
private psychiatric##9##2##(1991-2#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#2)(1993-2#1)(2012-2#1)
private schools##9##2##(2008-9#7)(2011-2#1)(2013-1#1)
private sector employment##3##3##(1994-12#1)(1996-1#1)(1996-2#1)
private sector participation##2##3##(2008-6#2)
private sector providers##3##3##(1996-12#1)(2013-1#2)
private sector##60##2##(1990-12#1)(1991-1#1)(1992-3#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-2#1)(1995-3#3)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#1)(1997-5#5)(2005-5#3)(2006-10#4)(2006-8#1)(2007-2#1)(2007-7#2)(2008-1#2)(2008-6#4)(2008-7#1)(2008-9#1)(2009-3#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#3)
private sectors##12##2##(1992-12#1)(1996-2#2)(1997-3#1)(2004-4#1)(2005-5#3)(2006-2#1)(2007-7#1)(2009-3#1)(2013-1#1)
private services##2##2##(2012-3#2)
private skin clinic in Dar es Salaam##2##7##(2007-7#2)
private sources##2##2##(1997-3#1)(2007-9#1)
private supplementary##3##2##(1991-2#1)(1996-3#2)
private supply##2##2##(2008-7#2)
private treatment##2##2##(1996-11#2)
private university##3##2##(1990-12#1)(2007-8#1)(2011-2#1)
private veterinarians and livestock producer##2##5##(2005-5#2)
private veterinarians and##3##3##(2005-5#2)(2010-4#1)
private##464##1##(1990-12#5)(1990-5#1)(1990-6#3)(1990-7#3)(1990-9#1)(1991-1#1)(1991-12#4)(1991-2#3)(1991-3#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#7)(1992-3#6)(1992-6#1)(1993-1#3)(1993-12#4)(1993-2#8)(1993-3#6)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#10)(1994-12#4)(1994-2#5)(1994-3#7)(1994-5#1)(1994-7#1)(1995-1#3)(1995-11#1)(1995-12#6)(1995-2#1)(1995-3#8)(1995-6#1)(1995-8#1)(1996-1#4)(1996-11#3)(1996-12#6)(1996-2#6)(1996-3#10)(1996-4#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#6)(1997-3#9)(1997-4#5)(1997-5#11)(1997-6#1)(1997-7#2)(1997-8#3)(2004-4#1)(2005-10#1)(2005-11#1)(2005-5#8)(2005-7#3)(2005-8#2)(2005-9#3)(2006-1#2)(2006-10#8)(2006-2#4)(2006-4#2)(2006-5#2)(2006-6#2)(2006-7#4)(2006-8#6)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#4)(2007-3#3)(2007-4#13)(2007-5#1)(2007-7#8)(2007-8#6)(2007-9#3)(2008-1#6)(2008-10#5)(2008-11#5)(2008-12#2)(2008-3#3)(2008-4#5)(2008-5#2)(2008-6#6)(2008-7#19)(2008-8#5)(2008-9#10)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#5)(2010-11#1)(2010-12#2)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#4)(2011-1#8)(2011-2#10)(2011-7#1)(2012-1#4)(2012-11#1)(2012-12#4)(2012-2#12)(2012-3#13)(2013-1#13)(2013-7#7)(2013-8#9)
private&quot##2##1##(2008-10#1)(2009-5#1)
private)##2##1##(1991-12#1)(2013-7#1)
private-practice perspective##2##2##(2007-4#2)
private-public mix##2##2##(2008-7#2)
private-sector companies##2##2##(2006-10#2)
private-sector##9##1##(1996-2#2)(1997-3#1)(2005-5#3)(2006-10#2)(2007-4#1)
privately funded abortions at military facilities##2##6##(1996-5#2)
privately funded abortions at##3##4##(1995-6#1)(1996-5#2)
privately funded##4##2##(1995-6#1)(1996-5#2)(2013-1#1)
privately insured##4##2##(1997-3#3)(2012-2#1)
privately##12##1##(1990-12#1)(1995-6#1)(1996-5#2)(1997-3#3)(2009-4#1)(2012-2#1)(2013-1#3)
privatization of public##2##3##(1997-1#1)(2008-11#1)
privatization of##6##2##(1993-2#1)(1997-1#1)(2007-8#1)(2008-11#1)(2010-7#1)(2013-1#1)
privatization##10##1##(1993-2#1)(1996-2#1)(1997-1#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-7#1)(2010-7#1)(2013-1#1)
privilege in##3##2##(2010-1#2)(2010-8#1)
privilege of##3##2##(1993-5#1)(1996-10#1)(2008-6#1)
privilege words over other linguistic##2##5##(2012-1#2)
privilege##19##1##(1993-5#1)(1996-10#1)(2006-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2009-7#1)(2010-1#5)(2010-8#1)(2011-2#1)(2012-1#3)(2012-12#1)
privileged##13##1##(2004-4#1)(2007-8#1)(2008-1#2)(2008-2#1)(2008-4#2)(2009-10#3)(2010-4#1)(2010-8#1)(2011-12#1)
privileges among##2##2##(2007-4#1)(2012-3#1)
privileges and##3##2##(1993-1#2)(2013-8#1)
privileges of##2##2##(1993-3#1)(2008-1#1)
privileges without##3##2##(1992-12#1)(1993-1#1)(1993-3#1)
privileges##27##1##(1990-12#1)(1991-12#3)(1991-4#2)(1992-12#1)(1992-2#1)(1992-3#2)(1993-1#3)(1993-3#3)(1994-1#2)(1996-1#1)(1996-9#1)(2007-4#2)(2008-1#1)(2008-7#1)(2012-3#2)(2013-8#1)
privileging##9##1##(1992-2#1)(1994-3#2)(2004-4#1)(2007-4#1)(2007-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
prize for##2##2##(2007-9#1)(2010-8#1)
prize##14##1##(1990-6#1)(1991-3#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-9#2)(2008-11#1)(2009-5#1)(2010-1#1)(2010-8#2)(2011-1#1)(2012-2#1)
prized##4##1##(1996-2#1)(2006-12#1)(2008-11#1)(2010-4#1)
prizes##2##1##(1996-11#1)(2010-5#1)
prmt5##5##1##(2009-7#5)
pro ANF##4##2##(1991-8#4)
pro alpha1 (I) collagen mRNA##2##5##(2006-9#2)
pro alpha1 (I)##3##3##(2006-9#3)
pro and##4##2##(1995-6#1)(2007-4#1)(2008-3#1)(2012-11#1)
pro forma##4##2##(2006-2#1)(2007-4#1)(2012-2#1)(2013-7#1)
pro##26##1##(1991-8#4)(1995-3#1)(1995-6#2)(1996-3#1)(2005-7#1)(2006-2#1)(2006-6#1)(2006-9#3)(2007-4#2)(2007-7#1)(2008-12#1)(2008-3#1)(2010-11#1)(2010-12#2)(2010-7#1)(2012-11#1)(2012-2#1)(2013-7#1)
pro- and anti-apoptotic##4##3##(2009-12#2)(2010-10#1)(2012-2#1)
pro- and anti-inflammatory##10##3##(1993-12#1)(1995-12#1)(2006-10#4)(2008-10#1)(2011-1#1)(2012-1#1)(2013-7#1)
pro- and eukaryotic##3##3##(1992-1#1)(1995-3#1)(2008-7#1)
pro- and##26##2##(1992-1#1)(1993-12#1)(1995-12#1)(1995-3#1)(1995-7#1)(2006-10#9)(2006-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-12#2)(2010-10#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-7#1)
pro- or##2##2##(1996-2#1)(2009-2#1)
pro-##31##1##(1992-1#1)(1993-12#1)(1995-12#1)(1995-3#1)(1995-7#1)(1996-2#1)(2006-10#9)(2006-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-12#2)(2009-2#1)(2010-10#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-7#1)
pro-BNP##3##1##(2010-6#1)(2012-2#2)
pro-C3 and proalbumin##2##3##(1990-8#2)
pro-C3##7##1##(1990-8#4)(1992-12#3)
pro-EGF##3##1##(1990-12#3)
pro-HGF##4##1##(1992-12#4)
pro-LPH##4##1##(1992-11#4)
pro-PO##4##1##(1997-2#4)
pro-S hydrogen from C-5 of##2##5##(1996-7#2)
pro-S hydrogen##3##2##(1992-1#1)(1996-7#2)
pro-S##6##1##(1992-1#1)(1996-7#5)
pro-SI##2##1##(1992-11#2)
pro-UK in urine##2##3##(1990-12#2)
pro-UK in##3##2##(1990-12#3)
pro-UK##13##1##(1990-12#12)(2007-7#1)
pro-Urokinase##2##1##(2008-7#2)
pro-active approach##2##2##(1991-1#1)(1994-1#1)
pro-active##7##1##(1991-1#1)(1994-1#1)(2007-5#1)(2007-7#1)(2008-11#3)
pro-alpha 1(III) delta 1##2##4##(1994-9#2)
pro-alpha 1(III)##4##2##(1994-9#4)
pro-alpha 2(I)##3##2##(1994-9#3)
pro-alpha##7##1##(1994-9#7)
pro-angiogenic and##2##2##(2009-11#1)(2013-1#1)
pro-angiogenic factors##3##2##(2008-8#1)(2010-12#1)(2013-1#1)
pro-angiogenic##8##1##(2005-7#1)(2008-10#1)(2008-8#1)(2009-11#1)(2010-12#1)(2010-9#1)(2013-1#2)
pro-apoptotic activity##2##2##(1995-6#1)(2008-10#1)
pro-apoptotic protein##4##2##(2009-12#1)(2010-12#1)(2010-6#1)(2013-1#1)
pro-apoptotic proteins##2##2##(2009-12#2)
pro-apoptotic##28##1##(1995-6#1)(1996-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-12#3)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#4)(2013-7#1)
pro-atherogenic##5##1##(1996-5#1)(2008-10#2)(2008-3#2)
pro-cathepsin D##3##2##(1990-9#3)
pro-cathepsin##5##1##(1990-9#4)(1992-12#1)
pro-choice##4##1##(1993-1#1)(1995-6#1)(1996-5#1)(2008-7#1)
pro-death##2##1##(2007-10#1)(2011-2#1)
pro-domain##4##1##(2008-4#4)
pro-drug##5##1##(1992-11#2)(1996-3#1)(2012-2#2)
pro-drugs##3##1##(1992-11#1)(2008-8#1)(2011-1#1)
pro-enzyme##4##1##(1992-12#2)(1993-5#1)(1996-5#1)
pro-estrus and##2##2##(1992-9#2)
pro-fibrogenic##2##1##(2012-12#2)
pro-inflammatory and##4##2##(1996-5#1)(2006-10#1)(2008-1#1)(2011-2#1)
pro-inflammatory chemokines##3##2##(2008-11#3)
pro-inflammatory cytokine##8##2##(1995-12#1)(2003-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2009-3#1)(2009-8#1)(2012-2#1)
pro-inflammatory cytokines TNF-alpha##2##3##(2008-10#2)
pro-inflammatory cytokines and##6##3##(1995-3#2)(2007-11#1)(2008-1#1)(2010-1#1)(2010-12#1)
pro-inflammatory cytokines##33##2##(1995-3#2)(1997-8#1)(2005-10#1)(2006-10#1)(2007-11#3)(2007-7#1)(2008-1#4)(2008-10#5)(2008-2#1)(2008-5#3)(2009-11#1)(2009-12#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-7#1)(2011-1#2)(2012-12#1)(2012-2#1)
pro-inflammatory effects##2##2##(2007-1#1)(2008-10#1)
pro-inflammatory genes##2##2##(2010-12#1)(2013-1#1)
pro-inflammatory mediators and##2##3##(2008-10#1)(2008-11#1)
pro-inflammatory mediators##13##2##(2004-12#1)(2006-2#2)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#3)(2010-12#2)(2012-2#1)
pro-inflammatory responses##4##2##(2003-11#1)(2008-7#3)
pro-inflammatory signaling##2##2##(2010-12#2)
pro-inflammatory##102##1##(1993-12#1)(1994-12#1)(1995-12#1)(1995-3#2)(1996-5#1)(1997-8#1)(2003-11#2)(2004-12#1)(2005-10#1)(2005-12#1)(2006-10#4)(2006-2#2)(2006-8#1)(2007-1#1)(2007-11#5)(2007-12#1)(2007-7#1)(2008-1#5)(2008-10#12)(2008-11#6)(2008-2#1)(2008-3#3)(2008-5#8)(2008-7#4)(2009-11#1)(2009-12#2)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-12#7)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#6)(2013-1#2)(2013-7#2)
pro-life##2##1##(1992-2#1)(1993-1#1)
pro-oncogenic##4##1##(2008-6#1)(2011-2#1)(2012-12#2)
pro-opiomelanocortin (POMC) gene##2##3##(1995-12#1)(2006-12#1)
pro-opiomelanocortin (POMC)##4##2##(1995-12#1)(1996-3#1)(2006-12#1)(2009-8#1)
pro-opiomelanocortin mRNA expression in##2##4##(2012-1#2)
pro-opiomelanocortin mRNA##5##2##(1991-9#1)(2012-1#4)
pro-opiomelanocortin##16##1##(1990-2#1)(1991-5#1)(1991-9#5)(1992-10#1)(1995-12#1)(1996-3#1)(2006-12#1)(2009-8#1)(2012-1#4)
pro-oxidant actions##2##2##(1995-1#2)
pro-oxidant activity##2##2##(1994-6#1)(1997-8#1)
pro-oxidant properties##4##2##(1992-4#1)(1997-8#1)(2008-5#1)(2010-8#1)
pro-oxidant##15##1##(1991-9#1)(1992-4#1)(1994-6#1)(1995-1#2)(1996-2#1)(1997-8#3)(2008-1#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-8#2)
pro-oxidant-induced##2##1##(1993-6#2)
pro-oxidants##5##1##(1991-9#4)(1997-6#1)
pro-oxidative properties##2##2##(2010-7#2)
pro-oxidative##3##1##(2010-7#2)(2011-2#1)
pro-peptide##6##1##(1990-5#4)(1993-3#1)(2012-12#1)
pro-region##2##1##(1992-8#1)(1993-12#1)
pro-rich inequity in##2##3##(2009-4#2)
pro-rich##3##1##(1991-9#1)(2009-4#2)
pro-sequence##2##1##(1994-12#2)
pro-tPA derivative##2##2##(1991-9#2)
pro-thrombotic##2##1##(2007-7#1)(2009-1#1)
pro-urokinase (pro-UK)##2##2##(1990-12#1)(2007-7#1)
pro-urokinase##6##1##(1990-12#2)(1990-8#3)(2007-7#1)
pro-vitamins##2##1##(2008-5#2)
proANF 1-98##2##2##(1990-12#2)
proANF 31-67##3##2##(1990-12#3)
proANF##6##1##(1990-12#6)
proC gene##3##2##(1994-2#3)
proC mutants##2##2##(1994-2#2)
proC##5##1##(1994-2#5)
proCCK##3##1##(1995-6#3)
proMMP-1 and##2##2##(1990-12#1)(1997-2#1)
proMMP-1##4##1##(1990-12#2)(1997-2#2)
proMMP-2##7##1##(1990-12#3)(1993-11#4)
proMMP-7##3##1##(1996-1#3)
proOmpA and membranes##2##3##(1993-9#2)
proOmpA##3##1##(1993-9#2)(1997-7#1)
proTNF##4##1##(1991-8#4)
proTRH contents##2##2##(1994-6#2)
proTRH##3##1##(1994-6#3)
proU##6##1##(1994-12#6)
proacrosin and##2##2##(1992-4#2)
proacrosin binding protein##3##3##(1992-4#3)
proacrosin gene##2##2##(1990-5#2)
proacrosin##14##1##(1990-5#6)(1992-4#7)(2006-5#1)
proacrosomal vesicles##2##2##(2012-2#2)
proactive LVs##2##2##(2008-11#2)
proactive approach##2##2##(2008-10#1)(2008-11#1)
proactive coping##4##2##(2010-3#4)
proactive in##3##2##(1995-12#1)(2004-3#1)(2013-8#1)
proactive patient-centered approach where treatment decisions are tailored to patients' individual patterns of chronic asthma control to prevent acute exacerbations##2##20##(2013-1#2)
proactive##43##1##(1991-12#1)(1991-3#1)(1992-2#1)(1994-2#3)(1995-12#2)(1996-1#2)(1996-3#1)(1997-8#1)(2004-3#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-4#1)(2008-10#1)(2008-11#6)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-3#5)(2010-8#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
proactively##11##1##(1991-12#1)(1992-1#1)(1993-1#1)(1996-12#1)(1996-2#1)(2008-9#1)(2010-10#1)(2013-1#4)
proactivity##3##1##(2007-12#3)
proalbumin and##2##2##(1992-12#2)
proalbumin associated with a second##2##5##(1993-2#2)
proalbumin convertase##2##2##(1992-12#1)(1993-2#1)
proalbumin##12##1##(1990-8#3)(1991-3#1)(1992-12#3)(1993-2#5)
proalpha-chains##2##1##(1996-8#2)
proangiogenic##6##1##(2008-7#1)(2009-12#1)(2009-3#1)(2011-2#2)(2013-1#1)
proanthocyanidin##5##1##(2006-12#3)(2007-1#1)(2007-6#1)
proanthocyanidins (100 mg/kg/day##2##3##(2011-2#2)
proanthocyanidins can##2##2##(2011-2#2)
proanthocyanidins##12##1##(2007-1#2)(2010-12#1)(2011-2#8)(2012-11#1)
proanthrocyanidin##3##1##(2011-1#3)
proapo A-I##3##2##(1990-8#3)
proapo A-I-converting activity##2##3##(1990-8#2)
proapo A-I-converting##4##2##(1990-8#4)
proapo A-I/apo A-I ratio in##2##5##(1990-8#2)
proapo A-I/apo A-I ratio##3##4##(1990-8#3)
proapo##10##1##(1990-8#10)
proapolipoprotein A-I##3##2##(1990-8#3)
proapoptotic function of##2##3##(2008-11#1)(2009-12#1)
proapoptotic function##3##2##(2008-11#2)(2009-12#1)
proapoptotic protein##3##2##(2010-12#1)(2012-1#2)
proapoptotic proteins##2##2##(2008-11#1)(2013-1#1)
proapoptotic##19##1##(2007-11#2)(2008-11#4)(2009-12#1)(2009-4#1)(2010-1#1)(2010-12#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
proarrhythmic##5##1##(1991-8#1)(1996-9#1)(2008-7#1)(2008-8#1)(2009-10#1)
proatherogenic##4##1##(2005-10#1)(2005-7#2)(2007-9#1)
probabilistic analyses##2##2##(2012-12#1)(2013-1#1)
probabilistic approach to##2##3##(2010-6#2)
probabilistic approach##6##2##(2008-2#1)(2010-6#2)(2013-1#2)(2013-7#1)
probabilistic description##2##2##(2008-7#2)
probabilistic fasteners with parabolic elements##2##5##(2005-10#2)
probabilistic framework for##2##3##(2008-7#1)(2009-12#1)
probabilistic framework##3##2##(2008-7#1)(2009-12#1)(2009-7#1)
probabilistic model##5##2##(2009-11#1)(2010-6#1)(2011-2#1)(2013-1#2)
probabilistic models of##2##3##(1997-8#1)(2008-2#1)
probabilistic neural network (PNN)##2##4##(2008-10#1)(2010-8#1)
probabilistic neural network##3##3##(2008-1#1)(2008-10#1)(2010-8#1)
probabilistic neural networks (PNNs)##2##4##(2008-10#1)(2010-8#1)
probabilistic neural networks##3##3##(2008-10#1)(2010-8#2)
probabilistic neural##6##2##(2008-1#1)(2008-10#2)(2010-8#3)
probabilistic risk##2##2##(2008-7#1)(2012-12#1)
probabilistic##74##1##(1990-7#1)(1990-9#1)(1991-6#1)(1997-8#1)(2005-10#2)(2005-11#1)(2006-10#1)(2006-7#1)(2007-7#1)(2008-1#4)(2008-10#3)(2008-2#4)(2008-3#1)(2008-6#1)(2008-7#7)(2008-9#1)(2009-11#4)(2009-12#5)(2009-7#1)(2010-12#1)(2010-2#1)(2010-6#4)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#1)(2012-1#2)(2012-12#4)(2012-2#2)(2013-1#8)(2013-7#2)(2013-8#1)
probabilistically##4##1##(2008-2#2)(2009-12#1)(2010-2#1)
probabilities and##10##2##(2008-5#1)(2008-8#4)(2008-9#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
probabilities are##9##2##(1992-9#1)(1994-12#2)(1996-7#1)(2007-9#1)(2008-2#1)(2008-8#3)
probabilities at##2##2##(1997-8#1)(2012-3#1)
probabilities based on the##2##4##(1992-9#1)(2012-3#1)
probabilities for##9##2##(1992-9#1)(1996-4#1)(2005-4#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-10#1)
probabilities is##2##2##(1997-2#1)(2008-8#1)
probabilities of death##2##3##(1995-2#1)(1995-4#1)
probabilities of survival##2##3##(1991-8#1)(2009-10#1)
probabilities of the##2##3##(1990-3#1)(2008-2#1)
probabilities of##35##2##(1990-3#1)(1991-4#2)(1991-8#1)(1993-9#2)(1994-6#1)(1995-2#1)(1995-4#1)(1995-6#1)(1997-6#1)(2004-11#1)(2005-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#2)(2009-7#1)(2010-6#1)(2010-8#1)(2012-2#1)(2012-3#1)
probabilities than##2##2##(1996-4#1)(2007-9#1)
probabilities that##4##2##(1993-9#1)(1997-6#1)(2005-8#1)(2008-10#1)
probabilities to##3##2##(1992-6#1)(2008-10#1)(2008-8#1)
probabilities were##3##2##(2009-10#1)(2009-5#1)(2012-12#1)
probabilities##133##1##(1990-1#1)(1990-3#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-4#2)(1991-8#1)(1992-6#2)(1992-9#3)(1993-9#3)(1994-11#1)(1994-12#2)(1994-6#1)(1995-2#2)(1995-4#1)(1995-6#3)(1996-1#1)(1996-2#1)(1996-4#3)(1996-7#2)(1997-2#2)(1997-6#3)(1997-8#1)(2004-11#1)(2005-4#1)(2005-8#2)(2006-12#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-10#9)(2008-12#3)(2008-2#4)(2008-3#2)(2008-5#1)(2008-7#4)(2008-8#17)(2008-9#4)(2009-10#5)(2009-12#4)(2009-5#1)(2009-7#1)(2010-1#2)(2010-2#1)(2010-6#3)(2010-8#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#7)(2013-1#6)
probabilities)##2##1##(1991-12#1)(2008-8#1)
probability and the##5##3##(2007-10#1)(2007-9#1)(2008-10#1)(2008-6#1)(2010-4#1)
probability and##14##2##(1992-6#1)(1993-4#1)(1994-5#1)(1994-7#1)(2007-10#1)(2007-9#2)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-4#1)(2010-8#1)
probability approach##2##2##(1990-3#1)(2012-7#1)
probability at##3##2##(1991-10#1)(2007-12#1)(2012-3#1)
probability both##2##2##(2008-7#1)(2011-1#1)
probability by##2##2##(2008-3#1)(2013-1#1)
probability can##2##2##(2008-10#1)(2012-2#1)
probability curves##2##2##(1993-4#1)(2007-4#1)
probability density for##2##3##(2007-12#1)(2013-7#1)
probability density function of the##4##5##(2008-2#2)(2008-3#2)
probability density function of##6##4##(2008-2#4)(2008-3#2)
probability density function##9##3##(2008-2#5)(2008-3#3)(2013-1#1)
probability density functions of##4##4##(2007-9#3)(2012-3#1)
probability density functions##9##3##(1994-5#1)(2007-9#3)(2008-10#2)(2008-3#2)(2012-3#1)
probability density##22##2##(1994-5#1)(2007-12#1)(2007-9#3)(2008-10#2)(2008-2#6)(2008-3#5)(2008-7#1)(2012-3#1)(2013-1#1)(2013-7#1)
probability discounting##4##2##(2008-11#4)
probability distribution for##2##3##(2007-12#1)(2009-4#1)
probability distribution of##3##3##(2007-12#1)(2008-6#1)(2012-1#1)
probability distribution##15##2##(2007-12#4)(2008-10#4)(2008-3#1)(2008-6#1)(2009-4#2)(2009-9#1)(2010-5#1)(2012-1#1)
probability distributions for##2##3##(2008-10#2)
probability distributions of##2##3##(2008-10#1)(2008-2#1)
probability distributions##11##2##(1993-9#1)(1994-11#1)(2005-11#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)
probability equal to##2##3##(1995-9#1)(2013-8#1)
probability estimates of##3##3##(2011-2#1)(2013-1#2)
probability estimates##4##2##(2011-2#2)(2013-1#2)
probability estimation##4##2##(2011-1#2)(2013-1#2)
probability for the##2##3##(1991-2#1)(2008-3#1)
probability for##8##2##(1991-2#1)(2007-11#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)
probability from##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
probability in##3##2##(1994-10#1)(2011-2#2)
probability is##8##2##(1994-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-12#1)
probability model##5##2##(1993-9#1)(2008-10#2)(2008-11#1)(2008-8#1)
probability models##6##2##(2008-2#1)(2008-8#2)(2010-10#3)
probability of 0##2##3##(2007-12#1)(2009-4#1)
probability of ASD##2##3##(2012-3#2)
probability of PE##3##3##(2010-8#3)
probability of a##20##3##(1990-6#1)(1993-8#1)(1995-4#2)(1995-8#1)(1996-3#1)(2004-12#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-2#1)(2012-3#1)(2013-1#1)
probability of achieving##3##3##(2005-5#1)(2008-10#1)(2012-3#1)
probability of an##5##3##(1995-12#1)(2007-10#1)(2007-12#1)(2008-8#1)(2012-3#1)
probability of being diagnosed##2##4##(1990-4#1)(1995-8#1)
probability of being##11##3##(1990-4#1)(1995-8#1)(1996-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-2#1)(2010-8#1)(2012-3#1)
probability of channel opening##3##4##(1990-10#1)(1994-3#1)(1997-7#1)
probability of conducting HIV test##2##5##(2011-1#2)
probability of correct##2##3##(2009-9#1)(2010-5#1)
probability of death##4##3##(1995-2#1)(2004-11#1)(2007-8#1)(2008-11#1)
probability of detecting##5##3##(1994-2#1)(1995-8#1)(1996-5#1)(2008-4#1)(2012-12#1)
probability of detection##2##3##(2008-10#2)
probability of developing##9##3##(1991-2#1)(1992-9#2)(1993-5#1)(2006-11#1)(2008-4#1)(2009-2#1)(2012-3#1)(2013-8#1)
probability of divorce##2##3##(2011-2#2)
probability of each##4##3##(2008-2#1)(2008-7#1)(2009-10#1)(2010-11#1)
probability of entry##2##3##(2008-10#2)
probability of having a##2##4##(2006-8#1)(2009-6#1)
probability of having##6##3##(1990-5#1)(2005-7#1)(2006-8#1)(2007-2#1)(2009-6#1)(2012-12#1)
probability of infection##2##3##(2007-9#1)(2008-10#1)
probability of limb salvage##2##4##(2011-3#2)
probability of misclassification##2##3##(1992-6#1)(2012-1#1)
probability of nodal malignancy##2##4##(2007-3#2)
probability of pregnancy##2##3##(1992-7#1)(2006-5#1)
probability of prolonged##2##3##(1993-5#1)(1997-6#1)
probability of quitting##2##3##(1991-12#1)(2007-11#1)
probability of reaching##3##3##(2005-8#1)(2008-11#1)(2011-2#1)
probability of remaining##2##3##(2006-2#1)(2011-2#1)
probability of success##5##3##(1991-9#1)(2006-9#1)(2008-11#1)(2010-8#1)(2013-1#1)
probability of survival##6##3##(1992-2#1)(2006-10#1)(2006-4#1)(2007-8#1)(2008-7#1)(2013-1#1)
probability of the##11##3##(1994-2#1)(1994-3#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2011-1#1)
probability of these##3##3##(1994-11#1)(1995-8#1)(2006-9#1)
probability of##312##2##(1990-10#1)(1990-11#1)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-9#2)(1992-11#1)(1992-2#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-1#2)(1993-12#1)(1993-5#2)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-4#1)(1994-6#1)(1995-1#1)(1995-12#5)(1995-2#3)(1995-3#1)(1995-4#2)(1995-5#1)(1995-8#5)(1995-9#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#4)(1996-7#1)(1997-3#2)(1997-4#3)(1997-6#2)(1997-7#1)(1997-8#2)(2004-11#2)(2004-12#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#5)(2007-11#3)(2007-12#4)(2007-2#4)(2007-3#4)(2007-4#5)(2007-5#2)(2007-8#3)(2007-9#4)(2008-1#2)(2008-10#28)(2008-11#4)(2008-12#4)(2008-2#7)(2008-3#6)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#13)(2008-8#15)(2008-9#7)(2009-10#4)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#4)(2009-9#3)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#6)(2011-1#6)(2011-2#11)(2011-3#4)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#11)(2013-1#8)(2013-7#1)(2013-8#2)
probability p of type I error##2##6##(2008-10#2)
probability ratio test##3##3##(2008-10#2)(2012-2#1)
probability ratio##4##2##(1996-12#1)(2008-10#2)(2012-2#1)
probability sample of##10##3##(1996-2#1)(2005-10#1)(2006-11#1)(2007-1#1)(2008-12#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
probability sample##12##2##(1996-2#1)(1997-2#1)(2005-10#1)(2006-11#1)(2007-1#1)(2008-12#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-12#2)(2013-1#1)
probability sampling##2##2##(2007-3#1)(2010-9#1)
probability that a particular##2##4##(2007-8#1)(2008-7#1)
probability that a##11##3##(1993-9#1)(1994-3#1)(1997-4#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2013-7#1)(2013-8#2)
probability that the##10##3##(1990-5#1)(1994-11#1)(1995-12#1)(1997-2#1)(1997-8#1)(2006-10#3)(2007-2#1)(2008-9#1)
probability that these##2##3##(1993-12#1)(2011-1#1)
probability that##49##2##(1990-2#1)(1990-5#1)(1991-12#2)(1993-12#1)(1993-9#1)(1994-11#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-6#4)(1995-8#1)(1997-2#1)(1997-4#1)(1997-8#1)(1997-9#1)(2005-8#1)(2006-10#3)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#2)(2008-9#2)(2011-1#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
probability theory##4##2##(2008-2#3)(2008-3#1)
probability to the##2##3##(1990-11#1)(2008-3#1)
probability to##10##2##(1990-11#1)(1990-12#1)(1991-4#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#2)
probability was##2##2##(2008-10#1)(2013-8#1)
probability with##2##2##(2010-12#1)(2011-2#1)
probability##665##1##(1990-10#2)(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#4)(1990-5#4)(1990-6#2)(1990-7#2)(1990-8#1)(1991-10#1)(1991-12#6)(1991-2#2)(1991-4#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-2#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#3)(1993-1#2)(1993-11#1)(1993-12#3)(1993-4#3)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#5)(1994-10#3)(1994-11#4)(1994-12#2)(1994-2#2)(1994-3#4)(1994-4#1)(1994-5#4)(1994-6#1)(1994-7#1)(1995-1#3)(1995-11#1)(1995-12#7)(1995-2#7)(1995-3#1)(1995-4#2)(1995-5#1)(1995-6#7)(1995-8#7)(1995-9#3)(1996-1#4)(1996-12#3)(1996-2#3)(1996-3#1)(1996-4#4)(1996-5#1)(1996-6#6)(1996-7#1)(1997-2#2)(1997-3#3)(1997-4#4)(1997-6#2)(1997-7#1)(1997-8#5)(1997-9#1)(2004-11#3)(2004-12#1)(2005-10#3)(2005-11#2)(2005-5#1)(2005-7#1)(2005-8#2)(2006-10#5)(2006-11#2)(2006-2#1)(2006-4#1)(2006-5#2)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#8)(2007-11#7)(2007-12#10)(2007-2#5)(2007-3#5)(2007-4#6)(2007-5#3)(2007-7#1)(2007-8#8)(2007-9#13)(2008-1#4)(2008-10#63)(2008-11#14)(2008-12#5)(2008-2#31)(2008-3#22)(2008-4#6)(2008-5#4)(2008-6#7)(2008-7#24)(2008-8#29)(2008-9#15)(2009-10#5)(2009-11#2)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#5)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#7)(2009-9#6)(2010-10#5)(2010-11#1)(2010-12#4)(2010-2#4)(2010-3#1)(2010-4#4)(2010-5#3)(2010-8#10)(2010-9#2)(2011-1#12)(2011-2#23)(2011-3#5)(2012-1#4)(2012-12#7)(2012-2#8)(2012-3#17)(2012-7#1)(2013-1#19)(2013-7#4)(2013-8#8)
probable Alzheimer's disease##3##3##(1994-5#1)(2008-7#1)(2012-2#1)
probable Alzheimer's##4##2##(1994-5#1)(1995-11#1)(2008-7#1)(2012-2#1)
probable cases and##2##3##(2005-10#1)(2006-2#1)
probable cases##7##2##(2005-10#1)(2006-10#2)(2006-2#2)(2007-7#1)(2008-5#1)
probable cause of##4##3##(1991-5#1)(2006-10#1)(2008-10#1)(2009-11#1)
probable cause##7##2##(1991-5#1)(1995-12#1)(2006-10#1)(2007-9#1)(2008-10#1)(2009-11#1)(2010-7#1)
probable causes of##2##3##(2008-2#1)(2012-2#1)
probable chronic migraine and probable medication-overuse headache##3##7##(2006-12#3)
probable diagnosis of##4##3##(2012-2#1)(2013-1#2)(2013-8#1)
probable effects of microwave exposure##2##5##(2008-12#2)
probable effects of##3##3##(2008-12#2)(2013-1#1)
probable effects##4##2##(2006-9#1)(2008-12#2)(2013-1#1)
probable explanation##2##2##(1991-12#1)(1992-5#1)
probable involvement of##2##3##(2005-11#1)(2008-11#1)
probable ligands##2##2##(1992-4#1)(1993-11#1)
probable location of##2##3##(1992-9#1)(2011-12#1)
probable mode of##2##3##(2007-8#1)(2008-6#1)
probable number (MPN)##3##3##(2006-3#1)(2007-12#1)(2008-10#1)
probable number##5##2##(2006-3#1)(2007-12#1)(2008-10#2)(2012-1#1)
probable or possible##3##3##(1996-11#1)(2008-4#1)(2008-7#1)
probable or##4##2##(1996-11#1)(2008-4#1)(2008-7#1)(2013-8#1)
probable role##2##2##(1992-6#1)(2008-7#1)
probable success##2##2##(1995-8#1)(1997-6#1)
probable superinfection##2##2##(1991-4#2)
probable that the##4##3##(2004-4#1)(2006-10#1)(2007-2#1)(2009-2#1)
probable that these##2##3##(1997-2#1)(2008-9#1)
probable that##20##2##(1991-1#1)(1992-3#1)(1993-9#1)(1995-12#1)(1995-8#1)(1997-2#1)(1997-8#1)(2004-12#1)(2004-4#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-12#1)(2007-2#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-2#1)(2012-1#1)(2012-12#1)
probable##210##1##(1990-3#1)(1990-5#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-4#3)(1991-5#1)(1991-7#1)(1992-11#1)(1992-3#1)(1992-4#3)(1992-5#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-7#1)(1995-1#1)(1995-11#2)(1995-12#3)(1995-3#3)(1995-6#1)(1995-8#2)(1996-11#2)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#1)(2004-12#1)(2004-4#1)(2005-10#2)(2005-11#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#8)(2006-2#4)(2006-3#1)(2006-6#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#14)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#2)(2009-6#1)(2010-11#1)(2010-2#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#7)(2012-12#3)(2012-2#7)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#10)
probably a consequence of##4##4##(1995-3#1)(1997-5#1)(2005-9#1)(2006-12#1)
probably a major##5##3##(2005-8#1)(2008-10#2)(2008-5#1)(2012-12#1)
probably a product of##2##4##(1991-12#1)(1992-11#1)
probably a result of##5##4##(1996-4#1)(1996-9#1)(2006-8#2)(2009-11#1)
probably a##41##2##(1990-2#1)(1990-4#1)(1990-6#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-7#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-5#1)(1997-6#1)(2005-11#1)(2005-8#1)(2005-9#2)(2006-12#1)(2006-4#1)(2006-8#2)(2007-11#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)(2011-2#1)(2012-12#1)
probably accounts for the##4##4##(1991-8#1)(1993-4#1)(1993-6#1)(2006-10#1)
probably acquired##2##2##(1993-8#1)(2007-8#1)
probably acting##2##2##(1991-5#1)(1993-11#1)
probably acts through##2##3##(1990-5#1)(1997-3#1)
probably acts##6##2##(1990-5#1)(1990-7#1)(1995-11#1)(1997-3#1)(2008-7#1)(2013-8#1)
probably after##2##2##(2008-5#1)(2008-6#1)
probably allelic##3##2##(2008-10#2)(2013-7#1)
probably also##19##2##(1990-12#1)(1991-11#1)(1991-6#1)(1992-6#1)(1993-11#1)(1993-6#2)(1995-2#1)(1996-1#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-10#1)(2011-2#2)
probably an important##2##3##(2008-10#1)(2009-7#1)
probably an##14##2##(1991-5#1)(1992-4#2)(1994-2#1)(1994-8#1)(1995-2#1)(1997-5#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-7#1)(2011-2#1)
probably analogous to the##2##4##(1990-11#1)(2008-5#1)
probably are##3##2##(1995-12#1)(1997-2#1)(2009-8#1)
probably arose##2##2##(1995-6#1)(2009-12#1)
probably as a consequence of##4##5##(1990-2#1)(1991-2#1)(1994-9#1)(2008-4#1)
probably as a result of##8##5##(1991-4#1)(1997-5#1)(1997-7#1)(2007-2#1)(2008-10#3)(2012-5#1)
probably as a##14##3##(1990-2#1)(1991-2#1)(1991-4#1)(1994-9#1)(1997-5#1)(1997-7#1)(2007-2#1)(2008-10#3)(2008-4#1)(2008-5#1)(2009-2#1)(2012-5#1)
probably as##19##2##(1990-2#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-9#1)(1994-9#1)(1995-6#1)(1997-5#1)(1997-7#1)(2007-2#1)(2008-10#3)(2008-4#1)(2008-5#2)(2009-2#1)(2012-5#1)
probably associated with##6##3##(1994-12#1)(2008-3#1)(2008-8#1)(2009-7#1)(2010-12#1)(2011-2#1)
probably associated##7##2##(1994-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-12#1)(2011-2#1)
probably at the##3##3##(1990-6#1)(1992-11#1)(1997-2#1)
probably at##4##2##(1990-6#1)(1992-11#1)(1997-2#1)(2006-10#1)
probably attributable to##2##3##(1997-2#1)(2011-2#1)
probably be due to##2##4##(1996-7#1)(2013-1#1)
probably be explained by##2##4##(1996-12#1)(2006-10#1)
probably be##34##2##(1990-10#2)(1990-9#1)(1991-11#1)(1991-7#1)(1992-2#1)(1992-4#1)(1993-10#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-4#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-1#1)(2012-2#1)(2013-1#1)
probably because it is##2##4##(1994-2#1)(1994-8#1)
probably because it##3##3##(1994-2#1)(1994-8#1)(2007-5#1)
probably because of a##2##4##(2007-11#1)(2008-5#1)
probably because of intensive##2##4##(2008-9#1)(2012-12#1)
probably because of its##2##4##(1991-6#1)(2008-5#1)
probably because of the presence of##2##6##(2006-8#1)(2010-4#1)
probably because of the##6##4##(1990-7#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-5#1)(2010-4#1)
probably because of##24##3##(1990-7#1)(1991-6#1)(1994-3#2)(1996-3#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#5)(2008-9#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-7#1)
probably because the##3##3##(2005-11#1)(2008-8#1)(2012-1#1)
probably because their##2##3##(1996-11#1)(2008-11#1)
probably because they are##3##4##(1990-3#1)(2007-5#1)(2010-6#1)
probably because##44##2##(1990-3#1)(1990-7#1)(1991-12#1)(1991-6#1)(1991-9#1)(1993-10#1)(1994-2#1)(1994-3#2)(1994-8#1)(1996-11#1)(1996-3#1)(2005-10#1)(2005-11#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#3)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#6)(2008-8#1)(2008-9#1)(2009-10#1)(2010-4#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
probably been##4##2##(1993-10#1)(1995-12#1)(1996-12#1)(2010-1#1)
probably by a##2##3##(1990-7#1)(1992-1#1)
probably by the##3##3##(2008-7#2)(2012-12#1)
probably by##25##2##(1990-7#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-1#1)(1993-3#1)(1995-5#2)(1995-7#1)(1996-8#1)(1997-7#1)(2006-10#1)(2007-1#1)(2007-11#4)(2008-10#3)(2008-7#2)(2009-10#1)(2011-2#1)(2012-12#1)
probably can be##2##3##(1997-6#1)(2008-10#1)
probably caused by a##2##4##(1994-3#1)(2006-8#1)
probably caused by changes in##2##5##(1992-8#1)(1994-8#1)
probably caused by the##4##4##(1991-10#1)(1995-12#1)(1997-3#1)(2006-11#1)
probably caused by##20##3##(1990-5#1)(1991-10#1)(1991-6#1)(1991-7#1)(1992-8#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1997-3#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-6#1)(2008-7#1)
probably caused##21##2##(1990-5#1)(1991-10#1)(1991-6#1)(1991-7#1)(1992-8#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1997-3#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-6#1)(2008-7#1)
probably change##2##2##(2005-11#1)(2006-10#1)
probably complex##2##2##(1994-5#1)(2004-12#1)
probably confers##3##2##(1990-9#1)(1994-9#1)(2010-8#1)
probably connected##2##2##(2008-5#1)(2012-3#1)
probably consist of##2##3##(1990-4#1)(1995-6#1)
probably constitutes##2##2##(1991-8#1)(1992-3#1)
probably contains##2##2##(1991-12#1)(1991-2#1)
probably continue to##2##3##(1990-12#2)
probably continue##4##2##(1990-12#2)(1995-2#1)(2011-2#1)
probably contribute to the##3##4##(2008-10#1)(2008-11#1)(2012-12#1)
probably contribute to##4##3##(2008-10#1)(2008-11#1)(2012-1#1)(2012-12#1)
probably contribute##5##2##(1996-12#1)(2008-10#1)(2008-11#1)(2012-1#1)(2012-12#1)
probably contributed to the##4##4##(1992-8#1)(2008-5#1)(2010-2#1)(2012-3#1)
probably contributed to##5##3##(1992-8#1)(2008-5#1)(2010-2#1)(2012-3#1)(2013-1#1)
probably contributed##6##2##(1992-6#1)(1992-8#1)(2008-5#1)(2010-2#1)(2012-3#1)(2013-1#1)
probably contributes to the##2##4##(1996-3#1)(1996-8#1)
probably contributes to##3##3##(1996-3#1)(1996-8#1)(2007-9#1)
probably contributes##4##2##(1996-3#1)(1996-8#1)(1997-4#1)(2007-9#1)
probably contributing to the##2##4##(2008-11#1)(2009-6#1)
probably dependent##2##2##(1992-9#1)(1995-12#1)
probably depends on##2##3##(1991-1#1)(2008-9#1)
probably derived from##2##3##(2008-10#1)(2012-11#1)
probably determined by##3##3##(1995-8#1)(1997-7#1)(2005-1#1)
probably did not##2##3##(1990-7#1)(2008-10#1)
probably differs##2##2##(1992-12#1)(2011-2#1)
probably do not##6##3##(1990-10#1)(1994-6#1)(1995-12#1)(1997-3#1)(1997-8#1)(2008-10#1)
probably does not##4##3##(1995-2#1)(1996-5#1)(2006-8#1)(2011-3#1)
probably due to a##11##4##(1990-11#1)(1991-11#1)(1991-3#1)(1991-4#1)(1992-11#1)(1992-6#1)(1994-5#1)(2005-11#2)(2008-5#1)(2012-12#1)
probably due to enhanced##2##4##(1992-8#1)(2012-5#1)
probably due to increased##4##4##(1990-6#1)(1997-2#1)(2008-4#1)(2009-5#1)
probably due to interactions##2##4##(1996-1#1)(2008-10#1)
probably due to its##2##4##(2008-10#1)(2010-4#1)
probably due to less##2##4##(2006-12#1)(2008-10#1)
probably due to limitation of##2##5##(1991-9#1)(2009-4#1)
probably due to nutrient##2##4##(2007-3#1)(2007-5#1)
probably due to poor##2##4##(2007-2#1)(2007-7#1)
probably due to some##2##4##(1996-6#1)(2012-2#1)
probably due to the fact that##2##6##(1993-9#1)(2005-11#1)
probably due to the formation of##3##6##(1994-11#1)(2008-10#2)
probably due to the presence of##3##6##(1991-11#1)(1993-11#1)(2005-11#1)
probably due to the##43##4##(1990-10#1)(1990-7#1)(1991-10#1)(1991-11#1)(1993-1#1)(1993-11#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-6#1)(1995-5#1)(1995-9#1)(1996-1#1)(1997-4#1)(1997-8#1)(2005-11#3)(2007-10#1)(2007-11#2)(2007-2#1)(2008-10#5)(2008-11#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
probably due to their##4##4##(1993-10#1)(1994-6#1)(1997-2#1)(2006-8#1)
probably due to##113##3##(1990-10#1)(1990-11#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-4#1)(1994-5#1)(1994-6#2)(1995-5#1)(1995-9#1)(1996-1#2)(1996-2#2)(1996-6#2)(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#1)(2005-11#5)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-2#2)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-8#1)
probably due##114##2##(1990-10#1)(1990-11#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-4#1)(1994-5#1)(1994-6#2)(1995-5#1)(1995-9#1)(1996-1#2)(1996-2#2)(1996-6#2)(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#1)(2005-11#5)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-2#2)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-8#1)
probably even##4##2##(2006-7#1)(2008-10#1)(2010-8#1)(2013-1#1)
probably evolved##3##2##(1995-6#1)(2006-5#1)(2008-10#1)
probably exist##3##2##(1993-3#1)(1995-1#1)(1996-5#1)
probably exists##2##2##(1995-4#1)(2008-10#1)
probably explain##2##2##(1996-3#1)(2007-12#1)
probably facilitates##2##2##(1995-1#1)(2011-2#1)
probably first##2##2##(2007-10#1)(2007-7#1)
probably form##2##2##(1991-2#1)(2008-10#1)
probably formed##4##2##(1990-5#1)(1991-3#1)(1994-3#1)(2011-1#1)
probably forms##2##2##(1993-11#1)(2007-7#1)
probably from##3##2##(1996-12#1)(2005-7#1)(2013-1#1)
probably functions##3##2##(2005-7#1)(2007-12#1)(2008-10#1)
probably generated##2##2##(1991-11#1)(1995-3#1)
probably had a##2##3##(1995-4#1)(2008-10#1)
probably had##5##2##(1995-4#1)(2006-10#1)(2008-10#3)
probably has a##2##3##(1991-12#1)(1996-3#1)
probably has not##2##3##(2005-1#1)(2008-10#1)
probably has##7##2##(1991-12#1)(1992-9#1)(1996-3#1)(1996-6#1)(2005-1#1)(2008-10#1)(2008-9#1)
probably have a##2##3##(1993-2#1)(2008-4#1)
probably have##10##2##(1991-10#1)(1992-5#1)(1992-6#1)(1993-2#1)(1994-6#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-4#1)
probably having##2##2##(1992-12#1)(2008-10#1)
probably highly##2##2##(1991-2#1)(1997-4#1)
probably hormonal##2##2##(1992-2#1)(2007-6#1)
probably identical to the antiestrogen binding site##2##7##(1990-2#2)
probably identical to##4##3##(1990-2#2)(1991-10#2)
probably identical##5##2##(1990-2#2)(1991-10#2)(1994-2#1)
probably in combination with##2##4##(2006-10#1)(2010-12#1)
probably in response to##2##4##(1992-1#1)(1992-9#1)
probably in the##2##3##(1991-2#1)(1993-2#1)
probably in##16##2##(1990-5#1)(1991-2#1)(1992-1#1)(1992-9#1)(1993-2#1)(2004-11#1)(2006-10#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-1#1)(2010-12#1)
probably include##2##2##(1991-12#1)(2012-12#1)
probably increase##4##2##(1992-6#1)(1995-5#1)(2007-11#1)(2009-10#1)
probably indicating##3##2##(1990-2#1)(2008-1#1)(2008-11#1)
probably induced by##3##3##(1990-2#1)(1993-10#1)(2009-3#1)
probably induced##4##2##(1990-2#1)(1993-10#1)(2008-10#1)(2009-3#1)
probably initiated by##2##3##(1990-2#1)(1993-11#1)
probably initiated##3##2##(1990-2#1)(1991-1#1)(1993-11#1)
probably interact in##2##3##(1991-10#1)(1992-10#1)
probably interact with##2##3##(1990-8#1)(1995-5#1)
probably interact##4##2##(1990-8#1)(1991-10#1)(1992-10#1)(1995-5#1)
probably involve##3##2##(1993-10#1)(2006-10#1)(2011-2#1)
probably involved in the##7##4##(1996-1#1)(1997-8#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-12#1)
probably involved in##14##3##(1990-5#1)(1991-9#1)(1992-9#1)(1996-1#1)(1996-8#1)(1997-8#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-8#1)(2011-12#1)
probably involved##17##2##(1990-5#1)(1991-9#1)(1992-4#1)(1992-9#1)(1995-6#1)(1996-1#1)(1996-8#1)(1997-8#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-8#1)(2011-12#1)
probably involves the##3##3##(1990-9#1)(1993-3#1)(2008-3#1)
probably involves##9##2##(1990-9#1)(1991-12#1)(1991-2#1)(1993-3#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-5#1)
probably involving##4##2##(1991-11#1)(1993-6#1)(1997-4#1)(2008-10#1)
probably is no##2##3##(1995-8#1)(2008-8#1)
probably is not##2##3##(2007-8#1)(2008-8#1)
probably is##11##2##(1993-11#1)(1995-3#1)(1995-8#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#2)
probably largely##2##2##(1991-12#1)(2008-7#1)
probably lead to##3##3##(1992-5#1)(1994-3#1)(2008-11#1)
probably lead##4##2##(1992-5#1)(1994-3#1)(1996-3#1)(2008-11#1)
probably lies in##2##3##(2005-12#1)(2007-6#1)
probably linked to##2##3##(1996-8#1)(2008-10#1)
probably located##2##2##(1992-11#1)(1992-6#1)
probably make##2##2##(1992-3#1)(2010-8#1)
probably mediated by##3##3##(1994-11#1)(1996-2#1)(1997-2#1)
probably mediated##5##2##(1994-11#1)(1996-2#1)(1997-2#1)(2008-10#1)(2013-1#1)
probably more##3##2##(2007-9#1)(2008-2#1)(2009-11#1)
probably most##2##2##(1993-6#1)(2012-2#1)
probably need more##2##3##(2011-2#1)(2012-2#1)
probably need##3##2##(2008-6#1)(2011-2#1)(2012-2#1)
probably no##3##2##(1990-4#1)(1994-8#1)(1997-1#1)
probably not be##2##3##(1991-11#1)(2008-8#1)
probably not##23##2##(1990-12#1)(1990-2#1)(1991-11#1)(1992-12#2)(1992-8#1)(1993-7#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-4#2)(1995-6#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#3)(2008-8#1)(2010-3#1)
probably occurred as the result of##2##6##(2008-10#1)(2008-2#1)
probably occurred##3##2##(2006-10#1)(2008-10#1)(2008-2#1)
probably occurs##3##2##(1992-10#1)(1993-9#1)(2007-8#1)
probably of##5##2##(1990-3#1)(1994-11#1)(1996-9#1)(1997-4#1)(2008-11#1)
probably on the##3##3##(1991-9#1)(1994-12#1)(2008-5#1)
probably on##4##2##(1991-9#1)(1994-12#1)(2008-5#1)(2010-12#1)
probably one##4##2##(2007-3#1)(2008-7#1)(2008-9#1)(2013-1#1)
probably originated from##2##3##(1993-3#1)(2005-11#1)
probably originates from the##2##4##(1992-7#1)(2008-10#1)
probably play a key role in##2##6##(1993-9#1)(2006-2#1)
probably play a role in##2##5##(2005-8#1)(2010-12#1)
probably play a role##3##4##(2005-8#1)(2008-7#1)(2010-12#1)
probably play a##8##3##(1993-9#1)(1994-2#1)(1995-6#1)(2005-8#1)(2006-2#1)(2008-12#1)(2008-7#1)(2010-12#1)
probably play##10##2##(1993-9#1)(1994-2#1)(1995-2#1)(1995-6#1)(2005-10#1)(2005-8#1)(2006-2#1)(2008-12#1)(2008-7#1)(2010-12#1)
probably plays an important role in##3##6##(1992-9#1)(1994-3#1)(1995-6#1)
probably plays an important##4##4##(1992-9#1)(1994-3#1)(1995-6#1)(1996-3#1)
probably plays##5##2##(1992-9#1)(1994-3#1)(1995-6#1)(1996-3#1)(2005-10#1)
probably present in##2##3##(1993-3#1)(1995-11#1)
probably prevents##2##2##(1991-6#1)(1997-5#1)
probably produce##2##2##(2007-12#1)(2010-5#1)
probably reduces the##2##3##(1994-9#1)(1996-1#1)
probably reflect##3##2##(2004-11#1)(2008-4#1)(2008-8#1)
probably reflected##3##2##(1996-11#1)(2008-10#1)(2008-8#1)
probably reflects the##6##3##(1991-11#1)(1991-2#1)(1992-6#1)(1996-3#1)(1996-4#1)(1997-8#1)
probably reflects##10##2##(1991-11#1)(1991-2#1)(1991-9#1)(1992-6#1)(1993-5#1)(1994-2#1)(1996-3#1)(1996-4#1)(1997-7#1)(1997-8#1)
probably regulated by##2##3##(1991-10#1)(2012-1#1)
probably related to the##9##4##(1991-11#1)(1997-2#1)(2006-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-2#1)(2011-2#1)
probably related to##27##3##(1991-11#1)(1992-11#1)(1992-8#1)(1993-6#1)(1994-3#1)(1996-2#1)(1996-5#1)(1997-2#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)
probably related##29##2##(1991-11#1)(1992-11#1)(1992-8#1)(1993-6#1)(1994-3#1)(1996-2#1)(1996-5#1)(1997-2#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#1)
probably remain##2##2##(2009-1#1)(2011-2#1)
probably represent a##2##3##(1990-6#1)(2012-2#1)
probably represent the##3##3##(1990-2#1)(2007-11#1)(2008-7#1)
probably represent##7##2##(1990-2#1)(1990-6#1)(1992-6#1)(1995-3#1)(2007-11#1)(2008-7#1)(2012-2#1)
probably representative##2##2##(1991-11#1)(1995-2#1)
probably representing##2##2##(1993-3#1)(1997-4#1)
probably represents the##2##3##(1993-7#1)(1995-4#1)
probably represents##3##2##(1993-7#1)(1995-4#1)(2007-8#1)
probably responsible for the displacement of##2##6##(1997-1#1)(2008-10#1)
probably responsible for the##9##4##(1994-12#1)(1995-9#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-10#1)(2007-12#1)(2008-10#1)(2011-2#1)
probably responsible for##12##3##(1994-12#1)(1995-9#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-10#1)(2006-1#1)(2007-12#1)(2008-10#2)(2010-11#1)(2011-2#1)
probably resulted from##3##3##(1996-10#1)(2007-11#1)(2008-10#1)
probably resulted in##2##3##(2007-5#1)(2012-3#1)
probably resulted##5##2##(1996-10#1)(2007-11#1)(2007-5#1)(2008-10#1)(2012-3#1)
probably resulting from##2##3##(2006-10#1)(2007-8#1)
probably resulting in##4##3##(1991-12#1)(1994-11#1)(2008-10#1)(2008-11#1)
probably resulting##6##2##(1991-12#1)(1994-11#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)
probably results from the##2##4##(2007-12#1)(2013-8#1)
probably results from##5##3##(1997-4#1)(2007-12#1)(2010-6#1)(2011-2#1)(2013-8#1)
probably results##6##2##(1997-4#1)(2007-12#1)(2008-2#1)(2010-6#1)(2011-2#1)(2013-8#1)
probably secondary to##3##3##(1995-1#1)(2006-10#1)(2010-2#1)
probably slightly##2##2##(2008-1#1)(2008-5#1)
probably takes place##3##3##(1992-1#1)(2005-11#2)
probably that##2##2##(1994-6#1)(2008-10#1)
probably the best##4##3##(1996-2#1)(2006-10#1)(2008-12#1)(2008-2#1)
probably the first##8##3##(1996-5#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-2#1)(2008-5#1)(2009-5#1)(2013-8#1)
probably the greatest##2##3##(2008-10#1)(2010-12#1)
probably the main##2##3##(1994-6#1)(2007-3#1)
probably the major##2##3##(1995-12#1)(2009-4#1)
probably the most important##4##4##(1993-11#1)(2006-11#1)(2007-11#1)(2008-1#1)
probably the most widely used method##2##6##(2006-12#1)(2008-4#1)
probably the most widely used##3##5##(2006-12#1)(2008-4#1)(2008-9#1)
probably the most##19##3##(1993-11#1)(2005-1#1)(2006-11#1)(2006-12#1)(2006-5#1)(2007-11#2)(2007-4#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-2#1)(2011-2#1)(2013-1#1)
probably the only##2##3##(1992-8#1)(2009-10#1)
probably the reason for##3##4##(2008-3#1)(2008-5#1)(2009-8#1)
probably the result of##5##4##(1990-11#1)(1997-7#1)(2007-8#1)(2008-1#1)(2012-3#1)
probably the##75##2##(1990-11#1)(1991-12#2)(1992-8#3)(1993-11#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-7#1)(2005-1#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
probably through an##2##3##(2008-6#1)(2013-1#1)
probably through the##2##3##(1991-9#1)(1995-6#1)
probably through##16##2##(1990-3#1)(1991-5#1)(1991-9#1)(1993-11#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-6#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2013-1#1)
probably to##7##2##(1997-6#1)(2006-10#1)(2006-2#1)(2008-5#1)(2008-8#1)(2009-3#1)(2011-2#1)
probably too##2##2##(1997-8#1)(2008-9#1)
probably uncommon##2##2##(1990-12#1)(2007-2#1)
probably underdiagnosed##2##2##(1991-9#1)(2010-6#1)
probably useful in##2##3##(2007-11#2)
probably via P2Y(1) receptor stimulation##2##5##(2008-4#2)
probably via the A1 type of P1 receptor##2##8##(1994-11#1)(1994-6#1)
probably via##5##2##(1994-11#1)(1994-6#1)(2006-2#1)(2008-4#2)
probably was not##2##3##(2005-11#1)(2008-6#1)
probably was##6##2##(1991-6#1)(2005-11#1)(2008-10#2)(2008-6#1)(2012-1#1)
probably will be##3##3##(1991-11#1)(1992-9#1)(2006-7#1)
probably will##4##2##(1991-11#1)(1992-9#1)(1996-2#1)(2006-7#1)
probably with a##2##3##(1995-3#1)(2008-2#1)
probably with##6##2##(1995-3#1)(2007-12#1)(2008-2#1)(2010-12#1)(2011-2#2)
probably would##2##2##(1995-12#1)(2008-10#1)
probably##1182##1##(1990-10#7)(1990-11#5)(1990-12#9)(1990-2#10)(1990-3#3)(1990-4#4)(1990-5#9)(1990-6#5)(1990-7#6)(1990-8#2)(1990-9#6)(1991-1#2)(1991-10#8)(1991-11#13)(1991-12#15)(1991-2#11)(1991-3#3)(1991-4#2)(1991-5#7)(1991-6#6)(1991-7#4)(1991-8#3)(1991-9#9)(1992-1#3)(1992-10#4)(1992-11#5)(1992-12#5)(1992-2#3)(1992-3#4)(1992-4#5)(1992-5#3)(1992-6#10)(1992-7#2)(1992-8#8)(1992-9#10)(1993-1#1)(1993-10#6)(1993-11#9)(1993-12#2)(1993-2#3)(1993-3#6)(1993-4#2)(1993-5#2)(1993-6#8)(1993-7#4)(1993-8#4)(1993-9#8)(1994-11#9)(1994-12#8)(1994-2#9)(1994-3#12)(1994-4#1)(1994-5#6)(1994-6#9)(1994-7#1)(1994-8#7)(1994-9#7)(1995-1#5)(1995-10#1)(1995-11#8)(1995-12#10)(1995-2#6)(1995-3#7)(1995-4#5)(1995-5#8)(1995-6#12)(1995-7#1)(1995-8#2)(1995-9#3)(1996-1#8)(1996-10#1)(1996-11#3)(1996-12#8)(1996-2#9)(1996-3#10)(1996-4#6)(1996-5#10)(1996-6#4)(1996-7#2)(1996-8#6)(1996-9#6)(1997-1#6)(1997-2#9)(1997-3#5)(1997-4#8)(1997-5#7)(1997-6#8)(1997-7#10)(1997-8#10)(2004-11#3)(2004-12#1)(2005-1#3)(2005-10#5)(2005-11#15)(2005-12#2)(2005-7#4)(2005-8#2)(2005-9#3)(2006-1#3)(2006-10#27)(2006-11#4)(2006-12#4)(2006-2#6)(2006-4#2)(2006-5#3)(2006-6#5)(2006-7#2)(2006-8#8)(2007-1#1)(2007-10#3)(2007-11#26)(2007-12#18)(2007-2#11)(2007-3#8)(2007-4#1)(2007-5#9)(2007-6#3)(2007-7#13)(2007-8#10)(2007-9#7)(2008-1#7)(2008-10#96)(2008-11#15)(2008-12#5)(2008-2#7)(2008-3#9)(2008-4#12)(2008-5#44)(2008-6#12)(2008-7#17)(2008-8#22)(2008-9#12)(2009-1#1)(2009-10#11)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#3)(2009-4#4)(2009-5#4)(2009-6#2)(2009-7#4)(2009-8#5)(2010-1#3)(2010-10#3)(2010-11#1)(2010-12#9)(2010-2#3)(2010-3#2)(2010-4#4)(2010-5#5)(2010-6#3)(2010-7#1)(2010-8#8)(2011-1#4)(2011-12#4)(2011-2#28)(2011-3#1)(2012-1#6)(2012-11#1)(2012-12#6)(2012-2#9)(2012-3#8)(2012-5#2)(2013-1#12)(2013-7#3)(2013-8#7)
proband and##5##2##(1997-5#1)(2006-7#1)(2009-4#1)(2010-2#1)(2011-1#1)
proband diagnosed with##2##3##(2008-8#1)(2010-3#1)
proband is a##2##3##(1991-12#1)(2012-12#1)
proband##23##1##(1991-12#3)(1993-3#1)(1995-1#1)(1997-5#5)(1997-7#1)(2006-7#1)(2007-12#1)(2008-11#1)(2008-8#1)(2009-4#1)(2010-2#2)(2010-3#2)(2011-1#1)(2012-12#1)(2012-3#1)
probands and##3##2##(1990-9#1)(1991-11#1)(1991-12#1)
probands had##3##2##(1990-9#1)(1996-5#1)(2008-7#1)
probands of##4##2##(1991-11#1)(2005-10#1)(2007-10#1)(2008-9#1)
probands were##3##2##(1991-2#1)(1997-8#1)(2011-2#1)
probands who##2##2##(1991-12#1)(2007-2#1)
probands with##8##2##(1992-9#1)(1995-11#2)(1996-3#1)(1996-5#1)(1997-5#2)(2009-4#1)
probands##51##1##(1990-9#6)(1991-10#1)(1991-11#3)(1991-12#4)(1991-2#1)(1992-9#3)(1994-2#1)(1995-10#1)(1995-11#3)(1996-3#2)(1996-5#5)(1997-5#4)(1997-8#1)(2005-10#1)(2007-10#1)(2007-2#4)(2008-3#1)(2008-7#1)(2008-9#1)(2009-4#4)(2010-2#1)(2011-2#2)
probands'##3##1##(1996-5#1)(1997-2#2)
probation and##2##2##(1996-11#1)(2009-11#1)
probation##4##1##(1996-11#1)(1997-5#1)(2006-5#1)(2009-11#1)
probative##2##1##(2008-10#1)(2008-12#1)
probe 1##5##2##(1995-3#1)(1997-1#1)(2008-10#3)
probe DNA molecules##2##3##(2008-5#2)
probe DNA##13##2##(1990-5#1)(1990-9#1)(1992-4#1)(1996-7#1)(2007-8#2)(2008-10#4)(2008-5#2)(2009-2#1)
probe RG57##7##2##(2008-10#7)
probe a##6##2##(1990-2#1)(1994-8#1)(1995-8#1)(2007-12#1)(2008-3#2)
probe also##4##2##(1991-3#1)(1993-2#1)(2008-5#1)(2013-8#1)
probe and a##3##3##(1996-7#1)(2007-12#1)(2008-10#1)
probe and by##2##3##(2008-10#2)
probe and genomic DNA##2##4##(1994-9#1)(2008-4#1)
probe and target##2##3##(2008-10#2)
probe and the target##2##4##(2008-1#1)(2008-7#1)
probe and the##11##3##(1994-11#1)(1997-6#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-3#2)(2008-7#1)(2010-5#1)
probe and##46##2##(1990-2#1)(1991-10#1)(1992-6#1)(1993-2#1)(1994-11#1)(1994-9#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-6#1)(2005-11#2)(2005-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#3)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-7#1)(2008-8#2)(2009-4#1)(2010-5#1)(2012-1#1)(2012-12#1)
probe angle##3##2##(1994-5#3)
probe are##3##2##(2007-12#1)(2008-10#2)
probe array with##2##3##(2007-12#1)(2008-3#1)
probe array##9##2##(2007-12#3)(2008-3#6)
probe as a##2##3##(2008-2#1)(2008-3#1)
probe as##5##2##(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-12#1)
probe at##3##2##(1991-12#1)(1993-7#1)(1995-5#1)
probe atomization##2##2##(2005-4#2)
probe axis##2##2##(1994-11#2)
probe based on the##3##4##(1990-5#1)(1994-12#1)(1994-9#1)
probe based on##5##3##(1990-5#1)(1994-12#1)(1994-9#1)(2008-10#1)(2008-11#1)
probe beam in##2##3##(2007-12#1)(2008-1#1)
probe beam that##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
probe beam##25##2##(2007-11#4)(2007-12#5)(2008-1#3)(2008-2#6)(2008-3#7)
probe beam)##3##2##(2008-3#3)
probe beams at##2##3##(2007-12#2)
probe beams##5##2##(2007-12#3)(2008-2#1)(2008-3#1)
probe by BSA was##2##4##(1997-3#2)
probe by##4##2##(1997-3#2)(2008-4#1)(2008-8#1)
probe complementary to a portion of the##2##7##(1990-5#1)(1993-3#1)
probe complementary to a##3##4##(1990-5#1)(1991-8#1)(1993-3#1)
probe concentration##4##2##(1994-2#1)(1994-5#1)(2007-11#1)(2008-9#1)
probe confirmed that##2##3##(2008-5#1)(2008-8#1)
probe confirmed##3##2##(2008-3#1)(2008-5#1)(2008-8#1)
probe containing the##3##3##(1995-3#1)(2008-10#1)(2008-5#1)
probe containing##6##2##(1991-2#1)(1995-3#1)(1995-6#1)(1996-3#1)(2008-10#1)(2008-5#1)
probe corresponding to the##5##4##(1991-7#1)(1995-1#1)(1996-5#2)(2008-10#1)
probe could##3##2##(1995-2#1)(2007-8#2)
probe demonstrated##2##2##(1991-5#1)(1995-11#1)
probe derived from the N-terminal##2##5##(1991-8#1)(1997-2#1)
probe derived from the##4##4##(1991-8#1)(1991-9#1)(1995-8#1)(1997-2#1)
probe derived from##8##3##(1991-1#1)(1991-8#1)(1991-9#1)(1994-5#1)(1995-8#1)(1997-2#1)(2008-10#1)(2008-8#1)
probe design and##2##3##(2008-2#1)(2011-1#1)
probe design for##3##3##(2011-1#2)(2012-2#1)
probe design##7##2##(2006-6#1)(2008-2#1)(2011-1#4)(2012-2#1)
probe designed from a highly conserved##2##6##(1993-12#1)(1994-12#1)
probe designed##4##2##(1992-9#1)(1993-12#1)(1994-12#1)(1994-5#1)
probe detected##2##2##(1992-12#1)(2008-5#1)
probe drug##3##2##(2010-2#1)(2011-2#2)
probe encoding the##2##3##(1993-3#1)(1997-6#1)
probe encoding##3##2##(1993-3#1)(1993-5#1)(1997-6#1)
probe for labeling##2##3##(1991-7#1)(1994-2#1)
probe for measuring##2##3##(2008-9#2)
probe for noninvasive##2##3##(2008-3#2)
probe for protein##2##3##(1994-8#1)(2008-8#1)
probe for screening##3##3##(1992-7#1)(1993-3#1)(2005-11#1)
probe for singlet oxygen##2##4##(2007-8#1)(2008-8#1)
probe for the##20##3##(1990-2#1)(1990-5#1)(1990-8#2)(1991-10#1)(1991-5#1)(1992-8#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-7#1)(2007-5#1)(2008-10#4)
probe for##80##2##(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-6#1)(1992-7#2)(1992-8#2)(1993-2#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-8#4)(1994-9#1)(1995-11#2)(1995-3#1)(1995-5#1)(1996-12#1)(1996-3#2)(1996-5#1)(1997-3#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#2)(2008-8#3)(2008-9#3)(2009-4#1)(2010-10#1)(2011-1#1)
probe frequency detuning##2##3##(2007-11#2)
probe from the##2##3##(1990-11#1)(1993-4#1)
probe from##4##2##(1990-11#1)(1990-9#1)(1993-4#1)(1996-7#1)
probe had##2##2##(2007-10#1)(2011-1#1)
probe has been##3##3##(2005-11#1)(2007-7#1)(2008-3#1)
probe hybridized to##2##3##(1993-3#1)(2008-10#1)
probe hybridized##3##2##(1993-3#1)(1997-7#1)(2008-10#1)
probe in the##9##3##(1991-5#1)(1992-6#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-8#1)(2008-2#1)(2012-2#1)
probe in##27##2##(1990-11#1)(1990-5#2)(1991-5#1)(1992-6#2)(1992-9#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-3#1)(1997-6#1)(2007-10#2)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-4#1)(2012-2#1)
probe indicated that the##2##4##(1997-2#1)(2008-8#1)
probe indicated that##4##3##(1995-6#1)(1997-2#1)(2008-8#1)(2008-9#1)
probe into the##2##3##(2008-10#1)(2008-8#1)
probe is a##2##3##(1991-2#1)(2008-2#1)
probe is inserted##2##3##(2006-10#1)(2007-9#1)
probe is introduced for##2##4##(1994-8#1)(2008-3#1)
probe is##34##2##(1991-2#1)(1992-11#1)(1994-8#2)(1997-7#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-5#1)(2007-9#2)(2008-10#7)(2008-11#1)(2008-2#5)(2008-3#3)(2008-9#1)(2010-2#1)(2010-5#1)(2012-11#1)(2013-1#1)
probe labeling##4##2##(2008-11#1)(2008-9#3)
probe laser beam##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
probe laser beams##2##3##(2007-12#1)(2008-3#1)
probe laser##12##2##(2007-12#8)(2008-2#2)(2008-3#2)
probe linked to the##2##4##(1997-7#2)
probe may be##2##3##(2008-4#1)(2011-2#1)
probe may##3##2##(1996-11#1)(2008-4#1)(2011-2#1)
probe measurements##2##2##(2007-12#1)(2011-1#1)
probe mechanisms##2##2##(2008-4#1)(2008-9#1)
probe methods##2##2##(1991-2#1)(2012-2#1)
probe microanalysis##6##2##(2004-9#1)(2008-5#1)(2010-8#1)(2012-2#3)
probe modified CPE##2##3##(2008-10#2)
probe modified##3##2##(2008-10#2)(2009-3#1)
probe molecule##2##2##(2008-7#1)(2013-1#1)
probe molecules##3##2##(2007-8#1)(2008-10#1)(2011-1#1)
probe motion##2##2##(1992-1#1)(1996-11#1)
probe obtained##2##2##(1993-9#1)(2011-2#1)
probe of the##7##3##(1990-2#1)(1991-6#1)(2007-12#3)(2008-10#1)(2008-3#1)
probe of two-dimensional##2##3##(2007-12#2)
probe of##31##2##(1990-2#2)(1991-2#1)(1991-6#1)(1992-4#1)(1992-7#1)(1993-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-3#1)(1996-7#1)(1997-7#1)(2007-12#6)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#2)(2009-5#1)(2011-1#1)
probe on the##5##3##(1997-6#1)(2008-10#3)(2008-3#1)
probe on##11##2##(1997-6#1)(1997-7#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-9#1)
probe or##4##2##(1992-6#2)(1996-1#1)(1997-4#1)
probe orientation##2##2##(2008-2#2)
probe particle##5##2##(2005-11#3)(2008-1#2)
probe positioning##2##2##(2007-9#1)(2008-5#1)
probe prepared from##2##3##(1993-6#1)(2008-10#1)
probe produced##2##2##(1997-3#1)(2007-10#1)
probe pulse and##2##3##(2007-11#1)(2007-12#1)
probe pulse at 400 nm##2##5##(2007-11#1)(2007-12#1)
probe pulse##12##2##(2007-11#5)(2007-12#7)
probe pulses##4##2##(2006-6#1)(2007-11#1)(2007-12#2)
probe recognition task##2##3##(1992-11#1)(2008-4#1)
probe revealed a##2##3##(1996-12#1)(2008-5#1)
probe revealed the##3##3##(1992-3#1)(1994-11#1)(2008-10#1)
probe revealed##10##2##(1990-5#1)(1991-2#1)(1992-3#1)(1994-11#1)(1994-7#1)(1996-10#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-5#1)
probe sequences##4##2##(2008-10#2)(2010-5#1)(2012-3#1)
probe set##2##2##(2008-10#1)(2008-5#1)
probe sets##6##2##(2008-7#1)(2012-3#5)
probe showed##3##2##(1992-6#1)(1993-8#1)(1997-2#1)
probe shows##3##2##(1992-12#1)(2008-3#1)(2010-8#1)
probe sonication##4##2##(2008-10#4)
probe specific for##4##3##(1993-11#1)(1993-8#1)(2008-10#2)
probe specific##5##2##(1993-11#1)(1993-8#1)(2007-5#1)(2008-10#2)
probe specifically##2##2##(1990-7#1)(1997-2#1)
probe studies##2##2##(1996-2#1)(2010-2#1)
probe study##2##2##(2005-11#1)(2008-10#1)
probe synthesis##2##2##(2008-9#2)
probe system##2##2##(2006-6#1)(2008-3#1)
probe technique##5##2##(2005-11#2)(2008-1#1)(2008-10#1)(2008-7#1)
probe techniques##2##2##(2005-11#1)(2010-4#1)
probe that is##3##3##(1995-11#1)(2006-12#1)(2010-4#1)
probe that##10##2##(1992-11#1)(1995-11#1)(1997-7#1)(2006-12#1)(2007-12#1)(2008-3#2)(2008-4#1)(2010-4#1)(2010-7#1)
probe the effects of##2##4##(1991-4#1)(1993-11#1)
probe the mechanism of##2##4##(1991-4#1)(1995-11#1)
probe the molecular##3##3##(1995-2#1)(2006-10#1)(2008-10#1)
probe the optical##2##3##(2007-11#1)(2007-12#1)
probe the role##2##3##(1990-2#1)(2009-10#1)
probe the structural##6##3##(1994-5#1)(1994-9#1)(1995-3#1)(1996-9#1)(2006-3#1)(2006-6#1)
probe the##68##2##(1990-10#1)(1990-2#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-3#1)(1991-4#3)(1992-3#1)(1992-6#2)(1993-11#2)(1993-5#2)(1993-6#1)(1993-7#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-6#1)(2005-8#1)(2006-10#3)(2006-3#1)(2006-6#1)(2007-11#4)(2007-12#3)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-7#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
probe this##2##2##(2009-12#1)(2012-2#1)
probe tip##6##2##(1996-5#1)(2007-12#1)(2008-2#1)(2008-3#2)(2011-1#1)
probe tips##2##2##(1992-1#1)(1994-9#1)
probe to be##2##3##(2008-4#1)(2011-2#1)
probe to detect##3##3##(1996-6#1)(2007-12#1)(2013-8#1)
probe to determine##3##3##(2008-10#2)(2011-2#1)
probe to identify the##2##4##(1990-9#1)(1993-2#1)
probe to monitor##3##3##(1990-3#1)(1992-6#1)(2012-3#1)
probe to screen##4##3##(1990-3#1)(1990-6#1)(1994-12#1)(1996-6#1)
probe to test##2##3##(1992-6#1)(2007-5#1)
probe to the##8##3##(1991-10#1)(1991-6#1)(1992-6#2)(1992-8#1)(2008-1#1)(2008-4#1)(2010-4#1)
probe to##53##2##(1990-3#3)(1990-6#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-6#6)(1992-8#1)(1993-2#1)(1993-3#1)(1994-12#1)(1996-6#2)(1997-1#1)(1997-7#1)(2006-10#1)(2006-3#1)(2006-5#1)(2007-11#2)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#3)(2008-7#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-8#2)
probe volume##7##2##(2008-3#7)
probe was immobilized##2##3##(2008-10#1)(2008-12#1)
probe was inserted into the##2##5##(1997-2#1)(2007-8#1)
probe was performed##2##3##(2008-8#1)(2008-9#1)
probe was prepared and##2##4##(1994-11#1)(2007-8#1)
probe was studied##2##3##(1990-3#1)(2013-8#1)
probe was used to##4##4##(1991-8#1)(1996-12#1)(2008-10#1)(2009-3#1)
probe was##35##2##(1990-3#1)(1991-8#1)(1992-12#1)(1993-8#1)(1994-11#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-4#1)(2006-5#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#9)(2008-12#1)(2008-2#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-7#1)(2012-1#1)(2012-3#1)(2013-8#2)
probe were found##2##3##(1990-5#1)(2008-10#1)
probe were##8##2##(1990-5#1)(1992-3#1)(1996-2#1)(1997-6#2)(2007-10#1)(2007-12#1)(2008-10#1)
probe which##2##2##(1997-3#1)(2008-5#1)
probe will be##2##3##(1990-2#1)(2008-1#1)
probe with an##2##3##(2007-12#1)(2008-3#1)
probe with the##2##3##(2008-10#1)(2013-8#1)
probe with##10##2##(1996-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#2)(2013-8#1)
probe##1348##1##(1990-10#5)(1990-11#10)(1990-12#6)(1990-2#12)(1990-3#7)(1990-4#4)(1990-5#13)(1990-6#2)(1990-7#5)(1990-8#3)(1990-9#5)(1991-1#1)(1991-10#3)(1991-12#10)(1991-2#8)(1991-3#2)(1991-4#7)(1991-5#7)(1991-6#6)(1991-7#9)(1991-8#4)(1991-9#7)(1992-1#2)(1992-10#1)(1992-11#7)(1992-12#9)(1992-2#1)(1992-3#11)(1992-4#3)(1992-5#1)(1992-6#22)(1992-7#3)(1992-8#8)(1992-9#2)(1993-1#2)(1993-11#7)(1993-12#4)(1993-2#7)(1993-3#8)(1993-4#1)(1993-5#6)(1993-6#7)(1993-7#4)(1993-8#5)(1993-9#6)(1994-10#2)(1994-11#8)(1994-12#6)(1994-2#5)(1994-3#6)(1994-5#14)(1994-6#2)(1994-7#1)(1994-8#15)(1994-9#11)(1995-1#2)(1995-10#4)(1995-11#8)(1995-12#4)(1995-2#4)(1995-3#8)(1995-5#8)(1995-6#6)(1995-8#9)(1995-9#1)(1996-1#2)(1996-10#4)(1996-11#7)(1996-12#6)(1996-2#5)(1996-3#5)(1996-5#11)(1996-6#6)(1996-7#9)(1996-8#2)(1996-9#3)(1997-1#7)(1997-2#12)(1997-3#6)(1997-4#8)(1997-6#13)(1997-7#18)(1997-8#4)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#26)(2005-12#3)(2005-4#3)(2005-8#2)(2006-10#8)(2006-12#10)(2006-2#1)(2006-3#2)(2006-5#4)(2006-6#5)(2006-7#1)(2006-8#2)(2007-10#11)(2007-11#28)(2007-12#81)(2007-2#2)(2007-5#9)(2007-7#5)(2007-8#14)(2007-9#7)(2008-1#17)(2008-10#187)(2008-11#9)(2008-12#5)(2008-2#41)(2008-3#83)(2008-4#30)(2008-5#24)(2008-7#20)(2008-8#28)(2008-9#30)(2009-10#3)(2009-11#2)(2009-12#6)(2009-2#3)(2009-3#3)(2009-4#5)(2009-5#2)(2009-6#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-2#6)(2010-4#7)(2010-5#8)(2010-7#6)(2010-8#3)(2010-9#1)(2011-1#14)(2011-2#7)(2012-1#4)(2012-11#1)(2012-12#7)(2012-2#14)(2012-3#9)(2013-1#3)(2013-7#1)(2013-8#10)
probe&quot##3##1##(1993-5#1)(2013-1#2)
probe)##10##1##(1991-5#1)(1994-3#1)(2007-10#2)(2008-10#3)(2008-3#1)(2008-4#1)(2010-7#1)
probe-enzyme combinations##2##2##(2008-10#2)
probe-to-probe##2##1##(2007-12#1)(2008-10#1)
probe-type##2##1##(2008-10#1)(2008-3#1)
probed as##2##2##(2009-12#1)(2010-12#1)
probed at##2##2##(2008-10#1)(2008-3#1)
probed by polarized Raman spectra##2##5##(2007-11#2)
probed by site-directed mutagenesis##2##4##(1992-9#1)(2008-4#1)
probed by time-resolved##2##3##(1992-2#1)(2007-11#1)
probed by##36##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-3#1)(1991-4#2)(1992-12#1)(1992-2#1)(1992-4#1)(1992-9#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-8#1)(1996-7#2)(2006-12#3)(2007-11#3)(2007-12#3)(2008-10#1)(2008-4#1)(2008-7#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-2#1)
probed for##5##2##(1991-2#1)(1996-8#1)(2005-11#1)(2008-4#1)(2011-12#1)
probed in##5##2##(1990-5#1)(1995-5#1)(2006-12#1)(2007-1#1)(2010-4#1)
probed the##5##2##(1996-11#1)(1996-8#1)(2007-12#2)(2008-9#1)
probed using site-directed mutagenesis##2##4##(1994-9#1)(1996-8#1)
probed using##5##2##(1990-8#1)(1994-9#1)(1995-8#1)(1996-8#1)(2005-11#1)
probed with a##11##3##(1992-4#1)(1993-3#1)(1993-8#1)(1993-9#1)(1995-8#1)(1997-3#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)
probed with the##5##3##(1991-5#1)(1991-6#1)(1993-6#1)(2008-10#1)(2008-2#1)
probed with##28##2##(1990-12#1)(1991-10#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-4#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-8#1)(1997-1#1)(1997-3#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#2)
probed##111##1##(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-4#2)(1992-9#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-2#1)(1995-5#1)(1995-8#3)(1996-11#1)(1996-7#2)(1996-8#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-11#3)(2006-12#5)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#7)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#5)(2008-3#7)(2008-4#4)(2008-7#1)(2008-9#2)(2009-12#1)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#4)(2011-12#1)(2012-2#1)
probenecid and##2##2##(1994-6#1)(2007-11#1)
probenecid##6##1##(1993-2#2)(1994-6#1)(1996-5#2)(2007-11#1)
probenecid-sensitive folate transporter##2##3##(1994-6#2)
probes a##2##2##(2007-3#1)(2008-3#1)
probes allows##2##2##(2007-12#1)(2008-3#1)
probes and a##2##3##(2005-12#1)(2008-10#1)
probes and##32##2##(1990-3#1)(1990-7#1)(1991-6#1)(1992-11#1)(1992-8#1)(1993-11#1)(1996-10#1)(1997-7#1)(2005-12#1)(2007-11#2)(2007-8#3)(2008-1#1)(2008-10#5)(2008-2#1)(2008-4#3)(2008-7#1)(2008-8#2)(2008-9#3)(2009-8#1)(2012-3#1)
probes are discussed##2##3##(1994-6#1)(2008-2#1)
probes are used##2##3##(2006-5#1)(2008-4#1)
probes are##22##2##(1991-2#1)(1992-12#1)(1994-6#1)(2006-5#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#6)(2008-9#4)(2009-12#1)(2010-5#1)
probes at##3##2##(1997-8#1)(2008-10#2)
probes based on##2##3##(1992-3#1)(2008-10#1)
probes between##2##2##(1990-3#1)(1991-7#1)
probes by##4##2##(1994-6#1)(1997-2#1)(2008-4#2)
probes can be##2##3##(2009-11#1)(2012-3#1)
probes can##4##2##(2007-5#1)(2008-4#1)(2009-11#1)(2012-3#1)
probes containing##2##2##(1996-7#1)(2008-10#1)
probes corresponding to##3##3##(1990-5#1)(1992-2#1)(2008-10#1)
probes demonstrated that##2##3##(1990-12#1)(2008-8#1)
probes demonstrated##3##2##(1990-12#1)(1990-3#1)(2008-8#1)
probes derived from the##3##4##(1991-9#1)(2008-10#1)(2008-7#1)
probes derived from##8##3##(1991-9#1)(1993-12#1)(1997-2#1)(2008-10#2)(2008-7#2)(2012-3#1)
probes designed to##3##3##(2008-10#2)(2008-4#1)
probes during##2##2##(2007-7#1)(2008-10#1)
probes encapsulated by biologically localized embedding (PEBBLEs)##2##7##(2008-10#2)
probes for chromosome##2##3##(2008-9#1)(2012-3#1)
probes for gene##2##3##(2006-6#1)(2008-4#1)
probes for imaging##2##3##(2010-7#1)(2012-11#1)
probes for molecular##2##3##(1994-8#1)(2008-9#1)
probes for mouse alpha 2(IX) and alpha 1(X) collagen##2##9##(1992-2#2)
probes for physical##2##3##(1992-6#1)(2010-3#1)
probes for protein##2##3##(1996-11#1)(2007-9#1)
probes for the##8##3##(1991-7#1)(1991-9#1)(1994-11#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-4#1)(2010-2#1)
probes for##66##2##(1990-12#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-10#1)(1991-7#2)(1991-9#1)(1992-2#2)(1992-6#1)(1994-11#2)(1994-5#1)(1994-8#3)(1996-11#3)(1996-3#1)(1997-2#1)(1997-8#1)(2004-4#1)(2006-12#1)(2006-6#2)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-4#3)(2008-5#2)(2008-7#1)(2008-9#7)(2009-5#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-5#4)(2010-7#1)(2011-1#1)(2012-11#2)(2012-12#1)(2012-3#1)
probes from the##2##3##(1993-7#1)(2008-10#1)
probes from##11##2##(1991-5#1)(1992-3#1)(1993-11#1)(1993-7#1)(1994-6#1)(2008-10#3)(2008-2#1)(2008-4#2)
probes generated from##2##3##(1992-6#1)(2008-10#1)
probes have been designed##2##4##(1992-3#1)(2008-10#1)
probes have been##5##3##(1990-4#1)(1992-3#1)(2008-10#1)(2008-3#1)(2010-5#1)
probes have##8##2##(1990-4#1)(1992-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-12#1)(2010-5#1)
probes hybridized to##2##3##(1993-3#1)(1997-6#1)
probes hybridized##3##2##(1993-3#1)(1997-6#1)(2008-10#1)
probes in a##2##3##(2005-9#1)(2008-4#1)
probes in multiple##2##3##(2007-12#1)(2009-12#1)
probes in the##4##3##(1990-4#1)(1995-5#1)(1996-4#1)(2012-3#1)
probes in##28##2##(1990-2#1)(1990-4#2)(1991-5#1)(1992-12#1)(1993-1#1)(1993-11#1)(1995-5#1)(1995-7#1)(1996-4#1)(2005-9#1)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-9#2)(2009-12#1)(2010-12#2)(2012-3#1)(2013-8#1)
probes indicated that the##2##4##(1993-6#1)(1996-11#1)
probes indicated that##4##3##(1993-6#1)(1996-11#1)(2005-10#1)(2008-5#1)
probes into##2##2##(1996-8#1)(2008-4#1)
probes is also included##2##4##(2008-4#2)
probes is based on##2##4##(2008-10#2)
probes is##10##2##(1990-4#2)(1997-7#1)(2008-10#2)(2008-2#1)(2008-4#3)(2009-2#1)
probes labeled with##2##3##(2008-10#1)(2008-4#1)
probes makes##2##2##(2006-7#1)(2008-4#1)
probes may be##2##3##(2008-4#2)
probes might##2##2##(1996-3#1)(2008-10#1)
probes obtained by##2##3##(2008-10#1)(2008-2#1)
probes of such##2##3##(1994-8#1)(1997-4#1)
probes of the local structure##2##5##(2005-11#1)(2008-4#1)
probes of the##8##3##(1991-2#1)(1991-5#2)(1993-3#1)(1994-8#1)(1997-1#1)(2005-11#1)(2008-4#1)
probes of##25##2##(1991-2#1)(1991-3#1)(1991-5#2)(1993-3#1)(1993-4#1)(1994-12#1)(1994-8#2)(1996-3#1)(1996-6#2)(1997-1#1)(1997-4#1)(1997-5#1)(2005-11#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)
probes on a##2##3##(2008-12#1)(2010-9#1)
probes on the##4##3##(1991-1#1)(1991-2#1)(1993-7#1)(2008-2#1)
probes on##8##2##(1990-5#1)(1991-1#1)(1991-2#1)(1993-7#1)(1996-8#1)(2008-12#1)(2008-2#1)(2010-9#1)
probes or##4##2##(1997-4#1)(1997-7#1)(2008-4#1)(2008-7#1)
probes representing the##2##3##(1993-5#2)
probes representing##4##2##(1993-5#2)(2008-10#1)(2009-4#1)
probes revealed##2##2##(2008-10#1)(2008-5#1)
probes should##3##2##(1994-9#1)(2006-10#1)(2008-10#1)
probes showed that the##2##4##(2005-12#1)(2008-10#1)
probes specific for##4##3##(1992-12#1)(1994-11#1)(1997-6#1)(2009-2#1)
probes such as##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
probes targeted##2##2##(2008-10#1)(2008-9#1)
probes tested##2##2##(2005-12#1)(2008-10#1)
probes that are##5##3##(1994-11#1)(2007-11#1)(2008-10#2)(2012-2#1)
probes that can be##2##4##(2006-12#1)(2008-9#1)
probes that recognize##2##3##(1996-12#2)
probes that##19##2##(1994-11#1)(1995-8#1)(1996-10#1)(1996-12#2)(2006-12#1)(2007-11#1)(2007-7#1)(2008-10#6)(2008-6#1)(2008-9#1)(2009-12#1)(2011-1#1)(2012-2#1)
probes the##3##2##(1994-5#1)(2007-12#1)(2008-10#1)
probes to both##2##3##(1996-12#1)(2008-10#1)
probes to detect##3##3##(1990-5#1)(1994-11#1)(2006-8#1)
probes to investigate the##2##4##(1993-2#1)(2008-10#1)
probes to investigate##3##3##(1993-2#1)(2008-10#1)(2012-2#1)
probes to study the##2##4##(1990-7#1)(1991-1#1)
probes to study##3##3##(1990-7#1)(1991-1#1)(1995-10#1)
probes to##25##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-1#1)(1993-11#1)(1993-2#1)(1994-11#1)(1995-10#1)(1995-8#1)(1996-12#1)(2006-12#1)(2006-8#1)(2007-2#1)(2008-10#9)(2008-4#1)(2008-9#1)(2012-2#1)
probes used in##2##3##(2008-4#1)(2008-9#1)
probes used##3##2##(1996-11#1)(2008-4#1)(2008-9#1)
probes was##8##2##(1990-2#1)(1990-3#1)(1991-2#1)(1996-3#1)(1997-6#1)(2008-3#1)(2008-5#1)(2010-5#1)
probes were also##2##3##(2007-10#1)(2008-10#1)
probes were applied to##2##4##(2007-5#1)(2008-10#1)
probes were applied##3##3##(2007-5#1)(2008-10#2)
probes were designed##3##3##(1997-4#1)(2008-5#1)(2010-4#1)
probes were inserted##2##3##(1993-4#1)(1996-1#1)
probes were selected##2##3##(2008-5#1)(2008-7#1)
probes were tested##2##3##(2008-10#2)
probes were then used to analyze##2##6##(2008-10#2)
probes were used in##2##4##(2008-10#2)
probes were used to##3##4##(1990-8#1)(2008-10#2)
probes were used##6##3##(1990-8#1)(2008-10#5)
probes were##40##2##(1990-7#1)(1990-8#1)(1992-6#1)(1992-8#1)(1993-4#1)(1996-1#1)(1997-4#1)(1997-7#1)(2006-12#2)(2007-10#1)(2007-5#1)(2007-7#1)(2008-10#18)(2008-5#3)(2008-7#1)(2009-11#1)(2009-8#1)(2010-3#1)(2010-4#1)(2013-7#1)
probes which##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
probes with##5##2##(1991-7#1)(2008-10#1)(2008-12#1)(2009-7#1)(2010-7#1)
probes within the##2##3##(1991-2#1)(2009-8#1)
probes within##4##2##(1991-2#2)(1997-2#1)(2009-8#1)
probes would##2##2##(1993-5#1)(1994-11#1)
probes##695##1##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#3)(1990-3#7)(1990-4#7)(1990-5#8)(1990-6#1)(1990-7#4)(1990-8#1)(1991-1#4)(1991-10#1)(1991-12#2)(1991-2#9)(1991-3#3)(1991-5#6)(1991-6#2)(1991-7#7)(1991-9#2)(1992-11#2)(1992-12#5)(1992-2#3)(1992-3#3)(1992-6#4)(1992-7#1)(1992-8#8)(1992-9#1)(1993-1#2)(1993-11#6)(1993-12#1)(1993-2#2)(1993-3#4)(1993-4#3)(1993-5#4)(1993-6#1)(1993-7#4)(1993-8#2)(1994-1#1)(1994-11#8)(1994-12#5)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#4)(1994-7#1)(1994-8#7)(1994-9#1)(1995-10#1)(1995-11#3)(1995-2#1)(1995-5#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-10#2)(1996-11#6)(1996-12#8)(1996-3#5)(1996-4#2)(1996-6#3)(1996-7#2)(1996-8#3)(1997-1#3)(1997-2#9)(1997-3#1)(1997-4#3)(1997-5#4)(1997-6#6)(1997-7#5)(1997-8#2)(2004-4#2)(2005-10#1)(2005-11#1)(2005-12#3)(2005-9#1)(2006-10#2)(2006-12#9)(2006-3#1)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#1)(2007-10#1)(2007-11#9)(2007-12#9)(2007-2#3)(2007-3#1)(2007-5#3)(2007-7#3)(2007-8#12)(2007-9#2)(2008-1#6)(2008-10#122)(2008-11#3)(2008-12#6)(2008-2#21)(2008-3#12)(2008-4#52)(2008-5#13)(2008-6#2)(2008-7#9)(2008-8#9)(2008-9#44)(2009-10#2)(2009-11#4)(2009-12#9)(2009-2#3)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#4)(2009-8#3)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#10)(2010-7#4)(2010-9#1)(2011-1#2)(2012-11#2)(2012-12#6)(2012-2#8)(2012-3#5)(2013-1#2)(2013-7#3)(2013-8#6)
probing a##3##2##(1991-9#1)(2007-11#1)(2008-2#1)
probing and##3##2##(2008-12#1)(2011-1#1)(2013-8#1)
probing beam##4##2##(2007-11#2)(2008-2#1)(2008-3#1)
probing depth (PD)##3##3##(2008-12#1)(2012-3#1)(2013-1#1)
probing depth and##5##3##(2008-12#1)(2008-8#1)(2012-12#2)(2013-1#1)
probing depth##15##2##(2008-12#3)(2008-8#3)(2010-4#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#3)
probing depths##4##2##(2007-12#2)(2008-6#1)(2012-11#1)
probing for##4##2##(2005-4#1)(2008-3#1)(2008-6#1)(2008-7#1)
probing in##2##2##(2008-10#1)(2010-5#1)
probing of a complex##2##4##(1996-5#1)(2008-2#1)
probing of the##2##3##(1991-5#1)(2008-8#1)
probing of##16##2##(1990-11#1)(1991-5#1)(1995-2#1)(1996-5#1)(2005-11#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#1)(2008-8#1)(2011-1#1)
probing pocket depth##2##3##(2013-1#1)(2013-8#1)
probing the dynamics of##2##4##(2006-12#1)(2007-12#1)
probing the functional##2##3##(1993-6#1)(1995-8#1)
probing the##30##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-3#1)(1992-12#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-8#1)(1996-5#1)(1997-4#1)(1997-7#1)(2006-12#1)(2006-4#1)(2007-12#3)(2007-9#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2011-1#2)(2012-12#1)
probing with##5##2##(1990-5#1)(1996-8#1)(2007-12#1)(2008-4#2)
probing##138##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#3)(1990-8#1)(1991-1#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#2)(1993-6#1)(1994-11#1)(1994-5#1)(1994-8#2)(1995-10#1)(1995-2#1)(1995-8#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-4#1)(1997-7#1)(2004-11#1)(2005-11#2)(2005-12#1)(2005-4#1)(2005-8#1)(2006-12#1)(2006-2#2)(2006-4#1)(2007-11#5)(2007-12#12)(2007-3#1)(2007-8#1)(2007-9#2)(2008-10#9)(2008-12#4)(2008-2#7)(2008-3#9)(2008-4#4)(2008-6#4)(2008-7#4)(2008-8#4)(2009-10#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#4)(2011-2#1)(2012-11#2)(2012-12#9)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#2)
probiotic E##2##2##(2011-2#2)
probiotic and##2##2##(2008-5#1)(2009-3#1)
probiotic bacteria can##2##3##(2010-9#1)(2012-2#1)
probiotic bacteria##6##2##(2010-10#1)(2010-9#2)(2012-2#1)(2013-1#2)
probiotic effects##2##2##(2010-10#1)(2011-2#1)
probiotic for##2##2##(2010-12#1)(2012-2#1)
probiotic microbes##2##2##(2008-4#1)(2012-1#1)
probiotic microorganisms##3##2##(2009-11#3)
probiotic on##2##2##(2007-3#1)(2010-12#1)
probiotic potential of##2##3##(2006-5#1)(2012-1#1)
probiotic potential##4##2##(2006-5#1)(2009-11#1)(2012-1#1)(2012-11#1)
probiotic preparations for##2##3##(2007-11#2)
probiotic preparations##6##2##(2007-11#5)(2013-1#1)
probiotic products##3##2##(2009-11#1)(2009-2#2)
probiotic properties##2##2##(2012-2#2)
probiotic strains##7##2##(2006-10#2)(2008-4#1)(2009-12#1)(2011-2#1)(2012-1#1)(2013-8#1)
probiotic use in Iberian dry-fermented sausages##2##6##(2010-4#2)
probiotic use##3##2##(2010-4#2)(2013-1#1)
probiotic##92##1##(2006-10#5)(2006-5#3)(2006-8#1)(2007-11#5)(2007-3#6)(2008-12#1)(2008-4#2)(2008-5#4)(2009-11#8)(2009-12#2)(2009-2#3)(2009-3#1)(2010-10#5)(2010-12#4)(2010-4#3)(2010-9#4)(2011-12#1)(2011-2#9)(2012-1#7)(2012-11#1)(2012-2#7)(2013-1#7)(2013-8#3)
probiotics and prebiotics##4##3##(2006-10#1)(2006-8#1)(2007-12#1)(2009-3#1)
probiotics and##8##2##(2006-10#2)(2006-2#1)(2006-8#1)(2007-12#1)(2008-10#1)(2009-3#1)(2010-12#1)
probiotics are##5##2##(2006-10#1)(2009-12#1)(2009-3#1)(2010-10#1)(2012-2#1)
probiotics can##2##2##(2010-9#1)(2012-1#1)
probiotics for##3##2##(2007-11#1)(2011-2#1)(2013-1#1)
probiotics have##2##2##(2011-2#1)(2013-7#1)
probiotics in the prevention##2##4##(2006-10#1)(2008-10#1)
probiotics in##14##2##(2006-10#2)(2006-5#1)(2008-10#1)(2009-11#1)(2009-12#1)(2012-1#3)(2012-11#1)(2012-2#1)(2013-7#3)
probiotics is##3##2##(2011-2#2)(2013-7#1)
probiotics may##3##2##(2006-10#1)(2009-9#1)(2013-7#1)
probiotics on##3##2##(2007-3#1)(2010-5#1)(2011-2#1)
probiotics##86##1##(2006-10#8)(2006-12#2)(2006-2#1)(2006-5#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#6)(2008-4#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#4)(2009-5#1)(2009-9#1)(2010-10#3)(2010-12#4)(2010-5#1)(2010-9#3)(2011-2#12)(2012-1#9)(2012-11#1)(2012-12#1)(2012-2#6)(2013-1#3)(2013-7#7)(2013-8#1)
probit analysis##2##2##(2008-12#1)(2008-8#1)
probit model for##3##3##(1995-6#1)(1997-4#1)(2008-7#1)
probit model##7##2##(1995-6#1)(1997-4#1)(2007-6#1)(2008-10#1)(2008-7#1)(2009-4#1)(2011-2#1)
probit models##3##2##(2008-7#1)(2009-4#2)
probit regression analysis##3##3##(1992-8#2)(2010-7#1)
probit regression##4##2##(1992-8#2)(1995-6#1)(2010-7#1)
probit##18##1##(1992-8#2)(1995-6#2)(1997-4#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-7#3)(2008-8#1)(2009-4#4)(2010-7#1)(2011-2#1)
problem -##2##2##(2007-11#1)(2007-4#1)
problem a##2##2##(2006-4#1)(2008-10#1)
problem affecting##4##2##(1996-8#1)(2008-2#1)(2008-5#1)(2013-8#1)
problem after##4##2##(1995-9#1)(1996-12#1)(2008-4#1)(2010-8#1)
problem among##11##2##(1991-4#1)(1996-12#1)(2007-12#1)(2007-3#1)(2008-12#1)(2008-4#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
problem and a##4##3##(1991-3#1)(1995-9#1)(2006-2#1)(2008-11#1)
problem and an##2##3##(2008-10#1)(2008-3#1)
problem and improve the##3##4##(2013-1#2)(2013-8#1)
problem and improve##4##3##(2007-2#1)(2013-1#2)(2013-8#1)
problem and is##5##3##(1993-11#1)(1994-8#1)(2008-3#1)(2011-1#1)(2012-12#1)
problem and its##5##3##(2007-2#1)(2007-8#1)(2008-6#1)(2009-6#1)(2011-1#1)
problem and should##2##3##(2006-9#1)(2009-3#1)
problem and the##7##3##(1994-8#1)(1995-1#2)(2006-10#1)(2008-2#1)(2008-8#1)(2012-12#1)
problem and##78##2##(1991-12#1)(1991-3#1)(1992-12#1)(1993-11#1)(1994-1#1)(1994-12#1)(1994-8#2)(1995-1#2)(1995-7#1)(1995-9#1)(1996-7#1)(1997-6#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-9#2)(2007-11#2)(2007-12#1)(2007-2#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#4)(2012-3#2)(2013-1#3)(2013-8#1)
problem are identified##2##3##(2005-11#1)(2008-2#1)
problem are needed##2##3##(2008-1#1)(2011-2#1)
problem are##10##2##(1993-6#1)(1994-6#1)(2005-11#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2010-11#1)(2011-2#1)
problem areas and##2##3##(2007-8#1)(2008-2#1)
problem areas##8##2##(1992-12#1)(1992-6#1)(1994-12#1)(1994-8#1)(2007-8#1)(2008-2#1)(2008-7#1)(2010-11#1)
problem arises##3##2##(2006-10#2)(2008-3#1)
problem as it##2##3##(2006-6#1)(2008-9#1)
problem as##6##2##(1990-5#1)(1995-5#1)(1997-6#1)(2006-6#1)(2008-10#1)(2008-9#1)
problem associated with the##2##4##(1994-11#1)(2006-12#1)
problem associated with##10##3##(1994-11#1)(1996-12#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2010-6#1)
problem at the##5##3##(1992-1#1)(2006-6#1)(2007-3#1)(2008-12#1)(2009-6#1)
problem at##10##2##(1992-1#1)(2006-6#1)(2007-3#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-4#1)(2009-6#1)(2011-2#1)(2012-12#1)
problem based learning##6##3##(2008-1#1)(2008-11#3)(2008-12#2)
problem based##10##2##(2008-1#1)(2008-11#5)(2008-12#3)(2008-2#1)
problem became##2##2##(1997-7#1)(2008-10#1)
problem because of high##2##4##(2006-10#1)(2013-8#1)
problem because of the##2##4##(2006-6#1)(2009-5#1)
problem because of##6##3##(1994-8#1)(2006-10#1)(2006-6#1)(2007-1#1)(2009-5#1)(2013-8#1)
problem because the##2##3##(2007-2#1)(2007-9#1)
problem because##12##2##(1994-8#1)(1996-7#1)(2006-1#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-5#1)(2009-5#1)(2013-8#1)
problem behavior and##2##3##(2008-12#1)(2013-7#1)
problem behavior in##2##3##(2008-12#1)(2009-9#1)
problem behavior##16##2##(2006-3#4)(2008-12#3)(2009-10#2)(2009-7#1)(2009-9#4)(2013-7#2)
problem behaviors were##3##3##(2008-12#2)(2008-9#1)
problem behaviors##12##2##(1994-2#1)(1997-1#1)(2007-1#1)(2008-12#4)(2008-9#2)(2010-2#1)(2010-4#2)
problem behaviour##3##2##(2005-10#2)(2008-12#1)
problem being##2##2##(2005-11#1)(2012-12#1)
problem but##3##2##(2006-10#1)(2007-11#1)(2007-2#1)
problem by solving##2##3##(2010-10#1)(2010-7#1)
problem by the high##2##4##(2011-2#2)
problem by the##3##3##(1994-3#1)(2011-2#2)
problem by use of##2##4##(2007-12#2)
problem by using##3##3##(2008-2#1)(2008-3#1)(2008-8#1)
problem by##28##2##(1990-12#1)(1991-9#1)(1992-9#1)(1994-3#1)(1995-2#1)(2006-10#1)(2007-12#3)(2008-10#2)(2008-2#4)(2008-3#2)(2008-8#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-2#3)(2012-3#2)(2013-1#1)
problem can be solved by##2##5##(2008-1#1)(2012-3#1)
problem can be solved##5##4##(2008-1#1)(2008-3#1)(2009-12#1)(2010-2#1)(2012-3#1)
problem can be##12##3##(1992-9#1)(1995-7#1)(1996-5#1)(1997-4#1)(2008-1#1)(2008-3#2)(2009-10#1)(2009-12#1)(2010-2#1)(2011-2#1)(2012-3#1)
problem concerning##3##2##(1990-2#1)(2007-8#1)(2011-2#1)
problem consists of##2##3##(2008-2#1)(2011-1#1)
problem could be##2##3##(2007-9#1)(2008-3#1)
problem could##4##2##(1993-9#1)(2006-8#1)(2007-9#1)(2008-3#1)
problem despite the availability of##2##5##(2007-11#1)(2008-3#1)
problem despite##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
problem drinkers##3##2##(1994-2#1)(1995-5#1)(2013-8#1)
problem drinking in##3##3##(1990-5#1)(1994-2#2)
problem drinking##10##2##(1990-5#1)(1994-2#7)(2007-6#1)(2010-2#1)
problem due to##5##3##(2006-2#1)(2007-8#1)(2010-11#1)(2013-1#2)
problem during follow-up##2##3##(2007-7#1)(2007-8#1)
problem during##9##2##(2006-10#1)(2007-11#2)(2007-7#2)(2007-8#1)(2008-12#1)(2010-9#1)(2012-2#1)
problem encountered by##2##3##(2006-10#1)(2006-2#1)
problem encountered##5##2##(1991-12#1)(2006-10#1)(2006-2#1)(2007-8#1)(2008-2#1)
problem even##3##2##(2007-3#1)(2008-9#1)(2013-1#1)
problem facing##2##2##(1991-3#1)(2007-7#1)
problem focused##4##2##(2006-8#3)(2011-2#1)
problem following##3##2##(2007-11#2)(2011-2#1)
problem for a##3##3##(2008-2#2)(2008-8#1)
problem for adults##2##3##(2006-10#1)(2012-2#1)
problem for all##2##3##(1994-3#1)(2011-2#1)
problem for clinicians##3##3##(2005-10#1)(2005-6#1)(2008-1#1)
problem for many##5##3##(1997-4#1)(2007-12#1)(2008-11#1)(2008-5#1)(2009-6#1)
problem for most##3##3##(2008-5#1)(2009-10#1)(2010-8#1)
problem for patients##4##3##(1990-11#1)(1997-4#1)(2006-7#1)(2008-7#1)
problem for surgeons##2##3##(2007-11#1)(2011-2#1)
problem for the surgeon##2##4##(1992-10#1)(2007-5#1)
problem for the##17##3##(1992-10#1)(1993-3#1)(1996-8#1)(1997-7#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)
problem for which##2##3##(2009-4#1)(2012-2#1)
problem for##99##2##(1990-10#1)(1990-11#1)(1991-12#1)(1991-2#1)(1992-10#1)(1993-3#1)(1993-9#1)(1994-3#1)(1995-1#1)(1996-2#1)(1996-8#1)(1997-4#2)(1997-7#1)(2005-10#1)(2005-6#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-7#2)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#6)(2007-2#2)(2007-5#2)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#10)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-8#3)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#4)(2013-8#1)
problem from##4##2##(2008-10#2)(2008-3#1)(2009-4#1)
problem gamblers##2##2##(2012-12#2)
problem gambling##3##2##(2008-11#2)(2013-1#1)
problem has been##8##3##(1997-4#1)(2005-8#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-9#1)(2013-8#1)
problem has led to the development##2##6##(1997-5#1)(2010-7#1)
problem has##19##2##(1995-5#1)(1997-4#1)(1997-5#1)(2005-8#1)(2006-10#1)(2007-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-9#1)(2009-10#1)(2010-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
problem have##5##2##(1994-6#1)(2007-6#1)(2008-3#1)(2008-6#1)(2010-1#1)
problem identification##3##2##(1993-1#1)(2008-12#1)(2013-1#1)
problem if##3##2##(2006-9#1)(2008-2#1)(2011-2#1)
problem in Europe##2##3##(1992-9#1)(2008-10#1)
problem in a##8##3##(1991-9#1)(1992-9#1)(1997-6#1)(2007-12#1)(2008-2#1)(2008-7#1)(2010-4#1)(2012-2#1)
problem in all age groups##2##5##(2006-2#1)(2007-7#1)
problem in all##4##3##(1992-9#1)(2006-12#1)(2006-2#1)(2007-7#1)
problem in analytical chemistry##3##4##(2008-10#3)
problem in both##5##3##(2005-8#1)(2006-3#1)(2006-4#1)(2007-2#1)(2013-1#1)
problem in children##2##3##(1996-8#1)(2008-10#1)
problem in developing countries##4##4##(2007-2#1)(2007-4#1)(2009-6#1)(2011-2#1)
problem in developing##5##3##(1995-11#1)(2007-2#1)(2007-4#1)(2009-6#1)(2011-2#1)
problem in endemic##3##3##(2007-2#1)(2010-12#1)(2011-2#1)
problem in general##2##3##(1993-2#1)(1993-9#1)
problem in hospitals##2##3##(2007-7#1)(2010-11#1)
problem in industrialized countries##3##4##(1990-6#1)(2007-11#1)(2008-4#1)
problem in many countries##3##4##(1991-6#1)(2008-12#1)(2012-2#1)
problem in many##6##3##(1990-10#1)(1991-6#1)(2008-1#1)(2008-11#1)(2008-12#1)(2012-2#1)
problem in older##2##3##(2013-1#1)(2013-8#1)
problem in our society##3##4##(2007-4#1)(2008-9#1)(2009-4#1)
problem in our##5##3##(2006-8#1)(2007-4#1)(2008-9#1)(2009-4#1)(2011-2#1)
problem in patients with##3##4##(1993-8#1)(2008-7#2)
problem in patients##5##3##(1993-8#1)(2007-7#1)(2008-12#1)(2008-7#2)
problem in rural##2##3##(2006-10#1)(2012-2#1)
problem in some##4##3##(1993-3#1)(2006-10#1)(2011-2#1)(2013-1#1)
problem in terms of the##2##5##(2007-8#1)(2009-4#1)
problem in terms of##4##4##(2005-11#1)(2007-8#1)(2008-1#1)(2009-4#1)
problem in the Indian##2##4##(2007-7#1)(2012-2#1)
problem in the United States##3##5##(1994-12#1)(2008-11#1)(2013-8#1)
problem in the developing world##3##5##(2007-4#1)(2008-5#1)(2013-8#1)
problem in the treatment of##2##5##(1991-9#1)(2013-8#1)
problem in the treatment##3##4##(1991-9#1)(2007-2#1)(2013-8#1)
problem in the##57##3##(1991-3#1)(1991-9#1)(1992-4#1)(1994-12#1)(1995-5#1)(1997-1#2)(1997-2#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-6#1)(2007-11#2)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
problem in their##3##3##(2011-1#1)(2013-1#2)
problem in this##4##3##(2005-8#1)(2006-8#1)(2007-12#1)(2007-7#1)
problem in urban##2##3##(1997-4#1)(2008-3#1)
problem in which the##2##4##(2008-3#1)(2008-6#1)
problem in which##3##3##(2008-2#1)(2008-3#1)(2008-6#1)
problem in women##2##3##(1993-11#1)(2011-1#1)
problem in##263##2##(1990-10#2)(1990-11#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-4#1)(1992-9#3)(1993-11#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#2)(1995-4#1)(1995-5#1)(1996-12#1)(1996-8#3)(1997-1#3)(1997-2#1)(1997-4#1)(1997-6#1)(2004-1#1)(2004-7#1)(2005-11#3)(2005-3#1)(2005-7#1)(2005-8#3)(2006-10#9)(2006-11#1)(2006-12#5)(2006-2#5)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-1#2)(2007-11#5)(2007-12#6)(2007-2#5)(2007-3#1)(2007-4#3)(2007-7#7)(2007-8#5)(2007-9#2)(2008-1#6)(2008-10#12)(2008-11#5)(2008-12#3)(2008-2#11)(2008-3#9)(2008-4#6)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#2)(2009-10#3)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#4)(2009-6#2)(2010-11#3)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#1)(2010-8#2)(2011-1#6)(2011-2#9)(2012-1#1)(2012-11#3)(2012-12#3)(2012-2#9)(2012-3#2)(2013-1#12)(2013-8#4)
problem including##2##2##(1994-6#1)(2008-12#1)
problem into a##3##3##(2008-6#1)(2009-4#1)(2012-2#1)
problem involving the##2##3##(2008-5#1)(2012-12#1)
problem involving##6##2##(2005-7#1)(2006-8#1)(2007-7#1)(2008-2#1)(2008-5#1)(2012-12#1)
problem is a##4##3##(2005-11#1)(2010-2#1)(2010-9#1)(2012-12#1)
problem is compounded by##2##4##(2010-3#1)(2012-2#1)
problem is compounded##3##3##(2008-9#1)(2010-3#1)(2012-2#1)
problem is considered##2##3##(2008-2#1)(2010-11#1)
problem is discussed##4##3##(1994-2#1)(2005-11#1)(2006-6#1)(2008-3#1)
problem is examined##2##3##(1991-8#1)(2005-11#1)
problem is not##6##3##(1991-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-12#1)
problem is posed##2##3##(2008-3#1)(2009-4#1)
problem is presented##7##3##(1996-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-6#1)
problem is that##7##3##(1993-11#1)(1996-2#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-8#1)
problem is the##9##3##(1990-3#1)(1997-3#1)(2005-1#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-2#1)
problem is to##11##3##(1992-8#1)(1993-12#1)(1996-9#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-2#1)
problem is##111##2##(1990-3#1)(1991-12#2)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-1#1)(1994-2#2)(1995-12#1)(1996-12#1)(1996-2#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-1#1)(2005-11#4)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#4)(2007-12#3)(2007-3#1)(2007-4#4)(2007-7#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#12)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-4#1)(2009-6#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#3)(2013-1#1)
problem itself##2##2##(1993-6#1)(2009-6#1)
problem lies in##2##3##(2008-11#1)(2009-10#1)
problem list##14##2##(2013-1#14)
problem lists that accommodate##4##4##(2013-1#4)
problem lists##12##2##(2013-1#12)
problem may be##2##3##(2006-10#1)(2010-2#1)
problem may##4##2##(2006-10#1)(2010-2#1)(2011-1#1)(2011-2#1)
problem not##2##2##(2006-2#1)(2007-11#1)
problem of a##2##3##(2007-5#1)(2008-10#1)
problem of computing the##2##4##(2008-3#1)(2011-3#1)
problem of computing##3##3##(2008-2#1)(2008-3#1)(2011-3#1)
problem of definition##2##3##(2004-10#2)
problem of detecting##4##3##(1997-7#2)(2007-12#1)(2009-2#1)
problem of determining the##2##4##(1996-8#1)(2008-10#1)
problem of determining##4##3##(1993-1#1)(1994-11#1)(1996-8#1)(2008-10#1)
problem of drug##2##3##(1991-7#1)(2012-2#1)
problem of estimating##3##3##(2008-2#1)(2008-3#1)(2013-7#1)
problem of global##3##3##(2008-1#1)(2008-2#1)(2008-7#1)
problem of great##2##3##(1995-3#1)(1997-3#1)
problem of how to##4##4##(1994-2#1)(2008-12#1)(2008-2#1)(2009-2#1)
problem of how##5##3##(1993-6#1)(1994-2#1)(2008-12#1)(2008-2#1)(2009-2#1)
problem of identifying##5##3##(2004-12#1)(2006-6#1)(2008-7#2)(2011-2#1)
problem of large##2##3##(1997-6#1)(2007-12#1)
problem of male##2##3##(2011-2#1)(2013-1#1)
problem of moral##2##3##(1991-2#1)(2007-4#1)
problem of multivariate classification##2##4##(2008-10#2)
problem of our##2##3##(1995-11#1)(2011-2#1)
problem of phase##2##3##(2007-11#1)(2008-3#1)
problem of public health##3##4##(1993-4#1)(2007-9#1)(2008-2#1)
problem of the##32##3##(1990-12#1)(1990-6#1)(1991-4#1)(1993-2#1)(1994-6#1)(1995-5#1)(1996-3#1)(2005-8#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#3)(2008-6#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#3)
problem of##388##2##(1990-10#1)(1990-12#4)(1990-3#1)(1990-6#2)(1991-11#1)(1991-2#1)(1991-4#2)(1991-6#3)(1991-7#1)(1991-9#2)(1992-4#2)(1992-6#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#4)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#2)(1996-3#3)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2004-10#3)(2004-12#1)(2004-7#1)(2005-10#1)(2005-11#6)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-6#6)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#2)(2007-11#14)(2007-12#16)(2007-2#3)(2007-3#1)(2007-4#4)(2007-5#4)(2007-6#4)(2007-7#9)(2007-8#5)(2007-9#2)(2008-1#8)(2008-10#21)(2008-11#6)(2008-12#4)(2008-2#34)(2008-3#21)(2008-4#3)(2008-5#3)(2008-6#6)(2008-7#12)(2008-8#3)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#3)(2010-10#3)(2010-11#2)(2010-2#2)(2010-3#1)(2010-4#3)(2010-8#2)(2010-9#2)(2011-1#3)(2011-2#9)(2011-3#2)(2012-1#1)(2012-12#5)(2012-2#10)(2012-3#2)(2013-1#11)(2013-7#2)(2013-8#7)
problem often##3##2##(2007-11#1)(2008-10#1)(2011-2#1)
problem on##7##2##(2007-2#1)(2008-10#2)(2008-2#1)(2009-6#2)(2013-1#1)
problem or##5##2##(1994-2#1)(2006-10#1)(2008-7#1)(2009-3#1)(2009-4#1)
problem over##3##2##(1997-7#1)(2007-7#1)(2012-3#1)
problem pre-definition##2##2##(2008-12#2)
problem presented##2##2##(2008-3#2)
problem related to the##2##4##(2006-2#1)(2011-2#1)
problem resolution##3##2##(1995-12#2)(1997-5#1)
problem resulting from##2##3##(2006-10#1)(2008-2#1)
problem resulting##3##2##(2006-10#1)(2006-8#1)(2008-2#1)
problem seems to be##2##4##(1990-10#1)(1996-5#1)
problem severity##2##2##(2006-3#2)
problem shared##2##2##(2008-2#1)(2012-12#1)
problem should##3##2##(1997-8#1)(2007-12#1)(2011-2#1)
problem since it##2##3##(2008-8#1)(2012-12#1)
problem since##4##2##(2007-2#1)(2007-3#1)(2008-8#1)(2012-12#1)
problem situations##3##2##(1996-1#3)
problem so##2##2##(2006-12#1)(2012-3#1)
problem solve##2##2##(2008-11#1)(2010-11#1)
problem solving and##6##3##(1994-2#1)(2007-3#2)(2008-11#1)(2010-10#1)(2011-2#1)
problem solving in##2##3##(2004-7#1)(2008-2#1)
problem solving##35##2##(1991-2#1)(1992-1#1)(1992-2#1)(1992-3#1)(1994-12#1)(1994-2#1)(1997-5#1)(2004-7#1)(2005-10#1)(2005-12#2)(2006-5#2)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-3#2)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2009-10#1)(2009-11#1)(2009-7#1)(2010-10#1)(2011-2#2)(2012-12#1)(2013-1#1)
problem than##3##2##(1995-3#1)(2008-7#1)(2013-8#1)
problem that affects##2##3##(2008-3#1)(2012-11#1)
problem that can##4##3##(2006-2#1)(2008-10#1)(2008-3#1)(2009-5#1)
problem that is##8##3##(1997-3#1)(2006-12#1)(2006-5#1)(2007-12#1)(2008-2#1)(2009-12#1)(2010-6#1)(2011-2#1)
problem that requires##2##3##(2005-7#1)(2011-2#1)
problem that##43##2##(1990-11#1)(1992-8#1)(1993-12#1)(1994-12#1)(1995-3#1)(1996-7#1)(1997-3#1)(2005-12#1)(2005-6#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#2)(2007-12#2)(2007-5#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#7)(2008-6#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-6#1)(2011-2#2)(2012-11#1)(2012-2#2)(2013-8#1)
problem through##3##2##(1997-8#1)(2008-2#1)(2012-12#1)
problem throughout the world##2##4##(2005-7#1)(2008-9#1)
problem throughout##3##2##(2005-7#1)(2006-10#1)(2008-9#1)
problem to be##8##3##(1990-2#1)(1991-2#1)(1994-4#1)(1997-5#1)(2007-11#1)(2008-3#1)(2008-6#1)(2012-2#1)
problem to find##2##3##(1990-12#1)(1992-6#1)
problem to the##3##3##(2007-1#1)(2008-10#1)(2010-3#1)
problem to##25##2##(1990-12#1)(1990-2#1)(1991-2#2)(1992-6#1)(1993-5#1)(1994-4#1)(1997-5#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#3)(2009-12#1)(2009-5#1)(2010-2#1)(2010-3#1)(2010-5#1)(2012-2#1)
problem under##5##2##(1997-7#1)(2007-9#1)(2008-2#1)(2008-3#1)(2013-8#1)
problem use##8##2##(2006-3#3)(2009-6#1)(2013-1#4)
problem users##2##2##(2006-3#1)(2012-12#1)
problem using##7##2##(1990-9#1)(2008-11#1)(2008-2#2)(2008-7#1)(2008-8#1)(2012-12#1)
problem was identified##2##3##(2011-2#1)(2012-12#1)
problem was to##2##3##(2008-10#2)
problem was##18##2##(1990-11#1)(1992-3#1)(1993-7#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-12#1)(2008-10#7)(2008-8#2)(2011-2#1)(2012-12#1)
problem we##4##2##(1991-1#1)(1991-8#1)(1996-5#1)(2008-2#1)
problem when##5##2##(1991-1#1)(1997-8#1)(2007-11#1)(2008-3#1)(2011-1#1)
problem which##4##2##(1991-9#1)(2007-2#1)(2008-2#1)(2008-7#1)
problem with a##6##3##(1995-3#1)(2007-12#1)(2008-3#1)(2011-2#2)(2013-1#1)
problem with an##3##3##(1997-3#1)(2008-10#1)(2011-2#1)
problem with many##3##3##(2007-4#1)(2008-3#2)
problem with the##4##3##(2005-11#1)(2008-10#1)(2008-3#1)(2013-1#1)
problem with##48##2##(1991-9#1)(1993-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-3#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-3#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-7#1)(2011-2#3)(2012-2#2)(2013-1#4)
problem within##2##2##(2007-12#1)(2012-1#1)
problem worldwide##9##2##(2006-10#2)(2006-2#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-5#1)(2013-8#1)
problem would##3##2##(1992-3#1)(2007-10#1)(2008-11#1)
problem!##3##1##(2008-7#1)(2009-2#1)(2009-9#1)
problem##2256##1##(1990-10#7)(1990-11#4)(1990-12#8)(1990-2#2)(1990-3#4)(1990-5#2)(1990-6#4)(1990-8#1)(1990-9#2)(1991-1#4)(1991-11#4)(1991-12#10)(1991-2#8)(1991-3#4)(1991-4#5)(1991-5#1)(1991-6#8)(1991-7#2)(1991-8#3)(1991-9#9)(1992-1#6)(1992-10#1)(1992-12#5)(1992-2#5)(1992-3#4)(1992-4#7)(1992-5#1)(1992-6#4)(1992-8#3)(1992-9#9)(1993-1#4)(1993-10#1)(1993-11#7)(1993-12#6)(1993-2#7)(1993-3#9)(1993-4#2)(1993-5#3)(1993-6#6)(1993-7#4)(1993-8#4)(1993-9#8)(1994-1#4)(1994-10#1)(1994-11#4)(1994-12#6)(1994-2#17)(1994-3#10)(1994-4#1)(1994-5#2)(1994-6#8)(1994-7#1)(1994-8#5)(1994-9#2)(1995-1#4)(1995-10#2)(1995-11#4)(1995-12#6)(1995-2#3)(1995-3#5)(1995-4#1)(1995-5#5)(1995-6#3)(1995-7#2)(1995-8#4)(1995-9#4)(1996-1#7)(1996-10#1)(1996-11#2)(1996-12#8)(1996-2#5)(1996-3#8)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#5)(1996-8#8)(1996-9#3)(1997-1#7)(1997-2#7)(1997-3#9)(1997-4#11)(1997-5#7)(1997-6#10)(1997-7#7)(1997-8#12)(2004-1#1)(2004-10#3)(2004-11#1)(2004-12#2)(2004-4#1)(2004-7#3)(2005-1#3)(2005-10#8)(2005-11#19)(2005-12#4)(2005-3#2)(2005-6#3)(2005-7#7)(2005-8#11)(2005-9#4)(2006-1#2)(2006-10#66)(2006-11#3)(2006-12#16)(2006-2#20)(2006-3#18)(2006-4#8)(2006-5#9)(2006-6#16)(2006-7#8)(2006-8#15)(2006-9#7)(2007-1#11)(2007-10#7)(2007-11#64)(2007-12#57)(2007-2#21)(2007-3#11)(2007-4#17)(2007-5#8)(2007-6#7)(2007-7#40)(2007-8#28)(2007-9#18)(2008-1#33)(2008-10#95)(2008-11#47)(2008-12#33)(2008-2#158)(2008-3#104)(2008-4#27)(2008-5#22)(2008-6#36)(2008-7#49)(2008-8#23)(2008-9#25)(2009-10#19)(2009-11#6)(2009-12#10)(2009-2#7)(2009-3#11)(2009-4#18)(2009-5#10)(2009-6#15)(2009-7#7)(2009-8#6)(2009-9#11)(2010-1#6)(2010-10#6)(2010-11#16)(2010-12#21)(2010-2#13)(2010-3#11)(2010-4#9)(2010-5#6)(2010-6#5)(2010-7#7)(2010-8#14)(2010-9#11)(2011-1#32)(2011-12#4)(2011-2#73)(2011-3#2)(2012-1#14)(2012-11#5)(2012-12#40)(2012-2#43)(2012-3#20)(2013-1#112)(2013-7#6)(2013-8#35)
problem&quot##13##1##(1990-12#1)(1993-1#1)(1994-12#1)(1995-1#1)(2007-9#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-12#2)(2012-11#1)(2013-1#2)
problem'##4##1##(1991-1#1)(1995-7#1)(2009-5#1)(2009-9#1)
problem)##2##1##(2007-12#1)(2009-6#1)
problem-based learning (PBL) in##2##4##(2008-12#2)
problem-based learning (PBL)##6##3##(2008-10#1)(2008-11#1)(2008-12#3)(2013-8#1)
problem-based learning curriculum##4##3##(2006-12#1)(2008-10#1)(2011-1#1)(2012-1#1)
problem-based learning in a##2##4##(2008-11#1)(2008-12#1)
problem-based learning is##2##3##(1995-2#2)
problem-based learning##29##2##(1995-2#3)(2006-12#1)(2006-8#1)(2007-1#1)(2008-10#2)(2008-11#7)(2008-12#6)(2008-4#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#2)
problem-based##32##1##(1995-2#3)(2006-12#1)(2006-8#1)(2007-1#1)(2008-10#2)(2008-11#8)(2008-12#7)(2008-4#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-8#2)
problem-focused coping strategies##3##3##(1991-1#1)(2008-1#1)(2008-11#1)
problem-focused coping##8##2##(1991-1#1)(2008-1#1)(2008-11#1)(2011-2#4)(2012-1#1)
problem-focused##9##1##(1991-1#2)(2008-1#1)(2008-11#1)(2011-2#4)(2012-1#1)
problem-oriented medical##3##2##(1994-6#1)(2013-1#2)
problem-oriented##7##1##(1990-12#1)(1994-6#1)(2005-7#1)(2010-5#2)(2013-1#2)
problem-solving approach to##2##3##(1993-2#1)(2010-10#1)
problem-solving approach##4##2##(1993-2#2)(2010-10#2)
problem-solving skills and##3##3##(2008-12#1)(2009-10#1)(2010-6#1)
problem-solving skills##13##2##(1993-12#1)(1995-2#1)(1997-8#1)(2005-10#1)(2006-3#1)(2006-8#1)(2008-12#1)(2009-10#4)(2010-11#1)(2010-6#1)
problem-solving##52##1##(1991-5#1)(1992-3#1)(1992-5#1)(1993-12#3)(1993-2#4)(1993-3#1)(1994-1#1)(1994-3#2)(1995-2#2)(1995-6#2)(1996-2#2)(1996-3#1)(1996-7#1)(1997-8#1)(2005-10#1)(2005-12#1)(2006-3#1)(2006-8#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-8#1)(2009-10#4)(2009-7#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-1#2)(2013-1#1)
problem?##13##1##(1991-3#1)(1992-1#1)(1992-12#1)(1994-11#1)(1994-2#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-3#1)(2010-12#1)(2012-12#1)(2012-3#2)
problem?]##4##1##(1993-1#1)(1995-3#1)(2007-11#1)(2010-12#1)
problem]##16##1##(1990-10#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-6#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-4#1)(2005-11#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
problematic adverse##2##2##(1993-6#1)(2008-3#1)
problematic alcohol use##2##3##(2008-11#1)(2010-7#1)
problematic and##3##2##(1992-12#1)(2006-10#1)(2013-1#1)
problematic area##2##2##(2008-10#1)(2011-2#1)
problematic areas of##2##3##(2006-2#1)(2011-1#1)
problematic areas##4##2##(2006-2#1)(2011-1#1)(2013-1#2)
problematic aspects of##2##3##(2011-12#1)(2011-2#1)
problematic aspects##3##2##(2008-2#1)(2011-12#1)(2011-2#1)
problematic because of##3##3##(2008-10#1)(2008-5#1)(2010-4#1)
problematic because##5##2##(2005-8#1)(2008-10#1)(2008-5#1)(2010-4#1)(2012-2#1)
problematic considering##3##2##(2013-1#2)(2013-7#1)
problematic drinking behavior##2##3##(2009-12#2)
problematic drinking##3##2##(1994-2#1)(2009-12#2)
problematic during##2##2##(2006-12#1)(2008-11#1)
problematic if##2##2##(1992-2#1)(2011-2#1)
problematic in##9##2##(1996-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-3#1)(2011-2#1)
problematic issues##2##2##(1991-3#1)(2012-1#1)
problematic of##2##2##(2008-12#1)(2011-3#1)
problematic to##2##2##(2005-8#1)(2013-1#1)
problematic use##2##2##(2008-9#1)(2012-12#1)
problematic with##3##2##(1991-12#1)(2008-1#1)(2010-7#1)
problematic##125##1##(1990-9#1)(1991-12#2)(1991-3#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-3#2)(1993-6#1)(1994-2#2)(1994-5#1)(1994-6#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-8#1)(2005-8#3)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#3)(2007-1#2)(2007-11#2)(2007-12#3)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#4)(2008-12#3)(2008-2#5)(2008-3#2)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#5)(2009-3#2)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#8)(2013-7#3)
problematic)##2##1##(2012-2#2)
problematical##5##1##(1996-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
problematizing##2##1##(2006-5#1)(2006-7#1)
problems (eg##2##2##(2006-12#1)(2009-5#1)
problems -##4##2##(2006-7#1)(2007-11#3)
problems affecting the##2##3##(1994-6#1)(1996-3#1)
problems affecting##3##2##(1994-6#1)(1996-3#1)(2008-9#1)
problems after##7##2##(1991-8#1)(1992-10#1)(1995-9#1)(2006-3#1)(2007-8#1)(2010-2#1)(2010-6#1)
problems among adolescents##2##3##(2008-2#1)(2012-12#1)
problems among##13##2##(1992-4#1)(1994-12#1)(1995-6#1)(1996-1#1)(1996-9#1)(2008-11#2)(2008-2#1)(2009-8#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
problems and a##3##3##(2007-12#1)(2008-10#1)(2008-4#1)
problems and are##2##3##(2008-3#1)(2011-2#1)
problems and consequences of##2##4##(2007-8#1)(2010-9#1)
problems and disorders##2##3##(2008-2#1)(2012-12#1)
problems and family##2##3##(2009-7#1)(2011-2#1)
problems and have##2##3##(2007-7#1)(2008-2#1)
problems and interventions##2##3##(1995-3#1)(2008-2#1)
problems and issues##4##3##(1995-3#1)(1997-2#1)(2013-8#2)
problems and many##2##3##(1991-3#1)(2008-3#1)
problems and new##2##3##(1995-1#1)(2008-10#1)
problems and other##3##3##(1993-1#1)(1994-1#1)(2011-2#1)
problems and perspectives##3##3##(1990-12#1)(2007-2#1)(2013-8#1)
problems and progress##2##3##(1997-3#1)(2010-11#1)
problems and prospects##4##3##(1992-3#1)(2005-7#1)(2008-8#1)(2009-10#1)
problems and related##2##3##(1990-6#1)(2012-12#1)
problems and solutions##7##3##(1991-12#1)(1992-2#2)(1992-3#1)(1996-2#1)(2007-4#1)(2012-1#1)
problems and the challenges##2##4##(2011-1#1)(2011-2#1)
problems and the##10##3##(1993-2#1)(1993-8#1)(1995-6#1)(1996-2#1)(1997-1#1)(1997-4#1)(2007-11#1)(2007-8#1)(2011-1#1)(2011-2#1)
problems and their##3##3##(2008-9#1)(2011-1#1)(2013-1#1)
problems and to##7##3##(1995-11#1)(2006-2#1)(2007-12#1)(2009-5#1)(2010-10#1)(2010-12#1)(2011-12#1)
problems and victimization##2##3##(2010-4#2)
problems and##180##2##(1990-12#3)(1990-2#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-3#2)(1992-2#2)(1992-3#2)(1992-5#1)(1993-1#1)(1993-10#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-1#4)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#3)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(2004-7#1)(2004-8#1)(2005-10#2)(2005-7#3)(2005-9#2)(2006-10#5)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#5)(2008-12#1)(2008-2#6)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#7)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-6#2)(2010-9#1)(2011-1#5)(2011-12#3)(2011-2#9)(2012-1#2)(2012-12#5)(2012-2#2)(2013-1#5)(2013-7#4)(2013-8#5)
problems appear to be##2##4##(2005-10#1)(2009-12#1)
problems appear##3##2##(2005-10#1)(2009-10#1)(2009-12#1)
problems are addressed##2##3##(2007-4#1)(2010-11#1)
problems are also##2##3##(1993-6#1)(2008-3#1)
problems are being##2##3##(1994-6#1)(2007-5#1)
problems are considered##2##3##(1992-5#1)(2005-10#1)
problems are discussed in an interactive case presentation##4##8##(2006-12#2)(2007-12#1)(2008-1#1)
problems are discussed##7##3##(1997-4#1)(2006-12#2)(2007-12#1)(2008-1#2)(2008-9#1)
problems are more##3##3##(1990-3#1)(1996-9#1)(2009-10#1)
problems are not##3##3##(2005-12#1)(2007-2#1)(2008-10#1)
problems are usually##3##3##(1994-11#1)(2007-7#1)(2008-8#1)
problems are well known##3##4##(1990-2#1)(1990-4#1)(1996-3#1)
problems are##72##2##(1990-2#2)(1990-3#1)(1990-4#1)(1991-12#1)(1992-5#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-4#1)(1995-9#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-10#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-12#3)(2006-2#2)(2007-10#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#5)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-8#1)
problems arise from##2##3##(2010-11#1)(2011-2#1)
problems arise##6##2##(2006-10#1)(2007-8#1)(2008-7#1)(2010-10#1)(2010-11#1)(2011-2#1)
problems arising from##5##3##(1990-6#1)(2007-5#1)(2008-10#1)(2010-7#1)(2013-1#1)
problems arising in##2##3##(2008-10#1)(2009-10#1)
problems arising##7##2##(1990-6#1)(2007-5#1)(2008-10#2)(2009-10#1)(2010-7#1)(2013-1#1)
problems as##12##2##(1991-10#1)(1994-6#1)(1996-3#1)(2005-10#1)(2006-2#1)(2007-2#1)(2008-2#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-3#1)
problems associated with a##2##4##(2005-11#1)(2010-4#1)
problems associated with the use of##4##6##(1992-3#1)(2008-1#1)(2008-11#1)(2008-3#1)
problems associated with the##20##4##(1992-3#1)(1993-1#1)(1996-2#1)(1996-9#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-9#1)(2010-6#1)(2013-1#1)
problems associated with their use##2##5##(2006-2#1)(2011-2#1)
problems associated with their##3##4##(2006-2#1)(2011-2#1)(2011-3#1)
problems associated with these##2##4##(2007-8#1)(2008-7#1)
problems associated with this##4##4##(1991-3#1)(2007-8#1)(2007-9#1)(2008-4#1)
problems associated with using##3##4##(2007-8#1)(2008-10#1)(2009-5#1)
problems associated with##74##3##(1991-3#2)(1992-3#1)(1993-1#2)(1993-11#1)(1993-3#1)(1994-1#1)(1996-12#1)(1996-2#1)(1996-9#1)(2005-11#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-5#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-5#1)(2009-9#1)(2010-12#2)(2010-4#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#2)(2011-3#1)(2013-1#3)(2013-8#1)
problems at the##4##3##(1997-2#1)(2008-12#1)(2011-1#1)(2012-2#1)
problems at##10##2##(1991-8#1)(1997-2#1)(2005-7#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-7#1)(2010-8#1)(2011-1#1)(2012-2#1)
problems based on##3##3##(1994-6#1)(2009-9#1)(2013-7#1)
problems because of##2##3##(1997-7#1)(2007-8#1)
problems because##4##2##(1997-7#1)(2005-10#1)(2007-8#1)(2009-9#1)
problems between##3##2##(1997-6#1)(2006-8#1)(2008-3#1)
problems but##2##2##(2006-3#1)(2008-10#1)
problems by utilizing##2##3##(1991-3#1)(2011-1#1)
problems by##12##2##(1991-3#1)(1992-12#1)(1996-1#1)(2005-8#1)(2006-3#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-12#1)(2011-1#1)
problems can be avoided##2##4##(1993-2#1)(2008-7#1)
problems can be solved by##2##5##(2010-7#1)(2011-12#1)
problems can be solved##5##4##(2006-3#1)(2007-11#1)(2008-11#1)(2010-7#1)(2011-12#1)
problems can be##15##3##(1992-11#1)(1993-2#1)(1994-12#1)(1997-8#1)(2006-3#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-7#1)(2011-12#1)
problems can##20##2##(1992-11#1)(1993-2#1)(1994-12#1)(1997-8#2)(2006-3#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-7#2)(2008-8#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-12#1)
problems caused by the##5##4##(1990-12#1)(2004-4#1)(2007-11#1)(2007-7#1)(2009-3#1)
problems caused by##10##3##(1990-12#1)(1991-1#1)(1992-3#1)(1996-3#1)(2004-4#1)(2005-8#1)(2007-11#1)(2007-7#1)(2009-3#1)(2011-2#1)
problems compared##2##2##(2005-9#1)(2009-8#1)
problems concerning the##4##3##(1996-12#1)(1997-1#1)(1997-8#1)(2007-8#1)
problems concerning##11##2##(1991-10#1)(1995-5#1)(1996-12#1)(1997-1#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)
problems confronting the##2##3##(1990-10#2)
problems connected to##5##3##(1993-6#1)(1994-11#1)(1994-6#1)(2008-11#1)(2009-7#1)
problems connected with##3##3##(1997-6#1)(2007-7#1)(2008-10#1)
problems connected##8##2##(1993-6#1)(1994-11#1)(1994-6#1)(1997-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-7#1)
problems considered##2##2##(1996-8#1)(2008-11#1)
problems continue to##2##3##(1995-12#1)(2006-10#1)
problems could##2##2##(2007-2#1)(2009-7#1)
problems currently##2##2##(1995-12#1)(2008-7#1)
problems derived from##2##3##(2009-10#1)(2009-9#1)
problems detected##2##2##(1993-5#1)(2011-2#1)
problems did not##2##3##(2007-9#1)(2013-8#1)
problems due to the##4##4##(2008-10#2)(2010-4#1)(2012-3#1)
problems due to their##2##4##(1995-12#1)(2008-1#1)
problems due to##11##3##(1990-11#1)(1990-3#1)(1991-12#1)(1995-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-4#1)(2012-3#1)
problems during pregnancy and##2##4##(2011-12#1)(2012-2#1)
problems during pregnancy##3##3##(2006-8#1)(2011-12#1)(2012-2#1)
problems during the##3##3##(1990-3#1)(1990-5#1)(2006-2#1)
problems during##10##2##(1990-3#1)(1990-5#1)(2006-10#2)(2006-2#1)(2006-8#1)(2011-12#1)(2011-2#1)(2012-2#2)
problems encountered and##2##3##(1990-9#1)(2010-10#1)
problems encountered by##3##3##(2005-7#1)(2008-12#1)(2012-12#1)
problems encountered during##2##3##(2008-7#1)(2010-12#1)
problems encountered in the##3##4##(2008-10#1)(2008-2#1)(2008-7#1)
problems encountered in##13##3##(1993-9#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-2#2)(2008-7#2)(2008-9#1)(2011-1#1)(2012-1#1)
problems encountered when##2##3##(1994-2#1)(2008-4#1)
problems encountered with##5##3##(2007-10#1)(2007-7#1)(2008-3#1)(2008-7#1)(2009-6#1)
problems encountered##32##2##(1990-9#1)(1993-12#1)(1993-9#1)(1994-2#1)(2004-9#1)(2005-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#2)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#6)(2008-9#1)(2009-10#1)(2009-6#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)
problems even##2##2##(2007-7#1)(2008-1#1)
problems exist##2##2##(1990-12#1)(2008-11#1)
problems existing in the##2##4##(2008-2#1)(2013-1#1)
problems experienced by patients in the postoperative period##2##8##(2010-10#2)
problems experienced by##4##3##(2005-12#1)(2006-2#1)(2010-10#2)
problems experienced##7##2##(2005-12#1)(2006-2#1)(2007-11#1)(2008-11#1)(2008-2#1)(2010-10#2)
problems faced by the##4##4##(2007-11#2)(2008-11#1)(2012-2#1)
problems faced by##12##3##(1993-12#1)(2006-9#1)(2007-11#3)(2008-1#1)(2008-11#1)(2008-6#1)(2009-4#1)(2010-1#1)(2012-2#1)(2013-8#1)
problems faced in##2##3##(1992-2#1)(2008-1#1)
problems faced##14##2##(1992-2#1)(1993-12#1)(2006-9#1)(2007-11#3)(2008-1#2)(2008-11#1)(2008-6#1)(2009-4#1)(2010-1#1)(2012-2#1)(2013-8#1)
problems facing##9##2##(1991-2#2)(1992-2#1)(2005-8#2)(2007-4#1)(2008-3#1)(2008-7#1)(2010-7#1)
problems for the drinker##2##4##(2005-10#2)
problems for the##11##3##(1993-10#1)(1994-11#1)(2004-10#1)(2005-10#2)(2006-6#1)(2006-9#1)(2007-11#1)(2008-9#1)(2009-3#1)(2012-1#1)
problems for which they##2##4##(2007-10#2)
problems for which##5##3##(2006-2#1)(2007-10#2)(2008-12#1)(2008-3#1)
problems for##41##2##(1993-10#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-2#1)(2004-10#1)(2005-10#4)(2006-12#1)(2006-2#2)(2006-6#1)(2006-9#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-12#3)(2009-3#1)(2009-8#1)(2012-1#1)(2012-2#1)
problems found in##2##3##(2009-12#1)(2010-2#1)
problems found##3##2##(2008-1#1)(2009-12#1)(2010-2#1)
problems from the##4##3##(1997-3#1)(2005-10#1)(2008-10#1)(2008-2#1)
problems from##7##2##(1997-3#1)(2004-7#1)(2005-10#2)(2008-10#1)(2008-2#1)(2011-1#1)
problems has##3##2##(1992-8#1)(1993-11#1)(2008-7#1)
problems have been##5##3##(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)
problems have##9##2##(1990-5#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)(2011-1#1)
problems hindering##2##2##(2005-6#1)(2008-8#1)
problems identified##3##2##(1992-3#1)(1994-6#1)(2006-5#1)
problems in a##4##3##(1997-7#1)(2008-8#1)(2009-8#1)(2010-11#1)
problems in advanced##2##3##(1990-3#1)(2007-4#1)
problems in analytical chemistry##3##4##(2008-10#3)
problems in biology##2##3##(2006-4#1)(2008-4#1)
problems in children with##4##4##(1992-2#1)(2006-10#1)(2011-1#1)(2012-11#1)
problems in children##12##3##(1992-2#1)(1995-3#1)(1996-1#1)(2006-10#2)(2008-11#1)(2011-1#1)(2012-11#1)(2013-7#3)(2013-8#1)
problems in clinical practice##2##4##(1993-2#1)(2008-12#1)
problems in clinical##3##3##(1993-2#1)(2008-12#1)(2010-11#1)
problems in connection with##2##4##(1990-11#1)(1991-5#1)
problems in defining##2##3##(1996-1#1)(2008-10#1)
problems in developing countries##4##4##(2006-10#1)(2006-4#1)(2007-11#1)(2010-12#1)
problems in drug##2##3##(1996-12#1)(2011-1#1)
problems in health care##2##4##(2008-7#1)(2010-8#1)
problems in health##3##3##(1994-2#1)(2008-7#1)(2010-8#1)
problems in management##2##3##(2006-9#1)(2009-12#1)
problems in many##3##3##(2006-4#1)(2006-6#1)(2009-8#1)
problems in modern##2##3##(2010-7#1)(2013-8#1)
problems in patients with##2##4##(2006-5#1)(2008-7#1)
problems in patients##7##3##(2006-5#1)(2006-6#1)(2007-7#2)(2008-7#2)(2009-11#1)
problems in primary##2##3##(1997-5#1)(2008-10#1)
problems in some##4##3##(1990-6#1)(2005-8#1)(2008-10#1)(2011-2#1)
problems in stem cell##2##4##(2009-3#1)(2010-11#1)
problems in terms of##4##4##(1994-3#1)(2008-10#1)(2012-12#1)(2012-2#1)
problems in the adolescent##3##4##(2008-7#3)
problems in the first##2##4##(2007-11#1)(2013-1#1)
problems in the health care system##2##6##(1993-6#1)(1994-2#1)
problems in the health care##3##5##(1993-3#1)(1993-6#1)(1994-2#1)
problems in the health##4##4##(1992-11#1)(1993-3#1)(1993-6#1)(1994-2#1)
problems in the management of##3##5##(2006-2#1)(2007-7#1)(2010-12#1)
problems in the presence of##2##5##(2008-10#1)(2012-3#1)
problems in the surgical##2##4##(1992-10#1)(2008-1#1)
problems in the treatment of##2##5##(1992-8#1)(1993-6#1)
problems in the##65##3##(1991-11#1)(1991-2#1)(1991-3#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-3#1)(1993-6#2)(1993-7#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-4#1)(1996-7#1)(1997-8#1)(2004-4#1)(2006-2#1)(2006-3#1)(2006-9#1)(2007-11#5)(2007-5#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#4)(2009-12#1)(2009-2#2)(2009-5#2)(2009-8#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
problems in their##2##3##(1992-1#1)(2010-2#1)
problems in this area##3##4##(1992-10#1)(1994-2#1)(2008-7#1)
problems in this##6##3##(1991-11#1)(1992-10#1)(1994-2#1)(1997-8#1)(2008-7#1)(2009-7#1)
problems in which the##2##4##(2010-11#2)
problems in which##3##3##(2010-11#2)(2010-8#1)
problems in women##3##3##(2005-9#1)(2007-11#1)(2007-12#1)
problems in##312##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-9#2)(1991-11#3)(1991-2#2)(1991-3#2)(1991-5#2)(1992-1#2)(1992-10#2)(1992-11#1)(1992-2#2)(1992-3#2)(1992-7#2)(1992-8#1)(1993-1#2)(1993-10#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#2)(1994-2#4)(1994-3#2)(1994-9#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-3#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-5#3)(1997-7#1)(1997-8#2)(2004-4#2)(2005-10#1)(2005-12#2)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#4)(2006-5#3)(2006-6#2)(2006-8#2)(2006-9#2)(2007-10#2)(2007-11#11)(2007-12#6)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#2)(2007-7#12)(2007-8#7)(2007-9#1)(2008-1#3)(2008-10#16)(2008-11#5)(2008-12#3)(2008-2#6)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#13)(2008-8#3)(2008-9#3)(2009-1#1)(2009-11#2)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#2)(2010-11#5)(2010-12#5)(2010-2#2)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#4)(2011-11#1)(2011-12#1)(2011-2#11)(2011-3#1)(2012-1#3)(2012-11#5)(2012-12#4)(2012-2#7)(2012-3#3)(2013-1#8)(2013-7#5)(2013-8#5)
problems included##2##2##(2008-3#1)(2013-7#1)
problems including##3##2##(2009-3#1)(2012-12#1)(2012-3#1)
problems inherent##4##2##(1993-3#1)(2008-10#1)(2008-6#1)(2011-2#1)
problems involve##2##2##(2008-7#1)(2009-9#1)
problems involved in the##2##4##(2007-11#1)(2007-7#1)
problems involved in##6##3##(1994-8#1)(1997-2#1)(2005-8#1)(2007-11#1)(2007-7#1)(2008-12#1)
problems involved##7##2##(1994-8#1)(1996-12#1)(1997-2#1)(2005-8#1)(2007-11#1)(2007-7#1)(2008-12#1)
problems involving the##3##3##(1990-3#1)(1995-4#1)(2008-1#1)
problems involving##5##2##(1990-3#1)(1995-4#1)(2008-1#1)(2008-3#1)(2011-2#1)
problems is an##2##3##(1994-10#1)(2011-2#1)
problems is discussed##2##3##(1995-9#1)(2006-12#1)
problems is##18##2##(1992-1#1)(1993-11#1)(1993-12#1)(1994-10#1)(1995-9#1)(1996-8#1)(1997-3#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-12#1)(2008-2#2)(2008-3#1)(2011-2#1)(2013-7#1)
problems like##5##2##(2006-10#1)(2006-12#1)(2007-12#1)(2007-3#1)(2012-2#1)
problems linked to the##2##4##(1996-11#1)(2008-2#1)
problems linked to##4##3##(1996-11#1)(2008-10#1)(2008-2#1)(2010-11#1)
problems may be##2##3##(1992-2#1)(2009-4#1)
problems may occur in##2##4##(2007-7#1)(2009-5#1)
problems may occur##3##3##(1993-6#1)(2007-7#1)(2009-5#1)
problems may##10##2##(1992-2#1)(1993-12#1)(1993-6#1)(1995-9#1)(1996-3#1)(1996-5#1)(2006-8#1)(2007-7#1)(2009-4#1)(2009-5#1)
problems more##3##2##(1992-9#1)(1994-1#1)(2009-8#1)
problems must be##2##3##(1994-2#1)(2008-12#1)
problems not##2##2##(1990-10#1)(1992-3#1)
problems now##2##2##(1992-2#1)(1993-3#1)
problems occur##2##2##(2009-10#1)(2013-1#1)
problems occurred##3##2##(1993-3#1)(1994-3#1)(2012-12#1)
problems occurring##3##2##(2007-12#1)(2007-7#1)(2007-8#1)
problems of a##3##3##(2008-2#1)(2008-5#1)(2011-1#1)
problems of acceptability##2##3##(2008-2#1)(2010-8#1)
problems of availability##2##3##(2010-8#2)
problems of bias##2##3##(1994-11#1)(2008-3#1)
problems of clinical##2##3##(1990-2#1)(2008-10#1)
problems of diagnosis and##3##4##(1993-10#1)(1993-9#1)(2008-1#1)
problems of diagnosis##4##3##(1991-12#1)(1993-10#1)(1993-9#1)(2008-1#1)
problems of emerging##2##3##(2005-7#1)(2011-1#1)
problems of health care##2##4##(1994-2#2)
problems of old age##2##4##(1992-1#1)(1994-6#1)
problems of overuse##2##3##(1994-3#2)
problems of poor##3##3##(2007-9#1)(2008-1#1)(2008-9#1)
problems of quality##2##3##(2008-10#1)(2013-1#1)
problems of residual##2##3##(2006-10#1)(2012-12#1)
problems of the health##2##4##(1990-12#1)(2007-5#1)
problems of the##17##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-3#1)(1993-12#1)(1994-2#2)(1994-3#1)(1995-3#1)(2007-5#2)(2007-7#1)(2008-1#1)(2011-1#1)(2012-12#1)(2013-1#2)
problems of this##4##3##(1990-9#1)(1994-6#1)(2007-8#1)(2008-3#1)
problems of using##2##3##(2006-6#1)(2011-2#1)
problems of##193##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#2)(1992-3#1)(1992-4#1)(1992-6#1)(1993-10#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#4)(1994-3#3)(1994-6#2)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-1#1)(2005-4#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-6#3)(2007-11#4)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#4)(2008-1#6)(2008-10#8)(2008-11#6)(2008-12#1)(2008-2#9)(2008-3#6)(2008-4#1)(2008-5#6)(2008-6#4)(2008-7#6)(2008-8#2)(2008-9#2)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#4)(2012-1#3)(2012-11#2)(2012-12#2)(2012-3#2)(2013-1#6)(2013-7#3)(2013-8#2)
problems often##6##2##(1994-6#1)(1997-2#1)(2007-9#1)(2008-4#1)(2009-10#1)(2013-7#1)
problems on a##2##3##(1993-5#1)(1997-2#1)
problems on##7##2##(1993-5#1)(1994-2#1)(1997-2#1)(2006-10#1)(2007-12#1)(2009-10#1)(2011-2#1)
problems or##22##2##(1990-6#1)(1993-2#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-2#4)(2008-4#1)(2008-8#1)(2009-11#1)(2009-7#2)(2010-12#1)(2010-4#1)(2010-7#1)(2012-2#3)(2013-1#2)
problems over##3##2##(2008-10#1)(2009-7#1)(2010-11#1)
problems owing to##2##3##(2009-11#1)(2010-12#1)
problems posed by##3##3##(1991-12#1)(2007-8#1)(2010-11#1)
problems presented##2##2##(1992-12#1)(2010-11#1)
problems provides##2##2##(1994-2#1)(2008-7#1)
problems raised##2##2##(1995-9#1)(2007-7#1)
problems regarding the##3##3##(1990-3#1)(1997-8#1)(2006-9#1)
problems regarding##9##2##(1990-3#1)(1991-2#1)(1995-10#1)(1997-8#2)(2006-11#1)(2006-8#1)(2006-9#1)(2008-6#1)
problems related to the##8##4##(1992-10#1)(1993-5#1)(1996-12#1)(2006-6#1)(2008-10#2)(2008-3#1)(2011-2#1)
problems related to this##2##4##(1990-10#1)(2008-8#1)
problems related to##35##3##(1990-10#1)(1990-4#1)(1991-3#1)(1992-10#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-5#1)(1994-10#1)(1995-5#1)(1996-12#2)(2006-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#3)(2008-8#1)(2008-9#1)(2010-11#1)(2010-5#2)(2011-1#1)(2011-2#2)
problems related with its##2##4##(2008-10#1)(2010-7#1)
problems related with##3##3##(2008-10#2)(2010-7#1)
problems related##38##2##(1990-10#1)(1990-4#1)(1991-3#1)(1992-10#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-5#1)(1994-10#1)(1995-5#1)(1996-12#2)(2006-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#3)(2008-8#1)(2008-9#1)(2010-11#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#2)
problems relating to the##3##4##(1992-5#1)(1993-6#1)(2011-2#1)
problems relating to##4##3##(1992-5#1)(1993-6#1)(2007-9#1)(2011-2#1)
problems remain##4##2##(1994-5#1)(2005-7#1)(2008-11#2)
problems reported by##2##3##(2008-3#1)(2013-1#1)
problems reported##3##2##(2006-10#1)(2008-3#1)(2013-1#1)
problems seen##3##2##(2008-10#1)(2008-12#1)(2010-12#1)
problems should be##5##3##(1996-2#1)(2008-1#1)(2008-6#1)(2010-7#2)
problems should##8##2##(1993-5#1)(1996-2#1)(1996-6#1)(2006-11#1)(2008-1#1)(2008-6#1)(2010-7#2)
problems such as the##2##4##(2007-4#1)(2008-1#1)
problems such as##20##3##(1990-4#1)(1995-9#1)(1996-11#2)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-7#1)(2012-3#1)(2013-1#1)
problems such##21##2##(1990-4#1)(1995-9#1)(1996-11#2)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-7#1)(2012-3#1)(2013-1#1)
problems surrounding##2##2##(1993-2#1)(2009-7#1)
problems than the##2##3##(1996-6#1)(2006-8#1)
problems than##9##2##(1992-1#1)(1994-3#1)(1996-6#1)(2006-8#1)(2007-12#1)(2008-7#2)(2008-9#1)(2009-9#1)
problems that are encountered in##2##5##(2008-3#1)(2008-4#1)
problems that are encountered##3##4##(2005-8#1)(2008-3#1)(2008-4#1)
problems that are##9##3##(1990-12#1)(2005-8#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-1#1)(2012-3#1)
problems that arise##3##3##(1992-2#1)(1995-6#1)(2006-10#1)
problems that can##3##3##(2008-7#1)(2010-4#1)(2011-2#1)
problems that could##2##3##(2008-10#1)(2010-3#1)
problems that have##3##3##(2006-7#1)(2011-1#1)(2013-1#1)
problems that lead to##2##4##(2006-4#1)(2013-8#1)
problems that may arise in##2##5##(2007-10#1)(2007-2#1)
problems that may arise##6##4##(1992-10#1)(1994-4#1)(2005-5#1)(2007-10#1)(2007-2#1)(2009-9#1)
problems that may be##2##4##(1993-2#1)(2008-1#1)
problems that may##9##3##(1992-10#1)(1993-2#1)(1994-4#1)(2005-5#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-9#1)(2009-9#1)
problems that need to be##2##5##(1995-11#1)(2013-8#1)
problems that need##4##3##(1995-11#1)(2011-1#1)(2012-12#1)(2013-8#1)
problems that we##2##3##(2008-2#1)(2012-2#1)
problems that##67##2##(1990-12#1)(1990-2#1)(1991-11#1)(1991-12#1)(1992-10#1)(1992-2#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-4#1)(1995-11#1)(1995-6#1)(1996-8#1)(2004-3#1)(2005-5#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-4#2)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#5)(2008-9#2)(2009-10#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#5)
problems the##4##2##(1991-3#1)(1992-9#1)(1996-9#1)(2010-7#1)
problems these##4##2##(1991-12#1)(2008-5#2)(2009-3#1)
problems they##6##2##(2006-10#2)(2006-12#1)(2006-2#1)(2008-4#1)(2010-10#1)
problems through##3##2##(2006-3#2)(2007-12#1)
problems to be addressed##4##4##(2006-6#1)(2013-8#3)
problems to be##6##3##(2006-6#1)(2007-7#1)(2012-2#1)(2013-8#3)
problems to##21##2##(1991-2#1)(1991-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1995-5#1)(1996-12#1)(1997-6#1)(2006-6#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-2#1)(2009-10#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#3)
problems under##3##2##(1991-2#1)(1993-6#1)(2010-11#1)
problems underlying##2##2##(2011-2#1)(2013-1#1)
problems unique to##2##3##(1992-2#1)(2013-1#1)
problems unrelated to wheelchair use##2##5##(2007-7#2)
problems using##4##2##(1994-9#1)(2008-2#1)(2008-4#1)(2010-2#1)
problems usually##2##2##(1994-9#1)(2008-10#1)
problems was##8##2##(1996-1#1)(1996-6#1)(2006-8#1)(2008-8#1)(2010-7#1)(2013-1#2)(2013-8#1)
problems were discussed##2##3##(2006-9#1)(2008-10#1)
problems were found in##2##4##(1997-6#1)(2013-7#1)
problems were found##4##3##(1997-6#1)(2007-2#1)(2008-3#1)(2013-7#1)
problems were identified##3##3##(2013-1#2)(2013-8#1)
problems were not##2##3##(1994-6#1)(2006-7#1)
problems were observed##2##3##(2008-1#1)(2008-10#1)
problems were solved##2##3##(2007-9#1)(2008-10#1)
problems were##45##2##(1990-2#1)(1991-2#1)(1991-8#1)(1992-5#1)(1994-3#1)(1994-6#1)(1997-6#1)(2004-3#1)(2006-3#1)(2006-7#1)(2006-9#1)(2007-2#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-12#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-1#2)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#2)
problems when##4##2##(1996-6#1)(2008-10#1)(2012-1#1)(2012-12#1)
problems where##4##2##(1990-4#1)(2006-10#1)(2009-9#1)(2010-11#1)
problems which are##3##3##(1996-12#1)(2006-10#1)(2010-3#1)
problems which the##2##3##(1995-5#1)(2007-8#1)
problems which##12##2##(1990-12#1)(1992-10#1)(1993-11#1)(1995-5#2)(1996-12#1)(2004-7#1)(2006-10#1)(2007-10#1)(2007-8#1)(2010-3#1)(2012-1#1)
problems will##2##2##(1993-1#1)(2008-12#1)
problems with a##2##3##(2010-2#1)(2010-7#1)
problems with computationally##2##3##(2007-9#2)
problems with contamination##2##3##(2008-4#1)(2008-6#1)
problems with hearing##2##3##(2006-11#1)(2008-4#1)
problems with high##2##3##(2008-3#1)(2011-1#1)
problems with mobility##2##3##(2007-6#2)
problems with regard to##2##4##(1994-2#1)(2007-10#1)
problems with respect to##2##4##(2006-10#1)(2008-11#1)
problems with the research##2##4##(2007-8#1)(2011-2#1)
problems with the##15##3##(1994-6#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-3#1)(2010-12#1)(2010-2#1)(2011-2#1)
problems with this##3##3##(2005-12#1)(2008-10#1)(2008-9#1)
problems with##107##2##(1990-11#2)(1991-10#1)(1991-12#2)(1992-10#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-7#1)(1995-9#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-9#2)(2005-12#1)(2006-10#4)(2006-11#1)(2006-2#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#3)(2007-2#1)(2007-5#1)(2007-6#4)(2007-8#3)(2007-9#3)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-6#4)(2008-7#3)(2008-9#2)(2009-11#2)(2009-3#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-2#3)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)
problems within##2##2##(2008-12#1)(2010-9#1)
problems##2543##1##(1990-10#4)(1990-11#8)(1990-12#14)(1990-2#7)(1990-3#9)(1990-4#5)(1990-5#6)(1990-6#8)(1990-7#1)(1990-8#5)(1990-9#5)(1991-1#2)(1991-10#4)(1991-11#8)(1991-12#16)(1991-2#11)(1991-3#15)(1991-5#3)(1991-6#4)(1991-8#3)(1991-9#1)(1992-1#14)(1992-10#7)(1992-11#4)(1992-12#3)(1992-2#13)(1992-3#15)(1992-4#3)(1992-5#9)(1992-6#3)(1992-7#3)(1992-8#4)(1992-9#6)(1993-1#13)(1993-10#6)(1993-11#6)(1993-12#12)(1993-2#12)(1993-3#13)(1993-5#8)(1993-6#10)(1993-7#2)(1993-8#2)(1993-9#7)(1994-1#8)(1994-10#2)(1994-11#5)(1994-12#5)(1994-2#19)(1994-3#16)(1994-4#3)(1994-5#3)(1994-6#12)(1994-7#1)(1994-8#3)(1994-9#6)(1995-1#7)(1995-10#2)(1995-11#2)(1995-12#7)(1995-2#4)(1995-3#10)(1995-4#2)(1995-5#10)(1995-6#5)(1995-8#2)(1995-9#14)(1996-1#10)(1996-10#1)(1996-11#5)(1996-12#14)(1996-2#11)(1996-3#12)(1996-4#2)(1996-5#1)(1996-6#8)(1996-7#2)(1996-8#3)(1996-9#6)(1997-1#4)(1997-2#13)(1997-3#9)(1997-4#7)(1997-5#8)(1997-6#7)(1997-7#4)(1997-8#14)(2004-10#1)(2004-2#1)(2004-3#4)(2004-4#3)(2004-7#4)(2004-8#1)(2004-9#4)(2005-1#2)(2005-10#23)(2005-11#4)(2005-12#5)(2005-4#1)(2005-5#2)(2005-6#1)(2005-7#14)(2005-8#13)(2005-9#5)(2006-1#2)(2006-10#64)(2006-11#8)(2006-12#15)(2006-2#16)(2006-3#16)(2006-4#8)(2006-5#6)(2006-6#11)(2006-7#11)(2006-8#12)(2006-9#12)(2007-1#6)(2007-10#25)(2007-11#62)(2007-12#45)(2007-2#24)(2007-3#11)(2007-4#10)(2007-5#12)(2007-6#10)(2007-7#47)(2007-8#43)(2007-9#29)(2008-1#42)(2008-10#99)(2008-11#68)(2008-12#30)(2008-2#106)(2008-3#55)(2008-4#28)(2008-5#27)(2008-6#27)(2008-7#81)(2008-8#32)(2008-9#45)(2009-1#2)(2009-10#20)(2009-11#14)(2009-12#20)(2009-2#6)(2009-3#9)(2009-4#10)(2009-5#11)(2009-6#7)(2009-7#25)(2009-8#13)(2009-9#19)(2010-1#4)(2010-10#8)(2010-11#25)(2010-12#21)(2010-2#16)(2010-3#5)(2010-4#15)(2010-5#9)(2010-6#11)(2010-7#20)(2010-8#19)(2010-9#9)(2011-1#50)(2011-11#1)(2011-12#9)(2011-2#70)(2011-3#3)(2011-7#1)(2012-1#22)(2012-11#8)(2012-12#33)(2012-2#45)(2012-3#18)(2013-1#72)(2013-7#22)(2013-8#35)
problems&quot##4##1##(1991-3#1)(1992-1#1)(1996-9#1)(2008-6#1)
problems)##10##1##(1991-12#1)(1993-11#1)(2005-10#1)(2005-7#1)(2006-11#1)(2008-11#1)(2008-7#1)(2009-11#1)(2012-12#1)(2013-1#1)
problems?##3##1##(2007-8#1)(2011-1#1)(2012-3#1)
problems?]##2##1##(1990-6#1)(1995-8#1)
problems]##20##1##(1990-12#1)(1990-4#1)(1991-5#1)(1992-3#2)(1992-5#1)(1993-11#1)(1993-3#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-3#1)(1996-6#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-9#2)(2012-3#1)
proboscis in##3##2##(2007-12#3)
proboscis##9##1##(1994-8#1)(2007-12#6)(2008-11#1)(2008-4#1)
probucol##5##1##(1991-5#1)(1992-8#1)(2005-8#2)(2008-11#1)
procainamide##7##1##(1992-9#1)(1994-3#2)(1997-3#1)(2007-8#1)(2008-10#1)(2008-5#1)
procaine hydrochloride and##2##3##(2005-4#1)(2008-10#1)
procaine hydrochloride##13##2##(1992-5#2)(2005-4#1)(2008-10#10)
procaine##30##1##(1990-2#1)(1991-1#1)(1992-5#2)(1993-2#1)(1993-9#4)(1994-3#1)(1996-5#1)(2005-4#3)(2006-7#1)(2008-10#14)(2008-3#1)
procalcitonin concentrations##3##2##(1993-2#3)
procalcitonin in patients with##3##4##(1993-2#1)(2008-5#1)(2012-12#1)
procalcitonin in##8##2##(1993-2#1)(2008-5#2)(2010-12#1)(2012-12#1)(2013-1#3)
procalcitonin level was##2##3##(2013-1#2)
procalcitonin level##5##2##(2013-1#5)
procalcitonin##26##1##(1991-2#2)(1993-2#7)(2008-5#3)(2009-2#1)(2010-12#2)(2011-2#1)(2012-12#1)(2013-1#9)
procapsid shells##2##2##(1995-1#2)
procapsid##4##1##(1995-1#4)
procarcinogenic##2##1##(1994-6#1)(2013-1#1)
procarcinogens##2##1##(1992-12#1)(1995-12#1)
procaryotic and eucaryotic##2##3##(1993-4#1)(1994-6#1)
procaryotic##3##1##(1993-11#1)(1993-4#1)(1994-6#1)
procathepsin E to##3##3##(1991-2#3)
procathepsin E##5##2##(1991-2#5)
procathepsin L##9##2##(1995-6#9)
procathepsin##14##1##(1991-2#5)(1995-6#9)
procede de##2##2##(2008-5#2)
procede##3##1##(1995-11#1)(2008-5#2)
procedes##2##1##(2008-5#2)
procedural and declarative##2##3##(2008-2#2)
procedural and sensory information##2##4##(1995-1#2)
procedural and##6##2##(1995-1#2)(2008-10#1)(2008-2#2)(2012-2#1)
procedural complexity##6##2##(2013-1#6)
procedural complications##4##2##(2006-6#2)(2007-11#1)(2007-8#1)
procedural due process##2##3##(1990-5#1)(2007-3#1)
procedural justice##2##2##(2006-5#1)(2011-2#1)
procedural learning in early Alzheimer's disease##2##6##(2012-1#2)
procedural learning in##3##3##(2012-1#3)
procedural learning##5##2##(2012-1#5)
procedural model##2##2##(2007-11#2)
procedural pain in infancy##2##4##(2008-10#2)
procedural pain in##4##3##(2008-10#3)(2012-1#1)
procedural pain##16##2##(1993-2#1)(2008-10#5)(2009-12#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#4)
procedural parameters##2##2##(2008-10#1)(2009-5#1)
procedural results##2##2##(2009-10#1)(2011-2#1)
procedural sedation and##3##3##(2007-7#1)(2009-6#2)
procedural sedation##6##2##(2006-10#2)(2007-7#1)(2009-6#3)
procedural success rates##2##3##(2008-11#1)(2008-12#1)
procedural success##3##2##(2007-5#1)(2008-11#1)(2008-12#1)
procedural techniques##2##2##(2006-6#1)(2008-7#1)
procedural terminology##3##2##(2006-8#3)
procedural time##2##2##(2007-8#2)
procedural variables##2##2##(2010-12#1)(2011-2#1)
procedural##111##1##(1990-5#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-9#1)(1993-2#2)(1995-1#2)(1996-1#1)(1996-2#2)(2005-12#1)(2005-8#1)(2006-10#5)(2006-11#1)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#4)(2007-11#3)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#4)(2008-10#10)(2008-11#1)(2008-12#3)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#3)(2009-4#1)(2009-5#1)(2009-6#4)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-1#8)(2012-12#1)(2012-2#7)(2013-1#6)
procedure (3##2##2##(1995-6#1)(2007-7#1)
procedure (n =##2##3##(2006-6#2)
procedure DROPCORA##2##2##(2008-10#2)
procedure Part##3##2##(2008-10#3)
procedure a##6##2##(1995-4#1)(2007-10#1)(2008-10#2)(2008-4#2)
procedure after##5##2##(1994-5#1)(1996-8#1)(2007-7#1)(2011-12#1)(2012-12#1)
procedure agree##2##2##(2008-10#2)
procedure aimed at##2##3##(2008-4#1)(2009-8#1)
procedure aimed##3##2##(2008-1#1)(2008-4#1)(2009-8#1)
procedure allowed the##6##3##(1992-6#1)(1993-9#1)(1996-8#1)(2008-10#3)
procedure allowed us to##2##4##(2007-12#1)(2008-2#1)
procedure allowed##9##2##(1992-6#1)(1993-9#1)(1996-8#1)(2007-12#1)(2008-10#4)(2008-2#1)
procedure allowing##4##2##(2007-1#1)(2007-8#1)(2008-10#1)(2008-11#1)
procedure allows determination of##2##4##(2008-10#2)
procedure allows the##10##3##(2007-7#1)(2007-8#1)(2008-10#6)(2008-2#1)(2010-7#1)
procedure allows us to##2##4##(2007-12#1)(2008-11#1)
procedure allows##20##2##(1994-12#1)(1996-4#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-2#1)(2010-7#1)
procedure alone##3##2##(1992-7#1)(2008-2#1)(2008-4#1)
procedure also##6##2##(1990-12#1)(1990-2#1)(1994-6#1)(1995-4#1)(1997-1#1)(2008-10#1)
procedure an##2##2##(2008-4#1)(2011-2#1)
procedure and a##4##3##(1994-11#1)(1996-1#1)(2008-4#1)(2011-1#1)
procedure and also##2##3##(2008-10#1)(2013-1#1)
procedure and an##3##3##(2008-10#1)(2008-6#1)(2008-9#1)
procedure and demonstrates the##2##4##(1996-4#1)(1997-5#1)
procedure and direct##2##3##(2006-11#1)(2010-2#1)
procedure and is##2##3##(2007-2#1)(2008-3#1)
procedure and its##5##3##(1997-2#1)(2006-5#1)(2006-8#1)(2008-1#1)(2008-4#1)
procedure and no##2##3##(1993-1#1)(2008-10#1)
procedure and report##2##3##(2008-5#1)(2013-1#1)
procedure and results##3##3##(1994-9#1)(2008-4#1)(2009-5#1)
procedure and show that the##2##5##(2008-3#2)
procedure and show that##3##4##(2008-3#2)(2012-3#1)
procedure and the use of##2##5##(2008-10#1)(2011-1#1)
procedure and the##26##3##(1997-1#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-6#1)(2007-7#1)(2008-10#8)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-1#1)(2011-11#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
procedure and therefore##2##3##(2006-8#1)(2010-12#1)
procedure and to##3##3##(2011-2#1)(2012-2#1)(2013-1#1)
procedure and was##2##3##(1991-2#1)(2008-10#1)
procedure and##129##2##(1990-11#1)(1990-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-5#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-3#1)(2006-5#3)(2006-6#1)(2006-8#5)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#3)(2008-1#2)(2008-10#27)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-7#2)(2011-1#3)(2011-11#1)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#1)
procedure applied##5##2##(1990-2#1)(1991-10#1)(2007-8#1)(2008-10#2)
procedure are also##2##3##(2008-10#1)(2008-2#1)
procedure are discussed##3##3##(2004-2#1)(2008-11#1)(2008-5#1)
procedure are presented##3##3##(1990-9#1)(2005-10#1)(2008-3#1)
procedure are summarized##2##3##(2008-3#1)(2008-4#1)
procedure are the##3##3##(1991-6#1)(1997-5#1)(2006-8#1)
procedure are##33##2##(1990-9#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1993-9#1)(1994-9#1)(1996-8#1)(1997-5#1)(2004-2#1)(2005-10#1)(2005-11#1)(2006-12#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2010-2#1)(2012-12#1)(2013-8#1)
procedure as a##3##3##(2007-9#1)(2008-10#1)(2008-7#1)
procedure as an alternative to##2##5##(1990-9#1)(2008-11#1)
procedure as an##4##3##(1990-9#1)(2007-12#2)(2008-11#1)
procedure as the##2##3##(1992-8#1)(2006-11#1)
procedure as well as##5##4##(2007-11#1)(2007-2#1)(2007-8#1)(2012-1#1)(2013-1#1)
procedure as##18##2##(1990-9#1)(1992-8#1)(1996-12#2)(2006-11#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-11#1)(2012-1#1)(2013-1#1)
procedure at the##4##3##(1990-9#1)(2008-10#2)(2008-11#1)
procedure at##6##2##(1990-9#1)(2008-10#4)(2008-11#1)
procedure based on a##3##4##(2005-11#1)(2008-10#1)(2008-3#1)
procedure based on the total dissolution of the samples##2##9##(2008-10#2)
procedure based on the##14##4##(1990-12#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-3#2)(2008-4#1)(2008-5#2)
procedure based on##34##3##(1990-12#1)(1992-8#1)(2005-11#3)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#18)(2008-3#3)(2008-4#1)(2008-5#2)(2012-2#1)(2012-3#1)
procedure because of##2##3##(2009-9#1)(2011-2#1)
procedure because##4##2##(2008-5#1)(2009-2#1)(2009-9#1)(2011-2#1)
procedure before##4##2##(1993-3#1)(2007-11#1)(2008-10#1)(2008-3#1)
procedure begins##2##2##(1996-12#1)(2008-11#1)
procedure being performed##2##3##(2006-7#1)(2007-8#1)
procedure being##4##2##(2006-7#1)(2007-8#1)(2013-1#2)
procedure but##7##2##(1997-5#1)(2006-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2012-1#1)
procedure by a##4##3##(1992-6#1)(2006-10#1)(2007-8#1)(2012-2#1)
procedure by the##2##3##(2008-10#1)(2008-12#1)
procedure by which##2##3##(2006-5#1)(2008-10#1)
procedure by##18##2##(1992-6#1)(1994-8#1)(1995-6#1)(1996-8#1)(2006-10#2)(2006-5#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#5)(2008-12#1)(2012-2#1)
procedure can also##4##3##(1991-12#1)(2007-11#1)(2008-2#1)(2008-4#1)
procedure can be applied##2##4##(2008-3#1)(2009-9#1)
procedure can be considered##2##4##(2007-7#1)(2008-10#1)
procedure can be used##4##4##(2008-10#2)(2008-6#1)(2008-8#1)
procedure can be##23##3##(1993-9#1)(1994-8#2)(1995-1#1)(2006-6#1)(2007-7#2)(2008-10#5)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-5#1)(2012-2#1)
procedure can##40##2##(1991-12#1)(1992-6#1)(1993-6#1)(1993-9#1)(1994-8#2)(1995-1#1)(1996-12#1)(2006-6#1)(2007-11#3)(2007-7#3)(2007-8#1)(2008-10#8)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-7#1)
procedure carried out##2##3##(1991-3#1)(2008-10#1)
procedure codes##5##2##(1991-3#1)(1995-8#2)(2007-4#1)(2007-8#1)
procedure combined##2##2##(2008-10#2)
procedure compared##3##2##(2006-5#1)(2008-10#1)(2011-2#1)
procedure comprises##2##2##(1992-8#1)(2007-7#1)
procedure consisted of##6##3##(1996-8#1)(1997-4#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-4#1)
procedure consisted##7##2##(1996-8#1)(1997-4#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-4#1)
procedure consisting of##4##3##(1991-12#1)(1992-6#1)(2008-10#1)(2008-4#1)
procedure consists in the##2##4##(1991-11#1)(2008-10#1)
procedure consists of##6##3##(2008-10#3)(2008-3#1)(2008-4#1)(2011-1#1)
procedure consists##8##2##(1991-11#1)(2008-10#4)(2008-3#1)(2008-4#1)(2011-1#1)
procedure controls the##2##3##(2009-9#1)(2012-2#1)
procedure could also be used for##2##6##(1992-2#1)(2008-11#1)
procedure could also be used##3##5##(1992-2#1)(2008-10#1)(2008-11#1)
procedure could also be##4##4##(1992-2#1)(2008-10#2)(2008-11#1)
procedure could be used to treat##2##6##(2005-9#1)(2007-12#1)
procedure could be##8##3##(1994-3#1)(1996-9#1)(2005-9#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-8#1)
procedure could##12##2##(1992-2#1)(1994-3#1)(1996-9#1)(2005-9#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-8#1)
procedure coupled##2##2##(1993-11#1)(2008-10#1)
procedure depends on##2##3##(2007-3#1)(2007-7#1)
procedure described for##2##3##(2008-10#1)(2008-3#1)
procedure described here is##2##4##(2008-4#2)
procedure described here##3##3##(2007-11#1)(2008-4#2)
procedure described in this##2##4##(2008-11#1)(2008-4#1)
procedure described in##4##3##(2008-10#1)(2008-11#1)(2008-4#2)
procedure described##12##2##(1991-4#1)(1996-2#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#4)
procedure describes##3##2##(2008-4#3)
procedure designed to##2##3##(2008-10#1)(2008-3#1)
procedure developed by the##2##4##(2008-7#1)(2008-9#1)
procedure developed by##5##3##(1994-12#1)(2007-4#1)(2008-3#1)(2008-7#1)(2008-9#1)
procedure developed##17##2##(1994-12#1)(2007-10#1)(2007-4#1)(2008-10#10)(2008-3#1)(2008-7#1)(2008-9#1)(2009-6#1)
procedure did not##4##3##(1996-5#1)(1996-6#1)(2007-12#1)(2010-8#1)
procedure does not##3##3##(1991-4#1)(2008-2#1)(2008-7#1)
procedure due to the##2##4##(2011-1#1)(2013-7#1)
procedure due to##7##3##(2007-8#1)(2008-10#1)(2008-7#1)(2011-1#1)(2013-1#2)(2013-7#1)
procedure duration was##2##3##(2013-8#2)
procedure during the##2##3##(2006-10#1)(2007-11#1)
procedure during##3##2##(2006-10#1)(2007-11#1)(2007-2#1)
procedure eliminates##2##2##(2007-7#1)(2008-10#1)
procedure employed##2##2##(1997-3#1)(2009-10#1)
procedure enabled##2##2##(2008-10#1)(2012-2#1)
procedure failed##2##2##(2006-3#1)(2007-3#1)
procedure followed by##2##3##(2008-10#1)(2011-1#1)
procedure followed##3##2##(2004-11#1)(2008-10#1)(2011-1#1)
procedure following##2##2##(1990-5#1)(2008-8#1)
procedure for Saccharomyces cerevisiae##2##4##(2008-2#2)
procedure for a variety of##2##5##(2007-3#1)(2008-10#1)
procedure for a##15##3##(1997-2#1)(2007-3#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2009-10#1)(2010-12#1)(2010-9#1)(2013-1#1)
procedure for acid##2##3##(2008-10#1)(2008-4#1)
procedure for analysis of##3##4##(2005-12#1)(2008-10#2)
procedure for analyzing##2##3##(2008-2#1)(2008-3#1)
procedure for arsenic##3##3##(2008-10#3)
procedure for assessing##4##3##(1996-12#1)(2008-4#1)(2008-9#1)(2009-7#1)
procedure for atrial fibrillation##2##4##(2007-8#1)(2011-2#1)
procedure for both##2##3##(1994-9#1)(2007-8#1)
procedure for bovine##2##3##(2008-10#2)
procedure for calculating the##3##4##(2005-11#1)(2008-2#1)(2008-3#1)
procedure for casting a solid##2##5##(2008-5#2)
procedure for determination of##10##4##(2007-8#3)(2008-10#5)(2008-2#1)(2012-1#1)
procedure for determining##9##3##(2008-10#3)(2008-2#2)(2008-4#3)(2011-2#1)
procedure for diagnosing##2##3##(1993-9#1)(2008-11#1)
procedure for diagnosis##2##3##(1991-2#1)(2007-5#1)
procedure for estimating the##2##4##(2008-2#1)(2008-3#1)
procedure for estimating##4##3##(1996-12#1)(2008-2#1)(2008-3#2)
procedure for evaluating##2##3##(2008-2#1)(2012-3#1)
procedure for fabricating##3##3##(2008-10#1)(2008-3#2)
procedure for handling and##2##4##(2008-10#1)(2008-4#1)
procedure for identifying##2##3##(1995-12#1)(2013-7#1)
procedure for insertion of##2##4##(2007-5#1)(2007-7#1)
procedure for investigating##2##3##(1997-2#1)(2008-2#1)
procedure for iron##2##3##(2008-10#2)
procedure for isolating##2##3##(2008-11#1)(2008-4#1)
procedure for lead determination##3##4##(2008-10#3)
procedure for lead##4##3##(2008-10#4)
procedure for measuring the##5##4##(1996-11#1)(2008-10#2)(2008-3#2)
procedure for measuring##6##3##(1996-11#1)(2008-10#2)(2008-3#2)(2010-8#1)
procedure for obtaining##3##3##(2008-3#1)(2008-4#1)(2009-5#1)
procedure for organotin##2##3##(2008-10#2)
procedure for parameter estimation##2##4##(1995-6#1)(2010-2#1)
procedure for patients with##3##4##(2006-6#1)(2007-8#1)(2012-2#1)
procedure for patients##4##3##(2006-12#1)(2006-6#1)(2007-8#1)(2012-2#1)
procedure for performing##2##3##(2008-4#2)
procedure for predicting##2##3##(2007-12#1)(2008-4#1)
procedure for preparing##3##3##(2008-2#1)(2008-4#1)(2008-9#1)
procedure for rapid##2##3##(1994-12#1)(2008-10#1)
procedure for selecting the##2##4##(2008-2#1)(2008-3#1)
procedure for separating##4##3##(2008-10#3)(2008-4#1)
procedure for separation##2##3##(2008-10#2)
procedure for simultaneous##3##3##(1997-3#1)(2008-10#2)
procedure for solid phase microextraction-gas chromatographic##2##6##(2008-10#2)
procedure for spectrophotometric determination of##3##5##(2008-10#3)
procedure for testing##2##3##(1997-8#1)(2008-10#1)
procedure for the accurate determination of##2##6##(2007-8#1)(2008-10#1)
procedure for the analysis of polycyclic aromatic hydrocarbons (PAHs)##2##9##(2008-10#2)
procedure for the analysis of##7##5##(2007-11#1)(2007-8#1)(2008-10#4)(2012-3#1)
procedure for the assay of##2##5##(1991-5#1)(2008-10#1)
procedure for the assessment of##3##5##(2006-11#1)(2007-8#1)(2012-2#1)
procedure for the characterization##2##4##(1990-11#1)(2008-3#1)
procedure for the determination of the##3##6##(1991-5#1)(2008-10#2)
procedure for the determination of trace levels of##2##8##(2008-10#2)
procedure for the determination of trace##4##6##(2008-10#4)
procedure for the determination of##41##5##(1990-12#2)(1990-3#1)(1991-1#1)(1991-5#1)(1996-5#1)(2007-10#1)(2008-10#32)(2008-5#1)(2010-4#1)
procedure for the diagnosis##2##4##(1997-5#1)(2007-8#1)
procedure for the isolation of##3##5##(1991-11#1)(1993-9#1)(2008-11#1)
procedure for the isolation##4##4##(1991-11#1)(1993-9#1)(2008-11#2)
procedure for the preparation of##2##5##(1994-2#1)(2008-9#1)
procedure for the purification of##3##5##(2008-10#1)(2008-4#1)(2010-10#1)
procedure for the purification##4##4##(1990-11#1)(2008-10#1)(2008-4#1)(2010-10#1)
procedure for the quantification of##2##5##(2008-10#1)(2012-12#1)
procedure for the rapid##2##4##(1996-3#1)(2008-10#1)
procedure for the separation##2##4##(1996-5#1)(2008-10#1)
procedure for the simultaneous determination of##4##6##(2008-10#4)
procedure for the simultaneous##5##4##(2008-10#5)
procedure for the speciation of antimony##2##6##(2008-10#2)
procedure for the spectrophotometric determination of##4##6##(2008-10#3)(2010-5#1)
procedure for the synthesis of##3##5##(2007-11#1)(2008-12#1)(2008-5#1)
procedure for the treatment of##6##5##(2006-5#1)(2006-8#1)(2006-9#1)(2007-7#1)(2008-10#1)(2011-2#1)
procedure for the##152##3##(1990-11#2)(1990-12#2)(1990-3#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-5#2)(1992-1#1)(1993-9#1)(1994-2#1)(1995-4#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-1#1)(1997-5#1)(2005-4#1)(2005-5#1)(2005-9#1)(2006-10#1)(2006-11#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#3)(2007-8#8)(2008-10#67)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
procedure for this##3##3##(1995-8#1)(2008-2#1)(2012-2#1)
procedure for treating##3##3##(2006-11#1)(2013-1#2)
procedure for##508##2##(1990-10#1)(1990-11#3)(1990-12#5)(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-5#3)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-3#2)(1992-5#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-12#1)(1995-4#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#3)(1996-3#2)(1996-5#2)(1996-6#3)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-5#2)(1997-6#1)(1997-8#2)(2004-9#1)(2005-11#2)(2005-12#1)(2005-4#1)(2005-5#2)(2005-9#1)(2006-10#3)(2006-11#3)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#3)(2006-8#4)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#6)(2007-2#1)(2007-3#2)(2007-5#2)(2007-7#4)(2007-8#18)(2007-9#1)(2008-1#1)(2008-10#158)(2008-11#14)(2008-12#3)(2008-2#28)(2008-3#24)(2008-4#44)(2008-5#6)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#10)(2009-10#2)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#1)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#2)(2010-6#2)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#14)(2012-1#1)(2012-12#6)(2012-2#3)(2012-3#2)(2013-1#7)(2013-7#2)
procedure from##4##2##(2006-6#1)(2007-9#1)(2008-2#1)(2008-9#1)
procedure gave##2##2##(2008-10#1)(2009-8#1)
procedure greatly##2##2##(1994-3#1)(2013-1#1)
procedure had##8##2##(1993-1#1)(1993-11#1)(1996-8#1)(2005-5#1)(2006-5#1)(2008-10#2)(2008-6#1)
procedure has a##5##3##(1994-12#1)(2006-9#1)(2008-10#1)(2008-12#1)(2009-5#1)
procedure has been applied successfully##2##5##(1996-7#1)(2008-10#1)
procedure has been applied##3##4##(1991-5#1)(1996-7#1)(2008-10#1)
procedure has been developed for the determination of##2##8##(2008-10#2)
procedure has been developed for the direct##2##7##(2008-10#2)
procedure has been developed for the##7##6##(1996-2#1)(2008-10#5)(2009-5#1)
procedure has been developed for##14##5##(1990-9#1)(1996-2#1)(2008-10#11)(2009-5#1)
procedure has been developed to##3##5##(1997-1#1)(2008-2#2)
procedure has been developed##18##4##(1990-9#1)(1996-2#1)(1997-1#1)(2008-10#11)(2008-2#2)(2009-10#1)(2009-5#1)
procedure has been optimized##2##4##(2008-10#1)(2008-4#1)
procedure has been performed##5##4##(2006-3#1)(2008-2#1)(2008-4#2)(2009-9#1)
procedure has been successfully##6##4##(2008-10#6)
procedure has been##59##3##(1990-9#1)(1991-5#1)(1993-12#1)(1996-2#1)(1996-7#1)(1997-1#1)(2005-4#1)(2005-7#1)(2006-11#1)(2006-3#1)(2007-8#1)(2008-10#34)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-11#1)
procedure has gained##2##3##(2006-2#1)(2009-5#1)
procedure has the##2##3##(1990-12#1)(1992-9#1)
procedure has to be##2##4##(2008-10#1)(2008-11#1)
procedure has##82##2##(1990-12#1)(1990-9#1)(1991-12#1)(1991-5#1)(1992-9#1)(1993-12#2)(1994-12#1)(1996-2#1)(1996-7#1)(1997-1#1)(2004-2#1)(2005-4#1)(2005-7#1)(2006-11#1)(2006-2#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#38)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#4)(2009-9#1)(2010-11#2)(2010-12#1)(2013-8#1)
procedure have been##4##3##(2008-10#3)(2010-6#1)
procedure have##6##2##(2008-10#4)(2010-6#1)(2013-1#1)
procedure hospital stay was##2##4##(2007-6#2)
procedure in a patient with##2##5##(2007-8#1)(2012-12#1)
procedure in a##5##3##(1995-1#1)(2006-10#1)(2007-8#1)(2008-10#1)(2012-12#1)
procedure in children##2##3##(2011-12#1)(2013-1#1)
procedure in deep##2##3##(1993-9#1)(2007-11#1)
procedure in infants##2##3##(2008-1#1)(2009-6#1)
procedure in most##2##3##(2006-5#1)(2007-12#1)
procedure in order to##3##4##(1994-12#1)(2008-10#1)(2008-8#1)
procedure in patients##2##3##(2006-8#1)(2011-2#1)
procedure in preteen and teen patients with brachial plexus birth palsy##2##11##(2013-1#2)
procedure in terms of##3##4##(2008-10#1)(2008-4#1)(2008-7#1)
procedure in the diagnosis of##2##5##(1990-11#1)(2007-11#1)
procedure in the management of##3##5##(2006-7#1)(2008-9#1)(2013-1#1)
procedure in the treatment of##6##5##(1990-2#1)(2006-11#1)(2007-8#2)(2013-7#1)(2013-8#1)
procedure in the##32##3##(1990-11#1)(1990-2#1)(1994-5#1)(2006-11#2)(2006-7#1)(2007-11#1)(2007-8#7)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#3)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
procedure in which a##5##4##(2006-8#1)(2008-4#2)(2008-5#1)(2012-3#1)
procedure in which the##3##4##(2006-2#1)(2006-5#1)(2006-6#1)
procedure in which##12##3##(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-2#1)(2008-10#1)(2008-4#2)(2008-5#1)(2012-3#1)
procedure in##139##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#4)(1991-4#1)(1991-9#2)(1992-10#1)(1992-11#1)(1993-9#2)(1994-12#1)(1994-3#1)(1994-5#2)(1995-1#1)(1995-11#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-3#2)(2005-5#1)(2006-10#2)(2006-11#2)(2006-2#1)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#4)(2007-10#2)(2007-11#9)(2007-12#2)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#12)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#5)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-3#2)(2010-6#1)(2010-8#2)(2011-12#1)(2011-2#7)(2012-12#4)(2012-2#1)(2012-3#4)(2013-1#6)(2013-7#2)(2013-8#1)
procedure includes##7##2##(1991-5#1)(2005-11#1)(2007-7#1)(2008-10#2)(2008-7#1)(2011-2#1)
procedure including##3##2##(1990-7#1)(1991-4#1)(2011-2#1)
procedure increases the##2##3##(2008-9#1)(2010-2#1)
procedure into##2##2##(2007-12#1)(2012-3#1)
procedure involved a##2##3##(1996-5#1)(1996-8#1)
procedure involved the##2##3##(2008-10#2)
procedure involved##10##2##(1995-8#1)(1996-5#1)(1996-8#1)(2006-12#1)(2008-10#4)(2008-12#1)(2008-8#1)
procedure involves the##6##3##(1990-12#1)(1991-5#1)(2008-10#1)(2011-1#1)(2013-1#2)
procedure involves##15##2##(1990-12#1)(1990-3#1)(1991-5#1)(1993-2#1)(1996-6#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#2)
procedure involving the##4##3##(2008-10#3)(2008-2#1)
procedure involving##19##2##(1990-7#1)(1991-1#1)(1991-3#1)(1994-8#1)(1995-1#1)(1996-4#1)(1996-5#1)(2007-11#1)(2008-10#8)(2008-2#1)(2008-4#1)(2013-1#1)
procedure is a safe and##2##5##(2008-10#1)(2008-9#1)
procedure is a##8##3##(1990-11#1)(1992-2#1)(2006-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-9#1)
procedure is also##5##3##(1995-4#1)(2007-11#1)(2008-2#1)(2008-3#2)
procedure is applicable##2##3##(2008-10#1)(2008-3#1)
procedure is applied to##3##4##(1996-2#1)(2008-2#1)(2008-6#1)
procedure is applied##4##3##(1996-2#1)(2008-10#1)(2008-2#1)(2008-6#1)
procedure is associated with##3##4##(2006-6#1)(2011-11#1)(2013-1#1)
procedure is based on a##2##5##(2008-10#1)(2013-1#1)
procedure is based on the##15##5##(1994-6#1)(2007-12#2)(2008-10#12)
procedure is based on##22##4##(1994-6#1)(1995-6#1)(2007-12#2)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
procedure is based##23##3##(1994-6#1)(1995-6#1)(1997-6#1)(2007-12#2)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
procedure is carried out##4##4##(1996-5#1)(2006-8#1)(2008-10#1)(2008-7#1)
procedure is characterized##2##3##(2007-8#1)(2008-10#1)
procedure is contraindicated##2##3##(2006-2#1)(2006-3#1)
procedure is demonstrated by the##3##5##(2008-10#1)(2008-2#1)(2009-2#1)
procedure is demonstrated##5##3##(2008-10#2)(2008-2#1)(2008-3#1)(2009-2#1)
procedure is described for the determination of##3##7##(2008-10#3)
procedure is described for the simultaneous##2##6##(1993-11#1)(1996-6#1)
procedure is described for the##9##5##(1992-8#1)(1993-11#2)(1996-6#2)(2008-10#4)
procedure is described for##15##4##(1992-8#1)(1993-11#2)(1996-6#2)(2008-10#4)(2008-2#1)(2008-4#4)(2008-8#1)
procedure is described in detail##2##5##(2007-8#1)(2008-10#1)
procedure is described in##3##4##(2007-8#1)(2008-10#1)(2011-2#1)
procedure is described##27##3##(1990-8#1)(1992-8#1)(1993-11#2)(1994-5#1)(1996-6#2)(2005-11#1)(2007-8#2)(2008-10#7)(2008-2#1)(2008-3#1)(2008-4#5)(2008-8#1)(2010-12#1)(2011-2#1)
procedure is developed for##2##4##(2008-10#2)
procedure is developed to##2##4##(2008-3#2)
procedure is developed##4##3##(2008-10#2)(2008-3#2)
procedure is done##2##3##(2006-8#1)(2007-9#1)
procedure is effective##2##3##(2007-8#1)(2008-2#1)
procedure is employed##2##3##(2007-11#1)(2008-10#1)
procedure is followed##2##3##(1996-12#1)(2008-3#1)
procedure is illustrated for##2##4##(2008-3#1)(2010-5#1)
procedure is illustrated##5##3##(2008-10#3)(2008-3#1)(2010-5#1)
procedure is indicated for##2##4##(2006-8#1)(2008-1#1)
procedure is indicated##3##3##(2006-8#1)(2008-1#1)(2009-3#1)
procedure is investigated##2##3##(2008-2#1)(2008-3#1)
procedure is less subject to errors##2##6##(2008-4#1)(2008-9#1)
procedure is more##2##3##(1993-6#1)(2008-10#1)
procedure is not affected by##2##5##(2008-10#2)
procedure is not##8##3##(2008-10#5)(2008-3#2)(2011-1#1)
procedure is only##3##3##(1996-8#1)(2006-11#1)(2011-2#1)
procedure is particularly useful##2##4##(2008-2#1)(2008-4#1)
procedure is performed under##2##4##(2006-10#1)(2006-8#1)
procedure is performed##4##3##(1996-3#1)(2006-10#1)(2006-8#1)(2008-10#1)
procedure is presented for the##5##5##(1994-12#1)(2008-10#2)(2008-2#1)(2008-4#1)
procedure is presented for##7##4##(1994-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#2)
procedure is presented##12##3##(1994-12#1)(2008-10#2)(2008-2#2)(2008-3#4)(2008-4#2)(2011-2#1)
procedure is proposed for the##5##5##(2008-10#5)
procedure is proposed for##8##4##(2008-10#7)(2010-11#1)
procedure is proposed##15##3##(2007-8#1)(2008-10#9)(2008-2#1)(2008-3#1)(2010-11#1)(2010-2#1)(2010-8#1)
procedure is provided##4##3##(2007-1#1)(2007-12#1)(2008-4#2)
procedure is rapid##2##3##(2008-10#1)(2008-9#1)
procedure is reported##2##3##(2007-8#1)(2008-12#1)
procedure is required##2##3##(1994-8#1)(2007-8#1)
procedure is safe and##3##4##(2006-5#1)(2006-6#1)(2009-2#1)
procedure is safe##5##3##(2006-5#1)(2006-6#1)(2007-1#1)(2009-2#1)(2010-6#1)
procedure is shown##3##3##(2008-2#2)(2010-7#1)
procedure is simple and##2##4##(2005-5#1)(2008-2#1)
procedure is simple##3##3##(2005-5#1)(2008-10#1)(2008-2#1)
procedure is suggested##2##3##(2008-2#2)
procedure is technically##2##3##(1994-9#1)(2010-12#1)
procedure is the##4##3##(2007-8#1)(2008-10#1)(2008-11#2)
procedure is to##4##3##(2008-11#1)(2008-3#1)(2008-4#1)(2009-9#1)
procedure is used to##2##4##(2008-10#1)(2008-3#1)
procedure is used##5##3##(2008-10#1)(2008-3#3)(2013-1#1)
procedure is well tolerated##2##4##(2007-7#1)(2011-2#1)
procedure is##281##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-8#2)(1991-12#1)(1992-2#1)(1992-8#1)(1993-11#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-4#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-8#2)(1997-6#2)(1997-8#1)(2005-11#1)(2005-5#1)(2006-10#2)(2006-11#1)(2006-2#2)(2006-3#3)(2006-5#2)(2006-6#2)(2006-8#5)(2007-1#2)(2007-11#5)(2007-12#7)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#10)(2007-9#1)(2008-1#2)(2008-10#77)(2008-11#9)(2008-12#2)(2008-2#21)(2008-3#26)(2008-4#18)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#7)(2009-2#2)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-11#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#4)
procedure it is possible to build components with##2##8##(2007-12#1)(2008-2#1)
procedure it is possible to##3##5##(2007-12#1)(2008-10#1)(2008-2#1)
procedure itself##4##2##(1990-11#1)(1994-12#1)(2008-9#1)(2012-1#1)
procedure leads to##2##3##(2008-10#1)(2008-3#1)
procedure makes use of##2##4##(1991-5#1)(2008-8#1)
procedure makes##3##2##(1991-5#1)(2008-2#1)(2008-8#1)
procedure may also be##3##4##(2007-7#1)(2008-1#1)(2008-2#1)
procedure may be useful##2##4##(2006-8#1)(2011-1#1)
procedure may be##10##3##(1996-12#1)(1997-8#1)(2005-11#1)(2006-12#1)(2006-8#2)(2007-6#1)(2011-1#2)(2011-2#1)
procedure may have##2##3##(2006-8#1)(2013-1#1)
procedure may##21##2##(1996-12#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-5#2)(2006-8#3)(2007-6#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-5#1)(2009-8#1)(2011-1#2)(2011-2#1)(2013-1#1)
procedure means##2##2##(2008-10#1)(2010-4#1)
procedure might##2##2##(2009-5#1)(2012-12#1)
procedure nor##3##2##(1992-7#1)(2007-5#1)(2008-7#1)
procedure not only##3##3##(2004-1#1)(2008-11#1)(2008-2#1)
procedure not##4##2##(2004-1#1)(2008-10#1)(2008-11#1)(2008-2#1)
procedure of 0##2##3##(2008-10#2)
procedure of a##3##3##(1996-5#1)(2008-4#1)(2010-4#1)
procedure of an##2##3##(2008-10#1)(2008-3#1)
procedure of choice for##5##4##(1996-11#1)(2007-4#1)(2008-5#1)(2010-10#1)(2010-8#1)
procedure of choice in##4##4##(1991-9#1)(2008-11#1)(2009-5#1)(2011-2#1)
procedure of choice##18##3##(1991-9#1)(1996-11#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
procedure of the##12##3##(2005-11#1)(2006-5#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-8#1)
procedure of tilt testing##2##4##(2006-9#2)
procedure of##89##2##(1990-8#1)(1991-6#1)(1991-9#1)(1992-12#1)(1993-5#1)(1994-8#1)(1995-10#1)(1996-11#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-8#2)(2006-9#2)(2007-11#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-10#20)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#2)(2009-5#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-8#3)(2011-2#3)(2012-2#1)(2013-1#5)(2013-8#3)
procedure offers high selectivity##2##4##(2008-10#2)
procedure offers##7##2##(1996-7#1)(2008-10#4)(2010-11#1)(2011-2#1)
procedure on a##2##3##(1997-3#1)(2008-10#1)
procedure on both##2##3##(2006-9#1)(2011-2#1)
procedure on the##7##3##(1992-9#1)(1996-12#1)(2005-11#1)(2007-9#1)(2008-10#1)(2012-3#2)
procedure on##18##2##(1992-9#1)(1996-12#1)(1997-3#1)(2005-11#1)(2006-3#1)(2006-9#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#3)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#2)
procedure only##3##2##(1990-12#1)(1993-11#1)(2008-10#1)
procedure or for##2##3##(2008-1#1)(2008-4#1)
procedure or the##3##3##(2006-12#1)(2006-8#1)(2007-12#1)
procedure or treatment##2##3##(2007-4#1)(2007-7#1)
procedure or##14##2##(1991-7#1)(1992-5#1)(1993-9#1)(1995-3#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-9#1)(2012-12#1)
procedure outside the##2##3##(2006-8#1)(2007-1#1)
procedure over the##2##3##(2006-5#1)(2008-7#1)
procedure over##6##2##(1991-8#1)(1994-10#1)(2004-2#1)(2006-5#1)(2008-7#1)(2013-7#1)
procedure performed in##3##3##(2006-10#1)(2006-2#1)(2012-12#1)
procedure performed##12##2##(1996-5#1)(2004-2#1)(2006-10#2)(2006-2#1)(2007-1#1)(2007-11#1)(2007-2#1)(2008-5#1)(2008-8#1)(2012-12#2)
procedure performs well##2##3##(2007-11#1)(2012-3#1)
procedure permits the##3##3##(2007-12#1)(2008-10#1)(2008-4#1)
procedure permits##5##2##(2007-12#1)(2008-10#3)(2008-4#1)
procedure presented##2##2##(2006-3#1)(2008-10#1)
procedure presents##3##2##(2007-8#1)(2008-10#1)(2008-4#1)
procedure previously reported##2##3##(2008-10#2)
procedure previously##6##2##(1993-9#1)(1996-12#1)(2008-10#2)(2009-2#1)(2011-1#1)
procedure prior to##3##3##(1994-12#1)(2012-12#1)(2012-3#1)
procedure produced a##2##3##(1996-9#1)(2008-10#1)
procedure proposed##7##2##(2008-10#6)(2011-1#1)
procedure provided##6##2##(2007-8#1)(2008-10#4)(2009-3#1)
procedure provides a##6##3##(2008-10#2)(2008-3#1)(2008-5#2)(2009-7#1)
procedure provides an##2##3##(1997-6#1)(2008-10#1)
procedure provides##11##2##(1993-3#1)(1997-6#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#2)(2009-7#1)
procedure reduces the##4##3##(1990-3#1)(2007-12#2)(2007-8#1)
procedure reduces##7##2##(1990-3#1)(2007-12#2)(2007-8#1)(2008-10#1)(2010-7#1)(2011-2#1)
procedure related##4##2##(2006-6#1)(2007-8#1)(2008-5#1)(2008-7#1)
procedure remains##2##2##(2008-10#1)(2011-11#1)
procedure requested##2##2##(2010-8#2)
procedure requires a##3##3##(2006-6#1)(2008-10#1)(2008-11#1)
procedure requires##7##2##(2006-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)
procedure requiring##2##2##(1994-9#1)(2007-8#1)
procedure resulted in a##4##4##(1993-12#1)(2007-12#1)(2008-10#1)(2009-4#1)
procedure resulted in##10##3##(1991-2#1)(1991-5#1)(1993-12#1)(1995-11#1)(1997-2#1)(2007-12#1)(2008-10#1)(2009-11#1)(2009-4#1)(2010-12#1)
procedure results in##3##3##(1994-5#1)(2006-6#1)(2012-3#1)
procedure revealed no##2##3##(2005-8#1)(2012-12#1)
procedure revealed##3##2##(1993-12#1)(2005-8#1)(2012-12#1)
procedure reveals##2##2##(1996-3#1)(2010-6#1)
procedure seems to be##4##4##(2007-8#1)(2009-8#1)(2012-12#1)(2013-1#1)
procedure seems##5##2##(2007-8#1)(2009-8#1)(2010-11#1)(2012-12#1)(2013-1#1)
procedure selects##2##2##(2010-8#1)(2012-12#1)
procedure should be##5##3##(1990-5#1)(1994-3#1)(2008-1#1)(2008-9#1)(2013-8#1)
procedure should##9##2##(1990-5#1)(1994-3#1)(2006-10#1)(2007-2#1)(2008-1#2)(2008-11#1)(2008-9#1)(2013-8#1)
procedure shows##3##2##(1991-2#1)(2008-10#2)
procedure similar to##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
procedure such as##2##3##(1990-11#1)(2008-10#1)
procedure takes##2##2##(1990-8#1)(2008-11#1)
procedure than##8##2##(1993-12#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)
procedure that allows##4##3##(1996-8#1)(2007-1#1)(2008-10#1)(2011-2#1)
procedure that can be used to##2##6##(2008-3#1)(2010-12#1)
procedure that can be used##3##5##(2008-3#1)(2010-12#2)
procedure that can be##6##4##(2008-3#1)(2008-9#1)(2010-12#2)(2011-2#1)(2012-2#1)
procedure that can##7##3##(1994-11#1)(2008-3#1)(2008-9#1)(2010-12#2)(2011-2#1)(2012-2#1)
procedure that has been##2##4##(2006-12#1)(2008-10#1)
procedure that has##3##3##(2006-12#1)(2006-3#1)(2008-10#1)
procedure that included##2##3##(1993-11#1)(2008-10#1)
procedure that includes##3##3##(1996-2#1)(2007-1#1)(2008-3#1)
procedure that is##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
procedure that may##5##3##(1994-9#1)(2006-7#1)(2008-10#1)(2010-8#1)(2013-8#1)
procedure that requires##2##3##(2005-7#1)(2007-11#1)
procedure that uses a##2##4##(2009-12#1)(2010-9#1)
procedure that uses##3##3##(2008-2#1)(2009-12#1)(2010-9#1)
procedure that utilizes##3##3##(2004-1#1)(2008-3#1)(2008-9#1)
procedure that was##2##3##(2008-2#1)(2008-3#1)
procedure that##72##2##(1990-9#1)(1991-2#1)(1993-11#2)(1993-3#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-4#1)(1995-6#1)(1996-2#1)(1996-8#1)(2004-1#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-3#2)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#7)(2008-2#6)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-12#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
procedure the##12##2##(1990-8#1)(1992-2#1)(1995-8#1)(1996-8#1)(2006-7#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-6#1)(2013-1#1)
procedure through##2##2##(1992-9#1)(2008-10#1)
procedure time##2##2##(2007-7#1)(2011-2#1)
procedure times##2##2##(2008-12#1)(2009-9#1)
procedure to achieve##2##3##(2006-10#1)(2008-4#1)
procedure to an##2##3##(1992-12#1)(2008-4#1)
procedure to analyze##2##3##(2008-10#1)(2009-5#1)
procedure to assess##3##3##(2006-11#1)(2012-3#1)(2013-1#1)
procedure to be carried out##2##5##(2005-12#1)(2008-10#1)
procedure to be performed##2##4##(1992-8#1)(2007-12#1)
procedure to be used##2##4##(2008-4#1)(2008-7#1)
procedure to be##10##3##(1992-12#1)(1992-8#1)(1993-6#1)(1994-12#1)(2005-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)
procedure to detect##2##3##(2008-11#1)(2010-12#1)
procedure to determine the##2##4##(1994-3#1)(2008-3#1)
procedure to determine##4##3##(1994-3#1)(2007-12#1)(2008-3#2)
procedure to estimate##3##3##(1997-2#1)(1997-5#1)(2009-12#1)
procedure to evaluate the##3##4##(2007-8#1)(2008-10#1)(2008-5#1)
procedure to improve the##3##4##(2007-8#2)(2008-2#1)
procedure to investigate the interaction##2##5##(1993-3#1)(1993-6#1)
procedure to investigate##3##3##(1993-3#1)(1993-6#1)(2007-8#1)
procedure to isolate##2##3##(1990-12#1)(1997-2#1)
procedure to measure the##4##4##(1994-3#1)(2007-12#1)(2008-10#1)(2008-5#1)
procedure to measure##6##3##(1994-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2012-1#1)(2012-2#1)
procedure to obtain the##2##4##(1990-10#1)(1996-11#1)
procedure to obtain##5##3##(1990-10#1)(1990-8#1)(1991-11#1)(1995-8#1)(1996-11#1)
procedure to perform##2##3##(2008-2#1)(2013-8#1)
procedure to quantify##2##3##(2006-5#1)(2012-2#1)
procedure to reduce the number of##2##6##(2008-10#1)(2008-3#1)
procedure to test##2##3##(1997-3#1)(2008-4#1)
procedure to the##7##3##(1991-8#1)(1996-8#1)(1997-2#1)(2008-10#3)(2012-12#1)
procedure to treat##2##3##(2006-5#1)(2007-9#1)
procedure to##124##2##(1990-10#1)(1990-12#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-12#2)(1992-8#2)(1993-3#1)(1993-6#2)(1994-12#1)(1994-3#3)(1994-8#1)(1994-9#1)(1995-8#1)(1996-11#1)(1996-7#1)(1996-8#1)(1997-2#3)(1997-3#1)(1997-5#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#2)(2007-12#6)(2007-8#7)(2007-9#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-2#8)(2008-3#9)(2008-4#6)(2008-5#4)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-2#1)(2011-1#3)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
procedure took##2##2##(1992-9#1)(1993-8#1)
procedure under##2##2##(2007-9#1)(2008-10#1)
procedure until##2##2##(2008-10#1)(2012-2#1)
procedure used in this##2##4##(1996-8#1)(2008-10#1)
procedure used in##4##3##(1996-8#1)(2006-7#1)(2008-10#1)(2010-2#1)
procedure used to##3##3##(1996-1#1)(2008-11#1)(2008-4#1)
procedure used##16##2##(1991-4#1)(1992-6#1)(1995-8#1)(1996-1#1)(1996-5#1)(1996-8#1)(2006-7#1)(2007-11#2)(2008-10#4)(2008-11#1)(2008-4#1)(2010-2#1)
procedure uses##4##2##(2008-11#1)(2008-2#1)(2008-4#2)
procedure using a##6##3##(1990-4#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#1)
procedure using the##5##3##(1997-4#1)(2006-4#1)(2008-10#2)(2008-9#1)
procedure using##42##2##(1990-4#1)(1991-11#1)(1992-1#1)(1992-9#1)(1994-2#1)(1995-8#1)(1996-3#1)(1997-4#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-8#8)(2008-10#10)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-1#1)(2012-12#2)(2013-1#2)(2013-7#2)
procedure via##4##2##(2007-7#1)(2009-6#1)(2011-2#1)(2012-1#1)
procedure volume and##4##3##(1990-12#1)(1996-2#2)(2007-4#1)
procedure volume##8##2##(1990-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1994-1#1)(1996-2#2)(2007-4#1)
procedure was achieved##2##3##(2008-10#2)
procedure was also##5##3##(1990-8#1)(1993-2#1)(2008-10#3)
procedure was applied for copper determination##2##6##(2008-10#2)
procedure was applied for the determination of##2##7##(2008-10#2)
procedure was applied for##6##4##(2008-10#6)
procedure was applied successfully##3##4##(2008-10#3)
procedure was applied to determination of##2##6##(2008-10#2)
procedure was applied to the analysis of##4##7##(2008-10#4)
procedure was applied to the determination of##6##7##(2008-10#6)
procedure was applied to the speciation of##2##7##(2008-10#2)
procedure was applied to the##14##5##(1990-3#1)(2008-10#13)
procedure was applied to##32##4##(1990-3#1)(1994-12#1)(1996-12#1)(2008-10#27)(2008-3#1)(2012-3#1)
procedure was applied##42##3##(1990-3#1)(1994-12#1)(1996-12#1)(2008-10#37)(2008-3#1)(2012-3#1)
procedure was based on the##5##5##(2008-10#5)
procedure was based on##9##4##(1995-12#1)(2007-10#1)(2007-8#1)(2008-10#6)
procedure was carried out##5##4##(1991-8#1)(1993-12#1)(2008-10#2)(2008-11#1)
procedure was checked by the##2##5##(2008-10#2)
procedure was checked by##3##4##(2008-10#3)
procedure was checked##5##3##(2008-10#5)
procedure was completed with##2##4##(2011-2#1)(2012-12#1)
procedure was completed##3##3##(1996-11#1)(2011-2#1)(2012-12#1)
procedure was confirmed by##5##4##(1993-12#1)(1995-2#1)(2008-10#3)
procedure was converted##2##3##(1994-2#1)(2007-6#1)
procedure was developed for simultaneous determination of##3##7##(2008-10#3)
procedure was developed for the determination of##6##7##(2006-12#1)(2008-10#3)(2009-3#1)(2012-1#1)
procedure was developed for the##11##5##(1990-11#1)(2006-12#1)(2007-8#1)(2008-10#6)(2009-3#1)(2012-1#1)
procedure was developed for##18##4##(1990-11#1)(1995-12#1)(2006-12#1)(2007-8#1)(2008-10#12)(2009-3#1)(2012-1#1)
procedure was developed in##2##4##(2008-10#2)
procedure was developed to##2##4##(2008-10#1)(2008-6#1)
procedure was developed which##3##4##(1991-11#1)(1993-2#1)(2008-10#1)
procedure was developed##31##3##(1990-11#1)(1990-5#1)(1991-11#1)(1993-12#1)(1993-2#1)(1995-12#1)(2006-12#1)(2007-8#1)(2008-10#20)(2008-6#1)(2009-3#1)(2012-1#1)
procedure was devised for##2##4##(1990-8#1)(1991-7#1)
procedure was devised##3##3##(1990-8#1)(1991-7#1)(2008-10#1)
procedure was done##4##3##(2007-7#1)(2007-8#1)(2008-7#1)(2009-6#1)
procedure was employed to##2##4##(2008-10#2)
procedure was established to##3##4##(1994-9#1)(2008-5#1)(2010-4#1)
procedure was established##4##3##(1990-9#1)(1994-9#1)(2008-5#1)(2010-4#1)
procedure was evaluated by##4##4##(2007-11#1)(2008-10#3)
procedure was evaluated##5##3##(2007-11#1)(2008-10#4)
procedure was found to##2##4##(2006-11#1)(2008-10#1)
procedure was found##3##3##(1990-12#1)(2006-11#1)(2008-10#1)
procedure was improved##2##3##(1990-7#1)(2006-6#1)
procedure was not##5##3##(1996-6#1)(2006-5#1)(2008-10#1)(2008-7#1)(2011-2#1)
procedure was optimized by##3##4##(2007-8#1)(2008-10#2)
procedure was optimized##6##3##(2006-8#1)(2007-8#1)(2008-10#4)
procedure was performed in the##2##5##(2007-8#1)(2009-4#1)
procedure was performed in##3##4##(2007-8#1)(2008-10#1)(2009-4#1)
procedure was performed on##3##4##(2006-8#1)(2007-8#1)(2010-2#1)
procedure was performed to##2##4##(2007-12#1)(2009-10#1)
procedure was performed using##2##4##(2006-5#1)(2008-10#1)
procedure was performed##19##3##(1991-11#1)(1991-2#1)(1993-3#1)(1995-12#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-8#4)(2007-9#1)(2008-10#3)(2009-10#1)(2009-4#1)(2010-2#1)
procedure was repeated three##2##4##(1990-8#1)(2013-1#1)
procedure was repeated##6##3##(1990-8#1)(1993-3#1)(1997-6#1)(2006-10#1)(2011-3#1)(2013-1#1)
procedure was successful in##2##4##(2007-7#1)(2012-2#1)
procedure was successful##4##3##(2007-7#1)(2012-12#2)(2012-2#1)
procedure was successfully applied for the determination of##2##8##(2008-10#2)
procedure was successfully applied for the##3##6##(2008-10#3)
procedure was successfully applied to the determination of##5##8##(2008-10#5)
procedure was successfully applied to the extraction and determination of##2##10##(2008-10#2)
procedure was successfully applied to the##8##6##(2008-10#8)
procedure was successfully applied to##11##5##(1995-10#1)(2008-10#9)(2012-11#1)
procedure was successfully applied##14##4##(1995-10#1)(2008-10#12)(2012-11#1)
procedure was successfully##15##3##(1995-10#1)(2008-10#13)(2012-11#1)
procedure was tested by analyzing##3##5##(2008-10#3)
procedure was tested by##4##4##(2008-10#4)
procedure was tested##7##3##(2008-10#7)
procedure was then##3##3##(2008-10#1)(2008-7#2)
procedure was used for the##2##5##(1992-8#1)(2008-10#1)
procedure was used for##4##4##(1992-8#1)(2008-10#3)
procedure was used to##15##4##(1991-1#1)(1992-7#1)(1993-5#1)(1994-2#1)(1996-10#1)(1996-3#1)(1997-4#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)
procedure was used##26##3##(1990-12#1)(1991-1#1)(1991-7#1)(1992-7#1)(1992-8#1)(1993-5#1)(1994-2#1)(1994-3#1)(1996-10#1)(1996-3#1)(1997-4#1)(2005-5#1)(2008-10#8)(2008-3#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-5#1)
procedure was validated by##5##4##(2008-10#4)(2013-8#1)
procedure was validated##6##3##(2008-10#5)(2013-8#1)
procedure was well tolerated##2##4##(2004-2#1)(2007-8#1)
procedure was##300##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#2)(1991-2#2)(1991-7#2)(1991-8#1)(1992-12#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-5#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-9#2)(1995-10#1)(1995-12#4)(1995-2#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-6#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-10#1)(2004-2#1)(2005-5#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-5#4)(2006-6#1)(2006-8#5)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#3)(2007-8#12)(2007-9#1)(2008-10#150)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-6#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#2)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#8)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
procedure we found##2##3##(1995-11#1)(2008-3#1)
procedure we have characterized the##2##5##(1994-3#1)(1995-3#1)
procedure we have##3##3##(1991-3#1)(1994-3#1)(1995-3#1)
procedure we##8##2##(1991-3#1)(1992-4#1)(1993-11#1)(1994-3#1)(1995-11#1)(1995-3#1)(2007-8#1)(2008-3#1)
procedure well##3##2##(2012-12#1)(2013-1#2)
procedure were evaluated##2##3##(2008-10#2)
procedure were in good agreement with those obtained by##2##9##(2008-10#2)
procedure were in##4##3##(2008-10#4)
procedure were studied##3##3##(2008-10#3)
procedure were##33##2##(1990-12#1)(1993-8#1)(1997-2#1)(1997-5#1)(1997-8#2)(2006-5#1)(2007-8#2)(2008-10#18)(2008-2#1)(2010-3#1)(2010-7#1)(2011-2#3)
procedure when##6##2##(1992-12#1)(2005-2#1)(2007-8#1)(2008-11#1)(2008-5#2)
procedure which can be##2##4##(2010-7#1)(2011-1#1)
procedure which is##3##3##(2006-12#1)(2008-12#1)(2012-3#1)
procedure which may##2##3##(2011-2#1)(2012-12#1)
procedure which yields##2##3##(1990-4#1)(1993-6#1)
procedure which##17##2##(1990-4#1)(1993-6#1)(1995-2#1)(1996-8#1)(2006-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-7#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)
procedure will##8##2##(1993-12#1)(1994-9#1)(1997-3#1)(1997-7#1)(2007-12#1)(2007-4#1)(2008-4#1)(2010-11#1)
procedure with a high##2##4##(1994-3#1)(2008-10#1)
procedure with a##14##3##(1994-3#1)(1995-2#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-7#1)(2009-3#1)(2010-12#1)(2012-3#1)
procedure with an average##2##4##(2006-2#1)(2008-6#1)
procedure with ethyl##2##3##(2008-10#2)
procedure with the##5##3##(1991-1#1)(1996-1#1)(1997-3#1)(2008-10#2)
procedure with two##2##3##(2009-2#1)(2011-2#1)
procedure with##62##2##(1990-6#2)(1991-1#1)(1991-12#1)(1991-3#1)(1992-2#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-12#1)(1997-3#2)(2005-10#1)(2006-10#1)(2006-2#1)(2006-8#2)(2007-11#3)(2007-12#1)(2007-4#1)(2007-8#4)(2008-10#17)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-7#1)
procedure without any##2##3##(2007-7#1)(2008-5#1)
procedure without##8##2##(2007-7#1)(2008-10#4)(2008-5#1)(2009-4#1)(2009-6#1)
procedure works well##3##3##(2008-10#1)(2008-2#1)(2012-1#1)
procedure would be##2##3##(1991-1#1)(2009-8#1)
procedure yielded##5##2##(1991-2#1)(1992-11#1)(1993-8#1)(1996-9#1)(2008-10#1)
procedure yields##4##2##(1994-11#1)(2008-4#1)(2012-2#1)(2012-3#1)
procedure##3917##1##(1990-10#5)(1990-11#15)(1990-12#21)(1990-2#5)(1990-3#7)(1990-4#9)(1990-5#6)(1990-6#2)(1990-7#5)(1990-8#15)(1990-9#16)(1991-1#5)(1991-10#4)(1991-11#9)(1991-12#9)(1991-2#13)(1991-3#10)(1991-4#5)(1991-5#13)(1991-6#8)(1991-7#5)(1991-8#4)(1991-9#4)(1992-1#4)(1992-10#5)(1992-11#2)(1992-12#15)(1992-2#9)(1992-3#6)(1992-4#3)(1992-5#4)(1992-6#7)(1992-7#6)(1992-8#13)(1992-9#10)(1993-1#4)(1993-10#4)(1993-11#14)(1993-12#17)(1993-2#4)(1993-3#10)(1993-4#3)(1993-5#6)(1993-6#9)(1993-7#2)(1993-8#4)(1993-9#10)(1994-1#2)(1994-10#1)(1994-11#7)(1994-12#16)(1994-2#6)(1994-3#20)(1994-5#8)(1994-6#5)(1994-8#9)(1994-9#16)(1995-1#5)(1995-10#3)(1995-11#7)(1995-12#11)(1995-2#8)(1995-3#3)(1995-4#6)(1995-5#1)(1995-6#9)(1995-8#11)(1995-9#2)(1996-1#5)(1996-10#1)(1996-11#6)(1996-12#25)(1996-2#8)(1996-3#11)(1996-4#6)(1996-5#10)(1996-6#12)(1996-7#4)(1996-8#19)(1996-9#9)(1997-1#8)(1997-2#15)(1997-3#14)(1997-4#6)(1997-5#8)(1997-6#7)(1997-7#3)(1997-8#16)(2004-1#2)(2004-10#6)(2004-11#1)(2004-12#2)(2004-2#9)(2004-4#1)(2004-9#1)(2005-10#3)(2005-11#18)(2005-12#6)(2005-2#1)(2005-4#3)(2005-5#8)(2005-7#4)(2005-8#1)(2005-9#3)(2006-1#2)(2006-10#52)(2006-11#22)(2006-12#19)(2006-2#10)(2006-3#19)(2006-4#5)(2006-5#33)(2006-6#38)(2006-7#12)(2006-8#56)(2006-9#11)(2007-1#11)(2007-10#11)(2007-11#71)(2007-12#57)(2007-2#16)(2007-3#11)(2007-4#11)(2007-5#16)(2007-6#14)(2007-7#65)(2007-8#165)(2007-9#19)(2008-1#20)(2008-10#976)(2008-11#85)(2008-12#17)(2008-2#114)(2008-3#126)(2008-4#141)(2008-5#56)(2008-6#25)(2008-7#48)(2008-8#25)(2008-9#50)(2009-1#1)(2009-10#12)(2009-11#7)(2009-12#5)(2009-2#11)(2009-3#10)(2009-4#11)(2009-5#18)(2009-6#7)(2009-7#4)(2009-8#10)(2009-9#12)(2010-1#6)(2010-10#4)(2010-11#15)(2010-12#19)(2010-2#14)(2010-3#7)(2010-4#14)(2010-5#8)(2010-6#8)(2010-7#18)(2010-8#22)(2010-9#5)(2011-1#37)(2011-11#5)(2011-12#7)(2011-2#104)(2011-3#5)(2012-1#11)(2012-11#3)(2012-12#60)(2012-2#49)(2012-3#37)(2013-1#94)(2013-7#14)(2013-8#30)
procedure's##2##1##(2007-1#1)(2013-1#1)
procedure) was##2##2##(2006-10#1)(2013-8#1)
procedure)##14##1##(1990-3#1)(1992-12#1)(1995-1#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
procedure-related complications##2##2##(2006-7#1)(2013-1#1)
procedure-related pain in##2##3##(2008-11#2)
procedure-related stress##2##2##(1994-12#2)
procedure-related##9##1##(1990-6#1)(1994-12#2)(1996-2#1)(2006-10#1)(2006-7#1)(2008-11#2)(2013-1#1)
procedure?##6##1##(1993-3#1)(2008-11#3)(2008-7#1)(2009-4#1)
procedure]##5##1##(1990-4#1)(1993-10#1)(1993-4#1)(1994-3#1)(2013-1#1)
procedures (e##3##2##(2006-2#1)(2008-10#1)(2011-2#1)
procedures (eg##2##2##(2006-10#1)(2008-11#1)
procedures (elemental##2##2##(2008-5#2)
procedures (i##3##2##(1990-11#1)(2008-4#2)
procedures (ie##2##2##(2006-10#1)(2006-3#1)
procedures (the##2##2##(1996-2#1)(2006-11#1)
procedures -##2##2##(2007-11#1)(2008-10#1)
procedures a##2##2##(2007-11#1)(2008-10#1)
procedures after##4##2##(1995-8#1)(1996-6#1)(2007-7#1)(2008-9#1)
procedures allow for the study of a variety of drug properties##2##11##(2008-4#1)(2012-3#1)
procedures allow for##3##3##(2008-4#2)(2012-3#1)
procedures allow##5##2##(2008-2#1)(2008-4#3)(2012-3#1)
procedures along with##5##3##(2006-10#1)(2008-4#1)(2008-9#2)(2013-7#1)
procedures also##4##2##(1991-8#1)(2008-10#2)(2008-4#1)
procedures among##4##2##(1994-11#1)(2008-10#1)(2010-8#1)(2011-2#1)
procedures and an##2##3##(1997-5#1)(2008-7#1)
procedures and analytical##2##3##(1994-12#1)(2010-9#1)
procedures and complications##2##3##(2007-7#1)(2011-1#1)
procedures and criteria##2##3##(1997-3#1)(2010-9#1)
procedures and evaluation##2##3##(1996-2#1)(2011-2#1)
procedures and in##3##3##(1995-10#1)(2008-10#1)(2011-2#1)
procedures and provides##2##3##(1991-10#1)(2008-10#1)
procedures and remarkable stability in##2##5##(2008-10#2)
procedures and results##2##3##(2008-9#1)(2012-1#1)
procedures and surgical##2##3##(1993-6#1)(2012-2#1)
procedures and the##9##3##(1992-4#1)(1992-7#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-6#1)(2010-11#2)(2011-1#1)
procedures and their##4##3##(1994-3#1)(2010-8#1)(2012-2#2)
procedures and treatment##3##3##(1996-3#1)(2010-4#1)(2011-1#1)
procedures and use of##2##4##(1995-3#1)(2009-12#1)
procedures and##142##2##(1990-10#1)(1990-8#1)(1990-9#1)(1991-10#1)(1992-2#3)(1992-4#1)(1992-7#1)(1993-10#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1996-2#1)(1996-3#2)(1997-3#3)(1997-5#1)(1997-8#1)(2005-7#1)(2006-10#4)(2006-11#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#2)(2006-8#1)(2006-9#2)(2007-11#2)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#14)(2008-11#4)(2008-12#1)(2008-2#3)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#4)(2010-12#1)(2010-4#1)(2010-8#5)(2010-9#2)(2011-1#5)(2011-2#10)(2012-1#2)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#2)(2013-8#1)
procedures appear to be##3##4##(2006-8#1)(2008-1#1)(2011-2#1)
procedures appeared##2##2##(1993-5#1)(1994-3#1)
procedures are also##3##3##(2007-3#1)(2008-2#1)(2008-4#1)
procedures are applied to##2##4##(2008-2#1)(2009-11#1)
procedures are associated with##3##4##(2008-3#1)(2010-2#1)(2011-2#1)
procedures are being##3##3##(2006-10#1)(2007-5#1)(2013-1#1)
procedures are complicated##2##3##(2006-10#1)(2006-6#1)
procedures are considered##2##3##(2006-10#1)(2006-8#1)
procedures are currently##2##3##(2008-10#1)(2009-9#1)
procedures are described in##4##4##(2008-3#1)(2008-4#2)(2008-9#1)
procedures are described##16##3##(1993-5#1)(1994-6#1)(1996-1#1)(2006-6#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-4#3)(2008-9#3)(2010-6#1)
procedures are discussed##3##3##(1991-5#1)(2008-10#1)(2008-4#1)
procedures are established##2##3##(2007-7#1)(2011-1#1)
procedures are given for##2##4##(2008-2#1)(2008-4#1)
procedures are important##3##3##(2005-12#1)(2007-10#1)(2008-12#1)
procedures are included##2##3##(2008-4#1)(2008-9#1)
procedures are less##2##3##(1996-3#1)(2008-10#1)
procedures are more##2##3##(2007-12#1)(2011-1#1)
procedures are necessary##3##3##(2006-10#1)(2006-8#1)(2011-2#1)
procedures are not##5##3##(1996-2#1)(1996-3#1)(2007-12#1)(2008-5#1)(2008-7#1)
procedures are now available##2##4##(1994-8#1)(2008-6#1)
procedures are now##4##3##(1994-8#1)(1997-6#1)(2008-3#1)(2008-6#1)
procedures are often##4##3##(2007-11#1)(2007-6#1)(2008-10#1)(2012-11#1)
procedures are outlined in the##2##5##(1994-6#1)(2006-3#1)
procedures are outlined##4##3##(1994-6#1)(2006-3#1)(2008-9#2)
procedures are performed in##2##4##(2006-10#1)(2010-2#1)
procedures are performed##6##3##(1990-9#1)(2006-10#3)(2007-11#1)(2010-2#1)
procedures are presented for##2##4##(2007-11#1)(2008-4#1)
procedures are presented##7##3##(1992-2#1)(2007-11#2)(2007-5#1)(2008-4#2)(2008-9#1)
procedures are proposed##2##3##(2008-10#1)(2012-1#1)
procedures are provided for##3##4##(1996-4#1)(2008-2#1)(2008-4#1)
procedures are provided##5##3##(1996-4#1)(2008-2#1)(2008-4#2)(2008-9#1)
procedures are safe##2##3##(1991-12#1)(2006-12#1)
procedures are time consuming##2##4##(2008-10#2)
procedures are used to##3##4##(1991-4#1)(2008-4#1)(2012-3#1)
procedures are used##6##3##(1991-4#1)(2006-4#1)(2008-4#2)(2010-12#1)(2012-3#1)
procedures are very##2##3##(2008-10#1)(2010-2#1)
procedures are widely##2##3##(2007-4#1)(2008-11#1)
procedures are##170##2##(1990-3#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-1#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-6#2)(1994-7#1)(1994-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-8#1)(1997-6#1)(2005-12#1)(2006-1#1)(2006-10#7)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#2)(2006-7#2)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#20)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#6)(2008-4#15)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#9)(2009-11#1)(2009-12#1)(2009-5#1)(2009-9#3)(2010-11#1)(2010-12#1)(2010-2#4)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#8)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#2)
procedures as well as##2##4##(2007-5#1)(2007-7#1)
procedures as##14##2##(1990-11#1)(1991-3#2)(1994-2#1)(2006-10#1)(2007-1#2)(2007-5#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-12#1)(2013-1#1)
procedures associated with##4##3##(2007-8#1)(2008-11#1)(2008-7#1)(2013-1#1)
procedures at##9##2##(1996-1#1)(2006-12#1)(2006-8#1)(2007-7#2)(2008-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
procedures available for##3##3##(1993-4#1)(2008-7#1)(2010-9#1)
procedures available##5##2##(1993-4#1)(2006-8#1)(2008-5#1)(2008-7#1)(2010-9#1)
procedures based on a##2##4##(1994-9#1)(1996-12#1)
procedures based on the##3##4##(1995-5#1)(1997-2#1)(2008-7#1)
procedures based on##11##3##(1994-9#1)(1995-5#1)(1996-12#1)(1997-2#1)(2005-11#1)(2008-10#3)(2008-7#1)(2009-11#1)(2012-3#1)
procedures based##12##2##(1994-9#1)(1995-5#1)(1996-12#1)(1997-2#1)(2005-11#1)(2006-8#1)(2008-10#3)(2008-7#1)(2009-11#1)(2012-3#1)
procedures become##2##2##(2007-8#1)(2008-10#1)
procedures before##3##2##(1995-12#1)(2006-10#1)(2007-12#1)
procedures being##2##2##(1992-9#1)(2013-1#1)
procedures by##9##2##(1990-4#1)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)
procedures can also be##2##4##(2008-4#1)(2012-3#1)
procedures can be used##2##4##(1996-5#1)(2008-2#1)
procedures can be##12##3##(1991-6#1)(1993-3#1)(1996-2#1)(1996-5#1)(2004-2#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-4#1)(2011-2#1)
procedures can provide##2##3##(2006-5#1)(2007-1#1)
procedures can##20##2##(1991-6#1)(1992-2#1)(1993-3#1)(1994-3#1)(1996-2#1)(1996-5#1)(2004-2#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2009-4#1)(2011-2#1)(2012-3#2)
procedures carried out in##3##4##(1991-8#1)(1992-10#1)(2006-12#1)
procedures carried out##6##3##(1991-8#1)(1992-10#1)(2006-12#1)(2007-8#1)(2008-3#1)(2008-7#1)
procedures combined with##2##3##(2009-6#1)(2010-3#1)
procedures continue to##2##3##(2006-10#1)(2007-9#1)
procedures could##5##2##(1993-2#1)(1996-12#1)(2007-8#1)(2008-10#2)
procedures cover##2##2##(2008-4#2)
procedures currently in use##2##4##(2007-11#1)(2008-10#1)
procedures currently##5##2##(2006-10#1)(2007-11#1)(2008-10#1)(2010-11#1)(2010-12#1)
procedures derived from##3##3##(2007-8#1)(2008-11#1)(2010-12#1)
procedures described in this##2##4##(1992-8#1)(2008-4#1)
procedures described in##3##3##(1992-8#1)(2008-10#1)(2008-4#1)
procedures described##5##2##(1992-12#1)(1992-8#1)(2008-10#1)(2008-4#2)
procedures designed to##3##3##(2008-4#2)(2012-2#1)
procedures designed##4##2##(1996-7#1)(2008-4#2)(2012-2#1)
procedures developed for##4##3##(2007-12#1)(2008-10#2)(2008-11#1)
procedures developed##7##2##(1994-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)
procedures do not##4##3##(2006-12#1)(2008-10#1)(2011-1#1)(2013-8#1)
procedures do##5##2##(2006-12#1)(2008-10#1)(2008-11#1)(2011-1#1)(2013-8#1)
procedures during##5##2##(2006-10#1)(2007-8#1)(2008-2#1)(2010-8#1)(2012-1#1)
procedures effectively##2##2##(2008-2#1)(2010-8#1)
procedures employed##4##2##(1992-2#1)(1992-3#1)(2008-2#1)(2008-5#1)
procedures exist##2##2##(2006-3#1)(2007-12#1)
procedures for a##5##3##(1992-9#1)(2007-10#1)(2008-10#1)(2008-4#2)
procedures for all the##2##4##(2007-8#1)(2008-10#1)
procedures for analyzing the##2##4##(2008-2#1)(2008-4#1)
procedures for analyzing##3##3##(2008-2#1)(2008-4#1)(2010-9#1)
procedures for calculating##3##3##(1992-2#1)(2007-7#1)(2008-4#1)
procedures for children with##2##4##(1993-5#1)(2010-7#1)
procedures for detecting##2##3##(2008-10#1)(2008-5#1)
procedures for measuring the##3##4##(2008-4#2)(2008-9#1)
procedures for measuring##4##3##(2008-4#3)(2008-9#1)
procedures for preparation of##2##4##(1996-1#1)(2009-9#1)
procedures for preparing##2##3##(2008-4#2)
procedures for producing##2##3##(1993-11#1)(2008-4#1)
procedures for simultaneous##4##3##(1995-7#1)(2008-10#2)(2012-3#1)
procedures for testing##3##3##(1992-2#1)(2008-4#1)(2008-9#1)
procedures for the analysis of##3##5##(2008-4#2)(2012-3#1)
procedures for the determination of##9##5##(1990-9#1)(2008-10#7)(2010-4#1)
procedures for the preparation of##4##5##(2008-4#3)(2008-9#1)
procedures for the preparation##5##4##(2008-10#1)(2008-4#3)(2008-9#1)
procedures for the qualitative and quantitative assessment of mRNA abundance are important##2##12##(2008-2#1)(2008-4#1)
procedures for the treatment of##2##5##(2010-1#1)(2012-12#1)
procedures for the##47##3##(1990-9#1)(1992-12#1)(1992-8#1)(1994-2#1)(1994-4#1)(1996-1#1)(1996-12#1)(1997-4#1)(2006-4#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-2#1)(2008-3#1)(2008-4#11)(2008-8#1)(2008-9#3)(2010-1#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-3#2)(2013-8#2)
procedures for which##3##3##(1995-2#1)(1996-9#1)(2008-6#1)
procedures for##226##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#1)(1992-12#1)(1992-2#4)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-2#2)(1994-4#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-4#3)(2006-10#3)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#5)(2006-7#2)(2007-10#1)(2007-11#4)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#44)(2008-11#2)(2008-12#2)(2008-2#6)(2008-3#3)(2008-4#48)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#12)(2009-2#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#6)(2013-8#2)
procedures from##5##2##(1990-3#1)(1991-2#1)(1991-6#1)(1992-3#1)(2006-10#1)
procedures give##3##2##(1994-12#1)(2006-9#1)(2013-8#1)
procedures had##3##2##(2007-2#1)(2007-8#1)(2013-1#1)
procedures has been##2##3##(2007-8#1)(2008-10#1)
procedures has##8##2##(2007-8#3)(2008-10#2)(2008-4#1)(2011-2#2)
procedures have also##2##3##(2006-6#1)(2008-10#1)
procedures have become##2##3##(1993-8#1)(1997-1#1)
procedures have been applied to the##2##6##(2008-10#2)
procedures have been applied##3##4##(2008-10#3)
procedures have been developed to##3##5##(1994-12#1)(2006-10#1)(2008-10#1)
procedures have been developed##6##4##(1991-3#1)(1994-12#1)(2006-10#1)(2008-10#1)(2008-2#1)(2010-1#1)
procedures have been performed##3##4##(2006-6#1)(2007-7#1)(2011-2#1)
procedures have been proposed##3##4##(2008-2#1)(2011-2#1)(2011-7#1)
procedures have been reported##2##4##(2008-5#1)(2010-7#1)
procedures have been shown##2##4##(1992-2#1)(1994-12#1)
procedures have been tested##2##4##(1993-6#1)(2008-10#1)
procedures have been used##2##4##(2008-10#1)(2008-4#1)
procedures have been##32##3##(1991-3#1)(1991-5#1)(1992-2#1)(1993-6#1)(1994-12#2)(2006-10#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#2)(2010-1#2)(2010-7#1)(2011-2#3)(2011-7#1)
procedures have##53##2##(1991-11#1)(1991-3#1)(1991-5#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-9#1)(1996-3#1)(1997-1#1)(2006-10#2)(2006-6#3)(2006-7#1)(2007-11#2)(2007-7#1)(2007-9#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2009-3#1)(2010-1#2)(2010-7#1)(2010-9#1)(2011-2#4)(2011-7#1)(2012-11#1)(2012-2#1)
procedures in a wide##2##4##(1993-4#1)(2006-6#1)
procedures in a##7##3##(1993-4#1)(1996-1#1)(2006-6#1)(2008-5#1)(2008-7#2)(2009-12#1)
procedures in acute##3##3##(1993-5#1)(2005-12#1)(2011-2#1)
procedures in all##2##3##(2007-12#1)(2011-2#1)
procedures in an##2##3##(2010-11#1)(2011-2#1)
procedures in cases of##2##4##(2007-11#1)(2008-12#1)
procedures in health##2##3##(1994-3#1)(2009-12#1)
procedures in infants and##2##4##(2006-10#1)(2012-2#1)
procedures in infants##3##3##(2006-10#1)(2008-10#1)(2012-2#1)
procedures in order to##2##4##(2007-12#1)(2008-10#1)
procedures in patients with##2##4##(2009-5#1)(2013-8#1)
procedures in patients##4##3##(1995-8#1)(2009-5#1)(2010-3#1)(2013-8#1)
procedures in the lumbar##2##4##(2007-8#1)(2012-12#1)
procedures in the same##3##4##(2006-4#1)(2006-9#1)(2008-11#1)
procedures in the treatment of##3##5##(2007-11#1)(2011-3#1)(2013-7#1)
procedures in the##30##3##(1994-2#1)(1995-1#1)(1996-12#2)(2004-2#1)(2006-10#2)(2006-11#1)(2006-4#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2010-8#1)(2010-9#1)(2011-3#1)(2012-12#2)(2013-7#1)
procedures in this##2##3##(2009-9#1)(2011-2#1)
procedures in which##2##3##(1996-12#1)(2006-5#1)
procedures in##116##2##(1990-9#1)(1991-9#1)(1993-4#1)(1993-5#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-4#1)(1995-8#2)(1996-1#1)(1996-12#3)(1996-9#1)(1997-3#1)(1997-6#2)(2004-2#1)(2005-10#1)(2005-12#1)(2005-5#1)(2005-8#1)(2005-9#2)(2006-10#3)(2006-11#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-11#4)(2007-12#6)(2007-2#2)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#4)(2008-8#1)(2009-12#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-8#1)(2010-9#3)(2011-1#1)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
procedures include##2##2##(2007-7#1)(2013-1#1)
procedures included##4##2##(1992-2#1)(1993-2#1)(2007-8#1)(2007-9#1)
procedures including##10##2##(1993-12#1)(2006-10#1)(2006-8#1)(2007-2#1)(2008-10#2)(2010-11#1)(2010-8#1)(2012-2#1)(2012-3#1)
procedures increased from##2##3##(2006-10#2)
procedures into##2##2##(2007-5#2)
procedures involve##3##2##(2007-1#1)(2007-12#1)(2008-10#1)
procedures involved in##2##3##(2008-11#1)(2008-2#1)
procedures involved##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)
procedures involving the gastrointestinal system##2##5##(2004-2#2)
procedures involving the use of##2##5##(1992-6#1)(2008-10#1)
procedures involving the##5##3##(1990-9#1)(1992-6#1)(2004-2#2)(2008-10#1)
procedures involving##10##2##(1990-9#1)(1992-6#1)(2004-2#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#3)
procedures is also##3##3##(2007-2#1)(2008-10#1)(2009-3#1)
procedures is an##2##3##(2010-7#1)(2011-2#1)
procedures is reviewed##2##3##(2005-11#1)(2009-4#1)
procedures is the##2##3##(1997-6#1)(2009-2#1)
procedures is##40##2##(1990-4#1)(1990-9#1)(1991-2#1)(1992-3#1)(1993-1#1)(1993-3#1)(1995-12#1)(1996-3#1)(1996-6#1)(1997-6#1)(1997-7#1)(2004-2#1)(2005-11#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-8#2)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-8#1)(2010-5#1)(2010-7#1)(2011-12#1)(2011-2#3)(2013-1#1)
procedures lead to##2##3##(2004-9#1)(2008-11#1)
procedures led to##2##3##(1992-12#1)(1992-3#1)
procedures like##4##2##(2006-10#1)(2008-10#1)(2008-11#1)(2010-3#1)
procedures may be required to##2##5##(2007-12#1)(2012-11#1)
procedures may be##6##3##(1993-8#1)(1997-5#1)(2006-10#1)(2007-12#1)(2011-1#1)(2012-11#1)
procedures may result##2##3##(2006-11#1)(2012-12#1)
procedures may##14##2##(1993-8#1)(1995-7#1)(1997-5#1)(2006-10#2)(2006-11#1)(2007-11#1)(2007-12#1)(2008-9#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
procedures might be##3##3##(2007-11#1)(2008-9#1)(2011-2#1)
procedures must be##5##3##(1995-8#1)(1996-3#1)(1997-2#1)(2006-12#1)(2007-7#1)
procedures must##8##2##(1992-8#1)(1995-8#1)(1996-3#1)(1996-6#1)(1997-2#1)(2006-12#1)(2007-7#1)(2008-10#1)
procedures needed for##2##3##(1991-1#1)(1994-12#1)
procedures now##4##2##(1992-2#1)(1994-12#1)(2006-11#1)(2008-1#1)
procedures occurred in##2##3##(1996-9#1)(2008-7#1)
procedures of a##2##3##(2008-3#1)(2011-1#1)
procedures of the##10##3##(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-5#1)(2009-6#1)(2012-2#1)(2013-7#1)
procedures of##51##2##(1990-4#1)(1991-10#1)(1991-11#1)(1991-3#1)(1992-2#1)(1992-3#1)(1992-9#2)(1993-10#1)(1994-12#1)(1996-3#1)(1996-9#2)(1997-6#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#2)(2008-7#1)(2009-10#1)(2009-5#2)(2009-6#1)(2011-1#1)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#1)
procedures offer##2##2##(1992-3#1)(2008-4#1)
procedures on microleakage##2##3##(2013-8#2)
procedures on the##6##3##(1996-9#2)(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)
procedures on##17##2##(1990-1#1)(1995-1#1)(1996-9#2)(2006-10#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-11#1)(2012-3#1)(2013-8#2)
procedures or##11##2##(1993-3#1)(1995-9#1)(1997-8#1)(2008-11#1)(2008-5#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
procedures per##4##2##(1994-1#1)(1994-2#1)(2006-10#1)(2006-6#1)
procedures performed by##2##3##(2004-2#1)(2009-3#1)
procedures performed in the hospital##2##5##(1995-2#2)
procedures performed in the##4##4##(1995-2#2)(2008-5#1)(2011-2#1)
procedures performed in##12##3##(1995-2#3)(2007-7#1)(2008-5#1)(2010-2#2)(2010-8#1)(2011-2#3)(2013-8#1)
procedures performed on##3##3##(2006-10#1)(2007-7#1)(2010-7#1)
procedures performed with the##2##4##(1993-8#1)(2007-5#1)
procedures performed##36##2##(1992-12#1)(1993-1#1)(1993-8#1)(1995-1#1)(1995-2#3)(1995-3#1)(1997-3#1)(2004-2#1)(2005-7#1)(2006-10#2)(2006-8#2)(2007-12#1)(2007-5#1)(2007-7#3)(2008-3#1)(2008-5#1)(2009-3#1)(2010-12#1)(2010-2#2)(2010-7#1)(2010-8#1)(2011-2#4)(2012-12#2)(2013-1#1)(2013-8#1)
procedures present##2##2##(2008-10#1)(2012-2#1)
procedures presented##2##2##(2008-4#1)(2008-9#1)
procedures prior to##4##3##(1992-8#1)(2006-8#1)(2007-8#1)(2008-4#1)
procedures provide##5##2##(1997-3#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-9#1)
procedures related to##2##3##(2008-12#2)
procedures reported##2##2##(1996-8#1)(2008-10#1)
procedures require a##2##3##(2006-10#1)(2007-12#1)
procedures require the##2##3##(2008-2#1)(2009-10#1)
procedures require##7##2##(2006-10#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-2#1)(2009-10#1)(2012-1#1)
procedures required for##3##3##(2005-7#1)(2008-4#2)
procedures required to##4##3##(1993-12#1)(2006-8#1)(2008-4#1)(2010-2#1)
procedures required##8##2##(1993-12#1)(2005-7#1)(2006-8#1)(2008-4#3)(2008-5#1)(2010-2#1)
procedures requiring##4##2##(2006-4#1)(2006-6#1)(2007-12#1)(2008-8#1)
procedures retrospectively##2##2##(2010-8#2)
procedures should allow##2##3##(1995-3#1)(2013-8#1)
procedures should be performed##2##4##(2006-10#1)(2010-6#1)
procedures should be planned##2##4##(2006-10#1)(2008-8#1)
procedures should be reserved for##3##5##(2006-10#1)(2010-7#2)
procedures should be##13##3##(2006-10#3)(2007-7#2)(2007-9#1)(2008-8#2)(2009-11#1)(2010-11#1)(2010-6#1)(2010-7#2)
procedures should##18##2##(1995-3#1)(2006-10#3)(2007-7#2)(2007-8#1)(2007-9#1)(2008-3#1)(2008-8#2)(2009-11#1)(2010-11#1)(2010-6#1)(2010-7#2)(2013-1#1)(2013-8#1)
procedures showed##3##2##(2006-12#1)(2007-10#1)(2011-2#1)
procedures such as##26##3##(1993-2#1)(1993-5#1)(1996-5#1)(2004-2#1)(2006-10#4)(2006-12#1)(2007-10#1)(2007-4#1)(2007-5#1)(2007-9#2)(2008-10#3)(2008-3#1)(2008-7#1)(2008-9#2)(2009-2#2)(2010-8#1)(2011-1#1)(2012-3#1)
procedures take##2##2##(2008-1#1)(2008-4#1)
procedures than##2##2##(2006-10#1)(2012-12#1)
procedures that allow##3##3##(2008-4#2)(2010-6#1)
procedures that are used##2##4##(2008-4#1)(2013-8#1)
procedures that are##11##3##(2005-5#1)(2006-10#2)(2007-12#1)(2008-1#1)(2008-2#1)(2008-4#4)(2013-8#1)
procedures that can be used##2##5##(1997-3#1)(2008-2#1)
procedures that can be##3##4##(1997-3#1)(2008-2#1)(2012-2#1)
procedures that can##4##3##(1997-3#1)(2008-10#1)(2008-2#1)(2012-2#1)
procedures that give##2##3##(1996-7#1)(2007-1#1)
procedures that have##5##3##(2004-4#1)(2008-12#1)(2008-4#2)(2008-7#1)
procedures that may##2##3##(1993-3#1)(2006-10#1)
procedures that were##3##3##(1995-3#1)(2007-4#1)(2007-8#1)
procedures that##52##2##(1992-5#1)(1993-3#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-3#1)(2004-4#1)(2005-5#1)(2006-10#3)(2007-1#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-12#2)(2008-2#2)(2008-4#13)(2008-7#1)(2010-11#1)(2010-6#2)(2012-2#1)(2012-3#2)(2013-8#1)
procedures the##6##2##(1990-3#1)(1990-9#1)(1996-3#1)(2007-11#1)(2008-2#1)(2008-4#1)
procedures through##5##2##(1997-2#1)(2011-2#2)(2013-1#2)
procedures to a minimum##2##4##(1992-12#1)(2008-7#1)
procedures to a##3##3##(1992-12#1)(2008-3#1)(2008-7#1)
procedures to achieve##2##3##(2008-11#1)(2008-3#1)
procedures to assess##2##3##(2008-10#1)(2010-8#1)
procedures to be performed##2##4##(1990-4#1)(2007-12#1)
procedures to be##4##3##(1990-4#1)(1996-6#1)(2007-12#1)(2008-10#1)
procedures to correct##2##3##(1990-9#1)(2008-9#1)
procedures to determine##3##3##(2008-10#2)(2008-4#1)
procedures to ensure that##2##4##(1993-2#1)(2011-12#1)
procedures to estimate the##2##4##(1997-2#1)(2008-10#1)
procedures to identify##4##3##(2008-12#1)(2008-5#1)(2009-12#1)(2012-3#1)
procedures to provide##2##3##(2007-11#1)(2008-7#1)
procedures to test##2##3##(1992-7#1)(1995-4#1)
procedures to the##2##3##(2008-10#1)(2008-3#1)
procedures to##76##2##(1990-11#1)(1990-4#1)(1990-8#1)(1990-9#1)(1992-10#2)(1992-12#1)(1992-2#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-3#1)(1995-4#1)(1996-1#1)(1996-6#1)(1997-2#1)(1997-8#1)(2004-2#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#5)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#3)
procedures under a##2##3##(1995-4#1)(1996-8#1)
procedures under##5##2##(1995-4#1)(1996-8#1)(2005-11#1)(2006-8#1)(2008-5#1)
procedures underlying##3##2##(2008-4#1)(2013-1#2)
procedures used by the##2##4##(1991-12#1)(2008-7#1)
procedures used by##4##3##(1991-12#1)(1993-5#1)(2007-1#1)(2008-7#1)
procedures used for##3##3##(2008-10#2)(2012-3#1)
procedures used in the##4##4##(1992-3#1)(1996-12#1)(2006-4#1)(2008-3#1)
procedures used in##9##3##(1992-3#1)(1996-12#2)(2006-4#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-2#1)
procedures used to##7##3##(2006-10#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-6#1)(2012-2#1)
procedures used##28##2##(1990-10#1)(1991-12#1)(1992-3#1)(1993-5#1)(1996-12#2)(2006-10#2)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#4)(2010-2#1)(2010-6#1)(2012-2#1)(2012-3#1)
procedures using the##2##3##(2007-6#1)(2007-8#1)
procedures using##19##2##(1990-12#1)(1992-2#1)(1993-1#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-7#1)(2008-9#2)(2011-2#1)
procedures utilizing##2##2##(1995-3#2)
procedures was performed##2##3##(2007-2#1)(2007-8#1)
procedures was##15##2##(1990-12#1)(1990-7#1)(1993-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#6)(2008-5#1)(2009-4#1)
procedures were also carried out##2##5##(2008-10#1)(2008-5#1)
procedures were also##4##3##(2008-10#1)(2008-5#1)(2011-1#1)(2013-8#1)
procedures were applied to the##2##5##(1991-8#1)(2008-10#1)
procedures were applied to##4##4##(1991-8#1)(2008-10#3)
procedures were applied##7##3##(1991-8#1)(1993-3#1)(2008-10#4)(2010-4#1)
procedures were carried out##3##4##(1996-5#1)(2006-8#1)(2008-10#1)
procedures were compared##3##3##(2008-10#1)(2009-3#1)(2011-2#1)
procedures were completed##2##3##(2006-5#1)(2008-9#1)
procedures were conducted##2##3##(2004-11#1)(2007-2#1)
procedures were developed to##2##4##(1991-4#1)(2008-8#1)
procedures were developed##3##3##(1991-4#1)(2008-10#1)(2008-8#1)
procedures were established##2##3##(2004-12#1)(2008-10#1)
procedures were evaluated for##2##4##(2004-8#1)(2008-10#1)
procedures were evaluated##3##3##(2004-8#1)(2008-10#2)
procedures were found to be##3##5##(2006-11#1)(2009-4#1)(2010-4#1)
procedures were investigated##3##3##(2007-8#1)(2008-10#2)
procedures were made##2##3##(2007-8#1)(2008-10#1)
procedures were performed at our institution##2##6##(2007-7#1)(2007-8#1)
procedures were performed for##3##4##(2005-5#1)(2011-3#1)(2013-8#1)
procedures were performed in##3##4##(1991-4#1)(2006-5#1)(2007-8#1)
procedures were performed on##5##4##(2007-7#2)(2007-8#1)(2008-8#1)(2008-9#1)
procedures were performed to##2##4##(2004-11#1)(2009-4#1)
procedures were performed under##3##4##(1992-3#1)(2007-8#1)(2011-3#1)
procedures were performed##28##3##(1990-12#2)(1991-4#1)(1991-8#1)(1992-3#1)(1992-6#1)(2004-11#1)(2005-5#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-3#1)(2007-7#3)(2007-8#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2011-3#3)(2013-8#1)
procedures were studied##2##3##(2007-8#2)
procedures were used to##4##4##(1992-8#1)(1993-9#1)(2011-2#1)(2012-2#1)
procedures were used##7##3##(1992-8#1)(1993-9#1)(2007-11#1)(2007-7#1)(2011-2#1)(2012-2#1)(2013-7#1)
procedures were##111##2##(1990-12#2)(1991-4#2)(1991-8#2)(1992-3#1)(1992-6#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-9#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-5#1)(1997-7#1)(1997-8#2)(2004-1#1)(2004-11#2)(2004-12#1)(2004-8#1)(2005-5#1)(2006-11#1)(2006-12#2)(2006-5#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#5)(2007-8#12)(2008-1#1)(2008-10#21)(2008-4#1)(2008-5#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#2)(2010-1#1)(2010-4#2)(2011-1#1)(2011-2#3)(2011-3#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
procedures where##2##2##(1996-9#1)(2012-3#1)
procedures which can be##2##4##(1996-12#1)(2008-4#1)
procedures which##9##2##(1990-5#1)(1992-6#1)(1992-9#1)(1996-12#2)(2006-6#1)(2008-11#1)(2008-4#1)(2013-1#1)
procedures while##3##2##(1995-2#1)(2006-5#1)(2010-2#1)
procedures will be##4##3##(2006-2#1)(2006-6#1)(2007-4#1)(2008-4#1)
procedures with high##2##3##(1995-8#1)(2007-5#1)
procedures with the##4##3##(1992-7#1)(2007-11#1)(2008-10#1)(2012-3#1)
procedures with##24##2##(1990-5#1)(1992-7#1)(1995-4#1)(1995-8#1)(2006-10#1)(2006-8#3)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-8#1)(2009-5#1)(2012-3#1)
procedures within##3##2##(2007-10#1)(2008-5#1)(2008-9#1)
procedures without##5##2##(2008-7#1)(2011-2#1)(2012-12#2)(2012-3#1)
procedures would##2##2##(2006-6#1)(2007-8#1)
procedures##2647##1##(1990-1#1)(1990-10#5)(1990-11#5)(1990-12#8)(1990-2#5)(1990-3#9)(1990-4#5)(1990-5#5)(1990-6#3)(1990-7#4)(1990-8#7)(1990-9#12)(1991-1#6)(1991-10#3)(1991-11#6)(1991-12#7)(1991-2#7)(1991-3#6)(1991-4#4)(1991-5#3)(1991-6#6)(1991-7#1)(1991-8#8)(1991-9#3)(1992-1#3)(1992-10#7)(1992-11#5)(1992-12#9)(1992-2#17)(1992-3#17)(1992-4#2)(1992-5#2)(1992-6#9)(1992-7#4)(1992-8#12)(1992-9#6)(1993-1#11)(1993-10#2)(1993-11#4)(1993-12#11)(1993-2#9)(1993-3#14)(1993-4#2)(1993-5#7)(1993-6#4)(1993-8#6)(1993-9#3)(1994-1#4)(1994-10#1)(1994-11#2)(1994-12#13)(1994-2#6)(1994-3#10)(1994-4#1)(1994-5#1)(1994-6#6)(1994-7#2)(1994-8#2)(1994-9#3)(1995-1#7)(1995-10#1)(1995-11#1)(1995-12#12)(1995-2#10)(1995-3#11)(1995-4#5)(1995-5#4)(1995-6#3)(1995-7#2)(1995-8#8)(1995-9#2)(1996-1#10)(1996-10#1)(1996-11#8)(1996-12#13)(1996-2#12)(1996-3#14)(1996-4#2)(1996-5#4)(1996-6#6)(1996-7#7)(1996-8#5)(1996-9#12)(1997-1#3)(1997-2#5)(1997-3#8)(1997-4#5)(1997-5#3)(1997-6#9)(1997-7#5)(1997-8#7)(2004-1#1)(2004-11#2)(2004-12#1)(2004-2#11)(2004-4#3)(2004-8#1)(2004-9#2)(2005-10#6)(2005-11#8)(2005-12#2)(2005-5#6)(2005-7#5)(2005-8#1)(2005-9#3)(2006-1#1)(2006-10#106)(2006-11#11)(2006-12#27)(2006-2#5)(2006-3#8)(2006-4#5)(2006-5#18)(2006-6#37)(2006-7#12)(2006-8#41)(2006-9#8)(2007-1#12)(2007-10#9)(2007-11#57)(2007-12#51)(2007-2#18)(2007-3#6)(2007-4#14)(2007-5#21)(2007-6#9)(2007-7#42)(2007-8#76)(2007-9#17)(2008-1#25)(2008-10#308)(2008-11#42)(2008-12#22)(2008-2#50)(2008-3#42)(2008-4#142)(2008-5#39)(2008-6#8)(2008-7#53)(2008-8#26)(2008-9#57)(2009-10#6)(2009-11#5)(2009-12#13)(2009-2#9)(2009-3#12)(2009-4#13)(2009-5#16)(2009-6#4)(2009-7#2)(2009-8#7)(2009-9#17)(2010-1#4)(2010-11#15)(2010-12#16)(2010-2#21)(2010-3#9)(2010-4#6)(2010-5#6)(2010-6#8)(2010-7#10)(2010-8#25)(2010-9#10)(2011-1#30)(2011-12#5)(2011-2#98)(2011-3#6)(2011-7#1)(2012-1#12)(2012-11#6)(2012-12#42)(2012-2#39)(2012-3#39)(2013-1#73)(2013-7#9)(2013-8#25)
procedures)##15##1##(2006-10#5)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#1)(2009-5#1)(2009-9#1)(2011-2#1)(2013-8#1)
procedures]##9##1##(1991-11#2)(1991-3#1)(1992-3#1)(1994-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
proceed at##2##2##(2008-10#1)(2013-8#1)
proceed by##9##2##(1990-12#2)(1990-8#1)(1993-8#1)(1995-1#1)(1996-2#1)(1997-1#1)(2008-2#1)(2010-5#1)
proceed from##2##2##(2006-9#1)(2012-2#1)
proceed in##6##2##(1996-7#1)(1997-1#1)(2005-8#1)(2007-12#1)(2008-11#1)(2008-3#1)
proceed slowly##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
proceed through##3##2##(1990-11#1)(2007-12#1)(2010-10#1)
proceed to a##2##3##(2008-11#1)(2011-2#1)
proceed to##13##2##(1990-12#1)(1991-5#1)(1992-12#1)(1992-2#1)(1995-1#1)(1995-4#1)(2006-2#1)(2006-3#1)(2007-9#1)(2008-1#1)(2008-11#1)(2011-2#2)
proceed via a##2##3##(1993-9#1)(1995-3#1)
proceed via##4##2##(1993-9#1)(1995-3#2)(2008-10#1)
proceed with a##5##3##(1993-2#1)(1996-11#1)(1996-12#1)(2006-10#1)(2010-12#1)
proceed with##18##2##(1990-12#1)(1990-5#1)(1990-8#1)(1993-2#1)(1993-4#2)(1996-11#1)(1996-12#2)(1996-5#1)(2005-8#1)(2006-10#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-12#1)(2013-1#1)
proceed##94##1##(1990-11#1)(1990-12#6)(1990-5#1)(1990-8#2)(1991-3#2)(1991-5#1)(1992-12#1)(1992-2#1)(1993-2#1)(1993-4#2)(1993-8#2)(1993-9#1)(1994-2#1)(1995-1#2)(1995-3#3)(1995-4#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-5#2)(1996-7#1)(1997-1#2)(1997-4#1)(1997-7#1)(2004-9#1)(2005-11#1)(2005-8#2)(2006-10#1)(2006-2#1)(2006-3#2)(2006-9#1)(2007-11#1)(2007-12#3)(2007-9#3)(2008-1#3)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#2)(2010-10#1)(2010-12#3)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
proceeded at##4##2##(1990-7#1)(2007-10#1)(2008-10#1)(2008-5#1)
proceeded from a##2##3##(2008-10#1)(2010-8#1)
proceeded from##4##2##(1996-2#1)(2006-10#1)(2008-10#1)(2010-8#1)
proceeded in the##2##3##(1997-1#1)(2007-1#1)
proceeded in##8##2##(1992-12#1)(1996-5#1)(1997-1#1)(2006-12#1)(2007-1#1)(2008-10#2)(2013-1#1)
proceeded rapidly##2##2##(1994-10#1)(1997-8#1)
proceeded to term##2##3##(1994-2#1)(2006-12#1)
proceeded to the##3##3##(1992-12#1)(1994-5#1)(2008-7#1)
proceeded to##11##2##(1992-12#1)(1994-2#1)(1994-5#1)(1995-6#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-7#2)(2011-1#1)(2011-2#1)
proceeded with##2##2##(2008-10#1)(2009-6#1)
proceeded##48##1##(1990-7#1)(1991-7#1)(1992-12#2)(1992-9#1)(1994-10#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#10)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-6#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#2)
proceeding in##2##2##(1990-5#1)(1995-2#1)
proceeding to the##2##3##(1990-10#1)(2008-6#1)
proceeding to##5##2##(1990-10#1)(1995-4#1)(2008-10#1)(2008-6#1)(2008-7#1)
proceeding##21##1##(1990-10#1)(1990-5#1)(1991-2#1)(1991-6#1)(1992-2#1)(1995-2#1)(1995-4#1)(2004-12#1)(2005-7#1)(2007-12#1)(2007-4#1)(2008-10#5)(2008-11#2)(2008-6#1)(2008-7#1)(2010-3#1)
proceedings and##2##2##(2008-8#1)(2010-7#1)
proceedings in##4##2##(1996-12#1)(2007-11#3)
proceedings of the##5##3##(1993-11#1)(2005-7#2)(2008-5#1)(2011-2#1)
proceedings of##7##2##(1993-11#1)(2005-7#3)(2008-12#1)(2008-5#1)(2011-2#1)
proceedings##49##1##(1990-5#1)(1991-10#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-12#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-12#2)(1996-5#1)(1996-9#1)(1997-5#1)(1997-6#1)(1997-8#2)(2005-7#4)(2007-11#5)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#2)(2009-4#2)(2010-1#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#4)(2013-7#1)
proceedings]##2##1##(2009-4#1)(2012-1#1)
proceeds along a##2##3##(1992-11#1)(2009-8#1)
proceeds along##4##2##(1992-11#1)(1994-12#1)(2009-8#1)(2012-2#1)
proceeds at a##2##3##(1994-9#1)(2008-10#1)
proceeds at##5##2##(1990-2#1)(1991-12#1)(1991-2#1)(1994-9#1)(2008-10#1)
proceeds by##7##2##(1990-12#2)(1991-3#1)(1995-8#1)(2008-10#1)(2010-2#1)(2012-1#1)
proceeds in the##3##3##(1992-2#1)(1995-8#1)(2010-6#1)
proceeds in##8##2##(1991-2#1)(1992-2#1)(1995-8#1)(2007-11#1)(2008-10#1)(2009-7#1)(2010-6#1)(2012-2#1)
proceeds more rapidly##2##3##(1992-3#1)(2010-8#1)
proceeds slowly in the##2##4##(1990-3#1)(2008-10#1)
proceeds slowly##3##2##(1990-3#1)(2007-11#1)(2008-10#1)
proceeds through a process that##2##5##(2008-10#2)
proceeds through a##5##3##(1991-8#1)(1993-11#1)(2008-10#2)(2008-11#1)
proceeds through##12##2##(1990-6#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-8#1)(1993-11#1)(1995-6#1)(2008-10#2)(2008-11#1)(2009-10#1)(2012-1#1)
proceeds to an##2##3##(1990-5#1)(2007-1#1)
proceeds to##3##2##(1990-5#1)(2007-1#1)(2008-8#1)
proceeds via a##4##3##(1996-2#1)(2004-12#1)(2008-7#1)(2010-2#1)
proceeds via an##2##3##(1996-2#1)(1997-2#1)
proceeds via the##3##3##(1994-5#1)(2006-10#1)(2008-11#1)
proceeds via##13##2##(1994-5#1)(1996-2#2)(1997-2#2)(2004-12#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-7#1)(2009-2#1)(2010-2#1)(2011-1#1)
proceeds with a##2##3##(1995-1#1)(1996-5#1)
proceeds with##13##2##(1991-2#1)(1991-3#1)(1992-8#1)(1995-1#1)(1996-2#2)(1996-5#3)(2004-10#1)(2008-10#1)(2008-7#1)(2010-5#1)
proceeds##96##1##(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-4#1)(1995-6#1)(1995-8#2)(1996-2#4)(1996-5#3)(1997-2#2)(1997-4#1)(2004-10#1)(2004-12#1)(2006-10#1)(2006-11#1)(2006-3#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-8#2)(2007-9#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2012-1#2)(2012-2#3)
procephalon##2##1##(2007-12#2)
procera##5##1##(2008-10#1)(2008-3#1)(2013-1#3)
process -##2##2##(2007-12#1)(2008-7#1)
process a special##2##3##(2008-10#1)(2008-5#1)
process a##10##2##(2007-12#1)(2008-10#2)(2008-5#3)(2008-9#1)(2009-4#1)(2009-7#1)(2010-11#1)
process about##2##2##(1997-1#1)(2011-2#1)
process achieved##3##2##(1997-5#1)(2007-10#1)(2008-11#1)
process across the##2##3##(1990-3#1)(1996-3#1)
process across##3##2##(1990-3#1)(1994-3#1)(1996-3#1)
process after##4##2##(1995-5#1)(2007-11#1)(2008-7#1)(2010-10#1)
process aimed at##4##3##(1993-9#1)(2008-11#1)(2009-4#1)(2012-3#1)
process allows the##2##3##(2007-12#1)(2008-10#1)
process allows##7##2##(2005-7#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)
process also##7##2##(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)
process among##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
process an##2##2##(1991-3#1)(2006-6#1)
process analysis on baseline data##2##5##(2008-3#2)
process analysis##5##2##(1995-3#1)(2008-3#2)(2013-8#2)
process and a##4##3##(1997-2#1)(2005-12#1)(2007-12#1)(2009-10#1)
process and are##3##3##(1995-2#1)(2009-2#1)(2013-1#1)
process and can##2##3##(2007-12#1)(2013-8#1)
process and characterized by##3##4##(2008-3#1)(2009-7#1)(2012-2#1)
process and have##2##3##(2008-2#1)(2013-8#1)
process and help##2##3##(1992-9#1)(2008-7#1)
process and how it##2##4##(1993-3#1)(2007-4#1)
process and how##5##3##(1993-3#1)(1993-6#1)(1994-2#1)(1996-1#1)(2007-4#1)
process and improve the##2##4##(1993-10#1)(2008-12#1)
process and in##5##3##(1994-2#1)(2006-6#1)(2008-5#1)(2010-7#1)(2013-8#1)
process and is##6##3##(1996-5#1)(1996-8#1)(2005-7#1)(2007-12#1)(2007-4#1)(2012-1#1)
process and it is##2##4##(2008-5#1)(2008-7#1)
process and its##6##3##(1990-11#1)(1990-4#1)(1991-1#1)(1992-2#1)(2008-1#1)(2010-6#1)
process and may be##2##4##(1991-12#1)(2006-10#1)
process and may##6##3##(1991-12#1)(1995-1#1)(2006-10#2)(2008-10#1)(2008-4#1)
process and not##2##3##(1992-7#1)(2008-6#1)
process and outcome of##2##4##(1991-1#1)(2008-12#1)
process and outcome##5##3##(1991-1#1)(2006-2#1)(2008-12#1)(2008-9#1)(2013-1#1)
process and outcomes##4##3##(1994-2#1)(2006-5#1)(2007-4#1)(2012-12#1)
process and present##2##3##(1995-12#1)(2012-1#1)
process and presentation##3##3##(2008-8#3)
process and provides##2##3##(1991-4#1)(2008-10#1)
process and that##5##3##(1995-8#1)(1997-4#1)(2006-3#1)(2008-10#2)
process and the effect of##3##5##(2008-2#1)(2010-10#2)
process and the##47##3##(1990-12#1)(1990-4#1)(1990-9#1)(1992-12#1)(1993-3#1)(1994-2#1)(1994-3#3)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#1)(2005-11#2)(2006-5#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
process and thereby##3##3##(1994-3#1)(2008-7#1)(2012-2#1)
process and thus##4##3##(1997-6#1)(2006-8#1)(2007-6#1)(2011-1#1)
process and to determine the##2##5##(1991-9#1)(2008-10#1)
process and to##7##3##(1991-9#1)(2006-1#1)(2008-10#2)(2010-12#1)(2012-1#1)(2012-2#1)
process and various##2##3##(1994-10#1)(2007-12#1)
process and##289##2##(1990-11#1)(1990-12#2)(1990-4#2)(1990-9#1)(1991-1#2)(1991-12#2)(1991-4#1)(1991-9#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-10#1)(1993-11#2)(1993-3#2)(1993-6#1)(1994-1#1)(1994-10#1)(1994-2#5)(1994-3#5)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#2)(1997-4#2)(1997-6#3)(2004-9#1)(2005-11#4)(2005-12#1)(2005-2#1)(2005-4#1)(2005-7#4)(2005-8#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#3)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#5)(2007-12#7)(2007-4#6)(2007-5#4)(2007-6#2)(2007-7#3)(2007-8#4)(2008-1#7)(2008-10#20)(2008-11#8)(2008-12#5)(2008-2#7)(2008-3#6)(2008-4#6)(2008-5#8)(2008-6#3)(2008-7#9)(2008-8#5)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#3)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#9)(2011-3#1)(2012-1#3)(2012-12#6)(2012-2#6)(2012-3#2)(2013-1#11)(2013-7#2)(2013-8#6)
process and/or##2##2##(2008-7#1)(2009-2#1)
process appears to be a##2##5##(1993-1#1)(2005-7#1)
process appears to be##3##4##(1993-1#1)(2005-7#1)(2008-3#1)
process appears to##4##3##(1993-1#1)(2005-7#1)(2008-3#1)(2008-7#1)
process are described##2##3##(2007-11#1)(2008-6#1)
process are evaluated##2##3##(1990-4#1)(2008-2#1)
process are not##2##3##(2008-10#1)(2012-12#1)
process are only##2##3##(1990-5#1)(2010-2#1)
process are##41##2##(1990-4#1)(1990-5#1)(1992-9#1)(1993-6#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-2#1)(2004-9#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#2)(2009-7#1)(2009-8#1)(2010-2#1)(2012-12#2)(2012-2#1)
process as a whole##2##4##(1992-3#1)(1996-8#1)
process as a##4##3##(1992-3#1)(1992-9#1)(1996-8#1)(2006-12#1)
process as it is##2##4##(1991-5#1)(2012-2#1)
process as the##2##3##(2007-12#1)(2010-2#1)
process as well as the##2##5##(1996-12#1)(2008-3#1)
process as well as##9##4##(1992-6#1)(1996-12#1)(2007-1#1)(2008-10#3)(2008-3#1)(2010-9#1)(2012-2#1)
process as well##11##3##(1990-10#1)(1992-6#1)(1996-12#1)(2007-1#1)(2008-10#3)(2008-3#1)(2008-6#1)(2010-9#1)(2012-2#1)
process as##27##2##(1990-10#1)(1991-4#1)(1991-5#1)(1992-3#1)(1992-6#1)(1992-9#1)(1994-5#1)(1995-5#1)(1996-12#1)(1996-8#1)(2004-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-6#2)(2010-2#1)(2010-9#1)(2012-2#3)
process associated with the##2##4##(2009-8#1)(2011-2#1)
process associated with##8##3##(2007-12#1)(2007-4#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-2#1)
process at a##5##3##(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)
process at room temperature##2##4##(2007-12#1)(2010-4#1)
process at the##6##3##(1991-5#1)(2005-11#1)(2006-9#1)(2008-10#1)(2008-3#1)(2010-1#1)
process at##30##2##(1991-5#1)(1993-12#1)(1993-3#2)(1994-11#1)(1994-2#1)(1995-5#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-9#1)(2007-12#2)(2008-10#6)(2008-2#2)(2008-3#2)(2008-8#1)(2009-11#1)(2010-1#1)(2010-4#1)(2010-8#1)(2010-9#1)
process based on##4##3##(2007-11#1)(2008-10#1)(2008-5#1)(2008-6#1)
process based##5##2##(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)
process because of##2##3##(2008-12#1)(2010-5#1)
process because the##2##3##(1995-3#1)(2011-12#1)
process because##7##2##(1995-3#1)(1996-6#1)(2006-5#1)(2007-6#1)(2008-12#1)(2010-5#1)(2011-12#1)
process becomes##3##2##(1994-5#1)(2005-11#1)(2008-10#1)
process before##2##2##(1991-12#1)(2008-10#1)
process being##3##2##(1992-6#1)(1995-8#1)(2008-2#1)
process between the##2##3##(1993-1#1)(2011-1#1)
process between##7##2##(1991-3#1)(1993-1#1)(1994-8#1)(2008-10#1)(2010-3#1)(2011-1#2)
process blank##2##2##(2008-10#2)
process but also##2##3##(1993-3#1)(1995-5#1)
process but##5##2##(1993-3#1)(1995-5#1)(2008-12#1)(2008-3#1)(2011-2#1)
process by each##2##3##(1992-6#1)(2008-10#1)
process by eliminating##2##3##(1996-1#1)(2008-6#1)
process by means of##2##4##(2004-9#1)(2007-9#1)
process by the##5##3##(1993-8#1)(2005-7#1)(2008-10#2)(2008-5#1)
process by using##3##3##(1991-6#1)(2008-10#2)
process by which an##2##4##(1995-3#1)(2008-2#1)
process by which we##2##4##(2008-2#1)(2008-7#1)
process by which##40##3##(1991-12#1)(1991-4#1)(1992-1#1)(1992-3#1)(1993-3#1)(1993-9#1)(1995-2#1)(1995-3#1)(1996-2#1)(2004-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2009-4#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
process by##81##2##(1991-12#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-8#2)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-7#1)(2004-8#1)(2004-9#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-12#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-2#7)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
process called##7##2##(1991-7#1)(1996-11#1)(2007-12#2)(2008-7#1)(2012-12#1)(2013-8#1)
process can be altered##2##4##(1991-6#1)(2008-6#1)
process can be divided into##2##5##(2008-10#1)(2010-6#1)
process can be successfully##2##4##(1993-3#1)(2010-4#1)
process can be used##2##4##(2010-8#1)(2013-1#1)
process can be##35##3##(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-8#1)(2005-11#1)(2005-12#1)(2006-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-8#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-6#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
process can occur##2##3##(1994-9#1)(2007-12#1)
process can##53##2##(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1992-3#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(2005-11#1)(2005-12#1)(2006-1#1)(2007-10#1)(2007-11#4)(2007-12#5)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-4#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
process carried out##2##3##(2007-11#1)(2007-6#1)
process catalysed by##2##3##(1995-11#1)(2008-5#1)
process change##5##2##(1993-2#1)(1995-2#1)(2008-10#1)(2008-8#1)(2013-8#1)
process changes##2##2##(2008-10#1)(2008-8#1)
process characterized by##2##3##(1995-11#1)(2006-5#1)
process comparability##3##2##(2012-2#3)
process comprising##2##2##(2005-8#1)(2013-1#1)
process conditions##2##2##(2008-2#1)(2008-6#1)
process consisted##2##2##(1996-3#1)(2008-5#1)
process consisting of a##2##4##(1997-4#1)(2008-10#1)
process consisting of##4##3##(1997-4#1)(2008-10#2)(2009-11#1)
process continues##2##2##(2010-10#1)(2010-7#1)
process control (SPC)##3##3##(1995-2#1)(1996-1#1)(2008-10#1)
process control in##5##3##(1995-2#1)(2006-12#1)(2008-10#1)(2010-2#1)(2010-8#1)
process control of##2##3##(1996-5#1)(2008-2#1)
process control parameters for the production of HA-2-91##2##8##(2006-9#2)
process control parameters##3##3##(2006-9#3)
process control##22##2##(1990-12#1)(1995-2#2)(1996-1#1)(1996-5#1)(2006-12#1)(2006-9#3)(2008-10#6)(2008-2#1)(2008-3#3)(2010-2#1)(2010-8#1)(2011-2#1)
process controls##3##2##(2007-4#1)(2008-11#2)
process could be##8##3##(1994-6#1)(1995-8#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2011-2#1)
process could have##2##3##(2006-10#1)(2012-2#1)
process could##15##2##(1994-2#1)(1994-6#1)(1995-8#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
process data##3##2##(2007-10#1)(2008-3#1)(2013-1#1)
process depending on##2##3##(1996-11#1)(2008-10#1)
process depends on##2##3##(2008-10#1)(2012-12#1)
process depends##3##2##(2008-10#1)(2009-3#1)(2012-12#1)
process described here##3##3##(2008-11#2)(2009-2#1)
process described##7##2##(1991-1#1)(1992-3#1)(2008-11#3)(2008-12#1)(2009-2#1)
process design and##2##3##(1994-5#1)(2008-7#1)
process design##8##2##(1994-5#1)(1995-12#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2011-2#1)
process despite##2##2##(2008-11#1)(2009-10#1)
process developed##3##2##(1995-3#1)(2008-10#1)(2013-1#1)
process development for##3##3##(2008-11#1)(2012-3#2)
process development##17##2##(1997-2#1)(2008-11#5)(2008-6#1)(2010-11#1)(2011-2#5)(2012-3#4)
process directly##2##2##(2008-11#1)(2008-2#1)
process does not occur##2##4##(2005-11#1)(2008-3#1)
process does not require##2##4##(1990-2#1)(1995-2#1)
process does not##11##3##(1990-2#1)(1995-2#1)(2005-11#1)(2007-12#1)(2007-2#1)(2008-2#1)(2008-3#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
process does##13##2##(1990-2#1)(1995-2#1)(1995-8#1)(2005-11#1)(2007-12#1)(2007-2#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
process dominates##3##2##(2005-11#1)(2008-11#1)(2008-3#1)
process driven by##3##3##(2006-5#1)(2007-12#1)(2008-8#1)
process due to##2##3##(1991-10#1)(2011-2#1)
process during the##3##3##(2008-10#3)
process during which##3##3##(1991-5#1)(1997-6#1)(2006-10#1)
process during##11##2##(1991-5#1)(1997-2#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-10#4)(2008-3#1)(2010-1#1)
process effectively##2##2##(2007-7#1)(2013-1#1)
process efficiency##2##2##(2007-12#1)(2007-8#1)
process either##2##2##(2008-12#1)(2010-9#1)
process enabled the##2##3##(2010-12#1)(2011-1#1)
process enabled##3##2##(2008-2#1)(2010-12#1)(2011-1#1)
process enables the##2##3##(2008-2#1)(2008-7#1)
process enhances##2##2##(2008-2#1)(2008-7#1)
process entails##2##2##(1995-12#1)(2008-7#1)
process evaluation##3##2##(1997-2#1)(2007-10#1)(2010-5#1)
process experienced by##2##3##(1990-10#1)(2006-5#1)
process factors##2##2##(1996-1#1)(2010-9#1)
process first##2##2##(2008-1#1)(2008-6#1)
process flow and##2##3##(2007-12#1)(2008-2#1)
process flow##3##2##(2007-12#1)(2008-2#1)(2010-1#1)
process followed by##2##3##(2007-2#1)(2010-4#1)
process followed##5##2##(1994-3#1)(2007-2#1)(2008-5#1)(2010-4#1)(2010-5#1)
process follows##2##2##(2010-7#1)(2011-2#1)
process for a##6##3##(1993-1#1)(2005-11#1)(2007-6#1)(2008-11#1)(2008-3#1)(2008-8#1)
process for biological##2##3##(2007-12#1)(2008-10#1)
process for developing##2##3##(1992-3#1)(2013-1#1)
process for identifying##3##3##(1994-2#1)(2013-1#2)
process for in vitro##2##4##(2008-11#1)(2008-7#1)
process for obtaining##2##3##(2008-5#1)(2012-1#1)
process for patients##2##3##(1994-12#1)(2008-12#1)
process for production of##4##4##(1994-11#1)(1996-7#1)(2008-6#1)(2012-3#1)
process for the continuous production of##2##6##(2008-6#1)(2008-7#1)
process for the preparation of##2##5##(1992-1#1)(2008-4#1)
process for the synthesis of##4##5##(1992-11#1)(2008-11#1)(2008-6#1)(2011-2#1)
process for the##28##3##(1992-1#1)(1992-11#1)(1993-7#1)(1994-12#1)(1994-6#1)(1996-12#1)(1996-6#1)(1997-5#1)(2006-3#1)(2007-4#2)(2008-10#1)(2008-11#5)(2008-4#1)(2008-6#3)(2008-7#2)(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
process for##139##2##(1990-11#1)(1991-4#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#2)(1993-1#2)(1993-6#1)(1993-7#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-6#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#2)(1997-2#2)(1997-5#1)(2005-11#2)(2005-5#1)(2005-8#1)(2006-10#2)(2006-3#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-4#3)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#7)(2008-11#11)(2008-12#2)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#5)(2008-6#8)(2008-7#3)(2008-8#5)(2009-2#1)(2009-4#2)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#7)
process fracture##2##2##(2007-3#1)(2013-8#1)
process from a##2##3##(2008-2#1)(2008-3#1)
process from the##6##3##(1994-1#1)(1994-3#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#1)
process from##27##2##(1990-12#1)(1994-1#1)(1994-3#2)(1995-11#1)(1996-1#1)(1996-4#1)(2005-11#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-8#1)(2009-10#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#2)
process further##2##2##(2005-10#1)(2007-12#1)
process has a##4##3##(1996-12#1)(2007-11#1)(2008-8#1)(2010-4#1)
process has become##2##3##(1991-1#1)(1996-1#1)
process has been developed##3##4##(2008-6#1)(2009-6#1)(2010-8#1)
process has been##24##3##(1990-8#1)(1991-12#1)(1992-11#1)(1994-12#1)(1995-1#1)(1996-2#1)(2006-11#1)(2007-1#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#2)(2009-10#1)(2009-6#1)(2009-8#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#2)
process has not been##6##4##(1993-4#1)(1995-8#1)(2007-8#1)(2008-11#1)(2008-7#1)(2011-12#1)
process has##55##2##(1990-8#1)(1991-1#1)(1991-12#1)(1992-11#1)(1992-2#1)(1993-3#2)(1993-4#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-6#1)(2005-11#1)(2006-11#1)(2007-1#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#3)(2012-12#1)(2013-1#3)
process have been identified##2##4##(2006-10#1)(2009-8#1)
process have been##6##3##(2005-8#1)(2006-10#1)(2007-12#1)(2008-9#1)(2009-12#1)(2009-8#1)
process have##10##2##(1995-2#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-12#1)(2013-1#1)
process if##3##2##(2006-7#1)(2013-7#1)(2013-8#1)
process improvement##20##2##(1994-12#2)(1994-2#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-2#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-6#1)(2010-2#1)(2010-8#2)(2011-2#2)
process improvements##2##2##(1996-1#1)(2008-3#1)
process impurity##2##2##(2010-12#2)
process in a##9##3##(1993-3#1)(1995-12#1)(1996-1#1)(2007-12#2)(2007-8#1)(2008-11#1)(2009-4#1)(2013-1#1)
process in an##4##3##(1994-2#1)(2008-10#1)(2008-2#1)(2008-3#1)
process in humans##2##3##(1997-3#1)(2006-10#1)
process in order to##6##4##(2006-5#1)(2006-8#1)(2008-10#2)(2008-5#1)(2008-6#1)
process in order##7##3##(2006-5#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-6#1)
process in patients with##5##4##(2008-9#1)(2011-1#2)(2011-2#1)(2012-12#1)
process in social##2##3##(2010-4#1)(2013-8#1)
process in some patients##2##4##(2006-8#1)(2007-11#1)
process in such##2##3##(1990-2#1)(2007-12#1)
process in terms of##2##4##(1996-4#1)(2008-3#1)
process in the United States##2##5##(1995-4#1)(2009-8#1)
process in the##43##3##(1991-12#1)(1992-6#1)(1993-1#1)(1993-3#2)(1995-12#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-1#1)(2005-11#1)(2005-9#1)(2006-10#1)(2007-11#2)(2007-6#2)(2008-1#2)(2008-10#4)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-2#2)(2009-8#1)(2010-7#1)(2011-2#1)(2012-12#4)(2013-1#1)(2013-7#1)
process in these##3##3##(2005-10#1)(2008-3#1)(2008-5#1)
process in this##2##3##(2007-2#1)(2013-8#1)
process in vitro##2##3##(1990-8#1)(1994-9#1)
process in vivo##4##3##(1997-1#1)(2007-11#1)(2008-7#1)(2010-3#1)
process in which an##2##4##(2008-10#1)(2011-8#1)
process in which the##8##4##(1990-12#1)(1994-6#1)(1996-5#1)(2008-10#1)(2008-3#2)(2008-5#1)(2013-1#1)
process in which##34##3##(1990-12#1)(1990-6#1)(1991-10#1)(1991-6#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1996-5#1)(1996-6#1)(2006-1#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-10#2)(2009-12#1)(2009-4#1)(2010-11#1)(2010-2#1)(2011-2#1)(2011-8#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
process in##219##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-6#2)(1990-8#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-2#1)(1992-6#3)(1993-1#1)(1993-3#6)(1994-1#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-12#2)(1995-4#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#2)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#1)(2005-10#1)(2005-11#2)(2005-9#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#3)(2006-9#1)(2007-11#7)(2007-12#12)(2007-2#1)(2007-4#1)(2007-6#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#19)(2008-11#4)(2008-12#3)(2008-2#5)(2008-3#9)(2008-4#4)(2008-5#8)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#3)(2009-8#3)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#3)(2011-8#1)(2012-12#11)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#5)
process include##3##2##(1993-12#1)(2006-10#1)(2006-9#1)
process included the##2##3##(1996-3#1)(2013-1#1)
process included##6##2##(1996-3#2)(2008-10#3)(2013-1#1)
process includes##3##2##(2008-10#1)(2008-11#1)(2010-8#1)
process including##2##2##(2008-3#1)(2008-9#1)
process incorporating##2##2##(1994-12#1)(2008-2#1)
process increased the##2##3##(2008-5#1)(2013-1#1)
process indicating that##2##3##(1995-11#1)(1995-5#1)
process indicators##3##2##(2011-1#2)(2011-2#1)
process induced by##6##3##(1992-5#1)(2003-11#2)(2006-10#1)(2012-12#2)
process induces a##2##3##(2008-10#1)(2009-9#1)
process induces##3##2##(1994-7#1)(2008-10#1)(2009-9#1)
process information about##2##3##(2007-12#1)(2009-5#1)
process information##5##2##(1996-1#1)(2007-12#1)(2008-4#1)(2008-7#1)(2009-5#1)
process initiated##2##2##(1997-7#1)(2007-7#1)
process instead of##2##3##(2008-2#1)(2008-3#1)
process into##4##2##(1990-3#2)(1993-12#1)(2008-10#1)
process involved in##5##3##(1990-5#1)(1991-5#1)(1996-8#1)(2008-7#1)(2009-6#1)
process involved##9##2##(1990-5#1)(1991-5#1)(1996-8#1)(2006-3#1)(2007-8#2)(2008-7#1)(2009-6#1)(2011-1#1)
process involves a##3##3##(1993-8#1)(1996-5#1)(2008-9#1)
process involves the##6##3##(1990-12#1)(2006-10#1)(2008-11#1)(2009-10#2)(2009-3#1)
process involves##16##2##(1990-12#1)(1993-8#1)(1994-11#1)(1994-3#2)(1996-5#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-10#2)(2009-3#1)(2009-7#1)(2011-8#1)
process involving a##4##3##(1990-5#1)(2007-9#1)(2008-10#1)(2012-2#1)
process involving multiple##2##3##(1990-2#1)(1996-5#1)
process involving the##4##3##(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#1)
process involving##32##2##(1990-2#1)(1990-5#1)(1991-2#1)(1992-3#1)(1992-9#1)(1994-2#1)(1996-5#1)(1996-6#1)(2005-10#1)(2005-11#1)(2006-11#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#4)(2008-2#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-5#1)(2012-2#3)(2013-1#2)
process is a##10##3##(1990-2#1)(1991-2#1)(1996-1#1)(2005-7#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#1)
process is accompanied by##2##4##(1990-5#1)(2009-8#1)
process is achieved##2##3##(2008-10#1)(2008-3#1)
process is also##9##3##(1991-12#1)(2005-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-10#1)(2010-5#1)(2013-8#1)
process is attributed to##2##4##(2008-10#1)(2008-7#1)
process is based on the##3##5##(2008-3#1)(2012-1#1)(2013-1#1)
process is based on##5##4##(1991-8#1)(2008-10#1)(2008-3#1)(2012-1#1)(2013-1#1)
process is called##2##3##(2008-3#1)(2011-2#1)
process is characterized by##4##4##(1990-4#1)(1996-10#1)(2008-10#1)(2009-12#1)
process is considered##3##3##(1991-11#1)(2005-7#1)(2007-12#1)
process is dependent on##2##4##(1991-3#1)(2008-10#1)
process is described in##2##4##(1991-2#1)(2013-1#1)
process is described##6##3##(1991-2#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-4#1)(2013-1#1)
process is different from##2##4##(2008-10#1)(2010-5#1)
process is discussed##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-4#1)
process is entirely##2##3##(2008-3#1)(2011-1#1)
process is exothermic in##2##4##(1996-1#1)(2005-11#1)
process is exothermic##3##3##(1996-1#1)(2005-11#2)
process is followed by##2##4##(1990-3#1)(2010-4#1)
process is further##3##3##(1993-3#1)(2008-10#1)(2008-6#1)
process is initiated##3##3##(2008-4#1)(2008-6#1)(2008-9#1)
process is introduced##2##3##(2008-3#1)(2013-1#1)
process is known##2##3##(1997-2#1)(2006-10#1)
process is made##2##3##(1996-1#1)(2008-10#1)
process is mediated##3##3##(1991-12#1)(2008-8#1)(2009-8#1)
process is modeled##2##3##(2007-9#1)(2008-6#1)
process is monitored##2##3##(1994-12#1)(2010-5#1)
process is more efficient##2##4##(2007-11#1)(2013-1#1)
process is needed##3##3##(1994-3#1)(1997-7#1)(2008-7#1)
process is not##8##3##(1991-3#1)(1992-2#1)(1992-4#1)(1993-2#1)(1994-12#1)(1995-2#1)(1996-7#1)(2007-12#1)
process is observed##2##3##(2006-10#1)(2008-2#1)
process is one##2##3##(2008-7#1)(2012-12#1)
process is presented##4##3##(1993-6#1)(2006-10#1)(2007-11#1)(2008-7#1)
process is proposed##3##3##(1991-5#1)(2005-11#1)(2008-3#1)
process is referred to as##2##5##(2007-9#1)(2008-4#1)
process is regulated##2##3##(2008-1#1)(2009-3#1)
process is related to##2##4##(1992-4#1)(2008-10#1)
process is strongly##2##3##(2008-1#1)(2008-4#1)
process is that##5##3##(1993-12#1)(2005-11#1)(2008-3#1)(2008-4#1)(2010-1#1)
process is the##10##3##(1994-12#1)(1995-7#1)(2005-10#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-5#1)(2012-12#2)(2012-2#1)
process is therefore##2##3##(2008-1#1)(2012-2#1)
process is time-consuming##3##3##(2008-2#1)(2012-12#2)
process is to##3##3##(2010-10#1)(2010-5#1)(2012-3#1)
process is very##3##3##(2007-8#1)(2008-11#1)(2008-5#1)
process is##259##2##(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#3)(1991-4#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-4#2)(1992-8#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#3)(1994-3#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#3)(1996-10#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-7#1)(2004-12#1)(2005-10#2)(2005-11#8)(2005-7#2)(2005-9#1)(2006-10#5)(2006-11#2)(2006-12#2)(2006-6#2)(2006-7#2)(2006-9#1)(2007-11#4)(2007-12#10)(2007-4#3)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#6)(2008-10#19)(2008-11#6)(2008-12#4)(2008-2#15)(2008-3#15)(2008-4#6)(2008-5#9)(2008-6#6)(2008-7#8)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-3#2)(2010-4#2)(2010-5#4)(2010-9#1)(2011-1#2)(2011-2#9)(2012-1#3)(2012-12#7)(2012-2#6)(2012-3#1)(2013-1#4)(2013-8#1)
process itself##8##2##(1993-9#1)(1994-3#1)(1996-4#1)(1997-1#1)(2008-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
process knowledge##2##2##(2008-11#1)(2013-1#1)
process known##9##2##(1990-10#1)(1990-2#1)(2007-11#1)(2007-12#2)(2011-1#1)(2012-2#2)(2012-3#1)
process large##4##2##(2008-10#1)(2008-7#1)(2013-1#2)
process leading to the##3##4##(1993-4#1)(2008-5#1)(2013-1#1)
process leading to##11##3##(1990-11#1)(1990-5#1)(1993-4#1)(1994-2#1)(1996-8#1)(2007-11#1)(2008-1#1)(2008-5#1)(2009-3#1)(2011-2#1)(2013-1#1)
process leads to the##2##4##(1991-11#1)(2007-11#1)
process leads to##5##3##(1991-11#1)(2007-11#1)(2007-8#1)(2009-9#1)(2010-7#1)
process leads##6##2##(1991-11#1)(2007-11#1)(2007-8#1)(2008-2#1)(2009-9#1)(2010-7#1)
process led to a##2##4##(2007-7#1)(2008-11#1)
process led to##4##3##(2006-10#1)(2007-11#1)(2007-7#1)(2008-11#1)
process makes##3##2##(2008-3#1)(2008-5#1)(2008-8#1)
process management##2##2##(1994-3#1)(2008-10#1)
process marked by##2##3##(1995-1#1)(2012-3#1)
process may be##13##3##(1992-3#1)(1995-1#1)(1995-8#1)(2005-7#1)(2007-3#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-11#1)(2009-12#1)(2013-1#2)
process may help##2##3##(2007-5#1)(2007-7#1)
process may occur##2##3##(1990-8#1)(2007-7#1)
process may##28##2##(1990-8#1)(1991-2#1)(1991-3#1)(1992-3#1)(1992-9#1)(1995-1#1)(1995-12#1)(1995-8#1)(2005-7#1)(2006-5#1)(2007-3#1)(2007-5#1)(2007-7#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-12#1)(2012-2#1)(2013-1#4)
process measures##8##2##(1994-12#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-8#1)(2013-1#2)
process might##2##2##(2005-11#1)(2008-7#1)
process model for##2##3##(2008-2#1)(2013-1#1)
process model##13##2##(2006-1#3)(2008-10#1)(2008-2#1)(2008-5#2)(2009-9#1)(2010-10#1)(2012-2#1)(2013-1#3)
process models are##2##3##(2009-9#1)(2013-1#1)
process models for##3##3##(2009-9#3)
process models##5##2##(2009-9#4)(2013-1#1)
process monitoring##12##2##(1994-9#1)(2007-8#2)(2008-10#3)(2008-11#3)(2008-2#2)(2010-5#1)
process more##6##2##(1991-9#1)(1996-3#1)(2006-9#1)(2007-4#1)(2008-10#1)(2010-2#1)
process must be##2##3##(2008-1#1)(2008-3#1)
process must##3##2##(1993-2#1)(2008-1#1)(2008-3#1)
process needs to be##3##4##(2008-10#1)(2013-1#2)
process needs##4##2##(1991-8#1)(2008-10#1)(2013-1#2)
process not##2##2##(2008-6#1)(2008-7#1)
process occurring##4##2##(1997-6#1)(1997-8#1)(2008-5#2)
process occurs at the##2##4##(2010-2#1)(2013-8#1)
process occurs at##3##3##(2007-12#1)(2010-2#1)(2013-8#1)
process occurs##8##2##(1991-4#1)(1996-11#1)(1996-2#1)(2007-12#2)(2009-3#1)(2010-2#1)(2013-8#1)
process of &quot##3##3##(2008-8#1)(2010-7#1)(2013-1#1)
process of DNA##3##3##(2008-10#3)
process of a new##2##4##(1992-5#1)(2009-7#1)
process of a##11##3##(1992-5#1)(1994-2#1)(1994-9#1)(1996-6#1)(2005-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-2#1)
process of accelerated atherosclerosis##2##4##(2007-7#1)(2010-12#1)
process of aging##4##3##(1992-9#1)(1993-12#1)(2008-5#1)(2008-7#1)
process of an##5##3##(1990-3#1)(2007-10#1)(2008-10#1)(2011-12#1)(2012-1#1)
process of beer##2##3##(1991-5#1)(2008-10#1)
process of bone union##2##4##(2007-11#2)
process of bone##8##3##(1996-3#1)(2005-2#1)(2007-11#4)(2007-8#1)(2011-2#1)
process of calcium-induced calcium release##2##5##(1990-8#1)(2007-9#1)
process of carcinogenesis##2##3##(2008-12#1)(2009-3#1)
process of care##11##3##(1994-12#2)(1996-3#2)(1997-1#1)(2007-4#1)(2008-3#4)(2008-6#1)
process of cell##6##3##(1996-10#1)(1997-6#1)(2007-11#1)(2008-9#1)(2009-8#1)(2010-9#1)
process of change##4##3##(1990-5#1)(2008-11#1)(2008-12#1)(2011-1#1)
process of chromosomal##2##3##(1993-6#1)(2010-3#1)
process of chronic##3##3##(1995-2#1)(2012-2#2)
process of collagen##2##3##(2012-12#1)(2013-1#1)
process of collecting##4##3##(1996-3#1)(1997-1#1)(1997-6#2)
process of conducting##2##3##(1996-12#1)(2007-10#1)
process of consent##3##3##(2005-11#1)(2006-3#2)
process of corn##2##3##(2005-4#1)(2007-8#1)
process of decentralization##2##3##(1993-6#1)(2011-2#1)
process of degradation of##2##4##(2008-8#1)(2013-1#1)
process of delayed neuronal cell death##2##6##(1995-5#1)(2008-2#1)
process of determining##5##3##(2006-8#1)(2007-4#1)(2008-11#1)(2008-4#1)(2008-9#1)
process of developing a##5##4##(2006-5#2)(2006-7#1)(2007-10#1)(2007-4#1)
process of developing##9##3##(1995-12#1)(2006-2#1)(2006-5#2)(2006-7#1)(2007-10#1)(2007-4#1)(2007-7#1)(2009-4#1)
process of development##3##3##(2005-7#1)(2006-2#1)(2009-12#1)
process of differentiation##2##3##(2008-11#1)(2012-2#1)
process of disease##2##3##(2008-8#1)(2009-6#1)
process of drug##3##3##(1997-4#1)(2008-4#1)(2008-8#1)
process of dye##2##3##(2008-2#2)
process of establishing##4##3##(1995-3#1)(2007-2#1)(2008-10#1)(2011-1#1)
process of evaluating##3##3##(1993-4#1)(2006-4#1)(2010-5#1)
process of exposure##3##3##(2007-12#1)(2008-2#1)(2011-2#1)
process of gene##2##3##(2008-7#1)(2010-6#1)
process of getting##2##3##(2009-9#1)(2010-4#1)
process of glucose##2##3##(2008-7#1)(2009-9#1)
process of grating regeneration##2##4##(2013-8#2)
process of group##2##3##(2008-11#1)(2013-1#1)
process of identification##3##3##(1992-6#1)(2009-4#1)(2010-4#1)
process of identifying##2##3##(2010-11#1)(2013-8#1)
process of implementation##3##3##(1992-2#1)(1996-1#1)(2008-5#1)
process of implementing##2##3##(1991-12#1)(2011-2#1)
process of in##2##3##(2008-11#1)(2009-12#1)
process of informed consent##3##4##(2010-2#1)(2012-1#2)
process of integrated##2##3##(2010-8#1)(2011-1#1)
process of integration##2##3##(1990-5#1)(2007-7#1)
process of lipid##2##3##(2006-6#1)(2008-3#1)
process of maturation##2##3##(2008-10#1)(2008-9#1)
process of membrane##2##3##(2008-11#2)
process of multiple##2##3##(1996-7#1)(2013-1#1)
process of neurodegeneration in##2##4##(1995-12#1)(1995-6#1)
process of phase##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
process of platelet##2##3##(1990-11#1)(1991-9#1)
process of post-testicular maturation##2##4##(2008-8#2)
process of producing a##2##4##(2008-11#1)(2011-1#1)
process of producing##4##3##(1992-3#1)(2007-8#1)(2008-11#1)(2011-1#1)
process of production##3##3##(2005-11#1)(2008-10#1)(2012-2#1)
process of programmed cell death##2##5##(2008-8#1)(2011-2#1)
process of rehabilitation##2##3##(2007-11#1)(2008-2#1)
process of risk assessment##2##4##(2006-10#1)(2013-7#1)
process of selecting##3##3##(1995-12#1)(2008-7#1)(2009-1#1)
process of sperm maturation##2##4##(2011-1#2)
process of spermatogenesis##4##3##(2007-12#1)(2008-4#1)(2009-10#1)(2011-1#1)
process of systems##2##3##(2008-10#1)(2008-7#1)
process of testing##2##3##(1993-3#1)(2012-2#1)
process of the pancreas##3##4##(2005-10#2)(2008-3#1)
process of the subjects##2##4##(1990-10#2)
process of the##63##3##(1990-10#2)(1992-1#1)(1993-1#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-5#1)(1996-1#1)(1996-4#1)(1997-3#1)(2004-11#1)(2004-9#1)(2005-10#2)(2005-11#3)(2006-11#2)(2006-12#2)(2006-2#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-1#2)(2012-3#2)(2013-1#2)
process of this##5##3##(1990-5#1)(1996-11#1)(2008-11#1)(2008-2#1)(2013-1#1)
process of tissue##3##3##(2006-6#1)(2007-12#1)(2008-4#1)
process of transformation##3##3##(2006-11#1)(2008-11#1)(2012-2#1)
process of treatment##2##3##(2006-6#1)(2013-8#1)
process of tumorigenesis##2##3##(1995-9#1)(2008-7#1)
process of unknown etiology##2##4##(1997-8#1)(2010-12#1)
process of using##3##3##(1995-2#1)(2012-3#1)(2013-8#1)
process of writing##3##3##(2006-10#1)(2009-4#1)(2012-1#1)
process of##877##2##(1990-10#5)(1990-11#3)(1990-2#1)(1990-3#3)(1990-5#5)(1990-6#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-2#4)(1991-3#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#5)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#5)(1992-4#3)(1992-5#4)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#4)(1993-1#1)(1993-11#2)(1993-12#6)(1993-2#2)(1993-3#3)(1993-4#1)(1993-6#4)(1993-7#1)(1993-8#1)(1994-1#1)(1994-10#2)(1994-11#2)(1994-12#3)(1994-2#5)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#5)(1995-2#5)(1995-3#6)(1995-4#1)(1995-5#2)(1995-6#4)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#5)(1996-3#6)(1996-4#3)(1996-5#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#4)(1997-2#1)(1997-3#2)(1997-4#4)(1997-6#5)(1997-7#2)(1997-8#3)(2004-11#1)(2004-12#1)(2004-3#1)(2004-9#1)(2005-10#5)(2005-11#21)(2005-12#1)(2005-2#1)(2005-4#1)(2005-7#2)(2006-10#11)(2006-11#5)(2006-12#7)(2006-2#7)(2006-3#5)(2006-4#1)(2006-5#5)(2006-6#4)(2006-7#4)(2006-8#6)(2006-9#4)(2007-1#1)(2007-10#9)(2007-11#20)(2007-12#20)(2007-2#5)(2007-3#2)(2007-4#10)(2007-5#1)(2007-7#7)(2007-8#11)(2007-9#2)(2008-1#11)(2008-10#59)(2008-11#37)(2008-12#17)(2008-2#23)(2008-3#23)(2008-4#10)(2008-5#25)(2008-6#5)(2008-7#18)(2008-8#22)(2008-9#18)(2009-1#1)(2009-10#3)(2009-11#3)(2009-12#5)(2009-2#1)(2009-3#6)(2009-4#8)(2009-6#5)(2009-7#6)(2009-8#6)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#4)(2010-2#5)(2010-3#3)(2010-4#6)(2010-5#4)(2010-6#5)(2010-7#4)(2010-8#1)(2010-9#2)(2011-1#18)(2011-10#1)(2011-12#7)(2011-2#22)(2012-1#9)(2012-11#1)(2012-12#14)(2012-2#21)(2012-3#21)(2012-8#1)(2013-1#23)(2013-7#7)(2013-8#13)
process often##2##2##(1997-1#1)(2008-10#1)
process on a##4##3##(1994-2#1)(1995-3#1)(2007-11#1)(2008-10#1)
process on the##12##3##(1996-6#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
process on##29##2##(1994-2#1)(1994-6#1)(1995-3#1)(1996-10#1)(1996-4#1)(1996-6#1)(1997-2#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2008-10#4)(2008-7#1)(2008-8#1)(2009-11#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
process optimization##2##2##(2008-10#2)
process or outcome##2##3##(1995-12#1)(2011-2#1)
process or##15##2##(1990-12#1)(1992-12#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-9#1)(2004-4#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#3)(2013-1#1)
process other##2##2##(2006-3#1)(2008-11#1)
process outcomes##3##2##(2005-11#1)(2011-12#2)
process outgrowth##3##2##(1991-11#1)(1995-11#1)(1995-6#1)
process over time##2##3##(2008-4#1)(2012-2#1)
process over##4##2##(1994-9#1)(1995-2#1)(2008-4#1)(2012-2#1)
process parameters and##3##3##(2008-11#1)(2008-5#1)(2010-4#1)
process parameters for the##2##4##(2004-12#1)(2008-10#1)
process parameters for##3##3##(2004-12#1)(2008-10#1)(2008-7#1)
process parameters such as##2##4##(2008-10#1)(2008-5#1)
process parameters##8##2##(2004-12#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2010-4#1)
process performance##5##2##(1993-12#1)(1996-3#1)(2008-11#1)(2008-6#1)(2011-2#1)
process plays##4##2##(1995-3#1)(2006-6#1)(2007-9#1)(2010-8#1)
process prior##2##2##(1996-3#1)(2012-3#1)
process proceeds##4##2##(2007-8#1)(2008-10#1)(2008-2#1)(2010-2#1)
process produces a##3##3##(2007-12#1)(2007-8#1)(2008-6#1)
process produces##5##2##(1993-12#1)(2007-12#2)(2007-8#1)(2008-6#1)
process producing##3##2##(1995-2#1)(1996-4#1)(2010-12#1)
process provided##4##2##(1996-3#1)(2007-9#1)(2008-10#2)
process provides##5##2##(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2010-11#1)
process quality##2##2##(2008-11#1)(2008-2#1)
process rather than in##2##4##(1990-7#1)(1994-5#1)
process rather than##5##3##(1990-7#1)(1993-11#1)(1994-5#1)(1997-8#1)(2008-2#1)
process redesign##3##2##(1993-12#1)(1993-3#2)
process related to##3##3##(1995-3#1)(1996-7#1)(2008-6#1)
process related##4##2##(1995-3#1)(1996-7#1)(2008-6#1)(2010-12#1)
process remain##2##2##(1996-11#1)(2011-2#1)
process remained##2##2##(2008-3#1)(2008-5#1)
process remains##2##2##(1995-9#1)(1996-9#1)
process reminiscent of the##2##4##(2006-10#1)(2009-12#1)
process required for##2##3##(1995-6#1)(2008-11#1)
process required##4##2##(1993-4#1)(1995-6#1)(2008-11#1)(2008-5#1)
process requires the##3##3##(2005-7#1)(2007-11#1)(2008-4#1)
process requires##10##2##(1997-8#1)(2005-7#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-9#1)
process requiring##4##2##(1992-7#1)(2008-2#1)(2008-6#1)(2009-6#1)
process resulted in##2##3##(2005-10#1)(2008-11#1)
process resulting##2##2##(2006-9#1)(2011-1#1)
process results in##3##3##(2008-10#1)(2008-2#1)(2011-12#1)
process results##5##2##(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#1)(2011-12#1)
process revealed that##2##3##(2008-11#1)(2011-12#1)
process samples##2##2##(2008-10#2)
process should be##5##3##(1990-8#1)(2007-4#1)(2008-3#1)(2008-6#1)(2013-8#1)
process should##11##2##(1990-8#1)(1993-1#1)(1995-5#1)(2007-4#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
process showed##4##2##(2007-8#1)(2008-7#1)(2009-6#2)
process similar to##3##3##(2008-11#1)(2008-2#1)(2010-12#1)
process stability##2##2##(2007-8#1)(2008-10#1)
process starts with##2##3##(2011-12#1)(2012-2#1)
process starts##4##2##(2007-5#1)(2008-10#1)(2011-12#1)(2012-2#1)
process startup##4##2##(2008-11#4)
process step##3##2##(2006-12#1)(2008-2#1)(2008-3#1)
process steps##3##2##(2008-3#1)(2008-5#1)(2012-2#1)
process streams##3##2##(2008-5#1)(2008-6#2)
process such as##4##3##(1996-8#1)(2008-10#1)(2009-5#1)(2012-12#1)
process such##5##2##(1996-8#1)(2008-10#1)(2008-2#1)(2009-5#1)(2012-12#1)
process suggest##2##2##(1992-8#1)(2007-12#1)
process takes##3##2##(1990-11#1)(2005-9#1)(2010-10#1)
process temperature##2##2##(2007-11#1)(2008-3#1)
process termed##4##2##(2008-4#1)(2010-5#1)(2011-1#1)(2011-2#1)
process than##5##2##(1991-5#1)(1996-7#1)(2007-11#1)(2007-12#1)(2013-8#1)
process that begins##2##3##(2012-12#1)(2012-2#1)
process that can be used##2##5##(2008-10#1)(2008-4#1)
process that can be##8##4##(1993-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#3)(2013-1#1)
process that can##13##3##(1993-2#1)(1993-4#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#3)(2010-11#1)(2010-12#2)(2013-1#1)
process that causes##2##3##(2006-10#1)(2011-1#1)
process that continues##2##3##(2006-10#1)(2006-6#1)
process that could be##2##4##(2005-11#1)(2008-10#1)
process that could##4##3##(2005-11#1)(2006-2#1)(2008-10#1)(2012-3#1)
process that has##4##3##(1991-9#1)(1997-3#1)(2006-1#1)(2008-5#1)
process that includes##3##3##(1995-1#1)(2008-7#1)(2011-1#1)
process that involves a##3##4##(2008-4#1)(2008-7#1)(2011-2#1)
process that involves##11##3##(1995-8#1)(1996-7#1)(1997-3#1)(2008-10#1)(2008-4#3)(2008-7#1)(2011-1#1)(2011-2#2)
process that is##26##3##(1991-6#1)(1992-12#1)(1993-8#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-11#1)(1997-1#1)(1997-6#1)(2006-2#1)(2007-12#2)(2008-1#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-9#1)(2012-12#2)
process that may be##3##4##(1996-12#1)(2008-1#1)(2010-10#1)
process that may##6##3##(1996-12#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-9#1)(2010-10#1)
process that occurs##3##3##(2004-12#1)(2006-10#1)(2011-2#1)
process that provide##2##3##(2010-11#1)(2011-1#1)
process that requires##5##3##(1994-2#1)(2007-12#1)(2008-2#1)(2008-4#1)(2009-3#1)
process that uses##4##3##(2007-12#1)(2008-1#1)(2008-3#1)(2008-6#1)
process that was##3##3##(2008-10#1)(2008-12#1)(2009-3#1)
process that##144##2##(1991-1#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-4#2)(1993-5#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-1#2)(1995-11#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#1)(2004-12#1)(2005-11#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-2#2)(2006-6#1)(2007-11#2)(2007-12#6)(2007-8#1)(2008-1#4)(2008-10#8)(2008-11#3)(2008-12#3)(2008-2#7)(2008-3#2)(2008-4#9)(2008-5#4)(2008-6#2)(2008-7#6)(2008-9#2)(2009-1#1)(2009-10#1)(2009-3#2)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-9#1)(2011-1#4)(2011-2#3)(2011-3#1)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
process the acquired##2##3##(2008-10#1)(2008-2#1)
process the information in##2##4##(2008-3#1)(2008-8#1)
process the##35##2##(1992-2#1)(1995-12#1)(1995-8#1)(1996-7#1)(2007-12#3)(2007-3#1)(2007-4#1)(2007-5#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#7)(2008-4#1)(2008-8#2)(2010-10#1)(2012-12#1)
process theory##3##2##(2007-6#1)(2008-9#1)(2009-11#1)
process there is a##2##4##(1994-2#1)(2007-12#1)
process there is##3##3##(1994-2#1)(2007-12#1)(2008-5#1)
process there##4##2##(1994-2#1)(2007-12#1)(2008-5#1)(2008-8#1)
process these##3##2##(1994-5#1)(2004-7#1)(2010-9#1)
process they##2##2##(1994-3#1)(1997-2#1)
process through the##3##3##(1993-2#1)(2008-2#1)(2010-5#1)
process through##16##2##(1993-12#2)(1993-2#1)(1994-12#1)(1994-8#1)(1996-12#1)(2005-11#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2009-9#1)(2010-5#1)(2011-2#1)(2013-8#1)
process thus##2##2##(2008-5#1)(2009-8#1)
process to be##7##3##(1990-7#1)(1992-12#1)(1993-4#1)(2006-4#1)(2007-11#1)(2008-2#1)(2008-5#1)
process to convert##2##3##(2008-5#1)(2008-6#1)
process to form##2##3##(1991-3#1)(1992-2#1)
process to improve##3##3##(1993-12#1)(2008-11#1)(2008-2#1)
process to increase##3##3##(1996-11#1)(2008-8#1)(2013-7#1)
process to make##2##3##(2008-5#1)(2008-8#1)
process to produce##3##3##(2005-11#1)(2008-11#1)(2008-6#1)
process to reduce##2##3##(2007-8#1)(2010-8#1)
process to remove##3##3##(2005-4#1)(2008-3#1)(2013-1#1)
process to the##3##3##(1994-11#1)(2007-2#1)(2009-4#1)
process to##71##2##(1990-7#1)(1990-9#1)(1991-3#1)(1992-12#2)(1992-2#2)(1993-1#1)(1993-12#1)(1993-4#1)(1994-11#1)(1995-12#2)(1996-11#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-5#1)(2005-11#2)(2005-4#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#6)(2008-6#3)(2008-8#2)(2009-4#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#4)(2013-7#2)
process triggered by##2##3##(1994-9#1)(2008-2#1)
process under##8##2##(1997-2#1)(2005-11#2)(2007-11#1)(2008-2#1)(2008-3#1)(2008-5#2)
process underlying##2##2##(1996-10#1)(2010-12#1)
process understanding##2##2##(2011-2#1)(2013-1#1)
process used by##3##3##(1991-2#1)(1992-2#1)(2012-3#1)
process used in##3##3##(1996-2#1)(2006-8#1)(2008-7#1)
process used to identify##2##4##(1995-1#1)(2008-11#1)
process used to##11##3##(1994-1#1)(1994-2#1)(1995-1#1)(1996-2#2)(2007-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-9#1)(2011-2#1)
process used##21##2##(1991-2#1)(1992-2#2)(1994-1#1)(1994-2#1)(1995-1#1)(1996-12#1)(1996-2#3)(2006-2#1)(2006-8#1)(2007-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-3#1)
process uses##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
process using F(2) and KrF excimer lasers##2##7##(2007-11#2)
process using the##5##3##(1995-2#1)(1995-6#1)(2008-5#1)(2008-9#1)(2009-4#1)
process using##23##2##(1991-5#1)(1992-3#1)(1995-2#1)(1995-6#1)(2007-11#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#5)(2008-9#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
process utilizing##2##2##(1992-2#1)(2009-11#1)
process variables##6##2##(1993-12#1)(2008-3#1)(2008-5#2)(2012-2#1)(2013-1#1)
process via##5##2##(1992-6#1)(1995-3#1)(2006-6#1)(2009-10#1)(2009-7#1)
process was also##3##3##(1991-5#1)(2008-10#1)(2009-11#1)
process was applied##4##3##(2007-12#1)(2008-10#1)(2008-5#1)(2009-11#1)
process was based on##2##4##(2008-10#1)(2008-11#1)
process was carried out in two steps##2##7##(2007-11#1)(2008-10#1)
process was carried out using##2##5##(2008-10#2)
process was carried out##6##4##(2007-11#1)(2008-10#3)(2008-5#1)(2008-6#1)
process was demonstrated##2##3##(2007-3#1)(2007-9#1)
process was developed for##3##4##(1993-12#1)(2008-10#1)(2008-11#1)
process was developed in##2##4##(2004-12#1)(2008-11#1)
process was developed##7##3##(1992-3#1)(1993-12#1)(2004-12#1)(2008-10#1)(2008-11#2)(2008-5#1)
process was found to be##2##5##(2007-10#1)(2008-10#1)
process was found to##3##4##(2007-10#2)(2008-10#1)
process was implemented in a##2##5##(2008-10#1)(2008-3#1)
process was implemented##6##3##(1996-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#2)
process was investigated##5##3##(2005-11#1)(2006-8#1)(2008-10#2)(2008-5#1)
process was not##4##3##(1993-12#1)(2005-11#1)(2006-9#1)(2008-10#1)
process was observed in##2##4##(1992-10#1)(2008-11#1)
process was observed##5##3##(1992-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)
process was repeated##3##3##(1992-7#1)(2008-10#1)(2010-8#1)
process was studied##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
process was then##2##3##(1993-2#1)(2008-10#1)
process was used##3##3##(2006-4#1)(2008-10#1)(2013-1#1)
process was##120##2##(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#2)(1993-2#2)(1996-3#1)(1996-6#1)(1996-8#1)(2004-12#1)(2005-11#7)(2006-4#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-3#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-10#30)(2008-11#9)(2008-12#1)(2008-3#5)(2008-4#1)(2008-5#9)(2008-6#4)(2008-7#1)(2008-9#2)(2009-11#2)(2009-9#2)(2010-4#1)(2010-8#3)(2011-12#1)(2012-12#1)(2013-1#7)(2013-7#1)
process water from thermomechanical pulping of spruce##2##7##(2008-5#2)
process water from##4##3##(2008-5#4)
process water##6##2##(2008-5#6)
process we##3##2##(1996-4#1)(2008-2#1)(2008-3#1)
process were also determined##2##4##(1992-2#1)(2008-10#1)
process were as follows##2##4##(2008-4#1)(2008-5#1)
process were calculated##2##3##(2008-10#1)(2008-5#1)
process were##35##2##(1991-3#1)(1992-2#1)(1995-2#1)(1995-3#1)(1995-8#1)(2004-12#1)(2004-9#1)(2005-11#1)(2006-8#1)(2007-11#2)(2007-7#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-7#1)(2010-8#1)(2013-1#3)
process when##4##2##(1992-2#1)(2008-12#1)(2008-5#1)(2010-7#1)
process where##5##2##(2005-11#1)(2009-4#1)(2011-2#1)(2012-12#2)
process whereby the##2##3##(2007-12#1)(2007-7#1)
process whereby##7##2##(1996-1#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-5#1)(2008-9#1)(2013-8#1)
process which allows##2##3##(2008-12#1)(2008-7#1)
process which can be##2##4##(1994-3#1)(1995-2#1)
process which has##2##3##(1990-2#1)(1993-3#1)
process which involves##2##3##(1991-12#1)(1992-6#1)
process which is##5##3##(1991-12#2)(1996-2#1)(2008-4#1)(2008-7#1)
process which##32##2##(1990-2#1)(1991-1#1)(1991-12#3)(1992-6#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#2)(1996-2#2)(1997-1#1)(2005-7#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#4)(2009-4#1)(2011-2#2)
process while the##2##3##(1991-4#1)(2008-10#1)
process while##3##2##(1991-4#1)(1992-5#1)(2008-10#1)
process will allow##2##3##(2006-12#1)(2007-8#1)
process will be##2##3##(1996-1#1)(2008-6#1)
process will##11##2##(1992-12#1)(1996-1#1)(1997-1#1)(2006-12#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2011-1#1)(2011-2#1)
process with a##12##3##(1990-2#1)(1990-4#1)(1992-2#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#2)(2010-7#1)
process with an##2##3##(1990-3#1)(1992-11#1)
process with high##2##3##(1994-2#1)(2012-2#1)
process with only##3##3##(2007-5#1)(2008-3#1)(2008-5#1)
process with the##4##3##(2008-10#2)(2008-7#1)(2012-1#1)
process with##60##2##(1990-11#1)(1990-2#2)(1990-3#1)(1990-4#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-9#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1997-3#1)(1997-4#1)(1997-6#1)(2004-9#1)(2006-12#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#3)(2008-7#5)(2009-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#2)
process within the##3##3##(2008-10#2)(2008-3#1)
process within##7##2##(1994-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)
process without##3##2##(1992-12#1)(2008-7#1)(2011-2#1)
process works##2##2##(2008-1#1)(2010-4#1)
process would##4##2##(1995-6#1)(2007-11#1)(2008-6#1)(2008-7#1)
process yield##2##2##(2008-6#1)(2008-7#1)
process##5677##1##(1990-10#17)(1990-11#14)(1990-12#16)(1990-2#15)(1990-3#12)(1990-4#10)(1990-5#18)(1990-6#8)(1990-7#3)(1990-8#10)(1990-9#4)(1991-1#11)(1991-10#3)(1991-11#10)(1991-12#21)(1991-2#26)(1991-3#19)(1991-4#14)(1991-5#17)(1991-6#9)(1991-7#6)(1991-8#9)(1991-9#18)(1992-1#17)(1992-10#2)(1992-11#7)(1992-12#16)(1992-2#34)(1992-3#22)(1992-4#7)(1992-5#8)(1992-6#25)(1992-7#10)(1992-8#8)(1992-9#18)(1993-1#15)(1993-10#1)(1993-11#11)(1993-12#30)(1993-2#16)(1993-3#35)(1993-4#12)(1993-5#1)(1993-6#13)(1993-7#3)(1993-8#8)(1993-9#8)(1994-1#16)(1994-10#4)(1994-11#12)(1994-12#32)(1994-2#43)(1994-3#40)(1994-5#9)(1994-6#16)(1994-7#2)(1994-8#14)(1994-9#14)(1995-1#25)(1995-10#3)(1995-11#12)(1995-12#28)(1995-2#38)(1995-3#38)(1995-4#3)(1995-5#15)(1995-6#17)(1995-7#7)(1995-8#19)(1995-9#5)(1996-1#39)(1996-10#5)(1996-11#12)(1996-12#22)(1996-2#36)(1996-3#31)(1996-4#15)(1996-5#15)(1996-6#13)(1996-7#16)(1996-8#9)(1996-9#9)(1997-1#34)(1997-2#40)(1997-3#22)(1997-4#13)(1997-5#3)(1997-6#19)(1997-7#10)(1997-8#10)(2003-11#2)(2004-11#4)(2004-12#9)(2004-2#2)(2004-3#5)(2004-4#4)(2004-7#1)(2004-8#1)(2004-9#10)(2005-1#1)(2005-10#16)(2005-11#100)(2005-12#7)(2005-2#2)(2005-4#4)(2005-5#7)(2005-7#19)(2005-8#10)(2005-9#6)(2006-1#12)(2006-10#67)(2006-11#20)(2006-12#37)(2006-2#23)(2006-3#13)(2006-4#7)(2006-5#22)(2006-6#14)(2006-7#13)(2006-8#24)(2006-9#16)(2007-1#9)(2007-10#32)(2007-11#113)(2007-12#176)(2007-2#18)(2007-3#10)(2007-4#51)(2007-5#28)(2007-6#18)(2007-7#41)(2007-8#62)(2007-9#20)(2008-1#72)(2008-10#486)(2008-11#203)(2008-12#60)(2008-2#181)(2008-3#202)(2008-4#84)(2008-5#201)(2008-6#96)(2008-7#152)(2008-8#76)(2008-9#78)(2009-1#4)(2009-10#25)(2009-11#24)(2009-12#29)(2009-2#13)(2009-3#22)(2009-4#37)(2009-5#9)(2009-6#22)(2009-7#23)(2009-8#30)(2009-9#21)(2010-1#10)(2010-10#22)(2010-11#16)(2010-12#37)(2010-2#28)(2010-3#17)(2010-4#39)(2010-5#34)(2010-6#12)(2010-7#19)(2010-8#39)(2010-9#17)(2011-1#71)(2011-10#2)(2011-12#18)(2011-2#133)(2011-3#4)(2011-8#2)(2012-1#33)(2012-11#7)(2012-12#78)(2012-2#120)(2012-3#71)(2012-8#1)(2013-1#153)(2013-7#26)(2013-8#60)
process&quot##2##1##(2008-8#1)(2009-4#1)
process(es)##5##1##(1991-12#1)(1992-11#1)(1995-11#1)(2008-4#1)(2008-5#1)
process)##9##1##(2005-5#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-7#2)(2011-12#1)(2012-2#1)
process-based quality##2##2##(2007-5#1)(2012-3#1)
process-based training##2##2##(2013-1#2)
process-based##4##1##(2007-5#1)(2012-3#1)(2013-1#2)
process-dependent##3##1##(2008-2#3)
process-oriented##3##1##(1996-2#1)(2006-6#1)(2008-11#1)
process-related##3##1##(1994-2#1)(1994-6#1)(2013-7#1)
process?##3##1##(1991-11#1)(1997-8#1)(2012-3#1)
process]##4##1##(1997-4#1)(2006-8#1)(2009-2#1)(2013-8#1)
processability##2##1##(2009-11#1)(2010-4#1)
processed COOH-terminal protein was##2##4##(1994-12#2)
processed according to##4##3##(2007-4#1)(2008-7#1)(2012-12#1)(2012-2#1)
processed allo-MHC peptides##2##3##(1995-2#2)
processed and secreted##2##3##(1992-3#1)(1995-3#1)
processed and##14##2##(1992-3#1)(1993-3#1)(1994-6#1)(1995-3#1)(1995-5#1)(1996-3#1)(1997-2#1)(2005-12#1)(2007-10#1)(2007-11#1)(2007-7#1)(2010-12#1)(2011-1#1)(2013-8#1)
processed as##2##2##(1994-12#1)(1996-11#1)
processed at a##2##3##(2007-4#1)(2011-1#1)
processed at##7##2##(1991-9#1)(1996-5#1)(1997-1#1)(2007-4#1)(2008-10#1)(2011-1#1)(2012-1#1)
processed by a##9##3##(2005-10#1)(2007-7#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#2)
processed by the##8##3##(1993-3#1)(2005-11#1)(2007-1#1)(2008-10#1)(2008-3#1)(2010-8#1)(2011-1#1)(2013-8#1)
processed by using##2##3##(2007-7#1)(2008-10#1)
processed by##42##2##(1990-5#1)(1993-3#2)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#1)(2005-10#1)(2005-11#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-7#2)(2008-10#13)(2008-2#2)(2008-3#4)(2008-4#2)(2010-10#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
processed food##2##2##(2008-10#1)(2011-2#1)
processed foods and##2##3##(2013-1#2)
processed foods##10##2##(1991-6#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#4)
processed for immunohistochemical##2##3##(1993-7#1)(2006-8#1)
processed for light microscopy##2##4##(2008-1#1)(2008-5#1)
processed for##34##2##(1991-7#1)(1993-7#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-9#1)(1996-5#3)(2004-9#1)(2006-12#1)(2006-8#1)(2007-2#1)(2007-5#1)(2007-7#3)(2008-1#1)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#2)(2010-12#1)(2010-4#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#2)
processed from the##3##3##(1990-3#1)(1996-5#1)(1997-7#1)
processed from##9##2##(1990-3#1)(1994-11#1)(1996-5#1)(1997-7#1)(2006-12#1)(2007-7#1)(2007-8#1)(2009-11#1)(2010-7#1)
processed gene##2##2##(1990-12#1)(1994-9#1)
processed in a##5##3##(1992-3#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
processed in such a way that##2##6##(1997-5#1)(2008-3#1)
processed in the##7##3##(1991-9#1)(1996-7#1)(2007-1#1)(2008-12#1)(2008-2#1)(2013-1#1)(2013-8#1)
processed in vitro##2##3##(1991-9#1)(1993-12#1)
processed in##29##2##(1990-12#2)(1991-9#2)(1992-3#1)(1993-12#1)(1993-2#1)(1994-2#1)(1995-12#1)(1996-7#1)(1997-5#1)(1997-7#1)(2007-1#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2009-9#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
processed into a##2##3##(2006-12#1)(2008-2#1)
processed into the##3##3##(1990-8#2)(1996-2#1)
processed into##9##2##(1990-5#1)(1990-8#2)(1992-11#1)(1996-2#1)(2006-12#1)(2008-2#1)(2012-1#1)(2012-2#1)
processed mRNA##2##2##(1990-12#1)(2012-1#1)
processed meat##2##2##(2010-4#1)(2011-1#1)
processed on line##2##3##(1996-6#1)(2008-3#1)
processed protein##3##2##(1995-6#3)
processed pseudogene and##2##3##(1991-6#1)(1997-2#1)
processed pseudogene##10##2##(1990-8#2)(1991-6#1)(1993-2#1)(1994-11#1)(1997-2#3)(1997-4#2)
processed pseudogenes##2##2##(1993-2#1)(1997-4#1)
processed recombinant##3##2##(1990-12#1)(1990-6#1)(1997-4#1)
processed to a##5##3##(1990-12#1)(1990-5#1)(1992-12#1)(1993-3#1)(1995-8#1)
processed to generate##2##3##(1997-7#1)(2009-8#1)
processed to the mature enzyme##2##5##(1992-12#1)(1992-2#1)
processed to the mature##5##4##(1992-11#1)(1992-12#1)(1992-2#1)(1995-2#1)(1997-1#1)
processed to##40##2##(1990-12#1)(1990-5#2)(1991-9#1)(1992-11#1)(1992-12#4)(1992-2#1)(1993-3#1)(1994-11#1)(1994-5#1)(1995-2#2)(1995-6#1)(1995-8#1)(1997-1#1)(1997-7#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
processed using a##2##3##(1996-4#1)(2008-7#1)
processed using partial least squares##2##5##(2008-10#2)
processed using##15##2##(1992-8#1)(1993-9#1)(1996-4#1)(1997-8#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
processed with a##4##3##(1990-12#1)(2006-5#1)(2008-10#1)(2008-7#1)
processed with##12##2##(1990-12#1)(2006-5#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-7#1)(2011-1#1)(2012-3#1)
processed##386##1##(1990-11#1)(1990-12#7)(1990-3#1)(1990-5#4)(1990-6#2)(1990-8#7)(1991-1#1)(1991-2#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#5)(1992-11#3)(1992-12#6)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#6)(1993-3#5)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#5)(1994-12#5)(1994-2#4)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#5)(1995-12#4)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#8)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#7)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#8)(1997-4#5)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#2)(2004-8#2)(2004-9#1)(2005-10#2)(2005-11#2)(2005-12#2)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#3)(2006-4#3)(2006-5#2)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#6)(2007-12#3)(2007-2#2)(2007-4#2)(2007-5#1)(2007-7#9)(2007-8#5)(2008-1#2)(2008-10#34)(2008-11#2)(2008-12#4)(2008-2#12)(2008-3#14)(2008-4#7)(2008-5#9)(2008-6#2)(2008-7#9)(2008-8#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#4)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#7)(2011-2#8)(2012-1#5)(2012-12#6)(2012-2#8)(2012-3#3)(2013-1#12)(2013-7#1)(2013-8#8)
processes (e##5##2##(2005-8#1)(2007-8#3)(2009-4#1)
processes (i##2##2##(2008-10#1)(2012-1#1)
processes -##2##2##(2008-12#1)(2012-3#1)
processes a##2##2##(2007-11#1)(2008-5#1)
processes accounted for##2##3##(1991-6#1)(2006-3#1)
processes after##2##2##(1995-5#1)(2005-4#1)
processes also occur##2##3##(1996-8#1)(2008-10#1)
processes also##3##2##(1996-8#1)(2008-10#2)
processes and activation of the##2##5##(2008-11#1)(2011-1#1)
processes and by##2##3##(2005-7#1)(2008-2#1)
processes and common factors in couple therapy##2##7##(2012-2#2)
processes and for##2##3##(2007-3#1)(2008-5#1)
processes and functions of##2##4##(2011-2#2)
processes and functions##3##3##(2008-7#1)(2011-2#2)
processes and gene##2##3##(2007-12#1)(2010-12#1)
processes and have##3##3##(1994-5#1)(2008-9#1)(2011-1#1)
processes and how##2##3##(2007-1#1)(2012-3#1)
processes and in##4##3##(2008-10#1)(2009-12#1)(2010-2#1)(2013-1#1)
processes and is##2##3##(2007-6#1)(2010-2#1)
processes and its##2##3##(1991-8#1)(2008-10#1)
processes and mechanisms##5##3##(1992-6#1)(1995-5#1)(2008-7#1)(2009-8#1)(2010-3#1)
processes and outcomes##4##3##(1993-3#1)(2008-12#1)(2008-8#1)(2009-8#1)
processes and pathways##2##3##(2008-7#1)(2012-2#1)
processes and systems##3##3##(1995-1#1)(2012-2#2)
processes and that##5##3##(1993-11#1)(1994-12#1)(1996-12#1)(2008-8#1)(2012-2#1)
processes and the##23##3##(1993-6#1)(1994-1#1)(1995-2#1)(1996-2#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-5#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
processes and their##3##3##(1994-3#1)(2010-10#1)(2011-2#1)
processes and thus##2##3##(2008-2#1)(2011-1#1)
processes and to##7##3##(1990-11#1)(1992-12#1)(1993-5#1)(2005-5#1)(2008-11#1)(2009-2#1)(2009-8#1)
processes and whether##2##3##(1994-8#1)(2009-8#1)
processes and##202##2##(1990-11#1)(1990-2#1)(1991-8#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#3)(1995-2#1)(1995-5#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#2)(2005-5#2)(2005-7#2)(2006-10#3)(2006-5#1)(2006-7#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-2#2)(2007-3#1)(2007-5#2)(2007-6#1)(2007-8#2)(2007-9#2)(2008-10#9)(2008-11#7)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#5)(2008-5#6)(2008-7#10)(2008-8#3)(2008-9#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-8#5)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#11)(2012-1#3)(2012-12#1)(2012-2#10)(2012-3#4)(2013-1#6)(2013-7#2)(2013-8#4)
processes appeared to be##2##4##(1992-1#1)(1995-5#1)
processes appeared##3##2##(1992-1#1)(1995-5#1)(2008-7#1)
processes are activated##2##3##(2004-9#1)(2005-10#1)
processes are critical for##2##4##(1997-7#1)(2012-2#1)
processes are described##3##3##(2005-11#1)(2008-10#1)(2008-11#1)
processes are discussed##3##3##(1996-2#1)(2006-6#1)(2008-10#1)
processes are dominated by##2##4##(1990-8#1)(2006-3#1)
processes are effective and##2##4##(1990-8#1)(2013-8#1)
processes are generally##3##3##(2006-8#1)(2008-8#1)(2012-3#1)
processes are in##2##3##(2007-12#1)(2010-9#1)
processes are involved in##4##4##(1993-12#1)(2008-7#1)(2011-2#1)(2012-12#1)
processes are linked##2##3##(2012-12#1)(2013-1#1)
processes are markedly##2##3##(1995-10#1)(2009-12#1)
processes are not##3##3##(2007-11#1)(2008-8#1)(2009-3#1)
processes are of##2##3##(2008-5#1)(2013-8#1)
processes are potentially##2##3##(2008-10#1)(2008-2#1)
processes are regulated by##2##4##(2008-1#1)(2010-2#1)
processes are regulated##3##3##(2008-1#1)(2010-2#1)(2013-1#1)
processes are the##4##3##(1995-2#1)(2007-11#1)(2011-2#1)(2013-7#1)
processes are unknown##2##3##(1995-1#1)(2012-3#1)
processes are used##2##3##(2008-10#1)(2008-2#1)
processes are##111##2##(1990-12#1)(1990-8#2)(1991-3#1)(1992-3#1)(1993-11#1)(1993-12#1)(1995-1#2)(1995-10#1)(1995-2#2)(1995-3#1)(1996-2#1)(1997-7#1)(2004-9#1)(2005-10#1)(2005-11#2)(2006-10#4)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#4)(2007-12#4)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#3)
processes arise##3##2##(2008-11#1)(2008-6#1)(2013-1#1)
processes as a##2##3##(2008-3#1)(2012-12#1)
processes as well as in##2##5##(2008-5#1)(2013-1#1)
processes as well as the##2##5##(2008-11#2)
processes as well as##9##4##(2005-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2009-10#1)(2010-12#1)(2013-1#2)
processes as##25##2##(1995-6#1)(1996-2#1)(2005-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-4#1)(2010-12#1)(2012-12#2)(2013-1#2)
processes associated with the##3##4##(2005-7#1)(2013-1#2)
processes associated with##17##3##(1992-12#1)(1992-8#1)(1993-2#1)(1995-12#1)(1995-2#1)(1996-2#1)(2005-7#1)(2006-8#1)(2008-1#1)(2008-11#2)(2008-8#1)(2010-10#1)(2012-2#1)(2012-3#1)(2013-1#2)
processes at the molecular level##3##5##(2005-7#1)(2011-2#1)(2012-2#1)
processes at the nanoscale##2##4##(2007-12#1)(2009-2#1)
processes at the##8##3##(1994-8#1)(1996-3#1)(2005-7#1)(2007-12#1)(2009-10#1)(2009-2#1)(2011-2#1)(2012-2#1)
processes at##17##2##(1992-12#1)(1992-7#1)(1992-9#1)(1994-8#1)(1996-3#1)(1997-3#1)(2005-7#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-2#1)
processes based on structural data##2##5##(2013-1#2)
processes based##3##2##(2004-1#1)(2013-1#2)
processes behind the##2##3##(2010-12#1)(2013-7#1)
processes behind##3##2##(2010-12#1)(2012-2#1)(2013-7#1)
processes being##4##2##(1996-8#1)(2008-11#1)(2010-12#1)(2011-2#1)
processes believed to##2##3##(2009-11#1)(2012-2#1)
processes between the##2##3##(2008-11#1)(2008-12#1)
processes between##3##2##(1992-7#1)(2008-11#1)(2008-12#1)
processes both##2##2##(1996-11#1)(2008-3#1)
processes but also##4##3##(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
processes but##6##2##(2007-5#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
processes by the##3##3##(2006-12#1)(2008-5#1)(2011-12#1)
processes by use of##2##4##(2007-12#1)(2008-10#1)
processes by using##3##3##(1996-12#1)(2007-11#2)
processes by which##6##3##(1996-5#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-5#1)
processes by##27##2##(1992-12#1)(1995-6#1)(1996-12#1)(1996-5#1)(2004-9#1)(2005-8#1)(2006-12#1)(2007-11#2)(2007-12#3)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-2#1)
processes can be##8##3##(1990-8#1)(1996-5#1)(2004-12#1)(2005-11#1)(2007-7#1)(2008-10#1)(2008-8#1)(2012-3#1)
processes can##15##2##(1990-8#1)(1991-6#2)(1996-5#1)(1997-5#1)(2004-12#1)(2005-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-8#1)(2009-12#1)(2009-8#1)(2012-3#1)
processes cannot##2##2##(2008-8#1)(2011-1#1)
processes caused by##3##3##(2006-8#1)(2008-10#1)(2008-12#1)
processes caused##4##2##(1990-3#1)(2006-8#1)(2008-10#1)(2008-12#1)
processes containing##2##2##(1992-3#1)(1992-7#1)
processes could##4##2##(1994-3#1)(2008-10#1)(2012-3#1)(2013-8#1)
processes described##2##2##(1996-5#1)(2008-11#1)
processes determining##2##2##(1997-7#1)(2008-1#1)
processes developed##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
processes due to##2##3##(1994-11#1)(2007-12#1)
processes during the past##2##4##(1993-4#1)(2008-11#1)
processes during the##4##3##(1993-4#1)(1995-12#1)(2008-11#2)
processes during##13##2##(1993-4#1)(1995-12#1)(1996-12#1)(1996-8#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-11#3)(2008-4#1)(2009-6#1)(2012-1#1)
processes enhance##2##2##(2005-7#1)(2008-8#1)
processes for making##2##3##(1992-2#1)(2006-4#1)
processes for production of alkene##2##5##(2008-5#2)
processes for the determination of##2##5##(2008-10#2)
processes for the##5##3##(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)
processes for##39##2##(1992-2#2)(1995-5#1)(1997-2#2)(2005-11#1)(2005-9#1)(2006-4#1)(2006-6#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-8#1)(2010-9#1)(2011-2#2)(2013-1#3)(2013-7#1)
processes from the##3##3##(1991-3#1)(2007-11#1)(2008-11#1)
processes from##7##2##(1990-2#1)(1990-4#1)(1991-3#1)(1993-12#1)(2007-11#1)(2008-11#1)(2008-6#1)
processes generated##2##2##(2008-10#1)(2009-11#1)
processes greatly##2##2##(2006-12#1)(2008-10#1)
processes has been##5##3##(2006-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)
processes has##9##2##(1991-3#1)(1994-12#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2011-12#1)(2011-2#1)
processes have been identified##2##4##(1996-6#1)(2012-2#1)
processes have been##12##3##(1994-2#1)(1995-12#1)(1995-9#1)(1996-6#1)(2005-11#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-8#1)
processes have##21##2##(1991-2#1)(1994-2#1)(1995-12#1)(1995-9#1)(1996-6#1)(2004-4#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-10#1)(2011-1#1)(2012-11#2)(2012-2#1)(2013-8#1)
processes implicated##2##2##(2011-1#1)(2011-2#1)
processes in AD##2##3##(1993-11#2)
processes in a##10##3##(1992-10#1)(2007-12#3)(2008-1#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-9#1)
processes in lipid##2##3##(1990-2#1)(2011-1#1)
processes in living##2##3##(2007-8#1)(2009-8#1)
processes in many##2##3##(2008-10#1)(2008-11#1)
processes in muscle##2##3##(1991-5#1)(1992-3#1)
processes in one-dimensional photonic bandgap structures##2##6##(2007-12#2)
processes in order to##2##4##(2008-10#1)(2013-1#1)
processes in patients with##2##4##(2008-6#1)(2012-1#1)
processes in patients##3##3##(2008-6#1)(2008-8#1)(2012-1#1)
processes in plants##2##3##(1994-3#1)(2009-8#1)
processes in response to low doses##2##6##(2008-7#2)
processes in response to##3##4##(2008-7#2)(2009-6#1)
processes in the atmosphere##2##4##(2008-11#1)(2011-1#1)
processes in the brain##2##4##(1994-6#1)(2008-8#1)
processes in the hippocampus##2##4##(1994-5#1)(1996-1#1)
processes in the human##2##4##(2008-5#1)(2012-12#1)
processes in the rat##2##4##(1991-2#1)(1996-11#1)
processes in the##63##3##(1990-4#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-7#1)(1993-12#2)(1993-3#1)(1993-4#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-7#1)(2006-6#1)(2007-11#2)(2007-12#5)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#3)(2009-10#1)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#1)
processes in these##2##3##(1995-2#1)(2012-2#1)
processes in this##5##3##(2006-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-11#1)
processes in various##4##3##(1995-2#1)(2010-12#1)(2012-1#1)(2012-12#1)
processes in vivo##2##3##(1993-12#1)(2008-2#1)
processes in which##5##3##(2006-5#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-3#1)
processes in##221##2##(1990-10#1)(1990-2#1)(1990-4#1)(1990-5#1)(1991-2#1)(1991-3#3)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#2)(1993-11#2)(1993-12#4)(1993-3#1)(1993-4#1)(1993-5#1)(1993-8#1)(1994-10#1)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#1)(1995-11#3)(1995-2#2)(1995-5#1)(1996-1#1)(1996-11#2)(1996-4#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#2)(2005-8#1)(2006-12#2)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#4)(2007-12#13)(2007-2#1)(2007-5#1)(2007-8#3)(2008-1#2)(2008-10#5)(2008-11#7)(2008-2#10)(2008-3#4)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#9)(2008-8#8)(2008-9#3)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#4)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#4)(2012-1#5)(2012-12#5)(2012-2#8)(2012-3#5)(2013-1#4)(2013-7#2)(2013-8#3)
processes include##4##2##(1997-5#1)(2008-11#1)(2008-5#1)(2011-2#1)
processes including cell##3##3##(2005-7#1)(2007-12#1)(2010-10#1)
processes including the##2##3##(2008-10#1)(2013-8#1)
processes including##21##2##(1995-10#1)(1995-11#2)(1995-12#1)(1996-10#1)(2005-7#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#2)(2009-11#1)(2009-2#1)(2010-10#1)(2010-5#1)(2011-12#1)(2011-2#1)(2011-9#1)(2013-1#1)(2013-8#1)
processes induced by##2##3##(2007-12#1)(2012-12#1)
processes induced##3##2##(2007-12#1)(2008-11#1)(2012-12#1)
processes into the##3##3##(2006-10#1)(2007-12#1)(2012-12#1)
processes into##5##2##(2006-10#1)(2007-12#1)(2008-11#1)(2011-12#1)(2012-12#1)
processes involve a##2##3##(2007-12#1)(2010-3#1)
processes involve##5##2##(1994-5#1)(2006-1#1)(2007-12#1)(2009-12#1)(2010-3#1)
processes involved in the regulation of##2##6##(1996-3#1)(2008-7#1)
processes involved in the##14##4##(1993-4#1)(1994-5#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-2#1)(2010-9#1)(2011-1#1)
processes involved in this##3##4##(1994-8#1)(2010-12#1)(2011-2#1)
processes involved in##39##3##(1993-4#1)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-12#1)(1996-3#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-3#2)
processes involved##44##2##(1990-3#1)(1993-4#1)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-5#1)(2006-11#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-3#2)
processes involving##16##2##(1991-4#1)(1991-9#1)(1994-8#1)(1995-8#1)(1997-2#1)(2007-6#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-7#1)(2012-1#1)
processes is a##3##3##(2008-7#1)(2010-12#1)(2012-2#1)
processes is discussed##3##3##(1991-2#1)(1996-4#1)(2008-10#1)
processes is presented##3##3##(1992-2#1)(2007-5#1)(2008-10#1)
processes is unknown##2##3##(1990-3#1)(1995-2#1)
processes is##35##2##(1990-3#1)(1991-12#1)(1991-2#1)(1992-2#1)(1995-2#1)(1996-4#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-5#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
processes leading to cell death##2##5##(1992-6#1)(1997-6#1)
processes leading to the##2##4##(1992-8#1)(2008-10#1)
processes leading to##14##3##(1991-2#1)(1992-6#2)(1992-8#1)(1993-2#1)(1994-10#1)(1997-6#1)(2006-12#1)(2008-1#1)(2008-10#1)(2009-4#1)(2010-11#1)(2012-12#1)(2012-3#1)
processes linked to##3##3##(2008-10#2)(2008-11#1)
processes may be a##2##4##(1995-5#1)(2008-7#1)
processes may be##7##3##(1995-5#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-1#1)(2013-1#2)
processes may contribute to##2##4##(2010-4#1)(2011-2#1)
processes may have##2##3##(2006-10#1)(2007-3#1)
processes may##17##2##(1995-5#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-4#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#2)
processes mediate the##2##3##(1994-5#1)(2008-9#1)
processes mediated by##2##3##(1993-12#1)(1993-2#1)
processes might##5##2##(2006-10#1)(2006-5#1)(2008-7#1)(2008-9#1)(2009-2#1)
processes must be##2##3##(2006-10#1)(2008-11#1)
processes must##4##2##(1994-3#1)(2006-10#1)(2006-12#1)(2008-11#1)
processes necessary to##3##3##(2006-10#1)(2010-5#1)(2012-2#1)
processes not only##2##3##(2005-5#1)(2008-12#1)
processes not previously##2##3##(2011-1#1)(2012-2#1)
processes not##7##2##(2005-5#1)(2008-10#1)(2008-12#1)(2009-2#1)(2009-4#1)(2011-1#1)(2012-2#1)
processes occur##2##2##(2007-11#1)(2007-3#1)
processes occurring at##4##3##(2005-11#1)(2008-5#1)(2008-7#2)
processes occurring during##2##3##(1994-3#1)(1997-3#1)
processes occurring in the##8##4##(1990-3#1)(2005-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-2#1)
processes occurring in##9##3##(1990-3#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-2#1)
processes occurring within##2##3##(2008-11#1)(2008-8#1)
processes occurring##19##2##(1990-3#1)(1994-3#1)(1997-3#1)(2005-11#2)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2010-2#1)(2012-3#1)
processes of bone##4##3##(1992-8#1)(2007-8#2)(2008-7#1)
processes of care##2##3##(1994-12#1)(2012-11#1)
processes of development##2##3##(2007-8#1)(2009-12#1)
processes of interest##2##3##(1990-8#1)(2008-7#1)
processes of molecular##2##3##(2008-2#1)(2010-4#1)
processes of the central##2##4##(2011-2#1)(2013-7#1)
processes of the two##2##4##(2008-10#2)
processes of the##29##3##(1990-10#1)(1990-11#1)(1994-9#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-3#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#2)(2010-5#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#1)(2013-7#1)
processes of their##2##3##(2012-1#1)(2013-1#1)
processes of these##2##3##(1990-5#1)(2010-12#1)
processes of##218##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-3#1)(1991-4#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-4#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#6)(2007-12#6)(2007-3#2)(2007-5#1)(2007-8#9)(2007-9#2)(2008-1#2)(2008-10#29)(2008-11#6)(2008-12#1)(2008-2#6)(2008-3#5)(2008-4#1)(2008-5#5)(2008-7#5)(2008-8#6)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#3)(2010-3#3)(2010-4#3)(2010-5#3)(2010-7#1)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#4)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#6)(2012-3#3)(2013-1#12)(2013-7#1)(2013-8#2)
processes on the##3##3##(2005-11#1)(2008-3#1)(2008-9#1)
processes on##13##2##(1996-3#1)(2005-11#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#2)(2008-8#1)(2008-9#1)(2012-3#1)(2012-5#1)
processes or to##3##3##(2007-12#1)(2010-10#1)(2012-2#1)
processes or##8##2##(1994-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-2#1)(2010-10#1)(2011-1#1)(2012-2#1)
processes play a##2##3##(2007-12#2)
processes play an important role in##2##6##(1992-4#1)(2009-7#1)
processes play##6##2##(1992-4#1)(1997-1#1)(2007-12#2)(2008-5#1)(2009-7#1)
processes present##2##2##(1997-2#1)(2013-1#1)
processes promoting##2##2##(2005-11#1)(2009-12#1)
processes provide##4##2##(2008-11#1)(2008-7#1)(2009-7#1)(2010-2#1)
processes provided by##2##3##(2007-10#1)(2008-11#1)
processes provides##2##2##(2007-8#1)(2013-1#1)
processes rather than##3##3##(1997-3#1)(2008-6#1)(2009-12#1)
processes related to##10##3##(1994-2#1)(1994-3#1)(1997-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-5#1)(2010-4#1)(2013-8#1)
processes relevant to##2##3##(2008-10#1)(2010-6#1)
processes represent##2##2##(2010-11#1)(2010-12#1)
processes required for##2##3##(2013-1#1)(2013-8#1)
processes required to##2##3##(2008-11#1)(2012-2#1)
processes required##5##2##(1992-3#1)(2008-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
processes responsible for the##3##4##(1991-5#1)(1996-6#1)(2008-4#1)
processes responsible for##11##3##(1991-5#1)(1996-4#1)(1996-6#2)(2007-12#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)
processes resulting in##2##3##(2007-11#1)(2009-11#1)
processes seems##2##2##(2008-10#1)(2009-2#1)
processes sensory##2##2##(2008-11#1)(2008-4#1)
processes should be considered in##2##5##(2006-12#1)(2006-5#1)
processes should be##7##3##(1990-9#1)(2005-5#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-4#1)(2009-10#1)
processes should##8##2##(1990-9#1)(2005-5#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-4#1)(2008-8#1)(2009-10#1)
processes such as cell proliferation##2##5##(2008-8#1)(2012-12#1)
processes such as cell##6##4##(1996-3#1)(2008-8#1)(2009-6#1)(2012-12#2)(2013-1#1)
processes such as gene duplication##2##5##(2008-4#1)(2013-1#1)
processes such as##58##3##(1990-11#1)(1993-5#1)(1995-3#1)(1996-3#1)(1997-1#1)(1997-4#1)(2004-4#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#5)(2009-11#1)(2009-12#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#4)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#1)
processes taking place during##2##4##(2007-5#1)(2008-10#1)
processes taking place in##5##4##(2006-10#1)(2007-11#2)(2008-12#1)(2010-12#1)
processes taking place##10##3##(2006-10#1)(2007-11#3)(2007-5#1)(2008-10#2)(2008-12#1)(2010-12#1)(2013-1#1)
processes than##2##2##(2007-12#1)(2007-3#1)
processes that affect##2##3##(2006-2#1)(2010-8#1)
processes that are linked to the##2##6##(2007-11#1)(2008-3#1)
processes that are linked to##3##5##(2007-11#1)(2008-10#1)(2008-3#1)
processes that are often##2##4##(2008-10#1)(2012-12#1)
processes that are taking place##2##5##(2006-12#1)(2008-2#1)
processes that are##24##3##(1991-3#1)(1993-3#1)(1994-1#1)(1997-1#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2009-3#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
processes that can be##2##4##(2008-10#1)(2011-12#1)
processes that control##2##3##(2008-2#1)(2010-3#1)
processes that determine the##2##4##(2008-3#1)(2010-9#1)
processes that enhance##2##3##(1995-3#1)(2006-3#1)
processes that have##4##3##(1991-3#1)(2010-1#1)(2010-12#1)(2012-3#1)
processes that include##2##3##(2008-7#1)(2010-7#1)
processes that influence##3##3##(1997-5#1)(2008-2#1)(2012-3#1)
processes that involve##3##3##(1992-5#1)(2008-10#1)(2009-8#1)
processes that lead to this##2##5##(2008-11#1)(2011-2#1)
processes that lead to##3##4##(2008-11#1)(2008-3#1)(2011-2#1)
processes that may be##2##4##(2009-10#1)(2010-12#1)
processes that may##6##3##(1992-7#1)(2007-12#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-1#1)
processes that mimic##2##3##(1997-6#1)(2005-8#1)
processes that occur in##4##4##(2006-10#1)(2008-2#1)(2008-4#2)
processes that occur##5##3##(2006-10#1)(2008-2#1)(2008-4#2)(2010-12#1)
processes that regulate##2##3##(1992-2#1)(2013-8#1)
processes that require##2##3##(1992-6#1)(2012-1#1)
processes that shape##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
processes that they##2##3##(2005-9#1)(2009-5#1)
processes that underlie##5##3##(2006-10#1)(2007-7#1)(2008-11#1)(2008-9#1)(2012-11#1)
processes that##125##2##(1990-9#1)(1991-3#2)(1992-2#1)(1992-5#2)(1992-6#1)(1992-7#2)(1993-3#2)(1994-1#1)(1995-3#2)(1996-2#1)(1996-6#1)(1997-1#1)(1997-5#1)(1997-6#1)(2005-11#1)(2005-12#1)(2005-8#2)(2005-9#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2007-10#2)(2007-11#4)(2007-12#4)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#6)(2008-3#5)(2008-4#5)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#2)(2009-5#2)(2009-8#3)(2010-1#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#3)
processes the##5##2##(1995-3#1)(2008-2#2)(2008-7#1)(2012-12#1)
processes they##2##2##(1991-3#1)(2008-7#1)
processes through the##3##3##(1990-12#1)(1993-9#1)(2009-7#1)
processes through##5##2##(1990-12#1)(1993-9#1)(1995-12#1)(2004-4#1)(2009-7#1)
processes to achieve##2##3##(1996-2#1)(2005-11#1)
processes to be##4##3##(2005-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
processes to eliminate##2##3##(1996-1#1)(2013-1#1)
processes to health##2##3##(1996-1#1)(2013-1#1)
processes to identify##2##3##(2008-11#1)(2010-6#1)
processes to provide##2##3##(1997-1#1)(2007-12#1)
processes to the##4##3##(1991-10#1)(2008-10#1)(2011-1#1)(2012-12#1)
processes to##38##2##(1991-10#1)(1994-8#1)(1995-2#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(2005-11#1)(2005-5#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#2)(2009-10#1)(2009-4#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#4)(2013-8#1)
processes under##4##2##(2004-9#1)(2006-12#1)(2008-4#1)(2009-4#1)
processes underlying the##5##3##(1995-4#1)(2006-10#1)(2007-12#1)(2008-4#1)(2008-5#1)
processes underlying##16##2##(1995-4#1)(2006-10#2)(2007-12#2)(2007-8#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-5#1)(2010-9#1)(2011-1#1)(2012-1#1)(2013-8#1)
processes used in##6##3##(1994-3#1)(2007-11#1)(2008-11#1)(2008-8#1)(2010-3#1)(2013-8#1)
processes used to##2##3##(1993-12#1)(2006-1#1)
processes used##10##2##(1993-12#1)(1994-3#1)(2006-1#1)(2007-11#1)(2007-7#1)(2008-11#2)(2008-8#1)(2010-3#1)(2013-8#1)
processes using##5##2##(2005-11#1)(2007-11#1)(2008-10#1)(2010-9#1)(2012-2#1)
processes was##8##2##(1990-2#1)(1992-1#1)(2007-3#1)(2008-10#3)(2008-7#1)(2008-8#1)
processes we##3##2##(1997-1#1)(2009-12#1)(2012-2#1)
processes were found##2##3##(1991-9#1)(2007-1#1)
processes were hypothesized to relate to##2##6##(2009-8#2)
processes were inhibited by##2##4##(2008-11#2)
processes were observed in the##3##5##(1990-5#1)(1994-2#1)(1995-5#1)
processes were observed##5##3##(1990-5#1)(1993-12#1)(1994-2#1)(1995-5#1)(2008-3#1)
processes were##40##2##(1990-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-12#1)(1994-2#1)(1995-12#1)(1995-5#2)(1996-3#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-7#1)(2009-8#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
processes where##3##2##(2008-11#2)(2013-1#1)
processes which are##4##3##(1993-12#1)(1996-2#1)(1996-8#1)(2012-2#1)
processes which may##2##3##(2008-7#1)(2009-10#1)
processes which##18##2##(1991-9#1)(1993-12#1)(1993-2#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-7#1)(1996-2#1)(1996-8#1)(2007-11#1)(2008-11#2)(2008-7#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-2#2)
processes will be##2##3##(1994-12#1)(1995-1#1)
processes will##6##2##(1994-12#1)(1995-1#1)(2005-8#1)(2008-11#1)(2008-3#1)(2011-2#1)
processes with the##2##3##(2007-12#1)(2011-2#1)
processes with##28##2##(1991-6#1)(1992-2#1)(1995-3#1)(1996-5#1)(1997-3#1)(2005-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-2#1)(2010-5#1)(2011-2#1)(2012-1#2)(2012-2#2)
processes within the##5##3##(1991-8#1)(2006-10#1)(2006-11#1)(2008-3#1)(2013-1#1)
processes within##10##2##(1991-8#1)(1993-3#1)(1996-9#1)(2006-10#1)(2006-11#1)(2007-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
processes##2853##1##(1990-10#4)(1990-11#5)(1990-12#5)(1990-2#6)(1990-3#10)(1990-4#5)(1990-5#5)(1990-6#1)(1990-8#5)(1990-9#4)(1991-1#1)(1991-10#5)(1991-11#1)(1991-12#3)(1991-2#5)(1991-3#14)(1991-4#5)(1991-5#8)(1991-6#7)(1991-7#3)(1991-8#7)(1991-9#6)(1992-1#8)(1992-10#4)(1992-11#5)(1992-12#7)(1992-2#9)(1992-3#6)(1992-4#1)(1992-5#4)(1992-6#11)(1992-7#8)(1992-8#12)(1992-9#4)(1993-1#1)(1993-11#6)(1993-12#18)(1993-2#7)(1993-3#11)(1993-4#6)(1993-5#6)(1993-6#5)(1993-7#3)(1993-8#5)(1993-9#2)(1994-1#4)(1994-10#5)(1994-11#6)(1994-12#10)(1994-2#9)(1994-3#19)(1994-5#11)(1994-6#8)(1994-8#17)(1994-9#3)(1995-1#9)(1995-10#3)(1995-11#8)(1995-12#28)(1995-2#16)(1995-3#13)(1995-4#2)(1995-5#12)(1995-6#3)(1995-7#3)(1995-8#7)(1995-9#1)(1996-1#7)(1996-10#2)(1996-11#8)(1996-12#9)(1996-2#12)(1996-3#9)(1996-4#8)(1996-5#8)(1996-6#8)(1996-7#2)(1996-8#9)(1996-9#6)(1997-1#13)(1997-2#7)(1997-3#15)(1997-4#10)(1997-5#7)(1997-6#9)(1997-7#10)(1997-8#5)(2003-11#1)(2004-1#1)(2004-11#3)(2004-12#2)(2004-4#7)(2004-9#3)(2005-10#4)(2005-11#27)(2005-12#1)(2005-3#1)(2005-4#2)(2005-5#7)(2005-7#12)(2005-8#14)(2005-9#2)(2006-1#6)(2006-10#47)(2006-11#6)(2006-12#22)(2006-2#3)(2006-3#5)(2006-4#2)(2006-5#16)(2006-6#8)(2006-7#4)(2006-8#6)(2006-9#4)(2007-1#7)(2007-10#9)(2007-11#64)(2007-12#107)(2007-2#9)(2007-3#10)(2007-4#8)(2007-5#15)(2007-6#6)(2007-7#12)(2007-8#38)(2007-9#13)(2008-1#30)(2008-10#181)(2008-11#121)(2008-12#24)(2008-2#66)(2008-3#51)(2008-4#53)(2008-5#74)(2008-6#21)(2008-7#101)(2008-8#64)(2008-9#48)(2009-10#20)(2009-11#9)(2009-12#21)(2009-2#16)(2009-3#16)(2009-4#29)(2009-5#16)(2009-6#6)(2009-7#13)(2009-8#44)(2009-9#6)(2010-1#2)(2010-10#16)(2010-11#7)(2010-12#33)(2010-2#20)(2010-3#16)(2010-4#20)(2010-5#24)(2010-6#7)(2010-7#15)(2010-8#11)(2010-9#12)(2011-1#49)(2011-12#18)(2011-2#77)(2011-3#1)(2011-9#1)(2012-1#36)(2012-11#8)(2012-12#47)(2012-2#75)(2012-3#37)(2012-5#1)(2012-7#1)(2013-1#89)(2013-7#16)(2013-8#45)
processes)##7##1##(1994-2#1)(1997-3#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-9#1)
processes?##4##1##(2005-8#1)(2006-10#1)(2009-9#1)(2012-2#1)
processes]##5##1##(1990-7#1)(1993-8#1)(2008-8#1)(2010-2#1)(2013-8#1)
processing a diverse##3##3##(1992-1#1)(2013-1#2)
processing a##4##2##(1992-1#1)(2008-10#1)(2013-1#2)
processing abilities##4##2##(1991-3#1)(1994-6#1)(2009-10#1)(2011-1#1)
processing ability##3##2##(1994-11#1)(1994-6#1)(2010-10#1)
processing activity##3##2##(1991-12#1)(1992-12#1)(1995-6#1)
processing algorithms##6##2##(2007-12#1)(2008-2#3)(2009-9#1)(2010-9#1)
processing and a##2##3##(1992-11#1)(2008-3#1)
processing and analysis##2##3##(2008-9#1)(2009-12#1)
processing and computer##3##3##(2008-2#1)(2013-1#2)
processing and joining##3##3##(1997-3#2)(1997-7#1)
processing and learning##2##3##(2008-4#1)(2012-1#1)
processing and motor skill performance in##2##6##(2013-7#2)
processing and motor##3##3##(2013-7#3)
processing and presentation of##4##4##(1994-11#2)(2006-10#1)(2008-11#1)
processing and presentation##7##3##(1994-11#2)(2006-10#2)(2008-11#1)(2009-10#1)(2013-1#1)
processing and secretion of##2##4##(1993-11#1)(1993-3#1)
processing and secretion##3##3##(1993-11#2)(1993-3#1)
processing and storage procedures##2##4##(1992-8#1)(2010-2#1)
processing and storage##4##3##(1992-8#1)(1993-2#1)(2007-7#1)(2010-2#1)
processing and the##9##3##(1992-12#1)(1992-6#1)(1993-11#1)(1994-8#1)(1997-4#1)(2006-10#1)(2007-3#1)(2009-6#1)(2012-3#1)
processing and##126##2##(1991-2#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#2)(1993-11#3)(1993-2#1)(1993-3#1)(1994-11#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#2)(1996-2#1)(1997-3#3)(1997-4#1)(1997-7#1)(2004-11#1)(2005-11#2)(2005-5#1)(2006-10#3)(2006-12#2)(2006-3#2)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#4)(2008-4#7)(2008-5#3)(2008-7#1)(2008-9#3)(2009-1#1)(2009-10#2)(2009-12#2)(2009-2#1)(2009-4#1)(2009-6#1)(2009-9#2)(2010-2#3)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#7)(2013-7#5)(2013-8#3)
processing applications##8##2##(1993-6#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)(2008-7#1)
processing approach##2##2##(2008-10#1)(2008-3#1)
processing architecture##3##2##(1997-1#2)(2008-3#1)
processing are important for##2##4##(2007-9#1)(2012-12#1)
processing are##13##2##(1995-11#1)(1995-6#1)(2006-7#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-4#1)(2012-1#1)(2012-12#1)(2013-7#1)
processing areas in##2##3##(1997-8#1)(2012-2#1)
processing areas##9##2##(1997-8#6)(2008-11#1)(2012-2#2)
processing as compared##2##3##(1993-12#1)(2008-7#1)
processing as well##2##3##(2008-7#1)(2010-8#1)
processing as##7##2##(1993-12#1)(2008-4#1)(2008-7#2)(2010-12#1)(2010-8#1)(2013-1#1)
processing at the C-terminus##2##4##(1993-11#1)(2008-4#1)
processing at the##5##3##(1993-11#1)(1995-8#1)(2006-10#1)(2008-4#1)(2008-5#1)
processing at##12##2##(1993-11#1)(1995-8#1)(1996-2#1)(1997-8#1)(2006-10#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2009-6#1)
processing based on##3##3##(2007-12#1)(2008-3#2)
processing based##4##2##(2007-12#1)(2008-11#1)(2008-3#2)
processing be##2##2##(1992-12#1)(2008-3#1)
processing between##2##2##(1996-5#1)(2008-11#1)
processing bias##3##2##(2007-12#2)(2008-11#1)
processing by human##2##3##(1990-7#1)(1995-10#1)
processing by means of##2##4##(2007-12#1)(2008-3#1)
processing by signal peptidase##2##4##(1991-11#1)(1993-12#1)
processing by the##4##3##(2008-11#1)(2009-3#3)
processing by##23##2##(1990-7#1)(1991-11#1)(1991-9#1)(1993-12#1)(1995-10#1)(1997-4#1)(2005-8#1)(2006-11#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2009-3#3)(2009-8#1)(2011-2#1)
processing can be##9##3##(1991-12#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-4#2)(2013-8#1)
processing can##11##2##(1990-9#1)(1991-12#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-4#2)(2013-8#2)
processing capability##2##2##(2008-2#1)(2008-3#1)
processing capacity##3##2##(1997-2#1)(2010-2#2)
processing chain##5##2##(2008-12#3)(2009-12#1)(2011-2#1)
processing chains##2##2##(2008-12#2)
processing characteristics of##2##3##(2010-4#2)
processing conditions##7##2##(2008-1#1)(2008-2#1)(2008-5#2)(2009-11#1)(2010-4#2)
processing could be##2##3##(1995-6#1)(2005-8#1)
processing deficit in##2##3##(2008-11#2)
processing deficit##4##2##(2005-10#1)(2008-11#2)(2008-4#1)
processing deficits in##3##3##(1996-2#1)(2006-3#1)(2008-4#1)
processing deficits##4##2##(1996-2#1)(2006-3#1)(2008-4#1)(2008-9#1)
processing devices##3##2##(2007-11#1)(2007-12#1)(2012-2#1)
processing differences##2##2##(2008-9#1)(2009-4#1)
processing difficulties##3##2##(1993-11#1)(2013-1#2)
processing efficiency##3##2##(2008-10#1)(2008-3#1)(2010-7#1)
processing enzymes in the##2##4##(1991-9#1)(1993-5#1)
processing enzymes in##3##3##(1991-9#1)(1993-5#1)(2008-4#1)
processing enzymes##6##2##(1991-9#2)(1993-5#3)(2008-4#1)
processing event##2##2##(1993-12#1)(2007-12#1)
processing events##2##2##(1992-6#1)(1997-7#1)
processing for##17##2##(1991-1#1)(1991-8#1)(2006-12#1)(2007-5#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#2)(2008-9#2)(2010-12#1)(2013-1#2)
processing functions##2##2##(1994-6#1)(1995-3#1)
processing has been##3##3##(1990-8#1)(2010-12#1)(2011-1#1)
processing has recently##2##3##(2008-1#1)(2008-2#1)
processing has##9##2##(1990-8#1)(1991-2#1)(1994-3#1)(2008-1#1)(2008-2#1)(2008-5#1)(2009-7#1)(2010-12#1)(2011-1#1)
processing have##3##2##(1991-2#1)(2006-6#1)(2008-2#1)
processing history##2##2##(2008-10#1)(2010-4#1)
processing in Prader-Willi syndrome##2##4##(2009-4#2)
processing in a##5##3##(1992-11#1)(1995-10#1)(2008-11#1)(2008-2#1)(2008-6#1)
processing in autism##2##3##(2008-1#1)(2009-4#1)
processing in healthy##2##3##(2008-11#1)(2012-2#1)
processing in schizophrenia##3##3##(2006-3#2)(2012-2#1)
processing in the brain##3##4##(2008-8#1)(2009-2#1)(2010-9#1)
processing in the human brain##2##5##(2008-11#2)
processing in the##19##3##(1990-12#1)(1992-9#1)(1993-5#1)(1993-6#1)(1996-12#1)(1997-4#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#1)
processing in these##3##3##(2007-8#1)(2008-2#1)(2011-1#1)
processing in vitro##2##3##(1993-12#2)
processing in vivo##2##3##(1990-11#1)(1993-12#1)
processing in##97##2##(1990-11#2)(1990-12#1)(1990-8#2)(1991-11#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-8#2)(1992-9#2)(1993-12#4)(1993-5#1)(1993-6#2)(1994-2#1)(1994-3#1)(1995-10#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-4#1)(2005-8#1)(2006-2#1)(2006-3#3)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#7)(2008-2#5)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-2#2)(2009-4#8)(2009-5#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#5)(2013-1#1)(2013-7#1)(2013-8#2)
processing industries##2##2##(2008-10#2)
processing inhibitor##2##2##(1990-10#1)(1993-8#1)
processing intermediates derived from##2##4##(1996-4#2)
processing intermediates##4##2##(1994-11#1)(1996-4#2)(1997-7#1)
processing into##2##2##(1995-12#1)(2008-10#1)
processing is discussed##2##3##(1997-4#1)(2008-10#1)
processing is used to##3##4##(2007-11#1)(2008-2#1)(2008-9#1)
processing is used##4##3##(2007-11#2)(2008-2#1)(2008-9#1)
processing is##28##2##(1991-8#1)(1992-11#1)(1994-2#1)(1995-12#1)(1996-5#1)(1997-1#1)(1997-4#2)(2006-8#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#7)(2008-4#1)(2008-9#2)(2009-4#1)(2010-7#1)
processing may be##3##3##(1991-7#1)(1993-6#1)(2009-10#1)
processing may##7##2##(1991-7#1)(1993-11#1)(1993-6#1)(1996-3#1)(2008-11#2)(2009-10#1)
processing mechanisms##3##2##(1996-5#1)(2009-12#1)(2009-3#1)
processing method based on##2##4##(2009-6#1)(2012-12#1)
processing method for##2##3##(2007-12#1)(2011-1#1)
processing method##8##2##(1994-12#1)(2004-9#1)(2007-12#1)(2008-3#1)(2009-6#1)(2011-1#1)(2012-12#1)(2012-3#1)
processing methods have##2##3##(2008-2#1)(2008-5#1)
processing methods##10##2##(1990-12#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2010-8#1)
processing mode##3##2##(1994-2#1)(2010-10#2)
processing model##4##2##(1997-8#1)(2007-12#1)(2008-3#1)(2011-1#1)
processing module##2##2##(2007-12#1)(2007-8#1)
processing modules##2##2##(2008-3#1)(2011-12#1)
processing occurs##2##2##(1991-9#1)(1997-8#1)
processing of APP##4##3##(1991-5#1)(1992-6#2)(1996-6#1)
processing of DNA damaged by##2##5##(1991-10#2)
processing of DNA##3##3##(1991-10#2)(1997-7#1)
processing of PKCs##2##3##(1995-5#2)
processing of a##8##3##(1992-12#1)(1992-8#1)(1993-12#1)(1994-11#1)(1995-11#1)(1995-2#1)(1996-5#1)(2008-2#1)
processing of amyloid precursor protein##2##5##(1995-6#1)(2012-3#1)
processing of amyloid##3##3##(1992-6#1)(1995-6#1)(2012-3#1)
processing of an##4##3##(2007-11#1)(2007-8#1)(2008-1#1)(2010-5#1)
processing of angry##2##3##(2008-11#2)
processing of beta APP##2##4##(1991-10#1)(1992-9#1)
processing of blood##2##3##(1990-12#1)(2008-2#1)
processing of both##3##3##(1990-8#1)(1997-5#1)(2008-2#1)
processing of data##2##3##(2008-10#1)(2008-3#1)
processing of emotional##3##3##(2008-1#1)(2008-11#1)(2008-4#1)
processing of faces##5##3##(1993-2#2)(2007-8#1)(2008-11#2)
processing of heavy##2##3##(1994-6#1)(2007-10#1)
processing of human##2##3##(1991-2#1)(1991-9#1)
processing of images##2##3##(2008-2#1)(2008-3#1)
processing of information##5##3##(1990-10#1)(1991-8#1)(1992-1#1)(1993-6#1)(1996-1#1)
processing of introns##2##3##(1993-11#1)(1997-5#1)
processing of irrelevant information##2##4##(1995-1#1)(2009-1#1)
processing of irrelevant stimuli##2##4##(1995-5#2)
processing of irrelevant##4##3##(1995-1#1)(1995-5#2)(2009-1#1)
processing of large##2##3##(1996-10#1)(2008-11#1)
processing of one of##2##4##(1994-9#1)(2008-5#1)
processing of one##3##3##(1994-9#1)(2008-5#1)(2010-7#1)
processing of primary##2##3##(1996-5#1)(2008-5#1)
processing of prorenin##2##3##(1991-9#2)
processing of samples##3##3##(1990-12#1)(2008-9#1)(2013-1#1)
processing of social##2##3##(2007-8#1)(2012-2#1)
processing of target##2##3##(2007-4#1)(2008-11#1)
processing of temporal##4##3##(1992-11#1)(2008-2#3)
processing of the Alzheimer##2##4##(1992-12#1)(1992-9#1)
processing of the amyloid##2##4##(1992-12#2)
processing of the data##2##4##(2008-10#1)(2008-3#1)
processing of the internal and##2##5##(2008-1#2)
processing of the precursor##4##4##(1990-9#1)(1991-7#1)(1992-12#1)(1997-1#1)
processing of the##57##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#3)(1990-9#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-12#6)(1992-9#1)(1993-8#1)(1994-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-8#1)(1997-1#3)(1997-2#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-12#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-10#1)(2011-1#1)(2011-3#1)(2013-8#1)
processing of these##3##3##(2008-2#1)(2008-7#1)(2013-8#1)
processing of this##3##3##(1991-10#1)(1992-10#1)(2009-12#1)
processing of wh-questions is##2##4##(2011-1#2)
processing of##328##2##(1990-10#2)(1990-11#2)(1990-12#7)(1990-2#1)(1990-5#5)(1990-6#1)(1990-8#8)(1990-9#2)(1991-1#2)(1991-10#4)(1991-2#3)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#6)(1992-1#1)(1992-10#2)(1992-11#6)(1992-12#8)(1992-2#2)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#1)(1993-5#2)(1993-6#4)(1993-8#1)(1994-11#4)(1994-12#1)(1994-2#2)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#2)(1995-5#5)(1995-6#3)(1995-8#3)(1996-1#4)(1996-10#1)(1996-11#2)(1996-3#1)(1996-5#4)(1996-6#4)(1996-7#1)(1996-8#2)(1997-1#3)(1997-2#1)(1997-3#2)(1997-5#2)(1997-7#2)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#9)(2007-3#1)(2007-4#2)(2007-8#4)(2007-9#3)(2008-1#6)(2008-10#11)(2008-11#14)(2008-12#1)(2008-2#16)(2008-3#11)(2008-4#7)(2008-5#3)(2008-6#4)(2008-7#7)(2008-8#1)(2008-9#5)(2009-1#2)(2009-10#3)(2009-12#1)(2009-2#2)(2009-4#5)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#5)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#3)
processing on the##4##3##(2004-9#1)(2007-12#1)(2012-12#1)(2013-8#1)
processing on##11##2##(1991-5#1)(1995-2#1)(2004-9#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
processing or##8##2##(1993-12#1)(1995-5#1)(1997-2#2)(2006-12#1)(2008-4#1)(2008-5#1)(2009-4#1)
processing over a##2##3##(2008-2#1)(2008-3#1)
processing parallelism##2##2##(2007-12#1)(2008-3#1)
processing parameters##4##2##(2008-5#4)
processing pathway##2##2##(1990-7#1)(1992-9#1)
processing pathways##2##2##(1992-12#1)(2008-4#1)
processing plant##4##2##(2006-8#1)(2007-8#1)(2010-9#1)(2012-2#1)
processing plants##3##2##(1997-6#1)(2007-5#1)(2010-9#1)
processing procedure##3##2##(2008-11#1)(2008-9#1)(2010-4#1)
processing procedures##2##2##(2008-11#1)(2009-4#1)
processing products##2##2##(1992-8#1)(2013-8#1)
processing proteinase##2##2##(1991-3#1)(1994-12#1)
processing rate##2##2##(2008-12#2)
processing region that##2##3##(1993-12#2)
processing regions##2##2##(1995-5#1)(2012-2#1)
processing regulation##2##2##(1992-6#1)(2012-2#1)
processing required##3##2##(2008-11#1)(2008-2#1)(2010-3#1)
processing research##2##2##(2008-11#1)(2009-4#1)
processing route##3##2##(2007-8#1)(2008-5#2)
processing scheme##6##2##(1995-12#1)(1996-12#1)(2008-2#3)(2008-3#1)
processing shows that##2##3##(2008-2#1)(2008-3#1)
processing signals##2##2##(1993-2#1)(1993-9#1)
processing site##7##2##(1990-2#1)(1991-10#2)(1994-11#2)(1995-6#1)(1996-10#1)
processing sites##3##2##(1990-12#1)(1992-12#1)(1997-4#1)
processing software##3##2##(2005-5#1)(2008-11#1)(2011-7#1)
processing speed and executive function##2##5##(2012-1#1)(2012-2#1)
processing speed of##3##3##(2007-12#1)(2008-3#1)(2012-2#1)
processing speed##21##2##(2007-12#1)(2007-7#1)(2007-9#1)(2008-2#6)(2008-3#2)(2010-2#4)(2011-1#1)(2012-1#2)(2012-12#1)(2012-2#2)
processing speeds##2##2##(1995-12#1)(2008-2#1)
processing step for##2##3##(2008-2#2)
processing step##4##2##(1993-3#1)(2008-10#1)(2008-2#2)
processing steps##7##2##(1990-11#1)(1994-11#1)(1995-8#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)
processing strategies in children##2##4##(2008-9#2)
processing strategies##7##2##(1992-2#1)(2008-12#1)(2008-9#4)(2009-4#1)
processing streams##2##2##(1997-8#1)(2012-2#1)
processing suggest##2##2##(1995-11#1)(2012-1#1)
processing system is##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
processing system that##4##3##(1994-12#1)(2008-3#1)(2013-1#2)
processing system##19##2##(1990-12#1)(1994-12#1)(1997-8#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-2#3)(2008-3#4)(2008-7#1)(2009-4#1)(2010-12#1)(2013-1#2)
processing systems##9##2##(1997-8#1)(2008-11#1)(2008-2#2)(2008-4#1)(2013-1#4)
processing tasks##3##2##(2009-1#1)(2010-12#1)(2013-8#1)
processing technique for##2##3##(1994-11#1)(2008-3#1)
processing technique##9##2##(1991-12#2)(1994-11#1)(1996-4#1)(2005-4#1)(2008-2#1)(2008-3#3)
processing techniques based on##4##4##(1990-9#1)(1991-12#1)(2008-2#1)(2008-3#1)
processing techniques can##2##3##(2008-2#1)(2008-7#1)
processing techniques to##2##3##(1997-8#1)(2010-8#1)
processing techniques##24##2##(1990-9#1)(1991-12#1)(1992-9#1)(1994-12#1)(1997-8#1)(2006-10#2)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#4)(2008-7#1)(2009-7#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#2)
processing technology##2##2##(2010-2#1)(2012-12#1)
processing temperature##2##2##(2004-9#2)
processing than##3##2##(1993-6#1)(1993-9#1)(2009-5#1)
processing that##8##2##(1991-9#1)(1994-3#1)(1995-2#1)(1995-8#1)(2007-12#1)(2009-7#1)(2010-12#1)(2011-12#1)
processing the##10##2##(1992-5#1)(1993-3#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-4#1)(2010-8#1)
processing time and##3##3##(2004-9#1)(2010-4#2)
processing time##13##2##(1990-12#1)(1997-3#1)(2004-12#1)(2004-9#1)(2008-10#1)(2008-2#4)(2008-3#1)(2010-2#1)(2010-4#2)
processing times and temperatures result in##2##6##(2004-9#2)
processing times and temperatures##4##4##(2004-9#3)(2008-5#1)
processing times##6##2##(2004-9#4)(2008-5#1)(2008-9#1)
processing to generate##2##3##(2007-8#1)(2008-3#1)
processing to##18##2##(1992-11#1)(1995-11#1)(1995-2#1)(1996-7#1)(2005-11#1)(2006-2#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-8#1)(2012-12#1)(2013-1#2)(2013-7#1)
processing tomato production##2##3##(2008-10#2)
processing tomato##5##2##(2008-10#5)
processing unit##6##2##(1995-6#1)(2008-3#1)(2009-6#1)(2011-1#2)(2012-2#1)
processing units##4##2##(1995-12#1)(2008-11#1)(2010-2#1)(2011-2#1)
processing using##4##2##(1991-10#1)(2008-2#2)(2008-4#1)
processing was##9##2##(1991-10#1)(1993-12#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2009-11#1)
processing were##6##2##(1990-8#1)(2006-6#1)(2009-6#1)(2010-10#1)(2011-2#1)(2013-7#1)
processing with a##4##3##(2007-12#2)(2008-3#2)
processing with##10##2##(1991-6#1)(2006-4#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#2)
processing##1778##1##(1990-10#4)(1990-11#5)(1990-12#13)(1990-2#2)(1990-3#1)(1990-5#5)(1990-6#1)(1990-7#3)(1990-8#14)(1990-9#4)(1991-1#6)(1991-10#8)(1991-11#3)(1991-12#5)(1991-2#8)(1991-3#3)(1991-4#1)(1991-5#4)(1991-6#5)(1991-7#3)(1991-8#4)(1991-9#11)(1992-1#2)(1992-10#3)(1992-11#10)(1992-12#16)(1992-2#7)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#9)(1992-7#2)(1992-8#8)(1992-9#10)(1993-1#1)(1993-11#9)(1993-12#20)(1993-2#6)(1993-3#6)(1993-4#1)(1993-5#10)(1993-6#10)(1993-7#1)(1993-8#6)(1993-9#4)(1994-11#20)(1994-12#5)(1994-2#9)(1994-3#8)(1994-5#2)(1994-6#7)(1994-8#6)(1994-9#2)(1995-1#1)(1995-10#2)(1995-11#6)(1995-12#17)(1995-2#12)(1995-3#4)(1995-5#12)(1995-6#15)(1995-7#2)(1995-8#10)(1996-1#8)(1996-10#3)(1996-11#4)(1996-12#6)(1996-2#8)(1996-3#5)(1996-4#3)(1996-5#11)(1996-6#4)(1996-7#3)(1996-8#3)(1997-1#9)(1997-2#4)(1997-3#7)(1997-4#8)(1997-5#2)(1997-6#3)(1997-7#9)(1997-8#18)(2004-11#1)(2004-12#1)(2004-4#1)(2004-9#12)(2005-10#1)(2005-11#5)(2005-4#1)(2005-5#3)(2005-7#2)(2005-8#6)(2006-10#9)(2006-11#2)(2006-12#7)(2006-2#3)(2006-3#7)(2006-4#2)(2006-5#1)(2006-6#4)(2006-7#2)(2006-8#4)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#22)(2007-12#63)(2007-3#7)(2007-4#4)(2007-5#6)(2007-6#2)(2007-7#6)(2007-8#17)(2007-9#7)(2008-1#32)(2008-10#75)(2008-11#92)(2008-12#14)(2008-2#124)(2008-3#138)(2008-4#37)(2008-5#34)(2008-6#16)(2008-7#31)(2008-8#13)(2008-9#36)(2009-1#8)(2009-10#10)(2009-11#2)(2009-12#6)(2009-2#11)(2009-3#6)(2009-4#33)(2009-5#3)(2009-6#7)(2009-7#10)(2009-8#4)(2009-9#5)(2010-10#6)(2010-11#3)(2010-12#11)(2010-2#19)(2010-3#1)(2010-4#15)(2010-5#5)(2010-6#1)(2010-7#5)(2010-8#8)(2010-9#7)(2011-1#19)(2011-12#5)(2011-2#21)(2011-3#1)(2011-7#1)(2012-1#19)(2012-11#4)(2012-12#16)(2012-2#36)(2012-3#10)(2013-1#60)(2013-7#10)(2013-8#18)
processing-independent analysis##2##2##(1995-6#2)
processing-independent##3##1##(1995-6#3)
processing?##2##1##(2009-5#1)(2012-3#1)
processive and##2##2##(1990-12#1)(1995-2#1)
processive##11##1##(1990-12#1)(1990-7#1)(1994-12#3)(1994-2#1)(1994-8#1)(1994-9#1)(1995-2#1)(1997-2#1)(2007-10#1)
processively##5##1##(1992-11#1)(1994-9#2)(2008-7#1)(2010-12#1)
processivity and##3##2##(1995-2#1)(2008-1#1)(2009-2#1)
processivity factor##5##2##(1994-12#2)(1994-8#1)(1995-2#1)(1995-6#1)
processivity of##2##2##(1994-8#1)(1997-5#1)
processivity on##2##2##(1997-5#2)
processivity##18##1##(1992-11#1)(1994-12#2)(1994-8#2)(1995-2#3)(1995-6#1)(1997-2#1)(1997-5#3)(2007-10#1)(2008-1#1)(2008-4#1)(2009-2#1)(2010-12#1)
processor and the##3##3##(2008-2#1)(2008-5#1)(2009-5#1)
processor and##8##2##(1991-5#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-9#1)(2009-5#1)
processor chip##2##2##(2008-2#2)
processor for##7##2##(2007-12#3)(2008-3#3)(2008-9#1)
processor has##2##2##(2008-3#1)(2008-9#1)
processor in##2##2##(2007-4#1)(2008-2#1)
processor is proposed##2##3##(2007-12#1)(2008-3#1)
processor is##12##2##(2007-12#1)(2008-2#4)(2008-3#7)
processor that is##2##3##(2007-12#2)
processor that##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
processor to##2##2##(2008-10#1)(2008-3#1)
processor with##7##2##(2007-12#1)(2008-2#3)(2008-3#2)(2008-9#1)
processor##112##1##(1991-5#1)(1993-5#1)(1995-6#1)(1996-8#1)(2006-3#1)(2006-6#1)(2007-11#3)(2007-12#11)(2007-3#3)(2007-4#1)(2007-9#1)(2008-10#1)(2008-2#31)(2008-3#31)(2008-5#1)(2008-6#2)(2008-9#19)(2009-5#1)(2010-8#1)
processors and##3##2##(2008-2#1)(2010-2#1)(2012-12#1)
processors are interconnected with##2##4##(2008-3#1)(2010-8#1)
processors are##4##2##(2007-9#1)(2008-2#1)(2008-3#1)(2010-8#1)
processors in##3##2##(2008-2#1)(2008-3#2)
processors is##2##2##(2008-2#1)(2008-3#1)
processors to##2##2##(2008-3#2)
processors##51##1##(2007-12#3)(2007-9#2)(2008-1#1)(2008-10#1)(2008-2#20)(2008-3#11)(2008-9#5)(2010-12#1)(2010-2#2)(2010-8#4)(2012-12#1)
processus##2##1##(2007-11#1)(2007-2#1)
prochiral ketones##3##2##(2007-11#1)(2010-2#2)
prochlorperazine##6##1##(1995-1#4)(2008-10#1)(2010-2#1)
procholecystokinin##4##1##(1991-8#1)(1992-8#1)(1995-6#2)
procidentia in##2##2##(2008-10#2)
procidentia##3##1##(2004-10#1)(2008-10#2)
proclaimed that##2##2##(1995-3#1)(2007-11#1)
proclaimed##4##1##(1991-3#1)(1995-3#1)(2007-11#1)(2011-2#1)
proclavaminate##3##1##(1991-2#3)
proclivity##2##1##(1992-4#1)(1994-4#1)
procoagulant activity##9##2##(1990-11#1)(1990-12#1)(1991-7#3)(1994-11#1)(2006-10#1)(2008-9#1)(2013-7#1)
procoagulant and##2##2##(1990-11#1)(1992-4#1)
procoagulant state##3##2##(2005-11#1)(2007-9#1)(2008-7#1)
procoagulant##25##1##(1990-11#2)(1990-12#1)(1991-7#6)(1992-4#5)(1994-11#1)(2005-11#2)(2006-10#2)(2007-9#1)(2008-7#2)(2008-9#1)(2009-3#1)(2013-7#1)
procolipase activation##3##2##(1991-8#3)
procolipase##15##1##(1991-8#5)(1995-5#10)
procollagen C-proteinase enhancer##2##3##(1990-11#2)
procollagen production##3##2##(1991-1#2)(1992-9#1)
procollagen synthesis##3##2##(1991-1#2)(2008-9#1)
procollagen type##2##2##(1996-8#1)(1996-9#1)
procollagen##42##1##(1990-11#4)(1991-1#11)(1991-2#3)(1992-5#2)(1992-9#1)(1993-6#1)(1994-3#1)(1994-8#5)(1994-9#3)(1996-8#2)(1996-9#1)(1997-2#2)(2006-2#1)(2008-7#1)(2008-9#3)(2011-12#1)
procollagen-I##5##1##(2008-5#5)
procollagens##2##1##(1991-1#2)
proconvulsant##2##1##(1997-5#1)(2008-11#1)
procreate##4##1##(1996-11#1)(2006-3#1)(2008-1#1)(2012-3#1)
procreation##3##1##(2006-11#1)(2011-2#1)(2012-2#1)
procrustes discriminant analysis##2##3##(2008-10#2)
proctectomy##3##1##(2007-8#2)(2011-2#1)
proctocolectomy##7##1##(1990-6#1)(1991-6#2)(1991-9#1)(2006-10#1)(2009-12#1)(2011-12#1)
proctolin##5##1##(1991-2#1)(2008-6#4)
procured##9##1##(2006-10#1)(2007-7#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#3)
procurement and the##2##3##(1997-6#1)(2007-12#1)
procurement and##3##2##(1997-6#1)(2007-12#1)(2012-12#1)
procurement of organs##2##3##(2006-10#2)
procurement of##7##2##(2005-8#1)(2006-10#2)(2009-7#1)(2012-2#3)
procurement##29##1##(1990-12#1)(1991-11#1)(1992-3#1)(1995-2#2)(1997-6#1)(2005-8#1)(2006-10#2)(2007-12#2)(2007-8#2)(2008-1#1)(2008-7#1)(2009-7#1)(2010-9#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-7#1)
procuring##3##1##(1992-12#2)(1996-2#1)
procyanidin##3##1##(1993-8#1)(2008-10#1)(2009-3#1)
procyanidins##9##1##(2008-10#4)(2008-5#5)
procymidone and##2##2##(2008-10#2)
procymidone##3##1##(2008-10#3)
procyonoides)##2##1##(2007-2#1)(2008-12#1)
prodigal son##2##2##(2008-12#2)
prodigious##2##1##(2008-10#1)(2008-11#1)
prodomain##8##1##(1995-11#8)
prodromal phase of##2##3##(1992-12#1)(2011-2#1)
prodromal phase##4##2##(1992-12#1)(2007-6#2)(2011-2#1)
prodromal##14##1##(1991-6#1)(1992-12#1)(1994-2#1)(1994-4#1)(2007-6#2)(2008-1#1)(2011-2#1)(2011-8#2)(2012-1#2)(2012-12#1)(2013-8#1)
prodromal&quot##3##1##(2006-9#2)(2008-1#1)
prodrome of##2##2##(2010-5#1)(2011-1#1)
prodrome##8##1##(2006-9#2)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-1#2)
prodrug 2##2##2##(2009-3#2)
prodrug form of##2##3##(1996-11#1)(2005-11#1)
prodrug of mycophenolic acid##2##4##(2007-11#2)
prodrug of##12##2##(1994-3#1)(1995-6#2)(1996-6#2)(2005-8#1)(2005-9#1)(2007-11#2)(2008-5#1)(2008-8#1)(2012-12#1)
prodrug was##3##2##(1994-11#3)
prodrug##46##1##(1991-8#1)(1992-5#1)(1994-11#4)(1994-3#1)(1994-5#1)(1995-3#2)(1995-6#2)(1996-11#1)(1996-4#1)(1996-6#2)(1996-8#1)(1997-6#1)(2005-11#1)(2005-7#7)(2005-8#2)(2005-9#1)(2006-10#1)(2007-11#2)(2008-1#1)(2008-4#1)(2008-5#3)(2008-8#1)(2009-3#4)(2009-4#1)(2010-9#1)(2011-3#1)(2012-12#1)
prodrugs for the##2##3##(1995-3#1)(2008-5#1)
prodrugs for##4##2##(1995-3#3)(2008-5#1)
prodrugs of##2##2##(1995-3#2)
prodrugs were##2##2##(1997-6#1)(2009-4#1)
prodrugs##28##1##(1991-6#1)(1991-9#1)(1992-3#1)(1994-11#5)(1995-3#7)(1997-6#2)(2006-12#1)(2008-4#4)(2008-5#3)(2009-4#3)
produce 2##4##2##(1993-6#1)(2008-10#3)
produce EndoA##3##2##(1993-3#3)
produce IAA##3##2##(2008-10#3)
produce IL-12##2##2##(1996-10#2)
produce NO##5##2##(1993-6#1)(2005-1#1)(2006-8#3)
produce PGE2##2##2##(1993-4#1)(1996-8#1)
produce TNF##2##2##(1995-9#2)
produce a better##3##3##(1992-9#1)(2008-3#1)(2011-1#1)
produce a functional##3##3##(2008-4#1)(2008-8#1)(2009-6#1)
produce a greater##2##3##(2008-12#1)(2008-3#1)
produce a higher level of##2##5##(1991-2#1)(2009-9#1)
produce a more##4##3##(2008-10#1)(2008-11#1)(2010-4#1)(2013-1#1)
produce a new##2##3##(1994-1#1)(2010-12#1)
produce a pulsed##2##3##(2006-5#1)(2008-10#1)
produce a range of##3##4##(2009-12#1)(2012-12#1)(2013-1#1)
produce a realistic##2##3##(2005-12#1)(2008-3#1)
produce a rich##2##3##(2008-10#1)(2008-4#1)
produce a severe##2##3##(2007-11#1)(2008-2#1)
produce a significant##3##3##(1997-5#1)(2006-8#1)(2007-11#1)
produce a variety of##5##4##(2007-10#1)(2007-9#1)(2008-9#1)(2009-5#1)(2013-7#1)
produce a##238##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#3)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#2)(1992-9#4)(1993-11#1)(1993-12#2)(1993-3#1)(1993-4#2)(1993-6#1)(1993-9#2)(1994-1#1)(1994-11#2)(1994-2#1)(1994-6#3)(1994-8#1)(1994-9#3)(1995-10#1)(1995-12#1)(1995-5#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-7#2)(1997-1#2)(1997-5#2)(1997-6#1)(1997-7#1)(2004-3#1)(2004-9#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-1#2)(2006-10#2)(2006-11#1)(2006-12#2)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#10)(2007-12#9)(2007-2#1)(2007-9#2)(2008-1#1)(2008-10#28)(2008-11#6)(2008-12#1)(2008-2#18)(2008-3#13)(2008-4#7)(2008-5#7)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-9#2)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#3)(2013-7#3)
produce about##2##2##(1990-2#1)(2008-7#1)
produce accurate##4##2##(1996-6#1)(2008-3#2)(2013-1#1)
produce adverse effects##2##3##(2007-7#1)(2008-10#1)
produce adverse##3##2##(1996-7#1)(2007-7#1)(2008-10#1)
produce aflatoxin##2##2##(2008-10#2)
produce an array of##2##4##(2007-12#1)(2012-1#1)
produce an aspheric##2##3##(2005-11#1)(2008-3#1)
produce an image##2##3##(2008-2#1)(2008-3#1)
produce an increase in##3##4##(1992-9#1)(1993-11#1)(2008-10#1)
produce an##58##2##(1990-12#2)(1990-7#1)(1990-8#1)(1991-7#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-9#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-5#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#1)(2007-11#2)(2007-12#3)(2008-10#5)(2008-11#1)(2008-2#5)(2008-3#3)(2008-4#3)(2008-5#4)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
produce analgesia by##2##3##(1990-4#1)(2007-11#1)
produce analgesia##7##2##(1990-4#1)(2006-10#2)(2007-11#1)(2009-12#1)(2009-3#1)(2011-2#1)
produce and release##3##3##(1991-10#1)(1996-8#1)(2006-2#1)
produce and secrete##4##3##(1995-2#1)(2008-10#1)(2013-1#2)
produce and##18##2##(1991-1#1)(1991-10#1)(1993-2#1)(1993-7#1)(1995-2#2)(1996-8#1)(1997-4#1)(2005-7#1)(2006-2#1)(2007-11#2)(2008-1#2)(2008-10#1)(2012-2#1)(2013-1#2)
produce antibodies against##2##3##(1992-4#1)(1995-5#1)
produce antibodies##3##2##(1992-4#1)(1993-9#1)(1995-5#1)
produce any significant##2##3##(1993-2#1)(1995-12#1)
produce any##14##2##(1992-9#1)(1993-2#1)(1994-3#1)(1995-12#2)(1995-2#1)(1996-2#1)(1997-1#1)(2005-9#1)(2006-8#1)(2008-10#1)(2008-5#2)(2013-1#1)
produce apo##2##2##(1996-10#2)
produce apoptosis##2##2##(1996-12#1)(1997-6#1)
produce beta##2##2##(1990-12#1)(1991-3#1)
produce beta-lactamase##2##2##(1997-3#1)(2006-5#1)
produce better results##2##3##(2007-11#1)(2009-4#1)
produce better##5##2##(2007-11#1)(2008-5#1)(2009-4#1)(2011-2#1)(2012-12#1)
produce both##11##2##(1991-1#1)(1991-5#1)(1994-11#1)(1996-9#1)(2005-7#1)(2007-12#1)(2008-10#1)(2008-4#1)(2010-6#1)(2011-2#1)(2013-1#1)
produce by##3##2##(1992-5#1)(2011-1#1)(2012-1#1)
produce carbon##2##2##(1996-3#1)(2008-8#1)
produce cell cycle##2##3##(2005-8#1)(2008-11#1)
produce changes in##2##3##(2010-4#2)
produce clinical##2##2##(1990-12#1)(1996-6#1)
produce competent##2##2##(1995-2#1)(2008-11#1)
produce complex##3##2##(1996-1#1)(2008-9#1)(2012-3#1)
produce compounds that##2##3##(2008-10#2)
produce compounds##4##2##(2005-8#1)(2008-10#2)(2010-12#1)
produce considerable amounts of##2##4##(1994-12#1)(2011-2#1)
produce considerable##3##2##(1994-12#1)(2008-6#1)(2011-2#1)
produce constant##2##2##(1990-11#1)(2008-3#1)
produce damage##2##2##(2006-8#1)(2008-10#1)
produce desirable##2##2##(1993-3#1)(2010-2#1)
produce detectable##4##2##(1990-4#1)(1992-7#1)(1996-1#1)(1997-7#1)
produce different##11##2##(1991-10#1)(1992-10#1)(1992-12#1)(1994-8#1)(2008-10#2)(2008-2#2)(2008-5#1)(2013-7#1)(2013-8#1)
produce distinct##3##2##(2008-2#1)(2008-4#1)(2009-1#1)
produce donor##2##2##(2007-12#1)(2007-2#1)
produce dramatic##2##2##(1993-9#1)(2007-12#1)
produce effects##2##2##(1993-3#1)(1996-12#1)
produce either##2##2##(1993-9#1)(2008-8#1)
produce enough##3##2##(1995-5#1)(2008-10#1)(2012-1#1)
produce ethanol##2##2##(2008-6#1)(2012-3#1)
produce exposure##2##2##(1994-6#1)(2012-12#1)
produce extended spectrum beta-lactamases##3##4##(2006-10#1)(2008-11#2)
produce few##2##2##(2007-12#1)(2008-8#1)
produce fewer##2##2##(2007-7#1)(2008-8#1)
produce four##2##2##(1993-8#1)(1995-5#1)
produce free radicals##3##3##(1993-11#1)(1995-3#1)(2007-11#1)
produce fumonisin##2##2##(2008-10#1)(2013-1#1)
produce functional##3##2##(1990-10#1)(2007-11#1)(2008-7#1)
produce germ tubes##2##3##(1990-3#1)(2008-10#1)
produce good##6##2##(1996-3#1)(2007-12#1)(2008-3#1)(2008-4#1)(2009-3#1)(2011-1#1)
produce greater quantities of aflatoxins than##2##6##(2008-10#2)
produce greater##7##2##(1991-7#1)(1996-11#1)(2008-10#2)(2009-8#1)(2010-5#1)(2012-3#1)
produce high levels of##6##4##(1994-11#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-5#1)(2012-3#1)
produce high##12##2##(1992-1#1)(1994-11#1)(1996-10#1)(1997-4#1)(2005-11#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-5#1)(2011-1#1)(2012-3#1)
produce high-quality##2##2##(2007-12#1)(2008-6#1)
produce high-resolution##3##2##(2006-6#1)(2008-2#1)(2008-7#1)
produce higher##5##2##(1992-12#1)(1993-2#1)(2007-11#1)(2008-10#1)(2008-5#1)
produce holes##2##2##(2008-10#1)(2008-3#1)
produce human##2##2##(1994-6#1)(2008-11#1)
produce hydrogen peroxide##2##3##(2005-7#1)(2008-5#1)
produce identical##3##2##(1991-6#1)(1997-9#1)(2008-7#1)
produce images##3##2##(2008-2#2)(2008-3#1)
produce immediate##2##2##(2007-11#1)(2010-4#1)
produce information##2##2##(1995-12#1)(2012-12#1)
produce interferon-gamma##3##2##(1996-10#1)(2007-11#1)(2008-11#1)
produce interleukin-12##2##2##(1996-10#1)(2006-7#1)
produce interpretable##2##2##(2009-8#1)(2013-1#1)
produce large amounts of##5##4##(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)
produce large offspring##2##3##(2008-8#2)
produce large quantities of##4##4##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
produce large##15##2##(1995-2#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)
produce larger##3##2##(1991-7#1)(2008-8#1)(2012-3#1)
produce less##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
produce local##3##2##(2008-2#3)
produce long-lasting##2##2##(2005-8#1)(2011-12#1)
produce long-term##2##2##(1994-8#1)(1995-9#1)
produce major##2##2##(1996-11#1)(2006-2#1)
produce many##3##2##(1993-1#1)(2006-10#1)(2008-8#1)
produce marked##2##2##(1994-3#1)(2004-12#1)
produce material for##2##3##(2008-11#2)
produce material##3##2##(2008-11#2)(2008-5#1)
produce meaningful##3##2##(2007-9#1)(2008-2#1)(2009-8#1)
produce minimal##2##2##(1994-3#1)(2008-3#1)
produce models##2##2##(2008-11#2)
produce modest##2##2##(1996-5#1)(2008-6#1)
produce morbidity##2##2##(2008-5#1)(2008-7#1)
produce more than##2##3##(1991-1#1)(2007-12#1)
produce more##13##2##(1991-1#1)(1993-11#1)(1994-2#1)(1996-3#1)(2004-2#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-8#2)(2008-9#1)(2009-8#1)
produce movement##2##2##(1995-5#1)(1995-8#1)
produce multiple##4##2##(1991-7#1)(1995-12#1)(2010-10#1)(2010-5#1)
produce mycotoxins##2##2##(2008-10#1)(2010-3#1)
produce nanoparticles with##2##3##(2008-7#1)(2010-12#1)
produce neurological deficits##2##3##(2007-11#2)
produce new##6##2##(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2012-2#1)
produce nitric oxide (NO)##2##4##(1992-7#1)(2006-8#1)
produce nitric oxide##8##3##(1992-7#1)(1993-4#4)(1994-6#2)(2006-8#1)
produce novel##4##2##(1992-2#1)(2008-7#1)(2009-11#1)(2013-8#1)
produce only a##2##3##(1995-1#1)(2006-10#1)
produce only##10##2##(1990-11#1)(1990-7#1)(1991-4#1)(1993-8#1)(1995-1#1)(1997-5#1)(2005-7#1)(2006-10#1)(2008-6#1)(2013-1#1)
produce oospores in##4##3##(2008-10#4)
produce oospores##8##2##(2008-10#8)
produce optically##3##2##(1990-4#2)(2008-1#1)
produce or##3##2##(2008-10#1)(2008-2#1)(2009-5#1)
produce oxygen##2##2##(1996-8#1)(2008-5#1)
produce pain##2##2##(2006-8#1)(2007-1#1)
produce peptides##2##2##(1994-2#1)(2008-9#1)
produce positive##4##2##(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)
produce rapid##2##2##(1990-7#1)(1991-3#1)
produce reactive oxygen species##2##4##(2005-7#1)(2009-6#1)
produce reasonable##2##2##(2008-10#1)(2011-1#1)
produce recombinant##8##2##(1994-2#1)(1995-5#1)(1996-5#1)(1997-7#1)(2006-12#1)(2007-6#1)(2008-11#1)(2008-2#1)
produce reliable##3##2##(1991-5#1)(2008-10#1)(2008-7#1)
produce results in##2##3##(2008-3#1)(2010-8#1)
produce results##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#1)
produce secondary##5##2##(2007-12#1)(2008-10#3)(2010-4#1)
produce severe##2##2##(1990-9#1)(1994-3#1)
produce side effects##2##3##(1993-11#1)(2008-7#1)
produce significant##21##2##(1991-6#1)(1993-11#1)(1994-11#1)(1996-10#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-5#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
produce significantly##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
produce similar##9##2##(1991-12#1)(1992-10#1)(1992-9#1)(1994-12#1)(2005-7#1)(2008-12#2)(2010-2#1)(2013-1#1)
produce sound##3##2##(2007-12#1)(2008-10#1)(2008-8#1)
produce specific##7##2##(1994-3#1)(2005-6#1)(2007-4#1)(2008-10#2)(2008-11#1)(2011-1#1)
produce strong##2##2##(2008-10#1)(2008-3#1)
produce substances##2##2##(2007-11#1)(2007-12#1)
produce substantial##3##2##(1990-4#1)(2005-8#1)(2008-6#1)
produce such##6##2##(2007-9#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-7#1)
produce sufficient amounts of##2##4##(2008-11#1)(2011-2#1)
produce sufficient##3##2##(1997-7#1)(2008-11#1)(2011-2#1)
produce sustainable##2##2##(1995-1#1)(2008-12#1)
produce sustained##2##2##(1992-6#1)(1994-2#1)
produce symptoms of##2##3##(2007-11#1)(2013-7#1)
produce the active##3##3##(2009-2#1)(2012-2#2)
produce the most##2##3##(2008-12#1)(2010-4#1)
produce the same##3##3##(1990-12#1)(2006-12#1)(2012-12#1)
produce the##96##2##(1990-12#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-5#1)(1995-7#1)(1996-11#2)(1996-12#1)(1996-5#1)(1996-8#1)(1997-2#1)(2005-10#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-12#3)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#4)(2007-8#2)(2007-9#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-4#3)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
produce their effects by##2##4##(1994-4#1)(2008-4#1)
produce their effects##3##3##(1994-10#1)(1994-4#1)(2008-4#1)
produce their##6##2##(1991-11#1)(1994-10#1)(1994-4#1)(2008-4#1)(2008-5#1)(2010-5#1)
produce them##2##2##(2008-5#2)
produce these##9##2##(1990-12#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-2#1)(2005-12#1)(2006-1#1)(2011-1#2)
produce this##6##2##(1991-1#1)(1992-2#1)(1996-2#1)(2008-10#1)(2008-8#1)(2012-3#1)
produce two##6##2##(1997-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)
produce up to##2##3##(1996-12#1)(2008-2#1)
produce useful##2##2##(2008-8#1)(2013-1#1)
produce valid##3##2##(1991-12#1)(2008-12#1)(2008-7#1)
produce various##5##2##(1992-7#1)(2008-10#2)(2008-5#1)(2008-7#1)
produce very low##2##3##(2008-2#1)(2012-2#1)
produce very##3##2##(2008-2#1)(2008-5#1)(2012-2#1)
produce##1711##1##(1990-10#4)(1990-11#5)(1990-12#12)(1990-2#7)(1990-3#6)(1990-4#7)(1990-5#5)(1990-6#2)(1990-7#4)(1990-8#4)(1990-9#3)(1991-1#12)(1991-10#4)(1991-11#1)(1991-12#8)(1991-2#4)(1991-3#10)(1991-4#3)(1991-5#4)(1991-6#5)(1991-7#5)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#4)(1992-11#6)(1992-12#5)(1992-2#5)(1992-3#4)(1992-4#2)(1992-5#2)(1992-6#5)(1992-7#4)(1992-8#3)(1992-9#14)(1993-1#1)(1993-11#10)(1993-12#10)(1993-2#5)(1993-3#9)(1993-4#11)(1993-5#6)(1993-6#7)(1993-7#2)(1993-8#4)(1993-9#9)(1994-1#1)(1994-10#1)(1994-11#9)(1994-12#6)(1994-2#11)(1994-3#8)(1994-4#1)(1994-5#4)(1994-6#11)(1994-8#7)(1994-9#5)(1995-1#5)(1995-10#2)(1995-11#1)(1995-12#7)(1995-2#11)(1995-3#5)(1995-5#10)(1995-6#3)(1995-7#1)(1995-8#4)(1995-9#4)(1996-1#3)(1996-10#11)(1996-11#6)(1996-12#12)(1996-2#7)(1996-3#4)(1996-4#5)(1996-5#9)(1996-6#5)(1996-7#4)(1996-8#7)(1996-9#6)(1997-1#6)(1997-2#2)(1997-3#1)(1997-4#4)(1997-5#10)(1997-6#6)(1997-7#7)(1997-8#4)(1997-9#1)(2004-12#3)(2004-2#1)(2004-3#1)(2004-9#4)(2005-1#1)(2005-10#2)(2005-11#11)(2005-12#3)(2005-4#1)(2005-6#1)(2005-7#10)(2005-8#10)(2005-9#1)(2006-1#4)(2006-10#18)(2006-11#7)(2006-12#14)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#7)(2006-6#4)(2006-7#3)(2006-8#14)(2006-9#3)(2007-1#7)(2007-10#3)(2007-11#50)(2007-12#63)(2007-2#4)(2007-4#6)(2007-5#1)(2007-6#4)(2007-7#2)(2007-8#7)(2007-9#8)(2008-1#19)(2008-10#183)(2008-11#51)(2008-12#15)(2008-2#84)(2008-3#54)(2008-4#41)(2008-5#56)(2008-6#26)(2008-7#37)(2008-8#38)(2008-9#24)(2009-1#1)(2009-10#2)(2009-11#6)(2009-12#5)(2009-2#9)(2009-3#6)(2009-4#7)(2009-5#8)(2009-6#4)(2009-7#1)(2009-8#8)(2009-9#8)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#11)(2010-2#13)(2010-3#7)(2010-4#14)(2010-5#3)(2010-6#3)(2010-7#4)(2010-8#8)(2010-9#5)(2011-1#22)(2011-12#4)(2011-2#18)(2011-3#1)(2012-1#15)(2012-11#6)(2012-12#19)(2012-2#22)(2012-3#20)(2013-1#33)(2013-7#9)(2013-8#8)
produce)##3##1##(2008-9#2)(2011-12#1)
produced 12##2##2##(2008-10#1)(2008-5#1)
produced 2##2##2##(2008-1#1)(2008-10#1)
produced BHV-1##2##2##(2008-11#2)
produced DNA products##2##3##(2008-10#2)
produced DNA##3##2##(2008-10#3)
produced IgG##3##2##(1990-12#1)(2008-11#2)
produced NO##2##2##(1993-4#1)(2005-1#1)
produced a 100% increase in##2##5##(1993-9#1)(1995-6#1)
produced a 25%##2##3##(2008-11#1)(2010-12#1)
produced a 50%##2##3##(2007-12#1)(2008-5#1)
produced a bilateral##2##3##(1990-9#1)(1994-5#1)
produced a biphasic##3##3##(1992-3#1)(1996-9#1)(1997-5#1)
produced a concentration-dependent reduction in##2##5##(1992-1#1)(1996-6#1)
produced a concentration-dependent##10##3##(1992-1#1)(1993-11#1)(1995-11#1)(1995-12#1)(1996-12#2)(1996-6#1)(1997-4#2)(2006-2#1)
produced a consistent##2##3##(2007-7#1)(2008-10#1)
produced a data set in which##2##6##(2006-8#2)
produced a decrease in motor activity and an##2##8##(1991-2#2)
produced a decrease in##4##4##(1990-7#1)(1991-2#2)(2008-10#1)
produced a dose-dependent decrease in##2##5##(1992-9#1)(1995-3#1)
produced a dose-dependent increase in the##3##6##(1993-12#1)(1995-12#1)(1997-8#1)
produced a dose-dependent increase in##5##5##(1993-12#1)(1995-12#2)(1997-8#1)(2005-7#1)
produced a dose-dependent increase##6##4##(1993-12#1)(1995-12#2)(1997-8#1)(2005-7#1)(2009-12#1)
produced a dose-dependent reduction in##3##5##(1991-12#1)(1993-11#1)(1997-2#1)
produced a dose-dependent##19##3##(1990-11#1)(1990-7#1)(1991-12#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1995-12#3)(1995-3#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-8#1)(2005-7#1)(2009-12#1)
produced a final##2##3##(2008-6#1)(2012-3#1)
produced a good##2##3##(2007-11#1)(2010-4#1)
produced a gradual##3##3##(1993-6#1)(1994-11#1)(1995-12#1)
produced a greater##3##3##(1990-2#1)(1997-8#1)(2008-10#1)
produced a high##3##3##(1995-1#1)(1997-1#1)(1997-4#1)
produced a higher##4##3##(1992-12#1)(1997-7#1)(2007-1#1)(2007-11#1)
produced a large##3##3##(1993-12#1)(2007-12#1)(2008-5#1)
produced a marked##8##3##(1992-11#1)(1992-8#1)(1993-3#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-8#1)(2009-6#1)
produced a more##3##3##(1990-11#1)(1994-6#1)(2008-4#1)
produced a new##3##3##(1990-6#1)(1994-3#1)(2010-12#1)
produced a number of##3##4##(1991-2#1)(1992-11#1)(2008-2#1)
produced a partial recovery##2##4##(1991-5#1)(1994-3#1)
produced a partial##4##3##(1990-2#1)(1991-5#2)(1994-3#1)
produced a positive##2##3##(2008-12#1)(2013-8#1)
produced a progressive increase in##2##5##(1994-2#1)(2009-10#1)
produced a progressive##3##3##(1994-2#2)(2009-10#1)
produced a protein##3##3##(1990-9#1)(1993-8#1)(2008-9#1)
produced a range of##2##4##(1990-10#1)(1995-6#1)
produced a rapid and##3##4##(1990-10#1)(1991-8#1)(1994-10#1)
produced a rapid##6##3##(1990-10#1)(1991-5#1)(1991-8#1)(1994-10#1)(1995-6#1)(2008-4#1)
produced a reduction in##2##4##(1994-6#1)(1996-5#1)
produced a response##3##3##(1991-5#1)(1991-7#1)(2006-10#1)
produced a significant decrease in both##2##6##(1994-5#1)(1995-7#1)
produced a significant decrease in##5##5##(1990-2#1)(1994-5#1)(1995-7#1)(1997-8#1)(2008-12#1)
produced a significant decrease of the##2##6##(1994-12#1)(1996-2#1)
produced a significant decrease##8##4##(1990-2#1)(1994-12#1)(1994-5#1)(1995-7#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-12#1)
produced a significant depletion of##2##5##(1996-10#2)
produced a significant enhancement##2##4##(2008-10#1)(2008-12#1)
produced a significant increase in##6##5##(1992-8#1)(1994-9#1)(1997-1#1)(2008-10#1)(2010-2#1)(2013-1#1)
produced a significant increase of##2##5##(1992-8#1)(2010-7#1)
produced a significant increase##8##4##(1992-8#2)(1994-9#1)(1997-1#1)(2008-10#1)(2010-2#1)(2010-7#1)(2013-1#1)
produced a significant inhibition of##2##5##(1997-5#1)(1997-7#1)
produced a significant reduction in##3##5##(1992-10#1)(1993-4#1)(2008-3#1)
produced a significant reduction##4##4##(1992-10#1)(1993-4#1)(1995-12#1)(2008-3#1)
produced a significant##37##3##(1990-2#1)(1990-3#1)(1992-10#1)(1992-2#1)(1992-8#3)(1993-4#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-7#1)(1996-10#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-12#3)(2008-3#1)(2008-4#1)(2009-5#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2013-1#2)
produced a similar##5##3##(1990-10#1)(1993-12#1)(2007-9#1)(2008-10#1)(2010-4#1)
produced a single##5##3##(1991-5#1)(1993-4#1)(1993-8#1)(1994-2#1)(1994-9#1)
produced a slight##4##3##(1991-9#1)(1997-2#1)(2006-10#1)(2008-10#1)
produced a small##3##3##(1995-3#1)(2007-12#1)(2008-9#1)
produced a smaller##2##3##(2006-10#1)(2008-10#1)
produced a statistically significant##2##4##(1995-6#1)(2007-8#1)
produced a strong##4##3##(1991-7#1)(1992-2#1)(2008-4#2)
produced a transient##3##3##(1991-1#1)(1991-8#1)(2008-3#1)
produced a two-fold increase##2##4##(1990-7#1)(1995-10#1)
produced a##325##2##(1990-10#5)(1990-11#2)(1990-12#1)(1990-2#4)(1990-3#1)(1990-4#2)(1990-6#2)(1990-7#4)(1990-9#2)(1991-1#2)(1991-11#2)(1991-12#4)(1991-2#4)(1991-5#6)(1991-7#3)(1991-8#2)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#4)(1992-3#1)(1992-5#2)(1992-7#2)(1992-8#5)(1992-9#1)(1993-11#3)(1993-12#4)(1993-2#2)(1993-3#3)(1993-4#2)(1993-6#1)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#5)(1994-3#7)(1994-5#2)(1994-6#3)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#9)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#5)(1995-7#5)(1995-8#2)(1996-1#2)(1996-10#5)(1996-12#5)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#2)(1996-8#3)(1996-9#3)(1997-1#2)(1997-2#6)(1997-4#6)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#5)(2004-1#1)(2005-10#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-4#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#4)(2007-7#5)(2007-8#3)(2007-9#3)(2008-10#27)(2008-11#3)(2008-12#5)(2008-2#3)(2008-3#7)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
produced about##2##2##(1990-7#1)(1995-2#1)
produced abundant##2##2##(1991-5#1)(2008-10#1)
produced abundantly##2##2##(2008-10#1)(2009-3#1)
produced acetic##2##2##(2006-5#1)(2013-7#1)
produced adenosine##2##2##(1990-12#1)(1994-11#1)
produced aflatoxin in##3##3##(2008-10#3)
produced aflatoxin##4##2##(2008-10#4)
produced after a##2##3##(1995-5#1)(2006-10#1)
produced after##7##2##(1995-5#1)(2006-10#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-7#1)
produced against a##2##3##(1992-3#1)(1996-12#1)
produced against the##3##3##(1995-2#1)(2008-10#2)
produced against##14##2##(1992-1#1)(1992-3#1)(1992-8#2)(1995-2#1)(1996-12#2)(2007-6#1)(2008-10#5)(2008-11#1)
produced almost##3##2##(1994-8#1)(1997-4#1)(2008-10#1)
produced alopecia##2##2##(1990-9#2)
produced ammonia##2##2##(2008-10#2)
produced an additive##2##3##(1992-3#1)(2012-11#1)
produced an augmentation of phenylephrine-induced tone##2##6##(1997-5#2)
produced an average##4##3##(1997-5#1)(2006-10#1)(2007-11#1)(2008-10#1)
produced an immediate increase in##2##5##(1996-1#1)(2009-6#1)
produced an immediate increase of##2##5##(1991-10#1)(1997-5#1)
produced an immediate increase##4##4##(1991-10#1)(1996-1#1)(1997-5#1)(2009-6#1)
produced an immediate##5##3##(1991-10#1)(1996-1#1)(1997-1#1)(1997-5#1)(2009-6#1)
produced an improvement in##2##4##(2008-6#1)(2012-12#1)
produced an increase in locomotor activity##2##6##(1994-2#1)(1996-12#1)
produced an increase in##7##4##(1994-2#1)(1994-3#1)(1996-12#2)(1997-8#1)(2008-5#1)(2012-3#1)
produced an increase of##3##4##(1992-7#1)(2008-11#1)(2011-1#1)
produced an increase##10##3##(1992-7#1)(1994-2#1)(1994-3#1)(1996-12#2)(1997-8#1)(2008-11#1)(2008-5#1)(2011-1#1)(2012-3#1)
produced an inhibition of##2##4##(1994-10#1)(1995-11#1)
produced an inward##2##3##(1995-7#1)(2008-8#1)
produced an##63##2##(1991-10#1)(1991-12#1)(1991-5#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-12#1)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-5#1)(1995-7#2)(1996-1#2)(1996-12#2)(1996-3#1)(1997-1#1)(1997-5#5)(1997-7#1)(1997-8#1)(2006-10#1)(2007-11#4)(2007-2#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-8#1)(2011-1#1)(2012-11#1)(2012-12#3)(2012-3#1)(2013-1#1)
produced and a##2##3##(1992-8#1)(1994-12#1)
produced and characterized##3##3##(1992-1#1)(1996-12#1)(2008-5#1)
produced and distributed##2##3##(1995-2#1)(2005-5#1)
produced and purified##2##3##(1993-8#1)(1994-5#1)
produced and released by##2##4##(2007-12#1)(2008-1#1)
produced and released##3##3##(1994-5#1)(2007-12#1)(2008-1#1)
produced and secreted by the##3##5##(1995-2#1)(1996-5#1)(2008-5#1)
produced and secreted by##6##4##(1990-2#1)(1993-3#1)(1995-2#1)(1996-5#1)(2006-11#1)(2008-5#1)
produced and secreted in##2##4##(1991-1#1)(1991-4#1)
produced and secreted##9##3##(1990-2#1)(1991-1#1)(1991-4#1)(1993-3#1)(1995-2#1)(1996-5#1)(2006-11#1)(2006-12#1)(2008-5#1)
produced and##55##2##(1990-2#1)(1990-3#1)(1991-1#1)(1991-4#1)(1992-1#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#2)(1994-9#1)(1995-2#2)(1995-5#1)(1995-7#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-6#1)(2005-4#1)(2005-5#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-5#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#1)
produced antibodies against##2##3##(1991-5#1)(1997-6#1)
produced antibody##2##2##(2008-11#2)
produced any##2##2##(1992-2#1)(1994-8#1)
produced are##2##2##(2008-10#1)(2008-3#1)
produced around##2##2##(2006-12#1)(2009-7#1)
produced as a result of##4##5##(1995-12#1)(1996-3#1)(2008-10#1)(2009-10#1)
produced as a##14##3##(1990-9#1)(1992-2#1)(1993-12#1)(1993-5#1)(1994-2#1)(1995-12#1)(1996-3#1)(1997-5#1)(2006-10#1)(2008-10#1)(2008-2#1)(2009-10#1)(2010-5#1)(2010-8#1)
produced as an##4##3##(1990-5#1)(1994-9#1)(2006-3#1)(2007-12#1)
produced as one of the##2##5##(2008-10#1)(2009-5#1)
produced as the##2##3##(1996-4#1)(2010-5#1)
produced as##30##2##(1990-5#1)(1990-9#1)(1992-2#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-12#1)(1996-3#1)(1996-4#1)(1997-5#1)(1997-8#1)(2006-10#1)(2006-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-5#2)(2010-8#1)(2011-1#1)
produced at 10°C and 30°C##3##5##(2011-2#3)
produced at 10°C##4##3##(2011-2#4)
produced at 30°C##2##3##(2011-2#2)
produced at a##2##3##(2008-5#1)(2008-6#1)
produced at least##3##3##(1997-4#1)(2008-10#2)
produced at levels##2##3##(1990-10#1)(2008-11#1)
produced at pH##2##3##(2006-10#1)(2008-10#1)
produced at the time##2##4##(1993-12#1)(2006-5#1)
produced at the##8##3##(1993-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)
produced at##46##2##(1990-10#1)(1992-8#1)(1993-12#2)(1993-2#1)(1994-9#2)(1996-7#1)(1997-4#2)(1997-6#1)(2004-9#2)(2006-10#1)(2006-4#1)(2006-5#3)(2007-11#2)(2007-12#2)(2008-10#7)(2008-11#1)(2008-3#2)(2008-5#3)(2008-6#2)(2011-2#6)(2012-5#1)(2013-1#1)(2013-7#1)
produced better##3##2##(2006-1#1)(2008-10#1)(2011-2#1)
produced between the##2##3##(1995-8#1)(2009-10#1)
produced between##4##2##(1995-8#1)(2007-11#1)(2008-11#1)(2009-10#1)
produced both##3##2##(1991-7#1)(1992-6#1)(1996-6#1)
produced but##2##2##(2008-10#1)(2009-8#1)
produced by 4##2##3##(1993-10#1)(1996-10#1)
produced by 5-HT##3##3##(1990-7#2)(1992-7#1)
produced by 8-OH-DPAT##2##3##(1991-2#2)
produced by A##2##3##(1991-9#1)(2013-8#1)
produced by Aspergillus##3##3##(2007-3#1)(2008-10#2)
produced by Bacillus subtilis##2##4##(2011-1#1)(2012-2#1)
produced by Bacillus##3##3##(1990-1#1)(2011-1#1)(2012-2#1)
produced by CHO cells##4##4##(1992-10#1)(2008-11#2)(2012-3#1)
produced by Chinese hamster ovary##5##5##(2008-11#4)(2008-7#1)
produced by Clostridium botulinum##2##4##(1990-2#1)(2007-12#1)
produced by Fusarium##2##3##(2008-10#2)
produced by P##3##3##(2008-10#3)
produced by PCR##2##3##(1997-3#1)(2010-5#1)
produced by Penicillium##2##3##(2008-10#1)(2008-6#1)
produced by Pseudomonas##4##3##(1995-2#1)(2008-10#2)(2008-6#1)
produced by Streptococcus mutans##2##4##(1997-6#2)
produced by Streptococcus##3##3##(1997-6#2)(2010-2#1)
produced by T cells##3##4##(2007-11#1)(2008-4#1)(2008-9#1)
produced by T##4##3##(1995-6#1)(2007-11#1)(2008-4#1)(2008-9#1)
produced by U##2##3##(2008-10#2)
produced by a combination of##3##5##(1990-12#1)(2006-10#1)(2007-12#1)
produced by a detergent-free##2##4##(1991-10#2)
produced by a number of##2##5##(1991-7#1)(1995-6#1)
produced by a particular##2##4##(2008-10#2)
produced by a rotating##2##4##(2008-2#1)(2008-8#1)
produced by a single##2##4##(2007-11#1)(2008-10#1)
produced by a variety of cells##2##6##(2008-4#1)(2009-3#1)
produced by a##71##3##(1990-12#1)(1990-5#1)(1991-10#2)(1991-2#1)(1991-7#1)(1992-12#1)(1993-12#1)(1995-3#1)(1995-6#1)(1996-3#1)(1996-9#4)(1997-8#1)(2004-9#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-11#5)(2007-12#5)(2008-10#8)(2008-11#1)(2008-2#11)(2008-3#8)(2008-4#3)(2008-8#1)(2008-9#3)(2009-3#1)(2010-5#1)(2011-2#1)(2012-12#2)(2013-7#1)
produced by activated##2##3##(1996-10#1)(2007-11#1)
produced by acute##3##3##(1997-1#1)(2005-9#1)(2008-4#1)
produced by administration of##3##4##(1990-7#1)(1995-2#1)(1996-1#1)
produced by alkali treatment of##2##5##(1992-6#2)
produced by all##7##3##(1993-12#1)(1993-3#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-7#1)
produced by alternative##2##3##(1994-9#1)(1995-12#1)
produced by an##12##3##(1990-9#1)(1991-3#1)(1993-6#1)(1995-2#1)(1997-2#1)(2008-2#1)(2008-3#3)(2008-8#1)(2013-1#1)(2013-8#1)
produced by bile-pancreatic juice diversion##2##5##(2008-7#2)
produced by both##4##3##(1993-1#1)(2006-1#1)(2008-10#1)(2008-3#1)
produced by capsaicin or pH 5 medium##2##7##(1992-8#2)
produced by carbachol##2##3##(1992-3#1)(1996-1#1)
produced by chemical and enzymatic##2##5##(1991-2#2)
produced by chemical##4##3##(1991-2#2)(1992-3#1)(2008-6#1)
produced by chronic##2##3##(1991-5#1)(1996-5#1)
produced by combining##2##3##(1996-1#1)(2008-4#1)
produced by conidial##2##3##(2008-10#2)
produced by conventional##2##3##(2008-10#1)(2008-2#1)
produced by crystal##2##3##(2006-4#1)(2007-12#1)
produced by different##9##3##(1995-2#1)(1995-3#1)(1997-2#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-7#2)(2011-2#1)
produced by digestion with##3##4##(1997-8#1)(2008-1#2)
produced by each of the##2##5##(1993-3#1)(2006-11#1)
produced by each of##3##4##(1993-3#1)(1996-9#1)(2006-11#1)
produced by each strain##2##4##(2008-10#2)
produced by each##9##3##(1993-2#1)(1993-3#1)(1996-9#1)(2006-11#1)(2007-10#1)(2008-10#3)(2008-2#1)
produced by either##4##3##(1990-8#1)(1991-9#1)(2004-9#1)(2008-2#1)
produced by electrical stimulation##4##4##(1991-5#3)(1992-11#1)
produced by electron-beam##2##3##(2008-2#2)
produced by electrospray ionization##2##4##(2006-1#1)(2009-12#1)
produced by enzyme##2##3##(2008-10#2)
produced by epithelial cells##2##4##(2006-11#1)(2007-11#1)
produced by ethanol##2##3##(1997-7#1)(2010-2#1)
produced by free##2##3##(1995-5#1)(2013-1#1)
produced by fusing splenocytes##2##4##(2008-11#2)
produced by fusing##4##3##(2008-11#4)
produced by heating##2##3##(2007-11#1)(2010-8#1)
produced by human##6##3##(1991-12#1)(1992-4#1)(1994-9#1)(1995-5#1)(2008-11#1)(2008-8#1)
produced by hybridomas##2##3##(2008-11#1)(2008-4#1)
produced by i##2##3##(1990-7#1)(1992-7#1)
produced by immune##3##3##(1991-10#1)(1994-11#1)(1995-12#1)
produced by injections of##2##4##(1991-3#1)(1996-2#1)
produced by ion exchange in##2##5##(2008-2#2)
produced by irradiation of##2##4##(2007-11#2)
produced by its##2##3##(2008-5#1)(2009-10#1)
produced by jet nebulizers##2##4##(1995-3#2)
produced by jet##3##3##(1991-1#1)(1995-3#2)
produced by laser ablation##2##4##(1991-2#1)(2008-3#1)
produced by less##2##3##(2008-10#1)(2011-2#1)
produced by leukocytes and##2##4##(1995-12#1)(2008-4#1)
produced by many##3##3##(2007-11#1)(2008-4#1)(2008-9#1)
produced by means of##2##4##(2008-2#1)(2008-7#1)
produced by mobile phones on the##2##6##(2008-12#2)
produced by mobile phones##3##4##(2008-12#3)
produced by mononuclear cells##2##4##(1990-4#1)(1992-8#1)
produced by morphine##2##3##(1993-12#1)(1994-2#1)
produced by multiple##4##3##(1992-6#1)(2008-2#1)(2008-9#1)(2010-10#1)
produced by murine##2##3##(1991-8#1)(1991-9#1)
produced by natural##2##3##(2008-5#1)(2011-1#1)
produced by one##3##3##(2005-11#1)(2007-12#1)(2011-1#1)
produced by osteoblasts##2##3##(2010-10#1)(2012-12#1)
produced by other##2##3##(1995-12#1)(2008-4#1)
produced by our##3##3##(2008-3#1)(2012-1#1)(2013-1#1)
produced by peripheral blood mononuclear cells##2##6##(1992-8#2)
produced by peripheral blood##3##4##(1990-4#1)(1992-8#2)
produced by plants##2##3##(2008-10#1)(2009-8#1)
produced by protein##2##3##(1993-11#1)(1993-3#1)
produced by recombinant DNA technology##2##5##(2007-11#2)
produced by recombinant##5##3##(1991-2#1)(1993-12#1)(2007-11#3)
produced by scattering##2##3##(2007-12#1)(2008-2#1)
produced by several##4##3##(2008-10#2)(2008-4#1)(2010-4#1)
produced by simple##2##3##(2008-10#1)(2010-7#1)
produced by some##2##3##(2009-3#1)(2012-12#1)
produced by static scattering##2##4##(2007-12#2)
produced by static##3##3##(2007-12#2)(2012-2#1)
produced by stimulation of##3##4##(1990-2#1)(1991-5#1)(1993-12#1)
produced by stimulation##4##3##(1990-2#1)(1991-5#1)(1993-12#1)(1993-7#1)
produced by strain##3##3##(1992-12#1)(2008-10#2)
produced by subsequent##3##3##(1991-3#1)(2005-11#1)(2013-1#1)
produced by systemic##2##3##(1993-12#1)(1994-2#1)
produced by the Canadian Health Services Research Foundation##4##8##(2009-3#1)(2009-4#1)(2010-5#1)(2010-8#1)
produced by the cells##2##4##(1994-11#1)(2008-11#1)
produced by the different##3##4##(2008-1#1)(2008-10#2)
produced by the endothelium##2##4##(1994-9#1)(2005-11#1)
produced by the immobilized-enzyme##2##4##(2008-10#2)
produced by the interaction##3##4##(2012-11#2)(2013-8#1)
produced by the reaction between##3##5##(2008-10#3)
produced by the reaction##4##4##(2006-10#1)(2008-10#3)
produced by the solgel method##2##5##(2008-2#2)
produced by the tumor##3##4##(1991-7#1)(1996-1#1)(2008-6#1)
produced by the use of##2##5##(2008-2#1)(2010-8#1)
produced by the##193##3##(1990-10#1)(1990-12#2)(1990-2#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#4)(1993-6#3)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#4)(1994-3#1)(1994-4#1)(1994-5#2)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-2#2)(1996-3#1)(1996-5#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-10#1)(2004-8#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#4)(2006-12#3)(2006-3#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#4)(2007-3#1)(2008-1#3)(2008-10#29)(2008-11#2)(2008-12#1)(2008-2#15)(2008-3#11)(2008-4#2)(2008-5#2)(2008-6#6)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#4)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-11#2)(2013-7#1)(2013-8#1)
produced by them##2##3##(2007-11#1)(2008-5#1)
produced by these cells##4##4##(1992-9#1)(2008-11#2)(2008-9#1)
produced by these##11##3##(1990-12#1)(1992-9#1)(1997-1#1)(2006-10#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-9#1)
produced by this method##2##4##(2006-12#1)(2008-6#1)
produced by this##8##3##(1992-8#1)(1993-11#1)(1996-4#1)(2006-12#1)(2006-8#1)(2008-6#1)(2011-1#1)(2013-8#1)
produced by those##2##3##(1994-5#1)(1996-10#1)
produced by treatment##2##3##(1994-2#1)(2005-8#1)
produced by two different##2##4##(1991-1#1)(2008-10#1)
produced by two##8##3##(1991-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#1)
produced by use of##2##4##(2007-11#1)(2008-2#1)
produced by using a##2##4##(1995-12#1)(2008-6#1)
produced by using##3##3##(1995-12#1)(2008-5#1)(2008-6#1)
produced by various##2##3##(1997-7#1)(2007-8#1)
produced by##999##2##(1990-1#1)(1990-10#6)(1990-11#3)(1990-12#5)(1990-2#6)(1990-3#2)(1990-4#3)(1990-5#5)(1990-6#1)(1990-7#12)(1990-8#4)(1990-9#3)(1991-1#7)(1991-10#3)(1991-11#1)(1991-12#6)(1991-2#10)(1991-3#5)(1991-4#1)(1991-5#9)(1991-6#1)(1991-7#6)(1991-8#7)(1991-9#8)(1992-1#1)(1992-10#3)(1992-11#4)(1992-12#7)(1992-3#5)(1992-4#1)(1992-6#8)(1992-7#5)(1992-8#9)(1992-9#6)(1993-1#1)(1993-10#4)(1993-11#5)(1993-12#14)(1993-2#3)(1993-3#10)(1993-4#1)(1993-6#6)(1993-7#2)(1993-8#3)(1993-9#6)(1994-10#2)(1994-11#5)(1994-12#2)(1994-2#11)(1994-3#5)(1994-4#1)(1994-5#4)(1994-6#3)(1994-8#1)(1994-9#6)(1995-1#2)(1995-10#1)(1995-11#8)(1995-12#9)(1995-2#6)(1995-3#7)(1995-4#1)(1995-5#2)(1995-6#6)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#5)(1996-10#4)(1996-2#3)(1996-3#3)(1996-4#4)(1996-5#7)(1996-6#1)(1996-8#1)(1996-9#10)(1997-1#2)(1997-2#8)(1997-3#2)(1997-4#6)(1997-5#8)(1997-6#4)(1997-7#5)(1997-8#3)(2004-10#1)(2004-11#1)(2004-2#1)(2004-8#1)(2004-9#3)(2005-10#2)(2005-11#10)(2005-12#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-1#3)(2006-10#10)(2006-11#4)(2006-12#10)(2006-3#2)(2006-4#1)(2006-8#3)(2007-1#2)(2007-10#3)(2007-11#25)(2007-12#25)(2007-2#1)(2007-3#5)(2007-4#1)(2007-6#1)(2007-7#4)(2007-8#5)(2007-9#3)(2008-1#8)(2008-10#122)(2008-11#36)(2008-12#8)(2008-2#49)(2008-3#45)(2008-4#23)(2008-5#20)(2008-6#15)(2008-7#18)(2008-8#11)(2008-9#14)(2009-10#4)(2009-11#3)(2009-12#3)(2009-2#1)(2009-3#4)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#3)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#4)(2010-4#5)(2010-5#4)(2010-7#5)(2010-8#4)(2011-1#10)(2011-2#6)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#7)(2012-2#5)(2012-3#4)(2013-1#13)(2013-7#3)(2013-8#5)
produced can be used##2##4##(1997-2#1)(2008-8#1)
produced can be##3##3##(1997-2#1)(2008-4#1)(2008-8#1)
produced ceramics##2##2##(2004-9#1)(2009-2#1)
produced characteristic##4##2##(1994-3#1)(1996-9#1)(2008-10#2)
produced commercially##2##2##(2011-2#2)
produced comparable results##2##3##(2006-1#1)(2008-7#1)
produced comparable##4##2##(1992-1#1)(2004-9#1)(2006-1#1)(2008-7#1)
produced complete##3##2##(1990-9#1)(2005-11#1)(2006-10#1)
produced concentration-dependent inhibition of##2##4##(1992-12#1)(1996-6#1)
produced concentration-dependent##7##2##(1992-12#1)(1993-3#1)(1994-6#2)(1996-6#1)(2010-12#2)
produced conidia##2##2##(2008-10#2)
produced consistent##3##2##(1990-2#1)(2008-10#1)(2008-12#1)
produced constitutively by##2##3##(1995-11#1)(2013-1#1)
produced constitutively##3##2##(1995-11#1)(2005-7#1)(2013-1#1)
produced cytopathic##2##2##(2006-10#1)(2008-5#1)
produced decreases in##2##3##(1993-3#1)(1993-6#1)
produced detectable##2##2##(1993-9#1)(2009-4#1)
produced directly from##2##3##(1994-2#1)(2007-12#1)
produced distinct##2##2##(2008-10#2)
produced dose-dependent increases in##3##4##(1995-12#1)(1996-2#1)(2004-12#1)
produced dose-dependent##6##2##(1990-2#1)(1993-3#1)(1995-12#1)(1996-2#1)(2004-12#1)(2011-1#1)
produced dose-related##3##2##(1994-11#1)(1994-2#1)(1997-8#1)
produced during submerged fermentation##2##4##(2006-9#1)(2008-5#1)
produced during the##10##3##(1990-8#1)(2007-10#1)(2007-11#3)(2007-8#2)(2008-10#1)(2008-4#1)(2012-2#1)
produced during##26##2##(1990-8#1)(1992-9#1)(1993-2#1)(1995-1#1)(1995-2#2)(1997-3#1)(1997-8#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-8#2)(2008-10#2)(2008-4#1)(2008-5#1)(2009-3#1)(2010-5#1)(2012-2#1)(2013-1#1)
produced early in the##2##4##(2008-10#1)(2008-8#1)
produced effects##2##2##(2006-3#1)(2010-12#1)
produced either##2##2##(1997-7#1)(2008-8#1)
produced endogenously##2##2##(1994-5#1)(1995-1#1)
produced enhanced##2##2##(1995-8#1)(2008-9#1)
produced equivalent##2##2##(1992-11#1)(1994-3#1)
produced equivocal results##2##3##(1997-5#1)(2012-12#1)
produced equivocal##3##2##(1997-5#1)(2007-12#1)(2012-12#1)
produced ethylene at##2##3##(2008-10#2)
produced ethylene##3##2##(2008-10#3)
produced excellent results##3##3##(2008-10#2)(2008-6#1)
produced exclusively##2##2##(2008-3#1)(2009-7#1)
produced few##2##2##(2008-10#1)(2009-11#1)
produced fewer##2##2##(2008-10#1)(2008-4#1)
produced following##3##2##(1991-7#1)(1995-5#1)(2006-5#1)
produced for the##4##3##(1990-12#1)(2008-10#1)(2008-3#2)
produced for##17##2##(1990-12#1)(1996-12#1)(2004-9#1)(2006-9#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2010-4#1)(2010-8#1)(2012-2#1)
produced from DEHP by##2##4##(2007-4#2)
produced from a single##2##4##(1993-7#1)(1996-6#1)
produced from a##12##3##(1991-1#1)(1991-2#1)(1993-5#1)(1993-7#1)(1996-6#1)(1996-8#1)(1997-5#1)(2007-11#2)(2007-12#1)(2008-2#2)
produced from an##2##3##(2008-3#1)(2011-2#1)
produced from each##2##3##(2007-1#1)(2008-10#1)
produced from the enzymatic reaction##2##5##(2008-10#2)
produced from the reaction##2##4##(2008-10#2)
produced from the same##2##4##(2008-3#1)(2008-5#1)
produced from the##23##3##(1990-7#1)(1994-11#2)(1995-11#1)(1995-3#1)(1997-6#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#4)(2011-1#1)(2012-1#1)(2013-1#1)
produced from these data##2##4##(1997-4#1)(2012-12#1)
produced from this##2##3##(1993-6#1)(1996-6#1)
produced from two##2##3##(1993-9#1)(2008-2#1)
produced from##103##2##(1990-10#1)(1990-2#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-6#2)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-11#3)(2005-4#1)(2006-2#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-4#2)(2008-10#23)(2008-11#5)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#8)(2008-6#1)(2009-3#1)(2009-9#1)(2010-8#2)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#4)(2013-1#1)
produced functional##4##2##(1991-5#1)(1994-8#1)(1994-9#1)(2005-8#1)
produced good results##2##3##(2007-8#1)(2008-10#1)
produced good##4##2##(1990-9#1)(1995-7#1)(2007-8#1)(2008-10#1)
produced greater##7##2##(1997-8#1)(2006-7#1)(2008-10#3)(2009-10#1)(2012-2#1)
produced high amounts##3##3##(2008-10#2)(2010-11#1)
produced high levels of##2##4##(2008-10#2)
produced high##9##2##(1992-7#1)(1992-9#1)(2004-9#1)(2007-8#1)(2008-10#4)(2010-11#1)
produced higher##5##2##(1996-12#1)(2008-10#2)(2008-11#1)(2009-7#1)
produced human##2##2##(1990-8#1)(1991-1#1)
produced hydrogen peroxide##4##3##(2008-10#3)(2009-8#1)
produced in E##11##3##(1990-11#1)(1990-5#1)(1990-7#1)(1990-8#1)(1992-8#2)(1993-4#1)(1993-5#1)(1994-8#1)(1995-1#1)(1997-1#1)
produced in Escherichia coli and##3##5##(1997-2#1)(2007-11#1)(2008-5#1)
produced in Escherichia coli##14##4##(1990-1#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-2#1)(1997-2#1)(2007-11#1)(2008-4#1)(2008-5#1)(2010-6#1)
produced in S##2##3##(1996-7#2)
produced in a baculovirus##2##4##(1994-8#1)(2008-11#1)
produced in a##19##3##(1990-5#1)(1990-9#1)(1991-9#1)(1994-2#1)(1994-8#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#2)(2009-11#1)(2009-7#1)
produced in all##2##3##(2008-11#1)(2010-8#1)
produced in an##8##3##(1994-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-10#1)(2011-2#1)
produced in bacteria and##2##4##(1993-12#1)(2013-8#1)
produced in bacteria##5##3##(1993-12#1)(1997-4#1)(2008-4#1)(2009-6#1)(2013-8#1)
produced in cultures##2##3##(2008-11#1)(2012-2#1)
produced in its##3##3##(2008-10#2)(2008-5#1)
produced in large amounts by##2##5##(1993-9#1)(2011-1#1)
produced in large quantities##2##4##(2008-11#1)(2008-4#1)
produced in large##4##3##(1993-9#1)(2008-11#1)(2008-4#1)(2011-1#1)
produced in less than##3##4##(2008-11#2)(2008-6#1)
produced in less##4##3##(2008-11#2)(2008-6#1)(2008-9#1)
produced in mice##3##3##(1992-3#1)(2008-10#1)(2012-3#1)
produced in response to##7##4##(1990-2#1)(1992-7#1)(2006-10#2)(2007-11#2)(2008-9#1)
produced in similar##2##3##(1994-7#1)(1995-10#1)
produced in the different##2##4##(2008-11#1)(2012-2#1)
produced in the laboratory##2##4##(2006-11#1)(2008-11#1)
produced in the liver##2##4##(2008-11#1)(2008-5#1)
produced in the process##2##4##(1995-3#1)(2007-1#1)
produced in the reaction##2##4##(2008-10#2)
produced in the##64##3##(1991-4#1)(1992-1#2)(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-3#2)(1993-7#1)(1994-10#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#1)(1995-8#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#5)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2010-2#1)(2010-9#1)(2012-2#2)
produced in this##7##3##(1991-2#1)(1991-9#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
produced in transgenic##3##3##(1997-4#1)(2006-12#2)
produced in vitro and##2##4##(1996-5#1)(2008-10#1)
produced in vitro by##5##4##(1990-11#1)(2007-3#1)(2008-10#2)(2008-7#1)
produced in vitro##13##3##(1990-11#1)(1991-3#1)(1996-5#1)(2006-5#1)(2007-3#2)(2008-10#6)(2008-7#1)
produced in vivo##3##3##(1993-12#1)(1994-5#1)(1995-2#1)
produced in yeast##2##3##(1996-12#2)
produced in##319##2##(1990-1#1)(1990-11#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#2)(1991-9#4)(1992-1#2)(1992-3#1)(1992-5#1)(1992-6#6)(1992-7#2)(1992-8#5)(1993-1#1)(1993-11#1)(1993-12#6)(1993-2#2)(1993-3#2)(1993-4#4)(1993-5#1)(1993-6#3)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#4)(1994-2#3)(1994-5#2)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#2)(1995-8#1)(1996-12#3)(1996-5#1)(1996-7#5)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(2005-12#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-10#11)(2006-11#2)(2006-12#2)(2006-3#1)(2006-5#2)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#5)(2007-3#3)(2007-5#1)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#46)(2008-11#18)(2008-2#8)(2008-3#11)(2008-4#9)(2008-5#11)(2008-6#5)(2008-7#6)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-6#1)(2009-7#3)(2009-8#1)(2010-2#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#2)
produced increased deformability##2##3##(1994-9#2)
produced increased##6##2##(1993-12#1)(1994-9#2)(2008-10#2)(2008-11#1)
produced increases in##3##3##(1996-11#2)(1996-7#1)
produced increases##5##2##(1990-10#1)(1993-3#1)(1996-11#2)(1996-7#1)
produced inhibition of##2##3##(1992-9#1)(1997-8#1)
produced interesting results##2##3##(2008-10#1)(2008-3#1)
produced is##4##2##(1993-6#1)(1995-8#1)(2008-10#1)(2008-7#1)
produced large amounts of ethanol##2##5##(2013-1#2)
produced large amounts of##6##4##(1992-8#1)(1995-2#1)(2008-10#1)(2008-11#1)(2013-1#2)
produced large##8##2##(1992-8#1)(1994-2#1)(1995-2#1)(2008-10#1)(2008-11#1)(2009-2#1)(2013-1#2)
produced larger##5##2##(1992-11#1)(2008-10#1)(2010-8#2)(2013-7#1)
produced less##8##2##(1992-1#1)(1993-1#1)(1995-2#1)(2008-10#2)(2008-3#1)(2008-8#1)(2012-2#1)
produced linear responses##2##3##(1993-11#1)(2010-4#1)
produced little or no##4##4##(1994-12#1)(1996-10#1)(2008-10#1)(2008-11#1)
produced little##5##2##(1993-9#1)(1994-12#1)(1996-10#1)(2008-10#1)(2008-11#1)
produced live##2##2##(1991-3#1)(2008-11#1)
produced locally##3##2##(1991-9#1)(1993-12#1)(2006-1#1)
produced long##2##2##(2008-10#1)(2008-8#1)
produced lower##2##2##(1990-4#1)(2008-2#1)
produced mainly by the##2##4##(1992-5#1)(2006-12#1)
produced mainly by##5##3##(1992-5#1)(2006-12#1)(2008-1#1)(2008-10#2)
produced mainly##7##2##(1992-5#1)(1995-1#1)(2006-12#1)(2006-8#1)(2008-1#1)(2008-10#2)
produced males and oviparae##2##4##(2008-9#2)
produced many##3##2##(1996-5#1)(2008-11#1)(2011-1#1)
produced maps##2##2##(1993-12#1)(2007-5#1)
produced marked##4##2##(1995-2#1)(1995-3#1)(1996-10#1)(1997-4#1)
produced mixtures of##2##3##(2007-11#1)(2008-10#1)
produced monoclonal antibodies##2##3##(1991-10#1)(1995-2#1)
produced more than##3##3##(1995-3#1)(2006-9#1)(2008-6#1)
produced more##26##2##(1991-9#1)(1992-11#1)(1995-10#1)(1995-3#1)(1996-12#1)(1997-5#1)(2004-2#1)(2006-9#1)(2007-11#2)(2008-10#8)(2008-12#1)(2008-6#2)(2008-8#2)(2008-9#1)(2010-12#1)(2011-2#1)
produced mostly##3##2##(2006-11#1)(2008-10#1)(2012-3#1)
produced multiple##5##2##(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)
produced near##2##2##(2007-12#1)(2008-11#1)
produced near-identical effects on reaction time##3##6##(2009-2#3)
produced neither##3##2##(1994-2#1)(1995-8#1)(1996-12#1)
produced no change in##3##4##(1991-6#1)(1995-1#1)(1995-11#1)
produced no change##4##3##(1991-6#1)(1995-1#1)(1995-11#1)(2011-2#1)
produced no detectable##4##3##(1992-7#1)(1994-9#1)(2008-10#1)(2009-4#1)
produced no significant change in the##2##6##(1995-5#1)(1997-5#1)
produced no significant change in##3##5##(1995-5#1)(1997-5#1)(2008-7#1)
produced no significant##6##3##(1993-1#1)(1995-5#1)(1997-5#1)(2007-11#1)(2008-7#1)(2010-4#1)
produced no##26##2##(1990-3#1)(1991-6#2)(1992-7#1)(1993-1#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-11#1)(1996-9#1)(1997-4#1)(1997-5#1)(2005-11#1)(2007-11#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-4#1)(2011-2#2)
produced normal##2##2##(1995-6#1)(2013-1#1)
produced objective##2##2##(2007-11#2)
produced on infected plants##2##4##(2008-10#2)
produced on leaves##2##3##(2008-10#2)
produced on the##4##3##(2008-10#3)(2012-3#1)
produced on##31##2##(1994-6#1)(2004-9#1)(2008-10#23)(2008-2#1)(2008-5#2)(2008-8#1)(2010-4#1)(2012-3#1)
produced one##2##2##(2008-10#1)(2009-5#1)
produced only a small##3##4##(1993-6#1)(1995-3#1)(2008-10#1)
produced only a##6##3##(1993-6#1)(1995-3#1)(1996-10#1)(1997-7#1)(2008-10#1)(2008-11#1)
produced only modest##2##3##(2008-10#1)(2009-7#1)
produced only##19##2##(1990-11#1)(1990-12#1)(1992-6#1)(1993-6#1)(1995-3#1)(1995-5#1)(1996-10#1)(1997-2#1)(1997-7#1)(2006-12#2)(2007-11#1)(2008-10#4)(2008-11#1)(2009-7#1)(2010-2#1)
produced oospores when grown on##2##5##(2008-10#2)
produced over the##3##3##(2008-1#1)(2008-10#1)(2008-3#1)
produced patterns##2##2##(1997-1#1)(2007-8#1)
produced peak##2##2##(2007-12#1)(2007-4#1)
produced per cotyledon##2##3##(2008-10#2)
produced per##9##2##(1994-8#1)(2007-6#1)(2008-10#5)(2008-11#1)(2009-12#1)
produced plasmas##2##2##(1995-11#1)(2008-10#1)
produced positive results in the##3##5##(1996-2#2)(2008-5#1)
produced predominantly by##3##3##(1994-9#1)(1995-5#1)(2007-1#1)
produced predominantly##5##2##(1991-10#2)(1994-9#1)(1995-5#1)(2007-1#1)
produced primarily by##2##3##(1994-11#1)(1994-9#1)
produced pronounced##2##2##(1991-10#1)(2010-8#1)
produced protein##3##2##(1994-12#1)(1995-8#1)(2008-11#1)
produced proteins##4##2##(1994-12#1)(1996-7#1)(2008-4#1)(2008-7#1)
produced pycnidia on##2##3##(2008-10#2)
produced quick##2##2##(2007-11#1)(2012-2#1)
produced rapidly##2##2##(2008-10#1)(2009-8#1)
produced recombinant##2##2##(1995-8#1)(2010-11#1)
produced relatively##2##2##(1991-12#1)(1995-12#1)
produced results##6##2##(1991-12#1)(2008-10#2)(2009-4#1)(2010-6#1)(2013-1#1)
produced robust##2##2##(1993-3#1)(2012-2#1)
produced satisfactory##2##2##(2007-8#1)(2008-10#1)
produced selective##2##2##(1990-2#1)(1990-7#1)
produced several##4##2##(1994-12#1)(1994-6#1)(2008-10#1)(2008-9#1)
produced severe##2##2##(1993-5#1)(1996-10#1)
produced shorter##2##2##(1995-12#1)(2009-10#1)
produced show##2##2##(1992-1#1)(2008-2#1)
produced significant amounts of##2##4##(1995-3#1)(2008-10#1)
produced significant changes##2##3##(1993-6#1)(2008-10#1)
produced significant decreases in##3##4##(1997-2#1)(2012-12#2)
produced significant depletion of##2##4##(1995-6#1)(2008-7#1)
produced significant improvements in##2##4##(1995-10#1)(2004-10#1)
produced significant improvements##3##3##(1995-10#1)(2004-10#2)
produced significant increases in##2##4##(1992-8#1)(1993-12#1)
produced significant##34##2##(1990-3#1)(1990-4#1)(1991-8#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-6#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-4#1)(2004-10#3)(2006-8#1)(2008-10#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
produced significantly (P &lt##2##4##(2007-10#1)(2008-10#1)
produced significantly different##2##3##(1993-1#1)(1996-3#1)
produced significantly more##9##3##(1990-12#1)(1990-5#1)(1990-8#1)(2008-10#2)(2009-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
produced significantly smaller##2##3##(1991-12#1)(2008-10#1)
produced significantly##18##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#1)(1993-1#1)(1996-3#1)(2005-7#1)(2007-10#1)(2008-10#6)(2009-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
produced similar results##3##3##(2007-5#1)(2008-10#1)(2012-3#1)
produced similar symptoms##2##3##(1997-3#1)(2008-10#1)
produced similar##19##2##(1990-2#1)(1990-5#1)(1992-2#1)(1995-3#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-10#6)(2008-2#1)(2008-5#1)(2008-8#1)(2012-1#1)(2012-3#1)
produced small##3##2##(1992-11#1)(1995-2#1)(2008-6#1)
produced some##7##2##(1991-8#1)(1993-11#1)(2006-10#1)(2006-3#1)(2007-3#1)(2008-10#1)(2008-5#1)
produced statistically significant##2##3##(2008-1#1)(2008-12#1)
produced strong##4##2##(1990-10#1)(1997-8#1)(2006-12#1)(2008-10#1)
produced structures##3##2##(1997-4#1)(2006-10#1)(2007-11#1)
produced substantial##4##2##(1991-7#1)(1995-3#1)(2008-12#1)(2008-3#1)
produced sustained inhibition of MGMT activity for##2##7##(1994-11#2)
produced symptoms##4##2##(2007-1#1)(2008-10#2)(2008-12#1)
produced that##6##2##(1991-8#1)(1992-1#1)(1995-6#1)(2007-7#1)(2008-10#2)
produced the best results##2##4##(1990-11#1)(2008-10#1)
produced the best##8##3##(1990-11#1)(1993-3#1)(2007-1#1)(2007-5#1)(2008-10#1)(2008-5#1)(2010-4#2)
produced the following##2##3##(2008-6#1)(2008-7#1)
produced the greatest##4##3##(1995-11#1)(1995-7#1)(2007-3#1)(2008-5#1)
produced the highest##12##3##(1994-9#2)(2007-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
produced the largest##3##3##(1995-11#1)(2008-10#1)(2010-2#1)
produced the lowest##2##3##(1995-7#1)(2008-10#1)
produced the most##4##3##(1991-9#1)(2006-12#1)(2009-2#1)(2009-7#1)
produced the same##5##3##(1990-12#1)(1990-2#1)(1992-3#1)(1994-3#1)(2012-12#1)
produced the##66##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-9#1)(1992-3#1)(1993-10#1)(1993-3#1)(1994-3#1)(1994-8#2)(1994-9#2)(1995-11#2)(1995-7#2)(1996-11#2)(1996-5#1)(1996-6#1)(2006-12#3)(2006-6#1)(2007-1#2)(2007-10#1)(2007-3#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-2#2)(2010-3#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#2)
produced three-dimensional##2##2##(1996-11#1)(2007-12#1)
produced through the use of##4##5##(1993-6#1)(2008-2#1)(2008-4#2)
produced through the##7##3##(1992-8#1)(1993-6#1)(1994-3#1)(2008-2#1)(2008-4#2)(2008-5#1)
produced through##19##2##(1992-8#1)(1993-10#1)(1993-5#1)(1993-6#1)(1994-3#1)(1994-5#1)(1995-10#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-8#1)(2009-8#1)
produced throughout##2##2##(2008-7#1)(2011-1#1)
produced to##8##2##(1993-11#1)(1995-2#1)(1995-8#1)(2007-5#1)(2008-10#1)(2008-2#1)(2009-5#2)
produced tolerance to##2##3##(1994-10#1)(1995-10#1)
produced too##3##2##(1995-12#1)(2008-10#2)
produced transgenic mice##2##3##(1990-8#1)(1992-11#1)
produced tumors in##2##3##(1991-12#1)(1992-11#1)
produced two##16##2##(1990-5#1)(1991-12#1)(1991-7#1)(1994-8#1)(1995-12#1)(1996-4#1)(1997-1#1)(2007-1#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)(2011-1#1)
produced typical##2##2##(2008-10#2)
produced under##5##2##(1990-6#2)(2008-11#1)(2008-9#1)(2010-4#1)
produced up to##5##3##(1990-5#1)(1995-6#1)(1996-10#1)(1997-2#1)(2007-3#1)
produced upon##5##2##(1991-7#1)(1992-4#1)(1994-8#1)(1996-12#1)(2008-10#1)
produced using a##4##3##(1993-3#1)(1994-12#1)(2008-10#2)
produced using##14##2##(1991-3#1)(1993-3#1)(1994-12#1)(1995-2#1)(1996-8#1)(1997-4#1)(2004-9#1)(2005-7#1)(2008-10#2)(2008-11#2)(2010-4#1)(2012-3#1)
produced various##2##2##(2008-10#2)
produced very##2##2##(2008-10#1)(2008-4#1)
produced via the##3##3##(1990-2#1)(2008-10#1)(2008-7#1)
produced via##8##2##(1990-2#1)(1993-6#1)(1995-12#2)(2004-9#1)(2008-10#1)(2008-5#1)(2008-7#1)
produced was##9##2##(1990-11#1)(1991-10#1)(1992-5#1)(1995-3#1)(2004-8#1)(2008-10#2)(2008-12#1)(2012-2#1)
produced water samples##2##3##(2008-10#2)
produced water was##2##3##(1994-3#1)(2013-1#1)
produced water##12##2##(1994-3#1)(2008-10#2)(2008-7#2)(2013-1#7)
produced waters##3##2##(2008-10#3)
produced weak##2##2##(1997-5#1)(2013-7#1)
produced were##7##2##(1993-9#1)(1994-2#1)(1996-6#1)(2005-11#1)(2005-7#1)(2006-8#1)(2008-10#1)
produced when the##3##3##(2007-11#1)(2008-10#1)(2008-5#1)
produced when this##2##3##(1994-8#1)(2006-5#1)
produced when##10##2##(1994-5#1)(1994-8#1)(1995-1#1)(2006-5#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-5#2)
produced with a##6##3##(1991-7#1)(2008-11#1)(2008-2#1)(2008-3#2)(2010-4#1)
produced with an##2##3##(2005-11#1)(2008-5#1)
produced with the##5##3##(2004-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2012-2#1)
produced with##35##2##(1991-7#1)(1995-1#1)(1997-4#1)(2004-1#1)(2004-9#1)(2005-11#2)(2006-10#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#2)(2010-4#2)(2011-1#1)(2011-2#1)(2012-2#1)
produced within a##2##3##(2007-11#1)(2013-8#1)
produced within the##3##3##(1995-6#1)(2008-5#1)(2012-2#1)
produced within##6##2##(1995-6#1)(2007-11#1)(2008-2#1)(2008-5#1)(2012-2#1)(2013-8#1)
produced without##2##2##(1994-3#1)(2008-10#1)
produced##3440##1##(1990-1#2)(1990-10#16)(1990-11#13)(1990-12#13)(1990-2#21)(1990-3#9)(1990-4#10)(1990-5#17)(1990-6#8)(1990-7#22)(1990-8#9)(1990-9#11)(1991-1#13)(1991-10#13)(1991-11#3)(1991-12#27)(1991-2#19)(1991-3#16)(1991-4#4)(1991-5#27)(1991-6#6)(1991-7#15)(1991-8#14)(1991-9#23)(1992-1#11)(1992-10#6)(1992-11#14)(1992-12#12)(1992-2#8)(1992-3#13)(1992-4#3)(1992-5#8)(1992-6#20)(1992-7#14)(1992-8#30)(1992-9#15)(1993-1#5)(1993-10#7)(1993-11#15)(1993-12#34)(1993-2#9)(1993-3#24)(1993-4#12)(1993-5#7)(1993-6#23)(1993-7#7)(1993-8#9)(1993-9#14)(1994-10#8)(1994-11#24)(1994-12#17)(1994-2#32)(1994-3#23)(1994-4#1)(1994-5#16)(1994-6#14)(1994-7#2)(1994-8#15)(1994-9#29)(1995-1#17)(1995-10#8)(1995-11#19)(1995-12#35)(1995-2#28)(1995-3#20)(1995-4#4)(1995-5#13)(1995-6#18)(1995-7#13)(1995-8#19)(1995-9#1)(1996-1#11)(1996-10#15)(1996-11#7)(1996-12#26)(1996-2#8)(1996-3#10)(1996-4#6)(1996-5#15)(1996-6#9)(1996-7#12)(1996-8#7)(1996-9#15)(1997-1#12)(1997-2#20)(1997-3#6)(1997-4#32)(1997-5#29)(1997-6#12)(1997-7#10)(1997-8#17)(2004-1#2)(2004-10#4)(2004-11#3)(2004-12#1)(2004-2#5)(2004-8#2)(2004-9#15)(2005-1#1)(2005-10#5)(2005-11#24)(2005-12#4)(2005-4#3)(2005-5#1)(2005-6#1)(2005-7#9)(2005-8#4)(2005-9#1)(2006-1#6)(2006-10#36)(2006-11#14)(2006-12#27)(2006-2#2)(2006-3#9)(2006-4#6)(2006-5#11)(2006-6#2)(2006-7#3)(2006-8#17)(2006-9#3)(2007-1#16)(2007-10#10)(2007-11#73)(2007-12#62)(2007-2#7)(2007-3#11)(2007-4#8)(2007-5#6)(2007-6#7)(2007-7#11)(2007-8#24)(2007-9#10)(2008-1#19)(2008-10#524)(2008-11#114)(2008-12#24)(2008-2#85)(2008-3#118)(2008-4#60)(2008-5#100)(2008-6#45)(2008-7#59)(2008-8#40)(2008-9#32)(2009-10#17)(2009-11#7)(2009-12#9)(2009-2#8)(2009-3#9)(2009-4#12)(2009-5#8)(2009-6#5)(2009-7#13)(2009-8#10)(2009-9#6)(2010-1#2)(2010-10#4)(2010-11#4)(2010-12#10)(2010-2#10)(2010-3#6)(2010-4#23)(2010-5#11)(2010-6#3)(2010-7#7)(2010-8#16)(2010-9#2)(2011-1#36)(2011-12#1)(2011-2#40)(2011-3#2)(2012-1#11)(2012-11#6)(2012-12#31)(2012-2#29)(2012-3#14)(2012-5#1)(2012-6#1)(2013-1#47)(2013-7#10)(2013-8#17)
produced)##2##1##(2008-9#1)(2009-12#1)
producer cell line##3##3##(1990-5#1)(2008-11#2)
producer cell##5##2##(1990-5#1)(2008-11#4)
producer cells##3##2##(2008-11#3)
producer from##2##2##(2008-10#2)
producer of##6##2##(1997-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-12#1)
producer regions##2##2##(2012-3#2)
producer##47##1##(1990-5#1)(1991-11#1)(1992-2#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-3#1)(1997-1#1)(2005-5#2)(2006-9#2)(2007-1#1)(2007-12#1)(2008-10#5)(2008-11#10)(2008-12#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
producers and##12##2##(1994-6#1)(1997-4#1)(2005-5#1)(2008-10#4)(2008-9#1)(2009-12#1)(2011-12#1)(2012-12#1)(2012-2#1)
producers from##3##2##(2005-11#1)(2008-10#1)(2010-10#1)
producers have been##2##3##(2007-7#1)(2008-10#1)
producers have##4##2##(1997-6#1)(2005-9#1)(2007-7#1)(2008-10#1)
producers in the##4##3##(2008-10#2)(2010-6#1)(2012-2#1)
producers in##6##2##(2008-10#4)(2010-6#1)(2012-2#1)
producers of##13##2##(1992-3#1)(1994-6#2)(2007-7#1)(2008-11#2)(2008-7#2)(2008-8#1)(2011-1#1)(2012-12#2)(2012-2#1)
producers showed##2##2##(1992-7#1)(2007-7#1)
producers to##4##2##(2007-7#1)(2008-10#1)(2008-5#1)(2013-8#1)
producers were##2##2##(2007-6#1)(2007-7#1)
producers##93##1##(1990-10#1)(1991-7#1)(1992-3#1)(1992-7#3)(1994-6#3)(1996-2#2)(1997-4#1)(1997-6#1)(2005-11#1)(2005-5#1)(2005-9#1)(2006-9#1)(2007-11#1)(2007-6#1)(2007-7#8)(2007-9#1)(2008-10#23)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-12#1)(2009-4#1)(2010-10#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#5)(2012-2#4)(2013-1#1)(2013-8#3)
produces 2##2##2##(1995-7#1)(2007-5#1)
produces DNA##2##2##(1997-4#1)(2008-11#1)
produces a decrease in##2##4##(1994-2#1)(2008-5#1)
produces a decrease##3##3##(1994-2#1)(2008-10#1)(2008-5#1)
produces a different##5##3##(1995-11#1)(1996-5#1)(2005-11#1)(2007-8#1)(2008-3#1)
produces a high##2##3##(1990-5#1)(2008-9#1)
produces a marked##3##3##(1990-5#1)(1992-6#1)(1993-6#1)
produces a maximum##2##3##(2005-7#1)(2008-10#1)
produces a mixture of##2##4##(2008-10#1)(2008-6#1)
produces a number of##3##4##(1990-4#1)(2007-11#1)(2008-3#1)
produces a range of##2##4##(2007-4#1)(2008-5#1)
produces a rapid##2##3##(1996-3#1)(2008-5#1)
produces a relatively##2##3##(2005-11#1)(2007-11#1)
produces a significant##3##3##(2005-11#1)(2006-12#1)(2009-2#1)
produces a single##4##3##(1992-12#1)(2008-10#1)(2008-5#1)(2008-8#1)
produces a toxin##2##3##(2008-10#2)
produces a very##2##3##(1990-2#1)(1990-3#1)
produces a wide range of##2##5##(1993-12#1)(2007-11#1)
produces a##159##2##(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-12#2)(1992-5#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-6#3)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-5#3)(1995-6#1)(1995-8#3)(1996-1#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#2)(1997-8#1)(2004-11#1)(2004-2#3)(2005-11#3)(2005-7#1)(2006-10#1)(2006-12#3)(2007-11#5)(2007-12#5)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#19)(2008-11#3)(2008-2#5)(2008-3#12)(2008-4#2)(2008-5#8)(2008-6#6)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
produces about##2##2##(1990-3#1)(1994-11#1)
produces accurate results##2##3##(2008-2#1)(2012-3#1)
produces airway##2##2##(2005-11#1)(2006-2#1)
produces an enzyme##2##3##(2008-10#1)(2009-11#1)
produces an image##2##3##(2008-1#1)(2008-2#1)
produces an increase in the##2##5##(1994-2#1)(2008-4#1)
produces an increase in##3##4##(1994-2#1)(1994-6#1)(2008-4#1)
produces an open##2##3##(1996-10#1)(1996-5#1)
produces an optimized##2##3##(2007-12#1)(2008-3#1)
produces an output##2##3##(2008-2#1)(2008-3#1)
produces an##45##2##(1991-12#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-6#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-5#1)(1997-5#1)(2004-8#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#2)(2008-8#1)(2009-11#1)(2010-11#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
produces and##5##2##(1991-6#1)(1997-4#1)(2009-6#1)(2010-10#1)(2010-9#1)
produces antinociception##2##2##(1996-2#1)(2009-6#1)
produces both##3##2##(2007-12#1)(2008-10#1)(2011-1#1)
produces changes##2##2##(1994-10#1)(2010-12#1)
produces dose-dependent##3##2##(1992-3#1)(2005-7#1)(2006-10#1)
produces dose-related##3##2##(1991-1#1)(1992-6#1)(1996-1#1)
produces errors##2##2##(2008-2#2)
produces excellent##2##2##(1997-6#1)(2007-8#1)
produces fewer##3##2##(2008-2#1)(2008-3#1)(2011-1#1)
produces good##3##2##(1991-3#1)(2008-4#1)(2008-7#1)
produces high##2##2##(1990-5#1)(2008-11#1)
produces high-quality##2##2##(2007-12#1)(2008-11#1)
produces its##4##2##(1996-3#1)(1996-7#1)(2005-7#1)(2008-6#1)
produces large quantities of##2##4##(1997-4#1)(2006-10#1)
produces large##4##2##(1996-4#1)(1997-4#1)(2006-10#1)(2010-10#1)
produces lethal##2##2##(1991-5#1)(2009-6#1)
produces long-term effects on##2##4##(1993-3#1)(1994-10#1)
produces long-term##3##2##(1993-3#1)(1994-10#1)(2007-12#1)
produces marked##2##2##(1991-4#1)(1995-12#1)
produces more than##2##3##(2006-4#1)(2007-12#1)
produces more##3##2##(1993-5#1)(2006-4#1)(2007-12#1)
produces multiple##3##2##(2008-10#2)(2008-3#1)
produces negative##2##2##(2006-8#1)(2010-7#1)
produces new##2##2##(1995-6#1)(1997-7#1)
produces one##2##2##(1994-9#1)(2011-2#1)
produces only a transient##2##4##(1996-5#1)(2008-8#1)
produces only two##2##3##(1992-5#1)(2008-2#1)
produces only##6##2##(1992-5#1)(1995-8#1)(1996-5#1)(2008-2#1)(2008-8#1)(2010-5#1)
produces optically pure##2##3##(2008-6#2)
produces pseudothecia and ascospores##2##4##(2008-10#2)
produces pseudothecia##3##2##(2008-10#3)
produces pulses##3##2##(2007-11#1)(2007-12#1)(2008-1#1)
produces quantitative##3##2##(2007-12#1)(2008-2#1)(2012-2#1)
produces results##2##2##(2006-3#1)(2009-10#1)
produces salicylic acid##2##3##(2008-10#1)(2013-7#1)
produces several##5##2##(1992-12#1)(1994-5#1)(2005-11#1)(2008-10#1)(2010-2#1)
produces severe##2##2##(2006-12#1)(2006-8#1)
produces significant##3##2##(1995-6#1)(2006-8#1)(2008-5#1)
produces some##3##2##(1997-2#1)(2007-11#1)(2009-12#1)
produces the characteristic##2##3##(2008-10#1)(2012-3#1)
produces the highest##2##3##(2007-12#1)(2007-7#1)
produces the same##3##3##(1997-6#1)(2006-6#1)(2010-10#1)
produces the##41##2##(1990-8#1)(1991-3#1)(1991-6#1)(1991-7#1)(1993-2#1)(1994-9#1)(1995-4#1)(1995-8#1)(1996-10#1)(1997-6#1)(2005-11#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#4)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-8#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#2)(2012-2#1)(2012-3#1)
produces three##2##2##(2006-8#1)(2007-12#1)
produces tunable##2##2##(2007-12#1)(2008-2#1)
produces two different##2##3##(1992-5#1)(2011-2#1)
produces two##4##2##(1990-2#1)(1992-5#1)(2008-8#1)(2011-2#1)
produces undesirable##2##2##(2007-8#1)(2011-2#1)
produces unique##3##2##(1991-3#1)(2008-3#1)(2009-4#1)
produces various##2##2##(1996-4#1)(1997-2#1)
produces##646##1##(1990-11#1)(1990-2#3)(1990-3#3)(1990-4#3)(1990-5#5)(1990-6#3)(1990-8#2)(1990-9#1)(1991-1#4)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#5)(1991-4#1)(1991-5#5)(1991-6#5)(1991-7#4)(1992-11#1)(1992-12#3)(1992-3#2)(1992-4#1)(1992-5#5)(1992-6#3)(1992-7#3)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#1)(1993-9#4)(1994-10#2)(1994-11#5)(1994-12#2)(1994-2#5)(1994-3#1)(1994-5#6)(1994-6#4)(1994-8#1)(1994-9#4)(1995-1#1)(1995-11#3)(1995-12#3)(1995-3#2)(1995-4#2)(1995-5#3)(1995-6#4)(1995-7#2)(1995-8#7)(1996-1#4)(1996-10#4)(1996-2#8)(1996-3#6)(1996-4#2)(1996-5#6)(1996-7#2)(1996-8#1)(1997-1#2)(1997-2#5)(1997-3#2)(1997-4#6)(1997-5#2)(1997-6#3)(1997-7#5)(1997-8#1)(2004-11#2)(2004-2#4)(2004-3#1)(2004-8#1)(2005-11#7)(2005-7#6)(2006-10#6)(2006-11#1)(2006-12#7)(2006-2#3)(2006-3#2)(2006-4#1)(2006-6#1)(2006-8#6)(2007-10#3)(2007-11#35)(2007-12#42)(2007-4#2)(2007-5#2)(2007-7#3)(2007-8#6)(2007-9#2)(2008-1#10)(2008-10#57)(2008-11#7)(2008-12#3)(2008-2#31)(2008-3#37)(2008-4#15)(2008-5#15)(2008-6#14)(2008-7#6)(2008-8#6)(2008-9#7)(2009-1#1)(2009-10#6)(2009-11#2)(2009-12#2)(2009-2#3)(2009-4#2)(2009-6#5)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#5)(2010-4#2)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#7)(2012-11#1)(2012-12#5)(2012-2#7)(2012-3#5)(2013-1#7)(2013-7#4)(2013-8#1)
producing 50%##2##2##(2007-11#1)(2008-10#1)
producing Escherichia coli##4##3##(2012-2#2)(2013-1#2)
producing OXA-23 carbapenemases##2##3##(2012-2#2)
producing a recombinant##2##3##(2008-11#1)(2012-2#1)
producing a variety of##4##4##(1991-6#1)(2007-11#1)(2009-5#1)(2010-12#1)
producing a##94##2##(1990-3#2)(1991-10#1)(1991-6#2)(1992-2#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-5#1)(1996-11#1)(1997-8#3)(2005-10#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-4#1)(2006-8#3)(2006-9#1)(2007-11#4)(2007-12#6)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#3)(2008-12#3)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-9#1)(2010-12#2)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#1)
producing an increase in##2##4##(1996-7#1)(1997-2#1)
producing an increase##3##3##(1996-7#1)(1997-2#1)(1997-7#1)
producing an##18##2##(1991-6#1)(1994-3#1)(1994-5#1)(1994-8#1)(1996-7#1)(1997-2#1)(1997-7#1)(2006-11#1)(2007-11#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-11#2)
producing analgesia##2##2##(1996-8#1)(2008-7#1)
producing and##7##2##(1994-5#1)(2008-1#2)(2008-2#1)(2008-4#1)(2009-10#1)(2010-3#1)
producing any##2##2##(1996-7#1)(2013-1#1)
producing area of##2##3##(2008-10#1)(2012-3#1)
producing area##4##2##(2008-10#2)(2008-5#1)(2012-3#1)
producing areas##2##2##(2008-10#1)(2008-5#1)
producing as##2##2##(2008-2#1)(2008-4#1)
producing autocrine##2##2##(1992-9#1)(2008-11#1)
producing both##3##2##(1991-2#1)(1996-4#1)(2008-3#1)
producing cell lines##3##3##(2008-11#3)
producing cell##5##2##(1992-7#1)(2008-11#4)
producing cells##14##2##(1992-9#2)(1994-12#1)(1994-6#2)(2008-11#4)(2008-12#1)(2008-7#1)(2010-11#1)(2012-11#2)
producing clinical##2##2##(2007-6#1)(2011-2#1)
producing clones##2##2##(1994-11#1)(1994-9#1)
producing diamond##2##2##(1994-6#2)
producing digital##2##2##(2008-2#1)(2008-3#1)
producing either##2##2##(1992-12#1)(2008-11#1)
producing epoxide hydrolase##2##3##(2005-11#2)
producing high##2##2##(1997-4#1)(2008-2#1)
producing higher##2##2##(2009-10#1)(2010-4#1)
producing highly##5##2##(2005-11#1)(2005-8#1)(2008-4#1)(2012-2#1)(2013-8#1)
producing human##4##2##(1995-6#1)(2007-11#1)(2008-11#2)
producing hydrogels with##2##3##(2009-10#2)
producing increased##2##2##(2010-12#1)(2012-2#1)
producing large amounts##2##3##(1994-6#1)(2008-4#1)
producing large##6##2##(1990-8#1)(1994-6#1)(2008-10#1)(2008-4#1)(2009-12#1)(2009-5#1)
producing light##2##2##(1991-2#1)(2008-3#1)
producing monoclonal antibodies##2##3##(1992-8#1)(1994-9#1)
producing monoclonal antibody##2##3##(1994-2#1)(1994-5#1)
producing monoclonal##4##2##(1992-8#1)(1994-2#1)(1994-5#1)(1994-9#1)
producing more##6##2##(1993-1#1)(1993-6#1)(2006-12#1)(2007-12#2)(2009-3#1)
producing moulds##2##2##(1994-6#1)(2009-3#1)
producing much##2##2##(2008-3#1)(2010-7#1)
producing new##5##2##(2006-10#1)(2007-8#1)(2008-11#1)(2008-9#1)(2011-1#1)
producing no##2##2##(1991-3#1)(1992-6#1)
producing optical##2##2##(2008-2#1)(2008-3#1)
producing or##2##2##(2006-10#1)(2008-10#1)
producing phenotype##2##2##(2008-4#2)
producing pulses##2##2##(2007-12#1)(2008-1#1)
producing quality##2##2##(2011-1#1)(2012-2#1)
producing rat pituitary##2##3##(1990-8#1)(1990-9#1)
producing rat##4##2##(1990-8#1)(1990-9#1)(1994-8#1)(2008-11#1)
producing recombinant human##3##3##(2008-11#3)
producing recombinant##12##2##(1993-12#1)(1994-2#1)(1995-5#1)(2008-11#6)(2008-5#1)(2008-8#2)
producing relatively##3##2##(1991-4#1)(2008-11#2)
producing reliable##3##2##(2008-9#2)(2010-10#1)
producing severe##2##2##(2008-10#1)(2008-6#1)
producing small##2##2##(1993-11#1)(1994-2#1)
producing strain##5##2##(1994-2#1)(2005-11#1)(2008-5#1)(2008-8#2)
producing strains of##2##3##(2007-7#1)(2012-2#1)
producing strains were##2##3##(2008-10#1)(2008-11#1)
producing strains##8##2##(1997-6#2)(2006-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2012-2#2)
producing sufficient##2##2##(2006-9#1)(2008-11#1)
producing systems##3##2##(1994-11#1)(2008-1#1)(2008-10#1)
producing the antibiotic 2##2##4##(2008-10#2)
producing the recombinant##2##3##(1992-7#1)(2008-7#1)
producing the##31##2##(1990-11#2)(1990-8#1)(1991-8#1)(1992-1#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-3#1)(1994-10#1)(1995-2#1)(1996-2#1)(1997-2#1)(2005-8#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#1)(2010-8#1)(2012-1#1)(2012-11#1)(2013-7#1)
producing these##2##2##(2007-1#1)(2007-12#1)
producing this##5##2##(1992-9#1)(2008-11#1)(2009-2#1)(2011-2#2)
producing β-cells##2##2##(2010-11#1)(2013-8#1)
producing##689##1##(1990-11#6)(1990-12#2)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#4)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#5)(1991-2#3)(1991-3#4)(1991-4#1)(1991-5#1)(1991-6#3)(1991-8#2)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#5)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#3)(1992-8#3)(1992-9#6)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#4)(1993-5#1)(1993-6#5)(1993-9#4)(1994-10#1)(1994-11#3)(1994-12#5)(1994-2#7)(1994-3#3)(1994-5#4)(1994-6#10)(1994-8#3)(1994-9#4)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-5#2)(1995-6#1)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-4#2)(1996-5#2)(1996-7#2)(1996-8#3)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#3)(2004-1#1)(2004-11#1)(2004-4#1)(2004-8#1)(2004-9#2)(2005-10#2)(2005-11#16)(2005-12#2)(2005-6#1)(2005-7#1)(2005-8#6)(2005-9#1)(2006-10#8)(2006-11#4)(2006-12#4)(2006-4#2)(2006-5#3)(2006-6#1)(2006-8#7)(2006-9#4)(2007-1#2)(2007-10#1)(2007-11#19)(2007-12#26)(2007-2#1)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#5)(2007-8#3)(2007-9#1)(2008-1#9)(2008-10#55)(2008-11#49)(2008-12#8)(2008-2#15)(2008-3#21)(2008-4#21)(2008-5#18)(2008-6#7)(2008-7#17)(2008-8#13)(2008-9#8)(2009-10#7)(2009-11#3)(2009-12#2)(2009-2#4)(2009-3#3)(2009-4#2)(2009-5#2)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#5)(2010-12#6)(2010-2#1)(2010-3#3)(2010-4#2)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-12#2)(2011-2#11)(2012-1#1)(2012-11#10)(2012-12#6)(2012-2#19)(2012-3#5)(2013-1#22)(2013-7#3)(2013-8#4)
product (Rb)##3##2##(1995-2#1)(1996-5#1)(2003-11#1)
product (r =##2##3##(2007-7#2)
product 2##2##2##(2008-10#2)
product CL##2##2##(2008-3#2)
product accumulation##3##2##(1995-12#1)(2006-12#1)(2007-8#1)
product activity##2##2##(1994-2#2)
product after##3##2##(1994-8#1)(1997-2#1)(2008-10#1)
product amplified##2##2##(2008-10#1)(2010-4#1)
product analysis##2##2##(2008-10#1)(2008-4#1)
product and also##2##3##(1992-3#1)(2006-8#1)
product and has##2##3##(2012-12#1)(2012-2#1)
product and in##2##3##(1996-6#1)(2008-10#1)
product and service##2##3##(1995-12#1)(1995-3#1)
product and that##2##3##(2008-3#1)(2008-7#1)
product and the##3##3##(1994-8#1)(1996-8#1)(2008-10#1)
product and##39##2##(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-9#1)(1993-6#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(2006-4#1)(2006-8#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
product and/or##2##2##(2012-2#2)
product application##5##2##(2008-5#5)
product are##7##2##(1990-2#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-5#1)
product as a##2##3##(1995-2#1)(2010-4#1)
product as##7##2##(1990-3#1)(1991-9#1)(1995-2#2)(1997-7#1)(2010-4#1)(2012-12#1)
product associates with##3##3##(1994-11#2)(1994-8#1)
product at the##2##3##(2010-5#1)(2013-1#1)
product at##6##2##(2008-10#3)(2008-5#1)(2010-5#1)(2013-1#1)
product between##2##2##(1992-11#1)(2008-10#1)
product but##2##2##(1997-3#1)(2010-8#1)
product by##7##2##(1994-12#1)(1996-8#1)(2005-9#1)(2008-10#2)(2008-2#1)(2009-9#1)
product called##3##2##(1991-9#1)(2008-5#1)(2010-5#1)
product can be##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
product can##9##2##(1994-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-9#1)(2012-2#1)(2013-1#1)
product characteristics##5##2##(2008-5#2)(2010-12#1)(2012-3#2)
product characterization##2##2##(1994-9#1)(2005-8#1)
product commercialization##2##2##(2008-10#1)(2012-2#1)
product compared##3##2##(2007-12#1)(2008-1#1)(2013-7#1)
product consumption##2##2##(2006-2#1)(2008-12#1)
product contained##4##2##(1990-7#1)(1992-7#1)(1995-2#1)(2008-10#1)
product containing 5%##2##3##(2008-5#2)
product containing##10##2##(1991-12#1)(1996-4#1)(2008-10#2)(2008-5#5)(2012-12#1)
product contains a##2##3##(1990-5#1)(1995-5#1)
product contains##5##2##(1990-11#1)(1990-5#1)(1995-3#1)(1995-5#1)(1995-8#1)
product could be##5##3##(1993-3#1)(1994-5#1)(2009-12#1)(2009-3#1)(2010-2#1)
product could not be##2##4##(1994-5#1)(2008-10#1)
product could##9##2##(1993-3#1)(1994-5#2)(1995-1#1)(2008-10#1)(2008-12#1)(2009-12#1)(2009-3#1)(2010-2#1)
product derived from the##2##4##(2008-5#1)(2010-2#1)
product derived from##5##3##(1990-4#1)(2005-11#1)(2008-5#1)(2010-2#2)
product design##4##2##(1992-2#1)(2009-7#3)
product detection##2##2##(2007-8#1)(2011-1#1)
product development and##2##3##(2008-5#1)(2013-7#1)
product development##11##2##(1994-12#1)(2005-8#2)(2006-5#1)(2007-1#1)(2008-10#1)(2008-5#4)(2013-7#1)
product did not show any##2##5##(1997-2#1)(2012-2#1)
product did not show##3##4##(1993-11#1)(1997-2#1)(2012-2#1)
product dissociation##2##2##(1994-8#1)(1995-8#1)
product does not##2##3##(1994-3#1)(2006-3#1)
product during##2##2##(2008-10#1)(2008-7#1)
product efficacy##2##2##(2008-10#1)(2008-5#1)
product even##2##2##(2007-6#1)(2008-3#1)
product expressed in##2##3##(1994-9#1)(1997-4#1)
product expression##2##2##(1995-6#1)(2008-11#1)
product flow##3##2##(2008-2#2)(2012-2#1)
product flux##2##2##(2008-7#1)(2010-10#1)
product for the##3##3##(2008-2#1)(2011-1#2)
product for##16##2##(1993-1#1)(2004-1#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-4#1)(2011-1#2)
product formation and##2##3##(2006-8#1)(2008-10#1)
product formation in##3##3##(1991-5#1)(1994-3#2)
product formation was##2##3##(1994-5#1)(1994-6#1)
product formation##31##2##(1990-9#1)(1991-5#3)(1992-11#2)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1995-10#4)(1996-10#1)(1996-2#2)(1996-7#1)(1997-4#3)(1997-8#1)(2006-6#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-8#2)
product formed from##2##3##(1997-4#1)(2008-10#1)
product formed##6##2##(1990-12#1)(1992-12#1)(1996-7#1)(1997-4#1)(2004-9#1)(2008-10#1)
product from a##4##3##(1997-8#1)(2006-12#1)(2008-10#1)(2008-6#1)
product from all##2##3##(2008-10#2)
product from the##3##3##(1991-1#1)(2006-1#1)(2009-10#1)
product from##19##2##(1991-1#1)(1992-12#1)(1993-3#1)(1994-12#1)(1996-11#1)(1997-8#1)(2006-1#1)(2006-12#2)(2006-5#1)(2007-12#1)(2007-6#1)(2008-10#4)(2008-6#1)(2009-10#1)(2012-3#1)
product generated##4##2##(1990-2#1)(1994-6#1)(2008-4#1)(2008-5#1)
product has a##3##3##(1993-2#1)(1995-8#1)(2013-1#1)
product has been##8##3##(1990-4#1)(1991-11#1)(2005-9#1)(2006-6#1)(2008-10#2)(2008-11#1)(2009-9#1)
product has##15##2##(1990-11#1)(1990-4#1)(1991-11#1)(1993-2#1)(1995-8#1)(1996-5#1)(2005-9#2)(2006-6#1)(2008-10#2)(2008-11#1)(2009-9#1)(2010-8#1)(2013-1#1)
product have##3##2##(1992-2#1)(1995-6#1)(2008-4#1)
product in brain##2##3##(1993-4#1)(1997-7#1)
product in the presence of##3##5##(1993-4#1)(1996-6#1)(2008-10#1)
product in the##12##3##(1990-7#1)(1991-2#1)(1993-4#1)(1996-6#1)(2006-12#1)(2006-5#1)(2006-8#1)(2008-10#2)(2008-5#1)(2013-1#1)(2013-8#1)
product in##40##2##(1990-3#1)(1990-6#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-4#2)(1994-9#1)(1995-3#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-3#1)(1997-7#1)(2005-7#1)(2006-12#1)(2006-5#1)(2006-8#1)(2008-10#8)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-3#1)(2010-4#1)(2010-5#1)(2013-1#1)(2013-8#1)
product indicated##2##2##(1990-8#1)(2008-5#1)
product information##2##2##(2008-1#1)(2010-4#1)
product inhibition##7##2##(1991-9#1)(1993-8#1)(1994-8#1)(1996-7#1)(2008-7#2)(2011-2#1)
product into##5##2##(1990-1#1)(1991-9#1)(2006-10#1)(2008-11#1)(2008-9#1)
product ion##6##2##(1997-3#1)(2008-10#4)(2010-4#1)
product ions##3##2##(2007-8#1)(2008-10#1)(2009-10#1)
product is a##17##3##(1990-1#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-6#1)(1993-11#2)(1993-9#1)(1994-2#1)(1996-5#1)(1996-7#1)(2008-11#1)(2008-3#1)(2011-1#1)(2013-1#1)
product is approximately##2##3##(1993-8#1)(1994-5#1)
product is detected##2##3##(1996-8#1)(2008-4#1)
product is involved in##2##4##(1990-5#1)(1991-11#1)
product is measured##2##3##(1991-5#1)(2008-10#1)
product is not##3##3##(1994-11#1)(1996-7#1)(2008-11#1)
product is required for##2##4##(1995-6#1)(1996-3#1)
product is required##3##3##(1991-7#1)(1995-6#1)(1996-3#1)
product is##90##2##(1990-1#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#2)(1995-1#1)(1995-2#4)(1995-6#2)(1995-8#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#2)(1996-7#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-12#1)(2005-8#1)(2006-5#1)(2007-11#2)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-9#1)(2009-12#1)(2009-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
product itself##2##2##(1997-4#1)(2008-6#1)
product labeling##2##2##(2006-5#1)(2011-2#1)
product labels##2##2##(2009-4#1)(2010-4#1)
product launch in##2##3##(2005-9#2)
product levels##2##2##(1990-12#1)(2008-10#1)
product limit##3##2##(1993-5#1)(1997-3#1)(2007-8#1)
product line##2##2##(1990-12#1)(1992-2#1)
product lines##4##2##(1993-12#1)(1995-2#1)(1996-3#1)(2008-1#1)
product may be##2##3##(1990-12#1)(2008-9#1)
product may##5##2##(1990-12#1)(2008-5#2)(2008-6#1)(2008-9#1)
product mixture##3##2##(1995-3#1)(1996-2#1)(1996-8#1)
product molecules##3##2##(1994-8#1)(2006-10#1)(2010-10#1)
product moment correlation##2##3##(1996-9#1)(2011-1#1)
product moment##3##2##(1996-9#1)(2008-5#1)(2011-1#1)
product must be##3##3##(2006-6#1)(2008-8#1)(2012-2#1)
product must##4##2##(2006-6#2)(2008-8#1)(2012-2#1)
product obtained##6##2##(1990-7#1)(1993-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2009-12#1)
product of Cr(VI)##2##3##(2008-10#2)
product of NO##2##3##(1993-6#1)(1995-5#1)
product of ORF##2##3##(1995-4#1)(2008-10#1)
product of a tumor suppressor gene##2##6##(2007-11#1)(2011-2#1)
product of a##15##3##(1990-4#1)(1991-1#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-8#1)(1996-4#1)(1996-5#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-11#1)
product of an##3##3##(1995-5#1)(1995-8#1)(2005-12#1)
product of gene##6##3##(1990-12#1)(1990-3#1)(1990-9#1)(1991-6#1)(1995-2#2)
product of glucose##2##3##(1996-5#1)(1997-2#1)
product of heme##2##3##(1992-3#1)(1992-4#1)
product of its##2##3##(1990-5#1)(1996-5#1)
product of lipoxygenase##2##3##(1992-12#2)
product of organic nitrate##2##4##(1991-9#2)
product of reaction between##2##4##(2008-10#2)
product of reaction##5##3##(2008-10#5)
product of the enzymatic reaction##5##5##(1990-8#1)(2008-10#4)
product of the enzymatic##7##4##(1990-8#1)(2008-10#5)(2008-4#1)
product of the enzyme reaction##3##5##(1997-6#1)(2008-10#2)
product of the enzyme##5##4##(1994-8#1)(1995-2#1)(1997-6#1)(2008-10#2)
product of the gene##2##4##(1991-12#1)(1995-6#1)
product of the reaction of##2##5##(1990-2#1)(1995-3#1)
product of the reaction##8##4##(1990-1#1)(1990-2#2)(1992-9#1)(1995-3#1)(2008-10#1)(2008-2#1)(2008-5#1)
product of the spatial##3##4##(2007-12#1)(2008-2#2)
product of the##132##3##(1990-1#1)(1990-11#3)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#2)(1991-11#3)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-6#3)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#2)(1995-7#2)(1995-8#1)(1996-7#2)(1997-1#1)(1997-3#3)(1997-4#1)(1997-6#2)(1997-8#1)(2005-11#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#16)(2008-2#9)(2008-3#11)(2008-4#2)(2008-5#2)(2008-9#2)(2009-10#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-7#1)(2013-1#2)
product of these##2##3##(1995-8#1)(2007-2#1)
product of this gene is##3##5##(1994-5#1)(1995-6#1)(1997-4#1)
product of this gene##6##4##(1993-8#1)(1994-5#1)(1995-6#1)(1997-4#1)(2008-6#1)(2011-1#1)
product of this##9##3##(1993-8#1)(1994-5#1)(1995-6#1)(1995-8#1)(1997-4#1)(2006-8#1)(2007-12#1)(2008-6#1)(2011-1#1)
product of two##7##3##(1990-11#1)(2007-12#2)(2008-2#1)(2008-3#2)(2011-2#1)
product of##351##2##(1990-1#1)(1990-11#5)(1990-12#2)(1990-2#4)(1990-3#5)(1990-4#2)(1990-5#5)(1990-6#2)(1990-7#4)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#2)(1991-9#3)(1992-1#2)(1992-11#5)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#5)(1992-8#3)(1992-9#2)(1993-11#3)(1993-12#4)(1993-2#4)(1993-3#2)(1993-4#2)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#1)(1994-12#7)(1994-2#2)(1994-5#2)(1994-8#5)(1994-9#5)(1995-1#3)(1995-12#2)(1995-2#6)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#4)(1995-7#2)(1995-8#6)(1996-11#1)(1996-12#1)(1996-4#2)(1996-5#5)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#5)(1997-6#3)(1997-7#1)(1997-8#1)(1997-9#1)(2004-11#1)(2005-11#4)(2005-12#2)(2005-7#1)(2006-10#1)(2006-3#2)(2006-4#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#4)(2007-12#9)(2007-2#2)(2007-4#1)(2007-8#4)(2008-10#53)(2008-11#2)(2008-2#14)(2008-3#17)(2008-4#4)(2008-5#9)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#4)(2009-10#1)(2009-2#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#2)(2011-1#3)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#5)(2013-8#1)
product on the market##2##4##(2006-6#2)
product on the##3##3##(2006-6#2)(2008-5#1)
product on##7##2##(1990-11#1)(2006-6#2)(2007-4#1)(2008-5#2)(2009-10#1)
product or##7##2##(1993-2#1)(1994-12#1)(1997-3#1)(2008-10#2)(2008-4#1)(2012-12#1)
product other than##2##3##(1995-2#1)(2010-4#1)
product over##2##2##(1997-4#1)(2013-8#1)
product participates in##2##3##(1995-6#1)(1996-4#1)
product peak##2##2##(1996-6#1)(2008-10#1)
product per##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
product performance##3##2##(2008-5#3)
product produces##2##2##(2008-10#1)(2010-12#1)
product profile##3##2##(1990-10#1)(2008-10#1)(2011-2#1)
product quality and##2##3##(2011-2#2)
product quality##16##2##(1992-2#1)(2008-10#6)(2008-11#2)(2008-7#1)(2011-2#4)(2012-2#1)(2013-1#1)
product ratios##2##2##(1996-5#1)(2007-11#1)
product registration##2##2##(2005-8#1)(2008-8#1)
product release and##2##3##(1995-1#1)(2008-7#1)
product release##7##2##(1990-8#1)(1991-9#1)(1994-8#1)(1995-1#1)(2008-5#1)(2008-7#2)
product removal##4##2##(2008-5#1)(2008-7#1)(2013-1#2)
product resulted##2##2##(1991-8#1)(2012-2#1)
product resulting from##2##3##(1991-3#1)(1995-3#1)
product results##2##2##(2008-7#1)(2010-12#1)
product safety##3##2##(2006-12#1)(2010-10#1)(2010-4#1)
product selection##2##2##(2007-11#1)(2008-1#1)
product should be##3##3##(1992-7#1)(2008-5#1)(2010-11#1)
product showed##6##2##(1991-7#1)(1993-11#1)(2008-10#2)(2008-5#1)(2012-1#1)
product shows##2##2##(1997-3#1)(2008-10#1)
product specifically##2##2##(2008-10#1)(2013-1#1)
product specification##2##2##(1994-3#2)
product spoilage##2##2##(2011-2#2)
product stability##2##2##(1992-3#1)(2008-5#1)
product synthesis##3##2##(1996-5#1)(2008-11#2)
product terms##3##2##(2008-3#1)(2008-6#1)(2011-2#1)
product testing##2##2##(2008-10#1)(2008-5#1)
product than##2##2##(1995-1#1)(2008-5#1)
product that can be##2##4##(2008-4#1)(2008-5#1)
product that##15##2##(1990-5#1)(1991-10#1)(1994-3#1)(1996-12#2)(1996-5#1)(1997-1#1)(1997-4#1)(2007-7#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-5#1)
product through##3##2##(2007-12#1)(2008-10#1)(2012-12#1)
product titre##3##2##(2008-11#3)
product to be##2##3##(1991-12#1)(2011-2#1)
product to##20##2##(1991-10#1)(1991-12#1)(1991-5#1)(1992-6#1)(1992-7#1)(1994-5#1)(1995-12#1)(1996-10#1)(2006-10#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-4#2)(2011-2#2)(2012-2#1)(2013-8#1)
product types##2##2##(2008-5#2)
product under##3##2##(1995-10#1)(2007-11#1)(2008-6#1)
product use##7##2##(2006-3#1)(2007-7#1)(2008-10#3)(2008-5#2)
product used in##2##3##(2008-5#1)(2008-7#1)
product used to##2##3##(1994-3#1)(2008-6#1)
product used##6##2##(1994-3#1)(2006-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)
product using##5##2##(1990-11#1)(1990-3#1)(2008-10#1)(2008-4#1)(2008-5#1)
product utilization##2##2##(2007-9#1)(2011-2#1)
product via##2##2##(1996-8#1)(2008-4#1)
product vs##2##2##(1997-4#1)(2008-5#1)
product was characterized by##2##4##(1993-12#1)(2008-5#1)
product was detected##4##3##(1990-11#1)(1991-12#1)(1991-3#1)(2008-10#1)
product was found to##2##4##(1996-8#1)(2010-5#1)
product was identified##2##3##(1990-9#1)(1994-5#1)
product was inserted##2##3##(2006-5#1)(2011-2#1)
product was observed##3##3##(1991-9#1)(2007-12#1)(2008-7#1)
product was obtained##3##3##(1994-3#1)(2006-8#1)(2008-5#1)
product was purified to homogeneity and##2##6##(1990-7#1)(1992-7#1)
product was purified##4##3##(1990-7#1)(1992-7#1)(1993-3#1)(1997-8#1)
product was then##2##3##(1993-4#1)(2008-10#1)
product was used to##2##4##(1994-2#1)(2008-10#1)
product was used##3##3##(1994-2#1)(2008-10#2)
product was##82##2##(1990-11#2)(1990-2#1)(1990-5#2)(1990-7#1)(1990-9#2)(1991-12#2)(1991-3#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-3#3)(1992-6#2)(1992-7#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-2#2)(1995-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-7#1)(1997-8#2)(2005-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#3)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#13)(2008-12#1)(2008-5#4)(2008-6#4)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)
product we##2##2##(2008-3#1)(2008-5#1)
product were determined##2##3##(1992-6#1)(1994-3#1)
product were##13##2##(1992-6#1)(1994-3#1)(1996-1#1)(1997-8#1)(2008-10#6)(2008-6#3)
product when##5##2##(1996-2#1)(1997-8#1)(2008-10#1)(2008-5#1)(2009-2#1)
product which is##4##3##(1990-11#1)(1990-7#1)(2008-11#1)(2013-8#1)
product which##11##2##(1990-11#1)(1990-7#1)(1992-11#1)(1994-11#1)(1995-8#1)(2008-10#1)(2008-11#3)(2012-3#1)(2013-8#1)
product will##2##2##(1990-12#1)(2005-9#1)
product with a##2##3##(1995-1#1)(2008-10#1)
product with the##4##3##(1990-5#1)(1990-9#1)(1991-12#1)(1994-11#1)
product with##23##2##(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1994-11#1)(1995-1#1)(1995-8#2)(1996-8#1)(1997-2#1)(1997-8#1)(2005-1#1)(2008-10#3)(2008-5#2)(2008-7#1)(2010-4#2)(2010-8#1)(2012-2#1)
product world##2##2##(2008-5#2)
product worlds##3##2##(2008-5#3)
product would be##2##3##(1995-12#1)(2009-9#1)
product would##3##2##(1995-12#1)(2008-10#1)(2009-9#1)
product yield was##2##3##(1990-7#1)(1995-1#1)
product yield##11##2##(1990-7#1)(1995-1#1)(1997-4#2)(1997-6#1)(2008-11#2)(2008-7#3)(2010-4#1)
product yields are##2##3##(2008-11#1)(2008-9#1)
product yields##6##2##(1996-5#1)(2006-12#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)
product##2022##1##(1990-1#4)(1990-10#2)(1990-11#20)(1990-12#14)(1990-2#14)(1990-3#19)(1990-4#6)(1990-5#16)(1990-6#7)(1990-7#16)(1990-8#9)(1990-9#6)(1991-1#3)(1991-10#4)(1991-11#11)(1991-12#14)(1991-2#9)(1991-3#7)(1991-4#3)(1991-5#22)(1991-6#1)(1991-7#9)(1991-8#11)(1991-9#17)(1992-1#8)(1992-10#1)(1992-11#15)(1992-12#11)(1992-2#10)(1992-3#16)(1992-4#2)(1992-5#1)(1992-6#11)(1992-7#5)(1992-8#8)(1992-9#7)(1993-1#2)(1993-11#11)(1993-12#14)(1993-2#11)(1993-3#7)(1993-4#9)(1993-5#2)(1993-6#4)(1993-7#2)(1993-8#5)(1993-9#7)(1994-1#3)(1994-10#3)(1994-11#15)(1994-12#25)(1994-2#12)(1994-3#13)(1994-5#15)(1994-6#7)(1994-8#31)(1994-9#16)(1995-1#12)(1995-10#7)(1995-11#4)(1995-12#6)(1995-2#30)(1995-3#18)(1995-4#5)(1995-5#13)(1995-6#14)(1995-7#2)(1995-8#22)(1995-9#1)(1996-1#4)(1996-10#6)(1996-11#4)(1996-12#9)(1996-2#14)(1996-3#5)(1996-4#7)(1996-5#23)(1996-6#6)(1996-7#11)(1996-8#15)(1996-9#4)(1997-1#6)(1997-2#14)(1997-3#12)(1997-4#24)(1997-5#1)(1997-6#7)(1997-7#12)(1997-8#10)(1997-9#1)(2003-11#1)(2004-1#3)(2004-11#1)(2004-12#3)(2004-7#1)(2004-8#1)(2004-9#2)(2005-1#1)(2005-11#12)(2005-12#2)(2005-4#1)(2005-5#1)(2005-7#4)(2005-8#9)(2005-9#6)(2006-1#1)(2006-10#16)(2006-11#4)(2006-12#13)(2006-2#2)(2006-3#6)(2006-4#3)(2006-5#8)(2006-6#10)(2006-7#1)(2006-8#10)(2006-9#1)(2007-1#3)(2007-10#3)(2007-11#31)(2007-12#33)(2007-2#5)(2007-3#4)(2007-4#4)(2007-5#3)(2007-6#5)(2007-7#9)(2007-8#15)(2007-9#2)(2008-1#8)(2008-10#261)(2008-11#50)(2008-12#4)(2008-2#23)(2008-3#36)(2008-4#27)(2008-5#133)(2008-6#19)(2008-7#36)(2008-8#12)(2008-9#14)(2009-10#8)(2009-11#3)(2009-12#5)(2009-2#6)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#5)(2009-8#5)(2009-9#7)(2010-1#1)(2010-10#7)(2010-11#1)(2010-12#4)(2010-2#7)(2010-3#1)(2010-4#25)(2010-5#14)(2010-6#1)(2010-7#4)(2010-8#9)(2010-9#1)(2011-1#13)(2011-12#1)(2011-2#39)(2012-1#6)(2012-11#4)(2012-12#15)(2012-2#34)(2012-3#8)(2012-7#1)(2013-1#21)(2013-7#4)(2013-8#8)
product's##4##1##(2005-9#1)(2007-10#1)(2012-2#1)(2013-1#1)
product(s) of##2##2##(1994-8#1)(2008-7#1)
product(s)##5##1##(1990-5#1)(1994-8#1)(2008-10#1)(2008-5#1)(2008-7#1)
product) in##2##2##(2008-10#1)(2008-3#1)
product)##16##1##(1991-11#1)(1993-11#1)(1994-12#1)(2007-5#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2010-4#1)
product-attribute##2##1##(2010-8#2)
product-based##3##1##(2008-1#2)(2010-7#1)
product-free##2##1##(1994-5#1)(2008-11#1)
product-line management##5##2##(1994-3#5)
product-moment correlation##2##2##(2007-12#1)(2007-8#1)
product-related##3##1##(2008-10#1)(2010-5#1)(2011-2#1)
product-sharing##3##1##(2007-7#3)
production (1##2##2##(2008-5#2)
production (determined##2##2##(2006-9#1)(2011-2#1)
production according to##2##3##(2008-9#1)(2009-9#1)
production after##3##2##(1994-11#1)(2008-5#1)(2012-2#1)
production also##2##2##(1995-3#1)(1997-1#1)
production among##2##2##(1996-10#1)(2008-8#1)
production and a##4##3##(1995-2#1)(2008-10#2)(2008-11#1)
production and accumulation##3##3##(2006-5#1)(2008-10#2)
production and action##2##3##(2008-4#1)(2010-12#1)
production and activation of##2##4##(1996-4#1)(2008-4#1)
production and activity of##2##4##(2006-10#1)(2008-3#1)
production and analysis of##2##4##(2008-7#1)(2013-8#1)
production and antioxidant defense##2##4##(2005-1#1)(2008-1#1)
production and antioxidant##3##3##(2005-1#2)(2008-1#1)
production and cell##4##3##(1994-2#1)(2006-6#1)(2008-10#1)(2012-2#1)
production and cellular##3##3##(2008-1#1)(2008-10#1)(2009-9#1)
production and characterization of##4##4##(1992-2#1)(1996-5#1)(2008-5#1)(2011-2#1)
production and collection##3##3##(2008-10#2)(2008-8#1)
production and composition##3##3##(1991-1#1)(2012-2#2)
production and consumption##3##3##(2006-2#1)(2008-7#1)(2013-1#1)
production and deposition of beta-amyloid##2##5##(1992-12#1)(1994-9#1)
production and detection of##2##4##(2008-3#1)(2013-1#1)
production and dissemination##3##3##(1992-12#1)(2008-10#1)(2008-9#1)
production and distribution##2##3##(2006-10#1)(2007-4#1)
production and export##2##3##(2008-7#1)(2011-2#1)
production and glycosylation##3##3##(2008-11#2)(2011-2#1)
production and growth##2##3##(2007-1#1)(2008-10#1)
production and has##2##3##(1994-8#1)(2008-1#1)
production and in##2##3##(1994-6#1)(1997-2#1)
production and increase in##2##4##(1997-1#1)(2007-8#1)
production and increased##4##3##(1990-11#1)(2008-10#2)(2008-6#1)
production and induction of##2##4##(2010-4#1)(2011-2#1)
production and integrin##2##3##(2008-5#2)
production and its##2##3##(1994-6#1)(2008-11#1)
production and may##2##3##(1992-7#1)(2008-8#1)
production and metabolism##2##3##(2006-8#1)(2008-11#1)
production and milk fat content##2##5##(2012-2#2)
production and milk##3##3##(2008-12#1)(2012-2#2)
production and oxygen##2##3##(1996-5#2)
production and processing##4##3##(1994-5#1)(1996-2#1)(2007-12#1)(2010-4#1)
production and protein kinase C##2##5##(1990-12#1)(1994-12#1)
production and protein##5##3##(1990-12#1)(1994-12#1)(2010-7#2)(2012-7#1)
production and purification of##2##4##(1991-2#1)(2008-4#1)
production and purification##4##3##(1991-2#1)(1995-8#1)(2008-4#2)
production and quality##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
production and recovery##2##3##(2008-11#2)
production and release by##3##4##(1990-12#1)(1996-2#1)(2010-4#1)
production and release of##3##4##(1994-3#1)(1994-6#1)(2005-12#1)
production and release##8##3##(1990-12#1)(1994-3#1)(1994-6#1)(1996-2#1)(1996-8#1)(2005-12#1)(2008-10#1)(2010-4#1)
production and resistance to##2##4##(2006-10#1)(2008-10#1)
production and secretion of##2##4##(1991-9#1)(1994-8#1)
production and secretion##4##3##(1991-9#1)(1994-8#1)(1995-10#1)(1997-2#1)
production and the##17##3##(1990-5#1)(1995-5#1)(1996-10#1)(1996-6#1)(2005-11#1)(2005-7#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2013-8#1)
production and their##2##3##(2008-10#2)
production and to##5##3##(1993-2#1)(2007-5#1)(2008-1#1)(2008-3#1)(2011-1#1)
production and use##3##3##(1991-12#1)(2008-11#1)(2010-4#1)
production and vaporization##2##3##(2007-4#2)
production and##325##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-1#4)(1991-10#3)(1991-12#1)(1991-2#1)(1991-5#2)(1991-8#3)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-10#2)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#2)(1995-10#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-10#3)(1996-12#1)(1996-2#4)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#3)(1997-1#1)(1997-2#2)(1997-4#2)(2004-12#1)(2005-1#2)(2005-11#2)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#6)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#3)(2006-9#3)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#2)(2007-4#4)(2007-5#3)(2007-6#2)(2007-8#3)(2008-1#5)(2008-10#37)(2008-11#19)(2008-12#4)(2008-2#3)(2008-3#5)(2008-4#7)(2008-5#17)(2008-6#3)(2008-7#11)(2008-8#9)(2008-9#3)(2009-12#1)(2009-3#1)(2009-8#4)(2009-9#3)(2010-10#1)(2010-12#2)(2010-2#2)(2010-4#5)(2010-7#3)(2011-1#3)(2011-12#2)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#12)(2012-3#3)(2012-7#1)(2013-1#13)(2013-7#1)(2013-8#4)
production and/or##4##2##(1994-8#1)(1997-3#1)(2008-1#1)(2010-10#1)
production are not##2##3##(2008-10#1)(2008-4#1)
production are##11##2##(1990-3#1)(2006-10#1)(2008-10#2)(2008-4#2)(2009-5#1)(2012-2#1)(2012-3#1)(2013-1#2)
production area##4##2##(2008-10#3)(2008-5#1)
production areas and##3##3##(1994-6#1)(2008-10#2)
production areas in Canada##2##4##(2008-10#2)
production areas in##3##3##(2008-10#2)(2011-2#1)
production areas of the world##2##5##(2008-10#2)
production areas of the##4##4##(2008-10#4)
production areas of##6##3##(2007-8#1)(2008-10#4)(2008-12#1)
production areas##20##2##(1994-6#2)(2007-8#2)(2008-10#14)(2008-12#1)(2011-2#1)
production as a result of##2##5##(1991-12#1)(2011-2#1)
production as a##6##3##(1991-12#1)(1991-5#1)(2006-10#1)(2007-6#1)(2011-2#2)
production as an##2##3##(1992-2#1)(2009-3#1)
production as compared to##2##4##(2008-12#1)(2012-11#1)
production as evidenced##2##3##(1994-5#1)(2008-10#1)
production as well as cell proliferation in##2##7##(2007-2#2)
production as well as##3##4##(2007-2#2)(2008-1#1)
production as##20##2##(1991-12#2)(1991-5#1)(1992-2#1)(1994-5#1)(1997-7#1)(2006-10#1)(2007-2#2)(2007-6#1)(2008-1#1)(2008-10#3)(2008-12#1)(2009-3#1)(2010-7#1)(2011-2#2)(2012-11#1)
production assay##4##2##(2008-11#4)
production assays##2##2##(2008-11#2)
production at a##2##3##(1993-6#1)(2008-11#1)
production at the##4##3##(1995-9#1)(1996-5#1)(2008-11#1)(2008-4#1)
production at##20##2##(1990-12#1)(1993-6#1)(1994-12#1)(1994-2#2)(1995-10#1)(1995-9#1)(1996-5#1)(2007-5#1)(2007-6#1)(2008-11#5)(2008-3#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-11#1)
production before and after##3##4##(1996-4#1)(2008-9#2)
production before##4##2##(1996-4#1)(2006-3#1)(2008-9#2)
production being##2##2##(2008-11#1)(2012-2#1)
production between##2##2##(2008-10#1)(2008-12#1)
production but##6##2##(1996-3#1)(2007-2#1)(2008-11#1)(2008-5#2)(2011-2#1)
production by A##2##3##(2008-10#2)
production by B##2##3##(2008-4#1)(2008-5#1)
production by Bacillus##2##3##(2007-12#1)(2011-2#1)
production by HOMC##2##3##(1990-11#2)
production by Pseudomonas aeruginosa##3##4##(2006-10#1)(2008-5#1)(2008-6#1)
production by Saccharomyces##2##3##(1995-6#1)(2012-3#1)
production by T##3##3##(2005-11#1)(2008-10#1)(2008-4#1)
production by a##7##3##(1993-9#1)(1994-9#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-9#1)(2012-2#1)
production by dendritic cells##2##4##(1996-10#1)(2009-9#1)
production by dermal fibroblasts##2##4##(2008-11#2)
production by fibroblasts##2##3##(1991-1#1)(2009-8#1)
production by human peripheral blood##3##5##(1993-11#1)(1996-4#1)(2008-11#1)
production by human##15##3##(1990-8#1)(1991-9#1)(1992-7#1)(1993-11#1)(1994-12#1)(1994-3#1)(1996-10#1)(1996-4#1)(2006-5#1)(2006-9#1)(2008-10#1)(2008-11#3)(2008-5#1)
production by in##4##3##(2008-11#4)
production by isolated##2##3##(1991-1#1)(1991-3#1)
production by macrophages##3##3##(1994-11#1)(2007-11#1)(2008-10#1)
production by peripheral blood mononuclear cells##2##6##(1996-10#2)
production by phorbol##2##3##(1991-9#1)(1993-11#1)
production by rat alveolar macrophages##2##5##(1992-6#2)
production by simultaneous saccharification and##2##5##(2008-5#2)
production by simultaneous##3##3##(2008-5#2)(2008-6#1)
production by the##18##3##(1993-11#1)(1997-3#1)(1997-8#1)(2006-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2010-7#2)(2011-1#1)(2013-8#1)
production by these cells##2##4##(1995-5#1)(1997-8#1)
production by this##2##3##(1991-12#1)(2008-10#1)
production by using##2##3##(2005-1#1)(2013-8#1)
production by##225##2##(1990-11#2)(1990-5#6)(1990-7#2)(1990-8#1)(1991-1#2)(1991-10#1)(1991-12#2)(1991-3#3)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#3)(1991-9#2)(1992-1#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#2)(1992-9#2)(1993-11#4)(1993-9#1)(1994-11#5)(1994-12#2)(1994-3#3)(1994-5#1)(1994-8#4)(1994-9#1)(1995-10#4)(1995-5#1)(1995-6#2)(1995-9#1)(1996-10#8)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-8#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-8#2)(2004-8#1)(2005-1#1)(2005-11#3)(2005-8#1)(2006-1#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-8#4)(2006-9#2)(2007-11#3)(2007-12#4)(2007-2#3)(2007-3#2)(2007-7#2)(2008-1#1)(2008-10#19)(2008-11#24)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#13)(2008-6#7)(2008-7#5)(2008-8#3)(2008-9#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
production can be##4##3##(2007-9#1)(2008-11#1)(2013-8#2)
production capabilities##2##2##(1992-12#1)(2012-1#1)
production capacity##6##2##(2006-12#1)(2007-7#1)(2008-11#3)(2008-6#1)
production caused by##2##3##(1994-5#1)(2007-11#1)
production caused##3##2##(1994-5#1)(2004-11#1)(2007-11#1)
production cell line##2##3##(2012-3#2)
production cell lines##3##3##(2008-11#2)(2012-3#1)
production cell##5##2##(2008-11#2)(2012-3#3)
production chain##2##2##(2008-10#2)
production compared to##2##3##(2008-11#1)(2008-5#1)
production conditions##3##2##(2006-12#1)(2008-11#1)(2012-1#1)
production constraints##4##2##(2006-3#1)(2008-10#1)(2011-1#2)
production control##2##2##(1994-8#1)(2008-5#1)
production cost of##2##3##(2006-11#1)(2008-6#1)
production cost##6##2##(2006-11#1)(2007-8#1)(2008-2#1)(2008-5#1)(2008-6#1)(2013-8#1)
production costs and their##2##4##(2008-12#2)
production costs and##4##3##(1995-2#1)(2007-11#1)(2008-12#2)
production costs##6##2##(1994-5#1)(1995-2#1)(2007-11#1)(2008-11#1)(2008-12#2)
production could be##2##3##(1992-3#1)(1997-6#1)
production could##5##2##(1992-3#1)(1995-3#2)(1997-6#1)(2008-11#1)
production cycle##3##2##(2008-11#1)(2008-7#1)(2011-2#1)
production data##4##2##(2008-11#1)(2008-5#1)(2013-8#2)
production decreased##3##2##(2008-10#1)(2008-11#2)
production depend##2##2##(1991-2#1)(1995-5#1)
production does not##3##3##(1993-11#1)(2006-4#1)(2008-11#1)
production due to##3##3##(1990-7#1)(2007-7#1)(2008-11#1)
production during ischemia##2##3##(1994-5#1)(1997-1#1)
production during reperfusion##2##3##(1994-5#2)
production during the initial##2##4##(1996-9#1)(2007-6#1)
production during the##5##3##(1996-9#1)(2007-6#1)(2008-5#1)(2008-8#1)(2013-1#1)
production during##18##2##(1990-12#1)(1994-5#4)(1995-5#1)(1996-9#1)(1997-1#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-6#1)(2008-5#2)(2008-8#1)(2009-9#1)(2010-9#1)(2013-1#1)
production efficiency and##3##3##(2008-11#2)(2008-6#1)
production efficiency##6##2##(1992-2#1)(2008-11#3)(2008-6#1)(2009-3#1)
production elicited by##2##3##(1992-11#1)(1994-9#1)
production enhancement##2##2##(1994-5#1)(2008-11#1)
production environment##2##2##(2008-10#1)(2011-12#1)
production evolved##2##2##(2008-10#1)(2013-8#1)
production field##2##2##(2011-2#2)
production fields in##2##3##(2008-10#2)
production fields##10##2##(2008-10#10)
production following##5##2##(1996-2#1)(1996-9#1)(2008-11#2)(2009-9#1)
production food safety##2##3##(2011-2#2)
production for##12##2##(1991-11#1)(1996-11#1)(2004-9#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-6#1)(2008-8#1)
production from a##3##3##(2008-11#3)
production from blood PMNs##2##4##(1995-1#2)
production from glucose##4##3##(1990-11#2)(1995-3#1)(2012-3#1)
production from human##2##3##(1997-8#1)(2010-4#1)
production from the##9##3##(1997-6#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2009-6#1)
production from##79##2##(1990-11#3)(1991-12#1)(1991-5#2)(1991-9#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-1#4)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-4#1)(1996-9#1)(1997-5#1)(1997-6#1)(1997-8#2)(2004-8#1)(2006-8#1)(2008-1#1)(2008-10#4)(2008-11#11)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#8)(2008-7#1)(2009-3#1)(2009-6#2)(2010-4#1)(2011-1#1)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#7)
production had##2##2##(2008-10#1)(2008-8#1)
production has been observed in##2##5##(1990-2#1)(2007-2#1)
production has been##5##3##(1990-2#1)(2005-11#1)(2007-2#1)(2008-5#2)
production has not been##3##4##(2008-10#1)(2008-11#1)(2012-7#1)
production has##13##2##(1990-2#1)(1991-3#1)(1994-9#1)(2005-11#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-5#2)(2012-7#2)
production have been##2##3##(1996-5#1)(2008-12#1)
production have##3##2##(1992-9#1)(1996-5#1)(2008-12#1)
production in B##2##3##(1990-11#1)(2011-1#1)
production in Bacillus megaterium##2##4##(2011-1#2)
production in Bacillus##3##3##(2011-1#2)(2011-2#1)
production in CHO cells##2##4##(2008-11#2)
production in Canada##3##3##(2008-10#2)(2008-5#1)
production in China##2##3##(1997-4#1)(2008-4#1)
production in E##2##3##(1993-9#1)(2010-10#1)
production in Escherichia coli##3##4##(1993-9#1)(2008-7#1)(2013-1#1)
production in GM-CSF primed##2##4##(1990-7#2)
production in LPS-stimulated##2##3##(1997-6#1)(2009-9#1)
production in PBMCs##4##3##(2011-1#4)
production in T##2##3##(2009-6#1)(2010-2#1)
production in a dose-dependent manner##4##5##(1993-6#1)(1996-8#1)(2008-10#1)(2008-11#1)
production in a##13##3##(1990-4#1)(1993-3#1)(1993-6#1)(1996-8#1)(2004-12#1)(2005-12#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-6#1)(2009-8#1)
production in activated##3##3##(1994-5#1)(1996-10#1)(2006-10#1)
production in aged mice##2##4##(1992-12#1)(1994-6#1)
production in all##4##3##(1992-8#1)(2008-10#2)(2008-11#1)
production in batch##2##3##(1994-8#1)(2008-11#1)
production in both##2##3##(2010-12#1)(2013-8#1)
production in cattle vaccinated with Brucella abortus strain RB51##2##9##(2010-4#2)
production in cells##2##3##(1994-11#1)(2005-8#1)
production in comparison##2##3##(1997-8#1)(2008-5#1)
production in culture##2##3##(1990-5#1)(1996-12#1)
production in cultured##6##3##(1990-11#1)(1990-3#1)(1990-7#1)(1992-3#1)(2008-10#1)(2013-1#1)
production in cultures##2##3##(1997-1#1)(2008-7#1)
production in human##6##3##(1991-9#1)(2008-10#2)(2011-1#1)(2011-12#1)(2012-12#1)
production in insulin-secreting##2##3##(1997-1#2)
production in lipopolysaccharide##2##3##(2009-9#1)(2011-1#1)
production in macrophages##2##3##(1997-6#1)(2007-2#1)
production in mice##4##3##(1995-9#1)(1997-7#2)(2008-10#1)
production in normal##2##3##(1996-5#1)(2005-10#1)
production in patients with##3##4##(2007-11#2)(2007-2#1)
production in patients##4##3##(2007-11#2)(2007-2#1)(2007-4#1)
production in perfusion culture##2##4##(1994-5#1)(2008-11#1)
production in peripheral##2##3##(2005-8#1)(2006-10#1)
production in peritoneal##2##3##(1993-12#1)(2008-10#1)
production in primary##2##3##(1994-11#1)(1997-8#1)
production in rat##2##3##(1991-12#1)(2012-2#1)
production in rats by##2##4##(1992-11#2)
production in rats##4##3##(1992-11#3)(1994-5#1)
production in recombinant Chinese hamster ovary##2##6##(2008-11#2)
production in recombinant##4##3##(2008-11#2)(2008-7#2)
production in response to##10##4##(1990-11#1)(1991-12#1)(1992-3#1)(1993-11#1)(1995-1#1)(1995-12#1)(1996-5#1)(2008-10#1)(2010-5#1)(2012-2#1)
production in serum-free##2##3##(2008-11#2)
production in suspension##2##3##(2008-11#2)
production in the United States##2##5##(2008-10#2)
production in the brain##3##4##(1994-2#1)(1995-12#1)(2012-2#1)
production in the cells##2##4##(1990-8#1)(1993-9#1)
production in the presence of cell walls from##2##8##(2008-10#2)
production in the rat##3##4##(1990-5#1)(1993-4#1)(1995-5#1)
production in the##57##3##(1990-5#1)(1990-8#1)(1991-9#1)(1992-11#1)(1992-9#1)(1993-4#1)(1993-9#2)(1994-11#1)(1994-2#1)(1995-1#2)(1995-12#2)(1995-5#1)(1996-2#1)(1997-4#1)(1997-8#1)(2005-12#1)(2006-3#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-6#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-9#1)(2010-8#2)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
production in these cells##2##4##(1994-3#1)(1996-11#1)
production in these##5##3##(1994-3#1)(1996-11#1)(2007-2#1)(2008-10#1)(2013-1#1)
production in this##3##3##(1997-4#1)(2009-10#1)(2009-8#1)
production in three##3##3##(2008-12#1)(2011-2#1)(2012-12#1)
production in various##3##3##(1992-8#1)(2006-6#1)(2011-2#1)
production in vitro and##3##4##(1991-8#1)(2008-10#1)(2008-5#1)
production in vitro##9##3##(1991-8#1)(1992-8#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2011-1#1)
production in vivo##7##3##(1990-2#1)(1991-8#2)(1995-12#1)(1995-8#1)(1996-10#1)(2007-11#1)
production in##409##2##(1990-10#2)(1990-11#4)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#4)(1990-8#3)(1991-12#5)(1991-5#1)(1991-8#4)(1991-9#2)(1992-1#2)(1992-11#5)(1992-12#3)(1992-3#2)(1992-4#1)(1992-5#2)(1992-8#6)(1992-9#3)(1993-11#1)(1993-12#1)(1993-3#4)(1993-4#1)(1993-6#3)(1993-9#4)(1994-10#3)(1994-11#7)(1994-2#2)(1994-3#3)(1994-5#5)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#3)(1995-12#4)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-10#2)(1996-11#2)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#1)(1997-4#5)(1997-6#2)(1997-7#2)(1997-8#4)(2004-12#1)(2005-10#1)(2005-12#2)(2005-8#2)(2006-10#5)(2006-12#1)(2006-3#1)(2006-4#2)(2006-6#1)(2006-9#1)(2007-1#3)(2007-11#6)(2007-12#6)(2007-2#6)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#56)(2008-11#28)(2008-12#2)(2008-4#6)(2008-5#14)(2008-6#3)(2008-7#11)(2008-8#5)(2008-9#2)(2009-10#1)(2009-12#3)(2009-3#2)(2009-4#6)(2009-6#2)(2009-8#5)(2009-9#5)(2010-10#2)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#3)(2010-5#1)(2010-8#3)(2011-1#14)(2011-12#3)(2011-2#7)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#13)(2013-7#1)(2013-8#3)
production increased with increasing##2##4##(2008-10#2)
production increased##7##2##(2007-12#1)(2008-10#3)(2008-11#1)(2012-2#1)(2013-1#1)
production indicates##2##2##(1995-8#1)(2008-10#1)
production induced by##9##3##(1990-12#1)(1991-5#1)(1994-9#1)(1996-2#1)(2006-10#1)(2008-10#2)(2008-4#1)(2011-1#1)
production induced##10##2##(1990-12#1)(1991-5#1)(1994-9#1)(1996-2#1)(2006-10#1)(2008-10#2)(2008-4#2)(2011-1#1)
production involves the##2##3##(2008-1#1)(2009-9#1)
production is a##2##3##(2005-8#1)(2008-8#1)
production is discussed##2##3##(2008-6#1)(2008-7#1)
production is increased in##2##4##(1995-3#1)(2010-4#1)
production is increased##4##3##(1995-3#1)(2005-1#1)(2006-10#1)(2010-4#1)
production is inhibited##2##3##(1991-2#1)(2005-1#1)
production is not##7##3##(1993-5#1)(1994-8#1)(1996-1#1)(2005-10#1)(2007-11#1)(2008-11#1)(2010-4#1)
production is proposed##2##3##(2008-10#1)(2008-8#1)
production is rapidly##2##3##(1993-12#1)(2010-12#1)
production is regulated##2##3##(1993-6#1)(1997-4#1)
production is##67##2##(1990-2#1)(1991-2#1)(1991-3#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-9#1)(1997-4#1)(2005-1#2)(2005-10#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-5#2)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-6#3)(2008-7#2)(2008-8#4)(2008-9#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-7#1)(2011-2#1)(2013-1#1)
production level of##5##3##(1993-6#1)(1994-2#1)(2007-2#1)(2008-11#1)(2008-7#1)
production level##8##2##(1993-6#1)(1994-2#1)(2007-2#1)(2008-11#3)(2008-7#1)(2013-8#1)
production levels##3##2##(1994-2#1)(2008-7#1)(2008-8#1)
production line and##2##3##(2012-2#2)
production line##7##2##(1994-4#1)(1994-6#1)(2008-10#1)(2008-2#1)(2012-2#2)(2013-8#1)
production losses##2##2##(2008-5#1)(2009-10#1)
production made##2##2##(2007-10#1)(2008-11#1)
production may be##3##3##(1991-9#1)(1994-8#1)(2008-7#1)
production may##6##2##(1991-9#1)(1994-8#1)(1997-5#1)(2007-9#1)(2008-3#1)(2008-7#1)
production mechanisms in the left hemisphere##2##6##(2007-7#2)
production mechanisms##4##2##(2007-7#3)(2008-2#1)
production medium##8##2##(2006-9#3)(2008-10#1)(2008-4#1)(2008-5#1)(2012-2#2)
production method##2##2##(1994-6#1)(2008-3#1)
production methods and##3##3##(2005-11#1)(2010-4#1)(2011-1#1)
production methods##6##2##(1992-11#1)(2005-11#1)(2008-10#1)(2008-11#1)(2010-4#1)(2011-1#1)
production might be##2##3##(1992-1#1)(1994-9#1)
production might##4##2##(1992-1#1)(1994-9#1)(2010-10#1)(2012-2#1)
production not only##2##3##(2007-8#1)(2008-11#1)
production obtained##2##2##(2008-10#1)(2008-11#1)
production occurred##3##2##(2008-11#1)(2008-5#1)(2013-1#1)
production occurs in the##2##4##(1993-7#1)(1996-5#1)
production occurs##7##2##(1993-7#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#1)
production of 1##3##3##(1992-5#1)(2008-5#1)(2008-7#1)
production of 6-APA##5##3##(1992-11#2)(2008-12#3)
production of A##3##3##(1996-6#1)(2008-10#2)
production of AM##2##3##(1994-6#1)(1994-8#1)
production of Anticarsia gemmatalis##3##4##(2008-11#3)
production of C2H6##2##3##(1996-5#2)
production of CEA per cell##2##5##(2008-11#2)
production of CEA##3##3##(2008-11#3)
production of HIV-1##3##3##(1993-9#1)(1994-3#1)(2011-2#1)
production of IFN-beta##3##3##(2008-11#3)
production of IFN-gamma by NK cells##2##6##(2009-9#2)
production of IFN-gamma by##3##4##(1993-4#1)(2009-9#2)
production of IFN-gamma##9##3##(1993-4#1)(1994-6#1)(1996-10#1)(2007-2#1)(2008-11#1)(2008-7#1)(2009-9#3)
production of IL-1##2##3##(2008-5#1)(2009-9#1)
production of IL-10 by##4##4##(1993-4#1)(1994-12#1)(2006-10#1)(2011-2#1)
production of IL-10##8##3##(1993-4#1)(1994-12#2)(1996-12#1)(2006-10#1)(2007-9#1)(2011-2#1)(2012-12#1)
production of IL-12 and##2##4##(2009-9#1)(2011-2#1)
production of IL-12##6##3##(1996-10#4)(2009-9#1)(2011-2#1)
production of IL-2##3##3##(1992-8#2)(2010-2#1)
production of IL-4##2##3##(2008-10#1)(2009-5#1)
production of IL-6 and##2##4##(1996-6#1)(2008-10#1)
production of IL-6##5##3##(1990-5#1)(1992-4#1)(1996-6#1)(2008-10#1)(2012-3#1)
production of IgM##3##3##(1991-5#1)(1993-12#1)(1995-2#1)
production of L-lactic acid##3##4##(2008-6#2)(2008-7#1)
production of MAb##2##3##(2008-11#2)
production of NADPH##2##3##(1990-2#1)(1991-6#1)
production of NGF##2##3##(1994-3#1)(1996-3#1)
production of NO##5##3##(1994-11#1)(1994-6#1)(2006-8#2)(2013-8#1)
production of O2##2##3##(1994-3#1)(2008-4#1)
production of OH##2##3##(1991-10#1)(2008-10#1)
production of P##2##3##(2008-10#2)
production of ROS and##2##4##(2008-10#1)(2008-6#1)
production of ROS##10##3##(1994-11#1)(1994-5#3)(2005-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2010-7#1)
production of TGF-beta##2##3##(1995-12#1)(2006-10#1)
production of TH by bulbar neurons##2##6##(1992-8#2)
production of TNF in##2##4##(1992-3#1)(1995-9#1)
production of TNF##6##3##(1992-3#1)(1995-9#4)(2006-8#1)
production of TNF-alpha##4##3##(1992-12#1)(1993-9#1)(1994-5#1)(2008-10#1)
production of Th2 cytokines##2##4##(2006-10#1)(2012-2#1)
production of VEGF##2##3##(1997-7#2)
production of [3-13C]lactate##2##3##(1995-1#2)
production of a highly##2##4##(1997-3#1)(2008-10#1)
production of a mature##2##4##(2011-3#2)
production of a murine##2##4##(1994-12#1)(2008-4#1)
production of a recombinant protein##2##5##(1994-2#1)(2008-11#1)
production of a recombinant##5##4##(1994-11#1)(1994-12#1)(1994-2#1)(2008-11#2)
production of a secreted##2##4##(1994-3#1)(2008-11#1)
production of a##66##3##(1990-11#1)(1990-12#1)(1990-7#2)(1991-7#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#3)(1997-3#1)(1997-4#1)(1997-7#3)(2005-7#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-11#10)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#3)(2008-7#2)(2009-3#1)(2009-8#1)(2011-2#2)(2011-3#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
production of abnormal##2##3##(1992-12#1)(2008-10#1)
production of an antimicrobial##2##4##(2008-5#1)(2011-2#1)
production of an##15##3##(1991-6#1)(1992-7#1)(1996-1#1)(1996-5#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
production of antibodies against##4##4##(1993-3#1)(1993-4#1)(2008-4#1)(2011-2#1)
production of antibodies##16##3##(1990-12#1)(1993-3#2)(1993-4#1)(1995-11#1)(1995-5#1)(2007-11#1)(2008-11#2)(2008-2#1)(2008-4#3)(2008-5#1)(2010-12#1)(2011-2#1)
production of antibody##3##3##(2007-8#1)(2008-11#1)(2011-2#1)
production of antidiuretic hormone##2##4##(2006-6#2)
production of antigen-specific##2##3##(1992-8#1)(2008-10#1)
production of apothecia##3##3##(2008-10#3)
production of ascospores##3##3##(2008-10#3)
production of autoantibodies##2##3##(1997-4#1)(2005-11#1)
production of bacterial##2##3##(1995-8#1)(2008-6#1)
production of beta##2##3##(1991-3#1)(1994-8#1)
production of beta-galactosidase##2##3##(2008-11#1)(2008-7#1)
production of beta-lactamases##3##3##(2008-12#2)(2012-12#1)
production of bioactive##2##3##(2008-11#1)(2012-11#1)
production of biodiesel##4##3##(2008-5#2)(2008-6#2)
production of bioethanol##3##3##(2008-5#3)
production of biologically active##9##4##(1993-6#2)(1994-8#1)(1996-10#1)(1996-11#1)(1997-4#1)(2007-11#1)(2008-11#1)(2008-5#1)
production of biopharmaceuticals##3##3##(2008-11#2)(2011-2#1)
production of biosurfactant by##2##4##(2007-12#1)(2008-6#1)
production of both##6##3##(1990-12#1)(1990-7#1)(1992-1#1)(1994-2#1)(2007-4#1)(2008-11#1)
production of bovine##2##3##(1993-9#1)(2008-11#1)
production of cAMP##2##3##(1995-3#1)(1997-2#1)
production of chimeric##2##3##(1994-3#1)(1995-3#1)
production of collagen##2##3##(1995-12#1)(2008-11#1)
production of conidia##2##3##(2008-10#2)
production of corn##2##3##(1997-4#1)(2008-10#1)
production of cultured##2##3##(1991-8#1)(1994-2#1)
production of cytokines and##2##4##(2008-11#1)(2008-4#1)
production of cytokines by##2##4##(1991-10#1)(1995-12#1)
production of cytokines##9##3##(1991-10#1)(1992-2#1)(1995-12#1)(2006-2#1)(2008-11#2)(2008-4#1)(2010-4#1)(2013-1#1)
production of diacylglycerol##2##3##(1991-9#1)(2008-11#1)
production of either##2##3##(1991-11#1)(1995-2#1)
production of endothelin##2##3##(1994-11#2)
production of erythropoietin##2##3##(1994-6#1)(2007-7#1)
production of estrogens##2##3##(2010-2#1)(2012-3#1)
production of ethanol from##2##4##(2008-6#2)
production of ethanol##4##3##(2008-6#2)(2008-7#1)(2008-8#1)
production of extracellular##5##3##(2006-9#1)(2007-3#1)(2008-10#2)(2011-2#1)
production of female##2##3##(2006-12#1)(2008-8#1)
production of fetal##2##3##(2005-11#1)(2008-10#1)
production of foreign proteins##3##4##(1991-7#1)(1997-4#1)(2011-12#1)
production of foreign##4##3##(1991-7#1)(1997-4#2)(2011-12#1)
production of free oxygen radicals##3##5##(1991-11#2)(2006-8#1)
production of free radicals##6##4##(1991-12#1)(2005-8#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-10#1)
production of free##9##3##(1991-11#2)(1991-12#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-9#1)(2008-10#1)
production of fuel ethanol##2##4##(2004-8#1)(2008-6#1)
production of fuels and chemicals##2##5##(2008-5#1)(2011-1#1)
production of fuels##3##3##(2008-5#2)(2011-1#1)
production of functional##3##3##(1990-5#1)(1993-9#1)(1994-11#1)
production of glucose from##2##4##(1991-9#1)(1997-7#1)
production of glucose##4##3##(1991-9#1)(1997-7#1)(2008-10#1)(2008-5#1)
production of glutamate##2##3##(1992-1#1)(2007-12#1)
production of glycoproteins##2##3##(2008-4#1)(2008-7#1)
production of good##2##3##(2008-11#1)(2010-2#1)
production of growth factors##4##4##(1993-11#1)(2005-7#1)(2008-1#1)(2013-8#1)
production of health##2##3##(1994-2#1)(2008-7#1)
production of high levels of##2##5##(2008-10#1)(2008-11#1)
production of high##6##3##(1994-11#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-6#1)(2012-7#1)
production of human insulin and its C-peptide##2##7##(1996-7#2)
production of human monoclonal antibodies##2##5##(2008-11#2)
production of human umbilical vein endothelial cells##2##7##(1994-9#2)
production of human##11##3##(1993-3#1)(1994-9#3)(1996-7#2)(2006-10#1)(2008-11#3)(2010-7#1)
production of human-human##2##3##(2008-11#2)
production of hybridomas##3##3##(1992-7#1)(1992-8#1)(2008-4#1)
production of hydrogen##2##3##(2008-10#1)(2008-4#1)
production of hydroxyl##2##3##(1997-8#1)(2007-11#1)
production of industrially##2##3##(2008-7#1)(2011-1#1)
production of infectious##2##3##(2008-9#1)(2012-2#1)
production of inflammatory mediators and##3##5##(2008-4#1)(2013-1#2)
production of inflammatory mediators##7##4##(2004-11#1)(2007-11#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#2)
production of inflammatory##9##3##(1996-3#1)(1997-3#1)(2004-11#1)(2007-11#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#2)
production of inositol phosphates##3##4##(1990-8#2)(1996-8#1)
production of inositol trisphosphate##4##4##(1990-8#2)(1991-12#1)(1994-10#1)
production of inositol##9##3##(1990-8#5)(1991-12#1)(1994-10#1)(1996-8#1)(1997-1#1)
production of inositol(1##2##3##(1990-12#1)(1994-11#1)
production of insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding##2##11##(1995-10#2)
production of interferon##3##3##(1990-8#1)(2008-11#1)(2008-5#1)
production of interferon-beta per unit cell##2##6##(2008-11#2)
production of interferon-beta##5##3##(2008-11#5)
production of interferon-gamma##3##3##(2007-2#2)(2009-9#1)
production of interleukin##2##3##(1991-8#1)(2006-10#1)
production of interleukin-6 (IL-6)##4##4##(1992-12#1)(1992-4#1)(1994-6#1)(2007-11#1)
production of interleukin-6##5##3##(1992-12#1)(1992-4#1)(1993-12#1)(1994-6#1)(2007-11#1)
production of lactic acid from cheese whey##3##7##(2008-5#2)(2008-6#1)
production of lactic acid##6##4##(2008-5#2)(2008-6#3)(2008-7#1)
production of large quantities of##3##5##(2008-11#2)(2008-7#1)
production of large##4##3##(1994-8#1)(2008-11#2)(2008-7#1)
production of lignin peroxidase##2##4##(2008-5#1)(2008-6#1)
production of lignin##3##3##(2008-11#1)(2008-5#1)(2008-6#1)
production of lignin-degrading enzymes by free and entrapped cells ofPhanerochoete chrysosporium in a tubular air-lift bioreactor##2##16##(2008-5#2)
production of lipid peroxidation##2##4##(1991-12#1)(2008-7#1)
production of local##2##3##(2008-10#1)(2008-8#1)
production of mRNA##2##3##(1997-8#1)(2009-10#1)
production of male##2##3##(2008-8#1)(2012-2#1)
production of manganese peroxidase##2##4##(2008-5#1)(2008-7#1)
production of many cytokines##2##4##(2006-10#1)(2008-4#1)
production of mature##4##3##(1992-4#1)(1994-9#1)(1995-6#1)(2011-3#1)
production of melanin##2##3##(1996-9#1)(2013-1#1)
production of metabolites##2##3##(1991-12#1)(1994-11#1)
production of methane##2##3##(2008-6#2)
production of monoclonal antibodies##10##4##(1992-8#2)(2008-11#2)(2008-4#3)(2008-9#1)(2011-2#1)(2012-3#1)
production of monoclonal antibody##4##4##(2008-11#3)(2008-4#1)
production of monoclonal##15##3##(1992-8#2)(1996-2#1)(2008-11#5)(2008-4#4)(2008-9#1)(2011-2#1)(2012-3#1)
production of most##2##3##(1996-10#1)(2008-11#1)
production of neuropeptide Y##2##4##(1996-1#2)
production of new##2##3##(2008-1#1)(2010-11#1)
production of nisin and lactic acid##2##6##(2008-5#2)
production of nisin##4##3##(2008-5#2)(2008-6#2)
production of nitric oxide (NO)##4##5##(1991-9#1)(1994-5#1)(1996-8#1)(1997-7#1)
production of nitric oxide and##4##5##(1993-12#1)(1996-11#1)(2006-10#1)(2008-7#1)
production of nitric oxide from##3##5##(1993-12#1)(1993-4#1)(2009-9#1)
production of nitric oxide##16##4##(1991-10#1)(1991-9#1)(1992-5#1)(1993-12#2)(1993-4#1)(1994-5#1)(1996-11#1)(1996-8#1)(1997-7#1)(2006-10#1)(2008-11#2)(2008-7#1)(2009-9#1)(2011-12#1)
production of nitrites##2##3##(1992-5#1)(1992-7#1)
production of numerous##2##3##(2007-12#1)(2008-10#1)
production of one##2##3##(1991-4#1)(2008-6#1)
production of other##2##3##(2008-11#1)(2009-8#1)
production of p53##2##3##(2003-11#2)
production of phosphate from 5'AMP##2##5##(2008-4#2)
production of plants##2##3##(2006-11#1)(2008-12#1)
production of podophyllotoxin##2##3##(2008-11#2)
production of poly-beta-hydroxybutyrate##2##3##(2008-7#2)
production of pro-inflammatory cytokines##5##4##(2005-10#1)(2008-1#1)(2008-10#1)(2010-12#1)(2011-1#1)
production of pro-inflammatory##8##3##(2005-10#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-10#2)(2010-12#1)(2011-1#1)
production of progeny##2##3##(1994-11#1)(1997-3#1)
production of proinflammatory cytokines##6##4##(2007-11#2)(2008-1#1)(2008-4#1)(2010-7#1)(2011-2#1)
production of prostaglandin E2##3##4##(1990-4#1)(1992-4#2)
production of prostaglandins##2##3##(1994-2#1)(2006-10#1)
production of protein##2##3##(1993-5#1)(2008-9#1)
production of proteins##5##3##(1995-7#2)(1995-8#1)(2008-11#1)(2011-1#1)
production of pseudothecia##2##3##(2008-10#2)
production of pure##2##3##(1992-11#1)(2008-6#1)
production of rabies##2##3##(2007-11#1)(2008-11#1)
production of reactive oxygen species (ROS)##7##6##(1994-5#1)(1997-4#1)(2008-11#1)(2008-3#1)(2009-5#1)(2009-8#1)(2011-2#1)
production of reactive oxygen species in the##2##7##(2008-4#1)(2009-12#1)
production of reactive oxygen species##18##5##(1994-5#1)(1997-4#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#3)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-8#2)
production of reactive oxygen##19##4##(1994-5#2)(1997-4#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#3)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-8#2)
production of reactive##21##3##(1994-5#2)(1997-4#2)(2005-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#4)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-8#2)
production of recombinant protein##3##4##(2008-11#2)(2012-3#1)
production of recombinant proteins by##2##5##(2008-11#2)
production of recombinant proteins for##3##5##(1997-4#1)(2008-11#2)
production of recombinant proteins##17##4##(1997-3#1)(1997-4#1)(1997-6#1)(2007-6#1)(2008-11#11)(2009-8#1)(2012-2#1)
production of recombinant##38##3##(1990-9#1)(1994-11#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-6#1)(2008-11#23)(2008-7#1)(2009-8#1)(2010-5#1)(2012-2#1)(2012-3#2)
production of second messengers##2##4##(1990-3#1)(1991-8#1)
production of second##3##3##(1990-3#1)(1991-8#1)(2013-1#1)
production of secondary##4##3##(2008-10#4)
production of secreted##3##3##(1992-9#1)(1997-3#1)(1997-4#1)
production of small##2##3##(1992-5#1)(2010-2#1)
production of sorbitol and gluconic acid##2##6##(2008-6#2)
production of specific##3##3##(1992-8#1)(1995-2#1)(1997-6#1)
production of sporangia and zoospores##2##5##(2008-10#2)
production of sporangia##3##3##(2008-10#3)
production of superoxide anion##4##4##(1990-12#1)(1994-8#1)(2005-8#1)(2012-2#1)
production of superoxide##10##3##(1990-12#1)(1993-12#1)(1994-8#1)(1995-6#1)(1995-7#1)(1997-5#1)(2005-8#1)(2007-10#1)(2009-9#1)(2012-2#1)
production of tPA##2##3##(1990-11#1)(2008-11#1)
production of the cyclic lipopeptide##2##5##(2008-10#2)
production of the different##2##4##(1990-12#1)(1990-9#1)
production of the##82##3##(1990-11#1)(1990-12#1)(1990-9#2)(1991-12#1)(1991-5#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(2005-12#1)(2006-2#1)(2006-5#2)(2006-6#1)(2007-11#2)(2007-5#3)(2007-6#1)(2008-10#16)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#4)(2009-2#2)(2009-6#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
production of therapeutic proteins is##2##5##(2008-11#1)(2012-2#1)
production of therapeutic##3##3##(2008-11#1)(2012-1#1)(2012-2#1)
production of these##7##3##(1994-11#1)(1994-8#1)(1994-9#1)(1996-10#1)(2008-5#1)(2010-12#1)(2010-2#1)
production of this##7##3##(1994-3#1)(2006-10#2)(2007-5#1)(2008-10#2)(2008-11#1)
production of three##3##3##(2008-12#1)(2008-2#1)(2011-1#1)
production of tissue##2##3##(1990-7#1)(2008-2#1)
production of toxic##3##3##(1995-2#1)(2008-10#1)(2008-11#1)
production of transformed##2##3##(1992-5#1)(1994-11#1)
production of transgenic plants##2##4##(2006-12#1)(2007-1#1)
production of transgenic##6##3##(1995-2#1)(2006-12#1)(2007-1#1)(2008-2#1)(2010-5#1)(2011-2#1)
production of tumor necrosis factor alpha##2##6##(1995-3#1)(2006-12#1)
production of tumor necrosis factor##4##5##(1992-3#1)(1994-8#1)(1995-3#1)(2006-12#1)
production of tumor necrosis##5##4##(1992-3#1)(1994-8#1)(1995-12#1)(1995-3#1)(2006-12#1)
production of tumour necrosis##2##4##(2007-11#1)(2010-9#1)
production of various viruses##2##4##(2008-11#2)
production of various##9##3##(1991-12#1)(1994-9#1)(2007-12#1)(2008-11#4)(2008-4#2)
production of viral##4##3##(1994-11#1)(2007-11#1)(2008-11#1)(2011-3#1)
production of vitamin D##2##4##(2012-12#1)(2012-3#1)
production of xylitol from##2##4##(2008-6#2)
production of##1479##2##(1990-10#3)(1990-11#7)(1990-12#8)(1990-2#5)(1990-3#2)(1990-4#3)(1990-5#4)(1990-7#7)(1990-8#8)(1990-9#4)(1991-1#3)(1991-10#3)(1991-11#3)(1991-12#11)(1991-3#4)(1991-4#3)(1991-5#6)(1991-6#3)(1991-7#3)(1991-8#6)(1991-9#7)(1992-1#3)(1992-10#2)(1992-11#7)(1992-12#5)(1992-2#1)(1992-3#5)(1992-4#7)(1992-5#9)(1992-6#2)(1992-7#5)(1992-8#11)(1992-9#8)(1993-11#5)(1993-12#7)(1993-2#2)(1993-3#4)(1993-4#6)(1993-5#2)(1993-6#5)(1993-7#1)(1993-8#4)(1993-9#10)(1994-10#2)(1994-11#21)(1994-12#11)(1994-2#13)(1994-3#12)(1994-4#1)(1994-5#13)(1994-6#12)(1994-7#1)(1994-8#13)(1994-9#8)(1995-1#4)(1995-10#5)(1995-11#2)(1995-12#7)(1995-2#8)(1995-3#8)(1995-5#3)(1995-6#2)(1995-7#3)(1995-8#4)(1995-9#4)(1996-1#4)(1996-10#11)(1996-11#3)(1996-12#2)(1996-2#7)(1996-3#5)(1996-4#1)(1996-5#8)(1996-6#4)(1996-7#4)(1996-8#3)(1996-9#2)(1997-1#2)(1997-2#5)(1997-3#5)(1997-4#21)(1997-5#2)(1997-6#6)(1997-7#11)(1997-8#6)(2003-11#3)(2004-11#1)(2004-12#1)(2004-8#1)(2004-9#2)(2005-10#1)(2005-11#9)(2005-12#2)(2005-5#1)(2005-6#1)(2005-7#5)(2005-8#3)(2005-9#2)(2006-1#2)(2006-10#23)(2006-11#5)(2006-12#10)(2006-2#5)(2006-3#3)(2006-4#1)(2006-5#6)(2006-6#8)(2006-7#1)(2006-8#5)(2006-9#4)(2007-1#3)(2007-10#1)(2007-11#30)(2007-12#19)(2007-2#8)(2007-3#6)(2007-4#3)(2007-5#7)(2007-6#3)(2007-7#6)(2007-8#5)(2007-9#6)(2008-1#10)(2008-10#136)(2008-11#148)(2008-12#18)(2008-2#17)(2008-3#8)(2008-4#47)(2008-5#60)(2008-6#41)(2008-7#39)(2008-8#14)(2008-9#11)(2009-10#5)(2009-12#2)(2009-2#4)(2009-3#4)(2009-5#3)(2009-6#5)(2009-7#1)(2009-8#5)(2009-9#10)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#5)(2010-2#11)(2010-3#2)(2010-4#9)(2010-5#6)(2010-6#3)(2010-7#6)(2010-8#1)(2010-9#3)(2011-1#16)(2011-12#6)(2011-2#27)(2011-3#4)(2012-1#5)(2012-11#8)(2012-12#9)(2012-2#27)(2012-3#15)(2012-7#1)(2013-1#20)(2013-7#2)(2013-8#15)
production ofinterferon-beta##2##2##(2008-11#2)
production on the##5##3##(2008-10#3)(2011-2#2)
production on##14##2##(2005-11#1)(2008-10#5)(2008-11#1)(2008-8#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)
production only##2##2##(2008-11#1)(2008-6#1)
production or to##2##3##(1994-9#1)(2008-3#1)
production or##20##2##(1991-6#1)(1992-2#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-9#1)(1996-10#1)(1996-4#1)(1996-8#1)(2005-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2010-12#1)(2012-11#1)(2013-7#1)
production over##3##2##(1997-3#1)(2008-7#1)(2010-10#1)
production parameters##3##2##(1994-4#1)(2008-5#1)(2008-7#1)
production pathway##2##2##(2007-6#1)(2008-6#1)
production patterns of##2##3##(2007-2#1)(2008-4#1)
production per cell##2##3##(1994-2#1)(2008-9#1)
production per lesion##3##3##(2008-10#3)
production per##15##2##(1992-12#1)(1994-2#1)(1995-9#1)(1997-6#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-9#1)(2010-4#1)
production period##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
production phase##11##2##(1997-2#1)(2006-5#1)(2008-11#7)(2008-7#2)
production plant and the##2##4##(2012-2#2)
production plant##10##2##(2004-4#1)(2007-4#1)(2008-10#4)(2012-1#1)(2012-2#3)
production plants##2##2##(2008-10#1)(2012-2#1)
production platform for##2##3##(2008-11#2)
production practices##2##2##(2007-8#1)(2008-5#1)
production procedures##2##2##(2008-10#1)(2008-5#1)
production process was##2##3##(2008-11#2)
production process##32##2##(1993-3#1)(1993-6#1)(1996-5#1)(2005-11#1)(2007-9#1)(2008-10#2)(2008-11#7)(2008-5#2)(2008-6#3)(2008-7#3)(2009-2#1)(2011-2#1)(2012-2#6)(2012-3#1)(2013-8#1)
production processes and the##3##4##(2007-8#1)(2008-11#1)(2008-5#1)
production processes and##6##3##(1996-2#1)(2005-5#1)(2007-8#1)(2008-11#1)(2008-5#1)(2012-2#1)
production processes are##2##3##(2008-11#2)
production processes##16##2##(1996-2#1)(2005-5#1)(2007-6#2)(2007-8#1)(2008-10#2)(2008-11#5)(2008-5#1)(2012-2#2)(2013-8#1)
production purposes##2##2##(1997-4#1)(2008-4#1)
production rate and egg number##2##5##(2008-12#2)
production rate and##4##3##(2008-11#1)(2008-12#2)(2008-8#1)
production rate from##2##3##(2008-11#1)(2008-6#1)
production rate in the##2##4##(2008-11#2)
production rate increased with##2##4##(2006-3#1)(2008-11#1)
production rate increased##3##3##(2006-3#1)(2008-11#1)(2013-1#1)
production rate of the##2##4##(1994-3#1)(2008-11#1)
production rate of##6##3##(1994-3#1)(1997-5#1)(2008-11#2)(2008-6#1)(2011-2#1)
production rate per cell##2##4##(2008-11#2)
production rate per##3##3##(2008-10#1)(2008-11#2)
production rate was##6##3##(1994-3#1)(2008-11#3)(2011-2#1)(2013-1#1)
production rate##46##2##(1992-5#1)(1994-11#1)(1994-3#2)(1994-8#1)(1997-5#1)(2006-3#4)(2008-10#1)(2008-11#19)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#2)(2008-8#2)(2011-2#2)(2013-1#2)
production rates of##4##3##(1996-5#1)(2008-11#2)(2012-2#1)
production rates were##5##3##(1994-3#1)(2008-11#2)(2008-7#1)(2013-1#1)
production rates##18##2##(1994-2#1)(1994-3#1)(1994-8#1)(1996-5#1)(2008-11#8)(2008-12#1)(2008-7#2)(2008-8#1)(2012-2#1)(2013-1#1)
production reached##3##2##(2008-12#1)(2008-5#1)(2008-6#1)
production region##3##2##(2007-3#1)(2008-10#2)
production relative to##2##3##(1992-5#1)(2008-3#1)
production requires##3##2##(2005-8#1)(2008-11#2)
production samples##3##2##(2008-10#3)
production seemed to be##2##4##(1995-6#1)(2008-10#1)
production should##2##2##(1994-3#1)(2011-2#1)
production significantly##5##2##(2007-11#1)(2008-3#1)(2008-5#1)(2010-11#1)(2010-12#1)
production sites##2##2##(2010-10#1)(2012-2#1)
production situations and##2##3##(2008-10#2)
production situations##5##2##(2008-10#5)
production stimulated by the##2##4##(1991-7#1)(1996-11#1)
production stimulating activity of##3##4##(2008-11#3)
production system as well as##2##5##(1991-12#1)(2008-11#1)
production system for##4##3##(2008-11#1)(2008-4#1)(2008-9#2)
production system that##2##3##(2010-2#1)(2013-1#1)
production system was##2##3##(2008-10#1)(2012-12#1)
production system##35##2##(1991-10#1)(1991-12#1)(1994-12#1)(1996-5#1)(1997-4#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#3)(2010-2#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-1#3)(2012-12#1)(2013-1#1)(2013-8#1)
production systems and##2##3##(2005-5#1)(2008-10#1)
production systems for##2##3##(1997-4#1)(2008-11#1)
production systems in##5##3##(2005-5#1)(2008-10#1)(2013-8#3)
production systems were##2##3##(2012-12#1)(2013-1#1)
production systems##31##2##(1997-4#1)(2005-5#2)(2006-8#1)(2008-10#11)(2008-11#1)(2008-4#1)(2010-4#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#7)
production techniques##4##2##(2008-10#3)(2011-2#1)
production than##4##2##(1994-11#1)(2006-9#1)(2007-8#1)(2011-1#1)
production that##2##2##(2008-11#1)(2008-5#1)
production through increased##2##3##(1996-8#1)(2011-1#1)
production through##7##2##(1995-11#1)(1996-8#1)(1997-8#1)(2008-11#1)(2008-5#1)(2010-10#1)(2011-1#1)
production throughout the##2##3##(2008-10#1)(2009-8#1)
production to control##2##3##(2008-10#2)
production to the##4##3##(1994-5#1)(2008-10#1)(2008-4#1)(2012-2#1)
production to##18##2##(1990-10#1)(1990-5#1)(1992-11#1)(1994-5#1)(1996-12#1)(1996-3#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)(2009-12#1)(2011-1#1)(2011-12#1)(2012-2#1)
production traits in##2##3##(2008-12#1)(2008-8#1)
production trial##5##2##(2013-8#5)
production under##8##2##(1992-4#1)(1992-9#1)(1994-11#1)(2007-11#1)(2007-6#1)(2008-12#1)(2009-10#1)(2011-1#1)
production up to##2##3##(1990-8#1)(2013-1#1)
production upon##4##2##(1992-8#1)(1993-12#1)(2010-12#2)
production using the##3##3##(2008-11#1)(2008-2#1)(2008-4#1)
production using##19##2##(1994-8#1)(1995-11#1)(1997-4#1)(2008-11#5)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#2)(2011-2#1)(2013-1#3)
production varied##2##2##(2007-8#1)(2008-11#1)
production via the##2##3##(1991-3#1)(2008-4#1)
production via##11##2##(1991-3#2)(1993-11#1)(1993-4#1)(1995-11#1)(2008-11#1)(2008-4#1)(2008-6#1)(2010-11#1)(2013-1#2)
production was achieved##4##3##(2006-12#1)(2008-10#1)(2008-6#1)(2008-7#1)
production was also##7##3##(1990-5#1)(1996-10#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-7#1)
production was assessed##2##3##(2006-8#1)(2007-7#1)
production was detectable##2##3##(2006-8#1)(2008-10#1)
production was detected in##2##4##(2007-7#1)(2010-12#1)
production was detected##4##3##(1990-12#1)(2006-8#1)(2007-7#1)(2010-12#1)
production was determined##4##3##(2008-11#1)(2008-5#1)(2008-6#1)(2009-5#1)
production was enhanced by##5##4##(1995-3#1)(1996-12#1)(2006-3#3)
production was enhanced in##2##4##(2008-11#1)(2009-9#1)
production was enhanced##8##3##(1995-3#1)(1996-12#1)(2006-3#3)(2008-11#1)(2008-5#1)(2009-9#1)
production was established##2##3##(1996-8#1)(2008-5#1)
production was evaluated##2##3##(2007-7#1)(2008-10#1)
production was followed##2##3##(2006-8#1)(2008-5#1)
production was found in##2##4##(1991-8#1)(2008-8#1)
production was found to be##5##5##(1993-3#1)(1994-5#1)(1997-8#1)(2007-7#1)(2008-5#1)
production was found##8##3##(1991-12#1)(1991-8#1)(1993-3#1)(1994-5#1)(1997-8#1)(2007-7#1)(2008-5#1)(2008-8#1)
production was higher##2##3##(2008-5#1)(2013-8#1)
production was highest##2##3##(2007-7#1)(2008-10#1)
production was increased##2##3##(1996-9#1)(2007-12#1)
production was induced in##2##4##(1991-5#1)(1994-12#1)
production was induced##3##3##(1991-5#1)(1994-12#1)(2008-4#1)
production was investigated using##3##4##(1994-5#1)(1996-12#1)(2007-2#1)
production was investigated##4##3##(1994-5#1)(1996-12#1)(2007-2#1)(2008-11#1)
production was low##3##3##(1996-2#1)(1997-3#1)(2007-7#1)
production was lower##2##3##(2006-8#1)(2009-4#1)
production was markedly##2##3##(1993-3#1)(2008-4#1)
production was measured by##2##4##(1991-9#1)(1992-7#1)
production was measured in##2##4##(1996-8#1)(2008-10#1)
production was measured using##2##4##(2008-10#1)(2008-11#1)
production was measured##7##3##(1991-9#1)(1992-7#1)(1996-8#1)(2008-10#2)(2008-11#1)(2008-12#1)
production was monitored in##2##4##(1994-3#1)(2008-10#1)
production was not affected##2##4##(1996-2#1)(2008-11#1)
production was not##9##3##(1995-3#2)(1996-2#1)(2008-10#1)(2008-11#4)(2008-4#1)
production was observed with##2##4##(2008-10#1)(2009-6#1)
production was observed##7##3##(1997-3#1)(2004-12#1)(2008-10#1)(2008-11#2)(2008-6#1)(2009-6#1)
production was obtained##3##3##(2008-10#1)(2008-5#1)(2013-7#1)
production was reduced by##3##4##(1997-1#1)(2008-10#2)
production was reduced##4##3##(1997-1#1)(1997-6#1)(2008-10#2)
production was seen##3##3##(1994-5#1)(2004-12#1)(2008-5#1)
production was similar##3##3##(2008-10#2)(2008-11#1)
production was studied##3##3##(1991-2#1)(1991-5#1)(1991-9#1)
production was##178##2##(1990-11#2)(1990-12#1)(1990-4#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#4)(1991-8#1)(1991-9#2)(1992-7#1)(1993-11#1)(1993-3#3)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#3)(1994-9#1)(1995-3#3)(1995-6#1)(1995-9#1)(1996-10#1)(1996-12#3)(1996-2#4)(1996-8#3)(1996-9#1)(1997-1#1)(1997-3#2)(1997-6#1)(1997-8#1)(2004-12#2)(2004-9#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-3#3)(2006-8#6)(2006-9#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#8)(2008-1#1)(2008-10#29)(2008-11#22)(2008-12#1)(2008-4#6)(2008-5#12)(2008-6#4)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#2)(2011-2#1)(2011-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
production water##2##2##(2006-8#2)
production were determined##2##3##(2008-5#1)(2010-12#1)
production were evaluated##3##3##(2008-10#2)(2011-2#1)
production were found to be##2##5##(2012-11#1)(2012-2#1)
production were investigated in##2##4##(1992-5#1)(1997-1#1)
production were investigated##4##3##(1992-5#1)(1997-1#1)(2008-11#1)(2013-1#1)
production were obtained by##2##4##(2008-10#2)
production were obtained##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
production were studied##2##3##(1993-3#1)(1997-2#1)
production were##47##2##(1991-3#1)(1991-4#1)(1992-2#1)(1992-5#1)(1993-3#1)(1993-4#1)(1995-10#1)(1997-1#1)(1997-2#1)(2007-12#2)(2007-3#1)(2007-8#2)(2008-10#15)(2008-11#4)(2008-5#4)(2008-7#1)(2010-12#3)(2010-2#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#1)
production when added##2##3##(1990-4#1)(1995-10#1)
production when the##3##3##(1997-2#2)(2006-8#1)
production when##10##2##(1990-4#1)(1991-7#1)(1994-5#1)(1995-10#1)(1996-12#1)(1997-2#2)(2006-8#1)(2008-6#1)(2011-2#1)
production which##2##2##(1991-12#1)(1991-2#1)
production while##2##2##(2008-11#2)
production with Candida boidinii##2##4##(2008-7#2)
production with a##2##3##(1995-10#1)(2010-1#1)
production with the##4##3##(1994-4#1)(1994-8#1)(2008-11#1)(2008-6#1)
production with##23##2##(1991-8#1)(1994-11#1)(1994-2#1)(1994-4#1)(1994-5#1)(1994-8#2)(1995-10#1)(1995-3#1)(2007-11#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#2)(2009-7#1)(2010-1#1)(2011-2#1)(2013-1#1)
production within##2##2##(1991-11#1)(2008-11#1)
production without##4##2##(1992-1#1)(1996-2#1)(2008-10#1)(2011-2#1)
production workers##3##2##(2008-10#1)(2010-8#2)
production worldwide##2##2##(2008-10#2)
production yield##5##2##(2008-11#2)(2008-6#1)(2013-1#2)
production yields##2##2##(1993-12#1)(2013-1#1)
production##4617##1##(1990-10#15)(1990-11#21)(1990-12#16)(1990-2#11)(1990-3#8)(1990-4#6)(1990-5#16)(1990-7#20)(1990-8#17)(1990-9#9)(1991-1#9)(1991-10#9)(1991-11#8)(1991-12#27)(1991-2#7)(1991-3#15)(1991-4#9)(1991-5#22)(1991-6#4)(1991-7#12)(1991-8#23)(1991-9#23)(1992-1#11)(1992-10#3)(1992-11#18)(1992-12#22)(1992-2#11)(1992-3#9)(1992-4#12)(1992-5#21)(1992-6#10)(1992-7#10)(1992-8#23)(1992-9#22)(1993-1#1)(1993-10#2)(1993-11#16)(1993-12#12)(1993-2#4)(1993-3#15)(1993-4#9)(1993-5#4)(1993-6#14)(1993-7#2)(1993-8#7)(1993-9#24)(1994-10#8)(1994-11#52)(1994-12#21)(1994-2#25)(1994-3#34)(1994-4#7)(1994-5#46)(1994-6#26)(1994-7#1)(1994-8#37)(1994-9#23)(1995-1#13)(1995-10#22)(1995-11#9)(1995-12#28)(1995-2#16)(1995-3#23)(1995-5#11)(1995-6#12)(1995-7#3)(1995-8#8)(1995-9#9)(1996-1#6)(1996-10#32)(1996-11#14)(1996-12#14)(1996-2#31)(1996-3#9)(1996-4#7)(1996-5#29)(1996-6#9)(1996-7#11)(1996-8#20)(1996-9#8)(1997-1#12)(1997-2#15)(1997-3#10)(1997-4#37)(1997-5#6)(1997-6#15)(1997-7#15)(1997-8#25)(2003-11#3)(2004-11#2)(2004-12#6)(2004-4#1)(2004-8#6)(2004-9#4)(2005-1#5)(2005-10#5)(2005-11#22)(2005-12#11)(2005-3#1)(2005-4#1)(2005-5#5)(2005-6#1)(2005-7#9)(2005-8#14)(2005-9#3)(2006-1#4)(2006-10#53)(2006-11#9)(2006-12#22)(2006-2#6)(2006-3#15)(2006-4#6)(2006-5#16)(2006-6#12)(2006-7#1)(2006-8#26)(2006-9#19)(2007-1#10)(2007-10#4)(2007-11#62)(2007-12#46)(2007-2#31)(2007-3#22)(2007-4#12)(2007-5#13)(2007-6#20)(2007-7#25)(2007-8#30)(2007-9#13)(2008-1#32)(2008-10#546)(2008-11#465)(2008-12#53)(2008-2#31)(2008-3#33)(2008-4#117)(2008-5#219)(2008-6#111)(2008-7#122)(2008-8#61)(2008-9#38)(2009-10#11)(2009-11#1)(2009-12#7)(2009-2#7)(2009-3#21)(2009-4#13)(2009-5#11)(2009-6#20)(2009-7#2)(2009-8#22)(2009-9#28)(2010-1#2)(2010-10#16)(2010-11#3)(2010-12#28)(2010-2#23)(2010-3#6)(2010-4#31)(2010-5#9)(2010-6#4)(2010-7#15)(2010-8#8)(2010-9#6)(2011-1#64)(2011-10#2)(2011-12#16)(2011-2#95)(2011-3#7)(2011-7#1)(2012-1#21)(2012-11#17)(2012-12#24)(2012-2#95)(2012-3#41)(2012-4#1)(2012-7#4)(2013-1#113)(2013-7#7)(2013-8#63)
production&quot##7##1##(2007-11#1)(2008-11#1)(2012-2#5)
production)##9##1##(1992-8#1)(1992-9#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-8#1)(2012-3#1)
production/consumption##3##1##(2006-8#3)
production]##3##1##(1992-7#1)(2008-5#1)(2013-1#1)
productions of##4##2##(1991-7#1)(2005-11#1)(2008-11#1)(2013-8#1)
productions##14##1##(1991-7#1)(1992-12#1)(2005-11#1)(2006-5#1)(2007-6#1)(2008-11#3)(2010-10#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
productive age##2##2##(2006-1#1)(2008-1#1)
productive and##7##2##(1996-1#1)(2006-4#1)(2007-3#1)(2008-5#1)(2010-7#1)(2012-2#1)(2013-1#1)
productive areas##2##2##(2008-10#1)(2008-9#1)
productive binding mode##2##3##(1990-7#1)(1994-5#1)
productive binding modes##2##3##(1990-7#2)
productive binding of##2##3##(1992-6#1)(1993-8#1)
productive binding##6##2##(1990-7#3)(1992-6#1)(1993-8#1)(1994-5#1)
productive by##2##2##(2008-11#1)(2011-2#1)
productive cell##2##2##(1992-8#1)(2008-11#1)
productive cough##6##2##(1991-8#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-4#1)
productive for##2##2##(1991-7#1)(2008-4#1)
productive infection of human monocytes by HIV-1##2##7##(1991-4#2)
productive infection##5##2##(1991-4#2)(1992-9#1)(1994-3#1)(2008-9#1)
productive interaction##2##2##(1991-4#1)(1993-12#1)
productive life##3##2##(1990-3#1)(1994-6#1)(2007-5#1)
productive patches##3##2##(2008-9#3)
productive substrate binding##2##3##(1991-5#1)(1994-8#1)
productive tree holes##2##3##(2008-9#2)
productive##122##1##(1990-11#1)(1990-3#1)(1990-7#3)(1991-2#1)(1991-4#3)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-7#1)(1993-8#2)(1994-11#2)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#2)(1996-1#1)(1997-1#2)(1997-4#1)(1997-5#1)(2004-3#1)(2004-4#1)(2004-8#1)(2005-4#1)(2006-1#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-2#1)(2007-3#2)(2007-5#6)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#5)(2008-10#3)(2008-11#9)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#9)(2009-10#1)(2009-2#2)(2010-12#2)(2010-7#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#5)(2013-8#2)
productively in##2##2##(1996-10#1)(1996-6#1)
productively##6##1##(1994-2#1)(1996-10#1)(1996-6#1)(1997-9#1)(2006-6#1)(2010-3#1)
productivities in##2##2##(2008-11#1)(2008-7#1)
productivities of##3##2##(1996-8#1)(1997-4#1)(2008-6#1)
productivities were##2##2##(2004-8#1)(2008-11#1)
productivities##18##1##(1996-8#1)(1997-4#1)(2004-8#2)(2008-11#4)(2008-6#3)(2008-7#2)(2008-8#4)(2008-9#1)
productivity and cell##2##3##(2006-12#1)(2008-11#1)
productivity and efficiency##2##3##(1993-3#1)(2007-9#1)
productivity and quality of life##2##5##(2008-1#1)(2012-3#1)
productivity and quality##3##3##(2008-1#1)(2009-6#1)(2012-3#1)
productivity and the##3##3##(2008-11#2)(2008-8#1)
productivity and turnover rate##2##4##(2008-5#2)
productivity and##42##2##(1990-3#1)(1990-9#1)(1991-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-12#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-4#2)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#8)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-6#1)(2010-8#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2012-5#1)
productivity are##3##2##(2007-3#1)(2008-8#1)(2011-2#1)
productivity as##4##2##(2008-11#2)(2008-6#2)
productivity because##2##2##(2008-11#1)(2008-9#1)
productivity but##3##2##(2007-3#1)(2008-8#2)
productivity by##5##2##(1994-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
productivity compared to##2##3##(2008-12#1)(2013-1#1)
productivity during##2##2##(2008-11#1)(2008-7#1)
productivity factor##2##2##(1996-1#2)
productivity following##2##2##(1992-3#1)(2007-11#1)
productivity for##5##2##(2007-3#1)(2008-10#1)(2008-11#2)(2008-7#1)
productivity from##3##2##(2008-6#1)(2008-9#1)(2010-6#1)
productivity gradient##4##2##(2008-8#1)(2008-9#3)
productivity in CHO##2##3##(2008-11#2)
productivity in terms of##2##4##(2008-11#1)(2009-4#1)
productivity in the##7##3##(1991-11#1)(1991-12#1)(1997-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2012-11#1)
productivity in##37##2##(1990-11#1)(1991-11#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-6#1)(1995-8#1)(1996-1#1)(1997-1#2)(2004-3#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-11#11)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-11#1)
productivity increased##2##2##(2008-11#2)
productivity is##10##2##(2007-4#1)(2007-8#1)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)
productivity of 0##3##3##(2008-11#1)(2008-6#1)(2013-1#1)
productivity of 2##3##3##(2005-11#1)(2008-11#1)(2013-1#1)
productivity of 293##2##3##(2008-11#2)
productivity of HA-2-91##4##3##(2006-9#4)
productivity of a##2##3##(2008-11#1)(2012-3#1)
productivity of hybridoma cell##2##4##(2008-11#1)(2012-3#1)
productivity of hybridoma##3##3##(2008-11#2)(2012-3#1)
productivity of recombinant##5##3##(2008-11#5)
productivity of the##16##3##(1991-1#1)(2007-3#1)(2007-5#2)(2008-10#1)(2008-11#5)(2008-5#4)(2008-7#1)(2010-8#1)
productivity of this##2##3##(2008-5#1)(2008-6#1)
productivity of##80##2##(1991-1#1)(1991-3#1)(1995-3#1)(1997-4#1)(2005-11#1)(2006-9#4)(2007-1#1)(2007-12#1)(2007-3#3)(2007-5#2)(2008-10#3)(2008-11#30)(2008-12#2)(2008-5#9)(2008-6#5)(2008-7#3)(2008-8#1)(2009-10#1)(2010-10#2)(2010-8#1)(2010-9#1)(2012-1#1)(2012-3#2)(2012-9#1)(2013-1#2)
productivity or##3##2##(1992-3#1)(2008-11#1)(2013-1#1)
productivity per##3##2##(2007-6#1)(2008-11#2)
productivity rate of##3##3##(2008-11#3)
productivity rate##6##2##(2008-11#6)
productivity through##2##2##(1993-3#1)(2006-10#1)
productivity was##19##2##(1992-12#1)(1993-2#1)(1994-4#1)(2008-11#6)(2008-3#1)(2008-5#2)(2008-6#4)(2008-7#1)(2009-6#1)(2011-2#1)
productivity were##4##2##(2004-3#3)(2007-5#1)
productivity while##3##2##(1995-1#1)(2008-10#1)(2012-3#1)
productivity with##2##2##(2008-7#1)(2011-1#1)
productivity without##2##2##(2007-3#1)(2013-1#1)
productivity##450##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#4)(1991-3#2)(1992-12#4)(1992-2#3)(1992-3#4)(1992-6#1)(1993-1#1)(1993-2#4)(1993-3#2)(1993-4#1)(1993-6#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#3)(1994-4#2)(1995-1#1)(1995-3#2)(1995-6#1)(1995-8#2)(1996-1#4)(1996-2#2)(1997-1#2)(1997-4#1)(1997-6#1)(2004-3#6)(2005-11#1)(2005-7#1)(2006-10#3)(2006-12#3)(2006-4#2)(2006-9#4)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#8)(2007-4#13)(2007-5#8)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#17)(2008-11#114)(2008-12#6)(2008-3#4)(2008-4#2)(2008-5#20)(2008-6#19)(2008-7#20)(2008-8#25)(2008-9#22)(2009-10#1)(2009-4#1)(2009-6#2)(2009-8#3)(2010-10#4)(2010-12#2)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#20)(2012-1#5)(2012-11#3)(2012-12#1)(2012-2#1)(2012-3#4)(2012-5#1)(2012-9#1)(2013-1#8)(2013-8#3)
productivity) and##2##2##(2008-8#1)(2013-8#1)
productivity)##5##1##(1993-2#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
products (free##2##2##(1996-7#1)(2010-3#1)
products (p &lt##2##3##(2008-12#2)
products (p##3##2##(2008-12#2)(2011-2#1)
products -##2##2##(2008-5#1)(2012-1#1)
products 2##2##2##(1994-6#1)(1997-3#1)
products able to##2##3##(2006-12#1)(2008-5#1)
products according to##2##3##(2008-5#1)(2010-6#1)
products across##2##2##(1997-6#1)(2008-1#1)
products after##2##2##(2010-12#1)(2011-1#1)
products against##3##2##(2008-12#1)(2012-2#1)(2013-1#1)
products also##2##2##(2007-11#1)(2008-5#1)
products and by##3##3##(1991-1#1)(1995-6#1)(2010-12#1)
products and in the##4##4##(1990-6#1)(2005-12#1)(2008-10#1)(2009-10#1)
products and oxidative##2##3##(2007-11#1)(2008-4#1)
products and processes##2##3##(2007-2#1)(2012-2#1)
products and reactive##2##3##(1995-7#1)(2008-7#1)
products and services##7##3##(1993-2#1)(1994-1#1)(1994-2#1)(1994-3#2)(2005-7#1)(2006-10#1)
products and that##2##3##(1995-8#1)(2004-4#1)
products and the##13##3##(1992-7#1)(1993-11#2)(1994-2#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-7#2)(2008-8#1)(2010-7#1)(2012-3#2)
products and their##7##3##(1995-3#1)(1997-1#1)(1997-3#1)(2007-2#1)(2008-10#1)(2008-5#2)
products and to##2##3##(1995-7#1)(2012-12#1)
products and##127##2##(1990-12#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#1)(1992-11#1)(1992-2#1)(1992-7#2)(1993-11#2)(1993-2#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2004-11#1)(2004-4#1)(2005-10#1)(2005-12#1)(2005-3#1)(2005-5#1)(2005-7#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#1)(2007-11#3)(2007-2#2)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#19)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#2)(2009-2#2)(2010-12#2)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-7#1)
products appear##2##2##(1990-3#1)(1995-8#1)
products are a##2##3##(1996-5#1)(2006-10#1)
products are also##6##3##(1991-1#1)(2005-7#1)(2008-2#1)(2009-3#1)(2010-7#1)(2012-1#1)
products are applied in##2##4##(2008-10#1)(2008-5#1)
products are being##3##3##(2007-11#1)(2007-12#1)(2011-2#1)
products are detected##3##3##(1994-11#1)(2008-4#2)
products are discussed##2##3##(2007-11#1)(2013-1#1)
products are formed##2##3##(1995-8#1)(2010-5#1)
products are formulated##2##3##(2008-3#1)(2008-8#1)
products are improved##2##3##(2005-7#1)(2008-3#1)
products are in good agreement with those obtained by##2##9##(2008-10#2)
products are in##4##3##(1991-12#1)(2008-10#3)
products are involved##2##3##(1993-12#1)(2011-12#1)
products are isolated##2##3##(2007-10#1)(2008-4#1)
products are known to##3##4##(2007-12#1)(2008-5#1)(2009-3#1)
products are necessary for##3##4##(1991-7#1)(1994-3#1)(1994-8#1)
products are needed for##2##4##(2007-12#1)(2012-2#1)
products are observed in the##2##5##(1991-5#1)(2005-11#1)
products are required for##2##4##(1997-1#1)(2008-11#1)
products are to##2##3##(2008-10#1)(2012-2#1)
products are used##4##3##(1990-2#1)(2007-8#1)(2011-2#1)(2012-12#1)
products are very similar to##2##5##(1994-12#1)(1997-4#1)
products are very##3##3##(1994-12#1)(1997-4#1)(2005-12#1)
products are##127##2##(1990-2#2)(1990-7#2)(1991-1#2)(1991-12#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-6#1)(1994-8#5)(1994-9#1)(1995-3#1)(1995-8#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-1#1)(1997-4#1)(2004-11#1)(2005-11#2)(2005-12#1)(2005-5#1)(2005-7#2)(2006-10#1)(2006-12#3)(2006-3#1)(2006-6#3)(2007-10#1)(2007-11#4)(2007-12#3)(2007-8#1)(2008-10#9)(2008-11#2)(2008-2#3)(2008-3#5)(2008-4#9)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#2)(2009-7#1)(2010-4#1)(2010-5#3)(2010-7#1)(2011-1#1)(2011-12#3)(2011-2#3)(2012-1#1)(2012-12#6)(2012-2#6)(2013-1#1)(2013-7#1)
products arising from##2##3##(1994-12#1)(2008-10#1)
products as a##6##3##(1990-5#1)(1997-2#1)(2007-11#3)(2008-6#1)
products as well as##2##4##(2010-7#1)(2011-1#1)
products as well##4##3##(2008-11#1)(2008-8#1)(2010-7#1)(2011-1#1)
products as##17##2##(1990-5#1)(1994-8#1)(1994-9#1)(1997-2#1)(2007-11#3)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#2)(2010-7#1)(2011-1#2)(2013-7#1)
products at the##4##3##(2005-11#1)(2008-5#1)(2008-8#1)(2013-1#1)
products at##12##2##(1994-9#1)(1996-12#1)(2005-11#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2013-1#1)
products available##2##2##(2008-5#1)(2012-2#1)
products based on##7##3##(2007-11#1)(2008-10#2)(2008-5#2)(2012-12#1)(2013-7#1)
products became##2##2##(1990-5#1)(2011-2#1)
products become##2##2##(2007-12#1)(2012-2#1)
products before and after##2##4##(1992-4#1)(2010-3#1)
products before##4##2##(1992-4#1)(1995-5#1)(2008-2#1)(2010-3#1)
products being##2##2##(1994-8#1)(2006-8#1)
products by HPLC##2##3##(1994-11#1)(2008-10#1)
products by high-performance liquid chromatography##2##5##(1992-11#1)(2008-5#1)
products by reverse-phase HPLC##2##4##(1991-8#1)(1994-5#1)
products by the##3##3##(1995-8#1)(2005-11#1)(2008-11#1)
products by##38##2##(1990-10#1)(1990-11#1)(1990-9#1)(1991-8#1)(1992-11#2)(1992-5#1)(1992-6#1)(1994-11#2)(1994-5#2)(1994-6#1)(1995-8#1)(1996-7#1)(1997-4#1)(2005-11#1)(2005-5#1)(2008-10#7)(2008-11#2)(2008-4#2)(2008-5#3)(2008-8#1)(2010-4#1)(2012-12#3)(2013-1#1)
products can be##12##3##(1991-1#1)(1992-5#1)(2006-12#1)(2008-2#2)(2008-4#2)(2008-5#4)(2010-8#1)
products can##17##2##(1991-1#1)(1992-5#1)(1994-6#1)(1995-2#1)(2006-12#1)(2008-11#1)(2008-2#2)(2008-4#4)(2008-5#4)(2010-8#1)
products confirmed that##2##3##(1996-10#1)(2008-5#1)
products confirmed##3##2##(1996-10#1)(2008-5#1)(2009-11#1)
products consisting of##2##3##(2008-10#1)(2012-2#1)
products consumption (p = 0##2##5##(2011-2#2)
products contain##3##2##(1993-6#1)(2010-8#1)(2011-2#1)
products contained a##2##3##(1990-5#1)(2009-5#1)
products contained##5##2##(1990-5#1)(1990-9#1)(1994-8#1)(1996-6#1)(2009-5#1)
products containing dihydroxyacetone##2##3##(2008-5#2)
products containing##20##2##(1991-12#1)(2005-11#1)(2005-7#1)(2006-12#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-5#3)(2008-8#1)(2010-9#1)(2011-2#2)(2012-11#2)(2012-12#1)(2013-7#1)
products continues to be##2##4##(2006-10#1)(2008-10#1)
products could be##4##3##(1992-3#1)(1997-4#1)(2008-11#1)(2009-12#1)
products could##5##2##(1992-3#1)(1997-4#1)(2007-12#1)(2008-11#1)(2009-12#1)
products decreased##2##2##(1990-5#1)(2005-8#1)
products depending##2##2##(1991-3#1)(2010-7#1)
products derived from the##3##4##(1993-12#1)(1995-2#1)(2008-5#1)
products derived from##8##3##(1993-12#1)(1994-8#1)(1995-2#1)(2005-8#1)(2007-11#1)(2008-11#1)(2008-5#1)(2012-2#1)
products destined for##2##3##(2008-5#1)(2011-12#1)
products differ##2##2##(2007-8#1)(2008-5#1)
products due to##2##3##(1996-9#1)(2010-5#1)
products during##7##2##(1997-6#1)(2007-12#1)(2008-10#1)(2008-4#2)(2009-5#1)(2013-1#1)
products except##3##2##(2007-6#2)(2008-2#1)
products exist##2##2##(1991-1#1)(2008-2#1)
products faster##3##2##(1995-1#1)(2008-11#1)(2008-5#1)
products following##4##2##(1991-12#1)(1994-9#1)(1996-3#1)(2008-4#1)
products for a##2##3##(2008-11#1)(2008-5#1)
products for the##9##3##(1992-11#1)(1992-3#1)(1996-7#1)(2004-5#1)(2005-8#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-5#1)
products for use##2##3##(2006-12#1)(2008-2#1)
products for##44##2##(1990-12#1)(1991-3#1)(1992-10#1)(1992-11#1)(1992-3#1)(1993-12#1)(1996-7#1)(1997-4#1)(2004-5#1)(2005-5#1)(2005-8#1)(2005-9#1)(2006-12#2)(2007-11#2)(2007-2#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#5)(2008-8#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-5#1)(2012-2#2)
products form##2##2##(2008-11#1)(2008-5#1)
products formed by reaction of##2##5##(1992-2#1)(1995-1#1)
products formed during##2##3##(1990-8#1)(2010-12#1)
products formed from##2##3##(1990-7#1)(1991-8#1)
products formed##13##2##(1990-7#1)(1990-8#2)(1991-8#1)(1992-1#1)(1992-2#1)(1993-4#1)(1995-1#1)(2004-4#1)(2008-10#2)(2008-7#1)(2010-12#1)
products found##2##2##(2006-8#1)(2008-10#1)
products from a##4##3##(1994-11#1)(2008-10#1)(2008-5#1)(2013-8#1)
products from different##3##3##(1997-8#1)(2008-8#1)(2010-6#1)
products from other##2##3##(1990-11#1)(1990-4#1)
products from the three##2##4##(1994-9#1)(2009-10#1)
products from the##14##3##(1990-11#1)(1992-3#1)(1994-12#1)(1994-9#2)(1997-6#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2009-10#1)
products from##53##2##(1990-1#1)(1990-11#2)(1990-4#1)(1990-8#1)(1991-11#1)(1991-9#2)(1992-3#2)(1992-6#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-9#2)(1996-10#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#2)(2006-8#1)(2007-2#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-5#5)(2008-8#1)(2009-10#1)(2010-6#1)(2010-7#2)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
products generated by##3##3##(1996-7#1)(2008-10#2)
products generated from##2##3##(1995-3#1)(2005-9#1)
products generated in##2##3##(1990-9#1)(1996-4#1)
products generated##8##2##(1990-9#1)(1995-3#1)(1996-4#1)(1996-7#1)(2005-9#1)(2008-10#3)
products had a##3##3##(1997-2#1)(2008-5#1)(2011-2#1)
products had##4##2##(1997-2#1)(2005-8#1)(2008-5#1)(2011-2#1)
products has been##7##3##(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(2007-1#1)(2008-10#1)(2008-5#1)
products has recently##2##3##(2006-10#1)(2008-1#1)
products has##12##2##(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-2#1)(2010-4#1)
products have a##4##3##(1991-6#1)(2008-12#1)(2008-3#1)(2008-5#1)
products have been identified##2##4##(2008-10#1)(2008-8#1)
products have been##10##3##(1995-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2009-3#1)(2012-2#2)
products have##24##2##(1991-6#1)(1994-5#1)(1995-2#1)(1996-5#1)(1997-3#1)(2006-10#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-7#2)(2011-1#1)(2012-2#2)
products having##4##2##(1992-2#1)(1995-9#1)(2005-11#1)(2008-5#1)
products identified##2##2##(1996-2#1)(2008-11#1)
products in a##6##3##(1997-4#1)(2007-1#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-5#1)
products in an##3##3##(1996-12#1)(2008-3#1)(2010-2#1)
products in clinical##3##3##(2012-3#2)(2013-1#1)
products in human##2##3##(1996-5#1)(2013-1#1)
products in plasma##4##3##(1995-6#2)(2013-1#2)
products in the prevention and##3##5##(2007-11#1)(2013-8#2)
products in the##28##3##(1990-4#1)(1990-5#2)(1990-9#1)(1991-11#1)(1993-5#1)(1994-5#1)(1994-8#1)(1996-4#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#5)(2008-9#1)(2009-10#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
products in vitro##3##3##(1990-8#1)(1993-4#1)(2011-1#1)
products in vivo##2##3##(1990-3#1)(2008-5#1)
products in##116##2##(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-3#1)(1991-5#1)(1992-1#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-6#3)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#3)(1996-7#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-8#2)(2006-12#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#4)(2008-3#2)(2008-5#12)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#6)(2013-8#3)
products include##2##2##(1992-8#1)(2006-11#1)
products including##8##2##(1992-4#1)(2005-7#1)(2008-10#4)(2008-5#1)(2013-7#1)
products increased##3##2##(1990-5#1)(2006-12#1)(2010-4#1)
products intended for##2##3##(2006-6#1)(2008-5#1)
products into the##2##3##(2010-7#1)(2010-9#1)
products into##5##2##(1990-2#1)(1995-2#1)(2008-11#1)(2010-7#1)(2010-9#1)
products involved in the##2##4##(1996-3#1)(2009-5#1)
products involved in##4##3##(1995-9#1)(1996-3#1)(2008-10#1)(2009-5#1)
products involved##5##2##(1995-9#1)(1996-3#1)(2007-11#1)(2008-10#1)(2009-5#1)
products is also##2##3##(2007-7#1)(2008-10#1)
products is not##2##3##(2008-10#1)(2010-4#1)
products is##34##2##(1990-7#1)(1990-8#1)(1992-2#1)(1993-11#1)(1994-11#1)(1995-9#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#9)(2008-12#1)(2008-2#2)(2008-5#3)(2008-7#1)(2009-11#1)(2010-12#1)(2010-4#2)(2011-1#1)(2012-1#1)(2012-12#1)
products isolated##2##2##(2007-11#1)(2011-2#1)
products it##2##2##(1996-3#1)(2008-5#1)
products leads to##2##3##(2005-10#1)(2008-10#1)
products like##4##2##(2008-10#2)(2010-4#1)(2010-9#1)
products made##2##2##(2006-6#1)(2008-12#1)
products may be used##2##4##(2006-6#1)(2008-4#1)
products may be##7##3##(1990-5#1)(1990-8#1)(1992-2#1)(2006-6#1)(2007-11#2)(2008-4#1)
products may not##2##3##(2008-6#1)(2009-6#1)
products may##17##2##(1990-5#1)(1990-8#1)(1991-4#1)(1992-2#1)(1993-12#1)(1994-8#1)(1996-12#1)(2006-6#1)(2007-11#3)(2007-12#1)(2008-4#1)(2008-6#1)(2009-3#1)(2009-5#1)(2009-6#1)
products more##3##2##(1996-5#1)(2008-10#1)(2012-2#1)
products must##4##2##(1995-5#1)(2006-6#2)(2013-1#1)
products need##2##2##(2006-10#1)(2012-2#1)
products observed during##2##3##(1993-8#2)
products observed##3##2##(1993-8#2)(2008-10#1)
products obtained from##3##3##(1991-5#1)(2004-12#1)(2007-1#1)
products obtained##9##2##(1991-5#1)(2004-12#1)(2005-8#1)(2006-12#1)(2007-1#1)(2007-8#1)(2008-10#1)(2010-12#1)(2010-4#1)
products of 1##3##3##(1994-5#1)(1994-8#1)(1995-3#1)
products of L-arginine##2##3##(1993-3#1)(1996-8#1)
products of a##4##3##(1991-1#1)(2006-8#1)(2007-12#1)(2008-9#1)
products of acid hydrolysis##2##4##(1995-1#1)(2012-1#1)
products of acid##3##3##(1995-1#1)(2009-12#1)(2012-1#1)
products of an##3##3##(1993-12#1)(1997-8#1)(2008-4#1)
products of animal origin##3##4##(2005-5#1)(2007-2#1)(2009-8#1)
products of cholesterol##2##3##(1996-5#2)
products of different##2##3##(1992-8#1)(2008-4#1)
products of genes in the##2##5##(1990-7#1)(1995-8#1)
products of glucose metabolism##3##4##(1990-2#1)(2006-5#1)(2006-8#1)
products of incomplete combustion are##2##5##(1996-12#2)
products of incomplete combustion##3##4##(1996-12#3)
products of lipid peroxidation and##3##5##(1995-1#2)(2010-12#1)
products of lipid peroxidation##8##4##(1994-3#1)(1995-1#4)(1996-7#1)(2009-5#1)(2010-12#1)
products of organophosphorous##2##3##(2010-5#2)
products of other##2##3##(1997-1#1)(2007-9#1)
products of oxidative modification of proteins##2##6##(2008-4#2)
products of oxidative##3##3##(1997-6#1)(2008-4#2)
products of reaction##2##3##(1996-5#1)(2007-12#1)
products of the bacterial reporter gene are##2##7##(1994-2#2)
products of the bacterial##3##4##(1994-2#3)
products of the reaction##4##4##(1992-11#1)(1994-8#1)(2008-10#2)
products of the same gene##2##5##(1996-5#1)(1997-4#1)
products of the same reaction##2##5##(1996-8#1)(2004-7#1)
products of the same##4##4##(1996-5#1)(1996-8#1)(1997-4#1)(2004-7#1)
products of the##77##3##(1990-11#1)(1990-3#1)(1990-7#1)(1991-10#1)(1991-12#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#3)(1993-11#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-8#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-8#1)(2004-7#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-10#11)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-4#1)(2010-9#1)(2012-1#1)(2013-7#1)
products of their##3##3##(2006-10#1)(2008-10#2)
products of these##5##3##(1990-9#1)(1991-12#1)(1994-8#1)(2005-11#1)(2009-8#1)
products of this##3##3##(1990-1#1)(1991-3#1)(2008-3#1)
products of three##2##3##(1994-12#1)(2008-4#1)
products of two##3##3##(1995-8#1)(2008-10#1)(2008-2#1)
products of##290##2##(1990-1#1)(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#5)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#5)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-8#2)(1991-9#4)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-5#2)(1992-6#1)(1992-8#4)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#3)(1994-11#2)(1994-12#4)(1994-2#4)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#7)(1994-9#4)(1995-1#6)(1995-11#1)(1995-2#5)(1995-3#2)(1995-6#3)(1995-8#4)(1996-12#5)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#8)(1996-6#2)(1996-7#3)(1996-8#2)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#2)(2004-7#1)(2005-11#3)(2005-12#2)(2005-5#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#2)(2006-7#2)(2006-8#6)(2007-1#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-5#1)(2007-8#2)(2007-9#2)(2008-10#31)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#9)(2008-5#5)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#5)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-7#2)(2010-9#2)(2011-1#2)(2012-1#4)(2013-7#1)(2013-8#2)
products offered##2##2##(2006-6#1)(2012-12#1)
products often##3##2##(1997-2#1)(2006-11#1)(2010-2#1)
products on a##4##3##(2006-12#1)(2008-10#1)(2008-2#1)(2008-8#1)
products on the basis of##2##5##(2008-10#1)(2008-5#1)
products on the market##3##4##(2006-10#1)(2008-11#1)(2013-8#1)
products on the##8##3##(1994-3#1)(1995-2#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2013-8#1)
products on##23##2##(1993-1#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-2#1)(2004-11#1)(2006-10#1)(2006-12#2)(2006-9#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-3#1)(2013-8#1)
products or dietary supplements##2##4##(2006-8#1)(2008-8#1)
products or services##2##3##(1994-3#1)(1995-3#1)
products or##23##2##(1991-10#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-12#1)(2005-7#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-11#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-12#1)(2011-2#1)(2012-2#1)
products other than##2##3##(1990-11#1)(1991-4#1)
products over##2##2##(2005-5#1)(2005-7#1)
products present in##2##3##(1994-12#1)(2009-3#1)
products prior to##2##3##(1994-8#1)(1995-5#1)
products produced##4##2##(2007-12#1)(2008-11#1)(2008-4#1)(2012-11#1)
products provide##4##2##(2006-10#1)(2006-12#1)(2008-3#1)(2008-5#1)
products quality##3##2##(2008-12#1)(2010-4#1)(2012-2#1)
products released##3##2##(1994-12#1)(2008-10#2)
products represent##2##2##(1992-7#1)(2007-11#1)
products required##2##2##(1990-9#1)(2008-11#1)
products resulting from the##3##4##(2008-7#1)(2010-12#1)(2010-2#1)
products resulting from##7##3##(1997-4#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-12#2)(2010-2#1)
products revealed##5##2##(1993-11#1)(1995-12#1)(1996-5#1)(2005-7#1)(2009-8#1)
products should##3##2##(1996-5#1)(2011-2#1)(2012-1#1)
products show that the##2##4##(1990-4#1)(2008-10#1)
products show##3##2##(1990-4#1)(2005-10#1)(2008-10#1)
products showed##6##2##(1995-12#1)(1996-7#1)(2007-6#1)(2008-12#1)(2008-5#1)(2011-2#1)
products sold in##2##3##(2007-7#1)(2009-4#1)
products such as##14##3##(2005-7#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-8#1)(2012-1#1)(2012-12#1)
products suggests##2##2##(1993-12#1)(1995-2#1)
products synthesized in##2##3##(1994-11#1)(2007-11#1)
products synthesized##3##2##(1994-11#1)(2007-11#1)(2009-2#1)
products tested##4##2##(1997-2#1)(2007-6#2)(2008-5#1)
products than##4##2##(2006-12#2)(2008-6#1)(2008-7#1)
products that are##8##3##(1990-5#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-9#1)(2011-12#1)
products that contain##3##3##(1995-3#1)(2008-4#1)(2008-8#1)
products that could##3##3##(2008-10#1)(2008-4#1)(2012-12#1)
products that have##2##3##(2007-6#1)(2008-10#1)
products that inhibit##3##3##(1992-2#1)(2007-6#2)
products that may##4##3##(1995-11#1)(1996-10#1)(1997-4#1)(2012-1#1)
products that were##5##3##(1990-10#1)(1995-12#1)(2008-10#2)(2008-5#1)
products that##45##2##(1990-10#1)(1990-5#1)(1991-6#2)(1992-1#1)(1992-2#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-4#1)(2006-10#1)(2006-8#1)(2007-12#3)(2007-3#1)(2007-6#3)(2007-8#1)(2008-10#5)(2008-11#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-9#1)(2011-12#1)(2012-1#1)(2012-12#1)
products through##2##2##(1996-5#1)(2008-5#1)
products to be##4##3##(1996-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
products to enhance##2##3##(2007-11#1)(2008-6#1)
products to the##3##3##(1996-2#1)(2008-11#1)(2008-9#1)
products to##23##2##(1996-11#2)(1996-2#1)(1996-3#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
products typically have##2##3##(2008-7#1)(2010-8#1)
products typically##3##2##(2008-5#1)(2008-7#1)(2010-8#1)
products under $100##2##3##(2004-5#2)
products under##3##2##(2004-5#2)(2008-4#1)
products using##14##2##(1994-6#1)(1996-2#1)(2005-11#1)(2006-12#1)(2008-10#4)(2008-4#1)(2008-5#4)(2012-12#1)
products varied##3##2##(2006-8#1)(2008-10#1)(2008-6#1)
products was also##2##3##(2005-12#1)(2007-8#1)
products was carried out##2##4##(2008-5#1)(2010-9#1)
products was observed##2##3##(2008-10#1)(2008-4#1)
products was##24##2##(1992-6#1)(1992-9#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-1#1)(2005-11#1)(2005-12#1)(2006-9#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-4#2)(2008-5#3)(2010-2#1)(2010-9#1)(2011-2#1)(2013-1#2)
products were also##4##3##(1991-8#1)(1993-9#1)(2007-8#1)(2008-10#1)
products were amplified##2##3##(1993-9#1)(2005-11#1)
products were analyzed##3##3##(1991-2#1)(2004-4#1)(2008-10#1)
products were assigned to be##2##5##(2012-3#2)
products were characterized by elemental##3##5##(2007-11#1)(2008-5#2)
products were characterized by##5##4##(2007-11#1)(2008-5#2)(2010-4#1)(2013-1#1)
products were cloned and sequenced##2##5##(2005-11#1)(2008-10#1)
products were cloned##3##3##(2005-11#2)(2008-10#1)
products were compared to##2##4##(2007-6#1)(2008-10#1)
products were compared##3##3##(2005-11#1)(2007-6#1)(2008-10#1)
products were deprotected##2##3##(1991-9#1)(2007-11#1)
products were detected by##2##4##(2008-12#1)(2008-4#1)
products were detected##6##3##(1992-4#1)(1996-10#1)(2008-10#1)(2008-12#1)(2008-4#1)(2011-12#1)
products were determined##3##3##(1991-9#1)(1992-5#1)(2011-2#1)
products were established##2##3##(2007-1#1)(2008-11#1)
products were estimated##2##3##(2008-10#1)(2013-8#1)
products were evaluated##2##3##(2008-2#1)(2008-6#1)
products were formed##2##3##(1994-8#1)(2005-8#1)
products were found##2##3##(1990-12#1)(1997-3#1)
products were generated##2##3##(1993-9#1)(2012-12#1)
products were identified as##2##4##(1994-6#1)(1995-6#1)
products were identified by##4##4##(1991-2#1)(1996-8#1)(2008-10#1)(2008-7#1)
products were identified##8##3##(1991-2#1)(1994-6#1)(1995-6#1)(1996-8#1)(2008-10#2)(2008-7#1)(2013-7#1)
products were investigated by##2##4##(2007-11#1)(2008-5#1)
products were isolated##4##3##(1997-7#1)(2007-10#1)(2007-11#1)(2008-10#1)
products were measured##3##3##(1993-7#1)(2007-9#1)(2008-5#1)
products were not##2##3##(1992-5#1)(2004-11#1)
products were observed##5##3##(1990-7#1)(1992-10#1)(2008-10#2)(2010-4#1)
products were obtained##4##3##(1995-2#1)(1995-6#1)(2007-11#1)(2012-3#1)
products were reported##2##3##(2008-2#1)(2012-12#1)
products were separated and##3##4##(1991-5#1)(1991-7#1)(2008-10#1)
products were separated by##2##4##(1990-5#1)(2008-10#1)
products were separated on##2##4##(2007-7#1)(2011-1#1)
products were separated##7##3##(1990-5#1)(1991-5#1)(1991-7#1)(2007-7#1)(2008-10#2)(2011-1#1)
products were subjected to##2##4##(2008-5#1)(2011-2#1)
products were used to##2##4##(1992-8#1)(2008-10#1)
products were well##3##3##(2007-7#1)(2008-10#2)
products were##154##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#2)(1991-2#2)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-4#1)(1992-5#3)(1992-8#3)(1992-9#1)(1993-7#2)(1993-9#3)(1994-11#1)(1994-6#1)(1994-8#3)(1995-10#1)(1995-2#2)(1995-6#3)(1996-1#1)(1996-10#1)(1996-4#2)(1996-8#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(2004-11#1)(2004-4#1)(2005-11#4)(2005-12#1)(2005-8#3)(2006-12#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#5)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-10#30)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-4#3)(2010-5#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#2)(2013-8#2)
products when##4##2##(1991-11#1)(2005-8#1)(2008-2#1)(2013-7#1)
products where##2##2##(1991-7#1)(2007-12#1)
products which were##2##3##(1991-2#1)(1996-6#1)
products which##10##2##(1991-2#1)(1992-11#1)(1994-11#1)(1994-8#1)(1996-6#1)(1997-4#1)(2005-7#1)(2008-4#1)(2008-5#2)
products whose##4##2##(1994-8#1)(2008-11#1)(2008-7#1)(2012-12#1)
products will be##2##3##(2007-11#1)(2011-12#1)
products will##4##2##(1995-1#1)(1995-5#1)(2007-11#1)(2011-12#1)
products with a new##2##4##(2008-10#2)
products with a##7##3##(1996-12#1)(2007-2#1)(2008-10#3)(2008-5#1)(2013-1#1)
products with different##2##3##(2008-5#1)(2010-4#1)
products with reduced amounts##2##4##(2008-5#1)(2012-12#1)
products with restriction enzymes##2##4##(1990-3#1)(2008-5#1)
products with the##6##3##(1993-4#1)(1996-1#1)(2005-8#1)(2006-10#1)(2008-10#2)
products with##51##2##(1990-2#1)(1990-3#1)(1993-4#1)(1993-6#1)(1994-10#1)(1995-11#2)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-6#2)(2005-8#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-4#2)(2008-5#6)(2009-10#1)(2009-11#1)(2010-4#4)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#1)
products within the##2##3##(1991-2#1)(2008-7#1)
products within##4##2##(1991-2#1)(2008-4#1)(2008-7#1)(2013-7#1)
products without##2##2##(2008-1#1)(2008-10#1)
products would##3##2##(1995-12#1)(2007-11#1)(2008-10#1)
products##2683##1##(1990-1#3)(1990-10#3)(1990-11#10)(1990-12#9)(1990-2#11)(1990-3#8)(1990-4#9)(1990-5#16)(1990-6#1)(1990-7#17)(1990-8#15)(1990-9#7)(1991-1#11)(1991-10#5)(1991-11#6)(1991-12#10)(1991-2#9)(1991-3#7)(1991-4#6)(1991-5#8)(1991-6#5)(1991-7#8)(1991-8#9)(1991-9#13)(1992-1#5)(1992-10#3)(1992-11#10)(1992-12#6)(1992-2#15)(1992-3#11)(1992-4#6)(1992-5#16)(1992-6#6)(1992-7#4)(1992-8#14)(1992-9#4)(1993-1#1)(1993-10#1)(1993-11#12)(1993-12#9)(1993-2#6)(1993-3#8)(1993-4#5)(1993-5#1)(1993-6#8)(1993-7#3)(1993-8#5)(1993-9#7)(1994-1#2)(1994-10#1)(1994-11#14)(1994-12#15)(1994-2#11)(1994-3#11)(1994-5#8)(1994-6#13)(1994-8#30)(1994-9#11)(1995-1#12)(1995-10#1)(1995-11#4)(1995-12#7)(1995-2#17)(1995-3#10)(1995-5#8)(1995-6#15)(1995-7#4)(1995-8#13)(1995-9#3)(1996-1#2)(1996-10#6)(1996-11#5)(1996-12#20)(1996-2#12)(1996-3#10)(1996-4#7)(1996-5#36)(1996-6#11)(1996-7#11)(1996-8#9)(1996-9#1)(1997-1#8)(1997-2#23)(1997-3#11)(1997-4#19)(1997-5#6)(1997-6#7)(1997-7#5)(1997-8#7)(2004-11#6)(2004-12#2)(2004-2#1)(2004-4#8)(2004-5#3)(2004-7#1)(2004-9#1)(2005-10#7)(2005-11#24)(2005-12#8)(2005-3#4)(2005-5#9)(2005-7#17)(2005-8#20)(2005-9#5)(2006-10#31)(2006-11#6)(2006-12#32)(2006-2#4)(2006-3#2)(2006-5#6)(2006-6#10)(2006-7#4)(2006-8#18)(2006-9#3)(2007-1#5)(2007-10#6)(2007-11#68)(2007-12#28)(2007-2#13)(2007-3#6)(2007-4#9)(2007-5#2)(2007-6#19)(2007-7#10)(2007-8#38)(2007-9#11)(2008-1#15)(2008-10#353)(2008-11#59)(2008-12#11)(2008-2#28)(2008-3#32)(2008-4#76)(2008-5#203)(2008-6#23)(2008-7#38)(2008-8#33)(2008-9#16)(2009-10#8)(2009-11#10)(2009-12#7)(2009-2#7)(2009-3#15)(2009-4#6)(2009-5#11)(2009-6#3)(2009-7#3)(2009-8#12)(2009-9#6)(2010-10#1)(2010-11#4)(2010-12#21)(2010-2#11)(2010-3#5)(2010-4#49)(2010-5#23)(2010-6#6)(2010-7#18)(2010-8#10)(2010-9#13)(2011-1#32)(2011-12#9)(2011-2#57)(2011-3#3)(2012-1#22)(2012-11#10)(2012-12#38)(2012-2#48)(2012-3#17)(2013-1#34)(2013-7#18)(2013-8#14)
products'##3##1##(2008-5#2)(2008-8#1)
products) were##2##2##(2008-10#1)(2008-2#1)
products)##8##1##(2006-10#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-8#1)(2012-2#1)
products?##2##1##(2006-4#1)(2008-5#1)
products]##8##1##(1990-4#1)(1991-2#1)(1993-11#1)(2005-4#1)(2009-2#1)(2010-3#1)(2012-12#1)(2013-1#1)
producís##2##1##(2013-8#2)
produits secondaires##2##2##(2008-5#2)
produits##9##1##(2008-5#9)
prodynorphin##5##1##(1993-11#1)(1995-12#2)(1997-2#1)(2006-10#1)
proefferalgan##2##1##(2007-11#2)
proenkephalin##4##1##(1991-1#1)(1994-2#2)(2006-10#1)
proenzyme cleavage##6##2##(1995-8#6)
proenzyme##16##1##(1990-3#1)(1992-11#1)(1992-12#1)(1992-4#1)(1993-3#1)(1995-3#1)(1995-8#6)(1996-7#1)(1997-2#1)(1997-4#2)
proenzymes##4##1##(1994-5#1)(1995-6#1)(2013-1#2)
proestrous##4##1##(1995-10#3)(2007-1#1)
proestrus##3##1##(1992-3#1)(1993-11#1)(1995-6#1)
prof##4##1##(1992-9#1)(2007-3#1)(2007-8#2)
profactor IX##6##2##(1994-11#6)
profession and the quality of##2##5##(2006-2#1)(2013-8#1)
profession and the##8##3##(2006-2#1)(2007-6#1)(2008-7#1)(2009-10#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
profession and##23##2##(1991-2#1)(1991-3#1)(1992-2#1)(1993-1#1)(1994-12#1)(2006-2#5)(2007-12#1)(2007-4#2)(2007-6#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
profession are##2##2##(1991-12#1)(2005-8#1)
profession as a whole##2##4##(1991-2#1)(1995-1#1)
profession as well##2##3##(2007-11#1)(2010-2#1)
profession as##7##2##(1991-2#2)(1995-1#1)(2007-11#1)(2008-11#1)(2010-2#1)(2013-8#1)
profession for##2##2##(1993-1#1)(2011-2#1)
profession had##2##2##(2007-8#1)(2012-2#1)
profession has been##3##3##(1991-3#1)(2006-2#1)(2008-3#1)
profession has##9##2##(1990-1#1)(1991-3#2)(2006-2#3)(2006-4#1)(2007-10#1)(2008-3#1)
profession in##7##2##(1990-12#1)(1993-2#1)(2006-2#2)(2007-4#1)(2008-1#1)(2008-5#1)
profession is##8##2##(1990-12#1)(1994-12#2)(1996-3#1)(2007-4#1)(2011-1#1)(2012-3#2)
profession needs to##3##3##(2007-9#1)(2008-7#1)(2013-1#1)
profession of##10##2##(1992-2#1)(1994-12#1)(1996-1#1)(2005-9#1)(2007-4#3)(2008-10#1)(2008-12#1)(2011-2#1)
profession that##2##2##(1993-12#1)(2008-1#1)
profession through##2##2##(2007-12#1)(2007-4#1)
profession to##6##2##(2007-4#2)(2007-8#1)(2008-5#1)(2012-3#2)
profession was##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
profession with##2##2##(2008-10#1)(2013-1#1)
profession##243##1##(1990-1#1)(1990-12#2)(1990-2#1)(1991-11#1)(1991-12#1)(1991-2#6)(1991-3#4)(1991-4#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#2)(1992-9#1)(1993-1#3)(1993-12#1)(1993-2#3)(1993-3#2)(1993-6#2)(1994-1#1)(1994-12#9)(1994-2#1)(1994-3#1)(1995-1#4)(1995-11#1)(1995-2#2)(1995-9#1)(1996-1#4)(1996-11#1)(1996-2#1)(1996-3#3)(1997-3#1)(2004-2#1)(2005-11#1)(2005-12#1)(2005-8#2)(2005-9#1)(2006-10#1)(2006-2#18)(2006-4#1)(2007-10#2)(2007-11#4)(2007-12#6)(2007-2#1)(2007-4#17)(2007-6#4)(2007-8#5)(2007-9#3)(2008-1#3)(2008-10#3)(2008-11#3)(2008-12#11)(2008-3#3)(2008-4#2)(2008-5#4)(2008-7#7)(2008-8#2)(2009-10#1)(2009-4#8)(2009-5#1)(2009-7#2)(2009-8#3)(2010-1#2)(2010-12#3)(2010-2#1)(2010-5#2)(2010-6#1)(2011-1#6)(2011-2#8)(2012-11#2)(2012-12#4)(2012-2#6)(2012-3#10)(2013-1#4)(2013-7#1)(2013-8#7)
profession's##10##1##(1992-12#2)(1993-2#1)(2007-4#1)(2007-9#2)(2008-12#1)(2008-4#1)(2012-11#1)(2012-2#1)
profession)##2##1##(2006-9#1)(2011-2#1)
profession?##3##1##(2007-3#1)(2007-6#1)(2013-1#1)
profession]##3##1##(1990-8#1)(1995-8#1)(2013-8#1)
professional advice##2##2##(2008-10#2)
professional and educational##3##3##(2006-2#2)(2008-12#1)
professional and legal issues in nursing##2##6##(2008-11#2)
professional and patient education##2##4##(2008-7#1)(2008-8#1)
professional and personal##4##3##(1994-1#1)(2011-12#1)(2012-1#1)(2013-8#1)
professional and##38##2##(1990-10#1)(1991-12#1)(1992-12#1)(1993-5#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-9#1)(2004-10#1)(2005-7#1)(2006-10#1)(2006-2#2)(2006-6#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-7#1)(2010-12#1)(2010-3#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#1)
professional antigen presenting cells##3##4##(2006-11#1)(2010-8#1)(2013-1#1)
professional antigen##4##2##(2006-11#1)(2007-2#1)(2010-8#1)(2013-1#1)
professional associations and private training and development corporations##2##8##(1993-3#1)(1997-3#1)
professional associations##9##2##(1993-2#1)(1993-3#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-3#1)(2006-4#1)(2008-12#1)(2011-1#1)
professional attitude##6##2##(1990-2#5)(2008-10#1)
professional background##2##2##(1994-3#1)(2007-2#1)
professional backgrounds and##2##3##(2007-9#1)(2008-11#1)
professional backgrounds##3##2##(1996-12#1)(2007-9#1)(2008-11#1)
professional basketball##2##2##(2013-7#2)
professional bleaching##3##2##(2013-1#3)
professional bodies##5##2##(1994-2#1)(2007-2#1)(2008-11#1)(2012-3#2)
professional body##3##2##(1994-12#1)(2009-6#1)(2010-3#1)
professional boundaries##5##2##(2004-5#1)(2008-11#2)(2008-12#1)(2009-9#1)
professional bullfighters##2##2##(2008-3#2)
professional care##3##2##(2006-2#1)(2007-11#1)(2010-12#1)
professional career##4##2##(1991-2#1)(2007-4#1)(2008-12#1)(2009-4#1)
professional careers##3##2##(2006-5#1)(2006-6#1)(2008-1#1)
professional challenge##3##2##(1992-3#1)(1996-1#1)(1997-1#1)
professional characteristics##2##2##(1992-3#1)(1994-3#1)
professional colleagues##2##2##(2012-11#2)
professional community##2##2##(1993-3#1)(2006-3#1)
professional competence##4##2##(1993-3#1)(2008-12#1)(2010-3#1)(2011-2#1)
professional competencies##2##2##(2009-3#1)(2012-12#1)
professional confidence as perceived by##2##5##(2008-11#1)(2008-12#1)
professional confidence as##3##3##(2008-11#1)(2008-12#2)
professional confidence in nursing##2##4##(2008-11#1)(2008-12#1)
professional confidence is##2##3##(2008-11#2)
professional confidence##11##2##(2008-11#7)(2008-12#4)
professional development and##5##3##(2005-5#1)(2008-11#1)(2012-1#1)(2013-1#1)(2013-8#1)
professional development for##2##3##(2006-10#1)(2009-10#1)
professional development in##3##3##(2006-2#1)(2008-11#1)(2010-9#1)
professional development of nurses##2##4##(2013-1#1)(2013-8#1)
professional development of the##2##4##(2008-12#2)
professional development of##7##3##(2007-10#1)(2007-9#1)(2008-12#2)(2010-9#1)(2013-1#1)(2013-8#1)
professional development programs##2##3##(2010-5#2)
professional development##53##2##(1993-1#1)(1994-4#1)(1996-2#1)(2004-8#2)(2005-5#1)(2006-10#3)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-4#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-11#12)(2008-12#2)(2008-6#1)(2009-10#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-5#3)(2010-9#2)(2012-1#1)(2013-1#4)(2013-8#4)
professional doctorates##3##2##(2013-8#3)
professional education in##4##3##(1996-1#1)(1997-3#1)(2008-12#1)(2008-3#1)
professional education##16##2##(1993-1#1)(1994-12#2)(1996-1#2)(1997-3#2)(2007-11#1)(2007-6#1)(2008-11#1)(2008-12#3)(2008-3#1)(2010-3#1)(2010-5#1)
professional environment and##2##3##(1993-6#1)(2008-9#1)
professional ethics##2##2##(1996-12#1)(2007-1#1)
professional experience##9##2##(1994-3#1)(2005-9#1)(2007-4#1)(2008-9#1)(2010-5#1)(2011-2#1)(2013-1#2)(2013-7#1)
professional factors##2##2##(1991-4#1)(2009-7#1)
professional grades of membership##2##4##(2007-2#2)
professional group##4##2##(1993-6#1)(2011-2#1)(2013-8#2)
professional groups##5##2##(1994-3#1)(1996-2#1)(2005-8#1)(2006-8#2)
professional growth##3##2##(1994-1#1)(2007-2#1)(2007-4#1)
professional health care##3##3##(1994-1#1)(2007-2#1)(2008-5#1)
professional health workers##2##3##(2008-2#2)
professional health##5##2##(1994-1#1)(2007-2#1)(2008-2#2)(2008-5#1)
professional help##2##2##(1990-6#1)(2007-10#1)
professional history##2##2##(2008-11#1)(2008-12#1)
professional identity##4##2##(1993-3#2)(1994-4#1)(2012-3#1)
professional image##2##2##(1993-3#2)
professional in##3##2##(2007-12#1)(2007-2#1)(2008-7#1)
professional institutions##2##2##(2011-12#2)
professional interaction##2##2##(2009-8#1)(2009-9#1)
professional journals##2##2##(1995-12#1)(2011-2#1)
professional knowledge and##5##3##(1993-3#1)(1997-3#1)(2007-10#1)(2010-10#2)
professional knowledge##10##2##(1993-3#1)(1997-3#1)(2007-10#1)(2008-11#2)(2009-10#2)(2010-10#2)(2010-5#1)
professional learning##4##2##(2008-11#1)(2008-12#3)
professional level##3##2##(1993-3#1)(2008-11#1)(2011-2#1)
professional liability insurance policy##2##4##(1993-3#2)
professional liability insurance##6##3##(1992-2#1)(1993-1#1)(1993-3#2)(2007-4#1)(2009-9#1)
professional liability##21##2##(1991-3#4)(1991-5#1)(1992-2#1)(1993-1#3)(1993-3#3)(1994-1#1)(1997-3#1)(2007-3#1)(2007-4#3)(2009-9#2)(2011-1#1)
professional life##6##2##(2008-2#1)(2009-11#1)(2009-4#1)(2010-9#1)(2012-11#1)(2012-3#1)
professional literature##3##2##(1995-12#1)(2007-11#1)(2012-12#1)
professional lives##4##2##(2007-7#1)(2008-11#2)(2013-1#1)
professional management##2##2##(1993-3#1)(1997-2#1)
professional medical##2##2##(2004-11#1)(2008-7#1)
professional misconduct##3##2##(1990-5#1)(2008-12#2)
professional model##3##2##(1992-5#2)(2007-12#1)
professional norms##3##2##(1993-3#1)(2006-3#1)(2008-12#1)
professional nurses in the##2##4##(2007-10#1)(2008-10#1)
professional nurses in##3##3##(2007-10#1)(2008-10#1)(2008-12#1)
professional nurses##7##2##(2005-9#1)(2007-1#1)(2007-10#2)(2008-10#1)(2008-11#1)(2008-12#1)
professional nursing journals##2##3##(2010-11#2)
professional nursing##9##2##(1991-2#2)(1993-6#1)(2008-11#1)(2010-10#1)(2010-11#2)(2013-1#2)
professional obligation##3##2##(2009-4#1)(2010-5#1)(2012-3#1)
professional opinion##3##2##(1994-3#1)(1996-9#1)(2007-7#1)
professional or##4##2##(1991-3#1)(2006-12#1)(2006-3#1)(2008-7#1)
professional organisations##2##2##(1996-1#1)(2006-1#1)
professional organizations and##2##3##(1996-1#1)(2008-3#1)
professional organizations##16##2##(1993-9#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-1#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-12#1)(2008-3#2)(2008-9#1)(2012-2#1)
professional paper##27##2##(1991-1#2)(1992-3#1)(1993-1#1)(1993-3#1)(1994-1#4)(1994-3#9)(1996-1#2)(1996-3#2)(1997-1#4)(2007-2#1)
professional performance##2##2##(1996-8#1)(2009-4#1)
professional personnel and the##2##4##(1990-12#1)(2012-12#1)
professional pharmacy##2##2##(2011-1#2)
professional practice and##3##3##(2008-1#1)(2008-8#1)(2009-4#1)
professional practice##28##2##(1991-3#1)(1997-7#1)(2006-5#1)(2006-8#1)(2007-12#1)(2008-1#3)(2008-10#1)(2008-11#7)(2008-12#3)(2008-8#3)(2009-4#1)(2009-8#1)(2011-12#1)(2012-12#1)(2013-1#2)
professional practices and##3##3##(2006-3#1)(2008-11#2)
professional practices##8##2##(2006-3#1)(2007-10#1)(2008-11#3)(2008-9#1)(2009-6#1)(2010-5#1)
professional problems##2##2##(1995-5#2)
professional profile##15##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(1995-12#1)(2008-10#1)(2010-7#2)(2012-2#1)
professional public##2##2##(1991-3#1)(2010-8#1)
professional qualifications##2##2##(1990-12#2)
professional recognition##2##2##(1990-12#1)(2012-3#1)
professional reflection##2##2##(2008-12#1)(2009-8#1)
professional relationships##6##2##(2007-4#1)(2007-5#1)(2008-7#2)(2008-8#1)(2010-1#1)
professional resources##2##2##(1996-1#1)(2012-1#1)
professional responsibilities##2##2##(1997-2#1)(2006-2#1)
professional responsibility##2##2##(1995-2#1)(2011-12#1)
professional role##7##2##(1996-2#1)(2007-2#1)(2008-11#2)(2009-7#1)(2010-10#1)(2011-2#1)
professional roles##4##2##(2008-11#1)(2009-4#2)(2012-12#1)
professional satisfaction##4##2##(2009-11#1)(2010-2#1)(2010-5#1)(2012-1#1)
professional self-esteem##2##2##(2008-11#2)
professional service firms##2##3##(1993-1#2)
professional service##3##2##(1993-1#2)(1994-12#1)
professional services##2##2##(1991-2#1)(2007-4#1)
professional should##2##2##(1993-1#1)(2008-7#1)
professional skill##3##2##(2008-12#1)(2010-4#1)(2012-3#1)
professional skills and##2##3##(1993-6#1)(2006-2#1)
professional skills##7##2##(1993-6#2)(2006-2#1)(2007-8#1)(2008-11#1)(2012-12#1)(2013-1#1)
professional soccer players##3##3##(2008-5#1)(2010-3#1)(2011-2#1)
professional societies##6##2##(2007-4#4)(2008-4#1)(2011-2#1)
professional society##3##2##(2008-5#1)(2012-1#1)(2012-2#1)
professional staff time##2##3##(1995-3#2)
professional staff to##2##3##(2004-12#1)(2008-7#1)
professional staff##13##2##(1991-12#2)(1993-2#1)(1994-2#1)(1995-3#2)(2004-12#1)(2008-7#1)(2008-8#3)(2012-12#1)(2012-3#1)
professional standards##3##2##(1996-3#1)(2007-2#1)(2007-4#1)
professional status##3##2##(1990-12#1)(2010-12#1)(2013-1#1)
professional strategies##2##2##(2008-12#1)(2013-8#1)
professional success##2##2##(1996-3#1)(2007-12#1)
professional support##7##2##(1992-3#2)(1993-2#1)(1993-5#1)(2013-1#2)(2013-8#1)
professional to##4##2##(1992-1#1)(1992-3#1)(1997-1#1)(2008-3#1)
professional training in##4##3##(1990-12#1)(2005-8#1)(2007-1#1)(2011-2#1)
professional training##8##2##(1990-12#1)(1992-3#1)(1995-1#1)(2005-8#2)(2007-1#1)(2008-7#1)(2011-2#1)
professional treatment##2##2##(2006-7#1)(2013-1#1)
professional uncertainty##2##2##(1993-3#2)
professional who##2##2##(1992-1#1)(2012-3#1)
professional women##2##2##(2006-7#2)
professional work hours##2##3##(2011-2#2)
professional work##10##2##(1990-6#1)(2007-11#1)(2008-1#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#1)
professional##821##1##(1990-10#2)(1990-11#1)(1990-12#7)(1990-2#8)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#3)(1990-9#1)(1991-1#5)(1991-12#4)(1991-2#6)(1991-3#7)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#1)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#11)(1992-4#2)(1992-5#2)(1992-9#1)(1993-1#10)(1993-12#1)(1993-2#5)(1993-3#19)(1993-5#2)(1993-6#5)(1993-9#1)(1994-1#10)(1994-12#8)(1994-2#6)(1994-3#17)(1994-4#2)(1994-8#2)(1995-1#5)(1995-12#5)(1995-2#2)(1995-3#6)(1995-4#2)(1995-5#2)(1995-9#1)(1996-1#14)(1996-11#1)(1996-12#8)(1996-2#7)(1996-3#9)(1996-8#1)(1996-9#4)(1997-1#7)(1997-2#3)(1997-3#5)(1997-7#1)(2004-10#2)(2004-11#1)(2004-12#2)(2004-5#1)(2004-8#2)(2005-5#1)(2005-7#3)(2005-8#3)(2005-9#2)(2006-1#2)(2006-10#9)(2006-11#1)(2006-12#2)(2006-2#13)(2006-3#7)(2006-4#1)(2006-5#5)(2006-6#2)(2006-7#6)(2006-8#3)(2007-1#5)(2007-10#6)(2007-11#12)(2007-12#6)(2007-2#13)(2007-3#2)(2007-4#19)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#4)(2007-9#7)(2008-1#14)(2008-10#12)(2008-11#64)(2008-12#41)(2008-2#5)(2008-3#10)(2008-4#6)(2008-5#4)(2008-6#2)(2008-7#11)(2008-8#9)(2008-9#11)(2009-10#6)(2009-11#2)(2009-2#3)(2009-3#1)(2009-4#8)(2009-6#2)(2009-7#3)(2009-8#4)(2009-9#11)(2010-1#2)(2010-10#5)(2010-11#2)(2010-12#4)(2010-2#5)(2010-3#7)(2010-4#1)(2010-5#11)(2010-7#3)(2010-8#2)(2010-9#6)(2011-1#7)(2011-12#5)(2011-2#31)(2012-1#9)(2012-11#4)(2012-12#12)(2012-2#12)(2012-3#12)(2012-6#1)(2013-1#29)(2013-7#9)(2013-8#16)
professional's approach##2##2##(2011-2#2)
professional's##7##1##(1991-6#1)(2008-5#1)(2009-8#1)(2011-2#3)(2012-3#1)
professionalisation of##2##2##(2007-11#1)(2008-11#1)
professionalisation##3##1##(2007-11#1)(2008-11#1)(2008-7#1)
professionalism and##5##2##(1990-5#1)(2007-1#1)(2007-4#1)(2007-7#1)(2011-2#1)
professionalism within dental education##2##4##(2012-1#2)
professionalism##22##1##(1990-5#1)(1993-12#1)(1993-3#1)(2005-5#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-4#2)(2007-7#1)(2008-12#1)(2008-2#1)(2008-4#1)(2011-2#1)(2012-1#3)(2012-11#1)(2013-1#4)
professionalism&quot##2##1##(2006-8#1)(2012-1#1)
professionalism]##2##1##(1992-5#1)(2007-3#1)
professionalization of##6##2##(1990-12#1)(1994-3#2)(2007-12#2)(2009-4#1)
professionalization##12##1##(1990-12#3)(1994-3#2)(2007-12#2)(2009-4#2)(2011-2#2)(2012-2#1)
professionalized##2##1##(2009-10#1)(2012-2#1)
professionally active##2##2##(1992-12#1)(2007-12#1)
professionally led##3##2##(1996-3#1)(2007-1#1)(2008-11#1)
professionally##21##1##(1990-10#1)(1991-3#1)(1992-12#1)(1992-4#1)(1993-3#1)(1996-3#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-4#2)(2007-6#2)(2007-7#1)(2008-11#1)(2010-1#1)(2010-11#1)(2010-9#1)(2011-1#1)(2013-8#2)
professionals &quot##2##2##(1993-2#2)
professionals about the##2##3##(1991-2#1)(2013-1#1)
professionals about##3##2##(1991-2#1)(2008-12#1)(2013-1#1)
professionals and consumers##2##3##(1997-1#1)(2007-2#1)
professionals and patients##3##3##(2006-12#1)(2011-2#1)(2012-3#1)
professionals and the##6##3##(1993-2#1)(1994-10#1)(2007-11#1)(2008-2#1)(2010-12#1)(2012-2#1)
professionals and their##2##3##(2008-2#1)(2008-3#1)
professionals and##48##2##(1990-12#2)(1990-2#2)(1991-6#1)(1992-3#3)(1993-2#1)(1994-1#1)(1994-10#1)(1995-3#1)(1995-5#1)(1997-1#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-2#3)(2007-5#1)(2008-1#1)(2008-11#3)(2008-2#3)(2008-3#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)
professionals are encouraged to##2##4##(1997-8#1)(2007-2#1)
professionals are##20##2##(1990-6#1)(1993-2#1)(1996-1#1)(1996-12#1)(1997-8#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-5#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-5#1)(2012-3#1)(2013-1#1)
professionals as##4##2##(1993-1#1)(2007-12#1)(2007-8#1)(2012-12#1)
professionals at the##2##3##(1995-1#1)(2008-1#1)
professionals but##2##2##(1995-1#1)(1996-2#1)
professionals by##3##2##(1996-2#1)(2007-12#1)(2011-2#1)
professionals can##5##2##(1992-3#1)(2006-10#1)(2007-12#1)(2009-1#1)(2013-8#1)
professionals caring for##2##3##(1992-3#1)(2008-11#1)
professionals could##2##2##(2007-2#1)(2011-1#1)
professionals entering the##2##3##(2007-12#1)(2008-12#1)
professionals face##2##2##(1992-3#1)(1997-2#1)
professionals from all##2##3##(1992-3#1)(2007-2#1)
professionals from##8##2##(1992-3#1)(1995-3#1)(2007-2#1)(2008-12#1)(2008-5#1)(2011-2#1)(2013-1#2)
professionals have a##2##3##(1991-12#1)(2005-11#1)
professionals have to##2##3##(2005-7#1)(2008-5#1)
professionals have##9##2##(1991-12#1)(1994-3#1)(1996-2#1)(2005-10#1)(2005-11#1)(2005-7#1)(2008-5#1)(2012-2#1)(2013-1#1)
professionals in Ibadan##2##3##(2004-10#2)
professionals in a##5##3##(1995-3#2)(1996-2#1)(2006-7#1)(2007-6#1)
professionals in health##2##3##(1996-1#1)(2010-2#1)
professionals in providing##2##3##(1993-12#1)(2008-4#1)
professionals in the##8##3##(2005-7#1)(2007-2#1)(2008-1#2)(2008-12#1)(2010-5#1)(2012-11#1)(2012-12#1)
professionals in these##2##3##(2005-5#1)(2008-7#1)
professionals in##44##2##(1991-1#1)(1991-2#2)(1993-12#1)(1993-3#1)(1994-12#1)(1995-3#2)(1996-1#1)(1996-2#1)(2004-10#3)(2005-5#1)(2005-7#2)(2006-1#1)(2006-4#1)(2006-7#1)(2006-8#2)(2007-12#1)(2007-2#1)(2007-6#3)(2008-1#3)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2010-2#1)(2010-4#1)(2010-5#1)(2012-11#2)(2012-12#1)(2013-1#1)
professionals into##2##2##(1996-3#1)(2005-5#1)
professionals involved in##3##3##(1992-1#1)(2005-11#1)(2008-2#1)
professionals involved##4##2##(1992-1#1)(2005-11#1)(2008-2#2)
professionals is to##3##3##(1996-1#1)(2004-12#1)(2006-10#1)
professionals is##12##2##(1992-3#1)(1994-1#1)(1996-1#1)(2004-12#1)(2006-10#1)(2007-6#1)(2007-9#1)(2008-12#1)(2010-10#1)(2013-1#3)
professionals make##2##2##(1993-2#1)(2008-12#1)
professionals may be##2##3##(1995-3#1)(1996-3#1)
professionals may##6##2##(1994-6#1)(1995-3#1)(1996-3#1)(2007-4#1)(2012-12#1)(2013-1#1)
professionals must be aware of##2##5##(2005-10#1)(2013-1#1)
professionals must be##3##3##(2005-10#1)(2010-3#1)(2013-1#1)
professionals must##5##2##(1996-2#1)(2005-10#1)(2005-11#1)(2010-3#1)(2013-1#1)
professionals need to be##2##4##(2008-2#1)(2008-9#1)
professionals need to know##2##4##(1996-3#1)(2007-12#1)
professionals need to##8##3##(1994-3#1)(1996-3#1)(2007-10#1)(2007-12#1)(2008-2#1)(2008-9#1)(2010-4#1)(2012-2#1)
professionals need##10##2##(1993-1#1)(1994-3#1)(1996-3#1)(2007-10#1)(2007-12#1)(2008-2#1)(2008-9#1)(2009-8#1)(2010-4#1)(2012-2#1)
professionals of a##2##3##(2009-10#1)(2011-2#1)
professionals of##10##2##(1994-1#2)(1994-4#1)(2008-12#1)(2008-2#1)(2009-10#1)(2011-2#2)(2012-3#2)
professionals on the##2##3##(2007-2#1)(2013-1#1)
professionals on##3##2##(2007-2#1)(2012-2#1)(2013-1#1)
professionals or##3##2##(1996-1#1)(2011-2#1)(2012-2#1)
professionals participated in##2##3##(2008-12#1)(2011-2#1)
professionals require##2##2##(2011-2#1)(2012-12#1)
professionals should be aware##3##4##(2010-1#1)(2013-1#2)
professionals should be##4##3##(2007-8#1)(2010-1#1)(2013-1#2)
professionals should##14##2##(1991-12#1)(1993-12#1)(1996-2#1)(1997-3#1)(2007-8#1)(2008-11#1)(2008-3#1)(2009-3#1)(2010-1#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
professionals specializing in##2##3##(2005-2#1)(2006-5#1)
professionals that##5##2##(1994-2#1)(2006-10#1)(2008-10#1)(2008-12#1)(2012-3#1)
professionals through##2##2##(2008-12#1)(2012-2#1)
professionals to adopt##2##3##(2008-11#1)(2013-1#1)
professionals to be##2##3##(2009-9#1)(2013-8#1)
professionals to use##3##3##(2007-11#1)(2007-4#1)(2008-11#1)
professionals to work##2##3##(2007-12#1)(2011-2#1)
professionals to##31##2##(1990-12#1)(1993-2#1)(1994-1#1)(1995-3#1)(1995-6#1)(1996-7#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-5#2)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#4)(2008-12#3)(2009-12#1)(2009-9#2)(2010-1#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
professionals towards##2##2##(2008-11#1)(2008-12#1)
professionals view their##2##3##(1993-2#1)(1994-3#1)
professionals was##2##2##(1994-1#1)(2009-5#1)
professionals were##2##2##(1992-1#1)(2012-2#1)
professionals who would##2##3##(2007-7#1)(2010-1#1)
professionals who##16##2##(1991-12#1)(2005-8#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2010-1#2)(2010-12#1)(2010-5#1)(2011-2#1)
professionals with a##5##3##(1991-1#1)(1994-12#1)(2006-2#1)(2008-12#1)(2013-8#1)
professionals with the##5##3##(2007-12#1)(2008-4#1)(2010-1#1)(2011-2#2)
professionals with##10##2##(1991-1#1)(1994-12#1)(2006-2#1)(2007-12#1)(2008-12#1)(2008-4#1)(2010-1#1)(2011-2#2)(2013-8#1)
professionals within##3##2##(1993-2#1)(2005-8#1)(2013-1#1)
professionals working in the##3##4##(1991-2#1)(2011-1#1)(2012-12#1)
professionals working in##7##3##(1991-2#1)(2011-1#2)(2012-12#1)(2013-1#2)(2013-8#1)
professionals working with##7##3##(1993-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#1)(2012-12#1)
professionals working##15##2##(1991-2#1)(1993-12#1)(1993-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#3)(2012-12#2)(2013-1#2)(2013-8#1)
professionals would##2##2##(2007-9#1)(2008-3#1)
professionals##569##1##(1990-10#2)(1990-12#4)(1990-2#2)(1990-6#1)(1990-8#1)(1991-1#3)(1991-12#6)(1991-2#6)(1991-3#2)(1991-5#1)(1991-6#2)(1991-7#1)(1992-1#2)(1992-12#1)(1992-3#11)(1992-6#1)(1993-1#4)(1993-12#6)(1993-2#9)(1993-3#5)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#9)(1994-10#1)(1994-12#6)(1994-2#1)(1994-3#5)(1994-4#1)(1994-6#2)(1995-1#4)(1995-2#1)(1995-3#8)(1995-5#2)(1995-6#1)(1996-1#5)(1996-11#1)(1996-12#3)(1996-2#8)(1996-3#7)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-8#4)(2004-10#4)(2004-11#2)(2004-12#2)(2005-10#2)(2005-11#5)(2005-2#1)(2005-5#3)(2005-6#1)(2005-7#5)(2005-8#4)(2006-1#2)(2006-10#8)(2006-12#2)(2006-2#4)(2006-4#3)(2006-5#3)(2006-6#2)(2006-7#3)(2006-8#4)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#15)(2007-2#13)(2007-3#1)(2007-4#6)(2007-5#5)(2007-6#5)(2007-7#7)(2007-8#3)(2007-9#6)(2008-1#12)(2008-10#5)(2008-11#30)(2008-12#23)(2008-2#11)(2008-3#8)(2008-4#6)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#3)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-8#2)(2009-9#2)(2010-1#10)(2010-10#3)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#4)(2010-7#1)(2010-8#3)(2010-9#6)(2011-1#10)(2011-12#1)(2011-2#22)(2012-1#3)(2012-11#3)(2012-12#16)(2012-2#13)(2012-3#11)(2013-1#34)(2013-7#1)(2013-8#8)
professionals' approach towards them##5##4##(2011-2#5)
professionals' approach##7##2##(2011-2#7)
professionals' attitudes##2##2##(1994-3#1)(2010-10#1)
professionals' perceptions##2##2##(1990-12#1)(2007-11#1)
professionals'##20##1##(1990-12#1)(1993-12#1)(1994-1#1)(1994-3#1)(1995-4#1)(2004-10#1)(2007-11#1)(2007-2#1)(2008-5#2)(2010-10#1)(2011-2#7)(2012-12#1)(2013-1#1)
professionals)##5##1##(2009-8#1)(2009-9#1)(2010-1#1)(2011-1#1)(2012-11#1)
professionals?##3##1##(1990-12#1)(1995-2#1)(2011-12#1)
professionals]##2##1##(1996-5#1)(2012-2#1)
professionnals##3##1##(2005-5#1)(2007-6#1)(2008-2#1)
professions and##4##2##(1990-12#1)(1996-1#1)(2006-8#1)(2011-12#1)
professions are##2##2##(1995-2#1)(2008-12#1)
professions in##4##2##(1990-12#1)(1990-4#1)(2006-2#1)(2010-3#1)
professions should##2##2##(1996-3#1)(2007-6#1)
professions to##2##2##(1995-1#1)(2013-1#1)
professions were##4##2##(1991-6#2)(1992-1#1)(2008-8#1)
professions##59##1##(1990-12#2)(1990-4#1)(1991-2#1)(1991-6#2)(1992-1#3)(1992-3#1)(1994-8#1)(1995-1#2)(1995-2#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-7#1)(1997-3#1)(1997-8#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-6#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#6)(2008-8#1)(2009-10#1)(2009-5#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#1)
professor at##2##2##(2009-2#1)(2013-8#1)
professor from##2##2##(1991-6#1)(2008-1#1)
professor in##2##2##(2009-10#1)(2013-8#1)
professor of clinical##2##3##(1997-5#1)(2007-5#1)
professor of##11##2##(1990-12#1)(1993-3#1)(1997-5#1)(2007-10#1)(2007-12#2)(2007-5#3)(2010-7#2)
professor##32##1##(1990-12#2)(1991-6#1)(1993-2#1)(1993-3#1)(1997-5#1)(2005-8#2)(2007-10#2)(2007-12#2)(2007-5#4)(2007-7#1)(2008-1#1)(2008-10#2)(2009-10#1)(2009-2#2)(2009-4#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#3)
professors of##3##2##(1990-12#1)(1993-6#1)(2010-1#1)
professors##17##1##(1990-12#1)(1993-6#1)(1995-2#1)(2006-5#1)(2007-8#1)(2007-9#3)(2009-2#1)(2010-1#1)(2012-12#2)(2012-2#2)(2012-3#3)
profibrotic##2##1##(2012-12#1)(2013-8#1)
proficiency and FL aptitude##2##4##(2007-9#2)
proficiency and##6##2##(2007-4#1)(2007-9#3)(2008-12#1)(2010-9#1)
proficiency in##5##2##(2007-9#2)(2008-11#1)(2008-8#1)(2010-7#1)
proficiency of##2##2##(1992-12#1)(1996-6#1)
proficiency testing##9##2##(1992-12#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-5#1)(2012-2#1)
proficiency##47##1##(1990-9#1)(1992-12#3)(1994-3#1)(1995-3#2)(1996-6#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-12#2)(2007-4#1)(2007-9#7)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-4#1)(2008-8#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
proficient in##5##2##(2006-3#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-5#1)
proficient mentor##4##2##(2008-7#4)
proficient##20##1##(1990-12#1)(1991-7#1)(1992-3#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-7#6)(2008-9#1)(2009-5#1)(2010-12#1)(2011-1#1)(2013-1#1)
profile after##2##2##(2008-2#1)(2009-8#1)
profile allows##2##2##(1996-1#1)(2007-12#1)
profile alone##2##2##(1990-3#1)(2007-12#1)
profile analysis (TPA)##2##3##(2010-4#2)
profile analysis##6##2##(2007-11#1)(2009-10#1)(2009-8#1)(2010-4#3)
profile and a##6##3##(1994-3#1)(2008-10#1)(2008-12#2)(2008-2#2)
profile and an##2##3##(1996-2#1)(2008-3#1)
profile and cholesterol##2##3##(2010-4#2)
profile and clinical##3##3##(1996-8#1)(2013-1#2)
profile and efficacy##2##3##(2006-12#1)(2011-2#1)
profile and for##2##3##(2008-10#1)(2011-2#1)
profile and is##2##3##(1991-7#1)(2007-7#1)
profile and its##4##3##(2005-4#1)(2008-7#2)(2010-11#1)
profile and outcome of##3##4##(2006-9#1)(2008-8#1)(2009-10#1)
profile and surgical outcome of##2##5##(2012-2#2)
profile and the##13##3##(1990-8#1)(1995-11#1)(1995-8#1)(2007-12#2)(2008-2#1)(2008-3#2)(2008-9#1)(2009-11#1)(2010-4#1)(2013-1#2)
profile and were##2##3##(1992-2#1)(2011-2#1)
profile and##123##2##(1990-8#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-2#1)(1992-8#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-8#1)(1996-2#2)(1996-5#1)(1996-8#2)(2005-10#1)(2005-11#2)(2005-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#3)(2008-2#8)(2008-3#9)(2008-4#2)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#2)(2009-11#1)(2009-3#1)(2010-11#2)(2010-12#3)(2010-4#4)(2010-5#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-12#6)(2012-2#7)(2012-3#2)(2013-1#5)(2013-7#1)
profile are##4##2##(1997-7#1)(2008-2#2)(2008-3#1)
profile as a##2##3##(2009-10#1)(2013-1#1)
profile as compared##2##3##(1995-5#1)(2006-9#1)
profile as native##2##3##(1995-8#1)(2007-11#1)
profile as the##2##3##(1991-9#1)(2008-3#1)
profile as##13##2##(1990-10#1)(1991-9#1)(1995-5#1)(1995-8#1)(2006-10#2)(2006-9#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-10#1)(2010-9#1)(2013-1#1)
profile at a certain##2##4##(2007-11#1)(2008-1#1)
profile at a##3##3##(2007-11#1)(2008-1#1)(2008-2#1)
profile at different##2##3##(2005-11#1)(2012-2#1)
profile at the##3##3##(2005-11#1)(2007-10#1)(2008-3#1)
profile at##13##2##(2005-11#2)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#3)(2012-2#1)
profile beam##4##2##(2007-12#1)(2008-3#3)
profile between##2##2##(2008-12#1)(2011-2#1)
profile but##2##2##(1993-2#1)(2008-11#1)
profile by a##2##3##(1994-6#1)(2007-12#1)
profile by##10##2##(1991-1#1)(1993-11#1)(1994-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-2#1)(2008-3#2)
profile can be determined##2##4##(2007-11#1)(2008-3#1)
profile can be##8##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#3)(2008-3#1)(2008-5#1)
profile can##12##2##(1991-2#1)(1993-8#1)(1996-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#4)(2008-3#1)(2008-5#1)
profile characteristics##3##2##(1996-2#1)(2008-10#1)(2008-3#1)
profile compared to##2##3##(2007-2#1)(2008-10#1)
profile compared with##3##3##(2008-5#1)(2012-12#1)(2012-2#1)
profile compared##5##2##(2007-2#1)(2008-10#1)(2008-5#1)(2012-12#1)(2012-2#1)
profile comparisons##3##2##(2008-10#1)(2008-4#2)
profile could be##3##3##(2006-10#1)(2008-5#1)(2010-4#1)
profile data##5##2##(2008-2#1)(2008-3#1)(2008-7#3)
profile dependence##2##2##(2006-2#1)(2008-3#1)
profile described##2##2##(1992-9#1)(2007-8#1)
profile did not##2##3##(1994-3#1)(2008-12#1)
profile during the modified diurnal tension curve##2##7##(2010-1#2)
profile during the##6##3##(2007-12#1)(2008-1#1)(2010-1#2)(2010-10#2)
profile during##7##2##(2007-12#1)(2008-1#1)(2008-7#1)(2010-1#2)(2010-10#2)
profile for a##2##3##(1997-1#1)(2007-8#1)
profile for each##4##3##(1994-6#1)(2008-10#1)(2008-12#1)(2012-1#1)
profile for the##2##3##(1992-4#1)(1995-11#1)
profile for##27##2##(1990-2#1)(1991-8#1)(1992-4#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1997-1#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-6#1)
profile from an##2##3##(2008-10#1)(2008-3#1)
profile from the urine of patients with##2##7##(1992-7#2)
profile from the##7##3##(1992-7#2)(2006-8#1)(2008-2#2)(2008-3#2)
profile from##18##2##(1990-11#1)(1992-7#2)(2006-1#1)(2006-8#1)(2008-10#2)(2008-2#4)(2008-3#4)(2008-4#1)(2009-5#1)(2011-1#1)
profile gives##2##2##(2005-11#1)(2007-12#1)
profile has been##4##3##(1995-10#1)(2007-12#1)(2008-3#2)
profile has##6##2##(1995-10#1)(2007-11#1)(2007-12#1)(2008-3#2)(2013-1#1)
profile have shown##2##3##(2006-2#1)(2010-12#1)
profile have##3##2##(2006-2#1)(2008-2#1)(2010-12#1)
profile if the##2##3##(2008-12#1)(2008-2#1)
profile if##3##2##(2008-12#1)(2008-2#2)
profile in a##8##3##(1993-12#1)(2005-7#1)(2007-12#3)(2008-3#2)(2009-1#1)
profile in an##2##3##(2008-10#1)(2008-2#1)
profile in patients with##4##4##(2007-10#1)(2007-5#1)(2011-2#1)(2012-1#1)
profile in postmenopausal women##2##4##(2008-3#1)(2010-12#1)
profile in the transverse and the longitudinal direction##2##8##(2008-3#2)
profile in the##21##3##(1996-12#1)(2005-11#1)(2007-12#1)(2007-2#1)(2008-2#7)(2008-3#5)(2008-5#1)(2010-11#1)(2012-2#2)(2013-8#1)
profile in##86##2##(1990-10#1)(1990-4#1)(1993-12#2)(1993-3#1)(1994-10#1)(1995-3#1)(1996-12#2)(1996-3#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-12#6)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#9)(2008-3#12)(2008-5#2)(2008-7#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-4#1)(2010-11#2)(2010-12#2)(2010-4#5)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#1)
profile indicated that##2##3##(1997-1#1)(2008-5#1)
profile indicated##4##2##(1997-1#1)(2008-10#1)(2008-5#1)(2008-6#1)
profile indicates that##2##3##(2005-8#1)(2008-10#1)
profile indicates##3##2##(1994-3#1)(2005-8#1)(2008-10#1)
profile into##2##2##(2007-12#1)(2010-6#1)
profile is a##3##3##(2007-11#1)(2008-10#1)(2008-11#1)
profile is also##2##3##(2008-2#2)
profile is an important##2##4##(2008-5#1)(2011-2#1)
profile is associated with##2##4##(1995-12#1)(2008-1#1)
profile is measured##2##3##(2008-1#1)(2008-3#1)
profile is not##2##3##(1996-1#1)(2010-5#1)
profile is obtained##2##3##(2007-11#1)(2008-3#1)
profile is similar to that of##2##6##(1996-12#1)(2009-8#1)
profile is used to##2##4##(2007-12#1)(2008-2#1)
profile is##53##2##(1993-2#2)(1993-8#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(2006-9#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#8)(2008-3#15)(2008-5#1)(2009-12#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
profile least-square-based##2##2##(2010-2#2)
profile likelihood##4##2##(1994-11#1)(2010-3#2)(2011-2#1)
profile may##3##2##(2005-7#1)(2008-5#1)(2008-8#1)
profile measurement##3##2##(2008-3#3)
profile measurements of##2##3##(2008-2#1)(2008-3#1)
profile measurements##8##2##(1997-1#1)(2008-2#4)(2008-3#3)
profile methods##2##2##(2008-10#1)(2010-3#1)
profile microscopy##2##2##(2006-12#2)
profile observed in##2##3##(1996-3#1)(2008-3#1)
profile observed##5##2##(1994-9#1)(1996-3#1)(1996-7#1)(1997-2#1)(2008-3#1)
profile obtained##5##2##(1992-1#1)(2007-11#1)(2008-3#1)(2008-5#1)(2011-2#1)
profile of a laser##2##4##(2007-12#1)(2008-3#1)
profile of a single-mode##2##4##(2007-11#1)(2008-2#1)
profile of a##36##3##(1990-2#1)(1990-8#1)(1992-7#1)(1993-2#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-4#1)(1996-10#1)(2006-10#1)(2006-8#1)(2007-11#4)(2007-12#5)(2008-10#1)(2008-2#3)(2008-3#8)(2009-12#1)(2010-12#1)(2010-4#1)(2013-7#1)
profile of action##2##3##(1990-6#1)(1991-2#1)
profile of activity##2##3##(1991-8#1)(2006-8#1)
profile of acute##2##3##(1992-3#1)(2009-12#1)
profile of adverse##2##3##(2008-1#1)(2009-6#1)
profile of an elderly population in Tabasco##2##7##(2012-12#2)
profile of an##6##3##(2006-10#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-12#2)
profile of cardiovascular##2##3##(2005-9#1)(2008-2#1)
profile of clozapine##2##3##(1996-7#1)(2005-8#1)
profile of cytokines##2##3##(2006-10#1)(2008-8#1)
profile of different##3##3##(2008-10#1)(2008-2#2)
profile of drug##2##3##(2006-1#1)(2008-4#1)
profile of each patient##3##4##(2007-3#1)(2008-3#1)(2009-5#1)
profile of each##4##3##(2007-3#1)(2008-3#1)(2009-5#2)
profile of face skills##2##4##(2009-4#2)
profile of gene##2##3##(2008-4#1)(2008-8#1)
profile of high##2##3##(1995-3#1)(2008-3#1)
profile of human##2##3##(1996-10#1)(2008-5#1)
profile of leprosy patients##2##4##(2008-3#2)
profile of metabolites##2##3##(2004-11#1)(2012-1#1)
profile of new##2##3##(2009-4#1)(2011-3#1)
profile of optical fibers##2##4##(2007-11#1)(2008-2#1)
profile of patients with##4##4##(2009-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
profile of patients##5##3##(2009-5#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
profile of public##2##3##(1993-1#1)(2008-9#1)
profile of salivary gland tumours presenting to a##2##8##(2012-2#2)
profile of the drug##4##4##(1996-7#1)(2005-10#1)(2008-10#1)(2012-12#1)
profile of the##101##3##(1990-4#1)(1990-6#1)(1991-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-5#1)(2004-11#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-5#2)(2007-11#3)(2007-12#8)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#9)(2008-3#12)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-1#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
profile of these##2##3##(2007-11#1)(2008-11#1)
profile of this##7##3##(1991-6#1)(1993-12#1)(1995-11#1)(1997-5#1)(2006-1#1)(2008-4#1)(2008-8#1)
profile of tuberculosis in##2##4##(2012-3#1)(2013-1#1)
profile of tuberculosis##3##3##(2012-3#1)(2013-1#2)
profile of urinary##2##3##(1995-11#1)(1997-8#1)
profile of##461##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#3)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#2)(1991-2#5)(1991-5#1)(1991-6#2)(1991-8#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#4)(1995-12#5)(1995-2#7)(1995-3#5)(1995-4#1)(1995-5#1)(1995-7#1)(1995-8#2)(1996-1#2)(1996-10#5)(1996-12#3)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#2)(1996-7#4)(1996-8#1)(1997-1#1)(1997-3#1)(1997-5#3)(1997-7#2)(1997-8#1)(2004-11#2)(2004-12#1)(2005-10#1)(2005-11#1)(2005-7#3)(2005-8#3)(2005-9#1)(2006-1#5)(2006-10#8)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#3)(2006-8#3)(2007-1#1)(2007-11#16)(2007-12#16)(2007-2#2)(2007-3#1)(2007-7#6)(2007-8#5)(2008-1#6)(2008-10#19)(2008-11#5)(2008-12#3)(2008-2#22)(2008-3#35)(2008-4#10)(2008-5#11)(2008-6#2)(2008-7#6)(2008-8#10)(2008-9#4)(2009-1#2)(2009-10#2)(2009-12#2)(2009-3#1)(2009-4#5)(2009-5#5)(2009-6#3)(2009-7#1)(2009-8#3)(2010-10#2)(2010-11#3)(2010-12#8)(2010-3#1)(2010-4#3)(2010-5#4)(2010-6#1)(2010-9#1)(2011-1#5)(2011-11#2)(2011-12#2)(2011-2#11)(2011-3#1)(2012-1#2)(2012-12#10)(2012-2#8)(2012-3#11)(2012-4#1)(2013-1#13)(2013-7#1)(2013-8#10)
profile on the##3##3##(2007-12#1)(2008-3#2)
profile on##5##2##(2006-8#1)(2007-12#1)(2008-3#2)(2008-7#1)
profile or##4##2##(2006-4#1)(2007-12#2)(2010-11#1)
profile retrieval##3##2##(2008-3#3)
profile revealed##2##2##(1997-2#1)(2011-2#1)
profile sampler##3##2##(2010-5#3)
profile scans##2##2##(2006-5#1)(2008-3#1)
profile seems##2##2##(2008-3#1)(2008-8#1)
profile show##2##2##(2008-2#1)(2008-5#1)
profile showed##5##2##(2005-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
profile shows##2##2##(1992-9#1)(2008-11#1)
profile similar to that of##2##5##(2008-4#1)(2013-1#1)
profile similar to that##3##4##(2008-4#1)(2008-7#1)(2013-1#1)
profile similar to##4##3##(2008-4#1)(2008-7#1)(2013-1#2)
profile suggests that the##2##4##(1990-4#1)(1997-5#1)
profile than##7##2##(2006-10#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2012-12#1)
profile that includes##2##3##(2006-7#1)(2010-12#1)
profile that is##9##3##(1993-12#1)(1994-9#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)(2010-11#1)
profile that##22##2##(1993-12#1)(1994-9#1)(2006-10#2)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#4)(2008-2#3)(2008-3#1)(2008-5#2)(2009-5#1)(2010-11#1)(2010-12#1)(2013-1#1)
profile the##5##2##(1994-12#1)(2006-10#1)(2006-12#1)(2009-12#1)(2009-6#1)
profile to a##2##3##(2008-10#1)(2008-7#1)
profile to the##2##3##(1995-2#1)(1996-1#1)
profile to##20##2##(1995-2#1)(1996-1#1)(2004-2#1)(2004-8#1)(2005-11#1)(2005-7#1)(2005-8#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-2#1)(2010-7#1)(2012-3#2)
profile types##2##2##(2008-5#2)
profile very##2##2##(1996-1#1)(2008-3#1)
profile was 0##2##3##(2008-9#1)(2010-8#1)
profile was analyzed##2##3##(2008-7#1)(2010-12#1)
profile was determined##2##3##(1997-4#1)(2009-3#1)
profile was observed##3##3##(1993-11#1)(2006-12#1)(2008-3#1)
profile was obtained##3##3##(1990-8#1)(1991-4#1)(2011-1#1)
profile was similar##2##3##(1992-3#1)(2008-3#1)
profile was studied##3##3##(2004-9#1)(2008-10#2)
profile was used##3##3##(2008-10#2)(2008-3#1)
profile was##44##2##(1990-7#1)(1990-8#1)(1991-4#1)(1992-3#1)(1993-11#1)(1993-12#1)(1997-3#1)(1997-4#1)(2004-9#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#5)(2008-7#3)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
profile were also##2##3##(2006-10#1)(2008-3#1)
profile were##7##2##(1991-2#1)(2006-10#1)(2008-10#1)(2008-3#3)(2013-1#1)
profile which##2##2##(1995-12#1)(1996-3#1)
profile with a##6##3##(2007-11#1)(2007-12#2)(2008-2#3)
profile with an##4##3##(2008-2#2)(2008-3#1)(2010-5#1)
profile with respect to##2##4##(1996-5#1)(2012-12#1)
profile with the##9##3##(1990-12#1)(1993-8#1)(1996-10#1)(2005-7#1)(2007-11#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-4#1)
profile with##34##2##(1990-12#1)(1993-8#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-9#2)(2005-7#1)(2006-6#1)(2007-11#3)(2007-12#2)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#7)(2008-3#3)(2008-4#1)(2009-6#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#1)
profile within the##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
profile within##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
profile without a##2##3##(2008-1#1)(2012-2#1)
profile##1645##1##(1990-1#1)(1990-10#5)(1990-11#2)(1990-12#4)(1990-2#5)(1990-3#3)(1990-4#4)(1990-5#1)(1990-6#3)(1990-7#2)(1990-8#3)(1990-9#4)(1991-1#4)(1991-11#1)(1991-12#3)(1991-2#9)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#3)(1991-7#2)(1991-8#4)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#5)(1992-3#3)(1992-4#2)(1992-6#2)(1992-7#4)(1992-8#7)(1992-9#4)(1993-1#3)(1993-11#4)(1993-12#12)(1993-2#5)(1993-3#4)(1993-4#2)(1993-5#2)(1993-8#6)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#3)(1994-3#6)(1994-5#2)(1994-6#3)(1994-8#2)(1994-9#4)(1995-1#2)(1995-10#2)(1995-11#7)(1995-12#10)(1995-2#11)(1995-3#9)(1995-4#1)(1995-5#2)(1995-7#1)(1995-8#4)(1996-1#7)(1996-10#6)(1996-12#11)(1996-2#7)(1996-3#10)(1996-4#2)(1996-5#5)(1996-7#7)(1996-8#3)(1996-9#9)(1997-1#6)(1997-2#4)(1997-3#2)(1997-4#2)(1997-5#4)(1997-6#2)(1997-7#4)(1997-8#8)(2004-11#2)(2004-12#2)(2004-2#1)(2004-8#1)(2004-9#1)(2005-10#3)(2005-11#13)(2005-3#1)(2005-4#1)(2005-6#1)(2005-7#10)(2005-8#11)(2005-9#3)(2006-1#9)(2006-10#27)(2006-11#3)(2006-12#12)(2006-2#6)(2006-3#2)(2006-4#5)(2006-5#8)(2006-6#4)(2006-7#3)(2006-8#6)(2006-9#5)(2007-1#2)(2007-10#7)(2007-11#47)(2007-12#79)(2007-2#9)(2007-3#3)(2007-5#2)(2007-7#14)(2007-8#23)(2007-9#7)(2008-1#25)(2008-10#72)(2008-11#21)(2008-12#19)(2008-2#120)(2008-3#186)(2008-4#26)(2008-5#38)(2008-6#9)(2008-7#35)(2008-8#21)(2008-9#11)(2009-1#4)(2009-10#11)(2009-11#6)(2009-12#6)(2009-2#2)(2009-3#4)(2009-4#9)(2009-5#7)(2009-6#6)(2009-7#3)(2009-8#9)(2009-9#2)(2010-1#3)(2010-10#5)(2010-11#12)(2010-12#22)(2010-2#3)(2010-3#7)(2010-4#23)(2010-5#16)(2010-6#4)(2010-7#5)(2010-8#3)(2010-9#3)(2011-1#24)(2011-11#4)(2011-12#6)(2011-2#47)(2011-3#1)(2012-1#6)(2012-11#3)(2012-12#26)(2012-2#32)(2012-3#22)(2012-4#2)(2012-6#1)(2013-1#46)(2013-7#6)(2013-8#14)
profile-based method##6##2##(2013-1#6)
profile-shaping system##2##2##(2008-2#2)
profile-shaping##3##1##(2008-2#3)
profile]##3##1##(2006-6#1)(2008-10#1)(2008-9#1)
profiled##10##1##(2006-5#1)(2007-12#1)(2008-10#2)(2008-5#2)(2008-7#2)(2010-4#1)(2010-5#1)
profiler and##2##2##(2008-3#1)(2013-8#1)
profiler based on##2##3##(2008-2#2)
profiler measurements##2##2##(2008-2#1)(2008-3#1)
profiler##16##1##(2007-11#1)(2007-12#2)(2008-2#9)(2008-3#3)(2013-8#1)
profilers##2##1##(2008-2#2)
profiles across the##2##3##(1992-1#1)(2010-2#1)
profiles across##4##2##(1992-1#1)(2008-7#1)(2009-4#1)(2010-2#1)
profiles after##2##2##(1995-2#1)(2012-1#1)
profiles along##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
profiles among##2##2##(2008-10#1)(2011-2#1)
profiles and a##2##3##(2007-2#1)(2008-3#1)
profiles and different##2##3##(2008-10#1)(2012-12#1)
profiles and polarization characteristics of airborne lidar return signals##2##9##(2008-2#2)
profiles and the##7##3##(1994-8#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-8#1)
profiles and their##5##3##(1995-6#1)(2007-11#1)(2007-12#1)(2008-3#1)(2010-4#1)
profiles and##74##2##(1990-4#1)(1990-8#1)(1993-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-6#1)(1997-2#2)(2004-3#1)(2005-7#1)(2006-10#2)(2006-2#1)(2007-1#1)(2007-11#2)(2007-12#7)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#7)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-11#2)(2009-8#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
profiles are analyzed to##2##4##(2008-5#1)(2011-1#1)
profiles are analyzed##3##3##(1996-2#1)(2008-5#1)(2011-1#1)
profiles are consistent with##2##4##(1992-4#1)(1997-7#1)
profiles are obtained##3##3##(2006-10#1)(2008-2#1)(2008-3#1)
profiles are presented##2##3##(2008-3#2)
profiles are##52##2##(1990-12#1)(1992-4#1)(1993-2#1)(1994-2#3)(1995-11#1)(1996-2#2)(1997-7#1)(2005-11#1)(2005-7#1)(2006-10#4)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#9)(2008-5#1)(2008-7#3)(2008-8#1)(2009-6#1)(2011-1#4)(2012-1#1)(2012-3#1)
profiles as##4##2##(2008-10#1)(2010-12#1)(2011-1#1)(2012-12#1)
profiles associated with the##2##4##(1993-11#1)(2008-5#1)
profiles associated with##6##3##(1993-11#1)(2008-5#1)(2013-1#4)
profiles associated##7##2##(1993-11#1)(2008-1#1)(2008-5#1)(2013-1#4)
profiles at an##2##3##(2008-3#1)(2010-12#1)
profiles at different##2##3##(2008-2#1)(2008-8#1)
profiles at##13##2##(1994-9#1)(2007-12#1)(2008-2#3)(2008-3#4)(2008-8#1)(2009-11#1)(2010-12#2)
profiles between the##2##3##(2008-10#1)(2008-3#1)
profiles between##5##2##(2008-10#3)(2008-3#2)
profiles by a##2##3##(2008-10#1)(2008-3#1)
profiles by use of a##2##5##(2007-12#2)
profiles by use of##3##4##(2007-12#2)(2008-3#1)
profiles by##8##2##(1990-6#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2009-3#1)
profiles can be##7##3##(1997-2#1)(2008-2#1)(2008-3#3)(2008-4#1)(2010-12#1)
profiles can##8##2##(1997-2#1)(2008-2#1)(2008-3#4)(2008-4#1)(2010-12#1)
profiles corresponding to##2##3##(1991-2#1)(2012-2#1)
profiles could##3##2##(1996-8#1)(2008-12#1)(2011-3#1)
profiles derived from##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
profiles described##2##2##(2008-2#1)(2009-6#1)
profiles determined##2##2##(1990-2#1)(2011-2#1)
profiles did not##4##3##(2007-7#1)(2007-9#1)(2008-10#2)
profiles due to##3##3##(1992-8#1)(2012-2#1)(2012-3#1)
profiles during the##2##3##(1993-9#1)(2010-12#1)
profiles during##4##2##(1990-4#1)(1993-9#1)(2010-12#1)(2011-12#1)
profiles for a##2##3##(2008-3#1)(2012-12#1)
profiles for the##8##3##(1991-9#1)(2006-10#1)(2008-2#2)(2008-3#2)(2008-8#1)(2010-4#1)
profiles for various##2##3##(2007-6#1)(2008-10#1)
profiles for##46##2##(1990-7#1)(1991-9#1)(1992-3#1)(1992-5#1)(1994-3#1)(1994-9#1)(1995-1#1)(1996-2#1)(1997-1#1)(2005-11#1)(2006-10#3)(2007-10#1)(2007-12#3)(2007-6#1)(2008-10#3)(2008-11#3)(2008-2#4)(2008-3#5)(2008-7#2)(2008-8#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-8#3)
profiles from a##3##3##(2006-4#1)(2008-3#1)(2008-5#1)
profiles from other##2##3##(1996-2#1)(2010-11#1)
profiles from the##3##3##(1991-11#1)(2008-2#1)(2008-3#1)
profiles from##29##2##(1991-11#1)(1992-11#1)(1996-2#1)(1997-1#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#1)(2010-11#1)(2011-1#1)(2012-2#1)
profiles generated by##2##3##(1997-3#1)(2008-10#1)
profiles generated from##2##3##(2008-3#1)(2010-2#1)
profiles generated##4##2##(1997-3#1)(2008-10#1)(2008-3#1)(2010-2#1)
profiles have been##5##3##(1990-5#1)(1991-5#1)(2008-3#1)(2008-8#1)(2009-12#1)
profiles have##6##2##(1990-5#1)(1991-5#1)(2008-3#1)(2008-8#1)(2009-12#1)(2011-12#1)
profiles in a##6##3##(1996-8#1)(1997-4#1)(2007-10#1)(2008-2#1)(2008-3#2)
profiles in human##2##3##(2008-11#1)(2010-12#1)
profiles in patients with##3##4##(2005-8#1)(2010-4#2)
profiles in patients##6##3##(1996-8#1)(2005-8#1)(2010-4#2)(2012-1#2)
profiles in rat##2##3##(2008-12#1)(2009-10#1)
profiles in such a##2##4##(2004-11#1)(2008-2#1)
profiles in the##12##3##(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#6)(2008-7#1)(2010-4#1)(2011-1#1)
profiles in##72##2##(1991-12#1)(1994-5#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-6#1)(1996-8#2)(1997-2#2)(1997-4#1)(2004-11#1)(2004-4#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-8#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#12)(2008-4#1)(2008-5#3)(2008-7#3)(2009-10#1)(2009-6#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-4#3)(2011-1#1)(2011-2#1)(2012-1#2)(2013-1#2)(2013-7#1)(2013-8#2)
profiles indicate##2##2##(2006-7#1)(2011-2#1)
profiles indicated that the##3##4##(1990-12#1)(2007-5#1)(2010-11#1)
profiles indicated that##4##3##(1990-12#1)(2007-5#1)(2008-10#1)(2010-11#1)
profiles induced by##4##3##(1996-10#1)(1996-8#1)(2007-11#1)(2012-2#1)
profiles induced##5##2##(1996-10#1)(1996-8#1)(2007-11#1)(2010-2#1)(2012-2#1)
profiles influence##2##2##(2008-3#1)(2008-9#1)
profiles is##11##2##(2006-5#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#1)(2008-7#1)(2008-8#1)
profiles may##3##2##(2009-5#1)(2011-2#1)(2013-8#1)
profiles measured by the##2##4##(1996-7#1)(2008-2#1)
profiles measured by##3##3##(1996-7#1)(2008-10#1)(2008-2#1)
profiles measured##4##2##(1996-7#1)(2008-10#1)(2008-2#2)
profiles observed##2##2##(2007-8#1)(2008-3#1)
profiles obtained at##2##3##(1995-5#1)(2008-3#1)
profiles obtained by##10##3##(2007-11#1)(2008-10#2)(2008-2#5)(2008-3#1)(2008-5#1)
profiles obtained were##2##3##(2008-5#1)(2010-5#1)
profiles obtained with##2##3##(2008-3#2)
profiles obtained##23##2##(1992-8#1)(1995-5#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-2#5)(2008-3#4)(2008-5#3)(2010-5#2)
profiles occurred##2##2##(2005-8#1)(2008-10#1)
profiles of DNA##2##3##(1993-3#1)(2013-8#1)
profiles of a##4##3##(1995-8#1)(2008-7#1)(2008-8#1)(2009-6#1)
profiles of aerosol##3##3##(2008-2#1)(2008-3#2)
profiles of all##4##3##(2008-10#1)(2008-12#1)(2012-2#1)(2012-3#1)
profiles of atmospheric##3##3##(2008-2#1)(2008-3#2)
profiles of cell##4##3##(2008-10#1)(2008-11#2)(2012-2#1)
profiles of circulating growth hormone##2##5##(1994-3#2)
profiles of circulating##4##3##(1994-3#2)(2008-8#1)(2012-1#1)
profiles of corresponding##2##3##(2008-12#1)(2012-2#1)
profiles of different##2##3##(1995-3#1)(2008-2#1)
profiles of fiber gratings##2##4##(2008-3#2)
profiles of fragrance##2##3##(2008-5#2)
profiles of glucose##2##3##(2008-5#1)(2008-7#1)
profiles of healthy##2##3##(2011-2#1)(2013-1#1)
profiles of human##4##3##(2009-1#1)(2009-6#1)(2009-9#1)(2013-1#1)
profiles of individual##4##3##(1993-12#1)(1995-8#1)(2006-3#1)(2012-1#1)
profiles of light##3##3##(2008-2#3)
profiles of multiple##2##3##(1996-10#1)(2008-3#1)
profiles of pressure##3##3##(2008-3#3)
profiles of skeletal muscles##2##4##(2012-1#2)
profiles of temperature##2##3##(2007-5#1)(2008-3#1)
profiles of the aerosol backscattering coefficient at 355 and 723##2##10##(2008-3#2)
profiles of the bacterial##2##4##(2008-10#1)(2008-7#1)
profiles of the lidar##2##4##(2008-2#2)
profiles of the refractive index##2##5##(2008-2#2)
profiles of the scattering coefficient##2##5##(2008-3#2)
profiles of the two##3##4##(1992-8#1)(2008-11#1)(2009-6#1)
profiles of the various##2##4##(2008-5#1)(2008-9#1)
profiles of the##77##3##(1991-3#1)(1991-6#1)(1992-3#1)(1992-8#1)(1994-3#1)(1995-6#1)(1996-10#1)(1997-1#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-11#1)(2007-12#8)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#12)(2008-3#12)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#3)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)
profiles of these##9##3##(1994-3#1)(2004-11#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-8#1)(2012-2#1)
profiles of three different##2##4##(2008-10#1)(2008-11#1)
profiles of three##3##3##(2008-10#1)(2008-11#1)(2010-2#1)
profiles of two##2##3##(2005-8#1)(2013-7#1)
profiles of various##3##3##(2008-10#3)
profiles of##314##2##(1990-10#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-3#1)(1994-11#2)(1994-3#4)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#3)(1996-12#1)(1996-2#1)(1996-8#2)(1996-9#2)(1997-1#3)(1997-2#1)(1997-7#1)(1997-8#2)(2004-11#1)(2005-10#1)(2005-11#2)(2005-7#2)(2005-8#4)(2006-10#2)(2006-12#3)(2006-2#1)(2006-3#1)(2006-8#2)(2007-10#1)(2007-11#6)(2007-12#12)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#35)(2008-11#9)(2008-12#4)(2008-2#31)(2008-3#38)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#2)(2009-1#1)(2009-11#1)(2009-4#2)(2009-6#4)(2009-7#1)(2009-8#4)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#3)(2010-3#2)(2010-4#4)(2010-5#2)(2010-6#1)(2011-1#5)(2011-10#2)(2011-2#8)(2011-3#1)(2012-1#8)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#1)(2012-6#1)(2013-1#6)(2013-7#2)(2013-8#1)
profiles on the##3##3##(1992-8#1)(1993-1#1)(2008-10#1)
profiles on##8##2##(1991-2#1)(1992-8#1)(1993-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-5#1)(2011-1#1)
profiles presented##3##2##(1996-8#1)(2007-12#1)(2010-1#1)
profiles resulting from##2##3##(1997-7#1)(2008-2#1)
profiles retrieved##2##2##(2008-3#2)
profiles revealed##5##2##(1995-6#1)(2008-10#2)(2009-12#1)(2012-2#1)
profiles should##2##2##(1995-4#1)(2008-2#1)
profiles show that##2##3##(1994-9#1)(2008-3#1)
profiles showed a##2##3##(1994-11#1)(2007-12#1)
profiles showed that##5##3##(2008-10#2)(2008-12#1)(2008-7#1)(2010-12#1)
profiles showed##12##2##(1990-11#1)(1994-11#1)(2006-8#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)
profiles that have##2##3##(2007-11#1)(2008-1#1)
profiles that were##5##3##(1994-8#1)(2008-10#1)(2008-12#2)(2008-7#1)
profiles that##16##2##(1994-8#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-7#1)(2009-4#2)(2011-2#1)(2013-7#1)
profiles the##3##2##(2008-3#1)(2008-7#2)
profiles to be##2##3##(2007-12#1)(2008-3#1)
profiles to##6##2##(1997-2#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
profiles under different##2##3##(2005-10#1)(2008-7#1)
profiles under##4##2##(2005-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
profiles using a##2##3##(1992-1#1)(2007-12#1)
profiles using##8##2##(1991-9#1)(1992-1#1)(1993-3#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-12#1)(2012-3#1)
profiles was##8##2##(1990-6#1)(1991-12#1)(1994-10#1)(2005-11#1)(2008-10#2)(2008-8#1)(2013-1#1)
profiles were also obtained##2##4##(2008-2#1)(2010-5#1)
profiles were also##4##3##(1994-3#1)(2008-10#1)(2008-2#1)(2010-5#1)
profiles were associated with##2##4##(1995-11#1)(2010-5#1)
profiles were determined##4##3##(1997-3#1)(2005-11#1)(2006-10#1)(2007-2#1)
profiles were evaluated##2##3##(1990-6#1)(2008-10#1)
profiles were found to be##4##5##(2006-12#1)(2008-10#2)(2010-3#1)
profiles were found to##5##4##(2006-12#1)(2008-10#3)(2010-3#1)
profiles were generated from##2##4##(2008-10#1)(2008-12#1)
profiles were generated##3##3##(1996-12#1)(2008-10#1)(2008-12#1)
profiles were measured from##2##4##(2007-12#1)(2008-11#1)
profiles were measured##5##3##(2007-12#1)(2008-11#1)(2008-3#1)(2008-7#2)
profiles were observed##2##3##(1996-8#1)(2008-10#1)
profiles were obtained for##3##4##(2008-10#2)(2008-12#1)
profiles were obtained##9##3##(1991-3#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#1)
profiles were seen##3##3##(1997-3#1)(2008-10#1)(2008-4#1)
profiles were similar##2##3##(1996-12#1)(2011-10#1)
profiles were##79##2##(1990-6#1)(1990-8#1)(1991-3#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#2)(1996-12#2)(1996-8#2)(1997-2#1)(1997-3#4)(1997-5#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-12#4)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#3)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2011-10#1)(2012-11#1)(2013-1#2)
profiles when##3##2##(2006-10#1)(2007-1#1)(2011-2#1)
profiles which##3##2##(1991-12#1)(1992-8#1)(2006-8#1)
profiles with##10##2##(2008-2#2)(2008-3#4)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
profiles within##3##2##(1994-10#1)(1995-5#1)(2008-10#1)
profiles##1287##1##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#4)(1990-7#3)(1990-8#4)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#6)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#4)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#1)(1992-8#6)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-5#1)(1993-8#1)(1993-9#1)(1994-10#3)(1994-11#5)(1994-2#4)(1994-3#7)(1994-5#1)(1994-6#3)(1994-8#3)(1994-9#8)(1995-1#3)(1995-11#3)(1995-12#1)(1995-2#5)(1995-3#3)(1995-4#1)(1995-5#5)(1995-6#4)(1995-7#1)(1995-8#3)(1996-10#5)(1996-11#1)(1996-12#6)(1996-2#7)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#9)(1996-9#3)(1997-1#5)(1997-2#13)(1997-3#5)(1997-4#4)(1997-5#1)(1997-7#7)(1997-8#3)(2004-11#2)(2004-3#2)(2004-4#1)(2005-10#3)(2005-11#10)(2005-7#4)(2005-8#8)(2006-10#25)(2006-11#1)(2006-12#8)(2006-2#2)(2006-3#1)(2006-4#5)(2006-5#7)(2006-6#2)(2006-7#1)(2006-8#8)(2007-1#2)(2007-10#5)(2007-11#24)(2007-12#55)(2007-2#4)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#7)(2007-7#7)(2007-8#8)(2007-9#3)(2008-1#14)(2008-10#153)(2008-11#23)(2008-12#22)(2008-2#113)(2008-3#156)(2008-4#10)(2008-5#28)(2008-6#4)(2008-7#35)(2008-8#16)(2008-9#5)(2009-1#1)(2009-10#4)(2009-11#5)(2009-12#3)(2009-3#2)(2009-4#8)(2009-5#2)(2009-6#9)(2009-7#2)(2009-8#8)(2009-9#5)(2010-1#2)(2010-10#1)(2010-11#6)(2010-12#17)(2010-2#9)(2010-3#5)(2010-4#14)(2010-5#10)(2010-6#1)(2010-7#2)(2011-1#21)(2011-10#6)(2011-12#4)(2011-2#26)(2011-3#5)(2012-1#12)(2012-11#4)(2012-12#15)(2012-2#20)(2012-3#11)(2012-6#1)(2013-1#27)(2013-7#5)(2013-8#11)
profiles) and##3##2##(1991-11#1)(2008-4#1)(2012-3#1)
profiles)##5##1##(1991-11#1)(2007-6#1)(2008-10#1)(2008-4#1)(2012-3#1)
profiles]##2##1##(1990-2#1)(2011-3#1)
profilin II##2##2##(1994-8#2)
profilin allergic patients##3##3##(1994-2#3)
profilin and##4##2##(1990-3#1)(1990-7#1)(1994-2#2)
profilin##28##1##(1990-3#5)(1990-7#3)(1994-2#12)(1994-8#5)(2008-1#1)(2009-10#1)(2010-12#1)
profiling analysis##2##2##(2008-10#1)(2008-7#1)
profiling and its##2##3##(1995-11#1)(2008-7#1)
profiling and##18##2##(1995-11#1)(2006-12#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#3)(2009-4#1)(2009-8#1)(2010-5#1)(2012-11#1)(2013-1#2)(2013-8#1)
profiling approach##3##2##(2012-3#2)(2013-1#1)
profiling as well as##2##4##(2007-12#1)(2012-12#1)
profiling as##3##2##(1996-9#1)(2007-12#1)(2012-12#1)
profiling by##4##2##(2008-2#1)(2008-3#1)(2008-4#1)(2010-3#1)
profiling can##3##2##(2008-12#1)(2012-12#2)
profiling data##5##2##(2008-2#1)(2008-7#3)(2009-10#1)
profiling has been##3##3##(1995-11#1)(2008-7#1)(2010-11#1)
profiling has##8##2##(1995-11#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2012-3#1)
profiling in the##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
profiling in##12##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-1#1)(2009-10#1)(2010-12#1)(2010-3#1)(2012-12#2)(2013-1#1)
profiling is##4##2##(2008-3#1)(2008-7#1)(2009-10#1)(2009-12#1)
profiling method##2##2##(2008-10#1)(2008-3#1)
profiling of biological samples##2##4##(2008-4#1)(2008-7#1)
profiling of biological##3##3##(2008-4#1)(2008-7#1)(2010-5#1)
profiling of human##3##3##(2008-7#1)(2011-2#1)(2012-3#1)
profiling of optical fibers##2##4##(2007-11#2)
profiling of tryptophan##2##3##(1993-11#2)
profiling of ultrafiltration was##2##4##(2008-1#2)
profiling of ultrafiltration##4##3##(2008-1#4)
profiling of##56##2##(1993-11#2)(1996-6#2)(2005-10#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-1#4)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-6#2)(2008-7#4)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#3)
profiling on##3##2##(2008-6#1)(2008-7#1)(2013-8#1)
profiling studies have##3##3##(2009-4#1)(2013-8#2)
profiling studies##6##2##(2008-2#1)(2008-4#1)(2008-7#1)(2009-4#1)(2013-8#2)
profiling system##3##2##(1995-3#1)(2008-12#2)
profiling systems for##2##3##(2008-12#2)
profiling systems##6##2##(1996-1#2)(2008-12#4)
profiling techniques##3##2##(1997-2#1)(2008-7#2)
profiling technologies##4##2##(2007-8#1)(2008-1#1)(2008-7#2)
profiling that##2##2##(2008-10#1)(2008-4#1)
profiling to identify##3##3##(2008-4#1)(2008-7#1)(2012-12#1)
profiling to##7##2##(2006-12#2)(2008-12#1)(2008-4#1)(2008-7#1)(2012-12#2)
profiling using##7##2##(2007-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#2)(2009-6#1)
profiling was performed##2##3##(2010-12#1)(2010-4#1)
profiling was##4##2##(2008-10#1)(2010-12#1)(2010-4#1)(2012-2#1)
profiling with##4##2##(1993-7#1)(2008-2#1)(2008-3#1)(2008-7#1)
profiling##235##1##(1993-11#2)(1993-3#1)(1993-7#1)(1995-11#2)(1995-2#1)(1995-3#2)(1996-1#2)(1996-6#2)(1996-9#1)(1997-2#2)(2004-4#1)(2005-10#1)(2005-8#1)(2006-12#3)(2006-7#1)(2007-1#1)(2007-11#3)(2007-12#3)(2007-4#1)(2007-6#1)(2007-8#6)(2008-1#6)(2008-10#19)(2008-11#6)(2008-12#11)(2008-2#14)(2008-3#9)(2008-4#13)(2008-5#2)(2008-6#6)(2008-7#29)(2008-8#1)(2009-1#1)(2009-10#5)(2009-12#3)(2009-2#1)(2009-4#3)(2009-6#1)(2009-8#4)(2010-11#4)(2010-12#9)(2010-3#2)(2010-4#3)(2010-5#4)(2010-6#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-11#3)(2012-12#10)(2012-2#2)(2012-3#5)(2013-1#5)(2013-7#3)(2013-8#6)
profilins are##2##2##(1994-2#1)(1994-8#1)
profilins##7##1##(1990-7#1)(1994-2#4)(1994-8#2)
profilometer as##2##2##(2008-1#1)(2008-2#1)
profilometer with##2##2##(2008-2#1)(2008-3#1)
profilometer##14##1##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#6)(2008-3#3)(2009-7#1)
profilometers##2##1##(2008-2#2)
profilometric measurement##2##2##(2008-3#2)
profilometric measurements##2##2##(2007-12#1)(2008-3#1)
profilometric##9##1##(2006-12#2)(2007-11#1)(2007-12#3)(2008-3#3)
profilometry (DDSP) are##2##3##(2008-3#2)
profilometry and##4##2##(2006-12#1)(2008-2#1)(2008-3#1)(2009-4#1)
profilometry based on##4##3##(2007-12#1)(2008-3#3)
profilometry by##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
profilometry is presented##2##3##(2007-12#1)(2008-3#1)
profilometry is##5##2##(2007-12#1)(2008-3#4)
profilometry method##2##2##(2006-12#1)(2008-2#1)
profilometry technique##3##2##(2007-12#2)(2008-3#1)
profilometry with a##2##3##(2007-12#1)(2008-3#1)
profilometry with##4##2##(2007-12#1)(2008-3#3)
profilometry##59##1##(2004-9#1)(2006-12#3)(2007-11#2)(2007-12#6)(2008-1#1)(2008-2#10)(2008-3#32)(2008-5#2)(2009-4#1)(2010-4#1)
profils##3##1##(2008-4#3)
profit and##4##2##(1996-11#1)(2008-1#1)(2008-11#1)(2011-2#1)
profit from the##2##3##(1994-10#1)(2008-1#1)
profit from this##2##3##(1997-4#1)(2008-3#1)
profit from##10##2##(1993-2#1)(1994-10#1)(1994-3#1)(1996-2#1)(1997-4#1)(2006-6#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-8#1)
profit growth##3##2##(1995-5#1)(1997-4#2)
profit making##2##2##(2006-8#1)(2008-7#1)
profit per unit area##2##4##(2008-12#2)
profit rates##2##2##(1993-12#1)(1993-3#1)
profit##52##1##(1991-1#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-4#1)(1995-10#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#2)(1996-2#1)(1997-2#1)(1997-4#3)(2004-3#1)(2005-8#1)(2006-6#1)(2006-8#1)(2007-4#1)(2008-1#3)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#4)(2012-11#1)
profitability of##8##2##(1991-1#1)(1994-3#1)(1995-1#1)(1995-3#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-6#1)
profitability##24##1##(1990-2#1)(1991-1#2)(1992-3#2)(1994-3#1)(1995-1#2)(1995-3#3)(2005-8#1)(2007-11#1)(2007-3#1)(2007-4#1)(2008-11#7)(2008-12#1)(2008-6#1)
profitable features such as a linear response##2##7##(2007-10#1)(2008-10#1)
profitable features such as a##3##5##(2007-10#1)(2008-10#2)
profitable features such as##6##4##(2007-10#1)(2008-10#5)
profitable##20##1##(1990-12#1)(1994-3#1)(2005-10#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-10#10)(2008-5#1)(2008-8#1)(2008-9#1)(2010-9#1)
profitably##3##1##(1996-2#1)(2008-10#1)(2008-3#1)
profited from a##2##3##(2011-2#2)
profited from##4##2##(2008-7#1)(2011-2#2)(2012-2#1)
profits are##2##2##(1996-12#1)(1996-2#1)
profits in the##3##3##(1992-2#1)(1993-3#1)(2008-11#1)
profits##36##1##(1991-1#1)(1991-10#2)(1991-3#2)(1992-2#1)(1993-1#3)(1993-12#1)(1993-3#2)(1994-2#1)(1994-3#1)(1996-12#2)(1996-2#1)(1996-9#1)(1997-2#1)(1997-4#2)(2006-2#1)(2006-5#1)(2007-4#1)(2007-5#1)(2008-11#3)(2008-7#2)(2009-9#1)(2010-5#2)(2012-2#1)(2013-1#2)
proflavine##4##1##(1991-12#2)(2008-10#2)
proform##3##1##(1995-6#1)(2008-4#1)(2008-5#1)
proforma##5##1##(1996-2#1)(2007-7#1)(2009-9#1)(2011-2#1)(2012-12#1)
profound alterations##2##2##(1994-6#1)(1995-2#1)
profound and##7##2##(1992-8#1)(2004-2#1)(2005-9#1)(2008-10#1)(2008-5#1)(2010-5#1)(2013-1#1)
profound bilateral sensorineural deafness##2##4##(1997-1#1)(2007-3#1)
profound bilateral##3##2##(1997-1#1)(2007-3#1)(2008-9#1)
profound changes in the##4##4##(1994-12#3)(2007-11#1)
profound changes in##6##3##(1994-12#3)(1994-3#1)(2007-11#1)(2007-2#1)
profound changes##11##2##(1994-12#3)(1994-3#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-5#2)(2010-1#1)(2011-1#1)
profound connection between##2##3##(2008-7#1)(2012-2#1)
profound deafness##3##2##(2008-9#3)
profound differences##2##2##(2009-11#1)(2013-8#1)
profound effect on##15##3##(1995-2#1)(1997-2#1)(1997-8#1)(2006-9#2)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-4#1)(2010-6#1)(2011-12#1)
profound effect##17##2##(1995-2#1)(1997-2#1)(1997-8#1)(2006-9#2)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#2)(2009-8#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-12#1)
profound effects on the##8##4##(2007-12#1)(2008-8#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-1#1)
profound effects on##16##3##(1990-8#1)(1995-2#1)(2005-11#1)(2007-12#1)(2008-5#2)(2008-6#1)(2008-8#3)(2010-1#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-1#1)
profound effects##17##2##(1990-8#1)(1995-11#1)(1995-2#1)(2005-11#1)(2007-12#1)(2008-5#2)(2008-6#1)(2008-8#3)(2010-1#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-1#1)
profound hearing loss##8##3##(2008-9#7)(2012-2#1)
profound immune##2##2##(2008-4#1)(2011-2#1)
profound impact on the##3##4##(2006-9#1)(2008-11#1)(2010-11#1)
profound impact on##8##3##(1994-12#1)(2006-9#1)(2007-11#1)(2008-11#1)(2010-11#1)(2011-1#1)(2013-1#2)
profound impact##10##2##(1993-4#1)(1994-12#1)(2006-9#1)(2007-11#1)(2008-11#1)(2010-11#1)(2011-1#2)(2013-1#2)
profound implications for##3##3##(2008-8#1)(2009-9#1)(2011-1#1)
profound implications##4##2##(2008-11#1)(2008-8#1)(2009-9#1)(2011-1#1)
profound in##3##2##(2008-10#1)(2012-12#1)(2013-1#1)
profound increase in##2##3##(1997-7#1)(2006-10#1)
profound influence on##6##3##(1994-6#1)(2005-11#1)(2008-11#2)(2008-5#1)(2010-7#1)
profound influence##7##2##(1994-6#1)(2005-11#1)(2008-11#2)(2008-5#1)(2009-3#1)(2010-7#1)
profound metabolic##2##2##(2006-10#1)(2008-7#1)
profound reduction##2##2##(1994-10#1)(1994-6#1)
profound sensorineural hearing loss##3##4##(2008-9#3)
profound skeletal##2##2##(1997-4#1)(2008-5#1)
profound social##2##2##(2006-12#1)(2008-7#1)
profound spatial##2##2##(1994-2#1)(1997-5#1)
profound##200##1##(1990-8#2)(1990-9#1)(1991-10#1)(1991-6#1)(1992-1#1)(1992-8#1)(1993-12#1)(1993-4#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#3)(1994-6#3)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#2)(1995-7#2)(1995-8#1)(1996-10#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-2#1)(2005-11#3)(2005-7#1)(2005-9#1)(2006-10#7)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2006-9#3)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#3)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#1)(2007-8#4)(2007-9#1)(2008-10#4)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#18)(2009-11#1)(2009-3#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#5)(2012-1#4)(2012-12#2)(2012-2#3)(2013-1#6)(2013-7#1)(2013-8#1)
profoundly affect the##5##3##(1994-12#1)(1995-5#1)(1995-9#1)(1997-6#1)(2009-3#1)
profoundly affect##8##2##(1994-12#1)(1995-5#1)(1995-9#1)(1997-5#1)(1997-6#1)(2008-8#1)(2009-3#1)(2010-2#1)
profoundly affected by##2##3##(1990-5#1)(1992-5#1)
profoundly affected##3##2##(1990-5#1)(1992-5#1)(2007-7#1)
profoundly affects##3##2##(1993-12#1)(2008-11#1)(2011-2#1)
profoundly altered##3##2##(1990-12#1)(1992-1#1)(1995-5#1)
profoundly alters the##2##3##(1990-5#1)(1994-12#1)
profoundly deaf##3##2##(2007-3#1)(2008-9#2)
profoundly decreased##2##2##(2008-5#1)(2008-7#1)
profoundly hearing-impaired children##3##3##(2008-9#3)
profoundly immunosuppressed##2##2##(2007-3#1)(2008-5#1)
profoundly influence the##3##3##(1991-5#1)(1994-3#1)(1995-1#1)
profoundly influence##5##2##(1991-5#1)(1994-3#1)(1995-1#1)(2009-4#1)(2011-1#1)
profoundly inhibited##2##2##(1994-10#1)(1994-2#1)
profoundly suppress FN expression##2##4##(1994-9#2)
profoundly##73##1##(1990-12#1)(1990-5#2)(1990-8#2)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-5#1)(1993-12#2)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-5#2)(1995-9#1)(1996-8#1)(1997-5#1)(1997-6#2)(2005-1#1)(2005-7#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#6)(2009-10#1)(2009-3#2)(2009-4#1)(2009-9#1)(2010-2#2)(2011-1#3)(2011-2#5)(2012-3#1)
profunda arteries##2##2##(2008-7#2)
profunda##6##1##(2006-4#2)(2008-7#3)(2013-1#1)
profundal##2##1##(2008-5#2)
profundus##12##1##(2006-3#1)(2007-7#2)(2010-6#1)(2011-2#2)(2013-1#6)
profuse bleeding##4##2##(1990-3#1)(2005-10#1)(2007-8#1)(2008-7#1)
profuse diarrhoea##2##2##(2008-5#2)
profuse##15##1##(1990-3#1)(1991-9#1)(1997-1#1)(2005-10#3)(2007-8#2)(2008-10#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
profusely##2##1##(1991-5#1)(2008-10#1)
profusion of##3##2##(2005-8#1)(2008-7#1)(2008-9#1)
profusion##4##1##(2005-8#1)(2006-12#1)(2008-7#1)(2008-9#1)
progabide##2##1##(1997-8#2)
progamic##2##1##(2009-12#2)
progastrin##3##1##(1992-8#3)
progelatinase A##5##2##(1992-6#1)(1994-5#3)(1997-4#1)
progelatinase was##2##2##(1991-8#1)(1992-6#1)
progelatinase##12##1##(1991-8#6)(1992-6#2)(1994-5#3)(1997-4#1)
progenies from##2##2##(2008-10#2)
progenies of crosses##2##3##(2008-10#2)
progenies of the##2##3##(1994-8#1)(2007-1#1)
progenies of##11##2##(1994-8#1)(2007-1#1)(2008-1#1)(2008-10#5)(2008-8#1)(2008-9#1)(2012-11#1)
progenies were##5##2##(1997-4#1)(2008-10#4)
progenies##42##1##(1994-8#1)(1995-8#1)(1996-6#1)(1997-4#2)(2006-12#1)(2007-1#2)(2008-1#1)(2008-10#18)(2008-11#1)(2008-5#3)(2008-8#2)(2008-9#2)(2009-12#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#2)
progenitor and differentiated pituitary##2##4##(1996-11#2)
progenitor and##4##2##(1996-11#2)(2008-1#1)(2013-1#1)
progenitor cell differentiation##5##3##(2008-1#1)(2008-10#2)(2012-12#1)(2012-8#1)
progenitor cell populations##4##3##(1995-6#1)(2008-4#1)(2008-9#1)(2009-4#1)
progenitor cell##29##2##(1992-5#1)(1994-10#1)(1995-12#1)(1995-6#2)(1996-11#1)(1997-6#1)(2005-7#1)(2006-4#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-4#2)(2008-7#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-7#1)(2012-12#4)(2012-8#1)(2013-1#1)
progenitor cells (EPC)##3##3##(2009-7#1)(2010-6#1)(2012-2#1)
progenitor cells and##11##3##(1996-5#1)(1996-8#1)(2006-1#1)(2007-3#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-9#1)(2010-6#1)(2011-12#1)
progenitor cells are##6##3##(2006-12#1)(2008-11#1)(2008-9#1)(2009-12#1)(2012-12#1)(2012-2#1)
progenitor cells by##2##3##(1990-4#1)(1997-7#1)
progenitor cells derived from##2##4##(2008-11#1)(2008-7#1)
progenitor cells ex vivo##2##4##(1997-4#1)(2007-1#1)
progenitor cells from##7##3##(1991-10#2)(1995-12#1)(1996-5#2)(2008-11#2)
progenitor cells have##2##3##(2012-2#1)(2013-1#1)
progenitor cells in the developing##2##5##(2010-11#1)(2012-3#1)
progenitor cells in the##4##4##(2010-11#1)(2010-12#1)(2012-3#2)
progenitor cells in##14##3##(1996-11#1)(2007-11#1)(2008-4#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
progenitor cells into##2##3##(2008-4#1)(2008-9#1)
progenitor cells is##4##3##(1995-12#1)(2008-1#1)(2008-11#1)(2012-2#1)
progenitor cells of the##5##4##(1994-2#1)(2008-11#2)(2008-7#1)(2013-1#1)
progenitor cells of##9##3##(1994-2#1)(2007-11#1)(2008-11#2)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
progenitor cells that##5##3##(2008-7#1)(2008-9#1)(2009-6#1)(2012-12#1)(2013-1#1)
progenitor cells to##3##3##(1995-12#1)(2009-9#1)(2012-2#1)
progenitor cells were##3##3##(1991-5#1)(1994-5#1)(1995-7#1)
progenitor cells##155##2##(1990-12#1)(1990-4#3)(1990-7#1)(1991-10#3)(1991-5#2)(1991-9#1)(1994-2#1)(1994-5#4)(1995-12#4)(1995-3#1)(1995-7#2)(1996-11#1)(1996-5#4)(1996-8#1)(1997-4#1)(1997-7#2)(2004-2#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-1#1)(2007-11#4)(2007-3#1)(2008-1#6)(2008-11#18)(2008-4#6)(2008-7#7)(2008-8#2)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#3)(2009-4#5)(2009-6#2)(2009-7#3)(2009-9#2)(2010-1#2)(2010-11#3)(2010-12#5)(2010-6#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#11)(2012-2#8)(2012-3#3)(2013-1#4)
progenitor cells)##3##2##(1990-5#2)(2012-2#1)
progenitor development##4##2##(2012-12#4)
progenitor differentiation##2##2##(2008-7#1)(2009-12#1)
progenitor of the##3##3##(1991-5#1)(2008-10#1)(2009-2#1)
progenitor of##6##2##(1991-12#1)(1991-5#1)(1994-12#1)(2008-10#1)(2009-2#1)(2011-2#1)
progenitor population##2##2##(1997-6#1)(2013-1#1)
progenitor species##2##2##(2008-10#1)(2008-5#1)
progenitor##240##1##(1990-12#1)(1990-4#3)(1990-5#3)(1990-7#1)(1991-10#3)(1991-12#1)(1991-5#3)(1991-9#1)(1992-3#2)(1992-5#1)(1994-10#2)(1994-12#1)(1994-2#1)(1994-5#5)(1994-8#1)(1995-12#5)(1995-3#1)(1995-6#4)(1995-7#2)(1996-10#1)(1996-11#4)(1996-5#4)(1996-8#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(2004-2#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-4#2)(2006-6#1)(2007-1#1)(2007-11#5)(2007-3#1)(2008-1#9)(2008-10#5)(2008-11#21)(2008-12#1)(2008-4#10)(2008-5#3)(2008-7#11)(2008-8#3)(2008-9#11)(2009-10#2)(2009-11#1)(2009-12#6)(2009-2#2)(2009-4#7)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#6)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#21)(2012-2#9)(2012-3#3)(2012-8#1)(2013-1#9)
progenitor/stem cells##2##2##(2009-9#1)(2013-1#1)
progenitors and##5##2##(2008-7#1)(2009-12#1)(2012-12#2)(2013-1#1)
progenitors expressing##2##2##(2008-4#1)(2008-7#1)
progenitors from normal##2##3##(1990-9#1)(1995-2#1)
progenitors from##6##2##(1990-9#1)(1995-2#1)(2008-4#2)(2008-8#1)(2009-3#1)
progenitors in the##4##3##(1991-10#1)(1991-6#1)(1995-1#1)(2008-10#1)
progenitors in##12##2##(1991-10#1)(1991-6#1)(1995-1#1)(1996-10#1)(1996-6#1)(2008-10#2)(2008-4#4)(2012-12#1)
progenitors into##2##2##(2011-2#2)
progenitors is##2##2##(1990-9#1)(2008-11#1)
progenitors lining the##4##3##(2008-11#4)
progenitors of##7##2##(1995-2#1)(1996-11#1)(2007-12#2)(2008-4#1)(2008-5#2)
progenitors or##2##2##(1995-6#1)(2008-5#1)
progenitors to##4##2##(1995-2#1)(1996-3#1)(2010-10#1)(2012-12#1)
progenitors were##7##2##(1993-9#1)(1995-2#2)(2008-1#1)(2008-5#1)(2009-12#1)(2009-4#1)
progenitors##119##1##(1990-5#2)(1990-9#4)(1991-10#3)(1991-6#2)(1993-2#1)(1993-6#1)(1993-9#2)(1995-1#1)(1995-12#3)(1995-2#10)(1995-6#1)(1996-10#2)(1996-11#2)(1996-12#2)(1996-3#2)(1996-6#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#2)(2008-11#9)(2008-12#1)(2008-4#15)(2008-5#5)(2008-7#5)(2008-8#2)(2009-12#2)(2009-3#1)(2009-4#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#11)(2012-7#1)(2013-1#3)
progeny and##4##2##(2008-10#2)(2008-5#1)(2008-9#1)
progeny are##3##2##(2008-1#1)(2012-12#2)
progeny cells##5##2##(1990-11#1)(1997-4#1)(2008-7#2)(2012-2#1)
progeny derived from the cross between##3##6##(2008-10#3)
progeny derived from##7##3##(2008-10#6)(2013-8#1)
progeny from a cross##2##4##(2008-10#2)
progeny from a##4##3##(2008-10#3)(2008-7#1)
progeny from crosses between##2##4##(2008-10#1)(2012-3#1)
progeny from crosses##3##3##(2008-10#2)(2012-3#1)
progeny from the##4##3##(2008-10#3)(2008-9#1)
progeny from##20##2##(2008-10#13)(2008-11#1)(2008-7#1)(2008-9#1)(2010-10#1)(2012-1#1)(2012-3#1)(2013-8#1)
progeny groups##3##2##(2013-8#3)
progeny in##6##2##(1990-3#1)(2008-1#2)(2008-10#1)(2011-12#1)(2012-3#1)
progeny indicated that a##2##4##(2008-10#1)(2008-5#1)
progeny isolates were##2##3##(2008-10#2)
progeny isolates##4##2##(2008-10#4)
progeny lines##4##2##(2008-10#1)(2008-5#1)(2012-3#1)(2013-1#1)
progeny of a cross between##2##5##(2008-10#1)(2008-9#1)
progeny of line##3##3##(2008-10#3)
progeny of matings between##2##4##(2008-10#2)
progeny of the##10##3##(1994-5#1)(2005-7#1)(2008-10#6)(2012-2#2)
progeny of two##4##3##(2008-10#2)(2009-10#1)(2012-2#1)
progeny of##44##2##(1994-5#1)(2004-4#1)(2005-7#1)(2006-10#1)(2007-12#2)(2008-10#21)(2008-4#3)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-8#1)(2012-2#3)(2013-1#1)
progeny possessed##2##2##(2008-10#1)(2013-8#1)
progeny production##2##2##(1990-3#1)(2008-12#1)
progeny segregated##2##2##(2008-10#2)
progeny testing##5##2##(1997-3#1)(2008-10#2)(2009-2#2)
progeny that##2##2##(2008-10#1)(2009-9#1)
progeny virus derived from cloned DNA##2##6##(2008-10#2)
progeny virus derived from##4##4##(2008-10#4)
progeny virus##10##2##(1993-5#1)(1995-12#1)(1997-3#1)(2008-10#7)
progeny was##4##2##(1991-4#1)(2008-10#3)
progeny were examined for virulence##2##5##(2008-10#2)
progeny were##15##2##(2008-10#11)(2008-11#1)(2008-5#1)(2012-2#1)(2013-8#1)
progeny with##2##2##(1990-7#1)(2008-10#1)
progeny##237##1##(1990-11#1)(1990-3#2)(1990-7#1)(1990-8#1)(1991-4#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-8#1)(1996-3#1)(1997-3#4)(1997-4#1)(2004-4#1)(2005-7#1)(2006-10#1)(2007-12#6)(2008-1#5)(2008-10#107)(2008-11#2)(2008-12#1)(2008-4#4)(2008-5#12)(2008-7#5)(2008-8#9)(2008-9#7)(2009-10#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#3)(2010-10#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-12#2)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#8)(2012-3#4)(2013-1#2)(2013-8#11)
progeny)##4##1##(2006-12#2)(2007-12#1)(2008-4#1)
progeria##8##1##(2007-8#2)(2009-12#3)(2011-2#1)(2012-12#2)
progerin in##2##2##(2012-12#2)
progerin##4##1##(2012-12#4)
progeroid-related##2##1##(2008-7#2)
progestagenic##3##1##(1994-9#1)(2012-12#2)
progestation##2##1##(2008-4#2)
progesteron##4##1##(2008-11#4)
progesterone (P)##8##2##(1993-2#1)(1994-9#1)(1995-11#1)(1996-8#1)(2006-5#1)(2007-10#1)(2007-9#1)(2008-10#1)
progesterone (P4)##2##2##(2006-5#1)(2008-5#1)
progesterone acetate##2##2##(2007-11#2)
progesterone action##2##2##(1995-11#1)(1996-5#1)
progesterone and 17beta-estradiol##2##3##(2007-12#2)
progesterone and GTP gamma S##2##5##(1994-12#2)
progesterone and estrogen##2##3##(1994-9#1)(2010-10#1)
progesterone and##24##2##(1991-11#1)(1991-12#1)(1991-7#1)(1994-12#2)(1994-9#2)(1995-12#1)(1995-4#2)(1997-8#2)(2005-7#1)(2006-5#1)(2007-1#1)(2007-12#2)(2007-2#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-10#1)(2011-1#1)(2013-1#1)
progesterone as##2##2##(2008-7#1)(2012-2#1)
progesterone assays##2##2##(1994-3#1)(2006-5#1)
progesterone concentrations##2##2##(1996-3#1)(2006-5#1)
progesterone in the##3##3##(1995-11#1)(2008-4#1)(2008-6#1)
progesterone in##9##2##(1990-3#1)(1990-5#2)(1994-9#1)(1995-11#1)(1996-4#1)(2007-12#1)(2008-4#1)(2008-6#1)
progesterone increased##2##2##(1991-6#1)(2007-12#1)
progesterone levels##8##2##(2006-12#1)(2007-1#1)(2008-6#1)(2011-1#3)(2011-2#1)(2012-2#1)
progesterone on the##4##3##(1991-7#1)(1997-8#1)(2006-5#1)(2008-8#1)
progesterone on##5##2##(1991-7#1)(1997-8#1)(2006-5#1)(2008-3#1)(2008-8#1)
progesterone or##5##2##(1993-2#1)(1994-9#1)(1997-8#1)(2005-6#1)(2007-12#1)
progesterone production in##2##3##(1991-9#1)(1997-8#1)
progesterone production##9##2##(1991-9#1)(1992-4#1)(1994-9#1)(1995-10#2)(1996-5#1)(1997-8#3)
progesterone receptor (PR)##3##3##(1996-5#1)(1997-7#1)(2007-5#1)
progesterone receptor (PgR)##7##3##(1993-4#1)(1993-7#1)(1996-11#1)(1996-6#1)(2007-12#1)(2007-5#1)(2011-2#1)
progesterone receptor and##3##3##(1994-12#1)(2008-11#1)(2009-12#1)
progesterone receptor level as well as plasminogen activator activity in MCF-7 cells##2##12##(2008-11#2)
progesterone receptor##36##2##(1990-2#1)(1992-2#2)(1993-11#1)(1993-4#1)(1993-7#1)(1994-12#1)(1995-3#1)(1996-11#2)(1996-4#1)(1996-5#4)(1996-6#1)(1997-7#1)(2006-12#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-5#2)(2008-11#3)(2008-4#3)(2009-12#2)(2010-3#1)(2011-1#1)(2011-2#2)
progesterone receptors (PR)##2##3##(1993-9#1)(2013-8#1)
progesterone receptors were##2##3##(1990-11#1)(2007-2#1)
progesterone receptors##17##2##(1990-11#2)(1990-2#1)(1990-9#1)(1991-12#1)(1993-2#1)(1993-8#1)(1993-9#2)(1994-2#1)(2007-10#1)(2007-2#2)(2013-1#1)(2013-8#3)
progesterone resistance##2##2##(2007-10#2)
progesterone to##6##2##(1990-11#1)(1990-5#1)(1994-9#1)(1995-12#1)(1997-8#2)
progesterone was##5##2##(1991-7#1)(1993-11#1)(1995-8#1)(2004-12#1)(2007-2#1)
progesterone were##3##2##(1993-2#1)(1996-5#1)(2011-2#1)
progesterone##247##1##(1990-11#7)(1990-2#2)(1990-3#3)(1990-5#4)(1990-9#1)(1991-11#3)(1991-12#4)(1991-3#2)(1991-4#1)(1991-6#1)(1991-7#12)(1991-9#1)(1992-1#2)(1992-2#2)(1992-4#1)(1992-5#1)(1993-11#2)(1993-2#9)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#7)(1994-2#2)(1994-3#2)(1994-9#13)(1995-10#4)(1995-11#4)(1995-12#3)(1995-3#1)(1995-4#3)(1995-7#2)(1995-8#4)(1996-11#3)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#7)(1996-6#1)(1996-8#1)(1997-7#1)(1997-8#12)(2004-12#2)(2004-2#1)(2005-11#2)(2005-6#2)(2005-7#3)(2006-10#1)(2006-12#2)(2006-5#8)(2007-1#3)(2007-10#7)(2007-11#3)(2007-12#8)(2007-2#5)(2007-5#2)(2007-6#1)(2007-9#1)(2008-10#4)(2008-11#3)(2008-12#4)(2008-3#1)(2008-4#8)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2009-12#2)(2010-10#1)(2010-3#1)(2010-8#1)(2011-1#5)(2011-2#6)(2012-11#1)(2012-12#1)(2012-2#4)(2013-1#2)(2013-8#4)
progesterone)##2##1##(1991-5#1)(1997-7#1)
progestin antagonist##3##2##(1993-9#3)
progestin therapy##4##2##(1990-2#2)(1992-2#1)(2007-10#1)
progestin were##2##2##(1992-2#1)(1994-9#1)
progestin##38##1##(1990-11#1)(1990-2#2)(1990-5#1)(1991-9#2)(1992-2#8)(1993-11#1)(1993-4#2)(1993-9#6)(1994-5#1)(1994-9#3)(2004-1#1)(2005-10#1)(2006-2#2)(2007-10#1)(2008-12#4)(2010-12#1)(2011-2#1)
progestin-only pills##2##2##(2004-10#2)
progestins as##2##2##(1993-4#1)(1994-4#1)
progestins in##2##2##(2004-1#1)(2005-12#1)
progestins##19##1##(1990-11#1)(1991-9#2)(1993-11#1)(1993-4#1)(1993-6#5)(1994-4#1)(1994-8#1)(1994-9#1)(1996-9#1)(2004-1#1)(2005-12#1)(2006-5#1)(2008-11#1)(2008-2#1)
progestogen concentrations were##2##3##(2007-2#2)
progestogen concentrations##3##2##(2007-2#3)
progestogen therapy is##2##3##(1994-9#2)
progestogen##12##1##(1994-9#5)(2006-5#1)(2007-2#3)(2008-5#1)(2011-2#2)
progestrone receptor##2##2##(2008-11#2)
prognoses for the##2##3##(1996-11#1)(2011-2#1)
prognoses##16##1##(1990-12#1)(1992-2#1)(1995-10#1)(1996-11#1)(2005-10#1)(2007-10#1)(2007-4#1)(2007-7#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
prognosis after treatment##2##3##(2008-7#2)
prognosis after##7##2##(1991-2#1)(1995-12#1)(2006-8#1)(2007-10#1)(2008-7#2)(2008-8#1)
prognosis and high mortality##2##4##(2013-1#2)
prognosis and high##3##3##(2011-1#1)(2013-1#2)
prognosis and outcome##3##3##(2009-8#2)(2013-1#1)
prognosis and prediction of##2##4##(2008-6#1)(2013-1#1)
prognosis and quality of life##2##5##(1995-5#1)(2013-1#1)
prognosis and response to##2##4##(2008-7#1)(2012-3#1)
prognosis and risk##2##3##(1994-9#1)(2013-7#1)
prognosis and survival##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
prognosis and the##4##3##(1996-1#1)(2008-4#1)(2010-12#1)(2013-1#1)
prognosis and therapeutic response##2##4##(2010-11#1)(2010-12#1)
prognosis and therapeutic##3##3##(2010-11#2)(2010-12#1)
prognosis and therapies##2##3##(2013-1#2)
prognosis and therapy of##2##4##(1991-10#1)(2008-3#1)
prognosis and therapy##5##3##(1991-10#1)(2007-11#1)(2008-3#1)(2010-12#2)
prognosis and treatment in the presence of of multiple diseases can be complex due to the various interactions between diseases##2##20##(2013-1#2)
prognosis and treatment##11##3##(1991-7#1)(1994-7#1)(2006-12#1)(2007-3#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#2)
prognosis and##88##2##(1990-2#1)(1990-3#1)(1991-10#1)(1991-3#2)(1991-7#1)(1991-8#1)(1994-7#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-4#1)(2005-10#1)(2005-8#2)(2006-12#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-6#2)(2008-7#5)(2008-8#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#2)(2010-11#2)(2010-12#8)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#5)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#15)(2013-7#1)
prognosis are##5##2##(2006-10#1)(2006-12#1)(2006-2#1)(2007-10#1)(2009-4#1)
prognosis as well##2##3##(1990-1#1)(2008-8#1)
prognosis as##6##2##(1990-1#1)(1990-5#1)(1991-5#1)(1992-8#1)(2008-8#1)(2012-3#1)
prognosis assessment##2##2##(2008-4#1)(2009-10#1)
prognosis associated with##3##3##(1990-5#1)(1993-1#1)(1997-7#1)
prognosis because of the##2##4##(2007-11#1)(2012-1#1)
prognosis because of##3##3##(1996-11#1)(2007-11#1)(2012-1#1)
prognosis because the##2##3##(1993-5#1)(2011-2#1)
prognosis because##5##2##(1993-5#1)(1996-11#1)(2007-11#1)(2011-2#1)(2012-1#1)
prognosis by##2##2##(1991-4#1)(2010-8#1)
prognosis can##2##2##(1991-11#1)(2006-2#1)
prognosis criteria##2##2##(2011-2#1)(2011-3#1)
prognosis depends on##2##3##(2007-2#1)(2009-1#1)
prognosis despite##3##2##(2008-11#1)(2008-5#1)(2008-8#1)
prognosis factors and##2##3##(1996-3#2)
prognosis factors##4##2##(1996-3#3)(2012-3#1)
prognosis following##2##2##(2008-6#1)(2012-3#1)
prognosis for both##2##3##(2008-6#1)(2012-2#1)
prognosis for patients with##6##4##(2005-8#1)(2006-10#1)(2006-7#1)(2008-6#1)(2010-3#1)(2013-1#1)
prognosis for patients##10##3##(1990-10#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-6#1)(2008-6#1)(2009-10#1)(2010-3#1)(2011-2#1)(2013-1#1)
prognosis for recovery##2##3##(2007-10#2)
prognosis for the##7##3##(1993-11#1)(1996-1#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-5#1)(2009-4#1)
prognosis for these##4##3##(1995-8#1)(2007-11#1)(2008-5#1)(2009-2#1)
prognosis for##54##2##(1990-10#1)(1992-5#1)(1993-10#1)(1993-11#1)(1993-7#1)(1995-8#1)(1996-1#1)(2004-1#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-7#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-5#2)(2008-6#5)(2008-7#4)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-2#2)(2013-1#3)
prognosis has##2##2##(1990-1#1)(2010-5#1)
prognosis if##3##2##(1994-6#1)(2006-10#1)(2007-6#1)
prognosis in breast cancer##2##4##(1990-12#1)(2011-12#1)
prognosis in breast##3##3##(1990-12#1)(2011-12#1)(2012-2#1)
prognosis in children##2##3##(2006-10#1)(2010-7#1)
prognosis in colorectal cancer##2##4##(2006-12#1)(2011-1#1)
prognosis in our##2##3##(1990-3#1)(2011-2#1)
prognosis in patients with##9##4##(1994-6#1)(2007-12#1)(2007-9#1)(2009-10#1)(2009-5#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
prognosis in patients##10##3##(1994-6#1)(2007-10#1)(2007-12#1)(2007-9#1)(2009-10#1)(2009-5#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
prognosis in stage##2##3##(2013-1#2)
prognosis in the##2##3##(2006-8#1)(2007-8#1)
prognosis in##64##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-2#1)(1991-3#1)(1992-2#1)(1992-6#1)(1993-12#1)(1994-6#1)(1994-7#1)(1995-5#1)(1996-11#1)(1996-4#1)(2004-1#1)(2005-10#2)(2005-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-12#1)(2008-5#1)(2009-10#2)(2009-5#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#2)
prognosis is better##2##3##(2008-3#1)(2011-2#1)
prognosis is excellent##2##3##(1996-9#1)(2007-8#1)
prognosis is generally##4##3##(2006-10#1)(2010-7#1)(2013-1#2)
prognosis is good if the##2##5##(1996-9#1)(2008-4#1)
prognosis is good if##3##4##(1996-8#1)(1996-9#1)(2008-4#1)
prognosis is good##5##3##(1996-8#1)(1996-9#1)(2007-11#1)(2008-4#1)(2010-11#1)
prognosis is poor in##3##4##(1993-3#1)(2006-10#1)(2011-2#1)
prognosis is poor##5##3##(1990-2#1)(1993-3#1)(1996-9#1)(2006-10#1)(2011-2#1)
prognosis is usually##2##3##(2005-11#1)(2007-9#1)
prognosis is worse##2##3##(2009-10#1)(2009-4#1)
prognosis is##43##2##(1990-2#1)(1990-8#1)(1990-9#1)(1991-4#1)(1991-6#1)(1992-6#1)(1993-3#1)(1993-8#1)(1995-6#1)(1996-8#1)(1996-9#3)(1997-3#1)(2005-10#1)(2005-11#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-10#1)(2009-4#2)(2010-11#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
prognosis of ARF##3##3##(2008-4#3)
prognosis of RCC##2##3##(2012-3#2)
prognosis of a##2##3##(1994-12#1)(2008-6#1)
prognosis of acute##2##3##(2008-3#1)(2013-7#1)
prognosis of breast cancer##5##4##(1993-9#1)(2007-1#1)(2007-11#1)(2008-4#1)(2010-8#1)
prognosis of cancer##2##3##(2008-11#1)(2012-2#1)
prognosis of chronic##2##3##(2010-12#1)(2011-1#1)
prognosis of coronary artery disease##2##5##(2007-1#1)(2012-12#1)
prognosis of coronary##4##3##(2005-10#1)(2007-1#1)(2008-8#1)(2012-12#1)
prognosis of course##2##3##(2013-1#2)
prognosis of patients who##2##4##(2005-6#1)(2006-10#1)
prognosis of patients with##11##4##(1996-6#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-5#1)(2010-11#2)(2010-5#1)(2012-1#1)(2013-1#1)(2013-8#1)
prognosis of patients##17##3##(1996-6#1)(2005-6#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-2#1)(2008-5#1)(2008-7#1)(2010-11#2)(2010-5#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
prognosis of some##2##3##(2007-6#1)(2008-4#1)
prognosis of the disease##9##4##(1992-2#1)(1993-8#1)(1995-1#1)(2007-11#3)(2010-6#1)(2012-2#1)(2013-8#1)
prognosis of the patients##3##4##(2006-10#1)(2011-3#1)(2013-8#1)
prognosis of the##22##3##(1990-2#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-8#1)(1995-1#1)(2006-10#1)(2006-6#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2010-6#2)(2010-8#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#2)
prognosis of these patients##4##4##(2007-11#1)(2007-8#1)(2009-5#1)(2010-8#1)
prognosis of these##9##3##(1993-5#1)(1994-6#1)(1996-4#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-5#1)(2010-8#1)
prognosis of this rare##3##4##(1993-8#1)(2008-10#1)(2008-6#1)
prognosis of this syndrome##2##4##(2006-7#1)(2008-9#1)
prognosis of this tumor##2##4##(1992-6#1)(2006-2#1)
prognosis of this##14##3##(1992-5#1)(1992-6#1)(1993-8#1)(1994-6#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)
prognosis of##175##2##(1990-1#2)(1990-11#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-6#2)(1995-1#1)(1995-5#1)(1995-9#2)(1996-12#2)(1996-3#1)(1996-4#1)(1996-6#3)(1997-3#2)(2004-2#1)(2005-1#1)(2005-10#2)(2005-6#1)(2005-8#2)(2006-10#7)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#3)(2007-10#5)(2007-11#7)(2007-12#2)(2007-2#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#7)(2008-5#1)(2008-6#5)(2008-7#4)(2008-8#3)(2008-9#1)(2009-2#1)(2009-5#3)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#3)(2010-12#6)(2010-3#1)(2010-5#1)(2010-6#3)(2010-8#4)(2011-1#1)(2011-12#1)(2011-2#6)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#4)
prognosis remains poor##3##3##(2007-11#1)(2010-5#1)(2013-1#1)
prognosis remains##6##2##(1991-9#1)(2007-11#1)(2008-6#1)(2010-5#1)(2011-2#1)(2013-1#1)
prognosis than the##3##3##(1990-10#1)(2009-5#1)(2012-2#1)
prognosis than those with##3##4##(1993-9#1)(2007-6#1)(2010-3#1)
prognosis than those##4##3##(1992-11#1)(1993-9#1)(2007-6#1)(2010-3#1)
prognosis than##12##2##(1990-10#1)(1991-6#1)(1992-11#1)(1993-9#1)(1995-5#1)(2007-6#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-3#1)(2012-2#1)(2013-1#1)
prognosis to##3##2##(1994-6#1)(1996-11#1)(2008-6#1)
prognosis was good##2##3##(1991-8#1)(2007-10#1)
prognosis was##15##2##(1990-5#1)(1990-8#1)(1991-6#1)(1991-8#1)(1992-7#1)(1994-12#1)(1995-8#1)(1996-1#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-6#1)
prognosis were##5##2##(1993-11#1)(1995-4#1)(2006-2#1)(2008-12#1)(2008-5#1)
prognosis when##6##2##(1993-1#1)(1997-6#1)(2006-10#1)(2006-6#1)(2006-7#1)(2008-6#1)
prognosis with##7##2##(1990-12#1)(2007-10#1)(2007-9#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
prognosis##921##1##(1990-1#4)(1990-10#4)(1990-11#3)(1990-12#5)(1990-2#5)(1990-3#3)(1990-4#5)(1990-5#5)(1990-6#1)(1990-8#9)(1990-9#5)(1991-10#5)(1991-11#3)(1991-2#4)(1991-3#4)(1991-4#2)(1991-5#2)(1991-6#7)(1991-7#2)(1991-8#7)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#5)(1992-7#2)(1992-8#5)(1992-9#1)(1993-1#5)(1993-10#4)(1993-11#4)(1993-12#2)(1993-2#1)(1993-3#2)(1993-5#3)(1993-7#5)(1993-8#4)(1993-9#7)(1994-10#2)(1994-11#2)(1994-12#4)(1994-2#1)(1994-6#7)(1994-7#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-4#3)(1995-5#4)(1995-6#2)(1995-8#4)(1995-9#2)(1996-1#4)(1996-11#3)(1996-12#2)(1996-2#2)(1996-3#4)(1996-4#4)(1996-6#3)(1996-8#1)(1996-9#5)(1997-1#1)(1997-3#4)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#3)(2004-1#2)(2004-2#2)(2005-1#1)(2005-10#12)(2005-11#4)(2005-6#1)(2005-8#12)(2006-1#2)(2006-10#28)(2006-12#5)(2006-2#7)(2006-6#4)(2006-7#3)(2006-8#5)(2006-9#5)(2007-1#5)(2007-10#14)(2007-11#20)(2007-12#16)(2007-2#10)(2007-3#3)(2007-4#3)(2007-6#9)(2007-7#7)(2007-8#17)(2007-9#9)(2008-1#12)(2008-10#20)(2008-11#8)(2008-12#10)(2008-2#1)(2008-3#15)(2008-4#14)(2008-5#10)(2008-6#26)(2008-7#24)(2008-8#12)(2008-9#7)(2009-1#3)(2009-10#6)(2009-11#3)(2009-12#1)(2009-2#3)(2009-3#6)(2009-4#4)(2009-5#9)(2009-6#3)(2009-8#6)(2010-1#2)(2010-11#10)(2010-12#22)(2010-2#4)(2010-3#6)(2010-4#1)(2010-5#5)(2010-6#9)(2010-7#5)(2010-8#6)(2010-9#2)(2011-1#13)(2011-11#1)(2011-12#6)(2011-2#46)(2011-3#5)(2011-7#1)(2012-1#5)(2012-11#1)(2012-12#11)(2012-2#26)(2012-3#18)(2013-1#54)(2013-7#5)(2013-8#18)
prognosis)##2##1##(1994-10#1)(2012-2#1)
prognosis]##7##1##(1992-8#1)(1995-7#1)(1996-9#1)(2007-10#1)(2008-4#1)(2011-1#1)(2013-1#1)
prognostic ability of##2##3##(2007-10#1)(2010-12#1)
prognostic and predictive factors##2##4##(1995-10#1)(2013-8#1)
prognostic and predictive##4##3##(1995-10#1)(2008-7#1)(2009-10#1)(2013-8#1)
prognostic and therapeutic implications##2##4##(2008-7#1)(2012-2#1)
prognostic and therapeutic targets##2##4##(2010-12#1)(2012-12#1)
prognostic and therapeutic##7##3##(1995-12#1)(2007-8#1)(2008-3#1)(2008-7#1)(2010-12#1)(2012-12#1)(2012-2#1)
prognostic and##16##2##(1995-10#1)(1995-12#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-10#1)(2009-4#1)(2010-12#1)(2010-6#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
prognostic assessment of##3##3##(2005-10#1)(2009-10#1)(2011-2#1)
prognostic assessment##8##2##(1990-10#1)(1991-6#1)(1993-5#1)(2005-10#1)(2008-10#1)(2008-3#1)(2009-10#1)(2011-2#1)
prognostic behavior##2##2##(2008-9#1)(2011-2#1)
prognostic biomarker##2##2##(2010-5#1)(2013-1#1)
prognostic biomarkers##3##2##(2007-10#1)(2008-7#1)(2011-3#1)
prognostic conclusions##2##2##(1990-9#2)
prognostic criteria##4##2##(1992-1#2)(2011-2#1)(2012-3#1)
prognostic effect of##2##3##(2007-8#1)(2013-1#1)
prognostic effect##5##2##(1990-6#1)(2007-8#1)(2009-11#1)(2013-1#2)
prognostic effects of##2##3##(2007-8#1)(2009-4#1)
prognostic evaluation of##2##3##(2006-8#1)(2011-2#1)
prognostic factor for##11##3##(1993-11#1)(1994-5#1)(1996-12#1)(2004-2#1)(2007-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-3#1)
prognostic factor in patients with Hodgkin's##2##6##(2008-7#2)
prognostic factor in patients with##5##5##(2007-8#1)(2008-7#2)(2009-10#1)(2011-2#1)
prognostic factor in##19##3##(1992-6#2)(1994-4#1)(1995-4#1)(1996-8#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-7#3)(2009-1#1)(2009-10#1)(2009-5#1)(2011-2#3)(2012-3#1)
prognostic factor of##4##3##(2007-8#1)(2008-6#1)(2009-10#1)(2012-1#1)
prognostic factor that##2##3##(2007-8#1)(2008-6#1)
prognostic factor##59##2##(1991-10#1)(1992-6#2)(1993-11#1)(1994-4#1)(1994-5#1)(1995-10#1)(1995-4#1)(1996-12#1)(1996-8#1)(1997-3#1)(2004-2#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#6)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#3)(2009-1#1)(2009-10#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#1)(2011-1#3)(2011-2#9)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
prognostic factors and patterns of failure in##2##7##(2008-6#2)
prognostic factors and side effects##2##5##(2006-6#2)
prognostic factors and##14##3##(1994-12#1)(2006-6#4)(2007-4#1)(2007-5#1)(2008-10#1)(2008-6#3)(2010-11#1)(2011-2#1)(2012-2#1)
prognostic factors are tumour grade##2##5##(1993-8#1)(2007-2#1)
prognostic factors are##6##3##(1990-9#1)(1993-8#1)(1996-12#1)(2007-2#1)(2011-2#2)
prognostic factors by##2##3##(1994-7#2)
prognostic factors for patients##2##4##(2011-2#1)(2013-1#1)
prognostic factors for survival##2##4##(1996-4#1)(2006-10#1)
prognostic factors for##14##3##(1991-9#1)(1996-4#1)(2004-1#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-6#2)(2009-2#1)(2011-2#1)(2012-1#1)(2013-1#1)
prognostic factors have##2##3##(2008-6#1)(2010-11#1)
prognostic factors in a##2##4##(1991-10#1)(2007-9#1)
prognostic factors in the##3##4##(2007-11#1)(2008-7#1)(2009-11#1)
prognostic factors in##20##3##(1990-10#1)(1991-10#2)(1991-11#1)(1993-6#1)(1995-4#1)(1995-8#1)(2006-6#1)(2007-11#1)(2007-3#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-11#1)(2011-2#3)
prognostic factors included##2##3##(1990-6#1)(2008-1#1)
prognostic factors influencing the##2##4##(2006-6#2)
prognostic factors of##5##3##(1990-9#1)(1991-11#1)(2007-10#1)(2013-7#1)(2013-8#1)
prognostic factors on##2##3##(1994-5#1)(2008-6#1)
prognostic factors to##4##3##(1995-4#1)(2007-9#1)(2008-1#1)(2008-6#1)
prognostic factors was##2##3##(2008-6#2)
prognostic factors were evaluated##2##4##(2008-6#1)(2012-3#1)
prognostic factors were##3##3##(2008-6#1)(2010-12#1)(2012-3#1)
prognostic factors##129##2##(1990-10#1)(1990-2#1)(1990-6#3)(1990-9#2)(1991-10#2)(1991-11#2)(1991-9#1)(1992-10#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-5#1)(1994-7#2)(1995-4#3)(1995-5#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-3#1)(1997-8#2)(2004-1#1)(2004-2#1)(2005-6#1)(2006-10#1)(2006-6#12)(2007-10#2)(2007-11#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#3)(2008-1#5)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#15)(2008-7#4)(2008-8#3)(2009-11#1)(2009-2#1)(2010-11#2)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#11)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
prognostic factors]##3##2##(1990-9#1)(1995-9#1)(1997-5#1)
prognostic features##10##2##(1992-2#1)(1996-12#1)(2006-10#1)(2006-6#1)(2008-6#1)(2008-9#1)(2010-12#2)(2011-1#2)
prognostic for##3##2##(2008-6#1)(2010-1#1)(2012-3#1)
prognostic groups##4##2##(1992-2#1)(2007-10#1)(2008-6#1)(2010-12#1)
prognostic impact in##2##3##(2012-12#1)(2012-2#1)
prognostic impact of##4##3##(1997-7#1)(2010-3#1)(2011-2#2)
prognostic impact##8##2##(1997-7#1)(2006-6#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
prognostic implication and##2##3##(2007-8#1)(2012-2#1)
prognostic implication##4##2##(2007-7#1)(2007-8#2)(2012-2#1)
prognostic implications##9##2##(2006-10#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-7#1)(2011-2#1)(2012-2#1)
prognostic importance of##2##3##(1990-6#1)(2007-8#1)
prognostic importance##5##2##(1990-6#1)(1992-6#1)(2007-8#2)(2008-1#1)
prognostic indicator for##2##3##(2008-5#1)(2011-1#1)
prognostic indicator in##6##3##(1993-9#3)(1994-12#1)(1997-4#1)(2005-8#1)
prognostic indicator of##4##3##(1993-7#1)(2007-2#1)(2008-7#1)(2009-9#1)
prognostic indicator##19##2##(1993-11#2)(1993-7#1)(1993-9#4)(1994-10#1)(1994-12#1)(1997-4#1)(2005-8#1)(2006-6#1)(2007-2#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-11#1)(2011-1#1)(2013-1#1)
prognostic indicators for##3##3##(1991-8#1)(2008-5#1)(2012-2#1)
prognostic indicators##13##2##(1991-8#1)(1993-11#1)(1994-7#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-5#1)(2009-11#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
prognostic information and##3##3##(2008-8#1)(2009-4#1)(2011-2#1)
prognostic information for##5##3##(1994-7#1)(2006-10#1)(2008-1#2)(2008-7#1)
prognostic information in##3##3##(2010-11#1)(2010-4#1)(2011-2#1)
prognostic information##18##2##(1990-5#1)(1991-2#1)(1994-7#1)(2005-12#1)(2006-10#1)(2008-1#2)(2008-7#1)(2008-8#1)(2009-4#1)(2010-11#2)(2010-4#1)(2010-5#1)(2011-2#2)(2012-2#2)
prognostic marker for##2##3##(2006-10#1)(2011-2#1)
prognostic marker in##5##3##(1990-8#1)(1995-5#1)(2011-1#1)(2012-2#2)
prognostic marker##9##2##(1990-8#1)(1995-5#1)(2004-1#1)(2006-10#1)(2011-1#1)(2011-2#2)(2012-2#2)
prognostic markers and##3##3##(2008-3#1)(2008-7#1)(2010-12#1)
prognostic markers for##2##3##(2007-11#1)(2011-2#1)
prognostic markers in##3##3##(2006-10#1)(2007-10#1)(2009-5#1)
prognostic markers##19##2##(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-3#4)(2008-6#2)(2008-7#1)(2009-5#1)(2010-12#2)(2010-5#1)(2011-2#2)(2012-2#1)
prognostic model##3##2##(1995-9#3)
prognostic models have been##2##4##(2006-10#1)(2007-11#1)
prognostic models have##3##3##(2006-10#1)(2007-11#1)(2009-11#1)
prognostic models##8##2##(1996-2#1)(2006-10#1)(2007-11#1)(2009-11#1)(2013-1#4)
prognostic or predictive##2##3##(2004-2#1)(2009-11#1)
prognostic parameters in##2##3##(1990-9#1)(1992-10#1)
prognostic parameters##7##2##(1990-9#1)(1992-10#1)(1992-8#1)(1994-7#1)(1997-8#1)(2008-2#1)(2011-2#1)
prognostic power##3##2##(1990-10#1)(2005-9#1)(2012-3#1)
prognostic purposes##2##2##(1990-6#1)(2010-3#1)
prognostic relevance of##2##3##(1991-2#1)(1992-6#1)
prognostic relevance##7##2##(1991-2#1)(1992-6#1)(2007-11#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
prognostic role of##4##3##(2008-10#1)(2010-12#1)(2010-7#1)(2013-7#1)
prognostic role##5##2##(2008-10#2)(2010-12#1)(2010-7#1)(2013-7#1)
prognostic scores##5##2##(2010-11#1)(2012-2#1)(2013-8#3)
prognostic significance in##5##3##(1990-6#1)(1997-7#1)(2006-9#1)(2008-7#1)(2013-1#1)
prognostic significance of Ki-67##2##4##(2008-7#1)(2009-2#1)
prognostic significance of cathepsin-D expression##2##5##(1993-9#2)
prognostic significance of genetic##2##4##(2007-8#1)(2011-1#1)
prognostic significance of##23##3##(1990-9#1)(1991-12#1)(1992-2#1)(1993-1#1)(1993-9#2)(1996-11#3)(1996-9#1)(2006-6#1)(2007-8#3)(2008-11#2)(2008-7#2)(2009-2#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
prognostic significance##40##2##(1990-12#1)(1990-6#1)(1990-9#2)(1991-12#1)(1992-2#1)(1993-1#1)(1993-9#2)(1994-6#1)(1994-8#1)(1996-11#3)(1996-9#2)(1997-7#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-6#1)(2007-8#4)(2008-11#2)(2008-4#1)(2008-7#3)(2009-2#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
prognostic signs##3##2##(1990-3#2)(2006-10#1)
prognostic stratification##2##2##(2009-10#1)(2010-12#1)
prognostic studies##2##2##(2005-10#1)(2008-12#1)
prognostic tool##3##2##(1993-9#1)(2008-8#1)(2013-1#1)
prognostic utility##2##2##(2008-9#1)(2013-1#1)
prognostic validity##3##2##(2008-10#1)(2010-12#1)(2011-2#1)
prognostic value and##2##3##(2008-3#1)(2011-1#1)
prognostic value for the##2##4##(2008-1#1)(2011-1#1)
prognostic value for##4##3##(2008-1#1)(2011-1#1)(2012-12#2)
prognostic value in##6##3##(1991-7#1)(1994-11#1)(2005-9#1)(2006-6#1)(2009-4#1)(2011-2#1)
prognostic value of the##2##4##(1991-6#1)(1993-9#1)
prognostic value of##32##3##(1991-6#2)(1993-8#1)(1993-9#1)(1994-6#1)(1996-4#2)(1996-9#1)(1997-7#1)(1997-8#1)(2005-5#1)(2006-10#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#2)(2009-1#1)(2009-4#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-2#2)(2012-3#1)(2013-7#1)
prognostic value##60##2##(1990-4#1)(1990-5#1)(1990-8#1)(1991-6#2)(1991-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-7#1)(1996-4#2)(1996-9#3)(1997-7#1)(1997-8#2)(2005-10#1)(2005-5#1)(2005-9#2)(2006-10#3)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#2)(2008-7#3)(2009-1#1)(2009-2#1)(2009-4#2)(2010-10#1)(2010-6#2)(2011-1#3)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-7#1)
prognostic variables and##2##3##(1994-6#1)(2012-3#1)
prognostic variables##7##2##(1991-3#1)(1991-4#1)(1994-6#1)(2009-8#1)(2012-1#1)(2012-3#2)
prognostic##585##1##(1990-10#3)(1990-12#1)(1990-2#2)(1990-3#3)(1990-4#3)(1990-5#2)(1990-6#8)(1990-8#2)(1990-9#8)(1991-10#3)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#5)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#3)(1992-2#4)(1992-6#5)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#5)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#8)(1994-10#1)(1994-11#1)(1994-12#4)(1994-4#1)(1994-5#2)(1994-6#3)(1994-7#6)(1994-8#1)(1995-10#3)(1995-12#1)(1995-4#5)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#5)(1996-11#4)(1996-12#3)(1996-2#1)(1996-4#3)(1996-8#2)(1996-9#6)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#3)(1997-8#5)(2004-1#2)(2004-2#3)(2005-10#3)(2005-11#1)(2005-12#1)(2005-5#1)(2005-6#1)(2005-8#2)(2005-9#3)(2006-10#15)(2006-6#19)(2006-8#2)(2006-9#2)(2007-10#7)(2007-11#5)(2007-12#4)(2007-2#4)(2007-3#1)(2007-4#2)(2007-5#3)(2007-6#2)(2007-7#3)(2007-8#22)(2007-9#3)(2008-1#12)(2008-10#10)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#11)(2008-4#5)(2008-5#3)(2008-6#27)(2008-7#20)(2008-8#7)(2008-9#4)(2009-1#2)(2009-10#5)(2009-11#5)(2009-2#3)(2009-3#1)(2009-4#7)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#9)(2010-12#15)(2010-3#3)(2010-4#3)(2010-5#5)(2010-6#4)(2010-7#2)(2010-9#2)(2011-1#12)(2011-2#44)(2011-3#2)(2011-8#1)(2012-1#4)(2012-11#1)(2012-12#8)(2012-2#19)(2012-3#15)(2013-1#18)(2013-7#4)(2013-8#7)
prognostically important##2##2##(1994-7#1)(2012-3#1)
prognostically informative##2##2##(2008-3#2)
prognostically##10##1##(1993-8#1)(1994-7#1)(1995-5#1)(2005-12#1)(2006-6#1)(2008-3#2)(2008-6#1)(2011-2#1)(2012-3#1)
prognosticate##2##1##(2009-10#1)(2010-6#1)
prognostication and##2##2##(2008-3#1)(2010-11#1)
prognostication of##4##2##(2008-6#1)(2010-3#1)(2011-2#2)
prognostication##14##1##(1994-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#3)(2013-1#2)
prognosticator##2##1##(2010-7#2)
prognosticators##3##1##(1990-10#2)(1995-1#1)
prognostics##2##1##(1992-2#1)(2008-8#1)
program &quot##2##2##(2006-7#1)(2013-1#1)
program according to##2##3##(2008-10#1)(2008-8#1)
program administrator##3##2##(1996-6#1)(2008-12#1)(2008-2#1)
program after##3##2##(2006-3#2)(2007-10#1)
program against##2##2##(1997-7#1)(2008-4#1)
program aimed at##3##3##(1990-6#1)(2007-2#1)(2013-1#1)
program aimed##4##2##(1990-6#1)(2007-2#1)(2013-1#2)
program allows the##2##3##(1990-12#1)(2007-11#1)
program allows##4##2##(1990-12#1)(2006-5#1)(2007-1#1)(2007-11#1)
program also##4##2##(1991-12#1)(1996-2#1)(2006-7#1)(2008-2#1)
program among female sex workers (FSWs) in##2##7##(2012-3#2)
program among##6##2##(2006-10#1)(2006-7#1)(2008-8#1)(2012-3#3)
program and an##2##3##(1994-12#1)(1995-3#1)
program and are##2##3##(1993-12#1)(2008-3#1)
program and in##2##3##(2006-11#1)(2008-1#1)
program and its##4##3##(1991-2#2)(2007-2#1)(2008-4#1)
program and the##9##3##(1991-10#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2011-2#1)(2012-2#2)
program and to##4##3##(1995-1#1)(1997-1#1)(2006-10#1)(2007-10#1)
program and##66##2##(1990-10#1)(1990-12#2)(1991-1#1)(1991-10#1)(1991-2#2)(1991-9#1)(1992-1#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#3)(1994-2#1)(1995-1#2)(1995-3#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-2#2)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#3)(2008-6#4)(2008-8#1)(2008-9#1)(2009-8#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
program appeared##2##2##(2007-1#1)(2008-7#1)
program appears to##3##3##(1993-12#1)(1994-2#1)(1997-2#1)
program are##13##2##(1990-12#1)(1992-9#1)(1993-5#1)(1996-1#1)(1996-2#1)(2006-1#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-4#1)(2009-10#1)(2012-3#1)
program as a##2##3##(1992-3#1)(2012-1#1)
program as##6##2##(1991-12#1)(1992-3#1)(2007-2#1)(2009-7#1)(2010-9#1)(2012-1#1)
program assessment##2##2##(2005-10#1)(2006-7#1)
program at Duke##2##3##(1991-2#1)(2012-2#1)
program at a##4##3##(1992-2#1)(1995-1#1)(1997-4#1)(2012-3#1)
program at an##2##3##(2007-10#1)(2007-7#1)
program at his hospital##2##4##(1991-1#1)(1994-2#1)
program at his##4##3##(1991-1#2)(1994-2#1)(1995-2#1)
program at the##8##3##(1991-12#1)(1994-12#1)(1996-6#1)(2007-12#1)(2008-1#1)(2008-8#1)(2009-3#1)(2013-1#1)
program at##33##2##(1991-1#2)(1991-12#1)(1991-2#1)(1992-2#1)(1994-12#2)(1994-2#1)(1995-1#1)(1995-2#2)(1996-2#1)(1996-6#2)(1997-4#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#2)(2009-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
program based on the##4##4##(1996-12#2)(2008-3#1)(2008-6#1)
program based on##13##3##(1993-5#1)(1995-6#2)(1996-12#2)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-6#2)(2009-11#1)
program based##14##2##(1993-5#1)(1995-6#2)(1996-12#2)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-6#2)(2009-11#1)(2013-8#1)
program because##3##2##(1991-1#1)(1994-3#1)(2012-2#1)
program began##3##2##(2006-4#1)(2008-11#1)(2008-12#1)
program between##2##2##(2008-4#1)(2011-2#1)
program by##3##2##(1991-1#1)(1991-12#1)(2008-6#1)
program calculates the##2##3##(1990-3#1)(1991-8#1)
program called &quot##3##3##(1996-3#1)(2007-7#1)(2010-12#1)
program called##9##2##(1995-8#1)(1996-3#1)(2007-7#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-11#1)(2010-12#1)(2012-12#1)
program can be used##2##4##(1991-8#1)(2012-2#1)
program can be##6##3##(1991-5#1)(1991-8#1)(2007-5#1)(2008-11#1)(2009-4#1)(2012-2#1)
program can##12##2##(1991-5#1)(1991-8#1)(1994-12#1)(1995-8#1)(1996-12#1)(2007-4#1)(2007-5#1)(2008-11#1)(2008-9#1)(2009-4#1)(2012-2#1)(2013-1#1)
program changes##2##2##(1995-2#1)(2008-11#1)
program components##3##2##(1991-4#1)(1992-1#1)(1993-3#1)
program comprised three##2##3##(2011-2#1)(2013-1#1)
program comprised##4##2##(2005-8#1)(2008-6#1)(2011-2#1)(2013-1#1)
program conducted a##2##3##(1991-6#1)(2008-3#1)
program conducted##3##2##(1991-6#1)(2007-11#1)(2008-3#1)
program cost##3##2##(1992-3#2)(1995-3#1)
program costs##4##2##(1993-3#1)(2009-4#2)(2010-12#1)
program could be##2##3##(2008-10#2)
program could##4##2##(1992-12#1)(2007-2#1)(2008-10#2)
program covering##2##2##(1995-1#1)(2008-10#1)
program delivery##3##2##(1990-12#1)(1992-3#1)(2012-2#1)
program demonstrated##3##2##(1991-2#1)(1995-1#1)(2010-9#1)
program described##2##2##(2008-2#1)(2008-4#1)
program design and evaluation##2##4##(1997-3#1)(2012-2#1)
program design and##4##3##(1991-2#1)(1995-1#1)(1997-3#1)(2012-2#1)
program design##6##2##(1991-2#1)(1995-1#1)(1997-2#1)(1997-3#1)(2008-1#1)(2012-2#1)
program designed to improve##2##4##(1997-2#1)(2008-12#1)
program designed to##13##3##(1994-12#1)(1994-3#1)(1996-1#2)(1997-1#1)(1997-2#1)(2006-6#1)(2007-7#1)(2008-1#2)(2008-12#1)(2013-1#2)
program designed##14##2##(1994-12#1)(1994-3#1)(1996-1#2)(1997-1#1)(1997-2#1)(2006-6#1)(2007-7#1)(2008-1#2)(2008-12#1)(2008-4#1)(2013-1#2)
program developed and##2##3##(1991-2#1)(2006-10#1)
program developed##6##2##(1991-2#1)(1995-2#1)(1996-1#1)(1996-2#1)(2006-10#1)(2007-11#1)
program development and##2##3##(1995-1#1)(1997-1#1)
program development##11##2##(1991-2#1)(1992-2#1)(1995-1#1)(1997-1#1)(2007-10#1)(2007-2#2)(2008-11#1)(2009-4#1)(2009-9#1)(2010-7#1)
program did not##2##3##(1996-2#1)(2008-8#1)
program directors who##2##3##(2007-9#1)(2010-4#1)
program directors##9##2##(1994-3#1)(2007-4#2)(2007-9#2)(2009-8#2)(2010-4#1)(2012-3#1)
program directors'##2##2##(2007-12#1)(2013-1#1)
program does not##2##3##(1994-3#1)(2006-7#1)
program during the##2##3##(1992-3#1)(1993-3#1)
program during##3##2##(1992-3#1)(1993-3#1)(1997-2#1)
program effect##3##2##(2008-8#3)
program effectiveness and##2##3##(1996-2#1)(1997-2#1)
program effectiveness##3##2##(1996-2#1)(1997-2#1)(2008-4#1)
program effects##5##2##(1996-3#1)(2008-2#1)(2008-8#3)
program efficacy##2##2##(2007-1#1)(2013-1#1)
program emphasizes##2##2##(1992-1#1)(1993-3#1)
program enrollment##2##2##(1991-3#1)(1997-2#1)
program evaluation are##2##3##(1993-12#1)(1993-2#1)
program evaluation is##2##3##(1992-1#1)(1993-12#1)
program evaluation##12##2##(1992-1#1)(1993-12#4)(1993-2#1)(1997-1#1)(1997-2#1)(2007-10#1)(2007-11#1)(2008-12#1)(2013-8#1)
program expenditures##3##2##(1992-1#1)(1993-1#1)(1993-3#1)
program experience##3##2##(1992-12#1)(2005-10#1)(2012-12#1)
program exposure##2##2##(2012-3#2)
program focus##3##2##(1993-12#2)(1996-3#1)
program focused on##2##3##(2008-7#1)(2010-10#1)
program for a##7##3##(1991-1#1)(1992-2#1)(1994-12#1)(1996-3#2)(2007-2#1)(2008-11#1)
program for assessing##2##3##(1997-8#1)(2008-10#1)
program for breast cancer##2##4##(1993-1#1)(1996-6#1)
program for children and##2##4##(1992-1#1)(1995-3#1)
program for children with##3##4##(1993-12#1)(2006-10#1)(2009-7#1)
program for children##6##3##(1992-1#1)(1993-12#2)(1995-3#1)(2006-10#1)(2009-7#1)
program for diabetes mellitus##2##4##(1993-2#1)(2012-3#1)
program for hospitals##2##3##(1992-2#1)(2009-11#1)
program for medical staff##2##4##(1993-1#1)(2012-11#1)
program for older adults##2##4##(1992-1#1)(2008-3#1)
program for patients with##4##4##(1990-2#1)(2005-4#1)(2011-1#1)(2012-1#1)
program for people with##3##4##(1993-3#1)(2010-4#1)(2010-9#1)
program for persons with##2##4##(1993-1#1)(1993-3#1)
program for persons##3##3##(1993-1#1)(1993-3#1)(2010-8#1)
program for predicting##2##3##(1994-9#1)(2008-4#1)
program for prevention##2##3##(1995-3#2)
program for rural##3##3##(1992-12#1)(1996-2#1)(2013-1#1)
program for the early detection of##2##6##(1996-9#1)(2011-2#1)
program for the##12##3##(1990-12#1)(1991-12#1)(1992-1#1)(1993-6#1)(1995-3#1)(1996-9#1)(2007-2#1)(2007-7#1)(2008-4#1)(2010-9#2)(2011-2#1)
program for urban##3##3##(2007-2#3)
program for##157##2##(1990-12#3)(1990-2#1)(1990-3#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#2)(1992-1#3)(1992-10#1)(1992-12#1)(1992-2#4)(1992-3#1)(1993-1#3)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-3#6)(1995-8#1)(1995-9#2)(1996-10#1)(1996-2#3)(1996-3#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#2)(2005-10#1)(2005-4#1)(2005-6#1)(2006-1#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-10#2)(2007-2#6)(2007-3#2)(2007-4#1)(2007-6#4)(2007-7#2)(2008-1#3)(2008-10#7)(2008-11#4)(2008-12#6)(2008-2#1)(2008-3#3)(2008-4#8)(2008-6#2)(2008-7#4)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-4#1)(2010-8#1)(2010-9#3)(2011-1#4)(2011-12#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#3)
program from##5##2##(1993-1#1)(1994-1#1)(1994-9#1)(1995-12#1)(2008-10#1)
program funded by the##2##4##(2008-7#1)(2009-5#1)
program funded by##3##3##(2008-1#1)(2008-7#1)(2009-5#1)
program graduates##2##2##(1993-2#1)(2011-2#1)
program had##2##2##(2007-10#1)(2007-2#1)
program has also been##3##4##(1993-3#1)(2008-3#2)
program has been designed##2##4##(2005-12#1)(2008-4#1)
program has been established##2##4##(1991-2#1)(2006-3#1)
program has been##13##3##(1991-2#1)(1996-3#1)(2005-12#1)(2006-3#1)(2007-12#1)(2007-6#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2011-3#1)(2013-1#1)
program has made##2##3##(1992-3#1)(1996-2#1)
program has##32##2##(1991-1#1)(1991-2#1)(1992-2#1)(1992-3#1)(1993-3#2)(1995-12#2)(1996-2#1)(1996-3#1)(2005-12#1)(2006-3#1)(2007-12#2)(2007-2#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-3#7)(2008-4#2)(2008-7#2)(2011-3#1)(2013-1#1)
program have been##2##3##(1991-7#1)(1994-9#1)
program have##5##2##(1991-7#1)(1994-9#1)(2005-8#1)(2009-11#1)(2011-2#1)
program impact##3##2##(2007-11#2)(2010-3#1)
program implementation and##2##3##(2007-10#1)(2008-9#1)
program implementation##11##2##(2006-1#1)(2007-10#2)(2007-11#1)(2007-2#1)(2008-2#1)(2008-3#1)(2008-9#2)(2012-3#1)(2013-1#1)
program improves##2##2##(1996-9#1)(2006-10#1)
program in Canada##2##3##(1992-2#1)(2006-5#1)
program in Finnmark]##3##3##(1993-11#1)(1995-6#2)
program in Japan##2##3##(1993-2#1)(1996-4#1)
program in Palau##2##3##(2005-11#1)(2008-1#1)
program in Saudi Arabia##2##4##(2007-2#2)
program in a##2##3##(2007-3#1)(2008-3#1)
program in an##4##3##(1996-3#1)(1997-1#1)(2007-7#1)(2008-7#1)
program in health##2##3##(1993-12#2)
program in order to##3##4##(1990-12#1)(2007-8#1)(2012-12#1)
program in our##2##3##(1993-2#1)(2010-1#1)
program in response to##2##4##(1992-9#1)(2008-1#1)
program in the United States##2##5##(1993-1#1)(2012-12#1)
program in the##24##3##(1990-11#1)(1990-7#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-3#2)(1994-3#1)(1995-1#2)(1996-1#1)(1996-11#1)(1996-2#1)(1997-2#1)(2006-2#1)(2006-8#2)(2007-4#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
program in which##5##3##(1994-3#1)(2007-5#1)(2008-7#1)(2013-1#2)
program in##121##2##(1990-11#1)(1990-12#2)(1990-7#1)(1991-12#1)(1991-3#2)(1991-4#1)(1992-1#1)(1992-2#3)(1992-3#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#4)(1994-12#1)(1994-2#1)(1994-3#3)(1995-1#3)(1995-2#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-1#2)(1997-2#2)(2005-11#2)(2006-10#1)(2006-2#2)(2006-5#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-12#2)(2007-2#4)(2007-3#2)(2007-4#2)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#3)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-4#1)(2009-8#2)(2010-1#2)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#6)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#2)
program include##4##2##(1996-12#1)(1996-6#1)(2005-8#1)(2008-12#1)
program included##4##2##(2005-8#1)(2007-8#1)(2012-11#1)(2012-12#1)
program includes##4##2##(1992-1#1)(2006-10#1)(2008-12#1)(2012-3#1)
program including##2##2##(2008-10#1)(2009-10#1)
program initiation##2##2##(2007-11#1)(2010-3#1)
program into a##2##3##(2009-11#1)(2012-2#1)
program into##5##2##(2008-11#2)(2009-11#1)(2010-6#1)(2012-2#1)
program is a##6##3##(1991-1#2)(1996-3#1)(1996-6#1)(2007-7#1)(2008-1#1)
program is also##2##3##(2008-4#1)(2011-1#1)
program is an##4##3##(1993-1#1)(1993-12#1)(2007-2#1)(2007-7#1)
program is arranged with##2##4##(1993-1#2)
program is designed to##2##4##(1997-3#1)(2013-1#1)
program is the##6##3##(1992-2#1)(1993-3#1)(1996-12#1)(2006-10#1)(2007-11#1)(2010-2#1)
program is to##7##3##(1993-12#1)(2007-4#1)(2008-11#2)(2008-2#1)(2008-4#1)(2012-3#1)
program is warranted##2##3##(2006-10#1)(2011-1#1)
program is##72##2##(1990-12#1)(1991-1#2)(1991-2#2)(1991-3#1)(1992-1#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-1#4)(1993-12#2)(1993-3#2)(1994-2#1)(1995-1#1)(1995-10#1)(1996-12#2)(1996-3#2)(1996-6#1)(1997-2#1)(1997-3#1)(2006-10#3)(2006-3#1)(2006-7#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-4#3)(2007-7#3)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#5)(2008-7#1)(2010-2#1)(2011-1#3)(2011-2#2)(2012-3#1)(2013-1#2)
program location and program reputation##2##5##(1996-1#2)
program location and##3##3##(1996-1#3)
program management in##2##3##(1995-2#2)
program management##10##2##(1994-12#2)(1994-3#3)(1995-2#3)(1996-2#1)(1996-3#1)
program managers##5##2##(1994-12#1)(1996-12#1)(2006-10#1)(2007-7#1)(2012-3#1)
program may be##4##3##(1995-2#1)(2008-12#1)(2008-4#1)(2012-1#1)
program may have##2##3##(1996-1#1)(2013-8#1)
program may##10##2##(1993-3#1)(1995-2#2)(1996-1#1)(2008-12#1)(2008-4#2)(2012-1#1)(2012-12#1)(2013-8#1)
program mission##2##2##(1992-12#1)(2009-8#1)
program model##2##2##(1990-3#1)(1995-3#1)
program monitoring data##2##3##(2012-3#2)
program monitoring##4##2##(2007-11#1)(2012-3#3)
program of all##2##3##(2005-10#1)(2008-1#1)
program of care##2##3##(1992-1#1)(2008-1#1)
program of instruction in operative laparoscopy##2##6##(1993-12#2)
program of rehabilitation##2##3##(2007-8#2)
program of research##3##3##(1995-4#1)(2008-11#1)(2012-3#1)
program of the##7##3##(1993-12#1)(1995-12#1)(1997-5#1)(2005-9#1)(2008-1#1)(2011-2#1)(2012-2#1)
program of##70##2##(1990-10#1)(1990-12#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#2)(1994-12#3)(1994-2#2)(1995-10#1)(1995-12#1)(1995-2#2)(1995-4#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-5#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-12#1)(2006-9#1)(2007-11#4)(2007-12#2)(2007-4#1)(2007-8#5)(2008-1#4)(2008-10#4)(2008-11#1)(2008-3#2)(2008-9#1)(2009-8#1)(2010-4#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
program offers##2##2##(1997-2#1)(2007-9#1)
program often##2##2##(1997-3#1)(2007-4#1)
program on the##7##3##(1990-3#1)(1992-1#1)(1995-1#1)(2008-10#1)(2008-6#1)(2012-2#1)(2013-1#1)
program on##32##2##(1990-3#1)(1991-2#1)(1992-1#1)(1995-1#1)(1995-2#1)(1997-3#1)(2004-12#1)(2006-10#2)(2006-3#1)(2007-10#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#1)(2011-3#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#1)
program operation##3##2##(2007-2#1)(2007-4#1)(2008-7#1)
program or by##2##3##(1993-2#1)(2008-4#1)
program or##6##2##(1993-2#1)(1997-8#1)(2005-10#1)(2006-5#1)(2008-12#1)(2008-4#1)
program outcomes##2##2##(2007-2#1)(2010-9#1)
program over the##3##3##(1992-1#1)(2008-4#1)(2011-2#1)
program participants##2##2##(1996-3#1)(2010-12#1)
program participation##4##2##(1995-12#1)(2008-12#3)
program payments##3##2##(1991-2#1)(1991-3#2)
program performance##3##2##(1995-1#2)(1995-3#1)
program planning and##3##3##(1994-7#1)(1995-1#1)(1997-8#1)
program planning##5##2##(1991-1#1)(1994-7#1)(1995-1#1)(1997-8#1)(2011-1#1)
program produces##2##2##(2007-9#1)(2008-10#1)
program proved##2##2##(1990-3#1)(2008-10#1)
program provide##2##2##(1996-3#1)(2012-3#1)
program providers##3##2##(1994-2#1)(2008-11#1)(2008-12#1)
program provides##6##2##(1993-12#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-4#1)
program providing##3##2##(1996-3#1)(2008-10#1)(2008-6#1)
program represents##2##2##(2007-2#1)(2008-7#1)
program reputation##3##2##(1996-1#3)
program requirements##3##2##(1995-1#1)(2008-2#1)(2009-4#1)
program requires##5##2##(1993-2#1)(1997-6#1)(2008-3#1)(2009-4#1)(2010-2#1)
program resulted in##2##3##(2008-10#2)
program should be##8##3##(1995-12#1)(1995-2#1)(2004-9#1)(2008-3#1)(2009-3#1)(2009-4#1)(2011-1#2)
program should##10##2##(1993-1#1)(1995-12#1)(1995-2#1)(2004-9#1)(2008-3#1)(2009-3#1)(2009-4#1)(2011-1#2)(2011-2#1)
program showed##2##2##(2007-12#1)(2010-7#1)
program so##2##2##(1993-7#1)(2010-7#1)
program specifically##2##2##(1991-1#1)(2007-1#1)
program staff##4##2##(1995-12#1)(1996-2#1)(1996-3#1)(2007-2#1)
program started##3##2##(1991-2#1)(2006-4#1)(2010-2#1)
program statement##4##2##(1996-2#4)
program structure##3##2##(2008-2#1)(2008-3#1)(2008-9#1)
program suggested##2##2##(2007-8#1)(2008-10#1)
program that addresses##3##3##(1991-12#1)(2006-7#1)(2012-3#1)
program that allows##2##3##(2007-12#1)(2008-4#1)
program that creates##2##3##(2008-11#1)(2008-9#1)
program that includes##2##3##(2007-12#1)(2008-11#1)
program that is##4##3##(1993-2#1)(1997-1#1)(1997-3#1)(2012-3#1)
program that targeted##2##3##(2010-2#1)(2012-3#1)
program that uses##2##3##(2008-3#1)(2008-7#1)
program that was##3##3##(1990-3#1)(1996-1#1)(2009-12#1)
program that works##2##3##(1992-12#1)(2008-4#1)
program that would##2##3##(1994-3#1)(2010-8#1)
program that##52##2##(1990-3#1)(1991-12#1)(1992-12#3)(1993-1#1)(1993-12#1)(1993-2#1)(1994-3#1)(1996-1#1)(1996-3#2)(1997-1#2)(1997-3#1)(2006-7#1)(2007-12#3)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#5)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-4#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
program the##3##2##(2005-12#1)(2008-11#1)(2011-2#1)
program through##2##2##(1997-2#1)(2012-3#1)
program to address the##2##4##(1997-2#1)(2007-2#1)
program to address##3##3##(1997-2#1)(2007-2#1)(2008-12#1)
program to aid##2##3##(1991-8#1)(1993-6#1)
program to be##2##3##(1995-12#1)(2012-2#1)
program to determine##5##3##(2007-11#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-12#1)
program to ensure the##2##4##(1996-2#1)(2008-4#1)
program to ensure##3##3##(1996-2#1)(2008-4#1)(2008-9#1)
program to improve##5##3##(2006-5#1)(2008-3#1)(2010-1#1)(2013-1#2)
program to prevent##3##3##(1997-7#1)(2007-1#1)(2013-8#1)
program to the##2##3##(1991-2#1)(1996-1#1)
program to train##2##3##(1997-1#1)(2010-7#1)
program to##71##2##(1991-1#2)(1991-2#1)(1991-8#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-10#1)(1995-12#2)(1995-2#2)(1996-1#2)(1996-11#1)(1996-2#3)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#1)(2006-12#1)(2006-3#2)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-2#2)(2007-5#1)(2007-8#1)(2007-9#2)(2008-10#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-7#1)(2008-9#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#4)
program took##2##2##(1992-1#1)(2008-1#1)
program used##4##2##(1993-12#1)(1995-3#1)(2006-3#1)(2008-6#1)
program using a##2##3##(2012-1#1)(2013-7#1)
program using##7##2##(1994-6#1)(2007-7#1)(2007-8#1)(2008-11#1)(2011-2#1)(2012-1#1)(2013-7#1)
program was based on##2##4##(2004-12#1)(2008-9#1)
program was carried out by employing a heating cycle in four steps##2##12##(2008-10#2)
program was carried out##3##4##(2008-10#2)(2008-11#1)
program was designed to##3##4##(1997-4#1)(2007-11#1)(2012-3#1)
program was developed and##2##4##(1997-2#1)(2008-11#1)
program was developed in##2##4##(1992-9#1)(2007-2#1)
program was developed##9##3##(1990-3#1)(1991-5#1)(1992-2#1)(1992-9#1)(1997-2#1)(2007-2#1)(2008-11#2)(2008-12#1)
program was established in##2##4##(1993-3#1)(1996-1#1)
program was established##3##3##(1993-3#1)(1996-1#1)(2006-4#1)
program was evaluated##3##3##(2004-3#1)(2006-4#1)(2008-10#1)
program was implemented##2##3##(1994-2#1)(2006-3#1)
program was optimized##2##3##(1996-3#1)(2008-10#1)
program was started##2##3##(2006-4#1)(2008-10#1)
program was successful in##2##4##(2008-4#1)(2012-11#1)
program was successful##3##3##(2007-5#1)(2008-4#1)(2012-11#1)
program was to develop##2##4##(1993-12#1)(1997-4#1)
program was to##3##3##(1992-1#1)(1993-12#1)(1997-4#1)
program was used to##5##4##(1992-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2012-2#1)
program was used##8##3##(1992-1#1)(1996-9#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-2#1)
program was##76##2##(1990-12#1)(1990-3#1)(1991-1#1)(1991-2#1)(1991-5#1)(1992-1#2)(1992-2#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-1#2)(1996-3#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#2)(2004-12#1)(2004-3#1)(2005-12#1)(2006-3#1)(2006-4#3)(2006-5#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-6#1)(2010-7#1)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
program we##2##2##(1995-6#1)(1997-1#1)
program were##16##2##(1991-12#1)(1991-2#1)(1994-1#1)(1995-1#1)(2004-12#1)(2007-2#2)(2008-10#3)(2010-10#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-3#2)
program when##2##2##(1995-5#1)(2009-5#1)
program which##7##2##(1992-1#1)(1993-5#1)(1994-9#1)(1996-12#1)(2007-7#1)(2008-10#2)
program while##2##2##(1991-12#1)(2007-8#1)
program will also##2##3##(1993-9#1)(1995-12#1)
program will be##2##3##(1993-12#1)(2010-11#1)
program will not##2##3##(1994-2#1)(2006-5#1)
program will##8##2##(1993-12#1)(1993-9#1)(1994-2#2)(1995-12#1)(2006-5#1)(2008-5#1)(2010-11#1)
program with a commercial##2##4##(1994-7#1)(2007-4#1)
program with a graphical##2##4##(2008-3#1)(2011-3#1)
program with a##5##3##(1994-7#1)(1997-1#1)(2007-4#1)(2008-3#1)(2011-3#1)
program with the##2##3##(2004-12#1)(2007-5#1)
program with##19##2##(1992-12#1)(1994-7#1)(1995-1#1)(1997-1#2)(2004-12#1)(2005-8#1)(2006-12#1)(2007-4#1)(2007-5#1)(2008-11#1)(2008-3#2)(2008-9#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
program within the##2##3##(1991-1#1)(2008-7#1)
program within##5##2##(1991-1#1)(1991-2#1)(1995-12#1)(2007-2#1)(2008-7#1)
program without##2##2##(1997-2#1)(2007-8#1)
program would be##3##3##(1997-6#1)(2009-4#1)(2012-12#1)
program would##9##2##(1992-12#1)(1995-1#1)(1997-6#1)(2006-3#1)(2008-11#1)(2009-4#2)(2012-12#1)(2013-1#1)
program written##4##2##(1992-2#1)(2008-10#3)
program##2261##1##(1990-10#2)(1990-11#2)(1990-12#20)(1990-2#1)(1990-3#9)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-1#26)(1991-10#2)(1991-11#1)(1991-12#19)(1991-2#30)(1991-3#13)(1991-4#6)(1991-5#2)(1991-6#4)(1991-7#3)(1991-8#6)(1991-9#4)(1992-1#28)(1992-10#2)(1992-12#19)(1992-2#24)(1992-3#12)(1992-5#1)(1992-6#1)(1992-8#6)(1992-9#4)(1993-1#19)(1993-11#7)(1993-12#31)(1993-2#25)(1993-3#30)(1993-4#1)(1993-5#4)(1993-6#3)(1993-7#2)(1993-9#4)(1994-1#5)(1994-10#1)(1994-11#1)(1994-12#31)(1994-2#17)(1994-3#27)(1994-5#2)(1994-6#3)(1994-7#3)(1994-9#11)(1995-1#30)(1995-10#3)(1995-12#25)(1995-2#27)(1995-3#21)(1995-4#1)(1995-5#3)(1995-6#7)(1995-7#1)(1995-8#4)(1995-9#6)(1996-1#31)(1996-10#1)(1996-11#3)(1996-12#29)(1996-2#27)(1996-3#26)(1996-4#1)(1996-6#9)(1996-7#2)(1996-8#1)(1996-9#4)(1997-1#20)(1997-2#42)(1997-3#11)(1997-4#5)(1997-5#3)(1997-6#4)(1997-7#2)(1997-8#4)(2004-10#1)(2004-12#4)(2004-3#1)(2004-9#2)(2005-10#7)(2005-11#11)(2005-12#3)(2005-4#1)(2005-6#1)(2005-8#12)(2005-9#3)(2006-1#4)(2006-10#23)(2006-11#3)(2006-12#7)(2006-2#5)(2006-3#15)(2006-4#13)(2006-5#11)(2006-6#1)(2006-7#16)(2006-8#12)(2006-9#5)(2007-1#11)(2007-10#25)(2007-11#36)(2007-12#39)(2007-2#53)(2007-3#7)(2007-4#30)(2007-5#10)(2007-6#14)(2007-7#32)(2007-8#19)(2007-9#19)(2008-1#29)(2008-10#108)(2008-11#49)(2008-12#47)(2008-2#31)(2008-3#56)(2008-4#60)(2008-5#12)(2008-6#26)(2008-7#27)(2008-8#23)(2008-9#22)(2009-10#5)(2009-11#6)(2009-12#6)(2009-2#2)(2009-3#5)(2009-4#20)(2009-5#5)(2009-7#3)(2009-8#12)(2009-9#6)(2010-1#4)(2010-10#7)(2010-11#8)(2010-12#12)(2010-2#12)(2010-3#11)(2010-4#5)(2010-5#2)(2010-6#6)(2010-7#9)(2010-8#4)(2010-9#9)(2011-1#19)(2011-12#1)(2011-2#53)(2011-3#3)(2011-7#1)(2011-9#1)(2012-1#14)(2012-10#1)(2012-11#7)(2012-12#37)(2012-2#41)(2012-3#59)(2013-1#59)(2013-7#10)(2013-8#18)
program's experience##2##2##(1994-3#1)(1995-3#1)
program's percentage of graduates passing the##2##6##(2007-12#2)
program's success##2##2##(1993-2#1)(2007-2#1)
program's##20##1##(1993-2#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-1#1)(1997-3#1)(2006-3#1)(2007-1#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-10#1)(2008-6#3)(2010-2#1)(2010-3#1)(2012-12#2)
program)##8##1##(1992-2#1)(2005-11#1)(2006-11#1)(2007-2#2)(2011-2#3)
program-based##2##1##(1992-12#1)(2011-1#1)
program?##3##1##(1993-3#1)(2011-2#2)
program]##10##1##(1990-3#1)(1991-10#1)(1993-4#1)(1995-6#1)(1996-2#1)(1997-4#1)(1997-5#1)(2006-8#1)(2010-11#1)(2012-12#1)
programmable and##4##2##(2006-8#1)(2007-12#1)(2008-2#2)
programmable array##3##2##(2008-2#1)(2008-3#1)(2008-9#1)
programmable digital##2##2##(2008-2#1)(2008-3#1)
programmable liquid-crystal spatial light modulator##2##5##(2007-12#2)
programmable liquid-crystal##3##2##(2007-11#1)(2007-12#2)
programmable logic arrays##2##3##(2008-2#1)(2008-3#1)
programmable logic##3##2##(2008-2#1)(2008-3#2)
programmable pulse shaper##3##3##(2007-12#3)
programmable pulse##4##2##(2007-12#4)
programmable temperature vaporizer (PTV-LV) injection##2##5##(2008-10#2)
programmable valve and##3##3##(2006-8#3)
programmable valve was##2##3##(2006-8#2)
programmable valve##7##2##(2006-8#7)
programmable weights##2##2##(2008-2#2)
programmable##91##1##(1991-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#12)(2007-11#7)(2007-12#17)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#22)(2008-3#10)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#2)(2010-12#1)(2011-1#1)(2013-1#1)(2013-7#1)
programmatic and##2##2##(1992-12#1)(1996-12#1)
programmatic areas##3##2##(2013-1#3)
programmatic moderators##2##2##(2012-2#2)
programmatic##23##1##(1992-12#1)(1996-12#1)(1997-3#2)(2006-10#1)(2008-10#1)(2009-4#1)(2010-8#1)(2012-11#2)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#1)
programme after##2##2##(1995-9#1)(2010-10#1)
programme and##21##2##(1991-5#1)(1993-8#1)(1995-11#1)(1995-6#1)(1996-1#1)(2004-7#1)(2006-2#1)(2007-11#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
programme are##3##2##(2004-2#1)(2008-1#1)(2008-10#1)
programme as##4##2##(2004-3#1)(2007-7#1)(2012-12#1)(2012-3#1)
programme at##3##2##(1990-12#1)(2007-12#1)(2008-12#1)
programme based on##3##3##(1994-4#1)(1996-4#2)
programme conducted##2##2##(1991-6#1)(2008-2#1)
programme design##2##2##(2006-2#1)(2013-8#1)
programme designed##2##2##(2004-10#1)(2008-10#1)
programme directors##2##2##(2011-2#2)
programme for diabetes##2##3##(1991-4#1)(2010-11#1)
programme for nurses##2##3##(2008-11#1)(2008-12#1)
programme for the##5##3##(2006-2#2)(2008-11#1)(2008-7#1)(2010-10#1)
programme for##28##2##(1990-12#1)(1990-4#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-3#1)(1993-6#1)(1995-2#1)(2006-2#2)(2007-11#1)(2007-6#1)(2008-11#4)(2008-12#3)(2008-7#2)(2008-9#1)(2010-10#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-8#1)
programme has been##4##3##(1990-8#1)(1995-9#1)(2010-4#1)(2012-3#1)
programme has##8##2##(1990-8#1)(1993-6#1)(1995-9#1)(2006-2#1)(2008-8#1)(2010-4#1)(2012-12#1)(2012-3#1)
programme in New##2##3##(2008-12#1)(2008-8#1)
programme in a##2##3##(1992-7#1)(2013-8#1)
programme in our##2##3##(2010-7#1)(2012-2#1)
programme in the##8##3##(1991-11#1)(1991-5#1)(1994-11#1)(1995-9#1)(2004-2#2)(2008-7#1)(2008-9#1)
programme in which##2##3##(2007-2#1)(2011-2#1)
programme in##45##2##(1990-11#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-7#1)(1994-11#1)(1994-4#1)(1995-9#2)(1997-7#1)(2004-2#3)(2005-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-3#1)(2009-7#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
programme involving##2##2##(2007-1#1)(2012-3#1)
programme is##14##2##(1991-11#1)(1992-3#1)(1994-12#1)(1996-12#1)(2004-2#1)(2007-6#1)(2008-11#2)(2008-12#2)(2008-3#1)(2010-9#1)(2013-1#1)(2013-7#1)
programme itself##2##2##(2008-10#1)(2008-11#1)
programme of the##4##3##(1990-4#1)(2004-9#1)(2006-2#1)(2006-9#1)
programme of treatment##2##3##(1990-2#1)(1990-8#1)
programme of##19##2##(1990-2#1)(1990-4#1)(1990-8#1)(1997-3#1)(1997-7#2)(2004-9#1)(2005-1#1)(2005-9#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-7#2)(2008-8#1)(2012-2#1)
programme on##19##2##(1990-10#1)(1990-3#1)(1990-8#1)(1991-8#1)(1992-7#1)(1994-6#2)(1995-3#1)(1996-3#1)(1996-5#1)(1996-6#1)(2008-11#1)(2008-12#2)(2008-7#4)(2013-8#1)
programme provides an##2##3##(2006-2#1)(2008-12#1)
programme provides##3##2##(2006-2#1)(2008-12#2)
programme reduced##2##2##(1995-5#1)(2013-1#1)
programme resulted in##2##3##(1997-3#1)(1997-5#1)
programme should be##2##3##(2007-7#1)(2010-10#1)
programme should##3##2##(2007-7#1)(2008-11#1)(2010-10#1)
programme that##6##2##(2007-11#1)(2007-2#1)(2008-11#1)(2008-12#1)(2010-9#1)(2012-3#1)
programme the##2##2##(1990-11#1)(2008-11#1)
programme to improve##3##3##(2011-2#2)(2012-1#1)
programme to reduce##2##3##(1990-2#1)(1994-4#1)
programme to##18##2##(1990-10#1)(1990-2#1)(1992-3#1)(1993-1#2)(1994-4#1)(1995-9#1)(2007-4#1)(2007-7#2)(2008-11#1)(2008-3#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)
programme was applied to##2##4##(2008-10#1)(2008-8#1)
programme was applied##3##3##(1990-2#1)(2008-10#1)(2008-8#1)
programme was developed##3##3##(2005-8#1)(2005-9#1)(2008-1#1)
programme was implemented##2##3##(2005-9#1)(2007-7#1)
programme was optimized##2##3##(2008-10#1)(2010-1#1)
programme was particularly##2##3##(1990-2#1)(2008-7#1)
programme was##28##2##(1990-2#2)(1991-9#1)(1994-4#1)(1995-11#1)(2005-8#1)(2005-9#2)(2006-8#1)(2007-2#1)(2007-7#4)(2008-1#1)(2008-10#2)(2008-2#1)(2008-7#2)(2008-8#2)(2008-9#2)(2010-1#2)(2012-12#1)(2013-8#1)
programme which##3##2##(1991-6#1)(1997-3#1)(2006-4#1)
programme with##7##2##(1990-2#2)(1990-9#1)(1993-1#1)(2007-6#1)(2010-9#2)
programme##491##1##(1990-10#2)(1990-11#4)(1990-12#2)(1990-2#7)(1990-3#1)(1990-4#2)(1990-5#1)(1990-8#3)(1990-9#2)(1991-11#2)(1991-2#1)(1991-3#1)(1991-4#3)(1991-5#2)(1991-6#4)(1991-8#4)(1991-9#4)(1992-3#3)(1992-5#1)(1992-7#2)(1992-8#1)(1993-1#3)(1993-5#1)(1993-6#5)(1993-7#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-4#6)(1994-6#4)(1994-7#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#7)(1996-1#1)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#3)(1996-5#1)(1996-6#1)(1997-3#5)(1997-5#1)(1997-7#5)(1997-8#1)(2004-10#1)(2004-2#14)(2004-3#1)(2004-7#1)(2004-9#1)(2005-1#4)(2005-5#1)(2005-8#5)(2005-9#5)(2006-10#5)(2006-12#1)(2006-2#10)(2006-4#3)(2006-5#1)(2006-8#3)(2006-9#2)(2007-1#2)(2007-11#6)(2007-12#4)(2007-2#4)(2007-4#2)(2007-5#6)(2007-6#8)(2007-7#13)(2007-8#4)(2008-1#10)(2008-10#17)(2008-11#34)(2008-12#20)(2008-2#5)(2008-3#8)(2008-5#3)(2008-6#1)(2008-7#14)(2008-8#10)(2008-9#19)(2009-1#2)(2009-3#1)(2009-4#3)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#3)(2010-10#5)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#3)(2010-7#1)(2010-8#2)(2010-9#11)(2011-1#4)(2011-2#12)(2012-1#1)(2012-11#2)(2012-12#17)(2012-2#10)(2012-3#16)(2013-1#10)(2013-7#4)(2013-8#12)
programme's##3##1##(2008-11#1)(2008-7#1)(2011-2#1)
programmed by##3##2##(1990-8#1)(2013-1#2)
programmed cell death (PCD) in##3##5##(2007-8#1)(2008-10#1)(2009-8#1)
programmed cell death (PCD)##8##4##(2007-8#1)(2008-10#2)(2008-4#1)(2009-8#3)(2011-1#1)
programmed cell death (apoptosis)##3##4##(1994-9#1)(1996-5#1)(2006-10#1)
programmed cell death by##3##4##(1991-12#1)(1993-9#1)(1994-6#1)
programmed cell death during##2##4##(1994-8#1)(2008-4#1)
programmed cell death in##13##4##(1990-12#1)(1991-12#1)(1993-4#1)(1994-8#2)(1995-8#1)(2003-11#1)(2007-12#1)(2007-2#1)(2008-8#1)(2009-10#1)(2009-8#1)(2012-12#1)
programmed cell death of##2##4##(1990-12#1)(2008-8#1)
programmed cell death or apoptosis##2##5##(2003-11#1)(2008-11#1)
programmed cell death or##3##4##(1996-12#1)(2003-11#1)(2008-11#1)
programmed cell death##68##3##(1990-12#3)(1991-11#3)(1991-12#4)(1991-3#1)(1993-4#1)(1993-9#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-8#2)(1996-12#1)(1996-5#3)(2003-11#3)(2006-10#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-4#5)(2008-7#1)(2008-8#4)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#6)(2009-9#1)(2011-1#1)(2011-2#3)(2012-12#1)
programmed cell##71##2##(1990-12#3)(1991-11#3)(1991-12#4)(1991-3#1)(1992-9#1)(1993-4#1)(1993-9#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-8#2)(1996-12#1)(1996-5#3)(2003-11#3)(2006-10#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#4)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#6)(2009-9#1)(2011-1#2)(2011-2#3)(2012-12#1)
programmed death of thymocytes##2##4##(1991-11#1)(1991-12#1)
programmed death##6##2##(1991-11#1)(1991-12#1)(1994-6#1)(2008-4#1)(2010-5#1)(2012-3#1)
programmed decomposition (TPDE) of [Mo(CO)(6)]##2##5##(2008-10#2)
programmed diode array photometric detection##2##5##(2008-10#2)
programmed electrical stimulation##4##3##(1996-12#1)(2007-8#1)(2008-12#1)(2011-2#1)
programmed electrical stimulation-induced arrhythmias in##2##5##(1992-3#1)(1996-12#1)
programmed electrical##6##2##(1992-3#1)(1996-12#2)(2007-8#1)(2008-12#1)(2011-2#1)
programmed flow systems##2##3##(2008-10#2)
programmed flow##3##2##(2008-10#3)
programmed in the##3##3##(1993-2#1)(1995-11#1)(2008-2#1)
programmed sequence##3##2##(2008-10#3)
programmed stimulation##3##2##(2005-1#1)(2006-9#1)(2007-8#1)
programmed to the##2##3##(1992-5#1)(2008-3#1)
programmed to##7##2##(1992-3#1)(1992-5#1)(2008-1#1)(2008-11#1)(2008-3#2)(2011-2#1)
programmed##160##1##(1990-12#3)(1990-6#1)(1990-8#1)(1991-11#4)(1991-12#5)(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-9#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-9#2)(1994-12#1)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-12#4)(1996-5#3)(1997-1#1)(1997-4#1)(2003-11#3)(2005-1#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-9#2)(2007-10#1)(2007-12#5)(2007-2#1)(2007-8#4)(2008-1#1)(2008-10#20)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#6)(2008-5#1)(2008-7#2)(2008-8#4)(2009-10#2)(2009-2#2)(2009-3#1)(2009-7#1)(2009-8#6)(2009-9#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#5)(2011-2#7)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
programmers##3##1##(1992-4#1)(2007-10#1)(2012-3#1)
programmes across the##2##3##(2009-4#1)(2011-2#1)
programmes aim##2##2##(2005-5#1)(2011-12#1)
programmes aimed at##3##3##(1997-7#1)(2007-6#1)(2012-12#1)
programmes and to##2##3##(2006-2#1)(2013-8#1)
programmes and##22##2##(1991-7#1)(1996-11#1)(1997-4#1)(2005-12#1)(2005-5#2)(2006-10#1)(2006-2#3)(2007-11#1)(2007-6#1)(2008-1#1)(2008-12#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-4#1)(2012-11#1)(2012-12#1)(2013-7#1)(2013-8#1)
programmes are##8##2##(1994-7#1)(1997-8#1)(2005-5#1)(2007-7#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-12#1)
programmes as well as##2##4##(1991-6#1)(2012-2#1)
programmes as##4##2##(1991-6#1)(1991-7#1)(1993-6#1)(2012-2#1)
programmes by##2##2##(2006-10#1)(2008-11#1)
programmes can##2##2##(2008-11#1)(2012-1#1)
programmes covering##2##2##(2005-5#1)(2012-3#1)
programmes do##2##2##(2008-12#1)(2011-2#1)
programmes for disease control##2##4##(2005-5#1)(2009-10#1)
programmes for the prevention of##2##5##(2007-1#1)(2008-10#1)
programmes for the##5##3##(1991-4#1)(2007-1#1)(2008-10#1)(2008-7#1)(2011-1#1)
programmes for##33##2##(1990-6#1)(1991-12#1)(1991-4#1)(1994-12#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-6#1)(2005-5#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-7#1)(2008-8#1)(2009-10#1)(2011-1#4)(2011-2#1)(2013-1#1)(2013-7#4)
programmes have been##2##3##(2007-8#1)(2008-10#1)
programmes have##6##2##(2006-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2012-1#1)
programmes in South##2##3##(2005-5#1)(2010-3#1)
programmes in the##2##3##(2010-3#1)(2012-1#1)
programmes in##16##2##(1991-5#1)(2005-5#2)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-3#2)(2011-1#2)(2011-2#1)(2012-1#1)(2013-7#1)
programmes is important##2##3##(1991-6#1)(2004-3#1)
programmes is##6##2##(1991-6#2)(1997-7#1)(2004-3#1)(2007-7#1)(2013-1#1)
programmes may##2##2##(2006-2#1)(2010-9#1)
programmes must be##2##3##(2010-8#1)(2013-1#1)
programmes must##3##2##(2010-8#1)(2011-2#1)(2013-1#1)
programmes need to##2##3##(1995-12#1)(2008-1#1)
programmes of growth and survival in early##2##7##(1991-3#2)
programmes of##6##2##(1990-5#1)(1991-3#2)(1991-6#1)(2007-6#1)(2008-11#1)
programmes on##2##2##(2011-1#1)(2012-3#1)
programmes or as##2##3##(2006-12#1)(2010-12#1)
programmes or##3##2##(2006-12#1)(2010-12#1)(2012-3#1)
programmes should##3##2##(2007-7#1)(2008-11#1)(2012-3#1)
programmes targeted at##2##3##(2006-5#1)(2012-12#1)
programmes that can be##2##4##(2008-11#1)(2008-12#1)
programmes that provide##2##3##(1992-2#1)(2010-8#1)
programmes that##12##2##(1992-2#1)(1994-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-8#2)(2011-2#1)(2012-1#1)
programmes to##8##2##(1991-4#1)(2004-7#1)(2005-5#1)(2007-7#1)(2008-2#1)(2010-3#1)(2012-12#1)(2013-8#1)
programmes were##8##2##(1994-4#1)(2007-6#1)(2008-10#2)(2011-1#3)(2011-2#1)
programmes which##2##2##(2005-5#1)(2008-12#1)
programmes with##4##2##(1991-4#1)(2005-5#1)(2007-7#1)(2009-7#1)
programmes##320##1##(1990-5#1)(1990-6#1)(1991-12#1)(1991-3#2)(1991-4#4)(1991-5#1)(1991-6#6)(1991-7#3)(1991-8#1)(1992-10#2)(1992-2#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-4#1)(1994-6#1)(1994-7#1)(1995-12#2)(1995-5#1)(1995-9#2)(1996-11#2)(1996-12#1)(1996-2#2)(1996-6#1)(1996-8#1)(1997-4#1)(1997-7#3)(1997-8#1)(2004-3#1)(2004-7#1)(2005-11#2)(2005-12#1)(2005-4#1)(2005-5#17)(2005-7#2)(2005-9#3)(2006-10#4)(2006-11#2)(2006-12#3)(2006-2#8)(2006-4#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#5)(2007-7#14)(2007-8#3)(2008-1#4)(2008-10#12)(2008-11#26)(2008-12#11)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#7)(2009-1#1)(2009-10#1)(2009-2#1)(2009-4#2)(2009-7#2)(2010-12#6)(2010-3#6)(2010-4#3)(2010-8#3)(2010-9#2)(2011-1#26)(2011-12#1)(2011-2#17)(2012-1#5)(2012-11#4)(2012-12#6)(2012-2#1)(2012-3#13)(2013-1#8)(2013-7#6)(2013-8#3)
programming (GP)##2##2##(2008-12#1)(2010-8#1)
programming (LP)##2##2##(2008-11#1)(2008-7#1)
programming and##15##2##(1994-3#1)(1995-1#1)(2005-5#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#2)(2009-3#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2013-1#1)
programming by##2##2##(1996-5#1)(2008-10#1)
programming can be used##2##4##(2008-11#1)(2008-7#1)
programming during##2##2##(2008-10#2)
programming for##6##2##(1992-3#1)(2006-9#1)(2007-11#1)(2008-2#1)(2008-7#1)(2012-12#1)
programming has##2##2##(2007-12#1)(2009-11#1)
programming in##4##2##(2008-10#1)(2008-4#1)(2009-10#1)(2009-9#1)
programming is##3##2##(2008-11#1)(2008-4#1)(2009-7#1)
programming language##4##2##(1996-12#1)(2008-10#2)(2008-3#1)
programming of the##8##3##(1996-12#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-9#1)(2011-2#1)(2013-1#1)
programming of this##2##3##(1996-5#1)(2008-2#1)
programming of##16##2##(1996-12#1)(1996-5#1)(1997-1#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2009-9#2)(2011-2#1)(2012-2#1)(2013-1#1)
programming problems##3##2##(2008-2#3)
programming pulses##4##2##(2007-12#4)
programming the speech processor of##2##5##(2008-9#2)
programming the##4##2##(1996-12#1)(2008-9#3)
programming to##3##2##(2008-11#1)(2008-4#1)(2009-5#1)
programming##150##1##(1990-3#1)(1991-1#1)(1991-6#1)(1992-3#1)(1994-3#2)(1995-1#1)(1996-12#3)(1996-5#2)(1997-1#1)(2005-5#1)(2006-10#2)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#11)(2007-5#1)(2008-10#13)(2008-11#5)(2008-12#1)(2008-2#15)(2008-3#5)(2008-4#7)(2008-7#6)(2008-8#1)(2008-9#13)(2009-10#2)(2009-11#3)(2009-3#3)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#3)(2010-12#4)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#4)(2013-1#4)(2013-8#2)
programming&quot##2##1##(1994-5#1)(2008-3#1)
programming-based##2##1##(2013-7#2)
programs -##2##2##(2007-11#1)(2008-6#1)
programs CSAFIT##2##2##(1992-8#2)
programs across##3##2##(2012-12#2)(2012-3#1)
programs addressing##4##2##(1996-3#1)(2008-1#1)(2008-9#1)(2009-5#1)
programs aimed at##13##3##(1992-4#1)(1992-7#1)(2004-2#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
programs aiming at##2##3##(2008-5#1)(2008-9#1)
programs also##2##2##(1991-10#1)(2008-7#1)
programs and community##2##3##(1997-1#1)(2012-1#1)
programs and for##2##3##(1994-2#1)(2008-10#1)
programs and in##3##3##(1993-2#1)(2007-6#1)(2008-8#1)
programs and information##2##3##(2006-10#1)(2008-1#1)
programs and policies##3##3##(1993-3#1)(2008-7#1)(2009-8#1)
programs and provider##2##3##(2005-8#1)(2012-2#1)
programs and services that##2##4##(1994-12#1)(1994-3#1)
programs and services##9##3##(1991-2#1)(1992-2#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-3#1)(2008-2#1)(2010-12#1)
programs and the##10##3##(1994-10#1)(1995-1#1)(1996-1#1)(2007-12#1)(2008-10#1)(2008-4#1)(2010-12#2)(2011-2#1)(2012-12#1)
programs and their##3##3##(1996-1#1)(2007-10#1)(2008-9#1)
programs and to##6##3##(1991-1#1)(1993-6#1)(1996-1#1)(2007-4#1)(2008-6#1)(2011-2#1)
programs and what##2##3##(1991-1#1)(2013-1#1)
programs and##105##2##(1991-1#4)(1991-2#1)(1991-4#1)(1992-1#1)(1992-2#2)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#4)(1994-3#1)(1995-1#1)(1995-12#2)(1995-3#1)(1996-1#3)(1996-12#2)(1996-4#2)(1996-6#1)(1997-1#1)(2005-10#3)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-5#1)(2007-10#1)(2007-12#2)(2007-2#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-5#1)(2009-8#1)(2009-9#2)(2010-12#3)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
programs are also##2##3##(1995-2#1)(2008-9#1)
programs are based on##3##4##(2007-4#1)(2008-3#1)(2011-3#1)
programs are being##3##3##(1991-12#1)(1992-1#1)(2009-6#1)
programs are described##2##3##(1995-1#1)(2008-4#1)
programs are discussed##3##3##(1995-12#1)(2008-10#1)(2012-11#1)
programs are established##2##3##(2006-2#1)(2009-2#1)
programs are implemented##2##3##(1991-12#1)(2012-12#1)
programs are in##2##3##(2012-12#1)(2012-2#1)
programs are presented##3##3##(1995-1#1)(1997-2#1)(2008-4#1)
programs are the##3##3##(1997-2#1)(2006-5#1)(2010-5#1)
programs are##67##2##(1991-1#1)(1991-12#2)(1991-4#1)(1992-1#3)(1992-3#1)(1993-1#1)(1993-2#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#2)(1995-2#1)(1996-1#2)(1996-3#1)(1997-2#2)(2004-11#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#3)(2008-6#2)(2008-7#2)(2008-9#2)(2009-2#1)(2009-6#1)(2009-7#1)(2010-5#1)(2011-2#3)(2011-3#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
programs around##2##2##(1995-1#1)(1997-2#1)
programs as a##2##3##(1996-6#1)(2008-11#1)
programs as well as##5##4##(1990-7#1)(1994-12#1)(2008-2#1)(2008-8#1)(2009-2#1)
programs as##10##2##(1990-7#1)(1994-12#1)(1995-12#1)(1996-6#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-2#1)(2009-8#1)(2012-11#1)
programs at the##3##3##(1993-6#1)(2007-8#1)(2013-1#1)
programs at##9##2##(1992-12#1)(1993-6#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-4#1)(2009-4#1)(2013-1#1)
programs available##3##2##(1995-2#1)(2008-4#2)
programs based on##2##3##(1996-12#1)(2008-8#1)
programs be##2##2##(1995-3#1)(2006-7#1)
programs by##7##2##(1993-9#1)(1994-4#1)(1996-1#1)(2005-10#1)(2006-12#1)(2008-4#2)
programs can be##9##3##(1993-1#1)(1995-3#1)(2006-1#1)(2008-10#1)(2008-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
programs can##23##2##(1990-12#1)(1991-1#2)(1992-1#1)(1992-3#1)(1993-1#1)(1995-3#1)(1997-1#1)(1997-8#1)(2005-9#1)(2006-1#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
programs dealing with##2##3##(1995-12#1)(2008-10#1)
programs designed to##10##3##(1993-1#1)(1996-12#1)(1996-4#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2010-12#1)
programs designed##12##2##(1993-1#1)(1996-12#1)(1996-4#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2010-12#1)(2013-1#1)
programs do##3##2##(1993-1#1)(1996-6#1)(2008-9#1)
programs focused on##2##3##(1994-12#1)(2009-12#1)
programs focusing on##2##3##(2008-5#1)(2010-11#1)
programs followed##2##2##(1995-5#1)(2007-11#1)
programs for children##2##3##(1995-12#1)(2010-3#1)
programs for clinical##3##3##(1994-12#2)(2008-12#1)
programs for health##2##3##(1994-2#1)(2007-6#1)
programs for high-risk##2##3##(1995-2#1)(2009-11#1)
programs for infants##2##3##(1995-12#1)(2010-10#1)
programs for low-income##2##3##(1992-2#1)(2006-3#1)
programs for patients with##2##4##(2004-3#1)(2013-1#1)
programs for the##15##3##(1991-5#1)(1992-12#1)(1993-3#1)(1994-2#1)(1995-2#1)(1995-3#1)(2004-12#1)(2006-2#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-12#1)
programs for##96##2##(1990-12#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1992-12#2)(1992-2#2)(1993-1#1)(1993-3#1)(1993-6#1)(1994-12#3)(1994-2#2)(1994-3#2)(1995-1#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-9#2)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-8#2)(2004-12#1)(2004-3#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#3)(2007-6#1)(2008-1#2)(2008-10#5)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)
programs has##5##2##(1991-12#1)(1992-1#1)(2007-11#1)(2013-1#2)
programs have a##2##3##(1995-1#1)(2008-12#1)
programs have been developed##2##4##(1994-12#1)(2012-3#1)
programs have been implemented##2##4##(2008-7#1)(2011-9#1)
programs have been shown to improve##2##6##(2009-7#1)(2012-2#1)
programs have been##12##3##(1991-12#1)(1994-12#1)(1995-2#1)(1997-2#1)(2007-11#1)(2008-7#1)(2009-7#1)(2011-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
programs have shown##3##3##(2010-2#1)(2012-1#1)(2012-2#1)
programs have the potential to##2##5##(1997-2#1)(2008-7#1)
programs have##49##2##(1990-10#1)(1990-12#1)(1991-1#1)(1991-12#2)(1992-1#1)(1992-5#1)(1993-6#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#2)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-2#1)(2011-9#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)
programs implemented##2##2##(2008-7#1)(2010-4#1)
programs in Canada##2##3##(1991-3#1)(2008-11#1)
programs in Iran and Turkey##2##5##(2012-11#2)
programs in Italy##2##3##(1990-10#1)(2008-8#1)
programs in TRM##3##3##(2008-1#3)
programs in health administration##10##4##(1991-1#1)(1994-1#1)(1995-1#2)(1996-1#3)(1996-2#1)(1996-3#2)
programs in health care administration##3##5##(1995-1#2)(1996-2#1)
programs in health services administration##2##5##(1996-2#1)(1996-3#1)
programs in health services##3##4##(1992-1#1)(1996-2#1)(1996-3#1)
programs in health##16##3##(1991-1#1)(1992-1#1)(1994-1#1)(1995-1#4)(1996-1#3)(1996-2#3)(1996-3#3)
programs in order to##3##4##(2006-7#1)(2008-10#1)(2012-12#1)
programs in the United States##6##5##(1993-1#1)(1997-2#1)(2008-11#1)(2012-12#1)(2013-1#1)(2013-7#1)
programs in the pharmaceutical industry##2##5##(2008-4#1)(2008-5#1)
programs in the##24##3##(1990-12#1)(1991-2#1)(1993-1#1)(1993-2#1)(1994-1#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-2#1)(2006-10#1)(2008-1#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#2)
programs in their##3##3##(1995-3#1)(1996-3#1)(2008-11#1)
programs in this##2##3##(1995-1#1)(2008-7#1)
programs in##114##2##(1990-10#2)(1990-12#1)(1990-3#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#2)(1992-2#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-1#2)(1994-2#2)(1994-3#1)(1995-1#5)(1995-12#2)(1995-3#1)(1996-1#5)(1996-10#1)(1996-12#1)(1996-2#3)(1996-3#5)(1997-1#2)(1997-2#1)(1997-3#1)(1997-6#1)(2004-11#1)(2005-12#1)(2006-10#2)(2006-7#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#3)(2008-11#6)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-3#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2012-11#5)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)
programs including##3##2##(2008-4#1)(2011-1#1)(2011-2#1)
programs into##2##2##(2007-11#1)(2008-11#1)
programs is a##3##3##(1994-2#1)(2005-11#1)(2007-2#1)
programs is to##2##3##(2006-8#1)(2008-11#1)
programs is##19##2##(1990-12#1)(1991-12#1)(1992-12#1)(1994-2#2)(1994-3#1)(2005-11#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-2#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2011-3#1)
programs like the##2##3##(1994-2#1)(2010-5#1)
programs like##3##2##(1994-2#1)(2010-5#1)(2012-12#1)
programs located in##3##3##(1996-3#1)(2013-1#2)
programs make##2##2##(1991-12#1)(2007-7#1)
programs may be downloaded and run locally on##2##8##(2008-4#1)(2008-9#1)
programs may be##5##3##(1993-9#1)(2007-11#1)(2008-4#1)(2008-9#1)(2012-12#1)
programs may help##2##3##(1993-5#1)(2012-3#1)
programs may##14##2##(1992-12#1)(1993-5#1)(1993-9#1)(1997-2#1)(2006-3#1)(2007-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-6#1)(2012-12#1)(2012-3#1)(2013-1#2)
programs must be##5##3##(1997-2#1)(2006-10#1)(2008-1#1)(2013-1#2)
programs must##10##2##(1991-1#1)(1993-12#1)(1997-2#3)(2006-10#1)(2008-1#1)(2011-2#1)(2013-1#2)
programs of the##5##3##(1995-6#1)(1997-2#1)(2006-10#1)(2007-4#1)(2013-1#1)
programs of this##2##3##(1995-2#1)(2012-3#1)
programs of##23##2##(1990-10#1)(1991-3#1)(1992-3#1)(1995-2#2)(1995-6#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-7#2)(2006-8#1)(2007-4#1)(2008-12#1)(2009-2#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
programs on the##3##3##(2006-3#1)(2007-9#1)(2012-12#1)
programs on##11##2##(1994-3#1)(2004-3#1)(2006-3#1)(2007-11#1)(2007-9#1)(2008-10#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
programs operating in##2##3##(1991-12#1)(1995-3#1)
programs or##3##2##(1992-3#1)(1995-1#1)(2007-10#1)
programs presents##2##2##(2004-12#1)(2007-10#1)
programs provide##6##2##(1995-1#2)(2006-1#1)(2008-11#2)(2009-4#1)
programs remained##2##2##(2007-4#1)(2011-3#1)
programs require##3##2##(2007-9#1)(2012-12#1)(2013-1#1)
programs requires##2##2##(1994-12#1)(1995-2#1)
programs responsible for##2##3##(2010-4#1)(2012-12#1)
programs run##2##2##(1996-5#1)(2008-9#1)
programs serve as a##2##4##(1997-3#1)(2004-3#1)
programs serve as##3##3##(1997-3#1)(2004-3#1)(2011-2#1)
programs should be##6##3##(2007-3#1)(2007-7#1)(2008-7#1)(2009-12#1)(2011-1#1)(2011-2#1)
programs should include##2##3##(1992-2#1)(2007-12#1)
programs should##14##2##(1992-1#1)(1992-2#1)(1997-2#1)(1997-3#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-12#1)(2008-7#1)(2009-12#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-11#1)
programs such as##8##3##(1992-12#1)(1996-3#1)(2006-1#1)(2007-12#1)(2008-10#2)(2010-12#1)(2012-3#1)
programs targeted toward##2##3##(1997-2#1)(2006-7#1)
programs targeting##3##2##(1996-2#1)(2008-11#1)(2008-12#1)
programs than##2##2##(1990-12#1)(2008-2#1)
programs that are##6##3##(1994-1#1)(1994-2#1)(2008-4#1)(2009-7#1)(2012-3#1)(2013-1#1)
programs that encourage##2##3##(2010-4#1)(2012-2#1)
programs that focus on##2##4##(2008-8#1)(2012-3#1)
programs that have proven##2##4##(1996-12#1)(1996-2#1)
programs that include##2##3##(2006-10#1)(2013-1#1)
programs that incorporate##2##3##(2012-12#1)(2012-3#1)
programs that meet##2##3##(1991-1#1)(2007-2#1)
programs that offer##2##3##(1996-1#1)(2004-12#1)
programs that provide##2##3##(1995-1#1)(2008-11#1)
programs that will##3##3##(1997-1#1)(2007-12#1)(2012-12#1)
programs that work##2##3##(1990-12#1)(2012-2#1)
programs that##55##2##(1990-12#2)(1991-1#2)(1993-1#1)(1994-1#2)(1994-2#1)(1994-3#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#1)(2004-12#1)(2004-3#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2008-11#2)(2008-4#3)(2008-6#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#4)
programs the##2##2##(1990-10#1)(2011-2#1)
programs they##3##2##(1991-2#1)(1995-1#1)(1995-3#1)
programs to achieve the##2##4##(1994-12#1)(2006-10#1)
programs to address##3##3##(2006-4#1)(2008-1#1)(2008-8#1)
programs to be##7##3##(1992-12#1)(1992-6#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-10#1)(2010-9#1)
programs to cover##2##3##(1990-12#1)(1991-2#1)
programs to establish##2##3##(2006-10#1)(2007-9#1)
programs to help##2##3##(2007-2#1)(2010-7#1)
programs to improve the##2##4##(2006-12#1)(2008-11#1)
programs to improve##7##3##(1994-3#1)(1997-3#1)(2006-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2013-1#1)
programs to increase##2##3##(1993-11#1)(2005-10#1)
programs to prevent##2##3##(2007-7#1)(2013-1#1)
programs to reduce##4##3##(1993-2#1)(2008-11#1)(2013-1#2)
programs to##80##2##(1990-12#2)(1990-4#1)(1991-2#1)(1992-12#2)(1992-6#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#3)(1995-9#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#2)(1997-8#1)(2004-12#1)(2005-10#1)(2006-10#2)(2006-12#2)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-4#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#1)(2009-5#1)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2013-1#5)
programs under##2##2##(1994-1#1)(1995-3#1)
programs using##4##2##(1995-2#1)(2005-8#1)(2007-11#1)(2012-1#1)
programs was##6##2##(1990-12#1)(1992-2#1)(1995-12#1)(1997-5#1)(2008-10#1)(2012-3#1)
programs were examined##2##3##(2008-10#2)
programs were identified as##2##4##(1996-1#2)
programs were##15##2##(1990-12#1)(1992-12#1)(1995-1#1)(1996-1#2)(1996-5#1)(1997-3#1)(1997-5#1)(2008-10#4)(2008-9#1)(2010-12#1)(2012-12#1)
programs where##3##2##(1995-8#1)(2008-1#1)(2008-11#1)
programs which##3##2##(1991-12#1)(1996-1#1)(2006-1#1)
programs will be##3##3##(1994-1#1)(1994-12#1)(2013-1#1)
programs will##6##2##(1994-1#1)(1994-12#1)(1996-12#1)(1996-6#1)(1997-8#1)(2013-1#1)
programs with the##3##3##(2008-10#1)(2010-9#1)(2013-8#1)
programs with##15##2##(1990-12#1)(1992-1#2)(1992-3#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-5#1)(2010-9#1)(2012-2#1)(2013-8#1)
programs within the##2##3##(2008-7#1)(2012-3#1)
programs within##6##2##(1991-12#1)(1995-1#1)(1997-2#1)(2007-11#1)(2008-7#1)(2012-3#1)
programs without##2##2##(2008-10#1)(2008-9#1)
programs would help##2##3##(1990-2#1)(2010-8#1)
programs would##5##2##(1990-2#1)(1992-12#1)(1994-3#1)(1995-2#1)(2010-8#1)
programs##1570##1##(1990-1#1)(1990-10#8)(1990-12#19)(1990-2#1)(1990-3#1)(1990-4#2)(1990-6#1)(1990-7#1)(1991-1#23)(1991-10#3)(1991-12#17)(1991-2#7)(1991-3#6)(1991-4#4)(1991-5#2)(1991-6#1)(1991-8#1)(1992-1#28)(1992-12#16)(1992-2#15)(1992-3#11)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-1#14)(1993-10#1)(1993-11#2)(1993-12#4)(1993-2#16)(1993-3#7)(1993-5#1)(1993-6#5)(1993-9#3)(1994-1#13)(1994-10#3)(1994-12#16)(1994-2#24)(1994-3#22)(1994-4#1)(1994-6#2)(1994-9#2)(1995-1#36)(1995-12#16)(1995-2#15)(1995-3#21)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#1)(1995-9#4)(1996-1#30)(1996-10#2)(1996-12#19)(1996-2#15)(1996-3#23)(1996-4#3)(1996-5#5)(1996-6#10)(1997-1#11)(1997-2#30)(1997-3#16)(1997-5#7)(1997-6#4)(1997-8#7)(2004-10#2)(2004-11#2)(2004-12#6)(2004-2#2)(2004-3#4)(2004-4#1)(2004-8#2)(2005-10#11)(2005-11#3)(2005-12#1)(2005-4#1)(2005-6#1)(2005-7#1)(2005-8#5)(2005-9#3)(2006-1#5)(2006-10#17)(2006-11#1)(2006-12#4)(2006-2#5)(2006-3#4)(2006-4#7)(2006-5#3)(2006-6#1)(2006-7#9)(2006-8#4)(2006-9#2)(2007-1#3)(2007-10#11)(2007-11#32)(2007-12#24)(2007-2#22)(2007-3#5)(2007-4#18)(2007-5#1)(2007-6#5)(2007-7#14)(2007-8#2)(2007-9#13)(2008-1#19)(2008-10#74)(2008-11#43)(2008-12#20)(2008-2#17)(2008-3#15)(2008-4#38)(2008-5#9)(2008-6#19)(2008-7#23)(2008-8#14)(2008-9#40)(2009-10#1)(2009-11#2)(2009-12#6)(2009-2#4)(2009-3#2)(2009-4#4)(2009-5#6)(2009-6#9)(2009-7#6)(2009-8#7)(2009-9#5)(2010-1#3)(2010-10#5)(2010-11#1)(2010-12#14)(2010-2#5)(2010-3#6)(2010-4#4)(2010-5#8)(2010-6#2)(2010-7#3)(2010-8#2)(2010-9#6)(2011-1#11)(2011-12#5)(2011-2#46)(2011-3#7)(2011-9#1)(2012-1#10)(2012-11#17)(2012-12#37)(2012-2#40)(2012-3#22)(2013-1#68)(2013-7#7)(2013-8#7)
programs'##3##1##(1997-3#1)(2007-11#1)(2012-3#1)
programs)##4##1##(1994-1#1)(2007-4#1)(2009-1#1)(2011-2#1)
programs?##2##1##(1991-4#1)(2012-3#1)
programs]##4##1##(1992-8#1)(2007-6#1)(2008-9#1)(2011-3#1)
progranulin gene##2##2##(2008-9#1)(2011-1#1)
progranulin##3##1##(2008-9#2)(2011-1#1)
progres##2##1##(2007-11#1)(2007-6#1)
progress achieved in##2##3##(2006-10#1)(2008-1#1)
progress achieved##4##2##(2006-10#3)(2008-1#1)
progress after##2##2##(2006-6#1)(2008-10#1)
progress and final##2##3##(2006-4#1)(2008-10#1)
progress and people##2##3##(2008-10#2)
progress and problems##3##3##(1991-3#1)(2007-2#1)(2010-12#1)
progress and response to therapy in##2##6##(1995-1#2)
progress and the##3##3##(2005-11#1)(2007-10#1)(2009-3#1)
progress and##36##2##(1991-3#1)(1991-5#1)(1993-6#1)(1994-12#1)(1995-1#2)(1996-3#1)(1997-6#1)(2005-11#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-10#5)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#2)(2011-1#2)(2011-2#2)(2012-1#1)
progress are##6##2##(1997-2#1)(2005-6#1)(2007-11#1)(2008-10#1)(2012-2#1)(2012-3#1)
progress as well as##2##4##(2010-12#1)(2011-12#1)
progress as##4##2##(1996-11#1)(2010-12#1)(2011-12#1)(2012-2#1)
progress at##5##2##(1991-2#1)(2006-10#1)(2007-11#2)(2012-2#1)
progress based on the##2##4##(2008-10#2)
progress being made in##3##4##(2005-8#1)(2005-9#1)(2006-10#1)
progress being made##4##3##(2005-8#1)(2005-9#1)(2006-10#1)(2008-5#1)
progress can be achieved by##2##5##(2006-10#1)(2013-8#1)
progress can be made##2##4##(2008-8#1)(2011-1#1)
progress can be##4##3##(2006-10#1)(2008-8#1)(2011-1#1)(2013-8#1)
progress continues to be made##2##5##(2008-9#1)(2010-4#1)
progress could be##2##3##(2006-4#1)(2008-11#1)
progress could##3##2##(2006-4#1)(2008-11#1)(2012-2#1)
progress curve##36##2##(2008-10#36)
progress curves and##4##3##(1997-6#1)(2008-10#3)
progress curves were##3##3##(2008-10#3)
progress curves##17##2##(1990-5#1)(1991-5#1)(1992-6#1)(1992-8#1)(1997-6#1)(2008-10#12)
progress during the last##2##4##(1996-4#1)(2005-6#1)
progress during the##4##3##(1996-4#1)(2005-6#1)(2008-5#1)(2008-9#1)
progress during##7##2##(1990-9#1)(1992-3#1)(1996-4#1)(2005-6#1)(2007-9#1)(2008-5#1)(2008-9#1)
progress feedback##3##2##(2012-2#3)
progress for##6##2##(2005-8#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-5#1)
progress from##3##2##(2007-12#1)(2008-10#1)(2010-3#1)
progress has been achieved in the##5##6##(1997-7#1)(2008-12#1)(2008-7#2)(2010-12#1)
progress has been achieved in##8##5##(1997-6#1)(1997-7#1)(2006-10#1)(2008-12#1)(2008-7#2)(2010-12#1)(2012-11#1)
progress has been achieved##10##4##(1995-5#1)(1997-6#1)(1997-7#1)(2006-10#2)(2008-12#1)(2008-7#2)(2010-12#1)(2012-11#1)
progress has been made by##2##5##(2010-12#1)(2011-1#1)
progress has been made in developing and##2##7##(2007-12#1)(2009-8#1)
progress has been made in developing##3##6##(2005-7#1)(2007-12#1)(2009-8#1)
progress has been made in improving##2##6##(2008-1#1)(2011-1#1)
progress has been made in reducing##2##6##(1997-1#1)(2012-12#1)
progress has been made in the development of##2##8##(2005-7#1)(2008-7#1)
progress has been made in the field of##2##8##(2006-10#2)
progress has been made in the treatment of##3##8##(2006-9#1)(2009-5#1)(2010-11#1)
progress has been made in the understanding of the molecular basis of##2##12##(1995-11#1)(2008-11#1)
progress has been made in the understanding of the##3##9##(1995-11#1)(2006-8#1)(2008-11#1)
progress has been made in the understanding of##6##8##(1992-2#1)(1995-11#1)(2006-8#1)(2008-11#2)(2008-7#1)
progress has been made in the##21##6##(1992-2#1)(1995-11#1)(2005-7#3)(2006-10#4)(2006-8#1)(2006-9#1)(2008-11#3)(2008-7#2)(2008-9#1)(2009-12#1)(2009-5#1)(2010-11#1)(2012-11#1)
progress has been made in understanding##4##6##(1993-11#1)(2006-10#1)(2008-5#1)(2011-2#1)
progress has been made in##49##5##(1992-2#1)(1992-7#1)(1993-11#1)(1995-11#1)(1997-1#1)(2004-11#1)(2005-7#4)(2006-10#6)(2006-4#2)(2006-6#1)(2006-8#3)(2006-9#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)
progress has been made over the past##3##7##(2006-10#1)(2007-11#1)(2008-7#1)
progress has been made over the##4##6##(2006-10#1)(2007-11#1)(2008-1#1)(2008-7#1)
progress has been made to##3##5##(2007-7#1)(2011-1#1)(2012-3#1)
progress has been made toward the##2##6##(2008-3#1)(2010-9#1)
progress has been made toward##3##5##(2007-12#1)(2008-3#1)(2010-9#1)
progress has been made towards##2##5##(2008-7#1)(2012-2#1)
progress has been made with##2##5##(2006-10#1)(2008-7#1)
progress has been made##74##4##(1990-9#1)(1992-2#1)(1992-7#1)(1993-10#1)(1993-11#1)(1993-6#1)(1995-11#1)(1996-1#1)(1997-1#1)(2004-11#1)(2005-7#4)(2006-10#8)(2006-4#2)(2006-6#1)(2006-8#3)(2006-9#1)(2007-11#3)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#5)(2008-3#2)(2008-5#1)(2008-7#7)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
progress has been##90##3##(1990-9#2)(1992-2#1)(1992-7#1)(1993-10#1)(1993-11#1)(1993-6#1)(1995-11#1)(1995-5#1)(1996-1#1)(1997-1#1)(1997-6#1)(1997-7#1)(2004-11#1)(2005-7#4)(2006-10#11)(2006-4#2)(2006-6#1)(2006-8#3)(2006-9#2)(2007-11#3)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#5)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#9)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
progress has resulted in##2##4##(2006-11#1)(2008-7#1)
progress has##99##2##(1990-9#2)(1992-2#1)(1992-7#1)(1993-10#1)(1993-11#1)(1993-6#1)(1995-11#1)(1995-5#1)(1996-1#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2004-11#1)(2005-7#4)(2006-10#12)(2006-11#1)(2006-4#2)(2006-6#1)(2006-8#3)(2006-9#2)(2007-11#3)(2007-12#2)(2007-7#2)(2008-1#2)(2008-10#3)(2008-11#5)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#10)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#1)(2012-11#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-8#1)
progress have been##2##3##(2008-5#1)(2011-2#1)
progress in all##3##3##(1997-8#1)(2005-7#1)(2007-11#1)
progress in clinical trials##2##4##(1991-12#1)(2005-7#1)
progress in clinical##3##3##(1991-12#1)(2005-7#1)(2010-12#1)
progress in determining##2##3##(1995-2#1)(2008-11#1)
progress in developing##2##3##(2005-8#1)(2008-6#1)
progress in development##2##3##(2010-10#1)(2011-2#1)
progress in early##2##3##(1990-2#1)(2010-12#1)
progress in elucidating the##4##4##(2007-8#1)(2008-1#1)(2008-8#1)(2013-8#1)
progress in elucidating##5##3##(2007-8#1)(2008-1#1)(2008-8#1)(2009-7#1)(2013-8#1)
progress in identifying##2##3##(2008-10#1)(2009-5#1)
progress in learning##2##3##(2008-11#2)
progress in medicine##3##3##(2006-6#1)(2008-5#1)(2009-4#1)
progress in molecular biology##2##4##(2006-10#1)(2012-12#1)
progress in molecular##3##3##(2006-10#1)(2012-12#1)(2013-8#1)
progress in new##2##3##(2006-10#1)(2013-8#1)
progress in our understanding of the##6##6##(2005-10#1)(2006-10#1)(2007-8#1)(2008-11#2)(2013-8#1)
progress in our understanding of##8##5##(2005-10#1)(2006-10#1)(2007-8#1)(2008-11#2)(2010-12#1)(2013-8#2)
progress in our understanding##9##4##(2005-10#1)(2006-10#1)(2007-8#1)(2008-11#2)(2010-12#1)(2010-6#1)(2013-8#2)
progress in our##11##3##(1994-9#1)(2005-10#1)(2006-10#1)(2007-8#1)(2008-11#2)(2009-3#1)(2010-12#1)(2010-6#1)(2013-8#2)
progress in recent years##2##4##(1994-10#1)(2013-8#1)
progress in recent##3##3##(1994-10#1)(2012-3#1)(2013-8#1)
progress in rehabilitation##3##3##(2007-11#2)(2007-7#1)
progress in researches of##2##4##(2013-8#2)
progress in studying##2##3##(2006-10#1)(2008-8#1)
progress in the area of##5##5##(1994-11#1)(1997-6#1)(2006-10#1)(2006-6#1)(2012-12#1)
progress in the development of HIV-1 fusion##2##7##(2011-3#2)
progress in the development of##11##5##(2007-8#2)(2008-10#4)(2008-8#1)(2011-2#1)(2011-3#2)(2013-1#1)
progress in the development##13##4##(1994-3#1)(2007-8#2)(2008-10#4)(2008-8#1)(2011-2#1)(2011-3#2)(2013-1#2)
progress in the diagnosis##2##4##(2007-3#1)(2012-3#1)
progress in the discovery##2##4##(2005-9#1)(2013-1#1)
progress in the field of##4##5##(2006-10#1)(2009-10#1)(2009-4#1)(2010-12#1)
progress in the field##8##4##(1993-6#1)(2006-10#1)(2007-5#1)(2009-10#1)(2009-4#1)(2010-12#1)(2011-1#1)(2012-2#1)
progress in the treatment of##4##5##(1996-6#1)(1997-4#1)(2007-11#1)(2010-3#1)
progress in the understanding of the##4##6##(1991-2#1)(2005-11#1)(2008-5#1)(2009-4#1)
progress in the understanding of##6##5##(1991-2#1)(2005-11#1)(2006-10#2)(2008-5#1)(2009-4#1)
progress in the use of##5##5##(2006-10#2)(2007-8#1)(2008-11#1)(2010-10#1)
progress in the##79##3##(1990-10#1)(1990-7#1)(1991-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-9#1)(1996-3#1)(1996-6#1)(1997-4#1)(1997-6#1)(2005-11#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#6)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#4)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-4#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#3)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
progress in these##3##3##(2008-1#1)(2008-9#1)(2010-7#1)
progress in this area##2##4##(2007-5#1)(2008-12#1)
progress in this field##5##4##(1993-3#1)(2005-8#1)(2005-9#1)(2008-10#1)(2013-8#1)
progress in this##9##3##(1993-3#1)(2005-8#1)(2005-9#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-8#1)
progress in understanding some of the##2##6##(2007-8#1)(2012-11#1)
progress in understanding the molecular basis##2##6##(1994-3#1)(2008-11#1)
progress in understanding the##6##4##(1994-3#1)(2007-12#1)(2008-11#1)(2008-7#1)(2010-12#1)(2012-2#1)
progress in understanding##12##3##(1994-3#1)(2006-10#2)(2007-12#1)(2007-8#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-11#1)(2012-2#2)
progress in##236##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-5#1)(1992-6#1)(1993-3#2)(1993-5#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-3#4)(1994-6#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-4#2)(1997-6#1)(1997-8#1)(2005-10#2)(2005-11#2)(2005-4#1)(2005-7#4)(2005-8#4)(2005-9#2)(2006-10#15)(2006-11#1)(2006-4#2)(2006-6#4)(2007-11#8)(2007-12#3)(2007-3#1)(2007-5#2)(2007-7#2)(2007-8#8)(2007-9#1)(2008-1#7)(2008-10#12)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#8)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#2)(2009-10#3)(2009-3#2)(2009-4#5)(2009-5#2)(2009-7#3)(2009-8#1)(2010-10#3)(2010-11#2)(2010-12#7)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#7)(2011-2#9)(2011-3#2)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#6)(2013-8#12)
progress into the##2##3##(2005-7#1)(2008-7#1)
progress into##9##2##(1990-7#1)(2005-7#1)(2005-8#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-1#1)(2011-12#1)(2013-7#1)
progress is being made in##3##5##(1997-8#1)(2006-10#1)(2012-12#1)
progress is being made##5##4##(1993-2#1)(1997-8#1)(2006-10#2)(2012-12#1)
progress is to##2##3##(2006-11#1)(2008-5#1)
progress is##17##2##(1990-10#1)(1993-2#1)(1994-2#1)(1997-4#1)(1997-8#1)(2006-10#5)(2006-11#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
progress made by the##2##4##(2008-11#1)(2010-9#1)
progress made by##5##3##(2008-11#1)(2008-9#1)(2010-9#1)(2012-3#2)
progress made during the##2##4##(2006-10#1)(2013-1#1)
progress made in the##6##4##(2008-10#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-12#2)
progress made in understanding##3##4##(2009-2#1)(2011-1#1)(2012-2#1)
progress made in##12##3##(2005-8#1)(2008-10#1)(2008-5#2)(2009-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)
progress made toward##2##3##(2006-10#1)(2012-3#1)
progress made towards##4##3##(2006-10#2)(2006-8#1)(2008-11#1)
progress made##27##2##(2005-8#1)(2006-10#5)(2006-8#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-9#1)(2009-2#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#1)
progress monitoring##8##2##(2008-12#1)(2011-2#7)
progress notes##3##2##(2007-3#1)(2013-1#2)
progress of gene##2##3##(2005-9#1)(2013-7#1)
progress of maturity##2##3##(2008-10#1)(2009-9#1)
progress of research##3##3##(2008-10#1)(2010-10#1)(2013-8#1)
progress of the disease##7##4##(1993-11#1)(1993-5#1)(2007-7#3)(2008-7#1)(2011-1#1)
progress of the##20##3##(1991-9#1)(1992-7#1)(1993-11#1)(1993-5#1)(1996-4#1)(2004-11#1)(2005-11#1)(2006-10#1)(2007-7#3)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
progress of their##2##3##(2005-7#1)(2006-7#1)
progress of these##2##3##(2008-10#1)(2010-10#1)
progress of##103##2##(1991-9#2)(1992-7#1)(1993-11#1)(1993-3#1)(1993-5#1)(1994-5#1)(1995-1#1)(1995-6#1)(1996-11#1)(1996-4#1)(1996-5#2)(1997-2#1)(1997-5#1)(1997-8#1)(2004-11#1)(2005-11#2)(2005-5#1)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#5)(2006-12#2)(2006-4#1)(2006-7#1)(2007-11#3)(2007-2#1)(2007-7#3)(2007-8#2)(2008-10#18)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-4#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#3)
progress on the##5##3##(1995-11#1)(2006-10#1)(2007-11#1)(2011-2#1)(2012-3#1)
progress on##18##2##(1995-1#1)(1995-11#1)(1996-1#1)(2006-10#1)(2007-11#2)(2008-10#3)(2008-12#1)(2009-7#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#1)
progress over the last##3##4##(1996-11#1)(2007-10#1)(2010-12#1)
progress over the past 25 years##2##6##(2007-12#1)(2012-2#1)
progress over the##5##3##(1996-11#1)(2007-10#1)(2007-12#1)(2010-12#1)(2012-2#1)
progress over##6##2##(1996-11#1)(2007-10#1)(2007-12#1)(2008-10#1)(2010-12#1)(2012-2#1)
progress recently##2##2##(2007-7#1)(2011-1#1)
progress relentlessly##2##2##(2007-6#1)(2008-1#1)
progress report##6##2##(1992-12#1)(1996-2#1)(2008-7#1)(2010-10#1)(2012-11#2)
progress signal##2##2##(2008-11#2)
progress so##2##2##(2008-7#1)(2011-2#1)
progress that has been made in the##2##7##(2006-12#1)(2007-6#1)
progress that has been made in understanding the##3##8##(2008-11#1)(2009-7#1)(2011-1#1)
progress that has been made in##6##6##(2006-12#1)(2007-6#1)(2008-11#1)(2008-8#1)(2009-7#1)(2011-1#1)
progress that has been made##8##5##(2006-12#1)(2007-6#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-1#1)
progress that has been##10##4##(2006-12#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-1#2)
progress that has##11##3##(2006-10#1)(2006-12#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-1#2)
progress that##13##2##(2006-10#1)(2006-12#1)(2007-6#1)(2008-1#2)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-7#1)(2011-1#2)
progress through the##6##3##(1990-8#1)(1993-11#1)(1993-12#1)(1996-1#1)(2009-3#1)(2011-1#1)
progress through##11##2##(1990-8#1)(1993-11#1)(1993-12#1)(1993-5#1)(1996-1#1)(2008-11#1)(2009-10#1)(2009-3#1)(2010-10#1)(2010-9#1)(2011-1#1)
progress to AIDS##2##3##(1997-3#1)(2012-2#1)
progress to a##4##3##(1994-8#1)(2005-10#1)(2009-10#1)(2013-1#1)
progress to be made in##2##5##(1992-9#1)(2008-4#1)
progress to cirrhosis##2##3##(2005-10#1)(2010-12#1)
progress to date in##4##4##(1997-2#1)(2008-1#1)(2008-12#1)(2011-1#1)
progress to develop##2##3##(2008-10#1)(2009-8#1)
progress to know##2##3##(2008-12#1)(2010-10#1)
progress to the##2##3##(1995-1#1)(2008-11#1)
progress to##59##2##(1991-9#1)(1992-5#1)(1992-9#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-7#1)(1996-4#1)(1997-2#2)(1997-3#1)(1997-4#1)(2004-11#1)(2005-10#4)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#3)(2011-2#2)(2012-11#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
progress toward the##2##3##(2006-10#1)(2007-12#1)
progress toward understanding##2##3##(2006-4#1)(2007-11#1)
progress toward##17##2##(1996-2#1)(1996-3#1)(1997-1#1)(2006-10#4)(2006-4#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-12#1)(2010-3#1)
progress towards a##2##3##(1996-1#1)(2008-4#1)
progress towards the development of##2##5##(2005-8#2)
progress towards##15##2##(1993-9#1)(1996-1#1)(2005-10#1)(2005-8#3)(2006-10#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-1#2)
progress was##11##2##(2006-8#1)(2006-9#1)(2008-10#4)(2009-2#1)(2010-1#1)(2010-2#1)(2012-2#1)(2013-8#1)
progress were##3##2##(2005-9#1)(2008-10#2)
progress will##5##2##(2006-10#2)(2006-2#1)(2007-8#1)(2008-8#1)
progress with##10##2##(2005-11#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-11#2)(2008-1#1)(2010-11#1)(2011-2#1)(2012-12#1)
progress##1020##1##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#3)(1990-7#2)(1990-8#1)(1990-9#3)(1991-12#4)(1991-2#3)(1991-3#3)(1991-5#2)(1991-9#3)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#3)(1992-7#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#4)(1993-12#2)(1993-2#2)(1993-3#3)(1993-5#3)(1993-6#3)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#5)(1994-5#3)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#6)(1995-11#3)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#5)(1996-11#5)(1996-12#1)(1996-2#2)(1996-3#5)(1996-4#3)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#3)(1997-4#4)(1997-5#2)(1997-6#4)(1997-7#2)(1997-8#4)(2004-11#3)(2005-10#7)(2005-11#6)(2005-4#1)(2005-5#1)(2005-6#2)(2005-7#14)(2005-8#14)(2005-9#6)(2006-10#61)(2006-11#4)(2006-12#7)(2006-2#4)(2006-3#2)(2006-4#8)(2006-5#1)(2006-6#8)(2006-7#2)(2006-8#8)(2006-9#4)(2007-10#3)(2007-11#34)(2007-12#10)(2007-2#4)(2007-3#3)(2007-4#1)(2007-5#3)(2007-6#3)(2007-7#9)(2007-8#17)(2007-9#5)(2008-1#18)(2008-10#121)(2008-11#34)(2008-12#11)(2008-2#5)(2008-3#10)(2008-4#7)(2008-5#24)(2008-6#8)(2008-7#35)(2008-8#19)(2008-9#16)(2009-10#10)(2009-12#2)(2009-2#4)(2009-3#5)(2009-4#7)(2009-5#6)(2009-6#1)(2009-7#7)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#9)(2010-11#5)(2010-12#16)(2010-2#3)(2010-3#4)(2010-4#2)(2010-5#5)(2010-6#3)(2010-7#5)(2010-8#5)(2010-9#5)(2011-1#34)(2011-12#3)(2011-2#33)(2011-3#3)(2012-1#5)(2012-11#6)(2012-12#18)(2012-2#26)(2012-3#13)(2013-1#21)(2013-7#4)(2013-8#24)
progress)##3##1##(2008-10#1)(2008-4#1)(2012-3#1)
progress?##4##1##(1994-10#1)(2006-4#1)(2008-9#1)(2012-1#1)
progressed and the patient##2##4##(2007-4#1)(2012-1#1)
progressed and the##3##3##(1996-3#1)(2007-4#1)(2012-1#1)
progressed and##5##2##(1996-3#1)(2007-4#1)(2010-11#1)(2012-1#1)(2013-1#1)
progressed during treatment##2##3##(1991-12#1)(2008-5#1)
progressed during##4##2##(1991-12#1)(2006-6#1)(2007-8#1)(2008-5#1)
progressed for the##2##3##(1991-7#1)(2008-10#1)
progressed for##3##2##(1991-7#1)(1992-5#1)(2008-10#1)
progressed from##13##2##(1993-2#1)(2005-8#1)(2007-12#2)(2008-10#1)(2008-8#1)(2008-9#1)(2010-6#1)(2010-7#1)(2012-1#2)(2013-1#2)
progressed in the##3##3##(1992-3#1)(2007-11#1)(2008-10#1)
progressed in##9##2##(1992-3#1)(1997-3#1)(2006-2#1)(2007-11#2)(2008-10#1)(2008-4#1)(2012-1#2)
progressed on treatment##2##3##(2008-6#1)(2008-7#1)
progressed rapidly##6##2##(1990-9#1)(2004-12#1)(2007-12#1)(2008-8#1)(2009-6#1)(2011-1#1)
progressed significantly##2##2##(1991-5#1)(2008-5#1)
progressed through four##2##3##(1996-3#1)(2010-11#1)
progressed through##8##2##(1996-3#1)(1996-8#1)(2004-12#1)(2008-10#1)(2008-11#1)(2010-11#1)(2011-2#1)(2012-12#1)
progressed to a##3##3##(1995-2#1)(2008-3#1)(2010-3#1)
progressed to advanced sclerosis##2##4##(2008-1#2)
progressed to the##3##3##(2007-9#1)(2008-10#1)(2008-5#1)
progressed to##30##2##(1993-12#1)(1994-12#1)(1995-2#1)(1997-3#2)(2007-11#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-1#6)(2008-10#2)(2008-3#1)(2008-5#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#2)(2011-1#2)(2012-2#2)
progressed with##4##2##(2008-12#1)(2008-5#1)(2011-2#2)
progressed##134##1##(1990-10#1)(1990-2#1)(1990-6#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1993-12#1)(1993-2#2)(1993-7#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-2#2)(1995-5#1)(1996-3#2)(1996-8#1)(1997-3#4)(2004-12#2)(2005-7#1)(2005-8#1)(2006-12#2)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#2)(2007-8#1)(2007-9#2)(2008-1#7)(2008-10#12)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-6#2)(2009-8#2)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-6#3)(2010-7#1)(2011-1#4)(2011-2#4)(2012-1#6)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
progresses and##2##2##(2008-11#1)(2008-12#1)
progresses during##2##2##(1993-10#1)(2004-2#1)
progresses have been made##2##4##(2008-10#1)(2008-5#1)
progresses in the##4##3##(2007-6#1)(2007-8#1)(2008-1#1)(2008-8#1)
progresses in##6##2##(2007-6#1)(2007-8#1)(2008-1#1)(2008-8#1)(2009-12#1)(2011-2#1)
progresses through##2##2##(1997-1#1)(2013-1#1)
progresses to fibrosis##2##3##(2005-8#1)(2011-2#1)
progresses to##8##2##(2005-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2010-12#1)(2010-5#1)(2011-2#2)
progresses toward##2##2##(1996-1#1)(2012-1#1)
progresses towards##2##2##(2013-1#1)(2013-8#1)
progresses##55##1##(1993-10#1)(1994-3#1)(1994-5#1)(1996-1#1)(1997-1#1)(2004-2#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#2)(2008-7#2)(2008-8#3)(2009-12#1)(2010-12#2)(2010-5#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#3)
progressing during##2##2##(2008-7#1)(2009-2#1)
progressing to##16##2##(1990-3#1)(1993-1#1)(1996-3#1)(2006-10#1)(2006-12#1)(2007-3#1)(2008-1#2)(2008-10#1)(2008-2#1)(2009-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)
progressing toward##2##2##(1993-3#1)(2008-2#1)
progressing##61##1##(1990-3#1)(1990-4#1)(1990-8#2)(1991-1#1)(1993-1#1)(1993-11#1)(1993-3#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-8#1)(2004-9#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#3)(2007-11#2)(2007-12#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-2#3)(2008-7#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2010-12#2)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#3)(2013-1#1)(2013-7#1)
progression (TTP) was##2##3##(2006-12#1)(2009-4#1)
progression (TTP)##4##2##(2004-1#1)(2006-12#1)(2008-10#1)(2009-4#1)
progression after##3##2##(1991-6#1)(1994-8#1)(2013-8#1)
progression and a##3##3##(2004-11#1)(2009-12#1)(2009-9#1)
progression and axial eye growth##2##5##(2010-1#2)
progression and development of##2##4##(2004-11#1)(2011-1#1)
progression and died##2##3##(1992-10#2)
progression and metastasis##7##3##(1997-4#1)(1997-7#1)(2009-3#1)(2009-9#1)(2012-1#1)(2012-12#1)(2012-2#1)
progression and prognosis##2##3##(2007-6#1)(2011-1#1)
progression and regression of##2##4##(1995-8#1)(2007-8#1)
progression and subsequent##2##3##(1992-10#1)(2012-2#1)
progression and survival##4##3##(1991-4#1)(1995-2#1)(2008-7#1)(2013-8#1)
progression and the##8##3##(1994-10#1)(1995-12#1)(1996-8#1)(2007-2#1)(2008-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
progression and treatment of##2##4##(2007-12#1)(2013-8#1)
progression and treatment##4##3##(2007-12#2)(2010-11#1)(2013-8#1)
progression and##105##2##(1990-12#1)(1991-10#1)(1991-4#2)(1991-9#1)(1992-10#3)(1992-8#1)(1994-10#1)(1994-12#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-8#1)(1997-4#1)(1997-7#1)(2003-11#1)(2004-11#2)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#3)(2009-10#1)(2009-12#1)(2009-3#3)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#2)(2010-1#2)(2010-11#1)(2010-12#2)(2010-4#2)(2010-7#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#6)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#6)
progression and/or##2##2##(2008-8#1)(2010-12#1)
progression are not##2##3##(2006-10#1)(2008-12#1)
progression are##5##2##(2006-10#1)(2007-10#1)(2008-12#1)(2008-8#1)(2009-3#1)
progression as well as##4##4##(2008-9#1)(2010-12#1)(2013-7#1)(2013-8#1)
progression as##5##2##(2008-9#1)(2009-6#1)(2010-12#1)(2013-7#1)(2013-8#1)
progression at 5 years##2##4##(1991-4#1)(2013-1#1)
progression at the##4##3##(1995-2#1)(2007-7#1)(2008-9#1)(2013-1#1)
progression at##9##2##(1991-4#1)(1995-2#1)(1996-2#1)(2007-7#1)(2008-9#1)(2010-3#1)(2012-3#1)(2013-1#2)
progression between##2##2##(2008-11#1)(2011-3#1)
progression but##4##2##(1991-5#1)(2007-11#1)(2008-5#1)(2011-2#1)
progression by##9##2##(1995-9#1)(1997-7#1)(2008-1#1)(2008-4#1)(2009-3#1)(2011-1#1)(2011-2#2)(2013-8#1)
progression can be##3##3##(1992-12#1)(1992-9#1)(2010-12#1)
progression can##4##2##(1992-12#1)(1992-9#1)(1995-2#1)(2010-12#1)
progression during##4##2##(1993-11#1)(2006-11#1)(2010-3#1)(2012-3#1)
progression factor##2##2##(1992-11#1)(1993-6#1)
progression factors##2##2##(1994-3#1)(2008-6#1)
progression for##7##2##(1991-4#1)(2006-6#1)(2007-8#1)(2008-6#1)(2012-3#2)(2013-8#1)
progression free survival##3##3##(2008-10#3)
progression free##4##2##(2008-10#3)(2008-3#1)
progression from G0##2##3##(1990-11#1)(1995-2#1)
progression from the##4##3##(1991-9#1)(2007-5#1)(2007-6#1)(2013-8#1)
progression from##20##2##(1990-11#1)(1991-9#1)(1995-2#1)(2006-10#3)(2007-11#1)(2007-5#2)(2007-6#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-2#2)(2013-8#1)
progression has been reported##2##4##(2006-6#1)(2012-12#1)
progression has been##5##3##(2006-6#1)(2007-11#2)(2012-12#1)(2012-3#1)
progression has##8##2##(1993-7#1)(2005-11#1)(2006-6#1)(2007-11#2)(2009-3#1)(2012-12#1)(2012-3#1)
progression have been##2##3##(2007-11#1)(2008-1#1)
progression have##3##2##(2007-11#2)(2008-1#1)
progression in human##3##3##(1992-9#1)(1997-1#1)(2013-8#1)
progression in multiple sclerosis (MS)##2##5##(2008-12#1)(2012-2#1)
progression in the##9##3##(2007-10#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-10#1)(2011-12#1)(2012-1#1)(2013-1#2)
progression in yeast##3##3##(1993-6#1)(1996-3#1)(2009-6#1)
progression in##70##2##(1990-5#1)(1991-4#1)(1991-5#1)(1992-6#1)(1992-9#2)(1993-6#1)(1993-9#2)(1994-5#1)(1994-8#1)(1996-3#1)(1997-1#2)(1997-3#1)(2004-1#1)(2005-1#1)(2005-2#1)(2005-8#1)(2007-10#1)(2007-11#3)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-5#2)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2012-8#3)(2013-1#6)(2013-8#3)
progression is##13##2##(1993-6#1)(1995-8#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-11#1)(2009-10#1)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
progression may##4##2##(1994-8#1)(2008-1#1)(2009-4#1)(2010-4#1)
progression model##3##2##(1993-6#1)(2010-7#2)
progression of ARM in##2##4##(2011-2#2)
progression of ARM##3##3##(2011-2#3)
progression of CKD and##2##4##(2013-8#2)
progression of DR##4##3##(2008-1#3)(2011-2#1)
progression of HIV##3##3##(1993-7#1)(1993-9#1)(2009-5#1)
progression of HPV infection##2##4##(2007-12#1)(2011-3#1)
progression of OA##2##3##(2005-8#1)(2013-1#1)
progression of a##8##3##(1991-7#1)(2007-2#1)(2007-9#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
progression of atherosclerosis in patients with##2##6##(2008-1#1)(2011-2#1)
progression of atherosclerosis in##3##4##(2008-1#2)(2011-2#1)
progression of atherosclerosis##15##3##(1993-12#1)(1995-1#1)(1995-12#1)(1995-6#1)(2007-10#1)(2008-1#5)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-7#1)
progression of atherosclerotic plaque##2##4##(1991-7#1)(2008-5#1)
progression of atherosclerotic##3##3##(1991-7#1)(2006-6#1)(2008-5#1)
progression of breast cancer##7##4##(1996-3#1)(2007-11#1)(2008-4#1)(2009-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
progression of cancer##4##3##(1993-9#1)(2006-11#1)(2011-2#1)(2013-1#1)
progression of cancers##2##3##(2006-9#1)(2008-3#1)
progression of cardiac##3##3##(2010-6#1)(2011-2#2)
progression of cell##5##3##(1996-4#2)(1997-1#1)(2008-8#1)(2010-7#1)
progression of chronic renal disease##2##5##(1994-3#1)(2008-1#1)
progression of chronic renal failure##2##5##(2006-9#1)(2008-1#1)
progression of chronic renal##7##4##(1994-3#1)(2006-8#2)(2006-9#1)(2008-1#3)
progression of chronic##11##3##(1994-3#1)(1997-7#2)(2005-7#1)(2006-8#2)(2006-9#1)(2008-1#3)(2009-8#1)
progression of colorectal cancer##4##4##(1994-6#1)(2008-11#1)(2008-4#1)(2009-4#1)
progression of coronary artery disease##4##5##(1996-1#1)(1996-3#1)(2007-8#1)(2009-11#1)
progression of coronary atherosclerosis##4##4##(1991-7#1)(1995-12#2)(2005-12#1)
progression of coronary##9##3##(1991-7#1)(1995-12#2)(1996-1#1)(1996-3#1)(1996-5#1)(2005-12#1)(2007-8#1)(2009-11#1)
progression of curvature##4##3##(2007-7#1)(2007-8#3)
progression of diabetic nephropathy##5##4##(1992-6#1)(2007-11#2)(2009-11#2)
progression of diabetic##10##3##(1992-6#1)(1997-6#2)(2007-11#3)(2008-1#1)(2009-11#2)(2011-2#1)
progression of disability##4##3##(2007-11#3)(2008-7#1)
progression of disease and##3##4##(1992-12#1)(2006-8#1)(2009-11#1)
progression of disease during##2##4##(1991-2#1)(1994-8#1)
progression of disease##19##3##(1990-10#1)(1990-8#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-2#1)(1994-8#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-11#1)(2013-1#2)
progression of fibrosis##2##3##(2006-6#1)(2012-12#1)
progression of gastric cancer##2##4##(2007-11#1)(2011-2#1)
progression of gastric##3##3##(2007-11#1)(2011-2#2)
progression of his##2##3##(2010-6#1)(2011-2#1)
progression of human##4##3##(2007-11#2)(2007-12#1)(2008-7#1)
progression of illness##2##3##(2006-6#1)(2006-9#1)
progression of injury##3##3##(1995-11#1)(1997-3#2)
progression of insulin resistance##2##4##(2008-1#2)
progression of insulin##3##3##(2008-1#3)
progression of left ventricular##2##4##(1990-1#1)(2008-2#1)
progression of liver disease##2##4##(2009-9#1)(2013-8#1)
progression of liver##7##3##(2006-6#2)(2009-9#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-8#1)
progression of lung##2##3##(2006-10#1)(2011-2#1)
progression of mild##2##3##(1993-12#1)(2009-2#1)
progression of nephropathy##4##3##(2008-1#3)(2011-1#1)
progression of neurodegenerative diseases##2##4##(2008-8#1)(2012-12#1)
progression of osteoarthritis##2##3##(2007-8#1)(2012-3#1)
progression of pediatric##2##3##(2006-10#2)
progression of prostate cancer##5##4##(1997-7#2)(2006-10#1)(2011-2#2)
progression of renal disease##2##4##(2005-7#1)(2007-8#1)
progression of renal failure##3##4##(1990-4#1)(2007-11#1)(2008-1#1)
progression of renal##15##3##(1990-4#1)(1990-5#1)(1990-9#1)(2004-11#1)(2005-10#2)(2005-7#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2011-1#1)(2012-12#2)
progression of scoliosis##2##3##(2007-8#2)
progression of spine curve##2##4##(2007-8#2)
progression of symptoms##2##3##(2011-2#1)(2013-1#1)
progression of the cells through##2##5##(1990-11#1)(1993-11#1)
progression of the disease and##4##5##(2006-2#1)(2006-6#1)(2007-11#1)(2011-2#1)
progression of the disease in##2##5##(1992-6#1)(2012-3#1)
progression of the disease##28##4##(1990-2#1)(1992-6#1)(1993-12#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-6#1)(1996-5#1)(1996-6#1)(2005-10#1)(2005-11#1)(2006-2#1)(2006-6#2)(2006-8#1)(2007-11#1)(2008-1#2)(2008-12#1)(2009-10#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#1)
progression of the lesion##2##4##(2010-12#1)(2012-3#1)
progression of the neurological##2##4##(1991-11#1)(1997-5#1)
progression of the##65##3##(1990-10#1)(1990-11#2)(1990-2#2)(1990-8#1)(1991-11#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-5#2)(1994-6#1)(1996-5#2)(1996-6#1)(1997-3#1)(1997-5#1)(2005-10#1)(2005-11#1)(2006-2#1)(2006-5#1)(2006-6#3)(2006-8#1)(2007-10#1)(2007-11#3)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-7#3)(2009-10#1)(2009-3#2)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-8#1)
progression of these##4##3##(2011-2#1)(2013-1#3)
progression of this##4##3##(1997-7#1)(2007-9#1)(2008-1#1)(2012-12#1)
progression of tumors##3##3##(1995-1#1)(2012-1#1)(2012-2#1)
progression of various##3##3##(2009-5#1)(2010-3#1)(2012-12#1)
progression of vascular##6##3##(2007-10#1)(2007-2#1)(2012-12#4)
progression of vitiligo##2##3##(2007-7#2)
progression of##457##2##(1990-1#1)(1990-10#2)(1990-11#2)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#2)(1991-2#2)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#5)(1993-7#2)(1993-8#1)(1993-9#4)(1994-12#2)(1994-3#1)(1994-5#4)(1994-6#4)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#5)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-3#2)(1996-4#3)(1996-5#4)(1996-6#2)(1997-1#2)(1997-2#1)(1997-3#3)(1997-5#2)(1997-6#2)(1997-7#6)(2004-11#1)(2004-4#1)(2004-9#1)(2005-10#4)(2005-11#2)(2005-12#1)(2005-7#3)(2005-8#1)(2006-1#1)(2006-10#10)(2006-11#4)(2006-12#2)(2006-2#5)(2006-5#3)(2006-6#9)(2006-8#4)(2006-9#4)(2007-1#1)(2007-10#4)(2007-11#20)(2007-12#3)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#7)(2007-8#13)(2007-9#3)(2008-1#25)(2008-10#9)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#15)(2008-8#6)(2008-9#2)(2009-10#1)(2009-11#6)(2009-2#3)(2009-3#3)(2009-4#3)(2009-5#4)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#6)(2010-3#2)(2010-4#1)(2010-6#3)(2010-7#1)(2010-8#2)(2011-1#7)(2011-12#1)(2011-2#29)(2011-3#3)(2012-1#1)(2012-12#22)(2012-2#8)(2012-3#6)(2013-1#20)(2013-7#3)(2013-8#12)
progression or persistence##2##3##(2006-10#1)(2007-10#1)
progression or regression of##2##4##(2004-3#1)(2008-8#1)
progression or##17##2##(1992-4#1)(1994-8#1)(2004-3#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-10#2)(2008-10#1)(2008-7#3)(2008-8#1)(2009-4#1)(2009-8#1)(2010-3#1)(2013-1#1)
progression reflects the##2##3##(2007-5#1)(2010-12#1)
progression remains##2##2##(1991-2#1)(2010-4#1)
progression than##3##2##(1995-8#1)(2006-2#1)(2008-3#1)
progression that##2##2##(1997-6#1)(2006-8#1)
progression through G1##2##3##(1997-8#1)(2007-8#1)
progression through the cell cycle##3##5##(1991-8#1)(1993-8#1)(2008-9#1)
progression through the##6##3##(1991-8#2)(1993-8#1)(1994-6#1)(2008-8#1)(2008-9#1)
progression through##16##2##(1991-8#2)(1993-6#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-6#1)(1997-7#1)(1997-8#1)(2006-12#1)(2007-8#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)
progression to AIDS##6##3##(2007-11#1)(2008-11#1)(2008-12#1)(2010-8#1)(2011-1#1)(2012-2#1)
progression to a##4##3##(1994-8#1)(2013-1#2)(2013-7#1)
progression to acute##2##3##(2011-2#1)(2012-12#1)
progression to blast crisis##2##4##(2007-12#2)
progression to cervical cancer##3##4##(2012-2#3)
progression to cervical##4##3##(1994-5#1)(2012-2#3)
progression to chronic renal failure##3##5##(2008-1#2)(2011-12#1)
progression to cirrhosis and##2##4##(2006-2#1)(2008-5#1)
progression to cirrhosis##5##3##(2006-10#2)(2006-2#1)(2008-5#2)
progression to disease##2##3##(2007-2#1)(2013-8#1)
progression to invasive##3##3##(2006-2#1)(2007-6#1)(2010-8#1)
progression to the##2##3##(2007-12#1)(2008-7#1)
progression to##66##2##(1990-5#1)(1990-6#1)(1993-7#1)(1994-5#1)(1994-8#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#2)(2007-11#1)(2007-12#4)(2007-2#1)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#3)(2008-11#1)(2008-12#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-12#3)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#4)(2011-3#1)(2012-12#5)(2012-2#4)(2013-1#3)(2013-7#1)(2013-8#1)
progression was observed##2##3##(1991-8#1)(2008-6#1)
progression was##23##2##(1990-10#1)(1990-2#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-8#1)(1993-1#1)(1993-7#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-6#2)(2009-12#1)(2010-12#2)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#2)
progression were##8##2##(1993-8#1)(1994-11#1)(2006-10#1)(2007-2#1)(2007-7#2)(2008-10#2)
progression with##7##2##(1993-10#1)(2005-4#1)(2007-7#1)(2008-6#1)(2010-9#1)(2012-12#2)
progression without##2##2##(1993-8#1)(2007-11#1)
progression##1246##1##(1990-1#2)(1990-10#3)(1990-11#3)(1990-12#2)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#3)(1991-11#3)(1991-12#1)(1991-2#6)(1991-3#1)(1991-4#6)(1991-5#4)(1991-6#3)(1991-7#4)(1991-8#5)(1991-9#3)(1992-10#5)(1992-11#3)(1992-12#4)(1992-2#2)(1992-4#2)(1992-6#3)(1992-8#4)(1992-9#5)(1993-1#1)(1993-10#1)(1993-11#4)(1993-12#7)(1993-2#1)(1993-6#7)(1993-7#5)(1993-8#4)(1993-9#7)(1994-10#1)(1994-11#2)(1994-12#7)(1994-2#2)(1994-3#2)(1994-4#1)(1994-5#6)(1994-6#7)(1994-7#1)(1994-8#13)(1995-1#2)(1995-11#1)(1995-12#6)(1995-2#7)(1995-3#1)(1995-5#1)(1995-6#4)(1995-8#4)(1995-9#4)(1996-1#1)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#4)(1996-5#4)(1996-6#3)(1996-7#1)(1996-8#1)(1997-1#5)(1997-2#1)(1997-3#4)(1997-4#2)(1997-5#3)(1997-6#3)(1997-7#13)(1997-8#2)(2003-11#1)(2004-1#2)(2004-11#5)(2004-3#1)(2004-4#1)(2004-9#1)(2005-1#1)(2005-10#6)(2005-11#8)(2005-12#3)(2005-2#1)(2005-4#1)(2005-7#6)(2005-8#5)(2006-1#1)(2006-10#26)(2006-11#5)(2006-12#10)(2006-2#16)(2006-3#1)(2006-5#4)(2006-6#14)(2006-8#7)(2006-9#6)(2007-1#1)(2007-10#11)(2007-11#43)(2007-12#10)(2007-2#6)(2007-3#1)(2007-4#1)(2007-5#4)(2007-6#12)(2007-7#21)(2007-8#21)(2007-9#7)(2008-1#43)(2008-10#33)(2008-11#18)(2008-12#7)(2008-2#6)(2008-3#11)(2008-4#13)(2008-5#14)(2008-6#18)(2008-7#29)(2008-8#19)(2008-9#11)(2009-10#5)(2009-11#9)(2009-12#4)(2009-2#3)(2009-3#13)(2009-4#10)(2009-5#11)(2009-6#9)(2009-7#3)(2009-8#9)(2009-9#5)(2010-1#13)(2010-10#4)(2010-11#8)(2010-12#24)(2010-2#3)(2010-3#7)(2010-4#8)(2010-5#5)(2010-6#11)(2010-7#5)(2010-8#6)(2010-9#2)(2011-1#26)(2011-12#6)(2011-2#51)(2011-3#6)(2011-7#3)(2012-1#10)(2012-12#56)(2012-2#36)(2012-3#23)(2012-8#3)(2013-1#61)(2013-7#8)(2013-8#33)
progression) or##2##2##(2007-11#1)(2008-12#1)
progression)##6##1##(2006-12#1)(2007-11#2)(2007-8#1)(2008-12#2)
progression-free and overall survival##2##4##(2008-6#2)
progression-free survival and##2##3##(2006-6#1)(2009-8#1)
progression-free survival in patients with##2##5##(2010-12#2)
progression-free survival in##5##3##(2008-3#1)(2010-12#3)(2012-2#1)
progression-free survival of##2##3##(2009-11#1)(2011-2#1)
progression-free survival were##2##3##(1990-6#1)(2006-6#1)
progression-free survival##22##2##(1990-6#2)(2006-6#2)(2008-3#1)(2008-6#2)(2009-11#2)(2009-8#1)(2010-11#1)(2010-12#5)(2011-2#1)(2012-2#2)(2013-1#3)
progression-free##26##1##(1990-6#2)(2006-6#3)(2008-3#1)(2008-6#4)(2009-11#2)(2009-8#1)(2010-11#1)(2010-12#5)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#3)
progression/regression of##3##2##(2010-12#3)
progressions##3##1##(1991-2#1)(1991-8#1)(2010-1#1)
progressive MS##4##2##(2005-7#1)(2010-12#3)
progressive accumulation of##2##3##(1991-2#1)(2008-9#1)
progressive accumulation##3##2##(1991-2#1)(2008-7#1)(2008-9#1)
progressive addition lens##3##3##(2008-2#1)(2010-4#2)
progressive addition##4##2##(2008-2#2)(2010-4#2)
progressive and lethal##2##3##(2010-12#1)(2011-2#1)
progressive and regressive##2##3##(1996-10#1)(2010-12#1)
progressive and##15##2##(1990-12#1)(1993-9#1)(1995-3#1)(1996-10#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-5#2)(2008-7#1)(2010-12#2)(2010-4#1)(2011-2#2)
progressive aphasia and##2##3##(2008-4#1)(2008-9#1)
progressive aphasia##6##2##(1995-3#1)(2008-4#1)(2008-9#2)(2012-11#2)
progressive articular##2##2##(1993-3#1)(2013-1#1)
progressive ataxia##5##2##(1991-2#1)(2006-11#1)(2013-1#3)
progressive bone##2##2##(1995-1#1)(2006-9#1)
progressive brain##3##2##(2008-7#1)(2009-10#2)
progressive cases##2##2##(2006-10#1)(2012-12#1)
progressive cell##3##2##(1996-6#1)(2007-12#2)
progressive changes in##3##3##(2008-7#1)(2010-1#1)(2013-8#1)
progressive changes##4##2##(1992-11#1)(2008-7#1)(2010-1#1)(2013-8#1)
progressive cholestasis##3##2##(1996-3#2)(2004-11#1)
progressive clinical##2##2##(2006-1#1)(2008-7#1)
progressive coding of##2##3##(2008-2#2)
progressive coding##3##2##(2008-2#3)
progressive conditions##2##2##(2007-10#1)(2009-10#1)
progressive course##9##2##(1990-3#1)(1991-6#1)(1993-10#1)(1995-6#1)(2006-1#1)(2006-2#1)(2007-11#1)(2007-6#1)(2008-11#1)
progressive decline in##9##3##(2004-3#1)(2006-12#1)(2007-8#1)(2009-12#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#2)
progressive decline of##2##3##(1995-1#1)(2013-1#1)
progressive decline##12##2##(1993-2#1)(1995-1#1)(2004-3#1)(2006-12#1)(2007-8#1)(2009-12#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
progressive decrease in the##6##4##(1991-5#1)(1994-7#1)(1995-5#1)(1996-5#2)(2008-5#1)
progressive decrease in##9##3##(1991-2#1)(1991-5#1)(1992-9#2)(1994-7#1)(1995-5#1)(1996-5#2)(2008-5#1)
progressive decrease##11##2##(1991-2#1)(1991-5#1)(1992-9#2)(1994-7#1)(1995-5#1)(1995-8#1)(1996-5#2)(2008-5#1)(2011-2#1)
progressive decreases##2##2##(1993-11#1)(2008-4#1)
progressive degeneration of the##2##4##(2005-7#1)(2008-9#1)
progressive degeneration of##4##3##(2005-7#1)(2007-11#1)(2008-9#1)(2012-1#1)
progressive dementia##5##2##(1993-5#1)(2007-12#1)(2011-2#1)(2013-7#2)
progressive destruction of##3##3##(1990-8#1)(1994-8#1)(2011-2#1)
progressive deterioration of the##2##4##(2005-10#1)(2007-3#1)
progressive deterioration of##7##3##(1991-2#1)(2005-10#1)(2007-3#1)(2008-7#1)(2009-12#1)(2012-2#1)(2013-7#1)
progressive deterioration##11##2##(1991-2#1)(2005-10#1)(2006-7#1)(2006-9#1)(2007-3#1)(2008-7#1)(2009-12#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
progressive development of##5##3##(1991-6#1)(2006-10#1)(2008-4#1)(2010-11#1)(2010-12#1)
progressive disease (PD)##2##3##(1990-10#1)(1990-2#1)
progressive disease after##2##3##(1990-12#1)(2010-9#1)
progressive disease and##2##3##(2007-11#1)(2011-1#1)
progressive disease in##2##3##(1992-12#1)(2008-5#1)
progressive disease with##3##3##(2006-12#1)(2007-5#1)(2013-1#1)
progressive disease##39##2##(1990-10#1)(1990-12#1)(1990-2#1)(1991-6#1)(1991-8#1)(1992-12#3)(1992-9#1)(1994-8#1)(1995-10#1)(1995-5#1)(1997-6#1)(2004-11#1)(2005-5#1)(2006-12#2)(2006-2#1)(2006-6#3)(2007-11#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#1)(2013-1#2)
progressive disorder##3##2##(2008-11#1)(2008-7#1)(2008-9#1)
progressive dyspnea##4##2##(1995-4#1)(1997-5#1)(2007-8#1)(2012-12#1)
progressive enlargement of the##2##4##(2007-10#1)(2007-12#1)
progressive enlargement of##3##3##(2007-10#1)(2007-12#1)(2007-8#1)
progressive enlargement##4##2##(2007-10#1)(2007-12#1)(2007-8#1)(2008-6#1)
progressive expansion of##2##3##(1996-11#1)(2011-1#1)
progressive failure of##2##3##(2007-11#1)(2008-7#1)
progressive fatigue##2##2##(1991-10#1)(2013-1#1)
progressive fibrosis##3##2##(2007-11#1)(2012-12#2)
progressive fibrotic##2##2##(2005-8#2)
progressive form##2##2##(2011-2#1)(2012-1#1)
progressive forms of##2##3##(2007-11#1)(2010-12#1)
progressive glomerulonephritis##7##2##(2007-2#1)(2007-7#3)(2008-1#2)(2008-7#1)
progressive group##2##2##(1995-12#1)(2006-12#1)
progressive growth##2##2##(2008-6#1)(2010-12#1)
progressive hearing loss##3##3##(2012-2#3)
progressive heart failure##2##3##(2007-8#1)(2010-11#1)
progressive hepatosplenomegaly##2##2##(2007-3#2)
progressive impairment of##2##3##(2009-10#1)(2011-2#1)
progressive improvement##2##2##(2009-4#1)(2011-1#1)
progressive in patients with##2##4##(1997-8#1)(2007-8#1)
progressive in##3##2##(1997-8#1)(2007-8#1)(2011-2#1)
progressive increase in serum##2##4##(2006-4#1)(2008-10#1)
progressive increase in the##9##4##(1990-7#1)(1991-8#1)(1991-9#1)(1994-2#2)(1995-2#1)(2006-6#1)(2008-11#1)(2010-10#1)
progressive increase in##26##3##(1990-7#1)(1991-8#1)(1991-9#1)(1992-8#1)(1993-7#1)(1994-2#4)(1995-2#1)(1995-5#1)(1996-10#1)(1997-7#1)(2006-4#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-2#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-2#1)
progressive increase of##2##3##(1993-6#1)(2011-2#1)
progressive increase##31##2##(1990-7#1)(1991-8#1)(1991-9#1)(1992-8#1)(1993-6#1)(1993-7#1)(1994-2#4)(1995-2#1)(1995-5#1)(1996-10#1)(1997-7#1)(1997-8#1)(2006-4#1)(2006-6#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-10#2)(2009-2#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
progressive infection##4##2##(1990-10#1)(2007-7#1)(2013-1#2)
progressive inflammatory##2##2##(2009-7#1)(2012-11#1)
progressive inhibition of##2##3##(1993-12#1)(1994-9#1)
progressive inhibition##3##2##(1992-8#1)(1993-12#1)(1994-9#1)
progressive inverse wavelet synthesis##2##4##(2008-2#2)
progressive ischemic##3##2##(1995-9#1)(2006-10#1)(2008-7#1)
progressive joint destruction##2##3##(2007-10#1)(2007-11#1)
progressive kyphosis##2##2##(2006-8#1)(2008-8#1)
progressive left##2##2##(2010-9#1)(2012-3#1)
progressive left-sided##2##2##(2008-5#1)(2010-11#1)
progressive lesions of##2##3##(2007-5#1)(2008-6#1)
progressive liver disease##5##3##(2007-5#2)(2009-5#1)(2009-8#1)(2013-1#1)
progressive liver injury##2##3##(2010-6#1)(2012-2#1)
progressive liver##9##2##(1996-11#1)(2007-5#2)(2009-5#1)(2009-8#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#1)
progressive loss of renal function##3##5##(2007-1#1)(2007-11#1)(2012-12#1)
progressive loss of##21##3##(1990-11#1)(1990-3#1)(1990-7#1)(1992-8#1)(1993-1#1)(1996-4#1)(1996-9#1)(2005-11#1)(2007-1#1)(2007-11#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-3#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
progressive loss##24##2##(1990-11#1)(1990-3#1)(1990-7#1)(1992-8#1)(1993-1#1)(1996-4#1)(1996-9#1)(2005-11#1)(2007-1#1)(2007-11#1)(2008-11#1)(2008-5#3)(2008-7#1)(2009-3#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
progressive low-grade##2##2##(2006-12#2)
progressive memory##3##2##(2008-2#2)(2013-1#1)
progressive monoarthritis tuberculosis of the hip without systemic symptoms##2##9##(2010-2#2)
progressive motor##3##2##(1995-10#1)(1997-5#1)(2008-7#1)
progressive multiple sclerosis##2##3##(2007-11#1)(2010-12#1)
progressive multiple##3##2##(2007-11#1)(2010-12#1)(2011-2#1)
progressive muscle##5##2##(2010-2#1)(2012-1#2)(2012-3#1)(2013-8#1)
progressive myelopathy##2##2##(2009-3#1)(2012-12#1)
progressive nature of##2##3##(2007-8#2)
progressive nature##3##2##(2007-8#2)(2008-4#1)
progressive neurodegenerative##8##2##(1995-1#1)(2005-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-6#1)(2011-2#1)(2013-8#1)
progressive neurologic##2##2##(1997-3#1)(2006-10#1)
progressive neurological deterioration##3##3##(2006-5#1)(2007-9#1)(2011-2#1)
progressive neurological##11##2##(2006-5#1)(2007-9#1)(2008-4#1)(2008-7#2)(2008-9#2)(2011-1#1)(2011-2#2)(2013-8#1)
progressive nonfluent aphasia (PNFA)##3##4##(2008-11#1)(2008-4#1)(2009-9#1)
progressive nonfluent aphasia##5##3##(2008-11#2)(2008-4#1)(2009-9#2)
progressive occlusion of the##2##4##(2008-3#1)(2012-3#1)
progressive or##2##2##(2007-11#1)(2008-6#1)
progressive pain in##2##3##(2006-10#1)(2006-12#1)
progressive pain##3##2##(2006-10#1)(2006-12#1)(2008-9#1)
progressive performance of##2##3##(2007-3#1)(2008-3#1)
progressive process##2##2##(2007-8#1)(2011-12#1)
progressive pulmonary fibrosis##2##3##(2005-8#1)(2006-8#1)
progressive reaction##2##2##(1995-5#2)
progressive reduction in the##2##4##(2006-4#1)(2010-11#1)
progressive reduction in##5##3##(1991-7#1)(2006-4#1)(2007-8#1)(2008-10#1)(2010-11#1)
progressive reduction of##2##3##(1995-10#1)(2007-12#1)
progressive reduction##8##2##(1991-7#1)(1995-10#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-10#2)(2010-11#1)
progressive renal disease##5##3##(1995-10#1)(2005-7#2)(2006-8#1)(2008-1#1)
progressive renal failure##5##3##(1990-9#1)(1992-12#1)(2006-10#2)(2008-1#1)
progressive renal insufficiency##2##3##(2007-7#1)(2008-1#1)
progressive renal##15##2##(1990-9#1)(1992-12#1)(1995-10#1)(2005-7#2)(2006-10#3)(2006-6#1)(2006-8#1)(2007-7#1)(2008-1#3)(2009-6#1)
progressive replacement of##2##3##(1992-12#1)(2008-8#1)
progressive resistance training##2##3##(2007-12#1)(2012-12#1)
progressive resistance##3##2##(2007-12#1)(2012-12#2)
progressive respiratory##3##2##(2006-10#1)(2007-3#1)(2010-12#1)
progressive right heart failure##2##4##(1993-8#1)(2010-10#1)
progressive right##5##2##(1993-8#1)(2008-7#1)(2009-3#1)(2010-10#2)
progressive right-sided##3##2##(2006-12#1)(2010-2#1)(2012-12#1)
progressive rise##4##2##(1990-4#1)(1992-8#1)(1993-6#1)(2013-1#1)
progressive scoliosis##4##2##(2007-7#1)(2007-8#3)
progressive supranuclear palsy (PSP) and##2##5##(1990-7#1)(2008-11#1)
progressive supranuclear palsy (PSP)##4##4##(1990-7#1)(1991-3#1)(1992-8#1)(2008-11#1)
progressive supranuclear palsy and##2##4##(1990-7#1)(1991-8#1)
progressive supranuclear palsy##15##3##(1990-7#2)(1991-3#2)(1991-8#1)(1992-8#2)(2007-7#1)(2008-11#5)(2008-7#1)(2012-12#1)
progressive systemic sclerosis##2##3##(1991-12#1)(1991-3#1)
progressive systemic##4##2##(1991-12#1)(1991-3#2)(2012-2#1)
progressive telomere shortening##2##3##(2007-11#1)(2008-11#1)
progressive type##3##2##(2007-11#1)(2013-1#2)
progressive vascular remodelling##2##3##(2010-10#1)(2010-6#1)
progressive visual loss##3##3##(2008-1#1)(2009-8#1)(2011-2#1)
progressive visual##4##2##(2006-12#1)(2008-1#1)(2009-8#1)(2011-2#1)
progressive weakness##5##2##(2010-12#1)(2012-2#4)
progressive##751##1##(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#3)(1990-4#1)(1990-7#4)(1990-8#2)(1990-9#1)(1991-10#2)(1991-12#1)(1991-2#4)(1991-3#4)(1991-5#2)(1991-6#4)(1991-7#3)(1991-8#3)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#8)(1992-2#2)(1992-3#1)(1992-4#1)(1992-8#6)(1992-9#4)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-5#2)(1993-6#4)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-12#1)(1994-2#7)(1994-3#3)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#3)(1995-10#5)(1995-12#2)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#5)(1995-6#4)(1995-8#2)(1995-9#1)(1996-10#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#4)(2004-11#4)(2004-12#1)(2004-3#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-5#1)(2005-7#9)(2005-8#4)(2006-1#3)(2006-10#19)(2006-11#2)(2006-12#15)(2006-2#3)(2006-3#1)(2006-4#4)(2006-5#2)(2006-6#5)(2006-7#2)(2006-8#6)(2006-9#3)(2007-1#2)(2007-10#7)(2007-11#24)(2007-12#9)(2007-2#3)(2007-3#5)(2007-5#6)(2007-6#3)(2007-7#18)(2007-8#21)(2007-9#4)(2008-1#12)(2008-10#11)(2008-11#16)(2008-12#1)(2008-2#15)(2008-3#7)(2008-4#13)(2008-5#16)(2008-6#9)(2008-7#28)(2008-8#6)(2008-9#13)(2009-10#8)(2009-11#1)(2009-12#2)(2009-2#4)(2009-3#8)(2009-4#2)(2009-5#1)(2009-6#5)(2009-7#1)(2009-8#4)(2009-9#5)(2010-1#1)(2010-10#5)(2010-11#6)(2010-12#18)(2010-2#5)(2010-3#1)(2010-4#5)(2010-5#2)(2010-6#5)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#10)(2011-12#1)(2011-2#23)(2011-7#1)(2012-1#5)(2012-11#3)(2012-12#21)(2012-2#19)(2012-3#15)(2013-1#30)(2013-7#8)(2013-8#13)
progressive)##3##1##(1995-11#1)(2007-11#1)(2012-3#1)
progressively accumulated##2##2##(1994-9#1)(2012-2#1)
progressively and##2##2##(1991-9#1)(1993-7#1)
progressively as##4##2##(1991-5#1)(1993-3#1)(2005-12#1)(2008-10#1)
progressively by##2##2##(1997-2#1)(2008-5#1)
progressively decline##2##2##(1995-8#1)(2009-12#1)
progressively declined##3##2##(1995-2#1)(2007-8#1)(2007-9#1)
progressively decreased##5##2##(1990-3#2)(1991-12#1)(1995-10#1)(1997-4#1)
progressively decreases##2##2##(2008-10#1)(2008-5#1)
progressively disabling disease##2##3##(1997-3#1)(2009-1#1)
progressively for##3##2##(1995-5#1)(2006-9#1)(2012-12#1)
progressively from 35##2##3##(2007-3#1)(2010-4#1)
progressively from##11##2##(1990-11#1)(1993-11#1)(1996-3#1)(2005-11#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2010-4#1)
progressively greater proportion of##2##4##(1990-11#1)(2006-8#1)
progressively higher##4##2##(1995-10#1)(1995-5#1)(1995-9#1)(2007-8#1)
progressively in the##3##3##(1994-5#1)(1995-5#1)(2008-4#1)
progressively in##5##2##(1990-12#1)(1991-11#1)(1994-5#1)(1995-5#1)(2008-4#1)
progressively increased in##3##3##(1993-12#1)(1995-2#1)(1997-6#1)
progressively increased with##2##3##(1993-2#1)(1995-5#1)
progressively increased##12##2##(1990-9#1)(1993-12#1)(1993-2#1)(1995-2#1)(1995-5#1)(1996-4#1)(1997-6#1)(2006-10#1)(2006-6#1)(2007-7#1)(2008-4#1)(2011-2#1)
progressively increases##2##2##(2006-9#1)(2008-10#1)
progressively increasing in##2##3##(2006-2#1)(2012-2#1)
progressively increasing the##2##3##(1997-2#1)(2010-7#1)
progressively increasing##19##2##(1991-12#1)(1993-8#1)(1997-2#1)(2006-2#2)(2007-2#1)(2007-3#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-2#3)(2013-1#2)
progressively inhibited##5##2##(1990-10#1)(1990-7#1)(1991-9#1)(1993-3#1)(1996-5#1)
progressively larger##2##2##(1996-5#1)(2007-12#1)
progressively less##3##2##(1992-8#1)(2006-10#1)(2009-8#1)
progressively longer periods##3##3##(1992-9#3)
progressively longer##6##2##(1990-7#1)(1992-9#4)(1995-11#1)
progressively lost##2##2##(1990-11#1)(2008-5#1)
progressively more complicated##2##3##(1992-9#1)(1993-12#1)
progressively more##12##2##(1990-3#1)(1992-10#1)(1992-9#1)(1993-12#2)(1994-2#2)(2004-9#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
progressively over##3##2##(2006-12#1)(2008-10#1)(2011-2#1)
progressively reduced and##2##3##(1991-6#1)(2012-2#1)
progressively reduced with##2##3##(2008-3#2)
progressively reduced##9##2##(1991-6#1)(1992-4#1)(1997-2#1)(2008-1#1)(2008-3#2)(2010-11#1)(2012-2#1)(2012-3#1)
progressively shifted##2##2##(1992-9#1)(2011-2#1)
progressively smaller##4##2##(1993-11#1)(1994-3#1)(2008-2#1)(2008-6#1)
progressively to##3##2##(1991-10#1)(1993-3#1)(2007-12#1)
progressively with increasing##3##3##(1990-9#1)(1994-12#1)(2008-3#1)
progressively with##9##2##(1990-9#1)(1992-5#1)(1994-10#1)(1994-12#1)(2007-9#1)(2008-10#2)(2008-3#1)(2010-2#1)
progressively##223##1##(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#1)(1990-3#4)(1990-6#1)(1990-7#2)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-4#1)(1992-5#3)(1992-8#1)(1992-9#10)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#4)(1993-7#1)(1993-8#2)(1994-10#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-9#1)(1995-10#3)(1995-11#2)(1995-2#3)(1995-3#1)(1995-5#5)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#3)(1997-2#4)(1997-3#1)(1997-4#2)(1997-6#1)(2004-11#1)(2004-9#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-5#3)(2006-6#1)(2006-8#1)(2006-9#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#11)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#3)(2008-9#2)(2009-1#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-8#2)(2010-1#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#2)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#9)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#4)(2013-8#2)
progressors##3##1##(2008-11#2)(2012-12#1)
proguanil##3##1##(1996-8#1)(1997-3#1)(2009-6#1)
prohemostatic##2##1##(2013-1#2)
prohibit or##2##2##(2008-10#1)(2009-7#1)
prohibit the use of##3##4##(2005-11#1)(2007-6#2)
prohibit the##8##2##(1990-2#2)(2005-11#1)(2006-8#1)(2007-12#1)(2007-6#2)(2008-3#1)
prohibit##20##1##(1990-2#3)(1996-1#1)(1996-11#1)(2005-11#2)(2006-7#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-6#2)(2008-10#3)(2008-3#1)(2009-7#1)(2012-1#1)(2013-8#1)
prohibited a##2##2##(2006-8#1)(2007-11#1)
prohibited by##2##2##(1992-12#1)(1996-11#1)
prohibited in##3##2##(1992-6#1)(1995-2#1)(2008-10#1)
prohibited list##3##2##(2010-4#2)(2013-7#1)
prohibited the##5##2##(1991-6#1)(1995-9#1)(1996-5#1)(2012-12#2)
prohibited##32##1##(1990-9#1)(1991-3#1)(1991-6#2)(1992-12#1)(1992-6#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-11#1)(1996-5#1)(1996-6#1)(2006-1#1)(2006-8#2)(2007-11#2)(2007-12#2)(2008-10#2)(2008-5#1)(2010-11#2)(2010-2#1)(2010-4#2)(2010-7#1)(2011-2#1)(2012-12#2)(2013-7#1)
prohibitin##4##1##(1994-12#1)(1994-5#2)(2010-12#1)
prohibiting##2##1##(1996-5#1)(2009-6#1)
prohibition of##4##2##(1990-12#1)(1993-5#1)(2006-6#1)(2008-8#1)
prohibition on##4##2##(1995-6#1)(1996-5#1)(1996-6#1)(2006-3#1)
prohibition##12##1##(1990-12#1)(1993-5#1)(1995-6#1)(1996-5#1)(1996-6#1)(2006-3#1)(2006-6#1)(2006-8#3)(2008-8#1)(2009-9#1)
prohibitions##3##1##(1990-9#2)(2008-4#1)
prohibitive##10##1##(1996-1#1)(2006-10#2)(2007-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-1#1)(2012-3#1)
prohibitively expensive##2##2##(2005-7#1)(2012-3#1)
prohibitively##4##1##(2005-7#1)(2008-10#1)(2010-9#1)(2012-3#1)
prohibits discrimination##2##2##(1994-1#1)(1995-6#1)
prohibits the##2##2##(1995-6#1)(2009-10#1)
prohibits##9##1##(1994-1#1)(1994-3#1)(1995-6#2)(1996-11#1)(1996-12#1)(1997-1#1)(2007-12#1)(2009-10#1)
prohormone isoforms##3##2##(1993-12#3)
prohormone were##2##2##(1990-12#1)(1991-8#1)
prohormone##24##1##(1990-11#1)(1990-12#3)(1990-5#1)(1991-4#1)(1991-8#1)(1992-12#1)(1993-12#13)(1993-5#1)(2008-4#2)
prohormones and propeptides##2##3##(1991-1#2)
prohormones and##3##2##(1991-1#2)(1993-5#1)
prohormones##12##1##(1991-1#4)(1992-6#1)(1993-5#1)(2008-4#5)(2008-6#1)
proinflammatory and anti-inflammatory##2##3##(2006-10#2)
proinflammatory and prothrombotic##2##3##(2008-3#1)(2013-1#1)
proinflammatory and##8##2##(2005-12#1)(2006-10#2)(2007-11#1)(2007-9#1)(2008-3#1)(2010-4#1)(2013-1#1)
proinflammatory cytokine IL-1beta##2##3##(2007-8#1)(2010-12#1)
proinflammatory cytokine expression##3##3##(2009-8#1)(2011-2#1)(2013-7#1)
proinflammatory cytokine levels##2##3##(2008-4#1)(2008-6#1)
proinflammatory cytokine##13##2##(1995-12#1)(1995-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-6#1)(2009-10#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-7#1)
proinflammatory cytokines and chemokines##4##4##(2006-10#1)(2007-11#1)(2008-4#1)(2012-12#1)
proinflammatory cytokines and##10##3##(2006-10#1)(2007-11#2)(2007-12#1)(2008-4#1)(2009-9#2)(2010-12#1)(2012-1#1)(2012-12#1)
proinflammatory cytokines are##2##3##(1996-4#1)(2007-8#1)
proinflammatory cytokines in the##2##4##(2013-7#2)
proinflammatory cytokines in##4##3##(2007-12#1)(2010-4#1)(2013-7#2)
proinflammatory cytokines synthesis##2##3##(2008-11#2)
proinflammatory cytokines##57##2##(1994-8#1)(1995-12#1)(1995-2#1)(1996-4#1)(2006-10#3)(2007-11#9)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#9)(2008-4#2)(2009-8#1)(2009-9#6)(2010-12#2)(2010-4#3)(2010-7#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2013-7#3)
proinflammatory mediator##2##2##(2008-10#1)(2008-7#1)
proinflammatory mediators and##3##3##(2007-11#1)(2008-7#1)(2012-2#1)
proinflammatory mediators##11##2##(1992-6#1)(1994-8#1)(2006-10#3)(2007-11#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-12#1)(2012-2#1)
proinflammatory molecules##2##2##(2010-2#1)(2011-2#1)
proinflammatory processes##3##2##(2010-4#3)
proinflammatory properties##2##2##(2007-9#1)(2008-10#1)
proinflammatory response##3##2##(2012-12#1)(2012-3#2)
proinflammatory state##4##2##(2005-10#1)(2008-3#2)(2013-1#1)
proinflammatory##136##1##(1992-6#1)(1993-9#1)(1994-8#2)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-4#1)(2005-10#1)(2005-12#1)(2006-10#11)(2007-11#13)(2007-12#3)(2007-3#1)(2007-8#2)(2007-9#3)(2008-1#2)(2008-10#8)(2008-11#9)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-3#2)(2009-8#2)(2009-9#6)(2010-1#1)(2010-12#5)(2010-2#1)(2010-4#9)(2010-5#1)(2010-7#1)(2011-2#10)(2012-1#2)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#5)(2013-8#1)
proinsulin and its conversion intermediates##2##5##(1996-3#2)
proinsulin and its##3##3##(1996-3#2)(1996-7#1)
proinsulin and##4##2##(1995-8#1)(1996-3#2)(1996-7#1)
proinsulin fusion protein##2##3##(1996-7#2)
proinsulin polypeptide##2##2##(1994-11#2)
proinsulin secretion##2##2##(2008-11#2)
proinsulin to##2##2##(1994-11#1)(2008-11#1)
proinsulin##30##1##(1990-5#4)(1991-3#1)(1994-11#5)(1995-5#1)(1995-6#1)(1995-8#1)(1996-3#7)(1996-7#4)(2005-1#1)(2008-11#4)(2008-4#1)
project &quot##5##2##(2005-10#1)(2005-7#1)(2010-4#1)(2011-2#2)
project (the##2##2##(1995-4#1)(2006-11#1)
project a##2##2##(2005-7#1)(2008-2#1)
project aimed at##5##3##(1997-7#1)(2006-5#1)(2008-10#2)(2008-3#1)
project aimed to##5##3##(2008-11#2)(2009-4#1)(2012-12#1)(2013-1#1)
project aimed##10##2##(1997-7#1)(2006-5#1)(2008-10#2)(2008-11#2)(2008-3#1)(2009-4#1)(2012-12#1)(2013-1#1)
project aims to##2##3##(2007-5#1)(2008-7#1)
project aims##3##2##(2007-5#1)(2008-7#1)(2011-2#1)
project also##2##2##(2005-10#1)(2008-11#1)
project and to##2##3##(2006-12#1)(2013-8#1)
project and##13##2##(1992-1#1)(1992-2#1)(1996-5#1)(2006-12#1)(2008-1#1)(2008-12#2)(2008-8#1)(2009-8#1)(2009-9#1)(2010-8#1)(2012-3#1)(2013-8#1)
project are to##3##3##(1996-1#1)(2008-6#1)(2008-7#1)
project are##10##2##(1993-3#1)(1996-1#1)(2005-10#1)(2006-1#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)
project as well as the##2##5##(2007-3#1)(2008-11#1)
project as well as##3##4##(2007-11#1)(2007-3#1)(2008-11#1)
project as##5##2##(2007-11#1)(2007-3#1)(2008-11#1)(2008-12#1)(2013-8#1)
project at##3##2##(1993-3#1)(2008-5#1)(2008-7#1)
project based on##2##3##(2007-5#1)(2008-1#1)
project began##2##2##(2007-11#1)(2011-9#1)
project between##2##2##(1996-11#1)(2007-4#1)
project by##4##2##(2011-12#1)(2011-2#1)(2013-1#2)
project called##2##2##(2007-9#1)(2012-1#1)
project can be##2##3##(1992-3#2)
project can##3##2##(1992-3#2)(2013-8#1)
project concerned##2##2##(2009-5#1)(2013-1#1)
project conducted in##2##3##(2008-9#1)(2011-1#1)
project conducted##3##2##(1992-1#1)(2008-9#1)(2011-1#1)
project contributed to##3##3##(2005-12#1)(2008-1#1)(2011-2#1)
project could have##2##3##(1997-3#2)
project designed##2##2##(1991-12#1)(2007-11#1)
project entitled##2##2##(2007-6#1)(2008-10#1)
project explored the##2##3##(2008-9#1)(2012-12#1)
project explores##2##2##(2008-1#1)(2008-4#1)
project for the##3##3##(1995-12#1)(2008-12#1)(2012-12#1)
project for##9##2##(1993-1#1)(1995-10#1)(1995-12#1)(1997-8#1)(2006-5#2)(2007-9#1)(2008-12#1)(2012-12#1)
project from##2##2##(1992-11#1)(2008-4#1)
project funded by the##3##4##(1995-3#1)(2008-2#1)(2009-4#1)
project guidelines##2##2##(2008-10#1)(2008-7#1)
project has developed##3##3##(2008-2#1)(2013-1#2)
project has##13##2##(1993-9#1)(2006-2#1)(2006-6#1)(2007-4#1)(2008-10#1)(2008-2#1)(2010-8#1)(2011-2#1)(2013-1#3)(2013-8#2)
project implementation##2##2##(2005-9#1)(2007-1#1)
project in the##8##3##(1991-1#1)(1993-3#2)(2006-6#1)(2007-2#1)(2008-2#1)(2008-9#1)(2013-1#1)
project in##21##2##(1991-1#1)(1992-11#1)(1993-3#2)(1994-1#1)(1996-3#1)(1996-4#1)(1996-8#1)(2006-5#1)(2006-6#1)(2007-2#2)(2008-1#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-9#1)(2011-12#1)(2013-1#1)
project included##3##2##(2008-1#1)(2008-11#1)(2008-8#1)
project initiation##2##2##(2010-8#2)
project into##3##2##(2007-10#1)(2007-12#2)
project involving##3##2##(1995-1#1)(2008-11#1)(2008-7#1)
project ipsilaterally##2##2##(1995-11#1)(1995-8#1)
project is a##2##3##(1996-12#1)(2005-10#1)
project is presented##2##3##(2007-10#1)(2008-4#1)
project is to##5##3##(1996-2#1)(2008-7#1)(2010-7#1)(2011-9#1)(2013-8#1)
project is##32##2##(1991-1#1)(1993-3#2)(1994-3#1)(1995-12#1)(1996-12#1)(1996-2#2)(2005-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-7#5)(2008-8#3)(2008-9#2)(2010-7#1)(2011-9#1)(2013-8#1)
project itself##2##2##(1993-12#1)(2010-10#1)
project led to##2##3##(2009-4#1)(2012-12#1)
project management##6##2##(1994-1#1)(2006-1#1)(2007-12#2)(2007-4#1)(2010-6#1)
project named##2##2##(2009-10#1)(2011-2#1)
project of##12##2##(1990-3#1)(1994-9#1)(2005-9#1)(2008-12#1)(2008-7#1)(2009-3#1)(2009-7#2)(2012-12#1)(2012-2#2)(2013-1#1)
project offers##2##2##(1995-12#1)(2010-5#1)
project on the##2##3##(1990-12#1)(2009-7#1)
project on##11##2##(1990-12#1)(1992-3#1)(1994-4#1)(1995-7#1)(2008-7#2)(2009-7#1)(2009-8#1)(2011-2#1)(2013-1#2)
project plan##3##2##(1995-12#1)(1995-2#1)(2008-7#1)
project plane##2##2##(2009-7#2)
project prioritization##2##2##(1996-12#2)
project provides a##3##3##(2010-4#1)(2013-1#2)
project team##4##2##(1995-3#3)(2008-7#1)
project teams##2##2##(1993-12#1)(2008-10#1)
project that is##2##3##(2008-11#1)(2009-4#1)
project that##17##2##(1991-9#1)(1996-2#1)(2006-12#1)(2008-1#1)(2008-11#3)(2008-12#3)(2008-8#1)(2009-4#1)(2010-10#1)(2010-11#1)(2011-12#1)(2011-2#1)(2012-3#1)
project the##6##2##(2007-1#1)(2007-12#1)(2008-2#1)(2009-8#1)(2011-2#1)(2012-2#1)
project to both##2##3##(1993-3#1)(2012-2#1)
project to evaluate the##2##4##(2008-10#1)(2008-12#1)
project to layer IV##2##4##(1991-3#1)(1995-2#1)
project to promote##2##3##(2007-9#1)(2010-10#1)
project to the pituitary##2##4##(1995-7#1)(1995-8#1)
project to the##16##3##(1994-10#1)(1995-11#2)(1995-7#1)(1995-8#1)(1996-5#2)(1997-3#2)(1997-6#2)(2007-12#1)(2008-11#1)(2008-4#1)(2012-12#1)(2013-8#1)
project to##52##2##(1991-3#1)(1991-6#1)(1991-9#1)(1993-3#1)(1993-9#1)(1994-10#2)(1995-11#2)(1995-2#2)(1995-5#1)(1995-7#1)(1995-8#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-3#2)(1997-6#2)(2006-10#2)(2006-4#1)(2007-12#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#3)(2008-7#1)(2009-2#1)(2009-8#1)(2010-10#2)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
project undertaken by##2##3##(1997-3#1)(2007-11#1)
project undertaken##3##2##(1997-3#1)(2007-11#1)(2012-3#1)
project using the##2##3##(2008-3#1)(2010-8#1)
project was a##3##3##(2005-6#1)(2007-4#1)(2008-4#1)
project was carried out##2##4##(1994-6#1)(2013-1#1)
project was conducted##3##3##(1996-2#1)(2008-11#1)(2012-3#1)
project was designed to##2##4##(1996-2#1)(2008-11#1)
project was evaluated##2##3##(2009-4#1)(2013-1#1)
project was initiated in response to##2##6##(2008-12#1)(2010-8#1)
project was initiated in##3##4##(2006-5#1)(2008-12#1)(2010-8#1)
project was initiated##5##3##(1993-3#1)(2006-5#1)(2008-12#1)(2009-4#1)(2010-8#1)
project was to develop##4##4##(1991-9#1)(1996-7#1)(2008-1#1)(2009-4#1)
project was to examine the##2##5##(1995-3#1)(2011-2#1)
project was to examine##3##4##(1995-3#1)(2007-4#1)(2011-2#1)
project was to##19##3##(1991-9#1)(1994-3#1)(1995-3#2)(1996-7#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-8#1)(2011-2#2)(2012-1#1)(2013-1#1)
project was undertaken in##2##4##(1992-2#1)(1993-12#1)
project was undertaken to##2##4##(2008-10#1)(2012-12#1)
project was undertaken##6##3##(1992-2#1)(1993-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2012-12#1)
project was##65##2##(1991-9#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-3#1)(1994-6#1)(1995-3#3)(1995-6#1)(1996-2#2)(1996-7#1)(1997-4#2)(2005-6#1)(2006-5#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#3)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#3)(2009-5#1)(2010-5#1)(2010-8#2)(2011-2#3)(2011-9#4)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)
project we##3##2##(2007-9#1)(2011-1#2)
project were##4##2##(1995-3#1)(2006-5#1)(2008-11#1)(2012-2#1)
project which##3##2##(1995-3#2)(2010-6#1)
project whose purpose is to##2##5##(1994-12#1)(2010-8#1)
project whose##3##2##(1992-1#1)(1994-12#1)(2010-8#1)
project will be##3##3##(1996-9#1)(2009-10#1)(2010-5#1)
project will provide##2##3##(2008-7#1)(2012-12#1)
project will##10##2##(1996-1#1)(1996-9#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-5#1)(2012-12#1)
project with##3##2##(1992-12#1)(1997-3#1)(2012-12#1)
project within the##4##3##(1992-9#1)(1995-6#2)(2012-2#1)
project##793##1##(1990-10#1)(1990-12#2)(1990-3#1)(1990-4#3)(1990-6#1)(1991-1#3)(1991-10#1)(1991-12#1)(1991-3#3)(1991-6#2)(1991-9#4)(1992-1#4)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#6)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-12#5)(1993-3#9)(1993-9#4)(1994-1#5)(1994-10#3)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#5)(1995-12#4)(1995-2#5)(1995-3#21)(1995-4#2)(1995-5#2)(1995-6#3)(1995-7#2)(1995-8#3)(1996-1#3)(1996-11#2)(1996-12#3)(1996-2#9)(1996-3#6)(1996-4#2)(1996-5#5)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#9)(1997-4#3)(1997-5#3)(1997-6#3)(1997-7#2)(1997-8#2)(2004-4#1)(2005-10#6)(2005-11#2)(2005-12#3)(2005-6#2)(2005-7#3)(2005-8#1)(2005-9#2)(2006-1#3)(2006-10#8)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#2)(2006-5#10)(2006-6#4)(2006-7#1)(2006-8#3)(2007-1#2)(2007-10#6)(2007-11#9)(2007-12#18)(2007-2#5)(2007-3#1)(2007-4#11)(2007-5#8)(2007-6#1)(2007-7#4)(2007-8#12)(2007-9#13)(2008-1#12)(2008-10#20)(2008-11#34)(2008-12#23)(2008-2#14)(2008-3#8)(2008-4#15)(2008-5#3)(2008-6#3)(2008-7#34)(2008-8#11)(2008-9#10)(2009-10#3)(2009-2#1)(2009-3#1)(2009-4#12)(2009-5#2)(2009-7#6)(2009-8#6)(2009-9#3)(2010-10#5)(2010-11#2)(2010-12#5)(2010-2#2)(2010-3#3)(2010-4#5)(2010-5#5)(2010-6#2)(2010-7#2)(2010-8#14)(2010-9#2)(2011-1#4)(2011-12#3)(2011-2#65)(2011-9#8)(2012-1#3)(2012-11#1)(2012-12#21)(2012-2#14)(2012-3#11)(2013-1#41)(2013-8#16)
project)##2##1##(2008-7#1)(2008-8#1)
project]##6##1##(1990-8#1)(1991-2#1)(1994-3#1)(1997-2#1)(2007-3#1)(2009-2#1)
projected for the##3##3##(1990-12#1)(2007-12#1)(2007-7#1)
projected for##6##2##(1990-12#1)(1995-12#1)(2007-12#2)(2007-7#1)(2012-2#1)
projected from a small##2##4##(2007-11#1)(2008-3#1)
projected increase in##3##3##(2008-6#1)(2013-1#2)
projected increase##4##2##(1992-6#1)(2008-6#1)(2013-1#2)
projected increases in##2##3##(1996-12#1)(2008-8#1)
projected into##4##2##(1997-8#1)(2007-12#1)(2008-3#1)(2008-8#1)
projected on a##2##3##(2008-12#1)(2009-5#1)
projected onto a##5##3##(2007-12#1)(2008-2#2)(2008-3#1)(2011-7#1)
projected onto the object##3##4##(2008-3#3)
projected onto the##7##3##(2008-2#2)(2008-3#3)(2011-1#1)(2012-1#1)
projected onto##16##2##(2007-12#1)(2008-2#4)(2008-3#6)(2011-1#1)(2011-2#2)(2011-7#1)(2012-1#1)
projected over the##3##3##(1993-11#1)(2008-4#1)(2012-12#1)
projected principal-edge distribution (PPED)##2##4##(2008-2#2)
projected random patterns##2##3##(2008-3#2)
projected to be##2##3##(1993-9#1)(1995-12#1)
projected to become the##2##4##(1994-9#1)(2010-8#1)
projected to both##2##3##(1993-12#1)(1996-9#1)
projected to increase##2##3##(2007-7#1)(2012-12#1)
projected to the##6##3##(1990-4#1)(1993-12#4)(2007-9#1)
projected to##25##2##(1990-4#2)(1993-12#5)(1993-9#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-2#1)(1996-9#2)(1997-2#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-3#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)
projected##137##1##(1990-12#2)(1990-4#2)(1990-9#1)(1991-1#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#5)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#4)(1994-5#1)(1994-9#1)(1995-12#2)(1995-9#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-9#3)(1997-2#1)(1997-8#1)(2005-5#1)(2005-8#1)(2006-4#1)(2007-11#5)(2007-12#10)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#10)(2008-3#17)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#4)(2009-5#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-8#1)(2011-1#4)(2011-2#4)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#4)
projectile##9##1##(1990-9#1)(1997-5#2)(2006-7#1)(2007-12#1)(2008-9#1)(2009-10#2)(2010-2#1)
projectiles##2##1##(2006-11#1)(2007-12#1)
projecting SPNs in##2##3##(1991-9#2)
projecting SPNs##3##2##(1991-9#3)
projecting a##2##2##(2007-11#1)(2008-1#1)
projecting from the medial##2##4##(1997-3#1)(2012-2#1)
projecting from the##3##3##(1997-3#1)(2012-2#2)
projecting from##4##2##(1996-9#1)(1997-3#1)(2012-2#2)
projecting into the##4##3##(1992-7#1)(1994-2#1)(1995-7#1)(2007-9#1)
projecting into##5##2##(1992-7#1)(1994-2#1)(1995-7#1)(2007-9#1)(2011-1#1)
projecting the##2##2##(2007-7#1)(2013-8#1)
projecting to the nucleus tractus solitarii##2##6##(1991-8#2)
projecting to the##17##3##(1990-4#1)(1990-7#2)(1991-1#1)(1991-8#2)(1994-12#1)(1994-2#2)(1996-1#1)(1996-5#1)(1996-9#2)(2009-10#2)(2009-2#1)(2010-10#1)
projecting to##20##2##(1990-4#1)(1990-7#2)(1991-1#1)(1991-8#2)(1994-12#1)(1994-2#2)(1995-10#1)(1996-1#1)(1996-5#3)(1996-9#2)(2009-10#2)(2009-2#1)(2010-10#1)
projecting##53##1##(1990-4#1)(1990-7#2)(1991-1#1)(1991-8#2)(1991-9#4)(1992-7#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#4)(1995-10#2)(1995-11#1)(1995-7#1)(1996-1#1)(1996-3#1)(1996-5#3)(1996-9#3)(1997-3#1)(1997-6#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-2#2)(2009-10#2)(2009-2#1)(2009-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
projection algorithm is##2##3##(2006-10#1)(2008-3#1)
projection algorithm##10##2##(1996-2#1)(2006-10#5)(2008-3#4)
projection and the##2##3##(2008-3#1)(2012-1#1)
projection and##7##2##(1996-9#1)(1997-7#1)(2008-2#1)(2008-3#1)(2010-7#1)(2010-8#1)(2012-1#1)
projection angles##2##2##(2007-11#1)(2008-3#1)
projection area of the most distal screws##2##7##(2011-2#2)
projection area of the most distal##3##6##(2011-2#3)
projection area of the##4##4##(1996-2#1)(2011-2#3)
projection area of##6##3##(1990-7#1)(1996-1#1)(1996-2#1)(2011-2#3)
projection area##9##2##(1990-7#1)(1993-12#1)(1996-1#1)(1996-2#1)(2008-5#2)(2011-2#3)
projection areas of the##2##4##(1995-7#1)(2008-8#1)
projection areas of##3##3##(1995-7#1)(1996-3#1)(2008-8#1)
projection areas##8##2##(1991-9#1)(1993-6#1)(1995-12#1)(1995-7#1)(1996-3#1)(1997-2#1)(2008-7#1)(2008-8#1)
projection data##6##2##(2008-2#1)(2009-10#1)(2010-12#1)(2010-2#1)(2012-1#2)
projection display##3##2##(2008-2#1)(2008-3#2)
projection displays##2##2##(2008-2#1)(2008-3#1)
projection for##5##2##(1990-11#1)(2007-12#1)(2008-10#1)(2010-10#1)(2013-1#1)
projection from the##10##3##(1991-3#1)(1991-5#1)(1993-9#1)(1994-2#1)(1995-7#1)(1996-6#1)(1996-9#1)(1997-6#1)(2008-11#1)(2010-2#1)
projection from##15##2##(1991-3#1)(1991-5#1)(1993-9#1)(1994-2#1)(1995-11#2)(1995-7#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-6#1)(2008-11#2)(2009-2#1)(2010-2#1)
projection grating##2##2##(2008-3#2)
projection has##2##2##(1992-10#1)(1997-6#1)
projection image data##2##3##(2008-5#2)
projection image##4##2##(2008-5#3)(2008-8#1)
projection images##6##2##(2008-5#5)(2011-1#1)
projection in adult##2##3##(1990-5#1)(1991-3#1)
projection in the##3##3##(1991-8#2)(2008-7#1)
projection in##6##2##(1990-5#1)(1991-3#1)(1991-8#2)(1991-9#1)(2008-7#1)
projection is##4##2##(1991-3#1)(1995-10#1)(1996-1#1)(2008-1#1)
projection lens##4##2##(2008-2#1)(2008-3#3)
projection lithography##4##2##(2006-12#2)(2008-2#1)(2008-3#1)
projection neurons in the##2##4##(1994-2#1)(2008-7#1)
projection neurons of the##5##4##(1995-12#1)(1996-12#2)(2009-12#1)(2012-1#1)
projection neurons##20##2##(1990-4#1)(1991-9#2)(1993-12#1)(1993-7#1)(1994-2#1)(1995-12#1)(1996-12#3)(2008-11#2)(2008-7#3)(2009-10#1)(2009-12#1)(2012-1#1)(2013-8#2)
projection of a##3##3##(2007-11#1)(2007-12#1)(2010-6#1)
projection of object-adapted fringes##2##4##(2007-12#1)(2008-2#1)
projection of the##7##3##(1991-8#1)(2008-2#2)(2008-4#1)(2008-6#1)(2009-1#1)(2011-2#1)
projection of##24##2##(1990-11#1)(1991-3#1)(1991-8#1)(1993-12#1)(1993-7#1)(1994-2#1)(1996-1#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-1#1)(2010-6#1)(2011-2#1)(2013-1#1)
projection on##2##2##(2007-7#1)(2013-7#1)
projection onto the##2##3##(1991-3#1)(2008-2#1)
projection onto##4##2##(1991-3#1)(2008-2#2)(2008-3#1)
projection optical system##3##3##(2008-2#2)(2008-3#1)
projection optical##5##2##(2008-2#3)(2008-3#2)
projection optics##3##2##(2008-3#3)
projection pattern##2##2##(2007-12#2)
projection patterns of##3##3##(2007-12#2)(2008-11#1)
projection profilometry##5##2##(2008-1#1)(2008-3#4)
projection should##2##2##(1990-2#1)(1996-1#1)
projection sites##2##2##(1991-9#1)(1994-5#1)
projection system##9##2##(1990-2#1)(1995-7#1)(2008-2#2)(2008-3#5)
projection systems##8##2##(1990-4#1)(1994-5#1)(2008-2#2)(2008-3#4)
projection that##2##2##(2008-3#1)(2011-1#1)
projection through##3##2##(2008-2#2)(2008-9#1)
projection to the ipsilateral##2##4##(1995-7#1)(1996-9#1)
projection to the##15##3##(1990-5#3)(1993-12#2)(1994-2#2)(1995-12#1)(1995-7#2)(1996-5#1)(1996-9#2)(2008-3#1)(2011-2#1)
projection to##18##2##(1990-5#3)(1993-12#2)(1994-2#2)(1995-12#1)(1995-7#2)(1996-1#1)(1996-5#1)(1996-9#2)(2007-12#1)(2008-2#1)(2008-3#1)(2011-2#1)
projection view##2##2##(2008-5#2)
projection views##2##2##(2008-5#1)(2009-10#1)
projection was##5##2##(1994-12#1)(2007-1#2)(2008-6#1)(2008-7#1)
projection##316##1##(1990-11#2)(1990-2#2)(1990-4#2)(1990-5#4)(1990-7#2)(1991-3#5)(1991-5#3)(1991-8#4)(1991-9#7)(1992-10#2)(1992-6#1)(1993-10#2)(1993-12#5)(1993-2#1)(1993-6#1)(1993-7#2)(1993-9#1)(1994-10#2)(1994-12#2)(1994-2#6)(1994-5#2)(1995-10#1)(1995-11#3)(1995-12#4)(1995-2#1)(1995-7#5)(1996-1#8)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-9#9)(1997-2#1)(1997-6#3)(1997-7#2)(2005-5#1)(2006-10#6)(2006-11#1)(2006-12#2)(2007-1#3)(2007-11#3)(2007-12#11)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#8)(2008-11#6)(2008-2#28)(2008-3#55)(2008-4#3)(2008-5#13)(2008-6#4)(2008-7#11)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#3)(2009-12#1)(2009-2#3)(2010-10#1)(2010-12#2)(2010-2#4)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#8)(2012-1#6)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#3)
projectional##4##1##(1991-3#1)(2008-7#1)(2010-12#2)
projections and##9##2##(1990-11#1)(1991-5#1)(1994-2#1)(2007-12#2)(2007-2#1)(2007-5#1)(2013-1#1)(2013-8#1)
projections are##8##2##(1990-8#1)(1991-9#1)(1994-5#3)(2008-2#1)(2010-12#1)(2011-1#1)
projections by##2##2##(1993-10#1)(2006-10#1)
projections for the##2##3##(1990-11#1)(1991-9#1)
projections for##3##2##(1990-11#1)(1991-9#1)(2008-11#1)
projections from single neurons##3##4##(1997-1#1)(1997-3#1)(2009-2#1)
projections from the globus pallidus to the##2##7##(1990-7#1)(1991-9#1)
projections from the globus pallidus##3##5##(1990-7#1)(1991-9#2)
projections from the medial##4##4##(1996-11#2)(1997-3#1)(2013-8#1)
projections from the##21##3##(1990-7#1)(1991-9#2)(1992-10#1)(1992-7#1)(1993-9#1)(1994-10#1)(1995-12#1)(1995-6#1)(1996-11#2)(1996-6#1)(1996-9#1)(1997-3#1)(1997-7#1)(2008-11#2)(2008-7#1)(2009-10#1)(2013-1#1)(2013-8#1)
projections from##30##2##(1990-7#1)(1991-9#2)(1992-10#1)(1992-7#1)(1993-9#1)(1994-10#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-11#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-7#1)(2008-11#3)(2008-3#1)(2008-7#1)(2009-10#1)(2009-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
projections in a##2##3##(2008-2#1)(2010-12#1)
projections in##9##2##(1991-11#1)(1991-9#2)(1992-7#1)(1996-3#1)(2006-3#1)(2008-2#1)(2010-12#1)(2011-2#1)
projections into##3##2##(1991-12#1)(1993-9#1)(2008-7#1)
projections is##2##2##(1990-4#1)(1997-3#1)
projections may##2##2##(1990-10#1)(2008-2#1)
projections of the##14##3##(1993-12#2)(1994-9#2)(1995-5#1)(1996-9#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-5#1)(2011-1#1)(2013-7#1)
projections of##26##2##(1990-7#1)(1992-9#1)(1993-12#2)(1993-9#1)(1994-9#2)(1995-5#1)(1996-9#1)(1997-5#2)(2007-1#1)(2007-12#4)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-12#1)(2010-5#1)(2011-1#1)(2013-7#1)
projections on the##3##3##(1990-4#1)(1994-8#1)(2008-4#1)
projections on##4##2##(1990-4#1)(1994-8#1)(2008-4#1)(2010-12#1)
projections originating in the lateral nucleus##2##6##(1995-5#2)
projections originating##3##2##(1995-5#3)
projections to the dorsal##2##4##(1993-6#1)(1995-12#1)
projections to the##15##3##(1991-6#1)(1993-6#1)(1995-12#3)(1995-8#1)(1996-5#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-5#1)(2009-10#1)(2009-2#1)(2011-2#1)
projections to##23##2##(1991-6#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-2#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-8#1)(1996-5#1)(1996-9#3)(1997-2#1)(1997-3#1)(1997-5#1)(2009-10#1)(2009-2#1)(2009-5#1)(2011-2#1)(2012-11#1)
projections was##2##2##(1992-7#1)(2008-11#1)
projections were##5##2##(1991-11#1)(1993-3#1)(1996-9#1)(2007-12#1)(2012-1#1)
projections##224##1##(1990-10#1)(1990-11#3)(1990-4#2)(1990-7#2)(1990-8#1)(1991-1#2)(1991-11#2)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#7)(1992-10#2)(1992-2#1)(1992-3#2)(1992-6#2)(1992-7#4)(1992-9#1)(1993-1#1)(1993-10#2)(1993-12#3)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#2)(1993-9#4)(1994-10#1)(1994-12#1)(1994-2#6)(1994-5#6)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#2)(1995-11#5)(1995-12#4)(1995-5#7)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-2#2)(1996-3#2)(1996-5#4)(1996-6#1)(1996-9#9)(1997-1#1)(1997-2#1)(1997-3#4)(1997-5#3)(1997-6#2)(1997-7#1)(2006-10#5)(2006-3#2)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#13)(2007-2#1)(2007-5#1)(2007-7#3)(2008-1#1)(2008-10#2)(2008-11#7)(2008-12#1)(2008-2#8)(2008-3#3)(2008-4#3)(2008-6#1)(2008-7#5)(2008-9#1)(2009-10#3)(2009-2#3)(2009-3#1)(2009-5#3)(2009-8#2)(2009-9#1)(2010-12#4)(2010-2#1)(2010-5#1)(2011-1#3)(2011-2#2)(2012-1#3)(2012-11#2)(2012-12#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
projective displays##2##2##(2008-3#2)
projective##9##1##(1997-8#3)(2008-3#2)(2008-6#1)(2009-10#1)(2013-1#2)
projective-introjective identification##2##2##(2009-11#2)
projector and##3##2##(2007-5#1)(2008-2#1)(2008-3#1)
projector for##2##2##(2008-2#1)(2008-3#1)
projector with a##2##3##(2008-3#2)
projector with##3##2##(2008-2#1)(2008-3#2)
projector##30##1##(2007-11#2)(2007-5#1)(2008-10#2)(2008-2#10)(2008-3#12)(2008-6#3)
projectors##5##1##(1995-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2013-8#1)
projects aimed at##2##3##(1995-12#1)(2013-1#1)
projects and##14##2##(1996-3#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)
projects are##6##2##(1996-2#1)(2005-7#1)(2008-12#1)(2008-7#1)(2013-1#2)
projects as##2##2##(2008-11#1)(2008-2#1)
projects concerning##4##2##(1993-3#2)(2008-8#1)(2010-4#1)
projects for##5##2##(1994-3#2)(2005-10#1)(2007-12#1)(2011-2#1)
projects from the##3##3##(1991-5#1)(1995-11#1)(2008-10#1)
projects have##4##2##(1991-12#1)(2008-4#1)(2010-3#1)(2011-2#1)
projects in the##4##3##(1991-12#1)(2009-6#1)(2011-2#1)(2013-1#1)
projects in which##3##3##(2009-4#1)(2013-1#2)
projects in##22##2##(1991-12#1)(2007-7#2)(2008-4#1)(2008-7#2)(2008-9#2)(2009-4#2)(2009-6#1)(2009-7#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#3)
projects is##4##2##(1996-12#1)(2006-4#1)(2008-7#2)
projects of this##2##3##(1995-7#1)(2010-8#1)
projects of##10##2##(1990-6#1)(1993-8#1)(1995-7#1)(1996-10#1)(1997-4#1)(2006-10#1)(2008-11#1)(2009-6#1)(2010-8#1)(2012-12#1)
projects on##2##2##(1997-7#1)(2006-4#1)
projects presented##2##2##(1995-6#1)(2012-2#1)
projects should be##3##3##(1992-12#1)(1996-8#1)(2013-1#1)
projects should##4##2##(1992-12#1)(1992-3#1)(1996-8#1)(2013-1#1)
projects that are##2##3##(1993-3#1)(2008-10#1)
projects that##10##2##(1993-12#1)(1993-3#1)(1994-7#1)(1997-1#1)(2007-9#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-4#1)(2012-3#1)
projects to the##8##3##(1991-6#1)(1992-8#2)(1994-2#1)(1996-6#2)(1997-7#1)(2010-10#1)
projects to##13##2##(1991-6#1)(1992-8#2)(1993-3#1)(1994-2#1)(1996-6#2)(1997-7#1)(2006-11#1)(2008-9#1)(2009-2#1)(2010-10#1)(2011-2#1)
projects undertaken in##2##3##(2008-10#1)(2008-11#1)
projects was##2##2##(2007-8#1)(2008-8#1)
projects were##7##2##(1996-12#1)(2008-8#1)(2009-4#2)(2011-2#1)(2012-3#1)(2013-7#1)
projects which##5##2##(1992-3#1)(1996-2#1)(1996-3#2)(2013-1#1)
projects will##3##2##(1994-1#1)(2010-4#1)(2011-1#1)
projects with##3##2##(2007-12#1)(2007-9#1)(2010-3#1)
projects within the##2##3##(1993-2#1)(1993-8#1)
projects within##5##2##(1993-2#1)(1993-8#1)(1995-3#1)(2012-12#1)(2012-3#1)
projects##263##1##(1990-6#1)(1990-9#2)(1991-1#1)(1991-12#3)(1991-5#2)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#2)(1993-12#2)(1993-2#1)(1993-3#8)(1993-8#2)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#4)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2004-4#1)(2005-10#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-11#2)(2006-4#3)(2006-5#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-12#6)(2007-2#1)(2007-4#2)(2007-6#1)(2007-7#5)(2007-8#4)(2007-9#5)(2008-1#4)(2008-10#9)(2008-11#6)(2008-12#3)(2008-2#4)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#9)(2008-8#6)(2008-9#6)(2009-2#1)(2009-4#11)(2009-6#2)(2009-7#1)(2010-10#3)(2010-3#5)(2010-4#3)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#10)(2012-12#3)(2012-2#6)(2012-3#15)(2013-1#14)(2013-7#3)
prokaryote##16##1##(1992-11#1)(1994-12#2)(1996-12#1)(1997-6#3)(2007-8#1)(2008-1#2)(2008-10#4)(2008-8#1)(2008-9#1)
prokaryotes and eukaryotes##5##3##(1996-12#1)(1997-4#1)(2007-6#1)(2011-2#1)(2012-3#1)
prokaryotes and##9##2##(1996-12#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-6#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-7#1)
prokaryotes are##2##2##(2008-1#1)(2011-1#1)
prokaryotes##32##1##(1990-12#1)(1994-11#1)(1994-12#1)(1996-12#1)(1996-8#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(2006-10#1)(2006-12#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#3)(2009-2#1)(2009-6#1)(2010-4#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
prokaryotic DNA##2##2##(1994-12#1)(2008-10#1)
prokaryotic and eukaryotic expression##2##4##(1997-4#1)(2009-9#1)
prokaryotic and eukaryotic organisms##2##4##(2008-11#1)(2008-7#1)
prokaryotic and eukaryotic##17##3##(1990-5#2)(1995-6#1)(1995-8#1)(1997-4#2)(1997-7#2)(2006-10#2)(2006-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-9#1)(2013-1#1)
prokaryotic and##19##2##(1990-5#2)(1993-9#1)(1995-6#1)(1995-8#1)(1997-4#2)(1997-7#2)(2006-10#2)(2006-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-9#1)(2013-1#1)
prokaryotic as well as##2##4##(1996-2#1)(2011-2#1)
prokaryotic cells##5##2##(1992-12#1)(1994-5#1)(1997-4#1)(2008-11#1)(2012-1#1)
prokaryotic counterparts##2##2##(2009-2#2)
prokaryotic expression system##2##3##(2008-1#1)(2011-1#1)
prokaryotic expression vector##2##3##(1995-11#1)(1995-8#1)
prokaryotic expression##7##2##(1994-3#1)(1995-11#1)(1995-8#1)(2005-11#1)(2008-1#1)(2008-4#1)(2011-1#1)
prokaryotic genomics##2##2##(2005-6#1)(2005-8#1)
prokaryotic homologue##2##2##(1995-6#1)(2007-8#1)
prokaryotic or eukaryotic##2##3##(1990-11#1)(1994-5#1)
prokaryotic organisms##5##2##(1992-11#1)(1995-1#1)(1995-2#1)(2009-2#1)(2011-2#1)
prokaryotic promoter sequences##2##3##(1990-5#1)(1990-9#1)
prokaryotic proteins##2##2##(1992-7#1)(2008-7#1)
prokaryotic vector##2##2##(2008-11#2)
prokaryotic##106##1##(1990-1#1)(1990-11#2)(1990-5#5)(1990-9#2)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-6#1)(1992-7#2)(1993-11#1)(1993-12#1)(1993-4#2)(1993-9#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#2)(1995-8#2)(1996-10#1)(1996-2#1)(1996-9#1)(1997-4#3)(1997-6#1)(1997-7#2)(2005-11#1)(2005-6#1)(2005-8#1)(2006-10#2)(2006-12#2)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#5)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#2)(2009-2#5)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#10)(2011-2#5)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
prokinetic drugs##3##2##(1994-2#2)(2012-2#1)
prokinetic##6##1##(1994-2#2)(2005-12#1)(2007-3#1)(2011-2#1)(2012-2#1)
prokineticins##2##1##(2008-7#2)
prokinetics##3##1##(2006-10#1)(2008-1#1)(2010-12#1)
prolactin (PRL) and##2##3##(1995-10#1)(2008-6#1)
prolactin (PRL) secretion##2##3##(1990-7#1)(1994-3#1)
prolactin (PRL) was detected##2##4##(2006-9#1)(2008-5#1)
prolactin (PRL)##18##2##(1990-11#1)(1990-7#1)(1990-9#1)(1991-12#1)(1994-3#2)(1994-8#1)(1995-10#4)(1996-2#1)(1996-8#1)(2006-1#1)(2006-9#1)(2008-5#1)(2008-6#1)(2013-8#1)
prolactin and##8##2##(1990-9#1)(1991-12#1)(1992-1#1)(1994-11#1)(2008-1#1)(2008-12#1)(2008-4#1)(2010-2#1)
prolactin concentration##6##2##(1991-11#5)(2008-11#1)
prolactin in the##2##3##(1992-7#1)(2008-12#1)
prolactin in##11##2##(1990-4#1)(1991-2#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-12#2)(1993-2#1)(2008-12#1)(2008-4#1)(2012-2#1)
prolactin level##6##2##(1997-8#1)(2004-1#4)(2013-8#1)
prolactin levels were##4##3##(1990-11#1)(1992-5#1)(2004-10#2)
prolactin levels##18##2##(1990-11#4)(1992-5#1)(1993-2#1)(1995-12#1)(1995-3#1)(1997-8#4)(2004-10#2)(2007-11#1)(2010-10#3)
prolactin production##2##2##(1995-10#2)
prolactin receptor gene##3##3##(1992-1#1)(2008-4#2)
prolactin receptor in##2##3##(1990-11#1)(1997-6#1)
prolactin receptor##14##2##(1990-11#1)(1992-1#3)(1994-3#1)(1995-10#1)(1995-11#2)(1997-6#2)(2008-4#3)(2011-2#1)
prolactin release in##3##3##(1994-6#1)(2008-5#2)
prolactin release##10##2##(1991-3#1)(1994-6#1)(1996-2#1)(2008-4#1)(2008-5#4)(2010-10#2)
prolactin secretion in##5##3##(1991-2#1)(1994-3#2)(1995-10#2)
prolactin secretion##14##2##(1990-7#1)(1991-2#1)(1993-11#1)(1994-3#2)(1995-10#3)(1996-2#4)(2010-10#1)(2010-2#1)
prolactin to##2##2##(1993-12#1)(1994-11#1)
prolactin were measured##2##3##(1993-12#1)(1995-1#1)
prolactin were##4##2##(1993-12#1)(1995-1#1)(1996-8#1)(2004-10#1)
prolactin##167##1##(1990-11#7)(1990-2#1)(1990-4#2)(1990-7#2)(1990-9#2)(1991-11#5)(1991-12#3)(1991-2#3)(1991-3#3)(1991-4#1)(1991-7#1)(1992-1#4)(1992-2#1)(1992-5#2)(1992-6#1)(1992-7#3)(1992-9#1)(1993-11#1)(1993-12#5)(1993-2#4)(1994-11#8)(1994-12#1)(1994-3#6)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#2)(1995-10#12)(1995-11#3)(1995-12#1)(1995-3#4)(1996-2#6)(1996-8#3)(1997-6#2)(1997-8#5)(2004-1#4)(2004-10#4)(2006-1#2)(2006-12#2)(2006-9#2)(2007-1#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-12#6)(2008-3#1)(2008-4#7)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#7)(2010-2#2)(2011-1#2)(2011-2#1)(2012-2#2)(2013-8#2)
prolactin-like##2##1##(1994-2#2)
prolactin-secreting pituitary##2##2##(1992-2#1)(2011-2#1)
prolactin-secreting##5##1##(1991-2#1)(1992-2#1)(1996-8#1)(2006-9#1)(2011-2#1)
prolactine##2##1##(2008-7#2)
prolactinoma from##2##2##(2010-10#2)
prolactinoma##10##1##(1993-2#1)(2005-10#2)(2007-12#1)(2009-4#1)(2010-10#5)
prolactinomas and##2##2##(2008-5#1)(2013-8#1)
prolactinomas##8##1##(1993-2#1)(2005-10#2)(2007-12#2)(2008-5#1)(2013-8#2)
prolamins##2##1##(1991-12#1)(2006-12#1)
prolaps of##2##2##(2009-2#2)
prolapse and##14##2##(1993-6#1)(1997-2#1)(2007-4#3)(2007-8#1)(2008-12#1)(2013-1#6)(2013-8#1)
prolapse associated with outlet obstruction##2##5##(2006-6#2)
prolapse at##2##2##(2006-6#1)(2013-1#1)
prolapse has been##2##3##(2007-4#1)(2013-1#1)
prolapse in a##2##3##(1993-5#1)(2007-4#1)
prolapse in##8##2##(1992-5#1)(1993-5#1)(2005-7#1)(2006-4#1)(2007-4#1)(2007-8#1)(2008-8#1)(2011-2#1)
prolapse is a##2##3##(2012-2#1)(2013-1#1)
prolapse is##7##2##(2006-4#1)(2007-4#1)(2012-2#2)(2013-1#3)
prolapse of the##6##3##(1990-6#1)(2006-4#1)(2006-6#1)(2007-6#1)(2007-8#1)(2010-5#1)
prolapse of##7##2##(1990-6#1)(2006-4#1)(2006-6#1)(2007-6#1)(2007-8#1)(2010-5#1)(2013-1#1)
prolapse stage##2##2##(2008-12#2)
prolapse was##7##2##(2007-3#1)(2008-12#2)(2013-1#4)
prolapse with##2##2##(2007-11#1)(2008-4#1)
prolapse##129##1##(1990-10#1)(1990-6#1)(1991-8#1)(1992-11#1)(1992-4#1)(1992-5#2)(1993-5#1)(1993-6#1)(1995-6#5)(1997-1#5)(1997-2#2)(1997-3#1)(2005-7#1)(2006-4#7)(2006-6#4)(2006-8#1)(2007-11#1)(2007-3#1)(2007-4#13)(2007-6#1)(2007-7#1)(2007-8#12)(2008-10#2)(2008-12#8)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-1#1)(2010-5#1)(2011-12#2)(2011-2#8)(2012-2#4)(2012-3#1)(2013-1#31)(2013-8#1)
prolapsed intervertebral disc##2##3##(2012-2#1)(2013-1#1)
prolapsed##10##1##(1993-9#1)(1997-1#1)(2007-1#1)(2007-2#1)(2007-4#2)(2008-10#1)(2009-6#1)(2012-2#1)(2013-1#1)
prolapses##2##1##(2006-6#1)(2008-12#1)
prolapsing##3##1##(2007-8#1)(2008-11#1)(2010-1#1)
prolate and##2##2##(2008-3#2)
prolate spheroids##2##2##(2008-3#2)
prolate##11##1##(1993-3#1)(1995-1#1)(2005-11#1)(2007-12#1)(2008-2#2)(2008-3#5)
prolene mesh##3##2##(2008-12#1)(2008-7#1)(2011-1#1)
prolene##5##1##(1992-3#2)(2008-12#1)(2008-7#1)(2011-1#1)
prolidase (EC 3##2##3##(1991-4#1)(1994-3#1)
prolidase I##2##2##(1990-1#2)
prolidase II from##2##3##(1990-1#2)
prolidase from##2##2##(1990-1#2)
prolidase mRNA##2##2##(1996-7#2)
prolidase##23##1##(1990-1#10)(1991-4#2)(1994-3#2)(1996-7#5)(2007-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
proliferate and differentiate into antibody secreting cells##2##7##(1996-11#2)
proliferate and differentiate into##3##4##(1996-11#2)(2008-4#1)
proliferate and differentiate##7##3##(1995-12#1)(1996-11#2)(2006-1#1)(2008-4#1)(2010-1#1)(2010-3#1)
proliferate and mature into##2##4##(2008-11#1)(2008-4#1)
proliferate and##20##2##(1995-12#1)(1996-11#3)(1997-6#1)(2005-7#1)(2006-1#1)(2007-11#1)(2008-11#4)(2008-4#2)(2008-7#1)(2009-5#1)(2010-1#1)(2010-3#1)(2012-2#2)
proliferate in response to##3##4##(1990-12#1)(1995-5#1)(2006-11#1)
proliferate in##12##2##(1990-12#1)(1992-9#1)(1994-2#1)(1995-5#1)(1997-1#1)(2006-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2013-8#1)
proliferate indefinitely##2##2##(2008-1#2)
proliferate to form##3##3##(1995-2#1)(2012-12#2)
proliferate to##6##2##(1995-2#2)(2008-4#1)(2011-1#1)(2012-12#2)
proliferate under##2##2##(1991-3#1)(2008-7#1)
proliferate##73##1##(1990-12#2)(1990-6#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-1#1)(1996-11#3)(1996-4#1)(1996-7#1)(1997-1#1)(1997-6#1)(2004-9#1)(2005-7#1)(2006-1#1)(2006-11#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#2)(2008-11#10)(2008-4#6)(2008-5#2)(2008-7#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#3)(2013-8#2)
proliferated in the##2##3##(1993-8#1)(1997-5#1)
proliferated in##9##2##(1993-8#1)(1997-5#1)(2006-8#1)(2008-10#1)(2008-11#2)(2012-1#1)(2013-1#2)
proliferated more##2##2##(2008-11#2)
proliferated rapidly##2##2##(2007-4#1)(2008-5#1)
proliferated##37##1##(1991-12#1)(1991-7#1)(1993-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-4#3)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-4#1)(2008-10#4)(2008-11#7)(2008-3#1)(2008-5#1)(2009-10#1)(2009-8#1)(2012-1#2)(2012-2#1)(2012-4#1)(2013-1#2)
proliferates in the##2##3##(1994-12#1)(2011-2#1)
proliferates##4##1##(1994-12#1)(2007-12#1)(2011-2#1)(2012-2#1)
proliferating HeLa interphase cells##2##4##(1992-6#2)
proliferating and##6##2##(1992-3#2)(1992-9#1)(1993-11#1)(2008-8#1)(2008-9#1)
proliferating cell nuclear antigen (PCNA) and##4##6##(1994-11#1)(1995-2#1)(2010-12#1)(2013-1#1)
proliferating cell nuclear antigen (PCNA) were##2##6##(1991-7#1)(1994-7#1)
proliferating cell nuclear antigen (PCNA)##23##5##(1991-7#1)(1994-11#1)(1994-12#1)(1994-7#1)(1994-8#1)(1995-2#2)(1995-4#1)(1995-6#1)(1995-8#1)(1996-11#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-6#1)(2009-2#1)(2009-8#1)(2010-12#2)(2011-2#1)(2012-1#1)(2013-1#2)
proliferating cell nuclear antigen and##2##5##(1992-10#1)(1994-8#1)
proliferating cell nuclear antigen##38##4##(1991-7#1)(1992-10#1)(1994-11#1)(1994-12#1)(1994-7#1)(1994-8#2)(1994-9#3)(1995-2#3)(1995-4#1)(1995-6#1)(1995-8#3)(1996-11#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2007-8#1)(2008-6#1)(2009-2#1)(2009-8#1)(2010-12#3)(2011-2#1)(2012-1#1)(2013-1#4)
proliferating cell##43##2##(1991-10#1)(1991-7#1)(1992-10#1)(1994-11#1)(1994-12#2)(1994-7#1)(1994-8#2)(1994-9#3)(1995-2#4)(1995-4#1)(1995-6#1)(1995-8#3)(1996-11#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2005-12#1)(2007-8#1)(2008-6#1)(2009-2#1)(2009-8#1)(2010-12#3)(2011-2#1)(2012-1#1)(2013-1#5)
proliferating cells and##2##3##(1991-8#1)(1996-4#1)
proliferating cells with##2##3##(1995-12#1)(1996-5#1)
proliferating cells##27##2##(1990-2#1)(1990-4#1)(1991-1#1)(1991-8#1)(1991-9#1)(1992-6#1)(1994-8#1)(1995-12#1)(1995-2#3)(1995-8#1)(1996-4#2)(1996-5#1)(1996-9#1)(1997-2#1)(2006-10#1)(2008-5#2)(2008-8#2)(2008-9#3)(2010-3#2)
proliferating cultures of##2##3##(1995-3#2)
proliferating cultures##3##2##(1995-3#3)
proliferating in##2##2##(1994-3#1)(2010-3#1)
proliferating periodontal tissue##3##3##(2010-2#3)
proliferating periodontal##4##2##(2010-2#4)
proliferating##151##1##(1990-2#1)(1990-4#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-3#2)(1992-6#4)(1992-8#2)(1992-9#2)(1993-11#3)(1993-2#1)(1993-4#2)(1993-8#2)(1994-10#1)(1994-11#1)(1994-12#3)(1994-3#2)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#6)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#9)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#4)(1996-11#2)(1996-4#2)(1996-5#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#1)(2004-1#3)(2005-12#2)(2005-8#1)(2006-10#3)(2007-12#1)(2007-2#2)(2007-8#1)(2008-11#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#4)(2009-2#1)(2009-3#1)(2009-8#2)(2009-9#1)(2010-12#6)(2010-2#4)(2010-3#4)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#7)
proliferation (Ki-67) and apoptosis##2##4##(2010-12#1)(2013-1#1)
proliferation (Ki-67) and##3##3##(2010-12#1)(2011-2#1)(2013-1#1)
proliferation ability##2##2##(2008-11#1)(2013-1#1)
proliferation after##8##2##(1991-10#1)(1997-8#1)(2008-10#2)(2008-11#1)(2012-2#1)(2013-1#2)
proliferation and IFN-γ secretion##2##4##(2011-12#1)(2013-1#1)
proliferation and a##5##3##(1993-11#1)(1997-1#1)(2006-10#1)(2008-11#1)(2012-3#1)
proliferation and activation of##2##4##(1995-3#1)(2010-12#1)
proliferation and activation##3##3##(1995-3#1)(1997-3#1)(2010-12#1)
proliferation and angiogenesis##2##3##(2011-1#1)(2012-12#1)
proliferation and apoptosis in##4##4##(1997-3#1)(2008-11#1)(2011-2#2)
proliferation and apoptosis of##4##4##(2011-2#2)(2012-12#1)(2013-1#1)
proliferation and apoptosis##14##3##(1997-3#2)(2008-1#1)(2008-11#2)(2008-7#1)(2011-2#4)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
proliferation and autocrine secretion of##2##5##(2011-12#2)
proliferation and cell death##5##4##(1993-4#2)(2008-11#3)
proliferation and cell##13##3##(1993-4#2)(1997-1#1)(2005-8#1)(2007-11#1)(2007-4#1)(2008-11#3)(2008-4#1)(2008-9#1)(2009-5#1)(2011-2#1)
proliferation and contraction##2##3##(1993-8#1)(1996-7#1)
proliferation and cytokine production##2##4##(2005-8#1)(2010-12#1)
proliferation and death##5##3##(1991-10#1)(1997-6#2)(2007-9#1)(2012-1#1)
proliferation and differentiation during##3##4##(1994-9#1)(2010-9#1)(2011-12#1)
proliferation and differentiation in##3##4##(1991-5#1)(1994-12#1)(1995-12#1)
proliferation and differentiation of MSC##2##5##(2008-5#2)
proliferation and differentiation of erythroid##2##5##(1990-4#1)(2008-11#1)
proliferation and differentiation of human##3##5##(1994-6#1)(2008-11#1)(2012-12#1)
proliferation and differentiation of##21##4##(1990-4#1)(1993-3#1)(1993-9#1)(1994-6#2)(1995-10#1)(1996-10#1)(1997-1#1)(2004-11#1)(2006-12#1)(2008-11#2)(2008-5#7)(2012-12#1)(2013-7#1)
proliferation and differentiation##52##3##(1990-4#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-6#2)(1994-9#2)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-10#1)(1996-4#1)(1997-1#1)(1997-6#1)(2004-11#1)(2004-9#1)(2006-12#2)(2007-10#1)(2008-11#4)(2008-4#1)(2008-5#8)(2008-9#2)(2009-8#1)(2010-11#1)(2010-9#1)(2011-12#1)(2012-12#3)(2012-2#2)(2013-7#1)
proliferation and enhances##2##3##(1996-8#1)(2012-1#1)
proliferation and for##2##3##(2004-9#1)(2008-11#1)
proliferation and function of##3##4##(1995-5#1)(2008-4#1)(2011-2#1)
proliferation and growth of##3##4##(1994-11#1)(2008-1#1)(2011-2#1)
proliferation and growth##5##3##(1994-11#1)(1996-4#1)(2008-1#1)(2010-4#1)(2011-2#1)
proliferation and immunoglobulin##2##3##(2006-1#1)(2008-4#1)
proliferation and increased##6##3##(2009-12#1)(2009-3#1)(2012-4#1)(2013-1#3)
proliferation and induced apoptosis##2##4##(2011-2#1)(2012-12#1)
proliferation and induced##3##3##(2008-5#1)(2011-2#1)(2012-12#1)
proliferation and induces##2##3##(2008-4#1)(2009-3#1)
proliferation and inducing##2##3##(1992-8#1)(1993-4#1)
proliferation and induction of##2##4##(1995-11#1)(2008-10#1)
proliferation and inhibits##2##3##(1994-6#1)(2009-2#1)
proliferation and invasion of##10##4##(2008-11#6)(2011-2#1)(2013-1#3)
proliferation and invasion##16##3##(1995-2#2)(2008-11#7)(2011-2#2)(2012-12#1)(2013-1#4)
proliferation and is##3##3##(1992-11#1)(2008-5#1)(2011-2#1)
proliferation and its##2##3##(1997-5#1)(2007-12#1)
proliferation and maturation of##2##4##(1996-5#1)(2011-1#1)
proliferation and migration of##6##4##(1991-12#1)(1993-9#2)(2008-4#2)(2009-6#1)
proliferation and migration##11##3##(1991-12#1)(1993-9#2)(2005-11#1)(2008-10#2)(2008-4#2)(2009-6#1)(2012-12#1)(2012-2#1)
proliferation and neuronal differentiation of human fetal##2##7##(2009-10#2)
proliferation and osteogenic differentiation of##2##5##(2008-5#2)
proliferation and osteogenic differentiation##3##4##(2008-5#3)
proliferation and recombinant##2##3##(2008-11#2)
proliferation and survival of##4##4##(2005-11#1)(2009-8#1)(2013-1#2)
proliferation and survival##12##3##(1991-12#1)(2005-11#1)(2008-3#1)(2008-5#1)(2009-12#1)(2009-3#1)(2009-8#1)(2012-12#1)(2013-1#3)(2013-8#1)
proliferation and the##12##3##(1990-11#1)(1991-12#1)(1992-3#1)(1993-3#1)(1994-3#1)(2008-1#1)(2008-11#3)(2008-4#2)(2013-8#1)
proliferation and to##3##3##(1993-12#1)(1995-2#1)(2012-2#1)
proliferation and transformation by##2##4##(1991-1#1)(2008-11#1)
proliferation and transformation##4##3##(1991-1#1)(1992-8#1)(1994-9#1)(2008-11#1)
proliferation and##320##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#5)(1991-2#1)(1991-5#3)(1991-6#1)(1992-11#1)(1992-3#1)(1992-7#1)(1992-8#5)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#3)(1993-4#3)(1993-7#3)(1993-8#1)(1993-9#4)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#6)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#6)(1995-2#7)(1995-3#2)(1995-5#4)(1996-10#2)(1996-11#1)(1996-4#3)(1996-5#1)(1996-7#2)(1996-8#3)(1997-1#4)(1997-3#3)(1997-5#1)(1997-6#5)(1997-7#3)(2004-11#1)(2004-12#1)(2004-9#2)(2005-11#2)(2005-8#2)(2006-1#2)(2006-10#2)(2006-12#2)(2006-6#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-4#2)(2007-8#1)(2007-9#1)(2008-1#7)(2008-10#4)(2008-11#29)(2008-12#1)(2008-3#2)(2008-4#10)(2008-5#19)(2008-7#3)(2008-8#1)(2008-9#6)(2009-10#2)(2009-12#2)(2009-2#1)(2009-3#4)(2009-5#1)(2009-6#2)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-12#4)(2011-2#17)(2012-1#3)(2012-11#2)(2012-12#11)(2012-2#7)(2012-3#3)(2012-4#1)(2012-5#1)(2013-1#16)(2013-7#1)(2013-8#6)
proliferation are##4##2##(1993-9#2)(2007-4#1)(2008-4#1)
proliferation as well as##2##4##(1991-5#1)(2008-11#1)
proliferation as##6##2##(1991-5#1)(1991-8#1)(1995-6#1)(2008-11#1)(2008-5#1)(2009-9#1)
proliferation assay for##2##3##(2008-10#1)(2013-1#1)
proliferation assay was##2##3##(1993-7#1)(2013-1#1)
proliferation assay##23##2##(1991-10#1)(1992-8#2)(1993-7#1)(1993-8#1)(1994-12#1)(1995-12#1)(1996-11#1)(1997-6#1)(2007-2#3)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#3)(2011-2#2)(2013-1#2)
proliferation assays##13##2##(1991-9#1)(1992-8#2)(1993-12#1)(2006-11#1)(2006-7#1)(2007-2#1)(2008-10#1)(2008-4#2)(2008-9#1)(2010-3#1)(2012-12#1)
proliferation associated with##3##3##(1992-3#1)(1992-8#1)(1996-5#1)
proliferation at the##2##3##(1991-12#1)(1993-11#1)
proliferation at##8##2##(1991-12#1)(1992-5#1)(1993-11#1)(1995-10#1)(2008-11#1)(2009-4#1)(2009-8#1)(2013-1#1)
proliferation but##2##2##(1993-8#1)(2006-10#1)
proliferation by an##2##3##(1991-5#1)(1994-3#1)
proliferation by the##2##3##(1992-5#1)(1995-2#1)
proliferation by##29##2##(1990-7#2)(1990-8#1)(1991-10#2)(1991-5#3)(1991-8#2)(1992-11#1)(1992-2#1)(1992-5#2)(1993-11#1)(1993-9#2)(1994-3#1)(1995-10#1)(1995-2#3)(1997-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#2)
proliferation can##2##2##(1990-8#1)(2008-6#1)
proliferation capacity##2##2##(2007-2#1)(2008-1#1)
proliferation characteristics##2##2##(1990-5#1)(2008-11#1)
proliferation control and##2##3##(1994-3#1)(2009-5#1)
proliferation control in##2##3##(2008-11#1)(2009-5#1)
proliferation control##5##2##(1994-3#1)(2008-11#2)(2009-5#2)
proliferation could be##3##3##(1992-11#1)(2012-11#2)
proliferation during##8##2##(1991-5#1)(1994-3#1)(2008-11#1)(2009-8#1)(2012-12#4)
proliferation experiments##2##2##(2009-3#1)(2011-2#1)
proliferation following##2##2##(1995-6#1)(1997-4#1)
proliferation for a##2##3##(2006-6#1)(2008-5#1)
proliferation for##4##2##(2006-6#1)(2008-11#1)(2008-5#1)(2011-2#1)
proliferation from##2##2##(1996-3#1)(2007-2#1)
proliferation has been##3##3##(1992-1#1)(1993-7#1)(1995-2#1)
proliferation in Arabidopsis##2##3##(2009-8#2)
proliferation in a##8##3##(1991-10#1)(1992-5#1)(1992-8#1)(1995-11#1)(1996-8#1)(2007-2#1)(2008-11#1)(2010-12#1)
proliferation in an##3##3##(1995-10#1)(2007-12#1)(2008-4#1)
proliferation in both##6##3##(1991-5#1)(1993-8#1)(2007-8#1)(2008-11#1)(2012-11#2)
proliferation in breast##2##3##(2008-10#1)(2008-4#1)
proliferation in different##2##3##(2012-3#1)(2013-7#1)
proliferation in normal##2##3##(1996-11#1)(1996-5#1)
proliferation in rats##2##3##(1995-3#1)(1996-12#1)
proliferation in response to##4##4##(1992-12#1)(2007-3#1)(2010-11#1)(2012-12#1)
proliferation in the##15##3##(1990-8#1)(1991-12#1)(1993-9#1)(1994-3#1)(1995-12#1)(1996-11#1)(2006-9#1)(2008-11#2)(2008-5#2)(2008-7#1)(2010-12#1)(2010-6#1)(2013-1#1)
proliferation in this##2##3##(1993-8#1)(2008-10#1)
proliferation in vitro##12##3##(1990-9#1)(1991-8#1)(1992-2#1)(1993-4#1)(1994-2#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-8#1)(2010-3#1)
proliferation in##120##2##(1990-11#1)(1990-12#2)(1990-6#1)(1990-8#3)(1990-9#1)(1991-10#1)(1991-12#1)(1991-5#4)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-8#2)(1993-9#2)(1994-11#2)(1994-2#2)(1994-3#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#3)(1995-6#1)(1995-9#1)(1996-11#5)(1996-12#2)(1996-5#2)(1996-8#1)(1997-2#1)(1997-5#1)(1997-6#1)(2004-1#2)(2005-12#1)(2006-1#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#9)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-11#3)(2012-12#2)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#1)(2013-7#1)(2013-8#1)
proliferation index##5##2##(1996-11#1)(2011-1#1)(2011-2#2)(2013-8#1)
proliferation indexes##2##2##(1996-11#2)
proliferation induced by##4##3##(1990-12#1)(1994-9#1)(2008-4#1)(2009-8#1)
proliferation inhibition##3##2##(1992-2#1)(2012-12#2)
proliferation is a##2##3##(2008-1#1)(2008-6#1)
proliferation is an##2##3##(2008-4#1)(2008-7#1)
proliferation is##17##2##(1992-5#1)(1995-6#1)(2004-9#1)(2005-12#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-4#2)(2008-6#1)(2008-7#2)(2010-11#1)(2011-2#1)(2012-1#1)(2012-12#2)
proliferation kinetics of adapted strain##2##5##(2013-8#2)
proliferation kinetics of adapted##3##4##(2013-8#3)
proliferation kinetics of##4##3##(1993-11#1)(2013-8#3)
proliferation kinetics##7##2##(1993-11#1)(1994-3#1)(2009-12#1)(2013-8#4)
proliferation marker##2##2##(2011-2#1)(2013-8#1)
proliferation markers and##2##3##(1991-10#1)(1997-7#1)
proliferation markers are##2##3##(2011-2#2)
proliferation markers##6##2##(1991-10#1)(1997-7#1)(2011-2#2)(2012-1#2)
proliferation may##2##2##(1990-7#1)(1996-12#1)
proliferation occurred##4##2##(1991-8#1)(1992-8#1)(2008-9#1)(2013-1#1)
proliferation of CD4+ Th clones##2##5##(1991-12#1)(1992-7#1)
proliferation of CD4+##3##3##(1991-12#1)(1992-7#1)(2007-9#1)
proliferation of CHO cells##2##4##(1995-2#1)(1997-1#1)
proliferation of Langerhans##2##3##(2010-6#1)(2012-3#1)
proliferation of MCF-7 cells##3##4##(1996-3#1)(2008-11#2)
proliferation of MCF-7 human breast cancer cells that contained high levels of estrogen receptor (1##2##15##(2008-11#2)
proliferation of MCF-7##5##3##(1996-3#1)(2008-11#4)
proliferation of NG108-15 cells##2##4##(1997-1#1)(1997-7#1)
proliferation of RPMI 1788 cells##2##5##(1990-12#2)
proliferation of RPMI 1788##3##4##(1990-12#3)
proliferation of T cells##5##4##(2004-12#4)(2008-5#1)
proliferation of T##8##3##(1993-3#1)(2004-12#4)(2008-10#1)(2008-5#1)(2012-2#1)
proliferation of a murine##2##4##(1994-5#1)(2008-4#1)
proliferation of a##3##3##(1994-5#1)(2008-4#1)(2010-6#1)
proliferation of activated##2##3##(1991-3#1)(2011-2#1)
proliferation of all##5##3##(1991-5#1)(2007-11#1)(2008-11#1)(2009-9#1)(2010-4#1)
proliferation of bone marrow cells##3##5##(1994-12#3)
proliferation of both##2##3##(1993-12#1)(1995-5#1)
proliferation of cells and##2##4##(2007-1#1)(2008-11#1)
proliferation of cells##6##3##(1990-7#1)(2007-1#1)(2007-11#1)(2008-11#1)(2008-5#2)
proliferation of chloride cells##2##4##(2008-10#1)(2013-1#1)
proliferation of compact##2##3##(2011-2#2)
proliferation of cultured human cells##2##5##(1994-3#1)(2004-9#1)
proliferation of cultured##4##3##(1994-3#1)(1995-5#1)(2004-9#1)(2010-12#1)
proliferation of endothelial cells and##2##5##(1993-4#1)(2004-3#1)
proliferation of endothelial cells in##2##5##(2008-6#1)(2009-7#1)
proliferation of endothelial cells##6##4##(1990-4#1)(1990-7#1)(1993-4#1)(2004-3#1)(2008-6#1)(2009-7#1)
proliferation of fibroblasts##2##3##(1994-5#1)(1996-3#1)
proliferation of gastric cancer##2##4##(2008-11#2)
proliferation of gastric##3##3##(2008-11#2)(2008-9#1)
proliferation of human cells##2##4##(1997-3#2)
proliferation of human lymphocytes##2##4##(1992-12#1)(2008-5#1)
proliferation of human umbilical##2##4##(1995-2#1)(2008-8#1)
proliferation of human##21##3##(1990-7#1)(1991-9#2)(1992-12#1)(1992-8#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-3#1)(1997-3#2)(2004-9#1)(2008-11#2)(2008-5#3)(2008-8#1)
proliferation of individual##2##3##(2008-4#1)(2011-2#1)
proliferation of lymphocytes##2##3##(1995-3#1)(1996-5#1)
proliferation of mammalian cells##2##4##(1997-1#1)(2008-11#1)
proliferation of mature##2##3##(2010-6#1)(2013-7#1)
proliferation of mouse##5##3##(1992-5#1)(2008-11#1)(2008-6#1)(2008-9#2)
proliferation of murine##4##3##(1995-2#1)(2006-10#2)(2008-8#1)
proliferation of neural stem cells##2##5##(1994-11#2)
proliferation of neural##3##3##(1994-11#2)(1995-11#1)
proliferation of new##2##3##(2005-7#1)(2008-3#1)
proliferation of nontransformed cells##2##4##(1995-2#2)
proliferation of normal##4##3##(1991-1#1)(1991-3#2)(1996-3#1)
proliferation of osteoblastic##4##3##(1991-12#2)(1991-8#1)(1993-8#1)
proliferation of pre-existing β-cells##2##4##(2010-11#2)
proliferation of primary##3##3##(1993-6#1)(1994-3#1)(1997-4#1)
proliferation of quiescent##2##3##(1997-3#2)
proliferation of rat PASMCs##3##4##(2011-3#3)
proliferation of rat##8##3##(1991-9#1)(1992-2#1)(1992-3#1)(2011-3#5)
proliferation of resident##2##3##(2008-10#1)(2010-12#1)
proliferation of small##4##3##(2008-8#2)(2009-1#1)(2009-3#1)
proliferation of smooth muscle cells##5##5##(1992-9#1)(1993-8#1)(1996-3#1)(2006-6#1)(2008-11#1)
proliferation of some##2##3##(2008-8#1)(2010-12#1)
proliferation of spindle##2##3##(2007-8#1)(2012-2#1)
proliferation of the human megakaryoblastic leukemia cell line##2##8##(2008-4#2)
proliferation of the human##4##4##(1994-6#1)(2007-11#1)(2008-4#2)
proliferation of the synovial membrane##2##5##(2009-3#1)(2010-12#1)
proliferation of the##36##3##(1991-9#1)(1993-11#1)(1993-9#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-3#2)(1997-2#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-11#1)(2008-11#5)(2008-3#1)(2008-4#7)(2008-5#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-1#1)
proliferation of these cells##3##4##(1994-2#1)(1995-3#1)(1997-7#1)
proliferation of these##6##3##(1992-7#1)(1994-2#1)(1995-10#1)(1995-3#1)(1997-7#1)(2008-10#1)
proliferation of various##3##3##(1993-9#1)(2012-11#2)
proliferation of vascular smooth muscle##2##5##(1990-12#1)(2010-12#1)
proliferation of vascular##4##3##(1990-12#1)(1993-3#1)(1997-1#1)(2010-12#1)
proliferation of##364##2##(1990-12#4)(1990-4#1)(1990-5#2)(1990-7#6)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#4)(1991-3#4)(1991-4#1)(1991-5#1)(1991-8#2)(1991-9#4)(1992-12#1)(1992-2#3)(1992-3#2)(1992-5#1)(1992-7#3)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#4)(1993-4#2)(1993-5#1)(1993-6#1)(1993-8#5)(1993-9#3)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#4)(1994-5#2)(1994-6#2)(1994-9#2)(1995-1#1)(1995-10#2)(1995-11#3)(1995-12#3)(1995-2#6)(1995-3#4)(1995-5#6)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#8)(1996-5#1)(1996-6#1)(1997-1#5)(1997-2#3)(1997-3#4)(1997-4#2)(1997-6#1)(1997-7#5)(2004-12#6)(2004-3#1)(2004-9#2)(2005-11#1)(2005-6#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#4)(2006-12#2)(2006-5#1)(2006-6#2)(2006-9#1)(2007-1#1)(2007-11#8)(2007-12#3)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#9)(2008-11#34)(2008-3#3)(2008-4#13)(2008-5#12)(2008-6#5)(2008-7#5)(2008-8#9)(2008-9#4)(2009-1#1)(2009-3#2)(2009-4#2)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#3)(2010-1#2)(2010-11#5)(2010-12#10)(2010-3#1)(2010-4#1)(2010-6#5)(2011-1#2)(2011-2#10)(2011-3#6)(2012-1#5)(2012-11#2)(2012-2#4)(2012-3#4)(2012-4#1)(2012-6#1)(2013-1#3)(2013-7#2)(2013-8#3)
proliferation on##5##2##(1991-1#1)(1995-4#1)(2004-12#1)(2008-5#2)
proliferation or apoptosis##2##3##(1996-10#1)(2013-8#1)
proliferation or##19##2##(1991-10#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-4#1)(1994-12#1)(1995-3#1)(1995-5#1)(1996-10#1)(2007-8#1)(2008-11#1)(2008-5#1)(2012-12#2)(2012-3#1)(2013-8#3)
proliferation over that of control##2##5##(2008-11#2)
proliferation over##3##2##(2006-12#1)(2008-11#2)
proliferation potential##4##2##(1996-11#1)(2007-12#1)(2008-11#2)
proliferation processes##2##2##(2012-1#2)
proliferation protein##3##2##(2012-1#3)
proliferation rate of##2##3##(1997-7#1)(2008-5#1)
proliferation rate##14##2##(1991-8#1)(1993-8#1)(1994-10#1)(1995-4#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-11#3)(2008-5#1)(2008-7#1)(2012-1#1)(2012-3#1)
proliferation rates##4##2##(1997-6#3)(2008-11#1)
proliferation rather than##3##3##(1991-8#1)(1996-11#1)(1997-7#1)
proliferation regulation##2##2##(2008-4#1)(2012-1#1)
proliferation responses##2##2##(1997-4#1)(1997-6#1)
proliferation stimulated by##3##3##(1990-7#1)(1991-1#2)
proliferation suppression##2##2##(2008-10#1)(2010-12#1)
proliferation than##3##2##(2008-5#1)(2010-12#1)(2010-3#1)
proliferation that##2##2##(2008-11#2)
proliferation the##2##2##(2006-10#1)(2008-1#1)
proliferation through##4##2##(1991-9#1)(1993-4#1)(1995-2#1)(2009-4#1)
proliferation to##4##2##(1993-8#1)(1995-10#1)(1997-2#1)(2008-5#1)
proliferation using##2##2##(2008-4#1)(2008-5#1)
proliferation via##4##2##(1991-3#1)(1993-9#1)(2008-3#1)(2013-1#1)
proliferation was analyzed##2##3##(2008-9#1)(2009-4#1)
proliferation was evaluated by##2##4##(2004-9#1)(2007-2#1)
proliferation was investigated##2##3##(1996-12#1)(2008-11#1)
proliferation was markedly##2##3##(1993-12#1)(1995-2#1)
proliferation was observed##3##3##(1994-5#1)(1997-2#1)(2012-1#1)
proliferation was reduced##3##3##(1995-8#1)(1997-2#1)(2008-11#1)
proliferation was significantly##3##3##(1990-5#1)(1991-12#1)(2008-9#1)
proliferation was##43##2##(1990-5#1)(1991-10#1)(1991-12#1)(1992-1#1)(1993-12#1)(1994-11#2)(1994-2#1)(1994-5#1)(1995-1#1)(1995-2#3)(1995-3#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-2#4)(1997-6#1)(2004-9#1)(2007-2#1)(2008-11#6)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-4#1)(2010-12#1)(2010-3#1)(2012-1#1)(2012-2#1)(2012-3#1)
proliferation were##13##2##(1991-5#1)(1995-5#1)(1996-6#1)(2004-1#1)(2004-9#1)(2008-11#5)(2008-5#2)(2008-9#1)
proliferation when##3##2##(1991-10#1)(2008-5#1)(2009-8#1)
proliferation which##2##2##(1991-6#1)(2010-7#1)
proliferation with##7##2##(1991-9#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-7#1)(2012-12#1)(2012-5#1)
proliferation zone at the side of the##2##7##(2007-12#2)
proliferation zone##3##2##(2007-12#3)
proliferation##1663##1##(1990-11#6)(1990-12#11)(1990-2#3)(1990-3#5)(1990-4#4)(1990-5#7)(1990-6#1)(1990-7#13)(1990-8#10)(1990-9#5)(1991-1#9)(1991-10#12)(1991-12#16)(1991-2#3)(1991-3#10)(1991-4#2)(1991-5#22)(1991-6#2)(1991-7#1)(1991-8#14)(1991-9#15)(1992-1#6)(1992-11#8)(1992-12#3)(1992-2#9)(1992-3#4)(1992-4#4)(1992-5#13)(1992-6#1)(1992-7#5)(1992-8#22)(1992-9#7)(1993-10#1)(1993-11#8)(1993-12#10)(1993-2#2)(1993-3#8)(1993-4#11)(1993-5#1)(1993-6#2)(1993-7#6)(1993-8#14)(1993-9#20)(1994-10#5)(1994-11#13)(1994-12#9)(1994-2#8)(1994-3#19)(1994-5#7)(1994-6#8)(1994-8#4)(1994-9#8)(1995-1#4)(1995-10#8)(1995-11#9)(1995-12#15)(1995-2#28)(1995-3#18)(1995-4#2)(1995-5#13)(1995-6#7)(1995-7#2)(1995-8#1)(1995-9#1)(1996-10#6)(1996-11#18)(1996-12#5)(1996-2#3)(1996-3#15)(1996-4#5)(1996-5#10)(1996-6#6)(1996-7#5)(1996-8#5)(1996-9#1)(1997-1#9)(1997-2#12)(1997-3#8)(1997-4#5)(1997-5#3)(1997-6#17)(1997-7#16)(1997-8#2)(2004-1#3)(2004-11#1)(2004-12#11)(2004-3#1)(2004-9#11)(2005-1#1)(2005-10#1)(2005-11#4)(2005-12#3)(2005-6#1)(2005-7#3)(2005-8#4)(2005-9#1)(2006-1#4)(2006-10#15)(2006-11#1)(2006-12#9)(2006-5#1)(2006-6#10)(2006-7#1)(2006-9#4)(2007-1#3)(2007-10#3)(2007-11#18)(2007-12#19)(2007-2#12)(2007-3#2)(2007-4#6)(2007-7#3)(2007-8#10)(2007-9#4)(2008-1#19)(2008-10#40)(2008-11#130)(2008-12#4)(2008-2#1)(2008-3#7)(2008-4#60)(2008-5#67)(2008-6#12)(2008-7#24)(2008-8#14)(2008-9#26)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#4)(2009-2#2)(2009-3#13)(2009-4#8)(2009-5#4)(2009-6#4)(2009-7#3)(2009-8#21)(2009-9#7)(2010-1#3)(2010-10#1)(2010-11#12)(2010-12#31)(2010-2#4)(2010-3#11)(2010-4#3)(2010-5#2)(2010-6#7)(2010-7#6)(2010-8#1)(2010-9#1)(2011-1#9)(2011-12#5)(2011-2#51)(2011-3#6)(2012-1#21)(2012-11#12)(2012-12#46)(2012-2#24)(2012-3#15)(2012-4#3)(2012-5#2)(2012-6#1)(2012-8#1)(2013-1#36)(2013-7#7)(2013-8#20)
proliferation)##3##1##(1995-3#1)(1996-5#1)(2008-4#1)
proliferation-associated proteins##2##2##(1994-7#1)(2008-9#1)
proliferation-associated##9##1##(1990-11#2)(1990-4#1)(1990-8#1)(1991-10#1)(1993-11#2)(1994-7#1)(2008-9#1)
proliferation-controlled cell lines##2##3##(2008-11#2)
proliferation-controlled##3##1##(2008-11#3)
proliferation-related##2##1##(1995-9#1)(2008-3#1)
proliferation-stimulating factors##2##2##(2009-3#2)
proliferation-stimulating##3##1##(1991-7#1)(2009-3#2)
proliferation/apoptosis##2##1##(2011-2#1)(2012-4#1)
proliferations are##2##2##(2010-1#1)(2011-2#1)
proliferations in##2##2##(2010-12#1)(2011-2#1)
proliferations##14##1##(1991-12#1)(1993-11#1)(2005-12#1)(2008-11#1)(2009-3#1)(2010-1#1)(2010-12#1)(2011-2#4)(2013-1#2)(2013-7#1)
proliferative GN##2##2##(2008-1#2)
proliferative actions of##2##3##(1991-3#1)(1991-4#1)
proliferative actions##3##2##(1991-3#2)(1991-4#1)
proliferative activation##2##2##(1990-12#2)
proliferative activities##5##2##(1994-6#1)(2013-1#4)
proliferative activity and##3##3##(1990-8#1)(1996-4#1)(2010-12#1)
proliferative activity in##4##3##(1994-8#1)(1995-12#2)(2008-6#1)
proliferative activity of breast##2##4##(1993-11#1)(1997-7#1)
proliferative activity of##12##3##(1990-5#2)(1993-11#1)(1994-9#1)(1997-7#2)(2008-11#1)(2008-4#1)(2010-12#1)(2012-1#3)
proliferative activity##29##2##(1990-5#2)(1990-8#1)(1993-11#2)(1994-8#2)(1994-9#2)(1995-12#2)(1995-4#2)(1996-4#1)(1997-7#2)(2005-12#1)(2008-11#1)(2008-4#2)(2008-6#1)(2010-11#1)(2010-12#3)(2012-1#4)
proliferative and##10##2##(1991-5#1)(1996-5#1)(2005-11#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-12#2)(2013-1#1)
proliferative capacity and##2##3##(1996-11#1)(2008-7#1)
proliferative capacity of##3##3##(2007-1#2)(2008-11#1)
proliferative capacity##7##2##(1996-11#1)(2007-1#3)(2008-11#1)(2008-7#1)(2013-7#1)
proliferative changes in##2##3##(1994-5#1)(2008-1#1)
proliferative changes##4##2##(1994-5#1)(2007-11#1)(2008-1#1)(2009-1#1)
proliferative diabetic retinopathy (PDR)##4##4##(1997-7#1)(2008-1#2)(2013-1#1)
proliferative diabetic retinopathy and coronary##2##5##(2013-1#2)
proliferative diabetic retinopathy in the##2##5##(2013-1#2)
proliferative diabetic retinopathy##10##3##(1997-7#1)(2008-1#3)(2011-1#1)(2013-1#5)
proliferative diabetic##11##2##(1997-7#1)(2008-1#3)(2011-1#1)(2013-1#6)
proliferative disease##2##2##(2005-7#1)(2013-1#1)
proliferative diseases##4##2##(1992-11#1)(1993-5#1)(2007-6#1)(2013-1#1)
proliferative disorder of##2##3##(1990-12#1)(2010-3#1)
proliferative disorder##3##2##(1990-12#1)(2010-3#1)(2011-2#1)
proliferative disorders##4##2##(2006-10#1)(2006-5#1)(2011-2#1)(2013-1#1)
proliferative effect of##2##3##(1991-6#1)(1992-8#1)
proliferative effect##4##2##(1991-6#1)(1992-7#1)(1992-8#1)(2012-1#1)
proliferative effects of##2##3##(1997-7#1)(2009-8#1)
proliferative effects##7##2##(1993-7#1)(1995-3#1)(1997-7#1)(2008-4#1)(2009-8#2)(2011-2#1)
proliferative endometrium##2##2##(2011-2#2)
proliferative function##2##2##(2008-11#1)(2008-7#1)
proliferative glomerulonephritis##8##2##(1990-6#2)(1992-11#1)(2005-12#1)(2007-7#3)(2008-1#1)
proliferative index##10##2##(1993-11#1)(1994-8#1)(1997-7#1)(2008-10#1)(2008-6#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
proliferative lesion##2##2##(1994-12#1)(2006-9#1)
proliferative lesions##3##2##(1992-9#1)(1994-12#1)(2008-1#1)
proliferative lupus nephritis##2##3##(2005-12#1)(2006-10#1)
proliferative markers##2##2##(2009-2#2)
proliferative mass##2##2##(2007-2#1)(2012-12#1)
proliferative phase of wound healing##2##5##(2006-9#2)
proliferative phase of##3##3##(1994-9#1)(2006-9#2)
proliferative phase##8##2##(1994-9#1)(2006-9#2)(2011-2#1)(2013-1#4)
proliferative population##2##2##(1997-6#1)(2011-2#1)
proliferative potential in meningiomas##2##4##(2007-12#2)
proliferative potential in##3##3##(2007-12#2)(2008-11#1)
proliferative potential of human##2##4##(1990-9#1)(2012-1#1)
proliferative potential of##5##3##(1990-5#1)(1990-9#1)(2007-12#1)(2008-11#1)(2012-1#1)
proliferative potential##13##2##(1990-5#2)(1990-9#2)(1991-8#1)(2007-12#3)(2008-1#1)(2008-11#2)(2012-1#1)(2012-2#1)
proliferative quiescence##3##2##(2012-12#3)
proliferative response of##16##3##(1991-1#1)(1991-12#2)(1992-7#1)(1994-6#1)(1994-8#2)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-8#1)(2007-2#1)(2008-7#2)
proliferative response to##8##3##(1990-3#1)(1991-5#1)(1992-5#1)(1994-2#1)(1995-2#1)(2006-12#1)(2008-7#1)(2012-3#1)
proliferative response##30##2##(1990-12#1)(1990-3#1)(1991-1#1)(1991-12#2)(1991-5#1)(1992-5#1)(1992-7#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-10#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-8#1)(2005-11#1)(2006-12#1)(2007-2#3)(2008-4#1)(2008-7#4)(2012-3#1)
proliferative responses in##3##3##(1995-2#1)(1995-5#1)(2008-11#1)
proliferative responses of T cells##2##5##(1995-12#1)(2008-4#1)
proliferative responses of##6##3##(1991-12#1)(1995-12#1)(1997-4#1)(2008-4#3)
proliferative responses to##6##3##(1995-2#2)(2005-8#1)(2008-4#1)(2011-2#2)
proliferative responses##21##2##(1991-12#1)(1992-12#1)(1992-8#1)(1995-12#1)(1995-2#3)(1995-5#1)(1997-4#2)(2005-8#1)(2008-11#1)(2008-4#4)(2008-7#3)(2011-2#2)
proliferative retinopathy##2##2##(1995-1#1)(2007-7#1)
proliferative signal##2##2##(1991-3#1)(1997-2#1)
proliferative state##4##2##(1995-10#1)(1995-11#1)(1996-4#1)(2009-12#1)
proliferative status##2##2##(1990-2#1)(1992-3#1)
proliferative stimulation##2##2##(1994-5#2)
proliferative vitreoretinopathy##4##2##(1991-2#3)(2009-4#1)
proliferative##289##1##(1990-12#4)(1990-2#1)(1990-3#1)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#3)(1991-1#1)(1991-12#3)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#3)(1991-6#2)(1991-8#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#2)(1993-11#4)(1993-12#1)(1993-5#1)(1993-7#1)(1994-12#3)(1994-2#1)(1994-5#4)(1994-6#2)(1994-8#6)(1994-9#3)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#4)(1995-2#6)(1995-3#2)(1995-4#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-4#2)(1996-5#3)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#6)(1997-8#1)(2005-11#2)(2005-12#3)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-9#3)(2007-1#3)(2007-11#1)(2007-12#4)(2007-2#4)(2007-5#1)(2007-6#1)(2007-7#4)(2008-1#11)(2008-10#4)(2008-11#14)(2008-4#8)(2008-5#2)(2008-6#3)(2008-7#12)(2008-9#5)(2009-1#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#3)(2009-9#2)(2010-11#1)(2010-12#6)(2010-3#1)(2011-1#2)(2011-2#12)(2012-1#6)(2012-12#7)(2012-2#3)(2012-3#2)(2013-1#20)(2013-7#1)(2013-8#1)
proliferatively##2##1##(1994-6#1)(2012-2#1)
proliferator activated receptor##8##3##(1992-8#2)(1994-2#2)(1997-7#1)(2006-8#1)(2012-2#1)(2013-8#1)
proliferator activated##11##2##(1992-8#2)(1994-2#2)(1997-7#2)(2005-7#1)(2006-8#1)(2008-10#1)(2012-2#1)(2013-8#1)
proliferator##22##1##(1992-4#1)(1992-5#1)(1992-8#3)(1994-2#2)(1994-8#2)(1995-2#2)(1995-3#3)(1997-7#2)(2005-7#1)(2006-8#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-8#1)
proliferator-activated receptor (PPAR)##6##3##(1995-2#1)(1995-3#1)(1995-6#1)(2008-1#2)(2008-5#1)
proliferator-activated receptor alpha##4##3##(1997-4#1)(2013-1#1)(2013-8#2)
proliferator-activated receptor gamma##2##3##(1994-12#1)(2007-10#1)
proliferator-activated receptor γ##2##3##(2010-12#1)(2012-2#1)
proliferator-activated receptor##26##2##(1994-12#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#2)(1997-4#1)(2006-2#1)(2007-10#1)(2008-1#3)(2008-3#1)(2008-4#1)(2008-5#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#3)
proliferator-activated receptors (PPARs)##6##3##(1997-4#1)(2008-1#2)(2008-3#1)(2010-12#1)(2013-7#1)
proliferator-activated receptors##13##2##(1997-4#3)(2005-11#1)(2008-1#2)(2008-3#1)(2008-5#1)(2010-12#1)(2010-3#1)(2010-7#1)(2013-1#1)(2013-7#1)
proliferator-activated##45##1##(1994-12#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#2)(1997-4#4)(2005-11#1)(2006-2#1)(2007-10#1)(2008-1#5)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#2)(2009-11#2)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#2)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#3)
proliferators##11##1##(1990-12#2)(1992-4#1)(1992-8#2)(1994-8#2)(1995-2#1)(1995-6#1)(2009-8#2)
proliferators-activated##2##1##(2008-10#2)
proliferatum##14##1##(2008-10#13)(2010-10#1)
proliferin gene##2##2##(1992-5#2)
proliferin##3##1##(1992-5#3)
prolific##8##1##(1994-3#1)(1997-4#1)(2005-11#1)(2008-11#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-2#1)
prolifica andN##2##2##(2008-5#2)
prolifica##6##1##(1991-8#1)(2008-5#5)
prolificans pneumonia##2##2##(2008-5#2)
prolificans##6##1##(2008-5#6)
proline analogue with##2##3##(2008-8#2)
proline analogue##4##2##(1990-5#1)(2008-8#2)(2010-7#1)
proline and ascorbic##2##3##(1991-7#2)
proline and glutamine##3##3##(1990-7#1)(1991-8#1)(1992-7#1)
proline and hydroxyproline##2##3##(1992-4#1)(1993-1#1)
proline and##11##2##(1990-7#1)(1991-7#2)(1991-8#1)(1992-4#1)(1992-7#1)(1993-1#1)(1993-12#1)(1997-5#1)(1997-6#1)(2008-12#1)
proline at position##2##3##(1994-3#1)(1997-4#1)
proline at##4##2##(1994-11#1)(1994-3#1)(1997-4#1)(2008-10#1)
proline content##2##2##(2006-10#1)(2011-12#1)
proline dehydrogenase##4##2##(1996-2#4)
proline in the##3##3##(1991-12#2)(1993-4#1)
proline in##6##2##(1991-12#2)(1993-4#1)(2008-10#3)
proline or##2##2##(1994-5#1)(2013-1#1)
proline peptidase family##3##3##(1994-12#3)
proline residue##6##2##(1991-5#1)(1992-6#1)(1994-5#1)(1995-11#1)(2007-11#1)(2008-5#1)
proline residues in##4##3##(1990-10#1)(1991-3#1)(1992-6#1)(1994-11#1)
proline residues##11##2##(1990-10#1)(1990-5#1)(1991-10#1)(1991-2#1)(1991-3#2)(1992-6#1)(1994-11#1)(1994-9#1)(1995-6#1)(1997-5#1)
proline substitution##3##2##(1997-5#3)
proline uptake##2##2##(1990-9#1)(1992-11#1)
proline were##3##2##(2008-10#2)(2008-12#1)
proline with##3##2##(1990-5#2)(1994-11#1)
proline##126##1##(1990-10#1)(1990-4#1)(1990-5#6)(1990-7#1)(1990-9#2)(1991-10#1)(1991-12#8)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#4)(1991-6#1)(1991-7#6)(1991-8#1)(1992-11#1)(1992-4#3)(1992-6#3)(1992-7#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-4#1)(1994-11#6)(1994-12#5)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-2#3)(1995-6#1)(1995-7#1)(1996-2#4)(1996-8#1)(1997-4#1)(1997-5#6)(1997-6#4)(2006-10#2)(2006-6#2)(2007-11#2)(2008-1#1)(2008-10#8)(2008-12#5)(2008-5#3)(2008-8#2)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-7#1)(2013-1#1)
proline-rich domain##5##2##(1990-5#2)(1995-3#1)(2008-8#1)(2013-8#1)
proline-rich motif##2##2##(1995-3#1)(1997-4#1)
proline-rich region##5##2##(1991-6#2)(1994-9#1)(1997-4#1)(1997-7#1)
proline-rich sequences##4##2##(1994-12#3)(1994-9#1)
proline-rich##23##1##(1990-5#2)(1991-10#1)(1991-5#1)(1991-6#2)(1994-12#3)(1994-9#4)(1995-11#1)(1995-3#2)(1996-4#1)(1996-8#1)(1997-4#2)(1997-7#1)(2008-8#1)(2013-8#1)
proline-substitution sites##2##2##(1997-5#2)
prolines##5##1##(1992-6#1)(1994-12#1)(1995-6#1)(1995-7#1)(2007-12#1)
prolixus and##3##2##(2008-8#1)(2012-12#2)
prolixus in palms##2##3##(2012-12#2)
prolixus in##3##2##(2012-12#3)
prolixus showed a##2##3##(2008-8#2)
prolixus##14##1##(2007-3#2)(2008-8#4)(2009-3#1)(2012-12#7)
prologue##3##1##(2008-1#1)(2008-6#1)(2009-5#1)
prolong life and##2##3##(2007-9#1)(2010-12#1)
prolong life##3##2##(1995-1#1)(2007-9#1)(2010-12#1)
prolong lifespan##2##2##(2009-12#1)(2012-3#1)
prolong survival##6##2##(1990-12#1)(2006-8#1)(2007-8#2)(2011-11#1)(2013-1#1)
prolong the QT interval##2##4##(2008-8#2)
prolong the cardiac QT(c) interval##2##5##(2007-11#2)
prolong the duration of postoperative analgesia##2##6##(2010-7#1)(2011-12#1)
prolong the duration of##6##4##(1994-2#1)(2006-7#1)(2010-5#1)(2010-7#2)(2011-12#1)
prolong the survival of##2##4##(1990-3#1)(1992-6#1)
prolong the survival##3##3##(1990-3#1)(1992-3#1)(1992-6#1)
prolong the##32##2##(1990-12#1)(1990-3#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-3#1)(1992-6#2)(1993-3#1)(1994-2#1)(1996-5#1)(2005-7#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#3)(2010-4#1)(2010-5#1)(2010-7#2)(2011-12#1)(2013-8#1)
prolong##74##1##(1990-12#2)(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-1#1)(1992-3#1)(1992-6#2)(1993-11#1)(1993-3#1)(1994-2#2)(1995-1#1)(1995-2#1)(1996-5#1)(1997-4#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#6)(2009-11#1)(2009-12#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#4)(2011-11#1)(2011-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
prolongation and##6##2##(1990-11#1)(2008-8#3)(2013-8#2)
prolongation of cell##2##3##(2008-11#2)
prolongation of life##3##3##(1990-11#1)(1991-4#1)(1994-6#1)
prolongation of pregnancy##2##3##(2004-10#1)(2006-1#1)
prolongation of survival##3##3##(1991-9#1)(2007-5#1)(2008-3#1)
prolongation of the lag##2##4##(1990-11#1)(1997-7#1)
prolongation of the transfer latency##2##5##(1991-2#2)
prolongation of the##26##3##(1990-11#2)(1990-12#1)(1990-8#1)(1991-2#2)(1991-3#1)(1994-8#1)(1996-5#1)(1996-9#1)(1997-7#1)(2005-1#1)(2005-7#1)(2006-10#2)(2007-8#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-1#1)(2010-12#1)(2011-2#2)(2013-1#1)
prolongation of##57##2##(1990-11#4)(1990-12#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-10#1)(1993-3#1)(1994-4#1)(1994-6#1)(1994-8#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-6#1)(1997-7#1)(2004-10#1)(2005-1#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-7#1)(2007-11#1)(2007-5#1)(2007-8#2)(2008-11#4)(2008-3#1)(2008-7#3)(2008-8#2)(2009-12#1)(2010-1#1)(2010-12#1)(2010-6#1)(2011-2#2)(2013-1#4)
prolongation##78##1##(1990-11#5)(1990-12#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-2#1)(1993-3#2)(1994-4#1)(1994-6#1)(1994-8#1)(1995-8#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-6#1)(1997-7#1)(2004-10#1)(2005-1#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-7#2)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#2)(2008-11#4)(2008-3#1)(2008-7#3)(2008-8#11)(2009-12#1)(2010-1#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#3)(2013-1#4)(2013-8#2)
prolongation)##2##1##(2007-8#1)(2008-3#1)
prolongations##2##1##(1997-5#1)(2012-12#1)
prolonged (&gt##2##2##(1997-5#1)(2007-11#1)
prolonged (p &lt##2##3##(2008-12#1)(2008-9#1)
prolonged CPB##3##2##(2007-8#1)(2007-9#2)
prolonged ICU##2##2##(2007-8#1)(2012-2#1)
prolonged QT interval##5##3##(2007-2#1)(2007-8#1)(2011-2#2)(2012-2#1)
prolonged QT##8##2##(2007-2#3)(2007-8#1)(2009-4#1)(2011-2#2)(2012-2#1)
prolonged acetylcholine receptor##3##3##(1995-1#2)(2013-1#1)
prolonged action potential duration##2##4##(1990-11#1)(1992-3#1)
prolonged action##3##2##(1990-11#1)(1992-3#1)(2010-5#1)
prolonged activation of##2##3##(1995-3#1)(2012-12#1)
prolonged administration of##6##3##(1991-11#1)(1991-9#1)(1993-11#1)(1994-6#1)(1995-6#1)(2008-4#1)
prolonged administration##7##2##(1991-11#1)(1991-9#1)(1993-11#1)(1994-6#1)(1995-6#1)(1997-1#1)(2008-4#1)
prolonged air leak##3##3##(2007-8#3)
prolonged analgesia##2##2##(2006-10#1)(2007-5#1)
prolonged and the##2##3##(1992-3#1)(2006-10#1)
prolonged and##11##2##(1992-3#1)(1993-5#1)(1994-5#1)(1994-6#1)(1996-5#1)(1997-2#1)(2006-10#1)(2008-9#1)(2010-12#1)(2010-6#1)(2011-2#1)
prolonged antibiotic##2##2##(2007-12#1)(2011-2#1)
prolonged artificial##2##2##(2006-10#1)(2009-2#1)
prolonged bleeding time##3##3##(1990-11#2)(2007-10#1)
prolonged bleeding##5##2##(1990-11#3)(1993-5#1)(2007-10#1)
prolonged brain retraction##2##3##(2008-7#2)
prolonged brain##3##2##(1992-2#1)(2008-7#2)
prolonged breast##2##2##(1995-8#1)(2006-10#1)
prolonged by NMDA receptor-mediated currents##2##5##(1992-8#2)
prolonged by##9##2##(1992-6#1)(1992-8#2)(1993-11#1)(1993-3#1)(1995-12#1)(1997-5#1)(2005-8#1)(2011-12#1)
prolonged cardiopulmonary##2##2##(2007-8#1)(2010-12#1)
prolonged cases and overtime are common##2##6##(2013-1#2)
prolonged cell##2##2##(1992-11#1)(2003-11#1)
prolonged cholestasis##2##2##(2005-12#1)(2008-9#1)
prolonged circulation##2##2##(1991-9#1)(2008-5#1)
prolonged complete brain ischaemia##2##4##(1995-12#2)
prolonged coronary artery##2##3##(1996-9#1)(2007-8#1)
prolonged coronary##3##2##(1996-9#2)(2007-8#1)
prolonged cough##2##2##(2007-2#1)(2008-7#1)
prolonged course of##2##3##(2008-1#1)(2010-9#1)
prolonged course##3##2##(1997-5#1)(2008-1#1)(2010-9#1)
prolonged courses of antibiotics##3##4##(2008-5#1)(2008-6#1)(2011-2#1)
prolonged courses of##5##3##(2007-11#1)(2008-5#1)(2008-6#1)(2009-8#1)(2011-2#1)
prolonged cultivation##2##2##(1994-3#1)(2008-11#1)
prolonged cultivations##2##2##(1993-6#1)(1997-2#1)
prolonged culture of F9##2##4##(1993-8#2)
prolonged culture of##3##3##(1993-8#3)
prolonged culture##8##2##(1990-4#1)(1993-8#3)(1996-9#1)(1997-7#1)(2008-4#1)(2008-9#1)
prolonged development##2##2##(2008-9#2)
prolonged disease-free survival##2##3##(2006-6#1)(2008-5#1)
prolonged drug release##2##3##(2010-1#1)(2010-2#1)
prolonged drug##3##2##(2008-7#1)(2010-1#1)(2010-2#1)
prolonged due to##2##3##(1996-3#1)(2007-8#1)
prolonged duration of##4##3##(2006-12#1)(2007-8#1)(2008-10#1)(2013-7#1)
prolonged duration##5##2##(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2013-7#1)
prolonged elevation##2##2##(2008-5#1)(2008-8#1)
prolonged epidural analgesia##2##3##(2006-10#1)(2006-12#1)
prolonged excitation##2##2##(1995-11#1)(1996-9#1)
prolonged exposure of##5##3##(1990-8#1)(1993-7#1)(1995-12#1)(1995-3#1)(2013-1#1)
prolonged exposure to phorbol##2##4##(1994-2#1)(1996-8#1)
prolonged exposure to##16##3##(1990-8#1)(1991-12#2)(1991-4#1)(1991-8#1)(1994-2#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-8#1)(1997-1#1)(2008-10#3)(2010-4#1)(2013-1#1)
prolonged exposure##22##2##(1990-8#2)(1991-12#2)(1991-4#1)(1991-8#1)(1993-7#1)(1994-2#1)(1995-11#1)(1995-12#2)(1995-3#1)(1996-12#1)(1996-8#1)(1997-1#1)(2008-10#3)(2008-5#1)(2010-4#1)(2013-1#2)
prolonged febrile##2##2##(2006-11#1)(2012-12#1)
prolonged fever##5##2##(2008-11#1)(2011-1#1)(2011-2#3)
prolonged food deprivation##2##3##(1997-2#2)
prolonged for##3##2##(2010-12#1)(2010-5#1)(2012-2#1)
prolonged graft survival to##3##4##(1993-11#1)(1995-2#2)
prolonged group##2##2##(2011-2#2)
prolonged half-life##2##2##(2008-3#1)(2012-12#1)
prolonged heat##2##2##(1995-6#1)(2008-5#1)
prolonged heating##3##2##(1991-11#1)(2008-10#1)(2013-1#1)
prolonged high phosphorus diet##2##4##(2008-4#2)
prolonged hospital admission##2##3##(2005-12#1)(2009-10#1)
prolonged hospital##4##2##(2005-12#1)(2006-10#1)(2007-11#1)(2009-10#1)
prolonged hospitalization##2##2##(2013-1#2)
prolonged hypoglycemic##2##2##(1994-8#1)(2010-1#1)
prolonged hypothermic storage##3##3##(2006-5#1)(2007-8#2)
prolonged immunosuppression##2##2##(1992-12#1)(2006-10#1)
prolonged in vitro culture##2##4##(1990-4#1)(1996-6#1)
prolonged in##7##2##(1990-4#1)(1994-6#1)(1996-6#1)(1997-3#1)(2007-11#1)(2008-10#1)(2009-2#1)
prolonged incubation and##2##3##(1990-5#1)(2010-8#1)
prolonged incubation with##2##3##(1992-5#1)(1994-3#1)
prolonged incubation##11##2##(1990-4#1)(1990-5#1)(1990-8#1)(1992-5#1)(1994-3#1)(1995-11#1)(1997-1#1)(2005-11#1)(2006-8#1)(2007-12#1)(2010-8#1)
prolonged intubation##2##2##(2006-10#1)(2009-9#1)
prolonged lag##2##2##(1991-4#1)(2010-2#1)
prolonged latency of##2##3##(2011-2#1)(2013-8#1)
prolonged latency##3##2##(2009-12#1)(2011-2#1)(2013-8#1)
prolonged life##2##2##(2005-10#1)(2008-7#1)
prolonged local##2##2##(2008-5#1)(2010-3#1)
prolonged maintenance of##2##3##(1994-12#1)(2006-10#1)
prolonged mechanical ventilation##3##3##(2006-10#1)(2007-11#1)(2007-8#1)
prolonged neutropenia##2##2##(2007-12#1)(2008-7#1)
prolonged operation##2##2##(1997-2#1)(2007-8#1)
prolonged or##5##2##(2006-6#1)(2007-11#1)(2007-2#1)(2009-5#1)(2009-9#1)
prolonged period of##9##3##(1993-10#1)(1995-6#2)(1996-5#1)(2006-10#1)(2008-8#1)(2008-9#2)(2011-2#1)
prolonged period##19##2##(1993-10#1)(1994-4#1)(1995-6#3)(1995-8#1)(1996-5#1)(2006-10#1)(2006-4#1)(2007-9#1)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#2)(2010-10#1)(2011-2#1)
prolonged periods of time##5##4##(2007-11#1)(2008-11#1)(2008-7#1)(2009-2#1)(2011-1#1)
prolonged periods of##7##3##(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-2#1)(2011-1#1)
prolonged periods##23##2##(1991-8#1)(1992-1#1)(1993-12#1)(2006-10#2)(2007-11#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-7#3)(2008-9#1)(2009-2#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)
prolonged plateau after hypoxia##2##4##(1997-5#2)
prolonged postoperative##3##2##(2006-10#1)(2007-5#1)(2007-8#1)
prolonged recovery##3##2##(1997-6#1)(2010-7#1)(2012-1#1)
prolonged reduction##2##2##(1995-12#1)(2005-10#1)
prolonged response to sunitinib##2##4##(2013-1#2)
prolonged response##4##2##(2008-11#1)(2013-1#3)
prolonged retention of##2##3##(1993-11#1)(1993-7#1)
prolonged retention##3##2##(1993-11#1)(1993-7#1)(1994-9#1)
prolonged seizure##3##2##(1992-3#1)(2007-2#1)(2008-4#1)
prolonged significantly##2##2##(2008-7#1)(2011-3#1)
prolonged stay in the##2##4##(2006-4#1)(2013-1#1)
prolonged stay##3##2##(2006-10#1)(2006-4#1)(2013-1#1)
prolonged stays##3##2##(1996-3#2)(2012-11#1)
prolonged stimulation##3##2##(1991-2#1)(1996-7#1)(2008-1#1)
prolonged storage##5##2##(1994-3#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-12#1)
prolonged stress##3##2##(1991-11#1)(1994-11#1)(2013-7#1)
prolonged surgical##2##2##(2006-10#1)(2011-2#1)
prolonged survival in##5##3##(1995-2#1)(1996-1#1)(2004-1#1)(2006-9#1)(2011-2#1)
prolonged survival of##2##3##(1993-8#1)(2008-5#1)
prolonged survival##18##2##(1993-8#1)(1995-2#1)(1996-1#1)(2004-1#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-12#2)(2011-2#1)(2012-12#1)(2013-7#1)
prolonged the culture period by##2##5##(2008-11#2)
prolonged the lag phase of the factor##2##7##(1990-11#2)
prolonged the reaction time##2##4##(1996-2#1)(2007-8#1)
prolonged the survival of##2##4##(2005-1#1)(2008-5#1)
prolonged the survival time##3##4##(1992-7#1)(1992-8#1)(2008-8#1)
prolonged the survival##6##3##(1991-9#1)(1992-7#1)(1992-8#1)(2005-1#1)(2008-5#1)(2008-8#1)
prolonged the##25##2##(1990-11#2)(1991-9#1)(1992-7#1)(1992-8#1)(1993-8#1)(1994-3#1)(1994-9#1)(1996-2#1)(2005-1#1)(2005-7#1)(2006-10#1)(2007-8#2)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-3#1)(2012-2#1)(2013-7#1)
prolonged therapy with##2##3##(2005-8#1)(2008-5#1)
prolonged thrombin##2##2##(1994-12#1)(1997-4#1)
prolonged time##6##2##(1990-12#1)(2007-10#1)(2008-11#1)(2008-5#2)(2013-1#1)
prolonged times##2##2##(1993-4#1)(2013-1#1)
prolonged to##4##2##(1990-11#1)(1997-3#1)(2008-11#1)(2010-12#1)
prolonged treatment of##2##3##(1991-12#1)(2009-6#1)
prolonged treatment with##9##3##(1990-12#1)(1991-12#1)(1994-6#1)(1995-3#1)(1997-3#1)(2006-10#1)(2007-11#1)(2008-3#1)(2008-5#1)
prolonged treatment##18##2##(1990-12#1)(1991-12#2)(1994-6#2)(1995-3#1)(1995-6#1)(1997-3#1)(2005-12#1)(2006-10#3)(2007-11#1)(2007-7#1)(2008-3#1)(2008-5#2)(2009-6#1)
prolonged tumor##2##2##(2009-2#1)(2010-6#1)
prolonged use of##7##3##(2005-10#1)(2008-1#2)(2008-8#1)(2010-1#1)(2012-3#1)(2013-8#1)
prolonged use##9##2##(2005-10#1)(2007-2#1)(2008-1#2)(2008-8#1)(2010-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
prolonged vascular access##2##3##(2007-7#2)
prolonged##702##1##(1990-11#8)(1990-12#4)(1990-3#2)(1990-4#5)(1990-5#1)(1990-6#2)(1990-8#4)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#7)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#1)(1991-8#4)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#4)(1992-9#1)(1993-10#1)(1993-11#4)(1993-12#3)(1993-3#1)(1993-4#1)(1993-5#3)(1993-6#2)(1993-7#3)(1993-8#7)(1994-10#1)(1994-11#3)(1994-12#5)(1994-2#3)(1994-3#5)(1994-4#1)(1994-5#2)(1994-6#11)(1994-7#1)(1994-8#3)(1994-9#2)(1995-1#4)(1995-11#4)(1995-12#13)(1995-2#7)(1995-3#3)(1995-5#1)(1995-6#7)(1995-8#2)(1995-9#2)(1996-1#2)(1996-10#1)(1996-12#4)(1996-2#2)(1996-3#8)(1996-4#1)(1996-5#4)(1996-6#3)(1996-7#1)(1996-8#2)(1996-9#10)(1997-1#4)(1997-2#6)(1997-3#4)(1997-4#3)(1997-5#8)(1997-6#3)(1997-7#2)(1997-8#2)(2003-11#1)(2004-1#1)(2004-10#1)(2004-11#1)(2005-1#2)(2005-10#6)(2005-11#1)(2005-12#3)(2005-7#4)(2005-8#2)(2006-1#1)(2006-10#27)(2006-11#1)(2006-12#6)(2006-2#2)(2006-3#1)(2006-4#6)(2006-5#3)(2006-6#4)(2006-8#4)(2006-9#2)(2007-1#2)(2007-10#4)(2007-11#15)(2007-12#5)(2007-2#8)(2007-3#2)(2007-5#3)(2007-7#8)(2007-8#30)(2007-9#7)(2008-1#7)(2008-10#18)(2008-11#16)(2008-12#5)(2008-2#2)(2008-3#8)(2008-4#8)(2008-5#18)(2008-6#4)(2008-7#20)(2008-8#11)(2008-9#13)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#6)(2009-3#5)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#2)(2010-1#4)(2010-10#1)(2010-12#9)(2010-2#3)(2010-3#4)(2010-4#3)(2010-5#4)(2010-6#2)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#8)(2011-12#4)(2011-2#19)(2011-3#2)(2012-1#3)(2012-11#1)(2012-12#10)(2012-2#9)(2012-3#6)(2013-1#25)(2013-7#4)(2013-8#4)
prolonging drugs##3##2##(1994-6#1)(2008-3#1)(2010-8#1)
prolonging observation##2##2##(2006-7#2)
prolonging the life of##3##4##(2006-10#1)(2006-9#1)(2007-7#1)
prolonging the##15##2##(1994-2#1)(1994-7#1)(1995-6#1)(1996-9#1)(2004-11#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
prolonging##33##1##(1993-11#1)(1994-2#1)(1994-6#3)(1994-7#2)(1995-6#1)(1996-9#1)(2004-11#1)(2006-10#1)(2006-6#1)(2006-7#2)(2006-9#1)(2007-11#1)(2007-7#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2010-3#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)
prolongs survival in##2##3##(2008-7#1)(2009-9#1)
prolongs survival of##2##3##(1992-7#1)(2008-10#1)
prolongs survival##8##2##(1992-7#1)(1997-4#1)(2007-5#1)(2008-10#1)(2008-7#1)(2009-5#1)(2009-9#1)(2011-2#1)
prolongs the##11##2##(1992-6#1)(1995-2#1)(1996-5#2)(2005-7#1)(2006-3#1)(2007-11#1)(2008-8#1)(2010-5#1)(2012-12#1)(2012-2#1)
prolongs##31##1##(1992-3#1)(1992-6#1)(1992-7#1)(1994-5#1)(1995-2#1)(1996-4#1)(1996-5#2)(1997-4#3)(2005-7#1)(2006-3#1)(2006-9#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#2)
prolyl 4-hydroxylase##3##2##(1994-11#1)(2006-2#1)(2008-10#1)
prolyl endopeptidase and##2##3##(1991-2#2)
prolyl endopeptidase##8##2##(1991-2#5)(1992-3#3)
prolyl hydroxylase##4##2##(2008-1#3)(2011-2#1)
prolyl isomerase##3##2##(1996-4#2)(2008-7#1)
prolyl peptides##4##2##(1990-5#4)
prolyl##32##1##(1990-2#1)(1990-5#4)(1991-2#5)(1992-3#4)(1993-2#2)(1994-11#1)(1996-4#2)(2006-2#1)(2006-6#1)(2008-1#4)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
prolyl-tRNA synthetase##2##2##(2006-12#2)
prolymphocytes##3##1##(2008-4#2)(2009-2#1)
prolymphocytic##2##1##(1990-9#1)(2012-12#1)
promastigote##8##1##(1990-10#1)(1991-10#2)(2008-9#2)(2012-2#2)(2013-1#1)
promastigotes##6##1##(1994-8#1)(2007-2#1)(2008-4#1)(2008-9#1)(2011-1#1)(2012-2#1)
promax rotation##2##2##(2008-6#1)(2012-3#1)
promazines in bovine##2##3##(2008-10#2)
promegestone##12##1##(1992-2#12)
prometaphase##4##1##(1992-12#1)(1996-5#1)(1997-6#1)(2008-4#1)
prometastatic microenvironment of the liver##2##5##(2009-3#2)
prometastatic microenvironment##3##2##(2009-3#3)
promethazine and##2##2##(1995-1#1)(1995-6#1)
promethazine hydrochloride##5##2##(2008-10#5)
promethazine##11##1##(1990-6#1)(1995-1#1)(1995-6#1)(2007-7#1)(2008-10#6)(2010-5#1)
promethazine-HCl##4##1##(2008-10#4)
prometryne##2##1##(2008-10#2)
prominence in the##3##3##(2009-4#1)(2010-12#1)(2011-1#1)
prominence in##5##2##(1996-7#2)(2009-4#1)(2010-12#1)(2011-1#1)
prominence is##3##2##(1997-4#1)(2008-2#1)(2008-4#1)
prominence of##6##2##(1991-11#1)(1992-8#1)(2008-11#1)(2009-5#1)(2010-4#1)(2013-7#1)
prominence to##2##2##(2007-11#1)(2012-12#1)
prominence##31##1##(1991-11#1)(1992-8#1)(1994-2#1)(1996-7#6)(1997-4#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-4#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)
prominences##3##1##(2006-7#1)(2008-5#1)(2012-12#1)
prominent among the##2##3##(2007-5#1)(2011-12#1)
prominent among##6##2##(1995-5#1)(1996-6#1)(2007-3#1)(2007-5#1)(2011-12#1)(2012-3#1)
prominent and persistent##2##3##(1990-12#1)(2008-1#1)
prominent and##7##2##(1990-12#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-7#2)(2012-3#1)
prominent at the##4##3##(1996-4#1)(2007-10#1)(2008-7#1)(2012-3#1)
prominent at##8##2##(1993-8#1)(1995-12#1)(1996-4#1)(2007-10#1)(2008-10#1)(2008-7#1)(2012-3#1)(2013-8#1)
prominent authority##2##2##(2010-4#1)(2012-11#1)
prominent cause of##2##3##(2011-2#1)(2012-2#1)
prominent component of the##2##4##(1990-5#1)(1992-7#1)
prominent components##2##2##(1990-12#1)(2007-11#1)
prominent effect##3##2##(2008-11#1)(2011-2#1)(2012-2#1)
prominent elements##2##2##(1994-12#1)(1994-2#1)
prominent feature##8##2##(1990-5#1)(1994-11#2)(1994-2#1)(1996-11#1)(1997-3#1)(2005-7#1)(2007-2#1)
prominent features of##4##3##(1996-1#1)(2007-10#1)(2007-12#1)(2011-2#1)
prominent immunoreactive band##2##3##(1995-7#1)(1995-9#1)
prominent in the##12##3##(1994-12#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-3#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-12#1)
prominent in##29##2##(1991-10#1)(1991-5#1)(1992-6#1)(1992-8#1)(1994-12#1)(1995-6#1)(1995-7#1)(1996-10#1)(1996-11#1)(1996-3#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2011-2#1)(2013-1#2)
prominent of##5##2##(1993-1#1)(1997-1#1)(2008-4#1)(2009-7#1)(2012-3#1)
prominent on##3##2##(2007-11#1)(2012-11#1)(2012-12#1)
prominent part of the##2##4##(1991-8#1)(2008-9#1)
prominent part of##3##3##(1991-8#1)(1995-1#1)(2008-9#1)
prominent part##5##2##(1991-8#1)(1995-1#1)(2007-12#1)(2007-7#1)(2008-9#1)
prominent pathological##2##2##(2008-7#2)
prominent peak##2##2##(1996-5#1)(1997-3#1)
prominent peaks##2##2##(1991-3#1)(1994-3#1)
prominent position in the##2##4##(2007-11#1)(2007-12#1)
prominent position in##3##3##(2007-11#1)(2007-12#1)(2008-9#1)
prominent position##4##2##(2007-11#1)(2007-12#1)(2008-9#1)(2009-8#1)
prominent protein##2##2##(1990-11#1)(2008-10#1)
prominent role in the##4##4##(1990-5#1)(2006-12#1)(2008-9#1)(2011-2#1)
prominent role in##15##3##(1990-12#1)(1990-5#1)(1992-6#1)(1995-3#1)(1996-5#1)(2005-5#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)
prominent role of the##3##4##(1990-8#1)(1994-8#1)(2006-10#1)
prominent role of##5##3##(1990-8#1)(1994-8#1)(2006-10#1)(2008-10#1)(2008-6#1)
prominent role##30##2##(1990-12#1)(1990-5#1)(1990-8#2)(1992-6#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-5#1)(2005-5#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-2#1)(2011-1#2)(2011-2#1)(2012-2#1)
prominent roles in##2##3##(2007-12#1)(2009-10#1)
prominent roles##3##2##(2007-12#1)(2008-8#1)(2009-10#1)
prominent source of##2##3##(2008-2#1)(2008-7#1)
prominent staining##2##2##(1991-7#1)(1996-9#1)
prominent symptom##2##2##(2008-5#1)(2008-6#1)
prominent symptoms of##2##3##(2005-9#1)(2012-2#1)
prominent than the##4##3##(1990-7#1)(2007-2#1)(2008-11#1)(2008-7#1)
prominent than##5##2##(1990-7#1)(1994-8#1)(2007-2#1)(2008-11#1)(2008-7#1)
prominent toxicity##3##2##(2008-6#1)(2008-7#1)(2011-1#1)
prominent tyrosine##2##2##(1995-12#1)(2012-12#1)
prominent when##5##2##(1991-3#1)(1991-5#1)(1995-2#1)(2008-5#2)
prominent with##2##2##(2008-7#1)(2008-9#1)
prominent##366##1##(1990-11#2)(1990-12#4)(1990-5#4)(1990-7#2)(1990-8#4)(1991-10#1)(1991-12#3)(1991-3#3)(1991-4#2)(1991-5#3)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#1)(1992-12#1)(1992-6#3)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-2#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#2)(1994-11#2)(1994-12#4)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#5)(1995-6#1)(1995-7#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#3)(1996-3#3)(1996-4#2)(1996-5#3)(1996-6#3)(1996-9#1)(1997-1#1)(1997-3#3)(1997-5#1)(1997-7#2)(1997-8#2)(2004-11#1)(2005-10#1)(2005-11#3)(2005-3#1)(2005-5#1)(2005-7#1)(2005-8#5)(2005-9#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#1)(2006-6#2)(2006-7#4)(2006-8#2)(2006-9#1)(2007-10#4)(2007-11#7)(2007-12#12)(2007-2#9)(2007-3#2)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#3)(2007-9#3)(2008-1#3)(2008-10#17)(2008-11#9)(2008-2#7)(2008-3#6)(2008-4#3)(2008-5#9)(2008-6#4)(2008-7#18)(2008-8#7)(2008-9#10)(2009-1#1)(2009-10#3)(2009-12#3)(2009-2#2)(2009-5#1)(2009-7#2)(2009-8#1)(2010-2#2)(2010-3#2)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#6)(2011-12#2)(2011-2#6)(2012-1#2)(2012-11#5)(2012-12#5)(2012-2#8)(2012-3#7)(2013-1#5)(2013-7#1)(2013-8#4)
prominently expressed##3##2##(1991-3#1)(2008-4#1)(2012-12#1)
prominently in the##4##3##(1992-6#1)(1996-5#1)(2006-7#1)(2012-3#1)
prominently in##9##2##(1992-6#1)(1992-7#1)(1996-11#1)(1996-5#1)(2006-7#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-3#1)
prominently##22##1##(1991-3#1)(1992-6#1)(1992-7#1)(1996-11#1)(1996-5#1)(2006-12#1)(2006-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#1)
promiscuity in##2##2##(1995-1#1)(2008-5#1)
promiscuity##12##1##(1995-1#1)(2005-10#1)(2006-5#1)(2007-2#1)(2007-7#1)(2008-5#1)(2008-9#1)(2009-3#2)(2009-5#1)(2010-7#1)(2012-3#1)
promiscuous##11##1##(1990-3#1)(1996-8#1)(1997-4#1)(2005-10#1)(2007-8#1)(2008-5#1)(2011-1#1)(2011-3#1)(2012-12#3)
promise a##2##2##(2006-6#1)(2009-8#1)
promise and##6##2##(1994-12#1)(1996-12#1)(1997-3#1)(2006-10#1)(2010-2#2)
promise as a##18##3##(1994-5#1)(1995-3#1)(1996-9#1)(2004-2#1)(2005-10#1)(2005-7#1)(2006-9#1)(2007-11#2)(2007-12#1)(2008-11#2)(2008-5#1)(2009-3#1)(2010-4#1)(2010-5#1)(2012-3#1)(2013-1#1)
promise as an alternative to##2##5##(2006-9#1)(2008-7#1)
promise as an##5##3##(1992-4#1)(2006-9#1)(2007-10#1)(2008-2#1)(2008-7#1)
promise as##32##2##(1992-2#1)(1992-4#1)(1994-5#1)(1995-3#1)(1996-9#1)(2004-2#1)(2005-10#1)(2005-7#2)(2005-8#2)(2006-11#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-2#1)(2010-4#1)(2010-5#1)(2012-3#2)(2013-1#1)
promise at##2##2##(2007-8#1)(2010-10#1)
promise for a##3##3##(2008-10#1)(2008-7#1)(2010-4#1)
promise for future##2##3##(2007-10#1)(2008-7#1)
promise for improving##5##3##(1991-3#1)(2007-12#1)(2008-3#1)(2011-2#1)(2012-3#1)
promise for rapid##2##3##(2007-8#1)(2009-4#1)
promise for reducing##2##3##(2008-6#1)(2010-4#1)
promise for such##3##3##(2008-10#1)(2012-12#2)
promise for the future##2##4##(2005-7#1)(2005-8#1)
promise for the treatment of##3##5##(2008-5#1)(2012-12#2)
promise for the##16##3##(1995-3#1)(2005-7#1)(2005-8#1)(2006-10#3)(2007-11#1)(2007-4#1)(2007-8#1)(2008-5#1)(2008-9#1)(2012-12#4)(2012-3#1)
promise for use in##2##4##(2007-12#1)(2012-1#1)
promise for##90##2##(1991-2#1)(1991-3#1)(1993-11#1)(1995-3#1)(1996-12#1)(1997-1#1)(1997-4#1)(2004-9#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-4#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-4#1)(2010-12#3)(2010-2#1)(2010-4#2)(2011-2#2)(2012-1#2)(2012-12#8)(2012-2#3)(2012-3#4)(2013-1#1)(2013-8#1)
promise if##2##2##(1997-1#1)(2006-4#1)
promise in animal models##2##4##(1994-5#1)(2008-8#1)
promise in animal##3##3##(1994-5#1)(2006-10#1)(2008-8#1)
promise in clinical trials##2##4##(2007-9#1)(2010-8#1)
promise in controlling##2##3##(2010-10#1)(2011-2#1)
promise in preventing##2##3##(2006-9#1)(2010-7#1)
promise in the treatment of##6##5##(1991-12#1)(2006-10#1)(2006-3#1)(2007-11#1)(2008-1#1)(2008-8#1)
promise in the treatment##7##4##(1991-12#1)(2006-10#1)(2006-3#1)(2007-11#1)(2008-1#1)(2008-8#1)(2010-6#1)
promise in the##12##3##(1991-12#1)(1994-3#1)(1996-5#1)(2006-10#2)(2006-3#1)(2007-11#2)(2008-1#1)(2008-8#1)(2010-6#1)(2011-12#1)
promise in##46##2##(1991-12#1)(1994-3#1)(1994-5#1)(1996-5#1)(1997-2#1)(2004-12#1)(2006-1#1)(2006-10#5)(2006-3#1)(2006-9#2)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#4)(2010-10#1)(2010-12#2)(2010-2#2)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-3#2)
promise into##2##2##(2008-11#1)(2010-5#1)
promise of a##2##3##(1993-1#1)(2008-7#1)
promise of enhanced##2##3##(1997-3#1)(2008-5#1)
promise of further##2##3##(2006-9#1)(2009-11#1)
promise of health##2##3##(1993-2#1)(2006-7#1)
promise of pharmacogenomics##2##3##(2008-10#1)(2008-8#1)
promise of the##3##3##(2007-9#1)(2009-7#1)(2010-8#1)
promise of##49##2##(1990-11#1)(1993-1#1)(1993-2#1)(1994-3#1)(1995-8#1)(1996-12#1)(1996-3#2)(1997-3#2)(2005-11#1)(2006-4#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-9#3)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-11#2)(2009-12#3)(2009-7#2)(2010-10#1)(2010-2#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
promise that##2##2##(2006-10#1)(2008-11#1)
promise to enhance the##2##4##(2006-10#1)(2009-5#1)
promise to enhance##3##3##(2006-10#1)(2009-5#1)(2010-12#1)
promise to help##2##3##(1997-1#1)(2012-11#1)
promise to improve##3##3##(2006-10#1)(2009-10#1)(2009-4#1)
promise to increase the##2##4##(1991-3#1)(1996-4#1)
promise to##34##2##(1991-3#1)(1993-12#1)(1993-2#1)(1995-3#1)(1996-4#1)(1997-1#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-4#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2010-12#1)(2011-2#1)(2012-11#1)(2012-12#1)
promise##311##1##(1990-11#1)(1990-12#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-2#1)(1992-4#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1994-12#1)(1994-3#2)(1994-5#2)(1995-3#3)(1995-8#1)(1996-12#3)(1996-3#2)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#3)(1997-4#1)(2004-12#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#8)(2005-8#6)(2006-1#1)(2006-10#18)(2006-11#1)(2006-3#1)(2006-4#2)(2006-6#2)(2006-7#2)(2006-8#1)(2006-9#6)(2007-1#2)(2007-10#2)(2007-11#10)(2007-12#7)(2007-4#2)(2007-8#9)(2007-9#6)(2008-1#5)(2008-10#17)(2008-11#9)(2008-2#5)(2008-3#9)(2008-4#5)(2008-5#6)(2008-6#2)(2008-7#7)(2008-8#12)(2008-9#3)(2009-10#3)(2009-11#2)(2009-12#5)(2009-3#2)(2009-4#4)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#4)(2010-12#8)(2010-2#7)(2010-4#6)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#5)(2012-11#1)(2012-12#12)(2012-2#6)(2012-3#9)(2013-1#4)(2013-8#2)
promised the##2##2##(1996-4#1)(2008-4#1)
promised to##2##2##(2007-9#1)(2008-3#1)
promised##15##1##(1991-4#1)(1993-3#1)(1995-1#1)(1995-12#1)(1996-4#1)(2007-2#1)(2007-9#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-1#1)(2009-4#1)(2010-11#1)
promisekeeping##2##1##(1996-12#2)
promises a##4##2##(1991-9#1)(2008-2#1)(2010-8#1)(2011-2#1)
promises and challenges##2##3##(2008-9#1)(2010-7#1)
promises and pitfalls##2##3##(2005-9#1)(2007-4#1)
promises and##7##2##(1991-11#1)(1991-3#1)(2005-9#1)(2007-4#1)(2008-6#1)(2008-9#1)(2010-7#1)
promises in##2##2##(1992-1#1)(2013-7#1)
promises new##2##2##(2008-4#1)(2009-8#1)
promises of##4##2##(1996-3#1)(2008-11#1)(2008-7#1)(2010-9#1)
promises the##2##2##(1991-10#1)(2008-3#1)
promises to be a powerful##2##5##(2007-12#1)(2008-11#1)
promises to be a##5##4##(1994-1#1)(2007-12#1)(2008-11#1)(2009-6#1)(2010-8#1)
promises to be an##2##4##(1996-2#1)(2012-2#1)
promises to be##9##3##(1994-1#1)(1996-2#1)(2004-5#1)(2007-12#1)(2008-1#1)(2008-11#1)(2009-6#1)(2010-8#1)(2012-2#1)
promises to enable##2##3##(2008-2#1)(2010-9#1)
promises to make##2##3##(1992-3#1)(2007-8#1)
promises to provide##3##3##(1997-5#1)(2007-9#1)(2009-10#1)
promises to reduce##2##3##(2004-11#1)(2007-10#1)
promises to significantly##2##3##(2006-10#1)(2007-9#1)
promises to##34##2##(1992-3#1)(1994-1#1)(1995-4#1)(1996-2#1)(1997-5#1)(2004-11#1)(2004-5#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-12#3)(2009-6#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2012-2#1)
promises##75##1##(1991-10#1)(1991-11#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-3#1)(1994-1#1)(1995-4#1)(1996-2#1)(1996-3#2)(1997-5#1)(1997-8#1)(2004-11#1)(2004-5#1)(2005-10#1)(2005-7#2)(2005-9#1)(2006-10#2)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#2)(2008-11#3)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#3)(2009-3#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-2#4)(2012-12#1)(2012-2#1)(2013-7#1)
promising advance##4##2##(2006-10#1)(2007-11#1)(2008-8#1)(2012-2#1)
promising agent for the##2##4##(2008-1#1)(2008-10#1)
promising agent for##4##3##(1997-1#1)(2008-1#1)(2008-10#1)(2012-12#1)
promising agent##6##2##(1992-5#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-3#1)(2012-12#1)
promising agents##5##2##(2005-11#1)(2008-4#2)(2008-5#1)(2009-9#1)
promising alternative to##4##3##(1997-4#1)(2008-10#2)(2010-8#1)
promising alternative##9##2##(1997-4#1)(2007-8#1)(2008-10#2)(2008-2#1)(2009-5#1)(2010-11#1)(2010-8#1)(2013-1#1)
promising an effective automatic system for discovering patient outcomes from large volumes of health information##2##15##(2013-1#2)
promising and valuable##2##3##(2008-10#1)(2011-2#1)
promising and##21##2##(1996-3#1)(2004-9#1)(2006-10#1)(2006-8#1)(2007-11#3)(2007-12#2)(2008-10#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#3)
promising anticancer##4##2##(2005-8#1)(2008-1#1)(2009-3#1)(2012-12#1)
promising application in##2##3##(2008-10#1)(2010-12#1)
promising application##4##2##(2007-12#1)(2008-10#1)(2010-12#1)(2010-7#1)
promising applications##2##2##(1994-5#1)(2008-10#1)
promising approach for the##7##4##(1992-8#1)(1993-11#1)(2008-5#1)(2010-4#1)(2010-5#1)(2012-2#2)
promising approach for##14##3##(1992-8#1)(1993-11#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-4#1)(2010-5#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-7#1)
promising approach to##11##3##(2007-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-2#1)(2010-5#2)(2010-9#1)(2012-1#1)(2012-2#1)
promising approach towards##2##3##(2007-12#1)(2008-10#1)
promising approach##29##2##(1992-8#1)(1993-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#4)(2008-8#1)(2009-10#1)(2010-2#1)(2010-4#1)(2010-5#4)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-7#1)
promising approaches for##4##3##(2010-7#1)(2012-11#2)(2012-2#1)
promising approaches##7##2##(1996-10#1)(2008-1#1)(2010-7#1)(2012-11#3)(2012-2#1)
promising as##6##2##(2006-10#2)(2006-8#1)(2007-12#1)(2007-6#1)(2008-10#1)
promising but##10##2##(1990-4#1)(2006-10#1)(2007-11#2)(2008-7#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
promising candidates and##2##3##(2008-3#1)(2013-1#1)
promising candidates for the##2##4##(2006-4#1)(2011-1#1)
promising candidates for##12##3##(2006-4#1)(2008-1#2)(2008-10#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
promising candidates##18##2##(2006-4#1)(2007-11#1)(2008-1#3)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
promising class of##2##3##(2007-8#1)(2008-7#1)
promising clinical##6##2##(1996-8#1)(2007-11#3)(2008-12#1)(2008-7#1)
promising data##2##2##(2009-4#1)(2011-3#1)
promising delivery systems for##2##4##(2008-11#1)(2008-2#1)
promising delivery systems##3##3##(2008-11#1)(2008-2#1)(2008-4#1)
promising development##2##2##(2007-11#1)(2010-11#1)
promising developments##2##2##(2005-8#1)(2011-7#1)
promising drug##3##2##(2005-7#1)(2008-8#1)(2011-3#1)
promising early results##4##3##(2006-10#2)(2008-5#1)(2009-9#1)
promising early##5##2##(2006-10#2)(2006-12#1)(2008-5#1)(2009-9#1)
promising effects in##2##3##(2005-8#1)(2007-11#1)
promising efficacy##2##2##(2007-11#1)(2007-8#1)
promising evidence##3##2##(1990-3#1)(2008-6#1)(2008-8#1)
promising experimental##4##2##(1991-3#1)(2006-10#2)(2008-4#1)
promising field of##4##3##(2007-11#1)(2008-10#1)(2009-1#1)(2012-3#1)
promising field##5##2##(2005-11#1)(2007-11#1)(2008-10#1)(2009-1#1)(2012-3#1)
promising findings##2##2##(2008-6#1)(2010-9#1)
promising first##3##2##(2009-10#1)(2013-1#2)
promising for development of##2##4##(2008-11#1)(2008-5#1)
promising for the future##2##4##(2006-10#1)(2009-1#1)
promising for the##12##3##(1991-9#1)(1993-4#1)(1996-6#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-7#1)(2009-1#1)(2009-7#1)(2013-8#1)
promising for##49##2##(1990-4#1)(1991-3#1)(1991-9#1)(1993-4#1)(1995-2#1)(1996-6#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#1)(2009-1#1)(2009-10#1)(2009-2#1)(2009-7#1)(2011-1#1)(2011-2#3)(2012-11#2)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#3)(2013-8#1)
promising formulations##3##2##(2010-2#1)(2010-3#2)
promising from##2##2##(1992-3#1)(2008-5#1)
promising future##2##2##(1992-8#1)(2012-3#1)
promising genes##2##2##(2004-4#1)(2011-2#1)
promising in terms of##2##4##(2006-2#1)(2013-1#1)
promising in the##4##3##(2008-1#1)(2008-10#1)(2012-2#2)
promising in vitro##2##3##(2008-5#1)(2012-12#1)
promising in vivo##2##3##(2008-11#1)(2008-4#1)
promising in##20##2##(1991-1#1)(1992-7#1)(2006-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
promising initial studies##2##3##(2011-2#1)(2012-2#1)
promising instrument##2##2##(1996-12#1)(2008-8#1)
promising intervention##3##2##(2008-6#1)(2010-6#1)(2010-9#1)
promising lead##2##2##(2006-12#1)(2008-1#1)
promising materials for##2##3##(1995-6#1)(2010-4#1)
promising materials##3##2##(1995-6#1)(2010-4#1)(2010-7#1)
promising means of##2##3##(1997-3#1)(2009-6#1)
promising means##4##2##(1991-2#1)(1997-3#1)(2009-10#1)(2009-6#1)
promising method for the##6##4##(1990-9#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-3#1)(2010-10#1)
promising method for##16##3##(1990-9#1)(2005-11#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#2)(2010-10#1)(2010-11#1)(2012-3#1)(2013-1#1)
promising method to##6##3##(2005-10#1)(2007-5#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-5#1)
promising method##26##2##(1990-9#1)(1991-9#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-7#1)(2012-3#1)(2013-1#2)
promising methods##2##2##(2008-3#1)(2008-7#1)
promising model for##2##3##(2010-8#1)(2012-2#1)
promising new treatment##2##3##(2005-6#1)(2012-12#1)
promising new##23##2##(2005-6#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-2#1)(2009-8#1)(2010-12#3)(2010-4#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-8#2)
promising novel##6##2##(1994-12#1)(2006-2#1)(2008-11#1)(2008-8#1)(2010-11#1)(2011-7#1)
promising of these##3##3##(2006-7#1)(2008-1#1)(2008-7#1)
promising of##4##2##(2006-7#1)(2008-1#1)(2008-6#1)(2008-7#1)
promising option for##5##3##(2009-7#1)(2010-12#1)(2012-1#1)(2012-3#1)(2013-8#1)
promising option##7##2##(2006-10#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
promising options##3##2##(2008-10#1)(2008-3#1)(2010-8#1)
promising outcomes##3##2##(2005-11#1)(2008-10#1)(2010-8#1)
promising perspectives##2##2##(2010-5#1)(2012-1#1)
promising platform##3##2##(2009-5#1)(2010-11#1)(2012-2#1)
promising potential for##3##3##(2006-12#1)(2008-5#1)(2013-8#1)
promising potential##9##2##(2005-8#1)(2006-12#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-3#1)(2012-1#1)(2013-8#1)
promising preliminary results##3##3##(2006-10#2)(2007-11#1)
promising prospect##2##2##(2007-9#1)(2008-5#1)
promising research##3##2##(2007-10#1)(2012-1#1)(2012-12#1)
promising response rates##2##3##(2008-5#1)(2010-11#1)
promising result##3##2##(2008-9#2)(2011-3#1)
promising results for##4##3##(2008-5#1)(2012-3#1)(2013-1#2)
promising results have been##3##4##(2005-2#1)(2007-11#1)(2010-12#1)
promising results have##4##3##(2005-2#1)(2007-11#1)(2009-8#1)(2010-12#1)
promising results in classifying##3##4##(2010-8#1)(2013-1#2)
promising results in vitro##2##4##(2007-11#1)(2011-2#1)
promising results in##24##3##(1992-10#1)(1992-3#1)(1993-3#1)(1996-12#2)(2006-10#1)(2007-11#2)(2007-5#1)(2007-7#2)(2008-1#1)(2008-7#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
promising results obtained##2##3##(2008-10#2)
promising results of##2##3##(2008-7#1)(2011-2#1)
promising results with##3##3##(2007-11#1)(2007-8#1)(2008-5#1)
promising results##67##2##(1992-10#1)(1992-3#1)(1993-3#1)(1996-1#1)(1996-10#1)(1996-12#2)(1997-1#1)(2004-1#1)(2005-12#1)(2005-2#1)(2006-10#4)(2006-12#1)(2007-11#7)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#3)(2008-7#2)(2009-11#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#3)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
promising source of##3##3##(2007-12#1)(2009-3#1)(2012-12#1)
promising source##4##2##(2007-12#1)(2009-3#1)(2009-6#1)(2012-12#1)
promising species##2##2##(2006-12#1)(2011-1#1)
promising strategy for reducing##2##4##(2009-3#1)(2012-2#1)
promising strategy for##5##3##(2006-10#1)(2008-1#1)(2008-3#1)(2009-3#1)(2012-2#1)
promising strategy to##5##3##(1991-2#1)(2008-10#1)(2008-11#1)(2010-10#1)(2013-8#1)
promising strategy##13##2##(1991-2#1)(2005-10#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-3#1)(2010-10#1)(2011-11#1)(2012-2#1)(2013-8#1)
promising target##8##2##(2005-8#1)(2006-12#1)(2008-1#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#2)
promising targets that##2##3##(2009-3#1)(2012-12#1)
promising targets##4##2##(1995-12#1)(2009-3#2)(2012-12#1)
promising technique to##2##3##(2008-2#1)(2011-1#1)
promising technique##15##2##(1990-11#1)(1991-9#1)(1994-3#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2010-3#1)(2011-1#2)(2013-1#1)
promising technologies##3##2##(2011-12#1)(2013-1#2)
promising technology for##4##3##(2008-11#1)(2008-5#1)(2010-12#1)(2012-2#1)
promising technology##6##2##(2008-11#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)
promising therapeutic agents##2##3##(2008-8#1)(2012-12#1)
promising therapeutic approach##6##3##(1997-5#1)(2007-11#1)(2008-5#1)(2012-12#2)(2013-1#1)
promising therapeutic targets##2##3##(2010-5#1)(2012-3#1)
promising therapeutic##28##2##(1994-5#1)(1994-6#1)(1995-2#1)(1997-5#1)(2006-1#1)(2007-11#1)(2008-1#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-6#3)(2011-2#1)(2012-11#1)(2012-12#6)(2012-2#1)(2012-3#1)(2013-1#1)
promising therapies for##2##3##(2006-12#1)(2012-1#1)
promising therapies##3##2##(2006-10#1)(2006-12#1)(2012-1#1)
promising therapy for##3##3##(2006-10#1)(2011-2#1)(2013-1#1)
promising therapy##6##2##(2006-10#2)(2007-8#1)(2008-1#1)(2011-2#1)(2013-1#1)
promising to be##2##3##(2008-5#1)(2013-1#1)
promising to##7##2##(1992-12#1)(1993-11#1)(2007-12#1)(2007-9#1)(2008-5#1)(2013-1#1)(2013-8#1)
promising tool for##10##3##(1994-12#1)(2005-11#1)(2007-8#1)(2008-10#3)(2008-3#1)(2009-10#1)(2009-11#1)(2012-3#1)
promising tool##19##2##(1992-6#1)(1994-12#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-12#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-3#1)(2009-10#1)(2009-11#1)(2012-3#1)
promising tools for##3##3##(2008-10#2)(2008-2#1)
promising tools##6##2##(2006-10#1)(2008-10#2)(2008-2#1)(2008-4#1)(2012-3#1)
promising treatment of##2##3##(2008-11#1)(2011-2#1)
promising treatment##7##2##(2005-11#1)(2006-7#1)(2008-11#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
promising way to##2##3##(1996-3#1)(2007-11#1)
promising way##5##2##(1996-3#1)(2007-11#1)(2008-10#1)(2009-10#1)(2012-1#1)
promising##881##1##(1990-11#2)(1990-12#1)(1990-3#1)(1990-4#2)(1990-8#2)(1990-9#2)(1991-1#2)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#1)(1991-9#4)(1992-10#2)(1992-12#3)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-3#2)(1993-4#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-6#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-1#2)(1996-10#2)(1996-12#4)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(2004-1#2)(2004-11#1)(2004-4#1)(2004-9#1)(2005-10#3)(2005-11#8)(2005-12#1)(2005-2#1)(2005-6#1)(2005-7#7)(2005-8#9)(2005-9#1)(2006-1#1)(2006-10#45)(2006-11#1)(2006-12#13)(2006-2#4)(2006-4#2)(2006-5#2)(2006-6#5)(2006-7#5)(2006-8#3)(2006-9#1)(2007-1#3)(2007-10#3)(2007-11#44)(2007-12#19)(2007-2#1)(2007-4#1)(2007-5#3)(2007-6#3)(2007-7#3)(2007-8#10)(2007-9#6)(2008-1#25)(2008-10#54)(2008-11#16)(2008-12#2)(2008-2#14)(2008-3#23)(2008-4#15)(2008-5#42)(2008-6#6)(2008-7#20)(2008-8#12)(2008-9#9)(2009-1#2)(2009-10#9)(2009-11#2)(2009-2#3)(2009-3#8)(2009-4#2)(2009-5#4)(2009-6#4)(2009-7#3)(2009-8#4)(2009-9#4)(2010-10#2)(2010-11#10)(2010-12#18)(2010-2#3)(2010-3#4)(2010-4#6)(2010-5#9)(2010-6#8)(2010-7#7)(2010-8#11)(2010-9#4)(2011-1#18)(2011-11#1)(2011-12#3)(2011-2#30)(2011-3#3)(2011-7#2)(2012-1#17)(2012-11#10)(2012-12#24)(2012-2#36)(2012-3#16)(2012-5#1)(2012-6#1)(2012-7#1)(2013-1#39)(2013-7#3)(2013-8#16)
promonocytic U937 cells##2##3##(1993-11#1)(2012-12#1)
promonocytic U937##3##2##(1993-11#1)(1993-4#1)(2012-12#1)
promonocytic##8##1##(1993-11#1)(1993-4#1)(1994-2#2)(1994-3#1)(1994-5#2)(2012-12#1)
promontory##5##1##(2008-9#5)
promotable##2##1##(1990-7#1)(1993-7#1)
promote Schwann cell migration##2##4##(1994-3#2)
promote a##22##2##(1992-12#1)(1993-1#1)(1994-8#1)(1996-3#1)(1997-3#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-4#1)(2008-7#2)(2008-8#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-7#1)
promote adherence##4##2##(1992-6#2)(2013-1#2)
promote an##5##2##(1991-2#1)(1992-6#1)(2007-4#1)(2009-11#1)(2012-2#1)
promote and protect##2##3##(1995-9#1)(2010-6#1)
promote and##16##2##(1993-1#1)(1993-5#1)(1995-9#1)(1996-2#1)(2007-2#2)(2007-9#1)(2008-12#2)(2008-5#2)(2008-7#1)(2010-6#1)(2012-1#1)(2012-2#1)(2012-3#1)
promote angiogenesis##2##2##(2012-12#1)(2013-1#1)
promote apoptosis##2##2##(2003-11#1)(2009-12#1)
promote autoimmunity was##2##3##(2008-10#2)
promote bacterial##3##2##(2008-3#2)(2009-3#1)
promote better##3##2##(2005-5#1)(2009-11#1)(2013-1#1)
promote breastfeeding##2##2##(2007-2#2)
promote cell growth##3##3##(1992-2#1)(2008-7#1)(2013-1#1)
promote cell motility##2##3##(2008-4#1)(2012-12#1)
promote cell proliferation##2##3##(2008-4#1)(2012-12#1)
promote cell survival##2##3##(1991-11#1)(2010-7#1)
promote cell##14##2##(1990-11#1)(1991-11#1)(1992-2#1)(1994-9#1)(1995-5#1)(1995-6#1)(2008-4#2)(2008-7#1)(2010-7#1)(2011-2#1)(2012-12#2)(2013-1#1)
promote cellular##2##2##(2008-5#1)(2008-9#1)
promote cholesterol##4##2##(1990-12#1)(2006-10#1)(2006-2#1)(2008-10#1)
promote clinical##2##2##(2005-12#1)(2008-11#1)
promote coexistence between##2##3##(2008-9#2)
promote critical thinking##2##3##(2006-3#1)(2008-12#1)
promote development##2##2##(2009-3#1)(2012-1#1)
promote differentiation##2##2##(2008-11#1)(2011-2#1)
promote effective##3##2##(1991-12#1)(2008-11#1)(2012-12#1)
promote formation of the##2##4##(1994-8#1)(2006-9#1)
promote functional recovery##2##3##(1994-8#1)(2008-7#1)
promote genetic##2##2##(2009-8#1)(2012-3#1)
promote growth##4##2##(1995-11#1)(2008-9#2)(2013-8#1)
promote healing##5##2##(2008-10#1)(2010-10#1)(2010-12#1)(2010-2#1)(2013-8#1)
promote health##9##2##(2007-10#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-6#1)(2010-12#2)(2012-1#1)(2012-3#1)
promote healthy##5##2##(2008-12#1)(2009-5#1)(2011-2#1)(2012-1#2)
promote learning and##2##3##(2008-5#1)(2012-12#1)
promote learning##4##2##(2008-11#1)(2008-3#1)(2008-5#1)(2012-12#1)
promote lifestyle##2##2##(2008-8#2)
promote lung##2##2##(1995-8#1)(2006-10#1)
promote mental health##2##3##(1996-1#1)(2009-10#1)
promote more##4##2##(2008-4#1)(2008-5#1)(2011-1#1)(2012-2#1)
promote neurite outgrowth##2##3##(1995-1#1)(2008-4#1)
promote neurite##3##2##(1995-1#1)(1995-3#1)(2008-4#1)
promote new##2##2##(2006-6#1)(2010-12#1)
promote normal birth##3##3##(2007-2#2)(2008-6#1)
promote normal##4##2##(2007-2#2)(2008-6#1)(2009-9#1)
promote or protect##2##3##(2008-1#1)(2013-1#1)
promote or##6##2##(1997-1#1)(2006-10#1)(2008-1#1)(2008-12#1)(2013-1#2)
promote patient##2##2##(2006-10#1)(2007-2#1)
promote peripheral##2##2##(2006-9#1)(2012-2#1)
promote physical activity##7##3##(2007-10#1)(2010-2#2)(2013-1#4)
promote plant##2##2##(2008-9#1)(2013-8#1)
promote professional##3##2##(2008-11#1)(2008-12#1)(2009-11#1)
promote proliferation of##2##3##(1990-4#1)(2011-2#1)
promote proliferation##3##2##(1990-4#1)(1991-1#1)(2011-2#1)
promote protein##2##2##(1997-7#1)(2011-2#1)
promote quality and##2##3##(1996-2#1)(2008-9#1)
promote quality##7##2##(1996-2#2)(1997-1#1)(2008-3#1)(2008-9#1)(2011-12#2)
promote regression##2##2##(1996-1#1)(2004-3#1)
promote research into##2##3##(2008-10#1)(2013-1#1)
promote research##3##2##(2008-10#1)(2008-6#1)(2013-1#1)
promote safe##3##2##(2007-2#1)(2008-12#1)(2012-3#1)
promote smoking initiation##2##3##(2012-12#2)
promote smoking##6##2##(1991-12#1)(1994-11#1)(1994-7#1)(2009-2#1)(2012-12#2)
promote specific##2##2##(2009-3#1)(2011-2#1)
promote student##2##2##(2007-5#1)(2008-11#1)
promote successful##3##2##(1991-2#1)(2009-8#1)(2012-2#1)
promote the conversion of##2##4##(1995-8#1)(2012-11#1)
promote the creation of##2##4##(2008-11#1)(2008-7#1)
promote the degradation of##3##4##(2008-3#2)(2008-8#1)
promote the deposition##2##3##(1996-8#1)(1996-9#1)
promote the development of##9##4##(1992-9#1)(1996-4#1)(2008-11#2)(2008-2#1)(2009-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
promote the differentiation of##2##4##(1994-12#1)(2008-11#1)
promote the formation of the##2##5##(1990-2#1)(1995-6#1)
promote the formation of##7##4##(1990-2#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-4#1)(2008-9#1)
promote the growth and##3##4##(2008-8#1)(2013-1#2)
promote the growth of##7##4##(1991-5#1)(1992-7#1)(2008-3#1)(2009-3#1)(2013-1#2)(2013-8#1)
promote the growth##10##3##(1991-5#1)(1992-7#1)(2008-3#1)(2008-8#1)(2009-3#1)(2013-1#4)(2013-8#1)
promote the health of##2##4##(2010-8#1)(2012-2#1)
promote the health##3##3##(2009-4#1)(2010-8#1)(2012-2#1)
promote the in##2##3##(1991-3#1)(2004-12#1)
promote the practice##2##3##(2008-8#1)(2010-11#1)
promote the production of##4##4##(1992-12#1)(2004-11#1)(2005-11#1)(2007-6#1)
promote the rapid##2##3##(1991-12#1)(1995-3#1)
promote the survival of##2##4##(1992-8#1)(1996-5#1)
promote the understanding##2##3##(2008-8#1)(2011-1#1)
promote the use of##4##4##(2008-10#1)(2008-8#1)(2013-1#2)
promote the##158##2##(1990-2#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#2)(1992-12#1)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-12#2)(1994-3#1)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#3)(1996-1#2)(1996-4#3)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-12#1)(2005-11#3)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-4#3)(2007-6#1)(2007-7#1)(2008-1#5)(2008-10#9)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#7)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-9#3)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#9)(2013-8#7)
promote their##3##2##(2009-3#1)(2009-9#1)(2012-1#1)
promote this##2##2##(1996-1#1)(2012-12#1)
promote tumor cell migration##2##4##(2011-2#2)
promote tumor growth##2##3##(2008-8#1)(2009-3#1)
promote tumor progression##2##3##(1991-5#1)(2011-1#1)
promote tumor##7##2##(1991-5#1)(2008-8#1)(2009-3#2)(2011-1#1)(2011-2#2)
promote tumour##2##2##(2011-2#1)(2013-1#1)
promote wider use of##2##4##(1997-2#1)(2012-3#1)
promote wound##2##2##(2010-3#1)(2012-3#1)
promote##734##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#5)(1991-2#4)(1991-3#3)(1991-5#4)(1991-6#2)(1991-7#1)(1991-9#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#4)(1992-6#5)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-7#1)(1994-1#2)(1994-10#2)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#3)(1994-7#1)(1994-8#4)(1994-9#1)(1995-1#3)(1995-11#3)(1995-12#4)(1995-2#4)(1995-3#6)(1995-5#3)(1995-6#4)(1995-8#4)(1995-9#1)(1996-1#7)(1996-10#1)(1996-11#1)(1996-2#6)(1996-3#5)(1996-4#3)(1996-5#6)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#4)(1997-4#3)(1997-5#1)(1997-7#3)(1997-8#1)(2003-11#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-3#1)(2004-9#1)(2005-10#2)(2005-11#4)(2005-12#4)(2005-5#4)(2005-6#2)(2005-7#1)(2005-8#2)(2006-10#12)(2006-11#1)(2006-12#2)(2006-2#3)(2006-3#2)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#4)(2007-1#1)(2007-10#8)(2007-11#5)(2007-12#9)(2007-2#20)(2007-4#6)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#13)(2008-10#34)(2008-11#22)(2008-12#11)(2008-2#5)(2008-3#11)(2008-4#12)(2008-5#13)(2008-6#11)(2008-7#13)(2008-8#22)(2008-9#13)(2009-10#4)(2009-11#7)(2009-12#5)(2009-2#1)(2009-3#10)(2009-4#6)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#6)(2009-9#8)(2010-10#6)(2010-11#4)(2010-12#10)(2010-2#6)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#13)(2011-12#5)(2011-2#29)(2012-1#6)(2012-11#2)(2012-12#22)(2012-2#21)(2012-3#17)(2013-1#42)(2013-7#8)(2013-8#13)
promoted a significant##2##3##(2008-12#2)
promoted a##7##2##(1991-6#1)(1997-2#1)(2006-9#1)(2008-12#2)(2008-5#1)(2012-11#1)
promoted an increase in##2##4##(1994-3#1)(2008-12#1)
promoted an##3##2##(1993-6#1)(1994-3#1)(2008-12#1)
promoted and##3##2##(1997-7#1)(2006-4#1)(2008-3#1)
promoted apoptosis##3##2##(1996-2#1)(2008-9#1)(2011-1#1)
promoted as a method of family##2##6##(1991-6#1)(2008-11#1)
promoted as##4##2##(1991-6#1)(1996-12#1)(2006-6#1)(2008-11#1)
promoted by a##4##3##(1995-6#1)(2007-12#1)(2008-8#1)(2010-12#1)
promoted by an##2##3##(1992-6#1)(1993-12#1)
promoted by increasing##2##3##(2008-12#1)(2008-9#1)
promoted by iodine(III)##2##3##(2007-10#2)
promoted by the##13##3##(1993-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1996-7#1)(2008-10#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-8#1)(2011-1#1)(2012-11#2)
promoted by these##2##3##(1994-8#1)(1994-9#1)
promoted by##63##2##(1990-12#1)(1990-2#1)(1991-10#1)(1991-12#1)(1992-6#1)(1993-11#2)(1993-12#3)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#3)(1996-2#1)(1996-7#1)(1997-4#1)(2006-5#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-7#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-12#3)(2011-1#1)(2012-1#1)(2012-11#2)(2012-3#1)(2013-1#1)(2013-8#2)
promoted cell##3##2##(1990-11#1)(1995-5#1)(2008-10#1)
promoted cell-attachment of##2##3##(1997-1#2)
promoted for##2##2##(2006-12#1)(2008-11#1)
promoted greater##2##2##(2010-8#1)(2012-1#1)
promoted growth and##3##3##(1995-11#2)(2008-6#1)
promoted in##5##2##(1994-6#1)(2009-2#1)(2010-10#1)(2011-1#1)(2011-2#1)
promoted on##3##2##(1996-1#1)(2006-10#1)(2008-11#1)
promoted platelet thrombus formation##2##4##(2006-6#2)
promoted rearrangement of##2##3##(2007-11#1)(2009-11#1)
promoted rearrangement##3##2##(2007-11#1)(2009-11#2)
promoted recovery##2##2##(2012-1#1)(2012-2#1)
promoted seed germination##2##3##(2006-11#1)(2008-5#1)
promoted significant##3##2##(2004-8#1)(2006-2#1)(2008-5#1)
promoted such##2##2##(2006-12#1)(2008-4#1)
promoted the adhesion##2##3##(1990-9#1)(2013-1#1)
promoted the development of IFN-gamma-producing##2##5##(1996-10#2)
promoted the development of##4##4##(1994-11#1)(1996-10#2)(2005-11#1)
promoted the formation of##2##4##(1990-9#1)(1997-4#1)
promoted the production##2##3##(1992-12#1)(1996-5#1)
promoted the##47##2##(1990-7#1)(1990-9#2)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-8#1)(1994-11#2)(1995-11#1)(1996-10#2)(1996-4#1)(1996-5#2)(1997-1#1)(1997-4#1)(2005-11#3)(2005-12#1)(2005-4#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#2)
promoted their##3##2##(2008-11#1)(2013-1#2)
promoted to the##2##3##(2006-9#1)(2010-12#1)
promoted to##5##2##(1990-7#1)(2006-9#1)(2008-1#1)(2010-12#1)(2012-3#1)
promoted with##2##2##(1996-11#1)(2011-1#1)
promoted##272##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#2)(1990-9#2)(1991-10#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#4)(1993-3#1)(1993-6#3)(1993-9#1)(1994-10#1)(1994-11#3)(1994-2#1)(1994-3#4)(1994-5#3)(1994-6#2)(1994-8#4)(1994-9#2)(1995-10#1)(1995-11#4)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#3)(1995-6#1)(1996-1#1)(1996-10#2)(1996-11#4)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#2)(1996-7#1)(1997-1#3)(1997-2#4)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#1)(2004-8#2)(2005-11#6)(2005-12#1)(2005-4#1)(2005-8#2)(2006-10#3)(2006-11#2)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#3)(2006-9#3)(2007-10#3)(2007-11#6)(2007-12#3)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#7)(2008-11#8)(2008-12#7)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#8)(2008-6#4)(2008-7#2)(2008-8#7)(2008-9#4)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#6)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#7)(2012-1#3)(2012-11#5)(2012-12#3)(2012-2#5)(2012-3#7)(2012-7#1)(2013-1#15)(2013-8#4)
promoter (for##2##2##(1995-5#2)
promoter CpG##4##2##(2007-10#1)(2007-11#2)(2008-7#1)
promoter DNA and##2##3##(1993-6#1)(1997-5#1)
promoter DNA##12##2##(1991-4#1)(1991-5#1)(1993-12#1)(1993-6#2)(1994-3#2)(1997-5#1)(2007-10#1)(2008-10#1)(2008-8#1)(2008-9#1)
promoter P2##2##2##(1990-11#1)(1992-7#1)
promoter activation##4##2##(1995-3#1)(2008-11#3)
promoter activities in##2##3##(1993-12#1)(2007-10#1)
promoter activities were##2##3##(1992-9#1)(2006-12#1)
promoter activities##6##2##(1992-9#2)(1993-12#1)(2006-12#1)(2007-10#1)(2008-5#1)
promoter activity and##4##3##(1994-11#1)(1994-12#1)(1997-4#1)(2007-12#1)
promoter activity in human##2##4##(1992-11#1)(1995-3#1)
promoter activity in the##2##4##(1990-1#1)(1996-5#1)
promoter activity in transgenic##2##4##(1994-8#1)(1995-6#1)
promoter activity in##18##3##(1990-1#1)(1991-9#2)(1992-11#1)(1992-9#1)(1993-4#1)(1994-11#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-3#2)(1995-6#2)(1996-5#2)(2008-9#1)
promoter activity is##6##3##(1993-3#1)(1994-9#2)(1995-6#1)(1996-5#1)(1997-2#1)
promoter activity of the 5'-flanking##2##5##(1992-5#1)(1997-8#1)
promoter activity of the##4##4##(1992-5#1)(1995-2#1)(1997-7#1)(1997-8#1)
promoter activity of##7##3##(1992-5#1)(1993-4#1)(1993-8#1)(1995-2#1)(1996-7#1)(1997-7#1)(1997-8#1)
promoter activity than##2##3##(1992-9#1)(1996-5#1)
promoter activity was observed##2##4##(1995-8#1)(1997-2#1)
promoter activity was##14##3##(1990-7#1)(1992-11#1)(1992-3#1)(1994-12#1)(1994-8#2)(1995-3#1)(1995-8#1)(1996-5#1)(1996-7#2)(1997-2#2)(2009-8#1)
promoter activity when##4##3##(1992-5#1)(1993-3#1)(1995-2#1)(2008-9#1)
promoter activity##99##2##(1990-1#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-9#4)(1992-11#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-9#3)(1993-3#2)(1993-4#2)(1993-8#1)(1994-11#5)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#5)(1994-9#3)(1995-1#1)(1995-10#1)(1995-2#4)(1995-3#4)(1995-6#4)(1995-8#2)(1996-5#6)(1996-7#3)(1996-8#2)(1997-2#10)(1997-4#1)(1997-7#3)(1997-8#2)(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#2)(2009-8#1)(2010-11#3)(2010-8#1)(2013-1#1)
promoter analysis##2##2##(2008-11#1)(2008-9#1)
promoter and 3'##2##3##(1992-12#1)(1997-6#1)
promoter and a##7##3##(1993-6#1)(1994-5#1)(1995-2#1)(1996-8#1)(1997-5#1)(2006-12#1)(2008-10#1)
promoter and an##4##3##(1991-4#1)(1993-3#1)(1995-12#1)(2010-12#1)
promoter and coding region##2##4##(1990-11#1)(1997-3#1)
promoter and enhancer region##2##4##(1996-10#1)(2011-2#1)
promoter and enhancer##7##3##(1992-6#1)(1996-10#1)(2008-1#1)(2008-4#1)(2008-8#1)(2011-2#2)
promoter and identified##2##3##(1993-6#1)(1995-10#1)
promoter and introduced##2##3##(1993-12#1)(1997-3#1)
promoter and its##2##3##(1996-10#1)(2008-11#1)
promoter and possibly##2##3##(1993-12#1)(2008-7#1)
promoter and terminator##5##3##(1993-12#1)(2008-10#1)(2008-8#3)
promoter and the##12##3##(1990-11#1)(1991-12#1)(1991-2#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-3#2)(1995-3#1)(1997-4#1)(2008-10#1)(2008-8#1)
promoter and##109##2##(1990-11#3)(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-6#2)(1993-12#4)(1993-3#3)(1993-6#3)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#2)(1996-11#1)(1996-2#1)(1996-4#1)(1996-8#2)(1997-2#1)(1997-3#3)(1997-4#4)(1997-5#1)(1997-6#2)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#2)(2007-1#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#5)(2008-9#2)(2009-8#2)(2010-11#1)(2010-12#2)(2010-5#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
promoter and/or##2##2##(1992-6#1)(2011-2#1)
promoter appears to##3##3##(1993-12#1)(1995-6#1)(1996-5#1)
promoter are##5##2##(1992-8#1)(1992-9#1)(1995-3#1)(1996-7#1)(1997-2#1)
promoter as##6##2##(1994-8#1)(1995-3#1)(2008-10#1)(2008-8#1)(2008-9#2)
promoter at the##2##3##(1993-12#1)(2007-12#1)
promoter at##4##2##(1991-5#1)(1993-12#1)(1993-3#1)(2007-12#1)
promoter based##2##2##(1991-9#1)(1997-4#1)
promoter binding##3##2##(1997-2#2)(1997-7#1)
promoter blocks the##2##3##(1993-6#2)
promoter but not##2##3##(1990-5#1)(1995-2#1)
promoter but##5##2##(1990-5#1)(1992-2#1)(1995-2#1)(1996-8#1)(1997-4#1)
promoter by the##4##3##(1996-4#2)(1997-4#1)(2008-10#1)
promoter by##21##2##(1992-5#1)(1993-12#1)(1993-5#1)(1993-7#1)(1994-12#2)(1994-8#1)(1995-6#1)(1996-4#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-8#1)
promoter can be##2##3##(1992-5#1)(1996-12#1)
promoter can##4##2##(1992-5#1)(1996-12#1)(1996-4#1)(2009-10#1)
promoter capable of##2##3##(1995-1#1)(1995-10#1)
promoter competition assay##2##3##(2006-10#2)
promoter constructs##7##2##(1992-1#1)(1994-12#2)(1994-3#1)(1995-6#2)(1997-2#1)
promoter contains a##4##3##(1994-11#1)(1994-12#2)(1996-5#1)
promoter contains##9##2##(1993-9#1)(1994-11#1)(1994-12#2)(1995-6#1)(1996-4#1)(1996-5#1)(1997-2#1)(2008-7#1)
promoter control##3##2##(1995-2#1)(2008-4#1)(2008-7#1)
promoter directs##4##2##(1994-3#2)(1996-5#1)(1996-7#1)
promoter downstream##2##2##(1990-3#1)(2008-1#1)
promoter drives##3##2##(1993-12#1)(1995-10#1)(1997-5#1)
promoter during##2##2##(1993-12#1)(1994-2#1)
promoter element and##4##3##(1990-6#1)(1991-11#1)(1991-8#1)(1993-5#1)
promoter element in##2##3##(1993-6#1)(2010-8#1)
promoter element of##2##3##(1992-12#1)(2008-5#1)
promoter element##17##2##(1990-6#1)(1991-11#1)(1991-8#1)(1992-12#1)(1992-5#1)(1993-5#1)(1993-6#2)(1994-12#1)(1995-6#4)(1996-4#1)(2008-5#1)(2008-9#1)(2010-8#1)
promoter elements are sufficient for##2##5##(1995-8#2)
promoter elements for##2##3##(1994-9#1)(2010-12#1)
promoter elements from##2##3##(1990-5#1)(2007-12#1)
promoter elements in##4##3##(1994-12#1)(1995-8#1)(2008-5#1)(2009-8#1)
promoter elements of##2##3##(1995-3#1)(2008-9#1)
promoter elements that##3##3##(1994-11#1)(1994-3#1)(2008-11#1)
promoter elements via##2##3##(1993-6#1)(1995-6#1)
promoter elements##31##2##(1990-5#2)(1991-9#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#4)(1994-3#1)(1994-9#1)(1995-3#1)(1995-6#3)(1995-8#4)(1996-10#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-9#2)(2009-8#1)(2010-12#1)(2012-12#2)
promoter for the##8##3##(1990-4#1)(1991-6#1)(1991-9#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-2#1)
promoter for##17##2##(1990-4#1)(1991-4#2)(1991-6#2)(1991-9#1)(1992-8#1)(1993-12#2)(1993-5#1)(1994-12#2)(1994-8#1)(1995-2#1)(1995-6#1)(2006-11#1)(2008-10#1)
promoter fragment##4##2##(1991-7#1)(1996-5#1)(1997-2#2)
promoter from##9##2##(1991-7#1)(1995-8#1)(1996-12#1)(2006-11#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-8#1)
promoter function##8##2##(1991-4#1)(1992-12#1)(1993-6#1)(1995-6#1)(1996-5#1)(1997-2#1)(2006-12#1)(2007-12#1)
promoter fused with##2##3##(1997-2#1)(2008-10#1)
promoter fused##3##2##(1994-12#1)(1997-2#1)(2008-10#1)
promoter had##2##2##(2006-12#1)(2008-10#1)
promoter has a##2##3##(1994-12#1)(2012-12#1)
promoter has been##6##3##(1990-11#1)(1991-5#1)(1996-3#1)(2008-3#1)(2008-5#1)(2008-9#1)
promoter has##9##2##(1990-11#1)(1990-9#1)(1991-5#1)(1994-12#1)(1996-3#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-12#1)
promoter hypermethylation of##2##3##(2007-10#1)(2011-2#1)
promoter hypermethylation##8##2##(2007-10#2)(2008-4#1)(2008-7#1)(2011-2#3)(2012-2#1)
promoter in Escherichia coli##2##4##(1996-11#1)(2008-7#1)
promoter in a##8##3##(1990-11#1)(1990-5#1)(1993-12#1)(1994-11#1)(1994-8#1)(1997-2#2)(1997-8#1)
promoter in the##10##3##(1990-12#1)(1991-6#1)(1992-2#1)(1996-4#2)(1997-4#1)(1997-6#1)(2005-11#1)(2007-11#1)(2007-12#1)
promoter in transgenic##2##3##(1995-10#1)(2008-10#1)
promoter in transient##3##3##(1993-8#1)(1994-11#1)(1996-5#1)
promoter in vitro##3##3##(1990-11#1)(1996-8#1)(1997-4#1)
promoter in vivo##2##3##(1996-8#1)(1997-4#1)
promoter in##64##2##(1990-11#2)(1990-12#1)(1990-5#1)(1991-6#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-8#1)(1995-10#1)(1995-2#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#3)(1996-4#2)(1996-5#2)(1996-8#3)(1997-1#1)(1997-2#4)(1997-4#4)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-11#1)(2006-12#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#3)(2009-8#1)(2012-12#1)
promoter into##2##2##(1993-5#1)(2008-11#1)
promoter is a##2##3##(1995-10#1)(1996-4#1)
promoter is active in##3##4##(1991-9#1)(1992-11#1)(1997-4#1)
promoter is active##6##3##(1990-12#1)(1991-9#1)(1992-11#1)(1995-1#1)(1997-4#1)(2008-2#1)
promoter is associated with##3##4##(1990-5#1)(1997-7#1)(2012-2#1)
promoter is reduced##2##3##(1994-11#1)(1995-8#1)
promoter is regulated by##2##4##(1993-12#1)(1997-7#1)
promoter is regulated##3##3##(1993-12#1)(1997-7#1)(2008-11#1)
promoter is required for##2##4##(1994-12#1)(1997-1#1)
promoter is similar to##2##4##(1990-11#1)(1996-5#1)
promoter is used##2##3##(1993-5#1)(1996-5#1)
promoter is##46##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-9#5)(1992-11#1)(1992-9#1)(1993-12#3)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-8#1)(1995-1#2)(1995-10#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-4#3)(1996-5#2)(1997-1#1)(1997-4#4)(1997-7#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2012-2#1)
promoter linked to the chloramphenicol acetyl transferase (CAT)##2##8##(1992-8#1)(1994-8#1)
promoter linked to the chloramphenicol##3##5##(1992-8#1)(1994-8#1)(1996-8#1)
promoter linked to##4##3##(1992-8#1)(1994-8#1)(1996-8#1)(1997-7#1)
promoter located##3##2##(1990-11#1)(1990-7#1)(1992-9#1)
promoter luciferase##2##2##(2012-12#1)(2012-2#1)
promoter mapping##2##2##(1995-6#1)(1997-5#1)
promoter may##2##2##(1996-5#1)(2008-9#1)
promoter methylation##7##2##(1995-2#1)(2008-4#1)(2008-7#2)(2009-8#1)(2013-1#1)(2013-8#1)
promoter of chronic diseases of Western societies##2##7##(2009-2#2)
promoter of the gene##3##4##(1993-3#1)(1996-12#1)(1997-2#1)
promoter of the human##4##4##(1990-11#1)(1997-2#2)(1997-7#1)
promoter of the rat##3##4##(1995-10#2)(1997-6#1)
promoter of the##35##3##(1990-10#1)(1990-11#1)(1990-9#1)(1991-9#1)(1992-11#2)(1993-11#2)(1993-3#1)(1994-12#1)(1994-9#1)(1995-10#2)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#1)(2006-6#2)(2008-10#2)(2008-11#2)(2008-9#1)(2009-7#2)(2011-2#1)(2012-12#1)
promoter of##70##2##(1990-10#1)(1990-11#2)(1990-9#1)(1991-7#1)(1991-9#2)(1992-11#2)(1992-4#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-8#2)(1994-9#1)(1995-10#2)(1995-2#1)(1995-3#2)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#4)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#2)(2007-10#1)(2008-10#3)(2008-11#3)(2008-8#1)(2008-9#5)(2009-2#2)(2009-7#3)(2009-8#1)(2011-2#2)(2012-12#2)(2013-1#1)
promoter on a##4##3##(1990-12#1)(1997-3#1)(1997-4#1)(2007-6#1)
promoter or the##4##3##(1993-12#1)(1996-8#1)(1997-1#1)(2012-3#1)
promoter or##16##2##(1993-12#1)(1993-3#1)(1993-5#1)(1994-8#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-5#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-3#2)
promoter pagC##3##2##(2005-11#3)
promoter polymorphism##3##2##(1996-5#1)(2008-6#1)(2013-8#1)
promoter polymorphisms and##4##3##(2012-12#1)(2013-1#3)
promoter polymorphisms##7##2##(2009-12#1)(2010-12#1)(2012-12#1)(2013-1#4)
promoter probe vectors##2##3##(1990-5#1)(1993-12#1)
promoter probe##3##2##(1990-3#1)(1990-5#1)(1993-12#1)
promoter recognition##3##2##(1992-5#1)(1995-6#1)(1997-4#1)
promoter recognized by##2##3##(1991-9#1)(1995-6#1)
promoter region and##4##3##(1991-6#1)(1992-9#1)(1994-12#1)(1997-2#1)
promoter region by##3##3##(1990-5#1)(1992-12#1)(2012-12#1)
promoter region contains a##2##4##(1994-8#1)(1995-6#1)
promoter region contains##6##3##(1993-3#1)(1993-6#1)(1994-8#1)(1995-1#1)(1995-6#1)(1997-4#1)
promoter region for##3##3##(1991-4#1)(1992-9#1)(1993-4#1)
promoter region has##3##3##(1990-3#1)(2008-9#1)(2011-1#1)
promoter region is##3##3##(1991-6#1)(1993-12#1)(2006-9#1)
promoter region of the human somatostatin receptor 5##2##8##(1994-12#2)
promoter region of the human##6##5##(1993-3#1)(1994-12#2)(1994-6#1)(1994-8#1)(1997-2#1)
promoter region of the rat##2##5##(1992-5#1)(1993-3#1)
promoter region of the##29##4##(1990-5#1)(1990-8#1)(1990-9#2)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#2)(1996-6#1)(1997-2#1)(1997-7#1)(2007-9#2)(2008-4#1)
promoter region of this##2##4##(1992-7#1)(2009-8#1)
promoter region of##52##3##(1990-5#1)(1990-8#1)(1990-9#2)(1991-6#2)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-2#3)(1995-3#2)(1996-6#1)(1997-2#2)(1997-6#1)(1997-7#2)(2007-10#1)(2007-8#1)(2007-9#2)(2008-4#1)(2009-4#1)(2009-8#3)(2011-2#1)(2012-2#2)(2013-1#1)
promoter region was sufficient##2##4##(1994-9#1)(1997-2#1)
promoter region was##6##3##(1990-11#1)(1991-6#1)(1993-3#1)(1994-12#1)(1994-9#1)(1997-2#1)
promoter region with##2##3##(1995-1#1)(1997-1#1)
promoter region##132##2##(1990-11#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-8#1)(1990-9#3)(1991-12#1)(1991-4#2)(1991-6#7)(1991-7#1)(1992-11#1)(1992-12#4)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#6)(1993-2#1)(1993-3#5)(1993-4#1)(1993-6#3)(1993-9#1)(1994-12#6)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#3)(1995-6#4)(1995-8#3)(1996-10#2)(1996-11#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#5)(1997-4#3)(1997-6#3)(1997-7#3)(1997-9#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-8#1)(2007-9#3)(2008-4#1)(2008-9#1)(2009-4#1)(2009-8#4)(2011-1#4)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#2)
promoter regions in the##2##4##(2007-10#1)(2012-3#1)
promoter regions of the##4##4##(1993-3#1)(2008-4#1)(2009-10#1)(2009-8#1)
promoter regions of##11##3##(1993-3#1)(1995-3#1)(1997-2#4)(2008-4#1)(2009-10#1)(2009-4#1)(2009-8#2)
promoter regions were##3##3##(1991-4#1)(1992-9#1)(1997-2#1)
promoter regions##30##2##(1991-4#2)(1991-9#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-10#1)(1997-2#5)(2007-10#1)(2008-4#2)(2008-8#1)(2009-10#1)(2009-4#2)(2009-8#4)(2011-1#1)(2012-3#2)
promoter requires##4##2##(1990-11#1)(1995-1#1)(1995-3#1)(1996-8#1)
promoter resulted in a##2##4##(1992-12#1)(1996-5#1)
promoter resulted in the##2##4##(1994-9#2)
promoter resulted in##6##3##(1992-12#1)(1994-9#2)(1996-3#1)(1996-5#1)(2006-12#1)
promoter revealed##3##2##(1990-5#1)(1993-3#1)(2012-12#1)
promoter selectivity##2##2##(1995-6#2)
promoter sequence of the human##2##5##(1996-5#1)(1997-7#1)
promoter sequence of##3##3##(1995-8#1)(1996-5#1)(1997-7#1)
promoter sequence##15##2##(1991-9#2)(1993-12#1)(1993-3#1)(1994-12#1)(1995-8#1)(1996-10#1)(1996-5#1)(1997-4#1)(1997-7#2)(2008-10#1)(2008-9#1)(2011-1#2)
promoter sequences of the##2##4##(2010-7#2)
promoter sequences of##3##3##(2010-7#3)
promoter sequences##27##2##(1990-11#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-2#1)(1992-12#1)(1993-11#2)(1993-12#2)(1994-3#1)(1994-9#1)(1996-11#1)(1996-4#3)(1996-5#3)(1996-8#1)(1997-4#3)(2009-5#1)(2010-7#3)
promoter showed##5##2##(1997-1#1)(1997-2#1)(2006-12#1)(2008-8#1)(2011-2#1)
promoter shows##2##2##(1991-12#1)(1992-11#1)
promoter sites##3##2##(1991-5#1)(1995-2#1)(1996-5#1)
promoter strength##4##2##(1990-5#1)(1996-4#2)(1996-8#1)
promoter structure##4##2##(1995-6#1)(1995-8#1)(1996-12#1)(1996-4#1)
promoter suggests that##2##3##(1991-4#1)(1992-4#1)
promoter system##2##2##(1990-4#1)(2011-2#1)
promoter that contains##2##3##(1995-1#1)(2010-11#1)
promoter that drives##2##3##(2007-12#2)
promoter that is##3##3##(1990-12#1)(1993-12#1)(1994-2#1)
promoter that##14##2##(1990-12#1)(1993-11#1)(1993-12#2)(1994-2#1)(1995-1#2)(1995-10#1)(1997-5#1)(2007-12#2)(2008-2#1)(2010-11#1)(2012-12#1)
promoter through the##2##3##(1994-6#1)(1996-8#1)
promoter to drive##2##3##(1997-8#1)(2006-11#1)
promoter to##8##2##(1990-9#1)(1994-5#1)(1996-11#1)(1997-2#1)(1997-5#1)(1997-8#1)(2006-11#1)(2012-12#1)
promoter together##2##2##(1992-5#1)(2011-1#1)
promoter upstream##2##2##(1995-8#1)(2011-1#1)
promoter variant of the##3##4##(2006-9#2)(2009-4#1)
promoter variant##6##2##(1996-4#1)(2006-9#2)(2009-4#3)
promoter variants##2##2##(1996-11#1)(2009-11#1)
promoter vectors##2##2##(1991-12#1)(1993-12#1)
promoter was constructed##2##3##(2008-8#1)(2008-9#1)
promoter was found to##2##4##(1997-8#1)(2007-10#1)
promoter was inserted into##2##4##(2008-11#1)(2010-5#1)
promoter was introduced into##2##4##(1996-5#1)(2008-9#1)
promoter was located between##2##4##(1995-10#1)(2012-2#1)
promoter was located##3##3##(1990-7#1)(1995-10#1)(2012-2#1)
promoter was then##2##3##(1996-6#1)(2010-5#1)
promoter was used to##3##4##(2008-4#1)(2008-8#1)(2010-5#1)
promoter was##50##2##(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-4#1)(1991-9#1)(1992-5#1)(1993-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-10#1)(1995-2#1)(1995-6#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#2)(1997-1#2)(1997-4#1)(1997-8#1)(2006-12#2)(2007-10#1)(2008-11#2)(2008-4#1)(2008-8#2)(2008-9#5)(2009-10#1)(2009-6#2)(2009-8#1)(2010-5#3)(2012-12#1)(2012-2#1)
promoter were constructed##2##3##(1993-5#1)(1995-2#1)
promoter were used to##2##4##(1990-6#1)(1990-7#1)
promoter were used##4##3##(1990-6#1)(1990-7#1)(1993-4#1)(1995-12#1)
promoter were##15##2##(1990-6#1)(1990-7#3)(1992-5#1)(1993-12#1)(1993-4#1)(1993-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(2006-11#1)(2008-10#1)(2008-5#1)(2008-9#1)
promoter when##3##2##(1991-6#1)(2007-10#1)(2008-9#1)
promoter which is##6##3##(1990-11#2)(1990-7#1)(1993-3#1)(1995-10#1)(2008-7#1)
promoter which was##2##3##(1997-3#1)(2008-11#1)
promoter which##14##2##(1990-11#2)(1990-7#1)(1992-5#1)(1992-9#1)(1993-3#1)(1994-8#1)(1995-10#2)(1996-5#2)(1997-3#1)(2008-11#1)(2008-7#1)
promoter with a##2##3##(1993-12#1)(1995-3#1)
promoter with the##2##3##(1992-11#1)(1994-9#1)
promoter with##8##2##(1992-11#1)(1993-12#1)(1994-9#2)(1995-3#1)(1996-7#1)(2006-12#1)(2008-11#1)
promoter##1593##1##(1990-1#1)(1990-10#5)(1990-11#27)(1990-12#8)(1990-3#9)(1990-4#8)(1990-5#24)(1990-6#8)(1990-7#14)(1990-8#3)(1990-9#10)(1991-1#2)(1991-11#2)(1991-12#8)(1991-2#3)(1991-4#15)(1991-5#14)(1991-6#12)(1991-7#11)(1991-8#5)(1991-9#26)(1992-1#4)(1992-10#2)(1992-11#13)(1992-12#14)(1992-2#5)(1992-3#5)(1992-4#5)(1992-5#13)(1992-6#6)(1992-7#5)(1992-8#5)(1992-9#20)(1993-11#6)(1993-12#47)(1993-2#1)(1993-3#28)(1993-4#4)(1993-5#11)(1993-6#26)(1993-7#7)(1993-8#4)(1993-9#19)(1994-11#21)(1994-12#40)(1994-2#10)(1994-3#14)(1994-5#6)(1994-6#8)(1994-8#31)(1994-9#23)(1995-1#15)(1995-10#17)(1995-11#1)(1995-12#5)(1995-2#33)(1995-3#37)(1995-4#1)(1995-5#5)(1995-6#43)(1995-8#24)(1995-9#2)(1996-10#13)(1996-11#12)(1996-12#9)(1996-2#7)(1996-3#4)(1996-4#28)(1996-5#39)(1996-6#3)(1996-7#17)(1996-8#22)(1996-9#1)(1997-1#14)(1997-2#55)(1997-3#10)(1997-4#46)(1997-5#13)(1997-6#9)(1997-7#26)(1997-8#8)(1997-9#1)(2005-11#7)(2006-10#4)(2006-11#7)(2006-12#28)(2006-2#1)(2006-6#3)(2006-9#3)(2007-1#2)(2007-10#13)(2007-11#5)(2007-12#8)(2007-2#1)(2007-6#2)(2007-8#1)(2007-9#4)(2008-1#2)(2008-10#31)(2008-11#48)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#10)(2008-5#13)(2008-6#3)(2008-7#16)(2008-8#25)(2008-9#49)(2009-10#5)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#8)(2009-5#1)(2009-6#3)(2009-7#3)(2009-8#22)(2010-1#1)(2010-10#1)(2010-11#5)(2010-12#4)(2010-2#1)(2010-3#1)(2010-5#5)(2010-7#3)(2010-8#2)(2011-1#13)(2011-10#1)(2011-12#1)(2011-2#18)(2012-12#19)(2012-2#12)(2012-3#10)(2013-1#11)(2013-8#4)
promoter)##4##1##(1995-2#1)(2008-10#1)(2008-9#2)
promoter-CAT##2##1##(1995-3#1)(1995-6#1)
promoter-activated production##2##2##(2008-11#2)
promoter-bound##2##1##(1992-5#1)(1994-12#1)
promoter-containing segment##2##2##(2008-10#1)(2011-1#1)
promoter-containing##3##1##(1991-8#1)(2008-10#1)(2011-1#1)
promoter-driven##2##1##(1993-4#1)(1996-7#1)
promoter-enhancer##3##1##(1990-12#1)(1990-5#1)(2008-11#1)
promoter-lacZ##4##1##(1990-5#1)(1991-12#1)(1995-6#1)(1997-6#1)
promoter-linked##2##1##(1993-12#1)(1997-7#1)
promoter-probe cassettes suitable for insertion mutagenesis and generation of transcriptional fusions##2##11##(1995-8#2)
promoter-probe plasmid##4##2##(1990-1#1)(1990-5#3)
promoter-probe vector##2##2##(1990-10#1)(1997-2#1)
promoter-probe##9##1##(1990-1#1)(1990-10#2)(1990-5#3)(1995-8#2)(1997-2#1)
promoter-reporter constructs##2##2##(1994-2#1)(1997-4#1)
promoter-reporter##4##1##(1993-3#1)(1994-2#1)(1997-4#1)(2011-1#1)
promoter/enhancer activity##2##2##(1994-2#2)
promoter/enhancer##5##1##(1993-12#1)(1993-3#1)(1994-2#2)(2008-4#1)
promoter/operator##4##1##(1991-8#2)(1993-12#1)(1994-12#1)
promoter/reporter##2##1##(1995-2#1)(2008-1#1)
promoterless Escherichia coli lacZ##2##4##(1993-12#1)(1995-8#1)
promoterless and##2##2##(1994-12#1)(2008-5#1)
promoterless chloramphenicol acetyltransferase##2##3##(1993-6#1)(1995-1#1)
promoterless lacZ##5##2##(1990-9#1)(1994-12#1)(1997-2#2)(1997-4#1)
promoterless##19##1##(1990-10#1)(1990-5#3)(1990-9#1)(1993-12#1)(1993-6#1)(1994-12#3)(1995-1#1)(1995-8#1)(1997-2#3)(1997-4#1)(1997-8#1)(2008-10#1)(2008-5#1)
promoters and that##2##3##(1995-10#1)(1996-8#1)
promoters and##20##2##(1990-11#1)(1990-12#1)(1990-3#1)(1991-7#1)(1991-8#1)(1993-8#2)(1995-10#1)(1995-2#1)(1995-7#1)(1996-8#1)(1997-4#2)(1997-5#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-4#1)
promoters are##2##2##(1990-5#1)(1991-11#1)
promoters by the##2##3##(1995-2#1)(1997-4#1)
promoters by##8##2##(1992-5#1)(1994-2#1)(1994-6#2)(1995-2#1)(1996-4#1)(1997-4#2)
promoters can be##3##3##(1990-5#1)(1993-9#1)(1994-9#1)
promoters containing##3##2##(1996-8#3)
promoters could##2##2##(1990-9#1)(1994-6#1)
promoters for the##4##3##(1990-5#1)(1994-11#1)(1995-8#1)(2006-12#1)
promoters for##8##2##(1990-5#2)(1994-11#1)(1994-12#1)(1994-9#1)(1995-8#1)(2006-12#1)(2010-7#1)
promoters from other##2##3##(1993-6#1)(1994-3#1)
promoters from##3##2##(1993-6#1)(1994-3#1)(2006-12#1)
promoters has been##2##3##(1993-12#1)(2008-7#1)
promoters in the##2##3##(1990-6#1)(2008-11#1)
promoters in##20##2##(1990-12#1)(1990-6#1)(1991-7#1)(1992-6#1)(1992-9#1)(1993-7#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-2#1)(1995-3#2)(1997-1#1)(2005-4#1)(2006-12#2)(2008-11#1)(2008-4#1)(2008-5#1)
promoters including##2##2##(1992-3#1)(1997-8#1)
promoters is##8##2##(1994-9#1)(1995-2#1)(1997-4#1)(2007-10#2)(2007-11#1)(2008-4#2)
promoters of genes##2##3##(2008-4#1)(2012-12#1)
promoters of many##2##3##(1992-5#1)(2008-9#1)
promoters of the##4##3##(1993-3#1)(1997-4#1)(1997-8#1)(2008-2#1)
promoters of these genes##3##4##(2008-1#1)(2008-7#1)(2009-8#1)
promoters of these##4##3##(2008-1#1)(2008-7#2)(2009-8#1)
promoters of##29##2##(1991-5#1)(1992-5#1)(1993-3#1)(1993-6#1)(1994-6#1)(1997-2#2)(1997-4#2)(1997-8#2)(2006-12#1)(2007-10#1)(2007-7#1)(2008-1#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-8#3)(2009-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
promoters that are##3##3##(1990-12#1)(1993-9#1)(2007-10#1)
promoters that##4##2##(1990-12#1)(1993-9#1)(2007-10#1)(2008-5#1)
promoters to drive##2##3##(1997-4#1)(2007-12#1)
promoters to##5##2##(1994-12#1)(1997-4#1)(2007-12#1)(2008-7#1)(2010-12#1)
promoters was found##2##3##(1995-2#1)(2006-12#1)
promoters was##6##2##(1995-2#1)(1996-3#1)(1997-5#1)(1997-8#1)(2006-12#1)(2008-8#1)
promoters were##6##2##(1992-6#2)(1994-6#1)(1995-2#1)(1997-2#1)(1997-4#1)
promoters with different##2##3##(1995-11#1)(1996-7#1)
promoters with##3##2##(1995-11#1)(1996-7#1)(2009-4#1)
promoters##308##1##(1990-11#4)(1990-12#3)(1990-3#1)(1990-5#9)(1990-6#3)(1990-9#4)(1991-11#1)(1991-2#2)(1991-4#4)(1991-5#3)(1991-7#6)(1991-8#6)(1992-1#1)(1992-11#2)(1992-2#3)(1992-3#3)(1992-5#3)(1992-6#4)(1992-9#9)(1993-11#1)(1993-12#4)(1993-3#2)(1993-6#2)(1993-7#6)(1993-8#4)(1993-9#4)(1994-11#1)(1994-12#6)(1994-2#2)(1994-3#5)(1994-5#2)(1994-6#6)(1994-8#2)(1994-9#6)(1995-1#1)(1995-10#2)(1995-11#1)(1995-2#11)(1995-3#2)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#5)(1996-11#3)(1996-2#2)(1996-3#1)(1996-4#4)(1996-5#1)(1996-7#3)(1996-8#6)(1997-1#1)(1997-2#6)(1997-4#18)(1997-5#3)(1997-6#1)(1997-8#5)(2005-4#1)(2006-11#2)(2006-12#15)(2006-5#1)(2007-10#5)(2007-11#2)(2007-12#4)(2007-7#1)(2008-1#3)(2008-10#4)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#9)(2008-5#6)(2008-7#8)(2008-8#1)(2008-9#3)(2009-10#1)(2009-4#1)(2009-8#5)(2009-9#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#4)(2012-3#6)(2013-1#2)
promoters)##2##1##(1995-2#1)(2011-1#1)
promotes a marked decrease of##2##5##(1990-7#1)(1991-12#1)
promotes a significant##2##3##(1995-6#1)(2007-10#1)
promotes a##12##2##(1990-7#1)(1991-12#1)(1993-2#1)(1993-4#1)(1994-12#1)(1995-3#1)(1995-6#2)(2007-10#1)(2008-10#2)(2009-8#1)
promotes adherence##2##2##(1991-3#1)(2013-8#1)
promotes aggregation##2##2##(1996-6#1)(2008-5#1)
promotes an increase in##2##4##(2007-11#1)(2008-5#1)
promotes an##8##2##(1991-1#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-3#1)
promotes and##2##2##(2009-8#1)(2013-1#1)
promotes angiogenesis##3##2##(2008-6#1)(2008-7#1)(2009-11#1)
promotes apoptosis in##2##3##(1996-5#2)
promotes apoptosis##3##2##(1996-5#2)(2011-1#1)
promotes apoptotic cell death##2##4##(2011-2#1)(2013-1#1)
promotes both##2##2##(1996-10#1)(2006-2#1)
promotes cell survival##3##3##(2009-3#1)(2010-12#2)
promotes cell##5##2##(2007-2#1)(2008-11#1)(2009-3#1)(2010-12#2)
promotes cellular differentiation and##2##4##(2008-3#1)(2012-12#1)
promotes differentiation in##3##3##(1994-2#1)(1996-8#2)
promotes endothelial##2##2##(1990-2#1)(2009-2#1)
promotes fusion##2##2##(1994-12#1)(1997-2#1)
promotes growth##4##2##(1991-11#1)(2008-9#1)(2012-1#1)(2012-12#1)
promotes high##2##2##(2008-4#1)(2008-9#1)
promotes hippocampal##3##2##(1996-1#1)(2009-3#1)(2013-8#1)
promotes increased##2##2##(2006-12#1)(2008-9#1)
promotes its##4##2##(1990-7#1)(2008-8#1)(2009-2#1)(2013-7#1)
promotes melanoma metastasis##2##3##(1995-8#2)
promotes melanoma##3##2##(1995-8#2)(2008-8#1)
promotes metastasis##3##2##(1991-2#1)(1995-8#2)
promotes neurite outgrowth and##3##4##(1996-12#1)(2008-11#1)(2011-1#1)
promotes neurite outgrowth##4##3##(1996-12#1)(1997-6#1)(2008-11#1)(2011-1#1)
promotes or##2##2##(2007-6#1)(2013-1#1)
promotes processes##2##2##(2008-7#1)(2009-10#1)
promotes survival##3##2##(1991-6#1)(1994-5#1)(2009-10#1)
promotes the acquisition of##3##4##(1996-10#1)(2008-9#1)(2012-2#1)
promotes the activation of##2##4##(2007-11#1)(2008-4#1)
promotes the binding of##2##4##(1994-11#1)(2006-12#1)
promotes the binding##3##3##(1994-11#1)(1995-2#1)(2006-12#1)
promotes the formation of##4##4##(1994-12#1)(1994-6#1)(2005-11#1)(2010-6#1)
promotes the growth and##2##4##(1993-7#1)(1997-4#1)
promotes the growth of##2##4##(1994-11#1)(2008-5#1)
promotes the growth##4##3##(1993-7#1)(1994-11#1)(1997-4#1)(2008-5#1)
promotes the production of##3##4##(1991-8#1)(2006-1#1)(2009-10#1)
promotes the proliferation##2##3##(2008-9#1)(2013-1#1)
promotes the survival of##2##4##(1991-3#1)(1994-5#1)
promotes the translocation of the##2##5##(1990-7#1)(2009-8#1)
promotes the##62##2##(1990-7#3)(1991-3#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-3#1)(1993-7#1)(1994-11#2)(1994-12#4)(1994-5#2)(1994-6#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-9#1)(1996-10#1)(1997-4#2)(1997-7#1)(2004-12#1)(2005-10#1)(2005-11#2)(2006-1#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
promotes tissue##3##2##(2006-5#1)(2007-8#1)(2012-2#1)
promotes tumor##2##2##(2009-3#1)(2013-8#1)
promotes##273##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#6)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#2)(1992-3#4)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-7#2)(1994-11#2)(1994-12#7)(1994-2#2)(1994-3#1)(1994-5#4)(1994-6#2)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#6)(1995-6#2)(1995-8#5)(1995-9#1)(1996-1#2)(1996-10#4)(1996-12#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#2)(1997-2#2)(1997-4#4)(1997-6#2)(1997-7#2)(1997-8#2)(2004-12#1)(2005-10#1)(2005-11#2)(2006-1#1)(2006-10#3)(2006-12#5)(2006-2#2)(2006-5#3)(2006-6#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#3)(2007-2#2)(2007-4#1)(2007-6#3)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#5)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#9)(2009-10#6)(2009-11#2)(2009-2#2)(2009-3#3)(2009-4#1)(2009-7#1)(2009-8#5)(2009-9#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#4)(2011-3#1)(2012-1#3)(2012-12#8)(2012-2#6)(2012-3#5)(2013-1#8)(2013-7#3)(2013-8#4)
promoting Lysenkoism##2##2##(2009-2#2)
promoting a more##2##3##(2006-5#1)(2008-11#1)
promoting a##13##2##(1992-9#1)(1993-9#1)(1994-8#1)(2005-10#1)(2006-10#1)(2006-3#1)(2006-5#1)(2008-11#2)(2008-8#1)(2010-10#1)(2012-12#1)(2013-8#1)
promoting activity of##4##3##(1993-9#1)(1994-11#1)(2008-11#1)(2008-7#1)
promoting activity##8##2##(1992-3#1)(1993-9#1)(1994-11#1)(1996-5#1)(2008-11#3)(2008-7#1)
promoting adipocyte differentiation##2##3##(2008-3#2)
promoting and##7##2##(1992-1#1)(1996-7#1)(2007-11#1)(2008-5#1)(2009-8#1)(2011-1#2)
promoting behaviour change##2##3##(2010-3#1)(2011-1#1)
promoting better##2##2##(2008-10#1)(2010-10#1)
promoting blood circulation##2##3##(2006-4#1)(2013-8#1)
promoting blood##3##2##(2006-4#1)(2008-10#1)(2013-8#1)
promoting both##2##2##(2006-8#1)(2010-5#1)
promoting breastfeeding##2##2##(1993-6#2)
promoting cancer cell growth##2##4##(1991-5#1)(2005-11#1)
promoting cancer##3##2##(1991-5#1)(2005-11#1)(2011-2#1)
promoting cell adhesion##2##3##(2007-8#1)(2010-9#1)
promoting cell growth##3##3##(2008-11#2)(2009-12#1)
promoting cell##8##2##(1994-10#1)(1996-5#1)(2007-8#1)(2008-11#2)(2008-7#1)(2009-12#1)(2010-9#1)
promoting cellular##3##2##(2009-4#1)(2012-12#1)(2013-1#1)
promoting coexistence##2##2##(2008-8#1)(2012-2#1)
promoting differentiation of##2##3##(2008-8#1)(2009-3#1)
promoting effect of##2##3##(1992-1#1)(1992-2#1)
promoting effect##5##2##(1992-1#1)(1992-2#1)(1996-5#1)(1996-8#1)(2008-11#1)
promoting effects of##4##3##(1992-9#4)
promoting effects##5##2##(1992-9#4)(2010-9#1)
promoting factors##3##2##(1994-2#1)(1996-1#1)(2008-5#1)
promoting growth and##2##3##(2006-10#1)(2012-12#1)
promoting growth##5##2##(2006-10#1)(2007-11#1)(2008-11#1)(2012-12#1)(2013-1#1)
promoting health and##4##3##(1990-8#1)(2008-9#1)(2012-3#1)(2013-7#1)
promoting health##7##2##(1990-8#1)(2007-5#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
promoting healthy##2##2##(2008-11#1)(2008-9#1)
promoting normal##2##2##(2007-11#1)(2008-6#1)
promoting optimal##2##2##(2008-5#1)(2010-3#1)
promoting phorbol##3##2##(1994-11#3)
promoting physical activity##2##3##(2008-4#1)(2008-7#1)
promoting play in hospitals##2##4##(2008-9#2)
promoting positive##4##2##(2009-10#1)(2010-10#1)(2010-9#1)(2012-1#1)
promoting proliferation##4##2##(1992-7#1)(1994-10#1)(2006-12#1)(2013-1#1)
promoting properties##2##2##(1992-2#1)(1996-1#1)
promoting regimen##2##2##(1994-6#2)
promoting research##2##2##(2006-4#1)(2008-7#1)
promoting safe##3##2##(2009-6#1)(2013-1#2)
promoting social##2##2##(2008-11#1)(2010-2#1)
promoting specific##2##2##(1995-8#1)(2008-8#1)
promoting the assembly of gp41 onto##2##6##(1994-12#2)
promoting the assembly##3##3##(1994-12#2)(2006-12#1)
promoting the translocation##2##3##(1990-2#1)(2007-12#1)
promoting the##42##2##(1990-2#1)(1990-7#1)(1991-6#1)(1992-2#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1996-10#1)(1996-7#1)(1997-6#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-8#1)(2010-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
promoting their##2##2##(2008-5#1)(2012-2#1)
promoting this##2##2##(2007-5#1)(2009-11#1)
promoting##350##1##(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-7#2)(1990-8#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#3)(1992-2#5)(1992-3#2)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#5)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#3)(1994-10#2)(1994-11#5)(1994-12#3)(1994-2#2)(1994-3#5)(1994-6#3)(1994-8#3)(1994-9#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-8#3)(1996-1#4)(1996-10#3)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#3)(1996-7#3)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2004-1#1)(2005-10#1)(2005-11#7)(2005-9#1)(2006-10#2)(2006-12#2)(2006-3#2)(2006-4#3)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#3)(2007-11#6)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-8#2)(2008-1#6)(2008-10#14)(2008-11#23)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#8)(2008-6#3)(2008-7#9)(2008-8#8)(2008-9#10)(2009-10#2)(2009-11#3)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#5)(2009-5#2)(2009-6#2)(2009-8#4)(2010-1#1)(2010-10#5)(2010-12#1)(2010-2#3)(2010-3#5)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#3)(2011-1#14)(2011-12#3)(2011-2#10)(2012-1#3)(2012-12#7)(2012-2#7)(2012-3#5)(2012-7#1)(2013-1#10)(2013-7#2)(2013-8#6)
promotion activity##4##2##(1992-2#1)(1993-8#1)(1994-12#1)(2008-11#1)
promotion and disease##7##3##(1994-12#1)(1995-12#2)(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)
promotion and prevention##4##3##(1991-1#1)(2008-5#1)(2009-9#1)(2013-1#1)
promotion and progression##3##3##(2007-10#1)(2009-11#1)(2011-2#1)
promotion and##33##2##(1990-10#1)(1991-1#1)(1992-7#1)(1993-12#1)(1994-12#1)(1995-12#2)(1995-9#1)(1997-3#1)(2005-11#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-12#4)(2008-5#2)(2008-7#2)(2009-11#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
promotion are discussed##2##3##(2008-7#1)(2009-3#1)
promotion are##6##2##(2008-11#1)(2008-7#1)(2009-3#1)(2010-2#1)(2013-1#2)
promotion at##2##2##(2012-1#1)(2013-1#1)
promotion by##2##2##(2007-12#1)(2009-9#1)
promotion campaigns##3##2##(1991-2#1)(2008-11#1)(2009-7#1)
promotion during##3##2##(1992-9#1)(2012-1#1)(2012-3#1)
promotion for##3##2##(2007-5#1)(2008-10#1)(2013-1#1)
promotion has##2##2##(1990-10#1)(2008-11#1)
promotion in a primary##2##4##(2007-11#1)(2008-12#1)
promotion in a##4##3##(1993-7#1)(2007-11#1)(2008-11#1)(2008-12#1)
promotion in the##6##3##(1992-7#1)(1994-9#1)(2006-5#1)(2008-11#2)(2013-8#1)
promotion in##23##2##(1990-8#1)(1991-5#1)(1992-7#1)(1992-8#2)(1993-7#2)(1993-8#2)(1994-9#1)(1996-11#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-11#5)(2008-12#1)(2013-8#2)
promotion is##5##2##(1995-12#1)(1997-1#1)(2006-4#1)(2011-2#2)
promotion of cell##4##3##(1991-2#1)(2008-3#1)(2011-1#1)(2012-12#1)
promotion of health##6##3##(1991-2#1)(1995-3#1)(2008-1#1)(2008-10#1)(2012-11#1)(2012-2#1)
promotion of morphological transformation##2##4##(1992-5#2)
promotion of the##7##3##(1994-3#1)(1995-2#1)(2007-9#1)(2008-3#1)(2010-5#1)(2013-1#1)(2013-8#1)
promotion of##111##2##(1990-12#1)(1990-7#2)(1991-12#3)(1991-2#2)(1991-3#1)(1991-9#1)(1992-12#2)(1992-5#2)(1992-8#1)(1993-3#1)(1993-6#2)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-11#4)(1996-3#1)(1996-4#1)(1996-5#1)(2004-9#1)(2005-11#1)(2005-3#1)(2005-7#1)(2005-8#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#6)(2007-6#2)(2007-8#2)(2007-9#4)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#3)(2011-1#3)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#2)(2013-1#4)(2013-8#4)
promotion or##2##2##(1996-7#1)(2005-10#1)
promotion program##4##2##(1994-3#1)(2007-10#1)(2008-3#1)(2012-12#1)
promotion programs##8##2##(1993-11#1)(1994-2#1)(1994-3#1)(2006-10#1)(2008-9#1)(2012-11#1)(2012-2#2)
promotion should##2##2##(1993-8#1)(2008-10#1)
promotion to##5##2##(1992-3#1)(2006-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
promotion##353##1##(1990-10#4)(1990-12#2)(1990-6#3)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#3)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#2)(1992-7#2)(1992-8#3)(1992-9#1)(1993-1#4)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-7#6)(1993-8#9)(1994-1#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#3)(1994-9#1)(1995-12#4)(1995-2#2)(1995-3#1)(1995-9#1)(1996-10#1)(1996-11#6)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-5#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-3#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-4#2)(2006-5#3)(2006-6#2)(2006-7#3)(2007-10#7)(2007-11#3)(2007-12#5)(2007-2#3)(2007-3#6)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#3)(2007-9#4)(2008-1#8)(2008-10#13)(2008-11#23)(2008-12#18)(2008-2#2)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#7)(2009-11#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#2)(2010-12#3)(2010-2#4)(2010-5#5)(2010-6#2)(2010-7#2)(2010-9#3)(2011-1#7)(2011-12#1)(2011-2#10)(2012-1#6)(2012-11#2)(2012-12#8)(2012-2#8)(2012-3#5)(2013-1#18)(2013-7#1)(2013-8#11)
promotion'##3##1##(2008-11#3)
promotion-focused##2##1##(2009-6#2)
promotional campaigns##3##2##(2006-4#1)(2007-3#1)(2012-2#1)
promotional practices##2##2##(2008-7#2)
promotional##14##1##(1991-1#1)(1991-4#1)(1993-12#1)(1994-12#1)(1996-5#1)(2004-10#1)(2006-4#1)(2007-3#1)(2008-11#1)(2008-7#2)(2011-2#1)(2012-2#1)(2013-1#1)
promotions##2##1##(2007-2#1)(2008-1#1)
promotive effect##2##2##(1993-7#1)(1997-1#1)
promotive##4##1##(1992-9#1)(1993-7#1)(1997-1#1)(2007-7#1)
promotor and##2##2##(1995-8#1)(2008-8#1)
promotor in##2##2##(1991-5#1)(1992-7#1)
promotor##15##1##(1990-8#1)(1991-5#1)(1992-7#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-1#1)(1997-7#1)(1997-8#1)(2007-9#3)(2008-1#1)(2008-8#1)
promotores programs##6##2##(2012-11#6)
promotores##10##1##(2012-11#10)
promotors of##2##2##(1994-11#1)(2007-1#1)
promotors##5##1##(1993-12#1)(1994-11#1)(1996-4#1)(1997-4#1)(2007-1#1)
prompt a##4##2##(1995-8#1)(2005-10#1)(2008-9#1)(2009-4#1)
prompt an early##3##3##(2013-1#3)
prompt and proper treatment##2##4##(2011-1#1)(2011-2#1)
prompt and proper##3##3##(2010-8#1)(2011-1#1)(2011-2#1)
prompt and##9##2##(1991-12#1)(2006-1#1)(2008-1#1)(2008-10#1)(2010-8#1)(2011-1#1)(2011-2#3)
prompt antibiotic##3##2##(2008-10#1)(2013-1#2)
prompt diagnosis and treatment is##3##5##(2008-7#1)(2011-1#1)(2012-12#1)
prompt diagnosis and treatment##4##4##(2007-2#1)(2008-7#1)(2011-1#1)(2012-12#1)
prompt diagnosis and##9##3##(1993-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-7#1)(2011-1#1)(2012-12#2)(2012-3#1)
prompt diagnosis may##2##3##(2008-7#1)(2011-2#1)
prompt diagnosis##16##2##(1991-8#1)(1993-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
prompt identification##2##2##(2008-1#1)(2013-1#1)
prompt medical##2##2##(2008-3#1)(2010-10#1)
prompt recognition and treatment##2##4##(2009-4#1)(2012-3#1)
prompt recognition and##6##3##(2007-8#1)(2008-1#1)(2009-4#1)(2012-3#2)(2013-1#1)
prompt recognition##7##2##(2007-8#1)(2008-1#1)(2008-3#1)(2009-4#1)(2012-3#2)(2013-1#1)
prompt referral##2##2##(2008-11#1)(2011-1#1)
prompt response to##3##3##(1996-3#1)(2008-2#1)(2010-11#1)
prompt response##4##2##(1996-3#1)(2006-10#1)(2008-2#1)(2010-11#1)
prompt surgical##4##2##(1990-8#1)(2008-12#1)(2011-2#2)
prompt the##6##2##(1993-8#1)(2006-10#2)(2009-1#1)(2009-5#1)(2013-1#1)
prompt therapeutic##2##2##(1992-7#1)(1993-10#1)
prompt treatment and##4##3##(2006-10#1)(2006-5#1)(2008-9#1)(2013-1#1)
prompt treatment##14##2##(1993-12#2)(2005-12#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-1#1)(2008-1#1)(2008-12#1)(2008-9#1)(2009-5#1)(2011-1#1)(2013-1#2)
prompt##148##1##(1990-11#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-7#1)(1993-1#1)(1993-10#2)(1993-12#2)(1993-3#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-3#2)(1997-7#1)(1997-8#1)(2005-10#3)(2005-12#1)(2006-1#1)(2006-10#8)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#4)(2008-1#6)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-1#1)(2009-11#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-8#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#8)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#15)(2013-7#3)(2013-8#2)
prompt&quot##2##1##(1994-11#2)
prompted a community health##2##4##(2007-2#2)
prompted a search for##4##4##(2007-11#1)(2008-5#1)(2012-1#1)(2013-1#1)
prompted a study##2##3##(1992-11#1)(1995-7#1)
prompted a##17##2##(1992-11#1)(1995-7#1)(2006-1#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
prompted an investigation of##2##4##(1993-3#1)(2012-8#1)
prompted an investigation##3##3##(1990-11#1)(1993-3#1)(2012-8#1)
prompted an##8##2##(1990-11#1)(1991-3#1)(1993-3#1)(2007-11#1)(2008-3#1)(2008-7#1)(2009-12#1)(2012-8#1)
prompted by##7##2##(1994-4#1)(1996-12#1)(2006-7#1)(2007-8#1)(2008-11#1)(2008-9#1)(2012-12#1)
prompted interest in##2##3##(2006-12#1)(2012-3#1)
prompted new##2##2##(1992-6#1)(2010-12#1)
prompted our study of##2##4##(1992-10#1)(2009-8#1)
prompted our##3##2##(1992-10#1)(2004-3#1)(2009-8#1)
prompted several##3##2##(2012-12#1)(2013-1#2)
prompted the authors to##3##4##(2006-12#1)(2009-4#2)
prompted the development of##5##4##(1991-2#1)(1994-12#1)(2007-11#1)(2008-2#1)(2012-12#1)
prompted the##24##2##(1991-2#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1997-3#1)(2005-7#1)(2006-12#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-4#2)(2010-12#1)(2010-3#1)(2010-8#1)(2012-12#1)
prompted this study##2##3##(2004-9#1)(2010-8#1)
prompted this##3##2##(2004-9#1)(2008-11#1)(2010-8#1)
prompted to##4##2##(1991-4#1)(1994-2#1)(2007-12#1)(2009-5#1)
prompted us to examine the##2##5##(1996-3#1)(2011-2#1)
prompted us to examine##4##4##(1996-3#1)(2007-9#1)(2009-4#1)(2011-2#1)
prompted us to initiate##2##4##(1995-12#1)(2008-10#1)
prompted us to study the##3##5##(1996-11#1)(2008-9#1)(2011-2#1)
prompted us to study##4##4##(1991-7#1)(1996-11#1)(2008-9#1)(2011-2#1)
prompted us to##28##3##(1990-6#1)(1991-1#1)(1991-7#1)(1994-10#1)(1994-7#1)(1995-11#1)(1995-12#2)(1996-11#2)(1996-3#1)(1997-6#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2011-2#2)(2012-3#1)
prompted##127##1##(1990-11#1)(1990-6#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-6#1)(1993-12#2)(1993-3#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-7#1)(1996-11#2)(1996-12#1)(1996-3#1)(1997-3#2)(1997-6#1)(2004-3#1)(2004-9#2)(2005-7#1)(2006-1#1)(2006-10#3)(2006-12#3)(2006-4#1)(2006-7#2)(2007-10#2)(2007-11#6)(2007-12#1)(2007-2#2)(2007-6#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#4)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#7)(2008-9#3)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#3)(2009-5#2)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2012-8#1)(2013-1#5)
prompting a need to educate underwriters about this technology##2##9##(1993-12#2)
prompting a##3##2##(1993-12#2)(2006-11#1)
prompting many##2##2##(2007-11#1)(2012-12#1)
prompting the##4##2##(2005-7#1)(2006-4#1)(2007-8#1)(2013-7#1)
prompting us to##3##3##(1997-2#1)(2008-1#1)(2008-7#1)
prompting##29##1##(1991-10#1)(1992-12#1)(1993-12#2)(1996-1#1)(1996-12#1)(1997-2#1)(1997-6#1)(2005-7#1)(2006-11#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-12#3)(2012-2#2)(2013-1#1)(2013-7#1)
promptly and##2##2##(1996-9#1)(2008-5#1)
promptly diagnosed and managed##2##4##(2007-3#1)(2011-12#1)
promptly diagnosed##3##2##(2006-10#1)(2007-3#1)(2011-12#1)
promptly report the results of##2##5##(2010-6#2)
promptly##44##1##(1990-3#1)(1992-8#1)(1993-10#1)(1993-12#3)(1994-3#1)(1994-6#1)(1995-7#1)(1996-9#1)(1997-6#1)(2005-12#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-6#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
prompts the##3##2##(1990-8#1)(2006-2#1)(2008-8#1)
prompts##11##1##(1990-8#1)(1994-6#1)(1995-3#1)(1996-12#1)(2006-2#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-8#1)(2013-1#1)
promulgate##4##1##(1991-3#1)(2006-8#1)(2008-3#1)(2009-8#1)
promulgated by the##2##3##(1994-12#1)(2005-11#1)
promulgated in##2##2##(2006-8#1)(2006-9#1)
promulgated##11##1##(1993-3#1)(1994-12#1)(2005-11#1)(2006-12#1)(2006-8#3)(2006-9#1)(2010-1#1)(2013-1#2)
promulgation of##2##2##(1996-2#1)(2010-2#1)
promulgation##3##1##(1996-12#1)(1996-2#1)(2010-2#1)
promutagens##2##1##(1997-2#1)(2008-4#1)
promyelocytes##4##1##(1990-9#1)(1996-2#1)(2007-11#1)(2008-11#1)
promyelocytic HL-60 cells##3##3##(1994-3#1)(1994-8#1)(1996-11#1)
promyelocytic HL-60##6##2##(1993-4#1)(1994-3#1)(1994-8#1)(1996-11#1)(1996-2#1)(2008-8#1)
promyelocytic HL60##2##2##(1991-7#1)(1993-3#1)
promyelocytic cell line HL-60##2##4##(1992-12#1)(1992-8#1)
promyelocytic cell line##5##3##(1992-12#1)(1992-8#2)(1993-6#1)(2008-3#1)
promyelocytic leukaemia##2##2##(2010-12#1)(2013-1#1)
promyelocytic leukemia HL-60 cells##2##4##(1992-5#1)(2008-8#1)
promyelocytic leukemia cell line##4##4##(1991-12#1)(1992-1#1)(1994-8#1)(2008-11#1)
promyelocytic leukemia cells##3##3##(1991-9#1)(1996-2#1)(2008-11#1)
promyelocytic leukemia##30##2##(1990-9#2)(1991-11#2)(1991-12#1)(1991-9#3)(1992-1#1)(1992-5#1)(1992-6#1)(1993-6#1)(1994-8#4)(1996-2#1)(2007-12#3)(2007-4#2)(2008-11#2)(2008-8#2)(2011-2#1)(2012-12#1)(2012-2#2)
promyelocytic leukemic cell line##2##4##(1994-6#1)(1995-3#1)
promyelocytic leukemic cell##3##3##(1994-5#1)(1994-6#1)(1995-3#1)
promyelocytic##52##1##(1990-9#2)(1991-11#3)(1991-12#1)(1991-7#1)(1991-9#3)(1992-1#2)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-3#1)(1993-4#1)(1993-6#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#5)(1995-3#1)(1996-11#1)(1996-2#2)(2005-10#1)(2007-12#3)(2007-4#2)(2008-11#2)(2008-3#2)(2008-8#3)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
promyeloid cells##2##2##(1996-5#2)
promyeloid##4##1##(1995-3#1)(1996-5#3)
pronase##8##1##(1990-4#1)(1991-5#2)(1992-9#1)(1994-3#1)(2006-12#1)(2008-10#2)
pronase-treated##2##1##(1992-6#2)
pronatalist##2##1##(2006-10#2)
pronation and supination##2##3##(1991-1#1)(2010-11#1)
pronation##4##1##(1991-1#1)(2010-11#2)(2011-2#1)
pronator teres##2##2##(2006-3#2)
pronator##3##1##(2006-3#2)(2008-8#1)
prone or##3##2##(2011-1#1)(2012-2#1)(2013-7#1)
prone position and##2##3##(1992-11#1)(1992-4#1)
prone position as##2##3##(1992-11#2)
prone position##21##2##(1992-11#8)(1992-4#4)(1993-1#1)(1996-9#1)(2005-8#1)(2008-7#1)(2010-10#3)(2013-1#1)(2013-7#1)
prone positioning##4##2##(2005-11#1)(2006-10#1)(2006-8#1)(2012-12#1)
prone sleeping position of##2##4##(1991-2#1)(2008-1#1)
prone sleeping position##7##3##(1991-2#1)(1992-11#2)(1992-4#1)(2007-1#2)(2008-1#1)
prone to a##4##3##(1990-4#1)(1995-1#1)(2008-12#1)(2013-7#1)
prone to cardiovascular##3##3##(2005-10#1)(2008-3#1)(2012-1#1)
prone to develop metabolic syndrome##2##5##(2009-6#2)
prone to develop##8##3##(1993-5#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-5#1)(2009-6#2)(2010-12#1)
prone to developing##3##3##(2006-5#1)(2008-1#1)(2012-2#1)
prone to spontaneous##2##3##(2008-4#1)(2008-7#1)
prone to the##5##3##(2006-8#1)(2007-8#1)(2008-4#1)(2008-8#1)(2012-3#1)
prone to##95##2##(1990-4#1)(1990-5#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-11#2)(1995-1#1)(1995-10#1)(1995-9#1)(1996-11#1)(1997-6#1)(1997-8#1)(2004-10#2)(2005-10#3)(2005-7#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-11#2)(2007-12#1)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#3)(2009-2#1)(2009-6#2)(2009-8#1)(2010-12#2)(2011-1#2)(2011-2#2)(2012-1#3)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
prone##162##1##(1990-4#1)(1990-5#1)(1991-2#1)(1992-11#11)(1992-12#1)(1992-4#8)(1993-1#1)(1993-12#1)(1993-3#1)(1993-4#2)(1993-5#1)(1994-11#2)(1995-1#1)(1995-10#2)(1995-9#1)(1996-11#3)(1996-9#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-10#2)(2005-10#3)(2005-11#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#6)(2006-12#1)(2006-5#1)(2006-8#4)(2006-9#1)(2007-1#2)(2007-11#2)(2007-12#2)(2007-3#1)(2007-7#4)(2007-8#1)(2008-1#5)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#6)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-12#3)(2009-2#1)(2009-6#3)(2009-8#1)(2010-10#3)(2010-12#2)(2010-5#1)(2010-7#3)(2011-1#3)(2011-2#3)(2012-1#3)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#5)(2013-7#3)(2013-8#1)
proneness and the##2##3##(1995-1#1)(2007-12#1)
proneness to##2##2##(2009-5#1)(2013-8#1)
proneness##5##1##(1995-1#1)(2007-12#2)(2009-5#1)(2013-8#1)
pronephros formation##2##2##(2012-12#2)
pronephros##14##1##(1997-3#6)(1997-9#3)(2012-12#5)
proneural##5##1##(2007-12#2)(2009-5#2)(2011-12#1)
prongs##4##1##(1992-11#1)(2008-7#3)
pronoun interpretation##2##2##(2008-11#2)
pronoun use##2##2##(2008-5#2)
pronoun##6##1##(2008-11#3)(2008-5#3)
pronounced after##6##2##(1997-7#1)(2008-10#1)(2008-7#2)(2009-2#1)(2010-12#1)
pronounced among##7##2##(1997-7#1)(2006-7#2)(2007-12#1)(2007-3#1)(2008-9#1)(2011-2#1)
pronounced and##7##2##(1992-9#1)(1993-12#1)(2006-5#1)(2008-11#2)(2008-5#1)(2012-2#1)
pronounced at the first##2##4##(1990-3#1)(2007-12#1)
pronounced at the##4##3##(1990-3#1)(2007-12#1)(2010-2#1)(2012-1#1)
pronounced at##22##2##(1990-3#1)(1991-2#1)(1992-11#2)(1994-11#1)(1994-8#1)(1995-1#2)(2007-12#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-8#2)(2010-2#1)(2011-12#1)(2012-1#1)(2012-2#1)
pronounced changes##2##2##(2009-2#1)(2010-4#1)
pronounced decrease in the##3##4##(1995-12#1)(1995-8#1)(1996-1#1)
pronounced decrease in##6##3##(1992-6#1)(1993-12#1)(1995-12#1)(1995-8#1)(1996-1#1)(2009-2#1)
pronounced differences between##2##3##(1996-4#1)(2008-5#1)
pronounced differences in##4##3##(1990-9#1)(1992-9#1)(1996-4#1)(2008-4#1)
pronounced differences##7##2##(1990-9#1)(1992-9#1)(1996-4#2)(2007-7#1)(2008-4#1)(2008-5#1)
pronounced during##4##2##(1990-3#1)(1995-7#1)(1997-4#1)(2013-8#1)
pronounced effect on the##5##4##(1991-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-4#1)
pronounced effect on##7##3##(1991-7#1)(1994-9#1)(1997-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-4#1)
pronounced effect##10##2##(1991-7#1)(1994-9#1)(1997-1#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)(2012-1#1)
pronounced effects on the##2##4##(1996-12#1)(1997-1#1)
pronounced effects on##4##3##(1996-12#1)(1997-1#1)(2009-9#1)(2012-2#1)
pronounced effects##6##2##(1996-12#1)(1996-8#1)(1997-1#1)(2009-10#1)(2009-9#1)(2012-2#1)
pronounced for##4##2##(1997-1#1)(2008-7#2)(2010-4#1)
pronounced immunological##2##2##(1996-12#1)(2006-6#1)
pronounced in the##29##3##(1990-7#2)(1993-3#1)(1994-2#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-11#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
pronounced in women##2##3##(2007-5#1)(2010-4#1)
pronounced in##80##2##(1990-4#1)(1990-7#2)(1991-1#1)(1992-4#1)(1993-2#3)(1993-3#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-9#2)(1996-12#1)(1996-3#1)(1996-5#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-6#1)(1997-7#2)(2004-11#1)(2005-11#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2012-6#1)
pronounced increase in##8##3##(1992-8#1)(1997-5#1)(1997-7#1)(2005-11#1)(2007-8#1)(2008-5#1)(2010-12#2)
pronounced increase##9##2##(1992-8#1)(1997-5#1)(1997-7#1)(2005-11#1)(2007-8#1)(2008-5#1)(2008-7#1)(2010-12#2)
pronounced inhibition of DNA##2##4##(1994-9#1)(2012-2#1)
pronounced inhibitory##2##2##(1990-11#1)(1997-2#1)
pronounced loss of motoneurons##2##4##(1996-11#1)(1996-9#1)
pronounced loss of##3##3##(1996-11#1)(1996-9#1)(2013-1#1)
pronounced negative##3##2##(1996-2#1)(2007-6#1)(2010-7#1)
pronounced on##3##2##(1994-5#1)(1996-3#1)(2008-3#1)
pronounced preference for##2##3##(1996-2#1)(1997-7#1)
pronounced reduction in##4##3##(1991-9#1)(2006-10#1)(2008-1#1)(2008-7#1)
pronounced reduction##6##2##(1991-9#1)(1996-12#1)(2006-10#1)(2008-1#1)(2008-7#1)(2013-1#1)
pronounced response to in situ conditions##2##6##(2013-8#2)
pronounced response to##3##3##(2010-4#1)(2013-8#2)
pronounced than in##5##3##(1990-2#1)(1992-11#1)(1996-12#1)(2006-6#1)(2012-1#1)
pronounced than those##3##3##(1996-10#1)(1996-9#1)(2008-10#1)
pronounced than##16##2##(1990-2#1)(1992-11#1)(1995-4#1)(1996-10#1)(1996-12#1)(1996-9#1)(2006-6#1)(2007-10#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-12#1)(2010-4#1)(2012-1#1)(2013-1#1)
pronounced was the##2##3##(1990-5#1)(2007-12#1)
pronounced when##6##2##(1991-12#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-9#1)
pronounced with##7##2##(1991-2#1)(1993-7#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
pronounced##375##1##(1990-10#1)(1990-11#3)(1990-2#6)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#4)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#4)(1993-12#2)(1993-2#4)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#3)(1994-9#2)(1995-1#3)(1995-10#1)(1995-12#3)(1995-2#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-7#2)(1995-8#2)(1995-9#2)(1996-1#4)(1996-10#1)(1996-11#1)(1996-12#6)(1996-2#3)(1996-3#2)(1996-4#2)(1996-5#7)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#5)(1997-1#5)(1997-2#3)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#8)(2004-11#1)(2005-11#4)(2006-1#1)(2006-10#3)(2006-5#4)(2006-6#2)(2006-7#2)(2006-8#3)(2006-9#1)(2007-10#2)(2007-11#4)(2007-12#9)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#31)(2008-11#7)(2008-2#3)(2008-3#9)(2008-4#6)(2008-5#15)(2008-7#14)(2008-8#7)(2008-9#3)(2009-10#1)(2009-12#2)(2009-2#5)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#5)(2010-11#1)(2010-12#10)(2010-2#3)(2010-3#1)(2010-4#7)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#4)(2011-2#6)(2012-1#8)(2012-12#1)(2012-2#5)(2012-3#2)(2012-6#1)(2013-1#5)(2013-8#5)
pronouncedly##3##1##(2008-10#1)(2008-8#1)(2012-2#1)
pronouncements##2##1##(1996-3#1)(2007-9#1)
pronouns and##2##2##(2008-2#1)(2008-5#1)
pronouns##5##1##(2008-11#2)(2008-2#1)(2008-5#2)
pronuclear formation##3##2##(2006-5#1)(2008-9#1)(2013-1#1)
pronuclear##7##1##(1991-1#1)(2006-5#1)(2008-2#1)(2008-9#3)(2013-1#1)
pronuclei##5##1##(2006-10#1)(2006-5#3)(2008-9#1)
pronucleus formation rates##2##3##(2006-5#2)
pronucleus formation##5##2##(2006-5#5)
pronucleus##9##1##(2006-5#6)(2008-7#1)(2008-9#2)
proof for the##6##3##(1990-7#1)(1991-3#1)(1994-2#1)(1997-6#1)(2012-2#1)(2012-3#1)
proof for##14##2##(1990-11#1)(1990-7#1)(1991-3#1)(1994-2#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2012-2#2)(2012-3#1)
proof is##3##2##(2007-12#1)(2009-2#1)(2012-1#1)
proof of a##3##3##(1995-5#1)(2007-8#1)(2008-3#1)
proof of concept of##3##4##(1996-6#1)(2008-1#1)(2012-12#1)
proof of concept that##2##4##(2009-4#1)(2012-1#1)
proof of concept##18##3##(1996-6#1)(2006-12#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-8#1)(2011-2#1)(2011-9#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)
proof of efficacy##3##3##(1996-12#1)(2008-1#1)(2011-2#1)
proof of principle that##2##4##(2009-4#1)(2012-1#1)
proof of principle##7##3##(2007-12#1)(2008-10#2)(2008-8#1)(2009-4#1)(2010-4#1)(2012-1#1)
proof of synergy##2##3##(2008-10#2)
proof of the existence##2##4##(2009-10#1)(2010-6#1)
proof of the##9##3##(2006-2#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-3#2)(2009-10#1)(2010-6#1)
proof of##59##2##(1990-5#1)(1990-7#1)(1992-3#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-4#2)(2006-12#1)(2006-2#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-3#5)(2008-5#1)(2008-6#1)(2008-8#3)(2009-10#1)(2009-4#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#3)(2011-9#1)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
proof that a##3##3##(1992-2#1)(1996-11#1)(1996-12#1)
proof that the##5##3##(1990-1#1)(1990-6#1)(1996-12#1)(2008-9#1)(2013-8#1)
proof that##15##2##(1990-1#1)(1990-6#1)(1990-7#1)(1992-2#1)(1993-3#1)(1996-11#1)(1996-12#2)(2007-11#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-9#1)(2009-12#1)(2013-8#1)
proof was##2##2##(1990-12#1)(2007-8#1)
proof##109##1##(1990-1#1)(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#3)(1991-3#1)(1992-2#2)(1992-3#1)(1993-3#2)(1993-8#1)(1994-2#1)(1994-8#1)(1995-5#1)(1996-11#2)(1996-12#5)(1996-6#2)(1997-4#3)(1997-6#1)(2006-12#1)(2006-2#2)(2007-1#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#6)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#1)(2009-4#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-9#1)(2012-1#5)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
proof-of-concept study##3##2##(2008-1#1)(2008-10#1)(2011-1#1)
proof-of-concept##12##1##(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#2)
proof-of-principle##6##1##(1995-12#1)(2007-12#1)(2008-1#1)(2008-2#1)(2010-12#1)(2011-1#1)
proof-reading by##2##2##(1990-12#1)(1997-6#1)
proof-reading##3##1##(1990-12#1)(1997-6#2)
proof-testing##2##1##(2008-3#2)
proofreading activity##2##2##(1990-3#1)(1991-9#1)
proofreading in##2##2##(1994-11#2)
proofreading##13##1##(1990-3#1)(1990-5#1)(1991-9#1)(1994-11#4)(1994-8#1)(1996-4#1)(2007-6#1)(2008-7#1)(2009-5#2)
proofs of##2##2##(2008-8#1)(2010-1#1)
proofs that##2##2##(1993-11#1)(2005-11#1)
proofs##9##1##(1992-7#1)(1993-11#1)(2005-11#1)(2007-11#1)(2007-6#1)(2007-9#1)(2008-8#1)(2010-1#1)(2010-10#1)
proopiomelanocortin (POMC)##5##2##(1993-12#1)(1993-5#1)(1996-12#1)(2008-4#2)
proopiomelanocortin and##3##2##(1993-5#1)(1996-4#2)
proopiomelanocortin gene##2##2##(1993-5#2)
proopiomelanocortin##14##1##(1993-12#1)(1993-5#6)(1996-12#1)(1996-4#2)(1997-8#1)(2006-10#1)(2008-4#2)
prooxidant effect of##2##3##(2006-12#1)(2008-8#1)
prooxidant effect##3##2##(1990-9#1)(2006-12#1)(2008-8#1)
prooxidant##7##1##(1990-9#1)(1995-6#2)(2006-12#3)(2008-8#1)
prop roots##2##2##(2008-5#2)
prop##3##1##(2007-5#1)(2008-5#2)
propacetamol##3##1##(1995-9#1)(2008-10#2)
propaganda and##3##2##(2009-2#2)(2011-12#1)
propaganda##5##1##(2009-2#2)(2011-12#1)(2011-2#1)(2012-2#1)
propagate a##2##2##(2007-9#1)(2012-12#1)
propagate along the##3##3##(2008-11#1)(2008-3#1)(2012-2#1)
propagate along##5##2##(2007-10#1)(2007-12#1)(2008-11#1)(2008-3#1)(2012-2#1)
propagate in the##4##3##(2007-11#1)(2007-12#2)(2008-9#1)
propagate in##9##2##(2006-10#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-2#1)(2008-9#1)
propagate on##2##2##(1990-1#1)(2008-2#1)
propagate over##2##2##(2007-12#2)
propagate the##2##2##(2006-10#1)(2008-9#1)
propagate through##7##2##(2007-11#3)(2007-12#1)(2008-3#2)(2009-7#1)
propagate to##5##2##(1995-11#1)(2006-6#1)(2008-2#1)(2008-3#1)(2013-1#1)
propagate within##2##2##(2007-12#1)(2009-6#1)
propagate##66##1##(1990-1#1)(1990-3#1)(1991-1#1)(1992-9#1)(1995-11#1)(1997-7#1)(2006-10#3)(2006-12#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#6)(2007-12#16)(2007-6#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-2#5)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
propagated and##2##2##(1997-3#1)(2008-8#1)
propagated as##4##2##(1990-11#1)(1990-9#1)(2008-10#1)(2008-8#1)
propagated at##2##2##(2005-11#1)(2007-12#1)
propagated by##6##2##(1994-9#1)(2008-2#1)(2008-6#1)(2008-8#1)(2010-2#1)(2011-2#1)
propagated for##3##2##(1995-2#1)(2008-10#1)(2012-12#1)
propagated from the##2##3##(1992-8#1)(1993-3#1)
propagated from##3##2##(1992-11#1)(1992-8#1)(1993-3#1)
propagated in the##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
propagated in##11##2##(1990-12#1)(1991-5#1)(1995-2#1)(2007-8#1)(2008-10#2)(2008-11#2)(2011-1#1)(2012-12#1)(2012-2#1)
propagated on##3##2##(2008-10#1)(2008-11#1)(2009-6#1)
propagated to##3##2##(1995-6#2)(2009-3#1)
propagated under##4##2##(2007-12#2)(2012-12#2)
propagated##61##1##(1990-11#1)(1990-12#1)(1990-9#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-8#1)(1993-3#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#1)(1997-3#1)(1997-7#1)(2004-11#1)(2005-11#1)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-2#3)(2008-4#1)(2008-6#1)(2008-8#5)(2009-2#2)(2009-3#1)(2009-6#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#1)
propagates from the##2##3##(2005-11#1)(2009-12#1)
propagates from##4##2##(2005-11#1)(2007-11#1)(2008-3#1)(2009-12#1)
propagates in the##2##3##(2007-12#1)(2008-3#1)
propagates in##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
propagates through a##2##3##(2008-1#1)(2009-6#1)
propagates through the##2##3##(2007-12#2)
propagates through##5##2##(2007-12#2)(2008-1#1)(2009-6#1)(2012-12#1)
propagates throughout the##2##3##(1997-7#1)(2008-3#1)
propagates to##2##2##(1995-8#1)(2008-2#1)
propagates toward a detector##2##4##(2007-12#1)(2008-3#1)
propagates toward##3##2##(2007-12#1)(2008-3#2)
propagates##31##1##(1995-8#1)(1997-2#1)(1997-7#2)(2005-11#1)(2007-11#5)(2007-12#4)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#7)(2009-12#1)(2009-6#3)(2009-7#1)(2012-12#1)
propagating along the longitudinal##2##4##(2008-9#2)
propagating along the##3##3##(2007-12#1)(2008-9#2)
propagating along##4##2##(2007-12#1)(2008-2#1)(2008-9#2)
propagating and evanescent waves##2##4##(2008-3#2)
propagating and evanescent##4##3##(2007-11#1)(2008-3#3)
propagating and##5##2##(2007-11#1)(2008-3#3)(2008-9#1)
propagating between##3##2##(2007-11#2)(2009-8#1)
propagating in a##9##3##(2007-11#2)(2008-2#3)(2008-3#4)
propagating in air##5##3##(2007-11#3)(2007-12#2)
propagating in free space##3##4##(2007-11#1)(2007-12#1)(2008-1#1)
propagating in the##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
propagating in##36##2##(2007-11#10)(2007-12#10)(2008-1#1)(2008-2#5)(2008-3#10)
propagating light in##2##3##(2008-3#2)
propagating light##4##2##(2008-2#2)(2008-3#2)
propagating pulse##3##2##(2007-11#2)(2007-12#1)
propagating species##2##2##(2008-3#1)(2008-9#1)
propagating surface##2##2##(2008-3#1)(2012-2#1)
propagating terahertz pulses##2##3##(2007-12#1)(2008-2#1)
propagating terahertz##3##2##(2007-12#2)(2008-2#1)
propagating the##4##2##(2005-8#1)(2008-1#1)(2013-1#2)
propagating through a##2##3##(2007-11#1)(2007-12#1)
propagating through##9##2##(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#2)
propagating wave##3##2##(2008-2#1)(2008-3#1)(2009-1#1)
propagating wave-fronts##2##2##(2006-10#2)
propagating##131##1##(1995-12#1)(1996-4#1)(1997-4#1)(2005-8#1)(2006-10#2)(2006-5#1)(2007-11#23)(2007-12#31)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-2#16)(2008-3#29)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#4)(2009-1#2)(2009-12#1)(2009-2#2)(2009-5#1)(2009-8#1)(2010-5#1)(2012-2#1)(2013-1#2)
propagation (BP)##2##2##(2010-4#1)(2010-8#1)
propagation algorithm##2##2##(2008-2#1)(2010-8#1)
propagation along the##2##3##(2007-11#1)(2008-7#1)
propagation along##4##2##(2006-4#1)(2007-11#1)(2008-3#1)(2008-7#1)
propagation and##22##2##(1995-2#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-11#1)(2008-2#4)(2008-3#6)(2008-4#1)(2008-7#1)(2008-9#3)(2013-8#1)
propagation angle##2##2##(2007-12#1)(2008-3#1)
propagation angles##2##2##(2008-2#1)(2008-3#1)
propagation at##3##2##(2007-12#2)(2008-3#1)
propagation axis##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
propagation based on##2##3##(2007-12#1)(2008-2#1)
propagation behavior of##2##3##(2007-12#1)(2008-3#1)
propagation behavior##3##2##(2007-12#2)(2008-3#1)
propagation by use of##2##4##(2008-3#2)
propagation by##5##2##(1991-11#1)(2007-11#1)(2008-3#2)(2008-5#1)
propagation can be##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
propagation can##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
propagation characteristics of##4##3##(2007-11#1)(2008-1#1)(2008-2#2)
propagation code##2##2##(2007-12#2)
propagation constant##6##2##(2007-11#2)(2007-12#3)(2008-2#1)
propagation constants of##2##3##(2007-12#1)(2008-3#1)
propagation constants##9##2##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#3)
propagation direction##9##2##(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#4)
propagation directions##2##2##(2007-12#1)(2008-3#1)
propagation distance of##3##3##(2007-11#1)(2007-12#2)
propagation distance##10##2##(2007-11#2)(2007-12#6)(2008-1#1)(2008-2#1)
propagation distances##2##2##(2007-12#1)(2008-3#1)
propagation dynamics of intense light##2##5##(2007-12#2)
propagation dynamics of##5##3##(2007-12#5)
propagation effects are##2##3##(2007-12#1)(2008-2#1)
propagation effects in an##2##4##(2007-12#2)
propagation effects##4##2##(2007-12#3)(2008-2#1)
propagation equation##5##2##(2007-12#4)(2008-2#1)
propagation for##2##2##(2007-12#1)(2008-3#1)
propagation from##4##2##(2007-12#1)(2007-9#1)(2008-3#1)(2008-8#1)
propagation in a dispersion-compensated##2##4##(2007-12#1)(2008-1#1)
propagation in a dispersive##2##4##(2007-11#1)(2007-12#1)
propagation in a normal-dispersion##2##4##(2007-12#2)
propagation in a turbulent atmosphere##2##5##(2008-3#2)
propagation in a##15##3##(1993-5#1)(1995-8#1)(2007-11#2)(2007-12#5)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)
propagation in an##2##3##(2008-1#1)(2008-2#1)
propagation in biological tissue##2##4##(2007-12#1)(2010-4#1)
propagation in fused silica##2##4##(2007-11#1)(2008-3#1)
propagation in optical fibers##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
propagation in optical##7##3##(2005-4#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-2#1)(2008-3#1)
propagation in photorefractive##2##3##(2007-12#2)
propagation in the atmosphere##3##4##(2008-3#3)
propagation in the##15##3##(2006-2#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-3#7)(2009-5#1)(2009-7#1)(2013-1#1)
propagation in##90##2##(1990-3#1)(1991-9#1)(1993-5#1)(1995-8#1)(1996-4#1)(2005-10#1)(2005-4#1)(2006-2#1)(2007-11#7)(2007-12#20)(2008-1#9)(2008-10#1)(2008-2#10)(2008-3#24)(2008-7#2)(2008-9#1)(2009-5#2)(2009-7#2)(2009-8#1)(2010-4#1)(2013-1#2)
propagation inside the##2##3##(2008-3#2)
propagation is##9##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#3)(2008-7#1)
propagation law##2##2##(2007-11#2)
propagation lengths##2##2##(2008-2#1)(2008-3#1)
propagation loss of##3##3##(2007-11#2)(2008-2#1)
propagation loss##6##2##(2006-2#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
propagation losses##4##2##(2007-12#2)(2008-2#2)
propagation method##15##2##(2007-11#4)(2007-12#1)(2008-1#1)(2008-2#3)(2008-3#6)
propagation mode##3##2##(2007-11#2)(2008-2#1)
propagation model##3##2##(2008-2#1)(2008-3#1)(2013-8#1)
propagation modes and##2##3##(2007-12#1)(2008-3#1)
propagation modes##5##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)
propagation of a cylindrical##2##4##(2007-12#2)
propagation of a liquid plug##2##5##(2009-6#2)
propagation of a##13##3##(1991-6#1)(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#3)(2008-4#1)(2009-6#2)
propagation of action potentials##2##4##(2009-12#1)(2009-8#1)
propagation of an off-axis Gaussian wave##2##6##(2008-3#2)
propagation of an optical##2##4##(2007-11#2)
propagation of an##5##3##(2007-11#2)(2008-3#3)
propagation of bacteriophage##2##3##(1992-1#1)(1994-9#1)
propagation of cylindrical electromagnetic fields##2##5##(2007-12#2)
propagation of depression to##2##4##(1997-7#2)
propagation of electromagnetic waves##6##4##(2007-12#6)
propagation of error##3##3##(2008-10#2)(2008-3#1)
propagation of high-power##2##3##(2007-12#2)
propagation of highly##2##3##(2007-11#1)(2007-12#1)
propagation of light from##2##4##(2007-12#2)
propagation of light through##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
propagation of light##8##3##(2007-12#5)(2008-10#1)(2008-2#1)(2008-3#1)
propagation of optical##2##3##(2007-12#1)(2008-2#1)
propagation of subpicosecond##2##3##(2007-11#1)(2007-12#1)
propagation of the photon##2##4##(2008-3#2)
propagation of the##16##3##(1991-11#1)(1994-3#1)(2005-11#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#4)(2009-5#1)(2011-1#1)
propagation of these##2##3##(2008-4#1)(2008-9#1)
propagation of##135##2##(1990-5#1)(1991-11#2)(1991-3#1)(1991-6#1)(1992-1#1)(1994-3#1)(1994-9#1)(1995-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(2004-12#1)(2004-9#1)(2005-11#3)(2005-8#1)(2006-10#1)(2007-1#3)(2007-11#10)(2007-12#36)(2008-1#3)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#10)(2008-3#21)(2008-4#3)(2008-5#3)(2008-9#5)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-8#1)
propagation over##5##2##(2007-11#1)(2007-12#3)(2012-2#1)
propagation parameter##3##2##(1993-11#2)(2007-12#1)
propagation path##2##2##(2008-3#2)
propagation paths##2##2##(2007-12#1)(2008-2#1)
propagation phase##5##2##(1997-8#3)(2008-11#2)
propagation properties##7##2##(2007-12#4)(2008-3#3)
propagation speed of##3##3##(2008-2#2)(2008-5#1)
propagation speed##4##2##(2008-2#2)(2008-5#1)(2009-6#1)
propagation step##3##2##(2008-3#1)(2012-12#2)
propagation through a##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
propagation through atmospheric turbulence##2##4##(2008-2#1)(2008-3#1)
propagation through large-core##2##3##(2007-11#1)(2008-3#1)
propagation through##25##2##(2005-11#1)(2007-11#3)(2007-12#9)(2008-2#5)(2008-3#7)
propagation time delay##2##3##(2008-2#2)
propagation time##3##2##(2007-11#1)(2008-2#2)
propagation to chain transfer ratios ranging##2##6##(2008-3#2)
propagation to##3##2##(1993-12#1)(2008-3#2)
propagation using##2##2##(2004-9#1)(2012-3#1)
propagation was##2##2##(2007-12#1)(2008-5#1)
propagation were##2##2##(2007-12#1)(2008-3#1)
propagation with##4##2##(2007-11#1)(2007-12#1)(2008-2#2)
propagation within the##5##3##(2008-10#2)(2008-7#2)(2009-6#1)
propagation within##6##2##(2008-10#2)(2008-3#1)(2008-7#2)(2009-6#1)
propagation##621##1##(1990-3#2)(1990-5#2)(1991-1#1)(1991-11#4)(1991-12#3)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1993-11#2)(1993-12#2)(1993-5#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-2#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-4#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#4)(2004-11#1)(2004-12#1)(2004-9#3)(2005-10#2)(2005-11#5)(2005-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-4#1)(2007-1#4)(2007-11#63)(2007-12#157)(2007-5#1)(2007-9#2)(2008-1#21)(2008-10#15)(2008-11#8)(2008-12#2)(2008-2#72)(2008-3#126)(2008-4#5)(2008-5#8)(2008-7#10)(2008-8#2)(2008-9#19)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#3)(2009-6#4)(2009-7#4)(2009-8#3)(2010-3#1)(2010-4#3)(2010-8#6)(2011-1#3)(2011-2#2)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#3)
propagation)##2##1##(2008-10#1)(2008-5#1)
propagation-invariant##2##1##(2007-11#1)(2007-12#1)
propagative material##2##2##(2008-10#2)
propagative##4##1##(2008-10#4)
propagator##3##1##(2007-11#2)(2007-12#1)
propagule germination##2##2##(2008-10#2)
propagule production##2##2##(2008-10#1)(2008-8#1)
propagule size##9##2##(2008-8#9)
propagule##21##1##(2008-10#7)(2008-8#12)(2008-9#2)
propagules and##2##2##(2008-10#1)(2008-8#1)
propagules in the##3##3##(2008-10#3)
propagules in##6##2##(2008-10#6)
propagules of F##4##3##(2008-10#4)
propagules of the pathogen##2##4##(2008-10#2)
propagules of##9##2##(2008-10#7)(2008-8#2)
propagules were##2##2##(2008-10#2)
propagules##45##1##(2008-10#34)(2008-8#11)
propagules/g##2##1##(2008-10#1)(2009-3#1)
propamocarb##3##1##(2008-10#3)
propan-2-ol##3##1##(1990-2#1)(2008-10#2)
propanal and hexanal##2##3##(2010-4#2)
propanal and##4##2##(1995-7#1)(2010-4#3)
propanal##10##1##(1990-12#1)(1995-7#4)(2010-4#5)
propane##20##1##(1991-7#1)(2004-9#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-7#2)(2009-6#2)(2010-5#2)(2011-2#1)(2013-8#1)
propane-air##3##1##(2007-12#1)(2008-2#2)
propanil##3##1##(2008-10#3)
propanoic##2##1##(2008-10#1)(2008-5#1)
propanol and##2##2##(2008-10#1)(2008-3#1)
propanol vapor##3##2##(2008-3#3)
propanol##12##1##(1990-12#1)(1991-4#1)(1997-7#1)(2008-10#3)(2008-3#6)
propanolol##2##1##(1990-4#1)(2008-10#1)
propargyl bromide##2##2##(2008-10#1)(2009-3#1)
propargyl##4##1##(1992-11#1)(1997-7#1)(2008-10#1)(2009-3#1)
propargylamine##2##1##(1996-5#1)(2008-5#1)
propargylic esters##2##2##(2010-2#2)
propargylic##5##1##(2006-9#1)(2007-11#1)(2010-2#2)(2013-7#1)
propel the##3##2##(2005-11#1)(2008-10#2)
propel##6##1##(1994-9#1)(2005-11#1)(2007-7#1)(2007-9#1)(2008-10#2)
propellant HFA134a##2##2##(1996-1#2)
propellant and##2##2##(1992-3#1)(1996-1#1)
propellant compositions##2##2##(2008-10#1)(2012-2#1)
propellant##21##1##(1991-12#1)(1992-3#2)(1996-1#9)(1996-2#1)(2005-8#1)(2007-8#1)(2008-10#5)(2012-2#1)
propellants in metered dose inhalers (MDIs)##2##6##(1992-3#1)(1996-1#1)
propellants in##4##2##(1992-3#3)(1996-1#1)
propellants##28##1##(1991-12#1)(1992-3#9)(1996-1#13)(1996-2#1)(2008-10#4)
propelled the##2##2##(2006-4#1)(2013-1#1)
propelled##10##1##(2006-4#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-7#1)(2012-1#1)(2013-1#1)
propeller twists##2##2##(1995-1#1)(1997-5#1)
propeller##4##1##(1995-1#2)(1997-5#1)(2007-12#1)
propeller-like##2##1##(1995-1#1)(2008-5#1)
propelling##6##1##(1992-10#1)(2007-10#2)(2008-10#3)
propene##2##1##(1991-12#1)(2007-11#1)
propensities for binding##2##3##(1994-9#2)
propensities for##3##2##(1994-9#3)
propensities of the##2##3##(1993-11#1)(1997-2#1)
propensities of##5##2##(1993-11#1)(1993-6#1)(1997-2#1)(2008-11#1)(2012-12#1)
propensities##21##1##(1993-11#1)(1993-6#1)(1994-9#4)(1995-4#3)(1997-2#6)(2006-12#1)(2008-11#3)(2008-9#1)(2012-12#1)
propensity for a##3##3##(1991-2#1)(1992-12#2)
propensity for folding##2##3##(1996-11#2)
propensity for##32##2##(1991-2#1)(1992-12#5)(1993-6#1)(1994-9#1)(1995-2#1)(1996-11#2)(1997-7#3)(2007-10#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-4#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
propensity of the##3##3##(1993-11#1)(2008-4#1)(2008-8#1)
propensity of##23##2##(1991-9#1)(1993-11#1)(1993-3#1)(1996-12#1)(1997-2#2)(1997-4#1)(2005-8#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#2)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)
propensity score analysis##2##3##(2007-8#2)
propensity score weighting method##2##4##(2011-1#2)
propensity score weighting##4##3##(2011-1#4)
propensity score##19##2##(2007-8#6)(2008-8#1)(2010-12#1)(2010-3#1)(2010-6#2)(2011-1#5)(2012-3#3)
propensity scores##6##2##(2008-11#2)(2008-12#1)(2008-8#2)(2009-9#1)
propensity to be##2##3##(2007-12#1)(2013-1#1)
propensity to cause##2##3##(2007-11#1)(2012-11#1)
propensity to develop##4##3##(1994-3#1)(2005-10#1)(2006-1#1)(2006-11#1)
propensity to form##2##3##(1992-9#1)(1993-12#1)
propensity to induce##2##3##(1997-2#1)(2010-6#1)
propensity to##37##2##(1991-7#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-7#1)(1997-1#1)(1997-2#1)(2005-1#1)(2005-10#1)(2006-1#1)(2006-11#1)(2006-7#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-1#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#2)(2010-6#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)
propensity towards##2##2##(2008-4#1)(2009-12#1)
propensity was##2##2##(2009-7#1)(2010-2#1)
propensity##135##1##(1991-10#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-12#5)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-4#3)(1995-7#1)(1996-11#2)(1996-12#1)(1996-8#2)(1997-1#1)(1997-2#3)(1997-4#1)(1997-7#3)(2005-1#1)(2005-10#1)(2005-8#1)(2006-1#1)(2006-11#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#6)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#3)(2009-3#3)(2009-4#1)(2009-5#1)(2009-7#4)(2009-9#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#3)(2011-1#6)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#1)
propensity-matched analysis##2##2##(2007-8#2)
propensity-matched##5##1##(2007-12#1)(2007-8#4)
propentofylline##2##1##(2004-12#1)(2005-8#1)
propeptide and##3##2##(1991-9#1)(1994-11#1)(1995-2#1)
propeptide is##3##2##(1991-5#1)(1995-3#2)
propeptide of profactor IX##2##4##(1994-11#2)
propeptide of type III procollagen##2##5##(1993-6#1)(2006-2#1)
propeptide of type##4##3##(1993-6#1)(1997-1#2)(2006-2#1)
propeptide of##7##2##(1993-6#1)(1994-11#2)(1994-9#1)(1997-1#2)(2006-2#1)
propeptide processing##2##2##(1991-9#2)
propeptide sequence##2##2##(1991-9#2)
propeptide which##2##2##(1993-12#1)(1995-3#1)
propeptide##45##1##(1990-5#2)(1991-11#1)(1991-5#3)(1991-8#1)(1991-9#7)(1992-2#1)(1993-12#1)(1993-6#1)(1994-11#6)(1994-5#1)(1994-9#2)(1995-2#1)(1995-3#5)(1995-6#4)(1997-1#2)(1997-2#1)(2006-2#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#2)
propeptides and##2##2##(1991-1#2)
propeptides that##2##2##(1991-1#2)
propeptides##7##1##(1991-1#5)(1996-8#2)
proper adjustment of the##2##4##(2007-12#1)(2008-2#1)
proper adjustment##3##2##(2007-12#1)(2008-2#1)(2010-12#1)
proper amount of##2##3##(1993-12#1)(2008-5#1)
proper analysis and##2##3##(2008-1#1)(2008-7#1)
proper analysis##4##2##(2006-10#2)(2008-1#1)(2008-7#1)
proper and##10##2##(1992-2#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-4#1)(2009-4#1)(2013-1#4)
proper application of##4##3##(2007-11#2)(2008-3#1)(2013-7#1)
proper approach for##2##3##(2008-12#1)(2009-12#1)
proper approach##3##2##(2008-12#1)(2009-12#1)(2010-2#1)
proper approaches##2##2##(1993-12#1)(2008-3#1)
proper assembly of##2##3##(1993-6#1)(2005-10#1)
proper assessment of##2##3##(1991-3#1)(2007-12#1)
proper assessment##3##2##(1991-3#1)(2007-12#1)(2008-11#1)
proper attention##4##2##(1996-6#1)(1997-6#1)(2006-10#1)(2007-10#1)
proper balance##4##2##(1991-12#1)(1997-2#1)(2007-11#1)(2008-5#1)
proper but##2##2##(1992-1#1)(2007-12#1)
proper care and##3##3##(1994-6#1)(1995-2#1)(2008-10#1)
proper care for##2##3##(1990-10#1)(1994-1#1)
proper care##5##2##(1990-10#1)(1994-1#1)(1994-6#1)(1995-2#1)(2008-10#1)
proper choice of the##3##4##(2007-12#1)(2008-1#1)(2008-2#1)
proper choice of##7##3##(2007-12#2)(2007-7#1)(2008-1#1)(2008-2#2)(2008-9#1)
proper choice##9##2##(1990-2#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-2#2)(2008-9#2)
proper classification##3##2##(2007-8#1)(2008-10#1)(2012-2#1)
proper clinical management##2##3##(2007-8#1)(2008-3#1)
proper clinical##3##2##(2006-9#1)(2007-8#1)(2008-3#1)
proper combination of the##3##4##(2005-11#1)(2012-2#1)(2013-7#1)
proper combination of##7##3##(1994-9#1)(2005-11#2)(2005-7#1)(2012-2#2)(2013-7#1)
proper concentration##2##2##(2008-10#1)(2008-2#1)
proper conditions for##3##3##(1993-11#1)(2007-12#1)(2008-3#1)
proper conditions##4##2##(1993-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
proper control of##3##3##(1993-1#1)(2008-8#1)(2012-2#1)
proper correction##2##2##(2005-1#1)(2007-11#1)
proper counselling##2##2##(2008-4#1)(2011-12#1)
proper course##3##2##(2007-11#3)
proper diagnosis and treatment##2##4##(2012-12#1)(2013-7#1)
proper diagnosis and##4##3##(2011-12#2)(2012-12#1)(2013-7#1)
proper diagnosis##14##2##(2007-11#5)(2007-6#1)(2007-9#2)(2011-12#2)(2012-12#3)(2013-7#1)
proper diagnostic##2##2##(2007-8#1)(2013-7#1)
proper documentation##2##2##(1995-2#1)(2007-2#1)
proper dosage##3##2##(2009-3#1)(2011-2#2)
proper dosing of##2##3##(1996-11#1)(2007-8#1)
proper dosing##3##2##(1996-11#1)(2005-10#1)(2007-8#1)
proper evaluation of the##2##4##(2007-11#1)(2011-2#1)
proper evaluation of##3##3##(2007-11#1)(2010-8#1)(2011-2#1)
proper evaluation##4##2##(2007-11#1)(2010-8#1)(2011-12#1)(2011-2#1)
proper execution of##2##3##(2008-10#1)(2008-4#1)
proper execution##3##2##(2008-1#1)(2008-10#1)(2008-4#1)
proper expression of##3##3##(2006-11#1)(2012-12#2)
proper folding##2##2##(1991-11#1)(2008-4#1)
proper formation of the##3##4##(1993-6#1)(2007-12#1)(2012-12#1)
proper formation of##4##3##(1991-12#1)(1993-6#1)(2007-12#1)(2012-12#1)
proper formation##5##2##(1991-12#1)(1993-6#1)(1996-3#1)(2007-12#1)(2012-12#1)
proper function of the##4##4##(1997-7#1)(2007-11#1)(2008-7#1)(2011-2#1)
proper function of##6##3##(1997-7#1)(2007-11#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
proper function##7##2##(1997-7#1)(2007-11#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
proper functional##2##2##(2006-10#1)(2008-3#1)
proper functioning##4##2##(2005-10#1)(2007-11#1)(2012-2#2)
proper genetic##2##2##(1995-12#1)(2008-1#1)
proper growth##2##2##(2007-5#1)(2007-8#1)
proper guidance##2##2##(2008-3#1)(2013-1#1)
proper handling##2##2##(2007-6#1)(2010-9#1)
proper identification of##4##3##(2006-5#1)(2007-11#1)(2010-12#1)(2013-8#1)
proper identification##6##2##(1991-3#1)(2006-5#1)(2007-11#1)(2010-12#1)(2013-1#1)(2013-8#1)
proper initial##3##2##(2007-12#1)(2008-3#1)(2013-8#1)
proper interpretation of##3##3##(1996-12#1)(2008-4#1)(2011-3#1)
proper intraoperative management##2##3##(2006-10#1)(2010-8#1)
proper knowledge##2##2##(2011-2#2)
proper management of##9##3##(2005-11#1)(2007-12#1)(2007-7#1)(2010-12#1)(2010-6#1)(2010-8#1)(2013-1#2)(2013-8#1)
proper management##16##2##(1991-6#1)(2005-11#1)(2007-12#1)(2007-7#1)(2008-7#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-6#1)(2010-8#2)(2011-2#1)(2013-1#2)(2013-8#1)
proper medical##2##2##(1996-11#1)(2006-8#1)
proper medication##2##2##(2008-12#1)(2011-2#1)
proper membrane##2##2##(2008-7#2)
proper methods for handling and restraining laboratory animals should be followed##2##11##(2008-4#2)
proper model##3##2##(1993-12#1)(2009-12#1)(2013-1#1)
proper names##3##2##(1991-2#1)(2008-11#1)(2008-5#1)
proper nutrition##4##2##(2005-3#2)(2007-1#1)(2009-3#1)
proper patient selection##4##3##(2006-10#1)(2008-7#1)(2011-2#2)
proper patient##7##2##(2006-10#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-7#1)(2011-2#2)
proper patterning##2##2##(2008-11#1)(2012-12#1)
proper perspective##3##2##(1994-1#2)(2007-11#1)
proper place##2##2##(1994-9#1)(2007-7#1)
proper planning##2##2##(2006-5#1)(2008-11#1)
proper positioning of the##2##4##(1993-6#1)(2010-8#1)
proper positioning of##3##3##(1993-6#1)(2010-8#1)(2013-1#1)
proper prior##2##2##(1995-12#1)(1997-8#1)
proper processing##2##2##(2008-9#1)(2012-3#1)
proper qualification##3##2##(2007-7#1)(2007-8#1)(2007-9#1)
proper randomization##2##2##(2007-1#1)(2012-3#1)
proper records##2##2##(1996-11#1)(2008-11#1)
proper regulation of##2##3##(2009-8#1)(2011-2#1)
proper screening##2##2##(2011-12#1)(2013-8#1)
proper selection of the##4##4##(2007-12#1)(2008-11#1)(2008-3#2)
proper selection of##17##3##(1990-5#1)(2006-1#2)(2006-10#1)(2007-11#2)(2007-12#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2010-5#1)(2012-2#2)
proper selection##18##2##(1990-5#1)(2006-1#2)(2006-10#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2010-5#1)(2012-2#2)
proper surgical technique##2##3##(2007-11#1)(2007-8#1)
proper surgical##5##2##(2007-11#1)(2007-8#3)(2012-3#1)
proper technique and##2##3##(2007-7#1)(2009-10#1)
proper technique##5##2##(2007-7#1)(2007-8#1)(2008-12#1)(2009-10#1)(2012-2#1)
proper therapy##2##2##(2006-8#1)(2011-2#1)
proper timing of##2##3##(1997-4#1)(2008-2#1)
proper timing##3##2##(1997-4#1)(2008-2#1)(2009-8#1)
proper tools##2##2##(2006-5#1)(2011-1#1)
proper training##7##2##(1993-3#1)(1994-7#1)(1996-2#1)(2007-7#1)(2008-12#1)(2008-2#1)(2012-12#1)
proper treatment remains##2##3##(2006-9#1)(2010-7#1)
proper treatment##20##2##(1993-2#1)(1993-5#1)(1996-11#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-5#1)(2009-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
proper usage of##3##3##(1996-2#1)(2007-6#1)(2011-2#1)
proper use of##12##3##(1991-11#1)(1993-12#1)(1997-2#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-4#1)(2010-9#1)(2012-2#2)(2013-8#1)
proper use##14##2##(1991-11#1)(1993-12#1)(1997-2#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-4#1)(2010-9#1)(2012-2#2)(2013-1#2)(2013-8#1)
proper utilization##2##2##(2008-1#1)(2008-10#1)
proper validation##2##2##(2008-7#1)(2013-1#1)
proper ventilation##2##2##(2007-9#1)(2013-1#1)
proper way to##3##3##(2007-5#1)(2008-7#1)(2011-1#1)
proper way##5##2##(1991-11#1)(2007-5#1)(2008-6#1)(2008-7#1)(2011-1#1)
proper##629##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-10#1)(1991-11#5)(1991-12#3)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#2)(1991-8#1)(1992-1#2)(1992-11#2)(1992-2#1)(1992-3#1)(1993-1#2)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#5)(1993-8#1)(1994-1#3)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#2)(1994-7#1)(1994-9#6)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#1)(1996-11#8)(1996-12#2)(1996-2#2)(1996-3#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-3#1)(2005-1#1)(2005-10#4)(2005-11#6)(2005-12#1)(2005-3#2)(2005-7#2)(2005-9#1)(2006-1#2)(2006-10#12)(2006-11#2)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#5)(2006-6#3)(2006-7#1)(2006-8#4)(2006-9#2)(2007-1#3)(2007-10#2)(2007-11#40)(2007-12#23)(2007-2#3)(2007-3#2)(2007-4#2)(2007-5#3)(2007-6#6)(2007-7#10)(2007-8#19)(2007-9#7)(2008-1#10)(2008-10#30)(2008-11#15)(2008-12#6)(2008-2#21)(2008-3#20)(2008-4#16)(2008-5#8)(2008-6#5)(2008-7#15)(2008-8#7)(2008-9#4)(2009-10#3)(2009-12#5)(2009-3#3)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#5)(2010-1#1)(2010-11#3)(2010-12#9)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#5)(2010-8#9)(2010-9#2)(2011-1#7)(2011-12#6)(2011-2#27)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#14)(2012-2#19)(2012-3#9)(2013-1#25)(2013-7#6)(2013-8#12)
properdin deficiency##3##2##(1995-9#3)
properdin##7##1##(1990-9#1)(1995-9#6)
properly accounted for##2##3##(2008-2#1)(2008-4#1)
properly addressed##4##2##(2006-10#1)(2006-8#1)(2007-5#1)(2013-1#1)
properly adjusted##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
properly aligned##2##2##(2008-2#1)(2008-3#1)
properly and##4##2##(1992-9#1)(1993-2#1)(2006-10#1)(2006-11#1)
properly applied##4##2##(1994-3#1)(2008-2#1)(2008-4#1)(2012-12#1)
properly assembled##2##2##(1993-6#1)(1997-3#1)
properly assessed##4##2##(2007-11#1)(2008-3#1)(2008-5#1)(2012-12#1)
properly chosen##2##2##(2008-2#2)
properly controlled##3##2##(2008-10#2)(2013-1#1)
properly designed##6##2##(1991-12#1)(2006-4#2)(2007-7#1)(2008-3#1)(2011-2#1)
properly evaluated##4##2##(1997-2#1)(2008-10#1)(2008-11#1)(2012-12#1)
properly folded##2##2##(1997-4#1)(2012-2#1)
properly for##2##2##(1997-1#1)(2007-4#1)
properly in##7##2##(1990-12#1)(1993-3#1)(1994-8#1)(1995-8#1)(2006-12#1)(2008-9#1)(2012-2#1)
properly investigated##2##2##(2006-11#1)(2009-5#1)
properly managed##4##2##(1995-12#1)(2006-10#1)(2007-6#1)(2008-10#1)
properly normalized##2##2##(1997-4#1)(2008-2#1)
properly oriented##2##2##(1994-11#1)(2008-3#1)
properly performed##3##2##(2007-11#1)(2008-1#1)(2008-6#1)
properly prepared##4##2##(1991-12#1)(2008-11#1)(2009-4#1)(2012-12#1)
properly processed##3##2##(1990-5#1)(1997-4#1)(2006-4#1)
properly selected patients##2##3##(2006-5#1)(2010-8#1)
properly selected##8##2##(1995-8#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-2#1)(2009-12#1)(2010-8#1)(2011-2#1)
properly structured##2##2##(1993-12#1)(1996-3#1)
properly targeted##2##2##(1996-4#1)(2008-11#1)
properly the##4##2##(1991-12#1)(2008-10#2)(2008-2#1)
properly to##2##2##(2008-1#1)(2011-2#1)
properly trained in##2##3##(1995-6#1)(2007-4#1)
properly trained##5##2##(1995-6#1)(2007-4#2)(2007-6#1)(2007-8#1)
properly treated##6##2##(2005-9#1)(2007-11#1)(2009-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
properly used##2##2##(2008-10#1)(2012-3#1)
properly with##2##2##(2010-12#1)(2012-2#1)
properly##241##1##(1990-11#1)(1990-12#1)(1990-5#2)(1990-8#1)(1991-12#5)(1991-2#1)(1992-9#2)(1993-12#2)(1993-2#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-12#2)(1995-5#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-10#1)(1996-3#2)(1996-4#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#5)(1997-6#1)(1997-7#1)(2004-7#1)(2005-1#1)(2005-10#4)(2005-11#1)(2005-5#2)(2005-9#2)(2006-10#5)(2006-11#4)(2006-12#2)(2006-4#3)(2006-5#4)(2006-8#1)(2007-1#2)(2007-11#7)(2007-12#7)(2007-2#1)(2007-4#4)(2007-5#3)(2007-6#2)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#8)(2008-12#2)(2008-2#16)(2008-3#11)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#3)(2009-1#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#3)(2010-2#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#8)(2012-1#3)(2012-12#6)(2012-2#7)(2012-3#5)(2013-1#10)(2013-7#2)(2013-8#2)
properties (e##5##2##(1996-1#1)(2007-12#1)(2008-1#1)(2008-4#1)(2010-11#1)
properties (i##3##2##(2008-3#2)(2008-5#1)
properties after##6##2##(1992-2#1)(2006-5#1)(2008-3#1)(2008-5#2)(2009-7#1)
properties against the##2##3##(1992-9#1)(1993-5#1)
properties against##9##2##(1992-9#1)(1993-5#1)(2005-11#1)(2008-3#1)(2008-5#3)(2010-12#1)(2012-1#1)
properties analogous to those of##3##5##(1990-7#1)(1995-5#2)
properties and a##3##3##(1995-10#1)(2008-2#1)(2012-12#1)
properties and amino acid##2##4##(1992-8#1)(2008-7#1)
properties and analytical##2##3##(2008-10#1)(2011-3#1)
properties and application of##2##4##(2005-11#1)(2008-10#1)
properties and application##4##3##(2005-11#1)(2007-8#1)(2008-10#1)(2008-3#1)
properties and applications of##3##4##(1996-3#1)(2008-10#1)(2008-11#1)
properties and applications##4##3##(1996-3#1)(2008-10#1)(2008-11#1)(2013-1#1)
properties and are##5##3##(1991-4#1)(2005-7#1)(2007-10#1)(2008-3#1)(2008-7#1)
properties and be##2##3##(2006-10#1)(2010-10#1)
properties and behaviour##2##3##(2008-10#1)(2010-12#1)
properties and biological##2##3##(2008-3#1)(2008-8#1)
properties and can##4##3##(2008-11#1)(2010-10#1)(2011-2#1)(2012-1#1)
properties and catalytic##2##3##(2008-10#1)(2008-3#1)
properties and clinical##2##3##(2008-7#1)(2011-1#1)
properties and diagnostic##2##3##(2013-1#2)
properties and even##2##3##(2008-1#1)(2010-8#1)
properties and for##3##3##(2007-12#1)(2008-3#2)
properties and function as##2##4##(2006-12#1)(2008-1#1)
properties and function##3##3##(1991-2#1)(2006-12#1)(2008-1#1)
properties and functions of##2##4##(2008-5#1)(2011-2#1)
properties and have been##2##4##(2007-12#1)(2010-2#1)
properties and have##3##3##(1990-5#1)(2007-12#1)(2010-2#1)
properties and is##3##3##(2009-3#2)(2011-1#1)
properties and its##3##3##(1990-5#1)(1990-8#1)(2008-10#1)
properties and mechanical stability##2##4##(2008-11#1)(2008-3#1)
properties and mechanical##3##3##(2007-12#1)(2008-11#1)(2008-3#1)
properties and potential applications##3##4##(2006-2#1)(2008-7#1)(2010-12#1)
properties and potential##5##3##(2006-2#1)(2007-12#1)(2008-5#1)(2008-7#1)(2010-12#1)
properties and results##3##3##(2007-11#1)(2008-3#1)(2010-2#1)
properties and shape##3##3##(2009-2#2)(2009-7#1)
properties and size distribution of##2##5##(2008-2#2)
properties and size##3##3##(2008-2#2)(2008-3#1)
properties and stability of##3##4##(1993-4#1)(1996-7#1)(2007-12#1)
properties and stability##4##3##(1991-8#1)(1993-4#1)(1996-7#1)(2007-12#1)
properties and structural##2##3##(1990-7#1)(2011-1#1)
properties and study##2##3##(2010-3#1)(2012-3#1)
properties and surface##4##3##(1997-2#1)(2005-11#2)(2008-10#1)
properties and synaptic##2##3##(1995-6#1)(2008-11#1)
properties and that##2##3##(2007-11#1)(2008-10#1)
properties and the optical##2##4##(2008-2#1)(2008-3#1)
properties and the##25##3##(1991-2#1)(1991-5#1)(1991-7#1)(1992-3#1)(1992-6#1)(1995-8#1)(2004-9#1)(2006-10#1)(2006-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-7#1)(2013-8#1)
properties and their ability to##2##5##(2006-11#1)(2010-5#1)
properties and their##9##3##(1991-6#1)(1996-2#1)(2006-11#1)(2006-4#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-5#1)(2011-1#1)
properties and therapeutic##2##3##(2007-11#1)(2013-1#1)
properties and thermal##2##3##(1993-8#1)(2009-9#1)
properties and to##5##3##(2006-12#1)(2007-4#1)(2008-5#1)(2010-4#2)
properties and uses of##2##4##(2008-1#2)
properties and was##2##3##(1995-12#1)(2010-4#1)
properties and##314##2##(1990-1#1)(1990-12#2)(1990-3#1)(1990-5#3)(1990-7#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#3)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#3)(1992-8#1)(1993-1#1)(1993-12#2)(1993-4#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#1)(1996-10#1)(1996-11#2)(1996-2#3)(1996-3#1)(1996-7#1)(1997-2#2)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#1)(2004-9#2)(2005-11#7)(2005-12#1)(2005-7#1)(2006-10#5)(2006-11#4)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#6)(2007-4#2)(2007-6#2)(2007-8#6)(2007-9#1)(2008-1#5)(2008-10#20)(2008-11#6)(2008-12#3)(2008-2#13)(2008-3#19)(2008-4#3)(2008-5#15)(2008-6#2)(2008-7#9)(2008-8#6)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#3)(2009-3#3)(2009-5#2)(2009-7#5)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#4)(2010-3#2)(2010-4#7)(2010-5#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#7)(2011-2#7)(2011-3#1)(2012-1#2)(2012-11#4)(2012-12#6)(2012-2#5)(2012-3#1)(2013-1#6)(2013-8#6)
properties are also discussed##2##4##(2008-10#1)(2008-4#1)
properties are also##4##3##(1992-8#1)(2008-10#1)(2008-4#1)(2010-4#1)
properties are consistent with##2##4##(1995-2#1)(1997-4#1)
properties are derived##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
properties are described##2##3##(2007-11#1)(2007-12#1)
properties are determined by the##2##5##(2008-1#1)(2008-5#1)
properties are determined##3##3##(2008-1#1)(2008-2#1)(2008-5#1)
properties are different##3##3##(1990-2#1)(1994-3#1)(2007-11#1)
properties are discussed##4##3##(2006-2#1)(2008-2#1)(2009-8#2)
properties are expressed##2##3##(1996-2#1)(2008-3#1)
properties are likely##2##3##(1996-2#1)(2008-10#1)
properties are not##2##3##(2008-9#1)(2011-1#1)
properties are obtained##2##3##(1990-8#1)(2007-12#1)
properties are reported##2##3##(2008-3#1)(2009-11#1)
properties are similar to those of##2##6##(1996-2#1)(2007-12#1)
properties are similar to those##3##5##(1996-2#1)(1997-6#1)(2007-12#1)
properties are similar to##4##4##(1991-3#1)(1996-2#1)(1997-6#1)(2007-12#1)
properties are still##2##3##(2006-10#1)(2012-2#1)
properties are strongly##2##3##(2006-6#1)(2008-3#1)
properties are used##2##3##(2007-12#1)(2012-2#1)
properties are##101##2##(1990-2#1)(1990-8#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-8#1)(1993-12#1)(1993-4#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#2)(1996-2#4)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-6#1)(2007-11#6)(2007-12#10)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#6)(2008-2#10)(2008-3#10)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#1)(2009-8#3)(2010-2#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#2)(2012-1#1)(2012-2#5)(2013-1#1)
properties as a function of anatomical position##2##7##(2012-2#2)
properties as a function of##4##5##(2008-5#1)(2009-9#1)(2012-2#2)
properties as a##7##3##(1993-11#1)(1997-4#1)(2008-5#1)(2009-9#1)(2012-2#3)
properties as the##2##3##(1993-8#1)(1994-12#1)
properties as well as their##2##5##(2005-11#1)(2008-5#1)
properties as well as##9##4##(1992-9#1)(2005-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-2#1)(2010-1#1)(2011-2#1)
properties as well##10##3##(1992-9#1)(1994-8#1)(2005-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-2#1)(2010-1#1)(2011-2#1)
properties as##39##2##(1992-10#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-5#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#2)(2006-4#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#1)(2009-2#1)(2009-9#2)(2010-1#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)
properties assessed by##2##3##(1995-2#1)(2008-5#1)
properties associated with##4##3##(1991-4#1)(1997-3#1)(2009-11#1)(2012-3#1)
properties at the##6##3##(1993-2#1)(1996-3#1)(2005-11#1)(2008-3#1)(2008-9#1)(2010-7#1)
properties at##23##2##(1993-2#1)(1993-8#1)(1996-3#1)(1997-2#1)(2005-11#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-3#5)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2010-7#1)(2011-1#1)(2012-11#2)(2012-2#1)
properties between##9##2##(1993-2#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-12#1)
properties both##2##2##(1991-9#1)(1993-8#1)
properties but is##2##3##(1992-1#1)(2010-4#1)
properties but##12##2##(1992-1#1)(1995-7#1)(1996-1#1)(1997-2#1)(2005-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-12#1)(2010-2#1)(2010-4#1)(2011-2#1)
properties by means of##3##4##(2008-10#1)(2008-3#1)(2012-2#1)
properties by##17##2##(2004-9#1)(2008-10#2)(2008-2#3)(2008-3#3)(2008-5#2)(2009-12#1)(2009-6#1)(2011-2#1)(2012-2#3)
properties can be obtained##2##4##(2008-2#1)(2010-4#1)
properties can be tailored##2##4##(2007-11#1)(2008-5#1)
properties can be##17##3##(1992-4#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)
properties can##18##2##(1992-4#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)
properties close to##2##3##(2008-3#1)(2009-7#1)
properties common to##2##3##(1990-7#1)(2009-10#1)
properties comparable##3##2##(2008-3#1)(2010-4#2)
properties compared to##2##3##(1992-6#1)(2007-11#1)
properties compared with other##4##4##(1992-9#1)(1995-12#1)(2007-11#1)(2007-12#1)
properties compared with##9##3##(1992-9#1)(1995-12#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-2#1)
properties compared##11##2##(1992-6#1)(1992-9#1)(1995-12#1)(1995-3#1)(2007-11#2)(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-2#1)
properties conferred##2##2##(1994-2#1)(1994-8#1)
properties could##2##2##(2008-1#1)(2009-7#1)
properties decreased##2##2##(2008-5#1)(2013-8#1)
properties demonstrated##2##2##(1990-5#1)(1992-6#1)
properties depend on##2##3##(1991-2#1)(2008-3#1)
properties depend##5##2##(1991-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-4#1)
properties depending##2##2##(2008-5#2)
properties described##3##2##(1991-1#1)(1994-3#1)(2005-8#1)
properties different from##2##3##(2008-10#1)(2009-7#1)
properties due to the##2##4##(2007-4#1)(2009-7#1)
properties due to##5##3##(2007-4#1)(2008-1#1)(2008-11#1)(2009-7#1)(2010-5#1)
properties during##8##2##(1990-5#1)(1993-2#1)(1996-1#1)(1996-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#1)
properties even##2##2##(2011-2#1)(2012-1#1)
properties expected##2##2##(1990-11#1)(2008-2#1)
properties for a##2##3##(2008-11#1)(2013-7#1)
properties for the brain##2##4##(2006-11#2)
properties for the various##2##4##(1991-5#1)(2006-12#1)
properties for the##16##3##(1990-3#1)(1991-5#1)(1995-1#1)(1997-3#1)(2006-11#2)(2006-12#1)(2007-6#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2011-1#1)(2012-2#1)
properties for##57##2##(1990-3#1)(1991-5#1)(1992-6#1)(1993-8#1)(1994-5#1)(1995-1#1)(1996-4#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-11#2)(2006-12#2)(2007-11#1)(2007-4#3)(2007-6#1)(2008-10#1)(2008-11#3)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#4)(2008-7#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-4#1)(2011-1#4)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)
properties from downwelling##2##3##(2008-3#2)
properties from lidar##3##3##(2008-2#1)(2008-3#2)
properties from the##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
properties from##30##2##(1993-6#1)(1994-12#1)(2006-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#7)(2008-3#15)(2009-7#1)(2011-1#1)
properties has been##3##3##(1994-9#1)(2008-1#1)(2013-1#1)
properties has##7##2##(1994-9#1)(2006-6#1)(2008-1#1)(2008-5#1)(2009-3#1)(2011-2#1)(2013-1#1)
properties have been##12##3##(1992-1#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-3#1)(2008-7#2)(2010-1#1)(2010-2#1)(2012-3#1)
properties have##16##2##(1990-7#1)(1992-1#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#2)(2010-1#1)(2010-2#1)(2010-7#1)(2012-3#1)
properties in a##3##3##(1992-3#1)(1994-9#1)(2005-11#1)
properties in addition to##2##4##(1995-11#1)(2008-2#1)
properties in both##2##3##(1992-6#1)(2008-2#1)
properties in comparison with##4##4##(1991-2#1)(1997-3#1)(2008-10#1)(2010-12#1)
properties in comparison##5##3##(1991-2#1)(1997-3#1)(2006-2#1)(2008-10#1)(2010-12#1)
properties in culture##2##3##(1991-1#2)
properties in response to##2##4##(1991-11#1)(2005-11#1)
properties in several##2##3##(2008-10#1)(2008-7#1)
properties in such##2##3##(2008-6#1)(2010-2#1)
properties in terms of##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
properties in the context of##2##5##(2007-12#1)(2008-11#1)
properties in the##32##3##(1990-5#1)(1991-10#1)(1991-8#1)(1992-7#1)(1992-8#1)(1993-2#1)(1994-9#1)(1996-9#1)(2005-11#1)(2007-11#2)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#4)(2008-8#1)(2009-2#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)
properties in vitro##4##3##(1992-9#1)(2008-11#1)(2008-6#1)(2009-3#1)
properties in vivo##3##3##(1995-11#1)(2009-3#1)(2010-11#1)
properties in##119##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-4#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#2)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-9#1)(1997-3#1)(2005-11#3)(2005-8#4)(2006-2#1)(2007-11#3)(2007-12#3)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#8)(2008-3#11)(2008-5#2)(2008-6#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#4)
properties include##2##2##(2007-6#1)(2008-11#1)
properties including##5##2##(1994-12#1)(2008-7#1)(2012-11#1)(2013-1#2)
properties induced by##3##3##(2004-9#1)(2008-4#1)(2008-5#1)
properties influence the##2##3##(2006-12#1)(2011-11#1)
properties influence##3##2##(2006-12#1)(2008-3#1)(2011-11#1)
properties inherent##2##2##(2008-10#1)(2009-5#1)
properties is a##2##3##(1990-3#1)(2008-11#1)
properties is important##2##3##(2006-1#1)(2008-2#1)
properties is investigated##2##3##(2007-12#1)(2008-2#1)
properties is presented##2##3##(1993-11#1)(2007-5#1)
properties is##18##2##(1990-3#1)(1993-11#1)(2005-11#1)(2006-1#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#5)(2008-5#1)(2011-1#2)
properties it##2##2##(2007-12#1)(2010-9#1)
properties like a##3##3##(1995-2#2)(2008-3#1)
properties like##8##2##(1994-5#1)(1994-8#1)(1995-2#2)(1996-2#1)(2008-10#1)(2008-3#1)(2008-6#1)
properties make##7##2##(1991-5#1)(1991-8#1)(2008-2#2)(2009-5#1)(2013-1#2)
properties makes##2##2##(2008-1#1)(2008-8#1)
properties match##2##2##(2007-11#1)(2013-8#1)
properties may be##4##3##(1991-12#1)(1992-12#1)(2008-4#1)(2010-7#1)
properties may##10##2##(1991-12#1)(1992-12#1)(1996-5#1)(2005-11#1)(2008-10#1)(2008-4#1)(2009-12#1)(2010-7#2)(2012-2#1)
properties measured##2##2##(2008-2#1)(2008-7#1)
properties might##3##2##(2008-2#1)(2010-1#1)(2011-2#1)
properties must be##2##3##(1992-7#1)(2008-3#1)
properties must##3##2##(1992-7#1)(1996-1#1)(2008-3#1)
properties observed##2##2##(2008-10#1)(2012-2#1)
properties obtained##4##2##(2008-2#3)(2008-3#1)
properties of 1##4##3##(1993-11#1)(1993-7#1)(1994-11#1)(1997-7#1)
properties of 1-phenyl-1##2##3##(2008-10#2)
properties of 2##3##3##(1996-5#1)(2008-10#1)(2009-3#1)
properties of 5##3##3##(2005-4#1)(2008-10#2)
properties of APs##2##3##(1992-7#1)(2008-10#1)
properties of DAST##2##3##(2007-12#2)
properties of DNA##2##3##(1994-11#1)(2008-10#1)
properties of HDL##3##3##(1995-1#1)(2008-5#2)
properties of MTs##3##3##(2009-8#3)
properties of NO##2##3##(2008-10#1)(2010-6#1)
properties of Nd##2##3##(2008-3#2)
properties of Rhodobacter sphaeroides##3##4##(1993-11#1)(2008-8#2)
properties of a highly translucent##2##5##(2013-8#2)
properties of a highly##3##4##(2007-12#1)(2013-8#2)
properties of a mutant##2##4##(1995-8#1)(2008-11#1)
properties of a new##9##4##(1990-7#1)(1991-3#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2012-12#1)
properties of a novel##3##4##(1990-7#1)(1997-7#1)(2010-6#1)
properties of a series of##2##5##(2007-11#1)(2011-1#1)
properties of a single##2##4##(2007-2#1)(2009-7#1)
properties of a spherical##2##4##(2008-3#2)
properties of a##114##3##(1990-12#1)(1990-7#2)(1990-8#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-4#1)(1992-7#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-8#4)(1995-2#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-7#1)(2004-9#2)(2005-11#3)(2006-10#1)(2006-3#1)(2007-10#1)(2007-11#5)(2007-12#8)(2007-2#1)(2007-9#1)(2008-10#6)(2008-11#3)(2008-2#16)(2008-3#13)(2008-4#2)(2008-5#3)(2008-6#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
properties of aerosols##2##3##(2008-2#1)(2008-3#1)
properties of all##4##3##(1995-3#1)(2006-12#1)(2008-4#1)(2009-5#1)
properties of altered proteins##2##4##(1994-9#1)(1997-5#1)
properties of amino acids##2##4##(2004-12#1)(2007-6#1)
properties of amino##3##3##(2004-12#2)(2007-6#1)
properties of an##25##3##(1991-2#1)(1991-5#1)(1992-2#1)(1992-6#1)(1994-11#1)(1994-5#1)(1995-6#1)(1997-6#1)(2004-1#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-3#7)(2008-6#1)(2008-8#2)(2009-7#1)
properties of anti-CD3 mAbs are##2##5##(1991-12#2)
properties of antibiotics##2##3##(1991-12#1)(2009-4#1)
properties of aqueous##2##3##(2005-11#2)
properties of atmospheric transmission##2##4##(2008-2#2)
properties of atmospheric##4##3##(2008-2#2)(2008-3#2)
properties of bacteriorhodopsin##2##3##(2007-12#1)(2008-2#1)
properties of beef##3##3##(2010-4#3)
properties of biological samples##2##4##(2007-12#1)(2008-4#1)
properties of biological tissue##3##4##(2004-9#1)(2007-12#1)(2008-3#1)
properties of biological##10##3##(1997-6#1)(1997-7#1)(2004-9#1)(2007-12#3)(2008-3#2)(2008-4#1)(2012-2#1)
properties of blood##4##3##(1991-8#1)(2009-4#1)(2012-12#2)
properties of bone##4##3##(2004-9#2)(2009-7#1)(2012-12#1)
properties of both##15##3##(1993-9#1)(1994-12#1)(1995-5#1)(2004-12#1)(2005-11#2)(2007-11#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2009-8#1)(2010-4#1)
properties of bovine##4##3##(1991-10#1)(1994-8#1)(2004-9#1)(2005-9#1)
properties of brain tissue##4##4##(2006-11#1)(2007-1#1)(2007-5#2)
properties of brain##6##3##(1991-1#1)(1991-4#1)(2006-11#1)(2007-1#1)(2007-5#2)
properties of cancer##2##3##(1992-4#1)(1992-8#1)
properties of carbon nanotubes##5##4##(2006-12#1)(2006-2#1)(2007-9#2)(2008-10#1)
properties of carbon##7##3##(2005-11#1)(2006-12#1)(2006-2#1)(2007-9#2)(2008-10#1)(2008-7#1)
properties of cat AMLS##2##4##(2008-9#2)
properties of cathepsin D##2##4##(1994-5#2)
properties of cell membranes##2##4##(2010-12#1)(2013-7#1)
properties of cells##2##3##(1990-8#1)(2008-9#1)
properties of certain##2##3##(1997-8#1)(2010-1#1)
properties of chemically##3##3##(1993-11#1)(2005-11#1)(2009-3#1)
properties of collagen##4##3##(2008-5#2)(2010-8#1)(2012-12#1)
properties of colloidal##2##3##(2005-11#1)(2013-8#1)
properties of commercial active alginate##2##5##(2009-2#2)
properties of complexes##2##3##(1993-9#1)(2012-2#1)
properties of composite##2##3##(1995-11#1)(2008-10#1)
properties of connective tissue##2##4##(2013-1#2)
properties of dendritic##2##3##(2012-2#2)
properties of dental##2##3##(2007-9#1)(2009-7#1)
properties of dexmedetomidine##2##3##(2011-2#2)
properties of different##4##3##(2006-12#1)(2008-10#1)(2008-2#1)(2008-8#1)
properties of dilute##2##3##(2008-3#1)(2009-2#1)
properties of distributed##3##3##(2008-3#2)(2008-8#1)
properties of drugs##3##3##(1991-2#1)(2008-1#1)(2008-8#1)
properties of each##8##3##(1991-10#1)(1993-2#1)(1997-4#1)(2004-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)
properties of engineered##3##3##(1995-1#1)(2008-7#1)(2010-8#1)
properties of erythrocytes##3##3##(1993-4#1)(2008-2#1)(2011-1#1)
properties of ethanol##3##3##(1992-9#1)(1996-10#2)
properties of fac-Re(CO)(3)(dpknph)Cl##3##3##(2008-10#3)
properties of fiber lasers with twist-induced##2##6##(2008-2#2)
properties of fiber lasers##3##4##(2008-2#3)
properties of fiber##4##3##(2007-12#1)(2008-2#3)
properties of five##2##3##(1993-3#1)(1996-3#1)
properties of food##2##3##(2009-11#1)(2009-8#1)
properties of four##2##3##(1996-8#1)(2008-9#1)
properties of gel##2##3##(2008-7#2)
properties of glass-ionomer##2##3##(2004-9#1)(2009-7#1)
properties of gold##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)
properties of hair##3##3##(2006-12#1)(2007-8#1)(2008-5#1)
properties of hemoglobin##3##3##(1990-8#1)(1991-6#1)(1993-8#1)
properties of hepatic##2##3##(1991-9#1)(1997-8#1)
properties of highly##7##3##(1992-3#1)(1993-12#1)(2007-12#1)(2008-2#1)(2008-3#2)(2009-7#1)
properties of human and bovine##2##5##(1997-4#1)(2006-11#1)
properties of human skin in vivo##2##6##(2008-5#2)
properties of human##18##3##(1990-8#1)(1991-10#1)(1992-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-5#1)(1997-4#1)(2006-11#1)(2008-2#1)(2008-4#1)(2008-5#5)(2012-1#2)
properties of hydrazine##2##3##(2010-5#2)
properties of hydroxyapatite reinforced##2##4##(2004-9#1)(2009-7#1)
properties of hydroxyapatite##4##3##(2004-9#2)(2009-7#2)
properties of ice##2##3##(2007-11#1)(2008-3#1)
properties of individual##8##3##(1990-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-2#1)(2009-4#1)(2012-2#2)
properties of inversely twisted nematic##2##5##(2008-2#2)
properties of iron##3##3##(1996-2#1)(2005-11#1)(2010-5#1)
properties of isolated##3##3##(1991-2#2)(2009-8#1)
properties of known##3##3##(1994-12#1)(2008-2#1)(2008-7#1)
properties of large##4##3##(1994-11#1)(2008-3#1)(2010-4#1)(2013-7#1)
properties of lean beef##2##4##(2010-4#2)
properties of light##5##3##(2008-1#1)(2008-2#1)(2008-3#2)(2008-4#1)
properties of living##2##3##(2006-7#1)(2010-11#1)
properties of local##3##3##(2008-3#1)(2008-8#1)(2013-7#1)
properties of macromolecular##2##3##(2005-4#1)(2007-12#1)
properties of mammalian##4##3##(1991-10#1)(2005-8#1)(2008-2#1)(2008-5#1)
properties of materials##6##3##(2005-10#1)(2007-12#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-7#1)
properties of medium-chain##2##3##(1995-5#2)
properties of melittin##2##3##(1992-6#2)
properties of mesenchymal##2##3##(2012-12#1)(2012-3#1)
properties of metallic##2##3##(2007-11#1)(2008-2#1)
properties of microtubules##2##3##(1995-1#1)(2006-10#1)
properties of molecules##2##3##(1991-5#1)(2010-7#1)
properties of mouse##2##3##(1990-7#1)(2008-9#1)
properties of muscle##3##3##(1990-3#1)(1991-2#1)(2006-11#1)
properties of mutant##2##3##(1995-11#1)(2005-11#1)
properties of nanocrystalline##2##3##(2005-11#1)(2007-9#1)
properties of nanoparticles##2##3##(2008-7#1)(2012-2#1)
properties of nanotubes##2##3##(2008-10#1)(2008-7#1)
properties of natural##5##3##(2007-9#1)(2008-11#1)(2008-3#1)(2009-12#1)(2011-2#1)
properties of neuronal##2##3##(1994-5#1)(1995-12#1)
properties of neurons##4##3##(1990-4#1)(1993-2#1)(1997-6#1)(2008-7#1)
properties of new##4##3##(1990-11#1)(2008-10#3)
properties of normal##4##3##(1996-4#1)(1997-1#1)(2007-11#1)(2010-8#1)
properties of novel##5##3##(1992-8#1)(2005-11#1)(2007-11#1)(2008-11#1)(2012-1#1)
properties of objects##2##3##(2007-11#1)(2009-8#1)
properties of one of these##2##5##(1990-3#1)(1995-10#1)
properties of optical##7##3##(1992-9#1)(2007-12#2)(2008-2#2)(2008-3#2)
properties of organic##2##3##(2008-10#1)(2008-3#1)
properties of other##3##3##(2005-11#1)(2008-10#1)(2008-2#1)
properties of our##2##3##(2008-6#1)(2010-1#1)
properties of particles##4##3##(1990-12#1)(1997-2#1)(2008-3#2)
properties of peptides##3##3##(1990-7#2)(2008-9#1)
properties of photonic crystal fibers##2##5##(2007-11#1)(2007-12#1)
properties of polarization mode dispersion##3##5##(2007-11#2)(2007-12#1)
properties of polyaniline##2##3##(2005-11#1)(2008-10#1)
properties of polymer##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
properties of polyphenols##2##3##(1996-1#1)(2008-7#1)
properties of porcine##2##3##(2007-4#1)(2009-4#1)
properties of porous##2##3##(2008-3#1)(2008-5#1)
properties of primary sensory##2##4##(1991-10#1)(1994-2#1)
properties of primary##3##3##(1991-10#1)(1994-2#1)(1996-1#1)
properties of protein##2##3##(1990-6#1)(2011-2#1)
properties of proteins in##2##4##(1995-4#1)(2008-1#1)
properties of proteins##7##3##(1995-4#1)(1997-5#1)(2005-11#1)(2008-1#1)(2008-4#1)(2008-7#1)(2012-1#1)
properties of pulmonary surfactant##2##4##(1994-3#1)(2011-1#1)
properties of pure##2##3##(2006-10#1)(2008-3#1)
properties of purified##3##3##(1995-2#1)(1996-4#1)(2008-4#1)
properties of randomly oriented hexagonal ice columns##2##7##(2008-3#2)
properties of randomly##3##3##(2008-3#3)
properties of rat##4##3##(1997-8#1)(2009-3#1)(2010-12#1)(2013-8#1)
properties of recombinant##4##3##(1990-11#1)(1990-5#1)(1993-12#1)(1995-3#1)
properties of red##3##3##(1994-6#1)(2006-6#1)(2011-2#1)
properties of retinol in primary cultured##2##6##(2008-5#2)
properties of scattering##2##3##(2008-3#2)
properties of seawater##4##3##(2008-2#2)(2008-3#2)
properties of selected##3##3##(1991-5#1)(2005-11#1)(2009-7#1)
properties of several types of##2##5##(2007-12#1)(2008-2#1)
properties of several##7##3##(1991-9#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-2#1)(2008-5#1)(2009-7#1)
properties of silica##2##3##(2008-10#1)(2010-4#1)
properties of single##5##3##(1994-12#1)(1995-2#1)(1995-5#1)(2008-5#1)(2010-2#1)
properties of single-stranded##3##3##(1992-2#1)(1996-11#1)(2006-12#1)
properties of six##3##3##(1994-2#1)(1997-7#1)(2008-10#1)
properties of skin##9##3##(1990-3#2)(2008-2#1)(2008-5#5)(2009-9#1)
properties of soft##2##3##(2008-2#1)(2010-4#1)
properties of solid##2##3##(2008-10#2)
properties of some##5##3##(1995-6#1)(2008-10#1)(2008-5#1)(2009-9#1)(2010-8#1)
properties of substances##2##3##(1993-12#1)(2008-3#1)
properties of such##5##3##(1992-7#1)(1996-12#1)(2008-10#2)(2008-3#1)
properties of supercritical fluids##2##4##(2008-10#1)(2012-2#1)
properties of surfaces##3##3##(2008-10#1)(2008-7#1)(2011-11#1)
properties of synaptic##3##3##(1996-2#1)(2008-3#1)(2009-9#1)
properties of synthetic##2##3##(1993-9#1)(2013-7#1)
properties of the C-terminal region of##2##6##(1992-6#1)(1993-8#1)
properties of the Ca2+##2##4##(1994-3#1)(1995-5#1)
properties of the TiNi##2##4##(2009-7#2)
properties of the active site##2##5##(1990-5#1)(1992-6#1)
properties of the aerosol##3##4##(1992-3#1)(2008-2#1)(2008-3#1)
properties of the atmosphere##2##4##(2008-2#2)
properties of the beta##2##4##(1995-11#1)(1996-8#1)
properties of the binding##2##4##(1995-1#1)(2009-10#1)
properties of the biosensors##2##4##(2008-10#2)
properties of the bone##2##4##(2007-8#1)(2011-1#1)
properties of the cell##6##4##(1991-6#1)(1992-1#1)(1995-3#1)(2008-11#1)(2008-5#1)(2009-8#1)
properties of the cells##3##4##(2008-11#1)(2008-4#1)(2012-1#1)
properties of the channel##3##4##(1994-5#1)(1995-8#1)(2007-12#1)
properties of the collagen##2##4##(1992-6#1)(2010-8#1)
properties of the complex##2##4##(1994-5#1)(1996-2#1)
properties of the compounds##3##4##(1996-5#1)(2005-11#1)(2008-3#1)
properties of the copper##2##4##(1994-9#2)
properties of the device are##2##5##(2008-2#1)(2008-3#1)
properties of the different##2##4##(2005-11#1)(2008-10#1)
properties of the diiron##2##4##(1991-8#1)(1995-10#1)
properties of the drug##2##4##(2008-10#1)(2008-8#1)
properties of the dye##4##4##(2008-10#1)(2008-2#1)(2008-9#1)(2010-4#1)
properties of the dyes##2##4##(2008-10#1)(2008-3#1)
properties of the electrode##3##4##(2008-10#3)
properties of the endothelium##2##4##(1992-12#1)(1996-9#1)
properties of the enzyme were studied##2##6##(1990-12#1)(2006-10#1)
properties of the enzyme were##3##5##(1990-12#1)(1991-5#1)(2006-10#1)
properties of the enzyme##11##4##(1990-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1995-2#1)(2006-10#1)(2007-6#1)(2009-12#2)
properties of the external##2##4##(1996-8#1)(2007-11#1)
properties of the fabricated##2##4##(2008-4#1)(2013-1#1)
properties of the fiber##2##4##(2007-11#1)(2007-8#1)
properties of the films were##2##5##(2008-10#1)(2008-3#1)
properties of the films##4##4##(2008-10#2)(2008-3#1)(2009-11#1)
properties of the final##3##4##(2004-9#1)(2005-11#1)(2008-7#1)
properties of the flow##2##4##(2008-3#1)(2008-6#1)
properties of the flower##2##4##(2009-12#2)
properties of the glass##2##4##(2008-3#2)
properties of the hair##3##4##(2008-5#3)
properties of the head##2##4##(1990-9#1)(2007-1#1)
properties of the human##6##4##(1990-7#1)(2006-11#1)(2007-1#1)(2007-4#1)(2008-3#1)(2009-8#1)
properties of the implant##2##4##(2007-8#2)
properties of the lung##2##4##(1991-12#1)(1994-12#1)
properties of the mammalian##2##4##(1992-7#1)(2005-11#1)
properties of the material##3##4##(2006-4#1)(2007-11#1)(2008-2#1)
properties of the materials##2##4##(2008-3#1)(2008-5#1)
properties of the medium##2##4##(1996-4#1)(2008-3#1)
properties of the membrane##7##4##(1991-2#1)(1992-6#1)(1993-8#1)(2008-10#2)(2009-5#1)(2012-2#1)
properties of the mixed##2##4##(2005-11#1)(2007-11#1)
properties of the model##4##4##(1993-9#1)(1994-12#1)(1997-8#1)(2008-6#1)
properties of the modified##2##4##(2005-11#1)(2008-10#1)
properties of the molecule##3##4##(1990-9#1)(1994-9#1)(2008-11#1)
properties of the molecules##2##4##(1996-8#1)(2006-10#1)
properties of the mutant##3##4##(1991-2#1)(1992-3#1)(2013-8#1)
properties of the native##3##4##(1993-8#1)(1994-11#1)(2008-10#1)
properties of the nervous system##2##5##(1997-6#1)(1997-7#1)
properties of the new##4##4##(1992-10#1)(2005-7#1)(2005-8#1)(2007-8#1)
properties of the newly##2##4##(2008-10#1)(2010-11#1)
properties of the optical##2##4##(2008-2#1)(2008-3#1)
properties of the outer##2##4##(1992-6#1)(1997-7#1)
properties of the peptide##2##4##(1994-11#1)(1995-12#1)
properties of the polymer##2##4##(2008-10#1)(2013-1#1)
properties of the polymeric##2##4##(1996-8#1)(2007-11#1)
properties of the porous##3##4##(2005-11#1)(2008-5#1)(2010-8#1)
properties of the product##2##4##(1991-11#1)(2008-6#1)
properties of the proposed estimators are established##2##7##(2010-11#1)(2010-2#1)
properties of the proposed estimators are##3##6##(2010-11#1)(2010-2#2)
properties of the proposed##7##4##(1990-9#1)(2008-3#1)(2009-12#1)(2010-11#1)(2010-2#2)(2012-3#1)
properties of the protein##5##4##(1991-2#1)(1991-7#1)(1995-12#1)(1995-8#1)(1996-1#1)
properties of the proteins##2##4##(2008-8#1)(2013-8#1)
properties of the purified##3##4##(1991-7#1)(2005-11#1)(2008-8#1)
properties of the random##2##4##(1993-12#1)(2007-12#1)
properties of the resin##2##4##(2008-10#2)
properties of the resulting##6##4##(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-6#1)(2010-4#1)
properties of the sample##2##4##(2008-3#1)(2008-7#1)
properties of the scaffolds##3##4##(2009-7#3)
properties of the silica##2##4##(2008-10#2)
properties of the stratum corneum##3##5##(2008-5#3)
properties of the structure##2##4##(2007-12#1)(2012-2#1)
properties of the surface##3##4##(1996-5#1)(2007-12#1)(2008-3#1)
properties of the system##4##4##(2005-11#1)(2006-10#2)(2010-4#1)
properties of the three##4##4##(1993-9#1)(2008-10#1)(2008-5#1)(2008-7#1)
properties of the tissue##4##4##(2004-9#1)(2006-6#1)(2007-12#1)(2008-2#1)
properties of the transition state##3##5##(1996-11#3)
properties of the tumor##3##4##(2008-2#2)(2010-3#1)
properties of the two##7##4##(1990-12#1)(1992-8#1)(1995-7#1)(1996-1#1)(1996-11#1)(1997-2#1)(2008-10#1)
properties of the whole##3##4##(2008-5#1)(2009-4#1)(2009-9#1)
properties of the wild-type enzyme##2##5##(1990-8#1)(1992-3#1)
properties of the wild-type##3##4##(1990-8#1)(1992-3#1)(2008-6#1)
properties of the yeast##3##4##(1993-8#1)(1996-2#1)(1996-3#1)
properties of the##696##3##(1990-1#1)(1990-12#4)(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#3)(1990-7#4)(1990-8#5)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#6)(1991-3#3)(1991-4#4)(1991-5#4)(1991-6#3)(1991-7#6)(1991-8#2)(1992-1#4)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#4)(1992-3#5)(1992-5#1)(1992-6#7)(1992-7#2)(1992-8#2)(1992-9#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-8#8)(1993-9#4)(1994-11#5)(1994-12#6)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#9)(1995-1#3)(1995-10#4)(1995-11#4)(1995-12#2)(1995-2#6)(1995-3#3)(1995-4#1)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#4)(1996-1#3)(1996-10#1)(1996-11#6)(1996-12#1)(1996-2#4)(1996-3#4)(1996-4#2)(1996-5#2)(1996-7#1)(1996-8#8)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#3)(1997-6#3)(1997-7#4)(1997-8#1)(2004-12#1)(2004-4#1)(2004-9#5)(2005-10#2)(2005-11#26)(2005-4#3)(2005-7#1)(2005-8#1)(2006-10#9)(2006-11#5)(2006-12#4)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2007-1#4)(2007-10#2)(2007-11#17)(2007-12#20)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#7)(2007-9#3)(2008-1#5)(2008-10#51)(2008-11#10)(2008-12#1)(2008-2#43)(2008-3#49)(2008-4#7)(2008-5#27)(2008-6#9)(2008-7#7)(2008-8#5)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#6)(2009-2#4)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#11)(2009-8#5)(2009-9#3)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#5)(2010-3#1)(2010-4#10)(2010-5#2)(2010-6#2)(2010-8#5)(2011-1#4)(2011-2#10)(2012-1#4)(2012-11#1)(2012-12#5)(2012-2#11)(2012-3#3)(2013-1#12)(2013-7#2)(2013-8#7)
properties of their##5##3##(1994-12#1)(1997-4#1)(2008-5#2)(2013-7#1)
properties of these complexes##2##4##(2009-3#1)(2010-7#1)
properties of these compounds##6##4##(1990-7#1)(1992-3#1)(1993-4#1)(1993-6#1)(2008-10#1)(2009-5#1)
properties of these films##2##4##(2005-11#1)(2007-11#1)
properties of these structures##2##4##(1991-11#1)(2007-11#1)
properties of these systems##3##4##(2008-3#1)(2008-7#1)(2008-8#1)
properties of these two types of##2##6##(2008-4#1)(2008-5#1)
properties of these two##3##4##(2008-4#1)(2008-5#2)
properties of these##67##3##(1990-3#1)(1990-4#1)(1990-7#3)(1991-11#2)(1991-12#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-4#1)(1993-6#1)(1994-4#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-6#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#3)(2006-10#2)(2007-11#4)(2007-12#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#2)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-12#3)(2010-2#2)(2010-5#1)(2010-7#1)
properties of thin##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2009-4#1)
properties of this cell##2##4##(2008-11#1)(2008-5#1)
properties of this class of##2##5##(1997-6#1)(2008-1#1)
properties of this compound##2##4##(2008-10#1)(2013-1#1)
properties of this enzyme##2##4##(1992-12#1)(2008-6#1)
properties of this plant##2##4##(2011-2#1)(2012-12#1)
properties of this protein##2##4##(1992-11#1)(1994-11#1)
properties of this##46##3##(1991-10#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-11#2)(1994-8#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-6#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)
properties of three##9##3##(1992-2#1)(1992-5#1)(1993-9#1)(1995-7#1)(2005-11#1)(2008-10#3)(2008-3#1)
properties of tissue##3##3##(2008-3#2)(2010-8#1)
properties of tissues##4##3##(1997-5#1)(2008-2#1)(2008-3#1)(2010-4#1)
properties of titanium##2##3##(2009-7#2)
properties of transmission##2##3##(2007-11#1)(2008-3#1)
properties of trypsin immobilized on##2##5##(1997-2#2)
properties of turbid##3##3##(2007-12#2)(2008-3#1)
properties of two##14##3##(1991-5#1)(1994-6#1)(1995-5#1)(1997-7#1)(2005-11#1)(2005-4#1)(2007-12#1)(2008-10#4)(2008-5#1)(2011-1#1)(2012-2#1)
properties of two-layer turbid media##2##5##(2008-3#2)
properties of two-layer##4##3##(2008-3#4)
properties of type-II ATP diphosphohydrolase##2##5##(1992-12#2)
properties of various##4##3##(1992-7#1)(1993-5#1)(2008-11#1)(2008-8#1)
properties of vertebrate##2##3##(1993-11#1)(2012-3#1)
properties of water##3##3##(1992-9#1)(2006-10#1)(2008-2#1)
properties of waterborne##2##3##(2010-4#2)
properties of wild type##2##4##(1997-7#1)(2005-12#1)
properties of##2353##2##(1990-1#1)(1990-10#1)(1990-11#5)(1990-12#8)(1990-2#11)(1990-3#8)(1990-4#6)(1990-5#6)(1990-6#3)(1990-7#16)(1990-8#14)(1990-9#3)(1991-1#7)(1991-10#8)(1991-11#9)(1991-12#10)(1991-2#14)(1991-3#7)(1991-4#8)(1991-5#15)(1991-6#5)(1991-7#9)(1991-8#8)(1991-9#4)(1992-1#4)(1992-10#1)(1992-11#4)(1992-12#8)(1992-2#9)(1992-3#14)(1992-4#5)(1992-5#7)(1992-6#16)(1992-7#9)(1992-8#9)(1992-9#8)(1993-1#1)(1993-11#11)(1993-12#10)(1993-2#2)(1993-3#4)(1993-4#3)(1993-5#2)(1993-6#4)(1993-7#2)(1993-8#10)(1993-9#12)(1994-10#2)(1994-11#16)(1994-12#12)(1994-2#5)(1994-3#8)(1994-4#1)(1994-5#10)(1994-6#7)(1994-8#18)(1994-9#17)(1995-1#7)(1995-10#6)(1995-11#8)(1995-12#8)(1995-2#14)(1995-3#9)(1995-4#2)(1995-5#12)(1995-6#10)(1995-7#3)(1995-8#10)(1995-9#1)(1996-1#9)(1996-10#8)(1996-11#8)(1996-12#4)(1996-2#10)(1996-3#9)(1996-4#5)(1996-5#12)(1996-6#3)(1996-7#8)(1996-8#13)(1996-9#5)(1997-1#5)(1997-2#9)(1997-3#4)(1997-4#11)(1997-5#5)(1997-6#13)(1997-7#14)(1997-8#8)(2004-1#1)(2004-12#5)(2004-2#2)(2004-4#1)(2004-9#18)(2005-10#4)(2005-11#79)(2005-12#1)(2005-3#1)(2005-4#9)(2005-7#3)(2005-8#9)(2005-9#1)(2006-10#30)(2006-11#8)(2006-12#17)(2006-2#4)(2006-3#1)(2006-4#3)(2006-5#5)(2006-6#5)(2006-7#4)(2006-8#1)(2006-9#1)(2007-1#6)(2007-10#9)(2007-11#73)(2007-12#87)(2007-2#3)(2007-4#10)(2007-5#5)(2007-6#3)(2007-7#2)(2007-8#15)(2007-9#17)(2008-1#22)(2008-10#167)(2008-11#31)(2008-12#4)(2008-2#148)(2008-3#185)(2008-4#31)(2008-5#100)(2008-6#19)(2008-7#37)(2008-8#26)(2008-9#19)(2009-10#5)(2009-11#6)(2009-12#11)(2009-2#13)(2009-3#9)(2009-4#7)(2009-5#9)(2009-6#1)(2009-7#30)(2009-8#20)(2009-9#8)(2010-1#7)(2010-10#4)(2010-11#5)(2010-12#10)(2010-2#11)(2010-3#3)(2010-4#35)(2010-5#8)(2010-6#4)(2010-7#7)(2010-8#12)(2010-9#2)(2011-1#12)(2011-11#1)(2011-12#2)(2011-2#27)(2012-1#18)(2012-11#3)(2012-12#19)(2012-2#39)(2012-3#12)(2012-8#1)(2013-1#29)(2013-7#11)(2013-8#30)
properties on the##14##3##(1992-12#1)(1993-4#1)(1995-8#1)(1997-1#1)(2005-4#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-5#3)(2011-2#1)
properties on##27##2##(1992-12#1)(1993-4#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-1#1)(2005-4#1)(2006-10#1)(2007-9#1)(2008-10#3)(2008-2#3)(2008-3#2)(2008-5#4)(2008-7#2)(2009-12#1)(2009-7#1)(2011-2#1)(2013-8#1)
properties only##2##2##(1994-12#1)(2008-5#1)
properties or##5##2##(1993-4#1)(2007-6#1)(2007-9#1)(2008-11#1)(2008-4#1)
properties over a wide##2##4##(2005-11#1)(2008-2#1)
properties over a##3##3##(2005-11#1)(2006-12#1)(2008-2#1)
properties over the##2##3##(2007-12#1)(2008-11#1)
properties over##6##2##(2005-11#1)(2006-12#1)(2007-12#1)(2008-11#1)(2008-2#1)(2010-4#1)
properties pertinent to##2##3##(1995-1#2)
properties provide the##2##3##(1994-11#1)(2012-1#1)
properties provide##5##2##(1994-11#1)(1997-7#1)(2008-5#1)(2012-1#1)(2012-2#1)
properties related to the##2##4##(2008-10#1)(2010-4#1)
properties related to##6##3##(2007-9#1)(2008-10#2)(2008-7#1)(2009-2#1)(2010-4#1)
properties relevant for##2##3##(2008-5#1)(2011-2#1)
properties relevant##4##2##(2008-11#1)(2008-2#1)(2008-5#1)(2011-2#1)
properties required for##2##3##(1997-4#1)(2008-5#1)
properties resulting from##2##3##(1990-5#1)(2010-8#1)
properties revealed##2##2##(1990-5#1)(1996-8#1)
properties show##2##2##(2010-4#1)(2012-2#1)
properties showed##2##2##(2008-11#1)(2010-4#1)
properties similar to the##2##4##(1996-12#1)(2009-7#1)
properties similar to those of the##5##6##(1990-5#1)(1991-5#1)(1995-10#1)(1996-7#1)(2007-12#1)
properties similar to those of##11##5##(1990-5#1)(1990-7#1)(1991-1#1)(1991-5#1)(1995-1#1)(1995-10#1)(1996-7#1)(2007-12#1)(2008-10#1)(2008-3#2)
properties similar to those##13##4##(1990-5#1)(1990-7#1)(1991-1#1)(1991-5#1)(1995-1#1)(1995-10#1)(1996-7#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-3#2)(2009-12#1)
properties similar to##19##3##(1990-5#1)(1990-7#1)(1991-1#1)(1991-5#1)(1991-6#1)(1995-1#1)(1995-10#1)(1996-12#1)(1996-7#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-3#2)(2009-11#1)(2009-12#1)(2009-7#1)(2010-9#1)
properties similar##20##2##(1990-5#1)(1990-7#1)(1991-1#1)(1991-5#1)(1991-6#1)(1992-11#1)(1995-1#1)(1995-10#1)(1996-12#1)(1996-7#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-3#2)(2009-11#1)(2009-12#1)(2009-7#1)(2010-9#1)
properties studied##2##2##(2008-10#1)(2008-3#1)
properties such as##24##3##(1990-3#1)(1991-12#1)(1991-3#1)(1993-2#1)(1993-4#1)(1995-2#1)(1997-6#1)(2006-12#1)(2006-7#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-1#1)
properties suggest that##3##3##(1993-8#1)(2011-2#1)(2013-1#1)
properties suggest##4##2##(1993-8#1)(1994-10#1)(2011-2#1)(2013-1#1)
properties suitable for##2##3##(2008-10#2)
properties superior to those of##2##5##(2007-11#1)(2007-12#1)
properties than##2##2##(2008-10#1)(2008-11#1)
properties that act##2##3##(2008-1#1)(2008-10#1)
properties that are not##2##4##(2007-8#1)(2012-1#1)
properties that are typical##2##4##(2008-2#1)(2008-7#1)
properties that are unique and##2##5##(2008-8#1)(2009-10#1)
properties that are##19##3##(1990-3#1)(1992-3#1)(1992-9#1)(1995-3#1)(1995-8#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-8#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2012-1#1)
properties that can be##5##4##(2007-12#2)(2007-9#1)(2008-7#1)(2012-12#1)
properties that closely##2##3##(1991-9#1)(2009-7#1)
properties that could##2##3##(2005-7#1)(2008-7#1)
properties that distinguish##3##3##(1991-6#1)(1995-10#1)(2006-10#1)
properties that have been##2##4##(2008-3#1)(2008-9#1)
properties that may##3##3##(1994-8#1)(1996-8#1)(2008-7#1)
properties that##58##2##(1990-3#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-9#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-8#1)(1996-8#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-7#2)(2006-10#4)(2006-12#2)(2007-11#1)(2007-12#5)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#1)(2012-1#3)(2012-12#1)(2012-2#3)
properties this##3##2##(2006-4#1)(2008-11#1)(2008-2#1)
properties through the##2##3##(1993-11#1)(2008-10#1)
properties through##6##2##(1991-4#1)(1992-1#1)(1993-11#1)(2006-6#1)(2008-10#1)(2011-2#1)
properties to a##2##3##(1991-3#1)(2008-6#1)
properties to be used as##2##5##(2008-10#1)(2010-8#1)
properties to be##6##3##(1990-9#1)(1991-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-8#1)
properties to the##8##3##(1991-5#1)(1993-12#1)(2007-4#1)(2008-5#1)(2010-12#1)(2010-4#2)(2011-2#1)
properties to##39##2##(1990-7#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-9#1)(1993-12#1)(1995-5#1)(1996-8#1)(1997-4#1)(1997-6#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-12#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)
properties towards##9##2##(1990-2#1)(1991-3#1)(1993-4#2)(2007-1#1)(2008-10#3)(2010-5#1)
properties typical of##3##3##(2008-3#2)(2012-2#1)
properties typical##4##2##(2006-10#1)(2008-3#2)(2012-2#1)
properties under##3##2##(2007-11#1)(2008-3#1)(2010-4#1)
properties upon##2##2##(2008-2#1)(2010-7#1)
properties used in##2##3##(1996-2#1)(2013-7#1)
properties used##3##2##(1996-2#1)(2007-4#1)(2013-7#1)
properties using##6##2##(1994-12#1)(1996-5#1)(1997-6#1)(2008-2#1)(2008-8#1)(2009-11#1)
properties very similar to those of##2##6##(1993-6#1)(1994-11#1)
properties very##3##2##(1993-6#1)(1994-11#1)(2008-8#1)
properties via##2##2##(1994-12#1)(2011-1#1)
properties was observed##2##3##(1991-3#1)(2008-7#1)
properties was studied##2##3##(1996-11#1)(2008-3#1)
properties was##16##2##(1990-12#1)(1991-3#1)(1996-11#1)(1996-2#1)(1997-6#1)(2005-11#1)(2006-12#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-2#1)
properties were also##2##3##(2008-10#1)(2010-11#1)
properties were analyzed##2##3##(1995-1#1)(2007-8#1)
properties were characterized by the##2##5##(1991-8#1)(2008-2#1)
properties were characterized by##3##4##(1991-8#1)(2005-10#1)(2008-2#1)
properties were characterized##5##3##(1990-3#1)(1991-8#1)(2005-10#1)(2008-11#1)(2008-2#1)
properties were compared##4##3##(1997-1#1)(2004-9#1)(2008-8#1)(2010-4#1)
properties were confirmed##2##3##(1991-2#1)(2008-5#1)
properties were considered##2##3##(1997-8#1)(2008-7#1)
properties were described##2##3##(1993-12#1)(2008-10#1)
properties were determined by##3##4##(1995-8#1)(2005-11#1)(2008-5#1)
properties were determined##9##3##(1995-8#1)(1997-2#1)(2005-11#1)(2007-4#1)(2008-5#2)(2010-12#1)(2010-4#1)(2012-2#1)
properties were established##2##3##(2008-10#2)
properties were evaluated by##2##4##(2008-10#1)(2011-2#1)
properties were evaluated##5##3##(2008-10#2)(2008-5#1)(2010-4#1)(2011-2#1)
properties were examined with##2##4##(1995-11#1)(2009-7#1)
properties were examined##7##3##(1991-9#1)(1994-12#1)(1995-11#1)(1996-4#1)(2008-2#1)(2009-7#1)(2010-8#1)
properties were found##2##3##(2008-3#1)(2011-2#1)
properties were investigated in##2##4##(1994-11#1)(2004-9#1)
properties were investigated##4##3##(1990-3#1)(1993-3#1)(1994-11#1)(2004-9#1)
properties were measured using##2##4##(2009-7#1)(2010-4#1)
properties were measured##5##3##(1995-3#1)(2008-3#1)(2009-7#1)(2010-10#1)(2010-4#1)
properties were observed##4##3##(1995-3#1)(2004-9#1)(2007-4#1)(2010-4#1)
properties were similar to those of the##2##7##(1993-9#1)(2011-2#1)
properties were similar to those of##3##6##(1993-9#1)(1995-8#1)(2011-2#1)
properties were studied##7##3##(1990-3#1)(1993-4#1)(2005-11#2)(2010-4#1)(2012-2#1)(2013-1#1)
properties were unaltered##2##3##(1990-4#1)(2006-12#1)
properties were##93##2##(1990-3#3)(1990-4#1)(1991-2#1)(1991-7#1)(1991-8#1)(1991-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-3#2)(1995-8#2)(1996-4#1)(1997-1#2)(1997-2#2)(1997-8#1)(2004-9#3)(2005-10#1)(2005-11#3)(2006-11#1)(2006-12#1)(2007-11#1)(2007-4#3)(2007-8#2)(2008-10#7)(2008-11#2)(2008-2#6)(2008-3#3)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#6)(2010-7#1)(2010-8#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
properties when compared to##2##4##(1993-6#1)(2004-9#1)
properties when##6##2##(1993-6#1)(2004-9#1)(2007-5#1)(2008-4#1)(2008-6#1)(2009-11#1)
properties which may be##2##4##(2007-1#1)(2010-4#1)
properties which may##4##3##(2007-1#1)(2008-5#2)(2010-4#1)
properties which##11##2##(1994-8#2)(2005-8#1)(2007-1#1)(2008-11#1)(2008-5#2)(2009-3#1)(2010-4#1)(2010-6#1)(2013-1#1)
properties will##2##2##(2008-5#1)(2010-4#1)
properties with a##4##3##(1997-1#1)(2008-10#2)(2008-9#1)
properties with age##2##3##(1991-10#1)(2008-5#1)
properties with respect to##5##4##(1990-12#2)(1995-9#1)(2008-2#1)(2008-3#1)
properties with the##8##3##(1993-11#1)(1996-2#1)(1996-9#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#1)
properties with those of##2##4##(1990-11#1)(1997-6#1)
properties with##43##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-7#1)(1991-10#1)(1991-8#1)(1992-12#1)(1993-11#1)(1995-9#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-6#1)(2006-10#1)(2007-11#3)(2007-5#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#2)(2008-9#2)(2009-12#1)(2009-8#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
properties##4953##1##(1990-1#3)(1990-10#2)(1990-11#11)(1990-12#16)(1990-2#20)(1990-3#19)(1990-4#10)(1990-5#17)(1990-6#5)(1990-7#32)(1990-8#23)(1990-9#8)(1991-1#11)(1991-10#14)(1991-11#13)(1991-12#21)(1991-2#28)(1991-3#16)(1991-4#18)(1991-5#26)(1991-6#8)(1991-7#16)(1991-8#15)(1991-9#12)(1992-1#10)(1992-10#2)(1992-11#9)(1992-12#17)(1992-2#13)(1992-3#18)(1992-4#8)(1992-5#9)(1992-6#25)(1992-7#15)(1992-8#15)(1992-9#17)(1993-1#2)(1993-11#19)(1993-12#19)(1993-2#10)(1993-3#7)(1993-4#16)(1993-5#3)(1993-6#8)(1993-7#3)(1993-8#25)(1993-9#18)(1994-10#5)(1994-11#22)(1994-12#23)(1994-2#9)(1994-3#14)(1994-4#2)(1994-5#16)(1994-6#10)(1994-8#36)(1994-9#30)(1995-1#13)(1995-10#11)(1995-11#19)(1995-12#15)(1995-2#27)(1995-3#25)(1995-4#2)(1995-5#22)(1995-6#17)(1995-7#6)(1995-8#19)(1995-9#2)(1996-1#17)(1996-10#11)(1996-11#11)(1996-12#10)(1996-2#27)(1996-3#13)(1996-4#10)(1996-5#23)(1996-6#5)(1996-7#13)(1996-8#19)(1996-9#7)(1997-1#12)(1997-2#25)(1997-3#10)(1997-4#21)(1997-5#10)(1997-6#28)(1997-7#24)(1997-8#12)(2004-1#1)(2004-11#1)(2004-12#9)(2004-2#2)(2004-4#1)(2004-8#1)(2004-9#34)(2005-1#1)(2005-10#9)(2005-11#127)(2005-12#3)(2005-3#1)(2005-4#11)(2005-7#12)(2005-8#21)(2005-9#3)(2006-1#1)(2006-10#63)(2006-11#22)(2006-12#47)(2006-2#8)(2006-3#1)(2006-4#8)(2006-5#13)(2006-6#12)(2006-7#8)(2006-8#1)(2006-9#1)(2007-1#17)(2007-10#12)(2007-11#133)(2007-12#138)(2007-2#4)(2007-4#28)(2007-5#11)(2007-6#15)(2007-7#5)(2007-8#35)(2007-9#37)(2008-1#50)(2008-10#338)(2008-11#88)(2008-12#14)(2008-2#290)(2008-3#368)(2008-4#62)(2008-5#237)(2008-6#46)(2008-7#103)(2008-8#55)(2008-9#38)(2009-10#17)(2009-11#21)(2009-12#31)(2009-2#28)(2009-3#21)(2009-4#19)(2009-5#21)(2009-6#8)(2009-7#65)(2009-8#40)(2009-9#14)(2010-1#15)(2010-10#14)(2010-11#14)(2010-12#30)(2010-2#21)(2010-3#7)(2010-4#95)(2010-5#24)(2010-6#9)(2010-7#30)(2010-8#31)(2010-9#14)(2011-1#48)(2011-11#2)(2011-12#6)(2011-2#73)(2011-3#3)(2012-1#43)(2012-11#20)(2012-12#46)(2012-2#95)(2012-3#23)(2012-8#1)(2012-9#1)(2013-1#80)(2013-7#17)(2013-8#55)
properties)##5##1##(2006-12#1)(2007-6#1)(2008-2#1)(2008-3#1)(2008-5#1)
properties/activities##3##1##(2007-11#2)(2013-1#1)
properties?##3##1##(2010-7#2)(2012-2#1)
property and the##3##3##(1993-9#1)(2006-8#1)(2008-5#1)
property and##13##2##(1993-9#1)(2006-4#1)(2006-8#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-8#1)(2013-7#1)(2013-8#1)
property appears to##2##3##(1991-5#1)(2008-2#1)
property can be##3##3##(2008-2#1)(2011-2#1)(2012-2#1)
property changes of##2##3##(2008-2#1)(2008-5#1)
property changes##5##2##(2008-2#1)(2008-5#1)(2009-10#1)(2011-1#2)
property dispute in favour of##2##5##(2010-12#2)
property for##4##2##(2005-4#1)(2007-2#1)(2008-10#2)
property has been##3##3##(1990-8#1)(1996-2#1)(2008-8#1)
property has led to the development of##2##7##(2008-12#1)(2008-2#1)
property has led to the##3##5##(2008-12#1)(2008-2#1)(2008-9#1)
property has##6##2##(1990-8#1)(1996-2#1)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#1)
property in the##2##3##(2011-2#1)(2012-3#1)
property in##7##2##(1993-11#1)(2008-2#2)(2008-3#1)(2010-1#1)(2011-2#1)(2012-3#1)
property is the##2##3##(1996-1#1)(2008-9#1)
property is unclear##2##3##(1993-2#1)(2012-1#1)
property is##12##2##(1990-12#1)(1990-8#1)(1993-2#1)(1996-1#1)(1997-2#1)(2008-2#2)(2008-3#1)(2008-7#2)(2008-9#1)(2012-1#1)
property loss up to##2##4##(2011-1#2)
property makes##2##2##(2008-9#1)(2010-4#1)
property may##7##2##(1991-5#1)(1994-12#1)(1996-8#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-5#1)
property means that##2##3##(2008-3#1)(2010-1#1)
property measurements of turbid media##2##5##(2007-12#1)(2008-3#1)
property measurements of##3##3##(2007-12#1)(2008-3#2)
property measurements##5##2##(1995-2#1)(2007-12#1)(2008-2#1)(2008-3#2)
property of MT##2##3##(1996-12#2)
property of a##12##3##(1991-11#1)(1991-12#1)(1991-9#1)(2005-10#1)(2005-4#1)(2007-12#2)(2008-2#2)(2008-3#3)
property of an##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
property of being##2##3##(2008-10#1)(2008-11#1)
property of curcumin##2##3##(2006-10#1)(2008-11#1)
property of dopamine##2##3##(2008-10#2)
property of the channel##2##4##(1997-4#1)(2005-11#1)
property of the##59##3##(1990-2#1)(1990-8#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-9#1)(1994-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-4#2)(2005-11#2)(2006-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2007-9#3)(2008-10#2)(2008-11#2)(2008-2#5)(2008-3#6)(2008-5#3)(2008-7#1)(2009-1#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
property of these##4##3##(2007-12#1)(2008-10#2)(2009-10#1)
property of this##5##3##(1990-7#1)(1992-12#1)(1996-2#1)(1996-5#1)(2008-3#1)
property of##194##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-7#1)(1990-8#2)(1991-10#2)(1991-11#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#3)(1995-6#2)(1995-8#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#2)(1997-1#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#2)(2005-12#2)(2005-4#1)(2006-10#3)(2006-4#1)(2007-11#6)(2007-12#9)(2007-8#2)(2007-9#4)(2008-1#3)(2008-10#10)(2008-11#8)(2008-12#1)(2008-2#13)(2008-3#14)(2008-5#7)(2008-7#2)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-4#5)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
property on##2##2##(2006-4#1)(2012-2#1)
property rights in##4##3##(1997-8#2)(2006-3#1)(2007-4#1)
property rights##11##2##(1997-8#2)(2006-3#1)(2006-7#1)(2006-8#1)(2007-4#1)(2007-7#1)(2008-6#1)(2012-3#3)
property tax exemption##2##3##(1992-6#2)
property that the##2##3##(2006-5#1)(2007-11#1)
property that was##2##3##(1994-3#1)(1995-12#1)
property that##11##2##(1990-7#1)(1990-8#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-5#1)(2006-5#1)(2007-11#1)(2008-2#1)(2008-5#1)(2012-2#1)
property to##9##2##(1994-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2010-4#1)(2012-2#1)
property values for##2##3##(2007-6#1)(2008-10#1)
property was##8##2##(1990-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-1#1)(2013-8#1)
property we##2##2##(1991-11#1)(1997-4#1)
property were##2##2##(2005-4#1)(2010-4#1)
property with##2##2##(2005-7#1)(2008-10#1)
property##452##1##(1990-11#3)(1990-12#2)(1990-2#3)(1990-6#1)(1990-7#3)(1990-8#5)(1990-9#1)(1991-10#2)(1991-11#2)(1991-12#1)(1991-5#4)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#4)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#3)(1994-11#2)(1994-12#1)(1994-3#6)(1994-5#2)(1994-6#7)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#5)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#2)(1996-8#3)(1997-1#2)(1997-2#2)(1997-4#4)(1997-6#2)(1997-7#4)(1997-8#3)(2004-11#1)(2005-10#2)(2005-11#3)(2005-12#2)(2005-4#3)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-4#3)(2006-5#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-11#12)(2007-12#18)(2007-2#1)(2007-3#1)(2007-4#4)(2007-6#2)(2007-7#1)(2007-8#4)(2007-9#5)(2008-1#5)(2008-10#29)(2008-11#18)(2008-12#5)(2008-2#31)(2008-3#29)(2008-4#2)(2008-5#22)(2008-6#4)(2008-7#8)(2008-8#5)(2008-9#4)(2009-1#1)(2009-10#2)(2009-2#2)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#4)(2010-10#3)(2010-12#5)(2010-4#8)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#8)(2011-2#9)(2012-1#4)(2012-12#1)(2012-2#9)(2012-3#7)(2013-1#3)(2013-7#1)(2013-8#6)
prophage encoded##2##2##(2011-2#2)
prophage excision and##2##3##(2011-1#2)
prophage excision##3##2##(2011-1#3)
prophage##15##1##(1990-11#2)(1990-8#1)(1990-9#1)(1993-9#1)(1995-2#1)(1996-12#1)(2011-1#4)(2011-2#4)
prophages##3##1##(1993-9#1)(1997-3#1)(2011-1#1)
prophase I and##2##3##(2011-2#1)(2013-8#1)
prophase I in##2##3##(2013-8#2)
prophase I##9##2##(2008-5#2)(2011-2#3)(2013-7#1)(2013-8#3)
prophase and##2##2##(2007-12#1)(2008-5#1)
prophase spindle##3##2##(2009-10#3)
prophase##32##1##(1990-8#1)(1991-5#1)(1992-11#1)(1997-1#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-12#3)(2008-11#2)(2008-4#1)(2008-5#4)(2008-7#1)(2009-10#6)(2009-12#1)(2011-2#3)(2013-7#1)(2013-8#3)
prophenoloxidase activation in##2##3##(1990-3#2)
prophenoloxidase activation##4##2##(1990-3#3)(2007-12#1)
prophenoloxidase##9##1##(1990-3#6)(1997-2#2)(2007-12#1)
prophylactic HPV##2##2##(2006-10#1)(2008-3#1)
prophylactic Sotalol##2##2##(2007-8#2)
prophylactic TBA##3##2##(2006-11#3)
prophylactic administration of steroids##2##4##(2007-8#2)
prophylactic administration of##7##3##(1990-10#1)(2007-11#1)(2007-8#2)(2008-7#1)(2012-1#2)
prophylactic agents##3##2##(2008-5#1)(2008-7#1)(2013-1#1)
prophylactic analgesic##2##2##(2011-2#2)
prophylactic and therapeutic##6##3##(1990-2#1)(1993-5#1)(1995-5#1)(2010-11#1)(2011-2#2)
prophylactic and##9##2##(1990-2#1)(1992-3#1)(1993-5#1)(1995-5#1)(2007-9#1)(2008-10#1)(2010-11#1)(2011-2#2)
prophylactic antibiotics for the prevention of##2##6##(2007-12#1)(2009-5#1)
prophylactic antibiotics to##2##3##(2008-3#1)(2009-5#1)
prophylactic antibiotics##12##2##(1994-2#1)(2006-10#2)(2007-12#1)(2007-2#1)(2008-3#1)(2008-7#2)(2009-5#3)(2009-8#1)
prophylactic antimicrobials##2##2##(1990-6#1)(2012-3#1)
prophylactic beta-blockers##3##2##(2007-8#3)
prophylactic cholecystectomy in##2##3##(1993-3#1)(2006-10#1)
prophylactic cholecystectomy##4##2##(1993-3#3)(2006-10#1)
prophylactic cranial irradiation##3##3##(1995-8#1)(1995-9#1)(2004-1#1)
prophylactic decompression##2##2##(2006-11#1)(2008-5#1)
prophylactic drugs##2##2##(2009-9#1)(2011-1#1)
prophylactic effect##6##2##(1997-3#1)(1997-4#1)(2005-7#1)(2006-5#1)(2007-11#2)
prophylactic effects of##3##3##(1993-12#2)(2010-12#1)
prophylactic efficacy of##3##3##(2006-12#1)(2009-12#1)(2010-4#1)
prophylactic efficacy##5##2##(2006-12#1)(2007-11#1)(2009-12#1)(2010-4#1)(2013-1#1)
prophylactic haemofiltration during cardiopulmonary bypass##2##5##(2007-8#2)
prophylactic infusion of saline into the epidural space##2##8##(1993-10#2)
prophylactic magnesium reduces the incidence of##2##6##(2007-8#2)
prophylactic measure##3##2##(1994-2#1)(2006-10#2)
prophylactic measures##9##2##(1991-11#1)(1992-9#1)(1993-5#1)(2006-10#2)(2007-2#1)(2008-9#1)(2009-10#1)(2010-4#1)
prophylactic or therapeutic##2##3##(2012-1#1)(2013-8#1)
prophylactic role##2##2##(2006-2#1)(2007-8#1)
prophylactic strategies##3##2##(2006-10#1)(2007-11#1)(2010-7#1)
prophylactic therapies##3##2##(2006-10#1)(2008-3#1)(2013-1#1)
prophylactic therapy##10##2##(1990-2#1)(1990-5#1)(1995-9#1)(2007-10#1)(2007-11#3)(2007-2#1)(2008-3#1)(2009-5#1)
prophylactic tranexamic acid##2##3##(2007-8#2)
prophylactic treatment in##2##3##(2007-6#1)(2011-1#1)
prophylactic treatment of##4##3##(1990-7#1)(1993-5#1)(2007-10#1)(2008-7#1)
prophylactic treatment with##2##3##(2006-10#1)(2007-2#1)
prophylactic treatment##10##2##(1990-3#1)(1990-7#1)(1993-5#1)(2006-10#1)(2007-10#2)(2007-2#1)(2007-6#1)(2008-7#1)(2011-1#1)
prophylactic treatments##3##2##(1996-11#1)(2008-5#1)(2011-2#1)
prophylactic use of dexamethasone##2##4##(1992-11#2)
prophylactic use of##9##3##(1990-5#1)(1992-11#2)(1992-12#1)(2006-10#2)(2010-11#1)(2010-7#2)
prophylactic use##10##2##(1990-5#1)(1992-11#2)(1992-12#1)(2005-12#1)(2006-10#2)(2010-11#1)(2010-7#2)
prophylactic vaccine##2##2##(2007-11#1)(2011-1#1)
prophylactic vaccines are##2##3##(2010-12#2)
prophylactic vaccines##5##2##(1994-2#1)(2007-11#1)(2010-12#2)(2011-1#1)
prophylactic##232##1##(1990-10#1)(1990-12#1)(1990-2#4)(1990-3#1)(1990-5#2)(1990-6#2)(1990-7#1)(1991-11#2)(1991-2#2)(1991-9#1)(1992-11#2)(1992-12#4)(1992-3#1)(1992-8#1)(1992-9#1)(1993-10#2)(1993-12#2)(1993-3#4)(1993-5#4)(1994-2#5)(1994-6#2)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#2)(1996-11#1)(1997-3#1)(1997-4#1)(2004-1#1)(2005-12#3)(2005-7#1)(2006-10#18)(2006-11#4)(2006-12#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-10#3)(2007-11#12)(2007-12#2)(2007-2#4)(2007-6#1)(2007-7#1)(2007-8#18)(2007-9#1)(2008-1#2)(2008-10#9)(2008-3#6)(2008-5#5)(2008-7#10)(2008-8#1)(2008-9#2)(2009-10#4)(2009-12#1)(2009-3#1)(2009-5#5)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#3)(2010-12#4)(2010-2#1)(2010-4#2)(2010-7#4)(2011-1#6)(2011-12#4)(2011-2#13)(2012-1#4)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#8)(2013-8#1)
prophylactically and##2##2##(1997-7#1)(2008-10#1)
prophylactically##18##1##(1990-3#1)(1993-3#1)(1994-3#1)(1997-7#1)(2006-12#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#2)
prophylactics of##3##2##(1993-3#2)(2009-2#1)
prophylaxis (to##2##2##(2008-3#2)
prophylaxis after acute myocardial infarction##2##5##(1990-9#1)(1993-8#1)
prophylaxis after total##2##3##(2008-8#1)(2011-2#1)
prophylaxis after##9##2##(1990-2#1)(1990-9#1)(1991-11#2)(1991-8#1)(1993-8#1)(2008-7#1)(2008-8#1)(2011-2#1)
prophylaxis against cytomegalovirus##4##3##(1996-10#3)(2007-7#1)
prophylaxis against##18##2##(1990-9#2)(1993-10#1)(1995-5#1)(1996-10#3)(2006-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-3#1)(2008-7#2)(2009-8#1)(2013-8#1)
prophylaxis among##2##2##(1996-12#1)(2013-1#1)
prophylaxis and therapy of candidiasis##3##5##(2008-5#3)
prophylaxis and therapy of##4##4##(2007-8#1)(2008-5#3)
prophylaxis and therapy##6##3##(2007-8#1)(2008-5#3)(2013-1#2)
prophylaxis and treatment of##11##4##(1990-4#1)(1990-6#1)(1992-2#1)(1993-2#1)(2005-8#1)(2006-10#2)(2007-12#1)(2008-11#1)(2010-12#1)(2013-1#1)
prophylaxis and treatment##17##3##(1990-4#1)(1990-6#1)(1992-12#1)(1992-2#1)(1993-2#1)(1996-11#1)(2005-8#1)(2006-10#3)(2007-12#1)(2007-2#1)(2007-9#1)(2008-11#1)(2010-12#1)(2013-1#2)
prophylaxis and##40##2##(1990-10#1)(1990-4#1)(1990-6#1)(1992-10#1)(1992-12#1)(1992-2#1)(1993-2#1)(1995-8#1)(1996-11#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-8#1)(2007-12#1)(2007-2#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-3#2)(2009-8#1)(2010-12#1)(2010-8#1)(2013-1#5)
prophylaxis are##2##2##(1995-7#1)(2011-2#1)
prophylaxis can be##2##3##(2008-7#1)(2011-2#1)
prophylaxis can##3##2##(2006-6#1)(2008-7#1)(2011-2#1)
prophylaxis during##3##2##(1993-10#1)(2010-11#1)(2011-1#1)
prophylaxis following sexual##2##3##(2006-9#1)(2012-3#1)
prophylaxis following##4##2##(1991-2#1)(2006-9#1)(2012-12#1)(2012-3#1)
prophylaxis for##12##2##(1992-12#1)(1993-2#1)(1997-4#1)(2005-10#1)(2006-10#2)(2006-2#1)(2006-4#2)(2006-9#1)(2012-1#1)(2012-12#1)
prophylaxis guidelines##2##2##(2006-2#1)(2010-3#1)
prophylaxis has been##2##3##(1990-10#1)(2011-2#1)
prophylaxis has##3##2##(1990-10#1)(2011-2#2)
prophylaxis have##3##2##(2008-8#1)(2009-5#1)(2012-2#1)
prophylaxis in orthopedic##2##3##(2011-2#2)
prophylaxis in patients with##2##4##(2008-8#1)(2012-12#1)
prophylaxis in reducing##2##3##(2011-1#1)(2012-12#1)
prophylaxis in surgery##3##3##(1990-6#1)(1992-6#1)(2008-8#1)
prophylaxis in this##2##3##(2008-7#1)(2008-8#1)
prophylaxis in##33##2##(1990-3#1)(1990-5#1)(1990-6#2)(1991-3#1)(1992-6#2)(1992-8#1)(1993-10#1)(2006-10#3)(2006-12#1)(2007-12#2)(2007-3#1)(2008-3#1)(2008-7#1)(2008-8#5)(2009-11#1)(2009-5#2)(2011-1#2)(2011-2#2)(2012-12#2)(2013-1#1)
prophylaxis is##13##2##(1990-11#1)(1993-5#1)(2005-10#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-1#1)(2008-8#2)(2008-9#1)(2009-1#1)
prophylaxis may be##2##3##(2007-11#1)(2011-2#1)
prophylaxis may##3##2##(2007-11#1)(2010-5#1)(2011-2#1)
prophylaxis of deep vein thrombosis##2##5##(1990-12#1)(2008-1#1)
prophylaxis of diarrhea##2##3##(1991-3#1)(1991-8#1)
prophylaxis of venous##2##3##(2010-11#1)(2012-3#1)
prophylaxis of##47##2##(1990-12#2)(1990-2#1)(1990-7#2)(1991-3#1)(1991-5#1)(1991-8#1)(2005-1#1)(2005-3#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-6#2)(2006-8#1)(2007-11#7)(2007-12#1)(2007-8#3)(2008-1#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-8#2)(2010-11#1)(2010-3#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-8#1)
prophylaxis on##3##2##(1993-7#2)(2012-6#1)
prophylaxis or##2##2##(2007-2#1)(2011-2#1)
prophylaxis should be considered##3##4##(1993-7#1)(2006-10#1)(2009-5#1)
prophylaxis should be##4##3##(1993-7#1)(2006-10#1)(2008-8#1)(2009-5#1)
prophylaxis significantly reduced##2##3##(2008-7#1)(2012-12#1)
prophylaxis to prevent##4##3##(2008-1#1)(2009-8#1)(2012-11#1)(2013-1#1)
prophylaxis was##7##2##(1993-10#1)(1996-4#1)(2006-8#1)(2007-8#1)(2011-2#2)(2013-1#1)
prophylaxis which##2##2##(1990-3#1)(1992-6#1)
prophylaxis with##16##2##(1990-11#1)(1990-6#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-5#1)(1993-5#1)(1997-6#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-7#1)(2010-2#1)(2011-2#2)
prophylaxis##352##1##(1990-10#2)(1990-11#2)(1990-12#4)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#4)(1990-7#2)(1990-9#5)(1991-11#2)(1991-2#1)(1991-3#3)(1991-5#2)(1991-8#2)(1992-10#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#4)(1992-8#1)(1992-9#2)(1993-10#4)(1993-11#1)(1993-2#2)(1993-5#4)(1993-7#3)(1993-8#1)(1994-6#1)(1995-5#1)(1995-7#3)(1995-8#1)(1995-9#1)(1996-10#3)(1996-11#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-6#2)(2005-1#1)(2005-10#5)(2005-3#1)(2005-7#2)(2005-8#1)(2006-10#20)(2006-12#1)(2006-2#3)(2006-4#5)(2006-6#3)(2006-8#7)(2006-9#2)(2007-10#1)(2007-11#20)(2007-12#10)(2007-2#10)(2007-3#1)(2007-7#3)(2007-8#13)(2007-9#1)(2008-1#5)(2008-10#3)(2008-11#2)(2008-3#5)(2008-4#2)(2008-5#10)(2008-6#1)(2008-7#13)(2008-8#13)(2008-9#3)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#6)(2009-7#1)(2009-8#5)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#2)(2010-5#2)(2010-6#2)(2010-8#1)(2011-1#3)(2011-2#21)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#8)(2012-3#4)(2012-6#1)(2013-1#13)(2013-7#1)(2013-8#4)
prophylaxis)##2##1##(2011-2#1)(2012-12#1)
prophylaxis]##5##1##(1990-2#1)(1990-5#1)(1992-12#1)(1992-2#1)(1993-2#1)
propiconazole resistance##2##2##(2008-10#2)
propiconazole sensitivity##3##2##(2008-10#3)
propiconazole##14##1##(2008-10#14)
propidium iodide (PI)##6##3##(1995-7#1)(2008-4#1)(2008-9#4)
propidium iodide staining##2##3##(2008-9#1)(2013-1#1)
propidium iodide was##2##3##(2008-11#2)
propidium iodide##22##2##(1992-8#2)(1994-2#1)(1995-7#1)(1996-6#1)(2006-5#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-9#6)(2009-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
propidium with RNA##3##3##(1992-3#3)
propidium##33##1##(1992-3#5)(1992-8#2)(1994-2#1)(1995-11#2)(1995-7#1)(1996-6#1)(1997-3#1)(2006-5#1)(2008-10#1)(2008-11#3)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#6)(2009-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
propiece##2##1##(1990-12#1)(1997-6#1)
propiolate##3##1##(2007-11#1)(2008-4#2)
propionate and acetate##2##3##(1991-1#1)(2006-8#1)
propionate and butyrate##3##3##(2006-8#3)
propionate and##6##2##(1991-1#1)(1992-4#1)(2006-8#4)
propionate on##2##2##(2010-8#1)(2013-8#1)
propionate##42##1##(1990-11#1)(1990-5#1)(1991-1#2)(1991-12#1)(1992-4#2)(1992-9#2)(1993-2#1)(1994-12#2)(1995-2#1)(1996-1#1)(1996-10#1)(1996-2#2)(2006-8#9)(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-5#2)(2010-8#1)(2013-8#2)
propionate)##3##1##(1993-3#1)(2007-7#1)(2007-8#1)
propionibacteria##6##1##(1993-2#1)(2011-2#5)
propionic acid and##2##3##(2007-11#1)(2011-2#1)
propionic acid##27##2##(1993-12#1)(1994-2#1)(1995-11#1)(1995-3#2)(2004-8#2)(2006-8#9)(2007-11#2)(2008-10#1)(2008-5#2)(2008-7#3)(2011-2#3)
propionic bacteria##2##2##(2013-1#2)
propionic##38##1##(1991-5#1)(1993-12#1)(1994-2#1)(1995-11#1)(1995-3#2)(2004-8#2)(2005-11#1)(2006-8#9)(2007-11#3)(2008-10#5)(2008-5#2)(2008-7#3)(2011-2#4)(2013-1#3)
propionyl-CoA##5##1##(1991-12#4)(1992-9#1)
propionylcarnitine##2##1##(1991-12#1)(1996-8#1)
propiverine and##5##2##(2008-10#5)
propiverine##8##1##(2008-10#8)
proplatelet##2##1##(2012-12#2)
propofol (Diprivan)##2##2##(1992-6#1)(1992-8#1)
propofol TIVA##2##2##(2011-2#1)(2013-7#1)
propofol and thiopentone##3##3##(1996-6#3)
propofol and##10##2##(1996-6#3)(2006-10#1)(2009-6#1)(2011-2#3)(2012-12#1)(2012-2#1)
propofol for##3##2##(1992-8#1)(2006-10#1)(2010-7#1)
propofol in##5##2##(1990-6#1)(1992-6#1)(1992-8#1)(1993-2#1)(2013-7#1)
propofol infusion##4##2##(1993-1#1)(2006-10#1)(2010-7#1)(2013-7#1)
propofol is##2##2##(2010-8#1)(2011-2#1)
propofol on##2##2##(1995-3#1)(2012-12#1)
propofol or a combination of ketamine and diazepam##2##8##(2013-1#2)
propofol or a##3##3##(2009-6#1)(2013-1#2)
propofol or##5##2##(2006-10#1)(2009-6#1)(2013-1#3)
propofol total intravenous anesthesia (TIVA)##2##5##(2011-2#1)(2013-7#1)
propofol total intravenous anesthesia##3##4##(2011-2#1)(2013-7#2)
propofol with##3##2##(2010-7#2)(2011-2#1)
propofol##81##1##(1990-3#1)(1990-6#1)(1992-6#4)(1992-8#4)(1993-1#2)(1993-2#2)(1995-12#1)(1995-3#4)(1996-6#4)(2006-10#11)(2007-7#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#3)(2010-7#9)(2010-8#1)(2011-2#9)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#7)(2013-8#2)
propofol-based sedation regimens administered during colonoscopy##2##6##(2013-8#2)
propofol-based##3##1##(2011-2#1)(2013-8#2)
propolis (bee glue)##3##3##(2006-8#3)
propolis and##2##2##(2008-10#2)
propolis in##2##2##(2008-10#2)
propolis is##2##2##(2008-10#2)
propolis on##2##2##(2008-10#1)(2008-11#1)
propolis##29##1##(2006-8#5)(2008-10#16)(2008-11#5)(2008-7#1)(2011-2#1)(2013-1#1)
propolis's##2##1##(2008-10#2)
proponent of##3##2##(1995-6#1)(2007-2#2)
proponents and opponents##2##3##(1994-1#1)(2007-4#1)
proponents of a##2##3##(2007-11#1)(2008-6#1)
proponents of##7##2##(2006-10#1)(2006-7#1)(2007-11#1)(2008-6#1)(2009-2#1)(2009-6#1)(2012-3#1)
proponents##14##1##(1992-2#1)(1994-1#1)(1996-5#1)(2006-10#2)(2006-7#2)(2007-11#1)(2007-4#1)(2008-6#1)(2009-2#2)(2009-6#1)(2012-3#1)
proportion among##2##2##(1990-9#1)(2011-1#1)
proportion and##5##2##(1990-4#2)(2008-10#1)(2012-3#1)(2013-1#1)
proportion as##2##2##(1991-2#1)(2011-2#1)
proportion decreased##2##2##(2006-8#1)(2008-11#1)
proportion in the##7##3##(1990-4#1)(1997-7#1)(2004-2#1)(2006-12#1)(2006-8#1)(2007-4#1)(2008-10#1)
proportion in##12##2##(1990-4#1)(1994-5#1)(1994-8#1)(1997-7#1)(2004-2#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-4#1)(2008-10#2)(2012-3#1)
proportion of 0##2##3##(2008-10#2)
proportion of 1##3##3##(1997-1#1)(2007-5#1)(2008-5#1)
proportion of ELBW##3##3##(2006-7#2)(2006-8#1)
proportion of HIV##2##3##(1995-12#1)(2007-7#1)
proportion of HIV-infected##3##3##(1990-11#1)(2007-7#1)(2010-12#1)
proportion of IDUs##2##3##(2012-3#2)
proportion of P##4##3##(2008-10#3)(2010-8#1)
proportion of R##2##3##(1995-3#1)(2008-10#1)
proportion of admissions##2##3##(1990-12#1)(2006-2#1)
proportion of adolescents with a very negative body image##2##9##(2007-12#2)
proportion of adolescents with a very##3##6##(2007-12#3)
proportion of adolescents with##4##4##(1993-3#1)(2007-12#3)
proportion of affected##5##3##(1992-9#2)(2007-7#1)(2008-2#1)(2008-5#1)
proportion of all##5##3##(1996-8#1)(2005-10#1)(2008-7#1)(2010-9#1)(2012-1#1)
proportion of alpha##3##3##(1994-3#1)(2012-2#2)
proportion of alpha-tocopherol##2##3##(2006-10#2)
proportion of an##2##3##(1992-3#1)(2010-2#1)
proportion of animals##2##3##(1992-9#1)(2008-4#1)
proportion of asymptomatic##2##3##(1990-3#1)(2006-2#1)
proportion of beta-structure##2##3##(1991-9#1)(2008-7#1)
proportion of blossoms##2##3##(2008-10#2)
proportion of breast cancer patients are##2##6##(2008-4#1)(2009-2#1)
proportion of breast cancer##3##4##(1994-9#1)(2008-4#1)(2009-2#1)
proportion of cases with##2##4##(2007-11#1)(2013-8#1)
proportion of cases##13##3##(1990-2#1)(1991-11#1)(1992-10#1)(1995-6#1)(1996-5#1)(2007-11#1)(2008-5#1)(2010-12#1)(2011-2#3)(2013-8#2)
proportion of cells in the S and##2##7##(1994-3#1)(2008-11#1)
proportion of cells in the##3##5##(1992-5#1)(1994-3#1)(2008-11#1)
proportion of cells in##6##4##(1992-5#1)(1993-11#1)(1993-9#1)(1994-3#1)(1996-6#1)(2008-11#1)
proportion of cells with##2##4##(1992-7#1)(1994-8#1)
proportion of cells##14##3##(1992-5#1)(1992-7#1)(1993-11#2)(1993-9#1)(1994-3#1)(1994-8#1)(1996-6#1)(1997-4#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-3#1)
proportion of chicks##2##3##(1990-3#1)(2008-6#1)
proportion of children under five##2##5##(2011-2#2)
proportion of children who##3##4##(2006-10#1)(2006-8#1)(2008-2#1)
proportion of children with##3##4##(1996-11#1)(2005-7#1)(2006-8#1)
proportion of children##12##3##(1993-1#1)(1996-11#1)(2005-7#1)(2006-10#1)(2006-8#2)(2006-9#1)(2008-2#2)(2011-2#2)(2012-2#1)
proportion of clinical##2##3##(1990-3#1)(2010-11#1)
proportion of correct know responses##2##5##(2008-9#2)
proportion of correct remember responses and##2##6##(2008-9#2)
proportion of correct##4##3##(2008-9#4)
proportion of deaths##6##3##(1991-3#1)(2005-11#1)(2006-2#2)(2008-9#1)(2011-1#1)
proportion of differentially expressed genes##3##5##(2012-2#3)
proportion of disease##3##3##(2008-10#3)
proportion of diseased##7##3##(2008-10#7)
proportion of elderly patients##2##4##(2007-7#1)(2008-7#1)
proportion of elderly##4##3##(2006-8#1)(2007-7#1)(2008-7#2)
proportion of embryos developing to the blastocyst stage##2##8##(2006-5#1)(2008-11#1)
proportion of embryos##4##3##(1996-8#1)(2006-5#2)(2008-11#1)
proportion of errors in##2##4##(1995-8#1)(1996-2#1)
proportion of events##2##3##(2007-7#2)
proportion of ewes##2##3##(2008-3#2)
proportion of female##2##3##(1994-5#1)(2012-3#1)
proportion of free##2##3##(2006-10#2)
proportion of genetic variance##2##4##(2013-8#2)
proportion of genetic##4##3##(1995-6#2)(2013-8#2)
proportion of helix##2##3##(1997-4#2)
proportion of hospital##2##3##(2006-4#1)(2012-2#1)
proportion of households##2##3##(2006-4#1)(2011-1#1)
proportion of human##2##3##(2006-8#1)(2008-1#1)
proportion of individuals with##4##4##(2007-8#1)(2008-10#1)(2011-2#1)(2012-3#1)
proportion of individuals##6##3##(2007-8#1)(2008-10#1)(2008-8#1)(2011-2#2)(2012-3#1)
proportion of infants##2##3##(1992-4#1)(1995-6#1)
proportion of isolates##4##3##(2006-5#1)(2008-10#3)
proportion of medical##2##3##(2006-10#1)(2008-7#1)
proportion of missing##2##3##(1994-5#1)(2007-10#1)
proportion of mummy berries##2##4##(2008-10#2)
proportion of neurons##4##3##(1991-3#1)(1991-7#1)(2008-7#1)(2009-2#1)
proportion of newly##3##3##(1995-12#1)(1996-4#1)(2013-1#1)
proportion of normal sperm##2##4##(2008-12#1)(2008-5#1)
proportion of older adults##2##4##(2011-1#1)(2012-12#1)
proportion of older people##2##4##(2008-1#1)(2013-8#1)
proportion of older##4##3##(2008-1#1)(2011-1#1)(2012-12#1)(2013-8#1)
proportion of other clinically relevant findings##2##6##(2011-2#2)
proportion of patients in##3##4##(2005-7#1)(2006-8#1)(2012-3#1)
proportion of patients is##2##4##(2011-2#1)(2013-1#1)
proportion of patients on##2##4##(2008-1#1)(2010-12#1)
proportion of patients requiring ventilator treatment##2##6##(2006-10#2)
proportion of patients requiring##3##4##(2006-10#2)(2007-11#1)
proportion of patients who##6##4##(1995-4#1)(2006-9#1)(2007-10#1)(2007-8#1)(2008-7#1)(2009-8#1)
proportion of patients with chronic##3##5##(2006-8#2)(2007-7#1)
proportion of patients with##33##4##(1991-5#1)(1992-10#1)(1992-5#1)(1994-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#2)(2006-8#2)(2007-10#1)(2007-11#1)(2007-7#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#3)
proportion of patients##81##3##(1991-4#2)(1991-5#1)(1992-10#1)(1992-5#1)(1994-4#1)(1995-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#3)(2005-7#1)(2006-10#3)(2006-12#1)(2006-8#4)(2006-9#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-5#2)(2007-7#4)(2007-8#1)(2007-9#2)(2008-1#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#2)(2009-11#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-8#5)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#3)
proportion of people##4##3##(1994-2#1)(1996-1#1)(2008-4#1)(2013-1#1)
proportion of pseudosclerotia##3##3##(2008-10#3)
proportion of recombinant offspring##2##4##(2012-3#2)
proportion of seed##2##3##(2008-10#1)(2013-8#1)
proportion of sink habitat##2##4##(2008-8#2)
proportion of smokers##2##3##(1991-10#1)(1994-5#1)
proportion of strains##2##3##(1997-7#1)(2010-4#1)
proportion of students##2##3##(2013-1#2)
proportion of subjects##5##3##(1997-1#1)(2008-3#1)(2010-12#1)(2012-2#2)
proportion of susceptible host##2##4##(2008-10#2)
proportion of the cases##2##4##(2006-4#1)(2008-1#1)
proportion of the maximum SS rate##2##6##(1990-10#2)
proportion of the maximum##3##4##(1990-10#3)
proportion of the patients##2##4##(1996-9#1)(2007-7#1)
proportion of the population##6##4##(1997-1#1)(2007-12#1)(2008-10#1)(2009-12#1)(2009-4#1)(2012-12#1)
proportion of the sample##3##4##(1995-12#1)(2006-7#2)
proportion of the total##14##4##(1994-1#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2010-2#1)(2010-5#1)(2013-8#1)
proportion of the vaccinated##2##4##(1994-11#1)(2007-2#1)
proportion of the##118##3##(1990-10#3)(1990-12#1)(1990-6#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-7#2)(1991-9#2)(1992-2#1)(1992-6#1)(1992-7#2)(1993-2#1)(1993-3#2)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-9#1)(1996-9#2)(1997-1#1)(1997-5#1)(2004-1#1)(2004-11#1)(2004-2#1)(2006-10#1)(2006-4#1)(2006-7#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#3)(2008-12#1)(2008-2#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#4)
proportion of their##3##3##(1992-12#2)(2008-3#1)
proportion of them##3##3##(2006-7#1)(2008-11#1)(2011-2#1)
proportion of these patients##2##4##(2007-7#1)(2013-7#1)
proportion of these##6##3##(1995-11#1)(1997-8#1)(2007-7#2)(2010-11#1)(2013-7#1)
proportion of this##2##3##(2011-2#1)(2012-3#1)
proportion of those##5##3##(1990-6#1)(1997-6#1)(2006-10#1)(2008-6#1)(2010-8#1)
proportion of time spent##4##4##(2008-8#1)(2011-2#1)(2012-2#2)
proportion of time##5##3##(1991-11#1)(2008-8#1)(2011-2#1)(2012-2#2)
proportion of total##18##3##(1990-11#1)(1990-5#1)(1991-5#1)(1995-3#2)(2005-10#3)(2007-8#2)(2008-10#3)(2008-8#2)(2010-11#1)(2010-12#1)(2012-2#1)
proportion of treatment##2##3##(1991-12#1)(2007-11#1)
proportion of true##2##3##(1991-6#1)(1996-12#1)
proportion of tumor cells in##2##5##(1990-4#1)(1991-4#1)
proportion of tumor cells##3##4##(1990-4#2)(1991-4#1)
proportion of ubiquinol-10##3##3##(1997-2#3)
proportion of untreated patients##2##4##(2008-3#1)(2013-8#1)
proportion of variation##2##3##(1992-2#1)(2008-8#1)
proportion of women##8##3##(1991-8#1)(1992-2#1)(1993-4#1)(1993-8#1)(1994-2#1)(2007-12#1)(2009-7#1)(2012-3#1)
proportion of##878##2##(1990-10#8)(1990-11#4)(1990-12#5)(1990-2#4)(1990-3#4)(1990-4#2)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#6)(1991-2#1)(1991-3#5)(1991-4#4)(1991-5#3)(1991-6#2)(1991-7#3)(1991-8#1)(1991-9#6)(1992-10#2)(1992-11#1)(1992-12#6)(1992-2#4)(1992-3#1)(1992-4#3)(1992-5#2)(1992-6#1)(1992-7#8)(1992-8#1)(1992-9#5)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#5)(1993-4#1)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#6)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#9)(1994-2#6)(1994-3#4)(1994-4#1)(1994-5#3)(1994-6#2)(1994-8#2)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#5)(1995-12#5)(1995-2#4)(1995-3#6)(1995-4#2)(1995-5#2)(1995-6#7)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#5)(1996-2#2)(1996-3#2)(1996-4#6)(1996-5#3)(1996-6#3)(1996-7#2)(1996-8#3)(1996-9#3)(1997-1#8)(1997-2#5)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#4)(1997-7#5)(1997-8#2)(2004-1#1)(2004-11#8)(2004-12#1)(2004-2#2)(2005-10#5)(2005-11#1)(2005-7#4)(2006-10#16)(2006-12#1)(2006-2#5)(2006-3#1)(2006-4#3)(2006-5#8)(2006-6#1)(2006-7#5)(2006-8#11)(2006-9#2)(2007-10#3)(2007-11#7)(2007-12#12)(2007-2#6)(2007-3#3)(2007-4#1)(2007-5#4)(2007-7#20)(2007-8#15)(2007-9#4)(2008-1#7)(2008-10#94)(2008-11#19)(2008-12#6)(2008-2#8)(2008-3#9)(2008-4#12)(2008-5#19)(2008-6#9)(2008-7#19)(2008-8#26)(2008-9#15)(2009-11#1)(2009-12#3)(2009-2#4)(2009-3#1)(2009-4#2)(2009-5#5)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#4)(2010-12#6)(2010-2#3)(2010-3#1)(2010-4#10)(2010-5#1)(2010-6#1)(2010-8#11)(2010-9#1)(2011-1#10)(2011-2#38)(2012-1#3)(2012-11#2)(2012-12#10)(2012-2#21)(2012-3#24)(2013-1#24)(2013-7#6)(2013-8#18)
proportion reporting##2##2##(2013-1#2)
proportion tested##2##2##(2012-3#2)
proportion to the amount of##2##5##(1990-4#1)(2008-4#1)
proportion to the concentration of##8##5##(1991-8#2)(1994-8#1)(2008-10#4)(2010-3#1)
proportion to the square root of##2##6##(2005-11#1)(2008-10#1)
proportion to the##34##3##(1990-3#2)(1990-4#1)(1990-8#1)(1991-8#2)(1992-6#1)(1994-8#1)(1996-6#1)(1996-7#1)(1996-9#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2010-3#1)
proportion to their##3##3##(1990-11#1)(2007-12#1)(2008-8#1)
proportion to##50##2##(1990-11#1)(1990-3#2)(1990-4#2)(1990-8#1)(1991-8#2)(1992-6#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-3#1)(1996-6#1)(1996-7#1)(1996-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-7#1)(2010-3#1)
proportion was##2##2##(2008-6#1)(2013-8#1)
proportion who##2##2##(1996-8#1)(2012-12#1)
proportion with the##2##3##(2008-10#1)(2009-7#1)
proportion with##4##2##(1991-10#1)(1996-8#1)(2008-10#1)(2009-7#1)
proportion##1043##1##(1990-10#8)(1990-11#5)(1990-12#6)(1990-2#4)(1990-3#6)(1990-4#8)(1990-5#1)(1990-6#3)(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-10#3)(1991-11#2)(1991-12#6)(1991-2#2)(1991-3#5)(1991-4#4)(1991-5#3)(1991-6#3)(1991-7#3)(1991-8#3)(1991-9#7)(1992-10#2)(1992-11#1)(1992-12#7)(1992-2#4)(1992-3#2)(1992-4#3)(1992-5#2)(1992-6#2)(1992-7#8)(1992-8#1)(1992-9#5)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#5)(1993-4#1)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#6)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#11)(1994-2#6)(1994-3#4)(1994-4#1)(1994-5#5)(1994-6#3)(1994-8#5)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#6)(1995-12#5)(1995-2#4)(1995-3#7)(1995-4#2)(1995-5#2)(1995-6#7)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#6)(1996-2#2)(1996-3#2)(1996-4#6)(1996-5#3)(1996-6#4)(1996-7#3)(1996-8#6)(1996-9#4)(1997-1#9)(1997-2#6)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#5)(1997-7#6)(1997-8#2)(2004-1#1)(2004-11#8)(2004-12#1)(2004-2#3)(2004-9#1)(2005-10#6)(2005-11#2)(2005-4#1)(2005-7#4)(2005-8#1)(2006-10#17)(2006-11#1)(2006-12#4)(2006-2#5)(2006-3#1)(2006-4#3)(2006-5#8)(2006-6#1)(2006-7#7)(2006-8#14)(2006-9#3)(2007-10#3)(2007-11#10)(2007-12#13)(2007-2#6)(2007-3#5)(2007-4#2)(2007-5#5)(2007-6#1)(2007-7#26)(2007-8#16)(2007-9#4)(2008-1#8)(2008-10#110)(2008-11#23)(2008-12#8)(2008-2#11)(2008-3#11)(2008-4#14)(2008-5#23)(2008-6#11)(2008-7#24)(2008-8#28)(2008-9#16)(2009-11#1)(2009-12#4)(2009-2#5)(2009-3#1)(2009-4#2)(2009-5#5)(2009-6#1)(2009-7#4)(2009-8#5)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#5)(2010-12#8)(2010-2#4)(2010-3#3)(2010-4#14)(2010-5#1)(2010-6#1)(2010-8#13)(2010-9#1)(2011-1#13)(2011-2#42)(2012-1#4)(2012-11#2)(2012-12#11)(2012-2#22)(2012-3#32)(2012-6#1)(2013-1#29)(2013-7#6)(2013-8#22)
proportion)##2##1##(2008-4#1)(2008-5#1)
proportional changes in##2##3##(2007-11#1)(2007-7#1)
proportional control##2##2##(2010-2#1)(2012-1#1)
proportional equations##3##2##(2008-10#3)
proportional hazard (PH)##2##3##(1996-12#1)(1997-3#1)
proportional hazard model##7##3##(2007-6#1)(2008-3#1)(2010-8#1)(2011-1#1)(2012-2#3)
proportional hazard##17##2##(1995-8#2)(1996-12#1)(1997-3#4)(2007-10#1)(2007-6#1)(2008-3#1)(2008-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#3)
proportional hazards analysis##2##3##(1997-8#1)(2007-8#1)
proportional hazards model and##2##4##(1994-2#1)(2010-8#1)
proportional hazards model for##2##4##(2007-10#1)(2010-7#1)
proportional hazards model##19##3##(1993-5#1)(1994-2#2)(1995-4#2)(1996-11#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-8#2)(2007-10#1)(2007-9#1)(2008-10#1)(2009-5#1)(2010-6#1)(2010-7#1)(2010-8#1)
proportional hazards models were used to##3##6##(1995-8#1)(2009-6#1)(2012-2#1)
proportional hazards models##5##3##(1995-6#1)(1995-8#1)(2009-6#1)(2009-8#1)(2012-2#1)
proportional hazards regression models##2##4##(1994-5#1)(2011-2#1)
proportional hazards regression##7##3##(1993-5#1)(1994-5#1)(2011-2#2)(2013-1#3)
proportional hazards##41##2##(1993-5#2)(1994-2#2)(1994-5#2)(1995-4#2)(1995-6#2)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#3)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)
proportional increase in##2##3##(2008-11#1)(2008-9#1)
proportional odds model##2##3##(2007-8#1)(2010-8#1)
proportional odds##3##2##(1997-2#1)(2007-8#1)(2010-8#1)
proportional rate##2##2##(1992-7#1)(1995-2#1)
proportional systematic error##2##3##(2008-10#2)
proportional to PEG##2##3##(2004-12#2)
proportional to a##4##3##(1991-8#1)(2007-11#1)(2008-5#1)(2011-1#1)
proportional to each##2##3##(2006-1#1)(2013-7#1)
proportional to its##2##3##(2008-10#1)(2008-2#1)
proportional to logarithm of##2##4##(2008-10#2)
proportional to scan##2##3##(2007-11#1)(2008-10#1)
proportional to that of##3##4##(1992-12#1)(1992-9#1)(2008-10#1)
proportional to the absorption##3##4##(2008-10#1)(2008-3#2)
proportional to the activity##2##4##(1991-8#1)(1997-8#1)
proportional to the amount of protein##2##6##(1992-7#1)(2008-2#1)
proportional to the amount of##14##5##(1991-10#1)(1992-7#1)(1994-3#1)(1995-10#1)(1997-8#1)(2006-12#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-4#1)(2010-7#1)
proportional to the concentration of U(VI)##2##6##(2008-10#2)
proportional to the concentration of nucleic acids##2##7##(2008-10#2)
proportional to the concentration of the##4##6##(1996-12#1)(2008-10#3)
proportional to the concentration of##41##5##(1990-8#1)(1991-2#1)(1991-3#1)(1996-12#1)(2005-12#1)(2006-3#1)(2007-8#3)(2008-10#30)(2008-12#1)(2008-5#1)
proportional to the concentration##44##4##(1990-8#1)(1991-2#1)(1991-3#1)(1991-8#1)(1996-12#1)(2005-12#1)(2006-3#1)(2007-8#3)(2008-10#32)(2008-12#1)(2008-5#1)
proportional to the degree of##5##5##(1991-7#1)(1991-9#1)(2008-11#1)(2008-3#1)(2010-11#1)
proportional to the distance##2##4##(2008-2#1)(2008-3#1)
proportional to the dose##2##4##(1993-3#1)(1993-6#1)
proportional to the effective##2##4##(2006-6#1)(2008-3#1)
proportional to the external##2##4##(2008-11#1)(2008-2#1)
proportional to the first##2##4##(2008-2#2)
proportional to the intensity of##2##5##(1997-3#1)(2007-12#1)
proportional to the level of##2##5##(2008-11#1)(2012-2#1)
proportional to the magnitude of##2##5##(1993-2#1)(1994-12#1)
proportional to the mass of##2##5##(1996-3#1)(2007-8#1)
proportional to the mass##3##4##(1996-3#1)(2007-8#1)(2008-4#1)
proportional to the modulus##2##4##(2007-12#1)(2008-6#1)
proportional to the number of##10##5##(1990-10#1)(1991-8#1)(1992-8#1)(2008-10#2)(2008-2#1)(2008-3#3)(2009-6#1)
proportional to the optical##2##4##(2007-12#1)(2008-9#1)
proportional to the product of##3##5##(2008-3#2)(2008-5#1)
proportional to the relative##3##4##(2007-12#1)(2008-1#1)(2010-4#1)
proportional to the specific energy dissipation rate##2##7##(2008-7#2)
proportional to the specific##3##4##(1994-3#1)(2008-7#2)
proportional to the square of the##7##6##(2007-11#1)(2007-12#1)(2008-3#5)
proportional to the square root of the##2##7##(2007-12#1)(2008-3#1)
proportional to the square root of##3##6##(2007-12#2)(2008-3#1)
proportional to the square##10##4##(2007-11#1)(2007-12#3)(2008-3#6)
proportional to the strength of the##2##6##(2007-12#1)(2008-5#1)
proportional to the total##3##4##(1990-3#1)(2012-2#2)
proportional to the##231##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#2)(1991-8#4)(1991-9#2)(1992-1#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-12#3)(1994-3#2)(1995-10#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#3)(2004-9#2)(2005-11#3)(2005-12#1)(2006-12#1)(2006-3#1)(2006-6#1)(2007-11#4)(2007-12#10)(2007-6#1)(2007-7#1)(2007-8#9)(2008-1#2)(2008-10#69)(2008-11#4)(2008-12#1)(2008-2#13)(2008-3#29)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-11#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-2#4)(2012-3#1)(2013-8#1)
proportional to their##5##3##(1995-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)
proportional to those##2##3##(1997-7#1)(2008-5#1)
proportional to viable##3##3##(2008-11#3)
proportional to##308##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-2#3)(1991-3#1)(1991-5#1)(1991-7#2)(1991-8#5)(1991-9#2)(1992-1#1)(1992-12#1)(1992-6#1)(1992-7#3)(1992-8#1)(1992-9#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#3)(1994-3#2)(1994-6#1)(1995-10#1)(1995-3#2)(1995-8#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#3)(2004-12#2)(2004-9#2)(2005-11#4)(2005-12#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-6#1)(2007-10#1)(2007-11#8)(2007-12#14)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#11)(2008-1#2)(2008-10#86)(2008-11#8)(2008-12#1)(2008-2#17)(2008-3#31)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#10)(2008-8#4)(2008-9#4)(2009-11#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#5)(2011-2#3)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
proportional##432##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#3)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#5)(1991-9#2)(1992-1#1)(1992-12#1)(1992-6#2)(1992-7#4)(1992-8#1)(1992-9#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#4)(1995-4#2)(1995-6#2)(1995-8#5)(1996-1#2)(1996-11#1)(1996-12#3)(1996-3#1)(1996-8#2)(1997-2#4)(1997-3#7)(1997-4#2)(1997-7#1)(1997-8#6)(2004-12#2)(2004-9#3)(2005-10#1)(2005-11#4)(2005-12#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-6#1)(2007-10#4)(2007-11#9)(2007-12#15)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#3)(2007-8#14)(2007-9#1)(2008-1#2)(2008-10#100)(2008-11#9)(2008-12#4)(2008-2#17)(2008-3#35)(2008-4#2)(2008-5#9)(2008-6#2)(2008-7#11)(2008-8#7)(2008-9#5)(2009-11#3)(2009-5#1)(2009-6#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#9)(2011-2#9)(2012-1#4)(2012-12#1)(2012-2#8)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
proportionality between the##2##3##(2007-12#1)(2011-1#1)
proportionality between##4##2##(1991-4#1)(2007-12#1)(2011-1#1)(2013-1#1)
proportionality in punitive damages awards##2##5##(1992-3#2)
proportionality##12##1##(1991-4#2)(1992-3#2)(1997-8#1)(2005-11#1)(2007-12#1)(2008-2#1)(2011-1#2)(2012-11#1)(2013-1#1)
proportionally greater##3##2##(1995-3#1)(1996-6#1)(2006-10#1)
proportionally more##4##2##(1991-6#1)(2006-7#1)(2008-4#1)(2011-2#1)
proportionally to the##7##3##(1995-12#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)
proportionally to##9##2##(1995-12#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-9#1)(2012-2#1)
proportionally with the##3##3##(2005-11#1)(2008-10#1)(2008-3#1)
proportionally with##6##2##(1990-5#1)(1993-3#1)(1993-7#1)(2005-11#1)(2008-10#1)(2008-3#1)
proportionally##31##1##(1990-5#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-7#1)(1993-3#1)(1993-7#1)(1995-12#1)(1995-3#1)(1995-7#1)(1996-6#1)(2005-11#1)(2006-10#2)(2006-7#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-4#1)(2010-7#1)(2011-2#1)(2012-2#1)
proportionate sample##2##2##(2007-7#1)(2008-11#1)
proportionate to the##3##3##(1993-1#1)(2005-8#1)(2008-7#1)
proportionate##10##1##(1991-5#1)(1993-1#2)(1995-8#1)(1996-12#1)(2005-8#1)(2007-7#1)(2008-11#1)(2008-7#1)(2012-12#1)
proportionately as##2##2##(1997-1#1)(2007-12#1)
proportionately less##2##2##(1991-5#1)(1997-8#1)
proportionately more##2##2##(2008-6#1)(2010-3#1)
proportionately with##2##2##(1994-3#1)(2008-10#1)
proportionately##14##1##(1990-12#1)(1990-5#1)(1991-1#1)(1991-5#1)(1992-3#1)(1994-3#1)(1995-12#1)(1997-1#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-6#1)(2010-3#1)
proportions (0##2##2##(1996-11#1)(2012-1#1)
proportions among##2##2##(2008-1#1)(2013-7#1)
proportions and##12##2##(1990-12#1)(1990-3#1)(1991-11#1)(1995-12#1)(2006-12#1)(2007-2#1)(2008-1#1)(2008-10#2)(2013-1#3)
proportions are##3##2##(1995-8#1)(2006-1#1)(2012-3#1)
proportions by##3##2##(1994-5#1)(2008-10#2)
proportions in the##9##3##(1996-7#1)(2006-10#1)(2007-5#1)(2008-5#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-4#1)(2013-8#1)
proportions in##15##2##(1993-4#1)(1994-6#1)(1996-7#1)(2006-10#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-5#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-4#1)(2013-1#1)(2013-8#1)
proportions of 0##2##3##(2008-10#2)
proportions of affected relatives##2##4##(1992-9#2)
proportions of affected##3##3##(1992-9#3)
proportions of cholestanol##2##3##(1992-6#2)
proportions of different##3##3##(1991-9#1)(2007-2#1)(2013-8#1)
proportions of oocytes##5##3##(2006-5#5)
proportions of patients##3##3##(1992-11#1)(2004-11#1)(2008-8#1)
proportions of the##17##3##(1992-2#1)(1992-6#1)(1994-10#1)(2005-10#1)(2007-10#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-7#2)(2010-4#1)(2012-3#1)(2013-8#1)
proportions of##112##2##(1990-12#2)(1990-2#2)(1990-3#1)(1991-10#2)(1991-12#1)(1991-8#1)(1991-9#2)(1992-11#2)(1992-2#1)(1992-3#1)(1992-6#4)(1992-9#3)(1993-1#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-4#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-6#2)(2004-11#2)(2005-10#1)(2005-12#1)(2006-10#1)(2006-2#2)(2006-4#1)(2006-5#6)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-10#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#6)(2010-5#1)(2011-2#2)(2012-2#4)(2012-3#5)(2013-8#6)
proportions to##4##2##(1990-12#1)(1996-12#1)(1997-6#1)(2013-8#1)
proportions were##6##2##(1991-1#1)(2005-10#1)(2008-10#2)(2011-2#1)(2013-8#1)
proportions with##3##2##(1995-9#1)(2008-10#1)(2011-1#1)
proportions##234##1##(1990-11#1)(1990-12#4)(1990-2#2)(1990-3#2)(1990-7#1)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#2)(1991-9#4)(1992-11#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#6)(1992-9#3)(1993-1#1)(1993-4#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-6#6)(1997-7#1)(2004-11#2)(2004-2#2)(2005-10#2)(2005-12#2)(2006-1#1)(2006-10#5)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#7)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#5)(2007-2#3)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#6)(2008-10#30)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#2)(2009-10#1)(2009-3#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#7)(2010-5#2)(2010-9#1)(2011-1#1)(2011-12#3)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#8)(2013-1#6)(2013-7#1)(2013-8#10)
proposal and##4##2##(1992-2#1)(2007-12#1)(2007-9#1)(2012-2#1)
proposal are##2##2##(1993-3#1)(1995-8#1)
proposal by##3##2##(1993-6#1)(2008-1#1)(2008-3#1)
proposal for a##11##3##(1993-11#1)(1994-6#1)(1996-12#1)(2006-6#1)(2006-7#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-8#1)
proposal for the##3##3##(1991-12#1)(2007-1#1)(2007-8#1)
proposal for##28##2##(1991-12#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-2#1)(1994-1#1)(1994-6#1)(1995-1#1)(1996-12#1)(2005-5#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-8#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
proposal in##3##2##(1995-6#1)(2006-8#1)(2008-10#1)
proposal includes##2##2##(1992-2#1)(2008-10#1)
proposal is based on##2##4##(1993-12#1)(2005-5#1)
proposal is that the##2##4##(1991-4#1)(1997-8#1)
proposal is##10##2##(1991-4#1)(1992-2#1)(1992-5#1)(1993-12#1)(1994-12#1)(1996-2#1)(1996-3#1)(1997-8#1)(2005-5#1)(2012-1#1)
proposal of a##7##3##(2006-10#1)(2006-11#1)(2008-3#2)(2008-5#1)(2009-1#1)(2009-4#1)
proposal of##17##2##(1990-5#1)(1991-9#1)(1995-2#1)(1997-2#1)(2005-10#1)(2006-10#1)(2006-11#1)(2007-12#1)(2008-1#1)(2008-3#2)(2008-5#1)(2009-1#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-4#1)
proposal that the##10##3##(1990-10#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-5#1)(1993-3#1)(1995-11#1)(1995-8#1)(1997-2#1)(2006-9#1)
proposal that##25##2##(1990-10#1)(1990-11#2)(1990-5#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-7#1)(1993-3#1)(1994-11#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-8#1)(1996-5#1)(1997-2#2)(2006-9#1)(2007-2#1)(2008-4#1)(2009-4#1)(2009-5#1)(2013-8#1)
proposal to change the##2##4##(2008-10#1)(2011-2#1)
proposal to classify##2##3##(2006-10#1)(2008-5#1)
proposal to##15##2##(1993-5#1)(1995-5#1)(1995-6#1)(1996-12#1)(2006-10#1)(2006-7#1)(2007-5#1)(2007-9#2)(2008-10#1)(2008-4#1)(2008-5#1)(2010-2#1)(2011-2#1)(2013-7#1)
proposal we##2##2##(2008-3#1)(2009-4#1)
proposal##170##1##(1990-10#1)(1990-11#4)(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-4#2)(1991-5#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-2#8)(1992-5#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#2)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#2)(1995-8#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#1)(1997-1#2)(1997-2#4)(1997-3#1)(1997-7#1)(1997-8#2)(2005-10#2)(2005-5#2)(2006-10#3)(2006-11#2)(2006-12#1)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-5#2)(2007-8#3)(2007-9#3)(2008-1#3)(2008-10#6)(2008-11#2)(2008-2#4)(2008-3#7)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#3)(2008-9#2)(2009-1#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-8#1)(2010-2#2)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#4)
proposals and##4##2##(1992-10#1)(1993-12#1)(2008-2#1)(2012-2#1)
proposals are##5##2##(1996-6#1)(2006-7#1)(2007-12#1)(2008-2#1)(2013-7#1)
proposals for health system reform##2##5##(1993-3#1)(1996-12#1)
proposals for health##3##3##(1993-3#1)(1996-12#1)(2010-9#1)
proposals for reform##2##3##(1992-12#1)(2008-4#1)
proposals for##24##2##(1991-2#1)(1992-12#1)(1992-4#1)(1993-3#1)(1996-12#1)(1996-6#1)(1997-3#1)(2005-8#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#4)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-9#1)(2011-2#1)(2013-1#1)
proposals have##3##2##(1991-4#1)(1992-10#1)(2012-2#1)
proposals in the##3##3##(1992-1#1)(1993-3#1)(1994-9#1)
proposals of##3##2##(2005-8#1)(2006-3#1)(2008-2#1)
proposals on##2##2##(1993-12#1)(1995-1#1)
proposals that##5##2##(1995-10#1)(1996-12#1)(2007-12#1)(2008-8#1)(2013-8#1)
proposals to##5##2##(1991-4#1)(1993-1#1)(1993-4#1)(2008-9#1)(2011-2#1)
proposals##88##1##(1990-12#1)(1991-2#1)(1991-4#2)(1992-1#1)(1992-10#2)(1992-12#1)(1992-4#1)(1993-1#1)(1993-12#4)(1993-3#3)(1993-4#2)(1994-11#2)(1994-3#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-3#2)(1996-1#1)(1996-12#3)(1996-3#1)(1996-6#2)(1997-3#3)(2004-9#1)(2005-8#3)(2005-9#1)(2006-10#1)(2006-3#1)(2006-7#1)(2006-9#2)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#4)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#2)
propose a &quot##3##3##(1995-2#1)(2005-11#1)(2009-3#1)
propose a classification of##2##4##(1996-4#1)(2008-11#1)
propose a comprehensive##2##3##(1992-9#1)(2007-4#1)
propose a framework##5##3##(2007-4#1)(2007-7#1)(2008-8#1)(2013-1#2)
propose a generalization of the##3##5##(1997-2#1)(2007-11#1)(2008-3#1)
propose a genetic##3##3##(2008-2#1)(2008-3#1)(2013-7#1)
propose a global##3##3##(1993-6#1)(2008-2#1)(2008-4#1)
propose a mechanism of##2##4##(2006-7#1)(2012-2#1)
propose a mechanism##6##3##(1994-8#1)(1995-11#1)(1995-6#1)(2006-7#1)(2008-7#1)(2012-2#1)
propose a method for the##3##5##(2007-3#1)(2008-10#1)(2010-8#1)
propose a method for##18##4##(2007-11#3)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#5)(2008-5#1)(2010-3#1)(2010-6#1)(2010-8#1)
propose a method of##6##4##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
propose a method that##2##4##(2007-12#1)(2008-2#1)
propose a method to improve##2##5##(2008-3#2)
propose a method to obtain a##2##6##(1993-1#1)(2008-3#1)
propose a method to##9##4##(1991-7#1)(1993-1#1)(2007-11#1)(2007-12#1)(2008-3#3)(2012-1#2)
propose a method##37##3##(1991-7#1)(1993-1#1)(1994-9#1)(2007-11#5)(2007-12#5)(2007-3#1)(2008-1#1)(2008-10#2)(2008-2#4)(2008-3#10)(2008-5#1)(2010-3#1)(2010-6#1)(2010-8#1)(2012-1#2)
propose a methodology##2##3##(2008-10#1)(2012-1#1)
propose a model for the interaction##2##6##(1993-3#1)(2011-1#1)
propose a model for the##5##5##(1991-7#1)(1993-3#1)(2009-3#1)(2009-8#1)(2011-1#1)
propose a model for##9##4##(1991-5#1)(1991-7#1)(1993-3#1)(1996-2#1)(2008-7#1)(2009-3#1)(2009-6#1)(2009-8#1)(2011-1#1)
propose a model in which##4##5##(1996-7#1)(2005-8#1)(2006-10#1)(2007-8#1)
propose a model of##2##4##(2008-10#1)(2008-11#1)
propose a model that##5##4##(1994-12#1)(1996-7#1)(2009-8#1)(2013-1#2)
propose a model##25##3##(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1993-11#1)(1993-3#1)(1994-12#1)(1996-1#1)(1996-2#1)(1996-7#2)(2005-8#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2009-8#2)(2011-1#1)(2013-1#2)
propose a modification##2##3##(1996-3#1)(2008-3#1)
propose a modified version of##2##5##(1997-3#1)(2012-2#1)
propose a modified##6##3##(1991-4#1)(1995-4#1)(1997-3#1)(2008-3#1)(2008-9#1)(2012-2#1)
propose a more##2##3##(2007-12#1)(2012-3#1)
propose a new approach to the##2##6##(2008-3#1)(2012-3#1)
propose a new approach to##5##5##(1997-8#1)(2008-3#1)(2008-6#1)(2012-3#1)(2013-8#1)
propose a new approach##9##4##(1997-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-10#1)(2012-2#1)(2012-3#1)(2013-8#1)
propose a new classification##2##4##(2012-3#1)(2013-7#1)
propose a new method for##8##5##(1990-10#1)(1997-2#1)(2007-12#1)(2008-2#5)
propose a new method##12##4##(1990-10#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-2#6)(2008-3#1)
propose a new technique##5##4##(2006-6#1)(2008-2#2)(2008-3#1)(2008-8#1)
propose a new type of##2##5##(2007-12#1)(2012-3#1)
propose a new##80##3##(1990-10#1)(1992-6#1)(1993-7#1)(1993-9#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-12#1)(2006-6#1)(2007-11#3)(2007-12#7)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#22)(2008-3#12)(2008-4#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#1)
propose a novel and simple##2##5##(1995-1#1)(2008-2#1)
propose a novel approach for##4##5##(2010-10#1)(2013-1#3)
propose a novel approach##6##4##(2008-3#1)(2010-10#1)(2012-3#1)(2013-1#3)
propose a novel design##2##4##(2007-12#1)(2008-3#1)
propose a novel method##3##4##(2007-12#2)(2010-8#1)
propose a novel##43##3##(1995-1#1)(2006-10#1)(2007-11#3)(2007-12#7)(2008-2#9)(2008-3#8)(2008-6#1)(2010-10#2)(2010-11#1)(2010-8#1)(2011-1#1)(2012-1#2)(2012-3#3)(2013-1#3)
propose a possible##3##3##(2007-10#1)(2007-12#1)(2008-5#1)
propose a preliminary##2##3##(1990-9#1)(2008-10#1)
propose a robust##3##3##(2008-3#2)(2013-1#1)
propose a role for##2##4##(2012-11#1)(2012-2#1)
propose a role##3##3##(1993-6#1)(2012-11#1)(2012-2#1)
propose a scheme for the##2##5##(1995-3#1)(2008-2#1)
propose a scheme for##3##4##(1995-3#1)(2008-2#2)
propose a set of##3##4##(2006-6#1)(2008-10#1)(2008-8#1)
propose a simple##17##3##(2005-11#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-8#1)(2009-2#2)(2012-3#2)(2013-1#1)
propose a solution##2##3##(1995-3#1)(2008-5#1)
propose a strategy##3##3##(2007-7#1)(2011-1#1)(2012-12#1)
propose a system##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
propose a theoretical model for the##2##6##(2007-12#1)(2013-7#1)
propose a theoretical##3##3##(2007-12#1)(2008-3#1)(2013-7#1)
propose a unified##3##3##(1993-6#1)(2007-12#1)(2008-3#1)
propose a##433##2##(1990-10#2)(1990-7#1)(1990-9#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-4#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#3)(1995-3#2)(1995-4#1)(1995-6#2)(1996-1#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-7#4)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#3)(2005-7#1)(2005-8#1)(2006-10#5)(2006-12#2)(2006-6#3)(2006-7#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#21)(2007-12#39)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#17)(2008-11#11)(2008-2#60)(2008-3#59)(2008-4#3)(2008-5#4)(2008-6#4)(2008-7#5)(2008-8#6)(2008-9#1)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#5)(2011-1#8)(2011-12#1)(2011-2#7)(2012-1#6)(2012-11#1)(2012-12#2)(2012-2#7)(2012-3#18)(2013-1#21)(2013-7#3)(2013-8#5)
propose an adaptive##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2010-12#1)
propose an algorithm for##2##4##(2010-2#1)(2013-1#1)
propose an algorithm##5##3##(1995-2#1)(2007-8#1)(2008-3#1)(2010-2#1)(2013-1#1)
propose an alternative approach to##3##5##(1995-4#1)(2013-1#2)
propose an alternative based on##2##5##(2010-11#1)(2013-1#1)
propose an alternative to the##2##5##(2008-7#1)(2012-3#1)
propose an alternative##16##3##(1995-4#1)(1996-8#1)(1997-8#1)(2007-11#2)(2008-11#1)(2008-2#1)(2008-7#1)(2009-2#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#4)
propose an approach to##3##4##(2007-11#1)(2008-2#2)
propose an approach##6##3##(2007-11#1)(2008-2#2)(2009-4#1)(2011-2#1)(2012-2#1)
propose an efficient##2##3##(2007-11#1)(2008-2#1)
propose an empirical##2##3##(2008-5#1)(2009-12#1)
propose an experimental##2##3##(2006-10#1)(2007-12#1)
propose an extension of##2##4##(2007-12#1)(2008-4#1)
propose an independent##2##3##(1991-10#1)(2007-12#1)
propose an integrative##2##3##(2006-5#1)(2012-2#1)
propose an##97##2##(1991-10#1)(1995-2#1)(1995-4#1)(1996-8#1)(1997-8#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-5#1)(2007-11#4)(2007-12#10)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#15)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#8)(2012-3#3)(2013-1#12)
propose and discuss##3##3##(2005-11#1)(2009-8#1)(2013-8#1)
propose and##43##2##(1991-3#1)(2005-11#1)(2007-11#3)(2007-12#17)(2008-1#5)(2008-2#5)(2008-3#7)(2009-8#1)(2010-8#1)(2012-3#1)(2013-8#1)
propose better##2##2##(1991-2#1)(2009-8#1)
propose combining local linear regression##2##5##(2009-5#1)(2010-2#1)
propose experiments##3##2##(2007-9#1)(2008-11#1)(2008-7#1)
propose guidelines for the##3##4##(2006-10#1)(2007-11#1)(2012-2#1)
propose here a##4##3##(1993-3#1)(1995-11#1)(2007-9#1)(2008-11#1)
propose here that##2##3##(1991-1#1)(2009-6#1)
propose here##8##2##(1991-1#1)(1993-3#1)(1995-11#1)(2006-5#1)(2007-9#1)(2008-11#1)(2009-6#1)(2010-8#1)
propose mechanisms##2##2##(2008-3#1)(2010-3#1)
propose new##4##2##(2008-2#2)(2010-2#1)(2012-11#1)
propose recommendations for##3##3##(1995-2#1)(2011-1#2)
propose separate##2##2##(1996-3#1)(2008-10#1)
propose several##2##2##(2008-9#1)(2013-1#1)
propose strategies##2##2##(2006-10#1)(2012-3#1)
propose that PKC##2##3##(1990-12#1)(1993-12#1)
propose that X##2##3##(2008-10#2)
propose that a##10##3##(1995-11#1)(1996-2#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-5#2)(2008-8#1)(2009-10#1)
propose that an##2##3##(1995-2#1)(1996-2#1)
propose that it##3##3##(1992-6#1)(2008-10#1)(2008-3#1)
propose that the combination of##2##5##(2006-12#1)(2006-4#1)
propose that the potential for##2##5##(2007-11#1)(2012-3#1)
propose that the##99##3##(1990-11#1)(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-2#2)(1991-5#3)(1991-7#1)(1991-9#3)(1992-12#3)(1992-6#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#3)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-1#2)(1997-3#1)(1997-6#1)(2004-10#1)(2004-11#1)(2005-11#1)(2006-10#6)(2006-12#1)(2006-4#2)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#3)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#2)
propose that there are##2##4##(1995-3#1)(2012-12#1)
propose that these##14##3##(1994-3#1)(1995-2#1)(1996-3#1)(1997-1#1)(1997-4#1)(2006-9#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
propose that this##21##3##(1990-9#1)(1991-2#2)(1992-3#1)(1994-12#1)(1994-9#1)(1995-8#1)(1996-6#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)
propose that##309##2##(1990-11#5)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#6)(1991-4#2)(1991-5#3)(1991-7#2)(1991-9#4)(1992-11#1)(1992-12#3)(1992-3#3)(1992-4#1)(1992-6#3)(1992-7#1)(1992-9#1)(1993-12#5)(1993-3#1)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#3)(1994-3#4)(1994-5#2)(1994-8#4)(1994-9#6)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#6)(1995-3#4)(1995-5#1)(1995-6#2)(1995-8#3)(1996-11#1)(1996-12#2)(1996-2#5)(1996-3#2)(1996-4#2)(1996-6#1)(1996-7#1)(1997-1#3)(1997-3#1)(1997-4#5)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#1)(2004-10#1)(2004-11#1)(2005-11#2)(2006-1#1)(2006-10#6)(2006-12#2)(2006-4#2)(2006-9#2)(2007-11#3)(2007-12#7)(2007-3#1)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#19)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#8)(2008-5#6)(2008-6#2)(2008-7#9)(2008-8#6)(2008-9#2)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#5)(2009-9#1)(2010-2#3)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#16)(2012-2#8)(2012-3#3)(2012-7#1)(2013-1#6)(2013-8#1)
propose the concept of##3##4##(2004-9#1)(2008-2#1)(2012-1#1)
propose the concept##4##3##(1995-2#1)(2004-9#1)(2008-2#1)(2012-1#1)
propose the following mechanism##2##4##(1996-4#1)(2008-7#1)
propose the following##4##3##(1991-12#1)(1996-4#1)(2008-10#1)(2008-7#1)
propose the name##3##3##(2008-10#2)(2008-4#1)
propose the possibility of##2##4##(2008-1#1)(2010-1#1)
propose the use of##17##4##(1993-9#1)(1994-6#1)(2007-11#3)(2007-12#3)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-7#1)(2008-9#1)(2012-12#1)
propose the##64##2##(1990-12#1)(1990-3#1)(1991-12#1)(1993-9#1)(1994-6#1)(1995-2#1)(1996-4#1)(1996-5#1)(1997-8#1)(2004-9#1)(2006-10#1)(2007-11#4)(2007-12#4)(2007-8#1)(2008-1#3)(2008-10#6)(2008-11#1)(2008-2#6)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#3)(2013-1#1)(2013-7#2)(2013-8#2)
propose therefore that##2##3##(1990-5#1)(1990-9#1)
propose therefore##3##2##(1990-5#1)(1990-9#1)(1994-2#1)
propose three##3##2##(2007-11#1)(2007-12#1)(2012-1#1)
propose to adapt the##2##4##(2011-1#1)(2012-3#1)
propose to adapt##3##3##(2007-11#1)(2011-1#1)(2012-3#1)
propose to add a##2##4##(2008-2#1)(2008-3#1)
propose to add##3##3##(2007-8#1)(2008-2#1)(2008-3#1)
propose to call##2##3##(1996-7#1)(2012-2#1)
propose to use the##3##4##(2007-12#1)(2008-3#1)(2008-7#1)
propose to use##17##3##(1992-5#1)(2007-1#1)(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#6)(2008-7#1)(2013-1#2)
propose to##58##2##(1990-11#1)(1991-2#1)(1992-5#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#1)(1996-3#1)(1996-7#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#5)(2007-8#1)(2008-10#2)(2008-2#5)(2008-3#13)(2008-5#1)(2008-7#2)(2008-9#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
propose two new##2##3##(1992-9#1)(2012-3#1)
propose two##14##2##(1992-9#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#2)(2008-6#1)(2009-9#1)(2010-12#1)(2010-8#1)(2012-3#1)
propose using a##2##3##(2007-11#1)(2007-12#1)
propose using##7##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)
propose ways##2##2##(2010-3#1)(2012-2#1)
propose what we believe is a new##2##7##(2008-3#2)
propose what we believe##4##4##(2008-3#4)
propose what##7##2##(2007-12#1)(2008-3#6)
propose##1181##1##(1990-10#2)(1990-11#6)(1990-12#2)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#2)(1990-8#2)(1990-9#5)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#9)(1991-3#2)(1991-4#3)(1991-5#4)(1991-7#4)(1991-8#1)(1991-9#4)(1992-11#1)(1992-12#3)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#5)(1993-3#4)(1993-4#1)(1993-6#6)(1993-7#2)(1993-8#2)(1993-9#3)(1994-10#1)(1994-11#4)(1994-12#6)(1994-2#4)(1994-3#4)(1994-4#1)(1994-5#2)(1994-6#1)(1994-8#7)(1994-9#8)(1995-1#2)(1995-10#1)(1995-11#8)(1995-12#3)(1995-2#13)(1995-3#6)(1995-4#2)(1995-5#1)(1995-6#5)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#6)(1996-3#6)(1996-4#4)(1996-5#2)(1996-6#1)(1996-7#6)(1996-8#1)(1997-1#3)(1997-2#3)(1997-3#2)(1997-4#6)(1997-5#2)(1997-6#4)(1997-7#3)(1997-8#4)(2004-10#1)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#6)(2005-5#1)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#17)(2006-11#1)(2006-12#7)(2006-2#1)(2006-4#3)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#2)(2006-9#3)(2007-1#2)(2007-10#3)(2007-11#46)(2007-12#93)(2007-2#1)(2007-3#2)(2007-4#3)(2007-5#2)(2007-7#5)(2007-8#8)(2007-9#3)(2008-1#17)(2008-10#51)(2008-11#22)(2008-12#3)(2008-2#110)(2008-3#112)(2008-4#13)(2008-5#13)(2008-6#8)(2008-7#22)(2008-8#16)(2008-9#8)(2009-10#8)(2009-11#2)(2009-12#4)(2009-2#6)(2009-3#4)(2009-4#3)(2009-5#8)(2009-6#4)(2009-8#13)(2009-9#4)(2010-1#4)(2010-10#3)(2010-11#3)(2010-12#5)(2010-2#10)(2010-3#5)(2010-4#3)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#10)(2010-9#2)(2011-1#17)(2011-12#2)(2011-2#18)(2011-3#1)(2012-1#11)(2012-11#3)(2012-12#21)(2012-2#29)(2012-3#32)(2012-7#1)(2013-1#50)(2013-7#6)(2013-8#11)
proposed $640 million settlement##2##4##(1996-12#1)(1996-5#1)
proposed 4D segmentation##2##3##(2010-3#2)
proposed Bayesian##2##2##(1994-9#1)(2009-10#1)
proposed FI system##2##3##(2008-10#2)
proposed FI##5##2##(2008-10#5)
proposed FIA##2##2##(2008-10#2)
proposed HPLC##2##2##(1990-8#1)(2008-10#1)
proposed SIA##3##2##(2008-10#3)
proposed a method for the##2##5##(1993-6#1)(2005-4#1)
proposed a method for##3##4##(1993-6#1)(2005-4#1)(2013-1#1)
proposed a method to##2##4##(2009-8#1)(2010-4#1)
proposed a method##5##3##(1993-6#1)(2005-4#1)(2009-8#1)(2010-4#1)(2013-1#1)
proposed a model##4##3##(1995-3#1)(2008-5#1)(2010-9#1)(2011-1#1)
proposed a new concept##2##4##(2006-6#1)(2008-8#1)
proposed a new##6##3##(1997-8#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)
proposed a novel mechanism for##2##5##(1990-5#1)(1996-7#1)
proposed a novel##4##3##(1990-5#1)(1996-7#1)(2010-3#1)(2012-3#1)
proposed a possible##2##3##(1992-11#1)(2009-10#1)
proposed a strategy##2##3##(2012-12#1)(2013-7#1)
proposed a##65##2##(1990-5#1)(1992-11#1)(1993-6#1)(1994-11#1)(1995-3#1)(1995-6#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-8#2)(2005-4#1)(2005-8#1)(2006-11#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-2#4)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-8#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
proposed active##3##2##(1994-5#1)(1995-1#1)(2008-8#1)
proposed after##3##2##(1993-5#1)(2006-2#2)
proposed algorithm can be##2##4##(2008-2#1)(2012-2#1)
proposed algorithm can##5##3##(2008-2#4)(2012-2#1)
proposed algorithm is evaluated##2##4##(2008-2#1)(2008-6#1)
proposed algorithm is##12##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-6#1)(2010-2#1)(2011-3#1)(2012-1#1)(2012-3#1)
proposed algorithm##36##2##(2007-12#3)(2008-10#2)(2008-2#14)(2008-3#3)(2008-6#1)(2009-12#1)(2010-2#3)(2010-8#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
proposed algorithms##9##2##(2008-2#8)(2012-1#1)
proposed amendments##2##2##(2012-11#2)
proposed an##6##2##(1993-9#1)(1996-1#1)(2008-10#1)(2008-2#1)(2010-8#1)(2012-1#1)
proposed analytical##4##2##(2005-4#1)(2008-10#2)(2012-3#1)
proposed and analyzed##5##3##(2007-11#1)(2008-2#2)(2008-3#2)
proposed and applied to the##2##5##(2008-10#1)(2008-3#1)
proposed and applied to##5##4##(2008-10#3)(2008-3#1)(2012-1#1)
proposed and applied##6##3##(2008-10#4)(2008-3#1)(2012-1#1)
proposed and assessed##2##3##(2006-10#1)(2008-3#1)
proposed and compared##2##3##(2008-10#1)(2010-6#1)
proposed and demonstrated for measuring the##2##6##(2007-12#2)
proposed and demonstrated##23##3##(2007-11#3)(2007-12#10)(2008-2#1)(2008-3#9)
proposed and discussed##5##3##(1994-9#1)(2008-10#2)(2008-2#1)(2008-3#1)
proposed and evaluated##3##3##(2007-12#1)(2008-10#1)(2011-12#1)
proposed and experimentally##8##3##(1997-2#1)(2007-12#5)(2008-2#1)(2008-3#1)
proposed and it##2##3##(2008-10#1)(2008-2#1)
proposed and studied##4##3##(2008-2#2)(2009-12#1)(2010-11#1)
proposed and tested##6##3##(1996-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2012-12#1)
proposed and the results##2##4##(2008-10#2)
proposed and the##5##3##(2008-10#4)(2011-1#1)
proposed and validated##2##3##(2008-10#1)(2012-1#1)
proposed and was##2##3##(2007-8#1)(2008-3#1)
proposed and##114##2##(1993-1#1)(1994-9#1)(1996-10#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(2005-11#3)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#4)(2007-12#20)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#28)(2008-11#1)(2008-12#1)(2008-2#11)(2008-3#19)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-12#1)(2012-1#2)(2012-12#2)(2012-3#1)
proposed angle##2##2##(2008-2#2)
proposed application##3##2##(1993-2#1)(2009-3#2)
proposed approach is##13##3##(2008-10#1)(2008-2#6)(2009-7#1)(2009-9#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-7#1)
proposed approach##46##2##(1994-11#1)(2007-11#2)(2008-10#7)(2008-2#13)(2008-3#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-1#4)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
proposed architecture is##3##3##(2008-2#3)
proposed architecture##10##2##(2007-12#1)(2008-11#1)(2008-2#4)(2008-3#1)(2009-11#1)(2010-8#2)
proposed are##3##2##(1996-3#1)(1996-8#1)(2008-10#1)
proposed arrangement of##2##3##(1994-3#1)(1997-6#1)
proposed as a complementary##2##4##(1990-11#1)(2013-7#1)
proposed as a marker of##3##5##(1993-6#1)(1995-2#1)(2008-10#1)
proposed as a means of##2##5##(2008-7#1)(2009-7#1)
proposed as a means##3##4##(2008-7#1)(2009-7#1)(2011-2#1)
proposed as a measure of##2##5##(2008-8#1)(2009-1#1)
proposed as a measure##3##4##(2008-10#1)(2008-8#1)(2009-1#1)
proposed as a new##5##4##(1997-8#1)(2006-10#1)(2008-10#1)(2008-3#1)(2010-3#1)
proposed as a novel##2##4##(2007-12#1)(2008-10#1)
proposed as a possible##5##4##(1992-4#1)(2008-10#1)(2008-5#1)(2010-4#1)(2012-12#1)
proposed as a simple##2##4##(2008-10#1)(2008-11#1)
proposed as a threshold##2##4##(1994-5#1)(2012-1#1)
proposed as a way##2##4##(2008-3#1)(2012-1#1)
proposed as a##71##3##(1990-11#1)(1990-5#2)(1990-7#1)(1991-6#1)(1992-12#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-2#2)(1997-5#1)(1997-8#1)(2005-8#1)(2006-10#3)(2006-5#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-7#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#2)(2011-7#1)(2012-1#3)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)
proposed as an alternate##2##4##(2008-2#1)(2013-1#1)
proposed as an alternative to##6##5##(1994-2#1)(1995-1#1)(2008-6#1)(2009-10#1)(2010-2#1)(2013-1#1)
proposed as an alternative##10##4##(1994-2#1)(1995-1#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-10#1)(2010-2#1)(2013-1#2)(2013-7#1)
proposed as an efficient##2##4##(1996-4#1)(2011-3#1)
proposed as an important##3##4##(1994-6#1)(2008-10#1)(2012-2#1)
proposed as an##30##3##(1991-5#1)(1992-6#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-12#1)(1996-4#1)(1997-7#1)(2005-12#1)(2006-5#1)(2006-6#1)(2007-11#1)(2008-10#3)(2008-2#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-2#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#3)(2013-7#1)
proposed as being##2##3##(1991-8#1)(2006-10#1)
proposed as the mechanism##2##4##(1990-11#1)(2008-8#1)
proposed as the##15##3##(1990-11#1)(1991-2#1)(1993-9#1)(1997-6#1)(2005-10#1)(2006-10#1)(2006-8#1)(2008-2#2)(2008-5#3)(2008-8#1)(2011-2#1)(2013-1#1)
proposed as well##2##3##(2007-10#1)(2008-2#1)
proposed as##149##2##(1990-11#3)(1990-5#2)(1990-7#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-5#2)(1996-3#1)(1996-4#1)(1996-8#1)(1997-2#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-12#2)(2005-8#1)(2006-10#6)(2006-2#1)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#13)(2008-11#4)(2008-12#2)(2008-2#9)(2008-3#5)(2008-5#6)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#1)(2009-1#1)(2009-10#2)(2009-7#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2011-7#1)(2012-1#3)(2012-12#1)(2012-2#6)(2013-1#7)(2013-7#2)
proposed based on a##2##4##(1990-8#1)(2008-10#1)
proposed based on the##10##4##(2005-11#1)(2007-12#1)(2008-10#5)(2009-2#1)(2013-1#2)
proposed based on##19##3##(1990-8#1)(1996-12#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-5#1)(2009-2#1)(2009-5#1)(2013-1#2)
proposed before##2##2##(1994-8#1)(2008-11#1)
proposed biosensor##4##2##(2008-10#3)(2010-5#1)
proposed by Enneking##2##3##(2007-11#2)
proposed by Ishida et al##2##5##(2012-3#2)
proposed by some##2##3##(1993-11#1)(1993-6#1)
proposed by the WHO##2##4##(1992-12#1)(2011-1#1)
proposed by the World Health Organization (WHO)##3##7##(1996-2#1)(2008-3#1)(2011-1#1)
proposed by the authors##3##4##(2008-10#2)(2008-3#1)
proposed by the##29##3##(1991-11#1)(1991-3#1)(1992-12#1)(1996-12#1)(1996-2#1)(1997-6#1)(2005-3#1)(2006-11#1)(2007-11#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-5#1)(2010-1#1)(2010-5#1)(2011-1#5)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
proposed by using##2##3##(2008-10#2)
proposed by##132##2##(1990-11#1)(1990-4#2)(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-5#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-6#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-7#1)(1997-2#2)(1997-6#1)(1997-8#1)(2005-11#2)(2005-3#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-11#7)(2007-12#2)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#10)(2008-3#9)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-2#2)(2010-5#1)(2010-8#1)(2011-1#6)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#6)(2013-1#2)(2013-7#2)(2013-8#2)
proposed can be##2##3##(1993-6#1)(2008-10#1)
proposed changes in the##2##4##(2006-8#1)(2010-8#1)
proposed changes in##4##3##(2006-8#1)(2008-10#1)(2008-4#1)(2010-8#1)
proposed changes to##2##3##(2007-4#1)(2008-11#1)
proposed changes##8##2##(1995-1#1)(1995-3#1)(2006-8#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-8#1)
proposed circuit uses##2##3##(2010-8#2)
proposed classification##2##2##(1996-11#1)(2008-2#1)
proposed clinical guidelines##2##3##(2006-8#1)(2010-10#1)
proposed clinical##3##2##(2006-10#1)(2006-8#1)(2010-10#1)
proposed concept##3##2##(2006-2#1)(2008-3#1)(2008-6#1)
proposed control##2##2##(2009-10#2)
proposed criteria for##2##3##(2006-10#1)(2006-8#1)
proposed criteria##3##2##(2006-10#1)(2006-8#1)(2012-3#1)
proposed definition of##2##3##(2007-6#1)(2012-1#1)
proposed design##6##2##(2008-3#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
proposed developments##2##2##(2007-5#1)(2008-11#1)
proposed device##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
proposed diagnostic##3##2##(2008-10#1)(2009-7#1)(2011-1#1)
proposed different##2##2##(2008-7#1)(2012-1#1)
proposed during##2##2##(1993-9#1)(2010-2#1)
proposed electrochemical method##2##3##(2008-10#2)
proposed electrode has##2##3##(2008-10#2)
proposed electrode was##3##3##(2008-10#3)
proposed electrode##17##2##(2008-10#17)
proposed electrodes could be reliably##2##5##(2008-10#2)
proposed electrodes could be##3##4##(2008-10#3)
proposed electrodes##8##2##(2008-10#8)
proposed electronic##2##2##(1992-5#1)(2008-2#1)
proposed estimators##5##2##(2010-11#1)(2010-2#4)
proposed explanation##2##2##(1991-2#1)(2009-3#1)
proposed extraction##2##2##(2008-10#2)
proposed filter##2##2##(2008-3#2)
proposed flow system##2##3##(2008-10#2)
proposed flow##5##2##(2008-10#5)
proposed flow-injection##3##2##(2008-10#3)
proposed followed by a##2##4##(2008-2#2)
proposed followed by##3##3##(2008-1#1)(2008-2#2)
proposed for a##3##3##(1997-1#1)(2008-2#2)
proposed for acceptance##2##3##(2013-7#2)
proposed for assessment of##2##4##(2008-10#1)(2009-5#1)
proposed for both##3##3##(2006-6#1)(2008-10#1)(2013-7#1)
proposed for clinical##2##3##(2008-5#1)(2008-8#1)
proposed for control##2##3##(2008-1#1)(2010-8#1)
proposed for determination of##3##4##(2007-11#1)(2008-10#2)
proposed for dynamic##2##3##(2007-8#1)(2008-2#1)
proposed for explaining##2##3##(1990-8#1)(2009-12#1)
proposed for genomic sequencing##2##4##(2008-10#2)
proposed for measuring the##4##4##(2008-3#3)(2012-2#1)
proposed for measuring##5##3##(2008-3#4)(2012-2#1)
proposed for obtaining##2##3##(2008-2#1)(2010-2#1)
proposed for rapid##2##3##(2006-7#1)(2010-4#1)
proposed for simultaneous##4##3##(2008-10#4)
proposed for the determination of ascorbic acid##2##7##(2008-10#2)
proposed for the determination of trace##6##6##(2008-10#5)(2013-8#1)
proposed for the determination of##46##5##(2007-8#1)(2008-10#44)(2013-8#1)
proposed for the preconcentration##2##4##(2008-10#2)
proposed for the preparation of##3##5##(2007-8#1)(2008-10#1)(2013-8#1)
proposed for the speciation##2##4##(2008-10#2)
proposed for the##144##3##(1990-5#1)(1990-6#1)(1990-7#1)(1991-5#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-8#2)(1997-3#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-8#4)(2008-1#1)(2008-10#94)(2008-11#1)(2008-2#5)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-3#1)(2010-11#1)(2010-5#1)(2010-6#1)(2012-12#2)(2012-2#1)(2012-6#1)(2013-1#1)(2013-7#1)(2013-8#2)
proposed for these##3##3##(1992-8#1)(1995-2#1)(2008-3#1)
proposed for this##2##3##(1996-5#1)(2008-10#1)
proposed for use in##2##4##(2007-11#1)(2007-12#1)
proposed for use##4##3##(2007-11#1)(2007-12#1)(2013-7#2)
proposed for##313##2##(1990-3#2)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-5#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#1)(1994-5#1)(1994-8#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-3#1)(1997-4#2)(1997-7#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-6#2)(2006-7#1)(2006-8#2)(2007-11#5)(2007-12#8)(2007-7#1)(2007-8#7)(2007-9#1)(2008-1#3)(2008-10#128)(2008-11#2)(2008-12#1)(2008-2#20)(2008-3#21)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-5#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#5)(2012-6#1)(2013-1#7)(2013-7#8)(2013-8#3)
proposed framework can##2##3##(1997-8#1)(2008-2#1)
proposed framework##10##2##(1997-8#1)(2005-10#1)(2006-10#1)(2008-2#2)(2008-7#2)(2008-9#1)(2012-2#2)
proposed from##2##2##(1994-11#1)(1997-2#1)
proposed function of##2##3##(1994-12#1)(2007-11#1)
proposed function##3##2##(1994-12#1)(1997-6#1)(2007-11#1)
proposed funding##3##2##(1991-10#1)(1996-1#2)
proposed government##2##2##(1993-3#2)
proposed guidelines##4##2##(1993-5#1)(2006-10#2)(2006-8#1)
proposed has##2##2##(2007-12#1)(2008-10#1)
proposed have been##2##3##(1997-2#1)(2008-8#1)
proposed here is##4##3##(1991-5#1)(2008-10#2)(2008-2#1)
proposed here to##2##3##(1993-11#1)(2007-9#1)
proposed here##17##2##(1991-5#1)(1993-11#1)(1994-1#1)(1997-1#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-2#3)(2008-3#1)(2011-2#1)(2013-7#1)
proposed herein##2##2##(1997-2#1)(2008-5#1)
proposed how##2##2##(2007-8#1)(2010-8#1)
proposed hybrid##2##2##(2006-10#1)(2008-3#1)
proposed hypothesis##2##2##(2007-12#1)(2008-3#1)
proposed immunosensor##3##2##(2008-10#3)
proposed in a##5##3##(1994-6#1)(1994-9#1)(1996-11#1)(2008-2#1)(2008-3#1)
proposed in advance##2##3##(2007-2#1)(2011-2#1)
proposed in an##3##3##(1994-3#1)(2007-8#1)(2008-2#1)
proposed in order to##4##4##(1994-3#1)(2008-10#1)(2008-8#1)(2008-9#1)
proposed in our##2##3##(2007-12#1)(2012-1#1)
proposed in the literature##11##4##(1996-11#1)(2006-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#2)(2009-9#1)(2013-1#2)
proposed in the present##2##4##(2013-8#2)
proposed in the##21##3##(1996-11#2)(2006-11#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#3)(2009-9#1)(2010-5#1)(2011-1#1)(2013-1#2)(2013-8#2)
proposed in this article##4##4##(1996-11#1)(2008-10#1)(2008-7#1)(2013-8#1)
proposed in this paper##15##4##(2008-10#9)(2008-2#3)(2008-3#1)(2008-6#1)(2013-8#1)
proposed in this work for the determination of##2##8##(2008-10#2)
proposed in this##22##3##(1996-11#1)(2008-10#12)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#1)(2012-1#1)(2013-8#2)
proposed in which##10##3##(1991-5#1)(1991-9#1)(1997-4#2)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-9#1)
proposed in##83##2##(1990-11#1)(1990-9#1)(1991-5#1)(1991-9#1)(1992-3#1)(1994-3#2)(1994-6#1)(1994-9#1)(1996-11#4)(1997-4#2)(1997-8#1)(2006-11#2)(2006-2#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#17)(2008-11#1)(2008-2#8)(2008-3#5)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-4#1)(2009-9#1)(2010-12#1)(2010-3#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-2#1)(2013-1#2)(2013-8#4)
proposed including##2##2##(1996-2#1)(2010-11#1)
proposed is##10##2##(2007-7#1)(2008-10#3)(2008-2#4)(2008-3#2)
proposed iterative##2##2##(2008-10#1)(2012-3#1)
proposed joint spatial encodings##2##4##(2008-2#2)
proposed joint##3##2##(2008-2#3)
proposed managed care##3##3##(1994-2#2)(1994-3#1)
proposed mechanism for the##2##4##(2005-8#1)(2013-1#1)
proposed mechanism for##7##3##(1995-6#1)(2005-8#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-1#1)
proposed mechanism involves##2##3##(1996-9#1)(2008-10#1)
proposed mechanism of action##4##4##(1994-3#1)(2004-3#1)(2010-12#2)
proposed mechanism of##8##3##(1994-3#1)(2004-3#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-12#2)
proposed mechanism##23##2##(1994-3#1)(1995-6#1)(1996-9#1)(2004-3#2)(2005-8#1)(2007-6#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#2)(2010-5#1)(2012-3#1)(2013-1#2)
proposed mechanisms of##5##3##(2006-12#1)(2006-7#1)(2006-9#1)(2007-11#1)(2008-1#1)
proposed mechanisms##9##2##(1994-2#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-11#2)(2008-1#1)(2008-3#1)
proposed method allowed##3##3##(2008-10#2)(2008-3#1)
proposed method allows the determination of##3##6##(2008-10#3)
proposed method allows the##4##4##(2008-10#4)
proposed method allows##8##3##(2007-8#1)(2008-10#7)
proposed method can be applied##2##5##(2007-12#1)(2008-6#1)
proposed method can be used for the##3##7##(2008-10#2)(2010-2#1)
proposed method can be used##5##5##(2008-10#4)(2010-2#1)
proposed method can be##14##4##(2007-12#1)(2008-10#4)(2008-3#1)(2008-6#1)(2010-2#3)(2010-5#1)(2011-2#1)(2012-2#1)(2013-7#1)
proposed method can##19##3##(2007-12#2)(2007-8#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-9#1)(2010-2#3)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
proposed method could be##3##4##(2008-10#2)(2008-5#1)
proposed method could##6##3##(2008-10#4)(2008-5#1)(2012-3#1)
proposed method exhibited##2##3##(2008-10#2)
proposed method for the##3##4##(2008-10#2)(2010-8#1)
proposed method for##14##3##(2008-10#11)(2008-7#2)(2010-8#1)
proposed method had been successfully applied to##2##7##(2008-10#2)
proposed method had been##3##4##(2008-10#3)
proposed method had##5##3##(1992-11#1)(2008-10#4)
proposed method has a##5##4##(2007-12#1)(2008-10#4)
proposed method has been applied to determine##2##7##(2008-10#2)
proposed method has been applied to the determination of##16##9##(2008-10#15)(2008-3#1)
proposed method has been applied to the##22##7##(2007-8#1)(2008-10#20)(2008-3#1)
proposed method has been applied to##27##6##(2007-8#1)(2008-10#25)(2008-3#1)
proposed method has been applied##30##5##(2007-8#1)(2008-10#28)(2008-3#1)
proposed method has been successfully applied to the determination of##3##10##(2008-10#3)
proposed method has been successfully applied to the##6##8##(2008-10#6)
proposed method has been successfully applied to##9##7##(2008-10#9)
proposed method has been successfully applied##10##6##(2008-10#10)
proposed method has been##50##4##(2007-8#1)(2008-10#46)(2008-2#1)(2008-3#1)(2012-1#1)
proposed method has##58##3##(2007-12#2)(2007-8#1)(2008-10#52)(2008-2#1)(2008-3#1)(2012-1#1)
proposed method is applied to##5##5##(2008-10#4)(2008-2#1)
proposed method is compared with##4##5##(2008-10#1)(2008-2#2)(2008-3#1)
proposed method is evaluated##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
proposed method is promising for##2##5##(2008-10#2)
proposed method is robust##5##4##(1995-4#1)(2012-3#1)(2013-1#2)(2013-7#1)
proposed method is simple##17##4##(1990-9#1)(2005-4#1)(2006-12#1)(2008-10#13)(2008-6#1)
proposed method is tested##2##4##(2008-2#1)(2010-2#1)
proposed method is##105##3##(1990-9#1)(1995-4#1)(2005-11#1)(2005-4#2)(2006-10#1)(2006-12#1)(2007-8#2)(2008-10#68)(2008-2#10)(2008-3#7)(2008-6#2)(2010-2#2)(2010-7#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
proposed method may##2##3##(2007-11#1)(2013-8#1)
proposed method of##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-9#1)(2012-1#1)
proposed method offers the##2##4##(2008-10#1)(2008-2#1)
proposed method provides a##4##4##(2008-3#2)(2008-7#1)(2012-12#1)
proposed method provides##5##3##(2007-8#1)(2008-3#2)(2008-7#1)(2012-12#1)
proposed method uses a##2##4##(2007-12#1)(2008-6#1)
proposed method was also applied satisfactorily to the determination of##3##10##(2007-8#1)(2008-10#2)
proposed method was also applied##4##5##(2007-8#1)(2008-10#2)(2012-2#1)
proposed method was also##5##4##(2007-8#1)(2008-10#2)(2010-5#1)(2012-2#1)
proposed method was applied to the analysis of##4##8##(2008-10#3)(2010-4#1)
proposed method was applied to the##26##6##(2008-10#25)(2010-4#1)
proposed method was applied to##42##5##(1996-3#1)(2007-8#1)(2008-10#39)(2010-4#1)
proposed method was applied##52##4##(1996-3#1)(2007-8#2)(2008-10#48)(2010-4#1)
proposed method was compared with##4##5##(2008-10#4)
proposed method was evaluated by analyzing certified reference##2##8##(2008-10#2)
proposed method was evaluated by analyzing##4##6##(2008-10#4)
proposed method was evaluated by##6##5##(2008-10#6)
proposed method was evaluated##7##4##(2008-10#7)
proposed method was successfully applied to the simultaneous determination of##8##10##(2008-10#8)
proposed method was successfully applied to the##26##7##(2007-8#2)(2008-10#23)(2012-1#1)
proposed method was successfully applied to##29##6##(2007-8#2)(2008-10#26)(2012-1#1)
proposed method was successfully applied##37##5##(2007-8#2)(2008-10#34)(2012-1#1)
proposed method was successfully##41##4##(2007-8#2)(2008-10#38)(2012-1#1)
proposed method was validated by##2##5##(2008-10#1)(2012-1#1)
proposed method was validated##4##4##(2008-10#1)(2011-1#1)(2012-1#2)
proposed method was##153##3##(1996-3#1)(2005-4#1)(2007-8#6)(2008-10#131)(2008-3#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-1#4)(2012-12#1)(2012-2#2)
proposed method##581##2##(1990-9#1)(1992-11#1)(1995-4#1)(1996-3#1)(2005-11#1)(2005-12#1)(2005-4#4)(2006-10#2)(2006-12#2)(2007-11#6)(2007-12#10)(2007-8#16)(2008-10#408)(2008-2#25)(2008-3#28)(2008-5#2)(2008-6#6)(2008-7#3)(2008-9#2)(2009-10#1)(2009-5#3)(2009-6#1)(2010-12#1)(2010-2#10)(2010-4#3)(2010-5#3)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#6)(2012-12#4)(2012-2#3)(2012-3#9)(2013-1#6)(2013-7#3)(2013-8#3)
proposed methodologies##2##2##(2008-10#2)
proposed methodology allows##2##3##(2008-10#1)(2012-1#1)
proposed methodology has been##3##4##(2008-10#3)
proposed methodology is##3##3##(2005-5#1)(2010-2#1)(2010-3#1)
proposed methodology was applied##2##4##(2008-10#2)
proposed methodology was##6##3##(2008-10#6)
proposed methodology##27##2##(2005-11#1)(2005-5#1)(2007-8#1)(2008-10#18)(2008-2#1)(2010-2#1)(2010-3#1)(2012-1#3)
proposed methods and##2##3##(2008-11#1)(2008-2#1)
proposed methods are##2##3##(1994-11#1)(2010-12#1)
proposed methods have been applied to##2##6##(2008-10#1)(2011-1#1)
proposed methods have been applied##3##5##(2008-10#2)(2011-1#1)
proposed methods have been##4##4##(2008-10#3)(2011-1#1)
proposed methods have##5##3##(2008-10#4)(2011-1#1)
proposed methods to##3##3##(2006-10#1)(2008-10#2)
proposed methods were selective and##2##5##(2008-10#2)
proposed methods were successfully applied to the determination of##2##9##(2008-10#2)
proposed methods were successfully applied to the##3##7##(2008-10#3)
proposed methods were validated by using##2##6##(2008-10#2)
proposed methods were##9##3##(2008-10#9)
proposed methods##37##2##(1994-11#1)(2006-10#1)(2008-10#23)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#2)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-3#1)
proposed mode of##2##3##(1994-9#1)(2010-2#1)
proposed model and##4##3##(2008-10#1)(2008-9#1)(2009-8#1)(2010-11#1)
proposed model considers the##2##4##(2008-2#1)(2008-5#1)
proposed model for##5##3##(1991-10#1)(1996-12#1)(2010-8#2)(2013-1#1)
proposed model has##3##3##(1994-2#1)(2007-12#1)(2010-8#1)
proposed model is##7##3##(1995-6#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)
proposed model of the##2##4##(1991-5#1)(1992-9#1)
proposed model of##3##3##(1991-5#1)(1992-9#1)(2009-9#1)
proposed model was##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
proposed model##49##2##(1991-10#1)(1991-5#1)(1992-9#1)(1994-2#1)(1994-3#1)(1995-6#3)(1996-12#1)(1996-7#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-3#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#2)
proposed models for the##2##4##(1994-9#1)(2008-2#1)
proposed models for##4##3##(1992-4#1)(1994-9#1)(1997-2#1)(2008-2#1)
proposed models##13##2##(1992-4#1)(1992-6#1)(1994-9#1)(1996-3#1)(1997-2#1)(2008-10#3)(2008-2#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-2#1)
proposed modified##3##2##(2005-11#1)(2008-10#1)(2008-2#1)
proposed new branch##2##3##(1995-6#2)
proposed new##14##2##(1991-2#1)(1995-6#2)(2005-12#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-3#3)(2011-2#1)(2013-1#2)
proposed nonparametric##2##2##(2010-9#2)
proposed nutrition delivery##2##3##(1996-1#2)
proposed nutrition##3##2##(1996-1#3)
proposed of##3##2##(1996-6#1)(2008-10#1)(2008-3#1)
proposed on the basis of##6##5##(1993-2#1)(1996-12#1)(2007-12#1)(2008-5#1)(2008-7#1)(2011-1#1)
proposed on the##7##3##(1993-2#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-5#1)(2008-7#1)(2011-1#1)
proposed optical##8##2##(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#2)
proposed or##4##2##(2006-10#1)(2008-5#1)(2009-6#1)(2012-12#1)
proposed over##2##2##(2008-10#1)(2013-8#1)
proposed previously that##2##3##(1994-11#1)(1997-4#1)
proposed previously##8##2##(1994-11#1)(1995-10#1)(1996-7#1)(1997-4#1)(2008-10#2)(2009-10#1)(2010-8#1)
proposed principle of##2##3##(2007-12#1)(2008-10#1)
proposed principle##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
proposed procedure allows the determination##2##5##(2007-8#1)(2008-10#1)
proposed procedure allows##3##3##(2007-8#1)(2008-10#2)
proposed procedure can be##2##4##(2008-10#2)
proposed procedure can##3##3##(2008-10#3)
proposed procedure for##3##3##(2008-10#2)(2010-5#1)
proposed procedure has been##7##4##(2008-10#7)
proposed procedure has##8##3##(2008-10#8)
proposed procedure is##8##3##(1994-6#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#4)
proposed procedure was##13##3##(2008-10#12)(2008-7#1)
proposed procedure##68##2##(1994-6#1)(1996-8#1)(1997-1#1)(1997-6#1)(1997-8#1)(2007-10#2)(2007-12#1)(2007-8#3)(2008-10#50)(2008-3#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-1#1)(2010-5#1)(2012-1#1)
proposed procedures##12##2##(2007-11#1)(2007-8#1)(2008-10#6)(2009-10#1)(2010-4#2)(2013-1#1)
proposed process##2##2##(2007-12#1)(2008-5#1)
proposed program##2##2##(1995-2#1)(2007-2#1)
proposed reaction##2##2##(1994-8#1)(2010-5#1)
proposed reactive##2##2##(1994-5#1)(2012-12#1)
proposed reagent-injection FI method##2##4##(2008-10#2)
proposed recently for##2##3##(2008-2#1)(2008-7#1)
proposed recently##5##2##(2007-1#1)(2008-2#3)(2008-7#1)
proposed recoded and nonrecoded##2##4##(2008-2#2)
proposed recoded##3##2##(2008-2#3)
proposed recording##2##2##(2007-12#2)
proposed reforms##2##2##(1996-12#1)(2008-6#1)
proposed refractive-index##2##2##(2008-2#2)
proposed regulations##4##2##(1991-12#1)(1991-2#1)(1993-3#1)(1994-12#1)
proposed robust##2##2##(2008-10#1)(2012-3#1)
proposed role for##2##3##(1991-12#1)(2006-12#1)
proposed role##7##2##(1991-12#1)(1994-12#1)(1996-11#1)(1996-2#1)(1996-9#1)(2004-12#1)(2006-12#1)
proposed roles##2##2##(1997-7#1)(2008-3#1)
proposed rule##3##2##(2006-8#3)
proposed sampling design##2##3##(2010-2#2)
proposed scheme is##4##3##(1995-2#1)(2007-12#1)(2008-2#2)
proposed scheme##13##2##(1995-2#1)(2007-12#4)(2008-1#2)(2008-2#3)(2008-3#2)(2010-6#1)
proposed sensor has##3##3##(2008-10#1)(2008-3#1)(2012-1#1)
proposed sensor##25##2##(1992-4#1)(2008-10#21)(2008-2#1)(2008-3#1)(2012-1#1)
proposed sensors##3##2##(2008-10#3)
proposed separation##3##2##(2006-10#1)(2008-10#2)
proposed sequential##2##2##(2008-10#2)
proposed setup##3##2##(2006-6#1)(2008-2#1)(2008-3#1)
proposed solution##5##2##(2007-11#1)(2007-6#1)(2008-6#1)(2013-1#2)
proposed solutions##3##2##(1995-2#1)(2007-10#1)(2011-2#1)
proposed some##2##2##(2008-10#1)(2013-8#1)
proposed strategy of##3##3##(2008-10#2)(2011-2#1)
proposed strategy##7##2##(1996-12#1)(2005-5#1)(2007-8#1)(2008-10#2)(2011-2#1)(2012-3#1)
proposed structure##7##2##(1994-10#1)(2008-10#1)(2008-2#2)(2008-3#2)(2012-1#1)
proposed system can##3##3##(2008-3#2)(2010-8#1)
proposed system handles about##2##4##(2008-10#2)
proposed system is##13##3##(2007-8#1)(2008-10#4)(2008-2#3)(2008-3#3)(2013-1#2)
proposed system was evaluated by##2##5##(2008-10#2)
proposed system was##10##3##(2008-10#8)(2008-2#1)(2012-1#1)
proposed system##51##2##(1994-2#2)(2007-11#3)(2007-8#1)(2008-10#23)(2008-2#6)(2008-3#10)(2010-8#2)(2012-1#2)(2013-1#2)
proposed targets##2##2##(2005-8#1)(2013-1#1)
proposed technique can##2##3##(2008-10#1)(2008-3#1)
proposed technique is##12##3##(1996-6#1)(1997-3#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-6#1)(2010-6#1)
proposed technique of brachial plexus block is##2##7##(2006-8#2)
proposed technique of##4##3##(2006-8#2)(2007-11#1)(2007-12#1)
proposed technique##47##2##(1996-6#1)(1997-3#1)(2006-8#2)(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#14)(2008-2#9)(2008-3#10)(2008-6#1)(2010-2#1)(2010-6#1)(2012-1#1)
proposed techniques##6##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-4#1)(2010-7#1)
proposed test##7##2##(1995-4#1)(1997-7#2)(2012-3#1)(2013-1#3)
proposed that a##6##3##(1994-9#1)(1996-12#1)(2006-5#1)(2006-7#1)(2008-10#1)(2008-11#1)
proposed that an##3##3##(1994-8#1)(1995-3#1)(2008-9#1)
proposed that has##3##3##(2007-11#1)(2008-2#1)(2010-4#1)
proposed that in##3##3##(1993-11#1)(2006-9#1)(2008-11#1)
proposed that is based on##4##5##(2007-11#1)(2008-3#3)
proposed that is##6##3##(2007-11#1)(2008-3#4)(2008-6#1)
proposed that the specificity##2##4##(1993-3#1)(1994-3#1)
proposed that the##61##3##(1990-5#1)(1990-7#1)(1991-6#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-3#2)(1993-8#2)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-2#3)(1995-5#1)(1995-6#1)(1996-1#1)(1996-5#1)(1997-4#1)(1997-7#1)(2005-8#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#2)(2010-10#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#3)
proposed that there##2##3##(2008-5#2)
proposed that these##6##3##(1991-8#1)(1993-11#1)(1996-12#1)(2005-7#1)(2008-11#1)(2011-1#1)
proposed that this##6##3##(1995-11#1)(1997-3#1)(2008-10#1)(2008-4#1)(2012-12#1)(2012-2#1)
proposed that two##2##3##(2008-7#1)(2009-5#1)
proposed that##239##2##(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#2)(1991-11#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-2#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#4)(1993-11#3)(1993-12#1)(1993-3#2)(1993-8#2)(1993-9#1)(1994-10#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#3)(1994-8#2)(1994-9#5)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#3)(1995-5#2)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-4#2)(1996-5#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#3)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-5#3)(2006-6#2)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#3)(2007-3#2)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#16)(2008-11#9)(2008-12#3)(2008-2#9)(2008-3#10)(2008-4#6)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#4)(2009-10#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-8#6)(2009-9#1)(2010-10#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#5)(2012-3#4)(2012-8#1)(2013-1#3)(2013-7#1)(2013-8#4)
proposed the##15##2##(1991-12#1)(1995-12#1)(1995-9#1)(1997-7#1)(2006-12#1)(2006-4#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)(2013-1#3)
proposed therapeutic##2##2##(2008-7#1)(2010-12#1)
proposed to account for the##4##5##(1996-5#1)(2005-11#1)(2007-12#1)(2008-3#1)
proposed to account for##10##4##(1990-8#2)(1991-2#1)(1996-5#1)(2005-11#1)(2007-12#1)(2007-9#1)(2008-3#1)(2008-9#1)(2010-5#1)
proposed to achieve##2##3##(2008-3#1)(2010-2#1)
proposed to address##2##3##(2007-12#1)(2009-4#1)
proposed to affect##2##3##(2008-1#1)(2009-7#1)
proposed to analyze##2##3##(2012-1#1)(2012-12#1)
proposed to arise##2##3##(1992-6#1)(2012-2#1)
proposed to assess the##2##4##(1994-3#1)(2008-2#1)
proposed to be a##8##4##(1991-10#1)(1991-7#1)(1994-6#1)(1995-2#1)(2007-12#1)(2012-1#1)(2013-1#2)
proposed to be important##2##4##(1995-5#1)(2013-1#1)
proposed to be involved in the##3##6##(1994-6#1)(1997-7#1)(2011-12#1)
proposed to be involved in##9##5##(1991-10#1)(1994-11#1)(1994-6#1)(1997-7#2)(2007-11#1)(2011-12#1)(2011-2#1)(2013-8#1)
proposed to be the##6##4##(1990-2#1)(1994-8#1)(2008-4#1)(2008-6#1)(2008-9#1)(2012-2#1)
proposed to be##44##3##(1990-12#1)(1990-2#1)(1990-9#1)(1991-10#2)(1991-2#1)(1991-7#1)(1992-3#1)(1993-12#2)(1993-4#1)(1994-11#1)(1994-6#2)(1994-8#1)(1995-2#1)(1995-5#2)(1996-4#1)(1997-3#1)(1997-7#2)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-8#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#3)(2013-8#1)
proposed to calculate the##3##4##(2007-3#1)(2008-10#1)(2010-2#1)
proposed to carry out##2##4##(1992-5#1)(2008-2#1)
proposed to classify##2##3##(2013-7#2)
proposed to contribute to##2##4##(1997-5#1)(2005-8#1)
proposed to describe the##5##4##(2005-11#1)(2006-5#1)(2008-10#2)(2008-3#1)
proposed to describe##8##3##(1990-9#1)(1991-12#1)(2005-11#1)(2006-5#1)(2008-10#3)(2008-3#1)
proposed to enhance the##2##4##(2007-8#1)(2012-1#1)
proposed to enhance##3##3##(2007-8#1)(2008-3#1)(2012-1#1)
proposed to evaluate##4##3##(2008-10#1)(2008-2#1)(2011-1#1)(2012-12#1)
proposed to explain the##15##4##(1996-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-2#1)(2010-6#1)(2012-3#1)
proposed to explain this##4##4##(1991-3#1)(2006-4#1)(2008-10#1)(2008-9#1)
proposed to explain##22##3##(1991-3#1)(1996-8#1)(2005-8#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-12#1)(2010-2#1)(2010-6#1)(2012-3#1)(2013-8#1)
proposed to form##2##3##(2008-8#1)(2012-2#1)
proposed to function##2##3##(1997-2#1)(1997-6#1)
proposed to have##3##3##(2007-8#1)(2009-8#1)(2013-8#1)
proposed to improve the##3##4##(2008-3#1)(2010-2#1)(2011-2#1)
proposed to improve##4##3##(2008-3#2)(2010-2#1)(2011-2#1)
proposed to include##2##3##(1992-3#1)(2012-3#1)
proposed to interpret the experimental##2##5##(2005-11#2)
proposed to involve##3##3##(2008-10#2)(2010-5#1)
proposed to mediate##2##3##(1995-3#1)(2010-11#1)
proposed to model the##2##4##(2008-3#1)(2011-2#1)
proposed to obtain##2##3##(2008-2#2)
proposed to optimize the##2##4##(2004-8#1)(2008-10#1)
proposed to optimize##3##3##(2004-8#1)(2008-10#1)(2013-1#1)
proposed to play a role in##2##6##(1991-5#1)(2006-10#1)
proposed to play a##9##4##(1990-11#1)(1991-5#1)(2006-10#1)(2008-1#1)(2008-9#1)(2010-2#1)(2011-2#1)(2013-8#2)
proposed to predict the##4##4##(2005-11#1)(2007-11#1)(2008-11#1)(2008-7#1)
proposed to predict##6##3##(2005-11#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-7#1)
proposed to reduce the##2##4##(2004-9#1)(2007-11#1)
proposed to reduce##5##3##(2004-9#1)(2007-11#1)(2007-12#1)(2008-2#1)(2013-1#1)
proposed to reflect the##2##4##(1991-2#1)(1994-2#1)
proposed to regulate##3##3##(1990-8#1)(1993-6#1)(2012-2#1)
proposed to solve##2##3##(2006-2#1)(2008-3#1)
proposed to study the##3##4##(2008-10#2)(2011-1#1)
proposed to study##4##3##(2008-10#3)(2011-1#1)
proposed to take##2##3##(1995-12#1)(1996-2#1)
proposed to the##3##3##(2006-10#1)(2008-10#1)(2013-1#1)
proposed to##268##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#3)(1990-9#2)(1991-10#2)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#1)(1992-3#3)(1992-5#1)(1992-6#1)(1993-12#3)(1993-4#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#2)(1996-5#2)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(2004-8#1)(2004-9#1)(2005-11#7)(2005-8#2)(2006-10#3)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#5)(2007-3#2)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#29)(2008-11#3)(2008-2#22)(2008-3#13)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#6)(2009-10#2)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#7)(2010-3#1)(2010-5#3)(2010-6#3)(2010-7#2)(2011-1#2)(2011-12#1)(2011-2#6)(2011-7#1)(2012-1#7)(2012-12#5)(2012-2#4)(2012-3#4)(2013-1#9)(2013-7#2)(2013-8#5)
proposed treatment##11##2##(1993-2#1)(1997-8#5)(2007-11#1)(2007-3#1)(2007-6#1)(2008-10#1)(2011-2#1)
proposed trial##3##2##(2013-8#3)
proposed use of the##2##4##(1992-5#1)(2008-4#1)
proposed using a##2##3##(2008-10#2)
proposed using the##3##3##(1993-11#1)(2007-1#1)(2008-10#1)
proposed using##10##2##(1992-9#1)(1993-11#1)(2007-1#1)(2007-12#1)(2008-10#5)(2010-8#1)
proposed was##8##2##(2008-10#8)
proposed were##4##2##(2008-10#4)
proposed when##3##2##(1991-2#2)(2008-10#1)
proposed where##2##2##(1993-6#1)(2008-10#1)
proposed which##11##2##(1990-2#1)(1992-1#1)(1992-4#1)(1992-6#1)(1994-8#1)(1995-6#1)(2006-8#1)(2008-11#1)(2009-10#1)(2009-12#1)(2009-9#1)
proposed with the##3##3##(1991-5#1)(2007-12#1)(2011-1#1)
proposed with##8##2##(1991-5#1)(2007-12#2)(2008-10#4)(2011-1#1)
proposed##4179##1##(1990-11#10)(1990-12#7)(1990-2#6)(1990-3#2)(1990-4#2)(1990-5#10)(1990-6#3)(1990-7#7)(1990-8#7)(1990-9#8)(1991-1#6)(1991-10#7)(1991-11#5)(1991-12#8)(1991-2#15)(1991-3#5)(1991-4#5)(1991-5#16)(1991-6#5)(1991-7#6)(1991-8#3)(1991-9#3)(1992-1#6)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#8)(1992-3#13)(1992-4#7)(1992-5#6)(1992-6#8)(1992-7#1)(1992-8#8)(1992-9#5)(1993-1#4)(1993-11#9)(1993-12#7)(1993-2#4)(1993-3#7)(1993-4#2)(1993-5#4)(1993-6#11)(1993-8#4)(1993-9#5)(1994-1#2)(1994-10#4)(1994-11#13)(1994-12#7)(1994-2#13)(1994-3#10)(1994-4#1)(1994-5#8)(1994-6#10)(1994-7#1)(1994-8#11)(1994-9#10)(1995-1#8)(1995-10#1)(1995-11#5)(1995-12#6)(1995-2#17)(1995-3#9)(1995-4#3)(1995-5#11)(1995-6#22)(1995-7#1)(1995-8#8)(1995-9#4)(1996-1#12)(1996-10#2)(1996-11#10)(1996-12#16)(1996-2#9)(1996-3#4)(1996-4#6)(1996-5#11)(1996-6#5)(1996-7#8)(1996-8#11)(1996-9#6)(1997-1#8)(1997-2#13)(1997-3#8)(1997-4#8)(1997-5#4)(1997-6#8)(1997-7#13)(1997-8#16)(2004-12#2)(2004-2#2)(2004-3#2)(2004-8#1)(2004-9#1)(2005-10#4)(2005-11#34)(2005-12#4)(2005-3#1)(2005-4#9)(2005-5#3)(2005-7#1)(2005-8#11)(2006-10#41)(2006-11#9)(2006-12#16)(2006-2#9)(2006-3#2)(2006-4#4)(2006-5#15)(2006-6#10)(2006-7#9)(2006-8#20)(2006-9#2)(2007-1#7)(2007-10#7)(2007-11#76)(2007-12#139)(2007-2#5)(2007-3#7)(2007-4#8)(2007-5#4)(2007-6#7)(2007-7#6)(2007-8#60)(2007-9#14)(2008-1#27)(2008-10#1268)(2008-11#47)(2008-12#12)(2008-2#344)(2008-3#287)(2008-4#19)(2008-5#51)(2008-6#40)(2008-7#50)(2008-8#37)(2008-9#29)(2009-1#2)(2009-10#20)(2009-11#4)(2009-12#11)(2009-2#4)(2009-3#9)(2009-4#12)(2009-5#11)(2009-6#5)(2009-7#6)(2009-8#21)(2009-9#13)(2010-1#5)(2010-10#6)(2010-11#13)(2010-12#16)(2010-2#47)(2010-3#13)(2010-4#14)(2010-5#17)(2010-6#9)(2010-7#7)(2010-8#44)(2010-9#5)(2011-1#39)(2011-12#4)(2011-2#47)(2011-3#2)(2011-7#2)(2012-1#56)(2012-11#5)(2012-12#47)(2012-2#47)(2012-3#57)(2012-6#1)(2012-8#1)(2013-1#84)(2013-7#30)(2013-8#44)
proposes a classification of##2##4##(1994-3#1)(2012-2#1)
proposes a clinical##2##3##(1997-2#1)(2013-1#1)
proposes a model##2##3##(1990-12#1)(1992-1#1)
proposes a new method to##2##5##(2008-10#1)(2008-5#1)
proposes a new method##4##4##(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#1)
proposes a new##15##3##(1997-3#1)(2007-9#1)(2008-10#2)(2008-2#4)(2008-5#2)(2008-6#1)(2009-10#1)(2010-8#1)(2011-3#1)(2012-3#1)
proposes a set of##2##4##(2008-1#1)(2008-7#1)
proposes a simple##2##3##(1991-6#1)(1993-5#1)
proposes a theoretical##2##3##(2006-1#1)(2012-12#1)
proposes a##73##2##(1990-12#1)(1991-6#1)(1992-1#1)(1992-3#1)(1993-2#1)(1993-5#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-3#1)(1997-2#2)(1997-3#1)(2006-1#1)(2007-1#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-2#14)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-6#1)(2010-11#1)(2010-3#1)(2010-8#2)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)
proposes an effective method##2##4##(2005-11#1)(2008-2#1)
proposes an##14##2##(1993-1#1)(1995-1#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-2#2)(2010-2#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
proposes possible##3##2##(1991-12#1)(1992-2#1)(2008-11#1)
proposes that it is##2##4##(2008-1#1)(2008-11#1)
proposes that the##5##3##(1994-12#1)(1995-8#1)(1996-2#1)(2012-12#1)(2012-2#1)
proposes that##30##2##(1991-1#1)(1993-1#1)(1994-12#1)(1994-9#1)(1995-8#1)(1996-2#1)(2004-11#1)(2005-10#1)(2005-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#2)(2009-9#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)
proposes the##7##2##(1996-12#1)(2006-12#1)(2007-8#1)(2008-11#1)(2011-12#1)(2011-2#1)(2012-1#1)
proposes three##2##2##(1991-12#1)(1994-6#1)
proposes to##5##2##(1991-4#1)(1995-2#1)(2007-6#1)(2010-8#1)(2010-9#1)
proposes two##2##2##(1993-3#1)(2008-10#1)
proposes##160##1##(1990-12#1)(1991-1#1)(1991-12#2)(1991-4#1)(1991-6#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-1#3)(1993-2#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-3#3)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#2)(1995-6#2)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#1)(2004-11#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#2)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#8)(2008-11#6)(2008-2#17)(2008-3#1)(2008-5#4)(2008-6#4)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#3)(2009-11#1)(2009-2#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-8#4)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#6)(2011-3#1)(2012-1#4)(2012-12#5)(2012-2#5)(2012-3#4)(2013-1#5)(2013-7#2)
proposing a more##2##3##(2008-9#1)(2010-9#1)
proposing a##10##2##(1997-1#1)(2007-7#1)(2008-9#2)(2010-12#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-12#1)(2012-3#1)
proposing that##6##2##(1995-12#1)(1996-3#1)(1996-7#1)(2006-3#1)(2008-7#1)(2012-12#1)
proposing the##2##2##(1991-1#1)(2007-2#1)
proposing##31##1##(1991-1#1)(1995-12#1)(1996-11#1)(1996-3#1)(1996-7#1)(1997-1#1)(2006-3#2)(2007-2#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#4)(2009-10#2)(2010-12#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-12#1)(2012-1#1)(2012-11#2)(2012-12#2)(2012-3#1)(2013-1#1)
proposita##12##1##(1992-12#6)(1993-3#3)(1994-12#2)(1997-3#1)
proposition for##3##2##(2007-11#1)(2010-2#2)
proposition that##16##2##(1991-11#1)(1991-5#1)(1993-3#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#3)(2009-8#1)(2010-2#1)(2012-2#1)
proposition##35##1##(1991-11#1)(1991-5#1)(1992-6#1)(1993-3#1)(1994-8#1)(1995-6#1)(1996-11#1)(2007-11#5)(2007-4#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#3)(2009-8#1)(2010-2#4)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
propositions in##2##2##(2008-1#1)(2008-4#1)
propositions that##3##2##(1996-12#1)(2009-8#1)(2012-2#1)
propositions##17##1##(1990-12#1)(1993-11#1)(1996-12#1)(1996-2#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-4#2)(2009-11#1)(2009-8#1)(2010-4#3)(2010-8#1)(2012-2#1)(2013-1#1)
propositus##5##1##(1993-5#1)(1996-6#1)(1997-3#1)(2006-7#2)
propounded by##2##2##(2004-12#1)(2005-7#1)
propounded##3##1##(2004-12#1)(2005-7#1)(2007-4#1)
propoxur##2##1##(1997-2#1)(2012-12#1)
propoxyphene##2##1##(1996-7#1)(2010-4#1)
propranolol (10(-8) M)##3##3##(1990-5#3)
propranolol (2##3##2##(1994-5#1)(1996-12#1)(2012-2#1)
propranolol and pindolol##4##3##(2008-10#4)
propranolol and##13##2##(1993-11#1)(1993-2#3)(1994-5#2)(2006-12#1)(2008-10#5)(2010-12#1)
propranolol antagonised the pressor##2##4##(1993-11#2)
propranolol for##2##2##(1994-9#1)(2013-1#1)
propranolol has##2##2##(2009-8#1)(2011-2#1)
propranolol hydrochloride##3##2##(2004-12#2)(2010-6#1)
propranolol in##6##2##(1990-5#1)(1993-5#1)(2008-10#1)(2008-9#1)(2009-8#2)
propranolol protects##2##2##(1991-2#2)
propranolol treatment##2##2##(1995-3#2)
propranolol##98##1##(1990-5#9)(1991-10#1)(1991-2#7)(1991-4#1)(1991-6#2)(1992-8#1)(1993-11#5)(1993-2#6)(1993-3#1)(1993-5#1)(1994-12#2)(1994-3#1)(1994-5#5)(1994-9#2)(1995-12#1)(1995-3#4)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-5#1)(1997-8#1)(2004-12#2)(2006-12#1)(2007-12#1)(2008-10#11)(2008-2#1)(2008-4#2)(2008-7#2)(2008-9#2)(2009-8#7)(2010-12#1)(2010-6#1)(2011-2#3)(2012-12#2)(2012-2#4)(2013-1#1)
propria and##3##2##(1996-10#1)(2009-2#1)(2011-2#1)
propria of the##3##3##(2007-2#1)(2011-2#2)
propria of##5##2##(2007-2#1)(2008-11#1)(2009-1#1)(2011-2#2)
propria##32##1##(1991-7#1)(1991-9#1)(1996-10#1)(1997-1#1)(1997-4#1)(1997-8#1)(2007-2#1)(2008-11#4)(2008-4#5)(2008-5#1)(2009-1#1)(2009-10#3)(2009-2#3)(2009-9#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#2)
propria)##3##1##(2011-2#1)(2013-1#2)
proprietary and##2##2##(2007-12#1)(2008-4#1)
proprietary security##2##2##(1992-12#2)
proprietary standards##2##2##(1996-12#2)
proprietary##25##1##(1992-12#2)(1993-3#1)(1994-3#1)(1996-12#2)(2005-7#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-4#1)(2008-10#4)(2008-4#2)(2008-5#2)(2008-6#1)(2009-11#1)(2009-2#1)(2009-4#1)(2010-5#1)
proprietes##4##1##(2008-5#4)
proprieties##4##1##(2007-11#2)(2012-1#1)(2013-1#1)
propriety##5##1##(1994-3#1)(1995-5#1)(1997-5#1)(1997-8#1)(2007-9#1)
proprioception and##2##2##(1992-8#1)(2007-11#1)
proprioception of the##3##3##(2007-11#1)(2007-7#1)(2010-12#1)
proprioception##17##1##(1992-8#1)(1995-8#1)(1996-5#1)(2006-3#1)(2007-11#3)(2007-5#1)(2007-7#3)(2009-8#1)(2010-12#3)(2012-1#2)
proprioceptive and##3##2##(1992-3#1)(1995-12#1)(2007-6#1)
proprioceptive feedback##2##2##(1993-12#1)(2006-12#1)
proprioceptive stimulation##2##2##(1996-5#2)
proprioceptive##25##1##(1990-6#1)(1992-3#1)(1993-12#2)(1994-8#1)(1995-12#1)(1995-8#1)(1996-5#2)(2006-12#1)(2007-6#1)(2009-1#2)(2009-8#1)(2011-1#4)(2012-1#6)(2013-1#1)
proprioceptive-tactile##2##1##(1993-9#2)
proprioceptors##3##1##(1997-3#1)(2007-11#1)(2009-1#1)
proprotein convertase subtilisin/kexin##2##3##(2008-6#1)(2013-1#1)
proprotein convertase##3##2##(1993-2#1)(2008-6#1)(2013-1#1)
proprotein##5##1##(1993-2#1)(1994-9#1)(2008-6#1)(2008-8#1)(2013-1#1)
proproteins##3##1##(1991-3#1)(1992-12#1)(1993-5#1)
props##3##1##(1996-3#1)(2007-2#1)(2007-3#1)
proptosis with##2##2##(2011-1#1)(2013-8#1)
proptosis##16##1##(2008-7#3)(2008-8#2)(2009-2#2)(2010-10#1)(2010-11#1)(2011-1#4)(2011-2#1)(2013-7#1)(2013-8#1)
propulsion##18##1##(1994-7#1)(2007-10#9)(2007-12#2)(2007-5#1)(2008-10#4)(2011-1#1)
propulsive##4##1##(2007-10#1)(2007-12#1)(2009-2#1)(2010-8#1)
propyl (Pr) and benzyl (Bn) esterifications of γ-PGA##2##8##(2012-11#2)
propyl gallate##2##2##(1992-9#1)(1996-2#1)
propyl##30##1##(1992-3#1)(1992-9#1)(1996-2#1)(1996-8#2)(1997-8#2)(2005-12#1)(2006-3#2)(2007-11#1)(2007-8#1)(2008-10#7)(2008-3#1)(2008-5#3)(2008-7#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-11#2)(2012-3#1)
propyl-beta-carboline-3-carboxylate##2##1##(1991-5#2)
propylene glycol and isopropanol##2##4##(1991-5#2)
propylene glycol and triethyl phosphate##2##5##(2008-11#2)
propylene glycol and##6##3##(1990-9#1)(1991-5#2)(2008-11#3)
propylene glycol##24##2##(1990-9#3)(1991-5#6)(1994-12#1)(2005-11#2)(2005-7#1)(2007-7#1)(2008-10#1)(2008-11#4)(2008-5#5)
propylene oxide (PO)##2##3##(1993-8#1)(2008-5#1)
propylene oxide production rate##2##4##(2008-6#2)
propylene oxide production##4##3##(2008-6#4)
propylene oxide##12##2##(1993-8#2)(2005-11#1)(2008-5#1)(2008-6#8)
propylene##50##1##(1990-9#3)(1991-5#6)(1993-8#2)(1994-12#1)(2005-11#3)(2005-7#1)(2007-10#1)(2007-11#9)(2007-7#1)(2008-10#3)(2008-11#4)(2008-5#8)(2008-6#8)
propylgallate##2##1##(1995-5#1)(2008-10#1)
propylparaben and##3##2##(2008-10#3)
propylparaben##6##1##(2008-10#4)(2013-7#2)
propylthiouracil (PTU) has been##2##4##(1995-3#1)(2006-10#1)
propylthiouracil##4##1##(1995-3#2)(1996-5#1)(2006-10#1)
proregion##6##1##(1992-2#4)(1995-6#2)
prorenin to renin in vitro##2##5##(1990-8#2)
prorenin##12##1##(1990-5#2)(1990-8#3)(1991-9#3)(1996-5#4)
proreninR-4 was##2##2##(1991-9#2)
proreninR-4##4##1##(1991-9#4)
pros and cons of##24##4##(1990-12#1)(1992-1#1)(1996-6#1)(2005-8#1)(2006-6#1)(2007-4#1)(2007-8#1)(2008-11#3)(2008-3#1)(2008-4#2)(2009-5#1)(2010-2#2)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
pros and cons##32##3##(1990-12#1)(1992-1#1)(1994-5#1)(1995-2#1)(1996-6#1)(2005-8#1)(2006-6#1)(2007-4#2)(2007-8#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#2)(2008-7#1)(2009-12#1)(2009-5#1)(2010-2#2)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
pros of changing##2##3##(2008-11#2)
pros##34##1##(1990-12#1)(1992-1#1)(1994-5#1)(1995-2#1)(1996-6#1)(2005-8#1)(2006-6#1)(2007-4#2)(2007-8#1)(2008-10#1)(2008-11#6)(2008-3#1)(2008-4#2)(2008-7#1)(2009-12#1)(2009-5#1)(2010-2#2)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
prosaikogenin##3##1##(2008-11#3)
prosaposin and prosaptides##2##3##(1997-4#2)
prosaposin and##3##2##(1990-11#1)(1997-4#2)
prosaposin##12##1##(1990-11#2)(1991-4#7)(1997-4#3)
prosaptide##2##1##(1997-4#2)
prosaptides at##2##2##(1997-4#2)
prosaptides##5##1##(1997-4#5)
proscription##2##1##(2006-10#1)(2007-10#1)
prosecuted##2##1##(2009-9#1)(2010-12#1)
prosecuting##2##1##(2006-4#1)(2009-4#1)
prosecution of##3##2##(1991-10#1)(2007-5#1)(2012-1#1)
prosecution##9##1##(1990-6#1)(1991-10#1)(1994-3#1)(2006-8#2)(2007-5#1)(2008-10#1)(2008-12#1)(2012-1#1)
prosecutor##3##1##(1995-12#2)(1996-12#1)
prosecutors##3##1##(1991-3#1)(1994-4#1)(2007-9#1)
prosensory cells##2##2##(2012-2#2)
prosequence##5##1##(1990-10#1)(1995-11#1)(1995-6#1)(1996-5#2)
prosesses##2##1##(2006-6#1)(2013-1#1)
prosimians##3##1##(1990-3#1)(2007-12#1)(2009-8#1)
prosobranch##2##1##(1990-2#1)(2011-1#1)
prosocial behavior is##2##3##(2012-12#1)(2012-2#1)
prosocial behavior##7##2##(2008-12#1)(2012-12#3)(2012-2#1)(2013-1#2)
prosocial norms##4##2##(2013-1#4)
prosocial##18##1##(2007-12#1)(2008-12#2)(2009-4#1)(2009-7#1)(2012-12#4)(2012-2#1)(2013-1#7)(2013-8#1)
prosodic cues##3##2##(2009-10#1)(2009-2#2)
prosodic structure##3##2##(2008-4#3)
prosodic##14##1##(2008-4#4)(2009-10#2)(2009-2#3)(2010-9#3)(2013-8#2)
prosody in##2##2##(2009-10#1)(2010-9#1)
prosody##14##1##(2008-11#1)(2008-9#1)(2009-10#4)(2009-2#3)(2010-9#5)
prosoma##2##1##(2007-12#2)
prosomatostatin##6##1##(1994-11#6)
prosomes##5##1##(1997-7#3)(2012-2#2)
prosopagnosia (CP)##2##2##(2009-4#2)
prosopagnosia and##3##2##(1996-11#1)(2008-4#1)(2009-4#1)
prosopagnosia is##2##2##(2009-4#2)
prosopagnosia with##2##2##(2009-4#2)
prosopagnosia##31##1##(1991-11#3)(1996-11#1)(2008-4#1)(2009-4#26)
prosopagnosic patients##3##2##(2009-4#3)
prosopagnosic##10##1##(2008-11#1)(2008-4#1)(2009-4#8)
prosopagnosics##6##1##(2008-11#4)(2009-4#2)
prospect and##2##2##(2006-5#1)(2012-2#1)
prospect for a##2##3##(2010-12#1)(2012-2#1)
prospect for##9##2##(1991-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-9#1)(2009-4#1)(2010-12#1)(2012-2#1)
prospect in the##2##3##(2013-8#2)
prospect in##5##2##(2011-3#1)(2012-1#1)(2013-8#3)
prospect of the##3##3##(1991-12#1)(2007-11#1)(2013-8#1)
prospect of##32##2##(1991-1#1)(1991-11#1)(1991-12#1)(1992-5#1)(1992-6#1)(1993-12#1)(1995-5#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-9#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-8#4)
prospect on##2##2##(2005-11#1)(2012-3#1)
prospect to##2##2##(2005-11#1)(2007-5#1)
prospect##64##1##(1991-1#1)(1991-11#3)(1991-12#1)(1992-5#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-5#1)(1995-5#1)(1997-4#1)(2005-11#3)(2005-7#2)(2006-10#2)(2006-12#3)(2006-5#2)(2007-11#2)(2007-12#1)(2007-5#1)(2007-9#3)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-6#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-8#7)
prospect]##5##1##(1993-2#1)(2004-10#1)(2012-1#1)(2013-7#1)(2013-8#1)
prospecting##3##1##(2006-12#1)(2007-12#1)(2008-9#1)
prospective analysis of##6##3##(2006-7#1)(2007-8#1)(2010-7#1)(2011-1#2)(2011-2#1)
prospective analysis##8##2##(2006-7#1)(2007-8#1)(2008-7#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#1)
prospective and randomized##2##3##(2007-11#1)(2007-8#1)
prospective and retrospective studies##2##4##(2005-12#1)(2011-2#1)
prospective and retrospective##5##3##(2005-12#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)
prospective and##15##2##(2005-12#1)(2006-1#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)
prospective associations##2##2##(2007-12#2)
prospective audit##2##2##(2008-6#1)(2013-1#1)
prospective case series we investigated the##2##6##(2011-2#2)
prospective case##3##2##(2007-6#1)(2011-2#2)
prospective case-based system##2##3##(1992-12#2)
prospective case-control study##3##3##(1992-12#1)(2007-2#1)(2007-8#1)
prospective clinical study##3##3##(2006-2#1)(2011-2#1)(2012-12#1)
prospective clinical trial##7##3##(1990-9#1)(2004-10#1)(2006-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
prospective clinical trials##3##3##(2006-10#1)(2007-8#1)(2011-12#1)
prospective clinical##19##2##(1990-9#1)(1995-2#1)(2004-10#1)(2006-10#2)(2006-2#1)(2006-6#1)(2007-8#1)(2007-9#1)(2009-3#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#1)
prospective cohort of##7##3##(2007-12#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-6#1)(2013-1#2)
prospective cohort studies of##3##4##(2005-10#3)
prospective cohort studies##11##3##(1996-12#1)(2005-10#5)(2008-11#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-4#1)
prospective cohort study of##5##4##(2007-3#1)(2008-3#1)(2008-7#1)(2009-5#1)(2012-1#1)
prospective cohort study on##2##4##(2011-1#1)(2013-1#1)
prospective cohort study was##2##4##(2006-2#1)(2013-1#1)
prospective cohort study##24##3##(1992-11#1)(1996-11#1)(2006-10#1)(2006-2#1)(2007-10#2)(2007-3#1)(2007-8#1)(2008-12#1)(2008-3#3)(2008-7#1)(2009-5#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
prospective cohort##46##2##(1992-11#1)(1996-11#1)(1996-12#1)(2005-10#5)(2006-10#1)(2006-2#1)(2007-10#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#2)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#2)(2012-6#1)(2013-1#5)(2013-7#1)(2013-8#1)
prospective controlled studies##4##3##(1991-2#1)(2006-6#1)(2008-1#1)(2010-5#1)
prospective controlled study##3##3##(1992-10#1)(2006-8#1)(2008-3#1)
prospective controlled##9##2##(1991-2#1)(1992-10#1)(2006-6#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-7#1)(2010-5#1)
prospective data##6##2##(2005-10#1)(2006-10#1)(2007-11#1)(2009-4#1)(2010-12#1)(2011-2#1)
prospective design##2##2##(1995-1#1)(2013-1#1)
prospective diabetes study##2##3##(2006-10#1)(2009-11#1)
prospective double blind##3##3##(1995-2#1)(2012-12#1)(2013-7#1)
prospective double-blind##2##2##(1995-2#1)(2008-8#1)
prospective epidemiological studies##2##3##(2005-10#1)(2010-10#1)
prospective epidemiological##5##2##(2005-10#2)(2008-3#1)(2008-7#1)(2010-10#1)
prospective evaluation is##2##3##(2006-11#1)(2008-4#1)
prospective evaluation of##5##3##(1992-12#1)(1995-4#1)(2008-8#1)(2013-1#2)
prospective evaluation##19##2##(1992-12#1)(1993-4#1)(1995-4#1)(2006-11#1)(2006-7#2)(2006-8#5)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2013-1#4)
prospective evaluation&quot##2##2##(2013-1#2)
prospective follow-up##2##2##(2005-7#1)(2011-2#1)
prospective for##2##2##(2006-8#1)(2013-1#1)
prospective hospital-based##2##2##(2007-10#1)(2007-3#1)
prospective investigation was##2##3##(1991-9#1)(2013-8#1)
prospective investigation##5##2##(1991-12#1)(1991-9#1)(1996-9#1)(2008-7#1)(2013-8#1)
prospective investigations##3##2##(1993-12#1)(2006-10#2)
prospective longitudinal studies##3##3##(2006-10#1)(2007-6#1)(2009-7#1)
prospective longitudinal study##5##3##(2008-8#1)(2010-12#1)(2010-4#1)(2012-12#1)(2013-8#1)
prospective longitudinal##11##2##(2006-10#1)(2007-6#1)(2008-8#1)(2009-10#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
prospective memory##7##2##(2008-1#2)(2013-7#5)
prospective multicenter study##3##3##(2006-12#1)(2008-4#2)
prospective multicenter##7##2##(2006-12#1)(2008-4#2)(2009-10#1)(2009-5#1)(2011-2#1)(2012-12#1)
prospective observational cohort##2##3##(2006-10#1)(2008-11#1)
prospective observational studies##3##3##(1990-3#2)(2005-10#1)
prospective observational study of##2##4##(2007-11#1)(2011-2#1)
prospective observational study was##4##4##(2008-4#1)(2011-2#1)(2012-2#1)(2012-5#1)
prospective observational study##15##3##(2006-1#1)(2007-11#1)(2007-2#1)(2008-3#1)(2008-4#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#1)(2013-8#1)
prospective observational##21##2##(1990-3#2)(2005-10#1)(2006-1#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-4#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#1)(2013-8#1)
prospective on##2##2##(2008-7#1)(2009-9#1)
prospective outcomes study##2##3##(2005-10#1)(2006-8#1)
prospective outcomes##3##2##(2005-10#1)(2006-8#1)(2009-11#1)
prospective parents##3##2##(2007-2#1)(2009-9#1)(2013-1#1)
prospective payment by##2##3##(1991-3#1)(1992-1#1)
prospective payment rates##2##3##(1991-1#2)
prospective payment system (PPS) for##4##5##(1993-3#1)(1994-12#1)(1994-3#1)(1995-3#1)
prospective payment system (PPS)##17##4##(1991-2#1)(1992-1#1)(1992-12#6)(1992-2#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-3#1)(1995-3#1)(1996-3#1)
prospective payment system are##2##4##(1990-12#1)(1991-3#1)
prospective payment system for hospitals##2##5##(1992-2#2)
prospective payment system for##4##4##(1991-1#2)(1992-2#2)
prospective payment system was##2##4##(1990-12#2)
prospective payment system##45##3##(1990-12#4)(1991-1#4)(1991-2#3)(1991-3#3)(1992-1#2)(1992-12#8)(1992-2#6)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-3#2)(1995-2#1)(1995-3#1)(1996-3#1)(2005-8#1)(2008-11#1)(2010-8#1)
prospective payment systems##3##3##(1990-12#2)(1993-12#1)
prospective payment##68##2##(1990-12#6)(1991-1#8)(1991-12#1)(1991-2#4)(1991-3#6)(1992-1#4)(1992-12#10)(1992-2#7)(1992-3#1)(1993-1#3)(1993-12#2)(1993-2#1)(1993-3#1)(1994-12#2)(1994-3#3)(1995-1#1)(1995-2#1)(1995-3#2)(1996-2#1)(1996-3#1)(2005-8#1)(2008-11#1)(2010-8#1)
prospective phase II study##3##4##(2008-10#3)
prospective phase II##4##3##(2008-10#3)(2008-6#1)
prospective phase##5##2##(2008-10#4)(2008-6#1)
prospective pilot study was##2##4##(2007-10#1)(2012-3#1)
prospective pilot study##5##3##(1994-1#1)(2007-10#1)(2012-3#1)(2013-1#2)
prospective pilot##6##2##(1994-1#1)(2006-8#1)(2007-10#1)(2012-3#1)(2013-1#2)
prospective population-based##2##2##(2005-10#1)(2010-3#1)
prospective randomised control trial##2##4##(2010-12#1)(2011-1#1)
prospective randomised control##3##3##(2007-11#1)(2010-12#1)(2011-1#1)
prospective randomised##8##2##(1995-6#1)(2007-11#2)(2007-8#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
prospective randomized clinical trial##3##4##(1991-2#1)(2006-10#1)(2008-5#1)
prospective randomized comparative##2##3##(1993-1#1)(2007-8#1)
prospective randomized controlled##6##3##(2007-5#1)(2008-7#2)(2011-2#1)(2013-8#2)
prospective randomized double blind##3##4##(2009-8#1)(2010-7#1)(2012-12#1)
prospective randomized study##12##3##(1993-1#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-8#2)(2009-10#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#2)
prospective randomized trial of##2##4##(1993-9#1)(2008-10#1)
prospective randomized trial##8##3##(1992-5#1)(1993-4#1)(1993-9#1)(1994-7#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-10#1)
prospective randomized trials##3##3##(1997-4#1)(2008-6#1)(2010-8#1)
prospective randomized##48##2##(1991-2#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-1#3)(1993-4#1)(1993-9#1)(1994-7#2)(1996-3#1)(1997-4#1)(1997-6#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#4)(2008-10#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-7#1)(2013-8#2)
prospective registration of##2##3##(1990-6#1)(2010-5#1)
prospective research##3##2##(2006-10#1)(2009-9#1)(2012-3#1)
prospective review of##3##3##(1992-3#1)(2008-7#1)(2008-8#1)
prospective series of##3##3##(1993-5#1)(1995-9#1)(2008-7#1)
prospective series##5##2##(1993-5#1)(1995-9#1)(2008-1#1)(2008-7#1)(2009-9#1)
prospective studies are needed to##2##5##(1993-11#1)(2008-7#1)
prospective studies are required##2##4##(1995-8#1)(2007-11#1)
prospective studies are warranted##2##4##(2004-3#1)(2006-7#1)
prospective studies are##12##3##(1993-11#1)(1995-8#1)(2004-3#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-7#1)
prospective studies have##6##3##(1997-6#1)(2006-2#1)(2008-7#1)(2008-8#1)(2010-10#1)(2012-3#1)
prospective studies in##2##3##(2009-5#1)(2011-1#1)
prospective studies of##2##3##(2006-2#1)(2008-9#1)
prospective studies provide##2##3##(1993-11#1)(2005-10#1)
prospective studies to##2##3##(1997-5#1)(2013-1#1)
prospective studies##52##2##(1990-10#1)(1990-6#1)(1993-10#1)(1993-11#2)(1995-5#1)(1995-8#1)(1996-11#1)(1997-5#1)(1997-6#1)(2004-3#1)(2005-10#3)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#4)(2006-7#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#2)(2010-10#2)(2010-12#1)(2011-1#1)(2011-12#2)(2012-2#1)(2012-3#1)(2013-1#4)
prospective study among##2##3##(2008-3#1)(2010-3#1)
prospective study at##3##3##(1990-11#1)(1990-5#1)(2008-1#1)
prospective study conducted##2##3##(2012-12#1)(2013-1#1)
prospective study evaluated##2##3##(1995-12#1)(2012-2#1)
prospective study from##4##3##(2007-10#1)(2007-2#1)(2007-7#1)(2010-10#1)
prospective study has been##2##4##(1992-10#1)(2006-6#1)
prospective study has##4##3##(1992-10#1)(2005-10#1)(2006-6#1)(2008-6#1)
prospective study in##9##3##(1990-9#1)(1996-6#1)(2005-7#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-9#1)(2013-1#1)
prospective study included##3##3##(2006-12#1)(2006-6#1)(2012-2#1)
prospective study investigated##2##3##(2007-12#1)(2008-6#1)
prospective study involving##2##3##(2004-2#1)(2007-7#1)
prospective study is##3##3##(2006-10#1)(2007-9#2)
prospective study of a##2##4##(1995-5#1)(2012-12#1)
prospective study of all##3##4##(2006-2#1)(2006-7#1)(2008-1#1)
prospective study of the##3##4##(1994-2#1)(2007-11#1)(2007-7#1)
prospective study of##41##3##(1990-1#1)(1990-10#1)(1990-2#2)(1990-3#1)(1990-5#1)(1991-5#1)(1992-6#3)(1993-2#1)(1993-8#1)(1994-2#1)(1995-2#2)(1995-5#1)(1995-7#1)(2004-11#1)(2006-2#2)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-4#1)(2008-7#4)(2009-3#1)(2009-8#1)(2009-9#1)(2010-6#1)(2011-1#1)(2012-12#1)
prospective study on##9##3##(1990-3#1)(2005-12#1)(2006-10#1)(2006-7#1)(2006-8#2)(2007-7#1)(2008-10#1)(2011-12#1)
prospective study to##4##3##(2006-7#1)(2010-12#1)(2010-2#1)(2010-5#1)
prospective study using##4##3##(1993-11#1)(2010-12#1)(2013-1#2)
prospective study was carried out##7##5##(1990-10#1)(1991-10#1)(2007-1#1)(2007-7#1)(2008-4#1)(2008-5#1)(2013-1#1)
prospective study was conducted in the##2##6##(2011-2#1)(2013-8#1)
prospective study was conducted in##3##5##(2011-2#1)(2012-12#1)(2013-8#1)
prospective study was conducted##12##4##(2005-8#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-3#1)(2009-10#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
prospective study was done on##3##5##(2007-12#1)(2013-8#2)
prospective study was done##4##4##(2007-12#1)(2007-8#1)(2013-8#2)
prospective study was performed in order to##2##7##(1997-5#1)(2008-7#1)
prospective study was performed##5##4##(1992-12#1)(1997-5#1)(2005-5#1)(2007-9#1)(2008-7#1)
prospective study was to##4##4##(1997-8#1)(2006-8#1)(2007-3#1)(2007-9#1)
prospective study was undertaken to##2##5##(2006-8#1)(2008-7#1)
prospective study was##41##3##(1990-10#1)(1991-10#1)(1992-12#1)(1994-6#1)(1997-5#1)(1997-8#1)(2005-5#1)(2005-8#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#4)
prospective study which##3##3##(2007-9#1)(2009-2#1)(2013-8#1)
prospective study##227##2##(1990-1#1)(1990-10#2)(1990-11#1)(1990-2#2)(1990-3#3)(1990-5#2)(1990-9#2)(1991-10#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-6#3)(1993-11#2)(1993-2#2)(1993-5#1)(1993-8#4)(1994-2#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-7#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-10#2)(2004-11#1)(2004-2#1)(2005-10#1)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#3)(2006-2#4)(2006-6#4)(2006-7#4)(2006-8#7)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#4)(2007-2#5)(2007-3#3)(2007-6#2)(2007-7#13)(2007-8#1)(2007-9#7)(2008-1#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#5)(2008-5#2)(2008-6#3)(2008-7#10)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#3)(2009-5#1)(2009-8#2)(2009-9#2)(2010-10#2)(2010-12#5)(2010-2#1)(2010-3#3)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#3)(2012-5#1)(2013-1#11)(2013-7#3)(2013-8#7)
prospective study]##9##2##(1990-3#1)(1990-4#1)(1990-6#1)(1991-3#1)(1991-9#1)(1993-5#1)(2005-1#1)(2009-5#1)(2013-1#1)
prospective survey was carried out in##2##6##(1996-3#1)(2006-10#1)
prospective surveys##4##2##(2008-10#3)(2008-8#1)
prospective systems##3##2##(1994-2#2)(2004-9#1)
prospective trial of##2##3##(1990-10#1)(1993-4#1)
prospective trial was conducted##2##4##(1991-2#1)(1997-2#1)
prospective trial##8##2##(1990-10#1)(1991-2#1)(1993-4#1)(1997-2#1)(2004-2#1)(2009-5#1)(2009-6#1)(2011-2#1)
prospective trials are##2##3##(1993-12#1)(2008-5#1)
prospective trials with##2##3##(2012-3#1)(2013-1#1)
prospective trials##15##2##(1993-12#1)(1996-4#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-5#1)(2007-8#1)(2008-5#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
prospective triple-blind randomized##2##3##(1997-3#2)
prospective##936##1##(1990-1#1)(1990-10#5)(1990-11#1)(1990-12#7)(1990-2#2)(1990-3#6)(1990-4#2)(1990-5#3)(1990-6#4)(1990-9#3)(1991-1#9)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#7)(1991-3#8)(1991-5#2)(1991-9#4)(1992-1#4)(1992-10#2)(1992-11#2)(1992-12#20)(1992-2#7)(1992-3#3)(1992-5#3)(1992-6#3)(1992-8#1)(1993-1#7)(1993-10#1)(1993-11#4)(1993-12#6)(1993-2#4)(1993-3#2)(1993-4#3)(1993-5#4)(1993-7#1)(1993-8#4)(1993-9#2)(1994-1#1)(1994-12#2)(1994-2#5)(1994-3#5)(1994-6#1)(1994-7#3)(1995-1#4)(1995-12#2)(1995-2#7)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#3)(1996-11#4)(1996-12#5)(1996-2#4)(1996-3#4)(1996-4#1)(1996-6#2)(1996-7#1)(1996-9#2)(1997-2#1)(1997-3#5)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#3)(2004-10#3)(2004-11#1)(2004-2#2)(2004-3#1)(2004-9#2)(2005-1#1)(2005-10#16)(2005-11#2)(2005-12#2)(2005-5#2)(2005-7#2)(2005-8#2)(2006-1#2)(2006-10#30)(2006-11#1)(2006-12#7)(2006-2#14)(2006-5#1)(2006-6#8)(2006-7#12)(2006-8#29)(2006-9#4)(2007-1#3)(2007-10#14)(2007-11#15)(2007-12#15)(2007-2#11)(2007-3#5)(2007-4#1)(2007-5#2)(2007-6#6)(2007-7#18)(2007-8#22)(2007-9#11)(2008-1#11)(2008-10#17)(2008-11#10)(2008-12#5)(2008-3#12)(2008-4#13)(2008-5#7)(2008-6#11)(2008-7#28)(2008-8#16)(2008-9#10)(2009-10#6)(2009-11#2)(2009-12#6)(2009-2#5)(2009-3#6)(2009-4#1)(2009-5#8)(2009-6#3)(2009-7#4)(2009-8#4)(2009-9#7)(2010-1#1)(2010-10#6)(2010-11#3)(2010-12#12)(2010-2#1)(2010-3#5)(2010-4#2)(2010-5#8)(2010-6#2)(2010-7#7)(2010-8#4)(2010-9#1)(2011-1#17)(2011-12#5)(2011-2#35)(2012-1#5)(2012-11#1)(2012-12#20)(2012-2#17)(2012-3#19)(2012-5#2)(2012-6#1)(2013-1#42)(2013-7#13)(2013-8#15)
prospectively analyzed##3##2##(2004-2#1)(2006-5#1)(2011-2#1)
prospectively and##5##2##(1991-3#1)(1997-8#1)(2007-8#2)(2010-3#1)
prospectively assessed##7##2##(1994-12#1)(1995-4#1)(2007-10#1)(2007-8#1)(2013-1#3)
prospectively by##3##2##(2008-5#1)(2010-4#1)(2013-7#1)
prospectively collected##7##2##(2006-8#1)(2007-8#4)(2010-11#1)(2012-12#1)
prospectively during##3##2##(1996-3#1)(2011-12#1)(2011-2#1)
prospectively enrolled##4##2##(2007-7#1)(2007-8#1)(2008-4#1)(2013-1#1)
prospectively evaluated by##2##3##(2008-6#1)(2013-1#1)
prospectively evaluated the##2##3##(2007-7#2)
prospectively evaluated##15##2##(1995-2#1)(1996-2#1)(2006-12#1)(2006-4#1)(2006-8#2)(2007-7#3)(2007-9#1)(2008-3#1)(2008-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
prospectively examined##4##2##(1990-9#1)(2006-12#1)(2007-10#1)(2007-12#1)
prospectively followed patients##2##3##(2008-6#2)
prospectively followed##7##2##(2007-10#1)(2007-7#1)(2008-6#4)(2011-2#1)
prospectively for##5##2##(1991-9#1)(1996-1#1)(2007-7#1)(2007-8#2)
prospectively from##3##2##(2004-10#1)(2008-6#1)(2012-3#1)
prospectively gathered##3##2##(2005-9#1)(2008-6#1)(2012-2#1)
prospectively in a##2##3##(2007-10#1)(2013-1#1)
prospectively in##12##2##(1990-11#1)(1990-3#1)(1990-9#1)(1991-4#1)(1991-9#1)(1994-3#1)(2005-12#1)(2007-10#1)(2007-9#1)(2008-7#1)(2012-3#1)(2013-1#1)
prospectively included##4##2##(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#1)
prospectively on##2##2##(2007-8#1)(2012-2#1)
prospectively performed##2##2##(1997-8#1)(2013-7#1)
prospectively randomized##3##2##(2007-7#1)(2007-8#1)(2013-1#1)
prospectively recorded##2##2##(2006-10#1)(2007-8#1)
prospectively recruited##3##2##(1992-2#1)(2007-3#1)(2008-3#1)
prospectively studied##13##2##(1994-12#1)(1995-2#1)(1995-6#1)(1997-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-7#3)(2013-8#1)
prospectively tested##2##2##(1990-12#1)(2008-10#1)
prospectively the##3##2##(1990-3#1)(2007-10#1)(2007-12#1)
prospectively to##4##2##(1992-2#1)(2006-10#1)(2007-10#1)(2012-12#1)
prospectively with emphasis on##2##4##(1990-10#1)(1990-9#1)
prospectively with##6##2##(1990-10#1)(1990-9#1)(1994-1#1)(2008-1#1)(2009-3#1)(2012-12#1)
prospectively##184##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#2)(1990-9#3)(1991-3#1)(1991-4#2)(1991-6#1)(1991-9#2)(1992-2#2)(1993-2#1)(1994-1#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-8#4)(2004-1#1)(2004-10#1)(2004-2#1)(2005-10#1)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#5)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#4)(2007-10#9)(2007-12#4)(2007-3#3)(2007-7#8)(2007-8#18)(2007-9#4)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#7)(2008-7#5)(2008-8#1)(2008-9#1)(2009-3#2)(2009-7#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#3)(2011-1#2)(2011-12#1)(2011-2#9)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#3)(2013-1#8)(2013-7#2)(2013-8#4)
prospectives]##2##1##(1990-12#1)(1997-5#1)
prospects and##4##2##(1995-2#1)(2006-8#1)(2009-10#1)(2009-3#1)
prospects are##5##2##(1990-11#1)(1990-3#1)(1993-11#1)(2008-1#1)(2008-3#1)
prospects for development##2##3##(2007-11#1)(2008-5#1)
prospects for further##5##3##(1990-11#1)(1990-12#1)(2007-11#2)(2008-3#1)
prospects for future##2##3##(1991-9#1)(2008-7#1)
prospects for human##2##3##(2005-7#1)(2006-11#1)
prospects for improvement##2##3##(2009-4#1)(2012-2#1)
prospects for prevention##2##3##(2008-9#1)(2010-2#1)
prospects for the future##6##4##(1997-7#1)(2006-10#1)(2006-5#1)(2007-11#1)(2009-4#1)(2010-3#1)
prospects for the##11##3##(1991-2#1)(1997-7#1)(2005-12#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-2#1)(2008-5#1)(2009-4#1)(2010-11#1)(2010-3#1)
prospects for using##2##3##(1997-6#1)(2008-7#1)
prospects for##83##2##(1990-11#1)(1990-12#1)(1991-2#2)(1991-9#1)(1992-12#1)(1992-3#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-5#1)(1996-12#1)(1997-6#1)(1997-7#1)(2005-12#1)(2005-7#5)(2005-9#1)(2006-10#2)(2006-11#2)(2006-12#2)(2006-5#1)(2006-7#2)(2007-1#1)(2007-11#8)(2007-12#2)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#2)(2009-4#2)(2009-9#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)
prospects in the##4##3##(1991-5#1)(1993-10#1)(2008-3#1)(2013-8#1)
prospects in##9##2##(1991-5#1)(1993-10#1)(1993-6#1)(2006-10#1)(2006-8#1)(2008-3#1)(2008-7#1)(2012-1#1)(2013-8#1)
prospects of##18##2##(1991-12#1)(1993-3#1)(1994-4#1)(1997-7#1)(2004-11#1)(2007-6#1)(2008-10#2)(2008-4#1)(2009-4#2)(2011-2#2)(2011-7#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
prospects##163##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-10#1)(1993-11#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-4#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1997-1#3)(1997-6#1)(1997-7#2)(2004-11#1)(2005-12#1)(2005-7#6)(2005-9#1)(2006-10#3)(2006-11#2)(2006-12#2)(2006-2#1)(2006-5#1)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-11#11)(2007-12#3)(2007-4#2)(2007-6#1)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#6)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#4)(2008-7#5)(2008-8#4)(2008-9#3)(2009-10#2)(2009-11#1)(2009-3#1)(2009-4#4)(2009-7#1)(2009-9#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#3)(2010-9#1)(2011-1#1)(2011-2#6)(2011-7#2)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
prospects]##7##1##(1990-12#1)(1990-3#1)(1991-3#1)(1992-3#1)(1997-3#1)(2012-1#1)(2013-8#1)
prosper##3##1##(1997-2#1)(2006-9#1)(2008-11#1)
prospered##2##1##(1993-12#1)(2004-1#1)
prosperity##4##1##(1994-9#1)(2007-9#1)(2009-10#1)(2011-1#1)
prospero##6##1##(1991-11#4)(2012-12#2)
prosperous##2##1##(1994-9#1)(2008-5#1)
prostacyclin (PGI2) production##2##3##(1991-9#1)(1994-5#1)
prostacyclin (PGI2)##4##2##(1991-9#1)(1994-5#1)(1995-11#1)(2008-3#1)
prostacyclin analogues##3##2##(1994-6#2)(2010-10#1)
prostacyclin and EDRF##2##3##(1992-1#2)
prostacyclin and thromboxane A2##2##4##(1992-1#2)
prostacyclin and##10##2##(1991-12#1)(1991-5#1)(1992-1#4)(2005-11#1)(2006-10#3)
prostacyclin production of##3##3##(1991-8#1)(1994-9#2)
prostacyclin production##12##2##(1991-5#2)(1991-8#3)(1991-9#1)(1992-1#1)(1994-5#1)(1994-9#4)
prostacyclin release from##3##3##(1991-5#2)(1995-11#1)
prostacyclin release##4##2##(1991-5#3)(1995-11#1)
prostacyclin synthase##5##2##(1993-12#1)(1994-8#2)(1995-11#2)
prostacyclin synthesis##5##2##(1991-5#3)(1991-8#1)(1994-5#1)
prostacyclin##67##1##(1990-6#1)(1991-12#1)(1991-2#1)(1991-5#12)(1991-8#5)(1991-9#2)(1992-1#6)(1992-6#1)(1993-12#2)(1994-12#3)(1994-3#1)(1994-5#4)(1994-6#2)(1994-8#2)(1994-9#5)(1995-11#4)(1996-10#1)(1996-2#2)(1996-8#1)(1997-7#1)(2005-11#1)(2006-10#3)(2008-11#1)(2008-3#1)(2010-10#3)(2010-6#1)
prostacyclins##2##1##(1990-3#1)(2010-12#1)
prostaglandin (PG)##3##2##(1993-7#1)(1994-5#1)(2012-2#1)
prostaglandin D2 and##2##3##(1990-2#1)(1992-3#1)
prostaglandin D2##7##2##(1990-2#4)(1992-3#2)(1996-2#1)
prostaglandin E##4##2##(1993-12#1)(1994-5#1)(1994-6#1)(2012-2#1)
prostaglandin E(2) (PGE(2))##3##3##(2008-11#1)(2008-7#1)(2010-9#1)
prostaglandin E1 (PGE1)##4##3##(1993-12#1)(1993-8#1)(1994-2#1)(1997-7#1)
prostaglandin E1##16##2##(1990-11#1)(1990-3#2)(1991-2#2)(1991-8#1)(1993-12#1)(1993-8#1)(1994-2#1)(1997-7#1)(2005-7#1)(2006-10#1)(2007-2#1)(2007-8#3)
prostaglandin E2 (PGE2) and##5##4##(1991-3#1)(1991-8#1)(1993-12#1)(2007-11#1)(2013-8#1)
prostaglandin E2 (PGE2)##14##3##(1990-2#1)(1991-3#1)(1991-8#1)(1992-1#1)(1993-12#1)(1993-7#1)(1995-3#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-11#1)(2008-4#1)(2008-8#1)(2013-8#1)
prostaglandin E2 and##3##3##(1992-4#1)(1993-8#1)(1996-2#1)
prostaglandin E2 levels##2##3##(1991-7#1)(1995-7#1)
prostaglandin E2 production##7##3##(1990-4#2)(1991-8#1)(1992-1#2)(1995-6#1)(1996-8#1)
prostaglandin E2 receptor EP3 subtype##2##5##(1993-7#1)(1994-9#1)
prostaglandin E2 synthesis by##3##4##(1997-1#3)
prostaglandin E2 synthesis##4##3##(1991-3#1)(1997-1#3)
prostaglandin E2##61##2##(1990-2#3)(1990-4#3)(1990-7#1)(1991-3#2)(1991-7#2)(1991-8#2)(1992-1#4)(1992-4#2)(1992-6#1)(1993-11#1)(1993-12#2)(1993-7#2)(1993-8#1)(1994-10#1)(1994-12#1)(1994-9#1)(1995-12#4)(1995-3#1)(1995-6#2)(1995-7#2)(1995-8#1)(1996-10#2)(1996-2#2)(1996-8#1)(1997-1#7)(1997-2#2)(1997-8#1)(2007-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#2)(2013-8#1)
prostaglandin F synthase##5##3##(1992-3#4)(1994-3#1)
prostaglandin F##6##2##(1992-3#4)(1994-3#1)(2005-1#1)
prostaglandin F2 alpha##3##3##(1990-8#1)(1992-11#1)(1996-10#1)
prostaglandin F2##4##2##(1990-8#1)(1990-9#1)(1992-11#1)(1996-10#1)
prostaglandin F2alpha##2##2##(1996-12#1)(2005-7#1)
prostaglandin F2alpha)##2##2##(1996-12#2)
prostaglandin G/H synthase##3##3##(1993-3#2)(1996-8#1)
prostaglandin G/H##4##2##(1993-3#2)(1994-5#1)(1996-8#1)
prostaglandin H synthase##10##3##(1992-8#2)(1994-5#5)(1997-6#1)(2008-4#2)
prostaglandin H synthase-1##2##3##(2008-4#2)
prostaglandin H synthase-2 in##2##4##(1993-3#2)
prostaglandin H synthase-2##10##3##(1993-3#5)(1994-8#1)(2008-1#1)(2008-4#3)
prostaglandin H##24##2##(1991-8#1)(1992-8#2)(1993-3#5)(1994-5#6)(1994-8#1)(1997-6#1)(2008-1#1)(2008-4#7)
prostaglandin H2##2##2##(1992-3#2)
prostaglandin analogues##2##2##(2009-8#1)(2010-2#1)
prostaglandin and##3##2##(1992-3#1)(1996-12#1)(1996-7#1)
prostaglandin biosynthesis##3##2##(2005-11#1)(2007-1#2)
prostaglandin derivatives##2##2##(2006-6#1)(2009-8#1)
prostaglandin endoperoxide H##2##3##(1995-5#2)
prostaglandin endoperoxide synthase (cyclooxygenase)##2##4##(1992-1#2)
prostaglandin endoperoxide synthase and lipoxygenase##2##5##(1991-4#2)
prostaglandin endoperoxide synthase and##3##4##(1991-4#3)
prostaglandin endoperoxide synthase##7##3##(1991-4#5)(1992-1#2)
prostaglandin endoperoxide##12##2##(1991-4#5)(1992-1#2)(1992-3#2)(1993-4#1)(1995-5#2)
prostaglandin formation##3##2##(2006-8#1)(2008-5#2)
prostaglandin production by##2##3##(1991-7#1)(1995-10#1)
prostaglandin production##6##2##(1991-7#1)(1995-10#3)(1996-2#2)
prostaglandin synthases##2##2##(1997-1#1)(2008-6#1)
prostaglandin synthesis in the##2##4##(1990-12#1)(2006-8#1)
prostaglandin synthesis in##5##3##(1990-12#2)(1994-8#1)(1997-1#1)(2006-8#1)
prostaglandin synthesis was##2##3##(1997-1#2)
prostaglandin synthesis##16##2##(1990-12#2)(1991-3#1)(1992-4#1)(1993-12#2)(1993-5#1)(1993-8#1)(1994-8#1)(1995-5#1)(1996-6#1)(1997-1#3)(2006-8#1)(2010-2#1)
prostaglandin##221##1##(1990-11#1)(1990-12#3)(1990-2#8)(1990-3#2)(1990-4#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#3)(1991-3#3)(1991-4#7)(1991-7#4)(1991-8#4)(1992-1#6)(1992-11#1)(1992-3#11)(1992-4#3)(1992-6#1)(1992-8#4)(1993-11#1)(1993-12#6)(1993-3#7)(1993-4#1)(1993-5#1)(1993-7#3)(1993-8#4)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#10)(1994-6#1)(1994-8#2)(1994-9#2)(1995-10#3)(1995-12#4)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#2)(1995-7#2)(1995-8#1)(1996-10#3)(1996-11#1)(1996-12#4)(1996-2#7)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#12)(1997-2#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-1#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-10#3)(2006-5#2)(2006-6#1)(2006-8#2)(2007-1#2)(2007-11#1)(2007-2#1)(2007-8#3)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#8)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-8#4)(2010-2#2)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#2)
prostaglandin-independent##3##1##(1992-8#1)(1993-11#1)(2005-11#1)
prostaglandins (PG)##2##2##(2006-6#1)(2008-4#1)
prostaglandins (PGE2##2##2##(1991-1#2)
prostaglandins (PGs)##3##2##(2008-11#2)(2008-7#1)
prostaglandins also##2##2##(2006-10#2)
prostaglandins and##7##2##(1993-6#1)(2006-10#3)(2008-4#1)(2008-8#1)(2011-2#1)
prostaglandins in the##4##3##(1993-7#1)(1994-12#1)(2006-10#2)
prostaglandins in##6##2##(1991-1#1)(1993-7#1)(1994-12#1)(2006-10#2)(2008-10#1)
prostaglandins on##2##2##(1990-2#1)(2006-10#1)
prostaglandins##70##1##(1990-2#1)(1990-3#1)(1991-1#5)(1991-4#1)(1991-8#2)(1992-11#1)(1992-8#1)(1993-4#2)(1993-6#2)(1993-7#1)(1993-8#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-1#2)(2005-10#1)(2006-10#12)(2006-12#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-4#2)(2008-7#4)(2008-8#1)(2009-8#1)(2010-1#2)(2010-12#1)(2011-2#2)
prostanoid biosynthesis in##2##3##(1991-3#1)(1993-9#1)
prostanoid formation##2##2##(1993-3#2)
prostanoid receptors##2##2##(2005-8#1)(2008-8#1)
prostanoid synthesis##7##2##(1993-3#1)(1994-3#4)(2008-5#1)(2009-1#1)
prostanoid##20##1##(1990-2#1)(1991-3#1)(1993-3#3)(1993-9#1)(1994-3#4)(2005-8#3)(2008-5#1)(2008-8#3)(2009-1#1)(2010-10#2)
prostanoids and##6##2##(1992-1#1)(1992-3#1)(2006-10#1)(2007-11#1)(2008-8#1)(2010-10#1)
prostanoids##23##1##(1992-1#1)(1992-3#2)(1992-8#3)(1993-3#1)(1993-9#2)(1994-8#1)(1995-12#1)(2005-8#1)(2006-10#4)(2007-11#1)(2008-8#2)(2009-7#1)(2010-10#2)(2010-5#1)
prostate (TURP)##3##2##(2006-12#1)(2006-8#1)(2011-1#1)
prostate -##2##2##(2007-11#2)
prostate adenocarcinoma##3##2##(2010-12#1)(2011-2#1)(2013-1#1)
prostate and breast##2##3##(1991-9#1)(2010-10#1)
prostate and colorectal cancer##2##4##(2009-5#2)
prostate and colorectal##3##3##(2009-5#3)
prostate and##22##2##(1990-8#1)(1991-5#1)(1991-9#1)(1992-9#1)(1993-3#1)(1995-11#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-11#1)(2008-2#1)(2008-6#2)(2009-5#3)(2010-10#1)(2013-1#1)
prostate are##2##2##(1991-9#1)(1996-4#1)
prostate biopsy##12##2##(2006-9#3)(2007-3#1)(2009-2#1)(2010-12#4)(2011-2#1)(2012-1#1)(2012-3#1)
prostate cancer (PCa)##2##3##(2013-1#2)
prostate cancer account for##2##4##(2007-11#1)(2008-7#1)
prostate cancer and##13##3##(2006-6#2)(2007-11#4)(2008-2#1)(2008-5#1)(2008-7#2)(2011-2#2)(2012-12#1)
prostate cancer are##2##3##(2008-4#1)(2009-5#1)
prostate cancer between##2##3##(2011-2#1)(2012-3#1)
prostate cancer bone metastases##3##4##(2007-11#2)(2011-2#1)
prostate cancer by##2##3##(1997-7#1)(2008-7#1)
prostate cancer cell line##4##4##(1990-12#1)(2008-9#2)(2012-12#1)
prostate cancer cell##6##3##(1990-12#1)(2008-8#1)(2008-9#2)(2010-1#1)(2012-12#1)
prostate cancer cells and##3##4##(2011-2#2)(2012-3#1)
prostate cancer cells is##2##4##(2011-2#2)
prostate cancer cells##16##3##(1991-8#1)(1996-4#1)(2008-2#1)(2008-6#1)(2009-10#1)(2010-7#1)(2011-2#7)(2012-3#2)(2013-1#1)
prostate cancer development##2##3##(2006-9#1)(2013-1#1)
prostate cancer diagnosis##4##3##(2008-10#1)(2009-2#1)(2011-2#1)(2012-12#1)
prostate cancer has been##3##4##(2006-10#1)(2006-6#1)(2007-3#1)
prostate cancer has##10##3##(1996-2#1)(2006-10#2)(2006-6#2)(2007-3#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#1)
prostate cancer in the United States##2##6##(1995-9#1)(2009-5#1)
prostate cancer in the##4##4##(1995-9#1)(2007-7#1)(2009-5#2)
prostate cancer in##16##3##(1994-12#1)(1995-9#1)(2006-9#1)(2007-11#1)(2007-3#2)(2007-7#1)(2008-8#1)(2009-5#4)(2010-1#1)(2011-2#2)(2012-3#1)
prostate cancer incidence and mortality##2##5##(2009-5#2)
prostate cancer incidence##3##3##(2008-12#1)(2009-5#2)
prostate cancer is##16##3##(1992-2#1)(2006-9#3)(2007-11#1)(2007-2#1)(2007-5#1)(2008-7#2)(2009-5#1)(2010-10#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
prostate cancer may##2##3##(2010-11#1)(2013-1#1)
prostate cancer pathogenesis##2##3##(2011-2#2)
prostate cancer patients with##3##4##(2007-11#2)(2011-2#1)
prostate cancer patients##13##3##(1992-8#2)(1994-8#1)(2006-6#1)(2007-11#3)(2009-5#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
prostate cancer progression##3##3##(2008-1#1)(2008-7#1)(2010-12#1)
prostate cancer risk##7##3##(2004-1#1)(2006-9#1)(2008-12#2)(2012-12#3)
prostate cancer screening##10##3##(2006-9#1)(2009-5#8)(2011-1#1)
prostate cancer should##2##3##(2008-1#1)(2008-4#1)
prostate cancer support groups##2##4##(2009-5#2)
prostate cancer survivors##2##3##(2012-3#2)
prostate cancer survivorship care##2##4##(2012-3#2)
prostate cancer survivorship##3##3##(2012-3#3)
prostate cancer that##2##3##(2007-3#1)(2013-8#1)
prostate cancer therapy##2##3##(2006-9#1)(2011-1#1)
prostate cancer treatment##4##3##(2006-9#1)(2008-7#1)(2009-5#1)(2010-1#1)
prostate cancer using##5##3##(1995-11#1)(1996-2#1)(2007-11#1)(2008-6#1)(2009-12#1)
prostate cancer was##4##3##(2007-2#1)(2007-3#1)(2011-2#1)(2012-12#1)
prostate cancer who##2##3##(1992-4#1)(2008-7#1)
prostate cancer with##3##3##(2006-6#1)(2013-1#2)
prostate cancer##407##2##(1990-12#1)(1990-2#2)(1991-8#2)(1992-11#1)(1992-2#1)(1992-4#1)(1992-8#3)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-4#6)(1995-8#4)(1995-9#3)(1996-2#2)(1996-4#3)(1997-3#1)(1997-7#4)(2004-1#1)(2005-10#3)(2005-3#1)(2005-7#1)(2005-8#2)(2006-10#12)(2006-6#10)(2006-8#1)(2006-9#38)(2007-1#1)(2007-11#20)(2007-12#3)(2007-2#4)(2007-3#7)(2007-4#2)(2007-5#6)(2007-6#4)(2007-7#1)(2008-1#6)(2008-10#4)(2008-11#1)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#8)(2008-5#3)(2008-6#5)(2008-7#33)(2008-8#6)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-5#32)(2009-8#1)(2010-1#4)(2010-10#9)(2010-11#2)(2010-12#11)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#49)(2012-11#1)(2012-12#11)(2012-2#1)(2012-3#12)(2013-1#16)(2013-7#3)(2013-8#9)
prostate cancer]##7##2##(1991-9#3)(2006-7#1)(2009-2#1)(2012-11#1)(2012-12#1)
prostate cancers##10##2##(2005-8#1)(2008-7#3)(2011-2#5)(2012-12#1)
prostate carcinogenesis and##2##3##(2006-9#2)
prostate carcinogenesis##4##2##(2006-9#2)(2008-6#2)
prostate carcinoma##13##2##(1990-12#1)(1994-12#2)(1997-7#1)(2007-11#1)(2008-9#2)(2010-12#1)(2011-2#1)(2013-1#4)
prostate cell##6##2##(1991-8#1)(1993-6#1)(2008-11#1)(2008-9#1)(2012-12#2)
prostate cells##5##2##(1993-6#1)(1995-11#2)(2007-9#1)(2010-1#1)
prostate disease and##2##3##(2008-1#2)
prostate epithelial cells##4##3##(2007-11#1)(2007-9#1)(2008-11#1)(2011-2#1)
prostate gland of##2##3##(2008-7#2)
prostate gland##8##2##(2007-2#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2012-3#2)
prostate glands##3##2##(2007-6#1)(2012-12#2)
prostate health##5##2##(2008-1#4)(2008-4#1)
prostate hyperplasia##4##2##(1990-9#1)(2007-2#3)
prostate images##2##2##(2012-1#2)
prostate in##6##2##(1993-8#1)(1995-4#1)(2007-7#1)(2009-4#1)(2012-3#2)
prostate of##3##2##(1996-11#1)(2007-9#2)
prostate or##3##2##(1991-2#1)(1995-5#1)(2008-7#1)
prostate specific antigen (PSA)##5##4##(1994-12#1)(2007-11#1)(2009-2#1)(2010-5#1)(2011-2#1)
prostate specific antigen##11##3##(1994-12#2)(1995-4#1)(2007-11#1)(2007-3#1)(2008-6#1)(2009-2#2)(2010-5#1)(2011-2#1)(2013-8#1)
prostate specific membrane antigen##2##4##(2007-11#2)
prostate specific##14##2##(1994-12#2)(1995-4#1)(2007-11#3)(2007-3#1)(2008-6#1)(2009-2#2)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
prostate specimens##3##2##(1996-4#1)(2008-6#1)(2011-2#1)
prostate testosterone##5##2##(1994-11#1)(2012-12#4)
prostate tissue##8##2##(2005-12#1)(2006-9#2)(2008-9#1)(2009-5#1)(2011-1#1)(2012-12#2)
prostate tumor cells##2##3##(2008-4#1)(2012-12#1)
prostate tumor##4##2##(2008-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
prostate tumors##7##2##(2008-1#1)(2008-3#1)(2008-4#2)(2011-2#1)(2012-12#2)
prostate volume##2##2##(2006-10#1)(2013-1#1)
prostate volumes##2##2##(2010-12#2)
prostate was##4##2##(1995-8#1)(2007-6#2)(2012-12#1)
prostate were##5##2##(1992-12#1)(1992-9#1)(1995-3#1)(2009-8#1)(2011-2#1)
prostate with##2##2##(1991-9#1)(2012-12#1)
prostate##748##1##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-7#3)(1990-8#2)(1990-9#3)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#4)(1991-8#6)(1991-9#8)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-4#1)(1992-8#3)(1992-9#4)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#4)(1993-9#1)(1994-11#4)(1994-12#7)(1994-2#1)(1994-8#1)(1994-9#2)(1995-11#5)(1995-12#1)(1995-3#1)(1995-4#12)(1995-5#1)(1995-6#2)(1995-8#9)(1995-9#3)(1996-11#4)(1996-2#2)(1996-4#10)(1997-3#2)(1997-6#1)(1997-7#7)(1997-8#1)(2004-1#1)(2005-10#4)(2005-11#1)(2005-12#2)(2005-3#1)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#14)(2006-12#2)(2006-2#2)(2006-6#12)(2006-7#1)(2006-8#2)(2006-9#51)(2007-1#1)(2007-10#1)(2007-11#31)(2007-12#4)(2007-2#8)(2007-3#13)(2007-4#2)(2007-5#7)(2007-6#11)(2007-7#2)(2007-9#8)(2008-1#16)(2008-10#7)(2008-11#8)(2008-12#5)(2008-2#4)(2008-3#6)(2008-4#19)(2008-5#5)(2008-6#12)(2008-7#40)(2008-8#6)(2008-9#6)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#8)(2009-4#2)(2009-5#39)(2009-8#2)(2010-1#5)(2010-10#11)(2010-11#2)(2010-12#23)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#10)(2011-2#69)(2012-1#5)(2012-11#2)(2012-12#37)(2012-2#7)(2012-3#17)(2013-1#26)(2013-7#3)(2013-8#10)
prostate-carcinoma##4##1##(1997-7#1)(2006-10#3)
prostate-specific antigen (PSA)##12##3##(2006-10#3)(2006-6#1)(2006-9#3)(2008-9#1)(2009-5#1)(2010-1#1)(2010-12#1)(2012-12#1)
prostate-specific antigen in the##2##4##(1996-11#1)(1996-9#1)
prostate-specific antigen in##5##3##(1995-4#1)(1996-11#1)(1996-9#1)(2006-9#1)(2007-4#1)
prostate-specific antigen level##3##3##(2006-9#1)(2007-7#1)(2011-1#1)
prostate-specific antigen##41##2##(1990-12#1)(1993-6#1)(1994-3#1)(1995-4#1)(1995-8#1)(1996-11#1)(1996-6#1)(1996-9#1)(2006-10#5)(2006-6#1)(2006-9#9)(2007-4#2)(2007-7#1)(2008-9#2)(2009-5#2)(2010-1#1)(2010-10#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)
prostate-specific membrane##2##2##(1995-11#1)(2008-4#1)
prostate-specific##45##1##(1990-12#1)(1993-6#3)(1994-3#1)(1995-11#1)(1995-4#1)(1995-8#1)(1996-11#1)(1996-6#1)(1996-9#1)(2006-10#5)(2006-6#1)(2006-9#9)(2007-4#2)(2007-7#1)(2008-4#1)(2008-9#2)(2009-5#2)(2010-1#1)(2010-10#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)
prostate]##3##1##(1996-9#1)(2005-10#1)(2007-9#1)
prostatectomies performed##2##2##(2007-7#1)(2010-11#1)
prostatectomies##5##1##(1996-9#1)(2007-7#2)(2008-10#1)(2010-11#1)
prostatectomy for cancer##2##3##(1990-9#1)(2007-7#1)
prostatectomy for##7##2##(1990-9#1)(2007-7#1)(2010-10#2)(2010-12#1)(2011-12#1)(2013-7#1)
prostatectomy in##6##2##(1991-9#1)(2007-3#1)(2008-6#1)(2010-10#1)(2011-2#1)(2013-1#1)
prostatectomy is##5##2##(2006-10#1)(2006-6#1)(2006-9#1)(2009-4#1)(2013-1#1)
prostatectomy##72##1##(1990-9#1)(1991-9#2)(1994-12#1)(1995-11#1)(2006-10#5)(2006-6#3)(2006-9#9)(2007-10#1)(2007-11#5)(2007-3#2)(2007-5#1)(2007-7#6)(2008-1#1)(2008-4#1)(2008-6#2)(2008-7#2)(2009-2#1)(2009-4#1)(2009-5#3)(2010-10#5)(2010-11#2)(2010-12#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#6)(2013-7#2)
prostates were##2##2##(2012-12#2)
prostates##4##1##(1996-4#1)(2008-4#1)(2012-12#2)
prostatic Zn##2##2##(2008-10#2)
prostatic adenocarcinoma##10##2##(1990-3#1)(1992-10#2)(2007-10#1)(2008-4#1)(2008-6#4)(2009-5#1)
prostatic adenoma##3##2##(1990-3#1)(1991-6#1)(1994-3#1)
prostatic biopsy##2##2##(2010-11#1)(2011-1#1)
prostatic cancer by##2##3##(1991-7#1)(1992-5#1)
prostatic cancer patients##3##3##(1992-4#2)(2007-3#1)
prostatic cancer##33##2##(1990-12#2)(1990-9#4)(1991-2#2)(1991-7#6)(1991-9#1)(1992-4#2)(1992-5#2)(1993-8#1)(1994-7#3)(1995-11#1)(1995-12#2)(1996-2#1)(1996-5#1)(1997-5#1)(2006-10#1)(2007-3#1)(2009-5#1)(2013-8#1)
prostatic cancer]##3##2##(1993-6#1)(1995-11#1)(1997-5#1)
prostatic carcinoma in##2##3##(1993-8#1)(1996-12#1)
prostatic carcinoma is##2##3##(1991-9#1)(1993-8#1)
prostatic carcinoma##16##2##(1990-12#1)(1991-2#5)(1991-9#1)(1993-8#3)(1994-11#1)(1996-12#1)(2006-10#1)(2007-6#1)(2008-4#2)
prostatic cell##2##2##(1990-7#1)(1991-2#1)
prostatic disease##3##2##(2006-10#1)(2011-1#1)(2012-12#1)
prostatic epithelial cell##2##3##(1997-7#1)(2008-11#1)
prostatic epithelial cells from##2##4##(1990-7#2)
prostatic epithelial cells##6##3##(1990-7#2)(1993-8#1)(1995-11#1)(1997-7#2)
prostatic epithelial##8##2##(1990-7#2)(1993-8#1)(1995-11#1)(1997-7#3)(2008-11#1)
prostatic glands##2##2##(2005-12#1)(2008-9#1)
prostatic hyperthermia##2##2##(1990-3#2)
prostatic hypertrophy##4##2##(1990-11#1)(1990-3#2)(2008-5#1)
prostatic inflammatory##2##2##(2006-9#1)(2008-10#1)
prostatic intraepithelial neoplasia##3##3##(2005-12#1)(2008-9#1)(2010-10#1)
prostatic involvement by TCC##2##4##(2007-7#2)
prostatic involvement##3##2##(2007-6#1)(2007-7#2)
prostatic lesions##4##2##(2007-6#3)(2009-5#1)
prostatic specific antigen##2##3##(2007-3#1)(2008-9#1)
prostatic urethra and##2##3##(1997-8#1)(2013-8#1)
prostatic urethra##8##2##(1997-8#1)(2006-1#1)(2007-7#2)(2011-12#1)(2012-3#1)(2013-8#2)
prostatic urethral polyp in##2##4##(2006-1#2)
prostatic urethral polyp##3##3##(2006-1#2)(2011-12#1)
prostatic urethral##4##2##(2006-1#2)(2007-7#1)(2011-12#1)
prostatic utricle##3##2##(2010-2#3)
prostatic##190##1##(1990-11#2)(1990-12#3)(1990-3#7)(1990-7#5)(1990-9#7)(1991-12#1)(1991-2#12)(1991-6#1)(1991-7#6)(1991-9#2)(1992-10#2)(1992-2#1)(1992-4#2)(1992-5#2)(1992-8#1)(1993-10#2)(1993-11#1)(1993-2#1)(1993-4#1)(1993-6#2)(1993-8#5)(1994-11#4)(1994-12#1)(1994-3#1)(1994-7#5)(1995-11#3)(1995-12#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-5#2)(1997-7#4)(1997-8#1)(2005-12#2)(2006-1#4)(2006-10#3)(2006-7#2)(2006-8#2)(2006-9#12)(2007-10#2)(2007-3#5)(2007-6#5)(2007-7#5)(2007-9#2)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#5)(2008-5#3)(2008-6#8)(2008-7#1)(2008-9#5)(2009-5#3)(2010-10#1)(2010-11#1)(2010-2#3)(2011-1#3)(2011-12#3)(2011-2#2)(2012-12#3)(2012-3#1)(2013-8#3)
prostatitis due to Trichomonas vaginalis##2##5##(2008-10#2)
prostatitis is##2##2##(2008-5#1)(2008-6#1)
prostatitis syndrome##3##2##(2008-10#3)
prostatitis##40##1##(1990-3#1)(1991-12#1)(2006-8#2)(2006-9#2)(2008-10#14)(2008-12#1)(2008-5#2)(2008-6#10)(2008-8#1)(2010-11#2)(2011-1#3)(2011-2#1)
prostatitis)##3##1##(2008-6#3)
prostatitis/chronic pelvic pain syndrome##7##4##(2006-8#2)(2008-5#1)(2008-6#3)(2010-10#1)
prostatitis]##2##1##(1991-6#1)(2010-11#1)
prostheses after##2##2##(2008-6#1)(2011-2#1)
prostheses and a##2##3##(1993-8#1)(2010-8#1)
prostheses and other##2##3##(1991-3#1)(2011-2#1)
prostheses and##15##2##(1990-11#1)(1991-3#1)(1992-1#1)(1993-10#1)(1993-8#1)(2004-9#1)(2008-1#1)(2008-6#1)(2009-1#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#2)
prostheses are##9##2##(1990-8#1)(1991-3#1)(1994-6#1)(2007-11#1)(2008-6#1)(2009-12#1)(2010-8#1)(2011-12#1)(2012-2#1)
prostheses for the##2##3##(2010-6#1)(2011-7#1)
prostheses for##3##2##(2008-8#1)(2010-6#1)(2011-7#1)
prostheses have##5##2##(1993-8#2)(2009-1#1)(2010-8#2)
prostheses in the treatment of##3##5##(1992-3#1)(2007-8#1)(2009-4#1)
prostheses in the##4##3##(1992-3#1)(1993-9#1)(2007-8#1)(2009-4#1)
prostheses in##8##2##(1990-7#1)(1991-5#1)(1992-3#1)(1993-9#1)(2006-2#1)(2007-8#1)(2009-4#1)(2012-2#1)
prostheses may##2##2##(2011-2#1)(2013-1#1)
prostheses of the##2##3##(2007-11#1)(2009-1#1)
prostheses of##3##2##(1990-8#1)(2007-11#1)(2009-1#1)
prostheses that##3##2##(2007-3#1)(2007-5#1)(2012-1#1)
prostheses to##3##2##(1992-2#1)(2011-2#1)(2013-1#1)
prostheses were##4##2##(2007-11#1)(2009-1#1)(2011-2#1)(2013-1#1)
prostheses##139##1##(1990-11#1)(1990-12#2)(1990-4#1)(1990-7#1)(1990-8#4)(1991-3#2)(1991-4#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-3#2)(1993-10#2)(1993-8#5)(1993-9#1)(1994-6#4)(1995-9#1)(2004-9#3)(2005-10#1)(2006-2#2)(2006-3#2)(2007-11#7)(2007-2#1)(2007-3#2)(2007-5#2)(2007-7#3)(2007-8#5)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#6)(2008-8#1)(2009-1#9)(2009-12#1)(2009-3#1)(2009-4#3)(2009-6#1)(2009-7#4)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-6#2)(2010-8#8)(2011-1#1)(2011-12#1)(2011-2#7)(2011-3#2)(2011-7#1)(2012-1#4)(2012-2#4)(2013-1#15)
prostheses]##6##1##(1990-10#1)(1990-12#1)(1993-2#1)(1994-11#1)(2010-8#1)(2012-2#1)
prosthesis after##2##2##(2009-4#1)(2013-1#1)
prosthesis and a##2##3##(2006-12#1)(2007-6#1)
prosthesis and##12##2##(1992-1#1)(1993-6#1)(2006-12#1)(2007-6#1)(2007-7#2)(2007-8#3)(2011-2#1)(2012-2#1)(2013-1#1)
prosthesis at##3##2##(1993-11#1)(2007-3#1)(2009-3#1)
prosthesis can be##2##3##(2009-3#2)
prosthesis can##4##2##(2009-3#2)(2011-3#1)(2012-1#1)
prosthesis during##2##2##(2011-7#1)(2013-1#1)
prosthesis fitting and rehabilitation##3##4##(2007-7#3)
prosthesis fitting##4##2##(2007-7#4)
prosthesis for a##3##3##(2011-12#1)(2012-1#1)(2013-8#1)
prosthesis for##6##2##(1990-10#1)(2007-11#1)(2011-12#1)(2011-3#1)(2012-1#1)(2013-8#1)
prosthesis has been reported to##2##5##(1992-2#1)(2009-4#1)
prosthesis has been##3##3##(1992-2#1)(1993-3#1)(2009-4#1)
prosthesis has##6##2##(1992-2#1)(1993-3#1)(2007-8#3)(2009-4#1)
prosthesis implant##2##2##(2009-4#1)(2013-1#1)
prosthesis implantation##4##2##(2007-11#1)(2007-8#2)(2013-8#1)
prosthesis in a patient##2##4##(1993-10#1)(2006-10#1)
prosthesis in a##4##3##(1993-10#1)(2006-10#1)(2007-2#1)(2007-8#1)
prosthesis in the treatment##2##4##(2006-12#1)(2008-6#1)
prosthesis in the##3##3##(2006-12#1)(2007-8#1)(2008-6#1)
prosthesis in##15##2##(1992-9#1)(1993-10#1)(2006-10#2)(2006-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-3#1)(2008-6#2)(2008-8#1)(2009-12#1)(2009-3#1)
prosthesis infection##2##2##(2008-1#1)(2011-3#1)
prosthesis insertion##5##2##(1993-6#1)(2008-10#1)(2013-8#3)
prosthesis is##5##2##(2008-6#1)(2010-5#1)(2012-1#1)(2013-1#2)
prosthesis occlusion##2##2##(1992-1#1)(1992-5#1)
prosthesis or##3##2##(2006-10#1)(2009-3#1)(2013-1#1)
prosthesis replacement##2##2##(2007-11#1)(2007-8#1)
prosthesis that##2##2##(2013-1#2)
prosthesis using##2##2##(2005-3#1)(2008-11#1)
prosthesis was implanted##2##3##(2007-8#1)(2009-4#1)
prosthesis was used##2##3##(2007-11#1)(2013-1#1)
prosthesis was##15##2##(1990-2#1)(2007-11#3)(2007-8#4)(2008-6#2)(2009-3#2)(2009-4#1)(2011-2#1)(2013-1#1)
prosthesis which##3##2##(1990-2#1)(2006-8#1)(2008-11#1)
prosthesis with##4##2##(2008-6#1)(2010-5#1)(2010-8#1)(2012-2#1)
prosthesis##243##1##(1990-10#2)(1990-2#4)(1990-8#1)(1991-2#3)(1992-1#2)(1992-2#1)(1992-5#2)(1992-9#1)(1993-10#3)(1993-11#3)(1993-3#2)(1993-6#3)(1993-8#1)(1994-3#1)(1996-6#1)(1997-5#1)(1997-6#1)(2005-12#1)(2005-3#1)(2006-10#3)(2006-12#2)(2006-8#6)(2007-11#12)(2007-2#2)(2007-3#4)(2007-5#1)(2007-6#1)(2007-7#20)(2007-8#36)(2007-9#4)(2008-1#2)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#2)(2008-6#14)(2008-8#2)(2008-9#3)(2009-1#1)(2009-12#5)(2009-3#11)(2009-4#5)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-12#3)(2011-2#9)(2011-3#5)(2011-7#1)(2012-1#13)(2012-12#2)(2012-2#4)(2013-1#18)(2013-7#1)(2013-8#6)
prosthesis)##2##1##(1992-5#2)
prosthesis]##6##1##(1990-10#1)(1990-3#1)(1996-6#1)(2007-9#1)(2011-2#1)(2013-1#1)
prosthesoplasty after tumor resection in the proximal femur##2##8##(2007-7#2)
prosthesoplasty after##3##2##(2007-7#3)
prosthetic complications were##2##3##(2013-1#2)
prosthetic components##2##2##(2013-1#2)
prosthetic device##2##2##(1993-5#1)(2008-2#1)
prosthetic devices##5##2##(2006-11#2)(2010-3#1)(2012-1#1)(2013-8#1)
prosthetic failure##2##2##(2009-3#1)(2010-3#1)
prosthetic finite element modeling##2##4##(2007-7#2)
prosthetic graft##6##2##(1992-3#1)(2007-7#1)(2009-6#1)(2011-3#2)(2012-1#1)
prosthetic grafts for##2##3##(2007-7#2)
prosthetic grafts##5##2##(1991-3#1)(2007-7#4)
prosthetic group and##2##3##(1992-10#1)(1994-11#1)
prosthetic group of the##2##4##(1995-3#1)(1996-5#1)
prosthetic group##19##2##(1990-12#1)(1990-7#1)(1992-10#1)(1992-11#1)(1992-8#2)(1993-8#1)(1994-11#2)(1994-12#1)(1995-3#1)(1995-8#3)(1996-5#1)(1997-5#1)(2007-11#1)(2008-12#1)(2013-1#1)
prosthetic groups##6##2##(2008-11#1)(2008-7#3)(2011-2#2)
prosthetic hands##2##2##(2012-1#2)
prosthetic head size##2##3##(2008-2#2)
prosthetic head##3##2##(2008-2#3)
prosthetic heart valve##4##3##(2005-12#2)(2006-1#1)(2007-8#1)
prosthetic heart valves##3##3##(2007-8#2)(2008-3#1)
prosthetic heart##9##2##(2005-12#2)(2005-9#1)(2006-1#1)(2007-8#4)(2008-3#1)
prosthetic implants##3##2##(2008-3#1)(2008-9#1)(2011-2#1)
prosthetic joint infection due to##2##5##(2007-12#1)(2010-9#1)
prosthetic joint infection##3##3##(2007-12#1)(2010-9#1)(2012-12#1)
prosthetic joint infections##2##3##(2011-2#1)(2013-1#1)
prosthetic joint##7##2##(2006-10#1)(2007-12#2)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
prosthetic knee##5##2##(2011-2#2)(2013-1#3)
prosthetic leaflet##2##2##(2007-8#2)
prosthetic material##3##2##(2011-1#1)(2011-2#1)(2012-2#1)
prosthetic materials in##2##3##(2010-2#1)(2012-2#1)
prosthetic materials##7##2##(1990-4#1)(2006-11#1)(2010-2#3)(2011-2#1)(2012-2#1)
prosthetic mesh##2##2##(2011-2#2)
prosthetic meshes##3##2##(2011-2#3)
prosthetic reconstruction##3##2##(1990-6#1)(2007-12#1)(2010-6#1)
prosthetic rehabilitation of a##3##4##(2009-11#1)(2012-2#1)(2013-8#1)
prosthetic rehabilitation of##4##3##(2009-11#1)(2011-12#1)(2012-2#1)(2013-8#1)
prosthetic replacement of##2##3##(2006-8#1)(2012-2#1)
prosthetic replacement##9##2##(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-6#1)(2008-7#1)(2012-1#1)(2012-2#1)
prosthetic treatment##2##2##(2007-9#1)(2013-1#1)
prosthetic valve dysfunction##3##3##(2008-4#2)(2012-2#1)
prosthetic valve endocarditis##3##3##(2005-12#2)(2011-2#1)
prosthetic valve methicillin-resistant Staphylococcus aureus endocarditis in a patient with chronic liver disease##2##13##(2007-8#2)
prosthetic valve##14##2##(2005-12#3)(2007-12#1)(2007-8#5)(2008-4#2)(2011-2#1)(2012-2#1)(2013-1#1)
prosthetic valves##5##2##(2004-9#1)(2007-8#4)
prosthetic##190##1##(1990-12#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#1)(1991-3#2)(1992-10#1)(1992-11#1)(1992-3#1)(1992-5#3)(1992-8#2)(1993-2#1)(1993-5#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-3#1)(1995-8#4)(1995-9#1)(1996-2#1)(1996-5#1)(1997-5#1)(2004-9#1)(2005-12#5)(2005-9#1)(2006-1#1)(2006-10#2)(2006-11#3)(2006-12#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-7#8)(2007-8#25)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#5)(2008-9#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-2#3)(2010-3#4)(2010-6#2)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#17)(2011-3#3)(2012-1#7)(2012-12#1)(2012-2#5)(2013-1#17)(2013-8#2)
prosthetically##2##1##(2007-12#1)(2012-2#1)
prosthetics##5##1##(2007-12#1)(2010-3#1)(2012-1#1)(2012-3#1)(2013-7#1)
prosthetist##2##1##(2010-3#1)(2013-1#1)
prosthodontic##8##1##(2007-12#1)(2008-11#1)(2008-4#1)(2010-12#1)(2011-12#1)(2012-2#1)(2012-7#1)(2013-1#1)
prosthodontics##7##1##(1990-3#1)(2008-6#2)(2010-10#2)(2013-1#2)
prostitute##4##1##(1992-9#2)(1996-5#1)(2008-5#1)
prostitutes were##2##2##(1990-6#1)(2006-10#1)
prostitutes who##2##2##(1990-3#2)
prostitutes##17##1##(1990-12#1)(1990-2#1)(1990-3#3)(1990-6#1)(1990-9#1)(1991-6#4)(1993-3#1)(1993-8#1)(1995-12#1)(2006-10#1)(2007-9#1)(2008-8#1)
prostitution##17##1##(1990-12#2)(1990-2#1)(1991-6#1)(1994-3#5)(1997-5#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2009-7#2)(2011-2#1)
prostomial##2##1##(2008-5#1)(2011-2#1)
prostrata##2##1##(2007-1#1)(2010-2#1)
prostratin##6##1##(1992-5#6)
prostration##2##1##(2007-2#1)(2008-2#1)
prosurvival##4##1##(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
prot)##4##1##(1993-4#2)(1993-8#1)(2006-5#1)
protachykinin mRNA levels##5##3##(1990-5#5)
protachykinin##6##1##(1990-5#5)(1995-5#1)
protagonists and##2##2##(2008-2#1)(2012-1#1)
protagonists##4##1##(1993-3#1)(2007-4#1)(2008-2#1)(2012-1#1)
protamine 1##3##2##(2012-12#3)
protamine P2##6##2##(1991-2#5)(1994-6#1)
protamine and##2##2##(1993-8#1)(1994-9#1)
protamine or##2##2##(1995-8#1)(1996-6#1)
protamine sulfate treatment##2##3##(1990-6#1)(2008-6#1)
protamine##35##1##(1990-6#1)(1990-7#1)(1990-9#3)(1991-2#5)(1992-1#1)(1993-8#2)(1994-6#2)(1994-9#2)(1995-8#1)(1996-6#1)(2007-8#4)(2008-10#2)(2008-6#2)(2008-8#1)(2010-1#1)(2011-1#1)(2012-12#5)
protamine-DNA##2##1##(1994-6#2)
protamines P1 and P2##2##4##(1991-2#1)(1994-6#1)
protamines were##2##2##(1990-9#1)(1992-1#1)
protamines##21##1##(1990-7#2)(1990-9#4)(1991-2#2)(1992-1#7)(1993-6#1)(1994-6#5)
protean clinical manifestations##2##3##(2007-7#1)(2008-7#1)
protean in##2##2##(1991-4#1)(2013-8#1)
protean manifestations##4##2##(2006-10#1)(2007-9#1)(2010-12#1)(2011-2#1)
protean##13##1##(1991-4#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-7#1)(2007-9#1)(2008-7#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
protease Do##4##2##(1991-4#4)
protease activation and##2##3##(2006-10#1)(2006-12#1)
protease activation##4##2##(2006-10#1)(2006-12#1)(2008-4#1)(2008-5#1)
protease activities##5##2##(2008-5#3)(2008-9#1)(2012-3#1)
protease activity and##5##3##(1992-4#1)(1996-9#1)(2008-1#1)(2008-4#1)(2011-2#1)
protease activity in##3##3##(1991-12#1)(2008-11#1)(2008-4#1)
protease activity was##2##3##(1991-4#1)(2011-2#1)
protease activity##33##2##(1991-1#1)(1991-10#1)(1991-12#2)(1991-4#1)(1992-4#1)(1995-10#1)(1995-8#2)(1996-2#1)(1996-9#7)(1997-4#2)(1997-7#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#4)
protease and a##3##3##(1996-3#1)(2006-10#1)(2008-2#1)
protease and of##2##3##(1994-12#1)(2005-9#1)
protease and the##3##3##(1991-10#1)(1992-4#1)(1994-12#1)
protease and##23##2##(1991-10#1)(1991-5#1)(1991-9#2)(1992-4#1)(1994-12#3)(1994-6#2)(1994-8#2)(1996-3#1)(2005-9#1)(2006-10#1)(2008-1#1)(2008-2#1)(2009-9#1)(2011-2#1)(2011-3#2)(2012-2#2)
protease as##2##2##(1991-5#1)(1991-9#1)
protease at##2##2##(1990-10#1)(1995-1#1)
protease binding##2##2##(1991-2#1)(1994-12#1)
protease by##4##2##(1992-4#1)(1994-5#1)(2010-2#2)
protease cascade##2##2##(1996-10#1)(2005-12#1)
protease cleavage site##2##3##(1995-5#1)(1996-2#1)
protease cleavage sites##3##3##(1992-5#1)(2008-11#1)(2008-4#1)
protease cleavage##8##2##(1992-5#1)(1994-2#1)(1995-5#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-4#2)
protease digestion##6##2##(1990-10#1)(1993-6#1)(1995-3#1)(1996-11#1)(2008-4#1)(2008-5#1)
protease domain of##2##3##(1994-12#1)(1995-6#1)
protease domain##9##2##(1994-12#2)(1995-3#2)(1995-6#3)(2012-1#1)(2012-2#1)
protease factor Xa##2##3##(1995-1#1)(1995-8#1)
protease for##2##2##(1997-7#1)(2010-2#1)
protease from##9##2##(1990-8#2)(1991-1#1)(1992-6#1)(1992-8#1)(1993-3#2)(1994-12#1)(1996-10#1)
protease gene##7##2##(1994-12#4)(1995-3#1)(1996-8#1)(2005-9#1)
protease has been##2##3##(1991-9#2)
protease has##4##2##(1990-10#1)(1991-12#1)(1991-9#2)
protease have been##2##3##(2008-1#1)(2013-1#1)
protease in the##4##3##(1992-6#2)(1994-12#1)(2011-3#1)
protease in vitro##2##3##(1994-5#1)(2011-3#1)
protease in##15##2##(1991-12#1)(1991-6#1)(1991-9#1)(1992-6#2)(1994-12#1)(1994-5#1)(1996-8#1)(1997-1#1)(1997-7#1)(2008-10#1)(2011-3#2)(2012-1#1)(2012-2#1)
protease inhibition##2##2##(1995-9#1)(2012-3#1)
protease inhibitor (KPI) domain##2##4##(1992-12#1)(1992-7#1)
protease inhibitor (KPI) insert##3##4##(1990-9#1)(1996-12#2)
protease inhibitor (KPI)##5##3##(1990-9#1)(1992-12#1)(1992-7#1)(1996-12#2)
protease inhibitor domain##10##3##(1990-8#2)(1990-9#1)(1991-11#1)(1991-2#1)(1992-12#1)(1992-7#1)(1994-11#2)(1994-6#1)
protease inhibitor therapy##2##3##(2007-12#1)(2013-1#1)
protease inhibitor##64##2##(1990-10#2)(1990-2#2)(1990-3#3)(1990-8#2)(1990-9#2)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#3)(1992-12#3)(1992-7#3)(1994-11#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-5#1)(1995-9#8)(1996-12#2)(1996-6#2)(1996-9#1)(2005-7#1)(2005-8#2)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-12#1)(2012-1#1)(2013-1#2)
protease inhibitor)##2##2##(1995-9#1)(1996-8#1)
protease inhibitors (PIs)##3##3##(2007-11#1)(2008-5#1)(2011-2#1)
protease inhibitors and##6##3##(1996-5#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-3#1)(2012-12#1)
protease inhibitors on##3##3##(1991-1#1)(1991-2#1)(2010-5#1)
protease inhibitors tested##2##3##(1990-2#1)(1995-1#1)
protease inhibitors that##2##3##(1996-5#1)(2006-9#1)
protease inhibitors to##3##3##(1991-2#1)(1996-12#1)(2013-1#1)
protease inhibitors were##3##3##(1990-11#1)(1991-8#1)(2009-4#1)
protease inhibitors with##2##3##(1991-3#1)(1995-9#1)
protease inhibitors##94##2##(1990-10#1)(1990-11#2)(1990-2#1)(1991-1#1)(1991-2#6)(1991-3#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#2)(1993-4#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-5#1)(1995-8#1)(1995-9#3)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#3)(1996-7#1)(1996-8#3)(1997-4#1)(1997-7#2)(2004-12#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-9#1)(2007-1#2)(2007-11#4)(2007-12#1)(2008-1#3)(2008-3#1)(2008-4#2)(2008-5#3)(2008-8#1)(2009-4#3)(2009-8#2)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-12#4)(2012-3#3)(2013-1#2)
protease inhibitors)##2##2##(1992-3#1)(2008-4#1)
protease inhibitory##3##2##(1991-12#1)(1992-7#1)(1995-6#1)
protease involved in##3##3##(1995-5#1)(2008-6#1)(2008-7#1)
protease is the##2##3##(1992-4#1)(1993-3#1)
protease is##16##2##(1990-12#1)(1990-2#1)(1991-9#1)(1992-4#3)(1993-3#1)(1994-12#1)(1994-5#1)(1995-8#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-7#1)(2010-2#1)
protease may##2##2##(1990-9#1)(2009-8#1)
protease nexin##3##2##(1991-6#2)(1995-1#1)
protease nexin-2 (PN-2)##3##3##(1991-2#1)(1992-12#1)(1992-7#1)
protease nexin-2/amyloid beta-protein precursor##3##4##(1992-12#1)(1992-7#1)(1995-1#1)
protease of##9##2##(1990-7#1)(1991-2#1)(1991-5#1)(1991-7#1)(1993-12#1)(1995-3#2)(2008-4#1)(2012-3#1)
protease or##2##2##(2005-7#1)(2008-4#1)
protease produced by##4##3##(1991-1#2)(2008-10#2)
protease produced##5##2##(1991-1#3)(2008-10#2)
protease production##4##2##(1992-6#2)(1993-9#1)(2008-10#1)
protease resistant##2##2##(1994-6#1)(1997-3#1)
protease sensitivity of##2##3##(1994-9#1)(1997-2#1)
protease sensitivity##3##2##(1994-9#2)(1997-2#1)
protease substrates##5##2##(1992-12#1)(2006-10#1)(2008-4#3)
protease that is##2##3##(1994-12#1)(2006-12#1)
protease to##3##2##(1990-12#1)(1990-8#1)(1991-10#1)
protease treatment##2##2##(1990-11#1)(2008-10#1)
protease was not##2##3##(2008-10#2)
protease was##9##2##(1990-8#1)(1992-3#1)(1995-3#1)(1996-8#1)(2008-10#4)(2010-2#1)
protease which is##2##3##(1996-8#1)(2013-8#1)
protease which##4##2##(1993-3#1)(1996-10#1)(1996-8#1)(2013-8#1)
protease with##10##2##(1991-7#1)(1992-12#1)(1992-8#2)(1993-11#1)(1994-12#3)(1994-5#1)(1996-8#1)
protease##635##1##(1990-10#9)(1990-11#3)(1990-12#4)(1990-2#6)(1990-3#4)(1990-4#1)(1990-5#1)(1990-7#3)(1990-8#6)(1990-9#3)(1991-1#9)(1991-10#4)(1991-11#2)(1991-12#12)(1991-2#17)(1991-3#2)(1991-4#6)(1991-5#4)(1991-6#6)(1991-7#6)(1991-8#1)(1991-9#17)(1992-1#2)(1992-11#7)(1992-12#15)(1992-3#5)(1992-4#11)(1992-5#4)(1992-6#17)(1992-7#6)(1992-8#10)(1992-9#5)(1993-11#4)(1993-12#12)(1993-2#1)(1993-3#8)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#25)(1994-2#2)(1994-3#3)(1994-5#10)(1994-6#6)(1994-8#7)(1994-9#4)(1995-1#13)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#14)(1995-5#4)(1995-6#6)(1995-7#2)(1995-8#11)(1995-9#14)(1996-1#1)(1996-10#5)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#2)(1996-5#4)(1996-6#2)(1996-7#2)(1996-8#12)(1996-9#10)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#6)(1997-7#10)(2004-12#1)(2005-10#1)(2005-12#1)(2005-7#2)(2005-8#3)(2005-9#3)(2006-1#1)(2006-10#5)(2006-11#2)(2006-12#2)(2006-4#1)(2006-6#1)(2006-9#1)(2007-1#2)(2007-11#6)(2007-12#4)(2007-3#1)(2007-6#1)(2008-1#8)(2008-10#20)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#18)(2008-5#16)(2008-6#4)(2008-7#3)(2008-8#3)(2008-9#2)(2009-12#1)(2009-4#4)(2009-7#1)(2009-8#5)(2009-9#1)(2010-12#3)(2010-2#7)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-12#2)(2011-2#8)(2011-3#7)(2012-1#3)(2012-12#7)(2012-2#7)(2012-3#6)(2013-1#7)(2013-8#2)
protease(s)##10##1##(1990-3#1)(1992-11#2)(1994-2#1)(1994-3#4)(1995-1#1)(1996-10#1)
protease)##6##1##(1992-1#1)(1992-6#1)(1992-9#1)(1993-11#1)(2005-7#1)(2009-8#1)
protease- and##2##2##(1992-9#1)(1995-3#1)
protease-activated##3##1##(2006-10#1)(2008-5#1)(2009-3#1)
protease-deficient##4##1##(1990-5#1)(1994-11#1)(1995-2#1)(1995-8#1)
protease-resistant##6##1##(1990-5#2)(1992-12#1)(1995-2#1)(1995-6#1)(1996-5#1)
protease-sensitive##8##1##(1992-4#1)(1992-9#1)(1993-12#1)(1994-3#1)(1995-8#2)(1996-7#1)(2006-10#1)
protease-transfected##2##1##(2008-4#2)
protease-treated##3##1##(1996-8#1)(2008-10#2)
proteases activity##2##2##(2006-10#2)
proteases and protease inhibitors in##2##5##(2009-8#2)
proteases and protease inhibitors##3##4##(1997-4#1)(2009-8#2)
proteases and protease##4##3##(1997-4#1)(2007-11#1)(2009-8#2)
proteases and their##6##3##(1996-10#1)(2007-11#1)(2008-4#3)(2010-3#1)
proteases and##22##2##(1991-2#2)(1991-8#1)(1994-6#1)(1995-1#1)(1996-10#1)(1996-4#1)(1997-4#1)(2005-8#1)(2006-9#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#3)(2009-8#2)(2010-3#1)(2013-1#1)
proteases are##4##2##(1994-3#1)(1996-10#1)(2006-10#1)(2008-4#1)
proteases based on##2##3##(1994-6#1)(1996-12#1)
proteases by##2##2##(1994-8#1)(1996-5#1)
proteases capable of##2##3##(1990-11#1)(1992-12#1)
proteases complex of##2##3##(2006-10#2)
proteases complex##3##2##(2006-10#3)
proteases constitute a##2##3##(2008-1#1)(2012-3#1)
proteases factor XIIa##2##3##(1995-5#2)
proteases from##7##2##(1990-12#1)(1990-8#1)(1991-3#1)(1991-6#1)(1992-6#1)(1994-6#1)(2011-2#1)
proteases have been##2##3##(1991-6#1)(2005-8#1)
proteases have##3##2##(1991-6#1)(1996-10#1)(2005-8#1)
proteases in the##9##3##(1990-11#1)(1990-5#1)(1990-7#1)(1991-7#1)(2008-1#3)(2008-11#1)(2008-5#1)
proteases in##14##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-7#1)(1991-9#2)(2008-1#3)(2008-11#1)(2008-4#1)(2008-5#1)(2009-8#1)(2013-1#1)
proteases involved in##4##3##(1991-6#1)(2003-11#1)(2008-4#1)(2010-11#1)
proteases is##2##2##(1996-10#1)(1996-4#1)
proteases of the##3##3##(1994-12#1)(1997-4#1)(2008-8#1)
proteases of##6##2##(1992-7#1)(1994-12#1)(1995-10#1)(1995-3#1)(1997-4#1)(2008-8#1)
proteases or##2##2##(1995-1#1)(2008-1#1)
proteases produced by the##2##4##(1993-3#2)
proteases produced by##3##3##(1993-3#2)(2006-11#1)
proteases produced##4##2##(1993-3#2)(2006-11#1)(2008-4#1)
proteases such as##2##3##(1994-6#1)(2008-5#1)
proteases that##3##2##(1990-7#1)(1991-3#1)(2006-10#1)
proteases to##2##2##(1990-9#1)(2004-12#1)
proteases was##2##2##(1992-6#1)(1994-6#1)
proteases were##10##2##(1991-1#1)(1991-6#1)(1991-9#1)(1992-12#1)(1994-12#1)(1994-3#1)(1996-2#1)(1997-4#1)(2005-8#1)(2010-5#1)
proteases which##3##2##(1991-1#1)(1992-6#1)(1997-4#1)
proteases with##4##2##(1990-7#1)(2008-4#1)(2011-2#1)(2013-1#1)
proteases##230##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#4)(1990-8#1)(1990-9#4)(1991-1#4)(1991-2#10)(1991-3#4)(1991-6#6)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#1)(1992-11#1)(1992-12#6)(1992-6#5)(1992-7#1)(1992-9#2)(1993-11#3)(1993-3#4)(1993-4#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#6)(1994-8#2)(1995-1#2)(1995-10#1)(1995-2#1)(1995-3#5)(1995-5#4)(1995-6#6)(1995-8#1)(1996-10#6)(1996-12#1)(1996-2#1)(1996-3#4)(1996-4#2)(1996-5#1)(1997-1#2)(1997-4#5)(1997-7#1)(2003-11#2)(2004-12#1)(2005-7#1)(2005-8#4)(2006-10#7)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-9#1)(2007-11#3)(2007-7#2)(2008-1#9)(2008-10#5)(2008-11#5)(2008-4#16)(2008-5#11)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#3)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-3#3)(2013-1#3)(2013-8#1)
proteasomal degradation of##2##3##(2011-12#1)(2011-2#1)
proteasomal degradation##10##2##(2008-1#2)(2008-8#1)(2009-7#2)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
proteasomal##15##1##(1996-9#1)(2008-1#2)(2008-4#1)(2008-7#1)(2008-8#2)(2009-7#3)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
proteasome and##6##2##(1994-10#1)(2007-8#1)(2009-7#1)(2009-8#3)
proteasome function##2##2##(1993-9#1)(2010-4#1)
proteasome inhibitor##8##2##(1997-7#1)(2008-1#2)(2008-3#1)(2008-8#1)(2010-7#1)(2010-8#1)(2012-12#1)
proteasome is##4##2##(2008-4#3)(2009-8#1)
proteasome or##3##2##(1994-10#1)(2007-12#1)(2009-8#1)
proteasome subunit##5##2##(1992-1#2)(1994-12#1)(2008-8#1)(2010-12#1)
proteasome subunits##3##2##(1994-12#2)(2009-8#1)
proteasome##71##1##(1992-1#2)(1993-11#1)(1993-9#1)(1994-10#7)(1994-12#3)(1996-11#3)(1996-2#4)(1996-9#1)(1997-7#3)(2007-12#1)(2007-8#3)(2008-1#4)(2008-3#1)(2008-4#11)(2008-5#2)(2008-8#5)(2009-7#1)(2009-8#6)(2010-12#2)(2010-4#2)(2010-7#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
proteasome-dependent degradation##2##2##(2008-8#1)(2009-8#1)
proteasome-dependent##3##1##(2007-5#1)(2008-8#1)(2009-8#1)
proteasomes from Saccharomyces cerevisiae##2##4##(2008-4#2)
proteasomes##11##1##(1992-1#4)(1994-12#2)(1996-9#2)(2005-7#1)(2008-4#2)
protect a##5##2##(1997-1#1)(2007-8#1)(2008-11#1)(2011-2#1)(2012-11#1)
protect against a##2##3##(1997-1#1)(2012-12#1)
protect against cell death##2##4##(1996-10#1)(2011-9#1)
protect against inactivation##2##3##(1990-3#1)(1993-3#1)
protect against infection##2##3##(2005-10#1)(2009-4#1)
protect against ischemic##2##3##(2005-10#1)(2011-2#1)
protect against oxidative stress##2##4##(1994-3#1)(2008-1#1)
protect against potentially##2##3##(1995-12#1)(1995-8#1)
protect against the development of##6##5##(1991-6#1)(1991-8#1)(1993-11#1)(2005-8#1)(2006-10#1)(2010-6#1)
protect against the##12##3##(1990-1#1)(1991-6#1)(1991-8#1)(1993-11#1)(1996-4#1)(2005-8#1)(2006-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-6#1)(2013-1#1)
protect against##87##2##(1990-1#1)(1990-11#1)(1990-3#1)(1990-4#1)(1991-6#4)(1991-8#1)(1991-9#1)(1992-10#1)(1992-2#3)(1993-11#2)(1993-3#1)(1994-3#3)(1994-8#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-6#1)(2005-10#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#4)(2007-11#1)(2007-2#1)(2007-6#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#7)(2008-7#3)(2009-4#1)(2010-2#2)(2010-6#2)(2010-8#2)(2011-2#8)(2011-9#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#7)(2013-8#1)
protect all##4##2##(1995-3#1)(1995-9#1)(2008-5#1)(2009-12#1)
protect and##5##2##(1995-6#1)(2009-12#1)(2010-4#1)(2011-2#1)(2013-1#1)
protect both##5##2##(2008-5#1)(2010-4#1)(2012-1#1)(2012-11#2)
protect cells from##8##3##(1996-12#1)(2005-7#1)(2007-2#1)(2007-6#1)(2008-11#1)(2008-5#1)(2009-6#1)(2011-1#1)
protect cells##13##2##(1991-10#1)(1994-11#1)(1996-10#1)(1996-12#1)(1997-2#1)(2005-7#1)(2006-10#1)(2007-2#1)(2007-6#1)(2008-11#1)(2008-5#1)(2009-6#1)(2011-1#1)
protect dopaminergic##2##2##(1994-12#1)(1995-12#1)
protect from the development of##2##5##(2007-11#1)(2009-12#1)
protect from##12##2##(1990-3#1)(1993-3#1)(1994-10#1)(1996-6#1)(2004-10#1)(2007-11#1)(2008-2#1)(2008-7#1)(2009-12#1)(2010-4#1)(2012-12#1)(2013-1#1)
protect health##2##2##(1997-1#1)(2013-1#1)
protect his##2##2##(1996-12#1)(2007-9#1)
protect human subjects##5##3##(2005-11#1)(2007-11#2)(2009-4#2)
protect human##9##2##(2005-11#1)(2006-7#1)(2007-11#2)(2007-12#1)(2009-4#2)(2010-7#1)(2013-8#1)
protect immunodeficient mice from candidiasis##2##5##(2008-5#2)
protect immunodeficient##4##2##(2008-5#4)
protect in##5##2##(1994-11#1)(1995-11#2)(1996-4#1)(2004-12#1)
protect leafhoppers##2##2##(2013-8#2)
protect mice from##2##3##(1990-11#1)(1995-5#1)
protect mice##3##2##(1990-11#1)(1995-5#1)(2009-6#1)
protect myocardium##3##2##(1996-9#2)(2006-10#1)
protect neurons from##4##3##(1995-10#1)(2008-4#1)(2008-7#2)
protect neurons##6##2##(1995-10#1)(2007-11#1)(2008-4#1)(2008-5#1)(2008-7#2)
protect normal birth##3##3##(2007-2#1)(2008-6#2)
protect normal##4##2##(1994-5#1)(2007-2#1)(2008-6#2)
protect other##2##2##(2008-11#1)(2011-2#1)
protect patients from##2##3##(2006-10#1)(2006-6#1)
protect patients##3##2##(2006-10#1)(2006-6#1)(2008-12#1)
protect skin##2##2##(2008-5#1)(2012-12#1)
protect some##2##2##(1994-12#1)(2007-8#1)
protect stroke patients##2##3##(2005-9#1)(2007-2#1)
protect the bird##2##3##(2005-9#2)
protect the brain##2##3##(2008-3#1)(2011-2#1)
protect the cell##2##3##(1991-9#1)(2009-10#1)
protect the cells##3##3##(1992-11#1)(2008-11#1)(2008-7#1)
protect the developing##2##3##(1993-4#1)(2008-7#1)
protect the ends of##2##4##(1990-9#1)(2008-11#1)
protect the enzyme##2##3##(1990-11#1)(1991-7#1)
protect the health of the##2##5##(2008-10#1)(2010-6#1)
protect the health of##3##4##(2008-10#1)(2008-11#1)(2010-6#1)
protect the heart against##3##4##(2006-10#1)(2008-1#1)(2012-3#1)
protect the heart##7##3##(2006-10#1)(2007-8#1)(2008-1#2)(2011-2#1)(2012-3#2)
protect the host##2##3##(1995-12#1)(2007-11#1)
protect the human##3##3##(1993-7#1)(2008-11#2)
protect the integrity of the##2##5##(2006-10#1)(2008-5#1)
protect the myocardium##3##3##(1993-7#1)(1996-9#2)
protect the patients##2##3##(1996-2#1)(2008-1#1)
protect the privacy of##3##4##(1997-5#1)(2013-1#2)
protect the##125##2##(1990-11#1)(1990-2#1)(1990-9#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-5#1)(1993-11#4)(1993-12#1)(1993-3#2)(1993-4#1)(1993-7#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#2)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-5#1)(2005-9#2)(2006-10#3)(2006-12#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#8)(2008-3#3)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-12#2)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#7)(2013-8#1)
protect their##11##2##(1991-9#1)(1992-3#2)(1994-6#1)(2006-5#1)(2007-12#1)(2007-2#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-8#1)
protect them against##3##3##(1994-3#1)(2008-5#1)(2013-1#1)
protect them from##3##3##(1993-12#1)(2009-9#1)(2011-2#1)
protect them##7##2##(1993-12#1)(1994-3#1)(2007-12#1)(2008-5#1)(2009-9#1)(2011-2#1)(2013-1#1)
protect themselves from##4##3##(2007-2#1)(2007-7#1)(2011-2#1)(2012-2#1)
protect themselves##10##2##(1991-6#1)(1997-7#1)(2006-10#1)(2007-2#1)(2007-7#2)(2008-12#1)(2010-3#1)(2011-2#1)(2012-2#1)
protect these##2##2##(1996-1#1)(2013-8#1)
protect this##2##2##(2008-1#1)(2008-8#1)
protect us##2##2##(2009-8#1)(2010-9#1)
protect wheat##3##2##(2008-10#2)(2011-2#1)
protect workers##2##2##(1996-12#1)(2004-9#1)
protect your##2##2##(1996-12#1)(2008-10#1)
protect##503##1##(1990-1#1)(1990-11#3)(1990-12#1)(1990-2#3)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-6#6)(1991-7#1)(1991-8#1)(1991-9#5)(1992-1#1)(1992-10#3)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#2)(1992-5#2)(1992-6#2)(1992-9#2)(1993-11#6)(1993-12#4)(1993-2#1)(1993-3#4)(1993-4#2)(1993-6#2)(1993-7#2)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#9)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#3)(1995-12#4)(1995-2#3)(1995-3#4)(1995-5#1)(1995-6#2)(1995-8#3)(1995-9#3)(1996-1#6)(1996-10#2)(1996-12#6)(1996-2#1)(1996-3#1)(1996-4#4)(1996-5#2)(1996-6#2)(1996-9#5)(1997-1#3)(1997-2#1)(1997-5#2)(1997-6#4)(1997-7#2)(2004-10#2)(2004-11#1)(2004-12#2)(2004-2#2)(2004-9#1)(2005-10#2)(2005-11#2)(2005-5#1)(2005-7#2)(2005-8#1)(2005-9#4)(2006-10#12)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#3)(2006-7#2)(2007-1#1)(2007-11#10)(2007-12#7)(2007-2#17)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#6)(2007-9#7)(2008-1#11)(2008-10#12)(2008-11#16)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#7)(2008-5#31)(2008-6#3)(2008-7#11)(2008-8#4)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#2)(2009-4#4)(2009-5#2)(2009-6#4)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#6)(2010-2#4)(2010-3#1)(2010-4#5)(2010-6#4)(2010-7#4)(2010-8#3)(2010-9#3)(2011-1#3)(2011-10#1)(2011-12#3)(2011-2#20)(2011-3#1)(2011-9#1)(2012-1#2)(2012-11#4)(2012-12#6)(2012-2#5)(2012-3#5)(2013-1#19)(2013-7#3)(2013-8#8)
protectant fungicide##2##2##(2008-10#2)
protectant fungicides##2##2##(2008-10#2)
protectant##9##1##(1994-2#1)(2007-8#1)(2008-10#6)(2013-8#1)
protected adenosine analogues##2##3##(2010-2#2)
protected against challenge##2##3##(1997-6#1)(2005-11#1)
protected against the##8##3##(1991-5#1)(1994-3#1)(1994-5#1)(1994-8#1)(1996-10#1)(2008-10#1)(2008-9#1)(2012-2#1)
protected against##36##2##(1991-5#1)(1991-9#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-7#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#3)(1996-10#1)(1997-1#2)(1997-3#1)(1997-6#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-7#1)(2012-2#1)(2012-3#1)
protected and unprotected##2##3##(1991-8#1)(2008-3#1)
protected and##7##2##(1991-8#1)(2007-10#1)(2007-2#1)(2008-3#2)(2008-4#1)(2008-5#1)
protected animals##2##2##(2008-4#1)(2013-1#1)
protected area##4##2##(2013-7#4)
protected areas##6##2##(2007-3#1)(2010-10#3)(2011-2#1)(2013-7#1)
protected as##3##2##(2007-10#1)(2008-5#1)(2013-8#1)
protected by a##2##3##(1996-9#1)(2008-7#1)
protected by the##3##3##(1991-9#1)(2007-12#1)(2010-1#1)
protected by##22##2##(1991-9#1)(1992-8#1)(1993-3#2)(1994-3#1)(1995-5#1)(1996-9#1)(1997-8#1)(2004-9#1)(2005-11#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-11#1)(2011-2#1)
protected cells##3##2##(2008-7#1)(2012-12#2)
protected for##3##2##(2007-3#1)(2008-11#1)(2010-7#1)
protected form##2##2##(2006-12#2)
protected fragments of##2##3##(1996-2#2)
protected from phenylglyoxal-mediated inactivation##2##4##(1990-3#2)
protected from the##5##3##(1993-9#1)(1996-6#1)(2008-10#1)(2009-3#1)(2013-1#1)
protected from##44##2##(1990-11#1)(1990-3#3)(1990-5#1)(1990-9#1)(1991-1#1)(1991-3#1)(1991-7#1)(1993-6#1)(1993-9#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#2)(1997-4#1)(2006-10#2)(2006-12#1)(2007-1#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2009-3#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
protected health information (PHI)##2##4##(2006-8#2)
protected health information##3##3##(2006-8#2)(2013-1#1)
protected hosts##3##2##(1996-5#3)
protected in##2##2##(2006-7#1)(2011-2#1)
protected maleimide##2##2##(2008-6#2)
protected mice against##4##3##(1990-3#1)(1992-12#1)(1994-8#1)(2009-6#1)
protected mice##5##2##(1990-3#1)(1992-12#1)(1994-8#1)(2009-6#1)(2012-12#1)
protected neuronal##2##2##(2009-10#1)(2010-12#1)
protected neurons##2##2##(2008-11#1)(2013-8#1)
protected nucleoside##2##2##(2008-4#2)
protected only##2##2##(1993-11#1)(2009-2#1)
protected or##2##2##(2007-2#1)(2011-2#1)
protected river##2##2##(2013-7#2)
protected sources of water##3##4##(2012-3#3)
protected the enzyme from inactivation##2##5##(1990-12#1)(1994-11#1)
protected the enzyme from##5##4##(1990-12#1)(1990-3#1)(1992-11#1)(1994-11#1)(1994-9#1)
protected the enzyme##6##3##(1990-12#1)(1990-3#1)(1992-11#1)(1994-11#1)(1994-9#1)(1996-7#1)
protected the##21##2##(1990-11#1)(1990-12#1)(1990-3#2)(1992-11#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-8#1)(2008-11#2)(2008-7#1)(2008-8#1)(2010-2#1)
protected their##2##2##(1991-7#1)(2008-4#1)
protected with a##2##3##(2008-3#1)(2010-4#1)
protected with##7##2##(1996-9#1)(2008-10#1)(2008-3#1)(2010-12#1)(2010-4#1)(2013-1#2)
protected##336##1##(1990-10#1)(1990-11#4)(1990-12#2)(1990-3#6)(1990-5#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-3#1)(1991-5#4)(1991-7#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#3)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#4)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-6#2)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#4)(1994-3#2)(1994-4#1)(1994-5#3)(1994-7#1)(1994-8#5)(1994-9#3)(1995-1#1)(1995-10#1)(1995-12#3)(1995-2#3)(1995-3#2)(1995-5#7)(1995-6#2)(1995-7#1)(1995-9#1)(1996-1#5)(1996-10#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#7)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#4)(1997-1#3)(1997-2#4)(1997-3#4)(1997-4#5)(1997-5#1)(1997-6#3)(1997-8#2)(2004-11#2)(2004-12#1)(2004-2#1)(2004-9#1)(2005-11#3)(2005-12#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-12#5)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#2)(2007-2#2)(2007-3#2)(2007-8#3)(2008-1#2)(2008-10#22)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#8)(2008-4#15)(2008-5#10)(2008-6#4)(2008-7#7)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#2)(2010-2#5)(2010-4#2)(2010-7#3)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#5)(2013-1#7)(2013-7#8)(2013-8#4)
protected&quot##2##1##(1996-5#1)(2007-5#1)
protecting against##16##2##(1990-10#1)(1992-5#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-1#1)(1994-3#1)(1994-5#1)(1994-9#2)(2008-10#1)(2008-7#1)(2008-8#2)(2009-12#1)(2011-2#1)
protecting and##5##2##(1993-1#1)(2007-2#1)(2008-9#2)(2010-8#1)
protecting cells from##3##3##(1992-7#1)(1995-2#1)(2003-11#1)
protecting cells##5##2##(1992-7#1)(1995-2#1)(2003-11#1)(2008-11#1)(2011-2#1)
protecting group for the##3##4##(2008-4#2)(2010-6#1)
protecting group##10##2##(2007-8#1)(2008-4#7)(2009-10#1)(2010-6#1)
protecting groups and##5##3##(1997-2#1)(1997-4#2)(2007-10#1)(2008-7#1)
protecting groups was##2##3##(1996-5#1)(2010-2#1)
protecting groups##21##2##(1991-1#1)(1994-12#1)(1994-9#1)(1995-11#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-2#2)(1997-4#2)(1997-5#1)(2007-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-6#1)
protecting health##2##2##(2010-12#1)(2011-2#1)
protecting instruments##2##2##(1991-6#2)
protecting it##2##2##(1994-2#1)(2008-7#1)
protecting mice against##2##3##(1992-8#1)(2008-7#1)
protecting neurons against##4##3##(1995-12#1)(2007-9#1)(2008-10#1)(2009-12#1)
protecting neurons##5##2##(1995-11#1)(1995-12#1)(2007-9#1)(2008-10#1)(2009-12#1)
protecting normal##3##2##(2004-1#1)(2008-6#1)(2008-7#1)
protecting patients##3##2##(1997-5#1)(2011-2#2)
protecting the health of##2##4##(1995-9#1)(1996-2#1)
protecting the rights of##2##4##(2008-7#2)
protecting the rights##3##3##(1992-3#1)(2008-7#2)
protecting the##37##2##(1990-3#1)(1991-1#1)(1992-3#2)(1992-8#1)(1993-11#1)(1995-12#1)(1995-9#2)(1996-2#1)(1996-6#1)(2006-10#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-2#2)(2008-5#3)(2008-7#2)(2009-9#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
protecting them from##2##3##(2007-6#1)(2013-8#1)
protecting##190##1##(1990-10#1)(1990-3#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-4#1)(1991-6#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-7#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#3)(1995-11#2)(1995-12#3)(1995-2#1)(1995-9#2)(1996-2#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#1)(2003-11#1)(2004-1#1)(2004-12#1)(2005-7#2)(2006-10#4)(2006-12#1)(2006-4#2)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-2#4)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#10)(2008-5#8)(2008-6#3)(2008-7#8)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#3)(2009-2#2)(2009-7#2)(2009-9#3)(2010-11#2)(2010-12#1)(2010-2#2)(2010-4#2)(2010-6#2)(2010-8#1)(2011-2#8)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#5)
protecting-group strategies##2##2##(1992-12#1)(2010-12#1)
protection afforded by##6##3##(1994-3#1)(1996-12#1)(2004-12#1)(2007-11#1)(2008-5#2)
protection afforded##9##2##(1991-5#1)(1994-3#2)(1996-12#1)(2004-12#1)(2006-11#1)(2007-11#1)(2008-5#2)
protection against FMDV##2##3##(2013-1#2)
protection against HIV infection##2##4##(1990-6#1)(2009-4#1)
protection against HIV##3##3##(1990-6#2)(2009-4#1)
protection against HIV-1 infection##2##4##(1996-4#1)(2010-1#1)
protection against a##4##3##(1995-5#1)(2008-10#2)(2012-2#1)
protection against autoimmune##2##3##(1997-4#1)(2008-11#1)
protection against bacterial##2##3##(2008-10#1)(2012-2#1)
protection against both##5##3##(1993-9#1)(2008-10#3)(2008-5#1)
protection against carbon##2##3##(1996-12#1)(2008-11#1)
protection against challenge with##2##4##(2005-9#1)(2008-4#1)
protection against challenge##3##3##(2005-9#1)(2006-10#1)(2008-4#1)
protection against disease##2##3##(2009-8#1)(2010-12#1)
protection against experimental##2##3##(1995-5#1)(2012-2#1)
protection against homologous##2##3##(2006-10#1)(2013-1#1)
protection against infection by##2##4##(2008-10#1)(2008-9#1)
protection against infection with##4##4##(1991-6#1)(2009-6#1)(2011-2#1)(2013-8#1)
protection against infection##6##3##(1991-6#1)(2008-10#1)(2008-9#1)(2009-6#1)(2011-2#1)(2013-8#1)
protection against infectious##2##3##(1995-12#1)(2009-9#1)
protection against ischemia-reperfusion injury##2##4##(2008-1#1)(2012-3#1)
protection against lethal##2##3##(1995-12#1)(2013-7#1)
protection against mosquito bites##2##4##(2006-4#1)(2008-2#1)
protection against oxidative damage##2##4##(2008-2#1)(2009-10#1)
protection against oxidative stress##3##4##(2008-10#1)(2010-4#1)(2010-5#1)
protection against oxidative##5##3##(2008-10#1)(2008-2#1)(2009-10#1)(2010-4#1)(2010-5#1)
protection against pulmonary tuberculosis##2##4##(2013-1#2)
protection against pulmonary##3##3##(2013-1#2)(2013-8#1)
protection against sensitisation##2##3##(1990-11#2)
protection against sexually transmitted diseases##2##5##(1992-2#1)(1993-2#1)
protection against skin##2##3##(2006-12#1)(2008-5#1)
protection against some##2##3##(1991-12#1)(2012-12#1)
protection against subsequent##3##3##(1990-11#1)(2006-2#1)(2008-5#1)
protection against the development of##2##5##(1991-2#1)(2009-6#1)
protection against the disease##2##4##(2008-10#1)(2011-2#1)
protection against the loss of##2##5##(1996-10#1)(2008-10#1)
protection against the##25##3##(1990-9#1)(1991-2#1)(1991-6#2)(1991-8#1)(1992-5#1)(1993-6#1)(1996-10#2)(1997-2#1)(2006-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2009-6#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#2)
protection against this##4##3##(1995-12#2)(2006-10#1)(2006-8#1)
protection against typical##2##3##(1995-5#2)
protection against virulent MDV challenge and induction of lymphoid organ atrophy are simultaneously attenuated by serial passage in vitro##2##19##(2013-8#2)
protection against##232##2##(1990-11#5)(1990-2#2)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#3)(1991-8#1)(1991-9#1)(1992-2#2)(1992-5#2)(1992-8#2)(1992-9#3)(1993-11#2)(1993-12#1)(1993-2#1)(1993-6#2)(1993-9#3)(1994-10#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-12#5)(1995-2#2)(1995-3#1)(1995-5#12)(1996-1#1)(1996-10#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#2)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#2)(2005-11#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#6)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-11#3)(2008-1#3)(2008-10#27)(2008-11#6)(2008-12#1)(2008-2#5)(2008-4#2)(2008-5#11)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#2)(2009-4#2)(2009-6#2)(2009-8#2)(2009-9#1)(2010-1#3)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-8#4)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#10)
protection analysis##7##2##(1992-3#1)(1993-3#1)(1994-6#1)(1994-8#1)(1996-4#1)(1997-7#1)(2008-2#1)
protection and enhancement of the##2##5##(1994-1#1)(1997-1#1)
protection and improved##2##3##(2006-10#1)(2009-12#1)
protection and in##2##3##(1995-2#1)(2008-1#1)
protection and primer extension##3##4##(1991-4#1)(1991-8#1)(1997-2#1)
protection and promotion##3##3##(2008-9#2)(2011-2#1)
protection and the##4##3##(1994-2#1)(2007-4#2)(2008-9#1)
protection and##62##2##(1990-2#1)(1991-4#1)(1991-8#1)(1992-2#1)(1992-6#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-6#2)(1997-8#1)(2005-10#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-4#3)(2008-5#3)(2008-7#1)(2008-9#3)(2009-12#2)(2009-4#1)(2009-5#2)(2010-11#1)(2010-7#1)(2010-9#2)(2011-2#5)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
protection are##4##2##(1990-6#1)(1993-3#1)(1994-12#1)(2008-7#1)
protection as well as##2##4##(2008-10#1)(2008-2#1)
protection as##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
protection assay and##2##3##(1994-8#1)(1995-10#1)
protection assay enables##2##3##(1996-12#1)(2008-4#1)
protection assay for##2##3##(1996-12#1)(2008-4#1)
protection assay to##2##3##(1993-4#1)(1996-12#1)
protection assay using##4##3##(1993-3#1)(1994-5#1)(1995-10#1)(1997-7#1)
protection assay##29##2##(1991-5#1)(1992-6#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-8#1)(1995-10#2)(1995-2#1)(1995-6#1)(1996-12#4)(1996-7#1)(1997-7#2)(1997-8#1)(2008-10#2)(2008-4#5)
protection assays were used to##3##5##(1991-5#1)(2008-4#1)(2009-5#1)
protection assays were##4##3##(1991-5#1)(1995-5#1)(2008-4#1)(2009-5#1)
protection assays##15##2##(1991-5#1)(1992-11#1)(1993-12#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-4#1)(2008-10#2)(2008-4#3)(2009-5#1)
protection at##5##2##(1994-12#1)(1995-5#1)(1996-4#1)(2008-5#1)(2011-2#1)
protection because##2##2##(1996-11#1)(2008-7#1)
protection by the##2##3##(2010-6#1)(2012-2#1)
protection by ventricular pacing##2##4##(1996-9#2)
protection by##25##2##(1990-12#1)(1990-2#1)(1992-9#1)(1993-4#1)(1993-7#1)(1994-3#2)(1995-2#1)(1996-4#2)(1996-9#2)(1997-1#1)(2008-10#2)(2008-5#4)(2008-6#1)(2008-8#1)(2010-1#1)(2010-6#1)(2012-2#1)(2013-8#1)
protection can be##2##3##(2006-11#1)(2008-2#1)
protection can##3##2##(2006-11#1)(2008-10#1)(2008-2#1)
protection compared to##2##3##(1990-6#1)(2008-12#1)
protection conferred by##2##3##(2009-2#1)(2013-1#1)
protection devices##6##2##(1994-2#1)(2008-11#1)(2009-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
protection during##5##2##(1991-3#1)(1993-12#1)(1996-6#1)(2006-5#1)(2007-8#1)
protection elicited by##2##3##(2008-10#2)
protection even when##2##3##(2008-10#2)
protection even##3##2##(1990-10#1)(2008-10#2)
protection experiments##3##2##(1991-11#1)(1991-6#1)(1991-7#1)
protection factor (SPF) of##2##4##(2008-5#2)
protection factor (SPF)##5##3##(2008-5#4)(2012-12#1)
protection factor##15##2##(1991-6#1)(1996-6#1)(2008-5#8)(2008-7#1)(2011-2#2)(2012-12#2)
protection factors##11##2##(1995-3#1)(2008-5#9)(2008-9#1)
protection for nurses##2##3##(2013-8#2)
protection for stem cell##2##4##(2005-11#2)
protection for the kidneys##2##4##(2006-10#1)(2013-7#1)
protection for the##5##3##(2006-10#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-7#1)
protection for##28##2##(1991-5#1)(1991-9#1)(1992-6#1)(1993-12#1)(1993-7#1)(1995-5#1)(1996-12#1)(2004-4#1)(2005-11#3)(2006-10#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#2)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-7#1)(2013-8#3)
protection from apoptosis##2##3##(1995-10#1)(2008-8#1)
protection from pregnancy##2##3##(1992-7#1)(2007-11#1)
protection from proteolysis##2##3##(1991-9#1)(1995-1#1)
protection from rotavirus##2##3##(2006-10#1)(2012-1#1)
protection from subsequent##2##3##(1996-1#1)(2007-2#1)
protection from the##5##3##(1996-11#1)(1996-8#1)(2007-11#1)(2011-2#1)(2012-11#1)
protection from##60##2##(1990-6#1)(1991-2#1)(1991-9#1)(1992-7#1)(1992-8#1)(1993-3#1)(1994-10#2)(1994-11#2)(1994-3#1)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-8#1)(1996-9#1)(1997-5#1)(2006-10#3)(2007-11#3)(2007-2#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-8#2)(2010-9#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
protection given##2##2##(1991-8#1)(2007-12#1)
protection has been achieved in##2##5##(1997-6#1)(2008-1#1)
protection has been##5##3##(1997-5#1)(1997-6#2)(2008-1#1)(2008-11#1)
protection has##7##2##(1997-5#1)(1997-6#2)(2006-8#1)(2008-1#1)(2008-11#1)(2008-5#1)
protection in humans##2##3##(2006-10#2)
protection in the##13##3##(1990-12#1)(1990-9#1)(1991-2#1)(1993-12#1)(1994-2#1)(1996-9#1)(2005-6#1)(2006-11#1)(2006-4#1)(2008-10#1)(2008-5#1)(2012-2#1)(2013-8#1)
protection in this##2##3##(1992-6#1)(1995-5#1)
protection in various##2##3##(1994-11#1)(1996-9#1)
protection in##58##2##(1990-12#1)(1990-9#1)(1991-2#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-11#4)(1995-5#3)(1995-7#1)(1996-9#2)(1997-4#1)(1997-6#1)(2005-6#2)(2005-7#2)(2006-10#2)(2006-11#1)(2006-4#1)(2007-11#2)(2007-4#2)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-5#4)(2009-4#1)(2010-1#1)(2010-12#2)(2010-3#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
protection index##2##2##(2008-5#1)(2013-8#1)
protection induced by##2##3##(1995-1#1)(2013-8#1)
protection induced##3##2##(1995-1#1)(1997-3#1)(2013-8#1)
protection is an important##2##4##(1993-3#1)(2010-9#1)
protection is the goal for vaccination against diseases that##2##9##(1994-3#2)
protection is##23##2##(1990-12#1)(1990-4#1)(1993-10#1)(1993-3#1)(1994-10#1)(1994-3#2)(1995-5#3)(2006-8#1)(2007-11#1)(2007-7#1)(2008-4#4)(2008-5#4)(2008-7#1)(2010-9#1)
protection legislation##3##2##(1992-1#1)(1996-4#1)(2008-6#1)
protection level##2##2##(1996-9#1)(2008-10#1)
protection may##2##2##(1994-11#1)(2007-3#1)
protection measures##4##2##(2008-8#1)(2011-2#2)(2012-2#1)
protection mechanism##3##2##(2006-10#1)(2011-12#1)(2012-2#1)
protection mechanisms##3##2##(1991-9#1)(2006-10#1)(2012-1#1)
protection occurs##2##2##(1994-11#1)(2008-10#1)
protection of both##2##3##(1990-9#1)(2006-2#1)
protection of cells##3##3##(1996-10#1)(2008-4#2)
protection of children##3##3##(1991-10#1)(1996-12#1)(2011-2#1)
protection of personal##2##3##(1997-2#1)(2007-1#1)
protection of target mRNA##2##4##(2008-4#2)
protection of the abducens nerve##2##5##(2006-12#2)
protection of the environment##2##4##(1996-1#1)(2006-6#1)
protection of the skin against##2##5##(2008-5#1)(2009-6#1)
protection of the skin##3##4##(2008-5#2)(2009-6#1)
protection of the##42##3##(1990-5#1)(1991-9#1)(1994-9#1)(1995-5#1)(1996-1#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-8#2)(2008-10#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-2#1)(2010-4#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-7#1)(2013-7#1)
protection of wheat##2##3##(2011-2#2)
protection of workers##4##3##(2009-12#1)(2010-9#3)
protection of##152##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#2)(1990-9#1)(1991-10#2)(1991-3#1)(1991-8#1)(1991-9#2)(1992-3#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-5#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-4#1)(1997-2#3)(1997-3#1)(1997-5#1)(1997-7#1)(2004-2#1)(2005-11#4)(2005-8#2)(2006-10#4)(2006-11#3)(2006-12#5)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#4)(2007-11#4)(2007-12#2)(2007-2#1)(2007-8#4)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#6)(2008-5#8)(2008-6#3)(2008-7#4)(2008-8#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-9#3)(2011-1#3)(2011-2#5)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-7#1)(2013-1#2)(2013-7#3)(2013-8#2)
protection on##3##2##(2008-10#1)(2008-3#1)(2009-10#1)
protection or pathology##2##3##(2006-10#2)
protection or risk factors for dental fluorosis in##2##8##(2011-2#2)
protection or risk##3##3##(2008-10#1)(2011-2#2)
protection or##6##2##(2006-10#2)(2008-10#1)(2008-4#1)(2011-2#2)
protection over##2##2##(1995-3#1)(2010-12#1)
protection policy##4##2##(1996-6#1)(2008-9#1)(2012-2#1)(2013-1#1)
protection potential of##3##3##(2006-11#3)
protection potential##6##2##(2006-11#5)(2008-11#1)
protection program##3##2##(1995-1#1)(2008-12#2)
protection programs##3##2##(2008-11#1)(2008-12#2)
protection provided by##4##3##(2008-10#1)(2008-5#2)(2013-1#1)
protection rates##3##2##(2005-9#1)(2007-12#1)(2008-5#1)
protection regulations##2##2##(2008-11#1)(2010-12#1)
protection requires##2##2##(1994-3#2)
protection services##3##2##(1996-12#1)(1997-2#1)(2008-9#1)
protection should be##3##3##(1997-7#1)(2007-11#1)(2010-5#1)
protection should##5##2##(1997-7#1)(2007-11#1)(2010-12#1)(2010-5#1)(2011-2#1)
protection strategies##6##2##(2007-2#1)(2007-8#2)(2010-5#2)(2011-10#1)
protection strategy##3##2##(1990-7#1)(2008-10#1)(2008-2#1)
protection studies reveal##2##3##(1992-6#1)(2006-12#1)
protection studies##6##2##(1992-6#1)(1992-8#2)(1995-5#2)(2006-12#1)
protection systems##3##2##(1990-5#1)(2008-5#1)(2012-2#1)
protection technology##2##2##(2007-1#1)(2008-10#1)
protection test##2##2##(2008-11#1)(2012-12#1)
protection than##2##2##(1991-2#1)(2006-2#1)
protection that##2##2##(2008-10#1)(2010-9#1)
protection through##2##2##(2008-5#1)(2012-12#1)
protection to HIV-infected##2##3##(2004-9#2)
protection to the##7##3##(1995-11#1)(2004-11#1)(2007-9#1)(2008-10#1)(2010-7#1)(2013-1#2)
protection to##21##2##(1992-6#1)(1992-7#1)(1995-11#1)(1995-3#1)(1996-4#1)(2004-11#1)(2004-9#2)(2006-10#1)(2006-12#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-9#1)(2009-12#1)(2010-7#1)(2011-2#1)(2013-1#2)
protection under the##3##3##(1997-5#1)(2008-12#1)(2012-12#1)
protection using the##2##3##(2008-4#1)(2012-2#1)
protection using##5##2##(2007-8#1)(2008-2#1)(2008-4#1)(2010-12#1)(2012-2#1)
protection value##2##2##(2008-10#1)(2011-1#1)
protection was also##2##3##(1990-5#1)(1995-12#1)
protection was not##3##3##(1992-5#1)(2008-10#1)(2009-5#1)
protection was observed##2##3##(2008-10#1)(2013-1#1)
protection was##30##2##(1990-5#1)(1990-6#1)(1991-12#1)(1991-5#1)(1992-5#1)(1992-9#1)(1994-8#1)(1995-12#3)(1995-2#1)(1996-12#1)(1996-9#1)(1997-3#1)(1997-6#1)(2007-2#1)(2008-10#5)(2008-5#4)(2009-5#1)(2010-4#1)(2013-1#2)(2013-8#1)
protection were evaluated##2##3##(2007-8#1)(2008-2#1)
protection were##3##2##(2007-8#1)(2008-2#1)(2008-5#1)
protection when##3##2##(1996-6#1)(2008-10#2)
protection while##2##2##(2008-10#1)(2011-1#1)
protection with##11##2##(1995-12#1)(1995-7#1)(2007-8#1)(2008-10#3)(2008-5#2)(2009-5#1)(2013-1#1)(2013-8#1)
protection without##2##2##(1991-10#1)(2010-9#1)
protection##1264##1##(1990-10#2)(1990-11#6)(1990-12#7)(1990-2#8)(1990-3#2)(1990-4#1)(1990-5#6)(1990-6#7)(1990-7#2)(1990-8#1)(1990-9#3)(1991-10#5)(1991-11#2)(1991-12#3)(1991-2#4)(1991-3#5)(1991-4#1)(1991-5#9)(1991-6#6)(1991-7#1)(1991-8#4)(1991-9#6)(1992-1#1)(1992-11#1)(1992-2#4)(1992-3#2)(1992-5#4)(1992-6#6)(1992-7#2)(1992-8#5)(1992-9#5)(1993-10#1)(1993-11#3)(1993-12#5)(1993-2#2)(1993-3#10)(1993-4#2)(1993-6#3)(1993-7#4)(1993-9#3)(1994-1#1)(1994-10#6)(1994-11#8)(1994-12#5)(1994-2#6)(1994-3#16)(1994-5#5)(1994-6#1)(1994-8#3)(1994-9#4)(1995-1#4)(1995-10#3)(1995-11#7)(1995-12#13)(1995-2#9)(1995-3#6)(1995-5#30)(1995-6#2)(1995-7#2)(1995-8#2)(1996-1#5)(1996-10#4)(1996-11#4)(1996-12#13)(1996-2#2)(1996-4#12)(1996-5#3)(1996-6#7)(1996-7#1)(1996-8#4)(1996-9#14)(1997-1#2)(1997-2#6)(1997-3#3)(1997-4#5)(1997-5#5)(1997-6#8)(1997-7#8)(1997-8#3)(2004-11#1)(2004-12#1)(2004-2#2)(2004-4#1)(2004-9#2)(2005-10#1)(2005-11#10)(2005-5#1)(2005-6#2)(2005-7#6)(2005-8#3)(2005-9#3)(2006-1#1)(2006-10#33)(2006-11#18)(2006-12#15)(2006-2#4)(2006-3#1)(2006-4#4)(2006-5#6)(2006-6#1)(2006-7#1)(2006-8#9)(2007-1#6)(2007-10#5)(2007-11#23)(2007-12#4)(2007-2#11)(2007-3#3)(2007-4#6)(2007-5#1)(2007-7#1)(2007-8#17)(2007-9#3)(2008-1#10)(2008-10#99)(2008-11#23)(2008-12#16)(2008-2#16)(2008-3#6)(2008-4#40)(2008-5#93)(2008-6#10)(2008-7#24)(2008-8#9)(2008-9#12)(2009-10#5)(2009-11#5)(2009-12#6)(2009-2#1)(2009-3#1)(2009-4#7)(2009-5#8)(2009-6#8)(2009-8#3)(2009-9#2)(2010-1#5)(2010-10#1)(2010-11#1)(2010-12#14)(2010-2#2)(2010-3#6)(2010-4#7)(2010-5#9)(2010-6#1)(2010-7#6)(2010-8#8)(2010-9#13)(2011-1#11)(2011-10#1)(2011-12#2)(2011-2#42)(2011-3#2)(2012-1#6)(2012-11#2)(2012-12#17)(2012-2#25)(2012-3#1)(2012-7#1)(2013-1#30)(2013-7#12)(2013-8#33)
protection&quot##2##1##(2006-8#1)(2012-12#1)
protection)##5##1##(1995-5#2)(2008-10#1)(2008-4#1)(2010-1#1)
protection?##3##1##(1991-6#1)(2007-8#1)(2010-10#1)
protection]##7##1##(1990-12#1)(1990-9#1)(1995-9#1)(1996-6#1)(2008-10#1)(2011-2#1)(2013-1#1)
protections are##2##2##(2005-7#1)(2009-4#1)
protections##7##1##(1992-12#1)(2004-9#1)(2005-10#1)(2005-7#1)(2008-4#1)(2009-4#2)
protective HDL##2##2##(1992-11#1)(2007-1#1)
protective ability##2##2##(2006-5#1)(2013-8#1)
protective action of adenosine##2##4##(1996-2#2)
protective action of##7##3##(1990-12#1)(1993-11#1)(1996-2#2)(1997-7#1)(2005-8#1)(2008-11#1)
protective action##9##2##(1990-12#1)(1993-11#1)(1993-5#1)(1996-2#2)(1997-2#1)(1997-7#1)(2005-8#1)(2008-11#1)
protective actions##6##2##(1993-11#1)(1993-12#2)(1995-10#1)(2004-12#1)(2008-8#1)
protective activity against##3##3##(1995-12#1)(2008-10#1)(2010-12#1)
protective activity of##4##3##(1997-5#2)(2008-11#1)(2013-1#1)
protective activity##10##2##(1995-12#1)(1997-5#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-12#1)(2013-1#1)
protective against the development of##2##5##(2008-8#1)(2012-3#1)
protective against the##4##3##(1996-10#1)(2008-8#1)(2011-2#1)(2012-3#1)
protective against##23##2##(1990-12#1)(1991-2#1)(1992-8#1)(1993-9#1)(1995-12#1)(1995-5#2)(1996-10#1)(1997-2#1)(1997-3#1)(2006-5#1)(2008-1#1)(2008-5#2)(2008-8#1)(2009-12#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
protective agent##8##2##(1992-11#1)(1993-2#1)(1996-4#1)(2008-10#1)(2008-12#1)(2009-3#1)(2010-4#1)(2010-8#1)
protective agents against##2##3##(2008-5#1)(2010-4#1)
protective agents##10##2##(1995-11#1)(1996-4#1)(1996-9#1)(2006-2#1)(2006-4#1)(2008-4#1)(2008-5#2)(2008-8#1)(2010-4#1)
protective and##16##2##(1992-6#1)(1995-3#1)(1995-8#1)(1996-5#1)(2005-12#1)(2006-8#2)(2007-10#1)(2008-10#1)(2008-5#1)(2008-7#2)(2010-5#1)(2011-1#1)(2012-12#1)(2012-3#1)
protective antibodies##4##2##(1997-6#1)(2006-12#1)(2006-2#1)(2010-10#1)
protective antibody##3##2##(2007-11#1)(2008-8#1)(2012-12#1)
protective antigen##3##2##(1991-10#2)(2010-8#1)
protective antigens##2##2##(2007-11#1)(2008-5#1)
protective antioxidant##2##2##(1995-1#1)(2008-11#1)
protective apoptosis-mediated##2##2##(2008-7#2)
protective as well as##2##4##(2006-10#1)(2007-11#1)
protective behavior##2##2##(2012-12#2)
protective behaviors##3##2##(2010-2#2)(2013-1#1)
protective clothing and##2##3##(2008-4#1)(2010-4#1)
protective clothing##5##2##(2008-4#4)(2010-4#1)
protective coating##3##2##(1995-4#1)(2008-3#2)
protective compounds##2##2##(1994-5#1)(2010-12#1)
protective devices##5##2##(1993-12#1)(1994-6#2)(2006-11#1)(2009-12#1)
protective diet##2##2##(2011-2#2)
protective effect against##11##3##(1996-8#1)(1996-9#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-3#1)(2009-8#1)(2012-12#1)(2012-2#1)
protective effect and##2##3##(2008-3#1)(2010-7#1)
protective effect could be##2##4##(1997-4#1)(2010-8#1)
protective effect for##2##3##(1997-3#1)(2010-3#1)
protective effect in the##2##4##(1990-5#1)(2011-1#1)
protective effect in##5##3##(1990-3#1)(1990-5#1)(1995-11#1)(2007-8#1)(2011-1#1)
protective effect is##2##3##(1993-6#1)(1995-12#1)
protective effect of the##5##4##(1995-12#1)(2008-10#2)(2013-1#1)(2013-8#1)
protective effect of vitamin E##2##5##(2007-2#1)(2010-12#1)
protective effect of##77##3##(1990-11#1)(1990-6#1)(1991-1#1)(1991-11#1)(1992-10#1)(1992-7#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#5)(1996-12#2)(1996-3#1)(1996-4#2)(1996-7#1)(1996-9#2)(1997-2#1)(1997-8#1)(2005-10#2)(2006-10#2)(2006-12#1)(2007-2#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#4)(2010-6#1)(2011-1#3)(2011-12#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
protective effect on the##5##4##(2006-6#1)(2008-12#1)(2008-9#1)(2010-7#1)(2012-1#1)
protective effect on##16##3##(1990-11#1)(1992-12#1)(1993-2#1)(1994-2#1)(2006-6#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-7#1)(2012-1#1)(2013-1#3)
protective effect was##2##3##(2008-7#1)(2010-8#1)
protective effect##148##2##(1990-11#2)(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-11#1)(1992-10#1)(1992-12#1)(1992-7#1)(1993-11#4)(1993-12#1)(1993-2#6)(1993-3#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-2#4)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#7)(1995-2#1)(1996-1#1)(1996-12#3)(1996-3#1)(1996-4#2)(1996-7#1)(1996-8#1)(1996-9#4)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-10#2)(2006-10#3)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-2#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#5)(2010-3#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#8)(2013-7#1)(2013-8#1)
protective effects against##4##3##(1991-10#1)(1993-4#1)(1994-5#1)(2009-11#1)
protective effects in##4##3##(1994-11#1)(2008-11#1)(2012-2#2)
protective effects of adaptation##2##4##(1996-9#1)(2012-3#1)
protective effects of ascorbic acid##2##5##(2008-6#2)
protective effects of different doses of##2##6##(1994-9#1)(2011-1#1)
protective effects of the##2##4##(1995-12#1)(2008-10#1)
protective effects of##40##3##(1992-6#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-9#2)(2006-10#3)(2007-11#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-7#1)(2010-12#2)(2010-7#1)(2011-1#4)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
protective effects on the##2##4##(2008-7#1)(2008-9#1)
protective effects on##10##3##(1994-3#1)(2008-11#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-7#1)(2011-3#1)
protective effects were##2##3##(1993-9#1)(2006-8#1)
protective effects##76##2##(1990-9#1)(1991-10#1)(1991-11#1)(1992-6#1)(1993-11#1)(1993-4#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-9#3)(1997-4#1)(2005-10#1)(2005-6#1)(2006-10#4)(2006-8#1)(2007-11#3)(2007-9#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#1)(2009-11#1)(2009-7#2)(2010-12#2)(2010-7#1)(2011-1#4)(2011-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)
protective efficacy against##2##3##(2007-11#1)(2008-5#1)
protective efficacy of the##3##4##(1992-10#1)(1995-12#1)(2008-10#1)
protective efficacy of##7##3##(1991-2#1)(1992-10#1)(1995-12#1)(1995-5#1)(2007-9#1)(2008-10#1)(2008-3#1)
protective efficacy##17##2##(1991-2#1)(1992-10#1)(1995-12#1)(1995-5#3)(2007-11#5)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#2)(2013-8#1)
protective enzyme activities##2##3##(2008-12#2)
protective enzymes##3##2##(2008-12#2)(2011-2#1)
protective equipment and##2##3##(2005-11#1)(2011-2#1)
protective equipment##10##2##(2005-11#1)(2006-3#1)(2007-7#1)(2008-12#4)(2008-8#2)(2011-2#1)
protective factor against doping##2##4##(2009-11#2)
protective factor against##6##3##(1995-12#1)(2009-11#2)(2009-7#1)(2011-1#1)(2013-1#1)
protective factor in##5##3##(2007-12#1)(2009-11#1)(2009-7#2)(2011-1#1)
protective factor##20##2##(1994-12#1)(1994-2#1)(1995-12#1)(2005-10#1)(2007-12#1)(2009-11#3)(2009-12#1)(2009-7#5)(2011-1#3)(2011-2#1)(2013-1#1)(2013-8#1)
protective factors for##2##3##(2006-3#1)(2009-7#1)
protective factors##18##2##(1994-12#1)(1996-7#1)(2006-3#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-7#4)(2010-5#1)(2011-1#3)(2011-2#1)(2013-1#2)
protective film##3##2##(2008-10#2)(2008-4#1)
protective for the##4##3##(2006-11#1)(2008-12#1)(2008-4#1)(2009-1#1)
protective for##6##2##(2006-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-1#1)(2013-1#1)
protective function of##2##3##(2008-11#1)(2013-1#1)
protective function##6##2##(1992-6#1)(1993-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2013-1#1)
protective functions##3##2##(2012-1#2)(2012-3#1)
protective humoral##2##2##(1992-1#1)(1996-12#1)
protective immune response to##3##4##(1991-12#1)(1992-8#1)(2007-11#1)
protective immune response##4##3##(1991-12#1)(1992-8#1)(1997-7#1)(2007-11#1)
protective immune responses##4##3##(2006-10#2)(2006-2#1)(2011-1#1)
protective immune##8##2##(1991-12#1)(1992-8#1)(1997-7#1)(2006-10#2)(2006-2#1)(2007-11#1)(2011-1#1)
protective immunity against##4##3##(1995-2#1)(1996-10#1)(2005-10#1)(2006-10#1)
protective immunity and##2##3##(2009-9#1)(2011-2#1)
protective immunity in##3##3##(1991-12#1)(2006-2#1)(2007-11#1)
protective immunity to##4##3##(1996-10#1)(2007-11#2)(2010-12#1)
protective immunity##26##2##(1991-12#1)(1995-2#1)(1996-10#3)(1997-3#1)(2005-10#1)(2006-10#3)(2006-12#1)(2006-2#1)(2007-11#3)(2007-5#1)(2008-3#1)(2008-4#2)(2009-9#1)(2010-12#1)(2011-2#4)(2012-2#1)
protective in animal##2##3##(2007-11#1)(2013-1#1)
protective in preclinical models##2##4##(2005-7#2)
protective in##8##2##(1993-5#1)(1995-12#1)(2005-7#2)(2007-11#1)(2008-7#1)(2009-5#1)(2013-1#1)
protective influence##2##2##(2008-10#1)(2008-7#1)
protective layer##3##2##(2007-2#1)(2008-10#1)(2008-3#1)
protective levels of antibody in the##2##6##(2008-8#2)
protective levels of antibody##3##4##(2008-8#3)
protective levels of##4##3##(1992-10#1)(2008-8#3)
protective measures are##2##3##(2007-2#1)(2009-10#1)
protective measures##12##2##(2006-8#3)(2007-2#2)(2008-12#1)(2009-10#1)(2011-2#1)(2012-11#2)(2013-7#1)(2013-8#1)
protective mechanism##9##2##(1990-6#1)(1991-7#1)(1994-6#1)(1994-8#1)(1997-8#1)(2010-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
protective mechanisms against##2##3##(2008-3#1)(2008-5#1)
protective mechanisms of##2##3##(2011-2#1)(2013-7#1)
protective mechanisms##11##2##(2008-3#1)(2008-4#2)(2008-5#4)(2009-3#1)(2011-1#1)(2011-2#1)(2013-7#1)
protective medium##3##2##(2006-5#1)(2008-10#2)
protective of##2##2##(1996-2#1)(2008-12#1)
protective or##4##2##(2006-10#1)(2008-1#1)(2008-10#1)(2008-6#1)
protective potential##3##2##(1992-12#1)(1994-2#1)(2008-5#1)
protective process##2##2##(2008-7#2)
protective properties against##2##3##(1993-5#1)(2008-5#1)
protective properties##7##2##(1993-5#1)(1997-2#1)(2007-9#1)(2008-1#1)(2008-5#1)(2011-2#1)(2013-1#1)
protective protein##7##2##(1994-11#7)
protective response to##2##3##(2008-5#1)(2008-7#1)
protective response##4##2##(1995-12#1)(2006-10#1)(2008-5#1)(2008-7#1)
protective responses##4##2##(1997-4#1)(2007-11#1)(2008-7#1)(2012-12#1)
protective role against##4##3##(1995-1#1)(2006-8#1)(2010-4#1)(2011-2#1)
protective role in##8##3##(1992-9#1)(2006-10#1)(2006-2#1)(2008-12#1)(2008-5#1)(2011-2#2)(2012-2#1)
protective role of the##2##4##(1995-12#2)
protective role of##23##3##(1991-10#1)(1991-9#1)(1992-6#1)(1995-12#2)(1995-3#1)(1996-12#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-8#1)(2009-6#1)(2010-11#1)(2010-8#1)(2012-12#1)(2012-4#1)(2013-1#7)
protective role##44##2##(1991-10#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-5#1)(1995-1#1)(1995-12#2)(1995-3#1)(1996-12#2)(1997-2#1)(1997-4#1)(1997-8#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-8#2)(2009-6#2)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-4#1)(2013-1#8)
protective roles of##2##3##(2008-8#2)
protective roles##3##2##(2005-8#1)(2008-8#2)
protective services##3##2##(1991-1#2)(2012-3#1)
protective strategies##2##2##(2006-10#1)(2007-8#1)
protective strategy##2##2##(2011-1#1)(2013-1#1)
protective substances##3##2##(1990-9#1)(2008-5#1)(2008-7#1)
protective than##2##2##(1992-2#1)(2011-2#1)
protective values against##2##3##(2008-10#1)(2008-12#1)
protective##770##1##(1990-11#2)(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-1#3)(1991-10#4)(1991-11#2)(1991-12#2)(1991-2#3)(1991-5#2)(1991-7#1)(1991-9#1)(1992-1#3)(1992-10#4)(1992-11#2)(1992-12#3)(1992-2#3)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#7)(1993-12#5)(1993-2#7)(1993-3#1)(1993-4#1)(1993-5#4)(1993-6#2)(1993-9#5)(1994-10#1)(1994-11#9)(1994-12#2)(1994-2#7)(1994-3#2)(1994-5#3)(1994-6#6)(1994-8#1)(1994-9#3)(1995-1#4)(1995-10#1)(1995-11#2)(1995-12#17)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#8)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#3)(1996-10#5)(1996-12#8)(1996-2#4)(1996-3#1)(1996-4#4)(1996-5#2)(1996-7#2)(1996-8#1)(1996-9#13)(1997-1#1)(1997-2#6)(1997-3#3)(1997-4#5)(1997-5#2)(1997-6#3)(1997-7#3)(1997-8#3)(2004-12#1)(2005-10#5)(2005-11#2)(2005-12#1)(2005-6#1)(2005-7#2)(2005-8#2)(2006-10#23)(2006-11#2)(2006-12#4)(2006-2#6)(2006-3#2)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#3)(2006-8#8)(2007-1#2)(2007-10#2)(2007-11#23)(2007-12#4)(2007-2#5)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#4)(2008-1#8)(2008-10#33)(2008-11#11)(2008-12#19)(2008-2#5)(2008-3#14)(2008-4#18)(2008-5#37)(2008-6#5)(2008-7#33)(2008-8#19)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#4)(2009-12#3)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#3)(2009-7#13)(2009-8#4)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#13)(2010-2#5)(2010-3#3)(2010-4#4)(2010-5#3)(2010-6#2)(2010-7#4)(2010-8#6)(2010-9#1)(2011-1#20)(2011-12#2)(2011-2#29)(2011-3#1)(2012-1#4)(2012-11#2)(2012-12#14)(2012-2#10)(2012-3#7)(2012-4#1)(2013-1#36)(2013-7#4)(2013-8#9)
protective&quot##2##1##(1995-5#1)(2005-10#1)
protector of##4##2##(1992-8#1)(2007-5#1)(2008-5#1)(2011-2#1)
protector##11##1##(1991-5#1)(1992-11#1)(1992-12#1)(1992-8#1)(2005-3#1)(2006-10#1)(2007-5#1)(2007-8#2)(2008-5#1)(2011-2#1)
protectors##3##1##(1993-11#1)(2007-10#1)(2008-8#1)
protects actin against##2##3##(1997-7#2)
protects actin##3##2##(1993-9#1)(1997-7#2)
protects against experimental##2##3##(1993-5#1)(1995-2#1)
protects against the##4##3##(1991-8#1)(1992-9#1)(1993-3#1)(2006-1#1)
protects against##35##2##(1991-5#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-9#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-12#3)(1995-2#1)(1995-3#1)(1996-1#1)(1996-9#1)(1997-6#1)(2005-7#2)(2006-1#1)(2006-9#1)(2007-11#2)(2008-5#1)(2009-6#2)(2010-12#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
protects and##3##2##(1995-6#2)(1997-4#1)
protects cells against##2##3##(1991-5#1)(1995-8#1)
protects cells from##4##3##(1992-7#1)(2008-5#1)(2008-9#1)(2009-12#1)
protects cells##7##2##(1991-5#1)(1992-7#1)(1994-11#1)(1995-8#1)(2008-5#1)(2008-9#1)(2009-12#1)
protects cultured##2##2##(1996-1#1)(2010-7#1)
protects from##3##2##(1990-7#1)(1996-9#1)(2006-12#1)
protects human keratinocytes##2##3##(2010-7#2)
protects it from##2##3##(2008-5#1)(2008-8#1)
protects it##4##2##(2006-7#1)(2008-5#2)(2008-8#1)
protects murine##2##2##(1995-12#1)(2010-8#1)
protects neurons##2##2##(1995-12#1)(2008-11#1)
protects the cell##3##3##(1990-9#1)(1996-10#1)(2009-6#1)
protects the enzyme from##2##4##(1995-11#1)(2008-10#1)
protects the##31##2##(1990-12#1)(1990-2#1)(1990-9#2)(1991-12#1)(1991-2#1)(1993-12#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-10#1)(2007-12#3)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#2)(2008-9#1)(2009-6#1)(2009-8#1)(2010-4#1)(2012-12#1)
protects them from##2##3##(2006-8#1)(2007-11#1)
protects them##3##2##(2006-8#1)(2007-11#1)(2008-10#1)
protects##158##1##(1990-12#2)(1990-2#1)(1990-7#1)(1990-9#2)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-7#3)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-9#3)(1994-11#5)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#4)(1996-1#5)(1996-10#1)(1996-12#1)(1996-9#2)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#1)(2004-12#1)(2005-7#2)(2006-1#1)(2006-12#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-11#4)(2007-12#4)(2007-2#1)(2007-7#3)(2007-8#1)(2008-10#4)(2008-11#6)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#2)(2009-3#1)(2009-6#3)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#4)(2010-8#2)(2012-12#2)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#1)
protein &gt##2##2##(1996-9#1)(2006-5#1)
protein (35%)##2##2##(2009-4#2)
protein (A beta)##9##3##(1994-12#1)(1994-8#1)(1995-12#2)(1995-3#2)(1996-1#1)(1996-6#2)
protein (A##11##2##(1994-12#1)(1994-8#1)(1995-12#2)(1995-3#2)(1995-6#1)(1996-1#1)(1996-5#1)(1996-6#2)
protein (ACBP)##2##2##(1994-11#1)(1994-8#1)
protein (AFP)##2##2##(1994-9#1)(2008-10#1)
protein (BMP)##2##2##(2008-11#1)(2009-8#1)
protein (CBP)##3##2##(1994-11#1)(1995-3#1)(1997-4#1)
protein (CP) gene##15##3##(1997-6#1)(2005-11#1)(2008-10#12)(2008-8#1)
protein (CP)##34##2##(1997-6#1)(2005-11#1)(2007-8#1)(2008-10#29)(2008-8#1)(2010-2#1)
protein (CREB) in##2##3##(1996-12#1)(2008-10#1)
protein (CREB)##9##2##(1995-3#2)(1996-12#2)(1997-4#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-3#1)
protein (CRP) and##6##3##(1992-12#1)(1992-3#1)(1997-7#1)(2008-10#1)(2012-12#1)(2013-8#1)
protein (CRP)##38##2##(1990-12#1)(1992-12#2)(1992-3#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-4#1)(1995-8#1)(1997-6#1)(1997-7#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-3#2)(2008-5#1)(2008-7#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#2)
protein (ECP)##2##2##(1996-12#1)(2008-10#1)
protein (EGFP)##3##2##(2006-12#1)(2007-8#1)(2008-11#1)
protein (FABP)##2##2##(1994-8#1)(2013-1#1)
protein (FKBP)##3##2##(1991-12#2)(1993-11#1)
protein (G protein)##4##3##(1990-7#1)(1990-8#1)(1993-8#1)(2008-3#1)
protein (G##5##2##(1990-7#1)(1990-8#1)(1993-8#1)(1995-2#1)(2008-3#1)
protein (G-protein)##3##2##(1990-11#1)(1992-7#1)(1993-7#1)
protein (GAP)##6##2##(1991-12#2)(1991-5#1)(1992-12#1)(1993-8#1)(1997-7#1)
protein (GFAP) and##3##3##(1995-12#1)(1997-3#1)(2010-12#1)
protein (GFAP)##18##2##(1990-7#2)(1991-12#1)(1993-12#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-10#1)(1997-2#1)(1997-3#1)(2007-10#3)(2008-11#1)(2010-12#2)(2010-2#1)
protein (GFP)##43##2##(1996-6#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-4#1)(2005-8#1)(2006-12#3)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#4)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#2)(2009-6#1)(2011-2#1)(2011-3#1)(2012-12#3)(2013-8#1)
protein (GHBP)##3##2##(2006-1#2)(2008-4#1)
protein (Gs alpha)##3##3##(1992-11#1)(1994-2#1)(1994-6#1)
protein (Gs)##3##2##(1992-3#1)(1992-7#1)(1993-9#1)
protein (HSP##2##2##(1991-2#1)(2008-10#1)
protein (HSP) 90##2##3##(1994-12#1)(2009-8#1)
protein (HSP)##8##2##(1993-5#1)(1993-8#1)(1994-11#1)(1994-12#1)(1997-2#1)(2008-7#1)(2009-8#1)(2013-1#1)
protein (Hsp70)##2##2##(1995-6#1)(1996-8#1)
protein (IRP)##2##2##(1995-2#1)(1996-7#1)
protein (JHBP)##2##2##(1992-1#1)(2012-2#1)
protein (M(r)##3##2##(1992-8#1)(1993-4#1)(1994-9#1)
protein (MAP) kinase##11##3##(1992-8#1)(1994-11#1)(1994-12#1)(1995-3#3)(1996-2#1)(1996-8#1)(2008-4#2)(2008-7#1)
protein (MAP) kinases##5##3##(1993-8#1)(1995-3#2)(1995-8#1)(2011-1#1)
protein (MAP)##17##2##(1992-8#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-3#5)(1995-8#1)(1996-2#1)(1996-4#1)(1996-8#1)(2008-4#2)(2008-7#1)(2011-1#1)
protein (MBP) fusion##3##3##(1995-12#2)(1995-2#1)
protein (MBP)##20##2##(1991-6#1)(1992-11#1)(1992-9#1)(1993-3#2)(1993-5#1)(1994-8#1)(1995-1#1)(1995-12#3)(1995-2#1)(1996-11#1)(1996-5#1)(1997-2#1)(2005-7#1)(2008-4#2)(2008-8#1)(2010-2#1)
protein (MCP)##2##2##(1990-7#1)(2007-8#1)
protein (MRP)##6##2##(1997-4#1)(1997-7#1)(2005-11#1)(2005-8#1)(2008-11#2)
protein (MSP)##3##2##(2007-12#1)(2007-8#1)(2008-8#1)
protein (MVDP)##2##2##(1996-11#2)
protein (MVP)##2##2##(1994-12#1)(2009-9#1)
protein (Mr =##3##3##(1990-11#1)(1992-3#2)
protein (Mr##7##2##(1990-10#1)(1990-11#2)(1990-4#1)(1991-7#1)(1992-3#2)
protein (OBP)##3##2##(1993-7#1)(2007-12#1)(2008-10#1)
protein (P50)##3##2##(1991-10#1)(2008-10#2)
protein (PTHrP)##6##2##(1991-5#1)(1991-7#1)(1991-8#1)(1994-7#1)(1996-1#1)(1996-11#1)
protein (RBP)##8##2##(1990-11#1)(1990-4#1)(1991-2#1)(1991-9#1)(1992-4#1)(1993-9#1)(1994-11#1)(1994-6#1)
protein (SAP)##3##2##(2007-2#1)(2009-10#1)(2013-1#1)
protein (TBP) in vitro##2##4##(1994-3#1)(1995-3#1)
protein (TBP)##11##2##(1992-5#1)(1993-2#2)(1993-8#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-4#1)(1996-5#1)(1997-2#1)
protein (TP)##6##2##(1990-3#1)(1997-5#1)(2008-10#1)(2009-5#1)(2012-2#1)(2013-1#1)
protein (TSPO) is a##3##4##(2012-2#3)
protein (TSPO)##6##2##(2012-2#6)
protein (a##3##2##(1990-10#1)(1990-5#1)(1994-9#1)
protein (and##2##2##(1992-6#1)(2009-4#1)
protein (beta##5##2##(1991-10#1)(1991-11#1)(1992-8#2)(1994-12#1)
protein (domain) evolution##2##3##(2009-5#2)
protein (hs-CRP)##7##2##(2008-10#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
protein (hsCRP) levels##2##3##(2008-3#1)(2010-12#1)
protein (hsCRP)##3##2##(2008-3#1)(2010-12#1)(2011-2#1)
protein (hsp)##2##2##(1992-6#1)(1995-3#1)
protein (nsL-TP##2##2##(1990-4#1)(1994-12#1)
protein (or peptide) in##2##4##(2008-2#2)
protein (or peptide)##4##3##(2008-2#4)
protein (or##6##2##(1993-4#1)(2008-2#4)(2008-4#1)
protein (p##2##2##(1990-7#1)(2013-8#1)
protein (r = 0##2##4##(2010-4#1)(2011-2#1)
protein (r =##3##3##(1993-2#1)(2010-4#1)(2011-2#1)
protein (sterol carrier protein 2)##3##5##(1990-4#1)(1990-5#1)(1994-12#1)
protein (the FRET &quot##2##4##(2008-9#2)
protein (the##5##2##(1990-10#1)(1992-3#1)(1994-12#1)(2008-9#2)
protein (triadin)##2##2##(1991-7#2)
protein -##2##2##(1991-10#1)(2006-9#1)
protein 1 (CaBP1)##2##3##(2009-7#2)
protein 1 and##2##3##(2008-1#1)(2013-1#1)
protein 1 in##5##3##(1990-11#1)(1991-9#4)
protein 1 which##2##3##(1991-9#1)(2006-2#1)
protein 1##60##2##(1990-11#2)(1991-9#8)(1992-12#1)(1993-12#1)(1993-8#1)(1994-3#3)(1994-8#2)(1995-6#1)(1995-8#1)(1996-7#1)(1997-5#1)(1997-6#2)(2005-12#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-9#1)(2009-10#2)(2009-7#3)(2009-8#1)(2010-12#1)(2011-2#3)(2012-1#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#9)
protein 1)##2##2##(1994-8#1)(2008-10#1)
protein 10##3##2##(1996-10#1)(2006-10#1)(2006-9#1)
protein 1B (MAP1B)##2##3##(1997-6#2)
protein 2 (BMP-2)##3##3##(1994-2#1)(2012-3#1)(2013-1#1)
protein 2 (Grb2)##2##3##(1994-12#1)(1994-9#1)
protein 2 and##3##3##(1995-7#1)(2012-12#2)
protein 2 in##2##3##(1997-4#1)(2012-1#1)
protein 2##31##2##(1991-1#1)(1993-11#3)(1994-12#3)(1994-2#1)(1994-9#2)(1995-7#2)(1996-12#2)(1996-5#2)(1997-4#1)(2006-10#1)(2007-10#2)(2008-10#1)(2009-8#1)(2012-1#1)(2012-12#5)(2012-3#1)(2013-1#2)
protein 24##2##2##(1997-2#1)(2008-5#1)
protein 25 kDa##2##3##(1997-7#1)(2010-2#1)
protein 25##3##2##(1992-11#1)(1997-7#1)(2010-2#1)
protein 3 (IGFBP-3)##3##3##(1995-10#1)(1996-7#1)(2011-12#1)
protein 3##13##2##(1991-7#2)(1995-10#1)(1996-7#1)(2008-10#1)(2008-11#1)(2010-6#2)(2011-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
protein 4##24##2##(1994-12#9)(1994-8#1)(2006-10#6)(2009-7#1)(2010-1#1)(2010-5#1)(2012-2#3)(2013-1#1)(2013-8#1)
protein 5##3##2##(2007-8#1)(2008-10#1)(2008-8#1)
protein 56##3##2##(1992-11#1)(1993-8#1)(2007-12#1)
protein 6##2##2##(2009-7#1)(2010-6#1)
protein 7##5##2##(1996-10#2)(2010-4#1)(2011-2#1)(2013-1#1)
protein 70##16##2##(1993-11#1)(1993-9#1)(1994-11#1)(1995-11#1)(1995-2#1)(1996-2#1)(2008-10#3)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-8#1)
protein 90 (HSP90)##2##3##(1994-12#1)(1994-3#1)
protein 90##9##2##(1994-12#1)(1994-3#2)(1995-6#1)(2005-10#1)(2009-8#1)(2012-1#1)(2012-12#1)(2013-8#1)
protein A (RPA)##2##3##(1994-11#1)(1996-8#1)
protein A (SP-A)##2##3##(2011-1#2)
protein A (SPA)##2##3##(1994-12#1)(2008-10#1)
protein A (on plasmid##2##4##(1993-11#2)
protein A affinity chromatography##3##4##(1991-11#2)(1992-7#1)
protein A and##5##3##(1990-12#1)(1990-8#1)(1992-7#1)(2005-11#1)(2008-4#1)
protein A containing##2##3##(1994-6#2)
protein A in human plasma##2##5##(1990-12#2)
protein A in##5##3##(1990-12#4)(1990-8#1)
protein A is##2##3##(1990-12#1)(1996-8#1)
protein A or Streptococcus##2##4##(2005-8#1)(2008-4#1)
protein A or protein G##2##5##(1992-7#1)(2005-8#1)
protein A or##5##3##(1990-11#1)(1992-7#1)(2005-8#2)(2008-4#1)
protein A with##2##3##(1990-12#1)(1994-11#1)
protein A##87##2##(1990-11#1)(1990-12#8)(1990-8#4)(1991-11#6)(1991-5#1)(1992-7#6)(1993-11#3)(1993-3#3)(1994-11#2)(1994-12#3)(1994-3#2)(1994-6#2)(1994-9#1)(1995-1#2)(1995-3#1)(1995-5#1)(1995-7#1)(1996-12#5)(1996-6#1)(1996-7#1)(1996-8#2)(1997-4#2)(2005-11#2)(2005-8#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-9#5)(2011-1#2)(2011-2#1)(2013-1#1)
protein A-Sepharose adsorbed GR##2##4##(1994-3#2)
protein A-Sepharose##4##2##(1994-3#2)(2008-11#1)(2008-8#1)
protein A1##8##2##(1992-7#6)(1997-4#1)(2008-4#1)
protein B##6##2##(1993-2#2)(1994-3#2)(1994-9#2)
protein C (APC)##2##3##(1993-11#1)(2007-12#1)
protein C activation by##2##4##(1990-5#1)(1995-5#1)
protein C activation##3##3##(1990-5#1)(1995-5#1)(1997-2#1)
protein C and activated##2##4##(1990-12#1)(1992-12#1)
protein C and##11##3##(1990-12#1)(1992-12#1)(1994-3#1)(1995-4#1)(1996-6#3)(1996-9#1)(2007-2#1)(2008-1#1)(2011-2#1)
protein C deficiency and##2##4##(1991-11#1)(2005-1#1)
protein C deficiency##8##3##(1991-11#1)(1991-8#1)(2005-1#1)(2008-12#3)(2013-1#2)
protein C in##4##3##(1992-12#1)(2006-4#1)(2008-12#1)(2011-1#1)
protein C was##3##3##(1992-12#1)(1995-1#1)(2008-12#1)
protein C##75##2##(1990-12#1)(1990-5#1)(1991-11#2)(1991-8#1)(1991-9#1)(1992-12#5)(1993-11#2)(1993-5#2)(1994-3#1)(1995-1#9)(1995-2#2)(1995-4#1)(1995-5#4)(1996-6#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#3)(2005-1#2)(2005-7#1)(2006-10#1)(2006-4#2)(2006-8#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-12#7)(2008-3#1)(2008-8#1)(2009-7#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
protein CheY##3##2##(1994-8#1)(1994-9#1)(1995-1#1)
protein D cDNA##2##3##(1992-3#1)(1992-8#1)
protein D##11##2##(1992-3#6)(1992-8#5)
protein D2##4##2##(1996-9#4)
protein E of dengue virus 4##3##6##(2007-11#3)
protein E##4##2##(2007-11#4)
protein E1##3##2##(1992-7#2)(1994-8#1)
protein F1##7##2##(1990-9#7)
protein G and##3##3##(1990-12#2)(1992-7#1)
protein G##31##2##(1990-12#5)(1992-7#6)(1994-11#3)(1995-5#1)(1996-4#1)(2005-8#2)(2008-10#7)(2008-4#2)(2010-7#1)(2013-1#3)
protein G-binding antibodies##2##3##(1990-12#2)
protein G-liposomal nanovesicles##8##3##(2008-10#8)
protein G-sepharose##2##2##(2008-10#2)
protein G-tagged##2##2##(2008-10#2)
protein GAP-43##3##2##(1991-9#1)(1996-3#1)(2008-7#1)
protein HPI1##3##2##(1990-7#3)
protein I##5##2##(1992-12#1)(1992-9#1)(1993-11#1)(1994-12#1)(2008-10#1)
protein II##3##2##(1991-2#1)(1992-12#1)(2006-10#1)
protein L##4##2##(1990-12#2)(1994-11#2)
protein L11##4##2##(1992-5#3)(1995-6#1)
protein L13##3##2##(1994-5#3)
protein L15##4##2##(1992-2#1)(1994-5#3)
protein L29##3##2##(1993-4#3)
protein L3##6##2##(1992-8#3)(1995-8#1)(2006-12#2)
protein L36##3##2##(1993-4#3)
protein L37##5##2##(1991-8#2)(1993-4#3)
protein L7/L12 Tyr14##3##3##(1996-11#3)
protein L7/L12 Tyr26##2##3##(1996-11#2)
protein L7/L12 and##2##3##(1996-11#2)
protein L7/L12##12##2##(1996-11#12)
protein LRP##2##2##(2008-11#2)
protein NCp7##3##2##(1991-10#2)(1994-9#1)
protein O-GlcNAcylation##3##2##(2012-3#3)
protein QUAD##2##2##(1994-11#2)
protein R2##3##2##(1993-11#1)(1997-7#2)
protein Ran##2##2##(1994-3#1)(1995-2#1)
protein S and##3##3##(1994-3#2)(2007-2#1)
protein S binds to##2##4##(1992-12#1)(1994-3#1)
protein S bound to##2##4##(1994-3#2)
protein S deficiency##3##3##(1991-11#1)(1993-5#2)
protein S is##2##3##(1992-12#1)(1993-5#1)
protein S that##2##3##(1992-12#1)(1994-3#1)
protein S to##3##3##(1992-12#3)
protein S was##2##3##(1992-12#1)(1994-3#1)
protein S##35##2##(1991-11#1)(1992-12#10)(1993-5#8)(1994-3#10)(1995-1#1)(1997-4#2)(2006-10#1)(2007-2#1)(2013-7#1)
protein S-C4BP complex##2##3##(1992-12#1)(1995-1#1)
protein S-depleted plasma##2##3##(1993-11#1)(1994-3#1)
protein S-nitrosylation##4##2##(2008-4#3)(2011-1#1)
protein S15##5##2##(1996-8#3)(2006-12#2)
protein S17##2##2##(1993-11#2)
protein SAP12##2##2##(2009-10#2)
protein SNAP-25 (synaptosome-associated protein##2##4##(1995-2#1)(1997-7#1)
protein SNAP-25##4##2##(1995-2#1)(1996-12#1)(1997-7#2)
protein TGF##2##2##(1991-8#1)(1994-12#1)
protein VanA##2##2##(1991-2#2)
protein X##5##2##(1994-5#1)(1995-3#2)(1996-5#1)(1997-7#1)
protein Z##4##2##(1997-4#4)
protein a##3##2##(1995-2#1)(2006-10#1)(2009-8#1)
protein abundance and##2##3##(1990-3#1)(2010-11#1)
protein abundance##6##2##(1990-3#1)(1990-5#1)(1996-3#1)(2008-7#1)(2009-5#1)(2010-11#1)
protein acceptor##2##2##(1990-5#1)(1991-12#1)
protein accumulated to##2##3##(2006-12#1)(2008-10#1)
protein accumulated##4##2##(1993-6#1)(2006-12#1)(2008-10#1)(2008-11#1)
protein accumulates##3##2##(1994-3#1)(2008-8#1)(2010-2#1)
protein accumulation##8##2##(1994-11#1)(1995-6#2)(2008-10#3)(2008-7#1)(2009-12#1)
protein activation of##2##3##(1995-5#1)(1997-7#1)
protein activation##8##2##(1991-12#1)(1995-5#1)(1995-8#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-8#1)(2009-12#1)
protein activator##2##2##(1995-7#1)(1996-1#1)
protein activities##4##2##(1994-9#1)(2008-10#1)(2008-11#1)(2008-8#1)
protein activity by##2##3##(1990-8#1)(2011-2#1)
protein activity in the##2##4##(1997-2#1)(2008-12#1)
protein activity in##3##3##(1997-2#1)(2007-8#1)(2008-12#1)
protein activity##14##2##(1990-8#1)(1992-5#1)(1992-8#1)(1997-2#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-12#3)(2008-5#1)(2009-7#1)(2011-2#1)(2012-3#1)
protein acts as a##2##4##(2006-10#1)(2012-2#1)
protein adducts##3##2##(1991-2#1)(1995-6#1)(2006-2#1)
protein adopts##2##2##(1991-5#1)(2009-7#1)
protein adsorption and##5##3##(2005-11#2)(2009-11#1)(2012-11#2)
protein adsorption from plasma##2##4##(2012-11#2)
protein adsorption from##4##3##(2008-10#2)(2012-11#2)
protein adsorption was##2##3##(2005-11#1)(2008-7#1)
protein adsorption##28##2##(2005-11#5)(2008-10#4)(2008-6#3)(2008-7#2)(2009-11#2)(2009-7#1)(2010-4#2)(2010-7#1)(2012-11#6)(2013-1#2)
protein aerosols##2##2##(1996-1#2)
protein after##7##2##(1990-7#1)(1994-12#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
protein against##3##2##(1994-8#1)(1995-12#1)(1996-11#1)
protein aggregates in the##2##4##(1995-3#1)(2010-4#1)
protein aggregates in##3##3##(1995-3#1)(2010-4#1)(2013-8#1)
protein aggregates##11##2##(1990-12#2)(1994-11#1)(1994-2#1)(1995-10#1)(1995-3#1)(2008-1#1)(2008-4#1)(2010-4#1)(2013-8#2)
protein aggregation##10##2##(1990-12#1)(1990-5#1)(2008-11#1)(2008-4#1)(2008-7#3)(2011-1#3)
protein allowed the##2##3##(1995-2#1)(1997-6#1)
protein allows the##3##3##(1991-2#1)(1995-11#1)(2008-5#1)
protein alone##4##2##(1995-3#2)(2008-4#1)(2008-5#1)
protein along its##2##3##(2006-10#1)(2006-6#1)
protein along the##2##3##(1991-12#1)(1991-5#1)
protein along##5##2##(1991-12#1)(1991-5#1)(2006-10#1)(2006-6#1)(2010-6#1)
protein alpha subunit in##2##4##(1995-1#1)(1997-7#1)
protein alpha subunit##3##3##(1993-8#1)(1995-1#1)(1997-7#1)
protein alpha##7##2##(1993-8#1)(1995-1#1)(1995-11#2)(1995-6#1)(1996-8#1)(1997-7#1)
protein also binds##2##3##(1994-11#1)(1994-6#1)
protein also##13##2##(1990-11#1)(1991-10#1)(1991-12#1)(1993-3#1)(1994-11#2)(1994-6#1)(1994-8#1)(1995-6#1)(1995-7#1)(1996-7#1)(1997-6#1)(2012-1#1)
protein alterations##2##2##(1995-12#1)(2012-1#1)
protein amino acid##3##3##(1995-4#1)(2008-10#1)(2012-2#1)
protein among##3##2##(1994-9#1)(1996-3#1)(2008-10#1)
protein amount##3##2##(2008-11#2)(2009-10#1)
protein amounts##2##2##(1996-7#1)(2007-2#1)
protein analysis using##2##3##(2008-10#1)(2008-4#1)
protein analysis##13##2##(1990-5#1)(1995-7#1)(1997-2#1)(2007-8#2)(2008-10#3)(2008-4#2)(2010-7#1)(2012-2#1)(2012-3#1)
protein analyzed##2##2##(1992-8#1)(2008-12#1)
protein anchors##2##2##(1994-12#2)
protein and DNA sequences##4##4##(2008-4#4)
protein and DNA##9##3##(1990-8#1)(1993-12#1)(1993-8#1)(1995-11#1)(2008-10#1)(2008-4#4)
protein and Kd2##2##3##(1995-11#1)(1995-5#1)
protein and NAD+##2##3##(1993-12#2)
protein and RNA##6##3##(1990-5#3)(2008-4#1)(2010-12#1)(2011-2#1)
protein and a##21##3##(1990-12#1)(1990-8#1)(1992-10#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-8#2)(1997-1#1)(2006-10#1)(2007-11#1)(2008-10#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-7#1)
protein and activity##2##3##(2011-12#2)
protein and albumin levels and##2##5##(2008-7#1)(2013-8#1)
protein and albumin##4##3##(1995-1#1)(1997-8#1)(2008-7#1)(2013-8#1)
protein and are##3##3##(1990-3#1)(1994-5#1)(1995-2#1)
protein and asialo-orosomucoid were##2##4##(1995-6#2)
protein and asialo-orosomucoid##4##3##(1995-6#4)
protein and calorie##2##3##(2007-12#2)
protein and cell##4##3##(2008-11#1)(2010-4#2)(2011-2#1)
protein and creatinine##2##3##(2008-1#1)(2011-1#1)
protein and demonstrates##2##3##(1995-3#1)(1995-8#1)
protein and energy##4##3##(2005-10#1)(2011-2#2)(2012-2#1)
protein and enzymatic activity##2##4##(1991-2#1)(1997-8#1)
protein and enzyme levels in##2##5##(2008-4#2)
protein and enzyme##3##3##(1996-12#1)(2008-4#2)
protein and fat##3##3##(2008-1#1)(2008-3#1)(2010-4#1)
protein and for##2##3##(1990-7#1)(1996-5#1)
protein and gene expression consistent with primary cultures of rods in vitro##2##12##(2012-12#2)
protein and gene expression##3##4##(2007-8#1)(2012-12#2)
protein and gene##5##3##(2007-8#1)(2008-7#1)(2010-2#1)(2012-12#2)
protein and has##2##3##(1994-12#1)(1997-8#1)
protein and have##2##3##(1995-6#1)(2010-11#1)
protein and in##2##3##(1994-9#1)(1996-12#1)
protein and is##6##3##(1992-10#1)(1994-3#1)(1994-8#1)(1996-6#1)(2011-1#1)(2013-1#1)
protein and its associated##2##4##(1994-9#1)(2009-3#1)
protein and its mRNA##3##4##(1990-7#1)(1994-3#1)(2006-12#1)
protein and its##14##3##(1990-7#1)(1991-9#1)(1993-11#1)(1994-3#1)(1994-9#1)(1996-8#1)(1997-4#1)(1997-6#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-3#1)(2011-1#1)
protein and lipid composition of##2##5##(1995-1#1)(2013-7#1)
protein and lipid domains##2##4##(1993-11#1)(1994-3#1)
protein and lipid##14##3##(1991-11#1)(1991-7#1)(1993-11#2)(1994-3#1)(1995-1#1)(2005-7#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#1)(2013-7#1)
protein and low##2##3##(2010-4#1)(2013-7#1)
protein and mRNA expression##3##4##(1992-1#1)(2012-12#1)(2013-1#1)
protein and mRNA in##3##4##(1991-6#1)(1995-8#1)(1996-8#1)
protein and mRNA levels##3##4##(1991-12#1)(1993-3#1)(2010-1#1)
protein and mRNA synthesis##2##4##(1993-12#1)(1995-3#1)
protein and mRNA##18##3##(1991-12#1)(1991-6#1)(1992-1#1)(1992-3#1)(1993-12#1)(1993-3#2)(1994-2#1)(1994-9#2)(1995-3#1)(1995-8#1)(1996-8#2)(2007-12#1)(2010-1#1)(2012-12#1)(2013-1#1)
protein and matrix##2##3##(1991-5#1)(2010-12#1)
protein and membrane##4##3##(1993-9#1)(2006-12#1)(2008-11#2)
protein and metabolite##2##3##(2008-7#1)(2011-2#1)
protein and not##4##3##(1991-1#1)(1991-9#1)(1994-11#1)(1994-8#1)
protein and nucleic acid##5##4##(1990-12#1)(1995-1#1)(1995-2#1)(2008-11#1)(2010-2#1)
protein and nucleotide##2##3##(1995-2#1)(2008-4#1)
protein and of##3##3##(1990-7#1)(1993-8#1)(1995-4#1)
protein and other##2##3##(1997-6#1)(2008-10#1)
protein and peptide##2##3##(1995-5#2)
protein and phospholipase C gamma##2##5##(1994-12#1)(1994-9#1)
protein and phospholipid##3##3##(1993-9#1)(1994-12#1)(2012-2#1)
protein and possibly##2##3##(1993-6#1)(1995-8#1)
protein and that the##4##4##(1992-6#1)(1994-3#2)(1997-7#1)
protein and that##5##3##(1992-6#1)(1994-3#2)(1997-7#1)(2009-10#1)
protein and the cell##2##4##(2008-11#1)(2008-2#1)
protein and the first##2##4##(1991-4#1)(1991-5#1)
protein and the##41##3##(1990-3#1)(1991-4#1)(1991-5#2)(1991-7#1)(1992-12#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-4#1)(1994-10#1)(1994-2#1)(1994-3#1)(1995-5#1)(1996-11#1)(1996-4#1)(1997-1#1)(1997-2#3)(1997-4#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-3#2)(2010-10#1)(2010-2#1)(2010-7#1)(2013-8#1)
protein and their##2##3##(1996-11#1)(1996-3#1)
protein and three##2##3##(1990-7#1)(2009-4#1)
protein and to assess the##2##5##(1995-8#1)(2013-8#1)
protein and to##6##3##(1991-5#1)(1994-11#1)(1995-8#1)(2008-10#1)(2013-1#1)(2013-8#1)
protein and two##2##3##(1995-3#1)(1995-9#1)
protein and was##5##3##(1990-2#1)(1992-12#1)(1992-6#1)(1992-9#1)(1996-7#1)
protein and were##2##3##(1991-12#1)(2010-12#1)
protein and##463##2##(1990-12#3)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#5)(1990-8#6)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#4)(1991-4#1)(1991-5#8)(1991-6#3)(1991-7#4)(1991-9#4)(1992-1#2)(1992-10#2)(1992-12#6)(1992-2#1)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#6)(1992-7#1)(1992-8#2)(1992-9#4)(1993-11#4)(1993-12#7)(1993-3#3)(1993-4#2)(1993-6#3)(1993-7#1)(1993-8#4)(1993-9#2)(1994-10#3)(1994-11#6)(1994-12#5)(1994-2#5)(1994-3#8)(1994-5#4)(1994-6#4)(1994-7#2)(1994-8#7)(1994-9#7)(1995-1#6)(1995-10#2)(1995-11#3)(1995-12#2)(1995-2#6)(1995-3#3)(1995-4#2)(1995-5#6)(1995-6#6)(1995-8#12)(1995-9#1)(1996-10#2)(1996-11#3)(1996-12#3)(1996-3#2)(1996-4#3)(1996-5#3)(1996-6#2)(1996-7#2)(1996-8#3)(1997-1#3)(1997-2#4)(1997-3#1)(1997-4#7)(1997-6#7)(1997-7#2)(1997-8#6)(2003-11#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#2)(2006-10#5)(2006-11#1)(2006-12#3)(2006-4#3)(2006-6#2)(2006-8#2)(2006-9#1)(2007-11#5)(2007-12#4)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#4)(2008-10#15)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#22)(2008-5#6)(2008-6#1)(2008-7#8)(2008-8#7)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#3)(2009-4#2)(2009-5#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#8)(2010-2#3)(2010-4#6)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-12#2)(2011-2#9)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#7)(2013-7#4)(2013-8#3)
protein and/or activity##2##3##(2012-3#2)
protein and/or##5##2##(1990-5#1)(1993-12#1)(2008-11#1)(2012-3#2)
protein antibodies##5##2##(1992-4#1)(1995-2#2)(2008-5#1)(2012-2#1)
protein antigen##4##2##(1995-2#1)(1996-10#1)(2009-3#1)(2011-2#1)
protein antigens##17##2##(1995-5#1)(2006-10#1)(2007-11#2)(2008-11#1)(2008-4#9)(2010-12#1)(2011-12#1)(2013-1#1)
protein appeared to be##5##4##(1992-7#1)(1995-2#1)(1996-11#1)(2008-7#1)(2008-8#1)
protein appears to be a##2##5##(1991-11#1)(1993-2#1)
protein appears to be the##2##5##(1991-10#1)(1991-12#1)
protein appears to be##7##4##(1990-11#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-6#1)(1993-2#1)(1997-4#1)
protein appears##10##2##(1990-11#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1993-2#1)(1995-1#1)(1997-4#1)
protein are also##2##3##(1995-6#1)(1996-8#1)
protein are discussed##2##3##(1992-12#1)(2008-10#1)
protein are essential for##2##4##(1993-2#1)(2009-7#1)
protein are found##2##3##(1992-11#1)(1994-9#1)
protein are low##2##3##(1991-6#1)(1996-3#1)
protein are present##2##3##(1993-2#1)(2013-1#1)
protein are the##2##3##(1993-11#1)(1996-10#1)
protein are##50##2##(1990-1#1)(1990-12#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-2#2)(1993-6#1)(1994-11#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#2)(2006-10#1)(2008-1#3)(2008-10#2)(2008-2#2)(2008-4#2)(2008-5#1)(2009-10#1)(2009-7#1)(2012-12#2)(2013-1#1)
protein arginine##2##2##(1997-4#1)(2009-7#1)
protein array##3##2##(2008-4#2)(2013-7#1)
protein arrays##3##2##(2008-7#2)(2011-2#1)
protein as a##23##3##(1990-7#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-6#1)(1993-1#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-5#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-5#1)(2005-7#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-8#1)(2013-8#1)
protein as an antigen##2##4##(1997-4#1)(2008-8#1)
protein as an##3##3##(1994-8#1)(1997-4#1)(2008-8#1)
protein as determined by##4##4##(1990-5#1)(1990-8#1)(1993-3#1)(1997-4#1)
protein as determined##5##3##(1990-5#1)(1990-8#1)(1993-3#1)(1994-11#1)(1997-4#1)
protein as the##5##3##(1992-2#1)(1993-12#1)(1994-9#1)(1996-11#1)(1997-1#1)
protein as well as##8##4##(1990-8#1)(1991-12#1)(1995-1#1)(1995-8#1)(2008-11#1)(2008-4#1)(2011-2#2)
protein as##72##2##(1990-5#5)(1990-7#1)(1990-8#2)(1991-11#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-8#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-1#2)(1997-4#2)(1997-5#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-4#3)(2008-5#1)(2008-8#3)(2008-9#1)(2009-8#1)(2011-2#2)(2013-8#1)
protein assay with##2##3##(2008-10#1)(2013-1#1)
protein assay##7##2##(1992-5#1)(2008-10#4)(2008-12#1)(2013-1#1)
protein assays such as##2##4##(2007-2#1)(2008-10#1)
protein assays##7##2##(2007-2#2)(2008-10#1)(2008-4#3)(2013-1#1)
protein assemblies##3##2##(2008-4#1)(2008-7#1)(2009-10#1)
protein assembly##4##2##(1991-4#1)(1997-1#1)(2008-4#1)(2011-2#1)
protein associated with##10##3##(1990-4#1)(1991-2#1)(1991-8#1)(1994-3#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-5#1)(2009-7#1)
protein associates with##2##3##(1994-12#1)(1994-2#1)
protein association##2##2##(1991-7#1)(1993-8#1)
protein at a##3##3##(1992-6#1)(1995-2#1)(2008-11#1)
protein at high##2##3##(1995-8#1)(2006-5#1)
protein at pH##2##3##(1990-5#1)(1995-1#1)
protein at the##5##3##(1990-3#1)(1991-4#1)(1992-9#1)(1993-8#1)(1996-5#1)
protein at##33##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-4#1)(1992-12#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-8#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-8#2)(1996-2#1)(1996-5#1)(2006-5#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-8#2)(2010-5#1)(2010-7#1)(2012-3#1)
protein atoms and##3##3##(1994-9#1)(1997-5#1)(2006-10#1)
protein atoms##7##2##(1992-4#1)(1994-9#1)(1997-1#1)(1997-5#1)(2006-10#1)(2006-12#2)
protein autofluorescence##2##2##(1995-6#1)(2009-12#1)
protein backbone##4##2##(1997-1#2)(2008-7#1)(2012-3#1)
protein balance##5##2##(2008-5#5)
protein band at about##2##4##(1994-9#1)(2006-8#1)
protein band at##3##3##(1994-9#2)(2006-8#1)
protein band corresponding to##2##4##(1992-11#1)(1993-11#1)
protein band in##2##3##(2008-9#1)(2009-8#1)
protein band of approximately##4##4##(1990-3#1)(1992-4#1)(1994-9#1)(1997-8#1)
protein band of##9##3##(1990-3#1)(1990-5#1)(1991-1#1)(1992-4#1)(1993-8#1)(1994-5#1)(1994-9#1)(1997-8#1)(2006-8#1)
protein band was detected##2##4##(1992-12#1)(2011-12#1)
protein band was##4##3##(1992-12#1)(1992-4#1)(2011-12#1)(2011-3#1)
protein band with##3##3##(1995-5#1)(2009-9#1)(2010-3#1)
protein band##38##2##(1990-3#3)(1990-4#1)(1990-5#1)(1991-1#2)(1992-11#2)(1992-12#1)(1992-4#4)(1993-11#1)(1993-8#1)(1993-9#1)(1994-5#2)(1994-9#3)(1995-5#1)(1996-5#1)(1997-8#1)(2006-8#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-3#2)(2011-12#1)(2011-3#1)
protein bands of##6##3##(1991-7#1)(1992-12#1)(1993-3#1)(1996-5#1)(2008-10#1)(2008-11#1)
protein bands that##2##3##(2008-10#2)
protein bands##28##2##(1990-2#1)(1990-5#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-3#1)(1994-11#1)(1994-9#3)(1996-5#1)(2004-11#3)(2008-10#6)(2008-11#3)(2008-4#1)(2008-7#1)(2010-11#1)(2010-3#1)
protein based on the##2##4##(1991-6#1)(2008-11#1)
protein based on##6##3##(1991-6#1)(1994-12#1)(2008-10#3)(2008-11#1)
protein based##12##2##(1991-6#1)(1994-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-12#3)
protein because##2##2##(1991-3#1)(1992-6#1)
protein before##2##2##(1995-12#1)(2008-10#1)
protein behaves##2##2##(1991-7#1)(1994-9#1)
protein behavior##2##2##(2008-1#1)(2008-6#1)
protein being analyzed##2##3##(2008-10#2)
protein being##5##2##(2008-10#2)(2008-11#1)(2008-5#1)(2011-1#1)
protein belonging to the##3##4##(1997-7#1)(2008-11#1)(2010-10#1)
protein beta##5##2##(1994-5#1)(1994-9#1)(1995-3#2)(1995-6#1)
protein between##7##2##(1991-9#1)(1993-5#1)(1994-8#1)(1995-1#1)(1997-2#1)(2005-8#1)(2008-8#1)
protein bind##2##2##(1997-1#1)(1997-4#1)
protein binding and##3##3##(1995-1#1)(2008-8#1)(2011-1#1)
protein binding assay for activin A/EDF##2##6##(1992-6#2)
protein binding assay##5##3##(1990-10#1)(1990-12#2)(1992-6#2)
protein binding at##2##3##(1994-9#1)(1995-10#1)
protein binding in##4##3##(1990-7#1)(1991-6#1)(1995-2#1)(1996-8#1)
protein binding of##5##3##(1990-12#1)(1990-6#1)(1997-8#1)(2008-10#1)(2008-5#1)
protein binding sites and##2##4##(1993-2#1)(2013-1#1)
protein binding sites are##2##4##(1991-5#1)(1995-10#1)
protein binding sites in##2##4##(1991-3#1)(1991-5#1)
protein binding sites##12##3##(1991-11#1)(1991-3#1)(1991-5#2)(1991-8#2)(1992-1#2)(1993-2#1)(1994-12#1)(1995-10#1)(2013-1#1)
protein binding to IGFI-FP1##2##4##(1995-10#2)
protein binding to a##3##4##(1992-11#1)(1995-10#1)(1996-8#1)
protein binding to the##4##4##(1992-11#1)(1992-12#1)(1994-8#1)(1995-8#1)
protein binding to##14##3##(1990-11#1)(1991-6#1)(1992-11#2)(1992-12#1)(1994-8#1)(1995-10#4)(1995-8#1)(1996-8#1)(1997-2#1)(2008-5#1)
protein binding##77##2##(1990-10#1)(1990-11#1)(1990-12#4)(1990-6#1)(1990-7#1)(1991-11#1)(1991-3#1)(1991-5#2)(1991-6#3)(1991-8#2)(1992-1#2)(1992-11#3)(1992-12#1)(1992-6#3)(1992-9#1)(1993-12#1)(1993-2#1)(1993-8#2)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#6)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-8#3)(1997-2#1)(1997-5#2)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-2#2)(2010-8#1)(2011-1#2)(2013-1#1)
protein binds specifically to the##2##5##(1990-6#1)(1992-12#1)
protein binds to##5##3##(1991-10#1)(1992-4#1)(1994-12#1)(1994-9#1)(1995-3#1)
protein binds##16##2##(1990-6#1)(1991-10#1)(1991-7#1)(1992-12#1)(1992-4#1)(1992-7#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-5#1)(2008-9#1)(2011-2#1)(2012-2#1)
protein bioavailability##2##2##(2011-2#1)(2012-2#1)
protein biomarker##2##2##(2010-6#1)(2010-9#1)
protein biomarkers##8##2##(2007-12#1)(2008-10#2)(2010-11#2)(2010-9#3)
protein biopharmaceuticals##2##2##(2011-2#2)
protein biosynthesis##10##2##(1992-8#1)(1994-8#1)(1995-3#1)(1995-7#3)(2006-12#1)(2006-3#1)(2008-4#1)(2008-7#1)
protein blot##3##2##(2008-10#3)
protein blots##3##2##(1996-3#2)(2008-10#1)
protein blotting##2##2##(1990-5#1)(1991-12#1)
protein bodies##4##2##(1992-7#1)(2006-12#3)
protein bound specifically to##2##4##(1993-12#1)(2008-11#1)
protein bound to the##2##4##(1992-12#1)(1997-6#1)
protein bound to##5##3##(1992-12#1)(1993-6#1)(1997-2#1)(1997-6#1)(2008-1#1)
protein bound##16##2##(1992-12#1)(1992-7#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-8#3)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-8#1)(2013-8#1)
protein bovine serum##2##3##(2008-10#1)(2008-2#1)
protein breakdown##6##2##(1991-4#1)(1995-6#2)(2008-5#2)(2010-8#1)
protein but not the##2##4##(1993-11#1)(1997-7#1)
protein but not to##3##4##(1992-8#1)(1994-3#1)(1994-9#1)
protein but not with##2##4##(1992-8#1)(1995-6#1)
protein but not##9##3##(1990-3#1)(1992-8#3)(1993-11#1)(1994-3#1)(1994-9#1)(1995-6#1)(1997-7#1)
protein but with##2##3##(1992-11#1)(2008-5#1)
protein but##21##2##(1990-3#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-8#3)(1993-11#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-6#1)(1997-4#1)(1997-7#1)(2006-6#1)(2008-5#1)(2009-5#1)
protein by Western blot##2##4##(1992-8#1)(1994-8#1)
protein by Western##3##3##(1992-8#1)(1994-8#1)(2007-9#1)
protein by a##2##3##(1992-12#1)(2008-2#1)
protein by its##2##3##(1991-8#1)(2008-10#1)
protein by means of##2##4##(1993-9#1)(1996-3#1)
protein by the##5##3##(1991-11#1)(1991-5#1)(1992-2#1)(1993-11#1)(1994-5#1)
protein by##67##2##(1990-10#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-11#2)(1991-5#2)(1991-8#3)(1991-9#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-4#2)(1992-5#1)(1992-8#1)(1993-11#2)(1993-12#3)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#3)(1994-5#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-4#1)(2012-1#1)
protein called##6##2##(1994-3#1)(1994-9#1)(2006-10#2)(2010-7#1)(2011-1#1)
protein calretinin##3##2##(1991-2#1)(1991-9#1)(1994-12#1)
protein can also##2##3##(1994-10#1)(2008-10#1)
protein can be detected in the##2##6##(1992-11#1)(2008-1#1)
protein can be detected##3##4##(1992-11#1)(1995-2#1)(2008-1#1)
protein can be##13##3##(1990-4#1)(1991-4#1)(1992-11#1)(1993-9#1)(1994-10#1)(1994-8#1)(1995-2#1)(1997-4#1)(2008-1#2)(2008-2#1)(2008-4#1)(2008-8#1)
protein can give##2##3##(1994-11#1)(2006-10#1)
protein can##31##2##(1990-11#1)(1990-4#1)(1991-4#1)(1992-11#2)(1992-3#1)(1993-3#1)(1993-9#1)(1994-10#2)(1994-11#1)(1994-8#2)(1995-2#1)(1995-8#1)(1996-11#1)(1997-4#2)(2006-10#1)(2007-1#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2011-12#1)(2011-2#1)(2012-12#1)
protein carbonyl##4##2##(2004-11#1)(2008-3#2)(2011-2#1)
protein carbonyls and##2##3##(1995-6#2)
protein carbonyls in##2##3##(2008-8#1)(2010-4#1)
protein carbonyls##7##2##(1995-6#3)(2008-8#1)(2010-4#2)(2010-8#1)
protein carrier##3##2##(1991-3#1)(1993-8#1)(1997-3#1)
protein carriers##3##2##(2005-7#1)(2008-10#1)(2010-1#1)
protein catabolic rate (PCR)##2##4##(1990-12#1)(2008-1#1)
protein catabolism##3##2##(1990-2#1)(1991-5#1)(1992-4#1)
protein causes transformation of##2##4##(1991-8#1)(1995-3#1)
protein causes##4##2##(1991-8#1)(1995-3#1)(1996-7#1)(2010-11#1)
protein chain##2##2##(1990-5#1)(2012-2#1)
protein chains##3##2##(1994-3#1)(2008-10#2)
protein changes##9##2##(1994-5#1)(1995-7#1)(2009-6#2)(2010-11#2)(2010-2#2)(2010-9#1)
protein chaperones##2##2##(1997-4#1)(2008-7#1)
protein characteristics##2##2##(1994-5#1)(2008-7#1)
protein characterization by##2##3##(1996-8#1)(2007-8#1)
protein charge##3##2##(2008-2#1)(2008-4#1)(2009-12#1)
protein chemical##2##2##(1993-11#1)(2011-1#1)
protein chemistry##3##2##(1997-4#1)(1997-6#1)(2008-7#1)
protein chromogranin##2##2##(2009-12#1)(2010-11#1)
protein classes##3##2##(1997-2#2)(1997-8#1)
protein cleavage##5##2##(1993-11#1)(1996-10#1)(2007-6#1)(2008-5#1)(2009-12#1)
protein co-localized with##2##3##(1997-5#1)(2008-10#1)
protein co-localized##3##2##(1995-6#1)(1997-5#1)(2008-10#1)
protein co-purified with##2##3##(1995-5#1)(1997-4#1)
protein coded for by##2##4##(1991-5#1)(1997-5#1)
protein coded##3##2##(1991-5#1)(1993-2#1)(1997-5#1)
protein coding and##2##3##(1995-10#1)(2008-4#1)
protein coding genes##2##3##(2008-7#1)(2009-5#1)
protein coding region##2##3##(1990-7#1)(1997-4#1)
protein coding regions##5##3##(1993-6#1)(1996-12#2)(1997-2#1)(2010-7#1)
protein coding sequence##3##3##(1991-7#1)(1994-9#1)(2011-2#1)
protein coding sequences##4##3##(1997-4#1)(2008-7#1)(2008-9#1)(2012-2#1)
protein coding##21##2##(1990-7#1)(1991-7#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-10#1)(1996-12#2)(1997-2#1)(1997-4#2)(2008-4#2)(2008-7#2)(2008-9#1)(2009-5#1)(2010-7#2)(2011-2#1)(2012-2#1)
protein cofactor##2##2##(1990-6#1)(1992-12#1)
protein cofactors##2##2##(1995-1#1)(2007-8#1)
protein comigrated##2##2##(1990-10#1)(1997-4#1)
protein compared to##2##3##(2008-11#1)(2008-3#1)
protein compared##3##2##(2004-11#1)(2008-11#1)(2008-3#1)
protein complex at the##2##4##(1994-8#1)(2012-2#1)
protein complex involved in##2##4##(1997-1#1)(1997-7#1)
protein complex is##2##3##(1996-4#1)(2008-4#1)
protein complex of##2##3##(1992-6#1)(2009-9#1)
protein complex that is required##3##5##(1995-10#1)(1995-2#1)(2008-5#1)
protein complex that##5##3##(1995-10#1)(1995-2#1)(1995-6#1)(2007-12#1)(2008-5#1)
protein complex to##3##3##(2008-4#1)(2009-7#1)(2012-1#1)
protein complex with##2##3##(1994-8#1)(1996-9#1)
protein complex##54##2##(1990-11#1)(1990-8#1)(1991-11#2)(1991-2#1)(1992-6#1)(1993-2#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-8#3)(1995-1#1)(1995-10#1)(1995-2#2)(1995-6#1)(1996-4#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(2005-10#2)(2006-10#1)(2007-12#2)(2008-2#3)(2008-4#2)(2008-5#1)(2008-9#2)(2009-7#1)(2009-8#3)(2009-9#1)(2011-2#2)(2012-1#1)(2012-2#2)
protein complexes and##2##3##(1995-8#1)(2008-7#1)
protein complexes are##2##3##(2006-12#1)(2008-7#1)
protein complexes formed##2##3##(1995-6#1)(1997-3#1)
protein complexes in the##2##4##(1994-5#1)(2008-4#1)
protein complexes in##6##3##(1994-5#1)(1995-8#1)(2006-12#1)(2008-4#1)(2008-5#1)(2010-9#1)
protein complexes of##2##3##(1993-9#1)(2006-12#1)
protein complexes that##2##3##(2008-4#1)(2010-10#1)
protein complexes##47##2##(1990-5#1)(1993-8#2)(1993-9#3)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-6#1)(1995-8#2)(1996-5#1)(1997-3#1)(2005-10#2)(2006-12#4)(2008-10#1)(2008-2#3)(2008-4#5)(2008-5#1)(2008-7#5)(2010-10#2)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#2)(2013-8#1)
protein component in##2##3##(2008-11#1)(2008-3#1)
protein component of the##3##4##(1996-10#1)(1997-8#1)(2008-5#1)
protein component of##7##3##(1993-6#1)(1995-6#1)(1996-10#1)(1997-4#1)(1997-8#1)(2007-2#1)(2008-5#1)
protein component with##3##3##(1991-6#1)(2008-10#2)
protein component##14##2##(1991-5#1)(1991-6#1)(1992-3#1)(1993-6#1)(1995-6#1)(1996-10#1)(1997-4#1)(1997-8#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)
protein components in##3##3##(1995-7#1)(2008-12#1)(2008-7#1)
protein components of nucleolar skeleton##2##5##(2008-8#2)
protein components of the##2##4##(2008-2#1)(2008-5#1)
protein components of##9##3##(1990-5#1)(1992-12#1)(1995-2#1)(1997-3#1)(2008-2#1)(2008-5#1)(2008-8#2)(2010-11#1)
protein components##24##2##(1990-12#1)(1990-5#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-11#1)(1993-8#1)(1994-3#1)(1995-10#1)(1995-2#1)(1995-7#1)(1996-12#1)(1997-3#1)(2006-8#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-11#1)(2013-8#1)
protein composed of##2##3##(1991-1#1)(1996-8#1)
protein composition and##4##3##(1995-11#1)(2008-5#1)(2010-11#1)(2012-2#1)
protein composition of the nucleolar skeleton of HeLa cells##2##9##(2008-8#2)
protein composition of the##6##4##(1990-7#1)(1991-2#1)(1991-8#2)(2008-8#2)
protein composition of##12##3##(1990-7#1)(1991-2#1)(1991-8#2)(1992-4#1)(1995-7#1)(1996-4#1)(2008-8#3)(2008-9#1)(2009-6#1)
protein composition##27##2##(1990-5#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-8#2)(1992-12#1)(1992-4#1)(1994-9#1)(1995-11#1)(1995-6#1)(1995-7#2)(1995-9#1)(1996-4#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-8#4)(2008-9#2)(2009-6#1)(2010-11#1)(2012-2#1)
protein compositions##2##2##(1993-6#2)
protein comprised of a##2##4##(1997-6#1)(2008-11#1)
protein comprised##4##2##(1992-12#1)(1997-6#1)(2008-10#1)(2008-11#1)
protein comprises##2##2##(1990-10#1)(1993-2#1)
protein comprising##3##2##(1997-2#2)(2008-10#1)
protein concentrates##2##2##(2010-4#2)
protein concentration and##10##3##(1990-7#1)(1991-2#1)(1991-7#1)(1992-10#1)(1994-9#1)(2009-7#2)(2010-12#1)(2010-2#1)(2013-7#1)
protein concentration but##2##3##(1997-8#1)(2004-12#1)
protein concentration in the##4##4##(1990-7#2)(1991-11#1)(2008-4#1)
protein concentration in##6##3##(1990-7#2)(1991-11#1)(2008-10#1)(2008-4#2)
protein concentration of##4##3##(1991-11#1)(1996-12#1)(1997-8#1)(2011-1#1)
protein concentration was##3##3##(1994-8#1)(1996-5#1)(2008-6#1)
protein concentration with##3##3##(1990-2#1)(1990-8#1)(1993-7#1)
protein concentration##79##2##(1990-10#2)(1990-12#1)(1990-2#1)(1990-7#3)(1990-8#3)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#3)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-7#2)(1993-7#1)(1993-9#2)(1994-8#2)(1994-9#1)(1995-2#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-6#1)(1997-8#2)(2004-12#2)(2006-10#2)(2008-1#3)(2008-10#3)(2008-11#1)(2008-2#3)(2008-4#6)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#1)(2009-4#1)(2009-7#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2011-1#1)(2011-2#2)(2013-7#2)(2013-8#1)
protein concentrations and##2##3##(1991-12#1)(2008-10#1)
protein concentrations in the##3##4##(1991-10#1)(1996-5#1)(2008-1#1)
protein concentrations in##4##3##(1991-10#1)(1996-5#1)(2008-1#1)(2013-7#1)
protein concentrations were##2##3##(1997-4#1)(2013-1#1)
protein concentrations##28##2##(1990-10#1)(1990-2#1)(1990-8#2)(1991-10#1)(1991-12#1)(1993-4#1)(1994-12#1)(1995-3#1)(1995-8#2)(1996-5#2)(1997-2#1)(1997-4#1)(2005-11#2)(2006-10#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2011-1#1)(2013-1#2)(2013-7#1)
protein conformation and##3##3##(1991-4#1)(1994-8#1)(2008-6#1)
protein conformation##10##2##(1991-4#1)(1992-7#1)(1994-8#1)(1995-5#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-12#1)(2010-4#1)
protein conformational change##3##3##(1995-1#1)(1995-6#2)
protein conformational changes in##2##4##(1995-8#2)
protein conformational changes##7##3##(1991-8#1)(1995-8#3)(2005-10#1)(2006-10#1)(2006-6#1)
protein conformational##12##2##(1991-8#1)(1992-12#1)(1995-1#1)(1995-6#2)(1995-8#3)(2005-10#1)(2006-10#1)(2006-6#1)(2008-10#1)
protein conformations on##2##3##(1995-2#1)(2009-2#1)
protein conformations##3##2##(1995-2#1)(2008-5#1)(2009-2#1)
protein conjugates##2##2##(1990-2#1)(2008-11#1)
protein consisting of the##6##4##(1994-9#2)(1995-3#1)(1997-1#1)(2007-11#1)(2008-4#1)
protein consisting of##16##3##(1990-2#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-9#2)(1995-3#1)(1995-8#2)(1997-1#1)(1997-7#1)(2007-11#1)(2008-4#1)(2008-9#1)(2009-3#1)
protein consists of two##2##4##(1991-5#1)(1992-6#1)
protein consists of##8##3##(1991-3#1)(1991-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1997-6#1)
protein constituent##2##2##(1991-8#1)(1994-9#1)
protein consumption##3##2##(2007-12#1)(2008-5#1)(2013-7#1)
protein contained a##2##3##(1990-12#1)(1993-12#1)
protein contained##8##2##(1990-11#1)(1990-12#1)(1991-4#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-12#1)
protein containing a##7##3##(1994-12#1)(1994-5#1)(1995-12#1)(1997-7#1)(2009-9#1)(2012-2#2)
protein containing an##4##3##(1990-11#1)(1994-6#1)(1994-9#1)(1995-2#1)
protein containing one SH2 and three SH3 domains##2##8##(1997-4#2)
protein containing only the##2##4##(1990-7#1)(1995-6#1)
protein containing the first##2##4##(1990-3#1)(1994-9#1)
protein containing the##14##3##(1990-3#1)(1990-8#1)(1991-7#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-9#2)(1995-6#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(2008-4#1)
protein containing two##5##3##(1991-10#1)(1991-7#1)(1993-8#1)(1995-8#1)(2008-4#1)
protein containing##47##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-5#1)(1991-7#2)(1991-9#1)(1992-6#1)(1993-12#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-9#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#3)(1995-8#2)(1996-10#1)(1996-2#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(2008-4#2)(2008-8#1)(2009-9#1)(2012-2#2)
protein contains a##7##3##(1990-8#1)(1991-11#1)(1993-12#1)(1994-12#2)(1995-3#1)(2008-8#1)
protein contains all##2##3##(1994-5#1)(1997-7#1)
protein contains no##2##3##(1990-7#1)(1991-7#1)
protein contains two##3##3##(1993-2#1)(1995-10#1)(2008-10#1)
protein contains##29##2##(1990-10#1)(1990-7#1)(1990-8#1)(1991-11#2)(1991-7#1)(1992-10#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-2#2)(1994-12#3)(1994-5#1)(1994-9#1)(1995-10#1)(1995-2#2)(1995-3#1)(1995-6#2)(1996-9#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-8#1)
protein content and##8##3##(1990-10#1)(1990-5#1)(1991-12#1)(1995-12#2)(2006-12#1)(2006-4#1)(2011-3#1)
protein content as##2##3##(1990-7#1)(1997-3#1)
protein content in##8##3##(1992-8#1)(1993-6#1)(1995-2#1)(2006-12#1)(2008-10#1)(2008-12#1)(2013-1#2)
protein content of the##6##4##(1992-9#1)(2005-11#1)(2006-12#1)(2008-4#1)(2008-5#1)(2013-1#1)
protein content of##17##3##(1990-10#1)(1992-8#1)(1992-9#1)(1993-4#1)(1994-9#1)(1995-9#1)(1997-4#1)(2004-4#1)(2005-11#1)(2006-12#2)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-11#1)(2013-1#1)
protein content was observed##2##4##(1997-5#1)(2012-2#1)
protein content was##3##3##(1994-2#1)(1997-5#1)(2012-2#1)
protein content were##2##3##(2008-12#1)(2010-11#1)
protein content##73##2##(1990-10#3)(1990-5#1)(1990-7#2)(1991-12#1)(1991-2#1)(1991-4#1)(1992-7#3)(1992-8#3)(1992-9#1)(1993-4#1)(1993-6#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-9#2)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-4#1)(2005-11#1)(2006-12#4)(2006-4#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-10#1)(2010-11#2)(2010-4#1)(2011-3#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-7#1)(2013-1#4)
protein contents of##2##3##(1994-5#1)(2008-10#1)
protein contents##15##2##(1991-8#1)(1992-12#1)(1994-11#1)(1994-5#1)(1995-3#1)(2007-3#1)(2008-10#3)(2008-12#2)(2008-8#1)(2010-2#1)(2011-12#1)(2012-12#1)
protein controlled##2##2##(1990-8#2)
protein core of##2##3##(1993-2#1)(1995-5#1)
protein core##9##2##(1991-7#1)(1993-2#2)(1995-1#1)(1995-5#2)(1997-8#2)(2009-8#1)
protein cores##3##2##(1995-5#1)(1995-8#1)(1997-7#1)
protein correlated##3##2##(1994-8#1)(1995-3#1)(2006-12#1)
protein corresponded to that of the##2##6##(1996-5#1)(2009-10#1)
protein corresponded to##3##3##(1992-12#1)(1996-5#1)(2009-10#1)
protein corresponding to a##2##4##(1995-2#1)(1996-3#1)
protein corresponding to##5##3##(1991-5#1)(1992-3#1)(1995-2#1)(1996-3#1)(2011-2#1)
protein could be detected in##2##5##(2005-11#1)(2008-8#1)
protein could be obtained##2##4##(1990-8#1)(1997-4#1)
protein could be precipitated##3##4##(1990-11#1)(2008-5#2)
protein could be recognized##2##4##(2005-11#1)(2008-4#1)
protein could be released from the##2##6##(1993-3#1)(2008-5#1)
protein could be used##2##4##(1992-7#1)(2006-10#1)
protein could be##26##3##(1990-11#2)(1990-8#1)(1991-7#1)(1991-8#1)(1992-7#1)(1993-3#2)(1993-6#1)(1994-5#3)(1994-6#1)(1997-4#1)(2005-11#2)(2006-10#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-8#2)(2013-8#2)
protein could bind##2##3##(1991-3#1)(1994-6#1)
protein could not be detected##2##5##(1994-3#1)(1996-5#1)
protein could not be##4##4##(1993-12#1)(1994-3#1)(1996-5#1)(1996-9#1)
protein could not##6##3##(1993-12#1)(1994-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(2008-9#1)
protein could##42##2##(1990-11#3)(1990-8#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-7#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-3#1)(1994-5#3)(1994-6#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-4#1)(2005-11#3)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#1)(2009-6#1)(2010-2#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-8#2)
protein coupled receptors##3##3##(1997-2#1)(2008-4#1)(2008-7#1)
protein coupled##5##2##(1997-2#3)(2008-4#1)(2008-7#1)
protein coupling during maturation##2##4##(2008-3#2)
protein coupling##10##2##(1990-2#1)(1993-8#1)(1996-10#1)(1996-2#2)(2008-3#4)(2011-1#1)
protein cross-linking##3##2##(1992-6#1)(1996-5#1)(2008-8#1)
protein crystal##5##2##(1992-7#1)(2006-10#2)(2008-4#1)(2010-7#1)
protein crystallization##6##2##(2006-12#1)(2007-5#2)(2008-10#1)(2009-11#1)(2009-5#1)
protein crystallography beamline##2##3##(2006-5#2)
protein crystallography##4##2##(2006-4#2)(2006-5#2)
protein crystals##12##2##(1994-11#1)(1994-6#1)(1996-12#2)(2006-4#3)(2007-5#2)(2008-4#1)(2009-12#1)(2009-5#1)
protein cytolysins##2##2##(1994-2#2)
protein damage and##2##3##(2008-7#1)(2010-8#1)
protein damage##3##2##(1997-8#1)(2008-7#1)(2010-8#1)
protein data banks##3##3##(1994-3#1)(1994-8#1)(2008-4#1)
protein data##5##2##(1994-3#1)(1994-8#1)(1995-6#1)(2008-4#1)(2011-2#1)
protein databank##2##2##(1995-7#1)(2008-7#1)
protein database##6##2##(1994-12#1)(1996-8#1)(1997-2#1)(2008-7#1)(2010-4#1)(2013-1#1)
protein databases revealed that##2##4##(1995-4#1)(2010-4#1)
protein databases##7##2##(1995-4#1)(2008-2#2)(2008-4#2)(2008-9#1)(2010-4#1)
protein decreased##5##2##(1993-12#1)(1997-6#1)(2008-9#1)(2009-10#1)(2012-2#1)
protein deficiency has##2##3##(1996-2#1)(2008-12#1)
protein deficiency##8##2##(1991-11#1)(1993-12#1)(1994-11#1)(1996-2#1)(2006-4#1)(2007-2#1)(2008-12#2)
protein degradation and##3##3##(1990-5#1)(1992-12#1)(2010-8#1)
protein degradation in the##2##4##(1995-2#1)(2008-7#1)
protein degradation in##3##3##(1995-2#1)(2008-7#1)(2009-8#1)
protein degradation were##3##3##(1992-4#1)(2011-2#1)(2011-3#1)
protein degradation##36##2##(1990-4#1)(1990-5#3)(1990-6#1)(1991-7#1)(1992-12#1)(1992-4#5)(1992-8#1)(1994-11#2)(1994-5#1)(1995-2#1)(1995-5#1)(1995-7#1)(2004-11#2)(2007-12#1)(2007-3#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#1)
protein delivery to##2##3##(2009-10#1)(2010-10#1)
protein delivery##9##2##(1994-8#1)(2008-11#4)(2009-10#1)(2010-10#1)(2010-4#1)(2012-6#1)
protein demonstrated##3##2##(2008-10#1)(2008-8#1)(2009-2#1)
protein denaturation##11##2##(1991-2#1)(1991-5#1)(1995-6#1)(1997-7#2)(2006-10#3)(2008-5#1)(2011-2#1)(2013-1#1)
protein dephosphorylation##2##2##(1991-7#1)(1996-2#1)
protein deposition##2##2##(1991-6#1)(1992-3#1)
protein derivative##8##2##(1992-6#1)(1993-7#1)(1997-2#1)(2006-2#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-7#1)
protein derivatives##2##2##(1991-7#1)(2008-5#1)
protein derived from the##3##4##(1991-2#1)(1995-1#1)(2008-6#1)
protein derived from##4##3##(1991-2#1)(1995-1#1)(2008-11#1)(2008-6#1)
protein described##2##2##(1990-5#1)(1991-7#1)
protein design and##2##3##(1991-7#1)(1995-7#1)
protein design##13##2##(1990-9#1)(1991-4#1)(1991-7#2)(1994-11#1)(1995-4#1)(1995-7#2)(1995-8#1)(1996-11#1)(1997-4#1)(1997-6#1)(2006-12#1)
protein designated##5##2##(1990-9#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-4#1)
protein detected in the##2##4##(2008-5#1)(2012-2#1)
protein detected in##3##3##(1994-12#1)(2008-5#1)(2012-2#1)
protein detected##8##2##(1990-9#1)(1994-12#1)(1994-2#1)(1994-9#1)(2008-10#1)(2008-5#1)(2010-12#1)(2012-2#1)
protein detection##3##2##(2008-10#1)(2008-4#2)
protein determination##6##2##(2007-2#1)(2007-9#1)(2008-10#3)(2008-9#1)
protein diet progressively##2##3##(1992-9#2)
protein diet##8##2##(1992-9#4)(2008-10#1)(2008-8#1)(2009-3#1)(2011-2#1)
protein differed##2##2##(1994-8#1)(1997-3#1)
protein differs from##2##3##(1990-11#1)(1995-1#1)
protein diffusion##3##2##(1991-11#2)(2006-10#1)
protein digestion within the phagocytic vacuole of##2##7##(1990-12#2)
protein digestion##10##2##(1990-12#2)(1996-2#1)(2007-8#1)(2008-10#2)(2012-3#4)
protein dimer interactions##3##3##(2007-6#3)
protein dimer##6##2##(1990-12#1)(2007-6#4)(2009-7#1)
protein discovered##2##2##(2008-5#1)(2008-9#1)
protein displayed##2##2##(1993-8#1)(2008-11#1)
protein displays##2##2##(1991-10#1)(1993-6#1)
protein dissociation was##2##3##(1995-8#2)
protein distinct from##2##3##(1991-1#1)(1993-6#1)
protein distribution##4##2##(1992-6#1)(1994-6#2)(1995-8#1)
protein disulfide isomerase (PDI)##3##4##(1990-7#1)(2008-7#1)(2013-1#1)
protein disulfide isomerase gene expression##2##5##(1990-7#2)
protein disulfide isomerase##20##3##(1990-7#3)(1993-6#6)(1995-3#1)(1996-7#7)(2008-7#1)(2013-1#2)
protein disulfide##26##2##(1990-7#3)(1991-4#1)(1993-6#6)(1995-3#1)(1996-7#9)(2008-7#1)(2009-8#1)(2009-9#1)(2012-2#1)(2013-1#2)
protein disulfide-thiol interchange##2##3##(2009-9#2)
protein docking##2##2##(2008-7#1)(2012-2#1)
protein does not##4##3##(1992-4#1)(1993-4#1)(1996-4#1)(2005-6#1)
protein domain that##3##3##(1992-7#1)(2009-10#1)(2011-1#1)
protein domain##13##2##(1992-7#1)(1993-9#1)(1995-4#1)(1996-4#1)(1997-2#1)(2006-6#1)(2008-4#2)(2009-10#1)(2009-7#1)(2011-1#1)(2011-2#2)
protein domains##15##2##(1995-2#1)(1995-8#1)(1997-6#1)(2006-10#1)(2008-4#3)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#3)(2012-12#2)
protein driven by##3##3##(2008-11#1)(2008-9#1)(2012-3#1)
protein drug##2##2##(2008-10#1)(2009-12#1)
protein drugs and##2##3##(2005-9#1)(2010-11#1)
protein drugs##3##2##(2005-9#1)(2010-1#1)(2010-11#1)
protein during liver regeneration and inflammation##2##6##(1994-8#2)
protein during liver regeneration##3##4##(1992-11#1)(1994-8#2)
protein during##12##2##(1990-12#1)(1990-7#1)(1992-11#1)(1992-3#1)(1993-8#1)(1994-8#2)(1995-3#1)(1996-3#1)(2008-11#1)(2010-12#1)(2011-1#1)
protein dynamics to##2##3##(2006-10#2)
protein dynamics##6##2##(2006-10#2)(2007-8#1)(2008-1#1)(2008-4#1)(2010-10#1)
protein either##3##2##(1993-4#1)(2008-4#1)(2008-9#1)
protein electroblots##2##2##(1992-8#2)
protein electrophoresis##4##2##(1993-9#1)(1996-6#1)(2006-10#1)(2007-2#1)
protein encoded by a##3##4##(1990-9#1)(1996-3#1)(2009-7#1)
protein encoded by the small RNA##2##6##(2008-10#2)
protein encoded by the##17##4##(1990-10#1)(1990-12#1)(1990-8#1)(1991-6#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-3#2)(1994-6#1)(1995-5#2)(1997-7#1)(2008-10#2)(2010-2#1)
protein encoded by this##2##4##(1993-11#1)(1994-3#1)
protein encoded by##30##3##(1990-10#1)(1990-12#1)(1990-8#1)(1990-9#1)(1991-6#1)(1991-8#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#3)(1994-6#1)(1995-5#2)(1996-3#1)(1996-6#1)(1997-7#1)(2005-8#1)(2008-10#2)(2009-7#1)(2010-2#1)(2011-2#1)
protein encoded in##2##3##(2008-10#1)(2012-2#1)
protein encoded##36##2##(1990-10#1)(1990-12#1)(1990-8#1)(1990-9#1)(1991-6#1)(1991-8#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#3)(1994-6#1)(1995-5#2)(1995-8#1)(1996-3#1)(1996-6#1)(1997-7#1)(2005-8#1)(2006-10#1)(2008-10#3)(2008-11#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-2#1)
protein endocytosis##2##2##(2012-2#1)(2013-1#1)
protein energy malnutrition##3##3##(1991-8#1)(2007-8#1)(2012-2#1)
protein engineering experiments##2##3##(1991-6#1)(2013-8#1)
protein engineering methods##2##3##(1995-4#1)(2008-9#1)
protein engineering##29##2##(1991-6#2)(1992-11#3)(1992-2#1)(1993-6#1)(1994-8#4)(1995-2#1)(1995-4#2)(1995-8#1)(1997-6#2)(2007-11#1)(2008-3#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#2)(2013-8#3)
protein enhances the##2##3##(1996-8#1)(2013-1#1)
protein enhances##3##2##(1993-9#1)(1996-8#1)(2013-1#1)
protein enriched in the##2##4##(1992-3#1)(1993-6#1)
protein entries from##2##3##(2008-4#1)(2008-7#1)
protein environment##7##2##(1991-7#1)(1992-12#1)(1992-6#1)(1995-1#1)(2006-12#1)(2009-2#1)(2010-2#1)
protein environments of##2##3##(1992-12#2)
protein environments##3##2##(1992-12#3)
protein epitopes##2##2##(1991-12#1)(2008-7#1)
protein equivalent##2##2##(1992-2#1)(2007-12#1)
protein essential for##2##3##(1994-9#1)(1995-6#1)
protein essential##3##2##(1991-4#1)(1994-9#1)(1995-6#1)
protein estimation##2##2##(2008-12#1)(2011-1#1)
protein evolution##10##2##(1991-12#1)(1996-10#1)(1997-6#1)(2008-11#1)(2008-6#1)(2008-7#3)(2011-1#1)(2013-8#1)
protein excretion and##2##3##(1993-12#1)(2007-1#1)
protein excretion##13##2##(1990-5#1)(1993-12#2)(1997-8#1)(2007-1#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-5#1)(2011-3#1)
protein exhibited a##3##3##(1993-9#1)(1994-6#1)(1996-10#1)
protein exhibited##9##2##(1991-8#1)(1991-9#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-3#1)(1996-10#1)(1997-4#1)(2009-3#1)
protein exhibiting##2##2##(1994-11#1)(1996-6#1)
protein exhibits a##2##3##(1991-1#1)(1991-7#1)
protein exhibits##10##2##(1991-1#1)(1991-7#2)(1991-9#1)(1993-3#1)(1995-1#1)(1995-10#2)(1995-6#1)(2006-10#1)
protein exists as a dimer##2##5##(1992-3#1)(1994-8#1)
protein exists##3##2##(1992-3#1)(1994-8#1)(2010-5#1)
protein export##4##2##(1994-3#1)(1996-4#2)(2008-7#1)
protein exposure##2##2##(2011-2#1)(2013-1#1)
protein expressed from a##2##4##(1995-8#1)(2010-10#1)
protein expressed from##4##3##(1995-3#1)(1995-8#1)(2008-8#1)(2010-10#1)
protein expressed in the##2##4##(1996-12#1)(1997-7#1)
protein expressed in##12##3##(1991-7#2)(1992-12#1)(1992-4#1)(1995-10#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-7#1)(2008-9#1)(2009-9#1)(2011-2#1)
protein expressed##23##2##(1990-11#1)(1990-8#1)(1991-7#2)(1992-12#1)(1992-4#1)(1993-6#1)(1994-11#1)(1995-10#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-7#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-10#1)(2011-2#1)
protein expression analysis##3##3##(2008-11#1)(2010-12#1)(2012-12#1)
protein expression and its##2##4##(1994-5#1)(2006-12#1)
protein expression and##17##3##(1990-10#1)(1994-12#2)(1994-5#1)(1997-6#1)(2006-12#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-2#1)
protein expression are##2##3##(2008-4#1)(2010-8#1)
protein expression as##2##3##(2007-11#1)(2011-2#1)
protein expression from##3##3##(1991-11#1)(1994-5#1)(1997-2#1)
protein expression in a##2##4##(2008-11#1)(2010-7#1)
protein expression in human##2##4##(1991-8#1)(1994-2#1)
protein expression in the##6##4##(1993-11#1)(1994-2#1)(2007-10#1)(2008-11#1)(2009-12#1)(2013-1#1)
protein expression in transfected##2##4##(2008-11#1)(2008-5#1)
protein expression in##42##3##(1990-8#1)(1991-10#1)(1991-8#1)(1993-11#1)(1994-2#2)(1995-5#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-6#1)(2005-8#1)(2007-10#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-11#9)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-5#1)(2010-7#1)(2012-12#3)(2013-1#1)(2013-8#1)
protein expression increased in##2##4##(1996-9#1)(2008-11#1)
protein expression is##7##3##(1990-10#1)(1997-4#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-8#1)(2013-1#1)
protein expression levels were##2##4##(2008-9#1)(2012-12#1)
protein expression levels##5##3##(2008-11#2)(2008-9#1)(2012-12#1)(2013-1#1)
protein expression of##15##3##(1996-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-12#1)(2010-11#1)(2010-4#1)(2010-9#1)(2012-1#1)(2012-2#2)(2013-8#2)
protein expression patterns of##2##4##(2008-1#1)(2008-6#1)
protein expression patterns##6##3##(2008-1#3)(2008-6#1)(2010-12#2)
protein expression profiles##3##3##(2010-12#1)(2010-5#1)(2012-2#1)
protein expression that##2##3##(2008-4#1)(2010-2#1)
protein expression vectors##2##3##(2008-2#1)(2008-4#1)
protein expression was found##2##4##(1990-10#1)(2007-10#1)
protein expression was##10##3##(1990-10#1)(1994-5#1)(1995-8#1)(1996-9#1)(2007-10#1)(2009-3#1)(2011-2#1)(2012-3#1)(2013-1#2)
protein expression were##2##3##(2008-7#1)(2013-1#1)
protein expression##198##2##(1990-10#3)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-3#1)(1993-11#2)(1993-12#1)(1993-5#1)(1993-6#1)(1994-12#3)(1994-2#2)(1994-5#3)(1995-11#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#2)(1996-3#1)(1996-5#3)(1996-8#1)(1996-9#3)(1997-2#1)(1997-4#2)(1997-5#3)(1997-6#2)(2005-8#1)(2006-12#1)(2006-2#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#2)(2008-1#7)(2008-10#3)(2008-11#25)(2008-12#1)(2008-2#4)(2008-4#12)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#7)(2008-9#3)(2009-10#3)(2009-12#2)(2009-3#4)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#12)(2010-2#4)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#7)(2012-2#5)(2012-3#2)(2012-7#1)(2013-1#7)(2013-8#4)
protein expressions##4##2##(2008-12#1)(2010-12#1)(2012-3#2)
protein extract from the##2##4##(1996-2#1)(2012-2#1)
protein extract##10##2##(1993-11#1)(1993-4#1)(1994-11#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-9#1)(2009-8#1)(2012-2#2)
protein extracted from##3##3##(1994-8#1)(2008-9#1)(2013-8#1)
protein extraction and##2##3##(2008-11#2)
protein extraction##5##2##(2008-10#1)(2008-11#3)(2010-4#1)
protein extracts from##4##3##(1991-12#1)(1995-1#1)(2008-10#1)(2010-12#1)
protein extracts prepared from##2##4##(1992-12#1)(1994-9#1)
protein extracts##15##2##(1991-12#1)(1992-12#1)(1994-10#1)(1994-9#2)(1995-1#1)(1996-8#1)(2008-10#3)(2008-11#1)(2008-4#3)(2010-12#1)
protein facilitates##2##2##(1992-12#1)(2011-3#1)
protein factor that##2##3##(1990-2#1)(1990-9#1)
protein factor##11##2##(1990-11#1)(1990-2#1)(1990-9#1)(1991-2#1)(1991-8#3)(1993-11#2)(1994-8#1)(2008-9#1)
protein factors involved in##2##4##(1991-11#1)(2008-11#1)
protein factors which##2##3##(1990-10#2)
protein factors##15##2##(1990-10#3)(1991-11#1)(1992-7#1)(1994-5#1)(1994-8#1)(2005-10#3)(2008-11#2)(2008-9#1)(2009-6#1)(2012-2#1)
protein families are##2##3##(1993-7#1)(2009-8#1)
protein families in##3##3##(2008-2#1)(2008-4#1)(2013-8#1)
protein families that##2##3##(2008-7#1)(2008-9#1)
protein families to##2##3##(1994-6#1)(2013-1#1)
protein families##27##2##(1992-6#1)(1993-7#1)(1994-6#1)(2007-11#3)(2007-6#1)(2007-8#2)(2008-2#1)(2008-4#2)(2008-7#2)(2008-9#3)(2009-10#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-7#2)(2011-1#1)(2012-11#1)(2013-1#1)(2013-8#1)
protein family and##3##3##(1994-12#1)(2006-10#1)(2013-1#1)
protein family are##2##3##(1995-2#1)(2009-8#1)
protein family in##2##3##(1996-10#1)(1997-4#1)
protein family of##3##3##(1994-11#1)(2006-8#1)(2008-4#1)
protein family that##2##3##(2008-8#1)(2012-3#1)
protein family which##2##3##(1996-12#1)(2012-12#1)
protein family##54##2##(1991-11#1)(1991-4#1)(1991-8#1)(1992-12#1)(1993-2#1)(1994-10#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2005-12#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-12#1)(2010-7#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#1)
protein farnesyl transferase##2##3##(1996-8#2)
protein farnesyltransferase (PFTase)##2##3##(1993-9#1)(1997-7#1)
protein farnesyltransferase##5##2##(1993-11#1)(1993-9#1)(1995-2#1)(1997-7#2)
protein features##2##2##(2006-10#1)(2008-4#1)
protein films##3##2##(2008-10#1)(2008-12#2)
protein fingerprints##2##2##(2008-10#1)(2013-1#1)
protein flexibility##4##2##(1991-7#1)(1992-12#1)(1997-5#1)(2010-4#1)
protein fluorescence##6##2##(1990-5#2)(1991-2#1)(1992-12#1)(1994-9#1)(1995-8#1)
protein fold##2##2##(2008-4#1)(2010-7#1)
protein folding and assembly##2##4##(1994-11#1)(1994-8#1)
protein folding and stability##2##4##(1990-8#1)(1991-6#1)
protein folding and##15##3##(1990-8#1)(1991-4#1)(1991-6#1)(1991-9#1)(1993-6#1)(1994-11#2)(1994-8#1)(2006-10#1)(2006-4#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-9#1)(2013-1#1)
protein folding by##4##3##(1993-6#1)(1996-8#1)(2008-11#1)(2009-8#1)
protein folding can be##2##4##(1991-4#1)(2011-1#1)
protein folding can##3##3##(1991-4#1)(2010-4#1)(2011-1#1)
protein folding intermediates##2##3##(1993-11#1)(1995-4#1)
protein folding is##3##3##(1995-4#2)(1996-11#1)
protein folding machinery##2##3##(1994-12#2)
protein folding mechanisms##2##3##(1996-11#1)(2010-2#1)
protein folding pathways##2##3##(1992-1#1)(1995-4#1)
protein folding problem##4##3##(1991-2#2)(1993-6#1)(2006-5#1)
protein folding simulations##2##3##(2011-2#2)
protein folding to##2##3##(2010-4#1)(2012-2#1)
protein folding with##2##3##(1996-4#1)(2010-2#1)
protein folding##90##2##(1990-5#1)(1990-8#1)(1991-2#2)(1991-4#4)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-6#9)(1994-11#3)(1994-12#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-4#11)(1995-5#1)(1995-8#1)(1996-11#2)(1996-4#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#1)(2006-10#2)(2006-4#1)(2006-5#3)(2008-1#1)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-8#1)(2009-9#3)(2010-12#1)(2010-2#2)(2010-4#3)(2011-1#2)(2011-2#5)(2012-2#1)(2013-1#1)
protein folds into##3##3##(1994-3#1)(2006-10#1)(2013-1#1)
protein folds##8##2##(1992-6#1)(1993-6#1)(1994-3#1)(2006-10#1)(2008-4#2)(2012-1#1)(2013-1#1)
protein following##4##2##(1992-2#1)(1992-8#1)(1994-10#1)(1996-1#1)
protein footprinting##2##2##(2008-4#2)
protein for Rab3A##6##3##(1994-11#1)(1994-12#2)(1994-9#3)
protein for a##2##3##(1996-7#1)(2006-12#1)
protein for both##2##3##(2007-3#1)(2008-6#1)
protein for the##12##3##(1991-10#1)(1991-2#1)(1991-5#1)(1991-9#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-5#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-8#1)
protein for##69##2##(1990-10#1)(1990-11#6)(1990-7#1)(1991-1#2)(1991-10#1)(1991-2#1)(1991-4#1)(1991-5#4)(1991-8#1)(1991-9#1)(1992-1#1)(1992-6#1)(1992-8#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#4)(1994-4#1)(1994-9#5)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-8#2)(1996-2#1)(1996-5#2)(1996-7#2)(1997-2#1)(1997-4#2)(1997-6#1)(2006-12#1)(2006-4#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-6#1)(2008-8#2)(2009-10#2)(2009-8#1)(2011-1#1)(2012-2#1)
protein formed##2##2##(1990-10#1)(1997-8#1)
protein forms an##2##3##(1991-6#1)(1994-12#1)
protein forms##5##2##(1991-6#1)(1991-7#1)(1994-12#1)(1997-7#1)(2008-7#1)
protein formulations##2##2##(2008-10#1)(2010-4#1)
protein found in the##3##4##(1994-3#1)(1994-5#1)(2007-12#1)
protein found in##7##3##(1990-5#1)(1993-9#1)(1994-3#1)(1994-5#1)(1997-2#1)(2007-12#1)(2012-2#1)
protein found predominantly##2##3##(1990-5#1)(1994-6#1)
protein found##14##2##(1990-5#3)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-4#1)(2012-2#1)(2013-7#1)(2013-8#1)
protein fraction derived##2##3##(2008-10#1)(2010-4#1)
protein fraction of##3##3##(1992-2#1)(1997-2#1)(2011-2#1)
protein fraction on##2##3##(1990-7#1)(2008-10#1)
protein fraction##26##2##(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-2#1)(1993-6#1)(1994-11#3)(1995-5#1)(1996-11#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-2#1)(2006-12#1)(2008-10#3)(2008-6#1)(2010-4#2)(2011-2#1)(2012-1#1)(2012-2#1)
protein fractionation##2##2##(2008-4#1)(2008-7#1)
protein fractions and##2##3##(2011-2#1)(2012-2#1)
protein fractions of##2##3##(1991-6#1)(2006-3#1)
protein fractions##14##2##(1991-11#1)(1991-12#3)(1991-6#1)(2006-3#1)(2008-10#2)(2008-4#2)(2008-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
protein fragment##7##2##(1992-9#1)(1994-10#2)(1994-11#1)(1994-9#1)(2006-5#1)(2008-5#1)
protein fragments##8##2##(1990-3#1)(1992-11#1)(1994-11#2)(1997-5#1)(2006-5#1)(2008-4#1)(2011-2#1)
protein from 1##2##3##(2006-5#1)(2008-11#1)
protein from Candida##2##3##(1990-5#1)(1995-4#1)
protein from Escherichia coli##6##4##(1991-8#1)(1993-11#2)(1994-5#1)(1994-9#1)(1997-2#1)
protein from Saccharomyces cerevisiae##2##4##(1990-6#1)(2009-7#1)
protein from a##6##3##(1994-8#1)(1997-3#1)(1997-4#1)(2005-8#1)(2007-11#1)(2008-11#1)
protein from an##6##3##(1991-3#1)(1992-7#1)(1994-12#1)(2008-4#3)
protein from bovine brain##2##4##(1991-7#1)(1996-4#1)
protein from cultured##3##3##(1991-6#2)(2008-11#1)
protein from flax seeds##2##4##(1992-8#2)
protein from human##6##3##(1990-12#1)(1991-11#1)(1991-4#1)(1992-12#1)(1994-2#1)(2008-12#1)
protein from mouse##4##3##(1990-11#1)(1993-11#1)(1993-9#1)(1995-2#1)
protein from other##2##3##(1991-10#1)(1996-2#1)
protein from rat brain##2##4##(1991-9#1)(1992-2#1)
protein from rat##6##3##(1991-9#1)(1992-2#1)(1993-11#1)(1994-12#1)(1994-9#1)(1995-9#1)
protein from such##2##3##(1997-4#1)(2008-4#1)
protein from the nucleus to the cytoplasm##3##7##(1992-3#1)(1993-9#1)(2009-8#1)
protein from the##27##3##(1990-12#1)(1990-2#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-1#2)(1995-8#1)(1996-1#1)(1997-4#1)(2008-1#1)(2008-10#2)(2009-12#2)(2009-7#2)(2009-8#2)(2010-2#1)(2012-2#1)
protein from##148##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-4#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#5)(1992-2#1)(1992-3#4)(1992-7#2)(1992-8#2)(1993-11#6)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#3)(1994-2#2)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#7)(1995-1#2)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#1)(1996-7#1)(1997-2#2)(1997-3#1)(1997-4#5)(1997-7#2)(2005-8#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-4#7)(2008-5#1)(2008-8#2)(2008-9#1)(2009-12#2)(2009-7#7)(2009-8#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
protein function and##7##3##(2008-1#1)(2008-9#1)(2009-5#1)(2011-2#3)(2013-8#1)
protein function has##2##3##(2006-11#1)(2008-4#1)
protein function in##2##3##(2008-2#1)(2008-9#1)
protein function specificity##2##3##(2011-2#2)
protein function were##2##3##(2006-12#2)
protein function##29##2##(1990-7#1)(1992-2#1)(1997-3#1)(2004-1#1)(2006-11#1)(2006-12#2)(2008-1#1)(2008-2#1)(2008-4#3)(2008-7#2)(2008-9#3)(2009-10#1)(2009-5#2)(2010-11#1)(2011-2#5)(2012-3#2)(2013-8#1)
protein functional##5##2##(1997-2#1)(1997-6#1)(2008-4#1)(2008-8#1)(2012-3#1)
protein functionality##3##2##(2006-10#1)(2008-7#2)
protein functions as a##2##4##(1993-4#2)
protein functions##8##2##(1993-4#2)(1994-5#1)(1995-1#1)(2008-4#1)(2008-7#1)(2009-6#1)(2011-2#1)
protein fused to##3##3##(1995-3#1)(1997-1#1)(1997-4#1)
protein fused##4##2##(1995-3#1)(1997-1#1)(1997-4#1)(2007-8#1)
protein fusions##3##2##(1995-11#1)(2008-4#1)(2009-10#1)
protein gamma##2##2##(1995-6#1)(1996-8#1)
protein gave a##2##3##(1993-12#1)(1996-7#1)
protein gene and##7##3##(1991-10#1)(1997-1#1)(1997-2#1)(2008-10#2)(2008-8#2)
protein gene expression##4##3##(2004-11#1)(2006-12#1)(2008-8#1)(2011-10#1)
protein gene from##2##3##(1991-1#1)(2008-8#1)
protein gene in##8##3##(1993-3#1)(1993-8#1)(1997-2#2)(2008-12#1)(2008-8#2)(2013-1#1)
protein gene of##11##3##(1991-8#1)(1997-1#1)(1997-2#1)(1997-6#1)(2005-11#2)(2008-10#3)(2008-5#1)(2009-5#1)
protein gene product 9##3##4##(1995-11#2)(1995-9#1)
protein gene sequences##2##3##(2008-10#2)
protein gene was##4##3##(1997-4#1)(2005-11#1)(2008-12#1)(2009-5#1)
protein gene##89##2##(1991-1#1)(1991-10#3)(1991-8#2)(1992-1#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-8#1)(1994-9#3)(1995-11#2)(1995-5#1)(1995-9#1)(1996-12#1)(1997-1#2)(1997-2#6)(1997-3#2)(1997-4#2)(1997-6#1)(2004-11#1)(2005-11#5)(2005-9#1)(2006-12#2)(2006-9#1)(2007-1#1)(2007-2#1)(2008-10#19)(2008-11#1)(2008-12#3)(2008-5#2)(2008-7#1)(2008-8#9)(2008-9#1)(2009-5#2)(2010-12#2)(2011-1#1)(2011-10#1)(2013-1#1)
protein gene)##2##2##(2008-9#1)(2013-1#1)
protein generated by##2##3##(1991-3#1)(2008-11#1)
protein generated##3##2##(1991-3#1)(1994-3#1)(2008-11#1)
protein genes and##4##3##(1996-5#1)(2006-12#1)(2008-10#1)(2008-8#1)
protein genes by##2##3##(1990-8#2)
protein genes on##2##3##(1993-11#1)(2008-9#1)
protein genes##27##2##(1990-8#2)(1993-11#1)(1994-8#2)(1995-10#1)(1996-3#1)(1996-5#1)(1996-6#3)(2006-12#1)(2007-3#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-8#1)(2011-12#1)
protein geranylgeranyltransferase##2##2##(1995-2#1)(1997-7#1)
protein glycosylation and##2##3##(2008-11#1)(2010-12#1)
protein glycosylation in##2##3##(1992-6#1)(2010-11#1)
protein glycosylation##10##2##(1992-6#1)(1994-2#1)(1996-8#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-11#2)(2010-12#1)(2011-1#1)
protein growth factor##2##3##(1996-12#1)(2008-5#1)
protein growth##3##2##(1996-12#1)(2007-11#1)(2008-5#1)
protein had a molecular weight of##2##6##(1991-1#1)(2008-10#1)
protein had a molecular##3##4##(1991-1#1)(1991-4#1)(2008-10#1)
protein had a##4##3##(1991-1#1)(1991-4#1)(2008-10#2)
protein had an apparent molecular mass of##2##7##(1993-6#1)(1993-8#1)
protein had an##5##3##(1991-7#1)(1993-6#1)(1993-8#1)(1996-10#1)(2008-10#1)
protein had been##2##3##(1992-6#1)(1995-2#1)
protein had no##2##3##(1992-11#1)(2008-8#1)
protein had##15##2##(1991-1#1)(1991-3#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-6#1)(1993-6#1)(1993-8#1)(1995-2#1)(1996-10#1)(2008-10#3)(2008-8#1)
protein half-life##3##2##(1994-9#1)(1995-12#1)(2008-11#1)
protein has a calculated molecular mass of##2##7##(1994-12#1)(1997-4#1)
protein has a##15##3##(1990-11#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-8#1)(1994-12#1)(1994-3#1)(1994-8#2)(1994-9#1)(1997-4#1)(1997-6#1)(2007-8#1)
protein has also been##2##4##(2006-10#1)(2009-3#1)
protein has an apparent molecular##2##5##(1990-12#1)(1992-7#1)
protein has an apparent##3##4##(1990-12#1)(1992-7#1)(1994-12#1)
protein has been found in##2##5##(2008-7#1)(2008-8#1)
protein has been identified as##2##5##(1990-5#1)(1993-9#1)
protein has been implicated in##3##5##(1992-12#1)(1992-3#1)(1993-3#1)
protein has been isolated##3##4##(1990-2#1)(1991-2#1)(1993-8#1)
protein has been purified##2##4##(1992-3#1)(1993-3#1)
protein has been studied using##2##5##(1992-8#1)(2008-10#1)
protein has been suggested to##2##5##(1995-10#1)(1995-8#1)
protein has been##31##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-2#2)(1991-4#1)(1991-9#1)(1992-12#1)(1992-3#3)(1992-8#1)(1993-3#2)(1993-4#1)(1993-8#1)(1993-9#1)(1995-10#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-6#1)(1997-7#2)(2006-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#1)
protein has recently been##2##4##(1990-5#1)(1990-7#1)
protein has the same molecular weight##2##6##(1994-11#1)(1994-2#1)
protein has the##3##3##(1994-11#1)(1994-12#1)(1994-2#1)
protein has two##2##3##(1991-7#1)(2011-2#1)
protein has##80##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#3)(1992-7#1)(1992-8#2)(1993-3#3)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#6)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-5#2)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#3)(2004-9#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-3#1)(2011-2#1)(2012-2#1)
protein have been##8##3##(1992-11#1)(1994-9#1)(1997-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-8#1)
protein have##15##2##(1992-11#1)(1992-7#1)(1992-8#1)(1993-5#1)(1994-9#1)(1995-6#1)(1997-5#1)(2005-11#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-4#1)(2011-1#1)(2012-8#1)
protein having##5##2##(1990-10#1)(1990-5#1)(1994-12#2)(1994-3#1)
protein heterodimers##3##2##(1992-6#3)
protein highly expressed##2##3##(1997-4#1)(1997-7#1)
protein highly homologous to the##3##5##(1990-12#1)(1990-2#1)(1992-12#1)
protein highly homologous to##5##4##(1990-12#1)(1990-2#1)(1992-12#1)(1993-2#1)(1994-11#1)
protein highly##9##2##(1990-12#1)(1990-2#1)(1992-12#1)(1993-2#1)(1994-11#1)(1997-4#1)(1997-7#1)(2006-12#1)(2008-11#1)
protein homeostasis##2##2##(2008-7#1)(2010-4#1)
protein homologous to the##4##4##(1993-5#1)(1994-12#2)(1995-4#1)
protein homologous to##6##3##(1990-5#1)(1993-5#1)(1994-12#2)(1995-4#1)(2013-1#1)
protein homologue##2##2##(1992-11#1)(1993-5#1)
protein hormone##2##2##(1992-7#1)(2010-4#1)
protein hydrolysate##4##2##(2008-10#1)(2008-11#2)(2010-2#1)
protein hydrolysates##11##2##(2007-8#1)(2008-10#1)(2008-11#6)(2008-5#3)
protein hydrolysis##2##2##(1992-7#2)
protein hydrolyzates##3##2##(1997-2#3)
protein hyper-producing cell lines##2##4##(2008-11#2)
protein hyper-producing##4##2##(2008-11#4)
protein identification using##2##3##(1993-12#1)(2008-7#1)
protein identification##10##2##(1993-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-2#1)(2012-11#1)
protein identified as##2##3##(1993-2#1)(1993-6#1)
protein identified by##2##3##(1994-6#1)(2008-9#1)
protein identified##6##2##(1990-5#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-6#1)(2008-9#1)
protein immobilization and##2##3##(2008-10#1)(2010-7#1)
protein immobilization##4##2##(1990-4#1)(2007-8#1)(2008-10#1)(2010-7#1)
protein immunohistochemistry##3##2##(1993-7#1)(2008-5#2)
protein immunoreactivity##3##2##(1992-2#1)(1995-9#1)(2009-1#1)
protein implicated in##4##3##(1994-11#1)(1994-3#1)(1995-2#1)(2009-7#1)
protein import machinery##2##3##(1995-3#1)(1997-2#1)
protein import##9##2##(1992-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1997-2#1)(2008-1#3)(2012-2#1)
protein important for##2##3##(1992-2#1)(1995-6#1)
protein in Aspergillus##2##3##(2007-7#1)(2008-5#1)
protein in Bacillus subtilis##3##4##(1994-12#1)(1997-4#1)(2009-7#1)
protein in DNA##2##3##(1997-4#1)(2007-8#1)
protein in Drosophila##3##3##(1990-11#1)(1991-11#2)
protein in E##5##3##(1990-11#1)(1992-3#1)(1994-12#1)(1995-8#1)(2010-12#1)
protein in Escherichia coli##10##4##(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-3#1)(1996-10#1)(1996-5#1)(1997-4#1)(1997-6#1)
protein in HeLa##2##3##(1993-12#1)(1994-11#1)
protein in Saccharomyces cerevisiae##3##4##(1992-1#1)(1995-5#1)(1996-10#1)
protein in Saccharomyces##4##3##(1992-1#1)(1995-5#1)(1996-10#1)(2012-3#1)
protein in a short period##2##5##(2008-11#1)(2008-2#1)
protein in a single##2##4##(1996-7#1)(1996-8#1)
protein in a##23##3##(1990-11#1)(1990-3#1)(1992-5#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-8#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-5#1)(2006-12#1)(2007-12#1)(2008-11#3)(2008-2#2)(2008-4#1)(2009-11#1)
protein in an in vitro##2##5##(1994-3#1)(1995-1#1)
protein in an##6##3##(1991-5#1)(1993-6#1)(1994-3#1)(1995-1#1)(2008-10#1)(2009-12#1)
protein in astrocytes##3##3##(2006-7#1)(2007-12#1)(2008-7#1)
protein in blood##2##3##(1991-2#1)(2006-12#1)
protein in both##5##3##(1992-1#1)(1994-10#1)(1994-2#1)(1995-1#1)(2008-5#1)
protein in bovine aortic smooth muscle cytosol##2##7##(1990-7#2)
protein in bovine##3##3##(1990-7#2)(1992-5#1)
protein in brain##2##3##(1994-12#1)(2013-8#1)
protein in crude##3##3##(1991-12#1)(2008-1#1)(2008-2#1)
protein in each case##2##4##(2005-11#1)(2008-11#1)
protein in human liver##2##4##(1990-12#1)(1992-11#1)
protein in human serum##7##4##(1993-6#1)(1995-8#1)(2008-10#5)
protein in human##25##3##(1990-12#2)(1990-3#1)(1990-5#1)(1991-3#1)(1991-9#1)(1992-11#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-8#2)(1996-2#1)(1996-9#1)(2008-10#6)(2008-11#1)(2010-2#1)(2013-8#1)
protein in insect cells##2##4##(1991-1#1)(2008-11#1)
protein in insect larvae##2##4##(2008-7#2)
protein in insect##4##3##(1991-1#1)(2008-11#1)(2008-7#2)
protein in liver##2##3##(1992-7#1)(2008-8#1)
protein in mammalian cells##3##4##(1997-7#2)(2008-11#1)
protein in mammalian##4##3##(1993-11#1)(1997-7#2)(2008-11#1)
protein in most##2##3##(1997-2#1)(2011-2#1)
protein in mouse##2##3##(1991-2#1)(1993-12#1)
protein in neurons##2##3##(1990-5#1)(1991-8#1)
protein in normal##2##3##(1990-3#1)(1994-11#1)
protein in patients with##5##4##(1990-12#1)(1992-11#1)(1996-12#1)(2007-5#1)(2008-4#1)
protein in patients##7##3##(1990-12#1)(1992-11#1)(1996-12#2)(2007-5#1)(2008-4#1)(2010-4#1)
protein in plants##2##3##(1993-6#1)(2008-10#1)
protein in primary##3##3##(1993-1#1)(2007-11#1)(2007-6#1)
protein in rat##4##3##(1995-12#1)(1997-4#1)(1997-6#1)(2007-12#1)
protein in red##2##3##(1994-12#1)(1994-2#1)
protein in response to##2##4##(1992-8#1)(1996-10#1)
protein in several##2##3##(1994-12#1)(2011-2#1)
protein in solution##5##3##(2008-1#1)(2008-2#1)(2008-4#2)(2009-7#1)
protein in synaptic##2##3##(1995-6#1)(2008-7#1)
protein in the absence of##3##5##(1990-7#1)(1995-2#1)(2007-8#1)
protein in the absence##4##4##(1990-7#1)(1995-2#1)(1996-5#1)(2007-8#1)
protein in the cytoplasm of##2##5##(1994-2#1)(1995-8#1)
protein in the cytoplasm##6##4##(1990-3#1)(1994-2#1)(1995-8#1)(1997-4#2)(2008-10#1)
protein in the cytosol##2##4##(1990-5#1)(1997-4#1)
protein in the endoplasmic reticulum##4##5##(1992-2#1)(1994-11#1)(1997-4#2)
protein in the mouse brain##2##5##(1997-5#2)
protein in the mouse##3##4##(1991-9#1)(1997-5#2)
protein in the mutant##2##4##(1991-4#1)(1995-6#1)
protein in the presence##2##4##(1992-9#1)(1997-7#1)
protein in the region of##2##5##(1990-7#1)(1995-3#1)
protein in the same##2##4##(1994-2#1)(1995-8#1)
protein in the sample##2##4##(2008-2#1)(2011-1#1)
protein in the tissue##2##4##(1995-12#1)(2013-1#1)
protein in the tumor##2##4##(2009-10#1)(2010-12#1)
protein in the##119##3##(1990-12#2)(1990-3#1)(1990-5#2)(1990-7#4)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-9#4)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-3#2)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#5)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#2)(1996-5#2)(1996-6#1)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#6)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
protein in these##2##3##(1991-12#1)(1992-12#1)
protein in transgenic plants##2##4##(2006-12#1)(2008-10#1)
protein in vitro##6##3##(1990-9#1)(1993-11#1)(1994-12#1)(1995-5#1)(1996-4#1)(2008-8#1)
protein in vivo##6##3##(1990-8#1)(1991-5#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-2#1)
protein in which the##2##4##(1995-5#1)(1997-7#1)
protein in which##4##3##(1992-3#1)(1994-2#1)(1995-5#1)(1997-7#1)
protein in yeast##4##3##(1992-8#1)(1995-2#1)(1996-5#2)
protein in##492##2##(1990-10#2)(1990-11#4)(1990-12#8)(1990-3#6)(1990-4#1)(1990-5#7)(1990-7#6)(1990-8#2)(1990-9#5)(1991-1#2)(1991-11#5)(1991-12#3)(1991-2#6)(1991-3#4)(1991-4#2)(1991-5#3)(1991-7#4)(1991-8#1)(1991-9#9)(1992-1#2)(1992-11#5)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#5)(1992-6#1)(1992-7#4)(1992-8#3)(1992-9#2)(1993-1#4)(1993-11#5)(1993-12#7)(1993-2#3)(1993-3#4)(1993-4#1)(1993-6#8)(1993-7#2)(1993-8#2)(1993-9#4)(1994-10#2)(1994-11#5)(1994-12#12)(1994-2#13)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#6)(1994-9#9)(1995-1#5)(1995-10#3)(1995-11#2)(1995-12#3)(1995-2#3)(1995-3#7)(1995-5#3)(1995-6#2)(1995-8#8)(1996-10#3)(1996-12#3)(1996-2#2)(1996-4#1)(1996-5#6)(1996-6#1)(1996-7#2)(1996-8#4)(1996-9#5)(1997-1#6)(1997-2#5)(1997-3#2)(1997-4#13)(1997-5#5)(1997-6#5)(1997-7#5)(1997-8#1)(2003-11#1)(2004-9#1)(2005-11#3)(2006-10#3)(2006-11#2)(2006-12#7)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#5)(2008-10#20)(2008-11#22)(2008-12#2)(2008-2#6)(2008-3#1)(2008-4#8)(2008-5#3)(2008-6#2)(2008-7#10)(2008-8#8)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#3)(2009-7#4)(2009-8#2)(2010-12#3)(2010-2#2)(2010-4#3)(2011-1#2)(2011-10#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#5)
protein including##2##2##(2008-10#1)(2008-8#1)
protein incorporation##2##2##(1992-6#2)
protein increase##2##2##(1997-4#1)(2005-12#1)
protein increased in##2##3##(1996-9#1)(2013-8#1)
protein increased##9##2##(1990-12#1)(1992-7#1)(1993-8#2)(1996-8#1)(1996-9#1)(2005-11#2)(2013-8#1)
protein increases##2##2##(2008-7#1)(2012-1#1)
protein indicated that it##2##4##(1992-8#1)(1994-8#1)
protein indicated that##5##3##(1992-8#1)(1993-11#1)(1994-8#1)(2006-12#2)
protein indicated##7##2##(1990-11#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-8#1)(2006-12#2)
protein indicates##2##2##(1993-12#1)(2008-1#1)
protein induced by##2##3##(1994-12#1)(2013-8#1)
protein induced the##2##3##(1997-4#1)(1997-6#1)
protein induced##6##2##(1994-12#1)(1995-4#1)(1997-4#1)(1997-6#1)(2013-1#1)(2013-8#1)
protein induces##2##2##(1994-12#1)(1995-8#1)
protein induction##7##2##(1991-11#1)(1994-9#1)(2008-10#4)(2008-11#1)
protein ingestion##2##2##(2008-1#1)(2008-5#1)
protein inhibited##2##2##(1993-3#1)(1994-2#1)
protein inhibitor of protein kinase C##2##6##(1991-10#1)(1994-6#1)
protein inhibitor of##4##3##(1991-10#1)(1994-6#1)(1995-2#1)(2008-7#1)
protein inhibitor##12##2##(1991-10#1)(1991-4#3)(1991-5#1)(1993-3#1)(1994-6#1)(1995-2#1)(1996-1#1)(2004-12#1)(2008-4#1)(2008-7#1)
protein inhibitors##5##2##(1993-6#1)(2004-12#1)(2005-8#1)(2008-10#1)(2013-1#1)
protein inhibits##4##2##(1990-6#1)(1990-7#1)(1997-3#2)
protein insertion into##3##3##(1992-6#1)(1994-2#1)(2008-9#1)
protein insertion##4##2##(1992-6#2)(1994-2#1)(2008-9#1)
protein intake and##7##3##(1990-12#1)(1991-5#1)(2008-1#1)(2008-5#1)(2013-8#3)
protein intake in healthy adults##2##5##(2013-8#2)
protein intake in##6##3##(1991-11#1)(2007-8#1)(2008-5#1)(2013-1#1)(2013-8#2)
protein intake on##3##3##(2007-8#1)(2008-5#2)
protein intake was##4##3##(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
protein intake##46##2##(1990-12#4)(1991-11#1)(1991-5#1)(1993-5#1)(2004-11#2)(2006-10#1)(2006-8#1)(2007-8#7)(2008-1#2)(2008-5#7)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#11)
protein intakes##7##2##(1992-2#2)(2008-5#2)(2013-1#3)
protein interacting with the##2##4##(1991-7#1)(1992-11#1)
protein interacting with##4##3##(1991-7#2)(1992-11#1)(1994-11#1)
protein interaction in##2##3##(1995-8#1)(2006-12#1)
protein interaction information##2##3##(2008-4#1)(2012-2#1)
protein interaction networks##4##3##(2008-7#2)(2011-2#1)(2013-8#1)
protein interaction specificity##2##3##(2008-7#1)(2013-1#1)
protein interaction##26##2##(1994-5#1)(1995-8#1)(1997-1#2)(2006-12#1)(2007-12#1)(2008-4#2)(2008-7#8)(2008-9#1)(2009-11#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#3)
protein interactions and##3##3##(2008-4#1)(2008-7#1)(2012-2#1)
protein interactions are##2##3##(1997-6#1)(2010-10#1)
protein interactions by##4##3##(2008-1#1)(2008-2#1)(2008-4#2)
protein interactions in##8##3##(2008-1#1)(2008-4#4)(2008-9#2)(2012-2#1)
protein interactions of##2##3##(1991-4#1)(1996-8#1)
protein interactions that can##2##4##(1993-11#1)(2008-9#1)
protein interactions that##3##3##(1993-11#1)(2008-9#1)(2012-2#1)
protein interactions were##2##3##(1996-8#1)(1997-2#1)
protein interactions with##5##3##(1996-4#1)(1997-2#1)(2008-1#1)(2008-4#1)(2011-2#1)
protein interactions##44##2##(1991-4#1)(1991-9#1)(1992-8#1)(1993-11#1)(1996-4#1)(1996-8#2)(1997-2#2)(1997-6#1)(1997-7#1)(2007-8#1)(2008-1#3)(2008-2#1)(2008-4#15)(2008-7#1)(2008-9#3)(2010-10#1)(2011-2#2)(2012-2#3)(2013-8#3)
protein interacts with##8##3##(1993-3#1)(1995-11#1)(1997-3#1)(1997-4#1)(2005-12#1)(2008-8#1)(2008-9#1)(2011-2#1)
protein interacts##9##2##(1992-11#1)(1993-3#1)(1995-11#1)(1997-3#1)(1997-4#1)(2005-12#1)(2008-8#1)(2008-9#1)(2011-2#1)
protein interface##2##2##(2008-7#1)(2013-1#1)
protein into the cytoplasm##2##4##(1994-11#1)(2008-11#1)
protein into the##12##3##(1990-11#1)(1990-5#1)(1990-9#1)(1991-5#1)(1991-7#1)(1994-11#1)(1995-8#1)(1997-2#1)(1997-7#1)(2006-10#1)(2008-11#1)(2009-3#1)
protein into three##2##3##(1990-4#1)(1992-7#1)
protein into##27##2##(1990-11#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-5#1)(1991-7#1)(1992-5#1)(1992-7#1)(1994-11#1)(1994-12#1)(1995-8#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#2)(2006-10#2)(2007-11#1)(2008-11#1)(2008-8#1)(2009-12#1)(2009-3#1)
protein involved in the control of##2##6##(1995-8#1)(2007-1#1)
protein involved in the##8##4##(1994-9#2)(1995-8#1)(2007-1#1)(2009-12#1)(2009-5#1)(2011-12#1)(2012-2#1)
protein involved in##20##3##(1991-1#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-12#1)(1994-9#2)(1995-8#2)(2007-1#1)(2008-5#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
protein involved##22##2##(1991-1#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-12#1)(1994-9#2)(1995-8#2)(2007-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
protein ions##3##2##(2009-10#2)(2010-7#1)
protein is a candidate##2##4##(1995-12#1)(2012-12#1)
protein is a major##3##4##(1990-2#1)(1991-12#1)(2008-7#1)
protein is a member of##2##5##(1991-6#1)(1994-10#1)
protein is a novel##2##4##(1992-5#1)(1994-12#1)
protein is a##36##3##(1990-10#1)(1990-11#2)(1990-2#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-5#2)(1993-6#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#1)(1996-11#1)(1996-4#1)(1996-5#2)(1997-2#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-3#1)
protein is able to##2##4##(1993-9#1)(2009-8#1)
protein is activated##3##3##(1993-4#2)(2008-1#1)
protein is actually##2##3##(1995-6#1)(2008-4#1)
protein is also##2##3##(1996-10#1)(1997-1#1)
protein is an early##2##4##(1991-3#1)(2010-5#1)
protein is an essential##2##4##(1994-3#1)(2013-1#1)
protein is an##13##3##(1991-3#3)(1993-6#1)(1994-3#2)(1995-1#1)(1995-2#1)(1995-9#1)(2008-7#1)(2009-6#1)(2010-5#1)(2013-1#1)
protein is associated with##2##4##(1991-9#1)(1995-3#1)
protein is associated##4##3##(1991-9#1)(1992-9#1)(1994-12#1)(1995-3#1)
protein is capable of##6##4##(1990-11#1)(1995-3#1)(1995-6#1)(1996-9#1)(2006-12#1)(2008-9#1)
protein is characterized by its##3##5##(2008-4#1)(2013-1#2)
protein is characterized by##5##4##(1994-9#1)(1997-6#1)(2008-4#1)(2013-1#2)
protein is composed of##5##4##(1990-3#1)(1994-8#1)(1995-2#1)(1997-4#1)(2011-2#1)
protein is derived from##2##4##(1990-11#1)(1990-12#1)
protein is described##4##3##(1997-2#1)(2004-9#1)(2008-2#1)(2008-4#1)
protein is detected##3##3##(2006-10#1)(2008-11#1)(2008-4#1)
protein is due to##2##4##(1995-2#1)(1996-2#1)
protein is encoded##2##3##(1997-7#1)(2012-12#1)
protein is essential for##3##4##(1991-11#2)(2005-8#1)
protein is exposed to##2##4##(1991-8#1)(2008-4#1)
protein is expressed in##4##4##(1996-2#1)(2007-10#1)(2008-4#1)(2010-11#1)
protein is expressed##8##3##(1995-10#1)(1996-2#1)(2007-10#1)(2008-4#1)(2008-5#1)(2010-11#1)(2011-12#1)(2013-8#1)
protein is folded##2##3##(2008-4#2)
protein is found##2##3##(1991-7#1)(1992-3#1)
protein is glycosylated##2##3##(1994-9#2)
protein is highly conserved in evolution##2##6##(1991-2#1)(1991-6#1)
protein is highly conserved in##3##5##(1991-2#1)(1991-6#1)(1994-6#1)
protein is highly conserved##5##4##(1991-2#1)(1991-6#1)(1992-5#1)(1993-12#1)(1994-6#1)
protein is highly homologous to the##3##6##(1994-12#1)(1994-9#1)(1996-7#1)
protein is highly##11##3##(1990-9#1)(1991-2#1)(1991-6#1)(1992-5#1)(1993-12#1)(1994-12#1)(1994-6#1)(1994-9#2)(1996-7#1)(2012-12#1)
protein is homologous to##2##4##(1990-2#1)(1996-10#1)
protein is identical to##2##4##(1990-5#1)(1993-6#1)
protein is important for##3##4##(1992-11#1)(2008-11#1)(2012-12#1)
protein is in the##3##4##(1990-8#1)(1991-2#1)(2009-10#1)
protein is in##5##3##(1990-8#1)(1991-2#1)(1994-8#1)(1996-8#1)(2009-10#1)
protein is increased##3##3##(1990-2#1)(1996-1#1)(2005-12#1)
protein is indistinguishable##2##3##(1993-4#1)(1996-9#1)
protein is induced by##3##4##(1992-7#1)(1993-6#1)(1995-12#1)
protein is involved in the##3##5##(1990-9#1)(1995-6#1)(2003-11#1)
protein is involved in##7##4##(1990-9#1)(1991-12#1)(1992-11#1)(1994-8#1)(1995-6#1)(1996-4#1)(2003-11#1)
protein is known to##3##4##(1991-12#2)(1995-2#1)
protein is less##2##3##(2008-9#2)
protein is mediated##2##3##(1990-12#1)(1994-12#1)
protein is necessary##2##3##(2008-11#1)(2008-5#1)
protein is neither##2##3##(1990-5#1)(1994-3#1)
protein is not##15##3##(1990-11#1)(1990-4#1)(1990-6#1)(1991-3#1)(1991-4#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-3#1)(1997-4#1)
protein is nuclear##2##3##(1995-3#1)(2012-12#1)
protein is observed##3##3##(1991-7#1)(1997-7#1)(2008-8#1)
protein is overexpressed in##2##4##(1992-9#1)(2012-2#1)
protein is overexpressed##3##3##(1992-9#1)(1994-7#1)(2012-2#1)
protein is precipitated##3##3##(2008-2#1)(2008-4#2)
protein is present in the##2##5##(1992-5#1)(2009-8#1)
protein is present in##8##4##(1992-11#1)(1992-5#1)(1992-6#1)(1994-10#1)(1994-2#1)(2008-10#1)(2009-8#1)(2012-12#1)
protein is present##11##3##(1992-11#1)(1992-5#1)(1992-6#1)(1994-10#1)(1994-2#1)(1994-9#1)(1995-3#1)(2008-10#2)(2009-8#1)(2012-12#1)
protein is processed##3##3##(1993-3#1)(1994-12#1)(1994-2#1)
protein is produced##3##3##(1994-11#1)(1995-8#1)(2012-1#1)
protein is regulated##2##3##(1994-11#1)(1997-2#1)
protein is related to##2##4##(1993-9#1)(1994-9#1)
protein is required for##5##4##(1994-12#1)(1994-8#1)(1996-9#1)(2012-12#2)
protein is required##6##3##(1994-12#2)(1994-8#1)(1996-9#1)(2012-12#2)
protein is restricted to##2##4##(1990-11#1)(2008-4#1)
protein is secreted##2##3##(1992-4#1)(1995-10#1)
protein is shown to##3##4##(1993-11#1)(1996-2#1)(1997-1#1)
protein is significantly##2##3##(1990-2#1)(2011-2#1)
protein is similar to##2##4##(1991-9#1)(1995-11#1)
protein is still##2##3##(1994-9#1)(1995-10#1)
protein is sufficient##2##3##(1990-6#1)(2008-6#1)
protein is synthesized in##2##4##(1990-3#1)(1995-6#1)
protein is synthesized##3##3##(1990-3#1)(1995-6#1)(2006-2#1)
protein is taken##2##3##(1991-2#1)(1995-6#1)
protein is the only##2##4##(1990-9#1)(1996-2#1)
protein is the##10##3##(1990-8#1)(1990-9#1)(1994-12#1)(1996-2#1)(1997-2#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-10#1)(2011-2#1)
protein is then##3##3##(1994-9#1)(2008-4#2)
protein is treated with##2##4##(1995-3#1)(2008-10#1)
protein is very##4##3##(1990-4#1)(1991-1#1)(1992-6#1)(1995-1#1)
protein is##409##2##(1990-10#1)(1990-11#10)(1990-12#3)(1990-2#5)(1990-3#3)(1990-4#2)(1990-5#4)(1990-6#3)(1990-7#4)(1990-8#2)(1990-9#8)(1991-1#1)(1991-11#3)(1991-12#5)(1991-2#9)(1991-3#6)(1991-4#1)(1991-5#1)(1991-6#4)(1991-7#5)(1991-8#2)(1991-9#3)(1992-1#2)(1992-11#4)(1992-12#3)(1992-3#3)(1992-4#1)(1992-5#8)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#7)(1993-6#5)(1993-7#1)(1993-8#4)(1993-9#3)(1994-10#2)(1994-11#7)(1994-12#15)(1994-2#4)(1994-3#4)(1994-5#2)(1994-6#4)(1994-7#2)(1994-8#8)(1994-9#14)(1995-1#9)(1995-10#3)(1995-11#3)(1995-12#3)(1995-2#6)(1995-3#9)(1995-6#7)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-4#4)(1996-5#5)(1996-7#3)(1996-8#2)(1996-9#4)(1997-1#2)(1997-2#9)(1997-4#6)(1997-5#1)(1997-6#1)(1997-7#2)(2003-11#1)(2004-9#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-1#3)(2008-10#7)(2008-11#6)(2008-2#2)(2008-3#1)(2008-4#21)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#7)(2009-10#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-5#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#9)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#2)
protein isoelectric point##3##3##(2005-11#1)(2008-4#2)
protein isoforms of##2##3##(1991-10#1)(2010-8#1)
protein isoforms with##2##3##(1992-11#1)(1994-2#1)
protein isoforms##9##2##(1991-10#1)(1992-11#1)(1993-5#1)(1994-2#1)(1994-9#1)(1995-2#1)(2008-7#2)(2010-8#1)
protein isolate##7##2##(2005-11#2)(2008-5#1)(2011-2#2)(2013-1#2)
protein isolated from human##2##4##(1990-12#1)(1996-2#1)
protein isolated from the venom of##2##6##(1991-7#1)(1994-11#1)
protein isolated from the##6##4##(1990-5#1)(1991-3#1)(1991-7#1)(1991-9#1)(1994-11#1)(2008-9#1)
protein isolated from##19##3##(1990-11#1)(1990-12#2)(1990-5#1)(1991-11#1)(1991-3#1)(1991-7#1)(1991-9#2)(1992-12#1)(1992-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-8#1)(1996-2#1)(2008-10#1)(2008-9#1)
protein isolated##21##2##(1990-11#1)(1990-12#2)(1990-5#1)(1991-11#1)(1991-3#1)(1991-7#1)(1991-9#2)(1992-12#1)(1992-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-2#1)(2008-10#1)(2008-9#1)
protein isolates##4##2##(2010-4#2)(2011-2#2)
protein isomers##3##2##(1991-2#3)
protein it##2##2##(1995-2#1)(2011-2#1)
protein itself##4##2##(1995-12#1)(1997-2#1)(2009-8#1)(2009-9#1)
protein kinase (AMPK)##3##3##(1996-5#1)(2010-11#1)(2011-2#1)
protein kinase (DNA-PK)##2##3##(1994-8#1)(1997-4#1)
protein kinase (MAPK) cascade##4##4##(1995-1#1)(1995-2#2)(2009-8#1)
protein kinase (MAPK) cascades##3##4##(2008-1#1)(2008-2#1)(2012-3#1)
protein kinase (MAPK) pathways##3##4##(2008-4#2)(2013-7#1)
protein kinase (MAPK)##32##3##(1994-12#1)(1995-1#1)(1995-2#2)(1995-3#3)(1996-2#1)(1996-5#1)(1996-8#1)(2005-11#1)(2006-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#3)(2008-7#1)(2009-6#1)(2009-8#1)(2009-9#1)(2011-2#2)(2012-3#4)(2013-7#2)
protein kinase (PK)##4##3##(1993-2#2)(1993-9#1)(1994-3#1)
protein kinase (PKA) and##3##4##(1994-2#1)(1995-2#1)(1995-3#1)
protein kinase (PKA)##19##3##(1991-5#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#2)(2008-8#1)
protein kinase (PKC)##3##3##(1990-9#1)(1993-12#1)(1997-2#1)
protein kinase (PKR)##2##3##(1995-8#1)(1996-10#1)
protein kinase (TPK)##2##3##(1990-3#1)(1995-12#1)
protein kinase (protein kinase C)##2##5##(1991-4#1)(1993-8#1)
protein kinase (protein kinase##5##4##(1991-4#1)(1993-8#2)(1994-9#1)(2008-4#1)
protein kinase 2##2##3##(2009-3#1)(2012-12#1)
protein kinase A (PKA) activator##2##5##(1995-5#1)(1996-9#1)
protein kinase A (PKA) and##3##5##(1993-7#1)(2008-10#1)(2008-5#1)
protein kinase A (PKA)##19##4##(1990-12#1)(1993-7#1)(1994-8#1)(1995-5#1)(1996-11#1)(1996-8#1)(1996-9#1)(1997-5#2)(1997-7#1)(2006-2#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-12#1)(2009-7#1)(2010-11#1)(2011-12#1)
protein kinase A (PKA)-mediated##2##4##(2008-1#1)(2011-2#1)
protein kinase A activity##5##4##(1994-8#1)(1995-1#3)(1996-5#1)
protein kinase A activity)##2##4##(1993-8#2)
protein kinase A and##5##4##(1991-2#1)(1992-11#1)(1992-7#1)(1994-9#2)
protein kinase A can##2##4##(1992-12#2)
protein kinase A catalytic subunit##2##5##(2007-12#1)(2010-12#1)
protein kinase A increased##2##4##(1995-3#1)(1996-6#1)
protein kinase A inhibitor##4##4##(1992-5#1)(1992-6#1)(1993-6#1)(1994-2#1)
protein kinase A may##2##4##(1993-8#1)(1994-6#1)
protein kinase A pathway##2##4##(1995-12#2)
protein kinase A phosphorylation##4##4##(1991-2#3)(1994-9#1)
protein kinase A##77##3##(1990-12#2)(1990-7#2)(1991-2#4)(1992-11#1)(1992-12#3)(1992-5#1)(1992-6#1)(1992-7#4)(1993-12#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#4)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#2)(1994-9#4)(1995-1#3)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-5#2)(1997-7#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#1)(2009-12#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-12#2)(2011-2#1)(2012-2#1)(2012-3#2)
protein kinase B##4##3##(1997-6#1)(2008-10#1)(2008-3#2)
protein kinase C (PK-C)##2##4##(1991-2#1)(1993-6#1)
protein kinase C (PKC) activation##3##5##(1994-12#1)(1997-7#1)(2010-2#1)
protein kinase C (PKC) activator##6##5##(1992-3#1)(1994-11#1)(1995-5#1)(1996-11#1)(1996-9#1)(1997-1#1)
protein kinase C (PKC) activity and##2##6##(1992-4#1)(1997-4#1)
protein kinase C (PKC) activity in##3##6##(1990-9#1)(1995-7#1)(2008-10#1)
protein kinase C (PKC) activity##9##5##(1990-9#1)(1991-10#1)(1992-4#1)(1995-7#1)(1996-11#1)(1997-4#1)(1997-7#1)(2005-7#1)(2008-10#1)
protein kinase C (PKC) and cAMP-dependent protein kinase (PKA) activities##2##10##(1993-3#1)(1997-7#1)
protein kinase C (PKC) and the##2##6##(1995-3#1)(2012-2#1)
protein kinase C (PKC) and##9##5##(1991-9#1)(1992-9#1)(1993-3#1)(1993-8#1)(1995-3#1)(1997-6#1)(1997-7#1)(2008-11#1)(2012-2#1)
protein kinase C (PKC) family##3##5##(1992-9#1)(1994-12#1)(1996-5#1)
protein kinase C (PKC) in the presence of##2##8##(1991-3#1)(1993-8#1)
protein kinase C (PKC) in the##4##6##(1991-3#1)(1991-9#1)(1993-8#1)(1996-5#1)
protein kinase C (PKC) in vitro##2##6##(1993-3#1)(1995-10#1)
protein kinase C (PKC) in##12##5##(1990-6#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1993-3#1)(1993-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1996-5#1)(2008-4#1)
protein kinase C (PKC) inhibitor##4##5##(1991-4#1)(1996-5#1)(2008-4#1)(2013-1#1)
protein kinase C (PKC) is##2##5##(1994-5#1)(1995-11#1)
protein kinase C (PKC) isozymes##4##5##(1991-8#1)(1992-7#1)(1996-8#1)(2008-1#1)
protein kinase C (PKC) pathway##3##5##(1993-6#1)(1996-5#1)(1997-1#1)
protein kinase C (PKC) translocation##2##5##(1994-10#1)(1996-3#1)
protein kinase C (PKC)##105##4##(1990-11#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-10#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#2)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#2)(1993-8#2)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#3)(1995-3#3)(1995-5#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#4)(1996-12#1)(1996-3#1)(1996-5#6)(1996-8#1)(1996-9#1)(1997-1#3)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#3)(2005-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-2#1)(2011-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
protein kinase C (PKC)-mediated##2##4##(1995-3#1)(1996-7#1)
protein kinase C activation in##3##5##(1990-9#1)(1991-10#1)(2008-11#1)
protein kinase C activation##24##4##(1990-11#1)(1990-12#1)(1990-3#1)(1990-9#2)(1991-10#1)(1992-6#3)(1992-8#1)(1993-3#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-5#1)(1996-8#1)(2008-11#1)(2008-3#1)(2013-1#1)
protein kinase C activators##4##4##(1993-3#3)(1995-11#1)
protein kinase C activities##2##4##(1991-7#1)(1995-3#1)
protein kinase C activity and##6##5##(1990-2#2)(1990-5#1)(1993-12#1)(1994-12#1)(2008-11#1)
protein kinase C activity has been##2##6##(1994-12#2)
protein kinase C activity in the##2##6##(1990-8#1)(1991-4#1)
protein kinase C activity in##10##5##(1990-8#1)(1991-4#1)(1992-11#1)(1992-4#1)(1993-12#1)(1993-4#2)(1993-8#1)(1993-9#1)(1994-11#1)
protein kinase C activity##38##4##(1990-11#1)(1990-2#2)(1990-4#2)(1990-5#2)(1990-7#1)(1990-8#2)(1991-10#1)(1991-4#2)(1992-1#1)(1992-11#1)(1992-4#1)(1993-12#3)(1993-4#2)(1993-7#1)(1993-8#1)(1993-9#4)(1994-11#1)(1994-12#5)(1994-2#1)(1997-6#1)(1997-8#1)(2008-11#1)(2008-3#1)
protein kinase C alpha (PKC alpha)##2##6##(1994-5#1)(1994-8#1)
protein kinase C alpha##5##4##(1994-5#1)(1994-8#2)(1995-11#1)(1996-11#1)
protein kinase C and protein kinase A##3##7##(1994-2#1)(1995-6#1)(2008-11#1)
protein kinase C and protein kinase##4##6##(1994-2#1)(1995-6#1)(2008-11#1)(2008-3#1)
protein kinase C and protein##5##5##(1991-9#1)(1994-2#1)(1995-6#1)(2008-11#1)(2008-3#1)
protein kinase C and the##3##5##(1991-2#1)(1994-8#1)(1997-2#1)
protein kinase C and##37##4##(1990-4#1)(1990-7#1)(1990-9#2)(1991-1#1)(1991-2#1)(1991-3#2)(1991-7#1)(1991-9#1)(1992-4#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-6#1)(1997-2#2)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#1)(2011-2#1)
protein kinase C by prolonged##2##5##(1990-12#1)(1996-8#1)
protein kinase C by##13##4##(1990-12#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-3#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-9#1)(1996-8#1)(2008-3#2)(2008-8#1)
protein kinase C gamma##3##4##(1990-12#2)(1994-5#1)
protein kinase C has##3##4##(1990-9#1)(1995-6#1)(1996-8#1)
protein kinase C in nuclei##2##5##(1990-4#2)
protein kinase C in the regulation of##2##7##(1990-3#1)(1990-6#1)
protein kinase C in the##10##5##(1990-3#1)(1990-4#3)(1990-6#1)(1994-11#1)(1994-12#1)(1996-9#1)(1997-1#2)
protein kinase C in vitro and in##3##7##(1990-10#2)(1991-9#1)
protein kinase C in vitro and##4##6##(1990-10#3)(1991-9#1)
protein kinase C in vitro##7##5##(1990-10#5)(1991-9#1)(1992-5#1)
protein kinase C in##48##4##(1990-10#6)(1990-11#2)(1990-2#1)(1990-3#1)(1990-4#7)(1990-6#1)(1991-10#1)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-6#2)(1993-7#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-8#1)(1996-9#2)(1997-1#2)(2008-11#3)
protein kinase C inhibitor##18##4##(1990-10#1)(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-7#1)(1991-9#1)(1992-5#1)(1992-6#3)(1993-12#1)(1993-8#1)(1994-11#1)(1995-6#1)(1995-8#1)(1996-2#1)(2008-11#1)
protein kinase C inhibitors##5##4##(1990-10#1)(1990-8#1)(1991-5#1)(1993-6#1)(1994-2#1)
protein kinase C is##8##4##(1990-4#1)(1990-8#1)(1991-6#1)(1991-7#1)(1992-4#1)(1992-6#1)(1994-3#1)(1994-5#1)
protein kinase C isoenzymes##2##4##(1994-11#1)(1994-12#1)
protein kinase C isoform##2##4##(1993-9#1)(2012-3#1)
protein kinase C isoforms##5##4##(1990-6#1)(1994-12#1)(1995-3#1)(2010-12#1)(2011-2#1)
protein kinase C isozymes##4##4##(1991-8#1)(1992-7#1)(1993-8#1)(1994-2#1)
protein kinase C mediated##2##4##(1990-5#1)(1991-6#1)
protein kinase C on the##2##5##(1990-9#1)(1994-9#1)
protein kinase C or##6##4##(1990-4#1)(1991-3#1)(1991-7#1)(1992-11#1)(1993-4#1)(2010-12#1)
protein kinase C pathway##4##4##(1990-10#1)(1990-11#1)(1995-12#1)(2008-1#1)
protein kinase C phosphorylation sites and##2##6##(2008-12#1)(2008-8#1)
protein kinase C phosphorylation sites##4##5##(1993-3#1)(2008-12#2)(2008-8#1)
protein kinase C phosphorylation##6##4##(1991-7#1)(1993-3#1)(1993-8#1)(2008-12#2)(2008-8#1)
protein kinase C signal pathway and##2##6##(1997-2#1)(2005-10#1)
protein kinase C subspecies##2##4##(1990-9#1)(1991-8#1)
protein kinase C substrates in##2##5##(1990-4#1)(1992-9#1)
protein kinase C substrates##5##4##(1990-4#2)(1992-9#1)(1993-9#1)(1996-5#1)
protein kinase C subtypes##3##4##(1990-6#1)(1991-4#1)(1991-7#1)
protein kinase C translocation in##2##5##(1993-4#1)(1994-10#1)
protein kinase C translocation##3##4##(1990-5#1)(1993-4#1)(1994-10#1)
protein kinase C was not##2##5##(1992-8#1)(1994-12#1)
protein kinase C was##7##4##(1990-11#1)(1990-5#1)(1990-9#1)(1992-8#1)(1994-12#1)(1994-9#1)(2008-11#1)
protein kinase C were##4##4##(1990-2#1)(1990-4#1)(1990-6#1)(1990-9#1)
protein kinase C with##6##4##(1992-4#1)(1992-9#1)(1993-6#1)(1994-5#1)(1995-2#1)(1995-8#1)
protein kinase C zeta##8##4##(1994-11#2)(1994-12#5)(1995-6#1)
protein kinase C##586##3##(1990-10#12)(1990-11#14)(1990-12#6)(1990-2#8)(1990-3#7)(1990-4#20)(1990-5#15)(1990-6#5)(1990-7#8)(1990-8#11)(1990-9#18)(1991-1#3)(1991-10#6)(1991-12#2)(1991-2#8)(1991-3#5)(1991-4#5)(1991-5#8)(1991-6#4)(1991-7#12)(1991-8#10)(1991-9#6)(1992-1#1)(1992-11#6)(1992-12#4)(1992-2#1)(1992-3#3)(1992-4#7)(1992-5#4)(1992-6#13)(1992-7#4)(1992-8#10)(1992-9#13)(1993-11#3)(1993-12#8)(1993-2#2)(1993-3#12)(1993-4#6)(1993-6#13)(1993-7#4)(1993-8#11)(1993-9#6)(1994-10#2)(1994-11#13)(1994-12#22)(1994-2#12)(1994-3#7)(1994-5#13)(1994-6#3)(1994-8#10)(1994-9#11)(1995-10#1)(1995-11#7)(1995-12#4)(1995-2#3)(1995-3#11)(1995-5#3)(1995-6#5)(1995-7#2)(1995-8#6)(1996-1#1)(1996-11#6)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#13)(1996-6#2)(1996-7#1)(1996-8#5)(1996-9#4)(1997-1#5)(1997-2#5)(1997-3#3)(1997-4#4)(1997-6#3)(1997-7#4)(1997-8#1)(2005-10#1)(2005-7#1)(2006-8#1)(2007-9#1)(2008-1#6)(2008-10#2)(2008-11#20)(2008-12#2)(2008-3#5)(2008-4#5)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-7#1)(2010-12#4)(2010-2#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
protein kinase C's##2##3##(1994-5#2)
protein kinase C(PKC)##2##3##(1990-4#1)(1997-8#1)
protein kinase C-alpha##2##3##(1991-9#1)(1995-3#1)
protein kinase C-dependent##3##3##(1992-4#1)(1994-2#1)(1997-3#1)
protein kinase C-epsilon##2##3##(1990-7#2)
protein kinase C-independent##3##3##(1992-5#1)(1993-2#1)(1993-3#1)
protein kinase C-mediated phosphorylation of endogenous substrates##2##7##(1993-12#2)
protein kinase C-mediated##3##3##(1993-12#2)(1994-2#1)
protein kinase CK2##2##3##(1997-6#1)(2009-8#1)
protein kinase Calpha##2##3##(1996-5#2)
protein kinase D##2##3##(1994-8#2)
protein kinase II (CaM kinase II)##3##6##(1990-7#1)(1993-6#1)(1994-2#1)
protein kinase II (CaM-kinase II)##3##5##(1991-1#1)(1991-3#1)(1995-2#1)
protein kinase II (CaMKII)##5##4##(1991-12#1)(1994-12#1)(2008-8#2)(2012-2#1)
protein kinase II inhibitor##3##4##(1991-12#1)(1994-2#1)(1996-2#1)
protein kinase II##42##3##(1990-5#1)(1990-7#2)(1991-1#2)(1991-10#1)(1991-12#2)(1991-3#2)(1991-7#2)(1992-11#2)(1993-6#3)(1994-12#2)(1994-2#3)(1995-2#4)(1995-8#2)(1996-1#2)(1996-2#3)(1997-2#1)(1997-8#2)(2007-10#1)(2008-10#1)(2008-8#3)(2012-2#1)
protein kinase M##2##3##(1991-1#1)(1992-9#1)
protein kinase activation by##2##4##(1994-11#1)(1995-3#1)
protein kinase activation##5##3##(1994-11#2)(1995-3#1)(1995-6#1)(1996-5#1)
protein kinase activities in##2##4##(1993-11#1)(2008-4#1)
protein kinase activities##10##3##(1991-3#3)(1993-11#2)(1996-5#1)(1997-2#1)(2008-1#1)(2008-2#1)(2008-4#1)
protein kinase activity and##2##4##(1992-3#1)(1996-9#1)
protein kinase activity in##6##4##(1992-3#1)(1993-8#1)(1994-3#2)(1996-10#1)(1996-5#1)
protein kinase activity is##3##4##(1991-1#1)(1991-6#1)(1994-5#1)
protein kinase activity of##2##4##(1991-11#1)(1991-7#1)
protein kinase activity with##2##4##(1991-11#1)(1993-11#1)
protein kinase activity##31##3##(1990-6#1)(1991-1#2)(1991-11#2)(1991-4#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-2#1)(1992-3#3)(1992-6#1)(1993-11#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-3#1)(1996-10#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-6#1)(2008-4#1)(2009-8#1)(2011-2#1)
protein kinase and protein kinase C##2##6##(1991-2#1)(1994-12#1)
protein kinase and protein##3##4##(1991-2#1)(1994-12#1)(2008-4#1)
protein kinase and##11##3##(1990-8#1)(1991-12#1)(1991-2#1)(1992-1#1)(1993-3#1)(1993-6#1)(1994-12#1)(1996-8#1)(2008-10#1)(2008-4#1)(2012-3#1)
protein kinase at##3##3##(1990-4#1)(1991-2#1)(1991-6#1)
protein kinase by##4##3##(1990-8#1)(1995-6#1)(1997-6#1)(1997-7#1)
protein kinase domain##5##3##(1990-7#3)(1993-3#1)(1997-6#1)
protein kinase encoded by the##2##5##(1993-9#1)(2008-10#1)
protein kinase expression##2##3##(1990-8#1)(1993-11#1)
protein kinase family##5##3##(1991-2#1)(1993-6#1)(2008-10#1)(2010-7#1)(2012-2#1)
protein kinase from the##2##4##(1990-3#1)(1991-4#1)
protein kinase from##7##3##(1990-2#1)(1990-3#1)(1990-8#1)(1991-4#1)(1991-8#1)(1992-7#1)(1994-3#1)
protein kinase has##2##3##(1990-12#1)(1993-6#1)
protein kinase in the##3##4##(1993-3#1)(1994-2#1)(2010-10#1)
protein kinase in##11##3##(1992-3#2)(1992-8#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(2010-10#1)(2013-1#1)
protein kinase inhibitor (PKI)##3##4##(1993-6#1)(1995-2#1)(1995-3#1)
protein kinase inhibitor##23##3##(1990-12#3)(1991-11#1)(1991-3#1)(1992-3#1)(1993-6#1)(1994-2#1)(1994-3#3)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1997-2#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-6#1)
protein kinase inhibitors H7##2##4##(1994-11#1)(1996-9#1)
protein kinase inhibitors##8##3##(1990-8#2)(1993-6#1)(1994-11#1)(1995-3#1)(1996-9#1)(2007-12#1)(2008-4#1)
protein kinase involved in##4##4##(1996-4#1)(1996-8#1)(1997-3#1)(1997-6#1)
protein kinase is a##2##4##(1994-8#1)(1996-2#1)
protein kinase is##12##3##(1990-12#1)(1990-5#1)(1991-1#1)(1991-5#1)(1991-6#1)(1991-8#1)(1993-11#1)(1993-6#1)(1994-8#1)(1994-9#1)(1996-2#1)(2008-4#1)
protein kinase kinase##4##3##(1994-8#2)(1996-5#1)(1996-8#1)
protein kinase may##2##3##(1990-8#1)(1994-11#1)
protein kinase on##2##3##(1990-8#1)(1996-9#1)
protein kinase pathway##4##3##(1996-5#1)(2009-4#1)(2010-4#1)(2013-8#1)
protein kinase phosphorylation site##2##4##(1995-3#1)(2008-12#1)
protein kinase phosphorylation sites##2##4##(2008-12#1)(2008-9#1)
protein kinase phosphorylation##4##3##(1995-3#1)(2008-12#2)(2008-9#1)
protein kinase signaling##3##3##(1994-12#1)(1996-8#1)(2008-10#1)
protein kinase superfamily##2##3##(1991-8#1)(1996-5#1)
protein kinase that##8##3##(1991-2#1)(1991-8#1)(1992-6#1)(1994-8#1)(1995-3#2)(2009-7#1)(2009-8#1)
protein kinase to##2##3##(1991-7#1)(1995-3#1)
protein kinase type##4##3##(1993-6#1)(1996-8#1)(2006-9#2)
protein kinase was activated##2##4##(1994-12#2)
protein kinase was##9##3##(1990-3#1)(1990-9#1)(1994-12#3)(1996-10#1)(1996-8#1)(1997-6#1)(2013-7#1)
protein kinase with a##2##4##(1997-6#1)(2007-2#1)
protein kinase with##3##3##(1991-3#1)(1997-6#1)(2007-2#1)
protein kinase##1184##2##(1990-10#13)(1990-11#14)(1990-12#15)(1990-2#10)(1990-3#11)(1990-4#22)(1990-5#17)(1990-6#6)(1990-7#19)(1990-8#23)(1990-9#20)(1991-1#12)(1991-10#9)(1991-11#5)(1991-12#10)(1991-2#19)(1991-3#12)(1991-4#9)(1991-5#11)(1991-6#10)(1991-7#21)(1991-8#16)(1991-9#7)(1992-1#2)(1992-11#9)(1992-12#9)(1992-2#3)(1992-3#11)(1992-4#9)(1992-5#7)(1992-6#17)(1992-7#10)(1992-8#11)(1992-9#15)(1993-11#9)(1993-12#17)(1993-2#6)(1993-3#20)(1993-4#6)(1993-5#2)(1993-6#31)(1993-7#5)(1993-8#20)(1993-9#9)(1994-10#2)(1994-11#21)(1994-12#38)(1994-2#22)(1994-3#24)(1994-5#17)(1994-6#9)(1994-8#24)(1994-9#21)(1995-1#5)(1995-10#1)(1995-11#9)(1995-12#8)(1995-2#19)(1995-3#32)(1995-5#7)(1995-6#15)(1995-7#2)(1995-8#11)(1996-1#4)(1996-10#4)(1996-11#7)(1996-12#2)(1996-2#8)(1996-3#1)(1996-4#2)(1996-5#30)(1996-6#4)(1996-7#1)(1996-8#18)(1996-9#8)(1997-1#8)(1997-2#13)(1997-3#5)(1997-4#13)(1997-5#3)(1997-6#14)(1997-7#10)(1997-8#5)(2005-10#1)(2005-11#1)(2005-7#1)(2006-12#1)(2006-2#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#3)(2008-1#9)(2008-10#18)(2008-11#24)(2008-12#4)(2008-2#3)(2008-3#8)(2008-4#19)(2008-5#2)(2008-7#5)(2008-8#11)(2008-9#6)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#8)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#5)(2010-2#1)(2010-4#2)(2010-6#1)(2010-7#1)(2011-1#2)(2011-12#3)(2011-2#8)(2012-12#2)(2012-2#4)(2012-3#9)(2013-1#5)(2013-7#3)(2013-8#4)
protein kinase(s)##2##2##(1993-6#1)(1995-5#1)
protein kinase-C (PKC)##2##3##(1990-10#1)(1996-8#1)
protein kinase-C##3##2##(1990-10#1)(1996-8#2)
protein kinase-like##2##2##(1990-11#1)(1995-3#1)
protein kinases (MAPKs) and##2##4##(1995-2#1)(2007-8#1)
protein kinases (MAPKs) are##2##4##(1995-6#1)(2012-3#1)
protein kinases (MAPKs)##9##3##(1995-2#1)(1995-6#2)(1996-2#1)(2007-11#1)(2007-8#1)(2008-9#1)(2010-10#1)(2012-3#1)
protein kinases A and C##2##5##(1990-8#1)(1995-6#1)
protein kinases C and A##2##5##(1995-6#1)(1996-8#1)
protein kinases C and##3##4##(1995-6#1)(1996-8#1)(2011-2#1)
protein kinases C##6##3##(1995-6#1)(1996-8#1)(1997-7#1)(2011-2#1)(2012-12#2)
protein kinases and phosphatases##3##4##(1991-10#1)(1992-1#1)(2008-4#1)
protein kinases and protein phosphatases##2##5##(2008-5#2)
protein kinases and protein##3##4##(1994-2#1)(2008-5#2)
protein kinases and##16##3##(1990-8#1)(1991-10#1)(1992-1#1)(1992-7#1)(1992-8#1)(1993-9#1)(1994-2#1)(1996-8#1)(1997-2#1)(2008-4#2)(2008-5#3)(2008-8#1)(2012-12#1)
protein kinases are##2##3##(2008-4#1)(2013-1#1)
protein kinases at##3##3##(1990-6#1)(1996-10#1)(1996-8#1)
protein kinases can##2##3##(1996-10#1)(2008-2#1)
protein kinases have##2##3##(1992-8#1)(1993-12#1)
protein kinases in the##5##4##(1990-10#1)(1990-4#1)(1994-9#1)(2008-11#1)(2012-3#1)
protein kinases in##11##3##(1990-10#3)(1990-4#1)(1991-1#1)(1994-12#1)(1994-9#2)(1997-1#1)(2008-11#1)(2012-3#1)
protein kinases such as##3##4##(1990-9#1)(1993-8#1)(1997-6#1)
protein kinases tested##2##3##(1991-7#1)(1994-2#1)
protein kinases that sequentially##3##4##(2008-1#1)(2008-2#1)(2011-1#1)
protein kinases that##7##3##(1993-3#1)(1995-3#1)(2008-1#1)(2008-2#1)(2008-8#1)(2011-1#1)(2013-1#1)
protein kinases was##2##3##(1990-10#1)(1990-8#1)
protein kinases were##3##3##(1990-9#1)(1997-6#1)(2005-8#1)
protein kinases##153##2##(1990-10#5)(1990-12#4)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#2)(1992-11#1)(1992-4#1)(1992-7#1)(1992-8#3)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#3)(1994-2#3)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#5)(1995-8#2)(1996-10#3)(1996-11#1)(1996-2#4)(1996-5#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#3)(1997-7#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-8#2)(2008-1#2)(2008-11#1)(2008-2#4)(2008-4#8)(2008-5#3)(2008-8#3)(2008-9#1)(2009-5#1)(2009-8#4)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)
protein known to be##2##4##(2007-12#1)(2008-10#1)
protein known to##5##3##(1992-2#1)(1994-9#1)(1995-8#1)(2007-12#1)(2008-10#1)
protein labeling##3##2##(1990-5#1)(1994-9#1)(2008-1#1)
protein lacking##5##2##(1990-4#1)(1992-6#1)(1993-6#1)(1994-8#1)(2012-2#1)
protein layer##7##2##(2005-11#2)(2008-10#1)(2008-2#2)(2008-5#2)
protein leads to##2##3##(1994-11#1)(2011-1#1)
protein level and##3##3##(1997-3#1)(2005-12#1)(2009-4#1)
protein level as well as##2##5##(1995-5#1)(2008-4#1)
protein level in##4##3##(2008-7#1)(2009-4#1)(2010-2#1)(2012-2#1)
protein level is##2##3##(2011-1#1)(2012-12#1)
protein level of the##4##4##(1992-10#1)(1994-6#1)(1997-4#1)(2008-4#1)
protein level of##6##3##(1992-10#1)(1994-6#1)(1997-1#1)(1997-4#1)(2008-4#1)(2008-9#1)
protein level was##2##3##(1993-1#1)(2012-3#1)
protein level##58##2##(1990-5#1)(1992-10#1)(1992-8#1)(1993-1#2)(1993-11#1)(1994-11#1)(1994-2#1)(1994-6#2)(1994-8#1)(1995-5#2)(1995-6#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#2)(2005-12#2)(2006-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#8)(2008-7#3)(2008-9#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
protein levels and increased##2##4##(2010-3#1)(2013-1#1)
protein levels and##14##3##(1995-5#1)(1997-7#1)(2008-10#1)(2008-8#1)(2009-10#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)
protein levels are##6##3##(1991-11#1)(1993-12#1)(1995-1#1)(1996-12#1)(1997-4#1)(2008-8#1)
protein levels as well##3##4##(1996-10#1)(1997-2#1)(2010-12#1)
protein levels as##5##3##(1996-10#1)(1997-2#1)(1997-7#1)(2010-12#1)(2011-2#1)
protein levels during##2##3##(1994-2#1)(1997-4#1)
protein levels in the##5##4##(1994-9#1)(1995-10#1)(1995-7#1)(2010-12#1)(2013-8#1)
protein levels in##21##3##(1990-9#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-5#1)(1995-7#1)(2007-4#1)(2008-11#2)(2008-5#1)(2010-12#2)(2011-2#2)(2012-12#1)(2013-8#6)
protein levels of the##4##4##(1994-6#1)(1996-10#1)(2008-2#1)(2011-3#1)
protein levels of##17##3##(1990-9#1)(1994-6#1)(1994-9#1)(1996-10#1)(1997-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-12#3)(2011-2#1)(2011-3#2)(2012-2#2)(2013-8#1)
protein levels were reduced##2##4##(1996-11#1)(2009-4#1)
protein levels were##13##3##(1991-12#1)(1992-5#1)(1992-7#1)(1994-12#1)(1995-10#1)(1996-11#1)(1996-7#1)(1997-6#1)(2008-6#1)(2009-4#1)(2009-6#1)(2010-12#1)(2012-12#1)
protein levels##132##2##(1990-5#2)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#1)(1992-5#1)(1992-7#2)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#3)(1994-11#1)(1994-12#2)(1994-2#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#6)(1995-12#1)(1995-5#4)(1995-7#3)(1996-10#3)(1996-11#1)(1996-12#1)(1996-3#1)(1996-7#3)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#1)(2006-11#1)(2007-4#1)(2008-10#4)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#2)(2009-6#1)(2010-10#1)(2010-12#11)(2010-3#1)(2010-5#2)(2011-2#7)(2011-3#2)(2012-12#5)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#8)
protein ligand##3##2##(1992-6#1)(1993-6#1)(2008-10#1)
protein ligands##2##2##(1994-8#1)(2008-1#1)
protein ligase##2##2##(1995-6#1)(1997-3#1)
protein like##2##2##(1996-8#1)(2012-2#1)
protein liquid chromatography##5##3##(1991-11#1)(1992-2#1)(1993-4#1)(1995-6#1)(2008-10#1)
protein liquid##10##2##(1991-11#4)(1992-2#1)(1993-4#1)(1995-6#1)(2008-10#3)
protein localization##4##2##(1990-11#1)(2007-8#1)(2008-7#1)(2008-9#1)
protein localized in##2##3##(1993-6#1)(1994-8#1)
protein localized to##2##3##(1995-10#1)(2008-8#1)
protein localized##5##2##(1993-6#1)(1994-8#1)(1995-10#1)(2006-12#1)(2008-8#1)
protein located##3##2##(1991-10#1)(2010-12#1)(2012-12#1)
protein loss##7##2##(1997-3#1)(2006-10#1)(2006-2#1)(2007-12#2)(2008-11#1)(2008-5#1)
protein losses##2##2##(2011-2#2)
protein mRNA in rat liver##2##5##(1991-10#1)(1995-8#1)
protein mRNA in##3##3##(1991-10#1)(1995-8#1)(1997-5#1)
protein mRNA##9##2##(1991-10#1)(1991-11#1)(1994-8#1)(1994-9#2)(1995-8#1)(1996-12#1)(1997-5#1)(2009-4#1)
protein mRNAs##2##2##(1995-6#1)(1995-8#1)
protein machinery##2##2##(1994-12#1)(2008-7#1)
protein maize##3##2##(2006-4#1)(2012-2#2)
protein malnutrition on##2##3##(2008-11#1)(2008-8#1)
protein malnutrition##8##2##(1990-4#1)(1994-10#3)(2008-11#1)(2008-8#2)(2012-2#1)
protein marker##6##2##(2008-1#1)(2008-10#2)(2008-4#1)(2009-6#1)(2010-12#1)
protein markers of##2##3##(1996-4#1)(2012-3#1)
protein markers##11##2##(1994-12#1)(1996-4#1)(1996-6#1)(2008-10#2)(2009-6#2)(2010-3#1)(2012-3#1)(2012-7#1)(2012-8#1)
protein mass recovery##2##3##(2008-10#1)(2008-6#1)
protein mass##7##2##(2008-10#1)(2008-11#1)(2008-6#2)(2008-7#3)
protein material##3##2##(1990-9#1)(1991-9#1)(1995-6#1)
protein matrix##10##2##(1990-8#2)(1994-5#1)(1995-11#1)(1996-8#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-6#2)
protein maturation##2##2##(1995-9#1)(1996-11#1)
protein may be an##3##4##(1991-9#1)(1996-1#1)(1997-3#1)
protein may be important in the##2##6##(1992-11#1)(1994-3#1)
protein may be important in##4##5##(1992-11#1)(1992-9#1)(1994-3#1)(2008-10#1)
protein may be involved in##3##5##(1993-6#1)(1993-8#1)(1994-8#1)
protein may be the##2##4##(1990-4#1)(2009-11#1)
protein may be useful##2##4##(1991-8#1)(1995-9#1)
protein may be##20##3##(1990-4#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-9#1)(1996-1#1)(1997-3#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-11#1)(2009-9#1)
protein may play a role in the##3##7##(1997-6#1)(2003-11#1)(2009-4#1)
protein may play a role in##4##6##(1997-6#1)(2003-11#1)(2009-4#1)(2009-7#1)
protein may play a##8##4##(1992-11#1)(1994-8#1)(1996-5#1)(1997-2#1)(1997-6#1)(2003-11#1)(2009-4#1)(2009-7#1)
protein may play an important role in##2##7##(2008-8#1)(2008-9#1)
protein may play##10##3##(1992-11#1)(1994-8#1)(1996-5#1)(1997-2#1)(1997-6#1)(2003-11#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)
protein may##40##2##(1990-11#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-2#1)(1991-8#1)(1991-9#2)(1992-11#2)(1992-8#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-8#2)(1995-10#2)(1995-12#1)(1995-9#1)(1996-1#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-6#1)(2003-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-4#1)(2009-7#1)(2009-9#1)
protein measurements and##2##3##(1993-10#1)(1996-9#1)
protein measurements##3##2##(1993-10#1)(1996-9#1)(2008-9#1)
protein mediates##5##2##(1992-1#1)(1993-9#1)(1996-5#1)(1996-8#1)(1997-4#1)
protein medium##2##2##(1994-3#1)(2008-11#1)
protein members of##2##3##(1994-6#1)(1995-8#1)
protein metabolism##6##2##(1990-4#1)(1995-1#1)(2006-2#1)(2008-10#2)(2009-10#1)
protein methylation##5##2##(1992-5#1)(1994-9#1)(2008-4#3)
protein methyltransferase##4##2##(1991-2#1)(1993-8#2)(1994-9#1)
protein microarray##5##2##(2007-8#2)(2008-10#2)(2010-2#1)
protein microarrays##10##2##(2007-8#4)(2008-4#2)(2009-12#1)(2010-7#1)(2013-1#2)
protein might be involved in the##2##6##(1996-12#1)(2009-5#1)
protein might be involved in##3##5##(1994-12#1)(1996-12#1)(2009-5#1)
protein might be##5##3##(1990-7#1)(1994-12#1)(1996-12#1)(2009-5#2)
protein might##10##2##(1990-7#1)(1991-7#1)(1991-9#1)(1994-10#1)(1994-12#1)(1996-12#1)(2008-10#1)(2008-9#1)(2009-5#2)
protein migrated##2##2##(1994-5#1)(1994-8#1)
protein migrates##3##2##(1991-7#2)(1995-3#1)
protein misfolding##2##2##(2010-4#1)(2013-8#1)
protein mixture##6##2##(1990-12#1)(2008-1#1)(2008-10#2)(2008-4#2)
protein mixtures followed by##2##4##(2008-4#1)(2010-12#1)
protein mixtures##7##2##(2006-9#1)(2008-11#1)(2008-4#4)(2010-12#1)
protein mobility##2##2##(1991-7#1)(2008-1#1)
protein model##2##2##(1996-6#1)(1997-3#1)
protein modification by##2##3##(2007-12#1)(2008-10#1)
protein modification##11##2##(1993-3#1)(1994-3#1)(1996-10#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-8#1)(2011-1#1)(2012-3#1)
protein modifications##4##2##(1997-8#1)(2008-11#1)(2009-12#1)(2010-12#1)
protein moieties##2##2##(1994-11#1)(1995-8#1)
protein moiety of the##3##4##(1992-3#2)(1994-11#1)
protein moiety##6##2##(1990-2#1)(1992-3#3)(1993-2#1)(1994-11#1)
protein molecular##4##2##(2008-4#2)(2009-12#1)(2012-3#1)
protein molecule##10##2##(1990-5#1)(1991-10#1)(1992-6#1)(1995-2#2)(1997-6#2)(2006-10#1)(2008-4#1)(2013-8#1)
protein molecules and##3##3##(1991-7#1)(2006-10#1)(2008-1#1)
protein molecules in##3##3##(1990-11#1)(1994-9#1)(2008-9#1)
protein molecules##22##2##(1990-11#1)(1990-12#1)(1991-4#1)(1991-7#1)(1994-8#1)(1994-9#1)(1995-4#1)(1995-5#1)(1996-5#1)(1997-1#1)(2005-11#2)(2006-10#2)(2006-12#1)(2008-1#1)(2008-10#1)(2008-9#2)(2009-12#1)(2010-10#1)(2010-4#1)
protein monomers##2##2##(1997-6#1)(2008-10#1)
protein most##3##2##(1994-11#1)(2005-11#1)(2008-5#1)
protein motifs##3##2##(1994-9#1)(1995-8#1)(1996-10#1)
protein must be##2##3##(1994-9#1)(1995-1#1)
protein mutants can##2##3##(2006-12#2)
protein mutants##5##2##(2006-12#3)(2007-12#1)(2008-10#1)
protein mutations##3##2##(1995-8#1)(1997-4#1)(2008-6#1)
protein myristoylation##2##2##(2009-8#2)
protein named##2##2##(2005-11#1)(2008-7#1)
protein names##2##2##(2008-7#2)
protein nanolithography##2##2##(2008-7#2)
protein needs##2##2##(1995-2#1)(2008-5#1)
protein network##7##2##(2005-10#2)(2007-9#1)(2008-2#1)(2010-10#1)(2010-2#1)(2012-1#1)
protein networks##3##2##(2006-10#1)(2008-7#1)(2010-2#1)
protein nitrogen##2##2##(2007-2#2)
protein not only##2##3##(2008-10#1)(2012-2#1)
protein not##4##2##(1990-5#1)(2008-10#1)(2008-5#1)(2012-2#1)
protein nuclear extracts##3##3##(2008-9#3)
protein nuclear##5##2##(2008-9#5)
protein obtained##2##2##(1996-9#1)(2008-1#1)
protein occur##2##2##(1994-9#1)(1997-6#1)
protein occurred in##2##3##(1994-11#1)(2009-8#1)
protein occurred##3##2##(1992-11#1)(1994-11#1)(2009-8#1)
protein occurs##2##2##(1995-11#1)(1997-2#1)
protein of 1##3##3##(1990-8#1)(2008-10#1)(2010-5#1)
protein of 130##2##3##(1990-3#1)(2008-11#1)
protein of 18##2##3##(1993-9#1)(1994-9#1)
protein of 294 amino acids##2##5##(1990-11#1)(1996-6#1)
protein of 294##3##3##(1990-11#1)(1996-10#1)(1996-6#1)
protein of 320##2##3##(1992-12#1)(2005-11#1)
protein of 327##3##3##(1990-12#1)(1992-12#1)(1993-3#1)
protein of 43 kDa##2##4##(1990-10#1)(1991-12#1)
protein of 48##2##3##(1990-3#1)(1997-4#1)
protein of Alzheimer's disease##3##4##(1991-11#1)(1991-9#1)(1996-9#1)
protein of B##2##3##(1990-9#1)(1997-4#1)
protein of Bacillus subtilis##3##4##(1993-9#1)(1995-2#1)(1995-6#1)
protein of Bacillus##4##3##(1993-9#1)(1995-2#1)(1995-6#1)(2004-11#1)
protein of Drosophila##2##3##(1990-8#1)(1995-6#1)
protein of E##3##3##(1990-3#1)(1992-8#1)(1993-12#1)
protein of Escherichia coli##7##4##(1990-3#1)(1991-12#1)(1991-7#1)(1991-8#1)(1994-5#1)(1994-8#1)(1996-2#1)
protein of HIV-1##2##3##(1994-9#1)(1996-4#1)
protein of M(r)##3##3##(1992-6#1)(1993-9#1)(2010-4#1)
protein of Mr =##3##4##(1990-12#1)(1990-8#1)(1991-12#1)
protein of Mr##7##3##(1990-11#1)(1990-12#1)(1990-8#2)(1990-9#1)(1991-12#1)(1992-2#1)
protein of Mr95K##2##3##(1991-7#2)
protein of Photosystem II##3##4##(1994-12#3)
protein of S##3##3##(1995-4#1)(1995-6#1)(2008-10#1)
protein of Streptococcus##2##3##(1996-12#1)(2005-11#1)
protein of a##3##3##(1990-9#1)(1997-1#1)(2005-9#1)
protein of about 52 kDa##2##5##(1991-7#1)(1994-8#1)
protein of about##4##3##(1990-11#1)(1991-7#1)(1993-12#1)(1994-8#1)
protein of adenovirus##2##3##(1994-3#1)(1994-9#1)
protein of apparent##3##3##(1990-7#1)(1991-5#1)(1995-10#1)
protein of approximately##8##3##(1990-7#1)(1992-9#1)(1993-6#1)(1994-8#2)(1995-2#1)(1996-10#1)(2007-11#1)
protein of bacteriophage T4##3##4##(1990-5#2)(1994-12#1)
protein of both##3##3##(1995-8#1)(2012-12#2)
protein of hepatitis C virus##2##5##(1992-11#1)(2012-2#1)
protein of hepatitis##3##3##(1992-11#1)(2012-2#2)
protein of human immunodeficiency virus type 1 (HIV-1)##2##8##(1994-8#1)(1997-1#1)
protein of human immunodeficiency virus type 1##3##7##(1994-8#1)(1996-10#1)(1997-1#1)
protein of human##9##3##(1990-5#2)(1990-7#1)(1991-10#1)(1992-9#1)(1994-8#1)(1996-10#1)(1997-1#1)(2010-1#1)
protein of interest is expressed as a fusion to the DNA binding protein##2##13##(2008-2#2)
protein of interest is immobilized on a solid support membrane##2##10##(2008-2#1)(2008-4#1)
protein of interest is##8##4##(2008-2#3)(2008-4#5)
protein of interest##19##3##(1992-5#1)(1993-12#1)(2008-1#2)(2008-2#3)(2008-4#10)(2008-9#1)(2012-2#1)
protein of liver##2##3##(1991-2#1)(2008-12#1)
protein of molecular##2##3##(1995-1#1)(2008-8#1)
protein of peripheral##2##3##(1991-10#1)(1995-12#1)
protein of photosystem II##2##4##(1992-3#1)(1994-8#1)
protein of protein##3##3##(1990-8#1)(1997-6#2)
protein of rat ileal cytosol##2##5##(1991-6#2)
protein of rat##4##3##(1991-12#1)(1991-6#2)(2013-8#1)
protein of relative molecular mass##3##5##(1991-11#2)(1991-2#1)
protein of ribonucleotide reductase from Escherichia coli##2##7##(1991-5#1)(1995-10#1)
protein of ribonucleotide reductase##4##4##(1991-5#2)(1993-11#1)(1995-10#1)
protein of similar##2##3##(1990-10#1)(1993-9#1)
protein of the central nervous system##2##6##(1996-12#1)(1997-2#1)
protein of the human##2##4##(1990-4#1)(2007-3#1)
protein of the inner##2##4##(1993-6#1)(2011-2#1)
protein of the mitochondrial##2##4##(1991-10#1)(2012-2#1)
protein of the oxygen-evolving complex##2##5##(1994-12#2)
protein of the##49##3##(1990-10#2)(1990-2#1)(1990-4#1)(1990-5#1)(1991-10#1)(1991-2#2)(1991-7#1)(1991-9#2)(1992-11#2)(1992-3#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-12#3)(1994-8#2)(1994-9#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#2)(1997-2#2)(1997-3#1)(1997-4#2)(2007-3#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
protein of unknown function##5##4##(1990-7#1)(1991-7#1)(1993-11#1)(2008-10#2)
protein of unknown##6##3##(1990-7#1)(1991-7#1)(1993-11#1)(1994-12#1)(2008-10#2)
protein of##465##2##(1990-10#5)(1990-11#6)(1990-12#5)(1990-2#2)(1990-3#6)(1990-4#3)(1990-5#8)(1990-6#1)(1990-7#8)(1990-8#5)(1990-9#6)(1991-10#3)(1991-11#6)(1991-12#4)(1991-2#7)(1991-4#1)(1991-5#9)(1991-6#2)(1991-7#8)(1991-8#3)(1991-9#8)(1992-11#7)(1992-12#5)(1992-2#5)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#4)(1992-9#6)(1993-11#5)(1993-12#7)(1993-2#6)(1993-3#5)(1993-4#1)(1993-5#1)(1993-6#4)(1993-7#2)(1993-8#2)(1993-9#9)(1994-11#8)(1994-12#19)(1994-2#2)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#13)(1994-9#8)(1995-1#3)(1995-10#2)(1995-12#3)(1995-2#11)(1995-3#3)(1995-4#3)(1995-6#6)(1995-8#6)(1995-9#1)(1996-10#7)(1996-11#2)(1996-12#8)(1996-2#1)(1996-4#1)(1996-6#5)(1996-7#2)(1996-8#1)(1996-9#6)(1997-1#7)(1997-2#10)(1997-3#4)(1997-4#7)(1997-5#1)(1997-6#6)(1997-7#4)(2004-11#1)(2005-11#4)(2005-6#1)(2005-9#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#29)(2008-11#3)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#11)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#6)(2009-10#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-5#2)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
protein oligomerization##3##2##(1992-12#1)(2010-8#1)(2011-1#1)
protein oligomers##2##2##(2010-8#1)(2011-2#1)
protein on a##4##3##(1991-5#1)(1994-6#1)(1997-4#1)(2008-4#1)
protein on immunoblots of##2##4##(1991-9#1)(1995-6#1)
protein on the cell##2##4##(1991-12#1)(1995-3#1)
protein on the membrane##2##4##(1994-2#1)(1997-4#1)
protein on the surface of endothelial cells##2##7##(1992-9#1)(1995-8#1)
protein on the surface of##5##5##(1990-9#1)(1992-9#2)(1995-8#1)(2008-9#1)
protein on the##21##3##(1990-2#1)(1990-3#1)(1990-9#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-9#2)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-8#1)(1997-4#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-9#1)
protein on##52##2##(1990-2#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-12#2)(1991-5#1)(1991-9#3)(1992-11#2)(1992-12#1)(1992-6#1)(1992-9#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-3#1)(1997-4#2)(2005-11#1)(2006-5#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-2#1)(2011-12#2)(2012-12#1)(2013-8#1)
protein only in##2##3##(2007-11#1)(2008-4#1)
protein only##7##2##(1993-6#1)(1994-3#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-3#1)(2008-4#1)
protein onto##5##2##(1994-12#3)(1994-9#1)(2008-10#1)
protein or DNA##3##3##(2008-9#1)(2010-2#1)(2010-4#1)
protein or a##5##3##(1991-11#1)(1993-12#1)(1995-1#1)(2008-4#1)(2008-5#1)
protein or peptide##2##3##(1995-5#1)(2008-11#1)
protein or protein##3##3##(1990-3#1)(1991-11#1)(2008-4#1)
protein or the##3##3##(1991-9#1)(1994-12#1)(1995-6#1)
protein or##42##2##(1990-3#1)(1990-6#1)(1991-11#2)(1991-4#1)(1991-7#2)(1991-9#1)(1992-4#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-8#2)(1995-1#1)(1995-2#1)(1995-5#2)(1995-6#3)(1995-8#1)(1996-8#1)(1997-4#1)(2005-12#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-4#8)(2008-5#1)(2008-9#1)(2009-9#1)(2010-2#1)(2010-4#1)(2013-7#1)
protein organization##2##2##(2008-7#2)
protein originally##2##2##(1990-11#1)(1991-8#1)
protein output and##2##3##(1997-5#2)
protein output was##2##3##(1997-5#2)
protein output##9##2##(1992-4#1)(1992-6#1)(1997-5#7)
protein overexpression in##3##3##(2010-7#1)(2011-1#2)
protein overexpression##7##2##(2007-6#1)(2008-2#1)(2008-3#1)(2010-7#1)(2011-1#3)
protein oxidation and##2##3##(2008-8#1)(2011-1#1)
protein oxidation in##4##3##(1995-1#1)(2010-4#3)
protein oxidation##17##2##(1994-11#1)(1995-1#3)(1995-6#2)(2007-11#1)(2008-1#1)(2008-4#1)(2008-8#1)(2010-4#6)(2011-1#1)
protein p1 and free TP##2##5##(1997-5#2)
protein p1##5##2##(1997-5#5)
protein p20##3##2##(2008-9#3)
protein p24##2##2##(1991-10#1)(1995-5#1)
protein p3##3##2##(1990-3#3)
protein p36##2##2##(1990-7#2)
protein p37##3##2##(1995-6#2)(1997-6#1)
protein p4##3##2##(1990-11#3)
protein p53##3##2##(2007-11#1)(2009-9#2)
protein pVIII##2##2##(2008-10#1)(2009-2#1)
protein part of##2##3##(2009-8#2)
protein part##3##2##(2009-8#3)
protein participates in##3##3##(1994-12#1)(1995-2#1)(2010-2#1)
protein participates##4##2##(1994-12#1)(1995-2#1)(2008-10#1)(2010-2#1)
protein particles##4##2##(1990-8#1)(1995-1#1)(1996-1#1)(2008-11#1)
protein partition##2##2##(2008-7#1)(2011-1#1)
protein partners##3##2##(1995-2#1)(2008-8#2)
protein pattern changes##2##3##(1997-1#1)(2008-4#1)
protein pattern##5##2##(1991-2#1)(1992-12#1)(1994-9#1)(1997-1#1)(2008-4#1)
protein patterns were##2##3##(2007-12#1)(2008-1#1)
protein patterns##5##2##(1994-9#1)(2007-12#1)(2008-1#2)(2010-4#1)
protein peaks##2##2##(2008-10#2)
protein per min##8##3##(1991-5#2)(1992-3#3)(2008-10#2)(2008-11#1)
protein per##21##2##(1990-12#1)(1990-7#1)(1991-10#1)(1991-5#2)(1992-2#1)(1992-3#3)(1995-1#1)(1995-8#1)(2006-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2010-7#1)
protein permeability##2##2##(2011-1#1)(2011-2#1)
protein pharmaceuticals##3##2##(1997-2#1)(2008-11#1)(2012-3#1)
protein phosphatase (PP)##2##3##(1990-12#1)(1991-9#1)
protein phosphatase 1##9##3##(1990-12#1)(1993-7#1)(1994-2#1)(1995-6#2)(1995-8#2)(1997-4#1)(2008-10#1)
protein phosphatase 1/2A##3##3##(1993-8#2)(1994-11#1)
protein phosphatase 2A##6##3##(1994-9#2)(1995-8#1)(1996-5#2)(2008-9#1)
protein phosphatase 2B##3##3##(1993-11#2)(1995-2#1)
protein phosphatase activator##2##3##(1993-6#2)
protein phosphatase and##5##3##(1993-6#2)(1994-11#1)(1996-2#1)(2012-3#1)
protein phosphatase in##5##3##(1991-4#3)(1991-9#1)(1993-6#1)
protein phosphatase inhibition##2##3##(1997-4#2)
protein phosphatase inhibitor##5##3##(1993-8#1)(1994-2#2)(1996-5#1)(2009-6#1)
protein phosphatase inhibitors to##2##4##(1993-6#1)(2008-4#1)
protein phosphatase inhibitors##9##3##(1992-12#2)(1992-8#1)(1993-6#1)(1995-6#1)(1997-6#1)(2008-2#1)(2008-4#2)
protein phosphatase one##2##3##(2012-12#2)
protein phosphatase that##2##3##(1995-1#1)(1995-6#1)
protein phosphatase type 2A##3##4##(1991-7#1)(1995-8#2)
protein phosphatase type##7##3##(1991-7#2)(1992-8#1)(1994-12#1)(1995-8#3)
protein phosphatase##91##2##(1990-11#1)(1990-12#2)(1991-2#1)(1991-4#3)(1991-7#2)(1991-9#2)(1992-12#4)(1992-8#7)(1993-11#2)(1993-6#8)(1993-7#3)(1993-8#5)(1994-11#3)(1994-12#3)(1994-2#3)(1994-8#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-5#2)(1995-6#4)(1995-8#6)(1996-10#1)(1996-2#2)(1996-5#6)(1997-4#3)(1997-6#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2012-12#2)(2012-3#1)
protein phosphatase-1##3##2##(1995-8#1)(1997-6#2)
protein phosphatases 1 and 2A##5##5##(1991-5#1)(1992-12#2)(1994-2#1)(1997-8#1)
protein phosphatases 1##7##3##(1990-8#1)(1991-5#1)(1992-12#2)(1994-2#1)(1995-8#1)(1997-8#1)
protein phosphatases in##4##3##(1994-2#1)(1995-6#1)(2008-4#1)(2013-7#1)
protein phosphatases type 1 and##2##5##(1990-12#1)(1994-11#1)
protein phosphatases##32##2##(1990-12#2)(1990-8#1)(1991-10#1)(1991-5#1)(1992-12#2)(1992-8#2)(1993-7#1)(1994-11#1)(1994-2#3)(1995-11#1)(1995-3#1)(1995-6#2)(1995-8#2)(1996-5#1)(1997-6#1)(1997-8#1)(2004-12#1)(2008-4#1)(2008-5#2)(2012-12#1)(2013-7#4)
protein phosphorylation and##3##3##(1993-8#1)(1994-8#1)(1994-9#1)
protein phosphorylation by##3##3##(1993-4#1)(1994-3#1)(1995-12#1)
protein phosphorylation can be##2##4##(1991-3#1)(2008-8#1)
protein phosphorylation events##4##3##(1990-12#1)(1990-4#1)(2008-2#1)(2008-4#1)
protein phosphorylation in##10##3##(1990-11#1)(1990-12#3)(1990-9#1)(1991-2#1)(1992-2#2)(1995-10#1)(1997-6#1)
protein phosphorylation is##3##3##(1995-12#1)(2008-2#1)(2008-4#1)
protein phosphorylation of##2##3##(1995-12#1)(1995-3#1)
protein phosphorylation##55##2##(1990-11#1)(1990-12#5)(1990-4#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-11#1)(1992-2#2)(1992-5#1)(1992-9#2)(1993-4#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#2)(1996-2#1)(1996-8#1)(1997-6#1)(2008-2#3)(2008-4#4)(2008-8#2)(2012-3#1)
protein phosphotyrosine##2##2##(1992-8#1)(1993-8#1)
protein plays an important role in##2##6##(2008-5#1)(2010-2#1)
protein plays##3##2##(2008-5#1)(2010-2#1)(2012-2#1)
protein plugs##3##2##(2008-10#1)(2009-7#2)
protein plus##2##2##(1994-11#1)(2008-10#1)
protein polymorphisms##2##2##(1993-7#1)(1997-4#1)
protein portion##2##2##(1992-12#1)(1997-1#1)
protein positive##2##2##(1995-9#1)(2005-9#1)
protein possessed##3##2##(1997-4#1)(2005-11#2)
protein possesses##2##2##(1994-11#1)(1996-10#1)
protein powders##2##2##(2008-5#2)
protein precipitation with##2##3##(1996-8#1)(2011-2#1)
protein precipitation##6##2##(1996-5#1)(1996-8#1)(1997-8#1)(2008-7#1)(2011-2#1)(2011-3#1)
protein precursor (APP)##7##3##(1991-9#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-11#1)
protein precursor and##2##3##(1993-12#1)(1994-8#1)
protein precursor in##3##3##(1992-9#1)(1996-6#1)(2004-11#1)
protein precursor is##2##3##(1992-6#1)(1992-9#1)
protein precursor##29##2##(1990-2#2)(1990-8#1)(1991-9#4)(1992-12#2)(1992-6#3)(1992-8#1)(1992-9#4)(1993-12#2)(1993-3#1)(1994-11#2)(1994-8#1)(1996-6#1)(2004-11#2)(2008-11#1)(2008-7#1)(2010-12#1)
protein predicted##3##2##(1996-5#1)(1997-2#1)(2008-10#1)
protein prediction##2##2##(2008-9#1)(2012-2#1)
protein predicts##2##2##(1990-1#1)(1992-7#1)
protein preparation with##2##3##(1993-2#1)(1994-10#1)
protein preparation##4##2##(1990-3#1)(1993-2#1)(1994-10#1)(1996-9#1)
protein preparations##5##2##(1990-11#1)(1990-12#1)(1994-11#1)(1996-9#1)(2011-2#1)
protein present in the##3##4##(1993-4#1)(1995-5#1)(1995-8#1)
protein present in##13##3##(1991-5#1)(1992-11#1)(1993-4#2)(1993-9#1)(1995-5#1)(1995-8#3)(1997-7#1)(2007-7#1)(2008-10#1)(2008-11#1)
protein present##16##2##(1991-5#1)(1992-11#1)(1993-4#2)(1993-9#1)(1995-5#1)(1995-8#3)(1997-7#1)(2005-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)
protein prevents##2##2##(1995-6#1)(2008-7#1)
protein previously##3##2##(1991-8#1)(1993-9#1)(2008-7#1)
protein processing##2##2##(1996-10#1)(2008-4#1)
protein produced by##3##3##(1991-8#1)(1993-12#1)(1993-3#1)
protein produced in E##4##4##(1992-8#2)(1993-4#1)(1994-8#1)
protein produced in##7##3##(1990-3#1)(1991-9#1)(1992-8#2)(1993-12#1)(1993-4#1)(1994-8#1)
protein produced##17##2##(1990-2#1)(1990-3#1)(1991-8#1)(1991-9#1)(1992-8#2)(1993-12#2)(1993-3#1)(1993-4#1)(1994-8#1)(1997-4#1)(2008-11#3)(2011-2#1)(2012-12#1)
protein product of the##4##4##(1991-12#1)(1993-12#1)(1993-4#1)(2010-2#1)
protein product of##8##3##(1990-5#1)(1991-12#1)(1993-11#1)(1993-12#1)(1993-4#1)(1997-4#1)(1997-9#1)(2010-2#1)
protein product##30##2##(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-7#1)(1991-8#2)(1992-2#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-6#1)(1996-12#1)(1996-4#1)(1997-4#2)(1997-7#1)(1997-9#1)(2003-11#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-2#1)(2013-1#1)
protein production and##8##3##(1995-8#1)(1997-2#1)(2008-11#3)(2012-2#2)(2012-3#1)
protein production by##2##3##(2008-11#1)(2008-4#1)
protein production from##3##3##(2008-11#1)(2012-2#1)(2012-3#1)
protein production in##11##3##(1997-2#1)(1997-4#1)(2008-11#3)(2008-7#4)(2011-2#2)
protein production is##3##3##(2007-11#1)(2008-7#1)(2011-2#1)
protein production of##3##3##(2008-11#3)
protein production was##2##3##(2008-11#2)
protein production##68##2##(1992-12#1)(1992-8#1)(1994-9#1)(1995-8#1)(1997-2#2)(1997-4#2)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#27)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#10)(2011-1#2)(2011-2#6)(2012-2#3)(2012-3#2)(2013-1#1)
protein productivity of##2##3##(2008-11#2)
protein productivity##7##2##(2008-11#5)(2008-7#2)
protein products are##3##3##(1992-12#1)(1997-4#1)(2011-2#1)
protein products of the bacterial##2##5##(1994-2#2)
protein products of##5##3##(1991-12#1)(1994-2#2)(2008-11#1)(2008-5#1)
protein products##22##2##(1990-3#1)(1990-8#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-2#2)(1995-8#1)(1996-10#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2011-2#1)
protein profile comparisons##2##3##(2008-4#2)
protein profile##8##2##(1997-8#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-4#2)(2011-2#1)(2013-1#1)
protein profiles of##2##3##(2007-8#1)(2010-12#1)
protein profiles##8##2##(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-12#2)
protein profiling##7##2##(2007-8#1)(2008-4#4)(2010-6#1)(2013-1#1)
protein promoter##4##2##(1996-12#1)(1997-4#2)(2008-12#1)
protein properties##2##2##(2008-4#1)(2008-7#1)
protein protects##4##2##(1990-9#1)(1992-7#1)(1995-6#1)(2008-8#1)
protein proved to be##2##4##(1995-8#1)(2011-2#1)
protein purification and##3##3##(1993-12#1)(1996-12#1)(2008-4#1)
protein purification##14##2##(1993-12#1)(1995-12#1)(1996-12#1)(1996-8#1)(2008-4#7)(2008-7#2)(2013-1#1)
protein purified from##6##3##(1990-12#1)(1990-8#1)(1992-8#1)(1996-2#1)(2008-10#1)(2009-2#1)
protein purified##9##2##(1990-12#1)(1990-5#1)(1990-8#1)(1992-8#1)(1995-6#2)(1996-2#1)(2008-10#1)(2009-2#1)
protein quality control##4##3##(2009-10#2)(2010-4#1)(2011-2#1)
protein quality##6##2##(2008-11#1)(2008-7#1)(2009-10#2)(2010-4#1)(2011-2#1)
protein quantification##5##2##(2007-8#3)(2008-10#1)(2013-1#1)
protein quantitation##4##2##(1994-8#1)(2010-5#3)
protein quantity##2##2##(2006-8#1)(2012-2#1)
protein radical##2##2##(1991-9#2)
protein rather than##5##3##(1995-1#1)(2005-12#1)(2006-10#1)(2008-10#2)
protein ratio##2##2##(1990-5#1)(1995-12#1)
protein reached a##2##3##(1990-7#1)(1994-2#1)
protein reacted with##3##3##(1990-2#1)(1991-6#1)(1993-11#1)
protein reacted##4##2##(1990-2#1)(1991-6#1)(1993-11#1)(1995-6#1)
protein reacts##2##2##(1990-5#2)
protein recently##2##2##(1993-3#1)(2010-5#1)
protein receptor##6##2##(1994-2#2)(1995-2#1)(2008-4#1)(2009-8#1)(2012-1#1)
protein receptors##2##2##(1994-11#1)(2008-4#1)
protein recognition and##4##3##(2007-9#1)(2013-1#3)
protein recognition##8##2##(1992-2#1)(1994-12#1)(1994-8#1)(1997-5#1)(2007-9#1)(2013-1#3)
protein recognized by##4##3##(1990-11#1)(1990-5#1)(1990-6#1)(1990-9#1)
protein recognized##5##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-9#1)(1997-6#1)
protein recognizes##2##2##(1990-5#1)(2006-12#1)
protein recovery in the##2##4##(1990-3#1)(2008-6#1)
protein recovery in##3##3##(1990-3#2)(2008-6#1)
protein redox##2##2##(1994-9#1)(2009-10#1)
protein refolded##2##2##(1995-11#1)(1995-2#1)
protein refolding##3##2##(2011-1#1)(2011-2#2)
protein region##2##2##(1994-3#1)(2008-10#1)
protein regucalcin##2##2##(1992-6#2)
protein regulates##4##2##(1994-9#1)(1996-4#1)(1997-4#1)(2012-2#1)
protein regulation##4##2##(1991-5#1)(1994-12#1)(2009-6#2)
protein related to##2##3##(1994-9#1)(1997-3#1)
protein relative to the##2##4##(1994-11#1)(2006-12#1)
protein relative to##5##3##(1994-11#1)(2006-12#1)(2008-4#2)(2011-2#1)
protein release##4##2##(1992-4#1)(1995-2#1)(1996-5#1)(2012-6#1)
protein released##2##2##(1993-11#1)(1996-2#1)
protein remains##5##2##(1990-7#1)(1994-3#1)(1994-9#1)(1995-8#1)(2005-11#1)
protein removal##2##2##(2008-5#1)(2011-2#1)
protein repair##3##2##(1994-8#1)(1995-8#1)(2009-10#1)
protein reported##2##2##(1991-5#1)(2009-7#1)
protein represents a##2##3##(1992-12#1)(2008-1#1)
protein represents##3##2##(1992-12#1)(2008-1#1)(2008-10#1)
protein required for the##2##4##(1996-4#1)(2010-7#1)
protein required for##7##3##(1993-9#1)(1994-9#1)(1996-4#1)(2008-9#2)(2009-8#1)(2010-7#1)
protein required##10##2##(1990-9#1)(1991-3#1)(1993-12#1)(1993-9#1)(1994-9#1)(1996-4#1)(2008-9#2)(2009-8#1)(2010-7#1)
protein requirements##4##2##(2008-5#3)(2012-2#1)
protein requires##5##2##(1993-5#1)(1994-11#1)(1996-2#1)(1997-2#1)(2008-4#1)
protein residue##2##2##(1991-7#1)(1994-11#1)
protein residues##2##2##(1996-5#1)(2006-10#1)
protein resistant##2##2##(2005-11#1)(2009-7#1)
protein response##8##2##(1997-1#1)(1997-4#2)(2006-4#1)(2006-6#1)(2009-8#1)(2011-2#1)(2012-3#1)
protein responses##2##2##(2008-7#1)(2013-8#1)
protein responsible for the##3##4##(1990-3#1)(1992-11#1)(2009-3#1)
protein responsible for##7##3##(1990-2#1)(1990-3#1)(1991-2#1)(1992-11#1)(1997-4#1)(2009-3#1)(2011-2#1)
protein result in##2##3##(1991-5#1)(2009-2#1)
protein resulted in##4##3##(1994-3#1)(1995-12#1)(2008-3#1)(2011-1#1)
protein resulting in##2##3##(1995-1#1)(2006-5#1)
protein resulting##3##2##(1992-3#1)(1995-1#1)(2006-5#1)
protein results in a##2##4##(1991-7#1)(2008-4#1)
protein results in##3##3##(1991-7#1)(1994-11#1)(2008-4#1)
protein retained##2##2##(2006-12#1)(2008-10#1)
protein retains##2##2##(1990-11#1)(1993-11#1)
protein retention##3##2##(1990-6#1)(2007-8#1)(2013-8#1)
protein revealed a##2##3##(1995-8#1)(1996-4#1)
protein revealed that it was##2##5##(1990-3#1)(1997-1#1)
protein revealed that the##4##4##(1993-2#1)(1997-6#1)(1997-7#1)(2008-10#1)
protein revealed that##8##3##(1990-3#1)(1991-12#1)(1993-2#1)(1994-12#1)(1997-1#1)(1997-6#1)(1997-7#1)(2008-10#1)
protein revealed##14##2##(1990-3#1)(1990-5#1)(1991-12#1)(1993-2#1)(1994-12#1)(1995-8#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-11#1)(2008-10#1)(2008-11#1)
protein reveals##2##2##(1990-7#1)(1994-12#1)
protein rich##3##2##(1997-3#1)(2006-12#1)(2008-11#1)
protein sample##2##2##(2008-1#1)(2008-4#1)
protein samples and##2##3##(2008-1#1)(2008-8#1)
protein samples##14##2##(1997-2#2)(2008-1#2)(2008-2#4)(2008-4#3)(2008-7#2)(2008-8#1)
protein science##4##2##(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)
protein secondary structure##7##3##(1990-12#1)(1991-11#1)(1991-4#1)(1994-9#1)(1996-2#1)(2008-10#1)(2009-5#1)
protein secondary##8##2##(1990-12#1)(1991-11#1)(1991-4#1)(1994-9#1)(1996-2#1)(2008-10#1)(2008-4#1)(2009-5#1)
protein secreted by##9##3##(1993-12#1)(1993-2#1)(1994-5#1)(1995-3#1)(1997-2#1)(1997-4#1)(2008-4#1)(2008-7#1)(2010-10#1)
protein secreted into the##2##4##(1990-3#1)(2006-11#1)
protein secreted##11##2##(1990-3#1)(1993-12#1)(1993-2#1)(1994-5#1)(1995-3#1)(1997-2#1)(1997-4#1)(2006-11#1)(2008-4#1)(2008-7#1)(2010-10#1)
protein secretion and##3##3##(1994-9#2)(2004-11#1)
protein secretion from##2##3##(1996-12#1)(1997-5#1)
protein secretion in##4##3##(1993-8#1)(1995-12#1)(1997-3#1)(1997-5#1)
protein secretion machinery##2##3##(1997-3#1)(2012-2#1)
protein secretion##32##2##(1992-9#1)(1993-8#1)(1994-8#1)(1994-9#3)(1995-12#1)(1996-10#1)(1996-12#1)(1996-4#2)(1996-5#1)(1997-3#2)(1997-4#1)(1997-5#6)(2004-11#3)(2008-11#2)(2008-7#2)(2009-8#1)(2012-2#2)(2013-1#1)
protein self-assembly##2##2##(1990-5#1)(2008-7#1)
protein separation##5##2##(1996-12#1)(1997-3#1)(2004-11#1)(2008-10#2)
protein separations##5##2##(1991-3#2)(1993-12#1)(1997-8#1)(2008-4#1)
protein sequence comparisons##3##3##(1995-1#1)(2008-9#2)
protein sequence data##4##3##(1994-6#1)(1995-2#1)(2008-4#2)
protein sequence database##3##3##(1990-9#1)(2008-4#1)(2008-9#1)
protein sequence databases##4##3##(1994-6#1)(2006-10#1)(2008-7#1)(2009-6#1)
protein sequence deduced from##2##4##(1992-1#1)(1995-8#1)
protein sequence from##2##3##(1994-8#1)(2008-4#1)
protein sequence had a##2##4##(1993-6#1)(2013-1#1)
protein sequence has##2##3##(1992-2#1)(1992-8#1)
protein sequence homology##2##3##(1997-3#1)(2011-2#1)
protein sequence information##2##3##(1990-2#1)(1991-9#1)
protein sequence is##3##3##(1992-5#1)(1996-12#1)(2008-4#1)
protein sequence of##3##3##(1991-4#1)(1992-12#1)(1993-4#1)
protein sequence space##2##3##(2007-6#1)(2008-7#1)
protein sequence with##3##3##(1990-6#1)(2007-6#1)(2008-10#1)
protein sequence##80##2##(1990-2#1)(1990-6#1)(1990-9#2)(1991-4#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#4)(1992-5#1)(1992-8#3)(1992-9#1)(1993-4#1)(1993-6#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-8#1)(1997-3#1)(1997-8#1)(2005-6#1)(2006-10#1)(2007-6#3)(2008-10#1)(2008-12#1)(2008-2#2)(2008-4#16)(2008-7#7)(2008-9#6)(2009-6#2)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
protein sequences are##3##3##(1994-8#1)(1996-10#1)(2009-3#1)
protein sequences by##3##3##(1994-6#1)(1995-8#1)(2008-4#1)
protein sequences for##3##3##(1991-9#1)(1996-4#1)(2009-5#1)
protein sequences from##2##3##(2008-7#1)(2013-8#1)
protein sequences of the##5##4##(1990-6#1)(1991-9#1)(1994-12#2)(1996-10#1)
protein sequences of##8##3##(1990-4#1)(1990-6#1)(1991-9#1)(1992-8#1)(1994-12#2)(1996-10#1)(2008-10#1)
protein sequences representing##2##3##(2013-1#2)
protein sequences that##2##3##(1995-2#1)(2008-4#1)
protein sequences using##2##3##(2008-4#1)(2008-9#1)
protein sequences were##2##3##(1992-2#1)(1997-8#1)
protein sequences##58##2##(1990-2#1)(1990-4#2)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#2)(1992-2#1)(1992-8#1)(1993-6#2)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#2)(1995-2#2)(1995-8#1)(1996-10#2)(1996-4#3)(1997-2#1)(1997-8#1)(2006-12#1)(2006-8#2)(2007-6#1)(2008-10#2)(2008-4#6)(2008-7#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
protein sequencing##10##2##(1990-11#1)(1991-6#2)(1993-3#1)(1993-4#1)(1993-9#1)(1994-3#1)(1995-6#1)(1996-8#1)(1997-2#1)
protein serine-threonine kinases##2##3##(1990-5#2)
protein serine/threonine kinase##2##3##(1991-11#2)
protein serine/threonine kinases##3##3##(1991-11#2)(1993-6#1)
protein serine/threonine phosphatases##2##3##(1994-11#1)(1995-8#1)
protein serine/threonine##9##2##(1991-11#4)(1993-6#1)(1994-11#1)(1995-8#2)(1997-6#1)
protein serum-free medium##2##3##(2008-11#2)
protein serving as##2##3##(1992-12#1)(1993-2#1)
protein share a##2##3##(1993-11#1)(1995-3#1)
protein share##4##2##(1993-11#1)(1995-3#1)(1995-8#1)(2008-10#1)
protein shared##4##2##(1994-12#1)(1994-2#1)(1995-6#1)(2008-10#1)
protein shares##5##2##(1990-3#1)(1990-6#1)(1996-7#1)(2008-10#1)(2009-5#1)
protein short motif search tool##2##5##(2012-2#2)
protein should not be##2##4##(1994-11#1)(2008-4#1)
protein should##4##2##(1991-4#1)(1992-12#1)(1994-11#1)(2008-4#1)
protein show a##2##3##(1994-9#1)(2011-12#1)
protein show##3##2##(1994-9#1)(1997-1#1)(2011-12#1)
protein showed a##5##3##(1991-3#1)(1993-11#1)(1996-9#1)(1997-4#1)(2010-1#1)
protein showed an##2##3##(1993-9#1)(1997-2#1)
protein showed high homology##2##4##(1990-5#1)(1993-8#1)
protein showed no##3##3##(1990-4#1)(1991-2#1)(1991-5#1)
protein showed that it##4##4##(1994-8#2)(1995-12#1)(1995-8#1)
protein showed that##6##3##(1994-8#3)(1995-12#1)(1995-5#1)(1995-8#1)
protein showed##28##2##(1990-4#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-5#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-8#3)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#2)(1996-3#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-7#1)(2008-10#1)(2008-9#1)(2009-10#1)(2010-1#1)(2010-12#1)
protein showing##3##2##(1992-12#1)(1994-12#2)
protein shows a##3##3##(1992-12#1)(1993-6#1)(2009-5#1)
protein shows that##2##3##(1991-2#1)(1992-3#1)
protein shows##16##2##(1991-2#1)(1991-5#1)(1991-7#1)(1992-12#2)(1992-3#1)(1992-7#1)(1993-6#2)(1994-3#2)(1996-10#1)(2006-5#1)(2007-12#1)(2008-8#1)(2009-5#1)
protein side chains##2##3##(1993-6#1)(1993-8#1)
protein signal##3##2##(1991-8#1)(1992-8#1)(1995-11#1)
protein signaling##3##2##(2007-12#1)(2008-4#1)(2012-1#1)
protein signalling##3##2##(2006-10#2)(2013-1#1)
protein significantly##6##2##(1994-8#1)(1994-9#1)(2008-12#1)(2008-9#1)(2010-12#1)(2012-12#1)
protein similar to##3##3##(1992-1#1)(1992-9#1)(2008-8#1)
protein sites##3##2##(1991-11#1)(2008-4#1)(2010-11#1)
protein size##2##2##(1993-6#1)(2008-10#1)
protein solders##4##2##(2008-3#4)
protein solubility##2##2##(1993-8#1)(2008-6#1)
protein solubilization##3##2##(1990-3#1)(2008-4#2)
protein solution##5##2##(2006-5#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)
protein solutions##13##2##(1991-5#1)(1997-1#1)(2006-10#2)(2008-10#1)(2008-3#1)(2008-4#3)(2009-3#1)(2009-5#1)(2011-2#2)
protein sorting in##2##3##(1993-6#1)(1997-6#1)
protein sorting##7##2##(1993-6#3)(1996-2#1)(1996-5#1)(1997-6#2)
protein source##5##2##(2006-12#1)(2006-5#1)(2011-2#1)(2012-2#1)(2013-7#1)
protein sources in##2##3##(2012-1#1)(2013-7#1)
protein sources##9##2##(1991-11#1)(2008-10#2)(2008-12#1)(2008-5#2)(2012-1#1)(2013-7#2)
protein space##3##2##(1997-8#1)(2008-7#2)
protein species of approximately##2##4##(2008-10#2)
protein species of##5##3##(1991-9#1)(1997-1#1)(1997-2#1)(2008-10#2)
protein species with##2##3##(1993-12#1)(1993-9#1)
protein species##15##2##(1991-9#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-8#1)(1997-1#1)(1997-2#1)(2008-10#3)(2008-4#1)(2008-7#2)(2013-8#1)
protein specifically##8##2##(1992-5#1)(1993-4#1)(1993-6#1)(1994-9#1)(1995-6#1)(1997-1#1)(1997-4#2)
protein splicing##7##2##(1993-12#3)(1995-8#2)(2007-8#1)(2011-3#1)
protein spots on the##2##4##(2007-8#1)(2011-3#1)
protein spots on##3##3##(1995-7#1)(2007-8#1)(2011-3#1)
protein spots were##4##3##(1996-8#1)(2008-10#1)(2010-12#1)(2010-4#1)
protein spots##12##2##(1995-7#1)(1996-8#1)(2007-8#2)(2008-10#3)(2010-12#2)(2010-4#1)(2011-3#1)(2013-1#1)
protein stability and##4##3##(1995-5#1)(2008-4#1)(2009-8#1)(2013-1#1)
protein stability in##3##3##(1991-4#1)(2010-2#2)
protein stability were##2##3##(1990-2#1)(1995-8#1)
protein stability##29##2##(1990-2#1)(1991-4#2)(1991-7#1)(1992-5#1)(1993-11#1)(1993-3#2)(1994-5#1)(1994-8#1)(1995-5#1)(1995-8#2)(2006-12#1)(2007-11#1)(2008-10#1)(2008-4#5)(2008-8#2)(2009-3#1)(2009-8#1)(2010-2#2)(2011-1#1)(2013-1#1)
protein stabilization##4##2##(1991-5#1)(1997-2#1)(2008-8#1)(2012-12#1)
protein stabilizers##2##2##(2008-5#2)
protein staining and##2##3##(1990-10#2)
protein staining##5##2##(1990-10#2)(1992-6#1)(1996-3#1)(2008-4#1)
protein starts##2##2##(1991-9#1)(1994-11#1)
protein stimulates##3##2##(1991-2#1)(1994-5#1)(2012-1#1)
protein storage##3##2##(2008-4#2)(2009-10#1)
protein stores##2##2##(2009-10#1)(2013-1#1)
protein streptavidin##2##2##(1995-11#1)(2008-4#1)
protein strongly##2##2##(1992-8#1)(2012-2#1)
protein structural##8##2##(1990-8#1)(1995-10#1)(1997-4#1)(2008-10#1)(2008-4#2)(2009-5#2)
protein structure and dynamics##4##4##(2008-4#2)(2011-1#1)(2012-3#1)
protein structure and function##5##4##(1997-7#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-3#1)
protein structure and##13##3##(1991-10#1)(1997-7#1)(2008-4#3)(2008-7#2)(2010-12#1)(2010-7#1)(2011-1#2)(2012-3#2)
protein structure determination##3##3##(1991-11#1)(2012-1#2)
protein structure is##6##3##(1994-12#1)(1994-8#1)(1995-11#1)(2008-10#1)(2008-4#1)(2008-7#1)
protein structure modeling##2##3##(2008-4#1)(2013-8#1)
protein structure of##4##3##(1994-9#1)(1997-7#1)(2005-10#1)(2009-8#1)
protein structure prediction##2##3##(2008-7#1)(2013-1#1)
protein structure##74##2##(1990-2#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-7#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#2)(1995-8#2)(1996-3#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-6#3)(1997-7#2)(2005-10#1)(2006-4#1)(2008-10#2)(2008-4#10)(2008-7#6)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-7#1)(2011-1#2)(2012-1#2)(2012-2#4)(2012-3#3)(2013-1#1)(2013-8#3)
protein structure-function##2##2##(1996-11#1)(2007-8#1)
protein structures and##2##3##(2008-7#1)(2013-1#1)
protein structures by##5##3##(1994-8#2)(1997-1#1)(2008-4#1)(2011-2#1)
protein structures in the##3##4##(1996-8#1)(2009-5#1)(2013-1#1)
protein structures is##2##3##(2007-6#1)(2008-4#1)
protein structures with##3##3##(1994-2#1)(1996-10#1)(2013-1#1)
protein structures##37##2##(1990-11#1)(1991-10#1)(1992-12#1)(1992-4#1)(1992-8#1)(1994-2#1)(1994-8#2)(1996-10#1)(1996-8#1)(1997-1#1)(2006-10#2)(2006-4#3)(2007-6#1)(2008-10#1)(2008-2#1)(2008-4#4)(2008-7#3)(2009-2#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#4)
protein studies##4##2##(1992-7#1)(1993-6#1)(2005-11#2)
protein study##2##2##(1991-11#1)(1997-6#1)
protein substrate##11##2##(1990-12#1)(1992-11#2)(1994-9#1)(1995-2#3)(2006-10#1)(2008-4#1)(2010-9#1)(2011-2#1)
protein substrates was##2##3##(1992-6#1)(1994-12#1)
protein substrates##9##2##(1990-5#1)(1992-6#2)(1992-8#1)(1994-12#1)(1994-3#1)(1995-3#1)(2008-4#1)(2011-2#1)
protein subunit of##2##3##(1993-8#1)(2005-11#1)
protein subunit##7##2##(1990-5#1)(1991-11#1)(1993-8#2)(1994-11#1)(1996-10#1)(2005-11#1)
protein subunits of the##2##4##(1990-5#1)(2007-11#1)
protein subunits of##3##3##(1990-5#1)(1994-9#1)(2007-11#1)
protein subunits##10##2##(1990-5#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-7#1)(2007-11#1)(2008-1#1)(2009-9#1)
protein such as##5##3##(1993-11#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#1)
protein suggests that it##2##4##(1991-12#1)(1993-6#1)
protein suggests that the##3##4##(1993-11#1)(1997-4#1)(2008-10#1)
protein suggests that this##2##4##(1994-12#1)(1995-3#1)
protein suggests that##7##3##(1991-12#1)(1993-11#1)(1993-6#1)(1994-12#1)(1995-3#1)(1997-4#1)(2008-10#1)
protein sumoylation##2##2##(2008-4#2)
protein superfamily##3##2##(1992-5#1)(1997-6#1)(2008-9#1)
protein supplement##2##2##(2008-11#1)(2008-6#1)
protein supplementation##5##2##(2013-1#5)
protein surface##14##2##(1990-5#1)(1991-4#1)(1991-7#1)(1993-3#1)(1995-2#1)(1997-4#1)(1997-7#1)(2006-10#1)(2008-4#2)(2008-7#2)(2008-8#1)(2011-1#1)
protein surfaces##4##2##(1990-10#1)(2007-8#1)(2012-1#1)(2012-5#1)
protein switches##2##2##(1990-8#1)(1994-3#1)
protein symbol##2##2##(2008-7#2)
protein synthesis and cell growth##2##5##(1990-10#1)(1996-2#1)
protein synthesis and degradation##3##4##(1991-6#3)
protein synthesis and##21##3##(1990-10#1)(1990-7#2)(1991-12#1)(1991-6#3)(1993-12#1)(1993-9#1)(1994-12#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-6#1)(1997-4#1)(2006-12#1)(2006-8#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-12#1)
protein synthesis are##4##3##(1995-6#2)(2009-3#2)
protein synthesis as well as##3##5##(1993-4#1)(2008-5#2)
protein synthesis at##2##3##(1991-2#1)(2008-10#1)
protein synthesis but##2##3##(1993-6#1)(1994-2#1)
protein synthesis by a##2##4##(1990-11#1)(2007-2#1)
protein synthesis by##9##3##(1990-11#1)(1991-10#1)(1992-11#1)(1992-12#1)(1992-8#1)(1994-6#1)(1995-8#1)(2007-2#1)(2013-8#1)
protein synthesis during##2##3##(1993-12#1)(1995-6#1)
protein synthesis following##2##3##(1994-11#1)(1996-11#1)
protein synthesis from the##2##4##(1994-2#1)(2007-11#1)
protein synthesis in L6 myotubes##3##5##(2008-11#3)
protein synthesis in RLC-16##2##4##(2008-11#2)
protein synthesis in a##3##4##(1993-3#1)(1995-11#1)(1995-12#1)
protein synthesis in both##2##4##(1994-6#1)(1995-11#1)
protein synthesis in the##6##4##(1994-2#1)(1994-5#1)(1996-11#1)(1996-4#1)(2008-12#1)(2008-9#1)
protein synthesis in##31##3##(1991-2#1)(1991-6#3)(1991-9#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#1)(1996-11#2)(1996-4#1)(1997-8#1)(2004-11#2)(2008-11#6)(2008-12#1)(2008-9#1)(2010-12#1)(2011-3#1)
protein synthesis inhibition##2##3##(1997-2#1)(2013-7#1)
protein synthesis inhibitor cycloheximide##2##4##(1995-3#1)(2013-7#1)
protein synthesis inhibitor##10##3##(1993-3#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-3#1)(1996-9#1)(1997-7#1)(2006-5#1)(2008-9#1)(2013-7#1)
protein synthesis inhibitor)##2##3##(1994-5#2)
protein synthesis inhibitors##8##3##(1991-2#1)(1991-5#3)(1992-5#1)(1994-9#1)(1997-2#1)(2005-7#1)
protein synthesis initiation factors##2##4##(1990-5#2)
protein synthesis is##5##3##(1992-2#1)(1993-6#1)(1995-3#1)(2004-11#1)(2008-5#1)
protein synthesis may##5##3##(1990-12#1)(1994-2#1)(1996-11#2)(1997-1#1)
protein synthesis or##5##3##(1994-2#1)(1995-6#1)(1996-4#1)(2006-12#1)(2008-7#1)
protein synthesis to##3##3##(1994-8#1)(1997-4#2)
protein synthesis was inhibited##3##4##(1990-10#1)(1993-12#1)(1994-11#1)
protein synthesis was##5##3##(1990-10#1)(1992-11#1)(1993-12#1)(1994-11#1)(2008-7#1)
protein synthesis were##3##3##(1991-9#1)(2008-11#2)
protein synthesis within##2##3##(1997-8#1)(2012-2#1)
protein synthesis##257##2##(1990-10#3)(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#4)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#3)(1991-2#5)(1991-5#3)(1991-6#8)(1991-9#2)(1992-11#2)(1992-12#4)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#5)(1993-3#2)(1993-4#2)(1993-6#3)(1993-9#5)(1994-11#5)(1994-12#5)(1994-2#5)(1994-3#1)(1994-5#6)(1994-6#4)(1994-8#5)(1994-9#2)(1995-10#1)(1995-11#6)(1995-12#5)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#7)(1995-8#1)(1996-11#5)(1996-12#1)(1996-2#2)(1996-4#4)(1996-5#2)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#6)(1997-4#4)(1997-7#1)(1997-8#3)(2004-11#3)(2005-10#1)(2005-7#1)(2006-10#2)(2006-11#2)(2006-12#7)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#21)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#9)(2008-7#5)(2008-8#1)(2008-9#4)(2009-3#3)(2009-4#2)(2009-5#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-8#4)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#3)(2013-1#1)(2013-7#2)(2013-8#2)
protein synthesized in vitro##2##4##(1994-8#1)(1997-5#1)
protein synthesized in##3##3##(1993-12#1)(1994-8#1)(1997-5#1)
protein synthesized##5##2##(1993-12#1)(1994-12#1)(1994-8#1)(1997-5#1)(2008-9#1)
protein system##4##2##(1994-11#1)(1994-12#1)(1997-8#1)(2008-4#1)
protein systems##4##2##(1992-4#1)(1992-5#1)(1993-11#1)(2006-10#1)
protein tags##3##2##(2008-11#1)(2008-7#2)
protein target##5##2##(1996-4#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-5#1)
protein targeted##3##2##(1991-12#1)(1994-6#1)(1997-4#1)
protein targets##5##2##(1995-11#1)(2007-12#1)(2008-1#1)(2008-7#1)(2009-12#1)
protein termed##9##2##(1990-12#1)(1990-4#1)(1990-7#1)(1992-3#1)(1992-6#2)(2007-2#1)(2008-10#1)(2009-8#1)
protein tertiary structure##2##3##(2010-7#2)
protein testing##2##2##(1995-6#1)(2011-2#1)
protein than##6##2##(1990-12#1)(1994-9#1)(1995-1#1)(1997-2#1)(1997-5#1)(2008-9#1)
protein that acts as a##2##5##(1991-12#2)
protein that are##4##3##(1993-12#1)(1993-3#1)(1997-4#1)(2008-10#1)
protein that belongs to the##2##5##(1995-1#1)(1995-2#1)
protein that binds to##4##4##(1991-10#1)(1994-5#1)(1996-7#1)(1996-8#1)
protein that binds##7##3##(1990-6#1)(1991-10#1)(1991-11#1)(1994-5#1)(1995-2#1)(1996-7#1)(1996-8#1)
protein that can be##2##4##(1992-7#1)(1994-8#1)
protein that can##6##3##(1991-5#1)(1992-7#1)(1994-8#1)(1996-5#1)(2008-9#1)(2012-2#1)
protein that contains##6##3##(1991-7#1)(1992-8#1)(1995-8#1)(1996-7#1)(1997-4#1)(2008-4#1)
protein that controls##2##3##(2007-12#1)(2012-12#1)
protein that exists##2##3##(1990-5#1)(1992-11#1)
protein that had##2##3##(1991-10#1)(2008-10#1)
protein that has##5##3##(1990-11#1)(1992-4#1)(2008-4#1)(2010-2#1)(2011-2#1)
protein that inhibits##4##3##(1990-7#1)(1991-4#1)(1994-8#1)(1995-8#1)
protein that interacts with the##3##5##(1990-6#1)(1996-5#1)(1997-1#1)
protein that interacts with##4##4##(1990-6#2)(1996-5#1)(1997-1#1)
protein that interacts##5##3##(1990-6#2)(1996-5#1)(1996-8#1)(1997-1#1)
protein that is encoded by T4 gene##2##7##(1992-5#2)
protein that is essential for##3##5##(1994-11#1)(1995-2#1)(1996-8#1)
protein that is expressed##4##4##(1990-11#1)(2008-1#1)(2008-11#1)(2008-4#1)
protein that is highly##4##4##(1991-7#1)(1992-12#1)(1997-1#1)(2011-2#1)
protein that is induced by##2##5##(1990-11#1)(2010-3#1)
protein that is involved in the##3##6##(1990-6#1)(1991-11#1)(2009-10#1)
protein that is involved in##4##5##(1990-6#1)(1991-11#1)(1995-6#1)(2009-10#1)
protein that is required for##3##5##(1995-12#1)(2009-10#2)
protein that is##46##3##(1990-11#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-4#1)(1991-7#2)(1992-12#1)(1992-3#1)(1992-5#3)(1994-11#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-6#3)(1996-5#1)(1996-8#1)(1997-1#1)(1997-4#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2009-10#3)(2009-3#1)(2009-5#1)(2010-11#1)(2010-3#1)(2011-2#1)
protein that may be##2##4##(1991-12#1)(2006-12#1)
protein that may##4##3##(1990-5#1)(1990-9#1)(1991-12#1)(2006-12#1)
protein that mediates the##3##4##(1994-12#1)(2009-8#1)(2012-2#1)
protein that mediates##4##3##(1993-12#1)(1994-12#1)(2009-8#1)(2012-2#1)
protein that modulates##2##3##(1991-10#1)(1995-8#1)
protein that regulates the##2##4##(1992-3#1)(2009-8#1)
protein that regulates##5##3##(1992-3#1)(1996-4#1)(1996-7#1)(2008-1#1)(2009-8#1)
protein that serves as##2##4##(1991-5#1)(2008-7#1)
protein that shares##2##3##(1994-3#1)(1994-9#1)
protein that was observed##2##4##(1990-9#1)(1993-8#1)
protein that was##11##3##(1990-12#1)(1990-6#1)(1990-9#1)(1993-12#1)(1993-8#1)(1995-6#1)(1995-8#1)(1996-8#2)(2007-7#1)(2009-12#1)
protein that we##2##3##(1992-3#1)(1992-8#1)
protein that##173##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-4#1)(1990-5#4)(1990-6#5)(1990-7#2)(1990-8#1)(1990-9#3)(1991-10#3)(1991-11#3)(1991-12#5)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-7#5)(1992-11#1)(1992-12#1)(1992-3#3)(1992-4#1)(1992-5#3)(1992-7#1)(1992-8#2)(1993-12#5)(1993-3#2)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#4)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#5)(1995-8#5)(1996-3#1)(1996-4#1)(1996-5#5)(1996-7#3)(1996-8#5)(1997-1#2)(1997-2#2)(1997-4#4)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-12#2)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-4#5)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#3)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#4)(2010-11#1)(2010-2#1)(2010-3#1)(2011-2#4)(2012-12#2)(2012-2#3)
protein the##2##2##(1994-3#1)(1995-10#1)
protein then##2##2##(1995-8#2)
protein therapeutics##4##2##(2008-10#3)(2012-3#1)
protein thermodynamics##2##2##(2006-10#1)(2009-9#1)
protein thermostability##2##2##(1990-9#1)(2008-4#1)
protein thermostabilization##3##2##(1997-5#3)
protein thiols##8##2##(1990-6#1)(1992-11#3)(1997-8#2)(2008-3#1)(2009-10#1)
protein through##8##2##(1992-8#1)(1994-2#1)(1995-1#1)(1996-5#1)(1997-2#1)(2005-12#1)(2010-12#1)(2013-1#1)
protein throughout##2##2##(1993-12#1)(2008-5#1)
protein to DNA##5##3##(1990-11#1)(1991-11#1)(1991-7#1)(1994-12#2)
protein to a##4##3##(1990-8#1)(1994-3#1)(1994-9#1)(1996-5#1)
protein to achieve##2##3##(1994-8#1)(2008-5#1)
protein to be##5##3##(1990-2#1)(1991-5#1)(1993-12#1)(2008-10#1)(2008-11#1)
protein to bind##2##3##(1990-5#1)(1993-3#1)
protein to form##4##3##(1990-10#1)(1996-2#1)(2008-10#1)(2008-4#1)
protein to homogeneity##3##3##(1991-7#1)(1994-12#1)(1997-4#1)
protein to its##4##3##(1992-9#1)(1993-6#1)(1995-2#1)(1995-4#1)
protein to maintain##2##3##(1994-2#1)(2012-12#1)
protein to the cell##2##4##(1996-8#1)(2006-12#1)
protein to the##24##3##(1990-11#1)(1990-5#2)(1991-11#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-8#1)(1997-6#1)(2006-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-5#1)(2013-1#1)
protein to##105##2##(1990-10#1)(1990-11#2)(1990-2#1)(1990-5#3)(1990-8#1)(1991-11#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#3)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#4)(1993-9#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#1)(1995-2#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
protein topology##3##2##(1995-4#1)(1996-5#1)(2013-8#1)
protein toxin##5##2##(2008-10#3)(2010-12#2)
protein toxins##5##2##(1994-5#1)(2010-12#1)(2011-1#1)(2012-11#2)
protein trafficking and##3##3##(1991-1#1)(2008-9#1)(2012-12#1)
protein trafficking##7##2##(1991-1#1)(1991-11#1)(2008-1#1)(2008-9#1)(2009-7#1)(2012-12#1)(2012-2#1)
protein transcription##5##2##(1990-2#1)(1993-7#1)(1995-6#1)(2007-9#1)(2008-10#1)
protein transfer##2##2##(1991-5#1)(1993-11#1)
protein transferase##2##2##(1991-7#1)(2005-8#1)
protein transferrin##2##2##(1996-8#1)(2008-5#1)
protein transiently##2##2##(1991-2#1)(1995-3#1)
protein translation##8##2##(2006-5#1)(2007-2#2)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#2)
protein translocation defects##2##3##(1995-6#2)
protein translocation into the ER##2##5##(1991-2#1)(1997-6#1)
protein translocation into##3##3##(1991-2#1)(1997-6#1)(1997-8#1)
protein translocation machinery##2##3##(1993-9#1)(1997-2#1)
protein translocation##13##2##(1991-2#1)(1991-5#1)(1993-8#2)(1993-9#1)(1994-3#1)(1995-6#2)(1997-2#1)(1997-6#1)(1997-8#2)(2006-10#1)
protein transport##6##2##(1990-6#1)(1992-12#1)(1992-7#1)(1995-3#1)(2008-1#2)
protein truncation test##3##3##(2004-2#1)(2008-4#2)
protein turnover in the##2##4##(1992-11#1)(2013-1#1)
protein turnover in##5##3##(1992-11#1)(1994-10#1)(2013-1#3)
protein turnover##19##2##(1990-2#1)(1991-6#1)(1992-11#2)(1992-12#2)(1994-10#1)(1995-6#1)(2004-11#2)(2008-11#1)(2008-3#2)(2009-4#1)(2013-1#5)
protein type##2##2##(1992-12#1)(1995-8#1)
protein types##3##2##(1995-1#1)(2009-12#1)(2013-1#1)
protein tyrosine kinase (PTK)##5##4##(1994-6#1)(1994-8#1)(1994-9#1)(1997-6#1)(2008-8#1)
protein tyrosine kinase inhibitors##2##4##(1993-3#1)(1994-3#1)
protein tyrosine kinase is##2##4##(1991-7#1)(1997-6#1)
protein tyrosine kinase of##2##4##(1992-3#1)(1996-6#1)
protein tyrosine kinase that is##2##5##(1997-6#1)(1997-7#1)
protein tyrosine kinase that##3##4##(1997-6#1)(1997-7#1)(2008-7#1)
protein tyrosine kinase##38##3##(1990-3#1)(1991-7#1)(1992-11#3)(1992-3#2)(1993-3#1)(1993-8#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#5)(1994-9#5)(1995-11#1)(1995-3#3)(1995-8#1)(1996-6#1)(1997-6#4)(1997-7#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-12#1)
protein tyrosine kinases (PTKs) in##2##5##(1992-9#1)(1995-11#1)
protein tyrosine kinases (PTKs)##4##4##(1992-9#1)(1993-3#1)(1995-11#1)(1997-7#1)
protein tyrosine kinases and##2##4##(1991-7#1)(1996-2#1)
protein tyrosine kinases of##2##4##(1990-7#1)(1991-7#1)
protein tyrosine kinases##20##3##(1990-7#1)(1991-7#2)(1992-11#2)(1992-3#1)(1992-9#1)(1993-3#2)(1994-12#1)(1994-3#2)(1995-11#2)(1995-3#1)(1996-2#2)(1997-7#1)(2005-7#1)(2012-2#1)
protein tyrosine phosphatase (PTP)##2##4##(1994-6#1)(1994-9#1)
protein tyrosine phosphatase (PTPase) activity##2##5##(1993-3#1)(1994-5#1)
protein tyrosine phosphatase (PTPase)##5##4##(1992-10#1)(1992-6#1)(1993-3#1)(1994-5#1)(2008-8#1)
protein tyrosine phosphatase activity##2##4##(1992-12#1)(1993-3#1)
protein tyrosine phosphatase from##2##4##(1992-6#1)(1997-7#1)
protein tyrosine phosphatase with##2##4##(1994-8#1)(1994-9#1)
protein tyrosine phosphatase##21##3##(1991-10#2)(1992-10#1)(1992-12#1)(1992-6#2)(1993-11#1)(1993-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-9#1)(1997-7#1)(2008-2#1)(2008-8#1)(2009-6#1)(2009-7#1)
protein tyrosine phosphatases##10##3##(1994-10#2)(1994-5#1)(1996-5#1)(1997-6#4)(2008-2#1)(2008-4#1)
protein tyrosine phosphorylation and phospholipase A2##2##6##(1994-6#2)
protein tyrosine phosphorylation and##5##4##(1992-11#1)(1994-6#2)(1996-5#1)(1997-2#1)
protein tyrosine phosphorylation in##2##4##(1994-6#1)(2012-3#1)
protein tyrosine phosphorylation of##2##4##(1994-12#1)(2012-3#1)
protein tyrosine phosphorylation##18##3##(1992-11#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-12#2)(1994-6#3)(1994-8#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-3#1)(2012-3#3)
protein tyrosine##108##2##(1990-3#1)(1990-7#1)(1991-10#2)(1991-7#3)(1992-10#1)(1992-11#6)(1992-12#1)(1992-3#3)(1992-6#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-3#6)(1993-8#2)(1994-10#2)(1994-12#3)(1994-3#3)(1994-5#3)(1994-6#5)(1994-8#8)(1994-9#7)(1995-11#3)(1995-3#4)(1995-8#1)(1995-9#1)(1996-2#2)(1996-5#3)(1996-6#2)(1997-2#1)(1997-3#1)(1997-6#8)(1997-7#3)(2005-7#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-6#1)(2009-7#1)(2009-8#1)(2012-12#1)(2012-2#1)(2012-3#3)
protein tyrosyl##3##2##(1992-12#2)(1993-3#1)
protein ubiquitination##3##2##(1990-2#1)(2008-4#1)(2011-1#1)
protein under the control of##2##5##(1991-12#1)(2008-11#1)
protein under the##3##3##(1991-12#1)(1992-12#1)(2008-11#1)
protein under##4##2##(1991-12#1)(1992-12#1)(1996-12#1)(2008-11#1)
protein undergoes##4##2##(1991-5#1)(1994-11#1)(1994-8#1)(1995-1#1)
protein underwent##2##2##(1991-7#1)(2008-9#1)
protein unfolding##5##2##(1995-1#1)(1995-3#1)(1995-4#1)(1997-2#1)(1997-7#1)
protein upon##4##2##(1992-9#1)(1997-7#1)(2006-10#1)(2010-4#1)
protein used##4##2##(1991-7#1)(1996-8#1)(1997-4#1)(2006-12#1)
protein using a##3##3##(1996-8#1)(2006-5#1)(2008-7#1)
protein using the##2##3##(1991-10#1)(2008-4#1)
protein using##19##2##(1991-10#1)(1991-7#1)(1991-8#1)(1992-4#1)(1993-12#1)(1994-11#1)(1994-12#1)(1996-8#1)(1997-4#1)(2006-12#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2010-6#1)(2013-1#1)
protein vaccine antigens##2##3##(2008-7#2)
protein vaccine##6##2##(1991-5#2)(2007-2#1)(2008-4#1)(2008-7#2)
protein value##2##2##(2006-5#1)(2008-5#1)
protein variants##4##2##(1997-2#1)(2008-8#1)(2011-1#1)(2012-12#1)
protein varied##2##2##(2008-10#1)(2008-9#1)
protein versus##2##2##(1991-2#1)(1997-4#1)
protein via##3##2##(1995-1#1)(2006-6#1)(2008-10#1)
protein was a##3##3##(1990-10#1)(1992-12#1)(1995-3#1)
protein was also found##2##4##(1993-6#1)(1995-8#1)
protein was also increased##2##4##(1993-12#1)(1996-11#1)
protein was also obtained##2##4##(1990-9#1)(1996-9#1)
protein was also##15##3##(1990-9#1)(1991-11#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-5#1)(1995-10#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-7#1)
protein was analyzed##4##3##(1992-8#1)(1997-4#1)(2011-1#1)(2013-8#1)
protein was approximately##3##3##(1991-6#1)(1995-2#1)(2008-8#1)
protein was blocked##2##3##(1990-11#1)(1994-8#1)
protein was characterized##2##3##(1994-12#1)(1994-9#1)
protein was cloned##2##3##(1993-11#1)(1995-2#1)
protein was confirmed##2##3##(1991-8#1)(1992-9#1)
protein was constructed##2##3##(1992-4#1)(1994-11#1)
protein was decreased##2##3##(1996-8#1)(2013-8#1)
protein was deduced##4##3##(1991-9#1)(1992-7#1)(1993-9#1)(2009-2#1)
protein was detectable##4##3##(1992-11#1)(2005-11#1)(2007-11#1)(2008-5#1)
protein was detected in##7##4##(1991-9#1)(1992-1#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-4#1)
protein was detected on##2##4##(1991-2#1)(1994-11#1)
protein was detected##13##3##(1990-4#1)(1991-2#1)(1991-9#1)(1992-1#2)(1994-11#2)(2006-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-4#1)
protein was determined##4##3##(1990-12#1)(1991-6#1)(1994-3#1)(1995-10#1)
protein was digested##2##3##(1993-9#1)(1996-12#1)
protein was diminished##2##3##(1993-5#1)(1995-8#1)
protein was enriched##2##3##(1991-2#1)(1995-6#1)
protein was enzymatically##2##3##(1990-11#1)(1994-8#1)
protein was evaluated##3##3##(1995-2#1)(1997-2#1)(2010-1#1)
protein was examined in the##3##5##(1990-2#1)(1996-4#1)(2008-8#1)
protein was expressed in E##2##5##(1994-12#1)(2008-9#1)
protein was expressed in##7##4##(1990-11#1)(1991-4#1)(1992-11#1)(1993-11#1)(1994-12#1)(2008-9#2)
protein was expressed##11##3##(1990-11#1)(1991-4#1)(1992-11#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-3#1)(2008-5#1)(2008-8#1)(2008-9#2)
protein was extracted from##2##4##(1991-2#1)(2013-8#1)
protein was extracted##4##3##(1991-2#1)(2008-10#1)(2008-8#1)(2013-8#1)
protein was found in the##3##5##(1994-12#1)(1994-6#1)(1997-7#1)
protein was found in##5##4##(1994-12#1)(1994-6#1)(1997-7#1)(2008-5#1)(2012-2#1)
protein was found to be##7##5##(1990-12#1)(1991-10#1)(1992-7#1)(1993-12#1)(1994-12#1)(1994-9#1)(2009-9#1)
protein was found to contain##2##5##(1994-5#1)(1997-1#1)
protein was found to##14##4##(1990-12#1)(1990-9#1)(1991-10#1)(1991-7#1)(1992-7#2)(1993-12#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-8#1)(1997-1#1)(2009-9#1)
protein was found##19##3##(1990-12#1)(1990-9#1)(1991-10#1)(1991-7#1)(1992-7#2)(1993-12#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-8#1)(1997-1#1)(1997-7#1)(2008-5#1)(2009-9#1)(2012-2#1)
protein was highly expressed##2##4##(1994-8#1)(2005-11#1)
protein was highly##4##3##(1994-8#1)(1997-4#1)(2005-11#1)(2008-8#1)
protein was identical with##2##4##(1990-7#1)(1997-7#1)
protein was identical##3##3##(1990-7#1)(1997-2#1)(1997-7#1)
protein was identified as the##3##5##(1997-3#1)(2006-10#1)(2008-10#1)
protein was identified as##9##4##(1990-10#1)(1993-3#1)(1994-10#1)(1994-12#1)(1994-6#1)(1996-5#1)(1997-3#1)(2006-10#1)(2008-10#1)
protein was identified by##5##4##(1992-6#1)(1994-8#1)(1996-11#1)(2005-11#1)(2008-8#1)
protein was identified in##3##4##(1990-11#1)(1990-8#1)(1995-12#1)
protein was identified that##2##4##(1990-11#1)(2008-10#1)
protein was identified##20##3##(1990-10#1)(1990-11#2)(1990-8#1)(1992-6#1)(1993-3#1)(1994-10#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#1)(1996-11#1)(1996-5#1)(1997-3#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-8#1)(2011-2#1)
protein was increased by##2##4##(1992-5#1)(2008-11#1)
protein was increased##4##3##(1991-6#1)(1992-5#1)(1993-12#1)(2008-11#1)
protein was inhibited by##2##4##(1991-3#1)(1993-3#1)
protein was investigated in##2##4##(1997-7#1)(2008-11#1)
protein was investigated##5##3##(1991-2#1)(1991-5#1)(1996-7#1)(1997-7#1)(2008-11#1)
protein was isolated from##2##4##(1990-2#1)(1992-5#1)
protein was isolated##4##3##(1990-2#1)(1991-1#1)(1992-5#1)(1997-2#1)
protein was localized in##3##4##(1992-3#1)(1997-6#1)(2009-10#1)
protein was localized to##2##4##(1990-6#1)(2006-10#1)
protein was localized##6##3##(1990-6#1)(1991-10#1)(1992-3#1)(1997-6#1)(2006-10#1)(2009-10#1)
protein was located in##2##4##(1990-5#1)(2008-9#1)
protein was located##3##3##(1990-3#1)(1990-5#1)(2008-9#1)
protein was measured by##2##4##(2008-11#1)(2011-2#1)
protein was measured in##2##4##(1992-6#1)(1993-1#1)
protein was measured##8##3##(1992-6#1)(1993-1#1)(1994-8#1)(1995-3#1)(2008-11#3)(2011-2#1)
protein was more than##2##4##(1990-12#1)(1996-5#1)
protein was more##4##3##(1990-12#1)(1990-5#1)(1996-5#1)(2010-12#1)
protein was much##2##3##(1994-3#1)(2008-10#1)
protein was named##2##3##(2007-8#1)(2011-2#1)
protein was not##14##3##(1990-2#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-3#2)(1994-12#1)(1994-8#1)(1994-9#1)(1997-6#1)(2008-11#2)(2008-8#1)(2009-10#1)
protein was observed in##3##4##(1991-5#1)(1995-6#1)(2008-10#1)
protein was observed with##3##4##(1994-3#1)(1995-3#1)(1995-8#1)
protein was observed##11##3##(1991-5#1)(1993-3#1)(1993-4#1)(1994-3#1)(1995-3#1)(1995-6#1)(1995-8#1)(2006-10#1)(2008-10#2)(2008-11#1)
protein was obtained##8##3##(1992-11#1)(1992-6#1)(1994-3#2)(1995-1#2)(2008-9#1)(2011-1#1)
protein was of##2##3##(1996-1#1)(2007-7#1)
protein was predominantly##2##3##(1992-7#1)(2011-2#1)
protein was present in##4##4##(1992-12#1)(1997-4#1)(1997-5#1)(1997-6#1)
protein was present##5##3##(1992-12#1)(1993-6#1)(1997-4#1)(1997-5#1)(1997-6#1)
protein was produced in##2##4##(1993-12#1)(2008-11#1)
protein was produced##6##3##(1993-12#1)(1994-8#1)(1995-2#1)(2008-11#3)
protein was purified and##3##4##(1992-7#1)(1997-7#1)(2008-10#1)
protein was purified by##3##4##(1993-9#1)(1996-11#1)(2011-2#1)
protein was purified from##4##4##(1990-5#1)(1993-11#1)(1997-4#2)
protein was purified to homogeneity by##3##6##(1990-8#1)(1993-12#1)(2009-3#1)
protein was purified to homogeneity##5##5##(1990-8#1)(1992-12#1)(1993-12#1)(1995-12#1)(2009-3#1)
protein was purified to##8##4##(1990-8#1)(1992-12#2)(1993-12#1)(1994-5#1)(1994-8#1)(1995-12#1)(2009-3#1)
protein was purified##22##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#1)(1992-12#2)(1992-7#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-11#1)(1997-4#2)(1997-7#1)(2008-10#1)(2008-11#1)(2009-3#1)(2011-2#1)
protein was quantified by##2##4##(1995-1#1)(2013-1#1)
protein was recognized by##2##4##(1990-5#1)(1996-4#1)
protein was refolded and##2##4##(1992-5#1)(1995-3#1)
protein was reported##2##3##(1996-12#1)(2011-2#1)
protein was resistant to##2##4##(1990-11#1)(1994-12#1)
protein was secreted into the medium##2##6##(1990-3#1)(1991-9#1)
protein was secreted into the##3##5##(1990-3#1)(1991-9#1)(1997-4#1)
protein was secreted##4##3##(1990-3#1)(1991-9#1)(1993-3#1)(1997-4#1)
protein was separated##2##3##(1996-5#1)(2008-8#1)
protein was shown to##4##4##(1991-1#1)(1991-5#1)(1994-9#1)(1997-6#1)
protein was shown##5##3##(1991-1#1)(1991-5#1)(1993-8#1)(1994-9#1)(1997-6#1)
protein was significantly##3##3##(1990-9#1)(2008-8#1)(2011-2#1)
protein was specifically##3##3##(1991-9#1)(1992-12#1)(1994-8#1)
protein was studied##2##3##(2007-12#1)(2007-8#1)
protein was subjected to##2##4##(1994-5#1)(2008-10#1)
protein was synthesized##2##3##(1990-5#2)
protein was targeted to the##2##5##(2008-5#1)(2011-2#1)
protein was the most##3##4##(1993-2#1)(2008-10#1)(2013-7#1)
protein was the only##2##4##(1994-2#1)(1994-8#1)
protein was the##5##3##(1993-2#1)(1994-2#1)(1994-8#1)(2008-10#1)(2013-7#1)
protein was unable to##2##4##(1994-8#1)(2008-10#1)
protein was upregulated in##2##4##(2010-12#2)
protein was upregulated##3##3##(1994-8#1)(2010-12#2)
protein was used as##2##4##(1995-1#1)(2010-10#1)
protein was used to##4##4##(1990-11#2)(1992-9#1)(1997-6#1)
protein was used##7##3##(1990-11#2)(1992-9#1)(1995-1#1)(1997-6#1)(2010-10#1)(2013-7#1)
protein was##442##2##(1990-10#3)(1990-11#10)(1990-12#5)(1990-2#4)(1990-3#4)(1990-4#2)(1990-5#9)(1990-6#3)(1990-7#2)(1990-8#2)(1990-9#3)(1991-1#8)(1991-10#3)(1991-11#1)(1991-12#1)(1991-2#7)(1991-3#4)(1991-4#1)(1991-5#3)(1991-6#3)(1991-7#3)(1991-8#1)(1991-9#7)(1992-1#3)(1992-11#6)(1992-12#12)(1992-3#4)(1992-4#1)(1992-5#4)(1992-6#7)(1992-7#8)(1992-8#2)(1992-9#2)(1993-1#2)(1993-11#6)(1993-12#6)(1993-2#2)(1993-3#9)(1993-4#1)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#4)(1994-10#1)(1994-11#5)(1994-12#9)(1994-2#3)(1994-3#7)(1994-5#4)(1994-6#2)(1994-8#13)(1994-9#5)(1995-1#4)(1995-10#3)(1995-11#3)(1995-12#4)(1995-2#5)(1995-3#6)(1995-5#1)(1995-6#5)(1995-8#5)(1996-1#1)(1996-11#3)(1996-12#3)(1996-2#2)(1996-4#2)(1996-5#5)(1996-7#3)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#6)(1997-3#1)(1997-4#11)(1997-5#3)(1997-6#6)(1997-7#6)(2004-9#1)(2005-11#5)(2006-10#5)(2006-12#1)(2006-5#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-10#19)(2008-11#17)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#13)(2008-9#6)(2009-10#2)(2009-2#2)(2009-3#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#3)(2011-2#10)(2012-11#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#4)
protein we##3##2##(1991-1#1)(1994-12#1)(2011-2#1)
protein weight##2##2##(1996-1#1)(2008-9#1)
protein were determined##4##3##(1996-12#1)(2007-10#1)(2007-8#1)(2009-3#1)
protein were examined##2##3##(1991-9#1)(1995-8#1)
protein were expressed in##3##4##(1992-12#1)(1995-8#1)(1997-7#1)
protein were found to##2##4##(1992-2#1)(1996-8#1)
protein were found##6##3##(1992-2#1)(1996-8#1)(1997-2#1)(1997-7#2)(2012-2#1)
protein were identified##4##3##(1990-4#1)(1990-5#1)(1992-12#1)(1994-9#1)
protein were isolated##4##3##(1991-6#1)(1994-12#1)(1996-4#1)(2008-9#1)
protein were localized in##2##4##(1991-8#1)(2008-10#1)
protein were not##3##3##(1990-5#1)(1993-3#1)(1994-12#1)
protein were observed##3##3##(1994-10#1)(1995-3#1)(1995-8#1)
protein were obtained##2##3##(1992-12#1)(1996-12#1)
protein were prepared by##2##4##(1997-6#1)(2009-4#1)
protein were produced##2##3##(1990-5#1)(1996-1#1)
protein were similar##2##3##(2008-10#2)
protein were studied in##3##4##(1991-9#1)(1995-1#1)(2008-10#1)
protein were studied##5##3##(1990-11#1)(1991-9#1)(1995-1#1)(2008-10#2)
protein were used to##2##4##(1991-2#1)(2009-11#1)
protein were used##3##3##(1991-2#1)(2009-11#1)(2012-12#1)
protein were##92##2##(1990-11#2)(1990-4#1)(1990-5#3)(1990-7#4)(1991-10#1)(1991-2#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#4)(1992-2#1)(1993-2#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#5)(1995-8#3)(1996-1#2)(1996-12#2)(1996-3#2)(1996-4#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#3)(2005-10#1)(2006-11#1)(2007-10#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#4)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)
protein when##11##2##(1990-11#1)(1990-5#1)(1991-6#1)(1992-11#1)(1993-6#1)(1994-11#1)(1995-2#1)(1995-7#1)(2007-6#1)(2008-4#1)(2010-2#1)
protein whereas##2##2##(1992-10#1)(1993-2#1)
protein which binds##4##3##(1990-2#1)(1992-12#1)(1994-12#1)(2009-7#1)
protein which can##2##3##(1991-3#1)(1995-10#1)
protein which did not##2##4##(1993-5#1)(1997-8#1)
protein which has a##2##4##(1990-4#1)(1994-11#1)
protein which has been implicated in##2##6##(1992-4#1)(1993-8#1)
protein which has##7##3##(1990-4#2)(1992-4#1)(1993-8#1)(1994-11#2)(2008-10#1)
protein which is highly##2##4##(1990-10#1)(1994-12#1)
protein which is temperature-sensitive for nuclear transport##2##7##(1991-2#2)
protein which is##16##3##(1990-10#1)(1991-2#3)(1992-12#2)(1992-3#1)(1994-11#1)(1994-12#2)(1995-6#1)(1997-3#1)(2003-11#1)(2008-11#1)(2008-4#1)(2008-8#1)
protein which shows##2##3##(1997-4#1)(1997-6#1)
protein which was##8##3##(1990-1#1)(1990-11#1)(1991-2#1)(1992-2#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-6#1)
protein which##75##2##(1990-1#2)(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#3)(1990-7#2)(1991-12#1)(1991-2#4)(1991-3#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#3)(1994-6#1)(1994-8#3)(1994-9#1)(1995-10#1)(1995-2#1)(1995-6#2)(1995-8#2)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#1)(2003-11#2)(2006-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-7#1)
protein while##3##2##(1990-8#1)(1991-7#1)(1992-4#1)
protein whose electrophoretic mobility##2##4##(1991-2#1)(1997-3#1)
protein whose tyrosine phosphorylation is##2##5##(1996-5#2)
protein whose##21##2##(1990-5#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-7#1)(1992-7#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-3#1)(1997-6#1)(2008-4#1)(2009-8#1)(2010-12#1)(2013-7#1)
protein will##6##2##(1993-4#1)(1993-6#1)(1995-8#1)(1996-4#1)(2008-2#1)(2008-4#1)
protein with 12##2##3##(1995-1#1)(1997-7#1)
protein with 54%##2##3##(1995-8#2)
protein with GARS##2##3##(1993-12#2)
protein with a Mr of about##2##6##(1992-1#1)(1994-11#1)
protein with a molecular mass of about##2##7##(1993-11#1)(1994-8#1)
protein with a molecular mass of##8##6##(1993-11#1)(1993-6#1)(1994-5#1)(1994-8#1)(1994-9#1)(1997-7#1)(2004-8#1)(2008-10#1)
protein with a molecular weight of##6##6##(1990-7#1)(1992-9#1)(1993-6#1)(2012-1#3)
protein with a molecular##14##4##(1990-7#1)(1992-9#1)(1993-11#1)(1993-6#2)(1994-5#1)(1994-8#1)(1994-9#1)(1997-7#1)(2004-8#1)(2008-10#1)(2012-1#3)
protein with a predicted Mr of##2##6##(1990-12#1)(2008-10#1)
protein with a predicted molecular##2##5##(1992-12#1)(1996-10#1)
protein with a predicted##7##4##(1990-12#1)(1992-12#1)(1994-8#1)(1996-10#1)(1996-7#1)(1997-5#1)(2008-10#1)
protein with a region that##2##5##(1990-10#1)(2008-5#1)
protein with a region##3##4##(1990-10#1)(2008-5#1)(2008-6#1)
protein with a single##2##4##(1990-10#1)(1995-3#1)
protein with a##58##3##(1990-10#2)(1990-12#1)(1990-7#2)(1991-3#1)(1991-5#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#4)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-12#1)(1995-3#1)(1995-8#2)(1996-10#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-5#1)(1997-7#3)(2004-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-1#1)(2012-1#3)(2012-2#1)
protein with an approximate molecular weight of##2##7##(1994-11#1)(1996-5#1)
protein with an##20##3##(1990-1#1)(1990-12#1)(1990-4#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-5#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-5#1)(1996-10#1)(1996-2#1)(1996-5#2)(1997-7#1)(2008-11#2)(2008-6#1)(2010-4#1)
protein with approximately##2##3##(1995-1#1)(2008-5#1)
protein with beta-galactosidase activity##2##4##(1990-3#2)
protein with beta-galactosidase##3##3##(1990-3#2)(1991-8#1)
protein with both##5##3##(1994-3#1)(1997-7#1)(2010-2#1)(2012-12#2)
protein with high homology to##2##5##(1994-8#1)(1996-10#1)
protein with high##6##3##(1991-5#1)(1993-11#1)(1994-8#1)(1995-4#1)(1996-10#1)(2006-12#1)
protein with homology to##2##4##(1997-1#1)(2008-6#1)
protein with no##2##3##(1997-4#1)(2007-2#1)
protein with respect to##3##4##(1990-11#1)(2008-8#1)(2011-2#1)
protein with seven##2##3##(1994-2#1)(1996-7#1)
protein with several##2##3##(1994-9#1)(2005-12#1)
protein with some##2##3##(1993-8#1)(2008-9#1)
protein with striking homology to##2##5##(1990-5#1)(1993-11#1)
protein with strong##2##3##(2008-8#2)
protein with the same##2##4##(1996-3#1)(2009-10#1)
protein with the##11##3##(1993-8#1)(1994-10#1)(1994-12#1)(1995-11#1)(1996-2#1)(1996-3#1)(1997-6#1)(1997-8#1)(2005-11#1)(2008-9#1)(2009-10#1)
protein with three##2##3##(1992-8#1)(1993-5#1)
protein with two##3##3##(1992-3#1)(1993-3#1)(1996-8#1)
protein with unknown function##3##4##(1990-5#1)(1994-3#1)(2008-10#1)
protein with##236##2##(1990-1#1)(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#3)(1990-7#4)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#4)(1991-7#4)(1991-8#1)(1992-1#1)(1992-11#5)(1992-12#4)(1992-3#3)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#4)(1992-9#2)(1993-11#4)(1993-12#3)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#5)(1993-7#1)(1993-8#4)(1993-9#1)(1994-10#2)(1994-11#4)(1994-12#6)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#2)(1994-8#4)(1994-9#6)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#3)(1995-5#1)(1995-8#6)(1996-10#3)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#5)(1996-7#3)(1996-8#3)(1997-1#4)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#7)(1997-8#1)(2004-8#1)(2005-11#2)(2005-12#1)(2006-10#1)(2006-12#2)(2007-2#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#5)(2008-6#3)(2008-8#10)(2008-9#3)(2009-10#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#4)(2012-12#4)(2012-2#2)(2012-3#1)
protein within the##3##3##(1991-9#1)(1992-8#1)(1994-9#1)
protein within##7##2##(1991-9#1)(1992-4#1)(1992-7#1)(1992-8#1)(1994-9#1)(1995-10#1)(2008-4#1)
protein without##3##2##(1991-5#1)(1997-7#1)(2006-11#1)
protein would therefore##2##3##(1995-6#1)(2010-4#1)
protein would##5##2##(1991-4#1)(1992-4#1)(1995-6#1)(2006-10#1)(2010-4#1)
protein yield##4##2##(2008-11#2)(2011-2#2)
protein yields##3##2##(1990-11#1)(2008-11#1)(2008-4#1)
protein##15817##1##(1990-1#10)(1990-10#80)(1990-11#153)(1990-12#151)(1990-2#86)(1990-3#87)(1990-4#80)(1990-5#179)(1990-6#52)(1990-7#145)(1990-8#112)(1990-9#96)(1991-1#65)(1991-10#85)(1991-11#109)(1991-12#100)(1991-2#149)(1991-3#65)(1991-4#67)(1991-5#143)(1991-6#83)(1991-7#161)(1991-8#102)(1991-9#137)(1992-1#33)(1992-10#10)(1992-11#120)(1992-12#185)(1992-2#53)(1992-3#126)(1992-4#65)(1992-5#68)(1992-6#113)(1992-7#107)(1992-8#135)(1992-9#82)(1993-1#10)(1993-10#1)(1993-11#149)(1993-12#152)(1993-2#68)(1993-3#124)(1993-4#75)(1993-5#34)(1993-6#204)(1993-7#25)(1993-8#122)(1993-9#109)(1994-10#36)(1994-11#218)(1994-12#317)(1994-2#144)(1994-3#175)(1994-4#1)(1994-5#131)(1994-6#94)(1994-7#6)(1994-8#260)(1994-9#282)(1995-1#139)(1995-10#66)(1995-11#70)(1995-12#92)(1995-2#184)(1995-3#194)(1995-4#46)(1995-5#94)(1995-6#191)(1995-7#33)(1995-8#227)(1995-9#14)(1996-1#27)(1996-10#76)(1996-11#66)(1996-12#75)(1996-2#81)(1996-3#44)(1996-4#76)(1996-5#177)(1996-6#49)(1996-7#69)(1996-8#124)(1996-9#69)(1997-1#99)(1997-2#193)(1997-3#72)(1997-4#233)(1997-5#83)(1997-6#181)(1997-7#154)(1997-8#58)(1997-9#2)(2003-11#8)(2004-1#1)(2004-11#31)(2004-12#9)(2004-2#2)(2004-4#3)(2004-8#1)(2004-9#7)(2005-1#2)(2005-10#25)(2005-11#93)(2005-12#17)(2005-5#1)(2005-6#3)(2005-7#21)(2005-8#24)(2005-9#9)(2006-1#5)(2006-10#126)(2006-11#14)(2006-12#103)(2006-2#13)(2006-3#3)(2006-4#23)(2006-5#27)(2006-6#14)(2006-7#4)(2006-8#23)(2006-9#11)(2007-1#7)(2007-10#17)(2007-11#63)(2007-12#72)(2007-2#28)(2007-3#7)(2007-4#2)(2007-5#7)(2007-6#32)(2007-7#14)(2007-8#109)(2007-9#21)(2008-1#129)(2008-10#623)(2008-11#412)(2008-12#54)(2008-2#116)(2008-3#72)(2008-4#540)(2008-5#205)(2008-6#49)(2008-7#278)(2008-8#226)(2008-9#220)(2009-1#1)(2009-10#67)(2009-11#13)(2009-12#34)(2009-2#18)(2009-3#40)(2009-4#32)(2009-5#44)(2009-6#37)(2009-7#66)(2009-8#100)(2009-9#40)(2010-1#10)(2010-10#32)(2010-11#35)(2010-12#124)(2010-2#61)(2010-3#9)(2010-4#86)(2010-5#24)(2010-6#17)(2010-7#37)(2010-8#17)(2010-9#11)(2011-1#122)(2011-10#3)(2011-12#29)(2011-2#214)(2011-3#20)(2011-9#1)(2012-1#44)(2012-11#13)(2012-12#131)(2012-2#201)(2012-3#98)(2012-5#2)(2012-6#3)(2012-7#3)(2012-8#2)(2012-9#1)(2013-1#198)(2013-7#47)(2013-8#115)
protein&quot##2##1##(1994-6#1)(2013-8#1)
protein'##2##1##(1992-7#1)(1997-7#1)
protein's isoelectric point##2##3##(1994-6#1)(1995-2#1)
protein's quadratic indices##2##3##(2007-11#2)
protein's##31##1##(1990-10#1)(1991-2#1)(1991-4#1)(1991-5#1)(1994-11#3)(1994-6#1)(1994-8#1)(1995-11#2)(1995-2#2)(1996-5#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-11#3)(2008-2#2)(2008-4#2)(2008-8#2)(2008-9#2)(2010-10#1)(2011-1#1)(2011-2#1)
protein(-1)##4##1##(1996-5#2)(1997-1#2)
protein(s) and##5##2##(1991-11#1)(1993-2#1)(1994-6#1)(1995-3#1)(1996-5#1)
protein(s) bound##2##2##(1994-12#1)(1997-1#1)
protein(s) could##2##2##(1994-12#2)
protein(s) is involved in##2##4##(1992-11#1)(1995-12#1)
protein(s) that##7##2##(1992-12#1)(1992-8#1)(1996-5#1)(1997-1#2)(1997-4#2)
protein(s) was##3##2##(1994-11#1)(1994-12#2)
protein(s)##40##1##(1990-2#1)(1991-11#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-8#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-11#2)(1994-12#6)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#3)(1995-8#1)(1996-5#3)(1997-1#3)(1997-4#3)(2008-10#1)(2008-11#1)(2008-8#1)
protein) and##19##2##(1990-11#2)(1990-3#2)(1991-2#1)(1991-9#1)(1993-11#1)(1994-3#1)(1995-11#1)(1996-2#1)(1997-8#1)(2004-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#2)(2012-2#1)
protein) family##3##2##(2008-7#1)(2012-12#1)(2013-8#1)
protein) for##2##2##(1992-11#1)(1993-4#1)
protein) from the##2##3##(2008-11#1)(2008-7#1)
protein) gene##3##2##(1994-9#1)(1995-2#1)(2012-3#1)
protein) has##2##2##(1991-10#1)(2012-12#1)
protein) in a##2##3##(1994-12#1)(2008-4#1)
protein) in##5##2##(1994-12#1)(1995-8#1)(2007-8#1)(2008-11#1)(2008-4#1)
protein) is a##2##3##(1990-12#1)(1991-1#1)
protein) is##4##2##(1990-12#1)(1991-1#1)(1992-11#1)(1996-5#1)
protein) of##3##2##(1990-2#1)(1990-9#1)(1993-6#1)
protein) or##3##2##(1993-11#1)(1996-9#2)
protein) than in##2##3##(1993-11#1)(1997-2#1)
protein) to##2##2##(1994-12#1)(2008-4#1)
protein) was##7##2##(1990-7#1)(1991-3#2)(1991-7#1)(1996-2#1)(1997-7#1)(2008-7#1)
protein) were detected##2##3##(1994-12#1)(1994-8#1)
protein) were##7##2##(1990-1#1)(1990-5#1)(1992-6#1)(1994-12#1)(1994-8#1)(1997-7#1)(2010-6#1)
protein) with a##3##3##(1990-7#1)(1991-2#1)(1996-5#1)
protein) with##5##2##(1990-7#1)(1991-2#1)(1995-8#1)(1996-10#1)(1996-5#1)
protein)##163##1##(1990-1#2)(1990-11#4)(1990-12#1)(1990-2#1)(1990-3#6)(1990-5#1)(1990-7#4)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-7#1)(1991-9#1)(1992-11#5)(1992-3#1)(1992-4#2)(1992-6#2)(1992-9#1)(1993-11#5)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#8)(1994-2#1)(1994-3#2)(1994-6#2)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#4)(1995-9#1)(1996-10#1)(1996-2#4)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#6)(1997-2#3)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#2)(2004-11#5)(2006-12#2)(2007-11#1)(2007-8#2)(2008-10#1)(2008-11#9)(2008-3#1)(2008-4#6)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#3)(2010-11#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#2)(2013-8#1)
protein)-1##2##1##(1995-10#1)(1996-1#1)
protein-##6##1##(1996-1#1)(1996-6#1)(2008-1#2)(2008-11#1)(2009-3#1)
protein-1 (IGFBP-1)##5##2##(1990-11#1)(1992-6#1)(1993-1#1)(1996-9#1)(2011-12#1)
protein-1 (MCP-1)##9##2##(1994-9#1)(1996-9#1)(2008-11#1)(2008-5#1)(2009-10#1)(2011-2#1)(2012-1#1)(2013-1#2)
protein-1 and##5##2##(1994-6#2)(2006-9#1)(2008-11#1)(2011-2#1)
protein-1 gene##2##2##(1992-6#1)(1993-4#1)
protein-1 in##6##2##(1993-1#1)(1993-4#1)(1996-9#1)(2012-1#1)(2012-2#2)
protein-1 of Plasmodium##2##3##(1992-12#1)(2008-4#1)
protein-1##62##1##(1990-11#2)(1990-8#1)(1991-7#1)(1992-12#2)(1992-6#2)(1993-1#2)(1993-12#3)(1993-4#5)(1994-12#2)(1994-6#5)(1994-9#1)(1995-8#1)(1996-10#2)(1996-3#1)(1996-9#4)(1997-2#1)(2006-4#1)(2006-9#3)(2008-11#4)(2008-4#1)(2008-5#3)(2009-10#1)(2009-7#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#4)
protein-1)##3##1##(1990-6#1)(1991-3#1)(2008-9#1)
protein-10##2##1##(2008-10#1)(2008-5#1)
protein-2##18##1##(1991-1#1)(1993-2#2)(1994-11#4)(1994-8#1)(2006-4#1)(2007-1#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-8#1)(2011-2#2)(2013-8#1)
protein-3 (IGFBP-3)##3##2##(1995-10#1)(2011-1#1)(2011-12#1)
protein-3##6##1##(1995-10#1)(2008-11#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-12#1)
protein-4 gene##2##2##(1993-6#1)(1996-2#1)
protein-4##8##1##(1991-9#1)(1993-6#2)(1996-2#2)(2008-9#1)(2011-1#1)(2013-1#1)
protein-7##5##1##(2008-5#1)(2011-2#2)(2012-2#2)
protein-89##2##1##(2010-8#2)
protein-C##2##1##(1995-4#1)(1996-8#1)
protein-DNA complex was##2##3##(1995-3#1)(1997-7#1)
protein-DNA complex##9##2##(1991-11#1)(1992-2#1)(1993-12#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-5#1)(1997-7#1)
protein-DNA complexes were##2##3##(1995-3#1)(1995-5#1)
protein-DNA complexes##7##2##(1993-11#2)(1995-10#1)(1995-3#1)(1995-5#1)(1996-11#1)(2008-10#1)
protein-DNA contacts##3##2##(1993-11#1)(1996-7#2)
protein-DNA interaction##3##2##(1992-11#1)(2008-7#1)(2008-8#1)
protein-DNA interactions##12##2##(1990-2#1)(1990-7#1)(1991-11#1)(1992-12#1)(1992-8#1)(1993-12#1)(1994-11#1)(1996-11#2)(2008-2#1)(2008-4#1)(2008-8#1)
protein-DNA interface##3##2##(1995-8#3)
protein-DNA##42##1##(1990-11#1)(1990-2#1)(1990-7#1)(1991-11#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-11#3)(1993-12#2)(1994-11#1)(1994-9#1)(1995-10#1)(1995-2#2)(1995-3#2)(1995-5#2)(1995-8#3)(1996-11#4)(1996-7#2)(1997-7#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-7#2)(2008-8#2)(2009-8#1)
protein-I##2##1##(1993-9#1)(1995-11#1)
protein-RNA interaction##2##2##(1997-4#2)
protein-RNA##5##1##(1994-9#1)(1997-4#2)(2008-2#1)(2011-3#1)
protein-SH and##2##2##(1994-3#2)
protein-SH##5##1##(1994-3#5)
protein-associated##3##1##(2008-11#1)(2008-7#1)(2012-12#1)
protein-based biofilms##3##2##(2008-5#3)
protein-based##21##1##(2005-7#1)(2007-8#2)(2008-1#1)(2008-4#2)(2008-5#3)(2008-8#1)(2008-9#2)(2009-3#2)(2010-4#1)(2012-12#1)(2012-2#1)(2013-7#3)(2013-8#1)
protein-binding sites##3##2##(1997-4#1)(2009-3#1)(2012-3#1)
protein-binding##13##1##(1993-6#1)(1995-2#1)(1997-4#2)(1997-5#1)(2006-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-3#1)(2012-3#1)
protein-bound carbohydrate sulfate##4##3##(1990-3#4)
protein-bound toxins##2##2##(2008-5#2)
protein-bound tyrosine sulfate##3##3##(1990-3#3)
protein-bound tyrosine##4##2##(1990-3#4)
protein-bound urinary##2##2##(1991-12#2)
protein-bound##36##1##(1990-3#10)(1991-12#4)(1991-7#1)(1991-8#1)(1991-9#1)(1992-8#1)(1994-11#1)(1995-1#1)(1996-2#1)(1997-2#1)(2004-11#1)(2008-10#5)(2008-3#1)(2008-5#2)(2008-7#3)(2008-9#1)(2010-6#1)
protein-calorie malnutrition##3##2##(1990-9#1)(2006-10#1)(2007-12#1)
protein-calorie##4##1##(1990-9#1)(1991-9#1)(2006-10#1)(2007-12#1)
protein-carbohydrate##3##1##(2006-8#1)(2008-1#1)(2008-4#1)
protein-coated beads##2##2##(2008-10#1)(2008-11#1)
protein-coated##3##1##(1990-12#1)(2008-10#1)(2008-11#1)
protein-coding and 47 RNA genes is##2##6##(2011-2#2)
protein-coding and 52 RNA genes is a part of the Genomic Encyclopedia of Bacteria and Archaea project##3##17##(2011-2#3)
protein-coding and 52 RNA genes is part of the Genomic Encyclopedia of Bacteria and Archaea project##2##16##(2011-2#2)
protein-coding and 52 RNA genes is##5##6##(2011-2#5)
protein-coding and 53 RNA genes is##2##6##(2011-2#2)
protein-coding and 55 RNA genes is a part of the Genomic Encyclopedia of Bacteria and Archaea project##3##17##(2011-2#3)
protein-coding and 55 RNA genes is##4##6##(2011-2#4)
protein-coding and 56 RNA genes is part of the Genomic Encyclopedia of Bacteria and Archaea project##2##16##(2011-2#2)
protein-coding and 57 RNA genes is a part of the Genomic Encyclopedia of Bacteria and Archaea project##3##17##(2011-2#3)
protein-coding and 58 RNA genes is##2##6##(2011-2#2)
protein-coding and 60 RNA genes##2##5##(2011-2#2)
protein-coding and 63 RNA genes is part of the Genomic Encyclopedia of Bacteria and Archaea project##2##16##(2011-2#2)
protein-coding and 63 RNA genes is##3##6##(2011-2#3)
protein-coding and##42##2##(2011-2#41)(2012-3#1)
protein-coding gene##2##2##(2007-11#1)(2008-10#1)
protein-coding gene-containing##2##2##(2008-7#2)
protein-coding genes and##4##3##(2009-5#1)(2011-2#2)(2012-12#1)
protein-coding genes in wild-type##2##4##(2008-7#2)
protein-coding genes in##3##3##(2008-7#2)(2011-2#1)
protein-coding genes##23##2##(1995-2#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#3)(2008-4#1)(2008-7#4)(2008-8#1)(2009-5#3)(2011-2#5)(2012-12#1)
protein-coding region of##2##3##(1991-2#1)(1992-12#1)
protein-coding region##4##2##(1991-2#1)(1992-12#1)(1993-6#1)(1996-6#1)
protein-coding regions##5##2##(1993-11#1)(1996-6#3)(2010-9#1)
protein-coding sequence##2##2##(1990-4#1)(1991-12#1)
protein-coding sequences##2##2##(1990-3#1)(1991-8#1)
protein-coding##93##1##(1990-3#1)(1990-4#3)(1991-12#1)(1991-2#1)(1991-8#1)(1992-12#1)(1993-11#1)(1993-6#1)(1995-2#1)(1996-6#4)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#4)(2008-10#1)(2008-4#2)(2008-7#6)(2008-8#1)(2009-3#1)(2009-5#5)(2010-8#1)(2010-9#1)(2011-2#47)(2012-12#1)(2012-3#2)
protein-containing##3##1##(1993-11#1)(1996-11#1)(2008-8#1)
protein-coupled##58##1##(1990-12#1)(1991-2#1)(1991-3#1)(1991-5#5)(1991-9#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#4)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-12#5)(1994-9#2)(1995-3#2)(1995-6#2)(1996-2#1)(1996-5#3)(1997-2#1)(1997-6#2)(2006-10#1)(2007-11#2)(2007-12#1)(2008-4#7)(2008-5#1)(2008-7#1)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
protein-dependent##10##1##(1993-8#1)(1994-11#1)(1995-6#1)(1997-1#1)(2008-4#1)(2008-8#1)(2012-3#4)
protein-domain##2##1##(2013-1#2)
protein-drug interactions##2##2##(2007-8#1)(2010-7#1)
protein-drug##3##1##(2007-8#1)(2010-4#1)(2010-7#1)
protein-dye##2##1##(1996-12#1)(2008-10#1)
protein-encoding gene of##2##3##(1990-3#1)(1993-11#1)
protein-encoding gene##4##2##(1990-3#1)(1993-11#1)(1993-12#1)(1994-12#1)
protein-encoding genes and##2##3##(1991-6#1)(2008-5#1)
protein-encoding genes##7##2##(1990-9#1)(1991-6#2)(1993-12#1)(1993-9#1)(1994-12#1)(2008-5#1)
protein-encoding##16##1##(1990-3#1)(1990-9#1)(1991-6#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-9#1)(1994-12#2)(1995-8#1)(2006-12#1)(2008-10#1)(2008-5#1)
protein-energy malnutrition##5##2##(2006-2#1)(2006-9#1)(2007-2#1)(2008-2#1)(2008-4#1)
protein-energy nutritional status##2##3##(1996-9#2)
protein-energy##8##1##(1996-9#3)(2006-2#1)(2006-9#1)(2007-2#1)(2008-2#1)(2008-4#1)
protein-folding##2##1##(1996-11#1)(2005-10#1)
protein-free and##2##2##(2008-11#2)
protein-free cell culture media##2##4##(2008-11#1)(2011-2#1)
protein-free conditions##4##2##(1993-9#3)(2008-11#1)
protein-free culture##5##2##(1993-9#1)(2008-11#4)
protein-free diet##3##2##(1993-12#3)
protein-free media##6##2##(2008-11#6)
protein-free medium and to be##2##5##(2008-11#2)
protein-free medium for##2##3##(1991-8#1)(1996-2#1)
protein-free medium in##3##3##(2008-11#2)(2011-2#1)
protein-free medium##22##2##(1991-8#1)(1996-2#5)(2008-11#15)(2011-2#1)
protein-free##49##1##(1991-5#1)(1991-8#1)(1993-12#3)(1993-9#4)(1996-2#5)(2008-11#32)(2011-2#3)
protein-freeculture##3##1##(2008-11#3)
protein-independent##2##1##(1997-2#1)(2012-12#1)
protein-induced##4##1##(1991-2#1)(1991-7#1)(1994-2#1)(2010-6#1)
protein-ligand binding sites##2##3##(2012-3#2)
protein-ligand binding##5##2##(2008-1#1)(2008-4#1)(2012-3#3)
protein-ligand complexes##2##2##(2011-3#1)(2012-3#1)
protein-ligand interactions##4##2##(1994-11#1)(1997-2#1)(2007-8#1)(2008-4#1)
protein-ligand##16##1##(1994-11#1)(1995-11#1)(1997-2#2)(2006-10#2)(2007-8#1)(2008-1#1)(2008-4#2)(2008-7#1)(2011-3#1)(2012-3#4)
protein-like molecules##2##2##(1995-7#2)
protein-like##5##1##(1995-7#2)(1996-8#2)(2008-10#1)
protein-linked##3##1##(1993-12#1)(1995-3#1)(2007-3#1)
protein-lipid interactions##3##2##(1992-7#1)(2008-9#1)(2011-3#1)
protein-lipid##6##1##(1992-7#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-9#1)(2011-3#1)
protein-losing##3##1##(2006-12#1)(2006-4#2)
protein-mediated activation of##2##3##(1992-6#1)(1995-11#1)
protein-mediated##21##1##(1990-10#1)(1990-2#3)(1991-6#1)(1992-6#3)(1994-12#1)(1995-11#3)(1995-8#1)(1996-5#1)(1997-1#2)(2007-8#1)(2008-10#1)(2009-8#1)(2011-2#1)(2012-11#1)
protein-membrane##2##1##(1995-6#1)(1996-1#1)
protein-mineral##3##1##(1996-3#1)(2006-6#2)
protein-nucleic acid complexes##2##3##(1997-4#2)
protein-nucleic acid interactions##3##3##(1993-6#1)(1995-11#1)(1997-4#1)
protein-nucleic acid##6##2##(1993-6#1)(1995-11#1)(1997-4#3)(2007-8#1)
protein-peptide##3##1##(2006-9#1)(2007-8#1)(2008-9#1)
protein-phospholipid##4##1##(1992-3#3)(1995-11#1)
protein-polysaccharide complexes##2##2##(1992-3#1)(2012-11#1)
protein-producing##2##1##(2007-6#1)(2008-10#1)
protein-profiling technologies##2##2##(2008-4#2)
protein-profiling##4##1##(2008-4#4)
protein-protein and peptide-protein interactions##2##4##(1992-9#2)
protein-protein and protein- DNA##2##4##(2008-1#2)
protein-protein and protein-DNA##3##3##(2008-2#2)(2008-7#1)
protein-protein and##8##2##(1992-9#2)(1993-9#1)(2008-1#2)(2008-2#2)(2008-7#1)
protein-protein binding##2##2##(1995-2#1)(2008-1#1)
protein-protein interaction are##2##3##(1996-8#1)(2010-5#1)
protein-protein interaction assays##2##3##(1995-3#1)(2012-2#1)
protein-protein interaction data##4##3##(2008-4#4)
protein-protein interaction domains that##2##4##(2009-7#1)(2013-8#1)
protein-protein interaction domains##3##3##(2009-7#1)(2013-8#2)
protein-protein interaction is an##2##4##(1996-8#1)(2013-1#1)
protein-protein interaction is##3##3##(1996-8#1)(2008-4#1)(2013-1#1)
protein-protein interaction networks##3##3##(2008-4#3)
protein-protein interaction studies##2##3##(2008-4#1)(2009-5#1)
protein-protein interaction##45##2##(1993-12#2)(1993-6#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-4#1)(1996-8#6)(1997-4#1)(1997-6#1)(2008-11#1)(2008-2#1)(2008-4#11)(2008-7#2)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-5#2)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#3)
protein-protein interactions and##3##3##(2008-1#1)(2008-11#1)(2008-7#1)
protein-protein interactions are##3##3##(2008-6#1)(2008-7#2)
protein-protein interactions by##7##3##(2008-2#1)(2008-4#4)(2008-7#2)
protein-protein interactions in living cells by##2##6##(2008-1#1)(2008-4#1)
protein-protein interactions in vivo##2##4##(2008-9#2)
protein-protein interactions in##11##3##(1990-10#1)(1993-6#1)(1993-9#1)(1997-1#1)(2008-1#1)(2008-4#4)(2008-9#2)
protein-protein interactions involved in##3##4##(1992-6#1)(1995-8#1)(2008-4#1)
protein-protein interactions of##2##3##(2008-10#1)(2008-4#1)
protein-protein interactions with##2##3##(2008-1#1)(2008-9#1)
protein-protein interactions##96##2##(1990-10#1)(1990-6#1)(1991-7#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-6#1)(1993-9#2)(1994-12#1)(1994-3#1)(1995-1#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-8#1)(1997-1#2)(1997-2#1)(2005-10#1)(2005-7#1)(2006-10#1)(2007-8#1)(2008-1#6)(2008-10#1)(2008-11#2)(2008-2#3)(2008-4#27)(2008-6#1)(2008-7#11)(2008-8#1)(2008-9#4)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
protein-protein interfaces##2##2##(2008-4#2)
protein-protein##168##1##(1990-10#1)(1990-6#1)(1991-7#2)(1992-10#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-12#2)(1993-6#2)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1995-1#2)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#3)(1996-11#1)(1996-4#1)(1996-8#7)(1997-1#2)(1997-2#1)(1997-4#2)(1997-6#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-8#2)(2008-1#9)(2008-10#1)(2008-11#3)(2008-2#6)(2008-4#42)(2008-6#1)(2008-7#16)(2008-8#1)(2008-9#5)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#2)(2010-10#1)(2010-5#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#4)
protein-receptor##2##1##(1992-9#1)(2007-12#1)
protein-related##2##1##(1991-12#1)(2012-3#1)
protein-restricted diet##2##2##(2008-7#2)
protein-restricted##3##1##(2008-7#3)
protein-secreting##2##1##(2008-7#1)(2012-2#1)
protein-serine kinase##3##2##(1993-11#1)(1995-3#1)(1996-2#1)
protein-serine##4##1##(1993-11#2)(1995-3#1)(1996-2#1)
protein-serine/threonine##2##1##(1994-11#1)(2011-1#1)
protein-small##2##1##(2007-8#1)(2010-5#1)
protein-sorting##2##1##(1993-3#1)(2008-11#1)
protein-specific##6##1##(1991-9#2)(1992-7#1)(1994-12#1)(1995-5#1)(2013-8#1)
protein-sugar binding##3##2##(1995-3#1)(2008-10#2)
protein-sugar##4##1##(1995-3#1)(1996-11#1)(2008-10#2)
protein-synthesis##2##1##(1994-2#2)
protein-tyrosine kinase from##3##3##(1990-3#1)(1996-5#2)
protein-tyrosine kinase inhibitor##3##3##(1993-6#2)(1994-12#1)
protein-tyrosine kinase##20##2##(1990-3#4)(1991-1#2)(1991-6#2)(1992-6#2)(1992-8#2)(1993-6#3)(1994-12#1)(1994-9#1)(1995-6#1)(1996-5#2)
protein-tyrosine kinases##6##2##(1992-8#1)(1993-6#1)(1994-3#1)(1994-9#1)(1996-5#1)(2008-1#1)
protein-tyrosine phosphatase (PTPase)##2##3##(1995-10#1)(1995-3#1)
protein-tyrosine phosphatase##4##2##(1995-10#1)(1995-3#2)(1996-2#1)
protein-tyrosine phosphorylation in##2##3##(1992-6#1)(1994-2#1)
protein-tyrosine phosphorylation##8##2##(1992-6#1)(1992-8#3)(1993-11#1)(1993-6#1)(1994-2#1)(1995-3#1)
protein-tyrosine##39##1##(1990-3#4)(1991-1#2)(1991-6#2)(1992-6#3)(1992-8#6)(1993-11#1)(1993-6#5)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-10#2)(1995-3#3)(1995-6#1)(1996-2#1)(1996-5#3)(2008-1#1)
protein/DNA##4##1##(1990-5#1)(1994-8#1)(2008-4#1)(2008-7#1)
protein/RNA ratios##4##2##(2008-4#4)
protein/kg body##2##2##(2006-6#1)(2013-8#1)
protein/ligand##2##1##(1996-7#1)(2008-10#1)
protein/min and##2##2##(1991-8#1)(2012-2#1)
protein/min##3##1##(1991-7#1)(1991-8#1)(2012-2#1)
protein/osmolality##5##1##(2008-5#5)
protein/peptide##3##1##(2008-1#1)(2008-4#1)(2011-2#1)
protein/water networks##2##2##(2006-12#2)
protein/water##3##1##(2006-12#3)
protein1##2##1##(2010-11#1)(2013-8#1)
protein]##6##1##(1991-5#1)(2005-10#1)(2005-8#1)(2010-12#2)(2010-4#1)
proteinaceous binding media##4##3##(2008-10#4)
proteinaceous components##3##2##(2006-8#1)(2008-5#2)
proteinaceous compounds##2##2##(2008-10#2)
proteinaceous metabolites##2##2##(2008-10#2)
proteinaceous##42##1##(1991-11#1)(1992-2#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-8#1)(2007-12#2)(2007-8#1)(2008-10#14)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#2)(2013-8#1)
proteinase 3##2##2##(2007-8#2)
proteinase A##2##2##(1991-2#1)(2008-10#1)
proteinase K treatment##2##3##(1996-12#1)(2008-10#1)
proteinase K##20##2##(1990-5#1)(1990-7#1)(1991-1#1)(1991-5#1)(1994-2#1)(1996-12#3)(2006-8#1)(2008-10#5)(2008-4#2)(2012-3#2)(2013-1#2)
proteinase activity##7##2##(1990-7#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-11#1)(1994-3#1)(2005-8#1)
proteinase and##5##2##(1990-5#2)(1991-8#1)(1997-2#1)(2007-7#1)
proteinase cDNA fragment##2##3##(1997-6#2)
proteinase cDNA##3##2##(1997-6#3)
proteinase cleaves##2##2##(1991-3#1)(1991-8#1)
proteinase concentrations##2##2##(1990-5#2)
proteinase from the##3##3##(1991-3#2)(1995-6#1)
proteinase from##9##2##(1990-8#1)(1991-3#2)(1991-8#1)(1994-12#1)(1995-6#1)(1996-7#2)(2008-10#1)
proteinase gene##2##2##(1996-7#1)(1997-6#1)
proteinase has been##3##3##(1991-3#1)(1991-5#1)(1994-12#1)
proteinase in plants##2##3##(1994-3#2)
proteinase in##4##2##(1994-12#1)(1994-3#2)(1994-9#1)
proteinase inhibitor##18##2##(1990-2#1)(1991-8#1)(1991-9#2)(1992-2#1)(1992-3#2)(1994-10#1)(1994-2#1)(1994-9#3)(1995-2#2)(1995-6#1)(1997-8#1)(2004-12#1)(2008-11#1)
proteinase inhibitors and##2##3##(1990-12#2)
proteinase inhibitors from##2##3##(1992-8#1)(2009-4#1)
proteinase inhibitors of##2##3##(2009-4#1)(2010-12#1)
proteinase inhibitors##25##2##(1990-12#3)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-8#1)(1994-3#1)(1996-12#2)(1996-2#2)(2005-8#2)(2006-10#1)(2006-12#1)(2008-5#2)(2009-4#3)(2010-12#2)
proteinase is##2##2##(1990-5#1)(1991-8#1)
proteinase of##3##2##(1990-5#1)(1992-9#1)(1993-11#1)
proteinase that##2##2##(1990-12#1)(1991-5#1)
proteinase to##3##2##(1990-2#2)(1997-2#1)
proteinase was##3##2##(1990-10#1)(1991-3#1)(1992-9#1)
proteinase which##2##2##(1992-6#1)(1992-9#1)
proteinase with##2##2##(1992-9#1)(1996-9#1)
proteinase##202##1##(1990-10#1)(1990-12#6)(1990-2#5)(1990-5#13)(1990-7#3)(1990-8#1)(1991-1#2)(1991-2#2)(1991-3#10)(1991-5#5)(1991-8#8)(1991-9#3)(1992-1#1)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#4)(1992-4#2)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#7)(1993-11#5)(1993-3#4)(1993-5#3)(1994-10#2)(1994-11#1)(1994-12#6)(1994-2#2)(1994-3#4)(1994-5#2)(1994-9#5)(1995-10#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#2)(1995-7#2)(1996-12#5)(1996-2#2)(1996-5#1)(1996-7#4)(1996-9#1)(1997-2#5)(1997-6#5)(1997-8#1)(2004-12#1)(2005-12#2)(2005-8#5)(2006-10#1)(2006-12#1)(2006-8#1)(2007-7#4)(2007-8#2)(2008-10#10)(2008-11#5)(2008-4#2)(2008-5#5)(2009-4#3)(2010-12#2)(2012-3#3)(2013-1#2)
proteinase-activated##2##1##(2005-7#1)(2012-3#1)
proteinase-inhibitory##2##1##(1995-6#2)
proteinases and their inhibitors in the##2##6##(2013-1#2)
proteinases and their inhibitors##3##4##(2012-12#1)(2013-1#2)
proteinases and their##4##3##(2008-4#1)(2012-12#1)(2013-1#2)
proteinases and##7##2##(1997-6#1)(2008-11#1)(2008-4#1)(2010-12#1)(2012-12#1)(2013-1#2)
proteinases are##2##2##(1990-7#1)(1993-11#1)
proteinases can##4##2##(1992-4#1)(1993-11#1)(2012-12#2)
proteinases from human##2##3##(1990-7#1)(1996-9#1)
proteinases from##4##2##(1990-7#1)(1991-8#1)(1993-11#1)(1996-9#1)
proteinases have been##2##3##(2008-10#1)(2009-4#1)
proteinases in the##2##3##(1993-11#1)(1996-2#1)
proteinases in##7##2##(1993-11#1)(1996-2#2)(1997-2#1)(2007-11#1)(2007-7#1)(2012-3#1)
proteinases including##2##2##(1990-5#1)(1991-8#1)
proteinases is##2##2##(1990-8#1)(1992-6#1)
proteinases such as##2##3##(1990-4#1)(1995-6#1)
proteinases was##3##2##(1990-5#2)(1996-12#1)
proteinases were##2##2##(1993-11#1)(1994-11#1)
proteinases##98##1##(1990-12#4)(1990-4#1)(1990-5#8)(1990-7#5)(1990-8#2)(1991-3#1)(1991-5#1)(1991-8#3)(1992-1#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#7)(1993-3#3)(1994-11#2)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#1)(1995-7#2)(1996-12#1)(1996-2#2)(1996-9#2)(1997-2#7)(1997-6#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-9#1)(2007-11#2)(2007-7#2)(2008-10#2)(2008-11#2)(2008-4#1)(2009-4#2)(2010-12#3)(2012-12#4)(2012-3#2)(2013-1#2)
proteinemia##2##1##(1997-3#1)(2006-7#1)
proteinkinase C##6##2##(1992-3#4)(2008-1#1)(2008-11#1)
proteinkinase-beta##3##1##(1992-3#3)
proteinogenic amino acids##3##3##(2006-12#3)
proteinogenic##5##1##(1992-11#1)(2006-12#4)
proteinopathies in the##2##3##(2010-4#2)
proteinopathies##5##1##(2008-7#1)(2010-4#4)
proteinosis##11##1##(2007-1#1)(2007-2#1)(2007-8#2)(2008-10#1)(2010-4#1)(2010-7#2)(2012-12#2)(2012-2#1)
proteinous##2##1##(1997-7#1)(2008-5#1)
proteins (1)##2##2##(1990-5#1)(1991-4#1)
proteins (30##2##2##(2008-10#1)(2011-2#1)
proteins (43##2##2##(2008-11#2)
proteins (50##2##2##(1990-7#1)(2008-11#1)
proteins (AFPs)##2##2##(2006-5#1)(2008-6#1)
proteins (AGPs)##2##2##(2009-8#2)
proteins (CRPs)##2##2##(1993-3#2)
proteins (G proteins)##9##3##(1990-3#1)(1990-7#1)(1992-1#1)(1993-6#1)(1994-3#1)(1995-6#1)(1996-10#1)(1996-5#1)(1997-7#1)
proteins (G##11##2##(1990-3#1)(1990-7#1)(1992-1#1)(1993-6#1)(1994-3#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-5#1)(1997-7#1)
proteins (G-proteins)##5##2##(1991-9#1)(1992-11#1)(1994-9#1)(1995-3#2)
proteins (GAPs)##3##2##(1991-5#1)(1992-8#1)(1995-11#1)
proteins (HSP)##5##2##(1992-9#1)(1993-4#1)(1994-11#2)(2012-3#1)
proteins (HSP70)##2##2##(1995-8#1)(1996-2#1)
proteins (HSPs)##7##2##(1991-9#1)(1996-9#1)(2005-10#1)(2006-8#1)(2008-4#1)(2008-7#1)(2013-1#1)
proteins (IGFBPs)##4##2##(1993-3#1)(2008-4#2)(2008-5#1)
proteins (MAPs)##5##2##(1990-10#1)(1997-4#1)(1997-6#1)(2009-8#1)(2011-2#1)
proteins (MPs)##2##2##(1997-3#1)(2008-7#1)
proteins (MRPs)##2##2##(2007-11#1)(2013-8#1)
proteins (P##2##2##(1996-12#1)(2008-10#1)
proteins (PGIPs)##2##2##(2008-10#1)(2011-10#1)
proteins (PP)##2##2##(2008-5#1)(2010-4#1)
proteins (RIPs)##5##2##(1990-11#1)(1990-12#1)(1994-5#1)(2008-10#2)
proteins (alpha##2##2##(1992-9#1)(1994-9#1)
proteins (beta##2##2##(1992-12#1)(1995-3#1)
proteins (bovine##2##2##(1995-4#1)(1996-11#1)
proteins (e##11##2##(1992-6#1)(2006-10#1)(2008-11#2)(2008-2#1)(2008-4#2)(2012-1#1)(2012-2#1)(2013-1#2)
proteins (including##3##2##(1994-8#2)(1995-12#1)
proteins (lysozyme##2##2##(1997-3#1)(2008-4#1)
proteins (mostly##2##2##(2006-12#1)(2007-8#1)
proteins (such as##2##3##(2008-10#1)(2009-10#1)
proteins 1 and 2##2##4##(1994-9#1)(2008-10#1)
proteins 1##3##2##(1994-9#1)(2008-10#1)(2012-3#1)
proteins A##3##2##(2005-11#1)(2011-1#2)
proteins MAP30 and GAP31##2##4##(1996-2#2)
proteins across and##2##3##(1992-12#1)(2012-1#1)
proteins across##5##2##(1991-5#1)(1992-12#1)(1992-6#1)(2009-8#1)(2012-1#1)
proteins act as##3##3##(2007-8#1)(2012-12#1)(2013-1#1)
proteins act##5##2##(1997-6#1)(2007-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
proteins acting##3##2##(1990-12#1)(2009-5#1)(2010-2#1)
proteins activated##2##2##(1994-8#1)(1995-6#1)
proteins adopt##2##2##(1990-9#1)(1992-5#1)
proteins adsorbed##2##2##(1997-2#1)(2004-8#1)
proteins after##5##2##(1992-1#1)(1993-4#1)(2008-11#1)(2010-3#1)(2010-4#1)
proteins against##4##2##(1991-5#1)(1993-4#1)(1996-2#1)(1997-7#1)
proteins all##3##2##(1994-2#1)(2006-1#1)(2010-11#1)
proteins alone##2##2##(1997-2#1)(2008-10#1)
proteins along with##2##3##(1993-11#1)(2009-6#1)
proteins along##4##2##(1993-11#1)(1994-9#1)(2007-8#1)(2009-6#1)
proteins also play##2##3##(2009-8#1)(2011-1#1)
proteins also##13##2##(1990-7#1)(1991-4#1)(1992-5#2)(1992-6#1)(1994-12#1)(1994-9#1)(1995-6#1)(1997-3#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-1#1)
proteins among##3##2##(1990-4#1)(1996-12#1)(2013-8#1)
proteins and DNA##7##3##(1990-6#1)(1996-9#1)(2005-11#1)(2008-1#1)(2008-4#1)(2008-5#1)(2011-1#1)
proteins and RNA##2##3##(2008-2#1)(2008-4#1)
proteins and a##6##3##(1992-9#1)(1993-2#1)(1995-1#1)(1997-2#1)(2006-2#1)(2013-8#1)
proteins and an##2##3##(1991-8#1)(1995-2#1)
proteins and are##5##3##(1990-5#1)(1993-12#1)(1995-8#1)(2011-2#2)
proteins and as a##2##4##(2008-10#1)(2008-4#1)
proteins and as##3##3##(1990-7#1)(2008-10#1)(2008-4#1)
proteins and associated##2##3##(2006-12#1)(2007-6#1)
proteins and by##2##3##(1992-8#1)(2008-10#1)
proteins and can be##2##4##(2007-11#1)(2010-11#1)
proteins and carbohydrates in the##2##5##(2009-2#1)(2011-1#1)
proteins and cells##2##3##(2009-12#1)(2009-3#1)
proteins and could##2##3##(1994-9#1)(2010-12#1)
proteins and endogenous##2##3##(2008-10#2)
proteins and enzymes##2##3##(1990-12#1)(2008-5#1)
proteins and for##2##3##(1997-4#1)(2007-8#1)
proteins and formation and##2##4##(2008-10#1)(2011-2#1)
proteins and found##2##3##(2008-5#1)(2009-8#1)
proteins and functions##2##3##(2008-9#1)(2013-1#1)
proteins and have##2##3##(1992-6#1)(2006-8#1)
proteins and identified##2##3##(2008-10#1)(2008-7#1)
proteins and in##7##3##(1990-3#1)(1994-9#1)(1995-8#1)(2008-7#1)(2009-6#1)(2009-8#1)(2011-1#1)
proteins and inhibits##2##3##(1991-12#1)(1996-5#1)
proteins and is##2##3##(1997-1#1)(2009-4#1)
proteins and its function##2##4##(2008-9#1)(2011-3#1)
proteins and its modulation by##2##5##(1990-3#2)
proteins and its##7##3##(1990-3#2)(1991-9#1)(2008-5#1)(2008-9#1)(2009-6#1)(2011-3#1)
proteins and lipids##12##3##(1990-2#1)(1993-11#1)(1995-3#1)(2007-9#1)(2008-1#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#2)(2012-2#1)
proteins and may##2##3##(1993-11#1)(2008-10#1)
proteins and membrane##3##3##(2006-10#1)(2008-7#1)(2008-8#1)
proteins and nuclear##3##3##(1991-3#1)(1995-2#1)(1997-2#1)
proteins and nucleic acids##8##4##(1992-1#1)(1995-2#1)(2005-1#1)(2007-11#1)(2008-4#2)(2008-6#1)(2012-3#1)
proteins and of##6##3##(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#1)(1995-8#1)(1997-8#1)
proteins and other biological macromolecules##2##5##(1996-11#1)(2006-10#1)
proteins and other##6##3##(1990-11#1)(1994-8#1)(1996-11#1)(2006-10#1)(2008-4#2)
proteins and peptides##15##3##(1991-3#1)(1992-12#1)(1994-3#1)(1995-2#1)(1996-3#1)(1996-5#2)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2011-3#1)(2013-1#1)
proteins and play##2##3##(1992-11#1)(1997-8#1)
proteins and receptors##2##3##(1995-1#1)(2013-8#1)
proteins and related##2##3##(1990-11#1)(2012-1#1)
proteins and salts##2##3##(1993-2#1)(2006-12#1)
proteins and should be##2##4##(1992-12#1)(1993-12#1)
proteins and small##4##3##(1996-5#1)(2008-10#1)(2008-7#1)(2012-2#1)
proteins and so##2##3##(1992-4#1)(2007-11#1)
proteins and subsequent##2##3##(1991-2#1)(2011-1#1)
proteins and that##4##3##(1993-3#1)(1994-3#1)(1994-8#1)(1997-2#1)
proteins and the##27##3##(1990-6#1)(1990-7#1)(1991-5#1)(1994-12#1)(1994-9#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-10#2)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#2)(2009-5#1)(2009-8#2)(2010-4#1)(2011-2#1)(2013-7#1)(2013-8#1)
proteins and their interaction with##2##5##(1995-2#1)(1995-6#1)
proteins and their##14##3##(1990-5#1)(1991-10#1)(1991-2#1)(1993-9#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-11#1)(2008-4#3)(2012-1#3)
proteins and thus##3##3##(1992-7#1)(2005-7#1)(2009-2#1)
proteins and to##3##3##(1993-1#1)(2007-8#1)(2008-4#1)
proteins and transcription factors##2##4##(2008-10#1)(2008-8#1)
proteins and transcriptional factors##3##4##(1991-5#1)(2008-9#2)
proteins and used##2##3##(1991-10#1)(2008-11#1)
proteins and various##4##3##(1991-5#1)(1994-12#1)(1996-12#1)(2007-11#1)
proteins and with##2##3##(1996-1#1)(1997-4#1)
proteins and##419##2##(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#3)(1990-5#3)(1990-6#2)(1990-7#3)(1990-8#1)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#2)(1991-4#3)(1991-5#6)(1991-6#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#4)(1993-8#2)(1993-9#2)(1994-11#5)(1994-12#3)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#6)(1995-1#4)(1995-12#3)(1995-2#6)(1995-3#2)(1995-6#4)(1995-7#1)(1995-8#6)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#6)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#6)(1997-4#4)(1997-6#1)(1997-8#2)(2005-1#1)(2005-10#2)(2005-11#3)(2005-7#1)(2006-10#11)(2006-12#6)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#6)(2007-12#2)(2007-2#2)(2007-5#1)(2007-6#2)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#24)(2008-11#13)(2008-2#5)(2008-4#22)(2008-5#10)(2008-6#4)(2008-7#12)(2008-8#7)(2008-9#7)(2009-10#2)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#4)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#9)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#6)(2010-7#1)(2011-1#8)(2011-2#8)(2011-3#3)(2012-1#5)(2012-12#3)(2012-2#7)(2012-3#2)(2012-6#1)(2013-1#11)(2013-7#2)(2013-8#5)
proteins and/or##6##2##(1997-3#1)(2007-11#1)(2008-3#1)(2009-3#1)(2010-1#1)(2013-1#1)
proteins appear to have##2##4##(1991-4#1)(1992-5#1)
proteins appear to##4##3##(1991-4#1)(1992-5#1)(1994-11#1)(2008-4#1)
proteins appear##5##2##(1991-4#1)(1992-5#1)(1994-11#1)(2008-4#1)(2009-9#1)
proteins appears##2##2##(2007-6#1)(2009-8#1)
proteins are a##3##3##(1993-3#1)(2006-10#1)(2010-3#1)
proteins are able to##2##4##(1994-12#1)(2012-12#1)
proteins are abundant##2##3##(1994-3#1)(2008-8#1)
proteins are also##7##3##(1990-10#1)(1994-6#1)(2008-4#2)(2012-12#3)
proteins are an##2##3##(2007-8#1)(2008-4#1)
proteins are associated with##2##4##(1997-3#1)(2011-2#1)
proteins are being##2##3##(2005-8#1)(2007-11#1)
proteins are bound##4##3##(2005-10#1)(2008-2#1)(2008-4#2)
proteins are capable of##2##4##(1992-11#1)(1995-2#1)
proteins are degraded##2##3##(1995-2#1)(2006-10#1)
proteins are described##3##3##(2008-1#1)(2008-4#1)(2008-8#1)
proteins are discussed##3##3##(1991-2#1)(2008-1#1)(2009-9#1)
proteins are encoded by##2##4##(1993-6#1)(1997-4#1)
proteins are encoded##3##3##(1993-6#1)(1997-4#1)(2005-8#1)
proteins are essential for##4##4##(1992-5#1)(2008-7#1)(2012-12#2)
proteins are essential##7##3##(1992-5#1)(1995-1#1)(2008-7#1)(2012-12#4)
proteins are expressed##3##3##(1993-5#1)(2008-1#1)(2008-7#1)
proteins are found in the##2##5##(1991-9#1)(1993-6#1)
proteins are found in##3##4##(1991-9#1)(1993-6#1)(2008-1#1)
proteins are found to##2##4##(1994-6#1)(1997-1#1)
proteins are found##5##3##(1991-9#1)(1993-6#1)(1994-6#1)(1997-1#1)(2008-1#1)
proteins are generally##2##3##(1992-6#1)(2012-1#1)
proteins are glycosylated##3##3##(1992-6#1)(2010-12#1)(2010-2#1)
proteins are highly##3##3##(1993-2#1)(2008-4#1)(2012-2#1)
proteins are identical##2##3##(1997-2#1)(2008-10#1)
proteins are important##3##3##(1992-12#1)(2009-2#1)(2012-12#1)
proteins are in##2##3##(1993-6#1)(1997-6#1)
proteins are induced##3##3##(1994-8#1)(1994-9#1)(1997-2#1)
proteins are involved in the##2##5##(1992-12#1)(2008-9#1)
proteins are involved in##7##4##(1992-12#1)(1995-4#1)(1996-10#1)(1996-12#1)(2006-10#1)(2008-7#1)(2008-9#1)
proteins are involved##8##3##(1992-12#1)(1995-4#1)(1996-10#1)(1996-12#1)(2006-10#1)(2008-6#1)(2008-7#1)(2008-9#1)
proteins are key##3##3##(2008-1#1)(2011-1#1)(2011-12#1)
proteins are known to##3##4##(1995-8#1)(2010-11#1)(2013-1#1)
proteins are known##5##3##(1991-5#1)(1995-8#1)(2006-12#1)(2010-11#1)(2013-1#1)
proteins are localized##2##3##(1996-3#1)(1996-5#1)
proteins are located##2##3##(1991-1#1)(2011-2#1)
proteins are lost##2##3##(1991-2#1)(1995-6#1)
proteins are modified##3##3##(2006-11#1)(2008-5#1)(2010-1#1)
proteins are not##9##3##(1994-11#1)(1995-10#1)(1996-4#1)(1997-4#1)(1997-7#1)(2005-8#1)(2006-10#1)(2008-4#1)(2009-8#1)
proteins are now##2##3##(2005-7#1)(2012-12#1)
proteins are of##2##3##(2007-10#1)(2013-8#1)
proteins are often##3##3##(2008-2#1)(2008-4#1)(2008-8#1)
proteins are phosphorylated##2##3##(1994-11#1)(1997-2#1)
proteins are present in##3##4##(1992-8#1)(1993-11#1)(2013-1#1)
proteins are present##4##3##(1992-8#1)(1993-11#1)(2008-4#1)(2013-1#1)
proteins are related##2##3##(1990-7#1)(1997-2#1)
proteins are required for the##2##5##(1993-12#1)(2012-3#1)
proteins are required for##3##4##(1993-12#1)(1995-6#1)(2012-3#1)
proteins are required##4##3##(1991-4#1)(1993-12#1)(1995-6#1)(2012-3#1)
proteins are responsible for##2##4##(1992-12#1)(2007-6#1)
proteins are separated##4##3##(2008-10#1)(2008-2#1)(2008-4#2)
proteins are shed##2##3##(2009-9#2)
proteins are synthesized##4##3##(1994-5#1)(1996-9#1)(2008-1#1)(2008-4#1)
proteins are the##6##3##(1990-3#1)(1992-4#1)(1993-11#1)(1995-2#1)(2009-4#1)(2013-8#1)
proteins are transcription factors##2##4##(2005-8#1)(2012-2#1)
proteins are transcription##3##3##(2005-8#1)(2008-7#1)(2012-2#1)
proteins are ubiquitinated##2##3##(1994-2#2)
proteins are unknown##2##3##(1994-6#1)(1995-2#1)
proteins are well##2##3##(2008-1#1)(2008-4#1)
proteins are##264##2##(1990-10#1)(1990-11#2)(1990-3#1)(1990-4#2)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#3)(1991-2#3)(1991-4#3)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#3)(1992-4#1)(1992-5#2)(1992-6#3)(1992-8#2)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#5)(1993-9#1)(1994-11#3)(1994-12#3)(1994-2#3)(1994-3#2)(1994-5#4)(1994-6#5)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#2)(1995-4#2)(1995-5#1)(1995-6#2)(1995-8#3)(1996-1#1)(1996-10#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#4)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#1)(2005-10#1)(2005-7#1)(2005-8#4)(2006-10#6)(2006-11#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#7)(2008-10#3)(2008-11#2)(2008-2#4)(2008-4#25)(2008-5#2)(2008-6#1)(2008-7#9)(2008-8#3)(2008-9#2)(2009-10#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#4)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#10)(2012-2#5)(2012-3#2)(2013-1#6)(2013-8#3)
proteins as a##2##3##(1990-5#1)(1994-11#1)
proteins as both##2##3##(1995-1#1)(2012-12#1)
proteins as potential##2##3##(2008-7#1)(2010-6#1)
proteins as sensor of##2##4##(2010-12#2)
proteins as the##4##3##(1990-7#2)(2007-8#1)(2011-2#1)
proteins as well as##6##4##(1990-4#1)(1993-3#1)(2007-12#1)(2008-1#1)(2008-7#1)(2012-2#1)
proteins as well##8##3##(1990-4#1)(1993-3#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2012-2#1)
proteins as##50##2##(1990-4#2)(1990-5#1)(1990-7#2)(1991-4#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-6#1)(1997-7#1)(2005-8#1)(2006-11#2)(2006-12#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-8#2)(2010-11#1)(2010-12#3)(2010-5#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
proteins assemble##2##2##(2007-8#1)(2012-2#1)
proteins associate##2##2##(1995-1#1)(2010-4#1)
proteins associated with nascent##2##4##(1990-12#1)(1996-4#1)
proteins associated with the##3##4##(1990-8#1)(1993-12#1)(1997-8#1)
proteins associated with##17##3##(1990-12#1)(1990-8#1)(1991-1#1)(1992-12#1)(1993-12#1)(1995-10#1)(1996-4#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-1#1)
proteins at the apical##2##4##(2012-2#2)
proteins at the interface##2##4##(1994-9#1)(2008-7#1)
proteins at the##14##3##(1993-5#1)(1993-8#1)(1994-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-1#1)(2012-2#5)(2012-3#1)(2013-8#1)
proteins at##36##2##(1990-12#1)(1990-5#1)(1991-3#1)(1992-6#1)(1992-8#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-3#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-7#2)(2009-10#1)(2009-3#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
proteins based on the interaction##2##5##(2008-10#2)
proteins based on the##5##4##(1994-9#1)(2008-10#3)(2008-7#1)
proteins based on##7##3##(1994-9#1)(2008-10#3)(2008-7#1)(2011-3#1)(2012-2#1)
proteins bearing##4##2##(1990-6#1)(1995-3#1)(2007-8#1)(2009-12#1)
proteins become##2##2##(1996-5#1)(2007-8#1)
proteins before##3##2##(1992-8#1)(1993-11#1)(1997-4#1)
proteins belonging to the##6##4##(1991-2#3)(1992-6#1)(1997-6#1)(2009-12#1)
proteins belonging to##9##3##(1991-2#3)(1992-6#1)(1995-12#1)(1995-8#1)(1997-6#1)(2008-7#1)(2009-12#1)
proteins between the##2##3##(1993-3#1)(2006-12#1)
proteins between##7##2##(1990-8#1)(1993-3#1)(1993-8#2)(2006-12#1)(2008-4#1)(2009-5#1)
proteins bind to##3##3##(1996-4#1)(2008-4#1)(2008-9#1)
proteins bind##4##2##(1996-12#1)(1996-4#1)(2008-4#1)(2008-9#1)
proteins binding to the##3##4##(1992-11#1)(1996-12#1)(1996-5#1)
proteins binding to##4##3##(1992-11#1)(1995-8#1)(1996-12#1)(1996-5#1)
proteins binding##6##2##(1992-11#1)(1994-9#1)(1995-8#1)(1996-12#1)(1996-5#1)(2009-5#1)
proteins both##2##2##(2008-10#1)(2008-7#1)
proteins bound to the##5##4##(1990-4#1)(1992-5#1)(1993-8#1)(1994-8#1)(2012-2#1)
proteins bound to##8##3##(1990-4#1)(1991-11#1)(1992-12#1)(1992-5#1)(1993-8#1)(1994-12#1)(1994-8#1)(2012-2#1)
proteins bound##9##2##(1990-4#1)(1991-11#1)(1992-12#1)(1992-5#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-3#1)(2012-2#1)
proteins but also##2##3##(2008-7#1)(2010-11#1)
proteins but##9##2##(1990-11#1)(1992-2#1)(1993-6#1)(1995-1#1)(1995-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-11#1)
proteins by SDS-PAGE##3##3##(1993-2#1)(1993-8#1)(2008-4#1)
proteins by UV##2##3##(2008-2#1)(2008-4#1)
proteins by a##4##3##(1995-11#1)(1995-8#1)(1996-12#1)(2008-11#1)
proteins by binding##2##3##(2004-11#1)(2009-12#1)
proteins by electrophoresis##2##3##(2009-12#1)(2013-8#1)
proteins by high##2##3##(1995-8#1)(2008-8#1)
proteins by sodium dodecyl##2##4##(1995-7#1)(2012-2#1)
proteins by the##6##3##(1990-11#1)(1995-8#1)(1996-12#1)(2006-5#1)(2008-10#1)(2008-11#1)
proteins by two-dimensional##3##3##(1990-6#1)(1994-8#1)(1995-12#1)
proteins by using##3##3##(1992-3#1)(2006-12#1)(2008-10#1)
proteins by yeast##2##3##(1991-8#1)(2008-9#1)
proteins by##93##2##(1990-11#2)(1990-2#2)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-2#1)(1991-3#1)(1991-8#2)(1991-9#1)(1992-12#3)(1992-3#2)(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-3#3)(1995-7#1)(1995-8#4)(1996-12#3)(1997-2#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2006-1#1)(2006-12#1)(2006-5#1)(2007-12#2)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#5)(2008-2#3)(2008-4#7)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#2)(2012-2#1)(2013-8#1)
proteins can be analyzed##3##4##(2008-4#3)
proteins can be considered as##2##5##(1990-11#1)(2006-2#1)
proteins can be studied##2##4##(2007-12#1)(2008-1#1)
proteins can be used##3##4##(2006-12#1)(2008-1#1)(2008-4#1)
proteins can be##32##3##(1990-11#1)(1991-5#1)(1993-6#2)(1993-9#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1997-2#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-12#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#7)(2009-5#1)(2012-2#1)(2013-1#1)
proteins can##47##2##(1990-11#1)(1991-5#1)(1992-6#1)(1993-6#2)(1993-9#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-2#1)(1997-2#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-12#1)(2008-1#6)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#10)(2008-5#1)(2009-5#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
proteins carrying##2##2##(1994-12#1)(1995-3#1)
proteins compared to##2##3##(1990-7#1)(1996-11#1)
proteins comprises##2##2##(2008-7#1)(2012-12#1)
proteins comprising the##3##3##(1995-8#1)(1997-2#1)(2008-10#1)
proteins comprising##5##2##(1995-2#1)(1995-8#1)(1997-2#1)(2008-10#1)(2008-4#1)
proteins consist of##2##3##(1992-6#1)(2009-7#1)
proteins constitute a##2##3##(1997-7#1)(2008-11#1)
proteins constitute##3##2##(1994-8#1)(1997-7#1)(2008-11#1)
proteins contain a##2##3##(1993-6#1)(1995-6#1)
proteins contain##8##2##(1990-3#1)(1992-7#1)(1993-6#1)(1995-1#1)(1995-6#2)(1997-7#1)(2013-1#1)
proteins contained##2##2##(1990-11#1)(2011-1#1)
proteins containing a##2##3##(1991-8#1)(1994-3#1)
proteins containing the##7##3##(1991-1#1)(1995-10#1)(1997-5#1)(2008-4#1)(2009-6#1)(2012-12#2)
proteins containing##26##2##(1991-1#1)(1991-8#1)(1992-12#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#2)(1996-10#2)(1996-2#1)(1997-5#1)(2008-10#1)(2008-4#4)(2009-10#1)(2009-6#1)(2010-11#1)(2011-2#1)(2012-12#2)(2013-1#1)
proteins content##4##2##(2008-10#2)(2008-12#2)
proteins contribute to the##3##4##(2008-6#1)(2013-1#1)(2013-8#1)
proteins contribute to##4##3##(2008-6#1)(2012-1#1)(2013-1#1)(2013-8#1)
proteins control##4##2##(1995-6#1)(2007-12#1)(2007-8#1)(2012-12#1)
proteins could be##6##3##(1990-4#1)(1994-11#1)(1995-8#1)(1996-8#1)(2008-6#1)(2009-2#1)
proteins could##15##2##(1990-10#1)(1990-4#1)(1991-12#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-8#1)(1996-8#1)(1996-9#1)(2007-2#1)(2008-6#1)(2009-2#1)(2009-8#1)(2013-1#1)
proteins cross-reacting##2##2##(1992-12#1)(1992-4#1)
proteins decreased##2##2##(1992-12#1)(1997-2#1)
proteins demonstrate##2##2##(1994-12#1)(2008-4#1)
proteins demonstrated that##2##3##(1992-12#1)(1997-2#1)
proteins derived from##6##3##(1991-2#1)(1992-6#1)(1993-5#1)(1994-12#1)(1994-3#1)(2006-12#1)
proteins described##2##2##(1991-4#1)(2006-10#1)
proteins destined for##2##3##(2008-10#1)(2008-4#1)
proteins detected in##2##3##(1996-2#1)(2005-12#1)
proteins did not##4##3##(1991-12#1)(1991-2#1)(1995-6#1)(1996-5#1)
proteins differ##3##2##(1992-1#1)(1995-3#1)(2008-9#1)
proteins differentially expressed in##2##4##(2009-8#1)(2010-4#1)
proteins differentially##3##2##(1993-11#1)(2009-8#1)(2010-4#1)
proteins directly from##2##3##(2008-4#2)
proteins directly##5##2##(1994-5#1)(2008-4#3)(2008-9#1)
proteins do not##4##3##(1990-9#1)(1991-8#1)(1997-3#1)(2013-1#1)
proteins does not##3##3##(1993-6#1)(1994-2#1)(1995-1#1)
proteins does##4##2##(1990-9#1)(1993-6#1)(1994-2#1)(1995-1#1)
proteins during development##4##3##(1990-5#1)(1993-5#1)(1994-3#1)(1995-5#1)
proteins during the##2##3##(1990-10#1)(2008-10#1)
proteins during##17##2##(1990-10#1)(1990-5#1)(1991-2#1)(1993-5#1)(1994-3#1)(1994-9#1)(1995-5#1)(1996-3#2)(2006-6#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-8#1)(2010-5#1)(2012-1#1)(2012-12#1)
proteins encoded by the mitochondrial genome##3##6##(1997-4#3)
proteins encoded by the##14##4##(1990-10#1)(1990-5#1)(1990-8#1)(1991-7#1)(1992-12#1)(1992-6#1)(1993-4#1)(1994-8#1)(1996-4#1)(1997-4#3)(2008-10#1)(2008-7#1)
proteins encoded by these##3##4##(1991-5#1)(1997-8#1)(2006-12#1)
proteins encoded by##26##3##(1990-10#1)(1990-3#1)(1990-5#1)(1990-8#2)(1991-5#1)(1991-7#1)(1992-12#1)(1992-6#1)(1993-4#1)(1993-6#2)(1994-12#1)(1994-8#1)(1996-4#1)(1997-4#3)(1997-8#1)(2006-12#1)(2008-10#3)(2008-7#1)(2009-8#1)(2012-3#1)
proteins encoded in the##3##4##(1995-8#1)(2008-4#2)
proteins encoded##31##2##(1990-10#1)(1990-3#1)(1990-5#1)(1990-8#2)(1991-5#1)(1991-7#1)(1992-12#1)(1992-6#1)(1993-4#1)(1993-6#2)(1994-12#1)(1994-8#1)(1995-8#1)(1996-4#1)(1997-4#3)(1997-8#1)(2006-12#1)(2008-10#3)(2008-4#2)(2008-7#1)(2009-8#1)(2012-3#1)(2013-1#2)
proteins especially##2##2##(2005-10#1)(2010-4#1)
proteins examined in##2##3##(1996-3#1)(1997-2#1)
proteins examined##5##2##(1990-9#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-9#1)
proteins exhibit##3##2##(1991-4#1)(1995-2#1)(2008-10#1)
proteins exhibited##4##2##(1990-7#1)(1994-2#1)(2008-1#1)(2008-10#1)
proteins exhibiting##2##2##(1992-8#1)(2008-11#1)
proteins exist##2##2##(1991-9#1)(1996-7#1)
proteins expressed by##5##3##(1991-10#1)(1991-5#1)(2006-10#1)(2008-4#1)(2009-3#1)
proteins expressed in E##2##4##(1992-8#1)(2008-4#1)
proteins expressed in##4##3##(1992-8#1)(1994-11#1)(2008-4#2)
proteins expressed##13##2##(1991-1#1)(1991-10#1)(1991-5#1)(1992-8#1)(1994-11#1)(2006-10#1)(2007-8#1)(2008-4#3)(2009-3#1)(2009-6#1)(2011-2#1)
proteins expression##2##2##(1994-5#1)(2011-1#1)
proteins extracted from the##3##4##(1993-7#1)(1994-5#1)(1996-8#1)
proteins extracted from##7##3##(1993-7#1)(1994-5#1)(1995-3#1)(1996-8#1)(2007-11#1)(2008-10#1)(2008-9#1)
proteins extracted##9##2##(1990-2#1)(1993-7#1)(1994-5#1)(1995-3#1)(1996-8#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-9#1)
proteins followed by##2##3##(2008-4#1)(2008-5#1)
proteins following##3##2##(1994-11#1)(1994-9#1)(1996-9#1)
proteins for diagnosis##2##3##(2008-1#2)
proteins for the##9##3##(1990-5#1)(1991-5#1)(1992-1#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)(2013-1#1)
proteins for use in##3##4##(1995-5#1)(2008-2#1)(2008-4#1)
proteins for which##6##3##(1991-4#1)(1992-8#1)(2008-2#1)(2008-4#2)(2011-1#1)
proteins for##63##2##(1990-5#1)(1991-10#1)(1991-4#2)(1991-5#1)(1991-8#1)(1992-1#3)(1992-11#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-8#1)(1997-1#1)(1997-4#1)(2007-6#1)(2007-8#2)(2008-1#4)(2008-10#1)(2008-11#6)(2008-12#1)(2008-2#2)(2008-4#6)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#2)
proteins form a##3##3##(1997-1#1)(2008-11#1)(2008-8#1)
proteins form the##2##3##(2008-1#1)(2011-2#1)
proteins form##10##2##(1995-1#1)(1997-1#1)(2008-1#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-8#1)(2011-2#2)
proteins found in the##4##4##(1993-9#1)(1995-2#1)(2009-3#1)(2010-11#1)
proteins found in##10##3##(1993-9#1)(1994-9#1)(1995-2#1)(1996-5#1)(1997-1#1)(1997-3#1)(2007-8#1)(2009-3#1)(2010-11#1)(2011-12#1)
proteins found##11##2##(1993-9#1)(1994-9#1)(1995-2#1)(1996-5#1)(1997-1#1)(1997-3#1)(2007-8#1)(2008-1#1)(2009-3#1)(2010-11#1)(2011-12#1)
proteins from Arabidopsis##2##3##(1994-3#1)(2008-4#1)
proteins from E##3##3##(1994-11#1)(2008-4#2)
proteins from Escherichia coli##3##4##(2008-4#3)
proteins from a##4##3##(1990-12#1)(1995-1#1)(1995-8#1)(2008-1#1)
proteins from bacteria##2##3##(1997-4#1)(2008-1#1)
proteins from bovine and##2##4##(1994-5#1)(1994-9#1)
proteins from bovine##4##3##(1990-4#1)(1993-8#1)(1994-5#1)(1994-9#1)
proteins from cell##2##3##(1994-9#1)(2008-11#1)
proteins from different##4##3##(1992-11#1)(1993-6#1)(1996-8#1)(2008-9#1)
proteins from each of##2##4##(1995-5#1)(2008-10#1)
proteins from each##3##3##(1992-2#1)(1995-5#1)(2008-10#1)
proteins from eubacterial##2##3##(1992-5#1)(1992-8#1)
proteins from five##4##3##(1995-11#1)(2008-10#1)(2011-12#2)
proteins from genetically##3##3##(2006-12#2)(2011-2#1)
proteins from higher##2##3##(1992-12#1)(1992-6#1)
proteins from human##2##3##(1991-2#1)(1994-12#1)
proteins from liver##2##3##(1992-7#1)(1993-12#1)
proteins from maize##2##3##(1995-2#1)(2008-10#1)
proteins from mammalian##2##3##(1993-6#1)(1995-2#1)
proteins from mouse##2##3##(1991-2#1)(1993-12#1)
proteins from normal##2##3##(1990-7#1)(1992-8#1)
proteins from other##7##3##(1991-12#1)(1992-5#1)(1992-8#1)(1994-5#2)(1995-9#1)(1997-2#1)
proteins from rat##4##3##(1990-4#1)(1991-4#1)(1992-4#1)(1994-2#1)
proteins from the secretory##3##4##(1990-6#2)(1996-5#1)
proteins from the##34##3##(1990-5#1)(1990-6#3)(1991-11#1)(1991-12#1)(1992-2#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-8#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-8#2)(2005-11#1)(2006-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#2)(2009-10#2)(2009-7#1)(2010-12#1)
proteins from various##3##3##(1991-8#1)(1994-5#1)(2008-7#1)
proteins from whole-cell extracts##6##4##(2008-2#2)(2008-4#4)
proteins from whole-cell lysates##2##4##(2008-4#2)
proteins from whole-cell##8##3##(2008-2#2)(2008-4#6)
proteins from yeast##2##3##(1994-11#1)(1995-6#1)
proteins from##177##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#3)(1990-5#4)(1990-6#3)(1990-7#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#3)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#4)(1993-8#1)(1994-11#4)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#7)(1994-6#1)(1994-8#1)(1994-9#5)(1995-1#2)(1995-10#1)(1995-11#2)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-7#1)(1996-8#2)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-8#3)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#4)(2006-2#1)(2006-8#2)(2007-2#1)(2008-1#3)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#19)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#4)(2009-10#3)(2009-7#2)(2010-12#2)(2010-4#2)(2010-6#1)(2011-12#2)(2011-2#1)(2011-3#1)(2013-1#1)
proteins function##2##2##(1994-11#1)(2012-12#1)
proteins fused to##2##3##(2008-4#2)
proteins gD##2##2##(2013-8#2)
proteins generate##2##2##(1995-6#1)(2012-1#1)
proteins generated##3##2##(1995-3#1)(1995-8#1)(1996-5#1)
proteins genes##2##2##(2005-11#1)(2008-8#1)
proteins had##7##2##(1990-2#1)(1990-6#1)(1991-12#1)(1992-5#1)(1994-2#1)(1994-9#1)(2008-10#1)
proteins has allowed##2##3##(1993-6#1)(2010-4#1)
proteins has been developed##2##4##(2008-10#2)
proteins has been##20##3##(1990-2#1)(1990-3#1)(1992-6#1)(1995-1#1)(1996-11#2)(1996-3#1)(1996-8#1)(1997-6#3)(2005-11#1)(2005-8#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-8#1)(2009-3#1)(2013-1#1)
proteins has##28##2##(1990-2#1)(1990-3#1)(1991-10#1)(1992-6#1)(1993-6#1)(1995-1#1)(1996-11#2)(1996-3#1)(1996-8#1)(1997-4#1)(1997-6#3)(2005-11#1)(2005-8#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)(2009-3#1)(2010-4#1)(2012-12#1)(2013-1#1)
proteins have a##3##3##(1991-6#1)(1994-12#1)(1995-11#1)
proteins have been found to##2##5##(1996-2#1)(2011-2#1)
proteins have been identified in##2##5##(1992-12#1)(2011-1#1)
proteins have been identified##7##4##(1992-12#1)(1996-5#1)(2005-8#1)(2008-7#1)(2010-2#1)(2011-1#1)(2011-2#1)
proteins have been investigated in##2##5##(1990-7#1)(1995-4#1)
proteins have been produced##3##4##(1997-4#1)(2005-7#2)
proteins have been shown to be##4##6##(1992-3#1)(2006-8#1)(2008-11#1)(2009-8#1)
proteins have been##33##3##(1990-7#1)(1990-9#1)(1991-10#1)(1992-12#1)(1992-3#1)(1995-2#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#2)(2005-7#2)(2005-8#1)(2006-2#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-3#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#2)
proteins have evolved##3##3##(1990-1#1)(1994-8#1)(2012-2#1)
proteins have the same##2##4##(2008-7#1)(2009-10#1)
proteins have the##3##3##(2008-7#2)(2009-10#1)
proteins have##69##2##(1990-1#1)(1990-11#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#2)(1997-1#2)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#2)(2005-7#2)(2005-8#2)(2006-10#3)(2006-2#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#5)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
proteins having##4##2##(1991-4#1)(1994-12#1)(2008-11#1)(2012-2#1)
proteins homologous to##5##3##(1994-12#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-4#1)
proteins identified by##2##3##(1997-6#1)(2007-12#1)
proteins identified##9##2##(1991-12#1)(1991-4#1)(1997-4#1)(1997-6#1)(2005-8#1)(2007-12#1)(2008-10#1)(2011-3#1)(2013-1#1)
proteins if##2##2##(1996-11#1)(1996-7#1)
proteins immunoreactivity##2##2##(1995-8#2)
proteins implicated in##3##3##(1995-11#1)(1996-12#1)(2010-2#1)
proteins important for##2##3##(1997-1#1)(2009-4#1)
proteins important##3##2##(1994-8#1)(1997-1#1)(2009-4#1)
proteins in Arabidopsis##4##3##(2009-8#3)(2011-10#1)
proteins in BCG##2##3##(1995-5#2)
proteins in Dictyostelium##2##3##(1993-6#1)(1995-8#1)
proteins in E##5##3##(1991-12#1)(1993-11#1)(1995-11#1)(1996-7#1)(2008-4#1)
proteins in Escherichia coli##8##4##(1990-11#1)(1991-12#1)(1991-5#1)(1994-12#1)(1994-5#1)(1995-11#1)(2005-11#1)(2008-4#1)
proteins in Saccharomyces cerevisiae##2##4##(1991-1#1)(1997-3#1)
proteins in a single##2##4##(2008-4#1)(2010-12#1)
proteins in a##20##3##(1990-12#1)(1992-12#2)(1992-3#1)(1994-12#1)(1994-5#1)(1995-3#1)(1997-4#1)(1997-7#1)(2006-12#2)(2007-11#1)(2008-12#1)(2008-2#1)(2008-4#3)(2008-7#1)(2010-12#1)(2013-1#1)
proteins in active##2##3##(1990-12#1)(1990-9#1)
proteins in an##4##3##(1990-12#1)(1997-4#1)(1997-6#1)(2009-5#1)
proteins in animal##2##3##(1993-2#1)(2009-8#1)
proteins in any##2##3##(1994-10#1)(2008-2#1)
proteins in aqueous##2##3##(2006-10#1)(2008-10#1)
proteins in association with##2##4##(1990-11#1)(1992-5#1)
proteins in bacterial##2##3##(1995-6#1)(2008-10#1)
proteins in bovine##2##3##(1990-7#2)
proteins in brain##2##3##(1992-1#1)(1994-11#1)
proteins in cancer##5##3##(2010-12#1)(2011-2#1)(2012-12#3)
proteins in cell##4##3##(1992-6#1)(1996-5#1)(2008-1#1)(2008-6#1)
proteins in cells expressing##2##4##(1994-12#1)(1995-3#1)
proteins in cells##7##3##(1994-12#1)(1995-3#2)(2008-1#1)(2008-4#1)(2008-9#1)(2010-10#1)
proteins in complex mixtures##2##4##(2008-1#1)(2008-4#1)
proteins in complex samples##2##4##(2008-4#1)(2010-11#1)
proteins in complex##6##3##(2007-11#1)(2008-1#1)(2008-4#3)(2010-11#1)
proteins in cultured cells##3##4##(1996-1#1)(2008-4#1)(2012-12#1)
proteins in cultured##5##3##(1991-6#1)(1994-10#1)(1996-1#1)(2008-4#1)(2012-12#1)
proteins in different##2##3##(2008-11#1)(2012-1#1)
proteins in eukaryotic##2##3##(1991-9#1)(2008-2#1)
proteins in gels##3##3##(2008-2#1)(2008-4#2)
proteins in higher##2##3##(1995-1#1)(2009-8#1)
proteins in human serum##3##4##(2008-10#2)(2008-4#1)
proteins in human##21##3##(1990-12#1)(1990-4#1)(1990-5#1)(1991-1#1)(1991-3#2)(1991-4#1)(1993-12#1)(1994-7#1)(1995-1#1)(1997-6#1)(2004-11#1)(2008-10#3)(2008-4#2)(2008-9#1)(2009-5#1)(2010-6#1)(2011-2#1)
proteins in infected##3##3##(2008-10#2)(2009-8#1)
proteins in live##2##3##(2008-1#1)(2008-3#1)
proteins in living##2##3##(1993-4#1)(2007-8#1)
proteins in mammalian cells##3##4##(1992-11#1)(1992-12#1)(2007-6#1)
proteins in mammalian##4##3##(1992-11#1)(1992-12#1)(1995-8#1)(2007-6#1)
proteins in melanogenesis##2##3##(1996-9#2)
proteins in membranes##2##3##(1991-9#1)(1992-6#1)
proteins in mouse peritoneal macrophages##2##5##(1993-6#2)
proteins in mouse##4##3##(1992-6#1)(1993-2#1)(1993-6#2)
proteins in murine##2##3##(1992-6#1)(2008-11#1)
proteins in other##3##3##(1992-9#1)(2008-8#1)(2009-6#1)
proteins in patients##2##3##(1997-3#1)(2013-8#1)
proteins in peritoneal##2##3##(1991-4#1)(1992-9#1)
proteins in photosynthetic organisms##2##4##(2008-7#1)(2009-10#1)
proteins in plasma##2##3##(1995-6#1)(2005-11#1)
proteins in rat skeletal muscle##2##5##(2008-8#2)
proteins in rat##8##3##(1990-7#2)(1991-4#1)(1994-3#1)(1996-2#1)(1997-7#1)(2008-8#2)
proteins in regulation of##2##4##(1991-1#1)(1993-6#1)
proteins in response to##3##4##(1993-9#1)(1997-2#1)(2009-12#1)
proteins in solution##10##3##(1990-12#1)(1991-9#1)(1995-4#1)(2006-10#2)(2008-10#1)(2008-4#4)
proteins in the cell##2##4##(2007-9#1)(2010-4#1)
proteins in the cells##3##4##(1990-2#1)(1990-3#1)(2008-8#1)
proteins in the control of##2##5##(1994-11#1)(1996-5#1)
proteins in the database##2##4##(1996-10#1)(1997-2#1)
proteins in the development of##2##5##(1995-6#1)(2008-11#1)
proteins in the human##3##4##(1994-2#1)(1994-8#1)(1997-2#1)
proteins in the presence of##4##5##(1994-10#1)(1995-5#1)(2008-10#2)
proteins in the range 0##2##5##(2005-11#1)(2008-10#1)
proteins in the range##3##4##(1995-2#1)(2005-11#1)(2008-10#1)
proteins in the rat##3##4##(1995-6#1)(1996-5#1)(2009-2#1)
proteins in the regulation of##3##5##(1994-8#1)(2005-8#1)(2008-4#1)
proteins in the skin##2##4##(2008-5#1)(2009-8#1)
proteins in the##128##3##(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#2)(1990-7#1)(1990-9#2)(1991-1#2)(1991-11#1)(1991-2#2)(1991-4#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#1)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#1)(1994-8#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1995-7#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#1)(1997-7#1)(2004-12#2)(2005-11#1)(2005-8#1)(2006-1#2)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#9)(2008-11#3)(2008-2#2)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#3)(2010-12#2)(2010-4#1)(2011-12#1)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#3)(2012-6#1)(2013-1#2)(2013-8#2)
proteins in their##5##3##(2006-10#1)(2007-11#1)(2008-8#1)(2009-8#1)(2013-8#1)
proteins in these##3##3##(1997-2#1)(2009-7#1)(2010-11#1)
proteins in tissue##2##3##(1996-12#1)(2012-12#1)
proteins in two##2##3##(1991-4#1)(1995-8#1)
proteins in two-dimensional##2##3##(1993-11#1)(1994-12#1)
proteins in vitro##9##3##(1991-4#1)(1994-5#1)(1995-1#1)(1996-4#1)(1997-4#2)(1997-6#1)(2005-10#1)(2009-10#1)
proteins in vivo##5##3##(1991-4#1)(1995-4#1)(1996-4#1)(2009-10#2)
proteins in western##2##3##(1990-3#1)(2008-10#1)
proteins in which##2##3##(1992-7#1)(1994-6#1)
proteins in yeast##5##3##(1991-5#1)(1991-7#2)(1994-11#1)(1996-7#1)
proteins in##570##2##(1990-11#9)(1990-12#8)(1990-2#2)(1990-3#5)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#5)(1990-9#3)(1991-1#6)(1991-10#3)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#2)(1991-4#7)(1991-5#3)(1991-6#2)(1991-7#2)(1991-9#7)(1992-1#1)(1992-11#2)(1992-12#6)(1992-3#3)(1992-5#3)(1992-6#7)(1992-7#1)(1992-8#3)(1992-9#2)(1993-11#4)(1993-12#5)(1993-2#5)(1993-3#3)(1993-4#2)(1993-6#7)(1993-8#2)(1993-9#2)(1994-10#3)(1994-11#10)(1994-12#9)(1994-2#4)(1994-3#6)(1994-5#7)(1994-6#3)(1994-7#1)(1994-8#4)(1994-9#6)(1995-1#4)(1995-11#5)(1995-12#2)(1995-2#5)(1995-3#6)(1995-4#2)(1995-5#3)(1995-6#6)(1995-7#2)(1995-8#6)(1996-1#3)(1996-10#1)(1996-12#4)(1996-2#1)(1996-3#4)(1996-4#3)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#3)(1997-2#6)(1997-3#3)(1997-4#6)(1997-6#3)(1997-7#3)(2004-11#1)(2004-12#2)(2005-10#1)(2005-11#5)(2005-8#3)(2006-1#3)(2006-10#8)(2006-11#1)(2006-12#8)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#7)(2007-12#4)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#8)(2008-10#31)(2008-11#11)(2008-12#2)(2008-2#8)(2008-3#1)(2008-4#29)(2008-5#3)(2008-6#4)(2008-7#16)(2008-8#16)(2008-9#7)(2009-10#5)(2009-12#2)(2009-2#2)(2009-3#2)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#14)(2010-10#2)(2010-11#4)(2010-12#9)(2010-2#1)(2010-4#4)(2010-5#1)(2010-6#1)(2011-1#4)(2011-10#1)(2011-12#2)(2011-2#8)(2011-3#1)(2011-9#1)(2012-1#6)(2012-12#7)(2012-2#3)(2012-3#4)(2012-6#1)(2013-1#6)(2013-7#1)(2013-8#7)
proteins include##5##2##(2008-4#1)(2008-6#2)(2010-11#1)(2010-6#1)
proteins included##3##2##(2008-7#1)(2009-6#2)
proteins including human##3##3##(1991-8#1)(1996-11#1)(2011-2#1)
proteins including##23##2##(1991-8#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-11#1)(1994-6#1)(1994-9#1)(1996-11#1)(1997-2#1)(1997-4#1)(2007-12#3)(2008-11#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
proteins increased##3##2##(1990-12#1)(1994-3#1)(2011-2#1)
proteins increases with##2##3##(1995-6#1)(2006-10#1)
proteins indicate that##3##3##(1991-1#1)(1993-9#1)(1995-3#1)
proteins indicated that##3##3##(1990-7#1)(2008-10#2)
proteins indicates##2##2##(1997-6#1)(2009-10#1)
proteins induce##3##2##(2007-10#1)(2008-10#1)(2008-9#1)
proteins induced by##2##3##(1995-6#1)(2011-2#1)
proteins induced##5##2##(1995-6#1)(2006-8#1)(2011-2#1)(2012-2#1)(2013-7#1)
proteins interact with##2##3##(1994-9#1)(2011-1#1)
proteins interact##7##2##(1993-8#1)(1994-9#2)(1995-6#1)(1996-4#1)(2008-4#1)(2011-1#1)
proteins interacting with##8##3##(1991-8#1)(1994-8#1)(1995-3#1)(1997-6#1)(2007-12#1)(2008-7#1)(2008-8#1)(2012-12#1)
proteins into a##4##3##(1991-2#1)(1996-10#1)(2006-11#1)(2013-7#1)
proteins into mammalian##2##3##(1993-8#1)(2008-7#1)
proteins into the nucleus##2##4##(1995-1#1)(1997-4#1)
proteins into the##12##3##(1990-12#1)(1991-2#1)(1992-12#1)(1992-6#1)(1994-11#1)(1994-12#1)(1995-1#1)(1997-2#1)(1997-4#1)(2008-4#1)(2012-1#2)
proteins into##33##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-2#2)(1992-12#1)(1992-6#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(1996-10#1)(1997-2#1)(1997-4#1)(2006-11#1)(2007-8#1)(2008-10#2)(2008-4#4)(2008-7#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
proteins involved in DNA##2##4##(2009-8#1)(2009-9#1)
proteins involved in a##2##4##(2008-4#1)(2008-7#1)
proteins involved in cell##3##4##(2007-6#1)(2011-3#1)(2013-7#1)
proteins involved in the regulation of##3##6##(1996-2#1)(1996-5#1)(2008-4#1)
proteins involved in the##13##4##(1994-8#1)(1996-2#1)(1996-5#2)(2006-10#1)(2008-4#2)(2008-7#1)(2010-2#1)(2011-12#1)(2012-2#1)(2013-8#2)
proteins involved in##52##3##(1990-10#1)(1991-2#1)(1993-6#2)(1993-9#1)(1994-8#2)(1994-9#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-8#1)(2006-10#2)(2006-8#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#5)(2008-7#4)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2011-1#4)(2011-12#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#2)
proteins involved##55##2##(1990-10#1)(1991-2#1)(1993-6#2)(1993-9#1)(1994-8#2)(1994-9#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-8#1)(2006-10#3)(2006-8#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#5)(2008-7#5)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2011-1#4)(2011-12#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#2)
proteins is a promising##2##4##(2007-11#1)(2008-11#1)
proteins is a##12##3##(1992-9#1)(1993-8#1)(1995-3#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-4#2)(2012-3#1)(2013-1#1)(2013-8#1)
proteins is also##2##3##(2008-4#2)
proteins is an important##2##4##(1995-8#1)(2008-4#1)
proteins is controlled by##2##4##(1991-5#1)(2009-10#1)
proteins is described##3##3##(2008-4#1)(2008-7#1)(2012-2#1)
proteins is discussed##3##3##(1992-7#1)(1994-10#1)(2008-4#1)
proteins is essential##2##3##(2008-11#1)(2008-9#1)
proteins is markedly##3##3##(1994-11#1)(1994-9#1)(1995-3#1)
proteins is mediated by##2##4##(1994-3#1)(1997-4#1)
proteins is not##2##3##(1996-8#1)(2008-10#1)
proteins is one of the##2##5##(2007-2#1)(2008-11#1)
proteins is presented##5##3##(1993-6#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#1)
proteins is required for##2##4##(2008-5#1)(2011-1#1)
proteins is required##3##3##(1995-3#1)(2008-5#1)(2011-1#1)
proteins is still##2##3##(1997-3#1)(2009-4#1)
proteins is the##4##3##(2008-5#1)(2008-7#1)(2010-4#1)(2012-2#1)
proteins is##108##2##(1990-9#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-4#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-6#2)(1993-7#1)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-2#2)(1995-3#3)(1995-6#1)(1995-8#4)(1996-2#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-10#3)(2006-12#2)(2007-11#2)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#4)(2008-4#12)(2008-5#3)(2008-7#7)(2008-8#1)(2008-9#2)(2009-10#3)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-4#2)(2011-1#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#3)
proteins isolated from##11##3##(1990-2#1)(1990-4#1)(1992-6#1)(1994-2#1)(1995-3#2)(1995-7#1)(1996-5#1)(1997-2#1)(2006-8#1)(2007-11#1)
proteins isolated##13##2##(1990-2#1)(1990-4#1)(1992-6#1)(1994-2#1)(1995-3#2)(1995-7#1)(1996-5#1)(1997-2#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-9#1)
proteins known as##5##3##(1993-9#1)(1995-2#1)(2007-11#1)(2008-5#1)(2008-9#1)
proteins known to be##2##4##(1992-11#1)(2005-8#1)
proteins known to##5##3##(1992-11#1)(2005-8#1)(2006-7#1)(2012-7#1)(2013-1#1)
proteins known##11##2##(1990-12#1)(1992-11#1)(1993-9#1)(1995-2#1)(2005-8#1)(2006-7#1)(2007-11#1)(2008-5#1)(2008-9#1)(2012-7#1)(2013-1#1)
proteins labelled with##2##3##(1995-2#1)(1996-4#1)
proteins lead to##2##3##(2009-8#1)(2013-1#1)
proteins leading to the##2##4##(2008-5#1)(2013-1#1)
proteins like histones##2##3##(1990-3#1)(2008-5#1)
proteins like##6##2##(1990-3#1)(1994-3#1)(1994-8#1)(1997-6#1)(2008-11#1)(2008-5#1)
proteins likely##2##2##(1997-7#1)(2007-12#1)
proteins linked to bovine spongiform encephalopathy and its human form##2##10##(2007-9#2)
proteins linked to##3##3##(2007-9#2)(2011-1#1)
proteins localize##2##2##(1995-2#1)(2011-2#1)
proteins localized to##2##3##(1997-7#1)(2008-7#1)
proteins localized##5##2##(1994-8#1)(1997-7#1)(2008-7#2)(2008-9#1)
proteins located##2##2##(2010-2#2)
proteins made by##6##3##(1996-5#1)(2006-10#3)(2008-1#1)(2010-5#1)
proteins made##8##2##(1990-9#1)(1996-5#1)(2006-10#4)(2008-1#1)(2010-5#1)
proteins mainly##2##2##(2008-10#1)(2008-5#1)
proteins make##2##2##(2008-6#1)(2010-12#1)
proteins may act##2##3##(1991-5#1)(2009-2#1)
proteins may affect##2##3##(1990-3#1)(1997-6#1)
proteins may be involved in##2##5##(1997-7#1)(2008-8#1)
proteins may be##21##3##(1990-3#1)(1990-7#1)(1990-8#1)(1991-6#1)(1992-12#1)(1995-4#1)(1995-5#1)(1996-5#1)(1997-3#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-11#1)(2011-2#1)
proteins may function##2##3##(1996-5#1)(2007-8#1)
proteins may have##3##3##(1994-2#1)(2008-1#1)(2008-7#1)
proteins may play a role in##3##6##(1994-3#1)(1994-6#1)(1996-12#1)
proteins may play an important role in##2##7##(1997-7#1)(2008-8#1)
proteins may play an##3##4##(1997-7#1)(2007-6#1)(2008-8#1)
proteins may play##8##3##(1994-3#1)(1994-6#1)(1994-8#1)(1996-12#1)(1997-7#1)(2007-6#1)(2008-8#2)
proteins may represent##2##3##(1993-4#1)(1994-3#1)
proteins may##56##2##(1990-3#3)(1990-7#1)(1990-8#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-4#1)(1995-5#1)(1996-12#1)(1996-5#2)(1996-7#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#2)(2005-12#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-2#1)(2010-11#2)(2011-1#1)(2011-2#1)(2013-1#2)
proteins mediate the##2##3##(1990-10#1)(2009-10#1)
proteins mediate##6##2##(1990-10#1)(1994-6#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-10#1)
proteins might be##3##3##(1991-2#1)(1994-5#1)(2008-9#1)
proteins might##7##2##(1991-2#1)(1994-5#1)(1996-5#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-12#1)
proteins migrate in response to an electrical field through pores in a polyacrylamide gel matrix##2##15##(2008-2#1)(2008-4#1)
proteins migrate##3##2##(2008-2#1)(2008-4#2)
proteins modified by O-GlcNAc##2##4##(2008-11#1)(2008-2#1)
proteins modified by##6##3##(2008-11#1)(2008-2#2)(2008-4#1)(2009-6#1)(2010-12#1)
proteins modified##7##2##(1990-4#1)(2008-11#1)(2008-2#2)(2008-4#1)(2009-6#1)(2010-12#1)
proteins must##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
proteins named##2##2##(2008-8#1)(2011-2#1)
proteins not##3##2##(1995-10#1)(2007-11#1)(2008-6#1)
proteins observed in##2##3##(2005-8#1)(2013-8#1)
proteins obtained##4##2##(1990-5#1)(1991-5#1)(1994-8#1)(1995-3#1)
proteins occurring##2##2##(1990-5#1)(1994-5#1)
proteins occurs##5##2##(1990-10#2)(1995-8#1)(2008-4#1)(2012-12#1)
proteins of 15##2##3##(1993-11#1)(1997-4#1)
proteins of Foot-and-Mouth Disease Virus##2##5##(2005-6#2)
proteins of M##3##3##(1995-2#2)(2008-7#1)
proteins of M(r) =##3##4##(1992-9#1)(1993-8#2)
proteins of P##2##3##(1991-8#1)(2008-5#1)
proteins of Pseudomonas aeruginosa##2##4##(1995-2#1)(2008-12#1)
proteins of apparent##2##3##(1990-12#1)(1992-1#1)
proteins of approximately##4##3##(1990-11#1)(1991-10#1)(1992-12#1)(2013-8#1)
proteins of cyclins##2##3##(1997-6#2)
proteins of human##6##3##(1990-9#2)(1992-3#1)(1992-8#1)(1994-2#1)(1994-5#1)
proteins of influenza##2##3##(2011-1#1)(2012-3#1)
proteins of interest##18##3##(1991-10#1)(1994-3#1)(1994-5#1)(2005-11#1)(2006-10#1)(2008-11#1)(2008-2#2)(2008-4#7)(2008-7#1)(2008-9#1)(2012-2#1)
proteins of known structure##2##4##(2008-4#2)
proteins of known##3##3##(1994-9#1)(2008-4#2)
proteins of molecular weight##3##4##(1993-4#1)(2008-12#1)(2011-2#1)
proteins of molecular##4##3##(1993-4#1)(1994-12#1)(2008-12#1)(2011-2#1)
proteins of non-maternal serum origin##2##5##(1991-10#2)
proteins of other##3##3##(1992-2#1)(2008-10#1)(2008-8#1)
proteins of photosystem##2##3##(1994-12#1)(2008-7#1)
proteins of rat##3##3##(1991-8#1)(1994-6#1)(1995-12#1)
proteins of relative##2##3##(1991-11#1)(1993-6#1)
proteins of several##2##3##(1995-2#1)(1996-7#1)
proteins of the Mre11 complex in irradiated##2##7##(2011-2#2)
proteins of the Mre11 complex##3##5##(2011-2#3)
proteins of the cell surface##2##5##(2009-9#2)
proteins of the##45##3##(1990-10#1)(1990-6#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-12#1)(1995-3#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-5#4)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-9#2)(2011-1#1)(2011-2#3)(2013-1#1)
proteins of these##2##3##(1994-12#1)(2008-10#1)
proteins of two##2##3##(1990-8#1)(2008-10#1)
proteins of unknown function##5##4##(1997-1#1)(1997-7#1)(2008-10#1)(2008-7#2)
proteins of##235##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-3#2)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#4)(1991-1#1)(1991-10#4)(1991-11#1)(1991-12#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#5)(1992-1#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#3)(1993-8#4)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#6)(1994-2#3)(1994-3#3)(1994-5#2)(1994-6#1)(1994-9#3)(1995-12#2)(1995-2#10)(1995-3#4)(1995-6#2)(1995-7#1)(1995-8#5)(1995-9#2)(1996-10#1)(1996-11#2)(1996-12#1)(1996-5#7)(1996-7#2)(1996-9#3)(1997-1#2)(1997-2#1)(1997-4#3)(1997-6#2)(1997-7#3)(2005-11#2)(2005-6#2)(2006-10#4)(2006-11#2)(2006-12#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-9#1)(2008-10#21)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#9)(2008-5#7)(2008-7#8)(2008-8#5)(2008-9#5)(2009-10#1)(2009-12#1)(2009-8#1)(2009-9#2)(2011-1#2)(2011-12#1)(2011-2#6)(2012-11#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
proteins often##2##2##(2007-11#1)(2010-4#1)
proteins on a##7##3##(1994-5#1)(1995-7#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-7#1)(2013-8#1)
proteins on cell##2##3##(1991-9#1)(2008-4#1)
proteins on the basis of##3##5##(1995-2#1)(2008-10#1)(2013-8#1)
proteins on the surface of##4##5##(1994-11#1)(1995-2#2)(1996-8#1)
proteins on the##18##3##(1990-8#1)(1993-5#1)(1994-11#3)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#3)(1996-8#1)(2008-10#2)(2008-11#1)(2012-5#1)(2013-8#1)
proteins on##54##2##(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#2)(1995-2#3)(1995-7#1)(1996-11#1)(1996-8#1)(2005-11#3)(2007-6#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-2#2)(2008-4#3)(2008-7#1)(2009-7#1)(2012-2#1)(2012-5#1)(2013-1#2)(2013-8#2)
proteins only##4##2##(1991-2#1)(1992-9#1)(1997-7#1)(2008-10#1)
proteins onto##3##2##(2006-11#1)(2012-2#1)(2013-8#1)
proteins or DNA sequences##2##4##(1994-6#1)(1996-2#1)
proteins or DNA##4##3##(1994-6#1)(1996-2#1)(2008-12#1)(2008-4#1)
proteins or a##2##3##(1992-7#1)(2008-4#1)
proteins or other##4##3##(1991-8#1)(2008-10#1)(2009-3#2)
proteins or peptides##8##3##(1995-5#1)(1997-7#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-8#1)
proteins or protein##2##3##(2008-4#1)(2010-4#1)
proteins or the##2##3##(1990-12#1)(1997-7#1)
proteins or##51##2##(1990-12#2)(1990-9#1)(1991-4#2)(1991-8#1)(1992-7#1)(1994-6#1)(1994-7#1)(1995-10#1)(1995-5#1)(1996-2#1)(1997-7#2)(2005-12#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#9)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#2)(2010-4#1)(2011-12#1)(2013-1#1)(2013-7#2)(2013-8#1)
proteins other than##2##3##(1993-8#1)(1994-9#1)
proteins over##2##2##(1993-5#1)(2008-6#1)
proteins play a central role in##2##6##(2008-7#1)(2009-7#1)
proteins play a key role in##2##6##(2011-2#1)(2012-2#1)
proteins play a role in##3##5##(1992-8#1)(1995-8#1)(2008-7#1)
proteins play a##9##3##(1992-8#1)(1993-5#1)(1995-8#1)(2008-5#1)(2008-7#2)(2009-7#1)(2011-2#1)(2012-2#1)
proteins play an important role in##2##6##(2007-9#1)(2008-3#1)
proteins play important roles in##3##5##(1997-2#1)(2006-10#1)(2007-11#1)
proteins play in the##2##4##(1994-8#1)(2008-5#1)
proteins play##19##2##(1992-8#1)(1993-5#1)(1994-8#1)(1995-8#1)(1997-2#2)(2006-10#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-7#1)(2011-2#1)(2012-2#1)
proteins plays a##2##3##(1994-10#1)(1994-12#1)
proteins plays##3##2##(1994-10#1)(1994-12#1)(2008-1#1)
proteins possess##5##2##(1991-1#1)(1994-12#2)(2005-11#1)(2012-1#1)
proteins possessed##2##2##(1994-12#1)(2008-9#1)
proteins possessing##2##2##(1991-1#1)(1994-12#1)
proteins prepared from##2##3##(1995-10#1)(1995-8#1)
proteins prepared##3##2##(1995-10#1)(1995-8#1)(1996-2#1)
proteins present in the##6##4##(1991-5#1)(1993-8#1)(2008-10#2)(2008-11#2)
proteins present in##14##3##(1991-5#1)(1993-8#1)(1995-3#1)(1997-3#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)
proteins present##15##2##(1991-5#1)(1993-8#1)(1995-3#1)(1997-3#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2011-2#1)
proteins preventing##2##2##(1995-10#1)(2008-9#1)
proteins previously##2##2##(1995-2#1)(1996-4#1)
proteins prior to##2##3##(1996-1#1)(2008-10#1)
proteins produced by recombinant##2##4##(1993-12#1)(2007-11#1)
proteins produced by##9##3##(1990-2#1)(1993-12#1)(2004-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-3#1)(2011-2#1)
proteins produced in##3##3##(1990-7#1)(2008-4#1)(2008-7#1)
proteins produced##14##2##(1990-2#1)(1990-7#1)(1993-12#1)(1994-5#1)(2004-8#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2009-3#1)(2011-2#1)
proteins promote##2##2##(1991-2#1)(2007-12#1)
proteins protect##2##2##(1996-9#1)(2009-6#1)
proteins provide##4##2##(1991-4#1)(2005-8#1)(2008-7#1)(2010-4#1)
proteins purified from##3##3##(1991-8#1)(1993-9#1)(1996-9#1)
proteins purified##5##2##(1991-8#1)(1993-6#1)(1993-9#1)(1994-6#1)(1996-9#1)
proteins ranged from##2##3##(2008-10#2)
proteins ranging##3##2##(1990-3#1)(1995-8#1)(2008-10#1)
proteins reacted with##3##3##(1991-2#1)(1996-5#1)(2008-10#1)
proteins reacted##4##2##(1991-2#1)(1991-4#1)(1996-5#1)(2008-10#1)
proteins recently##2##2##(1997-7#1)(2010-5#1)
proteins recognize##2##2##(1994-12#1)(1996-5#1)
proteins recognized by the##2##4##(1991-9#1)(1992-3#1)
proteins recognized by##5##3##(1991-4#1)(1991-9#1)(1992-3#1)(1994-12#1)(2008-7#1)
proteins recognized##7##2##(1991-4#1)(1991-9#1)(1992-3#1)(1994-12#1)(1995-6#1)(2005-12#1)(2008-7#1)
proteins reduced##2##2##(1996-11#1)(2008-12#1)
proteins regulate the##2##3##(2008-11#1)(2008-4#1)
proteins regulate##3##2##(2007-8#1)(2008-11#1)(2008-4#1)
proteins regulating##3##2##(1996-3#1)(2007-10#1)(2008-1#1)
proteins related to the##3##4##(1991-5#1)(2006-10#1)(2007-8#1)
proteins related to##10##3##(1991-5#1)(1994-3#1)(1994-9#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#1)(2009-6#1)(2010-11#1)(2010-2#1)
proteins relating to##2##3##(1997-4#1)(2010-2#1)
proteins released##3##2##(1991-2#1)(1992-3#1)(2010-3#1)
proteins relevant##2##2##(2007-12#1)(2009-7#1)
proteins remain##2##2##(1996-5#1)(2009-6#1)
proteins remained##2##2##(2003-11#1)(2008-1#1)
proteins remains##3##2##(1997-7#1)(2007-8#1)(2009-7#1)
proteins represent##2##2##(1992-5#1)(1994-8#1)
proteins required for##11##3##(1990-7#1)(1990-9#1)(1993-6#1)(1993-9#1)(1996-9#1)(1997-6#1)(2007-12#1)(2008-4#1)(2009-6#1)(2011-2#1)(2012-12#1)
proteins requires##5##2##(1994-10#1)(1994-9#1)(1995-1#1)(2006-12#1)(2008-11#1)
proteins respectively##2##2##(2010-2#1)(2012-12#1)
proteins responsible for a##2##4##(1992-3#1)(2008-10#1)
proteins responsible for##7##3##(1992-3#1)(1992-6#1)(1993-11#1)(1997-4#1)(1997-5#1)(2008-10#1)(2008-3#1)
proteins resulted in##2##3##(1993-5#1)(1994-9#1)
proteins resulted##3##2##(1993-5#1)(1994-9#1)(2010-12#1)
proteins results in##4##3##(1994-8#1)(2005-11#1)(2008-10#1)(2008-9#1)
proteins retained##2##2##(1995-11#1)(2008-10#1)
proteins revealed a##3##3##(1992-8#1)(1995-8#1)(2012-2#1)
proteins revealed by##2##3##(2007-12#1)(2008-10#1)
proteins revealed the##3##3##(1994-9#1)(2008-10#1)(2008-11#1)
proteins revealed##11##2##(1990-7#1)(1992-8#1)(1994-9#1)(1995-12#1)(1995-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2011-12#1)(2012-2#1)
proteins reveals a##2##3##(1990-6#1)(1997-2#1)
proteins reveals##5##2##(1990-6#1)(1994-9#1)(1996-7#1)(1997-2#1)(2010-6#1)
proteins secreted by##2##3##(1997-1#1)(2008-10#1)
proteins secreted##5##2##(1990-3#1)(1997-1#1)(2008-10#1)(2011-1#2)
proteins separated by##2##3##(1990-7#1)(1990-9#1)
proteins separated##3##2##(1990-7#1)(1990-9#1)(2008-11#1)
proteins serve##2##2##(1995-3#1)(2008-7#1)
proteins share##6##2##(1991-5#1)(1994-12#2)(1994-9#1)(1995-5#1)(1995-6#1)
proteins shared by##2##3##(2008-9#2)
proteins shared##3##2##(2008-9#2)(2009-8#1)
proteins should be##2##3##(1993-8#1)(2008-10#1)
proteins should##4##2##(1991-4#1)(1993-8#1)(2006-12#1)(2008-10#1)
proteins show the##2##3##(1994-11#1)(1995-10#1)
proteins show##4##2##(1994-11#1)(1995-10#1)(2009-10#1)(2012-3#1)
proteins showed a##3##3##(1990-11#1)(1995-2#1)(2010-12#1)
proteins showed the##3##3##(1994-8#1)(2012-12#2)
proteins showed##15##2##(1990-11#2)(1990-7#1)(1990-9#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-4#1)(2010-12#1)(2010-3#1)(2012-12#2)(2013-1#1)
proteins shows that the##2##4##(1990-12#1)(1996-5#1)
proteins shows##3##2##(1990-12#1)(1993-8#1)(1996-5#1)
proteins so far identified##2##4##(1992-7#1)(1996-7#1)
proteins so##3##2##(1990-7#1)(1992-7#1)(1996-7#1)
proteins specifically##4##2##(1997-7#1)(2008-10#1)(2009-5#1)(2012-2#1)
proteins studied##3##2##(1992-9#1)(2006-1#1)(2006-10#1)
proteins such as albumin##2##4##(1994-9#1)(2008-5#1)
proteins such as the cell##2##5##(1993-5#1)(1995-3#1)
proteins such as the##6##4##(1993-5#1)(1995-3#1)(1995-8#1)(2007-10#1)(2008-1#1)(2011-2#1)
proteins such as##36##3##(1991-1#1)(1991-5#1)(1991-9#1)(1992-11#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-1#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
proteins suggests a##2##3##(1996-7#1)(1997-4#1)
proteins suggests that##3##3##(1994-12#1)(1994-8#1)(2007-12#1)
proteins suggests##6##2##(1993-3#1)(1994-12#1)(1994-8#1)(1996-7#1)(1997-4#1)(2007-12#1)
proteins synthesized by##2##3##(1993-12#1)(2008-10#1)
proteins synthesized in the##2##4##(1990-11#1)(2008-6#1)
proteins synthesized in##3##3##(1990-11#1)(1991-4#1)(2008-6#1)
proteins synthesized##8##2##(1990-11#1)(1991-4#1)(1993-12#1)(1995-7#1)(1995-9#1)(2008-10#1)(2008-6#1)(2010-12#1)
proteins tau##2##2##(1991-1#1)(1996-3#1)
proteins tend to be##2##4##(1991-3#1)(1992-7#1)
proteins termed##2##2##(1994-12#1)(2012-12#1)
proteins than##3##2##(1991-5#1)(1992-8#1)(2006-12#1)
proteins that appear to##2##4##(1991-8#1)(2009-8#1)
proteins that are associated with the##2##6##(2008-11#1)(2010-2#1)
proteins that are associated with##3##5##(1992-3#1)(2008-11#1)(2010-2#1)
proteins that are encoded in##2##5##(1997-6#1)(2008-7#1)
proteins that are encoded##3##4##(1992-5#1)(1997-6#1)(2008-7#1)
proteins that are essential for the##2##6##(1995-2#1)(1997-4#1)
proteins that are expressed##2##4##(2010-6#1)(2013-1#1)
proteins that are highly##2##4##(2006-12#1)(2008-5#1)
proteins that are involved in the##2##6##(2008-10#1)(2008-5#1)
proteins that are involved in##3##5##(2008-1#1)(2008-10#1)(2008-5#1)
proteins that are similar to the##2##6##(1993-12#1)(1994-3#1)
proteins that are similar to##4##5##(1991-9#1)(1993-12#1)(1994-3#1)(1994-9#1)
proteins that are##53##3##(1991-2#1)(1991-5#1)(1991-9#2)(1992-3#2)(1992-5#1)(1993-12#1)(1993-4#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#3)(1995-6#1)(1996-1#1)(1997-4#1)(1997-6#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#5)(2008-5#3)(2008-7#2)(2008-9#1)(2009-4#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-6#2)(2011-3#1)(2012-12#1)(2013-1#3)
proteins that associate with##2##4##(1990-6#1)(1996-2#1)
proteins that bind to the##2##5##(1994-3#1)(2013-8#1)
proteins that bind to##8##4##(1991-10#1)(1992-10#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-6#1)(1995-8#1)(2013-8#1)
proteins that bind##14##3##(1991-10#1)(1992-10#1)(1993-6#1)(1994-3#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-6#1)(1995-8#1)(2008-4#1)(2009-8#1)(2013-8#1)
proteins that can##6##3##(1992-4#1)(2006-12#1)(2008-2#1)(2009-3#1)(2009-6#1)(2013-1#1)
proteins that contain a##2##4##(2008-9#1)(2010-10#1)
proteins that contain##5##3##(1990-8#1)(2007-11#1)(2008-4#1)(2008-9#1)(2010-10#1)
proteins that could##3##3##(2008-7#1)(2010-12#1)(2010-3#1)
proteins that do not##2##4##(1994-6#1)(2010-12#1)
proteins that have an##2##4##(1996-4#1)(2009-7#1)
proteins that have been##8##4##(1992-12#1)(1994-6#1)(1995-2#1)(1995-9#1)(1997-4#1)(2008-2#1)(2008-4#1)(2010-11#1)
proteins that have##16##3##(1991-11#1)(1992-12#1)(1994-6#1)(1995-2#1)(1995-9#1)(1996-4#1)(1997-4#1)(2006-5#1)(2008-1#2)(2008-2#1)(2008-4#1)(2008-7#1)(2009-7#1)(2010-11#1)(2011-2#1)
proteins that includes##2##3##(1990-4#1)(1991-9#1)
proteins that induce##2##3##(2008-10#1)(2008-4#1)
proteins that interact with the##3##5##(1992-7#1)(1995-3#1)(2012-3#1)
proteins that interact with##7##4##(1992-7#1)(1995-1#1)(1995-3#1)(1996-4#1)(2008-7#1)(2008-8#1)(2012-3#1)
proteins that interact##8##3##(1992-7#1)(1992-8#1)(1995-1#1)(1995-3#1)(1996-4#1)(2008-7#1)(2008-8#1)(2012-3#1)
proteins that lack##2##3##(1992-8#1)(2009-8#1)
proteins that make##2##3##(2008-7#1)(2012-12#1)
proteins that mediate##5##3##(1991-11#1)(1997-2#1)(2009-4#1)(2009-6#1)(2009-8#1)
proteins that participate in##2##4##(2008-1#1)(2011-2#1)
proteins that play##3##3##(1995-8#1)(2008-11#1)(2009-9#1)
proteins that produce##2##3##(2008-10#1)(2008-4#1)
proteins that recognize##3##3##(1993-6#1)(2008-7#1)(2011-1#1)
proteins that regulate##3##3##(2009-4#2)(2012-2#1)
proteins that share##2##3##(1993-9#1)(2009-10#1)
proteins that stimulate##2##3##(2006-10#1)(2008-10#1)
proteins that was##2##3##(1994-2#1)(1994-6#1)
proteins that were##3##3##(1996-5#1)(2008-9#1)(2009-8#1)
proteins that##203##2##(1990-11#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-11#2)(1991-2#1)(1991-5#2)(1991-8#1)(1991-9#3)(1992-10#1)(1992-12#1)(1992-3#3)(1992-4#2)(1992-5#1)(1992-7#1)(1992-8#2)(1993-12#1)(1993-4#1)(1993-6#3)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#4)(1994-8#3)(1994-9#2)(1995-1#3)(1995-2#4)(1995-3#5)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#1)(1996-2#1)(1996-4#3)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#2)(1997-6#1)(1997-7#1)(2005-7#2)(2006-10#1)(2006-12#2)(2006-5#2)(2007-11#1)(2007-12#2)(2008-1#4)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#1)(2008-4#14)(2008-5#5)(2008-7#8)(2008-8#2)(2008-9#6)(2009-10#2)(2009-3#1)(2009-4#4)(2009-6#2)(2009-7#1)(2009-8#7)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#5)(2010-2#1)(2010-3#1)(2010-6#2)(2011-1#2)(2011-12#1)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
proteins the##2##2##(1994-12#1)(2013-1#1)
proteins through the##2##3##(1995-6#1)(2007-12#1)
proteins through##10##2##(1995-6#1)(1995-8#1)(1996-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-5#1)(2013-7#1)
proteins tightly##2##2##(1990-5#1)(2008-5#1)
proteins to a##4##3##(1994-8#1)(1995-10#1)(2008-1#1)(2012-2#1)
proteins to activate##2##3##(1990-8#1)(1991-1#1)
proteins to be expressed##2##4##(2008-11#1)(2009-12#1)
proteins to be##6##3##(1990-7#1)(1992-11#1)(1995-8#1)(2008-11#1)(2009-12#1)(2013-8#1)
proteins to bind##2##3##(1995-5#1)(1995-6#1)
proteins to form##3##3##(1990-4#1)(1995-5#1)(2008-7#1)
proteins to give##2##3##(1992-3#1)(2010-7#1)
proteins to inhibit##2##3##(1994-11#1)(2008-4#1)
proteins to modulate##2##3##(1990-6#1)(2006-10#1)
proteins to produce##2##3##(1990-11#1)(1992-6#1)
proteins to specific##3##3##(2008-4#1)(2009-5#1)(2012-7#1)
proteins to the cell surface##3##5##(1993-6#1)(2008-1#1)(2011-1#1)
proteins to the cell##4##4##(1993-6#1)(2008-1#1)(2008-9#1)(2011-1#1)
proteins to the endoplasmic reticulum##2##5##(1994-12#1)(1995-3#1)
proteins to the same##2##4##(1996-7#1)(2010-12#1)
proteins to the##27##3##(1990-3#1)(1991-2#1)(1992-4#1)(1993-6#1)(1994-12#2)(1994-8#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-4#1)(1996-7#1)(1997-4#2)(1997-6#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-7#1)(2010-12#1)(2011-1#1)
proteins to##101##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-12#2)(1994-8#2)(1994-9#1)(1995-10#1)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-10#2)(1996-12#2)(1996-3#1)(1996-4#4)(1996-7#1)(1997-2#2)(1997-4#4)(1997-6#1)(2006-10#3)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-4#6)(2008-6#1)(2008-7#3)(2008-9#3)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-12#2)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-7#1)(2013-1#4)(2013-8#1)
proteins under mild conditions##2##4##(1992-1#1)(2008-7#1)
proteins under native conditions##2##4##(1995-8#1)(2011-2#1)
proteins under the control of the##2##6##(1993-5#1)(1995-1#1)
proteins under the##4##3##(1993-5#1)(1995-1#1)(1995-5#1)(2008-11#1)
proteins under##12##2##(1992-1#1)(1993-5#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-8#1)(2008-11#1)(2008-7#2)(2008-9#1)(2011-2#1)
proteins undergo##3##2##(2008-10#1)(2009-8#1)(2010-9#1)
proteins unique to a given##2##5##(2008-9#2)
proteins upon##2##2##(1992-2#1)(1992-5#1)
proteins used in##2##3##(1990-9#1)(2008-11#1)
proteins used##3##2##(1990-9#1)(2005-11#1)(2008-11#1)
proteins using a new##2##4##(1991-4#1)(2010-12#1)
proteins using a##5##3##(1991-4#1)(1997-1#1)(1997-4#1)(2008-9#1)(2010-12#1)
proteins using the##6##3##(1990-12#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-2#1)
proteins using##31##2##(1990-12#1)(1991-4#1)(1994-5#1)(1994-9#1)(1995-7#1)(1997-1#1)(1997-4#2)(2006-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-2#2)(2008-4#4)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
proteins usually##3##2##(1997-1#1)(1997-6#1)(2008-2#1)
proteins vary##3##2##(1994-9#1)(2008-7#1)(2011-2#1)
proteins via##7##2##(1990-5#1)(1996-10#1)(1996-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-7#1)
proteins was also##3##3##(1990-3#1)(2008-10#1)(2011-12#1)
proteins was detected##4##3##(1997-6#1)(2008-5#1)(2010-12#1)(2013-8#1)
proteins was determined##2##3##(1993-6#1)(2006-12#1)
proteins was developed##2##3##(1996-11#1)(2010-12#1)
proteins was estimated to be##2##5##(1992-12#1)(1997-6#1)
proteins was evaluated##2##3##(1997-2#1)(2013-1#1)
proteins was found to##3##4##(1990-3#1)(1995-12#1)(2004-11#1)
proteins was found##5##3##(1990-3#1)(1995-12#1)(2004-11#1)(2007-8#1)(2011-2#1)
proteins was investigated by##2##4##(1994-6#1)(1995-11#1)
proteins was investigated##3##3##(1994-6#1)(1995-11#1)(2006-12#1)
proteins was isolated and##2##4##(1990-11#1)(1994-12#1)
proteins was not##3##3##(1993-6#1)(1994-11#1)(1994-9#1)
proteins was observed##6##3##(1990-9#1)(1991-5#1)(1994-6#1)(1995-8#1)(2008-10#1)(2009-10#1)
proteins was##75##2##(1990-11#1)(1990-12#2)(1990-3#5)(1990-5#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-12#3)(1992-5#1)(1992-7#1)(1993-12#1)(1993-6#3)(1994-11#2)(1994-12#1)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-11#3)(1996-4#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-6#2)(2004-11#1)(2006-12#3)(2007-8#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-12#2)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#2)
proteins we have identified the##2##5##(1990-7#1)(1994-9#1)
proteins we##6##2##(1990-7#1)(1994-9#1)(1996-3#1)(2012-12#2)(2013-8#1)
proteins were also##2##3##(1992-12#1)(2011-2#1)
proteins were analyzed by##2##4##(1991-10#1)(1997-4#1)
proteins were analyzed##6##3##(1991-10#1)(1994-11#1)(1997-2#1)(1997-4#1)(2008-4#1)(2010-12#1)
proteins were characterized##3##3##(1994-9#1)(1995-2#1)(2009-4#1)
proteins were comparable##2##3##(1990-12#1)(1995-5#1)
proteins were compared##2##3##(1994-12#1)(2008-10#1)
proteins were completely##3##3##(1990-12#1)(2008-10#1)(2008-12#1)
proteins were confirmed##3##3##(1995-8#1)(2007-12#1)(2011-3#1)
proteins were constructed##2##3##(1997-4#2)
proteins were degraded##2##3##(1992-12#2)
proteins were detected in the##4##5##(1994-3#1)(1997-3#1)(2004-8#1)(2008-10#1)
proteins were detected in##10##4##(1990-9#1)(1991-12#1)(1994-3#1)(1995-2#1)(1996-11#1)(1997-3#1)(2004-8#1)(2007-12#1)(2008-10#1)(2008-4#1)
proteins were detected##15##3##(1990-3#1)(1990-9#1)(1991-12#1)(1991-5#1)(1994-3#1)(1995-2#1)(1996-11#1)(1997-3#1)(2004-8#2)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-8#1)
proteins were determined##4##3##(1991-2#1)(1992-3#1)(1993-4#1)(1997-2#1)
proteins were downregulated##3##3##(2010-12#3)
proteins were eluted##2##3##(1990-4#1)(1992-11#1)
proteins were examined using##2##4##(1994-9#1)(1997-3#1)
proteins were examined##3##3##(1994-9#1)(1997-3#1)(2008-10#1)
proteins were excluded from##2##4##(1995-2#1)(2009-8#1)
proteins were expressed in Escherichia coli##2##6##(1990-12#1)(1990-7#1)
proteins were expressed in##4##4##(1990-12#1)(1990-7#1)(1995-8#1)(2009-3#1)
proteins were expressed##5##3##(1990-12#1)(1990-7#1)(1995-8#1)(1997-4#1)(2009-3#1)
proteins were extracted from##2##4##(1994-10#1)(2008-11#1)
proteins were found to be##2##5##(2009-10#1)(2009-8#1)
proteins were found to bind##2##5##(1990-11#1)(1995-6#1)
proteins were found to##6##4##(1990-11#1)(1990-6#1)(1992-7#1)(1995-6#1)(2009-10#1)(2009-8#1)
proteins were found##9##3##(1990-11#1)(1990-6#1)(1991-8#1)(1992-7#1)(1995-6#1)(2007-12#1)(2009-10#1)(2009-8#2)
proteins were further##2##3##(1990-9#1)(2013-8#1)
proteins were highly expressed##2##4##(2005-11#1)(2010-12#1)
proteins were identified as##4##4##(1990-7#1)(1993-11#1)(2008-10#1)(2010-12#1)
proteins were identified in##3##4##(1993-12#1)(2007-12#1)(2012-12#1)
proteins were identified##17##3##(1990-7#2)(1993-11#1)(1993-12#1)(1993-6#1)(1994-2#1)(1996-5#1)(2005-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2009-10#1)(2010-12#1)(2012-12#1)(2013-8#2)
proteins were immunoprecipitated##2##3##(1991-10#1)(1993-2#1)
proteins were investigated##2##3##(1990-12#1)(1991-9#1)
proteins were isolated and##2##4##(1992-6#1)(2008-9#1)
proteins were isolated by##2##4##(1995-8#1)(1996-12#1)
proteins were isolated from a##2##5##(1994-12#1)(1997-8#1)
proteins were isolated from##5##4##(1990-11#1)(1991-1#1)(1993-4#1)(1994-12#1)(1997-8#1)
proteins were isolated##9##3##(1990-11#1)(1991-1#1)(1992-6#1)(1993-4#1)(1994-12#1)(1995-8#1)(1996-12#1)(1997-8#1)(2008-9#1)
proteins were made##2##3##(1995-12#1)(1995-5#1)
proteins were measured##3##3##(1996-12#1)(2004-11#1)(2005-11#1)
proteins were not##5##3##(1990-3#1)(1990-6#1)(1997-4#1)(2005-11#1)(2008-10#1)
proteins were observed##3##3##(1992-2#1)(1997-2#1)(2008-11#1)
proteins were obtained##2##3##(2008-10#2)
proteins were present in##2##4##(1990-11#1)(1991-3#1)
proteins were present##4##3##(1990-11#1)(1991-3#1)(1994-12#1)(2007-12#1)
proteins were produced in##2##4##(1993-5#1)(1994-5#1)
proteins were purified by##2##4##(1990-10#1)(1994-8#1)
proteins were purified from##2##4##(1996-5#1)(1997-8#1)
proteins were purified to homogeneity and##2##6##(1995-11#1)(1997-4#1)
proteins were purified##10##3##(1990-10#1)(1990-4#1)(1991-10#1)(1994-8#1)(1995-11#1)(1996-5#1)(1997-4#1)(1997-8#1)(2005-11#1)(2006-8#1)
proteins were retained##2##3##(1990-3#1)(2004-8#1)
proteins were revealed##2##3##(2007-12#1)(2008-10#1)
proteins were separated by##5##4##(1990-10#1)(1990-7#1)(1993-8#1)(2008-10#1)(2008-11#1)
proteins were separated using##2##4##(1991-3#1)(1992-8#1)
proteins were separated##8##3##(1990-10#1)(1990-7#1)(1991-3#1)(1992-8#1)(1993-4#1)(1993-8#1)(2008-10#1)(2008-11#1)
proteins were similar##2##3##(1997-3#1)(2013-8#1)
proteins were studied##4##3##(1990-7#1)(2005-11#1)(2008-10#1)(2008-8#1)
proteins were successfully##2##3##(1996-8#1)(2007-8#1)
proteins were synthesized##2##3##(1994-6#1)(2009-3#1)
proteins were tested for##3##4##(1993-4#1)(1994-3#1)(2008-10#1)
proteins were tested##4##3##(1993-4#1)(1994-3#1)(2008-10#1)(2010-3#1)
proteins were the##3##3##(1991-6#1)(2005-12#1)(2010-11#1)
proteins were upregulated##2##3##(2010-12#1)(2010-5#1)
proteins were used as##2##4##(1994-9#1)(2012-12#1)
proteins were used##3##3##(1994-9#1)(2008-10#1)(2012-12#1)
proteins were##248##2##(1990-10#2)(1990-11#3)(1990-12#4)(1990-3#3)(1990-4#2)(1990-5#1)(1990-6#2)(1990-7#5)(1990-9#2)(1991-1#2)(1991-10#4)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#3)(1991-6#2)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#2)(1992-6#1)(1992-7#2)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#4)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#5)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#4)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-5#4)(1995-6#2)(1995-8#4)(1996-11#3)(1996-12#2)(1996-2#2)(1996-4#1)(1996-5#4)(1996-8#2)(1996-9#2)(1997-2#5)(1997-3#4)(1997-4#7)(1997-5#1)(1997-8#3)(2004-11#2)(2004-8#3)(2005-11#6)(2005-12#2)(2005-7#1)(2005-8#1)(2006-12#1)(2006-8#2)(2007-11#1)(2007-12#7)(2007-8#1)(2008-1#1)(2008-10#21)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#6)(2009-3#3)(2009-4#1)(2009-6#1)(2009-8#5)(2010-11#3)(2010-12#7)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#3)(2013-8#6)
proteins where##2##2##(2008-4#1)(2012-2#1)
proteins which are##9##3##(1991-9#1)(1994-12#1)(1994-5#1)(1994-6#1)(1996-2#1)(1996-5#1)(1996-9#1)(2006-10#1)(2008-8#1)
proteins which bind to##2##4##(1993-5#1)(1994-3#1)
proteins which bind##5##3##(1993-5#1)(1993-6#1)(1994-3#1)(1995-11#1)(2005-7#1)
proteins which have been##2##4##(1992-3#1)(2013-7#1)
proteins which interact with##3##4##(1994-12#1)(1994-2#1)(1997-3#1)
proteins which is##2##3##(1992-6#1)(1997-2#1)
proteins which regulate##3##3##(1991-2#1)(2006-2#1)(2008-11#1)
proteins which share##2##3##(1992-5#1)(2008-4#1)
proteins which##52##2##(1991-2#1)(1991-9#2)(1992-10#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#2)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#2)(2005-7#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-3#1)(2010-12#1)(2010-7#1)(2013-7#1)
proteins while the##2##3##(1991-8#1)(2009-5#1)
proteins while##4##2##(1991-8#1)(1992-12#2)(2009-5#1)
proteins whose##8##2##(1992-4#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-7#2)(2009-8#1)(2012-3#1)
proteins with DNA##2##3##(1995-11#1)(1995-2#1)
proteins with a molecular weight of##3##6##(2006-8#1)(2012-1#2)
proteins with a variety of##2##5##(2008-4#1)(2008-7#1)
proteins with a##17##3##(1990-7#1)(1992-7#1)(1993-8#1)(1994-12#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-8#1)(2009-9#1)(2012-1#2)
proteins with acetonitrile##2##3##(1993-2#1)(2008-10#1)
proteins with an##8##3##(1992-6#3)(1994-11#2)(2008-4#1)(2009-9#1)(2010-4#1)
proteins with apparent molecular##2##4##(1994-11#1)(1997-2#1)
proteins with approximate molecular weights of##2##6##(1992-11#2)
proteins with different functions##2##4##(1990-5#1)(1993-6#1)
proteins with different##5##3##(1990-5#1)(1993-6#1)(1994-6#1)(2006-12#1)(2007-6#1)
proteins with diverse##2##3##(1995-8#1)(2008-10#1)
proteins with either##2##3##(1992-4#1)(1995-10#1)
proteins with high##3##3##(1997-2#1)(2008-4#1)(2008-7#1)
proteins with important##2##3##(1994-6#1)(2008-7#1)
proteins with inorganic##2##3##(1990-8#1)(2008-4#1)
proteins with mol##2##3##(1991-3#1)(1995-5#1)
proteins with molecular masses of##7##5##(1993-3#1)(1994-5#1)(1994-9#1)(2008-10#1)(2008-8#1)(2013-1#2)
proteins with molecular masses##8##4##(1993-3#1)(1994-5#1)(1994-9#1)(2008-10#2)(2008-8#1)(2013-1#2)
proteins with molecular##10##3##(1990-11#2)(1993-3#1)(1994-5#1)(1994-9#1)(2008-10#2)(2008-8#1)(2013-1#2)
proteins with novel structural##2##4##(2007-7#2)
proteins with novel##3##3##(2007-7#2)(2008-4#1)
proteins with specific genomic##4##4##(2008-1#2)(2008-2#2)
proteins with specific##7##3##(2007-6#1)(2008-1#2)(2008-2#3)(2011-1#1)
proteins with the cell##2##4##(2008-4#2)
proteins with the##10##3##(1993-11#1)(1994-3#1)(1995-6#1)(1996-3#1)(2006-10#1)(2007-5#1)(2008-11#1)(2008-4#2)(2008-5#1)
proteins with##165##2##(1990-11#4)(1990-5#1)(1990-7#2)(1990-8#3)(1991-1#1)(1991-10#3)(1991-3#1)(1992-1#1)(1992-11#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#4)(1992-7#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#2)(1995-7#2)(1995-8#3)(1996-12#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-4#4)(2005-11#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-8#1)(2007-12#1)(2007-5#1)(2007-6#2)(2007-7#2)(2008-1#3)(2008-10#14)(2008-11#2)(2008-2#4)(2008-3#2)(2008-4#7)(2008-5#3)(2008-7#6)(2008-8#2)(2009-1#1)(2009-10#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#3)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#3)(2011-2#2)(2012-1#3)(2012-12#3)(2012-2#3)(2013-1#2)(2013-8#1)
proteins within a##5##3##(2007-8#1)(2008-1#1)(2008-2#1)(2008-4#1)(2010-11#1)
proteins within the cell##2##4##(1990-6#1)(2008-1#1)
proteins within the##7##3##(1990-6#1)(1992-7#1)(1995-5#1)(2008-1#3)(2011-2#1)
proteins within##18##2##(1990-6#1)(1992-7#1)(1995-5#1)(2007-8#1)(2008-1#4)(2008-2#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-11#1)(2011-2#1)
proteins without##5##2##(1992-8#1)(2006-12#1)(2007-6#1)(2008-2#1)(2008-9#1)
proteins work##2##2##(2008-4#1)(2009-8#1)
proteins would##5##2##(1993-12#1)(1995-8#1)(1996-7#1)(2005-8#1)(2006-12#1)
proteins##6919##1##(1990-1#8)(1990-10#25)(1990-11#56)(1990-12#49)(1990-2#21)(1990-3#43)(1990-4#29)(1990-5#44)(1990-6#26)(1990-7#59)(1990-8#31)(1990-9#38)(1991-1#27)(1991-10#37)(1991-11#17)(1991-12#29)(1991-2#56)(1991-3#20)(1991-4#50)(1991-5#47)(1991-6#15)(1991-7#7)(1991-8#27)(1991-9#31)(1992-1#19)(1992-10#3)(1992-11#35)(1992-12#65)(1992-2#15)(1992-3#30)(1992-4#21)(1992-5#29)(1992-6#55)(1992-7#29)(1992-8#44)(1992-9#14)(1993-1#2)(1993-11#46)(1993-12#37)(1993-2#25)(1993-3#36)(1993-4#24)(1993-5#21)(1993-6#89)(1993-7#3)(1993-8#40)(1993-9#29)(1994-10#17)(1994-11#69)(1994-12#95)(1994-2#36)(1994-3#72)(1994-5#58)(1994-6#48)(1994-7#3)(1994-8#69)(1994-9#112)(1995-1#50)(1995-10#22)(1995-11#33)(1995-12#29)(1995-2#106)(1995-3#77)(1995-4#17)(1995-5#35)(1995-6#72)(1995-7#22)(1995-8#91)(1995-9#10)(1996-1#10)(1996-10#24)(1996-11#33)(1996-12#36)(1996-2#31)(1996-3#19)(1996-4#38)(1996-5#77)(1996-6#5)(1996-7#21)(1996-8#31)(1996-9#26)(1997-1#41)(1997-2#67)(1997-3#36)(1997-4#92)(1997-5#10)(1997-6#50)(1997-7#56)(1997-8#14)(1997-9#1)(2003-11#2)(2004-11#9)(2004-12#2)(2004-8#8)(2004-9#1)(2005-1#1)(2005-10#10)(2005-11#41)(2005-12#8)(2005-6#2)(2005-7#15)(2005-8#25)(2006-1#8)(2006-10#99)(2006-11#14)(2006-12#66)(2006-2#7)(2006-5#10)(2006-6#3)(2006-7#1)(2006-8#21)(2006-9#5)(2007-1#2)(2007-10#11)(2007-11#51)(2007-12#77)(2007-2#7)(2007-3#1)(2007-5#4)(2007-6#15)(2007-7#10)(2007-8#59)(2007-9#9)(2008-1#114)(2008-10#350)(2008-11#146)(2008-12#17)(2008-2#75)(2008-3#14)(2008-4#410)(2008-5#89)(2008-6#31)(2008-7#204)(2008-8#90)(2008-9#105)(2009-1#1)(2009-10#60)(2009-11#2)(2009-12#22)(2009-2#16)(2009-3#31)(2009-4#18)(2009-5#35)(2009-6#30)(2009-7#17)(2009-8#106)(2009-9#26)(2010-1#4)(2010-10#9)(2010-11#30)(2010-12#71)(2010-2#29)(2010-3#10)(2010-4#39)(2010-5#20)(2010-6#7)(2010-7#18)(2010-8#1)(2010-9#4)(2011-1#72)(2011-10#2)(2011-12#16)(2011-2#116)(2011-3#13)(2011-9#1)(2012-1#38)(2012-11#4)(2012-12#105)(2012-2#97)(2012-3#41)(2012-5#1)(2012-6#3)(2012-7#2)(2013-1#101)(2013-7#18)(2013-8#70)
proteins'##6##1##(1995-5#1)(2008-7#1)(2008-9#1)(2011-12#1)(2012-2#2)
proteins) and##3##2##(2008-1#1)(2008-10#1)(2008-5#1)
proteins) are##4##2##(1993-6#1)(1994-3#1)(1995-2#1)(1997-1#1)
proteins) catalyzed by##2##3##(1995-6#2)
proteins) in the##2##3##(2008-10#1)(2011-1#1)
proteins) were##2##2##(1992-1#1)(2008-5#1)
proteins)##42##1##(1990-10#1)(1990-2#1)(1990-3#1)(1990-7#1)(1992-1#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#3)(1996-10#1)(1996-5#1)(1997-1#1)(1997-7#1)(2004-12#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#3)(2008-5#2)(2008-7#6)(2011-1#2)(2013-8#1)
proteins--a##3##1##(1990-3#2)(1993-3#1)
proteins/peptides##2##1##(2008-3#1)(2012-2#1)
proteins?##4##1##(1990-11#1)(1992-4#1)(2008-11#1)(2009-8#1)
proteins]##4##1##(1992-10#1)(1996-1#1)(1996-11#1)(2010-11#1)
proteinuria &gt##2##2##(2007-8#1)(2008-8#1)
proteinuria after##2##2##(1995-2#1)(2007-7#1)
proteinuria among##2##2##(2007-8#1)(2012-2#1)
proteinuria and albuminuria##2##3##(2012-1#2)
proteinuria and hypertension##2##3##(1992-1#1)(2007-7#1)
proteinuria and leukocyturia##4##3##(1996-12#4)
proteinuria and renal##4##3##(2005-1#1)(2006-8#1)(2007-7#1)(2012-12#1)
proteinuria and##29##2##(1990-6#1)(1991-4#1)(1992-1#1)(1993-12#1)(1996-12#4)(2004-11#1)(2005-1#1)(2005-12#1)(2006-12#1)(2006-8#1)(2007-7#3)(2007-8#2)(2008-1#3)(2008-4#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)
proteinuria at##2##2##(2007-8#1)(2011-1#1)
proteinuria in diabetic##2##3##(2011-1#1)(2012-12#1)
proteinuria in##10##2##(1995-10#1)(1997-7#1)(2007-11#1)(2008-1#3)(2011-1#2)(2012-12#2)
proteinuria is##2##2##(2005-10#1)(2008-1#1)
proteinuria may##2##2##(2007-7#1)(2008-1#1)
proteinuria of##4##2##(2008-1#2)(2008-5#1)(2013-8#1)
proteinuria was##2##2##(2010-4#2)
proteinuria were##2##2##(1996-12#1)(2008-1#1)
proteinuria##139##1##(1990-12#1)(1990-6#5)(1991-4#2)(1992-1#1)(1992-12#1)(1993-12#4)(1993-3#1)(1993-4#1)(1994-5#1)(1995-10#1)(1995-2#2)(1996-12#6)(1996-6#1)(1997-3#1)(1997-7#1)(2004-11#2)(2005-1#1)(2005-10#1)(2005-12#1)(2006-10#4)(2006-12#1)(2006-4#1)(2006-7#2)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#4)(2007-2#2)(2007-7#10)(2007-8#13)(2008-1#31)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#3)(2010-12#1)(2010-4#2)(2011-1#3)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#4)(2013-1#1)(2013-8#2)
proteinuric nephropathy##2##2##(2007-8#2)
proteinuric patients##2##2##(2007-11#1)(2007-7#1)
proteinuric##9##1##(1990-6#1)(1993-12#2)(2007-11#1)(2007-7#1)(2007-8#3)(2008-1#1)
proteobacteria##2##1##(2008-7#1)(2008-9#1)
proteoglycan (PG)##2##2##(1994-12#1)(1995-10#1)
proteoglycan and##7##2##(1990-10#3)(1990-12#1)(1991-4#1)(1995-8#1)(2009-4#1)
proteoglycan are##2##2##(1992-6#1)(2008-7#1)
proteoglycan composition##2##2##(1997-8#2)
proteoglycan containing##2##2##(1991-4#1)(1995-5#1)
proteoglycan core protein##2##3##(1991-5#1)(2008-11#1)
proteoglycan core##3##2##(1990-5#1)(1991-5#1)(2008-11#1)
proteoglycan family##2##2##(1995-3#1)(2007-10#1)
proteoglycan fractions##2##2##(1994-10#2)
proteoglycan gene##2##2##(1990-9#2)
proteoglycan in##4##2##(1991-8#1)(1992-6#2)(2007-8#1)
proteoglycan or##2##2##(1990-10#1)(1993-9#1)
proteoglycan release##2##2##(1994-5#2)
proteoglycan synthesis and##3##3##(1994-12#1)(1997-8#1)(2007-11#1)
proteoglycan##81##1##(1990-10#5)(1990-12#1)(1990-3#1)(1990-5#2)(1990-9#3)(1991-10#1)(1991-4#2)(1991-5#2)(1991-7#1)(1991-8#5)(1992-1#2)(1992-11#1)(1992-2#2)(1992-5#1)(1992-6#11)(1993-2#1)(1993-4#1)(1993-9#1)(1994-10#4)(1994-12#3)(1994-5#3)(1994-9#1)(1995-10#1)(1995-3#3)(1995-5#1)(1995-8#1)(1996-4#1)(1997-2#1)(1997-8#3)(2005-3#1)(2007-10#3)(2007-11#2)(2007-8#1)(2008-11#2)(2008-7#2)(2008-9#1)(2009-4#1)(2011-1#1)(2012-12#2)
proteoglycans (PG)##2##2##(1994-8#1)(1994-9#1)
proteoglycans (PGs)##2##2##(1990-2#1)(2013-8#1)
proteoglycans and##7##2##(1991-9#2)(1995-6#1)(1997-4#1)(1997-8#1)(2007-11#2)
proteoglycans are##3##2##(1991-9#1)(1994-10#1)(2012-12#1)
proteoglycans during##2##2##(1991-5#1)(1995-5#1)
proteoglycans from##3##2##(1996-4#1)(1997-8#1)(2009-12#1)
proteoglycans in vitro##2##3##(1997-8#2)
proteoglycans in##4##2##(1997-8#2)(2008-1#1)(2010-1#1)
proteoglycans may##2##2##(1991-8#1)(1995-10#1)
proteoglycans of##2##2##(1995-3#1)(1995-5#1)
proteoglycans were##2##2##(1991-8#1)(1997-4#1)
proteoglycans with##2##2##(1990-2#1)(1994-10#1)
proteoglycans##62##1##(1990-2#2)(1991-5#1)(1991-8#3)(1991-9#5)(1992-12#2)(1993-2#1)(1993-6#1)(1994-10#2)(1994-12#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-3#1)(1995-5#6)(1995-6#2)(1996-4#4)(1997-4#3)(1997-5#1)(1997-8#6)(2005-8#1)(2007-11#5)(2008-1#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-1#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
proteoheparan sulfate##3##2##(1995-5#3)
proteolipid protein (PLP) and myelin basic protein (MBP)##2##8##(2008-4#2)
proteolipid protein (PLP)##3##3##(2007-10#1)(2008-4#2)
proteolipid protein gene##2##3##(1996-12#1)(2008-7#1)
proteolipid protein##11##2##(1993-6#4)(1996-12#1)(2005-7#1)(2007-10#1)(2008-4#2)(2008-7#2)
proteolipid##21##1##(1990-2#4)(1992-11#2)(1992-6#1)(1993-6#4)(1994-9#1)(1996-12#1)(2005-7#1)(2007-10#1)(2008-4#2)(2008-7#2)(2009-6#2)
proteoliposomes with##2##2##(1995-8#2)
proteoliposomes##25##1##(1990-11#3)(1990-12#1)(1990-2#1)(1992-1#2)(1992-12#1)(1992-6#3)(1992-7#1)(1993-3#1)(1994-2#2)(1994-8#2)(1995-8#7)(1997-6#1)
proteolysis and##12##2##(1991-7#1)(1992-9#1)(1995-6#1)(1995-8#1)(1997-2#1)(2006-12#1)(2008-4#1)(2008-9#1)(2010-4#1)(2010-6#1)(2011-1#1)(2013-1#1)
proteolysis are also##2##3##(1992-11#1)(2008-4#1)
proteolysis are##3##2##(1991-8#1)(1992-11#1)(2008-4#1)
proteolysis by trypsin##3##3##(1991-2#1)(1992-11#1)(1992-12#1)
proteolysis by##16##2##(1990-12#1)(1991-2#1)(1991-7#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-8#1)(1995-1#2)(1996-8#1)(1997-4#1)(2006-10#1)(2012-3#1)
proteolysis can##2##2##(1995-6#1)(2008-5#1)
proteolysis for##3##2##(1991-5#1)(1992-9#1)(1997-2#1)
proteolysis in the##3##3##(1990-5#1)(1992-2#1)(1994-8#1)
proteolysis in##16##2##(1990-3#1)(1990-5#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-2#1)(1993-12#1)(1994-8#1)(1995-11#1)(2006-9#1)(2008-4#1)(2009-2#1)(2011-2#1)(2012-1#1)(2013-1#2)
proteolysis is##3##2##(1991-8#1)(2008-4#1)(2013-8#1)
proteolysis may##3##2##(2006-9#1)(2008-9#1)(2011-1#1)
proteolysis of the##6##3##(1990-5#1)(1991-4#1)(1991-7#1)(1994-5#1)(1996-4#1)(2009-8#1)
proteolysis of##31##2##(1990-12#1)(1990-4#1)(1990-5#2)(1991-10#1)(1991-4#1)(1991-5#2)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-8#1)(1993-11#1)(1994-12#1)(1994-5#1)(1995-6#1)(1996-4#1)(1996-7#2)(1997-2#1)(2008-5#1)(2009-7#1)(2009-8#1)(2010-3#1)(2012-12#1)(2013-8#1)
proteolysis plays an important role##2##5##(1990-11#1)(2012-3#1)
proteolysis product of the##2##4##(1991-8#1)(2011-1#1)
proteolysis product##3##2##(1991-8#1)(1992-11#1)(2011-1#1)
proteolysis to##5##2##(1990-6#1)(1994-8#1)(1996-8#1)(1997-2#1)(2008-4#1)
proteolysis was observed##2##3##(1992-11#1)(1992-9#1)
proteolysis was##8##2##(1990-5#1)(1991-5#1)(1992-11#1)(1992-9#1)(1995-6#1)(1997-1#1)(1997-4#1)(2006-9#1)
proteolysis with trypsin and##2##4##(1990-5#1)(1996-8#1)
proteolysis with trypsin##3##3##(1990-5#2)(1996-8#1)
proteolysis with##7##2##(1990-5#2)(1991-12#1)(1992-11#1)(1996-7#1)(1996-8#1)(2007-8#1)
proteolysis##210##1##(1990-10#1)(1990-11#1)(1990-12#5)(1990-3#2)(1990-4#3)(1990-5#9)(1990-6#1)(1990-7#1)(1991-10#3)(1991-12#1)(1991-2#3)(1991-4#1)(1991-5#7)(1991-6#1)(1991-7#7)(1991-8#6)(1991-9#6)(1992-1#1)(1992-11#14)(1992-12#2)(1992-2#1)(1992-3#3)(1992-6#1)(1992-7#3)(1992-8#1)(1992-9#5)(1993-11#1)(1993-12#1)(1993-4#1)(1993-5#2)(1993-8#3)(1994-10#1)(1994-11#1)(1994-12#1)(1994-5#3)(1994-8#2)(1995-1#5)(1995-11#2)(1995-2#1)(1995-5#1)(1995-6#6)(1995-8#3)(1996-4#1)(1996-7#5)(1996-8#5)(1997-1#1)(1997-2#6)(1997-4#2)(1997-7#2)(2004-12#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-9#3)(2007-12#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-4#12)(2008-5#2)(2008-7#2)(2008-9#3)(2009-12#1)(2009-2#1)(2009-7#1)(2009-8#3)(2010-3#1)(2010-4#3)(2010-6#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#8)(2013-1#5)(2013-8#2)
proteolysis)##2##1##(1996-5#1)(2009-6#1)
proteolytic activation of##4##3##(1990-12#1)(1994-12#1)(2008-5#1)(2009-8#1)
proteolytic activation##5##2##(1990-12#1)(1994-12#1)(2008-5#2)(2009-8#1)
proteolytic activities##4##2##(2008-10#2)(2008-5#1)(2011-2#1)
proteolytic activity against##3##3##(1992-8#1)(1994-5#1)(1994-6#1)
proteolytic activity and##2##3##(1993-12#1)(2013-1#1)
proteolytic activity in the##2##4##(1990-2#1)(1994-3#1)
proteolytic activity in##5##3##(1990-2#1)(1992-5#2)(1994-3#1)(2006-9#1)
proteolytic activity is##2##3##(2006-1#1)(2008-4#1)
proteolytic activity of the##3##4##(1996-2#1)(2007-7#1)(2008-10#1)
proteolytic activity of##11##3##(1991-3#1)(1991-9#1)(1992-11#1)(1995-7#1)(1995-8#1)(1996-2#1)(2006-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2010-12#1)
proteolytic activity that##2##3##(1992-5#1)(1995-10#1)
proteolytic activity to##2##3##(1991-12#1)(2008-11#1)
proteolytic activity was inhibited by##2##5##(1994-3#2)
proteolytic activity was observed in##2##5##(1994-3#1)(2010-4#1)
proteolytic activity was##6##3##(1991-1#1)(1992-9#1)(1994-3#3)(2010-4#1)
proteolytic activity##61##2##(1990-2#4)(1990-7#1)(1991-1#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-9#1)(1992-11#1)(1992-4#1)(1992-5#7)(1992-8#1)(1992-9#2)(1993-12#1)(1993-3#1)(1994-3#5)(1994-5#1)(1994-6#1)(1995-10#1)(1995-7#1)(1995-8#1)(1996-2#1)(2005-7#1)(2006-1#1)(2006-12#1)(2006-9#2)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-4#4)(2008-6#2)(2010-12#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
proteolytic and##4##2##(1993-5#1)(1997-4#1)(2008-6#1)(2009-8#1)
proteolytic cleavage of the##6##4##(1990-7#1)(1991-2#1)(1994-11#1)(1994-12#2)(2008-4#1)
proteolytic cleavage of##10##3##(1990-5#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-8#1)(1991-9#1)(1994-11#1)(1994-12#2)(2008-4#1)
proteolytic cleavage##26##2##(1990-5#1)(1990-7#4)(1990-9#1)(1991-10#1)(1991-2#1)(1991-8#1)(1991-9#1)(1994-11#3)(1994-12#5)(1994-8#1)(1995-10#1)(1995-5#1)(1996-5#1)(2005-8#1)(2006-2#1)(2008-10#1)(2008-4#1)
proteolytic degradation and##2##3##(2006-12#1)(2008-11#1)
proteolytic degradation of##4##3##(1991-10#1)(1991-3#1)(2008-11#1)(2011-2#1)
proteolytic degradation##20##2##(1990-4#1)(1990-7#1)(1991-10#1)(1991-3#1)(1992-3#1)(1995-8#1)(1997-4#1)(2006-12#5)(2008-11#3)(2008-4#2)(2010-4#1)(2010-6#1)(2011-2#1)
proteolytic digest##2##2##(1992-11#1)(1994-5#1)
proteolytic digestion in##2##3##(1995-8#1)(1997-4#1)
proteolytic digestion of the##3##4##(1990-7#1)(1992-3#1)(2006-10#1)
proteolytic digestion of##4##3##(1990-7#1)(1992-3#1)(2006-10#1)(2008-6#1)
proteolytic digestion##14##2##(1990-7#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-8#1)(1994-8#1)(1995-8#1)(1996-8#1)(1997-4#1)(2006-10#1)(2008-6#1)
proteolytic digestions of##2##3##(1992-4#1)(1993-4#1)
proteolytic digestions##3##2##(1992-4#1)(1993-4#1)(1994-5#1)
proteolytic enzyme##7##2##(1990-11#1)(1990-12#1)(1990-5#1)(1994-12#1)(2006-5#1)(2008-10#1)(2008-9#1)
proteolytic enzymes and##3##3##(1993-4#1)(2006-6#1)(2010-2#1)
proteolytic enzymes have##2##3##(1991-1#1)(2008-5#1)
proteolytic enzymes in##2##3##(1994-11#1)(2005-8#1)
proteolytic enzymes of##2##3##(2006-12#1)(2008-5#1)
proteolytic enzymes##29##2##(1990-11#1)(1991-1#1)(1991-5#1)(1993-4#1)(1994-11#1)(1994-9#1)(1996-2#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-5#5)(2008-6#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-9#1)(2013-1#1)
proteolytic event##2##2##(1991-7#1)(1992-11#1)
proteolytic events##2##2##(1995-6#1)(1997-4#1)
proteolytic footprinting method##2##3##(1995-1#2)
proteolytic fragment of##4##3##(1990-7#1)(1990-9#1)(1991-4#1)(1995-1#1)
proteolytic fragments of##4##3##(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)
proteolytic fragments##10##2##(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1995-8#1)(1996-4#1)(1996-8#1)(2008-1#1)(2008-8#1)
proteolytic genes##2##2##(2013-1#2)
proteolytic inactivation of##3##3##(1990-7#1)(1993-11#1)(1996-4#1)
proteolytic pathway to##2##3##(1992-12#1)(1994-11#1)
proteolytic pathway##5##2##(1992-12#1)(1994-11#2)(1994-9#1)(1995-6#1)
proteolytic patterns##2##2##(1991-2#1)(1991-9#1)
proteolytic peptides##2##2##(1990-2#1)(1992-2#1)
proteolytic processing in##2##3##(1992-8#1)(2008-11#1)
proteolytic processing of both##2##4##(1990-8#1)(1997-5#1)
proteolytic processing of##10##3##(1990-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1994-9#1)(1997-5#1)(2008-11#1)(2008-6#2)
proteolytic processing##21##2##(1990-8#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-6#1)(1994-9#1)(1995-8#2)(1996-11#1)(1997-2#1)(1997-5#1)(2005-7#1)(2007-12#2)(2008-11#2)(2008-6#2)
proteolytic product##2##2##(2005-8#1)(2008-11#1)
proteolytic products##3##2##(1992-11#1)(1994-12#1)(1996-4#1)
proteolytic stability of##2##3##(2006-12#1)(2011-2#1)
proteolytic stability##4##2##(2006-12#3)(2011-2#1)
proteolytic susceptibility##4##2##(1992-12#1)(1995-1#1)(1996-7#1)(2008-4#1)
proteolytic system##5##2##(1994-3#1)(1996-2#1)(2008-4#2)(2013-1#1)
proteolytic systems##2##2##(1991-9#1)(1994-11#1)
proteolytic treatment##3##2##(2006-12#1)(2008-4#1)(2009-7#1)
proteolytic##293##1##(1990-11#2)(1990-12#2)(1990-2#5)(1990-4#1)(1990-5#2)(1990-7#12)(1990-8#1)(1990-9#2)(1991-1#3)(1991-10#2)(1991-12#2)(1991-2#3)(1991-3#3)(1991-4#2)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#6)(1992-1#2)(1992-10#1)(1992-11#6)(1992-12#5)(1992-2#2)(1992-3#3)(1992-4#2)(1992-5#7)(1992-6#2)(1992-8#2)(1992-9#4)(1993-11#2)(1993-12#1)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#8)(1994-12#8)(1994-2#1)(1994-3#7)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#5)(1995-1#4)(1995-10#2)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#6)(1996-11#1)(1996-2#3)(1996-4#3)(1996-5#2)(1996-7#2)(1996-8#2)(1996-9#2)(1997-2#1)(1997-4#4)(1997-5#1)(2004-12#1)(2005-7#2)(2005-8#6)(2006-1#1)(2006-10#2)(2006-12#11)(2006-2#1)(2006-5#1)(2006-6#1)(2006-9#3)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-1#3)(2008-10#9)(2008-11#8)(2008-4#15)(2008-5#10)(2008-6#7)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#5)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#4)(2013-1#6)(2013-8#2)
proteolytically cleaved##2##2##(1994-2#1)(1996-9#1)
proteolytically processed to##4##3##(1992-11#1)(1992-12#1)(1995-6#1)(1997-7#1)
proteolytically processed##6##2##(1992-11#2)(1992-12#1)(1995-6#1)(1997-2#1)(1997-7#1)
proteolytically##15##1##(1992-11#2)(1992-12#2)(1992-6#2)(1994-2#1)(1995-6#1)(1996-9#1)(1997-2#1)(1997-7#1)(2006-12#1)(2007-12#1)(2008-1#1)(2009-7#1)
proteolyzed##7##1##(1991-2#2)(1994-9#1)(1995-1#1)(1995-11#2)(2006-12#1)
proteome analyses##2##2##(2008-7#1)(2011-1#1)
proteome analysis of##4##3##(2007-12#1)(2008-7#1)(2009-2#1)(2010-12#1)
proteome analysis##12##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#2)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#2)
proteome and##2##2##(2009-5#1)(2012-2#1)
proteome as##2##2##(2008-4#1)(2008-7#1)
proteome by##2##2##(2008-7#1)(2012-3#1)
proteome catalog##3##2##(2008-9#3)
proteome comparisons##2##2##(2008-4#1)(2008-9#1)
proteome database##3##2##(2008-7#2)(2008-9#1)
proteome in##2##2##(2010-12#1)(2012-2#1)
proteome network##2##2##(2006-12#2)
proteome of##14##2##(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-12#3)(2010-6#2)(2011-3#1)(2013-1#1)
proteome profiles##3##2##(2009-4#1)(2009-6#2)
proteome research##2##2##(2012-3#2)
proteome that##2##2##(2010-12#2)
proteome##104##1##(2005-10#1)(2005-8#1)(2006-12#6)(2007-11#1)(2007-12#4)(2007-8#2)(2008-1#5)(2008-10#2)(2008-11#4)(2008-12#3)(2008-4#7)(2008-7#12)(2008-9#14)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#14)(2010-2#1)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#2)
proteome)##4##1##(2006-12#2)(2008-7#1)(2012-2#1)
proteome-wide##5##1##(2008-7#3)(2009-4#1)(2009-5#1)
proteomes of##3##2##(2008-4#1)(2008-7#1)(2013-8#1)
proteomes##22##1##(2006-12#1)(2006-5#1)(2008-4#5)(2008-7#2)(2008-9#5)(2009-5#1)(2010-12#4)(2010-7#1)(2011-2#1)(2013-8#1)
proteomic analyses##4##2##(2007-12#1)(2009-10#1)(2010-11#1)(2013-1#1)
proteomic analysis of##9##3##(2008-10#1)(2008-7#3)(2009-7#1)(2010-12#2)(2011-12#1)(2013-8#1)
proteomic analysis to##3##3##(2007-5#1)(2010-12#1)(2011-1#1)
proteomic analysis##22##2##(2007-5#1)(2008-10#2)(2008-4#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-7#1)(2010-12#7)(2011-1#1)(2011-12#1)(2013-8#2)
proteomic and##4##2##(2008-10#2)(2008-7#1)(2010-11#1)
proteomic approach could##2##3##(2007-12#1)(2010-12#1)
proteomic approach##4##2##(2007-12#1)(2008-9#1)(2010-12#1)(2013-1#1)
proteomic approaches##5##2##(2008-4#1)(2008-7#1)(2010-12#1)(2012-12#1)(2013-8#1)
proteomic data analysis##2##3##(2008-7#2)
proteomic data##12##2##(2008-11#1)(2008-4#2)(2008-7#5)(2009-8#1)(2010-12#2)(2010-2#1)
proteomic investigations##2##2##(2010-4#1)(2012-2#1)
proteomic methodologies##2##2##(2008-4#1)(2012-2#1)
proteomic methods to##2##3##(2010-11#1)(2011-1#1)
proteomic methods##5##2##(2010-11#3)(2011-1#1)(2013-8#1)
proteomic profiles of##2##3##(2009-6#1)(2013-1#1)
proteomic profiling##2##2##(2008-7#1)(2010-12#1)
proteomic studies on##2##3##(2009-4#1)(2010-12#1)
proteomic studies##11##2##(2007-8#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-4#1)(2010-12#4)(2010-2#1)(2013-8#1)
proteomic techniques are##2##3##(2009-4#1)(2010-12#1)
proteomic techniques##6##2##(2007-12#1)(2007-8#1)(2009-4#1)(2010-12#2)(2013-1#1)
proteomic technologies to##2##3##(2008-11#1)(2012-2#1)
proteomic technologies##5##2##(2008-11#1)(2009-2#1)(2009-4#1)(2010-12#1)(2012-2#1)
proteomic technology that##2##3##(2006-9#1)(2009-7#1)
proteomic technology##4##2##(2006-9#2)(2009-7#1)(2010-12#1)
proteomic##129##1##(2005-10#1)(2006-9#3)(2007-12#4)(2007-5#1)(2007-8#3)(2008-1#3)(2008-10#5)(2008-11#6)(2008-2#1)(2008-4#11)(2008-7#13)(2008-9#5)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-6#2)(2009-7#2)(2009-8#2)(2010-11#6)(2010-12#23)(2010-2#4)(2010-4#1)(2011-1#3)(2011-12#2)(2012-12#2)(2012-2#3)(2013-1#8)(2013-8#5)
proteomics analysis##2##2##(2008-7#1)(2010-12#1)
proteomics and metabolomics##2##3##(2011-2#2)
proteomics and##13##2##(2006-9#1)(2007-12#1)(2007-8#1)(2008-7#2)(2009-7#1)(2009-8#1)(2010-12#1)(2011-2#3)(2012-12#1)(2013-8#1)
proteomics approach##7##2##(2008-10#1)(2008-8#1)(2009-9#1)(2010-12#3)(2012-2#1)
proteomics approaches##5##2##(2008-9#1)(2010-12#1)(2012-12#1)(2013-1#2)
proteomics are##2##2##(2010-12#1)(2013-1#1)
proteomics as a##2##3##(2008-7#1)(2010-2#1)
proteomics as##3##2##(2008-7#1)(2010-2#1)(2011-2#1)
proteomics data##11##2##(2008-11#1)(2008-7#7)(2012-3#3)
proteomics has##2##2##(2008-9#1)(2010-12#1)
proteomics in##6##2##(2008-5#1)(2009-1#1)(2009-6#2)(2010-12#1)(2012-2#1)
proteomics is##2##2##(2008-4#1)(2009-4#1)
proteomics of##4##2##(2008-7#2)(2010-2#1)(2010-5#1)
proteomics technologies##2##2##(2008-9#1)(2010-12#1)
proteomics using##2##2##(2010-6#1)(2011-2#1)
proteomics##135##1##(2005-11#1)(2006-9#1)(2007-12#2)(2007-8#5)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#3)(2008-2#2)(2008-4#10)(2008-5#2)(2008-7#28)(2008-8#1)(2008-9#4)(2009-1#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#18)(2010-2#2)(2010-5#2)(2010-6#1)(2010-7#2)(2011-2#6)(2011-3#1)(2012-12#3)(2012-2#4)(2012-3#6)(2013-1#5)(2013-8#6)
proteophosphoglycan##3##1##(1994-9#1)(1996-8#2)
proteosome##2##1##(1997-7#1)(2009-4#1)
proteosome-mediated degradation##2##2##(2009-4#1)(2012-12#1)
protest##5##1##(1991-1#1)(1993-9#1)(1995-1#1)(1995-11#1)(2013-8#1)
protested##3##1##(1994-9#1)(2006-10#1)(2009-10#1)
protestors##5##1##(1997-1#5)
protests##5##1##(1991-10#3)(1993-6#1)(2012-2#1)
proteus##2##1##(2007-7#1)(2007-8#1)
protexin##5##1##(2010-4#5)
prothesis##3##1##(1990-1#1)(2007-7#1)(2011-2#1)
prothoracic gland##2##2##(1995-11#2)
prothoracic glands##4##2##(1995-11#3)(2008-6#1)
prothoracic##9##1##(1995-11#6)(2007-12#2)(2008-6#1)
prothoracicotropic hormone##2##2##(1995-11#2)
prothoracicotropic##3##1##(1995-11#3)
prothrombin time and##3##3##(1996-4#1)(2006-7#1)(2012-1#1)
prothrombin time was##2##3##(1990-12#1)(1990-6#1)
prothrombin time##22##2##(1990-11#1)(1990-12#4)(1990-6#1)(1991-11#1)(1991-6#1)(1993-6#2)(1993-7#1)(1996-4#1)(2004-11#2)(2006-7#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-7#1)(2010-3#1)(2012-1#1)(2012-2#1)
prothrombin times##3##2##(1990-11#1)(1993-6#1)(2007-11#1)
prothrombin##54##1##(1990-11#7)(1990-12#14)(1990-6#1)(1991-11#1)(1991-6#1)(1993-6#3)(1993-7#1)(1993-9#4)(1994-3#1)(1994-4#1)(1994-8#2)(1995-7#1)(1996-4#1)(2004-11#2)(2006-10#1)(2006-7#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
prothrombinase activity##6##2##(1993-3#1)(1994-3#2)(1994-8#1)(2013-7#2)
prothrombinase was##2##2##(1990-12#2)
prothrombinase##22##1##(1990-12#7)(1993-11#1)(1993-3#1)(1994-3#2)(1994-5#1)(1994-8#6)(1997-1#1)(2013-7#3)
prothrombotic environment##2##2##(1997-2#1)(2011-2#1)
prothrombotic state##8##2##(1997-7#2)(2005-10#3)(2008-1#1)(2012-2#1)(2013-1#1)
prothrombotic states##2##2##(2007-9#2)
prothrombotic##17##1##(1997-2#1)(1997-7#2)(2005-10#4)(2005-11#2)(2007-9#2)(2008-1#1)(2008-3#2)(2011-2#1)(2012-2#1)(2013-1#1)
prothymosin alpha mRNA##2##3##(1992-6#2)
prothymosin alpha##5##2##(1992-6#5)
protic and aprotic##2##3##(2008-10#1)(2009-9#1)
protic solvents##7##2##(1994-8#1)(1997-4#2)(2007-11#1)(2008-10#3)
protic##10##1##(1994-8#1)(1997-4#2)(2007-11#1)(2008-10#4)(2009-9#2)
protist Trichomonas vaginalis##3##3##(1997-4#2)(2008-7#1)
protist##6##1##(1995-2#1)(1997-4#3)(1997-6#1)(2008-7#1)
protistan communities##2##2##(2011-2#2)
protistan##5##1##(2007-3#1)(2011-2#4)
protists on bacterial density##2##4##(2008-8#2)
protists##7##1##(1997-2#1)(2008-11#1)(2008-7#1)(2008-8#4)
proto-oncogene and##2##2##(1990-4#1)(1995-5#1)
proto-oncogene c-fos in##2##3##(1991-11#1)(1992-9#1)
proto-oncogene c-fos##9##2##(1990-2#1)(1991-11#1)(1991-3#1)(1992-9#1)(1993-12#1)(1994-12#2)(1996-3#1)(1996-8#1)
proto-oncogene c-myc##2##2##(1994-9#1)(2008-8#1)
proto-oncogene could be##2##3##(1990-4#1)(2012-1#1)
proto-oncogene during##2##2##(1991-9#1)(1993-6#1)
proto-oncogene expression##5##2##(1990-12#2)(1991-3#1)(1992-8#1)(1994-6#1)
proto-oncogene family##2##2##(1993-12#1)(1996-4#1)
proto-oncogene has been reported##2##4##(1993-7#1)(2012-2#1)
proto-oncogene has been##3##3##(1990-8#1)(1993-7#1)(2012-2#1)
proto-oncogene induction##3##2##(1991-5#2)(1996-12#1)
proto-oncogene is##3##2##(1993-6#1)(1995-3#1)(2009-9#1)
proto-oncogene mRNA##4##2##(1990-12#3)(1993-12#1)
proto-oncogene product##4##2##(1993-5#1)(1995-3#2)(1997-8#1)
proto-oncogene products##3##2##(1990-3#1)(1991-5#1)(1996-2#1)
proto-oncogene promoters##3##2##(1994-6#3)
proto-oncogene protein##2##2##(2007-9#1)(2011-3#1)
proto-oncogene##90##1##(1990-12#5)(1990-2#2)(1990-3#1)(1990-4#3)(1990-8#3)(1991-11#4)(1991-3#2)(1991-5#6)(1991-6#2)(1991-9#3)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-5#1)(1993-6#6)(1993-7#2)(1994-12#4)(1994-6#4)(1994-9#1)(1995-3#3)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-7#1)(1997-8#1)(2003-11#1)(2007-9#1)(2008-1#1)(2008-4#2)(2008-8#2)(2008-9#4)(2009-9#1)(2010-6#1)(2010-7#1)(2011-2#1)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#1)
proto-oncogenes and tumour suppressor##2##4##(2008-3#1)(2009-3#1)
proto-oncogenes and##5##2##(1990-7#1)(1993-8#1)(2008-3#1)(2009-3#1)(2012-2#1)
proto-oncogenes in##2##2##(1991-3#1)(2008-7#1)
proto-oncogenes##18##1##(1990-11#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-6#1)(2008-3#1)(2008-7#2)(2009-3#1)(2009-4#1)(2010-3#2)(2011-2#1)(2012-2#1)
proto-oncoprotein##2##1##(1993-9#1)(1995-3#1)
protocatechuic acid##5##2##(2008-10#2)(2008-11#1)(2008-6#1)(2012-3#1)
protocatechuic##6##1##(2007-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2012-3#1)
protocells&quot##2##1##(2012-11#2)
protocerebral commissure##5##2##(2007-12#5)
protocerebral neuroblasts##2##2##(2007-12#2)
protocerebral##11##1##(2007-12#11)
protocerebrum##15##1##(1995-5#1)(2007-12#13)(2008-9#1)
protochlorophyllide oxidoreductase##2##2##(1995-1#2)
protochlorophyllide reduction##2##2##(1995-1#2)
protochlorophyllide##8##1##(1992-8#1)(1995-1#7)
protocol (group##3##2##(2005-1#1)(2011-2#1)(2012-3#1)
protocol -##2##2##(2007-11#1)(2013-7#1)
protocol A was##3##3##(2008-4#3)
protocol A##8##2##(2008-4#8)
protocol B##5##2##(2008-4#5)
protocol DIN 6800-2##2##3##(2012-1#2)
protocol administered##2##2##(2008-8#1)(2009-10#1)
protocol allows for##2##3##(2008-11#1)(2008-4#1)
protocol allows the##2##3##(2008-4#2)
protocol allows##6##2##(1995-12#1)(2008-11#1)(2008-4#4)
protocol also describes##2##3##(2008-4#2)
protocol also discusses##2##3##(2008-4#2)
protocol also##6##2##(2007-2#1)(2008-4#5)
protocol and a##4##3##(2007-8#1)(2008-11#1)(2008-5#1)(2008-9#1)
protocol and the##5##3##(1996-12#1)(2011-12#1)(2012-1#1)(2012-11#1)(2013-1#1)
protocol and therefore##2##3##(2006-10#1)(2007-11#1)
protocol and##44##2##(1990-4#1)(1990-6#1)(1991-2#1)(1991-7#1)(1992-8#1)(1996-12#1)(1996-9#1)(2005-1#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-11#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-8#1)(2008-9#1)(2009-1#1)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#3)(2012-11#2)(2012-3#2)(2013-1#6)
protocol are##3##2##(2008-11#1)(2008-8#1)(2013-1#1)
protocol as##3##2##(1996-11#1)(1996-9#1)(2007-11#1)
protocol at##3##2##(1997-5#1)(2008-10#1)(2012-2#1)
protocol based on##7##3##(1993-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#2)
protocol based##8##2##(1993-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#2)(2012-12#1)
protocol biopsies may##2##3##(1995-2#1)(2007-8#1)
protocol biopsies##8##2##(1995-2#3)(2007-8#5)
protocol by##3##2##(2005-8#1)(2008-10#1)(2008-2#1)
protocol can be modified##2##4##(2008-4#2)
protocol can be performed##2##4##(2008-4#1)(2008-9#1)
protocol can be used to##2##5##(2008-2#1)(2008-4#1)
protocol can be used##3##4##(2008-11#1)(2008-2#1)(2008-4#1)
protocol can be##11##3##(2008-11#1)(2008-2#1)(2008-4#6)(2008-8#1)(2008-9#1)(2010-2#1)
protocol can##12##2##(2007-9#1)(2008-11#1)(2008-2#1)(2008-4#6)(2008-8#1)(2008-9#1)(2010-2#1)
protocol combining##2##2##(2008-10#1)(2008-5#1)
protocol conditions##2##2##(2012-2#1)(2013-1#1)
protocol consisted of##2##3##(1990-3#1)(2008-10#1)
protocol described in this unit is##2##6##(2008-2#1)(2008-4#1)
protocol described in this unit##3##5##(2008-2#1)(2008-4#2)
protocol described in this##4##4##(1994-9#1)(2008-2#1)(2008-4#2)
protocol described in##5##3##(1994-9#1)(2008-2#1)(2008-4#3)
protocol described##9##2##(1994-9#1)(2008-2#2)(2008-4#5)(2012-12#1)
protocol describes a method for##8##5##(2008-2#1)(2008-4#6)(2008-9#1)
protocol describes a method##11##4##(2008-2#1)(2008-4#9)(2008-9#1)
protocol describes a##25##3##(2008-11#2)(2008-2#1)(2008-4#20)(2008-9#1)(2010-10#1)
protocol describes an##3##3##(2008-4#3)
protocol describes electroelution of the fragment of interest from standard agarose gels using buffer-filled dialysis bags##2##16##(2008-2#1)(2008-4#1)
protocol describes how to##8##4##(2008-2#1)(2008-4#7)
protocol describes how##10##3##(2008-2#2)(2008-4#8)
protocol describes methods##4##3##(2008-1#1)(2008-2#1)(2008-4#2)
protocol describes the use of##2##5##(2008-4#2)
protocol describes the##26##3##(2008-1#1)(2008-11#1)(2008-2#2)(2008-4#20)(2008-9#2)
protocol describes##92##2##(2008-1#2)(2008-11#6)(2008-2#8)(2008-4#70)(2008-9#5)(2010-10#1)
protocol describing##2##2##(2008-4#1)(2008-9#1)
protocol design##3##2##(1995-4#1)(1997-1#1)(2008-7#1)
protocol details the preparation of##2##5##(2008-4#2)
protocol details the##4##3##(2008-4#4)
protocol details##11##2##(2008-2#1)(2008-4#10)
protocol detected##3##2##(2008-10#3)
protocol determines##2##2##(2008-4#1)(2008-9#1)
protocol developed in this study##2##5##(2008-10#1)(2013-1#1)
protocol developed in##3##3##(2008-10#1)(2012-12#1)(2013-1#1)
protocol developed##5##2##(2008-10#2)(2008-11#1)(2012-12#1)(2013-1#1)
protocol during##2##2##(2007-11#1)(2013-8#1)
protocol for a##4##3##(2007-10#1)(2008-4#1)(2008-7#1)(2013-1#1)
protocol for administration##2##3##(1997-1#1)(2007-7#1)
protocol for assaying the##2##4##(2008-1#2)
protocol for assessing##2##3##(2008-11#1)(2008-9#1)
protocol for extracting##2##3##(1997-2#1)(2008-9#1)
protocol for flow cytometric##2##4##(2008-4#1)(2008-9#1)
protocol for flow##3##3##(2008-4#2)(2008-9#1)
protocol for identifying##2##3##(1997-2#1)(2007-7#1)
protocol for isolating##4##3##(2008-1#1)(2008-4#3)
protocol for patients##2##3##(2006-10#1)(2009-3#1)
protocol for primary##2##3##(2007-12#1)(2009-6#1)
protocol for the analysis of##3##5##(2008-10#1)(2008-2#1)(2008-4#1)
protocol for the derivation of##2##5##(2008-11#1)(2008-4#1)
protocol for the evaluation of##2##5##(1990-12#1)(2008-10#1)
protocol for the evaluation##3##4##(1990-12#1)(2008-10#1)(2008-3#1)
protocol for the preparation of##2##5##(1997-2#1)(2010-4#1)
protocol for the rapid##2##4##(1997-6#1)(2008-3#1)
protocol for the study of##2##5##(1991-9#1)(2008-4#1)
protocol for the use of##3##5##(2007-7#1)(2008-4#1)(2008-7#1)
protocol for the##51##3##(1990-12#1)(1991-9#1)(1992-8#1)(1993-6#1)(1996-10#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-6#1)(2005-7#1)(2005-9#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#6)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#9)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)
protocol for##201##2##(1990-12#1)(1990-3#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-6#1)(1993-9#1)(1994-2#1)(1995-12#1)(1996-10#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#5)(1997-6#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-7#2)(2007-10#5)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#12)(2008-10#12)(2008-11#11)(2008-12#1)(2008-2#9)(2008-3#5)(2008-4#50)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#8)(2009-11#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
protocol gives##2##2##(2008-4#2)
protocol has been##3##3##(2008-11#1)(2012-1#1)(2012-12#1)
protocol has##7##2##(2008-11#2)(2008-4#1)(2008-9#1)(2010-6#1)(2012-1#1)(2012-12#1)
protocol illustrates##3##2##(2008-11#3)
protocol implementation##2##2##(2007-11#1)(2013-1#1)
protocol in the##4##3##(1990-4#1)(1992-8#1)(2007-11#1)(2008-8#1)
protocol in this unit describes the##3##6##(2008-2#2)(2008-4#1)
protocol in this unit describes##6##5##(2008-2#2)(2008-4#4)
protocol in this unit is##2##5##(2008-4#2)
protocol in this unit##11##4##(2008-2#2)(2008-4#9)
protocol in which the##3##4##(2008-10#1)(2008-4#2)
protocol in which##9##3##(1993-11#1)(2008-1#1)(2008-10#2)(2008-4#5)
protocol in##40##2##(1990-12#1)(1990-4#1)(1992-8#1)(1993-11#1)(2007-11#2)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#14)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2011-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
protocol included a total of##2##5##(2012-1#2)
protocol included##4##2##(1994-3#1)(2008-6#1)(2012-1#2)
protocol includes##2##2##(2008-2#1)(2008-4#1)
protocol including##3##2##(1991-4#1)(2006-10#1)(2011-2#1)
protocol involves##2##2##(2008-11#1)(2008-4#1)
protocol is a##8##3##(2008-10#1)(2008-2#1)(2008-4#4)(2008-9#1)(2010-8#1)
protocol is also applicable##2##4##(2008-11#2)
protocol is also##7##3##(2008-1#1)(2008-11#2)(2008-4#4)
protocol is based on the##5##5##(1994-3#1)(2008-10#1)(2008-4#2)(2008-9#1)
protocol is based on##9##4##(1994-3#1)(2008-10#2)(2008-4#4)(2008-9#2)
protocol is described for##4##4##(2008-1#1)(2008-4#3)
protocol is described which##2##4##(2005-11#1)(2010-11#1)
protocol is described##6##3##(2005-11#1)(2008-1#1)(2008-4#3)(2010-11#1)
protocol is designed##3##3##(2008-4#3)
protocol is included for##2##4##(2008-4#1)(2008-9#1)
protocol is its##2##3##(2008-4#2)
protocol is offered##2##3##(2004-3#1)(2008-4#1)
protocol is presented for##3##4##(2008-4#3)
protocol is presented##5##3##(1994-3#1)(2008-4#3)(2009-10#1)
protocol is provided for inducing##2##5##(2008-4#2)
protocol is provided for##12##4##(2008-4#12)
protocol is provided##15##3##(2008-4#14)(2008-6#1)
protocol is that##2##3##(2008-4#1)(2012-12#1)
protocol is used##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
protocol is##98##2##(1991-8#1)(1994-2#1)(1994-3#2)(1994-5#1)(1997-2#1)(2004-3#1)(2005-11#1)(2006-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#5)(2008-11#5)(2008-2#5)(2008-3#1)(2008-4#51)(2008-5#1)(2008-6#1)(2008-9#5)(2009-10#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
protocol may##7##2##(1992-9#1)(1993-11#1)(1997-7#1)(2008-2#1)(2008-4#2)(2010-2#1)
protocol of early##2##3##(1996-11#1)(2006-11#1)
protocol of##20##2##(1990-4#1)(1991-6#1)(1992-6#1)(1996-11#1)(1996-2#1)(2005-11#1)(2006-11#1)(2006-5#1)(2007-11#2)(2008-10#2)(2008-11#3)(2008-4#1)(2008-9#2)(2009-5#1)(2012-1#1)
protocol offers##3##2##(2008-10#1)(2008-4#2)
protocol on the##2##3##(2008-4#1)(2011-2#1)
protocol on##9##2##(1994-11#1)(1997-7#1)(2007-4#1)(2008-3#1)(2008-4#1)(2008-9#2)(2009-2#1)(2011-2#1)
protocol outlines a##2##3##(2008-4#2)
protocol outlines##5##2##(2008-1#1)(2008-2#1)(2008-4#3)
protocol presented here##2##3##(2008-4#1)(2008-9#1)
protocol presented in this unit##2##5##(2008-4#1)(2008-9#1)
protocol presented in this##3##4##(2006-12#1)(2008-4#1)(2008-9#1)
protocol presented##5##2##(2006-12#1)(2008-4#2)(2008-9#2)
protocol presents a##3##3##(2008-11#1)(2008-4#2)
protocol presents an##2##3##(2008-11#1)(2008-4#1)
protocol presents##6##2##(2008-11#2)(2008-4#4)
protocol produced##4##2##(2007-2#1)(2008-10#1)(2008-7#1)(2011-2#1)
protocol provides a method to##2##5##(2008-4#2)
protocol provides a##8##3##(2008-4#4)(2008-9#2)(2013-1#2)
protocol provides##12##2##(2008-1#1)(2008-2#1)(2008-4#5)(2008-9#3)(2013-1#2)
protocol requires##2##2##(1996-2#1)(2008-9#1)
protocol results in##2##3##(2007-7#1)(2008-11#1)
protocol should be##2##3##(2008-4#1)(2012-11#1)
protocol should##4##2##(1997-5#1)(2008-10#1)(2008-4#1)(2012-11#1)
protocol that allows##2##3##(2008-9#1)(2010-8#1)
protocol that describes##2##3##(2008-4#2)
protocol that employs##2##3##(2008-4#2)
protocol that included##2##3##(1996-2#1)(2007-10#1)
protocol that uses##4##3##(2008-1#1)(2008-2#2)(2008-4#1)
protocol that##26##2##(1991-12#1)(1996-2#1)(2007-10#1)(2007-9#1)(2008-1#2)(2008-11#2)(2008-2#3)(2008-4#10)(2008-9#1)(2009-8#1)(2010-8#1)(2012-12#2)
protocol therapy##2##2##(2011-2#2)
protocol tissues##2##2##(1995-2#2)
protocol to assess##2##3##(2008-4#1)(2008-5#1)
protocol to detect##2##3##(2008-4#1)(2008-7#1)
protocol to examine##2##3##(2008-10#1)(2008-11#1)
protocol to investigate##2##3##(2008-11#2)
protocol to perform##2##3##(2008-4#1)(2008-7#1)
protocol to rapidly##2##3##(2007-1#1)(2012-2#1)
protocol to the##4##3##(1991-3#1)(2005-11#1)(2008-10#1)(2010-5#1)
protocol to##44##2##(1991-3#1)(1991-8#1)(1997-2#1)(1997-6#1)(2005-11#1)(2007-1#1)(2007-7#2)(2008-10#3)(2008-11#4)(2008-12#1)(2008-4#9)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-12#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
protocol used for##3##3##(1996-8#1)(2008-11#1)(2008-7#1)
protocol used##5##2##(1996-8#1)(2008-11#1)(2008-7#1)(2010-3#1)(2012-3#1)
protocol uses a##2##3##(2008-4#2)
protocol uses##6##2##(2008-2#1)(2008-4#4)(2008-9#1)
protocol using a##2##3##(2009-1#1)(2013-7#1)
protocol using the##2##3##(2008-11#1)(2008-9#1)
protocol using##9##2##(1995-12#1)(2006-2#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-1#1)(2011-2#1)(2013-7#1)
protocol utilizes the##2##3##(2008-2#1)(2008-4#1)
protocol utilizes##5##2##(2008-2#1)(2008-4#4)
protocol was applied##4##3##(2008-10#1)(2011-2#1)(2013-1#2)
protocol was changed##2##3##(2009-6#1)(2012-2#1)
protocol was designed to##2##4##(1992-8#1)(2008-10#1)
protocol was designed##5##3##(1992-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2010-10#1)
protocol was developed and##2##4##(2007-10#1)(2008-10#1)
protocol was developed to##3##4##(2004-4#1)(2008-10#1)(2008-11#1)
protocol was developed##6##3##(2004-4#1)(2007-10#1)(2008-10#2)(2008-11#1)(2013-1#1)
protocol was devised##2##3##(1994-3#1)(2008-5#1)
protocol was introduced##2##3##(1991-6#1)(2011-2#1)
protocol was used to##3##4##(2005-1#1)(2008-10#1)(2008-7#1)
protocol was used##5##3##(2005-1#2)(2008-10#1)(2008-7#1)(2008-8#1)
protocol was##54##2##(1990-4#1)(1991-3#1)(1991-6#1)(1992-8#1)(1994-3#1)(1995-5#1)(1996-6#1)(2004-4#1)(2005-1#4)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-1#1)(2009-6#1)(2010-10#3)(2010-12#1)(2010-7#1)(2011-2#3)(2012-2#2)(2013-1#6)(2013-8#1)
protocol we##7##2##(1995-7#1)(2008-11#5)(2011-2#1)
protocol were developed##2##3##(2008-10#2)
protocol were##10##2##(2006-10#1)(2007-1#1)(2007-7#1)(2007-8#3)(2008-10#2)(2011-2#2)
protocol which##5##2##(1995-3#1)(2007-8#1)(2008-4#1)(2012-12#1)(2013-1#1)
protocol will##9##2##(2006-12#1)(2006-2#1)(2008-10#2)(2008-4#2)(2008-8#1)(2008-9#2)
protocol with a##2##3##(2007-8#1)(2008-9#1)
protocol with##16##2##(1994-5#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-6#1)(2010-12#1)(2011-2#3)(2012-3#2)
protocol without##3##2##(2007-7#1)(2007-8#1)(2011-2#1)
protocol would##2##2##(2007-2#1)(2008-3#1)
protocol##1343##1##(1990-10#1)(1990-12#2)(1990-3#2)(1990-4#5)(1990-6#3)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-6#4)(1991-7#2)(1991-8#3)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#7)(1992-9#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-6#1)(1993-9#3)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#5)(1994-5#4)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#2)(1995-12#5)(1995-2#7)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#4)(1995-7#1)(1996-10#2)(1996-11#4)(1996-12#2)(1996-2#4)(1996-6#2)(1996-8#4)(1996-9#4)(1997-1#6)(1997-2#11)(1997-4#1)(1997-5#3)(1997-6#4)(1997-7#2)(1997-8#1)(2004-3#1)(2004-4#1)(2004-9#1)(2005-1#11)(2005-11#4)(2005-12#1)(2005-3#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#8)(2006-11#2)(2006-12#4)(2006-2#4)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#4)(2007-10#9)(2007-11#19)(2007-12#4)(2007-2#11)(2007-3#2)(2007-4#1)(2007-6#2)(2007-7#18)(2007-8#87)(2007-9#6)(2008-1#27)(2008-10#86)(2008-11#74)(2008-12#8)(2008-2#49)(2008-3#14)(2008-4#337)(2008-5#17)(2008-6#13)(2008-7#22)(2008-8#16)(2008-9#52)(2009-1#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#7)(2009-3#3)(2009-4#3)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#7)(2009-9#2)(2010-1#1)(2010-10#6)(2010-11#3)(2010-12#9)(2010-2#5)(2010-3#4)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#7)(2010-9#2)(2011-1#1)(2011-12#5)(2011-2#45)(2012-1#12)(2012-11#3)(2012-12#20)(2012-2#20)(2012-3#17)(2013-1#38)(2013-7#3)(2013-8#14)
protocol)##6##1##(2006-6#2)(2008-2#4)
protocol]##2##1##(2008-12#1)(2011-2#1)
protocols after##4##2##(2007-11#2)(2012-3#1)(2013-8#1)
protocols and##28##2##(1991-12#1)(1992-12#1)(1994-3#2)(2005-11#1)(2006-6#1)(2007-1#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-8#1)
protocols are accompanied by##2##4##(2008-4#1)(2008-9#1)
protocols are also##3##3##(2008-4#3)
protocols are applicable to##2##4##(2008-1#1)(2008-9#1)
protocols are available##2##3##(2008-8#2)
protocols are described for##3##4##(2008-2#1)(2008-4#1)(2008-9#1)
protocols are described##6##3##(2008-2#1)(2008-4#3)(2008-9#2)
protocols are designed for##3##4##(2008-2#2)(2008-4#1)
protocols are designed##4##3##(2008-2#2)(2008-4#1)(2008-9#1)
protocols are discussed##3##3##(1994-2#1)(2006-10#1)(2009-4#1)
protocols are given for##3##4##(2008-4#3)
protocols are given##4##3##(2008-4#4)
protocols are included for preparing##2##5##(2008-4#2)
protocols are included for##4##4##(2008-2#1)(2008-4#3)
protocols are included##5##3##(2008-2#1)(2008-4#3)(2008-9#1)
protocols are increasingly##2##3##(2006-10#1)(2007-11#1)
protocols are presented for##4##4##(2008-4#3)(2009-3#1)
protocols are presented##7##3##(2008-1#1)(2008-11#1)(2008-4#4)(2009-3#1)
protocols are provided for the assessment of##2##7##(2008-4#2)
protocols are provided for the##5##5##(2008-4#5)
protocols are provided for##17##4##(2008-1#1)(2008-2#1)(2008-4#13)(2008-9#2)
protocols are provided in##2##4##(2008-4#1)(2008-9#1)
protocols are provided to##2##4##(2008-4#2)
protocols are provided##26##3##(2008-1#1)(2008-2#2)(2008-4#20)(2008-9#3)
protocols are##92##2##(1991-12#1)(1994-2#1)(2005-11#1)(2006-10#3)(2006-4#1)(2006-6#1)(2007-11#2)(2007-9#1)(2008-1#3)(2008-11#1)(2008-2#8)(2008-4#49)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#11)(2009-3#1)(2009-4#1)(2011-1#1)(2013-1#1)(2013-7#1)
protocols at##2##2##(1994-3#1)(2010-9#1)
protocols based on##3##3##(2008-7#1)(2010-3#1)(2013-1#1)
protocols by##4##2##(1992-3#1)(2008-10#2)(2008-4#1)
protocols can be used to##2##5##(2008-1#1)(2008-4#1)
protocols can be used##6##4##(2007-10#1)(2008-1#1)(2008-4#2)(2008-9#2)
protocols can be##10##3##(1994-3#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-4#4)(2008-9#2)
protocols can##11##2##(1994-3#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-4#5)(2008-9#2)
protocols cover##6##2##(2008-1#1)(2008-2#1)(2008-4#2)(2008-9#2)
protocols currently##2##2##(2008-7#1)(2012-12#1)
protocols describe how to##7##4##(2008-1#1)(2008-4#5)(2008-9#1)
protocols describe methods for preparing##2##5##(2008-4#2)
protocols describe methods for##6##4##(2008-4#6)
protocols describe methods##7##3##(2008-4#7)
protocols describe preparation of the##2##5##(2008-4#2)
protocols describe preparation of##4##4##(2008-4#4)
protocols describe preparing##2##3##(2008-4#2)
protocols describe the preparation of##3##5##(2008-4#3)
protocols describe the##12##3##(2008-4#12)
protocols describe##65##2##(2008-1#1)(2008-2#4)(2008-4#55)(2008-9#5)
protocols described herein##3##3##(2008-4#2)(2008-9#1)
protocols described in this unit##3##5##(2008-1#1)(2008-4#2)
protocols described##10##2##(2008-1#1)(2008-4#8)(2008-9#1)
protocols describes##2##2##(2008-2#1)(2008-4#1)
protocols describing the##2##3##(2008-9#2)
protocols describing##3##2##(2008-4#1)(2008-9#2)
protocols designed to##2##3##(2008-4#1)(2009-6#1)
protocols detail the##4##3##(2008-4#4)
protocols detail##8##2##(2008-2#1)(2008-4#6)(2008-9#1)
protocols developed##3##2##(2008-11#1)(2008-9#1)(2010-2#1)
protocols discuss##3##2##(2008-4#3)
protocols employ##2##2##(2008-4#2)
protocols employing##2##2##(2008-4#1)(2008-9#1)
protocols enable##2##2##(2008-4#1)(2008-9#1)
protocols for all steps starting with solubilization of the protein samples##2##11##(2008-2#1)(2008-4#1)
protocols for all##4##3##(2007-9#1)(2008-2#1)(2008-4#1)(2008-8#1)
protocols for assessment of##2##4##(2008-9#2)
protocols for both##2##3##(2008-4#1)(2008-9#1)
protocols for cell##2##3##(2008-10#1)(2010-6#1)
protocols for detecting##4##3##(2008-2#1)(2008-4#3)
protocols for generating and##2##4##(2008-4#2)
protocols for generating##3##3##(2008-4#3)
protocols for growth of##2##4##(2008-4#1)(2008-9#1)
protocols for in##2##3##(2008-4#2)
protocols for infecting##2##3##(2008-4#1)(2008-9#1)
protocols for isolating##4##3##(2008-1#3)(2008-4#1)
protocols for labeling and##2##4##(2008-1#1)(2008-4#1)
protocols for long-term##2##3##(1991-6#1)(2008-4#1)
protocols for measuring##3##3##(2008-1#1)(2008-4#1)(2008-9#1)
protocols for more##2##3##(2008-4#1)(2008-9#1)
protocols for obtaining##2##3##(2008-1#1)(2008-4#1)
protocols for patients##2##3##(2008-3#1)(2013-1#1)
protocols for performing##4##3##(2008-2#1)(2008-4#1)(2008-9#2)
protocols for preparing##6##3##(2008-4#5)(2008-9#1)
protocols for probe labeling##3##4##(2008-11#1)(2008-9#2)
protocols for radioiodination of##2##4##(2008-1#1)(2008-2#1)
protocols for the detection##3##4##(2008-11#1)(2008-4#2)
protocols for the generation of##3##5##(1992-8#1)(2008-4#2)
protocols for the in##2##4##(2008-11#1)(2008-4#1)
protocols for the isolation of##2##5##(2008-4#1)(2008-9#1)
protocols for the most##3##4##(2008-4#2)(2011-2#1)
protocols for the preparation of##2##5##(2008-2#2)
protocols for the purification of##3##5##(2008-1#1)(2008-4#2)
protocols for the##47##3##(1992-8#1)(1994-5#1)(1995-5#1)(2007-4#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#21)(2008-6#1)(2008-7#1)(2008-9#9)(2011-2#1)(2012-12#1)(2012-3#1)
protocols for these##2##3##(2007-8#1)(2008-9#1)
protocols for this##2##3##(2008-4#1)(2008-9#1)
protocols for training##2##3##(1993-12#1)(2011-2#1)
protocols for using##2##3##(2008-4#2)
protocols for##245##2##(1991-5#1)(1991-6#1)(1992-8#1)(1993-12#1)(1993-4#1)(1994-5#1)(1995-3#1)(1995-5#1)(1997-1#1)(1997-8#1)(2004-9#1)(2006-11#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-1#16)(2008-10#8)(2008-11#4)(2008-2#12)(2008-3#2)(2008-4#92)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#50)(2009-12#1)(2009-7#1)(2009-8#1)(2010-6#1)(2011-12#1)(2011-2#5)(2012-12#8)(2012-2#3)(2012-3#3)(2013-1#3)(2013-7#2)
protocols from the##2##3##(1991-9#1)(2008-9#1)
protocols from##3##2##(1991-9#1)(1995-3#1)(2008-9#1)
protocols have been developed for##2##5##(2008-1#1)(2010-7#1)
protocols have been introduced##2##4##(2010-7#1)(2011-2#1)
protocols have been##10##3##(2006-10#2)(2008-1#1)(2008-4#1)(2008-9#2)(2010-7#3)(2011-2#1)
protocols have##15##2##(1996-12#1)(2005-11#2)(2006-10#2)(2008-1#1)(2008-10#1)(2008-4#2)(2008-9#2)(2010-7#3)(2011-2#1)
protocols herein##3##2##(2008-4#1)(2008-9#2)
protocols illustrate##2##2##(2008-4#2)
protocols in a##3##3##(1994-7#1)(2008-9#1)(2013-1#1)
protocols in patients with##2##4##(2010-5#1)(2011-1#1)
protocols in patients##3##3##(2005-1#1)(2010-5#1)(2011-1#1)
protocols in the##4##3##(2007-1#1)(2008-3#1)(2010-2#1)(2013-8#1)
protocols in this chapter##2##4##(2008-4#2)
protocols in this unit are##4##5##(2008-2#1)(2008-4#2)(2008-9#1)
protocols in this unit cover##2##5##(2008-2#1)(2008-9#1)
protocols in this unit describe##11##5##(2008-1#1)(2008-2#1)(2008-4#8)(2008-9#1)
protocols in this unit outline the##2##6##(2008-4#2)
protocols in this unit##27##4##(2008-1#1)(2008-2#4)(2008-4#16)(2008-9#6)
protocols in this##31##3##(2008-1#1)(2008-2#4)(2008-4#18)(2008-9#7)(2012-11#1)
protocols in##52##2##(1990-12#1)(1991-2#1)(1994-7#1)(2005-1#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#5)(2008-3#1)(2008-4#20)(2008-9#8)(2010-10#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-12#1)(2012-11#1)(2013-1#1)(2013-8#1)
protocols include##2##2##(2008-4#2)
protocols induce##2##2##(2009-4#1)(2013-8#1)
protocols involving##3##2##(1997-1#1)(2007-11#1)(2013-8#1)
protocols is##10##2##(1994-3#1)(2008-11#3)(2008-4#1)(2008-9#2)(2011-2#1)(2013-1#1)(2013-7#1)
protocols may be##4##3##(2008-10#1)(2008-4#3)
protocols may##6##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#3)
protocols must be##3##3##(2007-12#1)(2008-4#1)(2009-6#1)
protocols needed for##2##3##(2008-4#1)(2008-9#1)
protocols needed to##2##3##(2008-4#2)
protocols needed##4##2##(2008-4#3)(2008-9#1)
protocols of##7##2##(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-8#1)
protocols on##5##2##(2007-9#1)(2008-1#1)(2008-4#1)(2008-9#2)
protocols or##2##2##(1995-3#1)(1996-1#1)
protocols outlining##2##2##(2008-2#1)(2008-9#1)
protocols present methods for##4##4##(2008-4#3)(2008-9#1)
protocols present##6##2##(2008-4#5)(2008-9#1)
protocols presented##3##2##(2008-4#3)
protocols provide##10##2##(1992-3#1)(2008-4#7)(2008-9#1)(2009-10#1)
protocols provided##3##2##(2008-1#1)(2008-7#1)(2008-9#1)
protocols that are##2##3##(2008-1#1)(2008-4#1)
protocols that can be used to measure##2##7##(2008-4#2)
protocols that can be used to##6##6##(2008-1#1)(2008-4#5)
protocols that can be used##7##5##(2008-1#1)(2008-4#6)
protocols that describe##2##3##(2008-4#2)
protocols that have been##3##4##(2008-4#2)(2008-9#1)
protocols that utilize##2##3##(1997-3#1)(2008-4#1)
protocols that will##2##3##(2008-1#1)(2008-2#1)
protocols that##31##2##(1995-8#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-2#1)(2008-4#17)(2008-8#1)(2008-9#2)(2013-8#1)
protocols the##2##2##(2008-5#1)(2008-9#1)
protocols to measure##2##3##(2008-1#1)(2008-4#1)
protocols to##24##2##(2006-8#1)(2008-1#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#6)(2008-5#1)(2008-9#4)(2010-12#1)(2012-11#2)(2013-1#2)
protocols typically##2##2##(1993-11#1)(2006-11#1)
protocols used for##4##3##(2007-11#1)(2008-10#1)(2008-4#2)
protocols used in##2##3##(2007-7#1)(2011-2#1)
protocols used to##2##3##(2008-4#1)(2008-9#1)
protocols used##10##2##(2007-11#1)(2007-7#1)(2008-10#1)(2008-4#3)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
protocols using a##2##3##(2007-2#1)(2008-9#1)
protocols using##7##2##(2005-8#1)(2007-2#1)(2007-8#1)(2008-4#2)(2008-9#1)(2009-2#1)
protocols was##3##2##(2008-10#2)(2009-4#1)
protocols were used##3##3##(1990-10#1)(1994-3#1)(2011-2#1)
protocols were##14##2##(1990-10#2)(1994-3#1)(1997-2#1)(2008-10#2)(2008-4#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#3)
protocols when##3##2##(1994-3#1)(2008-10#1)(2008-2#1)
protocols which##3##2##(1994-8#1)(1997-1#1)(2008-4#1)
protocols will##4##2##(1994-3#1)(2005-10#1)(2008-9#1)(2012-12#1)
protocols with##4##2##(2008-10#1)(2008-11#1)(2008-4#2)
protocols would##3##2##(1996-8#1)(2013-1#2)
protocols##1042##1##(1990-10#2)(1990-12#1)(1990-6#1)(1991-12#2)(1991-2#1)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#3)(1992-3#3)(1992-8#5)(1993-11#2)(1993-12#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-2#1)(1994-3#11)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-3#4)(1995-5#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#2)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#3)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#6)(2005-2#1)(2005-7#1)(2005-8#2)(2006-10#7)(2006-11#2)(2006-12#3)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-8#1)(2007-1#3)(2007-10#5)(2007-11#14)(2007-12#10)(2007-2#6)(2007-4#4)(2007-5#3)(2007-7#4)(2007-8#6)(2007-9#5)(2008-1#40)(2008-10#46)(2008-11#22)(2008-12#2)(2008-2#49)(2008-3#13)(2008-4#364)(2008-5#7)(2008-6#4)(2008-7#20)(2008-8#8)(2008-9#130)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#7)(2009-5#2)(2009-6#5)(2009-7#4)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#5)(2010-2#5)(2010-3#4)(2010-5#3)(2010-6#2)(2010-7#6)(2010-8#2)(2010-9#4)(2011-1#6)(2011-12#3)(2011-2#23)(2012-1#4)(2012-11#4)(2012-12#18)(2012-2#10)(2012-3#5)(2013-1#20)(2013-7#6)(2013-8#12)
protogynous##2##1##(2010-5#2)
protoheme IX farnesyltransferase##2##3##(1992-12#2)
protoheme IX##7##2##(1992-12#4)(1994-8#1)(2009-2#2)
protoheme##14##1##(1990-3#1)(1990-5#2)(1990-8#2)(1992-12#4)(1994-8#1)(1995-2#2)(2009-2#2)
protolytic constants from##2##3##(2008-10#2)
protolytic constants of 4-(2-pyridylazo)##2##4##(2008-10#2)
protolytic constants##6##2##(2008-10#6)
protolytic equilibrium##3##2##(2008-10#3)
protolytic##11##1##(1996-5#1)(2008-10#10)
protomer##7##1##(1991-2#1)(1992-5#1)(1994-8#1)(1994-9#2)(1995-6#2)
protomers##3##1##(1992-4#1)(1994-8#1)(1997-6#1)
proton (1H)##2##2##(1993-8#1)(1997-5#1)
proton (on the nicotinamide##2##4##(1990-5#2)
proton MR spectroscopy##2##3##(2007-9#1)(2011-12#1)
proton MRS##4##2##(2007-12#2)(2007-9#2)
proton NMR ((1)H##2##3##(2008-10#1)(2009-10#1)
proton NMR experiments##2##3##(1992-12#1)(1992-9#1)
proton NMR spectra##5##3##(1991-11#1)(1994-8#1)(1995-11#1)(1995-3#1)(2009-3#1)
proton NMR spectroscopy##5##3##(1995-11#1)(1996-8#1)(2004-9#1)(2005-8#1)(2008-5#1)
proton NMR study##2##3##(2008-5#1)(2008-9#1)
proton NMR##31##2##(1990-10#1)(1991-11#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-6#2)(1993-8#1)(1994-5#1)(1994-8#1)(1995-11#2)(1995-3#1)(1995-5#1)(1996-8#1)(2004-9#1)(2005-8#1)(2008-10#1)(2008-5#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)
proton abstraction##3##2##(1993-8#1)(1994-8#1)(2008-10#1)
proton acceptor##3##2##(1994-9#1)(1997-4#1)(2007-11#1)
proton and##7##2##(1990-10#1)(1993-3#1)(1994-8#1)(2008-10#3)(2010-5#1)
proton beam treatment##7##3##(2009-8#7)
proton beam##9##2##(2006-6#1)(2009-8#7)(2010-9#1)
proton carrier##2##2##(1990-11#1)(1993-12#1)
proton channel##4##2##(1992-11#2)(1997-7#1)(2011-1#1)
proton chemical shift##3##3##(1992-12#1)(1994-5#1)(1997-4#1)
proton chemical##4##2##(1992-12#1)(1994-5#1)(1995-2#1)(1997-4#1)
proton concentration##3##2##(1990-8#1)(2008-10#1)(2010-4#1)
proton conductance of##2##3##(1994-8#1)(2013-1#1)
proton conductance##6##2##(1991-3#2)(1994-8#2)(2011-1#1)(2013-1#1)
proton conduction##3##2##(1992-11#1)(2010-12#1)(2011-1#1)
proton conductivity##2##2##(2010-4#2)
proton dissociation##4##2##(2006-10#4)
proton donor##3##2##(1990-7#1)(1995-11#2)
proton ejection##2##2##(1994-11#2)
proton exchange in periodically poled lithium niobate##2##7##(2007-11#1)(2007-12#1)
proton exchange with##2##3##(1992-9#1)(1997-3#1)
proton exchange##7##2##(1992-9#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-4#2)
proton extrusion##4##2##(1994-12#2)(1997-4#1)(2006-8#1)
proton flux##3##2##(1990-11#1)(1992-6#1)(2006-8#1)
proton fluxes##2##2##(1997-4#1)(2012-12#1)
proton from##7##2##(1992-10#1)(1992-6#1)(1994-8#1)(1995-5#1)(2008-10#1)(2008-3#1)(2008-5#1)
proton gradient across the##2##4##(1994-12#2)
proton gradient is##2##3##(1990-2#1)(1994-8#1)
proton gradient##11##2##(1990-2#2)(1993-3#1)(1994-12#2)(1994-8#1)(1995-2#1)(1996-4#1)(1996-8#2)(2008-11#1)
proton in##4##2##(1991-3#1)(2008-10#1)(2008-9#1)(2010-5#1)
proton ionophore##2##2##(1990-2#1)(2008-9#1)
proton is transferred##2##3##(1995-11#1)(2010-5#1)
proton is##7##2##(1990-5#2)(1995-10#1)(1995-11#1)(2006-3#1)(2008-5#1)(2010-5#1)
proton leak and##3##3##(1990-8#1)(1994-12#1)(1996-9#1)
proton leak in##2##3##(1994-8#2)
proton leak or##2##3##(1990-8#2)
proton leak##15##2##(1990-8#3)(1994-11#1)(1994-12#3)(1994-8#5)(1996-9#1)(1997-7#1)(2013-1#1)
proton magnetic resonance spectra##2##4##(2008-6#2)
proton magnetic resonance spectroscopy (1H-MRS)##2##5##(2007-12#1)(2008-11#1)
proton magnetic resonance spectroscopy in##2##5##(2008-6#1)(2008-7#1)
proton magnetic resonance spectroscopy##12##4##(1991-1#1)(1991-6#1)(1992-3#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2010-12#1)
proton magnetic resonance##16##3##(1991-1#1)(1991-6#1)(1992-3#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#3)(2008-7#2)(2010-12#1)
proton motive force##3##3##(1994-8#1)(2005-10#2)
proton nuclear magnetic resonance (NMR)##2##5##(1993-6#1)(2008-5#1)
proton nuclear magnetic resonance spectroscopy##5##5##(1990-10#1)(1990-2#1)(1992-1#1)(1992-7#1)(2008-5#1)
proton nuclear magnetic resonance##12##4##(1990-10#2)(1990-12#1)(1990-2#1)(1992-1#1)(1992-11#1)(1992-7#1)(1992-9#1)(1993-6#1)(2006-11#1)(2008-5#2)
proton of the##2##3##(1991-5#1)(1993-6#1)
proton of##4##2##(1990-9#1)(1991-5#1)(1993-6#2)
proton on the##2##3##(1991-2#1)(1996-7#1)
proton permeability of the##2##4##(1994-12#1)(1994-8#1)
proton permeability##4##2##(1990-11#1)(1994-12#2)(1994-8#1)
proton pump inhibition##2##3##(2006-10#1)(2006-2#1)
proton pump inhibitor (omeprazole)##2##4##(1996-3#1)(2012-2#1)
proton pump inhibitor therapy##2##4##(2006-10#1)(2010-12#1)
proton pump inhibitor##23##3##(1996-3#2)(1997-8#2)(2006-10#7)(2006-2#1)(2008-11#1)(2008-12#2)(2008-5#1)(2009-11#1)(2010-12#1)(2012-2#5)
proton pump inhibitors -##2##4##(2008-8#1)(2012-2#1)
proton pump inhibitors are##2##4##(2008-12#1)(2012-2#1)
proton pump inhibitors##20##3##(2006-10#2)(2006-2#1)(2008-12#1)(2008-6#1)(2008-8#1)(2010-12#6)(2011-2#1)(2012-2#7)
proton pump##62##2##(1990-7#1)(1992-11#1)(1992-12#1)(1994-12#4)(1994-6#1)(1995-11#1)(1996-3#2)(1997-4#1)(1997-6#1)(1997-8#2)(2005-1#1)(2005-12#1)(2006-10#12)(2006-2#3)(2006-6#1)(2008-11#1)(2008-12#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-2#1)(2010-12#7)(2011-2#1)(2012-2#12)
proton pumping and##3##3##(1992-11#2)(1994-8#1)
proton pumping##10##2##(1991-12#1)(1991-9#1)(1992-11#2)(1993-4#1)(1994-8#1)(1995-2#2)(2006-8#1)(2008-7#1)
proton reactions##2##2##(2008-10#2)
proton relaxation times##2##3##(2008-5#1)(2008-7#1)
proton relaxation##3##2##(1991-7#1)(2008-5#1)(2008-7#1)
proton release is##2##3##(1993-12#1)(1997-6#1)
proton release##13##2##(1990-8#3)(1993-11#1)(1993-12#1)(1994-3#2)(1994-8#1)(1997-4#1)(1997-6#4)
proton resonance assignments were made for##2##6##(1997-4#2)
proton resonance assignments##3##3##(1991-4#1)(1997-4#2)
proton resonance##4##2##(1991-4#1)(1997-4#2)(2012-12#1)
proton resonances of##2##3##(1991-4#1)(1991-7#1)
proton resonances##11##2##(1990-10#1)(1990-7#1)(1991-4#2)(1991-7#1)(1991-8#2)(1996-7#1)(1997-4#2)(2008-9#1)
proton scavengers##2##2##(1996-2#2)
proton shifts of##2##3##(1995-2#1)(2007-1#1)
proton shifts##4##2##(1995-2#2)(1997-4#1)(2007-1#1)
proton shuttle##2##2##(1995-10#1)(1996-7#1)
proton shuttling##2##2##(1996-7#2)
proton spectra##2##2##(1994-8#1)(1995-3#1)
proton spectrum##2##2##(1990-7#1)(1995-11#1)
proton symport##2##2##(1996-9#2)
proton therapy##4##2##(2006-2#1)(2010-3#1)(2010-9#1)(2012-12#1)
proton to##4##2##(1996-2#1)(2009-10#1)(2011-1#1)(2012-12#1)
proton transfer as##2##3##(1991-4#1)(1994-8#1)
proton transfer from##3##3##(1995-10#1)(1995-11#1)(2009-8#1)
proton transfer in the##3##4##(1992-6#1)(2008-10#2)
proton transfer reaction##2##3##(2008-10#1)(2009-6#1)
proton transfer reactions##2##3##(2009-10#1)(2011-1#1)
proton transfer to##3##3##(1995-10#1)(2006-3#2)
proton transfer##33##2##(1991-4#1)(1992-3#1)(1992-6#3)(1994-11#1)(1994-8#1)(1995-10#2)(1995-11#2)(1997-4#1)(2005-9#1)(2006-3#3)(2008-10#3)(2009-10#2)(2009-6#1)(2009-8#1)(2010-2#2)(2011-1#2)(2012-11#2)(2012-12#4)
proton translocation activity of##4##4##(1991-3#1)(2008-8#3)
proton translocation activity##5##3##(1991-3#1)(2008-8#4)
proton translocation##11##2##(1990-5#1)(1991-3#1)(1992-11#2)(1994-8#1)(1997-7#1)(2008-8#5)
proton transport##3##2##(1992-11#1)(1995-5#1)(1997-7#1)
proton treatment##3##2##(2010-9#3)
proton uptake and##2##3##(1994-9#2)
proton uptake by##2##3##(1994-9#2)
proton uptake##8##2##(1994-12#1)(1994-9#5)(1995-5#2)
proton was##2##2##(1990-5#1)(1990-9#1)
proton with##2##2##(1992-6#1)(1994-8#1)
proton##469##1##(1990-10#6)(1990-11#4)(1990-12#2)(1990-2#5)(1990-4#1)(1990-5#7)(1990-7#6)(1990-8#7)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#6)(1991-4#4)(1991-5#1)(1991-6#1)(1991-7#4)(1991-8#3)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#10)(1992-12#3)(1992-3#3)(1992-4#2)(1992-6#8)(1992-7#2)(1992-9#3)(1993-11#5)(1993-12#2)(1993-3#4)(1993-4#1)(1993-6#5)(1993-8#3)(1994-11#4)(1994-12#14)(1994-2#1)(1994-3#3)(1994-5#3)(1994-6#2)(1994-8#23)(1994-9#6)(1995-10#4)(1995-11#10)(1995-2#9)(1995-3#2)(1995-4#1)(1995-5#8)(1996-12#1)(1996-2#4)(1996-3#2)(1996-4#1)(1996-5#3)(1996-7#7)(1996-8#3)(1996-9#4)(1997-3#1)(1997-4#17)(1997-5#1)(1997-6#6)(1997-7#4)(1997-8#3)(2004-4#1)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#3)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#17)(2006-11#1)(2006-2#4)(2006-3#4)(2006-6#2)(2006-8#3)(2007-1#1)(2007-11#6)(2007-12#6)(2007-9#3)(2008-10#20)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#12)(2008-6#5)(2008-7#4)(2008-8#8)(2008-9#5)(2009-10#4)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#9)(2010-12#10)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#3)(2010-9#9)(2011-1#7)(2011-12#1)(2011-2#1)(2012-11#2)(2012-12#10)(2012-2#12)(2013-1#2)
proton-activated##3##1##(1990-7#3)
proton-coupled electron transfer##2##3##(2008-10#1)(2008-8#1)
proton-coupled##6##1##(1994-8#1)(1997-7#2)(2008-10#2)(2008-8#1)
proton-exchanged##3##1##(2008-2#3)
proton-motive force##3##2##(1996-9#3)
proton-proton distances defined by lower and upper bounds deduced from NOESY data sets as restraints in molecular mechanics computations in torsion angle space##2##23##(1995-1#1)(1996-7#1)
proton-proton##4##1##(1994-11#1)(1994-8#1)(1995-1#1)(1996-7#1)
proton-pump inhibitor##3##2##(2006-10#1)(2010-12#1)(2013-1#1)
proton-pump inhibitors##3##2##(2010-12#3)
proton-pump##6##1##(2006-10#1)(2010-12#4)(2013-1#1)
proton-pumping##4##1##(1991-12#1)(1996-9#1)(2006-8#2)
proton-transfer##5##1##(1994-8#1)(2006-3#3)(2009-9#1)
protonated Schiff base##2##3##(1991-7#1)(1995-1#1)
protonated Schiff##3##2##(1991-7#1)(1991-9#1)(1995-1#1)
protonated and##2##2##(1990-12#1)(2008-10#1)
protonated arginine dimer and##2##4##(2006-4#2)
protonated arginine dimer##3##3##(2006-4#3)
protonated base##3##2##(2006-3#3)
protonated bititanate##2##2##(2009-11#2)
protonated bradykinin##3##2##(1996-7#2)(2006-4#1)
protonated form of##3##3##(2006-10#1)(2008-10#2)
protonated form##8##2##(1991-5#1)(1994-8#1)(2006-10#1)(2006-4#1)(2008-10#4)
protonated in##2##2##(1990-12#1)(1992-12#1)
protonated ions##3##2##(1996-7#3)
protonated methyl ester of bradykinin##2##5##(1996-7#2)
protonated molecular ion##4##3##(2008-10#4)
protonated molecular##5##2##(1996-6#1)(2008-10#4)
protonated or##3##2##(2006-10#1)(2006-4#1)(2008-10#1)
protonated peptides##2##2##(2010-5#1)(2012-12#1)
protonated species##4##2##(1992-2#1)(2008-10#3)
protonated##109##1##(1990-11#1)(1990-12#5)(1991-5#1)(1991-7#2)(1991-9#4)(1992-12#1)(1992-2#1)(1992-6#2)(1994-12#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-2#2)(1996-6#1)(1996-7#9)(2006-10#3)(2006-2#1)(2006-3#8)(2006-4#9)(2007-8#2)(2008-10#31)(2008-3#1)(2008-5#3)(2008-6#1)(2009-11#2)(2009-3#1)(2010-12#1)(2010-4#1)(2010-5#4)(2011-2#1)(2012-12#2)
protonation and##3##2##(1996-2#1)(2008-10#2)
protonation constant of##2##3##(2008-10#2)
protonation constant##3##2##(2008-10#3)
protonation constants and##3##3##(2008-10#3)
protonation constants for##2##3##(2008-10#2)
protonation constants of##5##3##(2008-10#5)
protonation constants##15##2##(2008-10#15)
protonation of a##3##3##(1991-8#1)(1991-9#1)(1994-9#1)
protonation of both##2##3##(1995-10#1)(2008-10#1)
protonation of its##2##3##(1992-6#1)(1994-9#1)
protonation of the amine##2##4##(2008-10#2)
protonation of the internal##2##4##(1991-8#1)(1992-6#1)
protonation of the##16##3##(1990-10#1)(1991-8#1)(1992-6#1)(1993-3#1)(1995-10#1)(1996-7#1)(1997-7#1)(2005-11#2)(2006-10#1)(2008-10#4)(2010-5#1)(2012-2#1)
protonation of##35##2##(1990-10#1)(1991-8#2)(1991-9#1)(1992-6#2)(1993-3#1)(1994-9#3)(1995-10#3)(1995-2#1)(1996-7#1)(1997-1#2)(1997-4#1)(1997-7#1)(2005-11#3)(2006-10#2)(2008-10#9)(2010-5#1)(2012-2#1)
protonation or modification##2##3##(1995-3#2)
protonation or##3##2##(1993-8#1)(1995-3#2)
protonation sites of the##2##4##(2009-9#2)
protonation states##2##2##(2008-3#1)(2009-2#1)
protonation##79##1##(1990-10#1)(1990-5#1)(1990-8#1)(1991-8#2)(1991-9#1)(1992-6#2)(1993-3#1)(1993-8#1)(1994-9#3)(1995-10#3)(1995-2#2)(1995-3#2)(1996-2#2)(1996-5#1)(1996-7#1)(1997-1#4)(1997-4#1)(1997-7#2)(2005-11#4)(2006-10#3)(2008-10#32)(2008-3#1)(2009-2#1)(2009-9#2)(2010-2#1)(2010-5#2)(2010-8#1)(2012-2#1)
protonic##5##1##(1990-8#1)(1992-12#1)(2006-6#1)(2008-5#1)(2010-4#1)
protonizable nitrogen##2##2##(1993-12#2)
protonmotive force##11##2##(1994-8#5)(1995-1#1)(1996-8#1)(1996-9#4)
protonophore##3##1##(1990-2#1)(1994-9#1)(1996-9#1)
protonophores##7##1##(1994-6#1)(1996-4#6)
protons (delta##2##2##(1991-2#2)
protons across##2##2##(1990-5#1)(1994-9#1)
protons and the##2##3##(2008-3#1)(2012-11#1)
protons and##13##2##(1990-9#1)(1991-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1997-3#1)(2006-9#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-12#1)(2012-11#1)
protons are##4##2##(1990-7#1)(1993-11#1)(1995-1#2)
protons from the##3##3##(1994-9#1)(2005-11#1)(2008-10#1)
protons from##6##2##(1994-9#1)(1997-5#1)(2005-11#2)(2008-10#1)(2008-4#1)
protons in the##4##3##(1990-9#1)(1991-9#1)(1995-11#1)(1995-8#1)
protons in##10##2##(1990-2#1)(1990-9#2)(1991-9#1)(1993-8#1)(1995-10#1)(1995-11#2)(1995-8#1)(2010-12#1)
protons into##3##2##(1993-11#1)(2006-8#2)
protons is##3##2##(1990-9#1)(1997-6#1)(2011-1#1)
protons of amino acids##2##4##(1997-1#1)(1997-4#1)
protons of the C102T variant##2##5##(1990-7#2)
protons of the##8##3##(1990-7#3)(1991-2#1)(1996-7#2)(2012-12#2)
protons of##17##2##(1990-7#3)(1991-2#2)(1991-7#1)(1992-1#1)(1993-6#1)(1993-8#1)(1994-8#1)(1996-7#2)(1997-1#1)(1997-4#1)(2009-3#1)(2012-12#2)
protons were##7##2##(1993-3#1)(1995-1#2)(1995-11#1)(1997-4#1)(2009-3#1)(2011-1#1)
protons with##3##2##(1990-3#1)(1993-3#1)(1996-5#1)
protons##132##1##(1990-10#2)(1990-2#1)(1990-3#3)(1990-5#2)(1990-7#10)(1990-8#2)(1990-9#4)(1991-11#1)(1991-12#1)(1991-2#6)(1991-4#2)(1991-7#2)(1991-8#2)(1991-9#3)(1992-1#1)(1992-3#3)(1992-8#1)(1993-11#2)(1993-3#4)(1993-6#2)(1993-8#2)(1994-10#1)(1994-8#5)(1994-9#2)(1995-1#5)(1995-10#3)(1995-11#4)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-5#1)(1996-7#3)(1997-1#1)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#2)(2005-11#2)(2006-10#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-11#2)(2007-9#1)(2008-10#5)(2008-3#3)(2008-4#4)(2008-7#2)(2008-9#1)(2009-3#2)(2010-12#3)(2011-1#2)(2012-11#1)(2012-12#2)(2013-1#1)
protonymphal##2##1##(2007-12#2)
protooncogene encodes a##2##3##(1993-3#1)(1994-9#1)
protooncogene expression##2##2##(1992-8#1)(1996-11#1)
protooncogene in##2##2##(1995-1#1)(1995-2#1)
protooncogene product##3##2##(1991-11#1)(1994-8#1)(1995-3#1)
protooncogene##19##1##(1991-11#1)(1991-4#2)(1992-8#1)(1993-3#1)(1994-10#1)(1994-2#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#2)(1995-3#2)(1996-11#1)(2006-10#1)
protooncogenes##3##1##(1991-12#1)(1995-7#1)(2007-5#1)
protoplasm##3##1##(2008-10#3)
protoplasmic##8##1##(1990-5#2)(1993-12#1)(2006-10#1)(2007-3#1)(2008-12#2)(2008-7#1)
protoplast culture##3##2##(2008-8#3)
protoplast fusion between##2##3##(2008-11#1)(2008-8#1)
protoplast fusion##6##2##(1997-4#1)(2008-11#1)(2008-4#1)(2008-8#2)(2010-2#1)
protoplast preparation##2##2##(2008-9#2)
protoplast##24##1##(1993-12#2)(1997-1#2)(1997-4#1)(2007-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#8)(2008-9#2)(2009-10#1)(2010-2#1)
protoplast-derived hairy root clones##2##4##(2007-1#2)
protoplasts and##2##2##(1997-3#1)(2012-11#1)
protoplasts are##3##2##(2008-8#1)(2008-9#2)
protoplasts derived from##3##3##(2008-11#1)(2008-9#2)
protoplasts from##6##2##(1994-2#1)(1994-6#1)(1997-4#1)(2008-9#3)
protoplasts inoculated with##2##3##(2008-10#2)
protoplasts of##7##2##(1997-3#1)(2008-10#1)(2008-12#1)(2008-8#2)(2008-9#1)(2010-2#1)
protoplasts or##3##2##(1997-3#1)(2008-10#2)
protoplasts were##4##2##(1997-3#2)(2008-8#2)
protoplasts##78##1##(1991-8#3)(1992-3#1)(1993-8#3)(1994-11#1)(1994-2#3)(1994-6#1)(1995-3#1)(1997-3#7)(1997-4#1)(2005-11#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#1)(2008-8#17)(2008-9#19)(2009-8#2)(2010-2#2)(2012-11#1)
protoporphyrin (PP)##2##2##(1990-1#1)(1991-5#1)
protoporphyrin IX and##2##3##(1993-8#1)(1995-12#1)
protoporphyrin IX in the##2##4##(1993-8#1)(2012-3#1)
protoporphyrin IX in##3##3##(1993-8#1)(1996-9#1)(2012-3#1)
protoporphyrin IX were##2##3##(1993-8#1)(1995-12#1)
protoporphyrin IX##26##2##(1990-7#1)(1991-5#2)(1991-9#1)(1992-8#1)(1993-6#1)(1993-8#4)(1995-12#5)(1996-8#1)(1996-9#3)(2008-5#3)(2012-12#1)(2012-2#1)(2012-3#2)
protoporphyrin##42##1##(1990-1#2)(1990-3#1)(1990-7#1)(1991-10#1)(1991-4#1)(1991-5#4)(1991-9#1)(1992-8#1)(1993-6#1)(1993-8#4)(1994-5#1)(1995-12#5)(1995-2#2)(1996-1#3)(1996-8#1)(1996-9#5)(2008-5#3)(2009-10#1)(2012-12#1)(2012-2#1)(2012-3#2)
protoporphyrine IX##4##2##(2008-11#4)
protoporphyrinogen oxidase##5##2##(1991-5#4)(2008-10#1)
protoporphyrinogen##6##1##(1991-5#5)(2008-10#1)
protoporphyrins##2##1##(2007-9#1)(2010-6#1)
protostomes and deuterostomes##3##3##(2007-12#3)
protostomes##7##1##(2006-10#1)(2007-12#4)(2008-7#1)(2010-4#1)
prototergal glands##3##2##(2007-12#3)
prototrophic##4##1##(2008-10#4)
prototrophy##2##1##(1991-7#1)(2008-10#1)
prototropic tautomerism in 1-(2-benzimidazolyl)-3-phenyl-4##2##4##(2007-11#2)
prototype and##2##2##(2007-12#1)(2012-12#1)
prototype are##2##2##(2008-2#2)
prototype device##4##2##(2008-2#3)(2008-3#1)
prototype dummy##6##2##(2006-11#1)(2007-4#5)
prototype fiber##2##2##(2008-3#2)
prototype for a##3##3##(1996-7#1)(1997-3#1)(2012-1#1)
prototype for the##3##3##(1992-2#1)(1994-8#1)(2006-10#1)
prototype for##15##2##(1991-6#1)(1992-10#1)(1992-11#1)(1992-2#1)(1994-8#1)(1996-7#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-11#1)(2012-1#2)
prototype has##3##2##(2007-4#1)(2007-5#1)(2008-3#1)
prototype implementation##5##2##(2008-3#1)(2013-1#4)
prototype instrumentation##2##2##(1997-5#1)(2008-3#1)
prototype interferometer with##2##3##(2008-3#2)
prototype is##3##2##(2007-11#1)(2007-4#1)(2008-8#1)
prototype of a family of##2##5##(2008-4#1)(2008-9#1)
prototype of a new##3##4##(1996-7#1)(2006-3#1)(2008-10#1)
prototype of a novel##2##4##(2008-2#1)(2012-1#1)
prototype of a##14##3##(1992-4#1)(1994-9#1)(1996-7#1)(2006-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-1#1)
prototype of an##2##3##(1990-6#1)(2008-8#1)
prototype of the##5##3##(2007-11#1)(2008-2#2)(2008-3#1)(2008-9#1)
prototype of##34##2##(1990-6#1)(1991-12#1)(1992-4#1)(1994-9#1)(1996-5#1)(1996-7#1)(2006-3#1)(2007-11#2)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)
prototype sensor##3##2##(2008-2#2)(2008-3#1)
prototype system##5##2##(1994-5#1)(2006-6#1)(2008-3#1)(2008-5#1)(2008-6#1)
prototype that##6##2##(2007-12#1)(2009-4#1)(2013-1#4)
prototype was##6##2##(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-2#1)
prototype were##2##2##(2008-10#1)(2008-5#1)
prototype##238##1##(1990-12#1)(1990-6#1)(1991-12#2)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-7#1)(1993-11#2)(1993-9#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-2#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1997-3#1)(1997-5#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#4)(2007-11#9)(2007-12#5)(2007-4#11)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#22)(2008-11#2)(2008-12#1)(2008-2#34)(2008-3#30)(2008-4#3)(2008-5#8)(2008-6#5)(2008-7#1)(2008-8#4)(2008-9#3)(2009-11#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#4)(2011-2#2)(2012-1#5)(2012-12#4)(2012-2#1)(2013-1#20)(2013-7#1)
prototyped##2##1##(2006-2#1)(2012-1#1)
prototypes of##6##2##(1994-9#1)(1995-2#1)(2008-10#1)(2010-12#1)(2010-8#1)(2012-3#1)
prototypes were##2##2##(2008-10#1)(2008-5#1)
prototypes##23##1##(1991-11#1)(1994-9#1)(1995-2#1)(1997-7#1)(1997-8#2)(2005-10#1)(2007-5#1)(2007-7#3)(2008-10#2)(2008-2#1)(2008-5#2)(2010-12#1)(2010-2#1)(2010-8#1)(2010-9#1)(2012-1#2)(2012-3#1)
prototypic member of##2##3##(2008-4#1)(2011-2#1)
prototypic##17##1##(1990-7#1)(1994-12#1)(1995-8#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-6#1)(2005-2#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-4#2)(2011-2#1)(2012-12#1)(2013-1#2)
prototypical system##2##2##(2008-2#1)(2008-3#1)
prototypical##25##1##(1992-5#1)(1994-8#1)(1995-7#1)(1996-3#2)(1997-8#1)(2005-8#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#3)(2008-7#1)(2008-8#1)(2009-11#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-2#2)
prototyping and##2##2##(2008-3#1)(2009-12#1)
prototyping of##3##2##(2006-2#1)(2008-3#1)(2008-8#1)
prototyping##14##1##(2006-2#1)(2007-9#2)(2008-3#2)(2008-8#1)(2009-12#1)(2009-9#1)(2010-8#2)(2010-9#3)(2012-2#1)
protoxin##5##1##(1994-12#5)
protozoa and##5##2##(2005-9#1)(2006-10#1)(2009-10#1)(2011-2#1)(2012-12#1)
protozoa in##2##2##(2008-12#1)(2008-5#1)
protozoa isolates##3##2##(2008-12#3)
protozoa species in##2##3##(2009-10#2)
protozoa species##4##2##(2008-5#1)(2009-10#3)
protozoa##46##1##(1990-11#1)(1990-7#1)(1994-11#1)(1996-8#2)(1997-7#1)(2005-9#3)(2006-10#6)(2006-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#5)(2008-5#5)(2008-9#2)(2009-10#8)(2011-2#1)(2012-12#3)(2013-1#3)
protozoal survey was carried out in##2##6##(2005-9#1)(2008-5#1)
protozoal##13##1##(1993-5#2)(1995-5#1)(1996-2#1)(1997-7#1)(2005-8#1)(2005-9#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-5#1)(2009-10#1)(2012-3#1)
protozoan Paramecium tetraurelia##2##3##(1990-7#1)(1994-12#1)
protozoan and##3##2##(2006-10#2)(2008-12#1)
protozoan infections##2##2##(1996-3#1)(2006-10#1)
protozoan parasite Leishmania mexicana##2##4##(1993-5#1)(1994-9#1)
protozoan parasite##14##2##(1993-5#2)(1994-9#1)(1995-3#1)(1995-8#1)(1996-4#1)(2005-8#1)(2006-10#2)(2009-6#1)(2009-7#1)(2009-8#1)(2012-12#1)(2012-2#1)
protozoan parasites##4##2##(2006-10#1)(2011-1#2)(2013-1#1)
protozoan##47##1##(1990-7#1)(1992-2#1)(1992-8#1)(1993-5#2)(1993-9#2)(1994-12#3)(1994-9#1)(1995-3#2)(1995-8#1)(1996-1#1)(1996-3#1)(1996-4#1)(2005-8#1)(2006-10#8)(2007-12#4)(2007-2#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2009-6#1)(2009-7#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
protozoans##5##1##(2006-10#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#1)
protozoon##3##1##(2009-10#2)(2012-12#1)
protracted and##4##2##(1995-12#1)(1995-8#1)(2008-10#1)(2009-7#1)
protracted cauda equina constrictions##2##4##(1995-6#2)
protracted course of##2##3##(1996-10#1)(2011-2#1)
protracted course##4##2##(1992-4#1)(1996-10#1)(2007-9#1)(2011-2#1)
protracted##35##1##(1990-10#1)(1992-4#1)(1994-2#1)(1995-12#2)(1995-6#2)(1995-8#1)(1996-10#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2009-3#2)(2009-4#1)(2009-7#2)(2011-2#2)(2012-3#1)(2013-1#2)
protraction##2##1##(2012-12#1)(2012-2#1)
protrude through##2##2##(2008-5#1)(2011-2#1)
protrude##6##1##(1991-7#1)(1994-8#1)(1995-12#1)(2008-5#1)(2009-8#1)(2011-2#1)
protruded into the##3##3##(1991-12#1)(2006-12#1)(2012-12#1)
protruded##8##1##(1991-12#1)(1992-8#1)(2006-12#1)(2007-12#1)(2012-12#2)(2013-1#1)(2013-8#1)
protrudes from the##2##3##(1991-3#1)(1996-2#1)
protrudes##5##1##(1991-3#1)(1994-8#1)(1996-2#1)(1996-5#1)(2012-3#1)
protruding from the##3##3##(1991-9#1)(1993-3#1)(1994-2#1)
protruding into the spinal canal##2##5##(2006-10#1)(2009-4#1)
protruding into the##3##3##(2006-10#1)(2009-4#1)(2013-1#1)
protruding into##4##2##(2006-10#1)(2009-4#1)(2011-2#1)(2013-1#1)
protruding nictitating membranes and diarrhoea##3##5##(1990-9#3)
protruding thrombi##3##2##(2008-5#3)
protruding##36##1##(1990-5#1)(1990-9#3)(1991-9#1)(1993-3#2)(1994-2#1)(1995-11#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-5#7)(2009-10#1)(2009-4#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)
protrusion at the##3##3##(2008-12#2)(2012-2#1)
protrusion of the##9##3##(2007-8#2)(2008-9#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
protrusion of##11##2##(2007-8#2)(2008-10#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
protrusion or##3##2##(2006-8#1)(2007-11#1)(2007-8#1)
protrusion##37##1##(1990-2#1)(1996-11#1)(1996-3#1)(1997-6#1)(2006-8#2)(2007-11#1)(2007-7#2)(2007-8#3)(2008-10#1)(2008-12#2)(2008-3#3)(2008-5#3)(2008-7#3)(2008-9#1)(2010-11#1)(2011-2#3)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
protrusion/lateralisation##2##1##(2007-7#2)
protrusions and##2##2##(2008-7#1)(2010-7#1)
protrusions into the lumen##2##4##(2008-5#1)(2011-2#1)
protrusions that##2##2##(2007-10#1)(2007-12#1)
protrusions##20##1##(1991-5#1)(1996-11#1)(2006-5#1)(2007-10#3)(2007-11#1)(2007-12#3)(2008-5#1)(2008-7#2)(2009-9#2)(2010-5#2)(2010-7#1)(2011-2#2)
protrusive activity##2##2##(1996-11#2)
protuberance##4##1##(1992-4#1)(1993-11#1)(2007-12#1)(2012-2#1)
protuberances##4##1##(1990-3#1)(2008-10#1)(2008-5#1)(2009-12#1)
protuberans of##3##2##(1992-2#1)(2008-6#2)
protuberans##12##1##(1992-2#2)(2005-11#1)(2007-7#2)(2008-12#1)(2008-6#5)(2011-1#1)
protégés##4##1##(2009-4#1)(2009-9#3)
proud##8##1##(1990-2#1)(1992-3#1)(1996-3#1)(2007-4#1)(2007-9#1)(2008-9#1)(2011-2#1)(2012-2#1)
proueytoso contra ha pestenença##6##4##(2007-5#6)
proueytoso##9##1##(2007-5#9)
prourokinase and##2##2##(2008-11#2)
prourokinase##5##1##(2007-10#1)(2008-11#4)
prove a##12##2##(1992-3#1)(2003-11#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-3#2)(2009-9#1)
prove an##3##2##(1992-8#1)(2007-8#1)(2008-5#1)
prove as effective as##2##4##(2005-7#1)(2007-6#1)
prove as effective##3##3##(2005-7#1)(2007-6#1)(2008-10#1)
prove beneficial for##3##3##(2006-11#1)(2009-10#1)(2011-2#1)
prove beneficial##5##2##(2006-10#1)(2006-11#1)(2009-10#1)(2009-6#1)(2011-2#1)
prove difficult##2##2##(1995-3#1)(2006-12#1)
prove efficacious##2##2##(2009-10#1)(2012-11#1)
prove helpful in##3##3##(1996-5#1)(2006-2#1)(2008-3#1)
prove helpful##7##2##(1993-9#1)(1996-5#1)(1997-3#1)(2006-10#1)(2006-2#1)(2008-3#1)(2012-12#1)
prove important##2##2##(2007-5#1)(2010-3#1)
prove invaluable##2##2##(2007-6#1)(2010-12#1)
prove its##2##2##(2006-6#1)(2010-5#1)
prove more##2##2##(2008-1#1)(2008-10#1)
prove possible to##3##3##(1990-4#1)(2006-10#1)(2007-11#1)
prove that a##2##3##(2008-8#1)(2009-12#1)
prove that it is##2##4##(2004-9#1)(2008-7#1)
prove that our##2##3##(2008-10#1)(2009-4#1)
prove that the##14##3##(1992-8#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2009-9#1)
prove that this method is##2##5##(2007-7#1)(2008-2#1)
prove that this method##4##4##(2007-12#1)(2007-7#1)(2008-2#1)(2008-3#1)
prove that this##6##3##(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)
prove that##52##2##(1990-11#1)(1991-7#1)(1992-8#1)(1992-9#1)(1994-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1997-6#1)(2004-1#1)(2004-9#1)(2005-12#1)(2007-11#2)(2007-12#4)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#8)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-7#1)(2013-8#2)
prove the accuracy##2##3##(2007-8#1)(2008-10#1)
prove the effectiveness of##2##4##(1993-11#1)(2008-3#1)
prove the efficacy of##3##4##(2006-10#1)(2007-11#1)(2007-8#1)
prove the feasibility of##2##4##(2007-9#1)(2008-3#1)
prove the suitability of##2##4##(2006-2#1)(2008-2#1)
prove the##42##2##(1991-3#1)(1992-2#1)(1993-11#1)(1994-6#1)(1995-9#1)(1997-3#1)(2006-10#3)(2006-2#1)(2007-10#1)(2007-11#4)(2007-8#3)(2007-9#1)(2008-10#5)(2008-2#2)(2008-3#5)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-4#1)(2009-8#1)(2011-1#2)(2013-8#2)
prove to be a useful reagent##2##6##(1994-6#1)(1995-3#1)
prove to be a useful##5##5##(1994-3#1)(1994-6#1)(1995-3#1)(2006-10#1)(2008-1#1)
prove to be a very useful##2##6##(1996-12#1)(2005-7#1)
prove to be a##13##4##(1994-3#1)(1994-6#2)(1995-3#1)(1995-6#1)(1996-12#1)(2005-7#1)(2006-10#2)(2006-12#1)(2008-1#2)(2008-11#1)
prove to be effective##2##4##(1991-5#1)(2008-5#1)
prove to be instrumental##2##4##(1993-11#1)(2008-10#1)
prove to be of##2##4##(1992-8#1)(1993-7#1)
prove to be the##4##4##(1995-6#1)(1996-3#1)(2005-12#1)(2008-8#1)
prove to be useful for##2##5##(1997-2#1)(2007-11#1)
prove to be useful in the##2##6##(2008-10#1)(2013-8#1)
prove to be useful in##4##5##(1992-1#1)(2005-6#1)(2008-10#1)(2013-8#1)
prove to be useful##8##4##(1992-1#1)(1993-6#1)(1997-2#1)(2005-6#1)(2007-11#1)(2008-10#1)(2011-1#1)(2013-8#1)
prove to be very##3##4##(1994-2#1)(2007-11#1)(2008-10#1)
prove to be##60##3##(1990-9#1)(1991-5#1)(1992-1#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-7#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#2)(1995-3#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-2#1)(2005-11#3)(2005-12#1)(2005-6#1)(2005-7#2)(2006-10#2)(2006-12#1)(2007-11#4)(2007-2#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-3#1)(2012-12#1)(2013-8#2)
prove to have a##2##4##(2007-11#1)(2008-12#1)
prove to have##4##3##(1991-6#1)(1992-10#1)(2007-11#1)(2008-12#1)
prove to##67##2##(1990-9#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-7#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#2)(1995-3#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-2#1)(2005-11#3)(2005-12#1)(2005-6#1)(2005-7#2)(2006-10#3)(2006-12#1)(2007-11#5)(2007-2#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-3#1)(2012-12#1)(2013-8#2)
prove useful as a##5##4##(1995-2#1)(1997-4#1)(2007-10#1)(2008-10#2)
prove useful as##7##3##(1995-2#1)(1997-4#1)(2005-10#1)(2007-10#1)(2008-10#2)(2009-5#1)
prove useful for the##6##4##(1991-3#1)(1991-8#1)(1995-1#1)(2007-11#1)(2007-12#1)(2012-2#1)
prove useful for##15##3##(1991-3#1)(1991-6#1)(1991-8#1)(1994-3#1)(1995-1#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)
prove useful in determining##3##4##(1990-5#1)(1995-12#1)(1996-2#1)
prove useful in the design of##2##6##(2008-2#1)(2012-2#1)
prove useful in the##10##4##(1992-7#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2012-2#1)(2013-8#1)
prove useful in##27##3##(1990-11#1)(1990-5#1)(1990-7#1)(1992-7#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-7#1)(1996-2#1)(1997-2#1)(1997-7#1)(2005-8#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-2#3)(2008-4#1)(2008-5#1)(2012-2#1)(2013-1#3)(2013-8#1)
prove useful to##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
prove useful##58##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-7#1)(1994-3#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-4#1)(1995-7#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
prove valuable in##2##3##(1992-7#1)(2008-10#1)
prove valuable##4##2##(1992-7#1)(1992-8#1)(2008-10#1)(2010-8#1)
prove##348##1##(1990-11#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-12#2)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-7#2)(1992-8#4)(1992-9#2)(1993-11#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#1)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#3)(1995-7#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#2)(1997-6#1)(1997-7#1)(2003-11#1)(2004-1#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#3)(2005-12#2)(2005-6#1)(2005-7#3)(2005-8#2)(2006-10#15)(2006-11#1)(2006-12#2)(2006-2#2)(2006-5#1)(2006-6#2)(2006-9#2)(2007-10#3)(2007-11#18)(2007-12#9)(2007-2#1)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#10)(2007-9#5)(2008-1#5)(2008-10#31)(2008-11#5)(2008-12#2)(2008-2#9)(2008-3#18)(2008-4#3)(2008-5#10)(2008-6#2)(2008-7#8)(2008-8#7)(2008-9#2)(2009-10#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#2)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#3)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#7)
proved a##12##2##(1990-7#1)(1991-5#1)(1992-3#1)(2005-11#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-5#1)(2012-1#1)(2013-1#1)
proved able to##2##3##(1993-3#1)(2008-10#1)
proved active against##3##3##(1997-1#2)(2011-2#1)
proved active##4##2##(1997-1#2)(2005-7#1)(2011-2#1)
proved also that##4##3##(2007-11#2)(2008-10#2)
proved an important##2##3##(2007-7#1)(2008-3#1)
proved an##3##2##(1992-3#1)(2007-7#1)(2008-3#1)
proved as##5##2##(2006-10#1)(2010-5#1)(2010-8#1)(2012-2#1)(2012-3#1)
proved by the##6##3##(2007-2#1)(2008-10#5)
proved by##27##2##(1990-5#1)(1991-5#1)(1993-10#1)(1997-2#1)(1997-3#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)
proved capable##2##2##(2007-9#1)(2008-5#1)
proved difficult to##5##3##(1997-7#1)(1997-8#1)(2008-8#1)(2010-4#1)(2011-2#1)
proved difficult##8##2##(1997-7#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)
proved disappointing##2##2##(1995-5#1)(2008-5#1)
proved effective in the treatment of##2##6##(2006-11#1)(2008-6#1)
proved effective in##11##3##(1994-7#1)(2005-10#1)(2005-7#1)(2006-11#1)(2008-11#1)(2008-6#2)(2008-7#1)(2009-12#1)(2011-12#1)(2012-2#1)
proved effective##16##2##(1994-7#1)(2005-10#1)(2005-7#1)(2006-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-12#1)(2010-5#1)(2011-12#1)(2012-2#1)
proved experimentally##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
proved for##2##2##(2008-10#1)(2008-9#1)
proved fruitful##2##2##(2006-12#1)(2010-12#1)
proved good##2##2##(2007-11#1)(2011-1#1)
proved highly##3##2##(1994-2#1)(2006-10#1)(2009-3#1)
proved important##3##2##(1994-2#1)(2006-8#1)(2008-10#1)
proved in##4##2##(1990-11#1)(2007-8#1)(2007-9#1)(2013-8#1)
proved inadequate##2##2##(2006-4#1)(2011-2#1)
proved ineffective##2##2##(1993-3#1)(2008-10#1)
proved it##2##2##(2011-2#1)(2012-2#1)
proved its##3##2##(2008-1#1)(2008-3#1)(2008-9#1)
proved less##3##2##(1992-8#1)(1993-8#1)(2008-11#1)
proved lethal##2##2##(1993-12#1)(2008-10#1)
proved more##4##2##(1990-6#1)(1995-5#1)(2008-7#1)(2012-1#1)
proved most##3##2##(1993-12#1)(2007-11#1)(2008-2#1)
proved necessary##3##2##(1991-12#1)(2008-6#1)(2010-3#1)
proved no##2##2##(2005-12#1)(2008-5#1)
proved not to be##2##4##(2006-8#1)(2008-10#1)
proved not to##3##3##(2006-8#1)(2007-11#1)(2008-10#1)
proved of##2##2##(2008-5#1)(2011-2#1)
proved particularly##2##2##(2006-5#1)(2007-10#1)
proved possible##2##2##(2008-10#1)(2008-7#1)
proved refractory to##2##3##(2006-3#1)(2008-9#1)
proved relatively##2##2##(1991-3#1)(2008-11#1)
proved reliable in##2##3##(1991-4#1)(1994-3#1)
proved sensitive##2##2##(1992-7#1)(2007-7#1)
proved significant##2##2##(2006-8#1)(2011-1#1)
proved successful##5##2##(1990-9#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-3#1)
proved superior to##4##3##(1992-8#1)(1993-12#1)(2006-10#1)(2008-10#1)
proved superior##6##2##(1992-8#1)(1993-12#1)(2006-10#1)(2008-10#2)(2012-2#1)
proved that all the##2##4##(2007-11#1)(2008-10#1)
proved that both##2##3##(2008-10#2)
proved that the method##5##4##(1997-8#1)(2008-10#1)(2010-2#1)(2013-8#2)
proved that the##34##3##(1990-12#1)(1992-2#1)(1992-5#1)(1995-8#1)(1996-5#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-4#1)(2006-2#1)(2006-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-5#3)(2008-6#1)(2008-9#2)(2009-3#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#3)
proved that there##2##3##(2008-10#1)(2008-8#1)
proved that these##5##3##(1995-3#1)(1997-5#1)(2007-9#1)(2010-4#1)(2011-2#1)
proved that this##2##3##(2009-3#1)(2011-2#1)
proved that##86##2##(1990-12#1)(1990-8#1)(1992-2#1)(1992-5#1)(1994-10#1)(1995-3#1)(1995-8#2)(1996-5#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-4#1)(2006-2#2)(2006-5#1)(2007-10#1)(2007-11#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-10#16)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-11#1)(2009-2#1)(2009-3#2)(2010-12#2)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#4)
proved the best##2##3##(2004-2#1)(2008-8#1)
proved the efficacy of##2##4##(2008-1#1)(2009-8#1)
proved the presence of##2##4##(2007-7#1)(2008-11#1)
proved the strong predictive power of the##2##7##(2005-12#1)(2008-10#1)
proved the##30##2##(1993-10#1)(1996-7#1)(2004-2#1)(2005-11#2)(2005-12#1)(2006-12#1)(2007-5#1)(2007-7#3)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#3)(2009-3#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#1)
proved to be a characteristic##2##5##(2008-10#2)
proved to be a good##3##5##(1997-2#1)(2007-9#1)(2010-12#1)
proved to be a highly##2##5##(2008-10#1)(2008-4#1)
proved to be a more##2##5##(1995-2#1)(2011-1#1)
proved to be a potent##2##5##(1990-10#1)(1992-3#1)
proved to be a rapid##3##5##(2008-10#2)(2008-11#1)
proved to be a reliable##4##5##(1993-7#1)(1993-9#1)(1996-6#1)(2008-10#1)
proved to be a safe##2##5##(1993-8#1)(2006-6#1)
proved to be a significant##2##5##(1991-3#1)(2007-1#1)
proved to be a simple##2##5##(1993-5#1)(2004-12#1)
proved to be a valuable##3##5##(1992-4#1)(2006-10#1)(2013-8#1)
proved to be a very good##2##6##(2008-10#1)(2012-12#1)
proved to be a very sensitive##2##6##(1993-12#1)(1996-1#1)
proved to be a very##5##5##(1993-12#1)(1994-6#1)(1996-1#1)(2008-10#1)(2012-12#1)
proved to be a##57##4##(1990-10#1)(1990-2#1)(1991-11#1)(1991-3#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-4#1)(1996-1#1)(1996-6#1)(1997-1#1)(1997-2#1)(2004-12#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-1#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-7#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-7#1)(2012-12#1)(2012-2#1)(2013-8#2)
proved to be active##2##4##(1991-7#1)(2009-3#1)
proved to be advantageous over##2##5##(2008-10#1)(2008-4#1)
proved to be an adequate##2##5##(2008-11#1)(2008-3#1)
proved to be an effective treatment of##2##7##(2006-10#1)(2006-3#1)
proved to be an effective treatment##4##6##(1992-8#1)(1997-6#1)(2006-10#1)(2006-3#1)
proved to be an effective##7##5##(1990-10#1)(1992-8#1)(1997-6#1)(2006-10#1)(2006-3#1)(2008-10#1)(2010-8#1)
proved to be an efficient##3##5##(2007-8#1)(2011-2#1)(2013-8#1)
proved to be an excellent##2##5##(2008-10#1)(2013-1#1)
proved to be an##20##4##(1990-10#1)(1992-12#1)(1992-2#1)(1992-8#1)(1994-12#1)(1996-2#1)(1997-6#1)(2006-10#1)(2006-3#1)(2007-1#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
proved to be applicable to##2##5##(1990-6#1)(2008-10#1)
proved to be applicable##3##4##(1990-6#1)(2008-10#2)
proved to be both effective and##2##6##(1991-11#1)(2011-2#1)
proved to be both##3##4##(1991-11#1)(1993-12#1)(2011-2#1)
proved to be challenging##2##4##(1995-3#1)(2011-1#1)
proved to be colonized by##2##5##(1991-3#1)(1997-3#1)
proved to be dependent##2##4##(2004-9#1)(2007-11#1)
proved to be effective and##2##5##(1990-5#1)(2006-2#1)
proved to be effective in the treatment of##3##8##(2006-6#1)(2007-11#1)(2011-2#1)
proved to be effective in the##4##6##(2006-6#1)(2007-11#1)(2007-8#1)(2011-2#1)
proved to be effective in##11##5##(1992-12#1)(1992-9#1)(1994-7#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-6#1)(2011-2#2)(2013-1#1)
proved to be effective##20##4##(1990-5#3)(1992-10#1)(1992-12#1)(1992-9#1)(1994-7#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#2)(2012-6#1)(2013-1#1)
proved to be efficacious##2##4##(2005-10#1)(2008-8#1)
proved to be equal##3##4##(2008-10#1)(2012-12#2)
proved to be fully##2##4##(1994-2#1)(1995-12#1)
proved to be good substrates##2##5##(1992-11#1)(2008-10#1)
proved to be good##3##4##(1992-11#1)(2008-10#2)
proved to be highly##8##4##(1995-11#1)(2008-10#3)(2008-6#1)(2011-1#1)(2013-8#2)
proved to be important for##2##5##(1992-6#1)(2009-8#1)
proved to be in##2##4##(1996-2#1)(2008-2#1)
proved to be insensitive to##2##5##(1990-5#1)(2008-2#1)
proved to be insensitive##3##4##(1990-5#1)(1997-8#1)(2008-2#1)
proved to be less important##2##5##(2008-10#1)(2008-7#1)
proved to be less##4##4##(2006-2#1)(2008-10#1)(2008-7#2)
proved to be linear##2##4##(2008-10#2)
proved to be malignant##2##4##(1995-2#1)(2007-8#1)
proved to be more effective##2##5##(2007-11#1)(2008-10#1)
proved to be more resistant to##2##6##(2004-4#1)(2009-3#1)
proved to be more sensitive##2##5##(2007-10#1)(2008-10#1)
proved to be more##12##4##(1996-6#1)(2004-4#1)(2005-11#2)(2007-1#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-3#1)
proved to be much##4##4##(1994-6#1)(2008-10#1)(2011-2#1)(2013-1#1)
proved to be of##2##4##(1991-2#1)(1991-6#1)
proved to be one of the most##2##7##(2006-10#1)(2010-4#1)
proved to be potent##2##4##(2007-11#1)(2008-5#1)
proved to be reliable##2##4##(2007-12#1)(2008-10#1)
proved to be safe and##3##5##(1991-12#1)(1994-6#1)(2008-8#1)
proved to be safe##5##4##(1991-12#1)(1994-6#1)(2008-8#1)(2010-12#1)(2013-1#1)
proved to be secondary to##2##5##(2006-10#1)(2007-7#1)
proved to be significantly##2##4##(1996-12#1)(2007-12#1)
proved to be stable##4##4##(1993-2#1)(1996-9#1)(2008-11#1)(2008-3#1)
proved to be successful for##2##5##(2007-8#1)(2008-10#1)
proved to be successful##4##4##(1990-12#1)(2007-8#1)(2008-10#1)(2011-1#1)
proved to be suitable for##4##5##(2005-5#1)(2007-11#1)(2007-8#1)(2008-10#1)
proved to be suitable##7##4##(1992-8#1)(2005-5#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)
proved to be superior to##3##5##(1992-8#2)(2004-3#1)
proved to be superior##4##4##(1992-8#2)(2004-3#1)(2008-10#1)
proved to be the best##3##5##(1995-3#1)(2008-10#1)(2008-6#1)
proved to be the main##2##5##(2008-10#1)(2008-11#1)
proved to be the most effective##3##6##(1993-8#1)(2008-10#2)
proved to be the most sensitive##2##6##(1992-6#1)(2008-10#1)
proved to be the most##14##5##(1990-3#1)(1992-6#1)(1993-8#1)(1995-12#1)(2005-12#1)(2007-3#1)(2008-10#5)(2008-4#1)(2008-8#1)(2008-9#1)
proved to be the##35##4##(1990-3#1)(1991-2#1)(1992-6#1)(1993-6#1)(1993-8#1)(1995-12#1)(1995-3#1)(1995-9#1)(1997-6#1)(2005-12#1)(2006-6#2)(2007-3#1)(2007-7#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-8#1)(2013-1#2)
proved to be useful for##5##5##(2005-3#1)(2007-8#1)(2008-10#3)
proved to be useful in##2##5##(1990-10#1)(2007-9#1)
proved to be useful##12##4##(1990-10#1)(1990-6#1)(2005-3#1)(2006-12#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#4)(2011-2#1)
proved to be very effective##2##5##(2007-11#1)(2013-1#1)
proved to be very useful##2##5##(1994-3#1)(2008-10#1)
proved to be very##9##4##(1994-3#1)(2005-7#1)(2006-5#1)(2007-11#1)(2008-10#4)(2013-1#1)
proved to be##351##3##(1990-10#4)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#4)(1990-6#2)(1990-9#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#5)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#3)(1992-8#4)(1992-9#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#4)(1994-7#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#3)(1995-4#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-12#1)(2004-3#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-3#1)(2005-4#1)(2005-5#1)(2005-7#2)(2005-9#1)(2006-10#4)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#4)(2006-9#1)(2007-1#6)(2007-10#3)(2007-11#8)(2007-12#4)(2007-3#1)(2007-6#1)(2007-7#5)(2007-8#9)(2007-9#2)(2008-1#5)(2008-10#59)(2008-11#7)(2008-12#2)(2008-2#7)(2008-3#7)(2008-4#4)(2008-5#6)(2008-6#4)(2008-7#6)(2008-8#5)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#6)(2011-2#8)(2011-7#2)(2012-12#4)(2012-2#2)(2012-3#1)(2012-6#1)(2013-1#10)(2013-8#5)
proved to have a##3##4##(1991-10#1)(1991-6#1)(2006-8#1)
proved to have##16##3##(1991-10#1)(1991-6#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-4#1)(1996-6#1)(2006-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-8#1)(2010-4#1)
proved to induce##2##3##(2008-10#1)(2012-2#1)
proved to inhibit##2##3##(1990-7#1)(1997-6#1)
proved to work##2##3##(2008-10#1)(2008-2#1)
proved to##399##2##(1990-10#4)(1990-12#3)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#4)(1990-6#3)(1990-7#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#5)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#3)(1992-8#4)(1992-9#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#5)(1994-7#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#3)(1995-4#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#5)(1997-2#1)(1997-3#1)(1997-6#3)(1997-7#2)(1997-8#2)(2004-12#1)(2004-3#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-3#1)(2005-4#1)(2005-5#1)(2005-7#3)(2005-9#1)(2006-10#5)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#4)(2006-8#1)(2006-9#1)(2007-1#6)(2007-10#3)(2007-11#9)(2007-12#4)(2007-3#1)(2007-6#1)(2007-7#5)(2007-8#9)(2007-9#2)(2008-1#7)(2008-10#67)(2008-11#9)(2008-12#3)(2008-2#9)(2008-3#7)(2008-4#4)(2008-5#8)(2008-6#4)(2008-7#7)(2008-8#6)(2008-9#3)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#6)(2011-2#8)(2011-7#2)(2012-12#4)(2012-2#3)(2012-3#1)(2012-6#1)(2013-1#10)(2013-8#5)
proved useful for the##3##4##(2008-10#2)(2008-9#1)
proved useful for##5##3##(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#1)
proved useful in the##3##4##(1990-9#1)(1991-5#1)(2008-10#1)
proved useful in##5##3##(1990-9#1)(1991-5#1)(1992-9#1)(2008-10#1)(2008-5#1)
proved useful##13##2##(1990-9#1)(1991-12#1)(1991-5#1)(1992-9#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2010-7#1)(2011-2#1)
proved using##2##2##(2005-11#1)(2008-10#1)
proved valuable in##2##3##(1992-1#1)(2008-7#1)
proved valuable##3##2##(1990-3#1)(1992-1#1)(2008-7#1)
proved very difficult##2##3##(1996-2#1)(1997-7#1)
proved very useful##2##3##(1997-3#1)(2006-5#1)
proved very##6##2##(1990-5#1)(1995-5#1)(1996-2#1)(1997-3#1)(1997-7#1)(2006-5#1)
proved with##3##2##(1996-3#1)(2007-5#1)(2008-2#1)
proved##801##1##(1990-10#4)(1990-11#1)(1990-12#5)(1990-2#3)(1990-3#4)(1990-4#1)(1990-5#6)(1990-6#5)(1990-7#2)(1990-8#1)(1990-9#4)(1991-10#1)(1991-11#2)(1991-12#6)(1991-2#3)(1991-3#6)(1991-4#1)(1991-5#5)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#5)(1992-3#3)(1992-4#2)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#8)(1992-9#2)(1993-10#2)(1993-12#5)(1993-2#3)(1993-3#3)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#4)(1993-9#2)(1994-10#1)(1994-12#2)(1994-2#3)(1994-3#3)(1994-5#2)(1994-6#6)(1994-7#2)(1994-8#2)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#4)(1995-4#2)(1995-5#3)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-5#1)(1996-6#5)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#7)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#5)(1997-8#5)(2004-12#1)(2004-2#1)(2004-3#1)(2004-4#1)(2004-9#2)(2005-1#2)(2005-10#2)(2005-11#9)(2005-12#3)(2005-3#1)(2005-4#2)(2005-5#2)(2005-7#5)(2005-9#1)(2006-10#11)(2006-11#1)(2006-12#5)(2006-2#5)(2006-3#2)(2006-4#3)(2006-5#4)(2006-6#4)(2006-8#5)(2006-9#1)(2007-1#6)(2007-10#7)(2007-11#20)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#13)(2007-8#16)(2007-9#8)(2008-1#11)(2008-10#128)(2008-11#17)(2008-12#5)(2008-2#18)(2008-3#18)(2008-4#7)(2008-5#22)(2008-6#9)(2008-7#16)(2008-8#18)(2008-9#13)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#7)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#11)(2010-2#2)(2010-3#1)(2010-4#8)(2010-5#5)(2010-6#1)(2010-7#3)(2010-8#4)(2011-1#12)(2011-12#3)(2011-2#22)(2011-7#2)(2012-1#2)(2012-12#12)(2012-2#10)(2012-3#7)(2012-6#1)(2013-1#13)(2013-8#12)
proven ACE inhibitor##2##3##(2007-1#2)
proven ability##2##2##(1996-9#1)(2009-6#1)
proven acute##2##2##(1996-12#1)(2005-12#1)
proven an effective##2##3##(2007-11#1)(2012-12#1)
proven an##3##2##(2007-11#1)(2008-9#1)(2012-12#1)
proven and##2##2##(2007-11#1)(2011-1#1)
proven beneficial in##3##3##(2006-5#1)(2007-11#1)(2008-9#1)
proven beneficial##6##2##(2006-5#1)(2007-11#1)(2008-7#1)(2008-9#1)(2009-1#1)(2012-1#1)
proven benefit##2##2##(2007-11#1)(2007-2#1)
proven benefits of##2##3##(2006-12#1)(2012-12#1)
proven benefits##3##2##(2006-12#1)(2007-2#1)(2012-12#1)
proven by a##2##3##(2004-12#1)(2008-2#1)
proven by##22##2##(1990-2#1)(1990-4#2)(1990-7#1)(1991-5#1)(1997-1#1)(1997-6#1)(2004-12#1)(2005-11#1)(2006-1#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-7#2)(2011-2#1)
proven cases of##3##3##(2007-8#2)(2011-1#1)
proven cases##4##2##(1990-6#1)(2007-8#2)(2011-1#1)
proven diagnosis##2##2##(2008-5#1)(2013-1#1)
proven difficult to##8##3##(1991-12#1)(2006-10#1)(2006-7#1)(2006-8#1)(2008-6#1)(2009-4#1)(2010-12#1)(2012-2#1)
proven effective in##8##3##(1992-6#1)(1992-8#1)(1994-10#1)(2006-12#1)(2007-10#1)(2007-12#1)(2008-2#1)(2008-6#1)
proven effective##15##2##(1992-6#1)(1992-8#1)(1993-6#1)(1994-10#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2010-12#1)(2011-1#1)(2013-7#1)
proven efficacy in##7##3##(2007-10#1)(2007-11#1)(2008-3#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
proven efficacy##10##2##(2006-8#1)(2007-10#1)(2007-11#1)(2008-3#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)
proven extremely useful for##3##4##(1997-2#1)(2008-11#2)
proven for##5##2##(1993-3#1)(1996-5#1)(2010-12#1)(2011-2#1)(2013-8#1)
proven in##6##2##(1990-1#1)(1995-4#1)(2005-11#1)(2007-11#1)(2008-1#1)(2008-7#1)
proven lung cancer##2##3##(2007-6#1)(2007-8#1)
proven strategies to##2##3##(1994-2#1)(2010-12#1)
proven strategies##3##2##(1994-2#2)(2010-12#1)
proven successful in##4##3##(2004-9#1)(2006-10#1)(2006-12#1)(2012-12#1)
proven successful##5##2##(2004-9#1)(2006-10#1)(2006-12#1)(2008-10#1)(2012-12#1)
proven that the##5##3##(2005-4#1)(2008-10#2)(2008-2#1)(2012-12#1)
proven that##12##2##(2005-4#1)(2007-1#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-8#1)(2010-5#1)(2010-7#1)(2012-12#1)
proven the##4##2##(1993-12#1)(1996-12#1)(2008-10#1)(2011-1#1)
proven their effectiveness##3##3##(2009-2#1)(2010-2#1)(2011-2#1)
proven their##4##2##(1990-1#1)(2009-2#1)(2010-2#1)(2011-2#1)
proven therapy##2##2##(2005-8#1)(2006-10#1)
proven to be a practical##2##5##(2008-2#1)(2009-5#1)
proven to be a very##2##5##(2008-10#2)
proven to be a viable##2##5##(2008-10#1)(2008-11#1)
proven to be a##25##4##(1992-1#1)(1994-2#1)(2005-10#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#2)(2010-7#1)(2012-2#1)(2013-7#2)
proven to be an effective##4##5##(2006-6#2)(2010-5#1)(2011-2#1)
proven to be an extremely useful##2##6##(1991-5#1)(2008-4#1)
proven to be an##11##4##(1991-5#1)(2006-6#2)(2007-11#1)(2008-10#2)(2008-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
proven to be effective in##5##5##(2007-11#1)(2007-4#1)(2008-4#1)(2010-2#1)(2011-2#1)
proven to be effective##11##4##(1993-8#1)(1996-2#1)(2007-10#1)(2007-11#2)(2007-4#1)(2008-1#1)(2008-3#1)(2008-4#1)(2010-2#1)(2011-2#1)
proven to be highly efficient##2##5##(1996-8#1)(2007-8#1)
proven to be highly##4##4##(1996-8#1)(2007-8#1)(2008-10#1)(2012-2#1)
proven to be more clinically##2##5##(2008-11#1)(2008-6#1)
proven to be more##4##4##(2008-11#1)(2008-6#1)(2012-2#2)
proven to be safe##3##4##(1996-2#1)(2009-1#1)(2012-12#1)
proven to be the best##2##5##(2006-6#1)(2008-9#1)
proven to be the##6##4##(1996-11#1)(1996-12#1)(2006-6#1)(2008-5#1)(2008-8#1)(2008-9#1)
proven to be useful diagnostic##2##5##(2007-2#1)(2008-8#1)
proven to be useful in##3##5##(2008-9#1)(2009-10#1)(2012-12#1)
proven to be useful##8##4##(2006-6#1)(2007-2#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-12#1)(2013-1#2)
proven to be very effective##2##5##(1994-8#1)(2008-10#1)
proven to be very powerful##2##5##(1995-12#1)(2008-10#1)
proven to be very##9##4##(1994-6#1)(1994-8#1)(1995-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2010-9#1)
proven to be##122##3##(1991-5#1)(1992-1#1)(1992-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-7#1)(1996-8#1)(1997-2#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-6#5)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#3)(2008-3#2)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#4)(2009-1#1)(2009-10#2)(2009-3#3)(2009-5#2)(2010-1#1)(2010-2#2)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#5)(2013-1#3)(2013-7#2)(2013-8#3)
proven to have##3##3##(2008-1#1)(2008-8#1)(2011-2#1)
proven to##140##2##(1991-5#1)(1992-1#1)(1992-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#2)(1994-8#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#5)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#8)(2007-12#1)(2007-2#1)(2007-4#2)(2007-6#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#3)(2008-2#3)(2008-3#2)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#4)(2009-1#1)(2009-10#3)(2009-3#3)(2009-5#3)(2010-1#1)(2010-12#1)(2010-2#2)(2010-5#3)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#6)(2013-1#4)(2013-7#2)(2013-8#3)
proven treatment##3##2##(2008-1#1)(2008-3#1)(2010-12#1)
proven useful as##3##3##(1990-3#1)(2008-1#1)(2008-4#1)
proven useful for##2##3##(2009-10#1)(2010-7#1)
proven useful in a variety of##2##6##(1990-12#1)(2008-5#1)
proven useful in a##3##4##(1990-12#1)(2008-12#1)(2008-5#1)
proven useful in##12##3##(1990-12#1)(1996-1#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#1)(2011-7#1)
proven useful##17##2##(1990-12#1)(1990-3#1)(1996-1#1)(1996-5#1)(2007-11#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2009-10#1)(2010-7#1)(2011-7#1)
proven value##2##2##(2005-11#1)(2007-11#1)
proven very##4##2##(1992-7#1)(2008-4#2)(2008-9#1)
proven with##3##2##(2008-10#1)(2008-7#1)(2010-2#1)
proven##480##1##(1990-1#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#2)(1990-6#2)(1990-7#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-4#1)(1994-6#2)(1994-8#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#2)(1995-6#1)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#7)(1996-2#2)(1996-5#2)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2004-1#3)(2004-12#1)(2004-2#1)(2004-9#2)(2005-10#2)(2005-11#5)(2005-12#1)(2005-4#1)(2005-7#4)(2005-8#2)(2005-9#1)(2006-1#2)(2006-10#16)(2006-12#6)(2006-2#2)(2006-5#2)(2006-6#5)(2006-7#1)(2006-8#6)(2006-9#4)(2007-1#6)(2007-10#5)(2007-11#21)(2007-12#3)(2007-2#3)(2007-3#1)(2007-4#5)(2007-6#2)(2007-7#4)(2007-8#10)(2007-9#3)(2008-1#13)(2008-10#19)(2008-11#11)(2008-12#3)(2008-2#10)(2008-3#10)(2008-4#14)(2008-5#16)(2008-6#6)(2008-7#10)(2008-8#9)(2008-9#10)(2009-1#2)(2009-10#4)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#3)(2009-6#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#8)(2010-2#4)(2010-3#2)(2010-5#5)(2010-6#1)(2010-7#6)(2010-8#1)(2010-9#1)(2011-1#11)(2011-2#18)(2011-7#2)(2012-1#3)(2012-11#1)(2012-12#11)(2012-2#11)(2012-3#2)(2013-1#9)(2013-7#4)(2013-8#4)
provenance and##3##2##(2008-10#1)(2013-1#2)
provenance##19##1##(2004-4#2)(2006-12#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-2#1)(2012-5#1)(2012-9#1)(2013-1#3)
provenance)##3##1##(2008-10#1)(2011-10#2)
provenances of##2##2##(2012-5#1)(2012-9#1)
provenances or species##2##3##(2012-9#2)
provenances##19##1##(2004-4#3)(2008-10#1)(2011-10#2)(2012-5#7)(2012-9#6)
proventriculus##3##1##(1997-3#1)(2008-5#2)
proves a##5##2##(1993-9#1)(2012-12#1)(2012-3#1)(2013-1#2)
proves effective##2##2##(2006-8#1)(2008-3#1)
proves inadequate##2##2##(1994-6#1)(2013-1#1)
proves that it##2##3##(2006-10#1)(2011-2#1)
proves that the##5##3##(1996-6#1)(2008-10#2)(2008-3#1)(2008-6#1)
proves that##17##2##(1990-6#1)(1996-6#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-10#4)(2008-3#2)(2008-6#1)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#1)
proves the##12##2##(1991-12#1)(1995-1#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-5#1)(2009-7#1)(2011-2#1)
proves to be a##8##4##(2006-10#1)(2006-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-10#1)(2010-11#1)(2011-2#1)
proves to be an##2##4##(2007-11#1)(2008-11#1)
proves to be##15##3##(1995-3#1)(1997-6#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)(2010-11#1)(2011-2#1)
proves to##16##2##(1995-3#1)(1997-6#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)(2010-11#1)(2011-2#2)
proves##70##1##(1990-6#1)(1991-12#1)(1991-6#1)(1991-7#1)(1993-3#1)(1993-9#1)(1994-6#1)(1995-1#1)(1995-3#1)(1996-12#1)(1996-6#1)(1997-6#1)(2006-10#2)(2006-11#1)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-4#1)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#2)(2010-11#1)(2010-4#1)(2010-6#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
provide &quot##3##2##(1992-4#1)(2008-7#1)(2012-11#1)
provide 100%##2##2##(2008-5#1)(2010-2#1)
provide MLs##3##2##(2011-1#3)
provide a &quot##4##3##(1996-3#1)(2011-12#1)(2012-12#2)
provide a baseline##4##3##(1991-11#1)(2006-11#1)(2011-1#1)(2012-12#1)
provide a basic##2##3##(2008-7#1)(2012-2#1)
provide a basis for further##2##5##(2008-4#1)(2010-7#1)
provide a basis for the development of##2##7##(2009-5#1)(2010-12#1)
provide a basis for the##5##5##(1992-10#1)(1992-11#1)(1997-7#1)(2009-5#1)(2010-12#1)
provide a basis for understanding the##2##6##(1992-4#1)(2010-12#1)
provide a basis for understanding##4##5##(1992-4#1)(2004-9#1)(2008-10#1)(2010-12#1)
provide a basis for##27##4##(1990-10#1)(1991-11#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-4#1)(1994-11#1)(1995-5#1)(1996-4#1)(1997-2#1)(1997-7#1)(2004-9#1)(2007-2#2)(2007-4#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-5#1)(2010-12#3)(2010-5#1)(2010-7#1)(2012-3#1)(2013-8#1)
provide a basis##30##3##(1990-10#1)(1991-11#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-4#1)(1994-11#1)(1995-5#1)(1996-4#1)(1997-2#1)(1997-7#1)(2004-9#1)(2007-1#1)(2007-10#1)(2007-2#2)(2007-4#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#3)(2010-5#1)(2010-7#1)(2012-3#1)(2013-8#1)
provide a benefit##2##3##(2006-10#1)(2012-2#1)
provide a better understanding of the##3##6##(1997-2#1)(2006-6#1)(2008-10#1)
provide a better understanding of##4##5##(1997-2#1)(2006-6#1)(2007-8#1)(2008-10#1)
provide a better##14##3##(1994-6#1)(1995-3#1)(1997-2#1)(2005-11#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-3#1)(2011-12#1)
provide a bridge##2##3##(2006-10#1)(2013-1#1)
provide a brief overview of the##2##6##(2006-10#1)(2011-2#1)
provide a brief overview of##3##5##(2006-10#1)(2008-11#1)(2011-2#1)
provide a brief overview##5##4##(2006-10#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
provide a brief review of##3##5##(2005-8#1)(2008-4#1)(2010-8#1)
provide a brief summary of##3##5##(2010-6#1)(2011-12#1)(2012-2#1)
provide a brief##18##3##(1996-2#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-9#1)(2010-10#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)
provide a broad##4##3##(2007-8#1)(2008-7#1)(2011-1#1)(2012-3#1)
provide a broader##4##3##(1993-10#1)(2006-8#1)(2008-11#1)(2008-7#1)
provide a case example##2##4##(1993-12#1)(2012-12#1)
provide a case##3##3##(1993-12#1)(2011-1#1)(2012-12#1)
provide a clear##3##3##(2006-7#1)(2007-11#1)(2012-12#1)
provide a clinically##2##3##(1996-2#1)(2011-2#1)
provide a clue to##2##4##(2008-10#1)(2008-8#1)
provide a common##4##3##(1996-3#1)(2009-4#1)(2010-12#1)(2012-12#1)
provide a complete##5##3##(2008-2#1)(2008-3#2)(2008-6#1)(2009-11#1)
provide a comprehensive assessment of##2##5##(2011-2#2)
provide a comprehensive overview of the##2##6##(2008-11#1)(2013-8#1)
provide a comprehensive overview of##3##5##(2008-11#1)(2011-2#1)(2013-8#1)
provide a comprehensive##14##3##(1993-12#1)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-1#1)(2010-6#1)(2011-2#4)(2013-8#1)
provide a concise##5##3##(2007-12#1)(2008-11#2)(2008-7#1)(2012-12#1)
provide a convenient##4##3##(1991-7#1)(2005-10#1)(2008-4#1)(2008-9#1)
provide a cost-effective##3##3##(2006-10#1)(2008-1#1)(2008-10#1)
provide a critical review##2##4##(2009-10#1)(2012-2#1)
provide a critical##6##3##(2006-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-2#1)(2013-1#1)
provide a cure##4##3##(1994-6#1)(2007-11#1)(2008-7#1)(2011-2#1)
provide a deeper##2##3##(2009-2#1)(2012-2#1)
provide a definitive diagnosis##2##4##(2006-8#1)(2012-3#1)
provide a definitive##3##3##(2006-10#1)(2006-8#1)(2012-3#1)
provide a description of the##4##5##(1993-12#1)(2006-2#1)(2008-12#1)(2009-7#1)
provide a description of##5##4##(1991-12#1)(1993-12#1)(2006-2#1)(2008-12#1)(2009-7#1)
provide a detailed##12##3##(1992-6#1)(1995-3#1)(2006-10#1)(2006-8#1)(2008-11#1)(2008-7#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#1)
provide a direct comparison of##2##5##(1995-3#1)(2007-1#1)
provide a direct link between##2##5##(1994-8#1)(1996-4#1)
provide a direct##7##3##(1992-8#1)(1994-8#1)(1995-3#1)(1996-4#1)(2006-12#1)(2006-4#1)(2007-1#1)
provide a discussion of##2##4##(2006-8#1)(2007-12#1)
provide a fast##4##3##(2007-12#1)(2008-7#1)(2012-2#1)(2012-3#1)
provide a favorable##3##3##(1995-11#1)(2008-3#1)(2010-4#1)
provide a feasible##3##3##(1993-7#1)(1996-3#1)(2009-8#1)
provide a first##3##3##(1994-11#1)(2010-6#1)(2011-2#1)
provide a flexible##6##3##(1996-12#1)(1997-6#1)(2008-4#1)(2010-10#1)(2013-1#2)
provide a foundation for##6##4##(1996-2#1)(2008-10#1)(2009-5#1)(2010-3#1)(2013-1#2)
provide a foundation##9##3##(1996-2#1)(2008-10#1)(2008-12#1)(2009-5#1)(2010-3#1)(2012-12#1)(2013-1#3)
provide a framework for the##3##5##(1993-3#1)(2008-7#1)(2012-12#1)
provide a framework for##10##4##(1992-6#1)(1993-3#1)(2006-3#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
provide a framework that##2##4##(2006-3#1)(2007-12#1)
provide a framework##13##3##(1992-6#1)(1993-3#1)(1994-9#1)(2006-3#2)(2007-12#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
provide a free##3##3##(2008-10#1)(2013-1#2)
provide a functional##5##3##(1994-8#1)(1997-4#1)(2008-10#1)(2008-11#1)(2012-3#1)
provide a further##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
provide a general analysis##2##4##(2006-5#1)(2008-3#1)
provide a general overview of##2##5##(2008-7#1)(2012-2#1)
provide a general##15##3##(1994-3#1)(1997-3#1)(2005-6#1)(2006-5#1)(2007-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-2#1)(2012-2#1)
provide a global##3##3##(1996-11#1)(2008-7#1)(2010-12#1)
provide a good fit for the##2##6##(2008-3#1)(2012-1#1)
provide a good model##2##4##(1993-4#1)(1995-3#1)
provide a good##16##3##(1990-3#1)(1993-4#1)(1994-12#1)(1994-8#1)(1995-3#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-3#1)(2009-5#1)(2010-2#1)(2012-1#1)(2013-1#1)
provide a great##3##3##(2012-2#2)(2012-3#1)
provide a greater##2##3##(1996-10#1)(1997-4#1)
provide a guide to the##2##5##(2008-4#1)(2008-7#1)
provide a guide##3##3##(2008-4#2)(2008-7#1)
provide a high degree of protection for##2##7##(2012-2#2)
provide a high level of##2##5##(2007-4#1)(2011-2#1)
provide a high level##3##4##(2007-4#1)(2008-11#1)(2011-2#1)
provide a high##8##3##(2007-4#1)(2008-11#1)(2010-2#2)(2011-2#1)(2012-12#1)(2012-2#2)
provide a higher##2##3##(2008-2#2)
provide a highly sensitive detection##2##5##(2007-8#1)(2008-10#1)
provide a hydrophobic##2##3##(1994-2#1)(2008-10#1)
provide a key##2##3##(2010-10#1)(2010-12#1)
provide a large##3##3##(2007-12#1)(2007-9#1)(2008-11#1)
provide a link between##2##4##(1994-11#1)(2008-9#1)
provide a link##3##3##(1994-11#1)(2007-1#1)(2008-9#1)
provide a logical##3##3##(1992-2#1)(2007-10#1)(2012-12#1)
provide a major##2##3##(1995-3#1)(2011-2#1)
provide a means for##8##4##(1991-12#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2012-2#1)
provide a means of understanding the##2##6##(1990-5#1)(2009-4#1)
provide a means of##8##4##(1990-5#1)(1991-7#1)(1994-5#1)(2009-10#1)(2009-4#2)(2011-2#1)(2012-11#1)
provide a means to##4##4##(1997-3#1)(2007-5#1)(2008-11#1)(2011-2#1)
provide a means##20##3##(1990-5#1)(1991-12#1)(1991-7#1)(1994-5#1)(1996-2#1)(1997-3#1)(1997-8#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-4#2)(2011-2#2)(2012-11#1)(2012-2#1)
provide a measure of##3##4##(1990-8#1)(1994-8#1)(1996-3#1)
provide a measure##4##3##(1990-8#1)(1994-8#1)(1996-3#1)(2012-2#1)
provide a mechanism by which##2##5##(1995-1#1)(2006-12#1)
provide a mechanism for##5##4##(1991-9#1)(1995-3#1)(1995-8#1)(1997-4#1)(2008-3#1)
provide a mechanism to##2##4##(1995-8#1)(1996-12#1)
provide a mechanism##10##3##(1991-9#1)(1992-7#1)(1995-1#1)(1995-3#1)(1995-8#2)(1996-12#1)(1997-4#1)(2006-12#1)(2008-3#1)
provide a mechanistic##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
provide a method for##4##4##(2007-12#1)(2008-1#1)(2008-6#1)(2012-1#1)
provide a method to##3##4##(1995-8#1)(2007-8#1)(2008-3#1)
provide a method##9##3##(1995-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-7#1)(2012-1#1)
provide a model for##7##4##(1990-5#1)(1991-11#1)(1995-8#1)(2006-4#1)(2006-8#1)(2008-9#1)(2011-2#1)
provide a model system##2##4##(1992-6#1)(2009-8#1)
provide a model##13##3##(1990-5#1)(1990-6#1)(1991-11#1)(1992-6#1)(1993-3#1)(1995-8#1)(2006-4#1)(2006-8#1)(2008-9#1)(2009-8#1)(2011-10#1)(2011-2#1)(2012-3#1)
provide a molecular basis for##2##5##(1992-2#1)(2011-1#1)
provide a more accurate identification of microorganisms##2##7##(2012-2#2)
provide a more accurate##5##4##(2004-2#1)(2008-5#1)(2012-2#2)(2012-3#1)
provide a more complete##2##4##(1995-1#1)(2009-8#1)
provide a more comprehensive##2##4##(2006-10#1)(2008-1#1)
provide a more detailed understanding of##2##6##(1991-4#1)(2006-11#1)
provide a more detailed##3##4##(1991-4#1)(1992-6#1)(2006-11#1)
provide a more##23##3##(1991-4#1)(1992-6#1)(1994-12#1)(1995-1#1)(2004-2#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-9#1)(2009-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
provide a natural##2##3##(1996-12#1)(2008-8#1)
provide a new avenue##2##4##(1993-6#1)(2012-12#1)
provide a new insight into the##2##6##(1993-7#1)(2011-1#1)
provide a new method##2##4##(2012-2#1)(2013-8#1)
provide a new tool##2##4##(1994-8#1)(1997-7#1)
provide a new way##2##4##(1994-9#1)(2008-8#1)
provide a new##26##3##(1991-8#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-8#1)(1994-9#1)(1996-2#1)(1996-5#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-1#1)(2010-6#1)(2011-1#2)(2012-12#1)(2012-2#2)(2013-8#1)
provide a non-invasive diagnostic##3##4##(1997-2#1)(2013-1#2)
provide a non-invasive##6##3##(1997-2#1)(2010-8#1)(2013-1#4)
provide a novel and##2##4##(2007-9#1)(2008-10#1)
provide a novel##15##3##(1991-3#1)(1991-5#1)(1992-8#2)(1994-11#1)(1994-3#1)(1995-1#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-8#1)(2010-7#1)(2013-7#1)
provide a numerical##2##3##(1992-6#1)(2008-3#1)
provide a paradigm##3##3##(2006-3#1)(2007-9#1)(2010-1#1)
provide a partial##4##3##(1992-1#1)(1992-9#1)(1996-6#1)(2008-7#1)
provide a perspective on the##2##5##(2005-2#1)(2010-11#1)
provide a perspective on##3##4##(2005-2#1)(2010-11#1)(2011-11#1)
provide a perspective##4##3##(2005-2#1)(2010-11#1)(2010-3#1)(2011-11#1)
provide a picture of##2##4##(1996-3#1)(2013-8#1)
provide a platform for##2##4##(2005-7#1)(2012-2#1)
provide a platform##3##3##(2005-7#1)(2008-11#1)(2012-2#1)
provide a possibility##2##3##(1995-12#1)(2007-8#1)
provide a possible##3##3##(1995-6#1)(2007-2#1)(2008-9#1)
provide a potential mechanism to##2##5##(2009-5#1)(2011-1#1)
provide a potential##7##3##(1994-2#1)(1996-8#1)(2008-7#2)(2009-10#1)(2009-5#1)(2011-1#1)
provide a powerful tool for##6##5##(1990-7#1)(1991-8#2)(1993-2#1)(2007-11#1)(2010-2#1)
provide a powerful tool in##2##5##(1993-11#1)(2007-12#1)
provide a powerful tool##10##4##(1990-7#1)(1991-8#2)(1993-11#1)(1993-2#1)(2007-11#1)(2007-12#1)(2008-2#1)(2010-12#1)(2010-2#1)
provide a powerful##15##3##(1990-7#1)(1991-8#2)(1993-11#1)(1993-2#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-12#2)(2010-2#1)
provide a practical##5##3##(2006-10#1)(2008-11#1)(2008-6#1)(2012-5#1)(2013-8#1)
provide a preliminary##2##3##(2007-8#1)(2012-1#1)
provide a principled##2##3##(2008-5#1)(2013-8#1)
provide a promising##3##3##(2008-10#1)(2008-4#1)(2009-10#1)
provide a quantitative description of the##2##6##(2010-5#1)(2011-1#1)
provide a quantitative##6##3##(1991-4#1)(2008-2#1)(2009-7#1)(2010-5#1)(2011-1#2)
provide a rapid and##3##4##(1994-9#1)(2007-1#1)(2007-12#1)
provide a rapid means of##2##5##(1995-7#1)(2008-10#1)
provide a rapid##9##3##(1994-9#1)(1995-7#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-9#1)(2010-5#1)
provide a rare##2##3##(2011-1#1)(2012-1#1)
provide a rationale for the##3##5##(1990-3#1)(1994-6#1)(2006-12#1)
provide a rationale for##4##4##(1990-3#1)(1994-6#1)(2006-12#1)(2007-11#1)
provide a readily available##4##4##(1991-1#1)(2007-11#1)(2007-9#1)(2012-1#1)
provide a reference##2##3##(2009-5#1)(2013-8#1)
provide a relatively##3##3##(2005-11#1)(2008-10#1)(2008-7#1)
provide a reliable means of##2##5##(1993-12#1)(2011-7#1)
provide a reliable##10##3##(1993-12#1)(1995-2#1)(1997-8#1)(2006-5#1)(2008-3#2)(2011-2#1)(2011-7#1)(2012-2#1)(2012-3#1)
provide a review of the literature that##2##7##(2006-10#1)(2012-2#1)
provide a review of the##4##5##(2006-10#1)(2008-8#1)(2011-1#1)(2012-2#1)
provide a review of##7##4##(2006-10#1)(2006-9#1)(2008-8#1)(2010-10#1)(2011-1#1)(2012-2#1)(2012-3#1)
provide a rich##3##3##(2006-10#1)(2008-11#1)(2010-3#1)
provide a rigorous##3##3##(1995-10#1)(1996-3#1)(2008-2#1)
provide a robust method for##2##5##(2008-1#1)(2008-10#1)
provide a robust##7##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-2#1)
provide a route to##2##4##(2008-4#1)(2008-7#1)
provide a safe and effective##2##5##(1990-8#1)(2007-11#1)
provide a safe and##3##4##(1990-8#1)(1995-2#1)(2007-11#1)
provide a safe##6##3##(1990-8#1)(1995-2#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)
provide a second##3##3##(2006-10#1)(2008-4#1)(2011-2#1)
provide a sense of##2##4##(2006-7#1)(2008-7#1)
provide a sensitive##2##3##(1992-11#1)(2007-8#1)
provide a set of##2##4##(2008-6#1)(2008-9#1)
provide a significant##10##3##(2004-12#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-3#1)(2010-9#2)(2012-12#1)(2012-2#1)(2013-1#1)
provide a simple and##2##4##(2008-10#1)(2010-11#1)
provide a simple method for##2##5##(2006-5#1)(2008-4#1)
provide a simple method of##2##5##(1995-12#1)(2007-11#1)
provide a simple method##4##4##(1995-12#1)(2006-5#1)(2007-11#1)(2008-4#1)
provide a simple##13##3##(1995-12#1)(1995-3#1)(2006-5#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-7#1)(2012-3#1)
provide a skin##2##3##(2008-5#2)
provide a small##2##3##(2008-3#2)
provide a smooth##3##3##(2006-3#1)(2007-11#1)(2008-2#1)
provide a solid foundation for##2##5##(1995-1#1)(2008-4#1)
provide a solution to the##2##5##(2008-1#1)(2008-10#1)
provide a solution##5##3##(2005-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2011-2#1)
provide a sound##2##3##(1995-8#1)(1996-10#1)
provide a source of##4##4##(1994-11#1)(2006-3#1)(2007-12#1)(2008-10#1)
provide a specific##4##3##(1997-8#1)(2008-3#1)(2009-9#1)(2010-12#1)
provide a stable##4##3##(2008-4#2)(2009-11#1)(2011-2#1)
provide a starting point for the##2##6##(2010-4#1)(2013-1#1)
provide a starting point for##3##5##(2008-10#1)(2010-4#1)(2013-1#1)
provide a statistical##2##3##(1993-11#1)(2007-8#1)
provide a step-by-step##2##3##(1997-1#1)(2008-9#1)
provide a strong basis for##2##5##(1994-3#1)(2010-9#1)
provide a strong rationale for##2##5##(2008-5#1)(2009-4#1)
provide a strong##4##3##(1994-3#1)(2008-5#1)(2009-4#1)(2010-9#1)
provide a structural basis for the##2##6##(1993-11#2)
provide a structural basis for##3##5##(1993-11#2)(2011-1#1)
provide a structural##6##3##(1993-11#2)(1995-4#2)(2008-2#1)(2011-1#1)
provide a summary of##2##4##(2009-4#1)(2010-5#1)
provide a summary##4##3##(1994-3#2)(2009-4#1)(2010-5#1)
provide a superior##2##3##(2008-5#1)(2012-9#1)
provide a supporting 3D environment for massive proliferation of various cell types##2##12##(2012-11#2)
provide a supportive##3##3##(2010-9#1)(2012-2#1)(2013-1#1)
provide a survey of##2##4##(1994-3#1)(2012-12#1)
provide a theoretical basis##2##4##(2011-12#1)(2013-8#1)
provide a theoretical framework##3##4##(1992-3#1)(2008-8#2)
provide a theoretical##7##3##(1992-3#1)(1996-12#1)(2007-12#1)(2008-8#2)(2011-12#1)(2013-8#1)
provide a tool for##2##4##(2008-3#1)(2010-2#1)
provide a tool to##2##4##(2008-11#1)(2009-9#1)
provide a tool##4##3##(2008-11#1)(2008-3#1)(2009-9#1)(2010-2#1)
provide a unified##3##3##(1994-7#1)(2007-11#1)(2013-7#1)
provide a unifying##2##3##(2006-2#1)(2010-5#1)
provide a unique opportunity to##3##5##(2009-10#1)(2009-5#1)(2013-8#1)
provide a unique opportunity##4##4##(2009-10#1)(2009-5#1)(2009-9#1)(2013-8#1)
provide a unique##10##3##(1995-11#1)(2006-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-9#1)(2013-8#1)
provide a useful framework##2##4##(2006-10#1)(2008-11#1)
provide a useful model##3##4##(1990-5#1)(1997-4#1)(2007-10#1)
provide a useful tool for##7##5##(1993-9#1)(1994-8#1)(1996-4#1)(2006-6#2)(2008-2#1)(2011-1#1)
provide a useful tool##8##4##(1993-9#1)(1994-8#1)(1996-4#1)(2006-6#2)(2008-2#1)(2010-3#1)(2011-1#1)
provide a useful##30##3##(1990-5#1)(1991-11#1)(1992-2#1)(1993-9#1)(1994-3#1)(1994-8#1)(1994-9#1)(1996-4#1)(1997-4#1)(2006-10#1)(2006-6#2)(2007-10#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#2)
provide a valid##3##3##(1992-12#1)(2006-8#1)(2008-9#1)
provide a valuable model for##2##5##(2007-12#1)(2011-1#1)
provide a valuable model##4##4##(1996-9#1)(2007-12#1)(2008-5#1)(2011-1#1)
provide a valuable source##2##4##(2008-1#1)(2008-9#1)
provide a valuable tool for the study of##2##8##(2007-11#1)(2008-11#1)
provide a valuable tool for##4##5##(1993-12#1)(2007-11#1)(2008-11#1)(2009-12#1)
provide a valuable tool##6##4##(1993-12#1)(1993-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-12#1)
provide a valuable##19##3##(1991-12#1)(1992-1#1)(1993-12#1)(1993-4#1)(1996-6#1)(1996-9#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-5#2)(2008-9#1)(2009-12#1)(2010-5#1)(2011-1#1)
provide a vehicle##3##3##(2008-10#1)(2013-1#2)
provide a very efficient##2##4##(1994-6#1)(2007-12#1)
provide a very##4##3##(1994-6#1)(2007-12#1)(2008-10#1)(2012-2#1)
provide a viable##2##3##(2008-10#1)(2008-7#1)
provide a way to##4##4##(2007-11#1)(2008-10#1)(2012-2#2)
provide a way##6##3##(1991-3#1)(1997-8#1)(2007-11#1)(2008-10#1)(2012-2#2)
provide a wide##2##3##(2006-12#1)(2007-11#1)
provide a##1016##2##(1990-10#2)(1990-12#1)(1990-3#3)(1990-5#5)(1990-6#1)(1990-7#2)(1990-8#2)(1991-1#3)(1991-11#4)(1991-12#8)(1991-3#2)(1991-4#3)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#1)(1992-1#3)(1992-10#2)(1992-11#3)(1992-12#1)(1992-2#4)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#5)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#8)(1993-12#6)(1993-2#5)(1993-3#3)(1993-4#2)(1993-6#2)(1993-7#2)(1993-9#2)(1994-11#5)(1994-12#5)(1994-2#2)(1994-3#10)(1994-5#2)(1994-6#4)(1994-7#1)(1994-8#8)(1994-9#5)(1995-1#5)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#8)(1995-4#2)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#5)(1995-9#1)(1996-1#2)(1996-10#3)(1996-11#1)(1996-12#5)(1996-2#6)(1996-3#9)(1996-4#4)(1996-5#4)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#7)(1997-3#2)(1997-4#5)(1997-6#1)(1997-7#3)(1997-8#5)(2004-12#1)(2004-2#1)(2004-8#1)(2004-9#2)(2005-10#1)(2005-11#5)(2005-2#1)(2005-6#1)(2005-7#3)(2005-8#1)(2006-10#26)(2006-11#4)(2006-12#5)(2006-2#4)(2006-3#5)(2006-4#3)(2006-5#5)(2006-6#4)(2006-7#5)(2006-8#7)(2006-9#2)(2007-1#6)(2007-10#5)(2007-11#14)(2007-12#25)(2007-2#8)(2007-4#5)(2007-5#4)(2007-6#1)(2007-7#1)(2007-8#13)(2007-9#7)(2008-1#12)(2008-10#51)(2008-11#33)(2008-12#5)(2008-2#28)(2008-3#30)(2008-4#31)(2008-5#20)(2008-6#6)(2008-7#30)(2008-8#13)(2008-9#18)(2009-10#7)(2009-11#3)(2009-12#2)(2009-2#2)(2009-3#4)(2009-4#5)(2009-5#9)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#7)(2010-1#3)(2010-10#6)(2010-11#2)(2010-12#12)(2010-2#13)(2010-3#5)(2010-4#6)(2010-5#8)(2010-6#5)(2010-7#5)(2010-8#6)(2010-9#5)(2011-1#20)(2011-10#1)(2011-11#1)(2011-12#5)(2011-2#27)(2011-7#2)(2012-1#10)(2012-11#3)(2012-12#23)(2012-2#34)(2012-3#19)(2012-5#1)(2012-9#1)(2013-1#28)(2013-7#3)(2013-8#14)
provide acceptable##3##2##(2008-10#1)(2010-10#1)(2010-8#1)
provide access to##6##3##(1991-12#1)(1993-1#1)(2006-9#1)(2008-11#1)(2008-4#1)(2008-7#1)
provide access##7##2##(1991-12#1)(1993-1#1)(2006-9#1)(2008-11#1)(2008-4#1)(2008-7#2)
provide accurate and##5##3##(1993-12#1)(2006-2#1)(2008-7#1)(2012-2#1)(2013-8#1)
provide accurate##14##2##(1991-11#1)(1993-12#1)(2006-12#1)(2006-2#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
provide added##2##2##(2008-8#1)(2010-12#1)
provide additional benefits in##2##4##(2007-1#1)(2012-3#1)
provide additional evidence for##2##4##(1992-3#2)
provide additional evidence that##2##4##(1997-8#1)(2004-11#1)
provide additional evidence##6##3##(1991-5#1)(1992-3#2)(1995-5#1)(1997-8#1)(2004-11#1)
provide additional information for##3##4##(2006-12#1)(2008-10#1)(2009-5#1)
provide additional information to##2##4##(2007-10#1)(2008-4#1)
provide additional information##7##3##(2006-12#1)(2007-10#1)(2008-10#1)(2008-4#1)(2009-5#1)(2009-8#1)(2010-12#1)
provide additional insight into##3##4##(1991-10#1)(2009-10#1)(2012-3#1)
provide additional insights into the##2##5##(1992-11#1)(2012-2#1)
provide additional protection against##2##4##(2007-11#1)(2011-12#1)
provide additional support for the##2##5##(1994-12#1)(2011-1#1)
provide additional support for##3##4##(1993-2#1)(1994-12#1)(2011-1#1)
provide additional support to##3##4##(1991-7#1)(2008-12#1)(2013-1#1)
provide additional support##7##3##(1991-7#1)(1993-2#1)(1994-12#1)(2008-12#1)(2011-1#1)(2013-1#2)
provide additional tools for##2##4##(1995-1#1)(2008-11#1)
provide additional##53##2##(1991-10#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-3#2)(1993-2#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-5#1)(1997-4#1)(1997-8#1)(2004-11#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#2)(2009-5#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)
provide adequate exposure##2##3##(2006-12#1)(2006-5#1)
provide adequate pain##2##3##(2005-7#1)(2012-2#1)
provide adequate protection##3##3##(1992-6#1)(2007-2#1)(2008-2#1)
provide adequate##34##2##(1991-12#1)(1991-6#1)(1992-4#1)(1992-6#1)(1993-8#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#1)
provide advantages##3##2##(1997-1#1)(2006-12#1)(2009-7#1)
provide all the##2##3##(2008-4#1)(2009-5#1)
provide all##3##2##(1994-6#1)(2008-4#1)(2009-5#1)
provide an account of the##3##5##(1996-11#1)(2007-10#1)(2008-10#1)
provide an accurate and##2##4##(1996-7#1)(1997-4#1)
provide an accurate measure of##2##5##(1993-12#1)(2009-2#1)
provide an accurate##5##3##(1993-12#1)(1996-7#1)(1997-4#1)(2006-5#1)(2009-2#1)
provide an additional##10##3##(1992-7#1)(1993-5#1)(1994-8#1)(2006-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2012-2#1)
provide an algorithm##2##3##(2008-2#1)(2011-2#1)
provide an alternative explanation##2##4##(2008-9#1)(2009-3#1)
provide an alternative method for##3##5##(2006-5#1)(2008-10#1)(2008-2#1)
provide an alternative to##5##4##(2007-11#1)(2008-4#1)(2008-9#2)(2009-9#1)
provide an alternative##18##3##(2006-5#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#5)(2009-3#1)(2009-9#1)(2012-2#1)(2013-1#1)
provide an analysis##2##3##(2008-2#1)(2008-7#1)
provide an approach##2##3##(1991-7#1)(2007-10#1)
provide an appropriate##3##3##(1990-3#1)(2011-1#1)(2012-2#1)
provide an attractive##5##3##(1995-2#1)(2005-8#1)(2007-12#1)(2008-11#1)(2008-9#1)
provide an avenue##2##3##(2008-2#1)(2012-1#1)
provide an economical##2##3##(2008-1#1)(2008-9#1)
provide an effective means of##2##5##(1996-12#1)(2008-3#1)
provide an effective means##4##4##(1996-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
provide an effective tool##2##4##(2008-11#1)(2013-8#1)
provide an effective treatment for##2##5##(2007-11#1)(2008-1#1)
provide an effective##16##3##(1993-12#1)(1993-2#1)(1996-12#1)(2004-4#1)(2006-1#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2011-2#1)(2012-11#1)(2013-8#1)
provide an efficient way for##2##5##(1997-4#1)(2009-2#1)
provide an efficient##8##3##(1994-2#1)(1997-2#1)(1997-4#1)(2005-5#1)(2007-11#1)(2008-3#1)(2009-2#1)(2011-2#1)
provide an environment##2##3##(1995-3#1)(2008-11#1)
provide an estimate of##3##4##(1992-12#1)(2008-3#1)(2008-4#1)
provide an evidence-based##2##3##(2011-2#1)(2011-7#1)
provide an example##2##3##(1996-3#1)(2010-11#1)
provide an excellent##11##3##(1990-2#1)(1993-3#1)(1997-3#1)(1997-6#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-12#1)(2013-1#1)
provide an exciting##2##3##(1996-2#1)(2007-12#1)
provide an explanation for the elevated levels of##2##8##(1990-10#1)(1994-11#1)
provide an explanation for the##5##5##(1990-10#1)(1992-10#1)(1992-11#1)(1994-11#1)(2007-10#1)
provide an explanation for##7##4##(1990-10#1)(1992-10#1)(1992-11#1)(1994-11#1)(1995-2#1)(2007-10#1)(2008-3#1)
provide an explanation##10##3##(1990-10#1)(1992-10#1)(1992-11#1)(1994-11#1)(1995-2#1)(2007-10#1)(2008-3#2)(2011-1#2)
provide an ideal##5##3##(1994-9#1)(2007-11#1)(2009-2#1)(2010-12#1)(2011-1#1)
provide an important link between##2##5##(1991-11#1)(2013-8#1)
provide an important therapeutic##2##4##(2005-8#1)(2009-2#1)
provide an important##19##3##(1991-11#1)(1995-2#1)(1996-1#1)(1997-1#1)(2005-8#1)(2006-5#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-4#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
provide an improved##4##3##(2008-10#1)(2010-8#1)(2012-1#1)(2012-2#1)
provide an improvement##2##3##(2010-4#1)(2010-6#1)
provide an indication of##2##4##(2006-10#1)(2008-11#1)
provide an initial##4##3##(2008-3#1)(2008-4#1)(2010-8#1)(2013-1#1)
provide an insight into the##4##5##(1991-6#1)(2008-10#1)(2011-1#1)(2012-3#1)
provide an insight##5##3##(1991-6#1)(2008-10#1)(2008-7#1)(2011-1#1)(2012-3#1)
provide an interesting##3##3##(2007-8#1)(2012-2#1)(2012-3#1)
provide an introduction to##3##4##(2006-5#1)(2007-4#1)(2008-7#1)
provide an objective##4##3##(1996-5#1)(1996-7#1)(2007-3#1)(2013-7#1)
provide an opportunity for##2##4##(2008-10#1)(2009-2#1)
provide an opportunity to##3##4##(2011-1#1)(2011-2#1)(2013-1#1)
provide an opportunity##5##3##(2008-10#1)(2009-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
provide an optimal##5##3##(2008-10#2)(2008-3#2)(2010-10#1)
provide an outline of the##3##5##(1997-8#1)(2006-10#1)(2010-3#1)
provide an outline of##4##4##(1997-8#1)(2006-10#1)(2010-3#1)(2012-1#1)
provide an overall##3##3##(1992-6#1)(1997-8#1)(2007-2#1)
provide an overview about the##2##5##(2007-11#1)(2007-12#1)
provide an overview of the current##6##6##(2004-7#1)(2009-4#1)(2010-10#1)(2012-12#2)(2013-8#1)
provide an overview of the literature on##2##7##(2008-10#1)(2012-2#1)
provide an overview of the recent##2##6##(2011-2#1)(2012-3#1)
provide an overview of the##32##5##(1991-1#1)(2004-7#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-6#2)(2010-10#2)(2010-11#1)(2011-12#1)(2011-2#3)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
provide an overview of##52##4##(1991-1#1)(1995-1#1)(1995-3#1)(2004-7#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2010-10#2)(2010-11#3)(2010-12#1)(2011-12#1)(2011-2#4)(2012-11#2)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
provide an overview##56##3##(1991-1#1)(1995-1#1)(1995-3#1)(2004-7#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2010-10#2)(2010-11#4)(2010-12#1)(2011-12#1)(2011-2#4)(2012-11#2)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
provide an understanding of the##3##5##(2006-10#1)(2008-3#1)(2011-1#1)
provide an understanding of##4##4##(2006-10#1)(2007-12#1)(2008-3#1)(2011-1#1)
provide an unprecedented##2##3##(2006-4#1)(2009-2#1)
provide an update on the most recent##2##7##(2006-10#1)(2013-1#1)
provide an update on the##4##5##(2006-10#1)(2008-8#1)(2012-2#1)(2013-1#1)
provide an update on##8##4##(2006-10#1)(2006-7#1)(2008-8#1)(2009-3#1)(2012-11#2)(2012-2#1)(2013-1#1)
provide an update##9##3##(2006-10#1)(2006-7#1)(2008-5#1)(2008-8#1)(2009-3#1)(2012-11#2)(2012-2#1)(2013-1#1)
provide an updated##3##3##(2010-6#1)(2011-1#1)(2013-1#1)
provide an##342##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1991-1#1)(1991-11#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-2#4)(1995-3#2)(1995-6#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-4#1)(2004-7#1)(2005-11#1)(2005-3#1)(2005-5#1)(2005-8#2)(2006-1#1)(2006-10#7)(2006-12#1)(2006-4#1)(2006-5#4)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#8)(2007-12#8)(2007-2#3)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#6)(2008-10#23)(2008-11#10)(2008-12#2)(2008-2#7)(2008-3#16)(2008-4#7)(2008-5#4)(2008-6#3)(2008-7#9)(2008-8#5)(2008-9#9)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#6)(2009-3#3)(2009-4#5)(2009-5#2)(2009-6#3)(2009-8#2)(2009-9#1)(2010-10#4)(2010-11#7)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#2)(2011-1#9)(2011-12#1)(2011-2#11)(2011-7#1)(2012-1#4)(2012-11#5)(2012-12#4)(2012-2#15)(2012-3#6)(2013-1#9)(2013-7#1)(2013-8#6)
provide anatomical##3##2##(1994-5#1)(2008-1#1)(2013-1#1)
provide and##6##2##(1996-2#1)(1997-3#1)(2009-5#1)(2012-2#2)(2013-1#1)
provide answers##2##2##(1995-9#2)
provide any protection##3##3##(1995-11#2)(2008-10#1)
provide any##18##2##(1991-2#2)(1995-11#2)(1997-8#1)(2005-8#2)(2007-8#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-4#1)(2010-11#1)(2010-12#1)(2012-1#1)(2013-1#1)
provide appropriate##14##2##(1993-3#1)(1995-9#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-4#1)(2009-10#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-12#2)
provide assistance to##3##3##(2006-5#1)(2009-10#1)(2012-1#1)
provide assistance##5##2##(1996-3#1)(2006-5#1)(2007-12#1)(2009-10#1)(2012-1#1)
provide at##2##2##(2008-1#1)(2008-12#1)
provide avenues for##2##3##(2008-10#1)(2008-2#1)
provide avenues##3##2##(2008-10#1)(2008-2#1)(2012-12#1)
provide baseline##2##2##(1992-2#1)(2008-10#1)
provide basic##5##2##(2005-11#1)(2008-7#1)(2010-8#1)(2012-1#1)(2013-7#1)
provide beneficial##2##2##(2006-10#1)(2008-10#1)
provide benefit for##2##3##(2005-8#1)(2010-12#1)
provide benefit to##2##3##(2005-8#1)(2008-3#1)
provide benefit##6##2##(2005-8#3)(2008-3#1)(2010-12#1)(2012-12#1)
provide benefits in##2##3##(2012-2#2)
provide benefits to patients##2##4##(2006-2#1)(2008-10#1)
provide benefits to##3##3##(2006-2#1)(2008-10#1)(2009-4#1)
provide benefits##7##2##(2006-2#1)(2007-9#1)(2008-10#1)(2009-11#1)(2009-4#1)(2012-2#2)
provide better habitats##2##3##(2008-8#2)
provide better information##6##3##(1992-3#1)(2005-11#1)(2006-10#1)(2007-2#1)(2008-3#1)(2009-4#1)
provide better long-term patency##2##4##(1997-3#1)(2007-8#1)
provide better long-term##3##3##(1997-3#1)(2007-8#1)(2011-2#1)
provide better##32##2##(1992-3#1)(1993-12#1)(1996-2#1)(1997-3#1)(2005-11#1)(2006-1#1)(2006-10#2)(2006-12#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
provide both a##3##3##(2008-8#1)(2009-11#1)(2010-4#1)
provide both the##2##3##(2008-3#1)(2011-2#1)
provide both##14##2##(1996-4#1)(2005-11#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-4#1)(2011-2#2)
provide breeders##2##2##(2008-10#1)(2011-2#1)
provide broadband controlled dispersion##2##4##(2007-11#1)(2007-12#1)
provide capability##2##2##(2008-6#1)(2013-8#1)
provide care and##2##3##(2008-11#1)(2008-2#1)
provide care to##3##3##(1997-2#1)(2008-11#1)(2008-9#1)
provide care##13##2##(1991-2#1)(1993-12#1)(1994-3#1)(1997-2#1)(2005-11#1)(2008-11#3)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-3#1)
provide clear evidence that##2##4##(1997-6#1)(2005-8#1)
provide clear evidence##3##3##(1990-11#1)(1997-6#1)(2005-8#1)
provide clear##4##2##(1990-11#1)(1997-6#1)(2005-8#1)(2008-5#1)
provide clinical and##2##3##(2007-10#1)(2008-11#1)
provide clinical benefit##2##3##(2008-1#1)(2010-10#1)
provide clinical##9##2##(1993-9#1)(2007-10#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2010-10#1)(2011-2#1)
provide clinically relevant##2##3##(2008-3#1)(2009-3#1)
provide clinically##6##2##(2008-10#1)(2008-3#1)(2008-7#1)(2009-3#1)(2013-1#2)
provide clinicians with a##4##4##(2006-10#1)(2007-11#1)(2007-2#1)(2008-6#1)
provide clinicians with##6##3##(2006-10#1)(2007-11#1)(2007-2#1)(2008-3#1)(2008-6#1)(2008-8#1)
provide clinicians##8##2##(1997-5#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-4#1)
provide clues about the##3##4##(2010-10#1)(2012-12#1)(2013-8#1)
provide clues about##4##3##(2008-7#1)(2010-10#1)(2012-12#1)(2013-8#1)
provide clues for the##3##4##(1995-4#1)(2011-1#1)(2013-8#1)
provide clues for##5##3##(1995-4#1)(1997-6#1)(2009-2#1)(2011-1#1)(2013-8#1)
provide clues on the##2##4##(2008-7#1)(2008-8#1)
provide clues on##3##3##(2008-12#1)(2008-7#1)(2008-8#1)
provide clues to the##4##4##(1997-6#1)(2010-6#2)(2012-1#1)
provide clues to##9##3##(1996-8#1)(1997-6#1)(2008-11#1)(2010-12#1)(2010-3#1)(2010-6#2)(2012-1#1)(2012-3#1)
provide clues##23##2##(1995-4#1)(1996-8#1)(1997-6#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-6#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#2)
provide comfort##3##2##(1992-3#1)(2006-1#1)(2007-9#1)
provide comparable##3##2##(2008-11#2)(2012-2#1)
provide compelling evidence for the##2##5##(1997-2#1)(2012-12#1)
provide compelling evidence for##3##4##(1995-3#1)(1997-2#1)(2012-12#1)
provide compelling evidence that##2##4##(2009-8#1)(2011-2#1)
provide compelling evidence##5##3##(1995-3#1)(1997-2#1)(2009-8#1)(2011-2#1)(2012-12#1)
provide compelling##6##2##(1995-3#1)(1997-2#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
provide complementary information##2##3##(2008-1#1)(2012-2#1)
provide complementary##5##2##(2008-1#1)(2008-2#1)(2008-8#1)(2009-10#1)(2012-2#1)
provide complete compensation##2##3##(2008-2#2)
provide complete##8##2##(1992-8#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-8#1)(2012-11#1)
provide comprehensive##8##2##(1993-2#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2010-3#1)(2011-2#1)
provide conflicting##2##2##(2008-11#1)(2008-2#1)
provide consistent##2##2##(2008-5#1)(2009-7#1)
provide consumers with##2##3##(2005-10#1)(2012-1#1)
provide continuous##5##2##(1995-12#1)(2008-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
provide control##2##2##(2008-10#1)(2009-12#1)
provide controlled##2##2##(2007-1#1)(2007-11#1)
provide cost-effective##2##2##(2009-7#1)(2010-8#1)
provide critical information##3##3##(2006-10#1)(2007-8#1)(2008-12#1)
provide critical##8##2##(2006-10#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-7#1)(2012-2#1)(2013-1#2)
provide current##2##2##(1996-1#1)(2008-1#1)
provide data for##3##3##(1990-2#1)(2007-4#1)(2010-7#1)
provide data on##6##3##(1990-11#1)(1993-3#1)(2004-2#1)(2009-10#1)(2011-2#1)(2013-1#1)
provide data##18##2##(1990-11#1)(1990-2#1)(1993-3#1)(2004-11#1)(2004-2#1)(2004-3#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-12#2)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
provide decision##2##2##(2007-12#1)(2008-10#1)
provide decision-makers with##2##3##(2008-10#1)(2011-2#1)
provide detailed information##3##3##(2008-9#1)(2011-1#1)(2012-12#1)
provide detailed##8##2##(1991-1#1)(2007-12#1)(2008-1#1)(2008-9#2)(2011-1#2)(2012-12#1)
provide details about##2##3##(1992-3#1)(2006-10#1)
provide details of the##3##4##(1990-11#1)(2008-11#2)
provide details on the##2##4##(2008-10#1)(2008-11#1)
provide details##9##2##(1990-11#1)(1992-3#1)(1994-11#1)(2006-10#1)(2008-10#1)(2008-11#3)(2011-1#1)
provide diagnostic information##3##3##(2006-6#1)(2007-4#1)(2008-11#1)
provide diagnostic##4##2##(2006-6#1)(2007-4#1)(2008-11#1)(2008-9#1)
provide different##6##2##(2007-12#1)(2008-12#1)(2009-9#1)(2013-1#3)
provide direct access to##4##4##(2008-4#1)(2009-10#1)(2013-1#2)
provide direct evidence for##7##4##(1990-7#1)(1994-12#1)(1994-9#1)(1995-3#1)(1995-8#1)(1997-6#1)(2008-7#1)
provide direct evidence that the##4##5##(1993-12#1)(1994-3#1)(1995-7#1)(2009-8#1)
provide direct evidence that##12##4##(1993-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-7#2)(1996-1#1)(1996-11#1)(2008-10#1)(2009-8#1)
provide direct evidence##20##3##(1990-7#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-3#2)(1995-7#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1997-6#1)(2008-10#1)(2008-7#1)(2009-8#1)
provide direct experimental evidence##2##4##(1993-12#1)(2007-11#1)
provide direct experimental##3##3##(1993-12#1)(2007-11#1)(2008-10#1)
provide direct##38##2##(1990-2#1)(1990-7#1)(1991-5#1)(1992-2#1)(1993-12#2)(1994-12#1)(1994-3#2)(1994-8#1)(1994-9#2)(1995-11#1)(1995-3#2)(1995-5#1)(1995-7#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1997-6#1)(2004-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-8#1)(2012-3#1)(2013-1#2)
provide direction for##2##3##(1994-3#1)(2011-1#1)
provide documentation##2##2##(1991-12#1)(1992-12#1)
provide durable##2##2##(2008-10#2)
provide dynamic##2##2##(2005-11#1)(2008-10#1)
provide education##2##2##(1991-12#1)(2008-11#1)
provide effective analgesia##2##3##(2006-10#1)(2009-5#1)
provide effective control##3##3##(1991-8#1)(1992-4#1)(2011-2#1)
provide effective protection##2##3##(2008-10#1)(2011-2#1)
provide effective treatment##3##3##(1990-12#1)(2007-7#1)(2010-12#1)
provide effective##20##2##(1990-12#1)(1991-8#1)(1992-4#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#2)
provide emergency##3##2##(1997-1#1)(2007-5#2)
provide energy##2##2##(2006-8#1)(2010-9#1)
provide enhanced##3##2##(1991-9#1)(2008-3#1)(2010-12#1)
provide enough detail##2##3##(2008-10#1)(2008-7#1)
provide enough##5##2##(1991-6#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)
provide epidural##2##2##(2006-10#1)(2007-2#1)
provide equal##2##2##(1995-12#1)(2006-10#1)
provide equivalent##5##2##(1993-11#1)(1996-1#1)(1996-2#1)(2007-11#1)(2008-3#1)
provide essential information on##2##4##(2007-5#1)(2008-11#1)
provide essential information##5##3##(1993-2#1)(2007-5#1)(2008-11#1)(2012-2#1)(2013-8#1)
provide essential##8##2##(1993-2#1)(2007-11#1)(2007-3#1)(2007-5#1)(2008-11#1)(2012-12#1)(2012-2#1)(2013-8#1)
provide estimates of##8##3##(1995-2#1)(1996-8#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-3#1)
provide estimates##10##2##(1992-9#1)(1995-2#1)(1996-8#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-3#1)
provide evidence for a##10##4##(1991-4#1)(1991-7#1)(1993-12#1)(1994-12#1)(1996-4#1)(1997-2#1)(1997-4#1)(2007-10#1)(2008-4#1)(2013-1#1)
provide evidence for an essential role##2##6##(1994-3#1)(2008-4#1)
provide evidence for an##4##4##(1994-3#1)(2005-7#1)(2008-10#1)(2008-4#1)
provide evidence for the existence of##3##6##(1990-7#1)(1995-1#1)(1997-6#1)
provide evidence for the hypothesis that##2##6##(2009-4#1)(2011-2#1)
provide evidence for the involvement of##3##6##(1994-2#2)(1996-2#1)
provide evidence for the presence of##3##6##(1994-12#1)(2008-10#1)(2010-4#1)
provide evidence for the##21##4##(1990-11#1)(1990-7#2)(1994-12#1)(1994-2#2)(1994-8#1)(1995-1#1)(1995-8#1)(1996-2#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-2#1)(2009-4#1)(2010-4#1)(2011-2#1)
provide evidence for##54##3##(1990-11#1)(1990-7#2)(1991-4#1)(1991-5#1)(1991-7#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-8#3)(1996-12#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-4#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#1)
provide evidence of a##3##4##(1994-3#1)(1996-1#1)(1996-3#1)
provide evidence of an##5##4##(1991-12#1)(1997-7#1)(2010-10#1)(2010-12#1)(2012-2#1)
provide evidence of the existence of##2##6##(1995-8#1)(2008-3#1)
provide evidence of the##5##4##(1995-8#1)(2006-6#1)(2008-3#1)(2009-7#1)(2011-2#1)
provide evidence of##29##3##(1991-12#1)(1993-7#1)(1994-3#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-3#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
provide evidence on##3##3##(1995-6#1)(2008-11#1)(2012-2#1)
provide evidence that a##5##4##(1992-3#1)(1993-6#1)(1995-3#1)(1996-11#1)(2008-7#1)
provide evidence that although##2##4##(1990-7#1)(1995-3#1)
provide evidence that the##15##4##(1991-11#1)(1991-7#1)(1991-8#1)(1992-9#1)(1993-12#1)(1993-6#1)(1995-8#1)(1996-11#1)(1997-7#1)(2006-10#1)(2007-2#1)(2007-5#1)(2008-7#1)(2008-8#1)(2008-9#1)
provide evidence that##94##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-6#2)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-2#2)(1995-3#3)(1995-8#3)(1996-11#2)(1996-9#1)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(2004-2#1)(2004-9#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-11#1)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#1)
provide evidence to support the##3##5##(2010-3#1)(2011-1#1)(2013-1#1)
provide evidence to##4##3##(2010-3#1)(2011-1#1)(2012-12#1)(2013-1#1)
provide evidence##197##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-7#3)(1990-8#1)(1991-11#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#4)(1993-6#2)(1993-7#1)(1993-8#3)(1993-9#2)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#8)(1996-1#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-9#2)(1997-2#2)(1997-3#2)(1997-4#3)(1997-6#3)(1997-7#2)(1997-8#2)(2004-2#1)(2004-9#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#5)(2008-8#5)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#9)(2012-2#4)(2012-3#2)(2013-1#10)(2013-8#2)
provide evidence-based##2##2##(2007-12#1)(2013-1#1)
provide examples of how##2##4##(2006-5#1)(2008-7#1)
provide examples of##7##3##(2006-5#1)(2007-2#1)(2008-11#1)(2008-7#2)(2010-2#1)(2010-7#1)
provide excellent model##3##3##(2007-8#1)(2009-3#1)(2009-8#1)
provide excellent##16##2##(1996-1#1)(2006-10#2)(2007-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-3#1)(2009-8#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
provide experimental evidence that the##2##5##(1994-5#1)(1996-7#1)
provide experimental evidence that##3##4##(1994-5#1)(1996-7#1)(2006-12#1)
provide experimental evidence##5##3##(1994-5#2)(1996-7#1)(2006-12#1)(2007-12#1)
provide experimental##8##2##(1994-5#2)(1996-7#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-2#1)(2008-3#1)
provide extensive##4##2##(2008-7#1)(2008-9#2)(2011-2#1)
provide fast##2##2##(2008-10#1)(2012-3#1)
provide favorable##2##2##(2008-11#1)(2013-8#1)
provide feedback to##2##3##(2007-11#1)(2008-10#1)
provide financial##4##2##(2006-10#1)(2010-2#2)(2010-8#1)
provide fixed##2##2##(1997-4#1)(2011-2#1)
provide flexibility##2##2##(2008-10#1)(2008-9#1)
provide for a##4##3##(2005-9#1)(2008-10#1)(2008-6#1)(2013-1#1)
provide for more##2##3##(2008-8#1)(2013-1#1)
provide for the first time##2##5##(1994-11#1)(1997-8#1)
provide for the##7##3##(1994-11#1)(1995-1#1)(1997-6#1)(1997-8#1)(2008-11#1)(2008-7#1)(2013-7#1)
provide for##28##2##(1990-2#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-10#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-4#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2013-1#3)(2013-7#1)
provide free##3##2##(1993-2#1)(2007-11#1)(2011-2#1)
provide fundamental##3##2##(1994-8#1)(1996-2#1)(2005-11#1)
provide further evidence for a##2##5##(1994-2#1)(1997-7#1)
provide further evidence for##4##4##(1991-8#1)(1994-2#1)(1996-2#1)(1997-7#1)
provide further evidence of a##2##5##(1994-8#1)(2008-4#1)
provide further evidence of##3##4##(1993-6#1)(1994-8#1)(2008-4#1)
provide further evidence that##9##4##(1990-8#1)(1991-5#1)(1993-11#1)(1994-5#1)(1995-7#1)(1996-1#1)(1996-3#1)(1997-8#1)(2008-3#1)
provide further evidence##18##3##(1990-8#1)(1991-5#1)(1991-8#1)(1993-11#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-7#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-7#1)(1997-8#1)(2008-3#1)(2008-4#1)(2009-8#1)(2009-9#1)
provide further information about##2##4##(1992-12#1)(1992-7#1)
provide further information on##2##4##(2006-10#1)(2008-7#1)
provide further information##4##3##(1992-12#1)(1992-7#1)(2006-10#1)(2008-7#1)
provide further insight into the##7##5##(1990-7#1)(1992-2#1)(1993-12#1)(1995-12#1)(1995-3#1)(2007-12#1)(2008-7#1)
provide further insight##9##3##(1990-7#1)(1992-2#1)(1993-12#1)(1993-9#1)(1995-12#1)(1995-3#1)(2007-12#1)(2008-7#1)(2008-8#1)
provide further support for a role##2##6##(1995-12#1)(2008-8#1)
provide further support for the##4##5##(1991-9#1)(1995-5#1)(2008-4#1)(2009-4#1)
provide further support for##7##4##(1991-9#1)(1995-12#1)(1995-5#1)(2008-4#1)(2008-8#1)(2009-4#1)(2012-2#1)
provide further support##8##3##(1991-9#1)(1995-12#1)(1995-5#2)(2008-4#1)(2008-8#1)(2009-4#1)(2012-2#1)
provide further##51##2##(1990-1#1)(1990-7#1)(1990-8#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#2)(1995-3#1)(1995-5#2)(1995-7#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-7#1)(1997-8#1)(2006-10#1)(2006-3#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
provide future##3##2##(1992-4#1)(2008-5#1)(2012-11#1)
provide general##4##2##(1993-6#1)(1994-2#1)(1995-2#1)(2010-12#1)
provide genetic##7##2##(1994-3#1)(2008-10#1)(2008-4#2)(2008-7#1)(2010-2#1)(2011-2#1)
provide good results##4##3##(1990-12#1)(2006-10#1)(2007-8#1)(2013-8#1)
provide good##20##2##(1990-12#1)(1991-6#1)(1991-8#1)(1993-3#1)(2006-10#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-3#1)(2010-7#1)(2012-12#1)(2013-1#1)(2013-8#2)
provide greater insight into the##3##5##(2008-10#1)(2008-7#1)(2010-6#1)
provide greater insight into##4##4##(2008-10#1)(2008-7#1)(2010-6#1)(2012-1#1)
provide greater##14##2##(2007-11#1)(2007-9#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#2)(2009-10#1)(2010-6#1)(2012-1#1)
provide guidance for the##3##4##(2006-8#1)(2008-2#1)(2012-12#1)
provide guidance for##11##3##(2006-12#1)(2006-8#1)(2007-2#1)(2008-2#1)(2009-12#1)(2010-6#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
provide guidance on how##2##4##(2008-11#1)(2009-10#1)
provide guidance on##4##3##(2006-10#1)(2008-11#1)(2009-10#1)(2009-2#1)
provide guidance to##4##3##(1993-12#1)(2006-8#1)(2007-4#1)(2008-11#1)
provide guidance##26##2##(1992-2#1)(1993-12#1)(1996-3#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-2#1)(2007-4#1)(2008-11#3)(2008-2#3)(2008-3#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-2#1)(2010-6#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
provide guidelines for##4##3##(2008-10#1)(2009-9#1)(2011-2#1)(2012-1#1)
provide guidelines##9##2##(1992-3#1)(2005-10#1)(2006-2#1)(2008-10#1)(2009-11#1)(2009-9#2)(2011-2#1)(2012-1#1)
provide health care##4##3##(1994-12#1)(1995-3#1)(1997-3#1)(2006-2#1)
provide health##7##2##(1994-12#1)(1995-3#1)(1997-3#1)(2006-2#1)(2007-5#1)(2008-11#1)(2010-12#1)
provide help##2##2##(2012-12#1)(2013-8#1)
provide high quality##5##3##(1991-12#1)(1997-2#1)(2008-11#1)(2008-5#1)(2008-7#1)
provide high##18##2##(1991-12#1)(1994-6#1)(1997-2#1)(2006-8#1)(2007-1#1)(2007-12#3)(2008-10#2)(2008-11#2)(2008-5#2)(2008-7#4)
provide high-quality##4##2##(1991-2#1)(1997-1#1)(2008-1#1)(2011-2#1)
provide high-resolution##4##2##(2008-3#1)(2008-9#1)(2011-2#2)
provide higher##6##2##(1993-1#1)(1993-3#1)(2008-10#1)(2008-5#1)(2009-9#1)(2012-3#1)
provide histological##2##2##(2006-5#1)(2012-2#1)
provide important clues about##2##4##(2006-10#1)(2008-10#1)
provide important clues##5##3##(1996-7#1)(2006-10#1)(2008-10#1)(2008-4#1)(2011-1#1)
provide important diagnostic##3##3##(1991-2#1)(1992-4#1)(2006-8#1)
provide important evidence##3##3##(2005-7#1)(2010-4#1)(2011-2#1)
provide important information for##3##4##(2008-10#1)(2008-6#1)(2013-1#1)
provide important information on##3##4##(1991-2#1)(2008-3#1)(2013-1#1)
provide important information to##2##4##(2007-9#1)(2012-3#1)
provide important information##11##3##(1990-8#1)(1991-2#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-6#1)(2012-3#1)(2013-1#2)
provide important insights into the##2##5##(2008-7#1)(2013-1#1)
provide important insights into##4##4##(2006-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
provide important insights##6##3##(1992-7#1)(1993-3#1)(2006-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
provide important##41##2##(1990-8#1)(1991-2#2)(1992-4#1)(1992-7#1)(1993-3#2)(1995-12#1)(1996-7#1)(1996-8#1)(2005-7#2)(2006-10#1)(2006-5#2)(2006-8#1)(2007-1#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#4)(2013-7#1)
provide improved##7##2##(2006-7#1)(2007-1#1)(2007-12#1)(2008-2#1)(2008-3#1)(2012-2#1)(2013-7#1)
provide in the##3##3##(2009-7#1)(2010-10#1)(2011-2#1)
provide in##6##2##(1996-2#1)(1996-8#1)(2006-11#1)(2009-7#1)(2010-10#1)(2011-2#1)
provide inadequate##3##2##(1995-2#1)(2007-11#1)(2008-3#1)
provide incentives for##2##3##(1997-2#1)(2008-12#1)
provide incentives##3##2##(1994-2#1)(1997-2#1)(2008-12#1)
provide increased##5##2##(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)
provide increasing##2##2##(2009-11#1)(2010-8#1)
provide independent##8##2##(1990-8#1)(1996-9#1)(2005-8#1)(2008-10#1)(2008-6#1)(2008-9#2)(2010-4#1)
provide indications##2##2##(2008-12#1)(2008-2#1)
provide indicators of the##2##4##(1992-2#1)(2012-3#1)
provide indirect##2##2##(2007-12#1)(2010-11#1)
provide individual##2##2##(2006-5#1)(2011-2#1)
provide information about the##14##4##(1990-12#1)(1992-12#1)(1993-12#1)(1994-8#1)(2007-12#1)(2008-10#1)(2008-4#3)(2008-7#1)(2009-10#1)(2009-5#1)(2012-2#1)(2013-8#1)
provide information about##27##3##(1990-12#1)(1991-1#1)(1991-7#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-8#1)(1996-4#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-4#3)(2008-7#1)(2009-10#1)(2009-5#2)(2009-9#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
provide information and##3##3##(2007-2#1)(2009-5#1)(2012-3#1)
provide information for the##3##4##(1993-12#1)(2008-11#1)(2011-1#1)
provide information for##10##3##(1993-12#1)(1995-2#1)(1996-12#1)(1996-9#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2011-1#1)
provide information not##2##3##(1993-2#1)(2008-10#1)
provide information on cell##2##4##(2008-9#2)
provide information on the##13##4##(1995-3#1)(2004-9#1)(2006-2#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#1)(2008-7#1)(2011-1#1)
provide information on##27##3##(1991-5#1)(1995-3#1)(1995-6#1)(1996-6#1)(2004-9#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-9#2)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2010-12#1)(2011-1#1)(2012-2#1)
provide information regarding##2##3##(1996-3#1)(2006-12#1)
provide information that##2##3##(2007-11#1)(2007-2#1)
provide information to help##3##4##(1991-2#1)(2006-10#1)(2012-2#1)
provide information to##13##3##(1990-6#1)(1991-2#1)(1993-2#1)(1996-2#2)(1997-8#1)(2006-10#1)(2007-2#1)(2007-3#1)(2009-9#1)(2010-8#1)(2012-1#1)(2012-2#1)
provide information##101##2##(1990-12#1)(1990-6#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-12#2)(1993-2#2)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-8#1)(2004-9#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#4)(2007-3#1)(2007-6#1)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#2)(2008-4#6)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#1)(2009-3#2)(2009-5#3)(2009-9#2)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
provide initial##4##2##(2007-10#1)(2007-4#1)(2008-5#1)(2009-6#1)
provide innovative ways to##2##4##(2008-3#1)(2008-7#1)
provide innovative##4##2##(2008-3#1)(2008-7#1)(2010-8#1)(2012-2#1)
provide inpatient##2##2##(1992-2#1)(2011-1#1)
provide insight about the##2##4##(2007-2#1)(2010-4#1)
provide insight about##3##3##(1996-5#1)(2007-2#1)(2010-4#1)
provide insight as to##2##4##(2010-12#1)(2013-1#1)
provide insight as##3##3##(1991-2#1)(2010-12#1)(2013-1#1)
provide insight into how##4##4##(1997-7#1)(2007-12#1)(2008-11#1)(2008-2#1)
provide insight into the mechanisms of##2##6##(2007-8#1)(2008-4#1)
provide insight into the mechanisms##3##5##(2007-8#1)(2008-4#1)(2008-9#1)
provide insight into the role of##2##6##(1996-10#1)(2007-1#1)
provide insight into the##20##4##(1994-3#1)(1996-10#1)(1996-7#1)(2007-1#1)(2007-11#2)(2007-8#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#2)(2012-12#3)
provide insight into##45##3##(1991-11#1)(1991-2#1)(1992-12#1)(1994-3#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-7#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-4#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#4)(2009-9#1)(2010-2#1)(2010-5#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-8#1)
provide insight##53##2##(1991-11#1)(1991-2#2)(1992-12#1)(1994-3#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-7#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-4#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#4)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
provide insights into how##2##4##(2007-12#2)
provide insights into the##16##4##(1994-12#1)(1994-2#1)(1996-11#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
provide insights into##32##3##(1993-12#1)(1994-12#1)(1994-2#1)(1995-8#1)(1996-11#1)(1997-2#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)
provide insights on##2##3##(2006-10#1)(2008-4#1)
provide insights##37##2##(1993-12#1)(1994-12#1)(1994-2#1)(1995-8#1)(1996-11#1)(1997-2#1)(1997-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-1#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-10#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)
provide instructions for##2##3##(2008-4#2)
provide insurance##3##2##(1991-2#2)(1991-6#1)
provide interesting##3##2##(2005-10#1)(2006-12#1)(2010-12#1)
provide invaluable information##2##3##(2006-9#1)(2012-3#1)
provide invaluable##4##2##(2006-9#1)(2008-11#1)(2008-6#1)(2012-3#1)
provide it with##2##3##(2008-7#1)(2012-1#1)
provide key##2##2##(2011-1#1)(2012-11#1)
provide large##2##2##(2008-1#1)(2008-3#1)
provide leadership##2##2##(2007-7#1)(2008-7#1)
provide less##2##2##(2006-2#1)(2008-2#1)
provide limited##4##2##(2007-11#1)(2008-10#1)(2011-2#1)(2012-2#1)
provide little support for##2##4##(1991-7#1)(2006-5#1)
provide little##8##2##(1991-7#1)(1996-11#1)(2005-11#1)(2006-5#1)(2007-1#1)(2008-10#1)(2008-9#1)(2010-4#1)
provide long##2##2##(2004-9#1)(2012-2#1)
provide long-term immunity##2##3##(2008-4#1)(2011-1#1)
provide long-term##11##2##(1991-4#1)(2008-11#1)(2008-3#3)(2008-4#2)(2010-5#1)(2011-1#2)(2012-2#1)
provide many##3##2##(1995-2#1)(2008-2#1)(2012-1#1)
provide material##2##2##(2008-9#1)(2013-8#1)
provide maximum##2##2##(1997-4#1)(2011-2#1)
provide meaningful##3##2##(2008-5#1)(2010-10#1)(2013-1#1)
provide mechanical##4##2##(1995-3#1)(1996-4#1)(2007-12#1)(2008-5#1)
provide mechanistic##6##2##(2008-11#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#1)
provide medical##3##2##(1993-1#1)(1996-3#1)(2007-7#1)
provide mental health care##2##4##(2012-11#1)(2013-1#1)
provide mental health##3##3##(1991-1#1)(2012-11#1)(2013-1#1)
provide mental##4##2##(1991-1#1)(2010-1#1)(2012-11#1)(2013-1#1)
provide methods##2##2##(2008-10#1)(2008-4#1)
provide model##2##2##(2008-3#1)(2008-8#1)
provide moderate##3##2##(2008-10#1)(2010-12#1)(2011-2#1)
provide molecular##2##2##(1994-8#1)(2012-2#1)
provide more accurate##5##3##(1990-3#1)(1991-11#1)(1996-4#1)(2008-6#1)(2012-12#1)
provide more effective##2##3##(2007-2#1)(2011-2#1)
provide more information##5##3##(2006-10#1)(2007-10#1)(2007-3#1)(2007-4#1)(2008-3#1)
provide more insight into the##2##5##(1996-10#1)(2012-2#1)
provide more or less##2##4##(2007-2#1)(2007-6#1)
provide more##39##2##(1990-3#1)(1991-1#1)(1991-11#1)(1991-12#1)(1992-3#1)(1996-10#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#2)(2008-10#2)(2008-3#1)(2008-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
provide morphological evidence##2##3##(1992-3#1)(1994-2#1)
provide most of the##2##4##(2008-2#1)(2011-2#1)
provide most##3##2##(2008-2#1)(2009-11#1)(2011-2#1)
provide motor##2##2##(1993-9#1)(2008-11#1)
provide much needed##2##3##(2004-11#1)(2012-3#1)
provide much##6##2##(1992-12#1)(1997-8#1)(2004-11#1)(2008-2#1)(2008-4#1)(2012-3#1)
provide multiple##3##2##(2006-10#1)(2008-11#1)(2013-1#1)
provide names##2##2##(1990-11#1)(1991-10#1)
provide necessary##2##2##(1993-12#1)(2008-7#1)
provide new and##3##3##(2010-3#1)(2011-1#1)(2013-1#1)
provide new approaches to##2##4##(1993-2#1)(1995-3#1)
provide new approaches##3##3##(1993-2#1)(1995-3#1)(2009-3#1)
provide new avenues##2##3##(2008-11#1)(2008-4#1)
provide new evidence that##2##4##(1991-7#1)(2008-12#1)
provide new evidence##3##3##(1991-7#1)(2008-12#1)(2010-2#1)
provide new information about the##3##5##(1995-11#1)(1997-7#1)(2012-2#1)
provide new information on##6##4##(1990-4#1)(1991-7#1)(1992-1#1)(1996-5#1)(2006-6#1)(2008-3#1)
provide new information##11##3##(1990-4#1)(1991-7#1)(1992-1#1)(1995-11#1)(1996-5#1)(1997-7#1)(2006-6#1)(2008-2#1)(2008-3#1)(2012-1#1)(2012-2#1)
provide new insight into the##2##5##(2007-7#1)(2008-10#1)
provide new insight into##4##4##(1991-5#1)(2007-7#1)(2008-10#1)(2012-1#1)
provide new insight##6##3##(1991-5#1)(1995-6#1)(2007-7#1)(2008-10#2)(2012-1#1)
provide new insights into the mechanisms##2##6##(2008-7#1)(2013-8#1)
provide new insights into the##8##5##(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-2#1)(2013-8#1)
provide new insights into##14##4##(2006-10#2)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#3)(2009-2#1)(2009-4#1)(2009-8#1)(2010-5#1)(2013-8#1)
provide new insights on the##3##5##(2008-10#1)(2008-7#1)(2013-8#1)
provide new insights##17##3##(2006-10#2)(2008-10#2)(2008-4#1)(2008-7#3)(2008-8#3)(2009-2#1)(2009-4#1)(2009-8#1)(2010-5#1)(2013-8#2)
provide new leads for##2##4##(2006-10#1)(2008-4#1)
provide new opportunities for##3##4##(2008-1#1)(2009-12#1)(2013-8#1)
provide new opportunities##4##3##(2006-1#1)(2008-1#1)(2009-12#1)(2013-8#1)
provide new possibilities##2##3##(2008-11#1)(2010-12#1)
provide new therapeutic##2##3##(2007-9#1)(2008-4#1)
provide new therapies for##2##4##(2006-10#1)(2007-11#1)
provide new understanding of##2##4##(2005-11#1)(2008-5#1)
provide new understanding##3##3##(2005-11#1)(2008-5#2)
provide new##81##2##(1990-4#1)(1991-5#1)(1991-7#2)(1992-1#1)(1992-7#1)(1993-2#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-6#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#3)(2008-7#5)(2008-8#4)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#4)
provide no evidence that##3##4##(1993-6#1)(1995-10#1)(2010-4#1)
provide no evidence##5##3##(1993-6#1)(1994-9#1)(1995-10#1)(2010-2#1)(2010-4#1)
provide no support for the##2##5##(2008-5#1)(2009-2#1)
provide no##13##2##(1992-6#1)(1993-6#1)(1993-7#1)(1994-9#1)(1995-10#1)(1995-6#1)(1997-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-6#1)(2010-2#1)(2010-4#1)
provide noninvasive##2##2##(2006-7#1)(2008-3#1)
provide normal##3##2##(2007-7#1)(2008-7#1)(2013-3#1)
provide not only the##2##4##(1991-2#1)(2012-2#1)
provide not only##5##3##(1991-2#1)(2008-10#1)(2010-12#1)(2010-3#1)(2012-2#1)
provide novel insights into the##2##5##(2010-12#1)(2013-8#1)
provide novel insights into##3##4##(2010-11#1)(2010-12#1)(2013-8#1)
provide novel##13##2##(1994-9#1)(2006-1#1)(2006-10#1)(2008-4#2)(2008-7#1)(2009-6#1)(2010-11#1)(2010-12#1)(2011-12#1)(2012-12#1)(2013-8#2)
provide objective##3##2##(1995-12#1)(2008-3#1)(2013-8#1)
provide one of the##4##4##(1992-1#1)(2008-10#1)(2012-2#1)(2012-3#1)
provide one##6##2##(1992-1#1)(1994-12#1)(2006-8#1)(2008-10#1)(2012-2#1)(2012-3#1)
provide only##8##2##(1990-8#1)(1994-2#1)(2005-9#1)(2006-1#1)(2007-9#1)(2008-3#1)(2010-1#1)(2012-2#1)
provide opportunities for the development of##2##6##(2006-10#1)(2008-6#1)
provide opportunities for the##3##4##(2006-10#1)(2006-5#1)(2008-6#1)
provide opportunities for##9##3##(1993-6#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-10#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-10#1)
provide opportunities to##5##3##(2006-7#1)(2007-12#1)(2008-10#1)(2009-9#1)(2013-1#1)
provide opportunities##14##2##(1993-6#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-9#1)(2010-10#1)(2013-1#1)
provide optimal##10##2##(1993-11#1)(2006-10#1)(2007-11#1)(2008-2#1)(2009-9#1)(2010-11#1)(2010-4#1)(2011-3#1)(2012-1#1)(2013-1#1)
provide optimum##2##2##(1996-12#1)(2008-8#1)
provide other##3##2##(2008-8#1)(2008-9#1)(2011-2#1)
provide parental care##2##3##(2008-8#2)
provide part of the##2##4##(2008-3#1)(2008-5#1)
provide partial support for##2##4##(1995-2#1)(2009-8#1)
provide patient##3##2##(2007-4#1)(2010-5#1)(2013-1#1)
provide patients with##7##3##(1993-2#1)(1995-9#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-7#1)(2010-12#1)
provide personal##2##2##(1996-1#1)(2010-8#1)
provide physiological##2##2##(2006-7#1)(2008-7#1)
provide plausible##2##2##(2010-4#1)(2012-3#1)
provide potential##5##2##(1996-1#1)(2008-1#1)(2008-2#1)(2008-4#1)(2010-11#1)
provide powerful tools for##2##4##(1994-3#1)(2009-2#1)
provide powerful##6##2##(1994-3#1)(2008-11#1)(2008-7#1)(2009-2#1)(2010-6#1)(2010-7#1)
provide practical considerations for##2##4##(2006-8#2)
provide practical##10##2##(1991-2#1)(1993-1#1)(1997-7#1)(2006-8#2)(2008-10#1)(2008-12#1)(2009-3#1)(2010-12#1)(2011-2#1)
provide precise##5##2##(2005-7#1)(2006-2#2)(2008-2#1)(2008-3#1)
provide preliminary evidence##3##3##(2008-12#2)(2012-1#1)
provide preliminary##6##2##(2004-9#1)(2008-12#2)(2011-1#1)(2011-2#1)(2012-1#1)
provide prenatal##2##2##(1994-3#1)(2010-7#1)
provide preventive##2##2##(1995-12#1)(2012-2#1)
provide primary care##3##3##(2007-10#1)(2010-4#1)(2010-8#1)
provide promising results##2##3##(2007-11#1)(2010-6#1)
provide promising##4##2##(2007-11#1)(2008-6#1)(2010-6#1)(2012-2#1)
provide proof of##2##3##(2006-2#1)(2012-1#1)
provide proof##3##2##(1996-12#1)(2006-2#1)(2012-1#1)
provide protection against##8##3##(1990-11#1)(1991-12#1)(1995-12#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-9#1)
provide protection from##2##3##(1996-9#1)(2012-11#1)
provide protection##17##2##(1990-11#1)(1991-12#1)(1993-3#1)(1995-12#1)(1996-9#1)(2006-10#2)(2007-11#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-11#1)(2013-1#1)
provide qualitative and quantitative##2##4##(1991-2#1)(2010-5#1)
provide qualitative##3##2##(1991-2#1)(1994-2#1)(2010-5#1)
provide quality##10##2##(1994-3#1)(1995-3#1)(1997-1#1)(2006-1#1)(2007-9#1)(2008-11#2)(2010-9#1)(2011-1#2)
provide quantitative estimates##2##3##(2006-11#1)(2008-11#1)
provide quantitative##12##2##(2006-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2010-12#1)(2011-2#1)(2012-2#1)(2013-7#1)
provide quick##3##2##(2008-3#1)(2011-12#1)(2012-2#1)
provide rapid##8##2##(2006-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)
provide rational##2##2##(1990-12#1)(2006-10#1)
provide real##2##2##(1995-6#1)(2008-10#1)
provide real-time##5##2##(2006-10#1)(2008-2#1)(2010-2#1)(2013-1#2)
provide realistic##3##2##(2007-1#1)(2007-4#1)(2012-1#1)
provide reasonable##3##2##(1996-2#1)(2008-3#1)(2008-5#1)
provide recommendations for future##2##4##(2008-11#1)(2008-8#1)
provide recommendations for the##2##4##(2008-3#1)(2008-5#1)
provide recommendations for##11##3##(2006-10#1)(2007-4#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2012-3#1)(2013-1#1)
provide recommendations##12##2##(1992-3#1)(2006-10#1)(2007-4#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2012-3#1)(2013-1#1)
provide reference for##2##3##(2005-12#1)(2011-2#1)
provide relevant information on the##2##5##(2008-7#1)(2013-1#1)
provide relevant##4##2##(2006-10#1)(2007-2#1)(2008-7#1)(2013-1#1)
provide reliable data##2##3##(1993-9#1)(2008-10#1)
provide reliable information##2##3##(1997-3#1)(2008-7#1)
provide reliable##11##2##(1990-6#1)(1993-9#1)(1994-9#2)(1997-3#1)(2008-10#2)(2008-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
provide relief of##2##3##(2008-9#1)(2011-1#1)
provide relief##3##2##(2007-11#1)(2008-9#1)(2011-1#1)
provide reproducible##2##2##(2008-11#1)(2008-9#1)
provide researchers##3##2##(2007-1#1)(2008-10#1)(2010-5#1)
provide resistance to##2##3##(1997-6#1)(2008-10#1)
provide resistance##3##2##(1997-6#1)(2008-10#1)(2012-1#1)
provide results##3##2##(2007-1#1)(2008-7#1)(2008-8#1)
provide rich##3##2##(2008-5#1)(2008-9#1)(2009-12#1)
provide robust##5##2##(2007-12#1)(2007-8#1)(2008-2#1)(2008-8#1)(2013-1#1)
provide safe##6##2##(1994-3#1)(2007-12#2)(2008-10#1)(2008-6#1)(2009-2#1)
provide satisfactory results##2##3##(2008-10#2)
provide satisfactory##7##2##(1993-2#1)(1996-12#1)(2006-10#1)(2006-12#1)(2008-10#2)(2008-3#1)
provide scientific##4##2##(2011-2#1)(2013-8#3)
provide sedation##2##2##(2006-10#2)
provide services that##2##3##(2008-11#1)(2010-3#1)
provide services##7##2##(1992-3#1)(1993-12#1)(1994-1#2)(2008-11#2)(2010-3#1)
provide several##4##2##(1997-7#1)(2005-8#1)(2012-1#1)(2013-1#1)
provide short-term##4##2##(2008-1#1)(2010-11#1)(2011-1#1)(2013-1#1)
provide significant protection##2##3##(1991-2#1)(1995-12#1)
provide significant##16##2##(1991-2#1)(1992-6#1)(1995-12#1)(2006-10#2)(2007-12#1)(2007-3#1)(2008-10#2)(2008-7#1)(2009-3#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
provide similar results##2##3##(2008-3#1)(2010-9#1)
provide similar##7##2##(1996-6#1)(2006-8#1)(2007-7#1)(2008-3#1)(2008-4#1)(2010-9#1)(2011-2#1)
provide social##3##2##(1992-1#1)(2006-2#1)(2007-9#1)
provide solid##3##2##(2005-8#1)(2007-9#1)(2013-8#1)
provide solutions##2##2##(2007-12#1)(2012-3#1)
provide some answers##2##3##(2005-7#1)(2012-2#1)
provide some basic information about##2##5##(2008-1#1)(2010-5#1)
provide some benefits##2##3##(2007-11#1)(2008-11#1)
provide some clues##2##3##(1991-6#1)(2009-8#1)
provide some evidence of##2##4##(2006-10#1)(2013-1#1)
provide some evidence##4##3##(1996-3#1)(2006-10#2)(2013-1#1)
provide some form of##2##4##(1991-3#1)(2012-3#1)
provide some relief##2##3##(2008-11#1)(2008-5#1)
provide some support##2##3##(1991-12#1)(2007-1#1)
provide some useful information##2##4##(2009-10#1)(2012-3#1)
provide some useful insights##2##4##(1997-3#1)(2008-11#1)
provide some useful##4##3##(1997-3#1)(2008-11#1)(2009-10#1)(2012-3#1)
provide some##51##2##(1991-12#1)(1991-3#1)(1991-6#1)(1993-12#1)(1993-5#1)(1993-7#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-4#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#2)(2009-2#1)(2009-4#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
provide spatial and##2##3##(2008-2#1)(2012-2#1)
provide spatial##4##2##(2008-2#1)(2008-3#1)(2008-7#1)(2012-2#1)
provide specific##4##2##(1991-2#1)(1996-12#1)(2008-4#1)(2013-1#1)
provide spectroscopic##2##2##(1991-2#1)(2006-12#1)
provide stability of the##2##4##(2005-7#2)
provide stability##5##2##(2005-7#2)(2006-8#1)(2008-9#1)(2012-1#1)
provide stabilization of the##2##4##(2012-1#1)(2012-12#1)
provide stabilization##3##2##(1997-7#1)(2012-1#1)(2012-12#1)
provide stable##2##2##(2008-4#1)(2009-1#1)
provide standard##2##2##(1996-3#1)(1997-8#1)
provide strong evidence for##6##4##(1990-11#1)(1990-5#1)(1995-2#1)(1997-3#1)(2006-1#1)(2006-10#1)
provide strong evidence that##6##4##(1990-7#1)(1990-8#1)(1996-8#1)(1997-4#2)(2013-8#1)
provide strong evidence##14##3##(1990-11#1)(1990-5#1)(1990-7#1)(1990-8#1)(1995-11#1)(1995-2#1)(1996-8#1)(1997-3#1)(1997-4#2)(2006-1#1)(2006-10#1)(2006-12#1)(2013-8#1)
provide strong statistical support for##3##5##(1994-3#1)(1997-4#1)(2008-8#1)
provide strong support for the##5##5##(2007-8#1)(2008-11#1)(2012-3#1)(2013-1#2)
provide strong support for##7##4##(1992-2#1)(2007-8#1)(2007-9#1)(2008-11#1)(2012-3#1)(2013-1#2)
provide strong support##8##3##(1990-3#1)(1992-2#1)(2007-8#1)(2007-9#1)(2008-11#1)(2012-3#1)(2013-1#2)
provide strong##28##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1992-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-8#1)(1997-3#1)(1997-4#3)(2006-1#1)(2006-10#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-8#1)(2011-1#2)(2012-3#1)(2013-1#2)(2013-8#1)
provide structural information##2##3##(2007-1#1)(2007-8#1)
provide structural support##2##3##(2006-12#1)(2012-1#1)
provide structural##7##2##(1990-4#1)(2006-12#1)(2007-1#1)(2007-8#1)(2008-8#1)(2010-10#1)(2012-1#1)
provide students with a##2##4##(2005-10#1)(2006-5#1)
provide students with the##2##4##(2005-10#1)(2008-11#1)
provide students with##6##3##(2005-10#2)(2006-5#1)(2008-11#1)(2008-12#1)(2011-1#1)
provide students##7##2##(1995-1#1)(2005-10#2)(2006-5#1)(2008-11#1)(2008-12#1)(2011-1#1)
provide substantial##5##2##(1990-11#1)(2008-3#1)(2010-12#1)(2011-1#1)(2011-2#1)
provide substantive##2##2##(2004-10#1)(2007-10#1)
provide such services##3##3##(1993-1#1)(2005-11#1)(2011-1#1)
provide such##12##2##(1993-1#1)(1994-3#1)(1996-3#1)(2005-11#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
provide sufficient information##2##3##(2007-10#1)(2013-8#1)
provide sufficient##17##2##(1992-9#1)(1993-6#1)(1993-8#1)(1994-12#1)(1997-1#1)(2005-8#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#2)(2013-8#1)
provide suggestions for##3##3##(2007-8#1)(2008-6#1)(2012-12#1)
provide suggestions##4##2##(2006-11#1)(2007-8#1)(2008-6#1)(2012-12#1)
provide suitable##3##2##(2006-5#1)(2007-8#1)(2008-6#1)
provide superior##6##2##(1994-1#2)(2004-7#1)(2008-10#1)(2013-1#2)
provide support and##2##3##(2008-1#1)(2012-12#1)
provide support for a##2##4##(1994-9#1)(2008-1#1)
provide support for the hypothesis that##3##6##(1993-2#1)(1994-8#1)(2013-8#1)
provide support for the hypothesis##4##5##(1993-2#1)(1994-8#1)(2008-10#1)(2013-8#1)
provide support for the use of##2##6##(2007-10#1)(2012-1#1)
provide support for the##14##4##(1993-2#1)(1994-8#1)(1995-1#1)(1995-8#1)(2005-8#1)(2006-5#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-3#1)(2012-1#2)(2013-8#1)
provide support for##26##3##(1993-2#1)(1993-4#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-8#1)(2005-8#1)(2006-5#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-8#1)
provide support to##5##3##(1994-12#1)(2007-2#1)(2008-8#1)(2010-5#1)(2013-8#1)
provide support##37##2##(1993-2#1)(1993-4#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-8#1)(2005-8#1)(2006-5#1)(2007-10#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-3#2)(2010-5#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-8#2)
provide supportive##3##2##(2007-3#1)(2008-8#1)(2013-7#1)
provide surgeons##2##2##(2007-12#1)(2012-12#1)
provide symptomatic##2##2##(1992-8#1)(2007-1#1)
provide systemic##4##2##(2005-8#1)(2008-10#1)(2008-6#1)(2012-2#1)
provide that##4##2##(1990-2#1)(1996-1#1)(1996-3#1)(2011-1#1)
provide the appropriate##2##3##(2012-12#1)(2013-1#1)
provide the basic##3##3##(1990-12#1)(2008-7#1)(2011-1#1)
provide the basis for a##3##5##(1990-2#1)(1993-6#1)(2007-12#1)
provide the basis for further##3##5##(1992-11#1)(2007-7#1)(2009-7#1)
provide the basis for its##2##5##(1993-6#1)(1994-8#1)
provide the basis for novel##2##5##(2005-7#1)(2008-4#1)
provide the basis for the##3##5##(2004-11#1)(2005-11#1)(2008-11#1)
provide the basis for##30##4##(1990-2#1)(1991-1#1)(1992-11#1)(1992-6#1)(1993-5#1)(1993-6#2)(1994-8#1)(2004-11#1)(2005-11#1)(2005-7#1)(2007-12#2)(2007-7#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-8#1)
provide the basis of##3##4##(2006-10#1)(2006-12#1)(2012-11#1)
provide the basis##33##3##(1990-2#1)(1991-1#1)(1992-11#1)(1992-6#1)(1993-5#1)(1993-6#2)(1994-8#1)(2004-11#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-7#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-6#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-8#1)
provide the best##18##3##(2004-12#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-8#1)(2010-11#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
provide the cells with a##2##5##(1994-8#1)(2008-11#1)
provide the clue to##2##4##(2008-4#1)(2012-2#1)
provide the critical##2##3##(2009-8#1)(2010-7#1)
provide the desired##3##3##(1990-5#1)(2009-9#1)(2010-8#1)
provide the evidence for##2##4##(2012-3#2)
provide the evidence##3##3##(2008-12#1)(2012-3#2)
provide the first demonstration of a##2##6##(1992-11#1)(1992-8#1)
provide the first demonstration that##2##5##(1991-8#1)(2008-10#1)
provide the first demonstration##5##4##(1991-8#1)(1992-11#1)(1992-8#1)(2008-10#1)(2008-8#1)
provide the first direct evidence that##2##6##(2007-7#1)(2008-10#1)
provide the first direct evidence##3##5##(1995-3#1)(2007-7#1)(2008-10#1)
provide the first direct##5##4##(1995-3#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-4#1)
provide the first evidence for a##2##6##(1995-6#1)(2012-12#1)
provide the first evidence for##3##5##(1994-3#1)(1995-6#1)(2012-12#1)
provide the first evidence of##3##5##(1991-3#1)(2008-1#1)(2011-2#1)
provide the first evidence that##9##5##(1990-7#1)(1991-10#1)(1991-7#1)(1994-5#1)(2008-5#1)(2010-11#1)(2010-2#1)(2013-1#1)(2013-7#1)
provide the first evidence##16##4##(1990-7#1)(1991-10#1)(1991-3#1)(1991-7#1)(1994-3#1)(1994-5#1)(1995-6#1)(1997-4#1)(2008-1#1)(2008-5#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
provide the first example of##3##5##(2006-5#1)(2010-12#1)(2012-12#1)
provide the first report##2##4##(1992-1#1)(2012-12#1)
provide the first##53##3##(1990-7#2)(1991-10#1)(1991-3#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-5#1)(1992-8#1)(1993-11#1)(1994-3#2)(1994-5#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-4#2)(2005-11#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-3#2)(2008-5#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-4#2)(2009-6#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#3)(2013-1#1)(2013-7#1)
provide the foundation for a##2##5##(2007-11#1)(2009-10#1)
provide the foundation for##6##4##(2007-11#1)(2008-5#2)(2008-9#1)(2009-10#1)(2012-2#1)
provide the foundation necessary##2##4##(1991-1#1)(2008-1#1)
provide the foundation##10##3##(1991-1#1)(1993-3#1)(2007-11#1)(2008-1#1)(2008-5#2)(2008-9#1)(2009-10#1)(2012-2#1)(2013-1#1)
provide the framework for##5##4##(1993-4#1)(2006-10#1)(2007-4#1)(2008-5#1)(2011-2#1)
provide the functional##2##3##(2006-8#1)(2009-8#1)
provide the greatest##5##3##(1993-6#1)(1995-12#1)(1996-3#1)(2008-10#1)(2008-4#1)
provide the highest sensitivity##2##4##(2008-10#1)(2008-3#1)
provide the highest##7##3##(1990-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2013-1#1)
provide the information##4##3##(1997-8#1)(2006-8#1)(2008-9#2)
provide the level of##2##4##(2009-4#1)(2009-7#1)
provide the maximum##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
provide the means for##3##4##(1992-6#1)(1994-2#1)(2008-3#1)
provide the means to##7##4##(1990-11#1)(1994-6#1)(2008-10#1)(2008-11#1)(2010-10#1)(2011-12#2)
provide the means##11##3##(1990-11#1)(1992-6#1)(1994-2#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-10#1)(2010-5#1)(2011-12#2)
provide the most convincing evidence##2##5##(2008-8#1)(2011-2#1)
provide the most effective##2##4##(1996-3#1)(2008-11#1)
provide the most##15##3##(1994-12#1)(1996-3#1)(1997-2#1)(2005-10#2)(2007-3#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-8#1)(2011-2#3)(2012-2#1)
provide the necessary##13##3##(1996-10#1)(1997-8#1)(2005-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)(2011-1#1)(2013-1#1)
provide the only##2##3##(1991-5#1)(2008-4#1)
provide the opportunity to##3##4##(1995-9#1)(2006-11#1)(2009-3#1)
provide the opportunity##5##3##(1992-9#1)(1995-9#1)(2006-11#1)(2009-3#1)(2011-2#1)
provide the optimum##2##3##(2007-10#1)(2007-7#1)
provide the possibility of##2##4##(2008-10#1)(2012-1#1)
provide the reader with an##4##5##(1997-3#1)(2007-7#1)(2008-10#1)(2009-12#1)
provide the reader with##9##4##(1997-3#1)(2006-9#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-12#1)(2009-5#1)(2010-9#1)(2013-8#1)
provide the required##3##3##(2005-5#1)(2008-1#1)(2008-2#1)
provide the same##4##3##(2006-6#1)(2007-2#1)(2008-10#1)(2008-2#1)
provide the structural##2##3##(2007-12#1)(2010-1#1)
provide the substrate for##2##4##(2008-4#1)(2011-2#1)
provide the surface##2##3##(2005-11#1)(2008-2#1)
provide the##364##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-3#2)(1991-5#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#4)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-3#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#3)(1997-8#3)(2004-11#1)(2004-12#1)(2005-10#2)(2005-11#4)(2005-12#1)(2005-2#1)(2005-3#1)(2005-5#3)(2005-7#1)(2006-10#6)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#5)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#7)(2007-2#6)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#4)(2007-8#3)(2008-1#5)(2008-10#21)(2008-11#9)(2008-12#1)(2008-2#14)(2008-3#10)(2008-4#11)(2008-5#12)(2008-6#2)(2008-7#5)(2008-8#9)(2008-9#6)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#5)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#6)(2011-10#1)(2011-12#2)(2011-2#11)(2011-3#2)(2012-1#3)(2012-11#2)(2012-12#8)(2012-2#9)(2012-3#4)(2013-1#7)(2013-7#3)(2013-8#4)
provide their##6##2##(1997-2#1)(2008-9#1)(2010-8#1)(2013-1#3)
provide them with##6##3##(2007-2#1)(2007-7#1)(2011-2#1)(2013-1#1)(2013-8#2)
provide them##7##2##(1992-12#1)(2007-2#1)(2007-7#1)(2011-2#1)(2013-1#1)(2013-8#2)
provide theoretical##2##2##(2005-7#1)(2008-3#1)
provide therapeutic##3##2##(2010-3#1)(2011-1#1)(2013-1#1)
provide these##5##2##(1995-1#1)(1997-1#1)(2007-2#1)(2011-2#1)(2013-8#1)
provide this##2##2##(2008-1#1)(2011-2#1)
provide three##5##2##(1991-2#1)(1991-3#1)(2008-7#1)(2012-1#2)
provide time##2##2##(1992-1#1)(1994-3#1)
provide timely##4##2##(1992-12#1)(1997-3#1)(2008-8#1)(2012-12#1)
provide tissue##3##2##(2006-10#1)(2006-9#1)(2009-9#1)
provide to##7##2##(1997-1#1)(2006-11#1)(2007-7#1)(2010-8#1)(2012-11#1)(2013-1#1)(2013-8#1)
provide tolerance##3##2##(2006-11#2)(2008-7#1)
provide tools to##3##3##(2008-11#1)(2012-12#2)
provide training##3##2##(2011-2#2)(2012-12#1)
provide treatment##2##2##(1992-9#1)(2007-2#1)
provide trophic support##2##3##(1991-12#1)(1991-3#1)
provide tunable##2##2##(2007-12#1)(2008-12#1)
provide two##6##2##(2007-3#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#1)(2012-2#1)
provide two-dimensional##2##2##(2006-4#1)(2008-2#1)
provide unequivocal##2##2##(2011-2#1)(2012-3#1)
provide unique opportunities for##2##4##(2010-5#1)(2013-1#1)
provide unique##10##2##(1990-7#1)(2008-1#2)(2008-3#1)(2008-9#1)(2010-5#1)(2012-11#2)(2012-2#1)(2013-1#1)
provide unprecedented##2##2##(2008-9#1)(2010-12#1)
provide us with a useful##2##5##(1991-4#1)(1997-5#1)
provide us with a##3##4##(1991-4#1)(1992-8#1)(1997-5#1)
provide us with##9##3##(1990-8#1)(1991-4#1)(1992-8#1)(1994-6#1)(1997-5#1)(2008-9#1)(2013-1#3)
provide us##11##2##(1990-8#1)(1991-4#1)(1992-8#1)(1994-6#1)(1997-5#1)(2007-11#1)(2008-12#1)(2008-9#1)(2013-1#3)
provide useful data##2##3##(1994-5#1)(2008-4#1)
provide useful information about the##2##5##(1991-2#1)(2008-9#1)
provide useful information about##4##4##(1991-2#1)(2008-5#1)(2008-9#1)(2011-1#1)
provide useful information for the##2##5##(2008-10#1)(2010-5#1)
provide useful information for##8##4##(1996-3#1)(2008-10#2)(2008-2#1)(2010-5#2)(2012-12#1)(2013-1#1)
provide useful information on the##3##5##(1996-6#1)(2009-5#1)(2012-2#1)
provide useful information on##5##4##(1996-6#1)(2008-6#1)(2008-7#1)(2009-5#1)(2012-2#1)
provide useful information##21##3##(1991-2#1)(1996-3#1)(1996-6#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-5#2)(2011-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
provide useful insights##2##3##(2009-6#1)(2012-1#1)
provide useful tools to##2##4##(2008-7#1)(2011-1#1)
provide useful tools##3##3##(2008-5#1)(2008-7#1)(2011-1#1)
provide useful##47##2##(1991-2#1)(1994-3#1)(1994-5#1)(1995-8#1)(1996-3#1)(1996-6#1)(2004-11#1)(2004-4#1)(2006-3#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-10#4)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#3)(2009-5#1)(2009-6#1)(2010-11#1)(2010-5#2)(2011-1#3)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#1)
provide valid##4##2##(1994-2#1)(1995-2#1)(1995-8#1)(2007-4#1)
provide valuable information about##5##4##(2005-11#1)(2008-11#1)(2008-4#1)(2009-4#1)(2010-8#1)
provide valuable information for##4##4##(1996-8#1)(1997-4#1)(2008-8#1)(2012-1#1)
provide valuable information in##2##4##(2007-10#1)(2011-2#1)
provide valuable information on##4##4##(2008-10#1)(2009-5#1)(2010-4#1)(2012-12#1)
provide valuable information to##2##4##(2012-12#1)(2013-8#1)
provide valuable information##19##3##(1996-12#1)(1996-8#1)(1997-4#1)(2005-11#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-4#2)(2009-5#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-8#1)
provide valuable insight##2##3##(2008-3#1)(2011-2#1)
provide valuable insights##2##3##(2008-2#1)(2012-3#1)
provide valuable prognostic##2##3##(2008-6#1)(2010-5#1)
provide valuable##38##2##(1991-10#1)(1995-1#1)(1996-12#1)(1996-8#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-5#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2009-5#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
provide various##3##2##(2008-11#1)(2008-5#1)(2010-4#1)
provide very##4##2##(2008-4#2)(2010-2#1)(2011-2#1)
provide visual##2##2##(2008-10#1)(2009-12#1)
provide ways##2##2##(2006-5#1)(2008-12#1)
provide working##2##2##(2012-2#1)(2013-7#1)
provide##4622##1##(1990-1#1)(1990-10#6)(1990-11#15)(1990-12#9)(1990-2#6)(1990-3#6)(1990-4#5)(1990-5#9)(1990-6#3)(1990-7#12)(1990-8#10)(1991-1#10)(1991-10#5)(1991-11#12)(1991-12#22)(1991-2#20)(1991-3#9)(1991-4#6)(1991-5#9)(1991-6#9)(1991-7#11)(1991-8#9)(1991-9#5)(1992-1#11)(1992-10#3)(1992-11#7)(1992-12#13)(1992-2#16)(1992-3#24)(1992-4#7)(1992-5#2)(1992-6#13)(1992-7#5)(1992-8#11)(1992-9#11)(1993-1#8)(1993-10#2)(1993-11#13)(1993-12#29)(1993-2#17)(1993-3#14)(1993-4#4)(1993-5#3)(1993-6#13)(1993-7#5)(1993-8#6)(1993-9#9)(1994-1#6)(1994-10#1)(1994-11#12)(1994-12#20)(1994-2#19)(1994-3#35)(1994-5#10)(1994-6#12)(1994-7#1)(1994-8#23)(1994-9#16)(1995-1#21)(1995-10#3)(1995-11#9)(1995-12#17)(1995-2#27)(1995-3#29)(1995-4#3)(1995-5#9)(1995-6#9)(1995-7#6)(1995-8#21)(1995-9#7)(1996-1#19)(1996-10#9)(1996-11#11)(1996-12#20)(1996-2#22)(1996-3#30)(1996-4#11)(1996-5#12)(1996-6#5)(1996-7#6)(1996-8#8)(1996-9#8)(1997-1#16)(1997-2#20)(1997-3#22)(1997-4#23)(1997-5#5)(1997-6#13)(1997-7#15)(1997-8#25)(2004-10#2)(2004-11#5)(2004-12#2)(2004-2#4)(2004-3#1)(2004-4#2)(2004-7#2)(2004-8#1)(2004-9#8)(2005-10#10)(2005-11#27)(2005-12#3)(2005-2#2)(2005-3#3)(2005-5#5)(2005-6#1)(2005-7#18)(2005-8#19)(2005-9#3)(2006-1#10)(2006-10#112)(2006-11#18)(2006-12#36)(2006-2#20)(2006-3#7)(2006-4#11)(2006-5#32)(2006-6#17)(2006-7#16)(2006-8#24)(2006-9#8)(2007-1#25)(2007-10#26)(2007-11#70)(2007-12#98)(2007-2#43)(2007-3#12)(2007-4#27)(2007-5#18)(2007-6#10)(2007-7#19)(2007-8#46)(2007-9#27)(2008-1#52)(2008-10#225)(2008-11#148)(2008-12#41)(2008-2#117)(2008-3#138)(2008-4#114)(2008-5#74)(2008-6#36)(2008-7#142)(2008-8#77)(2008-9#90)(2009-1#1)(2009-10#27)(2009-11#17)(2009-12#16)(2009-2#22)(2009-3#22)(2009-4#25)(2009-5#30)(2009-6#15)(2009-7#19)(2009-8#28)(2009-9#30)(2010-1#8)(2010-10#27)(2010-11#27)(2010-12#51)(2010-2#30)(2010-3#20)(2010-4#26)(2010-5#27)(2010-6#16)(2010-7#18)(2010-8#31)(2010-9#17)(2011-1#87)(2011-10#2)(2011-11#1)(2011-12#16)(2011-2#129)(2011-3#4)(2011-7#3)(2012-1#61)(2012-11#23)(2012-12#95)(2012-2#146)(2012-3#73)(2012-5#1)(2012-9#1)(2013-1#160)(2013-3#1)(2013-7#17)(2013-8#77)
provided a basis for##2##4##(2006-10#1)(2008-11#1)
provided a better understanding of the##2##6##(2006-10#1)(2008-1#1)
provided a better understanding of##3##5##(1996-5#1)(2006-10#1)(2008-1#1)
provided a better##8##3##(1996-5#1)(2006-10#1)(2008-1#1)(2008-10#2)(2009-8#1)(2011-12#1)(2012-2#1)
provided a clear##2##3##(2007-9#1)(2008-11#1)
provided a convenient##2##3##(2008-1#1)(2008-7#1)
provided a direct##2##3##(1995-3#1)(2009-12#1)
provided a faster##2##3##(2005-9#1)(2008-10#1)
provided a forum for##2##4##(2005-7#1)(2008-5#1)
provided a forum##3##3##(2005-7#1)(2008-11#1)(2008-5#1)
provided a good fit to the##2##6##(2007-12#1)(2008-10#1)
provided a good##7##3##(1994-2#1)(1997-1#1)(2006-9#1)(2007-12#1)(2008-10#2)(2008-7#1)
provided a higher##2##3##(1992-8#1)(2012-2#1)
provided a limit of detection of##2##6##(2008-10#1)(2013-7#1)
provided a linear##4##3##(1990-6#1)(2008-10#3)
provided a more accurate##2##4##(2008-10#1)(2012-3#1)
provided a more##6##3##(1996-3#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2012-3#1)
provided a novel##3##3##(1996-12#1)(2008-8#1)(2013-1#1)
provided a number of##2##4##(2006-9#1)(2012-3#1)
provided a picture of##2##4##(2008-7#2)
provided a possible##2##3##(1993-12#1)(2008-10#1)
provided a powerful##3##3##(1993-9#1)(1996-12#1)(2005-7#1)
provided a rapid and##2##4##(1995-9#1)(2007-12#1)
provided a rapid##3##3##(1995-9#1)(2007-12#1)(2008-10#1)
provided a rational##2##3##(2007-11#1)(2007-12#1)
provided a reference for##2##4##(2008-10#1)(2012-12#1)
provided a reliable##2##3##(2008-10#2)
provided a rich##2##3##(1993-1#1)(2006-9#1)
provided a sensitive##2##3##(2008-10#2)
provided a significant##3##3##(2008-10#2)(2009-8#1)
provided a significantly##2##3##(2008-10#1)(2011-1#1)
provided a simple##4##3##(1994-9#1)(2006-12#1)(2008-10#1)(2011-1#1)
provided a slow##2##3##(2008-5#1)(2011-2#1)
provided a source of##2##4##(2008-10#1)(2010-4#1)
provided a stable##2##3##(1994-9#1)(2007-8#1)
provided a statistically significant##2##4##(2008-5#1)(2010-9#1)
provided a suitable##2##3##(2007-8#1)(2012-12#1)
provided a total##2##3##(2008-11#1)(2008-8#1)
provided a unique opportunity to##3##5##(1991-8#1)(2008-10#1)(2008-2#1)
provided a unique opportunity##4##4##(1991-8#1)(2007-11#1)(2008-10#1)(2008-2#1)
provided a unique##6##3##(1991-8#1)(1993-3#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-2#1)
provided a useful##3##3##(2008-3#1)(2009-9#1)(2012-3#1)
provided a variety of##3##4##(2008-12#1)(2011-1#1)(2013-8#1)
provided a very##3##3##(2006-4#1)(2007-11#1)(2013-8#1)
provided a##207##2##(1990-6#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#2)(1994-2#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-12#3)(1996-3#1)(1996-5#2)(1996-7#1)(1997-1#2)(1997-2#1)(1997-7#1)(1997-8#1)(2005-10#2)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#6)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-8#1)(2006-9#3)(2007-10#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-7#2)(2007-8#4)(2007-9#3)(2008-1#4)(2008-10#39)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#5)(2008-7#6)(2008-8#5)(2008-9#1)(2009-12#2)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#3)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#2)
provided about the##3##3##(1996-5#1)(2006-10#1)(2006-3#1)
provided about##6##2##(1995-4#1)(1996-5#1)(2006-10#1)(2006-3#1)(2007-12#1)(2012-12#1)
provided access to a##3##4##(2007-12#1)(2009-4#1)(2010-12#1)
provided access to##5##3##(2006-12#1)(2007-12#1)(2009-4#1)(2010-12#1)(2012-3#1)
provided accurate predictions of##2##4##(2008-10#2)
provided accurate##3##2##(2006-12#1)(2008-10#2)
provided additional evidence##5##3##(1994-7#1)(1996-8#1)(2007-10#1)(2008-11#1)(2010-2#1)
provided additional information##3##3##(1997-1#1)(2011-2#1)(2013-1#1)
provided additional##11##2##(1994-7#1)(1996-8#1)(1997-1#1)(2007-10#1)(2008-10#1)(2008-11#1)(2009-3#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-1#1)
provided adequate##5##2##(2006-4#1)(2007-7#1)(2008-6#1)(2011-1#1)(2011-2#1)
provided after##3##2##(2008-10#1)(2008-8#2)
provided along with##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
provided also##2##2##(2005-8#1)(2006-6#1)
provided an accurate##2##3##(1996-6#1)(2008-10#1)
provided an estimate of the##2##5##(1990-5#1)(2008-10#1)
provided an excellent##4##3##(2004-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
provided an indication of##2##4##(2007-6#1)(2008-10#1)
provided an opportunity for##7##4##(2006-2#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-9#1)
provided an opportunity to##9##4##(1991-8#1)(2004-11#1)(2005-11#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-8#1)(2012-1#1)
provided an opportunity##16##3##(1991-8#1)(2004-11#1)(2005-11#1)(2006-2#1)(2006-7#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-8#1)(2010-9#1)(2012-1#1)
provided an overview of##2##4##(2004-12#1)(2005-7#1)
provided an##48##2##(1990-5#1)(1991-8#1)(1994-6#1)(1995-6#1)(1996-6#1)(1997-6#1)(2004-11#1)(2004-12#1)(2004-7#1)(2005-11#1)(2005-7#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#3)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
provided and the##3##3##(2006-1#1)(2007-12#1)(2009-10#1)
provided and##17##2##(1991-11#1)(1994-4#1)(2005-10#1)(2006-1#1)(2006-11#1)(2007-12#2)(2008-11#4)(2008-2#1)(2008-3#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-1#1)
provided any evidence for##2##4##(1995-11#1)(2007-8#1)
provided any##3##2##(1995-11#1)(2007-8#1)(2008-6#1)
provided as a##2##3##(2007-11#1)(2008-4#1)
provided as an##2##3##(1996-11#1)(2008-4#1)
provided as##8##2##(1991-12#1)(1996-11#1)(2005-5#1)(2007-11#1)(2008-4#3)(2010-2#1)
provided at the##6##3##(2006-8#1)(2007-11#1)(2008-1#1)(2009-8#1)(2013-1#1)(2013-8#1)
provided at##13##2##(1997-8#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#2)
provided based on##2##3##(2007-4#1)(2008-10#1)
provided baseline##2##2##(2008-4#1)(2009-4#1)
provided better##9##2##(1996-6#1)(2006-6#1)(2007-7#1)(2008-1#1)(2008-10#2)(2011-2#1)(2012-2#1)(2012-3#1)
provided both##2##2##(1995-12#1)(2008-10#1)
provided by Genetic Analysis Workshop 17##3##6##(2012-3#3)
provided by Trichoderma spp##2##4##(2008-10#2)
provided by a moving##2##4##(1996-1#1)(2007-8#1)
provided by a##29##3##(1990-12#1)(1993-2#1)(1995-2#1)(1996-1#1)(1997-2#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-12#3)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#2)(2009-10#1)(2009-2#1)(2010-10#1)(2011-1#1)(2013-1#1)
provided by an##8##3##(1997-3#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-8#1)(2010-8#1)
provided by both##4##3##(2008-1#1)(2008-11#1)(2011-2#2)
provided by dental##2##3##(2006-2#1)(2013-8#1)
provided by different##5##3##(1996-1#1)(1997-7#1)(2007-1#2)(2008-2#1)
provided by either##3##3##(1992-6#1)(2007-12#1)(2007-9#1)
provided by its##2##3##(1997-2#1)(2008-10#1)
provided by local##2##3##(1991-6#1)(1995-12#1)
provided by physicians##2##3##(2010-2#1)(2012-3#1)
provided by synchrotron##2##3##(2008-10#1)(2008-3#1)
provided by the AOAC 920##4##5##(2008-10#4)
provided by the National##2##4##(2012-1#1)(2013-8#1)
provided by the identification of##2##5##(2007-7#1)(2012-3#1)
provided by the original##2##4##(2008-2#1)(2013-8#1)
provided by the same##3##4##(2006-11#1)(2013-1#2)
provided by the##135##3##(1990-12#1)(1990-5#2)(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-3#1)(1994-1#1)(1994-8#2)(1994-9#2)(1995-1#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-7#1)(1997-9#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-11#3)(2006-12#3)(2007-11#8)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#19)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#5)
provided by their##2##3##(2008-8#1)(2013-8#1)
provided by these##4##3##(1992-1#1)(1994-3#1)(2007-7#1)(2013-1#1)
provided by this##8##3##(2007-12#1)(2007-4#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#1)(2011-3#1)
provided by traditional##2##3##(1997-2#1)(2006-10#1)
provided by##377##2##(1990-12#3)(1990-5#3)(1990-6#2)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-1#2)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-1#1)(1994-2#3)(1994-3#3)(1994-8#4)(1994-9#2)(1995-1#1)(1995-12#2)(1995-2#1)(1996-1#5)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#6)(1997-3#1)(1997-6#1)(1997-7#4)(1997-9#1)(2005-10#1)(2005-11#3)(2005-3#1)(2005-7#2)(2006-1#2)(2006-10#7)(2006-11#3)(2006-12#4)(2006-2#1)(2007-1#2)(2007-10#4)(2007-11#9)(2007-12#13)(2007-4#3)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#5)(2008-10#45)(2008-11#10)(2008-12#3)(2008-2#10)(2008-3#12)(2008-4#6)(2008-5#7)(2008-6#4)(2008-7#12)(2008-8#7)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#2)(2009-6#2)(2009-8#3)(2009-9#2)(2010-10#1)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#10)(2010-9#1)(2011-1#9)(2011-2#6)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#6)(2012-2#3)(2012-3#12)(2013-1#18)(2013-7#1)(2013-8#8)
provided care##3##2##(1990-11#1)(1990-5#1)(2008-7#1)
provided clear evidence##3##3##(2007-10#1)(2007-12#1)(2010-2#1)
provided clear##6##2##(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-2#1)
provided complementary information##2##3##(1992-2#1)(2008-10#1)
provided complementary##4##2##(1992-1#1)(1992-2#1)(2006-4#1)(2008-10#1)
provided complete protection##2##3##(1995-7#1)(2010-3#1)
provided complete##6##2##(1993-2#1)(1995-7#1)(2008-5#1)(2008-7#1)(2010-3#1)(2012-2#1)
provided comprehensive information##2##3##(2005-8#1)(2008-1#1)
provided comprehensive##3##2##(2005-8#1)(2005-9#1)(2008-1#1)
provided continuous##2##2##(2008-3#1)(2009-8#1)
provided convincing evidence##2##3##(1990-11#1)(2012-2#1)
provided data for##4##3##(2006-1#1)(2007-2#1)(2010-12#1)(2013-8#1)
provided data on##4##3##(2006-10#1)(2007-11#1)(2012-3#1)(2013-8#1)
provided data that##2##3##(2005-7#1)(2009-10#1)
provided data##14##2##(2005-7#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-3#1)(2009-10#1)(2009-12#1)(2010-12#2)(2011-2#1)(2012-3#1)(2013-8#2)
provided detailed##2##2##(1996-10#1)(2013-1#1)
provided direct evidence for the##2##5##(2008-9#1)(2013-8#1)
provided direct##4##2##(2008-9#1)(2009-9#1)(2010-11#1)(2013-8#1)
provided during the##2##3##(2007-7#1)(2008-5#1)
provided during##5##2##(1992-12#1)(1993-2#1)(2007-7#1)(2008-10#1)(2008-5#1)
provided each##2##2##(1995-2#1)(2008-5#1)
provided effective##4##2##(1993-4#1)(2007-11#1)(2008-10#1)(2013-7#1)
provided efficient##3##2##(2007-11#1)(2008-11#1)(2012-12#1)
provided either by##2##3##(2008-4#1)(2012-3#1)
provided either##4##2##(2004-11#1)(2008-4#1)(2008-5#1)(2012-3#1)
provided encouraging results##2##3##(1992-9#1)(2010-2#1)
provided equivalent##2##2##(1996-1#1)(1996-10#1)
provided estimates##2##2##(1991-5#1)(2008-9#1)
provided evidence consistent with##2##4##(1996-3#1)(2009-1#1)
provided evidence for a##4##4##(1991-2#1)(1991-3#1)(1992-2#1)(2012-3#1)
provided evidence for the presence of##2##6##(1994-11#1)(2005-11#1)
provided evidence for the##4##4##(1994-11#1)(1994-5#1)(2005-11#1)(2010-5#1)
provided evidence for##13##3##(1991-2#1)(1991-3#1)(1992-2#1)(1994-11#1)(1994-5#1)(1995-1#1)(1995-3#2)(1996-5#1)(2005-11#1)(2009-11#1)(2010-5#1)(2012-3#1)
provided evidence of the##3##4##(1995-12#1)(2005-10#1)(2010-12#1)
provided evidence of##16##3##(1991-11#1)(1994-1#1)(1995-12#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
provided evidence supporting the##2##4##(2008-12#1)(2008-8#1)
provided evidence that the##6##4##(1991-2#1)(1992-3#1)(2007-6#1)(2008-10#1)(2009-11#1)(2010-11#1)
provided evidence that##20##3##(1991-2#1)(1992-12#1)(1992-3#1)(1992-7#1)(2006-7#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-9#1)(2009-11#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-11#1)
provided evidence##55##2##(1991-11#1)(1991-2#2)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-7#1)(1994-1#1)(1994-11#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-3#2)(1996-3#1)(1996-5#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#2)(2009-6#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
provided examples##2##2##(2009-10#1)(2010-10#1)
provided excellent##9##2##(1990-12#1)(1995-12#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)
provided experimental evidence of##2##4##(2008-9#1)(2011-1#1)
provided experimental##4##2##(2008-3#1)(2008-9#1)(2010-12#1)(2011-1#1)
provided facilities to##2##3##(2008-10#2)
provided facilities##3##2##(1992-5#1)(2008-10#2)
provided for a##10##3##(1992-2#1)(1993-1#1)(1995-3#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)(2012-11#1)
provided for all##3##3##(1996-3#1)(2010-2#1)(2011-2#1)
provided for assessing##3##3##(2006-11#1)(2008-4#2)
provided for both##5##3##(2007-9#1)(2008-4#3)(2008-7#1)
provided for detecting##2##3##(1992-2#1)(2008-1#1)
provided for determining the##2##4##(2008-4#2)
provided for determining##3##3##(2008-4#3)
provided for each##3##3##(2007-7#1)(2008-2#1)(2008-4#1)
provided for parents##2##3##(1990-12#1)(2010-10#1)
provided for preparation of##2##4##(2008-4#1)(2008-9#1)
provided for purification of##2##4##(2008-4#2)
provided for screening##3##3##(2008-4#2)(2008-9#1)
provided for the##17##3##(1997-3#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-2#1)(2008-2#1)(2008-4#9)(2008-5#1)(2008-7#1)
provided for three##2##3##(2008-9#1)(2012-1#1)
provided for##144##2##(1990-12#1)(1990-3#1)(1991-2#1)(1992-2#2)(1993-1#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-10#3)(2006-11#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#5)(2008-11#1)(2008-2#6)(2008-3#3)(2008-4#58)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#8)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#2)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#2)
provided free##3##2##(1996-1#1)(2007-2#1)(2007-7#1)
provided from##2##2##(2008-11#1)(2008-12#1)
provided full##2##2##(1996-8#1)(2008-5#1)
provided functional information##2##3##(1994-6#1)(2008-4#1)
provided further evidence for the##2##5##(1994-9#1)(2008-10#1)
provided further evidence for##3##4##(1992-5#1)(1994-9#1)(2008-10#1)
provided further evidence of##2##4##(2008-10#1)(2012-12#1)
provided further evidence##7##3##(1992-5#1)(1994-9#1)(2008-10#2)(2009-9#1)(2011-2#1)(2012-12#1)
provided further##13##2##(1990-7#1)(1992-5#1)(1994-9#1)(2006-10#2)(2008-10#2)(2008-12#1)(2009-8#1)(2009-9#1)(2011-2#2)(2012-12#1)
provided good##11##2##(2006-8#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#1)(2009-11#1)(2009-3#1)(2012-1#1)(2012-12#1)
provided greater##2##2##(1996-3#1)(2008-6#1)
provided guidance##2##2##(2008-11#1)(2013-1#1)
provided here##5##2##(1997-2#1)(1997-4#1)(2008-4#2)(2012-2#1)
provided herein##3##2##(1992-1#1)(2008-5#1)(2008-7#1)
provided high sensitivity##2##3##(2008-10#2)
provided high##4##2##(2008-10#2)(2008-3#1)(2011-2#1)
provided higher##3##2##(2008-10#1)(2008-5#1)(2010-4#1)
provided highly##3##2##(2007-12#1)(2008-10#1)(2012-3#1)
provided important clues about the##2##5##(1991-2#1)(2008-4#1)
provided important clues##3##3##(1991-2#1)(2008-4#1)(2008-9#1)
provided important information for##2##4##(1994-8#1)(2007-11#1)
provided important information on##2##4##(1993-10#1)(2007-6#1)
provided important information##8##3##(1992-11#1)(1993-10#1)(1994-8#1)(2005-8#1)(2006-9#1)(2007-11#2)(2007-6#1)
provided important##15##2##(1991-2#1)(1992-11#1)(1993-10#1)(1994-8#1)(1996-3#1)(1997-3#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-11#2)(2007-6#1)(2008-3#1)(2008-4#1)(2008-9#1)
provided in detail##2##3##(2008-9#2)
provided in other##2##3##(1996-2#1)(2009-8#1)
provided in the literature##2##4##(2007-1#1)(2008-11#1)
provided in the##19##3##(1994-3#2)(2004-10#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#2)(2008-9#1)(2011-2#1)(2012-12#1)
provided in this unit for##4##5##(2008-2#1)(2008-4#3)
provided in this unit##10##4##(2008-2#2)(2008-4#7)(2008-9#1)
provided in this##16##3##(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#8)(2008-9#1)(2012-1#1)
provided in which##2##3##(2008-2#1)(2008-4#1)
provided in##67##2##(1990-3#1)(1992-3#1)(1994-12#1)(1994-3#2)(1996-2#1)(1997-1#1)(2004-10#1)(2004-3#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#1)(2008-1#2)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#12)(2008-8#1)(2008-9#5)(2009-2#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#2)(2013-8#1)
provided including##2##2##(2008-11#2)
provided information about the##2##4##(2008-11#1)(2010-4#1)
provided information about their##2##4##(1993-1#1)(2013-8#1)
provided information about##5##3##(1993-1#1)(2006-12#1)(2008-11#1)(2010-4#1)(2013-8#1)
provided information on the##6##4##(1991-11#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-10#2)
provided information on##10##3##(1991-11#1)(1994-2#1)(1996-9#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-10#2)
provided information##19##2##(1991-11#1)(1993-1#1)(1994-2#1)(1996-8#1)(1996-9#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2010-4#1)(2013-1#2)(2013-8#1)
provided insight into the##3##4##(2007-11#1)(2007-12#1)(2009-3#1)
provided insight into##7##3##(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-11#1)(2009-3#1)
provided insight##8##2##(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-11#1)(2009-3#1)
provided insights into how##3##4##(2006-10#2)(2009-4#1)
provided insights into the##6##4##(2007-11#1)(2008-4#1)(2009-11#1)(2011-1#1)(2013-1#2)
provided insights into##12##3##(2006-10#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-9#1)(2009-11#1)(2009-4#1)(2011-1#1)(2013-1#2)
provided insights##15##2##(2006-10#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-1#1)(2011-1#1)(2012-2#1)(2013-1#3)
provided interesting##5##2##(1990-8#1)(2006-10#2)(2007-10#1)(2013-1#1)
provided is##7##2##(1995-12#1)(2008-2#1)(2008-4#3)(2008-9#1)(2009-10#1)
provided it is done##2##4##(2008-11#1)(2011-2#1)
provided it is##3##3##(1994-2#1)(2008-11#1)(2011-2#1)
provided limited##2##2##(1992-3#1)(2011-2#1)
provided little or no##2##4##(1991-12#1)(1996-9#1)
provided little##4##2##(1990-5#1)(1991-12#1)(1992-5#1)(1996-9#1)
provided long-term##2##2##(2006-11#1)(2008-7#1)
provided many##3##2##(2006-12#1)(2007-9#1)(2012-2#1)
provided more##17##2##(1992-3#1)(1994-1#1)(1997-2#1)(2007-2#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-6#1)(2009-10#1)(2009-8#1)(2010-2#1)(2012-11#2)
provided much information on##2##4##(2008-6#1)(2010-8#1)
provided much##3##2##(2007-12#1)(2008-6#1)(2010-8#1)
provided new evidence##2##3##(1996-7#1)(2008-9#1)
provided new insight into the##3##5##(1993-2#1)(2006-2#1)(2010-8#1)
provided new insight into##5##4##(1993-2#1)(2006-2#1)(2008-4#1)(2010-4#1)(2010-8#1)
provided new insight##6##3##(1993-2#1)(1996-8#1)(2006-2#1)(2008-4#1)(2010-4#1)(2010-8#1)
provided new insights into the##7##5##(1997-8#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2011-1#1)
provided new insights into##10##4##(1997-8#1)(2006-10#2)(2006-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2011-1#1)
provided new insights##13##3##(1997-8#1)(2006-10#2)(2006-11#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2010-8#1)(2011-1#1)(2011-2#1)
provided new##30##2##(1993-2#2)(1996-7#1)(1996-8#1)(1997-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-4#2)(2008-9#1)(2009-9#1)(2010-12#1)(2010-4#2)(2010-8#2)(2011-1#1)(2011-2#1)
provided no evidence of##3##4##(1991-12#1)(1992-5#1)(1995-7#1)
provided no evidence##4##3##(1991-12#1)(1992-5#1)(1995-7#1)(1997-2#1)
provided no##13##2##(1991-12#1)(1992-5#1)(1993-7#1)(1994-11#1)(1995-7#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-11#1)(2013-1#1)
provided novel insights##2##3##(2008-3#1)(2011-1#1)
provided novel##3##2##(2006-10#1)(2008-3#1)(2011-1#1)
provided of##7##2##(1997-2#1)(1997-7#1)(2005-7#1)(2007-11#1)(2007-12#1)(2010-11#1)(2013-8#1)
provided on a##3##3##(1994-3#1)(2011-1#1)(2012-12#1)
provided on the##6##3##(2007-5#1)(2008-4#1)(2008-7#1)(2010-2#1)(2010-5#1)(2010-8#1)
provided on##13##2##(1994-3#1)(2005-7#1)(2006-10#1)(2007-5#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-2#2)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#1)
provided one of##2##3##(1995-6#1)(2008-5#1)
provided only##8##2##(2006-5#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-6#1)
provided over##2##2##(2008-12#1)(2013-1#1)
provided palliative care##2##3##(2007-6#1)(2012-3#1)
provided physiotherapy for##2##3##(2012-12#2)
provided physiotherapy students##2##3##(2012-12#2)
provided physiotherapy##6##2##(2012-12#6)
provided preliminary##2##2##(2007-5#1)(2010-11#1)
provided protection against the##2##4##(1996-10#1)(2013-8#1)
provided protection against##3##3##(1996-10#1)(2008-2#1)(2013-8#1)
provided quantitative##3##2##(2007-8#1)(2010-10#1)(2012-1#1)
provided regarding##4##2##(2008-12#1)(2008-4#3)
provided reliable and##2##3##(2008-12#1)(2013-8#1)
provided reliable##6##2##(2006-3#1)(2008-10#1)(2008-12#1)(2010-2#1)(2013-8#2)
provided remarkably##2##2##(1996-2#1)(2007-11#1)
provided results between##2##3##(2008-10#2)
provided results in##2##3##(1993-1#1)(2008-10#1)
provided results##8##2##(1993-1#1)(2008-10#4)(2011-2#1)(2012-2#1)(2013-8#1)
provided satisfactory results##4##3##(2008-10#3)(2013-1#1)
provided satisfactory##8##2##(2007-7#1)(2007-8#1)(2008-10#3)(2011-2#2)(2013-1#1)
provided sensitive and##2##3##(1994-4#1)(2007-8#1)
provided sensitive##3##2##(1994-4#1)(2007-8#2)
provided services and##2##3##(1992-12#1)(2006-2#1)
provided services##3##2##(1992-12#1)(2006-2#1)(2008-6#1)
provided significant improvement##2##3##(2008-5#1)(2013-1#1)
provided significant protection against##2##4##(1995-12#1)(2008-10#1)
provided significant protection##4##3##(1992-6#1)(1995-12#1)(2008-10#2)
provided significant##13##2##(1992-6#1)(1995-12#1)(1997-7#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-7#1)(2009-4#1)(2013-1#1)(2013-8#1)
provided significantly better##2##3##(1991-2#1)(2008-10#1)
provided similar results##3##3##(2009-6#2)(2010-12#1)
provided similar##6##2##(2008-7#1)(2009-3#1)(2009-6#2)(2010-12#1)(2010-8#1)
provided so##2##2##(2008-4#1)(2012-1#1)
provided some insight into##3##4##(2007-12#1)(2008-9#1)(2012-2#1)
provided some support for the##2##5##(2007-1#1)(2011-1#1)
provided some##14##2##(1994-1#1)(1994-11#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-9#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
provided stable##2##2##(1997-1#1)(2007-8#1)
provided statistically significant results##2##4##(2012-3#2)
provided statistically##3##2##(2008-10#1)(2012-3#2)
provided strong evidence that##2##4##(1997-8#1)(2006-8#1)
provided strong evidence##3##3##(1997-8#1)(2006-8#1)(2007-12#1)
provided strong##4##2##(1997-8#1)(2006-8#1)(2007-12#1)(2008-12#1)
provided substantial##2##2##(2007-1#1)(2008-7#1)
provided sufficient##3##2##(2005-7#1)(2007-8#1)(2012-2#1)
provided support for##2##3##(2010-3#1)(2010-4#1)
provided support to##3##3##(2008-12#1)(2008-7#1)(2010-3#1)
provided support##5##2##(2008-12#1)(2008-7#1)(2010-3#2)(2010-4#1)
provided that a##6##3##(1991-6#2)(1994-5#1)(2007-7#1)(2008-3#1)(2008-9#1)
provided that adequate##2##3##(1992-2#1)(1994-2#1)
provided that all##2##3##(2008-3#1)(2008-4#1)
provided that an##2##3##(2005-7#1)(2007-11#1)
provided that any##2##3##(1990-6#1)(1996-9#1)
provided that some##2##3##(2008-3#1)(2012-1#1)
provided that species##2##3##(2008-8#2)
provided that the product##2##4##(2008-11#1)(2008-3#1)
provided that the##33##3##(1990-11#1)(1990-4#1)(1990-7#1)(1991-1#1)(1992-1#1)(1995-11#1)(1995-6#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#8)(2008-8#2)(2009-11#1)(2010-12#1)(2012-1#1)(2012-2#1)
provided that##95##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-5#1)(1991-6#2)(1992-1#1)(1992-2#1)(1993-3#1)(1993-5#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-6#1)(1995-9#1)(1996-4#1)(1996-7#1)(1996-9#2)(1997-6#1)(1997-7#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-2#6)(2008-3#13)(2008-4#4)(2008-7#2)(2008-8#6)(2008-9#3)(2009-11#2)(2009-2#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-2#3)(2013-8#1)
provided the basis for a##2##5##(2006-10#1)(2010-2#1)
provided the basis for##9##4##(2004-11#1)(2005-11#1)(2005-7#1)(2006-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-5#1)
provided the best fit##4##4##(2008-10#3)(2012-1#1)
provided the best model##2##4##(2008-10#1)(2012-1#1)
provided the best protection##2##4##(2008-10#1)(2009-4#1)
provided the best results##2##4##(2006-2#1)(2008-10#1)
provided the best##18##3##(1996-8#1)(2006-2#1)(2007-8#1)(2008-10#7)(2008-2#1)(2009-4#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#1)
provided the evidence##2##3##(2008-10#1)(2008-8#1)
provided the first evidence of the##2##6##(2010-7#1)(2012-12#1)
provided the first evidence of##4##5##(2006-5#1)(2008-8#1)(2010-7#1)(2012-12#1)
provided the first##6##3##(2006-5#1)(2007-9#1)(2008-4#1)(2008-8#1)(2010-7#1)(2012-12#1)
provided the flexibility##2##3##(2008-10#1)(2009-9#1)
provided the following##2##3##(1991-3#1)(2011-12#1)
provided the highest##2##3##(2009-8#1)(2012-3#1)
provided the impetus for##4##4##(1997-1#1)(1997-7#1)(2006-8#1)(2008-8#1)
provided the lowest##2##3##(2004-12#1)(2008-10#1)
provided the means to##2##4##(2007-2#1)(2008-4#1)
provided the means##3##3##(2007-2#1)(2008-11#1)(2008-4#1)
provided the most##2##3##(2008-10#2)
provided the opportunity for##3##4##(1994-12#1)(2008-11#1)(2012-12#1)
provided the opportunity to study##2##5##(2007-5#1)(2008-2#1)
provided the opportunity to##5##4##(1992-4#1)(1994-8#1)(2007-5#1)(2008-1#1)(2008-2#1)
provided the opportunity##8##3##(1992-4#1)(1994-12#1)(1994-8#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-2#1)(2012-12#1)
provided the patients are##2##4##(2007-8#2)
provided the primary##2##3##(2008-5#1)(2008-9#1)
provided the scientific##2##3##(2008-10#2)
provided the##145##2##(1990-5#1)(1991-11#2)(1991-3#1)(1992-3#1)(1992-4#1)(1993-2#1)(1993-4#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-6#2)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-8#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2004-11#1)(2004-12#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-4#1)(2005-6#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#3)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#22)(2008-11#5)(2008-12#1)(2008-2#6)(2008-3#2)(2008-4#4)(2008-5#6)(2008-7#2)(2008-8#8)(2008-9#1)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#3)(2010-2#1)(2010-5#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#6)
provided them with##2##3##(2007-12#1)(2007-7#1)
provided there are no##2##4##(2007-8#1)(2012-12#1)
provided there##3##2##(1991-8#1)(2007-8#1)(2012-12#1)
provided they were##2##3##(1996-4#1)(2010-8#1)
provided they##6##2##(1991-3#1)(1994-12#1)(1996-4#1)(1997-8#1)(2007-8#1)(2010-8#1)
provided three##2##2##(2006-12#1)(2010-5#1)
provided through##6##2##(1994-12#1)(1995-1#1)(1995-2#1)(1997-8#1)(2012-12#1)(2012-3#1)
provided to Medicare##2##3##(1991-3#1)(1996-2#1)
provided to a##3##3##(1995-12#1)(1995-3#1)(2012-3#1)
provided to all##2##3##(2007-4#1)(2008-5#1)
provided to employees##2##3##(2007-10#1)(2010-2#1)
provided to facilitate##2##3##(2008-11#1)(2008-3#1)
provided to illustrate the##2##4##(2008-11#2)
provided to illustrate##3##3##(1997-8#1)(2008-11#2)
provided to individuals##3##3##(2005-11#1)(2007-12#1)(2010-5#1)
provided to inpatients##2##3##(1992-1#1)(1993-12#1)
provided to people with disabilities##2##5##(1996-1#1)(2009-6#1)
provided to the patients##3##4##(2007-9#1)(2008-10#1)(2008-3#1)
provided to the##12##3##(1990-12#1)(1991-3#1)(1992-2#1)(1994-7#1)(2005-7#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-3#2)(2008-7#1)(2011-1#1)
provided to women##2##3##(1997-1#1)(2010-9#1)
provided to##89##2##(1990-11#1)(1990-12#1)(1991-3#2)(1992-1#1)(1992-2#1)(1993-12#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-2#2)(1997-1#1)(1997-8#2)(2005-11#1)(2005-7#2)(2006-10#2)(2006-2#1)(2006-5#1)(2006-9#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#8)(2008-5#2)(2008-7#4)(2008-9#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#2)
provided together##2##2##(1995-1#1)(2008-9#1)
provided training##2##2##(2008-1#1)(2008-12#1)
provided under##3##2##(1995-12#1)(2008-8#2)
provided unique information##2##3##(2009-9#1)(2010-8#1)
provided unique##3##2##(2009-9#1)(2010-4#1)(2010-8#1)
provided unprecedented##2##2##(2007-4#1)(2013-1#1)
provided unsatisfactory##2##2##(2008-12#1)(2008-7#1)
provided us with##4##3##(1995-12#1)(1997-3#1)(2008-11#1)(2008-9#1)
provided us##6##2##(1995-12#1)(1997-3#1)(2008-11#1)(2008-9#1)(2013-1#2)
provided useful information##2##3##(2007-11#1)(2013-7#1)
provided useful##6##2##(1996-4#1)(2007-11#2)(2008-10#1)(2008-7#1)(2013-7#1)
provided using##3##2##(2008-1#1)(2008-10#1)(2010-4#1)
provided valuable information##5##3##(2008-1#1)(2008-10#1)(2010-4#1)(2010-9#1)(2012-12#1)
provided valuable##11##2##(1992-7#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
provided values##2##2##(2008-10#1)(2013-7#1)
provided very good##2##3##(1995-2#1)(2008-7#1)
provided very high##2##3##(2008-10#1)(2010-2#1)
provided very##6##2##(1995-2#1)(2006-12#1)(2008-10#2)(2008-7#1)(2010-2#1)
provided with a##5##3##(1993-8#1)(1996-1#1)(2007-1#1)(2009-11#1)(2013-7#1)
provided with an##6##3##(1992-1#1)(1992-7#1)(2006-6#1)(2008-10#1)(2008-11#1)(2010-2#1)
provided with continuous##2##3##(1992-1#1)(2007-8#1)
provided with the##4##3##(1992-3#1)(2007-3#1)(2009-2#1)(2012-1#1)
provided with##56##2##(1992-1#2)(1992-3#1)(1992-7#1)(1993-8#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-1#2)(2004-11#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#2)(2009-2#1)(2009-9#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#2)(2013-8#1)
provided within the##4##3##(2006-3#1)(2008-12#1)(2008-2#1)(2012-2#1)
provided##2444##1##(1990-11#5)(1990-12#8)(1990-2#3)(1990-3#4)(1990-4#2)(1990-5#8)(1990-6#4)(1990-7#3)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#6)(1991-12#7)(1991-2#11)(1991-3#7)(1991-4#1)(1991-5#5)(1991-6#6)(1991-8#6)(1992-1#10)(1992-10#1)(1992-11#2)(1992-12#9)(1992-2#11)(1992-3#11)(1992-4#3)(1992-5#6)(1992-6#4)(1992-7#3)(1992-8#4)(1992-9#4)(1993-1#4)(1993-10#1)(1993-12#4)(1993-2#10)(1993-3#10)(1993-4#2)(1993-5#3)(1993-7#2)(1993-8#3)(1993-9#2)(1994-1#5)(1994-11#3)(1994-12#4)(1994-2#11)(1994-3#11)(1994-4#3)(1994-5#3)(1994-6#6)(1994-7#3)(1994-8#7)(1994-9#7)(1995-1#5)(1995-11#4)(1995-12#14)(1995-2#8)(1995-3#8)(1995-4#1)(1995-5#2)(1995-6#4)(1995-7#2)(1995-8#3)(1995-9#4)(1996-1#10)(1996-10#4)(1996-11#3)(1996-12#6)(1996-2#7)(1996-3#9)(1996-4#4)(1996-5#8)(1996-6#4)(1996-7#6)(1996-8#8)(1996-9#6)(1997-1#13)(1997-2#13)(1997-3#9)(1997-4#8)(1997-5#2)(1997-6#4)(1997-7#12)(1997-8#13)(1997-9#1)(2004-10#1)(2004-11#4)(2004-12#2)(2004-2#1)(2004-3#1)(2004-7#1)(2005-10#9)(2005-11#10)(2005-12#2)(2005-3#1)(2005-4#1)(2005-5#1)(2005-6#1)(2005-7#16)(2005-8#5)(2005-9#3)(2006-1#4)(2006-10#45)(2006-11#10)(2006-12#19)(2006-2#9)(2006-3#5)(2006-4#4)(2006-5#12)(2006-6#9)(2006-7#6)(2006-8#10)(2006-9#7)(2007-1#8)(2007-10#18)(2007-11#41)(2007-12#59)(2007-2#16)(2007-3#2)(2007-4#8)(2007-5#9)(2007-6#5)(2007-7#21)(2007-8#38)(2007-9#18)(2008-1#31)(2008-10#251)(2008-11#66)(2008-12#32)(2008-2#71)(2008-3#74)(2008-4#163)(2008-5#49)(2008-6#18)(2008-7#57)(2008-8#47)(2008-9#58)(2009-1#1)(2009-10#10)(2009-11#10)(2009-12#6)(2009-2#9)(2009-3#8)(2009-4#12)(2009-5#7)(2009-6#8)(2009-7#3)(2009-8#19)(2009-9#12)(2010-1#5)(2010-10#6)(2010-11#12)(2010-12#20)(2010-2#21)(2010-3#9)(2010-4#15)(2010-5#13)(2010-6#1)(2010-7#6)(2010-8#29)(2010-9#7)(2011-1#34)(2011-12#2)(2011-2#51)(2011-3#1)(2011-7#1)(2012-1#29)(2012-11#6)(2012-12#49)(2012-2#38)(2012-3#39)(2013-1#70)(2013-7#13)(2013-8#36)
provider a##2##2##(2009-10#1)(2012-1#1)
provider agreements##4##2##(2007-4#4)
provider analysis and##5##3##(1991-12#1)(1993-12#2)(1994-12#1)(1995-2#1)
provider analysis##6##2##(1991-12#1)(1992-12#1)(1993-12#2)(1994-12#1)(1995-2#1)
provider and patient##3##3##(1996-12#1)(1997-2#1)(2006-1#1)
provider and place of birth##2##5##(2007-2#1)(2008-9#1)
provider and##15##2##(1993-2#1)(1994-1#1)(1994-2#1)(1995-1#1)(1996-12#1)(1997-2#2)(2006-1#2)(2006-8#1)(2007-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-3#1)
provider as##2##2##(1995-3#1)(2007-4#1)
provider behaviors##2##2##(1993-1#1)(2006-10#1)
provider choice##2##2##(1991-3#1)(1997-2#1)
provider control##3##2##(1995-3#1)(1996-11#2)
provider education##4##2##(1997-2#2)(2008-1#1)(2012-11#1)
provider expertise##5##2##(1994-1#4)(2010-2#1)
provider for##3##2##(1996-5#1)(2007-12#1)(2009-3#1)
provider groups##3##2##(1996-12#1)(1996-2#1)(1997-3#1)
provider in##2##2##(1996-3#1)(2013-1#1)
provider information systems##2##3##(1996-12#2)
provider level##2##2##(1990-12#1)(1996-2#1)
provider network##3##2##(1996-12#1)(1996-3#1)(2007-12#1)
provider networks##3##2##(1994-2#2)(1994-3#1)
provider obligations##2##2##(1991-2#1)(1994-1#1)
provider of##11##2##(1995-12#1)(1995-3#1)(1997-3#1)(2004-12#1)(2008-4#1)(2008-7#1)(2010-3#1)(2010-8#1)(2012-12#1)(2013-1#2)
provider organizations (PPOs)##3##3##(1991-3#1)(1994-1#1)(1997-1#1)
provider organizations##9##2##(1991-3#2)(1992-2#1)(1993-12#1)(1994-1#2)(1997-1#2)(2010-2#1)
provider panels##2##2##(1995-2#1)(2006-8#1)
provider payment##3##2##(1995-2#2)(1997-1#1)
provider performance##5##2##(1994-3#1)(1995-3#1)(2006-6#1)(2010-12#1)(2013-1#1)
provider perspective##2##2##(1994-1#1)(2012-3#1)
provider practices##2##2##(1996-1#1)(2013-1#1)
provider preference##3##2##(2009-8#1)(2013-1#2)
provider profiling systems##2##3##(1996-1#2)
provider profiling##4##2##(1993-3#1)(1996-1#2)(2007-8#1)
provider relationship##2##2##(1993-12#1)(2013-8#1)
provider roles##2##2##(1996-3#1)(1997-1#1)
provider selection##2##2##(1994-1#1)(1996-2#1)
provider shortages##2##2##(2006-2#1)(2013-7#1)
provider to##10##2##(1992-2#1)(1994-2#2)(2005-7#1)(2007-8#1)(2008-1#2)(2008-11#1)(2012-3#1)(2013-7#1)
provider type##3##2##(2005-9#1)(2013-1#2)
provider utilization##2##2##(1997-2#1)(2009-2#1)
provider were##2##2##(2011-1#1)(2013-7#1)
provider##269##1##(1990-12#3)(1991-12#2)(1991-2#3)(1991-3#4)(1992-12#3)(1992-2#2)(1992-3#2)(1993-1#2)(1993-12#8)(1993-2#1)(1993-3#4)(1994-1#12)(1994-12#6)(1994-2#8)(1994-3#5)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#7)(1995-3#8)(1995-6#1)(1996-1#4)(1996-11#4)(1996-12#7)(1996-2#5)(1996-3#3)(1996-5#2)(1997-1#7)(1997-2#7)(1997-3#5)(2004-12#1)(2004-3#1)(2005-10#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#3)(2006-10#4)(2006-2#1)(2006-6#4)(2006-8#11)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#3)(2007-4#7)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-11#3)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#23)(2013-7#6)(2013-8#2)
provider&quot##2##1##(1997-3#1)(2007-10#1)
provider's perspective##2##2##(1994-1#1)(2011-2#1)
provider's##14##1##(1991-12#1)(1992-3#1)(1994-1#2)(1994-3#1)(1996-11#1)(2006-8#1)(2007-2#1)(2008-11#2)(2011-2#1)(2013-1#2)(2013-8#1)
provider-initiated##2##1##(2010-8#2)
provider-patient communication##5##2##(1995-12#1)(2012-12#1)(2013-1#2)(2013-8#1)
provider-patient relationship##5##2##(2013-8#5)
provider-patient##10##1##(1995-12#1)(2012-12#1)(2013-1#2)(2013-8#6)
provider-specific##2##1##(1996-1#2)
providers (physicians##2##2##(1994-3#1)(2012-3#1)
providers and consumers##2##3##(1993-1#1)(1997-3#1)
providers and first responders##2##4##(2006-10#1)(2008-2#1)
providers and places of birth##2##5##(2007-2#2)
providers and researchers##2##3##(1994-12#1)(2006-10#1)
providers and the##10##3##(1995-1#2)(1996-1#1)(1996-2#1)(2006-2#1)(2006-8#1)(2007-2#1)(2008-12#1)(2010-12#1)(2011-2#1)
providers and##55##2##(1992-12#1)(1993-1#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#4)(1995-2#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-2#4)(1997-3#3)(2006-10#2)(2006-2#1)(2006-8#1)(2007-2#3)(2008-1#2)(2008-11#4)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#2)(2010-10#1)(2010-12#3)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
providers are also##2##3##(1996-3#1)(2006-2#1)
providers are in a##3##4##(2007-2#1)(2007-7#1)(2012-2#1)
providers are##24##2##(1991-3#1)(1992-8#1)(1994-12#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-8#1)(2005-10#2)(2006-10#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-11#1)(2010-10#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
providers as##2##2##(2006-6#1)(2012-12#1)
providers at##4##2##(2008-6#1)(2009-2#1)(2011-1#1)(2012-12#1)
providers but##3##2##(1996-12#1)(2008-12#1)(2013-8#1)
providers can be##2##3##(2004-4#1)(2006-8#1)
providers can##11##2##(1994-12#1)(1994-3#1)(1996-3#1)(2004-4#1)(2006-8#1)(2009-11#1)(2010-7#1)(2011-1#1)(2013-1#3)
providers coded##2##2##(2011-2#2)
providers for##6##2##(1993-12#1)(1996-1#1)(1996-2#1)(2009-4#1)(2010-9#1)(2012-1#1)
providers from##2##2##(1996-9#1)(2006-8#1)
providers has##3##2##(1992-1#1)(1996-3#1)(2005-8#1)
providers have##13##2##(1992-11#1)(1993-12#1)(1995-1#1)(1996-12#1)(1997-5#1)(2006-7#1)(2008-11#1)(2008-12#1)(2010-9#1)(2013-1#3)(2013-7#1)
providers in order to##2##4##(1994-12#1)(1995-1#1)
providers in the##11##3##(1994-1#1)(1995-3#1)(2005-11#1)(2008-1#1)(2008-11#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
providers in##34##2##(1992-2#1)(1994-1#2)(1994-12#1)(1995-1#2)(1995-3#2)(1996-11#1)(1996-3#1)(2005-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-11#2)(2008-3#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-7#1)
providers into##3##2##(1993-3#2)(2010-5#1)
providers is to##3##3##(1992-12#1)(2008-11#1)(2008-6#1)
providers is##11##2##(1992-12#2)(1994-12#2)(2006-1#1)(2008-11#1)(2008-6#2)(2008-7#1)(2010-4#1)(2011-1#1)
providers may be##4##3##(2008-10#1)(2008-8#1)(2012-2#1)(2012-3#1)
providers may##5##2##(2006-8#1)(2008-10#1)(2008-8#1)(2012-2#1)(2012-3#1)
providers must be##2##3##(2008-6#1)(2009-11#1)
providers must##5##2##(1991-12#1)(1995-12#1)(2008-6#1)(2009-11#1)(2009-5#1)
providers need to recognize##2##4##(2007-2#1)(2012-3#1)
providers need to understand##3##4##(2007-10#1)(2007-9#1)(2008-3#1)
providers need to##11##3##(2005-7#1)(2007-10#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-4#1)(2012-3#1)(2013-8#1)
providers need##14##2##(2005-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-4#1)(2012-3#1)(2013-1#2)(2013-8#1)
providers of health care##4##4##(1995-1#1)(1997-1#1)(2006-8#1)(2008-7#1)
providers of health##6##3##(1995-1#1)(1997-1#1)(2006-8#1)(2008-1#1)(2008-7#2)
providers of##18##2##(1991-3#1)(1992-10#1)(1994-3#1)(1995-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(2006-8#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#1)(2010-10#1)(2012-2#1)
providers on##3##2##(1993-1#1)(1996-12#1)(2008-7#1)
providers play##2##2##(2011-1#1)(2012-3#1)
providers should be aware of##2##5##(2010-3#1)(2013-1#1)
providers should be##3##3##(1994-3#1)(2010-3#1)(2013-1#1)
providers should##11##2##(1994-3#1)(2007-10#1)(2007-6#1)(2008-3#1)(2009-10#1)(2009-11#1)(2009-7#1)(2010-3#1)(2011-1#1)(2013-1#2)
providers that##4##2##(1993-12#2)(1995-1#1)(2013-1#1)
providers to be##3##3##(2009-10#1)(2009-11#1)(2011-1#1)
providers to help##2##3##(2008-6#1)(2009-9#1)
providers to work##2##3##(2008-11#1)(2011-2#1)
providers to##48##2##(1990-2#1)(1991-2#1)(1992-12#1)(1993-12#1)(1994-12#3)(1994-2#1)(1994-3#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-7#1)(2005-10#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-2#3)(2007-4#2)(2008-11#2)(2008-3#1)(2008-6#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-3#2)(2013-1#3)(2013-7#1)
providers under##2##2##(1991-2#1)(1995-12#1)
providers using##4##2##(1994-3#1)(2008-1#1)(2013-1#2)
providers were##4##2##(1991-3#1)(1992-3#1)(1993-3#1)(1996-8#1)
providers when##3##2##(2008-1#1)(2013-1#2)
providers who##15##2##(1992-12#1)(1992-2#1)(1993-12#1)(1997-2#1)(2006-8#1)(2007-2#2)(2007-6#1)(2008-1#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)
providers will##6##2##(1990-12#1)(1994-12#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-6#1)
providers with##3##2##(2006-8#1)(2007-4#1)(2007-9#1)
providers working##3##2##(2009-7#2)(2013-8#1)
providers would be##2##3##(1996-5#1)(2006-8#1)
providers would##4##2##(1996-5#1)(1997-2#1)(2006-4#1)(2006-8#1)
providers##612##1##(1990-12#1)(1990-2#1)(1990-5#1)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#5)(1991-3#5)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#7)(1992-2#4)(1992-3#2)(1992-6#1)(1992-8#1)(1993-1#5)(1993-12#16)(1993-2#1)(1993-3#6)(1993-5#2)(1993-6#1)(1993-9#1)(1994-1#12)(1994-10#1)(1994-12#17)(1994-2#6)(1994-3#10)(1994-8#1)(1995-1#14)(1995-12#9)(1995-2#2)(1995-3#4)(1995-6#1)(1995-9#1)(1996-1#7)(1996-11#1)(1996-12#13)(1996-2#9)(1996-3#20)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#8)(1997-2#15)(1997-3#11)(1997-5#1)(1997-7#1)(1997-8#1)(2004-4#2)(2005-10#3)(2005-11#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#7)(2006-2#6)(2006-4#1)(2006-6#1)(2006-7#3)(2006-8#13)(2007-10#4)(2007-12#8)(2007-2#14)(2007-3#6)(2007-4#5)(2007-6#5)(2007-7#4)(2007-9#2)(2008-1#12)(2008-10#3)(2008-11#23)(2008-12#7)(2008-2#2)(2008-3#9)(2008-4#1)(2008-6#11)(2008-7#11)(2008-8#4)(2008-9#3)(2009-10#3)(2009-11#6)(2009-2#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#4)(2009-9#3)(2010-10#4)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#5)(2010-5#3)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#10)(2011-2#12)(2012-1#2)(2012-11#4)(2012-12#15)(2012-2#12)(2012-3#20)(2013-1#54)(2013-7#3)(2013-8#16)
providers'##17##1##(1993-3#1)(1994-1#1)(1994-2#2)(1994-3#1)(1996-11#1)(1996-2#1)(2008-11#1)(2008-3#1)(2009-7#1)(2010-10#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
providers) in##2##2##(1995-2#1)(1995-3#1)
providers)##6##1##(1995-2#1)(1995-3#1)(2008-1#1)(2009-10#1)(2012-1#1)(2012-2#1)
providers?##3##1##(1993-12#2)(2008-4#1)
provides &quot##3##2##(1992-3#1)(2008-1#1)(2013-1#1)
provides a &quot##2##3##(1991-12#1)(2008-2#1)
provides a base##2##3##(1990-12#1)(2012-12#1)
provides a baseline for##2##4##(2008-12#1)(2011-2#1)
provides a basis for a new##2##6##(2008-10#1)(2008-2#1)
provides a basis for a##3##5##(1994-10#1)(2008-10#1)(2008-2#1)
provides a basis for the##2##5##(2008-5#1)(2010-11#1)
provides a basis for##12##4##(1994-10#1)(1995-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2013-7#1)
provides a basis##14##3##(1993-4#1)(1994-10#1)(1995-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2012-12#1)(2013-7#1)
provides a better##9##3##(1990-6#1)(1993-3#1)(1995-12#1)(1996-5#1)(2005-11#1)(2008-10#1)(2008-9#1)(2010-2#1)(2011-1#1)
provides a brief background on##2##5##(2007-5#1)(2009-11#1)
provides a brief background##3##4##(2007-11#1)(2007-5#1)(2009-11#1)
provides a brief description of the##3##6##(2008-11#1)(2008-7#1)(2010-5#1)
provides a brief introduction to the##2##6##(2008-8#1)(2008-9#1)
provides a brief introduction##3##4##(2008-8#1)(2008-9#1)(2013-1#1)
provides a brief overview of the##6##6##(2008-12#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-7#1)(2010-8#1)
provides a brief overview of##12##5##(1993-2#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-4#2)(2008-9#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-12#1)
provides a brief overview##13##4##(1993-2#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-9#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-12#1)
provides a brief##30##3##(1993-2#1)(1996-9#1)(2006-10#1)(2006-7#1)(2007-11#2)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-12#1)(2013-1#1)
provides a case study##3##4##(1995-6#1)(2009-3#1)(2012-12#1)
provides a case##4##3##(1994-12#1)(1995-6#1)(2009-3#1)(2012-12#1)
provides a clear##4##3##(1992-8#1)(2008-2#1)(2008-6#1)(2008-9#1)
provides a compact##3##3##(2007-11#1)(2013-1#2)
provides a complementary##2##3##(2008-11#1)(2008-3#1)
provides a complete##3##3##(2007-4#1)(2008-9#1)(2011-2#1)
provides a comprehensive overview of##2##5##(2007-12#1)(2010-4#1)
provides a comprehensive overview##3##4##(2007-12#1)(2008-4#1)(2010-4#1)
provides a comprehensive##14##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#4)(2009-10#1)(2009-12#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-3#1)(2012-1#1)
provides a conceptual framework for##2##5##(1997-2#1)(2006-10#1)
provides a conceptual##5##3##(1997-2#1)(2006-10#1)(2008-11#1)(2008-8#1)(2013-8#1)
provides a concise##3##3##(2006-3#1)(2008-11#1)(2012-12#1)
provides a constructive##2##3##(1996-1#1)(2008-3#1)
provides a context for##2##4##(2009-6#1)(2012-3#1)
provides a context##3##3##(2007-4#1)(2009-6#1)(2012-3#1)
provides a continuous##2##3##(2007-1#1)(2008-10#1)
provides a convenient and##2##4##(2009-3#1)(2012-12#1)
provides a convenient##6##3##(1991-4#1)(2008-4#1)(2008-9#1)(2009-3#1)(2009-4#1)(2012-12#1)
provides a cost-effective##3##3##(1994-3#2)(2008-10#1)
provides a critical review of##2##5##(2008-10#1)(2009-9#1)
provides a critical##4##3##(1995-3#1)(2008-10#1)(2008-7#1)(2009-9#1)
provides a description of the##2##5##(1996-12#1)(1997-1#1)
provides a description of##5##4##(1996-12#1)(1997-1#1)(1997-7#1)(2008-12#2)
provides a descriptive##2##3##(1996-1#1)(2008-4#1)
provides a detailed discussion of the##2##6##(2008-8#1)(2008-9#1)
provides a detailed method for##2##5##(2008-4#1)(2008-9#1)
provides a detailed##11##3##(2005-11#1)(2006-7#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#4)(2011-1#1)
provides a diagnostic##2##3##(1996-2#1)(2011-2#1)
provides a direct##4##3##(2008-3#1)(2011-1#2)(2012-3#1)
provides a fast and##2##4##(1995-12#1)(2008-10#1)
provides a fast##3##3##(1995-12#1)(2008-10#2)
provides a flexible##5##3##(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)
provides a focused##2##3##(1997-3#1)(2010-2#1)
provides a foundation for##2##4##(2009-4#1)(2010-12#1)
provides a framework for the##2##5##(1997-8#1)(2007-12#1)
provides a framework for##10##4##(1997-8#2)(2007-12#1)(2007-7#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-6#1)(2010-7#1)
provides a framework to##2##4##(2007-12#1)(2012-2#1)
provides a framework##19##3##(1997-8#2)(2006-7#1)(2007-12#2)(2007-7#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
provides a further##2##3##(1997-8#1)(2004-11#1)
provides a general framework for##2##5##(2008-10#1)(2008-2#1)
provides a general guideline##2##4##(2008-10#1)(2010-5#1)
provides a general method##2##4##(1994-8#1)(1997-5#1)
provides a general##12##3##(1994-8#1)(1995-12#1)(1997-5#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-6#1)(2010-5#1)
provides a good##15##3##(1991-10#1)(1991-2#1)(1992-11#1)(1995-11#1)(1997-6#1)(2005-11#1)(2008-1#1)(2008-5#2)(2010-10#1)(2010-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
provides a guide for##3##4##(2008-4#1)(2011-2#1)(2012-12#1)
provides a guide to##5##4##(2006-5#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-4#1)
provides a guide##10##3##(2006-5#1)(2006-9#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-4#2)(2008-7#1)(2011-2#1)(2012-12#1)
provides a high##8##3##(2006-9#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#1)(2009-3#1)
provides a higher##2##3##(2007-11#1)(2011-1#1)
provides a highly##4##3##(2008-10#1)(2008-11#1)(2008-6#1)(2010-5#1)
provides a historical##3##3##(2005-7#1)(2006-5#1)(2009-6#1)
provides a limit of detection##2##5##(2008-10#2)
provides a link between the##2##5##(2007-12#1)(2009-7#1)
provides a link between##3##4##(2007-12#1)(2008-6#1)(2009-7#1)
provides a list of##2##4##(1993-2#1)(2007-2#1)
provides a map of##2##4##(2008-3#2)
provides a marker##2##3##(1995-6#1)(1996-3#1)
provides a means for##5##4##(1996-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-3#1)
provides a means of##9##4##(1992-5#1)(1996-8#1)(2005-8#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-11#1)
provides a means to##6##4##(1997-2#1)(2008-11#2)(2008-12#1)(2008-4#1)(2009-10#1)
provides a means##21##3##(1992-5#1)(1995-12#1)(1996-12#1)(1996-8#1)(1997-2#1)(2005-8#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-11#1)
provides a measure of the##3##5##(1997-2#1)(2008-2#1)(2008-9#1)
provides a measure of##6##4##(1996-2#1)(1997-2#1)(2007-12#1)(2007-7#1)(2008-2#1)(2008-9#1)
provides a mechanism by which##3##5##(1991-4#1)(1995-12#1)(1997-7#1)
provides a mechanism for the##2##5##(2008-11#1)(2013-1#1)
provides a mechanism for##5##4##(1991-12#1)(2008-11#1)(2009-5#1)(2013-1#2)
provides a mechanism whereby##2##4##(1991-1#1)(2008-9#1)
provides a mechanism##12##3##(1991-1#1)(1991-12#1)(1991-4#1)(1995-12#1)(1996-10#1)(1997-7#1)(2007-12#1)(2008-11#1)(2008-9#1)(2009-5#1)(2013-1#2)
provides a mechanistic##2##3##(2009-8#1)(2011-1#1)
provides a method for##7##4##(1995-1#1)(1996-5#1)(2008-3#1)(2008-4#2)(2009-5#1)(2010-4#1)
provides a method of##3##4##(1993-5#1)(2008-4#1)(2010-6#1)
provides a method to##6##4##(1992-9#1)(1993-11#1)(2008-4#2)(2008-6#1)(2010-2#1)
provides a method##17##3##(1992-9#1)(1993-11#1)(1993-5#1)(1995-1#1)(1996-5#1)(2008-3#1)(2008-4#5)(2008-6#1)(2009-5#1)(2010-2#1)(2010-4#1)(2010-6#1)(2012-2#1)
provides a minimum##2##3##(1990-8#1)(2008-3#1)
provides a model for the##4##5##(1992-6#1)(1997-4#1)(2006-12#1)(2006-7#1)
provides a model for##8##4##(1992-6#1)(1992-8#1)(1997-4#1)(2006-12#1)(2006-7#1)(2008-1#1)(2008-10#1)(2011-1#1)
provides a model of##2##4##(2008-4#1)(2008-7#1)
provides a model##13##3##(1991-1#1)(1991-6#1)(1992-6#1)(1992-8#1)(1995-5#1)(1997-4#1)(2006-12#1)(2006-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-1#1)
provides a more distinct##2##4##(2010-9#1)(2012-12#1)
provides a more##11##3##(1994-9#1)(2006-10#1)(2008-10#2)(2008-4#2)(2008-7#2)(2010-11#1)(2010-9#1)(2012-12#1)
provides a near##2##3##(2010-5#1)(2010-7#1)
provides a new and##5##4##(1996-5#1)(1996-8#1)(2007-8#1)(2008-6#1)(2013-8#1)
provides a new opportunity to##2##5##(2008-10#1)(2010-5#1)
provides a new promising##2##4##(2006-10#1)(2008-10#1)
provides a new route to##2##5##(2008-5#1)(2009-2#1)
provides a new tool##2##4##(1996-12#2)
provides a new##31##3##(1994-9#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(2006-10#2)(2007-12#2)(2007-8#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2010-5#1)(2010-6#1)(2012-2#2)(2013-8#3)
provides a noninvasive##2##3##(2008-3#1)(2010-4#1)
provides a novel##6##3##(2006-12#1)(2007-12#2)(2010-4#1)(2011-1#1)(2012-3#1)
provides a number of##2##4##(2004-2#1)(2008-12#1)
provides a path##2##3##(2007-12#1)(2010-4#1)
provides a perspective##3##3##(2008-1#1)(2010-10#1)(2012-12#1)
provides a physical##2##3##(2008-11#1)(2008-3#1)
provides a plausible##2##3##(2008-10#2)
provides a possible explanation for the##3##6##(1992-3#1)(1997-1#1)(2007-9#1)
provides a possible explanation for##4##5##(1992-2#1)(1992-3#1)(1997-1#1)(2007-9#1)
provides a possible##8##3##(1992-2#1)(1992-3#1)(1997-1#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-8#1)(2012-2#1)
provides a potent##2##3##(1992-8#1)(2008-10#1)
provides a potential##6##3##(1997-7#1)(2005-11#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-9#1)
provides a powerful tool for##8##5##(1996-10#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2012-3#1)
provides a powerful tool to##3##5##(2006-10#1)(2008-2#1)(2012-3#1)
provides a powerful tool##12##4##(1995-5#1)(1996-10#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2012-3#2)
provides a powerful##20##3##(1991-12#1)(1994-8#1)(1995-5#1)(1996-10#1)(1996-5#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#1)(2010-12#1)(2012-3#2)
provides a practical approach##2##4##(2010-12#1)(2012-2#1)
provides a practical##5##3##(2006-5#1)(2010-12#1)(2012-2#2)(2012-3#1)
provides a promising##4##3##(2009-5#1)(2010-5#1)(2012-1#1)(2013-1#1)
provides a protocol for performing##2##5##(2008-2#1)(2008-4#1)
provides a protocol for##4##4##(2008-2#1)(2008-4#3)
provides a protocol##7##3##(2008-2#1)(2008-4#6)
provides a quantitative approach to##2##5##(2008-9#1)(2011-2#1)
provides a quantitative##8##3##(1996-4#1)(2008-5#1)(2008-9#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-7#1)
provides a quick and##2##4##(2008-4#1)(2012-12#1)
provides a quick##4##3##(2008-10#1)(2008-4#2)(2012-12#1)
provides a rapid and sensitive alternative##2##6##(1990-12#1)(2008-10#1)
provides a rapid and sensitive##4##5##(1990-12#1)(1993-8#1)(2008-10#2)
provides a rapid and##10##4##(1990-12#1)(1993-8#1)(1994-9#1)(1996-11#1)(1997-4#1)(2008-10#5)
provides a rapid means##3##4##(1992-7#1)(2008-11#2)
provides a rapid##15##3##(1990-12#1)(1992-7#1)(1993-8#1)(1994-9#1)(1996-11#1)(1997-3#1)(1997-4#1)(2008-10#5)(2008-11#2)(2008-4#1)
provides a reference##4##3##(1991-9#1)(2007-12#1)(2007-7#1)(2008-3#1)
provides a relative##2##3##(2005-11#1)(2008-10#1)
provides a reliable and##5##4##(1990-12#1)(1992-7#1)(2006-6#1)(2009-5#1)(2013-1#1)
provides a reliable method##2##4##(2011-2#1)(2012-3#1)
provides a reliable##9##3##(1990-12#1)(1992-7#1)(2006-6#1)(2007-12#1)(2008-4#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
provides a remarkable##2##3##(2008-2#1)(2009-6#1)
provides a review of the current##2##6##(2010-12#1)(2011-7#1)
provides a review of the##9##5##(2007-4#1)(2008-10#1)(2008-8#1)(2010-11#1)(2010-12#3)(2010-7#1)(2011-7#1)
provides a review of##14##4##(1995-12#1)(2005-7#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-11#1)(2010-12#3)(2010-7#1)(2011-7#1)(2013-1#1)
provides a review##15##3##(1995-12#1)(2005-7#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-11#1)(2010-12#3)(2010-7#1)(2011-7#1)(2013-1#1)
provides a rich##3##3##(2012-3#1)(2013-1#2)
provides a robust and##2##4##(1996-12#1)(2008-4#1)
provides a robust##3##3##(1996-12#1)(2008-4#1)(2010-2#1)
provides a route##2##3##(1993-6#1)(1996-6#1)
provides a safe and##2##4##(2010-12#1)(2012-1#1)
provides a safe##3##3##(2010-12#1)(2012-1#1)(2012-2#1)
provides a scaffold for the##2##5##(2007-8#1)(2008-8#1)
provides a sensitive and##2##4##(1993-2#1)(1997-6#1)
provides a sensitive##5##3##(1993-2#1)(1996-4#1)(1996-7#1)(1997-6#1)(2006-10#1)
provides a series of##3##4##(1992-6#1)(2008-9#1)(2012-2#1)
provides a set of##5##4##(1994-3#1)(2008-4#2)(2008-8#1)(2010-4#1)
provides a short overview of##2##5##(1994-6#1)(2007-9#1)
provides a short##3##3##(1994-6#1)(2007-9#1)(2012-12#1)
provides a significant##4##3##(1990-5#1)(2008-1#1)(2008-10#1)(2010-11#1)
provides a simple and##6##4##(1994-5#1)(1995-12#1)(1997-1#1)(2008-10#1)(2008-9#1)(2012-12#1)
provides a simple way to##5##5##(2008-10#1)(2008-3#2)(2008-4#1)(2008-9#1)
provides a simple##21##3##(1990-9#1)(1991-8#1)(1993-11#1)(1994-5#1)(1995-12#1)(1997-1#1)(1997-4#1)(2006-7#1)(2007-8#1)(2008-10#3)(2008-3#3)(2008-4#2)(2008-5#1)(2008-9#2)(2012-12#1)
provides a solid##3##3##(2008-8#1)(2013-1#2)
provides a solution##3##3##(2008-2#1)(2008-4#2)
provides a source of##2##4##(1990-8#1)(2013-1#1)
provides a source##3##3##(1990-8#1)(2008-10#1)(2013-1#1)
provides a starting point##3##4##(2006-2#1)(2008-2#1)(2008-4#1)
provides a strong##3##3##(2008-5#1)(2010-4#1)(2012-12#1)
provides a structural basis for the##2##6##(1997-2#1)(2005-11#1)
provides a structural scaffold##2##4##(2008-11#1)(2010-1#1)
provides a structural##5##3##(1994-6#1)(1997-2#1)(2005-11#1)(2008-11#1)(2010-1#1)
provides a sufficient##2##3##(1995-9#1)(2008-10#1)
provides a suitable model##2##4##(1995-12#1)(1995-6#1)
provides a suitable##5##3##(1995-12#1)(1995-6#1)(2008-11#1)(2008-2#1)(2012-2#1)
provides a summary of the##3##5##(1992-3#1)(2008-4#1)(2008-7#1)
provides a summary of##13##4##(1992-3#1)(1996-1#1)(2004-3#1)(2008-4#4)(2008-7#1)(2009-9#1)(2010-3#1)(2011-2#2)(2013-1#1)
provides a systematic##2##3##(2008-11#1)(2008-4#1)
provides a testable##2##3##(2008-8#1)(2008-9#1)
provides a theoretical##2##3##(2007-3#1)(2008-10#1)
provides a therapeutic##2##3##(2006-12#1)(2011-2#1)
provides a thorough##2##3##(2008-1#1)(2008-10#1)
provides a tool for the##2##5##(2008-2#1)(2013-1#1)
provides a tool for##4##4##(1994-2#1)(2008-2#2)(2013-1#1)
provides a tool##7##3##(1994-2#1)(1994-5#1)(2007-8#1)(2008-2#2)(2008-7#1)(2013-1#1)
provides a unique opportunity to study##2##6##(1995-10#1)(2007-8#1)
provides a unique opportunity to##5##5##(1995-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-12#1)
provides a unique way to##2##5##(2007-11#1)(2007-12#1)
provides a unique way##3##4##(1993-1#1)(2007-11#1)(2007-12#1)
provides a unique##16##3##(1992-6#1)(1993-1#1)(1995-10#1)(1996-6#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-9#1)(2011-2#1)(2011-7#1)(2013-1#2)
provides a useful approach##2##4##(1990-7#1)(2008-7#1)
provides a useful framework for##4##5##(2007-8#1)(2008-5#1)(2009-12#1)(2010-2#1)
provides a useful tool for##4##5##(2006-10#1)(2008-4#2)(2009-10#1)
provides a useful tool in##2##5##(2008-8#1)(2011-1#1)
provides a useful tool to measure##2##6##(1997-8#1)(2008-4#1)
provides a useful tool to##5##5##(1993-9#1)(1997-8#1)(2007-10#1)(2008-4#1)(2008-5#1)
provides a useful tool##11##4##(1993-9#1)(1997-8#1)(2006-10#1)(2007-10#1)(2008-4#3)(2008-5#1)(2008-8#1)(2009-10#1)(2011-1#1)
provides a useful##31##3##(1990-7#1)(1991-2#1)(1993-3#1)(1993-9#1)(1994-8#1)(1995-3#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-3#1)
provides a user-friendly##2##3##(2006-5#1)(2011-1#1)
provides a valuable reference for##2##5##(2007-7#1)(2008-12#1)
provides a valuable##9##3##(1996-8#1)(2005-10#1)(2006-11#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-2#1)(2011-2#1)
provides a variety of##2##4##(2007-12#1)(2007-9#1)
provides a versatile##3##3##(2007-8#1)(2008-8#1)(2009-8#1)
provides a very simple##2##4##(2008-10#1)(2008-2#1)
provides a very##8##3##(1992-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2009-10#1)(2012-2#1)
provides a viable##2##3##(2008-2#1)(2012-3#1)
provides a way to##4##4##(1991-11#1)(1995-2#1)(2010-4#1)(2012-3#1)
provides a way##5##3##(1991-11#1)(1995-2#1)(2009-11#1)(2010-4#1)(2012-3#1)
provides a wide##2##3##(2006-12#1)(2008-2#1)
provides a wider##2##3##(1991-10#1)(2006-12#1)
provides a##892##2##(1990-12#6)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#3)(1991-2#2)(1991-3#3)(1991-4#3)(1991-6#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#5)(1992-7#2)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#4)(1993-2#4)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-12#2)(1994-2#2)(1994-3#4)(1994-5#3)(1994-6#2)(1994-8#4)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#9)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#4)(1995-8#1)(1995-9#1)(1996-1#3)(1996-10#3)(1996-11#1)(1996-12#6)(1996-2#5)(1996-3#6)(1996-4#5)(1996-5#5)(1996-6#2)(1996-7#1)(1996-8#4)(1996-9#1)(1997-1#4)(1997-2#5)(1997-3#4)(1997-4#6)(1997-5#1)(1997-6#4)(1997-7#6)(1997-8#4)(2004-11#1)(2004-2#1)(2004-3#1)(2005-10#2)(2005-11#8)(2005-7#3)(2005-8#3)(2005-9#1)(2006-10#10)(2006-11#1)(2006-12#9)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#4)(2006-6#2)(2006-7#5)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#8)(2007-12#31)(2007-2#2)(2007-3#1)(2007-4#7)(2007-5#2)(2007-7#6)(2007-8#8)(2007-9#6)(2008-1#17)(2008-10#62)(2008-11#27)(2008-12#15)(2008-2#38)(2008-3#28)(2008-4#62)(2008-5#14)(2008-6#7)(2008-7#23)(2008-8#17)(2008-9#30)(2009-10#5)(2009-11#2)(2009-12#3)(2009-2#3)(2009-3#4)(2009-4#2)(2009-5#7)(2009-6#4)(2009-7#3)(2009-8#5)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#5)(2010-12#11)(2010-2#7)(2010-3#1)(2010-4#10)(2010-5#9)(2010-6#3)(2010-7#5)(2010-8#3)(2010-9#3)(2011-1#15)(2011-12#1)(2011-2#17)(2011-3#1)(2011-7#2)(2012-1#4)(2012-12#13)(2012-2#14)(2012-3#12)(2013-1#29)(2013-7#5)(2013-8#8)
provides access to##7##3##(1992-2#1)(1994-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-12#1)(2010-7#1)
provides accurate##4##2##(1994-6#2)(2008-1#1)(2008-2#1)
provides additional evidence for##2##4##(1992-1#1)(2013-1#1)
provides additional evidence##5##3##(1992-1#1)(1997-6#1)(2006-12#1)(2009-8#1)(2013-1#1)
provides additional information##3##3##(2006-10#1)(2008-7#1)(2011-1#1)
provides additional##19##2##(1992-1#1)(1993-11#1)(1995-10#1)(1995-2#1)(1995-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-11#1)(2008-1#1)(2008-7#1)(2009-8#1)(2011-1#1)(2013-1#1)(2013-7#1)
provides adequate##4##2##(1992-1#1)(1992-12#1)(2007-8#2)
provides advantages##2##2##(1992-11#1)(2008-1#1)
provides all the##2##3##(2007-12#1)(2008-9#1)
provides also##2##2##(2006-6#1)(2008-10#1)
provides ample##2##2##(2008-12#1)(2011-1#1)
provides an acceptable##2##3##(2008-10#1)(2013-8#1)
provides an accurate##2##3##(1997-1#1)(2011-2#1)
provides an additional layer of safety to the process of medication administration in the hospital setting##2##16##(2013-1#2)
provides an additional##6##3##(2006-12#1)(2008-5#1)(2010-12#1)(2013-1#2)(2013-8#1)
provides an alternative and##2##4##(2008-10#2)
provides an alternative method##3##4##(1992-3#1)(2008-2#1)(2012-12#1)
provides an alternative to##4##4##(2006-10#1)(2007-7#1)(2008-1#1)(2011-1#1)
provides an alternative##16##3##(1992-3#1)(1994-12#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-12#1)
provides an analysis of the##3##5##(1996-7#1)(2008-8#1)(2010-8#1)
provides an analysis of##4##4##(1996-7#1)(2008-8#1)(2010-10#1)(2010-8#1)
provides an analysis##5##3##(1996-7#1)(2008-1#1)(2008-8#1)(2010-10#1)(2010-8#1)
provides an analytical##2##3##(1991-5#1)(2008-3#1)
provides an appropriate##2##3##(2007-11#1)(2012-1#1)
provides an attractive alternative##2##4##(1996-9#1)(2008-2#1)
provides an attractive##5##3##(1996-9#1)(1997-4#1)(2008-11#1)(2008-2#1)(2008-4#1)
provides an easy##3##3##(2007-12#1)(2008-10#1)(2012-2#1)
provides an effective and##3##4##(2008-2#2)(2013-1#1)
provides an effective means##2##4##(1996-12#1)(2008-10#1)
provides an effective##10##3##(1996-12#1)(1997-6#1)(2004-11#1)(2008-10#1)(2008-2#2)(2008-4#1)(2012-12#2)(2013-1#1)
provides an efficient means to##2##5##(1997-2#1)(2008-10#1)
provides an efficient method of##2##5##(2008-11#1)(2008-4#1)
provides an efficient method##3##4##(1996-4#1)(2008-11#1)(2008-4#1)
provides an efficient way##2##4##(2008-2#1)(2008-3#1)
provides an efficient##15##3##(1995-9#1)(1996-4#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2009-8#1)(2011-1#1)(2013-8#1)
provides an essential##2##3##(1994-2#1)(2007-12#1)
provides an estimate of the##3##5##(1996-4#1)(2008-10#2)
provides an estimate of##4##4##(1996-4#1)(2008-10#2)(2011-1#1)
provides an evidence##2##3##(2005-10#1)(2011-1#1)
provides an evidence-based##4##3##(2006-10#1)(2007-12#1)(2009-5#1)(2010-10#1)
provides an example of how##2##5##(2008-7#1)(2012-12#1)
provides an excellent example##2##4##(1993-12#1)(2008-2#1)
provides an excellent opportunity to##2##5##(2007-12#1)(2009-9#1)
provides an excellent platform##2##4##(2008-10#1)(2009-12#1)
provides an excellent##18##3##(1990-8#1)(1991-2#1)(1993-12#1)(1995-5#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#5)(2009-12#1)(2009-9#1)(2011-2#1)
provides an explanation for how##2##5##(1996-3#1)(2010-3#1)
provides an explanation for the##4##5##(1990-5#1)(1994-8#1)(1997-2#1)(2013-1#1)
provides an explanation for##7##4##(1990-5#1)(1994-8#1)(1996-3#1)(1997-2#1)(2008-4#1)(2010-3#1)(2013-1#1)
provides an explanation##8##3##(1990-5#1)(1994-8#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-4#1)(2010-3#1)(2013-1#1)
provides an ideal##3##3##(2008-11#1)(2008-7#1)(2013-1#1)
provides an important opportunity to##2##5##(1993-1#1)(2006-12#1)
provides an important##16##3##(1991-7#1)(1991-9#1)(1993-1#1)(1994-12#1)(1995-6#1)(1997-6#1)(2006-12#1)(2007-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#2)(2009-8#1)(2011-12#1)(2012-3#1)
provides an improved##3##3##(2008-2#1)(2010-12#1)(2010-8#1)
provides an increase##2##3##(1996-5#1)(2008-10#1)
provides an index##3##3##(1990-6#1)(1997-8#1)(2009-7#1)
provides an indication of##2##4##(2009-8#1)(2010-9#1)
provides an indirect measure of the##2##6##(2008-9#1)(2010-5#1)
provides an indirect##3##3##(2008-9#1)(2009-2#1)(2010-5#1)
provides an inexpensive##2##3##(2008-2#1)(2008-4#1)
provides an insight into the##3##5##(1997-2#1)(2007-12#1)(2010-12#1)
provides an insight into##5##4##(1997-2#1)(2007-11#1)(2007-12#1)(2008-11#1)(2010-12#1)
provides an interactive environment##3##4##(2005-10#1)(2013-1#2)
provides an interactive##4##3##(2005-10#1)(2008-10#1)(2013-1#2)
provides an introduction to the##3##5##(2008-10#1)(2008-2#1)(2008-4#1)
provides an introduction to##13##4##(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#5)(2008-7#1)(2012-12#2)
provides an opportunity for##5##4##(1996-12#1)(2006-1#1)(2008-10#1)(2013-1#2)
provides an opportunity to review##2##5##(2007-2#1)(2008-4#1)
provides an opportunity to##12##4##(1992-8#1)(1994-2#1)(1995-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-4#1)(2012-2#1)(2013-1#2)
provides an opportunity##18##3##(1992-8#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-12#1)(2006-1#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2009-4#1)(2012-2#1)(2013-1#4)
provides an outline of##2##4##(1996-2#1)(2008-11#1)
provides an overview of different##2##5##(2012-1#1)(2012-2#1)
provides an overview of recent##2##5##(2007-10#1)(2008-5#1)
provides an overview of the contribution of##2##7##(2009-4#1)(2011-1#1)
provides an overview of the current##2##6##(2009-2#1)(2013-1#1)
provides an overview of the field of##4##7##(2007-12#1)(2008-4#2)(2010-11#1)
provides an overview of the molecular mechanisms##2##7##(2007-12#1)(2011-3#1)
provides an overview of the types of##2##7##(1997-2#1)(2008-2#1)
provides an overview of the various##2##6##(2010-12#1)(2011-1#1)
provides an overview of the##51##5##(1993-2#1)(1993-3#4)(1994-1#1)(1994-12#1)(1994-3#1)(1996-3#1)(1997-1#1)(1997-2#1)(2005-8#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#6)(2008-7#1)(2008-8#1)(2009-1#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#5)(2011-1#2)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#3)(2013-8#1)
provides an overview of various##3##5##(1991-1#1)(2008-4#1)(2010-9#1)
provides an overview of##95##4##(1991-1#1)(1992-1#1)(1992-12#1)(1993-2#1)(1993-3#4)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-2#2)(2005-8#2)(2006-10#2)(2007-10#1)(2007-12#3)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#3)(2008-2#1)(2008-4#16)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#6)(2011-1#3)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
provides an update on the##2##5##(2008-1#1)(2011-1#1)
provides an update on##3##4##(2006-8#1)(2008-1#1)(2011-1#1)
provides an update##4##3##(2006-8#1)(2008-1#1)(2011-1#1)(2012-1#1)
provides an##337##2##(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#2)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-12#2)(1993-2#1)(1993-3#4)(1994-1#1)(1994-12#3)(1994-2#3)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-12#3)(1996-2#4)(1996-3#2)(1996-4#2)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#3)(1997-2#5)(1997-4#1)(1997-6#2)(1997-8#1)(2004-11#1)(2005-10#2)(2005-8#2)(2006-1#1)(2006-10#7)(2006-12#2)(2006-2#1)(2006-8#2)(2007-10#1)(2007-11#5)(2007-12#17)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#5)(2008-10#21)(2008-11#10)(2008-12#4)(2008-2#13)(2008-3#6)(2008-4#32)(2008-5#2)(2008-6#1)(2008-7#11)(2008-8#3)(2008-9#9)(2009-1#1)(2009-11#1)(2009-12#3)(2009-2#3)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#7)(2011-1#9)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#4)(2012-12#7)(2012-2#4)(2012-3#4)(2013-1#19)(2013-8#4)
provides analgesia##2##2##(2006-10#1)(2011-1#1)
provides analyses##2##2##(2008-1#1)(2008-8#1)
provides analytical##2##2##(2007-11#1)(2008-8#1)
provides and##4##2##(1996-12#1)(2007-11#1)(2008-4#1)(2012-2#1)
provides another##4##2##(1992-8#1)(2010-8#1)(2012-11#1)(2013-7#1)
provides background##5##2##(1991-12#1)(2008-9#1)(2009-4#1)(2012-12#1)(2012-2#1)
provides basic information##3##3##(2007-8#1)(2008-10#1)(2008-4#1)
provides basic##4##2##(2007-8#1)(2008-10#1)(2008-4#2)
provides better noise##2##3##(2008-2#1)(2013-7#1)
provides better##16##2##(2007-8#4)(2008-2#3)(2008-3#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
provides both a##3##3##(1993-4#1)(2006-8#1)(2010-11#1)
provides both an##2##3##(1993-12#1)(1996-12#1)
provides both##13##2##(1993-12#1)(1993-4#1)(1996-12#1)(2006-12#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-11#1)
provides brief##2##2##(1993-12#1)(1996-12#1)
provides cell##2##2##(2007-9#1)(2012-11#1)
provides clear evidence that##2##4##(2008-5#1)(2009-4#1)
provides clear##4##2##(2008-5#1)(2008-9#1)(2009-4#1)(2013-8#1)
provides clinically##2##2##(1996-9#1)(2006-8#1)
provides clues##2##2##(2008-9#1)(2011-2#1)
provides commonly used abbreviations for many terms used in##2##9##(2008-4#1)(2008-9#1)
provides compelling evidence that##2##4##(1990-11#1)(2008-2#1)
provides compelling evidence##4##3##(1990-11#1)(1995-3#1)(2008-2#1)(2010-8#1)
provides compelling##5##2##(1990-11#1)(1995-2#1)(1995-3#1)(2008-2#1)(2010-8#1)
provides complete##3##2##(2008-10#1)(2010-8#1)(2011-2#1)
provides comprehensive##2##2##(1996-9#1)(2007-12#1)
provides concise##2##2##(2006-12#1)(2008-9#1)
provides confirmation##2##2##(1995-8#1)(2007-11#1)
provides considerable detail##2##3##(1995-1#1)(2008-9#1)
provides considerable##4##2##(1995-1#1)(1996-1#1)(2008-10#1)(2008-9#1)
provides consistent##2##2##(2008-3#1)(2010-2#1)
provides coverage##2##2##(2007-2#1)(2008-3#1)
provides current##2##2##(2010-11#1)(2011-1#1)
provides data on##2##3##(2008-9#1)(2009-7#1)
provides data that##2##3##(1996-7#1)(2011-2#1)
provides data##6##2##(1996-7#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-11#1)(2011-2#1)
provides definitions##2##2##(1991-10#1)(2011-2#1)
provides detailed information##2##3##(2008-9#1)(2010-8#1)
provides detailed##9##2##(2005-11#1)(2008-4#3)(2008-9#4)(2010-8#1)
provides details of##2##3##(1995-11#1)(2007-4#1)
provides details on the##4##4##(1990-8#1)(2008-5#1)(2010-9#1)(2011-1#1)
provides details##6##2##(1990-8#1)(1995-11#1)(2007-4#1)(2008-5#1)(2010-9#1)(2011-1#1)
provides direct evidence##2##3##(2011-2#1)(2012-2#1)
provides direct##7##2##(1994-7#1)(2004-3#1)(2007-11#1)(2007-12#1)(2011-2#1)(2012-2#1)(2013-7#1)
provides dose-dependent##2##2##(2005-7#1)(2008-12#1)
provides easy##2##2##(1997-6#1)(2008-2#1)
provides effective##4##2##(2007-2#1)(2007-8#1)(2008-10#1)(2008-2#1)
provides efficient##2##2##(2008-10#1)(2008-3#1)
provides enhanced##3##2##(2007-12#1)(2008-10#1)(2009-11#1)
provides enough##3##2##(1995-11#1)(2006-12#1)(2008-10#1)
provides essential##2##2##(2008-1#1)(2008-9#1)
provides estimates of##2##3##(1996-1#1)(2012-1#1)
provides estimates##3##2##(1996-1#1)(1996-4#1)(2012-1#1)
provides even##2##2##(2008-2#1)(2008-3#1)
provides evidence against the##2##4##(2006-8#1)(2008-6#1)
provides evidence for a##7##4##(1992-7#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-10#1)(2010-10#1)
provides evidence for the##7##4##(1990-7#1)(1993-12#1)(1993-7#1)(1994-8#1)(1995-8#1)(1996-5#1)(1997-4#1)
provides evidence for##28##3##(1990-11#1)(1990-7#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-7#1)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-8#1)(1996-10#1)(1996-3#1)(1996-5#1)(1997-4#1)(2008-10#2)(2008-5#2)(2008-7#1)(2009-5#1)(2010-10#1)(2010-12#1)(2013-1#1)(2013-8#1)
provides evidence of the##2##4##(2008-10#1)(2010-5#1)
provides evidence of##7##3##(1992-3#1)(1995-6#1)(2008-10#2)(2008-11#1)(2010-5#1)(2011-2#1)
provides evidence that the##5##4##(1990-5#1)(1995-10#1)(1996-11#1)(2008-10#1)(2010-2#1)
provides evidence that##18##3##(1990-5#1)(1993-11#1)(1994-10#1)(1994-6#1)(1995-10#2)(1995-11#1)(1996-11#1)(2004-3#1)(2007-2#1)(2008-10#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-8#1)(2012-3#1)
provides evidence##58##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-7#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-4#1)(2004-3#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
provides evidences##2##2##(2010-12#1)(2012-11#1)
provides examples from the##2##4##(1993-12#1)(2008-7#1)
provides examples of how##3##4##(1997-3#1)(2008-12#1)(2010-11#1)
provides examples of##9##3##(1997-3#1)(2004-4#1)(2007-2#1)(2008-11#1)(2008-12#1)(2010-11#1)(2010-12#1)(2010-2#1)(2012-2#1)
provides examples##14##2##(1993-12#1)(1997-3#1)(2004-4#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2012-2#1)
provides excellent##16##2##(1991-12#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-6#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#2)(2011-7#1)(2012-2#1)
provides exquisite##2##2##(2008-12#1)(2012-2#1)
provides extremely##2##2##(2008-5#1)(2009-12#1)
provides fast##2##2##(2008-2#1)(2008-3#1)
provides flexibility##2##2##(2008-3#1)(2008-8#1)
provides for a##5##3##(1992-12#1)(1996-2#1)(1996-3#1)(2008-9#1)(2012-2#1)
provides for an##2##3##(1995-7#1)(2006-6#1)
provides for older adults and researchers##2##6##(2013-1#2)
provides for the##10##3##(1994-3#1)(1995-5#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-7#1)(2011-2#2)(2012-2#1)
provides for##29##2##(1992-12#1)(1994-3#1)(1995-5#2)(1995-7#1)(1996-2#1)(1996-3#1)(2006-6#1)(2006-7#2)(2007-2#1)(2007-5#2)(2008-10#2)(2008-3#2)(2008-4#1)(2008-9#3)(2009-1#1)(2009-7#1)(2011-2#2)(2012-2#2)(2013-1#2)
provides full##2##2##(2007-12#1)(2008-9#1)
provides fundamental##3##2##(2008-10#1)(2012-11#2)
provides further evidence for the##2##5##(2008-10#2)
provides further evidence for##3##4##(2008-10#2)(2008-7#1)
provides further evidence that a##2##5##(1991-2#1)(1994-8#1)
provides further evidence that##8##4##(1991-2#1)(1992-1#1)(1994-2#1)(1994-8#1)(1995-12#1)(1996-11#1)(1997-1#1)(1997-5#1)
provides further evidence##11##3##(1991-2#1)(1992-1#1)(1994-2#1)(1994-8#1)(1995-12#1)(1996-11#1)(1997-1#1)(1997-5#1)(2008-10#2)(2008-7#1)
provides further support for##3##4##(1990-11#1)(2008-10#1)(2013-8#1)
provides further support##4##3##(1990-11#1)(2006-12#1)(2008-10#1)(2013-8#1)
provides further##19##2##(1990-11#1)(1991-2#1)(1992-1#1)(1994-2#2)(1994-8#1)(1995-12#1)(1996-11#1)(1997-1#1)(1997-5#1)(2006-12#1)(2008-10#3)(2008-7#2)(2008-8#1)(2010-12#1)(2013-8#1)
provides good results##3##3##(2008-10#1)(2008-3#1)(2010-3#1)
provides good##17##2##(2005-9#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2009-6#1)(2010-12#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-12#2)
provides great##2##2##(2008-1#1)(2008-9#1)
provides greater protection##2##3##(2006-12#1)(2007-11#1)
provides greater##9##2##(2006-12#2)(2006-8#1)(2007-11#1)(2007-5#1)(2012-12#1)(2012-2#1)(2013-1#2)
provides guidance for##5##3##(2008-4#3)(2008-9#1)(2010-5#1)
provides guidance on##2##3##(1997-2#1)(2007-4#1)
provides guidance##8##2##(1993-1#1)(1997-2#1)(2007-4#1)(2008-4#3)(2008-9#1)(2010-5#1)
provides guidelines for##5##3##(1991-1#1)(1996-2#1)(2007-4#1)(2008-3#1)(2008-4#1)
provides guidelines to##2##3##(2006-9#1)(2008-1#1)
provides guidelines##9##2##(1991-1#1)(1996-2#1)(2006-8#1)(2006-9#1)(2007-4#1)(2008-1#1)(2008-3#1)(2008-4#2)
provides health care##2##3##(1991-4#1)(2008-12#1)
provides health##3##2##(1991-4#1)(2008-12#1)(2010-3#1)
provides high resolution##3##3##(2008-10#1)(2009-10#1)(2011-1#1)
provides high sensitivity and##2##4##(2007-11#1)(2008-3#1)
provides high sensitivity##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
provides high spectral resolution and high-throughput capabilities that##2##8##(2008-2#2)
provides high##24##2##(1997-4#1)(1997-5#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#5)(2008-3#4)(2008-6#1)(2009-10#1)(2011-1#1)
provides high-resolution images##2##3##(2007-12#1)(2012-2#1)
provides high-resolution##4##2##(2007-12#1)(2008-3#1)(2011-1#1)(2012-2#1)
provides higher resolution##2##3##(2007-12#1)(2008-4#1)
provides higher##9##2##(2006-12#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#2)(2010-9#1)(2011-1#1)
provides important information regarding##2##4##(2008-2#1)(2009-11#1)
provides important information##4##3##(2008-2#1)(2008-7#1)(2009-11#1)(2011-1#1)
provides important##10##2##(1993-3#1)(2007-1#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-11#2)(2011-1#1)
provides improved##5##2##(2006-2#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-12#1)
provides in vivo evidence for the##2##6##(1992-10#1)(1996-1#1)
provides in vivo##3##3##(1992-10#1)(1995-6#1)(1996-1#1)
provides in##6##2##(1992-10#1)(1995-12#1)(1995-6#1)(1996-1#1)(2012-12#1)(2012-2#1)
provides increased##2##2##(2007-12#1)(2008-3#1)
provides indications##2##2##(1991-6#1)(2008-10#1)
provides indirect##3##2##(1990-3#1)(1993-6#1)(2012-3#1)
provides information about the##15##4##(1996-1#1)(2005-8#1)(2007-12#2)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2011-2#1)
provides information about##20##3##(1996-1#1)(2005-8#1)(2007-12#2)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-11#1)
provides information concerning the##3##4##(1992-8#1)(1994-5#1)(2008-10#1)
provides information concerning##4##3##(1992-8#1)(1994-5#1)(1997-6#1)(2008-10#1)
provides information on the##11##4##(1991-6#1)(1995-11#1)(1997-4#1)(1997-7#1)(2006-5#1)(2006-6#2)(2008-1#1)(2008-5#1)(2008-6#1)(2008-9#1)
provides information on##20##3##(1991-5#1)(1991-6#1)(1992-3#1)(1995-11#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#2)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-8#1)(2011-12#1)
provides information regarding##3##3##(1995-3#1)(2008-2#1)(2011-12#1)
provides information##60##2##(1990-8#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-8#1)(1994-5#1)(1995-11#2)(1995-3#1)(1996-1#1)(1997-4#1)(1997-6#2)(1997-7#1)(2005-8#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#3)(2009-7#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-11#1)
provides initial##2##2##(1990-2#1)(1997-2#1)
provides insight in##2##3##(2008-10#1)(2008-12#1)
provides insight into both##2##4##(2006-7#1)(2011-2#1)
provides insight into the possible##2##5##(2006-6#1)(2007-10#1)
provides insight into the potential of##2##6##(2012-2#1)(2013-1#1)
provides insight into the##18##4##(1994-1#1)(2006-6#1)(2007-10#2)(2007-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-9#1)(2012-11#1)(2012-2#1)(2013-1#3)(2013-7#1)
provides insight into##27##3##(1994-1#1)(2006-6#1)(2006-7#1)(2007-10#2)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#2)(2009-3#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-7#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#3)(2013-7#1)
provides insight##30##2##(1994-1#1)(2006-6#1)(2006-7#1)(2007-10#2)(2007-12#2)(2007-6#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#2)(2009-3#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-7#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#3)(2013-7#1)
provides insights into the##8##4##(2008-2#1)(2008-4#2)(2008-5#1)(2010-11#1)(2010-4#1)(2011-2#1)(2013-1#1)
provides insights into##18##3##(1990-6#1)(2006-6#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-2#3)(2013-1#1)
provides instructions for##4##3##(2006-12#1)(2008-4#3)
provides interim recommendations##2##3##(1993-7#1)(1995-6#1)
provides its##2##2##(2008-5#1)(2010-12#1)
provides light##3##2##(1992-8#1)(1997-1#1)(2008-2#1)
provides limited##2##2##(2008-8#1)(2009-5#1)
provides links##2##2##(2008-4#2)
provides little##5##2##(1991-5#1)(1996-2#1)(2006-2#1)(2013-1#2)
provides lower##2##2##(2008-4#1)(2012-1#1)
provides managers with##2##3##(1993-12#1)(2009-3#1)
provides many##5##2##(2007-8#1)(2008-11#1)(2008-3#1)(2010-2#1)(2012-3#1)
provides maximum##2##2##(2008-2#2)
provides mechanisms for##2##3##(1990-9#1)(2007-9#1)
provides methods for the##3##4##(2008-2#1)(2008-4#2)
provides methods for##5##3##(2008-2#1)(2008-4#3)(2008-9#1)
provides methods##6##2##(2008-2#1)(2008-4#4)(2008-9#1)
provides minimal##4##2##(1993-2#1)(1996-12#1)(2006-2#1)(2008-9#1)
provides models##2##2##(1995-8#1)(2011-2#1)
provides molecular##6##2##(1993-6#1)(1995-11#1)(1996-5#1)(2008-10#1)(2011-2#1)(2013-1#1)
provides more##11##2##(1990-3#1)(1990-8#2)(2006-5#1)(2007-8#1)(2008-2#1)(2008-5#1)(2010-4#1)(2011-7#2)(2012-1#1)
provides much more##2##3##(2007-7#1)(2008-3#1)
provides much##5##2##(1994-7#1)(2004-1#1)(2007-7#1)(2008-3#1)(2012-12#1)
provides multiple##2##2##(2008-5#1)(2008-9#1)
provides national##2##2##(1997-2#1)(2013-8#1)
provides new information that##2##4##(2009-8#1)(2010-8#1)
provides new insight into##2##4##(1996-2#1)(2011-2#1)
provides new insight##3##3##(1996-2#1)(2009-8#1)(2011-2#1)
provides new insights into the##6##5##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-9#1)(2013-8#1)
provides new insights into##9##4##(1996-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-9#1)(2012-3#1)(2013-8#1)
provides new insights##13##3##(1996-2#2)(2006-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-9#1)(2011-1#1)(2012-3#1)(2013-8#1)
provides new opportunities for##2##4##(2007-7#1)(2013-1#1)
provides new opportunities##3##3##(2007-7#1)(2011-2#1)(2013-1#1)
provides new##31##2##(1993-8#1)(1995-5#1)(1996-2#3)(2006-12#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-8#2)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#3)
provides no evidence##2##3##(1990-12#1)(1996-3#1)
provides no information about##2##4##(2007-8#1)(2008-4#1)
provides no information##3##3##(2007-8#1)(2008-4#1)(2008-8#1)
provides no##10##2##(1990-12#2)(1991-4#1)(1995-1#1)(1996-3#1)(2006-3#1)(2007-8#1)(2008-4#1)(2008-8#1)(2011-2#1)
provides novel##5##2##(2005-10#1)(2007-8#1)(2008-10#1)(2012-2#1)(2013-1#1)
provides numerous##3##2##(2008-10#1)(2008-4#1)(2008-6#1)
provides one##4##2##(1997-8#1)(2008-12#1)(2013-1#2)
provides only a##2##3##(2006-1#1)(2008-1#1)
provides only##7##2##(1993-9#1)(2006-1#1)(2008-1#1)(2008-10#3)(2008-2#1)
provides opportunities for##3##3##(1995-1#1)(1995-12#1)(2008-12#1)
provides opportunities to##2##3##(1992-7#1)(2006-10#1)
provides opportunities##5##2##(1992-7#1)(1995-1#1)(1995-12#1)(2006-10#1)(2008-12#1)
provides optical##2##2##(2007-12#1)(2008-3#1)
provides optimal##3##2##(2005-12#1)(2007-8#1)(2008-1#1)
provides options for##2##3##(2006-4#1)(2011-2#1)
provides physiological##2##2##(1996-5#1)(2012-12#1)
provides population-based##2##2##(1993-9#1)(2011-2#1)
provides possible##2##2##(2007-8#1)(2009-11#1)
provides potential##2##2##(1993-2#1)(2013-8#1)
provides practical##3##2##(1995-12#1)(2010-12#1)(2012-12#1)
provides precise##2##2##(2008-3#1)(2008-7#1)
provides preliminary evidence that##2##4##(1992-7#1)(2008-12#1)
provides preliminary##6##2##(1992-7#1)(2006-12#1)(2007-2#1)(2008-12#1)(2011-1#1)(2011-2#1)
provides prognostic information for##2##4##(2006-10#1)(2008-1#1)
provides prognostic information##3##3##(2005-12#1)(2006-10#1)(2008-1#1)
provides protection##4##2##(1995-5#1)(1996-8#1)(2007-5#1)(2013-8#1)
provides protocols for##15##3##(2008-1#2)(2008-2#1)(2008-4#7)(2008-9#5)
provides protocols##20##2##(2008-1#3)(2008-2#1)(2008-4#10)(2008-9#6)
provides quantitative information##2##3##(2008-10#2)
provides quantitative##7##2##(1997-7#1)(2007-11#1)(2008-10#4)(2008-7#1)
provides radiologists with##3##3##(2007-4#1)(2013-1#2)
provides rapid##9##2##(1990-6#1)(1994-12#1)(2005-7#1)(2006-5#2)(2008-10#1)(2008-3#1)(2008-4#1)(2013-8#1)
provides readers with a##2##4##(2008-4#1)(2012-2#1)
provides readers with##3##3##(2007-4#1)(2008-4#1)(2012-2#1)
provides real-time##2##2##(2006-5#1)(2009-10#1)
provides reasonable##3##2##(2008-12#1)(2008-3#1)(2010-8#1)
provides reasonably##2##2##(1996-1#1)(2008-5#1)
provides recommendations for##6##3##(2006-9#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-9#1)
provides recommendations##8##2##(2006-9#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-10#1)(2010-9#1)(2011-2#1)
provides relative##2##2##(1997-1#1)(2008-10#1)
provides relatively high yields for fragments##2##6##(2008-2#1)(2008-4#1)
provides relatively##3##2##(2008-2#1)(2008-3#1)(2008-4#1)
provides reliable data in the 320-420-nm region##2##7##(2008-2#1)(2008-3#1)
provides reliable data##3##3##(2008-2#1)(2008-3#1)(2008-4#1)
provides reliable information on the##2##5##(2006-6#1)(2011-1#1)
provides reliable information on##3##4##(1991-2#1)(2006-6#1)(2011-1#1)
provides reliable##9##2##(1991-2#1)(1996-4#1)(2006-6#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-1#1)(2013-1#1)
provides resistance to##2##3##(2008-10#2)
provides results##3##2##(2008-10#1)(2008-11#1)(2011-12#1)
provides safe##2##2##(2010-7#1)(2012-2#1)
provides sensitive##2##2##(2008-10#1)(2008-2#1)
provides services to##2##3##(1995-3#1)(2007-2#1)
provides services##4##2##(1994-1#1)(1995-3#1)(2007-2#1)(2008-9#1)
provides several##7##2##(1992-3#1)(1995-4#1)(2007-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2013-1#1)
provides short-term##2##2##(1992-3#1)(2006-2#1)
provides significant##7##2##(1992-2#1)(1995-10#1)(1996-12#1)(2007-12#1)(2008-3#1)(2008-7#1)(2011-2#1)
provides significantly##2##2##(2007-12#1)(2008-3#1)
provides similar##4##2##(2006-8#1)(2008-10#1)(2008-2#1)(2013-1#1)
provides simultaneous##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
provides some insight##2##3##(1997-5#1)(2009-4#1)
provides some##19##2##(1992-12#1)(1994-2#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#3)(2012-2#1)(2013-1#1)(2013-7#1)
provides spatial##3##2##(1994-11#1)(2007-12#1)(2008-10#1)
provides specific##6##2##(1995-2#1)(2008-12#1)(2008-4#3)(2011-2#1)
provides spectra##2##2##(2007-12#1)(2008-2#1)
provides standardized ascertainment of mortality outcomes##2##6##(2013-1#2)
provides statistically##2##2##(2008-10#1)(2011-2#1)
provides step-by-step##2##2##(1993-3#1)(2008-12#1)
provides strategies##2##2##(2006-3#1)(2010-12#1)
provides strong evidence against##2##4##(1991-2#1)(1995-12#1)
provides strong evidence that the##3##5##(1996-1#1)(2006-2#1)(2008-7#1)
provides strong evidence that##6##4##(1991-3#1)(1996-1#1)(1997-4#1)(2006-2#1)(2008-7#1)(2012-3#1)
provides strong evidence##10##3##(1991-2#1)(1991-3#1)(1993-4#1)(1995-12#1)(1996-1#1)(1997-4#1)(2006-2#1)(2008-2#1)(2008-7#1)(2012-3#1)
provides strong support##2##3##(2012-3#2)
provides strong##13##2##(1991-2#1)(1991-3#1)(1993-4#1)(1995-12#1)(1996-1#1)(1997-4#1)(2006-2#1)(2008-2#1)(2008-7#1)(2012-1#1)(2012-3#3)
provides students with an##2##4##(1993-3#1)(2005-10#1)
provides substantial##5##2##(2006-10#1)(2007-11#1)(2008-7#1)(2009-11#1)(2010-3#1)
provides such a##2##3##(1997-1#1)(2008-11#1)
provides such##3##2##(1997-1#1)(2008-11#1)(2012-3#1)
provides sufficient##3##2##(1993-9#1)(2008-4#1)(2008-9#1)
provides suggestions##2##2##(1993-2#1)(2008-6#1)
provides support for a##3##4##(1994-3#1)(2008-2#1)(2009-6#1)
provides support for the##5##4##(2005-10#1)(2007-12#1)(2008-12#1)(2011-1#1)(2012-2#1)
provides support for##10##3##(1994-3#1)(2005-10#1)(2005-5#1)(2007-12#1)(2007-9#1)(2008-12#1)(2008-2#1)(2009-6#1)(2011-1#1)(2012-2#1)
provides temporary##2##2##(1992-1#1)(2005-12#1)
provides that##4##2##(1991-10#2)(1994-5#1)(2010-10#1)
provides the advantages of##2##4##(2008-3#1)(2012-2#1)
provides the background##2##3##(1996-12#1)(2008-9#1)
provides the basic biosafety information needed to perform the procedures detailed in this manual##2##14##(2008-4#1)(2008-9#1)
provides the basic##3##3##(2008-4#1)(2008-9#1)(2009-12#1)
provides the basis for the development of##2##7##(2009-5#1)(2012-1#1)
provides the basis for the##4##5##(1990-11#1)(2008-10#1)(2009-5#1)(2012-1#1)
provides the basis for##18##4##(1990-11#1)(1991-6#1)(1992-1#1)(1994-12#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-4#2)(2008-7#1)(2009-5#1)(2012-1#1)(2012-2#1)(2012-3#1)
provides the basis##19##3##(1990-11#1)(1991-6#1)(1992-1#1)(1994-12#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-4#2)(2008-7#1)(2009-5#1)(2012-1#2)(2012-2#1)(2012-3#1)
provides the best##7##3##(2006-10#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)
provides the clinician with a sensitive##2##6##(1990-4#1)(2005-11#1)
provides the clinician with a##3##5##(1990-4#1)(1993-11#1)(2005-11#1)
provides the correct##2##3##(1992-8#1)(2007-12#1)
provides the corresponding##2##3##(1996-5#1)(2006-12#1)
provides the essential##2##3##(2008-4#1)(2010-4#1)
provides the first evidence for##2##5##(1990-7#1)(1996-5#1)
provides the first evidence of##2##5##(1990-8#1)(1996-11#1)
provides the first evidence that##2##5##(1993-3#1)(2010-12#1)
provides the first evidence##6##4##(1990-7#1)(1990-8#1)(1993-3#1)(1996-11#1)(1996-5#1)(2010-12#1)
provides the first in vivo##2##5##(1990-8#1)(2012-1#1)
provides the first##21##3##(1990-2#1)(1990-7#2)(1990-8#2)(1992-7#1)(1993-3#1)(1995-2#1)(1996-11#1)(1996-5#1)(1997-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-2#1)(2010-1#1)(2010-12#2)(2012-1#2)
provides the flexibility##2##3##(2006-7#1)(2008-9#1)
provides the following##2##3##(1990-12#1)(2011-2#1)
provides the foundation for further##2##5##(2010-10#1)(2013-1#1)
provides the foundation for the##2##5##(1995-1#1)(2007-4#1)
provides the foundation for##4##4##(1995-1#1)(2007-4#1)(2010-10#1)(2013-1#1)
provides the framework for##3##4##(2008-1#1)(2013-1#2)
provides the framework##4##3##(2008-1#1)(2008-7#1)(2013-1#2)
provides the highest##3##3##(2008-1#1)(2008-5#1)(2010-4#1)
provides the latest##2##3##(1997-2#1)(2008-9#1)
provides the major##3##3##(1993-12#1)(1995-1#1)(2006-8#1)
provides the means to##6##4##(1995-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2013-1#2)
provides the means##7##3##(1995-5#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2013-1#2)
provides the most accurate prediction##2##5##(2008-5#2)
provides the most accurate##4##4##(2008-2#1)(2008-5#2)(2013-8#1)
provides the most##11##3##(1994-8#1)(1995-2#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-2#1)(2008-5#3)(2012-2#1)(2013-8#1)
provides the necessary##2##3##(2006-12#1)(2007-11#1)
provides the only##3##3##(1994-3#1)(2010-12#1)(2011-2#1)
provides the opportunity to##9##4##(1994-3#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#1)(2012-3#1)
provides the optimal##2##3##(2007-12#1)(2008-3#1)
provides the possibility of##3##4##(2008-1#1)(2008-11#1)(2012-1#1)
provides the possibility##4##3##(2008-1#1)(2008-10#1)(2008-11#1)(2012-1#1)
provides the potential to##2##4##(1994-8#1)(2008-10#1)
provides the rationale for a##2##5##(1996-10#1)(2010-11#1)
provides the rationale for##3##4##(1996-10#1)(2006-10#1)(2010-11#1)
provides the required##4##3##(2008-3#2)(2008-5#1)(2008-7#1)
provides the results##2##3##(1994-2#1)(2010-9#1)
provides the same##4##3##(2008-10#2)(2008-5#1)(2009-8#1)
provides the##237##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#2)(1990-8#3)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-12#4)(1994-2#2)(1994-3#4)(1994-8#3)(1994-9#1)(1995-1#2)(1995-2#2)(1995-5#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#2)(1997-1#1)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#3)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-12#3)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#5)(2007-12#11)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#17)(2008-11#3)(2008-12#2)(2008-2#11)(2008-3#14)(2008-4#11)(2008-5#7)(2008-7#4)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#3)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#3)(2011-8#1)(2012-1#5)(2012-12#1)(2012-2#6)(2012-3#4)(2013-1#8)(2013-8#2)
provides them with the##2##4##(1990-4#1)(2007-3#1)
provides these##4##2##(2005-11#1)(2007-1#1)(2007-6#1)(2008-9#1)
provides treatment##2##2##(2011-2#1)(2013-1#1)
provides two protocols for##4##4##(2008-4#3)(2008-9#1)
provides two protocols##5##3##(2008-4#4)(2008-9#1)
provides two##9##2##(1990-12#1)(2008-3#1)(2008-4#5)(2008-9#1)(2009-10#1)
provides two-dimensional##2##2##(2007-12#1)(2008-3#1)
provides unique##2##2##(2010-11#1)(2012-2#1)
provides universal##2##2##(2007-3#1)(2008-10#1)
provides us with a##4##4##(1992-1#1)(2008-6#1)(2008-9#2)
provides us with an##2##4##(2008-7#1)(2012-3#1)
provides us with##9##3##(1992-1#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-9#2)(2012-12#1)(2012-3#1)
provides useful information and##2##4##(2008-4#1)(2009-12#1)
provides useful information not##2##4##(2007-8#1)(2009-11#1)
provides useful information##7##3##(1992-10#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-11#1)(2009-12#1)(2010-8#1)
provides useful##13##2##(1992-10#1)(2005-4#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-11#1)(2009-12#1)(2010-3#1)(2010-7#1)(2010-8#1)
provides valuable information on the##3##5##(2008-5#1)(2012-1#1)(2012-2#1)
provides valuable information on##5##4##(1993-3#1)(2008-5#1)(2008-8#1)(2012-1#1)(2012-2#1)
provides valuable information to predict the##2##6##(2012-11#1)(2012-12#1)
provides valuable information##9##3##(1993-3#1)(2006-10#1)(2007-12#1)(2008-5#1)(2008-8#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)
provides valuable##13##2##(1993-3#1)(1994-7#1)(2006-10#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-11#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
provides vascular access##2##3##(2007-7#2)
provides very##6##2##(1991-1#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-4#2)
provides##2835##1##(1990-11#5)(1990-12#13)(1990-2#3)(1990-3#5)(1990-4#3)(1990-5#5)(1990-6#4)(1990-7#5)(1990-8#10)(1990-9#3)(1991-1#6)(1991-10#5)(1991-11#2)(1991-12#8)(1991-2#6)(1991-3#5)(1991-4#5)(1991-5#3)(1991-6#5)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#8)(1992-10#2)(1992-11#2)(1992-12#5)(1992-2#4)(1992-3#11)(1992-4#2)(1992-5#5)(1992-6#8)(1992-7#6)(1992-8#10)(1992-9#2)(1993-1#5)(1993-11#5)(1993-12#14)(1993-2#8)(1993-3#12)(1993-4#3)(1993-5#2)(1993-6#3)(1993-7#2)(1993-8#2)(1993-9#5)(1994-1#5)(1994-10#3)(1994-11#2)(1994-12#13)(1994-2#11)(1994-3#14)(1994-5#7)(1994-6#5)(1994-7#3)(1994-8#10)(1994-9#5)(1995-1#9)(1995-10#5)(1995-11#8)(1995-12#22)(1995-2#8)(1995-3#6)(1995-4#1)(1995-5#8)(1995-6#10)(1995-7#2)(1995-8#5)(1995-9#2)(1996-1#11)(1996-10#5)(1996-11#4)(1996-12#17)(1996-2#16)(1996-3#12)(1996-4#11)(1996-5#14)(1996-6#3)(1996-7#5)(1996-8#5)(1996-9#5)(1997-1#15)(1997-2#16)(1997-3#9)(1997-4#16)(1997-5#4)(1997-6#11)(1997-7#10)(1997-8#12)(2004-1#1)(2004-11#2)(2004-12#2)(2004-2#1)(2004-3#3)(2004-4#1)(2005-10#8)(2005-11#14)(2005-12#3)(2005-4#1)(2005-5#1)(2005-7#6)(2005-8#7)(2005-9#2)(2006-1#2)(2006-10#35)(2006-11#3)(2006-12#29)(2006-2#12)(2006-3#6)(2006-4#2)(2006-5#13)(2006-6#13)(2006-7#10)(2006-8#11)(2006-9#6)(2007-1#3)(2007-10#7)(2007-11#44)(2007-12#112)(2007-2#16)(2007-3#5)(2007-4#20)(2007-5#9)(2007-6#5)(2007-7#16)(2007-8#38)(2007-9#12)(2008-1#53)(2008-10#188)(2008-11#59)(2008-12#39)(2008-2#121)(2008-3#112)(2008-4#184)(2008-5#43)(2008-6#19)(2008-7#70)(2008-8#33)(2008-9#97)(2009-1#2)(2009-10#11)(2009-11#11)(2009-12#12)(2009-2#8)(2009-3#6)(2009-4#11)(2009-5#13)(2009-6#9)(2009-7#9)(2009-8#16)(2009-9#7)(2010-1#4)(2010-10#11)(2010-11#14)(2010-12#31)(2010-2#17)(2010-3#9)(2010-4#18)(2010-5#17)(2010-6#6)(2010-7#17)(2010-8#19)(2010-9#16)(2011-1#46)(2011-12#11)(2011-2#64)(2011-3#2)(2011-7#5)(2011-8#1)(2012-1#24)(2012-11#10)(2012-12#41)(2012-2#59)(2012-3#32)(2013-1#99)(2013-7#16)(2013-8#35)
providing &quot##2##2##(1992-12#1)(2012-1#1)
providing a balanced##2##3##(1995-12#1)(2013-1#1)
providing a better understanding of##2##5##(2010-12#1)(2012-12#1)
providing a brief overview of##2##5##(2006-5#1)(2011-1#1)
providing a brief##3##3##(2006-5#1)(2008-4#1)(2011-1#1)
providing a comprehensive##3##3##(1991-11#1)(2008-4#1)(2013-8#1)
providing a differential##2##3##(1990-6#1)(2008-3#1)
providing a direct##5##3##(1992-12#1)(2005-10#1)(2007-11#1)(2007-12#1)(2008-11#1)
providing a framework for##4##4##(1994-1#2)(2008-3#1)(2009-6#1)
providing a high##2##3##(2008-12#1)(2008-9#1)
providing a major##2##3##(2008-10#2)
providing a mean level of disease reduction of##2##8##(2008-10#2)
providing a means of##2##4##(1991-12#1)(2012-2#1)
providing a means##3##3##(1991-12#1)(2008-12#1)(2012-2#1)
providing a method##2##3##(1997-2#1)(2008-10#1)
providing a model##2##3##(2007-12#1)(2012-12#1)
providing a molecular basis for the Smad7-induced arrest of the cell cycle##2##12##(2012-12#2)
providing a molecular##3##3##(2012-12#2)(2013-8#1)
providing a more##3##3##(2005-10#1)(2006-10#1)(2012-2#1)
providing a new##7##3##(1995-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2012-3#1)
providing a novel access to the identification of the initial asymmetric signal generated by flow##2##15##(2012-12#2)
providing a novel##5##3##(2006-12#1)(2012-12#2)(2013-8#2)
providing a possible##4##3##(1993-1#1)(1996-8#1)(2008-10#1)(2011-2#1)
providing a potential##5##3##(1996-5#1)(2008-10#3)(2008-4#1)
providing a rationale for##2##4##(2008-11#1)(2008-4#1)
providing a ready source of##2##5##(2008-10#1)(2010-12#1)
providing a reliable##2##3##(2008-10#1)(2012-1#1)
providing a signal##2##3##(1995-6#1)(2007-3#1)
providing a similar##2##3##(1996-1#1)(2013-8#1)
providing a simple##2##3##(2006-5#1)(2011-1#1)
providing a single##2##3##(2008-3#1)(2012-2#1)
providing a solid##4##3##(2007-12#2)(2008-9#1)(2012-2#1)
providing a source of##2##4##(2005-10#1)(2005-7#1)
providing a suitable##2##3##(2008-10#2)
providing a temporary##2##3##(2008-9#1)(2010-8#1)
providing a tool##2##3##(2008-7#1)(2008-8#1)
providing a way to##2##4##(2007-11#1)(2010-4#1)
providing a##203##2##(1990-12#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#2)(1994-12#2)(1994-5#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#1)(1996-1#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-2#2)(1997-6#2)(2004-11#1)(2004-3#1)(2005-10#4)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-12#2)(2006-3#3)(2006-4#1)(2006-5#4)(2006-6#1)(2007-10#1)(2007-11#5)(2007-12#8)(2007-2#2)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#21)(2008-11#7)(2008-12#4)(2008-2#7)(2008-3#5)(2008-4#6)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#6)(2009-12#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-4#3)(2010-8#2)(2011-1#3)(2011-12#2)(2011-2#4)(2012-1#1)(2012-12#9)(2012-2#6)(2012-3#4)(2013-1#3)(2013-7#4)(2013-8#5)
providing abortions##3##2##(1994-2#2)(1997-2#1)
providing access for##2##3##(2006-8#1)(2008-4#1)
providing access to immunodetection reagents##2##5##(2008-2#1)(2008-4#1)
providing access to##9##3##(1994-2#1)(2007-12#1)(2008-2#1)(2008-4#3)(2008-8#1)(2010-12#1)(2012-2#1)
providing access##12##2##(1992-12#1)(1994-2#1)(2006-8#1)(2007-12#1)(2008-2#1)(2008-4#4)(2008-8#1)(2010-12#1)(2012-2#1)
providing additional information##2##3##(2008-10#1)(2008-2#1)
providing additional##7##2##(2006-2#1)(2008-10#3)(2008-2#1)(2013-1#2)
providing adequate##4##2##(1991-2#1)(2007-8#1)(2008-8#1)(2012-12#1)
providing aggressive##2##2##(2005-10#2)
providing all##2##2##(1995-12#1)(2009-10#1)
providing an additional##2##3##(1991-4#1)(2005-7#1)
providing an adequate##2##3##(1992-1#1)(2009-5#1)
providing an effective##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
providing an estimate of the##2##5##(1992-1#1)(2008-11#1)
providing an estimate##3##3##(1992-1#1)(1996-3#1)(2008-11#1)
providing an experimental##2##3##(1993-2#1)(2012-3#1)
providing an explanation##3##3##(1992-1#1)(1993-4#1)(1996-7#1)
providing an overview of##4##4##(2008-3#1)(2008-4#1)(2011-1#1)(2011-2#1)
providing an overview##5##3##(2008-3#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
providing an##48##2##(1991-4#1)(1992-1#3)(1992-7#1)(1993-2#1)(1993-4#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-3#1)(2004-3#1)(2005-7#1)(2006-3#1)(2007-11#2)(2007-12#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-7#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-1#2)(2011-2#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)
providing and##5##2##(1997-2#1)(2008-10#1)(2010-7#1)(2010-8#1)(2012-2#1)
providing appropriate##6##2##(1996-2#2)(2008-11#1)(2010-2#1)(2011-2#2)
providing as##2##2##(2008-3#1)(2013-7#1)
providing benefits to the##2##4##(1997-3#1)(2008-12#1)
providing better##8##2##(1991-2#1)(2005-10#1)(2008-11#2)(2008-3#1)(2008-7#2)(2011-2#1)
providing both##8##2##(1993-4#1)(1997-8#1)(2005-8#1)(2007-11#1)(2008-10#2)(2008-4#1)(2011-2#1)
providing care at##2##3##(1990-10#1)(1991-4#1)
providing care for##8##3##(1996-2#1)(2005-11#1)(2006-12#1)(2007-6#1)(2008-8#1)(2011-2#3)
providing care to a##2##4##(2009-5#1)(2010-9#1)
providing care to people with mental illness##2##7##(2011-1#2)
providing care to##16##3##(2006-1#1)(2007-10#1)(2007-6#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-5#3)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-11#1)
providing care##35##2##(1990-10#1)(1991-4#1)(1995-12#1)(1996-2#2)(1996-3#1)(2005-11#1)(2006-1#1)(2006-12#1)(2007-10#1)(2007-6#2)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#3)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-11#1)
providing clear##3##2##(1993-12#1)(2007-11#1)(2008-11#1)
providing clinical##6##2##(2007-11#1)(2008-1#1)(2008-11#1)(2008-8#1)(2010-12#1)(2012-12#1)
providing complete information on the##2##5##(2007-12#2)
providing comprehensive##2##2##(1995-12#1)(2010-9#1)
providing conclusive evidence##2##3##(2006-7#1)(2008-10#1)
providing consumer health information##2##4##(1993-1#1)(1997-3#1)
providing culturally##2##2##(2009-6#1)(2010-8#1)
providing current##2##2##(2010-9#1)(2012-2#1)
providing data on the##2##4##(2007-12#1)(2010-6#1)
providing data on##4##3##(2007-12#1)(2008-3#1)(2010-6#1)(2010-9#1)
providing descriptive##2##2##(1995-3#1)(2013-1#1)
providing detailed##3##2##(1996-3#1)(2008-5#1)(2011-1#1)
providing details of##2##3##(2008-11#1)(2012-12#1)
providing diagnostic##2##2##(2008-11#1)(2008-2#1)
providing direct evidence##2##3##(1995-2#1)(2011-2#1)
providing direct##5##2##(1995-2#1)(1996-2#1)(2007-9#1)(2008-1#1)(2011-2#1)
providing education##5##2##(2007-7#1)(2008-7#1)(2010-10#1)(2012-12#2)
providing educational##2##2##(1992-2#1)(2013-1#1)
providing effective##3##2##(1993-11#1)(1994-4#1)(2008-4#1)
providing efficient##2##2##(2007-4#1)(2010-8#1)
providing emergency##2##2##(1991-4#1)(2007-8#1)
providing estimates of##2##3##(1997-8#1)(2011-2#1)
providing evidence about##2##3##(2005-5#1)(2011-1#1)
providing evidence for the##5##4##(1991-5#1)(1992-12#1)(2008-3#1)(2010-3#1)(2011-1#1)
providing evidence for##11##3##(1991-5#1)(1992-12#1)(1992-6#1)(1994-9#2)(2008-1#1)(2008-3#1)(2008-4#1)(2009-10#1)(2010-3#1)(2011-1#1)
providing evidence of##2##3##(1994-11#1)(2009-12#1)
providing evidence that the##4##4##(1991-9#1)(2008-10#2)(2013-8#1)
providing evidence that##7##3##(1991-9#1)(1997-1#1)(2008-10#3)(2008-11#1)(2013-8#1)
providing evidence##22##2##(1991-5#1)(1991-9#1)(1992-12#1)(1992-6#1)(1994-11#1)(1994-9#2)(1997-1#1)(2005-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-12#1)(2010-3#1)(2011-1#2)(2013-8#1)
providing evidence-based##2##2##(2008-1#1)(2012-2#1)
providing examples of##2##3##(1996-3#1)(2013-8#1)
providing examples##3##2##(1996-3#1)(2010-7#1)(2013-8#1)
providing excellent##3##2##(1993-12#1)(2007-8#1)(2012-3#1)
providing experimental##2##2##(1995-3#1)(2009-3#1)
providing financial##2##2##(1993-1#1)(1993-12#1)
providing for the##2##3##(1992-12#1)(2010-10#1)
providing for##4##2##(1992-12#1)(2008-1#1)(2008-2#1)(2010-10#1)
providing further evidence of##2##4##(2009-10#1)(2013-7#1)
providing further evidence that this##2##5##(1991-12#1)(1997-7#1)
providing further evidence that##3##4##(1991-12#1)(1993-6#1)(1997-7#1)
providing further evidence##5##3##(1991-12#1)(1993-6#1)(1997-7#1)(2009-10#1)(2013-7#1)
providing further##7##2##(1991-12#1)(1993-6#1)(1997-7#1)(2008-11#2)(2009-10#1)(2013-7#1)
providing general##3##2##(1990-12#1)(1993-3#1)(2007-7#1)
providing good##3##2##(2007-11#1)(2008-9#1)(2011-1#1)
providing greater##4##2##(1993-11#1)(2004-12#1)(2007-4#1)(2010-11#1)
providing guidance##2##2##(2007-10#1)(2008-8#1)
providing health care services##2##4##(1996-12#1)(1996-2#1)
providing health care##4##3##(1996-12#1)(1996-2#1)(2007-6#1)(2008-12#1)
providing health services##2##3##(2011-1#1)(2011-2#1)
providing health##11##2##(1996-12#1)(1996-2#1)(2007-3#1)(2007-6#1)(2008-12#1)(2010-12#1)(2011-1#1)(2011-2#3)(2013-1#1)
providing high quality##3##3##(2007-11#1)(2008-11#1)(2011-1#1)
providing high resolution##2##3##(2007-1#1)(2008-2#1)
providing high##8##2##(2007-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-3#1)(2011-1#1)
providing high-quality##2##2##(2006-6#1)(2009-5#1)
providing home care##2##3##(1991-1#1)(1993-1#1)
providing home##3##2##(1991-1#1)(1993-1#1)(1995-3#1)
providing images##2##2##(2008-10#1)(2008-5#1)
providing immediate##2##2##(2008-4#1)(2008-8#1)
providing important information##2##3##(2008-10#1)(2008-4#1)
providing important##5##2##(2006-3#1)(2007-9#1)(2008-10#1)(2008-4#1)(2009-5#1)
providing improved##5##2##(1997-2#1)(2006-10#1)(2008-10#1)(2013-1#2)
providing information about##5##3##(1993-2#1)(2007-11#1)(2008-4#1)(2008-9#1)(2010-2#1)
providing information on the##4##4##(1990-11#1)(1997-3#1)(2008-10#1)(2013-1#1)
providing information on##11##3##(1990-11#1)(1990-4#1)(1994-1#1)(1994-9#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-11#1)(2010-5#1)(2013-1#1)
providing information regarding##2##3##(2008-4#2)
providing information to##2##3##(1996-2#1)(2009-9#1)
providing information##28##2##(1990-11#1)(1990-4#1)(1993-2#1)(1994-1#1)(1994-9#1)(1996-2#1)(1997-3#1)(2005-11#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-5#2)(2011-1#1)(2011-2#1)(2013-1#1)
providing informative##2##2##(2008-3#1)(2009-10#1)
providing insight into the nature of##2##6##(2008-1#1)(2008-9#1)
providing insight into##3##3##(2006-10#1)(2008-1#1)(2008-9#1)
providing insights into##2##3##(2008-10#1)(2008-7#1)
providing insights##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
providing integrated treatment##2##3##(2008-6#1)(2012-12#1)
providing it##2##2##(1993-3#1)(2008-10#1)
providing its##2##2##(1991-9#1)(2011-1#1)
providing key##2##2##(2008-5#1)(2010-7#1)
providing limited##2##2##(2007-4#1)(2008-4#1)
providing long-term##2##2##(2006-8#1)(2008-11#1)
providing many##2##2##(2006-12#1)(2008-5#1)
providing mental health care##2##4##(1991-1#1)(2012-11#1)
providing more accurate##2##3##(2008-3#1)(2012-3#1)
providing more detailed##3##3##(1997-8#1)(2005-11#1)(2010-2#1)
providing more##12##2##(1990-12#1)(1990-4#1)(1997-8#1)(2005-11#1)(2007-11#1)(2008-3#1)(2010-10#1)(2010-2#1)(2011-1#2)(2012-3#2)
providing new information##3##3##(1997-2#1)(2005-8#1)(2013-8#1)
providing new insights into the##2##5##(2007-12#1)(2008-5#1)
providing new insights into##3##4##(2007-12#1)(2008-5#1)(2012-1#1)
providing new##15##2##(1992-8#1)(1996-11#1)(1997-2#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-12#1)(2010-2#1)(2010-7#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
providing no##5##2##(1997-5#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
providing not only##2##3##(2004-2#1)(2008-5#1)
providing nutrients##2##2##(2004-4#1)(2011-2#1)
providing nutrition care##2##3##(1995-3#1)(2005-10#1)
providing objective##2##2##(2007-4#1)(2007-8#1)
providing opportunities for##2##3##(1993-8#1)(2009-3#1)
providing optimal##6##2##(1995-5#1)(2006-10#1)(2008-11#1)(2008-9#1)(2010-12#1)(2013-7#1)
providing pain relief##2##3##(2006-10#1)(2010-1#1)
providing patient##3##2##(2008-7#1)(2013-1#2)
providing patients##2##2##(2007-12#1)(2008-3#1)
providing precise##3##2##(2006-8#1)(2010-2#1)(2010-4#1)
providing preparation##2##2##(1993-12#1)(2010-1#1)
providing primary##2##2##(1997-4#1)(2008-1#1)
providing psychosocial##3##2##(1990-12#1)(1992-3#1)(2013-1#1)
providing quality##3##2##(1991-1#1)(2008-11#1)(2012-12#1)
providing quantitative##2##2##(2006-5#1)(2010-11#1)
providing real##2##2##(1991-12#1)(2006-10#1)
providing relief##2##2##(2007-8#1)(2008-11#1)
providing resources to##2##3##(2009-7#1)(2010-4#1)
providing resources##3##2##(2008-6#1)(2009-7#1)(2010-4#1)
providing responses##2##2##(2008-1#1)(2010-11#1)
providing safe##2##2##(2006-10#1)(2011-12#1)
providing satisfactory##2##2##(1993-1#1)(2007-12#1)
providing services to##2##3##(2007-3#1)(2012-2#1)
providing services##5##2##(1997-3#1)(2007-3#1)(2007-5#1)(2011-2#1)(2012-2#1)
providing significant advantages##2##3##(2006-4#1)(2008-10#1)
providing significant##4##2##(2006-4#1)(2007-3#1)(2008-10#1)(2011-12#1)
providing some##5##2##(2008-6#1)(2008-9#1)(2010-1#1)(2011-3#1)(2012-11#1)
providing spiritual care##4##3##(2009-11#1)(2011-1#3)
providing strong##2##2##(2008-2#1)(2011-1#1)
providing such information##2##3##(1997-3#1)(2008-4#1)
providing such##4##2##(1994-12#1)(1997-3#1)(2007-11#1)(2008-4#1)
providing sufficient##4##2##(2005-9#1)(2006-10#1)(2008-10#1)(2010-8#1)
providing support for the##4##4##(1993-1#1)(2012-1#1)(2012-12#1)(2012-3#1)
providing support for##7##3##(1993-1#1)(2007-12#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
providing support to##3##3##(1993-3#1)(2007-12#1)(2010-12#1)
providing support##12##2##(1993-1#1)(1993-3#1)(2007-12#2)(2008-11#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
providing technical##2##2##(1990-12#1)(2006-10#1)
providing temporary##2##2##(2010-10#1)(2011-2#1)
providing that##4##2##(1990-12#1)(1996-11#1)(1997-4#1)(2010-10#1)
providing the appropriate##2##3##(2010-7#1)(2013-8#1)
providing the basis for the##2##5##(2007-12#1)(2009-7#1)
providing the basis for##5##4##(1990-10#1)(1994-11#1)(1995-3#1)(2007-12#1)(2009-7#1)
providing the best##2##3##(2008-10#2)
providing the diagnosis##2##3##(1992-7#1)(2008-2#1)
providing the first direct evidence that##2##6##(1995-10#1)(1995-2#1)
providing the first##3##3##(1995-10#1)(1995-2#1)(2012-1#1)
providing the greatest##2##3##(2004-2#1)(2011-2#1)
providing the information##2##3##(1995-12#1)(1997-1#1)
providing the means for##2##4##(1993-3#1)(2006-12#1)
providing the necessary##4##3##(1995-2#1)(2006-11#1)(2010-12#1)(2012-12#1)
providing the##67##2##(1990-10#1)(1991-1#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-3#2)(1994-5#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-8#1)(1997-1#2)(1997-2#1)(2004-2#1)(2004-9#1)(2005-10#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-8#1)(2007-12#3)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-8#1)
providing therapy to##2##3##(1992-3#1)(2010-2#1)
providing therapy##3##2##(1992-3#1)(2006-10#1)(2010-2#1)
providing this##4##2##(1993-12#1)(1994-2#1)(1994-3#1)(2008-9#1)
providing timely##3##2##(1996-1#1)(2008-10#1)(2008-7#1)
providing training##2##2##(2007-4#1)(2008-1#1)
providing treatment##2##2##(2010-12#1)(2013-8#1)
providing universal##2##2##(1994-2#1)(2011-1#1)
providing useful##2##2##(2005-8#1)(2010-7#1)
providing valuable##3##2##(2006-7#1)(2010-8#1)(2011-1#1)
providing##1106##1##(1990-10#2)(1990-11#2)(1990-12#11)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#1)(1991-1#4)(1991-11#2)(1991-12#5)(1991-2#3)(1991-3#1)(1991-4#4)(1991-5#1)(1991-9#2)(1992-1#3)(1992-12#6)(1992-2#2)(1992-3#3)(1992-6#2)(1992-7#2)(1992-8#1)(1993-1#8)(1993-10#1)(1993-11#4)(1993-12#7)(1993-2#3)(1993-3#7)(1993-4#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-1#4)(1994-10#1)(1994-11#3)(1994-12#4)(1994-2#6)(1994-3#5)(1994-4#1)(1994-5#2)(1994-9#4)(1995-1#7)(1995-10#1)(1995-11#1)(1995-12#7)(1995-2#7)(1995-3#9)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#2)(1996-12#5)(1996-2#9)(1996-3#8)(1996-4#1)(1996-5#2)(1996-7#2)(1996-8#1)(1997-1#6)(1997-2#9)(1997-3#7)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#4)(2004-10#1)(2004-11#1)(2004-12#1)(2004-2#2)(2004-3#2)(2004-4#1)(2004-9#2)(2005-10#11)(2005-11#6)(2005-12#2)(2005-5#1)(2005-7#3)(2005-8#5)(2005-9#1)(2006-1#1)(2006-10#20)(2006-11#1)(2006-12#7)(2006-2#4)(2006-3#5)(2006-4#3)(2006-5#8)(2006-6#6)(2006-7#2)(2006-8#7)(2006-9#1)(2007-1#2)(2007-10#9)(2007-11#21)(2007-12#35)(2007-2#8)(2007-3#6)(2007-4#11)(2007-5#4)(2007-6#3)(2007-7#5)(2007-8#12)(2007-9#5)(2008-1#18)(2008-10#72)(2008-11#45)(2008-12#13)(2008-2#26)(2008-3#31)(2008-4#31)(2008-5#13)(2008-6#13)(2008-7#23)(2008-8#18)(2008-9#18)(2009-10#4)(2009-11#6)(2009-12#4)(2009-2#2)(2009-3#4)(2009-4#5)(2009-5#9)(2009-6#3)(2009-7#6)(2009-8#5)(2009-9#2)(2010-1#5)(2010-10#7)(2010-11#4)(2010-12#13)(2010-2#8)(2010-3#4)(2010-4#7)(2010-5#4)(2010-6#2)(2010-7#7)(2010-8#11)(2010-9#6)(2011-1#31)(2011-12#5)(2011-2#33)(2011-3#2)(2012-1#13)(2012-11#4)(2012-12#28)(2012-2#19)(2012-3#14)(2013-1#25)(2013-7#8)(2013-8#15)
province could##2##2##(2008-12#1)(2008-4#1)
province during##3##2##(2012-12#1)(2013-1#2)
province from##2##2##(2013-1#1)(2013-7#1)
province in eastern##2##3##(2008-8#1)(2009-6#1)
province in the##2##3##(1997-3#1)(2008-5#1)
province in##13##2##(1996-1#1)(1997-3#1)(2005-9#1)(2008-12#2)(2008-5#1)(2008-8#1)(2009-6#1)(2010-5#1)(2011-1#1)(2013-1#2)(2013-7#1)
province is##2##2##(2008-12#1)(2011-12#1)
province of Ontario##3##3##(2007-12#1)(2009-4#1)(2010-5#1)
province of Sancti Spiritus##2##4##(2007-11#2)
province of Varese##2##3##(1992-10#1)(1992-8#1)
province of##52##2##(1992-10#1)(1992-8#1)(1993-10#1)(1993-2#1)(1994-9#2)(1995-12#1)(1996-3#1)(1996-6#1)(1997-5#1)(2005-5#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#2)(2009-10#2)(2009-4#1)(2009-7#3)(2010-5#1)(2011-1#2)(2012-12#4)(2012-2#1)(2013-1#3)(2013-7#1)
province or territory##2##3##(2006-5#1)(2008-11#1)
province was##2##2##(2011-1#1)(2011-2#1)
province were##2##2##(2007-2#1)(2007-8#1)
province with##3##2##(1990-9#1)(1993-9#1)(2008-5#1)
province##183##1##(1990-9#1)(1991-7#2)(1992-1#1)(1992-10#6)(1992-8#1)(1993-1#1)(1993-10#1)(1993-2#1)(1993-9#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#2)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#1)(2005-4#1)(2005-5#1)(2005-9#2)(2006-2#2)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-2#3)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#4)(2008-11#2)(2008-12#19)(2008-3#1)(2008-4#4)(2008-5#7)(2008-6#1)(2008-8#5)(2009-10#2)(2009-4#3)(2009-6#1)(2009-7#5)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-9#1)(2011-1#16)(2011-12#4)(2011-2#6)(2012-11#1)(2012-12#10)(2012-2#7)(2012-3#5)(2013-1#13)(2013-7#3)
province)##2##1##(2007-6#1)(2013-7#1)
province-wide##3##1##(1991-2#1)(1994-1#1)(1996-1#1)
province]##12##1##(2010-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
provinces and##4##2##(2006-5#1)(2010-11#2)(2010-8#1)
provinces are##3##2##(2008-10#1)(2010-12#1)(2011-12#1)
provinces for##2##2##(2007-12#1)(2008-8#1)
provinces have##4##2##(1993-3#1)(2006-5#1)(2008-12#1)(2009-4#1)
provinces in China##3##3##(2008-5#1)(2008-9#1)(2011-12#1)
provinces in##11##2##(2005-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#1)(2011-12#2)(2013-8#2)
provinces of China##3##3##(2008-8#1)(2012-2#2)
provinces of##16##2##(1992-6#1)(2005-8#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#3)(2012-12#1)(2012-2#2)(2013-1#1)
provinces to##2##2##(1996-12#1)(2012-12#1)
provinces was##2##2##(2008-10#1)(2012-2#1)
provinces##114##1##(1992-12#1)(1992-6#1)(1993-3#2)(1994-2#1)(1994-6#1)(1996-12#1)(2005-8#2)(2006-2#1)(2006-5#6)(2006-8#3)(2007-1#2)(2007-12#4)(2007-2#1)(2007-5#2)(2007-7#1)(2008-1#1)(2008-10#18)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#8)(2008-9#2)(2009-12#1)(2009-4#7)(2009-7#1)(2010-11#2)(2010-12#1)(2010-8#7)(2011-12#6)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#5)
provincial and district##3##3##(2011-12#3)
provincial and federal##2##3##(1992-1#1)(1996-2#1)
provincial and national##3##3##(2007-7#1)(2009-5#1)(2012-3#1)
provincial and##12##2##(1992-1#1)(1993-1#1)(1993-2#1)(1996-2#1)(1997-5#1)(2007-7#1)(2009-5#1)(2010-12#1)(2011-12#3)(2012-3#1)
provincial government##6##2##(1992-2#1)(1995-2#1)(2009-4#1)(2011-12#2)(2012-12#1)
provincial governments##3##2##(2007-12#1)(2008-12#1)(2012-12#1)
provincial health directors##2##3##(2012-12#2)
provincial health##6##2##(1996-1#1)(2011-12#1)(2012-12#4)
provincial hospital##3##2##(1993-1#1)(2007-2#2)
provincial##71##1##(1991-1#1)(1991-3#1)(1992-1#1)(1992-2#1)(1993-1#2)(1993-2#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-5#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-3#2)(2009-4#5)(2009-5#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-8#5)(2010-9#1)(2011-12#6)(2012-12#9)(2012-3#2)(2013-8#1)
provincially##2##1##(2008-10#1)(2008-12#1)
proving a##2##2##(2008-10#1)(2013-8#1)
proving both##2##2##(2008-2#1)(2010-10#1)
proving hard metal exposure##2##4##(1994-6#2)
proving that the##3##3##(1990-9#1)(2008-10#2)
proving that##11##2##(1990-8#1)(1990-9#1)(1993-6#1)(1996-6#1)(2007-12#1)(2007-5#1)(2008-10#2)(2010-8#1)(2013-1#1)(2013-8#1)
proving the value of##2##4##(2007-5#1)(2009-4#1)
proving the##15##2##(1991-3#1)(2005-8#1)(2005-9#1)(2007-1#1)(2007-12#2)(2007-5#1)(2008-10#2)(2008-12#1)(2008-2#1)(2009-4#1)(2012-12#2)(2013-7#1)
proving to be a##2##4##(2008-4#1)(2012-12#1)
proving to be##9##3##(2006-10#2)(2006-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-4#1)(2012-12#1)
proving to have##2##3##(2005-11#1)(2011-1#1)
proving to##12##2##(2005-11#1)(2006-10#2)(2006-12#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-4#1)(2011-1#1)(2012-12#1)
proving##58##1##(1990-12#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-3#1)(1993-6#1)(1994-12#1)(1994-6#2)(1996-6#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-8#1)(2007-1#3)(2007-12#3)(2007-5#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-1#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
proviral DNA in blood##2##4##(1990-11#1)(2008-5#1)
proviral DNA in##3##3##(1990-11#1)(2008-4#1)(2008-5#1)
proviral DNA was##2##3##(1991-9#1)(2008-5#1)
proviral DNA##9##2##(1990-11#1)(1991-9#1)(1992-12#1)(1996-4#1)(1997-3#1)(2008-4#1)(2008-5#2)(2008-9#1)
proviral cell line##2##3##(2008-9#2)
proviral integration##2##2##(1994-8#1)(2008-2#1)
proviral sequences##3##2##(1990-6#1)(1991-12#1)(2008-5#1)
proviral##28##1##(1990-11#1)(1990-6#1)(1991-12#1)(1991-5#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-9#1)(1994-12#1)(1994-3#2)(1994-7#2)(1994-8#1)(1996-4#1)(1997-1#1)(1997-3#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-9#3)(2012-12#1)
provirus in the##2##3##(1994-3#2)
provirus tagging##3##2##(1991-5#3)
provirus##17##1##(1990-2#2)(1991-12#2)(1991-5#4)(1994-3#2)(1994-5#1)(1994-8#1)(1996-4#2)(2008-11#1)(2008-5#1)(2008-9#1)
proviruses##7##1##(1991-5#2)(1995-2#1)(1995-8#1)(1996-4#1)(2008-4#2)
provision and##7##2##(1996-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2010-1#1)(2012-3#1)
provision during##3##2##(1996-5#1)(2009-9#1)(2013-8#1)
provision for the##2##3##(2008-7#1)(2012-12#1)
provision for##15##2##(1993-5#1)(1994-1#2)(1994-5#1)(1995-2#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-11#1)(2011-1#1)(2012-11#1)(2012-12#3)
provision have##2##2##(2007-9#1)(2013-8#1)
provision in the##2##3##(1990-12#1)(1995-11#1)
provision in##6##2##(1990-12#1)(1995-11#1)(2005-5#1)(2007-2#1)(2008-11#1)(2012-2#1)
provision is##4##2##(2006-2#1)(2006-9#1)(2012-1#1)(2012-12#1)
provision of a group home##2##5##(2007-12#2)
provision of a public good##2##5##(1993-2#1)(2008-10#1)
provision of a##11##3##(1993-2#1)(1994-12#1)(1994-2#1)(2007-12#2)(2008-10#2)(2008-5#1)(2010-8#1)(2011-1#1)(2012-12#1)
provision of adequate##7##3##(2005-12#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-11#1)(2008-5#1)(2011-1#1)
provision of an##2##3##(1990-9#1)(2008-1#1)
provision of appropriate##4##3##(1995-9#1)(2007-3#1)(2008-11#1)(2008-8#1)
provision of care##4##3##(1995-3#1)(1997-8#1)(2007-9#1)(2011-1#1)
provision of family-centered##2##3##(1993-12#1)(2010-9#1)
provision of formal##2##3##(2008-7#1)(2011-1#1)
provision of health services##2##4##(1997-5#1)(2012-3#1)
provision of health##10##3##(1992-3#1)(1995-2#1)(1996-1#1)(1996-3#1)(1997-5#1)(2006-8#1)(2007-6#1)(2008-4#1)(2012-12#1)(2012-3#1)
provision of incentives##2##3##(1994-3#1)(1996-12#1)
provision of information##3##3##(1996-1#1)(1997-3#1)(2007-7#1)
provision of medical services##2##4##(1996-2#1)(2010-5#1)
provision of medical##3##3##(1996-2#1)(2010-5#1)(2011-2#1)
provision of mental##3##3##(1994-1#1)(2008-12#1)(2009-4#1)
provision of new##2##3##(2007-11#1)(2008-11#1)
provision of preventive##2##3##(1994-2#1)(2007-2#1)
provision of quality##3##3##(1992-2#1)(1994-2#2)
provision of safe and##3##4##(2008-12#1)(2010-10#1)(2013-8#1)
provision of services##8##3##(1990-2#1)(1992-12#1)(1993-2#1)(1996-3#1)(2004-12#1)(2005-5#1)(2007-12#1)(2008-10#1)
provision of specific##2##3##(2005-11#1)(2006-2#1)
provision of systematic##2##3##(2011-1#2)
provision of the##7##3##(1990-12#1)(1995-1#1)(1995-12#1)(1995-9#1)(2006-10#1)(2012-3#1)(2013-1#1)
provision of this##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
provision of##188##2##(1990-12#3)(1990-2#1)(1990-9#1)(1991-10#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-12#2)(1993-2#3)(1994-1#2)(1994-12#1)(1994-2#4)(1994-3#2)(1995-1#1)(1995-12#3)(1995-2#2)(1995-3#3)(1995-5#1)(1995-9#2)(1996-1#3)(1996-12#3)(1996-2#5)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-5#3)(1997-8#1)(2004-11#1)(2004-12#1)(2004-7#1)(2004-8#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-5#1)(2006-10#8)(2006-2#2)(2006-5#2)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#4)(2007-3#1)(2007-4#2)(2007-6#2)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#7)(2008-11#8)(2008-12#4)(2008-2#1)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#3)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#2)(2010-8#3)(2010-9#1)(2011-1#12)(2011-2#2)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#5)(2013-8#2)
provision to##3##2##(1991-1#1)(2007-9#1)(2010-7#1)
provision with##2##2##(2007-3#1)(2013-1#1)
provision##275##1##(1990-12#4)(1990-2#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#3)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-12#2)(1993-2#3)(1993-3#1)(1993-5#1)(1994-1#4)(1994-12#1)(1994-2#4)(1994-3#2)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#4)(1995-5#1)(1995-9#2)(1996-1#4)(1996-12#3)(1996-2#7)(1996-3#3)(1996-5#3)(1997-1#1)(1997-2#4)(1997-3#4)(1997-5#3)(1997-7#2)(1997-8#1)(2004-11#1)(2004-12#1)(2004-7#2)(2004-8#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-5#3)(2006-10#8)(2006-2#3)(2006-5#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#5)(2007-3#2)(2007-4#2)(2007-6#3)(2007-7#3)(2007-8#3)(2007-9#3)(2008-1#8)(2008-10#7)(2008-11#12)(2008-12#7)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#7)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#14)(2011-2#4)(2012-1#2)(2012-11#3)(2012-12#9)(2012-2#6)(2012-3#5)(2013-1#6)(2013-8#8)
provisional diagnosis of##6##3##(2006-4#1)(2007-7#1)(2011-1#2)(2012-2#2)
provisional diagnosis##10##2##(2006-4#1)(2007-7#1)(2010-10#1)(2011-1#2)(2012-2#5)
provisional material##2##2##(2010-2#2)
provisional prosthetic materials##3##3##(2010-2#3)
provisional restoration##2##2##(2007-9#1)(2008-4#1)
provisional restorations##2##2##(2009-8#1)(2012-2#1)
provisional total of##2##3##(1991-6#1)(1995-3#1)
provisional##51##1##(1990-5#1)(1991-6#1)(1992-12#1)(1992-6#1)(1993-2#1)(1995-3#1)(1995-6#1)(1997-1#1)(2005-5#1)(2006-11#1)(2006-4#1)(2007-1#1)(2007-3#2)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-4#2)(2008-9#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#5)(2011-1#5)(2012-2#10)(2012-7#1)(2013-1#3)
provisionally unique##2##2##(1996-12#2)
provisionally##10##1##(1990-8#1)(1991-9#1)(1992-4#1)(1994-6#1)(1996-12#2)(2007-4#1)(2007-7#1)(2008-10#2)
provisioning of##4##2##(2006-7#1)(2009-10#1)(2009-4#1)(2012-12#1)
provisioning##11##1##(2006-7#1)(2007-3#1)(2007-7#1)(2008-6#1)(2008-9#2)(2009-10#3)(2009-4#1)(2012-12#1)
provisions are##2##2##(1993-3#1)(2007-4#1)
provisions for##5##2##(1994-1#1)(1995-1#1)(2008-7#1)(2012-12#1)(2012-3#1)
provisions included##2##2##(1991-10#1)(1995-1#1)
provisions of a##2##3##(1992-6#1)(1995-9#1)
provisions of the Act##2##4##(1991-10#1)(1993-4#1)
provisions of the##12##3##(1991-1#1)(1991-10#1)(1992-1#1)(1993-2#1)(1993-4#1)(1994-3#1)(1995-9#1)(2005-5#2)(2010-12#1)(2010-5#1)(2010-9#1)
provisions of##18##2##(1991-1#1)(1991-10#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-4#1)(1994-3#1)(1995-9#2)(1996-1#1)(2005-5#2)(2007-4#1)(2010-12#1)(2010-5#1)(2010-9#1)
provisions that##2##2##(1991-3#1)(1993-1#1)
provisions to##2##2##(1991-10#1)(2008-11#1)
provisions##68##1##(1990-12#1)(1991-1#1)(1991-10#4)(1991-12#1)(1991-3#3)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#3)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#1)(1994-1#1)(1994-3#2)(1995-1#3)(1995-2#1)(1995-9#2)(1996-1#1)(1997-1#1)(1997-8#1)(2005-1#1)(2005-11#1)(2005-5#2)(2006-6#1)(2006-7#1)(2007-2#2)(2007-4#6)(2007-9#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#2)
provitamin A##2##2##(1992-9#1)(2006-12#1)
provocation by##2##2##(1996-2#1)(2004-12#1)
provocation discography##2##2##(2006-8#2)
provocation of pain by##2##4##(1990-6#2)
provocation of##3##2##(1990-6#2)(1991-3#1)
provocation positive##2##2##(2006-8#2)
provocation test was##2##3##(1994-6#1)(2013-1#1)
provocation test with##2##3##(2007-7#1)(2012-3#1)
provocation test##11##2##(1993-12#1)(1994-6#2)(1996-12#1)(2007-10#1)(2007-7#2)(2010-6#2)(2012-3#1)(2013-1#1)
provocation tests are##2##3##(1997-1#1)(2010-8#1)
provocation tests##12##2##(1990-6#1)(1994-6#1)(1997-1#1)(1997-3#4)(2007-7#2)(2007-8#1)(2010-8#1)(2013-1#1)
provocation##48##1##(1990-6#3)(1991-3#2)(1993-12#1)(1994-6#4)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#4)(2004-12#1)(2006-11#2)(2006-12#4)(2006-7#1)(2006-8#4)(2007-10#1)(2007-11#1)(2007-7#4)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-11#1)(2010-6#2)(2010-8#1)(2012-3#2)(2013-1#2)
provocative and##3##2##(1993-12#1)(1997-1#1)(2012-1#1)
provocative discography##6##2##(2006-8#5)(2007-11#1)
provocative test##2##2##(1992-10#1)(2007-11#1)
provocative testing##3##2##(2006-2#1)(2007-11#1)(2012-3#1)
provocative tests##10##2##(1997-6#1)(2006-1#1)(2006-11#1)(2006-8#4)(2007-11#2)(2007-8#1)
provocative##38##1##(1992-10#1)(1993-12#1)(1994-2#1)(1995-2#1)(1996-3#1)(1997-1#1)(1997-6#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-8#9)(2007-11#5)(2007-8#1)(2008-4#3)(2008-7#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
provoke a##8##2##(1990-10#1)(1991-1#1)(1993-3#1)(1994-5#1)(2007-11#1)(2008-4#1)(2010-4#1)(2011-1#1)
provoke##37##1##(1990-10#1)(1991-1#1)(1992-2#1)(1993-3#1)(1994-5#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-8#1)(1997-6#1)(2004-11#2)(2005-1#1)(2005-11#2)(2005-6#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-7#1)(2009-5#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
provoked a##6##2##(1993-11#1)(1994-8#1)(1994-9#1)(2006-4#1)(2008-6#1)(2011-2#1)
provoked by the##5##3##(1993-11#1)(2008-1#1)(2008-10#1)(2009-7#1)(2013-1#1)
provoked by##18##2##(1990-8#1)(1993-11#1)(1995-3#1)(1996-12#1)(1997-5#1)(2004-12#1)(2005-12#1)(2006-7#2)(2007-7#1)(2008-1#1)(2008-10#2)(2009-7#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
provoked the##4##2##(1992-3#1)(1994-12#1)(1995-12#1)(1996-8#1)
provoked##53##1##(1990-12#1)(1990-8#1)(1991-2#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-11#2)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#3)(1995-3#1)(1996-12#1)(1996-3#1)(1996-8#2)(1996-9#1)(1997-5#1)(2004-12#4)(2005-12#1)(2005-7#1)(2006-10#1)(2006-4#1)(2006-7#2)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-7#2)(2009-8#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
provokes a##3##2##(1997-7#1)(2012-2#1)(2012-3#1)
provokes an##2##2##(2005-11#1)(2011-2#1)
provokes the development of##2##4##(2009-7#1)(2011-1#1)
provokes##20##1##(1990-6#2)(1991-5#1)(1994-12#1)(1994-2#2)(1997-7#1)(2005-11#1)(2006-6#1)(2007-9#1)(2008-7#1)(2009-10#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
provoking and##2##2##(2008-11#1)(2008-7#1)
provoking##20##1##(1992-8#1)(1993-5#1)(1993-6#1)(1994-6#1)(1995-1#1)(1997-5#1)(2005-1#1)(2006-6#2)(2007-11#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2013-1#1)(2013-7#1)
prowazekii##3##1##(1994-12#2)(1995-12#1)
prowess##2##1##(1992-4#1)(2006-10#1)
proxies for the##2##3##(1992-1#1)(2008-7#1)
proxies for##3##2##(1992-1#1)(2008-7#1)(2011-1#1)
proxies##11##1##(1992-1#1)(1992-12#3)(2008-7#5)(2008-8#1)(2011-1#1)
proximal AVF##4##2##(2007-7#4)
proximal VS cells and##2##4##(2008-11#2)
proximal VS cells##3##3##(2008-11#3)
proximal anastomoses of##2##3##(2007-8#2)
proximal anastomosis was##2##3##(2005-10#1)(2007-8#1)
proximal anastomosis##6##2##(2005-10#1)(2007-8#5)
proximal anastomotic devices##3##3##(2010-8#3)
proximal anastomotic##5##2##(2007-8#1)(2010-8#4)
proximal and distal arm movements##3##5##(1993-9#3)
proximal and distal to##3##4##(1993-12#1)(2007-8#1)(2009-11#1)
proximal and distal##32##3##(1990-4#1)(1991-11#1)(1993-1#2)(1993-12#1)(1993-9#3)(1995-3#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-6#3)(2007-12#2)(2007-8#1)(2008-11#1)(2008-6#2)(2008-7#1)(2009-11#2)(2009-2#1)(2009-5#1)(2009-7#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
proximal and##39##2##(1990-4#1)(1991-11#1)(1992-5#1)(1993-1#2)(1993-12#1)(1993-9#3)(1995-3#1)(1997-2#2)(1997-8#1)(2006-10#1)(2006-6#3)(2007-12#2)(2007-8#2)(2008-11#3)(2008-5#1)(2008-6#2)(2008-7#1)(2009-11#2)(2009-2#1)(2009-5#1)(2009-7#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
proximal aortic##2##2##(1995-8#1)(2007-8#1)
proximal articular set angle##2##4##(2008-7#2)
proximal artificial caries##2##3##(2013-8#2)
proximal bond##2##2##(1994-5#2)
proximal caries##2##2##(2008-12#1)(2010-3#1)
proximal colon##9##2##(1992-8#1)(1993-11#2)(1994-12#1)(1996-12#1)(1996-2#1)(1997-4#1)(2008-12#1)(2012-12#1)
proximal components##2##2##(1996-1#1)(2013-7#1)
proximal contact##2##2##(1990-9#1)(2010-12#1)
proximal convoluted tubules##2##3##(1992-7#1)(2007-5#1)
proximal convoluted##3##2##(1992-7#2)(2007-5#1)
proximal cortical##2##2##(2013-8#2)
proximal dendrites##12##2##(1991-5#1)(1992-1#3)(1993-12#1)(1994-2#2)(1995-8#1)(1996-6#2)(1996-8#1)(1997-2#1)
proximal dendritic##2##2##(1992-1#1)(2010-11#1)
proximal element##2##2##(1991-5#1)(2008-5#1)
proximal end in##2##3##(2007-11#1)(2008-12#1)
proximal end of the femur##6##5##(2005-9#1)(2007-11#5)
proximal end of the##12##4##(1995-6#1)(1996-2#1)(2005-9#1)(2007-11#6)(2007-8#1)(2008-6#1)(2013-7#1)
proximal end of##14##3##(1995-6#1)(1996-2#1)(1997-7#1)(2005-9#1)(2007-11#6)(2007-8#1)(2008-6#1)(2013-7#1)(2013-8#1)
proximal end##17##2##(1995-6#1)(1996-2#1)(1997-7#1)(2005-9#1)(2007-11#7)(2007-8#1)(2008-12#1)(2008-6#1)(2011-2#1)(2013-7#1)(2013-8#1)
proximal ends of the##2##4##(2006-11#1)(2007-11#1)
proximal ends of##3##3##(2006-11#1)(2007-11#1)(2008-5#1)
proximal ends##4##2##(2006-11#1)(2007-11#1)(2008-5#1)(2011-1#1)
proximal epiphysis##8##2##(2007-11#5)(2007-8#2)(2009-2#1)
proximal femoral bone resorption in hybrid total hip arthroplasty##2##9##(2009-3#2)
proximal femoral growth plate in children with unilateral Perthes disease##2##10##(2007-11#2)
proximal femoral growth plate##3##4##(2007-11#3)
proximal femoral##13##2##(2007-11#3)(2007-7#3)(2008-6#2)(2009-3#2)(2012-2#1)(2013-1#1)(2013-7#1)
proximal femur and##2##3##(2007-11#1)(2011-2#1)
proximal femur fractures in children##2##5##(2009-3#2)
proximal femur fractures in##3##4##(2007-11#1)(2009-3#2)
proximal femur fractures##6##3##(2007-11#1)(2007-8#2)(2009-3#3)
proximal femur is a##2##4##(2007-5#1)(2007-7#1)
proximal femur using the##2##4##(2009-3#1)(2011-2#1)
proximal femur##63##2##(2005-12#1)(2006-10#1)(2006-2#1)(2007-11#19)(2007-4#1)(2007-5#3)(2007-7#20)(2007-8#3)(2008-6#3)(2009-3#5)(2011-2#4)(2013-1#2)
proximal fragment##5##2##(1991-6#1)(1995-10#1)(2006-3#3)
proximal gastric##2##2##(1993-2#1)(2013-1#1)
proximal half of the##3##4##(1992-9#1)(2008-6#1)(2012-2#1)
proximal heme##3##2##(1990-8#1)(1991-9#1)(1992-12#1)
proximal histidine##6##2##(1991-7#1)(1994-5#1)(1995-2#2)(2007-11#1)(2009-3#1)
proximal humeral plate can provide##2##5##(2013-1#2)
proximal humeral plate##3##3##(2013-1#3)
proximal humeral##8##2##(2007-11#1)(2009-3#1)(2010-7#3)(2013-1#3)
proximal humerus fractures are##2##4##(2007-8#2)
proximal humerus fractures##7##3##(2007-11#1)(2007-8#6)
proximal humerus of a dog##2##5##(2012-3#2)
proximal humerus of##3##3##(1996-11#1)(2012-3#2)
proximal humerus##23##2##(1996-11#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#8)(2008-6#4)(2009-3#2)(2009-4#1)(2010-7#1)(2012-3#2)
proximal hypospadias##6##2##(2008-10#1)(2009-10#2)(2009-5#3)
proximal interphalangeal joint##6##3##(2006-3#2)(2006-4#1)(2007-7#1)(2008-9#2)
proximal interphalangeal joints##3##3##(2006-10#2)(2012-3#1)
proximal interphalangeal##15##2##(2006-10#2)(2006-3#2)(2006-4#1)(2007-7#1)(2008-12#1)(2008-9#6)(2011-2#1)(2012-3#1)
proximal jejunum##4##2##(2006-8#1)(2008-10#1)(2010-12#1)(2013-7#1)
proximal left subclavian artery##2##4##(2007-8#2)
proximal left##3##2##(2007-8#2)(2008-4#1)
proximal ligand of sperm whale##2##5##(1994-5#2)
proximal ligand##5##2##(1994-5#4)(1995-5#1)
proximal limb##4##2##(2006-3#2)(2008-6#1)(2011-2#1)
proximal location##3##2##(1991-6#1)(1997-9#1)(2006-12#1)
proximal migration##3##2##(2009-3#3)
proximal muscle weakness##4##3##(2006-10#2)(2006-4#1)(2011-1#1)
proximal nerve##2##2##(2006-3#1)(2008-9#1)
proximal obstruction##2##2##(1993-1#1)(1997-8#1)
proximal occlusion in##2##3##(1997-3#1)(2008-7#1)
proximal occlusion##3##2##(1997-3#2)(2008-7#1)
proximal of##3##2##(1994-9#1)(1995-6#1)(2010-2#1)
proximal one##2##2##(2008-7#1)(2009-3#1)
proximal or distal##2##3##(1992-9#1)(2007-8#1)
proximal or##3##2##(1992-9#1)(2007-8#1)(2011-2#1)
proximal outcomes##2##2##(2010-3#2)
proximal part of the femur##2##5##(2007-5#1)(2011-12#1)
proximal part of the##8##4##(1991-5#1)(1993-12#1)(2007-5#1)(2008-7#1)(2011-12#1)(2012-12#2)(2013-8#1)
proximal part of##10##3##(1991-5#1)(1993-12#1)(2007-11#1)(2007-5#1)(2008-7#1)(2011-12#1)(2012-12#2)(2012-2#1)(2013-8#1)
proximal part##12##2##(1991-5#1)(1993-12#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-7#1)(2009-3#1)(2011-12#1)(2012-12#2)(2012-2#1)(2013-8#1)
proximal patency##2##2##(1993-1#2)
proximal phalangeal##2##2##(2006-3#2)
proximal phalanges##2##2##(2008-9#1)(2009-5#1)
proximal phalanx of##2##3##(2008-12#1)(2010-3#1)
proximal phalanx##5##2##(2008-12#1)(2010-3#3)(2012-2#1)
proximal pole fractures##2##3##(2006-3#2)
proximal pole##3##2##(2006-3#3)
proximal portions of##2##3##(2009-7#1)(2012-3#1)
proximal primary##2##2##(2007-12#1)(2008-6#1)
proximal promoter elements##2##3##(1994-12#2)
proximal promoter region##3##3##(1992-5#1)(1993-4#1)(1993-6#1)
proximal promoter##12##2##(1990-11#1)(1991-4#1)(1992-5#1)(1993-4#1)(1993-6#1)(1994-12#2)(1995-10#1)(1996-11#2)(1997-7#1)(2009-4#1)
proximal region of the##8##4##(1990-5#1)(1991-1#1)(1992-9#1)(1993-5#1)(1994-11#1)(1994-5#1)(2008-10#1)(2009-12#1)
proximal region of##10##3##(1990-5#1)(1991-1#1)(1992-9#1)(1993-2#1)(1993-5#1)(1994-11#1)(1994-5#1)(2008-10#1)(2009-12#1)(2013-8#1)
proximal region##13##2##(1990-5#1)(1990-8#1)(1991-1#2)(1992-9#1)(1993-2#1)(1993-5#1)(1994-11#1)(1994-5#1)(2008-10#1)(2009-12#1)(2013-8#2)
proximal regions of the##2##4##(1994-12#1)(1996-3#1)
proximal regions##4##2##(1994-12#1)(1994-9#2)(1996-3#1)
proximal right coronary##2##3##(2007-3#1)(2010-12#1)
proximal right##3##2##(2007-3#1)(2008-6#1)(2010-12#1)
proximal saphenous vein##2##3##(2007-8#2)
proximal segment##4##2##(1991-9#1)(1996-5#1)(2007-12#1)(2008-7#1)
proximal segments of the##2##4##(2007-9#1)(2008-4#1)
proximal side##2##2##(1994-5#1)(2008-5#1)
proximal site in##2##3##(1996-11#2)
proximal site##3##2##(1996-11#2)(1996-5#1)
proximal stumps##3##2##(2006-3#1)(2008-9#2)
proximal subsite##3##2##(1996-11#3)
proximal third of the##2##4##(2008-1#1)(2009-9#1)
proximal tibia##10##2##(1993-8#1)(2008-6#1)(2008-8#1)(2009-3#3)(2009-9#1)(2012-1#2)(2012-12#1)
proximal tibial slope##2##3##(2008-8#2)
proximal tibial##6##2##(2008-12#1)(2008-8#2)(2009-3#1)(2012-12#2)
proximal to the origin of the vertebral artery##2##8##(1993-3#1)(2007-11#1)
proximal to the##30##3##(1990-11#1)(1990-3#1)(1990-8#1)(1992-7#1)(1993-3#1)(1993-5#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-11#1)(1996-2#1)(1997-4#1)(2006-12#1)(2006-3#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-5#1)(2012-1#1)(2012-12#1)(2013-1#1)
proximal to##41##2##(1990-11#1)(1990-3#1)(1990-8#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-3#1)(1993-5#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-11#1)(1996-2#1)(1996-7#1)(1997-4#1)(2006-12#1)(2006-3#2)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
proximal tubular cells in##2##4##(1991-4#2)
proximal tubular cells##6##3##(1990-4#1)(1991-4#3)(2007-9#1)(2011-2#1)
proximal tubular epithelium##2##3##(1994-5#2)
proximal tubular necrosis##2##3##(1994-3#1)(1994-5#1)
proximal tubular##18##2##(1990-4#1)(1991-2#1)(1991-4#3)(1991-9#1)(1993-3#1)(1994-3#1)(1994-5#4)(1995-11#2)(2007-12#1)(2007-9#1)(2011-2#1)(2012-2#1)
proximal tubule and##2##3##(1993-3#2)
proximal tubule cells##5##3##(1991-5#1)(1992-8#3)(2008-11#1)
proximal tubule##21##2##(1990-11#1)(1990-9#1)(1991-5#1)(1991-9#2)(1992-8#3)(1993-3#2)(1994-5#1)(1997-1#1)(2007-9#2)(2008-11#2)(2008-12#1)(2008-9#1)(2009-10#1)(2009-3#1)(2013-8#1)
proximal tubules of##3##3##(1994-3#1)(1996-5#1)(1997-6#1)
proximal tubules##9##2##(1994-3#2)(1996-5#1)(1997-1#4)(1997-6#1)(1997-7#1)
proximal##752##1##(1990-11#3)(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#5)(1990-9#3)(1991-1#3)(1991-11#1)(1991-12#4)(1991-2#2)(1991-4#4)(1991-5#4)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#5)(1992-1#5)(1992-11#6)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#2)(1992-7#3)(1992-8#6)(1992-9#4)(1993-1#8)(1993-11#3)(1993-12#6)(1993-2#2)(1993-3#5)(1993-4#1)(1993-5#3)(1993-6#2)(1993-8#5)(1993-9#4)(1994-11#4)(1994-12#9)(1994-2#6)(1994-3#6)(1994-5#14)(1994-8#1)(1994-9#4)(1995-10#3)(1995-11#3)(1995-12#2)(1995-2#3)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#3)(1995-8#5)(1996-1#1)(1996-10#1)(1996-11#10)(1996-12#1)(1996-2#6)(1996-3#3)(1996-4#3)(1996-5#5)(1996-6#3)(1996-7#2)(1996-8#2)(1997-1#5)(1997-2#5)(1997-3#5)(1997-4#5)(1997-5#2)(1997-6#1)(1997-7#7)(1997-8#4)(1997-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#2)(2005-9#1)(2006-10#11)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#21)(2006-4#2)(2006-6#4)(2006-8#1)(2007-10#2)(2007-11#44)(2007-12#14)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#6)(2007-7#33)(2007-8#40)(2007-9#5)(2008-1#5)(2008-10#11)(2008-11#14)(2008-12#13)(2008-3#1)(2008-4#2)(2008-5#12)(2008-6#18)(2008-7#13)(2008-8#6)(2008-9#14)(2009-1#1)(2009-10#4)(2009-11#3)(2009-12#1)(2009-2#4)(2009-3#23)(2009-4#3)(2009-5#10)(2009-6#1)(2009-7#5)(2009-9#3)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#2)(2010-3#8)(2010-4#3)(2010-7#4)(2010-8#6)(2011-1#5)(2011-12#1)(2011-2#15)(2012-1#6)(2012-12#13)(2012-2#13)(2012-3#6)(2013-1#12)(2013-3#1)(2013-7#6)(2013-8#18)
proximal-to-distal##4##1##(1995-2#1)(2011-2#3)
proximally and##3##2##(1995-11#1)(2007-7#1)(2013-8#1)
proximally in##2##2##(1997-8#1)(2008-5#1)
proximally to##3##2##(1997-3#1)(2007-9#1)(2008-4#1)
proximally##22##1##(1992-11#2)(1995-11#1)(1996-6#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2013-7#1)(2013-8#2)
proximate analysis##2##2##(2010-2#1)(2010-4#1)
proximate and##2##2##(2008-8#1)(2009-5#1)
proximate composition and##2##3##(2011-2#1)(2012-2#1)
proximate composition##4##2##(2010-2#1)(2011-2#1)(2012-2#1)(2013-7#1)
proximate mechanism##2##2##(1996-9#1)(2008-9#1)
proximate mechanisms##3##2##(1996-1#1)(2008-6#1)(2009-10#1)
proximate##34##1##(1991-5#2)(1992-1#1)(1992-11#1)(1992-4#1)(1992-6#1)(1995-5#1)(1996-1#2)(1996-9#1)(2007-8#1)(2008-2#1)(2008-5#1)(2008-6#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#1)(2010-11#2)(2010-2#2)(2010-4#1)(2011-2#1)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
proximities of##2##2##(1995-6#1)(2012-3#1)
proximities##4##1##(1995-6#1)(2008-1#1)(2008-5#1)(2012-3#1)
proximity and##6##2##(1990-7#1)(1994-3#1)(2008-10#1)(2012-12#1)(2012-2#1)(2012-3#1)
proximity assay##6##2##(2008-11#1)(2008-4#4)(2013-1#1)
proximity between##4##2##(1994-10#1)(1995-2#1)(2008-7#1)(2012-2#1)
proximity fixed point##2##3##(2007-12#2)
proximity in##6##2##(1990-6#1)(1993-11#1)(2008-2#1)(2008-9#2)(2010-5#1)
proximity is a##2##3##(2008-4#1)(2012-12#1)
proximity of the##16##3##(1990-12#1)(1994-5#1)(1995-10#1)(1996-7#1)(1996-8#2)(2006-10#1)(2006-12#1)(2007-4#1)(2008-11#1)(2008-3#1)(2009-3#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
proximity of this##3##3##(1992-7#1)(1996-3#1)(2007-12#1)
proximity of##41##2##(1990-11#1)(1990-12#1)(1992-7#1)(1993-12#1)(1994-5#1)(1994-8#2)(1995-10#1)(1995-7#1)(1995-8#2)(1996-3#1)(1996-7#1)(1996-8#2)(1997-8#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-8#1)(2011-12#2)(2011-2#2)(2012-12#2)(2013-1#2)
proximity on the##3##3##(1996-8#1)(2008-1#1)(2008-2#1)
proximity or##3##2##(2006-6#1)(2008-9#1)(2011-1#1)
proximity patterns##5##2##(2008-10#5)
proximity searching##2##2##(1997-1#1)(1997-3#1)
proximity that##3##2##(1994-3#1)(1997-6#1)(2008-4#1)
proximity to a##2##3##(1997-4#1)(2008-6#1)
proximity to the##30##3##(1992-9#1)(1993-6#2)(1994-10#1)(1994-12#1)(1994-5#1)(1994-9#2)(1995-6#1)(1995-8#1)(1996-4#1)(1996-7#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-5#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-7#1)(2010-5#2)(2011-1#1)(2013-8#1)
proximity to##61##2##(1990-4#1)(1990-8#1)(1992-11#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#3)(1994-10#1)(1994-12#1)(1994-5#1)(1994-9#3)(1995-11#1)(1995-6#1)(1995-8#1)(1996-4#1)(1996-7#2)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#2)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#3)(2008-10#6)(2008-11#1)(2008-6#2)(2008-7#1)(2009-12#1)(2010-5#2)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
proximity was##3##2##(2008-7#1)(2008-9#1)(2009-4#1)
proximity##187##1##(1990-11#1)(1990-12#2)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#1)(1992-11#1)(1992-3#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#4)(1994-10#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#2)(1994-8#2)(1994-9#3)(1995-10#1)(1995-11#1)(1995-2#2)(1995-6#1)(1995-7#1)(1995-8#3)(1996-3#1)(1996-4#1)(1996-7#3)(1996-8#3)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#3)(2005-11#3)(2006-10#2)(2006-11#1)(2006-12#3)(2006-4#1)(2006-5#1)(2006-6#2)(2007-11#1)(2007-12#7)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-2#4)(2008-3#5)(2008-4#8)(2008-5#1)(2008-6#3)(2008-7#7)(2008-8#1)(2008-9#7)(2009-12#2)(2009-3#1)(2009-4#4)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-12#2)(2011-2#3)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#1)
proximity)##2##1##(2009-4#1)(2011-1#1)
proxy for##10##2##(2004-3#1)(2007-3#2)(2008-10#1)(2008-2#1)(2009-2#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
proxy informants##2##2##(2010-12#2)
proxy respondents in##2##3##(2011-1#2)
proxy respondents##4##2##(2011-1#4)
proxy##51##1##(1992-12#1)(1993-3#1)(1994-12#1)(1995-5#2)(1996-2#1)(1997-7#1)(2004-3#1)(2005-10#2)(2005-4#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-3#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#3)(2008-9#1)(2009-2#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#11)(2011-2#2)(2012-1#1)(2013-1#1)
prudence##3##1##(1994-12#1)(2009-4#1)(2012-2#1)
prudent approach##2##2##(2008-1#1)(2008-6#1)
prudent diet##2##2##(1990-12#1)(1991-7#1)
prudent exploitation##2##2##(2008-8#2)
prudent for##3##2##(1991-12#1)(1995-1#1)(2009-10#1)
prudent that##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
prudent to recommend##2##3##(2008-7#1)(2010-5#1)
prudent to##12##2##(1991-12#1)(1997-3#1)(2005-12#2)(2006-10#2)(2006-8#1)(2007-8#1)(2007-9#1)(2008-7#1)(2010-5#1)(2013-1#1)
prudent##34##1##(1990-12#2)(1991-12#2)(1991-7#1)(1995-1#1)(1997-3#2)(2005-12#2)(2006-10#2)(2006-8#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2009-10#1)(2009-5#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
prune (Prunus##2##2##(2008-10#2)
prune belly syndrome##3##3##(2008-7#3)
prune orchards in##3##3##(2008-10#3)
prune orchards##7##2##(2008-10#7)
prune##19##1##(2008-10#12)(2008-2#1)(2008-7#3)(2008-8#1)(2013-1#2)
pruned##3##1##(2008-1#1)(2008-10#1)(2008-3#1)
pruni##4##1##(2008-10#4)
pruning and shade management##2##4##(2008-10#2)
pruning##12##1##(2008-10#6)(2008-2#1)(2008-5#5)
pruriens##5##1##(2008-10#5)
prurigo##3##1##(2006-12#1)(2008-3#2)
pruritic papular##2##2##(2007-2#1)(2010-6#1)
pruritic papules##2##2##(2010-6#1)(2011-1#1)
pruritic rash##2##2##(2006-10#1)(2007-2#1)
pruritic##19##1##(2005-12#1)(2006-10#1)(2007-2#4)(2007-7#2)(2008-3#2)(2010-12#1)(2010-6#6)(2011-1#1)(2012-3#1)
pruritis##2##1##(2010-1#1)(2013-1#1)
pruritus and##9##2##(1992-6#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-5#1)
pruritus in##6##2##(1993-3#1)(1996-5#1)(2007-2#2)(2008-1#1)(2008-4#1)
pruritus is##4##2##(2004-11#1)(2007-1#1)(2007-8#1)(2008-1#1)
pruritus of cholestasis##3##3##(2004-11#3)
pruritus or##2##2##(1993-9#1)(2013-7#1)
pruritus was##2##2##(2008-1#2)
pruritus were##2##2##(2005-10#1)(2007-2#1)
pruritus##70##1##(1991-2#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-9#1)(1996-5#1)(2004-11#4)(2005-10#2)(2005-11#8)(2005-7#2)(2005-8#1)(2006-10#2)(2006-2#1)(2007-1#1)(2007-11#2)(2007-2#7)(2007-7#2)(2007-8#3)(2008-1#6)(2008-3#5)(2008-4#2)(2008-5#4)(2008-8#1)(2009-2#1)(2010-12#2)(2010-6#1)(2010-8#1)(2013-1#2)(2013-7#4)
prying##2##1##(2007-9#1)(2008-12#1)
précis##3##1##(2008-2#1)(2012-2#2)
préparation##2##1##(2011-2#1)(2012-2#1)
présence##2##1##(2012-2#2)
présentation##2##1##(2012-2#1)(2013-1#1)
ps and a##3##3##(2007-12#3)
ps and##9##2##(2007-1#1)(2007-12#4)(2008-1#1)(2008-2#1)(2008-8#1)(2013-8#1)
ps are##2##2##(2006-6#1)(2007-11#1)
ps at 20 K to##2##5##(1997-4#2)
ps at 240 K##2##4##(1997-4#2)
ps at##5##2##(1997-4#4)(2008-2#1)
ps in##3##2##(2007-12#1)(2008-2#1)(2009-9#1)
ps is##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
ps molecular dynamics simulations of##2##5##(1995-5#1)(1995-8#1)
ps of##2##2##(1996-7#1)(2007-12#1)
ps time##3##2##(1993-8#1)(1994-5#1)(2007-1#1)
ps was found##2##3##(1993-6#1)(1996-7#1)
ps were##2##2##(2008-1#1)(2008-2#1)
ps with##2##2##(2007-12#2)
ps##115##1##(1991-7#2)(1992-6#1)(1992-9#2)(1993-11#1)(1993-6#1)(1993-8#2)(1994-5#1)(1995-1#1)(1995-11#3)(1995-5#1)(1995-8#1)(1996-2#1)(1996-7#3)(1997-1#1)(1997-4#4)(2006-3#2)(2006-6#5)(2007-1#5)(2007-11#14)(2007-12#25)(2008-1#2)(2008-11#1)(2008-2#12)(2008-3#17)(2008-8#4)(2009-9#1)(2010-5#1)(2013-8#1)
ps)##12##1##(1990-8#1)(1991-12#1)(1995-3#1)(1996-7#1)(2006-6#3)(2007-12#1)(2008-2#1)(2008-3#3)
ps/(nm##2##1##(2007-12#2)
ps/nm##2##1##(2007-12#1)(2008-2#1)
ps15##3##1##(1994-5#3)
psR-II##2##1##(1994-2#2)
psaF gene##2##2##(1994-12#2)
psbA##2##1##(2006-12#2)
psbA-trnH intergenic##2##2##(2011-2#2)
psbA-trnH sequences##2##2##(2011-2#2)
psbA-trnH##6##1##(2011-2#6)
psbE##4##1##(1994-12#4)
psbF##3##1##(1994-12#3)
psbP gene encoding##2##3##(1996-10#2)
psbP gene##4##2##(1996-10#4)
psbP##6##1##(1996-10#6)
pseudaffective##2##1##(1992-7#2)
pseudarthrosis and##2##2##(1992-12#1)(2006-10#1)
pseudarthrosis of the##2##3##(2007-7#1)(2009-3#1)
pseudarthrosis##14##1##(1992-12#1)(2006-10#1)(2006-8#2)(2007-11#5)(2007-7#3)(2009-3#1)(2012-2#1)
pseudexin B##7##2##(1995-1#7)
pseudo first-order kinetics##2##3##(2008-10#1)(2008-11#1)
pseudo first-order##5##2##(1991-1#1)(1993-9#1)(2008-10#2)(2008-11#1)
pseudo##23##1##(1991-1#1)(1993-9#1)(1996-4#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-6#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-9#1)(2009-3#1)(2009-7#1)(2010-9#2)(2012-1#1)(2012-2#1)
pseudo-Kümmell's disease##3##2##(2006-7#2)(2006-8#1)
pseudo-Meigs' syndrome##2##2##(1994-6#2)
pseudo-atomic##2##1##(2008-4#1)(2009-8#1)
pseudo-digestion of##3##2##(2008-10#3)
pseudo-digestion were as follows##2##4##(2008-10#2)
pseudo-digestion##9##1##(2008-10#9)
pseudo-first order##8##2##(1990-11#1)(1991-5#1)(1992-5#1)(2008-10#4)(2008-5#1)
pseudo-first-order conditions##2##2##(1992-5#1)(2010-5#1)
pseudo-first-order rate constants##2##3##(1994-8#1)(2008-3#1)
pseudo-first-order rate##5##2##(1991-9#1)(1993-3#1)(1993-8#1)(1994-8#1)(2008-3#1)
pseudo-first-order##13##1##(1990-3#1)(1991-9#1)(1992-5#2)(1992-7#1)(1993-3#2)(1993-8#1)(1994-8#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-5#1)
pseudo-knots##4##1##(2007-9#4)
pseudo-nondiffracting beams##4##2##(2007-12#2)(2008-2#2)
pseudo-obstruction##3##1##(1991-5#1)(1992-3#1)(2011-2#1)
pseudo-pneumatosis##2##1##(2012-2#2)
pseudo-second-order##3##1##(2008-5#1)(2013-1#1)(2013-8#1)
pseudo-stationary phases##2##2##(1996-5#2)
pseudo-steady state##3##2##(1990-8#1)(2008-10#1)(2008-7#1)
pseudo-syringae##2##1##(2008-10#2)
pseudo-transient continuation##2##2##(2005-11#2)
pseudoanalog true-time-delay##2##2##(2008-3#2)
pseudoaneurysm after##2##2##(2006-7#1)(2009-4#1)
pseudoaneurysm and##4##2##(1991-12#1)(2007-8#2)(2008-8#1)
pseudoaneurysm caused by##2##3##(2009-10#1)(2009-7#1)
pseudoaneurysm formation##2##2##(2008-7#1)(2012-2#1)
pseudoaneurysm in##2##2##(2007-8#1)(2012-2#1)
pseudoaneurysm is##2##2##(2007-8#1)(2010-12#1)
pseudoaneurysm located at##2##3##(2007-8#2)
pseudoaneurysm of the MMA##2##4##(2008-12#2)
pseudoaneurysm of the anterior tibial artery##2##6##(2008-8#2)
pseudoaneurysm of the ascending aorta##2##5##(2007-8#2)
pseudoaneurysm of the##11##3##(2007-8#4)(2008-12#3)(2008-3#1)(2008-8#2)(2013-1#1)
pseudoaneurysm of##13##2##(2007-8#4)(2008-12#3)(2008-3#1)(2008-8#2)(2011-12#2)(2013-1#1)
pseudoaneurysm that##2##2##(2007-8#1)(2010-12#1)
pseudoaneurysm which was##2##3##(2007-8#1)(2012-2#1)
pseudoaneurysm##60##1##(1991-12#1)(1991-3#1)(2006-7#1)(2007-3#1)(2007-8#18)(2008-12#6)(2008-3#2)(2008-7#3)(2008-8#3)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-12#4)(2011-12#2)(2011-2#1)(2012-12#3)(2012-2#7)(2013-1#2)
pseudoaneurysms are##2##2##(2011-2#2)
pseudoaneurysms##18##1##(1991-12#3)(2006-8#1)(2007-7#1)(2007-8#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#4)(2011-2#2)(2012-2#1)(2013-1#1)
pseudoarthroses and bone defects##2##4##(2007-11#2)
pseudoarthroses##6##1##(2007-11#3)(2009-2#1)(2009-3#2)
pseudoarthrosis in##3##2##(2007-11#1)(2007-7#1)(2009-3#1)
pseudoarthrosis of the##4##3##(2007-2#1)(2007-8#2)(2009-2#1)
pseudoarthrosis##17##1##(1997-6#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#6)(2008-4#2)(2009-2#1)(2009-3#2)
pseudoautosomal boundary##3##2##(1990-11#3)
pseudoautosomal inheritance##3##2##(1995-11#3)
pseudoautosomal regions##2##2##(1990-11#1)(2008-7#1)
pseudoautosomal##13##1##(1990-11#7)(1995-11#5)(2008-7#1)
pseudobactin production##3##2##(2008-10#3)
pseudobactin##5##1##(2008-10#5)
pseudoboehmite formed##2##2##(2005-11#2)
pseudoboehmite##4##1##(2005-11#4)
pseudobranch##4##1##(2009-4#4)
pseudobranchial##2##1##(2009-4#2)
pseudobulbar##2##1##(2006-12#1)(2009-9#1)
pseudocatenulatum##2##1##(2008-11#2)
pseudocelli##3##1##(2007-1#3)
pseudocholinesterase##3##1##(1990-11#1)(1992-4#2)
pseudocontact shifts##8##2##(2007-10#8)
pseudocyst formation##3##2##(1990-12#1)(2007-11#1)(2008-7#1)
pseudocyst of the##4##3##(1991-6#2)(2008-3#1)(2011-2#1)
pseudocyst##23##1##(1990-12#1)(1991-6#2)(2006-6#1)(2007-11#1)(2008-3#3)(2008-7#4)(2009-2#1)(2011-2#4)(2012-3#1)(2013-1#5)
pseudocysts##22##1##(1991-6#1)(1991-8#6)(1993-5#1)(1994-7#1)(2005-10#1)(2006-10#1)(2006-6#1)(2008-3#1)(2008-7#1)(2010-12#4)(2011-2#1)(2012-3#1)(2013-1#2)
pseudocysts)##3##1##(2006-10#1)(2013-1#2)
pseudodata##2##1##(2008-2#2)
pseudodiaxial##2##1##(1995-1#1)(1996-8#1)
pseudodipeptides##3##1##(2008-5#3)
pseudodiverticula##2##1##(2010-5#2)
pseudodiverticulosis##2##1##(1990-5#1)(2010-5#1)
pseudoeosinophilia##2##1##(2007-12#2)
pseudoephedrine and##2##2##(1995-2#1)(2010-4#1)
pseudoephedrine##20##1##(1995-2#2)(2007-10#1)(2008-10#6)(2010-4#8)(2013-1#3)
pseudoepitheliomatous hyperplasia##2##2##(2010-6#2)
pseudoexfoliation glaucoma##4##2##(2011-2#3)(2013-1#1)
pseudoexfoliation##6##1##(2007-11#1)(2011-2#4)(2013-1#1)
pseudoexfoliative glaucoma in Primorsko-Goranska County##2##5##(2011-2#2)
pseudoexfoliative glaucoma##6##2##(2011-2#6)
pseudoflava##5##1##(1997-6#5)
pseudogamous parthenogenetic##3##2##(2008-5#3)
pseudogamous##5##1##(2008-5#5)
pseudogene and##4##2##(1991-6#1)(1993-6#1)(1997-2#1)(1997-4#1)
pseudogene for##3##2##(1994-2#1)(1997-4#2)
pseudogene from Bos taurus##2##4##(1993-2#2)
pseudogene in##2##2##(1991-6#1)(2008-7#1)
pseudogene is##3##2##(1993-12#1)(1993-2#1)(1994-11#1)
pseudogene was##3##2##(1990-8#1)(1994-11#1)(1997-4#1)
pseudogene##53##1##(1990-8#5)(1991-3#2)(1991-5#3)(1991-6#3)(1992-7#2)(1993-12#5)(1993-2#5)(1993-6#4)(1994-11#2)(1994-2#1)(1994-6#1)(1995-11#2)(1997-2#5)(1997-4#8)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)
pseudogenes for##3##2##(1991-6#3)
pseudogenes##26##1##(1990-8#3)(1991-12#3)(1991-2#1)(1991-6#7)(1993-2#1)(1993-8#1)(1995-11#3)(1996-6#1)(1997-4#1)(2008-4#1)(2008-7#1)(2009-10#1)(2012-2#2)
pseudoginseng##2##1##(2007-1#2)
pseudograph's##4##1##(2007-11#4)
pseudoguiding##2##1##(2008-3#2)
pseudohermaphroditism##6##1##(2008-2#2)(2008-4#2)(2008-5#1)(2009-2#1)
pseudohypoaldosteronism##3##1##(1995-4#2)(2012-12#1)
pseudohypoparathyroidism##2##1##(1992-11#1)(2013-8#1)
pseudoinvasion in an##2##3##(2010-5#2)
pseudoislets formation##3##2##(2010-11#3)
pseudoislets##12##1##(2010-11#12)
pseudoknot formation##2##2##(1995-6#1)(1996-8#1)
pseudoknot is##2##2##(1990-7#2)
pseudoknot structure##3##2##(1990-7#2)(2008-10#1)
pseudoknot##14##1##(1990-7#7)(1995-6#1)(1996-8#3)(1996-9#1)(2008-10#2)
pseudoknots##10##1##(1990-7#3)(2006-10#5)(2009-11#2)
pseudomaculata##5##1##(2004-11#5)
pseudomalignant osseous##2##2##(2009-3#2)
pseudomalignant##4##1##(2005-12#1)(2008-11#1)(2009-3#2)
pseudomallei##11##1##(1995-9#1)(2006-10#3)(2007-2#1)(2007-7#5)(2008-7#1)
pseudomembrane##5##1##(1996-11#1)(2012-12#4)
pseudomembranous colitis##2##2##(2007-12#1)(2009-5#1)
pseudomembranous##3##1##(2007-12#1)(2008-5#1)(2009-5#1)
pseudomeningocele##3##1##(2005-5#1)(2006-12#1)(2012-3#1)
pseudometallophyte##2##1##(2004-4#2)
pseudomolecular ions##3##2##(1994-3#3)
pseudomonad##9##1##(2008-10#9)
pseudomonad-based##2##1##(2008-10#2)
pseudomonads and xanthomonads##2##3##(2008-10#2)
pseudomonads and##3##2##(2008-10#3)
pseudomonads in##4##2##(2008-10#4)
pseudomonads##24##1##(2005-11#1)(2008-10#23)
pseudomonas##5##1##(1990-8#1)(2005-11#2)(2008-4#1)(2010-11#1)
pseudomonic acid##10##2##(1994-9#7)(1996-8#3)
pseudomonic acid-resistant mutant##2##3##(1994-9#2)
pseudomonic##13##1##(1994-9#10)(1996-8#3)
pseudomyxoma peritonei##11##2##(2006-6#4)(2007-2#1)(2008-2#1)(2008-9#1)(2009-1#1)(2009-5#2)(2009-6#1)
pseudonondiffracting beams##2##2##(2008-3#2)
pseudonygamai##3##1##(2008-10#3)
pseudoobstruction##3##1##(2005-12#1)(2006-10#1)(2006-2#1)
pseudopapillary neoplasm##2##2##(2013-1#1)(2013-8#1)
pseudopapillary tumor##2##2##(2008-3#1)(2013-1#1)
pseudopapillary##4##1##(2008-3#1)(2013-1#2)(2013-8#1)
pseudoparkinsonian##2##1##(2007-9#2)
pseudopeptide##3##1##(1997-2#1)(1997-3#1)(2008-5#1)
pseudopeptides##2##1##(1994-9#1)(2008-8#1)
pseudophakic##9##1##(1991-2#1)(2011-2#4)(2012-12#3)(2013-1#1)
pseudophase##3##1##(1990-5#1)(2005-11#2)
pseudophases##2##1##(1990-5#1)(2008-10#1)
pseudopod##3##1##(2007-12#3)
pseudopodia##2##1##(2008-11#1)(2012-12#1)
pseudopregnancy##7##1##(1992-9#2)(1993-1#2)(1995-6#3)
pseudopregnant period##2##2##(1995-6#2)
pseudopregnant rat##4##2##(1990-4#1)(1997-6#1)(2008-8#1)(2008-9#1)
pseudopregnant rats##2##2##(1995-6#1)(1997-6#1)
pseudopregnant##10##1##(1990-4#1)(1995-6#3)(1997-6#2)(2006-5#1)(2008-8#2)(2008-9#1)
pseudopseudohypoparathyroidism##2##1##(2010-6#2)
pseudorabies virus (PRV)##2##3##(1995-7#1)(2009-2#1)
pseudorabies virus##7##2##(1992-8#1)(1993-7#1)(1993-9#1)(1995-7#1)(1997-2#1)(2005-11#1)(2009-2#1)
pseudorandom code##3##2##(2007-12#2)(2008-3#1)
pseudorandom noise##3##2##(2008-2#3)
pseudorandom##14##1##(2007-11#1)(2007-12#5)(2008-2#3)(2008-3#5)
pseudorecombinant##2##1##(2008-10#2)
pseudorecombinants##2##1##(2008-10#2)
pseudoreplication##2##1##(2008-10#1)(2009-4#1)
pseudorevertant##2##1##(1992-11#1)(1997-1#1)
pseudorevertants##4##1##(1997-1#4)
pseudorotation##3##1##(1993-11#1)(1994-9#1)(1996-2#1)
pseudoryzae J34A-127(T)##2##2##(2012-2#2)
pseudosarcomatous polyp##2##2##(2008-11#2)
pseudosarcomatous##4##1##(1990-3#1)(2008-11#3)
pseudoscientific claims##3##2##(2009-4#3)
pseudoscientific##4##1##(2009-4#4)
pseudosclerotia and##2##2##(2008-10#2)
pseudosclerotia of##2##2##(2008-10#2)
pseudosclerotia or##2##2##(2008-10#2)
pseudosclerotia that##2##2##(2008-10#2)
pseudosclerotia##19##1##(2008-10#19)
pseudoscopic##2##1##(2008-2#1)(2008-3#1)
pseudostationary phase##3##2##(2005-11#1)(2008-10#2)
pseudostationary##4##1##(2005-11#1)(2008-10#3)
pseudosubstrate domain of##3##3##(1992-9#2)(1993-11#1)
pseudosubstrate##9##1##(1992-8#1)(1992-9#3)(1993-11#1)(1995-3#2)(1996-5#1)(1996-6#1)
pseudosyringae##4##1##(2008-10#4)
pseudothecia and ascospores##5##3##(2008-10#5)
pseudothecia and pycnidia##2##3##(2008-10#2)
pseudothecia and##9##2##(2008-10#9)
pseudothecia development##3##2##(2008-10#3)
pseudothecia formed##3##2##(2008-10#3)
pseudothecia matured##2##2##(2008-10#2)
pseudothecia maturity##6##2##(2008-10#6)
pseudothecia were##4##2##(2008-10#4)
pseudothecia##45##1##(2008-10#44)(2011-1#1)
pseudothecial density and##2##3##(2008-10#2)
pseudothecial initials##2##2##(2008-10#2)
pseudothecial##6##1##(2008-10#6)
pseudothecium##6##1##(2008-10#6)
pseudothrombocytopenia##4##1##(2012-2#4)
pseudotuberculosis endotoxin##2##2##(2012-1#2)
pseudotuberculosis##10##1##(1996-8#1)(2008-5#4)(2009-9#1)(2012-1#3)(2013-1#1)
pseudotumor cerebri##3##2##(1996-2#1)(2006-7#1)(2008-4#1)
pseudotumor in the##3##3##(1991-9#1)(2006-1#1)(2011-1#1)
pseudotumor of the bladder##2##4##(2006-9#2)
pseudotumor of the##7##3##(1990-10#2)(2006-9#2)(2008-12#2)(2010-12#1)
pseudotumor##25##1##(1990-10#2)(1991-9#1)(1996-2#1)(2006-1#2)(2006-4#2)(2006-7#1)(2006-9#2)(2007-8#2)(2008-12#2)(2008-4#1)(2009-3#2)(2010-12#3)(2010-7#1)(2011-1#1)(2012-2#2)
pseudotumors##2##1##(2006-4#1)(2007-8#1)
pseudotumour of the lung##8##4##(2007-8#1)(2008-7#1)(2013-1#6)
pseudotumour of the##10##3##(2007-8#1)(2008-3#1)(2008-7#1)(2012-12#1)(2013-1#6)
pseudotumour syndrome##2##2##(2008-7#2)
pseudotumour##14##1##(2007-8#2)(2008-3#1)(2008-7#4)(2012-12#1)(2013-1#6)
pseudotumoural lesions##2##2##(2012-2#2)
pseudotumoural##4##1##(2010-10#1)(2012-2#3)
pseudotumours of the##2##3##(2007-8#1)(2012-2#1)
pseudotype##2##1##(1990-5#2)
pseudotyped##3##1##(1990-5#1)(2005-6#1)(2009-10#1)
pseudouridine (psi)##4##2##(1990-8#1)(1991-4#1)(1993-8#1)(1994-8#1)
pseudouridine and 1-methyladenosine##6##3##(1992-3#5)(1993-8#1)
pseudouridine##22##1##(1990-8#5)(1991-4#3)(1992-1#1)(1992-3#5)(1993-8#2)(1994-8#2)(1996-11#1)(1996-8#1)(1997-2#2)
pseudowords and nonwords##2##3##(2009-10#2)
pseudowords##10##1##(1990-8#2)(2008-4#3)(2009-10#3)(2010-7#1)(2013-8#1)
pseudoxanthoma elasticum is##2##3##(2006-10#2)
pseudoxanthoma elasticum##7##2##(1995-6#1)(2006-10#6)
psi --&gt##2##2##(1992-8#1)(2008-3#1)
psi 14 =##2##3##(1994-11#2)
psi =##5##2##(1991-9#1)(1994-3#1)(2008-2#2)(2008-3#1)
psi COX6b-1##3##2##(1991-6#3)
psi COX6b-2 and psi COX6b-3##2##5##(1991-6#2)
psi [P = O(OPh)O]AA-OMe)##2##4##(1991-2#2)
psi [P = O(SPh)O]AA-OMe)##2##4##(1991-2#2)
psi [P =##5##3##(1991-2#5)
psi at##2##2##(1994-2#1)(1994-8#1)
psi for##2##2##(2007-8#1)(2012-2#1)
psi formation at position 53##2##5##(1994-8#2)
psi formation at positions 43 and 46##3##7##(1994-8#3)
psi formation at##5##3##(1994-8#5)
psi formation##8##2##(1994-8#8)
psi levels##2##2##(1990-8#1)(1994-8#1)
psi propensities##2##2##(1995-4#2)
psi scans##2##2##(2006-5#2)
psi##98##1##(1990-11#2)(1990-8#1)(1991-2#5)(1991-4#1)(1991-6#10)(1991-9#2)(1992-12#2)(1992-8#18)(1993-2#3)(1993-6#1)(1993-8#2)(1994-11#3)(1994-2#1)(1994-3#1)(1994-8#12)(1994-9#1)(1995-4#2)(2006-5#4)(2007-8#3)(2008-10#2)(2008-2#4)(2008-3#9)(2008-6#4)(2008-7#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
psi)##2##1##(1993-6#1)(2007-8#1)
psi-tectorigenin##2##1##(1992-1#2)
psilocin and psilocybin##4##3##(2008-10#4)
psilocin##6##1##(2008-10#5)(2010-8#1)
psilocybin##23##1##(2008-10#9)(2010-8#1)(2013-8#13)
psittaci and##3##2##(1991-4#1)(1992-5#1)(2012-12#1)
psittaci was##2##2##(2012-12#2)
psittaci##15##1##(1990-5#1)(1991-4#1)(1992-4#1)(1992-5#1)(1993-2#2)(1993-9#2)(2012-12#6)(2013-1#1)
psittacid herpesvirus##2##2##(2007-2#1)(2008-5#1)
psittacine beak and feather disease (PBFD)##2##6##(2008-5#2)
psittacine beak and feather disease virus and##3##7##(2008-5#3)
psittacine beak and feather disease virus##4##6##(2008-5#4)
psittacine beak and feather disease##8##5##(2008-5#7)(2012-2#1)
psittacine birds##4##2##(1997-6#1)(2008-5#2)(2012-2#1)
psittacine circovirus (PsCV)##2##3##(2008-5#2)
psittacine##18##1##(1997-6#1)(2008-5#14)(2012-2#3)
psittacines##4##1##(1992-2#2)(1997-3#1)(2008-5#1)
psoas hitch procedure##2##3##(2008-10#2)
psoas hitch##3##2##(2008-10#3)
psoas major and##2##3##(2008-7#1)(2010-12#1)
psoas major muscle##3##3##(2011-2#3)
psoas major##6##2##(2008-7#1)(2010-12#1)(2010-4#1)(2011-2#3)
psoas muscle##5##2##(1995-2#1)(2006-8#1)(2008-10#1)(2009-2#1)(2009-4#1)
psoas muscles##2##2##(1996-6#1)(1997-2#1)
psoas##25##1##(1991-3#1)(1993-10#1)(1995-2#1)(1996-11#1)(1996-6#1)(1997-2#1)(2006-8#1)(2007-1#1)(2008-10#5)(2008-7#1)(2009-2#1)(2009-4#5)(2010-12#1)(2010-4#1)(2011-2#3)
psoralen and##2##2##(1991-12#1)(2008-11#1)
psoralen photochemotherapy##3##2##(1992-6#1)(2007-8#2)
psoralen phototherapy##2##2##(1994-3#2)
psoralen was##2##2##(2008-11#2)
psoralen##29##1##(1990-5#1)(1991-12#1)(1992-6#7)(1994-3#4)(1995-2#1)(2007-7#1)(2007-8#6)(2008-11#7)(2011-12#1)
psoralens and##5##2##(1992-6#4)(2008-1#1)
psoralens are##2##2##(1992-6#2)
psoralens in combination with##2##4##(1992-6#2)
psoralens in##3##2##(1992-6#3)
psoralens##19##1##(1991-12#1)(1992-6#15)(2008-1#1)(2008-10#1)(2008-11#1)
psoriasiform##2##1##(2012-2#1)(2012-3#1)
psoriasis and multiple keloids for the last 26-years##2##8##(2007-7#2)
psoriasis and psoriatic arthritis##6##4##(2006-10#5)(2008-5#1)
psoriasis and##21##2##(1992-10#2)(1994-3#1)(2005-8#1)(2006-10#5)(2006-12#1)(2007-7#3)(2008-12#1)(2008-5#1)(2008-6#1)(2009-11#1)(2012-12#1)(2013-1#3)
psoriasis are##3##2##(2005-11#1)(2007-7#1)(2010-6#1)
psoriasis clinical##2##2##(1993-8#1)(2012-12#1)
psoriasis have##2##2##(2005-11#1)(2012-2#1)
psoriasis in the##2##3##(2008-6#1)(2010-6#1)
psoriasis in##8##2##(1997-8#1)(2005-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-6#1)(2010-6#1)(2011-2#1)
psoriasis is##5##2##(1995-5#1)(2007-8#1)(2011-2#2)(2012-2#1)
psoriasis or##2##2##(2010-12#1)(2011-2#1)
psoriasis patients##3##2##(2005-11#1)(2005-8#1)(2008-6#1)
psoriasis that is unresponsive to topical therapy##2##7##(2012-12#2)
psoriasis that##7##2##(1990-5#1)(1997-8#1)(2008-6#1)(2012-12#4)
psoriasis vulgaris##6##2##(2007-7#2)(2007-8#4)
psoriasis was##3##2##(1993-11#1)(2012-12#2)
psoriasis with##8##2##(1990-6#1)(1993-11#1)(2007-8#3)(2008-5#1)(2008-8#1)(2012-12#1)
psoriasis##202##1##(1990-5#2)(1990-6#2)(1991-1#1)(1991-12#1)(1992-10#3)(1992-6#1)(1993-11#4)(1993-8#4)(1994-3#1)(1995-5#2)(1996-2#1)(1997-8#3)(2005-11#6)(2005-6#1)(2005-8#6)(2006-10#9)(2006-12#5)(2006-2#1)(2006-5#1)(2007-11#10)(2007-3#1)(2007-7#15)(2007-8#20)(2008-1#6)(2008-12#3)(2008-3#4)(2008-5#12)(2008-6#8)(2008-8#1)(2009-11#2)(2009-12#1)(2009-2#1)(2010-12#1)(2010-6#7)(2010-8#1)(2011-1#1)(2011-2#8)(2012-1#2)(2012-11#1)(2012-12#21)(2012-2#11)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#1)
psoriasis]##4##1##(1990-5#1)(2005-11#1)(2011-2#1)(2013-7#1)
psoriatic arthritis (PsA)##5##3##(2006-10#2)(2008-3#2)(2013-1#1)
psoriatic arthritis and of##2##4##(1990-6#1)(2012-2#1)
psoriatic arthritis and##4##3##(1990-6#1)(2007-11#2)(2012-2#1)
psoriatic arthritis are##2##3##(2006-10#1)(2008-5#1)
psoriatic arthritis is unclear##2##4##(2006-10#1)(2007-11#1)
psoriatic arthritis is##3##3##(2006-10#2)(2007-11#1)
psoriatic arthritis patients##2##3##(2006-10#2)
psoriatic arthritis##42##2##(1990-6#2)(2006-10#17)(2007-10#3)(2007-11#4)(2007-7#1)(2007-8#1)(2008-3#6)(2008-5#3)(2008-7#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
psoriatic lesions##3##2##(2007-7#1)(2008-5#1)(2012-12#1)
psoriatic patients##6##2##(1993-8#1)(2007-7#3)(2011-2#1)(2012-2#1)
psoriatic plaques##5##2##(2007-7#1)(2012-12#1)(2012-2#3)
psoriatic spondyloarthropathy##3##2##(2006-10#3)
psoriatic##73##1##(1990-6#2)(1993-8#1)(2006-10#21)(2007-10#3)(2007-11#5)(2007-7#6)(2007-8#1)(2008-3#6)(2008-5#4)(2008-7#1)(2008-9#1)(2009-11#1)(2010-3#1)(2010-5#1)(2011-2#5)(2012-1#3)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#1)
psoriatics##2##1##(1991-12#1)(1992-10#1)
pstS-3##2##1##(1996-9#2)
psu and##2##2##(2007-5#2)
psu for##2##2##(2007-5#2)
psu##9##1##(1996-12#1)(2007-5#6)(2008-4#1)(2008-7#1)
psu) and##2##2##(2007-5#2)
psych care##2##2##(1993-5#1)(1994-10#1)
psych##5##1##(1992-9#2)(1993-3#1)(1993-5#1)(1994-10#1)
psyche##6##1##(1993-5#1)(1997-3#1)(1997-8#1)(2006-12#2)(2012-12#1)
psychiatric admission##3##2##(1996-9#1)(2008-1#1)(2008-6#1)
psychiatric adverse events##2##3##(2008-11#1)(2009-7#1)
psychiatric adverse##3##2##(2008-11#1)(2009-7#2)
psychiatric and general##2##3##(1991-2#1)(2006-6#1)
psychiatric and medical##2##3##(2008-1#1)(2011-2#1)
psychiatric and neurologic##2##3##(1995-1#1)(2013-7#1)
psychiatric and neurological disorders##3##4##(1994-11#2)(2011-2#1)
psychiatric and neurological##4##3##(1993-1#1)(1994-11#2)(2011-2#1)
psychiatric and substance##2##3##(1995-1#1)(2010-2#1)
psychiatric and##31##2##(1990-3#1)(1990-6#1)(1991-2#1)(1993-1#3)(1994-11#2)(1995-1#2)(1996-3#1)(1996-7#1)(2004-3#2)(2006-10#1)(2006-6#1)(2006-9#1)(2008-1#2)(2008-11#1)(2008-8#1)(2009-9#1)(2010-2#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
psychiatric assessment##5##2##(2007-2#1)(2009-12#2)(2010-12#2)
psychiatric care in##3##3##(1990-6#1)(2009-2#1)(2012-11#1)
psychiatric care of##2##3##(1992-5#1)(2006-9#1)
psychiatric care##16##2##(1990-6#1)(1992-3#1)(1992-5#2)(1993-12#1)(1993-7#1)(2004-3#1)(2006-9#1)(2008-2#1)(2009-2#2)(2010-5#1)(2011-2#1)(2012-11#1)(2012-12#2)
psychiatric casualties in Russia's##2##4##(2008-7#2)
psychiatric catatonias##2##2##(2008-1#2)
psychiatric clinic##4##2##(2006-2#1)(2008-2#3)
psychiatric clinics##4##2##(1997-8#1)(2006-9#1)(2008-2#1)(2009-10#1)
psychiatric comorbidities##3##2##(2008-6#1)(2009-4#1)(2013-1#1)
psychiatric comorbidity and##2##3##(2008-4#1)(2013-1#1)
psychiatric comorbidity in##2##3##(1991-1#1)(2009-10#1)
psychiatric comorbidity##9##2##(1991-1#1)(2004-3#1)(2005-6#1)(2006-4#1)(2008-4#1)(2008-6#1)(2009-10#1)(2013-1#2)
psychiatric complications in##3##3##(2007-9#1)(2008-4#2)
psychiatric condition##4##2##(2008-4#2)(2011-1#1)(2012-3#1)
psychiatric conditions and##2##3##(1995-5#1)(2009-9#1)
psychiatric conditions##14##2##(1993-5#1)(1995-5#1)(2004-3#1)(2005-6#1)(2005-7#1)(2006-9#1)(2007-7#1)(2008-7#1)(2009-6#1)(2009-9#1)(2011-2#2)(2012-12#1)(2012-3#1)
psychiatric consultation##2##2##(1992-11#1)(2008-4#1)
psychiatric crises##2##2##(2008-2#1)(2013-1#1)
psychiatric crisis and##2##3##(2008-2#1)(2013-1#1)
psychiatric department##3##2##(1993-3#1)(1996-1#1)(1996-11#1)
psychiatric departments and##2##3##(1992-3#2)
psychiatric departments##6##2##(1991-10#1)(1991-9#1)(1992-3#2)(1993-8#2)
psychiatric diagnoses##6##2##(2006-4#2)(2008-6#1)(2009-8#1)(2012-2#1)(2013-1#1)
psychiatric diagnosis and treatment##2##4##(2007-7#1)(2012-12#1)
psychiatric diagnosis was##2##3##(1993-5#1)(1995-4#1)
psychiatric diagnosis##7##2##(1993-5#1)(1995-4#1)(2006-4#1)(2006-9#1)(2007-7#1)(2012-12#1)(2012-2#1)
psychiatric disabilities##11##2##(1993-3#1)(1997-1#3)(2007-8#3)(2009-6#4)
psychiatric disability##2##2##(2007-8#1)(2011-2#1)
psychiatric disease in##2##3##(2008-9#1)(2011-1#1)
psychiatric disease##6##2##(1991-12#1)(1997-6#1)(2007-7#1)(2008-9#1)(2009-4#1)(2011-1#1)
psychiatric diseases were##2##3##(1993-8#1)(2013-8#1)
psychiatric diseases##8##2##(1993-8#1)(1996-12#1)(2007-7#1)(2009-4#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
psychiatric disorder that##4##3##(2006-4#1)(2007-7#1)(2008-4#1)(2012-12#1)
psychiatric disorder##20##2##(1993-7#1)(1994-2#1)(2004-3#2)(2005-10#2)(2006-1#1)(2006-4#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-8#1)(2011-1#1)(2012-12#1)
psychiatric disorders and other##2##4##(2008-1#1)(2009-7#1)
psychiatric disorders and the##2##4##(2006-2#1)(2006-4#1)
psychiatric disorders and##11##3##(1990-5#1)(1996-8#1)(2006-2#1)(2006-4#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-9#1)(2009-7#1)(2011-1#2)
psychiatric disorders are##2##3##(2004-3#1)(2009-4#1)
psychiatric disorders has##2##3##(1997-5#1)(2007-7#1)
psychiatric disorders in##5##3##(2005-9#1)(2007-1#1)(2008-1#1)(2011-1#1)(2011-12#1)
psychiatric disorders is##2##3##(2008-1#1)(2011-2#1)
psychiatric disorders may##2##3##(1996-5#1)(2008-1#1)
psychiatric disorders such as##2##4##(2005-10#1)(2006-7#1)
psychiatric disorders that##2##3##(1990-12#1)(2004-3#1)
psychiatric disorders with##2##3##(2008-6#1)(2008-8#1)
psychiatric disorders##135##2##(1990-12#1)(1990-5#1)(1991-1#3)(1993-6#1)(1995-1#1)(1995-11#3)(1995-3#1)(1995-9#1)(1996-10#1)(1996-11#3)(1996-5#1)(1996-6#1)(1996-8#1)(1997-5#2)(2004-3#4)(2005-10#1)(2005-8#2)(2005-9#3)(2006-10#1)(2006-2#2)(2006-4#1)(2006-7#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#3)(2007-8#1)(2008-1#10)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-8#2)(2008-9#6)(2009-10#3)(2009-11#2)(2009-4#7)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#12)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-2#11)(2013-1#3)(2013-7#2)(2013-8#4)
psychiatric disorders]##2##2##(2012-1#1)(2012-2#1)
psychiatric disturbances##2##2##(1993-8#1)(2008-11#1)
psychiatric emergencies##2##2##(1992-5#2)
psychiatric emergency##3##2##(2008-3#1)(2011-2#2)
psychiatric evaluation of##2##3##(1997-4#1)(2007-11#1)
psychiatric evaluation##3##2##(1997-4#1)(2007-11#1)(2011-2#1)
psychiatric facilities##6##2##(1991-2#1)(1993-2#1)(1993-3#1)(1996-1#1)(1997-5#1)(2010-4#1)
psychiatric facility##5##2##(1990-5#1)(1991-2#1)(1992-12#1)(1993-2#1)(2009-7#1)
psychiatric factors##2##2##(2008-1#1)(2008-6#1)
psychiatric family nurse practitioner##3##4##(2004-3#3)
psychiatric healthcare##6##2##(1991-2#2)(2011-2#4)
psychiatric history##2##2##(2004-3#1)(2010-3#1)
psychiatric hospital and##3##3##(1993-2#1)(2008-1#1)(2008-7#1)
psychiatric hospital with##2##3##(1991-9#1)(2008-2#1)
psychiatric hospital##31##2##(1991-12#1)(1991-2#3)(1991-9#1)(1992-2#1)(1992-3#3)(1993-1#1)(1993-12#2)(1993-2#5)(1995-9#1)(1997-8#2)(2008-1#1)(2008-11#1)(2008-2#2)(2008-7#1)(2009-7#2)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
psychiatric hospital]##2##2##(2008-9#1)(2009-10#1)
psychiatric hospitalization on##2##3##(1991-2#1)(1993-1#1)
psychiatric hospitalization##6##2##(1991-2#2)(1993-1#1)(1995-1#1)(2006-3#1)(2012-3#1)
psychiatric hospitals are##2##3##(1992-1#1)(1992-12#1)
psychiatric hospitals is##2##3##(1991-12#1)(1993-2#1)
psychiatric hospitals##19##2##(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#3)(1992-2#2)(1992-3#3)(1993-12#4)(1993-2#1)(2004-4#1)(2009-7#1)
psychiatric illness##12##2##(1993-12#1)(1993-5#1)(1994-2#2)(2004-3#1)(2005-7#1)(2005-9#1)(2008-4#1)(2008-9#1)(2009-7#1)(2012-11#1)(2012-3#1)
psychiatric illnesses##7##2##(1993-12#1)(2006-2#1)(2008-11#1)(2008-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
psychiatric inpatient treatment##2##3##(1990-12#1)(1992-3#1)
psychiatric inpatient unit##2##3##(1993-2#1)(2009-9#1)
psychiatric inpatient##7##2##(1990-12#1)(1991-2#1)(1992-3#1)(1993-2#1)(1993-7#1)(2009-7#1)(2009-9#1)
psychiatric inpatients##11##2##(1992-5#1)(1993-2#1)(1993-7#1)(1996-3#1)(1997-8#2)(2007-7#1)(2008-11#1)(2009-2#1)(2009-4#1)(2013-1#1)
psychiatric institutions##2##2##(1993-5#1)(2008-2#1)
psychiatric intervention##2##2##(1992-1#1)(1996-1#1)
psychiatric journals##2##2##(2004-11#1)(2011-1#1)
psychiatric medication##7##2##(2007-9#5)(2008-8#1)(2010-12#1)
psychiatric medications##2##2##(2007-9#1)(2009-9#1)
psychiatric mental health##4##3##(2007-10#1)(2008-1#1)(2008-12#2)
psychiatric morbidity and##2##3##(1992-10#1)(2012-3#1)
psychiatric morbidity in##2##3##(1993-5#1)(2006-9#1)
psychiatric morbidity##12##2##(1992-10#1)(1993-2#1)(1993-5#1)(2006-9#2)(2007-12#2)(2008-11#1)(2010-9#2)(2012-3#2)
psychiatric nurse##2##2##(2008-11#2)
psychiatric nurses##9##2##(2007-3#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-1#5)
psychiatric nurses'##4##2##(2007-3#1)(2008-11#2)(2008-12#1)
psychiatric nursing students##4##3##(2008-11#3)(2008-12#1)
psychiatric nursing##8##2##(2007-3#1)(2008-11#6)(2008-12#1)
psychiatric occupational therapy##8##3##(2012-1#8)
psychiatric or medical##2##3##(2009-4#1)(2009-9#1)
psychiatric or##4##2##(1995-1#1)(2009-11#1)(2009-4#1)(2009-9#1)
psychiatric outcome##2##2##(1994-2#1)(2009-9#1)
psychiatric outpatient clinics##2##3##(1994-8#2)
psychiatric outpatient##8##2##(1991-11#1)(1991-9#3)(1994-8#4)
psychiatric outpatients##3##2##(2007-2#1)(2008-6#1)(2011-2#1)
psychiatric patient##4##2##(1996-12#1)(1997-8#1)(2008-6#1)(2012-12#1)
psychiatric patients admitted##2##3##(1997-8#1)(2009-7#1)
psychiatric patients and##2##3##(1997-8#1)(2007-10#1)
psychiatric patients in##3##3##(1995-11#1)(2008-2#1)(2009-7#1)
psychiatric patients who##3##3##(1992-3#1)(1996-3#1)(2008-1#1)
psychiatric patients with##3##3##(2011-2#1)(2013-1#2)
psychiatric patients##52##2##(1990-12#1)(1991-6#1)(1992-1#1)(1992-3#1)(1993-12#2)(1994-11#1)(1995-11#2)(1996-3#3)(1996-5#2)(1996-7#1)(1997-2#1)(1997-8#3)(2006-10#2)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#4)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#3)(2009-4#1)(2009-7#3)(2009-9#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#2)
psychiatric patients]##5##2##(1993-3#1)(1996-11#1)(2007-1#1)(2007-10#1)(2008-6#1)
psychiatric population##3##2##(1991-2#1)(2008-3#1)(2011-2#1)
psychiatric populations##2##2##(2008-8#1)(2012-12#1)
psychiatric practice in an##2##4##(2012-12#2)
psychiatric practice in##4##3##(1992-1#1)(2012-12#3)
psychiatric practice##12##2##(1991-3#1)(1992-1#1)(2005-6#2)(2006-9#1)(2007-9#1)(2008-6#1)(2012-12#4)(2012-2#1)
psychiatric presentation of##2##3##(2008-11#1)(2010-3#1)
psychiatric problems##7##2##(1990-3#1)(1991-3#1)(2007-2#1)(2008-6#1)(2012-12#1)(2013-1#2)
psychiatric profile##2##2##(2012-12#1)(2013-1#1)
psychiatric reform##3##2##(2008-5#3)
psychiatric research##11##2##(1992-8#1)(1997-8#2)(2006-8#1)(2008-4#1)(2009-4#1)(2010-6#1)(2011-1#2)(2011-2#1)(2011-7#1)
psychiatric service##2##2##(2009-7#1)(2012-2#1)
psychiatric services##14##2##(1991-1#1)(1991-3#1)(1991-6#1)(1992-5#1)(1993-8#1)(2006-9#2)(2008-2#3)(2009-7#1)(2011-2#1)(2011-7#1)(2013-1#1)
psychiatric setting##4##2##(1992-2#2)(2008-2#1)(2009-6#1)
psychiatric side effects##2##3##(2007-9#1)(2009-7#1)
psychiatric subjects##2##2##(2009-4#2)
psychiatric symptom##2##2##(2012-1#2)
psychiatric symptomatology##2##2##(2008-4#1)(2012-1#1)
psychiatric symptoms and##3##3##(2008-11#1)(2012-1#1)(2013-8#1)
psychiatric symptoms are##2##3##(2009-5#1)(2012-1#1)
psychiatric symptoms##34##2##(1996-3#1)(1996-5#1)(1997-1#1)(2004-3#4)(2006-4#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2009-12#1)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-12#2)(2011-2#1)(2012-1#6)(2012-3#1)(2013-8#4)
psychiatric syndromes##2##2##(2009-10#1)(2012-2#1)
psychiatric terms##2##2##(1996-9#1)(2009-10#1)
psychiatric training##2##2##(1993-10#1)(2006-9#1)
psychiatric treatment are##2##3##(1992-2#1)(1993-2#1)
psychiatric treatment##22##2##(1991-2#1)(1991-6#2)(1992-2#2)(1992-3#2)(1992-6#1)(1993-1#1)(1993-2#1)(1995-11#1)(1997-3#2)(2007-1#1)(2008-11#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-5#1)(2012-3#1)(2013-1#1)
psychiatric treatments##2##2##(2004-3#1)(2008-1#1)
psychiatric unit in##2##3##(1993-1#1)(2007-2#1)
psychiatric unit##5##2##(1993-1#1)(1993-12#1)(1995-1#1)(2007-2#1)(2009-7#1)
psychiatric unit]##2##2##(2009-6#1)(2010-3#1)
psychiatric units in##2##3##(1993-12#2)
psychiatric units##5##2##(1993-12#2)(2006-9#1)(2007-3#2)
psychiatric wandering##2##2##(1996-5#2)
psychiatric ward of##2##3##(1993-2#1)(2008-2#1)
psychiatric ward##7##2##(1993-2#1)(1996-2#1)(2007-3#1)(2008-2#1)(2010-8#1)(2011-2#1)(2012-3#1)
psychiatric wards##2##2##(2008-2#1)(2013-1#1)
psychiatric##869##1##(1990-12#5)(1990-3#3)(1990-5#3)(1990-6#2)(1991-1#6)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#17)(1991-3#4)(1991-5#1)(1991-6#4)(1991-9#5)(1992-1#4)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#9)(1992-3#14)(1992-5#7)(1992-6#1)(1992-8#1)(1993-1#9)(1993-10#1)(1993-12#16)(1993-2#14)(1993-3#6)(1993-5#8)(1993-6#2)(1993-7#5)(1993-8#5)(1994-11#3)(1994-12#1)(1994-2#5)(1994-5#1)(1994-6#1)(1994-8#4)(1995-1#7)(1995-11#6)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#2)(1995-5#1)(1995-9#3)(1996-1#3)(1996-10#1)(1996-11#7)(1996-12#2)(1996-2#1)(1996-3#6)(1996-5#6)(1996-6#1)(1996-7#3)(1996-8#2)(1996-9#3)(1997-1#4)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#4)(1997-6#1)(1997-8#12)(2004-11#3)(2004-3#24)(2004-4#1)(2005-10#3)(2005-6#4)(2005-7#2)(2005-8#2)(2005-9#4)(2006-1#1)(2006-10#5)(2006-2#6)(2006-3#2)(2006-4#8)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#4)(2006-9#17)(2007-1#6)(2007-10#9)(2007-11#3)(2007-12#5)(2007-2#6)(2007-3#6)(2007-4#1)(2007-6#1)(2007-7#12)(2007-8#5)(2007-9#9)(2008-1#23)(2008-10#2)(2008-11#24)(2008-12#7)(2008-2#24)(2008-3#4)(2008-4#17)(2008-5#6)(2008-6#15)(2008-7#12)(2008-8#5)(2008-9#14)(2009-10#9)(2009-11#3)(2009-12#3)(2009-2#4)(2009-4#18)(2009-5#2)(2009-6#9)(2009-7#23)(2009-8#6)(2009-9#10)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#7)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#24)(2011-12#2)(2011-2#36)(2011-3#1)(2011-4#2)(2011-7#4)(2012-1#20)(2012-11#3)(2012-12#17)(2012-2#25)(2012-3#9)(2013-1#23)(2013-7#4)(2013-8#15)
psychiatrically hospitalized##2##2##(1993-12#1)(1995-1#1)
psychiatrically ill##2##2##(1995-8#1)(1996-1#1)
psychiatrically normal##2##2##(1997-5#1)(2007-7#1)
psychiatrically##8##1##(1993-12#1)(1993-3#1)(1995-1#1)(1995-8#1)(1996-1#1)(1997-5#1)(2007-7#1)(2012-12#1)
psychiatrist and##2##2##(1990-12#1)(1996-11#1)
psychiatrist is##3##2##(1995-4#2)(2010-12#1)
psychiatrist on the##2##3##(1996-1#1)(2012-12#1)
psychiatrist##26##1##(1990-12#1)(1992-5#1)(1995-11#1)(1995-4#3)(1996-1#1)(1996-11#1)(2005-7#2)(2005-8#1)(2006-4#1)(2007-10#2)(2007-7#1)(2008-7#1)(2009-2#1)(2009-9#2)(2010-11#1)(2010-12#1)(2012-12#3)(2013-1#1)(2013-8#1)
psychiatrist's##4##1##(1992-12#1)(2008-2#1)(2010-12#1)(2012-12#1)
psychiatrists and neurologists##2##3##(2008-4#1)(2008-6#1)
psychiatrists and psychologists in##2##4##(1996-11#1)(2010-12#1)
psychiatrists and psychologists##4##3##(1996-11#1)(2008-12#2)(2010-12#1)
psychiatrists and##11##2##(1995-11#1)(1996-11#1)(2006-8#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-6#1)(2009-9#1)(2010-12#1)(2012-3#1)
psychiatrists focused##2##2##(2006-4#1)(2012-2#1)
psychiatrists have##4##2##(2004-11#1)(2012-2#2)(2012-3#1)
psychiatrists in##2##2##(2006-8#1)(2011-1#1)
psychiatrists of the##2##3##(2006-9#1)(2011-1#1)
psychiatrists of##3##2##(2006-9#1)(2011-1#2)
psychiatrists or##2##2##(2005-7#1)(2006-8#1)
psychiatrists should##2##2##(1996-6#1)(2012-2#1)
psychiatrists were##3##2##(1996-1#1)(2005-7#1)(2008-7#1)
psychiatrists who##4##2##(2010-7#1)(2011-1#1)(2012-11#1)(2012-2#1)
psychiatrists##64##1##(1991-2#1)(1993-12#1)(1993-5#1)(1993-6#2)(1994-8#1)(1995-11#1)(1996-1#2)(1996-11#1)(1996-5#1)(1996-6#1)(2004-11#1)(2005-7#3)(2006-2#1)(2006-4#1)(2006-8#3)(2006-9#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#1)(2008-6#2)(2008-7#1)(2009-9#4)(2010-11#1)(2010-12#3)(2010-7#1)(2011-1#7)(2011-2#1)(2011-7#1)(2012-1#1)(2012-11#1)(2012-2#8)(2012-3#2)(2013-8#1)
psychiatrists'##3##1##(2008-2#1)(2008-7#1)(2013-8#1)
psychiatry and neurology##3##3##(2008-1#1)(2008-4#1)(2008-6#1)
psychiatry and the##2##3##(2005-7#1)(2006-9#1)
psychiatry and##27##2##(1990-8#1)(1991-3#1)(1993-3#1)(1994-3#1)(1996-1#1)(2004-11#1)(2005-7#1)(2006-3#1)(2006-9#1)(2008-1#1)(2008-2#2)(2008-4#3)(2008-6#1)(2009-8#1)(2009-9#4)(2010-7#1)(2010-9#2)(2011-2#1)(2011-3#1)(2013-1#1)
psychiatry appears to be##2##4##(1997-8#1)(2008-2#1)
psychiatry are##4##2##(1992-9#1)(2004-11#1)(2006-9#1)(2013-8#1)
psychiatry as a career##2##4##(2008-4#2)
psychiatry as a##4##3##(2008-4#2)(2011-1#1)(2012-2#1)
psychiatry as##6##2##(1991-3#1)(2008-2#1)(2008-4#2)(2011-1#1)(2012-2#1)
psychiatry at the##3##3##(2008-11#1)(2009-4#2)
psychiatry because##2##2##(2008-1#1)(2008-9#1)
psychiatry has been##2##3##(2011-7#2)
psychiatry has##6##2##(1993-7#1)(2006-9#1)(2011-2#1)(2011-7#2)(2012-2#1)
psychiatry have##2##2##(2008-6#1)(2011-2#1)
psychiatry in the##3##3##(1992-6#1)(2008-2#1)(2010-7#1)
psychiatry in##15##2##(1991-3#1)(1992-6#1)(1995-6#1)(2006-9#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-2#2)(2013-7#1)
psychiatry is##8##2##(1993-8#1)(2004-11#2)(2006-9#1)(2008-2#1)(2009-8#1)(2011-2#1)(2012-2#1)
psychiatry was##6##2##(1992-6#1)(2008-4#1)(2009-10#1)(2009-2#1)(2011-7#1)(2012-2#1)
psychiatry##208##1##(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#4)(1991-6#1)(1992-3#1)(1992-6#4)(1992-8#2)(1992-9#3)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-3#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-8#1)(2004-11#6)(2004-3#3)(2005-5#1)(2005-6#1)(2005-7#1)(2006-3#1)(2006-8#1)(2006-9#23)(2007-10#1)(2007-2#1)(2007-9#4)(2008-1#2)(2008-11#5)(2008-2#20)(2008-3#1)(2008-4#12)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-4#6)(2009-7#2)(2009-8#3)(2009-9#6)(2010-12#3)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#4)(2010-9#3)(2011-1#6)(2011-12#1)(2011-2#13)(2011-3#2)(2011-7#6)(2012-12#2)(2012-2#10)(2013-1#1)(2013-7#2)(2013-8#7)
psychiatry's##3##1##(2006-9#2)(2010-7#1)
psychiatry?##2##1##(2008-4#1)(2010-5#1)
psychiatry?]##3##1##(1995-6#1)(2010-3#1)(2013-8#1)
psychiatry]##14##1##(1990-1#1)(1991-5#1)(1992-11#1)(1992-8#1)(1993-10#1)(1993-8#1)(1996-9#1)(1997-6#1)(2008-2#1)(2009-10#2)(2011-3#1)(2012-1#1)(2013-8#1)
psychic disorders##4##2##(1990-3#1)(2005-10#3)
psychic##16##1##(1990-10#1)(1990-3#2)(1993-11#1)(1993-8#1)(1994-6#1)(1995-5#1)(1996-2#1)(2005-10#4)(2006-8#1)(2008-7#1)(2009-7#1)(2012-12#1)
psycho##3##1##(2004-8#2)(2010-8#1)
psycho-education##3##1##(1992-8#1)(2008-1#1)(2009-7#1)
psycho-educational intervention##2##2##(1997-8#1)(2010-7#1)
psycho-educational##3##1##(1997-8#1)(2010-7#2)
psycho-emotional##2##1##(2008-2#1)(2009-2#1)
psycho-geriatric##4##1##(1992-3#4)
psycho-organic syndrome##4##2##(1992-2#1)(2007-11#3)
psycho-organic##6##1##(1991-5#1)(1992-2#1)(1992-5#1)(2007-11#3)
psycho-physical##2##1##(1992-11#1)(2010-6#1)
psycho-social##6##1##(1992-12#1)(1994-8#2)(2007-7#1)(2008-12#1)(2011-2#1)
psychoacoustic##3##1##(2008-2#1)(2008-3#1)(2009-2#1)
psychoactive drug##3##2##(2010-12#1)(2012-3#2)
psychoactive drugs were##2##3##(1997-2#1)(2008-1#1)
psychoactive drugs##13##2##(1990-3#1)(1990-9#1)(1994-2#1)(1997-2#1)(2007-9#1)(2008-1#2)(2008-6#1)(2009-2#2)(2012-3#3)
psychoactive substance use##3##3##(2004-3#1)(2013-7#2)
psychoactive substance##6##2##(2004-3#1)(2010-9#1)(2013-1#1)(2013-7#3)
psychoactive substances and##2##3##(2008-1#1)(2011-1#1)
psychoactive substances##8##2##(2008-1#1)(2009-2#1)(2010-9#2)(2011-1#1)(2013-1#1)(2013-7#2)
psychoactive##38##1##(1990-12#1)(1990-3#1)(1990-9#1)(1994-2#1)(1996-5#1)(1997-2#1)(2004-3#1)(2007-9#1)(2008-1#4)(2008-6#2)(2008-7#2)(2009-2#3)(2010-12#1)(2010-9#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#5)(2013-1#2)(2013-7#5)
psychoanalysis and##2##2##(1990-3#1)(2006-9#1)
psychoanalysis as a##2##3##(2006-9#2)
psychoanalysis##20##1##(1990-3#3)(2006-9#5)(2008-10#1)(2008-2#1)(2008-5#2)(2009-4#1)(2011-2#4)(2012-2#3)
psychoanalytic process##2##2##(2008-4#1)(2011-2#1)
psychoanalytic##9##1##(1990-3#1)(2006-9#1)(2008-4#2)(2008-6#1)(2009-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
psychoanalytical approach to##2##3##(2008-12#1)(2011-7#1)
psychoanalytical##8##1##(1990-5#1)(1991-2#2)(2008-12#1)(2008-5#1)(2010-6#1)(2011-7#1)(2012-12#1)
psychobiological model##2##2##(2009-9#2)
psychobiological##7##1##(1993-12#1)(2006-12#1)(2008-1#1)(2008-4#1)(2009-12#1)(2009-9#2)
psychodynamic explanations##2##2##(2006-3#1)(2008-11#1)
psychodynamic##16##1##(1993-1#1)(1996-2#1)(2004-12#1)(2005-6#3)(2005-7#1)(2006-3#2)(2007-5#1)(2008-11#1)(2008-4#1)(2009-7#1)(2011-2#2)(2012-12#1)
psychoeducation about##2##2##(2010-9#1)(2012-2#1)
psychoeducation##12##1##(2005-6#1)(2006-9#1)(2007-12#2)(2009-11#1)(2010-9#1)(2012-12#3)(2012-2#3)
psychoeducational interventions##2##2##(2009-11#2)
psychoeducational##8##1##(1996-7#2)(2007-12#1)(2007-9#1)(2008-2#1)(2008-8#1)(2009-11#2)
psychogenetically selected lines##2##3##(1993-5#1)(1994-2#1)
psychogenic and neurogenic stressors##2##4##(2008-11#2)
psychogenic causes##2##2##(2009-3#1)(2010-11#1)
psychogenic in nature##2##3##(2009-3#1)(2011-2#1)
psychogenic##20##1##(1990-5#1)(1991-11#2)(1993-8#2)(1994-2#1)(1994-9#1)(2008-11#4)(2008-5#1)(2008-9#2)(2009-3#2)(2010-11#1)(2011-2#1)(2012-1#1)(2012-12#1)
psychogeriatric##5##1##(1992-3#1)(1994-6#1)(2007-3#1)(2010-12#1)(2013-1#1)
psychol##2##1##(1991-1#2)
psycholinguistic##3##1##(2009-11#1)(2012-11#2)
psychologic and social##2##3##(1992-2#1)(1996-7#1)
psychologic and##4##2##(1991-12#1)(1992-2#1)(1996-7#1)(2008-10#1)
psychologic##18##1##(1991-12#1)(1991-2#1)(1992-2#1)(1993-10#1)(1996-7#4)(2007-12#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-11#1)
psychological access to health care##2##5##(2009-4#2)
psychological access##3##2##(2009-4#3)
psychological adjustment and##5##3##(2009-11#2)(2010-2#1)(2013-1#2)
psychological adjustment of##2##3##(2010-2#1)(2012-3#1)
psychological adjustment##19##2##(1996-3#1)(2007-12#2)(2009-11#7)(2009-7#1)(2010-2#3)(2012-3#1)(2013-1#4)
psychological analysis##2##2##(2007-9#2)
psychological and biological##4##3##(1996-6#1)(2010-4#1)(2011-2#1)(2012-12#1)
psychological and emotional##3##3##(2009-4#1)(2010-12#1)(2012-12#1)
psychological and medical##2##3##(1993-12#1)(2008-4#1)
psychological and physical##2##3##(2004-12#1)(2008-2#1)
psychological and physiological##2##3##(1995-6#1)(2010-12#1)
psychological and psychophysical stress##2##4##(1993-7#2)
psychological and social consequences##2##4##(1991-12#1)(2006-9#1)
psychological and social##11##3##(1991-12#1)(1994-9#1)(1995-1#1)(2006-7#1)(2006-9#1)(2007-7#1)(2008-1#1)(2008-6#1)(2008-7#1)(2008-9#1)(2013-8#1)
psychological and sociological##4##3##(2008-6#3)(2009-9#1)
psychological and somatic sequelae##2##4##(2004-10#2)
psychological and somatic##3##3##(2004-10#3)
psychological and##58##2##(1991-12#2)(1993-12#1)(1993-7#2)(1994-9#1)(1995-1#1)(1995-6#1)(1996-2#1)(1996-6#1)(1996-9#1)(2004-10#3)(2004-12#1)(2005-11#1)(2006-6#1)(2006-7#2)(2006-9#2)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#2)(2008-6#4)(2008-7#2)(2008-9#1)(2009-11#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-12#4)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#1)
psychological approaches##3##2##(1991-12#1)(2006-9#2)
psychological aspects of##9##3##(1994-12#1)(2006-3#1)(2007-10#1)(2007-11#1)(2008-12#1)(2008-4#1)(2009-10#1)(2010-11#1)(2010-3#1)
psychological aspects##12##2##(1994-12#1)(2006-3#1)(2007-10#1)(2007-11#1)(2008-12#2)(2008-4#1)(2009-10#1)(2010-11#1)(2010-3#1)(2013-1#2)
psychological assault##2##2##(2007-9#2)
psychological assessment and##3##3##(1993-8#1)(2006-10#1)(2006-2#1)
psychological autopsy##3##2##(2009-7#3)
psychological benefit##2##2##(1990-10#1)(2006-10#1)
psychological challenges after cancer##2##4##(2009-10#2)
psychological challenges after##3##3##(2009-10#3)
psychological challenges##5##2##(2009-10#5)
psychological changes##2##2##(2007-3#2)
psychological characteristics##3##2##(2005-11#1)(2006-7#1)(2007-12#1)
psychological complaints##2##2##(2006-7#1)(2013-1#1)
psychological condition##4##2##(1994-12#2)(1995-4#1)(2007-11#1)
psychological conditions##4##2##(1997-4#1)(2006-8#1)(2008-4#1)(2009-7#1)
psychological consequences##5##2##(2006-10#1)(2006-4#1)(2008-2#1)(2010-9#1)(2012-2#1)
psychological descriptors##2##2##(2008-5#2)
psychological development##6##2##(2005-7#1)(2006-9#1)(2007-12#1)(2008-4#1)(2011-2#2)
psychological dimension of##2##3##(2008-10#1)(2008-2#1)
psychological disorder##2##2##(2006-9#1)(2013-8#1)
psychological disorders##4##2##(2006-8#1)(2007-2#1)(2007-3#1)(2010-9#1)
psychological distress and##9##3##(2006-4#1)(2007-12#1)(2008-3#1)(2008-6#1)(2009-12#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
psychological distress in##4##3##(1996-1#1)(2008-9#1)(2012-1#1)(2012-11#1)
psychological distress##46##2##(1996-1#1)(2004-11#3)(2004-2#2)(2006-3#1)(2006-4#3)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#2)(2009-8#1)(2010-6#3)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#5)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#1)
psychological disturbance##2##2##(2006-7#1)(2009-7#1)
psychological disturbances##3##2##(1992-5#1)(2008-10#1)(2009-7#1)
psychological effects of##4##3##(1992-5#1)(2007-2#1)(2008-11#1)(2012-12#1)
psychological effects##8##2##(1991-9#1)(1992-5#1)(1996-3#1)(2006-2#1)(2007-2#1)(2007-6#1)(2008-11#1)(2012-12#1)
psychological evaluation##2##2##(1991-7#1)(2006-8#1)
psychological factors in##2##3##(2005-11#1)(2006-9#1)
psychological factors##22##2##(1990-10#1)(1990-6#1)(1993-12#1)(1995-9#1)(2005-11#2)(2006-10#7)(2006-8#2)(2006-9#1)(2007-12#1)(2008-8#1)(2009-2#1)(2009-7#1)(2012-2#2)
psychological findings##3##2##(2007-8#2)(2008-5#1)
psychological follow-up##2##2##(2011-1#1)(2011-3#1)
psychological function and##2##3##(1995-10#1)(2008-4#1)
psychological function##4##2##(1995-10#1)(1996-11#1)(2008-4#1)(2011-1#1)
psychological functioning##6##2##(1995-2#1)(1996-8#1)(2006-3#1)(2008-12#2)(2008-2#1)
psychological functions##3##2##(2007-8#1)(2008-7#1)(2012-1#1)
psychological health##5##2##(2008-1#2)(2008-2#2)(2009-5#1)
psychological illness##2##2##(2006-12#1)(2007-2#1)
psychological impact of the##2##4##(1997-5#1)(2007-3#1)
psychological impact of##9##3##(1997-5#1)(2006-3#1)(2007-12#1)(2007-3#1)(2008-12#1)(2008-4#2)(2008-5#1)(2010-8#1)
psychological impact##14##2##(1997-5#1)(2006-10#1)(2006-3#1)(2006-4#1)(2007-12#1)(2007-3#1)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)
psychological implications##2##2##(1990-6#1)(2007-11#1)
psychological influence##2##2##(2008-5#1)(2011-1#1)
psychological intervention##2##2##(1996-6#1)(2012-1#1)
psychological interventions##5##2##(2006-10#2)(2006-12#1)(2008-12#1)(2012-12#1)
psychological investment in##2##3##(2007-12#2)
psychological issues##5##2##(1997-8#1)(2005-8#1)(2008-11#1)(2008-4#1)(2012-12#1)
psychological job demands##2##3##(2012-1#2)
psychological maladjustment##2##2##(2007-8#2)
psychological means##2##2##(2008-7#1)(2010-12#1)
psychological measures##2##2##(2006-2#1)(2011-1#1)
psychological mechanisms##4##2##(2006-10#1)(2006-2#1)(2008-12#1)(2008-2#1)
psychological methods##2##2##(1992-12#1)(2008-11#1)
psychological needs##5##2##(1996-12#1)(2004-3#1)(2007-7#2)(2008-9#1)
psychological or psychiatric##2##3##(2007-2#1)(2008-6#1)
psychological outcomes for##2##3##(2008-6#1)(2010-3#1)
psychological outcomes##4##2##(2006-12#1)(2008-6#1)(2009-7#1)(2010-3#1)
psychological perspective##2##2##(2006-7#1)(2010-8#1)
psychological phenomena##2##2##(2008-5#1)(2010-11#1)
psychological point of view##3##4##(1993-3#1)(2008-2#1)(2011-1#1)
psychological pressure##2##2##(2008-6#1)(2009-2#1)
psychological problems and##2##3##(2008-2#1)(2011-1#1)
psychological problems##12##2##(1991-8#1)(1993-10#1)(1993-6#1)(1996-12#1)(2006-1#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-2#1)(2009-11#1)(2010-4#1)(2011-1#1)
psychological process##4##2##(1990-10#4)
psychological processes##5##2##(2007-8#1)(2008-11#2)(2008-2#1)(2008-5#1)
psychological rather than##2##3##(2006-3#1)(2011-2#1)
psychological reactions##2##2##(1990-8#1)(1992-5#1)
psychological responses##5##2##(1991-11#1)(1992-4#2)(2006-10#1)(2010-6#1)
psychological sense of community##2##4##(2009-7#2)
psychological sequelae of##2##3##(2011-1#1)(2012-1#1)
psychological sequelae##8##2##(1995-9#1)(1996-2#1)(2005-6#1)(2005-7#1)(2007-11#1)(2007-8#1)(2011-1#1)(2012-1#1)
psychological services##2##2##(1992-1#2)
psychological state##2##2##(2008-9#1)(2009-5#1)
psychological states##2##2##(2008-11#1)(2010-6#1)
psychological status of##2##3##(2006-8#1)(2007-8#1)
psychological status##7##2##(2006-8#5)(2007-12#1)(2007-8#1)
psychological strain##2##2##(1996-2#1)(2008-6#1)
psychological strategies##2##2##(1996-9#1)(1997-5#1)
psychological stress and##2##3##(2008-10#1)(2008-5#1)
psychological stress##20##2##(1991-12#1)(1991-4#1)(1993-7#3)(2007-11#3)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2011-2#1)
psychological stressors (adjusted OR 1##2##5##(2008-10#2)
psychological stressors##3##2##(2008-10#3)
psychological support offered to##2##4##(2008-6#2)
psychological support##9##2##(1995-4#1)(2008-6#5)(2010-8#1)(2011-1#1)(2012-3#1)
psychological symptoms and sympathetic activation induced by##2##7##(2008-10#2)
psychological symptoms and##5##3##(2008-10#3)(2008-2#2)
psychological symptoms were##2##3##(1990-10#1)(2004-10#1)
psychological symptoms##21##2##(1990-10#1)(1995-1#1)(2004-10#1)(2005-8#1)(2006-3#1)(2006-9#1)(2008-10#5)(2008-2#2)(2008-4#2)(2010-6#1)(2012-2#1)(2013-1#4)
psychological tests##4##2##(1991-5#1)(2007-3#1)(2011-2#1)(2013-7#1)
psychological theories##4##2##(2006-6#1)(2008-9#1)(2009-8#1)(2010-8#1)
psychological theory and##2##3##(1993-12#1)(2010-2#1)
psychological theory##4##2##(1990-3#1)(1993-12#1)(1995-4#1)(2010-2#1)
psychological therapies for psychosis##2##4##(2006-9#2)
psychological therapies##5##2##(2006-3#1)(2006-9#3)(2008-6#1)
psychological therapy##4##2##(2006-12#1)(2006-3#1)(2008-7#1)(2013-8#1)
psychological trauma##4##2##(1991-4#1)(2007-3#1)(2007-7#1)(2012-2#1)
psychological treatments##5##2##(2006-10#1)(2011-2#3)(2011-7#1)
psychological variables##2##2##(2007-12#2)
psychological well-being and quality of life##2##6##(1997-8#2)
psychological well-being and##3##3##(1997-8#2)(2012-2#1)
psychological well-being of##4##3##(2008-11#2)(2011-12#1)(2013-1#1)
psychological well-being over time##3##4##(2010-7#3)
psychological well-being over##4##3##(2010-7#4)
psychological well-being##45##2##(1991-12#1)(1992-2#1)(1993-9#1)(1994-2#1)(1996-11#1)(1997-8#2)(2005-9#2)(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-7#1)(2009-11#1)(2009-3#1)(2009-7#2)(2010-2#2)(2010-7#5)(2011-12#1)(2012-2#6)(2013-1#6)
psychological wellbeing##4##2##(2007-11#1)(2009-9#1)(2011-2#1)(2013-1#1)
psychological##703##1##(1990-10#7)(1990-3#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#5)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#3)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#3)(1993-10#1)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#2)(1993-7#5)(1993-8#4)(1993-9#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#4)(1995-10#1)(1995-12#1)(1995-2#2)(1995-4#5)(1995-6#2)(1995-7#1)(1995-9#3)(1996-1#3)(1996-11#2)(1996-12#3)(1996-2#4)(1996-3#2)(1996-6#2)(1996-8#1)(1996-9#3)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#3)(1997-7#2)(1997-8#3)(2004-10#4)(2004-11#3)(2004-12#2)(2004-2#2)(2004-3#2)(2005-11#6)(2005-6#2)(2005-7#2)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#20)(2006-12#7)(2006-2#5)(2006-3#8)(2006-4#5)(2006-6#2)(2006-7#9)(2006-8#15)(2006-9#12)(2007-1#3)(2007-10#2)(2007-11#12)(2007-12#23)(2007-2#5)(2007-3#7)(2007-5#3)(2007-6#5)(2007-7#5)(2007-8#15)(2007-9#6)(2008-1#6)(2008-10#21)(2008-11#15)(2008-12#17)(2008-2#18)(2008-3#4)(2008-4#13)(2008-5#12)(2008-6#22)(2008-7#9)(2008-8#3)(2008-9#8)(2009-10#9)(2009-11#11)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#4)(2009-5#3)(2009-6#2)(2009-7#16)(2009-8#4)(2009-9#4)(2010-1#2)(2010-11#5)(2010-12#6)(2010-2#10)(2010-3#5)(2010-4#3)(2010-5#1)(2010-6#8)(2010-7#12)(2010-8#7)(2010-9#3)(2011-1#10)(2011-12#3)(2011-2#25)(2011-3#1)(2011-7#1)(2012-1#12)(2012-11#1)(2012-12#10)(2012-2#20)(2012-3#5)(2012-5#1)(2013-1#21)(2013-7#1)(2013-8#9)
psychologically healthy persons##2##3##(1996-9#2)
psychologically##20##1##(1992-12#1)(1993-11#1)(1995-1#1)(1995-12#1)(1995-9#1)(1996-9#2)(1997-8#1)(2006-10#1)(2006-4#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-6#1)(2009-8#1)(2011-2#1)
psychologique##3##1##(2008-2#1)(2009-4#1)(2012-2#1)
psychologist training program##2##3##(2012-2#2)
psychologist##16##1##(1994-12#1)(1994-5#1)(1996-11#1)(2004-12#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-6#1)(2009-2#1)(2009-6#1)(2010-2#1)(2011-2#1)(2012-2#2)(2013-1#2)
psychologist's##2##1##(2007-6#1)(2011-2#1)
psychologists and other##2##3##(2009-1#1)(2010-2#1)
psychologists and primary health agents##2##5##(2010-12#2)
psychologists and##7##2##(1996-1#1)(2009-1#1)(2010-12#2)(2010-2#1)(2011-1#1)(2012-12#1)
psychologists have studied the##2##4##(2008-5#1)(2009-12#1)
psychologists have##4##2##(2008-3#1)(2008-5#1)(2009-12#1)(2013-8#1)
psychologists in the##4##3##(2006-8#1)(2008-12#1)(2010-12#1)(2011-1#1)
psychologists in##9##2##(1996-11#1)(2006-8#1)(2008-12#5)(2010-12#1)(2011-1#1)
psychologists of##2##2##(2008-12#1)(2008-5#1)
psychologists who work##2##3##(1996-1#1)(2008-12#1)
psychologists who##3##2##(1996-1#1)(2008-12#1)(2008-3#1)
psychologists##73##1##(1990-6#1)(1993-10#1)(1993-12#1)(1993-5#1)(1994-8#1)(1995-11#1)(1996-1#3)(1996-11#1)(2005-7#1)(2006-1#2)(2006-10#1)(2006-2#2)(2006-6#1)(2006-7#1)(2006-8#3)(2007-11#1)(2007-6#1)(2007-8#4)(2008-12#22)(2008-3#5)(2008-5#4)(2009-1#1)(2009-10#1)(2009-12#2)(2010-12#3)(2010-2#1)(2010-7#1)(2011-1#3)(2012-12#2)(2013-8#1)
psychologists'##3##1##(2008-12#1)(2011-1#2)
psychology and psychiatry##2##3##(2011-1#2)
psychology and religion##2##3##(2008-12#2)
psychology and##22##2##(1990-2#1)(1990-8#1)(1991-3#1)(1993-3#1)(1994-2#1)(1996-11#1)(2006-3#1)(2006-7#1)(2008-11#1)(2008-12#2)(2008-8#1)(2009-10#2)(2009-12#1)(2010-12#1)(2011-1#4)(2011-2#1)(2013-8#1)
psychology as a##3##3##(2008-11#1)(2008-12#1)(2008-5#1)
psychology as##6##2##(2008-11#1)(2008-12#3)(2008-5#1)(2012-2#1)
psychology department##2##2##(1997-1#1)(2008-2#1)
psychology has##2##2##(2008-12#1)(2010-2#1)
psychology in the context of##2##5##(2008-2#1)(2009-10#1)
psychology in the##3##3##(2008-12#1)(2008-2#1)(2009-10#1)
psychology in##8##2##(1990-5#1)(1993-2#1)(2006-8#1)(2008-12#2)(2008-2#1)(2009-10#1)(2013-1#1)
psychology is##3##2##(2006-7#1)(2008-12#1)(2009-8#1)
psychology of##10##2##(2006-3#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-7#1)(2009-12#1)(2010-2#1)(2013-7#1)(2013-8#1)
psychology research##2##2##(2008-12#1)(2010-2#1)
psychology to##3##2##(2008-2#2)(2008-6#1)
psychology##128##1##(1990-2#2)(1990-5#1)(1990-8#2)(1991-2#1)(1991-3#1)(1993-12#1)(1993-2#4)(1993-3#1)(1994-12#4)(1994-2#1)(1995-6#1)(1996-11#1)(1996-6#2)(1997-1#1)(1997-8#1)(2004-12#4)(2006-12#1)(2006-3#2)(2006-6#2)(2006-7#3)(2006-8#1)(2007-11#2)(2007-12#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#19)(2008-2#6)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#7)(2009-11#1)(2009-12#5)(2009-4#1)(2009-7#1)(2009-8#5)(2010-12#2)(2010-2#3)(2010-6#3)(2010-9#1)(2011-1#4)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#2)
psychology's##2##1##(2008-12#1)(2009-10#1)
psychometric analysis##2##2##(2008-7#1)(2011-2#1)
psychometric characteristics##3##2##(1997-5#1)(2007-12#1)(2011-2#1)
psychometric data##2##2##(1997-8#1)(2006-12#1)
psychometric evaluation of the##4##4##(2006-9#1)(2007-12#1)(2012-2#1)(2013-7#1)
psychometric evaluation##9##2##(1990-3#1)(1994-6#1)(2006-9#1)(2007-12#2)(2008-6#1)(2012-1#1)(2012-2#1)(2013-7#1)
psychometric intelligence##2##2##(2008-3#1)(2010-2#1)
psychometric properties and can##2##4##(2010-10#1)(2012-1#1)
psychometric properties and##6##3##(2008-6#1)(2010-10#1)(2011-1#1)(2012-1#1)(2013-1#2)
psychometric properties for##2##3##(2006-12#1)(2011-1#1)
psychometric properties of a##2##4##(2007-10#1)(2007-9#1)
psychometric properties of the instrument##2##5##(2008-1#1)(2008-11#1)
psychometric properties of the revised##2##5##(2009-7#1)(2009-9#1)
psychometric properties of the##12##4##(2007-9#1)(2008-1#1)(2008-11#2)(2008-9#1)(2009-7#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#2)(2013-1#1)
psychometric properties of##22##3##(1996-3#1)(1997-8#1)(2007-10#1)(2007-9#2)(2008-1#1)(2008-11#3)(2008-6#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-11#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
psychometric properties were##2##3##(1997-8#1)(2013-7#1)
psychometric properties##47##2##(1996-3#1)(1997-8#2)(2006-12#1)(2007-1#1)(2007-10#1)(2007-9#2)(2008-1#1)(2008-11#3)(2008-6#3)(2008-9#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-11#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-1#4)(2012-11#2)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#1)
psychometric testing##2##2##(1994-6#1)(2008-7#1)
psychometric tests##4##2##(1990-3#1)(1990-6#1)(1994-6#1)(1996-4#1)
psychometric##95##1##(1990-3#3)(1990-6#1)(1994-2#1)(1994-6#3)(1995-3#1)(1996-3#1)(1996-4#1)(1997-5#1)(1997-8#3)(2005-8#1)(2006-12#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#6)(2007-9#2)(2008-1#3)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-2#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#5)(2012-1#5)(2012-11#2)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#1)
psychometrically sound##3##2##(2010-11#1)(2011-8#1)(2012-2#1)
psychometrically##6##1##(1997-8#1)(2008-6#1)(2010-11#1)(2011-8#1)(2012-2#1)(2012-3#1)
psychomimetic symptoms##2##2##(2012-2#2)
psychomimetic##4##1##(2006-10#1)(2012-2#3)
psychomotor alteration##4##2##(2013-8#4)
psychomotor and cognitive##3##3##(1991-2#1)(2005-9#1)(2007-6#1)
psychomotor and##4##2##(1991-2#1)(2005-9#1)(2007-6#1)(2008-1#1)
psychomotor development of##4##3##(1994-6#1)(2006-10#1)(2013-8#2)
psychomotor development##11##2##(1994-6#2)(2006-10#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#3)
psychomotor effects##2##2##(1991-2#1)(1996-8#1)
psychomotor function##2##2##(1997-6#1)(2007-11#1)
psychomotor poverty##2##2##(1997-2#1)(2006-3#1)
psychomotor retardation##2##2##(1996-3#1)(2010-9#1)
psychomotor skills##2##2##(2006-6#1)(2008-11#1)
psychomotor stimulants##2##2##(1994-2#1)(1996-10#1)
psychomotor##42##1##(1991-2#2)(1993-6#1)(1994-2#1)(1994-6#2)(1996-10#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-6#1)(2005-9#1)(2006-10#3)(2006-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#2)(2008-11#1)(2009-10#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#9)
psychomotoric##3##1##(1990-8#1)(1991-5#1)(1995-8#1)
psychomotricity##3##1##(2007-6#3)
psychoneuroimmunology##2##1##(1995-9#1)(2007-11#1)
psychoorganic##2##1##(2011-2#2)
psychopathic individuals##3##2##(2008-11#2)(2009-9#1)
psychopathic##6##1##(2008-11#2)(2009-9#1)(2010-12#1)(2010-5#1)(2011-1#1)
psychopathologic and##2##2##(2007-7#1)(2011-1#1)
psychopathologic##4##1##(2007-2#1)(2007-7#1)(2008-1#1)(2011-1#1)
psychopathological features##2##2##(2010-11#1)(2012-5#1)
psychopathological hand disorders##2##3##(2008-9#2)
psychopathological rating##2##2##(1994-6#1)(2008-6#1)
psychopathological symptoms##4##2##(1991-4#1)(2011-2#1)(2013-7#2)
psychopathological##24##1##(1991-3#1)(1991-4#1)(1994-6#1)(1996-2#2)(1996-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#5)(2009-10#2)(2010-11#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-5#1)(2013-7#2)
psychopathology and##9##2##(1992-5#1)(2006-3#1)(2008-11#2)(2008-2#1)(2008-6#1)(2009-7#1)(2011-2#1)(2012-2#1)
psychopathology in patients with##2##4##(2008-7#1)(2009-10#1)
psychopathology in##10##2##(1997-8#1)(2006-3#1)(2008-7#1)(2009-10#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
psychopathology including##2##2##(2006-8#1)(2012-2#1)
psychopathology is##4##2##(1994-2#1)(2006-3#3)
psychopathology of##7##2##(1993-10#1)(2006-2#1)(2008-1#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
psychopathology##83##1##(1991-1#1)(1992-5#1)(1993-10#1)(1993-5#1)(1994-2#1)(1995-5#1)(1996-11#1)(1996-7#1)(1996-8#2)(1997-8#4)(2004-12#1)(2006-2#1)(2006-3#12)(2006-8#2)(2006-9#1)(2007-12#1)(2007-7#1)(2008-1#6)(2008-11#4)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#2)(2009-10#3)(2009-11#3)(2009-7#1)(2009-9#2)(2010-2#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#4)(2012-5#3)(2013-1#4)(2013-8#3)
psychopaths##4##1##(2009-9#1)(2010-12#3)
psychopathy##8##1##(2009-12#3)(2009-9#3)(2010-12#1)(2012-2#1)
psychopharmacologic##6##1##(2005-6#1)(2008-4#5)
psychopharmacological and##3##2##(2005-7#1)(2009-9#1)(2011-1#1)
psychopharmacological interventions##2##2##(2008-6#1)(2011-2#1)
psychopharmacological therapy##2##2##(1993-5#1)(2011-2#1)
psychopharmacological treatment##2##2##(1990-3#1)(2008-6#1)
psychopharmacological##13##1##(1990-3#1)(1993-5#1)(2005-7#1)(2008-6#2)(2009-9#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-8#1)
psychopharmacology##9##1##(2005-7#1)(2008-11#1)(2008-4#5)(2009-12#1)(2011-2#1)
psychophysical data##3##2##(1991-2#1)(2009-3#1)(2010-6#1)
psychophysical experience of##2##3##(2008-7#1)(2008-9#1)
psychophysical experiments##3##2##(1990-5#1)(1996-12#1)(2008-9#1)
psychophysical findings##2##2##(1991-2#1)(2008-9#1)
psychophysical methods##3##2##(1992-4#2)(2010-5#1)
psychophysical parameters##3##2##(2008-9#3)
psychophysical##39##1##(1990-5#1)(1991-2#2)(1992-4#3)(1993-7#2)(1996-12#1)(1997-8#1)(2006-2#1)(2008-10#2)(2008-11#3)(2008-7#1)(2008-9#10)(2009-3#1)(2009-8#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#4)(2012-12#1)(2013-8#1)
psychophysics##3##1##(1990-11#1)(1991-2#1)(2007-6#1)
psychophysiologic##3##1##(2004-3#2)(2012-12#1)
psychophysiological##12##1##(1991-1#1)(1992-12#3)(1992-4#2)(1995-12#1)(2008-11#2)(2008-5#3)
psychoprophylactic##2##1##(2010-9#2)
psychoses and##3##2##(1995-11#1)(1996-5#1)(2012-2#1)
psychoses was##2##2##(1996-5#1)(1997-2#1)
psychoses##22##1##(1991-12#1)(1991-3#1)(1991-9#1)(1992-8#1)(1993-5#1)(1993-6#1)(1995-11#2)(1996-5#3)(1996-7#1)(1997-2#1)(1997-5#5)(2007-7#2)(2008-5#1)(2012-2#1)
psychosexual##3##1##(2004-10#2)(2007-7#1)
psychosis and##8##2##(1995-1#1)(1995-11#1)(1996-8#2)(2006-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
psychosis are##3##2##(1991-9#1)(2011-2#1)(2012-2#1)
psychosis based on the##2##4##(2011-1#1)(2011-2#1)
psychosis cases##2##2##(2008-1#2)
psychosis from##2##2##(2008-11#1)(2011-1#1)
psychosis has been##2##3##(1997-5#1)(2012-11#1)
psychosis has##3##2##(1995-11#1)(1997-5#1)(2012-11#1)
psychosis in an##2##3##(2008-11#1)(2008-4#1)
psychosis in the##5##3##(2007-7#1)(2007-8#2)(2008-1#1)(2011-1#1)
psychosis in##18##2##(1991-4#1)(1991-6#1)(1993-1#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-11#1)(2008-4#1)(2008-7#2)(2011-1#4)(2011-2#1)(2012-2#1)
psychosis is##2##2##(2006-9#1)(2012-1#1)
psychosis may##2##2##(1995-11#1)(2012-11#1)
psychosis were##3##2##(1991-9#1)(2004-3#1)(2011-1#1)
psychosis who##2##2##(2011-2#2)
psychosis##165##1##(1991-4#1)(1991-6#1)(1991-9#4)(1992-12#1)(1993-1#1)(1993-5#2)(1993-8#2)(1995-1#1)(1995-11#4)(1996-10#7)(1996-2#1)(1996-5#1)(1996-7#9)(1996-8#5)(1997-2#2)(1997-5#3)(2004-3#3)(2005-10#6)(2005-6#2)(2005-8#2)(2006-3#2)(2006-9#5)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#3)(2007-7#8)(2007-8#2)(2007-9#2)(2008-1#7)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#4)(2008-9#1)(2009-11#1)(2009-9#1)(2011-1#16)(2011-2#18)(2012-1#6)(2012-11#6)(2012-12#2)(2012-2#9)(2012-3#2)
psychosis&quot##16##1##(2005-10#1)(2011-2#1)(2012-2#11)(2013-8#3)
psychosis]##3##1##(2007-1#1)(2011-2#1)(2012-2#1)
psychosocial adaptation##2##2##(1996-1#1)(2013-1#1)
psychosocial adjustment of##2##3##(1993-1#1)(1997-8#1)
psychosocial adjustment##7##2##(1993-1#1)(1997-8#1)(2007-12#1)(2008-6#1)(2008-9#1)(2009-8#1)(2011-2#1)
psychosocial and behavioral##2##3##(2008-9#1)(2010-8#1)
psychosocial and economic##3##3##(2008-5#1)(2012-2#1)(2013-1#1)
psychosocial and financial##2##3##(2008-12#1)(2013-8#1)
psychosocial and spiritual distress##2##4##(2013-8#2)
psychosocial and spiritual suffering##2##4##(2013-8#2)
psychosocial and spiritual##5##3##(2007-5#1)(2013-8#4)
psychosocial and##26##2##(1992-3#1)(1997-4#1)(2006-2#2)(2006-9#2)(2007-5#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#6)
psychosocial aspects of##4##3##(1991-3#1)(1992-3#1)(2008-1#2)
psychosocial aspects##5##2##(1991-3#1)(1992-3#1)(2008-1#2)(2011-2#1)
psychosocial assessment##2##2##(2005-10#1)(2011-2#1)
psychosocial care##6##2##(1990-12#1)(1990-8#1)(1991-1#2)(2006-12#1)(2008-7#1)
psychosocial characteristics##5##2##(2006-3#1)(2008-1#1)(2010-12#1)(2011-2#1)(2013-1#1)
psychosocial concerns##2##2##(1991-3#1)(2006-4#1)
psychosocial consequences of##3##3##(2007-2#1)(2008-2#1)(2008-6#1)
psychosocial consequences##5##2##(2007-2#1)(2008-2#1)(2008-6#2)(2013-1#1)
psychosocial development of##3##3##(1993-1#2)(2008-9#1)
psychosocial development##6##2##(1993-1#2)(2008-11#1)(2008-9#1)(2012-12#1)(2012-2#1)
psychosocial difficulties##2##2##(2004-3#1)(2010-3#1)
psychosocial distress##2##2##(2009-9#1)(2011-12#1)
psychosocial dynamic##2##2##(2007-1#2)
psychosocial factors and##5##3##(2005-10#2)(2008-6#2)(2009-10#1)
psychosocial factors associated with##3##4##(2007-12#1)(2008-9#1)(2010-9#1)
psychosocial factors at work##3##4##(2011-1#3)
psychosocial factors in##3##3##(1992-9#1)(2005-10#1)(2013-8#1)
psychosocial factors##27##2##(1992-9#1)(1994-6#1)(1996-12#1)(2004-3#1)(2005-10#3)(2006-3#1)(2006-8#1)(2007-12#1)(2008-2#5)(2008-6#2)(2008-9#1)(2009-10#1)(2009-4#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#3)(2013-8#1)
psychosocial function##3##2##(2004-3#1)(2005-10#1)(2010-11#1)
psychosocial functioning##6##2##(2007-12#1)(2008-2#2)(2009-10#1)(2012-2#1)(2013-1#1)
psychosocial health problems##3##3##(2007-2#3)
psychosocial health##6##2##(2007-2#3)(2008-2#1)(2012-2#1)(2013-1#1)
psychosocial impact of##3##3##(1997-5#1)(2008-11#1)(2008-9#1)
psychosocial impact##5##2##(1997-5#1)(2008-11#2)(2008-9#1)(2012-12#1)
psychosocial impairment##2##2##(2006-3#1)(2011-2#1)
psychosocial intervention in##2##3##(2006-12#1)(2008-2#1)
psychosocial intervention##8##2##(1992-3#1)(2006-12#1)(2006-5#2)(2007-12#1)(2008-2#2)(2009-9#1)
psychosocial interventions to##2##3##(1992-12#1)(2013-1#1)
psychosocial interventions##13##2##(1992-12#1)(1992-5#1)(1995-1#1)(2005-6#1)(2006-2#1)(2006-6#1)(2008-11#1)(2008-2#1)(2008-4#2)(2009-6#1)(2009-7#1)(2013-1#1)
psychosocial issues and##2##3##(2006-8#1)(2008-10#1)
psychosocial issues##3##2##(1996-3#1)(2006-8#1)(2008-10#1)
psychosocial measures##2##2##(2006-6#1)(2006-7#1)
psychosocial model##3##2##(1991-1#1)(1994-3#1)(1996-12#1)
psychosocial needs of##4##3##(1990-12#1)(1991-2#1)(2008-4#1)(2008-9#1)
psychosocial needs##6##2##(1990-12#1)(1991-2#1)(2006-12#1)(2007-7#1)(2008-4#1)(2008-9#1)
psychosocial outcome##2##2##(2006-4#1)(2009-10#1)
psychosocial outcomes have been##2##4##(2008-1#1)(2011-2#1)
psychosocial outcomes##4##2##(2008-1#1)(2011-2#1)(2013-1#2)
psychosocial problems##8##2##(1997-2#1)(2004-3#1)(2007-12#1)(2007-3#1)(2007-7#1)(2013-1#2)(2013-7#1)
psychosocial rehabilitation##4##2##(1995-1#1)(1996-3#1)(2008-2#1)(2012-12#1)
psychosocial responses of school-age children to hospitalization##2##7##(1991-2#2)
psychosocial responses##3##2##(1991-1#1)(1991-2#2)
psychosocial risk factors for##2##4##(2006-12#1)(2012-2#1)
psychosocial risk factors##5##3##(2006-12#2)(2009-10#1)(2011-1#1)(2012-2#1)
psychosocial risks##4##2##(2007-2#1)(2007-8#1)(2011-2#2)
psychosocial services##5##2##(1991-3#1)(1992-12#1)(1994-1#2)(2008-2#1)
psychosocial stress and##2##3##(1995-12#1)(2010-2#1)
psychosocial stress##8##2##(1995-12#3)(2007-6#1)(2008-11#1)(2008-4#1)(2010-2#1)(2013-7#1)
psychosocial stressors##5##2##(2004-3#1)(2010-2#2)(2010-3#1)(2013-8#1)
psychosocial support for##2##3##(2010-3#1)(2013-7#1)
psychosocial support##8##2##(1992-3#2)(1994-8#1)(2006-10#1)(2008-2#1)(2010-3#1)(2011-2#1)(2013-7#1)
psychosocial treatment of##2##3##(1995-5#1)(2006-4#1)
psychosocial treatment##5##2##(1995-1#1)(1995-5#1)(2006-4#1)(2009-8#2)
psychosocial treatments##7##2##(1993-2#1)(2005-6#1)(2007-8#1)(2008-4#2)(2008-6#1)(2009-7#1)
psychosocial variables##2##2##(2006-3#1)(2011-2#1)
psychosocial well-being##2##2##(2007-12#1)(2008-11#1)
psychosocial work characteristics and##3##4##(2005-10#3)
psychosocial work##4##2##(2005-10#3)(2011-1#1)
psychosocial##316##1##(1990-12#2)(1990-6#1)(1990-8#1)(1991-1#4)(1991-2#3)(1991-3#3)(1991-8#1)(1992-12#2)(1992-3#7)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#3)(1993-10#1)(1993-2#1)(1994-1#2)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-1#4)(1995-12#3)(1995-5#3)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-3#5)(2005-10#10)(2005-6#3)(2005-7#1)(2006-1#1)(2006-10#3)(2006-12#9)(2006-2#3)(2006-3#5)(2006-4#3)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#2)(2006-9#2)(2007-1#2)(2007-10#1)(2007-12#10)(2007-2#5)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#3)(2008-1#6)(2008-10#3)(2008-11#10)(2008-12#1)(2008-2#20)(2008-4#8)(2008-5#1)(2008-6#7)(2008-7#3)(2008-8#1)(2008-9#7)(2009-10#4)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#4)(2009-8#3)(2009-9#4)(2010-11#1)(2010-12#3)(2010-2#6)(2010-3#5)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#16)(2012-12#5)(2012-2#8)(2013-1#19)(2013-7#3)(2013-8#8)
psychosociale##2##1##(2008-11#1)(2008-2#1)
psychosocially##3##1##(2010-11#2)(2010-4#1)
psychosomatic and##2##2##(2007-8#1)(2011-2#1)
psychosomatic disorders##5##2##(1997-6#1)(1997-7#1)(2008-7#1)(2011-2#1)(2012-2#1)
psychosomatic medicine##2##2##(2006-9#2)
psychosomatic##16##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1997-6#1)(1997-7#1)(2006-9#2)(2007-8#1)(2008-4#2)(2008-7#1)(2010-6#1)(2011-2#2)(2012-2#1)
psychostimulant drug##2##2##(1994-2#1)(1995-10#1)
psychostimulant properties##2##2##(1996-10#1)(2009-7#1)
psychostimulant##7##1##(1994-2#1)(1995-10#1)(1996-10#1)(1996-12#1)(1997-8#1)(2006-2#1)(2009-7#1)
psychostimulants and tics - past##2##5##(2008-4#2)
psychostimulants##17##1##(1993-3#1)(1995-12#2)(1996-10#4)(2006-2#1)(2007-11#1)(2008-4#5)(2008-7#2)(2008-8#1)
psychotherapeutic approaches##2##2##(2005-6#1)(2010-12#1)
psychotherapeutic drug therapy##2##3##(2006-8#2)
psychotherapeutic interventions##4##2##(1991-9#1)(2008-6#1)(2013-1#1)(2013-8#1)
psychotherapeutic practice##2##2##(2008-12#1)(2009-10#1)
psychotherapeutic treatment##2##2##(2005-7#1)(2012-2#1)
psychotherapeutic##27##1##(1990-3#1)(1991-9#2)(1995-6#1)(2005-6#1)(2005-7#1)(2006-8#2)(2008-1#1)(2008-12#1)(2008-2#1)(2008-6#1)(2009-10#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
psychotherapies for##3##2##(2005-6#1)(2006-9#1)(2011-7#1)
psychotherapies##5##1##(2005-6#2)(2006-9#1)(2011-2#1)(2011-7#1)
psychotherapists##6##1##(1995-1#1)(2008-6#1)(2009-9#1)(2010-12#1)(2010-9#1)(2012-2#1)
psychotherapy and mutual support##2##4##(2008-6#2)
psychotherapy and##13##2##(2004-3#4)(2008-1#1)(2008-10#1)(2008-2#2)(2008-6#2)(2009-12#2)(2011-2#1)
psychotherapy are##2##2##(2008-2#1)(2008-3#1)
psychotherapy at##2##2##(1991-9#1)(2013-1#1)
psychotherapy can##2##2##(1996-12#1)(2005-7#1)
psychotherapy for ethnic##2##3##(2010-7#2)
psychotherapy for patients with panic##2##5##(2007-10#2)
psychotherapy for patients with##3##4##(2007-10#2)(2011-2#1)
psychotherapy for##10##2##(1991-1#1)(1996-12#1)(2006-9#1)(2007-10#2)(2008-4#1)(2010-7#3)(2011-2#1)
psychotherapy in##2##2##(2006-9#1)(2010-2#1)
psychotherapy may##2##2##(2008-4#1)(2013-1#1)
psychotherapy of##3##2##(1991-9#1)(1993-1#1)(2013-8#1)
psychotherapy outcome##2##2##(2005-7#1)(2010-12#1)
psychotherapy research##4##2##(2005-7#1)(2008-9#1)(2013-1#2)
psychotherapy to##2##2##(2010-4#1)(2011-2#1)
psychotherapy was##3##2##(1991-9#1)(2006-9#1)(2013-8#1)
psychotherapy will##2##2##(2004-3#1)(2009-9#1)
psychotherapy##107##1##(1991-1#1)(1991-2#1)(1991-9#3)(1993-1#1)(1993-10#1)(1994-11#2)(1994-12#1)(1995-12#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-7#1)(2004-10#1)(2004-3#9)(2005-6#1)(2005-7#5)(2006-11#1)(2006-2#2)(2006-6#1)(2006-7#1)(2006-9#6)(2007-1#2)(2007-10#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#1)(2008-4#3)(2008-6#4)(2008-9#1)(2009-10#1)(2009-12#2)(2009-9#7)(2010-1#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-7#4)(2011-12#2)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#10)(2013-8#2)
psychotic and##2##2##(1991-9#1)(1993-5#1)
psychotic conditions with##2##3##(2012-2#2)
psychotic conditions##4##2##(1993-5#1)(2010-11#1)(2012-2#2)
psychotic depression##3##2##(1992-8#1)(2007-7#2)
psychotic disorder is##2##3##(2012-2#2)
psychotic disorder##11##2##(2005-10#1)(2008-1#1)(2008-4#2)(2008-9#1)(2011-2#2)(2012-2#4)
psychotic disorders and##2##3##(2008-11#1)(2008-3#1)
psychotic disorders##15##2##(1995-1#1)(2005-7#2)(2006-3#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#2)(2009-10#1)(2009-12#1)(2009-8#2)(2012-2#2)
psychotic episode##2##2##(2008-2#1)(2011-2#1)
psychotic episodes##2##2##(2012-12#1)(2012-2#1)
psychotic features##4##2##(2007-7#2)(2010-7#1)(2012-2#1)
psychotic illness##4##2##(1995-11#1)(2011-2#1)(2012-1#2)
psychotic or##2##2##(2011-10#1)(2013-8#1)
psychotic patients to##2##3##(1990-1#2)
psychotic patients##14##2##(1990-1#2)(1993-3#1)(1993-8#4)(1995-5#1)(2011-2#3)(2011-7#1)(2012-12#2)
psychotic symptoms as well as##2##5##(2009-8#1)(2012-1#1)
psychotic symptoms in PTSD##4##4##(2007-7#4)
psychotic symptoms in patients##2##4##(2007-7#1)(2009-12#1)
psychotic symptoms in##9##3##(1995-8#1)(2007-7#6)(2009-12#1)(2012-2#1)
psychotic symptoms##39##2##(1995-8#2)(1997-8#2)(2005-10#2)(2007-6#2)(2007-7#6)(2008-4#3)(2008-7#2)(2009-12#1)(2009-6#1)(2009-7#3)(2009-8#1)(2010-12#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2013-8#1)
psychotic syndromes##2##2##(2009-7#1)(2012-2#1)
psychotic##124##1##(1990-1#2)(1990-5#1)(1991-9#2)(1992-8#1)(1993-3#1)(1993-5#2)(1993-8#4)(1995-1#1)(1995-11#1)(1995-5#1)(1995-7#1)(1995-8#2)(1996-10#1)(1996-7#1)(1996-8#1)(1997-8#2)(2005-10#3)(2005-7#2)(2006-3#1)(2007-6#2)(2007-7#11)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#6)(2008-6#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#2)(2009-6#1)(2009-7#4)(2009-8#3)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#5)(2011-10#1)(2011-2#16)(2011-7#1)(2012-1#4)(2012-12#6)(2012-2#16)(2013-8#2)
psychotomimetic side effects##2##3##(2007-9#2)
psychotoxicity##2##1##(1996-10#2)
psychotropes##2##1##(2013-1#2)
psychotropic drug##2##2##(2012-12#1)(2012-3#1)
psychotropic drugs in##6##3##(1992-10#1)(1994-3#1)(1996-10#1)(2007-8#2)(2009-7#1)
psychotropic drugs##20##2##(1992-10#3)(1994-3#2)(1995-2#1)(1996-10#1)(1996-9#2)(2005-11#1)(2007-7#2)(2007-8#2)(2008-11#1)(2008-3#1)(2009-3#1)(2009-7#1)(2010-2#1)(2011-2#1)
psychotropic effects of##2##3##(2008-10#1)(2008-4#1)
psychotropic medication to##2##3##(1992-12#1)(2008-8#1)
psychotropic medication##7##2##(1992-12#1)(2005-7#1)(2007-3#2)(2008-8#1)(2009-7#1)(2012-3#1)
psychotropic medications##7##2##(1996-9#1)(2004-3#1)(2005-9#1)(2007-11#1)(2007-3#1)(2010-11#1)(2013-1#1)
psychotropic substances##2##2##(2010-2#1)(2013-1#1)
psychotropic##54##1##(1991-8#1)(1992-10#3)(1992-12#1)(1992-2#1)(1994-3#4)(1995-12#1)(1995-2#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-9#4)(2004-3#1)(2005-11#1)(2005-7#1)(2005-9#2)(2007-11#2)(2007-3#3)(2007-7#2)(2007-8#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-7#2)(2010-11#1)(2010-2#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
psychotropics##11##1##(1994-3#2)(2008-3#1)(2008-4#1)(2013-8#7)
psychrophilic##2##1##(2008-10#1)(2011-2#1)
psychrophilum and F##2##3##(2008-9#2)
psychrophilum and##3##2##(2008-9#3)
psychrophilum##8##1##(2008-9#3)(2009-5#5)
psychrotrophic and##2##2##(2007-3#1)(2011-2#1)
psychrotrophic##8##1##(2007-3#2)(2011-2#4)(2012-2#1)(2013-7#1)
psylla were##3##2##(2008-10#3)
psylla##11##1##(2008-10#11)
psyllid##3##1##(2007-12#1)(2011-2#1)(2013-8#1)
psyllids##2##1##(2007-12#1)(2008-12#1)
psyllium##5##1##(1993-11#3)(2004-11#2)
pt##4##1##(2007-2#1)(2007-7#1)(2007-8#1)(2010-3#1)
ptb##3##1##(1993-11#3)
ptc is##2##2##(1994-3#2)
ptc##7##1##(1994-3#6)(1997-6#1)
pteridine ring of##2##3##(1991-2#1)(1995-2#1)
pteridine ring##4##2##(1991-2#2)(1995-2#2)
pteridine##10##1##(1991-2#2)(1995-2#4)(1997-3#1)(2009-12#1)(2010-5#1)(2012-2#1)
pteridines##2##1##(1992-6#1)(2012-2#1)
pteridophytes##2##1##(2008-5#1)(2009-6#1)
pterin in##2##2##(2006-12#1)(2010-5#1)
pterin##16##1##(1991-3#1)(1991-5#3)(1992-3#1)(1995-2#3)(1997-8#1)(2006-12#3)(2010-5#4)
pterins##5##1##(1991-5#2)(1992-6#2)(2010-5#1)
pterional craniotomy##2##2##(2006-12#1)(2011-2#1)
pterional##3##1##(2006-12#1)(2011-2#2)
pterostilbene##4##1##(2008-10#3)(2008-8#1)
pterygia##4##1##(2008-1#4)
pterygium and##2##2##(2008-4#1)(2012-12#1)
pterygium##8##1##(2008-1#1)(2008-4#2)(2008-8#1)(2010-11#1)(2011-2#1)(2012-12#2)
pterygoid##5##1##(2010-2#4)(2011-2#1)
pterygote insects and##2##3##(2007-12#2)
pterygote insects##3##2##(2007-12#3)
pterygote##5##1##(2007-12#3)(2008-5#1)(2008-7#1)
pth##3##1##(1994-12#3)
pthN##3##1##(2008-10#3)
ptosis and##3##2##(2007-10#1)(2008-7#1)(2011-12#1)
ptosis##20##1##(1992-9#1)(2006-10#1)(2006-11#3)(2006-2#1)(2007-10#5)(2007-7#1)(2008-7#1)(2008-9#1)(2009-6#2)(2011-12#2)(2011-2#1)(2012-2#1)
ptpf##2##1##(1997-7#2)
pts according to IRS scale)##2##5##(2013-8#2)
pts in##2##2##(2007-7#1)(2010-12#1)
pts received##3##2##(1996-3#1)(2010-3#2)
pts were##2##2##(2010-3#2)
pts with SAP##3##3##(2006-6#3)
pts with##8##2##(2006-6#7)(2007-11#1)
pts##54##1##(1994-9#3)(1996-3#1)(2005-1#2)(2005-10#1)(2006-6#10)(2007-11#1)(2007-2#3)(2007-7#2)(2007-8#5)(2010-12#3)(2010-3#16)(2013-1#5)(2013-8#2)
pts) and##3##2##(1994-9#1)(2008-7#1)(2010-12#1)
pts) with##2##2##(2005-10#1)(2010-3#1)
pts)##10##1##(1994-9#2)(2005-10#1)(2007-7#2)(2008-7#1)(2010-12#3)(2010-3#1)
pu##2##1##(2013-1#2)
pu-erh and black teas##2##4##(2008-10#2)
pu-erh##4##1##(2008-10#4)
pub2##3##1##(2013-7#3)
pubertal development##3##2##(2006-5#1)(2008-4#1)(2011-1#1)
pubertal maturation##2##2##(2006-10#1)(2008-3#1)
pubertal rats##3##2##(2013-1#3)
pubertal stage III##2##3##(2011-2#2)
pubertal stage##4##2##(2008-7#1)(2011-2#3)
pubertal status##5##2##(2007-12#1)(2009-4#1)(2011-1#3)
pubertal##28##1##(2006-10#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-3#1)(2011-1#7)(2011-2#5)(2012-2#1)(2013-1#4)
puberty and in##2##3##(2006-10#1)(2011-2#1)
puberty and is##2##3##(1993-4#1)(2008-1#1)
puberty and##21##2##(1991-2#1)(1993-4#1)(1995-12#1)(2006-1#1)(2006-10#3)(2008-1#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-3#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-1#1)
puberty in boys##2##3##(2006-10#1)(2011-2#1)
puberty in##13##2##(2006-10#5)(2006-7#1)(2007-7#1)(2009-5#5)(2011-2#1)
puberty or##2##2##(2007-7#1)(2010-12#1)
puberty were##3##2##(1993-2#1)(2007-7#1)(2009-5#1)
puberty##103##1##(1990-5#2)(1991-1#1)(1991-12#1)(1991-2#3)(1991-9#1)(1993-2#2)(1993-4#1)(1993-7#1)(1994-11#1)(1995-12#1)(2006-1#1)(2006-10#10)(2006-11#1)(2006-5#1)(2006-7#2)(2006-9#2)(2007-11#1)(2007-2#1)(2007-7#3)(2007-8#1)(2008-1#4)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#2)(2008-7#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#9)(2009-6#4)(2010-12#3)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#6)(2011-2#9)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
pubes##2##1##(1995-6#2)
pubescence characteristics##3##2##(2012-11#3)
pubescence##8##1##(2012-11#6)(2013-7#2)
pubescens##9##1##(1994-3#3)(2008-10#1)(2008-11#1)(2008-8#2)(2012-6#2)
pubescentis##3##1##(2010-2#1)(2012-3#2)
pubic hair and toe nails##2##5##(1994-6#2)
pubic hair and##5##3##(1994-6#3)(2011-2#2)
pubic hair##10##2##(1994-6#4)(2006-10#2)(2007-8#1)(2008-4#1)(2011-2#2)
pubic symphysis##7##2##(1997-7#3)(2006-10#1)(2007-2#1)(2011-1#1)(2012-12#1)
pubic tubercles##2##2##(2008-6#2)
pubic##31##1##(1991-6#1)(1994-6#4)(1995-6#1)(1997-7#3)(2006-10#3)(2006-11#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-4#1)(2008-6#2)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
pubis##24##1##(1994-3#1)(1995-6#2)(2006-10#15)(2008-5#2)(2012-1#2)(2012-12#2)
public about the##4##3##(1991-11#1)(2006-8#1)(2010-5#1)(2012-2#1)
public about##7##2##(1991-11#1)(1992-1#1)(1995-1#1)(1996-2#1)(2006-8#1)(2010-5#1)(2012-2#1)
public acceptance##3##2##(1996-12#1)(1996-3#1)(2008-7#1)
public accommodations##2##2##(1992-12#1)(1996-11#1)
public accountability for##2##3##(1996-2#1)(2010-11#1)
public accountability##5##2##(1994-2#1)(1996-2#2)(2010-11#1)(2012-11#1)
public actions##2##2##(2008-9#1)(2010-12#1)
public administrators##2##2##(1991-3#1)(1995-12#1)
public and health##3##3##(2008-5#2)(2012-3#1)
public and medical##3##3##(2006-10#1)(2007-12#1)(2011-2#1)
public and personal health##2##4##(2008-10#2)
public and private health##2##4##(1993-3#1)(1996-3#1)
public and private healthcare##2##4##(2006-7#1)(2008-9#1)
public and private high school students##2##6##(2006-7#1)(2008-10#1)
public and private schools in##3##5##(2008-9#2)(2011-2#1)
public and private sector##2##4##(1996-12#1)(1996-2#1)
public and private sectors##9##4##(1992-12#1)(1996-2#1)(1997-3#1)(2004-4#1)(2005-5#2)(2007-7#1)(2009-3#1)(2013-1#1)
public and private##39##3##(1990-12#1)(1992-12#1)(1993-3#1)(1994-12#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#3)(1997-6#1)(2004-4#1)(2005-5#2)(2006-7#2)(2007-7#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#4)(2008-9#3)(2009-3#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
public and professional##2##3##(2006-10#1)(2008-3#1)
public and the##4##3##(1990-8#1)(1996-2#1)(2006-2#1)(2012-2#1)
public and##85##2##(1990-12#1)(1990-8#1)(1992-12#1)(1993-1#2)(1993-3#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#4)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#3)(1997-6#1)(2004-4#1)(2004-9#1)(2005-5#3)(2005-7#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#3)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#4)(2008-9#3)(2009-3#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-7#2)(2013-8#1)
public as##5##2##(1997-3#2)(2006-2#1)(2007-2#1)(2010-8#1)
public assistance##2##2##(2007-5#2)
public at large##5##3##(1997-2#1)(2008-1#1)(2009-12#1)(2009-4#1)(2010-12#1)
public at##6##2##(1997-2#1)(2006-9#1)(2008-1#1)(2009-12#1)(2009-4#1)(2010-12#1)
public attention##5##2##(1990-6#1)(1991-12#1)(1992-3#1)(2008-5#1)(2013-7#1)
public attitudes toward##2##3##(2008-11#1)(2010-12#1)
public attitudes##5##2##(1991-5#1)(1993-1#1)(2008-11#1)(2010-12#1)(2013-7#1)
public authorities##3##2##(1990-6#1)(1996-2#1)(2005-5#1)
public awareness about##2##3##(2007-8#1)(2008-1#1)
public awareness and##4##3##(1992-1#1)(2006-10#1)(2007-5#1)(2008-7#1)
public awareness of the##4##4##(1994-12#1)(2004-10#1)(2008-10#1)(2008-8#1)
public awareness of##8##3##(1994-1#1)(1994-12#1)(1995-1#1)(1996-11#1)(2004-10#1)(2008-10#1)(2008-8#1)(2012-2#1)
public awareness##20##2##(1992-1#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-1#1)(1996-11#1)(2004-10#1)(2006-10#1)(2006-2#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-1#1)(2012-2#1)(2013-8#1)
public body image##2##3##(2007-12#2)
public clinic##4##2##(1996-12#1)(2006-4#3)
public concern##8##2##(1992-4#1)(2006-12#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-12#1)(2011-2#1)
public concerns##3##2##(2006-11#1)(2006-9#1)(2010-12#1)
public confidence##2##2##(1995-3#1)(2012-11#1)
public consciousness##2##2##(1990-4#1)(2013-7#1)
public consultation##2##2##(2009-4#1)(2009-6#1)
public database##4##2##(1997-4#1)(2007-9#1)(2008-7#1)(2008-8#1)
public databases indicated that the sequences of##3##7##(1995-8#1)(1996-10#1)(1996-2#1)
public databases##12##2##(1995-8#1)(1996-10#1)(1996-2#1)(1997-3#1)(2005-7#1)(2006-10#1)(2008-4#3)(2008-7#3)
public datasets##2##2##(2008-4#1)(2011-3#1)
public debate on the##2##4##(2009-4#1)(2013-7#1)
public debate on##4##3##(1993-6#1)(2009-4#1)(2010-11#1)(2013-7#1)
public debate##10##2##(1993-6#1)(1995-2#1)(2006-8#2)(2008-11#1)(2008-7#1)(2009-4#1)(2010-11#1)(2010-9#1)(2013-7#1)
public debt##2##2##(2008-6#1)(2008-9#1)
public demand##2##2##(2007-4#1)(2009-3#1)
public dental##5##2##(1996-9#1)(2006-8#1)(2008-9#3)
public disclosure of##2##3##(2007-12#1)(2012-3#1)
public disclosure##4##2##(2007-12#1)(2009-4#2)(2012-3#1)
public discussions##2##2##(1996-9#1)(2009-4#1)
public domain##16##2##(1994-12#1)(1996-1#1)(1996-2#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-4#5)(2008-7#1)(2009-12#1)(2010-7#1)(2012-3#1)(2013-1#1)
public drinking##2##2##(2007-2#1)(2007-8#1)
public education##6##2##(1996-1#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-3#2)
public elementary##2##2##(2011-1#1)(2012-2#1)
public employees##4##2##(1994-2#3)(2008-12#1)
public engagement##2##2##(2013-1#1)(2013-7#1)
public expenditure##2##2##(1994-2#1)(2010-4#1)
public expenditures##4##2##(1993-6#1)(1994-2#3)
public face##2##2##(1993-3#1)(2007-4#1)
public for##2##2##(1996-11#1)(2005-5#1)
public forum##3##2##(1993-12#1)(1996-11#1)(2009-4#1)
public funding##6##2##(1991-12#1)(1994-2#1)(1996-1#1)(2007-9#1)(2008-5#1)(2011-12#1)
public funds##4##2##(1996-3#1)(2011-12#2)(2012-3#1)
public good##4##2##(1993-2#1)(1995-2#1)(2008-10#1)(2012-3#1)
public goods games##4##3##(2012-3#4)
public goods##11##2##(2005-11#1)(2006-7#1)(2008-10#4)(2012-3#5)
public have##2##2##(1997-8#1)(2007-11#1)
public health -##2##3##(2007-12#1)(2012-2#1)
public health activities##7##3##(1992-1#2)(1996-12#2)(2006-9#1)(2007-11#1)(2008-11#1)
public health agencies to##2##4##(1995-12#2)
public health agencies##17##3##(1995-12#5)(1996-1#3)(1996-2#1)(1996-3#2)(1997-1#1)(1997-3#2)(2007-11#1)(2008-1#1)(2009-5#1)
public health agency##3##3##(2007-11#1)(2010-8#2)
public health agenda##3##3##(1997-1#2)(2011-1#1)
public health and are##2##4##(1996-12#1)(2010-5#1)
public health and economic##3##4##(2007-4#1)(2012-12#1)(2013-8#1)
public health and health care##2##5##(2010-9#1)(2012-3#1)
public health and health##3##4##(2006-6#1)(2010-9#1)(2012-3#1)
public health and healthcare##2##4##(2008-2#2)
public health and medical##5##4##(1995-2#3)(2012-1#2)
public health and medicine##6##4##(1995-2#5)(2009-5#1)
public health and the##3##4##(2007-10#1)(2012-11#1)(2012-2#1)
public health and##61##3##(1992-8#1)(1994-1#1)(1995-2#9)(1996-1#1)(1996-12#3)(1996-2#1)(1997-2#1)(1997-3#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-10#2)(2007-12#3)(2007-2#4)(2007-4#1)(2007-5#1)(2008-11#1)(2008-2#3)(2008-5#1)(2008-6#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
public health approaches##2##3##(2007-12#1)(2008-11#1)
public health assessment##2##3##(1996-12#1)(2007-12#1)
public health authorities##9##3##(1992-9#1)(1995-6#1)(1997-3#1)(2005-10#1)(2007-2#2)(2010-5#1)(2013-1#2)
public health burden in##2##4##(2010-3#1)(2011-2#1)
public health burden##3##3##(2010-12#1)(2010-3#1)(2011-2#1)
public health by##3##3##(2008-8#1)(2013-1#2)
public health campaigns and##2##4##(2009-5#1)(2010-9#1)
public health capacity##2##3##(1997-2#1)(2008-1#1)
public health care system##2##4##(1994-9#1)(2011-2#1)
public health care##9##3##(1991-3#1)(1994-9#2)(1997-4#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#2)
public health clinics##3##3##(1994-3#1)(1995-12#1)(2013-7#1)
public health concepts##3##3##(1992-1#1)(2007-12#1)(2008-2#1)
public health concern##13##3##(2006-8#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-4#1)(2009-5#2)(2010-6#1)(2012-12#1)(2012-3#1)(2013-1#2)
public health concerns in the##2##5##(2012-12#1)(2013-8#1)
public health concerns in##4##4##(2010-4#1)(2012-12#1)(2013-8#2)
public health concerns with##2##4##(1995-12#1)(2012-2#1)
public health concerns##8##3##(1995-12#1)(2007-11#1)(2007-3#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-8#2)
public health consultant##2##3##(1993-7#2)
public health core functions##2##4##(1995-12#1)(1996-3#1)
public health course at##2##4##(2008-5#2)
public health decision making##3##4##(1996-2#2)(1997-3#1)
public health decision##4##3##(1996-2#3)(1997-3#1)
public health departments##5##3##(1996-12#2)(1996-2#1)(1997-1#1)(2008-6#1)
public health education##4##3##(1996-1#1)(1997-3#1)(2007-1#1)(2008-5#1)
public health efforts##3##3##(1996-2#1)(2012-2#2)
public health emergencies and disasters##2##5##(2008-2#2)
public health emergencies##9##3##(2007-2#1)(2008-2#3)(2008-8#1)(2010-8#1)(2010-9#1)(2012-2#2)
public health emergency preparedness##3##4##(2010-8#3)
public health emergency##6##3##(1991-3#1)(2008-1#1)(2010-8#3)(2011-2#1)
public health functions##7##3##(1995-12#2)(1996-12#1)(1996-2#3)(1996-3#1)
public health goals##2##3##(1996-2#2)
public health governance##2##3##(2008-2#1)(2011-1#1)
public health has##5##3##(1996-3#2)(2013-1#3)
public health have##2##3##(1997-2#1)(2007-12#1)
public health hazard##2##3##(2009-6#1)(2011-2#1)
public health impact of##6##4##(1991-3#2)(1993-6#1)(1997-3#1)(2006-10#2)
public health impact##10##3##(1991-3#3)(1993-12#1)(1993-6#1)(1997-3#1)(2006-10#2)(2010-4#1)(2012-12#1)
public health imperative##2##3##(2008-11#1)(2013-1#1)
public health implications of##4##4##(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)
public health implications##10##3##(1996-1#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
public health importance and##2##4##(2007-7#1)(2009-5#1)
public health importance because of the##2##6##(1994-7#1)(2007-11#1)
public health importance of##4##4##(2006-10#1)(2010-8#1)(2013-1#1)(2013-8#1)
public health importance##13##3##(1994-3#1)(1994-7#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-7#1)(2009-5#1)(2010-1#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
public health in the##4##4##(2007-11#1)(2008-1#1)(2010-12#1)(2012-1#1)
public health in##10##3##(1993-6#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-11#1)(2007-2#1)(2008-1#1)(2010-12#1)(2012-1#1)(2012-12#1)
public health informatics##3##3##(2007-11#1)(2011-1#2)
public health information and##3##4##(1995-12#1)(1997-2#1)(1997-3#1)
public health information systems##6##4##(1996-3#1)(1997-3#4)(2007-11#1)
public health information##18##3##(1995-12#3)(1996-3#1)(1997-2#2)(1997-3#7)(2007-11#1)(2008-11#1)(2013-1#3)
public health infrastructure##2##3##(1995-12#1)(1997-1#1)
public health initiatives##8##3##(1995-12#1)(1996-3#3)(2005-11#1)(2008-8#2)(2012-1#1)
public health institutions##2##3##(1997-7#1)(2012-12#1)
public health insurance##7##3##(1995-3#1)(2007-2#1)(2007-9#1)(2008-7#2)(2013-1#2)
public health interest##2##3##(2007-2#1)(2008-10#1)
public health intervention##2##3##(2008-7#1)(2010-12#1)
public health interventions##6##3##(1991-3#1)(2008-1#2)(2008-10#1)(2011-1#1)(2012-3#1)
public health is to##2##4##(1996-3#1)(1997-1#1)
public health is##5##3##(1996-3#1)(1997-1#1)(2010-8#1)(2012-12#1)(2013-1#1)
public health issue##14##3##(1991-6#1)(1996-1#1)(2007-1#1)(2008-9#2)(2009-5#1)(2010-12#2)(2010-7#1)(2011-2#2)(2013-1#2)(2013-8#1)
public health issues##10##3##(1993-2#1)(1995-5#1)(1996-2#1)(2007-12#1)(2008-8#1)(2009-12#1)(2011-1#2)(2011-2#1)(2012-2#1)
public health mandate##2##3##(2010-5#1)(2011-2#1)
public health measures for##2##4##(2006-7#1)(2008-9#1)
public health measures##11##3##(1997-3#1)(2006-7#2)(2008-1#1)(2008-9#1)(2010-1#1)(2010-12#1)(2011-2#3)(2012-12#1)
public health message##3##3##(1996-3#1)(2005-8#1)(2008-4#1)
public health model of Medicaid emergency room use##2##8##(1992-1#2)
public health model##3##3##(1992-1#2)(2012-3#1)
public health needs##4##3##(1994-3#1)(1996-3#1)(1997-3#1)(2009-4#1)
public health nurses and##5##4##(2010-9#4)(2011-1#1)
public health nurses##12##3##(1995-3#1)(1996-2#2)(2006-12#1)(2006-6#1)(2008-1#1)(2010-9#5)(2011-1#1)
public health nursing##5##3##(1996-2#5)
public health nutrition##3##3##(2011-2#1)(2012-1#1)(2012-12#1)
public health nutritionists##9##3##(1991-2#2)(1993-1#3)(1993-2#4)
public health of##4##3##(1996-2#1)(2010-9#1)(2011-1#1)(2013-7#1)
public health officials and##2##4##(1995-12#1)(2012-12#1)
public health officials to##3##4##(1996-5#1)(2008-1#1)(2012-12#1)
public health officials##13##3##(1993-6#1)(1995-12#3)(1996-1#1)(1996-3#1)(1996-5#1)(2007-4#1)(2008-1#1)(2009-12#1)(2012-12#2)(2013-7#1)
public health opportunity##2##3##(1997-2#1)(2013-1#1)
public health or##2##3##(2007-9#1)(2008-2#1)
public health outcomes##2##3##(2008-1#1)(2012-2#1)
public health overlap with##2##4##(1996-2#1)(2010-12#1)
public health performance##9##3##(1995-12#4)(1996-12#2)(1996-3#3)
public health perspective##5##3##(1995-12#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)
public health physicians##2##3##(1997-3#1)(2011-2#1)
public health planners##2##3##(2008-1#1)(2011-2#1)
public health policies##4##3##(1997-1#1)(2010-7#1)(2013-1#2)
public health policy and##2##4##(1993-2#1)(2011-1#1)
public health policy##7##3##(1993-2#1)(1997-2#1)(1997-3#2)(2006-5#1)(2011-1#1)(2013-1#1)
public health practice content##2##4##(1997-2#2)
public health practice in##2##4##(1996-2#1)(1997-3#1)
public health practice##20##3##(1995-12#1)(1996-1#4)(1996-12#1)(1996-2#3)(1996-3#2)(1997-2#3)(1997-3#2)(2005-12#1)(2007-11#1)(2010-12#1)(2012-2#1)
public health practices##2##3##(1996-12#1)(2008-7#1)
public health practitioners and##2##4##(2011-1#1)(2012-1#1)
public health practitioners##8##3##(1992-5#1)(1995-12#1)(1997-2#3)(2011-1#1)(2012-1#1)(2013-1#1)
public health priority##2##3##(2008-7#1)(2009-9#1)
public health problem and##5##4##(1997-8#1)(2008-12#1)(2009-5#1)(2010-12#1)(2011-2#1)
public health problem at##2##4##(2008-12#1)(2011-2#1)
public health problem because of##2##5##(1994-8#1)(2007-1#1)
public health problem in industrialized countries##2##6##(2007-11#1)(2008-4#1)
public health problem in the world##3##6##(2008-10#1)(2009-5#1)(2012-3#1)
public health problem in the##9##5##(1997-1#1)(2008-10#1)(2008-3#1)(2009-5#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
public health problem in##30##4##(1992-9#2)(1993-6#1)(1997-1#1)(1997-4#1)(2005-11#2)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-5#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
public health problem of##2##4##(2008-11#1)(2011-2#1)
public health problem since##2##4##(2007-2#1)(2007-3#1)
public health problem worldwide##4##4##(2008-1#1)(2008-3#1)(2010-5#1)(2013-8#1)
public health problem##90##3##(1991-6#1)(1992-5#1)(1992-9#2)(1993-6#1)(1993-7#1)(1994-8#1)(1995-6#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-11#2)(2006-1#1)(2006-10#2)(2006-2#3)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#2)(2007-9#1)(2008-1#4)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#3)(2010-12#2)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#6)(2012-11#1)(2012-12#5)(2012-2#6)(2012-3#1)(2013-1#4)(2013-8#2)
public health problems in developing countries##3##6##(2006-10#1)(2007-11#1)(2010-12#1)
public health problems in the##2##5##(2008-3#1)(2012-12#1)
public health problems in##8##4##(2006-10#1)(2007-11#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
public health problems worldwide##2##4##(2006-10#1)(2011-1#1)
public health problems##14##3##(1993-1#1)(2006-10#2)(2007-11#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#1)
public health professionals##10##3##(1996-1#1)(1996-2#1)(1997-8#1)(2006-10#1)(2009-3#1)(2012-3#1)(2013-1#4)
public health program##4##3##(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)
public health programmes##2##3##(2006-2#1)(2008-10#1)
public health programs##6##3##(1990-12#1)(1995-12#1)(1996-3#1)(1997-3#1)(2009-9#1)(2013-1#1)
public health providers##4##3##(1997-2#1)(1997-3#1)(2011-1#1)(2012-3#1)
public health reform##2##3##(2008-7#2)
public health regulations##3##3##(1995-2#2)(1996-11#1)
public health relevance##2##3##(1990-10#1)(2013-1#1)
public health research##5##3##(1997-1#1)(2007-11#1)(2008-12#1)(2008-8#1)(2011-1#1)
public health response to##5##4##(1991-3#1)(1997-1#2)(2005-6#1)(2007-12#1)
public health responses in##2##4##(2008-8#1)(2011-2#1)
public health responses##5##3##(1997-3#1)(2008-8#1)(2011-2#3)
public health risk##4##3##(2008-5#2)(2008-8#1)(2011-2#1)
public health science##2##3##(2008-2#1)(2012-1#1)
public health service##2##3##(1992-4#1)(1995-2#1)
public health services##12##3##(1990-12#1)(1994-3#1)(1996-3#1)(1997-1#1)(1997-2#1)(2005-5#1)(2011-1#5)(2011-2#1)
public health settings##2##3##(1995-1#1)(2012-2#1)
public health significance##3##3##(2006-4#1)(2008-3#1)(2010-4#1)
public health social history demonstrated additional complexity in coding temporality##2##10##(2013-1#2)
public health specialists##2##3##(1994-10#1)(1996-6#1)
public health staff##3##3##(2007-12#1)(2013-8#2)
public health stakeholders##2##3##(2008-11#1)(2013-7#1)
public health strategies to##2##4##(2012-12#1)(2012-2#1)
public health strategies##3##3##(1995-12#1)(2012-12#1)(2012-2#1)
public health students##2##3##(1996-1#1)(2008-1#1)
public health surveillance and assessment##2##5##(1997-3#2)
public health surveillance and response##2##5##(2008-1#1)(2008-11#1)
public health surveillance and##6##4##(1997-3#3)(2008-1#1)(2008-11#1)(2012-2#1)
public health surveillance in the##2##5##(1997-3#2)
public health surveillance system##4##4##(1997-3#2)(2008-8#1)(2012-12#1)
public health surveillance systems##5##4##(1997-3#1)(2008-7#4)
public health surveillance##31##3##(1990-11#1)(1993-11#1)(1997-3#16)(2006-12#1)(2008-1#2)(2008-11#2)(2008-7#5)(2008-8#1)(2012-12#1)(2012-2#1)
public health surveys##4##3##(2013-1#4)
public health system in Arizona##2##5##(1995-12#2)
public health system in##4##4##(1995-12#2)(1996-2#1)(1997-2#1)
public health system##12##3##(1995-12#3)(1996-2#2)(1997-2#2)(2006-5#1)(2007-11#1)(2008-6#1)(2008-9#1)(2012-1#1)
public health systems##2##3##(1997-3#1)(2007-11#1)
public health threat##8##3##(1996-3#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2011-1#1)(2011-2#1)
public health to##4##3##(1991-12#1)(1996-11#1)(1997-2#1)(2008-7#1)
public health training by##2##4##(1996-3#2)
public health training##3##3##(1996-3#2)(1997-2#1)
public health under##2##3##(1995-12#1)(2011-1#1)
public health was##2##3##(1996-3#1)(1997-2#1)
public health will##2##3##(1996-12#1)(1997-2#1)
public health work plan##2##4##(2008-1#2)
public health work##3##3##(1995-6#1)(2008-1#2)
public health worker##3##3##(1997-5#3)
public health workforce##3##3##(1997-3#1)(2011-1#1)(2013-1#1)
public health##1052##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#8)(1991-4#2)(1991-6#2)(1992-1#10)(1992-4#1)(1992-5#2)(1992-8#1)(1992-9#3)(1993-1#6)(1993-10#2)(1993-11#1)(1993-12#3)(1993-2#6)(1993-3#1)(1993-4#1)(1993-6#5)(1993-7#3)(1993-8#2)(1994-1#2)(1994-10#1)(1994-2#1)(1994-3#6)(1994-7#3)(1994-8#1)(1994-9#2)(1995-1#2)(1995-12#43)(1995-2#12)(1995-3#4)(1995-5#1)(1995-6#4)(1995-9#1)(1996-1#25)(1996-11#3)(1996-12#20)(1996-2#35)(1996-3#37)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#16)(1997-2#26)(1997-3#60)(1997-4#2)(1997-5#3)(1997-7#1)(1997-8#2)(2005-10#1)(2005-11#4)(2005-12#2)(2005-3#1)(2005-5#3)(2005-6#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#16)(2006-12#3)(2006-2#7)(2006-4#1)(2006-5#3)(2006-6#2)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#5)(2007-10#6)(2007-11#15)(2007-12#21)(2007-2#12)(2007-3#4)(2007-4#3)(2007-5#1)(2007-7#7)(2007-9#4)(2008-1#34)(2008-10#16)(2008-11#18)(2008-12#6)(2008-2#19)(2008-3#7)(2008-4#6)(2008-5#7)(2008-6#5)(2008-7#23)(2008-8#16)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#5)(2009-5#10)(2009-6#2)(2009-7#3)(2009-8#2)(2009-9#3)(2010-1#2)(2010-12#20)(2010-2#1)(2010-3#2)(2010-4#7)(2010-5#8)(2010-6#3)(2010-7#5)(2010-8#15)(2010-9#12)(2011-1#45)(2011-12#1)(2011-2#46)(2012-1#18)(2012-11#2)(2012-12#32)(2012-2#25)(2012-3#10)(2013-1#64)(2013-7#6)(2013-8#13)
public health's core functions##2##4##(1996-2#1)(1997-2#1)
public health's##5##2##(1995-12#1)(1996-2#1)(1996-3#1)(1997-2#2)
public health]##3##2##(1993-11#1)(1994-3#1)(2013-1#1)
public healthcare##5##2##(2007-12#1)(2008-3#1)(2009-4#1)(2012-12#2)
public heath##2##2##(2008-10#1)(2011-12#1)
public hospital with##2##3##(2008-6#1)(2013-8#1)
public hospital##25##2##(1990-5#1)(1992-1#1)(1992-11#1)(1995-12#1)(1996-7#1)(2007-7#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#2)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#6)(2013-8#2)
public hospitals and##3##3##(1990-6#1)(1994-2#1)(2012-2#1)
public hospitals in##4##3##(1995-6#1)(2007-7#1)(2008-9#1)(2009-10#1)
public hospitals##33##2##(1990-6#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-6#1)(1996-2#3)(1996-3#1)(2007-7#2)(2008-8#4)(2008-9#3)(2009-10#2)(2009-6#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
public housing complexes##2##3##(2008-3#2)
public housing##5##2##(2008-3#5)
public image##3##2##(1996-1#1)(1997-1#1)(2007-5#1)
public in the##2##3##(2008-7#1)(2011-2#1)
public in##8##2##(1994-3#1)(1996-12#2)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#2)
public information campaign##3##3##(1992-2#3)
public information##6##2##(1992-2#5)(1996-6#1)
public institutions##3##2##(1995-6#1)(2008-1#1)(2008-10#1)
public insurance##3##2##(2008-5#1)(2009-4#1)(2011-12#1)
public interest in##4##3##(1991-3#1)(2007-4#1)(2008-10#1)(2009-7#1)
public interest##10##2##(1991-3#2)(1993-1#1)(1996-12#1)(2005-10#1)(2005-11#1)(2007-4#1)(2008-10#1)(2008-8#1)(2009-7#1)
public interests##2##2##(2007-4#1)(2008-5#1)
public involvement in##3##3##(1996-12#2)(2005-11#1)
public involvement##7##2##(1996-12#2)(2005-11#1)(2008-7#4)
public is##11##2##(1991-3#1)(1996-3#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-12#1)(2010-5#1)(2013-1#2)
public library##2##2##(1993-1#2)
public managed care##2##3##(1995-1#1)(2006-10#1)
public may##2##2##(1997-8#1)(2008-11#1)
public mental health##4##3##(2006-9#2)(2009-9#2)
public microarray##2##2##(2008-7#2)
public notification##2##2##(1996-3#1)(2010-12#1)
public on##4##2##(1993-8#1)(1994-5#1)(2007-4#1)(2009-4#1)
public opinion and##3##3##(1996-1#1)(2006-11#1)(2008-12#1)
public opinion survey##2##3##(2006-7#1)(2013-1#1)
public opinion##11##2##(1990-12#2)(1991-3#1)(1993-1#1)(1996-1#1)(2006-11#1)(2006-7#1)(2007-4#1)(2008-12#1)(2013-1#2)
public opinions##2##2##(2008-11#1)(2012-3#1)
public or private##3##3##(1994-12#1)(2005-5#1)(2010-1#1)
public or##5##2##(1992-10#1)(1994-12#1)(2005-11#1)(2005-5#1)(2010-1#1)
public parks##5##2##(2011-1#5)
public participation##2##2##(1996-12#1)(2013-8#1)
public perception of##4##3##(2009-4#1)(2012-3#3)
public perception##7##2##(2009-4#2)(2011-1#1)(2012-3#4)
public perceptions##6##2##(2008-4#1)(2009-4#1)(2012-3#1)(2013-1#2)(2013-8#1)
public places##4##2##(1991-5#1)(1996-1#2)(2009-7#1)
public policies for##3##3##(2013-1#3)
public policies that##2##3##(2009-9#1)(2013-1#1)
public policies##17##2##(1993-1#1)(2008-12#1)(2008-9#4)(2009-9#1)(2010-1#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#5)
public policy and##2##3##(1996-4#1)(2007-12#1)
public policy decisions##2##3##(1991-3#1)(2011-1#1)
public policy##45##2##(1990-12#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-3#1)(1993-1#2)(1994-2#1)(1996-1#2)(1996-12#2)(1996-3#1)(1996-4#1)(1997-3#1)(1997-5#1)(2006-6#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-9#1)(2008-11#2)(2008-12#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#4)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
public primary##4##2##(2011-2#1)(2012-3#1)(2013-1#2)
public programs and##2##3##(2005-10#2)
public programs##4##2##(1991-2#1)(2005-10#3)
public relations activities in##2##4##(2008-12#2)
public relations activities##7##3##(2008-12#7)
public relations and##2##3##(2008-12#2)
public relations functions##2##3##(2008-12#2)
public relations has##2##3##(2008-12#2)
public relations##33##2##(1991-1#1)(1991-2#1)(1997-3#1)(2007-2#1)(2008-12#25)(2008-6#3)(2008-8#1)
public reporting in##2##3##(2010-11#2)
public reporting of##3##3##(2010-11#1)(2013-1#2)
public reporting##8##2##(2010-11#5)(2013-1#3)
public research##2##2##(2006-5#1)(2008-6#1)
public resources##3##2##(2008-5#1)(2009-7#1)(2013-8#1)
public safety##7##2##(1991-3#1)(2008-1#1)(2008-6#2)(2012-11#3)
public school setting##2##3##(2004-10#2)
public school students##5##3##(2008-7#1)(2012-12#4)
public school##12##2##(1993-5#1)(2004-10#2)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-12#4)(2013-8#1)
public schools and 1##3##4##(2008-9#3)
public schools in Meerut##2##4##(2011-1#2)
public schools in##4##3##(1991-11#1)(2011-1#2)(2012-12#1)
public schools##15##2##(1991-11#1)(1991-12#1)(2006-7#1)(2008-9#6)(2011-1#3)(2012-12#1)(2013-1#2)
public sector agencies##2##3##(2007-11#2)
public sector and##3##3##(1995-3#1)(2006-2#1)(2009-3#1)
public sector##25##2##(1991-1#1)(1994-3#1)(1995-3#2)(1996-1#1)(1996-12#2)(1997-2#1)(1997-3#1)(2005-5#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-2#1)(2009-3#1)(2010-3#1)(2011-1#1)(2011-7#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
public sectors##3##2##(1994-1#1)(2008-2#2)
public self-consciousness##2##2##(2006-6#1)(2007-12#1)
public service##3##2##(1994-2#1)(2010-8#1)(2012-12#1)
public services##7##2##(1996-3#1)(2006-10#1)(2008-7#1)(2008-9#1)(2012-3#3)
public should##4##2##(1992-8#1)(1993-9#1)(2007-10#1)(2008-10#1)
public sources##2##2##(1995-2#1)(2009-11#1)
public stigma##3##2##(2011-1#3)
public support##2##2##(1996-9#1)(2008-12#1)
public that##3##2##(1996-3#1)(2009-2#1)(2011-2#1)
public through##3##2##(2007-9#1)(2008-9#1)(2013-1#1)
public to the##4##3##(1991-3#1)(1991-8#1)(1992-2#1)(2006-11#1)
public to##15##2##(1991-3#2)(1991-8#1)(1992-2#1)(1993-8#1)(1994-1#1)(1996-4#1)(2006-11#1)(2007-9#1)(2008-4#1)(2008-5#3)(2008-7#2)
public understanding##2##2##(2006-4#1)(2009-4#1)
public university##3##2##(1993-1#1)(2012-3#1)(2013-1#1)
public views and use of##2##5##(2012-3#2)
public was##2##2##(1997-6#1)(2006-9#1)
public water supplies##2##3##(1992-5#1)(1996-6#1)
public water##4##2##(1992-5#1)(1996-6#1)(2006-8#1)(2013-8#1)
public##2125##1##(1990-10#2)(1990-11#2)(1990-12#8)(1990-4#2)(1990-5#2)(1990-6#3)(1990-8#2)(1990-9#1)(1991-1#4)(1991-10#1)(1991-11#5)(1991-12#8)(1991-2#7)(1991-3#23)(1991-4#2)(1991-5#3)(1991-6#3)(1991-8#2)(1992-1#14)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#6)(1992-3#5)(1992-4#2)(1992-5#3)(1992-6#1)(1992-8#2)(1992-9#5)(1993-1#18)(1993-10#2)(1993-11#2)(1993-12#5)(1993-2#13)(1993-3#8)(1993-4#1)(1993-5#2)(1993-6#7)(1993-7#3)(1993-8#4)(1993-9#1)(1994-1#5)(1994-10#1)(1994-12#4)(1994-2#18)(1994-3#19)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#3)(1994-8#1)(1994-9#3)(1995-1#8)(1995-11#1)(1995-12#50)(1995-2#16)(1995-3#8)(1995-5#3)(1995-6#9)(1995-8#2)(1995-9#1)(1996-1#37)(1996-10#1)(1996-11#11)(1996-12#40)(1996-2#55)(1996-3#51)(1996-4#4)(1996-5#4)(1996-6#5)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#17)(1997-2#35)(1997-3#71)(1997-4#3)(1997-5#6)(1997-6#4)(1997-7#1)(1997-8#5)(2004-1#1)(2004-10#3)(2004-3#1)(2004-4#1)(2004-5#1)(2004-9#2)(2005-10#7)(2005-11#8)(2005-12#2)(2005-3#1)(2005-5#11)(2005-6#1)(2005-7#6)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#31)(2006-11#4)(2006-12#6)(2006-2#15)(2006-4#8)(2006-5#4)(2006-6#6)(2006-7#13)(2006-8#8)(2006-9#11)(2007-1#8)(2007-10#9)(2007-11#20)(2007-12#36)(2007-2#18)(2007-3#7)(2007-4#16)(2007-5#8)(2007-6#3)(2007-7#16)(2007-8#8)(2007-9#15)(2008-1#39)(2008-10#37)(2008-11#32)(2008-12#47)(2008-2#26)(2008-3#25)(2008-4#21)(2008-5#25)(2008-6#16)(2008-7#67)(2008-8#29)(2008-9#35)(2009-10#6)(2009-11#5)(2009-12#5)(2009-2#2)(2009-3#5)(2009-4#24)(2009-5#11)(2009-6#7)(2009-7#8)(2009-8#5)(2009-9#6)(2010-1#4)(2010-11#9)(2010-12#40)(2010-2#2)(2010-3#5)(2010-4#10)(2010-5#13)(2010-6#7)(2010-7#7)(2010-8#20)(2010-9#15)(2011-1#67)(2011-12#7)(2011-2#70)(2011-3#2)(2011-7#2)(2012-1#25)(2012-11#9)(2012-12#51)(2012-2#41)(2012-3#45)(2013-1#118)(2013-7#23)(2013-8#30)
public's##27##1##(1991-3#1)(1992-12#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-3#2)(1997-8#1)(2005-11#1)(2006-2#2)(2006-5#1)(2007-11#1)(2007-4#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-4#2)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
public-health notifiable##4##2##(2013-1#4)
public-health##11##1##(1992-9#1)(2006-10#1)(2009-6#1)(2012-12#1)(2013-1#6)(2013-8#1)
public-private mix##3##2##(2013-7#3)
public-private partnership##5##2##(1995-3#1)(2006-10#3)(2013-7#1)
public-private partnerships##2##2##(1995-3#1)(1996-12#1)
public-private##12##1##(1995-1#1)(1995-3#2)(1996-12#2)(2006-10#3)(2013-7#4)
public-sector##2##1##(1996-2#1)(2007-4#1)
publication and##4##2##(2006-1#1)(2008-12#1)(2012-2#1)(2013-1#1)
publication bias##6##2##(1993-12#2)(2006-10#1)(2012-12#1)(2013-1#2)
publication by##2##2##(1991-6#1)(2008-10#1)
publication in the##2##3##(2008-11#1)(2009-4#1)
publication in##11##2##(1996-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-5#1)
publication is##2##2##(2007-6#1)(2007-8#1)
publication of a##2##3##(1991-2#1)(2008-8#1)
publication of clinical guidelines##2##4##(2008-3#2)
publication of clinical##4##3##(1992-10#1)(1992-2#1)(2008-3#2)
publication of research results##2##4##(1992-12#1)(1993-6#1)
publication of research##3##3##(1990-2#1)(1992-12#1)(1993-6#1)
publication of scientific##2##3##(2005-7#1)(2008-2#1)
publication of the##24##3##(1994-3#1)(1996-12#1)(1996-2#1)(2004-1#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-3#1)(2008-10#1)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#3)(2010-12#2)(2010-9#1)(2011-1#2)(2011-2#1)(2013-7#1)
publication of this##4##3##(2006-3#1)(2010-8#2)(2013-1#1)
publication of##63##2##(1990-2#1)(1991-2#1)(1992-10#1)(1992-12#1)(1992-2#1)(1993-6#1)(1994-10#1)(1994-3#2)(1996-12#1)(1996-2#1)(1997-7#1)(2004-1#2)(2005-7#1)(2006-10#3)(2006-3#2)(2006-4#2)(2006-5#1)(2006-7#1)(2007-10#1)(2007-3#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#2)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
publication or##2##2##(1992-9#1)(2008-9#1)
publication status##2##2##(1993-12#1)(2007-12#1)
publication we##2##2##(1994-12#1)(2008-11#1)
publication##396##1##(1990-2#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-10#1)(1993-12#5)(1993-6#1)(1994-10#1)(1994-12#1)(1994-3#3)(1994-6#1)(1995-9#1)(1996-12#2)(1996-2#2)(1996-6#1)(1997-3#1)(1997-7#1)(2004-1#2)(2005-7#4)(2006-1#2)(2006-10#5)(2006-11#1)(2006-3#2)(2006-4#2)(2006-5#3)(2006-7#1)(2006-8#2)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-4#2)(2007-6#2)(2007-8#64)(2007-9#2)(2008-10#11)(2008-11#10)(2008-12#7)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#5)(2008-7#5)(2008-8#3)(2008-9#5)(2009-2#1)(2009-4#4)(2009-8#1)(2010-1#1)(2010-12#13)(2010-4#1)(2010-5#1)(2010-8#4)(2010-9#1)(2011-1#57)(2011-12#4)(2011-2#15)(2011-3#1)(2012-1#74)(2012-12#4)(2012-2#4)(2012-3#3)(2013-1#12)(2013-7#8)(2013-8#2)
publication?]##2##1##(1991-11#1)(1992-3#1)
publications about##4##2##(2011-2#2)(2012-12#1)(2012-3#1)
publications and##6##2##(2007-2#2)(2007-6#1)(2008-10#1)(2008-4#1)(2013-1#1)
publications are##10##2##(1995-7#2)(1995-9#1)(2005-1#1)(2006-10#1)(2008-8#1)(2010-7#1)(2011-2#1)(2013-1#2)
publications concerning##2##2##(2007-8#1)(2012-12#1)
publications dealing##2##2##(2006-11#1)(2011-2#1)
publications discussing##2##2##(2006-3#1)(2006-8#1)
publications from the##2##3##(2006-10#1)(2011-2#1)
publications has##4##2##(2008-1#1)(2008-11#1)(2011-2#1)(2013-8#1)
publications have##8##2##(2006-10#3)(2007-4#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-9#1)
publications in the field of##2##5##(2005-8#1)(2008-7#1)
publications in the##8##3##(2005-8#1)(2006-10#2)(2006-4#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-7#1)
publications in this##2##3##(2008-1#1)(2008-4#1)
publications in##23##2##(1997-3#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-4#1)(2007-4#1)(2007-6#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-2#2)(2010-12#2)(2011-2#2)(2012-12#1)(2012-2#1)
publications indicate##2##2##(2007-8#1)(2011-2#1)
publications is##4##2##(1996-5#1)(2011-2#2)(2013-1#1)
publications of##2##2##(2008-7#1)(2009-4#1)
publications on the subject##2##4##(2006-10#1)(2010-4#1)
publications on the##12##3##(1994-3#1)(2006-10#3)(2008-10#2)(2008-9#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-3#2)
publications on this##3##3##(1990-9#1)(2008-8#1)(2008-9#1)
publications on##29##2##(1990-9#1)(1994-3#1)(1996-3#1)(2005-9#1)(2006-10#4)(2007-8#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-8#2)(2008-9#3)(2009-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-3#2)
publications regarding##2##2##(2006-10#1)(2007-4#1)
publications report##3##2##(2009-3#1)(2009-5#1)(2013-1#1)
publications since##2##2##(1995-2#1)(2011-2#1)
publications such as##2##3##(2005-7#2)
publications that are##2##3##(1995-8#1)(2013-7#1)
publications that##10##2##(1995-8#1)(2006-10#1)(2007-8#1)(2009-9#1)(2010-8#1)(2011-2#2)(2013-1#2)(2013-7#1)
publications using##2##2##(2008-10#1)(2008-11#1)
publications was##2##2##(2008-12#1)(2009-2#1)
publications were##5##2##(2006-10#1)(2007-8#1)(2008-12#1)(2011-2#1)(2013-1#1)
publications which##2##2##(2011-2#1)(2013-8#1)
publications with##2##2##(2007-3#1)(2008-6#1)
publications##248##1##(1990-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-7#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-7#3)(1995-8#1)(1995-9#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-8#1)(2005-1#1)(2005-10#2)(2005-7#3)(2005-8#2)(2005-9#1)(2006-10#24)(2006-11#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#3)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#4)(2007-7#2)(2007-8#7)(2008-1#5)(2008-10#13)(2008-11#8)(2008-12#9)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#2)(2009-2#10)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-9#2)(2010-12#5)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#4)(2011-1#3)(2011-2#30)(2012-1#2)(2012-11#1)(2012-12#7)(2012-2#5)(2012-3#3)(2013-1#19)(2013-7#3)(2013-8#3)
publications)##3##1##(2007-2#1)(2007-5#1)(2009-2#1)
publications]##3##1##(1992-2#1)(1993-10#1)(1993-3#1)
publicity in##2##2##(1993-9#1)(2005-12#1)
publicity plan##3##2##(1992-12#3)
publicity##19##1##(1991-2#1)(1992-12#4)(1993-12#1)(1993-9#2)(1996-11#1)(2005-12#1)(2005-5#1)(2005-7#1)(2007-11#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-6#1)(2010-5#1)
publicize##3##1##(1992-12#1)(2006-7#1)(2008-7#1)
publicized##7##1##(1991-2#1)(1993-3#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-5#1)(2012-2#1)
publicizing##4##1##(1995-12#1)(1996-2#1)(2007-5#1)(2009-4#1)
publicly accessible##2##2##(2006-12#1)(2008-7#1)
publicly available at##2##3##(2012-3#1)(2013-1#1)
publicly available databases##3##3##(2008-4#2)(2009-3#1)
publicly available##33##2##(1996-11#1)(2006-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#1)(2008-7#5)(2008-8#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-4#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
publicly financed competition##2##3##(1992-2#2)
publicly financed##4##2##(1992-2#2)(1994-2#1)(2008-12#1)
publicly funded##9##2##(1991-3#2)(1996-12#1)(2007-8#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-10#1)(2011-2#1)
publicly insured##4##2##(1994-2#2)(1997-3#1)(2009-4#1)
publicly##63##1##(1990-12#1)(1991-3#2)(1992-2#2)(1992-9#1)(1994-2#3)(1995-2#1)(1995-5#1)(1996-11#1)(1996-12#1)(1997-3#1)(1997-8#1)(2006-12#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2010-10#1)(2010-4#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
publics##7##1##(1992-3#1)(1997-1#2)(2008-12#3)(2013-7#1)
publique##3##1##(2012-2#3)
publish a##2##2##(1991-12#1)(2005-8#1)
publish hospital-specific report cards##2##4##(2011-2#2)
publish information on##2##3##(1996-12#1)(2011-2#1)
publish the##2##2##(1996-12#1)(2008-7#1)
publish##26##1##(1991-12#1)(1991-2#1)(1993-12#1)(1993-8#1)(1996-12#2)(2005-7#2)(2005-8#1)(2006-5#1)(2007-4#1)(2008-10#1)(2008-7#2)(2009-11#1)(2009-2#3)(2010-12#3)(2011-2#4)(2012-2#1)
published American Heart##3##3##(2007-9#1)(2008-3#2)
published American##4##2##(2007-9#1)(2008-3#3)
published DNA##2##2##(2008-10#2)
published ET cases##3##3##(2013-1#3)
published PCR##3##2##(1997-3#1)(2008-1#1)(2011-1#1)
published a##15##2##(1990-12#1)(1991-3#1)(1993-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(2006-10#1)(2007-2#1)(2008-5#1)(2009-2#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
published about##7##2##(1990-5#1)(2006-10#3)(2007-5#1)(2007-7#1)(2008-10#1)
published after the##2##3##(2008-10#1)(2010-9#1)
published after##3##2##(2008-10#1)(2010-9#1)(2013-1#1)
published algorithm##3##2##(2008-2#2)(2008-3#1)
published and unpublished##5##3##(1997-7#1)(2007-9#1)(2008-10#1)(2008-8#1)(2008-9#1)
published and##11##2##(1994-3#1)(1997-7#1)(2006-11#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-8#1)(2008-9#1)(2012-3#1)
published articles on##4##3##(1997-1#1)(2008-10#1)(2009-7#1)(2011-7#1)
published articles##12##2##(1994-3#1)(1997-1#1)(2005-10#1)(2006-10#2)(2007-4#1)(2008-10#1)(2009-7#1)(2010-2#1)(2011-7#1)(2012-12#1)(2013-1#1)
published as##6##2##(1993-11#1)(2008-8#1)(2011-2#1)(2013-7#3)
published at##2##2##(1990-12#1)(2008-4#1)
published before##4##2##(1990-6#1)(2008-3#1)(2010-2#1)(2012-12#1)
published between 1981 and##2##4##(2007-4#1)(2012-3#1)
published between 1990 and##2##4##(2005-7#1)(2013-1#1)
published between January##4##3##(2005-7#1)(2007-10#1)(2008-7#1)(2012-12#1)
published between October##2##3##(2006-10#1)(2008-12#1)
published between##25##2##(1994-2#1)(2005-7#2)(2006-10#3)(2006-2#1)(2007-10#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-7#2)(2008-8#1)(2011-2#2)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
published by Lamaze International and reprinted here with permission##2##9##(2007-2#2)
published by Lamaze International and reprinted here with##8##8##(2007-2#8)
published by other authors##2##4##(1990-9#1)(2008-10#1)
published by other##4##3##(1990-9#1)(1993-4#1)(2008-10#1)(2008-4#1)
published by the##10##3##(1993-11#1)(2006-5#1)(2007-12#1)(2007-4#1)(2008-8#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#1)
published by##43##2##(1990-9#1)(1993-11#1)(1993-4#1)(1993-6#1)(1994-2#1)(1994-4#1)(1996-3#1)(1996-7#1)(1996-9#1)(2005-11#2)(2005-12#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-12#1)(2007-2#8)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-8#1)(2010-2#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#1)(2013-1#2)(2013-8#2)
published case of##4##3##(1990-6#1)(1991-11#1)(2008-5#1)(2012-2#1)
published case reports##2##3##(2007-10#1)(2013-1#1)
published case##11##2##(1990-12#1)(1990-6#1)(1991-11#1)(1992-11#1)(2007-10#2)(2008-10#1)(2008-5#1)(2012-2#1)(2013-1#2)
published cases##11##2##(2006-10#1)(2006-9#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-2#1)(2010-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
published catalytic-spectrophotometric methods for##2##4##(2008-10#1)(2008-3#1)
published clinical trials##2##3##(1990-9#1)(2007-11#1)
published clinical##6##2##(1990-9#1)(2006-6#1)(2006-9#1)(2007-11#1)(2008-11#1)(2010-2#1)
published criteria for##2##3##(2008-8#1)(2008-9#1)
published criteria##3##2##(2008-8#1)(2008-9#1)(2010-8#1)
published data and##6##3##(1991-9#1)(2006-11#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-11#1)
published data are##3##3##(1993-8#1)(2011-2#1)(2012-2#1)
published data from##5##3##(1996-1#1)(2008-10#1)(2008-11#2)(2011-2#1)
published data in##2##3##(2009-10#1)(2011-2#1)
published data of##3##3##(1993-5#1)(2008-10#1)(2008-9#1)
published data on the##10##4##(1996-5#1)(1997-2#1)(2007-8#2)(2008-3#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
published data on##23##3##(1991-7#1)(1993-11#1)(1995-8#1)(1996-5#1)(1997-2#1)(2006-10#1)(2007-12#1)(2007-8#2)(2008-3#2)(2008-5#2)(2008-8#1)(2010-12#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)
published data regarding##3##3##(2008-11#1)(2011-2#1)(2013-1#1)
published data sets##2##3##(2008-11#1)(2009-4#1)
published data##89##2##(1990-3#1)(1990-4#1)(1991-2#2)(1991-7#1)(1991-9#1)(1992-10#1)(1992-7#1)(1993-11#1)(1993-5#1)(1993-8#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-11#1)(1995-8#1)(1996-1#1)(1996-5#1)(1997-2#1)(1997-7#1)(2006-10#1)(2006-11#3)(2006-8#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-2#2)(2008-3#3)(2008-5#5)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#2)(2009-4#1)(2009-8#2)(2010-12#2)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#4)
published datasets##2##2##(2008-6#1)(2008-7#1)
published descriptions of##2##3##(2008-5#1)(2008-6#1)
published descriptors##2##2##(2006-10#2)
published during the last##2##4##(2010-5#1)(2011-12#1)
published during the past year##3##5##(2006-10#3)
published during the past##5##4##(1997-6#1)(2006-10#3)(2008-1#1)
published during the##9##3##(1994-3#1)(1997-6#1)(2004-1#1)(2006-10#3)(2008-1#1)(2010-5#1)(2011-12#1)
published during##10##2##(1994-3#1)(1997-6#1)(2004-1#1)(2006-10#3)(2008-1#1)(2010-12#1)(2010-5#1)(2011-12#1)
published estimates##2##2##(2008-9#1)(2010-12#1)
published evidence from##2##3##(2005-10#1)(2009-7#1)
published evidence of##4##3##(1993-3#1)(1996-9#1)(2005-7#2)
published evidence##13##2##(1990-8#1)(1993-3#1)(1996-9#2)(2005-10#1)(2005-7#2)(2006-1#1)(2007-3#1)(2007-7#1)(2007-8#1)(2009-7#1)(2013-1#1)
published examples##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
published experience##4##2##(2006-10#1)(2009-2#1)(2011-7#1)(2012-2#1)
published experimental data##5##3##(2008-11#1)(2008-2#2)(2008-7#1)(2010-10#1)
published experimental results##2##3##(2007-4#1)(2007-9#1)
published experimental##9##2##(2007-4#1)(2007-9#1)(2008-11#2)(2008-2#2)(2008-6#1)(2008-7#1)(2010-10#1)
published experiments##2##2##(2007-4#2)
published findings##6##2##(1990-7#1)(2007-12#4)(2012-2#1)
published for the##5##3##(1993-6#1)(1995-11#1)(2005-11#1)(2007-4#1)(2011-2#1)
published for##18##2##(1991-6#1)(1993-6#1)(1994-2#1)(1995-10#1)(1995-11#1)(2005-11#1)(2007-11#2)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
published from 1966 to##2##4##(1996-9#1)(2008-8#1)
published from 1980 to##3##4##(2009-5#2)(2012-2#1)
published from 2001 to##2##4##(2011-2#1)(2012-12#1)
published from January##2##3##(2009-8#1)(2013-1#1)
published from##23##2##(1990-8#1)(1993-12#1)(1993-6#1)(1996-9#1)(2005-7#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-8#2)(2009-5#2)(2009-8#2)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#2)
published gene##2##2##(2006-9#1)(2008-12#1)
published genome##2##2##(2011-2#1)(2012-2#1)
published growth##2##2##(1991-6#1)(2010-8#1)
published guidelines for the##2##4##(2006-10#1)(2012-2#1)
published guidelines for##7##3##(1991-8#1)(1995-6#1)(2005-11#1)(2006-10#1)(2007-12#1)(2012-11#1)(2012-2#1)
published guidelines on##2##3##(2006-10#1)(2007-9#1)
published guidelines##15##2##(1991-8#1)(1995-6#1)(1997-8#1)(2005-11#1)(2006-10#3)(2007-12#1)(2007-9#1)(2009-6#1)(2010-11#1)(2012-11#1)(2012-2#1)(2013-1#2)
published here##4##2##(1992-8#1)(2006-11#1)(2008-11#1)(2009-10#1)
published his##2##2##(2006-11#1)(2008-1#1)
published in 1999##2##3##(2006-10#2)
published in 2001##2##3##(2008-8#1)(2012-12#1)
published in 2002##2##3##(2010-12#1)(2010-9#1)
published in English from##2##4##(2010-9#1)(2012-2#1)
published in English##6##3##(1996-9#1)(2008-7#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
published in Indian##2##3##(2007-7#1)(2012-2#1)
published in Mexico##2##3##(1997-8#2)
published in a journal##2##4##(1991-5#1)(2007-3#1)
published in a##5##3##(1991-5#1)(2005-10#1)(2005-7#1)(2006-11#1)(2007-3#1)
published in an##5##3##(1997-1#1)(2005-7#2)(2006-12#1)(2009-4#1)
published in literature##2##3##(2007-11#1)(2008-10#1)
published in other##2##3##(1997-8#1)(2008-5#1)
published in the English literature##3##5##(2006-10#1)(2008-5#1)(2009-3#1)
published in the English##4##4##(2006-10#2)(2008-5#1)(2009-3#1)
published in the Federal Register##2##5##(1994-12#1)(2006-8#1)
published in the IFSCC##2##4##(2008-5#2)
published in the Journal of##2##5##(2008-5#2)
published in the September issue of##2##6##(2007-8#1)(2007-9#1)
published in the international literature##2##5##(2008-5#1)(2008-7#1)
published in the last##2##4##(2008-10#1)(2008-3#1)
published in the literature##9##4##(2006-10#2)(2006-9#1)(2007-3#1)(2007-4#1)(2007-6#1)(2008-3#1)(2012-2#1)(2013-8#1)
published in the past year##2##5##(2006-10#2)
published in the period##3##4##(2006-10#2)(2006-2#1)
published in the##62##3##(1993-12#2)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-1#1)(2004-2#1)(2005-7#3)(2005-8#2)(2006-10#11)(2006-2#1)(2006-8#2)(2006-9#1)(2007-3#2)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#6)(2008-7#2)(2009-2#1)(2009-3#2)(2009-8#1)(2010-2#1)(2010-5#1)(2012-12#1)(2012-2#2)(2013-8#2)
published in this issue of EBCH##3##6##(2013-7#3)
published in this issue of the##6##6##(1994-12#1)(1996-3#1)(1997-2#1)(1997-3#2)(2006-11#1)
published in this issue of##11##5##(1994-12#1)(1996-3#1)(1997-2#1)(1997-3#2)(2006-11#1)(2008-7#1)(2010-11#1)(2013-7#3)
published in this##15##3##(1990-3#1)(1994-11#1)(1994-12#1)(1996-3#1)(1997-2#1)(1997-3#2)(2006-11#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-11#1)(2013-7#3)
published in##184##2##(1990-2#1)(1990-3#1)(1991-5#1)(1993-12#4)(1993-2#1)(1993-4#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#2)(1995-1#1)(1995-2#3)(1995-8#1)(1996-1#1)(1996-3#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-5#1)(1997-6#1)(1997-8#4)(2004-12#1)(2004-2#1)(2005-10#2)(2005-7#8)(2005-8#3)(2006-10#13)(2006-11#2)(2006-12#1)(2006-2#2)(2006-8#5)(2006-9#1)(2007-11#2)(2007-12#1)(2007-3#4)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#9)(2008-3#2)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-2#2)(2009-3#3)(2009-4#3)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#2)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#5)(2013-1#8)(2013-7#3)(2013-8#6)
published information on##2##3##(2006-8#1)(2008-1#1)
published information##5##2##(1997-1#1)(2006-8#1)(2007-5#1)(2008-1#1)(2012-2#1)
published its##3##2##(1993-12#1)(1996-12#1)(2013-1#1)
published literature and##7##3##(2004-12#1)(2006-3#1)(2008-10#1)(2010-10#1)(2010-12#2)(2010-8#1)
published literature is##2##3##(2007-11#1)(2008-11#1)
published literature on its##2##4##(2006-10#1)(2008-3#1)
published literature on##7##3##(2006-10#2)(2007-12#1)(2008-3#1)(2009-10#1)(2009-9#1)(2012-2#1)
published literature##36##2##(1991-3#1)(1996-2#1)(1997-1#1)(2004-12#1)(2005-8#1)(2006-10#2)(2006-3#1)(2006-6#1)(2007-11#3)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
published map##4##2##(2013-1#4)
published meta-analyses##3##2##(2010-2#1)(2013-1#2)
published meta-analysis##2##2##(1996-3#1)(1996-7#1)
published method##3##2##(1997-8#1)(2008-10#2)
published methods##8##2##(1997-2#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2012-1#1)
published model##3##2##(2008-3#1)(2010-10#1)(2012-3#1)
published models##3##2##(2008-10#1)(2008-2#1)(2012-12#1)
published more than##2##3##(1993-12#1)(2012-2#1)
published normal##2##2##(2007-12#1)(2007-7#1)
published observations##2##2##(2007-8#1)(2008-9#1)
published on this topic##3##4##(1997-1#1)(2013-1#2)
published on this##4##3##(1997-1#1)(2007-3#1)(2013-1#2)
published on##30##2##(1991-2#1)(1997-1#1)(2006-10#7)(2007-1#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2009-8#1)(2010-12#4)(2010-5#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#4)
published online##2##2##(2008-12#1)(2013-1#1)
published outcomes##2##2##(2005-5#1)(2013-8#1)
published over the last##2##4##(2007-11#1)(2008-2#1)
published over the past##3##4##(2006-10#1)(2008-8#1)(2010-8#1)
published over the##5##3##(2006-10#1)(2007-11#1)(2008-2#1)(2008-8#1)(2010-8#1)
published over##6##2##(2006-10#1)(2007-11#1)(2008-2#1)(2008-8#1)(2010-8#1)(2012-2#1)
published paper##4##2##(1996-9#1)(2006-12#1)(2008-2#1)(2013-1#1)
published papers##9##2##(1994-11#1)(2008-10#3)(2009-8#3)(2013-1#1)(2013-7#1)
published partial gene trees relating different##2##6##(2006-10#2)
published phase##4##2##(2005-8#1)(2006-8#1)(2007-12#1)(2008-5#1)
published previously##7##2##(2006-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#2)
published protocols##2##2##(2006-5#1)(2008-4#1)
published randomised controlled##2##3##(2007-11#1)(2012-3#1)
published randomised##3##2##(2007-11#1)(2008-5#1)(2012-3#1)
published randomized controlled trials and##2##5##(1995-2#1)(2010-11#1)
published randomized##3##2##(1995-2#1)(2008-6#1)(2010-11#1)
published rates##2##2##(2007-8#1)(2008-11#1)
published recently##6##2##(1990-6#1)(1994-3#1)(2006-10#1)(2008-2#1)(2011-1#1)(2012-2#1)
published recommendations##2##2##(1993-12#1)(2006-10#1)
published reference##2##2##(2007-11#1)(2012-2#1)
published regarding the##2##3##(2007-10#1)(2012-2#1)
published regarding##4##2##(2006-10#1)(2007-10#1)(2012-12#1)(2012-2#1)
published report of##2##3##(2006-8#1)(2008-11#1)
published report##7##2##(1990-12#1)(1992-11#1)(1996-1#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
published reports from##3##3##(2006-5#1)(2008-10#1)(2008-2#1)
published reports in##3##3##(1992-5#1)(2008-7#1)(2009-2#1)
published reports of##5##3##(2005-11#1)(2007-10#1)(2007-4#1)(2010-12#1)(2012-12#1)
published reports on##2##3##(2011-1#1)(2013-1#1)
published reports##37##2##(1990-9#1)(1992-5#1)(1993-12#1)(1995-9#1)(2004-3#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-5#1)(2007-10#1)(2007-4#1)(2007-5#2)(2007-7#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-7#1)(2009-2#1)(2010-12#3)(2010-2#1)(2011-1#2)(2012-12#2)(2012-3#1)(2013-1#2)
published research on##2##3##(1992-12#1)(2010-10#1)
published research##15##2##(1992-12#1)(1993-12#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-9#1)(2009-5#1)(2010-10#1)(2011-1#1)(2012-2#1)(2012-3#1)
published results from##2##3##(2008-8#1)(2009-11#1)
published results of the##2##4##(2006-8#1)(2007-1#1)
published results of##4##3##(1992-11#1)(2006-8#1)(2007-1#1)(2008-9#1)
published results##20##2##(1992-11#1)(1993-8#1)(1995-4#1)(2005-1#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-11#1)(2011-2#1)(2013-1#2)
published scientific##3##2##(2007-4#1)(2008-5#1)(2012-3#1)
published sequence##8##2##(1990-7#2)(1992-12#1)(1993-6#1)(1994-12#1)(1995-1#1)(1996-6#1)(2008-2#1)
published sequences for the##2##4##(1994-11#1)(2008-5#1)
published sequences of##3##3##(1990-9#1)(2008-10#2)
published sequences##8##2##(1990-9#1)(1994-11#1)(1995-6#1)(2006-8#1)(2008-10#2)(2008-5#1)(2010-10#1)
published series of##2##3##(2008-9#1)(2012-3#1)
published series##8##2##(1995-11#1)(2005-8#2)(2006-10#1)(2007-2#1)(2008-9#1)(2010-9#1)(2012-3#1)
published since 1980##2##3##(1997-3#1)(2008-10#1)
published since##6##2##(1997-3#1)(1997-5#1)(2006-10#1)(2006-12#1)(2008-10#1)(2011-2#1)
published structure of##2##3##(1996-8#1)(2008-7#1)
published studies are##2##3##(2007-8#1)(2008-11#1)
published studies examining the##2##4##(2006-3#1)(2011-1#1)
published studies have##6##3##(2006-10#2)(2006-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
published studies in which##2##4##(2006-8#1)(2012-3#1)
published studies in##3##3##(2006-8#1)(2009-2#1)(2012-3#1)
published studies of##5##3##(1990-6#1)(1996-9#1)(2006-10#1)(2008-12#1)(2008-8#1)
published studies on##3##3##(1991-5#1)(1994-4#1)(2008-7#1)
published studies showing##2##3##(2008-1#1)(2012-3#1)
published studies##51##2##(1990-2#1)(1990-6#1)(1991-5#1)(1993-11#1)(1994-2#1)(1994-4#1)(1995-1#1)(1996-9#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-3#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-2#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)
published study of##3##3##(2006-4#1)(2008-7#1)(2008-8#1)
published study##6##2##(2006-4#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-8#1)
published that##4##2##(2006-5#1)(2009-8#1)(2010-12#1)(2010-8#1)
published the first##2##3##(2007-11#1)(2008-8#1)
published the most##2##3##(2011-2#1)(2013-7#1)
published the results of##2##4##(2006-4#1)(2009-6#1)
published the##10##2##(2006-4#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-7#1)
published their##2##2##(2006-3#1)(2012-3#1)
published this past year##2##4##(2006-10#2)
published this##3##2##(2006-10#2)(2008-7#1)
published through##3##2##(2012-12#2)(2013-1#1)
published to date##6##3##(1990-11#1)(1992-11#1)(2007-11#1)(2008-9#1)(2009-9#1)(2011-2#1)
published to##10##2##(1990-11#1)(1992-11#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
published trials##7##2##(1990-1#1)(1995-9#1)(1996-6#1)(2006-10#1)(2006-8#1)(2008-12#1)(2012-2#1)
published values of the##2##4##(2007-3#1)(2008-10#1)
published values##7##2##(1990-11#1)(1990-12#1)(1994-9#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-9#1)
published within the##2##3##(2006-10#1)(2011-1#1)
published work##3##2##(2008-5#1)(2009-8#1)(2010-11#1)
published##1312##1##(1990-1#3)(1990-11#3)(1990-12#5)(1990-2#3)(1990-3#2)(1990-4#4)(1990-5#1)(1990-6#5)(1990-7#3)(1990-8#2)(1990-9#4)(1991-1#2)(1991-11#2)(1991-12#4)(1991-2#4)(1991-3#2)(1991-4#1)(1991-5#5)(1991-6#2)(1991-7#3)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#4)(1992-12#4)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#4)(1993-12#11)(1993-2#4)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#4)(1993-8#3)(1994-1#1)(1994-11#3)(1994-12#8)(1994-2#6)(1994-3#7)(1994-4#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#4)(1995-10#1)(1995-11#5)(1995-12#2)(1995-2#4)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#2)(1996-1#5)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#6)(1996-4#1)(1996-5#3)(1996-6#3)(1996-7#3)(1996-8#2)(1996-9#8)(1997-1#7)(1997-2#4)(1997-3#5)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#7)(2004-1#1)(2004-10#1)(2004-11#1)(2004-12#2)(2004-2#1)(2004-3#1)(2004-9#1)(2005-1#1)(2005-10#5)(2005-11#9)(2005-12#1)(2005-4#1)(2005-5#1)(2005-7#20)(2005-8#11)(2006-1#1)(2006-10#72)(2006-11#12)(2006-12#6)(2006-2#4)(2006-3#4)(2006-4#2)(2006-5#9)(2006-6#3)(2006-8#19)(2006-9#5)(2007-1#3)(2007-10#11)(2007-11#25)(2007-12#20)(2007-2#14)(2007-3#10)(2007-4#17)(2007-5#7)(2007-6#1)(2007-7#9)(2007-8#15)(2007-9#8)(2008-1#17)(2008-10#72)(2008-11#32)(2008-12#9)(2008-2#23)(2008-3#32)(2008-4#14)(2008-5#38)(2008-6#15)(2008-7#41)(2008-8#26)(2008-9#20)(2009-10#4)(2009-11#3)(2009-2#10)(2009-3#4)(2009-4#4)(2009-5#10)(2009-6#3)(2009-7#2)(2009-8#13)(2009-9#3)(2010-1#1)(2010-10#9)(2010-11#9)(2010-12#23)(2010-2#8)(2010-3#3)(2010-4#2)(2010-5#5)(2010-6#1)(2010-7#2)(2010-8#14)(2010-9#6)(2011-1#15)(2011-12#6)(2011-2#37)(2011-7#4)(2012-1#5)(2012-11#5)(2012-12#35)(2012-2#36)(2012-3#22)(2013-1#61)(2013-7#9)(2013-8#22)
publisher##31##1##(2007-4#1)(2008-11#2)(2008-12#1)(2008-4#2)(2012-3#1)(2013-1#2)(2013-8#22)
publishers and##2##2##(2005-8#1)(2012-3#1)
publishers for##3##2##(2008-4#2)(2012-3#1)
publishers have##2##2##(2007-4#2)
publishers##17##1##(2004-12#1)(2005-8#1)(2007-4#6)(2008-4#2)(2008-7#1)(2012-3#6)
publishes a##2##2##(1993-1#1)(1994-12#1)
publishes an##2##2##(1990-12#1)(2011-1#1)
publishes##4##1##(1990-12#1)(1993-1#1)(1994-12#1)(2011-1#1)
publishing and##2##2##(1991-5#1)(2007-4#1)
publishing clinical##2##2##(1993-12#1)(2012-12#1)
publishing in##6##2##(1996-2#1)(2005-7#1)(2007-4#3)(2012-3#1)
publishing medium##2##2##(2007-4#2)
publishing model##4##2##(2007-4#1)(2010-12#3)
publishing of##4##2##(2011-1#1)(2012-3#3)
publishing portrayals##2##2##(2011-1#2)
publishing scientific##2##2##(2006-10#1)(2007-8#1)
publishing##66##1##(1991-5#5)(1993-12#2)(1994-12#1)(1994-3#1)(1996-2#1)(2005-7#1)(2006-10#2)(2007-4#20)(2007-6#1)(2007-8#2)(2008-10#2)(2008-7#1)(2009-2#1)(2010-12#3)(2010-6#1)(2011-1#3)(2011-4#1)(2012-12#1)(2012-3#15)(2013-1#2)
pubmed##2##1##(2012-12#1)(2012-3#1)
pubovaginal sling##2##2##(2006-9#2)
pucker of##2##2##(1991-8#1)(1993-3#1)
pucker##5##1##(1991-6#1)(1991-8#1)(1993-11#1)(1993-3#2)
puckered methylene groups##2##3##(1996-8#2)
puckered##5##1##(1994-11#1)(1995-2#1)(1996-8#2)(2007-7#1)
pudendal nerve##4##2##(1992-6#1)(1992-7#1)(1997-7#1)(2009-4#1)
pudendal##6##1##(1992-6#1)(1992-7#1)(1997-7#1)(2006-10#1)(2006-8#1)(2009-4#1)
pudu##2##1##(2007-2#2)
puerarin##6##1##(1996-4#1)(2007-1#1)(2008-10#1)(2011-3#1)(2012-12#1)(2012-2#1)
puerperal madness&quot##3##2##(2009-10#3)
puerperal women should be##2##4##(1992-8#2)
puerperal women##5##2##(1992-8#2)(1995-6#3)
puerperal##13##1##(1992-8#2)(1995-6#3)(2007-7#1)(2009-10#5)(2012-12#1)(2013-1#1)
puerperas##2##1##(2009-2#2)
puerperium##13##1##(1991-3#1)(1991-5#1)(1992-5#1)(1993-10#1)(2006-10#1)(2007-11#3)(2007-9#1)(2008-11#1)(2008-8#1)(2011-1#1)(2012-12#1)
puff##10##1##(1991-10#1)(1992-10#1)(1995-7#1)(1995-8#2)(2007-12#3)(2007-8#2)
puffer fish##3##2##(1995-2#1)(2008-7#2)
puffer##4##1##(1995-2#1)(2008-7#2)(2013-1#1)
pufferfish##4##1##(2008-1#1)(2008-8#1)(2012-12#2)
puffiness##4##1##(2007-11#1)(2008-7#1)(2010-5#1)(2012-2#1)
puffs##6##1##(1992-2#1)(1995-7#1)(1995-8#2)(2007-2#2)
pugp##2##1##(1990-5#2)
puis##4##1##(2009-4#1)(2013-1#3)
pulcher##4##1##(2007-11#1)(2010-8#3)
pulcherrima isolated##2##2##(2008-10#2)
pulcherrima##6##1##(2008-10#5)(2011-2#1)
pulcherrimum disomic##2##2##(2008-8#2)
pulcherrimum##4##1##(2008-8#4)
pulcherrimus##5##1##(2008-5#5)
pulchrum##3##1##(2007-2#3)
pulegium L##3##2##(2008-10#3)
pulegone##3##1##(1990-12#1)(2008-10#2)
pulex was##2##2##(2012-2#2)
pulex##11##1##(2004-4#2)(2012-2#9)
pulicaria##2##1##(2008-10#1)(2012-3#1)
pull HIE##6##2##(2013-1#6)
pull out##4##2##(2007-7#1)(2008-7#1)(2009-7#1)(2012-2#1)
pull test##2##2##(2006-11#1)(2012-11#1)
pull the##4##2##(1994-3#1)(1995-2#1)(2007-9#1)(2008-11#1)
pull##28##1##(1990-8#1)(1994-3#1)(1995-2#1)(2006-11#1)(2006-7#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#8)
pull&quot##4##1##(1990-8#1)(1994-3#1)(2004-11#1)(2009-4#1)
pull-down assays##2##2##(2009-10#2)
pull-down##6##1##(2008-1#2)(2009-10#2)(2012-2#2)
pull-off force##3##2##(2005-11#2)(2006-7#1)
pull-off forces##2##2##(2005-11#2)
pull-off##7##1##(2005-11#5)(2006-7#1)(2012-1#1)
pull-out strength##4##2##(2007-11#3)(2013-1#1)
pull-out test##3##2##(2005-11#2)(2013-8#1)
pull-out##8##1##(2005-11#2)(2007-11#3)(2012-3#1)(2013-1#1)(2013-8#1)
pull-through##8##1##(2006-10#1)(2008-10#2)(2013-1#5)
pullback initiation/termination##2##2##(2011-1#2)
pullback##4##1##(2011-1#4)
pulled into the resection##2##4##(2006-6#2)
pulled into##3##2##(2006-6#2)(2013-1#1)
pulled off##2##2##(2010-4#1)(2013-1#1)
pulled out##3##2##(2009-7#1)(2013-7#1)(2013-8#1)
pulled straw##2##2##(2013-8#2)
pulled##16##1##(1991-12#1)(1992-5#1)(2006-6#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-7#1)(2010-4#1)(2013-1#2)(2013-7#1)(2013-8#3)
pullets and local chickens##3##4##(2008-5#3)
pullets and##4##2##(2008-5#4)
pullets##12##1##(2008-5#11)(2010-2#1)
pulley in##3##2##(2008-9#3)
pulley##12##1##(2006-10#1)(2008-9#10)(2009-5#1)
pulleys##4##1##(2008-9#3)(2011-2#1)
pulling force generated by interacting##2##5##(2009-12#2)
pulling force##3##2##(2008-6#1)(2009-12#2)
pulling forces##3##2##(2007-12#2)(2008-6#1)
pulling rates##4##2##(2009-7#4)
pulling the##2##2##(2006-5#1)(2011-2#1)
pulling##26##1##(1990-5#1)(1995-5#1)(2006-5#1)(2007-12#4)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#2)(2009-12#3)(2009-7#5)(2009-9#1)(2011-2#1)
pullorum##4##1##(1993-10#1)(2013-1#3)
pullout force##2##2##(2013-7#2)
pullout forces##2##2##(2009-3#2)
pullout##10##1##(2008-9#2)(2009-3#4)(2009-7#1)(2010-7#1)(2013-7#2)
pullulan##4##1##(2007-12#4)
pullulanase##3##1##(1991-12#1)(1993-9#2)
pullulans and##2##2##(2008-10#2)
pullulans##12##1##(1995-8#3)(2007-11#1)(2008-10#7)(2008-5#1)
pulmonaire##2##1##(2012-2#1)(2013-1#1)
pulmonal##2##1##(2006-8#1)(2012-12#1)
pulmonaris##2##1##(2008-3#1)(2008-4#1)
pulmonary AVMs##4##2##(2007-8#1)(2008-4#3)
pulmonary MT mRNA were##2##4##(1997-2#2)
pulmonary MT##4##2##(1997-2#4)
pulmonary SCC##2##2##(2009-8#2)
pulmonary TA##3##2##(2006-10#3)
pulmonary TB in children##4##4##(2011-2#3)(2013-8#1)
pulmonary TB in##5##3##(2011-2#4)(2013-8#1)
pulmonary TB patients were##2##4##(2007-2#1)(2008-5#1)
pulmonary TB patients##7##3##(2007-2#1)(2008-5#1)(2011-11#4)(2013-1#1)
pulmonary TB##17##2##(2007-2#1)(2008-5#1)(2010-5#1)(2010-7#1)(2011-11#4)(2011-2#5)(2012-2#1)(2013-1#1)(2013-8#2)
pulmonary abscess##4##2##(1991-3#1)(2006-8#1)(2007-2#1)(2007-6#1)
pulmonary actinomycosis##3##2##(2008-1#2)(2012-2#1)
pulmonary adenocarcinoma##3##2##(1994-3#1)(2008-5#2)
pulmonary adenomas##4##2##(1990-7#1)(2008-9#3)
pulmonary air leaks##2##3##(1994-6#2)
pulmonary air##3##2##(1992-2#1)(1994-6#2)
pulmonary alveolar macrophages (PAM) by##2##5##(1996-3#1)(1997-6#1)
pulmonary alveolar macrophages (PAM)##3##4##(1993-8#1)(1996-3#1)(1997-6#1)
pulmonary alveolar microlithiasis##2##3##(2005-11#1)(2012-12#1)
pulmonary alveolar proteinosis##3##3##(2007-1#1)(2007-2#1)(2010-4#1)
pulmonary alveolar##10##2##(1993-2#1)(1993-8#1)(1996-3#1)(1997-6#1)(2005-11#1)(2007-1#1)(2007-2#1)(2010-4#1)(2012-12#1)(2012-2#1)
pulmonary and central nervous##2##4##(1994-7#1)(1997-5#1)
pulmonary and cerebral##2##3##(2008-6#1)(2009-10#1)
pulmonary and hepatic metastases##2##4##(2011-1#2)
pulmonary and hepatic##4##3##(1992-9#1)(2009-8#1)(2011-1#2)
pulmonary and peritoneal##3##3##(2007-12#1)(2013-1#2)
pulmonary and renal##3##3##(2008-10#1)(2010-10#2)
pulmonary and systemic##6##3##(1994-12#1)(1996-3#1)(1997-1#1)(2007-8#1)(2008-11#1)(2010-10#1)
pulmonary and vascular##2##3##(2005-9#1)(2010-3#1)
pulmonary and##40##2##(1991-3#1)(1992-9#1)(1994-12#1)(1994-6#1)(1994-7#1)(1995-10#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-5#1)(1997-8#1)(2005-9#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#2)(2009-10#2)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#3)(2010-3#2)(2011-1#2)(2011-2#1)(2013-1#2)(2013-8#1)
pulmonary angiography##9##2##(2005-10#4)(2007-10#1)(2010-10#1)(2010-6#1)(2011-2#1)(2013-7#1)
pulmonary arterial blood were##3##4##(1996-3#3)
pulmonary arterial blood##5##3##(1996-3#5)
pulmonary arterial circulation of RHR##2##5##(2008-11#2)
pulmonary arterial hypertension (PAH)##7##4##(2009-10#1)(2010-10#6)
pulmonary arterial hypertension in##2##4##(2010-10#1)(2013-1#1)
pulmonary arterial hypertension##36##3##(1990-6#1)(1994-3#1)(1996-3#1)(2007-11#4)(2007-9#2)(2008-10#3)(2008-11#1)(2008-4#3)(2009-10#1)(2010-10#13)(2010-12#2)(2010-5#1)(2011-3#1)(2012-2#1)(2013-1#1)
pulmonary arterial hypertension]##3##3##(2008-10#2)(2013-1#1)
pulmonary arterial pressure##2##3##(1991-6#1)(2008-11#1)
pulmonary arterial thrombosis##2##3##(2006-10#1)(2010-6#1)
pulmonary arterial##61##2##(1990-6#1)(1991-2#1)(1991-6#1)(1994-3#3)(1995-6#1)(1996-3#6)(2006-10#1)(2007-11#4)(2007-9#2)(2008-10#7)(2008-11#5)(2008-4#4)(2009-10#1)(2009-12#1)(2010-10#13)(2010-12#2)(2010-5#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#2)
pulmonary arteries and veins##3##4##(2005-11#1)(2010-8#2)
pulmonary arteries and##8##3##(1993-3#1)(2005-11#1)(2010-5#1)(2010-6#2)(2010-8#2)(2012-3#1)
pulmonary arteries in##2##3##(2008-4#1)(2008-7#1)
pulmonary arteries##27##2##(1993-3#1)(1997-8#1)(2005-11#1)(2006-4#1)(2007-10#1)(2008-1#2)(2008-10#1)(2008-4#2)(2008-7#5)(2009-5#1)(2010-10#1)(2010-5#1)(2010-6#3)(2010-8#2)(2012-3#1)(2013-1#2)(2013-7#1)
pulmonary arterio-venous malformations##2##3##(2007-8#2)
pulmonary arteriography##2##2##(2010-6#2)
pulmonary arteriovenous fistulae##2##3##(2008-11#1)(2008-7#1)
pulmonary arteriovenous malformation##5##3##(2007-2#1)(2007-8#2)(2008-1#1)(2010-10#1)
pulmonary arteriovenous malformations##5##3##(2007-8#2)(2008-1#1)(2008-4#2)
pulmonary arteriovenous##16##2##(2007-2#1)(2007-8#4)(2008-1#2)(2008-11#3)(2008-4#2)(2008-7#1)(2009-10#2)(2010-10#1)
pulmonary artery (ALCAPA) is a rare congenital##3##7##(2007-11#1)(2008-4#1)(2010-5#1)
pulmonary artery (ALCAPA)##4##3##(2007-11#2)(2008-4#1)(2010-5#1)
pulmonary artery and##8##3##(1991-3#1)(1993-3#1)(1997-8#1)(2008-11#2)(2013-7#3)
pulmonary artery banding##7##3##(2007-8#5)(2008-4#2)
pulmonary artery catheter##6##3##(1991-6#1)(2006-10#3)(2007-9#1)(2008-11#1)
pulmonary artery catheterization##4##3##(2006-10#4)
pulmonary artery dissection##2##3##(2010-10#2)
pulmonary artery endothelial cells (BPAEC)##3##5##(1993-12#1)(1996-5#1)(2004-11#1)
pulmonary artery endothelial cells in##2##5##(1994-12#1)(1997-7#1)
pulmonary artery endothelial cells##8##4##(1991-9#1)(1993-12#1)(1993-3#1)(1994-12#1)(1996-5#1)(1997-3#1)(1997-7#1)(2004-11#1)
pulmonary artery endothelial##9##3##(1991-9#1)(1993-12#1)(1993-3#1)(1994-12#1)(1996-5#1)(1997-3#2)(1997-7#1)(2004-11#1)
pulmonary artery hypertension secondary to chronic##2##6##(2007-11#2)
pulmonary artery hypertension##6##3##(1994-6#1)(2007-11#3)(2007-9#1)(2008-11#1)
pulmonary artery involvement##2##3##(1997-8#1)(2006-10#1)
pulmonary artery is##4##3##(1997-8#1)(2007-8#2)(2008-11#1)
pulmonary artery occlusion##2##3##(1997-8#2)
pulmonary artery perforation##2##3##(2007-8#2)
pulmonary artery pressure (PAP)##2##4##(2007-8#1)(2010-8#1)
pulmonary artery pressure and##3##4##(1993-3#1)(2005-11#1)(2007-9#1)
pulmonary artery pressure in##2##4##(1997-4#1)(2005-11#1)
pulmonary artery pressure on##2##4##(2007-9#2)
pulmonary artery pressure with##2##4##(1992-2#1)(2006-10#1)
pulmonary artery pressure##24##3##(1991-8#1)(1992-2#1)(1993-3#1)(1997-4#1)(1997-5#1)(2005-11#2)(2006-10#3)(2007-11#1)(2007-8#1)(2007-9#8)(2009-6#1)(2010-10#1)(2010-4#1)(2010-8#1)
pulmonary artery pressures##2##3##(2006-10#1)(2010-5#1)
pulmonary artery sling##4##3##(1993-12#4)
pulmonary artery smooth muscle cells##3##5##(1995-2#1)(2011-3#1)(2012-2#1)
pulmonary artery smooth muscle##4##4##(1995-2#1)(2010-12#1)(2011-3#1)(2012-2#1)
pulmonary artery thrombosis##4##3##(2013-1#4)
pulmonary artery to the##3##4##(2007-8#2)(2013-7#1)
pulmonary artery using##4##3##(2007-8#1)(2012-12#2)(2013-7#1)
pulmonary artery was##2##3##(2007-8#1)(2013-7#1)
pulmonary artery with##2##3##(2007-8#1)(2010-8#1)
pulmonary artery##169##2##(1990-5#2)(1990-7#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-2#1)(1993-12#6)(1993-2#1)(1993-3#4)(1993-6#2)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-5#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#6)(2004-11#1)(2005-11#2)(2006-10#13)(2007-11#6)(2007-8#26)(2007-9#10)(2008-1#1)(2008-11#11)(2008-12#1)(2008-4#5)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#7)(2010-12#2)(2010-4#1)(2010-5#2)(2010-8#3)(2011-2#1)(2011-3#2)(2012-12#4)(2012-2#2)(2013-1#8)(2013-7#12)
pulmonary artery]##2##2##(2008-12#1)(2013-8#1)
pulmonary aspergilloma##3##2##(2008-1#2)(2012-2#1)
pulmonary aspergillosis in patients with##2##5##(2011-2#1)(2012-12#1)
pulmonary aspergillosis in##6##3##(2007-7#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-12#2)
pulmonary aspergillosis was##2##3##(2007-7#1)(2008-1#1)
pulmonary aspergillosis##25##2##(2006-10#1)(2007-7#3)(2008-1#4)(2008-5#2)(2010-12#2)(2011-2#3)(2012-11#2)(2012-12#6)(2013-1#2)
pulmonary aspiration##7##2##(1993-10#1)(2006-10#3)(2010-10#1)(2010-7#2)
pulmonary autograft patch##2##3##(2007-8#2)
pulmonary autograft##4##2##(2007-8#4)
pulmonary biopsy##2##2##(1994-6#1)(2010-12#1)
pulmonary blood flow##13##3##(1994-7#1)(1996-3#1)(2006-10#2)(2007-8#2)(2010-10#1)(2010-9#5)(2012-1#1)
pulmonary blood##14##2##(1994-7#1)(1996-3#1)(2006-10#2)(2007-8#2)(2007-9#1)(2010-10#1)(2010-9#5)(2012-1#1)
pulmonary cancer##3##2##(2011-2#3)
pulmonary capillary wedge pressure##5##4##(1991-6#1)(2007-9#2)(2008-3#1)(2010-8#1)
pulmonary capillary wedge##6##3##(1991-6#1)(2007-9#2)(2008-3#1)(2008-5#1)(2010-8#1)
pulmonary capillary##9##2##(1991-6#1)(1991-9#1)(2005-11#1)(2006-10#1)(2007-9#2)(2008-3#1)(2008-5#1)(2010-8#1)
pulmonary carcinoid##2##2##(2008-8#2)
pulmonary carcinoma##5##2##(1992-10#1)(1997-5#1)(2007-8#1)(2008-9#2)
pulmonary changes##2##2##(2006-12#1)(2008-10#1)
pulmonary circulation##8##2##(1992-3#1)(1994-8#1)(2005-11#1)(2006-10#2)(2007-9#1)(2008-4#1)(2010-10#1)
pulmonary clearance##4##2##(1990-3#1)(1991-8#3)
pulmonary complication##2##2##(2007-8#1)(2011-2#1)
pulmonary complications after##2##3##(1997-3#1)(2011-2#1)
pulmonary complications and##2##3##(1991-8#1)(2011-1#1)
pulmonary complications associated with##2##4##(1992-12#1)(2006-10#1)
pulmonary complications in##5##3##(1990-10#2)(1992-12#1)(2008-4#1)(2011-1#1)
pulmonary complications of##2##3##(2007-4#1)(2007-8#1)
pulmonary complications##37##2##(1990-10#2)(1991-10#1)(1991-8#1)(1992-12#2)(1992-3#1)(1997-3#2)(1997-4#1)(2006-10#4)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#7)(2007-9#1)(2008-4#1)(2010-9#3)(2011-1#2)(2011-2#3)(2012-1#1)(2013-8#2)
pulmonary congestion##2##2##(2006-6#1)(2008-1#1)
pulmonary contusion##3##2##(2006-10#1)(2012-2#2)
pulmonary contusions##2##2##(2006-4#1)(2007-3#1)
pulmonary cryptococcosis##2##2##(2008-10#1)(2012-3#1)
pulmonary cytochrome P450##2##3##(1992-6#2)
pulmonary delivery##5##2##(2005-8#1)(2010-1#4)
pulmonary deposition##2##2##(1996-12#2)
pulmonary diagnosis##2##2##(1996-2#1)(2010-12#1)
pulmonary disease (COPD)##46##3##(1991-10#1)(1991-4#2)(1992-3#1)(1995-12#2)(1996-1#2)(1997-4#1)(1997-7#1)(2005-8#6)(2006-5#1)(2006-9#2)(2007-11#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-7#2)(2010-10#3)(2010-12#1)(2010-5#1)(2011-2#8)(2011-3#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-8#3)
pulmonary disease and##16##3##(1990-12#2)(2006-10#1)(2006-12#1)(2007-10#1)(2007-12#1)(2008-7#2)(2009-1#1)(2009-6#1)(2010-5#1)(2011-12#1)(2011-2#3)(2012-12#1)
pulmonary disease in##10##3##(1991-12#1)(1992-1#1)(1995-12#1)(1997-3#1)(2006-10#1)(2007-12#1)(2010-2#1)(2010-8#1)(2012-2#2)
pulmonary disease is##6##3##(2005-11#1)(2006-10#4)(2011-2#1)
pulmonary disease##168##2##(1990-10#1)(1990-12#2)(1991-10#1)(1991-12#1)(1991-4#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-3#3)(1994-6#1)(1995-12#3)(1996-1#2)(1996-5#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(2005-11#3)(2005-8#8)(2005-9#1)(2006-10#11)(2006-12#2)(2006-2#2)(2006-5#2)(2006-7#1)(2006-8#1)(2006-9#3)(2007-10#2)(2007-11#2)(2007-12#4)(2007-3#1)(2007-6#2)(2007-7#1)(2007-8#10)(2008-1#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2009-1#1)(2009-3#1)(2009-6#2)(2010-10#6)(2010-12#4)(2010-2#2)(2010-3#1)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#22)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#4)
pulmonary disease]##6##2##(1996-2#1)(2008-9#1)(2011-2#3)(2013-1#1)
pulmonary diseases and##2##3##(2006-10#1)(2006-8#1)
pulmonary diseases##17##2##(1991-12#1)(1996-2#1)(2006-10#3)(2006-6#1)(2006-8#2)(2007-11#2)(2008-7#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)
pulmonary disorders##3##2##(2007-12#1)(2007-3#2)
pulmonary drug##2##2##(1992-3#1)(1997-1#1)
pulmonary dysfunction##2##2##(1994-5#1)(2006-10#1)
pulmonary edema as the##2##4##(1994-2#1)(2006-10#1)
pulmonary edema during##2##3##(2010-7#1)(2012-2#1)
pulmonary edema formation in##2##4##(1994-8#1)(2010-10#1)
pulmonary edema in##4##3##(1994-8#1)(2008-11#1)(2008-4#1)(2011-2#1)
pulmonary edema is##3##3##(1992-2#1)(1994-2#1)(2006-10#1)
pulmonary edema of##2##3##(1994-2#1)(2010-7#1)
pulmonary edema##46##2##(1991-10#2)(1991-9#1)(1992-2#5)(1994-2#3)(1994-8#3)(1997-4#1)(2006-10#3)(2007-2#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#2)(2009-1#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-7#2)(2011-2#5)(2012-2#4)(2013-1#1)
pulmonary edema]##2##2##(1994-3#1)(2008-10#1)
pulmonary effects of##3##3##(1996-12#2)(2007-11#1)
pulmonary emboli in##2##3##(1990-6#1)(2005-10#1)
pulmonary emboli##11##2##(1990-6#1)(1992-4#1)(1995-6#2)(2005-10#2)(2005-11#1)(2007-8#1)(2009-4#1)(2010-2#1)(2011-12#1)
pulmonary embolism (PE) and##2##4##(2008-3#1)(2011-2#1)
pulmonary embolism (PE)##8##3##(1993-2#1)(2007-8#1)(2008-3#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
pulmonary embolism and##7##3##(1991-11#1)(1991-3#1)(2006-4#1)(2007-11#1)(2009-10#1)(2010-10#1)(2013-1#1)
pulmonary embolism are the##2##4##(2007-10#1)(2008-7#1)
pulmonary embolism for##2##3##(2006-6#1)(2007-8#1)
pulmonary embolism in##5##3##(1991-9#1)(2005-10#2)(2008-7#1)(2009-4#1)
pulmonary embolism is a##2##4##(2009-4#1)(2011-12#1)
pulmonary embolism is##4##3##(2005-10#1)(2007-10#1)(2009-4#1)(2011-12#1)
pulmonary embolism of##2##3##(2005-10#1)(2013-1#1)
pulmonary embolism or##2##3##(2007-10#1)(2012-2#1)
pulmonary embolism with a##2##4##(2005-10#1)(2011-2#1)
pulmonary embolism##109##2##(1991-11#7)(1991-3#1)(1991-4#1)(1991-9#2)(1992-10#2)(1992-5#1)(1993-2#2)(1993-7#1)(1996-4#1)(1996-6#4)(1997-2#1)(1997-8#2)(2005-1#2)(2005-10#12)(2005-8#1)(2006-10#5)(2006-4#4)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#5)(2007-11#2)(2007-3#2)(2007-7#2)(2007-8#5)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#4)(2009-10#1)(2009-4#3)(2010-1#1)(2010-10#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#7)(2011-3#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#4)
pulmonary embolism]##6##2##(1991-11#1)(1993-10#1)(2005-10#1)(2007-10#1)(2013-8#2)
pulmonary embolisms##3##2##(1992-10#1)(1993-5#1)(1993-9#1)
pulmonary embolization##2##2##(2007-7#2)
pulmonary embolus##6##2##(1991-8#1)(1992-2#1)(2006-4#1)(2006-8#1)(2007-3#1)(2008-6#1)
pulmonary emphysema and##2##3##(2008-9#1)(2009-1#1)
pulmonary emphysema##6##2##(2008-7#3)(2008-9#1)(2009-1#1)(2009-7#1)
pulmonary endarterectomy##6##2##(2010-10#1)(2010-6#1)(2013-1#4)
pulmonary evaluation##2##2##(2006-10#2)
pulmonary failure##2##2##(2006-6#1)(2011-3#1)
pulmonary fibrosis (IPF)##6##3##(2005-8#3)(2010-12#2)(2012-12#1)
pulmonary fibrosis and pulmonary##2##4##(2011-3#2)
pulmonary fibrosis and##6##3##(2005-8#1)(2006-10#1)(2010-12#2)(2011-3#2)
pulmonary fibrosis in##5##3##(1994-6#2)(1995-7#1)(2010-6#1)(2012-1#1)
pulmonary fibrosis is##3##3##(2010-12#1)(2010-5#1)(2012-1#1)
pulmonary fibrosis with##3##3##(2006-10#1)(2007-2#1)(2010-5#1)
pulmonary fibrosis##61##2##(1994-3#1)(1994-6#2)(1995-7#1)(1995-8#1)(1996-5#2)(2005-8#9)(2006-10#6)(2006-8#2)(2007-11#1)(2007-2#1)(2007-3#1)(2008-1#1)(2009-10#1)(2010-10#1)(2010-12#7)(2010-5#3)(2010-6#3)(2010-9#1)(2011-3#2)(2012-1#4)(2012-12#8)(2012-2#2)(2013-8#1)
pulmonary fibrosis]##4##2##(2008-1#1)(2010-12#2)(2012-2#1)
pulmonary forms##2##2##(1990-10#1)(2006-8#1)
pulmonary function and##7##3##(2006-10#1)(2007-11#1)(2007-8#1)(2008-5#1)(2010-2#1)(2011-2#1)(2012-12#1)
pulmonary function deterioration##2##3##(2011-2#2)
pulmonary function measures##2##3##(2010-2#2)
pulmonary function test##7##3##(1994-6#2)(2007-2#1)(2007-3#1)(2010-12#1)(2010-8#2)
pulmonary function testing##4##3##(1997-3#1)(2005-8#1)(2006-10#1)(2012-2#1)
pulmonary function tests (PFTs)##2##4##(2008-8#1)(2012-1#1)
pulmonary function tests and##4##4##(1996-1#1)(1996-3#1)(2007-2#1)(2009-6#1)
pulmonary function tests##14##3##(1991-12#1)(1996-1#1)(1996-3#2)(2005-11#2)(2006-10#2)(2007-2#1)(2008-8#1)(2009-6#1)(2010-6#1)(2011-1#1)(2012-1#1)
pulmonary function##65##2##(1990-10#1)(1991-12#3)(1992-5#1)(1992-6#1)(1993-2#1)(1994-3#1)(1994-6#2)(1996-1#1)(1996-3#2)(1997-1#1)(1997-3#2)(1997-6#1)(2005-10#1)(2005-11#3)(2005-8#2)(2006-10#6)(2006-12#2)(2007-11#1)(2007-2#2)(2007-3#2)(2007-8#2)(2008-5#1)(2008-8#1)(2009-12#1)(2009-6#1)(2010-1#1)(2010-12#2)(2010-2#4)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
pulmonary functions in##2##3##(2012-2#2)
pulmonary functions##5##2##(2007-8#2)(2012-2#3)
pulmonary gas exchange##3##3##(1990-10#1)(2006-10#1)(2008-8#1)
pulmonary gas##4##2##(1990-10#1)(2006-10#1)(2007-9#1)(2008-8#1)
pulmonary gene##2##2##(2011-2#2)
pulmonary granulomas##2##2##(1997-3#1)(2008-5#1)
pulmonary haemorrhage##2##2##(1992-5#1)(2012-2#1)
pulmonary heart disease##3##3##(2011-2#3)
pulmonary heart##4##2##(2011-2#3)(2012-2#1)
pulmonary hemorrhage as##2##3##(2011-2#2)
pulmonary hemorrhage##5##2##(2005-8#1)(2006-10#1)(2008-1#1)(2011-2#2)
pulmonary hilar##2##2##(2008-1#1)(2010-8#1)
pulmonary hypertension (PH)##4##3##(2010-10#2)(2010-12#1)(2010-6#1)
pulmonary hypertension after pediatric heart##3##5##(2007-8#3)
pulmonary hypertension after##5##3##(2007-8#3)(2008-4#1)(2009-10#1)
pulmonary hypertension and other##2##4##(2009-10#1)(2012-2#1)
pulmonary hypertension and##7##3##(1993-8#1)(2006-10#1)(2008-5#1)(2008-7#1)(2009-10#1)(2012-12#1)(2012-2#1)
pulmonary hypertension in cardiac##2##4##(2006-10#1)(2011-2#1)
pulmonary hypertension in##11##3##(1991-2#1)(2005-9#1)(2006-10#3)(2006-4#1)(2008-1#1)(2009-6#2)(2011-2#1)(2013-7#1)
pulmonary hypertension is a##3##4##(1991-2#2)(2006-10#1)
pulmonary hypertension is##7##3##(1991-2#2)(2006-10#1)(2013-1#4)
pulmonary hypertension of the newborn##2##5##(2005-11#1)(2007-2#1)
pulmonary hypertension who##2##3##(2006-10#1)(2009-6#1)
pulmonary hypertension##127##2##(1991-2#5)(1991-6#1)(1992-7#1)(1993-8#1)(1994-3#1)(1994-5#1)(1996-11#1)(1996-3#1)(1996-7#1)(1997-5#2)(2005-11#4)(2005-9#5)(2006-10#15)(2006-4#1)(2007-10#1)(2007-2#1)(2007-8#8)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#3)(2009-10#4)(2009-4#2)(2009-6#5)(2010-10#8)(2010-12#4)(2010-5#5)(2010-6#12)(2011-2#2)(2011-3#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#11)(2013-7#2)
pulmonary hypertension]##9##2##(1994-6#1)(2010-6#8)
pulmonary hypoplasia##7##2##(1994-6#1)(1996-3#2)(2005-11#2)(2008-7#1)(2012-3#1)
pulmonary infarction##3##2##(2007-8#3)
pulmonary infection by##2##3##(1990-12#1)(2007-11#1)
pulmonary infection##13##2##(1990-12#1)(1991-11#1)(1991-3#1)(1995-7#1)(1996-11#1)(2007-11#1)(2007-12#2)(2007-7#1)(2010-10#1)(2010-12#2)(2012-2#1)
pulmonary infections##9##2##(1997-1#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
pulmonary infiltrate##2##2##(1990-6#1)(1993-6#1)
pulmonary infiltrates##5##2##(1990-9#1)(2005-12#1)(2008-5#1)(2010-11#1)(2010-12#1)
pulmonary inflammation##5##2##(1994-12#1)(2008-1#1)(2008-10#3)
pulmonary injury and##2##3##(1991-9#1)(1996-12#1)
pulmonary injury##7##2##(1991-9#1)(1996-12#1)(2005-8#1)(2006-10#2)(2007-11#2)
pulmonary involvement with##2##3##(1991-9#1)(2007-2#1)
pulmonary involvement##12##2##(1991-9#1)(2006-10#2)(2007-2#1)(2007-3#2)(2009-9#1)(2011-2#2)(2012-1#1)(2013-1#2)
pulmonary langerhans cell histiocytosis##2##4##(2005-11#1)(2012-3#1)
pulmonary lesion##3##2##(2006-10#1)(2007-8#1)(2012-1#1)
pulmonary lesions##17##2##(1991-8#1)(2006-10#1)(2007-10#1)(2008-5#1)(2010-8#5)(2012-1#1)(2012-2#1)(2013-8#6)
pulmonary lymphangiectasis##2##2##(1996-12#2)
pulmonary maintenance program##3##3##(2010-10#3)
pulmonary manifestations##3##2##(2005-8#1)(2006-10#1)(2012-3#1)
pulmonary masses##2##2##(2008-5#1)(2009-4#1)
pulmonary metastases and##3##3##(2010-3#2)(2013-8#1)
pulmonary metastases from##3##3##(2010-3#1)(2012-1#2)
pulmonary metastases in##3##3##(2010-3#2)(2013-1#1)
pulmonary metastases of##2##3##(2008-4#1)(2013-1#1)
pulmonary metastases##31##2##(1991-9#1)(1992-7#1)(2005-10#2)(2007-10#1)(2008-10#1)(2008-4#2)(2008-6#3)(2008-8#1)(2010-11#2)(2010-3#7)(2011-2#1)(2012-1#2)(2013-1#5)(2013-8#2)
pulmonary metastasis in##3##3##(2008-5#1)(2011-2#1)(2012-1#1)
pulmonary metastasis##14##2##(1992-8#1)(2006-8#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-3#2)(2011-1#2)(2011-2#1)(2012-1#2)(2013-7#1)
pulmonary metastatic nodules##2##3##(2010-12#1)(2011-1#1)
pulmonary metastatic##4##2##(2008-7#1)(2010-12#1)(2011-1#1)(2012-1#1)
pulmonary morbidity##2##2##(2006-10#1)(2007-8#1)
pulmonary mucormycosis##3##2##(2013-1#2)(2013-8#1)
pulmonary myxoid liposarcoma##2##3##(2007-8#2)
pulmonary nocardiosis##2##2##(1993-11#1)(2007-7#1)
pulmonary nodule##5##2##(1990-2#1)(2006-10#1)(2007-8#2)(2008-1#1)
pulmonary nodules and##2##3##(2008-6#1)(2012-12#1)
pulmonary nodules are##2##3##(2008-10#1)(2008-6#1)
pulmonary nodules##16##2##(2007-12#1)(2007-8#2)(2008-10#2)(2008-6#6)(2012-12#2)(2012-3#2)(2013-7#1)
pulmonary obstruction##3##2##(1991-4#1)(2008-10#1)(2011-2#1)
pulmonary oedema and##2##3##(2006-1#1)(2006-4#1)
pulmonary oedema##24##2##(1991-11#1)(1991-9#2)(1994-6#1)(1995-11#1)(1995-4#1)(2006-1#1)(2006-10#4)(2006-4#1)(2010-7#7)(2011-2#1)(2012-1#2)(2012-2#1)(2013-8#1)
pulmonary or##6##2##(2007-10#1)(2007-9#1)(2008-6#1)(2010-12#2)(2011-1#1)
pulmonary origin##4##2##(1992-12#1)(1994-7#1)(2011-2#2)
pulmonary oxygen##2##2##(2008-2#2)
pulmonary perfusion##8##2##(1993-2#3)(2005-8#1)(2006-10#2)(2007-11#1)(2007-9#1)
pulmonary pressure##4##2##(2010-10#2)(2010-6#2)
pulmonary rehabilitation in##2##3##(2011-2#2)
pulmonary rehabilitation programmes##2##3##(1997-8#1)(2011-2#1)
pulmonary rehabilitation##23##2##(1997-8#1)(2007-6#2)(2010-1#2)(2010-5#4)(2011-2#10)(2012-12#3)(2013-7#1)
pulmonary resection##10##2##(2007-8#8)(2007-9#1)(2010-8#1)
pulmonary resections in##2##3##(2007-8#1)(2008-10#1)
pulmonary resections##6##2##(2007-8#2)(2008-10#3)(2010-8#1)
pulmonary respiration##2##2##(1992-9#1)(2005-7#1)
pulmonary sarcoidosis##11##2##(2007-10#3)(2007-11#2)(2008-7#4)(2010-6#2)
pulmonary sequestration##4##2##(2007-8#2)(2010-12#2)
pulmonary status##3##2##(2007-8#1)(2013-1#2)
pulmonary stenosis and##2##3##(2009-4#1)(2013-8#1)
pulmonary stenosis##6##2##(1993-10#1)(1993-12#1)(2007-7#1)(2007-8#1)(2009-4#1)(2013-8#1)
pulmonary surfactant and##2##3##(2006-6#1)(2011-1#1)
pulmonary surfactant in##2##3##(1996-12#1)(2006-6#1)
pulmonary surfactant is##2##3##(2006-6#1)(2008-8#1)
pulmonary surfactant##15##2##(1993-3#2)(1994-12#1)(1994-3#1)(1996-12#2)(1996-5#2)(2006-6#3)(2008-5#1)(2008-8#1)(2010-7#1)(2011-1#1)
pulmonary symptoms##3##2##(1993-5#1)(2006-10#1)(2006-5#1)
pulmonary syndrome##3##2##(2011-2#3)
pulmonary system##2##2##(2012-3#1)(2013-8#1)
pulmonary thromboembolism (PTE)##2##3##(2008-1#1)(2008-10#1)
pulmonary thromboembolism in a patient with hereditary spherocytosis##2##8##(2008-12#2)
pulmonary thromboembolism##9##2##(2008-1#1)(2008-10#1)(2008-12#2)(2008-6#1)(2010-6#2)(2011-2#1)(2013-7#1)
pulmonary thromboembolism]##2##2##(2008-1#1)(2013-7#1)
pulmonary tissue##5##2##(1993-2#1)(1994-6#2)(2007-12#2)
pulmonary toxicity##3##2##(1990-5#1)(2012-2#2)
pulmonary tuberculosis (PTB)##2##3##(2011-1#1)(2013-8#1)
pulmonary tuberculosis and##4##3##(1996-11#1)(1996-4#1)(2010-5#1)(2013-1#1)
pulmonary tuberculosis in children##2##4##(2011-2#2)
pulmonary tuberculosis in##5##3##(1995-3#1)(2007-12#1)(2007-8#1)(2011-2#2)
pulmonary tuberculosis patients##4##3##(2008-7#1)(2011-1#2)(2013-1#1)
pulmonary tuberculosis##53##2##(1995-2#1)(1995-3#1)(1996-11#1)(1996-4#1)(1996-6#1)(1997-3#1)(2006-10#1)(2006-6#4)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#5)(2007-8#2)(2008-12#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#5)(2011-11#1)(2011-2#3)(2012-2#3)(2013-1#9)(2013-7#1)(2013-8#1)
pulmonary tuberculosis]##3##2##(1992-2#1)(2006-6#1)(2008-4#1)
pulmonary tumor##3##2##(2012-11#1)(2013-7#2)
pulmonary tumors were##2##3##(1993-9#1)(2008-7#1)
pulmonary tumors##4##2##(1992-4#1)(1993-9#1)(2007-5#1)(2008-7#1)
pulmonary tumours were##2##3##(2007-8#2)
pulmonary tumours##4##2##(2007-8#2)(2008-2#1)(2008-5#1)
pulmonary valve stenosis##2##3##(1993-10#1)(1996-12#1)
pulmonary valve##16##2##(1993-10#1)(1996-12#1)(2007-8#4)(2008-12#1)(2008-4#2)(2009-7#1)(2009-9#3)(2011-1#1)(2012-2#1)(2013-1#1)
pulmonary valvotomy##2##2##(2008-11#2)
pulmonary valvuloplasty##2##2##(2009-4#2)
pulmonary vascular bed##7##3##(1991-2#4)(1991-8#1)(2007-11#1)(2008-10#1)
pulmonary vascular disease##4##3##(1993-3#1)(2007-11#1)(2010-10#1)(2010-6#1)
pulmonary vascular diseases##2##3##(2005-11#1)(2006-10#1)
pulmonary vascular remodeling##2##3##(2008-1#2)
pulmonary vascular resistance and##3##4##(2005-11#1)(2007-8#1)(2010-10#1)
pulmonary vascular resistance##18##3##(1990-11#1)(1991-2#1)(1991-9#2)(1997-5#1)(2005-1#1)(2005-11#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#2)(2008-4#1)(2010-10#3)(2010-6#1)(2012-2#1)
pulmonary vascular response##2##3##(1992-2#1)(1993-3#1)
pulmonary vascular##50##2##(1990-11#1)(1991-2#6)(1991-8#1)(1991-9#2)(1992-2#1)(1993-3#4)(1994-12#1)(1997-5#1)(2005-1#1)(2005-11#2)(2006-10#2)(2007-11#4)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#1)(2009-10#1)(2010-10#4)(2010-6#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
pulmonary vasculature##14##2##(1993-10#1)(1994-12#1)(1997-1#1)(2005-8#1)(2006-10#2)(2007-11#2)(2007-8#1)(2010-10#1)(2010-5#1)(2013-1#3)
pulmonary vasculitides##4##2##(2005-8#3)(2012-1#1)
pulmonary vasculitis##2##2##(2006-10#1)(2012-1#1)
pulmonary vasoconstriction##5##2##(2006-10#4)(2008-10#1)
pulmonary vasodilators##2##2##(2010-12#1)(2010-6#1)
pulmonary vein isolation##5##3##(2007-8#1)(2008-10#1)(2009-10#1)(2011-2#2)
pulmonary vein myocardium##4##3##(2013-1#4)
pulmonary vein##25##2##(1994-8#1)(2007-8#8)(2008-10#1)(2009-10#3)(2009-7#1)(2010-4#1)(2011-2#5)(2013-1#4)(2013-7#1)
pulmonary veins myocardium##2##3##(2013-1#2)
pulmonary veins were##3##3##(2007-8#1)(2008-4#1)(2013-7#1)
pulmonary veins##16##2##(1997-1#1)(2006-8#1)(2007-8#5)(2008-11#1)(2008-4#1)(2009-10#1)(2013-1#4)(2013-7#2)
pulmonary veno-occlusive disease##3##3##(2005-11#1)(2010-10#2)
pulmonary venous obstruction##5##3##(2007-8#4)(2008-4#1)
pulmonary venous##21##2##(1997-1#1)(2007-8#13)(2008-10#1)(2008-11#4)(2008-4#1)(2010-9#1)
pulmonary ventilation with##2##3##(1991-1#1)(2009-2#1)
pulmonary vessels##8##2##(2005-8#1)(2007-8#1)(2007-9#1)(2008-1#1)(2011-1#1)(2012-12#2)(2012-3#1)
pulmonary##2078##1##(1990-10#8)(1990-11#1)(1990-12#6)(1990-2#2)(1990-3#3)(1990-5#3)(1990-6#4)(1990-7#2)(1990-9#2)(1991-1#1)(1991-10#4)(1991-11#11)(1991-12#10)(1991-2#15)(1991-3#7)(1991-4#5)(1991-5#1)(1991-6#4)(1991-8#10)(1991-9#17)(1992-1#2)(1992-10#4)(1992-11#4)(1992-12#6)(1992-2#13)(1992-3#7)(1992-4#3)(1992-5#6)(1992-6#5)(1992-7#2)(1992-8#3)(1992-9#3)(1993-1#1)(1993-10#5)(1993-11#2)(1993-12#7)(1993-2#10)(1993-3#13)(1993-5#3)(1993-6#6)(1993-7#2)(1993-8#3)(1993-9#5)(1994-10#1)(1994-11#1)(1994-12#8)(1994-2#4)(1994-3#18)(1994-5#5)(1994-6#17)(1994-7#3)(1994-8#6)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#3)(1995-4#1)(1995-6#5)(1995-7#2)(1995-8#1)(1996-1#4)(1996-11#3)(1996-12#14)(1996-2#4)(1996-3#15)(1996-4#4)(1996-5#6)(1996-6#6)(1996-7#1)(1996-9#1)(1997-1#8)(1997-2#6)(1997-3#11)(1997-4#5)(1997-5#7)(1997-6#3)(1997-7#3)(1997-8#11)(2004-11#1)(2005-1#3)(2005-10#23)(2005-11#27)(2005-12#1)(2005-7#1)(2005-8#31)(2005-9#8)(2006-1#1)(2006-10#125)(2006-12#6)(2006-2#2)(2006-4#9)(2006-5#3)(2006-6#13)(2006-7#2)(2006-8#11)(2006-9#3)(2007-1#1)(2007-10#19)(2007-11#35)(2007-12#16)(2007-2#17)(2007-3#13)(2007-4#2)(2007-5#1)(2007-6#6)(2007-7#19)(2007-8#169)(2007-9#31)(2008-1#34)(2008-10#42)(2008-11#33)(2008-12#12)(2008-2#5)(2008-3#6)(2008-4#34)(2008-5#23)(2008-6#22)(2008-7#36)(2008-8#9)(2008-9#10)(2009-1#3)(2009-10#18)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#11)(2009-5#5)(2009-6#10)(2009-7#4)(2009-8#3)(2009-9#5)(2010-1#10)(2010-10#62)(2010-11#4)(2010-12#42)(2010-2#9)(2010-3#14)(2010-4#3)(2010-5#26)(2010-6#50)(2010-7#20)(2010-8#22)(2010-9#13)(2011-1#20)(2011-11#5)(2011-12#5)(2011-2#113)(2011-3#11)(2012-1#25)(2012-11#6)(2012-12#44)(2012-2#47)(2012-3#21)(2013-1#80)(2013-7#33)(2013-8#36)
pulmonary/mediastinal##2##1##(2012-2#2)
pulmonates##2##1##(2008-9#2)
pulmonic##3##1##(1993-10#1)(2007-8#1)(2012-2#1)
pulmonologists##3##1##(2005-8#1)(2011-1#1)(2011-2#1)
pulmonology##5##1##(2007-9#1)(2010-9#1)(2013-1#3)
pulp and paper mill##2##4##(2008-10#1)(2008-5#1)
pulp and paper##3##3##(2008-10#2)(2008-5#1)
pulp and##7##2##(2006-12#1)(2007-2#1)(2008-10#3)(2008-5#2)
pulp at##2##2##(2008-5#2)
pulp chambers##3##2##(1991-2#1)(2007-2#1)(2013-8#1)
pulp exposure##2##2##(2011-2#1)(2012-2#1)
pulp fibers##3##2##(2008-3#3)
pulp for##2##2##(1996-6#1)(2008-3#1)
pulp in##3##2##(2008-5#1)(2013-8#2)
pulp is##2##2##(2008-10#1)(2011-2#1)
pulp mill##4##2##(1992-6#1)(2008-11#1)(2008-5#2)
pulp mill-based##2##2##(2008-5#2)
pulp mills##2##2##(2008-5#2)
pulp narrowing##2##2##(2013-8#2)
pulp of the##2##3##(1994-5#1)(2008-7#1)
pulp of##4##2##(1994-5#1)(2008-10#1)(2008-7#1)(2013-8#1)
pulp production##2##2##(2008-5#2)
pulp response to a##2##4##(2007-2#2)
pulp response##3##2##(1990-12#1)(2007-2#2)
pulp stones##3##2##(2013-8#3)
pulp therapy##3##2##(2011-2#2)(2012-12#1)
pulp tissue##3##2##(2005-10#1)(2012-2#1)(2013-1#1)
pulp was##3##2##(2008-6#2)(2010-12#1)
pulp with##2##2##(2008-5#2)
pulp##132##1##(1990-12#1)(1990-9#1)(1991-2#3)(1992-6#2)(1994-5#10)(1995-1#1)(1996-2#1)(1996-6#1)(1997-6#1)(2004-4#1)(2005-10#3)(2006-12#1)(2006-8#2)(2007-2#4)(2008-10#14)(2008-11#1)(2008-3#5)(2008-5#24)(2008-6#7)(2008-7#3)(2008-9#1)(2009-12#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#8)(2012-12#5)(2012-2#4)(2013-1#2)(2013-8#20)
pulp)##2##1##(2008-5#1)(2013-1#1)
pulpal##9##1##(1990-4#2)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
pulping##7##1##(1992-6#1)(2006-12#1)(2008-5#5)
pulposus herniations##2##2##(2006-7#2)
pulposus##19##1##(1997-2#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-11#2)(2007-7#1)(2007-8#4)(2009-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
pulpotomies##2##1##(2011-2#1)(2012-2#1)
pulpotomized primary molars##4##3##(2008-5#4)
pulpotomy##12##1##(1990-3#1)(2006-8#1)(2008-5#2)(2011-2#5)(2012-2#3)
pulps were##3##2##(2008-5#3)
pulps##8##1##(2008-10#1)(2008-5#5)(2012-2#1)(2013-8#1)
pulsatile blood##2##2##(1993-2#1)(2007-8#1)
pulsatile flow##2##2##(2008-11#1)(2008-7#1)
pulsatile hydrodynamics##2##2##(2008-7#2)
pulsatile pressure##2##2##(2007-12#1)(2008-3#1)
pulsatile secretion##3##2##(1990-9#1)(1995-9#1)(1997-7#1)
pulsatile tinnitus##6##2##(2006-12#2)(2007-9#4)
pulsatile##39##1##(1990-9#1)(1993-2#1)(1994-11#1)(1995-10#2)(1995-3#1)(1995-9#1)(1997-1#1)(1997-2#2)(1997-7#1)(2005-8#1)(2006-12#2)(2007-12#1)(2007-8#4)(2007-9#4)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#5)(2009-1#1)(2009-9#1)(2010-6#2)(2010-8#1)(2012-3#1)
pulsatility index (PI)##2##3##(1992-1#1)(1996-6#1)
pulsatility index in the affected##2##5##(2007-10#2)
pulsatility index##7##2##(1992-1#2)(1996-6#1)(2007-10#3)(2011-2#1)
pulsatility of##3##2##(1990-9#1)(1994-6#1)(2007-7#1)
pulsatility##15##1##(1990-9#1)(1992-1#2)(1994-3#1)(1994-6#4)(1996-6#1)(2007-10#3)(2007-7#1)(2011-2#1)(2013-1#1)
pulsating##7##1##(1996-2#1)(1997-3#1)(2007-11#1)(2008-12#1)(2008-8#1)(2009-3#1)(2009-7#1)
pulsation in##2##2##(2007-11#1)(2008-7#1)
pulsation##6##1##(2007-11#2)(2008-10#1)(2008-7#2)(2008-9#1)
pulsations and##2##2##(2007-11#2)
pulsations in class-B solid-state lasers##2##5##(2007-11#2)
pulsations in##4##2##(2007-11#3)(2011-8#1)
pulsations of##3##2##(2007-11#2)(2008-3#1)
pulsations that##2##2##(2007-11#2)
pulsations##17##1##(1993-1#1)(2006-5#1)(2007-11#10)(2007-12#2)(2008-2#1)(2008-3#1)(2011-8#1)
pulse ECT##3##2##(2012-12#3)
pulse allows the##2##3##(2007-11#1)(2007-12#1)
pulse amperometry##2##2##(2008-10#2)
pulse amplification##14##2##(2007-11#4)(2007-12#2)(2008-2#2)(2008-3#6)
pulse amplitude and##2##3##(1997-2#1)(2008-10#1)
pulse amplitude of##3##3##(2008-10#3)
pulse amplitude##13##2##(1997-2#2)(2007-12#2)(2008-10#8)(2008-3#1)
pulse and a##5##3##(1994-12#1)(2007-12#4)
pulse and its##2##3##(2007-12#1)(2008-2#1)
pulse and on##2##3##(2008-2#1)(2008-3#1)
pulse and the##10##3##(2007-11#3)(2007-12#3)(2008-2#1)(2008-3#2)(2009-10#1)
pulse and##37##2##(1992-12#1)(1993-2#1)(1994-12#1)(2007-11#5)(2007-12#9)(2007-3#1)(2008-1#1)(2008-10#9)(2008-2#3)(2008-3#4)(2009-10#1)(2011-2#1)
pulse anodic stripping voltammetric##4##4##(2008-10#4)
pulse anodic stripping voltammetry##20##4##(2008-10#19)(2010-2#1)
pulse anodic stripping##25##3##(2008-10#23)(2010-2#1)(2013-8#1)
pulse are##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
pulse as well as##2##4##(2007-12#2)
pulse as##3##2##(2007-11#1)(2007-12#2)
pulse asymmetry##2##2##(2007-12#2)
pulse at 800 nm##3##4##(2007-11#1)(2007-12#1)(2010-1#1)
pulse at a##2##3##(2007-12#1)(2008-3#1)
pulse at the##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
pulse at##13##2##(1995-2#1)(2007-11#4)(2007-12#4)(2008-1#1)(2008-3#2)(2010-1#1)
pulse breakup##2##2##(2007-11#1)(2008-3#1)
pulse broadening##3##2##(2007-12#2)(2008-2#1)
pulse by a grating##2##4##(2007-11#1)(2007-12#1)
pulse by a##4##3##(2007-11#1)(2007-12#3)
pulse by use of##3##4##(2007-11#1)(2007-12#2)
pulse by##10##2##(2007-11#3)(2007-12#6)(2008-2#1)
pulse can be##4##3##(2007-12#1)(2008-1#1)(2008-3#2)
pulse can##5##2##(2007-12#1)(2008-1#2)(2008-3#2)
pulse cathodic stripping voltammetry##5##4##(2008-10#5)
pulse cathodic stripping##8##3##(2008-10#8)
pulse cathodic##9##2##(2008-10#9)
pulse characteristics##3##2##(2007-12#3)
pulse characterization at 1##2##4##(2007-11#1)(2007-12#1)
pulse characterization is##2##3##(2007-11#2)
pulse characterization##7##2##(2007-11#5)(2007-12#2)
pulse chase##4##2##(1991-5#2)(1992-12#1)(2011-2#1)
pulse combination##2##2##(2009-10#2)
pulse compression and##2##3##(2007-11#1)(2007-12#1)
pulse compression by##4##3##(2007-11#1)(2007-12#2)(2008-1#1)
pulse compression in##6##3##(2007-11#3)(2007-12#2)(2008-1#1)
pulse compression to##2##3##(2007-11#2)
pulse compression##26##2##(2007-11#8)(2007-12#11)(2008-1#5)(2008-2#1)(2008-3#1)
pulse compressor##8##2##(2007-11#4)(2007-12#2)(2008-2#2)
pulse contrast##2##2##(2007-11#1)(2010-1#1)
pulse corticosteroid therapy##2##3##(1994-2#1)(2006-10#1)
pulse current##2##2##(2008-10#2)
pulse cyclophosphamide##3##2##(1993-2#1)(2007-7#2)
pulse data##2##2##(2007-12#1)(2008-11#1)
pulse delivery##2##2##(2007-11#1)(2007-12#1)
pulse differential voltammetry##2##3##(2008-10#2)
pulse differential##3##2##(2008-10#3)
pulse distortion##2##2##(2007-11#2)
pulse duration and a##3##4##(2007-11#2)(2008-3#1)
pulse duration and the##3##4##(2007-11#1)(2007-12#2)
pulse duration and wavelength##2##4##(2007-11#2)
pulse duration and##14##3##(2007-11#8)(2007-12#4)(2008-1#1)(2008-3#1)
pulse duration at##3##3##(2007-12#2)(2008-3#1)
pulse duration by##2##3##(2007-11#1)(2007-12#1)
pulse duration from##4##3##(2007-12#3)(2008-2#1)
pulse duration in##4##3##(2007-11#1)(2008-1#1)(2008-3#2)
pulse duration is##6##3##(1991-2#1)(2007-12#2)(2008-3#2)(2009-10#1)
pulse duration of 0##2##4##(2007-8#1)(2008-2#1)
pulse duration of 120 ns##2##5##(2008-3#2)
pulse duration of##18##3##(2007-11#2)(2007-12#5)(2007-8#1)(2008-11#1)(2008-2#3)(2008-3#6)
pulse duration was##2##3##(1991-2#1)(1994-3#1)
pulse duration were##4##3##(2008-3#1)(2009-8#1)(2010-8#2)
pulse duration##84##2##(1991-2#4)(1993-11#1)(1994-3#1)(2007-11#13)(2007-12#26)(2007-8#1)(2008-1#5)(2008-10#1)(2008-11#1)(2008-2#8)(2008-3#16)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#2)(2010-8#2)
pulse durations in the##2##4##(2006-5#1)(2007-12#1)
pulse durations in##3##3##(2006-5#1)(2007-11#1)(2007-12#1)
pulse durations of less than##2##5##(2008-3#2)
pulse durations of##8##3##(2007-12#4)(2008-1#1)(2008-2#1)(2008-3#2)
pulse durations##24##2##(2006-12#1)(2006-5#1)(2007-11#6)(2007-12#8)(2008-1#2)(2008-2#2)(2008-3#3)(2009-4#1)
pulse during##3##2##(2007-11#1)(2008-1#1)(2011-2#1)
pulse dynamics##2##2##(2007-12#2)
pulse energies as high as##2##5##(2007-12#2)
pulse energies as##3##3##(2007-11#1)(2007-12#2)
pulse energies of 1 and 10 mJ##2##7##(2008-2#2)
pulse energies of as much as 20##2##7##(2007-12#1)(2008-1#1)
pulse energies of as much as##3##6##(2007-12#1)(2008-1#2)
pulse energies of##13##3##(2007-12#8)(2008-1#3)(2008-2#2)
pulse energies##29##2##(2007-11#2)(2007-12#17)(2008-1#3)(2008-2#4)(2008-3#3)
pulse energy and the##3##4##(2007-11#2)(2008-3#1)
pulse energy and##13##3##(1992-12#1)(2007-11#5)(2007-12#2)(2008-3#5)
pulse energy at a##3##4##(2007-12#2)(2008-2#1)
pulse energy at##4##3##(2007-12#3)(2008-2#1)
pulse energy is##3##3##(2007-11#1)(2007-12#2)
pulse energy of 1##2##4##(2007-12#1)(2008-2#1)
pulse energy of 5##2##4##(2007-12#1)(2008-2#1)
pulse energy of as much as##2##6##(2007-11#1)(2008-2#1)
pulse energy of##18##3##(2007-11#3)(2007-12#10)(2008-1#1)(2008-2#3)(2008-3#1)
pulse energy to the##2##4##(2007-12#1)(2008-2#1)
pulse energy to##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
pulse energy was##4##3##(2007-12#3)(2008-3#1)
pulse energy##73##2##(1992-12#1)(2007-11#14)(2007-12#35)(2008-1#2)(2008-2#7)(2008-3#12)(2009-4#2)
pulse erasure##2##2##(2007-12#2)
pulse evolution##3##2##(2007-12#2)(2008-1#1)
pulse excitation##2##2##(2007-11#1)(2008-3#1)
pulse fluence##2##2##(2007-11#1)(2007-12#1)
pulse followed##2##2##(1997-5#1)(2009-10#1)
pulse for##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
pulse frequency delivered by the##2##5##(1990-10#2)
pulse frequency##12##2##(1990-10#3)(1992-11#2)(1992-12#1)(1994-3#1)(2008-10#1)(2008-5#1)(2013-1#3)
pulse from a##3##3##(2007-12#2)(2008-3#1)
pulse from the##2##3##(2008-3#2)
pulse from##7##2##(1991-9#1)(2007-11#1)(2007-12#2)(2008-3#3)
pulse generated by##2##3##(2007-11#1)(2007-12#1)
pulse generated##3##2##(2007-11#1)(2007-12#2)
pulse generation at##2##3##(2007-11#1)(2008-1#1)
pulse generation by##4##3##(2007-12#4)
pulse generation in the##2##4##(2007-12#2)
pulse generation in##4##3##(2007-12#3)(2008-1#1)
pulse generation##18##2##(2007-11#3)(2007-12#13)(2008-1#2)
pulse generator##2##2##(2006-6#1)(2008-11#1)
pulse height##3##2##(2008-10#3)
pulse in a##7##3##(2007-11#2)(2007-12#5)
pulse in an##2##3##(2007-11#1)(2007-12#1)
pulse in the##11##3##(2006-5#1)(2007-11#4)(2007-12#4)(2008-10#1)(2008-3#1)
pulse in##26##2##(2006-5#1)(2007-11#9)(2007-12#12)(2008-10#1)(2008-2#1)(2008-3#2)
pulse increases##2##2##(2008-2#1)(2008-3#1)
pulse intensities##2##2##(1990-10#1)(2007-12#1)
pulse intensity##6##2##(2007-11#2)(2007-12#3)(2008-3#1)
pulse interactions in dispersion-managed##3##4##(2007-11#2)(2007-12#1)
pulse interactions##4##2##(2007-11#3)(2007-12#1)
pulse into##4##2##(2007-11#1)(2007-12#3)
pulse irradiation of##2##3##(2008-8#1)(2008-9#1)
pulse irradiation##3##2##(2008-8#2)(2008-9#1)
pulse is##37##2##(1991-5#1)(2007-11#10)(2007-12#15)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#4)(2008-3#3)
pulse itself##2##2##(2007-11#1)(2008-3#1)
pulse labeling##3##2##(1995-5#1)(1997-4#1)(2011-2#1)
pulse laser##3##2##(2008-3#1)(2008-5#2)
pulse lasers##3##2##(2007-12#3)
pulse length of##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
pulse length##11##2##(1990-5#1)(1991-5#1)(2007-12#5)(2008-2#1)(2008-3#2)(2012-2#1)
pulse lengths of##2##3##(2008-1#1)(2008-2#1)
pulse lengths##5##2##(2007-12#3)(2008-1#1)(2008-2#1)
pulse measurement##3##2##(2007-12#1)(2012-11#2)
pulse mode##5##2##(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)
pulse modulation##2##2##(2007-12#1)(2008-10#1)
pulse nebulization##3##2##(2005-4#3)
pulse number##3##2##(2007-12#1)(2008-10#1)(2009-9#1)
pulse numbers##2##2##(2012-2#2)
pulse of the##4##3##(2007-12#1)(2008-2#1)(2008-7#1)(2013-1#1)
pulse of##22##2##(1991-6#1)(1992-9#1)(1993-8#1)(1994-5#1)(1994-6#1)(2007-11#1)(2007-12#6)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-7#2)(2013-1#1)
pulse on the##4##3##(2006-5#1)(2007-12#1)(2008-2#1)(2008-3#1)
pulse or##2##2##(2007-12#1)(2008-4#1)
pulse oximeter##2##2##(1993-1#1)(2007-1#1)
pulse oximetry##15##2##(1993-1#3)(1993-7#1)(2006-1#1)(2006-10#4)(2007-12#1)(2007-8#1)(2008-2#1)(2009-5#1)(2010-4#1)(2010-9#1)
pulse pairs##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
pulse parameters##3##2##(2007-11#1)(2007-12#2)
pulse peak power##3##3##(2007-12#1)(2008-3#2)
pulse per##2##2##(2008-10#1)(2008-5#1)
pulse permits##2##2##(2007-11#1)(2007-12#1)
pulse phase in a##2##4##(2007-12#2)
pulse phase##4##2##(2007-12#4)
pulse polarographic determination##8##3##(2008-10#8)
pulse polarographic##17##2##(2008-10#16)(2010-2#1)
pulse polarography (DPP)##7##3##(2008-10#7)
pulse polarography##24##2##(2008-10#22)(2010-2#2)
pulse power##2##2##(2007-11#2)
pulse pressure (PP)##3##3##(2007-10#1)(2008-4#1)(2011-1#1)
pulse pressure##18##2##(1990-5#2)(1990-8#1)(1992-8#1)(2006-5#1)(2007-10#5)(2007-7#3)(2008-4#1)(2008-7#1)(2011-1#3)
pulse pressure)##2##2##(1993-3#1)(2012-3#1)
pulse pressures##2##2##(2005-9#1)(2012-2#1)
pulse programming##2##2##(2007-11#1)(2007-12#1)
pulse propagating in##3##3##(2007-11#3)
pulse propagating##7##2##(2007-11#5)(2007-12#1)(2008-2#1)
pulse propagation in a##3##4##(2007-11#1)(2007-12#1)(2008-1#1)
pulse propagation in optical fibers##2##5##(2007-11#1)(2008-3#1)
pulse propagation in optical##3##4##(2007-11#1)(2008-1#1)(2008-3#1)
pulse propagation in##13##3##(2007-11#4)(2007-12#5)(2008-1#3)(2008-3#1)
pulse propagation##20##2##(2007-11#6)(2007-12#8)(2008-1#3)(2008-3#3)
pulse proteolysis##5##2##(2008-4#5)
pulse radiolysis and laser photolysis##2##5##(2005-4#2)
pulse radiolysis and laser##3##4##(2005-4#3)
pulse radiolysis and##4##3##(2005-4#3)(2008-10#1)
pulse radiolysis technique##3##3##(2006-10#1)(2008-9#2)
pulse radiolysis##16##2##(1990-2#2)(1997-1#1)(2005-4#3)(2006-10#4)(2008-10#1)(2008-4#1)(2008-9#3)(2010-5#1)
pulse rate and respiratory rate##2##5##(2008-4#2)
pulse rate and##3##3##(2008-4#2)(2009-9#1)
pulse rate training##3##3##(1993-2#3)
pulse rate##18##2##(1990-5#1)(1990-8#1)(1993-2#5)(1996-6#1)(2005-12#1)(2006-11#1)(2008-11#1)(2008-4#2)(2009-5#1)(2009-8#1)(2009-9#2)(2010-5#1)
pulse rates##3##2##(2007-12#1)(2009-9#2)
pulse regimens##2##2##(2009-10#2)
pulse relative to##3##3##(2007-12#3)
pulse repetition frequency of##3##4##(2007-12#3)
pulse repetition frequency##9##3##(2007-12#6)(2008-3#3)
pulse repetition rate of##4##4##(2007-11#1)(2007-12#1)(2008-3#2)
pulse repetition rate##7##3##(2007-11#2)(2007-12#3)(2008-3#2)
pulse repetition##16##2##(2007-11#2)(2007-12#9)(2008-3#5)
pulse response##3##2##(2008-10#1)(2008-2#2)
pulse routing in a##2##4##(2007-11#1)(2007-12#1)
pulse routing##3##2##(2007-11#2)(2007-12#1)
pulse self-frequency shift##2##3##(2008-1#2)
pulse separation##2##2##(2007-12#2)
pulse sequence is##2##3##(2012-2#1)(2012-8#1)
pulse sequence##17##2##(1997-8#3)(2006-8#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-10#1)(2011-1#1)(2012-2#1)(2012-8#1)(2013-1#1)
pulse sequences with##2##3##(2007-12#1)(2009-9#1)
pulse sequences##15##2##(1990-10#1)(1997-8#1)(2006-1#1)(2007-11#2)(2007-12#2)(2007-4#1)(2009-9#3)(2010-9#1)(2012-2#1)(2012-7#1)(2013-1#1)
pulse shape##13##2##(2007-11#2)(2007-12#6)(2008-1#3)(2008-2#1)(2008-3#1)
pulse shaper##17##2##(2007-11#3)(2007-12#10)(2008-1#1)(2012-11#3)
pulse shapes##2##2##(2006-11#1)(2007-12#1)
pulse shaping by##2##3##(2007-11#1)(2007-12#1)
pulse shaping in##2##3##(2007-12#2)
pulse shaping##13##2##(2007-11#6)(2007-12#7)
pulse shortening##4##2##(2007-11#1)(2007-12#1)(2008-2#2)
pulse spectrum is##2##3##(2008-3#2)
pulse spectrum##10##2##(2007-12#6)(2008-3#4)
pulse splitting##2##2##(2007-12#2)
pulse spreading##2##2##(2007-12#2)
pulse stimulation##2##2##(1993-2#1)(1997-7#1)
pulse stream##3##2##(2007-12#3)
pulse stretcher##3##2##(2007-12#2)(2008-1#1)
pulse stretching##3##2##(2008-3#3)
pulse technique##2##2##(1993-3#1)(2008-10#1)
pulse that could##2##3##(1991-8#1)(2008-11#1)
pulse that is##2##3##(2007-12#1)(2008-2#1)
pulse that##10##2##(1991-8#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)
pulse therapy in##4##3##(2006-4#1)(2007-7#3)
pulse therapy with##3##3##(2006-4#1)(2010-12#1)(2013-1#1)
pulse therapy##18##2##(2006-10#1)(2006-4#2)(2007-7#8)(2007-8#2)(2008-1#3)(2010-12#1)(2013-1#1)
pulse time##2##2##(1992-3#1)(2008-10#1)
pulse to the##2##3##(2007-12#1)(2008-1#1)
pulse to##11##2##(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#2)(2008-2#2)(2008-4#1)
pulse train and##2##3##(2007-12#1)(2008-2#1)
pulse train at##4##3##(2007-11#1)(2007-12#2)(2008-1#1)
pulse train emitted by a##2##5##(2007-11#1)(2007-12#1)
pulse train from a##2##4##(2007-11#1)(2007-12#1)
pulse train generated by##3##4##(2007-12#3)
pulse train generated##4##3##(2007-12#4)
pulse train in##3##3##(2007-11#1)(2007-12#2)
pulse train##38##2##(1991-2#1)(2006-5#1)(2007-11#8)(2007-12#22)(2008-1#4)(2008-2#1)(2008-3#1)
pulse trains at a##2##4##(2007-12#1)(2008-1#1)
pulse trains at##4##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)
pulse trains from##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
pulse trains in##2##3##(2007-11#1)(2007-12#1)
pulse trains with##3##3##(2007-12#2)(2008-3#1)
pulse trains##27##2##(2007-11#7)(2007-12#11)(2008-1#2)(2008-2#1)(2008-3#5)(2011-1#1)
pulse trapping##2##2##(2007-11#2)
pulse used##2##2##(2007-12#1)(2009-10#1)
pulse voltammetric determination of##2##4##(2008-10#2)
pulse voltammetric determination##3##3##(2008-10#3)
pulse voltammetric##10##2##(2008-10#10)
pulse voltammetry (DPV)##11##3##(2008-10#11)
pulse voltammetry##27##2##(1994-8#1)(1995-5#1)(2008-10#24)(2009-3#1)
pulse volume##2##2##(2008-3#1)(2011-2#1)
pulse was##11##2##(1994-6#1)(1996-1#1)(2005-4#1)(2007-11#1)(2007-12#5)(2008-1#1)(2009-10#1)
pulse wave velocity (PWV)##2##4##(2007-10#1)(2013-3#1)
pulse wave velocity##4##3##(2007-10#2)(2010-12#1)(2013-3#1)
pulse wave##9##2##(1990-9#1)(2007-10#2)(2007-9#1)(2008-5#2)(2010-12#1)(2013-3#1)(2013-8#1)
pulse were##5##2##(2007-11#1)(2007-7#1)(2008-1#1)(2008-3#1)(2013-8#1)
pulse width ECT##3##3##(2012-12#3)
pulse width and amplitude jitter noises of##2##7##(2007-12#2)
pulse width and##6##3##(2007-12#4)(2008-1#1)(2008-3#1)
pulse width as##2##3##(2008-1#1)(2008-3#1)
pulse width by##2##3##(2008-1#1)(2008-10#1)
pulse width in##2##3##(2007-11#2)
pulse width is##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
pulse width jitter##2##3##(2007-12#2)
pulse width of 170##2##4##(2007-12#2)
pulse width of the##3##4##(2007-12#1)(2008-2#1)(2012-12#1)
pulse width of##15##3##(2007-11#1)(2007-12#7)(2008-1#1)(2008-2#2)(2008-3#3)(2012-12#1)
pulse width remains constant##2##4##(2007-12#1)(2008-3#1)
pulse width was##3##3##(2007-11#1)(2007-12#2)
pulse width when##4##3##(2008-10#1)(2008-3#3)
pulse width##78##2##(2007-11#9)(2007-12#27)(2008-1#4)(2008-10#7)(2008-2#4)(2008-3#22)(2012-12#5)
pulse width)##2##2##(2007-12#1)(2010-12#1)
pulse widths of the##2##4##(2007-12#1)(2008-3#1)
pulse widths of##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
pulse widths##8##2##(1993-7#1)(2007-11#1)(2007-12#2)(2008-3#4)
pulse with a##8##3##(2006-5#1)(2007-12#4)(2008-1#1)(2008-3#2)
pulse with an##2##3##(2007-12#2)
pulse with the##2##3##(2007-12#1)(2010-8#1)
pulse with##20##2##(1990-3#1)(1992-12#1)(1992-3#1)(2006-5#2)(2007-11#1)(2007-12#8)(2007-7#1)(2008-1#1)(2008-3#3)(2010-8#1)
pulse##1595##1##(1990-10#6)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#4)(1990-8#2)(1990-9#1)(1991-2#7)(1991-3#1)(1991-5#5)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#5)(1992-3#5)(1992-6#2)(1992-8#2)(1992-9#2)(1993-1#5)(1993-11#1)(1993-2#10)(1993-3#3)(1993-5#1)(1993-6#1)(1993-7#2)(1993-8#1)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-5#3)(1995-6#2)(1996-1#2)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-4#3)(1997-5#3)(1997-6#2)(1997-7#1)(1997-8#5)(2005-12#1)(2005-4#8)(2005-9#1)(2006-1#2)(2006-10#12)(2006-11#4)(2006-12#1)(2006-4#3)(2006-5#8)(2006-6#2)(2006-8#1)(2007-1#2)(2007-10#8)(2007-11#221)(2007-12#475)(2007-3#1)(2007-4#4)(2007-5#1)(2007-7#20)(2007-8#10)(2007-9#2)(2008-1#69)(2008-10#197)(2008-11#8)(2008-2#91)(2008-3#164)(2008-4#11)(2008-5#11)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#4)(2009-1#1)(2009-10#13)(2009-3#1)(2009-4#3)(2009-5#2)(2009-8#5)(2009-9#8)(2010-1#2)(2010-10#1)(2010-12#3)(2010-2#4)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#9)(2012-11#5)(2012-12#10)(2012-2#9)(2012-3#1)(2012-7#2)(2012-8#1)(2013-1#11)(2013-3#1)(2013-7#2)(2013-8#6)
pulse's duration##2##2##(2007-11#2)
pulse's##4##1##(2007-11#4)
pulse)##5##1##(1997-5#1)(2007-12#2)(2008-10#1)(2008-11#1)
pulse-burst laser system has been##2##5##(2007-12#2)
pulse-burst laser system##3##3##(2007-12#3)
pulse-chase experiment##2##2##(1991-7#1)(1992-3#1)
pulse-chase experiments##3##2##(1992-12#2)(1996-3#1)
pulse-chase labeling##2##2##(2008-4#2)
pulse-chase##10##1##(1990-3#1)(1991-10#1)(1991-7#1)(1992-12#2)(1992-3#1)(1996-3#1)(2004-11#1)(2008-4#2)
pulse-compression systems##2##2##(2007-12#2)
pulse-compression##3##1##(2007-12#3)
pulse-coupled network##3##2##(2008-2#3)
pulse-coupled##5##1##(1995-2#1)(2008-2#4)
pulse-echo##2##1##(2004-9#1)(2009-5#1)
pulse-energy##2##1##(2007-11#1)(2007-12#1)
pulse-front tilt and##2##3##(2007-11#2)
pulse-front tilt##3##2##(2007-11#3)
pulse-front##4##1##(2007-11#4)
pulse-labeled cells##2##2##(1995-3#2)
pulse-labeled##4##1##(1990-7#1)(1995-3#3)
pulse-labeling##2##1##(1997-4#1)(2008-4#1)
pulse-mode neuron##2##2##(2008-2#2)
pulse-mode##3##1##(2008-2#3)
pulse-pair ratio##2##2##(2008-2#2)
pulse-pair##3##1##(2008-2#3)
pulse-repetition rate##6##2##(2007-11#2)(2007-12#3)(2008-3#1)
pulse-repetition##8##1##(2007-11#3)(2007-12#4)(2008-3#1)
pulse-sequence generation##2##2##(2007-12#2)
pulse-shape##2##1##(2007-12#1)(2008-3#1)
pulse-shaping technique##3##2##(2007-12#2)(2008-2#1)
pulse-shaping##4##1##(2007-12#3)(2008-2#1)
pulse-to-pulse timing jitter and##2##4##(2007-11#2)
pulse-to-pulse##11##1##(2007-11#3)(2007-12#5)(2008-2#1)(2008-3#2)
pulse-train generation from##3##3##(2007-12#3)
pulse-train generation##4##2##(2007-12#4)
pulse-train##5##1##(2007-12#5)
pulse-voltammetric##2##1##(2008-10#2)
pulse-width##2##1##(2007-12#1)(2008-3#1)
pulsed Nd##11##2##(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#3)(2008-3#2)
pulsed RF##3##2##(2006-12#3)
pulsed Ti##2##2##(2007-11#1)(2008-1#1)
pulsed UV laser##2##3##(2012-2#2)
pulsed UV##4##2##(2012-2#4)
pulsed Y##2##2##(1991-5#2)
pulsed amperometric detection (PAD)##3##4##(1991-7#1)(2008-10#2)
pulsed amperometric detection was##2##4##(2005-12#1)(2008-10#1)
pulsed amperometric detection##19##3##(1990-11#1)(1991-7#2)(1992-1#1)(1993-11#1)(1995-2#1)(2005-12#1)(2007-8#1)(2008-10#10)(2008-6#1)
pulsed amperometric##22##2##(1990-11#1)(1991-7#2)(1992-1#1)(1993-11#1)(1995-2#1)(2005-12#2)(2007-8#1)(2008-10#12)(2008-6#1)
pulsed and cw##3##3##(2008-2#3)
pulsed and##5##2##(1990-6#1)(2008-2#3)(2008-3#1)
pulsed beam propagation##2##3##(2007-12#2)
pulsed beam##3##2##(2007-12#3)
pulsed cavity ringdown experiment##2##4##(2008-3#2)
pulsed coherent##3##2##(2008-2#1)(2008-3#2)
pulsed digital holography is##2##4##(2008-3#2)
pulsed digital holography##4##3##(2008-3#4)
pulsed digital##5##2##(2008-3#5)
pulsed diode##2##2##(2007-11#1)(2008-3#1)
pulsed doubly resonant optical parametric##2##5##(2007-11#2)
pulsed dye laser##6##3##(1996-11#1)(2006-12#1)(2007-7#1)(2008-3#1)(2009-4#1)(2011-1#1)
pulsed dye##7##2##(1996-11#2)(2006-12#1)(2007-7#1)(2008-3#1)(2009-4#1)(2011-1#1)
pulsed electric fields##2##3##(1991-8#1)(2008-9#1)
pulsed electric##4##2##(1991-8#1)(2008-9#3)
pulsed electron paramagnetic resonance##3##4##(2007-3#1)(2008-3#2)
pulsed ex vivo with##2##4##(1996-10#1)(2006-7#1)
pulsed excitation##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
pulsed field gel electrophoresis (PFGE)##2##5##(2008-10#1)(2011-2#1)
pulsed field gel electrophoresis and##2##5##(2012-12#1)(2012-3#1)
pulsed field gel electrophoresis##8##4##(1995-8#1)(1996-9#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-3#3)
pulsed field##10##2##(1990-3#1)(1995-8#1)(1996-9#1)(2005-11#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-3#3)
pulsed flow of solution##2##4##(2008-10#2)
pulsed flow##4##2##(2008-10#4)
pulsed galvanostatic##2##2##(2008-10#2)
pulsed gradient magnetic field##3##4##(2008-9#3)
pulsed heating with##2##3##(2007-12#1)(2008-2#1)
pulsed infrared##2##2##(2008-3#2)
pulsed laser beam##5##3##(2007-12#1)(2008-2#1)(2008-3#2)(2012-2#1)
pulsed laser deposition##8##3##(2006-12#3)(2007-11#2)(2007-12#1)(2008-1#2)
pulsed laser microbeam-induced##3##3##(2009-4#3)
pulsed laser radiation##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
pulsed laser system##2##3##(2007-12#1)(2008-10#1)
pulsed laser vaporization##2##3##(2008-10#2)
pulsed laser##52##2##(1992-1#1)(2006-12#3)(2007-11#8)(2007-12#9)(2008-1#3)(2008-10#5)(2008-2#11)(2008-3#6)(2009-4#3)(2010-11#1)(2012-2#2)
pulsed lasers for##2##3##(1995-4#1)(2008-3#1)
pulsed lasers with##2##3##(2007-12#2)
pulsed lasers##7##2##(1995-4#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
pulsed lidar##2##2##(2008-3#2)
pulsed light is##2##3##(2008-3#2)
pulsed light##9##2##(2006-12#2)(2008-2#2)(2008-3#3)(2010-6#1)(2011-2#1)
pulsed magnetic field##4##3##(1997-1#2)(2009-11#1)(2011-2#1)
pulsed magnetic##5##2##(1997-1#2)(1997-7#1)(2009-11#1)(2011-2#1)
pulsed mode##6##2##(1992-3#1)(2006-7#1)(2007-11#1)(2007-12#2)(2008-2#1)
pulsed optical beam##2##3##(2008-3#2)
pulsed optical parametric oscillator##4##4##(2007-11#1)(2008-3#3)
pulsed optical##8##2##(2007-11#1)(2007-12#1)(2008-3#6)
pulsed photoacoustic##2##2##(2008-3#2)
pulsed photothermal radiometry##2##3##(2008-2#2)
pulsed quantum-cascade distributed feedback laser##2##5##(2008-3#2)
pulsed quench-flow apparatus##3##3##(1990-2#3)
pulsed radiofrequency##5##2##(2006-11#1)(2006-12#3)(2012-3#1)
pulsed regime##2##2##(2007-12#2)
pulsed single-longitudinal-mode##2##2##(2007-11#1)(2008-2#1)
pulsed top-hat beam excitation and a near-field detection scheme##2##9##(2007-12#1)(2008-3#1)
pulsed top-hat beam##4##3##(2007-12#1)(2008-3#3)
pulsed treatment##2##2##(1995-5#2)
pulsed tunable dye laser##2##4##(2008-10#1)(2008-2#1)
pulsed tunable dye##3##3##(2005-4#1)(2008-10#1)(2008-2#1)
pulsed ultrasound##4##2##(2008-3#2)(2012-2#1)(2013-1#1)
pulsed ultraviolet laser##2##3##(1995-7#1)(2008-10#1)
pulsed ultraviolet##3##2##(1995-7#1)(2007-12#1)(2008-10#1)
pulsed with tumor##2##3##(2006-9#1)(2008-8#1)
pulsed with##8##2##(1992-6#1)(1994-12#1)(1996-10#1)(2006-7#2)(2006-9#1)(2008-11#1)(2008-8#1)
pulsed##365##1##(1990-11#1)(1990-2#3)(1990-3#1)(1990-6#3)(1991-11#1)(1991-3#1)(1991-5#2)(1991-7#2)(1991-8#1)(1992-1#4)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-11#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#2)(1995-7#1)(1995-8#1)(1996-10#2)(1996-11#2)(1996-7#2)(1996-9#1)(1997-1#3)(1997-7#1)(1997-8#1)(2005-1#1)(2005-11#1)(2005-12#2)(2005-4#1)(2006-11#1)(2006-12#12)(2006-4#1)(2006-5#1)(2006-7#4)(2006-9#1)(2007-10#1)(2007-11#23)(2007-12#55)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#8)(2008-10#37)(2008-11#1)(2008-2#48)(2008-3#76)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#6)(2009-11#1)(2009-4#4)(2009-5#1)(2010-11#1)(2010-2#1)(2010-6#2)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#9)(2012-3#4)(2013-1#2)
pulsed-field gel electrophoresis (PFGE)##8##4##(1993-12#2)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#1)(2010-4#1)(2013-1#1)
pulsed-field gel electrophoresis##24##3##(1990-9#1)(1993-12#2)(1993-9#1)(1995-2#1)(1996-12#1)(1996-6#1)(1997-2#2)(1997-3#1)(2007-6#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-4#1)(2013-1#1)
pulsed-field gradient##3##2##(2005-11#1)(2008-3#2)
pulsed-field##29##1##(1990-9#1)(1993-12#2)(1993-9#1)(1994-12#1)(1995-2#1)(1996-12#1)(1996-6#1)(1997-2#2)(1997-3#1)(2005-11#1)(2007-6#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2010-4#1)(2013-1#1)
pulsed-laser deposition##3##2##(2007-12#3)
pulsed-laser excitation##3##2##(2007-11#3)
pulsed-laser##10##1##(2007-11#3)(2007-12#4)(2008-1#1)(2008-2#2)
pulseless electrical activity##2##3##(2006-4#1)(2009-6#1)
pulseless##5##1##(1990-8#1)(2006-10#1)(2006-4#2)(2009-6#1)
pulses (10##2##2##(2007-11#1)(2008-3#1)
pulses and a##3##3##(2007-12#1)(2008-3#1)(2008-7#1)
pulses and the##2##3##(2007-12#1)(2008-3#1)
pulses and##45##2##(1993-11#1)(2006-12#1)(2007-11#12)(2007-12#19)(2008-1#2)(2008-10#1)(2008-2#4)(2008-3#3)(2008-7#1)(2009-8#1)
pulses applied##2##2##(1995-6#1)(2006-5#1)
pulses are also##2##3##(2007-11#1)(2007-12#1)
pulses are amplified##2##3##(2007-11#1)(2007-12#1)
pulses are analyzed by##2##4##(2008-1#1)(2008-2#1)
pulses are analyzed##4##3##(2007-12#1)(2008-1#1)(2008-2#2)
pulses are detected##2##3##(2008-2#1)(2008-3#1)
pulses are generated by phase-matched difference-frequency mixing##2##7##(2007-12#2)
pulses are generated by##4##4##(2007-11#1)(2007-12#3)
pulses are generated##6##3##(2007-11#2)(2007-12#4)
pulses are used to##2##4##(2007-12#1)(2011-1#1)
pulses are##47##2##(1990-3#1)(2006-6#1)(2007-11#7)(2007-12#23)(2008-1#3)(2008-11#1)(2008-2#6)(2008-3#4)(2011-1#1)
pulses as a result of##2##5##(2007-11#1)(2007-12#1)
pulses as a##3##3##(2007-11#1)(2007-12#2)
pulses as short as##11##4##(2007-11#3)(2007-12#6)(2008-1#1)(2008-2#1)
pulses as##18##2##(2007-11#6)(2007-12#9)(2008-1#1)(2008-2#2)
pulses at 1##16##3##(1995-3#1)(2007-11#5)(2007-12#10)
pulses at 1064 nm##3##4##(2007-11#2)(2008-2#1)
pulses at 532 nm##2##4##(2007-12#1)(2008-2#1)
pulses at 780 nm##2##4##(2008-1#1)(2008-3#1)
pulses at 800 nm##5##4##(2007-12#5)
pulses at a 1-kHz repetition rate are obtained##2##8##(2007-11#1)(2007-12#1)
pulses at a 1-kHz repetition rate##4##6##(2007-11#1)(2007-12#1)(2008-1#2)
pulses at a 10-Hz repetition rate##2##6##(2007-12#1)(2008-2#1)
pulses at a center wavelength of##2##6##(2007-12#2)
pulses at a repetition rate of##5##6##(2007-11#1)(2007-12#4)
pulses at a wavelength near##2##5##(2007-11#1)(2007-12#1)
pulses at a wavelength##3##4##(2007-11#1)(2007-12#2)
pulses at a##29##3##(2007-11#5)(2007-12#17)(2008-1#2)(2008-2#2)(2008-3#1)(2011-1#1)(2012-11#1)
pulses at an##2##3##(2007-11#2)
pulses at approximately##2##3##(2007-12#1)(2008-2#1)
pulses at lambda##2##3##(2007-12#2)
pulses at the##6##3##(2007-12#4)(2008-1#1)(2008-3#1)
pulses at##99##2##(1993-2#1)(1995-3#1)(2007-11#18)(2007-12#53)(2008-1#10)(2008-2#7)(2008-3#7)(2011-1#1)(2012-11#1)
pulses based on##3##3##(2007-11#2)(2008-1#1)
pulses before##2##2##(1995-7#1)(2009-5#1)
pulses by a##4##3##(2007-12#3)(2008-2#1)
pulses by frequency doubling##2##4##(2007-11#1)(2007-12#1)
pulses by frequency##3##3##(2007-11#1)(2007-12#2)
pulses by the##2##3##(2007-11#1)(2012-11#1)
pulses by this##2##3##(2007-12#1)(2012-11#1)
pulses by use of a##8##5##(2007-11#4)(2007-12#3)(2008-2#1)
pulses by use of an##2##5##(2007-11#1)(2007-12#1)
pulses by use of##17##4##(2007-11#7)(2007-12#7)(2008-1#2)(2008-2#1)
pulses by using a##2##4##(2007-11#2)
pulses by using##4##3##(2007-11#2)(2007-12#2)
pulses by##58##2##(2007-11#16)(2007-12#32)(2008-1#3)(2008-2#3)(2008-3#2)(2012-11#2)
pulses can be##5##3##(2007-11#2)(2007-12#2)(2008-1#1)
pulses can##6##2##(2007-11#2)(2007-12#3)(2008-1#1)
pulses centered at##2##3##(2007-11#1)(2008-3#1)
pulses could be##2##3##(2007-12#1)(2008-5#1)
pulses directly from a##2##4##(2007-11#1)(2007-12#1)
pulses emitted##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
pulses for##9##2##(1991-8#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-3#2)
pulses from a Kerr-lens mode-locked Ti##3##6##(2007-12#3)
pulses from a Kerr-lens mode-locked##4##5##(2007-11#1)(2007-12#3)
pulses from a Q -switched Nd##2##6##(2007-11#1)(2007-12#1)
pulses from a Ti##10##4##(2007-11#1)(2007-12#8)(2008-3#1)
pulses from a diode-pumped##3##4##(2007-12#2)(2008-2#1)
pulses from a dual-wavelength oscillator##2##5##(2007-11#1)(2007-12#1)
pulses from a mode-locked Ti##3##5##(2007-12#3)
pulses from a mode-locked##6##4##(2007-12#5)(2008-1#1)
pulses from a##40##3##(2007-11#5)(2007-12#29)(2008-1#3)(2008-2#1)(2008-3#2)
pulses from an##2##3##(2007-12#2)
pulses from the##2##3##(2007-12#1)(2008-1#1)
pulses from these##2##3##(2007-12#2)
pulses from##56##2##(2007-11#8)(2007-12#41)(2008-1#4)(2008-2#1)(2008-3#2)
pulses generated by a##2##4##(2007-12#2)
pulses generated by##4##3##(2007-12#4)
pulses generated from##2##3##(2007-11#1)(2007-12#1)
pulses generated##8##2##(2007-11#2)(2007-12#5)(2008-1#1)
pulses had a##2##3##(1991-8#1)(2007-11#1)
pulses has been##3##3##(2007-11#1)(2007-12#2)
pulses have been##3##3##(2007-12#2)(2007-4#1)
pulses have##5##2##(2007-12#2)(2007-4#1)(2008-1#1)(2008-3#1)
pulses in a femtosecond##3##4##(2007-12#3)
pulses in a hollow waveguide##2##5##(2007-12#2)
pulses in a single transverse mode##2##6##(2007-12#1)(2008-3#1)
pulses in a##38##3##(1995-11#1)(2006-5#1)(2007-11#6)(2007-12#24)(2008-10#1)(2008-2#1)(2008-3#4)
pulses in dispersion-managed##3##3##(2007-11#1)(2007-12#2)
pulses in dispersive##2##3##(2007-11#2)
pulses in high-speed##3##3##(2007-11#1)(2007-12#2)
pulses in long-distance##2##3##(2007-12#2)
pulses in optical fiber##2##4##(2007-12#2)
pulses in optical##4##3##(2007-11#1)(2007-12#3)
pulses in strongly dispersion-managed##2##4##(2007-11#1)(2007-12#1)
pulses in the range##2##4##(2007-12#1)(2008-3#1)
pulses in the visible##3##4##(2007-12#3)
pulses in the##24##3##(1992-11#1)(1997-2#1)(1997-5#1)(2006-5#1)(2007-11#6)(2007-12#13)(2008-3#1)
pulses in##116##2##(1992-11#1)(1995-11#1)(1995-5#1)(1997-2#1)(1997-5#1)(2006-5#2)(2007-1#1)(2007-11#29)(2007-12#65)(2008-1#3)(2008-10#1)(2008-2#2)(2008-3#7)(2013-7#1)
pulses induced##2##2##(2008-2#1)(2008-5#1)
pulses into##5##2##(1991-9#1)(2007-11#2)(2007-12#2)
pulses is demonstrated##4##3##(2007-11#1)(2008-1#2)(2008-3#1)
pulses is used##2##3##(2007-12#1)(2008-2#1)
pulses is##22##2##(2007-11#5)(2007-12#9)(2008-1#3)(2008-2#3)(2008-3#2)
pulses near##4##2##(2007-12#2)(2008-1#1)(2008-3#1)
pulses of &lt##2##3##(2007-11#1)(2007-12#1)
pulses of 1##3##3##(1990-3#1)(2007-11#1)(2013-1#1)
pulses of a##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
pulses of an##2##3##(2007-12#1)(2008-2#1)
pulses of as much as##2##5##(2007-11#1)(2007-12#1)
pulses of terahertz (THz) radiation##3##5##(2007-12#3)
pulses of terahertz radiation##2##4##(2007-12#2)
pulses of terahertz##5##3##(2007-12#5)
pulses of the##3##3##(1996-12#1)(2007-12#1)(2011-1#1)
pulses of##69##2##(1990-11#1)(1990-3#1)(1991-5#1)(1991-8#2)(1992-8#1)(1994-2#1)(1995-6#1)(1996-12#1)(2006-10#1)(2007-11#15)(2007-12#22)(2008-1#2)(2008-2#7)(2008-3#8)(2011-1#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#1)
pulses on##5##2##(1991-2#1)(1995-10#1)(2007-11#1)(2007-12#2)
pulses or##4##2##(1990-10#1)(2007-12#1)(2008-6#1)(2012-11#1)
pulses over##3##2##(2007-11#1)(2007-12#1)(2008-1#1)
pulses overlap##2##2##(2007-12#2)
pulses per##2##2##(2008-1#1)(2008-2#1)
pulses propagating in air##3##4##(2007-11#1)(2007-12#2)
pulses propagating in##5##3##(2007-11#2)(2007-12#3)
pulses shorter than##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
pulses show##2##2##(2007-12#2)
pulses that are tunable##3##4##(2007-12#3)
pulses that are##14##3##(2007-11#4)(2007-12#9)(2008-1#1)
pulses that have##2##3##(2007-11#1)(2007-12#1)
pulses that is##2##3##(2007-11#1)(2007-12#1)
pulses that propagate##2##3##(2007-12#2)
pulses that were##2##3##(2007-12#2)
pulses that##27##2##(2007-11#8)(2007-12#17)(2008-1#1)(2012-11#1)
pulses the##2##2##(2007-11#1)(2007-12#1)
pulses through a##3##3##(2007-12#2)(2008-2#1)
pulses through##9##2##(2007-11#3)(2007-12#2)(2008-2#2)(2008-3#2)
pulses to a##6##3##(2007-12#4)(2008-3#2)
pulses to the##3##3##(1993-3#1)(2007-11#1)(2010-11#1)
pulses to##23##2##(1992-9#1)(1993-3#2)(2007-11#4)(2007-12#9)(2008-2#1)(2008-3#4)(2010-11#1)(2010-12#1)
pulses transmitted through##2##3##(2007-12#2)
pulses transmitted##3##2##(2007-12#2)(2008-3#1)
pulses tunable across the##2##4##(2007-12#1)(2008-1#1)
pulses tunable from##3##3##(2007-12#1)(2008-2#2)
pulses tunable in##2##3##(2007-11#1)(2007-12#1)
pulses tunable##9##2##(2007-11#1)(2007-12#3)(2008-1#2)(2008-2#2)(2008-3#1)
pulses under the##2##3##(2007-12#2)
pulses under##3##2##(2007-11#1)(2007-12#2)
pulses was generated##2##3##(2007-11#2)
pulses was##8##2##(2007-11#3)(2007-12#1)(2008-3#3)(2011-1#1)
pulses were characterized by##2##4##(2007-12#2)
pulses were obtained##5##3##(2007-12#3)(2008-1#1)(2008-3#1)
pulses were##22##2##(1992-3#1)(1993-3#1)(2007-11#4)(2007-12#9)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2013-1#1)
pulses when##2##2##(1992-9#1)(2007-12#1)
pulses with 1##2##3##(2007-12#2)
pulses with a##26##3##(2007-11#5)(2007-12#14)(2008-1#2)(2008-2#1)(2008-3#4)
pulses with an average power of 0##3##7##(2007-11#1)(2007-12#2)
pulses with an average power of##5##6##(2007-11#1)(2007-12#4)
pulses with an average power##6##5##(2007-11#1)(2007-12#4)(2008-3#1)
pulses with an##8##3##(2007-11#1)(2007-12#5)(2008-3#2)
pulses with durations##3##3##(2007-11#1)(2007-12#1)(2008-1#1)
pulses with energies as##3##4##(2007-11#1)(2007-12#1)(2008-1#1)
pulses with energies of as much as##2##7##(2007-12#2)
pulses with energies of##7##4##(2007-11#2)(2007-12#4)(2008-3#1)
pulses with energies##10##3##(2007-11#3)(2007-12#5)(2008-1#1)(2008-3#1)
pulses with energy of##2##4##(2007-11#1)(2007-12#1)
pulses with peak powers##2##4##(2007-12#2)
pulses with peak##3##3##(2007-12#2)(2008-3#1)
pulses with pulse##2##3##(2007-11#1)(2008-3#1)
pulses with##87##2##(2007-11#18)(2007-12#47)(2008-1#6)(2008-2#4)(2008-3#12)
pulses within##3##2##(2007-12#3)
pulses without##2##2##(2007-12#2)
pulses##1198##1##(1990-10#2)(1990-11#1)(1990-3#3)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#4)(1991-5#6)(1991-8#6)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-8#2)(1992-9#2)(1993-11#2)(1993-2#1)(1993-3#3)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-3#2)(1995-5#1)(1995-6#3)(1995-7#1)(1996-1#2)(1996-12#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-5#5)(2006-10#1)(2006-12#2)(2006-5#8)(2006-6#3)(2007-1#1)(2007-11#243)(2007-12#551)(2007-4#4)(2007-8#1)(2007-9#1)(2008-1#58)(2008-10#5)(2008-11#2)(2008-2#87)(2008-3#109)(2008-5#8)(2008-6#3)(2008-7#1)(2008-8#3)(2009-10#9)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-7#1)(2011-1#5)(2011-12#1)(2012-1#1)(2012-11#6)(2012-2#7)(2013-1#3)(2013-7#1)
pulses) and##2##2##(2007-12#1)(2012-2#1)
pulses)##5##1##(2007-12#2)(2008-1#1)(2012-2#2)
pulsing semiconductor lasers##3##3##(2007-12#3)
pulsing##8##1##(1993-5#1)(2007-12#4)(2008-11#1)(2008-4#1)(2008-5#1)
pulveratum##4##1##(2007-3#4)
pulverisation##2##1##(1991-12#1)(2007-2#1)
pulverized##6##1##(2008-10#3)(2010-9#1)(2012-3#1)(2013-1#1)
pumice##6##1##(2008-10#4)(2008-7#2)
pumilus##8##1##(1990-9#1)(2008-10#3)(2008-5#2)(2011-1#1)(2011-2#1)
pumilus)##4##1##(2008-10#4)
pummelo 2240##3##2##(2008-5#3)
pummelo##6##1##(2008-10#2)(2008-5#4)
pump CABG##2##2##(2013-1#2)
pump absorption##7##2##(2007-11#2)(2007-12#3)(2008-3#2)
pump activity##6##2##(1992-11#1)(1994-9#1)(1997-6#1)(2008-11#1)(2008-4#2)
pump an##3##2##(2007-11#1)(2007-12#2)
pump and Stokes##2##3##(2007-11#1)(2007-12#1)
pump and a##3##3##(1994-6#1)(2008-10#1)(2010-8#1)
pump and laser##2##3##(2007-12#1)(2008-3#1)
pump and probe##3##3##(2007-11#1)(2007-12#2)
pump and signal##5##3##(2007-12#5)
pump and##42##2##(1992-1#1)(1994-3#1)(1994-6#1)(2005-8#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#14)(2008-1#3)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#3)(2008-4#1)(2010-8#1)(2012-10#1)(2013-1#1)
pump at a##2##3##(2007-12#1)(2008-10#1)
pump at##5##2##(1991-8#1)(2007-12#1)(2008-10#1)(2008-3#2)
pump band excitation##2##3##(2008-3#2)
pump beam in the##2##4##(2008-1#1)(2008-3#1)
pump beam in##4##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
pump beam is##2##3##(2007-12#1)(2008-3#1)
pump beam of##2##3##(2008-1#1)(2008-2#1)
pump beam with##2##3##(2007-12#2)
pump beam##40##2##(2007-11#5)(2007-12#10)(2008-1#5)(2008-2#6)(2008-3#14)
pump beams is##2##3##(2008-1#2)
pump beams##8##2##(2007-12#3)(2008-1#4)(2008-2#1)
pump by##4##2##(1992-11#2)(1994-9#2)
pump can be##2##3##(2007-11#1)(2008-10#1)
pump can##3##2##(2007-11#1)(2008-10#2)
pump carrier solution##2##3##(2008-10#2)
pump cavity##3##2##(2007-12#1)(2008-2#2)
pump configuration##2##2##(2007-12#1)(2008-2#1)
pump coronary artery bypass##6##4##(2007-8#5)(2012-12#1)
pump coronary##8##2##(2007-8#7)(2012-12#1)
pump current in##2##3##(1992-11#2)
pump current##4##2##(1992-11#2)(1996-1#2)
pump current-voltage##2##2##(1992-11#1)(1996-1#1)
pump depletion of##2##3##(2008-1#2)
pump depletion##7##2##(2007-11#1)(2007-12#3)(2008-1#2)(2008-3#1)
pump depletions of##2##3##(2007-12#2)
pump diodes##2##2##(2007-12#1)(2008-1#1)
pump duty cycle##2##3##(2007-12#1)(2008-1#1)
pump efficiency##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
pump energies##4##2##(2008-3#4)
pump energy of 10##2##4##(2007-12#1)(2008-2#1)
pump energy of##5##3##(2007-11#2)(2007-12#1)(2008-2#2)
pump energy##11##2##(2007-11#3)(2007-12#1)(2008-2#3)(2008-3#3)(2008-7#1)
pump evolved##2##2##(1992-11#1)(2007-12#1)
pump failure##7##2##(1997-1#4)(1997-4#1)(2008-3#1)(2008-4#1)
pump field##3##2##(2007-11#1)(2007-12#1)(2008-1#1)
pump fields##3##2##(2007-12#3)
pump flow algorithm##2##3##(2007-8#2)
pump flow##7##2##(2007-8#4)(2008-10#3)
pump fluence##3##2##(2008-3#3)
pump for intravenous##2##3##(2008-4#1)(2009-6#1)
pump for##11##2##(1990-11#2)(1994-5#1)(2005-10#1)(2007-12#1)(2008-10#4)(2008-4#1)(2009-6#1)
pump frequencies##2##2##(2007-11#2)
pump from##2##2##(1992-11#1)(1994-5#1)
pump function##5##2##(1993-2#1)(1994-12#1)(1996-8#1)(2010-11#2)
pump geometry##2##2##(2007-12#2)
pump in a##2##3##(1993-3#1)(2007-12#1)
pump in the##5##3##(1994-8#2)(1995-11#1)(1996-1#1)(2008-11#1)
pump in##11##2##(1992-6#1)(1993-3#1)(1994-8#2)(1995-11#1)(1996-1#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-8#1)
pump inhibitor was##2##3##(1996-3#1)(2006-10#1)
pump inhibitor##29##2##(1996-2#2)(1996-3#4)(1997-8#2)(2006-10#7)(2006-2#1)(2007-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2009-11#1)(2010-12#1)(2012-2#5)(2013-1#1)
pump inhibitors and##2##3##(2009-8#1)(2012-2#1)
pump inhibitors are##3##3##(2008-12#1)(2012-2#2)
pump inhibitors were##3##3##(2006-6#1)(2010-12#1)(2012-2#1)
pump inhibitors##28##2##(2006-10#4)(2006-2#1)(2006-6#1)(2008-12#2)(2008-6#1)(2008-8#1)(2009-8#1)(2010-12#7)(2011-2#1)(2012-2#9)
pump input##2##2##(2007-12#2)
pump intensities##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
pump intensity of##2##3##(2007-12#1)(2008-3#1)
pump intensity##8##2##(2007-11#1)(2007-12#4)(2008-3#3)
pump is##9##2##(1990-11#1)(2007-12#3)(2007-8#1)(2008-11#2)(2008-8#1)(2013-7#1)
pump isoforms##2##2##(1992-11#2)
pump laser and##2##3##(2007-12#1)(2008-2#1)
pump laser is##2##3##(2007-11#2)
pump laser##18##2##(2007-11#6)(2007-12#5)(2008-2#4)(2008-3#2)(2012-11#1)
pump lasers##2##2##(2007-11#2)
pump level of##3##3##(2007-12#3)
pump levels##3##2##(2008-2#1)(2008-3#2)
pump light distributions##3##3##(2008-2#3)
pump light##13##2##(2007-12#5)(2008-1#2)(2008-2#6)
pump may##2##2##(2011-2#2)
pump of the##4##3##(1993-3#1)(1995-11#1)(2006-10#1)(2007-12#1)
pump of##9##2##(1993-3#1)(1994-11#1)(1995-11#1)(2006-10#1)(2007-11#1)(2007-12#3)(2012-3#1)
pump or##2##2##(1991-8#1)(2008-8#1)
pump performance##2##2##(2007-8#1)(2008-10#1)
pump polarization is##2##3##(2008-2#1)(2008-3#1)
pump polarization##3##2##(2008-2#2)(2008-3#1)
pump power and the##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
pump power and##6##3##(2007-12#2)(2008-2#1)(2008-3#3)
pump power at##6##3##(2007-12#4)(2008-2#1)(2008-3#1)
pump power by##2##3##(2007-12#2)
pump power corresponding to##2##4##(2008-2#2)
pump power in##2##3##(2007-12#2)
pump power increased##2##3##(2007-11#1)(2008-2#1)
pump power is##5##3##(2007-11#1)(2007-12#3)(2008-3#1)
pump power of 1##3##4##(2007-12#2)(2008-3#1)
pump power of 200 mW##2##5##(2007-12#1)(2008-3#1)
pump power of 8##2##4##(2007-11#1)(2008-2#1)
pump power of only##3##4##(2007-12#1)(2008-2#2)
pump power of##23##3##(2007-11#2)(2007-12#11)(2008-2#6)(2008-3#4)
pump power threshold of##3##4##(2007-11#1)(2007-12#2)
pump power threshold##4##3##(2007-11#2)(2007-12#2)
pump power was##6##3##(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
pump power##117##2##(2006-12#1)(2007-11#22)(2007-12#51)(2008-1#5)(2008-2#20)(2008-3#18)
pump power)##2##2##(2007-12#1)(2008-3#1)
pump powers as##2##3##(2007-12#1)(2008-1#1)
pump powers of##3##3##(2007-11#1)(2007-12#2)
pump powers##14##2##(2007-11#3)(2007-12#7)(2008-1#1)(2008-2#1)(2008-3#2)
pump profile##2##2##(2007-12#1)(2008-2#1)
pump pulse energy##2##3##(2008-2#2)
pump pulse in##2##3##(2007-11#1)(2007-12#1)
pump pulse to##2##3##(2007-11#1)(2008-2#1)
pump pulse##26##2##(1993-6#1)(2006-5#1)(2007-11#7)(2007-12#11)(2008-1#1)(2008-2#3)(2008-3#1)(2012-2#1)
pump pulses##16##2##(2007-11#1)(2007-12#13)(2008-1#1)(2008-3#1)
pump radiation##5##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
pump rate##4##2##(1991-1#3)(2008-10#1)
pump repetition##2##2##(2008-2#1)(2008-3#1)
pump source at##2##3##(2008-2#1)(2008-3#1)
pump source##28##2##(2007-11#3)(2007-12#13)(2008-1#1)(2008-2#3)(2008-3#8)
pump sources##3##2##(2007-11#1)(2007-12#2)
pump speed##2##2##(1991-3#1)(2008-10#1)
pump support##2##2##(2007-8#1)(2007-9#1)
pump system for##2##3##(2008-10#1)(2009-11#1)
pump system##3##2##(2008-10#1)(2009-11#1)(2012-3#1)
pump that##4##2##(1997-8#1)(2006-12#2)(2010-6#1)
pump therapy##7##2##(2008-1#7)
pump threshold##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
pump to##8##2##(1991-3#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#2)
pump tuning##2##2##(2007-12#2)
pump was found##2##3##(1994-5#1)(2006-7#1)
pump was measured##2##3##(1992-6#1)(2008-10#1)
pump was used##3##3##(2008-10#2)(2013-1#1)
pump was##12##2##(1992-6#2)(1994-5#2)(1994-8#1)(2006-7#1)(2007-12#1)(2008-10#4)(2013-1#1)
pump wave to##2##3##(2007-11#1)(2008-3#1)
pump wave##10##2##(2007-11#2)(2007-12#5)(2008-1#1)(2008-3#2)
pump wavelength and##2##3##(2007-11#1)(2007-12#1)
pump wavelength##15##2##(2007-11#4)(2007-12#10)(2008-2#1)
pump wavelengths##5##2##(2007-11#2)(2007-12#1)(2008-1#1)(2009-4#1)
pump waves##4##2##(2007-11#4)
pump were##4##2##(1992-12#1)(1994-5#1)(2008-10#2)
pump which has##2##3##(1994-12#1)(2007-2#1)
pump with an##2##3##(2008-10#2)
pump with##5##2##(1994-5#1)(1997-5#1)(2008-10#2)(2008-8#1)
pump##915##1##(1990-11#5)(1990-2#1)(1990-7#1)(1991-1#3)(1991-10#1)(1991-3#2)(1991-4#1)(1991-8#3)(1992-1#5)(1992-11#16)(1992-12#4)(1992-3#2)(1992-5#1)(1992-6#9)(1993-12#2)(1993-2#1)(1993-3#4)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#5)(1994-2#1)(1994-3#2)(1994-5#6)(1994-6#3)(1994-8#4)(1994-9#6)(1995-11#2)(1995-2#1)(1996-1#7)(1996-2#2)(1996-3#5)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#4)(1997-4#5)(1997-5#1)(1997-6#3)(1997-8#3)(2004-12#1)(2005-1#1)(2005-10#1)(2005-12#1)(2005-4#1)(2005-7#1)(2005-8#3)(2006-10#15)(2006-12#4)(2006-2#3)(2006-5#1)(2006-6#3)(2006-7#4)(2006-8#3)(2007-10#5)(2007-11#96)(2007-12#229)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#38)(2007-9#3)(2008-1#44)(2008-10#53)(2008-11#14)(2008-12#4)(2008-2#75)(2008-3#91)(2008-4#7)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#7)(2008-9#1)(2009-11#3)(2009-2#1)(2009-4#1)(2009-6#3)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#8)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#3)(2011-2#10)(2012-10#1)(2012-11#1)(2012-12#1)(2012-2#16)(2012-3#3)(2013-1#6)(2013-7#1)
pump)##7##1##(1994-2#1)(2006-7#1)(2007-8#1)(2008-6#1)(2008-7#1)(2009-11#1)(2011-2#1)
pump- and##2##2##(2007-12#1)(2008-2#1)
pump-beam intensity##2##2##(2007-12#1)(2008-3#1)
pump-beam##6##1##(2007-12#1)(2008-2#2)(2008-3#3)
pump-enhanced optical parametric oscillator##2##4##(2007-12#2)
pump-induced thermal##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
pump-induced##4##1##(2007-12#2)(2008-2#1)(2008-3#1)
pump-laser##2##1##(2007-11#1)(2007-12#1)
pump-light##2##1##(2007-12#2)
pump-power levels##2##2##(2007-12#1)(2008-3#1)
pump-power threshold##2##2##(2007-12#2)
pump-power##14##1##(2007-11#1)(2007-12#10)(2008-2#1)(2008-3#2)
pump-probe experiment##3##2##(2007-12#2)(2008-3#1)
pump-probe experiments##2##2##(1996-2#1)(2008-3#1)
pump-probe fluorescence microscopy##2##3##(2008-3#2)
pump-probe geometry##2##2##(2007-11#1)(2008-3#1)
pump-probe measurements##2##2##(2007-11#1)(2007-12#1)
pump-probe method##2##2##(2007-11#1)(2008-2#1)
pump-probe##29##1##(1991-8#2)(1996-2#1)(2006-6#1)(2007-11#5)(2007-12#10)(2008-2#2)(2008-3#7)(2010-7#1)
pump-pulse##2##1##(2007-12#2)
pump-signal conversion efficiencies##2##3##(2007-12#2)
pump-wavelength##2##1##(2007-11#2)
pumped Nd(3+)##2##2##(2007-12#1)(2008-3#1)
pumped at 0##2##3##(2008-10#2)
pumped at 1##2##3##(2007-12#1)(2008-3#1)
pumped at 532 nm by a##2##6##(2007-12#2)
pumped at 532 nm##4##4##(2007-12#3)(2008-3#1)
pumped at 975 nm##3##4##(2007-11#2)(2007-12#1)
pumped at a flow rate##2##5##(2007-8#1)(2010-3#1)
pumped at a flow-rate of 1##2##6##(1991-5#1)(1997-3#1)
pumped at a##5##3##(1991-5#1)(1997-3#1)(2007-8#1)(2008-10#1)(2010-3#1)
pumped at##22##2##(1991-5#1)(1997-3#1)(2007-11#3)(2007-12#7)(2007-8#1)(2008-1#2)(2008-10#3)(2008-3#3)(2010-3#1)
pumped by 1##2##3##(2007-12#2)
pumped by 10##2##3##(2007-11#1)(2007-12#1)
pumped by a 1##2##4##(2007-12#1)(2008-2#1)
pumped by a 4-W laser diode##2##6##(2007-12#1)(2008-2#1)
pumped by a Bessel beam##3##5##(2007-12#1)(2008-2#2)
pumped by a Nd##3##4##(2007-12#1)(2008-2#2)
pumped by a Q-switched Nd##3##5##(2007-11#1)(2008-3#1)(2008-5#1)
pumped by a compact##2##4##(2007-11#1)(2008-3#1)
pumped by a cw##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
pumped by a diode laser##4##5##(2007-12#4)
pumped by a diode##5##4##(2007-12#4)(2008-2#1)
pumped by a diode-pumped##3##4##(2007-11#1)(2007-12#2)
pumped by a fiber##2##4##(2007-12#2)
pumped by a frequency-doubled##2##4##(2007-12#1)(2008-1#1)
pumped by a multilongitudinal-mode beam##2##5##(2007-12#2)
pumped by a pulsed##2##4##(2008-10#1)(2008-3#1)
pumped by a single narrow-stripe AlGaInP laser diode##2##8##(2008-1#2)
pumped by a single##4##4##(2007-12#2)(2008-1#2)
pumped by a single-mode##2##4##(2007-11#1)(2007-12#1)
pumped by a tunable##2##4##(2007-11#1)(2007-12#1)
pumped by a##76##3##(2005-4#1)(2007-11#7)(2007-12#38)(2008-1#4)(2008-10#1)(2008-2#16)(2008-3#8)(2008-5#1)
pumped by an##8##3##(2007-12#3)(2008-1#2)(2008-2#2)(2008-3#1)
pumped by nanosecond pulses##2##4##(2007-11#1)(2008-2#1)
pumped by the second harmonic of a##3##7##(2007-12#2)(2008-3#1)
pumped by the second harmonic of the same Nd##3##9##(2008-1#1)(2008-2#2)
pumped by the second harmonic of##6##6##(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#1)
pumped by the##14##3##(2007-11#1)(2007-12#6)(2008-1#1)(2008-2#5)(2008-3#1)
pumped by two beam-shaped##2##4##(2007-11#1)(2007-12#1)
pumped by two##5##3##(2007-11#2)(2007-12#3)
pumped by##136##2##(2005-4#1)(2007-11#15)(2007-12#66)(2008-1#9)(2008-10#1)(2008-2#31)(2008-3#12)(2008-5#1)
pumped cw##2##2##(2007-12#1)(2008-3#1)
pumped from##2##2##(2007-8#1)(2008-10#1)
pumped into the##2##3##(1996-8#1)(2007-8#1)
pumped optical parametric oscillator##5##4##(2007-11#3)(2007-12#1)(2008-3#1)
pumped optical parametric oscillators##2##4##(2007-11#1)(2008-3#1)
pumped optical parametric##8##3##(2007-11#4)(2007-12#1)(2008-3#3)
pumped semiconductor resonator##2##3##(2007-12#2)
pumped through a##2##3##(2008-10#2)
pumped through the##5##3##(2008-10#4)(2008-11#1)
pumped through##7##2##(2008-10#6)(2008-11#1)
pumped to##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
pumped with a 458-nm Ar(+) laser##2##6##(2007-12#2)
pumped with a##12##3##(2007-11#3)(2007-12#8)(2008-1#1)
pumped with two##2##3##(2007-12#2)
pumped with##24##2##(2007-11#6)(2007-12#14)(2008-1#1)(2008-2#2)(2008-3#1)
pumped within##2##2##(2008-3#2)
pumped##278##1##(1990-2#1)(1990-9#1)(1991-5#1)(1993-5#1)(1993-6#1)(1994-2#1)(1996-1#3)(1996-8#1)(1997-3#1)(2005-4#1)(2007-11#38)(2007-12#108)(2007-8#3)(2008-1#15)(2008-10#14)(2008-11#2)(2008-2#38)(2008-3#43)(2008-5#1)(2008-7#2)(2008-9#1)(2010-3#1)
pumping a##2##2##(2007-12#1)(2008-3#1)
pumping activities##3##2##(1992-6#3)
pumping activity##2##2##(1990-3#1)(2008-7#1)
pumping and##8##2##(1992-11#2)(1994-8#1)(2006-12#1)(2007-12#2)(2007-8#1)(2008-3#1)
pumping at##10##2##(2007-11#2)(2007-12#6)(2008-3#1)(2008-7#1)
pumping by a##2##3##(2007-11#1)(2008-2#1)
pumping by##5##2##(1995-2#2)(1996-1#1)(2007-11#1)(2008-2#1)
pumping cavities are##2##3##(2008-2#1)(2008-3#1)
pumping conditions##2##2##(2007-12#1)(2008-2#1)
pumping efficiency was##2##3##(2008-2#2)
pumping efficiency##7##2##(2007-12#2)(2008-2#4)(2008-3#1)
pumping in the##2##3##(2007-11#1)(2007-12#1)
pumping in##9##2##(2007-10#1)(2007-11#2)(2007-12#6)
pumping intensity##3##2##(2007-12#1)(2008-2#2)
pumping is##4##2##(2007-11#1)(2007-12#2)(2010-2#1)
pumping method is##2##3##(2008-11#1)(2008-2#1)
pumping method##4##2##(2007-12#1)(2008-11#1)(2008-2#2)
pumping of a##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
pumping of the##5##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#1)
pumping of##16##2##(1997-8#1)(2007-11#2)(2007-12#7)(2008-10#1)(2008-2#1)(2008-3#4)
pumping power##5##2##(2007-12#3)(2008-2#1)(2008-3#1)
pumping process##2##2##(1995-2#1)(2007-12#1)
pumping radiation##2##2##(2008-2#2)
pumping rate##4##2##(1996-1#1)(2007-12#2)(2008-2#1)
pumping scheme for##3##3##(2007-12#2)(2008-3#1)
pumping scheme##6##2##(2007-12#3)(2008-1#1)(2008-3#2)
pumping source##4##2##(2007-12#1)(2008-3#3)
pumping system##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
pumping the##4##2##(1990-6#1)(2007-11#2)(2008-3#1)
pumping threshold##2##2##(2007-11#1)(2008-1#1)
pumping was##4##2##(1993-4#1)(2007-12#1)(2008-10#1)(2008-2#1)
pumping with a##5##3##(2007-12#3)(2008-2#2)
pumping with the##3##3##(2008-2#2)(2008-3#1)
pumping with##10##2##(2007-12#4)(2008-2#4)(2008-3#2)
pumping##206##1##(1990-11#1)(1990-3#2)(1990-6#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-11#2)(1992-6#4)(1992-9#1)(1993-4#1)(1994-8#1)(1995-2#4)(1996-1#3)(1997-8#1)(2005-4#1)(2005-8#1)(2006-1#1)(2006-12#2)(2006-8#1)(2007-10#1)(2007-11#25)(2007-12#60)(2007-8#1)(2008-1#5)(2008-10#5)(2008-11#2)(2008-2#33)(2008-3#32)(2008-7#2)(2008-9#1)(2009-7#1)(2010-2#2)(2010-6#1)(2010-8#3)(2011-2#1)(2012-3#1)
pumpkin and##2##2##(2008-10#1)(2012-3#1)
pumpkin##10##1##(1994-8#1)(1997-4#2)(2008-10#6)(2012-3#1)
pumpprobe##2##1##(2007-12#1)(2008-10#1)
pumps a##2##2##(2008-10#2)
pumps and their##3##3##(2006-5#1)(2010-2#1)(2010-6#1)
pumps and##6##2##(2006-5#1)(2007-9#1)(2010-2#1)(2010-6#1)(2011-2#1)(2013-1#1)
pumps can##2##2##(2011-2#2)
pumps for##3##2##(2008-7#1)(2010-6#1)(2011-1#1)
pumps has##2##2##(1992-11#1)(1992-5#1)
pumps have been##2##3##(2007-8#1)(2008-8#1)
pumps in bacteria##2##3##(2005-7#2)
pumps in##10##2##(1990-8#1)(2005-7#2)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-9#1)(2009-4#1)
pumps is##3##2##(1991-10#1)(2006-1#1)(2010-5#1)
pumps may##3##2##(1992-11#1)(2011-2#2)
pumps or##2##2##(1990-9#1)(1997-1#1)
pumps that##2##2##(1992-11#1)(2011-2#1)
pumps were##2##2##(1991-3#1)(1995-12#1)
pumps with##2##2##(1991-12#1)(2007-10#1)
pumps##133##1##(1990-7#1)(1990-8#4)(1990-9#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-11#9)(1992-5#3)(1994-4#1)(1994-8#1)(1995-12#2)(1996-11#1)(1996-4#1)(1996-8#2)(1997-1#2)(2005-7#5)(2005-8#7)(2006-1#1)(2006-10#4)(2006-12#1)(2006-5#1)(2006-6#2)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#4)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#10)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#1)(2009-6#1)(2010-2#2)(2010-5#2)(2010-6#3)(2010-8#1)(2010-9#3)(2011-1#3)(2011-2#18)(2012-12#1)(2012-3#1)(2013-1#1)
pumps)##2##1##(1992-11#1)(2008-10#1)
punch biopsies were taken from##2##5##(1996-6#1)(2008-5#1)
punch biopsies were##3##3##(1994-1#1)(1996-6#1)(2008-5#1)
punch biopsies##4##2##(1994-1#1)(1996-6#1)(2006-10#1)(2008-5#1)
punch biopsy##8##2##(1996-7#2)(2006-10#2)(2007-12#1)(2011-1#1)(2012-3#1)(2013-8#1)
punch grafting##2##2##(2007-7#2)
punch##23##1##(1994-1#1)(1996-6#1)(1996-7#2)(2006-10#3)(2006-12#2)(2006-6#2)(2007-12#1)(2007-7#2)(2008-4#2)(2008-5#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#2)
punches##5##1##(1994-2#1)(2006-12#1)(2006-6#1)(2006-7#1)(2011-1#1)
puncta##9##1##(1992-1#3)(1994-2#1)(1997-2#1)(1997-6#1)(2007-12#1)(2011-1#1)(2012-12#1)
punctata##13##1##(1995-11#3)(2008-10#5)(2008-7#3)(2009-10#1)(2010-2#1)
punctate alpha##2##2##(1994-2#2)
punctate palmoplantar##2##2##(2007-7#2)
punctate structures in##2##3##(1994-12#1)(2009-10#1)
punctate##17##1##(1991-12#1)(1992-3#1)(1994-12#1)(1994-2#2)(1995-6#1)(1996-12#1)(1997-4#1)(1997-6#1)(2007-7#3)(2008-8#1)(2009-10#1)(2009-8#3)
punctatus##12##1##(2005-11#2)(2007-12#2)(2008-10#3)(2008-7#1)(2010-3#2)(2012-3#2)
punctatus)##4##1##(1997-2#1)(1997-4#1)(2008-7#1)(2010-2#1)
punctigera##4##1##(2011-2#4)
punctual measures##3##2##(2007-3#3)
punctual##4##1##(2007-3#4)
punctuate##6##1##(1994-5#1)(1995-2#1)(2008-11#2)(2010-6#2)
punctuated by##2##2##(2011-2#1)(2012-2#1)
punctuated##3##1##(2011-2#1)(2012-2#1)(2012-3#1)
punctuation##3##1##(2007-4#1)(2012-1#2)
punctuational##2##1##(2008-8#1)(2010-6#1)
punctulata##3##1##(1994-11#1)(2007-5#2)
punctum##3##1##(2007-1#1)(2007-7#2)
puncture and##4##2##(1995-4#1)(2007-7#3)
puncture aspiration##2##2##(1994-2#1)(2009-2#1)
puncture at##3##2##(1992-5#1)(2011-1#1)(2013-1#1)
puncture headache (PDPH)##2##3##(1993-10#1)(2013-7#1)
puncture headache##8##2##(1993-10#3)(2006-10#2)(2009-7#1)(2011-1#1)(2013-7#1)
puncture in suspected purulent##2##4##(1995-11#2)
puncture in##5##2##(1992-2#1)(1995-11#2)(2007-7#2)
puncture is##3##2##(1990-10#1)(1995-11#1)(2007-7#1)
puncture of the carotid artery##2##5##(2007-7#2)
puncture of the femoral artery occurred in##2##7##(2007-7#2)
puncture of the vessel##2##4##(2007-7#2)
puncture of the##13##3##(1994-9#1)(1997-6#1)(1997-8#1)(2007-7#7)(2008-1#1)(2008-4#2)
puncture of##16##2##(1993-5#1)(1994-9#1)(1997-6#1)(1997-8#1)(2007-7#8)(2008-1#1)(2008-4#2)(2012-2#1)
puncture or##5##2##(2007-7#1)(2008-1#1)(2008-7#1)(2012-2#2)
puncture showed##2##2##(1991-5#1)(2012-3#1)
puncture site##4##2##(1991-12#1)(1992-2#1)(1994-9#1)(2011-2#1)
puncture technique##3##2##(2005-1#1)(2007-8#1)(2008-1#1)
puncture was performed##3##3##(1990-12#1)(1992-5#1)(2012-12#1)
puncture were##2##2##(2012-12#1)(2012-2#1)
puncture while##2##2##(2008-4#1)(2012-3#1)
puncture with##3##2##(2006-7#1)(2007-7#1)(2008-10#1)
puncture##127##1##(1990-10#2)(1990-12#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#2)(1992-2#3)(1992-5#2)(1992-6#1)(1993-10#6)(1993-12#1)(1993-5#2)(1994-12#1)(1994-2#1)(1994-9#2)(1995-11#5)(1995-4#2)(1996-6#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-1#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-7#25)(2007-8#1)(2008-1#6)(2008-10#3)(2008-11#5)(2008-4#4)(2008-7#2)(2009-2#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-2#3)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#4)(2011-3#1)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#1)(2013-7#1)
punctured##10##1##(1992-4#1)(1993-10#1)(1993-5#1)(1997-6#4)(2008-2#2)(2008-3#1)
punctures and##5##2##(1991-12#1)(1996-2#1)(2007-7#1)(2008-7#1)(2012-2#1)
punctures##14##1##(1990-3#1)(1990-6#1)(1991-12#1)(1992-2#1)(1996-2#1)(2007-7#3)(2008-7#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
pungency in##2##2##(1992-4#1)(2008-10#1)
pungency##8##1##(1992-4#4)(2008-10#4)
pungens##2##1##(2007-1#1)(2012-2#1)
pungent##12##1##(1990-7#1)(1992-4#2)(1997-5#1)(2004-11#1)(2006-12#3)(2008-10#1)(2009-3#1)(2010-12#1)(2011-1#1)
punic##2##1##(2008-5#2)
punish##2##1##(1993-12#1)(2006-2#1)
punished##2##1##(1991-11#1)(2008-8#1)
punishment in the##3##3##(1995-5#1)(2008-8#1)(2011-2#1)
punishment in##4##2##(1995-11#1)(1995-5#1)(2008-8#1)(2011-2#1)
punishment or##2##2##(1997-3#1)(2009-9#1)
punishment that##2##2##(2008-8#2)
punishment##39##1##(1991-10#1)(1992-1#2)(1993-9#1)(1994-3#6)(1995-11#1)(1995-5#1)(1995-9#2)(1996-11#1)(1996-5#1)(1997-3#1)(2005-8#1)(2006-4#1)(2006-7#1)(2007-2#1)(2008-11#1)(2008-8#7)(2009-2#1)(2009-9#1)(2010-11#1)(2010-2#1)(2011-2#2)(2012-2#3)(2013-8#1)
punishment--a medical##2##2##(1994-6#1)(1994-8#1)
punishments##4##1##(1992-1#2)(2005-8#1)(2009-2#1)
punitive damages##11##2##(1992-2#5)(1992-3#5)(1994-1#1)
punitive##13##1##(1992-2#5)(1992-3#5)(1994-1#1)(2008-5#1)(2012-11#1)
pup removal##2##2##(1993-2#1)(2008-11#1)
pup survival##2##2##(1992-9#1)(2005-7#1)
pup##14##1##(1992-9#1)(1993-2#1)(1994-2#1)(1996-8#1)(2005-7#1)(2008-11#1)(2008-4#2)(2008-8#1)(2012-12#3)(2013-8#2)
pup-directed##2##1##(2008-11#2)
pup-retrieving and##2##2##(1991-1#2)
pup-retrieving##3##1##(1991-1#3)
pup-searching behavior were##2##3##(1991-1#2)
pup-searching##3##1##(1991-1#3)
pupa##7##1##(2007-12#1)(2007-3#1)(2008-6#3)(2011-12#1)(2013-7#1)
pupae had##2##2##(1995-2#1)(2007-12#1)
pupae in cups##2##3##(2011-12#2)
pupae in##3##2##(2011-12#3)
pupae of Calliphora vicina##2##4##(1990-7#2)
pupae of##7##2##(1990-7#2)(2007-11#1)(2008-11#1)(2008-6#2)(2011-12#1)
pupae showed##2##2##(2007-12#2)
pupae were registered##2##3##(2008-5#2)
pupae were##5##2##(2008-5#4)(2011-12#1)
pupae##40##1##(1990-7#2)(1993-5#1)(1995-2#1)(1997-8#1)(2007-11#8)(2007-12#4)(2007-3#2)(2008-11#3)(2008-5#5)(2008-6#4)(2008-8#2)(2008-9#2)(2011-12#5)
pupal wings##3##2##(2008-11#3)
pupal##24##1##(1991-10#1)(1991-11#1)(2007-12#10)(2008-11#5)(2008-5#2)(2008-8#1)(2011-12#4)
puparia##3##1##(2011-2#3)
pupariation##3##1##(1995-2#2)(2011-12#1)
pupation##5##1##(2008-10#1)(2008-9#2)(2010-10#1)(2011-2#1)
pupil diameter of##2##3##(2007-11#1)(2013-1#1)
pupil diameter##3##2##(2007-11#1)(2013-1#2)
pupil dilation##2##2##(1992-4#1)(2008-7#1)
pupil filter##3##2##(2007-12#3)
pupil filters##2##2##(2007-12#1)(2008-2#1)
pupil function##5##2##(2008-2#5)
pupil is##3##2##(2007-11#1)(2008-2#2)
pupil of a##2##3##(2007-12#1)(2008-2#1)
pupil of##6##2##(2007-12#1)(2008-2#4)(2008-7#1)
pupil phase##2##2##(2008-2#2)
pupil rms##3##2##(2008-2#3)
pupil size and##2##3##(2007-11#1)(2012-12#1)
pupil size##7##2##(1993-11#2)(2007-11#2)(2008-7#1)(2012-12#1)(2013-1#1)
pupil with##3##2##(2007-3#2)(2008-3#1)
pupil##75##1##(1992-4#1)(1993-11#2)(2006-11#1)(2007-11#9)(2007-12#5)(2007-3#2)(2008-2#25)(2008-3#14)(2008-7#4)(2010-1#1)(2010-8#1)(2010-9#2)(2011-1#3)(2012-12#1)(2013-1#3)(2013-7#1)
pupil-plane filter##2##2##(2007-12#2)
pupil-plane##4##1##(2007-12#4)
pupillary##10##1##(1990-9#1)(1992-7#1)(2006-4#1)(2007-9#2)(2008-7#2)(2011-1#3)
pupils aged 12##2##3##(1991-8#1)(1994-6#1)
pupils aged##5##2##(1991-8#1)(1992-8#1)(1994-6#1)(2009-10#1)(2012-12#1)
pupils from##2##2##(2007-2#1)(2010-2#1)
pupils had##2##2##(1992-8#1)(1995-12#1)
pupils in the 4th##2##4##(2006-8#2)
pupils in the##6##3##(1992-8#1)(2006-8#3)(2009-10#1)(2010-2#1)
pupils in##11##2##(1991-8#1)(1992-8#1)(1993-10#1)(1996-6#1)(2006-8#4)(2009-10#1)(2010-2#1)(2012-3#1)
pupils of classes 3##3##4##(2007-2#1)(2007-7#2)
pupils of##6##2##(2007-2#1)(2007-7#2)(2008-2#1)(2009-2#1)(2012-2#1)
pupils were##2##2##(2007-9#1)(2008-7#1)
pupils who spoke##2##3##(1992-8#2)
pupils who##5##2##(1992-8#2)(1996-6#1)(2005-9#1)(2010-2#1)
pupils##53##1##(1991-5#1)(1991-8#2)(1992-8#6)(1993-10#2)(1994-6#2)(1995-12#1)(1995-9#1)(1996-6#3)(2005-9#1)(2006-4#2)(2006-8#8)(2007-2#4)(2007-7#2)(2007-9#1)(2008-10#1)(2008-2#2)(2008-7#1)(2009-10#3)(2009-2#1)(2010-2#3)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
pupils' attitudes towards mental illness##2##5##(2011-2#2)
pupils'##5##1##(1993-6#2)(2010-2#1)(2011-2#2)
puppet##2##1##(2008-12#1)(2012-3#1)
puppies##2##1##(2009-4#2)
puppy##5##1##(2012-12#1)(2012-2#4)
pups after##2##2##(2005-8#1)(2008-8#1)
pups and##3##2##(1992-8#1)(1994-3#1)(2010-12#1)
pups as##2##2##(1991-1#1)(1992-9#1)
pups at##2##2##(1995-11#1)(1995-9#1)
pups born##4##2##(1995-6#1)(2005-7#1)(2008-11#1)(2012-1#1)
pups by##2##2##(1991-1#1)(1993-2#1)
pups for##2##2##(1993-2#1)(2008-3#1)
pups from the same##2##4##(2008-3#2)
pups from the##3##3##(1992-3#1)(2008-3#2)
pups from##5##2##(1992-3#1)(2008-3#3)(2013-8#1)
pups in##3##2##(2008-11#1)(2008-3#1)(2010-12#1)
pups of##2##2##(1991-10#1)(2004-11#1)
pups treated with##2##3##(1992-10#1)(1996-12#1)
pups were injected with##2##4##(2012-3#2)
pups were##13##2##(1990-5#1)(1992-10#1)(1996-12#1)(1996-5#2)(2005-7#1)(2008-10#1)(2008-11#1)(2009-5#1)(2009-9#1)(2012-3#2)(2013-8#1)
pups##84##1##(1990-5#2)(1991-1#2)(1991-10#1)(1991-2#7)(1992-10#2)(1992-3#2)(1992-8#1)(1992-9#6)(1993-2#3)(1994-11#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-12#2)(1996-4#1)(1996-5#2)(2004-11#1)(2005-7#7)(2005-8#1)(2007-5#1)(2008-10#6)(2008-11#4)(2008-3#6)(2008-4#1)(2008-7#4)(2008-8#1)(2009-5#1)(2009-9#1)(2010-12#3)(2012-1#3)(2012-12#1)(2012-3#2)(2013-8#3)
pups'##5##1##(1992-9#5)
pupunha palm (Bactris gasipaes Kunth)##2##5##(2007-7#2)
purE##2##1##(1997-6#2)
purK##3##1##(1997-6#3)
purchase a##2##2##(1993-12#1)(2007-4#1)
purchase and use##2##3##(2006-10#1)(2010-9#1)
purchase and##11##2##(1991-1#1)(1992-12#2)(1996-2#2)(2006-10#1)(2008-3#1)(2008-9#1)(2010-12#1)(2010-5#1)(2010-9#1)
purchase in##2##2##(1992-12#1)(2009-3#1)
purchase of##7##2##(1994-10#1)(1994-4#1)(1996-12#1)(1996-2#1)(2008-10#1)(2008-4#1)(2010-9#1)
purchase##58##1##(1990-12#2)(1991-1#1)(1992-12#3)(1993-1#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-3#2)(1994-4#1)(1995-2#3)(1995-3#1)(1996-11#3)(1996-12#1)(1996-2#3)(1997-3#1)(1997-8#1)(2004-2#1)(2005-7#1)(2006-10#2)(2006-7#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-3#2)(2010-12#1)(2010-5#1)(2010-9#2)(2011-2#1)(2012-12#3)(2012-2#3)(2013-1#1)
purchased at a##2##3##(1996-3#1)(2011-2#1)
purchased from##4##2##(1997-4#1)(2007-2#1)(2007-6#1)(2013-8#1)
purchased##21##1##(1992-3#1)(1992-5#1)(1994-2#1)(1996-3#2)(1997-4#1)(1997-5#1)(2005-1#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-8#2)
purchaser and##2##2##(1994-1#1)(1996-2#1)
purchaser demands##2##2##(1994-2#1)(1996-1#1)
purchaser##8##1##(1994-1#1)(1994-12#1)(1994-2#1)(1996-1#1)(1996-2#2)(1997-2#1)(2006-5#1)
purchasers and providers is producing profound changes in the##2##9##(1994-12#2)
purchasers and providers##6##3##(1994-1#2)(1994-12#2)(1995-12#1)(1997-1#1)
purchasers and##9##2##(1990-12#1)(1994-1#2)(1994-12#2)(1995-12#1)(1995-2#1)(1996-12#1)(1997-1#1)
purchasers of care##3##3##(1993-3#1)(1996-2#1)(2007-4#1)
purchasers of health care##3##4##(1991-12#1)(1997-3#2)
purchasers of health##4##3##(1991-12#1)(1996-2#1)(1997-3#2)
purchasers of##9##2##(1991-12#2)(1993-3#1)(1996-12#1)(1996-2#2)(1997-3#2)(2007-4#1)
purchasers to##4##2##(1994-12#1)(1996-2#2)(1997-1#1)
purchasers##37##1##(1990-12#1)(1991-12#2)(1991-3#2)(1993-12#3)(1993-3#1)(1994-1#3)(1994-12#3)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#2)(1996-2#4)(1997-1#3)(1997-3#3)(2006-5#1)(2007-4#1)(2008-11#1)
purchases##8##1##(1991-1#1)(1993-5#1)(1994-1#1)(1994-12#1)(1994-3#1)(1997-1#1)(2011-2#2)
purchasing a##2##2##(1992-12#2)
purchasing and##2##2##(1996-2#1)(2008-11#1)
purchasing cooperatives##2##2##(1994-12#1)(1997-3#1)
purchasing decisions##6##2##(1991-2#1)(1994-3#2)(1996-8#1)(1997-3#1)(2008-10#1)
purchasing groups##2##2##(1990-5#1)(1992-9#1)
purchasing power##4##2##(1992-9#1)(1994-1#1)(2006-10#1)(2007-2#1)
purchasing strategies##2##2##(1994-1#1)(1996-12#1)
purchasing survey##2##2##(1992-9#2)
purchasing##49##1##(1990-5#1)(1991-2#1)(1991-4#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-9#4)(1993-1#1)(1994-1#2)(1994-10#1)(1994-12#3)(1994-2#1)(1994-3#4)(1995-12#1)(1995-3#1)(1996-12#1)(1996-2#3)(1996-8#1)(1997-2#1)(1997-3#2)(2004-5#1)(2005-7#1)(2006-10#1)(2007-2#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#2)(2010-9#2)(2013-8#1)
pure 1##2##2##(1996-2#1)(2009-3#1)
pure 2D PCs##2##3##(2007-11#2)
pure Ar##2##2##(2007-9#1)(2008-10#1)
pure B##2##2##(2012-1#2)
pure CH(4)##2##2##(2008-2#2)
pure DPPC##7##2##(1990-3#1)(1992-3#1)(1995-10#1)(2008-10#3)(2008-8#1)
pure L-(+)-lactic acid##2##3##(2008-6#2)
pure L-amino acids##4##3##(1992-11#1)(1995-3#3)
pure PLGA nanoparticles##2##3##(2010-1#2)
pure absorption spectrum##2##3##(2010-5#2)
pure active##2##2##(2008-4#1)(2008-5#1)
pure alcohols##2##2##(1995-8#1)(2010-2#1)
pure alexia##7##2##(2008-4#5)(2008-9#2)
pure and applied science##3##4##(2013-1#3)
pure and defined mixed cultures of anaerobic##2##7##(2006-3#2)
pure and mixed cultures as well as##2##7##(1997-6#1)(2011-1#1)
pure and mixed cultures##3##4##(1997-6#1)(2008-10#1)(2011-1#1)
pure and mixed##4##3##(1997-6#1)(2008-10#1)(2011-1#1)(2011-2#1)
pure and pharmaceutical##3##3##(2008-10#3)
pure and##28##2##(1991-1#1)(1991-3#1)(1991-5#1)(1994-5#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-6#1)(2006-3#2)(2007-11#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#4)
pure anthocyanins##2##2##(2011-2#2)
pure apatite##4##2##(2008-10#4)
pure cell##2##2##(1994-5#1)(2008-11#1)
pure cells##2##2##(2008-4#1)(2008-9#1)
pure collagen##2##2##(2008-5#1)(2009-7#1)
pure component spectra##3##3##(2007-12#3)
pure component##4##2##(2007-12#4)
pure components emission##2##3##(2008-10#2)
pure components##6##2##(2005-11#1)(2008-10#5)
pure compound##5##2##(1996-2#1)(1996-4#1)(2007-6#1)(2008-10#2)
pure compounds as##2##3##(2006-12#1)(2008-10#1)
pure compounds##6##2##(2006-12#2)(2007-6#2)(2008-10#2)
pure conjugate##2##2##(1990-8#2)
pure copper##5##2##(1996-2#1)(2008-8#4)
pure culture##14##2##(2006-10#1)(2006-8#1)(2007-5#1)(2008-10#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-4#1)(2012-2#2)
pure cultures and##2##3##(1992-7#1)(2008-10#1)
pure cultures of##6##3##(2006-3#1)(2006-8#1)(2007-5#1)(2008-10#2)(2008-9#1)
pure cultures##11##2##(1992-7#1)(2006-3#1)(2006-8#1)(2007-5#1)(2008-10#5)(2008-6#1)(2008-9#1)
pure curvature and twist distribution fields##2##6##(2008-3#2)
pure curvature and twist##3##4##(2008-3#3)
pure daidzin##3##2##(1996-4#3)
pure drug##6##2##(2008-10#4)(2010-2#1)(2012-2#1)
pure drugs-of-abuse##2##2##(2010-5#2)
pure fetal##2##2##(2013-1#2)
pure form and in pharmaceutical##2##5##(2008-10#2)
pure form and in##3##4##(2008-10#3)
pure form and##4##3##(2008-10#3)(2011-1#1)
pure form##18##2##(1991-7#1)(1994-2#1)(1996-8#1)(2008-10#10)(2008-5#1)(2010-5#1)(2011-1#1)(2012-2#2)
pure forms##3##2##(1992-12#1)(2007-11#1)(2008-11#1)
pure fractions##2##2##(1993-9#1)(1997-2#1)
pure fused silica##2##3##(2007-12#2)
pure gold##3##2##(2008-10#3)
pure henna is##2##3##(2006-12#2)
pure laparoscopic##3##2##(2013-8#3)
pure left hemialexia##2##3##(2008-4#2)
pure lipid model membranes##2##4##(1991-9#2)
pure lipid##4##2##(1990-4#1)(1991-9#2)(1993-9#1)
pure liquid phase##5##3##(1991-4#2)(1992-5#1)(2006-10#2)
pure liquid##8##2##(1991-4#2)(1992-5#1)(2006-10#3)(2008-2#1)(2008-3#1)
pure marble trout##3##3##(2008-3#3)
pure metal##2##2##(1996-8#1)(2008-3#1)
pure methyl##3##2##(2007-3#1)(2008-10#1)(2009-8#1)
pure moment and##2##3##(2006-11#1)(2012-2#1)
pure motor weakness of an##2##5##(2007-10#2)
pure nitrogen##2##2##(2008-10#1)(2008-3#1)
pure or##2##2##(1992-8#1)(2012-10#1)
pure organic##2##2##(2006-8#1)(2008-10#1)
pure pesticide vapor and##2##4##(2008-10#2)
pure phospholipid##7##2##(1990-2#1)(1997-4#1)(2006-10#5)
pure poplar##2##2##(2013-8#2)
pure population of##3##3##(1990-4#1)(1992-8#1)(2012-12#1)
pure population##4##2##(1990-4#1)(1992-8#1)(1995-1#1)(2012-12#1)
pure populations of##3##3##(2008-11#1)(2008-4#1)(2013-1#1)
pure populations##4##2##(2008-11#1)(2008-4#2)(2013-1#1)
pure preparations##3##2##(1991-5#2)(1997-8#1)
pure progenitors##2##2##(1990-9#2)
pure protein##11##2##(1991-5#1)(1991-7#1)(1996-3#1)(1996-4#1)(1997-4#1)(2006-10#1)(2007-8#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-7#1)
pure proteins##4##2##(1990-12#1)(1994-10#1)(1995-8#1)(2005-10#1)
pure psi##2##2##(2006-5#2)
pure random##2##2##(1993-12#1)(2008-10#1)
pure recombinant##4##2##(1995-3#1)(2006-12#1)(2008-4#2)
pure red cell aplasia (PRCA)##2##5##(2008-10#1)(2008-12#1)
pure red cell aplasia##4##4##(2007-10#1)(2008-10#1)(2008-12#1)(2013-1#1)
pure red cell##6##3##(2007-10#1)(2008-10#1)(2008-12#2)(2013-1#2)
pure red##7##2##(2007-10#1)(2008-10#1)(2008-12#2)(2013-1#3)
pure rotational CARS##2##3##(2008-2#2)
pure rotational Raman scattering##2##4##(2007-12#2)
pure rotational Raman##6##3##(2007-12#2)(2008-3#4)
pure rotational coherent anti-Stokes Raman scattering (CARS)##2##7##(2008-2#2)
pure rotational coherent anti-Stokes Raman scattering##3##6##(2008-2#2)(2008-3#1)
pure rotational coherent##4##3##(2008-2#2)(2008-3#2)
pure rotational##13##2##(2007-12#3)(2008-2#4)(2008-3#6)
pure science##6##2##(2010-8#1)(2013-1#5)
pure seawater##2##2##(2008-3#2)
pure seminoma##3##2##(2006-10#1)(2008-6#1)(2011-1#1)
pure silica##4##2##(2007-11#2)(2007-12#2)
pure solutions##2##2##(2008-10#2)
pure spherical##2##2##(2005-11#1)(2008-3#1)
pure stand##3##2##(2008-10#3)
pure standards##3##2##(1996-6#1)(1997-8#2)
pure stands and mixtures##2##4##(2008-10#2)
pure stands and##3##3##(2008-10#3)
pure stands##11##2##(2008-10#11)
pure state##2##2##(1996-1#1)(2008-10#1)
pure substances##2##2##(2008-5#1)(2008-7#1)
pure titanium##7##2##(2008-11#1)(2008-5#3)(2009-7#1)(2009-9#1)(2013-1#1)
pure tone##4##2##(1991-12#1)(2008-1#1)(2008-2#2)
pure tones##4##2##(1997-7#3)(2008-9#1)
pure variables##2##2##(2008-10#2)
pure water and seawater##2##4##(2008-2#2)
pure water and##6##3##(2005-11#4)(2008-2#2)
pure water at##2##3##(2008-2#1)(2013-8#1)
pure water clusters##2##3##(2006-8#2)
pure water was##2##3##(2008-11#1)(2008-2#1)
pure water with##2##3##(2008-10#1)(2008-3#1)
pure water##40##2##(1995-3#2)(1997-6#1)(2004-9#1)(2005-11#5)(2006-10#1)(2006-8#2)(2008-10#7)(2008-11#1)(2008-2#11)(2008-3#6)(2010-4#1)(2011-1#1)(2013-8#1)
pure μ-opioid##2##2##(2011-1#2)
pure##758##1##(1990-11#2)(1990-12#5)(1990-2#4)(1990-3#3)(1990-4#4)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#4)(1991-1#1)(1991-12#1)(1991-3#4)(1991-4#4)(1991-5#6)(1991-6#2)(1991-7#2)(1991-9#4)(1992-1#4)(1992-10#1)(1992-11#4)(1992-12#1)(1992-3#3)(1992-5#4)(1992-6#2)(1992-7#5)(1992-8#4)(1992-9#2)(1993-10#1)(1993-11#2)(1993-12#3)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#2)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#2)(1995-2#2)(1995-3#11)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-1#1)(1996-2#6)(1996-3#1)(1996-4#6)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#6)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#6)(1997-6#4)(1997-7#3)(1997-8#3)(2004-2#2)(2004-9#5)(2005-10#2)(2005-11#20)(2005-12#1)(2005-4#6)(2005-7#2)(2005-8#1)(2006-10#15)(2006-11#1)(2006-12#7)(2006-3#3)(2006-5#2)(2006-7#1)(2006-8#5)(2007-1#1)(2007-10#3)(2007-11#19)(2007-12#25)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#5)(2007-7#1)(2007-8#4)(2007-9#3)(2008-1#4)(2008-10#120)(2008-11#11)(2008-12#8)(2008-2#36)(2008-3#47)(2008-4#17)(2008-5#24)(2008-6#13)(2008-7#12)(2008-8#10)(2008-9#11)(2009-12#1)(2009-3#6)(2009-4#2)(2009-7#2)(2009-8#4)(2009-9#3)(2010-1#2)(2010-10#3)(2010-12#7)(2010-2#5)(2010-4#5)(2010-5#7)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#11)(2011-12#2)(2011-2#5)(2012-1#4)(2012-10#1)(2012-12#6)(2012-2#6)(2012-3#3)(2013-1#22)(2013-7#1)(2013-8#12)
pure&quot##6##1##(1991-1#1)(2007-8#1)(2011-2#1)(2013-1#3)
pure) by gavage for##2##4##(2008-9#2)
pure) dermally for##2##3##(2008-9#2)
pure) in##3##2##(2008-9#3)
pure)##10##1##(2008-11#1)(2008-8#1)(2008-9#8)
pure-phase##6##1##(2008-2#4)(2008-3#2)
pure-tone audiometry##3##2##(2008-1#3)
purebred##2##1##(2008-3#1)(2010-7#1)
purely electronic##2##2##(1992-5#1)(2008-3#1)
purely for##2##2##(2009-2#1)(2011-1#1)
purely mechanical##2##2##(2009-12#1)(2011-2#1)
purely medical##2##2##(1990-10#1)(2008-10#1)
purely of##3##2##(2009-10#1)(2009-9#1)(2011-1#1)
purely optical means##2##3##(2008-2#1)(2008-3#1)
purely optical##3##2##(2006-5#1)(2008-2#1)(2008-3#1)
purely technical##2##2##(2007-4#1)(2008-5#1)
purely##92##1##(1990-10#1)(1990-7#1)(1991-2#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-5#2)(1994-2#1)(1995-10#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-9#1)(2005-6#1)(2006-10#3)(2006-11#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#6)(2007-3#1)(2007-4#1)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#2)(2008-2#6)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-5#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#8)(2013-1#1)
purer##2##1##(1997-6#1)(2008-9#1)
purest##3##1##(1992-2#1)(2008-11#1)(2008-2#1)
purge and trap##3##3##(2008-10#2)(2010-11#1)
purge and##4##2##(2008-10#3)(2010-11#1)
purge gas##2##2##(2008-10#2)
purge##19##1##(1990-11#1)(1995-6#1)(1997-3#1)(2006-7#2)(2008-10#8)(2008-5#1)(2010-11#1)(2010-4#3)(2011-1#1)
purge-and-trap and##2##2##(2008-10#2)
purge-and-trap##5##1##(2008-10#5)
purged into the##2##3##(2008-10#2)
purged or unpurged##2##3##(1993-1#2)
purged##5##1##(1993-1#2)(1997-7#1)(2008-10#2)
purging of##3##2##(1991-11#1)(2005-9#1)(2013-1#1)
purging##22##1##(1990-4#2)(1991-11#1)(1994-5#1)(2005-9#1)(2006-7#4)(2007-12#1)(2007-7#1)(2008-10#7)(2008-3#1)(2011-12#1)(2013-1#2)
purification and analysis of##3##4##(1997-8#1)(2008-2#1)(2013-8#1)
purification and cDNA##2##3##(1992-1#1)(1994-12#1)
purification and characterization of DNA##2##5##(1991-7#1)(1996-10#1)
purification and characterization of a new##2##6##(1994-5#1)(1994-9#1)
purification and characterization of a##7##5##(1990-4#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-6#1)
purification and characterization of recombinant##3##5##(1990-8#1)(1991-10#1)(1991-7#1)
purification and characterization of the##6##5##(1990-7#1)(1991-5#1)(1995-8#1)(1997-6#1)(1997-7#1)(2008-4#1)
purification and characterization of##24##4##(1990-4#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-2#1)(1991-5#1)(1991-7#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-12#1)(1997-4#1)(1997-6#2)(1997-7#1)(2008-4#2)(2009-4#1)
purification and characterization##30##3##(1990-11#1)(1990-4#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-12#1)(1997-4#1)(1997-6#2)(1997-7#1)(2008-4#3)(2009-4#1)
purification and concentration of##2##4##(1992-1#1)(2008-10#1)
purification and concentration##4##3##(1992-1#1)(2008-10#1)(2008-2#1)(2008-4#1)
purification and identification by##2##4##(1990-2#1)(2010-11#1)
purification and identification of##3##4##(2008-4#1)(2008-6#1)(2012-11#1)
purification and identification##5##3##(1990-2#1)(2008-4#1)(2008-6#1)(2010-11#1)(2012-11#1)
purification and properties of the##3##5##(1990-12#1)(1992-3#1)(1995-2#1)
purification and properties of##4##4##(1990-12#1)(1992-3#1)(1992-4#1)(1995-2#1)
purification and properties##5##3##(1990-12#1)(1992-12#1)(1992-3#1)(1992-4#1)(1995-2#1)
purification and renaturation##2##3##(1991-7#1)(1994-12#1)
purification and synthesis##2##3##(2006-10#1)(2008-2#1)
purification and##97##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#2)(1990-5#3)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-1#3)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-4#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#5)(1995-3#1)(1995-8#1)(1996-10#1)(1996-12#2)(1996-4#1)(1996-5#1)(1996-8#5)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2006-10#1)(2008-1#2)(2008-10#4)(2008-2#3)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2010-11#1)(2012-11#1)(2013-8#1)
purification by chromatography##2##3##(1994-12#1)(1995-10#1)
purification by##19##2##(1990-11#1)(1990-2#1)(1992-11#1)(1992-3#2)(1993-8#1)(1994-12#1)(1994-5#1)(1995-10#1)(1996-9#1)(1997-8#1)(2008-11#1)(2008-4#4)(2008-5#1)(2008-9#1)(2012-2#1)
purification can be##2##3##(2008-10#1)(2008-4#1)
purification factor of##3##3##(1991-2#1)(1996-11#1)(2008-11#1)
purification factor##5##2##(1991-2#1)(1992-7#1)(1996-11#1)(1997-6#1)(2008-11#1)
purification factors##2##2##(1996-8#1)(2008-7#1)
purification from##10##2##(1992-12#1)(1993-6#1)(1993-8#1)(1995-1#1)(1995-12#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-11#1)
purification in order to investigate##2##5##(2007-9#2)
purification in##6##2##(1995-8#1)(1997-7#1)(2006-4#1)(2007-9#2)(2008-4#1)
purification method##5##2##(1990-12#1)(1991-12#1)(2008-4#1)(2008-5#1)(2013-1#1)
purification methods##3##2##(2008-1#1)(2008-11#1)(2008-4#1)
purification of DNA from small volumes (&lt##2##7##(2008-2#1)(2008-4#1)
purification of DNA from##3##4##(2008-10#1)(2008-2#1)(2008-4#1)
purification of IgM##3##3##(1996-8#1)(2008-4#2)
purification of T##2##3##(2008-11#1)(2008-4#1)
purification of a recombinant##2##4##(1993-12#1)(2008-4#1)
purification of a##16##3##(1990-11#1)(1990-8#1)(1991-11#1)(1992-3#1)(1993-12#1)(1993-4#1)(1993-7#1)(1994-12#1)(1995-3#1)(1996-4#1)(1996-9#1)(2008-10#2)(2008-4#3)
purification of active##3##3##(1994-12#1)(2008-4#2)
purification of an##4##3##(1990-5#1)(1993-12#1)(1993-4#1)(2010-10#1)
purification of antibodies##2##3##(1995-12#1)(2008-4#1)
purification of antigens is##2##4##(2008-4#2)
purification of crude##4##3##(1996-5#1)(1997-3#1)(2008-4#2)
purification of each##2##3##(1992-4#1)(2008-1#1)
purification of human##8##3##(1990-7#1)(1992-11#1)(1993-9#1)(1996-3#1)(2008-11#1)(2008-4#2)(2008-8#1)
purification of large##4##3##(1997-5#1)(2008-2#1)(2008-4#1)(2010-10#1)
purification of mitochondrial##2##3##(1992-2#1)(1997-4#1)
purification of monoclonal antibodies##2##4##(1997-3#2)
purification of mouse##2##3##(1994-11#1)(2008-4#1)
purification of nuclear##2##3##(1991-6#1)(1997-2#1)
purification of one of the##2##5##(2008-5#1)(2013-1#1)
purification of one##3##3##(1991-1#1)(2008-5#1)(2013-1#1)
purification of proteins##3##3##(1995-8#1)(2008-10#1)(2008-2#1)
purification of rat##3##3##(1991-6#1)(2008-4#1)(2011-2#1)
purification of recombinant proteins##2##4##(2008-2#1)(2008-4#1)
purification of recombinant##7##3##(1995-6#1)(1997-1#1)(2008-1#1)(2008-2#1)(2008-4#2)(2012-12#1)
purification of soluble##2##3##(1992-11#1)(2008-10#1)
purification of streptokinase##2##3##(2012-2#2)
purification of the enzyme##6##4##(1990-12#1)(1991-5#1)(1993-9#1)(1995-8#1)(1997-4#1)(2011-1#1)
purification of the fusion protein##2##5##(1997-4#1)(2008-4#1)
purification of the major##2##4##(1995-3#1)(2008-4#1)
purification of the protein##2##4##(1990-4#1)(1993-12#1)
purification of the##51##3##(1990-12#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-9#2)(1994-11#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-3#2)(1995-8#2)(1997-2#1)(1997-4#2)(1997-7#1)(2005-11#1)(2006-8#1)(2007-7#1)(2008-10#4)(2008-11#5)(2008-2#2)(2008-4#5)(2008-5#2)(2009-9#1)(2011-1#1)(2013-1#1)
purification of these enzymes##3##4##(1991-5#2)(1992-5#1)
purification of these##4##3##(1991-5#2)(1992-5#1)(2008-4#1)
purification of this##5##3##(1991-11#1)(1992-11#1)(1993-12#1)(1995-2#1)(1996-8#1)
purification of total##2##3##(2009-12#1)(2011-1#1)
purification of two##2##3##(1990-2#1)(1994-8#1)
purification of##281##2##(1990-11#1)(1990-12#5)(1990-2#2)(1990-4#4)(1990-5#2)(1990-6#1)(1990-7#5)(1990-8#5)(1991-1#2)(1991-11#4)(1991-12#1)(1991-2#3)(1991-5#4)(1991-6#3)(1992-11#6)(1992-2#2)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#1)(1992-9#1)(1993-12#4)(1993-4#2)(1993-7#1)(1993-9#4)(1994-11#3)(1994-12#3)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#5)(1995-5#1)(1995-6#4)(1995-8#4)(1996-2#1)(1996-3#4)(1996-4#1)(1996-5#2)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#2)(2005-11#1)(2006-8#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#9)(2008-10#15)(2008-11#13)(2008-2#10)(2008-4#64)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-9#1)(2010-10#2)(2010-12#1)(2011-1#5)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#3)
purification on a##2##3##(1992-2#1)(2008-10#1)
purification on##6##2##(1991-11#1)(1991-12#1)(1992-2#2)(1996-4#1)(2008-10#1)
purification or##3##2##(2008-4#1)(2009-12#1)(2011-1#1)
purification procedure by##2##3##(1992-6#1)(1994-8#1)
purification procedure for##3##3##(1990-12#1)(1992-12#1)(2008-10#1)
purification procedure to##2##3##(1994-8#1)(2008-3#1)
purification procedure using##2##3##(1992-1#1)(1995-8#1)
purification procedure which##2##3##(1990-4#1)(2008-10#1)
purification procedure##24##2##(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-6#1)(1994-8#2)(1995-1#1)(1995-8#1)(1996-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#2)(2009-12#1)
purification procedures for##2##3##(1995-3#1)(2008-10#1)
purification procedures##14##2##(1991-11#1)(1992-11#1)(1993-12#1)(1995-3#2)(1996-8#1)(2007-11#1)(2008-10#3)(2008-4#2)(2008-8#1)(2010-12#1)
purification process of##2##3##(2008-11#1)(2012-3#1)
purification process##10##2##(1992-1#2)(1994-2#1)(2005-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2012-12#1)(2012-3#1)
purification protocol##3##2##(2008-4#3)
purification protocols##2##2##(2008-4#2)
purification scheme##2##2##(1990-12#1)(2008-4#1)
purification schemes##2##2##(1995-12#1)(2008-1#1)
purification step is##2##3##(2008-10#1)(2008-5#1)
purification step of##2##3##(1994-8#1)(2008-10#1)
purification step##10##2##(1990-2#1)(1991-5#1)(1994-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
purification steps##9##2##(1990-9#1)(1996-12#1)(1996-3#1)(2008-10#4)(2008-12#1)(2008-7#1)
purification studies##2##2##(1991-4#1)(2007-1#1)
purification through##3##2##(1993-9#1)(2008-2#1)(2008-4#1)
purification to homogeneity of##2##4##(1990-11#1)(1991-3#1)
purification to homogeneity##4##3##(1990-11#1)(1991-3#1)(1994-12#1)(1995-2#1)
purification using methacrylate##2##3##(2013-1#2)
purification using##11##2##(1996-8#1)(1997-3#1)(2008-11#1)(2008-2#2)(2008-4#4)(2013-1#2)
purification was##9##2##(1990-11#1)(1991-7#1)(1992-7#1)(1994-5#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-7#1)
purification were##4##2##(1994-12#1)(1997-8#1)(2008-7#1)(2011-3#1)
purification with##2##2##(1994-5#1)(2008-4#1)
purification##700##1##(1990-10#1)(1990-11#6)(1990-12#13)(1990-2#6)(1990-3#1)(1990-4#10)(1990-5#9)(1990-6#2)(1990-7#7)(1990-8#9)(1990-9#3)(1991-1#3)(1991-10#1)(1991-11#7)(1991-12#5)(1991-2#6)(1991-3#1)(1991-4#2)(1991-5#8)(1991-6#4)(1991-7#6)(1991-8#1)(1991-9#1)(1992-1#6)(1992-11#10)(1992-12#3)(1992-2#5)(1992-3#6)(1992-4#3)(1992-5#3)(1992-6#4)(1992-7#5)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#8)(1993-4#3)(1993-6#2)(1993-7#1)(1993-8#3)(1993-9#6)(1994-10#1)(1994-11#7)(1994-12#10)(1994-2#3)(1994-5#6)(1994-6#3)(1994-8#4)(1994-9#1)(1995-1#5)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#9)(1995-3#10)(1995-5#1)(1995-6#4)(1995-8#7)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#5)(1996-4#4)(1996-5#6)(1996-7#1)(1996-8#13)(1996-9#3)(1997-1#2)(1997-2#4)(1997-3#4)(1997-4#5)(1997-5#2)(1997-6#4)(1997-7#4)(1997-8#5)(2004-8#1)(2004-9#1)(2005-11#2)(2005-4#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-8#1)(2007-1#1)(2007-11#4)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#16)(2008-10#54)(2008-11#26)(2008-12#1)(2008-2#20)(2008-3#2)(2008-4#122)(2008-5#7)(2008-6#3)(2008-7#16)(2008-8#6)(2008-9#8)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#3)(2009-4#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-5#1)(2010-7#1)(2011-1#8)(2011-2#5)(2011-3#1)(2012-11#1)(2012-12#4)(2012-2#7)(2012-3#2)(2013-1#9)(2013-7#2)(2013-8#6)
purification)##2##1##(2007-9#1)(2008-4#1)
purifications##12##1##(1990-12#2)(1994-12#3)(1996-5#2)(2008-10#2)(2008-4#2)(2008-7#1)
purified (approximately##2##2##(1993-3#1)(1997-6#1)
purified 25-fold##2##2##(1993-9#2)
purified A##2##2##(1990-11#1)(1994-12#1)
purified ASB##2##2##(1997-8#2)
purified B cells##2##3##(1996-1#1)(2008-4#1)
purified B##3##2##(1996-1#2)(2008-4#1)
purified C##2##2##(2007-12#1)(2008-10#1)
purified DNA##7##2##(1990-3#1)(1991-9#1)(1996-12#1)(1996-8#1)(2007-11#1)(2008-1#1)(2008-5#1)
purified G##2##2##(1995-6#1)(1995-8#1)
purified GDH##2##2##(1993-9#2)
purified HC##2##2##(2008-10#2)
purified HIV-1##2##2##(1992-8#1)(1997-3#1)
purified Lp(a)##3##2##(1995-2#1)(1996-12#2)
purified MHC##2##2##(2008-4#2)
purified MPH##2##2##(2005-11#2)
purified MT##3##2##(1991-4#1)(2008-10#2)
purified NK cells##2##3##(2008-4#2)
purified NK##5##2##(2008-4#5)
purified P450##2##2##(1991-11#1)(1993-8#1)
purified PKC##3##2##(1993-8#1)(1994-11#1)(2008-8#1)
purified PLRV##2##2##(2008-10#2)
purified RNA##6##2##(1991-8#1)(1994-3#1)(1995-5#1)(2008-10#1)(2008-9#2)
purified T cells##4##3##(2004-12#2)(2007-11#1)(2008-4#1)
purified T##5##2##(2004-12#2)(2007-11#1)(2008-4#1)(2008-7#1)
purified TFIID fractions from##2##4##(1990-6#1)(1997-6#1)
purified TFIID##3##2##(1990-6#2)(1997-6#1)
purified V-ATPase##2##2##(1994-9#1)(1995-6#1)
purified VR##2##2##(1992-6#2)
purified a##15##2##(1991-5#2)(1992-11#1)(1992-12#1)(1992-8#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-4#1)(2008-11#1)
purified about##2##2##(1990-4#1)(1994-6#1)
purified actin##2##2##(1993-4#1)(2011-2#1)
purified alpha 1-AT##2##3##(1994-11#1)(1997-8#1)
purified alpha##9##2##(1990-7#1)(1991-12#1)(1992-2#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-12#2)(1997-8#1)
purified and characterized by##2##4##(2007-11#1)(2008-5#1)
purified and characterized from the##2##5##(1992-12#1)(1997-6#1)
purified and characterized from##5##4##(1992-12#1)(1994-3#1)(1995-6#1)(1997-6#1)(2006-8#1)
purified and characterized##16##3##(1990-10#1)(1990-6#1)(1991-10#1)(1992-1#1)(1992-11#1)(1992-12#2)(1993-9#1)(1994-3#1)(1995-6#1)(1997-6#1)(2006-8#1)(2007-1#1)(2007-11#1)(2008-5#1)(2008-8#1)
purified and cloned##2##3##(1992-10#1)(2009-8#1)
purified and examined##2##3##(1990-7#1)(1993-6#1)
purified and identified by##2##4##(1990-4#1)(1991-1#1)
purified and identified##3##3##(1990-4#1)(1991-1#1)(1994-12#1)
purified and its##4##3##(1990-5#1)(1993-6#1)(1994-12#1)(2010-2#1)
purified and reconstituted##2##3##(1990-10#1)(1990-7#1)
purified and separated by##2##4##(1992-2#1)(2012-2#1)
purified and separated##3##3##(1992-2#1)(2008-10#1)(2012-2#1)
purified and sequenced##3##3##(1992-7#1)(2006-12#1)(2012-12#1)
purified and the##2##3##(1990-5#1)(1997-2#1)
purified and was shown to##2##5##(1994-11#1)(1997-8#1)
purified and##80##2##(1990-10#2)(1990-12#1)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#2)(1991-1#1)(1991-10#1)(1991-12#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-7#1)(1993-2#1)(1993-6#2)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-5#1)(1995-6#2)(1996-7#1)(1997-2#2)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#2)(2005-11#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-2#1)(2008-10#7)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-8#2)(2009-8#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
purified antibodies##6##2##(1991-5#1)(1991-9#1)(1992-8#2)(2008-4#2)
purified antigen##2##2##(1995-1#1)(2008-8#1)
purified antigens##2##2##(1995-5#1)(2007-11#1)
purified approximately##3##2##(1990-3#1)(1992-6#1)(1996-5#1)
purified as a stable##2##4##(1994-5#1)(2008-4#1)
purified as a##8##3##(1992-6#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-5#1)(1997-6#1)(2008-4#1)(2008-5#1)
purified as an##3##3##(1990-12#1)(1995-1#1)(2008-4#1)
purified as##12##2##(1990-12#1)(1990-4#1)(1992-6#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-5#1)(1995-1#1)(1997-6#1)(2008-4#2)(2008-5#1)
purified bacterial##4##2##(1992-3#2)(1992-8#1)(1996-8#1)
purified beta##2##2##(1991-9#1)(1995-3#1)
purified beta-cells##3##2##(1990-8#3)
purified bovine milk##2##3##(1991-2#1)(1992-12#1)
purified bovine##11##2##(1990-4#1)(1990-9#1)(1991-2#1)(1992-12#1)(1992-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-5#1)
purified butyrylcholinesterase##3##2##(1990-3#3)
purified by HPLC##6##3##(1990-10#1)(1992-3#1)(1994-9#1)(1995-11#1)(2008-6#1)(2012-1#1)
purified by Sephacryl S-200##2##4##(1991-1#1)(1993-9#1)
purified by a combination of affinity##2##6##(1991-5#1)(1994-3#1)
purified by a single affinity chromatography step##2##7##(1993-4#1)(1996-11#1)
purified by a##11##3##(1991-5#1)(1993-4#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-11#1)(1997-8#1)(2007-7#1)(2008-11#1)
purified by affinity chromatography and##2##5##(1991-6#1)(1991-9#1)
purified by affinity chromatography on##2##5##(1992-3#1)(1995-2#1)
purified by affinity chromatography using##2##5##(1995-2#1)(2008-9#1)
purified by affinity chromatography##16##4##(1991-6#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-9#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-8#1)(1997-2#1)(2008-5#1)(2008-6#1)(2008-9#2)(2010-4#1)
purified by affinity##17##3##(1991-6#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-9#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-2#1)(2008-5#1)(2008-6#1)(2008-9#2)(2010-4#1)
purified by ammonium sulfate##2##4##(2010-11#1)(2010-2#1)
purified by anion-exchange chromatography##3##4##(1990-2#1)(1994-12#1)(2008-4#1)
purified by centrifugation##2##3##(1990-11#1)(2008-4#1)
purified by chromatography on##3##4##(1993-5#1)(1996-4#1)(1996-6#1)
purified by chromatography##4##3##(1992-11#1)(1993-5#1)(1996-4#1)(1996-6#1)
purified by column chromatography##2##4##(1990-5#1)(2008-2#1)
purified by gel filtration##5##4##(1993-3#1)(1994-8#1)(2008-4#2)(2008-5#1)
purified by gel##6##3##(1990-8#1)(1993-3#1)(1994-8#1)(2008-4#2)(2008-5#1)
purified by high performance liquid chromatography (HPLC)##3##7##(1992-7#1)(2010-2#2)
purified by high performance liquid chromatography##6##6##(1990-8#1)(1992-6#1)(1992-7#1)(1995-3#1)(2010-2#2)
purified by immunoaffinity chromatography##2##4##(1994-11#1)(1995-1#1)
purified by immunoaffinity##4##3##(1993-12#1)(1994-11#1)(1995-1#1)(2008-10#1)
purified by ion exchange and##2##5##(1995-1#1)(2008-10#1)
purified by ion-exchange and##2##4##(1990-2#1)(1992-4#1)
purified by ion-exchange##3##3##(1990-2#1)(1992-4#1)(2005-11#1)
purified by means of ammonium sulfate precipitation##2##7##(2005-11#1)(2008-8#1)
purified by means of##3##4##(1991-3#1)(2005-11#1)(2008-8#1)
purified by preparative##3##3##(1990-4#1)(1992-1#1)(2006-3#1)
purified by reverse phase##2##4##(1991-8#1)(1997-4#1)
purified by reverse-phase##4##3##(1993-11#1)(1996-4#1)(2006-12#1)(2008-6#1)
purified by reversed-phase HPLC##2##4##(1996-8#1)(2006-12#1)
purified by reversed-phase##3##3##(1990-9#1)(1996-8#1)(2006-12#1)
purified by sequential##4##3##(1990-12#1)(1994-11#2)(1994-8#1)
purified by solid-phase##2##3##(1997-2#1)(2007-12#1)
purified by the##4##3##(1990-9#2)(1991-9#1)(2008-11#1)
purified by two different##2##4##(1992-12#1)(2008-12#1)
purified by using##3##3##(1992-11#1)(2008-8#1)(2010-12#1)
purified by##156##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#3)(1990-4#2)(1990-5#2)(1990-8#3)(1990-9#4)(1991-1#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#5)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-7#2)(1992-8#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#1)(1993-9#2)(1994-10#1)(1994-11#4)(1994-12#4)(1994-2#3)(1994-3#1)(1994-8#4)(1994-9#2)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#3)(1995-6#2)(1995-8#1)(1996-11#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-8#2)(1997-2#3)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#2)(2006-10#1)(2006-12#2)(2006-3#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#6)(2008-5#3)(2008-6#3)(2008-8#4)(2008-9#3)(2010-11#1)(2010-12#1)(2010-2#4)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
purified calpain##2##2##(1991-8#1)(1992-1#1)
purified cardiac myosin##4##3##(2008-4#4)
purified caveolae##2##2##(1995-2#2)
purified cell##2##2##(2006-6#1)(2008-11#1)
purified cells##2##2##(1993-11#1)(2008-4#1)
purified complex##2##2##(1990-11#2)
purified component##2##2##(2013-7#2)
purified components##2##2##(1993-8#1)(2008-4#1)
purified compound##4##2##(2008-10#1)(2008-11#1)(2010-11#1)(2011-2#1)
purified crystal proteins and##2##4##(2007-6#2)
purified cultures of##2##3##(2008-11#1)(2008-7#1)
purified cultures##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
purified cytochrome##6##2##(1991-8#1)(1992-8#1)(1993-4#1)(1994-5#1)(1995-2#1)(1996-2#1)
purified cytosolic##4##2##(1990-11#2)(1995-11#1)(1996-2#1)
purified dendritic##2##2##(2007-2#1)(2008-4#1)
purified diet##2##2##(2007-2#1)(2007-8#1)
purified diets containing either 0##3##5##(1997-4#3)
purified diets##6##2##(1991-2#1)(1997-4#3)(2008-10#1)(2012-2#1)
purified eIF-2B##2##2##(1991-12#2)
purified employing##2##2##(1990-7#1)(1992-5#1)
purified endopeptidase##2##2##(1990-11#1)(1996-8#1)
purified enzyme from##2##3##(1991-12#1)(1996-7#1)
purified enzyme is##2##3##(1990-7#1)(1993-8#1)
purified enzyme showed a single##2##5##(1990-2#1)(1996-5#1)
purified enzyme showed a##3##4##(1990-2#2)(1996-5#1)
purified enzyme was##9##3##(1990-11#1)(1990-2#1)(1990-3#1)(1991-8#1)(1993-5#1)(1994-8#1)(1995-3#1)(1997-6#1)(2008-5#1)
purified enzyme##59##2##(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#2)(1992-8#2)(1992-9#2)(1993-11#1)(1993-3#2)(1993-5#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-2#2)(1995-3#1)(1996-4#1)(1996-5#3)(1996-7#3)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-8#1)
purified enzymes##6##2##(1990-3#1)(1990-5#1)(1994-9#2)(1996-5#1)(1996-7#1)
purified extracts##2##2##(1990-6#1)(2008-10#1)
purified fibrinogen by##2##3##(1993-11#1)(2008-10#1)
purified fibrinogen##5##2##(1992-12#1)(1993-11#1)(2008-10#3)
purified for the##2##3##(1992-8#1)(2013-8#1)
purified for##5##2##(1992-8#1)(1993-12#1)(1997-8#1)(2010-3#1)(2013-8#1)
purified form##4##2##(1990-11#1)(1994-11#1)(2005-9#1)(2006-12#1)
purified forms of##2##3##(1991-12#1)(1994-12#1)
purified forms##5##2##(1991-11#1)(1991-12#1)(1994-12#1)(2008-10#2)
purified fraction##6##2##(1990-12#1)(1991-10#1)(1992-12#1)(1992-8#1)(1996-7#1)(2006-8#1)
purified fractions##7##2##(1990-5#1)(1992-12#1)(1993-9#1)(1994-6#1)(1995-1#1)(1996-12#1)(1996-4#1)
purified from E##6##3##(1990-8#1)(1991-10#1)(1991-3#1)(1994-11#1)(1994-3#1)(1994-9#1)
purified from Escherichia coli##4##4##(1990-5#1)(1993-8#1)(2008-9#1)(2009-5#1)
purified from HeLa##4##3##(1991-1#1)(1991-10#1)(1993-11#1)(1994-3#1)
purified from Jurkat cells##2##4##(1992-11#1)(1994-6#1)
purified from a##5##3##(1990-8#1)(1992-7#1)(1993-7#1)(1994-5#1)(2008-10#1)
purified from an##4##3##(1990-12#1)(1996-3#1)(1997-4#1)(1997-8#1)
purified from both##2##3##(1993-12#1)(1995-5#1)
purified from bovine brain##6##4##(1991-1#1)(1991-2#2)(1991-9#1)(1994-3#1)(1994-6#1)
purified from bovine serum##2##4##(1991-5#1)(1992-9#1)
purified from bovine##17##3##(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-6#1)(1997-6#1)(2008-8#1)(2008-9#1)
purified from calf##2##3##(1991-4#1)(1992-7#1)
purified from cell##3##3##(1990-12#1)(1992-2#1)(1993-4#1)
purified from cells##2##3##(1994-3#1)(1997-4#1)
purified from chicken gizzard##3##4##(1990-9#1)(1993-4#1)(1993-6#1)
purified from chicken##4##3##(1990-9#1)(1991-1#1)(1993-4#1)(1993-6#1)
purified from conditioned##2##3##(1994-11#1)(1995-3#1)
purified from culture filtrates of##2##5##(2008-10#2)
purified from culture##4##3##(1997-2#1)(2008-10#3)
purified from cultured##2##3##(1993-9#1)(2008-8#1)
purified from fetal##2##3##(1991-1#1)(1991-3#1)
purified from human cells##2##4##(1993-3#1)(1996-5#1)
purified from human liver##3##4##(1990-12#1)(1991-3#1)(1993-9#1)
purified from human neutrophils##3##4##(1990-9#1)(1996-1#1)(1997-2#1)
purified from human placenta##5##4##(1991-1#1)(1992-12#1)(1993-3#1)(1995-8#1)(1996-9#1)
purified from human placental membranes##2##5##(1990-5#1)(1991-1#1)
purified from human serum##2##4##(1991-3#1)(1991-6#1)
purified from human##36##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#2)(1991-3#2)(1991-4#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-3#2)(1993-8#1)(1993-9#3)(1994-11#1)(1994-2#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-5#2)(1996-7#2)(1996-9#1)(1997-2#1)
purified from insect Sf9 cells##2##5##(1995-6#1)(2008-5#1)
purified from insect##4##3##(1990-9#1)(1992-8#1)(1995-6#1)(2008-5#1)
purified from mammalian##3##3##(1994-12#1)(1996-9#1)(1997-8#1)
purified from mung bean##2##4##(1990-2#1)(1991-2#1)
purified from pig##2##3##(1993-3#1)(1994-2#1)
purified from plasma##2##3##(2008-10#1)(2009-4#1)
purified from porcine kidney##2##4##(1991-2#1)(1994-5#1)
purified from porcine##4##3##(1990-3#1)(1991-2#1)(1994-5#1)(2008-8#1)
purified from rabbit##4##3##(1991-8#1)(1993-8#1)(1995-2#1)(2005-8#1)
purified from rat brain##4##4##(1990-6#1)(1991-6#1)(1994-12#1)(1994-8#1)
purified from rat liver and##2##5##(1990-5#1)(1995-6#1)
purified from rat liver##9##4##(1990-5#1)(1991-9#1)(1992-8#1)(1993-8#2)(1993-9#1)(1994-12#1)(1995-6#1)(2008-10#1)
purified from rat##17##3##(1990-5#1)(1990-6#1)(1991-6#1)(1991-9#2)(1992-11#1)(1992-8#1)(1993-8#2)(1993-9#1)(1994-12#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-6#1)(2008-10#1)
purified from soybean##2##3##(1997-6#2)
purified from the culture medium##3##5##(1997-7#1)(2008-11#2)
purified from the extract##2##4##(1997-1#1)(2008-11#1)
purified from the liver of rats##2##6##(1992-9#2)
purified from the liver##3##4##(1992-9#2)(1993-9#1)
purified from the membrane fraction of a##2##7##(1990-3#1)(1996-5#1)
purified from the membrane fraction of##3##6##(1990-3#1)(1991-3#1)(1996-5#1)
purified from the venom of##6##5##(1990-2#1)(1992-12#1)(1992-5#1)(1993-3#1)(1994-5#1)(1996-2#1)
purified from the##55##3##(1990-11#1)(1990-2#1)(1990-3#2)(1990-8#1)(1990-9#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-3#3)(1993-4#1)(1993-9#2)(1994-12#2)(1994-5#1)(1994-9#1)(1995-1#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(2005-11#1)(2006-8#1)(2008-10#3)(2008-11#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2011-1#1)
purified from two##2##3##(1990-12#1)(1994-8#1)
purified from urine##2##3##(1990-12#1)(2013-1#1)
purified from##300##2##(1990-10#1)(1990-11#4)(1990-12#9)(1990-2#3)(1990-3#4)(1990-4#1)(1990-5#6)(1990-6#1)(1990-7#4)(1990-8#5)(1990-9#4)(1991-1#6)(1991-10#2)(1991-2#9)(1991-3#5)(1991-4#4)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#4)(1991-9#5)(1992-1#1)(1992-11#3)(1992-12#4)(1992-2#2)(1992-5#1)(1992-6#3)(1992-7#3)(1992-8#8)(1992-9#6)(1993-11#6)(1993-12#3)(1993-3#6)(1993-4#3)(1993-6#1)(1993-7#1)(1993-8#8)(1993-9#7)(1994-11#6)(1994-12#7)(1994-2#4)(1994-3#5)(1994-5#5)(1994-6#4)(1994-8#5)(1994-9#6)(1995-1#3)(1995-2#4)(1995-3#4)(1995-5#1)(1995-6#2)(1995-8#2)(1996-1#2)(1996-10#1)(1996-2#2)(1996-3#1)(1996-5#3)(1996-7#3)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#4)(1997-6#4)(1997-7#4)(1997-8#3)(2005-11#2)(2005-8#1)(2006-8#1)(2007-1#1)(2008-10#17)(2008-11#4)(2008-12#2)(2008-4#1)(2008-5#6)(2008-7#1)(2008-8#6)(2008-9#4)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
purified genomic DNA from##2##4##(2008-10#1)(2008-5#1)
purified glycosaminoglycans##2##2##(1992-5#1)(1996-6#1)
purified growth##2##2##(1990-8#1)(2012-12#1)
purified human DNA##2##3##(1997-7#2)
purified human fibrinogen##2##3##(2008-10#2)
purified human kidney##2##3##(1991-9#1)(1994-11#1)
purified human placental##3##3##(1990-7#1)(1991-2#1)(1995-8#1)
purified human##31##2##(1990-4#1)(1990-7#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-4#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-8#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#1)(2005-12#1)(2008-10#2)(2008-4#1)
purified in a single step##2##5##(2008-10#1)(2008-11#1)
purified in a##4##3##(1994-5#1)(1997-4#1)(2008-10#1)(2008-11#1)
purified in its##2##3##(1990-4#1)(1992-7#1)
purified in the presence of##2##5##(1994-5#1)(1995-3#1)
purified in the##3##3##(1994-5#1)(1994-8#1)(1995-3#1)
purified in this##2##3##(2008-10#1)(2008-11#1)
purified in##19##2##(1990-4#1)(1991-11#1)(1992-6#1)(1992-7#1)(1993-6#1)(1994-11#1)(1994-5#2)(1994-8#1)(1995-3#2)(1997-4#2)(1997-6#1)(2008-10#2)(2008-11#2)(2008-8#1)
purified insulin receptors##2##3##(1993-8#2)
purified iodinated products in##2##4##(2007-11#2)
purified is##2##2##(1996-12#1)(2008-4#1)
purified kinase##2##2##(1990-3#1)(1996-5#1)
purified lipase##2##2##(1996-5#1)(2008-7#1)
purified liver##4##2##(1991-10#1)(1991-12#1)(1992-3#1)(1994-9#1)
purified mammalian##2##2##(1990-12#1)(1992-11#1)
purified material##5##2##(1990-12#2)(1994-2#1)(1996-9#1)(2008-5#1)
purified materials##2##2##(2008-10#2)
purified membrane##3##2##(1990-3#1)(1993-12#1)(2008-4#1)
purified membranes##2##2##(1991-6#1)(1994-5#1)
purified monocytes##2##2##(1991-1#1)(1993-9#1)
purified murine##3##2##(1990-2#1)(1991-11#1)(2007-2#1)
purified mutant proteins##2##3##(1994-5#1)(1994-6#1)
purified mutant##4##2##(1990-10#1)(1993-8#1)(1994-5#1)(1994-6#1)
purified natural##2##2##(1990-7#1)(1994-2#1)
purified nodule SS##2##3##(1997-6#2)
purified nodule##4##2##(1997-6#4)
purified nucleocapsid##2##2##(2008-10#1)(2008-8#1)
purified on C18##2##3##(1990-6#1)(1997-8#1)
purified on a##3##3##(1993-4#1)(1995-11#1)(2008-2#1)
purified on##16##2##(1990-5#2)(1990-6#1)(1991-11#2)(1991-12#1)(1992-3#1)(1992-7#2)(1993-11#1)(1993-4#1)(1995-11#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-2#1)
purified or##3##2##(1996-12#1)(2008-1#1)(2008-2#1)
purified over##4##2##(1990-6#1)(1991-10#1)(1992-9#1)(1994-12#1)
purified p29##2##2##(1990-11#2)
purified p34cdc2 kinase##2##3##(1994-9#2)
purified pancreatic##3##2##(1991-5#1)(1996-7#1)(2010-12#1)
purified peptide##3##2##(1993-12#1)(1996-4#2)
purified peptides##4##2##(1990-11#1)(1990-5#1)(1990-7#1)(1995-11#1)
purified placental AP##2##3##(2008-11#2)
purified plasma membrane##2##3##(1992-3#1)(1993-8#1)
purified plasma membranes##2##3##(1994-11#1)(1997-4#1)
purified plasma##4##2##(1992-3#1)(1993-8#1)(1994-11#1)(1997-4#1)
purified polyclonal##2##2##(1990-4#1)(1990-5#1)
purified preparation of##7##3##(1990-12#1)(1990-2#2)(1991-8#1)(1993-2#1)(1997-8#1)(2013-1#1)
purified preparation##15##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#2)(1991-8#1)(1992-2#1)(1993-2#1)(1994-8#1)(1997-8#1)(2008-8#1)(2013-1#2)
purified preparations of##7##3##(1994-9#2)(1995-2#1)(1995-6#1)(1996-4#1)(1996-7#1)(1997-8#1)
purified preparations##8##2##(1994-9#3)(1995-2#1)(1995-6#1)(1996-4#1)(1996-7#1)(1997-8#1)
purified primary##2##2##(1995-12#1)(1995-2#1)
purified pro-PO##3##2##(1997-2#3)
purified product##2##2##(2008-4#2)
purified protein as##2##3##(1992-3#1)(1997-4#1)
purified protein derivative (PPD) positive##2##5##(1997-2#1)(2008-7#1)
purified protein derivative (PPD)##3##4##(1997-2#1)(2008-10#1)(2008-7#1)
purified protein derivative##6##3##(1993-7#1)(1997-2#1)(2006-2#1)(2007-4#1)(2008-10#1)(2008-7#1)
purified protein fraction##2##3##(1996-8#1)(2010-4#1)
purified protein in##2##3##(1996-9#1)(2008-4#1)
purified protein kinase C in vitro##2##6##(1990-10#2)
purified protein kinase C##6##4##(1990-10#2)(1990-11#1)(1991-2#1)(1992-9#2)
purified protein kinase##7##3##(1990-10#2)(1990-11#1)(1991-2#1)(1992-9#2)(1997-6#1)
purified protein was##8##3##(1990-12#1)(1990-5#1)(1992-5#1)(1994-6#1)(1995-11#1)(1996-12#1)(2008-10#1)(2008-9#1)
purified protein##66##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#2)(1991-11#2)(1991-2#1)(1991-7#4)(1991-9#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-7#2)(1992-8#3)(1992-9#2)(1993-7#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#2)(1996-12#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(2005-11#1)(2006-2#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#2)(2008-2#3)(2008-4#3)(2008-7#1)(2008-9#1)(2010-4#1)
purified proteins were##4##3##(1993-2#1)(1995-8#1)(1997-3#1)(2009-4#1)
purified proteins##17##2##(1991-4#2)(1993-2#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-8#1)(1997-3#1)(2008-4#6)(2009-10#1)(2009-4#1)(2009-9#1)
purified rabbit hsp70 and##2##4##(1996-5#2)
purified rabbit##7##2##(1991-2#1)(1993-8#1)(1994-5#1)(1996-5#3)(2008-11#1)
purified rat P450s##2##3##(1993-2#1)(1994-8#1)
purified rat brain##2##3##(1990-5#1)(2008-5#1)
purified rat liver##3##3##(1990-4#1)(1992-2#1)(1995-6#1)
purified rat##19##2##(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#2)(1992-2#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-5#2)(1994-8#1)(1995-11#1)(1995-6#1)(1996-2#1)(2008-5#1)
purified receptor preparations##2##3##(1990-11#1)(1991-1#1)
purified receptor##5##2##(1990-11#1)(1991-1#1)(1997-6#1)(2008-4#2)
purified receptors##4##2##(1995-3#1)(2012-2#3)
purified recombinant human##4##3##(1990-6#1)(1991-10#1)(1995-10#1)(2008-8#1)
purified recombinant proteins##2##3##(1991-5#1)(2006-12#1)
purified recombinant##21##2##(1990-12#1)(1990-6#1)(1991-10#1)(1991-5#1)(1991-7#1)(1992-7#1)(1992-8#1)(1993-9#1)(1994-8#1)(1995-10#1)(1995-2#2)(1995-8#1)(1997-4#1)(2006-12#1)(2008-11#2)(2008-4#1)(2008-8#1)(2010-11#1)(2013-1#1)
purified retroviral integrase##2##3##(1994-9#2)
purified rhodopsin##2##2##(1990-7#1)(1995-1#1)
purified sample##3##2##(1995-1#1)(2008-10#1)(2008-9#1)
purified separately##2##2##(1994-3#1)(2008-8#1)
purified serum proteins##2##3##(1990-11#1)(1992-12#1)
purified single compound showed##2##4##(2008-11#2)
purified sodium channels##2##3##(1995-3#1)(1995-9#1)
purified sodium##3##2##(1995-3#1)(1995-9#2)
purified soluble##3##2##(1990-5#1)(1996-6#1)(2008-1#1)
purified soybean##2##2##(1990-12#1)(1997-6#1)
purified substrates##2##2##(1995-1#1)(2008-1#1)
purified the##13##2##(1990-8#1)(1991-1#1)(1991-2#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-6#2)(1997-4#1)(2012-2#1)
purified this##2##2##(1992-8#1)(1994-12#1)
purified through##5##2##(1994-8#2)(2008-5#1)(2008-9#1)(2013-8#1)
purified to apparent homogeneity by##5##5##(1990-8#1)(1991-4#1)(1991-9#1)(1992-12#1)(1996-5#1)
purified to apparent homogeneity from human##2##6##(1990-12#1)(1990-4#1)
purified to apparent homogeneity from##3##5##(1990-12#1)(1990-4#1)(1994-8#1)
purified to apparent homogeneity##13##4##(1990-12#1)(1990-4#1)(1990-8#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-8#1)(1994-8#2)(1995-3#1)(1996-5#1)(1997-2#1)
purified to electrophoretic homogeneity from##2##5##(1990-4#1)(1994-8#1)
purified to electrophoretic homogeneity##7##4##(1990-4#1)(1990-7#1)(1991-2#1)(1993-8#1)(1994-8#1)(1995-2#1)(2005-11#1)
purified to homogeneity and##10##4##(1990-2#1)(1990-7#1)(1991-2#1)(1992-7#1)(1992-8#1)(1994-11#1)(1994-12#1)(1995-10#1)(1995-11#1)(1997-4#1)
purified to homogeneity by a##5##5##(1990-8#1)(1991-2#2)(1991-8#1)(1994-3#1)
purified to homogeneity by##21##4##(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-8#2)(1992-3#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-3#1)(1995-3#1)(1995-8#1)(1997-4#1)(1997-8#1)(2008-4#1)(2008-8#1)(2009-3#1)(2010-4#1)
purified to homogeneity from bovine##3##5##(1990-9#1)(1992-11#1)(1993-7#1)
purified to homogeneity from human##2##5##(1996-3#1)(2008-8#1)
purified to homogeneity from the##6##5##(1990-1#1)(1990-11#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-12#1)
purified to homogeneity from##21##4##(1990-1#1)(1990-11#2)(1990-3#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-8#1)(1993-7#1)(1995-2#1)(1996-3#1)(1997-2#1)(2006-3#1)(2008-10#1)(2008-8#2)
purified to homogeneity on##2##4##(1992-12#1)(2008-8#1)
purified to homogeneity through##2##4##(1994-12#1)(1995-1#1)
purified to homogeneity using##2##4##(1991-11#1)(1992-5#1)
purified to homogeneity with##2##4##(1990-5#1)(1995-12#1)
purified to homogeneity##89##3##(1990-1#1)(1990-10#1)(1990-11#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#4)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#4)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#2)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#3)(1995-6#1)(1995-8#2)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#2)(1997-8#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#4)(2009-3#1)(2010-4#1)
purified to near homogeneity and##2##5##(1990-7#1)(2008-4#1)
purified to near homogeneity from##4##5##(1990-5#2)(1990-8#1)(1993-11#1)
purified to near homogeneity##15##4##(1990-5#2)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-11#1)(1993-11#1)(1993-6#1)(1994-3#1)(1994-8#1)(1996-10#1)(1997-1#1)(2008-4#1)(2012-2#1)
purified to##132##2##(1990-1#1)(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#5)(1990-7#6)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#5)(1991-4#2)(1991-5#2)(1991-7#1)(1991-8#4)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#3)(1993-11#2)(1993-12#2)(1993-6#1)(1993-7#1)(1993-8#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#1)(1994-8#5)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#6)(1995-3#4)(1995-6#1)(1995-8#2)(1996-10#1)(1996-3#1)(1996-5#2)(1996-7#1)(1997-1#1)(1997-2#2)(1997-4#3)(1997-8#1)(2005-11#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#6)(2009-3#1)(2010-4#1)(2011-2#1)(2012-2#1)
purified two##2##2##(1994-9#1)(1996-2#1)
purified type##2##2##(1991-2#1)(1997-2#1)
purified uncoupling protein##2##3##(1991-3#2)
purified using a##4##3##(1994-11#1)(1997-4#1)(2008-1#1)(2008-4#1)
purified using##12##2##(1993-12#1)(1994-11#1)(1994-6#1)(1995-8#1)(1997-4#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)
purified virions##3##2##(2008-10#3)
purified virus##7##2##(2008-10#5)(2008-5#1)(2013-8#1)
purified water##4##2##(2004-12#1)(2008-10#2)(2012-2#1)
purified with a##5##3##(1990-12#1)(1990-5#1)(1992-8#1)(1994-3#1)(2012-2#1)
purified with the##2##3##(1992-6#1)(2008-10#1)
purified with##13##2##(1990-10#1)(1990-12#1)(1990-5#1)(1992-1#1)(1992-6#1)(1992-8#1)(1994-3#1)(1995-12#1)(2008-10#3)(2011-1#1)(2012-2#1)
purified without##2##2##(1990-12#1)(1995-3#1)
purified yeast##8##2##(1990-6#2)(1995-1#1)(1995-3#1)(1995-8#1)(1997-6#1)(1997-8#1)(2008-8#1)
purified##1914##1##(1990-1#2)(1990-10#12)(1990-11#34)(1990-12#34)(1990-2#18)(1990-3#25)(1990-4#23)(1990-5#32)(1990-6#15)(1990-7#36)(1990-8#29)(1990-9#14)(1991-1#22)(1991-10#10)(1991-11#15)(1991-12#18)(1991-2#35)(1991-3#16)(1991-4#15)(1991-5#22)(1991-6#6)(1991-7#15)(1991-8#22)(1991-9#16)(1992-1#8)(1992-10#1)(1992-11#16)(1992-12#29)(1992-2#14)(1992-3#16)(1992-4#7)(1992-5#8)(1992-6#23)(1992-7#20)(1992-8#35)(1992-9#15)(1993-11#22)(1993-12#18)(1993-2#5)(1993-3#20)(1993-4#12)(1993-5#6)(1993-6#13)(1993-7#5)(1993-8#31)(1993-9#22)(1994-10#3)(1994-11#29)(1994-12#30)(1994-2#17)(1994-3#20)(1994-5#18)(1994-6#19)(1994-8#37)(1994-9#36)(1995-1#19)(1995-10#4)(1995-11#9)(1995-12#5)(1995-2#33)(1995-3#29)(1995-5#9)(1995-6#18)(1995-7#1)(1995-8#18)(1995-9#2)(1996-1#4)(1996-10#3)(1996-11#2)(1996-12#9)(1996-2#9)(1996-3#5)(1996-4#10)(1996-5#27)(1996-6#5)(1996-7#16)(1996-8#14)(1996-9#8)(1997-1#5)(1997-2#18)(1997-3#5)(1997-4#31)(1997-6#29)(1997-7#16)(1997-8#17)(2004-11#1)(2004-12#4)(2004-9#1)(2005-10#1)(2005-11#20)(2005-12#1)(2005-8#2)(2005-9#1)(2006-10#5)(2006-12#6)(2006-2#1)(2006-3#4)(2006-6#1)(2006-8#8)(2007-1#2)(2007-11#13)(2007-12#7)(2007-2#5)(2007-4#1)(2007-6#4)(2007-7#2)(2007-8#1)(2008-1#14)(2008-10#101)(2008-11#30)(2008-12#5)(2008-2#12)(2008-4#65)(2008-5#24)(2008-6#8)(2008-7#6)(2008-8#32)(2008-9#17)(2009-10#1)(2009-2#2)(2009-3#3)(2009-4#3)(2009-5#1)(2009-6#3)(2009-8#4)(2009-9#3)(2010-1#1)(2010-11#4)(2010-12#3)(2010-2#7)(2010-3#1)(2010-4#4)(2011-1#6)(2011-2#9)(2012-1#1)(2012-12#5)(2012-2#15)(2013-1#6)(2013-7#2)(2013-8#4)
purified&quot##2##1##(2009-3#2)
purify a##3##2##(1995-10#1)(2012-12#2)
purify an##2##2##(1991-12#1)(1993-6#1)
purify cells##2##2##(2006-10#1)(2008-11#1)
purify proteins##3##2##(2008-2#1)(2008-4#2)
purify the##10##2##(1990-11#1)(1991-7#1)(1994-12#1)(1994-5#1)(1996-4#1)(1997-7#1)(2006-7#1)(2008-4#1)(2010-4#1)(2012-2#1)
purify##65##1##(1990-11#1)(1990-7#1)(1991-11#1)(1991-12#2)(1991-7#1)(1992-12#2)(1993-4#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-5#1)(1995-1#1)(1995-10#1)(1995-3#1)(1996-4#1)(1997-3#1)(1997-4#2)(1997-7#2)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-7#1)(2007-6#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-2#3)(2008-4#6)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2010-4#2)(2011-2#1)(2012-12#4)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
purifying selection##2##2##(2009-9#1)(2012-2#1)
purifying the##3##2##(1995-1#1)(1997-6#1)(2008-4#1)
purifying##33##1##(1991-11#4)(1991-8#1)(1991-9#2)(1992-1#1)(1992-7#1)(1993-11#1)(1995-1#1)(1997-6#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-4#13)(2008-7#1)(2009-9#1)(2012-2#1)
purine alkaloids##2##2##(1997-8#1)(2006-12#1)
purine analogues and##2##3##(1993-2#1)(2006-10#1)
purine analogues##5##2##(1993-2#1)(2006-10#1)(2007-11#1)(2007-5#1)(2011-2#1)
purine and pyrimidine##8##3##(1990-4#1)(1992-8#2)(1995-8#2)(2007-11#1)(2008-10#2)
purine and##11##2##(1990-4#1)(1992-8#2)(1995-8#2)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#2)(2010-2#1)
purine bases##5##2##(1993-12#1)(1997-1#2)(2006-12#1)(2008-10#1)
purine deoxynucleotide radical cations##2##4##(2008-9#2)
purine derivatives##3##2##(1994-11#1)(1996-5#1)(2006-12#1)
purine dinucleotides##2##2##(2008-4#2)
purine load##2##2##(2008-7#2)
purine metabolism##6##2##(1990-5#1)(1992-8#1)(1995-12#1)(1996-5#1)(2007-11#1)(2012-1#1)
purine nucleoside phosphorylase (PNP)##2##4##(1994-8#1)(1997-1#1)
purine nucleoside phosphorylase from##2##4##(1994-6#1)(1997-1#1)
purine nucleoside phosphorylase##11##3##(1994-6#3)(1994-8#1)(1995-1#3)(1997-1#2)(2010-4#2)
purine nucleoside##15##2##(1994-6#3)(1994-8#2)(1995-1#3)(1997-1#2)(1997-7#1)(2006-12#1)(2010-4#2)(2010-5#1)
purine nucleosides##3##2##(2008-4#2)(2010-2#1)
purine nucleotide metabolism in##2##4##(1991-4#2)
purine nucleotide##5##2##(1991-4#2)(1994-11#2)(1995-3#1)
purine nucleotides##9##2##(1993-8#1)(1994-9#1)(1996-5#1)(1996-8#1)(1997-2#1)(2006-12#1)(2008-10#1)(2008-4#1)(2012-2#1)
purine receptors##5##2##(2005-7#2)(2008-4#1)(2013-1#2)
purine repressor##3##2##(1994-9#2)(1996-11#1)
purine residues##4##2##(1992-4#1)(1996-4#1)(1996-5#1)(2008-10#1)
purine ribonucleosides##3##2##(2008-4#3)
purine ring of##2##3##(1996-7#1)(2008-10#1)
purine ring##5##2##(1996-7#1)(2006-12#1)(2008-10#1)(2010-2#2)
purine signaling##2##2##(2008-4#2)
purine synthesis##7##2##(1991-4#1)(1993-12#2)(1996-8#1)(2007-11#2)(2008-5#1)
purine units within the ODN-chains##2##5##(2008-10#2)
purine units within the##3##4##(2008-10#3)
purine units##5##2##(2008-10#5)
purine##155##1##(1990-11#1)(1990-4#1)(1990-5#1)(1991-4#3)(1992-4#4)(1992-8#5)(1992-9#1)(1993-12#3)(1993-2#1)(1993-8#3)(1994-11#6)(1994-6#3)(1994-8#3)(1994-9#3)(1995-1#3)(1995-12#4)(1995-3#4)(1995-8#4)(1996-11#1)(1996-4#2)(1996-5#4)(1996-7#1)(1996-8#3)(1997-1#4)(1997-2#2)(1997-4#1)(1997-7#2)(1997-8#2)(2005-7#3)(2006-10#1)(2006-12#9)(2007-11#6)(2007-5#1)(2008-10#15)(2008-11#1)(2008-3#2)(2008-4#13)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-2#2)(2010-2#7)(2010-4#2)(2010-5#1)(2011-2#1)(2012-1#3)(2012-2#1)(2013-1#2)
purine)##2##1##(1996-11#1)(2008-4#1)
purine-purine##3##1##(1991-6#1)(1991-7#1)(1996-8#1)
purine-pyrimidine##2##1##(1993-3#1)(1993-8#1)
purine-rich##3##1##(1992-12#1)(2008-10#2)
purine/pyrimidine##2##1##(1992-5#1)(2008-4#1)
purinergic activation of##2##3##(1995-8#1)(2008-4#1)
purinergic agonists##3##2##(1995-11#3)
purinergic receptor##3##2##(1995-8#1)(2008-4#1)(2008-6#1)
purinergic receptors##7##2##(1994-11#1)(1994-6#1)(2006-1#1)(2006-12#1)(2008-4#3)
purinergic signaling by##2##3##(2008-4#1)(2009-3#1)
purinergic signaling in the##2##4##(2008-4#1)(2009-3#1)
purinergic signaling##11##2##(2008-4#4)(2008-5#1)(2009-3#3)(2010-2#1)(2013-8#2)
purinergic signalling in##2##3##(2008-4#2)
purinergic signalling##4##2##(2008-4#4)
purinergic system##3##2##(1991-5#2)(2008-4#1)
purinergic##52##1##(1990-5#1)(1991-5#3)(1994-11#1)(1994-6#1)(1995-11#3)(1995-6#1)(1995-8#4)(1996-12#1)(2006-1#2)(2006-12#2)(2008-2#1)(2008-4#24)(2008-5#1)(2008-6#1)(2009-3#3)(2010-2#1)(2013-8#2)
purines ATP and adenosine##2##4##(2008-3#1)(2008-4#1)
purines and pyrimidines##6##3##(1990-8#2)(1991-10#3)(1992-2#1)
purines and##7##2##(1990-8#2)(1991-10#3)(1992-2#1)(1996-5#1)
purines are##3##2##(1990-4#1)(2013-8#2)
purines in##4##2##(1992-2#3)(2008-3#1)
purines with##2##2##(1994-11#1)(2008-8#1)
purines##40##1##(1990-4#1)(1990-8#2)(1991-10#3)(1992-2#6)(1992-4#1)(1994-11#1)(1995-12#1)(1995-3#1)(1996-5#1)(1997-2#2)(2006-10#1)(2006-12#1)(2006-8#1)(2008-10#2)(2008-3#2)(2008-4#8)(2008-8#1)(2013-8#5)
purinoceptor##9##1##(1990-7#2)(1995-11#5)(1995-12#1)(1997-7#1)
purinoceptors and##2##2##(1995-12#1)(2008-7#1)
purinoceptors##15##1##(1993-11#2)(1995-11#1)(1995-12#8)(1997-1#1)(2008-4#2)(2008-7#1)
purinoreceptors in##2##2##(2008-5#1)(2009-2#1)
purinoreceptors##6##1##(2008-5#1)(2009-2#5)
purities determined by##2##3##(2007-10#1)(2008-10#1)
purities of##3##2##(1994-5#1)(2007-5#1)(2008-9#1)
purities##11##1##(1994-5#1)(2005-10#1)(2005-4#1)(2007-10#1)(2007-5#1)(2008-10#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-12#2)
purity &gt##2##2##(1996-8#1)(2007-10#1)
purity (&gt##2##2##(2008-2#1)(2008-7#1)
purity and enantiopurity##2##3##(2008-10#2)
purity and##25##2##(1990-10#1)(1992-7#1)(1994-12#1)(1996-12#1)(1996-5#1)(1997-3#1)(2005-12#1)(2007-1#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-1#1)(2012-2#1)
purity by##3##2##(1997-2#1)(2008-1#1)(2008-2#1)
purity fluorapatite##2##2##(2008-10#2)
purity has##2##2##(2006-12#1)(2008-1#1)
purity in the##2##3##(2008-2#1)(2008-7#1)
purity in##5##2##(1995-1#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-7#1)
purity of 99##5##3##(2005-4#2)(2007-11#1)(2008-7#1)(2011-1#1)
purity of isolated cells##2##4##(2007-2#1)(2008-11#1)
purity of isolated##3##3##(2007-2#1)(2008-11#1)(2008-4#1)
purity of recombinant proteins##2##4##(2008-4#2)
purity of the##22##3##(1990-12#1)(1990-2#1)(1990-5#1)(1991-9#1)(1992-2#1)(1994-5#1)(1995-7#1)(2004-9#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-5#1)(2012-11#1)(2012-12#1)(2013-1#1)
purity of this##2##3##(2005-12#1)(2008-6#1)
purity of##69##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-2#1)(1992-7#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-7#1)(1996-5#1)(1996-8#1)(2004-9#1)(2005-12#1)(2005-4#2)(2005-7#1)(2006-12#3)(2007-11#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#2)(2009-3#1)(2009-5#2)(2010-12#1)(2010-2#1)(2011-1#4)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#2)
purity testing of##2##3##(1990-8#1)(2010-4#1)
purity was##6##2##(1995-2#1)(2007-10#1)(2008-4#1)(2008-7#1)(2009-2#1)(2012-12#1)
purity##194##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-8#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-2#1)(1992-7#2)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#4)(1995-7#1)(1996-12#1)(1996-5#4)(1996-8#3)(1997-2#2)(1997-3#1)(1997-8#1)(2004-9#2)(2005-12#2)(2005-4#3)(2005-7#1)(2006-12#4)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#2)(2007-2#2)(2007-9#1)(2008-1#9)(2008-10#35)(2008-11#9)(2008-2#9)(2008-3#2)(2008-4#10)(2008-5#6)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#2)(2009-10#1)(2009-2#2)(2009-3#1)(2009-5#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#7)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
purity)##3##1##(1991-11#1)(2008-11#1)(2009-3#1)
puroindoline##3##1##(1993-8#3)
puromycin aminonucleoside (PAN)##2##3##(2009-6#1)(2010-12#1)
puromycin aminonucleoside-induced##2##2##(1991-4#1)(2009-6#1)
puromycin and##2##2##(1994-9#1)(2006-11#1)
puromycin reaction##2##2##(1990-2#1)(1993-4#1)
puromycin sensitivity##2##2##(1992-8#2)
puromycin##16##1##(1990-2#1)(1991-10#1)(1991-4#1)(1992-6#1)(1992-8#3)(1993-4#2)(1994-9#1)(1997-1#1)(1997-7#1)(2006-11#1)(2009-6#2)(2010-12#1)
puromycin-induced nephropathy in the rat##2##5##(1991-4#2)
purple acid phosphatase##4##3##(1991-8#1)(1992-3#3)
purple acid##5##2##(1990-4#1)(1991-8#1)(1992-3#3)
purple bacteria##4##2##(1991-7#1)(1991-9#1)(1994-5#1)(2010-2#1)
purple bacterial##3##2##(1997-4#1)(2008-8#1)(2010-2#1)
purple bacterium##5##2##(1993-8#2)(1994-5#1)(1995-6#2)
purple color##3##2##(1994-5#1)(2008-10#2)
purple coloured##2##2##(2008-10#2)
purple coneflower (Echinacea purpurea)##2##4##(2008-10#2)
purple coneflower##3##2##(2008-10#3)
purple corn extract##2##3##(2011-2#2)
purple corn##3##2##(2011-2#3)
purple corn)##2##2##(2011-2#2)
purple gene##2##2##(1997-8#2)
purple membrane (PM)##2##3##(1990-4#1)(1991-10#1)
purple membrane##12##2##(1990-2#2)(1990-4#1)(1991-10#1)(1993-11#1)(1994-11#3)(1994-5#1)(1995-11#1)(1995-6#2)
purple membranes##4##2##(1990-3#2)(1994-5#2)
purple non-sulphur##2##2##(1995-6#1)(2008-8#1)
purple##79##1##(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#2)(1991-1#1)(1991-10#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-3#3)(1993-11#1)(1993-8#3)(1994-11#3)(1994-2#1)(1994-5#7)(1995-11#1)(1995-6#5)(1996-2#1)(1997-2#2)(1997-4#1)(1997-8#4)(2005-11#1)(2007-10#1)(2007-3#1)(2008-10#12)(2008-2#1)(2008-4#2)(2008-8#2)(2008-9#1)(2009-9#2)(2010-12#1)(2010-2#2)(2011-2#7)(2011-3#1)(2013-1#1)
purplish red##2##2##(2005-4#1)(2008-10#1)
purport to##3##2##(1995-7#1)(2009-5#1)(2010-12#1)
purported benefits of the##2##4##(1992-2#2)
purported benefits of##3##3##(1992-2#2)(2012-3#1)
purported benefits##4##2##(1992-2#2)(2006-9#1)(2012-3#1)
purported cues to perceived##2##4##(2007-12#2)
purported to be##2##3##(2008-10#1)(2010-1#1)
purported to have##2##3##(2008-5#1)(2012-2#1)
purported to##6##2##(2006-8#1)(2008-10#1)(2008-5#2)(2010-1#1)(2012-2#1)
purported##25##1##(1991-2#1)(1992-2#2)(1995-12#1)(1996-3#1)(1996-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-5#3)(2008-8#1)(2010-1#1)(2010-4#1)(2012-1#1)(2012-2#2)(2012-3#1)
purportedly##8##1##(1992-4#1)(2008-10#3)(2009-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
purports##2##1##(1993-8#1)(2008-7#1)
purpose a##5##2##(1991-3#1)(1997-1#1)(2008-10#1)(2008-3#2)
purpose and scope##2##3##(2012-3#1)(2013-1#1)
purpose and the##4##3##(1995-12#1)(1996-9#1)(2006-10#1)(2008-9#1)
purpose and##27##2##(1993-1#1)(1993-2#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-9#1)(1997-1#1)(1997-3#1)(2004-10#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-11#1)(2012-2#1)(2012-3#4)(2013-1#1)
purpose as##2##2##(2008-1#1)(2009-5#1)
purpose being to##2##3##(1995-12#1)(2005-8#1)
purpose by##2##2##(1996-2#1)(2012-3#1)
purpose for##6##2##(1992-1#1)(2006-8#1)(2008-1#1)(2008-9#1)(2010-1#1)(2010-11#1)
purpose in the##2##3##(2004-10#1)(2008-1#1)
purpose in##9##2##(1991-2#1)(1994-1#1)(2004-10#1)(2008-1#1)(2008-12#1)(2008-3#1)(2010-2#1)(2010-9#1)(2012-3#1)
purpose is not##2##3##(2008-8#1)(2010-3#1)
purpose is to analyze##3##4##(2008-9#2)(2009-7#1)
purpose is to assess the##3##5##(1994-12#1)(1995-3#1)(2007-11#1)
purpose is to introduce##2##4##(1996-2#1)(2008-3#1)
purpose is to make##2##4##(2008-10#1)(2012-2#1)
purpose is to##32##3##(1992-1#1)(1993-3#1)(1994-12#1)(1995-3#1)(1996-2#2)(2005-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)
purpose is##41##2##(1992-1#1)(1993-1#1)(1993-3#1)(1994-12#1)(1995-3#1)(1996-2#2)(2004-12#1)(2005-10#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-7#1)(2010-3#1)(2010-6#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)
purpose of a##4##3##(1993-1#1)(2008-11#1)(2008-2#1)(2008-9#1)
purpose of defining##2##3##(2007-4#1)(2008-7#1)
purpose of evaluating##2##3##(1992-3#1)(2008-7#1)
purpose of gene##2##3##(1993-8#1)(2013-8#1)
purpose of launching##6##3##(2010-12#6)
purpose of our research was to evaluate the##3##8##(2007-11#1)(2007-7#1)(2007-8#1)
purpose of our research was to evaluate##4##7##(1996-9#1)(2007-11#1)(2007-7#1)(2007-8#1)
purpose of our research was to##7##6##(1996-9#1)(2007-11#1)(2007-7#3)(2007-8#2)
purpose of our study##14##4##(1993-12#1)(2007-1#1)(2007-7#3)(2007-8#4)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)
purpose of our##26##3##(1993-12#1)(1996-9#1)(2007-1#1)(2007-11#1)(2007-7#6)(2007-8#7)(2007-9#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)
purpose of providing##7##3##(1997-1#1)(2008-1#1)(2008-7#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
purpose of public health##2##4##(1997-3#1)(2010-5#1)
purpose of the current study was to##6##7##(2007-1#1)(2007-12#2)(2009-2#1)(2009-5#1)(2011-2#1)
purpose of the current##8##4##(2007-1#1)(2007-12#2)(2008-4#1)(2009-2#1)(2009-5#1)(2011-2#1)(2013-8#1)
purpose of the present study is to##8##7##(2006-8#1)(2007-10#1)(2007-9#1)(2008-10#1)(2012-2#2)(2012-3#1)(2013-8#1)
purpose of the present study was to compare##2##8##(1993-12#1)(2007-9#1)
purpose of the present study was to##41##7##(1990-10#1)(1990-8#1)(1992-12#1)(1993-12#1)(1993-6#1)(1994-10#1)(1994-2#1)(1994-5#2)(1995-12#1)(1995-3#1)(1996-12#1)(1997-7#1)(1997-8#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-8#1)(2007-9#2)(2008-10#2)(2008-3#1)(2008-5#3)(2008-7#1)(2009-1#1)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
purpose of the present study##49##5##(1990-10#1)(1990-8#1)(1992-12#1)(1993-12#1)(1993-6#1)(1994-10#1)(1994-2#1)(1994-5#2)(1995-12#1)(1995-3#1)(1996-12#1)(1997-7#1)(1997-8#1)(2006-4#1)(2006-6#1)(2006-8#2)(2007-10#2)(2007-8#1)(2007-9#3)(2008-10#3)(2008-3#1)(2008-5#3)(2008-7#1)(2009-1#1)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#3)
purpose of the present##71##4##(1990-10#1)(1990-5#1)(1990-8#1)(1992-12#2)(1992-7#1)(1993-12#1)(1993-6#1)(1994-10#1)(1994-2#1)(1994-5#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-7#1)(1997-8#2)(2006-10#1)(2006-4#1)(2006-6#1)(2006-8#2)(2007-10#2)(2007-12#1)(2007-6#1)(2007-8#1)(2007-9#3)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-1#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#2)(2010-10#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#4)
purpose of the program##3##4##(1992-1#1)(1996-2#1)(2008-4#1)
purpose of the research##2##4##(1994-7#1)(2013-1#1)
purpose of the study was to assess the##3##8##(2007-8#1)(2008-4#1)(2011-2#1)
purpose of the study was to compare the##2##8##(2007-7#1)(2008-3#1)
purpose of the study was to evaluate##7##7##(1996-9#1)(2007-9#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-12#1)
purpose of the study was to identify the##4##8##(1996-12#1)(2007-8#1)(2010-1#1)(2011-2#1)
purpose of the study was to##36##6##(1990-8#1)(1993-1#1)(1993-2#1)(1996-12#1)(1996-9#1)(2005-10#1)(2006-5#1)(2006-8#1)(2007-10#3)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-4#1)(2011-12#1)(2011-2#3)(2012-3#1)(2013-8#1)
purpose of the study was##37##5##(1990-8#1)(1993-1#1)(1993-2#1)(1996-12#1)(1996-9#1)(2005-10#1)(2006-5#1)(2006-8#1)(2007-10#3)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-4#1)(2011-12#1)(2011-2#3)(2012-3#1)(2013-8#1)
purpose of the study##45##4##(1990-8#1)(1993-1#1)(1993-2#1)(1996-12#1)(1996-9#1)(2005-10#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-10#4)(2007-11#2)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-3#1)(2013-8#1)
purpose of the##174##3##(1990-10#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-7#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-1#1)(1994-10#1)(1994-2#1)(1994-5#2)(1994-7#1)(1995-12#2)(1995-3#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-9#2)(1997-4#1)(1997-7#1)(1997-8#2)(2005-10#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#4)(2007-1#1)(2007-10#7)(2007-11#4)(2007-12#5)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#4)(2008-1#3)(2008-10#5)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-2#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#2)(2010-1#3)(2010-10#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#5)(2013-8#6)
purpose of this article is to discuss##3##7##(1995-1#1)(1996-2#1)(2007-7#1)
purpose of this article is to##94##6##(1993-1#1)(1993-12#1)(1994-1#2)(1994-11#1)(1994-3#2)(1994-4#1)(1995-1#1)(1995-12#1)(1996-2#1)(1997-3#1)(2004-12#1)(2005-10#2)(2005-11#2)(2005-7#2)(2006-10#3)(2006-8#1)(2007-1#2)(2007-11#4)(2007-12#6)(2007-2#2)(2007-5#2)(2007-7#5)(2007-8#2)(2008-1#2)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-9#3)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#4)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#2)
purpose of this article is##95##5##(1993-1#1)(1993-12#1)(1994-1#2)(1994-11#1)(1994-3#2)(1994-4#1)(1995-1#1)(1995-12#1)(1996-2#1)(1997-3#1)(2004-12#1)(2005-10#2)(2005-11#2)(2005-7#2)(2006-10#4)(2006-8#1)(2007-1#2)(2007-11#4)(2007-12#6)(2007-2#2)(2007-5#2)(2007-7#5)(2007-8#2)(2008-1#2)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-9#3)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#4)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#2)
purpose of this article##105##4##(1992-1#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-1#2)(1994-11#1)(1994-3#2)(1994-4#1)(1995-1#1)(1995-12#1)(1996-2#1)(1997-3#1)(2004-12#1)(2005-10#2)(2005-11#2)(2005-7#2)(2006-10#4)(2006-8#1)(2007-1#2)(2007-11#4)(2007-12#6)(2007-2#2)(2007-5#2)(2007-7#6)(2007-8#3)(2008-1#2)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-9#3)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#3)(2012-2#5)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#2)
purpose of this case study is to##2##7##(1993-1#1)(2012-12#1)
purpose of this case study##3##5##(1993-1#1)(2010-5#1)(2012-12#1)
purpose of this case##6##4##(1993-1#1)(2010-5#1)(2010-9#1)(2012-12#1)(2013-1#2)
purpose of this clinical##2##4##(2011-1#1)(2012-11#1)
purpose of this meeting was to##3##6##(2008-5#2)(2011-1#1)
purpose of this paper is to demonstrate the##2##8##(2008-11#1)(2009-8#1)
purpose of this paper is to##62##6##(1991-4#1)(1992-1#1)(1992-2#1)(1995-6#1)(1995-8#1)(1997-1#1)(1997-6#1)(2004-10#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-2#3)(2006-5#1)(2006-6#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
purpose of this paper##70##4##(1991-4#1)(1992-1#1)(1992-2#2)(1995-6#1)(1995-8#1)(1997-1#1)(1997-6#1)(2004-10#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-2#3)(2006-5#1)(2006-6#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#4)(2007-8#2)(2008-1#1)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)
purpose of this pilot study was to examine the##4##9##(1995-3#1)(2007-2#1)(2008-11#1)(2008-12#1)
purpose of this pilot study was to investigate##2##8##(2008-12#2)
purpose of this pilot study was to##10##7##(1995-3#1)(2007-2#2)(2008-11#1)(2008-12#4)(2010-9#1)(2013-1#1)
purpose of this presentation is to##3##6##(2008-7#1)(2011-1#1)(2012-2#1)
purpose of this report is to describe a##2##8##(2006-10#1)(2007-3#1)
purpose of this report is to##12##6##(1992-12#1)(2004-1#1)(2006-10#1)(2007-10#1)(2007-3#1)(2008-1#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
purpose of this report##16##4##(1992-12#1)(2004-1#1)(2006-10#1)(2007-10#1)(2007-3#1)(2008-1#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
purpose of this review is to examine the##2##8##(2007-7#1)(2008-5#1)
purpose of this review is to examine##5##7##(2006-10#1)(2007-1#1)(2007-7#1)(2008-5#1)(2012-12#1)
purpose of this review is to##34##6##(1993-12#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#2)(2007-1#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-3#3)(2008-5#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#1)(2012-12#1)(2012-2#4)(2013-1#3)(2013-8#1)
purpose of this review is##35##5##(1993-12#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#2)(2007-1#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-3#3)(2008-5#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#1)(2010-7#1)(2012-12#1)(2012-2#4)(2013-1#3)(2013-8#1)
purpose of this review##43##4##(1993-12#1)(1996-6#1)(2005-10#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-9#1)(2007-1#1)(2007-11#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-3#3)(2008-5#2)(2008-8#1)(2009-6#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#5)(2013-1#3)(2013-8#1)
purpose of this study is to evaluate the##8##8##(2007-10#1)(2007-4#1)(2007-8#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)
purpose of this study is to evaluate##10##7##(2007-10#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-7#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)
purpose of this study is to##58##6##(1991-12#1)(1993-12#1)(1995-4#1)(1996-1#1)(2004-2#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-4#3)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#5)(2008-9#3)(2009-10#1)(2009-6#1)(2010-5#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#5)(2013-8#1)
purpose of this study is##62##5##(1991-12#1)(1993-12#1)(1995-4#1)(1996-1#1)(2004-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#3)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#5)(2008-9#3)(2009-10#1)(2009-6#1)(2010-5#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#5)(2013-8#1)
purpose of this study was to analyse the##3##8##(2008-6#1)(2010-3#1)(2013-8#1)
purpose of this study was to define##3##7##(2008-9#1)(2013-1#2)
purpose of this study was to describe##7##7##(2006-10#1)(2006-7#1)(2008-12#1)(2008-4#1)(2011-1#1)(2013-1#2)
purpose of this study was to determine if a relationship existed between##2##12##(2006-1#1)(2008-12#1)
purpose of this study was to determine if a##4##9##(2006-1#1)(2008-12#1)(2008-9#1)(2010-8#1)
purpose of this study was to determine if##9##8##(1995-2#1)(1996-5#1)(2006-1#1)(2006-7#1)(2008-12#1)(2008-9#1)(2010-3#1)(2010-6#1)(2010-8#1)
purpose of this study was to determine the##41##8##(1990-12#1)(1991-11#1)(1992-11#1)(1994-2#1)(1994-5#1)(1996-9#1)(1997-6#1)(2006-10#2)(2006-5#1)(2006-8#3)(2007-1#1)(2007-11#1)(2007-2#4)(2007-8#2)(2007-9#2)(2008-12#3)(2008-5#2)(2008-9#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#2)(2011-2#1)(2012-2#3)(2013-1#2)
purpose of this study was to determine##66##7##(1990-10#1)(1990-12#1)(1991-11#1)(1992-11#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-2#1)(1996-5#1)(1996-9#1)(1997-6#1)(1997-8#1)(2006-1#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#6)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#3)(2008-12#4)(2008-5#3)(2008-7#1)(2008-9#2)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#3)(2010-8#1)(2011-2#1)(2012-2#3)(2013-1#2)
purpose of this study was to develop a##9##8##(1993-11#1)(2006-11#1)(2007-10#1)(2007-4#1)(2007-9#1)(2012-1#2)(2013-1#2)
purpose of this study was to develop##16##7##(1993-11#1)(2006-11#1)(2007-1#1)(2007-10#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-9#1)(2012-1#3)(2013-1#2)
purpose of this study was to examine the effect of##3##10##(1995-10#1)(2008-5#1)(2010-2#1)
purpose of this study was to examine the##24##8##(1991-12#1)(1992-6#1)(1995-1#1)(1995-10#1)(1996-1#1)(1996-2#1)(2004-1#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-5#2)(2009-9#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
purpose of this study was to examine##36##7##(1991-12#1)(1992-2#1)(1992-6#1)(1995-1#1)(1995-10#1)(1996-1#1)(1996-2#1)(1997-2#1)(2004-1#1)(2006-7#3)(2006-8#1)(2007-1#1)(2007-10#1)(2007-6#2)(2007-8#1)(2008-12#1)(2008-5#2)(2009-12#1)(2009-7#1)(2009-9#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
purpose of this study was to obtain##4##7##(1993-1#1)(1997-3#1)(2006-8#1)(2008-10#1)
purpose of this study was to##366##6##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-11#2)(1992-2#1)(1992-3#3)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#3)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-4#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(2004-1#1)(2004-3#1)(2004-9#3)(2005-4#1)(2006-1#2)(2006-10#8)(2006-11#5)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-7#7)(2006-8#12)(2006-9#1)(2007-1#4)(2007-10#16)(2007-11#3)(2007-12#3)(2007-2#11)(2007-3#1)(2007-4#5)(2007-5#1)(2007-6#5)(2007-7#3)(2007-8#13)(2007-9#7)(2008-10#9)(2008-11#3)(2008-12#15)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#13)(2008-6#6)(2008-7#2)(2008-8#2)(2008-9#13)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#4)(2010-3#5)(2010-4#4)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#4)(2010-9#4)(2011-1#6)(2011-12#1)(2011-2#10)(2012-1#3)(2012-11#3)(2012-12#5)(2012-2#7)(2012-3#3)(2013-1#13)(2013-7#4)(2013-8#11)
purpose of this study was##374##5##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-11#2)(1992-2#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#3)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-4#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-8#2)(2004-1#1)(2004-3#1)(2004-9#3)(2005-4#1)(2006-1#2)(2006-10#8)(2006-11#5)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-7#7)(2006-8#12)(2006-9#2)(2007-1#4)(2007-10#16)(2007-11#3)(2007-12#3)(2007-2#11)(2007-3#1)(2007-4#5)(2007-5#1)(2007-6#6)(2007-7#5)(2007-8#13)(2007-9#7)(2008-10#9)(2008-11#3)(2008-12#15)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#13)(2008-6#6)(2008-7#2)(2008-8#2)(2008-9#13)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#4)(2010-3#5)(2010-4#4)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#4)(2010-9#4)(2011-1#6)(2011-12#1)(2011-2#10)(2012-1#3)(2012-11#3)(2012-12#5)(2012-2#7)(2012-3#3)(2013-1#14)(2013-7#4)(2013-8#11)
purpose of this study##445##4##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#2)(1991-11#1)(1991-12#2)(1991-5#1)(1991-7#1)(1992-11#2)(1992-2#1)(1992-3#4)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#3)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#2)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-8#3)(2004-1#1)(2004-2#1)(2004-3#1)(2004-9#3)(2005-4#1)(2006-1#2)(2006-10#8)(2006-11#5)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-7#7)(2006-8#12)(2006-9#2)(2007-1#4)(2007-10#17)(2007-11#4)(2007-12#4)(2007-2#11)(2007-3#2)(2007-4#8)(2007-5#1)(2007-6#6)(2007-7#8)(2007-8#15)(2007-9#8)(2008-1#1)(2008-10#13)(2008-11#5)(2008-12#16)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#15)(2008-6#6)(2008-7#7)(2008-8#2)(2008-9#16)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#4)(2010-3#5)(2010-4#4)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#8)(2010-9#5)(2011-1#7)(2011-12#3)(2011-2#16)(2012-1#4)(2012-11#3)(2012-12#7)(2012-2#9)(2012-3#3)(2013-1#20)(2013-7#4)(2013-8#12)
purpose of this unit is to##5##6##(2008-4#3)(2008-9#2)
purpose of this unit is##8##5##(2008-4#5)(2008-9#3)
purpose of this work##17##4##(1991-5#1)(1995-2#1)(1996-5#1)(1997-8#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-5#3)(2008-6#1)(2010-5#1)(2011-2#1)(2012-2#1)
purpose of this##825##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#2)(1991-11#1)(1991-12#3)(1991-4#1)(1991-5#2)(1991-7#1)(1992-1#2)(1992-11#2)(1992-12#2)(1992-2#4)(1992-3#4)(1992-6#1)(1992-8#1)(1993-1#3)(1993-11#1)(1993-12#10)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#2)(1994-11#2)(1994-12#2)(1994-2#5)(1994-3#4)(1994-4#1)(1994-5#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#4)(1995-4#2)(1995-6#2)(1995-8#1)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#2)(1996-5#3)(1996-6#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#3)(1997-8#4)(2004-1#2)(2004-10#1)(2004-12#2)(2004-2#1)(2004-3#1)(2004-9#3)(2005-10#3)(2005-11#2)(2005-4#1)(2005-7#3)(2005-8#1)(2006-1#4)(2006-10#22)(2006-11#7)(2006-12#4)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#2)(2006-7#8)(2006-8#17)(2006-9#3)(2007-1#8)(2007-10#18)(2007-11#11)(2007-12#13)(2007-2#21)(2007-3#4)(2007-4#9)(2007-5#4)(2007-6#7)(2007-7#22)(2007-8#23)(2007-9#9)(2008-1#5)(2008-10#18)(2008-11#15)(2008-12#27)(2008-2#5)(2008-3#11)(2008-4#11)(2008-5#30)(2008-6#12)(2008-7#15)(2008-8#9)(2008-9#25)(2009-10#4)(2009-11#3)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#5)(2009-5#3)(2009-6#4)(2009-7#4)(2009-8#5)(2009-9#6)(2010-1#1)(2010-10#2)(2010-11#6)(2010-12#10)(2010-2#8)(2010-3#6)(2010-4#8)(2010-5#8)(2010-6#4)(2010-7#5)(2010-8#9)(2010-9#9)(2011-1#17)(2011-12#4)(2011-2#30)(2012-1#6)(2012-11#5)(2012-12#13)(2012-2#28)(2012-3#9)(2013-1#34)(2013-7#6)(2013-8#18)
purpose of##1198##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#2)(1990-8#5)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#4)(1992-10#1)(1992-11#2)(1992-12#5)(1992-2#4)(1992-3#5)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#6)(1993-11#2)(1993-12#13)(1993-2#3)(1993-3#3)(1993-4#1)(1993-6#4)(1993-8#2)(1993-9#4)(1994-1#3)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#7)(1994-3#4)(1994-4#1)(1994-5#3)(1994-7#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#6)(1995-2#3)(1995-3#5)(1995-4#2)(1995-5#2)(1995-6#3)(1995-8#1)(1996-1#3)(1996-10#2)(1996-11#1)(1996-12#5)(1996-2#4)(1996-5#5)(1996-6#2)(1996-9#6)(1997-1#3)(1997-2#1)(1997-3#3)(1997-4#2)(1997-6#3)(1997-7#1)(1997-8#6)(2004-1#2)(2004-10#1)(2004-12#2)(2004-2#1)(2004-3#1)(2004-9#3)(2005-10#5)(2005-11#3)(2005-12#1)(2005-4#1)(2005-7#4)(2005-8#2)(2006-1#4)(2006-10#25)(2006-11#8)(2006-12#6)(2006-2#4)(2006-3#1)(2006-4#2)(2006-5#4)(2006-6#5)(2006-7#8)(2006-8#23)(2006-9#4)(2007-1#12)(2007-10#25)(2007-11#17)(2007-12#19)(2007-2#22)(2007-3#5)(2007-4#12)(2007-5#5)(2007-6#9)(2007-7#34)(2007-8#36)(2007-9#14)(2008-1#12)(2008-10#37)(2008-11#26)(2008-12#30)(2008-2#14)(2008-3#21)(2008-4#17)(2008-5#43)(2008-6#14)(2008-7#29)(2008-8#12)(2008-9#32)(2009-1#2)(2009-10#6)(2009-11#3)(2009-12#4)(2009-2#3)(2009-3#3)(2009-4#7)(2009-5#7)(2009-6#5)(2009-7#6)(2009-8#8)(2009-9#6)(2010-1#4)(2010-10#4)(2010-11#6)(2010-12#20)(2010-2#10)(2010-3#10)(2010-4#9)(2010-5#10)(2010-6#4)(2010-7#5)(2010-8#9)(2010-9#11)(2011-1#18)(2011-12#5)(2011-2#39)(2011-3#1)(2012-1#12)(2012-11#5)(2012-12#15)(2012-2#39)(2012-3#12)(2013-1#46)(2013-7#6)(2013-8#29)
purpose or##2##2##(1992-6#1)(2004-10#1)
purpose the##9##2##(1991-1#1)(1997-1#1)(2005-11#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-4#1)(2012-12#1)
purpose to##6##2##(2008-10#2)(2008-11#1)(2010-4#1)(2011-2#1)(2012-2#1)
purpose was to assess the##2##5##(1990-6#1)(2007-2#1)
purpose was to compare the##2##5##(1990-10#1)(2006-10#1)
purpose was to compare##4##4##(1990-10#1)(2006-10#1)(2006-7#1)(2013-1#1)
purpose was to determine if##2##5##(1993-2#1)(2006-2#1)
purpose was to determine the##2##5##(2010-10#1)(2013-1#1)
purpose was to determine##5##4##(1991-6#1)(1993-2#1)(2006-2#1)(2010-10#1)(2013-1#1)
purpose was to evaluate the##2##5##(1993-9#1)(2011-2#1)
purpose was to examine##2##4##(2007-10#1)(2013-1#1)
purpose was to identify##2##4##(1990-7#1)(2009-8#1)
purpose was to investigate the##2##5##(1995-12#1)(2008-3#1)
purpose was to##29##3##(1990-10#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-6#1)(1992-3#1)(1993-2#1)(1993-9#1)(1995-12#1)(1997-8#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-2#1)(2008-3#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-3#1)(2011-2#3)(2012-2#1)(2013-1#4)
purpose was##32##2##(1990-10#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-6#1)(1992-3#1)(1993-2#1)(1993-9#1)(1995-12#1)(1997-8#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-2#1)(2008-3#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#5)
purpose we##12##2##(1995-10#1)(1996-11#1)(1996-12#1)(1996-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-2#1)(2013-1#2)
purpose##1636##1##(1990-10#4)(1990-11#1)(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#1)(1990-8#7)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#3)(1991-4#1)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#7)(1992-10#1)(1992-11#3)(1992-12#5)(1992-2#4)(1992-3#7)(1992-6#2)(1992-7#1)(1992-8#1)(1993-1#10)(1993-10#1)(1993-11#2)(1993-12#18)(1993-2#5)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#4)(1993-8#2)(1993-9#5)(1994-1#4)(1994-10#1)(1994-11#2)(1994-12#5)(1994-2#9)(1994-3#4)(1994-4#1)(1994-5#4)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#4)(1995-10#2)(1995-11#2)(1995-12#10)(1995-2#5)(1995-3#6)(1995-4#3)(1995-5#4)(1995-6#4)(1995-8#1)(1996-1#3)(1996-10#2)(1996-11#3)(1996-12#9)(1996-2#8)(1996-3#1)(1996-5#5)(1996-6#2)(1996-8#1)(1996-9#8)(1997-1#7)(1997-2#3)(1997-3#5)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#9)(2004-1#2)(2004-10#4)(2004-11#1)(2004-12#3)(2004-2#1)(2004-3#1)(2004-9#3)(2005-10#7)(2005-11#8)(2005-12#1)(2005-4#2)(2005-7#4)(2005-8#3)(2005-9#1)(2006-1#5)(2006-10#30)(2006-11#8)(2006-12#7)(2006-2#7)(2006-3#1)(2006-4#2)(2006-5#6)(2006-6#5)(2006-7#11)(2006-8#27)(2006-9#4)(2007-1#12)(2007-10#29)(2007-11#26)(2007-12#23)(2007-2#25)(2007-3#6)(2007-4#12)(2007-5#5)(2007-6#9)(2007-7#38)(2007-8#43)(2007-9#16)(2008-1#22)(2008-10#92)(2008-11#40)(2008-12#34)(2008-2#23)(2008-3#39)(2008-4#26)(2008-5#57)(2008-6#18)(2008-7#39)(2008-8#19)(2008-9#38)(2009-1#2)(2009-10#7)(2009-11#4)(2009-12#6)(2009-2#3)(2009-3#4)(2009-4#10)(2009-5#8)(2009-6#5)(2009-7#10)(2009-8#10)(2009-9#6)(2010-1#5)(2010-10#5)(2010-11#9)(2010-12#20)(2010-2#11)(2010-3#12)(2010-4#11)(2010-5#12)(2010-6#6)(2010-7#5)(2010-8#13)(2010-9#13)(2011-1#25)(2011-12#5)(2011-2#55)(2011-3#1)(2012-1#12)(2012-11#6)(2012-12#22)(2012-2#52)(2012-3#22)(2012-9#1)(2013-1#69)(2013-7#7)(2013-8#31)
purpose&quot##2##1##(2008-10#1)(2009-4#1)
purpose-built##2##1##(2005-11#1)(2008-10#1)
purpose-designed##2##1##(2008-12#1)(2008-7#1)
purposeful movement##2##2##(1993-9#1)(2012-1#1)
purposeful sample of##2##3##(2008-11#1)(2013-8#1)
purposeful##14##1##(1993-5#1)(1993-9#1)(1995-5#1)(1995-7#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-11#1)(2009-2#1)(2010-8#2)(2012-1#1)(2013-1#1)(2013-8#1)
purposefully##4##1##(2006-7#1)(2008-1#1)(2009-10#1)(2013-7#1)
purposely##4##1##(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#1)
purposes (e##2##2##(2008-4#1)(2011-2#1)
purposes a##2##2##(2008-2#1)(2012-12#1)
purposes and for##3##3##(2008-1#1)(2008-12#2)
purposes and it##2##3##(2008-10#1)(2013-8#1)
purposes and to##3##3##(1990-6#1)(1994-2#1)(2008-2#1)
purposes and##22##2##(1990-6#1)(1991-2#1)(1993-10#1)(1994-2#1)(2006-12#1)(2006-8#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#1)(2012-12#1)(2013-8#1)
purposes are##5##2##(1991-9#1)(2005-7#1)(2008-10#1)(2010-8#1)(2013-8#1)
purposes as well as##2##4##(1992-12#1)(2008-11#1)
purposes for##3##2##(1993-1#1)(1996-9#1)(2006-5#1)
purposes in the##2##3##(1995-4#1)(2006-8#1)
purposes in##17##2##(1990-6#1)(1991-6#1)(1992-10#1)(1993-5#1)(1994-3#1)(1995-2#1)(1995-4#1)(1996-7#1)(2006-8#3)(2007-10#1)(2008-1#1)(2008-10#2)(2008-7#1)(2012-1#1)
purposes is presented##2##3##(2008-3#2)
purposes is##7##2##(1990-3#1)(1990-8#1)(2006-8#1)(2008-10#1)(2008-3#2)(2012-2#1)
purposes it is##2##3##(2005-10#1)(2012-2#1)
purposes may##2##2##(1993-2#1)(2007-12#1)
purposes of the##11##3##(1994-12#1)(1994-3#1)(1996-3#1)(1996-9#1)(2007-10#1)(2007-8#1)(2008-6#1)(2010-9#1)(2012-12#1)(2013-1#2)
purposes of this review##3##4##(1991-4#1)(2009-1#1)(2013-1#1)
purposes of this study were##9##5##(1993-12#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-12#1)(2010-11#1)(2010-3#1)
purposes of this study##12##4##(1993-12#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2010-11#1)(2010-3#1)
purposes of this##23##3##(1991-4#1)(1993-12#1)(2004-12#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-1#1)(2010-11#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
purposes of##69##2##(1990-3#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-6#1)(1992-3#1)(1993-12#2)(1993-3#1)(1994-1#2)(1994-12#1)(1994-3#1)(1994-6#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(2004-12#1)(2005-10#1)(2005-11#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-9#1)(2007-10#2)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-9#1)(2010-11#2)(2010-3#1)(2010-6#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
purposes only##2##2##(1992-2#1)(2009-7#1)
purposes or##3##2##(1992-7#1)(2009-4#1)(2013-1#1)
purposes since##2##2##(2008-10#1)(2008-7#1)
purposes such as##3##3##(1992-8#1)(1996-3#1)(2013-1#1)
purposes than##3##2##(1996-3#1)(2007-4#1)(2010-5#1)
purposes to##2##2##(2006-8#2)
purposes was##2##2##(2006-8#1)(2008-10#1)
purposes we##2##2##(1990-8#1)(2008-3#1)
purposes were##4##2##(1996-5#1)(2006-8#1)(2013-1#1)(2013-4#1)
purposes with##2##2##(1992-12#1)(2008-5#1)
purposes would##2##2##(1992-12#1)(2008-11#1)
purposes##427##1##(1990-12#1)(1990-2#3)(1990-3#2)(1990-6#3)(1990-8#5)(1991-11#1)(1991-12#6)(1991-2#2)(1991-4#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-7#2)(1992-8#1)(1993-1#3)(1993-10#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-5#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-2#4)(1996-3#6)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#2)(1997-8#1)(2004-11#1)(2004-12#3)(2005-10#3)(2005-11#3)(2005-12#1)(2005-5#1)(2005-7#2)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#4)(2006-2#2)(2006-3#1)(2006-5#2)(2006-7#2)(2006-8#13)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#5)(2007-12#7)(2007-3#2)(2007-4#2)(2007-5#2)(2007-6#4)(2007-7#3)(2007-8#6)(2007-9#1)(2008-1#7)(2008-10#47)(2008-11#16)(2008-12#9)(2008-2#12)(2008-3#12)(2008-4#15)(2008-5#10)(2008-6#3)(2008-7#6)(2008-8#1)(2008-9#7)(2009-1#1)(2009-11#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-11#5)(2010-12#3)(2010-3#5)(2010-5#5)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#5)(2011-1#6)(2011-12#2)(2011-2#10)(2012-1#3)(2012-11#1)(2012-12#8)(2012-2#6)(2012-3#4)(2013-1#14)(2013-4#1)(2013-7#4)(2013-8#3)
purposes)##2##1##(2008-10#2)
purposive sample of##6##3##(2007-10#1)(2007-11#1)(2008-11#1)(2008-12#1)(2010-10#1)(2011-1#1)
purposive sample##8##2##(2007-10#1)(2007-11#1)(2008-11#1)(2008-12#1)(2010-10#1)(2011-1#1)(2012-11#1)(2013-1#1)
purposive sampling##3##2##(2007-10#2)(2010-3#1)
purposive##14##1##(2007-10#3)(2007-11#1)(2008-11#1)(2008-12#1)(2009-9#1)(2010-10#2)(2010-3#1)(2011-1#2)(2012-11#1)(2013-1#1)
purposively sampled##3##2##(2007-7#1)(2010-10#1)(2012-12#1)
purposively selected for the study##2##5##(2010-3#1)(2011-1#1)
purposively selected##4##2##(2007-8#1)(2008-11#1)(2010-3#1)(2011-1#1)
purposively##11##1##(2007-7#2)(2007-8#1)(2008-11#1)(2008-4#1)(2010-10#1)(2010-11#1)(2010-3#1)(2011-1#1)(2012-12#1)(2013-1#1)
purpura (TTP)##5##2##(1991-3#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-12#1)
purpura and##8##2##(1990-8#1)(2006-10#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-4#1)(2012-2#1)(2013-8#1)
purpura in##8##2##(1991-6#1)(1997-8#1)(2006-10#1)(2006-8#3)(2008-1#1)(2008-10#1)
purpura is a##3##3##(1992-8#2)(2006-8#1)
purpura is##6##2##(1992-8#2)(1994-8#2)(2006-8#1)(2007-8#1)
purpura##74##1##(1990-12#1)(1990-6#1)(1990-8#1)(1991-11#2)(1991-3#2)(1991-6#3)(1992-5#1)(1992-8#5)(1994-8#3)(1995-3#2)(1996-4#1)(1997-4#1)(1997-8#5)(2005-6#1)(2006-10#5)(2006-4#3)(2006-6#1)(2006-8#9)(2006-9#1)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#5)(2008-1#3)(2008-10#1)(2008-4#1)(2009-7#1)(2010-6#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#3)
purpura]##3##1##(1992-8#1)(1994-3#1)(1997-8#1)
purpuratus##9##1##(1990-10#3)(2009-2#2)(2011-2#1)(2013-8#3)
purpurea and##2##2##(2008-10#2)
purpurea is a##2##3##(2008-10#1)(2012-1#1)
purpurea root##3##2##(2008-5#3)
purpurea##38##1##(1997-3#2)(2006-11#1)(2007-1#2)(2008-10#14)(2008-2#2)(2008-5#10)(2008-9#5)(2010-3#1)(2012-1#1)
purpurea)##4##1##(2008-10#4)
purpuric rash##2##2##(1997-8#1)(2008-8#1)
purpuric##8##1##(1997-8#2)(2007-11#1)(2007-7#1)(2008-8#1)(2010-6#1)(2010-9#1)(2013-1#1)
purpurin##10##1##(1992-1#1)(1992-4#4)(1994-10#1)(2007-11#1)(2008-10#2)(2009-3#1)
purpurin/RBP hybrid##2##2##(1992-4#2)
purse##3##1##(2007-8#1)(2008-10#1)(2012-3#1)
purse-string suture##3##2##(2007-8#3)
purse-string##5##1##(1990-3#1)(2007-8#3)(2010-1#1)
purslane##2##1##(2008-12#1)(2012-3#1)
pursuant to the##3##3##(1991-10#1)(2005-5#1)(2006-8#1)
pursuant to##9##2##(1991-10#1)(1991-8#1)(1992-4#1)(2005-5#2)(2006-8#3)(2008-11#1)
pursue a##7##2##(1990-10#1)(1992-1#1)(1996-6#1)(2007-4#1)(2008-10#1)(2009-5#1)(2012-3#1)
pursue the##5##2##(1992-3#1)(1993-3#1)(2008-11#1)(2008-9#1)(2011-2#1)
pursue this##6##2##(1992-1#1)(2007-2#1)(2008-8#1)(2012-12#1)(2013-1#2)
pursue to##2##2##(1991-3#1)(2008-11#1)
pursue##55##1##(1990-10#1)(1991-2#1)(1991-3#1)(1992-1#2)(1992-3#1)(1993-2#1)(1993-3#2)(1994-5#1)(1995-1#2)(1995-2#1)(1995-4#1)(1995-6#1)(1996-3#1)(1996-6#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)
pursued by the##2##3##(2009-12#1)(2010-5#1)
pursued by##3##2##(2004-12#1)(2009-12#1)(2010-5#1)
pursued for##3##2##(2004-11#1)(2010-1#1)(2010-2#1)
pursued in##3##2##(2006-10#1)(2006-6#1)(2010-8#1)
pursued to##5##2##(1991-12#1)(1994-5#1)(2005-7#1)(2006-1#1)(2011-2#1)
pursued##44##1##(1991-12#1)(1991-2#1)(1993-1#1)(1993-2#2)(1994-12#1)(1994-5#1)(1995-1#1)(1996-1#3)(1997-2#1)(2004-11#1)(2004-12#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-4#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-4#2)(2009-6#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-11#2)(2012-2#1)(2013-1#1)
pursues##4##1##(1994-1#1)(2008-1#1)(2008-2#2)
pursuing a##7##2##(1990-12#1)(1995-12#1)(2008-1#1)(2008-2#1)(2009-12#1)(2010-12#1)(2010-2#1)
pursuing the##3##2##(1994-1#1)(2008-5#1)(2008-9#1)
pursuing these##2##2##(1992-5#1)(2006-4#1)
pursuing this##2##2##(1995-12#1)(2008-5#1)
pursuing##39##1##(1990-12#1)(1992-5#1)(1993-12#1)(1994-1#1)(1995-12#3)(1995-9#1)(1996-12#1)(1997-2#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-4#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-2#3)(2010-4#1)(2012-2#2)(2013-1#1)(2013-8#1)
pursuit algorithm##2##2##(2008-2#2)
pursuit algorithms##2##2##(2008-2#2)
pursuit and##3##2##(1992-7#1)(1996-1#1)(1996-8#1)
pursuit deficits##3##2##(1993-2#2)(2008-11#1)
pursuit eye movements##4##3##(1993-2#1)(1996-1#3)
pursuit eye##7##2##(1993-2#1)(1996-1#4)(1996-8#1)(1997-8#1)
pursuit gain##3##2##(1996-1#3)
pursuit of a moving##2##4##(2009-8#2)
pursuit of a##7##3##(1994-3#1)(2005-7#1)(2006-10#1)(2009-8#2)(2012-3#1)(2013-8#1)
pursuit of quality##2##3##(1996-12#1)(1997-3#1)
pursuit of the##3##3##(2008-10#1)(2008-7#1)(2012-3#1)
pursuit of##33##2##(1993-2#3)(1994-2#1)(1994-3#1)(1996-1#1)(1996-12#1)(1997-3#1)(2004-12#1)(2005-7#1)(2006-10#2)(2006-7#1)(2006-8#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-12#1)(2009-5#1)(2009-8#2)(2010-11#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
pursuit velocity##2##2##(1996-1#2)
pursuit was##2##2##(1993-2#2)
pursuit##86##1##(1992-7#1)(1993-2#18)(1993-9#1)(1994-2#1)(1994-3#1)(1996-1#14)(1996-12#1)(1996-8#2)(1997-1#1)(1997-3#1)(1997-8#1)(2004-12#1)(2005-7#1)(2006-10#2)(2006-6#1)(2006-7#1)(2006-8#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#6)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#2)(2009-12#1)(2009-5#1)(2009-8#3)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-3#2)(2013-1#2)(2013-8#2)
pursuits##3##1##(1996-1#1)(2008-6#1)(2010-4#1)
purulent and##3##2##(1993-2#1)(2007-6#1)(2008-5#1)
purulent discharge##2##2##(2007-7#1)(2013-8#1)
purulent drainage##3##2##(1992-3#1)(2011-2#2)
purulent material##2##2##(1997-6#1)(2005-10#1)
purulent meningitis##5##2##(1993-1#3)(2010-2#2)
purulent secretion##2##2##(1993-2#2)
purulent sputum##2##2##(2007-11#1)(2008-1#1)
purulent##41##1##(1992-3#1)(1993-1#3)(1993-2#3)(1993-5#1)(1995-11#2)(1997-6#1)(2005-10#1)(2005-11#1)(2007-11#2)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-2#3)(2010-2#2)(2010-9#1)(2011-2#6)(2013-1#2)(2013-7#1)(2013-8#1)
purview##6##1##(2006-7#1)(2008-2#2)(2010-7#1)(2012-1#1)(2013-1#1)
puréed diets##2##2##(1995-3#2)
puréed##5##1##(1995-3#5)
pus culture##2##2##(1993-3#1)(2007-8#1)
pus were##2##2##(1993-3#1)(2011-2#1)
pus##19##1##(1991-5#1)(1991-8#1)(1993-3#3)(1993-8#1)(2007-12#1)(2007-7#3)(2007-8#3)(2008-1#1)(2008-12#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-12#1)
push component##2##2##(2009-8#2)
push for##2##2##(1995-2#1)(2010-7#1)
push the##6##2##(1996-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-3#1)(2010-12#1)
push to##5##2##(1994-2#1)(2005-9#1)(2007-9#1)(2008-3#1)(2013-1#1)
push##42##1##(1990-6#1)(1990-8#2)(1991-1#1)(1991-11#1)(1992-3#1)(1993-2#1)(1994-2#1)(1995-2#1)(1996-11#1)(1997-2#1)(2005-9#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-6#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2013-1#7)(2013-8#1)
push&quot##2##1##(2004-11#1)(2009-4#1)
push-pull perfusion##3##2##(1994-12#1)(1996-11#1)(2010-2#1)
push-pull tracking error signal##2##4##(2008-2#2)
push-pull##17##1##(1994-12#1)(1995-12#1)(1995-5#1)(1996-11#1)(2004-11#1)(2007-11#1)(2008-2#5)(2008-3#5)(2010-2#1)
push-pull&quot##2##1##(2004-11#2)
pushbroom##2##1##(2008-1#1)(2008-3#1)
pushed into the##2##3##(2008-10#1)(2013-7#1)
pushed through##2##2##(1996-5#1)(2007-9#1)
pushed to the##2##3##(1996-6#1)(2008-2#1)
pushed to##4##2##(1996-6#1)(2006-6#1)(2008-2#1)(2009-7#1)
pushed##16##1##(1996-5#1)(1996-6#1)(1997-5#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-1#1)(2013-7#1)
pushes the##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
pushes##7##1##(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-6#1)(2011-1#1)(2012-1#1)
pushing the##5##2##(1993-3#1)(1996-10#1)(2008-7#1)(2012-12#1)(2013-1#1)
pushing##19##1##(1992-1#2)(1993-3#1)(1994-9#1)(1995-3#1)(1996-10#1)(1996-11#1)(2007-2#2)(2007-9#1)(2008-6#3)(2008-7#2)(2009-7#1)(2012-1#1)(2012-12#1)(2013-1#1)
pushing'##3##1##(1990-5#3)
pushrim##2##1##(2007-10#2)
pusillus##2##1##(1992-8#1)(2008-5#1)
pustular psoriasis##5##2##(2007-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
pustular##15##1##(1997-5#2)(2006-8#1)(2007-7#3)(2007-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
pustule production was##2##3##(2008-10#2)
pustule production##3##2##(2008-10#3)
pustule##11##1##(2008-10#11)
pustules on##5##2##(2008-10#1)(2010-6#1)(2012-3#1)(2013-1#2)
pustules per##3##2##(2008-10#3)
pustules##19##1##(2006-8#1)(2007-8#1)(2008-10#9)(2010-4#1)(2010-6#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
pustulosis (AGEP)##4##2##(2007-8#1)(2012-2#1)(2013-1#2)
pustulosis##13##1##(1992-6#1)(1996-12#1)(2006-10#2)(2007-8#2)(2008-12#1)(2010-6#3)(2012-2#1)(2013-1#2)
put a##4##2##(2007-9#1)(2010-5#1)(2012-3#1)(2013-8#1)
put at risk##2##3##(2008-4#1)(2008-9#1)
put at##4##2##(1996-11#1)(2008-4#1)(2008-9#1)(2012-11#1)
put forth in##3##3##(1992-12#1)(1997-3#1)(2008-9#1)
put forth##10##2##(1992-12#1)(1994-12#1)(1996-8#1)(1997-3#1)(2006-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-12#1)(2012-2#1)
put forward a method##2##4##(2007-11#1)(2007-12#1)
put forward a##6##3##(2005-5#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-4#1)(2010-7#1)
put forward and##2##3##(2008-2#1)(2008-5#1)
put forward to explain the##3##5##(2005-10#1)(2008-3#1)(2013-1#1)
put forward to explain##4##4##(1994-8#1)(2005-10#1)(2008-3#1)(2013-1#1)
put forward to##6##3##(1994-8#1)(2005-10#1)(2005-11#1)(2008-3#1)(2013-1#1)(2013-8#1)
put forward##39##2##(1992-1#1)(1993-11#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-4#1)(1996-11#1)(1996-12#1)(2005-10#1)(2005-11#1)(2005-5#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2009-10#1)(2009-11#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#3)
put in place by##2##4##(1991-1#1)(2008-7#1)
put in place in##2##4##(2008-2#1)(2009-4#1)
put in place##16##3##(1991-1#1)(1991-3#1)(1995-12#1)(1995-2#2)(1997-2#1)(2007-7#1)(2008-2#2)(2008-7#2)(2009-4#1)(2010-1#1)(2011-3#1)(2012-12#1)(2012-3#1)
put in the##4##3##(1993-10#1)(1993-9#1)(2008-2#1)(2009-2#1)
put in##30##2##(1991-1#1)(1991-3#1)(1992-12#1)(1992-8#1)(1993-10#1)(1993-9#1)(1995-12#1)(1995-2#2)(1997-2#1)(1997-8#1)(2007-11#1)(2007-7#2)(2008-12#1)(2008-2#3)(2008-6#1)(2008-7#2)(2009-2#1)(2009-4#1)(2010-1#2)(2010-4#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)
put into a##4##3##(2004-9#1)(2007-12#1)(2008-5#1)(2008-8#1)
put into effect##2##3##(2007-8#1)(2008-2#1)
put into perspective##2##3##(1990-11#1)(2005-10#1)
put into practice##5##3##(2007-1#2)(2008-2#1)(2011-1#1)(2013-1#1)
put into the##3##3##(1995-3#1)(2007-11#1)(2013-1#1)
put into##32##2##(1990-11#1)(1990-7#1)(1994-1#2)(1995-3#1)(1997-6#1)(2004-12#1)(2004-9#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#2)
put it in##2##3##(2007-12#1)(2010-7#1)
put it##8##2##(1990-5#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2009-10#1)(2010-7#1)(2012-1#1)
put more##5##2##(1990-8#1)(1997-2#1)(2007-3#1)(2007-7#1)(2008-10#1)
put off##2##2##(2003-11#1)(2008-8#1)
put on a##4##3##(1993-12#1)(1995-2#1)(1997-3#1)(2012-12#1)
put on the##12##3##(1990-5#1)(1995-7#1)(1995-8#1)(1996-12#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-9#1)(2008-2#1)(2010-7#1)(2011-2#2)
put on##31##2##(1990-5#1)(1990-9#1)(1993-12#1)(1995-2#1)(1995-7#1)(1995-8#1)(1996-12#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-2#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)
put the##18##2##(1991-11#2)(1991-3#1)(1992-1#1)(1994-1#1)(1995-6#1)(2005-8#1)(2006-10#1)(2006-3#1)(2007-8#1)(2007-9#2)(2008-11#1)(2008-2#1)(2008-8#1)(2009-6#1)(2010-5#1)(2013-8#1)
put them at##2##3##(2007-12#1)(2013-7#1)
put them in a##2##4##(1997-6#1)(2013-7#1)
put them in##4##3##(1997-6#1)(2008-10#1)(2011-2#1)(2013-7#1)
put them##8##2##(1996-3#1)(1997-6#1)(2006-7#1)(2007-12#1)(2008-10#1)(2011-2#1)(2013-7#2)
put these##3##2##(1993-6#1)(2004-4#1)(2012-12#1)
put to the##3##3##(2006-10#1)(2008-1#1)(2008-10#1)
put to##9##2##(1991-1#1)(1993-4#1)(1997-3#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)
put together to##3##3##(2007-6#1)(2008-3#1)(2010-7#1)
put together##5##2##(2007-6#1)(2008-2#1)(2008-3#1)(2010-7#1)(2011-2#1)
put under##3##2##(1994-5#1)(1997-3#1)(2008-10#1)
put young women##2##3##(2007-7#2)
put##254##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#2)(1991-2#1)(1991-3#3)(1992-1#2)(1992-12#3)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-9#3)(1994-1#3)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-11#3)(1996-12#2)(1996-3#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#5)(1997-6#3)(1997-8#1)(2003-11#1)(2004-12#1)(2004-4#1)(2004-9#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-5#1)(2005-8#2)(2006-10#7)(2006-11#1)(2006-2#3)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-1#2)(2007-11#5)(2007-12#5)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#8)(2007-8#6)(2007-9#5)(2008-1#2)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#14)(2008-3#2)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#7)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#7)(2012-2#4)(2012-3#4)(2013-1#6)(2013-7#2)(2013-8#6)
putA gene##4##2##(1996-2#4)
putA##8##1##(1996-2#8)
putamen and caudate##2##3##(1995-5#1)(2008-7#1)
putamen and##7##2##(1995-5#1)(1995-8#1)(1996-12#2)(2008-7#2)(2012-3#1)
putamen of##4##2##(1993-12#1)(2007-1#1)(2008-7#2)
putamen##46##1##(1990-5#1)(1991-9#1)(1992-8#3)(1993-12#4)(1993-5#1)(1994-2#2)(1995-1#2)(1995-12#1)(1995-5#2)(1995-6#2)(1995-7#2)(1995-8#2)(1996-12#5)(1996-8#1)(1997-7#1)(2006-1#1)(2007-1#1)(2007-10#1)(2008-11#2)(2008-7#7)(2012-12#1)(2012-3#3)
putaminal hemorrhage##5##2##(2007-10#5)
putative &quot##2##2##(1996-6#1)(2008-10#1)
putative 'V3'##2##2##(1993-4#2)
putative ATP##3##2##(1993-8#1)(1994-9#1)(1997-7#1)
putative Ca2+ binding##2##3##(1990-11#1)(1992-6#1)
putative DNA binding domain##2##4##(1995-5#1)(1996-10#1)
putative DNA##7##2##(1990-11#1)(1995-5#1)(1996-10#1)(1997-4#1)(2012-2#3)
putative DNA-binding##3##2##(1990-10#1)(1994-12#2)
putative G protein-coupled receptor##2##4##(1992-9#1)(1993-12#1)
putative G-protein##2##2##(1996-5#1)(2010-12#1)
putative GTP-binding##3##2##(1992-6#1)(1993-3#2)
putative ORF##3##2##(1995-10#1)(1997-7#1)(2008-4#1)
putative OT neurones##3##3##(1997-8#3)
putative RNA helicase##2##3##(2006-12#1)(2008-10#1)
putative RNA##3##2##(2006-12#1)(2008-10#2)
putative active site##12##3##(1991-12#1)(1991-9#1)(1992-12#1)(1992-3#1)(1997-3#3)(1997-7#2)(2010-10#3)
putative amino acid sequence##2##4##(1990-9#1)(2006-5#1)
putative amino acid##3##3##(1990-9#1)(2006-5#1)(2008-10#1)
putative amino##4##2##(1990-9#1)(2006-5#1)(2008-10#1)(2013-1#1)
putative antigen##2##2##(1994-6#1)(2008-8#1)
putative avirulence gene##2##3##(2008-10#2)
putative avirulence##3##2##(2008-10#3)
putative binding sites for##3##4##(1993-12#1)(1993-3#1)(2008-7#1)
putative binding sites##5##3##(1993-12#1)(1993-3#1)(1994-6#1)(2008-7#1)(2009-8#1)
putative binding##9##2##(1991-12#1)(1992-8#1)(1993-12#2)(1993-3#2)(1994-6#1)(2008-7#1)(2009-8#1)
putative biological role of##2##4##(2011-2#2)
putative candidate genes##2##3##(2012-3#1)(2013-1#1)
putative cell##3##2##(1996-3#1)(1997-2#1)(2008-7#1)
putative cis-acting elements##2##3##(1992-12#1)(1997-2#1)
putative cis-regulatory elements##2##3##(2006-12#1)(2009-10#1)
putative closteroviruses##2##2##(2008-10#2)
putative coding region of##2##4##(1993-3#1)(1994-9#1)
putative coding region##4##3##(1992-7#1)(1993-3#1)(1994-9#2)
putative consensus##2##2##(1992-11#1)(1994-9#1)
putative converted isolates##2##3##(2008-10#2)
putative cyclic##2##2##(1991-2#1)(1996-8#1)
putative cytochrome##2##2##(1997-6#1)(2008-9#1)
putative cytoplasmic##4##2##(1993-9#1)(1994-3#1)(1994-6#1)(2008-7#1)
putative endogenous##4##2##(1993-11#1)(2008-1#1)(2012-2#2)
putative eukaryotic##3##2##(1991-9#1)(1994-3#1)(1995-8#1)
putative exon 1##2##3##(1991-10#1)(1992-8#1)
putative family of##3##3##(1995-5#2)(2009-9#1)
putative family##4##2##(1995-5#3)(2009-9#1)
putative function of##2##3##(2008-10#1)(2009-11#1)
putative function##4##2##(2005-8#1)(2008-10#1)(2009-11#1)(2011-12#1)
putative functional##5##2##(1992-8#1)(2008-10#3)(2012-2#1)
putative functions##3##2##(2008-11#1)(2008-7#1)(2009-12#1)
putative gap##2##2##(1992-7#1)(2008-7#1)
putative gene##6##2##(1996-4#1)(1996-6#2)(1997-1#1)(2008-11#1)(2008-5#1)
putative genes were identified##2##4##(1995-12#2)
putative genes##12##2##(1994-12#1)(1995-12#4)(1995-4#1)(1995-8#1)(1997-1#1)(1997-4#1)(2006-10#1)(2008-8#2)
putative genetic loci##3##3##(2008-10#3)
putative genetic##5##2##(2008-10#4)(2008-7#1)
putative glycoprotein hormone receptor##2##4##(1993-12#2)
putative glycoprotein##4##2##(1991-2#2)(1993-12#2)
putative helicase##2##2##(1994-5#1)(2012-3#1)
putative hormone##3##2##(1991-8#1)(1996-5#1)(2008-3#1)
putative human##3##2##(1994-12#1)(1995-3#1)(1997-4#1)
putative identification##2##2##(2008-10#1)(2012-3#1)
putative inhibitor##4##2##(1993-3#1)(1995-1#1)(1995-12#1)(2009-11#1)
putative inhibitory##6##2##(1995-11#3)(1995-3#1)(2007-12#2)
putative insect##2##2##(1992-3#1)(2008-10#1)
putative integral membrane protein##3##4##(1994-12#1)(1997-6#2)
putative lipoprotein##2##2##(2010-10#2)
putative locus##2##2##(1996-6#1)(2008-10#1)
putative mature##2##2##(1990-11#1)(1993-3#1)
putative mechanism for the##2##4##(2006-9#1)(2008-10#1)
putative mechanism for##3##3##(2006-11#1)(2006-9#1)(2008-10#1)
putative mechanisms##5##2##(2005-7#1)(2006-11#1)(2008-8#1)(2009-1#1)(2013-8#1)
putative melatonin receptor##3##3##(1990-7#1)(1992-3#2)
putative members##2##2##(1997-4#1)(2013-8#1)
putative membrane-interacting domain of CTP##2##5##(1994-5#2)
putative membrane-interacting domain##3##3##(1994-5#2)(1995-2#1)
putative membrane-spanning domains##3##3##(1991-2#1)(1995-2#1)(1997-7#1)
putative membrane-spanning##4##2##(1991-2#1)(1995-2#1)(1995-6#1)(1997-7#1)
putative molecular##2##2##(1990-5#1)(2011-2#1)
putative movement protein##3##3##(2008-10#3)
putative negative##2##2##(1993-2#1)(1995-5#1)
putative neural##2##2##(2008-4#1)(2013-1#1)
putative neurotransmitters##2##2##(1992-9#1)(1993-7#1)
putative new##9##2##(1991-1#2)(1992-6#1)(1994-8#1)(1995-9#1)(1997-3#1)(1997-8#1)(2008-10#1)(2011-2#1)
putative nitric oxide synthase-containing##2##4##(1995-5#2)
putative nitric oxide##3##3##(1995-5#2)(1995-7#1)
putative nuclear##4##2##(1991-10#1)(1997-6#1)(1997-7#1)(2008-7#1)
putative nucleotide-binding##2##2##(2008-11#1)(2009-7#1)
putative numt sequences##2##3##(2009-10#2)
putative odorant receptor##2##3##(1997-4#2)
putative open reading frames##2##4##(1991-7#1)(2008-10#1)
putative peptide##4##2##(1992-6#1)(1994-10#1)(1995-10#2)
putative phosphoinositide-specific##2##2##(1997-4#2)
putative phosphorylation sites##3##3##(1992-8#1)(1994-11#1)(1994-3#1)
putative physiological##3##2##(1990-5#1)(2006-7#1)(2012-2#1)
putative plant##2##2##(2006-12#1)(2008-8#1)
putative polyadenylation signal##2##3##(1992-2#1)(1997-2#1)
putative polyadenylation##3##2##(1992-2#1)(1997-2#2)
putative polypeptide##4##2##(1992-7#1)(1992-8#1)(1993-12#1)(1997-2#1)
putative positive##2##2##(1995-8#1)(1997-2#1)
putative precursor of##3##3##(1990-7#1)(1991-5#1)(1992-12#1)
putative primer tRNA##2##3##(1992-6#2)
putative product of##4##3##(1993-2#1)(1995-4#1)(1995-6#1)(1996-4#1)
putative product##5##2##(1993-2#1)(1995-4#1)(1995-6#1)(1996-4#1)(1997-7#1)
putative promoter region of##2##4##(1993-11#1)(2013-1#1)
putative promoter region##4##3##(1993-11#1)(1996-10#1)(2008-9#1)(2013-1#1)
putative promoter##14##2##(1992-10#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-6#1)(1994-12#1)(1996-10#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-10#1)(2013-1#2)
putative protective##2##2##(1994-12#1)(2007-8#1)
putative protein kinase C phosphorylation site##2##6##(1991-7#1)(1993-8#1)
putative protein kinase##8##3##(1991-7#3)(1991-8#1)(1993-8#1)(1994-3#1)(2008-10#1)(2008-9#1)
putative protein of##5##3##(1995-1#1)(1997-4#1)(2005-6#1)(2008-10#1)(2010-5#1)
putative protein##24##2##(1990-10#1)(1991-7#3)(1991-8#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-10#1)(1996-3#2)(1996-7#1)(1997-1#1)(1997-4#2)(2005-6#1)(2008-10#2)(2008-9#1)(2010-5#1)
putative proteinaceous##2##2##(2008-10#2)
putative proteins##5##2##(1995-9#1)(1996-4#1)(1997-1#1)(2008-10#1)(2008-8#1)
putative random amplified polymorphic DNA (RAPD) loci and##2##8##(2008-10#2)
putative random amplified polymorphic DNA##3##5##(2008-10#3)
putative ras gene of##2##4##(1997-4#2)
putative receptor##3##2##(1992-12#1)(1995-5#1)(1996-8#1)
putative receptors##2##2##(1990-5#1)(1995-11#1)
putative recombinant isolates##2##3##(2008-10#2)
putative regulatory elements##4##3##(1991-9#1)(1994-12#1)(1996-10#1)(1997-2#1)
putative regulatory regions##2##3##(1992-5#1)(1992-6#1)
putative regulatory##9##2##(1991-9#1)(1992-5#1)(1992-6#1)(1993-3#2)(1994-12#1)(1996-10#2)(1997-2#1)
putative resistance##2##2##(2008-10#2)
putative rice P450s##2##3##(2008-9#2)
putative risk factors##3##3##(1996-8#1)(2011-2#1)(2012-12#1)
putative risk##4##2##(1996-8#1)(2007-10#1)(2011-2#1)(2012-12#1)
putative role for##5##3##(1990-11#1)(1995-5#2)(1996-5#1)(2008-3#1)
putative role in##3##3##(1990-5#1)(1992-5#1)(2009-8#1)
putative role of##16##3##(1990-8#1)(1993-3#1)(1994-6#1)(1994-9#1)(2006-10#3)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#2)(2009-8#2)(2010-4#1)
putative role##25##2##(1990-11#1)(1990-5#1)(1990-8#1)(1992-5#1)(1993-3#1)(1994-6#1)(1994-9#1)(1995-5#2)(1996-5#1)(2006-10#3)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2009-8#3)(2010-4#1)
putative roles##3##2##(1997-7#1)(2013-1#2)
putative second messenger Ins(1##2##4##(1990-7#2)
putative second##6##2##(1990-11#1)(1990-7#2)(1993-7#1)(1997-2#2)
putative secreted proteins##2##3##(1993-12#2)
putative secreted##3##2##(1993-12#2)(2013-1#1)
putative serine/threonine protein kinase##2##4##(1995-6#1)(1997-4#1)
putative serine/threonine##3##2##(1995-6#1)(1997-4#2)
putative sigma##3##2##(1993-9#1)(1994-5#2)
putative signal peptide of##2##4##(1992-8#1)(1993-2#1)
putative signal peptide##6##3##(1990-12#1)(1991-8#1)(1992-5#1)(1992-8#1)(1993-2#1)(2009-2#1)
putative signal##10##2##(1990-12#1)(1990-3#1)(1991-11#1)(1991-8#2)(1992-5#1)(1992-8#1)(1993-2#1)(1993-3#1)(2009-2#1)
putative sister##2##2##(2008-10#2)
putative site##2##2##(1990-10#1)(1995-12#1)
putative sites of bleeding were##2##5##(1993-8#2)
putative sites of##3##3##(1993-8#2)(1997-8#1)
putative species##3##2##(2008-10#2)(2010-6#1)
putative stem cells##2##3##(2008-11#1)(2009-12#1)
putative stem##5##2##(2008-11#1)(2009-12#2)(2012-12#2)
putative subunit##2##2##(1994-12#2)
putative thioesterase##2##2##(2009-11#2)
putative transcription start##3##3##(1990-11#1)(1991-4#1)(1997-2#1)
putative transcription##7##2##(1990-11#1)(1991-4#1)(1991-9#1)(1993-6#1)(1994-8#1)(1995-2#1)(1997-2#1)
putative transcriptional##2##2##(1997-8#1)(2008-7#1)
putative transgenic##2##2##(2008-10#1)(2012-2#1)
putative transmembrane domain##4##3##(1996-5#1)(1996-8#1)(1997-2#1)(2008-3#1)
putative transmembrane domains##5##3##(1991-10#1)(1992-12#1)(1994-2#1)(1996-8#1)(1997-7#1)
putative transmembrane helices of##3##4##(1990-5#1)(1991-3#2)
putative transmembrane segments##3##3##(1991-3#2)(1995-2#1)
putative transmembrane##23##2##(1990-5#1)(1991-10#1)(1991-3#4)(1992-12#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-2#1)(1995-10#1)(1995-2#1)(1995-9#1)(1996-2#1)(1996-5#1)(1996-8#2)(1997-2#1)(1997-7#2)(2005-8#1)(2008-3#1)
putative transport##2##2##(1997-6#1)(2008-7#1)
putative transposable##3##2##(1995-12#1)(2008-10#2)
putative tumor suppressor genes##2##4##(1997-2#1)(2009-12#1)
putative tumor suppressor##4##3##(1991-10#1)(1991-2#1)(1997-2#1)(2009-12#1)
putative virus-resistant transgenic##2##3##(2008-10#2)
putative virus-resistant##3##2##(2008-10#3)
putative zinc finger##2##3##(1991-11#1)(1991-5#1)
putative zinc##6##2##(1990-3#1)(1991-11#1)(1991-5#1)(1993-3#1)(1994-12#1)(2008-10#1)
putative##972##1##(1990-1#2)(1990-10#5)(1990-11#9)(1990-12#3)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#12)(1990-6#1)(1990-7#9)(1990-8#4)(1990-9#2)(1991-1#3)(1991-10#4)(1991-11#5)(1991-12#3)(1991-2#8)(1991-3#7)(1991-4#3)(1991-5#4)(1991-6#2)(1991-7#6)(1991-8#7)(1991-9#11)(1992-1#4)(1992-10#1)(1992-11#6)(1992-12#13)(1992-2#1)(1992-3#8)(1992-4#1)(1992-5#6)(1992-6#16)(1992-7#4)(1992-8#11)(1992-9#6)(1993-11#14)(1993-12#22)(1993-2#8)(1993-3#24)(1993-4#3)(1993-6#8)(1993-7#2)(1993-8#5)(1993-9#4)(1994-10#5)(1994-11#5)(1994-12#25)(1994-2#8)(1994-3#6)(1994-5#11)(1994-6#4)(1994-8#10)(1994-9#11)(1995-1#6)(1995-10#5)(1995-11#5)(1995-12#8)(1995-2#13)(1995-3#7)(1995-4#2)(1995-5#14)(1995-6#9)(1995-7#2)(1995-8#13)(1995-9#4)(1996-10#9)(1996-11#1)(1996-12#7)(1996-2#4)(1996-3#4)(1996-4#6)(1996-5#7)(1996-6#5)(1996-7#1)(1996-8#7)(1996-9#4)(1997-1#10)(1997-2#25)(1997-3#8)(1997-4#23)(1997-5#3)(1997-6#15)(1997-7#15)(1997-8#10)(1997-9#2)(2005-10#1)(2005-11#1)(2005-6#1)(2005-7#1)(2005-8#4)(2005-9#1)(2006-10#7)(2006-11#2)(2006-12#5)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#2)(2006-8#3)(2006-9#3)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#6)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#6)(2008-10#91)(2008-11#12)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#6)(2008-5#8)(2008-6#6)(2008-7#16)(2008-8#14)(2008-9#7)(2009-1#1)(2009-10#12)(2009-11#5)(2009-12#4)(2009-2#3)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#7)(2009-9#3)(2010-10#5)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#1)(2010-9#3)(2011-1#2)(2011-12#1)(2011-2#10)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#18)(2012-3#7)(2013-1#13)(2013-7#1)(2013-8#3)
putatively identified as##2##3##(1996-10#1)(1996-5#1)
putatively identified##3##2##(1996-10#2)(1996-5#1)
putatively responsible for##2##3##(2007-12#1)(2011-1#1)
putatively##36##1##(1990-10#1)(1990-7#1)(1991-9#1)(1992-4#1)(1993-12#1)(1994-4#1)(1995-2#1)(1995-4#1)(1996-10#3)(1996-5#1)(1997-2#1)(1997-7#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-12#3)(2008-1#1)(2008-10#6)(2008-5#1)(2008-8#2)(2008-9#1)(2010-12#2)(2011-1#1)(2012-12#1)(2013-8#1)
putida PpG7##3##2##(1990-6#2)(1996-7#1)
putida WCS358##5##2##(2008-10#5)
putida and##6##2##(1992-1#1)(1992-7#2)(1997-2#1)(2008-10#2)
putida as##2##2##(2011-2#2)
putida strain##2##2##(2008-10#1)(2012-2#1)
putida was##3##2##(2008-10#2)(2008-7#1)
putida##100##1##(1990-1#1)(1990-11#1)(1990-6#3)(1990-7#1)(1991-5#1)(1991-7#2)(1992-1#1)(1992-2#1)(1992-7#2)(1993-11#4)(1994-11#1)(1994-12#3)(1994-3#1)(1994-5#2)(1994-6#1)(1995-8#1)(1996-7#4)(1997-2#4)(1997-4#1)(2004-4#1)(2005-11#3)(2008-10#35)(2008-3#1)(2008-6#1)(2008-7#7)(2011-1#1)(2011-2#12)(2012-2#3)(2013-7#1)
putida) gene##3##2##(2011-2#3)
putida)##6##1##(2008-10#1)(2011-2#5)
putidaredoxin##3##1##(1994-5#3)
putorius##2##1##(2008-6#2)
putrefaction##2##1##(2008-10#1)(2012-2#1)
putrefactive##2##1##(2008-10#1)(2010-4#1)
putrefied corpses##2##2##(1995-6#2)
putrefied##4##1##(1995-2#1)(1995-6#2)(2010-4#1)
putrescentiae##3##1##(2011-2#3)
putrescine (PUT)##2##2##(1997-8#1)(2011-2#1)
putrescine and cadaverine##3##3##(2008-10#3)
putrescine and spermidine##2##3##(1996-10#1)(1996-7#1)
putrescine and##11##2##(1994-11#2)(1994-9#1)(1996-10#1)(1996-7#1)(2008-10#6)
putrescine from##2##2##(1994-11#1)(2013-8#1)
putrescine oxidase (PUO)##2##3##(2008-10#2)
putrescine oxidase enzyme activity##2##4##(2008-10#2)
putrescine oxidase##6##2##(2008-10#6)
putrescine was##2##2##(2008-10#1)(2009-6#1)
putrescine##67##1##(1991-12#2)(1991-2#5)(1991-4#1)(1991-7#1)(1993-12#1)(1994-11#8)(1994-8#1)(1994-9#1)(1996-10#1)(1996-12#2)(1996-7#3)(1997-1#1)(1997-8#5)(2007-8#3)(2008-10#18)(2008-11#1)(2008-5#1)(2008-8#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-8#3)
puts a##2##2##(1997-2#1)(2006-10#1)
puts considerable##2##2##(1995-6#1)(1996-3#1)
puts forward the##2##3##(2009-9#1)(2012-2#1)
puts forward##3##2##(2008-2#1)(2009-9#1)(2012-2#1)
puts into perspective the##2##4##(2008-2#1)(2008-3#1)
puts into##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
puts on##2##2##(1990-12#1)(1992-3#1)
puts pressure on##2##3##(1992-3#1)(1993-2#1)
puts the##5##2##(2006-5#1)(2007-12#1)(2008-10#1)(2008-4#1)(2012-2#1)
puts them##2##2##(1991-6#1)(2007-8#1)
puts this##2##2##(1997-8#1)(2010-11#1)
puts up an##2##3##(2006-10#1)(2012-3#1)
puts##41##1##(1990-12#1)(1991-4#1)(1991-6#1)(1992-3#2)(1993-2#1)(1995-6#1)(1996-3#1)(1997-2#1)(1997-8#1)(2004-3#1)(2006-10#3)(2006-11#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-2#2)(2012-3#2)
putting a##3##2##(1997-3#1)(2005-11#1)(2011-12#1)
putting in##2##2##(1996-11#1)(2008-8#1)
putting on##4##2##(1990-3#1)(1993-3#1)(2006-8#1)(2013-1#1)
putting some financial muscle behind finding a cure##2##8##(2012-12#2)
putting the##7##2##(1997-3#1)(2006-10#1)(2007-6#1)(2008-2#1)(2008-5#1)(2009-6#1)(2010-6#1)
putting them##2##2##(2005-10#1)(2010-8#1)
putting##36##1##(1990-3#1)(1992-2#1)(1993-3#1)(1995-3#1)(1996-11#1)(1997-3#2)(1997-4#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-1#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-1#3)(2012-12#2)(2013-1#1)
puzzle in##4##2##(2009-2#1)(2009-7#1)(2010-7#1)(2013-1#1)
puzzle of##2##2##(2007-1#1)(2007-8#1)
puzzle with##2##2##(2007-10#1)(2010-12#1)
puzzle##22##1##(1990-3#1)(1990-8#1)(1995-2#1)(1996-3#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#2)
puzzled##3##1##(2006-10#1)(2007-2#1)(2007-9#1)
puzzles in##2##2##(2008-10#1)(2012-3#1)
puzzles##10##1##(2005-10#3)(2006-10#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-12#1)(2012-3#1)
puzzling finding##2##2##(2006-9#1)(2009-4#1)
puzzling##19##1##(1992-10#1)(1992-12#1)(1992-6#1)(1994-11#1)(1994-3#1)(1995-8#1)(1996-11#1)(1997-7#1)(2006-10#1)(2006-9#1)(2007-6#1)(2007-8#1)(2008-11#2)(2008-4#1)(2008-8#1)(2009-4#1)(2012-1#1)(2012-3#1)
pv##333##1##(1990-3#1)(1990-4#2)(1993-9#1)(2006-3#10)(2007-12#2)(2008-10#304)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#2)(2010-10#2)(2010-4#2)(2011-1#3)
pvs##19##1##(2008-10#19)
py = pyridine)##2##3##(2006-4#1)(2010-5#1)
py =##3##2##(2006-4#1)(2009-11#1)(2010-5#1)
py##8##1##(1995-11#1)(1996-2#1)(2006-4#4)(2009-11#1)(2010-5#1)
pycnia##2##1##(2008-10#2)
pycnial##2##1##(2008-10#2)
pycnidia and conidia##2##3##(2008-10#2)
pycnidia and##3##2##(2008-10#3)
pycnidia on##3##2##(2008-10#3)
pycnidia or ascocarps##2##3##(2008-10#2)
pycnidia per canker##2##3##(2008-10#2)
pycnidia##24##1##(2008-10#24)
pycnidial coverage##2##2##(2008-10#2)
pycnidiospore-derived isolates##3##2##(2008-10#3)
pycnodysostosis##4##1##(1996-8#2)(2009-1#2)
pycnogenol##4##1##(2004-12#4)
pycnometric density##2##2##(2008-10#2)
pyelectasis##5##1##(2007-8#4)(2008-7#1)
pyelo-ureteral junction obstruction##2##3##(2008-1#2)
pyelogram##5##1##(1991-1#1)(1992-7#1)(2007-7#1)(2008-7#1)(2009-1#1)
pyelography and##2##2##(1991-10#1)(1992-12#1)
pyelography##11##1##(1991-10#1)(1992-12#4)(2006-1#1)(2007-7#2)(2008-7#3)
pyelolithotomies##2##1##(2006-6#2)
pyelolithotomy##6##1##(2006-6#3)(2006-7#1)(2008-10#2)
pyelonephritic group##2##2##(2011-2#2)
pyelonephritic##4##1##(2011-2#4)
pyelonephritis and##6##2##(1995-2#1)(2007-7#1)(2011-1#1)(2011-2#3)
pyelonephritis in##4##2##(2007-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
pyelonephritis were##3##2##(2006-6#1)(2008-10#1)(2011-2#1)
pyelonephritis##48##1##(1992-12#3)(1995-2#2)(2006-10#1)(2006-6#1)(2006-7#2)(2007-10#1)(2007-7#4)(2008-1#2)(2008-10#3)(2008-8#3)(2009-1#2)(2010-11#2)(2010-9#6)(2011-1#2)(2011-2#8)(2012-3#2)(2013-1#4)
pyelonephritis]##3##1##(2006-7#2)(2013-1#1)
pyeloplasties were performed##2##3##(2008-7#1)(2009-6#1)
pyeloplasties##4##1##(2006-9#1)(2008-10#1)(2008-7#1)(2009-6#1)
pyeloplasty in##2##2##(2007-10#1)(2008-4#1)
pyeloplasty##13##1##(2007-10#1)(2008-10#3)(2008-4#1)(2008-7#2)(2009-6#6)
pygmeum##2##1##(2008-5#2)
pygmy hogs##3##2##(2011-2#3)
pygmy phenotype##2##2##(1995-8#2)
pygmy##7##1##(1995-8#2)(1995-9#1)(2011-2#4)
pygofer##3##1##(2007-12#3)
pyknotic cells##2##2##(1996-1#1)(2008-10#1)
pyknotic##4##1##(1995-3#1)(1996-1#1)(2008-1#1)(2008-10#1)
pylon##2##1##(2007-8#2)
pylori and Cag-A##2##3##(2006-8#2)
pylori and##21##2##(1991-2#1)(1996-12#1)(1996-6#1)(1997-1#3)(1997-4#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-8#2)(2008-1#1)(2008-12#2)(2008-4#1)(2010-5#1)(2013-1#1)
pylori are##4##2##(2006-10#1)(2008-1#1)(2011-2#1)(2013-7#1)
pylori associated##3##2##(1991-3#1)(2006-2#1)(2008-5#1)
pylori bound to##2##3##(1995-2#1)(1996-12#1)
pylori by##3##2##(2006-6#1)(2007-7#1)(2008-7#1)
pylori can##3##2##(1996-11#1)(1997-1#1)(2011-1#1)
pylori cells##2##2##(1996-12#2)
pylori clinical isolates##3##3##(2006-8#3)
pylori eradication and##2##3##(2006-10#2)
pylori eradication in##4##3##(2006-2#2)(2007-2#1)(2010-5#1)
pylori eradication on the##2##4##(2010-5#1)(2013-7#1)
pylori eradication on##3##3##(2005-12#1)(2010-5#1)(2013-7#1)
pylori eradication therapy##3##3##(2006-10#1)(2010-12#1)(2012-2#1)
pylori eradication##24##2##(1997-1#2)(2005-12#1)(2006-10#4)(2006-2#4)(2006-8#1)(2007-2#1)(2008-1#1)(2008-5#1)(2010-12#2)(2010-5#5)(2012-2#1)(2013-7#1)
pylori from gastric biopsy specimens##2##5##(2008-12#2)
pylori from##4##2##(1991-4#1)(1997-1#1)(2008-12#2)
pylori growth in##2##3##(2013-1#2)
pylori has been shown##2##4##(1997-1#1)(2011-2#1)
pylori has been##4##3##(1997-1#2)(2006-8#1)(2011-2#1)
pylori has##6##2##(1997-1#2)(2006-10#1)(2006-8#1)(2008-1#1)(2011-2#1)
pylori in children of##2##4##(2007-8#2)
pylori in children##3##3##(2007-8#2)(2013-7#1)
pylori in duodenal ulcer disease and its##2##7##(2006-8#1)(2007-7#1)
pylori in duodenal ulcer disease##3##5##(2006-10#1)(2006-8#1)(2007-7#1)
pylori in duodenal ulcer##4##4##(2006-10#1)(2006-8#1)(2007-3#1)(2007-7#1)
pylori in gastric##2##3##(1993-5#1)(2006-10#1)
pylori in the##3##3##(2006-10#2)(2013-1#1)
pylori in##26##2##(1991-12#1)(1992-10#1)(1993-5#1)(1995-4#1)(1997-8#2)(2006-10#7)(2006-2#1)(2006-8#1)(2007-3#1)(2007-7#1)(2007-8#3)(2008-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
pylori infected individuals##2##3##(2008-1#1)(2008-12#1)
pylori infected##3##2##(2008-1#1)(2008-12#1)(2012-12#1)
pylori infection among##2##3##(1990-2#1)(2006-2#1)
pylori infection and IR##3##4##(2013-1#3)
pylori infection and in##2##4##(2008-12#1)(2008-9#1)
pylori infection and##12##3##(1997-1#1)(2006-10#1)(2006-8#1)(2008-12#1)(2008-5#3)(2008-9#1)(2013-1#4)
pylori infection in the##2##4##(2006-2#1)(2012-12#1)
pylori infection in##13##3##(1992-5#1)(2006-10#2)(2006-2#3)(2006-6#1)(2008-1#2)(2011-1#2)(2011-2#1)(2012-12#1)
pylori infection is##3##3##(2006-8#1)(2010-12#1)(2011-1#1)
pylori infection rates##2##3##(2008-1#2)
pylori infection was##2##3##(2006-10#1)(2008-5#1)
pylori infection with chronic antral gastritis##2##6##(2008-5#2)
pylori infection with##5##3##(2006-10#1)(2006-2#1)(2008-5#2)(2013-8#1)
pylori infection##89##2##(1990-2#1)(1992-5#2)(1993-1#2)(1995-2#2)(1996-11#1)(1996-8#1)(1997-1#8)(2005-1#2)(2005-12#1)(2006-10#11)(2006-12#1)(2006-2#9)(2006-6#1)(2006-8#2)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#6)(2008-10#1)(2008-12#2)(2008-5#7)(2008-7#2)(2008-9#1)(2009-3#1)(2010-12#3)(2010-4#1)(2010-5#1)(2011-1#6)(2011-2#1)(2012-12#2)(2013-1#5)(2013-7#1)(2013-8#1)
pylori is associated with increased basal and stimulated##2##8##(2006-10#2)
pylori is##13##2##(1995-2#1)(2006-10#2)(2006-2#3)(2006-6#1)(2006-8#2)(2008-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
pylori isolates from##2##3##(2007-7#1)(2012-12#1)
pylori isolates##6##2##(1997-8#1)(2006-8#1)(2007-7#2)(2012-12#2)
pylori lipopolysaccharide##2##2##(1991-3#1)(2008-7#1)
pylori on##2##2##(2008-12#1)(2008-5#1)
pylori or##2##2##(2005-7#1)(2006-2#1)
pylori positive##5##2##(1993-1#2)(1997-8#1)(2008-1#1)(2008-5#1)
pylori positivity##2##2##(2008-5#2)
pylori proteins##2##2##(2009-6#2)
pylori results in##3##3##(2006-10#2)(2006-2#1)
pylori status##2##2##(2006-2#1)(2007-8#1)
pylori strains##8##2##(1997-7#1)(2006-8#4)(2008-12#3)
pylori to antimicrobial##2##3##(2012-12#2)
pylori to##5##2##(2006-10#1)(2011-2#1)(2012-12#3)
pylori treatment in##2##3##(2006-2#2)
pylori treatment##5##2##(2006-2#4)(2010-12#1)
pylori was diagnosed in##2##4##(2006-10#2)
pylori was present in##3##4##(2008-5#2)(2010-5#1)
pylori was##14##2##(1990-3#1)(2006-10#2)(2006-8#1)(2008-12#1)(2008-5#6)(2010-5#1)(2012-12#2)
pylori were##3##2##(1997-8#1)(2006-10#1)(2008-12#1)
pylori with##3##2##(2008-9#1)(2012-12#2)
pylori##430##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-12#2)(1991-2#1)(1991-3#5)(1991-4#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-5#3)(1992-7#1)(1993-1#5)(1993-5#2)(1993-7#2)(1993-8#1)(1995-11#1)(1995-2#4)(1995-3#1)(1995-4#2)(1996-11#9)(1996-12#10)(1996-2#1)(1996-6#1)(1996-8#2)(1997-1#27)(1997-4#1)(1997-7#7)(1997-8#6)(2005-1#3)(2005-10#1)(2005-12#5)(2005-7#2)(2006-10#59)(2006-11#1)(2006-12#2)(2006-2#35)(2006-6#4)(2006-8#20)(2007-11#1)(2007-12#3)(2007-2#2)(2007-3#3)(2007-7#10)(2007-8#9)(2008-1#22)(2008-10#2)(2008-12#16)(2008-4#2)(2008-5#31)(2008-7#6)(2008-8#1)(2008-9#3)(2009-3#1)(2009-6#5)(2009-8#1)(2010-12#8)(2010-2#1)(2010-4#1)(2010-5#9)(2011-1#13)(2011-2#8)(2012-1#2)(2012-12#17)(2012-2#2)(2013-1#11)(2013-7#4)(2013-8#2)
pylori) infection##2##2##(2008-5#2)
pylori)##7##1##(2006-2#1)(2008-5#4)(2011-1#1)(2011-2#1)
pylori-infected subjects##2##2##(1997-1#1)(2006-10#1)
pylori-infected##3##1##(1997-1#1)(1997-7#1)(2006-10#1)
pylori-infection##2##1##(1990-2#2)
pylori-mediated activation of NFκB and##2##5##(2011-2#2)
pylori-positive patients##2##2##(2007-11#1)(2010-5#1)
pylori-positive##4##1##(1993-1#1)(2006-10#1)(2007-11#1)(2010-5#1)
pylori]##5##1##(1991-4#1)(1995-3#1)(2007-5#2)(2008-1#1)
pyloric foregut##2##2##(2007-12#2)
pyloric muscle##2##2##(1997-8#1)(2010-12#1)
pyloric stenosis##13##2##(1990-9#1)(1993-12#1)(1993-2#1)(1996-6#1)(2005-12#2)(2006-10#1)(2007-5#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-2#2)
pyloric##39##1##(1990-6#4)(1990-9#2)(1991-12#1)(1991-3#1)(1993-12#2)(1993-2#1)(1994-4#1)(1996-6#1)(1997-1#1)(1997-8#1)(2005-12#5)(2006-10#1)(2007-12#3)(2007-5#1)(2008-5#1)(2008-6#3)(2009-4#1)(2009-5#1)(2010-12#3)(2011-2#1)(2012-2#2)(2013-8#2)
pyloridis##2##1##(1991-3#1)(2011-1#1)
pyloroplasty##5##1##(1990-6#5)
pylorus ligation##5##2##(1990-5#1)(2010-12#4)
pylorus##11##1##(1990-5#1)(1990-9#1)(1993-12#1)(2006-10#1)(2009-5#2)(2010-12#4)(2013-8#1)
pylorus-ligated rats##4##2##(1990-2#2)(1990-3#1)(1997-1#1)
pylorus-preserving##4##1##(2006-10#1)(2008-12#1)(2008-3#1)(2012-2#1)
pyo-inflammatory complications##3##2##(2009-2#3)
pyo-inflammatory diseases##3##2##(2009-2#3)
pyo-inflammatory##6##1##(2009-2#6)
pyoderma gangrenosum##14##2##(2005-12#1)(2006-10#5)(2006-12#1)(2007-11#2)(2007-7#3)(2007-8#1)(2013-1#1)
pyoderma##21##1##(1996-6#1)(2005-12#1)(2006-10#5)(2006-12#1)(2007-11#2)(2007-7#4)(2007-8#1)(2012-12#1)(2013-1#5)
pyodermas##4##1##(2007-7#4)
pyodermias of##2##2##(2005-8#2)
pyogenes and##3##2##(2007-8#1)(2008-8#2)
pyogenes in##6##2##(1990-8#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-9#1)
pyogenes infection##2##2##(2008-9#2)
pyogenes infections##4##2##(1990-8#1)(1992-2#1)(2011-2#2)
pyogenes is##2##2##(2008-9#2)
pyogenes was##2##2##(2007-2#2)
pyogenes##44##1##(1990-8#6)(1991-8#1)(1992-2#3)(1993-4#1)(1994-11#1)(1994-2#2)(1995-8#2)(1996-12#2)(2005-7#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-2#4)(2007-8#2)(2008-8#3)(2008-9#6)(2011-2#7)
pyogenic arthritis##2##2##(2006-10#1)(2010-12#1)
pyogenic granuloma##3##2##(2012-3#1)(2013-8#2)
pyogenic liver abscess is##2##4##(2006-10#2)
pyogenic liver abscess##12##3##(2006-10#6)(2008-3#2)(2010-12#3)(2013-7#1)
pyogenic liver abscesses##3##3##(1990-4#1)(2006-10#1)(2009-6#1)
pyogenic liver##15##2##(1990-4#1)(2006-10#7)(2008-3#2)(2009-6#1)(2010-12#3)(2013-7#1)
pyogenic meningitis with##2##3##(2007-8#2)
pyogenic meningitis##6##2##(2007-8#4)(2008-7#1)(2013-7#1)
pyogenic##32##1##(1990-4#1)(1991-7#1)(2006-10#9)(2007-8#5)(2008-3#2)(2008-7#1)(2009-6#1)(2010-12#4)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#2)
pyoluteorin##3##1##(2005-11#1)(2008-10#2)
pyomyositis##6##1##(2006-10#3)(2008-5#1)(2011-2#1)(2013-8#1)
pyopneumothorax##3##1##(2007-6#1)(2010-5#2)
pyoverdin##2##1##(2008-10#2)
pyramid wave-front##2##2##(2007-11#2)
pyramid##42##1##(1992-1#1)(1996-2#1)(2007-10#1)(2007-11#4)(2007-9#1)(2008-10#2)(2008-2#8)(2008-6#10)(2008-7#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-1#10)
pyramid-based##2##1##(2008-6#2)
pyramidal and##3##2##(1990-2#1)(1997-4#1)(2010-12#1)
pyramidal cell layer##3##3##(1992-8#1)(1994-10#1)(1996-3#1)
pyramidal cell##14##2##(1990-4#1)(1991-11#1)(1992-8#1)(1993-2#1)(1994-10#1)(1994-5#1)(1996-1#1)(1996-3#1)(1997-7#1)(2008-11#5)
pyramidal cells and##4##3##(1990-5#2)(1991-6#1)(1996-3#1)
pyramidal cells in the##4##4##(1991-6#1)(1994-10#1)(2008-11#2)
pyramidal cells in##9##3##(1991-6#1)(1994-10#2)(1995-3#1)(1996-1#1)(1997-3#1)(2007-10#1)(2008-11#2)
pyramidal cells of the hippocampus##3##5##(1994-5#1)(1995-11#1)(1995-5#1)
pyramidal cells of the##8##4##(1994-5#1)(1995-11#2)(1995-5#1)(1997-5#1)(1997-8#1)(2008-11#1)(2010-12#1)
pyramidal cells of##9##3##(1994-5#1)(1995-11#2)(1995-5#1)(1997-5#1)(1997-8#1)(2008-11#2)(2010-12#1)
pyramidal cells was##2##3##(1991-8#1)(1993-2#1)
pyramidal cells were##3##3##(1993-12#1)(1994-10#1)(1996-3#1)
pyramidal cells##55##2##(1990-5#3)(1991-3#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#1)(1993-12#2)(1993-2#1)(1994-10#5)(1994-5#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#2)(1996-1#1)(1996-12#1)(1996-3#4)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-8#2)(2007-10#3)(2007-8#1)(2008-1#1)(2008-11#6)(2009-8#1)(2010-12#2)
pyramidal crystals that##2##3##(2008-2#2)
pyramidal crystals##5##2##(2008-2#5)
pyramidal ice##2##2##(2008-2#1)(2008-3#1)
pyramidal layer of the hippocampus##2##5##(1992-11#1)(1997-1#1)
pyramidal layer##4##2##(1992-11#1)(1997-1#1)(2010-12#2)
pyramidal neurones in##2##3##(1992-8#2)
pyramidal neurones were##2##3##(1993-12#2)
pyramidal neurones##10##2##(1992-8#2)(1993-12#5)(1995-12#2)(1996-1#1)
pyramidal neurons freshly dissociated from rat hippocampus##2##7##(1993-2#2)
pyramidal neurons have a##2##4##(1993-2#1)(2007-10#1)
pyramidal neurons in the##2##4##(1994-10#1)(1997-8#1)
pyramidal neurons in##7##3##(1990-7#1)(1991-6#1)(1993-12#1)(1994-10#1)(1994-5#1)(1997-5#1)(1997-8#1)
pyramidal neurons of cerebral cortex##2##5##(1990-2#1)(1996-5#1)
pyramidal neurons of the##3##4##(1994-11#1)(1995-3#1)(2013-8#1)
pyramidal neurons of##5##3##(1990-2#1)(1994-11#1)(1995-3#1)(1996-5#1)(2013-8#1)
pyramidal neurons##45##2##(1990-2#2)(1990-7#3)(1991-2#1)(1991-6#3)(1992-12#1)(1993-12#2)(1993-2#3)(1994-10#3)(1994-11#2)(1994-5#1)(1995-12#1)(1995-3#2)(1995-8#2)(1996-5#3)(1996-9#1)(1997-1#2)(1997-5#2)(1997-7#1)(1997-8#1)(2007-10#1)(2008-11#2)(2008-4#2)(2009-8#1)(2010-12#1)(2011-2#1)(2013-8#1)
pyramidal signs##2##2##(1991-11#1)(1993-8#1)
pyramidal silicon##4##2##(2007-12#4)
pyramidal tract neuron##2##3##(1996-10#2)
pyramidal tract##7##2##(1996-10#2)(1996-5#3)(2007-10#1)(2012-2#1)
pyramidal##198##1##(1990-2#3)(1990-4#1)(1990-5#3)(1990-7#3)(1991-11#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#5)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-8#3)(1993-12#9)(1993-2#5)(1993-8#1)(1994-10#9)(1994-11#2)(1994-5#4)(1994-9#1)(1995-11#2)(1995-12#4)(1995-3#4)(1995-4#1)(1995-5#2)(1995-7#1)(1995-8#3)(1996-1#6)(1996-10#2)(1996-12#1)(1996-3#5)(1996-5#8)(1996-6#3)(1996-9#7)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#4)(1997-6#2)(1997-7#4)(1997-8#3)(2006-12#1)(2006-7#1)(2007-10#5)(2007-12#7)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#14)(2008-2#10)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#2)(2009-8#2)(2010-12#7)(2010-2#2)(2010-6#1)(2011-2#1)(2012-11#2)(2012-2#1)(2013-1#1)(2013-8#1)
pyramidale of CA3##2##3##(1997-5#1)(1997-7#1)
pyramidale##3##1##(1997-5#2)(1997-7#1)
pyramiding of##2##2##(2008-10#2)
pyramiding##9##1##(2008-10#8)(2008-8#1)
pyramids and##2##2##(1993-12#1)(2008-2#1)
pyramids in##2##2##(2008-2#1)(2010-2#1)
pyramids##19##1##(1993-12#3)(1997-7#1)(2007-10#3)(2008-10#2)(2008-2#5)(2008-3#1)(2008-6#2)(2010-2#1)(2011-2#1)
pyranine anion##2##2##(1993-3#2)
pyranine##6##1##(1990-11#1)(1992-11#1)(1993-3#3)(2008-11#1)
pyranone##2##1##(2007-11#1)(2010-6#1)
pyranose 2-oxidase##2##2##(2008-6#2)
pyranose oxidase##3##2##(1995-2#1)(1996-11#2)
pyranose ring##2##2##(1994-9#2)
pyranose##9##1##(1994-9#2)(1995-2#1)(1996-11#2)(2007-11#1)(2008-6#2)(2012-11#1)
pyrantel pamoate and mebendazole##2##4##(2008-10#2)
pyrantel pamoate in##2##3##(2008-10#2)
pyrantel pamoate##7##2##(2008-10#7)
pyrantel##8##1##(2008-10#8)
pyrazinamide##11##1##(2005-9#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-8#2)(2010-10#1)(2012-2#1)(2013-1#1)
pyrazine core##5##2##(2010-4#5)
pyrazine derivatives##2##2##(2010-4#2)
pyrazine ring##2##2##(1991-6#1)(2008-5#1)
pyrazine##14##1##(1991-6#2)(1992-10#1)(2008-10#2)(2008-5#1)(2010-4#8)
pyrazole##15##1##(1991-10#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1994-11#1)(1994-8#1)(1996-12#1)(2005-7#2)(2008-10#1)(2008-5#3)
pyrazoline##3##1##(2007-1#1)(2009-12#1)(2010-6#1)
pyrazolo[3##6##1##(2007-11#3)(2008-4#1)(2013-7#2)
pyrazoloacridine##2##1##(1996-6#2)
pyrazolone##3##1##(2008-10#2)(2013-1#1)
pyrazolyl##2##1##(1996-2#2)
pyrazolylpyridine##3##1##(2007-11#3)
pyrenaica##2##1##(2008-10#2)
pyrene at##2##2##(2008-10#1)(2008-4#1)
pyrene carboxylic acid to##2##4##(2008-10#2)
pyrene carboxylic acid##8##3##(2008-10#8)
pyrene fluorescence##5##2##(1993-9#2)(2005-11#3)
pyrene lifetimes##2##2##(2005-11#2)
pyrene probe##3##2##(1997-7#3)
pyrene##62##1##(1990-11#1)(1990-5#1)(1992-6#2)(1993-9#3)(1995-5#1)(1997-1#5)(1997-7#3)(2005-11#16)(2006-10#1)(2008-10#19)(2008-11#1)(2008-4#3)(2009-11#1)(2011-12#5)
pyrene-PG##6##1##(1993-9#6)
pyrene-PG)##3##1##(1993-9#3)
pyrene-cholesteryl ester##2##2##(1991-2#2)
pyrene-labeled##5##1##(1992-4#1)(1992-5#2)(1993-9#1)(2008-4#1)
pyrene-labelled##2##1##(1992-5#1)(1994-3#1)
pyrenocrata##3##1##(2013-7#3)
pyrenoid##3##1##(2007-3#1)(2009-10#2)
pyrethrins##3##1##(2010-2#2)(2011-2#1)
pyrethroid insecticides##5##2##(1995-1#1)(2008-10#2)(2008-5#1)(2013-1#1)
pyrethroid##21##1##(1994-6#1)(1995-1#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-5#2)(2006-4#1)(2007-10#1)(2008-10#5)(2008-5#1)(2008-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2013-1#1)
pyrethroids in##3##2##(1997-5#1)(2008-10#1)(2011-12#1)
pyrethroids##17##1##(1994-3#1)(1997-1#1)(1997-5#1)(2005-8#1)(2008-10#9)(2011-12#1)(2011-2#2)(2012-12#1)
pyrethrum spray catch##3##3##(2008-2#3)
pyrethrum spray##4##2##(2006-4#1)(2008-2#3)
pyrethrum##6##1##(2006-4#1)(2008-10#2)(2008-2#3)
pyretic responses##2##2##(1997-5#2)
pyretic##4##1##(1996-12#1)(1997-5#2)(2005-1#1)
pyrexia and##2##2##(1991-3#1)(1996-9#1)
pyrexia of unknown origin##2##4##(2007-7#1)(2012-12#1)
pyrexia##11##1##(1991-3#1)(1994-4#1)(1996-9#1)(2007-7#1)(2007-8#2)(2008-3#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
pyrheliometric##3##1##(2008-2#3)
pyri##3##1##(2008-10#3)
pyridazine##2##1##(1991-3#1)(1997-7#1)
pyridine (Py)##2##2##(2007-11#1)(2010-5#1)
pyridine 2##2##2##(2008-10#2)
pyridine administration##4##2##(1990-10#1)(1992-7#3)
pyridine afforded##3##2##(2005-7#2)(2007-11#1)
pyridine and its##2##3##(2007-11#1)(2008-10#1)
pyridine and##10##2##(1994-9#1)(1996-2#1)(1997-6#1)(2006-12#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-5#2)
pyridine derivative##3##2##(1995-11#2)(2007-11#1)
pyridine derivatives##5##2##(2007-11#1)(2008-10#3)(2008-8#1)
pyridine hemochrome##2##2##(1990-7#1)(1992-3#1)
pyridine ligand##2##2##(1995-11#1)(2006-4#1)
pyridine metabolite##2##2##(1990-6#2)
pyridine nitrogen##2##2##(2008-5#1)(2008-6#1)
pyridine nucleotide to##2##3##(1992-1#1)(1993-6#1)
pyridine nucleotide##12##2##(1990-5#1)(1992-1#3)(1992-11#1)(1993-4#1)(1993-6#1)(1994-3#2)(1994-8#1)(1996-2#1)(2009-9#1)
pyridine nucleotides##5##2##(1990-11#1)(1994-8#2)(1995-6#1)(1996-2#1)
pyridine or acetone##3##3##(1990-10#3)
pyridine or imidazole##2##3##(2009-11#1)(2012-12#1)
pyridine or##7##2##(1990-10#3)(2005-7#1)(2008-10#1)(2009-11#1)(2012-12#1)
pyridine ring as ionophores##2##4##(2008-10#2)
pyridine ring##10##2##(1993-4#1)(1995-2#1)(1997-2#1)(2004-7#1)(2007-11#1)(2008-10#3)(2008-3#1)(2009-11#1)
pyridine to##3##2##(1996-2#1)(2005-4#1)(2007-11#1)
pyridine##135##1##(1990-1#2)(1990-10#5)(1990-11#1)(1990-5#2)(1990-6#3)(1990-7#1)(1992-1#3)(1992-11#1)(1992-12#1)(1992-3#1)(1992-7#6)(1993-4#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#8)(1994-8#5)(1994-9#1)(1995-11#4)(1995-2#1)(1995-6#1)(1996-2#7)(1996-6#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#3)(2004-7#1)(2005-11#1)(2005-4#1)(2005-7#3)(2006-10#1)(2006-12#3)(2006-4#1)(2007-10#3)(2007-11#9)(2007-3#1)(2007-8#1)(2008-10#21)(2008-3#7)(2008-5#4)(2008-6#1)(2008-8#1)(2009-11#3)(2009-9#2)(2010-5#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
pyridine)##5##1##(1996-2#1)(1997-3#1)(2006-4#1)(2008-10#1)(2010-5#1)
pyridine-containing##2##1##(1997-2#1)(2009-10#1)
pyridine-fused##2##1##(2007-11#2)
pyridines##13##1##(1990-5#1)(1993-8#3)(1994-9#1)(1996-2#1)(1997-7#2)(2007-11#1)(2008-10#2)(2009-10#1)(2010-5#1)
pyridinic ring##5##2##(1991-2#3)(1994-8#2)
pyridinic##7##1##(1991-2#3)(1994-8#2)(1995-1#2)
pyridinium group##2##2##(2005-11#2)
pyridinium##20##1##(1990-1#1)(1990-7#1)(1992-12#2)(1994-2#1)(1995-8#1)(1996-12#1)(1997-8#1)(2005-11#3)(2007-11#1)(2008-10#4)(2008-4#1)(2010-6#1)(2011-2#2)
pyridinoline##18##1##(1994-12#1)(1995-2#14)(1995-3#1)(1995-6#1)(2012-12#1)
pyridinolines##3##1##(1995-2#3)
pyridium##2##1##(2005-11#1)(2010-4#1)
pyridone##3##1##(1994-9#2)(2010-7#1)
pyridostigmine##3##1##(2006-10#1)(2012-2#1)(2012-3#1)
pyridoxal 5'-phosphate (PLP)##4##3##(1992-6#1)(1996-5#1)(1997-7#1)(2005-11#1)
pyridoxal 5'-phosphate##15##2##(1991-4#1)(1992-6#2)(1993-6#1)(1995-2#1)(1995-3#1)(1996-5#1)(1996-8#1)(1997-7#1)(2004-11#1)(2005-11#1)(2006-12#4)
pyridoxal 5-phosphate##3##2##(1990-3#1)(1996-7#2)
pyridoxal##30##1##(1990-3#2)(1990-6#1)(1990-7#1)(1991-12#2)(1991-4#1)(1992-6#2)(1993-6#1)(1995-2#1)(1995-3#1)(1995-6#4)(1996-5#1)(1996-7#2)(1996-8#1)(1997-7#1)(2004-11#1)(2005-11#1)(2006-12#4)(2008-3#1)(2009-11#1)(2013-1#1)
pyridoxal-5'-phosphate##3##1##(1994-9#1)(2012-2#2)
pyridoxal-P##3##1##(1992-6#1)(1994-9#2)
pyridoxamine 5'-phosphate (PMP)##2##3##(1992-6#1)(2005-11#1)
pyridoxamine 5'-phosphate##3##2##(1992-6#1)(1996-7#1)(2005-11#1)
pyridoxamine and pyridoxal 5'-phosphate##2##4##(2006-12#2)
pyridoxamine##9##1##(1991-7#1)(1992-6#1)(1996-7#2)(2005-11#1)(2006-12#2)(2007-11#1)(2008-7#1)
pyridoxine HCl##2##2##(2008-10#1)(2008-11#1)
pyridoxine and carnitine##2##3##(1995-6#2)
pyridoxine and##6##2##(1995-6#4)(2007-3#1)(2007-7#1)
pyridoxine hydrochloride##6##2##(2008-10#6)
pyridoxine was##2##2##(1995-6#1)(2008-4#1)
pyridoxine##30##1##(1990-10#1)(1995-6#5)(2007-3#1)(2007-7#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-7#2)(2010-9#1)(2011-1#5)(2013-1#2)
pyridyl donor##2##2##(2008-5#2)
pyridyl ligands##2##2##(1997-7#2)
pyridyl nitrogen##2##2##(2007-11#1)(2010-5#1)
pyridyl substituted##2##2##(2008-5#2)
pyridyl##16##1##(1994-3#1)(1997-7#2)(2007-11#1)(2008-10#2)(2008-5#5)(2010-5#5)
pyridylamination##2##1##(1994-5#1)(1994-8#1)
pyridylamino##2##1##(1990-5#2)
pyridylazo##3##1##(2008-10#3)
pyrifoliae and##3##2##(2008-10#3)
pyrifoliae##6##1##(2008-10#6)
pyriform##2##1##(2009-8#1)(2013-8#1)
pyriformis##6##1##(1990-7#3)(2012-12#2)(2012-2#1)
pyrilamine##3##1##(1991-12#1)(1993-12#1)(1994-2#1)
pyrimethamine in##2##2##(2008-10#1)(2008-2#1)
pyrimethamine##12##1##(1990-9#1)(1993-5#1)(2007-1#1)(2008-10#4)(2008-2#2)(2008-4#2)(2010-12#1)
pyrimethamine-sulfadoxine##3##1##(2005-7#2)(2006-11#1)
pyrimethanil##4##1##(2007-8#2)(2011-2#2)
pyrimidine and purine##3##3##(1996-4#1)(1996-8#1)(2010-2#1)
pyrimidine bases with##3##3##(1990-4#1)(1991-4#1)(2008-11#1)
pyrimidine bases##6##2##(1990-4#1)(1991-12#1)(1991-4#1)(1992-6#1)(2008-10#1)(2008-11#1)
pyrimidine biosynthesis##6##2##(1990-7#1)(1992-8#1)(1995-3#1)(1995-5#1)(1997-2#2)
pyrimidine derivatives##2##2##(2008-5#1)(2012-2#1)
pyrimidine dimer##4##2##(1994-8#2)(1995-6#1)(2009-8#1)
pyrimidine dimers##6##2##(1992-6#2)(1994-8#1)(1997-1#1)(2008-8#1)(2010-7#1)
pyrimidine metabolism##3##2##(2007-11#1)(2007-3#1)(2008-6#1)
pyrimidine nucleobase assembly##3##3##(2006-12#3)
pyrimidine nucleoside##2##2##(1993-12#1)(2005-11#1)
pyrimidine nucleosides and##2##3##(2006-12#2)
pyrimidine residues##2##2##(1991-1#1)(1997-4#1)
pyrimidine ring##9##2##(1991-4#2)(1993-9#1)(1994-7#1)(1996-5#1)(1996-6#3)(2010-3#1)
pyrimidine strand##2##2##(1995-3#1)(2008-8#1)
pyrimidine##86##1##(1990-2#2)(1990-4#1)(1990-7#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#3)(1992-6#3)(1992-8#3)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-7#2)(1994-8#4)(1994-9#1)(1995-3#4)(1995-5#1)(1995-6#1)(1995-8#4)(1996-4#3)(1996-5#1)(1996-6#5)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#2)(2005-11#1)(2006-12#6)(2007-11#4)(2007-3#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-7#1)(2012-2#1)
pyrimidine-rich##2##1##(1995-6#1)(1997-7#1)
pyrimidines and purines on##2##4##(2008-10#2)
pyrimidines and##3##2##(1991-10#1)(2008-10#2)
pyrimidines in##2##2##(1991-10#1)(1994-4#1)
pyrimidines##18##1##(1990-8#2)(1991-10#3)(1992-2#1)(1992-5#1)(1994-4#1)(1996-8#1)(1997-8#1)(2008-10#2)(2008-8#1)(2008-9#3)(2009-9#1)(2010-3#1)
pyrimido[5##2##1##(2011-1#2)
pyrina##2##1##(2008-10#2)
pyriproxyfen and buprofezin##5##3##(2011-2#1)(2012-12#4)
pyriproxyfen##14##1##(2007-12#4)(2011-2#1)(2012-12#9)
pyrite as a sensor##2##4##(2008-10#2)
pyrite##3##1##(2008-10#3)
pyrithiamine##2##1##(1990-9#2)
pyrithione (ZPT)##2##2##(2008-10#1)(2008-5#1)
pyrithione##9##1##(2008-10#2)(2008-11#1)(2008-5#6)
pyrocarbon PIP##2##2##(2008-9#2)
pyrocarbon##3##1##(2008-9#3)
pyrocarbonate (DEPC)##3##2##(1991-9#1)(1992-6#1)(1995-5#1)
pyrocarbonate##18##1##(1990-11#1)(1990-12#1)(1991-4#2)(1991-7#3)(1991-8#1)(1991-9#2)(1992-6#1)(1995-3#1)(1995-5#1)(1996-7#4)(2008-4#1)
pyrocatechol violet and rhodamine 6G##2##5##(2005-4#2)
pyrocatechol violet and rhodamine B##3##5##(2005-4#3)
pyrocatechol violet and rhodamine##5##4##(2005-4#5)
pyrocatechol violet complexes on##2##4##(2008-10#2)
pyrocatechol violet##10##2##(2005-4#5)(2008-10#5)
pyrocatechol##21##1##(2005-4#5)(2007-8#1)(2008-10#15)
pyrochlore##3##1##(1992-11#1)(2008-10#2)
pyroelectric detector##7##2##(2007-12#1)(2008-10#1)(2008-2#5)
pyroelectric detectors##2##2##(2008-2#1)(2008-3#1)
pyroelectric radiometer##2##2##(2008-3#2)
pyroelectric##16##1##(2007-12#3)(2008-10#1)(2008-2#8)(2008-3#3)(2011-1#1)
pyrogallic acid##2##2##(2008-10#2)
pyrogallol and##3##2##(2007-8#1)(2008-10#2)
pyrogallol red##3##2##(2008-10#2)(2008-11#1)
pyrogallol##32##1##(1994-3#1)(2007-8#7)(2008-10#23)(2008-11#1)
pyrogen##3##1##(2007-8#3)
pyrogenal-induced fever##3##2##(2010-12#3)
pyrogenic activity##2##2##(1990-2#2)
pyrogenic##6##1##(1990-2#3)(2008-11#1)(2009-9#2)
pyrogenicity##2##1##(1992-5#1)(2007-8#1)
pyrogens##3##1##(2007-8#3)
pyroglutamic acid residue##2##3##(1991-2#1)(2008-7#1)
pyroglutamic acid##3##2##(1991-2#1)(1991-3#1)(2008-7#1)
pyroglutamic##4##1##(1991-2#1)(1991-3#1)(1994-8#1)(2008-7#1)
pyroglutamyl aminopeptidase##4##2##(1990-2#1)(1991-2#2)(1992-8#1)
pyroglutamyl##5##1##(1990-2#1)(1991-2#3)(1992-8#1)
pyrolusite and##2##2##(2005-11#2)
pyrolusite##5##1##(2005-11#3)(2010-4#2)
pyrolysed##3##1##(1990-8#1)(1993-4#1)(2008-10#1)
pyrolyses##2##1##(2006-12#1)(2008-10#1)
pyrolysis and atomization steps were##2##5##(2008-10#2)
pyrolysis and atomization temperatures were##2##5##(2008-10#2)
pyrolysis and atomization temperatures##13##4##(2008-10#13)
pyrolysis and atomization were respectively of##2##6##(2008-10#2)
pyrolysis and atomization were##3##4##(2008-10#3)
pyrolysis and atomization##22##3##(2007-10#1)(2008-10#21)
pyrolysis and vaporization##2##3##(2008-10#2)
pyrolysis and##29##2##(1991-4#1)(2005-11#1)(2007-10#1)(2008-10#25)(2008-11#1)
pyrolysis at 1350 degrees C##2##5##(2008-10#2)
pyrolysis behavior of##2##3##(2008-10#2)
pyrolysis of the##3##3##(2008-10#2)(2008-3#1)
pyrolysis of##12##2##(2005-11#1)(2008-10#4)(2008-3#1)(2008-5#2)(2009-2#3)(2010-4#1)
pyrolysis products##2##2##(2008-3#1)(2010-3#1)
pyrolysis temperature of##2##3##(2008-10#2)
pyrolysis temperature##9##2##(2008-10#9)
pyrolysis temperatures of##2##3##(2008-10#2)
pyrolysis temperatures##7##2##(2008-10#7)
pyrolysis##80##1##(1991-4#1)(2005-11#2)(2007-10#1)(2008-10#62)(2008-11#2)(2008-3#2)(2008-5#3)(2009-2#3)(2010-3#2)(2010-4#1)(2013-1#1)
pyrolysis-gas chromatography-mass spectrometry##4##3##(1993-12#2)(2007-8#2)
pyrolysis-gas chromatography/mass spectrometry##3##3##(2008-10#3)
pyrolysis-gas##7##1##(1993-12#2)(2007-8#2)(2008-10#3)
pyrolysis-mass spectrometry##2##2##(2008-10#2)
pyrolytic bio-oils##2##2##(2008-5#2)
pyrolytic carbon##3##2##(2008-8#1)(2008-9#1)(2010-8#1)
pyrolytic graphite electrode##2##3##(2008-10#2)
pyrolytic graphite electrodes##2##3##(1997-1#1)(2008-10#1)
pyrolytic graphite##13##2##(1997-1#1)(2005-4#1)(2008-10#10)(2008-8#1)
pyrolytic##20##1##(1997-1#1)(2005-4#1)(2008-10#11)(2008-5#2)(2008-8#2)(2008-9#1)(2010-8#1)(2013-1#1)
pyromania##3##1##(2008-6#3)
pyronin Y##2##2##(2008-9#2)
pyrophosphatase activity##3##2##(1990-8#2)(1991-7#1)
pyrophosphatase##21##1##(1990-12#3)(1990-8#2)(1991-12#2)(1991-2#6)(1991-7#1)(1997-6#4)(2008-11#1)(2008-7#1)(2009-6#1)
pyrophosphatases##7##1##(1991-12#2)(1991-2#4)(2008-4#1)
pyrophosphate and##2##2##(1995-1#1)(2008-10#1)
pyrophosphate bonds##2##2##(1996-4#1)(2008-4#1)
pyrophosphate dihydrate##2##2##(2006-10#2)
pyrophosphate from the##2##3##(1990-12#1)(1995-1#1)
pyrophosphate hydrolysis and##3##3##(1990-12#3)
pyrophosphate in##2##2##(1990-11#1)(1990-12#1)
pyrophosphate synthase##3##2##(1991-12#1)(2008-8#2)
pyrophosphate to the##2##3##(1995-1#1)(2008-10#1)
pyrophosphate to##4##2##(1995-1#2)(1995-3#1)(2008-10#1)
pyrophosphate##55##1##(1990-11#1)(1990-12#10)(1990-8#1)(1991-12#1)(1991-2#2)(1991-7#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-11#1)(1995-1#9)(1995-3#1)(1995-8#1)(1996-4#1)(1996-9#2)(1997-7#1)(2004-9#1)(2006-10#2)(2006-12#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-4#5)(2008-8#3)(2009-10#1)(2011-1#1)
pyrophosphate-lyase##2##1##(1993-7#1)(1996-6#1)
pyrophosphates##5##1##(2008-4#3)(2008-5#1)(2010-4#1)
pyrophosphorolysis##2##1##(1992-9#1)(1996-8#1)
pyrophosphorylase from##3##2##(1994-9#1)(1997-2#1)(2006-12#1)
pyrophosphorylase##12##1##(1994-9#3)(1996-5#3)(1997-2#3)(2006-12#3)
pyrosequencing of##3##2##(2011-2#1)(2012-3#1)(2013-8#1)
pyrosequencing##17##1##(2008-7#1)(2009-8#1)(2011-1#2)(2011-12#2)(2011-2#6)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
pyrosis and regurgitation##3##3##(2006-2#3)
pyrosis##4##1##(2006-2#3)(2008-3#1)
pyrotechnic##5##1##(2006-11#1)(2007-4#3)(2012-2#1)
pyrrolase##5##1##(2006-1#5)
pyrrole and##3##2##(2007-9#1)(2008-10#2)
pyrrole derivatives##3##2##(2007-11#1)(2008-5#1)(2010-4#1)
pyrrole in the##2##3##(1996-5#1)(2008-10#1)
pyrrole moiety##2##2##(2008-10#2)
pyrrole monomer##2##2##(2008-10#2)
pyrrole resonances##3##2##(1996-2#3)
pyrrole ring##4##2##(1992-3#1)(1994-9#2)(1995-3#1)
pyrrole units##2##2##(1995-3#1)(1996-5#1)
pyrrole##38##1##(1991-7#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-5#2)(1994-9#2)(1995-3#3)(1996-2#4)(1996-5#2)(2007-11#2)(2007-9#1)(2008-10#11)(2008-5#4)(2010-4#1)(2010-5#1)(2011-1#1)
pyrrole-imidazole##2##1##(2008-7#2)
pyrroles##3##1##(1994-5#1)(2009-5#2)
pyrrolic##2##1##(1990-8#1)(2011-1#1)
pyrrolidine derivatives##2##2##(2006-12#1)(2007-11#1)
pyrrolidine dithiocarbamate (APDC)##11##3##(2007-8#2)(2008-10#9)
pyrrolidine dithiocarbamate##13##2##(2007-8#3)(2008-10#10)
pyrrolidine ring##2##2##(1991-5#1)(2007-11#1)
pyrrolidine##25##1##(1991-5#1)(1992-8#1)(1995-11#1)(2006-12#1)(2007-11#3)(2007-8#3)(2008-10#11)(2009-5#1)(2012-2#3)
pyrrolidinecarbodithioate chelates##2##2##(2008-10#2)
pyrrolidinecarbodithioate##3##1##(2008-10#3)
pyrrolidinedithiocarbamate##3##1##(2008-10#2)(2008-11#1)
pyrrolidines##3##1##(1996-5#1)(2007-11#1)(2009-5#1)
pyrrolidinyl##2##1##(1990-7#1)(2005-8#1)
pyrrolidone##8##1##(1990-12#1)(2008-10#2)(2008-5#3)(2010-5#1)(2011-2#1)
pyrrolizidine alkaloid (PA)##2##3##(1993-3#1)(2004-2#1)
pyrrolizidine alkaloid content##2##3##(2007-1#2)
pyrrolizidine alkaloid##7##2##(1991-7#2)(1993-3#1)(2004-2#2)(2007-1#2)
pyrrolizidine alkaloids in##3##3##(2007-1#2)(2012-12#1)
pyrrolizidine alkaloids##8##2##(1991-7#1)(2007-1#4)(2010-6#1)(2012-12#1)(2013-8#1)
pyrrolizidine##16##1##(1991-7#3)(1993-3#1)(2004-2#2)(2007-1#6)(2010-6#2)(2012-12#1)(2013-8#1)
pyrrolnitrin##2##1##(2008-10#2)
pyrrolo[1##8##1##(2006-12#1)(2007-11#4)(2008-11#2)(2010-6#1)
pyrrolo[2##7##1##(1996-8#2)(1997-2#2)(2007-11#2)(2008-4#1)
pyrrolobenzoxazepine##2##1##(1996-8#2)
pyrrolobenzoxazepines##3##1##(1996-8#1)(2012-2#2)
pyrroloquinoline quinone##3##2##(1994-2#2)(2008-10#1)
pyrroloquinoline##4##1##(1994-2#2)(2008-10#2)
pyrroloquinoxalines##2##1##(2009-7#2)
pyruvate and##11##2##(1990-12#1)(1990-2#1)(1990-7#1)(1992-4#1)(1994-11#2)(1994-9#1)(2006-8#1)(2008-7#1)(2010-12#1)(2011-2#1)
pyruvate carboxylase activity in##2##4##(1991-8#2)
pyruvate carboxylase activity##3##3##(1991-8#3)
pyruvate carboxylase and##3##3##(1990-2#1)(1995-4#1)(2007-8#1)
pyruvate carboxylase##15##2##(1990-2#2)(1991-1#1)(1991-3#1)(1991-8#6)(1993-11#1)(1995-4#1)(2007-8#1)(2008-11#2)
pyruvate decarboxylase activity##4##3##(1990-3#4)
pyruvate decarboxylase and##2##3##(2008-10#1)(2011-2#1)
pyruvate decarboxylase structural##2##3##(1990-3#2)
pyruvate decarboxylase##17##2##(1990-12#1)(1990-3#7)(1993-8#1)(1995-10#4)(2008-10#2)(2008-6#1)(2011-2#1)
pyruvate dehydrogenase (PDH)##6##3##(1991-1#1)(1992-7#1)(1994-8#1)(2004-11#1)(2005-8#1)(2013-1#1)
pyruvate dehydrogenase complex##8##3##(1990-7#1)(1994-5#1)(1994-8#1)(1995-1#1)(1996-5#1)(2010-12#1)(2010-2#2)
pyruvate dehydrogenase in##2##3##(1991-3#1)(2005-8#1)
pyruvate dehydrogenase##27##2##(1990-2#1)(1990-7#4)(1991-1#1)(1991-2#1)(1991-3#2)(1992-7#1)(1994-5#2)(1994-8#2)(1995-1#2)(1996-5#2)(2004-11#1)(2005-8#3)(2010-12#1)(2010-2#2)(2013-1#2)
pyruvate ferredoxin oxidoreductase (POR)##2##4##(1995-5#1)(1997-4#1)
pyruvate in both##2##3##(1992-4#1)(2008-7#1)
pyruvate in the##4##3##(1992-5#2)(2008-10#2)
pyruvate in##10##2##(1992-4#1)(1992-5#2)(1997-7#1)(2008-10#5)(2008-7#1)
pyruvate is##3##2##(1992-8#1)(1994-11#1)(2013-8#1)
pyruvate kinase (PK)##3##3##(1997-6#1)(2008-7#1)(2013-1#1)
pyruvate kinase L gene##3##4##(1990-8#3)
pyruvate kinase activity##4##3##(1995-12#4)
pyruvate kinase and##3##3##(1990-5#1)(1990-8#1)(2008-7#1)
pyruvate kinase gene##5##3##(1995-5#3)(2006-8#2)
pyruvate kinase only##2##3##(1990-5#2)
pyruvate kinase##53##2##(1990-2#1)(1990-3#1)(1990-5#9)(1990-8#8)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#5)(1995-2#2)(1995-5#3)(1997-4#1)(1997-6#1)(2006-8#5)(2008-4#2)(2008-7#4)(2013-1#2)
pyruvate metabolism##6##2##(1991-5#3)(2008-10#1)(2008-6#2)
pyruvate oxidase G##2##3##(2008-10#2)
pyruvate oxidase##3##2##(2008-10#3)
pyruvate to##7##2##(1992-1#1)(1994-11#1)(1995-10#2)(1997-1#1)(2008-6#1)(2012-3#1)
pyruvate transport##2##2##(1992-4#1)(1993-8#1)
pyruvate was##3##2##(1992-4#1)(1992-6#1)(2008-10#1)
pyruvate were##5##2##(1993-11#1)(1994-9#1)(1995-9#1)(2008-10#1)(2011-12#1)
pyruvate##243##1##(1990-12#4)(1990-2#5)(1990-3#9)(1990-4#1)(1990-5#9)(1990-7#5)(1990-8#8)(1991-1#3)(1991-2#2)(1991-3#4)(1991-4#1)(1991-5#6)(1991-8#11)(1992-1#2)(1992-11#1)(1992-4#7)(1992-5#4)(1992-6#2)(1992-7#1)(1992-8#4)(1993-11#6)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#7)(1994-10#1)(1994-11#7)(1994-12#2)(1994-3#1)(1994-5#3)(1994-8#5)(1994-9#2)(1995-1#2)(1995-10#6)(1995-12#5)(1995-2#4)(1995-4#1)(1995-5#5)(1995-8#2)(1995-9#2)(1996-5#4)(1997-1#1)(1997-4#2)(1997-6#2)(1997-7#1)(2004-11#1)(2004-4#1)(2005-8#3)(2006-12#1)(2006-8#8)(2007-8#1)(2008-10#20)(2008-11#2)(2008-4#2)(2008-6#6)(2008-7#9)(2009-10#2)(2009-4#1)(2010-12#3)(2010-2#2)(2011-12#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#8)(2013-8#1)
pyruvate-kinase##2##1##(1991-3#2)
pyruvate/malate##2##1##(1992-1#2)
pyruvate/sulfate medium##2##2##(2006-8#2)
pyruvic acid##6##2##(1991-12#2)(1993-8#1)(1994-11#1)(1995-3#1)(2008-5#1)
pyruvic##11##1##(1991-12#2)(1993-8#1)(1994-11#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(2008-11#1)(2008-5#1)(2008-7#1)
pythiaceous species##3##2##(2008-10#3)
pythium species##2##2##(2008-10#2)
pythium##5##1##(2008-10#5)
python##7##1##(1997-8#6)(2008-10#1)
p &lt##12##1##(2012-12#1)(2012-5#7)(2013-1#2)(2013-8#2)
p =##3##1##(2013-1#3)
p = 0##10##1##(2012-5#3)(2013-1#4)(2013-8#3)
pαSyn-positive structures##2##2##(2012-1#2)
p &lt##12##1##(2010-11#7)(2011-12#3)(2011-2#1)(2012-2#1)
p = 0##30##1##(2010-11#4)(2011-12#12)(2011-2#3)(2012-2#2)(2012-7#2)(2013-1#5)(2013-7#2)
q (Ab)##3##2##(2008-11#3)
q##28##1##(1991-6#1)(1994-9#1)(1995-2#3)(1995-8#1)(1996-12#1)(1997-8#1)(2006-10#4)(2007-12#4)(2007-8#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-3#1)(2010-3#1)(2010-5#1)(2011-2#1)
q(2) = 0##2##3##(2007-11#2)
q(2)##4##1##(2007-11#2)(2010-12#1)(2011-2#1)
q-PCR##8##1##(2008-10#3)(2013-8#5)
q-grams##2##1##(2012-2#2)
q-switched laser##2##2##(2008-2#1)(2008-3#1)
q-switched##4##1##(2008-2#2)(2008-3#2)
q-value##2##1##(2008-3#1)(2010-12#1)
q/ha)##2##1##(2011-1#2)
q11##11##1##(1990-9#1)(1996-12#2)(2007-12#7)(2013-8#1)
q11) translocation##2##2##(2007-11#1)(2012-12#1)
q11)##4##1##(2007-11#3)(2012-12#1)
q13##2##1##(1997-1#2)
q2##4##1##(1995-3#4)
q21) translocation##2##2##(1990-5#1)(2010-11#1)
q21)##7##1##(1990-5#1)(2007-12#2)(2009-2#1)(2009-8#2)(2010-11#1)
q24)##4##1##(2009-2#4)
q34##2##1##(2007-11#2)
qDfm1##3##1##(2012-11#3)
qEEG##6##1##(2008-7#6)
qHBsAg##3##1##(2013-8#3)
qPCR assay##7##2##(2008-12#3)(2009-6#1)(2012-3#1)(2013-1#2)
qPCR##27##1##(2008-12#3)(2009-6#3)(2010-4#1)(2010-6#4)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#6)
qPTH assay was successful in##2##5##(2005-12#2)
qPTH assay##5##2##(2005-12#5)
qRT-PCR analysis##2##2##(2008-1#1)(2013-1#1)
qRT-PCR##10##1##(2008-1#1)(2008-7#1)(2010-2#1)(2012-1#2)(2012-3#1)(2013-1#2)(2013-8#2)
qRslx1 and qRslx2##3##3##(2012-11#3)
qRslx1##4##1##(2012-11#4)
q] and##2##2##(2009-3#2)
q] nanotubes##2##2##(2009-3#2)
q]##4##1##(2009-3#4)
qcr1 and qcr4##2##3##(2012-3#2)
qcr1##4##1##(2012-3#4)
qcr4##4##1##(2012-3#4)
qdot##2##1##(2008-10#2)
qdots##3##1##(2008-10#3)
qi and strengthening##2##3##(2013-8#2)
qi##6##1##(2008-10#3)(2013-8#3)
qigong##4##1##(2008-10#3)(2010-12#1)
qk(v) mice##5##2##(2006-11#3)(2012-2#2)
qk(v)##8##1##(2006-11#3)(2012-2#5)
qkI locus##2##2##(2012-2#2)
qkI##4##1##(2012-2#4)
qrsA##2##1##(1994-12#2)
qs##2##1##(1997-8#1)(2013-8#1)
qu'une##2##1##(2008-11#1)(2008-5#1)
qua##5##1##(2006-12#1)(2007-4#1)(2008-1#1)(2008-7#1)(2012-2#1)
quackery##3##1##(1997-7#1)(2008-7#2)
quad##5##1##(2007-12#1)(2008-10#1)(2008-2#1)(2012-12#1)(2013-1#1)
quadecaurelia##2##1##(2008-12#2)
quadrant and##3##2##(2005-12#1)(2008-3#1)(2012-3#1)
quadrant of left##2##3##(2011-1#1)(2012-2#1)
quadrant of the abdomen##2##4##(2011-2#1)(2012-2#1)
quadrant of the breast##4##4##(1994-7#3)(2009-6#1)
quadrant of the##10##3##(1991-12#1)(1993-9#1)(1994-7#3)(1996-6#1)(2009-6#1)(2009-7#1)(2011-2#1)(2012-2#1)
quadrant of##14##2##(1991-12#1)(1993-9#1)(1994-7#4)(1996-3#1)(1996-6#1)(2009-6#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#2)
quadrant pain##3##2##(2006-1#1)(2013-1#2)
quadrant##44##1##(1991-10#1)(1991-12#1)(1993-3#1)(1993-9#1)(1994-7#4)(1995-10#2)(1996-3#1)(1996-6#1)(2005-12#1)(2005-8#1)(2006-1#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-5#3)(2008-11#1)(2008-3#1)(2008-8#1)(2009-4#1)(2009-6#2)(2009-7#2)(2009-8#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#4)
quadrantectomy and##4##2##(1992-12#1)(1994-12#2)(2008-2#1)
quadrantectomy with axillary##2##3##(1995-10#1)(1996-6#1)
quadrantectomy##7##1##(1992-12#2)(1994-12#2)(1995-10#1)(1996-6#1)(2008-2#1)
quadrants of the##3##3##(1996-7#1)(2007-6#1)(2009-7#1)
quadrants of##4##2##(1996-7#1)(2007-6#1)(2009-7#2)
quadrants##18##1##(1991-5#1)(1993-7#1)(1996-7#1)(2005-11#1)(2006-12#1)(2007-5#1)(2007-6#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-7#4)(2009-8#3)(2011-2#1)
quadrapole detector in Shimadzu QP-5000 gas chromatograph-mass spectrometer##2##8##(2008-10#2)
quadrat shape##3##2##(2008-10#3)
quadrat size and shape##3##4##(2008-10#3)
quadrat size and##5##3##(2008-10#5)
quadrat size##15##2##(2008-10#14)(2008-8#1)
quadrat sizes tested##3##3##(2008-10#3)
quadrat sizes##6##2##(2008-10#6)
quadrat to the##2##3##(2008-10#2)
quadrat variance##3##2##(2008-10#3)
quadrat was##2##2##(2008-10#2)
quadrat##48##1##(2008-10#45)(2008-5#1)(2008-8#2)
quadrat-based##2##1##(2008-10#2)
quadratic and cubic nonlinearities##3##4##(2007-11#1)(2007-12#2)
quadratic and cubic##4##3##(2007-11#1)(2007-12#3)
quadratic and##6##2##(2007-11#1)(2007-12#5)
quadratic coefficients##2##2##(2007-12#1)(2008-10#1)
quadratic cost functional##2##3##(2007-12#1)(2008-2#1)
quadratic cost##4##2##(2007-12#1)(2008-2#2)(2012-12#1)
quadratic dependence of##2##3##(2007-12#1)(2008-3#1)
quadratic dependence##3##2##(2007-12#2)(2008-3#1)
quadratic discriminant analysis (QDA)##2##4##(2008-10#2)
quadratic discriminant##4##2##(1991-12#2)(2008-10#2)
quadratic effect##2##2##(2008-2#1)(2008-3#1)
quadratic equation##7##2##(1997-6#1)(2008-10#4)(2008-2#2)
quadratic functions##3##2##(2007-11#2)(2008-10#1)
quadratic growth##2##2##(2008-1#2)
quadratic indices##4##2##(2007-11#4)
quadratic media##9##2##(2007-11#2)(2007-12#5)(2008-1#2)
quadratic medium##3##2##(2007-11#1)(2007-12#2)
quadratic model##6##2##(1991-7#1)(1993-1#1)(1995-9#1)(2007-11#1)(2007-4#1)(2013-1#1)
quadratic nonlinear media##3##3##(2007-12#3)
quadratic nonlinear##12##2##(2007-11#1)(2007-12#10)(2008-1#1)
quadratic nonlinearities##2##2##(2007-12#2)
quadratic nonlinearity##7##2##(2007-12#4)(2008-1#1)(2008-2#2)
quadratic phase##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
quadratic processes##3##2##(2007-12#3)
quadratic regression##3##2##(1993-1#1)(1996-2#1)(2007-11#1)
quadratic relationship between##3##3##(2007-12#2)(2009-4#1)
quadratic relationship with##2##3##(2013-8#2)
quadratic relationship##5##2##(2007-12#2)(2009-4#1)(2013-8#2)
quadratic selection##4##2##(2008-8#4)
quadratic solitons##11##2##(2007-12#8)(2008-1#3)
quadratic spatial solitons in##3##4##(2007-11#1)(2007-12#2)
quadratic spatial solitons##6##3##(2007-11#2)(2007-12#2)(2008-1#2)
quadratic spatial##7##2##(2007-11#3)(2007-12#2)(2008-1#2)
quadratic with##2##2##(1992-10#1)(1993-5#1)
quadratic##168##1##(1991-12#3)(1991-7#1)(1992-10#1)(1993-1#2)(1993-5#1)(1993-9#1)(1994-4#1)(1995-9#1)(1996-2#1)(1997-6#1)(2006-4#2)(2007-11#23)(2007-12#59)(2007-4#1)(2007-9#2)(2008-1#12)(2008-10#17)(2008-2#13)(2008-3#8)(2008-6#3)(2008-7#1)(2008-8#4)(2009-4#1)(2010-2#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#3)
quadratically nonlinear##3##2##(2007-11#1)(2007-12#2)
quadratically##4##1##(2007-11#1)(2007-12#3)
quadrats and##2##2##(2007-5#1)(2008-10#1)
quadrats of##4##2##(2008-10#3)(2008-8#1)
quadrats with##2##2##(2008-10#2)
quadrats##25##1##(2007-3#1)(2007-5#1)(2008-10#21)(2008-5#1)(2008-8#1)
quadrature baseband##2##2##(2007-3#2)
quadrature detection to##2##3##(2007-11#2)
quadrature detection##3##2##(2007-11#2)(2008-2#1)
quadrature filter##3##2##(2008-3#3)
quadrature filters##2##2##(2007-12#2)
quadrature scheme for##2##3##(2008-3#2)
quadrature scheme##5##2##(2008-3#5)
quadrature signals##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
quadrature##40##1##(2006-12#1)(2007-11#4)(2007-12#5)(2007-3#2)(2008-2#8)(2008-3#17)(2009-3#1)(2011-1#1)(2012-1#1)
quadratus is##2##2##(2008-5#2)
quadratus##6##1##(1993-9#1)(2008-5#5)
quadriceps and hamstrings##2##3##(2008-3#1)(2009-9#1)
quadriceps and the##2##3##(2007-2#1)(2007-7#1)
quadriceps and##5##2##(2007-2#1)(2007-7#1)(2008-3#1)(2009-9#1)(2011-2#1)
quadriceps femoris##3##2##(2006-3#1)(2007-7#1)(2012-1#1)
quadriceps flexibility##2##2##(2007-7#1)(2008-12#1)
quadriceps muscle strength##6##3##(2011-2#3)(2013-1#3)
quadriceps muscle##18##2##(2005-1#1)(2007-11#2)(2008-4#1)(2009-9#1)(2011-2#6)(2012-1#1)(2012-3#2)(2013-1#4)
quadriceps muscles were##2##3##(1992-3#1)(2007-2#1)
quadriceps muscles##4##2##(1992-3#1)(1994-9#1)(2007-2#2)
quadriceps tendon and##2##3##(2009-4#1)(2012-11#1)
quadriceps tendon graft##3##3##(2009-3#3)
quadriceps tendon rupture##2##3##(2012-11#2)
quadriceps tendon##9##2##(2009-3#3)(2009-4#1)(2011-2#2)(2012-11#3)
quadriceps##58##1##(1992-3#1)(1994-9#1)(2005-1#1)(2005-7#1)(2006-3#1)(2007-11#2)(2007-2#4)(2007-7#6)(2007-8#3)(2008-12#2)(2008-3#1)(2008-4#1)(2009-3#5)(2009-4#3)(2009-9#2)(2011-2#10)(2012-1#2)(2012-11#3)(2012-3#2)(2013-1#7)
quadricuspid aortic valve##6##3##(2007-8#1)(2008-11#1)(2009-4#1)(2012-3#3)
quadrigeminal plate##2##2##(2008-7#2)
quadrigeminal##3##1##(1996-5#1)(2008-7#2)
quadrilateral space##2##2##(1993-9#1)(2008-8#1)
quadrilateral##3##1##(1993-9#2)(2008-8#1)
quadriparesis##7##1##(1993-8#1)(2006-10#1)(2006-9#1)(2008-12#1)(2008-7#2)(2013-1#1)
quadriplegia##5##1##(1990-2#1)(1996-9#1)(2006-9#1)(2008-7#2)
quadriplegic##4##1##(1992-2#1)(2005-10#1)(2008-7#1)(2009-3#1)
quadriplegics##2##1##(1990-2#2)
quadrivalent HPV-6/11/16/18##2##2##(2013-1#2)
quadrivalent meningococcal conjugate vaccine##2##4##(2010-10#1)(2013-1#1)
quadrivalent meningococcal vaccine##2##3##(2013-1#2)
quadrivalent meningococcal##4##2##(2010-10#1)(2013-1#3)
quadrivalent##16##1##(1995-5#1)(2006-10#1)(2007-2#1)(2010-10#1)(2011-1#1)(2011-2#5)(2013-1#6)
quadrupedal##4##1##(1994-8#2)(2011-1#1)(2011-2#1)
quadrupedalism##5##1##(2011-1#5)
quadruple mutant##3##2##(1996-4#1)(2010-12#2)
quadruple therapy##2##2##(2008-1#1)(2010-12#1)
quadruple##18##1##(1993-11#1)(1993-2#1)(1994-6#1)(1996-4#1)(2006-4#1)(2007-11#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-3#1)(2010-12#4)(2011-2#1)(2012-1#1)
quadrupled by##2##2##(2008-2#1)(2008-3#1)
quadrupled hamstring##3##2##(2008-11#1)(2008-4#1)(2013-7#1)
quadrupled##8##1##(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2013-7#1)
quadruplet##2##1##(2012-2#2)
quadruplex DNA##3##2##(1994-11#3)
quadruplex##18##1##(1994-11#4)(1995-11#2)(1996-7#1)(2005-11#1)(2006-10#3)(2007-9#2)(2008-12#4)(2008-4#1)
quadruplexes##5##1##(1991-7#1)(2007-9#4)
quadruplicate##2##1##(1992-6#1)(2008-10#1)
quadrupling##3##1##(2007-12#1)(2008-1#2)
quadruply bridged##2##2##(2009-11#2)
quadrupolar glass fiber##2##3##(2007-12#2)
quadrupolar splitting##2##2##(1995-1#1)(2012-7#1)
quadrupolar##9##1##(1990-7#1)(1995-1#1)(1997-7#1)(2006-2#1)(2007-11#1)(2007-12#3)(2012-7#1)
quadrupole and##2##2##(2008-10#2)
quadrupole coupling##3##2##(2006-2#2)(2008-3#1)
quadrupole deflector##2##2##(2007-12#2)
quadrupole ion trap##3##3##(2009-10#1)(2010-7#1)(2011-1#1)
quadrupole ion##4##2##(2008-10#1)(2009-10#1)(2010-7#1)(2011-1#1)
quadrupole mass spectrometer##5##3##(2007-8#1)(2008-10#2)(2010-9#1)(2012-12#1)
quadrupole mass spectrometry##3##3##(2008-10#3)
quadrupole mass##11##2##(2007-8#2)(2008-10#6)(2010-9#1)(2012-12#1)(2013-7#1)
quadrupole microelectrode##3##2##(2006-2#3)
quadrupole time-of-flight mass spectrometry]##2##4##(2013-8#2)
quadrupole time-of-flight mass##4##3##(2008-10#2)(2013-8#2)
quadrupole time-of-flight##5##2##(2008-10#3)(2013-8#2)
quadrupole##56##1##(1992-12#1)(1992-3#1)(1995-5#1)(2006-2#7)(2007-11#3)(2007-12#5)(2007-8#4)(2008-10#19)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-3#2)(2010-7#1)(2010-9#1)(2011-1#1)(2012-12#2)(2013-7#1)(2013-8#3)
quadrupoles##2##1##(2008-10#1)(2010-4#1)
quadtree##2##1##(2008-2#2)
quail (Coturnix##6##2##(1990-4#1)(1997-3#2)(2008-12#2)(2010-4#1)
quail OPN##2##2##(2009-7#2)
quail and##4##2##(1993-6#1)(1996-4#1)(1997-6#1)(2008-12#1)
quail brain##2##2##(1990-4#1)(1996-4#1)
quail chicks##4##2##(2008-6#4)
quail embryo fibroblasts##3##3##(1993-6#2)(1995-2#1)
quail##49##1##(1990-4#3)(1990-7#1)(1991-5#1)(1993-6#5)(1995-2#2)(1995-6#3)(1996-4#3)(1997-3#2)(1997-5#2)(1997-6#1)(2008-11#1)(2008-12#9)(2008-5#8)(2008-6#4)(2008-8#1)(2009-7#2)(2010-4#1)
quails##12##1##(1996-4#2)(1997-3#3)(2008-12#7)
quake##2##1##(1994-2#1)(2008-2#1)
quaking viable##2##2##(2006-11#1)(2012-2#1)
qualia##6##1##(1997-8#1)(2012-2#5)
qualification criteria##2##2##(2007-7#2)
qualification of the##3##3##(1992-9#1)(2007-8#1)(2009-4#1)
qualification of##8##2##(1992-9#1)(2007-11#1)(2007-8#2)(2008-2#1)(2008-3#1)(2009-4#1)(2011-2#1)
qualification##31##1##(1990-12#1)(1992-9#1)(1994-11#1)(1994-12#2)(1996-1#1)(2007-11#3)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-4#1)(2011-2#6)(2012-3#1)(2013-7#1)
qualifications and##4##2##(1996-3#1)(2005-5#2)(2007-3#1)
qualifications in##2##2##(1994-12#1)(2006-4#1)
qualifications of##4##2##(1990-12#1)(1992-1#1)(2005-5#1)(2008-9#1)
qualifications##26##1##(1990-12#3)(1992-1#2)(1993-3#1)(1993-5#1)(1994-12#1)(1996-3#1)(2005-5#4)(2006-4#1)(2007-3#1)(2007-4#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-1#1)(2012-2#1)
qualified Medicare beneficiaries##2##3##(1994-1#1)(2007-2#1)
qualified and##2##2##(1992-3#1)(2008-11#1)
qualified as a##3##3##(2007-12#1)(2012-11#1)(2012-3#1)
qualified as##7##2##(1991-6#1)(2007-12#1)(2009-4#1)(2011-2#1)(2012-11#1)(2012-3#2)
qualified by##2##2##(2008-11#1)(2010-1#1)
qualified faculty applicants##2##3##(2012-3#2)
qualified for surgery##2##3##(2007-7#1)(2007-8#1)
qualified for the##2##3##(1995-1#1)(2012-3#1)
qualified for this##2##3##(1991-12#1)(2007-8#1)
qualified for##15##2##(1991-12#1)(1995-1#1)(2006-7#1)(2007-7#3)(2007-8#3)(2008-1#1)(2011-12#1)(2011-2#1)(2012-3#2)(2013-1#1)
qualified health care providers##2##4##(2007-4#1)(2010-9#1)
qualified health##3##2##(2007-4#1)(2009-8#1)(2010-9#1)
qualified in the##2##3##(2008-10#1)(2013-8#1)
qualified in##3##2##(2008-10#1)(2009-12#1)(2013-8#1)
qualified managers##2##2##(1995-2#1)(2012-3#1)
qualified nurses in##2##3##(2008-11#1)(2011-1#1)
qualified nurses##6##2##(2005-7#2)(2008-11#2)(2008-12#1)(2011-1#1)
qualified personnel##5##2##(1992-1#1)(1995-2#1)(2008-2#1)(2009-4#1)(2011-1#1)
qualified practitioner##2##2##(2006-10#1)(2008-11#1)
qualified specialist##2##2##(2008-6#1)(2008-7#1)
qualified staff##2##2##(2005-5#1)(2008-11#1)
qualified to##12##2##(2007-1#1)(2007-11#1)(2007-4#2)(2007-7#1)(2008-3#1)(2008-6#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
qualified with##2##2##(1996-1#1)(2008-12#1)
qualified##109##1##(1990-4#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1993-7#1)(1994-1#1)(1995-1#1)(1995-2#2)(1995-3#1)(1996-1#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-5#1)(2005-7#2)(2006-10#1)(2006-2#3)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-4#4)(2007-7#6)(2007-8#3)(2007-9#2)(2008-1#5)(2008-10#3)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-8#1)(2010-1#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#8)(2013-1#3)(2013-8#2)
qualifies##5##1##(1991-11#1)(2005-11#1)(2008-7#1)(2013-1#2)
qualify as##5##2##(1992-12#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-3#1)
qualify for refugee status will be returned##2##7##(1991-10#2)
qualify for the##2##3##(1996-12#1)(2012-12#1)
qualify for##12##2##(1990-1#1)(1990-4#1)(1991-10#2)(1993-3#1)(1994-2#1)(1996-12#1)(2007-11#1)(2007-6#1)(2008-1#1)(2010-2#1)(2012-12#1)
qualify##19##1##(1990-1#1)(1990-4#1)(1991-10#2)(1992-12#1)(1993-3#1)(1994-2#1)(1996-12#1)(2007-11#3)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-3#1)(2010-2#1)(2012-12#1)(2012-3#1)
qualifying##20##1##(1990-10#1)(1991-11#1)(1993-3#1)(2005-7#1)(2006-12#1)(2006-2#1)(2007-9#1)(2008-11#5)(2009-4#1)(2010-4#1)(2011-2#1)(2012-12#2)(2013-8#3)
qualitative RT-PCR##3##2##(2008-3#2)(2008-9#1)
qualitative abnormalities in##2##3##(1997-7#1)(2012-12#1)
qualitative agreement between##2##3##(2007-9#1)(2008-2#1)
qualitative agreement with experimental##2##4##(2007-12#1)(2008-3#1)
qualitative agreement with the##3##4##(2005-11#1)(2008-2#1)(2013-8#1)
qualitative agreement with##14##3##(2005-11#2)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-2#1)(2008-3#2)(2008-5#1)(2013-8#1)
qualitative agreement##18##2##(2005-11#2)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#3)(2007-9#2)(2008-10#1)(2008-2#2)(2008-3#3)(2008-5#1)(2013-8#1)
qualitative analyses of##3##3##(2008-12#1)(2008-5#1)(2009-8#1)
qualitative analyses##4##2##(2008-12#2)(2008-5#1)(2009-8#1)
qualitative analysis and##3##3##(2008-2#1)(2013-1#2)
qualitative analysis of ethanol extracts##2##5##(2008-6#2)
qualitative analysis of the##5##4##(1993-3#1)(1994-2#1)(2008-2#1)(2009-5#1)(2011-2#1)
qualitative analysis of##25##3##(1991-7#1)(1993-3#1)(1994-2#1)(1996-1#2)(1996-12#1)(2006-7#1)(2007-11#1)(2008-10#7)(2008-2#1)(2008-6#2)(2008-8#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#3)
qualitative analysis##38##2##(1991-7#1)(1993-11#1)(1993-3#1)(1994-2#1)(1996-1#2)(1996-12#1)(2006-7#1)(2007-11#1)(2007-3#1)(2007-5#1)(2008-10#7)(2008-2#2)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-10#2)(2011-2#1)(2012-2#1)(2013-1#7)
qualitative and quantitative analyses##2##4##(2008-10#1)(2010-2#1)
qualitative and quantitative analysis of the##4##6##(2007-7#1)(2007-8#2)(2008-5#1)
qualitative and quantitative analysis of##12##5##(1993-6#1)(1996-12#1)(1997-2#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-5#2)(2012-3#1)
qualitative and quantitative analysis##15##4##(1993-6#1)(1996-12#1)(1997-2#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-5#2)(2012-3#1)(2013-7#1)
qualitative and quantitative data##4##4##(2006-5#1)(2008-11#1)(2008-12#1)(2008-7#1)
qualitative and quantitative differences in the##4##6##(1992-1#1)(2008-10#1)(2008-5#1)(2013-1#1)
qualitative and quantitative differences in##5##5##(1992-1#1)(2008-10#1)(2008-5#1)(2013-1#2)
qualitative and quantitative differences##6##4##(1990-8#1)(1992-1#1)(2008-10#1)(2008-5#1)(2013-1#2)
qualitative and quantitative evaluation##2##4##(1996-5#1)(2007-7#1)
qualitative and quantitative information##3##4##(1996-7#1)(2008-10#1)(2013-1#1)
qualitative and quantitative methods##2##4##(2008-2#1)(2013-1#1)
qualitative and quantitative research##3##4##(1996-4#1)(2008-1#1)(2010-2#1)
qualitative and quantitative results##3##4##(2007-12#1)(2008-10#1)(2010-2#1)
qualitative and quantitative sesquiterpene lactone##2##5##(2007-1#2)
qualitative and quantitative##87##3##(1990-8#1)(1991-2#1)(1992-1#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-4#2)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(2004-7#1)(2005-4#1)(2005-5#1)(2006-5#1)(2007-1#4)(2007-11#2)(2007-12#3)(2007-5#2)(2007-7#3)(2007-8#4)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#1)(2008-9#1)(2010-10#2)(2010-12#1)(2010-2#3)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#3)
qualitative and semi-quantitative##2##3##(1997-3#1)(2007-6#1)
qualitative and##97##2##(1990-8#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-3#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-4#2)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#2)(2004-7#1)(2005-4#1)(2005-5#1)(2006-10#1)(2006-5#1)(2007-1#4)(2007-11#2)(2007-12#3)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#4)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#1)(2008-9#1)(2009-6#1)(2010-10#2)(2010-12#1)(2010-2#3)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#4)(2013-1#5)(2013-7#3)
qualitative approach was##2##3##(2012-3#1)(2013-1#1)
qualitative approach##11##2##(2006-11#1)(2007-3#1)(2008-10#1)(2008-9#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
qualitative aspects of##5##3##(1992-9#1)(2008-5#1)(2009-10#1)(2009-9#1)(2011-2#1)
qualitative aspects##6##2##(1992-9#1)(2008-5#1)(2009-10#1)(2009-9#1)(2011-2#1)(2012-12#1)
qualitative assessment of the##4##4##(1995-10#1)(2006-10#1)(2007-7#1)(2008-2#1)
qualitative assessment of##7##3##(1995-10#1)(1996-12#1)(2006-10#1)(2006-4#1)(2007-7#1)(2008-2#1)(2012-3#1)
qualitative but##2##2##(2007-12#1)(2008-5#1)
qualitative case study##4##3##(2008-11#1)(2008-9#2)(2010-8#1)
qualitative change in##2##3##(1990-6#1)(2006-8#1)
qualitative change##3##2##(1990-6#1)(1992-12#1)(2006-8#1)
qualitative changes in the##2##4##(1993-9#1)(2008-5#1)
qualitative changes in##8##3##(1993-9#1)(1996-8#1)(1997-7#1)(2008-5#1)(2008-7#1)(2009-1#1)(2012-2#1)(2013-1#1)
qualitative changes##9##2##(1992-7#1)(1993-9#1)(1996-8#1)(1997-7#1)(2008-5#1)(2008-7#1)(2009-1#1)(2012-2#1)(2013-1#1)
qualitative comparisons##2##2##(2008-2#1)(2012-2#1)
qualitative conclusions##2##2##(1995-5#1)(2008-8#1)
qualitative content analysis of##2##4##(2012-11#1)(2012-12#1)
qualitative content analysis##10##3##(2008-12#1)(2009-5#1)(2009-6#1)(2010-10#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#2)
qualitative content##12##2##(2008-12#1)(2009-5#1)(2009-6#1)(2010-10#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#2)
qualitative data analysis##3##3##(2005-8#1)(2010-9#1)(2012-12#1)
qualitative data and##2##3##(2008-7#1)(2012-3#1)
qualitative data from##5##3##(2007-10#1)(2008-11#1)(2010-4#1)(2013-1#2)
qualitative data on the##5##4##(1991-8#1)(2007-11#1)(2008-8#1)(2010-7#1)(2011-1#1)
qualitative data on##7##3##(1991-8#1)(2007-11#1)(2008-8#1)(2009-5#1)(2010-7#1)(2011-1#1)(2012-2#1)
qualitative data##38##2##(1990-9#1)(1991-8#1)(2005-8#1)(2006-3#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-9#2)(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-7#2)(2010-9#1)(2011-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#1)
qualitative descriptive study##8##3##(2007-2#1)(2008-11#1)(2009-7#1)(2010-10#1)(2010-9#1)(2011-1#2)(2013-8#1)
qualitative descriptive##9##2##(2007-2#1)(2008-11#1)(2009-7#1)(2010-10#1)(2010-9#1)(2011-1#2)(2012-3#1)(2013-8#1)
qualitative detection##3##2##(2007-8#1)(2008-9#2)
qualitative determination of##4##3##(1990-4#1)(2007-8#1)(2008-7#1)(2010-9#1)
qualitative differences in the##5##4##(1992-1#1)(1994-3#1)(2007-11#1)(2008-10#1)(2013-1#1)
qualitative differences in##9##3##(1991-7#1)(1992-1#1)(1994-3#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#1)
qualitative differences were observed##2##4##(1992-1#2)
qualitative differences##16##2##(1991-7#1)(1992-1#3)(1993-6#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-3#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-8#1)(2013-1#1)(2013-8#1)
qualitative evaluation of##4##3##(1997-7#1)(2008-1#1)(2008-10#1)(2008-4#1)
qualitative evaluation##10##2##(1997-7#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2011-2#1)(2013-1#2)
qualitative evidence##2##2##(2008-11#1)(2012-3#1)
qualitative exploration of##4##3##(2007-11#1)(2011-2#1)(2012-11#1)(2012-2#1)
qualitative features of the##3##4##(1990-8#1)(1992-9#1)(2008-2#1)
qualitative features of##4##3##(1990-8#1)(1992-9#1)(2008-2#1)(2008-8#1)
qualitative features##7##2##(1990-8#1)(1992-9#1)(2007-11#1)(2008-2#2)(2008-8#2)
qualitative feedback from##2##3##(2008-11#1)(2010-5#1)
qualitative findings from a study##2##5##(2008-12#1)(2009-5#1)
qualitative findings from##3##3##(2008-12#1)(2009-5#1)(2010-10#1)
qualitative findings##4##2##(2008-12#1)(2009-5#1)(2009-7#1)(2010-10#1)
qualitative information##7##2##(1994-9#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-2#2)
qualitative interaction##3##2##(1997-7#3)
qualitative interpretation of the##2##4##(2008-10#1)(2008-3#1)
qualitative interview data##2##3##(2006-3#1)(2012-3#1)
qualitative interview study##2##3##(2011-1#1)(2013-1#1)
qualitative interview##7##2##(2005-8#1)(2006-3#1)(2006-7#1)(2008-4#1)(2011-1#1)(2012-3#1)(2013-1#1)
qualitative interviews were##3##3##(2007-3#1)(2010-4#1)(2013-1#1)
qualitative interviews with##4##3##(2008-2#1)(2009-4#1)(2012-11#1)(2012-12#1)
qualitative interviews##15##2##(2007-3#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-4#1)(2010-4#1)(2011-1#1)(2012-11#2)(2012-12#1)(2012-3#1)(2013-1#2)
qualitative investigation of##3##3##(2006-4#1)(2006-7#1)(2013-1#1)
qualitative investigation##5##2##(2006-4#1)(2006-7#2)(2011-2#1)(2013-1#1)
qualitative literature review##2##3##(2009-4#1)(2011-1#1)
qualitative measurements of##2##3##(1991-12#1)(2008-10#1)
qualitative measures##3##2##(1993-3#1)(2007-9#1)(2010-7#1)
qualitative method for the##2##4##(2008-10#1)(2013-1#1)
qualitative method##4##2##(2007-11#1)(2008-10#1)(2010-10#1)(2013-1#1)
qualitative methodology to explore##2##4##(2007-12#1)(2013-1#1)
qualitative methodology to##3##3##(2007-12#1)(2011-1#1)(2013-1#1)
qualitative methodology##10##2##(1994-3#1)(2005-2#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#2)(2009-4#1)(2011-1#1)(2013-1#1)
qualitative methods of##3##3##(2008-5#1)(2013-1#2)
qualitative methods to##5##3##(2008-12#1)(2008-6#1)(2012-3#1)(2013-1#2)
qualitative methods##19##2##(1994-3#1)(2006-2#1)(2007-7#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-7#1)(2010-11#1)(2010-2#1)(2011-1#1)(2012-3#1)(2013-1#5)
qualitative models##2##2##(2006-10#1)(2010-12#1)
qualitative narrative##2##2##(2005-10#1)(2011-1#1)
qualitative or quantitative##4##3##(2007-11#1)(2008-10#1)(2011-1#1)(2012-2#1)
qualitative or##5##2##(2007-11#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-2#1)
qualitative phase##2##2##(2008-11#1)(2011-2#1)
qualitative research and##3##3##(1997-3#1)(2008-10#1)(2012-3#1)
qualitative research design was##2##4##(2008-1#1)(2010-3#1)
qualitative research design##4##3##(1995-12#1)(2006-7#1)(2008-1#1)(2010-3#1)
qualitative research is##2##3##(1997-3#2)
qualitative research methodology##5##3##(1995-3#2)(2006-11#1)(2008-11#1)(2008-9#1)
qualitative research project##3##3##(1995-1#1)(2008-9#1)(2010-12#1)
qualitative research was##2##3##(2008-1#1)(2010-9#1)
qualitative research##46##2##(1992-2#1)(1995-1#1)(1995-12#1)(1995-3#2)(1997-1#2)(1997-3#5)(2006-11#1)(2006-7#1)(2007-2#2)(2008-1#2)(2008-10#1)(2008-11#5)(2008-12#1)(2008-3#1)(2008-9#2)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#7)(2012-3#2)
qualitative resistance##2##2##(2008-10#2)
qualitative result##2##2##(2008-10#1)(2011-2#1)
qualitative review of the##2##4##(2005-11#1)(2008-7#1)
qualitative review of##3##3##(2005-11#1)(2008-7#1)(2011-1#1)
qualitative review##6##2##(2005-11#1)(2008-7#1)(2011-1#2)(2013-1#2)
qualitative social##2##2##(2008-1#1)(2011-2#1)
qualitative studies of##3##3##(2008-10#1)(2010-5#1)(2012-11#1)
qualitative studies##8##2##(1997-3#1)(2007-6#1)(2008-10#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-12#1)
qualitative study among##3##3##(1995-6#2)(2013-1#1)
qualitative study based on##2##4##(1990-12#1)(2011-2#1)
qualitative study conducted##2##3##(2009-10#1)(2013-8#1)
qualitative study of the experiences of##2##6##(2008-11#1)(2008-9#1)
qualitative study of the##6##4##(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#1)(2013-1#2)
qualitative study of##18##3##(1996-3#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-5#1)(2011-1#1)(2012-11#1)(2012-12#1)(2013-1#4)(2013-8#1)
qualitative study to##3##3##(2006-10#1)(2008-7#1)(2012-12#1)
qualitative study using##2##3##(2008-12#1)(2008-7#1)
qualitative study was##6##3##(2008-11#1)(2008-12#1)(2009-7#1)(2009-9#1)(2010-10#1)(2011-2#1)
qualitative study with##2##3##(2007-2#1)(2013-8#1)
qualitative study##88##2##(1990-12#1)(1995-6#2)(1996-3#1)(2006-10#1)(2006-2#1)(2007-10#4)(2007-2#1)(2007-3#2)(2008-1#1)(2008-11#5)(2008-12#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-10#3)(2010-11#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#6)(2012-1#2)(2012-11#2)(2012-12#7)(2012-3#1)(2013-1#14)(2013-7#1)(2013-8#3)
qualitative study]##2##2##(1993-8#1)(2013-1#1)
qualitative thematic##2##2##(2010-6#1)(2012-11#1)
qualitative##732##1##(1990-10#1)(1990-12#1)(1990-4#1)(1990-6#1)(1990-8#3)(1990-9#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-1#4)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-9#2)(1993-1#2)(1993-11#4)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#5)(1995-5#2)(1995-6#2)(1996-1#3)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-4#3)(1996-5#1)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#2)(1997-3#10)(1997-4#1)(1997-7#6)(1997-8#1)(2004-7#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-2#1)(2005-4#1)(2005-5#1)(2005-8#3)(2006-10#5)(2006-11#2)(2006-12#3)(2006-2#4)(2006-3#2)(2006-4#4)(2006-5#3)(2006-6#1)(2006-7#6)(2006-8#1)(2007-1#4)(2007-10#5)(2007-11#13)(2007-12#9)(2007-2#6)(2007-3#6)(2007-5#4)(2007-6#2)(2007-7#12)(2007-8#8)(2007-9#8)(2008-1#8)(2008-10#56)(2008-11#31)(2008-12#17)(2008-2#17)(2008-3#13)(2008-4#10)(2008-5#14)(2008-6#3)(2008-7#12)(2008-8#13)(2008-9#15)(2009-1#1)(2009-10#4)(2009-3#1)(2009-4#7)(2009-5#8)(2009-6#4)(2009-7#6)(2009-8#3)(2009-9#4)(2010-1#1)(2010-10#16)(2010-11#2)(2010-12#6)(2010-2#7)(2010-3#2)(2010-4#2)(2010-5#5)(2010-6#2)(2010-7#5)(2010-8#4)(2010-9#6)(2011-1#23)(2011-2#25)(2011-7#1)(2012-1#4)(2012-11#9)(2012-12#23)(2012-2#14)(2012-3#23)(2013-1#63)(2013-7#7)(2013-8#8)
qualitative&quot##2##1##(1990-4#1)(2008-10#1)
qualitatively analyzed##2##2##(2007-12#1)(2007-8#1)
qualitatively and quantitatively compared##2##4##(2008-10#1)(2008-2#1)
qualitatively and quantitatively different from##2##5##(1990-8#1)(1993-3#1)
qualitatively and quantitatively different##3##4##(1990-8#1)(1993-3#1)(2008-11#1)
qualitatively and quantitatively in##2##4##(2007-12#1)(2008-2#1)
qualitatively and quantitatively##17##3##(1990-8#1)(1991-5#1)(1993-3#1)(1995-12#1)(1996-12#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-5#1)(2010-12#1)(2012-2#1)(2013-7#1)
qualitatively better##2##2##(2008-2#1)(2013-1#1)
qualitatively by##4##2##(1993-3#1)(2008-10#1)(2008-2#1)(2008-5#1)
qualitatively consistent with##7##3##(1995-8#1)(2007-12#1)(2008-3#1)(2009-10#1)(2011-1#1)(2013-1#2)
qualitatively different from that##2##4##(2008-5#1)(2010-12#1)
qualitatively different from the##2##4##(2008-7#1)(2008-9#1)
qualitatively different from##6##3##(1994-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)
qualitatively different to##2##3##(2008-10#1)(2008-12#1)
qualitatively different##22##2##(1991-6#1)(1993-6#1)(1994-10#1)(1996-5#1)(1996-7#1)(2005-11#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2012-1#1)
qualitatively distinct##4##2##(1994-5#1)(1995-11#1)(2008-5#1)(2009-12#1)
qualitatively explains##2##2##(2007-11#1)(2008-2#1)
qualitatively for##3##2##(1997-8#1)(2008-10#2)
qualitatively from that##2##3##(2007-12#1)(2008-1#1)
qualitatively from##3##2##(2007-12#1)(2008-1#1)(2010-8#1)
qualitatively in terms of##2##4##(1996-8#1)(2007-12#1)
qualitatively in##3##2##(1996-8#1)(2005-11#1)(2007-12#1)
qualitatively or quantitatively##2##3##(1990-5#1)(2008-11#1)
qualitatively preserved##2##2##(2008-7#2)
qualitatively reproduces##2##2##(1995-2#1)(2007-12#1)
qualitatively similar to that##2##4##(1995-3#1)(2008-4#1)
qualitatively similar to the##3##4##(1991-4#1)(1993-12#1)(1996-5#1)
qualitatively similar to those##2##4##(1993-5#1)(1994-3#1)
qualitatively similar to##8##3##(1991-4#1)(1993-12#1)(1993-5#1)(1994-3#1)(1995-3#1)(1996-5#1)(2008-4#1)(2008-8#1)
qualitatively similar##21##2##(1990-7#1)(1991-4#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-3#1)(1994-9#2)(1995-3#1)(1996-3#1)(1996-4#1)(1996-5#2)(1997-2#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-8#1)(2012-2#1)
qualitatively the##2##2##(2008-11#1)(2009-5#1)
qualitatively##166##1##(1990-5#2)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-4#1)(1991-5#1)(1991-6#2)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#2)(1994-10#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#2)(2005-11#4)(2006-10#2)(2006-11#1)(2006-3#1)(2006-4#2)(2007-11#2)(2007-12#9)(2007-8#1)(2008-1#3)(2008-10#14)(2008-11#7)(2008-12#3)(2008-2#10)(2008-3#4)(2008-4#3)(2008-5#4)(2008-7#4)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#8)(2013-7#1)
qualities and##8##2##(1990-12#1)(1996-8#1)(2008-1#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-11#1)(2012-5#1)
qualities are##2##2##(1990-9#1)(2008-1#1)
qualities in##2##2##(2009-4#1)(2011-2#1)
qualities of a##3##3##(1996-2#1)(2011-1#2)
qualities of the two##2##4##(2008-2#1)(2008-8#1)
qualities of the##13##3##(1992-8#1)(1996-8#1)(2006-12#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)
qualities of##36##2##(1991-2#1)(1992-8#1)(1992-9#1)(1995-3#1)(1996-2#1)(1996-5#1)(1996-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-2#1)(2010-11#2)(2011-1#2)(2012-12#2)(2012-2#1)(2013-1#1)
qualities that##4##2##(2006-10#1)(2008-2#1)(2008-9#1)(2012-1#1)
qualities were##5##2##(1993-3#1)(1995-1#1)(2004-11#1)(2011-2#2)
qualities##93##1##(1990-12#4)(1990-4#1)(1990-9#1)(1991-2#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-5#1)(1996-8#2)(1997-4#1)(1997-6#1)(2004-11#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-1#4)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#3)(2009-2#1)(2009-4#2)(2009-9#1)(2010-11#3)(2011-1#2)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#3)(2013-7#1)
quality (M(2)&lt##2##2##(2007-12#2)
quality -##3##2##(2012-3#2)(2013-1#1)
quality according to##2##3##(2008-5#1)(2011-1#1)
quality according##3##2##(2008-5#1)(2011-1#1)(2013-1#1)
quality across the##2##3##(2012-12#1)(2012-3#1)
quality across##5##2##(1995-2#1)(2007-7#1)(2008-2#1)(2012-12#1)(2012-3#1)
quality adjusted life years##2##4##(2008-5#1)(2012-12#1)
quality adjusted survival analysis##3##4##(1993-5#3)
quality adjusted##5##2##(1993-5#3)(2008-5#1)(2012-12#1)
quality affects##2##2##(2004-2#1)(2012-2#1)
quality after##5##2##(2007-11#2)(2008-10#1)(2008-3#1)(2012-2#1)
quality among##2##2##(1996-6#1)(2008-9#1)
quality and a##3##3##(1996-12#1)(2008-3#1)(2008-9#1)
quality and accessibility of##2##4##(1995-2#1)(2008-11#1)
quality and accessibility##3##3##(1995-2#1)(2008-11#2)
quality and cost##7##3##(1991-2#1)(1993-3#1)(1994-1#1)(1994-3#1)(1996-2#1)(2008-10#1)(2008-11#1)
quality and costs##2##3##(2004-9#1)(2006-10#1)
quality and duration of##2##4##(2012-2#1)(2013-8#1)
quality and efficiency##5##3##(1992-2#1)(1996-12#1)(1996-2#1)(2006-12#1)(2013-1#1)
quality and its##2##3##(1993-12#1)(2010-3#1)
quality and low##3##3##(1997-3#1)(2007-12#1)(2008-3#1)
quality and outcomes##4##3##(1994-2#1)(2009-12#1)(2013-1#2)
quality and patient safety##4##4##(2007-5#2)(2007-8#1)(2011-1#1)
quality and patient satisfaction##3##4##(1995-1#1)(1995-3#1)(2007-8#1)
quality and patient##8##3##(1995-1#1)(1995-3#1)(2007-5#2)(2007-8#2)(2011-1#1)(2011-2#1)
quality and performance##4##3##(1997-3#1)(2005-5#1)(2007-5#1)(2008-5#1)
quality and productivity##2##3##(1992-2#1)(2008-10#1)
quality and quantity culture##2##4##(2012-12#2)
quality and quantity of the##2##5##(2008-10#1)(2008-7#1)
quality and quantity of##9##4##(1997-6#1)(2004-12#1)(2006-12#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-10#1)(2012-2#1)
quality and quantity##18##3##(1991-9#1)(1997-6#1)(2004-12#1)(2004-2#1)(2006-12#2)(2006-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-2#1)(2011-10#1)(2012-12#4)(2012-2#1)(2013-1#1)
quality and resolution of##2##4##(2008-5#1)(2010-4#1)
quality and safety of##4##4##(2009-4#1)(2011-2#2)(2013-1#1)
quality and safety##13##3##(2007-4#1)(2009-4#1)(2010-7#1)(2010-8#2)(2011-2#4)(2013-1#2)(2013-8#2)
quality and satisfaction##2##3##(1996-3#1)(2007-12#1)
quality and service levels##2##4##(1996-1#1)(1996-2#1)
quality and service##4##3##(1995-12#1)(1996-1#1)(1996-2#1)(2007-5#1)
quality and shelf##2##3##(2007-3#1)(2010-4#1)
quality and supply##2##3##(1990-5#1)(2011-1#1)
quality and the ability to##2##5##(2006-10#1)(2008-9#1)
quality and the reliability of##2##5##(2007-2#1)(2008-3#1)
quality and the##14##3##(1993-8#1)(2004-9#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-4#1)(2012-2#1)
quality and to##3##3##(2007-5#1)(2008-2#1)(2013-1#1)
quality and utilization##2##3##(1994-12#1)(1995-1#1)
quality and value##2##3##(1993-3#1)(1995-2#1)
quality and##259##2##(1990-5#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-2#4)(1993-12#3)(1993-3#2)(1993-8#1)(1994-1#2)(1994-12#2)(1994-2#2)(1994-3#3)(1994-4#1)(1995-1#3)(1995-12#2)(1995-2#2)(1995-3#4)(1996-1#2)(1996-12#4)(1996-2#3)(1996-3#2)(1996-9#1)(1997-1#2)(1997-3#2)(1997-5#1)(1997-6#1)(2004-12#2)(2004-2#1)(2004-9#3)(2005-10#1)(2005-12#1)(2005-5#1)(2005-7#2)(2005-8#1)(2006-10#4)(2006-12#3)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#4)(2007-3#2)(2007-4#4)(2007-5#5)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#21)(2008-11#7)(2008-12#4)(2008-2#9)(2008-3#8)(2008-4#1)(2008-5#5)(2008-7#6)(2008-8#3)(2008-9#5)(2009-10#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#2)(2010-11#1)(2010-2#4)(2010-3#1)(2010-4#8)(2010-5#2)(2010-7#1)(2010-8#3)(2011-1#3)(2011-10#1)(2011-2#8)(2012-1#1)(2012-12#9)(2012-2#11)(2012-3#4)(2013-1#13)(2013-8#4)
quality are discussed##2##3##(2008-2#1)(2008-9#1)
quality are expected to##2##4##(1996-12#1)(2008-3#1)
quality are required##2##3##(2006-10#1)(2008-10#1)
quality are##14##2##(1993-3#1)(1995-1#1)(1996-12#1)(1996-2#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-8#2)(2012-1#1)(2013-8#1)
quality as the##2##3##(2007-12#1)(2008-2#1)
quality as##9##2##(1994-1#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-11#1)
quality aspect##2##2##(2007-8#1)(2012-12#1)
quality assessment and improvement system for long-term care##2##8##(1997-1#2)
quality assessment and improvement##7##4##(1993-2#3)(1996-1#1)(1997-1#2)(1997-2#1)
quality assessment and##10##3##(1993-2#3)(1993-3#1)(1996-1#1)(1997-1#2)(1997-2#1)(2008-10#1)(2012-2#1)
quality assessment of##5##3##(2007-6#1)(2007-8#2)(2013-1#2)
quality assessment that##2##3##(1991-3#1)(1992-2#1)
quality assessment tools##2##3##(2008-12#1)(2012-12#1)
quality assessment##45##2##(1990-1#2)(1991-3#1)(1992-2#2)(1993-2#3)(1993-3#1)(1996-1#1)(1997-1#3)(1997-2#1)(2005-11#1)(2005-5#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-10#4)(2008-12#2)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#5)
quality assurance (QA) in##3##4##(1993-3#1)(1995-3#1)(2005-5#1)
quality assurance (QA)##6##3##(1993-3#1)(1994-2#2)(1995-3#2)(2005-5#1)
quality assurance activities##7##3##(1990-12#1)(1993-3#3)(2006-2#2)(2008-6#1)
quality assurance and audits##2##4##(2008-11#2)
quality assurance and quality control##3##5##(2008-10#2)(2008-3#1)
quality assurance and quality management##4##5##(2006-2#4)
quality assurance and quality##8##4##(1991-1#1)(2006-2#4)(2008-10#2)(2008-3#1)
quality assurance and the##2##4##(2006-10#1)(2008-10#1)
quality assurance and##20##3##(1991-1#1)(1994-1#1)(1994-6#1)(1995-3#1)(2005-8#1)(2006-10#1)(2006-2#5)(2007-6#1)(2008-10#3)(2008-11#2)(2008-3#1)(2011-12#1)(2012-2#1)
quality assurance in health care##2##5##(2006-2#1)(2010-12#1)
quality assurance in##10##3##(1991-12#1)(1992-1#1)(1994-8#1)(1996-12#1)(2005-5#1)(2006-2#1)(2006-4#1)(2007-4#1)(2010-12#1)(2012-2#1)
quality assurance is##3##3##(1991-12#1)(1992-11#1)(1995-2#1)
quality assurance issues##2##3##(2008-10#1)(2009-4#1)
quality assurance mechanisms##4##3##(2005-5#1)(2006-2#2)(2008-11#1)
quality assurance of medical##2##4##(1992-9#1)(1993-10#1)
quality assurance of the##2##4##(2008-10#1)(2009-4#1)
quality assurance of##10##3##(1992-9#1)(1993-10#1)(1994-3#1)(2005-11#2)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#1)(2009-4#1)
quality assurance process##3##3##(1994-3#1)(2005-5#1)(2008-1#1)
quality assurance program##9##3##(1994-7#1)(1997-4#1)(2007-4#1)(2008-3#1)(2008-4#1)(2008-6#4)
quality assurance programmes##3##3##(1996-2#1)(2005-12#1)(2005-5#1)
quality assurance programs##7##3##(1991-1#1)(1991-12#1)(1993-2#1)(1993-3#1)(1995-1#1)(2010-12#1)(2012-2#1)
quality assurance standards##4##3##(1993-2#1)(2007-8#1)(2008-10#2)
quality assurance system##4##3##(2011-2#1)(2012-12#2)(2012-2#1)
quality assurance testing##2##3##(2008-10#1)(2008-9#1)
quality assurance to##6##3##(1993-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(2005-5#1)(2010-7#1)
quality assurance##163##2##(1990-12#4)(1990-9#1)(1991-1#3)(1991-12#4)(1992-1#1)(1992-11#4)(1992-5#1)(1992-9#2)(1993-10#1)(1993-2#3)(1993-3#10)(1993-9#1)(1994-1#1)(1994-2#4)(1994-3#4)(1994-6#1)(1994-7#1)(1994-8#2)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#5)(1996-1#1)(1996-12#3)(1996-2#1)(1997-1#1)(1997-4#1)(2005-11#2)(2005-12#1)(2005-5#12)(2005-8#1)(2006-10#2)(2006-2#11)(2006-4#2)(2007-11#1)(2007-4#4)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#8)(2008-9#1)(2009-4#2)(2010-12#2)(2010-6#1)(2010-7#1)(2011-12#3)(2011-2#1)(2012-12#4)(2012-2#5)(2013-1#6)
quality at an##2##3##(1996-2#1)(2007-11#1)
quality at the community level##2##5##(2013-1#2)
quality at the##5##3##(1997-3#1)(2007-5#1)(2009-6#1)(2013-1#2)
quality at##21##2##(1995-1#1)(1995-2#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2009-9#1)(2012-2#2)(2013-1#2)
quality attributes##5##2##(1995-12#1)(2010-4#3)(2012-2#1)
quality based##2##2##(2010-4#1)(2010-8#1)
quality benefits##2##2##(1995-12#1)(2006-10#1)
quality between##4##2##(2008-11#1)(2008-2#1)(2010-4#1)(2013-7#1)
quality bone and##2##3##(2008-4#1)(2009-3#1)
quality but##2##2##(2007-12#1)(2008-3#1)
quality by means of##3##4##(2012-2#1)(2013-1#2)
quality by##11##2##(2007-12#1)(2007-8#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
quality called##2##2##(1996-2#1)(2007-9#1)
quality can be improved##2##4##(2006-6#1)(2008-6#1)
quality can be##8##3##(1996-2#1)(2005-4#1)(2006-4#1)(2006-6#1)(2008-4#1)(2008-6#1)(2008-8#1)(2012-2#1)
quality can##11##2##(1995-1#1)(1996-2#1)(2005-4#1)(2006-4#1)(2006-6#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#2)(2012-2#1)
quality care and##2##3##(1994-1#1)(2007-4#1)
quality care coordination##2##3##(2013-1#2)
quality care for##5##3##(1992-12#1)(1995-1#1)(1997-2#1)(2007-4#1)(2011-1#1)
quality care to##2##3##(1994-2#1)(2008-11#1)
quality care##38##2##(1991-1#1)(1992-12#1)(1992-3#1)(1993-1#2)(1993-12#1)(1994-1#1)(1994-2#2)(1994-3#1)(1995-1#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2006-1#1)(2006-2#1)(2007-10#1)(2007-4#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#3)(2008-5#1)(2008-6#1)(2010-7#1)(2011-1#2)(2013-1#2)(2013-8#1)
quality category##3##2##(2013-1#3)
quality changes##3##2##(1993-1#2)(2011-2#1)
quality characteristics##3##2##(1991-3#1)(2010-4#1)(2013-7#1)
quality circles##5##2##(1992-3#1)(1994-2#1)(2010-11#3)
quality clinical##5##2##(1992-3#1)(1995-6#1)(2008-11#1)(2008-5#1)(2011-1#1)
quality concerns##2##2##(2005-8#1)(2008-10#1)
quality control (QC)##4##3##(1996-3#1)(2007-4#1)(2008-10#1)(2010-10#1)
quality control analysis##3##3##(2008-10#2)(2012-2#1)
quality control and##14##3##(1990-10#1)(1993-5#1)(1994-6#1)(2006-10#1)(2007-12#1)(2008-10#3)(2010-9#1)(2011-1#2)(2011-3#1)(2012-3#1)(2013-1#1)
quality control assessment of##2##4##(2007-8#1)(2008-10#1)
quality control at##2##3##(1995-8#1)(2007-4#1)
quality control during##2##3##(2010-8#1)(2012-2#1)
quality control for##2##3##(1992-10#1)(2008-2#1)
quality control in a##2##4##(1995-4#1)(2007-4#1)
quality control in the##3##4##(2008-10#1)(2008-9#1)(2010-4#1)
quality control in##15##3##(1992-11#1)(1994-3#1)(1995-4#1)(2004-9#1)(2005-9#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-9#2)(2010-4#1)
quality control is##5##3##(1990-10#2)(2007-4#1)(2008-10#1)(2010-5#1)
quality control laboratory##3##3##(2007-8#1)(2010-4#1)(2013-7#1)
quality control material##2##3##(2008-10#2)
quality control measure##2##3##(1996-12#1)(2007-8#1)
quality control measures##5##3##(1992-9#1)(1994-6#1)(1996-12#1)(1996-3#1)(2013-1#1)
quality control of pharmaceutical##2##4##(2010-2#1)(2011-1#1)
quality control of the##8##4##(1994-1#1)(2005-4#1)(2006-4#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)
quality control of##42##3##(1991-9#1)(1994-1#1)(1995-5#1)(2005-4#1)(2006-4#1)(2007-8#5)(2008-10#10)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-7#1)(2010-2#2)(2010-4#1)(2011-1#4)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
quality control or##2##3##(1996-7#1)(2008-10#1)
quality control process##2##3##(2005-7#1)(2007-4#1)
quality control program##7##3##(1994-12#1)(2004-9#1)(2008-9#1)(2013-1#4)
quality control samples##3##3##(1996-6#1)(1996-8#1)(2008-10#1)
quality control system##5##3##(1996-9#2)(2005-7#1)(2009-10#1)(2011-2#1)
quality control##197##2##(1990-10#4)(1991-8#1)(1991-9#1)(1992-10#3)(1992-11#1)(1992-9#2)(1993-12#1)(1993-5#1)(1993-6#1)(1994-1#2)(1994-12#1)(1994-3#1)(1994-4#1)(1994-6#2)(1995-1#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#3)(1996-3#3)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#2)(2004-9#3)(2005-12#1)(2005-4#1)(2005-7#2)(2005-9#1)(2006-10#3)(2006-11#2)(2006-4#1)(2007-11#1)(2007-12#3)(2007-4#6)(2007-7#2)(2007-8#11)(2008-10#35)(2008-11#2)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#1)(2008-9#13)(2009-10#4)(2009-6#1)(2009-7#3)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#3)(2011-3#2)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#6)(2013-1#9)(2013-7#1)
quality controls##5##2##(1993-1#1)(1996-8#2)(2007-12#1)(2008-11#1)
quality could be##2##3##(2006-5#1)(2008-2#1)
quality could##4##2##(2006-5#1)(2008-11#1)(2008-2#1)(2011-2#1)
quality course management##2##3##(2008-12#2)
quality criteria##10##2##(1994-3#1)(1995-2#1)(2005-10#1)(2008-11#4)(2008-5#1)(2010-4#1)(2011-2#1)
quality data of##2##3##(2008-1#2)
quality data##10##2##(1990-5#1)(1994-3#1)(2008-1#2)(2008-7#1)(2009-6#1)(2010-11#2)(2010-9#1)(2012-12#1)
quality degradation##3##2##(2004-9#1)(2008-3#1)(2013-1#1)
quality depends##2##2##(1992-9#1)(2008-2#1)
quality determinants##3##2##(1993-12#3)
quality development##3##2##(1995-5#1)(1997-5#1)(2008-2#1)
quality differences between##2##3##(1992-3#1)(2008-8#1)
quality differences##3##2##(1992-3#1)(2008-8#2)
quality dimensions##2##2##(1994-2#2)
quality due to the##2##4##(2008-10#1)(2008-7#1)
quality due to##6##3##(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)(2012-11#1)
quality early##2##2##(2006-2#1)(2010-12#1)
quality educational##2##2##(2007-2#1)(2008-12#1)
quality embryos##3##2##(2006-5#2)(2008-11#1)
quality evaluation of##3##3##(2011-2#1)(2012-2#1)(2013-8#1)
quality evaluation##5##2##(2008-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
quality factor of the##2##4##(2008-4#1)(2010-4#1)
quality factor of##4##3##(2008-3#1)(2008-4#1)(2009-5#1)(2010-4#1)
quality factor##17##2##(2007-11#2)(2007-12#5)(2008-2#1)(2008-3#3)(2008-4#1)(2009-5#1)(2010-4#1)(2012-2#1)(2013-8#2)
quality factors##2##2##(2007-8#1)(2012-12#1)
quality filters##2##2##(1992-12#1)(2008-9#1)
quality for Medicare##2##3##(1996-2#1)(2005-9#1)
quality for the##3##3##(1997-4#1)(2007-6#1)(2008-3#1)
quality for use##2##3##(2008-10#1)(2008-3#1)
quality for##20##2##(1996-2#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-9#1)(2007-1#1)(2007-10#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-6#1)(2009-3#1)(2010-4#1)(2010-8#1)(2013-1#1)
quality from##2##2##(1994-9#1)(2008-3#1)
quality goals##2##2##(1994-2#1)(1995-1#1)
quality grades##2##2##(2010-4#2)
quality habitat##2##2##(2008-5#1)(2008-9#1)
quality has become##2##3##(2008-7#1)(2009-4#1)
quality has been##3##3##(1992-11#1)(2013-1#2)
quality has##5##2##(1992-11#1)(2008-7#1)(2009-4#1)(2013-1#2)
quality have##2##2##(2008-3#1)(2008-7#1)
quality health care delivery##2##4##(2007-6#2)
quality health care services##2##4##(1994-12#1)(2008-11#1)
quality health care##12##3##(1991-1#1)(1992-1#1)(1993-12#1)(1994-12#1)(1994-3#2)(1996-3#1)(1997-3#1)(2007-6#2)(2008-11#1)(2010-11#1)
quality healthcare##3##2##(2007-12#1)(2011-12#1)(2012-12#1)
quality images##2##2##(2008-11#1)(2011-1#1)
quality implications##2##2##(2008-10#1)(2012-3#1)
quality improvement (CQI)##10##3##(1993-2#2)(1993-3#2)(1994-1#1)(1994-12#1)(1994-2#2)(1995-1#1)(1995-3#1)
quality improvement (QI)##3##3##(1994-12#1)(2007-5#1)(2013-1#1)
quality improvement activities##2##3##(1994-2#1)(1996-3#1)
quality improvement and research##2##4##(2007-7#2)
quality improvement and##12##3##(1993-12#1)(1993-3#2)(1994-3#1)(1995-3#2)(1996-2#1)(2007-7#2)(2009-3#1)(2010-11#2)
quality improvement at##2##3##(1993-3#1)(2010-6#1)
quality improvement efforts##10##3##(1992-12#1)(1994-12#1)(1995-1#1)(1995-12#3)(1995-3#1)(1997-1#1)(2012-3#1)(2013-1#1)
quality improvement in health care##2##5##(1994-1#1)(1995-12#1)
quality improvement in the##5##4##(1993-3#2)(1994-2#1)(1995-12#1)(1996-9#1)
quality improvement in##19##3##(1993-2#1)(1993-3#2)(1994-1#1)(1994-2#1)(1995-1#1)(1995-12#3)(1996-1#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-1#1)(2006-3#1)(2007-5#1)(2009-2#1)(2009-8#1)(2011-12#1)
quality improvement indicators##3##3##(1995-12#2)(1996-1#1)
quality improvement initiative##10##3##(1994-2#1)(1995-1#1)(2008-3#2)(2009-8#2)(2010-8#1)(2013-1#3)
quality improvement initiatives##4##3##(1995-3#1)(1997-1#1)(2009-6#1)(2010-8#1)
quality improvement methods and##3##4##(1994-12#1)(1995-3#2)
quality improvement methods##4##3##(1994-12#2)(1995-3#2)
quality improvement of##3##3##(1993-12#1)(1997-8#1)(2008-1#1)
quality improvement paradigm##2##3##(1996-2#2)
quality improvement process##4##3##(1993-2#1)(1995-2#2)(1996-3#1)
quality improvement program##2##3##(1992-3#1)(1993-12#1)
quality improvement programs##3##3##(1995-12#1)(1996-12#1)(2012-2#1)
quality improvement project models##2##4##(1993-12#2)
quality improvement project##4##3##(1993-12#2)(1993-3#1)(2013-1#1)
quality improvement strategies##3##3##(1994-3#1)(2008-7#1)(2013-1#1)
quality improvement team##3##3##(1993-12#2)(1994-12#1)
quality improvement teams##5##3##(1993-12#3)(1994-1#1)(2008-4#1)
quality improvement to manage##2##4##(1994-3#1)(1995-12#1)
quality improvement to##3##3##(1994-3#1)(1995-12#1)(1995-3#1)
quality improvement tool##4##3##(1994-3#1)(1997-1#3)
quality improvement tools##2##3##(1993-2#1)(1994-1#1)
quality improvement using##2##3##(1995-3#1)(2012-2#1)
quality improvement will##2##3##(1996-9#2)
quality improvement##198##2##(1992-12#2)(1992-3#1)(1993-12#14)(1993-2#8)(1993-3#14)(1994-1#8)(1994-12#10)(1994-2#8)(1994-3#9)(1995-1#7)(1995-12#11)(1995-2#6)(1995-3#11)(1995-6#1)(1996-1#4)(1996-11#1)(1996-12#4)(1996-2#6)(1996-3#7)(1996-9#3)(1997-1#11)(1997-2#4)(1997-3#2)(1997-8#1)(2006-3#1)(2007-4#2)(2007-5#2)(2007-7#3)(2008-1#3)(2008-3#3)(2008-4#2)(2008-7#1)(2009-2#1)(2009-3#4)(2009-6#1)(2009-8#3)(2010-11#2)(2010-6#1)(2010-8#3)(2011-12#1)(2012-2#2)(2012-3#2)(2013-1#8)
quality improvements and##2##3##(1997-2#1)(2006-11#1)
quality improvements##4##2##(1996-12#1)(1997-2#1)(2006-11#1)(2011-1#1)
quality in a##4##3##(1993-12#1)(2007-11#1)(2009-12#1)(2011-2#1)
quality in an##2##3##(2008-9#1)(2010-9#1)
quality in health care##3##4##(1995-3#1)(1996-1#1)(1996-2#1)
quality in health##7##3##(1995-1#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(2006-5#1)(2011-12#1)
quality in healthcare##3##3##(2008-8#1)(2011-12#1)(2013-8#1)
quality in qualitative research##2##4##(2008-11#2)
quality in terms of##2##4##(1995-2#1)(2008-3#1)
quality in the##11##3##(1992-11#1)(1992-2#1)(1994-12#1)(1995-12#1)(1996-2#1)(1996-9#1)(2007-10#1)(2008-10#1)(2008-2#1)(2009-10#1)(2010-4#1)
quality in##90##2##(1992-11#2)(1992-2#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#3)(1996-12#1)(1996-2#3)(1996-3#1)(1996-9#1)(1997-2#1)(2004-9#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#5)(2008-2#4)(2008-3#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#2)(2010-10#1)(2010-2#2)(2010-4#4)(2010-9#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
quality indicator development##2##3##(2009-4#2)
quality indicator##6##2##(1993-12#1)(2009-4#2)(2010-4#1)(2013-1#2)
quality indicators (QIs)##2##3##(1996-2#2)
quality indicators and##2##3##(1997-3#1)(2008-11#1)
quality indicators are##2##3##(2011-12#1)(2013-8#1)
quality indicators for##3##3##(1996-2#1)(2008-7#1)(2013-8#1)
quality indicators in##4##3##(2010-12#2)(2011-12#1)(2013-8#1)
quality indicators is##2##3##(2008-7#1)(2013-8#1)
quality indicators##36##2##(1995-9#1)(1996-2#4)(1996-9#1)(1997-3#4)(2006-10#1)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#3)(2009-4#1)(2009-8#1)(2010-12#2)(2010-6#2)(2011-1#1)(2011-12#5)(2012-2#1)(2013-8#4)
quality indices##2##2##(2008-11#1)(2012-2#1)
quality information##7##2##(1993-2#1)(1994-2#2)(1997-3#2)(2008-11#1)(2008-8#1)
quality initiative##7##2##(1994-12#2)(1995-3#1)(2013-1#4)
quality initiatives##3##2##(1995-1#1)(1995-12#1)(2011-1#1)
quality is directly##2##3##(2008-3#1)(2011-2#1)
quality is improved##2##3##(2008-10#1)(2008-3#1)
quality is needed##2##3##(1993-3#1)(2007-8#1)
quality is not##2##3##(2007-7#1)(2008-4#1)
quality is##41##2##(1991-3#1)(1991-6#1)(1993-3#2)(1995-2#1)(1996-3#1)(1997-3#1)(2006-5#1)(2006-8#1)(2007-11#4)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#1)(2010-4#2)(2011-1#1)(2011-2#3)(2013-8#1)
quality issues and##3##3##(1994-2#2)(2009-6#1)
quality issues##6##2##(1994-2#2)(2007-8#1)(2008-11#1)(2008-4#1)(2009-6#1)
quality leadership##2##2##(1993-12#1)(2007-5#1)
quality levels##2##2##(1996-3#1)(2013-1#1)
quality life##2##2##(1994-7#2)
quality management (TQM) is##2##4##(1994-2#1)(1995-3#1)
quality management (TQM)##17##3##(1993-12#1)(1993-2#1)(1993-3#3)(1994-1#1)(1994-2#4)(1995-1#2)(1995-3#4)(1996-2#1)
quality management activities##2##3##(2006-2#2)
quality management and##6##3##(1993-12#1)(1996-2#1)(1997-3#1)(2004-10#1)(2008-4#1)(2010-4#1)
quality management in##8##3##(1994-12#1)(1994-2#2)(1995-1#1)(2007-10#1)(2008-12#1)(2008-3#1)(2010-4#1)
quality management of##2##3##(1993-12#1)(2013-1#1)
quality management process##4##3##(1992-2#1)(1994-1#1)(1994-2#2)
quality management program##2##3##(1993-3#1)(1995-3#1)
quality management programs##4##3##(1994-2#1)(1995-3#1)(1996-1#1)(2013-1#1)
quality management system##5##3##(2007-8#2)(2010-9#1)(2012-11#1)(2013-1#1)
quality management systems##2##3##(2010-4#1)(2013-1#1)
quality management techniques##2##3##(1995-1#1)(1996-3#1)
quality management to improve##2##4##(1993-3#1)(1994-1#1)
quality management##112##2##(1992-12#2)(1992-2#1)(1993-12#3)(1993-2#2)(1993-3#7)(1994-1#12)(1994-12#2)(1994-2#13)(1994-3#2)(1995-1#6)(1995-12#4)(1995-3#12)(1996-1#2)(1996-12#1)(1996-2#3)(1996-3#2)(1997-2#1)(1997-3#2)(2004-10#2)(2006-2#6)(2007-10#1)(2007-8#2)(2008-1#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-4#5)(2010-9#2)(2012-11#1)(2013-1#5)(2013-8#1)
quality map##3##2##(2007-10#1)(2007-12#1)(2009-6#1)
quality may##2##2##(1994-3#1)(2008-10#1)
quality measure##3##2##(1991-3#1)(2007-8#1)(2012-2#1)
quality measurement##11##2##(1994-3#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#2)(2008-11#1)(2008-4#1)(2008-7#1)(2013-1#2)
quality measurements##2##2##(1995-2#1)(2010-4#1)
quality measures for##3##3##(1996-2#1)(2007-5#1)(2010-9#1)
quality measures##16##2##(1994-3#1)(1996-2#2)(1997-2#2)(2007-4#1)(2007-5#1)(2007-9#2)(2008-2#1)(2008-3#1)(2010-9#1)(2013-1#4)
quality medical care##4##3##(1991-2#1)(2007-4#1)(2007-7#1)(2009-6#1)
quality medical##5##2##(1991-2#1)(2007-4#1)(2007-7#1)(2009-3#1)(2009-6#1)
quality metric##2##2##(2008-2#1)(2008-5#1)
quality model##3##2##(1996-3#1)(1996-6#1)(2008-11#1)
quality monitoring##7##2##(1992-9#1)(2008-10#4)(2008-7#1)(2012-3#1)
quality movement##2##2##(1992-11#1)(1996-2#1)
quality need##2##2##(1996-12#1)(2007-5#1)
quality network##2##2##(2007-4#1)(2011-2#1)
quality nursing care##2##3##(1991-2#1)(1995-3#1)
quality nursing##3##2##(1991-2#1)(1995-3#1)(2008-11#1)
quality of Docetaxel injection##2##4##(2010-12#2)
quality of Veterinary Services##2##4##(2005-5#2)
quality of a##14##3##(2005-5#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#5)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)
quality of all##2##3##(2008-10#1)(2013-1#1)
quality of ambulance##2##3##(1993-5#2)
quality of analgesia##2##3##(1993-4#1)(2007-2#1)
quality of anastomosis##2##3##(2006-10#1)(2007-8#1)
quality of articles##2##3##(1996-11#1)(2009-5#1)
quality of attention##3##3##(2008-10#3)
quality of cancer##2##3##(2011-2#1)(2012-3#1)
quality of care among##2##4##(2012-2#1)(2012-3#1)
quality of care and QoL##2##5##(2007-5#2)
quality of care and##17##4##(1990-12#1)(1992-3#1)(1993-12#1)(1994-3#1)(1994-5#1)(1995-12#1)(1996-2#3)(1996-3#1)(2007-5#3)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)
quality of care as##2##4##(1991-1#1)(2008-11#1)
quality of care at##2##4##(1997-2#1)(2007-7#1)
quality of care delivered to##3##5##(1995-2#1)(1997-1#1)(2006-2#1)
quality of care delivered##4##4##(1995-2#1)(1997-1#1)(2006-2#1)(2008-7#1)
quality of care delivery##3##4##(2013-1#3)
quality of care for##3##4##(1996-12#1)(1997-2#1)(2008-3#1)
quality of care in acute##2##5##(1995-9#1)(2008-3#1)
quality of care in radiology##2##5##(2007-4#2)
quality of care in the##2##5##(1997-3#1)(2008-11#1)
quality of care in these##2##5##(1992-3#1)(1997-1#1)
quality of care in##18##4##(1992-3#1)(1994-12#1)(1995-12#1)(1995-9#1)(1996-2#3)(1997-1#1)(1997-3#1)(2007-4#2)(2007-5#1)(2008-11#1)(2008-3#1)(2012-2#2)(2012-3#2)
quality of care indicators for##2##5##(2008-6#1)(2009-4#1)
quality of care indicators##4##4##(2008-6#1)(2009-4#1)(2012-2#1)(2012-3#1)
quality of care is##7##4##(1996-12#1)(1996-3#1)(2006-10#1)(2006-8#1)(2007-4#1)(2012-2#2)
quality of care of patients with##3##6##(2007-7#1)(2008-1#1)(2008-3#1)
quality of care of##5##4##(1991-6#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-3#1)
quality of care provided##5##4##(1996-2#1)(2008-11#1)(2008-12#1)(2008-3#1)(2012-12#1)
quality of care to##2##4##(1996-1#1)(2010-10#1)
quality of care under##3##4##(1992-2#1)(1996-2#2)
quality of care while##2##4##(1996-3#1)(2011-1#1)
quality of care##171##3##(1990-12#2)(1990-6#1)(1991-1#3)(1991-12#2)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#3)(1993-1#2)(1993-12#2)(1993-3#2)(1993-6#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-1#1)(1995-12#3)(1995-2#3)(1995-3#3)(1995-9#2)(1996-1#6)(1996-12#6)(1996-2#13)(1996-3#5)(1996-9#1)(1997-1#5)(1997-2#6)(1997-3#4)(1997-8#1)(2006-10#3)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#3)(2007-10#1)(2007-3#1)(2007-4#4)(2007-5#4)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#1)(2008-11#6)(2008-12#2)(2008-3#8)(2008-6#1)(2008-7#3)(2008-8#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#10)(2012-3#5)(2013-1#6)(2013-8#1)
quality of care]##2##3##(1996-12#1)(2008-10#1)
quality of clinical##9##3##(1992-2#1)(1995-9#1)(1997-6#1)(2007-10#1)(2007-8#1)(2010-3#1)(2010-4#1)(2013-1#2)
quality of communication##4##3##(2007-3#1)(2010-4#1)(2011-2#1)(2013-1#1)
quality of data##13##3##(1990-10#1)(1994-2#1)(1995-8#1)(2006-6#2)(2009-10#1)(2009-11#1)(2009-4#1)(2010-2#1)(2012-12#2)(2013-1#2)
quality of dental hygiene##2##4##(2006-2#2)
quality of drinking water##4##4##(2009-7#1)(2011-2#1)(2013-8#2)
quality of food products##2##4##(2008-10#1)(2008-7#1)
quality of food##6##3##(2006-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-12#1)
quality of ground water##2##4##(2007-10#1)(2008-1#1)
quality of ground##3##3##(2007-10#1)(2007-3#1)(2008-1#1)
quality of health and##2##4##(2007-12#1)(2008-7#1)
quality of health care in##2##5##(1997-4#1)(2008-1#1)
quality of health care##16##4##(1990-12#1)(1991-12#1)(1991-6#1)(1993-12#1)(1993-2#1)(1994-3#1)(1996-2#2)(1996-3#1)(1997-3#1)(1997-4#1)(2006-8#1)(2007-1#1)(2008-1#1)(2008-7#1)(2010-1#1)
quality of health services##4##4##(1993-6#1)(1997-1#1)(2008-11#1)(2012-3#1)
quality of health##26##3##(1990-12#1)(1991-12#1)(1991-6#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-3#1)(1995-11#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(2006-8#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-7#2)(2010-1#1)(2010-2#1)(2012-3#1)(2013-8#1)
quality of healthcare##3##3##(2008-1#1)(2013-1#2)
quality of home-made##2##3##(1991-9#2)
quality of hospital care##5##4##(1990-12#1)(1990-7#1)(1992-3#1)(1994-3#1)(2006-2#1)
quality of hospital##7##3##(1990-12#1)(1990-7#1)(1991-12#1)(1991-3#1)(1992-3#1)(1994-3#1)(2006-2#1)
quality of images obtained##2##4##(2008-5#1)(2008-7#1)
quality of its##2##3##(1994-12#1)(2008-10#1)
quality of laparoscopic##2##3##(2006-6#1)(2011-2#1)
quality of life (HRQL) is##2##5##(2006-10#1)(2007-11#1)
quality of life (HRQL)##7##4##(2005-9#1)(2006-10#2)(2006-5#1)(2007-11#1)(2008-1#1)(2012-12#1)
quality of life (HRQOL)##4##4##(2007-7#1)(2008-7#1)(2009-7#1)(2011-1#1)
quality of life (HRQoL)##5##4##(2006-10#1)(2006-2#1)(2007-6#1)(2010-12#1)(2013-1#1)
quality of life (OR##2##4##(2012-1#1)(2012-12#1)
quality of life (QOL) and##2##5##(1995-10#1)(2004-3#1)
quality of life (QOL) in##5##5##(1994-12#1)(1995-4#1)(2008-5#1)(2011-12#1)(2011-2#1)
quality of life (QOL)##27##4##(1994-12#1)(1995-10#1)(1995-2#1)(1995-4#1)(2004-3#1)(2005-3#1)(2006-11#2)(2006-12#1)(2006-2#1)(2006-9#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-7#3)(2010-12#1)(2010-4#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-2#2)
quality of life (QoL) for##2##5##(2008-6#1)(2013-8#1)
quality of life (QoL) in##2##5##(2012-1#1)(2013-1#1)
quality of life (QoL) is##2##5##(2007-5#1)(2010-8#1)
quality of life (QoL)##16##4##(2004-1#1)(2007-5#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#2)
quality of life after surgery##2##5##(1995-8#1)(2007-8#1)
quality of life after##7##4##(1994-6#1)(1995-8#1)(2007-7#1)(2007-8#1)(2008-5#1)(2009-10#1)(2012-12#1)
quality of life among breast cancer##2##6##(2008-7#1)(2009-2#1)
quality of life among##8##4##(2006-10#1)(2008-7#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-5#1)(2011-12#1)(2011-2#1)
quality of life and ability to##2##6##(1992-5#1)(2008-6#1)
quality of life and also##2##5##(2006-9#1)(2008-3#1)
quality of life and better##2##5##(2007-7#1)(2011-2#1)
quality of life and cost##2##5##(2007-7#1)(2008-7#1)
quality of life and exercise tolerance##2##6##(2007-11#1)(2010-5#1)
quality of life and function##3##5##(2008-3#1)(2009-7#1)(2010-3#1)
quality of life and health##3##5##(1991-12#1)(2009-5#1)(2011-1#1)
quality of life and is##2##5##(2011-12#1)(2013-8#1)
quality of life and reduce the##2##6##(2010-11#1)(2011-2#1)
quality of life and results##3##5##(2006-6#1)(2009-3#1)(2011-12#1)
quality of life and social##2##5##(1992-1#1)(2011-2#1)
quality of life and survival for##3##6##(2006-10#1)(2010-12#1)(2011-2#1)
quality of life and survival##5##5##(2006-10#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#1)
quality of life and the##4##5##(2007-11#1)(2009-12#1)(2012-12#1)(2013-8#1)
quality of life and to##3##5##(2006-2#1)(2010-1#1)(2010-12#1)
quality of life and treatment##2##5##(1995-2#1)(2013-1#1)
quality of life and##91##4##(1991-12#1)(1991-5#1)(1992-1#1)(1992-5#1)(1994-11#1)(1995-2#1)(1995-8#1)(1996-6#1)(1996-9#1)(1997-4#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-6#1)(2006-9#2)(2007-11#4)(2007-12#2)(2007-4#1)(2007-7#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#4)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#2)(2011-1#2)(2011-12#3)(2011-2#8)(2012-1#2)(2012-12#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#2)
quality of life as well as##2##6##(1996-12#1)(2010-12#1)
quality of life as##6##4##(1996-12#1)(2005-10#1)(2005-9#1)(2008-6#1)(2008-7#1)(2010-12#1)
quality of life aspect##2##4##(1997-5#1)(2012-2#1)
quality of life assessment in##2##5##(1994-2#1)(2008-6#1)
quality of life at##2##4##(2006-8#1)(2008-1#1)
quality of life by##3##4##(2007-7#1)(2008-5#2)
quality of life compared with##2##5##(2010-12#1)(2012-12#1)
quality of life compared##3##4##(2010-12#1)(2012-12#1)(2013-1#1)
quality of life data in##2##5##(1996-12#2)
quality of life data##5##4##(1996-12#3)(2004-1#1)(2008-7#1)
quality of life despite##2##4##(1996-3#1)(2006-4#1)
quality of life due to##2##5##(2011-2#1)(2013-1#1)
quality of life during##3##4##(2006-7#1)(2008-9#2)
quality of life following##2##4##(2006-9#2)
quality of life for a##2##5##(2009-11#1)(2010-12#1)
quality of life for both##2##5##(2007-9#1)(2008-5#1)
quality of life for individuals with##2##6##(2008-11#2)
quality of life for many##4##5##(1990-4#1)(2010-8#1)(2012-1#1)(2012-12#1)
quality of life for patients and their families##3##8##(2010-7#2)(2012-3#1)
quality of life for patients and their##4##7##(2010-12#1)(2010-7#2)(2012-3#1)
quality of life for patients with##3##6##(2007-12#1)(2008-7#1)(2011-1#1)
quality of life for patients##7##5##(2007-12#1)(2008-7#1)(2010-12#1)(2010-7#2)(2011-1#1)(2012-3#1)
quality of life for the patient##3##6##(1991-7#1)(1992-5#1)(2010-5#1)
quality of life for the##4##5##(1991-7#1)(1992-5#1)(1995-1#1)(2010-5#1)
quality of life for##35##4##(1990-4#1)(1991-7#1)(1992-5#1)(1994-5#1)(1995-1#1)(1995-12#1)(2005-10#1)(2006-2#2)(2006-7#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-11#3)(2008-5#1)(2008-7#2)(2009-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#3)(2012-1#2)(2012-12#2)(2012-3#1)
quality of life has##2##4##(2008-7#1)(2009-11#1)
quality of life if##2##4##(2005-1#1)(2012-2#1)
quality of life improvement##3##4##(2006-8#2)(2012-2#1)
quality of life in Bulgaria##3##5##(2013-1#3)
quality of life in cancer##3##5##(1992-6#1)(2011-2#1)(2012-1#1)
quality of life in children with##4##6##(2008-7#1)(2009-3#1)(2012-2#2)
quality of life in children##5##5##(2007-7#1)(2008-7#1)(2009-3#1)(2012-2#2)
quality of life in elderly##2##5##(2008-7#1)(2013-1#1)
quality of life in multiple sclerosis##2##6##(2009-11#1)(2012-12#1)
quality of life in old##3##5##(1992-11#1)(1995-10#2)
quality of life in patients with chronic##2##7##(2008-4#1)(2011-2#1)
quality of life in patients with type 2 diabetes mellitus##2##10##(2012-1#1)(2013-8#1)
quality of life in patients with##21##6##(2005-6#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2009-7#2)(2009-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#3)
quality of life in patients##23##5##(1991-6#1)(2005-6#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-11#1)(2008-12#1)(2008-4#1)(2008-7#3)(2009-7#2)(2009-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#3)
quality of life in the##8##5##(1993-6#1)(2006-10#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#2)(2012-2#1)
quality of life in these patients##3##6##(1990-2#1)(1991-6#1)(2006-10#1)
quality of life in these##4##5##(1990-2#1)(1991-6#1)(2006-10#1)(2009-4#1)
quality of life in this##2##5##(2006-10#1)(2007-11#1)
quality of life in women##2##5##(2011-1#2)
quality of life in##97##4##(1990-2#1)(1991-6#2)(1992-11#1)(1992-6#1)(1993-11#1)(1993-6#1)(1995-10#2)(1995-12#1)(1996-9#1)(1997-4#1)(2005-6#1)(2005-9#1)(2006-10#5)(2006-12#2)(2006-2#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-11#4)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-4#2)(2008-6#2)(2008-7#7)(2009-11#2)(2009-3#1)(2009-4#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-11#2)(2010-6#1)(2011-1#6)(2011-12#1)(2011-2#9)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#7)(2013-8#3)
quality of life instrument##2##4##(2008-7#1)(2011-2#1)
quality of life is important##3##5##(2006-2#1)(2007-7#1)(2010-7#1)
quality of life is##11##4##(1996-11#1)(1996-9#1)(2006-1#1)(2006-10#1)(2006-2#1)(2007-7#2)(2007-8#1)(2010-7#1)(2011-2#1)(2013-1#1)
quality of life issues##3##4##(2006-2#1)(2006-7#1)(2008-3#1)
quality of life measure##2##4##(2008-2#1)(2008-7#1)
quality of life measures##2##4##(1992-10#1)(2008-3#1)
quality of life of elderly##2##5##(1992-12#1)(2006-7#1)
quality of life of older patients##2##6##(1995-10#1)(2008-7#1)
quality of life of patients with##6##6##(2006-11#1)(2008-5#1)(2008-7#1)(2009-1#1)(2010-12#1)(2011-2#1)
quality of life of patients##12##5##(1996-2#1)(2006-10#1)(2006-11#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-1#1)(2010-12#2)(2011-2#1)
quality of life of people##2##5##(1997-4#1)(2010-10#1)
quality of life of the patient##5##6##(1993-11#1)(2006-6#1)(2008-5#1)(2011-3#1)(2012-3#1)
quality of life of the patients##6##6##(1990-9#1)(2006-6#1)(2007-11#2)(2010-7#1)(2013-1#1)
quality of life of the##18##5##(1990-9#1)(1993-11#1)(1994-4#1)(2006-6#2)(2007-11#3)(2007-7#1)(2008-5#1)(2010-1#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
quality of life of these patients##3##6##(1990-10#1)(2007-11#1)(2009-9#1)
quality of life of these##5##5##(1990-10#1)(2006-1#1)(2007-11#1)(2009-9#1)(2011-2#1)
quality of life of##69##4##(1990-10#2)(1990-9#1)(1991-6#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-3#1)(1994-4#1)(1995-10#1)(1996-2#1)(1997-4#1)(2005-3#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-6#2)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#4)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#2)(2009-10#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#2)
quality of life on##2##4##(2008-6#1)(2013-8#1)
quality of life outcomes##2##4##(2007-11#1)(2009-12#1)
quality of life over the##2##5##(2007-9#1)(2009-12#1)
quality of life questionnaire##2##4##(2011-1#1)(2011-2#1)
quality of life score##2##4##(2011-1#2)
quality of life than##5##4##(1991-2#1)(2008-6#2)(2011-2#1)(2013-1#1)
quality of life through the##2##5##(2006-9#1)(2010-7#1)
quality of life through##6##4##(2006-9#1)(2007-11#1)(2009-4#1)(2010-7#1)(2012-3#1)(2013-8#1)
quality of life throughout##2##4##(2005-4#1)(2008-9#1)
quality of life to##4##4##(1992-10#1)(2006-10#1)(2009-12#1)(2011-2#1)
quality of life using##2##4##(2007-3#1)(2010-3#1)
quality of life was also##2##5##(2007-12#1)(2009-10#1)
quality of life was##12##4##(1992-10#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2008-7#2)(2009-10#1)(2009-12#1)(2009-7#1)(2011-2#1)
quality of life were##6##4##(2005-4#1)(2006-10#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-1#1)
quality of life when##2##4##(2006-10#1)(2010-12#1)
quality of life will##2##4##(2006-12#1)(2006-7#1)
quality of life with##3##4##(1995-3#1)(2007-11#1)(2009-6#1)
quality of life##817##3##(1990-1#1)(1990-10#3)(1990-12#3)(1990-2#1)(1990-4#2)(1990-9#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#4)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#3)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#1)(1992-8#1)(1993-10#1)(1993-11#4)(1993-3#1)(1993-5#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#2)(1995-1#1)(1995-10#5)(1995-12#2)(1995-2#3)(1995-3#2)(1995-4#2)(1995-5#1)(1995-8#4)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#4)(1996-3#3)(1996-4#1)(1996-6#1)(1996-7#2)(1996-9#5)(1997-1#4)(1997-3#3)(1997-4#4)(1997-5#1)(1997-8#3)(2004-1#5)(2004-10#1)(2004-3#2)(2005-1#1)(2005-10#7)(2005-11#2)(2005-3#2)(2005-4#2)(2005-6#1)(2005-8#1)(2005-9#4)(2006-1#6)(2006-10#34)(2006-11#4)(2006-12#6)(2006-2#12)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#6)(2006-7#7)(2006-8#9)(2006-9#13)(2007-1#2)(2007-10#3)(2007-11#35)(2007-12#8)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#3)(2007-7#20)(2007-8#15)(2007-9#3)(2008-1#11)(2008-10#8)(2008-11#8)(2008-12#5)(2008-2#3)(2008-3#10)(2008-4#12)(2008-5#16)(2008-6#17)(2008-7#52)(2008-8#4)(2008-9#6)(2009-1#2)(2009-10#6)(2009-11#9)(2009-12#13)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#4)(2009-6#3)(2009-7#8)(2009-8#3)(2009-9#5)(2010-1#2)(2010-10#5)(2010-11#6)(2010-12#19)(2010-3#5)(2010-4#2)(2010-5#4)(2010-6#2)(2010-7#5)(2010-8#9)(2010-9#2)(2011-1#26)(2011-12#9)(2011-2#55)(2011-3#2)(2011-7#1)(2012-1#11)(2012-12#23)(2012-2#14)(2012-3#13)(2013-1#28)(2013-7#3)(2013-8#20)
quality of life)##2##3##(2010-11#1)(2010-5#1)
quality of life]##5##3##(2006-6#1)(2008-2#1)(2008-4#1)(2009-10#1)(2012-1#1)
quality of medical care##9##4##(1991-2#1)(1991-4#1)(1992-2#2)(1993-3#1)(1996-12#1)(2006-10#1)(2006-6#1)(2013-8#1)
quality of medical##12##3##(1991-2#1)(1991-4#1)(1992-2#2)(1993-3#1)(1993-5#1)(1996-12#1)(1996-3#1)(1997-5#1)(2006-10#1)(2006-6#1)(2013-8#1)
quality of middle age and older women from Primorsko-Goranska County##2##10##(2011-2#2)
quality of natural##2##3##(2005-10#1)(2008-10#1)
quality of nursing home care##2##5##(1996-2#1)(2009-3#1)
quality of nursing##7##3##(1990-2#1)(1996-2#1)(2008-12#1)(2009-3#1)(2009-8#1)(2012-12#1)(2012-3#1)
quality of obstetric care##2##4##(2011-1#2)
quality of obstetric##3##3##(1993-4#1)(2011-1#2)
quality of optical##2##3##(2008-2#2)
quality of oral health care##2##5##(2006-2#1)(2006-8#1)
quality of our##3##3##(1994-12#1)(2009-4#1)(2011-2#1)
quality of outcomes and##2##4##(1995-12#1)(2007-12#1)
quality of pain##3##3##(2006-8#1)(2009-12#1)(2012-2#1)
quality of patient care##12##4##(1991-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1997-1#1)(2005-11#1)(2006-10#1)(2006-2#1)(2008-11#2)(2009-8#1)(2012-3#1)
quality of patient##17##3##(1991-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1997-1#1)(2005-11#1)(2006-10#1)(2006-2#1)(2008-11#2)(2009-8#1)(2012-11#2)(2012-3#1)(2013-1#3)
quality of perioperative care##2##4##(2012-2#2)
quality of pharmaceutical##2##3##(2010-2#1)(2010-3#1)
quality of pork##6##3##(2010-4#6)
quality of predictions##2##3##(2008-10#1)(2008-11#1)
quality of prenatal##5##3##(1993-3#1)(1994-3#1)(1995-12#1)(1996-6#1)(2013-1#1)
quality of primary##2##3##(1996-9#1)(2011-2#1)
quality of raw##2##3##(2007-3#1)(2008-10#1)
quality of recovery##5##3##(2006-10#1)(2012-3#1)(2013-1#3)
quality of reduction##3##3##(1991-9#1)(2007-11#1)(2007-8#1)
quality of research##3##3##(2007-7#1)(2010-3#1)(2012-3#1)
quality of restoration##2##3##(2008-3#2)
quality of rice##2##3##(2008-12#1)(2008-9#1)
quality of service##13##3##(1992-12#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-2#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-8#2)(2012-3#2)(2013-1#1)
quality of services##5##3##(1992-12#1)(1997-3#1)(2007-4#1)(2012-3#1)(2013-1#1)
quality of skin##3##3##(2008-5#3)
quality of sleep##2##3##(2006-10#1)(2008-12#1)
quality of some##3##3##(1996-8#1)(2007-2#2)
quality of teaching##2##3##(1993-3#1)(2008-7#1)
quality of the X-ray image##2##5##(2008-1#1)(2013-8#1)
quality of the data##6##4##(1990-3#1)(1992-3#1)(1995-8#1)(1996-11#1)(2008-3#1)(2013-1#1)
quality of the final##2##4##(2008-11#1)(2012-12#1)
quality of the individual##3##4##(2006-4#1)(2008-10#1)(2008-3#1)
quality of the laser##2##4##(2007-12#1)(2008-3#1)
quality of the medical##2##4##(1991-6#1)(1994-3#1)
quality of the muscles##2##4##(2010-4#2)
quality of the products##2##4##(2008-10#1)(2008-8#1)
quality of the reconstructed image##2##5##(2007-11#1)(2008-2#1)
quality of the reconstructed##3##4##(2006-5#1)(2007-11#1)(2008-2#1)
quality of the results##3##4##(2008-2#2)(2010-11#1)
quality of the service##3##4##(1993-1#1)(1996-7#1)(2012-3#1)
quality of the stump##2##4##(2007-11#2)
quality of the transmission##2##4##(2007-12#1)(2008-3#1)
quality of the trials was generally poor##2##7##(2008-10#1)(2013-8#1)
quality of the##209##3##(1990-3#3)(1990-4#1)(1991-11#1)(1991-6#3)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#1)(1993-1#1)(1993-10#1)(1994-3#2)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-8#1)(2005-7#2)(2006-4#2)(2006-5#1)(2006-6#2)(2007-1#3)(2007-10#1)(2007-11#10)(2007-12#12)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#6)(2008-1#4)(2008-10#16)(2008-11#7)(2008-12#1)(2008-2#12)(2008-3#22)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#9)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#5)(2010-7#1)(2010-8#2)(2010-9#1)(2011-12#3)(2011-2#6)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#7)(2012-3#6)(2013-1#3)(2013-8#7)
quality of their##10##3##(1992-2#1)(1993-3#1)(1997-7#1)(2008-1#1)(2008-11#2)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#1)
quality of these##5##3##(2007-12#1)(2008-1#1)(2008-3#1)(2010-3#1)(2012-2#1)
quality of this##5##3##(2006-12#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)
quality of those##2##3##(2008-10#1)(2008-2#1)
quality of tissue##2##3##(2007-12#1)(2012-2#1)
quality of total##2##3##(2007-9#1)(2008-10#1)
quality of vision##3##3##(2005-11#2)(2013-1#1)
quality of water##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#1)
quality of working life##3##4##(1992-3#1)(2008-11#2)
quality of working##4##3##(1992-3#1)(2008-11#2)(2012-3#1)
quality of##1786##2##(1990-1#2)(1990-10#4)(1990-11#1)(1990-12#8)(1990-2#2)(1990-3#3)(1990-4#4)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#3)(1991-11#4)(1991-12#9)(1991-2#2)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#9)(1991-7#2)(1991-8#1)(1991-9#7)(1992-1#2)(1992-10#4)(1992-11#1)(1992-12#4)(1992-2#8)(1992-3#8)(1992-4#3)(1992-5#4)(1992-6#1)(1992-8#1)(1993-1#4)(1993-10#2)(1993-11#4)(1993-12#6)(1993-2#5)(1993-3#9)(1993-4#2)(1993-5#6)(1993-6#3)(1993-8#1)(1994-1#3)(1994-11#2)(1994-12#5)(1994-2#4)(1994-3#10)(1994-4#1)(1994-5#2)(1994-6#4)(1995-1#3)(1995-10#5)(1995-11#2)(1995-12#7)(1995-2#9)(1995-3#7)(1995-4#3)(1995-5#2)(1995-6#1)(1995-8#7)(1995-9#6)(1996-1#11)(1996-11#4)(1996-12#14)(1996-2#25)(1996-3#11)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#3)(1996-8#3)(1996-9#8)(1997-1#11)(1997-2#7)(1997-3#10)(1997-4#7)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#5)(2004-1#5)(2004-10#1)(2004-11#1)(2004-12#1)(2004-3#2)(2005-1#1)(2005-10#8)(2005-11#5)(2005-12#1)(2005-3#2)(2005-4#2)(2005-5#6)(2005-6#1)(2005-7#2)(2005-8#2)(2005-9#4)(2006-1#7)(2006-10#48)(2006-11#4)(2006-12#8)(2006-2#19)(2006-3#1)(2006-4#6)(2006-5#6)(2006-6#16)(2006-7#9)(2006-8#15)(2006-9#13)(2007-1#8)(2007-10#9)(2007-11#51)(2007-12#35)(2007-2#7)(2007-3#5)(2007-4#10)(2007-5#7)(2007-6#3)(2007-7#28)(2007-8#36)(2007-9#4)(2008-1#29)(2008-10#57)(2008-11#41)(2008-12#15)(2008-2#30)(2008-3#57)(2008-4#13)(2008-5#31)(2008-6#27)(2008-7#70)(2008-8#19)(2008-9#14)(2009-1#2)(2009-10#9)(2009-11#12)(2009-12#17)(2009-2#2)(2009-3#4)(2009-4#8)(2009-5#6)(2009-6#5)(2009-7#10)(2009-8#6)(2009-9#11)(2010-1#5)(2010-10#8)(2010-11#11)(2010-12#27)(2010-2#6)(2010-3#10)(2010-4#28)(2010-5#7)(2010-6#3)(2010-7#6)(2010-8#17)(2010-9#5)(2011-1#42)(2011-12#13)(2011-2#88)(2011-3#2)(2011-7#1)(2012-1#16)(2012-11#6)(2012-12#35)(2012-2#40)(2012-3#40)(2013-1#70)(2013-7#6)(2013-8#42)
quality oflife##2##2##(2013-8#2)
quality on a##3##3##(1993-2#1)(1995-12#1)(2008-9#1)
quality on the##2##3##(2008-3#1)(2009-11#1)
quality on##10##2##(1990-6#1)(1993-2#1)(1995-12#1)(2004-9#1)(2008-11#1)(2008-3#1)(2008-9#2)(2009-11#1)(2010-3#1)
quality or##5##2##(1990-6#1)(1992-12#1)(1994-3#1)(1997-1#1)(2012-1#1)
quality organs##2##2##(2007-8#2)
quality orientation##3##2##(1997-3#3)
quality outcomes##2##2##(1996-2#2)
quality oversight##3##2##(1996-2#2)(2006-5#1)
quality parameters and##2##3##(2008-10#2)
quality parameters of beers##2##4##(2008-10#2)
quality parameters of##5##3##(2006-5#1)(2008-10#3)(2010-4#1)
quality parameters were##2##3##(2007-10#1)(2010-4#1)
quality parameters##20##2##(1996-8#1)(2006-5#1)(2007-10#2)(2008-10#7)(2010-2#4)(2010-4#2)(2010-7#1)(2011-12#1)(2013-1#1)
quality patient care in the##2##5##(1997-2#1)(2007-4#1)
quality patient care##11##3##(1991-12#1)(1994-1#1)(1994-3#1)(1995-3#1)(1996-12#1)(1997-1#1)(1997-2#1)(2006-1#1)(2007-4#2)(2008-3#1)
quality performance##3##2##(2007-5#1)(2008-10#1)(2008-11#1)
quality planning in##2##3##(2011-1#2)
quality planning##9##2##(1993-12#4)(1994-2#3)(2011-1#2)
quality possible##2##2##(1994-2#1)(1996-3#1)
quality problems##2##2##(1992-11#1)(2004-9#1)
quality process##3##2##(1993-3#1)(1994-1#1)(1995-1#1)
quality protein maize (QPM)##2##4##(2006-4#1)(2012-2#1)
quality protein##3##2##(1991-12#1)(2006-4#1)(2012-2#1)
quality requirements##5##2##(1990-12#1)(1995-5#1)(2007-8#1)(2008-11#1)(2012-2#1)
quality research##2##2##(2007-2#1)(2013-7#1)
quality revealed##3##2##(2008-12#1)(2010-11#1)(2011-2#1)
quality review##2##2##(1993-2#1)(1996-2#1)
quality scores for##2##3##(2012-1#1)(2012-3#1)
quality scores##7##2##(2008-12#1)(2012-1#1)(2012-2#1)(2012-3#4)
quality service##5##2##(1994-3#1)(1995-2#1)(1996-3#1)(2008-7#1)(2011-2#1)
quality services##4##2##(1993-12#1)(1995-12#1)(1997-2#1)(2008-2#1)
quality should be##5##3##(1994-2#1)(1995-3#1)(1996-2#1)(1997-2#1)(2013-1#1)
quality showed##2##2##(2007-10#1)(2007-5#1)
quality standard of##3##3##(2009-3#1)(2011-1#1)(2012-3#1)
quality standard##5##2##(1991-3#1)(2008-7#1)(2009-3#1)(2011-1#1)(2012-3#1)
quality standards of##2##3##(2006-5#1)(2008-10#1)
quality standards##9##2##(1992-11#1)(2006-11#1)(2006-5#1)(2008-10#1)(2008-3#1)(2009-4#1)(2009-6#1)(2011-1#1)(2013-1#1)
quality studies were##2##3##(2008-11#1)(2013-1#1)
quality studies##6##2##(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2013-1#1)
quality systems and##2##3##(2008-11#1)(2013-1#1)
quality systems##5##2##(2005-5#3)(2008-11#1)(2013-1#1)
quality teams##2##2##(1994-3#1)(1996-3#1)
quality techniques##2##2##(2008-3#1)(2010-12#1)
quality than##5##2##(2006-5#1)(2008-2#2)(2008-5#1)(2011-1#1)
quality that is##4##3##(1992-1#1)(2007-11#1)(2008-1#1)(2008-2#1)
quality that##10##2##(1992-1#1)(1993-12#1)(1997-6#1)(2005-5#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#2)(2011-12#1)
quality through##2##2##(2008-11#1)(2010-4#1)
quality to be##3##3##(2007-8#1)(2010-9#1)(2012-2#1)
quality to that##2##3##(1994-3#1)(2010-8#1)
quality to##13##2##(1994-3#1)(1994-8#1)(1995-2#1)(2007-3#1)(2007-8#1)(2008-10#1)(2009-4#1)(2010-12#1)(2010-8#1)(2010-9#1)(2012-12#2)(2012-2#1)
quality traits##10##2##(2010-4#9)(2012-2#1)
quality treatment##4##2##(1993-6#1)(1994-12#1)(2007-12#1)(2009-6#1)
quality using the##2##3##(2011-2#1)(2012-1#1)
quality using##5##2##(2004-9#1)(2007-8#1)(2008-3#1)(2011-2#1)(2012-1#1)
quality varied##2##2##(1993-12#1)(2010-4#1)
quality via##2##2##(2008-10#1)(2010-9#1)
quality was also##2##3##(1996-9#1)(1997-8#1)
quality was assessed using##2##4##(2008-10#1)(2013-1#1)
quality was assessed##4##3##(2007-12#1)(2008-10#1)(2011-2#1)(2013-1#1)
quality was evaluated##2##3##(2012-12#1)(2012-3#1)
quality was found##2##3##(2008-2#1)(2008-5#1)
quality was investigated using##2##4##(2007-12#1)(2010-4#1)
quality was not##3##3##(1995-9#1)(2007-5#1)(2008-1#1)
quality was##27##2##(1995-9#1)(1996-3#1)(1996-9#1)(1997-8#1)(2005-11#1)(2007-10#1)(2007-12#3)(2007-3#1)(2007-5#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-4#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
quality water##3##2##(2011-2#2)(2012-1#1)
quality were##13##2##(1995-3#1)(2008-10#4)(2008-12#1)(2008-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
quality when##5##2##(2008-2#3)(2008-3#1)(2010-4#1)
quality while##3##2##(1996-2#1)(2008-10#1)(2008-2#1)
quality will be##2##3##(1994-3#1)(2009-7#1)
quality will##3##2##(1994-3#1)(2008-8#1)(2009-7#1)
quality with##11##2##(1991-12#1)(1995-2#1)(1997-3#1)(2008-1#1)(2008-12#1)(2008-3#1)(2009-10#1)(2009-6#1)(2010-4#1)(2011-2#2)
quality work##5##2##(1995-1#1)(2008-11#1)(2012-12#1)(2012-3#2)
quality##4427##1##(1990-1#4)(1990-10#8)(1990-11#1)(1990-12#14)(1990-2#3)(1990-3#4)(1990-4#4)(1990-5#2)(1990-6#3)(1990-7#1)(1990-9#2)(1991-1#9)(1991-11#6)(1991-12#18)(1991-2#9)(1991-3#14)(1991-4#2)(1991-5#1)(1991-6#11)(1991-7#2)(1991-8#2)(1991-9#9)(1992-1#6)(1992-10#7)(1992-11#14)(1992-12#20)(1992-2#22)(1992-3#18)(1992-4#5)(1992-5#5)(1992-6#1)(1992-8#1)(1992-9#10)(1993-1#13)(1993-10#3)(1993-11#6)(1993-12#49)(1993-2#28)(1993-3#54)(1993-4#2)(1993-5#10)(1993-6#6)(1993-8#3)(1993-9#1)(1994-1#38)(1994-11#3)(1994-12#33)(1994-2#54)(1994-3#49)(1994-4#3)(1994-5#5)(1994-6#7)(1994-7#3)(1994-8#3)(1994-9#3)(1995-1#44)(1995-10#5)(1995-11#2)(1995-12#39)(1995-2#34)(1995-3#57)(1995-4#4)(1995-5#7)(1995-6#4)(1995-8#8)(1995-9#11)(1996-1#30)(1996-11#6)(1996-12#37)(1996-2#72)(1996-3#47)(1996-4#1)(1996-5#2)(1996-6#8)(1996-7#5)(1996-8#9)(1996-9#18)(1997-1#38)(1997-2#29)(1997-3#40)(1997-4#9)(1997-5#7)(1997-6#5)(1997-7#1)(1997-8#11)(2004-1#5)(2004-10#4)(2004-11#1)(2004-12#3)(2004-2#2)(2004-3#2)(2004-9#14)(2005-1#2)(2005-10#10)(2005-11#10)(2005-12#4)(2005-3#2)(2005-4#4)(2005-5#25)(2005-6#1)(2005-7#7)(2005-8#8)(2005-9#7)(2006-1#10)(2006-10#67)(2006-11#11)(2006-12#16)(2006-2#39)(2006-3#2)(2006-4#14)(2006-5#19)(2006-6#18)(2006-7#9)(2006-8#18)(2006-9#13)(2007-1#13)(2007-10#28)(2007-11#85)(2007-12#85)(2007-2#16)(2007-3#11)(2007-4#42)(2007-5#35)(2007-6#8)(2007-7#40)(2007-8#85)(2007-9#14)(2008-1#61)(2008-10#216)(2008-11#111)(2008-12#47)(2008-2#100)(2008-3#147)(2008-4#32)(2008-5#63)(2008-6#49)(2008-7#103)(2008-8#53)(2008-9#54)(2009-1#2)(2009-10#20)(2009-11#15)(2009-12#21)(2009-2#4)(2009-3#17)(2009-4#19)(2009-5#9)(2009-6#24)(2009-7#17)(2009-8#16)(2009-9#17)(2010-1#8)(2010-10#10)(2010-11#26)(2010-12#44)(2010-2#24)(2010-3#13)(2010-4#112)(2010-5#16)(2010-6#8)(2010-7#16)(2010-8#35)(2010-9#18)(2011-1#83)(2011-10#1)(2011-12#34)(2011-2#147)(2011-3#5)(2011-7#4)(2012-1#37)(2012-11#13)(2012-12#83)(2012-2#106)(2012-3#78)(2013-1#192)(2013-7#13)(2013-8#71)
quality&quot##3##1##(1994-1#1)(2005-5#1)(2007-4#1)
quality)##3##1##(2008-8#1)(2008-9#1)(2012-12#1)
quality--the##2##1##(1994-1#1)(1994-2#1)
quality-adjusted life years##2##3##(2011-1#1)(2013-1#1)
quality-adjusted life##5##2##(2007-8#1)(2008-4#1)(2011-1#1)(2012-12#1)(2013-1#1)
quality-adjusted survival##3##2##(1995-8#3)
quality-adjusted##11##1##(1993-1#1)(1995-8#3)(2006-12#1)(2007-8#1)(2008-4#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
quality-assurance (QA)##2##2##(1996-2#2)
quality-assurance##7##1##(1991-12#2)(1996-2#2)(2005-11#1)(2013-1#2)
quality-based compensation model##3##3##(1996-3#1)(1997-1#2)
quality-based##4##1##(1996-3#1)(1997-1#2)(1997-3#1)
quality-by-design##3##1##(2011-2#1)(2012-2#2)
quality-control##3##1##(2005-7#1)(2008-10#1)(2010-4#1)
quality-improvement##4##1##(1996-2#1)(2009-11#1)(2010-8#2)
quality-measurement##2##1##(1996-2#2)
quality-monitoring system##2##2##(1996-2#1)(1997-1#1)
quality-of-care issues##2##2##(1992-3#2)
quality-of-care##6##1##(1992-3#2)(1993-1#1)(1993-12#1)(1996-2#1)(2007-8#1)
quality-of-life instruments for##2##3##(2005-4#2)
quality-of-life measure##2##2##(2008-10#1)(2011-2#1)
quality-of-life measurement##2##2##(2005-4#1)(2013-8#1)
quality-of-life outcomes##2##2##(2007-11#1)(2008-9#1)
quality-of-life##31##1##(2005-4#4)(2006-10#2)(2006-12#2)(2006-6#1)(2006-9#1)(2007-11#2)(2007-6#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
quality-related##2##1##(1996-2#1)(2012-11#1)
quality-test of TiO(2)-photocatalyst in water##2##5##(2008-10#2)
quality?##3##1##(1992-5#1)(1993-3#1)(2006-12#1)
quandary##2##1##(2013-8#2)
quanta at##2##2##(1995-1#1)(1995-8#1)
quanta in##2##2##(1991-6#1)(1995-1#1)
quanta##21##1##(1990-7#1)(1991-6#2)(1995-1#7)(1995-8#6)(1997-7#1)(2007-10#1)(2007-12#1)(2008-3#1)(2008-7#1)
quantal content##2##2##(1991-5#1)(2009-9#1)
quantal data##2##2##(2010-2#2)
quantal events##3##2##(1995-8#2)(1997-7#1)
quantal latencies##2##2##(1995-8#2)
quantal presynaptic##2##2##(1997-7#2)
quantal release of##2##3##(1990-2#1)(1991-5#1)
quantal release##8##2##(1990-2#1)(1991-5#1)(1995-8#6)
quantal releases##4##2##(1995-8#4)
quantal secretions##3##2##(1995-8#3)
quantal size##3##2##(1991-5#1)(2012-12#2)
quantal##42##1##(1990-2#1)(1990-7#1)(1991-5#3)(1991-6#1)(1994-11#1)(1995-1#1)(1995-8#19)(1996-2#1)(1997-3#2)(1997-7#4)(2009-5#1)(2009-9#1)(2010-2#3)(2011-1#1)(2012-12#2)
quanti-qualitative##2##1##(2008-9#1)(2012-3#1)
quantifiable phenotype##2##2##(1991-1#2)
quantifiable##22##1##(1991-1#3)(1991-9#1)(1996-7#2)(2006-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#2)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
quantification (LOQ) were 0##2##4##(2008-10#2)
quantification (LOQ) were##4##3##(2008-10#2)(2011-1#1)(2013-8#1)
quantification (LOQ)##16##2##(1996-3#1)(2008-10#11)(2011-1#1)(2012-12#2)(2013-8#1)
quantification analysis##4##2##(2008-11#1)(2008-9#1)(2011-1#1)(2011-7#1)
quantification and confirmation of##3##4##(2007-8#2)(2013-8#1)
quantification and##28##2##(1991-5#1)(1993-11#1)(1996-7#1)(1997-3#1)(1997-5#1)(2005-10#1)(2006-4#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#2)
quantification are##4##2##(1997-8#1)(2008-10#2)(2013-7#1)
quantification at##3##2##(2008-10#2)(2011-1#1)
quantification by##7##2##(1993-2#1)(1995-3#1)(2007-8#1)(2008-10#1)(2008-9#1)(2012-12#1)(2012-3#1)
quantification can be##2##3##(2011-2#1)(2013-1#1)
quantification data##2##2##(2012-3#2)
quantification for##6##2##(1996-8#1)(2008-10#3)(2010-2#1)(2012-2#1)
quantification have been##2##3##(2008-10#2)
quantification have##3##2##(2008-10#2)(2010-7#1)
quantification in##16##2##(1990-8#1)(2007-11#1)(2008-10#8)(2008-5#1)(2008-9#1)(2010-4#1)(2011-1#1)(2012-3#2)
quantification is##10##2##(1993-2#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-5#1)(2010-2#2)(2011-2#1)
quantification limit (0##2##3##(2008-10#2)
quantification limit for##3##3##(2008-10#3)
quantification limit of##5##3##(2007-8#1)(2008-10#3)(2012-12#1)
quantification limit was 0##2##4##(2008-10#2)
quantification limit was##5##3##(2008-10#5)
quantification limit##20##2##(2007-8#1)(2008-10#18)(2012-12#1)
quantification limits were##7##3##(1997-8#1)(2007-8#1)(2008-10#4)(2009-3#1)
quantification limits##21##2##(1997-8#1)(2007-8#2)(2008-10#17)(2009-3#1)
quantification method##5##2##(2007-8#1)(2008-11#1)(2012-12#1)(2013-1#2)
quantification methods##2##2##(2007-8#1)(2009-5#1)
quantification of 0##2##3##(2008-10#2)
quantification of 7-DHC##2##3##(1997-1#2)
quantification of DNA##2##3##(2008-12#1)(2013-1#1)
quantification of Edwardsiella ictaluri in##2##5##(2012-3#2)
quantification of I##3##3##(1997-8#2)(2008-10#1)
quantification of M##2##3##(2008-10#2)
quantification of all##3##3##(1990-6#1)(2008-10#1)(2009-6#1)
quantification of ammonium##2##3##(2008-10#2)
quantification of antibacterial activity##2##4##(2007-11#2)
quantification of ascorbic acid##2##4##(2008-10#2)
quantification of atorvastatin and aspirin##2##5##(2012-12#2)
quantification of both##2##3##(2006-10#1)(2008-10#1)
quantification of cell growth##2##4##(2007-2#1)(2008-5#1)
quantification of cell##3##3##(2004-9#1)(2007-2#1)(2008-5#1)
quantification of cellular##2##3##(1997-3#1)(2009-2#1)
quantification of changes in##3##4##(2008-1#1)(2008-12#1)(2013-1#1)
quantification of chemical##2##3##(2008-3#2)
quantification of d-malate and l-malate##2##5##(2008-10#2)
quantification of damage##2##3##(1997-8#2)
quantification of drug##2##3##(1991-10#1)(2006-10#1)
quantification of eight##3##3##(2008-10#2)(2012-2#1)
quantification of fungal##2##3##(2008-10#1)(2011-1#1)
quantification of ligands##2##3##(2008-10#1)(2008-5#1)
quantification of monosaccharides and disaccharides used##2##6##(1993-11#2)
quantification of myocardial##3##3##(2009-10#1)(2010-5#1)(2012-12#1)
quantification of plasma##2##3##(2005-12#1)(2008-1#1)
quantification of protein##2##3##(1990-12#1)(2008-10#1)
quantification of proteins##3##3##(2007-12#1)(2008-4#1)(2013-8#1)
quantification of proteome##2##3##(2009-5#2)
quantification of pulmonary##3##3##(2011-2#1)(2013-1#2)
quantification of pyruvate##2##3##(2008-10#2)
quantification of sodium##2##3##(2008-10#2)
quantification of the number of##2##5##(2008-2#1)(2008-9#1)
quantification of the surface##2##4##(2005-11#1)(2009-7#1)
quantification of the various##2##4##(1995-6#1)(2008-9#1)
quantification of the##43##3##(1990-12#1)(1990-6#1)(1993-11#1)(1995-6#1)(1996-10#1)(1997-7#1)(2005-11#2)(2007-1#1)(2007-11#1)(2008-10#16)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-7#1)(2009-9#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)
quantification of these##5##3##(2007-8#1)(2008-10#2)(2010-1#1)(2013-7#1)
quantification of this##2##3##(2008-5#1)(2013-8#1)
quantification of total##2##3##(1993-2#1)(2008-10#1)
quantification of viral##2##3##(2008-6#2)
quantification of white matter infiltration##2##5##(2007-5#2)
quantification of##328##2##(1990-12#3)(1990-6#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-5#3)(1991-7#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-7#2)(1992-8#1)(1993-11#5)(1993-12#1)(1993-2#4)(1993-9#1)(1994-1#1)(1994-12#2)(1994-9#1)(1995-1#2)(1995-4#1)(1995-6#2)(1995-7#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-8#3)(1997-1#2)(1997-3#1)(1997-7#1)(1997-8#5)(2004-9#2)(2005-11#2)(2005-12#3)(2005-8#1)(2006-10#2)(2006-4#1)(2006-5#1)(2007-1#2)(2007-10#2)(2007-11#6)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#3)(2007-8#9)(2007-9#1)(2008-1#7)(2008-10#107)(2008-11#7)(2008-12#3)(2008-2#7)(2008-3#6)(2008-4#8)(2008-5#8)(2008-6#5)(2008-7#1)(2008-9#6)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-5#2)(2010-7#4)(2010-9#2)(2011-1#3)(2011-2#5)(2011-3#1)(2012-1#5)(2012-12#4)(2012-2#3)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#6)
quantification techniques##2##2##(2008-10#1)(2012-2#1)
quantification that##2##2##(2006-11#1)(2011-2#1)
quantification using a##2##3##(2008-10#1)(2008-4#1)
quantification using##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
quantification was 0##6##3##(1992-2#1)(1993-11#1)(1996-6#1)(2008-10#1)(2010-2#1)(2011-2#1)
quantification was carried out##2##4##(2008-10#2)
quantification was performed using##2##4##(2005-12#1)(2005-8#1)
quantification was performed##4##3##(1990-12#1)(2005-12#1)(2005-8#1)(2009-3#1)
quantification was##23##2##(1990-12#1)(1992-2#2)(1993-11#1)(1996-6#2)(1996-8#2)(2005-12#2)(2005-8#1)(2008-10#5)(2008-5#1)(2009-3#1)(2010-2#1)(2011-2#2)(2012-12#1)(2013-1#1)
quantification were 0##3##3##(2008-10#3)
quantification were carried out##2##4##(2008-10#1)(2010-5#1)
quantification were##15##2##(1996-6#1)(1997-3#1)(1997-8#1)(2008-10#9)(2010-5#1)(2011-3#1)(2012-12#1)
quantification##619##1##(1990-12#4)(1990-6#3)(1990-8#2)(1991-10#1)(1991-11#1)(1991-5#4)(1991-7#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-7#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#7)(1993-12#1)(1993-2#6)(1993-9#1)(1994-1#1)(1994-12#2)(1994-9#1)(1995-1#2)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#4)(1995-7#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#4)(1996-7#3)(1996-8#6)(1996-9#1)(1997-1#2)(1997-3#3)(1997-5#2)(1997-7#1)(1997-8#8)(2004-9#2)(2005-10#1)(2005-11#2)(2005-12#5)(2005-8#2)(2006-10#2)(2006-11#2)(2006-4#3)(2006-5#2)(2007-1#2)(2007-10#2)(2007-11#7)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#3)(2007-7#2)(2007-8#24)(2007-9#1)(2008-1#11)(2008-10#225)(2008-11#12)(2008-12#3)(2008-2#7)(2008-3#7)(2008-4#13)(2008-5#15)(2008-6#5)(2008-7#3)(2008-9#16)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#4)(2009-8#2)(2009-9#2)(2010-1#1)(2010-11#3)(2010-12#3)(2010-2#11)(2010-4#1)(2010-5#4)(2010-6#2)(2010-7#5)(2010-8#1)(2010-9#2)(2011-1#11)(2011-2#10)(2011-3#2)(2011-7#1)(2012-1#6)(2012-12#14)(2012-2#7)(2012-3#10)(2013-1#13)(2013-7#5)(2013-8#11)
quantifications of##2##2##(1996-3#1)(2011-1#1)
quantifications##6##1##(1996-3#1)(2008-10#2)(2010-11#1)(2010-6#1)(2011-1#1)
quantified and compared##2##3##(1990-3#1)(2008-10#1)
quantified and##14##2##(1990-3#1)(1996-3#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-9#1)(2011-1#1)(2012-11#2)(2012-2#1)(2013-1#1)
quantified as the##2##3##(1990-11#1)(2008-10#1)
quantified as##11##2##(1990-11#1)(1995-9#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-7#2)(2010-4#1)(2011-12#1)
quantified at##4##2##(1992-7#1)(2008-10#2)(2011-2#1)
quantified because##2##2##(2010-8#1)(2013-8#1)
quantified by HPLC##3##3##(1990-12#1)(1993-11#1)(2008-10#1)
quantified by a##2##3##(2008-1#1)(2013-7#1)
quantified by an##2##3##(2008-10#2)
quantified by image analysis##2##4##(2008-11#1)(2008-7#1)
quantified by mass##2##3##(1990-6#1)(1994-3#1)
quantified by measuring the##5##4##(1995-1#1)(1996-12#1)(1997-3#1)(2008-11#1)(2008-7#1)
quantified by measuring##7##3##(1995-1#1)(1996-12#1)(1996-4#1)(1997-3#1)(2008-11#1)(2008-5#1)(2008-7#1)
quantified by the##15##3##(1990-12#1)(1993-11#1)(1993-2#1)(1995-2#1)(1997-1#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-9#1)(2012-11#1)
quantified by using a##3##4##(2007-2#1)(2007-5#1)(2008-10#1)
quantified by using##4##3##(2006-6#1)(2007-2#1)(2007-5#1)(2008-10#1)
quantified by##100##2##(1990-12#2)(1990-4#1)(1990-6#1)(1991-10#1)(1991-12#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#2)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2008-1#6)(2008-10#18)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#4)(2008-7#2)(2008-9#1)(2009-5#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-4#1)(2013-1#2)(2013-7#2)
quantified directly##3##2##(2004-11#1)(2008-10#1)(2008-11#1)
quantified during the##2##3##(2004-9#1)(2011-2#1)
quantified during##3##2##(1997-2#1)(2004-9#1)(2011-2#1)
quantified for the##2##3##(2004-11#1)(2008-10#1)
quantified for##5##2##(1995-8#1)(2004-11#1)(2008-10#2)(2008-5#1)
quantified from##3##2##(2005-11#1)(2006-5#1)(2008-10#1)
quantified in four##2##3##(1990-3#1)(2008-10#1)
quantified in terms of the##2##5##(2007-11#1)(2008-2#1)
quantified in terms of##7##4##(2005-11#1)(2006-8#1)(2007-11#1)(2008-2#1)(2008-3#2)(2008-7#1)
quantified in the##8##3##(1995-11#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2009-3#1)(2013-1#1)(2013-8#1)
quantified in##44##2##(1990-3#2)(1991-11#1)(1993-6#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-5#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#14)(2008-2#1)(2008-3#2)(2008-7#2)(2009-2#1)(2009-3#1)(2009-4#1)(2010-8#2)(2012-2#1)(2013-1#1)(2013-8#1)
quantified on a##3##3##(1990-6#1)(2008-10#1)(2008-9#1)
quantified on##7##2##(1990-6#1)(2006-5#1)(2008-10#2)(2008-5#1)(2008-9#2)
quantified over a##2##3##(2008-10#1)(2008-5#1)
quantified smoking##3##2##(2008-10#3)
quantified the effect of##4##4##(1990-9#1)(2010-8#1)(2013-1#2)
quantified the##24##2##(1990-4#1)(1990-9#1)(1991-5#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-7#1)(1997-8#1)(2006-4#1)(2006-9#1)(2008-10#1)(2008-7#1)(2008-9#2)(2010-8#1)(2012-2#2)(2013-1#6)(2013-8#1)
quantified through##2##2##(2008-5#1)(2012-12#1)
quantified to##6##2##(1991-12#1)(2007-1#1)(2008-3#1)(2010-10#1)(2010-12#1)(2011-12#1)
quantified using a##7##3##(2006-11#1)(2008-2#1)(2008-5#1)(2009-10#1)(2009-7#1)(2011-2#1)(2012-2#1)
quantified using an##2##3##(1991-12#1)(2008-10#1)
quantified using the##5##3##(1997-4#1)(2008-10#1)(2009-3#1)(2012-1#1)(2012-12#1)
quantified using##34##2##(1991-12#1)(1993-2#1)(1994-10#1)(1994-6#1)(1996-11#1)(1997-4#1)(2006-11#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#3)(2009-10#1)(2009-3#1)(2009-7#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-7#1)
quantified with a##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
quantified with the##2##3##(2006-10#1)(2008-10#1)
quantified with##12##2##(1990-9#1)(2006-10#1)(2008-10#7)(2008-3#1)(2008-5#1)(2012-12#1)
quantified##384##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#3)(1990-4#2)(1990-6#2)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-5#2)(1992-2#1)(1992-3#2)(1992-7#2)(1992-8#1)(1992-9#3)(1993-11#2)(1993-12#2)(1993-2#3)(1993-6#1)(1993-7#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#1)(2004-11#2)(2004-9#1)(2005-10#1)(2005-11#5)(2006-10#2)(2006-11#2)(2006-12#2)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#2)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#7)(2007-2#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-8#7)(2008-1#8)(2008-10#76)(2008-11#7)(2008-12#1)(2008-2#10)(2008-3#11)(2008-4#6)(2008-5#17)(2008-7#11)(2008-8#4)(2008-9#7)(2009-10#1)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-8#10)(2011-1#2)(2011-12#2)(2011-2#7)(2012-1#6)(2012-11#4)(2012-12#4)(2012-2#9)(2012-3#1)(2012-4#1)(2013-1#14)(2013-7#3)(2013-8#5)
quantifier##2##1##(2012-2#1)(2013-1#1)
quantifies the##16##2##(1992-1#1)(1992-7#1)(1992-9#1)(1993-2#1)(2007-11#3)(2007-8#1)(2008-10#3)(2008-5#1)(2008-8#1)(2011-12#1)(2012-12#1)(2012-2#1)
quantifies##25##1##(1992-1#1)(1992-7#1)(1992-9#1)(1993-2#1)(1997-7#1)(2006-10#1)(2006-11#1)(2007-11#3)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-8#1)(2009-11#1)(2009-12#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
quantify and##14##2##(1997-3#1)(2006-11#1)(2006-6#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2010-2#1)(2010-4#1)(2010-5#1)(2012-2#2)
quantify differences##2##2##(1996-3#1)(2008-10#1)
quantify disease##2##2##(1991-12#1)(2009-10#1)
quantify five##2##2##(2008-10#2)
quantify human##2##2##(2008-12#1)(2012-2#1)
quantify its##3##2##(2007-11#1)(2008-10#1)(2008-5#1)
quantify optical##2##2##(2008-2#1)(2008-3#1)
quantify some##2##2##(2008-8#1)(2011-1#1)
quantify the accuracy of##2##4##(2008-2#2)
quantify the actual##2##3##(2008-7#1)(2010-6#1)
quantify the average##2##3##(2008-8#1)(2009-7#1)
quantify the degree of##5##4##(2008-10#1)(2008-2#1)(2008-8#1)(2010-3#1)(2012-1#1)
quantify the degree##6##3##(2007-5#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-3#1)(2012-1#1)
quantify the effect of##8##4##(2007-8#2)(2008-10#2)(2008-7#2)(2013-1#2)
quantify the effects of##9##4##(1991-11#1)(2007-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-2#1)(2012-1#1)(2012-3#1)
quantify the mechanical##2##3##(2006-8#1)(2007-1#1)
quantify the optical##2##3##(2008-2#1)(2008-3#1)
quantify the performance of the##3##5##(2008-2#1)(2008-3#1)(2012-1#1)
quantify the relationship between##2##4##(2008-10#1)(2013-8#1)
quantify the relative##2##3##(2008-4#1)(2009-2#1)
quantify the respiratory##2##3##(1993-7#1)(2008-12#1)
quantify the severity of##2##4##(2007-5#1)(2013-8#1)
quantify the##171##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-11#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-2#2)(1994-6#1)(1994-8#1)(1995-3#1)(1996-12#1)(1996-7#1)(1997-6#1)(1997-8#1)(2005-1#1)(2006-10#1)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#1)(2007-12#5)(2007-4#4)(2007-5#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#26)(2008-11#3)(2008-12#1)(2008-2#8)(2008-3#12)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#9)(2008-8#5)(2008-9#2)(2009-2#2)(2009-5#1)(2009-7#1)(2010-10#1)(2010-2#2)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#3)(2012-1#6)(2012-2#2)(2012-3#4)(2013-1#9)(2013-7#1)(2013-8#4)
quantify their##2##2##(2008-11#1)(2012-2#1)
quantify them##2##2##(2008-4#1)(2008-8#1)
quantify##379##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-12#1)(1992-12#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-2#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-12#2)(1996-3#2)(1996-6#2)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-1#1)(2006-10#4)(2006-11#1)(2006-12#3)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#4)(2007-12#7)(2007-3#1)(2007-4#4)(2007-5#2)(2007-8#9)(2007-9#3)(2008-1#4)(2008-10#80)(2008-11#9)(2008-12#4)(2008-2#11)(2008-3#18)(2008-4#14)(2008-5#10)(2008-6#2)(2008-7#14)(2008-8#12)(2008-9#5)(2009-10#2)(2009-2#4)(2009-5#1)(2009-6#1)(2009-7#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#3)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#7)(2012-1#8)(2012-12#4)(2012-2#11)(2012-3#8)(2013-1#19)(2013-7#2)(2013-8#5)
quantifying and##4##2##(2008-1#1)(2008-11#2)(2008-8#1)
quantifying of##3##2##(2007-8#1)(2008-10#1)(2008-4#1)
quantifying the amount of##2##4##(1995-6#1)(2008-10#1)
quantifying the effect of##2##4##(1992-9#1)(2008-12#1)
quantifying the effect##3##3##(1992-9#1)(1997-2#1)(2008-12#1)
quantifying the number of##2##4##(2008-10#1)(2008-4#1)
quantifying the##50##2##(1992-8#1)(1992-9#1)(1994-11#1)(1995-12#1)(1995-6#1)(1997-2#1)(1997-7#2)(2004-2#1)(2005-11#1)(2005-5#1)(2006-10#2)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#4)(2008-5#2)(2008-6#1)(2008-8#1)(2010-5#1)(2010-9#1)(2011-2#3)(2013-1#3)(2013-7#1)
quantifying their##2##2##(1992-7#1)(2008-10#1)
quantifying vascular geometry as depicted in tomographic imaging may provide a non-invasive diagnostic technique##2##14##(2013-1#2)
quantifying##119##1##(1990-8#1)(1992-7#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-2#1)(2005-11#1)(2005-5#1)(2006-10#2)(2006-3#2)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#5)(2008-1#2)(2008-10#25)(2008-11#5)(2008-12#1)(2008-3#5)(2008-4#9)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-4#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#9)(2013-7#2)
quantile##4##1##(1990-8#1)(2010-2#1)(2012-1#2)
quantiles are##2##2##(1990-8#1)(2012-1#1)
quantiles##4##1##(1990-8#1)(1995-6#2)(2012-1#1)
quantitate free##2##2##(1995-1#1)(2008-10#1)
quantitate the##18##2##(1990-12#1)(1990-6#1)(1991-9#1)(1992-12#1)(1992-6#2)(1993-3#1)(1996-11#1)(1996-8#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#1)(2009-10#1)
quantitate##68##1##(1990-12#4)(1990-2#1)(1990-6#1)(1991-9#2)(1992-12#2)(1992-6#2)(1992-8#1)(1993-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-1#1)(1996-11#3)(1996-12#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#1)(2006-10#1)(2006-5#1)(2007-1#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-4#14)(2008-6#1)(2008-9#6)(2009-10#1)(2012-2#1)
quantitated against##2##2##(1990-12#2)
quantitated and compared##2##3##(2004-12#1)(2010-7#1)
quantitated by the##3##3##(1995-7#1)(1996-11#1)(2008-4#1)
quantitated by this##2##3##(1992-1#1)(1996-11#1)
quantitated by##21##2##(1990-11#1)(1990-7#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#1)(1994-12#1)(1994-9#1)(1995-7#1)(1996-11#2)(1996-6#1)(2008-4#5)(2008-9#1)
quantitated from##2##2##(1994-2#1)(1997-2#1)
quantitated in##8##2##(1991-9#1)(1992-11#1)(1994-5#1)(2008-12#1)(2008-4#1)(2008-6#1)(2010-12#1)(2011-2#1)
quantitated through##2##2##(1992-11#1)(2008-10#1)
quantitated using##6##2##(1991-2#1)(1992-6#1)(1994-2#1)(2008-10#2)(2008-7#1)
quantitated##63##1##(1990-11#1)(1990-12#4)(1990-2#1)(1990-4#1)(1990-7#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-6#3)(1992-7#1)(1992-8#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-9#1)(1995-12#1)(1995-7#1)(1996-11#3)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(2004-12#1)(2008-10#5)(2008-12#1)(2008-4#9)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-7#1)(2011-2#1)
quantitating the##12##2##(1990-12#1)(1990-7#1)(1991-8#1)(1992-7#1)(1993-4#1)(1994-5#1)(1995-11#1)(1995-2#1)(1996-5#1)(2006-6#1)(2008-4#2)
quantitating##28##1##(1990-12#1)(1990-7#1)(1991-8#1)(1992-7#1)(1993-4#1)(1994-5#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-5#1)(1996-6#1)(2006-4#1)(2006-6#1)(2006-8#1)(2008-10#3)(2008-4#9)(2008-9#1)(2012-2#1)
quantitation (LOQ) of 1##2##4##(1992-8#1)(2008-10#1)
quantitation (LOQ) of##6##3##(1992-8#1)(1996-8#1)(1997-3#1)(2007-8#1)(2008-10#1)(2010-4#1)
quantitation (LOQ)##16##2##(1992-8#1)(1996-5#1)(1996-8#1)(1997-3#1)(2007-8#2)(2008-10#8)(2010-4#1)(2011-2#1)
quantitation and##7##2##(1996-8#1)(2008-2#1)(2008-4#2)(2008-9#1)(2010-4#1)(2013-1#1)
quantitation at##2##2##(2008-10#1)(2012-11#1)
quantitation by##5##2##(1990-12#1)(1993-12#1)(1995-11#1)(2008-10#2)
quantitation for##5##2##(2007-8#1)(2008-10#2)(2010-12#1)(2010-3#1)
quantitation in##3##2##(1991-9#1)(1992-4#1)(2007-2#1)
quantitation limit of 1##2##4##(1991-8#1)(2008-10#1)
quantitation limit of##7##3##(1991-8#2)(1997-3#1)(1997-8#2)(2008-10#2)
quantitation limit was 0##2##4##(2007-8#1)(2008-10#1)
quantitation limit was##4##3##(2007-8#1)(2008-10#3)
quantitation limit##14##2##(1991-8#2)(1997-3#1)(1997-8#2)(2007-10#1)(2007-8#2)(2008-10#6)
quantitation limits of##2##3##(2008-10#2)
quantitation limits##5##2##(2007-8#3)(2008-10#2)
quantitation method##2##2##(2008-10#2)
quantitation of 0##4##3##(1997-8#1)(2008-10#1)(2010-12#1)(2010-2#1)
quantitation of 1##2##3##(1995-1#1)(2008-10#1)
quantitation of Al##2##3##(1996-8#2)
quantitation of murine##2##3##(2008-4#2)
quantitation of parasite##2##3##(2006-10#1)(2008-4#1)
quantitation of plasma##2##3##(1990-11#1)(1990-4#1)
quantitation of the##24##3##(1991-9#1)(1992-1#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-4#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#1)(2007-8#2)(2008-10#7)(2008-4#1)(2008-9#1)(2010-10#1)
quantitation of##155##2##(1990-10#1)(1990-11#5)(1990-12#3)(1990-2#1)(1990-4#3)(1990-8#1)(1990-9#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-12#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-6#2)(1996-11#1)(1996-5#2)(1996-6#2)(1996-8#4)(1996-9#1)(1997-2#6)(1997-3#7)(1997-4#2)(1997-8#4)(2006-10#1)(2006-5#1)(2007-10#1)(2007-8#3)(2008-1#1)(2008-10#39)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#26)(2008-9#2)(2009-3#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#2)(2012-12#2)(2013-8#2)
quantitation on a##2##3##(1997-5#1)(2008-6#1)
quantitation was##13##2##(1993-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-3#3)(2008-10#4)(2008-5#1)(2009-10#1)
quantitation were 0##2##3##(2008-10#1)(2012-11#1)
quantitation were##9##2##(1996-4#1)(2008-10#6)(2010-2#1)(2012-11#1)
quantitation within##2##2##(1997-5#2)
quantitation##280##1##(1990-10#1)(1990-11#5)(1990-12#5)(1990-2#1)(1990-4#3)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-5#1)(1991-8#4)(1991-9#3)(1992-1#2)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-6#2)(1996-11#1)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#2)(1996-7#1)(1996-8#9)(1996-9#1)(1997-2#6)(1997-3#13)(1997-4#3)(1997-5#3)(1997-8#6)(2004-11#1)(2004-12#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-5#1)(2007-10#2)(2007-2#1)(2007-8#12)(2008-1#1)(2008-10#81)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#29)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#4)(2009-10#1)(2009-3#1)(2009-4#2)(2010-10#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#4)(2010-5#3)(2011-2#1)(2012-11#2)(2012-12#2)(2013-1#1)(2013-8#2)
quantitations##2##1##(1996-9#1)(2008-10#1)
quantitative &quot##2##2##(2007-5#1)(2008-4#1)
quantitative DNA##3##2##(2007-10#1)(2008-10#1)(2010-4#1)
quantitative EEG##2##2##(1996-7#1)(2008-7#1)
quantitative EMG##4##2##(2006-7#4)
quantitative PCR (qPCR)##4##3##(2008-4#1)(2013-1#1)(2013-8#2)
quantitative PCR assays were##2##4##(2008-10#2)
quantitative PCR for##2##3##(2008-4#1)(2013-1#1)
quantitative PCR in##3##3##(1993-6#1)(2008-11#1)(2011-2#1)
quantitative PCR methods##2##3##(2007-12#1)(2008-9#1)
quantitative PCR was##3##3##(1993-6#1)(2010-12#1)(2013-8#1)
quantitative PCR##31##2##(1993-6#2)(1995-2#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#1)(2009-12#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#5)
quantitative RT-PCR and##2##3##(2008-5#1)(2011-2#1)
quantitative RT-PCR assay##2##3##(1993-9#1)(2008-11#1)
quantitative RT-PCR##9##2##(1993-9#1)(2007-11#1)(2008-11#3)(2008-5#2)(2008-7#1)(2011-2#1)
quantitative abnormalities of non-albumin##2##4##(1993-12#2)
quantitative abnormalities##3##2##(1993-12#2)(2008-9#1)
quantitative accuracy##4##2##(1997-6#1)(2009-5#1)(2011-1#1)(2012-12#1)
quantitative agreement between##3##3##(1997-5#1)(2007-11#1)(2007-12#1)
quantitative agreement with the##2##4##(1993-7#1)(2007-12#1)
quantitative agreement with##6##3##(1993-7#1)(2007-11#1)(2007-12#3)(2008-3#1)
quantitative agreement##12##2##(1993-7#1)(1997-5#1)(2007-11#2)(2007-12#5)(2008-2#1)(2008-3#1)(2009-5#1)
quantitative alterations in##2##3##(2006-5#1)(2013-7#1)
quantitative analyses of the##3##4##(1997-2#2)(2009-7#1)
quantitative analyses of##9##3##(1991-8#1)(1995-1#1)(1997-2#2)(2008-10#2)(2008-9#1)(2009-7#1)(2011-2#1)
quantitative analyses##19##2##(1991-8#1)(1994-10#1)(1995-1#1)(1997-2#3)(2006-5#1)(2008-10#3)(2008-9#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
quantitative analysis and##5##3##(1997-5#1)(2004-9#1)(2008-10#2)(2011-1#1)
quantitative analysis by##2##3##(1996-8#1)(2013-1#1)
quantitative analysis in##3##3##(2006-10#1)(2008-10#2)
quantitative analysis is##2##3##(1991-10#1)(2008-10#1)
quantitative analysis of calcium carbonate##2##5##(2008-10#2)
quantitative analysis of camphor and borneol in##2##7##(2007-8#2)
quantitative analysis of fluorescence##2##4##(2008-10#1)(2008-2#1)
quantitative analysis of nerve##2##4##(1994-11#1)(1996-12#1)
quantitative analysis of some##2##4##(1996-12#1)(2008-2#1)
quantitative analysis of the##35##4##(1991-11#1)(1994-6#1)(1995-8#1)(1996-12#2)(1997-2#1)(1997-6#1)(1997-7#1)(2005-10#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-2#5)(2008-5#2)(2008-7#2)(2008-9#1)(2009-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
quantitative analysis of##117##3##(1990-11#1)(1990-12#1)(1991-11#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-8#1)(1996-12#5)(1996-5#1)(1996-8#1)(1997-2#2)(1997-6#1)(1997-7#1)(2005-10#1)(2005-12#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#8)(2008-1#1)(2008-10#39)(2008-12#1)(2008-2#9)(2008-3#1)(2008-5#4)(2008-7#3)(2008-9#2)(2009-12#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#2)
quantitative analysis##168##2##(1990-11#1)(1990-12#1)(1991-10#2)(1991-11#1)(1993-6#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-6#2)(1995-8#1)(1996-12#5)(1996-2#1)(1996-5#1)(1996-8#2)(1997-2#2)(1997-5#1)(1997-6#1)(1997-7#1)(2004-9#1)(2005-10#1)(2005-12#2)(2006-10#3)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#2)(2007-8#8)(2008-1#1)(2008-10#59)(2008-12#1)(2008-2#9)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#3)(2008-9#2)(2009-12#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#2)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#4)
quantitative analytical##4##2##(2008-10#2)(2010-4#1)(2012-2#1)
quantitative and qualitative analyses of##2##5##(2008-12#1)(2008-5#1)
quantitative and qualitative aspects of##2##5##(2008-5#1)(2009-9#1)
quantitative and qualitative aspects##3##4##(2008-5#1)(2009-9#1)(2012-12#1)
quantitative and qualitative assessments##3##4##(1995-2#1)(2008-8#1)(2009-10#1)
quantitative and qualitative changes in##3##5##(2008-5#1)(2008-7#1)(2009-1#1)
quantitative and qualitative data##7##4##(1991-8#1)(2008-11#1)(2010-1#1)(2011-1#1)(2013-1#2)(2013-8#1)
quantitative and qualitative differences in##2##5##(1991-7#1)(2008-5#1)
quantitative and qualitative differences##3##4##(1991-7#1)(2008-10#1)(2008-5#1)
quantitative and qualitative methods##3##4##(2008-12#1)(2008-8#1)(2010-11#1)
quantitative and qualitative performance##2##4##(2008-3#1)(2008-7#1)
quantitative and qualitative traits##2##4##(2006-4#1)(2012-3#1)
quantitative and qualitative##53##3##(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-1#1)(1994-3#1)(1995-2#1)(1997-2#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#3)(2008-12#3)(2008-3#1)(2008-5#4)(2008-7#2)(2008-8#4)(2009-1#1)(2009-10#1)(2009-9#1)(2010-1#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
quantitative and reproducible##2##3##(2008-10#2)
quantitative and##78##2##(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#2)(1997-2#2)(2006-10#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-11#4)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#3)(2008-12#3)(2008-3#3)(2008-5#5)(2008-7#2)(2008-8#4)(2009-1#1)(2009-10#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
quantitative appraisal##3##2##(2012-3#3)
quantitative approach for assessing##2##4##(2008-5#1)(2012-2#1)
quantitative approach to##4##3##(1990-12#1)(2008-10#1)(2008-9#1)(2011-2#1)
quantitative approach##15##2##(1990-12#1)(2006-4#1)(2008-10#6)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#1)
quantitative approaches##2##2##(2010-2#1)(2012-2#1)
quantitative aspects of##5##3##(1992-3#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
quantitative assay of the##3##4##(2007-8#1)(2009-6#1)(2011-1#1)
quantitative assay of##6##3##(1996-8#1)(2007-8#1)(2008-10#2)(2009-6#1)(2011-1#1)
quantitative assay##15##2##(1990-4#1)(1996-8#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-12#1)(2008-4#1)(2009-6#1)(2010-4#2)(2011-1#1)
quantitative assays##2##2##(2008-9#1)(2011-1#1)
quantitative assessment of the##9##4##(2005-11#1)(2005-7#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-10#1)(2010-5#1)
quantitative assessment of##28##3##(1995-5#1)(1996-12#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)
quantitative assessment##29##2##(1995-5#1)(1996-12#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)
quantitative assessments##2##2##(2006-11#1)(2008-10#1)
quantitative at##3##2##(1997-4#1)(2008-10#2)
quantitative autoradiographic analysis##2##3##(1991-9#2)
quantitative autoradiographic##4##2##(1991-9#2)(1996-4#1)(2007-1#1)
quantitative autoradiography and##4##3##(1991-5#1)(1994-2#2)(1995-12#1)
quantitative autoradiography of##3##3##(1991-9#1)(1992-8#1)(1994-3#1)
quantitative autoradiography##18##2##(1991-2#1)(1991-5#2)(1991-9#2)(1992-5#1)(1992-8#1)(1993-12#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-5#1)(1996-4#2)(1996-5#1)(1996-9#2)
quantitative behavior of##2##3##(2005-11#2)
quantitative bioassay##2##2##(1996-11#1)(2008-10#1)
quantitative biochemical##2##2##(2008-1#1)(2008-4#1)
quantitative blood##2##2##(2007-7#1)(2010-8#1)
quantitative changes in genomic DNA##2##5##(2008-4#2)
quantitative changes in the##2##4##(2007-9#1)(2008-11#1)
quantitative changes in##6##3##(1995-5#1)(2007-9#1)(2008-11#1)(2008-4#2)(2009-3#1)
quantitative changes with##2##3##(2007-9#1)(2011-1#1)
quantitative changes##10##2##(1995-5#1)(1996-11#1)(2007-9#2)(2008-11#1)(2008-12#1)(2008-4#2)(2009-3#1)(2011-1#1)
quantitative characterisation of##2##3##(2008-10#2)
quantitative characterisation##3##2##(2006-2#1)(2008-10#2)
quantitative characteristics##3##2##(1995-5#1)(2006-10#1)(2010-1#1)
quantitative characterization of##7##3##(1995-3#2)(2006-10#1)(2008-2#1)(2008-7#1)(2009-5#1)(2012-2#1)
quantitative chemical analysis##2##3##(2006-12#1)(2007-8#1)
quantitative chemical##3##2##(2006-12#1)(2007-12#1)(2007-8#1)
quantitative comparison of the##3##4##(1990-3#1)(2007-12#1)(2008-10#1)
quantitative comparison of##9##3##(1990-3#1)(1996-7#1)(1997-6#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)
quantitative comparison with##2##3##(2008-3#1)(2012-2#1)
quantitative comparison##13##2##(1990-3#1)(1996-7#1)(1997-6#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
quantitative concentration##3##2##(2008-3#2)(2013-7#1)
quantitative contribution of each##2##4##(2008-10#1)(2008-7#1)
quantitative contribution of##3##3##(2008-10#1)(2008-7#1)(2009-10#1)
quantitative control of the##2##4##(1994-9#1)(2010-7#1)
quantitative conversion of##2##3##(2008-10#1)(2008-6#1)
quantitative coronary angiography##2##3##(2008-7#1)(2009-10#1)
quantitative correlation##3##2##(1994-8#1)(2008-5#1)(2010-9#1)
quantitative criteria##4##2##(2005-5#3)(2007-11#1)
quantitative cultures##2##2##(1996-9#1)(2008-5#1)
quantitative data about##2##3##(2007-11#1)(2008-9#1)
quantitative data from##4##3##(2006-4#1)(2008-12#1)(2009-5#1)(2010-4#1)
quantitative data on##5##3##(2006-10#1)(2007-7#1)(2008-10#1)(2010-11#1)(2011-12#1)
quantitative data to##2##3##(1994-3#1)(2008-12#1)
quantitative data##28##2##(1990-5#1)(1990-8#1)(1990-9#1)(1994-3#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-12#1)(2013-1#1)
quantitative defect of the##2##4##(1990-5#1)(2013-1#1)
quantitative description of the##7##4##(1997-4#1)(1997-6#1)(2008-10#1)(2008-11#1)(2010-5#1)(2011-1#1)(2012-1#1)
quantitative description of##10##3##(1996-1#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-5#1)(2011-1#1)(2012-1#1)
quantitative descriptions##2##2##(2008-12#1)(2010-5#1)
quantitative descriptive##4##2##(2008-10#1)(2010-4#1)(2011-2#2)
quantitative design##2##2##(2007-4#1)(2008-3#1)
quantitative detection of##9##3##(2008-1#1)(2008-10#3)(2008-12#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-8#1)
quantitative detection range##2##3##(2007-8#1)(2008-10#1)
quantitative detection##12##2##(2007-8#1)(2008-1#1)(2008-10#5)(2008-12#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-8#1)
quantitative determination by##2##3##(2008-10#1)(2008-5#1)
quantitative determination in##2##3##(2008-10#1)(2011-2#1)
quantitative determination method for##2##4##(2008-10#2)
quantitative determination method##3##3##(2008-10#3)
quantitative determination of both##2##4##(1991-2#1)(2008-10#1)
quantitative determination of harpagoside##2##4##(2007-1#2)
quantitative determination of individual##2##4##(2008-10#1)(2008-6#1)
quantitative determination of lead##2##4##(2008-10#2)
quantitative determination of small##4##4##(1990-12#1)(2008-10#3)
quantitative determination of the##10##4##(1990-11#1)(1991-5#1)(1992-2#1)(1997-8#1)(2006-4#1)(2007-8#1)(2008-10#3)(2008-2#1)
quantitative determination of various##2##4##(2008-10#2)
quantitative determination of##92##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-2#1)(1991-5#3)(1992-2#1)(1995-4#1)(1995-7#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-8#2)(2005-12#1)(2006-10#1)(2006-4#1)(2007-1#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#46)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#4)(2008-6#2)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-12#3)(2013-1#1)(2013-8#1)
quantitative determination##114##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-2#1)(1991-5#3)(1992-2#1)(1993-1#1)(1995-4#1)(1995-7#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-8#2)(2005-12#1)(2006-10#1)(2006-4#1)(2007-1#3)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#59)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#8)(2008-6#2)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#3)(2013-1#2)(2013-8#1)
quantitative determinations##2##2##(1997-8#1)(2008-10#1)
quantitative difference in the##2##4##(1996-5#1)(2007-1#1)
quantitative difference##3##2##(1996-5#1)(2007-1#1)(2007-11#1)
quantitative differences in the##5##4##(1992-1#1)(2008-10#1)(2008-5#1)(2009-6#1)(2013-1#1)
quantitative differences in##6##3##(1992-1#1)(2008-10#1)(2008-5#1)(2009-6#1)(2013-1#2)
quantitative differences##12##2##(1990-8#1)(1992-1#1)(1994-12#1)(1995-1#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-6#1)(2009-9#1)(2012-2#1)(2013-1#2)
quantitative disease##2##2##(1993-8#1)(2008-9#1)
quantitative effect##3##2##(1993-3#1)(2008-7#1)(2008-8#1)
quantitative enrichment##2##2##(2008-10#2)
quantitative enzymatic##3##2##(1991-4#1)(2008-1#1)(2008-10#1)
quantitative estimates of##6##3##(1993-9#1)(1995-8#1)(2006-11#1)(2008-10#1)(2008-8#1)(2010-12#1)
quantitative estimates##7##2##(1993-9#1)(1995-8#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-12#1)
quantitative estimation of##13##3##(1990-12#1)(1991-8#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-2#1)(2010-5#1)(2012-2#1)(2012-3#2)(2013-7#1)
quantitative estimation##14##2##(1990-12#1)(1991-8#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-2#1)(2010-5#2)(2012-2#1)(2012-3#2)(2013-7#1)
quantitative evaluation of surface##2##4##(2005-11#1)(2008-3#1)
quantitative evaluation of the##11##4##(1990-12#1)(1995-10#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-12#1)(2010-4#1)(2012-1#1)(2013-1#1)
quantitative evaluation of##30##3##(1990-12#1)(1991-12#1)(1994-12#1)(1995-10#1)(1995-3#1)(1996-5#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#4)
quantitative evaluation##39##2##(1990-12#1)(1991-12#2)(1992-8#1)(1993-1#1)(1994-12#1)(1995-10#1)(1995-3#1)(1996-5#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#4)
quantitative evidence##2##2##(2008-3#1)(2012-3#1)
quantitative experiments##2##2##(2006-10#1)(2008-2#1)
quantitative expression of##2##3##(1991-9#1)(2008-4#1)
quantitative extraction of##13##3##(2007-8#1)(2008-10#12)
quantitative extraction##16##2##(2007-8#1)(2008-10#15)
quantitative features##2##2##(2008-10#1)(2008-3#1)
quantitative flow cytometric technique##2##4##(1992-8#2)
quantitative flow##3##2##(1992-8#2)(2008-9#1)
quantitative fluorescence in situ hybridization##2##5##(2008-1#1)(2008-9#1)
quantitative fluorescence##4##2##(1995-5#1)(2008-1#1)(2008-2#1)(2008-9#1)
quantitative footprinting##2##2##(1992-9#2)
quantitative form##2##2##(1994-5#1)(2008-10#1)
quantitative formation of##2##3##(1992-12#1)(1996-2#1)
quantitative framework for##3##3##(2006-10#1)(2009-5#2)
quantitative framework##5##2##(1994-11#2)(2006-10#1)(2009-5#2)
quantitative gas##2##2##(1990-11#1)(2008-3#1)
quantitative genetic##8##2##(1990-6#1)(1997-5#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-5#1)(2012-3#1)(2013-1#1)
quantitative genetics##3##2##(1997-5#2)(2008-8#1)
quantitative high-performance liquid##2##3##(1991-8#2)
quantitative histological analysis##2##3##(1991-9#1)(2012-1#1)
quantitative histopathological parameters##2##3##(1996-9#2)
quantitative histopathological##4##2##(1996-1#1)(1996-9#2)(2013-1#1)
quantitative host resistance##4##3##(2008-10#4)
quantitative image analysis and##2##4##(1994-2#1)(1995-7#1)
quantitative image analysis##3##3##(1994-2#1)(1995-1#1)(1995-7#1)
quantitative images of##2##3##(2007-12#1)(2010-11#1)
quantitative images##3##2##(2007-12#1)(2008-2#1)(2010-11#1)
quantitative imaging of##2##3##(2008-3#1)(2010-5#1)
quantitative imaging##4##2##(2007-6#1)(2008-2#1)(2008-3#1)(2010-5#1)
quantitative immunoblot##3##2##(1990-3#1)(1995-11#1)(1997-5#1)
quantitative immunoblots##2##2##(1990-7#1)(1995-11#1)
quantitative in situ hybridization##4##4##(1993-5#1)(1993-7#1)(1996-12#1)(1997-8#1)
quantitative in vitro##3##3##(1993-1#1)(2007-1#1)(2008-1#1)
quantitative in##8##2##(1993-1#1)(1993-5#1)(1993-7#1)(1996-12#1)(1997-8#1)(2007-1#1)(2008-1#1)(2008-10#1)
quantitative indexes##2##2##(1991-12#2)
quantitative indices##3##2##(2008-11#1)(2012-1#1)(2013-8#1)
quantitative information about the##2##4##(2008-10#2)
quantitative information about##6##3##(2008-10#2)(2008-2#2)(2013-1#2)
quantitative information from##2##3##(2005-7#1)(2009-4#1)
quantitative information in##3##3##(1996-7#1)(2008-3#1)(2012-2#1)
quantitative information on the##3##4##(2005-11#1)(2008-5#1)(2008-7#1)
quantitative information on##7##3##(2005-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
quantitative information regarding##2##3##(2005-11#1)(2013-7#1)
quantitative information that##2##3##(2008-10#1)(2012-2#1)
quantitative information to##2##3##(2008-11#1)(2008-2#1)
quantitative information##35##2##(1996-3#1)(1996-7#1)(2005-11#2)(2005-7#1)(2007-5#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-4#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#1)
quantitative investigation of##4##3##(2008-10#1)(2008-3#1)(2009-3#1)(2010-12#1)
quantitative investigation##5##2##(2008-10#1)(2008-3#1)(2009-3#1)(2010-12#1)(2012-2#1)
quantitative isolation of##2##3##(1994-12#1)(2008-10#1)
quantitative liver##2##2##(1993-7#2)
quantitative magnetic resonance##3##3##(2008-7#1)(2010-8#2)
quantitative manner##3##2##(2008-4#1)(2010-2#1)(2012-1#1)
quantitative means to##2##3##(2009-7#1)(2010-12#1)
quantitative means##3##2##(2009-7#1)(2010-12#1)(2010-7#1)
quantitative measurement of the##8##4##(1995-3#1)(2007-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2012-2#1)
quantitative measurement of##23##3##(1991-12#1)(1991-8#1)(1992-2#1)(1993-11#1)(1995-3#1)(2007-12#2)(2008-10#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-7#1)(2012-12#1)(2012-2#1)
quantitative measurement##30##2##(1991-12#1)(1991-8#1)(1992-2#1)(1993-11#1)(1995-3#1)(2006-5#2)(2007-12#2)(2008-10#5)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-7#1)(2012-12#1)(2012-2#1)
quantitative measurements of the##2##4##(1990-4#1)(2008-5#1)
quantitative measurements of##14##3##(1990-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#3)(2011-2#1)(2012-12#1)
quantitative measurements were##2##3##(2008-11#1)(2008-2#1)
quantitative measurements##26##2##(1990-4#1)(1997-1#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-9#5)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
quantitative measures of the##2##4##(1991-2#1)(2008-10#1)
quantitative measures of##5##3##(1991-2#1)(1997-8#1)(2008-10#1)(2011-2#1)(2012-1#1)
quantitative measures that##2##3##(2008-10#1)(2009-5#1)
quantitative measures##9##2##(1991-2#1)(1992-9#1)(1997-8#1)(2006-5#1)(2008-10#2)(2009-5#1)(2011-2#1)(2012-1#1)
quantitative metal ion##2##3##(2008-10#2)
quantitative metal##3##2##(2008-10#3)
quantitative method for the analysis of##2##6##(1991-7#1)(2007-10#1)
quantitative method for##7##3##(1991-7#1)(1996-6#1)(1996-8#2)(2007-10#1)(2008-3#1)(2012-2#1)
quantitative method has been##2##4##(2008-10#2)
quantitative method to assess##2##4##(2004-9#2)
quantitative method to##5##3##(1990-12#1)(2004-9#2)(2008-10#1)(2008-5#1)
quantitative method##23##2##(1990-12#1)(1990-6#1)(1991-7#1)(1996-6#1)(1996-8#2)(1997-2#1)(2004-9#2)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#3)(2012-2#1)(2012-3#1)
quantitative methodology##2##2##(2004-11#1)(2008-1#1)
quantitative methods to##3##3##(1997-8#1)(2008-9#1)(2013-1#1)
quantitative methods##15##2##(1993-11#1)(1993-3#1)(1997-8#1)(2006-10#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-10#1)(2011-1#1)(2013-1#2)
quantitative microscopy##4##2##(2008-3#2)(2008-9#2)
quantitative model##10##2##(2005-12#1)(2006-10#1)(2006-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)(2011-2#2)
quantitative models for##2##3##(2009-5#1)(2013-8#1)
quantitative models##6##2##(1991-5#1)(1993-12#1)(2007-11#1)(2008-9#1)(2009-5#1)(2013-8#1)
quantitative monitoring of##3##3##(2007-7#1)(2008-10#1)(2008-11#1)
quantitative monitoring##4##2##(2007-7#1)(2008-10#2)(2008-11#1)
quantitative morphometric##2##2##(2011-1#1)(2012-12#1)
quantitative numerical##2##2##(2009-4#2)
quantitative observations##2##2##(2008-10#1)(2008-11#1)
quantitative optical##3##2##(1997-6#1)(2007-12#1)(2008-3#1)
quantitative or qualitative##3##3##(2006-12#1)(2006-6#1)(2009-9#1)
quantitative or##4##2##(2006-12#1)(2006-6#1)(2009-9#2)
quantitative parameters of##2##3##(1995-11#1)(2011-1#1)
quantitative parameters##5##2##(1995-11#1)(2008-10#1)(2008-6#1)(2011-1#2)
quantitative pharmacophore model##2##3##(2012-3#2)
quantitative pharmacophore##3##2##(2012-3#3)
quantitative phase##7##2##(2007-11#2)(2007-12#1)(2008-10#1)(2011-1#2)(2011-2#1)
quantitative phase-contrast##3##2##(2007-12#2)(2008-3#1)
quantitative phenotype##3##2##(2012-3#3)
quantitative phenotypes in##2##3##(2012-3#2)
quantitative phenotypes##6##2##(2012-3#6)
quantitative planar stress-redistribution-reinjection thallium##2##4##(1997-1#2)
quantitative planar stress-redistribution-reinjection##3##3##(1997-1#3)
quantitative polymerase chain reaction (PCR) with##2##6##(2008-10#2)
quantitative polymerase chain reaction (PCR)##5##5##(2008-10#4)(2013-1#1)
quantitative polymerase chain reaction (Q-PCR)##2##5##(2008-10#2)
quantitative polymerase chain reaction (qPCR)##2##5##(2009-6#1)(2012-3#1)
quantitative polymerase chain reaction for##2##5##(2013-1#1)(2013-8#1)
quantitative polymerase chain reaction##21##4##(1994-8#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-2#1)(2009-6#1)(2010-7#1)(2012-3#1)(2013-1#2)(2013-8#1)
quantitative prediction of the##4##4##(2008-5#1)(2008-7#1)(2009-6#1)(2013-8#1)
quantitative prediction of##6##3##(1992-5#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-5#1)(2013-8#1)
quantitative prediction##8##2##(1992-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-5#2)(2013-8#1)
quantitative protein##4##2##(2008-4#3)(2009-6#1)
quantitative proteome##3##2##(2006-12#1)(2008-4#1)(2008-9#1)
quantitative proteomic analysis##3##3##(2008-9#1)(2010-12#1)(2011-1#1)
quantitative proteomic methods##3##3##(2010-11#3)
quantitative proteomic##7##2##(2008-2#1)(2008-9#1)(2010-11#3)(2010-12#1)(2011-1#1)
quantitative proteomics##2##2##(2008-9#1)(2009-5#1)
quantitative rather than qualitative##2##4##(1995-3#1)(2012-2#1)
quantitative real time PCR##2##4##(2010-12#1)(2010-2#1)
quantitative real##3##2##(2008-5#1)(2010-12#1)(2010-2#1)
quantitative real-time PCR##10##3##(2009-2#2)(2010-11#1)(2010-5#1)(2010-7#1)(2012-2#1)(2012-3#3)(2013-8#1)
quantitative real-time polymerase chain reaction##5##5##(2008-10#1)(2009-6#1)(2012-12#1)(2012-2#1)(2013-8#1)
quantitative real-time reverse##2##3##(2011-2#2)
quantitative real-time##20##2##(2008-10#2)(2008-8#1)(2008-9#1)(2009-2#2)(2009-6#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-8#2)
quantitative receptor autoradiography##2##3##(1990-2#1)(1994-12#1)
quantitative receptor##3##2##(1990-2#2)(1994-12#1)
quantitative recoveries of##3##3##(1995-6#1)(2008-10#2)
quantitative recoveries were##2##3##(2008-10#2)
quantitative recoveries##8##2##(1995-6#1)(2008-10#7)
quantitative recovery and##3##3##(2008-10#3)
quantitative recovery of##8##3##(1995-1#1)(2008-10#6)(2011-1#1)
quantitative recovery##17##2##(1995-1#1)(2007-8#1)(2008-10#13)(2011-1#2)
quantitative relation between##2##3##(2008-3#1)(2009-6#1)
quantitative relations##3##2##(1990-9#1)(1992-11#1)(2005-4#1)
quantitative relationship between##4##3##(1990-4#1)(2008-12#1)(2008-8#1)(2010-11#1)
quantitative relationship with##2##3##(1990-4#1)(1997-8#1)
quantitative relationship##7##2##(1990-4#2)(1997-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-11#1)
quantitative relationships between##3##3##(1996-2#1)(2006-12#1)(2008-10#1)
quantitative relationships##4##2##(1996-2#1)(2006-12#1)(2008-10#1)(2008-7#1)
quantitative release##2##2##(1991-5#1)(2008-4#1)
quantitative research is##3##3##(2007-6#1)(2013-1#2)
quantitative research study##3##3##(2008-11#2)(2010-2#1)
quantitative research##16##2##(1993-2#1)(1996-4#1)(2007-6#2)(2008-1#1)(2008-11#4)(2010-2#2)(2012-12#1)(2012-3#1)(2013-1#3)
quantitative resistance to##8##3##(2006-12#1)(2008-10#7)
quantitative resistance##19##2##(2006-12#1)(2008-10#14)(2008-9#1)(2009-10#2)(2011-10#1)
quantitative results for##2##3##(2008-10#2)
quantitative results obtained##2##3##(2006-1#1)(2008-10#1)
quantitative results of##3##3##(1996-7#1)(2007-12#1)(2011-1#1)
quantitative results were obtained##2##4##(2008-10#2)
quantitative results##22##2##(1993-11#2)(1996-6#1)(1996-7#1)(1997-2#1)(2005-12#1)(2006-1#1)(2007-12#1)(2007-6#1)(2008-10#7)(2009-7#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#2)
quantitative reverse transcription##3##3##(2008-2#1)(2012-3#2)
quantitative reverse transcription-PCR (Q-RT-PCR) analysis of##2##6##(2008-9#2)
quantitative reverse transcription-polymerase chain reaction##3##5##(2008-10#1)(2011-1#1)(2011-2#1)
quantitative reverse##11##2##(1995-10#1)(2008-10#1)(2008-2#1)(2008-9#2)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
quantitative review of##3##3##(2008-10#2)(2008-8#1)
quantitative risk assessment##2##3##(2007-12#1)(2010-2#1)
quantitative risk assessments##2##3##(2008-10#1)(2011-2#1)
quantitative risk##5##2##(2007-12#1)(2008-10#1)(2010-2#1)(2011-2#1)(2012-3#1)
quantitative screening##2##2##(2008-10#1)(2012-2#1)
quantitative sensory testing##4##3##(2008-1#1)(2011-1#3)
quantitative separation of##3##3##(2008-10#3)
quantitative solution hybridisation-RNase protection assay##2##5##(1996-12#2)
quantitative sorption of metal##2##4##(2008-10#2)
quantitative sorption of##4##3##(2008-10#4)
quantitative sorption##10##2##(2008-10#10)
quantitative sorting##2##2##(2011-2#2)
quantitative structure activity##2##3##(2007-11#1)(2012-2#1)
quantitative structure-activity relationship (QSAR)##3##4##(1996-8#1)(2008-10#2)
quantitative structure-activity relationship##11##3##(1995-3#1)(1996-8#2)(1997-2#3)(2008-10#2)(2008-5#1)(2009-3#1)(2010-12#1)
quantitative structure-activity relationships##3##3##(1992-5#2)(1993-4#1)
quantitative structure-activity##15##2##(1992-4#1)(1992-5#2)(1993-4#1)(1995-3#1)(1996-8#2)(1997-2#3)(2008-10#2)(2008-5#1)(2009-3#1)(2010-12#1)
quantitative structure-property relationship##2##3##(2008-10#2)
quantitative structure-retention relationships##2##3##(2005-12#1)(2007-8#1)
quantitative structure-retention##3##2##(2005-12#1)(2007-8#1)(2008-10#1)
quantitative studies##6##2##(1995-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-5#1)(2012-2#1)
quantitative study of the##4##4##(1995-7#1)(2008-10#1)(2012-2#1)(2013-7#1)
quantitative study of##6##3##(1990-8#1)(1995-7#1)(2008-10#1)(2009-10#1)(2012-2#1)(2013-7#1)
quantitative study was##2##3##(1992-8#1)(2012-2#1)
quantitative study##14##2##(1990-8#1)(1991-1#1)(1992-8#1)(1995-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-5#1)(2012-12#1)(2012-2#2)(2013-7#1)
quantitative survey##3##2##(2008-1#1)(2011-1#1)(2012-2#1)
quantitative systematic##2##2##(2007-5#1)(2013-7#1)
quantitative technique for##2##3##(2008-1#1)(2010-3#1)
quantitative techniques##2##2##(1996-2#1)(2007-10#1)
quantitative terms##4##2##(2004-7#1)(2007-11#1)(2008-3#2)
quantitative test of the##2##4##(1994-3#1)(2009-5#1)
quantitative test##3##2##(1994-3#1)(2004-9#1)(2009-5#1)
quantitative tests##3##2##(1997-5#2)(2008-4#1)
quantitative tool for##2##3##(2007-11#1)(2010-8#1)
quantitative tool##3##2##(1996-5#1)(2007-11#1)(2010-8#1)
quantitative trait Loci for##5##4##(2008-10#5)
quantitative trait Loci##7##3##(2008-10#6)(2010-2#1)
quantitative trait loci (QTL) affecting##2##5##(2008-10#1)(2012-1#1)
quantitative trait loci (QTL) analysis##2##5##(2008-10#1)(2012-3#1)
quantitative trait loci (QTL) associated with##4##6##(2008-10#4)
quantitative trait loci (QTL) for##7##5##(2008-10#7)
quantitative trait loci (QTL) in##3##5##(2006-12#1)(2008-7#1)(2008-8#1)
quantitative trait loci (QTL) studies##2##5##(2008-10#1)(2008-8#1)
quantitative trait loci (QTL) that contribute to##2##7##(2008-10#1)(2008-8#1)
quantitative trait loci (QTL) that##5##5##(2006-12#1)(2008-10#3)(2008-8#1)
quantitative trait loci (QTL) were identified for##2##7##(2008-10#2)
quantitative trait loci (QTL) were identified##3##6##(2008-10#3)
quantitative trait loci (QTL)##39##4##(2006-12#2)(2008-10#25)(2008-7#2)(2008-8#4)(2009-2#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-3#2)
quantitative trait loci (QTLs) for##4##5##(2008-10#1)(2008-8#1)(2012-11#2)
quantitative trait loci (QTLs) were##2##5##(2008-10#1)(2008-4#1)
quantitative trait loci (QTLs)##9##4##(2008-10#2)(2008-4#1)(2008-8#2)(2008-9#1)(2012-11#3)
quantitative trait loci affecting##2##4##(2008-9#1)(2012-1#1)
quantitative trait loci##61##3##(2006-12#3)(2008-10#29)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#7)(2008-9#2)(2009-10#1)(2009-2#1)(2010-2#1)(2011-1#1)(2012-1#2)(2012-11#3)(2012-3#5)
quantitative trait locus (QTL) analysis using##2##6##(2008-10#1)(2012-11#1)
quantitative trait locus (QTL) analysis##3##5##(2008-10#1)(2008-8#1)(2012-11#1)
quantitative trait locus (QTL) for##2##5##(2008-10#1)(2012-11#1)
quantitative trait locus (QTL) mapping##2##5##(2008-8#1)(2012-3#1)
quantitative trait locus (QTL) on chromosome##3##6##(2008-10#3)
quantitative trait locus (QTL)##15##4##(2008-10#9)(2008-8#2)(2012-11#2)(2012-3#1)(2013-8#1)
quantitative trait locus for##5##4##(2008-10#4)(2012-11#1)
quantitative trait locus##25##3##(2008-10#15)(2008-5#1)(2008-8#2)(2010-4#1)(2012-11#4)(2012-3#1)(2013-8#1)
quantitative trait##112##2##(2006-12#3)(2008-10#50)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#12)(2008-9#3)(2009-10#1)(2009-2#1)(2009-4#1)(2010-2#2)(2010-4#1)(2011-1#1)(2012-1#2)(2012-11#7)(2012-3#20)(2013-8#1)
quantitative traits Q1##2##3##(2012-3#2)
quantitative traits in##4##3##(2008-8#1)(2012-1#1)(2012-3#2)
quantitative traits##31##2##(2008-10#5)(2008-12#1)(2008-4#1)(2008-8#3)(2008-9#2)(2009-2#1)(2010-10#1)(2012-1#1)(2012-3#16)
quantitative two-dimensional##3##2##(2008-2#1)(2008-3#1)(2008-4#1)
quantitative understanding of##6##3##(1991-5#1)(1996-4#1)(2006-10#2)(2008-9#1)(2009-3#1)
quantitative variables##2##2##(2011-2#1)(2012-3#1)
quantitative ways##2##2##(2008-7#1)(2010-10#1)
quantitative##1899##1##(1990-11#4)(1990-12#8)(1990-2#5)(1990-3#4)(1990-4#4)(1990-5#3)(1990-6#3)(1990-7#2)(1990-8#3)(1990-9#4)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#8)(1991-2#4)(1991-4#2)(1991-5#8)(1991-6#1)(1991-7#2)(1991-8#8)(1991-9#6)(1992-1#3)(1992-11#2)(1992-12#3)(1992-2#5)(1992-3#1)(1992-4#1)(1992-5#5)(1992-8#6)(1992-9#4)(1993-1#5)(1993-11#7)(1993-12#12)(1993-2#2)(1993-3#2)(1993-4#4)(1993-5#1)(1993-6#3)(1993-7#6)(1993-8#1)(1993-9#2)(1994-10#2)(1994-11#3)(1994-12#5)(1994-2#5)(1994-3#6)(1994-5#1)(1994-6#5)(1994-7#1)(1994-8#4)(1994-9#2)(1995-1#7)(1995-10#2)(1995-11#3)(1995-12#3)(1995-2#4)(1995-3#7)(1995-4#2)(1995-5#5)(1995-6#2)(1995-7#4)(1995-8#4)(1996-1#3)(1996-10#1)(1996-11#2)(1996-12#9)(1996-2#7)(1996-3#2)(1996-4#7)(1996-5#9)(1996-6#4)(1996-7#7)(1996-8#9)(1996-9#7)(1997-1#5)(1997-2#18)(1997-3#2)(1997-4#3)(1997-5#9)(1997-6#8)(1997-7#3)(1997-8#7)(2004-11#2)(2004-7#1)(2004-9#4)(2005-10#1)(2005-11#9)(2005-12#6)(2005-4#1)(2005-5#4)(2005-7#5)(2005-8#1)(2006-1#2)(2006-10#20)(2006-11#3)(2006-12#8)(2006-2#2)(2006-4#5)(2006-5#9)(2006-6#2)(2006-7#6)(2007-1#9)(2007-10#6)(2007-11#29)(2007-12#26)(2007-3#1)(2007-4#2)(2007-5#3)(2007-6#6)(2007-7#13)(2007-8#30)(2007-9#9)(2008-1#18)(2008-10#456)(2008-11#28)(2008-12#15)(2008-2#54)(2008-3#51)(2008-4#32)(2008-5#52)(2008-6#7)(2008-7#35)(2008-8#34)(2008-9#47)(2009-1#1)(2009-10#10)(2009-12#5)(2009-2#6)(2009-3#6)(2009-4#5)(2009-5#14)(2009-6#8)(2009-7#4)(2009-8#1)(2009-9#6)(2010-1#4)(2010-10#7)(2010-11#11)(2010-12#10)(2010-2#16)(2010-3#3)(2010-4#11)(2010-5#15)(2010-7#5)(2010-8#9)(2010-9#2)(2011-1#38)(2011-10#1)(2011-12#2)(2011-2#34)(2011-3#2)(2011-7#1)(2012-1#15)(2012-11#7)(2012-12#20)(2012-2#35)(2012-3#79)(2012-7#1)(2013-1#49)(2013-7#14)(2013-8#29)
quantitatively accurate##3##2##(2008-3#2)(2011-1#1)
quantitatively adsorbed by the##2##4##(2008-10#1)(2008-3#1)
quantitatively adsorbed on##7##3##(2008-10#7)
quantitatively adsorbed##9##2##(2008-10#8)(2008-3#1)
quantitatively analyze##5##2##(2008-2#1)(2008-4#1)(2009-7#1)(2010-6#1)(2013-1#1)
quantitatively analyzed by##3##3##(2008-10#1)(2008-2#1)(2012-3#1)
quantitatively analyzed the##2##3##(1990-10#1)(2013-8#1)
quantitatively analyzed##12##2##(1990-10#1)(1996-5#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-8#2)(2012-2#1)(2012-3#1)(2013-8#1)
quantitatively and almost all##2##4##(2008-10#1)(2008-6#1)
quantitatively and qualitatively##8##3##(1991-4#1)(1994-5#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-5#1)
quantitatively and##17##2##(1991-4#1)(1992-6#1)(1994-3#1)(1994-5#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#2)(2010-12#1)(2010-5#1)(2012-12#1)
quantitatively as##3##2##(1993-12#1)(2008-10#1)(2008-2#1)
quantitatively assess##6##2##(2007-8#1)(2008-10#2)(2008-8#1)(2011-1#1)(2013-1#1)
quantitatively assessed##4##2##(1990-4#1)(1996-12#1)(1996-3#1)(2008-11#1)
quantitatively assessing the##3##3##(2007-10#1)(2008-2#2)
quantitatively assessing##4##2##(1990-5#1)(2007-10#1)(2008-2#2)
quantitatively at##3##2##(2008-10#3)
quantitatively bound##2##2##(1995-2#1)(1995-3#1)
quantitatively by measuring the##2##4##(1990-6#1)(1997-8#1)
quantitatively by the##3##3##(1990-5#1)(2005-11#1)(2008-10#1)
quantitatively by##17##2##(1990-5#1)(1990-6#1)(1992-6#1)(1997-8#1)(2005-11#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#1)(2009-5#1)(2010-8#1)(2012-3#1)
quantitatively characterized##3##2##(1991-7#1)(1995-2#1)(2010-1#1)
quantitatively compare##2##2##(2007-9#1)(2010-12#1)
quantitatively compared to##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
quantitatively compared with those##2##4##(2008-10#1)(2009-4#1)
quantitatively compared##8##2##(2008-10#4)(2008-11#1)(2008-2#1)(2008-8#1)(2009-4#1)
quantitatively converts##2##2##(1990-11#1)(1991-4#1)
quantitatively describe##2##2##(1993-3#1)(2008-2#1)
quantitatively described by a##2##4##(1995-6#1)(2009-11#1)
quantitatively described by##3##3##(1990-5#1)(1995-6#1)(2009-11#1)
quantitatively described##4##2##(1990-5#1)(1995-6#1)(2005-11#1)(2009-11#1)
quantitatively detect##2##2##(2008-10#1)(2013-8#1)
quantitatively detects##2##2##(2008-10#1)(2009-7#1)
quantitatively determined by##2##3##(1992-12#1)(2007-8#1)
quantitatively determined in##3##3##(1996-12#1)(2008-10#1)(2011-2#1)
quantitatively determined##17##2##(1992-12#1)(1996-12#1)(1997-3#1)(2005-12#1)(2005-4#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#2)(2011-2#1)
quantitatively different from##3##3##(1990-8#1)(1993-3#1)(2008-3#1)
quantitatively different##5##2##(1990-8#1)(1993-3#1)(2004-12#1)(2008-11#1)(2008-3#1)
quantitatively diminished##2##2##(1992-11#1)(2007-11#1)
quantitatively during passage of aqueous##2##5##(2008-10#2)
quantitatively eluted from the##2##4##(2008-10#1)(2008-3#1)
quantitatively eluted with 0##2##4##(2008-10#2)
quantitatively eluted with##3##3##(2008-10#3)
quantitatively eluted##6##2##(1990-12#1)(2008-10#4)(2008-3#1)
quantitatively enriched##2##2##(2008-10#2)
quantitatively evaluate##3##2##(2007-10#1)(2008-3#1)(2010-2#1)
quantitatively evaluated by the##2##4##(1995-8#1)(2008-3#1)
quantitatively evaluated by##3##3##(1995-8#1)(2008-3#1)(2010-8#1)
quantitatively evaluated##11##2##(1995-8#1)(1996-11#1)(2006-10#1)(2007-12#1)(2008-3#1)(2009-10#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
quantitatively explain the##2##3##(2008-11#1)(2008-9#1)
quantitatively explain##4##2##(2005-11#1)(2008-11#1)(2008-7#1)(2008-9#1)
quantitatively explained##3##2##(1990-5#1)(1994-11#1)(2005-11#1)
quantitatively extracted into##2##3##(2008-10#2)
quantitatively extracted to the##2##4##(2008-10#2)
quantitatively extracted##9##2##(2008-10#8)(2010-2#1)
quantitatively for the##2##3##(2008-3#1)(2008-5#1)
quantitatively for##5##2##(2006-9#1)(2008-10#2)(2008-3#1)(2008-5#1)
quantitatively from##5##2##(2007-11#1)(2008-10#3)(2008-2#1)
quantitatively in terms of##3##4##(1991-8#2)(2008-3#1)
quantitatively in the##3##3##(1993-6#1)(2008-10#1)(2008-11#1)
quantitatively in##12##2##(1991-8#2)(1993-6#1)(1994-8#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)
quantitatively inherited##2##2##(2008-10#1)(2012-11#1)
quantitatively measure##12##2##(1992-6#2)(1994-9#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-9#1)(2012-12#2)(2013-1#2)
quantitatively measured##2##2##(1993-9#1)(2008-10#1)
quantitatively monitor##3##2##(2008-7#1)(2011-7#1)(2012-1#1)
quantitatively on a##2##3##(2008-10#2)
quantitatively on the##2##3##(1997-8#1)(2008-10#1)
quantitatively on##6##2##(1997-8#1)(2008-10#4)(2008-2#1)
quantitatively recovered##6##2##(1990-7#1)(1992-9#1)(1997-2#1)(2008-10#3)
quantitatively retained on the column##2##5##(2008-10#2)
quantitatively retained on the##3##4##(2008-10#3)
quantitatively retained on##8##3##(2008-10#8)
quantitatively retained##13##2##(2008-10#13)
quantitatively separated##2##2##(1990-6#1)(2008-10#1)
quantitatively similar##2##2##(1995-3#1)(2008-10#1)
quantitatively smaller##2##2##(1990-3#1)(2005-11#1)
quantitatively studied##2##2##(1993-12#1)(2008-8#1)
quantitatively the effect##2##3##(1996-3#1)(2009-5#1)
quantitatively the same##2##3##(1993-6#1)(1995-8#1)
quantitatively the##30##2##(1991-9#1)(1993-12#1)(1993-6#1)(1994-6#2)(1994-7#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-3#1)(2007-6#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#4)(2009-5#1)(2011-2#1)
quantitatively through##3##2##(1997-8#1)(2008-2#1)(2008-3#1)
quantitatively to##8##2##(1990-2#1)(1991-11#1)(1992-6#1)(1993-8#1)(1994-3#1)(2006-12#1)(2008-10#2)
quantitatively using##5##2##(1992-1#1)(2008-10#1)(2008-5#1)(2010-8#1)(2011-2#1)
quantitatively with the##2##3##(2008-10#1)(2008-3#1)
quantitatively with##14##2##(1990-12#1)(1992-4#1)(1997-8#1)(2006-2#1)(2008-10#6)(2008-3#2)(2008-7#1)(2010-5#1)
quantitatively##446##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-4#1)(1992-6#5)(1992-7#1)(1992-9#1)(1993-12#4)(1993-3#2)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#4)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#1)(1995-12#3)(1995-2#3)(1995-3#3)(1995-5#2)(1995-6#2)(1995-8#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-7#1)(1997-8#5)(2004-12#1)(2004-9#1)(2005-11#7)(2005-12#1)(2005-4#2)(2006-10#2)(2006-12#2)(2006-2#2)(2006-3#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#7)(2007-5#1)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#139)(2008-11#11)(2008-12#3)(2008-2#16)(2008-3#24)(2008-4#8)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#8)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#3)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#5)(2010-2#2)(2010-5#5)(2010-6#1)(2010-8#4)(2011-1#2)(2011-2#4)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#5)(2013-7#2)(2013-8#7)
quantities and##9##2##(1996-11#1)(2005-11#1)(2006-10#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#1)
quantities are##6##2##(2006-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-2#1)
quantities as##5##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)
quantities at##2##2##(2005-11#1)(2008-3#1)
quantities by##3##2##(1994-11#1)(1994-9#1)(2008-4#1)
quantities can be separated##2##4##(2008-10#1)(2008-4#1)
quantities can be##3##3##(2008-10#2)(2008-4#1)
quantities extracted from##2##3##(2007-8#1)(2008-3#1)
quantities for the##2##3##(1996-11#1)(2008-3#1)
quantities for##3##2##(1996-11#1)(2008-3#1)(2008-4#1)
quantities from##6##2##(1990-8#1)(1992-6#1)(2006-2#1)(2008-10#2)(2013-8#1)
quantities in the##3##3##(2005-11#1)(2008-10#1)(2008-2#1)
quantities in##12##2##(1994-8#1)(2005-11#1)(2007-10#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)
quantities is##2##2##(2008-3#1)(2010-2#1)
quantities obtained##2##2##(2005-11#1)(2010-6#1)
quantities of DNA of##2##4##(2008-10#2)
quantities of DNA##4##3##(2008-10#4)
quantities of a##4##3##(1990-8#1)(1993-12#1)(2008-10#1)(2008-11#1)
quantities of bacteria were##2##4##(2012-3#2)
quantities of bacteria##3##3##(2012-3#2)(2013-8#1)
quantities of data##3##3##(2007-10#1)(2008-3#1)(2008-7#1)
quantities of hydrogen##2##3##(2006-8#1)(2007-8#1)
quantities of interest##2##3##(1997-8#1)(2005-10#1)
quantities of nitrite##2##3##(1994-3#1)(2008-10#1)
quantities of one or##2##4##(1992-10#1)(2008-10#1)
quantities of protein##3##3##(2007-6#1)(2008-11#2)
quantities of pure##2##3##(2008-10#1)(2008-7#1)
quantities of purified##3##3##(1994-11#1)(1994-5#1)(2008-4#1)
quantities of the protein##2##4##(1994-11#1)(2008-9#1)
quantities of the##10##3##(1991-8#1)(1992-8#1)(1993-4#1)(1994-11#1)(1997-4#1)(2006-12#1)(2008-10#2)(2008-9#1)(2012-12#1)
quantities of these##3##3##(1996-5#1)(2008-10#1)(2008-11#1)
quantities of this##2##3##(1992-10#1)(1995-8#1)
quantities of total##2##3##(2010-3#1)(2011-2#1)
quantities of viral##2##3##(1991-2#1)(1993-9#1)
quantities of##174##2##(1990-11#1)(1990-5#1)(1990-8#3)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#2)(1991-9#1)(1992-10#2)(1992-6#4)(1992-8#1)(1992-9#1)(1993-12#2)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-3#2)(1994-5#3)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-7#1)(1997-1#1)(1997-3#2)(1997-4#2)(1997-7#1)(1997-8#1)(2004-11#1)(2004-4#3)(2005-10#1)(2005-11#3)(2005-12#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-12#2)(2006-3#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#31)(2008-11#10)(2008-3#2)(2008-4#3)(2008-5#5)(2008-7#6)(2008-9#6)(2009-10#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#2)
quantities such as the##2##4##(1997-8#1)(2008-3#1)
quantities such as##5##3##(1997-8#1)(2005-11#1)(2008-10#1)(2008-3#1)(2013-1#1)
quantities than##2##2##(2010-7#1)(2011-2#1)
quantities to##3##2##(1993-6#1)(2007-12#1)(2008-10#1)
quantities were##4##2##(1997-4#1)(2008-10#2)(2008-5#1)
quantities##332##1##(1990-11#1)(1990-5#1)(1990-6#1)(1990-8#7)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#3)(1991-9#1)(1992-10#2)(1992-4#1)(1992-6#5)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#4)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#3)(1994-3#2)(1994-5#4)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-11#3)(1996-12#2)(1996-2#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#1)(1997-7#1)(1997-8#4)(2004-11#1)(2004-2#2)(2004-4#3)(2005-10#1)(2005-11#14)(2005-12#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-3#2)(2006-4#2)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#60)(2008-11#16)(2008-2#7)(2008-3#22)(2008-4#6)(2008-5#8)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#9)(2009-10#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#2)(2011-2#2)(2012-1#6)(2012-12#6)(2012-2#4)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#3)
quantitive##2##1##(1991-5#1)(1995-11#1)
quantity and quality of##8##4##(1994-2#1)(1996-12#1)(2006-4#1)(2008-12#1)(2008-5#1)(2010-2#1)(2012-3#1)(2013-1#1)
quantity and quality##14##3##(1994-2#1)(1996-12#1)(2006-4#1)(2006-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#1)(2010-2#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
quantity and the##2##3##(2008-10#1)(2013-7#1)
quantity and##27##2##(1990-12#1)(1994-1#1)(1994-2#1)(1996-12#1)(2006-10#1)(2006-4#1)(2006-8#1)(2008-10#4)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#3)(2009-11#1)(2010-2#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
quantity as##2##2##(2008-12#1)(2013-1#1)
quantity but##2##2##(2008-11#1)(2008-9#1)
quantity for##2##2##(1997-4#1)(2005-11#1)
quantity in##5##2##(1990-5#1)(2008-2#1)(2008-3#1)(2008-5#1)(2013-1#1)
quantity is an##2##3##(2008-2#2)
quantity is##10##2##(1995-5#1)(1997-4#1)(2006-12#1)(2008-10#1)(2008-2#2)(2008-8#1)(2011-2#1)(2012-12#2)
quantity of AHLV were##2##4##(2011-1#2)
quantity of HCl##2##3##(2008-10#2)
quantity of cells##2##3##(2008-5#1)(2010-2#1)
quantity of drug##3##3##(1992-3#3)
quantity of ethanol##2##3##(1993-12#2)
quantity of food##2##3##(2008-9#2)
quantity of sperm stored by females after copulation##2##8##(2012-12#2)
quantity of the##14##3##(1990-6#1)(1994-10#1)(1994-12#1)(1996-12#1)(1997-8#1)(2005-8#1)(2008-10#5)(2008-7#1)(2008-9#1)(2010-2#1)
quantity of this##2##3##(1990-11#1)(1992-9#1)
quantity of virus##2##3##(1995-5#1)(2006-1#1)
quantity of##129##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-12#1)(1992-1#1)(1992-12#2)(1992-3#3)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#1)(1994-10#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-4#2)(1995-5#2)(1996-1#1)(1996-12#3)(1996-8#1)(1997-2#1)(1997-5#1)(1997-6#2)(1997-8#1)(2004-12#1)(2004-4#2)(2004-9#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#2)(2008-1#2)(2008-10#24)(2008-11#1)(2008-2#1)(2008-4#4)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-4#1)(2009-6#2)(2009-9#2)(2010-12#1)(2010-2#2)(2010-4#1)(2011-1#3)(2011-10#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
quantity on##2##2##(2008-10#1)(2008-9#1)
quantity or##3##2##(1992-2#1)(2008-10#1)(2012-2#1)
quantity than##2##2##(1993-4#1)(2006-12#1)
quantity that##2##2##(2006-10#1)(2008-3#1)
quantity to##3##2##(1995-6#1)(2008-5#1)(2012-2#1)
quantity was##2##2##(2008-1#1)(2008-5#1)
quantity##263##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-8#2)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-4#2)(1995-5#4)(1995-6#1)(1996-1#1)(1996-12#4)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-8#2)(2004-12#1)(2004-2#2)(2004-4#2)(2004-9#1)(2005-11#3)(2005-8#1)(2006-1#1)(2006-10#4)(2006-12#4)(2006-4#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#2)(2007-8#2)(2008-1#3)(2008-10#42)(2008-11#3)(2008-12#3)(2008-2#4)(2008-3#4)(2008-4#5)(2008-5#16)(2008-7#3)(2008-8#5)(2008-9#10)(2009-1#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-9#2)(2010-12#1)(2010-2#6)(2010-4#1)(2010-9#1)(2011-1#8)(2011-10#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#11)(2012-2#6)(2012-3#3)(2013-1#8)(2013-7#3)(2013-8#2)
quantity)##3##1##(2008-10#2)(2010-7#1)
quantization and sampling##2##3##(2008-2#2)
quantization and##4##2##(2008-2#2)(2008-6#1)(2008-7#1)
quantization errors##3##2##(2008-2#3)
quantization for diffractive##2##3##(2007-11#1)(2007-12#1)
quantization for##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
quantization noise##3##2##(2007-12#1)(2008-2#2)
quantization of a##2##3##(2007-12#1)(2008-2#1)
quantization of the##6##3##(1995-5#1)(2007-12#1)(2008-2#2)(2008-3#1)(2013-1#1)
quantization of##14##2##(1995-5#1)(2007-12#3)(2007-9#1)(2008-2#6)(2008-3#2)(2013-1#1)
quantization process##7##2##(2007-11#2)(2007-12#5)
quantization scheme##3##2##(2007-11#1)(2008-2#2)
quantization step size##2##3##(2008-2#2)
quantization##76##1##(1993-3#1)(1995-5#1)(2007-11#5)(2007-12#11)(2007-9#1)(2008-2#42)(2008-3#11)(2008-6#1)(2008-7#1)(2013-1#2)
quantized##18##1##(1993-8#1)(2007-11#1)(2007-12#4)(2007-9#1)(2008-10#1)(2008-2#4)(2008-3#4)(2008-7#1)(2013-1#1)
quantizers##3##1##(2008-2#3)
quantum Hall effect##6##3##(1993-6#1)(1993-8#1)(1994-5#1)(1995-11#1)(1995-7#1)(2007-9#1)
quantum Hall liquid##2##3##(1993-5#1)(1995-5#1)
quantum Hall regime##2##3##(1993-8#1)(2012-2#1)
quantum Hall states##3##3##(1990-4#1)(2007-9#1)(2012-2#1)
quantum Hall##18##2##(1990-4#1)(1990-7#2)(1992-5#1)(1993-5#1)(1993-6#2)(1993-8#3)(1994-5#1)(1995-11#1)(1995-5#1)(1995-7#1)(2007-9#2)(2012-2#2)
quantum Monte Carlo##2##3##(1992-9#1)(1993-3#1)
quantum and classical##3##3##(2012-2#1)(2013-1#2)
quantum and##4##2##(2012-2#2)(2013-1#2)
quantum beat##2##2##(2007-12#2)
quantum boxes located in pillar microcavities##2##6##(2007-12#2)
quantum cascade (QC) lasers##2##4##(2007-12#2)
quantum cascade (QC)##4##3##(2007-11#1)(2007-12#3)
quantum cascade distributed-feedback##2##3##(2007-11#2)
quantum cascade laser##3##3##(2007-11#2)(2007-12#1)
quantum cascade lasers##3##3##(2007-11#1)(2007-12#1)(2013-8#1)
quantum cascade##13##2##(2007-11#6)(2007-12#6)(2013-8#1)
quantum chemical calculations##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
quantum chemical descriptors##2##3##(2007-11#1)(2012-2#1)
quantum chemical method##2##3##(2008-10#1)(2012-12#1)
quantum chemical methods##2##3##(1996-8#1)(2013-8#1)
quantum chemical studies##3##3##(2010-10#1)(2013-1#2)
quantum chemical##20##2##(1996-8#1)(2005-12#1)(2007-11#1)(2008-10#3)(2008-5#2)(2010-10#1)(2010-7#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#5)(2013-8#1)
quantum chemistry (QC)##2##3##(2008-11#1)(2011-2#1)
quantum chemistry calculation##2##3##(2011-2#1)(2013-8#1)
quantum chemistry##8##2##(2005-11#1)(2008-11#1)(2011-1#2)(2011-2#2)(2011-3#1)(2013-8#1)
quantum coherence##3##2##(1991-9#1)(1993-3#1)(1995-11#1)
quantum computation##2##2##(2010-12#2)
quantum computers##2##2##(2007-9#1)(2008-7#1)
quantum computing##2##2##(2007-11#1)(2007-9#1)
quantum control##2##2##(2007-11#1)(2007-12#1)
quantum correlation##2##2##(2007-11#2)
quantum critical##2##2##(2012-2#2)
quantum cryptographic##2##2##(2008-2#2)
quantum cryptography##5##2##(1992-8#1)(2007-12#2)(2007-9#2)
quantum devices##3##2##(2007-12#3)
quantum dot and##2##3##(2008-7#1)(2010-2#1)
quantum dot fluorescence##3##3##(2008-10#1)(2011-2#2)
quantum dot##25##2##(1992-11#1)(2007-11#1)(2007-2#1)(2007-9#2)(2008-10#1)(2008-7#5)(2009-11#1)(2010-12#1)(2010-2#4)(2011-2#6)(2012-2#2)
quantum dots (QDs) by##2##4##(2008-10#1)(2009-11#1)
quantum dots (QDs)##12##3##(2008-10#4)(2008-11#1)(2009-11#2)(2009-2#1)(2010-7#1)(2013-7#2)(2013-8#1)
quantum dots allow##2##3##(2007-9#1)(2009-10#1)
quantum dots and##8##3##(2007-8#3)(2008-10#2)(2008-7#1)(2009-12#1)(2010-2#1)
quantum dots are##2##3##(2008-7#1)(2012-2#1)
quantum dots as##4##3##(2007-11#2)(2008-10#1)(2013-8#1)
quantum dots embedded in##2##4##(2007-11#1)(2010-2#1)
quantum dots for##2##3##(2008-3#1)(2013-7#1)
quantum dots in##6##3##(2007-11#3)(2007-2#1)(2008-10#1)(2008-5#1)
quantum dots on the##3##4##(2008-7#1)(2009-11#1)(2009-12#1)
quantum dots on##5##3##(2008-7#3)(2009-11#1)(2009-12#1)
quantum dots to##2##3##(2008-7#1)(2009-12#1)
quantum dots was##3##3##(2007-11#2)(2008-3#1)
quantum dots##91##2##(1992-6#1)(1994-5#1)(1995-3#2)(2007-11#12)(2007-12#5)(2007-2#1)(2007-8#4)(2007-9#1)(2008-10#16)(2008-11#1)(2008-3#4)(2008-5#1)(2008-7#13)(2009-10#1)(2009-11#6)(2009-12#5)(2009-2#4)(2009-6#1)(2010-2#3)(2010-7#1)(2012-11#1)(2012-2#1)(2013-7#3)(2013-8#3)
quantum effects in##2##3##(2007-11#1)(2008-11#1)
quantum efficiencies##3##2##(2004-4#1)(2008-2#2)
quantum efficiency and##2##3##(2008-2#1)(2008-4#1)
quantum efficiency is##2##3##(2007-11#1)(2008-1#1)
quantum efficiency of##8##3##(2007-11#2)(2007-12#4)(2008-2#2)
quantum efficiency was##2##3##(2007-11#1)(2008-2#1)
quantum efficiency##29##2##(2007-11#5)(2007-12#8)(2008-1#1)(2008-10#1)(2008-2#7)(2008-3#4)(2008-4#2)(2010-4#1)
quantum electrodynamics##2##2##(2007-11#1)(2008-3#1)
quantum fluctuations##2##2##(2007-12#1)(2012-2#1)
quantum information##3##2##(2007-12#1)(2010-12#1)(2012-2#1)
quantum interference in##5##3##(1992-11#1)(2007-11#3)(2007-12#1)
quantum interference##9##2##(1992-11#1)(2007-11#4)(2007-12#1)(2008-2#1)(2008-7#2)
quantum key distribution##3##3##(2007-11#2)(2007-12#1)
quantum limit##5##2##(2007-12#3)(2008-2#1)(2008-3#1)
quantum mechanical (QM)##2##3##(2006-10#1)(2008-10#1)
quantum mechanical calculations##2##3##(2006-8#1)(2010-5#1)
quantum mechanical methods to##2##4##(2005-9#1)(2006-8#1)
quantum mechanical##11##2##(2005-9#1)(2006-10#1)(2006-8#2)(2008-10#1)(2008-11#1)(2009-2#1)(2010-5#1)(2011-2#1)(2012-2#2)
quantum mechanics and##2##3##(1994-7#1)(2008-5#1)
quantum mechanics##16##2##(1993-6#1)(1994-7#1)(1995-2#1)(1996-5#1)(2007-12#1)(2007-9#3)(2008-1#1)(2008-2#1)(2008-5#2)(2009-3#1)(2010-10#1)(2010-2#1)(2012-2#1)
quantum noise in##3##3##(1992-8#1)(2007-11#1)(2007-12#1)
quantum noise on the##2##4##(2007-11#1)(2007-12#1)
quantum noise##10##2##(1992-8#1)(2007-11#2)(2007-12#6)(2008-2#1)
quantum nondemolition##2##2##(2007-12#1)(2008-3#1)
quantum partition function##2##3##(2009-9#2)
quantum phase##2##2##(2007-12#1)(2008-7#1)
quantum physics##4##2##(2006-2#1)(2007-9#1)(2009-9#1)(2012-2#1)
quantum rods##2##2##(2010-2#2)
quantum size effect##3##3##(2005-11#2)(2010-7#1)
quantum size##4##2##(1993-5#1)(2005-11#2)(2010-7#1)
quantum state##3##2##(1993-3#1)(1993-5#1)(2007-12#1)
quantum states##3##2##(1994-5#1)(2007-12#1)(2007-9#1)
quantum structure##2##2##(1992-9#1)(1995-3#1)
quantum systems##6##2##(1993-8#1)(1995-10#1)(2008-7#1)(2010-12#2)(2010-7#1)
quantum teleportation##2##2##(2007-12#2)
quantum theory##3##2##(2007-9#2)(2008-3#1)
quantum wave##2##2##(1995-7#1)(2007-11#1)
quantum well structure can be used to produce##2##8##(2008-2#2)
quantum well structure##3##3##(2008-2#2)(2008-3#1)
quantum well with a##3##4##(2007-12#3)
quantum well with##4##3##(2007-12#3)(2008-2#1)
quantum well##17##2##(1995-2#1)(2007-12#10)(2008-2#5)(2008-3#1)
quantum wells near the##2##4##(2007-12#2)
quantum wells##30##2##(1991-11#1)(1991-12#2)(1992-12#1)(1994-2#1)(1995-7#1)(2007-11#3)(2007-12#14)(2008-2#6)(2008-3#1)
quantum wires##2##2##(1991-11#1)(1995-10#1)
quantum yield and##3##3##(1992-2#1)(2008-9#1)(2010-4#1)
quantum yield for##3##3##(1990-3#1)(1992-7#1)(2005-11#1)
quantum yield of 0##2##4##(1995-8#1)(2007-12#1)
quantum yield of##13##3##(1991-2#1)(1992-12#1)(1992-2#1)(1994-12#1)(1995-8#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)
quantum yield##42##2##(1990-3#1)(1991-2#1)(1992-12#2)(1992-2#2)(1992-4#1)(1992-7#1)(1994-12#2)(1995-8#1)(1997-7#1)(2005-11#2)(2007-12#2)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-9#6)(2009-4#1)(2009-7#1)(2010-4#1)
quantum yields of##3##3##(2008-7#1)(2009-2#1)(2012-11#1)
quantum yields were##2##3##(2008-2#1)(2009-5#1)
quantum yields##19##2##(1990-4#1)(1991-7#1)(1996-2#1)(2006-12#1)(2007-8#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-2#2)(2009-5#1)(2010-2#1)(2012-11#1)
quantum yields) of##3##3##(1990-4#2)(2008-5#1)
quantum##532##1##(1990-12#1)(1990-3#1)(1990-4#4)(1990-7#2)(1990-8#1)(1991-11#3)(1991-12#3)(1991-2#1)(1991-7#1)(1991-9#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#3)(1993-3#6)(1993-5#3)(1993-6#4)(1993-8#4)(1994-12#2)(1994-2#1)(1994-5#3)(1994-7#1)(1995-10#3)(1995-11#2)(1995-2#3)(1995-3#3)(1995-5#2)(1995-7#6)(1995-8#4)(1996-2#1)(1996-5#1)(1996-8#1)(1997-7#1)(2004-4#1)(2005-11#5)(2005-12#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#2)(2007-11#48)(2007-12#88)(2007-2#2)(2007-8#8)(2007-9#18)(2008-1#3)(2008-10#39)(2008-11#6)(2008-2#32)(2008-3#21)(2008-4#3)(2008-5#8)(2008-7#28)(2008-9#6)(2009-10#1)(2009-11#7)(2009-12#5)(2009-2#8)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#7)(2010-10#2)(2010-12#12)(2010-2#12)(2010-4#2)(2010-5#1)(2010-7#5)(2011-1#2)(2011-2#9)(2011-3#2)(2012-11#2)(2012-12#1)(2012-2#23)(2013-1#7)(2013-7#3)(2013-8#6)
quantum-cascade (QC) lasers##2##3##(2007-12#1)(2008-3#1)
quantum-cascade distributed-feedback laser##2##3##(2007-12#1)(2008-3#1)
quantum-cascade distributed-feedback lasers##2##3##(2007-12#2)
quantum-cascade distributed-feedback##5##2##(2007-12#4)(2008-3#1)
quantum-cascade laser##2##2##(2007-12#1)(2008-3#1)
quantum-cascade lasers##6##2##(2007-11#2)(2007-12#2)(2008-3#2)
quantum-cascade##17##1##(2007-11#2)(2007-12#8)(2008-3#7)
quantum-chemical calculations##3##2##(1994-7#1)(2006-12#1)(2007-12#1)
quantum-chemical##6##1##(1994-7#1)(2005-12#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)
quantum-confined##2##1##(1990-12#1)(2008-7#1)
quantum-dot##3##1##(2006-12#1)(2007-12#2)
quantum-limited##6##1##(2007-11#2)(2007-12#2)(2008-1#1)(2008-3#1)
quantum-mechanical##2##1##(2008-2#1)(2009-3#1)
quantum-noise reduction##2##2##(2007-11#2)
quantum-noise##5##1##(2007-11#2)(2007-12#3)
quantum-noise-limited##2##1##(2007-12#1)(2008-3#1)
quantum-sized ZnO was##2##3##(2009-8#2)
quantum-sized ZnO##3##2##(2009-8#3)
quantum-sized##4##1##(2008-10#1)(2009-8#3)
quantum-statistical##2##1##(2009-9#1)(2010-12#1)
quantum-well intermixing##2##2##(2007-12#1)(2008-1#1)
quantum-well lasers##3##2##(2008-3#3)
quantum-well##10##1##(1994-5#1)(2007-12#2)(2008-1#2)(2008-3#5)
quarantine and##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
quarantine barriers##2##2##(2008-10#1)(2011-2#1)
quarantine in Denmark##2##3##(2008-5#2)
quarantine measures##5##2##(2008-10#4)(2012-2#1)
quarantine pest##2##2##(2008-10#1)(2011-2#1)
quarantine##46##1##(1992-6#1)(1996-11#1)(1996-8#1)(1997-3#1)(2005-5#1)(2007-12#1)(2007-5#1)(2008-10#20)(2008-12#1)(2008-5#6)(2010-3#1)(2011-2#4)(2012-2#5)(2013-1#1)(2013-8#1)
quarantined##2##1##(2008-10#1)(2013-1#1)
quarks##3##1##(1992-5#1)(2007-8#2)
quarries##2##1##(2008-10#2)
quarry##4##1##(1991-11#1)(2008-10#1)(2010-4#1)(2012-12#1)
quarter 1995##3##2##(1995-12#1)(1997-1#1)(1997-2#1)
quarter and center layer##2##4##(2013-8#2)
quarter and##3##2##(2010-8#1)(2013-8#2)
quarter as##2##2##(1991-3#1)(1993-3#1)
quarter cases##2##2##(1996-8#2)
quarter century##4##2##(2006-7#1)(2007-12#1)(2009-12#1)(2011-2#1)
quarter milk samples##3##3##(1993-2#3)
quarter of 1997##2##3##(2008-5#2)
quarter of 1998##2##3##(2005-8#1)(2007-2#1)
quarter of 1999##3##3##(2005-8#1)(2008-5#2)
quarter of 2000##3##3##(2005-6#1)(2005-7#2)
quarter of the adult population##2##5##(2008-11#1)(2013-1#1)
quarter of the children##2##4##(2006-10#1)(2012-2#1)
quarter of the##18##3##(1991-3#2)(1993-12#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)
quarter of them##2##3##(2008-5#1)(2008-7#1)
quarter of##42##2##(1990-12#1)(1990-5#1)(1991-3#2)(1992-3#2)(1992-6#2)(1993-12#1)(1996-9#1)(2005-6#1)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#2)(2006-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#5)(2008-7#1)(2009-3#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
quarter##80##1##(1990-12#1)(1990-5#1)(1991-3#4)(1992-3#2)(1992-6#3)(1992-9#1)(1993-12#1)(1993-2#4)(1993-3#3)(1995-12#1)(1995-5#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#1)(2005-6#1)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-7#1)(2009-12#1)(2009-3#1)(2010-11#1)(2010-8#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#2)
quarter-wave liquid-crystal cell for a high-contrast reflective display##2##8##(2007-12#2)
quarter-wave plate (QWP)##2##3##(2008-2#1)(2008-3#1)
quarter-wave plate and##2##3##(2008-2#1)(2008-3#1)
quarter-wave plate##11##2##(2007-12#5)(2008-2#3)(2008-3#3)
quarter-wave plates##5##2##(2006-5#1)(2007-11#1)(2008-3#3)
quarter-wave retardance##2##2##(2008-2#2)
quarter-wave retarder##2##2##(2007-12#1)(2008-2#1)
quarter-wave stacks##2##2##(2008-3#2)
quarter-wave##32##1##(2006-5#1)(2007-11#2)(2007-12#8)(2008-2#8)(2008-3#13)
quarter-wavelength##4##1##(2007-11#1)(2007-12#2)(2008-3#1)
quartered##2##1##(2008-10#1)(2012-2#1)
quarterly##14##1##(1995-2#1)(1995-3#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(2007-4#1)(2008-5#1)(2009-3#5)(2012-3#1)
quarters of the cows in##2##5##(1990-6#2)
quarters of the##3##3##(1990-6#2)(1992-8#1)
quarters of##7##2##(1990-6#2)(1992-8#1)(2007-2#1)(2007-5#1)(2010-6#1)(2012-2#1)
quarters##19##1##(1990-6#3)(1991-5#1)(1992-8#1)(1996-3#2)(1996-8#2)(1997-8#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-5#1)(2010-5#1)(2010-6#1)(2012-2#1)(2012-3#2)
quartet of##4##2##(1992-9#1)(1995-12#1)(2008-5#2)
quartet##8##1##(1992-9#3)(1995-12#1)(1997-7#1)(2008-4#1)(2008-5#2)
quartets##6##1##(1995-2#1)(1997-5#1)(1997-6#1)(2008-4#1)(2013-1#2)
quartic##3##1##(2006-4#2)(2007-12#1)
quartile for##2##2##(2010-4#1)(2010-8#1)
quartile of##9##2##(2007-10#1)(2008-3#1)(2008-7#1)(2010-4#2)(2011-2#3)(2013-1#1)
quartile##26##1##(2007-10#5)(2007-8#1)(2008-3#2)(2008-7#1)(2009-3#3)(2010-4#4)(2010-8#1)(2010-9#1)(2011-2#6)(2012-12#1)(2013-1#1)
quartile)##2##1##(2007-11#1)(2013-1#1)
quartiles of##2##2##(1993-4#1)(2011-2#1)
quartiles were##2##2##(2007-10#1)(2011-2#1)
quartiles##8##1##(1991-5#1)(1993-4#1)(1996-9#1)(2007-10#1)(2008-9#1)(2009-3#1)(2011-2#2)
quartiles) in##2##2##(1994-5#2)
quartiles)##5##1##(1994-5#5)
quartz (SiO(2))##2##2##(2005-11#1)(2008-3#1)
quartz and##8##2##(2005-11#1)(2005-4#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#1)
quartz as##2##2##(2005-11#1)(2007-8#1)
quartz cell##5##2##(2005-11#1)(2008-10#4)
quartz crystal impedance analysis##2##4##(2008-10#2)
quartz crystal impedance##6##3##(2008-10#6)
quartz crystal in##3##3##(2008-10#2)(2013-8#1)
quartz crystal microbalance (QCM) in##2##5##(1996-11#1)(2009-6#1)
quartz crystal microbalance (QCM) was##2##5##(2008-10#2)
quartz crystal microbalance (QCM)##15##4##(1996-11#1)(2007-11#1)(2008-10#11)(2009-6#1)(2011-1#1)
quartz crystal microbalance was used##2##5##(2005-11#1)(2008-10#1)
quartz crystal microbalance##41##3##(1996-11#1)(2005-11#7)(2007-11#1)(2007-8#4)(2008-10#25)(2009-6#1)(2010-4#1)(2011-1#1)
quartz crystal sensor##2##3##(2007-8#1)(2008-10#1)
quartz crystal was##2##3##(2007-8#1)(2008-10#1)
quartz crystal##84##2##(1996-11#1)(2005-11#7)(2007-11#1)(2007-8#9)(2008-10#57)(2008-2#1)(2008-3#1)(2009-5#2)(2009-6#1)(2010-4#1)(2011-1#1)(2013-8#2)
quartz crystals##3##2##(2007-12#1)(2008-10#2)
quartz cuvette##2##2##(2007-12#1)(2008-2#1)
quartz fiber##6##2##(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)
quartz filter##2##2##(2008-10#2)
quartz filters##2##2##(2008-5#2)
quartz flow cell##3##3##(2008-10#3)
quartz glass by##2##3##(2008-3#2)
quartz glass##4##2##(2007-8#1)(2008-10#1)(2008-3#2)
quartz in the##3##3##(2010-5#1)(2013-8#2)
quartz in##7##2##(2008-10#1)(2010-5#1)(2013-8#5)
quartz or##2##2##(2008-10#1)(2008-5#1)
quartz plate##5##2##(2007-11#2)(2007-9#1)(2008-2#1)(2008-3#1)
quartz plates##3##2##(2005-11#1)(2008-3#2)
quartz sand##3##2##(2008-2#2)(2008-6#1)
quartz substrate##5##2##(2007-12#2)(2008-2#1)(2008-5#1)(2009-11#1)
quartz substrates##3##2##(2007-12#2)(2008-10#1)
quartz surface##3##2##(2005-11#1)(2008-10#2)
quartz surfaces##4##2##(2008-10#4)
quartz was##3##2##(2005-11#1)(2008-1#1)(2008-5#1)
quartz##215##1##(1990-8#1)(1996-11#1)(2005-11#19)(2005-4#1)(2006-5#1)(2007-11#3)(2007-12#16)(2007-8#12)(2007-9#1)(2008-1#3)(2008-10#97)(2008-2#9)(2008-3#17)(2008-5#8)(2008-6#1)(2008-7#1)(2009-11#1)(2009-5#2)(2009-6#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-8#15)
quartz-crystal microbalance##2##2##(2007-8#1)(2010-4#1)
quartz-crystal##3##1##(2007-8#1)(2008-10#1)(2010-4#1)
quartz-crystal-microbalance##3##1##(2008-10#2)(2010-4#1)
quartz-enhanced photoacoustic spectroscopy##4##3##(2013-8#4)
quartz-glass##2##1##(2008-2#1)(2008-3#1)
quasars##2##1##(2007-8#1)(2007-9#1)
quasi extinction##2##2##(2008-8#2)
quasi phase matching in a##2##5##(2007-12#2)
quasi phase matching##4##3##(2007-11#2)(2007-12#2)
quasi phase##5##2##(2007-11#3)(2007-12#2)
quasi solitons##2##2##(2007-12#2)
quasi##23##1##(1994-8#1)(2007-11#3)(2007-12#7)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2012-2#2)
quasi-Newton##3##1##(2008-2#2)(2008-3#1)
quasi-brush##2##1##(2005-11#2)
quasi-chemical##3##1##(2008-3#1)(2008-5#2)
quasi-circulator with##3##2##(2007-12#3)
quasi-continuous##5##1##(2008-11#2)(2008-2#1)(2008-3#2)
quasi-cw diode-pumped Nd##2##3##(2007-11#1)(2008-1#1)
quasi-cw mode##2##2##(2007-12#1)(2008-3#1)
quasi-cw##9##1##(2007-11#1)(2007-12#3)(2008-1#2)(2008-2#1)(2008-3#2)
quasi-elastic light scattering##7##3##(1997-1#1)(2008-10#2)(2008-2#2)(2008-3#2)
quasi-elastic light-scattering##2##2##(2008-2#2)
quasi-elastic##11##1##(1995-3#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#2)
quasi-end-pumping##2##1##(2007-12#2)
quasi-equivalent##3##1##(1994-9#2)(2007-12#1)
quasi-experimental design##5##2##(2008-11#1)(2008-2#1)(2010-12#1)(2013-1#2)
quasi-experimental evaluation##2##2##(1995-1#1)(2008-12#1)
quasi-experimental studies##2##2##(2007-11#2)
quasi-experimental study##7##2##(2008-12#2)(2008-4#1)(2012-1#1)(2013-1#2)(2013-7#1)
quasi-experimental##22##1##(1993-11#1)(1995-1#1)(1996-3#1)(2006-12#1)(2007-11#2)(2007-2#1)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-1#4)(2013-7#1)
quasi-firm##3##1##(1992-12#3)
quasi-firms##2##1##(1992-12#2)
quasi-infinite##4##1##(2007-12#2)(2008-10#1)(2008-7#1)
quasi-likelihood##5##1##(1993-9#2)(2008-4#1)(2010-12#2)
quasi-linear constitutive##2##2##(2006-11#2)
quasi-linear##10##1##(2006-11#3)(2007-11#5)(2008-10#1)(2008-3#1)
quasi-monochromatic light##2##2##(2008-3#2)
quasi-monochromatic##15##1##(2007-11#1)(2007-12#6)(2008-2#1)(2008-3#6)(2012-1#1)
quasi-optical##4##1##(2007-12#2)(2008-3#1)(2011-1#1)
quasi-periodic optical superlattice##2##3##(2007-11#2)
quasi-periodic structure##2##2##(2007-11#1)(2007-12#1)
quasi-periodic##9##1##(1994-7#1)(2007-11#4)(2007-12#1)(2008-3#3)
quasi-periodically domain-inverted##2##2##(2008-1#2)
quasi-periodically##3##1##(1996-4#1)(2008-1#2)
quasi-phase matched##2##2##(2007-12#2)
quasi-phase matching in a##2##4##(2007-12#2)
quasi-phase matching in##4##3##(2007-11#1)(2007-12#2)(2008-1#1)
quasi-phase matching##13##2##(2007-11#4)(2007-12#8)(2008-1#1)
quasi-phase##17##1##(2007-11#4)(2007-12#12)(2008-1#1)
quasi-phase-matched GaAs crystal##3##3##(2007-12#3)
quasi-phase-matched KTiOPO(4)##2##2##(2007-12#2)
quasi-phase-matched crystal##2##2##(2007-12#2)
quasi-phase-matched device##3##2##(2007-11#1)(2008-2#2)
quasi-phase-matched frequency doubling##3##3##(2007-12#3)
quasi-phase-matched generation of##2##3##(2007-12#2)
quasi-phase-matched optical parametric##2##3##(2007-12#2)
quasi-phase-matched parametric##3##2##(2007-12#3)
quasi-phase-matched periodically poled##2##3##(2007-12#2)
quasi-phase-matched second-harmonic generation in##2##4##(2007-11#1)(2008-1#1)
quasi-phase-matched second-harmonic generation##8##3##(2007-11#2)(2007-12#4)(2008-1#1)(2008-3#1)
quasi-phase-matched##68##1##(2007-11#8)(2007-12#52)(2008-1#4)(2008-2#2)(2008-3#2)
quasi-phase-matching (QPM) grating##2##3##(2007-12#1)(2008-1#1)
quasi-phase-matching (QPM)##3##2##(2007-12#2)(2008-1#1)
quasi-phase-matching grating##3##2##(2007-11#1)(2007-12#2)
quasi-phase-matching gratings##6##2##(2007-11#2)(2007-12#4)
quasi-phase-matching period##2##2##(2007-12#2)
quasi-phase-matching##20##1##(2007-11#3)(2007-12#14)(2008-1#2)(2008-3#1)
quasi-public##2##1##(2008-3#1)(2010-9#1)
quasi-real-time##2##1##(2007-11#1)(2008-2#1)
quasi-reversible##6##1##(1990-5#1)(2007-8#1)(2008-10#3)(2008-5#1)
quasi-simultaneous##2##1##(2008-10#1)(2008-3#1)
quasi-solid-state##2##1##(2010-4#2)
quasi-solitons##2##1##(2007-12#2)
quasi-species##4##1##(1995-1#1)(1997-6#1)(2006-10#1)(2012-2#1)
quasi-stadium laser diodes##2##3##(2007-11#2)
quasi-static and##3##2##(2008-2#2)(2008-3#1)
quasi-static elastography##3##2##(2010-8#3)
quasi-static rate##2##2##(2007-1#2)
quasi-static roll tilt##2##3##(2012-2#2)
quasi-static##20##1##(2007-1#6)(2007-4#1)(2008-2#5)(2008-3#2)(2010-8#3)(2012-2#3)
quasi-steady state##2##2##(2005-11#1)(2008-9#1)
quasi-steady##3##1##(2005-11#1)(2008-7#1)(2008-9#1)
quasi-steady-state##2##1##(2007-12#2)
quasi-three-dimensional##2##1##(2007-12#1)(2009-11#1)
quasi-three-level longitudinally pumped##2##3##(2008-3#2)
quasi-three-level##3##1##(2008-2#1)(2008-3#2)
quasi-transparent##2##1##(2008-2#1)(2010-7#1)
quasicontinuous##2##1##(1997-5#1)(2008-11#1)
quasicrystalline##2##1##(2006-5#1)(2007-9#1)
quasicrystals##5##1##(1994-10#1)(2005-11#1)(2006-4#1)(2006-5#1)(2012-2#1)
quasielastic light scattering (QLS)##2##4##(1990-2#2)
quasielastic light scattering##3##3##(1990-2#2)(1992-3#1)
quasielastic##5##1##(1990-2#2)(1991-12#1)(1991-4#1)(1992-3#1)
quasiexperimental##2##1##(2007-10#1)(2010-8#1)
quasilikelihood##3##1##(2009-5#1)(2010-2#2)
quasiparticle##2##1##(1994-2#1)(1995-7#1)
quasispecies##12##1##(1996-11#1)(1997-3#1)(2006-10#1)(2009-9#1)(2013-1#1)(2013-8#7)
quasistatic##5##1##(1996-4#2)(2007-2#2)(2012-2#1)
quassinoids##3##1##(2007-1#3)
quaternary Bohr##2##2##(1994-8#1)(1997-2#1)
quaternary T structure##2##3##(1994-8#2)
quaternary T##4##2##(1994-8#4)
quaternary alkylammonium cations##2##3##(2008-10#2)
quaternary amine##2##2##(2009-8#1)(2013-7#1)
quaternary ammonium groups##2##3##(2009-10#2)
quaternary ammonium ion##3##3##(2008-10#2)(2013-1#1)
quaternary ammonium ions##3##3##(2008-10#3)
quaternary ammonium methacrylate polymer##2##4##(2013-7#2)
quaternary ammonium salt is##2##4##(2008-10#2)
quaternary ammonium salt##3##3##(2008-10#2)(2010-4#1)
quaternary ammonium salts in##2##4##(2008-10#2)
quaternary ammonium salts##3##3##(2008-10#3)
quaternary ammonium##36##2##(1994-9#2)(2005-11#3)(2007-8#1)(2008-10#19)(2008-3#1)(2009-10#2)(2010-4#1)(2011-2#1)(2013-1#1)(2013-7#5)
quaternary assembly##2##2##(1994-8#2)
quaternary carbon##3##2##(1996-5#1)(2007-11#1)(2008-6#1)
quaternary chloride##2##2##(1997-2#2)
quaternary complex##4##2##(1994-9#3)(1995-8#1)
quaternary complexes##2##2##(1994-9#1)(2012-2#1)
quaternary enhancement effect##4##3##(1990-8#1)(1997-2#3)
quaternary enhancement##10##2##(1990-8#6)(1997-2#4)
quaternary mixtures of##2##3##(2008-10#2)
quaternary mixtures##5##2##(2008-10#4)(2013-8#1)
quaternary state##2##2##(1990-8#1)(1990-9#1)
quaternary structural##3##2##(1990-8#2)(2008-4#1)
quaternary structure and##2##3##(1991-5#1)(1992-11#1)
quaternary structure as##2##3##(2008-4#1)(2009-10#1)
quaternary structure has##2##3##(1993-6#1)(2008-4#1)
quaternary structure of##7##3##(1990-8#1)(1991-5#1)(1992-2#1)(1994-8#1)(1995-5#1)(1996-7#1)(2008-4#1)
quaternary structure##24##2##(1990-4#1)(1990-8#2)(1990-9#1)(1991-5#4)(1992-11#1)(1992-2#1)(1993-6#2)(1994-8#1)(1995-5#1)(1996-7#1)(1997-2#1)(2008-4#7)(2009-10#1)
quaternary##128##1##(1990-11#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#13)(1990-9#3)(1991-11#1)(1991-3#1)(1991-5#4)(1991-7#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-6#2)(1994-8#10)(1994-9#6)(1995-11#1)(1995-5#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-2#9)(2005-11#3)(2005-8#1)(2006-12#1)(2007-11#1)(2007-8#2)(2008-10#29)(2008-3#2)(2008-4#9)(2008-6#1)(2008-7#1)(2009-10#3)(2009-8#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#6)(2013-8#2)
quaternization##2##1##(2005-11#1)(2010-4#1)
quaternized##10##1##(1995-3#2)(2007-8#1)(2008-10#3)(2008-5#2)(2010-4#2)
quatrième ventricule##2##2##(2013-1#2)
quattrocistronic artificial##2##2##(2008-11#2)
qubit##2##1##(2008-7#2)
qubits##5##1##(2008-7#4)(2012-2#1)
que la##4##2##(2008-5#3)(2012-2#1)
que le##2##2##(2008-5#1)(2013-1#1)
que les##5##2##(2008-11#1)(2008-5#2)(2012-2#2)
que##19##1##(2008-11#2)(2008-5#9)(2009-4#2)(2012-2#4)(2013-1#2)
quebec##2##1##(2008-10#1)(2012-2#1)
queen honey bees##2##3##(2009-5#2)
queen number##2##2##(2008-5#1)(2008-8#1)
queen of France##2##3##(2007-3#2)
queen##17##1##(1991-2#1)(2007-12#2)(2007-3#2)(2007-5#1)(2007-7#1)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#1)(2009-5#2)(2010-3#1)
queen)##2##1##(2008-5#2)
queen-worker conflict over reproductive allocation##3##5##(2008-8#3)
queen-worker conflict over##4##3##(2008-8#4)
queens and workers##4##3##(2008-8#4)
queens and##7##2##(2007-12#2)(2008-5#1)(2008-8#4)
queens in##4##2##(2007-12#1)(2008-5#2)(2008-8#1)
queens##21##1##(2007-12#7)(2008-11#1)(2008-5#4)(2008-8#7)(2009-5#2)
queer and trans patients##3##4##(2012-11#3)
queer##7##1##(2009-7#3)(2012-11#4)
queers##3##1##(2012-11#3)
queleas##3##1##(2008-8#3)
quench of cellular fura-2##3##4##(1992-5#3)
quench of##5##2##(1990-5#1)(1992-5#4)
quench the fluorescence of##5##4##(1995-5#1)(1997-4#1)(2008-10#2)(2008-9#1)
quench the##10##2##(1995-5#1)(1996-2#1)(1997-4#1)(2006-10#2)(2008-10#2)(2008-8#1)(2008-9#1)(2010-7#1)
quench##28##1##(1990-5#1)(1991-4#1)(1992-5#7)(1992-9#1)(1995-5#1)(1996-2#1)(1996-7#1)(1997-4#1)(2006-10#3)(2007-4#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-7#1)
quench-flow##4##1##(1990-2#3)(1994-11#1)
quenched at##2##2##(2007-12#1)(2008-3#1)
quenched by addition of##2##4##(1992-5#2)
quenched by##12##2##(1992-5#2)(1996-9#1)(1997-7#1)(2005-11#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-7#1)(2008-8#1)
quenched fluorescence##4##2##(2008-10#3)(2008-7#1)
quenched in the##3##3##(1993-9#1)(2005-4#1)(2008-10#1)
quenched in##4##2##(1993-9#1)(1996-6#1)(2005-4#1)(2008-10#1)
quenched the##3##2##(1994-9#1)(1995-6#2)
quenched##42##1##(1990-12#1)(1992-5#2)(1992-6#1)(1992-7#1)(1993-9#1)(1994-9#2)(1995-2#1)(1995-6#2)(1996-4#1)(1996-6#1)(1996-9#1)(1997-7#1)(2005-11#1)(2005-4#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#10)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-8#1)
quencher in##3##2##(1997-2#1)(2008-10#2)
quencher of##3##2##(1990-1#1)(1994-5#1)(2012-11#1)
quencher##31##1##(1990-1#1)(1990-8#1)(1991-5#1)(1991-7#1)(1992-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-2#1)(1996-9#3)(1997-2#2)(2005-11#3)(2006-10#1)(2007-11#1)(2008-10#5)(2008-3#2)(2008-5#1)(2008-9#1)(2010-5#1)(2012-11#1)
quenchers like##2##2##(1991-2#1)(1993-3#1)
quenchers of##2##2##(1990-11#1)(1992-6#1)
quenchers that##2##2##(1992-6#1)(1994-3#1)
quenchers##11##1##(1990-11#1)(1991-2#1)(1992-12#1)(1992-6#2)(1993-3#1)(1994-3#2)(2006-10#1)(2008-5#1)(2008-7#1)
quenches the fluorescence##2##3##(2008-10#2)
quenches the##5##2##(1992-3#1)(2007-12#1)(2008-10#3)
quenches##10##1##(1992-10#1)(1992-3#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-10#4)(2012-2#1)
quenching action of##2##3##(2005-4#1)(2008-10#1)
quenching and##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
quenching by a##2##3##(1990-3#1)(1994-5#1)
quenching by##13##2##(1990-3#1)(1991-2#1)(1992-12#1)(1994-5#1)(1996-1#1)(1997-1#1)(1997-7#1)(2006-10#1)(2008-10#3)(2008-6#1)(2008-8#1)
quenching component is##2##3##(2006-10#2)
quenching constant##5##2##(1997-1#1)(2008-10#3)(2008-9#1)
quenching constants were##2##3##(1991-7#1)(2008-10#1)
quenching constants##5##2##(1991-7#1)(1992-7#1)(2007-11#1)(2008-10#2)
quenching corrections##2##2##(2008-2#2)
quenching cross sections for##2##4##(2008-2#2)
quenching data##5##2##(1995-6#1)(1997-4#1)(2008-10#2)(2008-4#1)
quenching effect of##5##3##(2005-4#1)(2008-10#3)(2013-8#1)
quenching effect on 8-OHdG formation##2##5##(2008-4#2)
quenching effect on##5##3##(1992-7#1)(2008-10#1)(2008-4#3)
quenching effect##15##2##(1992-7#1)(2005-4#1)(2007-12#1)(2008-10#8)(2008-4#3)(2013-8#1)
quenching efficiencies##2##2##(1990-4#1)(2005-11#1)
quenching efficiency##4##2##(1994-5#1)(2006-10#1)(2013-8#2)
quenching experiments##3##2##(1995-8#1)(1997-4#1)(1997-8#1)
quenching for##2##2##(2007-8#1)(2008-3#1)
quenching group##2##2##(1991-5#2)
quenching in a##2##3##(1993-3#1)(2006-10#1)
quenching in##11##2##(1992-12#1)(1993-3#2)(1997-4#1)(2005-11#1)(2006-10#3)(2008-2#1)(2008-3#1)(2008-7#1)
quenching intensity##2##2##(2008-10#1)(2013-8#1)
quenching is##3##2##(1995-5#1)(2006-10#1)(2008-10#1)
quenching measurements##3##2##(1993-3#1)(2006-10#1)(2008-2#1)
quenching mechanism is##3##3##(1993-3#1)(2008-10#2)
quenching mechanism##4##2##(1990-2#1)(1993-3#1)(2008-10#2)
quenching method for the determination of##2##6##(2005-4#1)(2008-10#1)
quenching method was##2##3##(2008-10#2)
quenching method##8##2##(2005-4#1)(2008-10#7)
quenching methods##2##2##(2008-4#2)
quenching of a##4##3##(2008-10#3)(2013-8#1)
quenching of conjugated##2##3##(2009-11#2)
quenching of dansyl fluorescence##2##4##(2008-10#2)
quenching of enzyme##2##3##(1997-1#2)
quenching of fluorescence##3##3##(1994-11#1)(1994-12#1)(2008-10#1)
quenching of intrinsic fluorescence##2##4##(1992-6#1)(1995-5#1)
quenching of protein fluorescence##2##4##(1990-5#1)(1995-8#1)
quenching of the Trp##2##4##(2008-4#1)(2008-5#1)
quenching of the fluorescence of##2##5##(2008-10#2)
quenching of the fluorescence##4##4##(2008-10#3)(2008-3#1)
quenching of the protein##2##4##(1992-12#1)(1994-6#1)
quenching of the##24##3##(1991-7#1)(1992-12#1)(1993-3#1)(1994-5#1)(1994-6#2)(1997-2#1)(1997-4#1)(2005-11#1)(2007-11#2)(2007-12#1)(2008-10#7)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)
quenching of##73##2##(1990-2#1)(1990-5#1)(1991-10#1)(1991-4#1)(1991-5#1)(1991-7#2)(1992-1#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#2)(1995-5#1)(1995-8#1)(1997-1#2)(1997-2#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#30)(2008-3#1)(2008-4#1)(2008-5#4)(2008-8#1)(2008-9#1)(2009-11#2)(2009-7#1)(2013-1#1)(2013-8#1)
quenching on##2##2##(1995-2#1)(2007-12#1)
quenching process##4##2##(1997-2#1)(2006-10#1)(2008-10#1)(2008-3#1)
quenching rate constants##3##3##(1997-7#1)(2006-10#1)(2012-11#1)
quenching rate##7##2##(1991-7#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-12#1)(2010-5#1)(2012-11#1)
quenching reaction of##2##3##(2008-10#2)
quenching reaction##4##2##(2008-10#4)
quenching spectra##2##2##(2008-10#2)
quenching studies##2##2##(1996-5#1)(1997-1#1)
quenching that depends on##2##4##(2008-3#2)
quenching the##5##2##(2003-11#1)(2006-10#1)(2008-11#1)(2008-5#1)(2010-4#1)
quenching was##4##2##(1991-10#1)(2006-10#1)(2008-10#2)
quenching will##2##2##(2008-9#2)
quenching with##4##2##(2007-10#1)(2007-11#1)(2008-10#1)(2008-3#1)
quenching##294##1##(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-10#2)(1991-2#1)(1991-4#1)(1991-5#3)(1991-7#4)(1991-8#2)(1992-1#1)(1992-12#3)(1992-6#4)(1992-7#3)(1992-9#1)(1993-12#2)(1993-3#8)(1993-8#1)(1994-11#4)(1994-12#1)(1994-5#3)(1994-6#2)(1995-11#2)(1995-2#5)(1995-5#2)(1995-6#1)(1995-8#3)(1996-1#1)(1996-5#1)(1996-9#3)(1997-1#8)(1997-2#2)(1997-4#6)(1997-7#2)(1997-8#1)(2003-11#1)(2005-11#8)(2005-4#3)(2006-10#17)(2007-10#1)(2007-11#5)(2007-12#5)(2007-8#3)(2008-1#1)(2008-10#98)(2008-11#1)(2008-2#8)(2008-3#10)(2008-4#8)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#5)(2009-11#2)(2009-7#1)(2010-4#3)(2010-5#1)(2010-7#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#6)
quercetagetin##2##1##(2008-11#2)
quercetin (QCT)##2##2##(1994-8#1)(2005-4#1)
quercetin 3-##2##2##(2007-1#2)
quercetin and luteolin##2##3##(2008-10#1)(2008-4#1)
quercetin and##11##2##(1997-8#1)(2007-1#3)(2008-10#4)(2008-4#1)(2008-5#1)(2012-12#1)
quercetin in##5##2##(1997-8#1)(2008-10#2)(2008-11#1)(2009-12#1)
quercetin##69##1##(1992-7#2)(1993-9#1)(1994-8#1)(1995-11#1)(1995-3#2)(1997-8#6)(2004-4#1)(2005-4#1)(2006-10#1)(2006-12#2)(2007-1#10)(2007-6#1)(2008-1#2)(2008-10#16)(2008-11#4)(2008-4#7)(2008-5#2)(2008-6#1)(2008-9#3)(2009-12#1)(2009-3#1)(2012-1#1)(2012-11#1)(2012-12#1)
quercetin-3-O-glucoside##4##1##(2008-11#4)
quercetin-induced DNA damage##2##3##(1992-4#2)
quercetin-induced nuclear DNA damage##3##4##(1992-4#3)
quercetin-induced nuclear##4##2##(1992-4#4)
quercetin-induced suppression##2##2##(1992-7#1)(1994-8#1)
quercetin-induced##8##1##(1992-4#6)(1992-7#1)(1994-8#1)
quercina from##2##2##(2008-10#2)
quercina##6##1##(2008-10#6)
quercitrin##4##1##(2007-1#2)(2008-10#2)
queried##13##1##(2006-12#1)(2007-10#1)(2007-2#2)(2007-6#3)(2008-7#2)(2011-2#1)(2012-12#1)(2012-2#2)
queries and##5##2##(2008-7#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-3#1)
queries are##3##2##(2007-12#1)(2010-2#2)
queries in a##2##3##(2008-4#1)(2008-7#1)
queries was##2##2##(1995-12#1)(2007-7#1)
queries##39##1##(1995-12#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-2#1)(2008-4#5)(2008-6#1)(2008-7#6)(2009-11#1)(2009-2#1)(2010-12#1)(2010-2#3)(2010-5#1)(2012-1#1)(2012-3#1)(2013-1#12)
query and##2##2##(2007-5#1)(2012-1#1)
query expansion##8##2##(2013-1#8)
query of##3##2##(2008-8#1)(2013-1#2)
query options##6##2##(2013-1#6)
query or##2##2##(2004-9#1)(2008-4#1)
query to##3##2##(2008-4#1)(2009-4#1)(2013-7#1)
query##65##1##(1994-9#1)(2004-9#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#11)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-4#1)(2009-9#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#26)(2013-7#1)(2013-8#1)
querying##11##1##(1997-2#1)(2006-10#1)(2008-4#1)(2008-7#3)(2011-9#1)(2013-1#4)
quest for mercy##4##3##(2008-8#4)
quest for quality##2##3##(1992-2#1)(2004-10#1)
quest for the##2##3##(2006-10#1)(2012-3#1)
quest for##24##2##(1992-2#1)(1992-6#1)(1993-3#1)(2004-10#1)(2005-7#1)(2006-10#2)(2006-12#2)(2006-7#1)(2007-5#1)(2007-6#1)(2008-12#1)(2008-8#4)(2008-9#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
quest of##4##2##(1996-3#1)(2006-10#2)(2010-5#1)
quest religious##2##2##(2008-12#1)(2009-7#1)
quest to##8##2##(2007-9#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-1#1)(2010-4#1)(2010-6#1)(2013-1#1)
quest##39##1##(1992-2#1)(1992-6#1)(1993-3#1)(1996-3#1)(2004-10#1)(2005-7#1)(2006-10#4)(2006-12#2)(2006-7#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-8#4)(2008-9#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
questing A##2##2##(2004-11#2)
questing I##2##2##(2004-11#2)
questing nymphs##4##2##(2004-11#4)
questing##11##1##(2004-11#10)(2013-8#1)
question a##2##2##(1992-12#1)(1997-2#1)
question about the##2##3##(1992-5#1)(1994-6#1)
question about##6##2##(1992-4#1)(1992-5#1)(1994-5#1)(1994-6#1)(2008-5#1)(2012-2#1)
question and the##3##3##(1993-11#1)(1996-4#1)(2008-8#1)
question and##13##2##(1993-11#1)(1996-4#1)(1997-1#1)(2005-5#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-8#2)(2010-8#1)(2013-1#3)
question answering##3##2##(2010-12#1)(2013-1#2)
question arises as to what##2##5##(2007-10#1)(2011-2#1)
question arises##6##2##(1992-10#1)(2006-6#1)(2007-10#1)(2011-1#1)(2011-2#2)
question as to how##2##4##(2006-4#1)(2011-1#1)
question as to whether##8##4##(1991-3#1)(1993-5#1)(1996-8#1)(2006-10#1)(2006-7#1)(2008-10#1)(2010-8#1)(2012-3#1)
question as to##15##3##(1991-3#1)(1993-5#2)(1995-12#1)(1995-5#1)(1996-8#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-12#1)(2008-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-3#1)
question as##18##2##(1990-12#1)(1991-12#1)(1991-3#1)(1993-5#2)(1995-12#1)(1995-5#1)(1996-8#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-12#1)(2008-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)
question can##2##2##(2007-1#1)(2009-8#1)
question concerning##2##2##(1993-6#1)(1996-7#1)
question from##2##2##(2010-10#1)(2011-1#1)
question has been##3##3##(1992-4#1)(2006-10#1)(2009-4#1)
question has##9##2##(1990-12#1)(1992-4#1)(1994-3#1)(2006-10#1)(2007-4#1)(2009-10#1)(2009-4#1)(2010-8#1)(2011-1#1)
question in the##2##3##(2006-10#1)(2008-11#1)
question in##16##2##(1995-2#1)(2005-7#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-10#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
question involves##2##2##(2004-3#1)(2006-9#1)
question is how##7##3##(1995-1#1)(2007-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
question is whether the##3##4##(1994-2#1)(1996-4#1)(2007-9#1)
question is whether##8##3##(1994-2#1)(1996-4#2)(2006-4#1)(2007-9#1)(2008-1#1)(2010-12#1)(2010-7#1)
question is##35##2##(1992-6#1)(1994-2#1)(1995-1#1)(1996-1#1)(1996-4#2)(1996-9#2)(2006-10#3)(2006-4#1)(2007-12#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-2#1)(2009-5#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-12#1)(2011-2#1)(2013-8#1)
question its##3##2##(1991-1#1)(2008-5#1)(2010-2#1)
question of a##4##3##(1995-12#1)(1997-3#1)(2005-11#1)(2007-12#1)
question of finding##2##3##(1995-8#1)(2006-10#1)
question of how to##3##4##(1995-9#1)(1996-12#1)(2012-2#1)
question of how##24##3##(1990-11#1)(1991-9#1)(1995-8#1)(1995-9#1)(1996-12#1)(2005-7#1)(2006-12#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#3)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
question of interest is##2##4##(1994-2#1)(2008-11#1)
question of interest##4##3##(1994-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
question of the##33##3##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#2)(1991-12#1)(1992-9#1)(1993-10#2)(1993-4#1)(1995-1#1)(1995-12#1)(1995-7#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-7#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#2)(2009-12#1)(2009-8#1)(2010-7#1)(2011-2#2)
question of what##4##3##(2008-7#1)(2008-9#1)(2013-1#2)
question of where##4##3##(1994-8#1)(2008-5#1)(2010-7#1)(2011-1#1)
question of whether a##2##4##(1991-3#1)(2007-12#1)
question of whether or not##4##5##(2006-12#1)(2007-7#1)(2008-10#1)(2008-12#1)
question of whether the##11##4##(1994-3#1)(1996-4#1)(2004-9#1)(2006-11#1)(2006-12#1)(2007-12#1)(2008-11#1)(2008-3#1)(2009-7#1)(2011-12#1)(2012-2#1)
question of whether to##3##4##(1996-2#1)(1997-1#1)(2008-7#1)
question of whether##50##3##(1990-12#2)(1991-3#1)(1992-10#1)(1992-12#1)(1994-3#1)(1994-5#1)(1995-2#1)(1996-1#1)(1996-2#2)(1996-4#1)(1996-8#1)(1997-1#1)(1997-6#1)(2004-9#1)(2006-10#5)(2006-11#2)(2006-12#2)(2006-8#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-7#2)(2010-12#1)(2010-2#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#3)
question of why##4##3##(1996-4#1)(2008-8#1)(2009-3#1)(2013-7#1)
question of##184##2##(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#2)(1990-8#1)(1991-12#2)(1991-3#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#2)(1992-9#1)(1993-10#2)(1993-12#1)(1993-2#3)(1993-4#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-7#1)(1995-8#3)(1995-9#2)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#2)(1997-8#1)(2004-11#1)(2004-12#2)(2004-9#1)(2005-11#1)(2005-7#2)(2006-10#8)(2006-11#2)(2006-12#3)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#4)(2007-2#3)(2007-6#2)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#4)(2008-9#7)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#1)
question on##3##2##(2011-1#1)(2012-12#1)(2013-7#1)
question one##2##2##(2007-6#1)(2012-12#1)
question raised##2##2##(1996-8#1)(2006-10#1)
question remains as to whether##3##5##(2005-12#1)(2006-8#1)(2008-11#1)
question remains##7##2##(1994-5#1)(2005-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2008-11#1)(2010-12#1)
question that has##3##3##(2007-9#1)(2008-6#1)(2013-1#1)
question that the##2##3##(1995-12#1)(2013-1#1)
question that##17##2##(1990-4#1)(1992-2#1)(1995-12#1)(1996-2#1)(2006-10#1)(2006-5#2)(2007-9#1)(2008-11#2)(2008-3#1)(2008-6#2)(2010-2#1)(2012-1#1)(2013-1#2)
question the##29##2##(1992-3#1)(1993-2#1)(1995-3#1)(1995-5#2)(1996-2#1)(1997-4#1)(1997-8#1)(2004-12#1)(2005-12#1)(2006-5#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-7#2)(2008-9#1)(2009-6#1)(2010-10#1)(2010-6#1)(2011-1#1)(2012-3#1)(2013-1#2)
question through##2##2##(2010-2#1)(2013-1#1)
question to##6##2##(1992-5#1)(2007-12#1)(2008-11#1)(2009-10#1)(2010-3#1)(2011-2#1)
question was##11##2##(1995-6#1)(1995-8#2)(1995-9#1)(1996-11#2)(1997-5#1)(2007-11#1)(2007-2#1)(2008-10#1)(2010-11#1)
question we##4##2##(1994-11#1)(2009-6#1)(2010-2#1)(2013-8#1)
question whether the##7##3##(1990-9#1)(1992-12#1)(1994-4#1)(2006-10#1)(2007-6#1)(2008-7#1)(2009-6#1)
question whether they##2##3##(1995-2#1)(2006-8#1)
question whether##28##2##(1990-9#1)(1991-12#1)(1991-9#1)(1992-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-4#1)(1994-8#2)(1994-9#1)(1995-2#1)(1996-10#1)(1996-9#1)(1997-2#1)(2006-10#1)(2006-8#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-7#2)(2009-10#1)(2009-4#1)(2009-6#1)(2010-12#1)(2011-12#2)
question which##3##2##(1990-8#1)(1993-5#1)(2007-12#1)
question why##2##2##(1996-5#1)(2006-10#1)
question with the##2##3##(2006-10#1)(2011-2#1)
question with##4##2##(1996-4#1)(2006-10#1)(2011-2#1)(2012-1#1)
question!##2##1##(1994-3#1)(1995-4#1)
question##755##1##(1990-11#2)(1990-12#8)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#4)(1990-6#2)(1990-8#3)(1990-9#1)(1991-1#2)(1991-12#7)(1991-3#4)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#3)(1992-11#1)(1992-12#6)(1992-2#3)(1992-3#1)(1992-4#2)(1992-5#3)(1992-6#1)(1992-9#1)(1993-10#2)(1993-11#2)(1993-12#4)(1993-2#5)(1993-3#4)(1993-4#1)(1993-5#5)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#4)(1994-3#7)(1994-4#1)(1994-5#3)(1994-6#4)(1994-8#3)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#6)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#4)(1995-6#2)(1995-7#1)(1995-8#5)(1995-9#3)(1996-1#5)(1996-10#1)(1996-11#4)(1996-12#3)(1996-2#4)(1996-3#2)(1996-4#7)(1996-5#3)(1996-6#2)(1996-7#2)(1996-8#5)(1996-9#3)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-8#2)(2004-11#1)(2004-12#6)(2004-3#1)(2004-9#1)(2005-10#3)(2005-11#1)(2005-12#2)(2005-5#1)(2005-7#4)(2006-10#22)(2006-11#3)(2006-12#5)(2006-2#1)(2006-3#2)(2006-4#2)(2006-5#5)(2006-6#4)(2006-7#4)(2006-8#6)(2006-9#1)(2007-1#2)(2007-10#6)(2007-11#7)(2007-12#13)(2007-2#7)(2007-4#1)(2007-5#2)(2007-6#4)(2007-7#3)(2007-8#119)(2007-9#5)(2008-1#1)(2008-10#13)(2008-11#19)(2008-12#10)(2008-2#9)(2008-3#2)(2008-4#6)(2008-5#7)(2008-6#3)(2008-7#12)(2008-8#16)(2008-9#13)(2009-10#5)(2009-11#2)(2009-12#4)(2009-2#2)(2009-3#2)(2009-4#4)(2009-5#2)(2009-6#11)(2009-7#5)(2009-8#5)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#8)(2010-2#5)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#7)(2010-9#1)(2011-1#9)(2011-12#4)(2011-2#20)(2011-3#1)(2012-1#5)(2012-12#19)(2012-2#12)(2012-3#10)(2013-1#22)(2013-7#3)(2013-8#7)
question&quot##3##1##(1991-6#1)(1993-8#1)(2012-11#1)
question?##4##1##(2005-12#1)(2005-8#1)(2006-9#1)(2008-11#1)
question]##4##1##(1993-3#1)(1994-6#1)(2008-4#1)(2013-1#1)
questionable accuracy##2##2##(2008-1#1)(2008-12#1)
questionable and##5##2##(2005-7#1)(2008-10#1)(2008-7#1)(2011-12#1)(2012-3#1)
questionable efficacy##2##2##(2007-11#1)(2011-2#1)
questionable for##3##2##(1992-6#1)(1995-2#1)(2008-2#1)
questionable from an##2##3##(2005-7#1)(2007-6#1)
questionable in##2##2##(2006-3#1)(2008-8#1)
questionable##68##1##(1990-10#1)(1990-12#1)(1990-6#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-6#2)(1992-2#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-6#2)(1994-3#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-3#3)(1997-4#1)(2005-7#2)(2006-10#3)(2006-3#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
questionable]##2##1##(1992-6#1)(1996-9#1)
questioned and##3##2##(2008-11#1)(2011-1#1)(2012-3#1)
questioned as##2##2##(2006-7#1)(2006-8#1)
questioned because of##3##3##(1994-9#1)(2008-10#1)(2012-2#1)
questioned because##6##2##(1994-9#1)(2008-10#2)(2008-3#1)(2010-12#1)(2012-2#1)
questioned by the gift-giver##2##4##(2008-11#2)
questioned by the##3##3##(2008-11#2)(2008-9#1)
questioned by##9##2##(1990-8#1)(1992-11#1)(1992-9#2)(2005-9#1)(2006-8#1)(2008-11#2)(2008-9#1)
questioned document##2##2##(2008-10#1)(2013-7#1)
questioned in##4##2##(1995-1#1)(2006-8#1)(2008-12#1)(2011-11#1)
questioned on their##2##3##(2006-8#1)(2009-12#1)
questioned the##5##2##(2004-10#1)(2006-10#2)(2007-4#1)(2008-8#1)
questioned whether##5##2##(1996-1#1)(2008-5#1)(2009-3#1)(2013-7#2)
questioned##87##1##(1990-4#2)(1990-8#1)(1991-11#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-10#1)(1993-3#1)(1993-5#2)(1994-11#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-8#1)(1997-3#2)(2004-10#1)(2004-12#1)(2005-8#2)(2005-9#3)(2006-10#5)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#5)(2007-4#2)(2007-6#1)(2007-9#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-9#1)(2011-1#1)(2011-11#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#3)
questioning about##2##2##(1996-5#1)(2008-7#1)
questioning and##3##2##(1997-5#1)(2008-2#1)(2012-12#1)
questioning its##2##2##(1995-11#1)(2010-2#1)
questioning the##2##2##(2006-10#2)
questioning##24##1##(1990-3#1)(1992-12#1)(1995-11#1)(1996-5#2)(1997-5#1)(2005-12#2)(2006-10#2)(2006-6#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-2#2)(2008-5#1)(2008-7#1)(2009-4#1)(2009-6#1)(2010-2#1)(2012-12#1)
questionnaire about the##2##3##(1996-1#1)(1997-2#1)
questionnaire about their##4##3##(1992-8#1)(2008-1#1)(2012-1#1)(2012-3#1)
questionnaire about##8##2##(1992-8#1)(1994-12#1)(1996-1#1)(1997-2#1)(2008-1#1)(2012-1#1)(2012-3#2)
questionnaire administered##3##2##(2008-7#1)(2011-2#1)(2012-3#1)
questionnaire among##4##2##(1992-6#1)(1996-9#1)(2012-2#1)(2013-1#1)
questionnaire and a##5##3##(2006-10#1)(2007-4#1)(2007-9#1)(2008-7#1)(2013-1#1)
questionnaire and by##2##3##(2007-2#1)(2009-11#1)
questionnaire and the results##2##4##(2005-8#1)(2010-3#1)
questionnaire and the##7##3##(1993-11#1)(1996-12#1)(2005-8#1)(2006-8#1)(2007-2#1)(2010-3#1)(2011-2#1)
questionnaire and##33##2##(1993-11#1)(1993-2#1)(1994-12#1)(1996-12#1)(2005-8#1)(2006-10#1)(2006-8#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-11#1)(2009-3#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#3)
questionnaire applied##2##2##(1993-6#1)(2011-2#1)
questionnaire as a##2##3##(2012-2#1)(2013-1#1)
questionnaire as##5##2##(1995-5#1)(2005-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
questionnaire assessing##3##2##(2004-3#1)(2007-12#2)
questionnaire at 6##2##3##(1996-11#1)(2008-6#1)
questionnaire at##4##2##(1996-11#1)(2008-6#1)(2009-10#1)(2011-2#1)
questionnaire based on##3##3##(2008-11#1)(2009-2#1)(2012-11#1)
questionnaire based##5##2##(2007-2#1)(2008-11#1)(2008-3#1)(2009-2#1)(2012-11#1)
questionnaire before and after the##2##5##(1993-5#1)(2012-11#1)
questionnaire before and after##3##4##(1993-5#1)(2010-11#1)(2012-11#1)
questionnaire before##4##2##(1993-5#1)(2005-9#1)(2010-11#1)(2012-11#1)
questionnaire between##2##2##(2004-10#1)(2011-2#1)
questionnaire by##4##2##(1991-4#1)(2007-7#1)(2011-1#1)(2012-2#1)
questionnaire completed##4##2##(1993-11#1)(2008-10#1)(2008-12#1)(2010-8#1)
questionnaire concerning##4##2##(1993-3#1)(1996-9#1)(2006-10#1)(2006-7#1)
questionnaire consisted of##3##3##(1991-2#1)(2008-1#1)(2011-2#1)
questionnaire consisting of##4##3##(1993-12#1)(2007-8#1)(2007-9#1)(2012-2#1)
questionnaire constitutes##2##2##(2010-4#1)(2011-2#1)
questionnaire contained##4##2##(1992-8#1)(2007-12#1)(2012-2#1)(2013-1#1)
questionnaire containing##3##2##(2007-10#1)(2011-2#2)
questionnaire covering##3##2##(2007-4#1)(2011-2#1)(2012-3#1)
questionnaire data were##2##3##(2007-2#1)(2012-2#1)
questionnaire data##6##2##(1994-2#1)(1996-2#1)(2007-2#1)(2008-12#1)(2011-1#1)(2012-2#1)
questionnaire designed for##2##3##(1992-2#1)(2006-12#1)
questionnaire designed to##4##3##(2006-11#1)(2007-12#1)(2007-9#1)(2008-11#1)
questionnaire designed##7##2##(1992-2#1)(2006-11#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-11#1)(2013-1#1)
questionnaire developed for parents of preschool children##2##7##(2013-1#2)
questionnaire developed##4##2##(2007-10#1)(2012-12#1)(2013-1#2)
questionnaire during a##2##3##(1990-10#1)(2008-1#1)
questionnaire during##6##2##(1990-10#1)(1990-2#1)(1995-9#1)(2006-2#1)(2008-1#1)(2010-10#1)
questionnaire for the diagnosis of##2##5##(1994-6#1)(1997-2#1)
questionnaire for the diagnosis##3##4##(1993-2#1)(1994-6#1)(1997-2#1)
questionnaire for the##4##3##(1993-2#2)(1994-6#1)(1997-2#1)
questionnaire for##15##2##(1993-2#2)(1994-6#1)(1997-2#1)(2006-12#1)(2007-3#1)(2008-11#1)(2008-8#2)(2009-7#1)(2011-1#1)(2011-2#1)(2013-1#3)
questionnaire form##2##2##(2006-8#1)(2010-6#1)
questionnaire from##3##2##(2007-10#1)(2007-2#1)(2008-5#1)
questionnaire has been##2##3##(1991-11#1)(2007-7#1)
questionnaire improved##3##2##(2008-11#1)(2008-12#1)(2010-8#1)
questionnaire in the##5##3##(1992-12#1)(1996-3#1)(2008-11#1)(2008-9#1)(2012-3#1)
questionnaire in##11##2##(1992-12#1)(1996-3#1)(2008-11#2)(2008-7#2)(2008-9#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
questionnaire included##4##2##(2006-7#1)(2012-2#1)(2013-1#2)
questionnaire including##4##2##(1993-8#1)(2006-8#1)(2011-2#1)(2013-1#1)
questionnaire indicated##2##2##(2006-8#1)(2008-12#1)
questionnaire is more##2##3##(2011-1#1)(2013-1#1)
questionnaire is##4##2##(1994-3#1)(2004-10#1)(2011-1#1)(2013-1#1)
questionnaire measuring##2##2##(2007-12#1)(2008-11#1)
questionnaire of##5##2##(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
questionnaire on the##3##3##(1992-6#1)(1997-4#1)(2006-8#1)
questionnaire on their##3##3##(1993-10#1)(1994-8#1)(2006-7#1)
questionnaire on##16##2##(1992-6#1)(1993-10#1)(1993-5#1)(1994-6#1)(1994-8#1)(1997-4#1)(2006-10#1)(2006-7#2)(2006-8#1)(2007-12#1)(2008-11#1)(2011-1#1)(2012-1#1)(2013-1#2)
questionnaire regarding the##2##3##(1992-3#1)(2008-10#1)
questionnaire regarding##5##2##(1992-3#1)(2006-8#1)(2008-10#1)(2008-11#1)(2013-7#1)
questionnaire related to##2##3##(2006-12#1)(2007-2#1)
questionnaire requesting##2##2##(1996-9#1)(2010-10#1)
questionnaire revealed##3##2##(2010-6#1)(2011-12#1)(2011-2#1)
questionnaire scores##2##2##(2004-10#1)(2007-6#1)
questionnaire sent to##3##3##(1990-10#1)(1992-3#1)(2011-2#1)
questionnaire sent##4##2##(1990-10#1)(1992-3#1)(2007-10#1)(2011-2#1)
questionnaire study among##2##3##(1993-3#1)(1996-1#1)
questionnaire study of the##2##4##(1990-4#1)(1997-3#1)
questionnaire study of##3##3##(1990-4#1)(1997-3#1)(2008-1#1)
questionnaire study was carried out to evaluate the##2##8##(1992-6#1)(1996-1#1)
questionnaire study##19##2##(1990-4#1)(1992-6#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1995-2#1)(1996-1#2)(1996-8#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-11#1)(2010-10#1)(2011-2#1)
questionnaire survey of##9##3##(1992-11#1)(1994-6#1)(1995-2#1)(1997-5#1)(1997-7#1)(2004-7#2)(2007-8#1)(2008-1#1)
questionnaire survey on##2##3##(1992-6#1)(2007-2#1)
questionnaire survey was carried out##5##5##(1997-3#1)(2007-2#1)(2010-5#1)(2011-1#1)(2013-7#1)
questionnaire survey was##14##3##(1992-6#1)(1997-3#1)(2005-10#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-11#1)(2008-8#1)(2010-1#2)(2010-5#1)(2011-1#1)(2012-2#1)(2013-7#1)
questionnaire survey##39##2##(1992-11#1)(1992-6#2)(1993-8#1)(1994-6#1)(1995-2#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-7#1)(2004-7#2)(2005-10#1)(2007-10#1)(2007-2#3)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#2)(2010-1#2)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
questionnaire that included##2##3##(2006-7#1)(2013-1#1)
questionnaire that##12##2##(1995-2#1)(1997-8#1)(2004-12#1)(2005-11#1)(2006-10#1)(2006-7#1)(2008-11#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
questionnaire to assess##5##3##(2004-2#1)(2008-10#1)(2010-12#1)(2012-1#1)(2013-1#1)
questionnaire to collect##2##3##(2006-2#1)(2012-12#1)
questionnaire to determine##2##3##(1992-1#1)(2011-2#1)
questionnaire to examine##4##3##(2007-12#1)(2008-11#2)(2009-5#1)
questionnaire to identify##3##3##(2005-5#1)(2006-2#1)(2008-8#1)
questionnaire to##34##2##(1991-4#1)(1992-1#1)(1992-12#1)(1993-12#1)(1993-3#1)(1995-11#1)(1996-12#1)(2004-2#1)(2005-5#1)(2006-2#2)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-4#1)(2008-8#1)(2009-5#1)(2010-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
questionnaire was administered to##9##4##(2004-10#1)(2006-4#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-7#1)(2012-12#1)
questionnaire was administered##12##3##(2004-10#1)(2006-4#1)(2007-1#1)(2007-12#1)(2007-2#2)(2007-9#1)(2008-10#1)(2008-7#1)(2010-1#1)(2012-12#2)
questionnaire was also##3##3##(1993-2#1)(2008-11#1)(2008-4#1)
questionnaire was completed by the##2##5##(1992-8#1)(2012-1#1)
questionnaire was completed by##5##4##(1992-8#1)(2006-8#1)(2008-9#1)(2012-1#1)(2013-1#1)
questionnaire was completed##7##3##(1992-8#1)(2006-2#1)(2006-8#1)(2008-9#1)(2012-1#1)(2013-1#2)
questionnaire was conducted##2##3##(2010-2#1)(2011-1#1)
questionnaire was designed to assess##2##5##(2007-2#1)(2008-8#1)
questionnaire was designed to##6##4##(1991-1#1)(1993-8#1)(2007-2#1)(2007-7#1)(2008-8#1)(2012-12#1)
questionnaire was developed and##3##4##(1992-1#1)(1994-12#1)(1995-12#1)
questionnaire was developed to##2##4##(2006-10#1)(2010-9#1)
questionnaire was developed##6##3##(1992-1#1)(1994-12#1)(1995-12#1)(2005-5#1)(2006-10#1)(2010-9#1)
questionnaire was distributed to##3##4##(1990-5#1)(1992-4#1)(1996-9#1)
questionnaire was distributed##4##3##(1990-5#1)(1991-10#1)(1992-4#1)(1996-9#1)
questionnaire was employed##2##3##(1992-8#1)(2011-2#1)
questionnaire was given to##7##4##(1993-12#1)(2004-10#1)(2007-2#1)(2008-12#1)(2008-4#1)(2013-1#1)(2013-8#1)
questionnaire was given##9##3##(1993-12#1)(2004-10#1)(2007-2#1)(2008-12#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
questionnaire was made##2##3##(2013-1#1)(2013-7#1)
questionnaire was mailed to##7##4##(1991-3#1)(1993-8#1)(1996-3#1)(2006-7#1)(2008-4#2)(2013-8#1)
questionnaire was sent by##2##4##(2006-8#1)(2011-2#1)
questionnaire was sent to all##5##5##(1995-6#3)(2006-8#1)(2012-2#1)
questionnaire was sent to the##2##5##(1994-1#1)(2007-7#1)
questionnaire was sent to##27##4##(1990-2#1)(1991-6#1)(1993-2#2)(1994-1#1)(1994-4#1)(1995-6#3)(1996-1#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-2#4)(2007-7#2)(2007-9#1)(2008-1#2)(2008-5#1)(2012-2#1)(2013-1#1)
questionnaire was sent##29##3##(1990-2#1)(1991-6#1)(1993-2#2)(1994-1#1)(1994-4#1)(1995-6#3)(1996-1#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-8#2)(2007-2#4)(2007-7#2)(2007-9#1)(2008-1#2)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
questionnaire was used for##2##4##(2011-1#1)(2013-8#1)
questionnaire was used to collect##2##5##(2013-1#1)(2013-8#1)
questionnaire was used to evaluate the##2##6##(2007-7#1)(2008-7#1)
questionnaire was used to evaluate##3##5##(1994-12#1)(2007-7#1)(2008-7#1)
questionnaire was used to obtain##2##5##(2008-10#1)(2008-4#1)
questionnaire was used to##12##4##(1990-9#1)(1994-12#1)(1996-2#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-8#1)(2013-1#1)(2013-8#1)
questionnaire was used##20##3##(1990-9#1)(1994-12#1)(1995-5#1)(1996-2#1)(2004-10#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-12#1)(2013-1#1)(2013-8#2)
questionnaire was##129##2##(1990-2#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-4#1)(1992-8#2)(1993-12#1)(1993-2#4)(1993-3#1)(1993-8#2)(1994-1#1)(1994-12#2)(1994-4#1)(1995-12#1)(1995-5#1)(1995-6#3)(1996-1#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(2004-10#3)(2005-5#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#1)(2006-7#3)(2006-8#8)(2007-1#1)(2007-12#1)(2007-2#8)(2007-3#1)(2007-7#4)(2007-9#2)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#5)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-1#2)(2010-2#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#1)(2013-1#7)(2013-7#1)(2013-8#7)
questionnaire were##5##2##(1992-3#1)(2007-11#1)(2010-1#1)(2010-3#1)(2013-8#1)
questionnaire which was sent to##2##5##(1992-12#1)(2005-8#1)
questionnaire which we administered to##2##5##(2007-6#2)
questionnaire which##6##2##(1992-10#1)(1992-12#1)(2004-10#1)(2005-8#1)(2007-6#2)
questionnaire with##6##2##(2006-10#1)(2007-7#1)(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
questionnaire##766##1##(1990-10#2)(1990-2#3)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#2)(1991-3#2)(1991-4#2)(1991-6#2)(1991-8#2)(1991-9#1)(1992-1#5)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#5)(1992-4#1)(1992-6#6)(1992-8#5)(1993-1#1)(1993-10#3)(1993-11#4)(1993-12#5)(1993-2#11)(1993-3#8)(1993-5#9)(1993-6#4)(1993-8#6)(1993-9#3)(1994-1#1)(1994-12#5)(1994-2#2)(1994-3#2)(1994-4#2)(1994-6#4)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-4#2)(1995-5#3)(1995-6#3)(1995-9#2)(1996-1#10)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#5)(1996-4#1)(1996-6#2)(1996-8#2)(1996-9#5)(1997-1#1)(1997-2#5)(1997-3#4)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#3)(2004-1#2)(2004-10#15)(2004-12#1)(2004-2#1)(2004-3#2)(2004-7#2)(2005-10#1)(2005-11#4)(2005-5#2)(2005-8#2)(2005-9#3)(2006-10#14)(2006-11#1)(2006-12#4)(2006-2#7)(2006-4#1)(2006-6#1)(2006-7#10)(2006-8#22)(2007-1#2)(2007-10#12)(2007-11#3)(2007-12#10)(2007-2#24)(2007-3#8)(2007-4#2)(2007-5#2)(2007-6#4)(2007-7#19)(2007-8#10)(2007-9#6)(2008-1#15)(2008-10#13)(2008-11#28)(2008-12#10)(2008-2#3)(2008-3#3)(2008-4#7)(2008-5#6)(2008-6#3)(2008-7#13)(2008-8#11)(2008-9#11)(2009-10#2)(2009-11#1)(2009-2#3)(2009-3#2)(2009-5#2)(2009-7#1)(2010-1#6)(2010-10#5)(2010-11#3)(2010-12#2)(2010-2#3)(2010-3#4)(2010-4#6)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#7)(2010-9#2)(2011-1#21)(2011-12#2)(2011-2#41)(2012-1#13)(2012-11#3)(2012-12#16)(2012-2#21)(2012-3#14)(2013-1#45)(2013-7#6)(2013-8#17)
questionnaire-based study was##2##3##(2007-7#1)(2012-2#1)
questionnaire-based study##4##2##(2007-2#1)(2007-7#1)(2012-2#1)(2013-1#1)
questionnaire-based##13##1##(2005-7#1)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-6#1)(2010-5#1)(2012-12#1)(2012-2#2)(2013-1#2)
questionnaires about their##2##3##(1996-9#1)(2010-7#1)
questionnaires about##5##2##(1995-1#1)(1996-9#1)(2008-9#1)(2010-7#1)(2011-1#1)
questionnaires administered##2##2##(2007-2#1)(2012-3#1)
questionnaires and a##4##3##(2006-7#1)(2012-12#2)(2013-1#1)
questionnaires and##23##2##(1993-2#1)(1994-12#1)(1997-3#1)(2004-8#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-7#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-3#1)(2009-6#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
questionnaires are##5##2##(2007-10#2)(2007-8#1)(2010-1#1)(2012-2#1)
questionnaires assessing##6##2##(2006-10#2)(2007-12#1)(2008-11#1)(2012-2#1)(2013-1#1)
questionnaires at##5##2##(2006-9#1)(2007-12#1)(2009-12#1)(2011-1#1)(2012-12#1)
questionnaires based on##2##3##(2010-11#1)(2012-2#1)
questionnaires completed##2##2##(1992-5#1)(2004-3#1)
questionnaires for evaluating##2##3##(2007-8#1)(2010-11#1)
questionnaires for##5##2##(1991-12#1)(2007-8#1)(2008-8#1)(2010-11#1)(2012-12#1)
questionnaires from##3##2##(1993-3#1)(1993-9#1)(2009-9#1)
questionnaires have##2##2##(2006-9#1)(2007-8#1)
questionnaires in##3##2##(2010-3#1)(2010-4#1)(2013-8#1)
questionnaires measuring##2##2##(2008-10#1)(2010-3#1)
questionnaires on##7##2##(2007-12#1)(2007-8#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
questionnaires or##3##2##(2008-11#2)(2010-8#1)
questionnaires plus##2##2##(2009-4#2)
questionnaires regarding##2##2##(1993-1#1)(2006-8#1)
questionnaires related to##2##3##(2007-2#1)(2007-3#1)
questionnaires that were##3##3##(2006-10#2)(2011-2#1)
questionnaires that##5##2##(2006-10#2)(2006-8#1)(2007-9#1)(2011-2#1)
questionnaires to investigate##2##3##(2008-11#1)(2013-1#1)
questionnaires to##14##2##(1990-5#1)(1992-5#1)(1992-6#1)(1997-4#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-10#1)(2011-1#1)(2012-12#1)(2013-1#1)
questionnaires used##2##2##(1992-4#1)(2009-2#1)
questionnaires were administered##2##3##(2007-12#1)(2008-2#1)
questionnaires were collected##3##3##(2007-11#1)(2007-2#1)(2013-1#1)
questionnaires were completed##2##3##(2010-12#1)(2013-1#1)
questionnaires were distributed##4##3##(1993-8#1)(2006-7#1)(2006-8#1)(2012-2#1)
questionnaires were mailed##2##3##(1993-12#1)(2008-1#1)
questionnaires were received##2##3##(1990-10#1)(2008-10#1)
questionnaires were returned by##2##4##(1996-1#1)(1997-3#1)
questionnaires were returned##8##3##(1996-1#1)(1997-3#1)(2007-2#1)(2007-9#1)(2008-4#1)(2008-8#1)(2012-11#1)(2013-8#1)
questionnaires were sent to##6##4##(1994-2#1)(1996-6#1)(1997-8#1)(2007-10#1)(2007-7#1)(2011-1#1)
questionnaires were sent##7##3##(1994-2#1)(1996-6#1)(1997-8#1)(2007-10#1)(2007-7#1)(2008-1#1)(2011-1#1)
questionnaires were used to##3##4##(2008-8#1)(2008-9#1)(2010-3#1)
questionnaires were used##6##3##(2008-1#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-3#1)
questionnaires were##50##2##(1990-10#1)(1991-12#1)(1993-12#1)(1993-8#1)(1994-2#1)(1996-1#1)(1996-6#1)(1997-3#1)(1997-8#1)(2004-10#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-12#1)(2010-3#1)(2011-1#3)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
questionnaires which##2##2##(1990-2#1)(2007-9#1)
questionnaires##265##1##(1990-10#1)(1990-2#1)(1990-5#1)(1991-12#3)(1991-2#1)(1992-4#2)(1992-5#2)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#2)(1995-1#2)(1995-12#1)(1995-2#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-6#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-8#1)(2004-10#1)(2004-3#1)(2004-8#1)(2005-11#1)(2005-7#1)(2006-10#6)(2006-2#2)(2006-3#1)(2006-4#1)(2006-6#2)(2006-7#5)(2006-8#4)(2006-9#2)(2007-10#7)(2007-11#1)(2007-12#9)(2007-2#9)(2007-3#3)(2007-4#1)(2007-7#6)(2007-8#5)(2007-9#4)(2008-1#3)(2008-10#5)(2008-11#10)(2008-12#4)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#5)(2008-7#3)(2008-8#5)(2008-9#4)(2009-10#2)(2009-12#2)(2009-2#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#3)(2010-11#3)(2010-12#1)(2010-2#3)(2010-3#4)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#4)(2011-1#9)(2011-2#13)(2012-1#3)(2012-11#1)(2012-12#12)(2012-2#8)(2012-3#2)(2013-1#13)(2013-7#3)(2013-8#6)
questionned##2##1##(2008-2#2)
questions a##2##2##(1990-10#1)(1991-3#1)
questions about how##5##3##(2007-12#1)(2008-11#2)(2009-12#1)(2013-7#1)
questions about its##3##3##(2006-8#1)(2008-8#1)(2009-1#1)
questions about the future##2##4##(2006-5#1)(2012-2#1)
questions about the origin##2##4##(1997-1#1)(2009-8#1)
questions about the role of##4##5##(1992-12#1)(1993-6#1)(2007-7#1)(2010-12#1)
questions about the safety of##2##5##(2008-8#1)(2010-11#1)
questions about the##38##3##(1991-2#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-3#2)(1993-6#1)(1994-1#2)(1995-12#1)(1996-2#1)(1997-1#1)(2004-12#1)(2006-5#1)(2007-10#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
questions about their##6##3##(1991-2#1)(1991-8#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
questions about whether##4##3##(1995-2#1)(2006-9#1)(2007-4#1)(2008-9#1)
questions about##99##2##(1990-5#2)(1991-2#2)(1991-8#2)(1992-12#2)(1992-2#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-1#2)(1994-3#2)(1995-12#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-1#1)(2004-12#1)(2005-11#1)(2005-3#1)(2005-9#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#7)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)
questions addressed##4##2##(1996-2#1)(2006-5#1)(2008-1#1)(2008-11#1)
questions and a##3##3##(2009-8#1)(2012-12#1)(2012-2#1)
questions and concerns regarding##2##4##(2007-2#1)(2013-1#1)
questions and the##2##3##(1990-2#1)(2011-12#1)
questions and##41##2##(1990-2#1)(1990-9#1)(1991-1#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-3#2)(1994-6#1)(2005-10#1)(2006-2#1)(2007-1#1)(2007-2#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-11#1)(2011-12#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#2)
questions answered##2##2##(2008-6#1)(2013-1#1)
questions are a##2##3##(2006-10#1)(2008-12#1)
questions are addressed##4##3##(1996-3#1)(2006-10#1)(2009-5#1)(2012-3#1)
questions are also##3##3##(2006-10#1)(2006-6#1)(2009-3#1)
questions are asked##2##3##(2005-7#1)(2012-2#1)
questions are being##2##3##(1993-4#1)(2008-8#1)
questions are discussed##3##3##(1995-12#1)(2008-8#1)(2012-2#1)
questions are highlighted##2##3##(2012-2#2)
questions are raised##2##3##(2010-10#1)(2012-1#1)
questions are##28##2##(1991-12#1)(1991-2#1)(1993-4#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-3#1)(2005-7#1)(2006-10#3)(2006-6#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-10#1)(2011-1#1)(2012-1#1)(2012-2#4)(2012-3#1)
questions arise as to how##2##5##(1992-12#1)(2008-3#1)
questions arise as to##3##4##(1992-12#1)(2007-5#1)(2008-3#1)
questions arise##4##2##(1992-12#1)(2007-5#1)(2008-11#1)(2008-3#1)
questions as to what##2##4##(1993-12#1)(2011-1#1)
questions as to##5##3##(1993-12#1)(1995-11#1)(2008-10#1)(2008-9#1)(2011-1#1)
questions as##8##2##(1993-12#1)(1995-11#1)(2006-8#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
questions asked by##2##3##(1991-5#1)(1993-2#1)
questions asked##6##2##(1990-2#1)(1991-5#1)(1993-2#1)(2006-10#1)(2007-3#1)(2007-8#1)
questions assessed##2##2##(2006-10#1)(2007-10#1)
questions at##3##2##(1990-10#1)(1991-2#1)(2010-6#1)
questions but also##2##3##(2008-11#1)(2012-2#1)
questions but##3##2##(2008-11#1)(2011-1#1)(2012-2#1)
questions by##6##2##(1994-3#1)(2009-2#2)(2009-4#1)(2013-8#2)
questions can be##2##3##(2008-11#1)(2013-8#1)
questions can##3##2##(2008-11#1)(2008-8#1)(2013-8#1)
questions concerned##2##2##(2006-8#1)(2008-3#1)
questions concerning the##10##3##(1993-12#1)(1995-12#1)(1995-7#1)(2006-10#2)(2007-12#1)(2007-5#1)(2008-2#1)(2010-12#1)(2012-12#1)
questions concerning##24##2##(1992-1#1)(1993-12#2)(1994-12#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-7#1)(2006-10#3)(2007-1#1)(2007-12#2)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-5#1)(2010-12#1)(2012-12#1)(2013-1#1)(2013-7#1)
questions correctly##3##2##(2007-9#2)(2013-1#1)
questions covered##2##2##(2012-3#2)
questions emerge##3##2##(2008-11#1)(2008-12#1)(2011-2#1)
questions examined##2##2##(1992-6#1)(2006-7#1)
questions for the##4##3##(2007-10#1)(2009-5#1)(2010-12#1)(2011-12#1)
questions for##16##2##(1993-1#1)(1993-6#1)(1994-1#1)(1995-2#1)(1995-9#1)(2007-10#3)(2008-1#1)(2009-5#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
questions from the##3##3##(2008-7#2)(2012-3#1)
questions from##12##2##(1990-2#1)(2006-3#1)(2008-1#1)(2008-11#1)(2008-7#3)(2009-9#1)(2010-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
questions have been raised##3##4##(2006-6#1)(2008-8#1)(2009-1#1)
questions have been the##2##4##(1992-9#1)(2010-9#1)
questions have been##6##3##(1992-9#1)(1996-1#1)(2006-6#1)(2008-8#1)(2009-1#1)(2010-9#1)
questions have##8##2##(1992-9#1)(1995-8#1)(1996-1#1)(2006-6#1)(2007-10#1)(2008-8#1)(2009-1#1)(2010-9#1)
questions in a##7##3##(1991-6#1)(2005-12#1)(2005-7#1)(2006-7#1)(2008-11#1)(2010-3#1)(2013-8#1)
questions in the field##2##4##(2006-10#1)(2012-12#1)
questions in the##6##3##(2006-10#1)(2008-11#1)(2008-7#1)(2012-1#1)(2012-12#1)(2012-2#1)
questions in their daily##2##4##(1997-3#1)(2007-8#1)
questions in##32##2##(1991-3#1)(1991-6#1)(1997-3#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-4#2)(2007-8#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-1#2)(2012-12#3)(2012-2#1)(2013-7#1)(2013-8#2)
questions is yes##3##3##(1991-11#1)(1996-8#1)(1997-3#1)
questions is##6##2##(1991-11#1)(1993-2#1)(1995-8#1)(1996-8#1)(1997-3#1)(2005-10#1)
questions may##2##2##(1996-6#1)(2008-3#1)
questions must##3##2##(1993-2#1)(1997-1#1)(2008-7#1)
questions of interest##2##3##(1997-8#1)(2010-2#1)
questions of the##5##3##(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)
questions of whether##2##3##(2012-12#1)(2012-3#1)
questions of##29##2##(1990-5#1)(1991-1#1)(1994-12#1)(1995-2#1)(1995-8#1)(1997-8#1)(2006-10#2)(2006-5#1)(2006-6#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#3)(2009-2#1)(2009-3#1)(2009-4#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)
questions on the##8##3##(1997-3#1)(2006-10#1)(2008-10#1)(2008-7#1)(2010-12#2)(2012-2#1)(2013-8#1)
questions on##26##2##(1991-9#1)(1992-3#1)(1992-9#1)(1994-3#1)(1997-3#1)(2004-10#1)(2006-10#1)(2006-7#1)(2006-8#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#2)(2009-9#1)(2010-12#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
questions or##2##2##(1995-1#1)(2008-1#1)
questions over##2##2##(2007-11#1)(2008-3#1)
questions pertaining to##2##3##(1997-2#1)(2012-2#1)
questions posed##4##2##(1992-2#1)(2004-12#1)(2008-3#1)(2008-7#1)
questions raised by the##4##4##(2005-7#1)(2008-2#1)(2008-3#1)(2010-8#1)
questions raised by##7##3##(1997-8#1)(2005-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-12#1)(2010-8#1)
questions regarding how##2##3##(2007-12#1)(2008-7#1)
questions regarding the##25##3##(1991-10#1)(1991-3#1)(1992-10#1)(1992-6#1)(1993-2#1)(2004-5#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-7#1)(2011-2#3)(2012-11#1)(2013-1#1)
questions regarding their##2##3##(2004-12#1)(2008-12#1)
questions regarding##46##2##(1990-11#1)(1991-10#1)(1991-2#1)(1991-3#1)(1992-10#1)(1992-6#1)(1993-11#1)(1993-2#1)(1994-12#1)(1996-9#1)(2004-12#1)(2004-5#1)(2006-12#1)(2006-8#1)(2007-12#2)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-2#3)(2012-11#1)(2012-2#2)(2013-1#4)(2013-8#1)
questions related to the##2##4##(2008-10#1)(2009-4#1)
questions related to##8##3##(1991-6#1)(2005-10#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-9#1)(2008-10#1)(2009-4#1)
questions relevant to##2##3##(2007-12#1)(2008-8#1)
questions remain about##3##3##(1994-3#1)(1997-6#1)(2008-11#1)
questions remain regarding the##3##4##(2007-9#1)(2010-6#1)(2011-2#1)
questions remain to be answered before its##2##7##(2008-5#1)(2012-1#1)
questions remain to be answered##5##5##(1992-11#1)(1994-11#1)(2006-10#1)(2008-5#1)(2012-1#1)
questions remain##27##2##(1992-11#1)(1994-11#1)(1994-3#1)(1997-6#1)(2006-10#3)(2006-9#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#3)(2009-6#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-7#1)(2013-8#1)
questions require##2##2##(2008-11#1)(2008-7#1)
questions resulting from##2##3##(2008-10#1)(2010-12#1)
questions should##3##2##(2007-11#1)(2011-2#1)(2011-8#1)
questions showed##2##2##(2012-1#2)
questions still##6##2##(1990-10#1)(1993-7#1)(2005-8#1)(2006-10#1)(2013-1#1)(2013-8#1)
questions such as##3##3##(2007-8#1)(2008-7#1)(2010-5#1)
questions surrounding##2##2##(2008-2#1)(2008-8#1)
questions than answers##4##3##(2005-11#1)(2006-10#1)(2007-4#1)(2012-3#1)
questions that a##2##3##(2007-7#1)(2009-3#1)
questions that are##4##3##(2007-5#1)(2008-7#2)(2009-3#1)
questions that could be##3##4##(2005-10#1)(2010-10#1)(2010-2#1)
questions that may##2##3##(1994-11#1)(1994-3#1)
questions that might##2##3##(1993-12#1)(2013-8#1)
questions that must be##3##4##(1996-8#1)(2006-5#1)(2009-12#1)
questions that need to be addressed##2##6##(2006-10#1)(2008-7#1)
questions that remain to be answered##2##6##(2009-6#1)(2010-7#1)
questions that remain##4##3##(2007-8#1)(2009-6#1)(2010-7#1)(2013-8#1)
questions that should be##2##4##(2007-4#1)(2010-12#1)
questions that the##2##3##(2008-1#1)(2008-7#1)
questions that were##5##3##(1993-2#1)(1995-1#2)(1996-1#1)(2008-2#1)
questions that will be##2##4##(1995-1#1)(2008-5#1)
questions that will##3##3##(1995-1#1)(1996-1#1)(2008-5#1)
questions that##48##2##(1992-5#1)(1993-12#2)(1993-2#1)(1994-11#1)(1994-3#1)(1995-1#3)(1996-1#2)(1996-8#1)(1997-3#1)(2005-10#1)(2006-10#2)(2006-11#1)(2006-5#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-11#2)(2008-2#2)(2008-5#1)(2008-7#4)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-7#1)(2012-3#1)(2013-8#2)
questions the##11##2##(1990-12#1)(1994-12#1)(1997-7#1)(2006-7#1)(2007-2#1)(2008-2#3)(2008-3#1)(2010-2#1)(2011-2#1)
questions they##3##2##(2005-10#1)(2007-8#1)(2013-1#1)
questions to ask in##2##4##(2005-10#1)(2008-10#1)
questions to be addressed##2##4##(2006-12#1)(2011-2#1)
questions to be answered##3##4##(1990-12#1)(2006-9#1)(2008-10#1)
questions to be##7##3##(1990-12#1)(1993-4#1)(2005-10#1)(2006-12#1)(2006-9#1)(2008-10#1)(2011-2#1)
questions to##22##2##(1990-12#1)(1992-5#1)(1993-2#2)(1993-4#1)(1995-2#1)(1995-6#1)(1996-12#1)(2005-10#2)(2006-12#1)(2006-9#1)(2007-10#1)(2007-3#1)(2008-10#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)
questions unanswered##2##2##(1996-11#1)(2010-8#1)
questions used in##4##3##(1993-2#1)(2006-10#1)(2008-12#2)
questions using##2##2##(2008-7#1)(2010-5#1)
questions was completed##2##3##(1996-1#1)(2006-2#1)
questions was used to collect##2##5##(2008-3#1)(2012-3#1)
questions was used##4##3##(2007-8#1)(2008-3#1)(2008-9#1)(2012-3#1)
questions was##10##2##(1996-1#1)(2006-2#1)(2007-8#1)(2008-3#1)(2008-9#2)(2009-5#1)(2010-4#1)(2012-1#1)(2012-3#1)
questions were analyzed##2##3##(2013-1#1)(2013-7#1)
questions were asked##5##3##(1992-6#1)(2006-10#1)(2006-7#1)(2008-2#2)
questions were put to##2##4##(2006-10#1)(2008-5#1)
questions were used##3##3##(2008-8#1)(2013-1#1)(2013-8#1)
questions were##32##2##(1991-8#1)(1992-1#1)(1992-6#1)(1993-2#1)(2006-10#2)(2006-7#1)(2007-12#1)(2008-12#3)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-11#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-12#1)(2013-1#4)(2013-7#1)(2013-8#1)
questions whether##3##2##(1994-2#1)(2007-2#1)(2011-2#1)
questions which have to be##2##5##(1994-1#1)(2012-3#1)
questions which##4##2##(1994-1#1)(1994-11#1)(2006-10#1)(2012-3#1)
questions will be##4##3##(2008-4#2)(2009-10#1)(2013-7#1)
questions will##6##2##(2006-10#1)(2008-4#2)(2009-10#1)(2012-3#1)(2013-7#1)
questions with regard to##2##4##(1990-10#1)(2006-10#1)
questions with##6##2##(1990-10#1)(2006-10#2)(2008-11#1)(2013-1#2)
questions within##2##2##(2008-9#1)(2013-7#1)
questions##918##1##(1990-10#5)(1990-11#1)(1990-12#3)(1990-2#4)(1990-5#4)(1990-7#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#6)(1991-3#6)(1991-5#1)(1991-6#2)(1991-8#3)(1991-9#2)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#3)(1992-3#2)(1992-5#2)(1992-6#3)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#9)(1993-2#11)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-1#4)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#9)(1994-6#3)(1994-8#1)(1995-1#6)(1995-10#1)(1995-11#4)(1995-12#6)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#3)(1995-9#2)(1996-1#7)(1996-11#3)(1996-12#4)(1996-2#4)(1996-3#6)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#3)(1996-8#2)(1996-9#1)(1997-1#5)(1997-2#3)(1997-3#7)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#6)(2004-10#2)(2004-12#3)(2004-4#1)(2004-5#2)(2005-10#11)(2005-11#2)(2005-12#2)(2005-3#1)(2005-4#1)(2005-5#1)(2005-7#4)(2005-8#3)(2005-9#2)(2006-10#43)(2006-11#2)(2006-12#3)(2006-2#5)(2006-3#1)(2006-4#2)(2006-5#7)(2006-6#4)(2006-7#11)(2006-8#10)(2006-9#3)(2007-1#3)(2007-10#11)(2007-11#4)(2007-12#15)(2007-2#8)(2007-3#6)(2007-4#9)(2007-5#4)(2007-6#2)(2007-7#5)(2007-8#10)(2007-9#8)(2008-1#11)(2008-10#14)(2008-11#42)(2008-12#17)(2008-2#14)(2008-3#11)(2008-4#8)(2008-5#7)(2008-6#2)(2008-7#35)(2008-8#16)(2008-9#9)(2009-1#3)(2009-10#4)(2009-11#3)(2009-12#3)(2009-2#4)(2009-3#5)(2009-4#13)(2009-5#5)(2009-6#2)(2009-8#6)(2009-9#3)(2010-1#1)(2010-10#5)(2010-11#4)(2010-12#12)(2010-2#6)(2010-3#7)(2010-4#4)(2010-5#4)(2010-6#2)(2010-7#4)(2010-8#5)(2010-9#2)(2011-1#12)(2011-11#1)(2011-12#6)(2011-2#29)(2011-8#2)(2012-1#12)(2012-11#1)(2012-12#24)(2012-2#20)(2012-3#20)(2013-1#39)(2013-7#12)(2013-8#17)
questions)##3##1##(1994-12#1)(2006-7#1)(2010-12#1)
questions?##2##1##(2008-8#2)
questions]##3##1##(1993-10#1)(1995-11#1)(2009-1#1)
quetiapine##12##1##(2004-3#1)(2005-8#1)(2008-3#1)(2010-7#4)(2011-1#1)(2013-1#4)
queue##4##1##(1997-1#1)(2013-1#3)
queuine uptake##3##2##(1990-8#3)
queuine##14##1##(1990-8#9)(1993-12#3)(1995-11#2)
queuing##6##1##(2008-8#3)(2008-9#2)(2009-3#1)
qui a été##2##3##(2013-1#2)
qui a##4##2##(2012-2#2)(2013-1#2)
qui##18##1##(2008-5#2)(2009-4#1)(2011-2#1)(2012-2#10)(2013-1#4)
quick and accurate##3##3##(2005-9#1)(2008-4#1)(2008-5#1)
quick and cost-effective##2##3##(2007-10#1)(2010-8#1)
quick and easy to##3##4##(2008-4#2)(2008-5#1)
quick and easy##8##3##(1995-5#1)(2007-7#1)(2008-11#1)(2008-4#3)(2008-5#2)
quick and effective##4##3##(2007-11#1)(2008-10#2)(2009-8#1)
quick and reliable##3##3##(1990-8#1)(2005-8#1)(2008-1#1)
quick and simple method##2##4##(2008-10#2)
quick and simple##4##3##(2008-10#3)(2008-4#1)
quick and##38##2##(1990-8#1)(1992-3#1)(1995-5#1)(2005-8#1)(2005-9#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-4#6)(2008-5#4)(2008-9#1)(2009-8#1)(2010-8#1)(2012-12#1)(2012-2#1)
quick assessment##2##2##(2008-10#1)(2013-1#1)
quick diagnosis##2##2##(2007-9#1)(2010-6#1)
quick in##2##2##(1992-4#1)(2008-10#1)
quick leaching test##3##3##(2008-10#3)
quick method##6##2##(1991-8#1)(1997-1#1)(2008-10#2)(2012-2#1)(2013-8#1)
quick onset of##2##3##(2012-2#2)
quick recovery##2##2##(1990-2#1)(2009-3#1)
quick release##2##2##(2006-12#1)(2008-7#1)
quick response to##2##3##(2006-10#1)(2008-12#1)
quick response##4##2##(2006-10#1)(2008-10#1)(2008-12#1)(2013-1#1)
quick to##4##2##(1992-9#1)(1993-3#1)(2006-10#1)(2008-10#1)
quick##170##1##(1990-2#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-8#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-3#2)(1993-8#1)(1994-12#2)(1994-9#1)(1995-5#1)(1995-8#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-5#1)(2004-4#1)(2005-11#1)(2005-12#2)(2005-8#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#2)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#34)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#10)(2008-5#13)(2008-7#4)(2008-8#2)(2008-9#4)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-4#3)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#9)(2013-1#4)(2013-8#3)
quicken##3##1##(2013-1#3)
quicker and more##4##3##(2007-7#1)(2008-10#1)(2013-1#2)
quicker and##8##2##(2007-7#1)(2008-10#3)(2008-4#1)(2009-2#1)(2013-1#2)
quicker return to##2##3##(2010-1#1)(2010-2#1)
quicker than##5##2##(1997-2#1)(2006-2#1)(2008-3#1)(2009-2#1)(2013-1#1)
quicker to##3##2##(1996-1#1)(2006-12#1)(2007-12#1)
quicker##39##1##(1990-7#1)(1993-6#1)(1996-1#1)(1997-2#1)(1997-8#1)(2005-11#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#3)(2009-2#2)(2010-1#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#4)
quickest##3##1##(2006-8#1)(2008-10#1)(2008-4#1)
quickly and accurately##9##3##(1992-9#1)(1996-7#1)(2005-4#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-11#1)
quickly and automatically##3##3##(1996-12#1)(2008-3#1)(2009-3#1)
quickly and easily##4##3##(1996-12#1)(2008-12#1)(2008-9#1)(2013-7#1)
quickly and efficiently##5##3##(1994-12#1)(2005-5#1)(2005-9#1)(2007-8#1)(2008-11#1)
quickly and reproducibly##2##3##(2012-2#2)
quickly and with##2##3##(2013-1#1)(2013-8#1)
quickly and##46##2##(1992-9#1)(1994-12#1)(1996-12#3)(1996-7#1)(1997-1#1)(1997-5#1)(2005-4#2)(2005-5#1)(2005-9#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#3)(2013-8#2)
quickly at##2##2##(2008-10#1)(2008-3#1)
quickly be##2##2##(1992-12#1)(2009-6#1)
quickly become##2##2##(2008-4#1)(2008-7#1)
quickly by##2##2##(1990-4#1)(2008-7#1)
quickly due to##2##3##(2006-2#1)(2012-2#1)
quickly identify##3##2##(1997-6#1)(2008-10#1)(2011-2#1)
quickly if##2##2##(1994-8#1)(2012-2#1)
quickly in the##3##3##(1993-12#1)(2008-11#1)(2011-2#1)
quickly in##10##2##(1993-12#1)(1996-9#1)(2006-9#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2011-2#1)(2012-12#1)
quickly reached##2##2##(2008-10#1)(2008-3#1)
quickly the##3##2##(2007-8#2)(2008-2#1)
quickly to##7##2##(1995-1#1)(1997-3#1)(2006-8#1)(2008-4#1)(2008-6#1)(2011-2#1)(2013-7#1)
quickly under##3##2##(2007-8#1)(2008-10#1)(2013-8#1)
quickly with##4##2##(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)
quickly without##2##2##(2008-2#1)(2009-6#1)
quickly##254##1##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-9#2)(1991-1#1)(1991-12#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-12#2)(1993-2#3)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#2)(1995-3#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#4)(1996-2#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#3)(2005-11#2)(2005-4#2)(2005-5#1)(2005-7#2)(2005-9#1)(2006-10#1)(2006-2#2)(2006-4#3)(2006-6#1)(2006-8#2)(2006-9#1)(2007-11#7)(2007-12#3)(2007-2#1)(2007-3#1)(2007-6#2)(2007-8#8)(2007-9#3)(2008-1#1)(2008-10#27)(2008-11#14)(2008-12#3)(2008-2#8)(2008-3#8)(2008-4#9)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#6)(2008-9#11)(2009-1#1)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#6)(2011-3#2)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#8)(2012-3#2)(2012-5#1)(2013-1#8)(2013-7#4)(2013-8#7)
quid##7##1##(1993-4#1)(2008-1#1)(2008-4#5)
quiescence and##3##2##(1991-2#1)(1996-4#1)(2008-10#1)
quiescence of##4##2##(1996-10#1)(2006-10#1)(2007-12#1)(2013-8#1)
quiescence##25##1##(1991-2#1)(1991-8#1)(1994-8#2)(1996-10#1)(1996-4#2)(2006-10#1)(2006-5#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-8#1)(2009-12#1)(2012-12#4)(2012-2#1)(2013-8#1)
quiescent and##5##2##(1995-3#1)(1996-8#1)(2005-11#1)(2008-10#1)(2008-4#1)
quiescent cells##7##2##(1990-3#1)(1991-2#1)(1991-5#1)(1992-2#2)(1993-6#1)(1993-8#1)
quiescent conditions##3##2##(2005-11#1)(2008-10#1)(2008-7#1)
quiescent cultures of##3##3##(1992-3#2)(1995-3#1)
quiescent cultures##5##2##(1992-3#2)(1995-3#1)(1996-8#1)(2008-3#1)
quiescent embryos##2##2##(1994-8#2)
quiescent infections##5##2##(2008-10#5)
quiescent lysates##3##2##(1994-8#3)
quiescent peripheral blood##3##3##(1994-6#2)(1997-3#1)
quiescent##85##1##(1990-3#2)(1991-2#1)(1991-5#1)(1992-2#2)(1992-3#2)(1992-6#1)(1992-8#1)(1993-12#5)(1993-6#1)(1993-8#1)(1994-10#1)(1994-12#3)(1994-6#4)(1994-8#6)(1994-9#2)(1995-1#1)(1995-3#3)(1995-6#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-8#4)(1996-9#1)(1997-3#3)(1997-7#2)(2005-11#2)(2006-10#4)(2007-12#1)(2007-9#1)(2008-10#15)(2008-11#1)(2008-3#1)(2008-4#3)(2008-7#2)(2008-8#1)(2010-4#1)(2012-2#2)
quiet rest##4##2##(2007-12#1)(2010-3#3)
quiet sleep##4##2##(1994-4#3)(2012-1#1)
quiet##15##1##(1994-4#3)(2007-12#1)(2007-4#1)(2007-7#1)(2008-3#1)(2008-5#1)(2010-3#3)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
quietly##2##1##(2007-6#1)(2007-9#1)
quill##2##1##(1997-3#1)(2008-5#1)
quin 2##2##2##(1990-8#2)
quin2##5##1##(1990-8#1)(1990-9#1)(1991-1#1)(1992-6#2)
quinacrine##4##1##(1993-11#1)(1994-3#1)(1994-9#1)(2006-8#1)
quinalizarine##2##1##(2008-10#2)
quinalphos in##3##2##(2008-10#3)
quinapril##5##1##(1995-3#3)(2010-5#2)
quinazoline##5##1##(1990-7#1)(1994-9#2)(2007-10#1)(2007-11#1)
quinazolines##4##1##(2005-7#1)(2007-11#3)
quince##5##1##(2009-6#1)(2012-11#4)
quinic acid derivatives##2##3##(2007-1#2)
quinic acid##4##2##(2007-1#3)(2008-10#1)
quinic##8##1##(2007-1#3)(2008-10#2)(2008-11#3)
quinidine and##3##2##(1994-3#1)(1996-5#1)(2008-10#1)
quinidine##14##1##(1990-12#2)(1993-4#1)(1994-3#4)(1996-3#3)(1996-5#1)(2006-12#1)(2008-10#1)(2010-8#1)
quinine and##10##2##(1992-11#1)(1992-6#1)(1993-2#1)(1993-8#1)(1996-8#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-2#1)
quinine for##2##2##(1997-4#1)(2006-8#1)
quinine has been##2##3##(2009-6#2)
quinine hydrochloride##2##2##(1993-12#1)(1995-11#1)
quinine in##3##2##(2008-10#2)(2012-12#1)
quinine modified resin##3##3##(2008-10#3)
quinine sulfate##2##2##(2007-12#1)(2008-10#1)
quinine##75##1##(1990-9#1)(1991-2#1)(1992-11#5)(1992-6#1)(1993-12#2)(1993-2#1)(1993-8#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#1)(1996-5#1)(1996-8#3)(1996-9#1)(1997-4#3)(2004-2#1)(2006-10#1)(2006-12#1)(2006-4#2)(2006-8#10)(2007-11#1)(2007-12#1)(2007-2#2)(2008-10#16)(2008-2#2)(2008-8#1)(2009-6#6)(2010-6#1)(2011-1#1)(2012-12#2)
quinoa##12##1##(2008-10#12)
quinoidal base##2##2##(2008-10#2)
quinoidal##6##1##(2008-10#3)(2011-2#3)
quinol oxidase##2##2##(1990-11#1)(1995-11#1)
quinol##9##1##(1990-11#1)(1990-7#2)(1995-1#1)(1995-11#2)(2008-10#3)
quinolinate##4##1##(1990-7#2)(1992-1#1)(1995-12#1)
quinolinate-lesioned##2##1##(1992-3#2)
quinoline N-oxide##2##2##(2008-5#2)
quinoline alkaloids##2##2##(2007-1#2)
quinoline and##3##2##(1993-9#1)(2008-10#1)(2008-7#1)
quinoline degradation##2##2##(2008-7#2)
quinoline derivatives##3##2##(1993-8#1)(1995-5#1)(2008-10#1)
quinoline oxidoreductase##3##2##(1993-11#3)
quinoline sulfides##3##2##(2008-5#3)
quinoline##37##1##(1992-3#1)(1993-11#3)(1993-8#1)(1993-9#2)(1995-5#1)(1997-2#1)(2006-10#1)(2007-1#4)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-12#3)(2008-5#5)(2008-7#5)(2009-3#2)
quinoline-8-ol##4##1##(2008-10#4)
quinolines##4##1##(1993-6#1)(1993-9#2)(2007-10#1)
quinolinic acid in##3##3##(1990-7#1)(1993-12#1)(1995-5#1)
quinolinic acid lesions##3##3##(1994-2#1)(1995-12#1)(2004-11#1)
quinolinic acid##18##2##(1990-7#2)(1992-1#1)(1992-11#1)(1993-12#2)(1994-2#1)(1994-8#1)(1995-12#2)(1995-5#3)(1996-3#1)(2004-11#2)(2007-12#1)(2008-5#1)
quinolinone acid-containing compounds##2##3##(2011-3#2)
quinolinone and dihydroquinolinone p38 MAP kinase inhibitors##2##7##(2008-3#2)
quinolinone##5##1##(2008-3#3)(2011-3#2)
quinolone alkaloids##3##2##(2007-1#1)(2008-10#2)
quinolone antibacterial agent##2##3##(2008-10#1)(2008-5#1)
quinolone antibacterial##5##2##(1995-3#1)(2005-7#2)(2008-10#1)(2008-5#1)
quinolone antibacterials##3##2##(1990-8#1)(2008-10#2)
quinolone drugs##4##2##(1994-9#3)(2008-5#1)
quinolone resistance##3##2##(1994-9#1)(2008-5#1)(2011-2#1)
quinolone##33##1##(1990-8#1)(1991-12#3)(1994-9#5)(1995-3#2)(2005-7#2)(2007-1#1)(2007-8#1)(2008-10#6)(2008-3#1)(2008-5#6)(2009-6#1)(2011-2#2)(2012-3#2)
quinolone)##2##1##(2008-5#2)
quinolone-resistant##3##1##(2005-8#1)(2008-5#1)(2010-12#1)
quinolones and##3##2##(1991-12#1)(2008-5#2)
quinolones are##4##2##(1991-12#1)(2005-7#1)(2008-5#2)
quinolones have##2##2##(2012-3#2)
quinolones in##5##2##(2006-10#2)(2007-8#2)(2008-7#1)
quinolones on the##2##3##(1991-12#1)(2008-10#1)
quinolones on##3##2##(1991-12#1)(2008-10#2)
quinolones or##2##2##(1993-5#1)(2008-1#1)
quinolones were##2##2##(1994-9#1)(2008-10#1)
quinolones##53##1##(1991-12#9)(1993-5#2)(1994-9#2)(1996-3#1)(2005-6#1)(2005-7#3)(2005-8#1)(2006-10#3)(2006-6#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#8)(2008-3#1)(2008-5#8)(2008-7#1)(2009-1#1)(2011-2#1)(2012-3#4)
quinone carbonyl##2##2##(1996-5#2)
quinone cofactor##2##2##(1994-3#1)(1995-5#1)
quinone compounds are##2##3##(2013-8#2)
quinone electron acceptor##3##3##(1992-6#2)(1994-8#1)
quinone form##2##2##(1994-3#1)(2008-10#1)
quinone hepatotoxicity##5##2##(2013-8#5)
quinone is##3##2##(1995-8#2)(2013-8#1)
quinone levels##2##2##(1996-1#2)
quinone oxidoreductase (DT-diaphorase)##2##3##(1995-1#1)(2008-11#1)
quinone oxidoreductase##7##2##(1992-11#1)(1992-6#1)(1993-3#1)(1995-1#1)(1997-8#1)(2008-11#1)(2011-1#1)
quinone oxidoreductase1##2##2##(1994-8#2)
quinone oxidoreductases##2##2##(2011-1#2)
quinone was##2##2##(1990-7#1)(1994-11#1)
quinone##75##1##(1990-7#4)(1991-5#2)(1992-11#2)(1992-12#1)(1992-6#3)(1992-7#3)(1993-3#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#4)(1994-8#5)(1995-1#1)(1995-5#3)(1995-8#4)(1996-1#2)(1996-5#2)(1996-6#1)(1997-1#1)(1997-3#2)(1997-8#1)(2005-11#1)(2006-8#1)(2007-11#1)(2008-10#9)(2008-11#1)(2010-8#2)(2011-1#3)(2012-1#1)(2013-8#9)
quinone-containing##2##1##(1993-8#1)(1994-3#1)
quinoneimine##2##1##(1990-12#2)
quinones and##3##2##(1992-6#1)(2008-10#1)(2011-2#1)
quinones are more##2##3##(2009-9#2)
quinones are##3##2##(1990-7#1)(2009-9#2)
quinones on##2##2##(2009-9#2)
quinones##39##1##(1990-7#2)(1991-5#1)(1992-3#1)(1992-6#1)(1993-8#6)(1994-11#2)(1994-8#2)(1997-1#4)(2006-8#1)(2007-11#4)(2008-10#4)(2008-11#1)(2009-9#8)(2011-2#1)(2013-8#1)
quinonoid##2##1##(1991-7#1)(1993-6#1)
quinoxaline##6##1##(1993-9#1)(2007-11#2)(2010-5#3)
quinoxalines##2##1##(1993-9#2)
quinpirole (0##2##2##(1993-3#1)(1993-6#1)
quinpirole##20##1##(1990-2#2)(1990-5#1)(1992-3#1)(1993-12#1)(1993-3#8)(1993-6#3)(1996-1#1)(1996-12#1)(2005-8#1)(2008-7#1)
quinpirole-induced##2##1##(1993-12#2)
quinquefasciatus larvae##2##2##(2007-11#2)
quinquefasciatus##17##1##(1994-6#1)(2004-11#2)(2005-8#1)(2006-12#1)(2006-4#1)(2007-11#2)(2007-12#2)(2008-2#2)(2008-8#1)(2009-2#1)(2011-1#1)(2012-12#2)
quinquefolium##6##1##(2005-6#2)(2007-1#3)(2012-12#1)
quinquefolius)##5##1##(1997-2#1)(2008-10#4)
quinquestriatus##6##1##(1990-2#4)(1990-7#1)(2013-1#1)
quinquetaeniata##4##1##(2010-3#4)
quintana##5##1##(2007-12#3)(2013-1#2)
quintessential##2##1##(2010-12#1)(2010-8#1)
quintet##3##1##(1992-9#2)(1997-7#1)
quintile##2##1##(2010-5#1)(2011-2#1)
quintiles##6##1##(1991-10#1)(2007-2#1)(2010-5#2)(2011-2#1)(2012-3#1)
quinuclidine##3##1##(1991-4#1)(1995-7#1)(2010-6#1)
quinupristin/dalfopristin##2##1##(2005-8#2)
quipazine##4##1##(1994-2#1)(1995-1#3)
quirogae##2##1##(2008-5#2)
quis##3##1##(1991-9#3)
quisqualate and##3##2##(1990-11#1)(1991-9#1)(1993-12#1)
quisqualate##16##1##(1990-11#1)(1990-2#2)(1990-8#2)(1991-5#1)(1991-9#1)(1992-10#1)(1993-12#2)(1994-2#3)(1995-12#2)(1996-5#1)
quisqualic acid resulted in##2##4##(1990-2#1)(1992-8#1)
quisqualic acid##5##2##(1990-2#1)(1992-10#1)(1992-8#3)
quisqualic##9##1##(1990-2#1)(1991-9#2)(1992-10#1)(1992-8#5)
quisqualis##6##1##(2008-10#6)
quit attempts and##2##3##(2013-1#2)
quit attempts##8##2##(2008-4#1)(2010-11#1)(2012-1#1)(2013-1#5)
quit outcomes##4##2##(2013-1#4)
quit rate##2##2##(2013-1#2)
quit rates of##3##3##(2011-2#2)(2013-1#1)
quit rates##5##2##(2007-12#1)(2011-2#3)(2013-1#1)
quit smoking##13##2##(1993-2#1)(1997-4#1)(2007-9#1)(2008-11#1)(2008-8#1)(2012-2#2)(2013-1#2)(2013-8#4)
quit than##2##2##(1994-7#1)(1996-3#1)
quit##64##1##(1991-12#2)(1991-5#1)(1993-2#1)(1994-7#2)(1996-12#1)(1996-3#1)(1997-4#1)(2006-2#2)(2007-12#1)(2007-9#1)(2008-11#2)(2008-4#3)(2008-6#1)(2008-8#1)(2010-11#1)(2010-2#3)(2011-2#7)(2012-1#3)(2012-2#5)(2013-1#19)(2013-8#6)
quite a number of##2##4##(1994-3#1)(2011-2#1)
quite a##12##2##(1990-8#1)(1994-3#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
quite challenging##5##2##(2007-12#1)(2007-8#1)(2008-4#1)(2010-12#1)(2013-1#1)
quite clear##3##2##(2008-9#1)(2009-12#1)(2009-3#1)
quite close##3##2##(1991-7#1)(1993-3#1)(2008-10#1)
quite common in the##2##4##(1991-6#1)(2008-10#1)
quite common in##5##3##(1991-6#1)(1995-3#1)(2008-10#1)(2008-3#1)(2008-8#1)
quite common##14##2##(1990-5#1)(1991-6#1)(1993-10#1)(1993-6#1)(1995-3#1)(1996-2#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-8#1)(2011-12#1)(2013-1#2)
quite comparable to##2##3##(2006-8#1)(2008-10#1)
quite complex and##2##3##(2010-12#1)(2011-12#1)
quite complex##10##2##(1993-8#1)(1994-12#1)(1995-3#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-12#1)(2013-1#1)
quite considerably##3##2##(1994-9#1)(2005-11#1)(2008-5#1)
quite consistent##3##2##(2007-9#1)(2008-10#1)(2008-8#1)
quite different from each other##2##5##(2005-12#1)(2012-2#1)
quite different from that of##5##5##(1990-7#1)(1995-10#1)(1996-2#1)(2008-3#1)(2010-12#1)
quite different from the##3##4##(2008-8#1)(2010-11#1)(2010-7#1)
quite different from those of the##2##6##(1992-4#1)(2008-5#1)
quite different from those of##4##5##(1992-12#1)(1992-4#1)(1992-7#1)(2008-5#1)
quite different from those##5##4##(1992-12#1)(1992-4#1)(1992-7#1)(1996-5#1)(2008-5#1)
quite different from##21##3##(1990-7#1)(1992-12#1)(1992-4#1)(1992-7#1)(1993-9#1)(1995-10#1)(1996-2#1)(1996-5#1)(1997-8#1)(2005-12#1)(2007-11#1)(2007-4#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-7#1)(2012-2#1)
quite different than##2##3##(2006-10#1)(2008-7#1)
quite different##60##2##(1990-3#1)(1990-7#1)(1991-3#1)(1992-11#1)(1992-12#2)(1992-4#1)(1992-7#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-12#1)(1995-7#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#2)(1997-8#1)(2005-11#2)(2005-12#1)(2005-7#1)(2006-10#2)(2007-11#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
quite difficult to obtain##3##4##(2005-10#1)(2008-3#1)(2008-9#1)
quite difficult to##5##3##(2005-10#1)(2008-10#1)(2008-3#1)(2008-9#2)
quite difficult##12##2##(2005-10#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-9#3)(2009-1#1)(2013-8#1)
quite distinct##5##2##(1991-5#1)(1996-4#1)(1997-8#1)(2007-12#1)(2008-7#1)
quite distinctive##3##2##(1990-10#1)(1992-12#1)(2008-8#1)
quite easily##2##2##(1992-4#1)(2008-10#1)
quite effective in##4##3##(1992-12#1)(2005-10#1)(2007-8#1)(2009-12#1)
quite effective##7##2##(1992-12#1)(1997-1#1)(2004-3#1)(2005-10#1)(2007-11#1)(2007-8#1)(2009-12#1)
quite extensive##2##2##(2007-5#1)(2008-7#1)
quite frequent##4##2##(2007-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
quite frequently##2##2##(2008-1#1)(2012-2#1)
quite general in##2##3##(2005-8#1)(2008-8#1)
quite general##5##2##(1990-3#1)(1994-10#1)(2005-8#1)(2007-12#1)(2008-8#1)
quite good##6##2##(1991-6#1)(2006-1#1)(2008-1#1)(2008-10#3)
quite heterogeneous##3##2##(2005-11#1)(2008-10#1)(2008-11#1)
quite high in##3##3##(2007-7#1)(2007-8#1)(2013-1#1)
quite high##17##2##(1991-12#1)(1992-12#2)(1993-3#1)(2004-4#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2011-1#1)(2012-3#1)(2013-1#2)
quite insensitive to##3##3##(1995-5#1)(2007-11#1)(2007-12#1)
quite large##6##2##(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-4#1)(2013-8#1)
quite likely that##5##3##(1991-2#1)(1995-12#1)(1995-3#1)(1997-1#1)(2008-4#1)
quite likely##7##2##(1990-5#1)(1991-2#1)(1995-12#1)(1995-3#1)(1995-8#1)(1997-1#1)(2008-4#1)
quite limited##4##2##(2006-11#1)(2008-9#1)(2010-6#1)(2011-2#1)
quite low and##3##3##(2007-8#1)(2010-12#1)(2011-2#1)
quite low##15##2##(1996-2#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-12#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-8#1)
quite often##8##2##(1990-9#1)(1996-2#1)(1997-4#1)(2005-10#1)(2005-11#1)(2006-4#1)(2011-2#1)(2013-1#1)
quite poor##2##2##(2008-6#1)(2009-3#1)
quite possibly##2##2##(2008-5#1)(2008-8#1)
quite rare in##2##3##(2006-12#1)(2012-2#1)
quite rare##8##2##(2006-10#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-5#1)(2010-5#1)(2012-2#2)
quite recently##3##2##(1995-11#1)(2006-10#1)(2008-4#1)
quite satisfactory##6##2##(1992-4#1)(2008-10#3)(2008-3#1)(2011-1#1)
quite sensitive to the##2##4##(1996-2#1)(2008-10#1)
quite sensitive to##5##3##(1996-2#1)(1997-1#1)(2007-8#1)(2008-10#2)
quite sensitive##6##2##(1996-2#1)(1997-1#1)(2007-8#1)(2008-10#2)(2008-9#1)
quite short##2##2##(1993-9#1)(1996-3#1)
quite significant##2##2##(2008-10#1)(2012-2#1)
quite similar for##2##3##(1997-1#1)(2008-5#1)
quite similar to that##2##4##(1994-3#1)(2007-7#1)
quite similar to##10##3##(1992-5#1)(1993-6#1)(1994-3#1)(2006-5#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-11#1)(2008-4#1)
quite similar##21##2##(1992-1#1)(1992-5#1)(1993-6#1)(1994-3#1)(1995-1#1)(1995-3#1)(1997-1#1)(2005-10#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)
quite simple##3##2##(1994-2#1)(2008-10#1)(2008-9#1)
quite small##6##2##(1992-1#1)(1992-5#1)(1992-9#1)(2008-10#1)(2008-3#1)(2011-1#1)
quite specific##2##2##(1991-7#1)(1995-6#1)
quite stable and##4##3##(1996-5#1)(2008-10#1)(2008-2#1)(2008-5#1)
quite stable for##2##3##(2008-10#1)(2008-2#1)
quite stable##11##2##(1996-5#1)(1996-6#1)(1997-4#1)(2005-4#1)(2008-10#3)(2008-2#3)(2008-5#1)
quite strong##2##2##(2006-12#1)(2008-10#1)
quite strongly##2##2##(1993-1#1)(2008-2#1)
quite substantial##3##2##(1994-3#1)(2008-1#1)(2008-3#1)
quite successful##3##2##(2006-10#1)(2006-8#1)(2013-7#1)
quite sufficient##2##2##(2008-3#1)(2008-4#1)
quite the same##2##3##(2009-9#1)(2010-4#1)
quite the##3##2##(1990-6#1)(2009-9#1)(2010-4#1)
quite thoroughly##2##2##(2007-12#1)(2013-8#1)
quite toxic##2##2##(2008-12#1)(2010-11#1)
quite uniform##3##2##(2007-11#1)(2008-2#2)
quite useful##5##2##(1990-5#1)(1992-1#1)(2008-4#1)(2011-12#1)(2012-1#1)
quite variable##9##2##(1994-3#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#1)(2012-3#1)(2013-8#1)
quite weak##3##2##(2008-8#1)(2010-4#1)(2012-2#1)
quite well in##2##3##(1997-8#1)(2010-10#1)
quite well##13##2##(1991-7#1)(1994-2#1)(1997-8#1)(2004-2#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-10#1)
quite widespread##2##2##(1993-6#1)(1995-11#1)
quite##481##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#3)(1990-6#4)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#3)(1992-1#4)(1992-11#2)(1992-12#6)(1992-2#1)(1992-3#1)(1992-4#3)(1992-5#3)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#4)(1993-8#2)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#4)(1994-3#6)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-3#4)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#1)(1996-12#1)(1996-2#5)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#4)(1997-2#1)(1997-3#2)(1997-4#4)(1997-5#1)(1997-8#4)(2004-2#1)(2004-3#1)(2004-4#1)(2005-10#4)(2005-11#6)(2005-12#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#14)(2006-11#1)(2006-12#5)(2006-2#1)(2006-4#2)(2006-5#2)(2006-6#2)(2006-8#4)(2007-10#1)(2007-11#9)(2007-12#11)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#10)(2007-8#7)(2007-9#3)(2008-1#9)(2008-10#47)(2008-11#3)(2008-12#4)(2008-2#16)(2008-3#19)(2008-4#9)(2008-5#18)(2008-6#1)(2008-7#9)(2008-8#12)(2008-9#10)(2009-1#1)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#7)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#3)(2011-1#5)(2011-12#3)(2011-2#9)(2012-1#2)(2012-12#1)(2012-2#9)(2012-3#3)(2013-1#14)(2013-7#2)(2013-8#6)
quitting smoking##5##2##(2006-8#2)(2010-2#1)(2011-2#1)(2013-7#1)
quitting##24##1##(1991-12#1)(1993-12#1)(1995-6#1)(2005-10#1)(2006-8#2)(2007-11#1)(2007-12#1)(2008-4#1)(2010-2#3)(2011-2#3)(2012-1#2)(2012-2#1)(2013-1#5)(2013-7#1)
quiz##22##1##(2004-3#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-4#5)(2007-5#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#2)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#1)
quorum sensing (QS)##4##3##(2008-10#1)(2009-6#1)(2010-10#1)(2013-1#1)
quorum sensing##14##2##(1995-2#1)(2007-12#2)(2008-10#3)(2008-8#1)(2009-6#1)(2009-8#2)(2010-10#2)(2010-12#1)(2013-1#1)
quorum##18##1##(1995-2#1)(2007-12#2)(2008-10#3)(2008-7#1)(2008-8#1)(2009-6#2)(2009-8#3)(2010-10#2)(2010-12#1)(2012-2#1)(2013-1#1)
quorum-quenching enzymes##4##2##(2008-9#4)
quorum-quenching##5##1##(2008-9#5)
quorum-sensing signal##3##2##(2008-9#2)(2009-6#1)
quorum-sensing signals##4##2##(2007-12#1)(2008-9#3)
quorum-sensing##12##1##(2007-12#1)(2008-9#6)(2009-6#1)(2010-12#2)(2011-1#1)(2012-12#1)
quot##14##1##(2012-2#6)(2013-7#6)(2013-8#2)
quota##6##1##(1993-6#1)(1995-2#1)(1996-5#1)(2007-9#1)(2008-10#1)(2008-11#1)
quotas##2##1##(1992-1#1)(2007-8#1)
quotations from the classics of Marxism and Lysenkoism##2##8##(2009-2#2)
quote the##2##2##(2008-10#1)(2009-4#1)
quoted as saying##2##3##(1992-5#1)(2006-9#1)
quoted as##8##2##(1992-5#1)(2006-9#1)(2007-2#1)(2007-4#1)(2008-12#1)(2009-12#1)(2012-12#1)(2012-2#1)
quoted##21##1##(1991-3#1)(1992-5#1)(1994-6#1)(1995-4#1)(1996-6#1)(2006-12#2)(2006-3#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-12#1)(2010-7#1)(2012-12#1)(2012-2#1)
quotidian##2##1##(2012-3#2)
quotient between##3##2##(1994-5#1)(2008-10#2)
quotient of##5##2##(2008-3#2)(2012-3#2)(2012-6#1)
quotient##28##1##(1990-8#1)(1992-2#1)(1992-4#1)(1992-8#1)(1994-5#1)(1995-3#1)(2005-1#1)(2006-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2009-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2012-6#1)(2013-1#1)
quotients##4##1##(1992-2#1)(1993-8#1)(2008-11#2)
quoting##2##1##(2008-5#1)(2012-3#1)
r &gt##2##2##(2008-10#1)(2011-1#1)
r (2)##2##2##(2008-10#1)(2008-4#1)
r = -##3##3##(1990-8#2)(2008-9#1)
r = -0##24##3##(1991-2#1)(1991-3#1)(1993-12#2)(1997-2#1)(2006-6#4)(2007-5#2)(2008-12#1)(2008-4#4)(2010-10#2)(2011-3#2)(2012-2#2)(2013-1#1)(2013-8#1)
r = 0##74##3##(1990-10#3)(1990-8#3)(1991-10#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#2)(1992-2#2)(1993-8#1)(1995-1#1)(1995-11#2)(1995-2#4)(1995-7#4)(1996-11#3)(1996-4#2)(1996-7#1)(1997-8#2)(2005-12#1)(2005-4#1)(2005-9#2)(2006-4#2)(2006-6#2)(2007-2#2)(2008-10#5)(2008-3#3)(2008-4#5)(2008-5#1)(2008-8#1)(2010-10#2)(2010-12#2)(2011-2#1)(2011-3#4)(2012-2#2)(2013-1#3)
r = 1##3##3##(1990-2#1)(1990-8#1)(2008-9#1)
r =##120##2##(1990-10#3)(1990-2#2)(1990-8#10)(1991-10#1)(1991-2#3)(1991-3#2)(1991-5#1)(1991-8#2)(1992-2#2)(1993-12#2)(1993-8#1)(1994-11#4)(1995-1#1)(1995-11#2)(1995-2#4)(1995-7#4)(1996-11#3)(1996-4#2)(1996-7#1)(1997-2#1)(1997-8#2)(2005-12#1)(2005-4#1)(2005-9#2)(2006-4#2)(2006-6#6)(2007-10#2)(2007-2#2)(2007-5#2)(2008-10#5)(2008-12#1)(2008-3#3)(2008-4#10)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-10#4)(2010-12#2)(2010-8#3)(2011-2#1)(2011-3#6)(2012-2#4)(2013-1#4)(2013-8#1)
r =0##2##2##(2005-12#1)(2010-5#1)
r and the##2##3##(2008-10#1)(2008-2#1)
r and##5##2##(1997-4#1)(2008-10#3)(2008-2#1)
r of##4##2##(2007-11#1)(2008-10#1)(2012-2#2)
r values##5##2##(1990-12#1)(2008-10#3)(2008-7#1)
r was##2##2##(2006-10#1)(2008-10#1)
r##244##1##(1990-10#3)(1990-12#1)(1990-2#7)(1990-8#10)(1990-9#5)(1991-1#1)(1991-10#1)(1991-12#4)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#9)(1991-8#2)(1991-9#11)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#7)(1993-12#2)(1993-8#1)(1994-11#4)(1995-1#1)(1995-11#2)(1995-2#4)(1995-6#2)(1995-7#4)(1996-11#3)(1996-4#2)(1996-7#1)(1997-2#2)(1997-4#1)(1997-8#2)(2005-11#1)(2005-12#2)(2005-4#1)(2005-9#2)(2006-10#1)(2006-4#2)(2006-5#2)(2006-6#6)(2007-10#2)(2007-11#3)(2007-2#2)(2007-5#3)(2008-1#1)(2008-10#32)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#6)(2008-4#11)(2008-5#5)(2008-7#3)(2008-8#4)(2008-9#4)(2009-10#1)(2009-9#1)(2010-10#4)(2010-12#2)(2010-5#1)(2010-8#3)(2010-9#4)(2011-1#1)(2011-2#1)(2011-3#6)(2012-2#7)(2013-1#5)(2013-8#2)
r&amp##5##1##(1993-4#1)(1995-9#1)(2009-3#2)(2011-2#1)
r&gt##2##1##(2007-8#1)(2013-1#1)
r(0) and theta(0)##2##3##(2008-2#2)
r(0)##5##1##(2008-2#5)
r(1) relaxivity##2##2##(2010-2#2)
r(1)##3##1##(2010-2#2)(2012-11#1)
r(2) = 0##11##3##(2006-5#1)(2007-10#1)(2008-10#6)(2010-5#2)(2011-2#1)
r(2) =##12##2##(2006-5#1)(2007-10#1)(2008-10#6)(2010-5#2)(2011-2#1)(2012-11#1)
r(2) values of##3##3##(2008-10#3)
r(2) values##4##2##(2008-10#4)
r(2)##25##1##(2006-5#1)(2007-10#1)(2007-11#1)(2008-10#13)(2008-7#1)(2009-3#2)(2010-12#1)(2010-5#2)(2011-2#1)(2012-1#1)(2012-11#1)
r(2)&gt##3##1##(1995-3#2)(2012-2#1)
r(2))##2##1##(2008-10#1)(2010-12#1)
r(2)=0##19##1##(2008-10#18)(2008-4#1)
r(G) = 0##2##3##(2008-10#2)
r(ext##2##1##(2007-12#2)
r(g)##4##1##(2008-10#4)
r(m) values##2##2##(2011-2#2)
r(m)##4##1##(2008-12#1)(2011-2#3)
r(rs) values##2##2##(2008-2#2)
r(rs)##4##1##(2008-2#4)
r)##2##1##(2006-10#1)(2011-1#1)
r-Hu-EPO##4##1##(2010-12#4)
r-HuEPO therapy##2##2##(2007-7#2)
r-HuEPO##7##1##(2007-7#3)(2008-1#4)
r-PDE##2##1##(1993-7#2)
r-TMVP##3##1##(1990-5#3)
r-[K4HPgK5HPg]##3##1##(1993-8#3)
r-[K4HPg]##3##1##(1993-8#3)
r-[K5HPg]##3##1##(1993-8#3)
r-bp key strings##2##3##(2008-7#2)
r-hu IFN-gamma##4##2##(1993-9#4)
r-l##3##1##(1993-2#3)
r-protein##4##1##(1991-6#1)(1991-7#1)(1995-8#2)
r-proteins in##2##2##(1991-5#1)(2008-8#1)
r-proteins##6##1##(1991-5#1)(1991-6#1)(1991-8#1)(1995-8#1)(2008-11#1)(2008-8#1)
r-selected##2##1##(2008-10#2)
r/min##4##1##(2005-11#1)(2008-8#1)(2009-2#1)(2011-1#1)
r/min)##2##1##(2009-2#2)
r1 relaxivity##2##2##(2008-7#2)
r1-sc##2##1##(2012-3#2)
r2 = -0##2##3##(2011-2#2)
r2 = 0##5##3##(1992-3#1)(1997-8#1)(2008-5#2)(2011-2#1)
r2 =##7##2##(1992-3#1)(1997-8#1)(2008-5#2)(2011-2#3)
r2 values##3##2##(1996-6#1)(1997-2#1)(2006-12#1)
r2##12##1##(1992-3#1)(1996-6#1)(1997-2#1)(1997-8#1)(2006-12#1)(2008-5#3)(2011-2#3)(2012-12#1)
r2=0##2##1##(2007-8#2)
r4##2##1##(1995-6#2)
r=##4##1##(2007-9#2)(2008-4#2)
r=0##33##1##(2005-12#3)(2006-4#1)(2007-8#1)(2008-10#18)(2008-7#3)(2010-11#1)(2010-4#1)(2011-1#1)(2013-8#4)
r=1##5##1##(2008-10#5)
rAAV is##2##2##(2008-5#1)(2008-9#1)
rAAV production##3##2##(2008-11#1)(2008-8#2)
rAAV was##2##2##(2008-8#1)(2008-9#1)
rAAV##21##1##(2008-11#2)(2008-5#5)(2008-8#6)(2008-9#8)
rAAV-mediated gene##2##2##(2008-8#1)(2008-9#1)
rAAV2/1 vectors##2##2##(2009-10#2)
rANF99-126##3##1##(1991-9#3)
rBCG expressing##2##2##(1995-5#2)
rBCG##6##1##(1995-5#6)
rCA-GTase##2##1##(1992-9#2)
rCBF in the##2##3##(1996-2#1)(2008-7#1)
rCBF in##4##2##(1994-11#1)(1995-5#1)(1996-2#1)(2008-7#1)
rCBF##18##1##(1994-11#1)(1995-12#2)(1995-5#3)(1996-2#2)(1996-5#3)(2006-11#2)(2007-10#4)(2008-7#1)
rCBFs in##3##2##(1992-8#3)
rCBV and rCBF##2##3##(2007-10#2)
rCBV in the striatum were##3##5##(2006-11#3)
rCBV in the striatum##4##4##(2006-11#4)
rCBV in the##5##3##(2006-11#5)
rCBV##7##1##(2006-11#5)(2007-10#2)
rCGCCCGCG##3##1##(1991-8#3)
rCGCUUGCG##2##1##(1991-8#2)
rCHO cells##2##2##(2008-11#2)
rCHO##3##1##(2008-11#3)
rCHO-A##2##1##(2008-11#2)
rCHO-B##2##1##(2008-11#2)
rCMRO2##3##1##(2006-11#2)(2007-10#1)
rCRBPI##2##1##(1992-9#2)
rCYP3A4##2##1##(2011-2#2)
rCYP3A5##2##1##(2011-2#2)
rDNA ITS region##2##3##(2008-10#1)(2008-5#1)
rDNA ITS##3##2##(2008-10#2)(2008-5#1)
rDNA analysis##3##2##(2008-10#2)(2008-9#1)
rDNA and##13##2##(2005-11#1)(2007-3#2)(2008-10#8)(2008-7#1)(2013-1#1)
rDNA fragment##3##2##(1996-5#1)(2008-10#1)(2008-9#1)
rDNA from isolates of AG-13##2##5##(2008-10#2)
rDNA from##6##2##(1996-9#1)(2006-8#1)(2008-10#4)
rDNA gene##9##2##(1993-9#1)(2006-8#1)(2008-10#3)(2008-12#2)(2012-2#2)
rDNA genotypes##2##2##(2008-10#2)
rDNA in the##2##3##(2008-10#1)(2012-2#1)
rDNA in##3##2##(2007-12#1)(2008-10#1)(2012-2#1)
rDNA intergenic spacer##4##3##(1991-12#1)(1995-8#2)(2008-10#1)
rDNA intergenic##5##2##(1991-12#1)(1995-8#2)(2008-10#1)(2008-5#1)
rDNA is##3##2##(1995-8#1)(2006-10#1)(2008-10#1)
rDNA of the##3##3##(1996-9#2)(1997-3#1)
rDNA of##8##2##(1995-8#1)(1996-9#3)(1997-3#1)(2005-11#1)(2006-8#1)(2008-10#1)
rDNA repeat units##2##3##(2008-5#2)
rDNA repeat##4##2##(1997-2#1)(2008-10#1)(2008-5#2)
rDNA restriction analysis##2##3##(2006-5#1)(2008-10#1)
rDNA revealed##2##2##(2008-10#2)
rDNA sequence analysis##3##3##(2008-10#1)(2008-11#1)(2013-7#1)
rDNA sequence and RAPD##2##4##(2008-10#2)
rDNA sequence##13##2##(2006-8#4)(2007-12#1)(2008-10#6)(2008-11#1)(2013-7#1)
rDNA sequences were##2##3##(2006-8#1)(2008-10#1)
rDNA sequences##10##2##(2005-11#1)(2006-8#4)(2007-12#1)(2008-10#1)(2010-10#1)(2013-7#2)
rDNA showed that##2##3##(2008-10#2)
rDNA spacer##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
rDNA transcription##7##2##(1991-11#1)(1991-12#1)(1993-3#2)(1993-5#2)(2008-2#1)
rDNA units##2##2##(1995-6#1)(2008-5#1)
rDNA variation##2##2##(1993-11#1)(2008-5#1)
rDNA was##5##2##(2006-8#1)(2008-10#3)(2008-2#1)
rDNA were used to##2##4##(2008-10#2)
rDNA were##6##2##(1993-9#1)(1996-9#1)(2008-10#4)
rDNA##200##1##(1991-11#2)(1991-12#4)(1991-8#2)(1993-11#2)(1993-3#5)(1993-5#4)(1993-9#3)(1995-6#1)(1995-8#6)(1996-5#3)(1996-9#6)(1997-2#1)(1997-3#1)(1997-4#1)(2005-11#3)(2006-10#3)(2006-5#1)(2006-8#18)(2007-12#7)(2007-3#2)(2008-10#82)(2008-11#2)(2008-12#2)(2008-2#6)(2008-5#9)(2008-7#1)(2008-8#1)(2008-9#3)(2010-10#4)(2010-3#1)(2010-8#2)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#4)(2013-1#1)(2013-7#4)
rDNA) of##3##2##(1993-11#1)(2008-10#1)(2011-2#1)
rDNA)##4##1##(1993-11#1)(2008-10#2)(2011-2#1)
rDNA-ITS region##3##2##(2008-10#3)
rDNA-ITS sequences##3##2##(2008-10#2)(2012-3#1)
rDNA-ITS##6##1##(2008-10#5)(2012-3#1)
rDNA-internal transcribed spacer##2##3##(2008-10#2)
rDR4##2##1##(1997-4#2)
rEP3 receptor##3##2##(1993-7#2)(1994-9#1)
rEP3A receptor##2##2##(1994-9#2)
rEP3A##4##1##(1994-9#4)
rEP3B receptor cDNA##2##3##(1994-9#2)
rEP3B receptor##4##2##(1994-9#4)
rFVIII concentrates##2##2##(2007-11#2)
rFVIII##4##1##(2007-11#4)
rFVIIa has been##2##3##(2005-10#2)
rFVIIa has##3##2##(2005-10#3)
rFVIIa##12##1##(2005-10#9)(2007-11#1)(2008-8#1)(2011-12#1)
rFurin##8##1##(2008-11#8)
rGBM##3##1##(2006-6#3)
rGH promoter activity##2##3##(1996-8#2)
rGH promoter##4##2##(1996-8#4)
rGO sheets##2##2##(2013-1#2)
rGO##4##1##(2013-1#4)
rGO/SWCNT-modified##2##1##(2013-1#2)
rH##8##1##(2013-8#8)
rHDL at##2##2##(1995-5#2)
rHDL##5##1##(1995-5#5)
rHGH##5##1##(2007-11#5)
rHV2-Lys47##2##1##(1994-2#2)
rHsp70/FCA##2##1##(2009-5#2)
rHu-Epo treatment##2##2##(2005-10#2)
rHuEPO therapy##2##2##(2008-5#2)
rHuEPO##7##1##(1995-1#5)(2008-5#2)
rIFN-gamma##2##1##(1994-8#2)
rIII##4##1##(1993-11#4)
rIL-2 and IFNalpha##2##3##(2007-11#2)
rIL-2 and##3##2##(1990-12#1)(2007-11#2)
rIL-2 is##2##2##(2007-11#2)
rIL-2 with##2##2##(2007-11#2)
rIL-2##20##1##(1990-12#5)(1991-8#1)(2007-11#14)
rIPL##2##1##(2008-11#2)
rMOR1##2##1##(1995-12#2)
rMRP1##6##1##(2008-5#6)
rMd5##2##1##(2013-8#2)
rMtL##4##1##(2008-10#4)
rNG-hCGalpha##7##1##(1995-8#7)
rNT-3##3##1##(2008-8#3)
rNuc##4##1##(1994-3#4)
rOAT expression is##2##3##(1993-3#2)
rOAT##5##1##(1993-3#5)
rOEF in the MCA territories##2##5##(2006-11#2)
rOEF##4##1##(2006-11#3)(2007-10#1)
rP27(kip 1)##2##2##(2008-9#2)
rP27(kip##3##1##(2008-9#3)
rPA##6##1##(2007-9#6)
rPEA##4##1##(2008-10#4)
rPRL promoter activity##2##3##(1994-8#2)
rPRL promoter was obtained##2##4##(1994-8#2)
rPRL promoter##4##2##(1994-8#4)
rPRL##8##1##(1994-8#5)(1995-10#2)(1995-11#1)
rPlg##6##1##(1995-6#6)
rQT3##4##1##(1990-8#4)
rRNA A-site##2##2##(2008-4#2)
rRNA and mRNA##2##3##(1992-11#1)(2006-12#1)
rRNA and tRNA##2##3##(1996-6#1)(1996-8#1)
rRNA and##18##2##(1992-11#1)(1992-6#3)(1996-6#1)(1996-8#1)(2006-11#2)(2006-12#1)(2006-8#3)(2007-12#1)(2008-10#3)(2008-5#1)(2012-2#1)
rRNA are##2##2##(1996-5#1)(1997-7#1)
rRNA cluster XV##2##3##(2006-5#2)
rRNA decreased##2##2##(1996-8#1)(2006-11#1)
rRNA gene as##2##3##(2008-8#1)(2011-1#1)
rRNA gene of P##2##4##(2006-8#1)(2011-2#1)
rRNA gene of##5##3##(1996-3#1)(2006-8#1)(2008-12#1)(2008-8#1)(2011-2#1)
rRNA gene sequence##10##3##(2006-8#1)(2007-5#1)(2009-5#1)(2009-6#2)(2010-6#1)(2011-2#2)(2012-2#2)
rRNA gene sequences##5##3##(1996-11#1)(2008-10#2)(2011-2#1)(2013-1#1)
rRNA gene were##2##3##(2006-8#1)(2010-3#1)
rRNA gene##60##2##(1994-12#1)(1996-11#1)(1996-3#1)(2006-11#1)(2006-5#1)(2006-8#7)(2007-5#1)(2008-10#11)(2008-12#2)(2008-6#1)(2008-8#4)(2009-5#4)(2009-6#3)(2010-3#2)(2010-4#1)(2010-6#2)(2011-1#2)(2011-2#7)(2012-2#3)(2013-1#3)(2013-8#2)
rRNA genes and##2##3##(2008-10#1)(2008-8#1)
rRNA genes are##2##3##(2011-2#2)
rRNA genes positively correlated with##2##5##(2008-10#2)
rRNA genes##22##2##(1992-3#1)(1992-4#1)(2006-10#1)(2006-8#2)(2008-10#6)(2008-5#3)(2008-8#2)(2009-5#1)(2011-2#3)(2012-2#1)(2013-1#1)
rRNA has been##2##3##(1997-2#1)(2006-12#1)
rRNA has##3##2##(1995-8#1)(1997-2#1)(2006-12#1)
rRNA homology##2##2##(2005-12#1)(2008-7#1)
rRNA in this##2##3##(2010-4#2)
rRNA in##4##2##(1990-11#1)(2010-4#3)
rRNA internal transcribed spacer##2##4##(2006-3#1)(2008-10#1)
rRNA internal##3##2##(2006-3#1)(2008-10#1)(2008-9#1)
rRNA is##3##2##(2007-12#1)(2008-8#2)
rRNA locus##2##2##(2008-5#2)
rRNA nucleotides that##2##3##(1992-6#1)(2006-11#1)
rRNA of the##2##3##(2005-7#2)
rRNA of##4##2##(1995-8#2)(2005-7#2)
rRNA operon##2##2##(1993-12#1)(1995-8#1)
rRNA operons##4##2##(1990-5#3)(2011-2#1)
rRNA or##2##2##(1997-1#1)(2005-8#1)
rRNA sequences were##2##3##(1997-2#1)(2008-5#1)
rRNA sequences##7##2##(1997-2#3)(2006-8#1)(2008-10#1)(2008-5#1)(2011-1#1)
rRNA structure##2##2##(1991-2#1)(2006-12#1)
rRNA synthesis##4##2##(1993-5#1)(1997-1#2)(2008-7#1)
rRNA transcription##2##2##(1997-1#1)(2011-2#1)
rRNA was##3##2##(1994-9#1)(2011-1#1)(2013-1#1)
rRNA were##3##2##(1997-1#1)(2008-8#1)(2009-2#1)
rRNA with##2##2##(1996-8#1)(2010-4#1)
rRNA##266##1##(1990-11#1)(1990-4#1)(1990-5#5)(1991-2#1)(1991-4#1)(1991-5#1)(1992-11#3)(1992-12#1)(1992-3#3)(1992-4#1)(1992-6#6)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-9#5)(1994-12#2)(1994-3#2)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#1)(1995-8#8)(1996-11#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#12)(1997-1#9)(1997-2#10)(1997-6#3)(1997-7#3)(2004-11#1)(2004-4#1)(2005-12#2)(2005-7#3)(2005-8#3)(2006-10#1)(2006-11#7)(2006-12#4)(2006-3#1)(2006-5#4)(2006-8#17)(2007-12#6)(2007-5#1)(2008-10#27)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#11)(2008-6#1)(2008-7#2)(2008-8#14)(2008-9#4)(2009-2#1)(2009-5#5)(2009-6#3)(2010-3#2)(2010-4#7)(2010-6#2)(2011-1#7)(2011-2#15)(2012-2#8)(2013-1#5)(2013-7#2)(2013-8#2)
rRNA)##5##1##(1992-6#1)(1993-12#1)(1996-8#1)(2011-1#2)
rRNA-encoding gene (rDNA)##2##3##(1993-5#1)(1993-9#1)
rRNA-encoding gene##3##2##(1993-12#1)(1993-5#1)(1993-9#1)
rRNA-encoding genes##2##2##(1993-12#1)(1993-5#1)
rRNA-encoding##6##1##(1993-12#2)(1993-5#2)(1993-9#1)(2008-10#1)
rRNAs from##2##2##(1997-1#1)(2006-8#1)
rRNAs in##3##2##(1994-9#1)(2008-5#1)(2010-4#1)
rRNAs##16##1##(1993-11#1)(1993-9#4)(1994-9#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-8#1)(2008-5#2)(2010-4#1)(2011-1#1)
rRbIL-lra##2##1##(1996-11#2)
rSVGs##2##1##(2007-8#2)
rT alpha GDP does not##2##5##(1994-11#2)
rTFA intake and##2##3##(2012-2#2)
rTFA isomers##2##2##(2012-2#2)
rTFA##5##1##(2012-2#5)
rTFPI##2##1##(1992-10#2)
rTIMP-1##2##1##(1994-8#2)
rTMS and##4##2##(2010-6#2)(2010-7#1)(2013-1#1)
rTMS as an##2##3##(2012-2#1)(2013-8#1)
rTMS as##4##2##(2010-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
rTMS for the treatment##2##4##(2010-3#1)(2012-2#1)
rTMS for##3##2##(2010-3#1)(2012-2#2)
rTMS have##2##2##(2010-3#1)(2013-1#1)
rTMS in##4##2##(1996-1#1)(2010-7#1)(2012-2#2)
rTMS is##2##2##(2008-9#1)(2011-2#1)
rTMS over the left DLPFC##2##5##(2008-10#2)
rTMS over the left##3##4##(2008-10#3)
rTMS over the##4##3##(2008-10#3)(2010-3#1)
rTMS to##3##2##(2008-9#1)(2011-2#2)
rTMS treatment##3##2##(2010-3#1)(2013-1#2)
rTMS##53##1##(1996-1#3)(2008-10#5)(2008-4#2)(2008-9#2)(2010-3#5)(2010-6#3)(2010-7#3)(2011-2#9)(2012-2#10)(2013-1#10)(2013-8#1)
rTNF-alpha was##2##2##(1994-8#2)
rTNF-alpha##7##1##(1991-12#3)(1994-8#4)
rTNFalpha##6##1##(2007-11#6)
rTPA and##2##2##(2007-7#2)
rTSA##5##1##(2008-6#5)
rTSH-R##2##1##(1993-12#2)
rVIIa##8##1##(1995-6#2)(2007-7#6)
rZIC gene##2##2##(2008-9#2)
ra##3##1##(1995-12#3)
rab family##2##2##(1993-8#1)(1994-12#1)
rab proteins##4##2##(1993-8#4)
rab##16##1##(1992-8#6)(1993-8#6)(1994-12#1)(1996-10#2)(1996-5#1)
rab-related small GTP binding protein##2##5##(1997-4#2)
rab2##2##1##(1996-5#1)(1997-4#1)
rab3##5##1##(1993-3#2)(1995-8#1)(1996-5#2)
rab6##2##1##(1995-8#1)(1996-5#1)
rabbit (Oryctolagus cuniculus)##2##3##(2010-4#1)(2012-2#1)
rabbit CK-II##2##2##(1993-2#2)
rabbit DSIP##2##2##(1990-5#2)
rabbit HCII##2##2##(1995-5#2)
rabbit IgG and##2##3##(2008-10#2)
rabbit IgG was##2##3##(2008-10#2)
rabbit IgG##14##2##(2008-10#13)(2009-6#1)
rabbit UGT1##4##2##(1994-8#4)
rabbit alpha 1-acid glycoprotein##2##4##(1991-7#1)(1992-12#1)
rabbit alveolar##2##2##(1992-8#1)(1994-12#1)
rabbit and human##5##3##(1990-12#1)(1992-7#1)(1994-9#1)(1996-9#1)(2008-10#1)
rabbit and pig##3##3##(1990-11#2)(1992-11#1)
rabbit and rat##3##3##(1992-6#1)(1993-12#1)(2008-10#1)
rabbit and##20##2##(1990-11#4)(1990-12#1)(1990-5#1)(1992-1#1)(1992-11#2)(1992-6#1)(1992-7#2)(1993-12#1)(1994-9#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-4#1)(2008-10#2)
rabbit anti-human##2##2##(1990-7#1)(2012-2#1)
rabbit anti-rat##2##2##(1991-1#1)(1994-3#1)
rabbit anti-sera which were generated by immunizing rabbits with a##2##10##(1991-7#2)
rabbit anti-sera##4##2##(1991-7#4)
rabbit antibodies toward##2##3##(1991-12#1)(1991-5#1)
rabbit antibodies##8##2##(1990-12#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-8#2)(1996-5#1)(2008-10#1)
rabbit antibody##3##2##(1990-3#1)(1995-6#1)(2008-10#1)
rabbit antisera against##4##3##(1991-10#1)(1992-7#1)(1996-12#1)(2013-8#1)
rabbit antisera##10##2##(1991-10#2)(1992-7#2)(1992-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1996-12#1)(2013-8#1)
rabbit antiserum raised against##4##4##(1990-3#1)(1990-7#1)(2008-10#2)
rabbit antiserum to##2##3##(1993-11#1)(1993-2#1)
rabbit antiserum##13##2##(1990-12#1)(1990-3#1)(1990-7#1)(1992-2#1)(1993-11#1)(1993-2#1)(1993-9#1)(2008-10#5)(2008-3#1)
rabbit aorta##17##2##(1990-12#1)(1990-2#3)(1990-7#1)(1992-6#4)(1993-11#1)(1993-6#1)(1995-12#2)(1996-10#1)(1996-12#2)(1997-5#1)
rabbit aortae##2##2##(1995-12#1)(2009-5#1)
rabbit aortic smooth muscle##2##4##(2009-5#2)
rabbit aortic smooth##3##3##(2009-5#3)
rabbit aortic##7##2##(1990-7#1)(1991-5#1)(1992-1#1)(1997-2#1)(2009-5#3)
rabbit arteries##6##2##(1996-2#1)(2008-4#2)(2011-1#3)
rabbit articular chondrocytes##4##3##(1994-2#3)(2007-11#1)
rabbit beta-VLDL##2##2##(1995-6#1)(1997-4#1)
rabbit beta-globin gene##3##3##(1991-9#1)(1992-12#1)(1994-12#1)
rabbit beta-globin##5##2##(1991-9#1)(1992-12#1)(1994-12#1)(2008-11#2)
rabbit bladder smooth muscle##2##4##(1994-8#2)
rabbit bladder##4##2##(1994-8#3)(1996-12#1)
rabbit blood##4##2##(1994-2#1)(1995-1#1)(2008-10#2)
rabbit bone marrow##2##3##(1991-8#1)(2005-9#1)
rabbit bone##4##2##(1991-8#1)(2004-9#1)(2005-9#1)(2008-5#1)
rabbit brain##7##2##(1991-9#1)(1992-3#1)(1993-12#2)(1993-4#1)(1994-2#1)(1997-1#1)
rabbit bronchus##2##2##(1993-3#2)
rabbit by##2##2##(2008-9#1)(2012-3#1)
rabbit calvarial##2##2##(2009-3#2)
rabbit cardiac muscle microvessel endothelial##2##5##(1991-5#2)
rabbit cardiac myocytes##3##3##(1997-7#3)
rabbit cardiac##6##2##(1991-5#2)(1992-8#1)(1997-7#3)
rabbit carotid artery##4##3##(1995-12#1)(1997-5#1)(2007-10#1)(2013-1#1)
rabbit carotid##6##2##(1994-10#2)(1995-12#1)(1997-5#1)(2007-10#1)(2013-1#1)
rabbit cells##2##2##(1992-7#1)(1994-6#1)
rabbit corpus##3##2##(1990-7#2)(1992-9#1)
rabbit cytochrome##2##2##(1992-6#1)(1994-9#1)
rabbit ear##6##2##(1992-12#1)(2005-10#1)(2008-9#4)
rabbit erythrocyte##2##2##(1991-6#1)(1994-9#1)
rabbit erythrocytes but##2##3##(1994-8#1)(1997-8#1)
rabbit erythrocytes##8##2##(1991-2#3)(1992-1#1)(1994-2#1)(1994-8#1)(1997-8#1)(2005-9#1)
rabbit gamma-preprotachykinin I cDNA##2##4##(1993-8#2)
rabbit gastric glands##2##3##(1995-12#2)
rabbit gastric##4##2##(1994-3#1)(1995-12#3)
rabbit genomic##2##2##(1992-6#1)(1993-6#1)
rabbit haemorrhagic disease virus##3##4##(1997-6#1)(2005-7#2)
rabbit haemorrhagic disease##4##3##(1997-6#1)(2005-7#3)
rabbit heart##5##2##(1991-9#2)(1997-8#2)(2007-8#1)
rabbit hearts##4##2##(1990-7#1)(1997-4#1)(2007-8#2)
rabbit hepatocytes##3##2##(1992-7#1)(1994-9#1)(2004-11#1)
rabbit immunoglobulin G##2##3##(2008-10#1)(2008-2#1)
rabbit immunoglobulin##4##2##(2008-10#2)(2008-2#2)
rabbit in##2##2##(1991-7#1)(2008-8#1)
rabbit intestinal brush-border membrane##2##4##(1992-6#1)(1996-1#1)
rabbit intestinal##3##2##(1992-6#2)(1996-1#1)
rabbit isolated bladder##2##3##(1996-12#2)
rabbit isolated##3##2##(1992-1#1)(1996-12#2)
rabbit kidney##3##2##(1990-3#1)(1993-6#1)(1994-8#1)
rabbit lens##3##2##(1992-5#1)(1997-8#2)
rabbit liver MT complexes##2##4##(2008-10#2)
rabbit liver MT##3##3##(2008-10#3)
rabbit liver##19##2##(1990-12#2)(1991-7#2)(1992-3#1)(1992-7#1)(1993-6#2)(1994-12#3)(1994-5#1)(1994-8#1)(1995-3#1)(2008-10#5)
rabbit lung cytosolic##2##3##(1991-1#1)(1991-2#1)
rabbit lung##7##2##(1991-1#2)(1991-2#3)(1993-8#1)(1994-12#1)
rabbit mEH##2##2##(1997-7#2)
rabbit mature osteoclasts##3##3##(1997-6#3)
rabbit model##11##2##(1996-3#1)(1997-6#2)(2004-9#1)(2005-11#1)(2006-9#1)(2007-8#1)(2007-9#1)(2008-4#1)(2009-3#1)(2012-3#1)
rabbit monoclonal antibodies##4##3##(2012-12#4)
rabbit muscle LDH##2##3##(1992-11#2)
rabbit muscle phosphofructokinase##4##3##(1990-8#2)(1991-2#1)(1997-2#1)
rabbit muscle##20##2##(1990-8#3)(1991-2#1)(1991-8#2)(1992-11#3)(1992-12#1)(1992-4#1)(1993-11#1)(1994-5#1)(1997-2#1)(2005-8#2)(2008-11#4)
rabbit myocardium##4##2##(1990-11#1)(1994-3#1)(1994-8#2)
rabbit myosin heads##2##3##(1990-4#2)
rabbit ooplasm##3##2##(2008-9#3)
rabbit or human##3##3##(1995-2#2)(1995-6#1)
rabbit or rat##2##3##(1993-8#1)(2006-9#1)
rabbit or##5##2##(1993-8#1)(1995-2#2)(1995-6#1)(2006-9#1)
rabbit peptide chain release factor##2##5##(1991-12#1)(1992-3#1)
rabbit peritoneal neutrophils was##2##4##(1994-8#1)(1996-2#1)
rabbit peritoneal neutrophils##5##3##(1991-2#2)(1992-1#1)(1994-8#1)(1996-2#1)
rabbit peritoneal##6##2##(1991-2#2)(1992-1#1)(1994-8#1)(1995-1#1)(1996-2#1)
rabbit plasma and##3##3##(1990-7#1)(1992-2#1)(2008-10#1)
rabbit plasma##5##2##(1990-7#1)(1992-2#1)(1992-8#1)(2008-10#1)(2008-8#1)
rabbit platelets##14##2##(1990-12#6)(1994-3#2)(1995-11#2)(1997-3#3)(2007-1#1)
rabbit polyclonal antibodies raised against##2##5##(1990-8#1)(1996-12#1)
rabbit polyclonal antibodies##5##3##(1990-8#1)(1992-6#1)(1995-10#1)(1995-8#1)(1996-12#1)
rabbit polyclonal antibody##4##3##(2008-10#3)(2013-8#1)
rabbit polyclonal##11##2##(1990-8#1)(1992-6#1)(1993-9#1)(1995-10#1)(1995-8#1)(1996-12#1)(1997-7#1)(2008-10#3)(2013-8#1)
rabbit pulmonary artery##3##3##(1991-4#1)(1993-3#1)(1995-12#1)
rabbit reticulocyte lysate and##2##4##(1990-11#1)(1995-6#1)
rabbit reticulocyte lysate##12##3##(1990-11#2)(1991-10#1)(1991-12#1)(1991-7#1)(1993-12#1)(1994-3#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-5#2)
rabbit reticulocyte lysates and##2##4##(1990-2#1)(1990-6#1)
rabbit reticulocyte lysates##5##3##(1990-2#2)(1990-6#1)(1992-11#1)(1994-8#1)
rabbit reticulocyte##24##2##(1990-10#1)(1990-11#3)(1990-2#2)(1990-6#1)(1991-10#1)(1991-12#1)(1991-7#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-5#2)(1995-6#1)(1996-5#2)
rabbit reticulocytes##5##2##(1990-5#1)(1991-2#1)(1996-2#2)(1996-6#1)
rabbit retina##7##2##(1997-3#1)(2008-11#3)(2008-4#2)(2012-3#1)
rabbit sera##2##2##(1993-9#1)(1996-12#1)
rabbit serum amyloid A##2##4##(1993-6#1)(1995-3#1)
rabbit serum##9##2##(1990-12#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-3#1)(1995-3#1)(1997-2#1)(2012-12#2)
rabbit showed##2##2##(1992-10#1)(2008-11#1)
rabbit skeletal muscle actin##2##4##(1990-7#1)(1995-1#1)
rabbit skeletal muscle fiber##2##4##(1991-12#2)
rabbit skeletal muscle ryanodine##3##4##(1994-9#1)(2008-9#2)
rabbit skeletal muscle##23##3##(1990-12#1)(1990-7#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-11#1)(1992-7#2)(1993-4#2)(1994-5#2)(1994-9#2)(1995-1#1)(1995-2#1)(1995-6#1)(1997-7#2)(2008-9#2)
rabbit skeletal##25##2##(1990-12#1)(1990-7#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1992-11#1)(1992-7#2)(1993-4#2)(1994-5#2)(1994-9#3)(1995-1#1)(1995-2#1)(1995-6#1)(1997-7#2)(2008-9#2)
rabbit skin and##2##3##(2004-12#1)(2008-5#1)
rabbit skin liquefaction model##2##4##(2010-12#2)
rabbit skin##14##2##(1992-6#4)(2004-12#2)(2007-11#1)(2008-5#2)(2008-8#1)(2010-12#3)(2010-9#1)
rabbit small intestinal##2##3##(1990-11#2)
rabbit small intestine##5##3##(1990-11#1)(1991-12#2)(1992-11#1)(1994-11#1)
rabbit small##7##2##(1990-11#3)(1991-12#2)(1992-11#1)(1994-11#1)
rabbit spermatozoa##10##2##(2006-5#10)
rabbit spines##2##2##(2008-8#2)
rabbit thoracic aorta##2##3##(1992-9#1)(1996-10#1)
rabbit using a##2##3##(2008-10#1)(2008-5#1)
rabbit using##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
rabbit uterine horn model##2##4##(1992-1#1)(1994-6#1)
rabbit uterine##4##2##(1990-5#1)(1992-1#1)(1993-8#1)(1994-6#1)
rabbit vena cava##2##3##(1992-7#1)(1995-12#1)
rabbit ventricular myocytes##6##3##(1995-5#1)(1996-2#3)(1997-4#1)(2013-1#1)
rabbit ventricular##9##2##(1990-11#2)(1993-11#1)(1995-5#1)(1996-2#3)(1997-4#1)(2013-1#1)
rabbit was##3##2##(1991-3#1)(1995-8#1)(2008-12#1)
rabbit were##2##2##(1990-12#1)(2012-3#1)
rabbit with##3##2##(1997-2#1)(2012-1#1)(2013-1#1)
rabbit##752##1##(1990-10#2)(1990-11#16)(1990-12#22)(1990-2#5)(1990-3#3)(1990-4#6)(1990-5#11)(1990-6#2)(1990-7#10)(1990-8#4)(1991-1#6)(1991-10#3)(1991-12#10)(1991-2#14)(1991-3#2)(1991-4#6)(1991-5#6)(1991-6#4)(1991-7#12)(1991-8#9)(1991-9#8)(1992-1#10)(1992-10#2)(1992-11#15)(1992-12#8)(1992-2#5)(1992-3#3)(1992-4#4)(1992-5#1)(1992-6#20)(1992-7#13)(1992-8#7)(1992-9#5)(1993-11#10)(1993-12#8)(1993-2#5)(1993-3#6)(1993-4#4)(1993-6#8)(1993-7#3)(1993-8#7)(1993-9#3)(1994-10#5)(1994-11#6)(1994-12#13)(1994-2#7)(1994-3#9)(1994-5#4)(1994-6#3)(1994-8#22)(1994-9#10)(1995-1#7)(1995-10#1)(1995-11#5)(1995-12#11)(1995-2#4)(1995-3#2)(1995-5#9)(1995-6#7)(1995-8#4)(1996-1#2)(1996-10#4)(1996-11#4)(1996-12#9)(1996-2#8)(1996-3#1)(1996-4#1)(1996-5#8)(1996-6#1)(1996-9#2)(1997-1#3)(1997-2#8)(1997-3#4)(1997-4#4)(1997-5#3)(1997-6#8)(1997-7#14)(1997-8#11)(2004-11#1)(2004-12#2)(2004-9#3)(2005-10#1)(2005-11#1)(2005-7#4)(2005-8#2)(2005-9#2)(2006-5#10)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#4)(2007-5#1)(2007-8#5)(2007-9#4)(2008-1#1)(2008-10#46)(2008-11#17)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#19)(2008-5#11)(2008-8#9)(2008-9#22)(2009-3#4)(2009-5#4)(2009-6#1)(2010-12#3)(2010-2#1)(2010-4#4)(2010-9#1)(2011-1#5)(2011-3#1)(2012-1#2)(2012-12#7)(2012-2#2)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#2)
rabbit's##7##1##(1990-10#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-5#2)
rabbiteye blueberry##2##2##(2008-10#2)
rabbiteye##3##1##(2008-10#3)
rabbits after##3##2##(2008-10#1)(2011-1#1)(2012-3#1)
rabbits and guinea pigs##5##4##(2006-8#3)(2008-10#1)(2011-2#1)
rabbits and rats##3##3##(2008-9#1)(2010-7#1)(2012-1#1)
rabbits and##18##2##(1992-7#1)(1995-8#2)(1996-6#1)(2006-8#3)(2007-9#1)(2008-10#1)(2008-9#2)(2009-7#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#1)
rabbits are##3##2##(1995-9#1)(1997-8#1)(2008-11#1)
rabbits as##3##2##(1994-3#1)(1995-6#1)(2007-10#1)
rabbits associated with##2##3##(1995-9#1)(2005-7#1)
rabbits by##3##2##(1990-4#1)(1994-9#1)(1997-8#1)
rabbits expressing##2##2##(2008-11#2)
rabbits fed##5##2##(1991-2#2)(1996-12#3)
rabbits from the##2##3##(1997-5#1)(2008-12#1)
rabbits from##5##2##(1993-12#1)(1997-5#1)(2008-12#1)(2010-4#2)
rabbits given antigen with RA##2##5##(1992-7#2)
rabbits given antigen with##4##4##(1992-7#4)
rabbits given##5##2##(1992-7#5)
rabbits immunized with##2##3##(1992-7#1)(2008-7#1)
rabbits immunized##4##2##(1992-7#1)(1992-8#1)(2008-7#1)(2008-9#1)
rabbits in the##5##3##(1996-3#1)(2008-11#2)(2012-1#1)(2013-1#1)
rabbits in##10##2##(1996-3#1)(2007-4#1)(2008-11#3)(2008-5#1)(2010-12#1)(2011-1#1)(2012-1#1)(2013-1#1)
rabbits is##2##2##(1994-8#1)(1995-9#1)
rabbits of the##2##3##(1993-12#1)(2008-12#1)
rabbits only##2##2##(1994-8#1)(1996-12#1)
rabbits showed that##2##3##(2008-10#1)(2010-12#1)
rabbits showed##4##2##(1991-9#1)(2008-10#1)(2008-5#1)(2010-12#1)
rabbits under##2##2##(2006-6#1)(2012-1#1)
rabbits underwent##2##2##(2006-9#1)(2008-9#1)
rabbits using##3##2##(1997-4#1)(2008-10#1)(2010-12#1)
rabbits was##6##2##(1994-8#1)(2005-10#1)(2005-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
rabbits were anesthetized##3##3##(1992-3#2)(2007-9#1)
rabbits were treated##2##3##(1993-4#1)(1994-8#1)
rabbits were used##3##3##(2007-11#1)(2008-8#1)(2012-3#1)
rabbits were##22##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-6#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-3#4)(1993-4#1)(1994-8#1)(1996-3#1)(2007-11#1)(2007-4#1)(2007-9#2)(2008-8#1)(2008-9#1)(2010-4#1)(2012-3#1)
rabbits when##3##2##(1996-1#1)(2008-5#2)
rabbits with a##5##3##(1991-7#2)(1997-6#1)(2008-10#2)
rabbits with diabetic retinopathy##2##4##(2012-1#2)
rabbits with pineal gland hypofunction##2##5##(2012-1#2)
rabbits with the##2##3##(1996-2#1)(2008-10#1)
rabbits with##27##2##(1991-7#2)(1995-1#2)(1995-5#1)(1996-12#1)(1996-2#1)(1997-6#1)(2005-10#2)(2005-12#2)(2006-9#1)(2007-11#1)(2008-10#3)(2008-7#1)(2008-8#3)(2010-12#1)(2012-1#5)
rabbits##325##1##(1990-11#6)(1990-12#4)(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#2)(1990-6#2)(1990-8#1)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-7#3)(1991-8#3)(1991-9#7)(1992-1#1)(1992-10#2)(1992-11#2)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#9)(1992-8#3)(1993-1#1)(1993-12#6)(1993-2#1)(1993-4#3)(1993-7#2)(1994-11#1)(1994-12#1)(1994-3#6)(1994-8#6)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#6)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#2)(1995-9#5)(1996-1#4)(1996-11#1)(1996-12#6)(1996-2#2)(1996-3#3)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#4)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#2)(1997-8#6)(2004-11#4)(2004-9#4)(2005-10#4)(2005-12#7)(2005-7#2)(2005-8#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#7)(2006-9#5)(2007-10#1)(2007-11#5)(2007-4#2)(2007-8#1)(2007-9#4)(2008-1#1)(2008-10#12)(2008-11#11)(2008-12#5)(2008-3#1)(2008-4#6)(2008-5#13)(2008-7#3)(2008-8#5)(2008-9#8)(2009-3#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-12#8)(2010-4#10)(2010-7#1)(2011-1#7)(2011-2#2)(2011-3#1)(2012-1#11)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#1)
rabbits]##7##1##(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
rabeprazole (20 mg/kg)##2##3##(2010-12#1)(2012-2#1)
rabeprazole and lansoprazole against##2##4##(2010-12#1)(2012-2#1)
rabeprazole and lansoprazole##6##3##(2010-12#2)(2012-2#4)
rabeprazole is##2##2##(2008-5#1)(2010-12#1)
rabeprazole##21##1##(2008-10#2)(2008-5#8)(2010-12#4)(2012-2#7)
rabiei in##4##2##(2008-10#4)
rabiei##15##1##(2008-10#15)
rabies and##3##2##(2005-5#1)(2012-12#1)(2013-1#1)
rabies control##3##2##(1991-12#1)(2011-2#1)(2012-3#1)
rabies in##9##2##(1992-5#1)(1993-8#1)(2007-10#1)(2007-12#2)(2007-4#1)(2011-2#2)(2012-3#1)
rabies incidence##2##2##(2011-2#2)
rabies vaccine##8##2##(1996-11#1)(1996-8#2)(2007-11#3)(2008-8#2)
rabies vaccines##3##2##(2005-7#1)(2007-11#2)
rabies virus##7##2##(1994-2#1)(1995-2#2)(2007-12#1)(2007-2#2)(2008-11#1)
rabies##67##1##(1991-12#9)(1991-9#1)(1992-5#1)(1992-8#1)(1993-8#1)(1994-2#1)(1995-2#3)(1996-11#1)(1996-4#1)(1996-8#2)(2005-5#1)(2005-7#3)(2007-10#2)(2007-11#7)(2007-12#5)(2007-2#5)(2007-4#1)(2008-10#1)(2008-11#2)(2008-8#2)(2011-1#1)(2011-2#8)(2012-12#4)(2012-3#2)(2013-1#2)
rabphilin-3A bound to##2##3##(1994-12#2)
rabphilin-3A in##2##2##(1994-11#1)(1994-12#1)
rabphilin-3A is associated with synaptic vesicles##2##6##(1994-12#2)
rabphilin-3A##11##1##(1994-11#1)(1994-12#10)
rac 1 and rac 2##3##5##(1996-2#3)
rac p21s##7##2##(1993-8#7)
rac##20##1##(1990-6#2)(1993-6#2)(1993-8#7)(1996-2#9)
rac-1##2##1##(1996-5#2)
rac1 p21##3##2##(1992-1#3)
raccoon dog (Nyctereutes##2##3##(2007-2#1)(2008-12#1)
raccoon dogs##4##2##(2004-4#2)(2008-12#2)
raccoon##7##1##(1990-5#1)(2004-4#2)(2007-2#1)(2008-12#3)
race (multiple r=##2##3##(2007-9#2)
race (race##2##2##(2008-10#2)
race 0##9##2##(2008-10#9)
race 1 and race 2##4##5##(2008-10#4)
race 1 and race##5##4##(2008-10#5)
race 1 and##8##3##(2008-10#8)
race 1 in##3##3##(2008-10#3)
race 1 isolate##2##3##(2008-10#2)
race 1 isolates##10##3##(2008-10#10)
race 1 of##3##3##(2008-10#3)
race 1##59##2##(2008-10#57)(2012-11#2)
race 1)##2##2##(2008-10#2)
race 2 and race##2##4##(2008-10#2)
race 2 isolates##3##3##(2008-10#3)
race 2 of##2##3##(2008-10#2)
race 2##38##2##(2008-10#38)
race 3 (T3)##2##3##(2008-10#2)
race 3 in the##2##4##(2008-10#2)
race 3 in##3##3##(2008-10#3)
race 3 isolates from##2##4##(2008-10#2)
race 3 isolates##4##3##(2008-10#4)
race 3 was##3##3##(2008-10#3)
race 3##21##2##(2008-10#21)
race 3)##2##2##(2008-10#1)(2012-11#1)
race 4##6##2##(2008-10#6)
race 5##11##2##(2008-10#11)
race 6##6##2##(2008-10#6)
race 6-specific##2##2##(2008-10#2)
race 65##2##2##(2008-10#2)
race 7##4##2##(2008-10#4)
race 8##3##2##(2008-10#3)
race Ct1##2##2##(2008-10#2)
race and ethnicity##3##3##(2010-9#1)(2011-2#1)(2012-12#1)
race and gender##5##3##(2007-10#2)(2008-3#1)(2008-8#1)(2009-4#1)
race and##20##2##(1992-7#1)(2007-10#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
race between##2##2##(1996-11#1)(2013-1#1)
race car head##2##3##(2007-4#2)
race car##3##2##(2007-4#3)
race clusters using the 195 isolates##2##6##(2008-10#2)
race clusters##4##2##(2008-10#4)
race designation##2##2##(2008-10#2)
race distance##3##2##(2012-1#3)
race for##3##2##(1991-12#1)(2008-4#1)(2009-4#1)
race in the##3##3##(1995-2#2)(2009-7#1)
race in##7##2##(1995-2#2)(2007-3#1)(2007-7#1)(2008-10#1)(2009-7#1)(2011-2#1)
race is##6##2##(1991-11#1)(1996-9#1)(2007-3#3)(2008-11#1)
race of G##4##3##(2008-10#4)
race of P##3##3##(1997-6#1)(2008-10#2)
race of##17##2##(1990-2#1)(1997-6#1)(2007-3#2)(2008-10#10)(2008-8#1)(2009-4#1)(2011-1#1)
race on##4##2##(1991-1#1)(1995-12#1)(2008-7#1)(2011-2#1)
race or gender##2##3##(2007-10#1)(2008-7#1)
race or##5##2##(2007-10#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-2#1)
race specific pathways##2##3##(2009-7#2)
race specific##3##2##(2008-10#1)(2009-7#2)
race specificity##2##2##(2008-8#2)
race structure##8##2##(2008-10#8)
race to##2##2##(1997-3#1)(2006-2#1)
race was##3##2##(2007-12#1)(2008-10#1)(2010-7#1)
race were##3##2##(1990-6#1)(2007-7#1)(2008-10#1)
race with##2##2##(1990-2#1)(2008-10#1)
race##430##1##(1990-2#2)(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-10#2)(1992-3#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-7#1)(1995-12#1)(1995-2#3)(1996-11#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(2004-3#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-1#1)(2007-10#7)(2007-12#1)(2007-2#1)(2007-3#9)(2007-4#4)(2007-6#1)(2007-7#6)(2007-8#3)(2007-9#4)(2008-10#255)(2008-11#8)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#6)(2008-7#4)(2008-8#9)(2009-12#1)(2009-2#1)(2009-4#4)(2009-5#5)(2009-6#2)(2009-7#5)(2009-9#3)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#4)(2010-9#1)(2011-1#3)(2011-2#13)(2012-1#5)(2012-11#5)(2012-12#3)(2012-2#4)(2013-1#4)(2013-7#1)(2013-8#2)
race&quot##2##1##(1991-4#1)(2008-10#1)
race) and##2##2##(1992-8#1)(2007-9#1)
race)##4##1##(1992-8#1)(2007-9#2)(2008-5#1)
race-based##2##1##(2007-2#1)(2008-12#1)
race-change mutants##6##2##(2008-10#6)
race-ethnicity##2##1##(2009-7#1)(2012-2#1)
race-nonspecific resistance##3##2##(2008-10#3)
race-of-face##2##1##(2008-11#2)
race-related amygdala activity##2##3##(2008-11#2)
race-related##6##1##(2007-2#1)(2008-11#2)(2009-7#3)
race-specific genes##3##2##(2008-10#3)
race-specific resistance to##3##3##(2008-10#3)
race-specific resistance##7##2##(2008-10#7)
race-specific##15##1##(2008-10#15)
race/ethnicity and language##2##3##(2013-1#2)
race/ethnicity and##5##2##(2007-2#1)(2009-7#1)(2013-1#2)(2013-8#1)
race/ethnicity##20##1##(2007-10#1)(2007-2#1)(2008-10#1)(2008-12#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-2#3)(2012-1#2)(2013-1#5)(2013-8#1)
racehorses and##2##2##(1996-9#1)(2012-1#1)
racehorses##9##1##(1993-1#1)(1996-9#2)(2012-1#6)
racemase activity##2##2##(1995-2#2)
racemase##9##1##(1995-2#4)(1996-7#2)(2006-3#2)(2012-2#1)
racemases##2##1##(1992-11#1)(2005-11#1)
racemate or##2##2##(1992-12#1)(2006-10#1)
racemate##9##1##(1992-12#1)(1994-3#4)(1997-2#1)(2006-10#1)(2010-12#1)(2010-4#1)
racemates in##2##2##(1990-6#1)(2013-1#1)
racemates##7##1##(1990-6#1)(2007-11#1)(2008-10#4)(2013-1#1)
racemic 1##2##2##(1990-3#1)(1997-7#1)
racemic amino acid##2##3##(1992-11#1)(2010-12#1)
racemic bupivacaine##3##2##(2006-10#2)(2009-4#1)
racemic ceralure B1##2##3##(2004-2#2)
racemic ibuprofen##2##2##(1990-6#1)(2012-12#1)
racemic mixture##6##2##(1996-5#1)(2006-12#2)(2007-11#1)(2008-10#1)(2008-5#1)
racemic mixtures##2##2##(1995-3#1)(1996-8#1)
racemic naproxen amide##2##3##(1994-3#2)
racemic naproxen nitrile##4##3##(1994-3#4)
racemic naproxen##6##2##(1994-3#6)
racemic salbutamol##5##2##(2007-11#5)
racemic##58##1##(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#2)(1991-2#2)(1991-5#1)(1992-11#1)(1992-12#1)(1993-2#2)(1994-2#1)(1994-3#7)(1994-9#1)(1995-3#1)(1996-3#2)(1996-5#3)(1996-8#2)(1996-9#1)(1997-4#1)(1997-7#1)(2004-2#2)(2006-10#2)(2006-12#2)(2007-11#7)(2007-8#1)(2008-10#2)(2008-5#4)(2009-4#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)
racemization of##3##2##(1992-8#1)(1996-6#1)(1996-7#1)
racemization##6##1##(1992-8#1)(1996-6#2)(1996-7#1)(2007-7#1)(2010-12#1)
racemosa##13##1##(1991-9#1)(1993-1#2)(2005-11#1)(2007-8#2)(2007-9#2)(2008-10#3)(2008-5#2)
racemosus roots##2##2##(2010-5#1)(2013-1#1)
racemosus##9##1##(1996-9#1)(2006-12#1)(2008-10#1)(2010-5#3)(2013-1#3)
races 0 and##2##3##(2008-10#2)
races 0##5##2##(2008-10#5)
races 1 and 2 of##2##5##(2008-10#2)
races 1 and 2##3##4##(2008-10#3)
races 1 and 3##2##4##(2008-10#2)
races 1 and 8##3##4##(2008-10#3)
races 1 and##15##3##(2008-10#14)(2012-11#1)
races 1##28##2##(2008-10#27)(2012-11#1)
races 2 and 5##2##4##(2008-10#2)
races 2 and##3##3##(2008-10#3)
races 2##7##2##(2008-10#7)
races 6##2##2##(2008-10#2)
races PST-41 and PST-45##2##4##(2008-10#2)
races and##12##2##(1992-2#1)(2006-9#1)(2007-12#1)(2007-2#1)(2008-10#6)(2008-9#1)(2010-3#1)
races are##2##2##(2008-10#2)
races from##2##2##(1996-6#1)(2008-10#1)
races in Malaysia##2##3##(2011-2#2)
races in##8##2##(2008-10#3)(2008-9#1)(2010-1#1)(2011-2#2)(2012-11#1)
races is##2##2##(2006-5#1)(2008-10#1)
races of F##4##3##(2008-10#4)
races of P##9##3##(2008-10#8)(2012-11#1)
races of Podosphaera xanthii and one race of G##2##9##(2008-10#2)
races of S##2##3##(2008-10#2)
races of the fungus##2##4##(2008-10#2)
races of the pathogen##5##4##(2008-10#5)
races of the##7##3##(2008-10#7)
races of##40##2##(1993-9#1)(2006-5#1)(2008-10#33)(2008-8#1)(2008-9#1)(2010-1#1)(2011-1#1)(2012-11#1)
races that##2##2##(2008-10#2)
races was##5##2##(1991-9#1)(2008-10#4)
races were##9##2##(2008-10#9)
races with race 1##2##4##(2008-10#2)
races with##4##2##(2008-10#4)
races##204##1##(1991-9#1)(1992-2#1)(1993-9#1)(1995-12#1)(1995-2#1)(1996-6#1)(1997-4#1)(1997-6#1)(2004-3#1)(2006-12#1)(2006-5#3)(2006-9#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#160)(2008-11#1)(2008-12#1)(2008-8#2)(2008-9#4)(2009-12#2)(2009-4#1)(2010-1#2)(2010-11#1)(2010-3#2)(2010-7#1)(2011-1#2)(2011-2#4)(2012-11#4)
rachilla##2##1##(2008-10#1)(2008-5#1)
rachis and##2##2##(2008-10#1)(2009-8#1)
rachis branches##2##2##(2006-9#1)(2008-9#1)
rachis susceptibility##3##2##(2008-10#3)
rachis##16##1##(2006-9#1)(2008-10#12)(2008-9#1)(2009-8#1)(2012-12#1)
rachises##2##1##(2008-10#2)
rachitic##3##1##(1993-5#1)(1994-3#1)(2009-11#1)
racial and economic##2##3##(2009-7#1)(2011-2#1)
racial and ethnic disparities##2##4##(2011-2#2)
racial and ethnic groups and##2##5##(1997-1#1)(2008-5#1)
racial and ethnic groups##6##4##(1997-1#1)(2008-5#2)(2009-5#1)(2011-2#1)(2013-1#1)
racial and ethnic minorities##3##4##(2007-2#1)(2008-10#1)(2010-2#1)
racial and ethnic##16##3##(1997-1#1)(2007-2#1)(2008-10#1)(2008-5#5)(2009-5#1)(2010-2#1)(2011-1#2)(2011-2#3)(2013-1#1)
racial and geographic##2##3##(2006-10#1)(2009-7#1)
racial and##26##2##(1997-1#1)(1997-8#1)(2004-12#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-5#5)(2008-7#2)(2009-5#1)(2009-7#3)(2010-2#1)(2011-1#2)(2011-2#4)(2013-1#1)
racial barrier##2##2##(2009-7#2)
racial bias##3##2##(2005-12#3)
racial categories##4##2##(2007-10#1)(2008-12#3)
racial centrality##2##2##(2010-7#2)
racial composition##2##2##(2007-9#1)(2011-2#1)
racial differences in##7##3##(1992-5#1)(1996-9#1)(2007-10#1)(2007-2#1)(2007-8#1)(2011-2#1)(2012-12#1)
racial differences##11##2##(1991-7#1)(1992-4#1)(1992-5#1)(1996-9#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
racial disparities in medical##2##4##(2006-10#1)(2006-3#1)
racial disparities in##7##3##(2006-10#1)(2006-3#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
racial disparities##12##2##(2006-10#1)(2006-3#1)(2010-3#3)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#1)
racial distribution##2##2##(2008-1#1)(2009-10#1)
racial ethnic##3##2##(2007-12#1)(2013-1#2)
racial gap##2##2##(2011-2#2)
racial groups and##2##3##(2007-1#1)(2008-5#1)
racial groups##9##2##(1992-7#1)(2007-1#1)(2007-8#1)(2008-11#1)(2008-5#4)(2009-6#1)
racial identity##3##2##(2004-12#1)(2009-7#1)(2009-9#1)
racial minorities##2##2##(1994-12#1)(2011-2#1)
racial or ethnic##2##3##(2007-12#1)(2013-1#1)
racial socialization and democratic-involved parenting##2##5##(2009-7#2)
racial socialization and##4##3##(2009-7#4)
racial socialization##7##2##(2009-7#5)(2009-9#2)
racial##116##1##(1991-7#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-6#1)(1994-12#1)(1994-3#2)(1996-9#3)(1997-1#1)(1997-4#1)(1997-8#1)(2004-12#2)(2004-3#1)(2005-12#3)(2006-10#2)(2006-3#1)(2007-1#1)(2007-10#3)(2007-12#2)(2007-2#3)(2007-3#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#4)(2008-5#11)(2008-7#3)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#14)(2009-9#5)(2010-2#1)(2010-3#3)(2010-7#2)(2011-1#2)(2011-2#11)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#5)
racial-ethnic centrality##2##2##(2009-7#2)
racial-ethnic identities##2##2##(2009-7#2)
racial-ethnic##5##1##(2009-7#5)
racial/ethnic groups##2##2##(2011-2#1)(2012-12#1)
racial/ethnic minorities##2##2##(2011-2#1)(2013-1#1)
racial/ethnic##11##1##(1992-5#1)(2006-7#1)(2008-8#1)(2009-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
racially and ethnically diverse##3##4##(2010-1#1)(2012-3#2)
racially diverse##2##2##(1994-2#1)(2010-11#1)
racially##9##1##(1990-12#1)(1994-2#1)(2007-10#1)(2008-11#1)(2010-1#1)(2010-11#1)(2010-12#1)(2012-3#2)
racially/ethnically##2##1##(2012-2#1)(2013-1#1)
racing performance##4##2##(2012-1#4)
racing##6##1##(2008-12#1)(2010-9#1)(2012-1#4)
racism and##3##2##(2004-12#2)(2007-9#1)
racism##12##1##(2004-12#3)(2006-7#3)(2007-9#2)(2009-7#3)(2011-1#1)
racist##3##1##(1996-8#1)(2004-12#1)(2009-7#1)
rack##4##1##(2008-10#1)(2008-11#1)(2008-4#1)(2012-2#1)
racket and ball kinematics##2##4##(2011-2#2)
racket and ball##3##3##(2011-2#3)
racket##5##1##(2011-2#5)
raclopride on##4##2##(2008-6#4)
raclopride##15##1##(1990-2#1)(1995-7#1)(1996-12#1)(1997-7#3)(2008-6#8)(2008-7#1)
racquet##4##1##(1991-6#1)(2011-2#3)
rad and##3##2##(2007-12#1)(2008-3#2)
rad##11##1##(2006-5#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#6)
rad)##2##1##(2008-2#1)(2008-3#1)
rad/ radicalHz##2##2##(2008-1#1)(2008-2#1)
rad/s##2##1##(2007-1#1)(2007-4#1)
rad/s(2)##3##1##(2007-4#3)
rad16 delta##2##2##(1997-1#2)
rad21##3##1##(1995-3#3)
rad32 gene##2##2##(2007-9#2)
rad32##3##1##(2007-9#3)
rad9 delta cells##2##3##(1996-3#2)
rad9 delta##3##2##(1996-3#3)
rad9##4##1##(1996-3#3)(1997-6#1)
radA null mutants##2##3##(1997-4#2)
radA##6##1##(1997-4#6)
radar and the##3##3##(2008-3#3)
radar and##4##2##(2008-2#1)(2008-3#3)
radar cross sections##2##3##(2008-3#2)
radar cross##3##2##(2008-3#3)
radar image##3##2##(2007-12#2)(2008-3#1)
radar images##3##2##(1992-2#1)(2007-12#1)(2008-3#1)
radar imaging##2##2##(2008-2#1)(2008-3#1)
radar parameters##2##2##(2008-3#2)
radar safety##2##2##(2008-3#2)
radar technique##2##2##(2007-12#1)(2008-3#1)
radar##63##1##(1992-2#1)(1993-2#1)(1994-7#1)(2006-6#1)(2007-11#2)(2007-12#7)(2007-8#1)(2008-2#11)(2008-3#33)(2008-6#1)(2008-7#1)(2011-12#3)
radars##5##1##(1993-2#1)(2008-2#2)(2008-3#1)(2011-12#1)
radial access##5##2##(2010-12#1)(2011-2#4)
radial and axial##2##3##(2008-3#1)(2008-5#1)
radial and circumferential##2##3##(2008-7#1)(2009-7#1)
radial and ulnar##2##3##(2008-7#1)(2008-9#1)
radial and##12##2##(2007-12#1)(2007-3#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#1)(2011-2#1)
radial approach##4##2##(2010-12#1)(2011-2#3)
radial arm maze (RAM)##2##4##(1993-2#1)(2012-2#1)
radial arm maze task##3##4##(1996-3#1)(2008-4#2)
radial arm maze##8##3##(1991-2#1)(1992-12#1)(1993-2#1)(1996-3#1)(2008-4#3)(2012-2#1)
radial arm##10##2##(1991-2#1)(1992-12#1)(1993-2#2)(1996-3#1)(2008-4#3)(2008-7#1)(2012-2#1)
radial artery as a##2##4##(2007-8#2)
radial artery for##2##3##(1990-8#1)(2006-9#1)
radial artery graft##3##3##(2006-9#1)(2007-8#1)(2008-7#1)
radial artery harvest for##3##4##(2007-8#3)
radial artery harvest##6##3##(2007-8#6)
radial artery in a##2##4##(2011-2#1)(2013-1#1)
radial artery in##4##3##(1990-8#1)(2007-8#1)(2011-2#1)(2013-1#1)
radial artery is##5##3##(1990-8#1)(2006-3#1)(2008-11#1)(2011-2#2)
radial artery occlusion and radial artery spasm##3##7##(2011-2#3)
radial artery occlusion##5##3##(2007-8#1)(2011-2#4)
radial artery perforators##3##3##(2008-9#3)
radial artery spasm##6##3##(2007-8#1)(2011-2#5)
radial artery was##4##3##(2007-7#1)(2007-8#2)(2011-2#1)
radial artery##82##2##(1990-4#2)(1990-8#6)(2005-12#2)(2006-3#1)(2006-9#3)(2007-7#3)(2007-8#27)(2008-11#2)(2008-7#2)(2008-9#9)(2011-2#21)(2013-1#3)(2013-8#1)
radial basis function (RBF) network##2##5##(2006-4#1)(2008-10#1)
radial basis function (RBF) neural network##2##6##(2008-2#2)
radial basis function (RBF) neural##3##5##(2008-2#3)
radial basis function (RBF)##5##4##(2006-4#1)(2008-10#1)(2008-2#3)
radial basis function networks##4##4##(2006-4#1)(2008-10#2)(2008-2#1)
radial basis function neural networks##4##5##(2008-10#2)(2008-2#2)
radial basis function neural##5##4##(2008-10#3)(2008-2#2)
radial basis function##16##3##(2006-4#2)(2008-10#7)(2008-2#6)(2012-1#1)
radial basis function-artificial neural networks (RBF-ANN)##2##6##(2008-10#2)
radial basis##19##2##(2006-4#2)(2008-10#9)(2008-2#7)(2012-1#1)
radial bone##2##2##(2007-8#1)(2010-11#1)
radial breathing mode##2##3##(2008-10#1)(2010-7#1)
radial breathing##3##2##(2008-10#2)(2010-7#1)
radial club hand##3##3##(2006-4#3)
radial data##2##2##(2008-10#2)
radial deviation of the##2##4##(1993-3#1)(2006-3#1)
radial direction##7##2##(2007-1#1)(2007-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-12#1)
radial distribution functions##2##3##(1992-9#1)(2008-10#1)
radial distribution of##3##3##(2006-5#1)(2008-10#2)
radial distribution##7##2##(1992-9#1)(2006-10#1)(2006-5#1)(2008-10#3)(2008-2#1)
radial domain folding##4##3##(2013-1#4)
radial fins##2##2##(2012-11#2)
radial flow cell for##2##4##(2008-10#2)
radial flow cell##4##3##(2008-10#4)
radial flow monolithic column##2##4##(2008-10#2)
radial flow##8##2##(2008-10#8)
radial forearm fascial##2##3##(2008-9#2)
radial forearm flap##6##3##(2006-3#1)(2007-12#1)(2008-9#3)(2011-2#1)
radial forearm free flap##5##4##(2006-12#1)(2007-12#1)(2011-2#3)
radial forearm free##6##3##(2006-12#1)(2007-12#1)(2011-2#4)
radial forearm##15##2##(1996-8#1)(2006-12#1)(2006-3#1)(2007-12#2)(2008-9#5)(2011-2#5)
radial growth in##2##3##(2011-12#2)
radial growth of strain##2##4##(2008-10#1)(2008-5#1)
radial growth of the##2##4##(2008-10#1)(2011-12#1)
radial growth of##6##3##(2008-10#2)(2008-5#1)(2011-12#3)
radial growth reduction##2##3##(2011-12#1)(2012-5#1)
radial growth##15##2##(2008-10#5)(2008-5#1)(2011-12#8)(2012-5#1)
radial head##12##2##(2006-11#1)(2006-3#1)(2007-11#1)(2008-4#7)(2011-2#2)
radial immunodiffusion (RID)##2##3##(2007-10#1)(2008-4#1)
radial immunodiffusion##8##2##(1990-2#1)(1993-2#1)(2006-2#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-4#1)(2010-12#1)
radial lines##2##2##(2008-10#1)(2012-11#1)
radial maze was##2##3##(1993-2#1)(1994-6#1)
radial maze##14##2##(1990-7#1)(1991-2#1)(1991-5#2)(1993-2#2)(1993-6#1)(1994-2#1)(1994-6#1)(2009-11#3)(2012-2#2)
radial migration##2##2##(1995-11#1)(1995-5#1)
radial nerve injury##6##3##(2007-7#2)(2008-9#1)(2012-2#3)
radial nerve palsy##6##3##(2006-3#3)(2007-8#1)(2012-2#1)(2012-3#1)
radial nerve transection##3##3##(2008-9#1)(2012-3#2)
radial nerve was##2##3##(2008-7#1)(2012-3#1)
radial nerve##30##2##(2006-3#6)(2006-4#1)(2007-10#1)(2007-7#3)(2007-8#2)(2008-7#5)(2008-9#2)(2012-2#6)(2012-3#4)
radial occlusion##2##2##(2011-2#2)
radial or##3##2##(1990-11#1)(2006-3#1)(2008-10#1)
radial position##3##2##(2006-10#1)(2006-11#1)(2006-12#1)
radial profiles##2##2##(2007-12#1)(2008-3#1)
radial rate##2##2##(2008-10#2)
radial recurrent fasciocutaneous flap##2##4##(2011-2#2)
radial scars##2##2##(2007-6#2)
radial sensory nerve##3##3##(2006-3#3)
radial shrinkage of fresh##2##4##(2012-2#2)
radial shrinkage##3##2##(2012-2#3)
radial strain##3##2##(2008-3#1)(2010-6#1)(2013-7#1)
radial tunnel syndrome##2##3##(2006-3#2)
radial tunnel##3##2##(2006-3#3)
radial variation of##2##3##(2007-12#1)(2008-2#1)
radial variation##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
radial velocity of##2##3##(2008-10#1)(2008-3#1)
radial velocity##4##2##(2008-10#1)(2008-3#3)
radial##415##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#6)(1990-9#1)(1991-12#1)(1991-2#2)(1991-5#2)(1991-8#2)(1992-12#1)(1992-9#1)(1993-2#5)(1993-3#1)(1993-6#2)(1994-2#1)(1994-6#1)(1995-11#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-3#2)(2005-1#1)(2005-11#1)(2005-12#2)(2006-10#2)(2006-11#2)(2006-12#3)(2006-2#1)(2006-3#21)(2006-4#6)(2006-5#1)(2006-9#3)(2007-1#1)(2007-10#2)(2007-11#10)(2007-12#9)(2007-2#1)(2007-3#3)(2007-6#4)(2007-7#6)(2007-8#35)(2007-9#1)(2008-10#42)(2008-11#2)(2008-2#22)(2008-3#17)(2008-4#11)(2008-5#2)(2008-7#14)(2008-9#21)(2009-11#3)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#6)(2010-6#1)(2010-7#2)(2011-12#9)(2011-2#57)(2012-1#3)(2012-11#3)(2012-2#13)(2012-3#4)(2012-5#1)(2013-1#8)(2013-7#2)(2013-8#5)
radial-arm maze##5##2##(1992-10#4)(1993-9#1)
radial-growing##2##1##(2008-10#2)
radial-ulnar deviation##2##2##(2012-1#2)
radial-ulnar##3##1##(2006-3#1)(2012-1#2)
radially and##2##2##(2006-3#1)(2007-11#1)
radially from##2##2##(1995-9#1)(2008-10#1)
radially inhomogeneous##2##2##(2008-2#2)
radially symmetric##4##2##(1994-2#1)(2007-12#1)(2008-3#1)(2013-8#1)
radially##19##1##(1994-2#1)(1995-9#1)(2006-3#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#2)(2009-10#1)(2009-7#1)(2012-1#1)(2013-1#1)(2013-8#2)
radiance and the##3##3##(2008-2#1)(2008-3#1)(2008-6#1)
radiance and##10##2##(2008-2#4)(2008-3#5)(2008-6#1)
radiance at the##2##3##(2008-2#1)(2008-3#1)
radiance at##4##2##(2008-2#2)(2008-3#2)
radiance data over the##2##4##(2008-2#1)(2008-3#1)
radiance distribution##3##2##(2008-2#3)
radiance for each##2##3##(2008-2#2)
radiance for##6##2##(2008-2#2)(2008-3#4)
radiance from##4##2##(2008-2#1)(2008-3#3)
radiance in the##2##3##(2008-2#1)(2008-3#1)
radiance in##6##2##(2008-2#2)(2008-3#4)
radiance is##2##2##(2008-3#2)
radiance measured by##3##3##(2008-2#1)(2008-3#2)
radiance measured##4##2##(2008-2#1)(2008-3#3)
radiance measurements##8##2##(2008-2#5)(2008-3#3)
radiance model inversion theory##2##4##(2008-2#2)
radiance model inversion##3##3##(2008-2#2)(2008-3#1)
radiance model##6##2##(2008-2#5)(2008-3#1)
radiance of##3##2##(2008-2#2)(2008-3#1)
radiance over##3##2##(2008-2#3)
radiance spectra##3##2##(2008-3#3)
radiance spectrum##2##2##(2008-2#1)(2008-3#1)
radiance that##2##2##(2008-2#1)(2008-3#1)
radiance values##2##2##(2008-2#1)(2008-3#1)
radiance with##2##2##(2008-2#2)
radiance##136##1##(2008-2#65)(2008-3#70)(2008-6#1)
radiances at##3##2##(2008-2#2)(2008-3#1)
radiances exiting the##2##3##(2008-2#2)
radiances from##4##2##(2008-2#1)(2008-3#3)
radiances have##2##2##(2008-3#2)
radiances in the##2##3##(2008-2#1)(2008-3#1)
radiances in##3##2##(2008-2#2)(2008-3#1)
radiances is##3##2##(2008-2#1)(2008-3#2)
radiances measured##3##2##(2008-2#3)
radiances to##3##2##(2008-2#2)(2008-3#1)
radiances with##4##2##(2008-2#1)(2008-3#3)
radiances##51##1##(2008-2#24)(2008-3#27)
radiant energy##2##2##(1990-8#1)(2008-2#1)
radiant heat##4##2##(1992-3#1)(2006-6#1)(2008-5#1)(2011-2#1)
radiant##11##1##(1990-8#1)(1992-3#1)(2006-6#1)(2008-2#2)(2008-3#3)(2008-5#1)(2011-2#1)(2013-8#1)
radiata and##2##2##(2010-8#2)
radiata from the##2##3##(1997-4#1)(2008-12#1)
radiata##35##1##(1991-8#1)(1995-2#2)(1997-4#1)(2004-2#2)(2007-10#7)(2007-4#1)(2008-10#4)(2008-12#12)(2008-7#1)(2010-8#3)(2013-7#1)
radiata)##6##1##(1991-12#1)(1997-4#1)(2007-2#2)(2008-10#1)(2009-4#1)
radiate##3##1##(1995-3#1)(2008-3#1)(2008-7#1)
radiated by the##2##3##(2008-3#2)
radiated by##3##2##(2008-3#2)(2008-5#1)
radiated from the##2##3##(2008-3#1)(2008-8#1)
radiated tortoise (Geochelone radiata)##2##4##(2007-2#2)
radiated##16##1##(1996-6#1)(1997-6#1)(1997-7#1)(2006-8#1)(2007-12#2)(2007-2#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-8#2)
radiating from the##5##3##(1994-8#1)(2006-10#1)(2006-12#1)(2008-2#1)(2008-9#1)
radiating##17##1##(1994-8#1)(2005-10#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-12#4)(2008-2#3)(2008-3#2)(2008-9#1)(2013-8#1)
radiation (193 nm)##2##3##(2008-2#2)
radiation (366 nm)##2##3##(1990-5#2)
radiation (IR)##3##2##(2008-11#1)(2009-5#1)(2010-12#1)
radiation (LDR)##3##2##(2008-7#1)(2013-1#2)
radiation (UVR)##8##2##(1992-6#1)(1995-4#1)(1996-11#1)(2006-12#2)(2007-11#1)(2008-1#1)(2011-2#1)
radiation (up to##3##3##(1996-6#2)(2007-12#1)
radiation -##2##2##(2006-5#1)(2008-1#1)
radiation B (UVRB)##2##3##(2011-2#2)
radiation X-ray fluorescence##2##3##(2008-10#2)
radiation a##2##2##(2008-8#1)(2013-1#1)
radiation absorbed by the##2##4##(1991-4#1)(2013-1#1)
radiation absorbed##3##2##(1991-4#1)(1992-7#1)(2013-1#1)
radiation adaptive response##2##3##(2008-7#2)
radiation affects##3##2##(2006-3#1)(2011-2#1)(2013-1#1)
radiation after the##2##3##(1995-6#1)(2009-12#1)
radiation after##5##2##(1991-2#1)(1995-6#1)(2008-2#1)(2009-11#1)(2009-12#1)
radiation and cancer##3##3##(2007-4#1)(2010-1#2)
radiation and chemotherapy##7##3##(1993-2#1)(1994-4#1)(2007-11#1)(2007-12#1)(2010-3#1)(2010-5#1)(2013-1#1)
radiation and hydrogen peroxide##2##4##(1990-5#2)
radiation and other##2##3##(2008-7#1)(2013-1#1)
radiation and reduce##2##3##(2007-11#1)(2013-8#1)
radiation and the##6##3##(2007-12#2)(2008-1#1)(2008-2#2)(2008-8#1)
radiation and vitamin D##2##4##(2006-12#1)(2010-7#1)
radiation and##78##2##(1990-10#1)(1990-5#2)(1990-7#1)(1992-3#1)(1992-6#1)(1993-2#2)(1993-8#1)(1994-2#1)(1994-4#1)(1995-8#1)(1996-6#2)(1997-5#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-4#2)(2006-5#1)(2006-6#2)(2007-10#1)(2007-11#3)(2007-12#3)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#8)(2008-8#3)(2009-2#1)(2010-1#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2012-2#2)(2013-1#3)(2013-8#4)
radiation and/or hyperthermia##2##3##(2007-11#2)
radiation and/or##3##2##(1990-9#1)(2007-11#2)
radiation applications##2##2##(2006-5#1)(2008-7#1)
radiation are discussed##3##3##(2008-10#1)(2008-3#1)(2010-6#1)
radiation are##12##2##(2006-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#3)(2010-6#2)(2011-2#1)(2013-1#1)
radiation around##2##2##(2008-3#1)(2012-2#1)
radiation as a##2##3##(2008-3#1)(2008-6#1)
radiation as##6##2##(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2011-2#1)
radiation at 1064##2##3##(2007-12#1)(2008-2#1)
radiation at 2##3##3##(2007-11#2)(2007-12#1)
radiation at 355 nm##2##4##(2008-10#1)(2008-3#1)
radiation at a wavelength of 10##4##6##(2007-11#3)(2007-12#1)
radiation at a wavelength of##8##5##(2007-11#3)(2007-12#3)(2008-2#2)
radiation at the##4##3##(2006-5#2)(2008-3#1)(2013-1#1)
radiation at wavelengths of##2##4##(2006-5#1)(2008-3#1)
radiation at wavelengths##4##3##(2006-5#1)(2007-12#1)(2008-3#2)
radiation at##52##2##(1997-7#1)(2006-4#1)(2006-5#4)(2007-11#7)(2007-12#12)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#4)(2008-3#9)(2008-6#1)(2008-7#1)(2010-12#1)(2010-4#1)(2013-1#1)(2013-7#1)
radiation based##2##2##(2008-10#1)(2010-7#1)
radiation beam##4##2##(2006-4#1)(2008-2#1)(2008-3#2)
radiation burden from##2##3##(2012-2#2)
radiation burden##5##2##(2012-2#5)
radiation burns##3##2##(2008-4#3)
radiation by an##2##3##(2007-11#1)(2008-3#1)
radiation by use of##2##4##(2007-12#1)(2008-2#1)
radiation by##16##2##(2007-11#4)(2007-12#4)(2008-2#3)(2008-3#3)(2008-7#1)(2011-1#1)
radiation can be##7##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)
radiation can cause##2##3##(2008-7#2)
radiation can lead to##2##4##(2008-2#1)(2008-7#1)
radiation can##14##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#7)
radiation causes##2##2##(2007-12#1)(2008-5#1)
radiation characteristics of##2##3##(2008-2#2)
radiation close to the##2##4##(2006-4#1)(2008-2#1)
radiation compared##2##2##(2008-7#1)(2011-2#1)
radiation concentrators##2##2##(2008-2#1)(2008-3#1)
radiation contaminated territories and##2##4##(2011-1#2)
radiation cross-linking##2##2##(2008-12#2)
radiation damage in##3##3##(1994-7#1)(2007-11#1)(2008-2#1)
radiation damage of##3##3##(2006-4#2)(2008-10#1)
radiation damage##16##2##(1990-12#1)(1994-3#1)(1994-7#1)(1995-6#1)(2006-4#5)(2006-8#1)(2007-11#2)(2008-10#2)(2008-2#1)(2013-1#1)
radiation delivered##4##2##(2008-6#1)(2008-7#2)(2013-1#1)
radiation delivery##3##2##(2007-1#1)(2008-3#2)
radiation diagnostic##2##2##(2007-8#2)
radiation did not##2##3##(2006-12#1)(2008-10#1)
radiation dose distribution##2##3##(1994-3#1)(2007-4#1)
radiation dose of##4##3##(1992-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
radiation dose was##2##3##(2012-2#2)
radiation dose##41##2##(1992-11#1)(1993-2#1)(1994-3#3)(1994-7#1)(1997-8#1)(2004-1#2)(2006-2#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#6)(2009-10#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#5)
radiation doses delivered##2##3##(2008-3#1)(2013-1#1)
radiation doses from##2##3##(1995-12#1)(2013-1#1)
radiation doses than##2##3##(2006-6#1)(2009-10#1)
radiation doses##17##2##(1995-12#1)(1996-6#2)(2006-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#4)(2009-10#1)(2010-5#1)(2012-2#2)(2013-1#2)
radiation during##2##2##(1995-12#1)(2008-10#1)
radiation effects##8##2##(1996-6#2)(2006-1#1)(2007-9#1)(2008-11#1)(2008-7#2)(2009-12#1)
radiation emanating from the##2##4##(2007-12#1)(2010-9#1)
radiation emitted from##2##3##(2007-12#1)(2008-2#1)
radiation emitted##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
radiation exposure and##5##3##(1994-3#1)(1996-6#1)(2008-4#1)(2008-7#2)
radiation exposure are##2##3##(2008-7#2)
radiation exposure from##2##3##(1996-6#1)(2008-4#1)
radiation exposure of the##2##4##(2007-5#1)(2012-2#1)
radiation exposure of##3##3##(2006-8#1)(2007-5#1)(2012-2#1)
radiation exposure to the spinal interventionalist performing lumbar discography##2##9##(2006-8#2)
radiation exposure to the##7##4##(2006-8#3)(2008-7#1)(2009-12#1)(2009-5#1)(2012-1#1)
radiation exposure was##3##3##(2006-8#3)
radiation exposure##52##2##(1994-3#1)(1995-6#1)(1996-6#3)(2006-8#9)(2007-5#2)(2008-1#1)(2008-10#2)(2008-12#2)(2008-4#2)(2008-7#16)(2009-12#1)(2009-5#2)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-2#3)(2013-8#1)
radiation exposures##6##2##(1996-6#1)(2008-7#3)(2010-9#1)(2013-1#1)
radiation field##7##2##(2007-12#1)(2008-2#1)(2008-3#1)(2010-6#1)(2010-7#2)(2013-1#1)
radiation fields##5##2##(1992-10#1)(2007-12#1)(2007-6#1)(2008-3#2)
radiation for the##4##3##(1992-2#1)(2006-4#1)(2007-4#1)(2009-11#1)
radiation for##20##2##(1991-12#1)(1992-2#1)(1995-9#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-12#2)(2007-2#1)(2007-4#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-6#1)(2009-11#1)(2010-7#1)(2011-2#1)
radiation from a conventional##2##4##(2006-5#2)
radiation from a##16##3##(1995-1#1)(2006-5#3)(2007-11#3)(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#2)
radiation from natural sources##2##4##(1996-6#1)(2008-7#1)
radiation from the##9##3##(1990-12#2)(1997-7#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#2)
radiation from##45##2##(1990-12#2)(1993-3#1)(1993-4#1)(1994-2#1)(1995-1#1)(1996-6#1)(1997-7#1)(2006-4#1)(2006-5#3)(2007-11#6)(2007-12#10)(2007-8#1)(2008-10#3)(2008-2#5)(2008-3#6)(2008-7#1)(2012-2#1)
radiation generated by##2##3##(2007-12#1)(2008-2#1)
radiation generated##3##2##(2007-12#2)(2008-2#1)
radiation had##3##2##(1996-3#1)(2008-10#1)(2008-4#1)
radiation has an##2##3##(2008-10#1)(2010-12#1)
radiation has been##9##3##(1994-3#1)(2004-1#1)(2007-12#3)(2008-10#2)(2008-3#1)(2008-7#1)
radiation has##17##2##(1994-3#1)(2004-1#1)(2007-12#3)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#2)(2010-12#1)(2011-2#2)(2012-12#1)
radiation have been##3##3##(2006-4#1)(2006-5#1)(2008-3#1)
radiation have##6##2##(2006-4#1)(2006-5#2)(2007-12#1)(2008-3#2)
radiation hormesis in##3##3##(2008-7#1)(2013-1#2)
radiation hormesis##12##2##(2008-7#9)(2013-1#3)
radiation hormesis)##4##2##(2008-7#3)(2013-1#1)
radiation hybrid##5##2##(1997-8#2)(2008-8#3)
radiation hybrids##4##2##(1994-12#2)(1996-6#2)
radiation in a##11##3##(2007-12#6)(2008-10#1)(2008-2#3)(2008-5#1)
radiation in human##2##3##(1997-1#1)(2007-10#1)
radiation in pure##2##3##(2008-2#1)(2008-5#1)
radiation in the range of##2##5##(2008-3#1)(2008-5#1)
radiation in the range##4##4##(2007-11#1)(2008-3#1)(2008-5#1)(2010-4#1)
radiation in the treatment of##3##5##(1992-6#1)(1993-9#1)(2012-2#1)
radiation in the##36##3##(1992-6#2)(1993-4#1)(1993-9#1)(1995-1#2)(2006-5#1)(2006-8#1)(2007-11#4)(2007-12#2)(2008-10#1)(2008-2#12)(2008-3#4)(2008-5#1)(2008-7#1)(2010-4#1)(2012-1#1)(2012-2#1)
radiation in##88##2##(1990-9#1)(1992-6#2)(1993-4#1)(1993-9#1)(1995-1#4)(1995-6#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#9)(2007-12#10)(2007-4#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#18)(2008-3#6)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#3)(2010-4#1)(2011-2#1)(2012-1#2)(2012-2#2)(2013-1#1)(2013-8#2)
radiation incident on##2##3##(2008-2#2)
radiation incident##3##2##(2008-2#2)(2008-3#1)
radiation induced damage##2##3##(2013-8#2)
radiation induced##18##2##(1995-1#1)(1996-2#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-5#2)(2008-7#2)(2013-8#6)
radiation injury##5##2##(1995-4#1)(2007-12#1)(2008-5#1)(2010-12#1)(2012-2#1)
radiation intensity##3##2##(2007-12#1)(2008-10#1)(2009-10#1)
radiation into##4##2##(1996-4#1)(2007-12#2)(2008-2#1)
radiation is a##6##3##(2006-5#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-3#1)
radiation is also##2##3##(2007-12#1)(2008-3#1)
radiation is being##2##3##(1997-4#1)(2008-3#1)
radiation is coupled##2##3##(2007-12#1)(2008-2#1)
radiation is demonstrated##3##3##(2007-11#1)(2007-12#2)
radiation is due##2##3##(2008-2#2)
radiation is generated by a##2##5##(2007-11#1)(2008-3#1)
radiation is generated by##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
radiation is generated##5##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
radiation is incident##2##3##(2008-2#2)
radiation is produced##2##3##(2007-12#1)(2008-2#1)
radiation is reported##3##3##(2007-11#1)(2007-12#1)(2009-9#1)
radiation is the##3##3##(2008-10#1)(2008-7#1)(2013-8#1)
radiation is tunable##2##3##(2006-5#1)(2007-12#1)
radiation is##63##2##(1997-4#1)(2006-5#2)(2006-8#1)(2007-11#3)(2007-12#16)(2008-10#1)(2008-2#14)(2008-3#6)(2008-5#2)(2008-7#9)(2008-8#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-3#1)(2012-2#2)(2013-8#1)
radiation level##2##2##(2013-1#2)
radiation levels##3##2##(1993-12#1)(2008-7#1)(2012-2#1)
radiation linear dichroism##2##3##(2010-5#2)
radiation load)##2##2##(2006-6#2)
radiation loss##3##2##(2008-3#3)
radiation may##5##2##(1994-8#1)(2006-12#1)(2008-7#2)(2013-1#1)
radiation measurements##2##2##(2008-2#1)(2008-3#1)
radiation myelopathy##2##2##(2007-11#2)
radiation near##7##2##(2007-12#4)(2008-2#2)(2008-3#1)
radiation of a##4##3##(2007-12#1)(2008-1#1)(2008-2#2)
radiation of the subgenus##2##4##(1997-4#2)
radiation of the##11##3##(1997-4#2)(2007-12#2)(2008-10#1)(2008-3#2)(2008-5#1)(2010-8#1)(2013-8#2)
radiation of##33##2##(1990-9#1)(1995-3#1)(1996-6#2)(1997-4#2)(1997-5#1)(2006-7#1)(2007-12#5)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#1)(2010-3#1)(2010-8#1)(2012-12#1)(2013-8#2)
radiation on some##2##3##(2008-12#1)(2008-4#1)
radiation on the##12##3##(1993-4#1)(1995-10#1)(2005-11#1)(2006-3#1)(2008-2#1)(2008-3#3)(2011-2#1)(2013-1#2)(2013-7#1)
radiation on##37##2##(1991-1#1)(1993-4#1)(1993-9#1)(1995-1#1)(1995-10#1)(1995-4#1)(2005-11#1)(2006-3#2)(2008-10#1)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#3)(2008-7#2)(2008-8#2)(2010-1#2)(2010-12#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-7#2)
radiation oncologist##6##2##(2007-11#1)(2007-4#1)(2008-7#1)(2009-11#2)(2011-2#1)
radiation oncologists and##3##3##(2007-4#1)(2008-10#1)(2013-1#1)
radiation oncologists##11##2##(1994-7#1)(2007-11#1)(2007-4#5)(2008-10#2)(2009-2#1)(2013-1#1)
radiation oncology is##2##3##(2007-4#2)
radiation oncology##24##2##(1990-12#1)(1994-3#3)(1994-7#1)(1996-2#1)(2007-11#1)(2007-4#13)(2008-10#1)(2008-6#1)(2010-7#1)(2012-11#1)
radiation or##13##2##(1991-7#2)(1992-7#1)(1995-8#1)(2008-10#1)(2008-5#1)(2008-7#4)(2008-9#1)(2010-7#1)(2012-2#1)
radiation over##2##2##(2007-12#1)(2012-1#1)
radiation pattern of##2##3##(2007-12#2)
radiation pattern##3##2##(2007-12#3)
radiation plays a major role##2##5##(2008-10#1)(2010-4#1)
radiation pollution##2##2##(2010-4#2)
radiation power##5##2##(2007-11#1)(2008-2#3)(2008-3#1)
radiation pressure forces##2##3##(2008-2#1)(2008-3#1)
radiation pressure noise##2##3##(2007-12#2)
radiation pressure##13##2##(2005-11#1)(2007-12#7)(2008-2#4)(2008-3#1)
radiation procedure##2##2##(2004-1#1)(2008-5#1)
radiation propagating in##2##3##(2007-12#1)(2008-2#1)
radiation propagating##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
radiation properties##2##2##(2006-5#1)(2008-2#1)
radiation protection and##2##3##(1996-6#1)(2010-7#1)
radiation protection policy##2##3##(1996-6#1)(2013-1#1)
radiation protection practices##3##3##(2008-7#3)
radiation protection standards##2##3##(1994-12#1)(2008-7#1)
radiation protection##29##2##(1993-12#1)(1994-12#1)(1995-1#1)(1996-6#3)(2006-5#1)(2007-4#1)(2008-12#2)(2008-7#9)(2010-5#1)(2010-7#1)(2012-2#4)(2013-1#2)(2013-8#2)
radiation protection]##2##2##(1996-6#1)(2013-1#1)
radiation received##2##2##(2007-10#1)(2008-5#1)
radiation resistance##3##2##(1993-4#1)(2007-12#1)(2013-1#1)
radiation respectively##2##2##(2007-11#1)(2010-12#1)
radiation response##3##2##(1993-4#1)(2007-11#1)(2008-9#1)
radiation results##2##2##(1997-8#1)(2007-12#1)
radiation risk from##2##3##(2008-7#2)
radiation risk##11##2##(1997-8#1)(2006-8#1)(2007-4#1)(2008-7#8)
radiation safety##6##2##(1994-12#2)(1995-1#1)(2007-4#1)(2013-1#2)
radiation scheme##2##2##(2008-3#1)(2008-6#1)
radiation sensitivity of##7##3##(1994-11#1)(1994-8#1)(1995-4#1)(2008-5#1)(2008-9#3)
radiation sensitivity##16##2##(1993-4#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-4#1)(1997-4#1)(2007-10#1)(2007-2#1)(2008-5#1)(2008-7#1)(2008-9#5)(2013-1#1)
radiation sensitizer##3##2##(1991-3#1)(1995-8#1)(2007-11#1)
radiation sensor##2##2##(2008-1#1)(2010-12#1)
radiation sensors##3##2##(2008-1#2)(2010-12#1)
radiation source for extreme-ultraviolet lithography##2##5##(2008-3#2)
radiation source for##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
radiation source##21##2##(1991-5#1)(2006-4#2)(2006-5#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-2#1)(2008-3#7)(2008-5#1)
radiation sources have##2##3##(2008-10#1)(2008-7#1)
radiation sources##7##2##(2006-4#3)(2006-5#1)(2008-10#1)(2008-2#1)(2008-7#1)
radiation spectra##4##2##(2008-2#1)(2008-3#3)
radiation spectrum##4##2##(2008-2#2)(2008-3#2)
radiation study##3##2##(1990-6#1)(2007-8#1)(2008-6#1)
radiation such##2##2##(2008-3#2)
radiation temperature of##2##3##(2008-3#1)(2013-1#1)
radiation temperature##3##2##(2008-2#1)(2008-3#1)(2013-1#1)
radiation than the##2##3##(1991-5#1)(2008-2#1)
radiation than##5##2##(1991-5#1)(1994-3#1)(2006-10#1)(2008-11#1)(2008-2#1)
radiation that could##3##3##(2006-2#1)(2008-7#2)
radiation that has been##2##4##(2007-11#1)(2008-7#1)
radiation that is tunable over##2##5##(2007-11#1)(2008-2#1)
radiation that is##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
radiation that##13##2##(1993-4#1)(2006-2#1)(2007-11#3)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#3)
radiation the##2##2##(2008-2#1)(2008-3#1)
radiation therapy (IMRT) of##2##4##(2008-3#1)(2009-10#1)
radiation therapy (IMRT)##8##3##(2006-2#1)(2008-3#1)(2008-6#1)(2009-10#2)(2009-3#1)(2010-5#1)(2012-1#1)
radiation therapy (RT)##4##3##(1996-3#1)(2008-6#1)(2008-7#2)
radiation therapy alone##2##3##(1990-4#1)(2004-1#1)
radiation therapy and chemotherapy##5##4##(2006-11#1)(2008-7#1)(2010-2#1)(2013-8#2)
radiation therapy and##20##3##(1991-2#1)(1992-10#1)(1993-8#1)(1994-2#1)(2006-11#1)(2008-11#1)(2008-5#1)(2008-7#3)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-2#3)(2013-8#3)
radiation therapy and/or chemotherapy##2##4##(2007-6#1)(2008-7#1)
radiation therapy following##2##3##(1994-12#1)(1996-3#1)
radiation therapy for prostate cancer##2##5##(1995-4#1)(2013-8#1)
radiation therapy for retroperitoneal##2##4##(2006-6#1)(2008-6#1)
radiation therapy for the##2##4##(1994-6#1)(1996-3#1)
radiation therapy for##25##3##(1991-2#2)(1993-8#1)(1994-10#1)(1994-12#1)(1994-6#1)(1994-7#1)(1995-4#2)(1996-3#1)(2005-9#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-12#1)(2008-6#2)(2008-7#2)(2009-5#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-8#2)
radiation therapy have been##2##4##(2007-5#1)(2008-9#1)
radiation therapy in the treatment of##2##6##(1994-4#1)(1995-9#1)
radiation therapy in the##5##4##(1992-4#1)(1994-10#1)(1994-4#1)(1994-6#1)(1995-9#1)
radiation therapy in##15##3##(1992-4#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-4#2)(1994-6#2)(1995-9#1)(2006-9#1)(2007-11#2)(2008-3#1)(2008-7#2)
radiation therapy is a##2##4##(1990-12#1)(2012-2#1)
radiation therapy is##8##3##(1990-12#1)(1994-6#1)(2008-10#1)(2008-6#2)(2010-2#1)(2012-2#1)(2013-8#1)
radiation therapy must be##2##4##(1997-5#1)(2007-8#1)
radiation therapy of head and neck##2##6##(1990-12#1)(1993-4#1)
radiation therapy of##7##3##(1990-12#1)(1992-12#1)(1993-4#1)(1994-8#1)(2008-7#2)(2011-2#1)
radiation therapy or##3##3##(2007-6#1)(2008-1#1)(2008-6#1)
radiation therapy plus##2##3##(1994-7#2)
radiation therapy results in##2##4##(2008-6#1)(2012-2#1)
radiation therapy was##5##3##(2006-8#1)(2007-2#1)(2007-6#1)(2008-6#1)(2012-2#1)
radiation therapy were##2##3##(2006-12#1)(2008-7#1)
radiation therapy with##2##3##(1995-9#1)(2008-6#1)
radiation therapy##232##2##(1990-12#6)(1990-2#1)(1990-4#3)(1990-9#1)(1991-2#5)(1992-10#1)(1992-12#2)(1992-4#1)(1993-2#1)(1993-4#3)(1993-8#5)(1993-9#2)(1994-10#2)(1994-12#5)(1994-2#1)(1994-3#1)(1994-4#2)(1994-6#5)(1994-7#3)(1994-8#3)(1995-10#2)(1995-4#3)(1995-5#1)(1995-8#2)(1995-9#3)(1996-1#1)(1996-3#3)(1997-3#1)(1997-5#1)(2004-1#3)(2004-11#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#6)(2006-2#3)(2006-6#5)(2006-8#1)(2006-9#7)(2007-10#1)(2007-11#5)(2007-12#2)(2007-2#2)(2007-4#5)(2007-5#1)(2007-6#4)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#4)(2008-5#1)(2008-6#17)(2008-7#27)(2008-8#1)(2008-9#1)(2009-10#3)(2009-11#1)(2009-2#1)(2009-3#4)(2009-5#1)(2009-8#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-5#1)(2011-1#3)(2011-2#3)(2012-1#5)(2012-12#3)(2012-2#12)(2013-7#1)(2013-8#6)
radiation therapy-induced mucositis##2##3##(2008-7#2)
radiation therapy-induced##3##2##(2008-7#3)
radiation through a##3##3##(2007-11#1)(2008-2#1)(2009-8#1)
radiation through the##3##3##(2008-2#1)(2008-3#2)
radiation through##10##2##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#3)(2009-8#1)
radiation to be##2##3##(2008-2#2)
radiation to generate##2##3##(2006-5#1)(2007-11#1)
radiation to the##7##3##(1993-9#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-1#1)
radiation to##27##2##(1993-9#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-4#1)(2008-10#2)(2008-11#2)(2008-2#5)(2008-3#2)(2008-7#2)(2011-2#3)(2012-1#1)(2012-2#1)
radiation tolerance##2##2##(2008-6#1)(2013-1#1)
radiation toxicity##3##2##(1991-12#1)(2008-7#1)(2011-2#1)
radiation transfer##2##2##(2008-2#1)(2008-3#1)
radiation transport##4##2##(1994-3#2)(2008-2#1)(2008-3#1)
radiation treatment for##4##3##(1992-6#1)(1992-7#1)(2005-9#1)(2008-7#1)
radiation treatment planning##4##3##(1994-7#1)(1995-8#1)(2009-11#1)(2010-5#1)
radiation treatment to##2##3##(1996-12#1)(2010-12#1)
radiation treatment##25##2##(1992-6#1)(1992-7#1)(1994-7#1)(1995-8#1)(1996-12#1)(2005-9#1)(2006-12#1)(2007-6#3)(2008-6#3)(2008-7#3)(2009-11#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
radiation treatments##6##2##(1996-12#1)(2006-6#1)(2007-1#2)(2009-10#1)(2010-9#1)
radiation used##3##2##(2006-12#1)(2008-3#1)(2008-7#1)
radiation using##2##2##(2008-10#1)(2010-1#1)
radiation was generated##4##3##(2007-12#2)(2008-1#1)(2008-2#1)
radiation was obtained##2##3##(2007-11#1)(2008-2#1)
radiation was significantly reduced##2##4##(2006-3#1)(2008-9#1)
radiation was significantly##3##3##(2006-3#1)(2008-9#1)(2010-1#1)
radiation was##29##2##(1991-5#1)(1992-9#1)(1993-2#1)(2006-3#1)(2006-5#2)(2007-11#2)(2007-12#2)(2008-1#2)(2008-2#5)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#2)(2009-8#1)(2010-1#1)(2010-9#1)(2011-2#2)(2012-2#1)
radiation were performed##2##3##(1997-8#1)(2008-3#1)
radiation were##10##2##(1990-10#1)(1997-8#1)(2006-12#1)(2006-5#1)(2008-2#2)(2008-3#1)(2008-6#1)(2010-9#1)(2013-1#1)
radiation when##2##2##(2008-2#1)(2008-3#1)
radiation will be##2##3##(2007-10#1)(2008-1#1)
radiation with a##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
radiation with respect to the##2##5##(2008-3#1)(2013-1#1)
radiation with the##2##3##(2007-12#1)(2008-2#1)
radiation with wall plug efficiency of 0##2##7##(2007-12#2)
radiation with##18##2##(2007-11#2)(2007-12#5)(2007-4#1)(2008-2#2)(2008-3#2)(2008-7#2)(2010-3#1)(2011-1#1)(2012-1#1)(2013-1#1)
radiation within##3##2##(1993-4#1)(2008-2#1)(2008-3#1)
radiation without##3##2##(2008-3#1)(2008-6#1)(2011-2#1)
radiation##2061##1##(1990-10#3)(1990-11#2)(1990-12#10)(1990-2#1)(1990-4#3)(1990-5#4)(1990-6#1)(1990-7#3)(1990-9#6)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#6)(1991-3#3)(1991-4#1)(1991-5#5)(1991-6#2)(1991-7#4)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#1)(1992-4#2)(1992-6#6)(1992-7#4)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#5)(1993-3#4)(1993-4#11)(1993-6#2)(1993-8#7)(1993-9#7)(1994-10#2)(1994-11#1)(1994-12#11)(1994-2#5)(1994-3#13)(1994-4#3)(1994-6#5)(1994-7#8)(1994-8#9)(1995-1#10)(1995-10#4)(1995-12#3)(1995-3#2)(1995-4#8)(1995-5#1)(1995-6#6)(1995-8#11)(1995-9#5)(1996-1#2)(1996-11#4)(1996-12#2)(1996-2#3)(1996-3#6)(1996-4#2)(1996-5#1)(1996-6#28)(1996-8#1)(1997-1#1)(1997-3#2)(1997-4#10)(1997-5#4)(1997-6#1)(1997-7#4)(1997-8#7)(2004-1#8)(2004-11#1)(2004-4#2)(2005-11#3)(2005-9#4)(2006-1#1)(2006-10#4)(2006-11#2)(2006-12#24)(2006-2#7)(2006-3#9)(2006-4#31)(2006-5#46)(2006-6#17)(2006-7#2)(2006-8#18)(2006-9#9)(2007-1#3)(2007-10#11)(2007-11#101)(2007-12#158)(2007-2#4)(2007-3#1)(2007-4#41)(2007-5#3)(2007-6#13)(2007-7#6)(2007-8#10)(2007-9#3)(2008-1#28)(2008-10#79)(2008-11#23)(2008-12#14)(2008-2#174)(2008-3#152)(2008-4#13)(2008-5#33)(2008-6#46)(2008-7#229)(2008-8#23)(2008-9#18)(2009-10#9)(2009-11#9)(2009-12#4)(2009-2#6)(2009-3#5)(2009-5#5)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#7)(2010-12#19)(2010-2#4)(2010-3#9)(2010-4#10)(2010-5#14)(2010-6#4)(2010-7#10)(2010-8#2)(2010-9#9)(2011-1#12)(2011-2#46)(2012-1#14)(2012-11#2)(2012-12#13)(2012-2#58)(2012-3#3)(2013-1#58)(2013-7#8)(2013-8#30)
radiation&quot##2##1##(2006-6#1)(2008-8#1)
radiation) or##2##2##(2008-7#1)(2013-1#1)
radiation)##8##1##(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2010-7#1)(2013-1#1)
radiation- or##2##2##(2008-4#1)(2008-9#1)
radiation-##3##1##(2006-10#1)(2008-4#1)(2008-9#1)
radiation-associated##2##1##(2008-6#1)(2011-2#1)
radiation-induced CAS##2##2##(2011-2#2)
radiation-induced DNA damage##3##3##(2008-11#1)(2008-7#2)
radiation-induced DNA##5##2##(1994-5#1)(1997-4#1)(2008-11#1)(2008-7#2)
radiation-induced DSBs##2##2##(2011-2#1)(2013-1#1)
radiation-induced PTCs##2##2##(2009-12#2)
radiation-induced apoptosis##2##2##(1995-12#1)(1997-4#1)
radiation-induced cancer risk##2##3##(2008-7#1)(2012-2#1)
radiation-induced cancer##4##2##(2008-7#3)(2012-2#1)
radiation-induced cell death##2##3##(1995-12#2)
radiation-induced changes in##2##3##(2008-7#2)
radiation-induced decomposition products of##2##4##(1992-2#2)
radiation-induced heritable##2##2##(2008-7#2)
radiation-induced lung##3##2##(1994-8#1)(2011-12#2)
radiation-induced mutations##2##2##(2008-7#2)
radiation-induced necrosis of the##2##4##(2007-12#2)
radiation-induced necrosis##7##2##(2007-12#7)
radiation-induced stenosis##5##2##(2006-11#5)
radiation-induced thymic##2##2##(1995-11#1)(2008-7#1)
radiation-induced tumor necrosis##2##3##(2007-12#2)
radiation-induced tumors##2##2##(1992-4#1)(2009-12#1)
radiation-induced##100##1##(1990-10#1)(1991-3#1)(1991-5#2)(1992-12#1)(1992-2#3)(1992-4#2)(1992-9#2)(1993-4#1)(1993-5#1)(1994-5#1)(1994-8#3)(1995-1#1)(1995-11#1)(1995-12#3)(1996-10#1)(1997-4#2)(2005-9#1)(2006-10#1)(2006-11#5)(2006-12#3)(2007-10#1)(2007-12#10)(2007-4#1)(2008-11#3)(2008-12#3)(2008-2#2)(2008-5#5)(2008-7#23)(2009-12#3)(2011-12#2)(2011-2#4)(2012-12#4)(2012-2#1)(2013-1#1)(2013-8#1)
radiation-resistant bacterium##2##2##(2005-11#1)(2006-12#1)
radiation-resistant##4##1##(2005-11#3)(2006-12#1)
radiation-sensitive##2##1##(1995-1#1)(2008-11#1)
radiation]##4##1##(1991-2#1)(2005-4#1)(2009-2#1)(2013-8#1)
radiationless##2##1##(2005-11#1)(2011-1#1)
radiations are##5##2##(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#2)
radiations##25##1##(1991-2#2)(1996-4#1)(1997-4#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#5)(2008-8#3)(2008-9#1)(2010-5#2)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
radiative characteristics of##2##3##(2008-2#2)
radiative characteristics##4##2##(2007-11#1)(2008-2#3)
radiative cooling##2##2##(2008-10#1)(2008-2#1)
radiative dissociation##8##2##(1996-7#2)(2006-1#1)(2006-2#2)(2006-3#1)(2006-4#2)
radiative efficiency##2##2##(2008-2#2)
radiative energy##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
radiative forcing by use of##2##5##(2008-2#2)
radiative forcing##7##2##(1994-7#1)(2008-2#5)(2013-8#1)
radiative perturbation theory to##2##4##(2008-2#2)
radiative perturbation theory##3##3##(2008-2#3)
radiative properties of a##2##4##(2008-2#2)
radiative properties of##6##3##(2008-2#5)(2008-3#1)
radiative properties##8##2##(1996-5#1)(2008-2#5)(2008-3#2)
radiative recombination##2##2##(2007-11#2)
radiative transfer calculations##4##3##(2008-2#2)(2008-3#2)
radiative transfer code for##2##4##(2008-3#2)
radiative transfer code##5##3##(2008-2#2)(2008-3#3)
radiative transfer equation for##4##4##(2008-2#1)(2008-3#2)(2010-4#1)
radiative transfer equation##18##3##(2007-12#2)(2008-2#10)(2008-3#5)(2010-4#1)
radiative transfer from a##3##4##(2007-12#3)
radiative transfer in a##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
radiative transfer in the##2##4##(2008-2#1)(2008-3#1)
radiative transfer in##8##3##(2008-10#1)(2008-2#4)(2008-3#3)
radiative transfer model and##2##4##(2008-2#1)(2008-3#1)
radiative transfer model is##2##4##(2008-3#2)
radiative transfer model that is##2##5##(2008-2#1)(2008-3#1)
radiative transfer model##17##3##(2008-2#6)(2008-3#11)
radiative transfer models##3##3##(2008-2#1)(2008-3#2)
radiative transfer problem##2##3##(2008-3#2)
radiative transfer simulations##2##3##(2008-3#2)
radiative transfer theory and##2##4##(2008-2#1)(2008-3#1)
radiative transfer theory##7##3##(2008-2#2)(2008-3#5)
radiative transfer##88##2##(2007-11#1)(2007-12#7)(2008-10#1)(2008-2#31)(2008-3#47)(2010-4#1)
radiative transport##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
radiative##146##1##(1992-3#1)(1994-7#1)(1995-10#1)(1996-5#1)(1996-7#2)(2006-1#1)(2006-2#2)(2006-3#1)(2006-4#3)(2007-11#6)(2007-12#11)(2008-10#3)(2008-2#56)(2008-3#55)(2010-4#1)(2013-8#1)
radiative-transfer model##4##2##(2008-2#2)(2008-3#2)
radiative-transfer##8##1##(2008-2#5)(2008-3#3)
radiatively##4##1##(2008-11#1)(2008-2#2)(2008-3#1)
radiator##3##1##(2007-7#1)(2008-10#1)(2008-3#1)
radiators##2##1##(2007-12#1)(2008-3#1)
radiatum and lacunosum moleculare##2##4##(1997-7#1)(2011-2#1)
radiatum and##6##2##(1991-6#1)(1994-10#1)(1997-5#1)(1997-7#2)(2011-2#1)
radiatum stimulation##2##2##(1997-5#2)
radiatum##19##1##(1990-2#1)(1990-4#1)(1991-6#1)(1991-9#1)(1994-10#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-5#4)(1997-7#2)(2007-10#1)(2008-7#1)(2011-2#2)
radiatus##3##1##(2012-2#3)
radical (##5##2##(1990-5#1)(1991-7#1)(1995-3#1)(1995-7#1)(1997-8#1)
radical Hz##3##2##(2008-3#3)
radical and anionic##2##3##(2008-3#2)
radical and its##4##3##(1994-11#1)(1994-3#1)(1996-5#1)(2008-10#1)
radical and superoxide##2##3##(1990-5#1)(2008-10#1)
radical and the##3##3##(1990-5#1)(1993-11#1)(1997-8#1)
radical and##25##2##(1990-5#3)(1993-11#2)(1994-11#2)(1994-3#1)(1995-10#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-8#1)(2006-12#1)(2007-11#1)(2008-10#4)(2008-3#2)(2008-7#2)(2009-5#1)
radical anion##16##2##(1992-1#1)(1995-6#1)(2006-10#9)(2008-10#2)(2008-5#2)(2010-5#1)
radical aromatic substitution##2##3##(2009-5#2)
radical at##2##2##(1995-1#1)(2007-11#1)
radical attack##3##2##(2008-10#1)(2008-4#1)(2008-5#1)
radical by##4##2##(1993-3#1)(1997-8#1)(2008-10#1)(2008-2#1)
radical can##2##2##(2008-10#1)(2012-1#1)
radical cation##5##2##(1992-6#1)(2007-11#1)(2008-10#1)(2010-12#1)(2011-1#1)
radical cations##8##2##(2008-9#5)(2009-12#1)(2010-12#1)(2010-5#1)
radical chain reaction##2##3##(2008-10#2)
radical chain transfer##2##3##(2005-12#2)
radical chain##6##2##(1991-2#1)(1996-2#1)(2005-12#2)(2008-10#2)
radical change in the##2##4##(1993-6#1)(1995-1#1)
radical change##6##2##(1993-6#1)(1995-1#1)(1995-8#1)(1996-12#1)(2005-11#1)(2008-7#1)
radical changes in the##2##4##(2006-2#1)(2008-10#1)
radical changes in##3##3##(2006-2#1)(2008-10#1)(2008-11#1)
radical clearance##2##2##(1997-4#2)
radical concentration in##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
radical concentration##7##2##(2007-3#2)(2008-10#1)(2008-2#3)(2008-3#1)
radical cyclization##4##2##(1996-5#2)(2007-11#1)(2009-10#1)
radical cyclizations##4##2##(2007-11#2)(2008-9#1)(2009-5#1)
radical cystectomy##10##2##(2006-10#2)(2006-6#2)(2007-4#1)(2008-1#1)(2008-10#1)(2010-9#1)(2011-2#1)(2013-1#1)
radical damage and##2##3##(1996-11#1)(2006-11#1)
radical damage to##2##3##(1997-3#1)(2008-10#1)
radical damage##9##2##(1992-12#1)(1994-2#1)(1994-6#1)(1995-1#1)(1996-11#1)(1997-3#1)(2006-11#1)(2008-10#1)(2009-3#1)
radical debridement##2##2##(2008-9#1)(2011-2#1)
radical dose##3##2##(1990-11#1)(2007-3#1)(2008-6#1)
radical during##2##2##(1992-11#1)(1996-9#1)
radical excision of##3##3##(1992-2#1)(1994-7#1)(2012-12#1)
radical excision##6##2##(1992-2#1)(1994-7#1)(2006-3#1)(2006-6#1)(2008-7#1)(2012-12#1)
radical form##2##2##(1990-10#1)(1990-3#1)
radical formation during##2##3##(1992-11#1)(2008-10#1)
radical formation was##2##3##(1995-5#1)(1996-6#1)
radical formation##11##2##(1992-11#1)(1995-1#1)(1995-3#2)(1995-5#1)(1996-6#1)(2006-10#1)(2008-10#2)(2008-11#1)(2013-8#1)
radical from##5##2##(1991-9#1)(1992-3#2)(1996-5#1)(2008-10#1)
radical generating azo compound##3##4##(1995-6#3)
radical generating system##3##3##(1992-12#1)(2007-9#1)(2008-5#1)
radical generating##9##2##(1992-12#1)(1994-2#1)(1994-6#1)(1995-6#3)(1997-1#1)(2007-9#1)(2008-5#1)
radical generation and##4##3##(1994-11#1)(2009-5#1)(2009-9#1)(2011-1#1)
radical generation are##2##3##(1994-9#1)(2011-1#1)
radical generation associated with##2##4##(1995-3#1)(1996-6#1)
radical generation by##3##3##(1990-11#1)(1990-12#1)(1991-12#1)
radical generation in human##6##4##(1990-3#4)(1994-9#2)
radical generation in##10##3##(1990-3#4)(1993-3#1)(1994-11#1)(1994-12#1)(1994-9#2)(2008-11#1)
radical generation##35##2##(1990-11#1)(1990-12#1)(1990-3#4)(1991-12#1)(1991-9#1)(1993-11#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-9#7)(1995-3#1)(1996-2#1)(1996-6#1)(1997-8#1)(2006-10#1)(2008-11#1)(2008-5#1)(2009-5#1)(2009-9#1)(2010-5#1)(2010-8#2)(2011-1#2)(2012-3#1)
radical hepatic resection##2##3##(2007-7#1)(2008-4#1)
radical hysterectomy and##3##3##(1993-8#1)(1994-2#1)(2011-2#1)
radical hysterectomy##8##2##(1993-8#1)(1994-2#4)(2009-2#1)(2011-2#2)
radical in the presence of a##2##6##(1991-3#1)(1997-4#1)
radical in the##5##3##(1990-7#1)(1991-3#1)(1996-2#1)(1997-4#1)(2007-12#1)
radical in##13##2##(1990-7#1)(1991-3#1)(1991-9#1)(1994-11#1)(1996-2#2)(1996-5#1)(1997-4#1)(2005-2#1)(2007-12#1)(2008-10#2)(2010-5#1)
radical initiator##2##2##(1995-6#1)(2008-5#1)
radical injury##2##2##(1992-12#1)(2008-8#1)
radical intermediates##4##2##(1992-11#1)(1997-7#1)(2006-10#1)(2008-3#1)
radical is a##2##3##(1993-11#1)(2008-4#1)
radical is##13##2##(1990-5#1)(1993-11#3)(1993-3#2)(1996-2#1)(1997-7#1)(2008-10#3)(2008-2#1)(2008-4#1)
radical lymph##3##2##(2007-8#2)(2008-10#1)
radical lymphadenectomy##3##2##(2006-10#1)(2008-10#1)(2013-1#1)
radical mastectomy and##2##3##(1990-12#1)(1992-12#1)
radical mastectomy for##2##3##(1994-12#1)(1994-7#1)
radical mastectomy was performed##3##4##(1996-6#1)(2008-10#2)
radical mastectomy##18##2##(1990-12#1)(1990-3#1)(1990-4#1)(1992-12#2)(1994-12#2)(1994-7#2)(1995-10#1)(1995-4#1)(1996-6#2)(2008-10#2)(2009-2#2)(2009-9#1)
radical mechanism in##2##3##(1994-5#1)(2006-12#1)
radical mechanism##4##2##(1994-5#1)(1995-6#1)(2006-12#1)(2008-5#1)
radical neck dissection##4##3##(2006-12#1)(2008-6#1)(2010-7#2)
radical neck##6##2##(2006-12#1)(2008-6#1)(2010-7#2)(2011-12#1)(2011-2#1)
radical nephrectomy and thrombectomy of the IVC##2##7##(2011-2#2)
radical nephrectomy and##4##3##(2008-1#1)(2010-12#1)(2011-2#2)
radical nephrectomy for##2##3##(2006-9#2)
radical nephrectomy##13##2##(1991-9#1)(1992-8#1)(2006-9#5)(2008-1#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-2#1)
radical of##6##2##(1990-2#1)(1994-8#3)(1995-2#1)(2008-8#1)
radical operation##7##2##(1990-3#2)(1990-9#2)(1993-11#1)(2007-8#1)(2008-12#1)
radical operations for##2##3##(1990-9#2)
radical operations##3##2##(1990-9#2)(2012-3#1)
radical or##2##2##(1993-3#1)(2004-1#1)
radical oxygen species##2##3##(2011-2#2)
radical pair effects in##2##4##(2009-8#2)
radical pair states##2##3##(1991-7#2)
radical pair##12##2##(1991-7#7)(1996-7#1)(1997-4#1)(2006-10#1)(2009-8#2)
radical polymerization of##3##3##(2008-12#1)(2008-3#1)(2009-10#1)
radical polymerization##16##2##(1994-9#1)(2004-9#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-10#2)(2010-4#2)(2013-7#1)(2013-8#5)
radical production and##2##3##(2005-1#1)(2008-3#1)
radical production in the##2##4##(1995-1#1)(1995-12#1)
radical production in##4##3##(1992-1#1)(1995-1#1)(1995-12#1)(2005-8#1)
radical production is##2##3##(1992-12#1)(1995-3#1)
radical production was##2##3##(1991-9#1)(1997-8#1)
radical production##22##2##(1990-12#1)(1991-9#1)(1992-1#1)(1992-12#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-6#1)(1997-5#1)(1997-8#1)(2005-1#1)(2005-8#2)(2007-11#3)(2008-3#1)(2008-5#2)(2012-2#1)(2013-8#1)
radical prostatectomies##2##2##(2008-10#1)(2010-11#1)
radical prostatectomy -##2##3##(2012-12#1)(2012-2#1)
radical prostatectomy and##5##3##(2007-11#1)(2009-2#1)(2009-5#1)(2011-2#2)
radical prostatectomy for##5##3##(1990-9#1)(2010-10#2)(2010-12#1)(2013-7#1)
radical prostatectomy in the##2##4##(2008-6#1)(2011-2#1)
radical prostatectomy in##4##3##(1991-9#1)(2008-6#1)(2010-10#1)(2011-2#1)
radical prostatectomy is##3##3##(2006-6#1)(2006-9#1)(2009-4#1)
radical prostatectomy##43##2##(1990-9#1)(1991-9#2)(1995-11#1)(2006-10#1)(2006-6#3)(2006-9#4)(2007-10#1)(2007-11#3)(2007-3#1)(2007-7#3)(2008-4#1)(2008-6#2)(2008-7#1)(2009-2#1)(2009-4#1)(2009-5#2)(2010-10#4)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
radical radiotherapy##2##2##(1990-6#1)(2007-11#1)
radical reaction##7##2##(1990-4#1)(1996-2#4)(2007-11#1)(2010-4#1)
radical reactions##4##2##(1996-5#1)(2006-10#1)(2008-10#1)(2008-4#1)
radical reacts##2##2##(2005-4#1)(2010-5#1)
radical removal##2##2##(1994-4#1)(2011-1#1)
radical resection and##2##3##(2007-11#1)(2009-12#1)
radical resection of the##3##4##(1997-6#1)(2006-12#1)(2007-11#1)
radical resection of##8##3##(1990-10#1)(1997-6#1)(2006-12#1)(2006-4#1)(2007-11#2)(2008-3#1)(2011-1#1)
radical resection##19##2##(1990-10#1)(1990-2#1)(1997-6#1)(2005-5#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-11#3)(2007-8#2)(2008-3#1)(2008-6#3)(2009-12#1)(2011-1#1)(2013-7#1)
radical retropubic prostatectomy##4##3##(2006-10#1)(2006-9#1)(2007-11#1)(2008-1#1)
radical retropubic##5##2##(1996-9#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-1#1)
radical scavenger and##2##3##(2007-8#1)(2010-2#1)
radical scavenger##35##2##(1990-9#1)(1991-12#1)(1991-9#1)(1992-7#1)(1992-9#1)(1993-4#1)(1993-6#1)(1994-5#1)(1994-6#2)(1995-11#1)(1995-12#2)(1995-8#3)(1996-2#1)(1997-8#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-5#2)(2009-8#1)(2010-2#2)(2011-2#1)(2012-2#2)
radical scavengers and antioxidants##2##4##(2008-11#1)(2008-5#1)
radical scavengers and##4##3##(2008-11#2)(2008-5#1)(2008-7#1)
radical scavengers from##2##3##(1995-10#1)(2008-5#1)
radical scavengers in##2##3##(1993-4#1)(2006-8#1)
radical scavengers##30##2##(1990-3#1)(1991-9#3)(1993-2#1)(1993-4#1)(1994-2#1)(1994-6#1)(1995-10#1)(1995-2#2)(1995-6#2)(1996-2#2)(2006-12#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-5#6)(2008-7#1)(2011-2#2)
radical scavenging ability##3##3##(2006-10#1)(2007-11#1)(2008-5#1)
radical scavenging activities of the##2##5##(2008-12#1)(2008-5#1)
radical scavenging activities##4##3##(2008-12#1)(2008-5#1)(2009-3#1)(2013-1#1)
radical scavenging activity and##2##4##(2008-11#1)(2009-6#1)
radical scavenging activity in##2##4##(1993-4#1)(2008-11#1)
radical scavenging activity of##2##4##(2006-12#1)(2008-10#1)
radical scavenging activity##16##3##(1993-4#1)(2006-12#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-5#3)(2009-6#1)(2010-4#1)(2011-1#1)(2011-2#1)
radical scavenging and##4##3##(2008-10#2)(2008-7#1)(2009-6#1)
radical scavenging capacity##4##3##(1996-2#1)(2008-11#2)(2012-2#1)
radical scavenging effect##2##3##(2008-11#2)
radical scavenging properties##4##3##(1991-2#1)(2007-1#1)(2008-11#1)(2011-1#1)
radical scavenging##56##2##(1991-2#2)(1993-12#1)(1993-4#2)(1995-1#1)(1996-2#1)(2006-10#1)(2006-12#1)(2007-1#2)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#11)(2008-12#2)(2008-5#6)(2008-6#1)(2008-7#3)(2009-3#1)(2009-6#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#2)
radical species##7##2##(1994-12#1)(1996-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-5#1)
radical surgery and##5##3##(1992-10#1)(1994-12#1)(2006-10#1)(2007-8#1)(2008-6#1)
radical surgery as##3##3##(1990-9#1)(2008-6#1)(2011-2#1)
radical surgery for##2##3##(2013-1#2)
radical surgery in the##2##4##(2008-10#1)(2013-7#1)
radical surgery in##3##3##(1992-4#1)(2008-10#1)(2013-7#1)
radical surgery or##2##3##(1992-6#1)(2010-12#1)
radical surgery to##2##3##(1994-6#1)(2006-10#1)
radical surgery with##3##3##(2010-11#1)(2010-5#1)(2012-2#1)
radical surgery##48##2##(1990-10#2)(1990-6#2)(1990-9#4)(1991-10#1)(1991-4#2)(1992-10#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-9#1)(1994-12#1)(1994-6#1)(1997-7#1)(2006-10#3)(2006-6#2)(2007-8#5)(2008-10#1)(2008-5#1)(2008-6#3)(2008-8#1)(2009-4#1)(2010-11#2)(2010-12#1)(2010-5#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-7#1)
radical surgical resection##3##3##(1994-6#1)(2007-8#1)(2008-7#1)
radical surgical treatment of##2##4##(1990-6#1)(2011-2#1)
radical surgical treatment##4##3##(1990-6#1)(2006-2#1)(2011-2#2)
radical surgical##14##2##(1990-6#2)(1991-11#1)(1994-6#1)(2006-2#1)(2007-11#1)(2007-8#2)(2008-6#1)(2008-7#1)(2009-2#1)(2011-1#1)(2011-2#2)
radical system##2##2##(1990-3#1)(2008-5#1)
radical that##2##2##(1995-10#1)(2011-1#1)
radical to##5##2##(1995-2#2)(2008-10#1)(2008-4#1)(2010-7#1)
radical trachelectomy with pelvic lymphonodectomy could be##2##7##(2009-2#2)
radical trachelectomy with pelvic lymphonodectomy##3##5##(2009-2#3)
radical trachelectomy##4##2##(2009-2#4)
radical transformation##3##2##(1990-12#1)(1997-1#2)
radical trapping##3##2##(1992-3#1)(1993-4#1)(2013-8#1)
radical treatment of##3##3##(1992-8#1)(2006-10#1)(2008-10#1)
radical treatment##4##2##(1992-8#1)(2006-10#1)(2008-10#1)(2012-12#1)
radical was##3##2##(1992-11#1)(2008-10#1)(2012-3#1)
radical were##2##2##(1991-4#1)(1992-3#1)
radical with##6##2##(1990-2#1)(1993-11#1)(1993-3#1)(2008-8#1)(2008-9#2)
radical##989##1##(1990-10#6)(1990-11#2)(1990-12#7)(1990-2#6)(1990-3#18)(1990-4#3)(1990-5#8)(1990-6#6)(1990-7#2)(1990-9#14)(1991-10#3)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#3)(1991-4#7)(1991-7#9)(1991-9#19)(1992-1#2)(1992-10#2)(1992-11#4)(1992-12#6)(1992-2#1)(1992-3#7)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#4)(1992-9#6)(1993-11#12)(1993-12#1)(1993-2#1)(1993-3#8)(1993-4#8)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#3)(1994-11#6)(1994-12#7)(1994-2#8)(1994-3#3)(1994-4#1)(1994-5#6)(1994-6#10)(1994-7#3)(1994-8#5)(1994-9#10)(1995-1#9)(1995-10#9)(1995-11#2)(1995-12#3)(1995-2#8)(1995-3#7)(1995-4#1)(1995-5#1)(1995-6#11)(1995-7#2)(1995-8#5)(1996-11#1)(1996-12#1)(1996-2#26)(1996-5#15)(1996-6#6)(1996-7#2)(1996-8#2)(1996-9#3)(1997-1#6)(1997-2#2)(1997-3#4)(1997-4#5)(1997-5#1)(1997-6#1)(1997-7#8)(1997-8#12)(2004-1#2)(2004-12#1)(2004-2#3)(2004-9#1)(2005-1#1)(2005-11#1)(2005-12#2)(2005-2#1)(2005-4#4)(2005-5#1)(2005-8#5)(2006-10#28)(2006-11#2)(2006-12#6)(2006-2#2)(2006-3#1)(2006-4#1)(2006-6#10)(2006-7#1)(2006-8#2)(2006-9#11)(2007-1#4)(2007-10#2)(2007-11#30)(2007-12#2)(2007-3#7)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#19)(2007-9#8)(2008-1#6)(2008-10#66)(2008-11#25)(2008-12#5)(2008-2#6)(2008-3#13)(2008-4#12)(2008-5#32)(2008-6#14)(2008-7#14)(2008-8#10)(2008-9#13)(2009-10#4)(2009-12#3)(2009-2#9)(2009-3#3)(2009-4#2)(2009-5#8)(2009-6#3)(2009-7#1)(2009-8#4)(2009-9#2)(2010-10#4)(2010-11#4)(2010-12#9)(2010-2#3)(2010-3#1)(2010-4#6)(2010-5#20)(2010-7#5)(2010-8#4)(2010-9#2)(2011-1#20)(2011-12#1)(2011-2#24)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#4)(2012-2#13)(2012-3#5)(2013-1#13)(2013-7#4)(2013-8#14)
radical)##5##1##(1994-5#1)(1997-7#1)(2005-8#2)(2008-10#1)
radical-induced DNA damage##2##3##(1997-1#1)(2004-12#1)
radical-induced##7##1##(1990-5#1)(1991-2#1)(1992-9#1)(1995-12#1)(1997-1#1)(2004-12#2)
radical-mediated##8##1##(1991-9#1)(1995-12#2)(1996-8#1)(2005-7#1)(2008-4#2)(2012-2#1)
radical-scavenging activities##3##2##(2006-12#3)
radical-scavenging activity##2##2##(2006-12#1)(2008-10#1)
radical-scavenging effects##2##2##(1997-8#1)(2008-10#1)
radical-scavenging##13##1##(1992-5#1)(1994-6#1)(1995-6#1)(1997-8#1)(2006-12#5)(2008-10#2)(2008-11#1)(2008-12#1)
radical?(I)##2##1##(2007-12#2)
radicalHz and##4##2##(2007-12#2)(2008-3#2)
radicalHz in##2##2##(2008-2#2)
radicalHz was##2##2##(2008-2#2)
radicalHz##15##1##(2007-11#1)(2007-12#6)(2008-1#1)(2008-2#4)(2008-3#3)
radicale##3##1##(2008-6#1)(2011-2#2)
radicality and quality of##2##4##(2006-6#1)(2008-10#1)
radicality of##3##2##(1991-4#1)(1995-9#1)(2010-12#1)
radicality##9##1##(1991-4#1)(1995-9#3)(2006-6#1)(2008-10#1)(2008-6#1)(2010-12#2)
radically alter the##2##3##(2006-2#1)(2008-3#1)
radically altered##3##2##(1992-10#1)(1994-12#1)(2007-11#1)
radically and##2##2##(1995-11#1)(2007-10#1)
radically changed##4##2##(1992-5#1)(2009-3#1)(2010-12#1)(2013-1#1)
radically different##4##2##(1990-10#1)(1995-12#1)(2007-12#1)(2008-11#1)
radically excised##3##2##(1990-9#2)(2008-9#1)
radically improved##2##2##(2007-7#1)(2008-10#1)
radically##35##1##(1990-10#1)(1990-9#2)(1991-8#1)(1992-10#1)(1992-5#1)(1994-1#1)(1994-12#1)(1994-4#1)(1995-11#1)(1995-12#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-12#1)(2011-2#1)(2011-7#1)(2013-1#2)(2013-7#1)
radicals (##5##2##(1991-12#1)(1991-9#1)(1993-7#1)(1994-6#1)(1995-12#1)
radicals and facilitate##2##3##(2008-1#1)(2010-7#1)
radicals and other##4##3##(1994-3#1)(1994-6#1)(2008-10#1)(2008-5#1)
radicals and the##8##3##(1990-4#1)(1995-6#1)(1997-8#1)(2005-8#1)(2007-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
radicals and##52##2##(1990-11#1)(1990-4#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-1#2)(1992-7#1)(1992-9#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-6#1)(1995-8#3)(1996-2#2)(1996-9#1)(1997-8#1)(2005-1#1)(2005-8#3)(2006-10#1)(2007-11#3)(2007-3#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#4)(2009-6#1)(2010-12#1)(2010-4#1)(2010-7#1)(2012-1#3)(2012-2#1)(2013-1#1)(2013-8#2)
radicals are capable of##2##4##(1994-11#1)(1996-2#1)
radicals are the##2##3##(2008-10#1)(2010-10#1)
radicals are thought to be##2##5##(1995-1#1)(1996-1#1)
radicals are##23##2##(1993-3#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-5#1)(1996-1#1)(1996-2#1)(1997-4#1)(2005-8#1)(2006-10#1)(2007-3#3)(2007-9#1)(2008-10#4)(2008-5#1)(2008-8#1)(2010-10#2)(2013-8#1)
radicals as##2##2##(2007-11#1)(2008-4#1)
radicals by human##2##3##(1990-3#1)(2008-4#1)
radicals by the##2##3##(1996-2#1)(2006-10#1)
radicals by##10##2##(1990-12#1)(1990-3#1)(1991-12#1)(1992-1#1)(1994-6#1)(1996-2#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#1)
radicals could##2##2##(1994-8#1)(2008-10#1)
radicals derived from##2##3##(1991-9#1)(1997-8#1)
radicals during##2##2##(1997-8#1)(2008-7#1)
radicals for##2##2##(1990-5#1)(1996-12#1)
radicals formed in##2##3##(1992-7#1)(1997-8#1)
radicals formed##3##2##(1992-7#1)(1997-8#1)(2008-9#1)
radicals from##5##2##(1992-11#2)(1994-12#2)(2008-7#1)
radicals generated by the##3##4##(1993-12#1)(1997-8#1)(2005-11#1)
radicals generated by##9##3##(1990-12#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-1#1)(1997-8#1)(2005-11#1)(2008-9#1)
radicals generated from##4##3##(1990-7#1)(1995-8#1)(2008-10#1)(2008-11#1)
radicals generated##17##2##(1990-12#1)(1990-7#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-9#1)(1997-8#1)(2005-11#1)(2008-10#3)(2008-11#1)(2008-9#1)
radicals has been##2##3##(2008-8#1)(2009-5#1)
radicals in a##3##3##(1990-12#1)(2008-10#2)
radicals in the##6##3##(1994-2#1)(2005-11#1)(2008-10#1)(2008-5#1)(2012-1#1)(2013-1#1)
radicals in##39##2##(1990-10#1)(1990-12#1)(1990-3#1)(1991-11#2)(1991-2#1)(1991-9#1)(1992-12#3)(1992-9#1)(1993-12#1)(1993-2#1)(1994-10#1)(1994-12#1)(1994-2#4)(1994-8#1)(1995-12#1)(1996-10#1)(1996-9#1)(1997-8#1)(2005-11#1)(2005-8#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2010-7#1)(2012-1#1)(2013-1#1)
radicals is##7##2##(1993-3#1)(1994-2#1)(2007-11#1)(2007-3#1)(2008-3#2)(2010-4#1)
radicals of##4##2##(2006-10#1)(2008-10#1)(2008-5#1)(2010-4#1)
radicals on##5##2##(1993-12#1)(1995-6#1)(2007-9#2)(2008-5#1)
radicals or##3##2##(1994-2#1)(1994-3#1)(2010-5#1)
radicals play a##3##3##(1991-9#1)(1992-9#1)(1995-12#1)
radicals play an important role in the##2##7##(1995-8#1)(2011-2#1)
radicals play##5##2##(1991-9#1)(1992-9#1)(1995-12#1)(1995-8#1)(2011-2#1)
radicals produced by##4##3##(1990-12#1)(1991-12#1)(1993-6#1)(2006-10#1)
radicals produced during##2##3##(1993-2#1)(1995-1#1)
radicals produced##8##2##(1990-12#1)(1991-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1995-1#1)(1995-6#1)(2006-10#1)
radicals that##7##2##(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2009-10#1)(2009-8#1)(2012-2#1)
radicals to##3##2##(1996-2#1)(1997-2#1)(2008-11#1)
radicals was##6##2##(1991-11#1)(1991-2#1)(1997-5#1)(2012-11#1)(2012-12#1)(2013-1#1)
radicals were generated##2##3##(2005-11#1)(2007-9#1)
radicals were##10##2##(1993-3#1)(1994-2#1)(1995-10#1)(2005-11#1)(2007-11#1)(2007-9#1)(2008-10#2)(2011-2#1)(2012-1#1)
radicals which##5##2##(1990-4#1)(1991-11#1)(2006-10#1)(2006-6#1)(2007-9#1)
radicals with##3##2##(2008-4#2)(2012-11#1)
radicals##436##1##(1990-10#2)(1990-11#2)(1990-12#6)(1990-3#5)(1990-4#3)(1990-5#1)(1990-7#1)(1991-11#4)(1991-12#5)(1991-2#4)(1991-7#1)(1991-9#10)(1992-1#5)(1992-11#3)(1992-12#4)(1992-7#2)(1992-9#8)(1993-1#2)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#6)(1993-4#1)(1993-6#5)(1993-7#1)(1993-8#1)(1994-10#2)(1994-11#7)(1994-12#4)(1994-2#8)(1994-3#6)(1994-6#3)(1994-8#8)(1994-9#6)(1995-1#8)(1995-10#1)(1995-12#5)(1995-3#2)(1995-5#4)(1995-6#5)(1995-8#6)(1995-9#2)(1996-1#2)(1996-10#2)(1996-12#1)(1996-2#13)(1996-3#1)(1996-5#2)(1996-6#2)(1996-8#2)(1996-9#4)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#13)(2004-11#1)(2005-1#2)(2005-11#5)(2005-4#1)(2005-8#6)(2006-10#9)(2006-6#1)(2006-8#2)(2007-11#21)(2007-12#1)(2007-2#2)(2007-3#6)(2007-7#1)(2007-8#1)(2007-9#12)(2008-1#3)(2008-10#37)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#8)(2008-5#15)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#1)(2010-10#3)(2010-12#3)(2010-3#3)(2010-4#6)(2010-5#2)(2010-7#4)(2010-8#1)(2011-1#2)(2011-2#8)(2012-1#7)(2012-11#2)(2012-12#2)(2012-2#2)(2013-1#5)(2013-8#7)
radicals)##4##1##(1992-12#1)(1992-6#1)(1994-2#1)(2005-11#1)
radicicola##2##1##(2008-10#2)
radicina and##3##2##(2008-10#3)
radicina##6##1##(2008-10#6)
radicis-cucumerinum##5##1##(2008-10#5)
radicis-lycopersici and##3##2##(2008-10#3)
radicis-lycopersici##19##1##(2008-10#19)
radicle##2##1##(2008-9#2)
radicles##2##1##(2008-10#2)
radicular artery##2##2##(2008-7#1)(2012-1#1)
radicular compression##2##2##(1990-2#1)(2010-12#1)
radicular cyst##3##2##(2012-2#3)
radicular neuroma##3##2##(2006-2#3)
radicular pain##18##2##(1996-12#1)(2006-11#1)(2006-7#2)(2006-8#7)(2007-11#1)(2007-7#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-2#2)
radicular symptoms##8##2##(2006-7#1)(2006-8#1)(2007-11#4)(2008-7#2)
radicular##47##1##(1990-12#1)(1990-2#1)(1991-11#1)(1996-12#3)(1997-3#1)(2006-11#1)(2006-2#3)(2006-7#3)(2006-8#10)(2007-11#5)(2007-7#1)(2008-7#3)(2009-4#1)(2009-5#1)(2010-12#1)(2011-2#3)(2012-1#1)(2012-2#6)(2013-1#1)
radiculopathy and a##2##3##(2006-7#1)(2012-3#1)
radiculopathy and##4##2##(2006-7#1)(2008-7#2)(2012-3#1)
radiculopathy secondary to##2##3##(2005-10#1)(2006-8#1)
radiculopathy was diagnosed in##2##4##(2005-10#1)(2007-11#1)
radiculopathy was##3##2##(2005-10#1)(2006-8#1)(2007-11#1)
radiculopathy were##2##2##(2005-10#1)(2012-12#1)
radiculopathy##53##1##(2005-10#6)(2006-10#1)(2006-11#3)(2006-12#1)(2006-7#4)(2006-8#13)(2007-1#1)(2007-11#4)(2007-8#2)(2008-12#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#3)(2012-3#4)(2013-8#1)
radii and##7##2##(1992-11#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-2#1)
radii as small as##2##4##(2008-3#2)
radii down to##2##3##(2006-12#1)(2008-2#1)
radii in the##2##3##(2005-4#1)(2009-12#1)
radii of both the drop base and the wetted region inside the porous layer##2##14##(2005-11#2)
radii of both the drop base and the wetted##3##9##(2005-11#3)
radii of curvature of the resulting aspheric surfaces##2##8##(2008-2#2)
radii of curvature of the##3##5##(2006-4#1)(2008-2#2)
radii of curvature of##4##4##(2006-4#1)(2008-2#2)(2010-2#1)
radii of curvature##7##3##(1992-3#1)(2006-4#1)(2008-2#2)(2008-3#1)(2010-2#2)
radii of the##5##3##(1996-2#1)(2005-11#2)(2008-10#1)(2008-3#1)
radii of##19##2##(1990-11#1)(1992-3#1)(1996-2#1)(2005-11#6)(2006-10#1)(2006-4#1)(2008-10#1)(2008-2#3)(2008-3#2)(2010-2#2)
radii##58##1##(1990-11#1)(1990-2#2)(1992-11#1)(1992-3#1)(1996-12#1)(1996-2#1)(2005-11#10)(2005-4#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-4#1)(2007-12#2)(2008-10#6)(2008-2#10)(2008-3#6)(2009-12#3)(2010-2#3)(2011-2#4)
radio and TV##2##3##(1992-3#1)(1993-5#1)
radio and television##3##3##(2008-8#1)(2009-4#1)(2010-8#1)
radio and##8##2##(1992-3#1)(1993-5#1)(1996-5#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-8#1)(2013-1#1)
radio frequencies##3##2##(2007-11#1)(2007-3#1)(2008-3#1)
radio frequency (RF)##3##3##(2007-11#1)(2010-4#2)
radio frequency identification (RFID)##2##4##(2008-7#2)
radio frequency##17##2##(1992-1#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#2)(2008-7#2)(2008-9#1)(2009-10#1)(2010-4#3)(2010-7#1)(2011-2#1)
radio programmes##2##2##(2007-7#2)
radio to##2##2##(1995-2#1)(2009-3#1)
radio waves##2##2##(1993-8#1)(2011-2#1)
radio##70##1##(1990-11#1)(1990-6#1)(1992-1#1)(1992-3#1)(1993-5#1)(1993-8#1)(1995-2#1)(1995-6#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-10#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-7#4)(2007-9#3)(2008-1#2)(2008-10#3)(2008-2#1)(2008-3#4)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#4)(2009-4#1)(2010-3#1)(2010-4#3)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
radio- and##3##2##(1990-9#1)(2009-2#1)(2009-4#1)
radio-##5##1##(1990-9#1)(2006-2#1)(2007-4#1)(2009-2#1)(2009-4#1)
radio-HPLC##2##1##(1991-5#1)(2013-1#1)
radio-cephalic##4##1##(2007-7#4)
radio-frequency ablation##2##2##(1995-11#1)(2011-2#1)
radio-frequency##19##1##(1992-3#1)(1995-11#1)(2006-12#1)(2007-11#4)(2007-12#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)
radio-immunoassay##2##1##(1990-12#1)(2008-10#1)
radio-iodinated##4##1##(1991-12#2)(1992-6#1)(2008-2#1)
radio-isotope scanning##2##2##(2008-4#2)
radio-labeled##3##1##(1993-12#1)(2011-1#2)
radio-labelled##2##1##(1990-1#1)(1990-11#1)
radio-opaque##5##1##(2008-3#1)(2008-7#1)(2010-5#1)(2010-8#1)(2012-2#1)
radio-ulnar##2##1##(2007-11#2)
radioactive and##2##2##(1990-3#1)(2008-4#1)
radioactive band##2##2##(1991-5#1)(1992-8#1)
radioactive colloid##2##2##(1990-6#1)(2004-2#1)
radioactive contamination##2##2##(1990-12#1)(1994-9#1)
radioactive dynamic##2##2##(2008-10#2)
radioactive iodine was##2##3##(2011-1#1)(2012-12#1)
radioactive iodine##8##2##(2006-1#1)(2008-5#2)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
radioactive isotopes##3##2##(1996-8#1)(2009-12#1)(2012-2#1)
radioactive ligand##3##2##(1990-2#2)(1992-7#1)
radioactive materials##2##2##(1991-9#1)(2008-10#1)
radioactive microspheres##2##2##(2011-2#2)
radioactive nucleotides##2##2##(1992-6#1)(1995-2#1)
radioactive or nonradioactive##2##3##(2008-4#2)
radioactive or##3##2##(2008-10#1)(2008-4#2)
radioactive palmitic acid##2##3##(1992-8#1)(1993-11#1)
radioactive peptide##3##2##(1992-5#1)(1994-5#1)(1997-2#1)
radioactive phosphatidylcholine##2##2##(1996-4#1)(1996-5#1)
radioactive source##3##2##(2005-4#1)(2008-10#1)(2008-2#1)
radioactive spot on##2##3##(1995-2#1)(2008-9#1)
radioactive substances##7##2##(1990-11#1)(2008-4#1)(2008-9#1)(2012-2#4)
radioactive tracer##4##2##(1990-12#1)(1990-2#1)(1993-8#1)(2008-7#1)
radioactive urine##2##2##(2006-10#2)
radioactive waste##6##2##(1990-3#1)(1991-3#1)(2008-10#2)(2009-4#2)
radioactive##145##1##(1990-11#4)(1990-12#3)(1990-2#5)(1990-3#3)(1990-5#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#3)(1992-9#2)(1993-11#2)(1993-2#1)(1993-8#2)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-2#2)(1995-3#1)(1995-5#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-2#2)(1997-3#2)(1997-6#1)(2004-11#1)(2004-2#1)(2005-4#1)(2005-7#2)(2006-1#1)(2006-10#3)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#2)(2008-1#2)(2008-10#13)(2008-2#1)(2008-4#13)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#4)(2009-12#1)(2009-4#2)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#6)(2013-1#4)
radioactively labeled##3##2##(1995-1#1)(1996-2#1)(2008-4#1)
radioactively##7##1##(1993-11#1)(1995-1#1)(1996-2#1)(2008-4#4)
radioactivities##4##1##(1990-10#1)(1995-3#1)(1995-6#1)(2008-11#1)
radioactivity after##2##2##(1992-7#1)(1997-8#1)
radioactivity and the##3##3##(1992-2#1)(2008-2#2)
radioactivity and##8##2##(1990-12#1)(1991-3#1)(1992-2#1)(1993-11#1)(1997-8#1)(2007-1#1)(2008-2#2)
radioactivity at the##2##3##(1990-11#1)(1990-12#1)
radioactivity at##4##2##(1990-11#1)(1990-12#1)(1993-4#1)(1997-8#1)
radioactivity by##2##2##(1990-12#1)(1996-5#1)
radioactivity counts##2##2##(2010-9#2)
radioactivity for##2##2##(1990-12#1)(1990-3#1)
radioactivity from##4##2##(1994-6#1)(1994-8#1)(1995-8#1)(2008-11#1)
radioactivity in the##10##3##(1990-7#1)(1991-4#1)(1992-2#1)(1992-3#1)(1994-3#1)(1995-1#1)(1996-1#1)(1997-3#1)(2008-2#1)(2008-4#1)
radioactivity in##21##2##(1990-7#1)(1991-1#1)(1991-4#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-8#2)(1993-9#1)(1994-3#1)(1994-9#1)(1995-1#2)(1996-1#1)(1997-3#1)(1997-8#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#1)
radioactivity incorporated##2##2##(1994-5#1)(1996-2#1)
radioactivity into the##4##3##(1990-11#1)(1994-8#1)(2008-4#2)
radioactivity into##5##2##(1990-11#1)(1994-3#1)(1994-8#1)(2008-4#2)
radioactivity is##4##2##(1992-4#1)(1997-8#1)(2006-12#1)(2008-4#1)
radioactivity of the##6##3##(1993-11#1)(1995-10#1)(1995-6#1)(2007-11#1)(2008-11#1)(2008-5#1)
radioactivity of##13##2##(1990-10#1)(1990-8#1)(1991-1#1)(1991-3#1)(1992-6#1)(1993-11#1)(1995-10#2)(1995-6#1)(2007-11#1)(2008-11#2)(2008-5#1)
radioactivity was incorporated into a##2##5##(1991-1#1)(1994-11#1)
radioactivity was recovered##3##3##(1990-3#1)(1991-12#1)(1994-11#1)
radioactivity was##20##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1991-1#1)(1991-12#1)(1991-7#1)(1992-3#1)(1992-4#1)(1993-11#1)(1994-11#2)(1994-3#2)(1994-6#1)(1994-9#1)(1997-2#1)(1997-8#1)(2006-8#1)(2008-10#1)
radioactivity were##4##2##(1990-3#1)(1995-3#1)(1997-8#1)(2006-8#1)
radioactivity##149##1##(1990-10#2)(1990-11#4)(1990-12#8)(1990-2#1)(1990-3#5)(1990-7#1)(1990-8#2)(1991-1#3)(1991-12#2)(1991-3#2)(1991-4#1)(1991-7#2)(1992-1#1)(1992-2#3)(1992-3#3)(1992-4#3)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#3)(1993-11#5)(1993-4#3)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#3)(1994-3#5)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#2)(1995-1#3)(1995-10#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#11)(2006-12#2)(2006-8#2)(2007-1#3)(2007-11#2)(2008-10#2)(2008-11#7)(2008-2#3)(2008-4#7)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-9#2)(2011-1#1)
radioactivity)##2##1##(1997-8#2)
radioassay for##3##2##(1992-3#1)(1997-8#2)
radioassay##6##1##(1992-3#2)(1994-11#1)(1997-7#1)(1997-8#2)
radiobacter strain K84##3##3##(2008-10#3)
radiobacter##9##1##(1997-8#2)(2008-10#7)
radiobiologic##2##1##(1992-10#1)(2007-4#1)
radiobiological and##2##2##(1994-9#1)(2007-4#1)
radiobiological basis##2##2##(1993-9#1)(2008-7#1)
radiobiological##13##1##(1993-9#1)(1994-3#1)(1994-9#1)(1995-9#2)(2006-7#1)(2007-11#2)(2007-4#2)(2008-7#2)(2011-2#1)
radiobiology##9##1##(2004-1#1)(2007-4#1)(2008-10#3)(2008-7#3)(2013-1#1)
radiocaesium activities##2##2##(1993-9#2)
radiocaesium content of##2##3##(1992-6#1)(1993-9#1)
radiocaesium is##2##2##(1992-3#1)(1993-8#1)
radiocaesium levels in muscle##2##4##(1993-9#2)
radiocaesium levels in##4##3##(1993-9#4)
radiocaesium##17##1##(1992-3#5)(1992-6#3)(1993-8#2)(1993-9#7)
radiocarbon##3##1##(2006-3#2)(2007-5#1)
radiocarbon-dated##3##1##(1991-2#1)(1993-4#1)(2006-7#1)
radiocarpal joint##3##2##(2005-7#1)(2008-10#1)(2012-2#1)
radiocarpal##8##1##(2005-7#1)(2006-3#2)(2007-8#1)(2008-10#1)(2008-9#2)(2012-2#1)
radiocephalic fistula##4##2##(2007-7#4)
radiocephalic fistulae##3##2##(2007-7#3)
radiocephalic fistulas##2##2##(2007-7#2)
radiocephalic##10##1##(2007-7#10)
radiocesium##2##1##(1992-4#2)
radiochemical assay##3##2##(1990-1#1)(1991-12#2)
radiochemical methods##2##2##(1991-4#1)(1996-4#1)
radiochemical oxidation##2##2##(2010-12#2)
radiochemical purity##2##2##(2007-10#1)(2010-12#1)
radiochemical separation##3##2##(1992-4#1)(2008-10#2)
radiochemical##22##1##(1990-1#1)(1991-12#2)(1991-4#1)(1991-5#2)(1992-4#1)(1993-9#1)(1994-9#2)(1996-4#1)(1996-8#1)(2007-10#1)(2007-8#1)(2008-10#3)(2010-12#3)(2010-5#2)
radiochemotherapy in##2##2##(1993-3#1)(2013-1#1)
radiochemotherapy##7##1##(1993-3#1)(2007-12#3)(2008-5#1)(2013-1#2)
radiocontrast##2##1##(2006-10#1)(2011-12#1)
radiodermatitis##5##1##(1991-12#1)(1997-7#4)
radiodiagnosis of##3##2##(2008-6#1)(2008-7#2)
radiodiagnosis##9##1##(1996-8#1)(2008-6#1)(2008-7#5)(2009-10#2)
radiodiagnostic techniques##2##2##(2008-6#1)(2008-7#1)
radiodiagnostic##4##1##(2008-6#2)(2008-7#2)
radiodurans##4##1##(2005-11#1)(2006-12#2)(2008-7#1)
radioembolization##10##1##(2011-2#2)(2013-1#8)
radiofluorography##2##1##(2008-7#2)
radiofrequency (RF) ablation##4##3##(2006-9#1)(2007-8#1)(2010-12#1)(2010-6#1)
radiofrequency (RF)##8##2##(2006-12#2)(2006-9#1)(2007-8#2)(2010-12#1)(2010-6#1)(2011-2#1)
radiofrequency ablation (RFA)##2##3##(2008-8#1)(2012-2#1)
radiofrequency ablation for##4##3##(2007-8#1)(2009-6#1)(2013-7#2)
radiofrequency ablation is##3##3##(2006-9#1)(2007-8#2)
radiofrequency ablation of the##2##4##(2006-6#1)(2007-8#1)
radiofrequency ablation of##7##3##(2006-6#1)(2007-8#1)(2008-11#1)(2008-8#1)(2011-1#2)(2013-8#1)
radiofrequency ablation##43##2##(1996-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#2)(2006-9#4)(2007-8#9)(2008-10#1)(2008-11#1)(2008-8#2)(2009-10#1)(2009-6#2)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#6)
radiofrequency and##2##2##(2006-11#1)(2007-8#1)
radiofrequency catheter ablation##4##3##(1993-12#1)(1996-4#1)(2006-9#1)(2008-10#1)
radiofrequency catheter ablations##2##3##(2006-8#1)(2008-5#1)
radiofrequency catheter##8##2##(1993-12#1)(1996-4#1)(2006-8#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
radiofrequency current##2##2##(1991-6#2)
radiofrequency data analysis##3##3##(2009-5#1)(2010-5#2)
radiofrequency denervation##6##2##(2006-8#5)(2010-1#1)
radiofrequency device##4##2##(2011-1#2)(2013-1#2)
radiofrequency energy##2##2##(1990-10#1)(2007-8#1)
radiofrequency is##2##2##(2006-12#1)(2006-7#1)
radiofrequency lesioning of the##2##4##(2006-7#2)
radiofrequency lesioning of##3##3##(2006-7#3)
radiofrequency lesioning##8##2##(2006-12#4)(2006-7#4)
radiofrequency lesions##3##2##(1991-1#1)(1992-11#1)(1994-3#1)
radiofrequency maze##2##2##(2007-8#2)
radiofrequency needle##2##2##(2006-7#2)
radiofrequency neurolysis##2##2##(2006-7#2)
radiofrequency procedures##2##2##(2006-12#2)
radiofrequency treatment##2##2##(2006-12#2)
radiofrequency##141##1##(1990-10#3)(1990-2#1)(1991-1#1)(1991-6#2)(1992-11#1)(1993-11#1)(1993-12#1)(1994-3#1)(1996-4#2)(2005-11#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#19)(2006-6#7)(2006-7#10)(2006-8#8)(2006-9#6)(2007-8#18)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#2)(2009-3#2)(2009-5#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-5#3)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#6)
radiogenic##3##1##(1991-5#1)(1996-5#2)
radiogram##7##1##(2007-11#2)(2007-7#3)(2007-8#1)(2008-10#1)
radiograms of##3##2##(2007-11#1)(2007-8#2)
radiograms##12##1##(2007-11#3)(2007-8#9)
radiograph and##7##2##(2007-12#2)(2007-8#1)(2008-1#1)(2008-7#1)(2011-2#1)(2012-1#1)
radiograph can##2##2##(2012-12#1)(2013-8#1)
radiograph of the##2##3##(1990-9#1)(2007-8#1)
radiograph of##3##2##(1990-9#1)(2007-8#1)(2011-2#1)
radiograph revealed a##2##3##(2007-3#1)(2010-2#1)
radiograph revealed##3##2##(2007-3#1)(2010-2#1)(2012-3#1)
radiograph showed##4##2##(2006-10#1)(2010-10#1)(2010-9#1)(2011-1#1)
radiograph was##3##2##(2008-3#1)(2008-8#1)(2011-2#1)
radiograph##55##1##(1990-9#1)(1991-11#1)(1991-3#1)(1991-8#1)(1991-9#1)(1997-8#2)(2005-11#1)(2005-8#1)(2006-10#1)(2007-12#2)(2007-3#2)(2007-8#3)(2008-1#1)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
radiographed##4##1##(1997-8#1)(2007-1#1)(2009-4#1)(2011-2#1)
radiographer##2##1##(1992-1#1)(2008-4#1)
radiographers in the##2##3##(1992-1#1)(2008-4#1)
radiographers in##4##2##(1992-1#1)(1996-1#1)(2008-4#2)
radiographers##11##1##(1991-2#1)(1992-1#1)(1995-2#1)(1996-1#2)(2008-10#1)(2008-4#5)
radiographers' organizational commitment##2##3##(1996-1#2)
radiographic ASD##2##2##(2012-12#2)
radiographic abnormalities of##2##3##(2007-11#1)(2011-2#1)
radiographic abnormalities##4##2##(2006-10#1)(2007-11#1)(2008-1#1)(2011-2#1)
radiographic analysis of##2##3##(2006-8#1)(2008-8#1)
radiographic anatomy##3##2##(2007-2#1)(2009-4#1)(2012-1#1)
radiographic and clinical##4##3##(2007-11#1)(2008-3#1)(2011-2#1)(2012-12#1)
radiographic and endoscopic##2##3##(1991-11#1)(2008-5#1)
radiographic and histologic##2##3##(2010-3#1)(2012-12#1)
radiographic and##18##2##(1991-11#1)(2007-11#2)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-8#1)(2010-3#1)(2011-2#1)(2012-12#2)(2012-2#1)
radiographic assessment##2##2##(1991-12#1)(2006-11#1)
radiographic bone##2##2##(2013-1#1)(2013-7#1)
radiographic changes##2##2##(1991-12#1)(2007-11#1)
radiographic contrast##2##2##(1992-3#1)(2009-4#1)
radiographic diagnosis##2##2##(1993-1#1)(2008-10#1)
radiographic evaluation of##4##3##(2007-11#1)(2007-7#1)(2008-4#1)(2011-12#1)
radiographic evaluation##12##2##(2005-8#1)(2007-11#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#1)(2011-12#1)(2012-12#1)
radiographic evidence of##5##3##(2006-8#2)(2010-2#1)(2011-2#1)(2013-1#1)
radiographic examination##9##2##(1997-4#1)(2006-10#1)(2006-3#1)(2007-11#1)(2008-5#1)(2008-9#1)(2010-2#1)(2011-2#2)
radiographic features and##2##3##(2008-4#1)(2010-12#1)
radiographic features of##7##3##(1993-12#1)(2005-8#2)(2006-10#1)(2006-5#1)(2008-12#1)(2012-2#1)
radiographic features##19##2##(1993-12#1)(2005-8#4)(2006-10#2)(2006-5#2)(2007-12#1)(2007-6#1)(2007-7#1)(2008-12#1)(2008-4#1)(2009-3#1)(2010-12#1)(2012-2#2)(2013-8#1)
radiographic findings in##3##3##(1993-1#1)(2006-9#1)(2009-10#1)
radiographic findings of##2##3##(2006-10#1)(2008-6#1)
radiographic findings were##2##3##(2009-1#1)(2013-8#1)
radiographic findings##15##2##(1993-1#1)(1997-1#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-7#1)(2008-6#2)(2009-1#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
radiographic follow-up##4##2##(1993-6#1)(2008-8#1)(2012-3#1)(2013-1#1)
radiographic images##4##2##(2007-1#1)(2008-12#1)(2008-6#1)(2011-1#1)
radiographic imaging in##3##3##(2006-1#1)(2008-12#2)
radiographic imaging##7##2##(2006-1#1)(2007-11#1)(2008-12#2)(2010-12#1)(2011-1#1)(2012-2#1)
radiographic interpretation##2##2##(2012-12#1)(2013-1#1)
radiographic measurements##3##2##(2008-12#2)(2009-10#1)
radiographic outcomes##5##2##(2011-2#1)(2013-1#4)
radiographic parameter##2##2##(2007-8#2)
radiographic presentation of##2##3##(1992-2#1)(2012-2#1)
radiographic results of##2##3##(2008-4#1)(2013-1#1)
radiographic results##3##2##(2008-4#1)(2009-3#1)(2013-1#1)
radiographic signs of##3##3##(2006-10#2)(2007-11#1)
radiographic signs##4##2##(2005-11#1)(2006-10#2)(2007-11#1)
radiographic studies##7##2##(1997-8#1)(2005-10#1)(2006-10#1)(2007-12#1)(2010-12#1)(2012-2#2)
radiographic study##3##2##(2007-11#1)(2009-3#1)(2010-10#1)
radiographic technique##3##2##(2006-4#1)(2008-12#1)(2009-4#1)
radiographic techniques##2##2##(2006-5#1)(2011-12#1)
radiographic union##2##2##(2006-3#1)(2009-10#1)
radiographic##222##1##(1991-1#1)(1991-11#1)(1991-12#4)(1992-2#1)(1992-3#1)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-6#1)(1995-10#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-8#1)(2005-10#1)(2005-11#2)(2005-8#7)(2006-1#2)(2006-10#11)(2006-11#1)(2006-12#1)(2006-3#3)(2006-4#1)(2006-5#3)(2006-8#6)(2006-9#1)(2007-1#2)(2007-11#11)(2007-12#3)(2007-2#4)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#4)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#8)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#4)(2008-6#8)(2008-7#1)(2008-8#5)(2008-9#4)(2009-1#1)(2009-10#3)(2009-12#1)(2009-3#5)(2009-4#3)(2010-10#2)(2010-12#4)(2010-2#2)(2010-3#1)(2010-7#1)(2011-1#2)(2011-12#2)(2011-2#12)(2012-1#1)(2012-12#9)(2012-2#11)(2012-3#4)(2013-1#20)(2013-7#1)(2013-8#3)
radiographically##18##1##(1990-12#1)(1991-12#1)(1993-1#1)(1997-4#2)(1997-8#1)(2006-12#2)(2006-8#2)(2007-11#1)(2008-12#2)(2008-6#1)(2009-10#1)(2011-12#1)(2012-2#1)(2013-1#1)
radiographs (DRRs)##3##2##(2009-10#1)(2009-11#1)(2009-2#1)
radiographs and CT scan##3##4##(2008-12#1)(2013-1#2)
radiographs and computed##2##3##(2009-3#1)(2011-2#1)
radiographs and##18##2##(2006-11#1)(2006-9#1)(2007-7#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
radiographs are##4##2##(2005-8#1)(2008-12#1)(2008-3#1)(2012-12#1)
radiographs for##4##2##(1991-12#1)(2008-12#1)(2012-2#1)(2013-8#1)
radiographs from##2##2##(2006-11#1)(2008-12#1)
radiographs had##2##2##(2010-10#1)(2011-2#1)
radiographs in##6##2##(2005-8#1)(2007-7#1)(2013-1#3)(2013-8#1)
radiographs is##2##2##(2007-7#1)(2009-3#1)
radiographs of the##5##3##(2006-1#1)(2007-1#1)(2007-7#1)(2008-9#1)(2013-1#1)
radiographs of##13##2##(2006-1#1)(2007-1#1)(2007-2#1)(2007-7#3)(2007-8#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-9#1)(2013-1#1)
radiographs on##3##2##(2009-10#2)(2012-12#1)
radiographs revealed a##2##3##(2008-12#1)(2008-5#1)
radiographs revealed##3##2##(2008-12#1)(2008-5#1)(2008-9#1)
radiographs showed##4##2##(1997-3#1)(2008-8#1)(2013-1#2)
radiographs suggested the presence of##2##5##(2009-3#1)(2013-8#1)
radiographs that##3##2##(2007-7#1)(2008-1#1)(2008-11#1)
radiographs were digitized##2##3##(2008-12#1)(2008-3#1)
radiographs were evaluated for##2##4##(2009-3#1)(2013-1#1)
radiographs were evaluated##5##3##(2007-8#1)(2008-8#1)(2009-3#1)(2012-2#1)(2013-1#1)
radiographs were##16##2##(2007-7#1)(2007-8#1)(2008-12#2)(2008-3#2)(2008-8#2)(2008-9#1)(2009-3#1)(2012-2#3)(2013-1#1)(2013-8#2)
radiographs##137##1##(1991-12#2)(1992-5#1)(1996-5#1)(1997-3#1)(2004-3#1)(2005-11#1)(2005-2#1)(2005-8#2)(2006-1#1)(2006-10#2)(2006-11#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-2#2)(2007-4#2)(2007-5#1)(2007-7#12)(2007-8#3)(2008-1#2)(2008-11#1)(2008-12#9)(2008-3#5)(2008-5#2)(2008-7#1)(2008-8#6)(2008-9#5)(2009-10#6)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#8)(2009-4#1)(2009-9#2)(2010-10#1)(2010-3#1)(2010-5#2)(2010-7#1)(2010-9#2)(2011-2#5)(2012-12#3)(2012-2#10)(2013-1#15)(2013-8#5)
radiography and computed tomography##2##4##(2005-8#1)(2011-2#1)
radiography and computed##3##3##(2005-8#1)(2011-2#2)
radiography and fluoroscopy##2##3##(1993-12#1)(2008-9#1)
radiography and ultrasonography##4##3##(2005-12#1)(2007-11#1)(2007-8#1)(2012-3#1)
radiography and##19##2##(1993-12#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-9#2)(2009-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
radiography in the##4##3##(1997-8#1)(2007-4#1)(2008-9#1)(2011-2#1)
radiography in##9##2##(1996-2#1)(1997-8#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
radiography is the##3##3##(2010-3#1)(2011-2#1)(2012-2#1)
radiography is##10##2##(1997-8#2)(2007-7#1)(2008-9#2)(2010-3#1)(2011-12#1)(2011-2#1)(2012-2#2)
radiography of the##2##3##(1993-1#1)(2013-1#1)
radiography of##5##2##(1993-1#1)(1997-8#1)(2009-1#2)(2013-1#1)
radiography system##2##2##(2007-4#1)(2010-9#1)
radiography using the##2##3##(1991-4#1)(2005-7#1)
radiography were##3##2##(1990-3#1)(2007-11#1)(2008-3#1)
radiography with##2##2##(2011-1#1)(2012-2#1)
radiography##114##1##(1990-3#1)(1991-12#1)(1991-4#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-4#2)(1995-2#4)(1995-5#1)(1996-2#1)(1997-8#6)(2004-2#2)(2005-12#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-4#2)(2006-6#2)(2006-8#1)(2006-9#1)(2007-11#5)(2007-12#1)(2007-4#8)(2007-6#1)(2007-7#3)(2007-8#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#5)(2009-1#2)(2009-4#2)(2009-9#3)(2010-1#1)(2010-12#2)(2010-3#2)(2010-6#2)(2010-9#3)(2011-1#4)(2011-12#1)(2011-2#7)(2012-12#4)(2012-2#7)(2012-3#1)(2013-1#6)
radiography) and##2##2##(2008-4#1)(2013-1#1)
radioimmune##3##1##(2006-6#1)(2008-10#1)(2008-3#1)
radioimmunoassay (RIA) and##2##3##(1996-6#1)(2007-8#1)
radioimmunoassay (RIA) for##3##3##(1991-3#1)(1992-7#1)(1994-10#1)
radioimmunoassay (RIA)##25##2##(1990-11#1)(1990-2#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-10#2)(1994-12#1)(1996-6#1)(1997-5#1)(2006-6#1)(2007-8#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-12#1)
radioimmunoassay and by##2##3##(1992-5#1)(2008-4#1)
radioimmunoassay and##9##2##(1990-12#2)(1990-8#1)(1991-1#1)(1991-3#1)(1991-6#1)(1992-5#1)(2006-9#1)(2008-4#1)
radioimmunoassay for the##3##3##(1996-1#1)(1996-9#1)(1997-7#1)
radioimmunoassay for##10##2##(1990-7#1)(1990-8#1)(1992-12#1)(1992-7#1)(1993-9#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-7#1)
radioimmunoassay has been developed##2##4##(1990-8#1)(1996-9#1)
radioimmunoassay in##7##2##(1990-5#1)(1990-9#1)(1991-3#1)(1992-3#2)(1996-2#1)(1996-4#1)
radioimmunoassay kit##2##2##(1990-10#1)(1996-9#1)
radioimmunoassay of##5##2##(1991-5#1)(1993-1#2)(1994-5#1)(2008-2#1)
radioimmunoassay specific for##2##3##(1993-12#1)(1995-6#1)
radioimmunoassay technique##3##2##(2007-1#1)(2007-9#1)(2008-5#1)
radioimmunoassay was##5##2##(1993-6#1)(1995-12#1)(1995-6#1)(2008-5#1)(2010-8#1)
radioimmunoassay with##2##2##(1991-10#1)(1995-5#1)
radioimmunoassay##114##1##(1990-10#4)(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#3)(1990-9#3)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#4)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#5)(1991-9#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-7#5)(1992-8#1)(1992-9#2)(1993-1#2)(1993-12#3)(1993-6#1)(1993-9#2)(1994-10#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-5#3)(1995-6#2)(1996-1#3)(1996-12#1)(1996-2#3)(1996-4#1)(1996-6#1)(1996-8#3)(1996-9#3)(1997-3#2)(1997-5#1)(1997-7#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-8#1)(2007-9#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2010-8#1)(2011-1#2)(2011-12#1)
radioimmunoassayable##2##1##(1992-4#1)(1996-2#1)
radioimmunoassayed##2##1##(1991-12#1)(1996-2#1)
radioimmunoassays (RIA)##2##2##(1990-11#1)(1992-8#1)
radioimmunoassays (RIAs)##2##2##(1990-10#1)(1996-12#1)
radioimmunoassays##13##1##(1990-10#1)(1990-11#1)(1990-2#2)(1992-8#4)(1994-12#2)(1996-12#1)(2007-12#1)(2008-4#1)
radioimmunoconjugates##2##1##(1993-11#1)(1997-7#1)
radioimmunodetection##2##1##(2008-3#2)
radioimmunological##2##1##(1992-4#1)(1997-4#1)
radioimmunologically##4##1##(1991-12#1)(1991-3#1)(1995-12#2)
radioimmunoprecipitation##2##1##(1990-11#1)(1990-12#1)
radioimmunotherapy (RIT)##2##2##(2006-6#1)(2007-10#1)
radioimmunotherapy with##2##2##(1995-8#1)(1995-9#1)
radioimmunotherapy##10##1##(1995-4#1)(1995-8#1)(1995-9#1)(1997-7#1)(2006-6#1)(2007-10#1)(2008-3#2)(2011-1#2)
radioiodinated fatty acids##2##3##(1992-10#2)
radioiodinated##17##1##(1990-12#1)(1990-2#1)(1990-7#1)(1990-9#1)(1992-10#3)(1992-2#2)(1993-11#1)(1993-4#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-6#1)(2008-4#1)
radioiodination of cell surface proteins##2##5##(1991-2#1)(2008-1#1)
radioiodination of proteins##3##3##(1993-4#1)(2008-1#1)(2008-2#1)
radioiodination of purified##2##3##(2008-1#2)
radioiodination of##8##2##(1991-2#1)(1992-2#1)(1993-4#1)(2008-1#4)(2008-2#1)
radioiodination##11##1##(1991-2#1)(1991-3#1)(1992-2#1)(1993-4#2)(2008-1#5)(2008-2#1)
radioiodine is##2##2##(2011-2#2)
radioiodine therapy##3##2##(1991-10#1)(1992-5#1)(2007-12#1)
radioiodine##11##1##(1991-10#2)(1992-5#1)(2006-9#1)(2007-12#1)(2008-11#1)(2008-4#1)(2011-2#2)(2013-1#2)
radioisotope and##4##2##(1992-2#2)(2007-11#1)(2008-4#1)
radioisotope##21##1##(1990-11#1)(1990-12#1)(1991-9#1)(1992-1#1)(1992-2#3)(1996-11#2)(1997-7#1)(2007-1#1)(2007-11#4)(2008-1#1)(2008-10#2)(2008-4#1)(2010-12#1)(2010-9#1)
radioisotopes##23##1##(1990-12#1)(1997-4#1)(2007-11#2)(2007-4#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-4#7)(2008-7#2)(2008-9#3)(2010-3#1)(2012-2#1)
radioisotopic method##2##2##(1995-3#1)(2007-1#1)
radioisotopic##7##1##(1991-5#1)(1991-7#1)(1995-3#1)(1996-9#1)(2007-1#1)(2007-8#1)(2008-7#1)
radiolabel in##4##2##(1991-1#1)(1992-3#1)(1992-9#1)(1995-9#1)
radiolabel was##4##2##(1991-12#1)(1991-3#1)(1993-4#1)(1993-7#1)
radiolabel##29##1##(1990-10#1)(1990-2#4)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-2#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-12#1)(1995-9#1)(1996-2#1)(1997-1#1)(1997-7#1)(2006-3#1)(2008-11#2)(2008-4#1)(2008-7#1)
radiolabeled Affibody molecule##2##3##(2009-9#2)
radiolabeled DNA##3##2##(1996-3#1)(2008-4#2)
radiolabeled GTP to##2##3##(1990-7#1)(1990-9#1)
radiolabeled PCR products##2##3##(1993-3#1)(2008-4#1)
radiolabeled PCR##3##2##(1990-2#1)(1993-3#1)(2008-4#1)
radiolabeled RNA##3##2##(1990-11#1)(2008-4#2)
radiolabeled analog of##2##3##(1990-8#1)(1993-8#1)
radiolabeled and##2##2##(1991-12#1)(2008-4#1)
radiolabeled antigen##3##2##(1990-12#1)(2008-4#2)
radiolabeled in##3##2##(1990-7#1)(1992-6#1)(1997-6#1)
radiolabeled ligands##2##2##(2008-4#1)(2008-7#1)
radiolabeled nucleotides##2##2##(1992-11#1)(2008-4#1)
radiolabeled peptide##2##2##(1995-1#1)(2008-3#1)
radiolabeled precursor##3##2##(1996-8#1)(2008-10#1)(2008-4#1)
radiolabeled probe##3##2##(1994-5#1)(2008-4#2)
radiolabeled proteins##3##2##(2008-4#3)
radiolabeled with##7##2##(1991-2#1)(1992-2#1)(1994-12#1)(2010-10#2)(2012-2#1)(2013-7#1)
radiolabeled##143##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#1)(1990-7#4)(1990-8#3)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-7#2)(1991-8#1)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-3#4)(1993-6#1)(1993-7#1)(1993-8#2)(1994-11#3)(1994-12#7)(1994-5#4)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#5)(1996-3#4)(1996-8#3)(1996-9#1)(1997-1#3)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(2005-11#1)(2006-12#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#24)(2008-7#1)(2008-8#2)(2009-12#1)(2009-2#1)(2009-9#3)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-6#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
radiolabeling and##2##2##(1990-7#1)(2005-11#1)
radiolabeling method##2##2##(1992-2#1)(2008-4#1)
radiolabeling of##7##2##(1990-2#1)(1991-3#1)(1992-2#1)(1996-8#2)(2008-4#2)
radiolabeling##20##1##(1990-2#1)(1990-7#1)(1991-3#1)(1992-2#2)(1993-2#1)(1995-8#1)(1996-8#2)(2005-11#3)(2006-8#1)(2007-10#1)(2008-1#1)(2008-4#4)(2008-7#1)
radiolabelled IGF-I revealed##2##3##(1992-12#2)
radiolabelled annexin A5##2##3##(2008-8#2)
radiolabelled annexin##3##2##(2008-11#1)(2008-8#2)
radiolabelled antibodies##2##2##(2007-11#2)
radiolabelled dopamine##2##2##(1990-1#2)
radiolabelled##48##1##(1990-1#2)(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-7#2)(1991-2#1)(1991-4#1)(1992-12#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-2#2)(1997-1#1)(2004-11#1)(2006-10#1)(2006-9#2)(2007-11#5)(2007-12#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)
radiolabelling##5##1##(1991-9#1)(1995-7#1)(1995-8#1)(2008-5#2)
radiolar appendages##2##2##(2011-2#2)
radiolar##5##1##(2011-2#5)
radioligand and##2##2##(1990-5#1)(1995-1#1)
radioligand binding assays##6##3##(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-11#1)(2006-2#1)
radioligand binding at##2##3##(1994-8#2)
radioligand binding studies##6##3##(1991-2#1)(1993-4#1)(2008-4#4)
radioligand binding technique##2##3##(1991-6#1)(1996-3#1)
radioligand binding to##2##3##(1995-3#1)(2008-4#1)
radioligand binding##30##2##(1990-3#1)(1991-2#1)(1991-3#1)(1991-6#2)(1992-11#1)(1993-4#1)(1993-6#1)(1994-10#1)(1994-2#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#2)(1995-3#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-4#1)(2006-2#1)(2008-4#6)
radioligand for##4##2##(1991-1#1)(1994-8#1)(1996-12#1)(2008-4#1)
radioligand in##2##2##(1996-12#1)(1997-4#1)
radioligand was##7##2##(1990-5#1)(1991-11#1)(1991-5#1)(1994-8#2)(1995-5#1)(1996-3#1)
radioligand##73##1##(1990-11#1)(1990-3#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#2)(1992-10#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-3#2)(1993-4#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-8#7)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#3)(1995-3#1)(1995-5#2)(1996-10#1)(1996-11#1)(1996-12#4)(1996-3#2)(1996-5#1)(1997-2#5)(1997-4#2)(2005-9#1)(2006-2#1)(2008-4#8)
radioligands and##2##2##(1991-5#1)(2008-4#1)
radioligands for the##2##3##(1992-10#1)(2008-4#1)
radioligands for##6##2##(1992-10#2)(2005-9#2)(2008-4#2)
radioligands were##3##2##(1992-3#1)(1993-3#1)(1995-7#1)
radioligands##18##1##(1990-2#2)(1991-5#1)(1992-10#3)(1992-3#1)(1993-3#2)(1995-7#2)(2005-9#4)(2008-4#3)
radiologic and endoscopic##2##3##(2007-11#1)(2013-8#1)
radiologic and histologic margins##3##4##(2004-2#3)
radiologic and histologic##4##3##(2004-2#3)(2009-3#1)
radiologic and##12##2##(1992-1#1)(2004-2#3)(2007-11#1)(2008-10#1)(2008-3#1)(2009-12#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
radiologic characteristics to predict##2##4##(2007-12#2)
radiologic evaluation##4##2##(1994-6#1)(2007-11#1)(2011-12#1)(2012-3#1)
radiologic evidence##2##2##(2006-2#1)(2012-3#1)
radiologic examination##3##2##(2010-12#1)(2010-8#1)(2010-9#1)
radiologic features of##4##3##(1991-1#1)(2009-3#1)(2011-2#1)(2013-7#1)
radiologic features##8##2##(1991-1#1)(1991-6#1)(2007-12#1)(2009-3#1)(2011-2#3)(2013-7#1)
radiologic findings##6##2##(2005-12#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-7#1)(2013-8#1)
radiologic imaging##2##2##(2006-6#2)
radiologic procedures##2##2##(2007-8#1)(2013-1#1)
radiologic research##2##2##(2007-4#2)
radiologic technologists##12##2##(1993-12#1)(1994-1#2)(1995-1#1)(1996-2#1)(1996-3#1)(2007-4#6)
radiologic##99##1##(1990-10#1)(1990-12#1)(1991-1#1)(1991-6#1)(1992-1#2)(1993-12#1)(1994-1#3)(1994-6#1)(1995-1#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-2#3)(2005-12#1)(2006-10#6)(2006-12#2)(2006-2#2)(2006-6#2)(2006-8#1)(2007-11#5)(2007-12#5)(2007-2#1)(2007-4#12)(2007-8#1)(2008-10#2)(2008-3#2)(2008-6#1)(2008-7#2)(2009-12#1)(2009-3#3)(2010-12#4)(2010-8#1)(2010-9#2)(2011-12#1)(2011-2#9)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#2)
radiological abnormalities##3##2##(1991-11#1)(2005-11#1)(2007-8#1)
radiological analysis##3##2##(2007-7#1)(2008-3#1)(2011-2#1)
radiological anatomy of the##2##4##(2008-7#1)(2011-2#1)
radiological anatomy##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
radiological and biological##3##3##(1992-5#1)(2012-11#2)
radiological and clinical##4##3##(1991-11#1)(2007-11#1)(2007-7#1)(2007-8#1)
radiological and histological findings##2##4##(2009-3#1)(2010-5#1)
radiological and histological##3##3##(1991-11#1)(2009-3#1)(2010-5#1)
radiological and histopathological findings##2##4##(2010-11#1)(2010-12#1)
radiological and histopathological##4##3##(2007-12#1)(2007-7#1)(2010-11#1)(2010-12#1)
radiological and laboratory investigations##2##4##(1991-10#1)(2007-3#1)
radiological and laboratory##3##3##(1991-10#1)(2007-3#1)(2007-7#1)
radiological and pathological findings##2##4##(1992-10#1)(2009-5#1)
radiological and pathological##4##3##(1992-10#2)(2008-7#1)(2009-5#1)
radiological and serological##2##3##(2007-8#1)(2008-3#1)
radiological and##45##2##(1990-11#1)(1991-10#1)(1991-11#2)(1991-6#1)(1992-10#2)(1992-4#1)(1992-5#1)(1993-5#1)(1993-8#1)(2005-8#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-3#2)(2007-7#3)(2007-8#5)(2008-3#1)(2008-5#1)(2008-7#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-5#1)(2011-1#1)(2012-11#2)(2012-2#2)(2013-8#1)
radiological appearance of##6##3##(1993-8#1)(2005-8#1)(2008-1#1)(2011-1#1)(2012-12#1)(2012-3#1)
radiological appearance##7##2##(1993-8#1)(2005-8#1)(2008-1#1)(2010-11#1)(2011-1#1)(2012-12#1)(2012-3#1)
radiological assessment##5##2##(1990-12#1)(1990-8#1)(2007-7#1)(2013-1#2)
radiological changes##5##2##(2007-8#1)(2008-8#1)(2010-3#1)(2011-2#1)(2013-1#1)
radiological characteristics##4##2##(2006-12#2)(2007-9#1)(2009-3#1)
radiological clearance##2##2##(2010-5#2)
radiological control##3##2##(1990-3#1)(1993-10#1)(2007-7#1)
radiological criteria##3##2##(2007-7#1)(2007-8#1)(2010-5#1)
radiological data##2##2##(2007-11#1)(2008-7#1)
radiological diagnosis##11##2##(2007-11#2)(2007-6#1)(2007-8#2)(2007-9#1)(2009-6#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
radiological diagnostics##2##2##(2007-11#1)(2009-2#1)
radiological evaluation of the##2##4##(2007-8#1)(2012-3#1)
radiological evaluation of##5##3##(2007-11#2)(2007-8#2)(2012-3#1)
radiological evaluation##12##2##(2007-11#4)(2007-7#1)(2007-8#2)(2008-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
radiological evidence of##3##3##(2007-7#1)(2013-1#2)
radiological examination of##2##3##(1995-6#1)(1995-9#1)
radiological examination was##2##3##(1993-3#1)(2011-1#1)
radiological examination##22##2##(1991-3#1)(1993-3#1)(1993-5#1)(1995-6#1)(1995-9#1)(1997-4#1)(2004-2#1)(2007-7#3)(2007-8#4)(2008-10#1)(2008-4#2)(2009-5#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#1)
radiological examinations##9##2##(1992-9#1)(1993-1#1)(1995-8#1)(2004-2#2)(2007-11#2)(2007-7#1)(2013-1#1)
radiological features and##2##3##(1992-4#1)(2008-6#1)
radiological features of##8##3##(1992-12#1)(2005-8#1)(2008-7#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-2#2)
radiological features##21##2##(1992-12#1)(1992-4#1)(2005-8#1)(2006-12#1)(2006-8#1)(2008-3#1)(2008-6#2)(2008-7#3)(2009-9#2)(2010-12#1)(2010-2#1)(2010-5#2)(2011-2#1)(2012-2#2)(2013-1#1)
radiological findings and the##2##4##(2008-8#1)(2013-1#1)
radiological findings and##5##3##(1997-3#1)(2008-8#1)(2009-10#1)(2012-3#1)(2013-1#1)
radiological findings in##2##3##(1993-10#1)(2012-12#1)
radiological findings is##2##3##(2009-5#1)(2012-2#1)
radiological findings were##3##3##(1991-3#1)(1993-10#1)(2012-2#1)
radiological findings##34##2##(1991-3#1)(1993-10#2)(1993-8#1)(1997-1#1)(1997-3#1)(2005-12#1)(2006-12#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-4#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-4#1)(2011-2#2)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#1)
radiological follow up##2##3##(1993-10#1)(2010-11#1)
radiological follow-up##3##2##(1997-3#1)(2006-4#1)(2008-7#1)
radiological image##2##2##(2007-11#1)(2007-7#1)
radiological images of##3##3##(1993-10#1)(2007-11#2)
radiological images##5##2##(1993-10#1)(2007-11#2)(2012-2#2)
radiological imaging##10##2##(2006-8#1)(2007-11#1)(2007-8#2)(2008-2#1)(2008-3#1)(2008-6#1)(2012-2#3)
radiological improvement##2##2##(2008-6#1)(2010-7#1)
radiological information##2##2##(2006-12#1)(2013-8#1)
radiological intervention##2##2##(1991-5#1)(2008-7#1)
radiological investigation##2##2##(1990-12#1)(1991-12#1)
radiological investigations##4##2##(1990-12#1)(1991-11#1)(2012-2#1)(2012-3#1)
radiological lesions##2##2##(1992-5#1)(2007-8#1)
radiological literature##2##2##(1997-8#1)(2006-4#1)
radiological methods (CT##2##3##(2007-11#1)(2011-2#1)
radiological methods##7##2##(1990-5#1)(1995-8#1)(1997-1#1)(2007-10#1)(2007-11#1)(2011-2#1)(2012-2#1)
radiological observations using##4##3##(2013-1#4)
radiological observations##6##2##(2013-1#6)
radiological or##2##2##(1990-3#1)(2008-1#1)
radiological outcomes##2##2##(2007-7#2)
radiological parameters##3##2##(2010-3#1)(2011-2#2)
radiological pattern##3##2##(2005-8#1)(2006-12#1)(2008-4#1)
radiological patterns of##2##3##(2005-8#1)(2006-9#1)
radiological patterns##3##2##(2005-8#1)(2006-9#1)(2010-12#1)
radiological physics and technology##3##4##(2010-9#3)
radiological picture has##2##3##(1994-6#1)(2007-11#1)
radiological picture##5##2##(1994-6#1)(2007-11#3)(2008-5#1)
radiological presentation##3##2##(1997-8#1)(2006-5#1)(2012-12#1)
radiological procedures##5##2##(2006-10#1)(2007-11#1)(2008-1#1)(2008-7#1)(2012-2#1)
radiological progression##2##2##(2007-11#1)(2008-5#1)
radiological protection##2##2##(1996-6#1)(2009-12#1)
radiological report##2##2##(2012-2#1)(2013-8#1)
radiological reports##2##2##(2006-6#1)(2011-2#1)
radiological resolution##2##2##(2008-7#1)(2010-11#1)
radiological results##4##2##(1993-10#1)(2007-11#1)(2007-8#2)
radiological risk factors##2##3##(2007-7#1)(2007-8#1)
radiological signs in##2##3##(1992-5#1)(2007-11#1)
radiological signs of##7##3##(1991-9#1)(1993-10#1)(2006-7#1)(2006-9#1)(2007-7#1)(2008-6#1)(2011-2#1)
radiological signs##13##2##(1991-9#1)(1992-5#2)(1993-10#1)(1993-5#1)(1997-3#1)(2005-12#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-6#1)(2011-2#1)
radiological studies##6##2##(2006-10#1)(2006-8#2)(2006-9#1)(2007-7#1)(2010-12#1)
radiological study##3##2##(1990-6#1)(1992-5#1)(2008-11#1)
radiological symptoms##2##2##(1991-11#1)(2007-11#1)
radiological techniques to##2##3##(2007-7#1)(2007-8#1)
radiological techniques##3##2##(2007-7#1)(2007-8#1)(2008-7#1)
radiological technologists##4##2##(2006-8#1)(2007-4#3)
radiological temporal bone##2##3##(2008-9#2)
radiological tests were##2##3##(2005-9#1)(2010-9#1)
radiological##415##1##(1990-11#2)(1990-12#3)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-11#7)(1991-12#2)(1991-3#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#2)(1992-12#2)(1992-4#2)(1992-5#5)(1992-9#1)(1993-1#1)(1993-10#8)(1993-3#2)(1993-5#3)(1993-8#3)(1994-6#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-11#1)(1996-6#2)(1996-8#2)(1997-1#2)(1997-2#1)(1997-3#4)(1997-4#1)(1997-8#2)(2004-2#3)(2005-11#2)(2005-12#2)(2005-8#6)(2005-9#1)(2006-1#1)(2006-10#5)(2006-12#6)(2006-2#1)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#8)(2006-9#3)(2007-10#2)(2007-11#30)(2007-12#2)(2007-3#3)(2007-4#9)(2007-6#2)(2007-7#26)(2007-8#26)(2007-9#3)(2008-1#5)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#6)(2008-5#3)(2008-6#10)(2008-7#17)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#4)(2009-4#2)(2009-5#3)(2009-6#2)(2009-8#2)(2009-9#4)(2010-10#1)(2010-11#4)(2010-12#6)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#7)(2010-7#1)(2010-9#4)(2011-1#3)(2011-2#14)(2012-11#2)(2012-12#12)(2012-2#26)(2012-3#6)(2013-1#22)(2013-8#6)
radiological-pathological correlation##2##2##(2012-2#2)
radiologically and histologically##3##3##(2005-8#1)(2010-3#1)(2010-9#1)
radiologically and##8##2##(1992-3#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2010-3#1)(2010-9#1)
radiologically confirmed##6##2##(2006-12#1)(2006-5#2)(2007-8#1)(2008-7#1)(2008-8#1)
radiologically evident##2##2##(2008-6#1)(2008-7#1)
radiologically guided fine-needle aspiration biopsy##2##5##(2008-6#2)
radiologically in##2##2##(2007-7#2)
radiologically##51##1##(1992-3#1)(1993-5#2)(2004-2#1)(2005-5#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-5#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#5)(2007-8#8)(2007-9#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#5)(2008-7#3)(2008-8#1)(2010-11#1)(2010-3#2)(2010-9#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
radiologist and##8##2##(1991-3#1)(1994-4#1)(2007-4#1)(2008-7#1)(2010-8#1)(2010-9#1)(2012-1#1)(2013-1#1)
radiologist assistant##5##2##(2007-4#5)
radiologist assistants##3##2##(2007-4#3)
radiologist can help##2##3##(2008-1#1)(2011-12#1)
radiologist expert##2##2##(2007-4#2)
radiologist extenders##7##2##(2007-4#7)
radiologist is##2##2##(2007-4#1)(2008-1#1)
radiologist to##6##2##(2007-4#1)(2010-4#1)(2011-2#1)(2012-2#3)
radiologist##67##1##(1991-3#1)(1993-3#2)(1994-4#1)(1995-3#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-4#27)(2008-1#2)(2008-3#1)(2008-4#2)(2008-7#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-4#2)(2010-8#3)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#7)(2013-1#5)
radiologist's##6##1##(2007-4#1)(2007-7#1)(2008-7#1)(2008-8#1)(2010-9#1)(2012-2#1)
radiologists and radiation oncologists##3##4##(2007-4#3)
radiologists and radiological technologists##2##4##(2007-4#2)
radiologists and the##2##3##(2007-4#1)(2012-2#1)
radiologists and##25##2##(1990-10#1)(1992-1#1)(1993-1#1)(1993-8#1)(1995-3#1)(1996-3#1)(2007-4#14)(2008-1#1)(2008-6#1)(2008-7#1)(2012-12#1)(2012-2#1)
radiologists are more##2##3##(2007-4#2)
radiologists are##7##2##(2007-4#6)(2012-2#1)
radiologists can##2##2##(2007-4#2)
radiologists for##2##2##(1997-8#1)(2007-11#1)
radiologists have##2##2##(2007-4#2)
radiologists in their##2##3##(1993-3#1)(2007-4#1)
radiologists in##8##2##(1993-3#1)(2007-4#7)
radiologists is##4##2##(1990-12#1)(2007-11#1)(2007-4#2)
radiologists must##2##2##(2007-4#2)
radiologists need to##5##3##(2007-4#4)(2008-2#1)
radiologists should##2##2##(2007-4#1)(2008-12#1)
radiologists to##12##2##(2004-9#2)(2007-4#9)(2012-2#1)
radiologists was##3##2##(2007-8#1)(2012-2#2)
radiologists who##4##2##(2007-4#4)
radiologists with##4##2##(2007-4#2)(2013-1#2)
radiologists##159##1##(1990-10#1)(1990-12#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-3#2)(1993-8#1)(1993-9#1)(1995-12#1)(1995-3#1)(1996-2#3)(1996-3#1)(1997-8#3)(2004-9#3)(2007-11#2)(2007-4#95)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#3)(2010-12#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#14)(2012-3#1)(2013-1#4)
radiologists'##3##1##(1992-3#1)(2007-4#2)
radiology administrators##11##2##(1991-12#1)(1993-1#1)(1994-1#3)(1995-12#3)(1996-2#3)
radiology administrators' salaries and##2##4##(1991-2#1)(1991-3#1)
radiology and the##2##3##(2007-4#2)
radiology and##22##2##(1990-5#1)(1991-12#1)(1993-9#1)(1995-3#2)(2004-9#1)(2006-10#1)(2006-6#1)(2007-4#8)(2007-8#1)(2008-6#2)(2009-4#1)(2009-9#1)(2013-1#1)
radiology as a career##2##4##(2007-4#1)(2012-2#1)
radiology as a##4##3##(2007-4#2)(2012-2#2)
radiology as##7##2##(2007-4#4)(2012-2#3)
radiology can##2##2##(2005-11#1)(2008-1#1)
radiology community##2##2##(2007-4#2)
radiology department and##3##3##(1995-2#1)(2004-9#1)(2007-4#1)
radiology department has##2##3##(1993-12#1)(1996-1#1)
radiology department is##2##3##(1993-3#1)(1996-3#1)
radiology department##29##2##(1991-12#1)(1991-2#1)(1993-12#1)(1993-3#2)(1994-3#1)(1995-1#1)(1995-2#2)(1996-1#3)(1996-2#1)(1996-3#1)(1997-8#1)(2004-9#4)(2006-10#1)(2007-4#3)(2008-3#1)(2009-6#1)(2009-9#1)(2012-2#3)
radiology departments and##2##3##(1992-3#1)(2007-4#1)
radiology departments##31##2##(1990-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1996-1#1)(1996-2#1)(2004-9#1)(2007-4#18)(2012-2#2)
radiology educators##2##2##(2007-4#2)
radiology equipment insurance program##2##4##(1993-12#2)
radiology equipment##3##2##(1993-12#2)(1996-3#1)
radiology examinations##2##2##(2008-3#1)(2012-12#1)
radiology fellowship match##2##3##(2007-4#2)
radiology fellowship##3##2##(2007-4#3)
radiology film##2##2##(1996-3#1)(2008-10#1)
radiology group and##2##3##(2007-4#2)
radiology groups and their##2##4##(2007-4#2)
radiology groups##7##2##(2007-4#7)
radiology has##3##2##(2007-4#2)(2009-9#1)
radiology imaging##2##2##(1993-1#1)(2010-8#1)
radiology in the management of##4##5##(2007-7#1)(2008-1#1)(2009-9#1)(2010-12#1)
radiology in the##9##3##(1993-10#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-1#2)(2009-9#1)(2010-12#1)(2012-2#1)
radiology in##16##2##(1993-10#1)(1995-3#1)(2007-11#1)(2007-3#1)(2007-6#1)(2007-7#1)(2008-1#3)(2009-9#4)(2010-12#1)(2012-2#2)
radiology information system##8##3##(1991-1#1)(1992-12#2)(1994-2#1)(1996-3#1)(2004-9#2)(2007-4#1)
radiology information systems##2##3##(1993-1#1)(1994-2#1)
radiology information##11##2##(1991-1#1)(1992-12#2)(1992-2#1)(1993-1#1)(1994-2#2)(1996-3#1)(2004-9#2)(2007-4#1)
radiology is gaining##2##3##(2007-4#2)
radiology is##7##2##(1997-8#1)(2007-4#4)(2008-1#1)(2011-2#1)
radiology labor market##2##3##(2007-4#2)
radiology leaders##2##2##(2007-4#2)
radiology management##2##2##(1992-12#1)(1993-2#1)
radiology managers can##2##3##(1991-12#1)(1993-2#1)
radiology managers must##2##3##(1993-2#1)(1995-1#1)
radiology managers##11##2##(1990-12#1)(1991-1#1)(1991-12#1)(1993-2#3)(1993-3#1)(1994-1#1)(1994-2#1)(1995-1#2)
radiology nurses##2##2##(1995-2#1)(1995-3#1)
radiology practice##10##2##(1995-1#1)(1996-1#1)(2007-4#6)(2009-9#2)
radiology practices to##2##3##(1993-3#2)
radiology practices##11##2##(1993-3#6)(2007-4#5)
radiology reporting##6##2##(2007-4#4)(2013-1#2)
radiology reports##9##2##(2007-7#1)(2012-2#4)(2013-1#4)
radiology research##3##2##(2007-4#3)
radiology residency##2##2##(2007-4#2)
radiology residents##3##2##(2007-4#3)
radiology service##4##2##(1993-1#1)(2007-4#2)(2012-2#1)
radiology services##5##2##(1991-12#1)(1993-1#1)(2007-4#2)(2012-2#1)
radiology staff##4##2##(1995-2#2)(1995-3#2)
radiology studies##2##2##(2007-4#2)
radiology teaching##4##2##(2012-2#4)
radiology to##2##2##(2008-7#1)(2012-1#1)
radiology will##2##2##(2007-4#2)
radiology workforce##5##2##(2007-4#5)
radiology##455##1##(1990-12#4)(1990-5#1)(1991-1#6)(1991-12#8)(1991-2#3)(1991-3#1)(1992-1#2)(1992-12#6)(1992-2#2)(1992-3#3)(1993-1#7)(1993-10#2)(1993-12#5)(1993-2#6)(1993-3#14)(1993-9#1)(1994-1#8)(1994-12#4)(1994-2#4)(1994-3#1)(1995-1#7)(1995-12#3)(1995-2#9)(1995-3#10)(1996-1#6)(1996-2#12)(1996-3#6)(1997-8#4)(2004-9#11)(2005-11#1)(2006-10#5)(2006-5#1)(2006-6#1)(2007-11#2)(2007-3#1)(2007-4#185)(2007-6#2)(2007-7#5)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#1)(2008-3#3)(2008-6#4)(2008-7#3)(2008-8#1)(2009-2#1)(2009-4#2)(2009-6#2)(2009-7#1)(2009-9#14)(2010-12#2)(2010-8#3)(2010-9#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#31)(2013-1#8)(2013-8#2)
radiology?##6##1##(2007-4#5)(2010-12#1)
radiology]##3##1##(1995-11#1)(1995-2#1)(1997-2#1)
radiolucency##5##1##(1991-12#1)(1993-9#1)(2008-12#2)(2013-1#1)
radiolucent##11##1##(1993-9#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-5#1)(2009-3#1)(2010-5#2)(2011-2#1)(2012-2#1)(2013-1#1)
radiolysis products##3##2##(2010-5#3)
radiolysis##22##1##(1990-2#2)(1997-1#2)(2005-4#3)(2006-10#4)(2008-10#1)(2008-4#1)(2008-9#3)(2010-5#6)
radiolytic##4##1##(1995-3#1)(2008-8#1)(2010-5#2)
radiometer and##2##2##(2008-10#1)(2008-2#1)
radiometer for##5##2##(1992-6#1)(2008-3#4)
radiometer is##3##2##(2007-11#1)(2008-2#2)
radiometer with##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
radiometer##45##1##(1992-6#1)(1995-6#1)(2007-11#4)(2007-9#1)(2008-10#1)(2008-2#11)(2008-3#25)(2012-11#1)
radiometers##19##1##(2007-11#1)(2008-2#10)(2008-3#8)
radiometric BACTEC 460 TB##2##4##(2007-7#2)
radiometric BACTEC##3##2##(2007-7#3)
radiometric accuracy##3##2##(2008-2#1)(2008-3#2)
radiometric analysis##2##2##(2007-11#1)(2008-3#1)
radiometric and##2##2##(2008-2#1)(2008-3#1)
radiometric calibration method##2##3##(2008-2#2)
radiometric calibration of the##4##4##(2008-2#2)(2008-3#2)
radiometric calibration that##2##3##(2008-3#2)
radiometric calibration##12##2##(2008-2#8)(2008-3#4)
radiometric error##2##2##(2008-2#1)(2008-3#1)
radiometric force##2##2##(2008-2#2)
radiometric measurements of##2##3##(2008-2#1)(2008-3#1)
radiometric measurements##6##2##(2008-2#3)(2008-3#3)
radiometric method##4##2##(2008-10#3)(2008-2#1)
radiometric sensitivity##3##2##(2008-3#3)
radiometric stability of##2##3##(2008-2#1)(2008-3#1)
radiometric stability##4##2##(2008-2#2)(2008-3#2)
radiometric##61##1##(1991-9#1)(1996-3#1)(2007-11#1)(2007-7#3)(2008-10#3)(2008-2#26)(2008-3#26)
radiometrically##2##1##(2008-2#1)(2008-3#1)
radiometry for##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
radiometry is##2##2##(2008-2#2)
radiometry##16##1##(1990-3#1)(2007-11#2)(2008-10#3)(2008-2#7)(2008-3#2)(2012-1#1)
radionecrosis of rectum##2##3##(2008-12#2)
radionecrosis##8##1##(1991-5#1)(2008-12#2)(2011-1#5)
radionuclide and##3##2##(1997-7#1)(2007-10#1)(2008-12#1)
radionuclide imaging is##2##3##(2008-5#1)(2008-7#1)
radionuclide imaging##7##2##(2007-11#3)(2008-5#2)(2008-7#2)
radionuclide technique##2##2##(2007-8#1)(2008-7#1)
radionuclide therapy##3##2##(2007-11#2)(2010-3#1)
radionuclide treatment##2##2##(2007-11#1)(2008-7#1)
radionuclide ventriculography##3##2##(1991-2#1)(1996-4#1)(1997-1#1)
radionuclide##55##1##(1991-2#1)(1992-5#1)(1993-12#1)(1993-9#1)(1994-1#1)(1994-6#2)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#3)(1997-7#1)(2006-6#1)(2007-10#1)(2007-11#10)(2007-5#1)(2007-8#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#9)(2008-8#1)(2009-10#1)(2010-2#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-11#2)(2012-2#1)(2013-1#2)(2013-7#1)
radionuclides from##2##2##(1994-9#1)(1996-8#1)
radionuclides in##2##2##(2006-6#1)(2012-2#1)
radionuclides of##2##2##(1994-6#1)(2008-10#1)
radionuclides##22##1##(1992-4#1)(1993-8#1)(1994-6#2)(1994-9#2)(1995-12#2)(1996-2#1)(1996-8#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2010-6#1)(2012-2#2)
radiopacifier##2##1##(2013-1#2)
radiopacifying##3##1##(2004-9#2)(2013-1#1)
radiopacities##2##1##(1991-6#1)(2012-12#1)
radiopacity##2##1##(2010-4#1)(2011-2#1)
radiopaque##6##1##(2008-12#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#2)
radiopharmaceutical for##3##2##(1993-4#1)(1994-9#1)(2010-10#1)
radiopharmaceutical##11##1##(1993-4#1)(1994-9#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-10#1)
radiopharmaceuticals for##4##2##(1994-5#1)(2010-2#1)(2010-6#1)(2012-12#1)
radiopharmaceuticals##16##1##(1994-5#1)(2006-6#2)(2007-11#2)(2008-10#1)(2008-2#2)(2010-2#1)(2010-6#1)(2012-12#3)(2013-1#3)
radioprotectant##3##1##(2008-5#3)
radioprotected##2##1##(1996-12#2)
radioprotection was##2##2##(2008-10#2)
radioprotection##7##1##(2007-11#3)(2008-10#2)(2008-5#1)(2008-7#1)
radioprotective activity of##2##3##(2008-5#2)
radioprotective activity##3##2##(2008-5#3)
radioprotective agent##5##2##(1994-5#2)(2011-2#3)
radioprotective##13##1##(1990-10#1)(1994-5#2)(2008-10#1)(2008-5#3)(2008-7#2)(2011-2#4)
radioprotector##2##1##(2004-1#1)(2008-10#1)
radioprotectors##2##1##(2011-2#1)(2013-8#1)
radioreceptor assay##9##2##(1990-11#1)(1991-7#1)(1993-11#1)(1995-5#2)(1995-8#1)(2008-4#3)
radioreceptor##11##1##(1990-11#1)(1991-3#1)(1991-7#1)(1993-11#1)(1995-5#2)(1995-8#1)(1996-11#1)(2008-4#3)
radiorecovery##2##1##(2008-5#2)
radioresistance in##2##2##(1994-7#1)(2013-1#1)
radioresistance##4##1##(1991-7#1)(1994-7#1)(2008-5#1)(2013-1#1)
radioresistant##4##1##(1993-9#1)(2010-4#1)(2012-2#1)(2013-1#1)
radiosensitive and##3##2##(1993-9#1)(1994-6#1)(2013-1#1)
radiosensitive##13##1##(1990-12#1)(1993-8#1)(1993-9#1)(1994-6#1)(1995-3#1)(1997-1#2)(1997-3#2)(2012-2#1)(2013-1#3)
radiosensitivity of##4##2##(1991-12#1)(2008-5#3)
radiosensitivity##11##1##(1991-12#1)(1993-4#1)(1993-9#1)(1997-1#2)(2008-5#3)(2008-9#1)(2011-1#1)(2013-1#1)
radiosensitization and##2##2##(2007-11#1)(2011-2#1)
radiosensitization in##2##2##(1994-4#1)(2008-6#1)
radiosensitization##8##1##(1994-4#1)(1995-8#1)(2007-11#3)(2008-6#1)(2010-3#1)(2011-2#1)
radiosensitizer in##2##2##(1991-2#1)(2013-1#1)
radiosensitizer##7##1##(1990-6#1)(1991-2#1)(1995-6#2)(2005-4#1)(2008-9#1)(2013-1#1)
radiosensitizers##2##1##(1994-4#1)(2008-10#1)
radiosensitizing##7##1##(1995-6#1)(1997-2#1)(2007-11#4)(2008-6#1)
radiosonde measurements##2##2##(2008-3#2)
radiosonde sensor response##2##3##(2008-3#2)
radiosonde##4##1##(2008-3#4)
radiosondes##3##1##(2008-2#2)(2008-3#1)
radiosurgery after##2##2##(1996-3#2)
radiosurgery and##5##2##(2006-2#1)(2006-6#1)(2009-5#2)(2011-2#1)
radiosurgery as##5##2##(1995-9#1)(2005-5#1)(2006-11#1)(2006-2#1)(2010-9#1)
radiosurgery for##9##2##(1995-4#1)(1997-4#1)(2006-12#1)(2006-7#1)(2007-12#2)(2008-7#1)(2011-2#2)
radiosurgery in patients with##2##4##(2006-12#1)(2006-7#1)
radiosurgery in##5##2##(1995-4#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#1)
radiosurgery on##2##2##(2008-7#1)(2011-2#1)
radiosurgery or##2##2##(2008-7#2)
radiosurgery was##3##2##(1996-3#2)(2009-5#1)
radiosurgery##85##1##(1993-4#1)(1993-9#3)(1994-3#1)(1994-9#1)(1995-12#1)(1995-4#3)(1995-8#1)(1995-9#1)(1996-3#5)(1997-4#3)(2004-1#3)(2005-5#4)(2006-11#7)(2006-12#2)(2006-2#5)(2006-6#1)(2006-7#4)(2007-12#3)(2007-9#1)(2008-7#18)(2009-5#4)(2010-9#1)(2011-2#9)(2012-2#1)(2013-7#1)(2013-8#1)
radiosurgical treatment##4##2##(1996-3#2)(2007-12#1)(2008-7#1)
radiosurgical##8##1##(1996-3#3)(2005-5#1)(2007-12#3)(2008-7#1)
radiotelemetry##2##1##(2008-8#1)(2009-4#1)
radiotherapeutic care##2##2##(1996-12#2)
radiotherapeutic treatment##3##2##(1991-2#1)(2007-12#1)(2008-6#1)
radiotherapeutic##11##1##(1991-2#1)(1992-10#1)(1993-9#3)(1994-7#1)(1996-12#2)(2006-10#1)(2007-12#1)(2008-6#1)
radiotherapists##2##1##(2008-10#1)(2008-6#1)
radiotherapy (IMRT)##6##2##(2008-2#2)(2009-10#1)(2009-5#2)(2011-2#1)
radiotherapy (RT)##5##2##(1995-5#1)(2007-10#1)(2008-6#1)(2010-3#1)(2013-1#1)
radiotherapy after##3##2##(1992-10#1)(2008-10#1)(2008-6#1)
radiotherapy alone in##3##3##(1990-6#1)(1992-4#1)(1993-5#1)
radiotherapy alone or##4##3##(2007-11#2)(2008-6#1)(2012-3#1)
radiotherapy alone##18##2##(1990-6#2)(1992-4#1)(1993-5#1)(1995-9#1)(1997-6#2)(2006-2#2)(2006-8#1)(2007-11#2)(2007-2#1)(2008-6#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-3#1)
radiotherapy and chemotherapy in the treatment of##2##7##(1993-9#1)(2013-1#1)
radiotherapy and chemotherapy in##4##4##(1993-9#1)(2012-1#1)(2013-1#1)(2013-7#1)
radiotherapy and chemotherapy##24##3##(1990-10#1)(1990-8#1)(1992-10#1)(1993-9#1)(1997-6#2)(2006-2#1)(2006-4#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
radiotherapy and concomitant##3##3##(2007-11#1)(2008-6#2)
radiotherapy and one##2##3##(1993-10#1)(2006-12#1)
radiotherapy and surgery##3##3##(1995-11#1)(2006-2#2)
radiotherapy and systemic##2##3##(1991-8#1)(2007-11#1)
radiotherapy and the##4##3##(1995-8#1)(2008-7#2)(2011-2#1)
radiotherapy and##82##2##(1990-10#1)(1990-6#1)(1990-8#1)(1991-8#1)(1992-10#3)(1992-12#1)(1992-8#1)(1993-10#2)(1993-5#1)(1993-9#2)(1994-3#1)(1995-11#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-2#1)(1997-6#2)(1997-7#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#4)(2006-4#1)(2006-5#2)(2006-9#1)(2007-11#6)(2007-2#1)(2007-3#1)(2007-4#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#6)(2008-7#4)(2008-8#2)(2009-10#1)(2009-11#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
radiotherapy and/or chemotherapy##3##3##(1990-5#1)(1992-12#1)(2012-3#1)
radiotherapy are##8##2##(1990-2#1)(1990-6#1)(2006-2#1)(2006-9#1)(2008-6#1)(2010-8#1)(2011-2#1)(2013-1#1)
radiotherapy as the##3##3##(1991-9#1)(1994-4#1)(1997-6#1)
radiotherapy as##6##2##(1991-9#1)(1994-4#1)(1996-6#1)(1997-6#1)(2006-10#1)(2012-2#1)
radiotherapy at a##2##3##(2008-10#1)(2010-7#1)
radiotherapy at##4##2##(2007-11#1)(2008-10#1)(2010-7#1)(2012-12#1)
radiotherapy but##2##2##(2011-3#1)(2012-1#1)
radiotherapy by##6##2##(2007-6#1)(2008-6#2)(2008-7#1)(2012-12#2)
radiotherapy can##3##2##(1991-4#1)(1992-3#1)(2007-11#1)
radiotherapy combined with##3##3##(2004-1#1)(2008-6#1)(2010-8#1)
radiotherapy compared##2##2##(1996-9#1)(2013-8#1)
radiotherapy delivery##2##2##(2006-8#1)(2008-2#1)
radiotherapy did not##3##3##(1992-10#1)(1996-12#1)(2008-6#1)
radiotherapy dose##5##2##(2007-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-1#1)
radiotherapy following##2##2##(2008-6#2)
radiotherapy for bone metastases##2##4##(2007-11#1)(2008-10#1)
radiotherapy for breast##2##3##(2007-10#1)(2011-3#1)
radiotherapy for cancer##2##3##(2007-10#1)(2010-9#1)
radiotherapy for carcinoma of the##2##5##(1992-3#1)(1995-4#1)
radiotherapy for carcinoma of##3##4##(1992-3#1)(1995-4#1)(2007-7#1)
radiotherapy for local control of##2##5##(2012-2#2)
radiotherapy for prevention of##2##4##(1994-8#1)(2007-11#1)
radiotherapy for the##5##3##(1996-9#1)(1997-3#1)(2006-9#1)(2008-2#1)(2011-12#1)
radiotherapy for##47##2##(1992-10#1)(1992-12#1)(1992-3#1)(1993-2#1)(1994-4#1)(1994-7#1)(1994-8#1)(1995-4#2)(1995-8#1)(1995-9#3)(1996-9#1)(1997-3#2)(2004-1#1)(2005-1#1)(2006-6#1)(2006-9#1)(2007-10#2)(2007-11#3)(2007-7#1)(2008-10#1)(2008-2#1)(2008-6#3)(2009-3#1)(2010-3#1)(2010-9#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#4)(2013-1#4)(2013-8#1)
radiotherapy had##3##2##(1990-6#1)(1996-9#1)(2008-11#1)
radiotherapy has been##2##3##(2006-6#1)(2011-2#1)
radiotherapy has##3##2##(2006-10#1)(2006-6#1)(2011-2#1)
radiotherapy in a##2##3##(2008-6#1)(2012-2#1)
radiotherapy in advanced##2##3##(2007-11#2)
radiotherapy in breast cancer patients##2##5##(1993-4#1)(2007-4#1)
radiotherapy in the management of##4##5##(1991-4#1)(1993-9#1)(1995-9#1)(2007-10#1)
radiotherapy in the treatment of patients with##2##7##(1995-9#1)(1997-6#1)
radiotherapy in the treatment of##11##5##(1990-6#1)(1994-8#1)(1995-9#1)(1997-6#1)(2006-2#1)(2007-4#2)(2008-3#1)(2011-2#1)(2012-2#2)
radiotherapy in the##19##3##(1990-6#1)(1991-4#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-8#2)(1995-9#2)(1997-6#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-4#2)(2008-3#1)(2011-2#1)(2012-2#2)
radiotherapy in##66##2##(1990-10#2)(1990-6#2)(1991-4#1)(1992-10#1)(1992-4#1)(1993-2#1)(1993-4#2)(1993-8#2)(1993-9#2)(1994-4#1)(1994-8#4)(1995-4#1)(1995-9#3)(1996-12#1)(1997-3#1)(1997-6#2)(2005-11#1)(2006-2#1)(2006-6#3)(2007-10#2)(2007-11#6)(2007-4#3)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-6#3)(2008-7#2)(2009-11#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
radiotherapy interventions##2##2##(2004-1#2)
radiotherapy into##2##2##(1995-9#1)(2010-12#1)
radiotherapy is a##2##3##(1991-12#1)(2007-11#1)
radiotherapy is an##2##3##(2006-12#1)(2011-2#1)
radiotherapy is effective##2##3##(2007-11#1)(2013-1#1)
radiotherapy is the##2##3##(2006-9#1)(2008-6#1)
radiotherapy is##21##2##(1990-12#1)(1991-12#1)(1997-6#2)(2006-12#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-2#1)(2008-2#1)(2008-6#3)(2009-1#1)(2009-3#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
radiotherapy of brain##2##3##(1990-9#1)(2008-7#1)
radiotherapy of head and neck cancer##2##6##(1992-10#1)(2008-5#1)
radiotherapy of head and neck##3##5##(1992-10#2)(2008-5#1)
radiotherapy of locally##2##3##(1995-8#1)(2006-7#1)
radiotherapy of prostate##2##3##(2012-12#2)
radiotherapy of the pelvis##2##4##(1992-12#2)
radiotherapy of the##5##3##(1992-12#2)(2006-10#1)(2011-1#1)(2013-1#1)
radiotherapy of##29##2##(1990-10#2)(1990-9#1)(1992-10#3)(1992-12#2)(1994-4#1)(1995-8#1)(1995-9#1)(2004-9#1)(2006-10#1)(2006-12#1)(2006-7#2)(2007-11#2)(2008-5#1)(2008-7#4)(2009-11#1)(2011-1#1)(2012-12#3)(2013-1#1)
radiotherapy on##4##2##(1994-7#1)(1995-8#1)(2007-6#1)(2007-8#1)
radiotherapy only##3##2##(2007-11#1)(2008-6#2)
radiotherapy or chemotherapy in##2##4##(1990-5#1)(2012-2#1)
radiotherapy or chemotherapy##4##3##(1990-5#1)(2006-10#1)(2008-7#1)(2012-2#1)
radiotherapy or##11##2##(1990-5#1)(1993-11#1)(2004-1#1)(2006-1#1)(2006-10#1)(2006-11#1)(2008-1#1)(2008-7#1)(2012-2#2)(2013-1#1)
radiotherapy physicists##2##2##(2007-4#2)
radiotherapy planning##9##2##(1994-7#2)(2008-2#4)(2008-6#1)(2008-7#1)(2009-5#1)
radiotherapy plus##3##2##(1991-2#1)(2011-2#1)(2013-8#1)
radiotherapy provides##2##2##(2006-8#1)(2008-6#1)
radiotherapy seems to be##2##4##(2006-6#1)(2007-10#1)
radiotherapy seems to##3##3##(1992-12#1)(2006-6#1)(2007-10#1)
radiotherapy should be##6##3##(1997-3#1)(2006-12#1)(2007-10#1)(2007-6#1)(2007-8#1)(2010-12#1)
radiotherapy to the hand##2##4##(2008-6#2)
radiotherapy to the##9##3##(2006-12#1)(2007-11#2)(2007-6#2)(2008-6#4)
radiotherapy to##17##2##(1993-2#1)(1995-4#1)(2006-12#1)(2007-11#3)(2007-6#2)(2008-10#1)(2008-12#1)(2008-6#6)(2010-12#1)
radiotherapy treatment for##2##3##(2008-11#1)(2008-7#1)
radiotherapy treatment##5##2##(2008-11#1)(2008-2#1)(2008-7#1)(2010-8#1)(2013-1#1)
radiotherapy treatments##3##2##(2007-11#1)(2009-5#1)(2009-8#1)
radiotherapy unit##2##2##(2007-4#2)
radiotherapy using##2##2##(2008-3#1)(2008-6#1)
radiotherapy versus##2##2##(1991-4#1)(2006-6#1)
radiotherapy was carried out##2##4##(1990-6#1)(1993-5#1)
radiotherapy was given##2##3##(1991-8#1)(2007-5#1)
radiotherapy was##15##2##(1990-6#1)(1991-4#1)(1991-8#1)(1992-8#1)(1993-5#2)(2006-2#1)(2007-1#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-6#2)(2012-1#1)(2012-2#1)
radiotherapy were##6##2##(1990-12#2)(1992-2#1)(1992-8#1)(2010-3#1)(2011-2#1)
radiotherapy with##10##2##(1990-12#1)(1992-10#1)(1993-5#1)(2007-12#1)(2007-4#2)(2009-11#2)(2011-2#1)(2013-1#1)
radiotherapy##750##1##(1990-10#6)(1990-12#4)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#3)(1990-6#9)(1990-8#3)(1990-9#2)(1991-10#1)(1991-12#1)(1991-2#2)(1991-4#7)(1991-5#2)(1991-8#4)(1991-9#4)(1992-1#1)(1992-10#17)(1992-11#1)(1992-12#10)(1992-2#1)(1992-3#4)(1992-4#5)(1992-8#5)(1993-10#2)(1993-11#2)(1993-12#1)(1993-2#4)(1993-4#3)(1993-5#5)(1993-6#2)(1993-8#4)(1993-9#7)(1994-2#1)(1994-3#3)(1994-4#10)(1994-7#6)(1994-8#6)(1994-9#1)(1995-11#1)(1995-4#4)(1995-5#1)(1995-8#4)(1995-9#14)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-6#2)(1996-9#5)(1997-3#4)(1997-4#1)(1997-5#3)(1997-6#12)(1997-7#1)(2004-1#13)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#4)(2005-5#1)(2006-1#2)(2006-10#15)(2006-11#2)(2006-12#11)(2006-2#11)(2006-4#1)(2006-5#2)(2006-6#9)(2006-7#6)(2006-8#7)(2006-9#8)(2007-1#1)(2007-10#11)(2007-11#45)(2007-12#2)(2007-2#7)(2007-3#1)(2007-4#20)(2007-5#3)(2007-6#11)(2007-7#3)(2007-8#8)(2007-9#1)(2008-1#4)(2008-10#13)(2008-11#8)(2008-12#5)(2008-2#19)(2008-3#4)(2008-5#5)(2008-6#62)(2008-7#22)(2008-8#5)(2009-1#1)(2009-10#4)(2009-11#7)(2009-2#3)(2009-3#4)(2009-5#5)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#8)(2010-3#10)(2010-5#1)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#10)(2011-12#1)(2011-2#27)(2011-3#3)(2012-1#12)(2012-12#14)(2012-2#23)(2012-3#7)(2013-1#21)(2013-7#2)(2013-8#8)
radiotherapy)##2##1##(1992-10#1)(2010-3#1)
radiotherapy?##3##1##(1994-4#2)(1995-9#1)
radiothermometry##2##1##(2008-7#2)
radiotoxicity##4##1##(1991-12#4)
radiotracer##7##1##(1993-4#1)(1996-5#1)(2006-9#2)(2008-10#1)(2008-7#1)(2012-11#1)
radiotracers##14##1##(1994-9#1)(2007-11#1)(2008-10#3)(2010-2#1)(2010-6#5)(2010-9#2)(2013-1#1)
radioulnar ligaments##3##2##(2008-9#3)
radioulnar##7##1##(2006-4#1)(2008-9#4)(2011-2#1)(2012-2#1)
radish (Raphanus sativus)##2##3##(2008-10#2)
radish (Raphanus##4##2##(1990-3#1)(2008-10#2)(2008-8#1)
radish and##2##2##(2008-10#2)
radish plasmalemma##2##2##(1990-3#2)
radish##37##1##(1990-3#3)(1990-6#1)(1996-8#1)(2006-12#1)(2008-10#27)(2008-12#2)(2008-5#1)(2008-8#1)
radium##2##1##(2006-10#1)(2010-3#1)
radius and the##8##3##(1995-6#2)(2006-3#1)(2008-2#2)(2008-3#3)
radius and ulna##6##3##(1995-6#1)(2006-3#1)(2009-3#2)(2010-3#1)(2012-1#1)
radius and##26##2##(1993-8#1)(1995-6#3)(1995-8#1)(1996-5#1)(2005-11#1)(2006-3#2)(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#2)(2010-3#1)(2012-1#1)(2012-2#1)
radius approximately##2##2##(2005-11#1)(2008-3#1)
radius are##3##2##(1991-10#1)(2008-2#1)(2012-2#1)
radius capillaries##2##2##(2005-11#2)
radius deformity##2##2##(2008-9#2)
radius for##3##2##(1991-4#1)(2007-11#1)(2008-2#1)
radius fractures are##2##3##(2008-9#1)(2011-2#1)
radius fractures##23##2##(2006-3#3)(2006-4#2)(2008-12#1)(2008-9#10)(2009-4#1)(2011-2#3)(2012-2#3)
radius has##3##2##(1991-11#1)(1995-6#1)(2006-3#1)
radius in a##3##3##(1996-5#1)(2008-3#1)(2010-11#1)
radius in the##4##3##(1991-11#1)(2007-8#1)(2008-2#2)
radius in##9##2##(1991-11#1)(1996-5#1)(2006-3#1)(2007-8#1)(2008-2#2)(2008-3#1)(2008-9#1)(2010-11#1)
radius is##10##2##(2005-11#2)(2006-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-3#1)(2013-8#1)
radius of 0##2##3##(2007-12#1)(2008-3#1)
radius of a##2##3##(2007-8#1)(2008-3#1)
radius of convergence##2##3##(2008-2#2)
radius of curvature of the##3##5##(2008-3#3)
radius of curvature of##6##4##(2007-11#1)(2008-2#1)(2008-3#3)(2013-8#1)
radius of curvature##15##3##(1990-12#1)(1992-3#1)(2007-11#1)(2008-2#2)(2008-3#7)(2008-9#1)(2012-2#1)(2013-8#1)
radius of gyration of the##2##5##(1992-7#1)(2008-3#1)
radius of gyration of##4##4##(1992-7#2)(2006-5#1)(2008-3#1)
radius of gyration##14##3##(1992-7#2)(1994-9#1)(1996-11#1)(2005-11#2)(2006-12#1)(2006-5#1)(2007-7#1)(2008-2#2)(2008-3#2)(2008-9#1)
radius of the##25##3##(1990-5#1)(1990-7#1)(1991-7#1)(1992-9#1)(1994-3#1)(1994-5#1)(1995-3#1)(1997-7#1)(2005-11#5)(2006-11#1)(2008-10#2)(2008-2#6)(2008-3#1)(2009-5#1)(2013-8#1)
radius of##89##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#2)(1991-4#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-7#2)(1992-9#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1997-7#1)(2005-11#7)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-2#15)(2008-3#15)(2008-5#1)(2008-9#2)(2009-5#4)(2010-10#1)(2010-4#1)(2012-2#1)(2013-8#2)
radius on the##2##3##(2005-11#1)(2008-3#1)
radius on##3##2##(2005-11#1)(2008-10#1)(2008-3#1)
radius r##2##2##(2007-11#1)(2008-2#1)
radius the##2##2##(2006-10#1)(2008-3#1)
radius to##2##2##(2005-11#1)(2007-8#1)
radius was##3##2##(2007-3#1)(2008-3#1)(2008-5#1)
radius with##3##2##(2006-4#1)(2008-2#1)(2008-3#1)
radius##302##1##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#3)(1990-7#3)(1991-10#2)(1991-11#2)(1991-4#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-9#3)(1995-3#1)(1995-5#1)(1995-6#5)(1995-8#2)(1996-11#1)(1996-5#2)(1996-8#1)(1997-7#1)(2004-9#1)(2005-11#28)(2006-10#4)(2006-11#2)(2006-12#1)(2006-3#20)(2006-4#7)(2006-5#1)(2006-6#1)(2006-7#2)(2007-11#12)(2007-12#4)(2007-3#2)(2007-7#2)(2007-8#4)(2008-10#13)(2008-12#1)(2008-2#39)(2008-3#44)(2008-4#1)(2008-5#4)(2008-7#3)(2008-9#22)(2009-3#6)(2009-4#1)(2009-5#5)(2010-10#1)(2010-11#2)(2010-3#1)(2010-4#3)(2011-2#7)(2012-1#1)(2012-2#9)(2013-1#2)(2013-8#3)
radius)##10##1##(1991-10#1)(1997-6#1)(2006-2#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-7#1)
radix and##2##2##(2010-8#1)(2011-1#1)
radix was##2##2##(1992-2#1)(2008-10#1)
radix##21##1##(1992-2#3)(2008-10#2)(2010-8#1)(2011-1#7)(2011-2#1)(2012-3#6)(2013-8#1)
radon and##3##2##(1991-11#1)(1996-6#1)(2008-1#1)
radon concentration in northern region of Haryana varied from##2##9##(2008-1#2)
radon concentration##4##2##(2008-1#3)(2012-2#1)
radon exposure##2##2##(2008-7#2)
radon in the##2##3##(1995-2#1)(1996-3#1)
radon in##4##2##(1992-6#1)(1995-2#1)(1996-3#1)(2013-1#1)
radon levels and##2##3##(2008-7#2)
radon##44##1##(1991-11#4)(1991-3#1)(1992-6#2)(1995-2#1)(1996-3#6)(1996-4#3)(1996-6#1)(2008-1#8)(2008-11#1)(2008-7#14)(2012-2#2)(2013-1#1)
radula##3##1##(1990-2#1)(1994-8#1)(2011-2#1)
rae1 gene##2##2##(1995-3#2)
rae1##3##1##(1995-3#3)
rae1-1 cells##2##2##(1995-3#2)
rae1-1##4##1##(1995-3#4)
raf kinase##2##2##(1994-6#1)(2005-11#1)
raf##14##1##(1991-1#2)(1993-6#5)(1994-6#2)(1995-2#1)(2005-11#4)
raffinose##7##1##(1990-5#1)(1996-4#1)(1997-2#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-12#1)
raft cultures of##3##3##(2008-4#3)
raft cultures##4##2##(2008-4#4)
raft formation##4##2##(2007-12#4)
raft mussels##4##2##(2010-5#4)
raft##19##1##(1995-5#1)(2007-12#4)(2008-4#5)(2009-2#1)(2009-7#1)(2010-5#5)(2011-1#2)
rafts are##4##2##(2006-10#1)(2010-5#3)
rafts##31##1##(2005-7#1)(2006-10#4)(2006-9#1)(2007-8#1)(2008-11#5)(2008-4#3)(2008-7#3)(2009-12#3)(2009-8#2)(2010-5#5)(2011-1#2)(2011-2#1)
rag1##3##1##(2010-6#3)
rage##2##1##(1996-3#1)(2008-10#1)
ragged##3##1##(1994-11#1)(2007-7#1)(2008-10#1)
rai (Brassica juncea)##2##3##(2011-1#2)
raids##2##1##(1990-6#1)(2007-8#1)
rail coach syndrome##2##3##(2012-2#2)
rail##15##1##(2007-10#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#4)(2011-2#1)(2012-2#5)
railroad workers##6##2##(1991-12#3)(2006-6#2)(2011-1#1)
railroad##9##1##(1991-12#3)(2006-6#2)(2008-2#1)(2011-1#1)(2012-12#2)
railroads##5##1##(1991-12#5)
rails##7##1##(1997-4#7)
railway##4##1##(1990-12#1)(2007-10#1)(2009-10#2)
rain and##5##2##(2007-8#1)(2008-10#3)(2013-8#1)
rain but##2##2##(2008-10#2)
rain episodes##3##2##(2008-10#3)
rain event##2##2##(2008-10#2)
rain events##7##2##(2008-10#7)
rain forest##7##2##(2008-5#5)(2008-9#1)(2010-3#1)
rain forests##4##2##(1991-3#1)(1994-3#1)(2008-5#1)(2008-8#1)
rain intensity and##3##3##(2008-10#3)
rain intensity##8##2##(2008-10#8)
rain of##2##2##(2007-9#1)(2013-8#1)
rain or##3##2##(2008-10#3)
rain shields##2##2##(2008-10#2)
rain simulation##2##2##(2008-10#2)
rain simulator##2##2##(2008-10#2)
rain splash##3##2##(2008-10#3)
rain was##4##2##(2008-10#4)
rain water##3##2##(2008-10#2)(2008-3#1)
rain were##2##2##(2008-10#1)(2008-5#1)
rain##111##1##(1991-3#1)(1994-3#1)(1996-8#1)(2007-11#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#81)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#9)(2008-8#2)(2008-9#1)(2010-2#1)(2010-3#1)(2012-7#1)(2013-8#2)
rainbow angle##2##2##(2008-2#1)(2008-3#1)
rainbow hologram##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
rainbow holograms##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
rainbow is##2##2##(2008-2#1)(2008-3#1)
rainbow lorikeet (Trichoglossus haematodus)##3##4##(2008-5#3)
rainbow position##2##2##(2007-12#2)
rainbow refractometry##3##2##(2008-2#3)
rainbow thermometry##5##2##(2007-12#3)(2008-2#2)
rainbow trout (Oncorhynchus mykiss)##8##4##(1992-1#1)(1993-5#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-5#1)(2013-7#1)
rainbow trout (Oncorhynchus##10##3##(1992-1#1)(1993-5#1)(2008-5#1)(2008-6#1)(2008-7#4)(2009-5#1)(2013-7#1)
rainbow trout Oncorhynchus mykiss##9##4##(1992-12#1)(2010-8#6)(2012-3#2)
rainbow trout Oncorhynchus##10##3##(1992-12#1)(2010-8#7)(2012-3#2)
rainbow trout and##4##3##(1991-4#1)(1997-2#3)
rainbow trout cell##2##3##(2008-11#2)
rainbow trout liver##3##3##(1990-12#1)(1996-11#1)(1997-3#1)
rainbow trout##70##2##(1990-12#1)(1991-4#1)(1991-9#1)(1992-1#3)(1992-12#2)(1993-5#1)(1994-11#1)(1994-5#3)(1995-7#1)(1996-11#2)(1997-2#6)(1997-3#2)(1997-9#2)(2005-10#3)(2008-10#1)(2008-11#2)(2008-5#2)(2008-6#2)(2008-7#6)(2009-4#4)(2009-5#3)(2009-6#1)(2010-4#2)(2010-8#8)(2012-3#8)(2013-7#2)
rainbow##119##1##(1990-12#1)(1991-4#1)(1991-9#1)(1992-1#3)(1992-12#2)(1993-5#1)(1994-11#1)(1994-5#3)(1995-7#1)(1996-11#2)(1997-2#6)(1997-3#2)(1997-9#2)(2005-10#3)(2007-11#1)(2007-12#9)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#23)(2008-3#10)(2008-5#5)(2008-6#2)(2008-7#6)(2009-4#4)(2009-5#3)(2009-6#1)(2010-4#2)(2010-8#8)(2012-3#8)(2013-7#2)
rainbows of a##2##3##(2008-2#2)
rainbows of##3##2##(2008-2#3)
rainbows produced by##2##3##(2008-2#1)(2008-3#1)
rainbows##11##1##(2008-2#7)(2008-3#4)
raindrop##4##1##(2008-10#2)(2008-3#2)
raindrops##8##1##(2008-10#2)(2008-3#6)
rainfall amounts##2##2##(2008-10#2)
rainfall and air and water##2##5##(2013-7#2)
rainfall and##10##2##(2006-12#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-2#2)(2011-12#1)(2013-7#2)
rainfall data##2##2##(2008-1#1)(2008-10#1)
rainfall during##2##2##(2008-10#2)
rainfall environment##2##2##(2008-10#2)
rainfall events##4##2##(2008-10#3)(2010-2#1)
rainfall for infection##2##3##(2008-10#2)
rainfall for##3##2##(2008-10#3)
rainfall in##6##2##(2006-7#1)(2007-7#1)(2008-10#3)(2010-2#1)
rainfall on##3##2##(2008-8#1)(2010-2#2)
rainfall or##3##2##(2008-10#3)
rainfall seasonality##2##2##(2013-7#2)
rainfall was##2##2##(2004-11#1)(2013-7#1)
rainfall##87##1##(1991-11#1)(2004-11#1)(2004-4#1)(2006-12#1)(2006-7#2)(2007-1#2)(2007-10#1)(2007-2#1)(2007-3#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#42)(2008-5#4)(2008-8#3)(2008-9#1)(2009-10#2)(2010-2#7)(2011-12#1)(2011-2#1)(2012-9#1)(2013-7#6)(2013-8#1)
rainfall)##5##1##(2008-10#4)(2008-5#1)
rainfall-runoff##2##1##(2008-1#2)
rainforest tree##2##2##(1992-8#1)(2010-10#1)
rainforest##13##1##(1992-8#1)(2007-12#4)(2007-3#1)(2008-10#1)(2010-10#2)(2010-7#2)(2011-2#1)(2013-7#1)
raining##2##1##(2009-4#1)(2010-9#1)
rains##11##1##(2007-5#1)(2008-10#7)(2008-3#1)(2010-8#1)(2012-2#1)
rainstorms with wind##2##3##(2008-10#2)
rainstorms##3##1##(2008-10#3)
rainwater and##2##2##(2008-10#2)
rainwater collected##2##2##(2008-10#2)
rainwater samples and##3##3##(2007-8#2)(2008-10#1)
rainwater samples##8##2##(2007-8#5)(2008-10#3)
rainwater was##2##2##(2007-8#1)(2008-10#1)
rainwater##37##1##(2004-4#1)(2007-8#11)(2008-10#25)
rainy and dry season##2##4##(2012-2#1)(2013-7#1)
rainy and dry##3##3##(2012-2#1)(2013-7#2)
rainy and##6##2##(1997-6#1)(2008-3#1)(2012-2#1)(2013-7#3)
rainy days in April and May##5##6##(2008-10#5)
rainy days in##6##3##(2008-10#6)
rainy days##7##2##(2008-10#7)
rainy season##46##2##(1990-6#1)(1994-9#1)(1997-6#1)(2005-8#1)(2006-2#1)(2007-10#1)(2007-2#1)(2007-3#5)(2007-5#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#14)(2008-6#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-7#4)(2013-8#1)
rainy seasons##11##2##(2007-2#1)(2007-5#1)(2007-8#2)(2008-3#1)(2008-5#1)(2008-8#1)(2012-2#2)(2013-7#2)
rainy##77##1##(1990-6#1)(1993-3#1)(1994-9#1)(1997-6#2)(2005-8#1)(2006-2#1)(2007-10#1)(2007-2#2)(2007-3#5)(2007-5#4)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#11)(2008-3#3)(2008-5#16)(2008-6#1)(2008-8#4)(2011-12#1)(2012-12#1)(2012-2#5)(2013-7#9)(2013-8#1)
rainy)##2##1##(2007-8#1)(2008-8#1)
raise a##11##2##(1993-1#1)(1994-12#1)(1996-1#1)(1996-11#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-8#1)(2010-11#1)(2011-2#1)(2013-1#1)
raise an##4##2##(1990-2#1)(2008-6#1)(2008-8#1)(2011-2#1)
raise concern about##2##3##(2006-10#1)(2007-9#1)
raise concern##4##2##(2006-10#1)(2007-12#1)(2007-6#1)(2007-9#1)
raise concerns##3##2##(2007-12#1)(2009-12#1)(2011-1#1)
raise considerations##2##2##(2007-11#1)(2012-2#1)
raise doubts##2##2##(2008-8#1)(2009-10#1)
raise important questions##2##3##(2008-9#1)(2009-11#1)
raise important##4##2##(2006-10#1)(2008-9#1)(2009-11#1)(2009-4#1)
raise new##3##2##(2008-11#1)(2008-7#1)(2010-7#1)
raise of##2##2##(1992-3#1)(2008-2#1)
raise public awareness##2##3##(2007-8#1)(2012-1#1)
raise questions about the##5##4##(1997-1#1)(2007-5#1)(2009-8#1)(2010-11#1)(2012-2#1)
raise questions about##8##3##(1993-1#1)(1995-2#1)(1997-1#1)(2007-5#1)(2008-8#1)(2009-8#1)(2010-11#1)(2012-2#1)
raise questions##10##2##(1993-1#1)(1995-2#1)(1995-7#1)(1997-1#1)(2007-5#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-11#1)(2012-2#1)
raise specific##2##2##(1997-9#1)(2005-11#1)
raise standards##2##2##(2006-5#1)(2008-2#1)
raise the possibility of a##2##5##(1992-12#1)(1997-8#1)
raise the possibility of##6##4##(1992-12#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-8#1)
raise the possibility that the##3##5##(1992-7#1)(1994-8#1)(1995-1#1)
raise the possibility that##24##4##(1990-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1992-3#1)(1992-7#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-7#1)(1996-5#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-9#1)(2009-8#1)(2010-4#1)(2012-12#1)(2013-8#1)
raise the possibility##32##3##(1990-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-7#1)(1996-5#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-4#1)(2012-12#1)(2013-8#1)
raise the question of whether##2##5##(2009-11#1)(2009-7#1)
raise the question of##5##4##(1995-12#1)(2007-11#1)(2008-8#1)(2009-11#1)(2009-7#1)
raise the question##8##3##(1995-12#2)(2007-11#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-7#1)(2011-2#1)
raise the risk##2##3##(1993-1#1)(1995-10#1)
raise the##81##2##(1990-11#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1992-12#2)(1992-3#1)(1992-7#1)(1993-1#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#3)(1995-5#1)(1995-7#1)(1995-9#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-10#1)(2005-4#1)(2005-6#1)(2006-10#2)(2006-6#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#3)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-7#1)(2009-8#2)(2010-3#1)(2010-4#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-10#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
raise theoretical##2##2##(2007-11#1)(2008-7#1)
raise##200##1##(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#2)(1992-12#2)(1992-3#2)(1992-7#1)(1992-8#1)(1993-1#3)(1993-2#2)(1993-5#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-5#2)(1995-6#1)(1995-7#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(1997-9#1)(2004-10#1)(2005-11#1)(2005-4#1)(2005-5#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#8)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#3)(2007-11#4)(2007-12#3)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-8#9)(2007-9#2)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#8)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#4)(2010-11#3)(2010-3#1)(2010-4#1)(2010-7#2)(2011-1#5)(2011-2#8)(2012-1#2)(2012-10#1)(2012-11#2)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#3)
raised (P&lt##2##2##(2007-6#1)(2007-8#1)
raised C-reactive protein##2##3##(1991-12#1)(2013-1#1)
raised ICP and##2##3##(1996-9#1)(2008-7#1)
raised ICP##9##2##(1996-9#1)(2008-7#3)(2010-5#5)
raised a##7##2##(1994-12#1)(1994-9#1)(2007-4#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
raised about##8##2##(2006-10#1)(2008-10#3)(2009-1#1)(2009-7#1)(2013-1#2)
raised above##2##2##(2008-1#1)(2010-10#1)
raised against a purified##2##4##(1990-3#1)(1994-10#1)
raised against a synthetic peptide corresponding to##2##7##(1996-5#1)(1997-5#1)
raised against a synthetic peptide##5##5##(1990-6#1)(1991-5#1)(1996-5#1)(1997-5#1)(2010-4#1)
raised against a synthetic##7##4##(1990-6#1)(1990-7#1)(1991-5#1)(1991-8#1)(1996-5#1)(1997-5#1)(2010-4#1)
raised against a##17##3##(1990-3#1)(1990-6#2)(1990-7#2)(1991-5#1)(1991-7#1)(1991-8#1)(1993-8#1)(1994-10#1)(1996-10#1)(1996-2#1)(1996-5#1)(1997-5#1)(1997-6#1)(1997-7#1)(2010-4#1)
raised against bacterially expressed##2##4##(1990-11#1)(1997-4#1)
raised against bovine##2##3##(1997-8#2)
raised against different##2##3##(1990-7#1)(1991-12#1)
raised against human placental aromatase##2##5##(1990-4#1)(1993-12#1)
raised against human##4##3##(1990-4#1)(1991-5#1)(1991-9#1)(1993-12#1)
raised against pseudexin B##2##4##(1995-1#2)
raised against purified rat cerebellar NOS##2##6##(1991-12#1)(1992-8#1)
raised against purified##9##3##(1990-3#1)(1990-4#1)(1991-1#1)(1991-12#1)(1992-8#2)(1993-9#1)(1994-2#1)(1996-8#1)
raised against the amino##2##4##(1994-8#1)(2007-12#1)
raised against the purified rat##2##5##(1990-7#1)(1993-5#1)
raised against the purified##6##4##(1990-7#1)(1991-4#1)(1992-8#1)(1993-12#1)(1993-5#1)(2007-12#1)
raised against the recombinant##2##4##(1990-8#1)(1996-5#1)
raised against the##44##3##(1990-3#2)(1990-5#2)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-5#2)(1992-12#1)(1992-2#3)(1992-3#2)(1992-7#1)(1992-8#1)(1993-12#2)(1993-5#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-4#1)(2007-12#3)(2008-10#3)(2008-11#1)(2008-4#1)
raised against two##2##3##(1992-11#1)(1997-7#1)
raised against##135##2##(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#5)(1990-4#3)(1990-5#5)(1990-6#3)(1990-7#6)(1990-8#3)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#2)(1991-4#1)(1991-5#4)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#5)(1992-12#1)(1992-2#3)(1992-3#2)(1992-7#3)(1992-8#5)(1993-12#3)(1993-5#1)(1993-8#1)(1993-9#2)(1994-10#2)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2006-8#2)(2007-12#5)(2008-10#9)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2010-4#1)
raised an##3##2##(1991-3#1)(1991-9#1)(1993-7#1)
raised and##6##2##(1992-5#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-8#1)(2012-2#1)
raised as to the##5##4##(1990-10#1)(2008-10#3)(2010-10#1)
raised at##4##2##(2007-7#1)(2008-5#1)(2008-6#1)(2008-9#1)
raised blood pressure##3##3##(1996-6#1)(1997-2#1)(2013-1#1)
raised blood##5##2##(1990-5#1)(1996-6#1)(1997-2#1)(2010-12#1)(2013-1#1)
raised by immunizing##2##3##(2008-7#1)(2008-8#1)
raised by parents##2##3##(2006-10#1)(2008-11#1)
raised by the use of##2##5##(1991-12#1)(1993-3#1)
raised by the##11##3##(1991-12#1)(1993-3#1)(1996-11#1)(1996-12#1)(1996-3#1)(2005-7#1)(2007-10#2)(2008-2#1)(2008-3#1)(2010-8#1)
raised by these##2##3##(1991-3#1)(2013-1#1)
raised by this study##2##4##(1993-7#1)(1997-8#1)
raised by this##5##3##(1990-12#1)(1991-12#1)(1993-7#1)(1997-8#1)(2006-7#1)
raised by##46##2##(1990-12#1)(1991-12#2)(1991-2#1)(1991-3#1)(1993-3#1)(1993-7#1)(1994-1#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-8#2)(2005-7#3)(2006-10#2)(2006-2#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-10#2)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-8#2)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#2)
raised concentrations of##2##3##(1990-4#1)(1993-8#1)
raised concentrations##4##2##(1990-4#1)(1991-12#1)(1992-11#1)(1993-8#1)
raised concern about possible##2##4##(2006-10#1)(2008-6#1)
raised concern##4##2##(2006-10#1)(2007-9#1)(2008-6#1)(2012-12#1)
raised concerns about##4##3##(2007-12#1)(2007-8#1)(2009-4#1)(2011-1#1)
raised concerns over##2##3##(1994-3#1)(2007-8#1)
raised concerns##7##2##(1994-3#1)(1996-12#1)(2007-12#1)(2007-8#2)(2009-4#1)(2011-1#1)
raised during##2##2##(1993-2#1)(2007-11#1)
raised for##5##2##(1997-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-1#1)
raised from room temperature##2##4##(2008-3#1)(2011-2#1)
raised from##11##2##(1990-3#1)(1991-12#1)(1992-7#1)(1993-3#1)(1996-9#1)(2004-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2011-2#1)
raised in patients with##2##4##(1991-3#1)(2008-9#1)
raised in rabbit##5##3##(1991-5#2)(1997-4#1)(2008-10#2)
raised in rabbits against synthetic peptides##2##6##(1995-10#1)(1996-11#1)
raised in rabbits against synthetic##3##5##(1995-10#1)(1996-11#1)(2008-5#1)
raised in rabbits against##5##4##(1990-12#1)(1991-7#1)(1995-10#1)(1996-11#1)(2008-5#1)
raised in rabbits##8##3##(1990-12#1)(1990-3#1)(1990-8#1)(1991-7#1)(1994-9#1)(1995-10#1)(1996-11#1)(2008-5#1)
raised in the##10##3##(1991-12#2)(1991-6#1)(1992-9#1)(1995-10#1)(2006-2#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#1)
raised in this study##2##4##(1994-3#1)(1997-2#1)
raised in this##4##3##(1994-3#1)(1997-2#1)(2006-9#1)(2007-10#1)
raised in##56##2##(1990-11#1)(1990-12#3)(1990-3#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#2)(1992-8#1)(1992-9#2)(1993-11#1)(1994-3#1)(1994-9#1)(1995-10#2)(1995-12#1)(1996-11#1)(1997-2#1)(1997-4#1)(2006-2#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-6#1)(2011-2#1)(2012-3#1)
raised lesions##2##2##(2008-10#1)(2012-11#1)
raised level of##3##3##(1992-1#1)(1992-9#1)(2011-1#1)
raised level##4##2##(1992-1#1)(1992-9#1)(2008-1#1)(2011-1#1)
raised levels of##3##3##(1991-2#1)(1993-9#1)(1997-6#1)
raised on PLT(R)-treated litter##2##4##(2008-5#2)
raised on##5##2##(1990-12#1)(1997-5#1)(2008-5#3)
raised or##2##2##(1992-1#1)(2008-7#1)
raised plasma##4##2##(1993-7#1)(2005-10#1)(2006-5#1)(2010-12#1)
raised polyclonal antibodies against##2##4##(1992-8#1)(2008-5#1)
raised pressure##2##2##(1995-11#1)(2010-5#1)
raised questions about##5##3##(1990-5#1)(1992-2#1)(2006-9#1)(2008-9#1)(2012-12#1)
raised questions##7##2##(1990-5#1)(1992-2#1)(2006-9#1)(2008-9#1)(2009-9#1)(2012-12#1)(2013-1#1)
raised regarding the##2##3##(1992-3#1)(2008-8#1)
raised regarding##5##2##(1992-3#1)(2006-10#1)(2008-8#1)(2011-1#1)(2013-1#1)
raised serum##8##2##(1991-12#1)(1994-3#1)(1996-11#1)(1996-12#1)(1996-9#1)(2007-7#1)(2011-2#1)(2013-1#1)
raised the possibility of##2##4##(2011-2#1)(2012-2#1)
raised the possibility that it##2##5##(1995-11#1)(2007-11#1)
raised the possibility that##4##4##(1990-3#1)(1995-11#1)(2007-11#1)(2009-4#1)
raised the possibility##6##3##(1990-3#1)(1995-11#1)(2007-11#1)(2009-4#1)(2011-2#1)(2012-2#1)
raised the question as to whether##2##6##(2006-10#1)(2008-10#1)
raised the question of whether##3##5##(2006-12#1)(2007-2#1)(2011-12#1)
raised the question of##5##4##(1992-12#1)(2006-12#1)(2007-2#1)(2008-7#1)(2011-12#1)
raised the question##8##3##(1992-12#1)(2006-10#2)(2006-12#1)(2007-2#1)(2008-10#1)(2008-7#1)(2011-12#1)
raised the##28##2##(1990-3#1)(1992-12#1)(1992-2#1)(1993-3#1)(1994-2#1)(1995-11#1)(1995-12#2)(1996-3#1)(1997-1#1)(1997-7#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-4#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
raised their##2##2##(1991-10#1)(2008-2#1)
raised through##2##2##(1990-12#1)(2009-5#1)
raised to a synthetic peptide##2##5##(1995-10#1)(2004-2#1)
raised to a##6##3##(1990-7#1)(1992-9#1)(1995-10#1)(1997-4#1)(2004-2#1)(2013-1#1)
raised to the##4##3##(1991-2#1)(1992-1#1)(1994-12#1)(2008-7#1)
raised to##31##2##(1990-11#1)(1990-2#1)(1990-7#2)(1990-9#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-8#1)(1995-10#1)(1996-4#1)(1997-2#1)(1997-4#1)(2004-2#1)(2005-12#2)(2008-10#2)(2008-7#1)(2008-9#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-1#1)
raised triglyceride##3##2##(1993-12#1)(2013-1#2)
raised under the##2##3##(2006-5#1)(2010-4#1)
raised under##5##2##(2006-5#1)(2010-12#1)(2010-4#1)(2010-8#2)
raised using##2##2##(1995-11#1)(2013-1#1)
raised whether##4##2##(1996-9#1)(2007-11#1)(2008-8#1)(2009-10#1)
raised while##2##2##(2007-11#1)(2009-6#1)
raised##600##1##(1990-10#3)(1990-11#6)(1990-12#8)(1990-2#4)(1990-3#9)(1990-4#4)(1990-5#7)(1990-6#3)(1990-7#10)(1990-8#5)(1990-9#4)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#15)(1991-2#7)(1991-3#3)(1991-4#1)(1991-5#6)(1991-6#3)(1991-7#2)(1991-8#4)(1991-9#5)(1992-1#3)(1992-10#1)(1992-11#8)(1992-12#3)(1992-2#5)(1992-3#3)(1992-5#2)(1992-6#3)(1992-7#4)(1992-8#7)(1992-9#5)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#5)(1993-5#1)(1993-6#1)(1993-7#3)(1993-8#2)(1993-9#4)(1994-1#2)(1994-10#3)(1994-11#2)(1994-12#4)(1994-2#4)(1994-3#4)(1994-5#2)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#4)(1995-10#4)(1995-11#3)(1995-12#6)(1995-2#5)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#3)(1996-12#4)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#2)(1996-7#1)(1996-8#3)(1996-9#6)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#6)(1997-5#3)(1997-6#2)(1997-7#5)(1997-8#5)(2004-11#1)(2004-12#1)(2004-2#1)(2004-4#1)(2005-10#1)(2005-11#2)(2005-12#2)(2005-4#1)(2005-7#3)(2005-9#1)(2006-10#10)(2006-12#3)(2006-2#3)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#6)(2006-9#4)(2007-1#2)(2007-10#7)(2007-11#7)(2007-12#8)(2007-2#3)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#7)(2007-8#10)(2007-9#2)(2008-1#3)(2008-10#36)(2008-11#12)(2008-12#5)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#14)(2008-6#7)(2008-7#11)(2008-8#4)(2008-9#7)(2009-1#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#6)(2009-5#1)(2009-6#3)(2009-7#1)(2009-9#2)(2010-10#2)(2010-12#5)(2010-2#1)(2010-4#4)(2010-5#7)(2010-6#1)(2010-7#3)(2010-8#6)(2010-9#1)(2011-1#5)(2011-12#3)(2011-2#8)(2012-1#1)(2012-11#2)(2012-12#5)(2012-2#2)(2012-3#5)(2013-1#18)(2013-7#1)(2013-8#3)
raises a number of##5##4##(1996-5#1)(1997-1#1)(2006-11#1)(2008-11#1)(2012-11#1)
raises a##8##2##(1994-5#1)(1996-5#2)(1997-1#1)(2006-11#1)(2008-10#1)(2008-11#1)(2012-11#1)
raises an important##2##3##(2006-10#1)(2008-2#1)
raises an##4##2##(2006-10#1)(2008-10#1)(2008-2#1)(2012-3#1)
raises concern##4##2##(1992-8#1)(1996-3#2)(2012-12#1)
raises concerns about the##3##4##(1995-1#1)(2008-10#1)(2008-11#1)
raises concerns about##4##3##(1995-1#1)(1996-11#1)(2008-10#1)(2008-11#1)
raises concerns##5##2##(1995-1#1)(1996-11#1)(2007-8#1)(2008-10#1)(2008-11#1)
raises ethical##2##2##(1996-11#1)(2007-9#1)
raises important##3##2##(1994-7#1)(2006-5#1)(2012-1#1)
raises issues of##2##3##(1996-11#1)(2006-10#1)
raises problems##2##2##(1990-3#1)(1997-8#1)
raises questions about how##2##4##(2008-11#1)(2009-12#1)
raises questions about##4##3##(1990-5#1)(2007-11#1)(2008-11#1)(2009-12#1)
raises questions as to##2##4##(1995-11#1)(2008-10#1)
raises questions concerning##2##3##(2007-1#1)(2008-10#1)
raises questions##11##2##(1990-5#1)(1995-11#1)(2006-11#1)(2006-5#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-11#1)(2009-12#1)(2013-8#1)
raises serious##2##2##(2006-5#1)(2013-8#1)
raises several##2##2##(2008-2#1)(2012-2#1)
raises significant ethical##2##3##(2013-8#2)
raises significant##3##2##(2008-11#1)(2013-8#2)
raises some interesting##2##3##(1991-3#1)(2012-11#1)
raises some issues##2##3##(1990-12#1)(2008-1#1)
raises some##8##2##(1990-12#1)(1991-3#1)(1993-6#1)(2007-9#1)(2008-1#2)(2008-3#1)(2012-11#1)
raises the issue of##3##4##(1991-3#1)(1994-3#1)(2008-2#1)
raises the issue##5##3##(1991-3#1)(1992-12#1)(1994-3#1)(1997-8#1)(2008-2#1)
raises the need for##2##4##(1994-3#1)(2010-9#1)
raises the possibility of a##2##5##(1995-5#1)(1995-6#1)
raises the possibility of##9##4##(1990-7#1)(1995-5#1)(1995-6#1)(1996-3#2)(1997-1#1)(2006-10#1)(2007-12#1)(2008-5#1)
raises the possibility that the##2##5##(1996-3#1)(2008-5#1)
raises the possibility that##13##4##(1991-2#1)(1991-3#1)(1991-4#1)(1992-8#1)(1994-8#1)(1995-1#2)(1995-8#1)(1996-10#1)(1996-3#1)(2007-2#1)(2008-5#1)(2011-2#1)
raises the possibility##23##3##(1990-7#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-8#1)(1994-8#1)(1995-1#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-3#3)(1997-1#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-5#2)(2010-2#1)(2011-2#1)
raises the problem of##2##4##(1991-6#1)(1993-6#1)
raises the question as to##2##5##(1995-12#1)(2012-3#1)
raises the question of how##2##5##(1990-11#1)(2008-2#1)
raises the question of the##5##5##(1992-9#1)(1993-10#1)(1995-1#1)(1996-12#1)(2007-10#1)
raises the question of whether the##2##6##(2006-12#1)(2007-12#1)
raises the question of whether##5##5##(1995-2#1)(1996-2#1)(2006-12#1)(2007-12#1)(2012-2#1)
raises the question of##16##4##(1990-11#1)(1992-9#1)(1993-10#1)(1993-2#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(2006-12#1)(2007-10#1)(2007-12#1)(2008-2#1)(2012-2#1)(2013-8#1)
raises the question whether##3##4##(1993-2#1)(1994-12#1)(1996-9#1)
raises the question##21##3##(1990-11#1)(1992-9#1)(1993-10#1)(1993-2#2)(1994-12#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#1)(1996-12#1)(1996-2#1)(1996-9#1)(2006-12#1)(2007-10#1)(2007-12#1)(2008-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
raises the temperature##2##3##(1991-7#1)(2005-11#1)
raises the##77##2##(1990-11#1)(1990-7#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#4)(1993-5#1)(1993-6#1)(1994-12#1)(1994-3#2)(1994-8#2)(1995-1#3)(1995-12#3)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-9#1)(1997-1#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-8#3)(2009-10#1)(2009-8#1)(2010-2#1)(2010-9#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-7#1)(2013-8#1)
raises##175##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-3#4)(1991-4#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-8#2)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#4)(1993-5#2)(1993-6#2)(1994-12#1)(1994-3#2)(1994-5#1)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#5)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#5)(1996-4#1)(1996-5#2)(1996-9#1)(1997-1#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-11#2)(2006-10#4)(2006-11#2)(2006-12#2)(2006-4#1)(2006-5#3)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#1)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#6)(2008-11#5)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#2)(2008-8#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-3#4)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#4)(2012-3#3)(2013-7#2)(2013-8#6)
raising a##2##2##(1993-1#1)(2008-8#1)
raising an##3##2##(2008-10#1)(2008-6#1)(2009-12#1)
raising awareness of##2##3##(2006-10#1)(2011-2#1)
raising awareness##5##2##(2006-10#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
raising children##5##2##(1991-12#1)(2007-3#1)(2007-9#1)(2008-9#1)(2009-12#1)
raising concerns over##2##3##(2010-8#1)(2013-8#1)
raising concerns##4##2##(2005-12#1)(2010-8#1)(2011-2#1)(2013-8#1)
raising in##5##2##(1991-11#1)(1991-3#1)(1992-3#1)(1993-3#1)(1997-1#1)
raising its##3##2##(1990-5#1)(2005-9#1)(2011-2#1)
raising livestock##2##2##(2011-2#2)
raising of the##2##3##(2008-11#1)(2008-6#1)
raising of##3##2##(2005-10#1)(2008-11#1)(2008-6#1)
raising plasma##2##2##(1991-12#1)(1991-7#1)
raising polyclonal##2##2##(1991-9#2)
raising questions about##2##3##(2009-8#1)(2010-12#1)
raising questions##3##2##(1992-6#1)(2009-8#1)(2010-12#1)
raising serum##2##2##(2008-3#1)(2009-8#1)
raising the awareness of##3##4##(2007-11#1)(2008-7#1)(2013-1#1)
raising the issue of##2##4##(1995-11#1)(2006-10#1)
raising the possibility of##3##4##(2006-10#1)(2008-7#1)(2012-3#1)
raising the possibility that a##2##5##(1996-6#1)(2008-10#1)
raising the possibility that it##2##5##(1990-10#1)(2008-10#1)
raising the possibility that the##2##5##(1993-3#1)(1996-10#1)
raising the possibility that##14##4##(1990-10#1)(1991-2#1)(1993-3#1)(1994-8#1)(1996-10#1)(1996-6#1)(1996-8#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2012-12#1)
raising the possibility##17##3##(1990-10#1)(1991-2#1)(1993-3#1)(1994-8#1)(1996-10#1)(1996-6#1)(1996-8#1)(1997-6#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#1)(2012-12#1)(2012-3#1)
raising the question of##2##4##(2007-11#1)(2013-7#1)
raising the question##4##3##(2007-11#1)(2008-7#1)(2011-2#1)(2013-7#1)
raising the##59##2##(1990-10#1)(1990-11#2)(1990-6#1)(1990-7#2)(1991-2#1)(1991-7#1)(1991-9#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-5#1)(1995-7#2)(1996-10#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-6#1)(2006-10#3)(2006-4#1)(2007-11#3)(2007-4#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
raising##171##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#2)(1991-3#2)(1991-7#2)(1991-8#1)(1991-9#3)(1992-1#2)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#4)(1994-1#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-7#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(2005-10#1)(2005-12#1)(2005-9#1)(2006-10#5)(2006-4#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-3#2)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-10#4)(2008-11#7)(2008-12#2)(2008-3#3)(2008-5#4)(2008-6#6)(2008-7#7)(2008-8#2)(2008-9#1)(2009-12#2)(2009-8#5)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#7)(2012-11#1)(2012-12#7)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
raisins##7##1##(1995-9#1)(2008-10#6)
raison du##2##2##(2008-5#1)(2013-1#1)
raison##4##1##(1996-6#1)(2008-5#2)(2013-1#1)
raked##2##1##(2008-10#2)
ral##4##1##(1992-8#3)(2007-6#1)
rales##2##1##(1993-5#1)(2008-5#1)
rally##3##1##(1993-2#1)(1995-8#1)(2008-4#1)
rallying##4##1##(1995-5#1)(1996-12#1)(1997-4#1)(2008-10#1)
raloxifene can##2##2##(2008-4#1)(2010-10#1)
raloxifene response##3##2##(1996-8#2)(1997-2#1)
raloxifene##19##1##(1996-8#4)(1997-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#5)(2010-10#6)
raltegravir are##2##2##(2009-6#1)(2011-2#1)
raltegravir is##3##2##(2009-6#3)
raltegravir##8##1##(2009-6#6)(2010-9#1)(2011-2#1)
raltitrexed##5##1##(2005-7#4)(2009-5#1)
ram epididymal##2##2##(2008-12#2)
ram lambs##2##2##(2008-12#2)
ram p25##6##2##(1992-11#6)
ram##21##1##(1992-11#6)(1992-2#1)(1995-8#1)(1996-2#1)(2005-7#1)(2006-11#1)(2006-5#3)(2007-4#2)(2008-12#4)(2008-5#1)
ramadan##5##1##(2012-3#5)
ramets in##2##2##(2008-10#1)(2008-9#1)
ramets of the##2##3##(2008-9#1)(2009-12#1)
ramets##6##1##(2008-10#1)(2008-5#1)(2008-9#3)(2009-12#1)
rami##6##1##(1995-6#1)(2006-11#1)(2006-7#1)(2006-8#2)(2009-2#1)
ramification and##2##2##(1994-5#1)(1995-11#1)
ramification of##2##2##(2006-11#1)(2007-9#1)
ramification##8##1##(1994-5#2)(1995-11#1)(2006-10#1)(2006-11#1)(2007-9#1)(2008-10#1)(2013-7#1)
ramifications are##2##2##(2006-10#1)(2007-12#1)
ramifications for##3##2##(1995-8#1)(2007-10#1)(2008-8#1)
ramifications in##2##2##(1993-9#1)(2008-3#1)
ramifications of##2##2##(2008-11#1)(2008-5#1)
ramifications that##2##2##(1995-12#1)(2008-11#1)
ramifications##26##1##(1990-7#1)(1993-9#1)(1995-12#1)(1995-8#1)(1996-2#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#3)(2010-4#1)(2013-7#1)
ramified and##3##2##(1994-5#2)(1995-3#1)
ramified##10##1##(1994-5#2)(1995-3#1)(2006-10#1)(2007-12#3)(2008-10#1)(2008-12#1)(2008-6#1)
ramipril + irbesartan + spironolactone##2##5##(2007-8#2)
ramipril + irbesartan##3##3##(2007-8#3)
ramipril and telmisartan##3##3##(2010-3#3)
ramipril and##4##2##(2010-12#1)(2010-3#3)
ramipril##10##1##(2007-8#3)(2010-12#2)(2010-3#5)
ramnogalacturonan##3##1##(2008-10#3)
ramoplanin##6##1##(1995-2#1)(2006-5#5)
ramorum DNA##2##2##(2008-10#2)
ramorum and##3##2##(2008-10#3)
ramorum elicitins##2##2##(2008-10#2)
ramorum from##5##2##(2008-10#4)(2009-2#1)
ramorum in plant material##3##4##(2008-10#3)
ramorum in##10##2##(2008-10#9)(2009-2#1)
ramorum was detected##2##3##(2008-10#2)
ramorum was recovered from##2##4##(2008-10#2)
ramorum was##8##2##(2008-10#8)
ramorum##73##1##(2008-10#66)(2009-2#7)
ramosa##5##1##(2008-10#5)
ramosus##2##1##(1994-12#1)(2008-11#1)
ramp and##2##2##(2012-2#1)(2013-1#1)
ramp direction##3##2##(2008-10#3)
ramp mode##2##2##(2007-9#2)
ramp##21##1##(1992-3#1)(1993-5#1)(1995-11#1)(1996-1#2)(2007-9#2)(2008-10#8)(2008-2#1)(2008-3#2)(2012-2#1)(2013-1#2)
ramp-like dose gradients##2##3##(2008-3#2)
rampant##7##1##(1991-7#1)(1997-8#1)(2006-12#1)(2006-5#1)(2007-2#1)(2008-1#1)(2011-1#1)
ramped##5##1##(2008-10#3)(2008-3#1)(2012-2#1)
ramping up##2##2##(2006-11#1)(2007-4#1)
ramping##5##1##(2006-11#1)(2007-12#1)(2007-4#2)(2009-6#1)
ramps##2##1##(1991-9#1)(1996-3#1)
rams##7##1##(2005-7#2)(2006-5#2)(2008-12#2)(2012-1#1)
ramsdellite##8##1##(2005-11#6)(2010-4#2)
ramus of##2##2##(1993-11#1)(1995-6#1)
ramus##16##1##(1993-11#1)(1995-6#3)(1995-9#1)(2007-12#1)(2007-7#1)(2007-9#2)(2010-2#5)(2010-9#1)(2012-3#1)
ramus-condyle unit fractures in growing patients##2##6##(2007-12#2)
ramus-condyle unit fractures##4##3##(2007-12#4)
ran a##3##2##(1992-11#1)(1993-8#1)(2011-2#1)
ran in##4##2##(1995-3#1)(2011-12#1)(2013-1#2)
ran over##2##2##(2005-7#1)(2007-5#1)
ran parallel##2##2##(1993-12#1)(2013-2#1)
ran with##2##2##(1992-8#1)(1994-12#1)
ran##27##1##(1990-5#1)(1990-8#1)(1992-11#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-12#1)(1995-1#3)(1995-12#1)(1995-3#1)(2004-10#1)(2005-7#1)(2007-5#1)(2007-9#2)(2008-4#1)(2008-5#1)(2010-12#1)(2011-12#1)(2011-2#1)(2011-7#1)(2013-1#3)(2013-2#1)
ranarum##3##1##(2007-7#3)
ranch##3##1##(2008-4#1)(2008-5#1)(2008-6#1)
rancid and##2##2##(2010-4#2)
rancid rapeseed##2##2##(2008-10#2)
rancid##4##1##(2008-10#2)(2010-4#2)
random DNA sequences##3##3##(1996-3#1)(2007-8#2)
random DNA##11##2##(1990-5#1)(1996-3#1)(1996-5#1)(1996-7#1)(2007-8#6)(2008-8#1)
random access##3##2##(2008-3#2)(2009-11#1)
random addition model##2##3##(1990-7#2)
random allocation##4##2##(2006-8#1)(2012-1#2)(2012-3#1)
random amplified microsatellite##2##3##(2008-10#1)(2008-5#1)
random amplified polymorphic DNA (RAPD) analysis##7##6##(2007-1#1)(2007-7#1)(2008-10#5)
random amplified polymorphic DNA (RAPD) markers were##2##7##(2008-10#2)
random amplified polymorphic DNA (RAPD) markers##12##6##(2008-10#11)(2013-7#1)
random amplified polymorphic DNA (RAPD) technique##3##6##(2008-10#3)
random amplified polymorphic DNA (RAPD)##39##5##(1993-12#1)(2005-11#2)(2007-1#1)(2007-7#1)(2008-10#33)(2013-7#1)
random amplified polymorphic DNA and##3##5##(2008-10#3)
random amplified polymorphic DNA loci##2##5##(2008-10#2)
random amplified polymorphic DNA marker##3##5##(2008-10#3)
random amplified polymorphic DNA markers##7##5##(2008-10#7)
random amplified polymorphic DNA##68##4##(1993-12#2)(2005-11#2)(2007-1#3)(2007-10#1)(2007-7#1)(2008-10#56)(2011-2#1)(2012-3#1)(2013-7#1)
random amplified polymorphic##71##3##(1993-12#2)(1994-3#1)(2005-11#3)(2007-1#3)(2007-10#1)(2007-7#1)(2008-10#56)(2008-5#1)(2011-2#1)(2012-3#1)(2013-7#1)
random amplified polymorphism DNA##2##4##(2008-10#2)
random amplified##77##2##(1993-12#2)(1994-3#1)(2005-11#3)(2007-1#3)(2007-10#1)(2007-7#1)(2008-10#61)(2008-5#2)(2011-2#1)(2012-3#1)(2013-7#1)
random and conditional##2##3##(2012-2#2)
random and systematic##2##3##(2008-2#1)(2008-3#1)
random and##21##2##(1995-7#1)(1996-2#1)(1996-3#1)(2004-11#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-2#5)(2008-3#1)(2008-5#1)(2008-8#1)(2012-2#3)(2012-3#1)(2013-8#1)
random assignment##6##2##(1994-6#1)(2009-11#1)(2012-2#1)(2013-1#2)(2013-7#1)
random background##2##2##(2007-12#1)(2008-10#1)
random binary sequences##2##3##(1996-4#2)
random birefringence##3##2##(2007-12#3)
random blood##2##2##(1992-6#1)(2009-5#1)
random closed set##4##3##(2008-2#4)
random cluster##3##2##(2006-2#1)(2012-3#1)(2013-1#1)
random code##2##2##(2008-2#2)
random coefficient regression##2##3##(1994-6#2)
random coefficient##3##2##(1994-6#2)(1996-12#1)
random coil and##2##3##(2005-11#1)(2008-7#1)
random coil to##2##3##(1993-3#1)(2005-11#1)
random coil##10##2##(1990-3#1)(1993-3#1)(1993-9#1)(1994-9#1)(1996-2#1)(2005-11#2)(2008-10#1)(2008-7#1)(2008-8#1)
random copolymers##5##2##(1994-10#1)(2005-11#1)(2009-7#1)(2010-4#2)
random design##2##2##(2006-10#1)(2008-10#1)
random differences##2##2##(2012-3#2)
random dimer##3##2##(1991-6#3)
random distribution of##7##3##(2007-11#2)(2008-10#2)(2008-12#1)(2008-3#1)(2010-12#1)
random distribution##10##2##(1995-9#1)(1996-4#2)(2007-11#2)(2008-10#2)(2008-12#1)(2008-3#1)(2010-12#1)
random dot##3##2##(1991-1#1)(2008-8#2)
random drift##3##2##(1995-5#1)(1996-6#1)(2008-10#1)
random effect in the##2##4##(1993-5#1)(2010-11#1)
random effect models##2##3##(1997-8#1)(2008-8#1)
random effect##7##2##(1993-5#1)(1997-8#1)(2008-7#2)(2008-8#1)(2009-11#1)(2010-11#1)
random effects distribution##2##3##(2008-8#2)
random effects meta-analysis##2##3##(1996-12#1)(1996-3#1)
random effects method##2##3##(1996-3#2)
random effects model for##2##4##(1993-11#1)(1997-4#1)
random effects model##3##3##(1993-11#1)(1997-4#1)(2011-1#1)
random effects models##3##3##(1997-4#1)(1997-8#1)(2012-2#1)
random effects##25##2##(1993-11#2)(1994-8#1)(1995-6#1)(1996-12#1)(1996-3#4)(1997-4#2)(1997-8#1)(2008-10#2)(2008-8#4)(2009-10#1)(2011-1#2)(2011-12#1)(2012-2#2)(2012-3#1)
random error##6##2##(1992-5#1)(2008-10#2)(2008-3#2)(2008-7#1)
random errors and##2##3##(2008-2#1)(2010-4#1)
random errors of##2##3##(2008-10#1)(2011-2#1)
random errors##14##2##(1996-5#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-7#1)(2009-5#1)(2010-12#2)(2010-4#1)(2011-2#1)(2012-12#1)
random field##13##2##(2007-12#1)(2008-10#1)(2008-2#5)(2008-4#1)(2008-6#1)(2010-12#1)(2012-3#1)(2013-1#2)
random fields##5##2##(2007-12#1)(2008-2#4)
random fluctuations in##2##3##(1990-3#1)(2008-9#1)
random fluctuations##7##2##(1990-3#1)(2006-12#1)(2007-12#2)(2008-3#2)(2008-9#1)
random for##3##2##(1992-6#1)(1997-8#1)(2008-10#1)
random forest##3##2##(2012-3#1)(2013-1#2)
random forests and logic regression##2##5##(2012-3#2)
random forests and##3##3##(2012-3#3)
random forests##4##2##(2011-1#1)(2012-3#3)
random from##10##2##(1991-7#1)(1991-8#1)(1991-9#1)(1995-2#1)(1996-12#1)(2005-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2012-3#1)
random gain##2##2##(2008-3#2)
random genetic drift##5##3##(1996-6#2)(2008-10#3)
random genetic##6##2##(1996-6#3)(2008-10#3)
random genomic##2##2##(2008-10#1)(2008-8#1)
random group##2##2##(2007-11#1)(2012-3#1)
random image##2##2##(2008-2#2)
random in##3##2##(1997-8#1)(2008-10#1)(2010-8#1)
random insertional##2##2##(1996-11#1)(2008-10#1)
random integrations##2##2##(2006-12#2)
random light##2##2##(2007-12#2)
random loss##2##2##(1993-4#1)(2008-10#1)
random mating model##2##3##(2008-9#2)
random mating##10##2##(2008-10#7)(2008-8#1)(2008-9#2)
random matrices##4##2##(1990-7#1)(1992-3#1)(2008-5#1)(2012-2#1)
random measurement errors##2##3##(2008-3#2)
random measurement##3##2##(2007-9#1)(2008-3#2)
random mechanism##3##2##(1991-1#1)(1991-4#1)(1991-5#1)
random media##10##2##(2007-11#1)(2007-12#2)(2008-2#5)(2008-3#2)
random medium with##2##3##(2008-2#2)
random medium##7##2##(2007-11#1)(2007-12#1)(2008-2#5)
random migration##3##2##(1991-8#1)(1993-12#1)(1994-8#1)
random mutagenesis##6##2##(1990-3#2)(1993-2#1)(1995-7#1)(2008-10#1)(2008-8#1)
random mutation##2##2##(2008-10#1)(2010-5#1)
random mutations##3##2##(1996-9#1)(2008-7#1)(2008-9#1)
random noise and##2##3##(2006-2#1)(2008-3#1)
random noise components##2##3##(2008-2#2)
random noise##11##2##(2006-2#1)(2007-12#1)(2008-2#6)(2008-3#2)(2009-9#1)
random nucleotides##3##2##(1992-6#2)(1995-2#1)
random number generator##2##3##(2008-11#1)(2008-7#1)
random number##5##2##(2008-11#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-1#1)
random numbers##3##2##(2008-3#1)(2010-2#1)(2011-2#1)
random or##3##2##(1991-9#1)(1993-6#1)(2011-1#1)
random order##7##2##(1991-8#1)(1992-11#1)(1994-12#1)(1995-11#1)(1995-6#1)(2006-7#1)(2013-8#1)
random orientation of the##2##4##(2008-3#1)(2009-5#1)
random orientation##6##2##(2008-2#1)(2008-3#3)(2009-5#1)(2009-8#1)
random pattern of##3##3##(1995-1#1)(1997-8#1)(2008-10#1)
random pattern##4##2##(1995-1#1)(1997-8#1)(2008-10#2)
random patterns##6##2##(2008-3#6)
random peptide library##3##3##(1997-2#1)(2007-2#1)(2008-8#1)
random peptide sequences##2##3##(1995-11#1)(2006-10#1)
random peptide##7##2##(1994-9#2)(1995-11#1)(1997-2#1)(2006-10#1)(2007-2#1)(2008-8#1)
random peptides##3##2##(2008-4#1)(2008-8#1)(2009-2#1)
random phage display##2##3##(1994-9#1)(2008-10#1)
random phase codes##8##3##(2007-12#4)(2008-3#4)
random phase encoding##2##3##(2008-3#2)
random phase mask##2##3##(2008-2#2)
random phase masks##3##3##(2008-3#3)
random phase##24##2##(2007-12#6)(2008-2#4)(2008-3#14)
random plasma glucose##2##3##(1992-9#1)(2008-7#1)
random point mutations##2##3##(1990-3#1)(1997-4#1)
random primers were##3##3##(2007-1#1)(2008-10#2)
random procedure##2##2##(2008-2#1)(2008-5#1)
random process##6##2##(1997-2#1)(1997-6#1)(2008-10#1)(2008-2#1)(2010-6#1)(2011-2#1)
random processes##3##2##(2007-8#1)(2008-2#2)
random resistor network approach of##2##5##(2005-11#2)
random rough surface##2##3##(2007-12#1)(2008-3#1)
random rough##4##2##(2007-12#2)(2008-3#2)
random sample from##4##3##(1992-6#1)(2006-10#1)(2008-7#2)
random sample of 30##2##4##(1992-1#1)(2012-3#1)
random sample of 300##2##4##(2012-1#1)(2012-3#1)
random sample of 500##2##4##(1991-3#1)(1993-12#1)
random sample of family##4##4##(1991-3#1)(1991-8#2)(2007-6#1)
random sample of the##7##4##(1995-3#1)(1996-8#1)(2006-10#2)(2010-11#1)(2013-1#1)(2013-7#1)
random sample of##68##3##(1990-9#1)(1991-3#2)(1991-8#2)(1992-1#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-6#1)(1996-8#2)(1997-3#2)(1997-4#1)(2005-8#1)(2006-10#3)(2006-8#2)(2007-10#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-4#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#1)
random sample##86##2##(1990-9#1)(1991-3#2)(1991-8#2)(1992-1#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-12#2)(1993-2#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-6#1)(1996-8#2)(1997-3#3)(1997-4#1)(1997-8#1)(2005-8#1)(2006-10#6)(2006-8#3)(2007-10#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#4)(2008-8#2)(2009-12#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#7)(2013-1#4)(2013-7#1)(2013-8#1)
random samples of##3##3##(2004-1#1)(2008-10#1)(2009-5#1)
random samples##4##2##(2004-1#1)(2004-11#1)(2008-10#1)(2009-5#1)
random sampling approach##2##3##(2008-2#1)(2011-2#1)
random sampling method##2##3##(1993-12#1)(2007-1#1)
random sampling technique##3##3##(2006-8#1)(2007-10#1)(2012-2#1)
random sampling was##3##3##(2007-2#1)(2011-2#1)(2013-8#1)
random sampling##26##2##(1993-11#1)(1993-12#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-5#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
random scattering##2##2##(2007-11#2)
random search##2##2##(2006-3#1)(2008-10#1)
random selection of##4##3##(2006-10#1)(2007-2#1)(2007-3#1)(2007-6#1)
random selection##6##2##(2006-10#1)(2007-2#1)(2007-3#1)(2007-6#1)(2008-8#1)(2012-12#1)
random sequence RNA molecules##2##4##(1990-8#2)
random sequence##7##2##(1990-5#1)(1990-8#2)(1995-2#1)(1996-11#1)(1996-3#1)(2008-10#1)
random sequences##7##2##(1993-6#2)(1994-6#1)(1995-8#1)(1996-4#2)(2008-11#1)
random sequencing##2##2##(1995-12#1)(1995-7#1)
random sequential##2##2##(1991-9#1)(2005-11#1)
random shape##2##2##(2008-3#2)
random sound##2##2##(2013-8#2)
random spatial distribution##2##3##(1991-6#1)(2007-11#1)
random spatial##3##2##(1991-6#1)(2007-11#1)(2008-10#1)
random spot##2##2##(2011-1#2)
random structure##3##2##(1991-10#1)(2005-11#1)(2009-2#1)
random subject##2##2##(1997-2#1)(2009-11#1)
random target##2##2##(2008-2#1)(2008-3#1)
random targets##3##2##(2008-10#3)
random time##2##2##(2008-7#2)
random times##2##2##(1996-3#1)(2008-7#1)
random to##3##2##(2007-3#1)(2008-1#1)(2008-10#1)
random urine samples##4##3##(1990-11#1)(2005-12#3)
random urine##6##2##(1990-11#1)(1992-9#1)(2005-12#3)(2011-1#1)
random variables that##2##3##(1996-7#1)(2009-10#1)
random variables##14##2##(1993-5#1)(1996-7#2)(2007-12#1)(2008-2#4)(2008-3#1)(2008-7#1)(2009-10#1)(2009-4#3)
random variates##2##2##(1992-9#1)(2008-10#1)
random variation##3##2##(1994-5#1)(2006-10#1)(2010-8#1)
random variations##2##2##(2010-8#1)(2013-7#1)
random walk##10##2##(2007-10#1)(2007-12#3)(2008-2#3)(2008-9#1)(2012-3#1)(2013-8#1)
random walks##3##2##(1993-12#2)(2009-9#1)
random wave##4##2##(2008-2#2)(2008-3#2)
random white Gaussian##2##3##(2007-12#2)
random with respect to##2##4##(1995-2#1)(2008-9#1)
random zero##3##2##(1991-3#1)(1993-8#2)
random##988##1##(1990-11#5)(1990-12#1)(1990-3#5)(1990-5#2)(1990-6#2)(1990-7#5)(1990-8#2)(1990-9#2)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#4)(1991-4#1)(1991-5#1)(1991-6#8)(1991-7#1)(1991-8#7)(1991-9#3)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#3)(1992-6#7)(1992-8#1)(1992-9#3)(1993-11#3)(1993-12#10)(1993-2#2)(1993-3#2)(1993-4#2)(1993-5#2)(1993-6#4)(1993-7#1)(1993-8#3)(1993-9#1)(1994-10#2)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#3)(1994-6#4)(1994-8#5)(1994-9#8)(1995-1#4)(1995-11#3)(1995-12#3)(1995-2#10)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#6)(1995-7#7)(1995-8#4)(1995-9#3)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#4)(1996-3#8)(1996-4#7)(1996-5#2)(1996-6#5)(1996-7#5)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#4)(1997-4#5)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#9)(1997-9#1)(2004-1#1)(2004-11#2)(2004-9#1)(2005-1#1)(2005-11#20)(2005-12#3)(2005-8#3)(2006-10#14)(2006-12#7)(2006-2#4)(2006-3#1)(2006-4#6)(2006-6#1)(2006-7#1)(2006-8#5)(2007-1#5)(2007-10#5)(2007-11#14)(2007-12#44)(2007-2#5)(2007-3#5)(2007-5#1)(2007-6#3)(2007-7#4)(2007-8#10)(2007-9#3)(2008-1#4)(2008-10#139)(2008-11#9)(2008-12#4)(2008-2#86)(2008-3#69)(2008-4#7)(2008-5#11)(2008-6#2)(2008-7#28)(2008-8#22)(2008-9#10)(2009-10#3)(2009-11#5)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#4)(2009-5#5)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#3)(2010-3#2)(2010-4#5)(2010-5#1)(2010-6#2)(2010-8#9)(2011-1#13)(2011-12#1)(2011-2#10)(2012-1#7)(2012-12#7)(2012-2#12)(2012-3#24)(2013-1#20)(2013-7#4)(2013-8#13)
random)##6##1##(1992-12#1)(2007-12#1)(2008-1#1)(2008-8#1)(2012-1#1)(2012-12#1)
random-access##3##1##(2007-12#1)(2008-2#2)
random-coil in a##2##3##(2006-10#2)
random-coil##5##1##(1992-6#1)(1997-2#1)(2006-10#2)(2009-2#1)
random-digit##2##1##(1991-2#1)(2009-9#1)
random-effects meta-analysis##2##2##(1995-12#1)(2008-10#1)
random-effects models##3##2##(1993-9#1)(1995-12#1)(2012-3#1)
random-effects regression##3##2##(1995-2#3)
random-effects##16##1##(1993-5#1)(1993-9#1)(1995-12#3)(1995-2#4)(1996-7#3)(2008-10#1)(2010-9#1)(2012-12#1)(2012-3#1)
random-field##2##1##(1991-9#1)(2008-2#1)
random-mated populations##2##2##(2008-10#2)
random-mated##4##1##(2008-10#4)
random-number generator##2##2##(2008-3#2)
random-phase screen##2##2##(2007-12#1)(2008-3#1)
random-phase##4##1##(2007-12#1)(2008-3#3)
random-time (45##2##2##(2008-5#2)
random-walk##8##1##(1995-10#1)(2007-12#3)(2008-2#1)(2008-3#1)(2010-7#2)
randomisation and##3##2##(1993-2#1)(2006-6#1)(2012-3#1)
randomisation##11##1##(1993-2#1)(1997-7#2)(2006-2#1)(2006-6#1)(2008-8#1)(2010-2#1)(2012-3#4)
randomised and##4##2##(1997-4#1)(1997-7#1)(2008-5#1)(2012-1#1)
randomised clinical trial##10##3##(1990-6#1)(1991-3#1)(1993-7#1)(2007-11#1)(2007-5#2)(2010-5#1)(2012-3#1)(2013-1#2)
randomised clinical trials##3##3##(2007-1#1)(2007-8#1)(2010-5#1)
randomised clinical##14##2##(1990-6#1)(1991-3#1)(1993-7#1)(1995-6#1)(2007-1#1)(2007-11#1)(2007-5#2)(2007-8#1)(2010-5#2)(2012-3#1)(2013-1#2)
randomised control trials##3##3##(2007-11#1)(2008-8#1)(2013-1#1)
randomised control##6##2##(2007-11#1)(2008-8#1)(2010-12#1)(2010-7#1)(2011-1#1)(2013-1#1)
randomised controlled clinical trial##2##4##(2010-5#2)
randomised controlled clinical trials##2##4##(2005-3#1)(2007-11#1)
randomised controlled clinical##4##3##(2005-3#1)(2007-11#1)(2010-5#2)
randomised controlled experimental study on##2##5##(2010-2#2)
randomised controlled studies (RCT)##2##4##(2011-2#2)
randomised controlled trial of##4##4##(1993-5#1)(2008-4#1)(2010-2#1)(2012-3#1)
randomised controlled trial##27##3##(1990-3#1)(1993-10#1)(1993-5#1)(1996-11#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-3#3)(2013-1#5)
randomised controlled trials (RCTs)##2##4##(2007-8#1)(2012-12#1)
randomised controlled trials are##2##4##(2007-9#1)(2010-12#1)
randomised controlled trials have##2##4##(2007-11#1)(2011-2#1)
randomised controlled trials in##3##4##(2005-11#1)(2007-11#1)(2010-12#1)
randomised controlled trials of##2##4##(1993-8#1)(2010-10#1)
randomised controlled trials##25##3##(1993-12#1)(1993-8#1)(1994-7#1)(1996-9#1)(2005-11#2)(2006-9#1)(2007-11#3)(2007-6#1)(2007-8#2)(2007-9#1)(2008-8#1)(2010-10#1)(2010-12#3)(2010-3#1)(2011-2#2)(2012-12#1)(2012-3#2)
randomised controlled##64##2##(1990-3#1)(1993-10#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-7#2)(1996-11#1)(1996-6#1)(1996-9#1)(2005-11#2)(2005-3#1)(2006-9#1)(2007-11#6)(2007-12#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-10#2)(2010-12#4)(2010-2#4)(2010-3#2)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#5)(2012-11#1)(2012-12#1)(2012-3#6)(2013-1#5)
randomised design##2##2##(2006-1#1)(2010-2#1)
randomised double-blind trial##2##3##(2007-11#1)(2012-2#1)
randomised double-blind##4##2##(2007-11#2)(2008-2#1)(2012-2#1)
randomised intervention study##2##3##(1994-7#1)(1997-2#1)
randomised intervention##3##2##(1994-7#1)(1997-2#1)(2005-7#1)
randomised into##3##2##(1995-9#1)(2011-2#1)(2012-2#1)
randomised prospective##2##2##(1990-3#1)(2006-8#1)
randomised studies##5##2##(2007-11#3)(2007-12#1)(2010-3#1)
randomised study##8##2##(1996-3#1)(2006-2#2)(2007-5#1)(2007-7#1)(2007-8#1)(2011-12#1)(2013-8#1)
randomised surgical##2##2##(2008-8#1)(2012-3#1)
randomised to a##2##3##(2008-3#1)(2010-3#1)
randomised to##12##2##(1990-12#1)(1992-10#1)(1993-2#2)(1993-7#1)(2005-12#1)(2008-3#1)(2008-8#2)(2010-3#1)(2010-4#1)(2012-11#1)
randomised trial comparing##2##3##(1991-11#1)(2007-11#1)
randomised trial of##6##3##(1990-2#1)(1995-9#1)(1996-2#1)(1997-3#1)(1997-5#1)(2008-8#1)
randomised trial##19##2##(1990-2#1)(1991-11#1)(1991-8#1)(1992-2#1)(1993-2#1)(1993-7#1)(1995-9#1)(1996-2#1)(1996-8#1)(1997-3#1)(1997-5#1)(2007-11#3)(2007-12#1)(2007-2#1)(2008-8#1)(2012-3#1)(2013-1#1)
randomised trials in##2##3##(2008-5#1)(2012-3#1)
randomised trials of##2##3##(1996-3#1)(2012-3#1)
randomised trials##18##2##(1993-8#1)(1996-3#1)(1997-7#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#4)(2008-5#1)(2012-2#1)(2012-3#6)
randomised##209##1##(1990-12#1)(1990-2#1)(1990-3#3)(1990-6#1)(1991-11#1)(1991-3#2)(1991-8#1)(1992-10#2)(1992-2#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#5)(1993-4#1)(1993-5#1)(1993-7#3)(1993-8#3)(1993-9#1)(1994-7#3)(1995-6#1)(1995-9#3)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#2)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#3)(2004-12#1)(2005-11#3)(2005-12#2)(2005-3#1)(2005-7#1)(2006-1#1)(2006-12#1)(2006-2#3)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#3)(2007-11#26)(2007-12#3)(2007-2#1)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#6)(2009-4#1)(2009-9#1)(2010-10#3)(2010-12#5)(2010-2#5)(2010-3#4)(2010-4#2)(2010-5#5)(2010-7#1)(2011-1#2)(2011-12#2)(2011-2#6)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#16)(2013-1#10)(2013-8#1)
randomised-controlled trial in##2##3##(2008-8#2)
randomization and##6##2##(1993-1#1)(1993-8#1)(2005-11#1)(2006-8#1)(2008-11#1)(2012-3#1)
randomization by##2##2##(2008-2#1)(2013-1#1)
randomization of##3##2##(2006-5#1)(2011-2#1)(2012-2#1)
randomization tests##4##2##(1993-4#1)(2008-9#1)(2009-4#1)(2012-3#1)
randomization to##2##2##(2008-10#1)(2012-3#1)
randomization##47##1##(1990-5#1)(1993-1#2)(1993-4#1)(1993-8#1)(1995-12#1)(1996-12#3)(2005-11#2)(2006-5#1)(2006-8#1)(2007-1#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#2)(2009-4#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#6)(2012-3#5)(2013-1#1)
randomize##2##1##(2006-10#1)(2006-5#1)
randomized and controlled clinical trial##2##5##(2011-2#2)
randomized and controlled clinical##3##4##(2011-2#3)
randomized and controlled##6##3##(1996-12#1)(2006-10#1)(2008-5#1)(2011-2#3)
randomized and##13##2##(1992-5#1)(1996-12#1)(1996-5#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-5#3)(2011-2#3)(2013-7#1)
randomized as##2##2##(2007-7#1)(2010-12#1)
randomized block design##2##3##(2008-10#2)
randomized by##2##2##(2004-1#1)(2007-10#1)
randomized case-control study##2##3##(2005-10#1)(2013-7#1)
randomized clinical study to##2##4##(2011-2#1)(2013-1#1)
randomized clinical study##5##3##(2008-5#2)(2011-2#1)(2012-3#1)(2013-1#1)
randomized clinical trial comparing##2##4##(1995-11#1)(1995-2#1)
randomized clinical trial data##2##4##(2007-9#1)(2008-7#1)
randomized clinical trial of##2##4##(1994-2#1)(2011-1#1)
randomized clinical trial was##3##4##(1991-2#1)(2008-4#1)(2008-5#1)
randomized clinical trial with##2##4##(2006-10#1)(2013-1#1)
randomized clinical trial##48##3##(1990-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1993-1#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-2#2)(1996-3#1)(1996-6#2)(1997-4#1)(2005-11#2)(2006-10#2)(2006-8#1)(2007-10#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2010-2#1)(2011-1#1)(2011-2#4)(2012-12#5)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
randomized clinical trials (RCTs)##3##4##(2008-10#1)(2009-5#1)(2010-3#1)
randomized clinical trials are##2##4##(2006-10#1)(2011-2#1)
randomized clinical trials have been##2##5##(2008-1#1)(2012-1#1)
randomized clinical trials have##3##4##(2008-1#1)(2008-8#1)(2012-1#1)
randomized clinical trials in##3##4##(2008-12#1)(2008-9#1)(2010-6#1)
randomized clinical trials of long duration##2##6##(2013-1#2)
randomized clinical trials of##5##4##(2008-7#1)(2009-4#1)(2012-2#1)(2013-1#2)
randomized clinical trials to##2##4##(2008-8#1)(2011-1#1)
randomized clinical trials with##2##4##(1992-9#1)(2007-10#1)
randomized clinical trials##50##3##(1992-9#1)(1993-1#1)(1993-9#1)(1995-2#2)(1997-3#1)(2005-11#1)(2006-10#2)(2006-5#1)(2006-8#3)(2007-10#2)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-6#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
randomized clinical##106##2##(1990-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-9#1)(1993-1#2)(1993-9#2)(1994-2#1)(1994-8#1)(1995-11#1)(1995-2#4)(1996-3#1)(1996-6#2)(1997-3#1)(1997-4#1)(2005-11#3)(2006-10#4)(2006-12#1)(2006-5#1)(2006-8#4)(2007-10#3)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#6)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#2)(2010-9#1)(2011-1#4)(2011-2#8)(2012-1#1)(2012-12#5)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#1)
randomized comparative study##3##3##(1991-7#1)(2007-3#1)(2007-8#1)
randomized comparative trial##4##3##(1995-4#1)(2007-7#1)(2007-8#1)(2011-2#1)
randomized comparative##9##2##(1991-7#1)(1993-1#1)(1994-6#1)(1995-4#1)(2007-3#1)(2007-7#1)(2007-8#2)(2011-2#1)
randomized comparison of##5##3##(1990-4#1)(1994-7#1)(1995-9#1)(2010-1#1)(2012-12#1)
randomized complete block design with##3##5##(2008-10#1)(2008-12#2)
randomized complete block design##7##4##(2007-2#1)(2008-10#4)(2008-12#2)
randomized control studies##2##3##(2010-12#1)(2011-1#1)
randomized control trial of##3##4##(2013-1#3)
randomized control trial##8##3##(2008-10#2)(2010-7#1)(2012-1#1)(2013-1#4)
randomized control trials##4##3##(2008-10#1)(2009-8#1)(2012-2#2)
randomized control##17##2##(1995-12#1)(2008-10#3)(2008-8#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#4)(2013-8#1)
randomized controlled clinical trial##5##4##(2006-9#1)(2008-8#1)(2010-12#1)(2011-1#1)(2013-1#1)
randomized controlled clinical trials (RCTs)##2##5##(2009-8#1)(2010-11#1)
randomized controlled clinical trials##3##4##(2009-8#1)(2010-11#1)(2010-4#1)
randomized controlled clinical##9##3##(2006-9#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2013-1#2)
randomized controlled pilot##2##3##(2009-11#1)(2010-10#1)
randomized controlled studies##5##3##(2008-7#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)
randomized controlled study on the##2##5##(2006-8#1)(2008-6#1)
randomized controlled study##15##3##(2005-8#1)(2006-12#1)(2006-8#1)(2007-8#1)(2008-12#3)(2008-6#1)(2008-8#2)(2009-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
randomized controlled trial (RCT)##5##4##(2006-2#1)(2011-2#1)(2013-1#2)(2013-8#1)
randomized controlled trial in##2##4##(1997-6#1)(2008-7#1)
randomized controlled trial of the##2##5##(2010-8#1)(2012-2#1)
randomized controlled trial of##11##4##(2006-10#1)(2007-5#1)(2008-8#1)(2009-12#1)(2010-8#1)(2012-2#3)(2013-1#2)(2013-8#1)
randomized controlled trial to##3##4##(2008-8#1)(2010-3#1)(2012-2#1)
randomized controlled trial was##2##4##(2007-7#1)(2011-12#1)
randomized controlled trial##60##3##(1997-2#1)(1997-4#1)(1997-6#1)(2006-10#2)(2006-2#2)(2006-3#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-3#2)(2008-7#3)(2008-8#4)(2009-12#2)(2009-5#2)(2010-10#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#2)(2011-1#2)(2011-12#2)(2011-2#2)(2012-2#5)(2012-3#1)(2013-1#10)(2013-7#2)(2013-8#2)
randomized controlled trials (RCT)##4##4##(2009-4#1)(2011-2#2)(2013-8#1)
randomized controlled trials (RCTs) of##2##5##(2008-10#1)(2012-11#1)
randomized controlled trials (RCTs)##9##4##(1993-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2009-11#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-12#1)
randomized controlled trials and##9##4##(1995-2#1)(2005-10#1)(2008-12#1)(2010-11#1)(2010-12#1)(2010-2#1)(2012-12#3)
randomized controlled trials are##3##4##(2006-10#1)(2007-7#1)(2012-2#1)
randomized controlled trials have been##3##5##(2008-8#1)(2013-1#2)
randomized controlled trials have##7##4##(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#2)(2013-1#2)
randomized controlled trials in##2##4##(2007-10#1)(2008-11#1)
randomized controlled trials including##2##4##(2007-10#1)(2009-11#1)
randomized controlled trials of##4##4##(2006-10#1)(2006-5#1)(2008-10#1)(2012-3#1)
randomized controlled trials that##5##4##(1993-12#1)(2005-8#1)(2010-2#1)(2012-3#1)(2013-8#1)
randomized controlled trials to##3##4##(2006-12#1)(2007-10#1)(2011-2#1)
randomized controlled trials##88##3##(1993-12#2)(1993-2#1)(1994-6#1)(1995-2#1)(2005-10#3)(2005-11#2)(2005-8#1)(2006-10#6)(2006-12#3)(2006-5#2)(2006-7#1)(2006-9#1)(2007-10#4)(2007-4#1)(2007-7#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#2)
randomized controlled##195##2##(1991-7#1)(1993-12#2)(1993-2#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-10#3)(2005-11#2)(2005-3#1)(2005-8#2)(2006-10#8)(2006-12#4)(2006-2#2)(2006-3#1)(2006-5#2)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#4)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#6)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#4)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#12)(2008-9#1)(2009-11#3)(2009-12#4)(2009-2#2)(2009-4#1)(2009-5#2)(2009-8#2)(2009-9#1)(2010-10#4)(2010-11#2)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#5)(2011-12#3)(2011-2#12)(2012-1#1)(2012-11#2)(2012-12#5)(2012-2#8)(2012-3#6)(2013-1#21)(2013-7#2)(2013-8#6)
randomized cross-over##2##2##(1990-7#1)(2009-4#1)
randomized crossover design##2##3##(2007-2#1)(2012-1#1)
randomized design##7##2##(2007-8#1)(2008-12#2)(2008-7#1)(2009-4#1)(2011-12#1)(2012-2#1)
randomized designs##3##2##(1993-1#1)(2008-6#1)(2009-4#1)
randomized double blind placebo-controlled##2##4##(2009-8#1)(2010-9#1)
randomized double blind##4##3##(2009-8#1)(2010-7#1)(2010-9#1)(2012-12#1)
randomized double-blind placebo-controlled study##2##4##(2008-5#1)(2013-7#1)
randomized double-blind placebo-controlled##3##3##(2008-3#1)(2008-5#1)(2013-7#1)
randomized double-blind study##4##3##(1992-2#1)(1993-4#2)(1993-9#1)
randomized double-blind trial##2##3##(1992-12#1)(2008-7#1)
randomized double-blind##18##2##(1992-12#1)(1992-2#1)(1992-3#1)(1993-4#2)(1993-9#1)(1995-4#1)(1997-1#1)(2006-10#1)(2006-6#1)(2008-3#1)(2008-5#3)(2008-7#1)(2012-2#2)(2013-7#1)
randomized experiment##2##2##(2005-9#1)(2010-6#1)
randomized fashion##2##2##(1997-2#1)(2006-12#1)
randomized field trial##2##3##(2010-10#1)(2012-12#1)
randomized field##3##2##(1994-2#1)(2010-10#1)(2012-12#1)
randomized in##6##2##(1993-8#1)(1995-8#2)(2008-7#1)(2011-2#2)
randomized into##16##2##(1991-2#1)(1992-4#1)(2005-1#1)(2007-2#1)(2007-9#2)(2008-5#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-4#1)(2011-1#1)(2012-2#2)(2013-1#2)
randomized multicenter trial##2##3##(2008-10#1)(2012-11#1)
randomized multicenter##3##2##(1993-1#1)(2008-10#1)(2012-11#1)
randomized multicentre study##2##3##(1993-3#1)(2006-6#1)
randomized patients##2##2##(2006-8#1)(2008-7#1)
randomized phase III##5##3##(2006-10#1)(2008-3#2)(2009-11#1)(2009-3#1)
randomized phase##6##2##(2006-10#1)(2008-3#2)(2009-11#1)(2009-3#2)
randomized pilot study##3##3##(1996-12#1)(2006-10#1)(2007-8#1)
randomized pilot##4##2##(1992-12#1)(1996-12#1)(2006-10#1)(2007-8#1)
randomized placebo controlled##3##3##(2006-9#1)(2008-11#1)(2012-3#1)
randomized placebo-controlled clinical##2##3##(2006-10#1)(2008-3#1)
randomized placebo-controlled study##2##3##(2006-10#1)(2012-1#1)
randomized placebo-controlled trial##2##3##(2006-10#1)(2013-1#1)
randomized placebo-controlled trials of##2##4##(2010-2#1)(2013-1#1)
randomized placebo-controlled trials##3##3##(2008-7#1)(2010-2#1)(2013-1#1)
randomized placebo-controlled##10##2##(2006-10#3)(2007-9#1)(2008-3#1)(2008-7#1)(2010-2#1)(2012-1#1)(2013-1#2)
randomized prospective##5##2##(2006-10#1)(2006-8#1)(2009-6#1)(2013-1#1)(2013-7#1)
randomized sample of##3##3##(1993-2#1)(1995-12#1)(2013-1#1)
randomized studies are needed to##2##5##(2006-10#1)(2010-12#1)
randomized studies are required##2##4##(1990-6#1)(2007-4#1)
randomized studies are##5##3##(1990-6#1)(1997-3#1)(2006-10#1)(2007-4#1)(2010-12#1)
randomized studies have##4##3##(1993-1#1)(1996-1#1)(2007-8#1)(2008-5#1)
randomized studies on##2##3##(2005-11#1)(2010-5#1)
randomized studies with##2##3##(2007-2#1)(2008-3#1)
randomized studies##21##2##(1990-6#1)(1991-8#1)(1993-1#1)(1995-9#1)(1996-1#1)(1996-11#1)(1997-3#2)(2005-11#1)(2006-10#1)(2007-2#1)(2007-4#1)(2007-8#2)(2008-10#2)(2008-3#1)(2008-5#1)(2010-12#1)(2010-5#1)(2011-2#1)
randomized study comparing##2##3##(1992-4#1)(2011-2#1)
randomized study for##3##3##(1990-10#1)(2008-1#1)(2008-11#1)
randomized study of##5##3##(1993-12#1)(1994-12#1)(1994-4#1)(2007-11#1)(2007-12#1)
randomized study on##3##3##(2006-2#1)(2007-12#1)(2013-1#1)
randomized study was designed##2##4##(1993-4#1)(2012-2#1)
randomized study was##5##3##(1993-4#1)(1997-3#1)(2007-7#1)(2009-6#1)(2012-2#1)
randomized study with##3##3##(1991-8#1)(1993-8#1)(2013-1#1)
randomized study##48##2##(1990-10#1)(1991-10#1)(1991-8#1)(1992-4#1)(1993-1#2)(1993-12#1)(1993-4#1)(1993-8#1)(1994-12#1)(1994-4#1)(1994-8#1)(1996-3#1)(1997-3#1)(1997-6#1)(2004-1#1)(2006-11#1)(2006-2#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-6#1)(2010-10#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#2)
randomized study]##2##2##(1997-3#1)(2008-10#1)
randomized to adalimumab##2##3##(2012-2#2)
randomized to continue##2##3##(2008-4#1)(2010-3#1)
randomized to either continue##2##4##(2010-3#1)(2012-3#1)
randomized to either##8##3##(2004-1#1)(2008-8#1)(2009-12#1)(2009-9#1)(2010-3#1)(2010-4#1)(2012-3#1)(2013-1#1)
randomized to one of three##2##5##(2010-11#1)(2012-12#1)
randomized to one of##4##4##(1995-9#1)(2010-11#1)(2011-1#1)(2012-12#1)
randomized to receive either##7##4##(1992-4#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-6#1)(2013-1#2)
randomized to receive##22##3##(1992-4#1)(2004-2#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-6#2)(2008-7#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
randomized to the##7##3##(2004-1#1)(2006-8#1)(2006-9#1)(2008-4#1)(2012-12#1)(2012-3#1)(2013-8#1)
randomized to##79##2##(1991-10#1)(1992-4#1)(1992-8#1)(1993-4#1)(1995-9#1)(1997-6#1)(2004-1#4)(2004-2#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#2)(2009-12#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#3)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#8)(2013-8#3)
randomized trial comparing two##2##4##(1993-1#1)(1994-7#1)
randomized trial comparing##7##3##(1993-1#2)(1993-11#1)(1994-7#1)(1995-12#1)(2007-7#1)(2008-5#1)
randomized trial in##6##3##(1990-10#1)(1990-5#1)(1992-12#1)(1994-8#1)(1996-9#1)(2005-11#1)
randomized trial of one-day vs##2##5##(2007-2#2)
randomized trial of the##2##4##(2006-8#1)(2008-10#1)
randomized trial of##18##3##(1991-11#1)(1993-9#1)(1994-3#1)(1995-3#1)(1995-4#1)(1997-7#1)(2004-3#1)(2006-5#1)(2006-8#2)(2007-2#2)(2007-4#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-4#1)(2012-2#1)
randomized trial on##3##3##(1993-11#1)(1996-1#1)(2012-12#1)
randomized trial was conducted to##3##5##(1994-7#1)(1995-4#1)(2010-4#1)
randomized trial was##4##3##(1994-7#1)(1995-4#1)(1997-6#1)(2010-4#1)
randomized trial##82##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-6#1)(1991-11#1)(1992-12#1)(1992-5#1)(1993-1#2)(1993-11#2)(1993-2#1)(1993-4#1)(1993-9#1)(1994-3#1)(1994-4#1)(1994-7#2)(1994-8#2)(1995-12#1)(1995-3#1)(1995-4#2)(1995-9#1)(1996-1#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-6#1)(1997-7#1)(2004-3#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-8#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-12#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#2)
randomized trials and##2##3##(2008-10#1)(2010-12#1)
randomized trials are##8##3##(1997-4#1)(2006-10#1)(2009-10#1)(2009-2#1)(2010-12#1)(2012-1#1)(2012-3#1)(2013-1#1)
randomized trials comparing##2##3##(2008-6#1)(2009-12#1)
randomized trials have##5##3##(1991-7#1)(1993-2#1)(1996-3#1)(2007-11#1)(2008-10#1)
randomized trials in##2##3##(1996-12#1)(2005-11#1)
randomized trials of##5##3##(2006-8#1)(2007-10#1)(2008-5#1)(2008-8#1)(2009-9#1)
randomized trials on##3##3##(2006-10#1)(2008-3#1)(2011-12#1)
randomized trials that##3##3##(2007-10#1)(2007-8#2)
randomized trials with##3##3##(2007-8#1)(2012-3#2)
randomized trials##71##2##(1991-7#1)(1992-10#1)(1993-12#4)(1993-2#1)(1995-11#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-4#1)(2004-1#1)(2005-10#1)(2005-11#4)(2006-10#7)(2006-12#1)(2006-6#1)(2006-8#4)(2007-10#2)(2007-11#1)(2007-5#2)(2007-8#3)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#3)(2012-3#5)(2013-1#1)
randomized within##3##2##(2007-10#1)(2008-11#1)(2010-4#1)
randomized##1004##1##(1990-1#1)(1990-10#3)(1990-12#3)(1990-4#2)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#1)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#4)(1991-8#3)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#4)(1992-2#3)(1992-3#2)(1992-4#3)(1992-5#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#12)(1993-11#2)(1993-12#11)(1993-2#5)(1993-3#1)(1993-4#5)(1993-8#3)(1993-9#4)(1994-11#3)(1994-12#2)(1994-2#3)(1994-3#1)(1994-4#2)(1994-6#4)(1994-7#3)(1994-8#4)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#4)(1995-2#6)(1995-3#1)(1995-4#4)(1995-8#2)(1995-9#5)(1996-1#2)(1996-11#1)(1996-12#3)(1996-3#3)(1996-5#1)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#5)(1997-3#6)(1997-4#3)(1997-5#1)(1997-6#5)(1997-7#2)(2004-1#8)(2004-12#1)(2004-2#1)(2004-3#3)(2005-1#1)(2005-10#5)(2005-11#13)(2005-3#1)(2005-7#1)(2005-8#8)(2005-9#1)(2006-10#42)(2006-11#1)(2006-12#9)(2006-2#6)(2006-3#1)(2006-5#4)(2006-6#5)(2006-7#4)(2006-8#22)(2006-9#5)(2007-10#19)(2007-11#7)(2007-12#6)(2007-2#6)(2007-3#4)(2007-4#4)(2007-5#3)(2007-7#16)(2007-8#34)(2007-9#10)(2008-1#4)(2008-10#29)(2008-11#8)(2008-12#16)(2008-2#3)(2008-3#28)(2008-4#11)(2008-5#25)(2008-6#14)(2008-7#32)(2008-8#26)(2008-9#5)(2009-10#3)(2009-11#5)(2009-12#8)(2009-2#3)(2009-3#3)(2009-4#6)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#6)(2009-9#4)(2010-1#1)(2010-10#8)(2010-11#8)(2010-12#11)(2010-2#7)(2010-3#4)(2010-4#9)(2010-5#2)(2010-6#4)(2010-7#6)(2010-8#7)(2010-9#4)(2011-1#17)(2011-12#7)(2011-2#44)(2012-1#10)(2012-11#3)(2012-12#23)(2012-2#30)(2012-3#31)(2013-1#59)(2013-7#11)(2013-8#13)
randomized)##2##1##(1992-10#1)(1993-12#1)
randomly 10##2##2##(1995-3#1)(2009-11#1)
randomly allocated to four groups##2##5##(2006-8#1)(2007-8#1)
randomly allocated to##26##3##(1990-11#1)(1990-6#1)(1990-9#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-5#1)(1993-4#1)(1995-5#1)(1997-1#1)(1997-8#1)(2004-1#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-7#2)
randomly allocated##40##2##(1990-11#1)(1990-6#1)(1990-9#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-5#1)(1993-4#1)(1995-5#1)(1997-1#1)(1997-8#1)(2004-1#1)(2006-12#2)(2006-6#1)(2006-8#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2009-10#1)(2010-12#2)(2010-7#2)(2011-12#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#2)
randomly amplified polymorphic DNA (RAPD) fragments##2##6##(2008-10#1)(2008-5#1)
randomly amplified polymorphic DNA (RAPD) markers##2##6##(1995-6#1)(1996-10#1)
randomly amplified polymorphic DNA (RAPD)##8##5##(1995-6#1)(1996-10#1)(2008-10#4)(2008-5#1)(2013-1#1)
randomly amplified polymorphic DNA##10##4##(1995-6#1)(1996-10#1)(1997-8#1)(2008-10#4)(2008-5#2)(2013-1#1)
randomly and independently##3##3##(1992-6#1)(2007-12#1)(2008-6#1)
randomly and##7##2##(1992-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-12#1)
randomly arranged##2##2##(2007-12#1)(2013-1#1)
randomly assigned into three##2##4##(2009-5#1)(2012-12#1)
randomly assigned into two##4##4##(2005-10#1)(2008-12#1)(2010-7#1)(2013-8#1)
randomly assigned into##11##3##(2005-10#1)(2005-8#1)(2007-11#1)(2008-12#1)(2008-5#1)(2009-5#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
randomly assigned patients##2##3##(2006-10#1)(2006-8#1)
randomly assigned to 10##2##4##(2008-10#1)(2013-1#1)
randomly assigned to a control group##2##6##(2005-8#1)(2008-12#1)
randomly assigned to a##12##4##(2004-10#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-12#2)(2008-6#1)(2009-11#1)(2010-2#1)(2012-2#2)(2013-1#1)
randomly assigned to be##4##4##(1991-5#1)(2006-5#1)(2013-1#1)(2013-7#1)
randomly assigned to either a control group##2##7##(2006-5#1)(2010-2#1)
randomly assigned to either a##6##5##(2006-5#1)(2008-12#1)(2008-4#1)(2010-2#1)(2010-3#1)(2013-1#1)
randomly assigned to either##12##4##(2006-5#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2013-1#1)(2013-7#1)
randomly assigned to one of the three groups##2##8##(2007-6#1)(2013-8#1)
randomly assigned to one of the##3##6##(2007-6#1)(2010-4#1)(2013-8#1)
randomly assigned to one of three##5##6##(2006-11#1)(2006-9#1)(2008-4#2)(2009-5#1)
randomly assigned to one of##14##5##(1994-7#1)(1996-8#1)(2006-11#1)(2006-9#1)(2007-6#1)(2008-4#2)(2009-5#1)(2010-4#2)(2011-2#2)(2012-2#1)(2013-8#1)
randomly assigned to receive a##2##5##(2008-8#1)(2009-12#1)
randomly assigned to receive##20##4##(1990-12#1)(1990-9#1)(1993-1#1)(1994-2#1)(1996-2#1)(2006-6#1)(2007-2#1)(2007-8#4)(2008-8#1)(2009-12#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)
randomly assigned to treatment with##2##5##(2006-10#1)(2007-8#1)
randomly assigned to treatment##4##4##(2006-10#1)(2007-8#1)(2008-2#1)(2008-6#1)
randomly assigned to##123##3##(1990-12#1)(1990-9#1)(1991-11#1)(1991-5#1)(1991-7#2)(1992-12#1)(1992-8#1)(1993-1#2)(1993-9#1)(1994-2#1)(1994-7#1)(1996-1#1)(1996-2#1)(1996-8#1)(1996-9#1)(2004-10#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#5)(2006-6#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#1)(2007-6#1)(2007-8#8)(2007-9#2)(2008-10#1)(2008-11#2)(2008-12#7)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#3)(2010-6#2)(2011-1#2)(2011-2#5)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#6)(2013-7#3)(2013-8#3)
randomly assigned treatment##2##3##(1995-3#1)(2010-3#1)
randomly assigned##149##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-5#1)(1991-7#2)(1992-12#1)(1992-8#1)(1993-1#2)(1993-9#1)(1994-2#2)(1994-7#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-8#1)(1996-9#1)(2004-10#1)(2005-10#1)(2005-8#2)(2006-10#3)(2006-11#1)(2006-2#2)(2006-4#1)(2006-5#5)(2006-6#1)(2006-8#3)(2006-9#1)(2007-10#2)(2007-11#4)(2007-12#2)(2007-2#2)(2007-3#1)(2007-6#1)(2007-8#8)(2007-9#2)(2008-10#1)(2008-11#2)(2008-12#8)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#3)(2010-3#2)(2010-4#3)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-12#4)(2012-2#7)(2012-3#1)(2013-1#7)(2013-7#4)(2013-8#4)
randomly birefringent##2##2##(2007-11#2)
randomly by##3##2##(1993-2#1)(1995-2#1)(2008-2#1)
randomly chosen from##4##3##(2007-9#1)(2008-10#2)(2009-5#1)
randomly chosen##14##2##(2006-10#2)(2007-9#1)(2008-10#6)(2008-5#1)(2008-6#2)(2009-5#1)(2012-3#1)
randomly collected from##4##3##(2008-12#1)(2008-4#1)(2011-1#1)(2012-12#1)
randomly collected##5##2##(2008-12#1)(2008-4#1)(2011-1#1)(2012-12#2)
randomly distributed and##2##3##(1993-9#1)(1996-3#1)
randomly distributed in##2##3##(2008-9#1)(2013-8#1)
randomly distributed into##3##3##(2008-12#1)(2008-5#1)(2009-4#1)
randomly distributed##20##2##(1990-4#1)(1991-3#1)(1993-9#1)(1996-3#1)(2004-9#1)(2006-5#1)(2007-12#1)(2007-6#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2012-12#1)(2013-8#1)
randomly divided into three groups of##2##6##(2008-4#1)(2009-5#1)
randomly divided into three groups##4##5##(2008-4#1)(2009-5#1)(2009-8#1)(2012-3#1)
randomly divided into two equal groups##2##6##(2007-7#1)(2007-9#1)
randomly divided into two groups of##4##6##(1991-3#1)(2008-10#1)(2008-5#1)(2010-7#1)
randomly divided into two groups##15##5##(1991-3#1)(1993-2#1)(1994-7#1)(2006-4#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-5#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#2)
randomly divided into two##18##4##(1991-3#1)(1993-2#1)(1994-7#1)(2006-4#1)(2007-2#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#1)(2008-5#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#2)
randomly divided into##47##3##(1991-3#1)(1993-12#1)(1993-2#1)(1994-7#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-5#1)(2008-6#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-7#3)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
randomly divided##49##2##(1991-3#1)(1993-12#1)(1993-2#1)(1994-7#1)(1997-3#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-5#1)(2008-6#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-7#4)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
randomly from##8##2##(1993-1#1)(1994-3#1)(2007-9#1)(2008-10#2)(2008-12#1)(2010-3#1)(2011-2#1)
randomly generated##5##2##(1995-6#1)(2008-3#1)(2012-2#1)(2013-1#2)
randomly given##2##2##(2010-12#1)(2010-7#1)
randomly in##4##2##(1992-11#1)(2008-10#1)(2008-11#1)(2013-1#1)
randomly incorporated into##2##3##(1993-11#1)(2008-4#1)
randomly oriented hexagonal ice columns##3##5##(2008-3#3)
randomly oriented hexagonal##4##3##(2008-3#4)
randomly oriented in the horizontal plane##2##6##(2008-3#2)
randomly oriented##15##2##(1995-12#1)(1997-1#1)(2008-2#2)(2008-3#9)(2008-4#1)(2008-5#1)
randomly picked clones##2##3##(1994-3#1)(2006-12#1)
randomly picked##3##2##(1994-3#1)(1997-1#1)(2006-12#1)
randomly placed##2##2##(2007-5#1)(2008-7#1)
randomly polarized##2##2##(2008-2#1)(2008-3#1)
randomly presented##3##2##(1997-7#1)(2007-12#1)(2011-1#1)
randomly primed##2##2##(1991-6#1)(2008-10#1)
randomly received##2##2##(2004-12#1)(2007-11#1)
randomly rough boundary##3##3##(2008-3#3)
randomly rough surfaces##2##3##(2007-12#1)(2008-2#1)
randomly rough##11##2##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#5)
randomly sampled clones were##2##4##(1997-2#1)(1997-4#1)
randomly sampled##10##2##(1997-2#2)(1997-4#1)(2006-8#1)(2008-10#3)(2012-2#2)(2012-3#1)
randomly selected Canadian organizations having at least 500 employees##2##9##(1993-1#1)(1994-2#1)
randomly selected children##2##3##(2006-10#1)(2008-10#1)
randomly selected clones##2##3##(2007-2#1)(2008-5#1)
randomly selected for##8##3##(1993-12#1)(1996-12#1)(1997-3#1)(2006-8#1)(2008-3#1)(2008-5#1)(2012-2#1)(2013-1#1)
randomly selected from a##3##4##(1992-11#1)(2008-7#2)
randomly selected from##18##3##(1990-12#1)(1992-11#1)(1996-12#1)(2006-7#1)(2006-8#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-2#1)(2010-3#1)(2011-1#1)(2013-1#1)
randomly selected in##3##3##(2008-10#1)(2013-1#2)
randomly selected individuals##2##3##(2009-10#1)(2011-1#1)
randomly selected patients with##2##4##(1997-6#1)(2008-6#1)
randomly selected patients##5##3##(1993-2#1)(1994-2#1)(1997-6#1)(2007-10#1)(2008-6#1)
randomly selected population##2##3##(1993-9#1)(2006-10#1)
randomly selected sample of##5##4##(1990-5#1)(1994-12#1)(2006-10#2)(2012-12#1)
randomly selected sample##6##3##(1990-5#2)(1994-12#1)(2006-10#2)(2012-12#1)
randomly selected samples##3##3##(1992-10#1)(2008-10#1)(2012-2#1)
randomly selected schools##2##3##(2007-2#2)
randomly selected to be##2##4##(1995-6#1)(2013-1#1)
randomly selected to##5##3##(1995-6#1)(2007-2#1)(2009-7#1)(2011-2#1)(2013-1#1)
randomly selected were##2##3##(2009-5#1)(2011-1#1)
randomly selected women##2##3##(2007-7#1)(2010-5#1)
randomly selected##147##2##(1990-12#1)(1990-5#2)(1990-7#2)(1992-10#1)(1992-11#1)(1993-1#2)(1993-12#3)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(2004-10#1)(2004-8#1)(2005-11#1)(2006-10#5)(2006-2#1)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#3)(2007-1#2)(2007-10#6)(2007-2#7)(2007-3#1)(2007-6#1)(2007-7#4)(2008-1#2)(2008-10#11)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#3)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#4)(2009-10#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-2#2)(2010-3#2)(2010-5#1)(2010-8#1)(2011-1#7)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#14)(2013-7#1)(2013-8#2)
randomly shifted##2##2##(2008-2#2)
randomly to##9##2##(1991-1#1)(1992-1#1)(1994-2#1)(1995-11#1)(2006-10#1)(2007-9#1)(2008-5#1)(2008-8#1)(2009-6#1)
randomly varying##2##2##(2007-12#1)(2008-2#1)
randomly were##2##2##(2008-12#1)(2012-2#1)
randomly with##2##2##(1995-6#1)(2007-9#1)
randomly##621##1##(1990-11#2)(1990-12#2)(1990-4#1)(1990-5#4)(1990-6#2)(1990-7#2)(1990-9#2)(1991-1#1)(1991-11#1)(1991-3#3)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#1)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-1#5)(1993-11#1)(1993-12#4)(1993-2#4)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#3)(1994-10#1)(1994-12#1)(1994-2#5)(1994-3#3)(1994-6#1)(1994-7#2)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#4)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#6)(1997-2#3)(1997-3#2)(1997-4#2)(1997-6#3)(1997-7#1)(1997-8#2)(2004-1#2)(2004-10#2)(2004-12#1)(2004-8#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-8#2)(2006-10#12)(2006-11#1)(2006-12#3)(2006-2#3)(2006-4#4)(2006-5#7)(2006-6#2)(2006-7#1)(2006-8#9)(2006-9#1)(2007-1#2)(2007-10#9)(2007-11#9)(2007-12#14)(2007-2#13)(2007-3#2)(2007-5#1)(2007-6#3)(2007-7#7)(2007-8#16)(2007-9#7)(2008-1#4)(2008-10#46)(2008-11#5)(2008-12#17)(2008-2#15)(2008-3#28)(2008-4#11)(2008-5#20)(2008-6#9)(2008-7#8)(2008-8#8)(2008-9#3)(2009-10#3)(2009-11#4)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#8)(2009-6#1)(2009-7#2)(2009-8#3)(2010-1#3)(2010-10#1)(2010-12#7)(2010-2#7)(2010-3#5)(2010-4#4)(2010-5#1)(2010-6#2)(2010-7#8)(2010-8#2)(2010-9#1)(2011-1#14)(2011-12#2)(2011-2#14)(2011-3#1)(2012-1#1)(2012-12#10)(2012-2#19)(2012-3#9)(2013-1#37)(2013-7#9)(2013-8#10)
randomly-firing type##2##2##(1994-10#2)
randomly-rearranged##2##1##(2013-1#2)
randomly-selected##2##1##(1995-2#1)(2005-9#1)
randomness of the##2##3##(2008-10#1)(2012-2#1)
randomness of##4##2##(2008-10#3)(2012-2#1)
randomness##17##1##(1993-6#1)(1994-11#1)(1996-2#1)(2004-11#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-6#1)(2010-10#1)(2012-12#2)(2012-2#1)(2013-8#1)
ranelate##5##1##(2008-3#1)(2013-1#4)
rang of 0##2##3##(2005-4#1)(2008-10#1)
range (&gt##3##2##(1995-10#1)(2006-9#1)(2007-3#1)
range (&lt##2##2##(1995-10#1)(2008-10#1)
range (0##9##2##(1991-9#1)(1993-12#1)(1993-2#1)(1994-3#1)(2007-8#1)(2008-10#3)(2008-5#1)
range (1##11##2##(2008-10#11)
range (2##2##2##(2008-10#2)
range (3##2##2##(1993-8#1)(2008-10#1)
range (7##3##2##(1992-2#1)(1992-4#1)(2008-3#1)
range (alb/Cr ratio &gt##2##4##(1992-9#2)
range (d=0##2##2##(2012-2#2)
range (e##2##2##(2008-10#1)(2010-5#1)
range (from##2##2##(2007-1#1)(2008-10#1)
range (i##3##2##(1992-8#1)(2006-2#1)(2008-3#1)
range (pH##3##2##(1991-5#1)(2008-10#2)
range 0 &lt##3##3##(2008-3#3)
range 0 degrees to 180 degrees##2##6##(2007-12#2)
range 0 degrees##3##3##(2007-12#2)(2008-2#1)
range 0##180##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-5#1)(1991-8#1)(1992-12#2)(1993-1#1)(1993-2#2)(1993-4#2)(1993-8#1)(1994-11#1)(1995-3#1)(1996-5#1)(1996-6#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-9#1)(2005-11#2)(2005-7#2)(2006-9#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#121)(2008-2#6)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#2)(2012-1#1)(2012-12#2)(2013-7#3)(2013-8#1)
range 0-100##2##2##(1996-1#1)(2008-10#1)
range 0-2##2##2##(1990-2#1)(2008-10#1)
range 1 to##2##3##(2008-7#1)(2013-1#1)
range 1##59##2##(1992-8#1)(1994-2#1)(1996-1#1)(1996-6#1)(1997-1#1)(1997-7#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-5#1)(2007-8#2)(2008-10#33)(2008-2#2)(2008-5#3)(2008-7#1)(2010-5#1)(2013-1#3)
range 1-20##2##2##(2008-10#1)(2008-12#1)
range 10##3##2##(1997-3#1)(2007-11#1)(2008-2#1)
range 100##3##2##(1990-6#1)(2005-11#1)(2008-10#1)
range 13##2##2##(2005-9#1)(2007-8#1)
range 15##2##2##(2008-2#1)(2009-3#1)
range 15-45##4##2##(2008-2#1)(2008-7#1)(2013-1#2)
range 2##29##2##(1992-11#1)(1992-2#2)(1993-7#1)(1996-6#1)(2008-10#22)(2008-2#1)(2009-3#1)
range 2-52##2##2##(1992-3#1)(1996-9#1)
range 2-6##2##2##(2008-1#1)(2008-10#1)
range 2-8##2##2##(2008-10#1)(2008-5#1)
range 20##2##2##(1995-2#1)(2005-11#1)
range 20-100 ng ml(-1)##2##4##(2008-10#2)
range 20-100##4##2##(1995-11#1)(2008-10#3)
range 24##2##2##(1992-12#1)(2007-10#1)
range 3##19##2##(1990-5#1)(1996-5#1)(2007-12#1)(2008-10#14)(2008-3#1)(2013-8#1)
range 3-11##2##2##(1991-12#1)(2007-11#1)
range 3-6##3##2##(1997-2#1)(2007-11#1)(2008-10#1)
range 4##16##2##(1990-5#1)(1992-6#1)(1995-2#1)(1996-2#1)(2007-11#1)(2008-10#10)(2010-4#1)
range 5##21##2##(1991-10#1)(1991-9#1)(1992-6#1)(1994-9#1)(1996-11#1)(2008-10#15)(2008-3#1)
range 5-100##2##2##(2006-10#1)(2008-10#1)
range 5-100%)##3##2##(2008-9#3)
range 6##15##2##(1991-5#1)(1992-7#1)(1997-4#1)(2008-10#10)(2008-5#1)(2008-7#1)
range 650-1000 nm##2##3##(2008-3#2)
range 7##9##2##(1992-12#1)(1995-5#1)(1997-1#2)(2008-10#5)
range 8##3##2##(1997-3#1)(2008-10#2)
range 9##4##2##(2008-10#4)
range =##4##2##(1995-11#2)(2007-7#1)(2008-8#1)
range accuracy##2##2##(2008-3#2)
range after##3##2##(2008-7#1)(2009-2#1)(2013-8#1)
range also##2##2##(2006-6#1)(2010-10#1)
range and a##5##3##(1994-12#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-3#1)
range and are##3##3##(2006-4#1)(2008-2#1)(2009-9#1)
range and detection##3##3##(2008-10#3)
range and good##2##3##(2008-10#1)(2008-2#1)
range and higher##2##3##(2007-8#1)(2008-10#1)
range and in the##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
range and in##5##3##(2007-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
range and is##3##3##(1997-6#1)(2007-11#1)(2007-12#1)
range and not##2##3##(1996-6#1)(2008-10#1)
range and sensitivity##3##3##(2008-10#1)(2008-3#2)
range and slope##4##3##(2008-10#4)
range and spectral##2##3##(2006-2#1)(2008-2#1)
range and symptomatology##2##3##(2008-10#2)
range and that##2##3##(1990-12#1)(1997-2#1)
range and the sensitivity##2##4##(2008-2#2)
range and the##16##3##(1996-1#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#2)(2013-1#2)(2013-8#1)
range and to##2##3##(2008-10#1)(2008-3#1)
range and##140##2##(1990-12#2)(1990-3#1)(1992-10#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-4#1)(1994-9#1)(1995-10#1)(1995-7#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-5#1)(2007-1#1)(2007-11#8)(2007-12#6)(2007-8#1)(2008-10#44)(2008-11#1)(2008-2#13)(2008-3#13)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-3#1)(2009-9#1)(2010-3#1)(2010-4#1)(2011-1#3)(2012-12#1)(2013-1#8)(2013-8#1)
range approximately##2##2##(1995-6#1)(2008-10#1)
range are discussed##3##3##(2007-11#2)(2008-2#1)
range are measured for channel waveguides with##2##7##(2008-2#2)
range are reported##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
range are##19##2##(1991-9#1)(1993-11#1)(1996-4#1)(2006-10#1)(2007-11#3)(2007-8#1)(2008-10#2)(2008-2#5)(2008-3#1)(2008-8#1)(2010-10#1)(2012-3#1)
range as a function of##2##5##(2008-2#1)(2008-3#1)
range as the##4##3##(1991-3#1)(1992-3#1)(1994-11#1)(2008-2#1)
range as well as##2##4##(2008-2#1)(2008-3#1)
range as##20##2##(1990-11#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-11#1)(1995-5#1)(2006-9#1)(2007-12#1)(2007-4#1)(2008-2#3)(2008-3#3)(2012-2#1)(2013-1#1)(2013-8#1)
range associated with##2##3##(1994-6#1)(2007-1#1)
range at a##2##3##(2007-11#1)(2008-3#1)
range at##7##2##(2004-11#2)(2007-11#1)(2007-5#1)(2008-2#1)(2008-3#1)(2013-7#1)
range based on##2##3##(2008-10#1)(2012-2#1)
range below##2##2##(1996-5#1)(2008-3#1)
range between 0 and##2##4##(2008-10#2)
range between 0##18##3##(1990-12#1)(2006-2#1)(2007-8#1)(2008-10#13)(2008-3#1)(2012-2#1)
range between 1 and##3##4##(2008-10#2)(2008-3#1)
range between 1##11##3##(2007-8#1)(2008-10#8)(2008-2#1)(2008-3#1)
range between 10 and##3##4##(2007-8#1)(2008-10#2)
range between 10 pg and##2##5##(2008-10#2)
range between 10##5##3##(2007-8#1)(2008-10#4)
range between 2 and##2##4##(2008-10#1)(2013-7#1)
range between 2##3##3##(2008-10#2)(2013-7#1)
range between 20##2##3##(2006-2#1)(2007-11#1)
range between 4 and##2##4##(2008-10#2)
range between 4##4##3##(2008-10#3)(2008-3#1)
range between 6##2##3##(2006-5#1)(2009-5#1)
range between 7##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
range between 96##2##3##(2008-10#2)
range between##75##2##(1990-12#1)(1991-2#1)(1992-3#1)(1993-2#1)(1995-1#1)(1997-1#1)(2005-11#1)(2005-12#1)(2006-2#2)(2006-5#1)(2007-11#1)(2007-8#3)(2008-10#42)(2008-11#1)(2008-2#7)(2008-3#3)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-7#1)
range but with##2##3##(2008-3#1)(2008-5#1)
range but##6##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)
range by the##4##3##(1997-1#1)(2007-12#1)(2008-3#1)(2011-2#1)
range by use of##4##4##(2007-12#2)(2008-3#2)
range by##25##2##(1997-1#1)(2007-11#5)(2007-12#4)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#4)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#2)
range calculated from##3##3##(1991-4#1)(2013-1#2)
range can be extended up to##2##6##(2008-10#2)
range can be##9##3##(2007-11#2)(2007-12#2)(2007-7#1)(2008-10#3)(2008-2#1)
range can##10##2##(2007-11#2)(2007-12#2)(2007-7#1)(2008-10#3)(2008-2#2)
range centered##2##2##(2007-12#1)(2008-2#1)
range covered by##2##3##(1996-1#1)(2007-11#1)
range covered##3##2##(1996-1#1)(2007-11#1)(2008-10#1)
range covers##2##2##(2007-12#1)(2008-10#1)
range data##2##2##(2008-2#1)(2008-6#1)
range dependence of the##2##4##(2008-3#2)
range divided by##2##3##(2008-10#1)(2008-2#1)
range divided##3##2##(2008-10#1)(2008-2#2)
range down to##2##3##(1996-4#1)(2006-12#1)
range during the##2##3##(2010-8#1)(2012-2#1)
range during##4##2##(1993-12#1)(2004-11#1)(2010-8#1)(2012-2#1)
range effects##2##2##(2008-3#1)(2012-2#1)
range employed##2##2##(1995-10#1)(1997-2#1)
range estimates##2##2##(1995-3#1)(2008-3#1)
range examined##4##2##(2008-10#4)
range expanded##5##2##(2008-11#4)(2013-1#1)
range expansion of##2##3##(2007-12#1)(2011-12#1)
range expansion##7##2##(1997-4#1)(2004-11#1)(2006-5#1)(2007-12#1)(2010-6#1)(2010-8#1)(2011-12#1)
range extended up to##2##4##(2007-8#1)(2008-10#1)
range extended##5##2##(1993-12#1)(2007-8#2)(2008-10#2)
range extends##2##2##(2008-10#2)
range for a set of##2##5##(2008-10#2)
range for a##6##3##(2008-10#2)(2008-2#1)(2008-3#3)
range for all##4##3##(1996-6#1)(2006-6#1)(2007-12#1)(2008-2#1)
range for both the##2##4##(2008-10#1)(2010-2#1)
range for detection##2##3##(2008-2#1)(2009-4#1)
range for determination of##2##4##(2008-10#1)(2008-3#1)
range for determination##3##3##(2008-10#2)(2008-3#1)
range for each##2##3##(2007-8#1)(2011-2#1)
range for the determination of##5##5##(2008-10#5)
range for the two##2##4##(2006-12#1)(2008-10#1)
range for the##24##3##(1994-11#1)(1996-5#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-2#1)(2008-10#12)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)
range for this##2##3##(2008-10#1)(2008-11#1)
range for which the##2##4##(2007-12#1)(2012-1#1)
range for##108##2##(1990-11#2)(1991-10#1)(1991-12#1)(1992-11#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-11#1)(1994-9#1)(1995-1#1)(1996-3#1)(1996-5#1)(1996-6#2)(1997-2#1)(2004-11#2)(2006-12#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#6)(2007-2#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#37)(2008-11#3)(2008-2#8)(2008-3#8)(2008-7#2)(2008-8#1)(2009-2#1)(2009-4#2)(2010-2#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#1)
range found##3##2##(1997-8#1)(2008-10#1)(2008-3#1)
range from 0 to 0##2##5##(2008-10#1)(2010-4#1)
range from 0 to 1##3##5##(2008-10#2)(2008-5#1)
range from 0 to##19##4##(1993-8#1)(1995-3#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-5#1)(2010-4#1)(2010-5#1)(2013-1#1)
range from 0##76##3##(1990-12#2)(1991-8#1)(1992-11#1)(1992-12#1)(1993-8#1)(1994-6#1)(1995-3#1)(1995-5#1)(1996-7#1)(2005-11#1)(2007-11#2)(2007-12#2)(2007-8#6)(2008-10#32)(2008-11#1)(2008-2#4)(2008-3#6)(2008-5#1)(2010-4#3)(2010-5#2)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
range from 1 to 2##2##5##(1993-9#1)(2007-11#1)
range from 1 to##8##4##(1993-9#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-3#1)
range from 1##33##3##(1990-2#1)(1993-9#1)(1994-8#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#2)(2008-10#16)(2008-11#1)(2008-2#3)(2008-3#2)(2013-1#1)
range from 10 to 100##2##5##(2008-4#1)(2008-8#1)
range from 10 to##10##4##(1990-8#1)(1997-2#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-8#1)
range from 10##12##3##(1990-8#1)(1997-2#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)
range from 10(-1) to##2##4##(2008-10#2)
range from 10(-4) to##3##4##(1995-1#1)(2008-10#2)
range from 10(-5)##2##3##(2008-10#1)(2008-2#1)
range from 100##2##3##(2006-2#1)(2008-10#1)
range from 125##2##3##(2008-2#1)(2008-3#1)
range from 15 to##2##4##(1995-10#1)(2008-2#1)
range from 18##2##3##(2007-12#1)(2012-12#1)
range from 19 to##2##4##(2008-10#1)(2008-2#1)
range from 2 to##7##4##(2007-7#1)(2008-10#5)(2012-2#1)
range from 2##19##3##(1996-2#2)(2005-8#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#10)(2012-2#1)
range from 20 to##4##4##(1990-8#1)(1991-2#1)(2008-10#1)(2008-12#1)
range from 25 to##3##4##(2007-11#1)(2008-10#2)
range from 25##4##3##(2007-11#1)(2008-10#2)(2008-5#1)
range from 27##2##3##(2008-10#1)(2009-2#1)
range from 3 to##2##4##(2008-10#2)
range from 3##13##3##(1990-4#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-2#1)
range from 30 to##2##4##(2005-11#1)(2008-3#1)
range from 300 to##4##4##(2008-2#1)(2008-3#3)
range from 4 to##2##4##(2008-10#1)(2008-11#1)
range from 4##9##3##(1996-9#1)(2007-12#2)(2008-10#5)(2008-11#1)
range from 40 to##2##4##(2008-10#1)(2008-2#1)
range from 400 to##2##4##(2008-10#1)(2008-3#1)
range from 5 to##8##4##(2008-10#5)(2008-3#1)(2008-4#1)(2013-1#1)
range from 5##20##3##(1996-7#1)(1997-2#1)(2007-8#2)(2008-10#11)(2008-3#2)(2008-4#1)(2012-12#1)(2013-1#1)
range from 50 to##5##4##(2008-10#3)(2008-3#1)(2008-5#1)
range from 500##2##3##(2008-3#1)(2013-1#1)
range from 54 to##2##4##(1995-3#1)(2008-2#1)
range from 6##5##3##(1992-12#1)(1994-3#1)(1994-9#1)(2006-4#1)(2008-9#1)
range from 7 to##2##4##(2007-8#1)(2008-10#1)
range from 7##5##3##(1991-9#1)(1994-10#1)(2007-8#1)(2008-10#1)(2012-1#1)
range from 70 to##2##4##(1992-2#1)(1994-3#1)
range from 70##3##3##(1992-2#1)(1994-3#1)(2008-10#1)
range from 8##4##3##(2008-10#3)(2008-3#1)
range from 80 to##3##4##(2008-10#2)(2008-3#1)
range from 80##5##3##(1993-8#1)(2007-5#1)(2008-10#2)(2008-3#1)
range from 91 to##4##4##(2008-10#4)
range from a##8##3##(1991-8#1)(1996-6#1)(2007-7#1)(2008-12#1)(2008-2#2)(2008-8#1)(2012-2#1)
range from about##3##3##(1997-2#1)(2007-12#1)(2011-2#1)
range from approximately##3##3##(1991-9#1)(2006-4#1)(2008-2#1)
range from assessing##2##3##(1997-2#1)(2008-10#1)
range from asymptomatic##2##3##(2005-12#1)(2007-2#1)
range from minimal##3##3##(2004-4#1)(2005-8#1)(2006-9#1)
range from minor##2##3##(1995-2#1)(2008-11#1)
range from pH##2##3##(2007-8#1)(2008-5#1)
range from the##8##3##(1993-10#2)(2007-11#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-9#1)
range from##421##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-8#4)(1991-2#1)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#2)(1992-2#2)(1993-10#2)(1993-11#1)(1993-4#2)(1993-8#2)(1993-9#1)(1994-10#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-2#4)(1996-6#1)(1996-7#2)(1996-9#2)(1997-2#7)(1997-7#2)(2004-11#1)(2004-4#1)(2005-11#6)(2005-12#1)(2005-8#2)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#3)(2006-5#1)(2006-8#1)(2006-9#4)(2007-10#2)(2007-11#13)(2007-12#19)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#14)(2007-9#2)(2008-10#145)(2008-11#4)(2008-12#2)(2008-2#31)(2008-3#29)(2008-4#3)(2008-5#9)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#1)(2010-11#2)(2010-12#2)(2010-4#5)(2010-5#2)(2010-8#2)(2011-1#1)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#4)(2012-3#4)(2013-1#10)(2013-7#2)
range gate##3##2##(2008-2#1)(2008-3#2)
range greater than##2##3##(2007-12#2)
range has been obtained##2##4##(2008-2#1)(2008-3#1)
range has been##8##3##(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#2)(2009-2#1)
range has##10##2##(1993-11#1)(1993-9#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#2)(2009-2#1)
range have been##2##3##(2008-2#2)
range in a##2##3##(2007-12#1)(2011-1#1)
range in both groups##2##4##(1991-10#1)(2013-1#1)
range in size from##4##4##(1991-12#1)(1992-12#1)(1997-8#1)(2008-2#1)
range in size##5##3##(1991-12#1)(1992-12#1)(1997-8#1)(2005-8#1)(2008-2#1)
range in the##7##3##(1995-2#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2012-1#1)
range in which##3##3##(2005-7#1)(2008-10#1)(2008-2#1)
range in##67##2##(1991-10#2)(1991-12#1)(1991-4#1)(1992-12#1)(1993-2#1)(1993-7#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#1)(1996-10#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-11#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-7#5)(2008-1#1)(2008-10#11)(2008-2#4)(2008-3#1)(2008-6#1)(2008-7#3)(2009-4#1)(2010-11#1)(2010-7#1)(2011-1#2)(2011-11#1)(2012-1#1)(2013-1#2)(2013-8#1)
range includes##2##2##(2008-10#1)(2008-3#1)
range including##2##2##(2007-12#1)(2008-3#1)
range increases##3##2##(2008-3#1)(2008-5#1)(2009-11#1)
range into##2##2##(1991-4#1)(2010-8#1)
range investigated##5##2##(1991-12#1)(2004-9#1)(2008-10#2)(2008-3#1)
range is 0##5##3##(1991-9#1)(2008-10#4)
range is 1##3##3##(2008-10#3)
range is 2##4##3##(2005-4#1)(2008-10#3)
range is 5##2##3##(2005-4#1)(2012-2#1)
range is between##4##3##(1995-3#1)(1997-8#1)(2008-10#1)(2013-8#1)
range is demonstrated##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
range is described##2##3##(1990-12#1)(2007-12#1)
range is set##2##3##(2007-12#1)(2008-1#1)
range is used##2##3##(2007-11#1)(2007-2#1)
range is##72##2##(1990-12#1)(1991-9#1)(1992-12#1)(1993-9#1)(1995-1#1)(1995-3#1)(1995-9#1)(1997-8#1)(2005-4#2)(2006-6#1)(2007-11#5)(2007-12#7)(2007-2#1)(2008-1#3)(2008-10#29)(2008-2#4)(2008-3#6)(2008-5#1)(2008-7#1)(2008-8#2)(2012-2#1)(2013-8#1)
range limit##2##2##(2008-3#2)
range limits##4##2##(2008-3#1)(2008-8#2)(2008-9#1)
range may##3##2##(1997-2#1)(1997-5#1)(2006-9#1)
range measured##2##2##(1990-11#1)(1995-5#1)
range measurements##2##2##(2008-2#2)
range near##2##2##(2007-11#1)(2007-12#1)
range obtained##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
range of &gt##3##3##(2008-2#2)(2008-3#1)
range of (1##2##3##(1995-2#1)(2008-10#1)
range of 0##201##3##(1990-12#2)(1990-7#3)(1991-10#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-8#2)(2005-12#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-8#7)(2008-10#135)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#6)(2008-8#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#2)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#4)(2013-1#2)(2013-8#2)
range of 0-10##2##3##(2008-10#2)
range of 0-25##2##3##(2008-10#1)(2010-5#1)
range of 0-7##3##3##(2005-4#1)(2008-10#2)
range of 1 to##3##4##(1995-3#1)(2008-5#1)(2010-4#1)
range of 1 x##2##4##(2008-10#2)
range of 1##63##3##(1990-5#1)(1992-1#1)(1993-4#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-5#1)(1996-6#1)(2006-7#1)(2007-1#1)(2007-12#2)(2008-10#34)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#3)(2010-12#1)(2010-4#2)(2011-1#2)(2011-2#1)(2012-12#1)
range of 1-10##3##3##(1994-12#1)(2008-10#1)(2010-2#1)
range of 1-100##2##3##(2008-10#1)(2008-2#1)
range of 1-1000##2##3##(1992-8#1)(2008-10#1)
range of 1-20##2##3##(1990-5#1)(2007-8#1)
range of 1-4##2##3##(1991-2#1)(2008-5#1)
range of 10 to##4##4##(1993-9#1)(2007-2#1)(2008-10#1)(2012-11#1)
range of 10##20##3##(1993-9#1)(1994-8#1)(1996-1#1)(2005-12#2)(2007-12#4)(2007-2#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#1)(2012-11#1)
range of 10-100##4##3##(1994-8#1)(2005-4#1)(2008-10#2)
range of 10-60##2##3##(2008-10#1)(2008-2#1)
range of 100 nM##2##4##(1994-5#1)(2009-11#1)
range of 100##9##3##(1992-6#1)(1994-5#1)(2007-11#2)(2008-11#1)(2008-2#1)(2008-3#1)(2009-11#1)(2010-11#1)
range of 100-10##2##3##(2008-10#2)
range of 12##3##3##(1991-10#1)(1996-9#1)(2005-7#1)
range of 13##2##3##(1993-1#1)(2007-1#1)
range of 14##2##3##(2007-2#1)(2012-3#1)
range of 15##2##3##(2008-10#1)(2008-3#1)
range of 15%##2##3##(2007-12#1)(2008-2#1)
range of 150##3##3##(1995-12#1)(2008-3#1)(2008-9#1)
range of 17##2##3##(2007-12#1)(2010-5#1)
range of 1x10(-7) to##3##4##(2007-8#1)(2008-10#2)
range of 2##43##3##(1991-8#1)(1996-8#1)(2005-4#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-10#31)(2008-2#1)(2008-3#1)(2008-5#1)(2010-2#1)(2013-1#1)
range of 2-10##2##3##(2008-10#1)(2008-2#1)
range of 2-8##3##3##(2006-1#1)(2006-8#1)(2007-12#1)
range of 20 to##3##4##(1997-6#1)(2008-1#1)(2008-5#1)
range of 20##7##3##(1993-12#1)(1997-6#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)
range of 200-800##2##3##(2007-8#1)(2008-5#1)
range of 25##3##3##(2005-12#1)(2008-3#1)(2008-6#1)
range of 28##2##3##(1995-5#1)(2007-11#1)
range of 3##27##3##(1993-12#1)(1994-8#1)(1996-9#1)(1997-2#1)(2005-11#1)(2006-12#1)(2006-2#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-12#1)(2010-12#1)(2010-3#1)
range of 3-7 for##2##4##(1991-9#2)
range of 30##3##3##(1991-9#1)(2007-12#1)(2009-5#1)
range of 32##2##3##(2005-8#1)(2007-11#1)
range of 4 to##2##4##(2008-10#1)(2013-1#1)
range of 4##23##3##(1992-12#1)(1995-12#1)(2006-2#1)(2006-8#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-9#1)(2013-1#2)
range of 40##2##3##(2007-12#1)(2008-2#1)
range of 46##2##3##(1996-7#1)(2007-11#1)
range of 48##2##3##(2008-3#1)(2011-1#1)
range of 5 to##5##4##(1996-8#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-7#1)
range of 5 x##2##4##(2008-10#2)
range of 5##29##3##(1996-8#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#20)(2008-3#2)(2010-5#1)(2013-8#1)
range of 5-100##2##3##(2007-8#2)
range of 5-30##2##3##(1991-4#1)(2008-10#1)
range of 50##4##3##(2007-11#1)(2008-10#1)(2008-2#2)
range of 50-1000##2##3##(2008-10#2)
range of 500##2##3##(2008-2#1)(2008-3#1)
range of 6 to##3##4##(1992-7#1)(2011-2#2)
range of 6##17##3##(1992-7#1)(1993-3#1)(1997-8#1)(2006-12#2)(2007-9#1)(2008-10#6)(2008-7#1)(2008-8#1)(2011-2#2)(2013-1#1)
range of 60##2##3##(1993-9#1)(2011-1#1)
range of 7##15##3##(1992-12#1)(1996-5#1)(2008-1#1)(2008-10#8)(2008-3#1)(2008-4#1)(2010-5#1)(2012-2#1)
range of 8##7##3##(2006-4#1)(2007-8#1)(2008-10#4)(2008-4#1)
range of 80 nm##2##4##(2007-12#1)(2008-3#1)
range of 80##3##3##(2007-10#1)(2007-12#1)(2008-3#1)
range of 9##5##3##(1996-2#1)(2007-8#1)(2008-10#3)
range of 90##2##3##(2008-10#1)(2008-2#1)
range of 94-100%##2##3##(2008-10#2)
range of DNA##2##3##(1994-6#1)(2008-10#1)
range of H(2)O(2) and##2##4##(2008-10#1)(2013-1#1)
range of a few##2##4##(2008-3#2)
range of a##10##3##(1993-9#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#3)
range of about##5##3##(1994-2#1)(1996-7#1)(1997-3#1)(2008-10#2)
range of absorption##2##3##(2008-3#1)(2008-5#1)
range of acceptance##2##3##(2007-10#1)(2008-3#1)
range of actions##3##3##(1993-9#1)(2008-1#1)(2008-8#1)
range of activities##4##3##(2008-12#2)(2008-5#1)(2011-1#1)
range of acute##2##3##(2006-9#1)(2008-5#1)
range of adult##3##3##(1994-2#1)(2005-7#1)(2012-12#1)
range of adverse##3##3##(2005-7#1)(2009-3#1)(2013-1#1)
range of age##2##3##(1992-7#1)(2006-2#1)
range of alkyl##2##3##(2005-8#1)(2011-1#1)
range of allele##2##3##(1991-12#1)(2008-10#1)
range of alternative##2##3##(2008-8#1)(2008-9#1)
range of amino acids##2##4##(1992-9#1)(2011-2#1)
range of amino##3##3##(1992-9#1)(1996-9#1)(2011-2#1)
range of amplitudes##2##3##(1994-9#1)(2012-7#1)
range of an##2##3##(2007-12#1)(2011-1#1)
range of analytes##2##3##(2008-10#1)(2008-5#1)
range of analytical methods##2##4##(2010-4#1)(2011-2#1)
range of analytical##4##3##(1996-3#1)(2007-12#1)(2010-4#1)(2011-2#1)
range of angles of incidence##3##5##(2008-2#1)(2008-3#2)
range of angles##6##3##(2006-2#1)(2007-12#1)(2008-2#1)(2008-3#3)
range of animal##3##3##(2006-5#1)(2010-12#1)(2012-2#1)
range of annual##3##3##(2011-2#3)
range of applicability##3##3##(2006-11#1)(2008-2#1)(2008-3#1)
range of application##2##3##(2008-10#2)
range of applications for##2##4##(2008-11#1)(2008-2#1)
range of applications of##3##4##(1997-4#1)(2008-7#1)(2012-2#1)
range of applications##25##3##(1996-5#1)(1997-4#1)(1997-8#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#2)(2010-12#2)(2011-1#1)(2012-2#3)
range of approximately 1##2##4##(2007-12#1)(2008-3#1)
range of approximately##8##3##(1991-10#1)(2007-12#3)(2008-2#1)(2008-3#3)
range of at least##3##4##(2008-10#1)(2008-3#2)
range of available##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
range of bacterial##5##3##(1995-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2013-1#1)
range of benchmark##2##3##(2010-2#1)(2013-1#1)
range of biological activities##4##4##(2008-7#1)(2011-3#1)(2012-12#1)(2012-2#1)
range of biological##11##3##(1991-2#1)(1993-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-3#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
range of biologically##2##3##(1993-6#1)(2007-7#1)
range of biomedical applications##2##4##(2009-12#1)(2010-9#1)
range of body sizes##2##4##(2006-11#1)(2012-2#1)
range of body##4##3##(2006-11#1)(2007-12#1)(2009-10#1)(2012-2#1)
range of both##3##3##(2005-7#1)(2006-10#1)(2008-10#1)
range of calcium concentrations##2##4##(1990-7#1)(1993-6#1)
range of cancers##4##3##(2008-3#1)(2009-11#1)(2010-1#1)(2011-2#1)
range of cell types##4##4##(1991-10#1)(1994-5#1)(2008-10#1)(2010-5#1)
range of cell##6##3##(1991-10#1)(1994-5#1)(1994-8#1)(2008-10#1)(2010-5#1)(2012-1#1)
range of cellular processes##5##4##(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
range of cellular##8##3##(1993-9#1)(1994-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
range of chemical##3##3##(1994-8#1)(2007-12#1)(2008-1#1)
range of chemicals##2##3##(2010-12#1)(2012-2#1)
range of chemistries that##2##4##(2008-10#1)(2012-1#1)
range of choices##2##3##(1994-9#1)(2008-7#1)
range of chronic conditions##3##4##(1992-12#1)(2006-2#1)(2013-1#1)
range of chronic##4##3##(1992-12#1)(2006-2#1)(2008-7#1)(2013-1#1)
range of clinical conditions##2##4##(2005-8#1)(2007-7#1)
range of clinical##12##3##(1990-2#1)(1996-3#1)(1997-1#1)(2005-8#1)(2006-8#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-11#2)(2011-2#1)
range of commercially##3##3##(1993-3#1)(2008-10#1)(2008-8#1)
range of complications##2##3##(2007-12#1)(2011-2#1)
range of compounds##6##3##(1995-12#1)(2007-11#1)(2008-10#1)(2010-9#1)(2011-1#2)
range of concentration##9##3##(1994-11#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-6#1)(2009-4#1)(2010-3#1)
range of concentrations and##2##4##(2005-11#1)(2008-10#1)
range of concentrations in##2##4##(1992-6#1)(2008-10#1)
range of concentrations of##5##4##(1993-1#1)(1995-3#1)(1997-3#1)(2005-12#1)(2008-7#1)
range of concentrations##26##3##(1992-6#2)(1993-1#1)(1993-3#1)(1994-11#1)(1995-3#1)(1997-3#1)(1997-8#1)(2005-11#2)(2005-12#1)(2008-10#9)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2012-1#1)
range of conditions##16##3##(1990-8#1)(1993-4#1)(1997-2#1)(2006-11#1)(2008-10#4)(2008-2#2)(2008-8#3)(2009-7#1)(2010-5#1)(2012-2#1)
range of conformations##3##3##(1991-7#1)(1994-8#1)(2008-3#1)
range of content##2##3##(2008-10#1)(2011-1#1)
range of copper##2##3##(2008-10#2)
range of current##2##3##(2007-12#1)(2008-2#1)
range of decision##4##3##(1997-3#3)(2013-1#1)
range of demographic characteristics##2##4##(2009-9#1)(2012-3#1)
range of demographic##3##3##(2009-9#1)(2010-11#1)(2012-3#1)
range of densities##4##3##(1995-1#1)(1996-4#1)(1997-3#1)(2008-10#1)
range of detection##3##3##(2007-8#1)(2008-10#2)
range of diagnoses##2##3##(2006-10#1)(2008-11#1)
range of differences##4##3##(2004-11#1)(2006-12#1)(2008-10#1)(2008-2#1)
range of different##11##3##(1997-6#1)(1997-7#1)(2005-10#1)(2006-2#1)(2007-12#1)(2008-11#1)(2008-4#1)(2009-10#1)(2009-6#1)(2011-1#2)
range of disciplines##3##3##(2008-12#1)(2009-11#1)(2009-4#1)
range of disease##3##3##(2008-10#3)
range of diseases##9##3##(1991-12#1)(1992-11#1)(1997-8#1)(2005-8#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#2)
range of dissolved##3##3##(2008-10#1)(2008-11#1)(2010-8#1)
range of doses##6##3##(1991-5#1)(1992-5#1)(1996-3#1)(1996-9#1)(2004-12#1)(2011-2#1)
range of drug##2##3##(2005-7#1)(2005-8#1)
range of dye concentrations##2##4##(1996-1#1)(2008-2#1)
range of effects##2##3##(2012-3#1)(2013-1#1)
range of electron##2##3##(1996-5#1)(2011-1#1)
range of elements##2##3##(2008-10#1)(2013-8#1)
range of energy##2##3##(2006-4#1)(2012-2#1)
range of engineering##2##3##(2008-10#2)
range of environmental chemicals##2##4##(1994-3#1)(2009-9#1)
range of environmental conditions##5##4##(2008-10#3)(2008-5#2)
range of environmental##7##3##(1994-3#1)(2008-10#3)(2008-5#2)(2009-9#1)
range of environments##5##3##(2007-12#1)(2008-8#1)(2011-2#2)(2013-1#1)
range of existing##2##3##(1997-4#1)(2007-11#1)
range of experimental conditions##3##4##(2005-11#1)(2006-11#1)(2008-2#1)
range of experimental##8##3##(1995-8#1)(1997-2#1)(2005-11#1)(2006-11#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-2#1)
range of factors##5##3##(1995-3#1)(2005-5#1)(2008-11#1)(2008-8#1)(2012-2#1)
range of flexion##5##3##(2007-7#1)(2007-8#3)(2008-9#1)
range of flow##4##3##(1996-2#1)(2007-11#1)(2007-12#1)(2008-9#1)
range of forces##3##3##(2007-12#2)(2007-5#1)
range of four##2##3##(2008-10#1)(2012-1#1)
range of free Ca2+##2##4##(1995-11#1)(1995-6#1)
range of from##4##3##(2008-2#3)(2008-3#1)
range of functions##6##3##(1992-1#1)(1992-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2012-3#1)
range of fusion was##3##4##(2007-7#3)
range of fusion##4##3##(2007-7#4)
range of gaze angles##2##4##(2009-8#2)
range of genetic##4##3##(1996-6#1)(1997-8#1)(2008-10#1)(2008-9#1)
range of glucose concentrations##2##4##(1990-12#1)(1991-10#1)
range of health##8##3##(1994-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-12#1)(2013-1#2)
range of highly##2##3##(2008-10#1)(2008-6#1)
range of hip motion##2##4##(2007-11#1)(2007-7#1)
range of hip movement##4##4##(2007-7#4)
range of hip##6##3##(2007-11#1)(2007-7#5)
range of host plants##5##4##(2008-10#3)(2010-10#1)(2012-11#1)
range of host##7##3##(2008-10#5)(2010-10#1)(2012-11#1)
range of human##6##3##(1992-8#1)(2008-10#1)(2009-8#1)(2012-3#1)(2013-1#2)
range of images##2##3##(2008-2#1)(2010-4#1)
range of immune##3##3##(1994-9#1)(2007-5#1)(2008-4#1)
range of important##3##3##(1997-3#1)(2008-10#1)(2009-10#1)
range of indications##3##3##(2006-10#2)(2010-7#1)
range of inflammatory mediators##2##4##(2008-7#2)
range of influence##2##3##(2008-10#1)(2013-1#1)
range of initial##2##3##(2008-2#1)(2012-2#1)
range of injuries##2##3##(2010-3#1)(2012-2#1)
range of input##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
range of interest for##2##4##(2008-3#1)(2008-7#1)
range of interest##3##3##(2008-3#1)(2008-7#1)(2009-9#1)
range of issues##3##3##(1994-12#1)(2008-11#1)(2009-4#1)
range of knee##2##3##(2011-2#1)(2013-1#1)
range of known##2##3##(1992-1#1)(2009-5#1)
range of length##2##3##(1996-12#1)(2008-2#1)
range of light##2##3##(2008-5#1)(2013-8#1)
range of linear response##2##4##(2008-10#2)
range of linear##4##3##(2008-10#3)(2011-1#1)
range of linearity##9##3##(2008-10#6)(2009-8#1)(2011-2#1)(2013-1#1)
range of low##3##3##(1990-5#1)(2008-10#1)(2008-7#1)
range of malformations##2##3##(2005-11#1)(2006-2#1)
range of malignancies##5##3##(2005-7#1)(2006-10#1)(2007-11#1)(2009-12#1)(2012-2#1)
range of measured##2##3##(2008-1#1)(2008-12#1)
range of medical and surgical##3##5##(2005-7#1)(2007-10#1)(2010-6#1)
range of medical and##4##4##(2005-7#1)(2007-10#1)(2007-12#1)(2010-6#1)
range of medical##6##3##(2005-7#1)(2007-10#1)(2007-12#1)(2008-11#1)(2009-7#1)(2010-6#1)
range of memory##2##3##(2007-8#1)(2008-2#1)
range of mental##2##3##(1996-3#1)(2009-5#1)
range of methods##6##3##(1996-11#1)(2008-5#1)(2009-7#1)(2010-5#1)(2012-1#1)(2012-12#1)
range of microbial pathogens##2##4##(2008-10#1)(2011-1#1)
range of mixture compositions##2##4##(2008-6#2)
range of molecular weights##3##4##(2008-11#1)(2008-4#1)(2009-10#1)
range of molecular##6##3##(2007-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-10#1)(2009-12#1)
range of more than##2##4##(2007-12#1)(2008-2#1)
range of more##3##3##(2007-12#1)(2008-2#2)
range of motion (AROM)##3##4##(2007-7#1)(2008-12#2)
range of motion (ROM) and##3##5##(2008-8#1)(2009-1#1)(2012-1#1)
range of motion (ROM)##7##4##(2006-8#1)(2008-12#2)(2008-8#1)(2009-1#1)(2012-1#1)(2013-1#1)
range of motion and##13##4##(1992-3#1)(1993-11#1)(1996-3#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-7#2)(2009-1#1)(2010-12#1)(2011-2#1)(2012-1#2)
range of motion at the##2##5##(2007-11#1)(2012-1#1)
range of motion in subjects with a history of lateral ligament sprain##2##12##(2007-11#2)
range of motion in the##5##5##(2007-7#4)(2007-8#1)
range of motion in##14##4##(2006-10#1)(2007-11#3)(2007-7#5)(2007-8#1)(2008-12#1)(2008-8#1)(2010-3#1)(2013-1#1)
range of motion is##3##4##(2007-12#1)(2008-9#1)(2010-12#1)
range of motion of the knee##3##6##(2007-8#1)(2011-2#1)(2013-1#1)
range of motion of the##8##5##(2007-11#1)(2007-12#1)(2007-8#3)(2011-2#2)(2013-1#1)
range of motion of##10##4##(2007-11#1)(2007-12#1)(2007-8#4)(2011-2#2)(2013-1#2)
range of motion or##2##4##(2007-11#1)(2011-2#1)
range of motion preoperatively##2##4##(2008-4#2)
range of motion was##5##4##(1991-12#1)(2007-7#1)(2007-8#2)(2012-2#1)
range of motion were##3##4##(2007-11#2)(2012-12#1)
range of motion##112##3##(1991-12#1)(1992-3#1)(1993-11#1)(1996-3#1)(2006-10#3)(2006-3#2)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#11)(2007-12#3)(2007-7#12)(2007-8#9)(2007-9#1)(2008-12#9)(2008-2#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#4)(2009-1#2)(2009-6#1)(2009-7#1)(2010-12#3)(2010-3#1)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#6)(2012-1#6)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#11)(2013-7#1)
range of motions##2##3##(1991-2#1)(2009-2#1)
range of movement in the hip##3##6##(2007-7#1)(2007-8#2)
range of movement in the##5##5##(2007-11#1)(2007-7#1)(2007-8#3)
range of movement is##2##4##(2007-7#1)(2013-8#1)
range of movement of the knee##2##6##(2007-11#1)(2007-8#1)
range of movement of the##4##5##(2007-11#2)(2007-8#1)(2012-1#1)
range of movement of##6##4##(2007-11#2)(2007-8#1)(2011-12#1)(2012-1#1)(2012-2#1)
range of movement##31##3##(1992-9#1)(2006-6#1)(2007-11#7)(2007-7#7)(2007-8#8)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
range of necrotrophic fungi##2##4##(2009-6#1)(2009-8#1)
range of neurological##5##3##(1994-10#1)(2007-11#2)(2008-1#1)(2013-1#1)
range of new##3##3##(2005-8#1)(2010-12#1)(2011-2#1)
range of normal##2##3##(2004-1#1)(2007-2#1)
range of novel##2##3##(2008-7#1)(2010-12#1)
range of nutrient##2##3##(2008-11#1)(2013-1#1)
range of only##4##3##(1994-12#1)(1995-11#1)(2013-1#2)
range of operation##3##3##(2007-11#1)(2007-9#1)(2008-2#1)
range of optical##4##3##(2007-11#2)(2008-3#1)(2010-4#1)
range of options##4##3##(1994-1#1)(2007-8#1)(2008-5#1)(2008-6#1)
range of organic##2##3##(1992-7#1)(1997-4#1)
range of organisms##4##3##(1995-2#1)(2008-10#1)(2008-4#1)(2008-8#1)
range of other##6##3##(1995-2#1)(2005-7#1)(2008-10#3)(2009-7#1)
range of outcome##2##3##(2006-2#1)(2011-1#1)
range of outcomes##2##3##(2008-2#1)(2009-5#1)
range of pH 2##2##4##(2008-10#2)
range of pH and##2##4##(2007-10#1)(2008-5#1)
range of pH from##2##4##(2008-10#2)
range of pH values##5##4##(1992-8#2)(2005-11#1)(2008-10#2)
range of pH##28##3##(1992-8#2)(1994-3#1)(1995-2#1)(1996-12#1)(2004-4#1)(2005-11#1)(2005-4#1)(2007-10#1)(2008-10#14)(2008-5#4)(2013-1#1)
range of pHs##2##3##(1991-7#1)(2011-12#1)
range of parameter values##6##4##(1994-2#1)(2006-5#1)(2008-3#1)(2008-8#2)(2008-9#1)
range of parameter##7##3##(1994-2#1)(2006-5#1)(2008-3#1)(2008-8#3)(2008-9#1)
range of parameters corresponding to##2##5##(2008-2#2)
range of parameters##9##3##(2007-6#1)(2008-2#3)(2008-3#2)(2008-8#2)(2008-9#1)
range of parasites##2##3##(1997-7#1)(2008-8#1)
range of pathogens##6##3##(2008-10#4)(2011-1#1)(2011-2#1)
range of pathological##2##3##(2005-11#1)(2007-9#1)
range of patients##2##3##(2008-2#1)(2009-5#1)
range of performance##2##3##(2008-3#1)(2012-1#1)
range of personal care##2##4##(2008-5#2)
range of phenotypes##3##3##(1990-8#1)(2008-9#1)(2009-10#1)
range of phenotypic##2##3##(1996-3#1)(2009-5#1)
range of physical##9##3##(1994-5#1)(1996-7#1)(2005-7#1)(2007-10#1)(2007-12#1)(2008-10#1)(2010-4#1)(2012-1#1)(2012-2#1)
range of physiological and##2##4##(1991-2#1)(1992-6#1)
range of physiological##8##3##(1990-11#1)(1991-2#1)(1992-6#1)(1996-2#1)(1997-3#1)(1997-7#1)(2008-11#1)(2011-2#1)
range of plant##7##3##(1991-11#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)
range of polar to non-polar xenobiotics##2##6##(1993-2#2)
range of polymers##2##3##(2006-12#1)(2008-10#1)
range of possible##5##3##(1995-6#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-5#1)
range of potential applications##2##4##(1990-3#1)(2008-7#1)
range of potential##8##3##(1990-10#1)(1990-3#1)(1995-1#1)(2005-11#1)(2006-11#1)(2007-4#1)(2008-4#1)(2008-7#1)
range of practical##2##3##(2008-2#1)(2013-1#1)
range of problems##4##3##(1992-4#1)(1993-12#1)(2006-2#1)(2008-7#1)
range of productivities##2##3##(2008-8#1)(2008-9#1)
range of products##2##3##(2008-10#1)(2012-1#1)
range of properties##4##3##(2005-11#1)(2005-7#1)(2008-11#1)(2008-7#1)
range of protein##4##3##(1990-8#1)(1996-2#1)(2006-10#1)(2007-11#1)
range of proteins##4##3##(1994-6#1)(1996-12#2)(2007-11#1)
range of psychological##2##3##(2006-9#1)(2008-11#1)
range of pulse##2##3##(2007-11#1)(2007-12#1)
range of pump##3##3##(2007-12#1)(2008-2#1)(2009-4#1)
range of putative##2##3##(2008-10#1)(2010-12#1)
range of refractive indices##3##4##(2007-12#1)(2008-3#1)(2009-5#1)
range of research##2##3##(2010-5#1)(2011-1#1)
range of resources##2##3##(2007-7#1)(2012-12#1)
range of response times##2##4##(2010-3#2)
range of responses to##2##4##(1993-9#1)(2009-3#1)
range of responses##5##3##(1993-9#1)(1996-1#1)(2008-8#1)(2009-12#1)(2009-3#1)
range of s##2##3##(2008-11#1)(2008-3#1)
range of sample##2##3##(2008-2#1)(2009-5#1)
range of samples##2##3##(2010-5#1)(2013-1#1)
range of scales##2##3##(2008-2#1)(2008-3#1)
range of scattering##2##3##(2007-12#1)(2011-1#1)
range of scientific and technological##2##5##(1995-1#1)(2006-4#1)
range of sensitivities##3##3##(1994-12#1)(2008-10#2)
range of sensitivity##2##3##(1994-6#1)(2008-10#1)
range of serine proteinases##2##4##(1991-8#1)(1996-9#1)
range of serious##2##3##(2009-6#1)(2009-9#1)
range of serum##3##3##(1991-2#1)(2008-3#1)(2011-11#1)
range of services and##2##4##(1993-1#1)(2008-1#1)
range of services##7##3##(1992-12#1)(1993-1#1)(1994-1#1)(2004-12#1)(2008-1#1)(2008-5#1)(2009-6#1)
range of sexual##2##3##(2006-7#2)
range of silica##2##3##(2007-12#1)(2010-7#1)
range of situations##3##3##(2008-2#1)(2010-1#1)(2010-11#1)
range of size##2##3##(2007-11#1)(2011-1#1)
range of sizes##2##3##(1991-11#1)(2012-11#1)
range of skills##3##3##(1996-3#1)(2010-11#1)(2011-1#1)
range of small##4##3##(1994-12#1)(2008-10#1)(2010-11#1)(2012-12#1)
range of social and##2##4##(2005-7#1)(2008-4#1)
range of social##3##3##(2005-7#1)(2008-4#1)(2012-2#1)
range of soil##2##3##(2008-10#1)(2011-12#1)
range of solid##2##3##(2005-11#1)(2009-4#1)
range of solvent composition##3##4##(2008-10#2)(2009-3#1)
range of spatial##7##3##(2007-11#1)(2008-10#4)(2008-2#1)(2008-9#1)
range of species##6##3##(2007-2#1)(2008-11#2)(2008-8#1)(2009-5#1)(2013-8#1)
range of speeds##2##3##(1990-4#2)
range of stability##3##3##(2008-11#1)(2008-6#1)(2009-10#1)
range of standard##4##3##(1996-6#1)(2006-5#1)(2008-10#1)(2012-12#1)
range of strains##2##3##(2006-5#1)(2008-9#1)
range of structurally##2##3##(1992-8#1)(2008-11#1)
range of studies##5##3##(2006-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2013-8#1)
range of subjects##3##3##(2006-10#2)(2006-8#1)
range of substrates##5##3##(1993-2#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-8#1)
range of surface##2##3##(2008-2#1)(2011-1#1)
range of surgical##4##3##(2006-6#1)(2007-12#1)(2008-6#1)(2012-2#1)
range of symptoms##3##3##(1995-6#1)(1996-9#1)(2010-12#1)
range of targets##4##3##(2008-11#1)(2008-5#1)(2012-12#1)(2013-1#1)
range of temperature and pH##2##5##(2006-8#1)(2008-10#1)
range of temperature##4##3##(2005-12#1)(2006-8#1)(2008-10#2)
range of temperatures and##3##4##(1991-4#1)(2008-10#1)(2008-3#1)
range of temperatures##21##3##(1990-3#1)(1991-4#1)(1992-2#1)(1995-11#1)(2005-11#1)(2006-12#1)(2007-6#1)(2008-10#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-8#2)(2009-3#1)(2012-8#1)
range of tests##2##3##(2008-4#1)(2008-5#1)
range of the assay##4##4##(2007-8#1)(2008-10#1)(2008-11#2)
range of the calibration graph is##2##6##(2008-10#2)
range of the calibration graph##3##5##(2008-10#3)
range of the calibration##6##4##(2008-10#6)
range of the deformable mirror##2##5##(2008-2#1)(2008-3#1)
range of the device##2##4##(2007-11#1)(2007-12#1)
range of the experimental##2##4##(2007-1#1)(2008-2#1)
range of the instrument##2##4##(2008-10#1)(2008-3#1)
range of the investigated##2##4##(2008-3#2)
range of the laser##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
range of the method was##2##5##(2008-10#2)
range of the method##8##4##(2008-10#7)(2008-5#1)
range of the optical path##2##5##(2013-8#2)
range of the optical##5##4##(2007-12#1)(2008-3#1)(2011-2#1)(2013-8#2)
range of the proposed##2##4##(2008-10#1)(2008-3#1)
range of the sensor##5##4##(2008-10#4)(2008-3#1)
range of the standard##3##4##(2005-4#1)(2008-10#2)
range of the virus##4##4##(1990-11#1)(2008-10#3)
range of the##140##3##(1990-11#2)(1991-2#1)(1992-12#1)(1993-9#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-8#1)(1997-3#1)(2005-11#2)(2005-4#1)(2006-10#1)(2006-11#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#5)(2007-12#11)(2007-8#1)(2008-1#1)(2008-10#51)(2008-11#3)(2008-2#9)(2008-3#15)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#6)
range of their##3##3##(2008-5#1)(2011-1#1)(2012-12#1)
range of therapeutic##6##3##(1991-11#1)(1997-8#1)(2005-7#1)(2005-8#1)(2008-5#1)(2012-2#1)
range of these##6##3##(1996-9#1)(2008-10#3)(2008-5#1)(2012-2#1)
range of this method is##2##5##(2008-10#2)
range of this method was##3##5##(2008-10#3)
range of this method##5##4##(2008-10#5)
range of this##11##3##(1995-6#1)(2007-12#2)(2008-10#7)(2008-5#1)
range of those##5##3##(2007-11#2)(2007-12#1)(2008-10#1)(2008-5#1)
range of tissues##4##3##(1992-1#1)(2008-1#2)(2008-7#1)
range of topics##5##3##(1994-12#1)(2007-5#1)(2008-5#2)(2012-2#1)
range of toxic##2##3##(1996-8#1)(2008-5#1)
range of toxicity##2##3##(2007-8#1)(2008-8#1)
range of treatment##4##3##(1993-1#1)(1993-11#1)(2005-7#1)(2008-2#1)
range of tree##2##3##(2008-8#1)(2008-9#1)
range of tumor types##2##4##(2005-11#1)(2008-7#1)
range of tumors##3##3##(2005-11#1)(2008-1#1)(2008-4#1)
range of turbulent##2##3##(2007-12#1)(2008-2#1)
range of typical##3##3##(2008-2#1)(2008-5#1)(2012-2#1)
range of up to##3##4##(1997-8#1)(2008-2#1)(2012-2#1)
range of validity##8##3##(2008-2#3)(2008-3#5)
range of values for##2##4##(2007-12#1)(2008-3#1)
range of values from##3##4##(1990-2#1)(1992-12#1)(1993-12#1)
range of values of##3##4##(1997-1#1)(2006-10#1)(2008-2#1)
range of values##18##3##(1990-2#2)(1992-12#1)(1993-12#1)(1993-9#1)(1995-3#1)(1997-1#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2010-5#1)(2013-1#1)
range of variation in the##2##5##(2008-10#1)(2011-2#1)
range of variation in##4##4##(2008-10#1)(2008-8#1)(2009-11#1)(2011-2#1)
range of variation##9##3##(1990-10#1)(2008-1#1)(2008-10#1)(2008-8#2)(2009-11#1)(2009-9#1)(2011-2#1)(2012-2#1)
range of water##3##3##(2006-10#1)(2008-10#1)(2008-3#1)
range of wavelengths##12##3##(2007-11#3)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#4)(2011-2#1)
range of ~10##2##3##(2007-11#1)(2008-3#1)
range of##3111##2##(1990-10#3)(1990-11#5)(1990-12#6)(1990-2#5)(1990-3#4)(1990-4#3)(1990-5#5)(1990-7#8)(1990-8#5)(1990-9#2)(1991-10#5)(1991-11#3)(1991-12#6)(1991-2#8)(1991-3#1)(1991-4#4)(1991-5#3)(1991-7#3)(1991-8#3)(1991-9#4)(1992-1#6)(1992-10#1)(1992-11#3)(1992-12#10)(1992-2#2)(1992-3#4)(1992-4#4)(1992-5#1)(1992-6#5)(1992-7#6)(1992-8#7)(1992-9#4)(1993-1#5)(1993-11#3)(1993-12#7)(1993-2#6)(1993-3#7)(1993-4#3)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#12)(1994-1#3)(1994-10#2)(1994-11#7)(1994-12#11)(1994-2#10)(1994-3#7)(1994-5#6)(1994-6#8)(1994-7#1)(1994-8#12)(1994-9#5)(1995-1#9)(1995-10#2)(1995-11#8)(1995-12#7)(1995-2#10)(1995-3#8)(1995-4#2)(1995-5#5)(1995-6#7)(1995-7#2)(1995-8#5)(1996-1#5)(1996-10#2)(1996-11#1)(1996-12#9)(1996-2#8)(1996-3#11)(1996-4#5)(1996-5#7)(1996-6#5)(1996-7#4)(1996-8#10)(1996-9#9)(1997-1#5)(1997-2#8)(1997-3#20)(1997-4#9)(1997-5#2)(1997-6#4)(1997-7#5)(1997-8#15)(2004-1#1)(2004-11#3)(2004-12#2)(2004-2#2)(2004-4#5)(2004-9#1)(2005-10#2)(2005-11#30)(2005-12#7)(2005-2#1)(2005-4#16)(2005-5#2)(2005-7#17)(2005-8#10)(2006-1#1)(2006-10#32)(2006-11#15)(2006-12#15)(2006-2#15)(2006-3#3)(2006-4#5)(2006-5#9)(2006-6#4)(2006-7#6)(2006-8#15)(2006-9#5)(2007-1#5)(2007-10#10)(2007-11#91)(2007-12#102)(2007-2#10)(2007-3#1)(2007-4#4)(2007-5#4)(2007-6#6)(2007-7#38)(2007-8#66)(2007-9#12)(2008-1#32)(2008-10#776)(2008-11#61)(2008-12#28)(2008-2#125)(2008-3#145)(2008-4#37)(2008-5#88)(2008-6#25)(2008-7#56)(2008-8#57)(2008-9#31)(2009-1#2)(2009-10#13)(2009-11#6)(2009-12#8)(2009-2#7)(2009-3#6)(2009-4#12)(2009-5#16)(2009-6#12)(2009-7#7)(2009-8#14)(2009-9#7)(2010-1#4)(2010-10#6)(2010-11#8)(2010-12#25)(2010-2#16)(2010-3#7)(2010-4#14)(2010-5#22)(2010-6#3)(2010-7#9)(2010-8#5)(2010-9#7)(2011-1#43)(2011-11#1)(2011-12#12)(2011-2#61)(2011-3#3)(2011-7#1)(2012-1#29)(2012-11#5)(2012-12#42)(2012-2#50)(2012-3#20)(2012-7#1)(2012-8#2)(2013-1#71)(2013-7#5)(2013-8#27)
range on a##2##3##(2008-3#1)(2010-10#1)
range on##6##2##(2008-10#2)(2008-2#1)(2008-3#2)(2010-10#1)
range or##9##2##(1995-10#1)(2006-5#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#1)(2010-4#1)(2011-1#1)
range over which the##2##4##(2006-11#1)(2008-10#1)
range over which##7##3##(1995-8#1)(2006-11#1)(2007-11#1)(2007-12#2)(2008-10#2)
range over##14##2##(1991-10#1)(1992-6#1)(1995-8#1)(2006-11#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#1)(2010-5#1)(2011-1#1)
range pH##4##2##(2008-10#4)
range proteinuria##2##2##(2007-2#1)(2008-4#1)
range provided by##2##3##(2007-12#1)(2008-10#1)
range reported##2##2##(2008-5#1)(2013-7#1)
range resolution of##2##3##(2008-2#1)(2008-3#1)
range resolution##7##2##(2007-12#1)(2008-2#4)(2008-3#2)
range shifts##3##2##(2010-4#1)(2010-6#1)(2013-8#1)
range showed##2##2##(2008-2#1)(2008-9#1)
range size and##2##3##(2008-8#2)
range size##4##2##(2008-8#4)
range spanning##5##2##(1990-11#1)(1994-5#1)(1997-4#1)(2008-10#1)(2012-2#1)
range studied##12##2##(1991-5#1)(1997-3#1)(1997-6#1)(2004-9#1)(2006-9#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)
range studies##4##2##(2008-10#3)(2010-10#1)
range than conventional##2##3##(2008-10#1)(2008-2#1)
range than##6##2##(1993-12#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-5#1)
range that is##3##3##(2007-12#1)(2008-3#2)
range that##15##2##(1990-7#1)(1994-5#1)(1995-8#1)(1997-7#1)(2007-12#4)(2007-2#1)(2008-3#3)(2008-7#1)(2011-1#1)(2013-8#1)
range the##9##2##(1994-3#1)(1995-5#1)(1996-9#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-2#2)
range to 1##2##3##(2008-10#2)
range to a##2##3##(1993-8#1)(2008-2#1)
range to be##4##3##(2007-11#1)(2008-10#2)(2008-2#1)
range to the##6##3##(2006-11#2)(2008-10#1)(2008-3#2)(2010-8#1)
range to##24##2##(1990-7#1)(1992-2#1)(1993-8#1)(1997-2#1)(2006-11#2)(2007-11#1)(2008-10#6)(2008-2#3)(2008-3#6)(2010-8#1)(2013-1#1)
range typically##2##2##(1996-5#1)(2008-3#1)
range under investigation##2##3##(2005-11#1)(2008-6#1)
range under##3##2##(2005-11#1)(2008-3#1)(2008-6#1)
range up to 3##3##4##(2007-11#1)(2007-2#1)(2008-10#1)
range up to##13##3##(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#8)(2008-2#1)(2008-3#1)
range used in the##2##4##(1991-9#1)(2012-12#1)
range used##4##2##(1991-9#1)(2008-10#1)(2008-2#1)(2012-12#1)
range using##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
range varying from##2##3##(2008-10#1)(2013-7#1)
range was 0##14##3##(1994-3#1)(2005-12#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-10#6)(2010-5#1)(2011-1#1)(2012-3#1)
range was 1##4##3##(1990-8#1)(2007-8#1)(2008-10#2)
range was 10##2##3##(2005-12#1)(2008-10#1)
range was achieved with##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
range was also##2##3##(2008-10#1)(2008-2#1)
range was between 1##3##4##(2008-10#3)
range was between##4##3##(2008-10#4)
range was considerably smaller##2##4##(2008-10#1)(2008-2#1)
range was determined##2##3##(2007-11#1)(2011-2#1)
range was found to be 3##2##6##(2008-10#2)
range was found to be##3##5##(2008-10#2)(2008-3#1)
range was found##4##3##(1993-11#1)(2008-10#2)(2008-3#1)
range was from 0##3##4##(2007-8#1)(2008-10#1)(2010-12#1)
range was from 1##2##4##(2008-10#2)
range was from##11##3##(2007-5#1)(2007-8#1)(2008-10#8)(2010-12#1)
range was observed##2##3##(2008-10#1)(2008-2#1)
range was obtained##2##3##(2008-10#2)
range was very##2##3##(1995-2#1)(2008-5#1)
range was##104##2##(1990-8#1)(1992-12#1)(1992-9#1)(1993-11#1)(1994-3#1)(1995-1#1)(1995-2#1)(1997-2#1)(1997-5#1)(1997-6#1)(2005-12#2)(2005-9#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-5#2)(2007-8#5)(2008-10#59)(2008-11#1)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
range were determined##2##3##(2008-2#2)
range were estimated##2##3##(2006-11#1)(2008-5#1)
range were found##2##3##(1996-12#1)(2008-10#1)
range were identified##2##3##(2006-12#2)
range were obtained##4##3##(2005-4#1)(2008-10#3)
range were used to##2##4##(2007-10#1)(2008-10#1)
range were##34##2##(1993-6#1)(1994-12#1)(1996-12#1)(1997-3#1)(2005-4#1)(2006-11#1)(2006-12#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#13)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2010-8#1)(2012-2#2)
range where##5##2##(1990-2#1)(1993-9#2)(1994-8#1)(2013-1#1)
range whereas##2##2##(1991-3#1)(2008-9#1)
range which is##2##3##(1996-2#1)(2008-10#1)
range which##5##2##(1996-2#1)(2006-5#1)(2007-9#1)(2008-10#2)
range with a detection limit of##2##6##(1992-4#1)(2008-10#1)
range with a detection limit##4##5##(1992-4#1)(2008-10#3)
range with a##8##3##(1992-4#1)(2007-12#1)(2008-10#5)(2008-3#1)
range with an##2##3##(1991-10#1)(2007-11#1)
range with high##2##3##(2007-11#1)(2008-2#1)
range with the##3##3##(1994-11#1)(2008-2#2)
range with##28##2##(1991-10#1)(1991-9#1)(1992-4#1)(1994-11#1)(1995-1#1)(2006-6#1)(2007-11#3)(2007-12#3)(2007-8#1)(2008-10#5)(2008-2#6)(2008-3#3)(2010-9#1)
range within the##2##3##(2008-10#1)(2008-5#1)
range within##5##2##(2008-10#3)(2008-5#1)(2010-8#1)
range without##4##2##(2007-12#3)(2008-3#1)
range##6457##1##(1990-10#3)(1990-11#15)(1990-12#17)(1990-2#13)(1990-3#13)(1990-4#5)(1990-5#12)(1990-6#4)(1990-7#11)(1990-8#12)(1990-9#3)(1991-10#14)(1991-11#3)(1991-12#12)(1991-2#16)(1991-3#4)(1991-4#11)(1991-5#11)(1991-6#1)(1991-7#6)(1991-8#10)(1991-9#16)(1992-1#7)(1992-10#2)(1992-11#9)(1992-12#21)(1992-2#14)(1992-3#15)(1992-4#8)(1992-5#2)(1992-6#10)(1992-7#10)(1992-8#14)(1992-9#12)(1993-1#6)(1993-10#2)(1993-11#11)(1993-12#13)(1993-2#15)(1993-3#14)(1993-4#9)(1993-5#1)(1993-6#4)(1993-7#5)(1993-8#12)(1993-9#20)(1994-1#4)(1994-10#5)(1994-11#19)(1994-12#18)(1994-2#13)(1994-3#13)(1994-4#1)(1994-5#12)(1994-6#12)(1994-7#1)(1994-8#15)(1994-9#16)(1995-1#16)(1995-10#10)(1995-11#13)(1995-12#10)(1995-2#22)(1995-3#15)(1995-4#2)(1995-5#14)(1995-6#10)(1995-7#6)(1995-8#13)(1995-9#1)(1996-1#12)(1996-10#4)(1996-11#5)(1996-12#21)(1996-2#17)(1996-3#16)(1996-4#8)(1996-5#18)(1996-6#14)(1996-7#8)(1996-8#16)(1996-9#19)(1997-1#16)(1997-2#28)(1997-3#31)(1997-4#16)(1997-5#11)(1997-6#10)(1997-7#14)(1997-8#20)(2004-1#1)(2004-11#11)(2004-12#5)(2004-2#3)(2004-3#1)(2004-4#8)(2004-9#6)(2005-10#4)(2005-11#55)(2005-12#13)(2005-2#1)(2005-4#20)(2005-5#2)(2005-7#22)(2005-8#13)(2005-9#4)(2006-1#3)(2006-10#48)(2006-11#25)(2006-12#29)(2006-2#23)(2006-3#4)(2006-4#17)(2006-5#29)(2006-6#18)(2006-7#11)(2006-8#22)(2006-9#16)(2007-1#10)(2007-10#26)(2007-11#199)(2007-12#250)(2007-2#27)(2007-3#7)(2007-4#8)(2007-5#14)(2007-6#7)(2007-7#64)(2007-8#124)(2007-9#21)(2008-1#50)(2008-10#1908)(2008-11#91)(2008-12#34)(2008-2#382)(2008-3#393)(2008-4#54)(2008-5#141)(2008-6#43)(2008-7#99)(2008-8#89)(2008-9#54)(2009-1#3)(2009-10#14)(2009-11#10)(2009-12#10)(2009-2#12)(2009-3#10)(2009-4#22)(2009-5#20)(2009-6#13)(2009-7#9)(2009-8#17)(2009-9#9)(2010-1#4)(2010-10#13)(2010-11#13)(2010-12#31)(2010-2#19)(2010-3#14)(2010-4#30)(2010-5#35)(2010-6#5)(2010-7#12)(2010-8#21)(2010-9#8)(2011-1#65)(2011-11#3)(2011-12#17)(2011-2#83)(2011-3#6)(2011-7#1)(2012-1#43)(2012-11#7)(2012-12#58)(2012-2#76)(2012-3#32)(2012-5#1)(2012-7#1)(2012-8#2)(2013-1#121)(2013-7#20)(2013-8#45)
range'##2##1##(1992-9#1)(2008-1#1)
range) and##5##2##(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-1#1)
range)##38##1##(1991-8#1)(1992-3#1)(1994-7#1)(1995-12#1)(1996-3#1)(1997-8#2)(2006-2#1)(2007-12#2)(2007-4#6)(2007-8#1)(2008-10#9)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#1)(2009-12#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
range-dependent##5##1##(2007-12#1)(2008-3#4)
range-finding applications##2##2##(2007-11#1)(2008-2#1)
range-finding##3##1##(2007-11#1)(2008-2#1)(2011-2#1)
range-resolved##3##1##(2008-3#3)
ranged 3##2##2##(2013-8#2)
ranged as high as##3##4##(1993-8#1)(1995-12#1)(2008-10#1)
ranged between 0##22##3##(1990-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#7)(2008-12#2)(2008-5#3)(2011-2#1)(2012-1#1)(2012-2#2)(2013-7#1)
ranged between 1##5##3##(2004-11#1)(2007-12#1)(2008-10#2)(2008-6#1)
ranged between 10##2##3##(2007-7#1)(2012-2#1)
ranged between 15 and##2##4##(2008-4#1)(2008-5#1)
ranged between 20##2##3##(2007-7#1)(2010-9#1)
ranged between 4 and##2##4##(2007-9#1)(2008-9#1)
ranged between 4##3##3##(2007-9#1)(2008-9#1)(2013-1#1)
ranged between 86##2##3##(2008-10#2)
ranged between 95##3##3##(2008-10#3)
ranged between 97##3##3##(2004-11#1)(2008-10#2)
ranged between 98##2##3##(2008-10#2)
ranged between 99##2##3##(2008-10#1)(2010-12#1)
ranged between##110##2##(1990-10#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-2#1)(1993-2#1)(1994-11#1)(1994-6#1)(1995-12#1)(1996-3#1)(1996-8#1)(2004-11#2)(2005-12#1)(2006-1#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#2)(2007-5#2)(2007-7#6)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#27)(2008-12#2)(2008-4#2)(2008-5#12)(2008-6#2)(2008-9#2)(2009-10#1)(2010-12#1)(2010-2#2)(2010-9#1)(2011-1#2)(2011-10#1)(2011-12#3)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#6)(2013-1#2)(2013-7#3)(2013-8#1)
ranged form##3##2##(2006-10#1)(2007-2#1)(2007-8#1)
ranged from &lt##4##3##(1993-1#1)(2008-10#1)(2008-7#1)(2010-8#1)
ranged from -3##2##3##(1992-7#1)(1997-3#1)
ranged from -9%##2##3##(1993-10#2)
ranged from 0 to##10##4##(2005-8#1)(2006-5#1)(2007-8#1)(2008-10#2)(2008-9#2)(2011-1#1)(2012-8#1)(2013-8#1)
ranged from 0##161##3##(1990-11#2)(1991-12#1)(1992-11#1)(1992-2#2)(1992-7#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-3#2)(1996-5#3)(1997-3#1)(2004-11#1)(2004-4#1)(2004-9#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-3#1)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#6)(2008-10#63)(2008-12#1)(2008-3#3)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#2)(2009-3#1)(2009-4#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#2)(2011-1#5)(2011-12#1)(2011-2#6)(2012-1#2)(2012-12#4)(2012-8#1)(2013-1#1)(2013-7#1)(2013-8#3)
ranged from 0% in##2##4##(2008-10#1)(2010-8#1)
ranged from 0%##3##3##(2008-10#1)(2010-8#1)(2011-2#1)
ranged from 1 to 10##2##5##(2007-3#1)(2008-7#1)
ranged from 1 to 24##2##5##(2006-11#1)(2007-7#1)
ranged from 1 to 5 degrees##2##6##(2007-7#1)(2011-2#1)
ranged from 1 to 50##2##5##(2007-11#1)(2007-3#1)
ranged from 1 to 6##2##5##(2012-2#1)(2013-1#1)
ranged from 1 to##15##4##(1997-3#2)(1997-6#1)(2006-11#1)(2007-11#1)(2007-3#2)(2007-7#2)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
ranged from 1##52##3##(1992-2#1)(1992-8#1)(1993-3#1)(1993-9#1)(1996-8#1)(1997-3#2)(1997-6#1)(2004-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-2#1)(2007-3#2)(2007-7#2)(2007-8#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#3)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#2)
ranged from 10 to##9##4##(1990-12#1)(1993-8#1)(2006-4#1)(2008-10#4)(2011-1#1)(2011-2#1)
ranged from 10##10##3##(1990-12#1)(1993-8#1)(2005-12#1)(2006-4#1)(2008-10#4)(2011-1#1)(2011-2#1)
ranged from 100 to##2##4##(2008-7#1)(2011-1#1)
ranged from 100##3##3##(2008-7#1)(2011-1#2)
ranged from 11 to##2##4##(2006-8#1)(2008-9#1)
ranged from 12 to##7##4##(1997-8#1)(2007-7#2)(2008-10#1)(2008-6#1)(2009-7#1)(2013-8#1)
ranged from 12##12##3##(1997-8#2)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-7#1)(2012-2#1)(2013-8#1)
ranged from 13##2##3##(1996-5#1)(2005-8#1)
ranged from 14 to 57##2##5##(1991-10#1)(2008-1#1)
ranged from 14 to##3##4##(1991-10#1)(2008-1#1)(2008-10#1)
ranged from 14##4##3##(1991-10#1)(2007-6#1)(2008-1#1)(2008-10#1)
ranged from 15 to##2##4##(2011-1#1)(2012-2#1)
ranged from 16##4##3##(2008-12#1)(2008-6#1)(2010-3#1)(2011-2#1)
ranged from 17 to##3##4##(2007-4#1)(2007-7#1)(2009-3#1)
ranged from 17##6##3##(2007-4#1)(2007-7#1)(2008-10#3)(2009-3#1)
ranged from 18 to##6##4##(1994-12#1)(2006-12#1)(2007-3#1)(2008-4#1)(2008-6#1)(2008-9#1)
ranged from 18##8##3##(1994-12#1)(1997-3#1)(2006-12#1)(2007-3#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#1)
ranged from 2 to##8##4##(1991-2#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2011-12#1)(2012-12#1)
ranged from 2##36##3##(1991-2#1)(1993-12#1)(1994-12#1)(1995-4#1)(1997-8#2)(2006-12#2)(2006-5#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-7#2)(2010-5#1)(2011-1#3)(2011-12#1)(2012-12#1)(2013-8#1)
ranged from 20 to 30 years##2##6##(2006-6#1)(2012-12#1)
ranged from 20 to##7##4##(1996-12#1)(2006-5#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2012-12#1)
ranged from 20##8##3##(1991-6#1)(1996-12#1)(2006-5#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2012-12#1)
ranged from 200 to##2##4##(1991-12#1)(2008-10#1)
ranged from 21 to##2##4##(2007-7#1)(2008-10#1)
ranged from 23 to 192 months##2##6##(2008-6#2)
ranged from 23##3##3##(2008-5#1)(2008-6#2)
ranged from 25 to##2##4##(2006-12#1)(2008-7#1)
ranged from 25##3##3##(2006-12#1)(2008-7#1)(2008-9#1)
ranged from 27 to##2##4##(2008-10#1)(2012-12#1)
ranged from 27##4##3##(1990-12#1)(2008-10#2)(2012-12#1)
ranged from 28%##2##3##(1995-3#1)(2008-10#1)
ranged from 29##3##3##(2007-2#1)(2008-6#1)(2011-12#1)
ranged from 3 to##4##4##(2007-11#1)(2007-8#1)(2008-10#1)(2013-8#1)
ranged from 3##13##3##(1997-2#1)(2007-10#1)(2007-11#1)(2007-5#2)(2007-8#2)(2008-10#4)(2011-12#1)(2013-8#1)
ranged from 30 to##3##4##(1997-8#1)(2008-5#1)(2011-2#1)
ranged from 31 to##3##4##(2005-8#1)(2007-12#1)(2008-10#1)
ranged from 31##4##3##(1996-3#1)(2005-8#1)(2007-12#1)(2008-10#1)
ranged from 34 to##2##4##(2006-11#1)(2008-10#1)
ranged from 35 to##3##4##(2006-6#1)(2007-4#1)(2009-7#1)
ranged from 35##5##3##(2006-6#1)(2007-4#1)(2008-10#2)(2009-7#1)
ranged from 36##3##3##(2007-8#1)(2007-9#1)(2013-8#1)
ranged from 37 to##2##4##(1992-9#1)(2007-11#1)
ranged from 38##2##3##(2005-12#1)(2008-5#1)
ranged from 4 to##2##4##(2006-8#1)(2007-8#1)
ranged from 4##14##3##(1990-11#1)(2006-8#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-9#1)(2010-10#1)(2011-1#1)
ranged from 40 to##2##4##(1990-4#1)(2008-6#1)
ranged from 45 to##3##4##(2006-11#1)(2010-7#1)(2011-2#1)
ranged from 47 to##2##4##(2007-2#1)(2013-1#1)
ranged from 48##2##3##(2007-11#1)(2011-2#1)
ranged from 5 to##11##4##(1990-6#1)(1995-3#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-9#1)(2009-7#1)(2010-3#1)(2012-2#1)
ranged from 5##23##3##(1990-12#1)(1990-2#1)(1990-6#1)(1993-6#1)(1995-2#1)(1995-3#1)(2004-11#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-3#1)(2010-5#1)(2012-12#1)(2012-2#1)
ranged from 5%##3##3##(2008-10#2)(2008-9#1)
ranged from 50 to##2##4##(1993-11#1)(2008-2#1)
ranged from 54 to##2##4##(2008-10#2)
ranged from 54##3##3##(2008-10#3)
ranged from 58##2##3##(2004-10#1)(2008-10#1)
ranged from 6 to##3##4##(1993-12#1)(2007-12#1)(2011-2#1)
ranged from 6##11##3##(1993-12#1)(1993-8#1)(1996-4#1)(2007-11#1)(2007-12#1)(2007-5#2)(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
ranged from 60##3##3##(1996-12#1)(2012-12#2)
ranged from 62##2##3##(2008-10#1)(2011-1#1)
ranged from 64 to##2##4##(2006-8#1)(2008-10#1)
ranged from 64##3##3##(1996-1#1)(2006-8#1)(2008-10#1)
ranged from 65 to##2##4##(2006-11#1)(2008-10#1)
ranged from 65##3##3##(2006-11#1)(2008-10#1)(2012-12#1)
ranged from 68 to##2##4##(2008-10#2)
ranged from 68##3##3##(2008-10#3)
ranged from 7 to##3##4##(2006-11#1)(2008-10#2)
ranged from 7##11##3##(1993-6#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-2#1)(2008-10#3)(2008-2#1)(2010-2#1)(2011-2#1)
ranged from 74 to##2##4##(2007-8#1)(2008-6#1)
ranged from 74##3##3##(2007-8#1)(2008-6#1)(2013-7#1)
ranged from 75 to##2##4##(2008-10#1)(2011-1#1)
ranged from 79##2##3##(2008-5#1)(2009-3#1)
ranged from 8 to##3##4##(2005-12#1)(2009-11#1)(2013-1#1)
ranged from 8##6##3##(2005-12#1)(2008-10#1)(2009-11#1)(2011-1#2)(2013-1#1)
ranged from 80 to##2##4##(2008-10#2)
ranged from 81##2##3##(2008-10#2)
ranged from 86 to##2##4##(2008-10#2)
ranged from 88 to##3##4##(2007-4#1)(2008-10#2)
ranged from 88##4##3##(2007-4#1)(2008-10#3)
ranged from 89 to##2##4##(2006-12#1)(2008-10#1)
ranged from 89##3##3##(2006-12#1)(2008-10#2)
ranged from 9 to##4##4##(2008-7#1)(2012-2#2)(2013-1#1)
ranged from 9##7##3##(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
ranged from 90 to##2##4##(2008-10#2)
ranged from 91 to##2##4##(2008-10#2)
ranged from 91##3##3##(2008-10#2)(2011-12#1)
ranged from 92 to##2##4##(1997-3#1)(2008-10#1)
ranged from 93 to##2##4##(2008-10#2)
ranged from 95##5##3##(2007-8#1)(2008-10#4)
ranged from 96 to 103%##2##5##(2008-10#2)
ranged from 96 to##3##4##(2008-10#3)
ranged from 96##7##3##(2007-8#1)(2008-10#5)(2013-1#1)
ranged from 97##5##3##(1992-11#1)(2008-10#4)
ranged from 98##4##3##(2008-10#2)(2011-12#2)
ranged from 99 to 101%##3##5##(2008-10#3)
ranged from 99 to##4##4##(2008-10#4)
ranged from 99##11##3##(1991-3#1)(1992-11#1)(2008-10#8)(2010-3#1)
ranged from a##2##3##(1990-3#1)(1996-9#1)
ranged from approximately 0##2##4##(2008-10#1)(2008-2#1)
ranged from approximately##6##3##(1995-3#1)(2008-10#2)(2008-2#1)(2010-9#1)(2012-2#1)
ranged from less than 1##2##5##(2007-7#1)(2008-10#1)
ranged from mild##3##3##(1995-8#1)(2008-10#1)(2011-12#1)
ranged from minor##2##3##(1994-6#1)(2007-1#1)
ranged from one to three##2##5##(2007-7#1)(2012-2#1)
ranged from two to##2##4##(2008-5#2)
ranged from##706##2##(1990-1#1)(1990-11#3)(1990-12#3)(1990-2#3)(1990-3#1)(1990-4#1)(1990-6#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#3)(1992-12#1)(1992-2#3)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-1#2)(1993-10#5)(1993-11#1)(1993-12#5)(1993-3#4)(1993-6#3)(1993-8#2)(1993-9#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-10#1)(1995-2#2)(1995-3#5)(1995-4#1)(1995-8#2)(1996-1#1)(1996-12#3)(1996-3#3)(1996-4#1)(1996-5#5)(1996-8#1)(1996-9#2)(1997-2#2)(1997-3#6)(1997-6#1)(1997-7#1)(1997-8#5)(2004-10#1)(2004-11#4)(2004-4#1)(2004-9#1)(2005-11#1)(2005-12#5)(2005-7#2)(2005-8#3)(2006-10#4)(2006-11#5)(2006-12#10)(2006-4#1)(2006-5#4)(2006-6#4)(2006-7#1)(2006-8#9)(2007-1#7)(2007-10#5)(2007-11#8)(2007-12#3)(2007-2#7)(2007-3#6)(2007-4#9)(2007-5#9)(2007-6#4)(2007-7#18)(2007-8#20)(2007-9#1)(2008-1#5)(2008-10#205)(2008-11#3)(2008-12#12)(2008-2#5)(2008-3#5)(2008-4#3)(2008-5#19)(2008-6#9)(2008-7#11)(2008-8#3)(2008-9#9)(2009-11#1)(2009-12#2)(2009-3#4)(2009-4#1)(2009-7#4)(2010-10#1)(2010-11#3)(2010-2#3)(2010-3#3)(2010-4#2)(2010-5#5)(2010-6#1)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#21)(2011-12#8)(2011-2#27)(2012-1#3)(2012-11#1)(2012-12#15)(2012-2#13)(2012-8#1)(2013-1#11)(2013-7#2)(2013-8#11)
ranged in age from 3##2##5##(2008-9#1)(2011-2#1)
ranged in age from##11##4##(1992-4#1)(1993-6#1)(1997-1#1)(2006-11#1)(2006-3#1)(2006-8#1)(2007-1#1)(2007-11#1)(2008-9#1)(2010-10#1)(2011-2#1)
ranged in size##2##3##(2006-6#1)(2008-5#1)
ranged in##14##2##(1992-4#1)(1993-6#1)(1997-1#1)(2006-11#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)
ranged over##4##2##(1991-5#1)(1994-11#1)(2007-5#1)(2008-5#1)
ranged widely##2##2##(1997-3#1)(2006-11#1)
ranged##859##1##(1990-1#1)(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#3)(1990-3#1)(1990-4#1)(1990-6#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-11#3)(1992-12#1)(1992-2#4)(1992-4#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-1#2)(1993-10#5)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#4)(1993-6#4)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-5#1)(1994-6#4)(1994-8#1)(1994-9#2)(1995-10#1)(1995-12#2)(1995-2#2)(1995-3#5)(1995-4#1)(1995-8#2)(1996-1#1)(1996-12#3)(1996-3#6)(1996-4#1)(1996-5#5)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#7)(1997-6#1)(1997-7#1)(1997-8#5)(2004-10#1)(2004-11#6)(2004-4#1)(2004-9#1)(2005-11#1)(2005-12#6)(2005-7#2)(2005-8#3)(2006-1#1)(2006-10#5)(2006-11#7)(2006-12#10)(2006-3#1)(2006-4#1)(2006-5#4)(2006-6#5)(2006-7#1)(2006-8#10)(2007-1#8)(2007-10#7)(2007-11#10)(2007-12#5)(2007-2#10)(2007-3#7)(2007-4#9)(2007-5#12)(2007-6#4)(2007-7#24)(2007-8#22)(2007-9#2)(2008-1#6)(2008-10#237)(2008-11#4)(2008-12#14)(2008-2#5)(2008-3#5)(2008-4#6)(2008-5#34)(2008-6#11)(2008-7#12)(2008-8#3)(2008-9#12)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#4)(2009-4#1)(2009-7#4)(2010-10#2)(2010-11#3)(2010-12#1)(2010-2#6)(2010-3#3)(2010-4#2)(2010-5#5)(2010-6#1)(2010-7#2)(2010-8#5)(2010-9#2)(2011-1#23)(2011-10#1)(2011-12#12)(2011-2#33)(2012-1#4)(2012-11#1)(2012-12#16)(2012-2#19)(2012-8#1)(2013-1#14)(2013-7#6)(2013-8#14)
rangelands##2##1##(2008-10#1)(2008-12#1)
rangeof##2##1##(2008-11#2)
ranges (1##2##2##(2008-10#1)(2008-2#1)
ranges 0##6##2##(1990-3#1)(1992-7#1)(2007-8#1)(2008-10#3)
ranges 1##2##2##(2008-10#2)
ranges 4##2##2##(2008-10#2)
ranges 9##2##2##(1990-1#1)(2008-10#1)
ranges and##13##2##(1991-11#1)(1997-2#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)
ranges are 0##5##3##(2008-10#5)
ranges are##17##2##(1990-12#1)(1995-4#1)(2007-12#1)(2008-10#9)(2008-8#1)(2010-8#1)(2011-1#1)(2013-1#2)
ranges as##2##2##(1996-11#1)(2008-3#1)
ranges at the##2##3##(2008-10#1)(2008-9#1)
ranges at##4##2##(2007-12#1)(2008-10#2)(2008-9#1)
ranges between 0##3##3##(2007-8#1)(2008-10#1)(2012-2#1)
ranges between 1##3##3##(1995-3#1)(2007-8#1)(2008-8#1)
ranges between##13##2##(1995-3#1)(2006-10#1)(2007-12#1)(2007-8#3)(2008-10#3)(2008-8#1)(2008-9#1)(2012-2#1)(2013-8#1)
ranges by##2##2##(2008-2#1)(2008-3#1)
ranges for the analysis of##2##5##(2008-10#2)
ranges for the##5##3##(2008-10#5)
ranges for##27##2##(1992-9#1)(1995-3#1)(1995-4#1)(2005-7#2)(2006-10#1)(2006-4#1)(2007-12#1)(2007-2#1)(2008-10#14)(2008-8#1)(2008-9#1)(2009-2#1)(2012-2#1)
ranges from 0##13##3##(1993-12#1)(2005-4#1)(2006-2#1)(2008-10#2)(2008-2#2)(2008-7#2)(2010-6#1)(2012-2#1)(2013-1#2)
ranges from 1##4##3##(1992-7#1)(1995-11#1)(2008-10#1)(2013-8#1)
ranges from 15% to##2##4##(2006-8#1)(2012-12#1)
ranges from 2##4##3##(1992-6#1)(2007-12#1)(2008-10#1)(2010-2#1)
ranges from 2% to##2##4##(2007-10#1)(2012-12#1)
ranges from 3 to##2##4##(2008-4#1)(2011-1#1)
ranges from 3##6##3##(1992-6#1)(2007-3#1)(2008-10#2)(2008-4#1)(2011-1#1)
ranges from 5 to##2##4##(2008-10#2)
ranges from 5##4##3##(2006-2#1)(2008-1#1)(2008-10#2)
ranges from 95##2##3##(2005-4#1)(2008-10#1)
ranges from a##2##3##(1990-10#1)(2008-6#1)
ranges from approximately 0##2##4##(2008-3#1)(2010-5#1)
ranges from one##2##3##(2008-10#2)
ranges from the##2##3##(2007-2#1)(2008-2#1)
ranges from##93##2##(1990-10#1)(1990-3#1)(1991-3#1)(1991-5#1)(1992-5#1)(1992-6#2)(1992-7#1)(1993-12#1)(1993-3#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-7#1)(1996-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-4#2)(2005-8#1)(2006-10#3)(2006-2#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#18)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#4)(2009-12#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#3)(2013-1#3)(2013-8#1)
ranges have been established##2##4##(1991-8#1)(1997-6#1)
ranges have##3##2##(1991-8#1)(1997-6#1)(2011-11#1)
ranges in the##2##3##(2007-12#1)(2008-10#1)
ranges in##8##2##(1990-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-6#1)(2012-2#1)
ranges may##2##2##(2007-12#1)(2008-8#1)
ranges of 0##5##3##(2008-10#4)(2011-1#1)
ranges of 1##9##3##(1991-3#1)(2007-12#1)(2008-10#6)(2013-8#1)
ranges of 2##5##3##(2007-12#1)(2008-10#3)(2011-1#1)
ranges of 8##2##3##(2008-10#1)(2008-5#1)
ranges of CEC and CEP##2##5##(2010-1#2)
ranges of about##2##3##(2008-10#1)(2013-8#1)
ranges of drug concentrations (microgram/g)##2##5##(1995-2#2)
ranges of motion##3##3##(2011-2#3)
ranges of the calibration##5##4##(2007-8#1)(2008-10#4)
ranges of the order of 10##2##6##(2008-2#1)(2008-3#1)
ranges of the order of##4##5##(2008-2#1)(2008-3#3)
ranges of the##19##3##(2007-8#1)(2008-10#5)(2008-2#2)(2008-3#6)(2008-7#1)(2012-1#1)(2012-12#2)(2012-2#1)
ranges of these##3##3##(2007-12#1)(2008-10#2)
ranges of##129##2##(1991-3#1)(1992-6#1)(1992-8#1)(1994-12#2)(1995-10#1)(1995-2#3)(1995-3#1)(1995-6#1)(1996-3#1)(1996-5#2)(1996-8#2)(2005-11#1)(2005-4#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-8#4)(2007-9#1)(2008-10#53)(2008-2#7)(2008-3#10)(2008-4#1)(2008-5#5)(2008-7#1)(2009-11#1)(2010-1#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-8#2)
ranges over##2##2##(2008-10#1)(2010-4#1)
ranges studied##3##2##(1991-10#1)(2008-10#1)(2008-11#1)
ranges than##3##2##(2008-10#1)(2008-8#2)
ranges that##4##2##(1997-3#1)(2007-5#1)(2008-10#1)(2008-6#1)
ranges to be##2##3##(2008-10#2)
ranges to##6##2##(2008-10#3)(2008-2#1)(2008-3#1)(2013-1#1)
ranges up to##2##3##(1994-8#1)(2008-10#1)
ranges were 0##6##3##(2008-10#5)(2008-7#1)
ranges were 5##2##3##(2008-10#2)
ranges were found to##2##4##(2008-10#1)(2008-3#1)
ranges were obtained##2##3##(2008-10#2)
ranges were##33##2##(1990-11#1)(1994-12#1)(1995-4#1)(1997-2#1)(2005-11#1)(2008-10#23)(2008-3#2)(2008-7#1)(2010-6#2)
ranges where the##2##3##(2006-2#1)(2008-2#1)
ranges with##2##2##(2007-3#1)(2008-8#1)
ranges##543##1##(1990-1#1)(1990-10#1)(1990-11#3)(1990-12#1)(1990-3#2)(1991-10#1)(1991-11#2)(1991-3#3)(1991-5#1)(1991-8#1)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-5#1)(1994-10#1)(1994-11#2)(1994-12#4)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#4)(1995-3#3)(1995-4#3)(1995-6#3)(1995-7#2)(1995-8#1)(1996-11#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#2)(1997-2#4)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#1)(2005-11#3)(2005-12#2)(2005-4#3)(2005-7#2)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#3)(2006-4#1)(2006-8#2)(2007-10#1)(2007-11#7)(2007-12#21)(2007-2#3)(2007-3#2)(2007-5#2)(2007-7#1)(2007-8#10)(2007-9#2)(2008-1#3)(2008-10#192)(2008-11#5)(2008-12#1)(2008-2#25)(2008-3#28)(2008-4#5)(2008-5#11)(2008-6#8)(2008-7#6)(2008-8#12)(2008-9#5)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-2#3)(2010-4#6)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#9)(2011-11#1)(2011-2#8)(2012-1#2)(2012-12#6)(2012-2#11)(2012-3#2)(2013-1#13)(2013-7#1)(2013-8#4)
ranges)##3##1##(1992-9#1)(2006-10#1)(2008-2#1)
ranging 0##3##2##(2006-12#1)(2008-10#2)
ranging and##7##2##(1997-4#1)(2008-1#2)(2008-2#2)(2008-3#1)(2008-8#1)
ranging between 0##16##3##(1990-10#1)(1992-3#1)(1993-4#1)(1994-6#1)(2004-11#1)(2005-8#1)(2008-10#6)(2008-3#1)(2011-2#1)(2013-1#2)
ranging between 1##2##3##(2008-10#1)(2011-3#1)
ranging between 4##2##3##(2008-10#1)(2008-3#1)
ranging between 97##2##3##(2008-10#2)
ranging between##51##2##(1990-10#1)(1990-3#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-4#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#1)(1996-3#1)(2004-11#1)(2004-9#1)(2005-10#1)(2005-8#1)(2006-6#3)(2007-6#1)(2007-8#2)(2008-10#13)(2008-3#5)(2008-5#1)(2008-7#1)(2009-2#1)(2011-2#1)(2011-3#1)(2012-1#2)(2013-1#3)(2013-7#1)
ranging from 0 to 1##3##5##(2005-11#1)(2008-2#1)(2009-6#1)
ranging from 0 to 100##2##5##(2008-10#1)(2011-2#1)
ranging from 0 to##16##4##(1991-8#1)(1993-12#1)(1997-8#1)(2005-11#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2009-11#1)(2009-6#2)(2010-5#1)(2011-2#1)
ranging from 0##115##3##(1991-12#1)(1991-5#1)(1991-7#3)(1991-8#1)(1992-12#1)(1992-7#1)(1992-9#3)(1993-1#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-3#1)(1995-4#1)(1996-4#1)(1996-6#1)(1997-4#1)(1997-8#3)(2004-11#2)(2004-9#1)(2005-11#2)(2005-12#1)(2005-4#1)(2005-8#1)(2006-1#1)(2006-12#1)(2006-4#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#32)(2008-11#3)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#3)(2009-11#2)(2009-6#2)(2009-7#2)(2009-8#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#2)
ranging from 0% to##3##4##(2007-10#1)(2008-11#1)(2013-8#1)
ranging from 1 to 4##2##5##(2008-10#1)(2011-2#1)
ranging from 1 to##17##4##(1994-12#1)(1994-5#1)(1995-5#1)(2007-9#1)(2008-10#9)(2008-4#1)(2008-5#1)(2010-8#1)(2011-2#1)
ranging from 1##47##3##(1991-9#1)(1992-7#1)(1994-12#1)(1994-5#1)(1995-5#1)(1996-9#1)(2006-1#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#18)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#3)(2008-7#1)(2008-9#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
ranging from 1% to##2##4##(1994-12#1)(2008-2#1)
ranging from 10 to 100##2##5##(1996-4#1)(2010-4#1)
ranging from 10 to##9##4##(1991-4#1)(1995-8#1)(1996-4#1)(2008-10#3)(2008-3#1)(2008-6#1)(2010-4#1)
ranging from 10##11##3##(1991-4#1)(1995-8#1)(1996-4#1)(2006-6#1)(2007-5#1)(2008-10#3)(2008-3#1)(2008-6#1)(2010-4#1)
ranging from 100 to##2##4##(1996-3#1)(2008-10#1)
ranging from 100##3##3##(1996-3#1)(2008-10#1)(2012-1#1)
ranging from 12 to##5##4##(2008-1#1)(2008-10#3)(2013-1#1)
ranging from 12##6##3##(2008-1#1)(2008-10#3)(2010-8#1)(2013-1#1)
ranging from 13##3##3##(2005-11#1)(2007-6#1)(2008-1#1)
ranging from 14 to##4##4##(1993-12#1)(2008-1#1)(2009-7#1)(2013-1#1)
ranging from 14##5##3##(1993-11#1)(1993-12#1)(2008-1#1)(2009-7#1)(2013-1#1)
ranging from 15 to##2##4##(2007-12#1)(2008-10#1)
ranging from 15##3##3##(2007-10#1)(2007-12#1)(2008-10#1)
ranging from 15% to##2##4##(2006-8#1)(2009-8#1)
ranging from 16 to##2##4##(1991-10#1)(2007-8#1)
ranging from 16##3##3##(1991-10#1)(2007-8#1)(2010-8#1)
ranging from 17##3##3##(1997-7#1)(2007-11#1)(2008-11#1)
ranging from 18##3##3##(1992-3#1)(1992-6#1)(2007-8#1)
ranging from 19 to##2##4##(1990-3#1)(2006-10#1)
ranging from 2 to##10##4##(1990-2#1)(1991-8#1)(1995-1#1)(1995-5#1)(1996-8#1)(2005-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2011-2#1)
ranging from 2##22##3##(1990-2#1)(1991-8#1)(1993-5#1)(1995-1#1)(1995-5#2)(1996-8#1)(2005-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#1)(2011-2#1)(2013-1#1)
ranging from 20 to 300##2##5##(1992-9#1)(2007-2#1)
ranging from 20 to 80##2##5##(1992-11#1)(2008-2#1)
ranging from 20 to##9##4##(1990-6#1)(1990-8#1)(1992-11#1)(1992-4#1)(1992-9#1)(2007-2#1)(2008-10#1)(2008-2#2)
ranging from 20##11##3##(1990-6#1)(1990-8#1)(1992-11#1)(1992-4#1)(1992-9#1)(1994-8#1)(2007-2#1)(2008-10#1)(2008-2#3)
ranging from 200 to##3##4##(2005-11#1)(2008-10#1)(2010-4#1)
ranging from 200##4##3##(2005-11#1)(2008-10#1)(2008-2#1)(2010-4#1)
ranging from 22 to##4##4##(1997-2#1)(2007-2#1)(2008-10#2)
ranging from 22##5##3##(1990-9#1)(1997-2#1)(2007-2#1)(2008-10#2)
ranging from 23 to##3##4##(1996-3#1)(2005-8#1)(2009-3#1)
ranging from 23##4##3##(1996-3#1)(2005-8#1)(2009-3#1)(2011-2#1)
ranging from 25 to##3##4##(1995-5#1)(1995-8#1)(2008-10#1)
ranging from 250 to##2##4##(2008-10#1)(2008-2#1)
ranging from 250##3##3##(1990-12#1)(2008-10#1)(2008-2#1)
ranging from 27##2##3##(1991-7#1)(2009-2#1)
ranging from 3 to 9##2##5##(2007-6#1)(2012-3#1)
ranging from 3 to##7##4##(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2012-3#1)
ranging from 3##19##3##(1990-3#1)(1993-11#1)(2004-4#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#3)(2008-9#1)(2011-1#1)(2012-3#1)
ranging from 30 to##4##4##(1991-9#1)(1996-12#1)(2008-10#1)(2008-3#1)
ranging from 30##5##3##(1991-9#1)(1994-11#1)(1996-12#1)(2008-10#1)(2008-3#1)
ranging from 35 to##2##4##(1996-3#1)(2008-10#1)
ranging from 39##3##3##(1995-3#1)(2008-10#1)(2012-1#1)
ranging from 4 to##4##4##(2006-11#1)(2008-10#2)(2008-5#1)
ranging from 4##10##3##(1996-12#1)(2006-11#1)(2007-4#1)(2008-10#5)(2008-5#1)(2008-6#1)
ranging from 40 to##4##4##(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)
ranging from 400 to##3##4##(2008-10#2)(2008-2#1)
ranging from 400##5##3##(2008-10#3)(2008-2#1)(2008-3#1)
ranging from 5 to 15##2##5##(2008-10#2)
ranging from 5 to##7##4##(1996-12#1)(2007-7#1)(2008-10#4)(2008-2#1)
ranging from 5 x##2##4##(2004-9#1)(2008-10#1)
ranging from 5##16##3##(1990-11#2)(1991-9#1)(1996-12#1)(2004-9#1)(2006-10#1)(2007-5#1)(2007-7#1)(2008-10#6)(2008-2#1)(2009-4#1)
ranging from 5% to##3##4##(2008-3#2)(2013-1#1)
ranging from 50 to##4##4##(2008-10#3)(2008-5#1)
ranging from 50##5##3##(2008-10#3)(2008-5#1)(2011-2#1)
ranging from 59##2##3##(2008-1#1)(2012-3#1)
ranging from 6 to##8##4##(1994-11#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2010-4#1)(2011-2#1)
ranging from 6##12##3##(1990-12#1)(1994-11#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2010-4#1)(2011-2#1)(2013-8#1)
ranging from 7 to##3##4##(2008-10#2)(2013-1#1)
ranging from 70 to 80 kDa##2##6##(1992-8#1)(1995-8#1)
ranging from 70 to##3##4##(1991-9#1)(1992-8#1)(1995-8#1)
ranging from 8 to##3##4##(1997-1#1)(2008-1#1)(2010-4#1)
ranging from 8##6##3##(1997-1#1)(2007-8#1)(2008-1#1)(2008-11#1)(2009-7#1)(2010-4#1)
ranging from 90 to 100%##2##5##(2008-10#1)(2012-12#1)
ranging from 90 to##3##4##(2008-10#2)(2012-12#1)
ranging from 90##4##3##(2005-4#1)(2008-10#2)(2012-12#1)
ranging from 97##4##3##(1990-9#1)(2008-10#2)(2008-8#1)
ranging from a few to##2##5##(2008-1#1)(2008-2#1)
ranging from a few##3##4##(2007-7#1)(2008-1#1)(2008-2#1)
ranging from a##6##3##(1997-2#1)(2007-7#1)(2008-1#1)(2008-2#1)(2009-10#1)(2010-12#1)
ranging from about##3##3##(1992-12#1)(2007-12#1)(2007-3#1)
ranging from approximately 1##2##4##(1992-8#1)(2008-10#1)
ranging from approximately##8##3##(1990-3#1)(1992-8#1)(1997-8#1)(2008-10#3)(2008-3#1)(2010-7#1)
ranging from asymptomatic to##3##4##(1996-12#1)(2010-11#1)(2013-1#1)
ranging from asymptomatic##4##3##(1994-11#1)(1996-12#1)(2010-11#1)(2013-1#1)
ranging from basic##3##3##(2005-9#1)(2008-5#1)(2011-2#1)
ranging from cell##2##3##(2007-6#1)(2011-2#1)
ranging from effects on##2##4##(2008-1#1)(2008-4#1)
ranging from effects##3##3##(2008-1#1)(2008-4#1)(2010-2#1)
ranging from fully susceptible to highly resistant##2##7##(2008-10#2)
ranging from fully##3##3##(2008-10#2)(2012-12#1)
ranging from large##2##3##(1991-8#1)(2008-7#1)
ranging from less than##2##4##(1990-12#1)(2008-10#1)
ranging from medical##2##3##(2008-4#1)(2008-7#1)
ranging from mild##6##3##(2006-1#1)(2007-8#1)(2008-2#1)(2008-9#1)(2012-11#1)(2013-7#1)
ranging from pH##2##3##(2008-10#2)
ranging from simple##3##3##(2007-11#1)(2008-2#1)(2008-4#1)
ranging from small##2##3##(2008-2#1)(2010-5#1)
ranging from tens of##2##4##(1993-3#1)(2010-4#1)
ranging from the dipeptide sugar-substitute aspartame to clinically used hormones##2##10##(2008-4#2)
ranging from the##13##3##(1994-11#1)(1995-7#1)(1996-5#1)(2005-11#1)(2005-8#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#3)(2008-8#1)
ranging from very low to##2##5##(2008-10#1)(2012-2#1)
ranging from very low##3##4##(1997-1#1)(2008-10#1)(2012-2#1)
ranging from very##5##3##(1994-12#1)(1997-1#1)(2006-4#1)(2008-10#1)(2012-2#1)
ranging from##696##2##(1990-11#2)(1990-12#4)(1990-2#2)(1990-3#4)(1990-6#1)(1990-8#1)(1990-9#2)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#4)(1991-8#3)(1991-9#5)(1992-11#1)(1992-12#3)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#5)(1993-1#1)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#6)(1993-5#1)(1993-6#1)(1993-9#2)(1994-11#5)(1994-12#6)(1994-5#2)(1994-8#1)(1994-9#2)(1995-1#2)(1995-3#3)(1995-4#2)(1995-5#7)(1995-6#1)(1995-7#1)(1995-8#3)(1996-1#1)(1996-10#1)(1996-12#5)(1996-3#7)(1996-4#2)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#2)(1997-7#1)(1997-8#6)(2004-11#2)(2004-4#2)(2004-9#2)(2005-10#1)(2005-11#6)(2005-12#2)(2005-4#2)(2005-7#2)(2005-8#5)(2005-9#1)(2006-1#3)(2006-10#8)(2006-11#3)(2006-12#3)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#2)(2006-6#2)(2006-8#6)(2007-1#1)(2007-10#3)(2007-11#11)(2007-12#17)(2007-2#6)(2007-3#3)(2007-4#1)(2007-5#6)(2007-6#6)(2007-7#6)(2007-8#13)(2007-9#3)(2008-1#13)(2008-10#144)(2008-11#13)(2008-12#1)(2008-2#28)(2008-3#18)(2008-4#14)(2008-5#18)(2008-6#2)(2008-7#11)(2008-8#5)(2008-9#5)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#4)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#3)(2009-7#9)(2009-8#4)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#3)(2010-4#8)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#16)(2012-1#4)(2012-11#3)(2012-12#4)(2012-2#13)(2012-3#6)(2013-1#15)(2013-7#3)(2013-8#9)
ranging in age from 12 to##2##6##(2006-7#1)(2007-11#1)
ranging in age from 18 to##3##6##(2007-2#1)(2008-11#1)(2013-8#1)
ranging in age from 18##4##5##(2007-2#1)(2008-1#1)(2008-11#1)(2013-8#1)
ranging in age from 2 to##3##6##(1996-5#1)(2007-4#1)(2008-5#1)
ranging in age from 2##4##5##(1996-5#1)(2007-4#1)(2007-7#1)(2008-5#1)
ranging in age from 23 to 77 years##2##8##(1990-2#1)(2007-7#1)
ranging in age from 29 to##3##6##(1993-12#1)(2007-8#2)
ranging in age from 7 to 14 years##2##8##(2007-8#2)
ranging in age from 8 to##2##6##(2009-9#2)
ranging in age from##36##4##(1990-2#1)(1993-12#1)(1996-5#1)(1997-3#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-2#2)(2007-4#1)(2007-7#6)(2007-8#9)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-9#2)(2010-7#1)(2013-8#1)
ranging in age##37##3##(1990-2#1)(1993-12#1)(1996-5#1)(1997-3#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-2#2)(2007-4#1)(2007-7#6)(2007-8#9)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-9#2)(2010-7#1)(2013-8#1)
ranging in size from##10##4##(1990-12#1)(1991-8#1)(1992-8#1)(1995-8#2)(1996-4#1)(2007-12#1)(2008-10#1)(2008-4#1)(2012-3#1)
ranging in##64##2##(1990-12#1)(1990-2#1)(1990-4#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-12#1)(1994-3#1)(1995-10#1)(1995-8#2)(1996-4#1)(1996-5#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#6)(2007-8#9)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-11#1)(2009-9#2)(2010-10#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
ranging over##5##2##(1990-5#1)(1990-7#1)(2007-12#1)(2008-1#1)(2008-3#1)
ranging system##3##2##(2008-2#1)(2008-3#2)
ranging##853##1##(1990-10#1)(1990-11#2)(1990-12#5)(1990-2#3)(1990-3#5)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-7#4)(1991-8#4)(1991-9#5)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#4)(1992-9#6)(1993-1#1)(1993-11#2)(1993-12#5)(1993-2#2)(1993-3#7)(1993-4#2)(1993-5#1)(1993-6#1)(1993-9#2)(1994-11#5)(1994-12#7)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-10#2)(1995-11#1)(1995-3#3)(1995-4#2)(1995-5#7)(1995-6#1)(1995-7#1)(1995-8#5)(1996-1#1)(1996-10#1)(1996-12#5)(1996-3#8)(1996-4#3)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#3)(1997-7#1)(1997-8#6)(2004-11#3)(2004-4#2)(2004-9#3)(2005-10#2)(2005-11#7)(2005-12#2)(2005-4#2)(2005-7#2)(2005-8#6)(2005-9#1)(2006-1#3)(2006-10#9)(2006-11#3)(2006-12#5)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#2)(2006-6#5)(2006-7#1)(2006-8#6)(2007-1#1)(2007-10#4)(2007-11#13)(2007-12#19)(2007-2#9)(2007-3#3)(2007-4#2)(2007-5#7)(2007-6#7)(2007-7#12)(2007-8#24)(2007-9#3)(2008-1#21)(2008-10#163)(2008-11#14)(2008-12#1)(2008-2#33)(2008-3#35)(2008-4#16)(2008-5#20)(2008-6#2)(2008-7#13)(2008-8#6)(2008-9#5)(2009-1#1)(2009-10#3)(2009-11#3)(2009-12#1)(2009-2#5)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#3)(2009-7#9)(2009-8#5)(2009-9#2)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#3)(2010-4#9)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#7)(2011-2#18)(2011-3#1)(2012-1#6)(2012-11#3)(2012-12#4)(2012-2#15)(2012-3#7)(2013-1#18)(2013-7#5)(2013-8#10)
ranibizumab##5##1##(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
ranitidine (100 microM)##2##3##(1993-6#2)
ranitidine and##3##2##(1991-5#1)(1995-12#1)(1995-3#1)
ranitidine##45##1##(1990-12#2)(1991-5#2)(1992-11#4)(1992-2#2)(1992-3#4)(1992-8#2)(1993-6#4)(1995-12#1)(1995-3#4)(1996-11#2)(1997-8#1)(2008-10#4)(2008-11#7)(2012-12#1)(2013-8#5)
rank among the most##2##4##(1997-6#1)(2012-2#1)
rank among the##4##3##(1997-6#1)(2007-9#1)(2008-9#1)(2012-2#1)
rank and replace and combined methods##2##6##(2010-3#2)
rank and replace##4##3##(2010-3#4)
rank and##6##2##(1993-2#1)(2010-3#4)(2012-1#1)
rank as##2##2##(1990-8#1)(2005-8#1)
rank correlation between the##2##4##(2008-10#1)(2011-1#1)
rank correlation between##3##3##(2008-10#1)(2011-1#2)
rank correlation coefficient##3##3##(1997-2#1)(2008-7#2)
rank correlation coefficients were calculated##2##5##(1991-2#1)(2008-10#1)
rank correlation coefficients##3##3##(1991-2#1)(2008-10#2)
rank correlation##18##2##(1990-1#1)(1991-2#1)(1992-12#1)(1997-2#1)(2005-10#1)(2006-11#1)(2008-10#5)(2008-7#2)(2011-1#2)(2012-3#1)(2013-1#2)
rank deficiency occurs##2##3##(2007-8#2)
rank deficiency##3##2##(2007-8#3)
rank for each##2##3##(1997-3#1)(2006-11#1)
rank for##4##2##(1997-3#1)(2006-11#3)
rank in##2##2##(2007-4#1)(2008-8#1)
rank is##2##2##(2008-10#1)(2012-1#1)
rank order of potencies##2##4##(1993-3#1)(1995-12#1)
rank order of potency for##5##5##(1994-3#1)(1995-12#2)(1995-6#1)(1996-12#1)
rank order of potency of##2##5##(1990-2#1)(1995-12#1)
rank order of potency was##2##5##(1993-3#1)(1996-10#1)
rank order of potency##16##4##(1990-2#1)(1993-3#2)(1993-6#1)(1994-3#1)(1995-1#2)(1995-12#3)(1995-6#1)(1995-7#1)(1996-10#1)(1996-12#1)(2009-12#1)(2010-12#1)
rank order of the##2##4##(1995-11#1)(2007-10#1)
rank order of##34##3##(1990-2#2)(1991-11#1)(1991-8#1)(1993-3#3)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-1#2)(1995-11#2)(1995-12#6)(1995-2#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-6#1)(2007-10#2)(2008-10#1)(2009-12#1)(2010-12#1)
rank order potencies##2##3##(1994-2#1)(1996-6#1)
rank order##48##2##(1990-11#1)(1990-12#1)(1990-2#2)(1991-11#1)(1991-3#1)(1991-8#1)(1993-3#3)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#6)(1995-2#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-10#1)(1996-12#2)(1996-6#2)(1997-2#1)(2005-11#1)(2007-10#2)(2008-10#1)(2008-9#1)(2009-12#1)(2009-4#2)(2010-12#1)
rank test##8##2##(1990-8#1)(1997-3#1)(1997-8#1)(2006-10#2)(2010-6#1)(2013-1#1)(2013-8#1)
rank test)##2##2##(1990-6#1)(1997-7#1)
rank tests##2##2##(1997-3#1)(2010-8#1)
rank the##9##2##(1991-2#1)(1992-11#1)(2007-8#1)(2008-5#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-8#2)
rank them##2##2##(2008-10#1)(2010-2#1)
rank transformed##3##2##(1993-1#2)(1995-2#1)
rank##176##1##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-6#1)(1990-8#2)(1991-11#1)(1991-2#2)(1991-3#1)(1991-6#2)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-1#3)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#6)(1995-2#2)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#2)(1996-6#2)(1997-2#4)(1997-3#4)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#6)(2006-11#4)(2007-10#3)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-10#16)(2008-11#6)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#4)(2008-9#3)(2009-12#1)(2009-4#2)(2010-12#4)(2010-2#1)(2010-3#6)(2010-6#1)(2010-8#3)(2011-1#2)(2011-2#2)(2012-1#4)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#4)
rank-deficient##3##1##(2007-8#3)
rank-order of the##2##3##(1995-11#2)
rank-order stability##2##2##(2010-1#2)
rank-order##6##1##(1992-8#1)(1995-11#2)(2008-4#1)(2010-1#2)
rank-sum test##4##2##(1996-3#1)(2010-2#2)(2013-1#1)
rank-sum tests##3##2##(1992-2#2)(2013-1#1)
rank-sum##11##1##(1992-2#3)(1996-3#1)(2010-2#3)(2012-1#2)(2013-1#2)
ranked according to their##3##4##(1992-11#1)(1993-12#1)(2007-8#1)
ranked according to##4##3##(1992-11#1)(1993-12#1)(2007-8#1)(2012-3#1)
ranked among the most##2##4##(2005-11#1)(2010-12#1)
ranked as the##3##3##(1991-3#1)(2008-9#1)(2011-2#1)
ranked as##5##2##(1991-3#1)(1994-12#1)(2008-5#1)(2008-9#1)(2011-2#1)
ranked based on##3##3##(1995-3#1)(2008-10#1)(2008-7#1)
ranked by##4##2##(1995-9#1)(1997-4#1)(2007-6#1)(2008-5#1)
ranked first in adults whole membranous##2##6##(2008-1#1)(2010-4#1)
ranked first in##3##3##(2008-1#1)(2010-12#1)(2010-4#1)
ranked for##2##2##(2010-12#1)(2011-12#1)
ranked highest##2##2##(1991-6#1)(2008-10#1)
ranked in the##3##3##(1990-4#1)(1995-6#1)(2010-8#1)
ranked in##7##2##(1990-4#1)(1995-2#1)(1995-6#1)(2007-6#1)(2008-11#1)(2008-8#1)(2010-8#1)
ranked on##3##2##(1993-12#1)(1994-6#1)(2008-10#1)
ranked the##4##2##(2006-10#1)(2006-11#1)(2008-7#1)(2008-9#1)
ranked within##2##2##(1997-4#2)
ranked##78##1##(1990-12#1)(1990-4#1)(1991-3#3)(1991-6#2)(1992-11#1)(1993-12#3)(1994-12#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#1)(1997-3#1)(1997-4#3)(2005-11#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-4#1)(2010-12#6)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#1)(2013-8#2)
ranking and##2##2##(2012-12#1)(2012-2#1)
ranking in the##2##3##(1997-3#1)(2010-3#1)
ranking in##3##2##(1997-3#1)(2007-3#1)(2010-3#1)
ranking of the##5##3##(1993-12#1)(1993-2#1)(2006-11#1)(2008-5#1)(2009-4#1)
ranking of##14##2##(1990-6#1)(1991-2#1)(1993-12#1)(1993-2#1)(2006-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-11#1)(2009-4#1)(2010-9#1)(2012-2#1)(2012-3#1)
ranking system for##5##3##(2006-11#1)(2008-11#4)
ranking system##6##2##(2006-11#2)(2008-11#4)
ranking##61##1##(1990-6#1)(1991-2#1)(1992-11#1)(1992-2#2)(1993-1#2)(1993-12#2)(1993-2#1)(1993-3#1)(1994-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-3#2)(2004-3#1)(2006-11#3)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#3)(2008-11#6)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-3#2)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#1)
rankings in##2##2##(1992-2#1)(2008-11#1)
rankings of##2##2##(2010-4#1)(2013-1#1)
rankings##19##1##(1992-11#1)(1992-2#1)(1993-2#2)(1995-3#2)(1997-3#2)(2007-4#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-3#1)(2010-4#2)(2010-8#1)(2013-1#2)
ranks among the most##2##4##(2007-7#1)(2011-2#1)
ranks and##3##2##(2007-9#1)(2010-8#1)(2012-7#1)
ranks differ##2##2##(1992-2#1)(2012-3#1)
ranks high##2##2##(1990-12#1)(2010-12#1)
ranks of the##4##3##(1994-12#1)(1994-5#1)(1995-2#1)(1997-2#1)
ranks of##5##2##(1994-12#1)(1994-5#1)(1995-2#1)(1997-2#1)(2008-12#1)
ranks##38##1##(1990-12#1)(1990-8#1)(1991-5#1)(1992-2#3)(1993-1#1)(1993-6#1)(1994-12#2)(1994-5#1)(1995-2#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-4#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-3#2)(2012-7#1)(2013-1#1)(2013-8#1)
ranolazine in##5##2##(2005-8#5)
ranolazine##16##1##(2005-8#14)(2008-8#1)(2009-12#1)
rap-1b##4##1##(1990-7#4)
rap-2B protein##2##2##(1990-8#2)
rap-2B##6##1##(1990-8#6)
rap1 and##2##2##(1992-11#2)
rap1##3##1##(1992-11#3)
rap1-GAPm##3##1##(1992-11#3)
rap1A/Krev-1/smgp21A##2##1##(1991-9#2)
rap1ts##2##1##(1996-7#2)
rap2 protein##5##2##(1991-9#3)(1992-11#2)
rap2##7##1##(1991-9#4)(1992-11#3)
rap2A##3##1##(1992-11#3)
rapa cv##4##2##(2008-10#4)
rapa##18##1##(2008-10#15)(2008-7#3)
rapae crucivora##3##2##(2008-5#1)(2008-6#2)
rapae##12##1##(1997-8#2)(2007-12#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-8#5)
rapamycin and##4##2##(1993-8#1)(1994-6#1)(2007-11#1)(2010-12#1)
rapamycin on##3##2##(1993-11#1)(2008-12#1)(2013-7#1)
rapamycin##52##1##(1991-9#1)(1992-7#1)(1993-11#7)(1993-8#3)(1994-6#2)(1995-2#1)(1995-6#1)(1996-2#1)(1997-6#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-12#6)(2010-7#2)(2011-2#2)(2013-1#5)(2013-7#2)
rape against women##2##3##(2007-3#2)
rape and##6##2##(2005-8#2)(2006-12#1)(2007-12#2)(2007-3#1)
rape in##2##2##(1995-9#1)(2008-11#1)
rape straw##2##2##(2013-1#2)
rape trauma##2##2##(1991-8#1)(2008-6#1)
rape##57##1##(1990-12#5)(1990-9#1)(1991-8#4)(1995-9#2)(1996-5#1)(1996-6#1)(2005-10#1)(2005-8#6)(2006-12#2)(2007-12#3)(2007-3#3)(2008-10#14)(2008-11#2)(2008-12#1)(2008-6#4)(2009-5#1)(2010-12#1)(2011-2#2)(2013-1#2)(2013-8#1)
raped##6##1##(1991-10#1)(1991-8#1)(2007-12#2)(2007-3#1)(2009-10#1)
rapeseed meal##2##2##(2008-10#2)
rapeseed methyl ester##2##3##(2008-6#1)(2011-2#1)
rapeseed myrosinase##2##2##(1990-12#2)
rapeseed oil##8##2##(2008-10#1)(2008-6#5)(2010-8#2)
rapeseed oils##2##2##(2008-10#2)
rapeseed##37##1##(1990-12#3)(1991-1#2)(1992-2#2)(2008-10#10)(2008-11#4)(2008-6#6)(2008-7#4)(2010-8#2)(2011-1#3)(2011-2#1)
raphani and##2##2##(2008-10#2)
raphani##5##1##(2008-10#5)
raphe and##3##2##(1994-2#1)(1995-5#1)(1995-6#1)
raphe injection of##2##3##(1995-12#2)
raphe nuclei of the##2##4##(1996-12#1)(2008-7#1)
raphe nuclei##17##2##(1991-2#1)(1992-8#1)(1993-7#1)(1994-10#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-9#1)(1997-2#1)(2008-7#7)
raphe nucleus and##3##3##(1993-7#1)(1994-12#1)(1995-6#1)
raphe nucleus##16##2##(1990-2#1)(1991-2#1)(1991-3#1)(1992-3#2)(1993-12#3)(1993-3#1)(1993-7#1)(1994-12#2)(1995-5#1)(1995-6#2)(2012-3#1)
raphe obscurus##3##2##(1991-12#1)(1994-2#1)(1997-2#1)
raphe on##2##2##(1996-4#2)
raphe pontis##2##2##(1991-3#2)
raphe##69##1##(1990-2#1)(1991-12#2)(1991-2#4)(1991-3#5)(1992-3#2)(1992-8#1)(1993-12#3)(1993-3#2)(1993-7#4)(1994-10#1)(1994-12#2)(1994-2#7)(1995-12#5)(1995-5#2)(1995-6#4)(1996-12#3)(1996-4#3)(1996-9#2)(1997-2#2)(1997-3#1)(1997-6#1)(2008-7#10)(2012-2#1)(2012-3#1)
rapid (&lt##4##2##(1994-9#1)(2006-3#1)(2008-10#2)
rapid (approximately##2##2##(1996-5#1)(2008-10#1)
rapid (less than##2##3##(1995-1#1)(2008-10#1)
rapid (t1/2##2##2##(1991-7#1)(1994-12#1)
rapid (within##3##2##(1990-3#1)(2008-10#1)(2008-12#1)
rapid Ca2+##2##2##(1993-8#1)(1996-2#1)
rapid DNA extraction##2##3##(2008-10#1)(2008-12#1)
rapid DNA##5##2##(1991-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)
rapid PCR-based##2##2##(1994-12#1)(2012-2#1)
rapid absorption and##2##3##(2007-11#1)(2008-4#1)
rapid absorption##3##2##(1997-4#1)(2007-11#1)(2008-4#1)
rapid access neurology clinic##2##4##(2010-12#2)
rapid access to the##2##4##(1990-6#1)(2006-5#1)
rapid access to##4##3##(1990-6#1)(2005-11#1)(2006-5#1)(2008-10#1)
rapid access##7##2##(1990-6#1)(1997-8#1)(2005-11#1)(2006-5#1)(2008-10#1)(2010-12#2)
rapid accumulation of##5##3##(1991-6#1)(1995-9#1)(1997-6#1)(2007-11#1)(2011-2#1)
rapid accumulation##6##2##(1991-6#1)(1995-9#1)(1997-6#1)(2007-11#1)(2007-9#1)(2011-2#1)
rapid acting analogs##2##3##(2008-1#2)
rapid acting##3##2##(2008-1#3)
rapid activation of phospholipase D##2##5##(1995-3#1)(2010-9#1)
rapid activation of##7##3##(1990-11#1)(1995-3#2)(1996-5#1)(1996-6#1)(2008-11#1)(2010-9#1)
rapid activation##10##2##(1990-11#1)(1992-12#1)(1994-8#1)(1995-3#2)(1996-5#1)(1996-6#1)(2008-11#1)(2008-4#1)(2010-9#1)
rapid adaptation##3##2##(2008-4#1)(2008-7#1)(2009-9#1)
rapid advancement in the##2##4##(2009-10#1)(2009-5#1)
rapid advancement of##2##3##(2008-4#1)(2008-8#1)
rapid advancement##4##2##(2008-4#1)(2008-8#1)(2009-10#1)(2009-5#1)
rapid advances in the##2##4##(2007-1#1)(2007-8#1)
rapid advances in##6##3##(1992-1#1)(1994-9#1)(2006-10#2)(2007-1#1)(2007-8#1)
rapid advances##8##2##(1992-1#1)(1994-9#1)(2006-10#2)(2006-11#1)(2007-1#1)(2007-8#1)(2011-2#1)
rapid after##2##2##(2006-10#1)(2008-7#1)
rapid agonist-induced desensitization##2##3##(1996-5#2)
rapid amplification of cDNA ends (RACE)##5##6##(1992-12#1)(1997-6#1)(2005-11#1)(2010-5#2)
rapid amplification of cDNA ends##9##5##(1991-5#1)(1992-12#1)(1996-11#1)(1997-6#1)(2005-11#1)(2008-5#1)(2009-5#1)(2010-5#2)
rapid analysis of##10##3##(1994-6#1)(2005-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2010-9#1)(2011-1#1)
rapid analysis##13##2##(1994-6#1)(1996-5#1)(2005-12#1)(2005-8#1)(2007-8#1)(2008-10#5)(2008-11#1)(2010-9#1)(2011-1#1)
rapid analytical test methods##2##4##(2008-10#2)
rapid analytical##6##2##(2008-10#6)
rapid and accelerated rises##2##4##(2010-4#2)
rapid and accelerated##3##3##(2010-4#3)
rapid and accurate identification of##2##5##(2008-10#1)(2008-5#1)
rapid and accurate method for the##3##6##(2008-10#3)
rapid and accurate##18##3##(1990-8#1)(1993-11#1)(2005-12#1)(2005-4#1)(2008-10#10)(2008-5#2)(2010-2#1)(2010-5#1)
rapid and automated##2##3##(2007-11#1)(2008-10#1)
rapid and capable##2##3##(2007-8#1)(2008-10#1)
rapid and complete##6##3##(1991-8#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-5#1)(2009-4#1)
rapid and convenient model##2##4##(1996-10#1)(2011-1#1)
rapid and convenient##5##3##(1996-10#1)(1997-3#1)(2005-12#1)(2008-4#1)(2011-1#1)
rapid and cost##2##3##(1991-12#1)(2008-10#1)
rapid and cost-effective##4##3##(2005-4#1)(2008-9#1)(2010-6#1)(2011-2#1)
rapid and direct##6##3##(1997-4#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-3#1)
rapid and dramatic##2##3##(1993-4#1)(2007-4#1)
rapid and easy##5##3##(1992-6#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-11#1)
rapid and economical differential pulse polarographic##2##6##(2008-10#2)
rapid and economical method for##2##5##(2008-10#1)(2008-8#1)
rapid and economical##8##3##(1992-8#1)(2007-8#1)(2008-10#4)(2008-8#1)(2009-8#1)
rapid and effective##3##3##(2006-10#1)(2007-8#1)(2008-7#1)
rapid and efficient separation##2##4##(1992-2#1)(2013-8#1)
rapid and efficient##19##3##(1991-12#1)(1991-5#1)(1992-2#1)(1994-11#1)(1996-5#1)(2005-4#1)(2007-12#2)(2007-7#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-7#1)(2010-11#1)(2013-8#1)
rapid and extensive##3##3##(1994-3#1)(1995-1#1)(2005-11#1)
rapid and has##2##3##(2005-4#1)(2008-10#1)
rapid and highly efficient##2##4##(1994-5#1)(2012-1#1)
rapid and highly sensitive##2##4##(2008-10#2)
rapid and highly##6##3##(1994-12#1)(1994-5#1)(2008-10#3)(2012-1#1)
rapid and inexpensive##3##3##(1994-2#1)(2008-10#2)
rapid and marked##3##3##(1990-7#1)(1995-6#1)(2007-9#1)
rapid and massive##3##3##(1990-5#1)(2007-10#1)(2011-1#1)
rapid and persistent##2##3##(1993-11#1)(1997-3#1)
rapid and precise##12##3##(1990-11#1)(1995-9#1)(1997-3#1)(2007-7#1)(2008-10#6)(2008-2#1)(2011-2#1)
rapid and quantitative##2##3##(2008-7#1)(2008-9#1)
rapid and reliable diagnosis##2##4##(2005-11#1)(2007-2#1)
rapid and reliable method for##2##5##(1996-3#1)(2007-2#1)
rapid and reliable method##4##4##(1996-3#1)(2007-2#1)(2008-10#2)
rapid and reliable##15##3##(1991-3#1)(1996-3#1)(2005-11#1)(2007-1#1)(2007-12#1)(2007-2#3)(2007-8#1)(2008-10#3)(2008-7#1)(2011-2#1)(2013-8#1)
rapid and reproducible method##2##4##(1992-8#1)(2008-10#1)
rapid and reproducible##6##3##(1992-8#1)(1994-3#1)(2008-10#2)(2008-5#2)
rapid and reversible##3##3##(1993-6#1)(1995-10#1)(2008-11#1)
rapid and robust##3##3##(2008-10#1)(2008-6#1)(2012-2#1)
rapid and safe##4##3##(1990-10#1)(2008-10#1)(2008-4#1)(2010-2#1)
rapid and selective determination##2##4##(2008-10#2)
rapid and selective##8##3##(1993-2#1)(1993-4#1)(2008-10#6)
rapid and sensitive analysis of##2##5##(2006-9#1)(2008-10#1)
rapid and sensitive and has been##2##6##(2008-10#2)
rapid and sensitive and##4##4##(2008-10#4)
rapid and sensitive assay for##2##5##(1992-7#1)(2008-10#1)
rapid and sensitive assay##3##4##(1990-12#1)(1992-7#1)(2008-10#1)
rapid and sensitive flow injection##3##5##(2008-10#3)
rapid and sensitive liquid chromatographic technique to determine##2##8##(1992-6#1)(1993-9#1)
rapid and sensitive liquid chromatographic##3##5##(1992-6#1)(1993-9#1)(2008-10#1)
rapid and sensitive means of##2##5##(1995-3#1)(1997-3#1)
rapid and sensitive method for the determination of##5##8##(2008-10#5)
rapid and sensitive method for the##12##6##(2007-7#1)(2008-10#9)(2008-5#1)(2010-4#1)
rapid and sensitive method for##13##5##(2007-7#1)(2008-10#10)(2008-5#1)(2010-4#1)
rapid and sensitive method is##3##5##(2008-10#3)
rapid and sensitive method was##2##5##(2008-10#2)
rapid and sensitive method##21##4##(1990-6#1)(1991-5#1)(2007-7#1)(2008-10#15)(2008-5#1)(2010-4#1)(2011-2#1)
rapid and sensitive procedure##2##4##(2008-10#2)
rapid and sensitive spectrophotometric method has been developed for the assay of##2##12##(2008-10#2)
rapid and sensitive spectrophotometric##4##4##(2008-10#4)
rapid and sensitive##78##3##(1990-12#3)(1990-6#2)(1991-5#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-3#1)(1995-5#1)(1997-3#1)(2005-4#1)(2006-4#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-10#49)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#2)
rapid and significant##2##3##(1995-5#1)(2012-12#1)
rapid and simple and##2##4##(2008-10#1)(2010-4#1)
rapid and simple determination of##2##5##(2007-8#1)(2008-10#1)
rapid and simple method for##3##5##(2006-3#1)(2008-10#1)(2012-3#1)
rapid and simple method##8##4##(1992-7#1)(1992-8#1)(2006-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2012-3#1)
rapid and simple procedure##3##4##(1990-4#1)(1996-12#1)(2008-10#1)
rapid and simple##38##3##(1990-4#1)(1992-7#1)(1992-8#1)(1993-10#1)(1994-9#1)(1996-12#1)(1997-2#1)(2005-10#1)(2006-3#1)(2007-8#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-11#1)(2010-4#1)(2011-12#1)(2012-3#1)
rapid and simultaneous determination of##3##5##(1996-6#1)(2008-10#1)(2008-5#1)
rapid and simultaneous##5##3##(1996-6#1)(2008-10#2)(2008-5#1)(2008-9#1)
rapid and specific##7##3##(2007-7#1)(2008-10#5)(2008-7#1)
rapid and suitable for automatic and continuous analysis##2##8##(2008-10#2)
rapid and suitable for##4##4##(2008-10#3)(2012-12#1)
rapid and sustained##6##3##(1991-6#1)(1993-4#1)(1994-10#1)(1996-2#1)(1996-8#1)(2008-10#1)
rapid and the##3##3##(1994-8#1)(1995-8#1)(2008-10#1)
rapid and transient tyrosine phosphorylation of##2##6##(1991-12#1)(1995-3#1)
rapid and transient##15##3##(1990-10#1)(1990-12#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-2#1)(1997-1#1)(2008-5#1)
rapid and uniform##2##3##(2012-1#1)(2012-12#1)
rapid and##414##2##(1990-10#2)(1990-11#1)(1990-12#8)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#3)(1991-2#2)(1991-3#3)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-6#4)(1992-7#2)(1992-8#4)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#3)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#4)(1994-11#4)(1994-12#2)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#4)(1995-1#1)(1995-10#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#2)(2005-10#1)(2005-11#2)(2005-12#3)(2005-4#5)(2006-10#2)(2006-3#1)(2006-4#1)(2006-6#2)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#6)(2007-2#4)(2007-4#1)(2007-6#1)(2007-7#5)(2007-8#7)(2007-9#1)(2008-10#150)(2008-11#6)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#6)(2008-5#10)(2008-6#4)(2008-7#8)(2008-8#1)(2008-9#6)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#6)(2010-5#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#3)(2012-12#5)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#4)
rapid antigen detection##2##3##(2007-2#1)(2007-7#1)
rapid appearance of##5##3##(1991-2#1)(1994-10#1)(1994-12#1)(1995-5#1)(2006-12#1)
rapid appearance##6##2##(1991-2#1)(1991-7#1)(1994-10#1)(1994-12#1)(1995-5#1)(2006-12#1)
rapid as##4##2##(1993-1#1)(2007-2#1)(2007-8#1)(2008-9#1)
rapid assay##6##2##(1992-8#1)(1993-12#1)(2008-10#2)(2008-11#1)(2011-1#1)
rapid assays of##2##3##(2008-10#1)(2008-9#1)
rapid assays##3##2##(2007-12#1)(2008-10#1)(2008-9#1)
rapid assembly of##3##3##(1994-12#1)(2008-4#1)(2008-8#1)
rapid assessment of##5##3##(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)
rapid assessment##11##2##(2008-10#2)(2008-3#4)(2008-4#1)(2008-8#1)(2008-9#1)(2009-9#1)(2012-3#1)
rapid association of##2##3##(1990-2#1)(1995-5#1)
rapid association##4##2##(1990-2#1)(1992-12#1)(1995-5#1)(1997-5#1)
rapid atrial##2##2##(1995-12#1)(2007-9#1)
rapid bactericidal##3##2##(2005-7#1)(2006-8#1)(2008-5#1)
rapid binding of##3##3##(1992-6#1)(2007-11#1)(2007-8#1)
rapid blood##3##2##(1995-1#1)(1996-8#1)(2008-11#1)
rapid bone loss##4##3##(1993-11#1)(2005-3#1)(2008-11#1)(2012-12#1)
rapid bone##5##2##(1993-11#1)(2005-3#1)(2007-11#1)(2008-11#1)(2012-12#1)
rapid but##3##2##(1996-12#1)(1996-9#1)(2011-1#1)
rapid by##2##2##(2009-12#1)(2012-12#1)
rapid cell death in##2##4##(1997-2#1)(2008-10#1)
rapid cell death##4##3##(1997-2#1)(2008-10#2)(2012-12#1)
rapid cell##13##2##(1991-1#2)(1994-11#1)(1997-2#1)(1997-4#1)(2008-10#3)(2008-11#2)(2008-7#1)(2011-1#1)(2012-12#1)
rapid cellular##2##2##(1990-7#1)(1992-4#1)
rapid change in##5##3##(1996-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2013-1#1)
rapid change##9##2##(1993-12#1)(1996-2#1)(1997-3#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2013-1#1)
rapid changes in the##4##4##(2007-3#1)(2008-11#1)(2008-8#1)(2009-5#1)
rapid changes in##12##3##(1990-2#1)(1990-8#1)(1991-5#1)(1996-3#1)(2006-1#1)(2007-1#1)(2007-3#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#1)
rapid changes of##2##3##(1991-5#1)(1997-6#1)
rapid changes##17##2##(1990-2#1)(1990-6#1)(1990-8#1)(1991-5#2)(1993-1#1)(1996-3#1)(1997-6#1)(2006-1#1)(2007-1#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#1)
rapid chemical##2##2##(1994-11#1)(2008-2#1)
rapid clearance of##3##3##(1991-2#1)(1996-1#1)(2008-10#1)
rapid clearance##6##2##(1991-2#1)(1992-10#1)(1996-1#1)(2007-11#1)(2008-10#1)(2010-12#1)
rapid clinical and##2##3##(2008-5#1)(2009-6#1)
rapid clinical response##3##3##(2007-11#1)(2007-5#1)(2010-9#1)
rapid clinical##11##2##(2007-11#1)(2007-5#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-6#1)(2010-9#1)(2011-2#2)(2013-7#1)
rapid closure of the##2##4##(1990-4#1)(2009-8#1)
rapid cold hardening##4##3##(2011-12#4)
rapid communication##2##2##(2006-10#1)(2008-8#1)
rapid comparison##2##2##(2008-4#1)(2008-5#1)
rapid construction of##3##3##(1993-2#2)(2013-1#1)
rapid contraction##2##2##(2009-11#1)(2011-1#1)
rapid convergence##3##2##(2007-12#1)(2008-8#1)(2009-9#1)
rapid cooling contractures##2##3##(1996-12#2)
rapid cooling##3##2##(1996-12#2)(2005-11#1)
rapid cycle##2##2##(2008-7#1)(2013-8#1)
rapid cycling##8##2##(1992-8#3)(1997-4#1)(1997-8#2)(2005-6#1)(2008-10#1)
rapid death of##3##3##(1994-6#1)(2008-10#1)(2012-12#1)
rapid death##4##2##(1994-6#1)(2007-6#1)(2008-10#1)(2012-12#1)
rapid decline in##11##3##(1991-4#1)(1994-7#1)(1996-4#1)(2007-11#2)(2008-6#1)(2008-8#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-12#1)
rapid decline of##3##3##(1997-6#1)(2008-11#1)(2011-2#1)
rapid decline##15##2##(1991-4#1)(1994-7#1)(1996-4#1)(1997-6#1)(2007-11#2)(2008-11#1)(2008-6#1)(2008-8#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
rapid decompression and##2##3##(2008-3#1)(2008-7#1)
rapid decompression##3##2##(2006-9#1)(2008-3#1)(2008-7#1)
rapid decrease in##8##3##(1990-12#1)(1992-1#1)(1992-2#1)(1994-10#1)(1994-3#1)(1996-4#1)(2007-8#1)(2008-11#1)
rapid decrease of##2##3##(1996-11#1)(2008-7#1)
rapid decrease##12##2##(1990-12#1)(1992-1#1)(1992-2#1)(1994-10#1)(1994-3#1)(1996-11#1)(1996-4#1)(2005-11#1)(2007-8#1)(2008-11#1)(2008-7#1)(2013-1#1)
rapid degradation of##3##3##(1990-7#1)(1991-2#1)(1996-7#1)
rapid degradation##6##2##(1990-7#1)(1991-2#1)(1994-3#1)(1996-2#1)(1996-7#1)(2008-5#1)
rapid delivery of##2##3##(2007-5#1)(2008-8#1)
rapid depletion of##6##3##(1990-5#1)(1995-5#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-5#1)
rapid desensitization protocols##2##3##(2008-8#2)
rapid desensitization to##2##3##(2011-1#2)
rapid desensitization##8##2##(1990-10#1)(1992-3#1)(2008-8#4)(2011-1#2)
rapid desensitizations##3##2##(2008-8#3)
rapid detection of the##3##4##(2008-10#2)(2010-4#1)
rapid detection of toxic##2##4##(2006-7#1)(2008-11#1)
rapid detection of##22##3##(1995-2#1)(1996-7#1)(1997-3#1)(2006-7#1)(2007-12#2)(2007-7#1)(2007-8#3)(2008-10#4)(2008-11#1)(2009-6#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-12#1)(2012-2#1)(2012-3#1)
rapid detection##28##2##(1993-12#1)(1995-2#1)(1996-7#1)(1997-3#1)(2006-7#1)(2007-12#2)(2007-7#2)(2007-8#3)(2008-10#7)(2008-11#1)(2008-5#1)(2009-6#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-12#1)(2012-2#1)(2012-3#1)
rapid deterioration of##2##3##(1993-2#1)(2012-11#1)
rapid deterioration##5##2##(1993-2#1)(1995-2#1)(2006-10#1)(2008-1#1)(2012-11#1)
rapid determination of the##4##4##(2006-12#1)(2006-3#1)(2008-10#2)
rapid determination of##27##3##(1991-9#1)(1997-1#1)(2005-12#1)(2006-12#1)(2006-3#1)(2007-12#1)(2008-10#18)(2008-5#1)(2011-2#1)(2012-12#1)
rapid determination##29##2##(1991-9#1)(1997-1#1)(2005-12#1)(2006-12#1)(2006-3#1)(2007-12#1)(2008-10#19)(2008-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
rapid development of##28##3##(1990-2#1)(1994-12#1)(1996-11#1)(1997-4#1)(2005-7#1)(2006-10#2)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#4)(2008-5#3)(2008-9#1)(2009-11#1)(2009-5#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
rapid development##36##2##(1990-2#1)(1994-12#1)(1996-11#2)(1997-4#1)(2005-7#1)(2006-10#2)(2006-7#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-10#4)(2008-5#4)(2008-9#1)(2009-11#1)(2009-5#1)(2010-2#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#2)
rapid developments in##2##3##(1990-3#1)(1992-12#1)
rapid developments##4##2##(1990-3#1)(1992-12#1)(2010-12#1)(2012-12#1)
rapid diagnoses##2##2##(2006-10#1)(2008-10#1)
rapid diagnosis and treatment##2##4##(2007-11#1)(2012-12#1)
rapid diagnosis and##5##3##(2007-11#2)(2008-7#1)(2011-2#1)(2012-12#1)
rapid diagnosis of##15##3##(1993-12#1)(2006-6#1)(2007-7#3)(2007-8#1)(2008-10#2)(2008-5#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-12#2)(2012-2#1)
rapid diagnosis##24##2##(1993-12#1)(1996-3#1)(2006-6#1)(2007-11#2)(2007-7#3)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-10#2)(2010-4#1)(2010-5#1)(2011-12#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
rapid diagnostic test##3##3##(2005-8#1)(2007-2#1)(2008-10#1)
rapid diagnostic tests##5##3##(2013-1#4)(2013-8#1)
rapid diagnostic##13##2##(2005-8#1)(2006-12#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-8#1)(2011-2#1)(2013-1#4)(2013-8#1)
rapid differential##3##2##(2008-10#2)(2013-8#1)
rapid differentiation of##3##3##(1995-8#1)(2007-12#1)(2012-12#1)
rapid dip stick##2##3##(2010-8#2)
rapid disease progression##2##3##(2009-9#1)(2013-1#1)
rapid disintegration##2##2##(2008-5#1)(2010-12#1)
rapid dissemination of##2##3##(2007-4#1)(2008-9#1)
rapid dissemination##3##2##(1991-4#1)(2007-4#1)(2008-9#1)
rapid dissociation of##2##3##(1991-3#1)(1994-9#1)
rapid diversification of##2##3##(2008-8#1)(2010-5#1)
rapid down-regulation of##2##3##(1991-4#1)(1996-7#1)
rapid drop in##3##3##(1995-3#1)(2008-5#1)(2010-8#1)
rapid during the first##3##4##(2004-4#1)(2008-12#1)(2008-5#1)
rapid during the##4##3##(2004-4#1)(2008-10#1)(2008-12#1)(2008-5#1)
rapid dynamic equilibrium##2##3##(1993-6#1)(1994-9#1)
rapid dynamic##3##2##(1993-6#1)(1994-9#1)(2008-10#1)
rapid effects##3##2##(1994-10#1)(1994-9#1)(2008-7#1)
rapid efflux of##3##3##(1990-5#1)(1996-9#1)(2004-11#1)
rapid efflux##4##2##(1990-5#1)(1996-7#1)(1996-9#1)(2004-11#1)
rapid elimination of the##2##4##(1990-11#1)(2008-11#1)
rapid elimination of##3##3##(1990-11#1)(2008-11#1)(2010-8#1)
rapid elimination##4##2##(1990-11#1)(1994-6#1)(2008-11#1)(2010-8#1)
rapid emergence of##2##3##(2006-10#1)(2008-7#1)
rapid emergence##3##2##(2006-10#2)(2008-7#1)
rapid energy##4##2##(2006-12#1)(2006-4#3)
rapid enough##2##2##(1992-6#1)(2007-12#1)
rapid environmental##2##2##(2010-8#1)(2012-1#1)
rapid enzymatic assay of##2##4##(2008-10#2)
rapid equilibrium between##2##3##(1991-4#1)(1995-3#1)
rapid equilibrium binding##2##3##(1994-8#1)(1995-3#1)
rapid equilibrium##8##2##(1990-10#1)(1991-4#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-3#2)(1995-6#1)
rapid establishment of##2##3##(1993-9#1)(2008-11#1)
rapid evaluation of##5##3##(1994-3#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-11#1)
rapid evaluation##6##2##(1994-3#1)(2008-2#1)(2008-3#2)(2008-9#1)(2010-11#1)
rapid evolution of the##3##4##(1994-8#1)(2006-10#1)(2013-1#1)
rapid evolution of##8##3##(1994-8#1)(2005-7#1)(2006-10#1)(2008-10#1)(2008-8#3)(2013-1#1)
rapid evolution##14##2##(1991-4#1)(1994-8#1)(1995-12#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#3)(2010-8#2)(2013-1#1)
rapid evolutionary##2##2##(2007-12#1)(2011-2#1)
rapid exchange##4##2##(1991-8#1)(1994-8#1)(1995-2#1)(2008-10#1)
rapid expansion in the##2##4##(2009-11#1)(2013-7#1)
rapid expansion of##12##3##(2006-10#1)(2007-11#2)(2007-4#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-1#1)(2013-1#3)
rapid expansion##17##2##(2006-10#1)(2006-11#1)(2007-11#2)(2007-4#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-11#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#3)(2013-7#1)
rapid expression of##2##3##(1995-2#1)(2008-11#1)
rapid extraction of##2##3##(2007-11#1)(2009-9#1)
rapid extraction##5##2##(2007-11#1)(2008-10#3)(2009-9#1)
rapid eye movement (REM) sleep##11##5##(1990-7#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-3#1)(1994-12#1)(1996-6#1)(2004-11#1)(2008-11#1)(2008-7#1)(2013-8#1)
rapid eye movement (REM)##12##4##(1990-7#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-3#1)(1994-12#1)(1996-1#1)(1996-6#1)(2004-11#1)(2008-11#1)(2008-7#1)(2013-8#1)
rapid eye movement##13##3##(1990-11#1)(1990-7#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-3#1)(1994-12#1)(1996-1#1)(1996-6#1)(2004-11#1)(2008-11#1)(2008-7#1)(2013-8#1)
rapid eye##14##2##(1990-11#1)(1990-7#1)(1991-5#1)(1991-6#1)(1992-1#2)(1992-3#1)(1994-12#1)(1996-1#1)(1996-6#1)(2004-11#1)(2008-11#1)(2008-7#1)(2013-8#1)
rapid fall##2##2##(1991-3#1)(2008-7#1)
rapid filtration##2##2##(1990-8#1)(2008-1#1)
rapid flow##2##2##(1995-2#1)(2006-5#1)
rapid fluctuations in##2##3##(1996-11#1)(2010-8#1)
rapid fluctuations##3##2##(1994-3#1)(1996-11#1)(2010-8#1)
rapid for##2##2##(1994-6#1)(1996-11#1)
rapid formation of an##2##4##(1995-10#2)
rapid formation of##5##3##(1991-6#1)(1991-7#1)(1995-10#2)(1995-8#1)
rapid formation##6##2##(1991-6#1)(1991-7#1)(1995-10#2)(1995-8#1)(2009-4#1)
rapid functional##2##2##(1996-6#1)(2012-2#1)
rapid generation of##3##3##(2008-4#1)(2009-9#1)(2013-8#1)
rapid growth and##5##3##(1992-2#1)(1996-3#1)(2006-1#1)(2007-12#1)(2010-2#1)
rapid growth in the##4##4##(2007-8#1)(2009-11#1)(2009-3#1)(2010-11#1)
rapid growth in##9##3##(1992-1#1)(1992-2#1)(1994-2#1)(1994-3#1)(2007-11#1)(2007-8#1)(2009-11#1)(2009-3#1)(2010-11#1)
rapid growth of the##5##4##(1991-9#1)(2006-6#1)(2008-5#1)(2008-7#1)(2009-5#1)
rapid growth of##15##3##(1990-11#1)(1991-12#1)(1991-9#1)(1996-9#1)(2006-6#1)(2007-11#1)(2007-4#2)(2008-10#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-7#1)(2012-3#2)
rapid growth rate##2##3##(1992-2#2)
rapid growth##46##2##(1990-11#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#4)(1994-2#1)(1994-3#1)(1996-3#1)(1996-9#1)(2006-1#1)(2006-6#1)(2007-11#3)(2007-12#1)(2007-4#2)(2007-8#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-7#1)
rapid high performance##3##3##(2010-2#2)(2010-3#1)
rapid high-performance liquid chromatographic method##2##5##(1993-2#1)(1997-3#1)
rapid high-throughput##4##2##(2007-8#1)(2008-10#1)(2011-1#1)(2011-2#1)
rapid identification and##2##3##(2006-12#1)(2008-10#1)
rapid identification of the##6##4##(2006-12#1)(2006-8#1)(2007-6#1)(2010-4#1)(2011-1#1)(2012-12#1)
rapid identification of##18##3##(1991-12#1)(1994-9#1)(2006-12#1)(2006-8#1)(2007-6#2)(2007-7#1)(2008-10#3)(2008-9#1)(2010-12#1)(2010-4#2)(2011-1#1)(2012-12#2)(2013-1#1)
rapid identification protocol##3##3##(2007-7#3)
rapid identification system for##2##4##(2006-8#1)(2007-6#1)
rapid identification##27##2##(1991-12#1)(1994-9#1)(2006-12#2)(2006-8#2)(2007-6#3)(2007-7#4)(2008-10#4)(2008-12#2)(2008-9#1)(2010-12#1)(2010-4#2)(2011-1#1)(2012-12#2)(2013-1#1)
rapid immunochromatographic##6##2##(2005-8#2)(2006-10#1)(2008-10#1)(2012-2#1)(2012-3#1)
rapid improvement in##2##3##(1996-4#1)(2008-6#1)
rapid improvement of the##3##4##(2005-11#1)(2007-11#1)(2008-11#1)
rapid improvement##8##2##(1991-6#1)(1992-8#1)(1996-4#1)(2005-11#1)(2007-11#1)(2008-11#1)(2008-6#1)(2012-2#1)
rapid in onset##2##3##(1996-9#1)(2008-1#1)
rapid in situ##2##3##(2006-12#1)(2008-3#1)
rapid in##12##2##(1991-12#1)(1991-6#1)(1995-9#1)(1996-9#1)(2006-12#1)(2006-3#1)(2008-1#1)(2008-10#2)(2008-3#1)(2010-4#1)(2013-1#1)
rapid inactivation##4##2##(1990-12#1)(1990-5#1)(1993-11#1)(1994-9#1)
rapid incorporation of##2##3##(1994-12#1)(2006-4#1)
rapid increase in [Ca2+]i##3##4##(1994-2#2)(1997-1#1)
rapid increase in electrolyte leakage##2##5##(2008-10#2)
rapid increase in frequency##2##4##(1995-6#1)(2008-10#1)
rapid increase in the demand for medical manpower##2##8##(1990-6#2)
rapid increase in the number of##3##6##(2008-10#1)(2008-2#1)(2013-8#1)
rapid increase in the##14##4##(1990-2#1)(1990-6#2)(1991-2#1)(1991-5#1)(1995-4#1)(1995-6#1)(1996-9#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2013-8#1)
rapid increase in##47##3##(1990-2#1)(1990-5#1)(1990-6#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-12#2)(1992-9#1)(1994-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1996-11#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#2)(2006-10#3)(2007-10#1)(2007-12#2)(2008-10#7)(2008-2#1)(2008-3#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-8#2)
rapid increase of the##2##4##(1990-2#1)(2008-11#1)
rapid increase of##14##3##(1990-2#1)(1990-7#1)(1992-4#1)(1994-2#1)(1996-3#1)(2005-10#1)(2007-10#1)(2008-11#1)(2008-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#2)
rapid increase##66##2##(1990-2#2)(1990-5#1)(1990-6#2)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-12#2)(1992-4#1)(1992-9#1)(1994-2#3)(1995-10#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1996-11#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#2)(2005-10#1)(2006-10#4)(2007-10#2)(2007-12#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#3)(2013-1#2)(2013-8#2)
rapid increases in##5##3##(1991-2#1)(1995-3#1)(1996-12#1)(1997-8#1)(2008-10#1)
rapid increases##6##2##(1991-2#1)(1995-3#1)(1996-12#1)(1997-8#1)(2008-10#1)(2010-12#1)
rapid induction of##9##3##(1992-12#1)(1997-6#1)(2006-10#1)(2008-10#2)(2010-12#1)(2012-12#2)(2013-8#1)
rapid influenza diagnostic test methods##2##5##(2011-1#2)
rapid influenza##5##2##(2011-1#2)(2011-2#3)
rapid information##2##2##(2006-6#1)(2012-12#1)
rapid inhibition of##4##3##(1992-12#1)(1992-3#1)(2008-5#1)(2008-8#1)
rapid inhibition##5##2##(1992-12#1)(1992-3#1)(1992-4#1)(2008-5#1)(2008-8#1)
rapid initial decay##2##3##(2008-3#1)(2011-2#1)
rapid initial##5##2##(1996-7#1)(2008-3#1)(2011-2#1)(2013-1#2)
rapid initiation of##3##3##(1994-2#1)(1997-6#1)(2011-2#1)
rapid intervention##2##2##(2007-9#1)(2008-3#1)
rapid intravenous administration of phenytoin##2##5##(2008-7#2)
rapid intravenous##3##2##(2006-10#1)(2008-7#2)
rapid introduction of##2##3##(2008-4#1)(2009-8#1)
rapid introduction##3##2##(1996-3#1)(2008-4#1)(2009-8#1)
rapid invasion of##2##3##(1994-9#1)(2008-12#1)
rapid isolation and##2##3##(2006-8#1)(2008-10#1)
rapid isolation of##2##3##(1994-6#1)(2008-11#1)
rapid isolation##4##2##(1994-6#1)(2006-8#1)(2008-10#1)(2008-11#1)
rapid kinetic##2##2##(1991-7#1)(1995-4#1)
rapid kinetics##2##2##(1991-4#1)(2008-10#1)
rapid letter naming##2##3##(2007-9#2)
rapid liver clearance##2##3##(2008-1#2)
rapid local##2##2##(2008-11#1)(2008-7#1)
rapid longitudinal##2##2##(1991-7#1)(2008-10#1)
rapid loss of##6##3##(1990-4#1)(1990-5#1)(1991-12#1)(1994-3#1)(2008-6#1)(2008-9#1)
rapid loss##7##2##(1990-4#1)(1990-5#1)(1991-12#1)(1994-3#1)(1996-8#1)(2008-6#1)(2008-9#1)
rapid manner##2##2##(2010-7#1)(2012-2#1)
rapid means of##5##3##(1992-7#1)(1993-9#1)(1994-12#1)(1995-7#1)(2008-10#1)
rapid means##7##2##(1992-7#1)(1993-9#1)(1994-12#1)(1995-7#1)(2008-10#1)(2008-11#2)
rapid measurement of##3##3##(1991-10#1)(2005-11#1)(2007-1#1)
rapid measurement##5##2##(1991-10#1)(2005-11#1)(2007-1#1)(2007-12#1)(2008-3#1)
rapid mechanism##2##2##(1995-10#1)(2012-3#1)
rapid membrane##2##2##(1992-5#1)(2009-2#1)
rapid metabolism##3##2##(1991-3#1)(2009-8#1)(2011-2#1)
rapid method for determination of##2##5##(1991-1#1)(2008-10#1)
rapid method for determining##2##4##(2008-10#2)
rapid method for genotyping##2##4##(1990-12#2)
rapid method for simultaneous determination of##2##6##(2008-10#2)
rapid method for the analysis of##2##6##(1997-3#1)(2011-1#1)
rapid method for the determination of##7##6##(2007-8#1)(2008-10#6)
rapid method for the isolation of##2##6##(1990-11#1)(1992-8#1)
rapid method for the simultaneous determination of##2##7##(1996-6#1)(2008-10#1)
rapid method for the##18##4##(1990-11#1)(1992-8#1)(1996-6#1)(1997-3#1)(2007-8#1)(2008-10#11)(2010-12#1)(2011-1#1)
rapid method for##37##3##(1990-11#2)(1990-12#2)(1991-1#1)(1991-11#1)(1992-8#1)(1995-2#1)(1996-11#1)(1996-6#1)(1997-1#1)(1997-3#1)(2007-8#1)(2008-10#19)(2008-11#1)(2008-4#2)(2010-12#1)(2011-1#1)
rapid method has been developed for the determination##2##8##(2008-10#2)
rapid method is described for the##2##6##(2008-10#2)
rapid method is described for##3##5##(1995-5#1)(2008-10#2)
rapid method is##4##3##(1995-5#1)(2008-10#3)
rapid method to##4##3##(1996-1#1)(1996-8#1)(2008-10#1)(2008-7#1)
rapid method##58##2##(1990-11#2)(1990-12#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1992-8#1)(1994-11#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#2)(2007-5#1)(2007-8#1)(2008-10#28)(2008-11#2)(2008-4#3)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)
rapid methods##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
rapid migration of##2##3##(1992-6#1)(2011-2#1)
rapid mixing##2##2##(1993-3#1)(2008-7#1)
rapid modification##2##2##(1990-9#1)(2013-8#1)
rapid molecular##5##2##(2008-8#1)(2010-5#2)(2012-12#1)(2013-7#1)
rapid naming##2##2##(2007-9#2)
rapid noninvasive##2##2##(2012-2#1)(2013-8#1)
rapid on-line##2##2##(2008-10#2)
rapid onset and##2##3##(2006-10#1)(2009-6#1)
rapid onset of action##6##4##(2006-9#1)(2007-11#1)(2008-3#2)(2009-9#1)(2010-1#1)
rapid onset of##10##3##(1995-12#1)(1996-4#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-3#3)(2009-9#1)(2010-1#1)
rapid onset##18##2##(1995-12#1)(1995-7#1)(1996-10#1)(1996-4#1)(2006-10#2)(2006-9#1)(2007-11#1)(2008-3#3)(2009-10#1)(2009-6#2)(2009-9#1)(2010-1#1)(2013-1#2)
rapid pace of##4##3##(1996-2#1)(2007-4#1)(2008-3#1)(2011-1#1)
rapid pace##10##2##(1994-2#1)(1996-2#1)(1997-3#1)(2006-8#1)(2007-4#1)(2008-10#1)(2008-3#2)(2011-1#1)(2011-2#1)
rapid peak##2##2##(1993-3#2)
rapid phase of##3##3##(1993-11#1)(1993-9#1)(1994-8#1)
rapid phase##10##2##(1992-10#1)(1993-11#1)(1993-9#1)(1994-8#2)(1996-1#1)(2005-11#1)(2007-12#1)(2008-3#1)(2008-5#1)
rapid phosphoryl transfer##2##3##(1990-5#2)
rapid phosphorylation of##4##3##(1990-12#1)(1991-5#1)(1993-6#2)
rapid phosphorylation##5##2##(1990-12#1)(1991-5#1)(1993-6#3)
rapid polymerase chain reaction-based##2##4##(2008-10#2)
rapid polymerase chain##3##3##(2008-10#3)
rapid polymerization##3##2##(1993-3#1)(1994-9#1)(2009-12#1)
rapid potentiometric##2##2##(2008-10#2)
rapid preliminary diagnosis##2##3##(2008-6#1)(2013-8#1)
rapid preparation of##2##3##(2008-4#1)(2009-3#1)
rapid procedure##6##2##(1994-12#1)(1994-8#1)(1996-12#1)(2008-10#3)
rapid procedures##2##2##(1992-2#1)(2008-9#1)
rapid processing and##2##3##(2009-10#1)(2010-5#1)
rapid production of large quantities of##2##6##(2008-11#2)
rapid production of##7##3##(1990-9#1)(1995-7#1)(1995-8#1)(1997-6#1)(2008-11#2)(2012-11#1)
rapid production##8##2##(1990-9#1)(1995-7#1)(1995-8#1)(1997-6#1)(2008-10#1)(2008-11#2)(2012-11#1)
rapid progress in##3##3##(2005-8#1)(2007-11#1)(2008-10#1)
rapid progress of##3##3##(1993-3#1)(2006-4#1)(2007-8#1)
rapid progress##9##2##(1993-3#1)(2005-8#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-7#1)
rapid progression of a##2##4##(2008-6#1)(2011-2#1)
rapid progression of the##2##4##(1996-5#1)(2009-3#1)
rapid progression of##9##3##(1996-5#1)(2007-12#1)(2007-8#1)(2008-6#1)(2009-3#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
rapid progression to##2##3##(2007-12#1)(2009-10#1)
rapid progression##16##2##(1996-5#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-6#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
rapid proliferation of##2##3##(1994-6#1)(2008-11#1)
rapid proliferation##3##2##(1994-6#1)(2006-10#1)(2008-11#1)
rapid protein##3##2##(1990-12#1)(1990-6#1)(2007-8#1)
rapid prototyping of##2##3##(2006-2#1)(2008-8#1)
rapid prototyping techniques##3##3##(2010-8#2)(2010-9#1)
rapid prototyping##10##2##(2006-2#1)(2007-9#2)(2008-3#1)(2008-8#1)(2009-9#1)(2010-8#2)(2010-9#2)
rapid purification of##2##3##(1990-4#1)(1996-8#1)
rapid purification##3##2##(1990-4#1)(1996-8#1)(2008-4#1)
rapid qualitative##2##2##(2007-8#1)(2010-9#1)
rapid quality control of##2##4##(2011-1#1)(2012-2#1)
rapid quality##3##2##(2011-1#1)(2012-2#2)
rapid quantitative##3##2##(1996-8#2)(2008-9#1)
rapid quench of##2##3##(1992-5#2)
rapid quenching##2##2##(1995-8#2)
rapid radiation##2##2##(1996-4#1)(2008-7#1)
rapid rate of growth##2##4##(1991-1#1)(2012-12#1)
rapid rate of##4##3##(1991-1#1)(1995-11#1)(1996-8#1)(2012-12#1)
rapid rate##7##2##(1991-1#1)(1995-11#1)(1995-12#1)(1996-8#1)(2006-10#2)(2012-12#1)
rapid rates##2##2##(2008-2#1)(2008-9#1)
rapid reaction##5##2##(1990-8#1)(1995-10#1)(1996-7#1)(2008-10#2)
rapid recovery of the##2##4##(1993-8#1)(2012-1#1)
rapid recovery of##4##3##(1990-5#1)(1993-8#1)(1995-7#1)(2012-1#1)
rapid recovery##10##2##(1990-5#1)(1993-8#1)(1995-5#1)(1995-7#1)(2006-10#1)(2007-11#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
rapid reduction in##4##3##(1996-9#1)(2005-7#1)(2006-4#2)
rapid reduction of##2##3##(1997-6#1)(2006-7#1)
rapid reduction##6##2##(1996-9#1)(1997-6#1)(2005-7#1)(2006-4#2)(2006-7#1)
rapid regression##2##2##(1996-4#1)(2012-12#1)
rapid release of##6##3##(1990-5#1)(1990-7#1)(1991-8#1)(1991-9#2)(1995-11#1)
rapid release##7##2##(1990-5#1)(1990-7#1)(1991-8#1)(1991-9#2)(1995-11#1)(1995-8#1)
rapid relief of symptoms##2##4##(1997-1#1)(2007-11#1)
rapid relief of##3##3##(1997-1#1)(2007-11#1)(2008-7#1)
rapid relief##4##2##(1997-1#1)(2007-11#2)(2008-7#1)
rapid removal##2##2##(1990-2#1)(1994-5#1)
rapid research##2##2##(2007-12#2)
rapid resolution of##4##3##(1994-12#1)(2007-8#1)(2008-8#1)(2012-12#1)
rapid resolution##5##2##(1994-12#1)(2007-8#1)(2008-8#1)(2010-12#1)(2012-12#1)
rapid response time##4##3##(2006-5#1)(2008-10#2)(2008-2#1)
rapid response to##6##3##(2006-10#1)(2006-4#1)(2007-3#1)(2008-10#1)(2010-5#1)(2010-9#1)
rapid response##17##2##(1992-1#1)(1994-12#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-2#1)(2010-5#1)(2010-9#1)(2011-2#1)
rapid responses##8##2##(1994-3#1)(2004-2#1)(2007-8#5)(2012-2#1)
rapid results##2##2##(1994-3#1)(2008-8#1)
rapid return to##3##3##(1991-6#1)(2008-10#1)(2008-7#1)
rapid reversal of the##2##4##(1996-2#1)(2006-4#1)
rapid reversal of##4##3##(1995-7#1)(1996-2#1)(2006-4#1)(2008-7#1)
rapid reversed-phase HPLC##2##3##(2008-10#1)(2008-7#1)
rapid rise in##4##3##(1991-5#1)(1992-12#1)(1993-12#1)(2006-8#1)
rapid rise##7##2##(1991-5#1)(1992-12#1)(1993-12#1)(1994-1#1)(1994-2#1)(2006-8#1)(2007-9#1)
rapid scan stopped flow##2##4##(1994-9#2)
rapid scan##3##2##(1994-6#1)(1994-9#2)
rapid screening methods for##2##4##(1997-4#1)(2008-10#1)
rapid screening of##13##3##(1991-10#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#1)(2011-1#1)(2013-1#1)
rapid screening test##2##3##(1996-11#1)(2006-10#1)
rapid screening##23##2##(1991-10#1)(1996-11#1)(1996-6#1)(1997-4#2)(2006-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#1)(2010-5#1)(2011-1#1)(2013-1#1)
rapid secretion of##2##3##(1994-9#1)(2008-5#1)
rapid selection of neural activities##2##5##(1995-12#2)
rapid separation and purification of acid-soluble nuclear proteins##2##8##(1997-2#2)
rapid separation and purification of##3##5##(1997-2#2)(2008-10#1)
rapid separation and##6##3##(1997-2#2)(2008-10#4)
rapid separation of##4##3##(1996-5#1)(2005-11#1)(2008-10#2)
rapid separation##15##2##(1992-8#1)(1993-12#1)(1996-5#1)(1997-2#2)(2005-11#1)(2008-10#8)(2009-10#1)
rapid sequence induction##3##3##(1993-4#2)(2006-10#1)
rapid sequence intubation in the emergency department##3##7##(2007-3#2)(2007-7#1)
rapid sequence intubation in the emergency##4##6##(2007-3#2)(2007-7#2)
rapid sequence intubation##7##3##(2007-3#3)(2007-7#3)(2013-1#1)
rapid sequence##10##2##(1993-4#2)(2006-10#1)(2007-3#3)(2007-7#3)(2013-1#1)
rapid sequencing##2##2##(1991-12#1)(2009-5#1)
rapid serial visual presentation (RSVP)##2##5##(2008-1#1)(2009-4#1)
rapid serial visual presentation##3##4##(2008-1#1)(2009-4#1)(2010-7#1)
rapid serum##3##2##(1992-12#1)(1995-5#1)(2008-5#1)
rapid speciation##2##2##(2010-6#1)(2010-8#1)
rapid spectral##2##2##(2007-12#1)(2009-12#1)
rapid spectrophotometric method for the determination of##2##7##(2008-10#2)
rapid spectrophotometric method##4##3##(2008-10#4)
rapid spectrophotometric##6##2##(2008-10#6)
rapid speed##2##2##(1997-5#1)(2007-11#1)
rapid spread of the##2##4##(2008-10#1)(2011-2#1)
rapid spread of##5##3##(1996-12#1)(2008-10#3)(2011-2#1)
rapid spread##11##2##(1996-12#1)(2008-1#1)(2008-10#3)(2008-9#4)(2009-6#1)(2011-2#1)
rapid staining##3##2##(1991-2#1)(2008-2#1)(2008-4#1)
rapid steroid##2##2##(1996-2#1)(2010-7#1)
rapid stimulation of##3##3##(1993-9#1)(2008-10#1)(2012-2#1)
rapid stimulation##5##2##(1992-1#1)(1993-9#1)(2006-9#1)(2008-10#1)(2012-2#1)
rapid structural##2##2##(1993-6#1)(1996-9#1)
rapid switching##2##2##(1994-8#1)(2008-3#1)
rapid synthesis of##4##3##(1991-7#1)(1992-8#1)(2008-10#1)(2008-12#1)
rapid technique for the##3##4##(1991-6#1)(2008-10#1)(2008-8#1)
rapid technique##6##2##(1991-6#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-8#1)
rapid technological##5##2##(2007-4#1)(2008-4#1)(2008-7#1)(2009-5#1)(2013-1#1)
rapid test kit##2##3##(2007-12#1)(2010-12#1)
rapid test kits##2##3##(2007-12#2)
rapid test was##2##3##(2007-11#1)(2012-2#1)
rapid test##15##2##(1990-12#1)(2007-11#3)(2007-12#3)(2007-8#2)(2008-10#1)(2010-12#1)(2012-2#4)
rapid tests in##2##3##(1991-11#1)(2012-2#1)
rapid tests##4##2##(1991-11#1)(2007-2#1)(2012-2#2)
rapid than##6##2##(1991-12#1)(1992-10#1)(1996-5#1)(1996-6#1)(2008-11#1)(2008-6#1)
rapid throughput##3##2##(1990-11#1)(1990-12#1)(2006-10#1)
rapid time##2##2##(1990-2#1)(1993-2#1)
rapid tool##2##2##(1997-4#1)(2013-1#1)
rapid trace##2##2##(2008-10#2)
rapid transcription##2##2##(2008-10#1)(2011-2#1)
rapid transcriptional##2##2##(1994-8#1)(2010-5#1)
rapid translation##3##2##(2008-1#1)(2011-2#1)(2012-1#1)
rapid transport##2##2##(2006-10#1)(2008-10#1)
rapid tumor##2##2##(1993-10#1)(2012-1#1)
rapid turnover of the##2##4##(1990-7#1)(1992-1#1)
rapid turnover of##5##3##(1990-7#1)(1991-1#1)(1992-1#1)(1993-9#1)(2008-9#1)
rapid turnover##6##2##(1990-7#1)(1991-1#1)(1992-1#1)(1993-9#1)(2008-1#1)(2008-9#1)
rapid tyrosine phosphorylation of several cellular proteins including##2##8##(1992-8#1)(1994-6#1)
rapid tyrosine phosphorylation of several cellular proteins##3##7##(1992-8#1)(1994-6#1)(1994-9#1)
rapid tyrosine phosphorylation of##7##4##(1992-8#1)(1994-6#1)(1994-9#1)(1995-3#2)(1995-6#1)(1995-8#1)
rapid tyrosine phosphorylation##8##3##(1992-8#1)(1994-6#1)(1994-9#1)(1995-3#2)(1995-6#2)(1995-8#1)
rapid uptake##4##2##(1990-5#1)(1996-1#1)(2005-11#1)(2013-7#1)
rapid urease test##8##3##(1993-5#1)(2005-12#1)(2007-2#1)(2007-7#1)(2008-4#1)(2008-5#1)(2010-5#1)(2012-12#1)
rapid visual##2##2##(2008-7#1)(2011-2#1)
rapid washout##3##2##(1992-2#1)(2006-8#1)(2008-10#1)
rapid wastewater toxicity assessment##2##4##(2008-10#2)
rapid water stress##2##3##(2013-8#2)
rapid water##4##2##(2008-10#1)(2013-8#3)
rapid wavelength tuning##2##3##(2008-1#2)
rapid weight##2##2##(2005-7#1)(2006-10#1)
rapid with##5##2##(1995-8#1)(1997-4#1)(2008-10#2)(2012-2#1)
rapid##2613##1##(1990-10#6)(1990-11#14)(1990-12#25)(1990-2#12)(1990-3#6)(1990-4#8)(1990-5#17)(1990-6#9)(1990-7#10)(1990-8#8)(1990-9#3)(1991-1#7)(1991-10#6)(1991-11#3)(1991-12#12)(1991-2#8)(1991-3#10)(1991-4#9)(1991-5#11)(1991-6#10)(1991-7#15)(1991-8#3)(1991-9#9)(1992-1#12)(1992-10#6)(1992-11#1)(1992-12#11)(1992-2#11)(1992-3#6)(1992-4#3)(1992-5#3)(1992-6#10)(1992-7#6)(1992-8#16)(1992-9#4)(1993-1#5)(1993-10#2)(1993-11#8)(1993-12#11)(1993-2#7)(1993-3#8)(1993-4#6)(1993-5#1)(1993-6#10)(1993-7#1)(1993-8#6)(1993-9#9)(1994-1#1)(1994-10#8)(1994-11#14)(1994-12#15)(1994-2#16)(1994-3#17)(1994-4#1)(1994-5#7)(1994-6#11)(1994-7#2)(1994-8#11)(1994-9#22)(1995-1#4)(1995-10#8)(1995-11#5)(1995-12#9)(1995-2#13)(1995-3#17)(1995-4#3)(1995-5#14)(1995-6#10)(1995-7#6)(1995-8#12)(1995-9#4)(1996-1#5)(1996-10#3)(1996-11#14)(1996-12#11)(1996-2#13)(1996-3#12)(1996-4#9)(1996-5#14)(1996-6#8)(1996-7#6)(1996-8#14)(1996-9#8)(1997-1#8)(1997-2#6)(1997-3#16)(1997-4#15)(1997-5#3)(1997-6#9)(1997-7#7)(1997-8#8)(2004-11#2)(2004-2#1)(2004-4#2)(2004-9#1)(2005-10#4)(2005-11#18)(2005-12#7)(2005-3#1)(2005-4#15)(2005-5#1)(2005-6#1)(2005-7#8)(2005-8#10)(2005-9#1)(2006-1#2)(2006-10#47)(2006-11#5)(2006-12#8)(2006-2#1)(2006-3#5)(2006-4#11)(2006-5#10)(2006-6#6)(2006-7#4)(2006-8#8)(2006-9#8)(2007-1#6)(2007-10#5)(2007-11#44)(2007-12#50)(2007-2#15)(2007-3#10)(2007-4#7)(2007-5#4)(2007-6#8)(2007-7#30)(2007-8#56)(2007-9#15)(2008-1#21)(2008-10#489)(2008-11#49)(2008-12#15)(2008-2#21)(2008-3#44)(2008-4#54)(2008-5#44)(2008-6#13)(2008-7#51)(2008-8#42)(2008-9#42)(2009-10#7)(2009-11#5)(2009-12#3)(2009-2#2)(2009-3#6)(2009-4#8)(2009-5#9)(2009-6#6)(2009-7#2)(2009-8#11)(2009-9#10)(2010-1#4)(2010-10#5)(2010-11#5)(2010-12#19)(2010-2#12)(2010-3#6)(2010-4#17)(2010-5#20)(2010-6#9)(2010-7#8)(2010-8#15)(2010-9#7)(2011-1#38)(2011-12#11)(2011-2#50)(2011-3#2)(2012-1#10)(2012-11#4)(2012-12#36)(2012-2#41)(2012-3#17)(2013-1#46)(2013-7#8)(2013-8#29)
rapid-acting insulin analogues##3##3##(2006-1#1)(2007-11#2)
rapid-acting##4##1##(2006-1#1)(2007-11#3)
rapid-cycling##4##1##(1996-7#3)(2008-4#1)
rapid-eye-movement##2##1##(1995-6#1)(1996-1#1)
rapid-response##2##1##(1996-1#1)(2008-3#1)
rapid-scan##4##1##(1992-8#2)(2007-12#2)
rapid-scanning##2##1##(2007-12#1)(2008-1#1)
rapid-sequence intubation##2##2##(2006-10#2)
rapid-switching##2##1##(2008-2#2)
rapide##2##1##(2011-2#1)(2013-1#1)
rapidity and##7##2##(1990-12#1)(1997-4#1)(1997-7#1)(2008-10#2)(2009-6#1)(2012-12#1)
rapidity of action##2##3##(1991-4#1)(2011-2#1)
rapidity of onset##2##3##(1993-5#1)(2008-5#1)
rapidity of##12##2##(1991-4#1)(1992-9#1)(1993-5#1)(1995-3#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-5#1)(2011-1#2)(2011-2#1)
rapidity with which##2##3##(1997-4#1)(2008-10#1)
rapidity##38##1##(1990-12#1)(1990-7#1)(1991-2#1)(1991-4#1)(1992-9#1)(1993-5#1)(1995-3#1)(1997-4#2)(1997-7#1)(2007-7#1)(2008-10#16)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-6#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)
rapidly (&lt##3##2##(1993-6#1)(1995-12#1)(1996-11#1)
rapidly (less than 10 min)##2##5##(1990-8#1)(1992-8#1)
rapidly (t1/2 &lt##2##3##(1995-6#1)(1996-5#1)
rapidly (t1/2 approximately##2##3##(1994-12#1)(1995-1#1)
rapidly (t1/2##5##2##(1991-7#1)(1994-12#1)(1995-1#1)(1995-6#1)(1996-5#1)
rapidly (within 2##2##3##(1990-3#1)(2008-10#1)
rapidly (within##8##2##(1990-3#1)(1993-6#1)(1994-9#2)(1996-2#1)(1997-6#1)(2008-10#1)(2011-1#1)
rapidly absorbed after##2##3##(1996-1#1)(2005-7#1)
rapidly absorbed##5##2##(1995-3#1)(1996-1#1)(2005-7#1)(2005-9#1)(2012-12#1)
rapidly accumulating##2##2##(2008-10#1)(2009-4#1)
rapidly acquire##3##2##(2008-4#1)(2011-1#2)
rapidly activated by##4##3##(1990-12#1)(1994-2#1)(1995-3#1)(1995-7#1)
rapidly activated##7##2##(1990-12#1)(1993-11#1)(1993-9#1)(1994-2#1)(1995-3#1)(1995-7#1)(1996-5#1)
rapidly after##11##2##(1990-8#1)(1994-3#1)(1996-1#1)(1996-2#2)(2004-9#1)(2007-8#1)(2008-10#2)(2008-11#1)(2012-12#1)
rapidly aging population##3##3##(1990-12#1)(2007-4#1)(2011-2#1)
rapidly among##5##2##(1990-3#1)(1996-11#2)(2008-10#1)(2008-3#1)
rapidly and accurately##4##3##(1992-9#1)(2008-10#1)(2008-11#1)(2008-4#1)
rapidly and completely##4##3##(1991-8#1)(1994-8#1)(2008-7#1)(2008-8#1)
rapidly and easily##4##3##(2008-10#2)(2008-4#1)(2010-6#1)
rapidly and effectively##2##3##(1995-1#1)(1995-5#1)
rapidly and efficiently##4##3##(2008-7#1)(2008-9#1)(2012-11#1)(2012-2#1)
rapidly and quantitatively##2##3##(2008-10#2)
rapidly and reversibly##4##3##(1993-12#1)(1994-6#1)(1997-1#1)(1997-6#1)
rapidly and the##3##3##(1997-2#1)(2004-10#1)(2007-9#1)
rapidly and to##3##3##(1994-2#1)(1994-9#1)(2008-10#1)
rapidly and transiently##4##3##(1993-12#1)(1994-12#1)(1996-11#1)(1997-7#1)
rapidly and with##2##3##(2004-9#1)(2012-12#1)
rapidly and without##2##3##(2006-7#1)(2008-10#1)
rapidly and##82##2##(1990-6#2)(1991-8#1)(1992-11#1)(1992-2#1)(1992-9#1)(1993-12#3)(1993-4#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(2004-10#2)(2004-9#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-7#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-4#4)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-6#1)(2010-8#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
rapidly appear##2##2##(2007-12#1)(2007-9#1)
rapidly appearing##3##2##(1995-7#1)(2008-4#1)(2013-7#1)
rapidly around the##2##3##(1995-6#1)(2008-10#1)
rapidly as the##4##3##(2008-10#2)(2008-2#1)(2008-9#1)
rapidly as##13##2##(1993-3#1)(1994-2#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-9#1)
rapidly at higher temperatures##2##4##(2008-10#1)(2008-6#1)
rapidly at##10##2##(1993-12#1)(1997-7#1)(2007-10#1)(2008-10#4)(2008-5#1)(2008-6#1)(2012-2#1)
rapidly because##2##2##(2005-11#1)(2008-10#1)
rapidly becoming the##4##3##(2008-3#1)(2008-4#1)(2008-6#1)(2012-2#1)
rapidly becoming##7##2##(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-6#1)(2012-2#1)
rapidly being##4##2##(2006-12#1)(2007-7#1)(2008-10#1)(2013-8#1)
rapidly by##4##2##(1992-5#1)(1997-6#1)(2008-11#1)(2008-3#1)
rapidly changed the##2##3##(2006-6#1)(2012-2#1)
rapidly changes##2##2##(1991-11#1)(2008-6#1)
rapidly changing environment##3##3##(2007-10#1)(2008-10#1)(2013-1#1)
rapidly changing health##2##3##(1992-1#1)(2007-4#1)
rapidly changing##25##2##(1990-8#1)(1991-12#1)(1992-1#1)(1993-2#1)(1994-2#1)(1995-12#1)(1996-3#1)(1996-9#1)(1997-3#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2009-12#1)(2010-12#1)(2012-2#1)(2013-1#1)
rapidly cleared from the circulation##2##5##(1994-3#2)
rapidly cleared from##3##3##(1994-11#1)(1994-3#2)
rapidly cleared##5##2##(1990-3#1)(1994-11#1)(1994-3#2)(2007-11#1)
rapidly converted to##6##3##(1990-12#1)(1994-5#1)(1996-8#1)(1997-4#1)(2007-11#1)(2008-8#1)
rapidly converted##10##2##(1990-12#1)(1994-2#1)(1994-5#1)(1996-8#1)(1997-4#1)(2005-9#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)
rapidly corrected##2##2##(2008-1#1)(2008-10#1)
rapidly declined to##2##3##(1994-8#1)(2008-10#1)
rapidly declined##4##2##(1994-8#1)(1996-1#1)(2008-10#2)
rapidly decreased in##4##3##(1991-8#1)(1996-5#1)(2008-10#1)(2008-11#1)
rapidly decreased##9##2##(1990-6#1)(1991-8#1)(1992-8#2)(1996-5#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-4#1)
rapidly decreases##5##2##(1991-5#1)(1997-1#1)(2005-11#1)(2008-5#1)(2010-12#1)
rapidly degraded by##3##3##(1992-7#1)(2008-1#1)(2008-7#1)
rapidly degraded in##3##3##(1991-9#1)(2006-10#1)(2006-12#1)
rapidly degraded##8##2##(1990-11#1)(1991-9#1)(1992-7#1)(2006-10#1)(2006-12#1)(2006-6#1)(2008-1#1)(2008-7#1)
rapidly dephosphorylated##3##2##(1994-5#1)(1996-2#1)(2004-12#1)
rapidly detect##5##2##(2008-10#2)(2008-4#1)(2012-2#2)
rapidly deteriorated and##3##3##(2006-10#1)(2012-12#1)(2012-2#1)
rapidly deteriorated##4##2##(2006-10#1)(2011-12#1)(2012-12#1)(2012-2#1)
rapidly deteriorating##2##2##(2008-7#1)(2012-12#1)
rapidly determine##2##2##(2008-10#2)
rapidly developed##3##2##(1990-10#1)(2008-10#1)(2008-5#1)
rapidly developing field##3##3##(2006-6#1)(2010-7#1)(2011-2#1)
rapidly developing fields##2##3##(2007-8#1)(2008-11#1)
rapidly developing##14##2##(1990-6#1)(1991-4#1)(1992-9#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-11#2)(2008-12#1)(2010-7#1)(2011-1#1)(2011-2#1)
rapidly diffuse##2##2##(1990-11#1)(2008-4#1)
rapidly disappear##2##2##(1990-3#1)(2005-11#1)
rapidly disappeared##2##2##(1990-3#1)(1996-2#1)
rapidly dividing##3##2##(1996-4#2)(2012-12#1)
rapidly due to##2##3##(2006-6#1)(2008-7#1)
rapidly during the past##2##4##(2008-8#1)(2011-1#1)
rapidly during the##6##3##(1993-12#1)(1997-1#1)(2008-10#1)(2008-8#1)(2011-1#1)(2012-2#1)
rapidly during##10##2##(1993-12#1)(1993-2#1)(1997-1#1)(2005-8#1)(2008-10#1)(2008-8#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)
rapidly eliminated##2##2##(1994-12#1)(2008-8#1)
rapidly emerging and##2##3##(2006-10#1)(2008-10#1)
rapidly emerging##11##2##(1992-1#1)(1993-12#1)(2006-10#3)(2007-10#1)(2008-10#2)(2010-11#1)(2010-8#1)(2013-7#1)
rapidly enter##2##2##(2012-2#2)
rapidly equilibrate##2##2##(1991-7#1)(1992-10#1)
rapidly established##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
rapidly evolve##3##2##(1995-5#1)(2011-12#1)(2013-7#1)
rapidly evolving field##3##3##(2006-10#1)(2007-2#1)(2008-4#1)
rapidly evolving health care##2##4##(1994-1#1)(2008-1#1)
rapidly evolving##22##2##(1991-11#1)(1991-4#1)(1994-1#1)(1994-12#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#3)(2010-11#1)(2010-5#2)(2011-1#1)(2013-1#1)(2013-8#2)
rapidly exchangeable sites##3##3##(1995-6#3)
rapidly exchangeable##5##2##(1995-6#3)(1996-5#2)
rapidly expanding field of##3##4##(1994-9#1)(2005-7#1)(2006-10#1)
rapidly expanding field##8##3##(1994-3#1)(1994-9#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-5#1)(2008-7#1)(2013-7#1)
rapidly expanding##19##2##(1994-3#1)(1994-9#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-1#1)(2013-1#2)(2013-7#1)
rapidly fatal##8##2##(1995-1#1)(1996-3#1)(2006-1#1)(2007-8#1)(2010-12#2)(2012-2#1)(2013-1#1)
rapidly followed by##3##3##(1994-11#1)(2006-12#1)(2006-8#1)
rapidly following##3##2##(1991-9#1)(2008-10#1)(2008-11#1)
rapidly for##2##2##(1994-10#1)(2008-3#1)
rapidly form##2##2##(2007-10#1)(2008-10#1)
rapidly formed##2##2##(1992-9#1)(2008-11#1)
rapidly from a##2##3##(1990-11#1)(2010-6#1)
rapidly from the##5##3##(1991-4#1)(1994-11#1)(2008-3#1)(2009-10#1)(2009-11#1)
rapidly from##19##2##(1990-11#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-4#1)(1994-11#1)(1994-4#1)(1997-7#1)(2006-3#1)(2006-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-11#1)(2010-6#1)
rapidly generate##6##2##(1991-5#1)(1992-7#1)(2007-10#1)(2007-6#1)(2008-11#1)(2008-6#1)
rapidly growing field##2##3##(2007-7#1)(2010-5#1)
rapidly growing inoperable breast##2##4##(1992-10#2)
rapidly growing##36##2##(1990-5#1)(1991-6#1)(1992-10#2)(1992-3#1)(1992-8#1)(1993-2#1)(1994-10#1)(1994-11#1)(1994-8#1)(1994-9#1)(2005-10#1)(2006-4#1)(2007-7#3)(2008-12#2)(2008-4#2)(2008-6#2)(2010-1#1)(2010-10#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#2)
rapidly identified##4##2##(1995-3#1)(2005-11#1)(2008-10#2)
rapidly improved##2##2##(1994-3#1)(2013-8#1)
rapidly improving##3##2##(1990-8#1)(2007-9#1)(2008-7#1)
rapidly in a##3##3##(1992-6#1)(1995-11#1)(1995-8#1)
rapidly in response to##2##4##(1997-4#1)(2007-8#1)
rapidly in the presence of##3##5##(1990-3#1)(1991-7#1)(2007-1#1)
rapidly in the##16##3##(1990-3#1)(1990-5#1)(1991-7#1)(1994-2#1)(1995-3#1)(1997-2#1)(1997-3#1)(2006-11#1)(2007-1#1)(2007-10#1)(2008-1#2)(2008-11#1)(2008-3#1)(2009-8#1)(2010-5#1)
rapidly in##54##2##(1990-3#1)(1990-5#1)(1991-1#1)(1991-7#1)(1992-11#1)(1992-6#1)(1992-9#1)(1994-1#1)(1994-2#1)(1994-4#1)(1995-11#2)(1995-3#1)(1995-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-10#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#2)(2011-7#1)(2012-2#1)
rapidly inactivated##3##2##(1990-11#1)(1992-12#1)(2008-5#1)
rapidly increase##2##2##(1995-3#1)(1997-6#1)
rapidly increased by##3##3##(1990-2#1)(1997-2#1)(2013-8#1)
rapidly increased in the##2##4##(1994-6#1)(1996-3#1)
rapidly increased in##8##3##(1992-8#1)(1994-11#1)(1994-6#1)(1996-3#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
rapidly increased##22##2##(1990-2#1)(1990-7#1)(1992-4#2)(1992-8#1)(1993-9#2)(1994-11#1)(1994-6#2)(1996-3#1)(1996-5#1)(1997-2#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-12#1)(2013-8#2)
rapidly increases in##2##3##(2007-9#1)(2010-12#1)
rapidly increases##3##2##(1995-7#1)(2007-9#1)(2010-12#1)
rapidly increasing number of##2##4##(2006-12#1)(2007-9#1)
rapidly increasing rate##2##3##(1994-12#1)(2008-7#1)
rapidly increasing##12##2##(1994-12#1)(2006-12#1)(2006-4#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
rapidly induced a##2##3##(1994-11#1)(2008-4#1)
rapidly induced and##2##3##(1996-10#1)(2008-10#1)
rapidly induced by##4##3##(1994-11#1)(1994-12#1)(1995-6#1)(1996-12#1)
rapidly induced##18##2##(1991-2#1)(1991-5#1)(1991-7#1)(1992-6#1)(1994-11#2)(1994-12#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-10#2)(1996-12#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-4#1)
rapidly induces##4##2##(1992-6#1)(1996-9#1)(2008-4#2)
rapidly internalized##2##2##(1993-6#1)(1994-6#1)
rapidly lost with##2##3##(1991-8#1)(2010-7#1)
rapidly lost##5##2##(1991-8#1)(1994-12#1)(2008-11#1)(2010-7#1)(2011-3#1)
rapidly metabolized to##2##3##(1991-8#1)(1994-8#1)
rapidly metabolized##5##2##(1991-8#1)(1993-6#1)(1994-8#1)(2008-10#1)(2008-3#1)
rapidly moving##2##2##(2011-10#1)(2012-12#1)
rapidly on##6##2##(1991-3#1)(1992-8#1)(1994-11#1)(1994-3#1)(2008-10#1)(2008-8#1)
rapidly or##2##2##(1995-4#1)(2013-8#1)
rapidly over the past##2##4##(2007-7#1)(2008-5#1)
rapidly over the##4##3##(1991-2#1)(1993-11#1)(2007-7#1)(2008-5#1)
rapidly over##8##2##(1991-2#1)(1993-11#1)(2005-11#1)(2006-4#1)(2007-7#1)(2008-5#1)(2008-8#1)(2009-10#1)
rapidly performed##2##2##(1990-12#1)(2006-12#1)
rapidly phosphorylated##7##2##(1990-8#1)(1991-1#1)(1991-5#2)(1995-6#1)(1995-8#1)(2009-5#1)
rapidly processed##3##2##(1994-5#1)(2005-12#1)(2012-2#1)
rapidly produce##3##2##(1991-1#1)(2007-1#1)(2008-11#1)
rapidly progressed##2##2##(2008-12#1)(2010-6#1)
rapidly progressing##12##2##(2007-12#1)(2008-1#1)(2008-10#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#3)(2012-2#1)
rapidly progressive IPF##2##3##(2012-12#2)
rapidly progressive decline##2##3##(1993-2#1)(1995-1#1)
rapidly progressive dementia##2##3##(2013-7#2)
rapidly progressive glomerulonephritis (RPGN)##3##4##(2007-2#1)(2007-7#1)(2008-1#1)
rapidly progressive glomerulonephritis##6##3##(2007-2#1)(2007-7#3)(2008-1#1)(2008-7#1)
rapidly progressive##37##2##(1992-12#1)(1993-2#1)(1995-1#1)(1995-4#1)(1996-2#1)(1997-4#1)(1997-7#1)(2005-8#1)(2006-10#3)(2006-4#1)(2007-11#2)(2007-2#1)(2007-7#5)(2008-1#3)(2008-7#1)(2009-6#1)(2011-2#3)(2012-12#2)(2013-1#4)(2013-7#2)(2013-8#1)
rapidly reduced##5##2##(1990-3#1)(1992-2#1)(1994-8#1)(1995-6#1)(2006-3#1)
rapidly released from the##2##4##(1990-4#1)(1991-5#1)
rapidly replaced by##2##3##(2007-6#1)(2008-5#1)
rapidly resolved##2##2##(1993-12#1)(1997-8#1)
rapidly reversible##6##2##(1990-5#2)(1992-3#3)(2008-4#1)
rapidly rewarmed##2##2##(1993-8#2)
rapidly rising##3##2##(1991-12#1)(1992-3#1)(2006-10#1)
rapidly rotating##2##2##(1993-4#2)
rapidly since##2##2##(1991-6#1)(2008-2#1)
rapidly spread##3##2##(1995-1#1)(2008-10#1)(2008-6#1)
rapidly spreading##3##2##(2005-10#1)(2009-12#1)(2010-12#1)
rapidly stimulated##2##2##(1991-9#1)(1995-2#1)
rapidly stimulates##3##2##(1992-10#1)(1994-9#1)(1997-1#1)
rapidly suppressed##2##2##(2006-10#1)(2012-3#1)
rapidly than other##2##3##(2008-10#1)(2012-3#1)
rapidly than##32##2##(1990-2#1)(1992-3#1)(1992-4#1)(1992-9#1)(1995-11#1)(1995-3#2)(1996-1#1)(1997-8#1)(2004-11#1)(2004-9#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-9#1)(2011-2#1)(2012-3#1)
rapidly the##2##2##(1994-9#1)(2008-10#1)
rapidly through##7##2##(1992-6#1)(1994-12#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-8#1)(2012-3#1)
rapidly to a##2##3##(1993-7#1)(2008-9#1)
rapidly to infection##2##3##(2008-10#1)(2008-2#1)
rapidly to the##4##3##(1991-7#1)(1995-1#1)(2008-10#1)(2011-2#1)
rapidly to##29##2##(1990-11#1)(1990-8#1)(1991-7#1)(1992-4#1)(1993-12#1)(1993-4#1)(1993-7#1)(1993-9#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-7#1)(1996-12#1)(1996-5#1)(1997-3#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-2#2)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
rapidly under##2##2##(1992-11#1)(2007-12#1)
rapidly upon##2##2##(2007-5#1)(2008-3#1)
rapidly varying##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
rapidly when##6##2##(2006-12#1)(2007-5#1)(2008-10#2)(2008-7#1)(2012-2#1)
rapidly while##2##2##(2008-10#1)(2008-4#1)
rapidly with increasing##4##3##(1996-3#1)(2007-12#1)(2008-3#1)(2008-7#1)
rapidly with the##3##3##(1997-4#1)(2007-12#1)(2008-8#1)
rapidly with##22##2##(1991-1#1)(1991-9#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-4#1)(1997-7#1)(2006-10#3)(2007-12#2)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)
rapidly within##2##2##(1997-8#1)(2008-1#1)
rapidly##1269##1##(1990-10#2)(1990-11#8)(1990-12#4)(1990-2#4)(1990-3#10)(1990-4#2)(1990-5#8)(1990-6#6)(1990-7#1)(1990-8#6)(1990-9#2)(1991-1#6)(1991-11#4)(1991-12#3)(1991-2#4)(1991-3#2)(1991-4#7)(1991-5#7)(1991-6#5)(1991-7#10)(1991-8#6)(1991-9#8)(1992-1#2)(1992-10#5)(1992-11#4)(1992-12#3)(1992-2#2)(1992-3#6)(1992-4#7)(1992-5#2)(1992-6#7)(1992-7#5)(1992-8#9)(1992-9#5)(1993-1#1)(1993-11#5)(1993-12#9)(1993-2#9)(1993-3#6)(1993-4#5)(1993-5#1)(1993-6#4)(1993-7#4)(1993-8#3)(1993-9#9)(1994-1#3)(1994-10#3)(1994-11#9)(1994-12#13)(1994-2#7)(1994-3#12)(1994-4#3)(1994-5#5)(1994-6#6)(1994-8#8)(1994-9#16)(1995-1#8)(1995-10#2)(1995-11#5)(1995-12#4)(1995-2#11)(1995-3#13)(1995-4#3)(1995-5#4)(1995-6#9)(1995-7#8)(1995-8#6)(1996-1#6)(1996-10#3)(1996-11#5)(1996-12#4)(1996-2#9)(1996-3#6)(1996-4#2)(1996-5#9)(1996-7#1)(1996-8#2)(1996-9#3)(1997-1#7)(1997-2#5)(1997-3#4)(1997-4#6)(1997-5#3)(1997-6#8)(1997-7#8)(1997-8#4)(2004-10#2)(2004-11#1)(2004-12#2)(2004-4#1)(2004-9#3)(2005-10#7)(2005-11#8)(2005-12#2)(2005-3#3)(2005-5#1)(2005-7#7)(2005-8#5)(2005-9#4)(2006-1#4)(2006-10#33)(2006-11#1)(2006-12#9)(2006-2#2)(2006-3#3)(2006-4#9)(2006-5#5)(2006-6#5)(2006-7#2)(2006-8#4)(2006-9#1)(2007-1#2)(2007-10#12)(2007-11#16)(2007-12#22)(2007-2#5)(2007-3#3)(2007-4#7)(2007-5#3)(2007-6#2)(2007-7#12)(2007-8#11)(2007-9#9)(2008-1#17)(2008-10#114)(2008-11#33)(2008-12#8)(2008-2#20)(2008-3#26)(2008-4#28)(2008-5#24)(2008-6#10)(2008-7#24)(2008-8#15)(2008-9#9)(2009-10#3)(2009-11#1)(2009-12#4)(2009-2#4)(2009-3#6)(2009-4#2)(2009-5#2)(2009-6#5)(2009-7#1)(2009-8#4)(2009-9#5)(2010-1#2)(2010-10#2)(2010-11#4)(2010-12#15)(2010-2#2)(2010-3#4)(2010-5#8)(2010-6#3)(2010-7#9)(2010-8#6)(2010-9#1)(2011-1#12)(2011-10#1)(2011-12#3)(2011-2#21)(2011-3#1)(2011-7#1)(2012-1#3)(2012-11#3)(2012-12#25)(2012-2#27)(2012-3#4)(2012-8#1)(2013-1#17)(2013-7#7)(2013-8#13)
rapidly-growing##3##1##(1990-5#2)(1995-10#1)
rapidness and##3##2##(2008-10#2)(2013-8#1)
rapifera##2##1##(2008-10#2)
rapists##2##1##(1992-9#1)(2009-10#1)
rapport and##2##2##(2008-11#1)(2008-8#1)
rapport##7##1##(1996-12#1)(2008-11#1)(2008-8#2)(2011-1#1)(2011-2#1)(2013-1#1)
rapportons un cas##4##3##(2011-2#1)(2012-2#2)(2013-1#1)
rapportons un##5##2##(2011-2#1)(2012-2#3)(2013-1#1)
rapportons##16##1##(2011-2#2)(2012-2#8)(2013-1#6)
rapsyn##7##1##(1996-1#7)
raptorellus##3##1##(2011-12#3)
raptors##5##1##(2004-4#1)(2007-2#4)
rare (1##2##2##(2008-10#1)(2012-12#1)
rare SNP##2##2##(2012-3#2)
rare SNPs to##2##3##(2012-3#2)
rare SNPs##7##2##(2012-3#7)
rare X-linked##3##2##(2007-8#1)(2010-10#1)(2012-3#1)
rare adverse##2##2##(2007-7#1)(2008-11#1)
rare allele##6##2##(1997-2#2)(1997-4#2)(2007-2#1)(2008-8#1)
rare alleles and##2##3##(2006-5#1)(2012-3#1)
rare alleles##12##2##(2006-5#1)(2008-10#2)(2012-3#9)
rare among young##2##3##(1992-9#1)(2011-11#1)
rare among##6##2##(1992-9#1)(2008-5#1)(2009-12#1)(2010-12#1)(2011-11#2)
rare and a##5##3##(1990-9#1)(2007-8#1)(2010-12#1)(2011-12#1)(2012-2#1)
rare and aggressive##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
rare and are##3##3##(2008-4#1)(2008-7#2)
rare and associated with##2##4##(2008-6#1)(2011-3#1)
rare and benign##2##3##(2007-3#2)
rare and challenging##2##3##(2008-9#1)(2012-2#1)
rare and common SNPs for##2##5##(2012-3#2)
rare and common variants in##3##5##(2012-3#3)
rare and common variants##13##4##(2012-3#13)
rare and common##21##3##(2010-5#1)(2012-1#1)(2012-3#19)
rare and difficult to##3##4##(2008-10#1)(2012-2#1)(2013-1#1)
rare and difficult##4##3##(2008-10#1)(2009-6#1)(2012-2#1)(2013-1#1)
rare and few##2##3##(1993-12#1)(2007-3#1)
rare and has been reported##2##5##(1992-8#1)(2007-11#1)
rare and has##3##3##(1992-8#1)(1993-11#1)(2007-11#1)
rare and in##2##3##(1992-9#1)(1993-8#1)
rare and is associated with##2##5##(2006-10#1)(2010-9#1)
rare and is##9##3##(1990-8#1)(2005-8#1)(2006-10#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
rare and it##2##3##(2010-12#1)(2010-8#1)
rare and metastasis##2##3##(2008-6#1)(2010-6#1)
rare and most##2##3##(1991-11#1)(2009-5#1)
rare and not##3##3##(2008-6#1)(2012-2#1)(2013-7#1)
rare and only##5##3##(1991-11#1)(1991-9#1)(2010-6#1)(2012-2#1)(2013-8#1)
rare and serious##2##3##(1991-10#1)(2007-8#1)
rare and the##6##3##(2006-6#1)(2007-12#1)(2007-8#1)(2012-3#1)(2013-1#2)
rare and to our knowledge##2##5##(2009-10#1)(2013-8#1)
rare and unusual##3##3##(2006-10#1)(2008-11#1)(2011-1#1)
rare and was##3##3##(2008-12#1)(2009-10#1)(2012-3#1)
rare and when##3##3##(1991-3#1)(2008-7#1)(2011-2#1)
rare and##166##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#3)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1997-1#1)(1997-3#1)(2004-4#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-6#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#3)(2007-5#1)(2007-6#2)(2007-8#11)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#3)(2008-7#6)(2008-9#3)(2009-10#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#3)(2011-1#2)(2011-12#2)(2011-2#8)(2011-3#1)(2012-1#1)(2012-2#8)(2012-3#22)(2013-1#10)(2013-7#5)(2013-8#8)
rare anomalies##2##2##(2008-10#1)(2008-7#1)
rare anomaly##9##2##(1996-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-9#1)(2010-12#1)(2011-1#1)
rare association is##2##3##(1994-6#1)(2009-5#1)
rare association with##4##3##(2007-7#1)(2008-7#1)(2012-2#2)
rare association##16##2##(1994-6#1)(2007-2#1)(2007-7#3)(2007-9#1)(2008-10#1)(2008-7#2)(2009-5#1)(2010-8#2)(2012-12#1)(2012-2#3)
rare autoimmune##3##2##(1997-5#1)(2005-11#1)(2013-8#1)
rare autopsy case##2##3##(1995-11#1)(1996-9#1)
rare autosomal dominant disorder##2##4##(2011-1#1)(2012-2#1)
rare autosomal dominant##6##3##(2007-4#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
rare autosomal##24##2##(1992-4#1)(1997-8#1)(2005-10#1)(2006-7#1)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-8#1)(2009-5#1)(2009-9#1)(2011-1#5)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
rare because##3##2##(2005-9#1)(2008-4#1)(2009-3#1)
rare benign mesenchymal neoplasm##2##4##(1996-9#1)(2013-7#1)
rare benign mesenchymal##3##3##(1996-9#1)(2010-6#1)(2013-7#1)
rare benign tumor##4##3##(2009-5#1)(2010-12#1)(2012-12#2)
rare benign tumors of the##3##5##(1992-8#1)(2010-3#1)(2013-8#1)
rare benign tumors##5##3##(1992-8#1)(2007-6#1)(2009-2#1)(2010-3#1)(2013-8#1)
rare benign tumour##5##3##(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
rare benign##33##2##(1992-2#1)(1992-8#1)(1996-9#1)(2006-10#1)(2007-6#2)(2007-8#2)(2008-10#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-2#1)(2009-5#1)(2010-12#3)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#6)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#4)
rare but clinically##2##3##(2007-8#1)(2010-12#1)
rare but devastating##3##3##(2008-9#1)(2011-1#1)(2012-2#1)
rare but dramatic##2##3##(1993-10#1)(2005-10#1)
rare but frequently fatal##2##4##(2009-6#1)(2011-2#1)
rare but important cause##2##4##(2007-2#1)(2008-7#1)
rare but important complication##2##4##(2005-11#1)(2007-2#1)
rare but important##7##3##(2005-11#1)(2007-12#1)(2007-2#2)(2008-4#1)(2008-7#1)(2010-4#1)
rare but life threatening##3##4##(2008-8#1)(2011-2#1)(2013-8#1)
rare but life-threatening##5##3##(2005-10#1)(2008-12#1)(2010-9#1)(2012-12#1)(2013-7#1)
rare but often fatal##3##4##(2007-12#1)(2007-8#1)(2008-4#1)
rare but potentially fatal##5##4##(2007-3#1)(2007-8#1)(2009-4#1)(2010-2#1)(2012-12#1)
rare but potentially##11##3##(2006-10#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-2#1)(2012-12#1)(2013-8#1)
rare but serious##7##3##(2006-10#2)(2007-7#1)(2008-11#1)(2009-6#1)(2010-2#1)(2011-2#1)
rare but severe##3##3##(2007-11#1)(2007-8#1)(2010-12#1)
rare but usually##2##3##(1995-9#1)(2010-3#1)
rare but##77##2##(1992-12#1)(1993-10#1)(1995-9#1)(1996-12#1)(1997-4#1)(2005-10#2)(2005-11#2)(2005-9#1)(2006-10#5)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#4)(2007-8#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#2)(2009-4#1)(2009-6#2)(2009-9#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#2)
rare cancer syndrome##2##3##(1990-11#1)(1993-10#1)
rare cancer##4##2##(1990-11#1)(1993-10#1)(2012-2#2)
rare case and review##3##4##(2013-1#3)
rare case is##2##3##(1991-11#1)(2006-7#1)
rare case of a patient##2##5##(2013-1#1)(2013-7#1)
rare case of a##25##4##(1993-12#1)(2006-9#1)(2007-11#1)(2007-4#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#3)(2008-8#1)(2010-12#2)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-2#1)(2013-7#1)(2013-8#1)
rare case of an adult##2##5##(2009-4#1)(2012-2#1)
rare case of an##6##4##(1992-12#1)(2009-4#1)(2011-1#1)(2012-12#1)(2012-2#2)
rare case of bilateral##3##4##(2010-12#1)(2012-12#1)(2012-2#1)
rare case of breast##3##4##(1992-6#1)(2004-1#1)(2008-10#1)
rare case of cholostasis from tuberculotic infiltration of##2##8##(2006-2#2)
rare case of ectopic thoracic kidney and spleen##2##8##(2012-2#2)
rare case of giant##3##4##(2007-7#1)(2008-2#1)(2012-2#1)
rare case of herniation of##2##5##(2007-8#1)(2011-2#1)
rare case of impacted##2##4##(2012-12#2)
rare case of short bowel##2##5##(2008-10#2)
rare case of##160##3##(1990-5#2)(1991-12#2)(1991-3#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-7#1)(1996-6#1)(2004-1#1)(2005-10#1)(2006-2#3)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#2)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#4)(2008-2#1)(2008-5#2)(2008-6#2)(2008-7#11)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#4)(2010-5#4)(2010-6#1)(2010-7#2)(2011-1#5)(2011-12#2)(2011-2#11)(2012-1#2)(2012-12#11)(2012-2#12)(2012-3#4)(2013-1#8)(2013-2#1)(2013-7#2)(2013-8#6)
rare case report and review of literature##3##7##(2010-9#1)(2012-2#1)(2013-7#1)
rare case report and review of##4##6##(2010-9#1)(2012-2#2)(2013-7#1)
rare case report of##3##4##(2007-7#1)(2012-12#1)(2012-2#1)
rare case report##18##3##(2006-2#1)(2007-7#1)(2008-7#1)(2010-10#1)(2010-4#1)(2010-9#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
rare case with##3##3##(2008-12#1)(2008-7#1)(2010-5#1)
rare case##200##2##(1990-5#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-5#1)(1993-8#2)(1994-7#1)(1996-6#1)(1997-3#1)(2004-1#1)(2005-10#1)(2006-12#1)(2006-2#4)(2006-7#1)(2006-9#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#2)(2007-7#5)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#5)(2008-2#1)(2008-5#2)(2008-6#2)(2008-7#14)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-12#6)(2010-3#1)(2010-4#1)(2010-5#5)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#5)(2011-12#3)(2011-2#11)(2012-1#2)(2012-12#13)(2012-2#19)(2012-3#5)(2013-1#13)(2013-2#1)(2013-7#3)(2013-8#7)
rare cases of##6##3##(1993-3#2)(2006-11#1)(2006-2#1)(2008-7#1)(2013-8#1)
rare cases##26##2##(1990-1#1)(1991-7#1)(1992-6#1)(1993-3#2)(1993-6#1)(1993-8#1)(1997-1#1)(2006-11#1)(2006-2#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-6#1)(2010-4#1)(2010-9#1)(2011-2#2)(2013-8#1)
rare causal variants##2##3##(2012-3#2)
rare causal##5##2##(2012-3#5)
rare causative##2##2##(2007-7#1)(2012-3#1)
rare cause of acute##3##4##(2005-12#2)(2007-8#1)
rare cause of chronic##2##4##(1993-10#1)(2008-3#1)
rare cause of facial##2##4##(1990-5#1)(2013-1#1)
rare cause of intestinal obstruction##3##5##(2008-12#2)(2009-7#1)
rare cause of severe##2##4##(2007-8#1)(2011-2#1)
rare cause of upper##3##4##(1992-10#1)(2007-8#2)
rare cause of##64##3##(1990-5#1)(1992-10#1)(1993-10#1)(1996-3#1)(2005-12#3)(2006-10#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-12#1)(2007-8#8)(2008-11#1)(2008-12#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#4)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
rare cause##73##2##(1990-5#1)(1991-11#1)(1992-10#1)(1993-10#1)(1996-3#1)(1996-6#1)(2005-12#3)(2006-10#2)(2006-2#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-12#1)(2007-8#8)(2008-11#1)(2008-12#3)(2008-3#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#5)(2010-2#1)(2010-3#1)(2010-5#2)(2011-1#2)(2011-2#3)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#1)
rare causes of##3##3##(2009-7#1)(2010-4#1)(2012-12#1)
rare causes##5##2##(2009-7#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-12#1)
rare cells expressing shared lymphoma idiotypes##2##6##(1990-7#2)
rare cells##10##2##(1990-7#2)(1993-6#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2012-12#3)
rare chez##3##2##(2012-2#1)(2013-1#2)
rare chromosomal##2##2##(2008-5#1)(2009-8#1)
rare clinical condition##3##3##(2010-6#1)(2012-2#2)
rare clinical entity##11##3##(2004-1#1)(2007-7#2)(2007-8#1)(2008-5#1)(2008-7#1)(2009-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
rare clinical finding##2##3##(2008-10#1)(2009-10#1)
rare clinical##21##2##(1991-12#1)(2004-1#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-2#1)(2010-6#1)(2012-1#1)(2012-2#3)(2013-1#2)
rare combination of##7##3##(1993-12#1)(2008-4#2)(2009-11#1)(2010-7#2)(2012-3#1)
rare combination##11##2##(1993-12#1)(2007-7#1)(2008-4#2)(2009-11#1)(2010-7#3)(2012-3#1)(2013-1#2)
rare combined##2##2##(2007-11#1)(2007-12#1)
rare compared to##2##3##(1993-5#1)(2012-12#1)
rare complication after##8##3##(2007-8#4)(2008-12#1)(2009-3#1)(2012-1#1)(2012-12#1)
rare complication following##2##3##(2007-8#1)(2007-9#1)
rare complication in patients with##3##5##(2007-10#1)(2011-2#1)(2012-1#1)
rare complication in##5##3##(1996-12#1)(2006-4#1)(2007-10#1)(2011-2#1)(2012-1#1)
rare complication of a##3##4##(1991-4#1)(1993-10#1)(2011-2#1)
rare complication of coronary artery bypass grafting (CABG)##2##8##(2007-8#2)
rare complication of##61##3##(1990-5#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-5#1)(1993-10#1)(1993-5#1)(1996-3#1)(2005-12#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-8#5)(2008-2#1)(2008-6#1)(2008-7#2)(2009-1#1)(2009-5#1)(2009-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#10)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#1)
rare complication##92##2##(1990-5#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-5#1)(1993-10#1)(1993-5#1)(1993-8#1)(1996-12#1)(1996-3#1)(2005-12#2)(2006-10#3)(2006-12#1)(2006-4#2)(2006-9#1)(2007-10#2)(2007-11#1)(2007-8#13)(2007-9#1)(2008-1#1)(2008-12#2)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#2)(2009-1#1)(2009-11#1)(2009-3#2)(2009-5#1)(2009-6#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#11)(2012-1#2)(2012-12#7)(2012-2#3)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#1)
rare complications##2##2##(2007-11#1)(2008-4#1)
rare condition of##2##3##(2007-5#1)(2009-9#1)
rare condition with an##2##4##(2008-4#1)(2012-3#1)
rare condition with only##3##4##(2007-8#1)(2012-2#1)(2012-3#1)
rare condition with##7##3##(1992-9#1)(2007-8#1)(2008-10#1)(2008-4#1)(2012-2#1)(2012-3#2)
rare condition##56##2##(1990-12#1)(1992-9#1)(1993-3#1)(1994-4#1)(1995-4#1)(1997-8#1)(2004-10#1)(2006-10#3)(2006-11#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#5)(2008-10#3)(2008-2#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#3)
rare conditions##4##2##(2005-11#1)(2010-3#1)(2012-1#1)(2012-3#1)
rare congenital anomalies##2##3##(2008-7#1)(2010-2#1)
rare congenital anomaly in##2##4##(1991-8#1)(2008-9#1)
rare congenital anomaly##11##3##(1991-8#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-9#1)(2010-11#1)(2010-5#1)(2013-1#1)
rare congenital cardiac malformation##3##4##(2007-11#1)(2007-8#1)(2012-2#1)
rare congenital cardiac##5##3##(1993-8#1)(2007-11#1)(2007-8#1)(2010-6#1)(2012-2#1)
rare congenital malformation##7##3##(2008-10#2)(2008-11#2)(2010-2#1)(2011-2#1)(2013-8#1)
rare congenital##40##2##(1991-8#1)(1993-8#1)(2006-12#1)(2007-11#1)(2007-7#2)(2007-8#3)(2008-10#3)(2008-11#3)(2008-3#2)(2008-4#4)(2008-7#1)(2008-9#1)(2009-9#1)(2010-11#2)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-12#2)(2011-2#1)(2012-2#3)(2013-1#2)(2013-8#1)
rare connective tissue disease##3##4##(1995-11#2)(2006-10#1)
rare coronary anomaly##2##3##(2009-11#1)(2011-2#1)
rare coronary artery##2##3##(2007-8#1)(2009-8#1)
rare coronary##4##2##(2007-8#1)(2009-11#1)(2009-8#1)(2011-2#1)
rare cutter##2##2##(1993-6#1)(1996-10#1)
rare cutting enzymes##2##3##(1992-6#1)(1996-6#1)
rare cutting##3##2##(1992-6#1)(1996-6#1)(2008-10#1)
rare cystic lesion##2##3##(2009-7#1)(2012-1#1)
rare cystic##3##2##(2008-7#1)(2009-7#1)(2012-1#1)
rare cytogenetic##2##2##(2012-2#2)
rare diagnosis##6##2##(2006-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-6#1)
rare differential diagnosis##2##3##(2008-10#1)(2012-2#1)
rare disease in##8##3##(1992-8#1)(2007-3#1)(2008-1#1)(2008-7#1)(2009-10#1)(2011-2#2)(2013-8#1)
rare disease of the##2##4##(1992-10#1)(2013-8#1)
rare disease of##4##3##(1992-10#1)(1996-3#1)(2011-2#1)(2013-8#1)
rare disease with a##3##4##(1997-5#1)(2006-6#1)(2008-12#1)
rare disease with##9##3##(1997-5#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-9#1)(2008-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
rare disease##76##2##(1990-10#1)(1990-9#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-10#1)(1993-6#2)(1993-8#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-3#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#2)(2006-8#2)(2007-10#1)(2007-11#2)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#1)(2009-6#2)(2010-11#1)(2010-3#2)(2011-12#1)(2011-2#6)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#6)(2013-8#4)
rare diseases in##2##3##(2011-7#1)(2013-1#1)
rare diseases##17##2##(1996-4#1)(2007-2#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-7#3)(2012-2#1)(2012-3#1)(2013-1#3)
rare disorder of##3##3##(1990-5#1)(1991-11#1)(2010-2#1)
rare disorder with##2##3##(2006-1#1)(2006-7#1)
rare disorder##19##2##(1990-5#1)(1991-11#1)(1996-3#1)(2005-11#1)(2006-1#1)(2006-7#1)(2007-11#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)
rare disorders of unknown##2##4##(1993-7#1)(2012-2#1)
rare disorders##7##2##(1993-7#1)(1996-4#2)(1997-6#1)(2006-10#1)(2007-2#1)(2012-2#1)
rare due to##3##3##(2007-3#1)(2011-2#1)(2013-1#1)
rare earth complexes##4##3##(2005-4#4)
rare earth element##4##3##(2008-10#4)
rare earth elements (REE) in##2##5##(2008-10#2)
rare earth elements (REE)##6##4##(2008-10#5)(2012-2#1)
rare earth elements (REEs)##4##4##(2008-10#3)(2008-9#1)
rare earth elements and##5##4##(2005-4#1)(2008-10#4)
rare earth elements by##2##4##(2005-4#1)(2008-10#1)
rare earth elements in soils and sediments##2##7##(2008-10#2)
rare earth elements in##7##4##(2008-10#7)
rare earth elements were##2##4##(2005-4#2)
rare earth elements##32##3##(2005-4#6)(2008-10#24)(2008-9#1)(2012-2#1)
rare earth impurities in Y2O3##2##5##(2005-4#2)
rare earth impurities in##7##4##(2005-4#5)(2008-10#2)
rare earth impurities##11##3##(2005-4#8)(2008-10#3)
rare earth ions##2##3##(2006-4#1)(2008-10#1)
rare earth mixtures##2##3##(2008-10#2)
rare earth oxide##3##3##(2005-4#2)(2012-11#1)
rare earth##73##2##(2005-4#23)(2006-4#1)(2007-12#1)(2008-10#44)(2008-9#1)(2010-7#1)(2012-11#1)(2012-2#1)
rare earths and##4##3##(2008-10#4)
rare earths has been##2##4##(2008-10#2)
rare earths with##2##3##(2008-10#2)
rare earths##18##2##(1992-11#1)(2008-10#17)
rare entities##3##2##(2006-11#1)(2008-3#1)(2012-12#1)
rare entity and is##2##4##(2006-7#1)(2007-7#1)
rare entity and##7##3##(2006-7#1)(2007-7#1)(2007-8#1)(2009-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
rare entity having##2##3##(2010-11#1)(2012-3#1)
rare entity in##3##3##(2010-2#1)(2011-2#1)(2013-8#1)
rare entity of##4##3##(2006-10#1)(2008-6#1)(2009-4#1)(2012-1#1)
rare entity##56##2##(1993-8#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-5#3)(2007-7#4)(2007-8#3)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-5#2)(2010-6#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#4)
rare etiology of##3##3##(2008-7#1)(2010-9#2)
rare event##22##2##(1990-10#1)(1993-10#1)(1996-12#1)(2006-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-3#2)(2008-7#1)(2009-10#1)(2009-6#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
rare events##7##2##(1996-12#1)(2005-11#1)(2006-10#1)(2008-6#1)(2008-9#2)(2010-1#1)
rare example of a##3##4##(2010-7#1)(2011-1#1)(2012-2#1)
rare exceptions##3##2##(2008-12#2)(2012-3#1)
rare finding of##2##3##(2006-10#1)(2013-8#1)
rare finding##8##2##(1991-2#1)(1992-12#1)(2006-10#1)(2006-12#1)(2011-2#1)(2012-3#1)(2013-8#2)
rare findings##2##2##(2005-11#1)(2009-5#1)
rare for##10##2##(1990-4#1)(1996-12#1)(1997-2#1)(2007-7#1)(2007-9#1)(2008-5#1)(2008-6#2)(2009-5#1)(2011-1#1)
rare form of##19##3##(1990-10#1)(1991-6#1)(2005-11#1)(2005-8#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-6#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
rare form##22##2##(1990-10#1)(1991-4#1)(1991-6#1)(1991-9#1)(1994-5#1)(2005-11#1)(2005-8#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-6#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
rare forms of##3##3##(2006-6#1)(2007-4#1)(2013-1#1)
rare functional variants##4##3##(2012-3#4)
rare gastric##2##2##(1992-5#1)(2007-9#1)
rare genetic disorder##4##3##(2006-10#1)(2008-7#1)(2009-4#1)(2011-1#1)
rare genetic variants and##2##4##(2012-3#2)
rare genetic variants##7##3##(2012-3#7)
rare genetic##16##2##(2006-10#1)(2008-11#2)(2008-7#1)(2009-4#2)(2011-1#1)(2012-3#9)
rare genotypes##2##2##(2008-10#1)(2008-8#1)
rare group of##8##3##(2006-4#1)(2007-11#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-11#1)
rare hereditary disorder##5##3##(1994-11#1)(1994-8#1)(2007-7#1)(2011-2#1)(2013-8#1)
rare hereditary##7##2##(1994-11#1)(1994-8#1)(2007-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
rare in Western countries##2##4##(1996-8#1)(2008-2#1)
rare in adult##2##3##(2010-12#1)(2011-1#1)
rare in adults##4##3##(2008-5#1)(2011-1#1)(2012-12#1)(2013-8#1)
rare in birds##2##3##(2008-5#1)(2008-9#1)
rare in childhood##3##3##(2008-10#1)(2008-7#1)(2013-8#1)
rare in children##9##3##(2005-11#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-12#2)(2012-3#1)
rare in general##2##3##(2007-12#1)(2011-2#1)
rare in other##2##3##(2008-5#1)(2008-9#1)
rare in our##2##3##(2010-2#1)(2012-2#1)
rare in patients with##2##4##(2006-10#2)
rare in patients##3##3##(2006-10#2)(2009-1#1)
rare in the literature##2##4##(2012-1#1)(2012-2#1)
rare in the pediatric population##2##5##(2008-4#2)
rare in the##22##3##(1990-11#1)(2006-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#3)
rare in##105##2##(1990-11#1)(1990-9#1)(1991-11#1)(1996-11#2)(1996-8#2)(1997-2#1)(2005-11#1)(2005-8#1)(2006-10#6)(2006-12#2)(2007-11#2)(2007-12#4)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#8)(2008-2#1)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#5)(2009-1#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#5)(2010-2#1)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#1)(2012-1#4)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#2)
rare infection##2##2##(2006-10#1)(2012-3#1)
rare infections##2##2##(1993-3#1)(2011-2#1)
rare inflammatory##5##2##(2011-1#1)(2013-1#4)
rare inherited cancer##2##3##(2011-2#1)(2012-12#1)
rare inherited##8##2##(1992-10#1)(2006-4#1)(2007-7#1)(2008-11#1)(2008-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
rare injury##7##2##(1991-4#1)(2007-8#1)(2008-12#1)(2009-3#1)(2010-7#1)(2012-12#1)(2012-2#1)
rare instances##8##2##(2006-9#1)(2007-2#1)(2007-5#1)(2008-10#2)(2008-3#1)(2010-12#1)(2011-2#1)
rare late complication of##2##4##(1991-9#1)(2012-12#1)
rare lesion of the##2##4##(1993-10#1)(2006-5#1)
rare lesion##10##2##(1990-10#1)(1993-10#1)(1993-12#1)(2006-10#2)(2006-12#1)(2006-5#1)(2008-10#1)(2012-12#1)(2013-1#1)
rare lesions##7##2##(1991-5#1)(2006-12#1)(2008-1#1)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
rare leukodystrophy##2##2##(2012-12#2)
rare localization##3##2##(1992-6#1)(2008-10#1)(2010-3#1)
rare location of##2##3##(1996-9#1)(2007-12#1)
rare location##6##2##(1996-9#1)(2006-5#1)(2007-12#1)(2007-8#1)(2012-12#1)(2013-1#1)
rare malformation##3##2##(2006-1#1)(2008-10#1)(2010-12#1)
rare malignancy##4##2##(1997-5#1)(2007-11#1)(2010-3#1)(2011-1#1)
rare malignant tumor of the##2##5##(2007-8#1)(2008-10#1)
rare malignant tumor##5##3##(1992-1#1)(2007-5#1)(2007-8#1)(2008-10#1)(2013-1#1)
rare malignant##8##2##(1992-1#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-6#2)(2013-1#1)(2013-8#1)
rare manifestation of##7##3##(2006-10#3)(2006-12#1)(2010-10#1)(2012-2#1)(2013-7#1)
rare manifestation##8##2##(2006-10#3)(2006-12#1)(2010-10#1)(2012-12#1)(2012-2#1)(2013-7#1)
rare mesenchymal##2##2##(2008-6#2)
rare metabolic##2##2##(2005-12#1)(2007-11#1)
rare mitotic figures##3##3##(1997-6#2)(2008-11#1)
rare multi-level isthmic spondylolisthesis##2##4##(2007-6#2)
rare mutation##3##2##(2008-2#1)(2011-1#1)(2011-3#1)
rare mutations##2##2##(1993-6#1)(2011-1#1)
rare neoplasia##4##2##(1990-12#1)(2006-10#1)(2006-6#1)(2010-12#1)
rare neoplasm with##2##3##(1991-9#1)(2010-7#1)
rare neoplasm##19##2##(1991-5#1)(1991-9#1)(1993-8#1)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-3#1)(2010-7#1)(2010-8#1)(2013-1#1)
rare neoplasms of##2##3##(2005-12#1)(2008-1#1)
rare neoplasms##6##2##(2005-12#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-7#1)(2011-2#1)
rare occurrence and##4##3##(1992-9#1)(2009-7#1)(2011-1#1)(2011-2#1)
rare occurrence in##2##3##(1991-10#1)(2009-10#1)
rare occurrence of##4##3##(2008-10#2)(2011-12#1)(2013-1#1)
rare occurrence##26##2##(1991-10#1)(1992-9#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-3#2)(2009-10#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
rare on##3##2##(2008-10#2)(2008-7#1)
rare or##5##2##(1992-4#1)(2007-3#1)(2008-5#1)(2008-8#1)(2013-1#1)
rare pathology##8##2##(1991-10#1)(1992-6#1)(2007-8#3)(2008-6#1)(2009-2#1)(2012-2#1)
rare patients##2##2##(2008-4#1)(2008-8#1)
rare phenomenon##13##2##(1996-2#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
rare presentation of##6##3##(2007-11#1)(2007-3#1)(2007-7#2)(2010-12#1)(2012-3#1)
rare presentation##16##2##(2007-11#1)(2007-3#1)(2007-7#3)(2008-4#1)(2010-12#1)(2010-5#1)(2010-9#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
rare primary##9##2##(1993-3#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-6#1)(2010-11#1)(2010-6#1)(2012-12#1)(2012-2#1)
rare pulmonary##3##2##(2006-10#1)(2007-8#1)(2012-12#1)
rare qui##3##2##(2012-2#3)
rare recessive##3##2##(2006-6#1)(2008-8#2)
rare reports##2##2##(2006-2#1)(2007-9#1)
rare sequelae##2##2##(2006-10#1)(2008-8#1)
rare side effects##3##3##(1991-3#1)(2005-11#1)(2012-12#1)
rare side##6##2##(1991-3#2)(2005-11#1)(2006-10#1)(2010-4#1)(2012-12#1)
rare single##2##2##(1991-11#1)(2008-12#1)
rare site of##2##3##(2005-5#1)(2007-5#1)
rare site##7##2##(2005-5#1)(2007-4#1)(2007-5#1)(2008-6#1)(2009-3#1)(2010-3#1)(2010-6#1)
rare skin##4##2##(2007-11#1)(2008-2#1)(2011-2#1)(2013-7#1)
rare skull base##2##3##(2006-12#1)(2011-2#1)
rare small##2##2##(1993-9#1)(1997-3#1)
rare soft tissue##4##3##(2007-8#1)(2011-2#1)(2012-12#1)(2013-7#1)
rare species and##2##3##(2007-5#1)(2010-10#1)
rare species##5##2##(2005-10#2)(2007-5#1)(2008-12#1)(2010-10#1)
rare structural##2##2##(2012-11#1)(2012-12#1)
rare survivors##2##2##(1994-3#2)
rare syndrome##8##2##(1996-3#1)(1997-3#1)(2005-8#1)(2006-10#1)(2008-11#1)(2009-11#1)(2011-1#1)(2012-2#1)
rare systemic##3##2##(2005-11#1)(2006-10#2)
rare to find##2##3##(2008-11#1)(2010-6#1)
rare to##4##2##(2006-10#1)(2008-10#1)(2008-11#1)(2010-6#1)
rare tumor and##4##3##(2010-3#1)(2011-2#1)(2013-1#2)
rare tumor of the##3##4##(2008-10#1)(2012-2#1)(2012-3#1)
rare tumor of##6##3##(2007-8#1)(2008-10#1)(2009-7#1)(2012-2#2)(2012-3#1)
rare tumor that##3##3##(2007-6#1)(2010-5#1)(2012-3#1)
rare tumor##34##2##(1991-6#1)(1992-6#1)(2005-12#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-6#2)(2009-7#1)(2009-8#1)(2010-12#2)(2010-3#2)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#6)(2012-3#2)(2013-1#5)
rare tumors of##2##3##(2006-12#1)(2010-5#1)
rare tumors##17##2##(1990-6#1)(1997-8#1)(2005-10#1)(2006-1#1)(2006-12#3)(2007-5#1)(2007-8#1)(2008-5#1)(2010-12#1)(2010-5#1)(2012-1#1)(2012-3#1)(2013-1#3)
rare tumour of##2##3##(2013-7#1)(2013-8#1)
rare tumour##6##2##(2008-6#1)(2008-8#1)(2010-9#1)(2012-2#1)(2013-7#1)(2013-8#1)
rare tumours##10##2##(1994-7#1)(2007-8#1)(2008-7#1)(2010-11#1)(2011-1#1)(2012-2#3)(2013-1#1)(2013-7#1)
rare type of##9##3##(1997-7#1)(2005-11#1)(2007-8#1)(2011-1#1)(2011-2#4)(2012-3#1)
rare variant analysis##2##3##(2012-3#2)
rare variant data##7##3##(2012-3#7)
rare variant genotypes predict##2##4##(2012-3#2)
rare variant genotypes##3##3##(2012-3#3)
rare variant methods##3##3##(2012-3#3)
rare variant of##12##3##(1990-6#1)(2007-8#1)(2008-12#1)(2008-6#2)(2009-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
rare variant##45##2##(1990-6#1)(1997-2#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-6#2)(2009-10#1)(2010-12#1)(2010-6#1)(2010-9#2)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#27)(2013-1#2)
rare variants and common##2##4##(2012-3#2)
rare variants and##6##3##(2012-3#6)
rare variants are##6##3##(2012-3#6)
rare variants associated with a phenotype##2##6##(2012-3#2)
rare variants associated with a##3##5##(2012-3#3)
rare variants associated with##6##4##(2012-3#6)
rare variants at##2##3##(2012-3#2)
rare variants by##3##3##(2012-3#3)
rare variants have##3##3##(2012-3#3)
rare variants in a##2##4##(2012-3#2)
rare variants in##15##3##(2012-1#1)(2012-3#14)
rare variants into##3##3##(2012-3#3)
rare variants is##2##3##(2012-3#2)
rare variants may##2##3##(2012-3#2)
rare variants on##3##3##(2012-3#3)
rare variants or##3##3##(2012-3#3)
rare variants that are##2##4##(2012-3#2)
rare variants that may have##2##5##(2012-3#2)
rare variants that##8##3##(2012-3#8)
rare variants using a##2##4##(2012-3#2)
rare variants using the##2##4##(2012-3#2)
rare variants using##9##3##(2012-3#9)
rare variants were##3##3##(2012-3#3)
rare variants with##3##3##(2012-3#3)
rare variants within genes##2##4##(2012-3#2)
rare variants within##3##3##(2012-3#3)
rare variants##147##2##(1990-8#1)(1991-8#1)(2012-1#1)(2012-3#144)
rare variation##2##2##(2012-2#1)(2012-3#1)
rare variety of##5##3##(2007-7#1)(2008-10#1)(2011-12#2)(2011-2#1)
rare variety##6##2##(1994-2#1)(2007-7#1)(2008-10#1)(2011-12#2)(2011-2#1)
rare vascular##7##2##(2005-12#1)(2007-7#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#2)
rare when##2##2##(2006-10#1)(2008-10#1)
rare with##9##2##(1997-3#1)(2006-10#2)(2008-5#1)(2008-6#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
rare yet##3##2##(2012-1#1)(2012-2#1)(2013-1#1)
rare##2856##1##(1990-1#2)(1990-10#7)(1990-11#5)(1990-12#5)(1990-2#1)(1990-4#4)(1990-5#8)(1990-6#5)(1990-7#2)(1990-8#5)(1990-9#4)(1991-10#3)(1991-11#11)(1991-12#3)(1991-2#4)(1991-3#6)(1991-4#5)(1991-5#4)(1991-6#6)(1991-7#2)(1991-8#3)(1991-9#8)(1992-1#1)(1992-10#6)(1992-11#7)(1992-12#6)(1992-2#3)(1992-4#4)(1992-5#5)(1992-6#8)(1992-8#3)(1992-9#6)(1993-1#3)(1993-10#10)(1993-11#2)(1993-12#5)(1993-2#2)(1993-3#5)(1993-5#5)(1993-6#7)(1993-7#1)(1993-8#9)(1993-9#3)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#5)(1995-2#1)(1995-4#3)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#3)(1996-10#1)(1996-11#2)(1996-12#9)(1996-2#1)(1996-3#10)(1996-4#4)(1996-6#4)(1996-7#3)(1996-8#4)(1996-9#4)(1997-1#2)(1997-2#5)(1997-3#7)(1997-4#3)(1997-5#5)(1997-6#6)(1997-7#3)(1997-8#6)(2004-1#3)(2004-10#2)(2004-4#1)(2005-10#12)(2005-11#16)(2005-12#10)(2005-4#24)(2005-5#2)(2005-8#5)(2005-9#4)(2006-1#6)(2006-10#73)(2006-11#4)(2006-12#18)(2006-2#14)(2006-3#3)(2006-4#6)(2006-5#6)(2006-6#7)(2006-7#7)(2006-8#8)(2006-9#10)(2007-1#2)(2007-10#13)(2007-11#44)(2007-12#27)(2007-2#20)(2007-3#16)(2007-4#14)(2007-5#18)(2007-6#13)(2007-7#57)(2007-8#119)(2007-9#15)(2008-1#21)(2008-10#149)(2008-11#26)(2008-12#40)(2008-2#14)(2008-3#18)(2008-4#33)(2008-5#26)(2008-6#45)(2008-7#67)(2008-8#27)(2008-9#38)(2009-1#7)(2009-10#15)(2009-11#5)(2009-12#4)(2009-2#6)(2009-3#29)(2009-4#21)(2009-5#22)(2009-6#17)(2009-7#12)(2009-8#16)(2009-9#23)(2010-1#6)(2010-10#9)(2010-11#15)(2010-12#46)(2010-2#13)(2010-3#22)(2010-4#7)(2010-5#21)(2010-6#19)(2010-7#20)(2010-8#11)(2010-9#21)(2011-1#56)(2011-11#2)(2011-12#18)(2011-2#126)(2011-3#3)(2011-7#4)(2012-1#25)(2012-11#9)(2012-12#105)(2012-2#142)(2012-3#299)(2012-8#1)(2012-9#1)(2013-1#165)(2013-2#1)(2013-7#31)(2013-8#62)
rare)##2##1##(2008-9#1)(2012-2#1)
rare-cutting##3##1##(1996-6#1)(1997-2#1)(2008-10#1)
rare-earth compounds##3##2##(2006-5#1)(2008-2#2)
rare-earth elements##4##2##(2008-10#4)
rare-earth fluorides##2##2##(2010-7#2)
rare-earth ions##2##2##(2007-11#1)(2008-3#1)
rare-earth metal##7##2##(2007-8#1)(2010-5#6)
rare-earth##29##1##(2005-4#2)(2006-5#2)(2007-11#1)(2007-8#2)(2008-10#5)(2008-2#6)(2008-3#1)(2010-5#6)(2010-7#4)
rare-earth-doped crystals##2##2##(2007-12#2)
rare-earth-doped solid##2##2##(2008-1#2)
rare-earth-doped##10##1##(2007-12#4)(2008-1#2)(2008-2#3)(2008-3#1)
rare-event analysis##2##2##(2008-9#2)
rarefaction is##3##2##(2009-5#3)
rarefaction##12##1##(1991-11#2)(2008-10#1)(2008-3#1)(2008-8#1)(2009-5#5)(2012-12#1)(2012-3#1)
rarefied##2##1##(1995-7#1)(2007-10#1)
rarely achieved##2##2##(1993-12#1)(1994-5#1)
rarely address##2##2##(2008-11#1)(2012-11#1)
rarely addressed in##2##3##(1995-2#1)(2008-9#1)
rarely affected##4##2##(2008-10#2)(2012-12#1)(2013-1#1)
rarely and##4##2##(1991-4#1)(2009-2#1)(2012-2#1)(2012-3#1)
rarely associated with##10##3##(1995-1#1)(2005-9#1)(2006-10#2)(2007-7#1)(2009-3#1)(2011-12#2)(2012-12#1)(2013-1#1)
rarely associated##11##2##(1995-1#1)(2005-9#1)(2006-10#3)(2007-7#1)(2009-3#1)(2011-12#2)(2012-12#1)(2013-1#1)
rarely be##5##2##(1996-9#1)(2007-9#1)(2010-6#1)(2012-2#1)(2013-8#1)
rarely been described in the literature##2##6##(2007-11#1)(2012-2#1)
rarely been described in##4##4##(2006-10#2)(2007-11#1)(2012-2#1)
rarely been described##6##3##(1990-2#1)(2006-10#2)(2007-11#1)(2011-2#1)(2012-2#1)
rarely been reported in the##2##5##(2006-5#1)(2010-6#1)
rarely been reported in##3##4##(2006-5#1)(2007-7#1)(2010-6#1)
rarely been reported previously##2##4##(2006-10#1)(2013-8#1)
rarely been reported##13##3##(1990-6#1)(1991-8#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2009-3#1)(2009-5#2)(2010-6#1)(2011-2#1)(2013-8#1)
rarely been##31##2##(1990-2#1)(1990-6#1)(1991-3#1)(1991-8#1)(1992-5#1)(2004-9#1)(2006-10#3)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#2)(2009-2#1)(2009-3#1)(2009-5#2)(2010-6#1)(2011-2#3)(2012-2#2)(2013-8#1)
rarely cause##3##2##(2006-10#1)(2007-11#1)(2012-3#1)
rarely caused by##2##3##(1996-11#1)(2007-7#1)
rarely causes##6##2##(1990-2#1)(2006-9#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-12#1)
rarely described in##3##3##(2008-7#1)(2009-4#1)(2010-12#1)
rarely described##7##2##(2006-1#1)(2008-7#2)(2009-4#1)(2010-12#1)(2012-3#1)(2013-1#1)
rarely detected##2##2##(1996-11#1)(2010-12#1)
rarely diagnosed##5##2##(1995-11#1)(1996-11#1)(2008-7#1)(2009-2#1)(2013-8#1)
rarely discussed##4##2##(1993-10#1)(1996-2#1)(1996-6#1)(2008-11#1)
rarely during##2##2##(2008-10#1)(2012-3#1)
rarely effective##2##2##(2006-10#1)(2012-2#1)
rarely encountered by the##3##4##(2009-3#1)(2013-1#2)
rarely encountered##7##2##(2007-7#1)(2008-3#1)(2009-3#1)(2010-10#1)(2011-2#1)(2013-1#2)
rarely formed##2##2##(1993-12#1)(1995-8#1)
rarely found in other##3##4##(2011-2#1)(2012-3#2)
rarely found in##11##3##(1990-9#1)(1994-12#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#2)(2012-3#2)
rarely found##19##2##(1990-9#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#1)(1993-6#1)(1994-12#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-5#3)(2008-7#1)(2008-8#1)(2011-2#2)(2012-3#2)
rarely give rise to##2##4##(2006-4#1)(2013-1#1)
rarely had a##2##3##(2006-7#1)(2008-10#1)
rarely had##4##2##(2006-7#1)(2007-10#1)(2008-10#1)(2011-2#1)
rarely have##2##2##(2007-2#1)(2008-9#1)
rarely in the##9##3##(1991-3#1)(1994-10#1)(2006-10#1)(2008-10#2)(2008-5#2)(2011-2#1)(2012-12#1)
rarely in##17##2##(1991-2#1)(1991-3#1)(1994-10#1)(2005-12#2)(2006-10#1)(2006-6#1)(2007-10#1)(2008-10#2)(2008-5#3)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
rarely include##2##2##(2011-1#1)(2011-2#1)
rarely involved##2##2##(2010-12#1)(2013-7#1)
rarely it##2##2##(2010-12#1)(2012-12#1)
rarely lead to##4##3##(2007-11#1)(2007-8#1)(2008-3#1)(2011-2#1)
rarely manifest##2##2##(2009-8#1)(2010-6#1)
rarely met##2##2##(2008-10#1)(2010-9#1)
rarely observed in the##3##4##(1990-3#1)(1994-2#1)(2006-10#1)
rarely observed in##8##3##(1990-3#2)(1994-2#1)(1995-2#1)(2006-10#1)(2007-12#1)(2008-5#1)(2011-2#1)
rarely observed##17##2##(1990-3#2)(1992-11#1)(1994-2#1)(1995-2#1)(1997-3#1)(1997-5#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-5#2)(2010-5#1)(2011-2#1)
rarely occur during##2##3##(2005-11#1)(2007-6#1)
rarely occur in##3##3##(1996-2#1)(2007-7#1)(2010-11#1)
rarely occur##8##2##(1996-2#1)(2005-11#1)(2007-10#1)(2007-6#1)(2007-7#1)(2010-11#1)(2010-2#1)(2011-2#1)
rarely occurs in the##2##4##(1991-10#1)(2008-7#1)
rarely occurs in##5##3##(1991-10#1)(2008-7#1)(2013-7#2)(2013-8#1)
rarely occurs without##2##3##(2007-11#1)(2008-8#1)
rarely occurs##8##2##(1991-10#1)(2007-11#1)(2008-7#2)(2008-8#1)(2013-7#2)(2013-8#1)
rarely present as##2##3##(2012-12#1)(2013-8#1)
rarely present in##5##3##(2006-10#1)(2007-8#1)(2008-6#1)(2009-8#1)(2013-1#1)
rarely present##8##2##(2006-10#1)(2007-8#1)(2008-6#1)(2008-7#1)(2009-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
rarely presents##2##2##(1991-9#1)(2006-10#1)
rarely produce##2##2##(2007-11#1)(2008-10#1)
rarely reported in the literature##3##5##(1991-10#1)(2011-2#1)(2013-1#1)
rarely reported in the##4##4##(1991-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
rarely reported in##9##3##(1991-10#1)(2006-10#1)(2007-12#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
rarely reported##27##2##(1991-10#1)(1991-6#1)(2006-10#2)(2006-4#1)(2007-12#1)(2007-7#4)(2007-8#1)(2007-9#1)(2009-3#2)(2010-12#2)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#4)
rarely seen in the##5##4##(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
rarely seen in##8##3##(1992-11#1)(2007-7#1)(2010-2#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
rarely seen##13##2##(1992-11#1)(1996-3#1)(2006-10#1)(2007-5#1)(2007-7#1)(2008-11#2)(2010-2#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
rarely severe##2##2##(2007-11#1)(2009-6#1)
rarely studied in##2##3##(2007-12#1)(2009-11#1)
rarely studied##3##2##(2007-12#1)(2009-11#1)(2010-1#1)
rarely the##4##2##(1990-8#1)(2006-10#1)(2009-10#1)(2009-3#1)
rarely to##3##2##(2009-4#1)(2010-3#1)(2011-1#1)
rarely used##9##2##(1996-5#1)(1997-7#1)(2005-10#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-4#1)(2013-8#1)
rarely were##3##2##(1993-3#1)(1994-6#1)(2008-10#1)
rarely with##2##2##(1997-3#1)(2006-9#1)
rarely##443##1##(1990-12#2)(1990-2#2)(1990-3#3)(1990-6#3)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#3)(1991-12#2)(1991-2#2)(1991-3#4)(1991-4#2)(1991-5#1)(1991-6#4)(1991-8#2)(1991-9#2)(1992-11#4)(1992-2#3)(1992-4#2)(1992-5#3)(1992-9#1)(1993-10#1)(1993-12#3)(1993-3#2)(1993-5#1)(1993-6#2)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-8#1)(1996-11#3)(1996-2#2)(1996-3#3)(1996-5#1)(1996-6#3)(1996-9#2)(1997-2#2)(1997-3#3)(1997-5#2)(1997-7#2)(1997-8#1)(2004-10#1)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#3)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#22)(2006-12#2)(2006-2#4)(2006-4#3)(2006-5#2)(2006-6#4)(2006-7#3)(2006-8#1)(2006-9#3)(2007-1#1)(2007-10#5)(2007-11#7)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#17)(2007-8#8)(2007-9#4)(2008-1#1)(2008-10#17)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#12)(2008-6#3)(2008-7#16)(2008-8#9)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#5)(2009-3#8)(2009-4#2)(2009-5#2)(2009-6#3)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#8)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#5)(2010-8#2)(2010-9#3)(2011-1#4)(2011-12#4)(2011-2#21)(2012-1#3)(2012-11#1)(2012-12#17)(2012-2#13)(2012-3#8)(2013-1#15)(2013-7#4)(2013-8#10)
rareness of##4##2##(2006-2#1)(2008-10#1)(2011-2#1)(2012-11#1)
rareness##5##1##(2006-2#1)(2007-5#1)(2008-10#1)(2011-2#1)(2012-11#1)
rarer and##2##2##(2007-3#1)(2007-7#1)
rarer forms of##2##3##(2005-8#1)(2008-6#1)
rarer than##6##2##(1993-10#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-7#1)(2010-12#1)
rarer##40##1##(1990-10#1)(1990-2#1)(1993-10#1)(1993-9#1)(1996-9#1)(2004-10#1)(2005-8#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-12#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
rarest##9##1##(1990-4#1)(1990-6#1)(1997-7#1)(2008-4#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
rareté##2##1##(2012-2#2)
rarity and the##2##3##(2006-12#1)(2011-2#1)
rarity and to emphasize##2##4##(2007-8#1)(2011-1#1)
rarity and##15##2##(1990-12#1)(2006-12#2)(2007-11#1)(2007-7#2)(2007-8#3)(2008-12#1)(2011-1#1)(2011-2#3)(2013-8#1)
rarity in##4##2##(1992-9#1)(2005-10#1)(2007-7#1)(2012-12#1)
rarity of its##3##3##(1991-11#1)(2008-7#1)(2011-2#1)
rarity of the##9##3##(1990-12#1)(1990-5#1)(1991-4#1)(2006-2#1)(2007-12#1)(2008-8#1)(2010-12#1)(2010-5#1)(2013-1#1)
rarity of these##6##3##(2007-2#1)(2008-6#2)(2010-7#2)(2012-12#1)
rarity of this condition##4##4##(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
rarity of this lesion and##2##5##(1990-9#1)(2008-5#1)
rarity of this##17##3##(1990-10#1)(1990-9#1)(1991-10#1)(1992-11#1)(1992-5#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-5#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#2)(2013-8#1)
rarity of##48##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-4#1)(1992-11#1)(1992-5#1)(1992-8#1)(2006-10#1)(2006-2#2)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#1)(2010-12#2)(2010-5#3)(2010-7#2)(2011-2#3)(2012-12#4)(2012-3#1)(2013-1#1)(2013-8#1)
rarity##89##1##(1990-10#1)(1990-12#2)(1990-5#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-4#1)(1992-11#1)(1992-5#1)(1992-8#1)(1992-9#1)(1996-12#1)(2005-10#2)(2006-10#1)(2006-12#2)(2006-2#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#5)(2007-8#7)(2007-9#1)(2008-10#1)(2008-12#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-5#4)(2010-7#3)(2011-1#1)(2011-2#7)(2012-12#5)(2012-3#2)(2013-1#4)(2013-8#2)
ras and##3##2##(1992-8#1)(2005-11#1)(2008-11#1)
ras clone I##6##3##(2008-11#6)
ras expression##2##2##(1990-11#1)(1991-8#1)
ras gene of the##2##4##(1991-8#1)(1997-4#1)
ras gene of##3##3##(1991-8#1)(1997-4#2)
ras gene##12##2##(1990-11#1)(1991-8#3)(1992-7#1)(1993-3#2)(1995-2#1)(1997-4#4)
ras genes are##2##3##(1995-2#2)
ras genes was##2##3##(1991-2#1)(1991-8#1)
ras genes##5##2##(1991-2#1)(1991-8#1)(1992-12#1)(1995-2#2)
ras homologue##2##2##(1997-4#2)
ras oncogene##7##2##(1991-2#1)(1992-8#1)(1993-6#1)(2008-11#4)
ras oncogenes##5##2##(1990-7#2)(1991-10#1)(1991-7#1)(2008-11#1)
ras p21##3##2##(1991-5#2)(1992-11#1)
ras protein##4##2##(1990-11#1)(1994-12#1)(1997-4#1)(2008-11#1)
ras proteins##5##2##(1990-11#1)(1991-11#1)(1991-9#1)(1992-11#2)
ras##90##1##(1990-11#8)(1990-3#1)(1990-4#1)(1990-7#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-5#5)(1991-7#2)(1991-8#6)(1991-9#1)(1992-1#1)(1992-11#3)(1992-12#1)(1992-5#1)(1992-7#1)(1992-8#6)(1992-9#1)(1993-3#3)(1993-6#4)(1993-9#1)(1994-12#1)(1994-6#1)(1995-2#3)(1995-3#1)(1995-8#1)(1997-4#7)(2004-1#3)(2005-11#2)(2008-11#15)
ras-GAP##2##1##(1992-11#2)
ras-amplified recombinant BHK-21##2##3##(2008-11#2)
ras-amplified##3##1##(2008-11#3)
ras-induced maturation of Xenopus oocytes##2##5##(1991-12#2)
ras-induced##3##1##(1991-12#2)(1991-9#1)
ras-like##2##1##(1992-8#1)(1996-6#1)
ras-p21 that##2##2##(1993-3#2)
ras-p21##5##1##(1991-12#1)(1993-3#3)(1995-9#1)
ras-rBHK-IgG##3##1##(2008-11#3)
ras-related protein##3##2##(1990-4#2)(1990-8#1)
ras-related##10##1##(1990-4#2)(1990-8#1)(1991-9#2)(1992-11#1)(1992-8#1)(1993-12#1)(1995-8#1)(1996-7#1)
ras-transfected cells##2##2##(1992-9#2)
ras-transfected##3##1##(1992-9#3)
ras-transformants##2##1##(1992-9#2)
ras-transformed cells##3##2##(1991-7#1)(1993-6#1)(1993-9#1)
ras-transformed##8##1##(1991-7#3)(1992-5#1)(1992-6#1)(1993-6#2)(1993-9#1)
rasGAP##2##1##(1991-5#2)
rasagiline is##2##2##(2008-5#2)
rasagiline##6##1##(2008-11#1)(2008-5#5)
rasburicase dosing for##2##3##(2008-7#2)
rasburicase##7##1##(2008-7#7)
rash and##10##2##(1997-8#1)(2007-11#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
rash is a##2##3##(2007-7#1)(2013-1#1)
rash is##4##2##(2006-10#1)(2007-7#1)(2013-1#2)
rash of##2##2##(2006-10#1)(2007-7#1)
rash on the##4##3##(2006-4#2)(2008-6#1)(2010-6#1)
rash on##7##2##(2006-4#2)(2008-6#1)(2009-12#1)(2010-6#1)(2012-3#1)(2013-1#1)
rash or##3##2##(2006-10#2)(2007-8#1)
rash was##2##2##(2009-11#1)(2012-2#1)
rash with##2##2##(2006-10#1)(2013-1#1)
rash##100##1##(1991-3#1)(1991-9#1)(1992-11#1)(1992-3#1)(1995-11#1)(1996-3#1)(1997-4#1)(1997-6#1)(1997-8#3)(2006-10#17)(2006-12#2)(2006-4#5)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#6)(2007-7#2)(2007-8#2)(2008-1#1)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#4)(2009-11#3)(2009-12#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#1)
rashes and##2##2##(2007-11#1)(2012-2#1)
rashes are##3##2##(2007-2#1)(2008-12#1)(2008-3#1)
rashes##18##1##(1997-1#1)(2006-10#2)(2007-11#1)(2007-2#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2010-8#1)(2011-1#1)(2012-2#1)
raspberry##4##1##(2008-10#1)(2009-3#3)
raster images##2##2##(2008-3#2)
raster scan##3##2##(2008-2#2)(2008-3#1)
raster scanning##2##2##(2007-12#1)(2008-3#1)
raster##12##1##(2007-12#2)(2008-2#2)(2008-3#4)(2011-1#1)(2012-3#3)
rat (WKY)##3##2##(1990-7#1)(1991-12#1)(1993-2#1)
rat (r)##2##2##(1993-7#1)(1994-8#1)
rat 3-DG-reducing enzyme##3##3##(1993-5#3)
rat 40 S ribosomal subunit##2##5##(1994-2#2)
rat 9L gliosarcoma##2##3##(1995-5#1)(2007-3#1)
rat 9L##3##2##(1992-9#1)(1995-5#1)(2007-3#1)
rat A(1)##2##2##(2008-4#2)
rat A3 receptors##4##3##(1994-8#2)(1994-9#2)
rat A3##6##2##(1994-8#2)(1994-9#4)
rat ALR cDNA##3##3##(1993-5#2)(2008-8#1)
rat ALR##5##2##(1993-5#3)(2008-8#2)
rat AM##2##2##(1994-6#1)(1994-8#1)
rat AT1 receptor##4##3##(1992-2#1)(1992-3#2)(1992-5#1)
rat AT1##5##2##(1992-2#1)(1992-3#3)(1992-5#1)
rat AT1A##2##2##(1992-7#1)(1995-5#1)
rat AT1a receptor##2##3##(1994-3#2)
rat C6 glioma cells##3##4##(1995-10#2)(2012-2#1)
rat C6 glioma##4##3##(1994-11#1)(1995-10#2)(2012-2#1)
rat C6##5##2##(1994-11#2)(1995-10#2)(2012-2#1)
rat CA II##2##3##(1997-2#2)
rat CA1##2##2##(1994-11#1)(1997-2#1)
rat CBF-C##2##2##(1995-2#2)
rat CC10##2##2##(1993-11#2)
rat CCKB##2##2##(1992-11#2)
rat CCSP gene##2##3##(1997-2#2)
rat CGRP##3##2##(1990-6#1)(1992-6#1)(1992-9#1)
rat CII##2##2##(1996-4#2)
rat CL##5##2##(2008-8#2)(2008-9#3)
rat CNS##5##2##(1994-10#1)(1994-11#1)(1996-1#2)(1996-6#1)
rat CYP2E1##2##2##(1991-8#1)(1997-3#1)
rat CalBP##2##2##(1992-7#2)
rat DENA hepatocarcinogenesis##2##3##(1992-1#2)
rat DNA polymerase beta##3##4##(1990-5#2)(2006-10#1)
rat DRG##6##2##(1991-12#1)(1993-12#1)(1995-12#2)(1996-12#1)(2010-12#1)
rat EFIA cDNA##3##3##(1993-2#3)
rat EFIA##4##2##(1993-2#4)
rat ER##2##2##(1991-6#1)(1996-2#1)
rat Epo##4##2##(2008-11#4)
rat Gadd45 cDNA##2##3##(1994-12#2)
rat Gadd45##3##2##(1994-12#3)
rat HDC##3##2##(1990-12#3)
rat Hx##2##2##(1992-5#2)
rat IA2 and IA1##2##4##(1990-5#2)
rat IA2##3##2##(1990-5#3)
rat IAPP gene##2##3##(1993-4#2)
rat IAPP##3##2##(1993-4#2)(1994-8#1)
rat IGFBP-6 gene##2##3##(1993-3#2)
rat IIA##2##2##(1990-7#2)
rat IL-10 was##3##3##(1992-11#1)(1993-4#2)
rat IL-10##5##2##(1992-11#2)(1993-4#3)
rat L1##2##2##(1996-12#2)
rat LH##3##2##(1994-12#3)
rat Leydig cell##2##3##(1990-5#1)(1992-12#1)
rat Leydig cells##4##3##(1990-2#1)(1994-12#3)
rat Leydig##6##2##(1990-2#1)(1990-5#1)(1992-12#1)(1994-12#3)
rat MPP alpha##2##3##(1993-8#2)
rat MTHFR##2##2##(2008-8#2)
rat Microryzomys minutus##2##3##(2008-5#2)
rat NR2C##2##2##(1996-12#2)
rat P-450(11 beta)##2##3##(1990-5#2)
rat P450##2##2##(1994-8#1)(1995-3#1)
rat PACAP type##2##3##(1994-12#1)(1994-3#1)
rat PACAP##6##2##(1990-12#4)(1994-12#1)(1994-3#1)
rat PEPT1##2##2##(1996-9#2)
rat PKC##2##2##(1994-8#2)
rat PROT##2##2##(1995-6#2)
rat PTP1##2##2##(1995-10#2)
rat S1 cDNA##2##3##(1994-9#2)
rat Schwann cell incorporation of [3H]thymidine##2##6##(1995-2#2)
rat Schwann cells##4##3##(1993-5#1)(1995-5#3)
rat Schwann##6##2##(1993-5#1)(1995-2#2)(1995-5#3)
rat Sertoli##2##2##(1992-3#1)(1992-5#1)
rat T##2##2##(1995-12#1)(2008-11#1)
rat TG##4##2##(2009-12#1)(2012-3#3)
rat TGF-beta type II receptor##2##5##(1993-3#2)
rat TGF-beta type##3##3##(1992-11#1)(1993-3#2)
rat TMJ##2##2##(2010-12#2)
rat V1A##2##2##(1994-8#2)
rat VIP1##2##2##(1996-5#2)
rat VSMC##6##2##(1990-11#4)(1992-3#1)(1996-2#1)
rat abdominal##3##2##(1990-5#1)(1996-5#1)(2004-9#1)
rat acini##2##2##(1992-6#1)(1993-6#1)
rat adenosine##2##2##(1992-5#1)(2008-4#1)
rat adipocyte##5##2##(1990-6#1)(1990-8#1)(1992-3#1)(1997-1#2)
rat adipocytes with##2##3##(1994-8#1)(1997-7#1)
rat adipocytes##20##2##(1990-6#2)(1990-7#1)(1991-2#3)(1991-5#2)(1992-11#1)(1992-4#1)(1994-3#2)(1994-8#2)(1997-1#2)(1997-7#1)(2008-8#2)(2011-2#1)
rat adipose tissue and##2##4##(1993-6#1)(2008-11#1)
rat adipose tissue##5##3##(1993-6#1)(2008-10#1)(2008-11#2)(2010-6#1)
rat adipose##6##2##(1993-6#1)(2008-10#1)(2008-11#3)(2010-6#1)
rat adjuvant arthritis##2##3##(1993-12#1)(2008-10#1)
rat adrenal and brain##2##4##(1995-10#1)(1995-12#1)
rat adrenal and##3##3##(1995-10#1)(1995-12#2)
rat adrenal cortex##5##3##(1991-5#1)(1995-10#2)(1996-2#1)(1996-5#1)
rat adrenal gland##5##3##(1990-5#1)(1993-12#1)(1996-12#2)(1996-2#1)
rat adrenal glands##4##3##(1990-2#3)(1995-10#1)
rat adrenal glomerulosa##2##3##(1990-7#1)(1991-12#1)
rat adrenal medulla pheochromocytoma cell line##2##6##(2008-11#2)
rat adrenal medulla##3##3##(1991-2#1)(2008-11#2)
rat adrenal tissue preparations##2##4##(1993-4#2)
rat adrenal##33##2##(1990-2#3)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1993-11#1)(1993-12#1)(1993-4#2)(1994-2#1)(1995-10#6)(1995-12#4)(1996-12#2)(1996-2#2)(1996-5#1)(1996-8#1)(2008-11#4)
rat adrenals##4##2##(1991-2#1)(1995-10#3)
rat adrenocortical##2##2##(1995-10#2)
rat after a##2##3##(1993-9#1)(1994-10#1)
rat after##5##2##(1993-9#1)(1994-10#1)(1995-12#1)(1997-2#1)(2007-9#1)
rat albumin##2##2##(1991-5#1)(2008-11#1)
rat aldolase C gene##2##4##(1991-1#2)
rat aldolase##5##2##(1990-12#1)(1991-1#2)(1991-4#2)
rat alpha 1-protease inhibitor##2##4##(1990-8#2)
rat alpha##7##2##(1990-8#2)(1991-9#1)(1993-11#1)(1994-9#3)
rat alpha-CGRP##2##2##(1992-6#2)
rat alveolar Type II##2##4##(1997-5#2)
rat alveolar macrophages##5##3##(1990-5#1)(1992-6#2)(1993-3#2)
rat alveolar##9##2##(1990-4#1)(1990-5#1)(1992-6#2)(1993-3#2)(1993-9#1)(1997-5#2)
rat amygdala##8##2##(1991-11#2)(1993-2#3)(1997-6#3)
rat amygdaloid##2##2##(1992-7#1)(1995-5#1)
rat amylin##5##2##(1990-3#1)(1991-6#2)(1993-11#1)(1997-4#1)
rat and also##2##3##(1990-3#1)(1994-2#1)
rat and bovine oxytocin##2##4##(1991-2#2)
rat and bovine##7##3##(1990-11#1)(1991-2#2)(1992-3#1)(1993-6#1)(1994-5#1)(1994-8#1)
rat and chick brain##2##4##(1990-7#1)(1996-12#1)
rat and chick##8##3##(1990-7#1)(1996-12#3)(1996-2#1)(1997-1#3)
rat and chicken##4##3##(1991-4#2)(1992-2#1)(1996-5#1)
rat and dog##2##3##(1994-6#1)(1997-3#1)
rat and guinea pig brains##4##5##(1991-1#4)
rat and guinea pig##8##4##(1991-1#6)(1992-3#1)(1995-12#1)
rat and hamster##4##3##(1995-3#1)(1996-11#1)(2008-4#2)
rat and human liver membranes##2##5##(1994-2#2)
rat and human liver microsomes##2##5##(1991-4#1)(1991-5#1)
rat and human liver##9##4##(1991-4#1)(1991-5#1)(1991-8#1)(1994-11#2)(1994-2#3)(1995-2#1)
rat and human receptors##2##4##(1995-2#1)(1996-5#1)
rat and human##44##3##(1990-8#1)(1991-10#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-2#1)(1992-6#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#4)(1994-3#2)(1994-6#1)(1994-8#2)(1995-2#3)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-4#1)(2006-10#1)(2007-9#2)(2008-10#1)(2008-3#1)(2009-4#1)(2011-12#1)(2012-2#2)
rat and its##3##3##(1991-1#1)(1991-2#1)(2008-11#1)
rat and monkey preparations##2##4##(1994-9#2)
rat and monkey##4##3##(1991-4#1)(1994-9#2)(1996-9#1)
rat and mouse brain##3##4##(1992-4#1)(1992-6#1)(1996-10#1)
rat and mouse embryos##4##4##(1995-3#4)
rat and mouse liver##2##4##(1991-8#2)
rat and mouse##49##3##(1990-8#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#4)(1992-2#1)(1992-4#1)(1992-6#2)(1992-7#2)(1992-9#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#5)(1994-9#1)(1995-3#4)(1995-5#1)(1995-7#1)(1996-10#1)(1996-5#1)(1997-2#2)(2006-7#1)(2006-9#1)(2008-10#1)(2008-4#6)(2010-11#1)
rat and ox##2##3##(1992-2#1)(1995-7#1)
rat and rabbit##7##3##(1991-6#1)(1992-3#1)(1992-7#1)(1993-11#1)(2008-4#2)(2012-1#1)
rat and the##3##3##(1994-11#1)(2008-11#2)
rat and yeast##2##3##(1994-6#1)(1997-2#1)
rat and##178##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#8)(1991-10#1)(1991-12#1)(1991-2#3)(1991-4#6)(1991-5#3)(1991-6#3)(1991-7#1)(1991-8#5)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#4)(1992-3#3)(1992-4#1)(1992-6#3)(1992-7#3)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#5)(1994-12#2)(1994-2#7)(1994-3#2)(1994-5#6)(1994-6#3)(1994-8#3)(1994-9#3)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#5)(1995-5#2)(1995-6#1)(1995-7#2)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#2)(1996-5#4)(1996-6#2)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#3)(1997-8#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-9#2)(2008-10#4)(2008-11#4)(2008-3#1)(2008-4#12)(2008-5#1)(2008-7#1)(2009-4#1)(2010-11#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-2#2)
rat angiotensin II receptor##2##4##(1991-5#1)(1992-9#1)
rat angiotensin II##5##3##(1990-7#1)(1991-5#1)(1992-7#1)(1992-9#1)(1994-3#1)
rat angiotensin##6##2##(1990-7#1)(1991-5#1)(1992-3#1)(1992-7#1)(1992-9#1)(1994-3#1)
rat anococcygeus muscle##2##3##(1993-11#2)
rat anterior pituitary cells in##2##5##(1990-10#1)(1990-2#1)
rat anterior pituitary cells##4##4##(1990-10#1)(1990-12#1)(1990-2#1)(1996-2#1)
rat anterior pituitary##8##3##(1990-10#1)(1990-12#1)(1990-2#1)(1992-3#1)(1992-7#1)(1994-6#1)(1996-2#1)(1996-5#1)
rat anterior##10##2##(1990-10#1)(1990-12#1)(1990-2#1)(1992-3#1)(1992-7#1)(1994-6#1)(1995-11#1)(1996-2#1)(1996-5#1)(2009-2#1)
rat antibodies##2##2##(2007-11#1)(2008-4#1)
rat aorta and##2##3##(1996-10#1)(2008-8#1)
rat aorta by##2##3##(2007-9#1)(2010-5#1)
rat aorta during##2##3##(1991-9#1)(1994-11#1)
rat aorta##33##2##(1990-12#2)(1990-2#1)(1991-5#1)(1991-9#3)(1992-6#2)(1993-3#2)(1994-11#3)(1994-2#1)(1995-1#2)(1995-12#2)(1996-10#3)(1996-2#1)(1997-7#4)(2007-9#1)(2008-3#1)(2008-8#1)(2010-5#1)(2010-6#1)(2011-2#1)
rat aortic rings with##2##4##(1994-2#1)(2009-5#1)
rat aortic rings##7##3##(1990-11#2)(1994-2#2)(1994-5#2)(2009-5#1)
rat aortic smooth muscle (RASM)##2##5##(1993-3#1)(1995-6#1)
rat aortic smooth muscle cells##8##5##(1991-5#1)(1991-9#2)(1992-2#1)(1994-6#1)(1995-6#1)(1996-10#1)(1997-5#1)
rat aortic smooth muscle##11##4##(1991-5#1)(1991-9#2)(1992-2#1)(1993-3#1)(1994-6#1)(1995-6#2)(1996-10#1)(1997-5#1)(2008-6#1)
rat aortic smooth##12##3##(1991-5#1)(1991-9#2)(1992-2#1)(1993-3#1)(1994-6#1)(1995-6#2)(1996-10#1)(1997-2#1)(1997-5#1)(2008-6#1)
rat aortic tissue##2##3##(1990-12#1)(1997-2#1)
rat aortic vascular smooth muscle cells##2##6##(1990-12#1)(2008-11#1)
rat aortic##28##2##(1990-11#2)(1990-12#2)(1990-8#1)(1991-5#1)(1991-9#2)(1992-2#1)(1993-3#1)(1994-2#2)(1994-5#2)(1994-6#1)(1995-11#1)(1995-2#1)(1995-6#2)(1996-10#1)(1997-2#3)(1997-5#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-5#1)
rat area postrema##2##3##(2008-4#2)
rat arterial##2##2##(2006-6#1)(2007-8#1)
rat as a model##3##4##(1995-2#1)(2008-4#1)(2008-7#1)
rat as a##4##3##(1995-2#1)(2005-10#1)(2008-4#1)(2008-7#1)
rat as well as##2##4##(1994-11#1)(2013-8#1)
rat as##8##2##(1992-12#1)(1994-11#1)(1995-2#1)(1997-2#1)(2005-10#1)(2008-4#1)(2008-7#1)(2013-8#1)
rat ascites hepatoma AH66##2##4##(1996-11#2)
rat ascites hepatoma##8##3##(1996-11#2)(2008-11#6)
rat ascites##10##2##(1993-8#1)(1996-11#2)(2008-11#7)
rat astrocyte##3##2##(1991-2#1)(2008-11#2)
rat astrocytes##11##2##(1993-7#1)(1994-10#2)(1994-3#2)(1994-5#1)(1995-5#1)(1996-12#1)(2008-4#1)(2008-5#1)(2011-12#1)
rat at##8##2##(1990-5#1)(1991-2#1)(1993-12#1)(1993-2#1)(1994-2#1)(1996-4#1)(2008-8#1)(2012-1#1)
rat atria##5##2##(1990-10#2)(1990-3#1)(1992-7#1)(2013-1#1)
rat basal forebrain##4##3##(1997-5#2)(2007-10#2)
rat basophilic leukemia cell line##2##5##(1995-10#1)(2008-4#1)
rat basophilic leukemia cells (RBL-2H3)##3##5##(1991-5#2)(1996-2#1)
rat basophilic leukemia cells##6##4##(1990-8#1)(1991-5#2)(1991-8#1)(1994-11#1)(1996-2#1)
rat basophilic leukemia##11##3##(1990-8#2)(1991-5#2)(1991-8#1)(1993-3#2)(1994-11#1)(1995-10#1)(1996-2#1)(2008-4#1)
rat bile and##2##3##(1997-8#2)
rat blood and##3##3##(1991-4#1)(1997-8#1)(2008-10#1)
rat blood##10##2##(1991-4#2)(1996-6#1)(1997-8#1)(2008-10#2)(2013-1#4)
rat bone marrow and##2##4##(1992-6#1)(2008-5#1)
rat bone marrow cells##4##4##(1991-1#1)(1996-5#1)(2008-8#1)(2008-9#1)
rat bone marrow##11##3##(1990-12#1)(1990-3#1)(1991-1#2)(1992-6#1)(1995-11#1)(1996-5#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#1)
rat bone##15##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-7#1)(1991-1#2)(1992-6#1)(1995-11#1)(1996-5#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2012-2#1)
rat brain NOS##2##3##(1995-5#1)(2008-5#1)
rat brain RNA##2##3##(1990-12#1)(1990-7#1)
rat brain after##5##3##(1990-7#1)(1993-12#1)(1997-8#2)(2008-10#1)
rat brain and##21##3##(1990-5#2)(1990-6#1)(1990-9#1)(1991-7#1)(1992-1#1)(1992-9#1)(1993-11#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-1#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-2#2)(1997-8#1)(2008-4#2)
rat brain as##2##3##(1990-5#1)(1995-7#1)
rat brain by in situ##4##5##(1992-12#1)(1995-5#1)(1996-12#2)
rat brain by in##5##4##(1992-12#1)(1995-5#1)(1996-12#2)(1997-1#1)
rat brain by##18##3##(1990-9#1)(1991-11#1)(1992-12#1)(1994-10#2)(1994-2#1)(1995-3#1)(1995-5#1)(1996-12#3)(1997-1#2)(1997-8#1)(2007-1#1)(2008-10#1)(2009-12#1)(2010-2#1)
rat brain cDNA library##5##4##(1992-11#1)(1992-5#1)(1992-6#1)(1994-12#1)(1996-12#1)
rat brain cDNA##6##3##(1991-2#1)(1992-11#1)(1992-5#1)(1992-6#1)(1994-12#1)(1996-12#1)
rat brain cerebral##2##3##(1990-2#1)(1991-9#1)
rat brain cortex##3##3##(1996-12#2)(2007-10#1)
rat brain cortical slices##2##4##(1996-11#1)(1997-1#1)
rat brain cortical##6##3##(1993-4#1)(1993-6#2)(1996-11#1)(1997-1#1)(1997-2#1)
rat brain during##3##3##(1991-3#2)(2010-12#1)
rat brain following##5##3##(1990-4#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-3#1)
rat brain for##2##3##(1991-3#1)(2008-11#1)
rat brain had##2##3##(1992-7#1)(1994-6#1)
rat brain in vivo##3##4##(1993-3#1)(1995-11#1)(1996-1#1)
rat brain in##6##3##(1991-4#1)(1991-9#1)(1993-3#1)(1994-8#1)(1995-11#1)(1996-1#1)
rat brain is highly expressed in the##2##7##(1993-8#1)(1995-12#1)
rat brain is##5##3##(1993-8#1)(1995-12#1)(1996-8#1)(2008-10#2)
rat brain membranes##5##3##(1990-10#1)(1992-9#2)(1993-11#1)(1993-6#1)
rat brain microdialysate##3##3##(1997-3#2)(2008-10#1)
rat brain mitochondria##2##3##(1990-6#1)(1996-5#1)
rat brain neuronal cultures##2##4##(1993-4#2)
rat brain neurons##4##3##(1990-7#2)(1993-4#1)(1995-2#1)
rat brain of##2##3##(1992-5#1)(1996-12#1)
rat brain regions##8##3##(1991-11#1)(1991-4#1)(1994-12#1)(1995-11#1)(1996-10#1)(1996-12#1)(1997-2#1)(2008-4#1)
rat brain sections##2##3##(1991-2#1)(2009-12#1)
rat brain slices##6##3##(1990-7#1)(1992-7#1)(1993-5#1)(2008-2#2)(2009-12#1)
rat brain synaptic membranes##2##4##(1991-4#1)(1994-2#1)
rat brain synaptic vesicles##2##4##(1990-11#1)(1996-8#1)
rat brain synaptic##4##3##(1990-11#1)(1991-4#1)(1994-2#1)(1996-8#1)
rat brain synaptosomal membranes##2##4##(1992-3#1)(1993-7#1)
rat brain synaptosomal##4##3##(1992-3#1)(1993-7#1)(1995-11#1)(2008-4#1)
rat brain synaptosomes##3##3##(1994-12#3)
rat brain tissue##5##3##(1990-7#1)(1995-7#1)(1996-6#1)(2008-11#1)(2013-1#1)
rat brain to##2##3##(1996-5#2)
rat brain using the##3##4##(1995-12#1)(1995-7#1)(2010-12#1)
rat brain using##10##3##(1993-8#1)(1994-2#1)(1995-12#1)(1995-5#1)(1995-7#1)(1996-9#1)(2008-1#1)(2008-7#1)(2010-12#1)(2011-1#1)
rat brain was##9##3##(1991-4#1)(1993-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-8#1)
rat brain were##6##3##(1991-4#1)(1994-9#1)(1995-6#1)(1996-2#1)(1997-8#1)(2008-10#1)
rat brain##409##2##(1990-10#4)(1990-11#2)(1990-12#3)(1990-2#3)(1990-4#1)(1990-5#7)(1990-6#3)(1990-7#16)(1990-9#3)(1991-1#4)(1991-10#3)(1991-11#2)(1991-12#4)(1991-2#3)(1991-3#5)(1991-4#8)(1991-5#7)(1991-6#2)(1991-7#1)(1991-9#4)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-5#5)(1992-6#2)(1992-7#4)(1992-8#3)(1992-9#5)(1993-11#9)(1993-12#4)(1993-3#4)(1993-4#6)(1993-5#3)(1993-6#4)(1993-7#1)(1993-8#3)(1993-9#2)(1994-10#5)(1994-11#3)(1994-12#17)(1994-2#8)(1994-3#6)(1994-5#3)(1994-6#3)(1994-8#6)(1994-9#4)(1995-1#3)(1995-10#1)(1995-11#4)(1995-12#8)(1995-2#1)(1995-3#7)(1995-5#6)(1995-6#6)(1995-7#6)(1995-8#3)(1995-9#3)(1996-1#3)(1996-10#5)(1996-11#6)(1996-12#17)(1996-2#9)(1996-3#4)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#6)(1996-9#1)(1997-1#5)(1997-2#10)(1997-3#3)(1997-5#6)(1997-7#7)(1997-8#8)(2005-8#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-9#1)(2008-1#2)(2008-10#14)(2008-11#3)(2008-2#3)(2008-3#1)(2008-4#6)(2008-5#2)(2008-7#2)(2009-10#2)(2009-12#5)(2009-9#1)(2010-12#3)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-3#1)(2013-1#1)
rat brains and##3##3##(1991-7#1)(1997-1#1)(2008-1#1)
rat brains##16##2##(1990-4#1)(1991-5#1)(1991-7#2)(1995-9#1)(1996-12#3)(1997-1#1)(2007-9#2)(2008-1#1)(2008-11#1)(2008-8#1)(2009-12#1)(2010-2#1)
rat brainstem##4##2##(1992-9#1)(1995-5#1)(1996-3#1)(1997-7#1)
rat brown adipocytes##2##3##(1991-12#1)(1997-6#1)
rat brown##3##2##(1991-12#1)(1997-6#2)
rat but##4##2##(1992-12#1)(1995-7#1)(2008-8#1)(2011-2#1)
rat by##16##2##(1990-11#1)(1991-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-2#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-3#1)(2008-4#1)(2010-2#1)(2013-8#1)
rat cDNA encoding##2##3##(1991-12#1)(1995-2#1)
rat cDNA##14##2##(1991-12#1)(1992-10#1)(1992-12#1)(1992-8#1)(1993-7#1)(1993-9#3)(1994-8#1)(1995-10#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-6#1)
rat calvaria##4##2##(1990-7#2)(1992-1#2)
rat can##3##2##(1992-9#1)(1994-8#1)(1997-7#1)
rat carbonic anhydrase II gene##2##5##(1997-2#2)
rat carcinogenesis##3##2##(2009-3#1)(2011-1#2)
rat cardiac allografts##2##3##(1993-11#1)(1995-2#1)
rat cardiac myocytes in##2##4##(1993-3#1)(2008-7#1)
rat cardiac myocytes##7##3##(1992-11#2)(1993-3#2)(2007-11#1)(2008-7#1)(2008-9#1)
rat cardiac##14##2##(1992-11#2)(1992-7#2)(1993-11#2)(1993-3#2)(1994-11#1)(1995-2#1)(1996-12#1)(2007-11#1)(2008-7#1)(2008-9#1)
rat cardiomyocytes##10##2##(1994-3#1)(1994-6#1)(1994-8#2)(1995-11#1)(2007-8#1)(2010-12#3)(2013-1#1)
rat cardiomyocytes]##2##2##(2008-12#1)(2013-8#1)
rat carotid arteries##2##3##(1991-3#1)(1995-8#1)
rat carotid artery##2##3##(1992-9#1)(1997-2#1)
rat carotid body##2##3##(1995-12#1)(2011-12#1)
rat carotid##7##2##(1991-3#1)(1992-9#1)(1995-12#1)(1995-8#1)(1997-2#1)(2011-12#2)
rat cdk4 is##2##3##(1993-3#2)
rat cell lines##2##3##(1994-9#2)
rat cell##4##2##(1994-2#1)(1994-8#1)(1994-9#2)
rat cells##17##2##(1990-5#3)(1990-8#1)(1992-3#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-2#5)(2007-3#1)
rat central nervous system (CNS)##2##5##(1991-12#1)(1993-11#1)
rat central nervous system and##2##5##(1993-11#1)(1995-5#1)
rat central nervous system##10##4##(1991-12#1)(1992-6#1)(1993-11#2)(1993-12#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-5#1)
rat central##11##2##(1991-12#1)(1992-6#1)(1993-11#2)(1993-12#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-5#1)
rat cerebellar cortex##4##3##(1994-2#2)(1995-2#1)(1995-8#1)
rat cerebellar granule cells##2##4##(1994-10#1)(1996-5#1)
rat cerebellar granule neurons##2##4##(1996-3#2)
rat cerebellar granule##5##3##(1994-10#1)(1996-3#2)(1996-5#2)
rat cerebellar membranes##3##3##(1992-3#1)(1992-6#1)(1996-2#1)
rat cerebellar##22##2##(1991-12#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-10#1)(1994-2#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-7#3)(1995-8#1)(1996-2#1)(1996-3#2)(1996-5#2)(1997-7#1)
rat cerebellum by##2##3##(1993-11#1)(1993-12#1)
rat cerebellum##14##2##(1990-2#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#3)(1993-11#3)(1993-12#1)(1995-2#1)(1996-12#1)
rat cerebral cortex and##3##4##(1996-12#2)(1997-2#1)
rat cerebral cortex was##3##4##(1991-12#1)(1992-12#1)(1996-5#1)
rat cerebral cortex##26##3##(1990-2#2)(1990-7#2)(1991-12#1)(1992-12#2)(1994-10#1)(1994-12#1)(1995-6#1)(1995-7#1)(1996-12#3)(1996-5#2)(1996-8#1)(1997-2#3)(1997-5#3)(1997-8#1)(2005-8#1)(2008-11#1)
rat cerebral cortical slices##3##4##(1994-12#1)(1995-12#2)
rat cerebral cortical##4##3##(1994-12#1)(1995-12#2)(1996-1#1)
rat cerebral##34##2##(1990-2#2)(1990-7#2)(1991-12#1)(1992-12#2)(1994-10#1)(1994-12#2)(1994-3#1)(1995-12#2)(1995-6#1)(1995-7#1)(1996-1#1)(1996-11#2)(1996-12#3)(1996-5#2)(1996-8#1)(1997-2#3)(1997-5#3)(1997-8#1)(2005-8#1)(2008-11#1)(2010-12#1)
rat cerebrocortical##3##2##(1990-2#1)(1996-10#1)(1997-1#1)
rat cerebrum##7##2##(1990-9#1)(1991-1#2)(1991-2#2)(1994-6#1)(1996-12#1)
rat chondrocyte##2##2##(1992-1#1)(1992-7#1)
rat chondrocytes##2##2##(1992-1#1)(1992-7#1)
rat choroid plexus##4##3##(1994-10#3)(2008-10#1)
rat chow##5##2##(2007-1#1)(2009-5#4)
rat chronic myocardial infarction model##2##5##(2012-12#2)
rat cingulate cortex##3##3##(1991-11#2)(1991-5#1)
rat cingulate##4##2##(1991-11#2)(1991-5#1)(1995-7#1)
rat closely##2##2##(1993-12#1)(2008-4#1)
rat collagen##4##2##(1990-11#2)(1991-11#1)(1995-12#1)
rat colon##11##2##(1991-12#1)(1993-9#1)(1995-1#2)(1996-5#1)(1997-4#5)(2008-10#1)
rat colonic particulate guanylate cyclase##3##5##(1994-9#3)
rat colonic##6##2##(1994-9#3)(1995-8#1)(1996-5#2)
rat connective##2##2##(1990-5#1)(1992-3#1)
rat corpus luteum##2##3##(1994-6#1)(2008-9#1)
rat corpus##4##2##(1992-7#1)(1994-6#1)(2008-9#1)(2009-5#1)
rat cortex##8##2##(1990-7#1)(1992-7#1)(1993-11#1)(1994-9#1)(1996-1#1)(1996-8#1)(2008-11#1)(2008-7#1)
rat cortical astrocytes##6##3##(1996-12#1)(1997-5#2)(1997-8#1)(2007-12#1)(2008-4#1)
rat cortical cultures with##2##4##(1993-12#2)
rat cortical cultures##3##3##(1993-12#2)(1995-12#1)
rat cortical membranes##4##3##(1990-5#1)(1994-11#2)(1996-2#1)
rat cortical neurons in##3##4##(1994-2#1)(1996-9#1)(2007-12#1)
rat cortical neurons##6##3##(1992-3#1)(1993-12#1)(1994-2#1)(1996-9#1)(2007-12#1)(2013-8#1)
rat cortical##22##2##(1990-4#1)(1990-5#1)(1992-3#1)(1993-12#3)(1994-11#2)(1994-2#1)(1995-12#2)(1996-12#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-5#2)(1997-8#1)(2007-12#2)(2008-4#1)(2013-8#1)
rat counterparts##2##2##(1991-12#1)(1993-5#1)
rat cranium##2##2##(2007-12#2)
rat cultures##3##2##(1996-2#3)
rat cytochrome P450##3##3##(1991-10#1)(1994-2#1)(1994-6#1)
rat cytochrome##4##2##(1991-10#1)(1991-2#1)(1994-2#1)(1994-6#1)
rat dams##5##2##(2012-12#2)(2012-3#3)
rat dentate gyrus##7##3##(1990-5#1)(1992-7#1)(1995-11#1)(1995-12#1)(1997-6#1)(1997-7#1)(2009-8#1)
rat diaphragm##4##2##(1994-8#1)(1995-3#1)(1996-12#2)
rat dorsal horn following##2##4##(1990-7#1)(1997-3#1)
rat dorsal horn##4##3##(1990-7#1)(1994-10#1)(1995-11#1)(1997-3#1)
rat dorsal root ganglia##7##4##(1990-4#1)(1990-7#1)(1996-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#1)
rat dorsal root ganglion (DRG) neurons##2##6##(1992-8#1)(1993-12#1)
rat dorsal root ganglion (DRG)##3##5##(1992-8#1)(1993-12#1)(1995-12#1)
rat dorsal root ganglion##4##4##(1992-8#2)(1993-12#1)(1995-12#1)
rat dorsal root##12##3##(1990-4#1)(1990-7#1)(1991-12#1)(1992-8#2)(1993-12#1)(1995-12#1)(1996-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#1)
rat dorsal##17##2##(1990-4#1)(1990-7#2)(1991-12#1)(1992-8#2)(1993-12#1)(1994-10#1)(1995-11#1)(1995-12#1)(1996-3#1)(1997-3#1)(1997-7#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#1)
rat duodenal##4##2##(1990-7#1)(1996-2#1)(1996-5#2)
rat duodenum##2##2##(1993-3#1)(1996-5#1)
rat embryo fibroblasts##3##3##(1991-10#1)(1993-8#2)
rat embryo##7##2##(1990-11#1)(1991-10#1)(1993-8#2)(1994-3#1)(1995-12#1)(2007-2#1)
rat embryonic development##3##3##(1994-10#1)(1997-8#2)
rat embryonic##7##2##(1994-10#1)(1994-12#1)(1997-6#1)(1997-8#2)(2008-11#1)(2012-1#1)
rat embryos##4##2##(1993-12#1)(2008-11#1)(2011-2#1)(2012-1#1)
rat enteropeptidase##2##2##(1996-2#2)
rat enzyme##3##2##(1991-8#1)(1993-12#1)(1996-8#1)
rat epidermal##2##2##(1990-11#1)(1992-11#1)
rat epididymal fat##2##3##(1992-11#1)(1993-6#1)
rat epididymal##3##2##(1990-10#1)(1992-11#1)(1993-6#1)
rat epiphyseal cartilage cells##2##4##(1990-11#2)
rat epiphyseal cartilage##3##3##(1990-11#3)
rat erythrocyte##4##2##(1990-2#3)(1991-5#1)
rat erythrocytes##5##2##(1990-2#1)(1991-7#1)(1992-1#1)(1993-3#1)(1994-3#1)
rat exposed to##2##3##(1997-3#1)(2013-1#1)
rat eye##8##2##(1992-6#1)(1997-2#2)(2008-11#3)(2008-4#2)
rat fat##3##2##(1990-11#1)(1996-7#1)(1997-1#1)
rat femoral##2##2##(1991-5#1)(2006-7#1)
rat fetal##5##2##(1992-3#1)(1994-3#1)(1995-7#1)(1997-7#2)
rat fetuses##3##2##(1993-12#1)(1995-11#1)(1996-3#1)
rat fibroblast cell line##2##4##(1996-9#1)(1997-1#1)
rat fibroblasts##8##2##(1990-6#1)(1991-1#1)(1991-11#1)(1995-5#1)(1997-1#1)(2006-9#1)(2012-1#2)
rat fibronectin##2##2##(1993-8#2)
rat focal cerebral##3##3##(1996-12#2)(2007-10#1)
rat following##6##2##(1992-9#1)(1995-12#1)(1996-1#2)(1996-7#1)(1997-3#1)
rat for##5##2##(1995-5#1)(1997-2#1)(2008-11#1)(2008-6#1)(2009-5#1)
rat forebrain##11##2##(1990-7#1)(1992-3#1)(1992-6#1)(1994-10#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-12#2)(1995-5#1)(1995-6#1)
rat from##3##2##(1995-11#1)(2008-5#2)
rat frontal cortex and hippocampus##2##5##(1990-2#1)(1994-6#1)
rat frontal cortex##7##3##(1990-2#2)(1994-6#1)(1995-12#1)(1996-6#2)(1997-1#1)
rat galanin##2##2##(1994-8#2)
rat galectin-5##2##2##(1997-2#2)
rat gastric##4##2##(1992-3#1)(1992-6#1)(1993-11#1)(1994-2#1)
rat gastrointestinal##3##2##(2008-5#1)(2013-1#2)
rat genes##2##2##(1993-3#1)(1997-5#1)
rat genome##7##2##(1991-1#1)(1991-6#1)(1992-3#1)(1993-8#1)(1996-10#1)(2007-9#1)(2008-4#1)
rat genomic DNA##5##3##(1990-12#1)(1991-1#1)(1991-5#1)(1991-9#1)(1993-12#1)
rat genomic library##8##3##(1991-9#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-12#1)
rat genomic##15##2##(1990-12#1)(1991-1#1)(1991-5#1)(1991-9#2)(1992-3#1)(1992-4#2)(1993-12#2)(1993-3#1)(1993-4#1)(1993-8#1)(1994-12#1)(2007-3#1)
rat glial##2##2##(1993-6#1)(1996-8#1)
rat glioma cell line##5##4##(1990-10#1)(1991-12#1)(1993-9#1)(1997-8#1)(2007-1#1)
rat glioma cells in##2##4##(1990-10#1)(2008-4#1)
rat glioma cells##3##3##(1990-10#1)(1997-8#1)(2008-4#1)
rat glioma hybrid cell line##2##5##(1993-6#1)(2008-4#1)
rat glioma##16##2##(1990-10#2)(1990-4#1)(1991-12#1)(1991-7#2)(1992-1#1)(1993-6#1)(1993-9#2)(1995-9#1)(1997-8#2)(2007-1#1)(2008-4#2)
rat glomerular mesangial cells##5##4##(1992-5#2)(1993-2#2)(1993-8#1)
rat glomeruli##2##2##(2007-9#2)
rat glucagon receptor##2##3##(1994-11#2)
rat growth hormone##4##3##(1990-12#1)(1990-8#1)(1996-8#2)
rat growth##5##2##(1990-12#1)(1990-2#1)(1990-8#1)(1996-8#2)
rat guanylin##3##2##(1994-12#2)(1994-9#1)
rat has an##2##3##(1994-2#1)(1994-5#1)
rat has##3##2##(1994-2#1)(1994-5#1)(1994-8#1)
rat have been examined##2##4##(1992-7#1)(2008-3#1)
rat have##4##2##(1991-3#1)(1992-7#1)(2008-3#1)(2008-4#1)
rat heart mitochondria was##2##4##(1992-1#1)(1992-11#1)
rat heart mitochondria##6##3##(1992-1#2)(1992-11#2)(1992-12#1)(1994-6#1)
rat heart model##4##3##(1991-1#1)(1995-3#1)(2010-7#1)(2011-1#1)
rat heart sarcolemma##2##3##(1990-7#2)
rat heart##58##2##(1990-10#1)(1990-5#2)(1990-7#4)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#5)(1991-12#1)(1991-2#2)(1991-8#1)(1991-9#2)(1992-1#2)(1992-11#4)(1992-12#1)(1992-7#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-9#1)(1997-5#2)(2007-9#2)(2008-12#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-7#1)(2011-1#1)(2013-1#1)(2013-7#1)
rat hearts were##3##3##(1994-12#2)(1996-5#1)
rat hearts##23##2##(1991-1#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-3#1)(1993-6#1)(1994-12#4)(1995-3#1)(1996-5#2)(1996-9#1)(2007-8#1)(2007-9#2)(2012-12#2)(2013-7#4)
rat heatstroke by reducing hypothalamic serotonin release##2##7##(1995-12#2)
rat hemopexin##2##2##(1992-5#2)
rat hepatic and##3##3##(1990-11#1)(2008-10#1)(2009-6#1)
rat hepatic lectin 1##2##4##(1994-12#2)
rat hepatic microsomal##3##3##(1991-8#1)(1992-11#1)(1996-4#1)
rat hepatic microsomes##4##3##(1994-6#1)(2011-1#3)
rat hepatic stellate##2##3##(2008-11#1)(2013-8#1)
rat hepatic##24##2##(1990-10#1)(1990-11#1)(1990-7#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-5#1)(1993-12#1)(1994-11#1)(1994-12#2)(1994-6#2)(1995-2#1)(1995-3#1)(1996-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#1)(2011-1#3)(2013-8#1)
rat hepatocyte cell lines##2##4##(2008-11#2)
rat hepatocyte cultures##7##3##(1991-10#1)(1993-3#1)(1994-12#2)(1997-3#1)(2008-4#2)
rat hepatocyte##16##2##(1991-10#2)(1991-12#1)(1993-3#2)(1993-5#1)(1994-12#2)(1994-8#2)(1997-3#1)(2008-11#3)(2008-4#2)
rat hepatocytes and##6##3##(1993-8#1)(1994-11#1)(1996-5#1)(2004-11#1)(2008-11#1)(2008-8#1)
rat hepatocytes as##4##3##(1991-6#1)(1991-7#1)(1994-5#1)(1995-8#1)
rat hepatocytes by##2##3##(1992-3#1)(1995-6#1)
rat hepatocytes in primary culture##2##5##(1991-10#1)(1992-5#1)
rat hepatocytes in##3##3##(1991-10#1)(1992-5#1)(1993-6#1)
rat hepatocytes is##3##3##(1990-3#1)(1990-5#1)(1993-12#1)
rat hepatocytes or##3##3##(1991-4#1)(1994-11#1)(1997-4#1)
rat hepatocytes was##2##3##(1992-3#1)(2008-9#1)
rat hepatocytes were##5##3##(1991-10#1)(1992-3#1)(1993-3#1)(1995-12#1)(2012-12#1)
rat hepatocytes##120##2##(1990-12#3)(1990-2#2)(1990-3#2)(1990-5#4)(1990-7#5)(1990-8#1)(1990-9#5)(1991-1#5)(1991-10#3)(1991-12#3)(1991-4#1)(1991-6#2)(1991-7#4)(1991-8#2)(1991-9#1)(1992-1#2)(1992-2#2)(1992-3#6)(1992-4#3)(1992-5#2)(1992-7#2)(1993-11#1)(1993-12#4)(1993-3#4)(1993-6#2)(1993-8#4)(1994-11#4)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-3#2)(1995-6#3)(1995-8#2)(1996-2#2)(1996-5#1)(1997-2#2)(1997-4#1)(2004-11#2)(2008-1#2)(2008-11#6)(2008-7#1)(2008-8#1)(2008-9#3)(2012-12#4)
rat hepatoma 3924A##2##3##(1990-5#2)
rat hepatoma cell line##3##4##(1991-12#1)(1991-7#1)(2008-11#1)
rat hepatoma cell##4##3##(1991-12#1)(1991-7#1)(1994-6#1)(2008-11#1)
rat hepatoma cells and##2##4##(1992-3#1)(1992-6#1)
rat hepatoma cells by##2##4##(1992-3#1)(2008-11#1)
rat hepatoma cells##12##3##(1990-10#1)(1991-10#1)(1992-10#1)(1992-3#3)(1992-6#1)(1993-3#1)(1994-11#1)(1994-12#1)(2008-11#2)
rat hepatoma##19##2##(1990-10#1)(1990-5#2)(1991-10#1)(1991-12#1)(1991-7#1)(1992-10#1)(1992-3#3)(1992-6#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-6#1)(2008-11#3)
rat hindlimb muscle membranes with##2##5##(1993-11#2)
rat hindlimb muscle##3##3##(1993-11#2)(1996-10#1)
rat hindlimb##6##2##(1993-11#3)(1994-2#1)(1996-10#2)
rat hippocampal CA1 neurons##5##4##(1990-12#1)(1995-3#2)(1995-6#1)(2005-8#1)
rat hippocampal CA1##11##3##(1990-12#1)(1995-3#2)(1995-6#1)(1996-5#1)(1997-1#2)(1997-2#2)(1997-5#1)(2005-8#1)
rat hippocampal and##2##3##(2008-4#2)
rat hippocampal astrocytes##3##3##(2008-4#1)(2008-8#2)
rat hippocampal mossy fiber##2##4##(1992-3#2)
rat hippocampal neurones##4##3##(1993-9#1)(1994-2#1)(1995-5#1)(1996-2#1)
rat hippocampal neurons##12##3##(1992-7#1)(1992-8#1)(1993-12#1)(1993-4#2)(1994-2#1)(1994-5#2)(1995-6#3)(2012-1#1)
rat hippocampal slice preparation##2##4##(1992-1#1)(1997-1#1)
rat hippocampal slice##7##3##(1990-4#1)(1991-9#2)(1992-1#1)(1994-2#1)(1996-6#1)(1997-1#1)
rat hippocampal slices##32##3##(1990-12#2)(1990-7#1)(1992-1#2)(1992-3#2)(1992-9#2)(1993-12#1)(1994-2#4)(1995-12#1)(1995-3#1)(1996-2#1)(1996-3#2)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-5#3)(1997-8#3)(2008-2#1)
rat hippocampal tissue##3##3##(1991-11#2)(1993-12#1)
rat hippocampal##88##2##(1990-12#3)(1990-2#1)(1990-4#1)(1990-7#1)(1991-11#2)(1991-9#2)(1992-1#3)(1992-3#4)(1992-7#2)(1992-8#2)(1992-9#2)(1993-12#3)(1993-2#1)(1993-4#2)(1993-9#1)(1994-11#2)(1994-2#7)(1994-5#2)(1995-12#2)(1995-3#3)(1995-5#1)(1995-6#5)(1996-1#2)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#2)(1997-1#4)(1997-2#3)(1997-5#4)(1997-6#1)(1997-8#3)(2005-8#1)(2008-2#1)(2008-4#3)(2008-7#1)(2008-8#2)(2012-1#1)
rat hippocampus following##2##3##(1994-11#1)(1995-7#1)
rat hippocampus in##2##3##(1994-11#1)(2008-7#1)
rat hippocampus was##3##3##(1990-5#1)(1993-2#1)(1995-5#1)
rat hippocampus##49##2##(1990-2#3)(1990-5#2)(1990-7#2)(1991-3#1)(1991-5#3)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-2#2)(1994-11#3)(1994-12#1)(1994-2#2)(1994-5#1)(1995-11#1)(1995-12#6)(1995-5#1)(1995-7#3)(1996-10#1)(1996-12#1)(1996-5#1)(1997-2#2)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#1)(2008-7#1)
rat homolog of##2##3##(1993-3#1)(1996-12#1)
rat homologue of##2##3##(1991-12#1)(1997-1#1)
rat homologue##3##2##(1991-12#1)(1997-1#1)(1997-7#1)
rat hypothalamic slices##3##3##(1990-2#1)(1992-3#2)
rat hypothalamic##8##2##(1990-2#1)(1992-3#2)(1995-1#1)(1995-10#1)(1995-7#1)(1996-11#2)
rat hypothalamus##18##2##(1990-7#1)(1991-4#2)(1991-8#1)(1992-12#2)(1993-12#1)(1994-8#1)(1995-1#4)(1995-11#2)(1995-12#1)(1996-11#1)(1996-9#2)
rat ileal brush border membrane##3##5##(1990-11#1)(1991-9#2)
rat ileal##6##2##(1990-11#1)(1991-6#2)(1991-9#2)(1992-3#1)
rat ileum during development##2##4##(1997-6#2)
rat ileum##8##2##(1993-11#3)(1997-4#1)(1997-6#3)(2007-1#1)
rat in##11##2##(1990-2#1)(1991-3#1)(1991-8#1)(1992-8#1)(1993-3#1)(1995-12#1)(1996-3#2)(2008-5#1)(2008-7#1)(2013-1#1)
rat indicated that##2##3##(1990-7#1)(1992-6#1)
rat inner medullary collecting duct##2##5##(1990-7#2)
rat insulin-like growth factor##3##4##(1992-6#1)(1993-3#1)(1994-9#1)
rat insulin-like growth##4##3##(1992-6#1)(1993-3#1)(1994-9#1)(1995-10#1)
rat intestinal mucin##3##3##(1991-12#3)
rat intestinal##16##2##(1991-12#3)(1992-9#1)(1993-8#1)(1994-8#2)(1995-2#1)(1996-10#1)(1996-4#1)(1997-8#1)(2008-11#1)(2008-4#1)(2010-2#1)(2011-1#1)(2011-3#1)
rat intestine##9##2##(1991-9#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-6#2)(1994-9#2)(2007-8#1)
rat is the##2##3##(1996-1#1)(2008-4#1)
rat is##16##2##(1991-12#1)(1992-3#1)(1994-3#1)(1994-8#2)(1994-9#1)(1996-1#1)(2007-8#1)(2007-9#1)(2008-4#2)(2008-8#1)(2008-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
rat islet isolation##2##3##(2008-11#2)
rat islet##6##2##(1992-1#1)(1992-4#1)(1993-4#1)(1993-8#1)(2008-11#2)
rat islets and##2##3##(1991-2#1)(1991-6#1)
rat islets of Langerhans##2##4##(1995-8#1)(1997-4#1)
rat islets##9##2##(1990-12#1)(1991-2#1)(1991-6#1)(1991-8#2)(1994-2#1)(1995-8#1)(1997-4#2)
rat isolated soleus muscle##2##4##(1992-8#2)
rat isolated##5##2##(1992-8#2)(1993-9#2)(1997-5#1)
rat jejunum##5##2##(1991-12#1)(1991-5#3)(1992-6#1)
rat kappa-opioid receptor##4##3##(1993-8#2)(1997-8#2)
rat kidney Na+##2##3##(1995-1#2)
rat kidney and##3##3##(1991-5#1)(1992-9#1)(1993-4#1)
rat kidney by##2##3##(1992-11#1)(2009-2#1)
rat kidney cDNA library##2##4##(1993-5#1)(1993-7#1)
rat kidney cDNA##3##3##(1992-5#1)(1993-5#1)(1993-7#1)
rat kidney cells##5##3##(1991-12#1)(1991-8#3)(1992-11#1)
rat kidney cortex##2##3##(1993-3#1)(1994-9#1)
rat kidney epithelial cells##3##4##(1991-8#2)(1993-3#1)
rat kidney were##2##3##(1991-3#1)(1995-11#1)
rat kidney with##2##3##(1992-6#1)(2010-12#1)
rat kidney##75##2##(1990-3#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#7)(1991-9#1)(1992-11#2)(1992-3#2)(1992-5#5)(1992-6#1)(1992-7#1)(1992-9#2)(1993-2#1)(1993-3#3)(1993-4#7)(1993-5#1)(1993-7#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#4)(1995-1#2)(1995-11#2)(1995-12#2)(1995-2#1)(1996-10#3)(1996-7#1)(1997-2#1)(1997-6#1)(1997-7#3)(2008-11#3)(2008-3#1)(2009-2#3)(2010-12#1)(2012-1#1)(2012-2#1)
rat kidneys##8##2##(1990-2#2)(1992-11#3)(1994-6#1)(1997-8#1)(2008-10#1)
rat knee joint##3##3##(1992-6#3)
rat lacrimal##2##2##(1990-5#2)
rat leukocyte##2##2##(1995-12#1)(2008-4#1)
rat light neurofilament##2##3##(1993-4#2)
rat limbic##2##2##(1993-11#1)(1994-10#1)
rat line##2##2##(1992-3#2)
rat lines##8##2##(1992-3#1)(1993-5#2)(1993-6#1)(1996-4#4)
rat liver DT-diaphorase##2##3##(1995-8#1)(1996-6#1)
rat liver HMG-CoA reductase##2##4##(1994-11#1)(1994-9#1)
rat liver P450##2##3##(1990-12#1)(1994-8#1)
rat liver S9##3##3##(2008-8#2)(2008-9#1)
rat liver after partial hepatectomy##3##5##(1991-4#1)(1991-5#1)(1997-8#1)
rat liver after##4##3##(1991-4#1)(1991-5#1)(1993-12#1)(1997-8#1)
rat liver and##17##3##(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#2)(1991-12#1)(1991-5#1)(1991-9#1)(1992-4#1)(1992-6#2)(1993-9#1)(1995-6#1)(2008-10#3)(2009-4#1)
rat liver are##2##3##(1991-12#1)(1992-4#1)
rat liver as##2##3##(1990-7#1)(1992-4#1)
rat liver at##2##3##(1997-8#1)(2008-8#1)
rat liver bilirubin UDP-glucuronosyltransferase##2##4##(1990-5#2)
rat liver by##6##3##(1991-1#1)(1993-8#1)(1994-6#1)(1994-8#2)(1995-2#1)
rat liver cDNA library in lambda gt11##2##7##(1994-5#1)(1994-6#1)
rat liver cDNA library##6##4##(1990-4#2)(1990-5#1)(1990-9#1)(1994-5#1)(1994-6#1)
rat liver canalicular##2##3##(1991-4#1)(1994-12#1)
rat liver cells and##2##4##(1991-7#1)(1993-6#1)
rat liver cells##14##3##(1990-12#2)(1991-7#2)(1993-6#1)(1994-6#3)(1995-1#1)(1995-6#1)(2008-8#3)(2012-1#1)
rat liver cysteine dioxygenase##4##4##(1990-4#4)
rat liver cytosol##11##3##(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#1)(1994-5#2)(1996-5#1)(2010-10#2)
rat liver cytosolic##5##3##(1991-4#1)(1991-8#1)(1993-8#2)(1995-2#1)
rat liver during##2##3##(1990-3#1)(1992-1#1)
rat liver enzyme##5##3##(1991-1#1)(1991-4#1)(1992-2#1)(1993-5#1)(1995-6#1)
rat liver epithelial##2##3##(1992-11#1)(1993-7#1)
rat liver extracts##2##3##(1990-2#1)(1993-12#1)
rat liver glucocorticoid receptor##2##4##(1994-3#2)
rat liver glucokinase##3##3##(1990-11#1)(1990-7#2)
rat liver glycogen##2##3##(1991-12#1)(1993-8#1)
rat liver homogenate##3##3##(1994-8#1)(2008-11#2)
rat liver in vivo##2##4##(1990-8#1)(1992-4#1)
rat liver is described##3##4##(1990-12#1)(1996-5#1)(2008-10#1)
rat liver is##4##3##(1990-12#1)(1991-6#1)(1996-5#1)(2008-10#1)
rat liver lambda gt11##2##4##(1991-12#1)(1992-2#1)
rat liver lysosomal cathepsin D##2##5##(1991-8#2)
rat liver lysosomal##4##3##(1990-10#1)(1991-7#1)(1991-8#2)
rat liver macrophages##3##3##(1992-3#3)
rat liver membranes##5##3##(1990-8#1)(1991-4#1)(1994-3#2)(1996-12#1)
rat liver microsomal cytochrome P-450##2##5##(1990-4#1)(1991-11#1)
rat liver microsomal fatty acid##2##5##(1991-2#2)
rat liver microsomal##9##3##(1990-4#1)(1991-11#1)(1991-2#2)(1993-11#1)(1994-8#1)(1994-9#1)(1995-7#2)
rat liver microsomes and##3##4##(1991-4#1)(1991-7#1)(1997-8#1)
rat liver microsomes but##2##4##(1994-8#2)
rat liver microsomes by##2##4##(1990-12#1)(1994-8#1)
rat liver microsomes containing##2##4##(1994-8#2)
rat liver microsomes in the presence of NADPH##2##8##(1990-12#1)(1991-5#1)
rat liver microsomes in the presence of##3##7##(1990-12#1)(1991-5#1)(1995-6#1)
rat liver microsomes is##3##4##(1991-11#1)(1991-7#1)(1991-9#1)
rat liver microsomes to##3##4##(1990-11#1)(1991-7#1)(1996-2#1)
rat liver microsomes were##2##4##(1991-2#1)(2011-3#1)
rat liver microsomes##46##3##(1990-11#2)(1990-12#2)(1990-2#3)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#3)(1991-7#6)(1991-9#1)(1992-1#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-4#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-3#1)(1994-8#7)(1995-6#1)(1996-11#1)(1996-2#1)(1997-8#1)(2011-3#2)
rat liver mitochondria and##2##4##(1990-2#1)(1994-12#1)
rat liver mitochondria in the presence of##3##7##(1991-5#1)(1992-4#1)(1994-8#1)
rat liver mitochondria##23##3##(1990-2#1)(1990-9#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-7#1)(1992-1#2)(1992-4#2)(1994-11#1)(1994-12#4)(1994-8#2)(1995-12#1)(1996-9#1)(1997-2#1)(2005-8#1)(2013-1#1)
rat liver mitochondrial##7##3##(1990-10#1)(1991-2#1)(1991-7#1)(1992-2#1)(1994-11#1)(1995-2#2)
rat liver monoamine##2##3##(1993-4#1)(1994-8#1)
rat liver non-specific lipid transfer protein##2##6##(1990-4#2)
rat liver nuclear##2##3##(1995-1#1)(1995-2#1)
rat liver nuclei##3##3##(1990-4#1)(1992-7#2)
rat liver plasma membrane##2##4##(1990-9#1)(1993-4#1)
rat liver plasma membranes##5##4##(1992-7#2)(1995-8#3)
rat liver plasma##7##3##(1990-9#1)(1992-7#2)(1993-4#1)(1995-8#3)
rat liver proteins##2##3##(1991-10#1)(1993-6#1)
rat liver revealed##2##3##(1993-6#2)
rat liver showed##3##3##(1993-4#1)(1994-11#1)(1995-7#1)
rat liver tissues##2##3##(1993-12#1)(2011-2#1)
rat liver uricase##3##3##(1990-11#1)(1992-8#2)
rat liver vitamin##3##3##(1990-5#1)(1991-5#1)(2011-2#1)
rat liver was##7##3##(1991-3#1)(1991-5#1)(1992-6#1)(1994-11#1)(1995-1#1)(1996-12#1)(2009-8#1)
rat liver##440##2##(1990-10#4)(1990-11#8)(1990-12#8)(1990-2#10)(1990-3#7)(1990-4#11)(1990-5#13)(1990-6#1)(1990-7#7)(1990-8#6)(1990-9#4)(1991-1#5)(1991-10#6)(1991-11#2)(1991-12#10)(1991-2#9)(1991-3#6)(1991-4#8)(1991-5#10)(1991-6#4)(1991-7#16)(1991-8#4)(1991-9#3)(1992-1#4)(1992-10#2)(1992-11#5)(1992-12#3)(1992-2#10)(1992-3#3)(1992-4#10)(1992-5#2)(1992-6#7)(1992-7#7)(1992-8#9)(1993-11#2)(1993-12#8)(1993-2#4)(1993-3#3)(1993-4#6)(1993-5#2)(1993-6#6)(1993-7#2)(1993-8#10)(1993-9#5)(1994-11#8)(1994-12#7)(1994-3#11)(1994-5#6)(1994-6#12)(1994-8#22)(1994-9#7)(1995-1#5)(1995-12#3)(1995-2#6)(1995-5#1)(1995-6#6)(1995-7#3)(1995-8#5)(1995-9#1)(1996-11#3)(1996-12#3)(1996-2#1)(1996-4#1)(1996-5#5)(1996-6#1)(1996-9#1)(1997-2#2)(1997-7#2)(1997-8#3)(2005-8#2)(2006-2#1)(2007-1#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-2#1)(2008-4#4)(2008-8#7)(2008-9#1)(2009-11#1)(2009-4#2)(2009-8#2)(2010-10#2)(2011-2#2)(2011-3#2)(2012-1#1)(2013-1#1)
rat livers##8##2##(1990-11#1)(1991-3#2)(1991-4#1)(1995-1#3)(2008-8#1)
rat long bones##2##3##(1993-9#1)(2008-11#1)
rat long##3##2##(1992-8#1)(1993-9#1)(2008-11#1)
rat lumbar dorsal##2##3##(1991-8#1)(2008-4#1)
rat lumbosacral spinal cord##2##4##(1991-5#1)(1995-4#1)
rat lung and##2##3##(1997-5#1)(2009-3#1)
rat lung##23##2##(1990-7#1)(1990-9#3)(1991-1#1)(1991-2#2)(1991-5#1)(1993-3#1)(1994-11#1)(1995-2#3)(1995-3#1)(1995-8#2)(1997-5#5)(2009-2#1)(2009-3#1)
rat lungs##6##2##(1994-3#1)(1994-5#1)(2007-8#2)(2008-12#2)
rat luteal##2##2##(1994-6#1)(1997-1#1)
rat lymphoma##3##2##(1992-2#1)(1997-6#2)
rat macrophages##3##2##(2008-10#3)
rat major##2##2##(1992-8#1)(2009-9#1)
rat males##2##2##(2013-7#2)
rat malignant fibrous histiocytoma##2##4##(2008-11#1)(2012-1#1)
rat mammary carcinoma##2##3##(1990-5#2)
rat mammary cells##4##3##(1990-5#1)(1995-11#3)
rat mammary gland##4##3##(1990-5#1)(1993-2#1)(1995-11#1)(1995-2#1)
rat mammary tumor##3##3##(1993-11#1)(1995-8#1)(1997-4#1)
rat mammary tumors##2##3##(1993-1#1)(1995-9#1)
rat mammary##21##2##(1990-5#5)(1993-1#1)(1993-11#2)(1993-2#2)(1993-7#1)(1995-11#5)(1995-2#1)(1995-8#1)(1995-9#1)(1997-4#1)(2008-10#1)
rat mandible##3##2##(2008-7#3)
rat mast cell##2##3##(1992-12#1)(1993-3#1)
rat mast cells##2##3##(1991-2#1)(1997-2#1)
rat mast##4##2##(1991-2#1)(1992-12#1)(1993-3#1)(1997-2#1)
rat may be##4##3##(1990-5#1)(1994-8#1)(1994-9#1)(2013-8#1)
rat may##7##2##(1990-5#1)(1991-9#1)(1993-5#1)(1994-8#1)(1994-9#1)(1996-7#1)(2013-8#1)
rat medial frontal cortex##3##4##(1996-9#3)
rat medial##6##2##(1996-9#3)(1997-2#1)(1997-7#1)(2013-8#1)
rat mesangial cells##12##3##(1990-2#1)(1991-10#2)(1992-6#1)(1993-6#1)(1993-8#1)(1994-12#4)(1994-2#1)(1995-11#1)
rat mesangial##13##2##(1990-2#1)(1991-10#2)(1992-6#1)(1993-6#1)(1993-8#1)(1994-12#4)(1994-2#1)(1995-11#1)(2011-2#1)
rat mesencephalon##2##2##(1995-12#1)(1996-10#1)
rat mesenteric artery##2##3##(1991-6#2)
rat mesenteric##4##2##(1990-6#1)(1991-10#1)(1991-6#2)
rat mesentery##4##2##(1990-10#1)(1993-11#2)(2008-11#1)
rat mesentery-derived mesothelial-cell (M-cell)##2##4##(2008-11#2)
rat mesentery-derived##3##2##(2008-11#3)
rat microglia##2##2##(2008-4#1)(2008-8#1)
rat midbrain dopamine##2##3##(1990-7#2)
rat midbrain periaqueductal grey##2##4##(1992-8#1)(1997-5#1)
rat midbrain##7##2##(1990-7#2)(1992-8#1)(1996-1#1)(1997-1#1)(1997-5#1)(2013-1#1)
rat mitochondria##2##2##(1990-5#1)(1994-11#1)
rat mitochondrial##3##2##(1993-4#1)(1994-10#2)
rat model by##2##3##(2008-7#1)(2012-2#1)
rat model for##2##3##(1991-11#1)(1994-3#1)
rat model of Parkinson's disease##5##5##(1993-4#1)(1995-12#1)(1996-5#1)(1996-9#1)(2008-12#1)
rat model of acute renal failure induced by uranyl nitrate##2##10##(2008-8#2)
rat model of acute##4##4##(1993-11#1)(2007-11#1)(2008-8#2)
rat model of##51##3##(1990-5#1)(1991-9#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-4#1)(1994-6#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-7#1)(1996-5#4)(1996-9#1)(1997-2#1)(1997-8#1)(2004-12#3)(2006-8#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#5)(2009-12#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#2)(2011-2#5)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)
rat model was##3##3##(1995-2#1)(1996-11#1)(2011-3#1)
rat model##92##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-9#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-4#5)(1994-3#1)(1994-6#2)(1994-8#1)(1995-12#4)(1995-2#3)(1995-6#1)(1995-7#1)(1996-11#1)(1996-5#4)(1996-9#1)(1997-1#1)(1997-2#2)(1997-8#1)(2004-12#3)(2006-8#1)(2007-1#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#3)(2008-7#1)(2008-8#5)(2008-9#1)(2009-12#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#2)(2011-2#6)(2011-3#1)(2012-12#4)(2012-2#8)(2012-3#2)(2013-1#3)(2013-8#1)
rat models of parkinsonism and##2##5##(1997-2#2)
rat models of##6##3##(1993-8#1)(1997-2#3)(2007-11#1)(2008-1#1)
rat models##14##2##(1992-9#2)(1993-4#1)(1993-8#1)(1997-2#3)(1997-5#1)(2007-1#1)(2007-11#2)(2008-1#1)(2009-4#2)
rat monoclonal##2##2##(1992-8#1)(1994-6#1)
rat motor activity##3##3##(1993-2#3)
rat motor##5##2##(1990-5#1)(1993-2#3)(2013-8#1)
rat mu opioid##2##3##(1995-12#1)(1995-6#1)
rat mu##3##2##(1995-12#1)(1995-6#1)(1997-2#1)
rat mucin##2##2##(1991-12#1)(1993-8#1)
rat mucosal mast cell##2##4##(1990-5#1)(1997-2#1)
rat mucosal##3##2##(1990-5#1)(1997-2#1)(2008-10#1)
rat muscle##7##2##(1990-10#1)(1990-5#1)(1991-5#1)(1993-11#1)(2005-8#1)(2008-8#1)(2008-9#1)
rat muscles##3##2##(1990-10#2)(1995-9#1)
rat myoblasts##3##2##(1990-12#2)(1997-1#1)
rat myocardial cell culture system##2##5##(1992-3#2)
rat myocardial##4##2##(1992-3#2)(2008-12#1)(2011-2#1)
rat myocardium##3##2##(1996-12#1)(2010-6#2)
rat myometrial##2##2##(1990-3#1)(1991-1#1)
rat myometrium##2##2##(1990-3#1)(1991-1#1)
rat neocortex##8##2##(1991-3#1)(1991-9#1)(1995-10#1)(1995-6#1)(1996-1#1)(2008-11#3)
rat neocortical##4##2##(1992-8#1)(1995-6#1)(1996-1#2)
rat neonatal##2##2##(1994-6#1)(1996-3#1)
rat neostriatal##2##2##(1993-3#1)(1996-1#1)
rat neostriatum##3##2##(1992-3#2)(2012-1#1)
rat nerve##2##2##(1993-5#1)(2011-2#1)
rat nervous system##4##3##(1990-8#1)(1994-12#1)(1996-4#1)(1996-8#1)
rat neuronal cell##6##3##(1993-6#2)(1995-12#1)(2008-11#3)
rat neuronal cells##2##3##(1993-6#1)(1994-12#1)
rat neuronal##12##2##(1993-6#3)(1994-12#1)(1995-12#1)(1995-8#1)(1996-9#1)(2008-11#3)(2008-9#1)(2010-12#1)
rat neurones##2##2##(1995-12#1)(1996-1#1)
rat neurons and##3##3##(1990-7#1)(1994-5#1)(2010-12#1)
rat neurons##10##2##(1990-7#1)(1994-5#3)(1997-8#1)(2008-11#3)(2010-12#1)(2012-2#1)
rat neutrophil##2##2##(1993-4#1)(2008-10#1)
rat nuclear##3##2##(1992-4#1)(1993-11#2)
rat of##3##2##(1990-7#1)(1992-8#2)
rat offspring##2##2##(2013-1#2)
rat offsprings##2##2##(2013-8#2)
rat olfactory bulb membranes and synaptosomes##2##6##(1995-5#2)
rat olfactory bulb##13##3##(1990-2#2)(1990-7#1)(1992-3#2)(1993-7#2)(1995-5#4)(1996-3#1)(1996-7#1)
rat olfactory system##3##3##(1991-11#2)(1997-3#1)
rat olfactory##20##2##(1990-2#2)(1990-7#1)(1991-11#2)(1991-2#2)(1992-3#2)(1993-7#2)(1995-5#4)(1996-10#1)(1996-3#1)(1996-7#1)(1997-3#2)
rat optic nerve##5##3##(1990-7#1)(1992-2#1)(1994-2#2)(1995-11#1)
rat or hamster liver S9##2##5##(2008-9#2)
rat or human##3##3##(1990-2#1)(1994-2#1)(2012-12#1)
rat or mouse##3##3##(1992-7#1)(2008-4#2)
rat or rabbit##2##3##(1992-6#1)(1995-11#1)
rat or##12##2##(1990-2#1)(1992-6#1)(1992-7#1)(1992-9#1)(1994-2#1)(1995-11#1)(1996-12#1)(2008-4#2)(2008-9#2)(2012-12#1)
rat organs##2##2##(1991-5#1)(1992-12#1)
rat osteoclasts##6##2##(1990-6#1)(1991-8#3)(1992-3#1)(1993-9#1)
rat osteosarcoma cells##3##3##(1994-9#1)(1995-3#1)(1996-11#1)
rat osteosarcoma##5##2##(1990-9#1)(1991-3#1)(1994-9#1)(1995-3#1)(1996-11#1)
rat ovarian##6##2##(1990-4#1)(1992-2#1)(1994-6#1)(1995-8#1)(1996-8#1)(2008-9#1)
rat ovaries##3##2##(1990-4#1)(1995-10#1)(2010-10#1)
rat ovary##15##2##(1990-10#2)(1990-4#2)(1992-3#1)(1993-4#1)(1994-5#2)(1996-8#2)(1997-1#1)(2008-12#1)(2008-5#1)(2008-9#2)
rat oxytocin##2##2##(1991-2#1)(1995-10#1)
rat pancreas and##2##3##(1990-3#1)(1995-11#1)
rat pancreas##17##2##(1990-12#2)(1990-3#2)(1991-1#2)(1992-1#1)(1992-2#1)(1992-6#1)(1992-8#2)(1993-6#1)(1994-9#1)(1995-11#2)(1996-5#1)(1997-1#1)
rat pancreatic acinar cells##4##4##(1991-10#1)(1991-5#1)(1993-6#1)(2006-10#1)
rat pancreatic acini##10##3##(1990-3#1)(1991-1#1)(1991-5#2)(1991-7#1)(1991-8#2)(1992-12#1)(1994-2#1)(1995-11#1)
rat pancreatic islet##3##3##(1992-1#1)(1992-4#1)(2008-11#1)
rat pancreatic islets##10##3##(1990-12#1)(1991-6#1)(1992-11#1)(1994-12#1)(1995-8#1)(1996-5#1)(1996-6#2)(2008-11#1)(2010-12#1)
rat pancreatic##32##2##(1990-12#1)(1990-2#1)(1990-3#2)(1991-1#1)(1991-10#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-4#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-8#1)(1996-5#1)(1996-6#2)(1997-5#1)(2006-10#2)(2008-11#2)(2010-12#1)
rat parietal cells##3##3##(1992-3#2)(1993-9#1)
rat parietal##4##2##(1991-10#1)(1992-3#2)(1993-9#1)
rat parotid acinar cells##7##4##(1991-8#2)(1992-3#2)(1996-5#3)
rat parotid gland acinar cells##2##5##(1993-4#2)
rat parotid##12##2##(1991-3#3)(1991-8#2)(1992-3#2)(1993-4#2)(1996-5#3)
rat paw edema##3##3##(2007-1#1)(2010-2#1)(2011-1#1)
rat paw##6##2##(1995-12#1)(2007-1#1)(2010-2#1)(2011-1#1)(2013-7#2)
rat penis##2##2##(1992-8#2)
rat peripheral nerve##2##3##(1997-2#2)
rat peripheral##7##2##(1990-12#2)(1991-12#1)(1995-5#2)(1997-2#2)
rat peritoneal macrophages##4##3##(1992-11#2)(2008-10#1)(2008-11#1)
rat peritoneal mast cells##7##4##(1991-12#2)(1991-2#1)(1992-3#1)(1995-11#1)(1997-2#1)(2008-10#1)
rat peritoneal mast##8##3##(1991-12#2)(1991-2#1)(1992-3#1)(1995-11#1)(1997-2#1)(2008-10#1)(2010-12#1)
rat peritoneal##16##2##(1991-12#2)(1991-2#1)(1992-11#2)(1992-3#1)(1992-7#2)(1995-11#1)(1996-5#1)(1997-2#1)(2008-10#2)(2008-11#2)(2010-12#1)
rat peritoneum##2##2##(1996-5#1)(1997-2#1)
rat pheochromocytoma (PC12) cells##2##4##(2008-4#1)(2013-8#1)
rat pheochromocytoma PC-12 cells##2##4##(1990-2#1)(1995-3#1)
rat pheochromocytoma PC12 cells##4##4##(1992-11#2)(1997-2#1)(2008-10#1)
rat pheochromocytoma cell line PC12##4##5##(1990-5#1)(1997-8#1)(2008-11#2)
rat pheochromocytoma cell line##9##4##(1990-5#1)(1993-8#1)(1994-11#1)(1995-12#1)(1997-2#1)(1997-8#1)(2005-8#1)(2008-11#2)
rat pheochromocytoma cells##5##3##(1992-8#2)(2008-4#1)(2010-8#1)(2013-8#1)
rat pheochromocytoma##22##2##(1990-2#1)(1990-5#1)(1992-11#2)(1992-8#2)(1993-8#1)(1994-11#1)(1995-12#1)(1995-3#1)(1997-2#2)(1997-8#1)(2005-8#1)(2008-10#1)(2008-11#2)(2008-4#2)(2010-8#1)(2013-8#2)
rat pineal gland and##2##4##(2008-10#2)
rat pineal gland##4##3##(1994-9#2)(2008-10#2)
rat pituitary adenylate cyclase activating polypeptide (PACAP)##2##7##(1990-12#2)
rat pituitary and##3##3##(1992-12#1)(1993-3#2)
rat pituitary cell##4##3##(1990-7#1)(1990-8#1)(1992-9#1)(1995-10#1)
rat pituitary cells##11##3##(1990-3#1)(1990-9#1)(1991-2#1)(1991-6#1)(1992-6#3)(1994-3#1)(1994-9#1)(1996-2#1)(1997-2#1)
rat pituitary gland##6##3##(1990-10#1)(1992-6#1)(1992-7#1)(1993-3#1)(1995-11#2)
rat pituitary glands##2##3##(1992-7#1)(2008-5#1)
rat pituitary intermediate lobe##3##4##(1991-9#2)(1993-5#1)
rat pituitary lactotropes##2##3##(1993-11#2)
rat pituitary tumor cells##2##4##(1991-7#1)(1995-10#1)
rat pituitary tumor##3##3##(1991-7#2)(1995-10#1)
rat pituitary tumoral##2##3##(1992-2#2)
rat pituitary##54##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#3)(1992-12#6)(1992-2#2)(1992-6#5)(1992-7#2)(1992-9#1)(1993-11#2)(1993-3#4)(1993-5#1)(1994-12#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-10#2)(1995-11#2)(1996-2#1)(1997-2#1)(2008-5#1)
rat placenta##3##2##(1995-12#2)(2008-10#1)
rat plasma and##7##3##(1990-11#1)(1990-6#3)(1990-7#2)(1991-5#1)
rat plasma in vitro##2##4##(1991-3#1)(1995-5#1)
rat plasma##32##2##(1990-11#1)(1990-12#2)(1990-6#3)(1990-7#2)(1990-8#1)(1991-3#3)(1991-5#1)(1993-11#1)(1995-5#1)(1996-6#1)(1996-8#1)(1997-2#3)(1997-8#3)(2008-10#4)(2008-6#1)(2010-6#1)(2011-2#2)(2013-1#1)
rat platelet cAMP##3##3##(1992-9#1)(1993-3#2)
rat platelet##4##2##(1992-9#1)(1993-3#2)(1994-11#1)
rat platelets##7##2##(1990-8#2)(1992-9#2)(1993-8#2)(1995-6#1)
rat poison##2##2##(2011-2#2)
rat portal vein##2##3##(1991-4#1)(1993-11#1)
rat posterior##3##2##(1991-5#1)(1992-8#2)
rat preproendothelin-1##2##2##(1991-2#2)
rat primary cortical##3##3##(1995-5#1)(2008-4#2)
rat primary hepatocytes and##2##4##(1995-3#1)(2008-11#1)
rat primary hepatocytes##4##3##(1995-3#2)(2008-11#2)
rat primary##16##2##(1990-5#1)(1991-11#1)(1995-12#1)(1995-3#2)(1995-5#2)(1996-1#1)(1997-4#1)(2008-11#4)(2008-4#2)(2011-2#1)
rat prolactin##5##2##(1994-11#3)(1995-11#1)(2008-4#1)
rat prostacyclin receptor##3##3##(1994-12#3)
rat prostate testosterone 5α-reductase##4##4##(2012-12#4)
rat prostate##8##2##(1991-10#1)(1991-5#1)(1993-8#1)(1995-8#1)(2012-12#4)
rat prostatic##2##2##(1993-8#1)(1995-6#1)
rat protein##2##2##(1990-9#1)(1992-10#1)
rat pulmonary artery##5##3##(1990-5#2)(1991-9#1)(1993-6#1)(2011-3#1)
rat pulmonary veins##2##3##(2013-1#2)
rat pulmonary##7##2##(1990-5#2)(1991-9#1)(1993-6#1)(2011-3#1)(2013-1#2)
rat pups and##2##3##(1992-8#1)(1994-3#1)
rat pups compared##2##3##(2008-10#1)(2008-7#1)
rat pups were##3##3##(1990-5#1)(1992-10#1)(1996-12#1)
rat pups##18##2##(1990-5#1)(1991-2#1)(1992-10#2)(1992-3#1)(1992-8#1)(1994-3#1)(1995-12#1)(1996-12#1)(2005-8#1)(2008-10#3)(2008-7#2)(2012-1#3)
rat pyruvate kinase##2##3##(1990-8#2)
rat receptor##2##2##(1991-12#1)(1992-9#1)
rat receptors##2##2##(1996-5#1)(2008-4#1)
rat renal anemia##2##3##(2008-8#2)
rat renal brush-border membrane##3##4##(1990-4#2)(1991-2#1)
rat renal brush-border##4##3##(1990-11#1)(1990-4#2)(1991-2#1)
rat renal cortex##2##3##(1994-3#1)(1995-1#1)
rat renal cortical##2##3##(1990-11#1)(1994-3#1)
rat renal inner medullary collecting duct cells##2##7##(1990-7#2)
rat renal inner medullary##3##4##(1990-7#2)(1992-5#1)
rat renal inner##4##3##(1990-7#2)(1992-5#2)
rat renal##29##2##(1990-11#4)(1990-2#2)(1990-4#2)(1990-7#2)(1991-10#2)(1991-2#2)(1991-7#1)(1992-5#2)(1993-3#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1997-1#2)(2008-8#2)(2009-3#1)
rat results in##3##3##(1991-5#1)(1996-10#2)
rat retina##2##2##(1996-2#1)(2008-7#1)
rat retinal explants##3##3##(1996-5#3)
rat retinal##9##2##(1996-1#2)(1996-3#1)(1996-5#5)(2012-3#1)
rat retinas##2##2##(1994-5#1)(1996-6#1)
rat ribosomal protein##7##3##(1992-5#1)(1992-8#1)(1993-4#3)(1994-5#2)
rat ribosomal##8##2##(1992-5#1)(1992-8#1)(1993-3#1)(1993-4#3)(1994-5#2)
rat sciatic nerve##2##3##(1991-9#1)(1996-2#1)
rat sciatic##3##2##(1991-9#1)(1996-2#1)(2008-7#1)
rat sensory neurons##3##3##(1990-7#1)(1995-12#1)(1995-2#1)
rat sensory##4##2##(1990-7#1)(1995-12#1)(1995-2#1)(1996-10#1)
rat sequence##4##2##(1991-9#1)(1996-10#1)(1997-5#1)(2008-7#1)
rat sera##4##2##(2008-10#1)(2008-11#3)
rat serum and##3##3##(1990-4#1)(1994-6#1)(2012-12#1)
rat serum##14##2##(1990-4#2)(1991-12#1)(1994-11#3)(1994-6#1)(1996-6#1)(1997-2#1)(1997-8#1)(2008-11#2)(2012-12#2)
rat sexual behavior##8##3##(1991-2#6)(1995-6#1)(1997-5#1)
rat showed##2##2##(1991-4#1)(1994-2#1)
rat single-pass intestinal perfusion##2##4##(2011-3#2)
rat skeletal muscle extensor digitorum longus##2##6##(2008-9#2)
rat skeletal muscle tissue under two-photon excitation##2##7##(2008-2#2)
rat skeletal muscle tissue##3##4##(2008-2#2)(2009-10#1)
rat skeletal muscle to##2##4##(1991-12#1)(1995-8#1)
rat skeletal muscle##35##3##(1990-10#1)(1990-2#2)(1991-12#4)(1991-2#1)(1991-5#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-8#2)(1995-9#2)(1996-3#2)(1997-1#1)(1997-7#1)(2008-10#1)(2008-2#2)(2008-8#2)(2008-9#2)(2009-10#1)(2011-2#1)
rat skeletal##37##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1991-12#4)(1991-2#1)(1991-5#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-8#2)(1995-9#2)(1996-3#2)(1997-1#1)(1997-7#1)(2008-10#1)(2008-2#2)(2008-8#2)(2008-9#2)(2009-10#1)(2011-2#1)
rat skin##10##2##(1992-3#1)(1992-6#2)(1996-5#1)(2005-10#1)(2007-2#1)(2009-7#1)(2010-12#1)(2010-2#1)(2012-12#1)
rat small intestinal##3##3##(1994-3#1)(1996-3#1)(2008-4#1)
rat small intestine##9##3##(1990-12#2)(1991-12#2)(1994-3#2)(1995-11#1)(1996-11#1)(1997-6#1)
rat small##12##2##(1990-12#2)(1991-12#2)(1994-3#3)(1995-11#1)(1996-11#1)(1996-3#1)(1997-6#1)(2008-4#1)
rat soleus muscle##3##3##(1991-12#1)(1995-12#1)(1995-9#1)
rat soleus##6##2##(1991-12#1)(1991-2#1)(1995-12#1)(1995-9#1)(1996-10#1)(1996-8#1)
rat somatosensory cortex##4##3##(1991-3#1)(1995-12#2)(1997-3#1)
rat somatosensory##6##2##(1991-3#1)(1995-12#2)(1997-3#1)(1997-5#1)(2008-1#1)
rat spatial memory##2##3##(1997-4#1)(2009-11#1)
rat sperm##2##2##(1994-6#1)(1995-6#1)
rat spermatozoa##3##2##(1993-9#2)(2012-2#1)
rat spinal cord in vitro##3##5##(1992-6#1)(1994-2#2)
rat spinal cord in##4##4##(1992-6#1)(1994-2#2)(2008-11#1)
rat spinal cord is##2##4##(1991-9#1)(1992-11#1)
rat spinal cord was investigated##2##5##(1991-5#1)(1992-9#1)
rat spinal cord was##3##4##(1991-5#1)(1992-9#1)(1994-10#1)
rat spinal cord##45##3##(1990-7#2)(1991-11#2)(1991-5#3)(1991-9#2)(1992-11#1)(1992-6#1)(1992-8#3)(1992-9#2)(1993-11#2)(1993-12#1)(1993-5#1)(1994-10#2)(1994-2#5)(1994-3#1)(1995-12#3)(1995-3#3)(1995-5#1)(1995-7#2)(1996-12#1)(1996-5#2)(1996-8#1)(1997-7#1)(1997-8#1)(2008-11#2)
rat spinal motor neurones##2##4##(1992-8#2)
rat spinal##54##2##(1990-7#2)(1991-11#2)(1991-5#4)(1991-9#2)(1992-11#1)(1992-6#2)(1992-8#5)(1992-9#2)(1993-11#2)(1993-12#1)(1993-5#1)(1994-10#2)(1994-2#7)(1994-3#1)(1995-12#3)(1995-3#4)(1995-5#1)(1995-7#2)(1996-12#1)(1996-5#2)(1996-8#1)(1997-7#1)(1997-8#1)(2006-11#1)(2008-11#2)(2008-4#1)
rat spleen or lymph##2##4##(1992-8#2)
rat spleen##8##2##(1990-9#1)(1991-10#1)(1992-8#2)(1993-4#1)(1993-7#2)(2008-11#1)
rat splenic##3##2##(1991-10#1)(1995-12#2)
rat splenocytes##2##2##(2004-12#1)(2008-11#1)
rat stomach##14##2##(1991-5#1)(1992-2#1)(1992-6#1)(1993-11#2)(1994-5#1)(1995-5#1)(1996-12#3)(1997-4#2)(1997-7#1)(2012-12#1)
rat strain##7##2##(1992-9#1)(1994-11#1)(1995-2#1)(2006-6#2)(2008-4#1)(2009-11#1)
rat strains##11##2##(1992-2#2)(1993-12#1)(1993-3#1)(1997-2#1)(2008-11#1)(2008-4#3)(2012-3#2)
rat striatal membranes and##2##4##(1990-7#1)(1996-5#1)
rat striatal membranes##5##3##(1990-7#1)(1995-11#1)(1995-7#2)(1996-5#1)
rat striatal slices##5##3##(1991-6#1)(1993-12#1)(1995-12#2)(2008-5#1)
rat striatal##13##2##(1990-7#1)(1991-6#1)(1993-12#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-7#2)(1996-2#1)(1996-5#1)(2008-5#1)
rat striatum after##2##3##(1992-3#1)(1996-10#1)
rat striatum##39##2##(1990-7#1)(1991-1#1)(1991-5#1)(1992-3#1)(1993-3#1)(1994-2#2)(1995-1#1)(1995-11#5)(1995-12#4)(1995-5#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-5#5)(1996-6#1)(1997-1#1)(1997-7#1)(2009-10#1)(2012-1#1)
rat stroke model##3##3##(2007-9#1)(2008-7#2)
rat subfornical organ##3##3##(1995-6#3)
rat superior cervical ganglia##2##4##(1990-8#1)(2011-12#1)
rat superior cervical ganglion##2##4##(1996-5#1)(2008-8#1)
rat superior cervical##4##3##(1990-8#1)(1996-5#1)(2008-8#1)(2011-12#1)
rat superior colliculus##2##3##(2008-4#1)(2008-7#1)
rat superior##6##2##(1990-8#1)(1996-5#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-12#1)
rat suprachiasmatic nucleus (SCN)##3##4##(1993-9#1)(1996-1#1)(1997-8#1)
rat suprachiasmatic nucleus##6##3##(1993-12#1)(1993-9#1)(1994-2#1)(1995-7#1)(1996-1#1)(1997-8#1)
rat suprachiasmatic##8##2##(1993-12#1)(1993-9#2)(1994-2#1)(1995-7#1)(1996-1#1)(1996-6#1)(1997-8#1)
rat sympathetic##4##2##(1991-1#1)(1991-7#1)(1996-8#2)
rat synaptosomal##2##2##(1993-7#1)(1995-12#1)
rat tail tendon##2##3##(2008-3#2)
rat tail##3##2##(1996-5#1)(2008-3#2)
rat testes##7##2##(1992-7#1)(1995-10#1)(1995-3#1)(1995-6#1)(1996-5#1)(2012-1#1)(2012-2#1)
rat testis##24##2##(1990-5#1)(1991-2#2)(1991-7#1)(1991-9#1)(1992-3#1)(1992-7#2)(1993-11#1)(1993-7#2)(1994-11#1)(1996-7#3)(2008-4#2)(2008-9#2)(2009-10#1)(2012-2#3)(2013-1#1)
rat than in##3##3##(1990-7#1)(1994-2#1)(1994-9#1)
rat than##4##2##(1990-7#1)(1994-2#2)(1994-9#1)
rat that##4##2##(1990-11#1)(1991-3#1)(1992-3#1)(2008-4#1)
rat the##4##2##(1991-10#1)(1993-9#1)(1994-11#1)(1994-2#1)
rat thoracic aorta##4##3##(1992-6#1)(1995-11#1)(2007-9#1)(2010-12#1)
rat thoracic##5##2##(1992-6#1)(1995-11#1)(1995-12#1)(2007-9#1)(2010-12#1)
rat thymocytes in##2##3##(1997-3#1)(1997-6#1)
rat thymocytes##12##2##(1991-3#1)(1992-9#1)(1993-4#2)(1994-12#4)(1994-9#1)(1997-3#2)(1997-6#1)
rat thymus##7##2##(1992-11#1)(1994-3#1)(1996-5#1)(2013-1#4)
rat thyroid cell##2##3##(1992-2#1)(1992-8#1)
rat thyroid cells##5##3##(1990-11#1)(1991-9#1)(1992-2#1)(1993-2#1)(1993-8#1)
rat thyroid lobes##4##3##(1991-12#2)(1991-7#2)
rat thyroid##13##2##(1990-11#1)(1990-12#1)(1991-12#2)(1991-7#2)(1991-9#1)(1992-2#2)(1992-8#1)(1993-2#1)(1993-8#2)
rat thyrotropin receptor##2##3##(1990-11#1)(1992-2#1)
rat thyrotropin##3##2##(1990-11#1)(1992-2#1)(1993-8#1)
rat thyroxine binding globulin##2##4##(1990-2#1)(1995-12#1)
rat tibiae##2##2##(2008-5#1)(2012-2#1)
rat tissue homogenate##2##3##(1997-8#2)
rat tissue##7##2##(1991-11#1)(1994-6#1)(1997-8#2)(2007-3#2)(2011-2#1)
rat tissues during##2##3##(2008-4#1)(2008-5#1)
rat tissues examined##2##3##(1996-7#1)(1997-4#1)
rat tissues revealed##2##3##(1996-2#1)(1997-5#1)
rat tissues were##2##3##(1990-8#1)(1993-4#1)
rat tissues##44##2##(1990-11#2)(1990-12#1)(1990-8#2)(1991-2#3)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#2)(1993-5#1)(1994-11#1)(1994-12#4)(1994-3#1)(1995-11#1)(1995-9#1)(1996-2#3)(1996-7#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2008-4#1)(2008-5#2)(2009-8#1)(2012-3#1)
rat to##5##2##(1990-7#1)(1992-11#1)(1996-5#1)(2005-10#1)(2008-4#1)
rat tooth##2##2##(1994-5#1)(2010-12#1)
rat trachea##9##2##(1990-4#2)(1991-8#1)(2008-9#6)
rat tracheal##4##2##(1990-4#1)(1991-2#2)(1993-3#1)
rat transforming growth factor-beta##2##4##(1993-3#2)
rat trigeminal and hippocampal neurones##2##5##(1995-11#2)
rat trigeminal ganglion##5##3##(1990-7#1)(1996-12#2)(2008-6#1)(2012-3#1)
rat trigeminal##11##2##(1990-7#1)(1995-11#2)(1996-12#2)(1997-2#1)(1997-5#2)(2008-6#1)(2012-3#2)
rat type 1 angiotensin II##2##5##(1992-3#1)(1992-7#1)
rat type 1##3##3##(1992-3#1)(1992-7#1)(1997-8#1)
rat type##7##2##(1991-5#1)(1992-3#1)(1992-7#1)(1996-4#1)(1997-5#1)(1997-8#1)(2005-8#1)
rat urinary bladder##6##3##(1992-12#1)(1992-3#3)(1992-8#1)(1993-3#1)
rat urine##13##2##(1990-6#1)(1994-6#1)(1994-8#1)(1996-8#4)(2008-10#4)(2013-8#2)
rat using the##3##3##(1990-5#1)(2008-4#2)
rat using##10##2##(1990-5#2)(1993-2#1)(1994-5#2)(1996-9#1)(2008-10#1)(2008-4#3)
rat uterine model of##2##4##(1992-12#2)
rat uterine smooth muscle##2##4##(1991-8#2)
rat uterine##11##2##(1991-6#1)(1991-8#3)(1992-12#2)(1994-8#1)(1996-8#1)(2007-1#1)(2012-1#2)
rat uterus##10##2##(1990-8#2)(1990-9#1)(1991-5#1)(1991-6#1)(1992-10#1)(1995-10#3)(2013-7#1)
rat vaginal##4##2##(1990-11#2)(1994-8#1)(2007-7#1)
rat vagus nerve##2##3##(1992-3#2)
rat vas deferens##4##3##(1993-3#2)(1997-5#2)
rat vas##5##2##(1993-3#3)(1997-5#2)
rat vascular AT1 receptor##2##4##(1992-9#2)
rat vascular smooth muscle cells (VSMC)##4##6##(1990-11#1)(1991-12#1)(1991-7#1)(1992-3#1)
rat vascular smooth muscle cells##6##5##(1990-11#2)(1991-12#1)(1991-7#2)(1992-3#1)
rat vascular smooth muscle##8##4##(1990-11#2)(1991-12#1)(1991-7#2)(1992-3#1)(1992-6#1)(2008-9#1)
rat vascular##12##2##(1990-11#2)(1991-12#1)(1991-7#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#2)(1995-12#1)(2008-9#1)
rat ventral prostate##6##3##(1990-7#2)(1990-8#1)(1995-6#2)(1996-11#1)
rat ventral##7##2##(1990-7#2)(1990-8#1)(1995-6#2)(1996-11#1)(1997-3#1)
rat ventricular myocytes##4##3##(1993-3#2)(1994-12#1)(1994-6#1)
rat ventricular##10##2##(1990-2#3)(1992-2#1)(1993-3#2)(1994-12#1)(1994-3#1)(1994-6#1)(2008-7#1)
rat vibrissal##3##2##(2011-2#3)
rat visual cortex##5##3##(1992-8#1)(1996-3#2)(2011-2#2)
rat was examined##2##3##(1995-5#1)(2012-1#1)
rat was investigated##2##3##(1992-10#1)(1994-8#1)
rat was##17##2##(1992-10#1)(1993-6#2)(1994-8#1)(1995-3#1)(1995-5#1)(1996-12#1)(1997-2#1)(2008-4#4)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)
rat were##15##2##(1990-10#1)(1990-4#1)(1990-9#1)(1991-12#2)(1992-8#1)(1993-12#1)(1993-2#1)(1994-2#2)(1994-3#1)(1995-12#1)(1996-5#1)(1996-8#1)(2011-3#1)
rat which##4##2##(1991-11#1)(1992-3#1)(1997-5#2)
rat whole embryo culture##2##4##(1993-12#2)
rat whole##3##2##(1993-12#2)(1994-2#1)
rat with##10##2##(1991-2#1)(1993-4#1)(1995-12#1)(1997-8#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-4#1)(2013-1#2)
rat##5416##1##(1990-10#32)(1990-11#64)(1990-12#60)(1990-2#67)(1990-3#26)(1990-4#34)(1990-5#90)(1990-6#19)(1990-7#104)(1990-8#38)(1990-9#29)(1991-1#48)(1991-10#38)(1991-11#32)(1991-12#70)(1991-2#79)(1991-3#40)(1991-4#39)(1991-5#79)(1991-6#37)(1991-7#43)(1991-8#50)(1991-9#55)(1992-1#37)(1992-10#16)(1992-11#48)(1992-12#44)(1992-2#39)(1992-3#94)(1992-4#24)(1992-5#31)(1992-6#68)(1992-7#60)(1992-8#69)(1992-9#57)(1993-1#3)(1993-11#84)(1993-12#92)(1993-2#55)(1993-3#91)(1993-4#75)(1993-5#28)(1993-6#40)(1993-7#25)(1993-8#58)(1993-9#37)(1994-10#27)(1994-11#78)(1994-12#93)(1994-2#93)(1994-3#67)(1994-4#1)(1994-5#58)(1994-6#61)(1994-8#90)(1994-9#68)(1995-1#32)(1995-10#39)(1995-11#66)(1995-12#125)(1995-2#43)(1995-3#52)(1995-4#1)(1995-5#45)(1995-6#45)(1995-7#34)(1995-8#26)(1995-9#21)(1996-1#35)(1996-10#34)(1996-11#28)(1996-12#89)(1996-2#57)(1996-3#29)(1996-4#20)(1996-5#87)(1996-6#22)(1996-7#15)(1996-8#32)(1996-9#29)(1997-1#39)(1997-2#89)(1997-3#26)(1997-4#26)(1997-5#62)(1997-6#29)(1997-7#52)(1997-8#55)(1997-9#1)(2004-11#2)(2004-12#4)(2004-9#1)(2005-10#6)(2005-7#1)(2005-8#10)(2006-1#1)(2006-10#10)(2006-11#2)(2006-12#2)(2006-2#2)(2006-6#4)(2006-7#3)(2006-8#1)(2006-9#4)(2007-1#11)(2007-10#5)(2007-11#5)(2007-12#5)(2007-2#2)(2007-3#10)(2007-5#1)(2007-7#1)(2007-8#9)(2007-9#28)(2008-1#14)(2008-10#84)(2008-11#112)(2008-12#15)(2008-2#12)(2008-3#9)(2008-4#133)(2008-5#30)(2008-6#7)(2008-7#33)(2008-8#49)(2008-9#42)(2009-10#7)(2009-11#6)(2009-12#9)(2009-2#8)(2009-3#5)(2009-4#6)(2009-5#10)(2009-6#2)(2009-7#2)(2009-8#5)(2009-9#4)(2010-1#1)(2010-10#6)(2010-11#2)(2010-12#29)(2010-2#8)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#7)(2010-7#2)(2010-8#2)(2011-1#22)(2011-12#5)(2011-2#37)(2011-3#14)(2012-1#30)(2012-12#26)(2012-2#22)(2012-3#17)(2012-4#1)(2013-1#40)(2013-7#16)(2013-8#23)
rat&quot##2##1##(2005-10#2)
rat's blood and brain##4##4##(2008-10#4)
rat's ileum##2##2##(2008-12#2)
rat's##23##1##(1991-2#1)(1992-7#2)(1993-2#1)(1993-3#1)(1993-9#4)(1994-2#1)(1995-12#1)(1997-7#1)(2008-10#4)(2008-12#4)(2008-3#1)(2011-2#1)(2013-1#1)
rat) and##2##2##(1990-2#1)(1991-8#1)
rat)##7##1##(1990-2#1)(1990-6#1)(1991-8#1)(1992-7#1)(1995-2#1)(1997-4#1)(2008-11#1)
rat-##2##1##(1992-3#1)(2008-11#1)
rat-kidney cortex##2##2##(1994-6#2)
rat-kidney##3##1##(1994-6#2)(1994-8#1)
rat-liver epithelial-cells##2##2##(1992-9#2)
rat-liver mitochondria##3##2##(1990-8#3)
rat-liver##10##1##(1990-8#3)(1991-3#1)(1992-4#1)(1992-9#5)
rat/human##3##1##(1993-5#1)(1995-1#1)(1996-5#1)
rat1 fibroblasts##2##2##(1996-5#2)
rat]##4##1##(2010-12#1)(2011-3#1)(2012-2#1)(2013-1#1)
ratchet in##4##2##(1990-11#3)(1996-11#1)
ratchet##15##1##(1990-11#8)(1995-11#2)(1995-2#1)(1996-11#3)(2010-12#1)
ratchet-like##2##1##(1990-11#1)(2008-7#1)
rate (&gt##3##2##(2007-11#1)(2007-2#1)(2012-12#1)
rate (&lt##2##2##(1996-8#1)(2008-4#1)
rate (0##4##2##(2008-10#1)(2008-12#1)(2008-5#2)
rate (1##4##2##(1991-6#1)(1992-2#1)(1993-8#1)(2008-9#1)
rate (100##2##2##(2007-8#1)(2010-1#1)
rate (2##2##2##(2008-7#1)(2009-9#1)
rate (5##2##2##(1996-11#1)(2012-3#1)
rate (50##2##2##(2008-2#1)(2008-5#1)
rate (BER) of##2##3##(2008-2#1)(2008-3#1)
rate (BER)##6##2##(2007-11#1)(2008-2#4)(2008-3#1)
rate (CPR)##2##2##(2012-12#1)(2012-3#1)
rate (DR)##2##2##(2008-10#1)(2011-1#1)
rate (FCR)##2##2##(1991-2#1)(2013-7#1)
rate (FR)##2##2##(2008-10#1)(2012-12#1)
rate (GFR) is##2##3##(2007-1#1)(2013-1#1)
rate (GFR)##11##2##(1993-4#1)(1995-2#1)(1995-5#1)(2007-1#1)(2007-2#1)(2008-1#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
rate (HR) and##6##3##(1991-4#1)(1992-12#1)(2012-12#1)(2013-8#3)
rate (HR)##30##2##(1990-5#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-12#1)(1993-4#1)(1996-11#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#5)
rate (P &lt##3##3##(2006-5#1)(2008-10#1)(2011-2#1)
rate (P##5##2##(1996-6#1)(2006-5#1)(2008-10#1)(2008-7#1)(2011-2#1)
rate (RR)##4##2##(1992-12#1)(2008-10#2)(2012-2#1)
rate (from##2##2##(2008-12#2)
rate (i##2##2##(2008-10#1)(2011-2#1)
rate (per 100##2##3##(1994-12#1)(2013-8#1)
rate (t1/2##2##2##(1992-8#1)(1995-3#1)
rate (the##2##2##(2012-1#1)(2013-8#1)
rate (up to##2##3##(1992-5#1)(2006-11#1)
rate 0##8##2##(1994-3#1)(2006-12#1)(2008-10#4)(2008-6#1)(2010-11#1)
rate 1##10##2##(1995-12#1)(2007-1#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#1)
rate 2##6##2##(2007-1#4)(2008-10#1)(2008-2#1)
rate 33##2##2##(2010-8#1)(2011-1#1)
rate 4##2##2##(1990-3#1)(2009-5#1)
rate 5##2##2##(1990-3#1)(2008-10#1)
rate 94%)##3##2##(1991-8#2)(2008-6#1)
rate = 92##2##3##(2004-11#1)(2007-12#1)
rate =##6##2##(1991-12#1)(2004-11#1)(2007-12#2)(2009-2#1)(2011-2#1)
rate V(max)) of the##2##4##(2008-10#2)
rate a##3##2##(2007-12#2)(2008-2#1)
rate acceleration##4##2##(1991-8#1)(1997-4#1)(2008-5#1)(2009-11#1)
rate accelerations##3##2##(1992-9#1)(1996-7#1)(2010-4#1)
rate according to##2##3##(2007-8#1)(2008-7#1)
rate achieved was##2##3##(1995-2#1)(2008-3#1)
rate achieved##5##2##(1991-12#1)(1995-2#1)(1995-8#1)(2007-12#1)(2008-3#1)
rate after elective lumbar spine surgery##2##6##(2012-12#2)
rate after surgical##3##3##(2007-11#1)(2009-7#1)(2010-12#1)
rate after the##3##3##(1993-8#1)(2008-5#1)(2011-2#1)
rate after treatment was##2##4##(1990-12#1)(1991-9#1)
rate after##25##2##(1990-12#1)(1991-3#1)(1991-9#1)(1992-8#1)(1993-8#1)(1994-6#1)(1995-6#1)(1995-7#1)(1995-9#1)(2006-11#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-12#3)(2010-3#1)(2011-2#2)(2012-12#2)(2012-2#1)
rate against##4##2##(2005-11#1)(2007-7#1)(2008-11#1)(2008-12#1)
rate allocation##3##2##(2008-2#3)
rate alpha##3##2##(1992-12#1)(1995-8#1)(1997-4#1)
rate also##4##2##(1993-9#1)(1995-3#1)(1995-5#1)(2009-6#1)
rate among the##5##3##(1995-1#1)(2006-8#1)(2008-7#1)(2011-11#1)(2011-2#1)
rate among women##2##3##(1991-11#1)(2013-8#1)
rate among##26##2##(1990-3#1)(1991-11#1)(1991-12#1)(1991-8#1)(1992-2#1)(1992-5#1)(1995-1#1)(1997-2#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2011-11#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#1)
rate and a##12##3##(1990-8#1)(1992-8#1)(1995-12#1)(1996-12#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-6#1)(2011-2#1)
rate and an##7##3##(1990-10#1)(1994-12#1)(2006-10#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-8#1)
rate and arterial pressure##2##4##(1990-6#1)(1993-12#1)
rate and better##2##3##(2008-3#1)(2012-12#1)
rate and blood##7##3##(1991-3#1)(1991-4#1)(2006-10#1)(2007-10#1)(2009-6#1)(2010-7#1)(2012-2#1)
rate and body##3##3##(1990-9#1)(2008-5#1)(2013-8#1)
rate and decreased##2##3##(2008-3#1)(2008-4#1)
rate and decreasing##2##3##(1990-2#1)(1992-5#1)
rate and distribution of##2##4##(1996-3#1)(2010-2#1)
rate and efficiency##2##3##(2008-8#1)(2011-12#1)
rate and extent of deuterium oxide-mediated fluorescence enhancement of##2##9##(1992-6#2)
rate and extent of##15##4##(1992-6#4)(1992-8#1)(1994-12#1)(1996-4#1)(1996-5#1)(1997-3#2)(2006-1#1)(2006-10#1)(2007-11#1)(2008-10#2)
rate and final##2##3##(2008-10#1)(2008-11#1)
rate and frequency response##2##4##(2007-12#2)
rate and higher##2##3##(1993-1#1)(2010-10#1)
rate and in##6##3##(1990-9#1)(1991-8#1)(1991-9#1)(2008-3#1)(2008-7#1)(2009-5#1)
rate and increased the##2##4##(1996-3#1)(2008-10#1)
rate and increased##4##3##(1991-10#1)(1996-3#1)(2008-10#1)(2012-12#1)
rate and initial##2##3##(2008-10#1)(2013-8#1)
rate and its##3##3##(2007-11#1)(2007-12#1)(2007-4#1)
rate and lower##3##3##(2007-10#1)(2007-12#1)(2013-8#1)
rate and major##2##3##(2006-10#1)(2006-6#1)
rate and maximum cell##2##4##(2008-11#2)
rate and maximum##3##3##(2008-11#2)(2011-2#1)
rate and of##2##3##(1997-1#1)(2008-11#1)
rate and output##2##3##(2008-10#1)(2009-12#1)
rate and oxidative##2##3##(1994-11#1)(1994-3#1)
rate and pattern##3##3##(1993-5#1)(1997-6#1)(2008-5#1)
rate and peak##2##3##(2007-10#2)
rate and pulse##4##3##(2007-12#1)(2008-1#1)(2008-10#1)(2011-2#1)
rate and rate of##2##4##(2008-8#1)(2012-12#1)
rate and relative##3##3##(2008-10#2)(2008-8#1)
rate and respiratory rate were##2##5##(2008-4#1)(2008-5#1)
rate and respiratory rate##3##4##(2008-4#2)(2008-5#1)
rate and respiratory##5##3##(1992-8#1)(2008-4#2)(2008-5#1)(2013-7#1)
rate and rhythm##2##3##(1997-4#1)(2013-1#1)
rate and severity of##2##4##(2007-11#1)(2010-10#1)
rate and shorter##2##3##(2008-4#1)(2013-8#1)
rate and should be##3##4##(2007-11#2)(2008-10#1)
rate and strength of##2##4##(2008-4#1)(2008-8#1)
rate and stroke##3##3##(2008-10#1)(2008-4#1)(2009-1#1)
rate and temperature on##3##4##(2005-12#1)(2009-7#1)(2010-4#1)
rate and temperature were##2##4##(2008-10#1)(2008-5#1)
rate and temperature##6##3##(2005-12#1)(2008-10#2)(2008-5#1)(2009-7#1)(2010-4#1)
rate and that the##2##4##(2008-10#1)(2008-7#1)
rate and that##3##3##(2008-10#1)(2008-6#1)(2008-7#1)
rate and the cell##2##4##(1994-2#1)(1994-5#1)
rate and the discharge##2##4##(1997-7#1)(2008-3#1)
rate and the rate##2##4##(2008-3#1)(2008-6#1)
rate and the temperature##2##4##(2009-7#1)(2011-2#1)
rate and the total##2##4##(1996-2#1)(2007-1#1)
rate and the##56##3##(1990-2#1)(1990-7#1)(1992-8#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-10#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-7#1)(2004-12#1)(2004-9#1)(2005-1#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2011-2#1)(2012-3#2)
rate and time to##2##4##(2008-3#1)(2008-8#1)
rate and time##4##3##(1990-9#1)(2005-11#1)(2008-3#1)(2008-8#1)
rate and to##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
rate and volume##3##3##(1997-8#1)(2008-10#2)
rate and with##2##3##(1995-5#1)(2008-5#1)
rate and##458##2##(1990-10#1)(1990-2#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#4)(1991-1#1)(1991-10#2)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#4)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#3)(1993-4#1)(1993-5#1)(1993-6#1)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#4)(1994-5#2)(1994-7#1)(1994-8#2)(1995-1#2)(1995-10#2)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#3)(1996-4#2)(1996-5#1)(1996-6#2)(1997-1#1)(1997-3#2)(1997-4#1)(1997-6#4)(1997-7#2)(1997-8#3)(2004-1#1)(2004-12#2)(2004-9#3)(2005-1#1)(2005-11#6)(2005-12#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#13)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#5)(2006-6#4)(2006-8#2)(2007-1#3)(2007-10#7)(2007-11#14)(2007-12#14)(2007-2#3)(2007-3#2)(2007-4#3)(2007-6#2)(2007-7#5)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#60)(2008-11#19)(2008-12#7)(2008-2#3)(2008-3#13)(2008-4#7)(2008-5#10)(2008-6#4)(2008-7#14)(2008-8#12)(2008-9#7)(2009-1#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#1)(2010-10#3)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#15)(2012-1#2)(2012-12#5)(2012-2#7)(2012-3#9)(2012-5#1)(2013-1#11)(2013-7#2)(2013-8#10)
rate are achieved##2##3##(1991-1#1)(2007-12#1)
rate are discussed##3##3##(1993-10#1)(2007-8#1)(2008-2#1)
rate are##20##2##(1991-1#1)(1992-12#1)(1993-10#1)(1993-2#1)(1997-8#1)(2007-11#4)(2007-12#4)(2007-6#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-6#1)(2010-4#1)
rate as a function of##3##5##(2006-9#1)(2008-3#2)
rate as a##4##3##(2006-9#1)(2007-11#1)(2008-3#2)
rate as an##2##3##(1994-5#1)(2008-8#1)
rate as compared##2##3##(2008-11#1)(2008-8#1)
rate as high as##4##4##(2008-10#1)(2008-3#2)(2011-1#1)
rate as that##2##3##(1990-3#1)(1990-7#1)
rate as the##3##3##(2008-10#1)(2008-8#1)(2010-1#1)
rate as well as##4##4##(1995-9#1)(2006-10#1)(2008-10#1)(2011-2#1)
rate as well##5##3##(1995-9#1)(2006-10#1)(2008-10#1)(2008-7#1)(2011-2#1)
rate as##32##2##(1990-3#1)(1990-7#1)(1993-3#1)(1994-5#1)(1995-3#1)(1995-6#1)(1995-9#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#3)(2010-1#1)(2011-1#2)(2011-2#1)(2013-8#1)
rate associated with the anterior approach##2##6##(2006-8#2)
rate associated with the##3##4##(2006-8#2)(2008-10#1)
rate associated with##8##3##(1992-8#1)(1995-12#1)(2006-8#2)(2007-8#1)(2008-10#1)(2008-9#1)(2013-8#1)
rate at 1##2##3##(2007-12#1)(2007-7#1)
rate at 25 degrees C##2##5##(1990-2#1)(2008-10#1)
rate at 25##3##3##(1990-2#1)(2004-1#1)(2008-10#1)
rate at the end of##2##5##(2007-12#1)(2007-5#1)
rate at the##9##3##(1990-9#1)(1996-4#1)(2005-11#1)(2007-12#1)(2007-5#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-2#1)
rate at three months##2##4##(2007-2#1)(2007-7#1)
rate at which the##10##4##(1990-2#1)(1991-2#2)(1993-8#1)(2008-5#1)(2008-7#3)(2008-8#1)(2010-8#1)
rate at which##33##3##(1990-12#1)(1990-2#1)(1991-2#2)(1992-1#1)(1992-2#1)(1992-6#1)(1993-8#1)(1994-12#1)(1995-6#1)(2005-7#1)(2006-9#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#6)(2010-12#1)(2010-8#1)(2013-1#1)(2013-8#1)
rate at##74##2##(1990-12#1)(1990-2#2)(1990-9#1)(1991-2#2)(1991-9#1)(1992-1#1)(1992-2#1)(1992-6#3)(1993-8#1)(1994-12#1)(1995-6#1)(1995-9#1)(1996-4#1)(2004-1#1)(2005-11#1)(2005-7#1)(2006-11#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-9#2)(2008-10#8)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#8)(2010-12#2)(2010-2#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
rate because##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
rate before##3##2##(1992-10#1)(1994-7#1)(2006-10#1)
rate being##3##2##(1991-2#1)(1994-3#1)(2007-3#1)
rate below##3##2##(2008-2#1)(2008-8#1)(2013-1#1)
rate between patients##2##3##(1990-6#1)(2007-8#1)
rate between the two groups##2##5##(1993-1#1)(1995-10#1)
rate between the two##3##4##(1991-10#1)(1993-1#1)(1995-10#1)
rate between the##7##3##(1991-10#1)(1993-1#1)(1993-2#1)(1995-10#1)(1996-3#1)(2008-12#1)(2013-1#1)
rate between##24##2##(1990-6#2)(1990-8#1)(1991-10#1)(1993-1#1)(1993-11#1)(1993-2#1)(1995-10#1)(1996-3#1)(2004-12#1)(2006-5#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-2#2)(2008-8#2)(2008-9#1)(2010-8#1)(2012-12#1)(2013-1#1)
rate both##3##2##(1991-3#1)(1996-12#1)(2008-7#1)
rate but the##2##3##(1996-11#1)(2010-2#1)
rate but##6##2##(1996-11#1)(2006-6#1)(2010-2#1)(2011-1#2)(2013-8#1)
rate by a##2##3##(1992-7#1)(1994-8#1)
rate by about##2##3##(2010-10#1)(2013-8#1)
rate by the##4##3##(2007-6#1)(2008-11#2)(2008-12#1)
rate by##37##2##(1992-10#1)(1992-5#1)(1992-7#1)(1993-8#1)(1994-8#1)(1995-12#1)(1996-2#1)(1996-6#1)(1996-8#1)(2005-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#2)(2008-6#2)(2008-7#1)(2008-9#2)(2010-10#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-8#1)
rate calculations##2##2##(2004-9#1)(2008-8#1)
rate calibration##2##2##(2008-9#2)
rate can be decreased##2##4##(2008-11#1)(2008-5#1)
rate can be reduced##2##4##(1994-6#1)(2007-11#1)
rate can be##11##3##(1991-8#1)(1994-6#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-5#1)(2011-3#1)
rate can##12##2##(1990-11#1)(1991-8#1)(1994-6#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-5#1)(2011-3#1)
rate cannot be##2##3##(2006-10#1)(2008-1#1)
rate changed##2##2##(1993-2#1)(2012-2#1)
rate changes##5##2##(1990-2#1)(2008-10#1)(2008-6#1)(2008-7#2)
rate coefficients of##2##3##(2010-9#2)
rate coefficients##5##2##(1991-2#1)(2005-11#1)(2010-9#2)(2011-1#1)
rate comparable to that##4##4##(1995-8#1)(1997-4#2)(1997-7#1)
rate comparable to##5##3##(1991-1#1)(1995-8#1)(1997-4#2)(1997-7#1)
rate comparable with##2##3##(1990-8#1)(2009-8#1)
rate comparable##7##2##(1990-8#1)(1991-1#1)(1995-8#1)(1997-4#2)(1997-7#1)(2009-8#1)
rate compared to the other##2##5##(1995-1#1)(2007-2#1)
rate compared to the##5##4##(1995-1#1)(2007-2#1)(2007-7#1)(2012-3#1)(2013-1#1)
rate compared to##13##3##(1992-8#1)(1995-1#1)(2004-12#1)(2006-9#1)(2007-2#1)(2007-7#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
rate compared with the##2##4##(1994-10#1)(2006-8#1)
rate compared with##4##3##(1994-10#1)(2006-8#1)(2008-12#1)(2010-8#1)
rate compared##17##2##(1992-8#1)(1994-10#1)(1995-1#1)(2004-12#1)(2006-8#1)(2006-9#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
rate condition##2##2##(1996-2#1)(2007-12#1)
rate conditions##3##2##(1991-4#1)(2008-10#1)(2008-11#1)
rate constant (k(app))##2##3##(2008-1#1)(2008-10#1)
rate constant (k(s)) for##3##4##(2005-11#1)(2008-10#2)
rate constant (k(s))##6##3##(2005-11#1)(2008-10#5)
rate constant 0##2##3##(1997-6#2)
rate constant and the##2##4##(1993-3#1)(1996-12#1)
rate constant for the conversion##2##5##(1990-5#1)(1995-10#1)
rate constant for the reaction of##2##6##(1990-7#1)(1994-5#1)
rate constant for the reaction##3##5##(1990-7#1)(1994-5#1)(2008-10#1)
rate constant for the##16##4##(1990-5#2)(1990-7#1)(1991-5#1)(1992-6#1)(1994-11#1)(1994-5#1)(1995-1#1)(1995-10#1)(1996-5#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-5#2)
rate constant for##34##3##(1990-5#2)(1990-7#2)(1991-2#2)(1991-5#1)(1992-6#2)(1993-3#1)(1994-11#2)(1994-12#3)(1994-5#1)(1994-6#2)(1995-1#1)(1995-10#1)(1995-2#2)(1995-5#1)(1996-5#1)(1997-5#2)(2008-10#3)(2008-7#2)(2008-8#1)(2010-5#2)
rate constant in##4##3##(1997-5#1)(1997-8#1)(2004-12#1)(2008-10#1)
rate constant is##2##3##(1990-2#1)(2008-10#1)
rate constant k##3##3##(2008-10#2)(2008-7#1)
rate constant of 0##6##4##(1990-2#2)(1992-6#1)(1994-3#1)(1995-6#1)(1997-4#1)
rate constant of 1##2##4##(1990-7#1)(2010-7#1)
rate constant of 2##2##4##(1990-7#1)(1992-6#1)
rate constant of 3##3##4##(1990-5#1)(1996-7#1)(2008-10#1)
rate constant of the chemical##2##5##(2006-12#1)(2008-10#1)
rate constant of the reaction##2##5##(1994-12#1)(1997-7#1)
rate constant of the##12##4##(1994-11#1)(1994-12#1)(1995-2#1)(1996-7#1)(1997-4#2)(1997-7#1)(2006-12#1)(2008-10#4)
rate constant of##45##3##(1990-2#2)(1990-5#4)(1990-7#3)(1991-2#1)(1991-7#1)(1992-6#2)(1993-12#1)(1994-11#2)(1994-12#1)(1994-3#1)(1995-2#2)(1995-6#2)(1996-1#1)(1996-7#2)(1997-1#1)(1997-4#3)(1997-7#2)(2006-10#1)(2006-12#1)(2008-10#6)(2008-11#1)(2008-4#1)(2010-5#2)(2010-7#1)(2012-1#1)
rate constant to##2##3##(1990-11#1)(1995-1#1)
rate constant was##8##3##(1991-1#1)(1991-7#1)(1992-6#2)(1994-3#1)(1995-11#1)(2008-10#1)(2008-5#1)
rate constant were##2##3##(1991-1#1)(2008-8#1)
rate constant with##3##3##(1994-11#1)(1995-1#1)(2013-1#1)
rate constant##177##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#7)(1990-7#7)(1990-9#1)(1991-1#4)(1991-2#3)(1991-5#1)(1991-7#3)(1991-9#1)(1992-3#2)(1992-6#6)(1993-12#1)(1993-3#2)(1993-8#2)(1994-11#7)(1994-12#5)(1994-3#2)(1994-5#3)(1994-6#2)(1994-8#2)(1995-1#5)(1995-10#1)(1995-11#2)(1995-2#7)(1995-5#2)(1995-6#2)(1996-1#1)(1996-12#1)(1996-5#1)(1996-7#2)(1997-1#4)(1997-4#4)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#4)(2004-12#2)(2005-11#5)(2006-10#1)(2006-12#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#30)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#6)(2008-8#2)(2009-8#2)(2010-5#4)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
rate constants and the##3##4##(1994-8#2)(2007-8#1)
rate constants and##9##3##(1990-5#1)(1992-6#1)(1994-8#2)(1995-8#1)(1997-7#1)(2007-8#1)(2008-10#2)
rate constants are##4##3##(1991-9#1)(1997-3#1)(2008-11#1)(2008-5#1)
rate constants by##2##3##(1995-8#1)(2008-10#1)
rate constants for the##11##4##(1990-12#1)(1990-2#1)(1991-4#2)(1995-10#1)(1995-2#1)(1996-5#1)(1996-7#1)(1997-3#1)(2005-8#1)(2012-1#1)
rate constants for their##2##4##(1990-5#1)(1997-4#1)
rate constants for##35##3##(1990-12#1)(1990-2#2)(1990-5#2)(1991-11#1)(1991-4#2)(1992-8#1)(1994-11#1)(1994-9#1)(1995-10#1)(1995-2#1)(1996-5#1)(1996-7#2)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-8#2)(2005-8#2)(2006-1#1)(2006-4#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-3#1)(2012-1#1)
rate constants in##2##3##(1994-9#1)(1997-1#1)
rate constants k (on) for the interaction of##2##8##(2009-4#2)
rate constants obtained##2##3##(2008-10#2)
rate constants of the##8##4##(1990-7#1)(1992-1#1)(1996-5#1)(1996-9#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)
rate constants of##26##3##(1990-2#1)(1990-4#1)(1990-7#1)(1990-9#1)(1991-2#1)(1992-1#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-3#1)(1994-8#3)(1996-5#1)(1996-7#1)(1996-9#1)(2006-10#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)(2012-11#1)
rate constants to##2##3##(1991-7#1)(1997-8#1)
rate constants was obtained##3##4##(1992-11#1)(1994-12#1)(1997-1#1)
rate constants was##4##3##(1992-11#1)(1994-12#1)(1997-1#1)(2008-5#1)
rate constants were determined by##2##5##(1993-3#1)(2008-9#1)
rate constants were determined##5##4##(1993-3#1)(1995-1#1)(1997-2#1)(1997-8#1)(2008-9#1)
rate constants were##12##3##(1993-1#1)(1993-3#1)(1995-1#1)(1995-8#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-9#1)
rate constants##153##2##(1990-12#2)(1990-2#3)(1990-4#1)(1990-5#3)(1990-7#2)(1990-9#2)(1991-11#1)(1991-2#2)(1991-4#2)(1991-5#3)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#1)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#3)(1993-1#2)(1993-3#2)(1994-11#2)(1994-12#1)(1994-3#1)(1994-8#6)(1994-9#2)(1995-1#1)(1995-10#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#5)(1996-1#3)(1996-11#1)(1996-2#2)(1996-5#2)(1996-7#4)(1996-8#1)(1996-9#3)(1997-1#3)(1997-2#5)(1997-3#3)(1997-4#4)(1997-7#2)(1997-8#4)(2005-8#2)(2006-1#1)(2006-10#5)(2006-4#3)(2007-11#3)(2007-8#1)(2008-1#2)(2008-10#14)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#4)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#2)(2009-8#1)(2012-1#1)(2012-11#1)
rate continued##2##2##(2007-2#1)(2013-1#1)
rate control for##2##3##(2008-2#2)
rate control##5##2##(2008-2#2)(2008-3#1)(2008-7#1)(2012-2#1)
rate controlled##2##2##(2008-10#1)(2008-11#1)
rate could be##3##3##(1991-2#1)(2008-7#1)(2010-7#1)
rate could##5##2##(1991-2#1)(1997-7#1)(2006-10#1)(2008-7#1)(2010-7#1)
rate coupled with##2##3##(1995-11#1)(2008-7#1)
rate data##7##2##(1997-2#1)(2008-10#3)(2008-7#1)(2010-5#2)
rate declined with##2##3##(2008-10#1)(2008-3#1)
rate declined##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
rate decrease##5##2##(2007-10#2)(2008-11#1)(2008-8#1)(2009-8#1)
rate decreased by##5##3##(2008-7#1)(2009-6#1)(2013-1#3)
rate decreased from##4##3##(1995-6#1)(2008-1#1)(2008-3#1)(2011-12#1)
rate decreased with increasing##2##4##(2008-11#1)(2008-7#1)
rate decreased with##3##3##(2007-2#1)(2008-11#1)(2008-7#1)
rate decreased##22##2##(1991-8#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-6#1)(2005-9#1)(2006-3#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-6#1)(2011-12#1)(2012-12#1)(2013-1#3)
rate decreases with increasing##2##4##(1993-8#1)(2008-10#1)
rate decreases##5##2##(1991-11#1)(1993-8#1)(2008-10#1)(2010-7#1)(2011-2#1)
rate dependence of##2##3##(1996-4#1)(2009-10#1)
rate dependence##5##2##(1996-4#1)(2008-10#2)(2009-10#1)(2011-1#1)
rate dependency##2##2##(2007-4#1)(2009-2#1)
rate dependent##2##2##(2007-4#1)(2009-9#1)
rate depends on##2##3##(1996-6#1)(2007-12#1)
rate depends##3##2##(1996-12#1)(1996-6#1)(2007-12#1)
rate determined##2##2##(2008-10#1)(2009-11#1)
rate determining##4##2##(1991-6#1)(1995-10#1)(2008-10#1)(2009-8#1)
rate did not##2##3##(1990-8#1)(1996-9#1)
rate distortion##2##2##(2008-2#1)(2008-3#1)
rate due to the##2##4##(2008-11#1)(2012-2#1)
rate due to##9##3##(1997-7#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-6#1)(2012-2#2)(2013-8#1)
rate during the first##4##4##(1991-3#1)(1993-1#2)(2006-8#1)
rate during the period of##2##5##(2008-7#1)(2011-2#1)
rate during the period##3##4##(2007-2#1)(2008-7#1)(2011-2#1)
rate during the##16##3##(1991-3#2)(1993-1#2)(1993-6#1)(1993-7#1)(2005-11#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2011-2#1)
rate during##29##2##(1990-11#1)(1991-3#2)(1991-8#1)(1992-12#1)(1992-4#1)(1993-1#2)(1993-6#1)(1993-7#1)(1996-6#1)(1997-1#1)(2005-11#1)(2005-12#1)(2006-8#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
rate enhancement##7##2##(1990-5#1)(1991-8#1)(1993-9#1)(1994-3#1)(1996-7#1)(1997-4#1)(2011-2#1)
rate equation model##2##3##(2008-3#2)
rate equation##14##2##(1990-8#1)(1993-3#1)(2008-10#4)(2008-3#8)
rate equations for##2##3##(1990-8#1)(2008-2#1)
rate equations##16##2##(1990-8#1)(2006-10#2)(2006-12#1)(2007-12#2)(2008-2#4)(2008-3#3)(2008-7#2)(2008-9#1)
rate estimates##2##2##(2005-8#1)(2008-8#1)
rate estimation##2##2##(2007-10#1)(2011-2#1)
rate even##2##2##(1996-12#1)(2008-1#1)
rate exceeds##3##2##(2007-11#1)(2008-7#1)(2008-8#1)
rate exhibited##2##2##(1993-11#1)(1994-3#1)
rate expressed as##2##3##(2008-7#1)(2008-9#1)
rate fell from##2##3##(1990-5#1)(1995-9#1)
rate fell##4##2##(1990-5#1)(1995-9#1)(2008-4#1)(2013-8#1)
rate following##11##2##(1992-1#1)(1993-1#1)(1993-3#1)(1994-9#1)(1995-1#1)(1995-8#1)(1997-8#1)(2006-6#1)(2006-9#1)(2008-6#1)(2008-7#1)
rate for Maori##2##3##(1991-2#2)
rate for a##6##3##(1994-12#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-9#1)
rate for all patients##2##4##(2010-3#1)(2012-1#1)
rate for all the##2##4##(2007-12#1)(2012-3#1)
rate for all##10##3##(1990-12#1)(1997-2#1)(2005-5#1)(2007-12#1)(2008-6#1)(2009-5#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-3#1)
rate for an##2##3##(2007-12#1)(2011-1#1)
rate for blood##2##3##(2007-11#1)(2011-2#1)
rate for both##2##3##(2004-9#1)(2006-8#1)
rate for each##3##3##(1995-3#1)(2008-7#1)(2010-2#1)
rate for patients##4##3##(2009-9#1)(2010-3#1)(2010-5#1)(2012-3#1)
rate for the experimental##2##4##(1995-2#1)(2011-2#1)
rate for the second##2##4##(2005-11#1)(2008-10#1)
rate for the##31##3##(1990-8#1)(1991-4#1)(1992-5#1)(1993-5#1)(1993-8#1)(1994-6#1)(1995-2#1)(1995-5#1)(1995-6#2)(1997-7#1)(2005-11#1)(2007-3#1)(2007-7#2)(2007-8#2)(2008-10#6)(2008-12#1)(2008-2#1)(2008-5#2)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
rate for these##3##3##(1996-3#1)(2008-6#1)(2013-1#1)
rate for this##3##3##(1991-3#1)(1993-1#1)(2009-12#1)
rate for##143##2##(1990-12#2)(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#3)(1991-8#2)(1992-10#1)(1992-12#1)(1992-5#1)(1993-1#1)(1993-5#1)(1993-8#2)(1994-12#2)(1994-2#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#4)(1997-8#1)(2004-1#1)(2004-9#1)(2005-11#3)(2005-5#1)(2005-7#2)(2005-9#1)(2006-10#1)(2006-11#2)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#3)(2007-8#4)(2007-9#3)(2008-10#10)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-3#3)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-2#5)(2012-3#3)(2013-1#2)(2013-8#2)
rate from a##3##3##(2007-12#1)(2008-1#1)(2008-2#1)
rate from the##7##3##(1991-2#1)(1995-1#1)(1995-11#1)(1996-1#1)(2007-10#1)(2011-2#1)(2012-2#1)
rate from##48##2##(1990-5#1)(1991-2#1)(1991-6#2)(1993-1#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1997-5#1)(1997-7#2)(2005-9#1)(2006-10#7)(2007-10#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)
rate gamma##3##2##(1994-8#1)(1995-8#1)(2005-11#1)
rate had##3##2##(2008-5#1)(2011-2#1)(2013-8#1)
rate has been##3##3##(1991-8#1)(2007-12#1)(2008-7#1)
rate has##14##2##(1991-8#1)(1994-4#1)(1995-5#1)(1995-9#1)(1997-7#1)(2006-10#2)(2007-12#2)(2008-1#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-2#1)
rate have been##5##3##(1994-2#1)(2007-8#1)(2008-1#1)(2008-10#2)
rate have##6##2##(1994-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2009-4#1)
rate imaging##3##2##(2008-6#1)(2009-10#1)(2010-5#1)
rate in 1991 was##2##4##(1992-2#1)(1993-5#1)
rate in 1991##4##3##(1992-2#1)(1993-5#1)(1995-2#1)(2006-2#1)
rate in S1 was##2##4##(2013-8#2)
rate in a##13##3##(1990-6#1)(1992-1#1)(1994-6#1)(1996-6#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-8#2)(2011-1#1)(2013-1#1)
rate in any##2##3##(1995-5#1)(2008-3#1)
rate in both##4##3##(1990-3#1)(2004-12#1)(2008-9#1)(2012-3#1)
rate in children##2##3##(1992-11#1)(2006-5#1)
rate in diabetes##2##3##(1993-5#1)(2010-7#1)
rate in males##2##3##(1991-4#1)(2006-4#1)
rate in our##2##3##(2008-8#1)(2012-2#1)
rate in patients with##8##4##(1997-2#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-3#1)(2009-8#1)(2011-2#1)(2012-3#1)
rate in patients##9##3##(1997-2#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-3#1)(2009-8#1)(2011-2#1)(2012-3#1)
rate in prepared serum group##2##5##(2008-10#2)
rate in rabbits##2##3##(2006-2#1)(2006-8#1)
rate in response to##2##4##(1993-12#1)(1995-8#1)
rate in terms of##2##4##(2006-2#1)(2008-10#1)
rate in the first##2##4##(1993-7#1)(2008-4#1)
rate in the presence of##3##5##(1994-12#1)(2007-11#1)(2008-4#1)
rate in the range of##2##5##(2007-8#1)(2008-10#1)
rate in the range##3##4##(2007-8#1)(2008-10#2)
rate in the##52##3##(1990-2#1)(1991-2#2)(1991-6#1)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-1#2)(1995-5#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-8#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-3#3)(2008-4#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
rate in this##5##3##(1991-12#1)(1997-2#1)(2004-2#1)(2007-3#1)(2012-3#1)
rate in##227##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-4#1)(1991-5#1)(1991-6#2)(1992-1#2)(1992-11#1)(1992-2#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-4#1)(1993-5#3)(1993-7#1)(1993-8#3)(1993-9#1)(1994-10#1)(1994-12#4)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#3)(1995-5#2)(1995-8#1)(1996-12#1)(1996-3#3)(1996-6#4)(1997-2#2)(1997-4#1)(1997-7#2)(1997-8#1)(2004-10#1)(2004-12#2)(2004-2#2)(2005-7#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-2#4)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#4)(2007-11#5)(2007-12#2)(2007-2#3)(2007-3#2)(2007-4#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#6)(2008-12#5)(2008-2#1)(2008-3#9)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#4)(2009-10#2)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-10#1)(2011-2#5)(2012-12#2)(2012-2#6)(2012-3#9)(2013-1#8)(2013-7#1)(2013-8#7)
rate increase##2##2##(1994-12#1)(2009-11#1)
rate increased and##2##3##(2007-10#1)(2010-3#1)
rate increased by##2##3##(1991-10#1)(1995-1#1)
rate increased from##4##3##(1995-5#1)(2007-2#1)(2013-8#2)
rate increased steadily##2##3##(1994-12#1)(2006-10#1)
rate increased to##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
rate increased with increasing##2##4##(2006-3#1)(2008-11#1)
rate increased with the increase##2##5##(2007-2#1)(2008-11#1)
rate increased with the##6##4##(1996-7#1)(2007-2#1)(2008-11#1)(2008-8#1)(2012-12#2)
rate increased with##11##3##(1996-7#1)(2006-3#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2012-12#2)(2013-7#1)
rate increased##37##2##(1990-6#1)(1991-10#1)(1991-5#1)(1994-12#1)(1995-1#1)(1995-5#1)(1996-7#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-2#3)(2008-10#5)(2008-11#3)(2008-5#1)(2008-8#1)(2008-9#2)(2010-3#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
rate increases sharply##2##3##(1991-5#1)(2008-8#1)
rate increases with age##3##4##(1990-3#1)(2008-7#1)(2011-2#1)
rate increases with##5##3##(1990-3#1)(1990-6#1)(1991-8#1)(2008-7#1)(2011-2#1)
rate increases##18##2##(1990-3#1)(1990-6#1)(1991-5#1)(1991-8#1)(1992-9#1)(1994-12#1)(2005-11#1)(2008-11#2)(2008-2#1)(2008-7#2)(2008-8#2)(2008-9#1)(2011-2#1)(2012-3#2)
rate induced by the##2##4##(1996-12#1)(2009-8#1)
rate induced by##4##3##(1993-11#1)(1996-12#1)(2008-3#1)(2009-8#1)
rate information##2##2##(2008-11#1)(2008-4#1)
rate into##2##2##(2007-7#1)(2008-10#1)
rate is 1##4##3##(1992-9#1)(2006-2#1)(2008-9#2)
rate is 25##2##3##(2008-10#1)(2012-11#1)
rate is a##3##3##(1993-8#1)(2008-8#1)(2008-9#1)
rate is about##2##3##(1995-1#1)(2008-8#1)
rate is also##2##3##(1994-2#1)(2007-12#1)
rate is applied##2##3##(2005-11#1)(2013-8#1)
rate is considerably##2##3##(1996-10#1)(1997-5#1)
rate is controlled by##2##4##(2007-10#1)(2008-10#1)
rate is dependent upon the##2##5##(1990-11#1)(2008-5#1)
rate is every##2##3##(2008-10#2)
rate is greater on the##2##5##(1997-6#2)
rate is greater##3##3##(1992-9#1)(1997-6#2)
rate is high and##2##4##(2006-10#1)(2007-11#1)
rate is high##10##3##(1990-11#1)(2006-10#2)(2007-11#1)(2008-1#1)(2008-11#1)(2008-8#2)(2011-1#1)(2012-1#1)
rate is higher##2##3##(2007-2#1)(2008-8#1)
rate is increased##4##3##(1994-11#1)(1994-9#1)(2008-5#1)(2013-8#1)
rate is known to##2##4##(1990-8#1)(2008-8#1)
rate is less than##2##4##(2006-11#1)(2009-7#1)
rate is low##3##3##(2007-12#1)(2008-8#2)
rate is maintained##2##3##(1992-7#1)(2008-10#1)
rate is much##2##3##(1996-4#1)(2012-2#1)
rate is not##4##3##(1994-11#1)(2006-8#1)(2008-8#1)(2012-2#1)
rate is obtained##3##3##(1995-6#1)(2007-12#1)(2008-10#1)
rate is reduced by##3##4##(2006-8#1)(2008-3#1)(2008-6#1)
rate is reduced##5##3##(1996-6#1)(2006-8#2)(2008-3#1)(2008-6#1)
rate is shown to##2##4##(1992-1#1)(2007-12#1)
rate is significantly##2##3##(2008-4#1)(2013-8#1)
rate is still##2##3##(2008-7#1)(2009-5#1)
rate is the##3##3##(1991-8#1)(1992-5#1)(2008-8#1)
rate is##172##2##(1990-11#2)(1990-12#1)(1990-5#2)(1990-8#2)(1991-6#2)(1991-8#1)(1992-1#1)(1992-5#2)(1992-7#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-8#3)(1994-9#2)(1995-1#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-10#1)(1996-3#1)(1996-4#1)(1996-6#2)(1997-1#1)(1997-5#1)(1997-6#6)(1997-7#2)(2004-1#1)(2005-11#4)(2005-3#2)(2005-4#2)(2006-10#2)(2006-11#3)(2006-2#1)(2006-4#1)(2006-8#3)(2007-10#1)(2007-11#5)(2007-12#9)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#18)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#16)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-7#1)(2010-8#1)(2011-1#2)(2011-12#3)(2012-1#1)(2012-11#1)(2012-2#5)(2012-3#2)(2013-1#3)(2013-8#3)
rate isomorphy in##2##3##(2008-8#2)
rate isomorphy##8##2##(2008-8#8)
rate lambda##2##2##(2008-10#1)(2008-7#1)
rate law##3##2##(2006-11#1)(2008-10#1)(2008-5#1)
rate laws##2##2##(1997-1#1)(2008-10#1)
rate limited##3##2##(2007-11#1)(2008-7#1)(2008-8#1)
rate limiting enzyme of##3##4##(1993-3#1)(1995-12#1)(2006-1#1)
rate limiting enzyme##5##3##(1993-3#1)(1994-6#1)(1995-12#1)(2006-1#1)(2008-4#1)
rate limiting enzymes for the synthesis of##2##7##(1996-12#1)(2008-5#1)
rate limiting enzymes##3##3##(1993-12#1)(1996-12#1)(2008-5#1)
rate limiting for##3##3##(1990-5#1)(1993-8#1)(1994-3#1)
rate limiting step in the##3##5##(1997-4#1)(2008-10#1)(2008-11#1)
rate limiting step in##5##4##(1990-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#1)
rate limiting step of##2##4##(1991-9#1)(1994-9#1)
rate limiting step##7##3##(1990-3#1)(1991-9#1)(1994-9#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#1)
rate limiting##27##2##(1990-3#1)(1990-5#1)(1991-9#2)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-4#1)(2006-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2009-5#1)(2013-1#1)
rate may be higher##2##4##(1990-9#1)(2012-12#1)
rate may be##7##3##(1990-9#1)(1991-3#1)(1995-9#1)(1996-8#1)(2005-10#1)(2011-1#1)(2012-12#1)
rate may vary##2##3##(1997-2#1)(2007-11#1)
rate may##16##2##(1990-9#1)(1991-3#1)(1993-9#1)(1995-4#1)(1995-9#1)(1996-8#1)(1997-2#1)(2005-10#1)(2006-8#1)(2007-11#1)(2008-11#1)(2008-5#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-3#1)
rate measurements##5##2##(1993-3#1)(1994-5#1)(2008-10#2)(2008-2#1)
rate method##3##2##(2008-10#3)
rate methods##2##2##(2008-10#2)
rate models##2##2##(2012-3#2)
rate more than##5##3##(1991-3#1)(1996-5#1)(2008-1#1)(2010-12#1)(2012-11#1)
rate mu##2##2##(1994-2#1)(2008-7#1)
rate must be##2##3##(1995-8#1)(2008-10#1)
rate nor the##3##3##(1997-7#2)(2008-5#1)
rate nor##4##2##(1990-8#1)(1997-7#2)(2008-5#1)
rate observed for##3##3##(1994-11#1)(1997-8#1)(2013-1#1)
rate observed in##2##3##(2007-3#1)(2013-1#1)
rate observed##8##2##(1990-12#1)(1994-11#1)(1995-2#1)(1997-8#1)(2007-3#1)(2008-5#1)(2013-1#2)
rate obtained is##2##3##(2006-6#1)(2012-1#1)
rate obtained##5##2##(2006-5#1)(2006-6#1)(2008-10#1)(2012-1#1)(2012-12#1)
rate of &gt##5##3##(2008-10#1)(2008-5#1)(2009-3#1)(2012-12#2)
rate of &lt##4##3##(2007-12#2)(2008-10#1)(2009-11#1)
rate of 0##63##3##(1991-2#1)(1992-12#1)(1993-4#1)(1994-2#1)(1995-1#1)(1995-2#1)(2004-12#1)(2004-9#1)(2005-12#2)(2006-2#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#6)(2008-6#5)(2008-7#2)(2009-5#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#6)(2012-2#1)(2013-7#1)
rate of 0%##3##3##(2006-6#1)(2008-5#1)(2013-1#1)
rate of 1##63##3##(1990-9#2)(1991-6#1)(1991-8#1)(1992-12#1)(1993-4#1)(1997-6#1)(2005-12#2)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#25)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2010-12#2)(2010-2#4)(2010-3#2)(2010-9#1)(2011-1#3)(2011-2#1)(2012-12#4)(2013-7#1)
rate of 10 Hz##2##4##(2008-3#2)
rate of 10 kHz##3##4##(2007-12#3)
rate of 10##15##3##(1992-1#1)(1992-5#1)(1995-10#1)(2004-9#1)(2007-12#3)(2008-10#2)(2008-3#2)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#1)
rate of 10(-9)##2##3##(2007-12#1)(2008-2#1)
rate of 100 Hz##5##4##(2007-12#2)(2008-3#3)
rate of 100##15##3##(1993-4#2)(2007-12#5)(2008-10#4)(2008-3#3)(2011-2#1)
rate of 100% in##3##4##(2007-11#2)(2008-10#1)
rate of 100%##4##3##(2007-11#2)(2008-10#1)(2011-1#1)
rate of 11##4##3##(2007-8#1)(2008-7#1)(2012-2#1)(2013-1#1)
rate of 12##5##3##(1993-7#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-2#1)
rate of 14##3##3##(1992-10#1)(2007-9#1)(2011-2#1)
rate of 15 samples h(-1)##2##5##(2008-10#2)
rate of 15##10##3##(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2011-1#1)
rate of 154 GHz##2##4##(2007-11#2)
rate of 17%##3##3##(2006-7#1)(2013-1#2)
rate of 2 kHz##3##4##(2008-1#2)(2008-3#1)
rate of 2##29##3##(1990-12#1)(1990-8#1)(1992-10#1)(1992-12#1)(1994-11#1)(2007-12#6)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-2#1)(2008-3#2)(2008-7#1)(2009-4#1)(2011-2#1)
rate of 20##5##3##(1991-7#1)(1995-12#1)(2008-10#2)(2013-1#1)
rate of 200##5##3##(2006-10#1)(2007-12#2)(2008-10#1)(2008-2#1)
rate of 24##2##3##(2008-10#2)
rate of 25##5##3##(1996-5#1)(2007-11#1)(2008-10#1)(2008-7#1)(2011-1#1)
rate of 250##2##3##(2007-12#1)(2008-6#1)
rate of 26%##2##3##(1994-6#1)(2006-12#1)
rate of 3##11##3##(2007-4#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-12#1)
rate of 30##7##3##(2005-7#1)(2008-10#4)(2008-2#1)(2013-8#1)
rate of 300##2##3##(1990-2#1)(2008-10#1)
rate of 31##3##3##(1995-11#1)(2006-9#1)(2012-12#1)
rate of 34%##2##3##(2006-12#1)(2007-7#1)
rate of 35##3##3##(1993-5#1)(2007-8#2)
rate of 36##2##3##(1991-12#1)(2007-7#1)
rate of 37%##2##3##(1992-2#1)(2006-8#1)
rate of 39%##2##3##(2006-8#1)(2010-12#1)
rate of 4##9##3##(1992-10#1)(2006-2#1)(2007-12#1)(2008-10#4)(2008-7#1)(2009-8#1)
rate of 40##8##3##(1991-6#1)(2007-12#1)(2008-10#4)(2008-5#1)(2008-6#1)
rate of 42##3##3##(1991-9#1)(1994-8#1)(2009-4#1)
rate of 49%##2##3##(2005-7#1)(2008-12#1)
rate of 5##13##3##(1997-5#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-7#1)(2010-3#1)(2012-12#1)(2012-3#1)
rate of 50##5##3##(2007-11#1)(2007-12#3)(2008-10#1)
rate of 50%##4##3##(1992-7#1)(1993-12#1)(1994-6#1)(2013-8#1)
rate of 500##2##3##(2008-10#2)
rate of 52##2##3##(2007-12#1)(2012-12#1)
rate of 54%##2##3##(2008-1#1)(2008-12#1)
rate of 55##2##3##(2011-1#1)(2013-8#1)
rate of 58%)##2##3##(2006-2#1)(2011-1#1)
rate of 6##11##3##(1993-3#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-3#2)(2012-2#1)(2013-8#1)
rate of 60##7##3##(2008-10#5)(2008-3#1)(2011-2#1)
rate of 60%##3##3##(2007-12#1)(2008-7#1)(2012-2#1)
rate of 63%##2##3##(2006-8#1)(2009-6#1)
rate of 64%##2##3##(2004-1#1)(2007-11#1)
rate of 7##6##3##(1990-6#1)(1991-5#1)(1992-4#1)(2005-11#1)(2007-7#1)(2012-3#1)
rate of 75##2##3##(2007-7#1)(2008-10#1)
rate of 8 turns/m##3##4##(2007-12#3)
rate of 8##6##3##(1996-5#1)(2007-12#3)(2007-7#1)(2008-10#1)
rate of 82##3##3##(1990-12#1)(1992-10#1)(2010-10#1)
rate of 87##2##3##(2007-1#1)(2008-5#1)
rate of 9##3##3##(1993-4#1)(2007-12#1)(2007-7#1)
rate of 90##5##3##(2007-12#1)(2008-10#4)
rate of 90%##2##3##(2006-6#1)(2010-3#1)
rate of 93##2##3##(2010-8#1)(2013-1#1)
rate of 94##3##3##(1996-8#1)(2006-10#1)(2007-8#1)
rate of 95% was achieved##2##5##(1993-1#1)(1997-4#1)
rate of 96%##2##3##(1995-7#1)(2006-8#1)
rate of ATP synthesis depends##2##5##(1991-2#2)
rate of ATP synthesis##5##4##(1991-2#3)(1996-7#1)(1996-9#1)
rate of ATP##8##3##(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#3)(1996-7#1)(1996-9#1)
rate of Ca2+ influx##3##4##(1990-12#2)(1995-5#1)
rate of Ca2+##5##3##(1990-12#2)(1992-6#2)(1995-5#1)
rate of DNA synthesis##4##4##(1990-8#1)(1993-3#1)(1994-6#1)(1995-5#1)
rate of DNA##10##3##(1990-2#2)(1990-8#1)(1992-11#1)(1993-3#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-5#1)(1996-7#1)
rate of GFR decline was##3##5##(2013-1#3)
rate of GTP hydrolysis##3##4##(1991-5#1)(1995-11#1)(2007-12#1)
rate of HCC was##2##4##(2006-10#1)(2010-12#1)
rate of HCC##3##3##(1993-7#1)(2006-10#1)(2010-12#1)
rate of HPV##2##3##(2011-1#1)(2011-2#1)
rate of JH synthesis##2##4##(2008-7#2)
rate of NADPH oxidation by NOS##2##6##(2008-5#2)
rate of NADPH oxidation##7##4##(2008-5#7)
rate of P##2##3##(2010-8#1)(2011-2#1)
rate of Si##2##3##(2008-10#2)
rate of a given##2##4##(2004-1#1)(2008-3#1)
rate of a##23##3##(1993-2#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-8#1)(2004-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#7)(2008-3#2)(2008-8#2)(2008-9#1)(2013-8#1)
rate of about 50##2##4##(2007-11#1)(2008-10#1)
rate of about##14##3##(1992-9#1)(1996-11#1)(1996-3#1)(2006-3#1)(2007-11#2)(2007-5#1)(2008-10#6)(2008-7#1)
rate of accumulation of##3##4##(1990-11#1)(1990-5#1)(2006-9#1)
rate of accumulation##5##3##(1990-11#1)(1990-5#1)(2005-8#1)(2006-9#2)
rate of acid##2##3##(1990-2#1)(1997-4#1)
rate of acquisition and##2##4##(1993-9#1)(2007-9#1)
rate of acquisition##5##3##(1991-9#1)(1993-9#1)(2007-9#2)(2008-10#1)
rate of activation##6##3##(1992-9#2)(1995-6#1)(1996-10#2)(1997-5#1)
rate of admission##3##3##(2006-10#3)
rate of admissions##2##3##(2006-10#1)(2011-2#1)
rate of adult##2##3##(1996-5#1)(2011-2#1)
rate of adverse events##3##4##(1992-4#1)(2007-11#1)(2008-8#1)
rate of adverse##5##3##(1992-4#2)(1993-2#1)(2007-11#1)(2008-8#1)
rate of aggregation##2##3##(2008-11#1)(2008-5#1)
rate of aging in##2##4##(2008-9#2)
rate of aging is##2##4##(2008-9#2)
rate of aging##9##3##(1993-11#1)(1994-5#1)(2008-9#6)(2009-5#1)
rate of albumin##3##3##(2008-11#2)(2011-1#1)
rate of all##3##3##(1995-3#1)(2006-7#1)(2007-12#1)
rate of an##3##3##(1991-8#1)(1996-5#1)(2007-12#1)
rate of approximately 1##2##4##(1997-5#1)(2010-2#1)
rate of approximately##11##3##(1997-5#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#2)(2010-2#1)(2013-7#1)
rate of around##2##3##(1990-3#1)(2006-9#1)
rate of as much as##2##5##(2008-3#2)
rate of ascospore##2##3##(2008-10#2)
rate of aspartate##3##3##(1990-7#1)(1991-3#2)
rate of associated##2##3##(2011-2#1)(2012-3#1)
rate of bilirubin##2##3##(1992-3#1)(2008-5#1)
rate of binding##2##3##(1991-2#1)(1994-8#1)
rate of bone##2##3##(1993-11#2)
rate of both##6##3##(2005-10#2)(2007-10#1)(2008-5#1)(2008-6#1)(2012-3#1)
rate of brain##2##3##(1994-10#1)(1996-11#1)
rate of breast cancer was##2##5##(1995-4#1)(2009-2#1)
rate of breast cancer##3##4##(1991-5#1)(1995-4#1)(2009-2#1)
rate of caesarean section in##2##5##(2007-2#2)
rate of caesarean section##5##4##(2007-2#3)(2011-12#2)
rate of calcification and##2##4##(2004-9#1)(2006-10#1)
rate of cancer##2##3##(1996-7#1)(2012-2#1)
rate of carp##2##3##(2008-7#2)
rate of cattle##2##3##(2006-5#1)(2012-3#1)
rate of cell proliferation##2##4##(1994-11#1)(1996-5#1)
rate of cell##7##3##(1994-11#1)(1995-5#1)(1995-7#1)(1996-12#1)(1996-5#1)(1997-1#1)(2008-7#1)
rate of cells##6##3##(1991-11#1)(1992-3#1)(1995-2#1)(1995-6#1)(2008-11#2)
rate of cellular metabolism##2##4##(1997-8#2)
rate of cellular##4##3##(1996-11#1)(1997-8#2)(2011-2#1)
rate of change at##2##4##(2007-8#1)(2008-1#1)
rate of change in##5##4##(1990-7#1)(2008-10#2)(2008-8#2)
rate of change of the##2##5##(2007-11#1)(2012-12#1)
rate of change of##9##4##(2006-3#1)(2007-11#1)(2007-4#2)(2008-8#1)(2009-6#1)(2012-12#1)(2013-1#2)
rate of change##24##3##(1990-7#1)(1992-12#1)(2006-3#1)(2007-11#1)(2007-4#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-8#3)(2009-6#1)(2009-9#4)(2012-12#1)(2013-1#2)
rate of chemical##2##3##(1997-7#1)(2007-11#1)
rate of clearance from the##2##5##(1991-2#1)(1995-1#1)
rate of clearance of##3##4##(1991-2#1)(2007-8#1)(2011-3#1)
rate of clearance##6##3##(1991-2#2)(1995-1#1)(2006-10#1)(2007-8#1)(2011-3#1)
rate of cleavage was due to##2##6##(1997-7#2)
rate of cleavage##4##3##(1992-7#1)(1997-1#1)(1997-7#2)
rate of colonization of##2##4##(2007-8#1)(2008-10#1)
rate of colonization##4##3##(2007-8#2)(2008-10#1)(2013-8#1)
rate of comorbidity##2##3##(1995-11#1)(2006-10#1)
rate of complete##4##3##(1994-2#1)(2006-10#1)(2010-12#1)(2011-2#1)
rate of complications and##2##4##(2013-1#2)
rate of complications in##4##4##(1990-9#1)(1991-9#1)(2008-1#1)(2010-4#1)
rate of complications was##2##4##(2007-7#2)
rate of complications##25##3##(1990-12#1)(1990-9#2)(1991-3#1)(1991-9#2)(1992-1#1)(1992-10#1)(1993-8#1)(1996-11#1)(1996-9#1)(1997-8#1)(2007-5#1)(2007-7#2)(2008-1#1)(2010-4#1)(2010-7#1)(2012-12#1)(2013-1#5)(2013-7#1)
rate of conduction##2##3##(2006-9#1)(2008-10#1)
rate of consanguineous marriages##2##4##(2008-4#1)(2011-2#1)
rate of contact##2##3##(1993-8#2)
rate of convergence##6##3##(1996-8#1)(2008-10#1)(2008-2#3)(2008-7#1)
rate of decline of##2##4##(1994-6#1)(2007-11#1)
rate of decline##5##3##(1994-6#1)(2007-11#1)(2007-7#1)(2008-7#1)(2010-8#1)
rate of decrease##2##3##(2006-10#1)(2008-3#1)
rate of degeneration##2##3##(2009-4#1)(2010-12#1)
rate of degradation of the##2##5##(1992-5#1)(2010-8#1)
rate of degradation of##6##4##(1990-11#1)(1990-5#1)(1992-12#1)(1992-5#1)(2008-10#1)(2010-8#1)
rate of degradation##7##3##(1990-11#1)(1990-5#1)(1991-7#1)(1992-12#1)(1992-5#1)(2008-10#1)(2010-8#1)
rate of development and##2##4##(2008-8#1)(2013-1#1)
rate of development##3##3##(2008-8#1)(2008-9#1)(2013-1#1)
rate of disease increase##3##4##(2008-10#3)
rate of disease progress and##2##5##(2008-10#2)
rate of disease progress##3##4##(2008-10#3)
rate of disease progression##4##4##(2004-11#1)(2008-10#2)(2012-2#1)
rate of disease##19##3##(1996-7#1)(2004-11#1)(2007-11#1)(2008-10#11)(2012-2#1)(2013-8#4)
rate of distal##2##3##(1993-7#1)(2007-7#1)
rate of drugs##3##3##(2008-10#1)(2008-5#2)
rate of each##4##3##(1994-12#1)(1995-9#1)(1996-5#1)(2013-1#1)
rate of early##5##3##(1991-9#1)(2006-7#1)(2007-1#1)(2007-7#1)(2008-8#1)
rate of eggs##2##3##(1996-12#1)(2010-8#1)
rate of either##2##3##(2007-8#1)(2008-10#1)
rate of electrode##2##3##(2007-10#1)(2008-10#1)
rate of electron transfer from##2##5##(1991-2#1)(2008-10#1)
rate of electron transfer##4##4##(1991-2#1)(1994-8#1)(1995-8#1)(2008-10#1)
rate of electron##5##3##(1991-2#1)(1994-8#1)(1995-8#1)(1997-6#1)(2008-10#1)
rate of emergence of##2##4##(2008-12#1)(2012-2#1)
rate of endoscopic##2##3##(2007-5#1)(2011-1#1)
rate of energy transfer##2##4##(2008-10#1)(2012-2#1)
rate of ethanol##5##3##(2005-11#1)(2005-9#3)(2008-7#1)
rate of evolution##3##3##(1995-11#1)(2006-5#1)(2011-2#1)
rate of exchange##4##3##(1993-11#1)(1994-12#1)(1994-8#1)(2009-3#1)
rate of expression##2##3##(1991-3#1)(1993-3#1)
rate of external##2##3##(1994-12#1)(2013-8#1)
rate of failure for##2##4##(1991-8#2)
rate of failure##5##3##(1991-8#2)(2004-9#1)(2006-5#1)(2013-8#1)
rate of fall##2##3##(1994-3#1)(2008-10#1)
rate of false##2##3##(1996-9#1)(2008-7#1)
rate of favorable neonatal outcome##2##5##(1992-12#2)
rate of first##3##3##(2010-7#1)(2013-1#2)
rate of fluorescence##2##3##(1994-12#1)(2008-10#1)
rate of force##2##3##(1991-12#1)(1997-4#1)
rate of formation and##2##4##(2007-11#1)(2010-5#1)
rate of formation of the##5##5##(1991-2#2)(1991-7#1)(1996-6#1)(2008-5#1)
rate of formation of##11##4##(1991-2#2)(1991-6#1)(1991-7#1)(1992-12#2)(1993-11#1)(1993-3#1)(1994-3#1)(1996-6#1)(2008-5#1)
rate of formation##15##3##(1991-2#2)(1991-6#1)(1991-7#1)(1992-11#1)(1992-12#2)(1993-11#2)(1993-3#1)(1994-3#1)(1996-6#1)(2007-11#1)(2008-5#1)(2010-5#1)
rate of fusion##2##3##(1991-5#1)(2012-12#1)
rate of glucose feeding##2##4##(2008-6#2)
rate of glucose##7##3##(1991-7#1)(1993-2#1)(2008-11#1)(2008-6#2)(2008-7#1)(2013-1#1)
rate of group##2##3##(2006-7#1)(2010-7#1)
rate of growth and##4##4##(1994-5#1)(2008-8#1)(2009-6#1)(2011-1#1)
rate of growth in##4##4##(1990-12#1)(1992-2#1)(1994-5#1)(2013-7#1)
rate of growth of##7##4##(1990-12#1)(1990-7#1)(1996-3#1)(1997-1#1)(2005-10#1)(2011-2#1)(2012-2#1)
rate of growth##24##3##(1990-12#2)(1990-7#1)(1991-1#1)(1992-2#1)(1992-5#1)(1994-5#2)(1996-3#1)(1997-1#1)(1997-2#1)(2005-10#1)(2007-12#2)(2008-7#1)(2008-8#2)(2009-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
rate of guanine##2##3##(1990-8#1)(1992-7#1)
rate of heat##3##3##(1990-9#1)(2008-2#1)(2008-3#1)
rate of hemoglobin##2##3##(1993-8#1)(2013-8#1)
rate of hepatic##4##3##(1991-7#2)(1993-3#1)(2012-2#1)
rate of human##3##3##(1992-2#1)(1994-12#1)(1996-3#1)
rate of hydride transfer from NADPH to dihydrofolate##2##8##(1990-5#2)
rate of hydrolysis of the##5##5##(1992-11#1)(1992-5#1)(1993-6#1)(2008-5#1)(2009-4#1)
rate of hydrolysis of##12##4##(1990-11#1)(1990-5#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-6#2)(1994-11#1)(2007-6#1)(2008-5#1)(2009-4#1)(2010-8#1)
rate of hydrolysis##17##3##(1990-11#2)(1990-5#1)(1992-11#1)(1992-12#3)(1992-5#1)(1993-6#3)(1994-11#1)(2007-6#1)(2008-5#1)(2009-4#1)(2010-8#1)(2013-1#1)
rate of improvement##2##3##(1991-4#1)(1997-8#1)
rate of in vivo##2##4##(1995-1#1)(1995-6#1)
rate of inactivation##6##3##(1992-12#1)(1993-11#2)(1994-9#1)(1995-1#1)(1995-2#1)
rate of incidence##3##3##(1997-7#1)(2008-9#1)(2009-5#1)
rate of incorporation##5##3##(1991-12#1)(1996-7#1)(1997-1#1)(2008-1#1)(2008-11#1)
rate of increase in the##2##5##(1990-12#1)(1994-9#1)
rate of increase in##9##4##(1990-12#1)(1990-7#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-9#1)(2007-8#1)(2008-5#1)(2008-9#1)
rate of increase of##5##4##(1996-1#2)(2008-10#2)(2008-8#1)
rate of increase##21##3##(1990-12#1)(1990-7#2)(1992-6#1)(1993-12#1)(1993-3#3)(1994-9#1)(1996-1#2)(2006-10#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#2)
rate of increased##4##3##(1995-4#1)(2013-1#2)(2013-7#1)
rate of individual##2##3##(2005-11#1)(2008-5#1)
rate of induced abortion among married women##2##7##(1991-8#2)
rate of induced abortion among##3##5##(1991-8#3)
rate of induced abortion in##2##5##(1991-8#2)
rate of induced abortion##8##4##(1991-8#7)(1992-2#1)
rate of infected and##2##4##(1994-9#1)(2008-10#1)
rate of infection among##2##4##(2004-9#1)(2006-2#1)
rate of infection of##2##4##(2008-10#2)
rate of infection##9##3##(1993-8#1)(2004-9#1)(2006-2#2)(2007-10#1)(2008-10#3)(2009-9#1)
rate of infusion##3##3##(1990-4#1)(2008-4#1)(2008-7#1)
rate of inhibition##2##3##(1990-3#1)(1991-2#1)
rate of insulin users##2##4##(2007-3#2)
rate of insulin##4##3##(1994-11#1)(2007-3#2)(2011-1#1)
rate of internalization of##2##4##(1995-2#1)(2008-5#1)
rate of intravenous rt-PA use##2##5##(2007-10#2)
rate of isolated##2##3##(1994-8#1)(2011-2#1)
rate of isolation of##2##4##(2008-12#1)(2009-5#1)
rate of isolation##3##3##(2008-12#1)(2008-5#1)(2009-5#1)
rate of its##2##3##(2008-10#1)(2012-3#1)
rate of knee##3##3##(2007-10#1)(2007-4#1)(2011-2#1)
rate of laser##2##3##(1991-3#1)(2009-11#1)
rate of late##6##3##(1994-11#1)(1996-2#1)(2006-10#1)(2007-11#1)(2008-8#1)(2010-11#1)
rate of lesion expansion##2##4##(2008-10#2)
rate of ligand dissociation##2##4##(1990-2#1)(1992-6#1)
rate of lipid##2##3##(1994-6#1)(2007-6#1)
rate of liver##2##3##(2006-2#2)
rate of living##2##3##(2007-8#1)(2008-8#1)
rate of loading##6##3##(2007-4#5)(2008-11#1)
rate of local recurrence##3##4##(2007-8#1)(2008-11#1)(2008-6#1)
rate of local##8##3##(1991-4#1)(2007-8#2)(2008-11#1)(2008-6#2)(2008-8#1)(2009-12#1)
rate of lymph node##2##4##(2008-1#1)(2013-1#1)
rate of lysis of##4##4##(1990-12#4)
rate of mRNA##2##3##(1990-3#1)(1994-5#1)
rate of major##3##3##(1994-1#1)(2006-8#1)(2008-11#1)
rate of malaria by##2##4##(2007-2#2)
rate of malaria##3##3##(2007-2#2)(2007-8#1)
rate of medical##2##3##(1992-3#1)(2010-2#1)
rate of metabolism##2##3##(1997-8#1)(2008-9#1)
rate of metal ion##2##4##(2008-10#2)
rate of metal##3##3##(2008-10#3)
rate of metastasis##3##3##(1994-12#1)(2008-6#1)(2012-2#1)
rate of migration##2##3##(1992-6#1)(2008-8#1)
rate of mitochondrial##2##3##(1994-12#1)(1995-6#1)
rate of mixed##3##3##(2006-8#2)(2008-5#1)
rate of morbidity and mortality##2##5##(1993-6#1)(2007-12#1)
rate of morbidity##4##3##(1993-6#1)(2006-3#1)(2007-12#1)(2012-2#1)
rate of more than##3##4##(2007-12#1)(2008-2#1)(2013-7#1)
rate of mortality##2##3##(2012-12#1)(2012-2#1)
rate of movement of##3##4##(1991-5#2)(1995-11#1)
rate of muscle##2##3##(1993-11#1)(1994-8#1)
rate of natural##5##3##(2007-7#3)(2011-2#2)
rate of nearly##2##3##(1996-1#1)(2010-8#1)
rate of new##5##3##(1991-8#1)(2007-11#1)(2007-5#1)(2010-5#1)(2013-1#1)
rate of nosocomial infections##2##4##(1996-12#1)(2007-12#1)
rate of nosocomial##3##3##(1992-10#1)(1996-12#1)(2007-12#1)
rate of nucleotide##2##3##(1994-9#1)(2008-6#1)
rate of occurrence of##3##4##(1991-9#1)(1996-4#2)
rate of occurrence##4##3##(1991-9#1)(1996-4#2)(2011-2#1)
rate of only 17%##2##4##(2006-5#1)(2007-12#1)
rate of only##4##3##(2006-5#1)(2007-12#2)(2008-10#1)
rate of osteoarthrosis##2##3##(2008-3#2)
rate of overall##3##3##(1992-11#1)(2008-4#1)(2012-12#1)
rate of oxidation of##2##4##(1991-1#1)(2008-12#1)
rate of oxidation##6##3##(1991-1#1)(1996-5#1)(2005-8#1)(2008-10#2)(2008-12#1)
rate of oxidative phosphorylation##2##4##(1994-12#1)(1996-9#1)
rate of oxidative##3##3##(1994-12#1)(1996-9#1)(2008-10#1)
rate of oxygen consumption##5##4##(1997-1#1)(2008-10#1)(2009-6#1)(2010-11#2)
rate of oxygen evolution##2##4##(1994-12#1)(2008-6#1)
rate of oxygen uptake##2##4##(2008-5#2)
rate of oxygen##13##3##(1994-12#1)(1995-11#1)(1997-1#1)(1997-8#1)(2006-11#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-6#1)(2010-11#2)
rate of pancreatic##3##3##(1995-5#1)(2004-12#1)(2013-1#1)
rate of patients with##2##4##(2007-10#1)(2008-1#1)
rate of patients##7##3##(1997-8#2)(2007-10#1)(2008-1#1)(2008-11#1)(2009-6#1)(2012-2#1)
rate of penetration of##3##4##(1990-3#3)
rate of perceived exertion##2##4##(2012-12#2)
rate of photoinhibition is slow##2##5##(1995-8#2)
rate of photoinhibition is##3##4##(1995-8#3)
rate of plasma##2##3##(1996-3#1)(2008-2#1)
rate of platelet aggregation##4##4##(1995-12#2)(2008-5#2)
rate of population growth##2##4##(1994-7#1)(2006-12#1)
rate of population##5##3##(1994-7#1)(2006-12#1)(2008-10#1)(2008-8#1)(2012-2#1)
rate of positive##6##3##(1997-4#1)(2005-1#1)(2008-12#1)(2008-3#1)(2011-1#1)(2012-12#1)
rate of positivity##3##3##(1997-2#2)(2006-8#1)
rate of post-ESD##2##3##(2012-2#2)
rate of pregnancy##3##3##(1996-12#1)(2007-3#1)(2008-3#1)
rate of pressure##2##3##(2012-2#2)
rate of primary##7##3##(1991-11#1)(2007-7#1)(2008-10#2)(2008-7#1)(2011-1#1)(2011-2#1)
rate of probe##2##3##(1991-7#1)(1992-1#1)
rate of product##4##3##(1992-11#2)(1995-3#1)(2008-7#1)
rate of production##3##3##(1993-9#1)(1996-5#2)
rate of progression to##3##4##(2006-12#1)(2011-3#1)(2012-2#1)
rate of progression##7##3##(1991-8#1)(2005-7#1)(2006-12#1)(2007-7#2)(2011-3#1)(2012-2#1)
rate of protein##12##3##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#1)(1991-7#1)(1994-6#1)(1995-1#1)(1995-6#2)(1996-7#1)(2008-4#1)(2008-5#1)
rate of proton##3##3##(1994-8#1)(1994-9#1)(1997-6#1)
rate of psychiatric##3##3##(2007-1#1)(2011-1#1)(2013-1#1)
rate of pustule appearance##3##4##(2008-10#3)
rate of pustule##4##3##(2008-10#4)
rate of quench##2##3##(1992-5#2)
rate of reaction with##2##4##(1995-5#1)(1997-8#1)
rate of reaction##7##3##(1995-10#1)(1995-5#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#2)
rate of receptor##2##3##(1992-9#1)(2008-1#1)
rate of recovery of##3##4##(2008-11#1)(2008-5#1)(2008-7#1)
rate of recovery##8##3##(1992-9#1)(1996-6#1)(2005-4#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)
rate of recurrence##7##3##(1990-4#1)(2006-6#1)(2008-10#1)(2008-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
rate of recurrent##3##3##(1996-11#1)(2007-1#1)(2013-1#1)
rate of reduction##6##3##(1991-10#1)(1991-12#1)(1993-4#1)(2006-3#2)(2008-10#1)
rate of relapse##2##3##(2007-11#1)(2012-12#1)
rate of release of##8##4##(1991-2#1)(1991-7#1)(1992-3#1)(2010-8#4)(2011-2#1)
rate of release##12##3##(1991-2#1)(1991-7#1)(1992-3#1)(2004-12#1)(2008-10#1)(2010-8#4)(2011-2#3)
rate of renal##3##3##(1994-5#1)(1995-12#1)(2008-1#1)
rate of reoperation##2##3##(2010-3#1)(2012-12#1)
rate of reported##7##3##(1994-2#1)(2006-10#1)(2007-12#1)(2013-1#2)(2013-8#2)
rate of resistance to##2##4##(2006-8#1)(2012-2#1)
rate of resistance##4##3##(2006-8#1)(2008-10#1)(2010-8#1)(2012-2#1)
rate of resolution in the placebo group##2##7##(2006-10#2)
rate of resolution in##3##4##(2006-10#3)
rate of resource##3##3##(2008-8#3)
rate of responders##2##3##(1996-12#1)(2008-6#1)
rate of responding##4##3##(1993-6#1)(1996-10#1)(1997-7#1)(2008-5#1)
rate of response to##2##4##(1993-11#1)(2009-8#1)
rate of response##3##3##(1993-11#1)(2009-12#1)(2009-8#1)
rate of return##5##3##(1992-1#1)(1992-12#1)(2007-4#2)(2007-9#1)
rate of rise of the##2##5##(1994-3#1)(2009-6#1)
rate of rise of##3##4##(1994-3#1)(1997-8#1)(2009-6#1)
rate of rise##4##3##(1994-3#1)(1997-8#1)(2007-10#1)(2009-6#1)
rate of rotation of the##2##5##(2006-4#1)(2008-3#1)
rate of rotation of##3##4##(1997-1#1)(2006-4#1)(2008-3#1)
rate of secretion##5##3##(1990-8#1)(1991-5#1)(1991-6#1)(1993-9#1)(1997-2#1)
rate of side effects##3##4##(1997-8#1)(2007-11#1)(2011-2#1)
rate of smoking##2##3##(1991-11#1)(2007-8#1)
rate of sperm##2##3##(1995-2#1)(2008-5#1)
rate of spontaneous##5##3##(1991-2#1)(1993-3#1)(1994-3#1)(2007-1#1)(2012-2#1)
rate of spread of the##2##5##(2008-10#2)
rate of stage IA##2##4##(2007-8#2)
rate of streptokinase production##2##4##(2012-2#2)
rate of substrate##4##3##(1990-3#1)(1995-10#1)(2008-10#1)(2008-7#1)
rate of success##4##3##(1991-2#1)(1993-8#1)(2006-10#1)(2007-7#1)
rate of successful##3##3##(2006-5#1)(2007-2#1)(2011-2#1)
rate of suicide##2##3##(2011-2#1)(2012-2#1)
rate of surface tension##2##4##(1994-5#1)(2005-11#1)
rate of surface##5##3##(1994-5#1)(2005-11#1)(2007-7#1)(2008-4#1)(2009-12#1)
rate of surfactant##3##3##(1994-5#2)(2005-11#1)
rate of surgical##3##3##(2006-9#1)(2008-8#1)(2010-2#1)
rate of survival##3##3##(1991-6#1)(1992-2#1)(2008-5#1)
rate of synthesis of##2##4##(1992-6#1)(1994-8#1)
rate of synthesis##4##3##(1992-6#1)(1994-2#1)(1994-8#2)
rate of t-PA##3##3##(1990-11#3)
rate of telomere shortening##2##4##(2009-5#1)(2010-3#1)
rate of temporal##4##3##(2008-10#3)(2011-1#1)
rate of the ATPase##2##4##(1992-6#1)(1997-4#1)
rate of the cells##2##4##(1997-7#1)(2008-11#1)
rate of the disease and##2##5##(2008-1#1)(2011-2#1)
rate of the disease##7##4##(1996-7#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-8#1)(2011-1#1)(2011-2#1)
rate of the enzyme##2##4##(1992-12#1)(1994-9#1)
rate of the metabolic##2##4##(1992-1#1)(2008-3#1)
rate of the micropump##2##4##(2007-2#2)
rate of the overall##3##4##(1995-9#1)(2008-7#1)(2008-8#1)
rate of the particles##2##4##(1993-8#1)(2005-11#1)
rate of the propagation period##3##5##(1991-12#3)
rate of the protein##3##4##(2008-2#1)(2008-4#1)(2009-12#1)
rate of the reaction##4##4##(1990-2#1)(2008-10#3)
rate of the skin##2##4##(2008-5#1)(2012-3#1)
rate of the titrant##3##4##(2008-10#3)
rate of the two##3##4##(2008-10#1)(2009-8#1)(2013-8#1)
rate of the##191##3##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#4)(1991-10#2)(1991-12#4)(1991-2#1)(1991-4#2)(1991-6#1)(1991-9#3)(1992-1#2)(1992-12#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-8#2)(1994-11#2)(1994-12#2)(1994-3#2)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#2)(1995-12#1)(1995-2#2)(1995-9#2)(1996-11#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#2)(2004-8#1)(2005-11#4)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#4)(2007-12#1)(2007-2#3)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#31)(2008-11#3)(2008-12#3)(2008-2#5)(2008-3#7)(2008-4#2)(2008-5#6)(2008-7#6)(2008-8#4)(2008-9#4)(2009-12#1)(2009-2#2)(2009-6#1)(2009-8#1)(2010-12#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
rate of their##3##3##(1991-9#1)(2007-11#1)(2007-7#1)
rate of these##6##3##(1991-8#1)(1996-4#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-5#1)
rate of this##9##3##(1994-10#1)(1994-2#1)(1996-3#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-5#1)(2011-2#1)
rate of tissue##3##3##(1990-9#1)(1991-12#1)(2007-3#1)
rate of tobacco##2##3##(2013-1#2)
rate of transcription##10##3##(1990-7#1)(1991-2#2)(1991-7#1)(1992-1#1)(1992-12#1)(1994-3#1)(1994-9#1)(1996-8#2)
rate of transfer##3##3##(1993-3#1)(2008-3#1)(2010-5#1)
rate of translation##2##3##(1995-2#1)(1995-9#1)
rate of transmission##4##3##(1996-11#1)(2006-10#1)(2006-4#1)(2008-10#1)
rate of transport was##2##4##(1990-3#1)(2008-10#1)
rate of transport##9##3##(1990-3#2)(1995-11#1)(1996-11#1)(1996-8#1)(1997-8#1)(2008-10#3)
rate of treatment##2##3##(1991-12#1)(2008-2#1)
rate of tuberculosis##2##3##(1996-3#1)(2007-4#1)
rate of tumor growth##2##4##(1990-7#1)(2013-8#1)
rate of tumor##5##3##(1990-7#1)(1993-7#1)(1997-7#1)(2013-1#1)(2013-8#1)
rate of tumour##2##3##(1991-7#1)(2008-11#1)
rate of turnover of##3##4##(1990-12#1)(1995-3#1)(2008-4#1)
rate of turnover##6##3##(1990-12#1)(1992-4#1)(1994-12#1)(1995-3#1)(1996-9#1)(2008-4#1)
rate of two##2##3##(1996-7#1)(2008-10#1)
rate of undesired##2##3##(1994-12#1)(1996-4#1)
rate of up to 30##3##5##(1997-1#1)(2008-10#1)(2011-1#1)
rate of up to##10##4##(1997-1#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-12#1)(2010-12#1)(2010-8#1)(2011-1#1)(2013-1#1)
rate of uptake of##4##4##(1991-3#1)(1991-5#1)(1992-6#1)(2008-7#1)
rate of uptake##7##3##(1991-3#1)(1991-5#1)(1992-6#1)(1995-11#2)(2008-10#1)(2008-7#1)
rate of urea##2##3##(1993-11#1)(2013-8#1)
rate of vertical transmission of HBV##2##6##(2011-1#2)
rate of very##2##3##(2007-11#1)(2011-2#1)
rate of viral##3##3##(1996-4#1)(2009-5#1)(2012-2#1)
rate of water##6##3##(2007-7#2)(2008-10#2)(2009-5#1)(2010-4#1)
rate of zinc##2##3##(2004-11#1)(2012-2#1)
rate of##2704##2##(1990-10#3)(1990-11#21)(1990-12#25)(1990-2#11)(1990-3#15)(1990-4#5)(1990-5#10)(1990-6#7)(1990-7#16)(1990-8#9)(1990-9#10)(1991-1#7)(1991-10#8)(1991-11#7)(1991-12#20)(1991-2#23)(1991-3#7)(1991-4#8)(1991-5#15)(1991-6#7)(1991-7#15)(1991-8#16)(1991-9#14)(1992-1#8)(1992-10#11)(1992-11#11)(1992-12#17)(1992-2#13)(1992-3#6)(1992-4#6)(1992-5#10)(1992-6#14)(1992-7#7)(1992-8#2)(1992-9#10)(1993-1#6)(1993-10#3)(1993-11#15)(1993-12#5)(1993-2#3)(1993-3#13)(1993-4#7)(1993-5#2)(1993-6#9)(1993-7#4)(1993-8#10)(1993-9#7)(1994-1#3)(1994-10#2)(1994-11#16)(1994-12#21)(1994-2#13)(1994-3#13)(1994-5#14)(1994-6#13)(1994-7#5)(1994-8#24)(1994-9#15)(1995-1#9)(1995-10#7)(1995-11#17)(1995-12#12)(1995-2#11)(1995-3#10)(1995-4#3)(1995-5#10)(1995-6#11)(1995-7#2)(1995-8#7)(1995-9#4)(1996-1#4)(1996-10#3)(1996-11#11)(1996-12#6)(1996-2#5)(1996-3#11)(1996-4#7)(1996-5#18)(1996-6#4)(1996-7#10)(1996-8#14)(1996-9#8)(1997-1#12)(1997-2#9)(1997-3#2)(1997-4#19)(1997-5#5)(1997-6#7)(1997-7#11)(1997-8#18)(2003-11#1)(2004-1#3)(2004-10#2)(2004-11#5)(2004-12#3)(2004-2#1)(2004-4#1)(2004-8#1)(2004-9#8)(2005-1#1)(2005-10#4)(2005-11#20)(2005-12#5)(2005-4#2)(2005-7#5)(2005-8#4)(2005-9#5)(2006-10#34)(2006-11#1)(2006-12#11)(2006-2#11)(2006-3#8)(2006-4#5)(2006-5#9)(2006-6#4)(2006-7#8)(2006-8#26)(2006-9#8)(2007-1#8)(2007-10#16)(2007-11#53)(2007-12#69)(2007-2#16)(2007-3#17)(2007-4#13)(2007-5#6)(2007-6#3)(2007-7#47)(2007-8#45)(2007-9#10)(2008-1#33)(2008-10#317)(2008-11#55)(2008-12#32)(2008-2#31)(2008-3#49)(2008-4#18)(2008-5#79)(2008-6#33)(2008-7#56)(2008-8#44)(2008-9#30)(2009-10#1)(2009-11#4)(2009-12#4)(2009-2#6)(2009-3#7)(2009-4#8)(2009-5#11)(2009-6#7)(2009-7#2)(2009-8#9)(2009-9#9)(2010-10#2)(2010-11#7)(2010-12#14)(2010-2#11)(2010-3#10)(2010-4#8)(2010-5#8)(2010-6#3)(2010-7#4)(2010-8#22)(2010-9#4)(2011-1#43)(2011-11#1)(2011-12#4)(2011-2#60)(2011-3#3)(2011-7#1)(2012-1#4)(2012-11#5)(2012-12#47)(2012-2#48)(2012-3#29)(2013-1#68)(2013-7#12)(2013-8#38)
rate on the##22##3##(1993-8#1)(1996-2#2)(1996-4#1)(1997-2#3)(1997-7#1)(2004-12#1)(2004-9#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-5#1)(2009-11#1)(2009-7#1)(2009-8#1)(2011-2#1)(2013-8#1)
rate on##55##2##(1990-2#1)(1993-8#1)(1994-11#2)(1994-2#1)(1996-12#2)(1996-2#2)(1996-4#1)(1997-2#3)(1997-7#1)(1997-8#1)(2004-12#1)(2004-9#1)(2007-10#1)(2007-11#1)(2007-4#3)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-11#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#3)
rate or survival##2##3##(2007-11#1)(2010-8#1)
rate or the##4##3##(1991-5#1)(1994-11#1)(1994-5#1)(2008-10#1)
rate or##25##2##(1990-2#1)(1991-3#2)(1991-5#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-5#1)(1996-7#1)(2005-1#1)(2005-8#2)(2006-5#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-7#1)(2008-8#1)(2010-2#1)(2010-8#1)(2013-1#1)
rate over##13##2##(1994-9#1)(1997-1#1)(2006-12#1)(2006-4#1)(2008-11#2)(2008-2#1)(2008-6#2)(2008-8#1)(2009-10#1)(2010-3#1)(2011-2#1)
rate parameter##4##2##(1996-2#1)(2008-10#3)
rate parameters##5##2##(1994-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-11#1)
rate per 100##2##3##(2007-8#1)(2011-2#1)
rate per enzyme adsorbed##2##4##(2008-7#2)
rate per unit of##2##4##(2007-11#1)(2008-10#1)
rate per year##2##3##(2008-7#1)(2008-8#1)
rate per##16##2##(1996-3#1)(2004-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#2)(2011-2#1)(2013-1#1)
rate procedure##2##2##(2008-10#1)(2011-1#1)
rate process##2##2##(2005-11#2)
rate profiles of##2##3##(2008-5#1)(2008-7#1)
rate profiles##3##2##(1991-9#1)(2008-5#1)(2008-7#1)
rate provided##2##2##(2008-1#1)(2008-10#1)
rate raises the##2##3##(1993-12#1)(2008-3#1)
rate ranged between##2##3##(2007-2#1)(2011-10#1)
rate ranged##3##2##(2007-2#1)(2008-8#1)(2011-10#1)
rate ranging between##2##3##(2006-6#2)
rate ranging from##3##3##(2007-12#1)(2008-10#1)(2009-10#1)
rate ranging##5##2##(2006-6#2)(2007-12#1)(2008-10#1)(2009-10#1)
rate ratio of##4##3##(1991-9#1)(2008-10#1)(2008-3#1)(2012-2#1)
rate ratio##12##2##(1991-9#3)(1993-9#2)(1994-5#1)(1994-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-12#1)(2012-2#1)
rate ratios and##2##3##(2008-10#1)(2011-2#1)
rate ratios were##2##3##(1994-7#1)(2012-2#1)
rate ratios##6##2##(1994-7#1)(1996-12#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-2#1)
rate reached##5##2##(2008-10#1)(2008-11#1)(2008-8#1)(2009-6#1)(2012-3#1)
rate reduction##6##2##(2007-8#1)(2008-1#1)(2008-2#1)(2008-7#2)(2013-1#1)
rate remained constant##2##3##(1994-5#2)
rate remained##3##2##(1994-5#2)(2008-11#1)
rate remains constant##2##3##(2008-10#1)(2008-11#1)
rate remains##3##2##(2008-10#1)(2008-11#1)(2010-12#1)
rate required for##2##3##(1991-8#1)(2008-6#1)
rate restrictions and open enrolment##3##5##(2008-7#3)
rate seemed##2##2##(1996-5#1)(2011-2#1)
rate seems to be##2##4##(2007-12#1)(2007-8#1)
rate seems to##4##3##(2006-6#1)(2007-12#1)(2007-8#1)(2008-7#1)
rate should be##3##3##(2006-5#1)(2007-12#1)(2007-8#1)
rate should##4##2##(2006-5#1)(2007-12#1)(2007-7#1)(2007-8#1)
rate showed a##3##3##(2007-7#1)(2008-11#1)(2012-12#1)
rate showed##6##2##(1991-8#1)(1996-1#1)(2007-7#1)(2008-11#1)(2008-5#1)(2012-12#1)
rate significantly##5##2##(1994-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-5#1)
rate similar to that of the##2##6##(1994-8#1)(1995-2#1)
rate similar to that##5##4##(1993-8#1)(1994-8#1)(1995-2#1)(1996-8#1)(2007-1#1)
rate so##2##2##(1991-6#1)(1997-8#1)
rate stability##2##2##(1991-1#1)(2008-10#1)
rate still remains##2##3##(1993-5#1)(2010-11#1)
rate studies##2##2##(1991-9#1)(1993-8#1)
rate system##3##2##(1995-2#1)(2008-4#2)
rate tended to##2##3##(2007-10#1)(2008-10#1)
rate than did##3##3##(2007-9#1)(2008-10#1)(2008-3#1)
rate than in##3##3##(1993-9#1)(1995-5#1)(2007-2#1)
rate than that of the##2##5##(2007-12#1)(2013-1#1)
rate than that##6##3##(1990-12#2)(2007-12#1)(2008-11#1)(2008-6#1)(2013-1#1)
rate than the##11##3##(1990-2#1)(1991-10#1)(1992-12#1)(1995-3#1)(1996-8#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2009-10#1)
rate than those##2##3##(2007-2#1)(2011-2#1)
rate than##57##2##(1990-12#2)(1990-2#1)(1990-8#1)(1991-10#1)(1991-3#2)(1991-7#1)(1992-12#1)(1993-9#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-8#1)(1997-1#1)(1997-5#2)(1997-8#1)(2004-12#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-9#3)(2008-1#1)(2008-10#1)(2008-11#6)(2008-2#5)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
rate that is##5##3##(1994-2#1)(1997-6#1)(2004-12#1)(2007-11#1)(2013-1#1)
rate that##21##2##(1991-8#1)(1994-2#1)(1997-6#1)(1997-7#1)(2004-12#1)(2005-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2012-2#1)(2013-1#3)
rate the##12##2##(1991-2#1)(1993-12#1)(1995-3#1)(1996-2#1)(1997-8#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2012-3#1)(2013-8#1)
rate their overall##2##3##(2007-8#1)(2008-7#1)
rate their##11##2##(1993-1#1)(1993-2#1)(1996-2#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-7#2)(2010-3#1)(2010-4#2)
rate through##3##2##(2005-9#1)(2011-1#1)(2012-3#1)
rate throughout the##4##3##(1994-7#1)(2008-11#1)(2008-7#1)(2010-8#1)
rate throughout##5##2##(1994-7#1)(1996-5#1)(2008-11#1)(2008-7#1)(2010-8#1)
rate times##3##2##(1993-1#1)(1994-12#1)(1996-12#1)
rate to be##3##3##(2008-11#1)(2008-3#1)(2010-12#1)
rate to generate##2##3##(1995-6#1)(2008-7#1)
rate to predict##2##3##(2008-10#1)(2008-7#1)
rate to the##8##3##(2006-10#1)(2006-12#2)(2006-2#1)(2007-12#1)(2008-11#2)(2008-3#1)
rate to##39##2##(1990-10#1)(1990-11#1)(1990-9#1)(1993-6#1)(1995-6#1)(1996-9#1)(1997-2#1)(2006-10#1)(2006-12#2)(2006-2#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#3)(2009-11#1)(2010-12#1)(2012-12#1)(2012-2#3)(2012-3#1)(2012-8#1)
rate up to##3##3##(1994-3#1)(2008-6#1)(2011-2#1)
rate using##4##2##(2008-10#1)(2008-12#1)(2008-8#2)
rate value of##2##3##(2008-10#1)(2013-1#1)
rate values##4##2##(2008-10#1)(2008-5#1)(2009-3#1)(2013-1#1)
rate variability (HRV)##10##3##(1995-3#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-10#1)(2009-11#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-8#1)
rate variability and##5##3##(1994-5#1)(2008-12#1)(2008-7#1)(2010-12#1)(2010-5#1)
rate variability in##5##3##(1995-3#1)(1995-6#1)(2006-12#2)(2006-9#1)
rate variability##40##2##(1991-4#1)(1993-5#2)(1994-5#1)(1995-3#2)(1995-6#2)(1996-2#1)(2005-12#1)(2006-11#1)(2006-12#2)(2006-9#1)(2008-10#1)(2008-12#3)(2008-6#1)(2008-7#1)(2009-10#2)(2009-11#2)(2010-12#2)(2010-5#3)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#4)(2013-8#2)
rate varied from##5##3##(2008-10#2)(2008-6#1)(2008-9#2)
rate varied##7##2##(2007-5#1)(2008-10#2)(2008-6#1)(2008-9#2)(2009-6#1)
rate versus the##2##3##(2008-2#1)(2010-1#1)
rate vs##4##2##(1992-4#1)(1995-7#1)(2006-12#1)(2008-8#1)
rate was 0##12##3##(1990-6#1)(1994-3#1)(2007-2#1)(2007-3#1)(2007-5#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
rate was 0% and the##2##5##(1991-2#1)(2011-1#1)
rate was 0%##3##3##(1991-2#1)(2008-6#1)(2011-1#1)
rate was 1##10##3##(1991-2#1)(1994-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-2#1)(2011-2#1)
rate was 10%##2##3##(1993-2#1)(2011-2#1)
rate was 100%##7##3##(1992-10#1)(1997-3#1)(2006-8#1)(2008-1#1)(2008-2#1)(2012-3#2)
rate was 11##2##3##(2007-7#1)(2008-10#1)
rate was 11%##4##3##(1992-1#1)(1996-12#1)(2007-8#1)(2010-3#1)
rate was 12##2##3##(1996-8#1)(1997-7#1)
rate was 12%##3##3##(1994-3#1)(1996-9#1)(2011-11#1)
rate was 13##4##3##(2005-8#1)(2011-1#2)(2013-8#1)
rate was 13%##3##3##(2005-9#1)(2008-9#1)(2013-1#1)
rate was 14%##2##3##(2007-8#1)(2011-1#1)
rate was 15##2##3##(2007-8#2)
rate was 2##9##3##(1992-9#1)(2006-12#1)(2007-8#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
rate was 2%##2##3##(2007-11#1)(2011-2#1)
rate was 20##3##3##(2008-10#1)(2013-1#2)
rate was 20%##3##3##(1990-6#1)(1993-5#1)(2008-9#1)
rate was 22##2##3##(2007-2#1)(2007-8#1)
rate was 27##3##3##(2006-4#1)(2008-10#1)(2011-11#1)
rate was 27%##2##3##(1993-8#1)(2011-2#1)
rate was 3##7##3##(1991-9#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-5#1)(2012-2#1)
rate was 30##2##3##(2008-10#1)(2013-8#1)
rate was 33%##2##3##(1991-2#1)(2009-10#1)
rate was 4##7##3##(1991-4#1)(1992-1#1)(1992-9#1)(2006-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
rate was 40%##3##3##(1995-5#1)(2007-3#1)(2012-2#1)
rate was 41%##2##3##(2010-12#1)(2011-2#1)
rate was 46##2##3##(2006-4#1)(2011-1#1)
rate was 50%##3##3##(2007-11#1)(2007-12#1)(2007-6#1)
rate was 52%##2##3##(2006-10#1)(2007-9#1)
rate was 53%##3##3##(1991-3#1)(2008-6#1)(2010-8#1)
rate was 55%##2##3##(2004-1#1)(2011-2#1)
rate was 58%##2##3##(1993-1#1)(2008-12#1)
rate was 6##5##3##(2007-5#1)(2007-9#1)(2008-7#1)(2013-1#2)
rate was 60##2##3##(2008-10#1)(2011-1#1)
rate was 60%##2##3##(1992-2#1)(2004-1#1)
rate was 61##5##3##(1990-9#1)(1992-1#1)(1993-8#1)(2007-7#1)(2011-1#1)
rate was 64##2##3##(1996-12#1)(1997-7#1)
rate was 71##2##3##(2007-7#1)(2007-8#1)
rate was 71%##2##3##(1993-1#1)(2006-10#1)
rate was 72%##2##3##(1993-5#1)(2008-11#1)
rate was 75%##2##3##(1990-6#1)(2006-10#1)
rate was 77##2##3##(1997-7#1)(2007-8#1)
rate was 8##3##3##(2006-6#1)(2007-7#1)(2007-9#1)
rate was 80%##2##3##(2006-7#1)(2007-1#1)
rate was 82%##2##3##(2006-12#1)(2006-4#1)
rate was 84%##3##3##(1992-10#1)(2007-7#1)(2008-7#1)
rate was 85##2##3##(2007-8#1)(2008-1#1)
rate was 87##2##3##(2004-10#1)(2013-8#1)
rate was 88%##3##3##(1991-2#1)(1991-6#1)(2008-7#1)
rate was 9##4##3##(1990-12#1)(2006-2#1)(2011-3#1)(2013-8#1)
rate was 90##3##3##(2008-10#1)(2008-11#1)(2012-12#1)
rate was 92%##2##3##(2008-12#1)(2013-7#1)
rate was 93##2##3##(2008-10#1)(2008-8#1)
rate was 94##3##3##(2008-3#1)(2011-2#1)(2013-1#1)
rate was 95##3##3##(2006-12#1)(2008-10#1)(2013-7#1)
rate was about##4##3##(2008-10#2)(2008-11#1)(2013-1#1)
rate was achieved##4##3##(1991-4#1)(2007-8#1)(2011-2#1)(2013-8#1)
rate was also##4##3##(1997-2#1)(2008-10#1)(2008-6#1)(2008-7#1)
rate was approximately##2##3##(2008-10#1)(2008-3#1)
rate was as high as##2##5##(2012-2#1)(2013-1#1)
rate was calculated as##2##4##(2008-5#1)(2012-2#1)
rate was calculated##8##3##(1990-9#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-8#2)(2012-2#1)
rate was comparable##3##3##(2006-7#1)(2008-10#1)(2012-12#1)
rate was considerably##2##3##(1993-6#1)(1995-3#1)
rate was decreased by##2##4##(1995-12#1)(2012-3#1)
rate was decreased##3##3##(1995-12#1)(2008-10#1)(2012-3#1)
rate was derived##2##3##(1993-2#1)(2008-7#1)
rate was determined##2##3##(2008-7#1)(2010-5#1)
rate was equal to##2##4##(1990-12#1)(2008-10#1)
rate was equal##3##3##(1990-12#1)(1996-7#1)(2008-10#1)
rate was estimated to be##2##5##(2007-11#1)(2012-2#1)
rate was found to be##9##5##(1990-10#2)(1994-3#1)(1995-12#2)(2006-3#1)(2007-8#1)(2008-7#1)(2010-8#1)
rate was found to##11##4##(1990-10#2)(1994-3#1)(1995-12#2)(2006-3#1)(2007-5#1)(2007-8#1)(2008-7#2)(2010-8#1)
rate was found##15##3##(1990-10#2)(1992-6#1)(1994-3#1)(1995-12#2)(2006-3#1)(2007-5#1)(2007-8#1)(2008-3#1)(2008-7#3)(2010-8#1)(2013-8#1)
rate was halved##2##3##(1992-2#1)(2009-10#1)
rate was high in##2##4##(2007-7#1)(2008-8#1)
rate was high##4##3##(1991-6#1)(2007-7#1)(2008-10#1)(2008-8#1)
rate was higher in the##2##5##(2007-8#1)(2012-2#1)
rate was higher in##9##4##(1991-4#1)(2004-10#1)(2006-2#1)(2006-5#1)(2007-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
rate was higher than##2##4##(2008-11#1)(2013-1#1)
rate was higher##14##3##(1990-12#1)(1991-4#1)(1992-5#2)(2004-10#1)(2006-2#1)(2006-5#1)(2007-8#1)(2008-11#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
rate was highest in the##2##5##(2006-7#1)(2008-10#1)
rate was highest in##3##4##(2006-2#1)(2006-7#1)(2008-10#1)
rate was highest##6##3##(1991-4#1)(1996-6#1)(2006-2#1)(2006-7#1)(2008-10#2)
rate was important##2##3##(1991-12#1)(2006-12#1)
rate was in##2##3##(2007-7#1)(2008-10#1)
rate was increased##4##3##(1993-3#1)(1996-2#1)(2006-10#1)(2008-10#1)
rate was low##3##3##(1990-3#1)(2006-10#1)(2008-11#1)
rate was lower in##2##4##(2006-5#1)(2013-1#1)
rate was lower than##3##4##(1992-9#1)(2008-10#1)(2008-7#1)
rate was lower##8##3##(1992-9#1)(2006-5#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-6#1)(2013-1#1)
rate was maintained at##2##4##(1996-2#1)(2008-5#1)
rate was maintained##4##3##(1994-3#1)(1996-2#1)(2008-10#1)(2008-5#1)
rate was measured##2##3##(1995-3#1)(2009-11#1)
rate was monitored##2##3##(2008-10#1)(2008-6#1)
rate was much lower##3##4##(1994-9#1)(2008-6#1)(2013-8#1)
rate was not significantly affected##2##5##(2008-11#1)(2010-11#1)
rate was not##5##3##(1991-2#1)(2008-11#1)(2010-11#1)(2011-2#1)(2012-3#1)
rate was observed in##4##4##(1990-10#1)(2005-7#1)(2008-11#1)(2011-1#1)
rate was observed##9##3##(1990-10#1)(1994-5#1)(1995-7#1)(2005-7#1)(2007-2#1)(2008-11#2)(2008-3#1)(2011-1#1)
rate was obtained##5##3##(2008-11#1)(2008-3#1)(2008-5#2)(2012-2#1)
rate was only##4##3##(1992-10#1)(1994-7#1)(2007-10#1)(2007-3#1)
rate was over##2##3##(1994-2#1)(2008-10#1)
rate was positively##2##3##(2008-7#1)(2010-8#1)
rate was reduced##3##3##(1993-1#1)(1994-3#1)(2013-8#1)
rate was seen in##2##4##(2005-7#1)(2006-5#1)
rate was seen##3##3##(1992-6#1)(2005-7#1)(2006-5#1)
rate was significantly higher in##6##5##(1990-12#1)(1991-6#1)(2007-7#2)(2008-10#1)(2008-7#1)
rate was significantly higher##10##4##(1990-12#1)(1991-6#1)(1994-5#1)(2004-10#1)(2006-5#1)(2007-7#2)(2008-10#1)(2008-6#1)(2008-7#1)
rate was significantly lower##2##4##(1996-2#1)(2007-7#1)
rate was significantly##16##3##(1990-12#1)(1991-6#1)(1993-4#1)(1994-5#1)(1996-2#1)(1997-2#1)(2004-10#1)(2006-5#1)(2007-7#3)(2008-10#1)(2008-6#1)(2008-7#1)(2010-3#2)
rate was similar in##2##4##(2006-8#1)(2008-7#1)
rate was similar##3##3##(2006-8#1)(2008-7#1)(2013-7#1)
rate was slightly##3##3##(1990-11#1)(1997-8#1)(2008-6#1)
rate was slower in##2##4##(1995-12#1)(2013-1#1)
rate was taken as##2##4##(1992-11#1)(1996-7#1)
rate was the##4##3##(2008-10#1)(2013-1#3)
rate was used##2##3##(1991-8#1)(2008-4#1)
rate was##517##2##(1990-10#4)(1990-11#2)(1990-12#6)(1990-3#2)(1990-6#4)(1990-7#1)(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#7)(1991-3#2)(1991-4#5)(1991-6#4)(1991-8#2)(1991-9#1)(1992-1#3)(1992-10#4)(1992-11#1)(1992-2#2)(1992-5#3)(1992-6#3)(1992-8#1)(1992-9#3)(1993-1#5)(1993-10#2)(1993-11#3)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#6)(1994-5#3)(1994-7#2)(1994-9#2)(1995-10#1)(1995-12#7)(1995-3#2)(1995-4#1)(1995-5#1)(1995-7#2)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#5)(1997-8#5)(2004-1#3)(2004-10#5)(2004-4#1)(2005-10#1)(2005-11#1)(2005-4#1)(2005-5#2)(2005-7#3)(2005-8#1)(2005-9#1)(2006-10#9)(2006-12#4)(2006-2#4)(2006-3#1)(2006-4#3)(2006-5#6)(2006-6#4)(2006-7#3)(2006-8#6)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#2)(2007-2#6)(2007-3#4)(2007-5#4)(2007-6#2)(2007-7#16)(2007-8#20)(2007-9#3)(2008-1#4)(2008-10#41)(2008-11#15)(2008-12#4)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#8)(2008-6#10)(2008-7#19)(2008-8#7)(2008-9#6)(2009-10#2)(2009-11#1)(2009-5#2)(2009-6#1)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#3)(2010-5#2)(2010-8#4)(2010-9#1)(2011-1#11)(2011-11#2)(2011-2#20)(2011-3#2)(2012-1#4)(2012-12#8)(2012-2#11)(2012-3#8)(2013-1#20)(2013-7#3)(2013-8#13)
rate were also##6##3##(2005-8#1)(2007-12#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-12#1)
rate were calculated##2##3##(2012-2#1)(2013-8#1)
rate were comparable##2##3##(2006-6#1)(2008-7#1)
rate were not affected by##2##5##(2006-5#1)(2010-7#1)
rate were observed##3##3##(2008-5#1)(2011-1#1)(2012-1#1)
rate were optimized##3##3##(2008-10#3)
rate were recorded##3##3##(1996-2#1)(2008-5#1)(2012-12#1)
rate were seen##2##3##(1994-2#1)(2007-2#1)
rate were significantly##5##3##(1997-8#1)(2006-5#1)(2007-10#1)(2008-7#1)(2011-12#1)
rate were statistically significant##2##4##(1992-11#1)(2008-5#1)
rate were studied in##2##4##(1991-2#1)(1996-2#1)
rate were systematically##2##3##(2005-11#1)(2008-10#1)
rate were##55##2##(1990-12#1)(1991-2#1)(1992-11#1)(1993-10#1)(1993-11#1)(1993-4#1)(1994-2#1)(1994-5#1)(1996-2#2)(1997-8#1)(2005-11#1)(2005-8#1)(2006-5#2)(2006-6#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-10#9)(2008-11#1)(2008-4#1)(2008-5#5)(2008-7#3)(2008-9#1)(2009-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-8#1)
rate when the##2##3##(1995-5#1)(1997-6#1)
rate when##13##2##(1993-4#1)(1995-5#1)(1996-5#1)(1997-6#2)(2006-5#2)(2007-11#1)(2007-12#1)(2007-5#1)(2008-8#1)(2009-10#1)(2011-2#1)
rate which was##2##3##(1991-9#1)(2006-11#1)
rate which##6##2##(1991-9#1)(1993-5#1)(2006-11#1)(2008-11#1)(2011-2#1)(2012-12#1)
rate while the##3##3##(1990-9#1)(2008-10#1)(2008-12#1)
rate while##4##2##(1990-9#1)(2008-10#1)(2008-12#1)(2013-1#1)
rate will##2##2##(1996-3#1)(2008-3#1)
rate with a##2##3##(2006-8#1)(2008-3#1)
rate with increasing##2##3##(1995-1#1)(2009-10#1)
rate with respect to the##2##5##(1997-6#1)(2007-12#1)
rate with respect to##4##4##(1997-6#2)(2007-12#1)(2011-1#1)
rate with temperature##2##3##(2008-10#1)(2010-4#1)
rate with the##7##3##(1990-2#1)(1993-8#1)(2007-7#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-12#1)
rate with##43##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1993-8#1)(1995-1#1)(1996-5#1)(1996-9#1)(1997-6#2)(2005-11#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
rate within the##4##3##(2007-12#1)(2007-6#1)(2008-7#1)(2010-8#1)
rate within##12##2##(1991-3#1)(1993-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-2#1)(2008-7#1)(2010-8#1)
rate without##3##2##(2008-2#1)(2011-1#1)(2011-2#1)
rate would##2##2##(2012-12#1)(2013-8#1)
rate yielded##2##2##(1991-12#1)(1994-3#1)
rate##7628##1##(1990-10#19)(1990-11#33)(1990-12#53)(1990-2#30)(1990-3#29)(1990-4#9)(1990-5#31)(1990-6#20)(1990-7#31)(1990-8#22)(1990-9#29)(1991-1#20)(1991-10#15)(1991-11#15)(1991-12#33)(1991-2#57)(1991-3#26)(1991-4#26)(1991-5#24)(1991-6#24)(1991-7#22)(1991-8#44)(1991-9#30)(1992-1#23)(1992-10#22)(1992-11#16)(1992-12#29)(1992-2#22)(1992-3#13)(1992-4#10)(1992-5#23)(1992-6#38)(1992-7#14)(1992-8#17)(1992-9#22)(1993-1#32)(1993-10#8)(1993-11#32)(1993-12#17)(1993-2#20)(1993-3#26)(1993-4#17)(1993-5#15)(1993-6#20)(1993-7#11)(1993-8#36)(1993-9#18)(1994-1#3)(1994-10#5)(1994-11#36)(1994-12#48)(1994-2#30)(1994-3#41)(1994-4#2)(1994-5#37)(1994-6#22)(1994-7#16)(1994-8#46)(1994-9#31)(1995-1#31)(1995-10#17)(1995-11#24)(1995-12#44)(1995-2#34)(1995-3#31)(1995-4#6)(1995-5#31)(1995-6#28)(1995-7#10)(1995-8#25)(1995-9#15)(1996-1#16)(1996-10#6)(1996-11#22)(1996-12#33)(1996-2#37)(1996-3#30)(1996-4#15)(1996-5#31)(1996-6#22)(1996-7#24)(1996-8#26)(1996-9#17)(1997-1#29)(1997-2#30)(1997-3#9)(1997-4#41)(1997-5#14)(1997-6#33)(1997-7#48)(1997-8#51)(2003-11#1)(2004-1#10)(2004-10#10)(2004-11#7)(2004-12#17)(2004-2#3)(2004-4#2)(2004-8#1)(2004-9#19)(2005-1#5)(2005-10#12)(2005-11#69)(2005-12#10)(2005-3#3)(2005-4#6)(2005-5#3)(2005-7#17)(2005-8#15)(2005-9#12)(2006-1#4)(2006-10#107)(2006-11#18)(2006-12#28)(2006-2#28)(2006-3#17)(2006-4#25)(2006-5#43)(2006-6#25)(2006-7#17)(2006-8#60)(2006-9#19)(2007-1#31)(2007-10#58)(2007-11#150)(2007-12#191)(2007-2#65)(2007-3#37)(2007-4#37)(2007-5#17)(2007-6#14)(2007-7#97)(2007-8#114)(2007-9#41)(2008-1#81)(2008-10#822)(2008-11#219)(2008-12#86)(2008-2#116)(2008-3#162)(2008-4#64)(2008-5#179)(2008-6#97)(2008-7#220)(2008-8#177)(2008-9#104)(2009-1#1)(2009-10#24)(2009-11#19)(2009-12#9)(2009-2#10)(2009-3#14)(2009-4#14)(2009-5#27)(2009-6#25)(2009-7#13)(2009-8#23)(2009-9#17)(2010-1#4)(2010-10#10)(2010-11#17)(2010-12#49)(2010-2#25)(2010-3#36)(2010-4#19)(2010-5#34)(2010-6#5)(2010-7#18)(2010-8#56)(2010-9#11)(2011-1#101)(2011-10#2)(2011-11#5)(2011-12#18)(2011-2#189)(2011-3#8)(2011-7#1)(2012-1#24)(2012-11#10)(2012-12#117)(2012-2#147)(2012-3#97)(2012-5#2)(2012-8#1)(2013-1#182)(2013-7#29)(2013-8#133)
rate'##2##1##(2004-10#1)(2008-10#1)
rate) and##12##2##(1991-6#1)(1994-3#1)(2006-10#1)(2006-8#1)(2007-11#2)(2008-10#1)(2008-7#1)(2009-7#1)(2012-2#1)(2013-1#2)
rate) for##2##2##(1996-7#1)(2008-10#1)
rate) was##2##2##(2008-11#1)(2010-12#1)
rate) were##7##2##(2008-10#5)(2013-1#1)(2013-7#1)
rate)##59##1##(1991-6#1)(1991-8#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-3#1)(1996-7#1)(1997-1#1)(2005-7#1)(2006-10#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-5#1)(2009-7#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#3)(2013-7#2)
rate- and state-dependent##2##3##(1996-4#2)
rate-compatible punctured##2##2##(2008-2#2)
rate-corrected##2##1##(2006-12#2)
rate-dependent friction##2##2##(1996-4#2)
rate-dependent##5##1##(1996-4#3)(2008-8#1)(2010-2#1)
rate-determining step##6##2##(1992-6#1)(1994-8#1)(1995-4#1)(1997-4#2)(2008-10#1)
rate-determining##11##1##(1992-6#1)(1994-11#1)(1994-8#1)(1995-4#2)(1997-4#2)(1997-7#1)(2006-10#1)(2006-12#1)(2008-10#1)
rate-distortion##5##1##(2008-2#5)
rate-equation##3##1##(2008-3#2)(2009-11#1)
rate-independent##2##1##(1996-4#1)(2010-2#1)
rate-limited##2##1##(1991-2#1)(1995-11#1)
rate-limiting at##2##2##(1991-9#1)(1995-10#1)
rate-limiting chemical step in##2##4##(1991-9#2)
rate-limiting during##2##2##(1991-5#2)
rate-limiting enzyme for##2##3##(1993-8#1)(1997-4#1)
rate-limiting enzyme in the##7##4##(1991-9#1)(1994-6#1)(1994-8#1)(1997-5#1)(2005-9#1)(2010-2#1)(2012-2#1)
rate-limiting enzyme in##18##3##(1990-4#1)(1991-9#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#1)(1997-5#1)(2004-11#3)(2005-9#1)(2007-11#1)(2008-5#1)(2010-2#1)(2012-2#1)
rate-limiting enzyme of##4##3##(1994-12#1)(1997-5#1)(2010-12#1)(2012-2#1)
rate-limiting enzyme##25##2##(1990-4#1)(1991-9#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#2)(1994-8#1)(1997-4#1)(1997-5#2)(2004-11#3)(2005-9#1)(2007-11#1)(2008-11#1)(2008-5#1)(2010-12#1)(2010-2#1)(2012-2#2)
rate-limiting events##2##2##(1991-5#1)(1996-5#1)
rate-limiting for##4##2##(1995-10#2)(2006-10#1)(2008-8#1)
rate-limiting in##3##2##(1992-3#1)(1997-4#1)(2007-11#1)
rate-limiting process in the##2##4##(1995-8#1)(2005-11#1)
rate-limiting step for##4##3##(2006-10#1)(2006-8#1)(2008-1#1)(2008-5#1)
rate-limiting step from##2##3##(1991-7#1)(1991-9#1)
rate-limiting step in the formation of##2##6##(1994-12#1)(1996-8#1)
rate-limiting step in the##9##4##(1990-2#2)(1992-6#2)(1994-12#2)(1996-8#1)(2010-1#1)(2013-1#1)
rate-limiting step in##17##3##(1990-2#3)(1990-5#1)(1991-5#1)(1992-6#2)(1994-12#2)(1995-1#1)(1995-10#1)(1995-6#1)(1996-2#1)(1996-8#1)(1997-4#1)(2010-1#1)(2013-1#1)
rate-limiting step is##2##3##(1993-3#1)(2005-11#1)
rate-limiting step of the##2##4##(1992-12#1)(1997-4#1)
rate-limiting step of##9##3##(1992-12#2)(1997-4#2)(2011-2#1)(2012-2#3)(2012-3#1)
rate-limiting step##45##2##(1990-2#5)(1990-5#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#2)(1992-6#2)(1993-3#1)(1994-12#2)(1995-1#1)(1995-10#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-4#3)(2005-11#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-8#1)(2008-1#2)(2008-5#1)(2008-6#1)(2010-1#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)
rate-limiting steps in##3##3##(1992-6#1)(1995-10#2)
rate-limiting steps##4##2##(1992-6#1)(1995-10#2)(2009-3#1)
rate-limiting##119##1##(1990-2#8)(1990-4#1)(1990-5#4)(1991-5#4)(1991-7#5)(1991-9#5)(1992-12#2)(1992-3#2)(1992-6#4)(1992-8#1)(1992-9#2)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#4)(1994-3#1)(1994-6#2)(1994-8#4)(1995-1#1)(1995-10#8)(1995-2#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#5)(1997-5#2)(2004-11#3)(2005-11#2)(2005-9#1)(2006-10#3)(2006-12#1)(2006-8#1)(2007-11#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-3#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#5)(2012-3#1)(2013-1#1)
rate-ratio##2##1##(1997-7#2)
rate-related##2##1##(1993-11#1)(1996-2#1)
rate-responsive##2##1##(2008-3#1)(2008-4#1)
rate?##2##1##(1995-4#1)(2008-10#1)
rated a##4##2##(1995-9#1)(2007-10#1)(2007-4#1)(2010-8#1)
rated according to##2##3##(1994-11#1)(2008-6#1)
rated as appropriate##3##3##(2007-10#3)
rated as good##2##3##(2006-10#1)(2006-8#1)
rated as more##2##3##(2009-7#1)(2012-2#1)
rated as not##2##3##(2008-8#1)(2012-2#1)
rated as the most##2##4##(2007-6#1)(2010-10#1)
rated as the##4##3##(1995-9#1)(2007-11#1)(2007-6#1)(2010-10#1)
rated as##46##2##(1993-2#1)(1995-9#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-7#2)(2006-8#1)(2007-10#4)(2007-11#1)(2007-12#1)(2007-6#9)(2008-10#2)(2008-11#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-2#2)(2013-8#1)
rated by the##3##3##(1991-2#1)(2007-12#1)(2007-2#1)
rated by##11##2##(1991-2#1)(2004-9#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2010-4#1)(2012-2#2)
rated each##4##2##(1996-1#1)(2007-10#2)(2009-9#1)
rated for##2##2##(2007-12#1)(2008-10#1)
rated higher##3##2##(1993-12#2)(2008-9#1)
rated highest##3##2##(1993-2#1)(2009-11#1)(2011-2#1)
rated highly##2##2##(1995-1#1)(2012-12#1)
rated on a##3##3##(2008-7#1)(2010-12#1)(2012-3#1)
rated satisfaction with##2##3##(1993-2#1)(2012-3#1)
rated severity##2##2##(2007-12#2)
rated significantly higher than##2##4##(1993-2#2)
rated the course##2##3##(1996-12#1)(1997-3#1)
rated the overall##2##3##(2008-11#1)(2012-12#1)
rated the##19##2##(1993-2#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-3#1)(2004-12#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-11#1)(2009-5#1)(2010-2#2)(2011-2#2)(2012-12#1)
rated their functional##2##3##(2006-10#2)
rated their##17##2##(2004-10#1)(2006-10#2)(2006-12#2)(2007-11#1)(2007-12#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-2#1)(2011-1#1)
rated them as##2##3##(2007-4#1)(2008-12#1)
rated them##3##2##(2007-4#1)(2008-12#1)(2012-12#1)
rated themselves positively##2##3##(2010-3#2)
rated themselves##4##2##(2007-7#1)(2007-9#1)(2010-3#2)
rated using##2##2##(2008-10#1)(2011-2#1)
rated##188##1##(1990-12#2)(1991-2#1)(1992-2#2)(1993-12#2)(1993-2#7)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-1#2)(1995-10#1)(1995-2#3)(1995-3#1)(1995-9#3)(1996-1#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-3#2)(2004-10#2)(2004-12#1)(2004-9#1)(2006-10#5)(2006-11#1)(2006-12#3)(2006-3#1)(2006-7#3)(2006-8#1)(2007-10#8)(2007-11#6)(2007-12#9)(2007-2#1)(2007-4#2)(2007-5#2)(2007-6#10)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#7)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#3)(2009-5#2)(2009-7#2)(2009-9#3)(2010-10#1)(2010-12#7)(2010-2#5)(2010-3#2)(2010-4#1)(2010-8#3)(2011-1#1)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#6)(2013-8#2)
ratemeter##5##1##(1996-2#5)
rater##7##1##(2006-10#2)(2008-10#1)(2010-12#1)(2012-1#1)(2012-2#2)
raters and##2##2##(2010-12#2)
raters in##2##2##(1995-5#1)(2012-3#1)
raters or##2##2##(2010-12#1)(2012-2#1)
raters to##3##2##(1997-3#2)(2013-1#1)
raters were blinded##2##3##(2008-12#1)(2008-2#1)
raters##45##1##(1992-2#4)(1993-12#2)(1994-2#1)(1995-5#1)(1997-3#5)(2006-10#1)(2008-10#3)(2008-12#2)(2008-2#2)(2008-9#2)(2009-11#1)(2010-12#4)(2010-8#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#7)
rates &gt##3##2##(1997-3#1)(2006-5#1)(2007-7#1)
rates (&lt##3##2##(2008-3#1)(2008-7#1)(2010-8#1)
rates (1##3##2##(1995-1#1)(2008-10#1)(2010-5#1)
rates (P =##2##3##(1995-2#1)(2006-5#1)
rates (P##4##2##(1994-9#1)(1995-2#1)(2006-5#2)
rates (SRR)##2##2##(2012-12#1)(2013-8#1)
rates (chance that a##2##4##(2012-3#2)
rates (i##2##2##(2007-8#1)(2008-10#1)
rates (typically##2##2##(2008-10#1)(2009-3#1)
rates (up to##2##3##(2008-3#1)(2012-3#1)
rates (which are##2##3##(2007-8#1)(2008-8#1)
rates 0##2##2##(2005-10#1)(2006-5#1)
rates 2##2##2##(2005-10#1)(2008-7#1)
rates 4##2##2##(1991-8#1)(2008-7#1)
rates achieved##2##2##(2007-11#1)(2009-7#1)
rates across##6##2##(2007-2#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-3#2)
rates affect##2##2##(1994-3#1)(1995-3#1)
rates after##17##2##(1991-3#1)(1992-11#1)(1997-6#1)(2004-4#1)(2006-10#3)(2007-11#2)(2007-8#2)(2009-6#1)(2010-12#2)(2010-3#1)(2010-8#1)(2013-8#1)
rates allowed##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
rates along with##2##3##(1996-12#1)(2007-7#1)
rates along##3##2##(1996-12#1)(2007-7#1)(2012-2#1)
rates also##2##2##(1995-5#1)(2008-9#1)
rates always##2##2##(2008-10#1)(2008-3#1)
rates among American Indians##2##4##(2007-2#1)(2011-2#1)
rates among the three##2##4##(2008-5#1)(2012-2#1)
rates among the##3##3##(1997-2#1)(2008-5#1)(2012-2#1)
rates among young##2##3##(1990-6#1)(2011-12#1)
rates among##32##2##(1990-6#1)(1990-9#1)(1991-1#1)(1994-5#1)(1995-8#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-3#1)(2004-9#1)(2006-9#1)(2007-11#1)(2007-2#2)(2007-5#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-5#3)(2010-10#1)(2010-8#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
rates and a##3##3##(2008-2#1)(2012-12#1)(2013-1#1)
rates and associated##3##3##(2009-6#2)(2013-8#1)
rates and clinical##3##3##(1997-5#1)(2006-8#1)(2008-3#1)
rates and good##2##3##(2008-2#1)(2011-2#1)
rates and high##4##3##(2007-10#1)(2007-12#2)(2008-3#1)
rates and improved##3##3##(2005-2#1)(2008-10#1)(2009-5#1)
rates and increased##2##3##(2006-11#1)(2010-2#1)
rates and is##2##3##(1994-9#1)(2007-11#1)
rates and longer##2##3##(2007-12#1)(2010-12#1)
rates and low##4##3##(2008-6#1)(2011-11#1)(2013-1#1)(2013-8#1)
rates and of##3##3##(1995-11#1)(1996-3#1)(2010-11#1)
rates and percentage of##2##4##(2010-7#1)(2011-2#1)
rates and population##2##3##(2008-11#1)(2008-8#1)
rates and rheological properties##2##4##(2008-5#2)
rates and risk##2##3##(2008-7#1)(2009-7#1)
rates and shorter##2##3##(1997-3#1)(2011-12#1)
rates and survival##2##3##(1994-7#1)(1997-7#1)
rates and temporal##2##3##(2008-11#1)(2008-7#1)
rates and that the##2##4##(2008-8#2)
rates and the##14##3##(1990-5#1)(1990-8#1)(1995-12#1)(1995-8#1)(1995-9#1)(2007-3#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-5#1)(2010-5#1)(2011-12#1)
rates and##221##2##(1990-10#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#2)(1993-1#1)(1993-12#3)(1993-3#2)(1994-11#1)(1994-7#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#3)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-3#4)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#2)(2004-10#2)(2004-4#1)(2005-10#1)(2005-11#2)(2005-2#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-5#4)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#3)(2007-11#2)(2007-12#5)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#13)(2008-12#3)(2008-2#6)(2008-3#5)(2008-4#1)(2008-5#9)(2008-6#3)(2008-7#4)(2008-8#10)(2008-9#4)(2009-5#2)(2009-6#2)(2009-7#2)(2009-9#2)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#3)(2010-3#1)(2010-5#2)(2010-7#5)(2010-8#3)(2011-1#2)(2011-11#1)(2011-12#2)(2011-2#10)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#4)
rates appear to be##2##4##(2007-11#2)
rates appear to##3##3##(1997-6#1)(2007-11#2)
rates appears##2##2##(2006-10#1)(2009-8#1)
rates approaching##2##2##(2008-10#1)(2013-8#1)
rates are a##2##3##(2006-8#1)(2007-11#1)
rates are also##4##3##(1994-3#1)(2005-11#1)(2007-3#1)(2012-3#1)
rates are associated with##2##4##(2007-12#1)(2011-2#1)
rates are at##2##3##(2006-10#1)(2008-10#1)
rates are generally##2##3##(1997-6#1)(2006-4#1)
rates are high##4##3##(2008-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
rates are higher##4##3##(1991-6#1)(1997-7#1)(2007-9#1)(2008-9#1)
rates are in##3##3##(1990-2#1)(2007-12#1)(2010-1#1)
rates are linear##2##3##(2008-10#1)(2012-3#1)
rates are low##2##3##(2008-8#1)(2011-2#1)
rates are more##2##3##(1992-12#1)(1995-2#1)
rates are relatively##3##3##(2007-3#1)(2008-6#1)(2011-2#1)
rates are reported##2##3##(1992-10#1)(2005-11#1)
rates are significantly higher##2##4##(2007-9#1)(2009-7#1)
rates are significantly##4##3##(2005-10#1)(2007-9#1)(2009-7#1)(2013-8#1)
rates are similar##2##3##(2006-6#1)(2007-8#1)
rates are within##2##3##(2008-2#1)(2012-2#1)
rates are##112##2##(1990-2#1)(1990-4#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#3)(2006-10#2)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#6)(2007-12#4)(2007-3#2)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#4)(2008-11#4)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-9#1)(2011-1#2)(2011-2#12)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#3)
rates around##3##2##(2008-6#1)(2008-7#1)(2009-4#1)
rates as a##2##3##(1990-12#1)(2007-12#1)
rates as compared to##2##4##(1991-6#1)(2009-5#1)
rates as high as##4##4##(2007-12#1)(2008-10#1)(2008-8#1)(2012-3#1)
rates as the##2##3##(1994-8#1)(2006-5#1)
rates as well as##2##4##(1997-6#1)(2008-10#1)
rates as##30##2##(1990-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1994-2#1)(1994-7#1)(1994-8#1)(1995-4#1)(1997-2#1)(1997-6#1)(2006-5#2)(2007-11#1)(2007-12#3)(2007-4#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#2)(2009-11#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
rates assessed##2##2##(1996-8#1)(2012-6#1)
rates associated with the##2##4##(2008-6#1)(2011-2#1)
rates associated with##7##3##(1991-11#1)(1995-3#1)(2006-10#1)(2008-6#1)(2010-12#2)(2011-2#1)
rates at 5 years were##2##5##(1994-12#1)(2010-3#1)
rates at 5##3##3##(1994-12#1)(2007-8#1)(2010-3#1)
rates at the##2##3##(1992-2#1)(2008-8#1)
rates at which##5##3##(1992-12#1)(2007-8#1)(2008-10#1)(2013-1#1)(2013-8#1)
rates at##30##2##(1992-12#1)(1992-2#1)(1994-12#1)(1995-10#1)(2007-11#2)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
rates based on##2##3##(1997-4#1)(2012-12#1)
rates based##3##2##(1997-4#1)(2008-7#1)(2012-12#1)
rates because of##2##3##(1993-5#1)(2012-12#1)
rates because##3##2##(1993-5#1)(2008-5#1)(2012-12#1)
rates being##2##2##(2006-9#1)(2008-10#1)
rates below##2##2##(2008-7#1)(2009-7#1)
rates between 0##2##3##(2007-5#1)(2013-7#1)
rates between 1##2##3##(1994-2#1)(2013-7#1)
rates between groups##2##3##(2006-5#1)(2007-9#1)
rates between the two groups##2##5##(1996-3#1)(2012-2#1)
rates between the two##3##4##(1995-4#1)(1996-3#1)(2012-2#1)
rates between the##5##3##(1995-4#1)(1996-12#1)(1996-3#1)(2007-8#1)(2012-2#1)
rates between##31##2##(1991-12#1)(1993-6#2)(1994-2#1)(1995-10#1)(1995-4#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-7#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-1#2)(2012-2#1)(2013-1#1)(2013-7#2)
rates beyond##2##2##(1994-8#1)(2008-11#1)
rates but also##2##3##(2004-1#1)(2006-10#1)
rates but##8##2##(1990-12#1)(1993-6#1)(2004-1#1)(2006-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2013-7#1)
rates by##22##2##(1992-9#1)(1993-12#1)(1995-4#1)(1996-12#2)(1996-3#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-6#1)(2008-9#1)(2010-10#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
rates can be##7##3##(1992-1#1)(1992-6#1)(1992-9#1)(2006-11#1)(2007-11#1)(2010-12#1)(2010-3#1)
rates can##13##2##(1992-1#1)(1992-6#1)(1992-9#1)(1996-12#1)(2006-11#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-8#2)(2009-4#1)(2010-12#1)(2010-3#1)
rates change##2##2##(2007-5#1)(2012-12#1)
rates changed during##2##3##(1991-1#1)(1992-5#1)
rates changed##3##2##(1991-1#1)(1992-5#1)(1994-3#1)
rates close to##2##3##(1995-12#1)(2008-10#1)
rates comparable to that##2##4##(1992-6#1)(2006-9#1)
rates comparable to those##2##4##(1995-1#1)(2008-6#1)
rates comparable to##5##3##(1992-1#1)(1992-6#1)(1995-1#1)(2006-9#1)(2008-6#1)
rates comparable with##2##3##(2009-8#1)(2013-8#1)
rates comparable##7##2##(1992-1#1)(1992-6#1)(1995-1#1)(2006-9#1)(2008-6#1)(2009-8#1)(2013-8#1)
rates compared to##3##3##(2006-12#1)(2007-7#1)(2012-12#1)
rates compared with##5##3##(2006-11#1)(2007-12#1)(2008-2#1)(2008-5#2)
rates compared##10##2##(2006-11#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#2)(2012-12#2)
rates continue to##3##3##(1992-2#1)(2008-7#1)(2009-3#1)
rates could be##4##3##(2008-1#1)(2008-7#1)(2011-12#1)(2012-12#1)
rates could##5##2##(2008-1#1)(2008-7#1)(2011-12#1)(2012-12#1)(2013-8#1)
rates declined##3##2##(1995-9#1)(2008-7#1)(2012-3#1)
rates decrease as the##2##4##(1995-1#1)(2008-10#1)
rates decrease##3##2##(1995-1#1)(2008-10#1)(2011-2#1)
rates decreased##6##2##(1991-6#2)(1994-12#1)(2008-11#1)(2011-3#1)(2012-3#1)
rates depend on the##3##4##(2008-11#2)(2013-1#1)
rates determined##2##2##(2008-5#1)(2011-12#1)
rates did not differ##2##4##(2006-5#1)(2011-1#1)
rates did not##3##3##(2006-5#1)(2011-1#1)(2012-2#1)
rates differ in##2##3##(1994-1#1)(2012-3#1)
rates differ##5##2##(1993-10#1)(1994-1#1)(2007-2#1)(2012-12#1)(2012-3#1)
rates dropped##2##2##(2008-8#1)(2013-8#1)
rates due to##4##3##(1993-5#1)(2008-11#2)(2009-7#1)
rates during the##8##3##(1991-12#1)(1992-5#1)(1994-6#1)(1995-4#1)(2006-1#1)(2007-10#1)(2007-5#1)(2008-4#1)
rates during this##2##3##(1992-5#1)(2007-7#1)
rates during##18##2##(1991-12#1)(1992-2#1)(1992-5#2)(1994-6#1)(1995-12#1)(1995-4#1)(2006-1#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-12#1)
rates especially##2##2##(2006-5#1)(2012-12#1)
rates exhibited by##2##3##(1990-2#1)(1992-5#1)
rates expected##2##2##(1997-3#1)(2008-7#1)
rates followed##2##2##(2008-10#1)(2008-5#1)
rates following a##2##3##(2008-11#1)(2008-8#1)
rates following##8##2##(1991-3#1)(1993-3#1)(2006-11#1)(2007-5#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#1)
rates for Medicare##2##3##(1992-1#1)(2012-3#1)
rates for a##3##3##(1991-2#1)(2008-8#1)(2009-12#1)
rates for all##5##3##(1990-4#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-3#1)
rates for both##2##3##(2004-1#1)(2012-1#1)
rates for children##2##3##(1995-3#1)(2013-1#1)
rates for each##5##3##(2007-11#1)(2007-8#1)(2010-9#1)(2011-1#1)(2013-1#1)
rates for other##2##3##(2004-4#1)(2008-6#1)
rates for patients with advanced##2##5##(2007-7#1)(2012-3#1)
rates for patients with##5##4##(2007-7#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-3#1)
rates for patients##7##3##(2007-7#1)(2009-2#1)(2010-11#1)(2010-3#2)(2011-2#1)(2012-3#1)
rates for stomach##2##3##(1991-6#1)(2011-2#1)
rates for the##16##3##(1993-12#1)(1994-8#1)(1997-2#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-11#1)(2012-3#1)(2013-1#1)
rates for this##2##3##(1992-10#1)(2006-10#1)
rates for various##2##3##(1990-9#1)(2007-12#1)
rates for##153##2##(1990-12#4)(1990-4#2)(1990-7#1)(1990-9#1)(1991-2#2)(1991-6#3)(1992-1#3)(1992-10#1)(1993-12#1)(1994-1#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-6#1)(1997-7#1)(2004-1#1)(2004-10#1)(2004-4#1)(2005-10#3)(2005-11#1)(2005-7#2)(2005-8#1)(2006-10#4)(2006-12#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2010-11#3)(2010-12#1)(2010-3#5)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#9)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#7)(2013-1#5)(2013-7#1)(2013-8#1)
rates from 0##2##3##(2007-8#1)(2013-7#1)
rates from 10 to##2##4##(2008-6#1)(2009-7#1)
rates from breast cancer##3##4##(1991-12#2)(1997-7#1)
rates from the##3##3##(2007-11#1)(2010-7#1)(2011-2#1)
rates from##34##2##(1991-12#2)(1993-3#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-7#1)(2004-12#1)(2006-4#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-12#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-7#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#2)(2013-7#2)
rates greater than##2##3##(2008-10#1)(2008-6#1)
rates had##4##2##(2006-5#1)(2008-10#1)(2008-5#1)(2010-4#1)
rates has##2##2##(2006-6#1)(2008-8#1)
rates have been declining in##2##5##(1990-4#1)(2006-10#1)
rates have been reported with##2##5##(2008-10#1)(2011-2#1)
rates have been##20##3##(1990-2#1)(1990-4#1)(1991-1#1)(1991-3#1)(1992-12#1)(1993-12#1)(1993-4#1)(1996-8#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-5#1)(2008-10#3)(2008-3#1)(2008-6#1)(2009-5#1)(2011-2#1)(2012-11#1)
rates have declined##2##3##(1990-12#1)(2008-4#1)
rates have increased##4##3##(1990-12#1)(1997-8#1)(2007-2#1)(2011-2#1)
rates have not been##2##4##(2010-9#1)(2012-3#1)
rates have not##3##3##(2010-9#1)(2011-1#1)(2012-3#1)
rates have##36##2##(1990-12#2)(1990-2#1)(1990-4#1)(1991-1#1)(1991-2#1)(1991-3#1)(1992-12#1)(1993-12#1)(1993-4#1)(1996-8#1)(1997-6#1)(1997-8#1)(2005-7#1)(2006-10#2)(2006-5#1)(2007-2#2)(2008-10#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-5#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-3#1)
rates if##2##2##(1991-11#1)(2006-6#1)
rates in New##2##3##(1996-3#1)(2008-8#1)
rates in a##5##3##(2006-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-11#1)
rates in all##2##3##(1996-12#1)(2012-12#1)
rates in an##2##3##(1990-11#1)(2009-9#1)
rates in both##2##3##(1997-7#1)(2008-8#1)
rates in children##4##3##(2007-1#1)(2007-12#1)(2007-8#1)(2010-8#1)
rates in comparison to##2##4##(2007-1#1)(2007-10#1)
rates in comparison##3##3##(2007-1#1)(2007-10#1)(2008-11#1)
rates in general##2##3##(2005-8#1)(2012-2#1)
rates in patients with diabetes##2##5##(2006-6#1)(2008-1#1)
rates in patients with##4##4##(2006-6#1)(2007-8#1)(2008-1#1)(2012-2#1)
rates in patients##8##3##(2006-6#1)(2007-1#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-7#1)(2012-2#1)
rates in terms of##2##4##(2008-8#1)(2010-12#1)
rates in the &quot##2##4##(1996-1#1)(1996-7#1)
rates in the United States##5##5##(1994-3#1)(2007-7#1)(2008-10#1)(2009-4#1)(2010-7#1)
rates in the absence of##2##5##(1991-12#1)(2008-11#1)
rates in the population##4##4##(1994-6#1)(1995-9#1)(2008-8#1)(2010-2#1)
rates in the presence of##3##5##(1995-6#1)(2007-3#1)(2008-11#1)
rates in the range##2##4##(2008-7#1)(2011-1#1)
rates in the two groups##3##5##(2006-5#1)(2007-7#1)(2013-8#1)
rates in the whole##2##4##(2007-10#1)(2011-1#1)
rates in the##52##3##(1990-3#1)(1991-12#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-7#1)(1997-7#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#5)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-2#2)(2010-7#2)(2011-1#3)(2011-12#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
rates in these##2##3##(2005-11#1)(2013-8#1)
rates in this##2##3##(1996-1#1)(2008-3#1)
rates in##202##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-5#1)(1991-6#2)(1992-2#1)(1993-1#1)(1993-11#1)(1993-12#2)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#3)(1997-8#1)(2005-11#3)(2005-7#1)(2005-8#1)(2006-10#3)(2006-2#3)(2006-5#1)(2006-6#2)(2007-1#4)(2007-10#6)(2007-11#4)(2007-12#7)(2007-2#1)(2007-3#1)(2007-5#3)(2007-7#7)(2007-8#4)(2007-9#3)(2008-1#2)(2008-10#5)(2008-11#8)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#7)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#3)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#3)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#6)(2011-10#1)(2011-12#2)(2011-2#8)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#5)(2012-3#4)(2013-1#6)(2013-8#7)
rates increase and##2##3##(2007-10#1)(2008-5#1)
rates increase##7##2##(1990-6#1)(2006-10#1)(2007-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-7#1)
rates increased from 0##2##4##(2008-10#1)(2011-12#1)
rates increased from##3##3##(2008-10#1)(2008-6#1)(2011-12#1)
rates increased significantly##2##3##(2008-6#1)(2009-4#1)
rates increased with##2##3##(2006-2#1)(2008-11#1)
rates increased##16##2##(1991-10#1)(1996-9#1)(2006-2#1)(2006-6#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#2)(2009-4#1)(2011-12#1)(2011-2#1)(2013-1#1)
rates investigated##2##2##(2008-10#1)(2008-11#1)
rates is very##2##3##(1995-1#1)(2008-9#1)
rates is##12##2##(1990-9#1)(1991-1#1)(1992-12#1)(1995-1#1)(1997-7#2)(2006-4#1)(2006-8#1)(2008-1#1)(2008-4#1)(2008-9#1)(2013-8#1)
rates leads to a##2##4##(2008-10#1)(2009-6#1)
rates may be##4##3##(1994-3#1)(1996-12#1)(2008-8#1)(2012-3#1)
rates may##9##2##(1993-12#1)(1994-3#1)(1996-12#1)(2006-10#1)(2008-8#2)(2010-4#1)(2011-2#1)(2012-3#1)
rates measured##4##2##(1993-12#1)(1993-3#1)(1995-12#1)(2005-11#1)
rates more##2##2##(2008-12#1)(2012-3#1)
rates observed in##4##3##(1992-7#2)(1995-1#1)(2006-10#1)
rates observed with the##2##4##(1995-6#1)(1996-9#1)
rates observed##11##2##(1992-7#3)(1995-1#1)(1995-6#1)(1996-9#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-8#1)(2012-3#1)
rates obtained##5##2##(1996-12#1)(2006-10#1)(2006-12#1)(2007-2#1)(2008-10#1)
rates occur##2##2##(2010-3#1)(2013-1#1)
rates occurred##4##2##(1990-3#1)(1991-1#1)(2008-11#1)(2013-1#1)
rates of 0##9##3##(1991-9#1)(1994-2#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)
rates of 1##2##3##(2008-10#1)(2013-7#1)
rates of 16##2##3##(1991-2#1)(2007-7#1)
rates of 2##6##3##(1995-11#1)(2007-12#1)(2007-8#1)(2008-11#2)(2009-6#1)
rates of 24 and##2##4##(2007-8#1)(2008-10#1)
rates of 25##2##3##(2006-8#1)(2009-9#1)
rates of 30 to##2##4##(2005-8#1)(2008-11#1)
rates of 8##2##3##(1991-12#1)(2008-10#1)
rates of 9##3##3##(2007-7#1)(2008-10#2)
rates of AMP phosphorylation##2##4##(1995-3#2)
rates of JH synthesis##2##4##(2008-7#2)
rates of JH##3##3##(2008-7#3)
rates of L##2##3##(2006-8#1)(2008-6#1)
rates of Si##3##3##(2008-10#3)
rates of a##10##3##(1994-3#1)(1994-9#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-9#1)
rates of about##4##3##(1990-6#1)(1995-2#1)(2008-1#1)(2008-8#1)
rates of acquisition##2##3##(2008-10#1)(2008-5#1)
rates of adverse##2##3##(1995-2#1)(2008-11#1)
rates of all##6##3##(1997-4#1)(2008-7#1)(2011-2#1)(2013-1#2)(2013-8#1)
rates of amino##2##3##(1992-4#1)(2007-7#1)
rates of as much as##2##5##(2007-11#1)(2008-3#1)
rates of association##2##3##(1993-1#1)(2009-4#1)
rates of average##2##3##(2005-8#1)(2008-2#1)
rates of between##3##3##(1991-4#1)(2007-2#1)(2008-7#1)
rates of both##3##3##(1990-8#1)(1993-4#1)(2013-1#1)
rates of cancer##2##3##(1990-2#1)(2010-12#1)
rates of cardiovascular##3##3##(2007-8#1)(2008-1#1)(2012-12#1)
rates of catalysis and##2##4##(1991-4#1)(1995-6#1)
rates of catalysis##3##3##(1990-12#1)(1991-4#1)(1995-6#1)
rates of cell##3##3##(2006-12#1)(2008-7#1)(2012-12#1)
rates of cervical intraepithelial neoplasia##2##5##(1994-12#1)(2011-1#1)
rates of change in the##2##5##(1992-12#1)(2007-12#1)
rates of change of##3##4##(2004-11#1)(2008-3#1)(2009-7#1)
rates of change##9##3##(1992-12#2)(2004-11#4)(2007-12#1)(2008-3#1)(2009-7#1)
rates of childhood##2##3##(2008-11#1)(2010-3#1)
rates of children##2##3##(1994-2#1)(2008-4#1)
rates of cholesterol synthesis##3##4##(1991-2#1)(1992-2#1)(1995-12#1)
rates of choline##2##3##(1993-9#1)(1994-10#1)
rates of clonal##2##3##(2008-9#2)
rates of complications##4##3##(2006-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
rates of coronary artery##2##4##(2008-7#1)(2011-2#1)
rates of coronary heart disease##2##5##(1997-3#1)(1997-8#1)
rates of coronary##5##3##(1992-6#1)(1997-3#1)(1997-8#1)(2008-7#1)(2011-2#1)
rates of death##3##3##(1991-12#1)(2007-2#1)(2013-1#1)
rates of decline##2##3##(1993-11#1)(1993-3#1)
rates of dephosphorylation##2##3##(1996-2#2)
rates of depression##2##3##(2008-2#1)(2011-1#1)
rates of different##3##3##(2008-11#1)(2008-7#1)(2013-1#1)
rates of diffusion and##2##4##(1991-8#1)(2008-2#1)
rates of disappearance##2##3##(1990-4#1)(1994-3#1)
rates of disease##4##3##(1994-3#1)(2008-10#2)(2013-8#1)
rates of disfluency##3##3##(2008-2#3)
rates of dispersal##2##3##(2008-8#2)
rates of each of##2##4##(1993-12#1)(2008-8#1)
rates of each##3##3##(1993-12#1)(1996-6#1)(2008-8#1)
rates of enzymatic##2##3##(1994-8#1)(2008-5#1)
rates of evolution##3##3##(1991-9#1)(1992-12#2)
rates of formation of##2##4##(1993-6#1)(2008-5#1)
rates of formation##4##3##(1991-7#1)(1993-6#1)(2008-10#1)(2008-5#1)
rates of gastrovascular transport##2##4##(2010-2#2)
rates of glucose##4##3##(1993-7#1)(1997-8#1)(2008-11#1)(2008-7#1)
rates of growth and##2##4##(1995-1#1)(2008-11#1)
rates of growth##3##3##(1995-1#2)(2008-11#1)
rates of herbivory##2##3##(1995-8#1)(2008-8#1)
rates of heterotopic ossification##2##4##(2012-12#2)
rates of hip and knee joint replacement##2##7##(2011-2#2)
rates of hydrolysis##3##3##(2008-5#1)(2009-2#1)(2010-8#1)
rates of incorporation of##5##4##(1994-10#1)(1996-7#2)(2006-3#2)
rates of infant mortality##2##4##(2007-2#1)(2012-1#1)
rates of infection##10##3##(1990-4#1)(1993-1#1)(2007-7#3)(2008-10#1)(2009-9#2)(2012-12#1)(2013-1#1)
rates of inhibition of##2##4##(1994-11#2)
rates of injury##2##3##(2008-10#1)(2010-11#1)
rates of insulin##2##3##(1991-6#1)(2008-3#1)
rates of loading##2##3##(2007-4#1)(2008-10#1)
rates of local##2##3##(2008-6#2)
rates of long-term##2##3##(2009-12#1)(2013-1#1)
rates of low##3##3##(1992-2#1)(1994-8#1)(2008-7#1)
rates of major depressive disorder##2##5##(1991-2#1)(2011-2#1)
rates of major##3##3##(1991-2#1)(2007-9#1)(2011-2#1)
rates of many##2##3##(1994-3#1)(2009-7#1)
rates of medical##2##3##(2010-2#1)(2010-8#1)
rates of microbial##2##3##(2005-12#1)(2008-10#1)
rates of molecular evolution##2##4##(1992-12#1)(2007-12#1)
rates of molecular##3##3##(1992-12#1)(1996-5#1)(2007-12#1)
rates of mood disorders##2##4##(2004-3#2)
rates of mood##3##3##(2004-3#2)(2009-4#1)
rates of morbidity and mortality in##2##6##(2006-2#1)(2010-12#1)
rates of morbidity and mortality##4##5##(2006-2#1)(2006-4#1)(2007-3#1)(2010-12#1)
rates of morbidity and##5##4##(2006-2#1)(2006-4#1)(2007-3#1)(2008-1#1)(2010-12#1)
rates of morbidity##6##3##(2005-5#1)(2006-2#1)(2006-4#1)(2007-3#1)(2008-1#1)(2010-12#1)
rates of more than##2##4##(1997-5#1)(2007-12#1)
rates of mortality##4##3##(2008-9#1)(2009-10#1)(2013-1#1)(2013-8#1)
rates of most##2##3##(2004-4#1)(2012-2#1)
rates of movement##3##3##(2008-8#1)(2011-12#2)
rates of native AVFs##2##4##(2007-7#2)
rates of net##2##3##(1991-8#1)(1995-6#1)
rates of nonadherence to##2##4##(2008-3#1)(2012-1#1)
rates of nucleotide##3##3##(1990-4#1)(2008-4#1)(2009-9#1)
rates of oral stereotypic behavior##2##5##(2009-4#2)
rates of other##2##3##(2006-10#1)(2009-12#1)
rates of over##2##3##(1992-2#1)(2008-3#1)
rates of oxygen uptake and carbon dioxide evolution of animal cell##2##11##(2008-11#2)
rates of oxygen uptake and carbon dioxide evolution##3##8##(2008-11#3)
rates of oxygen##5##3##(1995-6#1)(2008-11#3)(2010-5#1)
rates of pH##2##3##(1994-9#1)(2008-8#1)
rates of patients##4##3##(2006-10#1)(2007-11#1)(2007-5#1)(2012-2#1)
rates of peritonitis##2##3##(2007-12#1)(2008-4#1)
rates of photosynthesis##3##3##(2006-12#1)(2009-10#1)(2012-12#1)
rates of population increase for##2##5##(2010-8#1)(2012-2#1)
rates of population increase##3##4##(2010-8#1)(2011-2#1)(2012-2#1)
rates of population##4##3##(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
rates of primary##6##3##(1996-12#1)(2007-7#2)(2008-10#2)(2011-2#1)
rates of procollagen synthesis and degradation in vitro##2##8##(1991-1#2)
rates of protein synthesis##3##4##(1991-6#1)(1995-6#1)(1996-11#1)
rates of protein##5##3##(1991-6#1)(1995-6#2)(1996-11#1)(2008-7#1)
rates of re-bleeding and mortality in##2##6##(2013-1#2)
rates of reaction of##2##4##(1994-5#1)(2010-5#1)
rates of recombination and##4##4##(2008-10#3)(2009-10#1)
rates of recombination##5##3##(2008-10#4)(2009-10#1)
rates of recurrence##5##3##(2009-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
rates of reduction of##2##4##(1990-12#1)(1996-9#1)
rates of reported##2##3##(1995-12#1)(2005-10#1)
rates of response##3##3##(1993-6#2)(2006-10#1)
rates of rotation##2##3##(1992-10#1)(1997-7#1)
rates of schizotypal traits in##2##5##(2008-1#2)
rates of serious infections##2##4##(2009-11#1)(2011-2#1)
rates of serious##4##3##(2005-10#1)(2008-11#1)(2009-11#1)(2011-2#1)
rates of several##4##3##(1991-3#1)(1994-3#2)(2008-5#1)
rates of smoking##2##3##(1991-11#1)(2013-8#1)
rates of solvolysis##2##3##(2009-3#1)(2011-1#1)
rates of somatic##2##3##(2009-4#1)(2009-8#1)
rates of specific##3##3##(1994-6#1)(1995-3#1)(2012-12#1)
rates of spread and##2##4##(2008-8#2)
rates of spread##5##3##(2008-8#4)(2011-12#1)
rates of subsequent##2##3##(2010-4#1)(2012-12#1)
rates of success and##2##4##(2011-12#1)(2013-8#1)
rates of success##5##3##(1991-12#1)(1994-7#1)(2006-12#1)(2011-12#1)(2013-8#1)
rates of sustained##2##3##(2012-2#1)(2013-1#1)
rates of synthesis##2##3##(1991-3#1)(2004-11#1)
rates of the cell##2##4##(2008-11#2)
rates of the latter##2##4##(1997-7#1)(2008-7#1)
rates of the two##2##4##(1994-8#1)(2008-10#1)
rates of the##46##3##(1990-12#2)(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#1)(1993-12#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1997-2#1)(1997-7#3)(2004-11#1)(2004-4#1)(2006-9#1)(2007-7#2)(2007-8#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2010-10#1)(2010-7#1)(2012-2#1)
rates of their##4##3##(1994-9#1)(2004-11#1)(2008-10#2)
rates of these##6##3##(1991-7#1)(1995-6#1)(2008-2#1)(2008-8#1)(2010-8#1)(2011-1#1)
rates of this##3##3##(2005-10#1)(2008-3#1)(2012-1#1)
rates of total##3##3##(1991-6#1)(2009-3#1)(2013-1#1)
rates of transport##2##3##(1990-3#1)(2008-10#1)
rates of up to##4##4##(2007-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
rates of washing##2##3##(2009-2#2)
rates of##977##2##(1990-11#3)(1990-12#7)(1990-2#4)(1990-3#2)(1990-4#7)(1990-5#4)(1990-6#1)(1990-8#2)(1991-1#2)(1991-11#2)(1991-12#6)(1991-2#5)(1991-3#3)(1991-4#2)(1991-5#4)(1991-6#4)(1991-7#5)(1991-8#3)(1991-9#5)(1992-10#3)(1992-11#1)(1992-12#8)(1992-2#3)(1992-3#1)(1992-4#4)(1992-6#3)(1992-7#2)(1993-1#3)(1993-11#1)(1993-12#3)(1993-3#2)(1993-4#2)(1993-6#3)(1993-7#3)(1993-9#4)(1994-10#2)(1994-11#6)(1994-12#2)(1994-2#4)(1994-3#10)(1994-5#3)(1994-6#2)(1994-7#2)(1994-8#7)(1994-9#5)(1995-1#6)(1995-10#2)(1995-11#5)(1995-12#6)(1995-2#6)(1995-3#12)(1995-5#1)(1995-6#9)(1995-7#2)(1995-8#6)(1995-9#1)(1996-10#1)(1996-11#3)(1996-12#3)(1996-2#5)(1996-3#1)(1996-4#3)(1996-5#5)(1996-6#1)(1996-7#2)(1996-8#5)(1996-9#2)(1997-2#2)(1997-3#4)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#9)(1997-8#4)(2004-1#1)(2004-11#12)(2004-12#2)(2004-3#2)(2004-4#2)(2004-9#1)(2005-10#5)(2005-11#4)(2005-12#1)(2005-2#1)(2005-4#1)(2005-5#1)(2005-8#4)(2005-9#1)(2006-10#11)(2006-11#4)(2006-12#6)(2006-2#2)(2006-3#4)(2006-4#2)(2006-5#7)(2006-7#5)(2006-8#4)(2006-9#1)(2007-10#3)(2007-11#10)(2007-12#14)(2007-2#6)(2007-3#3)(2007-4#3)(2007-5#2)(2007-7#18)(2007-8#14)(2007-9#3)(2008-1#15)(2008-10#80)(2008-11#36)(2008-12#12)(2008-2#16)(2008-3#18)(2008-4#6)(2008-5#26)(2008-6#7)(2008-7#26)(2008-8#33)(2008-9#20)(2009-1#1)(2009-10#4)(2009-11#2)(2009-12#3)(2009-2#5)(2009-3#3)(2009-4#11)(2009-5#5)(2009-6#3)(2009-7#4)(2009-8#7)(2009-9#4)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#6)(2010-3#2)(2010-4#5)(2010-5#5)(2010-7#3)(2010-8#12)(2010-9#3)(2011-1#13)(2011-12#8)(2011-2#30)(2011-7#1)(2012-1#8)(2012-11#1)(2012-12#17)(2012-2#17)(2012-3#7)(2013-1#40)(2013-7#1)(2013-8#11)
rates on the##6##3##(1991-8#1)(2004-11#1)(2010-11#1)(2013-8#3)
rates on##21##2##(1991-8#1)(1992-10#1)(1994-11#1)(1996-4#1)(2004-11#1)(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#2)(2012-2#1)(2013-8#3)
rates only##3##2##(1991-5#1)(2008-10#1)(2011-2#1)
rates or##9##2##(1994-2#1)(1995-1#1)(1996-2#1)(1996-6#1)(2008-6#1)(2008-7#1)(2009-7#1)(2011-2#2)
rates over a##3##3##(2008-6#1)(2008-7#1)(2009-4#1)
rates over##11##2##(1991-1#1)(1992-2#1)(1995-12#1)(2006-5#1)(2007-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-9#1)
rates per 1000##2##3##(1990-9#1)(1993-7#1)
rates per##4##2##(1990-9#1)(1993-7#1)(1996-7#1)(2013-1#1)
rates ranged from##5##3##(1991-11#1)(2007-11#1)(2007-5#2)(2011-2#1)
rates ranged##6##2##(1991-11#1)(2007-11#1)(2007-5#2)(2011-2#1)(2012-2#1)
rates ranging from 0##3##4##(2004-9#1)(2008-10#1)(2009-7#1)
rates ranging from 8##2##4##(2008-1#1)(2009-7#1)
rates ranging from##10##3##(1995-3#1)(2004-9#1)(2005-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-7#2)(2012-12#1)(2012-2#1)
rates reached##2##2##(1990-3#1)(2012-12#1)
rates recorded##2##2##(2007-3#1)(2012-2#1)
rates reduced##2##2##(1996-8#1)(2013-8#1)
rates related to##2##3##(2009-12#1)(2011-2#1)
rates remain high##2##3##(2005-7#1)(2006-10#1)
rates remain##5##2##(1993-3#1)(2005-7#1)(2006-10#1)(2006-5#1)(2012-12#1)
rates remained##3##2##(1995-5#1)(1996-3#1)(2008-11#1)
rates reported in the literature##2##5##(1991-3#1)(1993-11#1)
rates reported in the##3##4##(1991-3#1)(1993-11#1)(2008-8#1)
rates reported in##5##3##(1991-3#1)(1993-11#1)(2005-8#1)(2008-8#1)(2010-5#1)
rates reported##8##2##(1991-3#1)(1993-11#1)(1993-12#1)(2005-8#1)(2008-8#1)(2010-5#1)(2013-8#2)
rates resulting in##2##3##(2008-11#1)(2008-8#1)
rates revealed##2##2##(1990-6#1)(1993-3#1)
rates rise##2##2##(2004-10#1)(2004-9#1)
rates seen##2##2##(2008-11#1)(2013-1#1)
rates should be##4##3##(2008-10#1)(2008-7#1)(2008-9#2)
rates should##6##2##(2007-7#1)(2008-10#2)(2008-7#1)(2008-9#2)
rates show##2##2##(2007-1#1)(2008-7#1)
rates showed a##2##3##(1990-5#1)(2007-5#1)
rates showed##7##2##(1990-5#1)(1991-6#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-11#1)(2011-1#1)
rates significantly decreased##2##3##(2006-6#1)(2010-8#1)
rates significantly higher than##2##4##(1991-12#1)(2005-7#1)
rates significantly##4##2##(1991-12#1)(2005-7#1)(2006-6#1)(2010-8#1)
rates similar to those obtained##2##5##(1996-8#1)(2008-10#1)
rates similar to those of##2##5##(1992-12#1)(2011-2#1)
rates similar to those##6##4##(1992-12#1)(1996-8#1)(2007-7#1)(2008-10#1)(2008-7#1)(2011-2#1)
rates similar to##8##3##(1992-12#1)(1996-8#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-2#1)(2011-1#1)(2011-2#1)
rates suggest that##2##3##(1997-5#1)(2008-8#1)
rates tended to##2##3##(1995-12#1)(1997-8#1)
rates than in##2##3##(2012-7#1)(2013-1#1)
rates than other##3##3##(2006-10#1)(2008-10#1)(2008-11#1)
rates than those##3##3##(2006-5#1)(2008-6#1)(2013-1#1)
rates than##27##2##(1991-7#1)(1991-8#1)(1995-2#1)(1997-7#1)(2004-12#1)(2005-9#1)(2006-10#1)(2006-5#2)(2007-11#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#3)(2008-8#1)(2009-7#1)(2010-2#1)(2010-9#1)(2012-12#1)(2012-7#1)(2013-1#3)
rates that are##8##3##(2006-11#1)(2008-3#2)(2011-1#1)(2012-3#1)(2013-8#3)
rates that may be##2##4##(2008-3#1)(2008-4#1)
rates that were##4##3##(2007-1#1)(2008-10#1)(2012-3#1)(2013-8#1)
rates that##25##2##(1992-2#1)(2006-1#1)(2006-11#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#3)(2013-8#4)
rates the##2##2##(2007-12#1)(2009-4#1)
rates through##3##2##(2008-10#2)(2013-1#1)
rates to be##2##3##(2008-10#1)(2008-8#1)
rates to standard##2##3##(2008-6#1)(2010-11#1)
rates to those##4##3##(1991-3#1)(1992-2#1)(2007-11#1)(2008-8#1)
rates to##37##2##(1990-2#1)(1990-8#1)(1991-3#2)(1992-2#1)(1993-7#2)(1994-11#1)(1995-2#1)(2006-10#2)(2006-8#2)(2007-11#2)(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-12#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
rates under different##2##3##(1995-6#1)(2013-7#1)
rates under##6##2##(1990-12#1)(1995-6#1)(1996-4#1)(2006-10#1)(2009-10#1)(2013-7#1)
rates up to 2##2##4##(2007-12#1)(2009-11#1)
rates up to##14##3##(1996-1#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-11#1)(2010-11#1)(2013-8#1)
rates used##2##2##(1994-2#1)(2008-10#1)
rates using##3##2##(1997-1#1)(2006-4#1)(2008-9#1)
rates varied from##3##3##(2008-10#1)(2010-8#1)(2013-1#1)
rates varied##8##2##(2005-11#1)(2007-5#1)(2008-10#2)(2008-7#1)(2010-12#1)(2010-8#1)(2013-1#1)
rates vary##4##2##(1994-2#1)(2009-7#1)(2012-3#1)(2013-1#1)
rates was examined##2##3##(1996-3#1)(2007-12#1)
rates was##12##2##(1992-10#1)(1993-5#1)(1996-3#1)(1996-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-3#1)(2012-12#1)(2012-2#2)(2013-8#1)
rates were 0##4##3##(2007-3#1)(2008-11#1)(2008-8#1)(2012-3#1)
rates were 27##2##3##(1996-6#1)(2011-2#1)
rates were 30##2##3##(1991-8#1)(2011-1#1)
rates were 5##2##3##(2007-7#1)(2012-3#1)
rates were 7##2##3##(1996-4#1)(2005-10#1)
rates were 92% and##2##4##(1991-8#1)(2006-10#1)
rates were also##3##3##(2006-1#1)(2008-1#1)(2008-10#1)
rates were analyzed##3##3##(1994-3#1)(2008-12#1)(2011-2#1)
rates were approximately##2##3##(1990-6#1)(1992-4#1)
rates were associated with##2##4##(1996-12#1)(2013-8#1)
rates were calculated and##2##4##(2008-11#1)(2013-8#1)
rates were calculated for##2##4##(1992-3#1)(1995-3#1)
rates were calculated from##2##4##(2008-11#1)(2011-2#1)
rates were calculated using##2##4##(2011-2#2)
rates were calculated##11##3##(1992-3#1)(1995-3#1)(2008-11#3)(2011-2#5)(2013-8#1)
rates were comparable with##2##4##(2007-2#1)(2010-8#1)
rates were comparable##4##3##(2004-1#1)(2007-2#1)(2010-3#1)(2010-8#1)
rates were compared##4##3##(1994-11#1)(2007-8#1)(2009-6#1)(2011-2#1)
rates were determined by##2##4##(1996-1#1)(2008-10#1)
rates were determined##9##3##(1991-12#1)(1996-1#1)(2005-11#1)(2007-3#1)(2007-5#1)(2007-6#1)(2008-10#2)(2012-3#1)
rates were estimated from##2##4##(1997-4#1)(2008-5#1)
rates were estimated##4##3##(1994-10#1)(1997-4#1)(2008-3#1)(2008-5#1)
rates were evaluated##3##3##(2007-8#1)(2008-10#1)(2008-6#1)
rates were found to be##2##5##(1996-5#1)(2008-7#1)
rates were found to##5##4##(1990-2#1)(1991-3#1)(1995-3#1)(1996-5#1)(2008-7#1)
rates were found##9##3##(1990-2#1)(1991-3#1)(1993-12#1)(1995-3#1)(1996-5#1)(2007-12#1)(2008-6#1)(2008-7#1)(2009-9#1)
rates were higher for##2##4##(2011-2#1)(2013-8#1)
rates were higher in the##3##5##(2006-4#1)(2007-5#1)(2011-2#1)
rates were higher in##7##4##(1990-9#1)(2006-4#1)(2006-5#1)(2007-5#1)(2011-2#3)
rates were higher##14##3##(1990-9#1)(2006-4#1)(2006-5#2)(2007-11#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-6#1)(2011-2#4)(2013-8#1)
rates were highest for##2##4##(1991-2#1)(1997-7#1)
rates were highest in##2##4##(2006-2#1)(2008-7#1)
rates were highest##5##3##(1991-2#1)(1997-7#1)(2006-2#1)(2008-5#1)(2008-7#1)
rates were in##2##3##(2004-4#1)(2008-10#1)
rates were increased##2##3##(1994-3#1)(2008-9#1)
rates were low##2##3##(1995-3#1)(2011-2#1)
rates were lower in##2##4##(1991-12#1)(2008-8#1)
rates were lower than##2##4##(1993-3#1)(2008-10#1)
rates were lower##7##3##(1991-12#1)(1993-3#1)(2006-6#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-7#1)
rates were measured##2##3##(2007-5#1)(2011-1#1)
rates were not different##2##4##(2006-5#1)(2007-8#1)
rates were not significantly different##2##5##(1992-10#1)(2006-5#1)
rates were not significantly##3##4##(1992-10#1)(2005-8#1)(2006-5#1)
rates were not##9##3##(1991-5#1)(1992-10#1)(1997-2#1)(2005-8#1)(2006-5#2)(2007-8#1)(2008-11#1)(2011-2#1)
rates were observed between##2##4##(1990-8#1)(2013-1#1)
rates were observed in##2##4##(1990-8#1)(2013-8#1)
rates were observed##9##3##(1990-8#2)(1995-5#1)(1996-3#1)(2008-10#1)(2008-12#1)(2011-12#1)(2013-1#1)(2013-8#1)
rates were obtained##3##3##(1995-12#1)(2008-10#1)(2008-11#1)
rates were recorded##4##3##(1993-6#1)(2007-2#1)(2007-7#1)(2008-12#1)
rates were respectively##2##3##(1992-8#1)(2008-1#1)
rates were significantly better##2##4##(2007-11#1)(2007-7#1)
rates were significantly higher##3##4##(1993-5#1)(2007-11#1)(2008-7#1)
rates were significantly increased##2##4##(1992-8#1)(2011-2#1)
rates were significantly lower##3##4##(1997-3#1)(2008-10#1)(2012-3#1)
rates were significantly##14##3##(1990-12#1)(1992-8#1)(1993-5#1)(1995-11#1)(1997-3#1)(2006-9#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-3#1)
rates were similar##5##3##(1990-2#1)(1994-5#1)(2007-8#1)(2008-3#1)(2012-12#1)
rates were##248##2##(1990-12#3)(1990-2#2)(1990-6#2)(1990-8#2)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-10#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#3)(1993-6#1)(1994-10#1)(1994-11#1)(1994-3#3)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#3)(1995-5#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#3)(2004-1#2)(2004-4#1)(2005-10#1)(2005-11#3)(2005-4#1)(2005-8#3)(2006-1#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-5#5)(2006-6#4)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#2)(2007-3#3)(2007-5#3)(2007-6#1)(2007-7#4)(2007-8#8)(2007-9#1)(2008-1#4)(2008-10#19)(2008-11#14)(2008-12#5)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#1)(2009-2#1)(2009-6#2)(2009-9#1)(2010-3#2)(2010-8#2)(2011-1#5)(2011-11#1)(2011-12#2)(2011-2#22)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#8)(2013-1#6)(2013-7#1)(2013-8#6)
rates when##6##2##(1991-5#1)(2006-5#1)(2007-10#1)(2007-9#1)(2008-10#1)(2012-12#1)
rates which##4##2##(1990-12#1)(1991-1#1)(2007-2#1)(2008-11#1)
rates will##3##2##(2006-11#1)(2010-8#1)(2013-1#1)
rates with a##3##3##(2004-12#1)(2008-11#1)(2008-7#1)
rates with the##4##3##(1990-5#1)(2006-10#1)(2008-7#1)(2008-9#1)
rates with##33##2##(1990-5#1)(1992-3#1)(1992-7#1)(1993-1#1)(1994-4#1)(1996-12#3)(2004-12#1)(2005-11#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#4)(2008-9#2)(2010-12#3)(2010-6#1)(2011-10#1)(2011-2#1)(2012-2#1)(2012-3#2)
rates within##8##2##(1994-12#1)(1997-3#1)(2006-8#1)(2007-8#1)(2008-11#1)(2008-8#1)(2010-12#1)(2012-12#1)
rates without##6##2##(1997-6#1)(2007-10#1)(2007-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
rates##3577##1##(1990-10#4)(1990-11#7)(1990-12#24)(1990-2#11)(1990-3#6)(1990-4#17)(1990-5#8)(1990-6#8)(1990-7#3)(1990-8#7)(1990-9#9)(1991-1#11)(1991-10#1)(1991-11#9)(1991-12#19)(1991-2#11)(1991-3#16)(1991-4#2)(1991-5#14)(1991-6#17)(1991-7#8)(1991-8#10)(1991-9#11)(1992-1#10)(1992-10#10)(1992-11#3)(1992-12#20)(1992-2#18)(1992-3#5)(1992-4#7)(1992-5#5)(1992-6#8)(1992-7#7)(1992-8#5)(1992-9#5)(1993-1#8)(1993-10#1)(1993-11#5)(1993-12#19)(1993-2#3)(1993-3#12)(1993-4#5)(1993-5#9)(1993-6#10)(1993-7#7)(1993-9#6)(1994-1#3)(1994-10#3)(1994-11#13)(1994-12#15)(1994-2#17)(1994-3#22)(1994-4#2)(1994-5#10)(1994-6#6)(1994-7#5)(1994-8#16)(1994-9#13)(1995-1#15)(1995-10#8)(1995-11#9)(1995-12#17)(1995-2#16)(1995-3#24)(1995-4#7)(1995-5#9)(1995-6#13)(1995-7#3)(1995-8#9)(1995-9#5)(1996-1#6)(1996-10#1)(1996-11#6)(1996-12#30)(1996-2#10)(1996-3#19)(1996-4#7)(1996-5#6)(1996-6#8)(1996-7#5)(1996-8#11)(1996-9#8)(1997-1#5)(1997-2#11)(1997-3#11)(1997-4#6)(1997-5#5)(1997-6#16)(1997-7#31)(1997-8#14)(2004-1#5)(2004-10#8)(2004-11#16)(2004-12#5)(2004-3#2)(2004-4#6)(2004-9#8)(2005-10#15)(2005-11#28)(2005-12#3)(2005-2#2)(2005-4#2)(2005-5#2)(2005-7#8)(2005-8#17)(2005-9#3)(2006-1#5)(2006-10#58)(2006-11#11)(2006-12#13)(2006-2#7)(2006-3#7)(2006-4#8)(2006-5#43)(2006-6#13)(2006-7#11)(2006-8#16)(2006-9#9)(2007-1#8)(2007-10#30)(2007-11#56)(2007-12#65)(2007-2#25)(2007-3#13)(2007-4#11)(2007-5#22)(2007-6#4)(2007-7#63)(2007-8#48)(2007-9#17)(2008-1#43)(2008-10#237)(2008-11#138)(2008-12#38)(2008-2#50)(2008-3#67)(2008-4#19)(2008-5#72)(2008-6#41)(2008-7#102)(2008-8#118)(2008-9#59)(2009-1#1)(2009-10#10)(2009-11#6)(2009-12#9)(2009-2#9)(2009-3#12)(2009-4#23)(2009-5#21)(2009-6#13)(2009-7#23)(2009-8#13)(2009-9#12)(2010-1#5)(2010-10#9)(2010-11#13)(2010-12#31)(2010-2#20)(2010-3#18)(2010-4#18)(2010-5#9)(2010-6#9)(2010-7#18)(2010-8#36)(2010-9#10)(2011-1#53)(2011-10#3)(2011-11#2)(2011-12#25)(2011-2#151)(2011-3#2)(2011-7#1)(2012-1#18)(2012-11#3)(2012-12#56)(2012-2#65)(2012-3#71)(2012-6#1)(2012-7#1)(2013-1#119)(2013-7#15)(2013-8#69)
rates&quot##2##1##(2007-4#1)(2008-5#1)
rates) and the##2##3##(2008-10#1)(2013-1#1)
rates)##15##1##(1992-11#1)(2005-11#1)(2007-10#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2010-8#5)(2011-1#1)(2013-1#1)
rates--a##2##1##(1994-8#1)(2008-9#1)
rates?##2##1##(2007-8#1)(2008-8#1)
ratesetting##5##1##(1991-2#2)(1993-12#2)(1994-2#1)
rather a##11##2##(1991-12#1)(1994-2#1)(2006-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-4#1)
rather as##6##2##(1995-6#1)(2008-5#2)(2008-6#1)(2012-11#1)(2013-8#1)
rather be##3##2##(1996-12#1)(2007-8#1)(2010-12#1)
rather closely##2##2##(2005-11#1)(2007-1#1)
rather common and##2##3##(2008-7#1)(2011-2#1)
rather complex##2##2##(1993-12#1)(2008-9#1)
rather complicated##2##2##(2008-2#1)(2008-3#1)
rather constant##2##2##(1991-7#1)(1996-5#1)
rather general##2##2##(2009-9#1)(2010-7#1)
rather heterogeneous##2##2##(2007-11#1)(2011-2#1)
rather high detection##2##3##(1996-5#1)(2008-10#1)
rather high##14##2##(1991-1#1)(1991-11#2)(1996-5#1)(2005-6#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-8#1)(2013-1#1)
rather homogeneous##3##2##(1996-12#1)(1997-4#1)(2010-4#1)
rather homogenous##2##2##(2005-8#1)(2008-10#1)
rather in##4##2##(1994-3#1)(1996-11#1)(2003-11#1)(2009-8#1)
rather insensitive##2##2##(1990-2#1)(1995-12#1)
rather it##4##2##(1992-8#1)(1994-11#1)(1996-3#1)(2007-12#1)
rather large##6##2##(2004-12#1)(2007-11#1)(2007-12#2)(2008-3#1)(2008-5#1)
rather limited##9##2##(1990-10#1)(1996-11#1)(1996-2#1)(2007-8#1)(2008-12#1)(2008-2#1)(2009-5#1)(2010-7#1)(2013-1#1)
rather low and##2##3##(2008-10#1)(2008-8#1)
rather low##15##2##(1991-7#1)(1992-10#1)(1993-6#1)(2007-3#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-4#1)(2012-2#1)
rather modest##3##2##(1991-1#1)(1995-5#1)(2006-1#1)
rather more##2##2##(1990-2#1)(1994-12#1)
rather poor##10##2##(1996-5#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-4#2)(2011-2#1)
rather rare##10##2##(1993-9#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-2#1)
rather recent##2##2##(1991-6#1)(1995-7#1)
rather robust##2##2##(2008-10#1)(2009-2#1)
rather scarce##2##2##(1990-5#1)(2008-10#1)
rather selective##2##2##(1993-6#1)(2010-1#1)
rather serious##2##2##(2008-4#1)(2012-11#1)
rather short##4##2##(1990-6#1)(1996-12#1)(2013-1#1)(2013-7#1)
rather similar##7##2##(1992-3#1)(1997-4#1)(1997-6#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-7#1)
rather simple##5##2##(1993-6#1)(1997-8#1)(2008-10#2)(2011-12#1)
rather slow##6##2##(1993-3#1)(1995-8#1)(1997-7#1)(2005-7#1)(2008-10#1)(2013-8#1)
rather small##9##2##(1990-4#1)(1994-4#1)(1995-2#1)(1996-6#1)(2008-12#1)(2008-2#1)(2008-5#1)(2010-11#1)(2010-9#1)
rather specific##3##2##(1994-11#1)(2008-7#1)(2011-2#1)
rather stable##2##2##(1995-5#1)(2008-10#1)
rather strong##2##2##(1992-2#1)(2005-4#1)
rather structured##2##2##(1997-2#2)
rather surprising##2##2##(2007-12#1)(2007-8#1)
rather than &quot##3##3##(1997-5#1)(2007-1#1)(2012-12#1)
rather than a &quot##2##4##(2011-2#1)(2013-8#1)
rather than a cause of##2##5##(2008-1#1)(2013-8#1)
rather than a cause##3##4##(2005-9#1)(2008-1#1)(2013-8#1)
rather than a continuous##2##4##(2007-11#1)(2008-10#1)
rather than a direct##2##4##(1994-8#1)(2006-7#1)
rather than a general##2##4##(1994-9#1)(2006-2#1)
rather than a single##6##4##(2006-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2013-1#2)
rather than a specific##5##4##(1990-9#1)(1995-12#1)(1996-11#1)(2009-8#1)(2012-2#1)
rather than a##89##3##(1990-10#1)(1990-2#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-5#1)(1992-11#1)(1992-2#2)(1992-4#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-4#2)(1996-8#1)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-10#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-10#5)(2006-2#1)(2006-5#1)(2006-7#2)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#3)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#2)(2013-8#3)
rather than an increased##2##4##(1992-2#1)(1994-10#1)
rather than an##23##3##(1990-7#1)(1991-11#1)(1992-2#1)(1993-8#1)(1994-10#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-7#1)(1997-5#1)(1997-7#1)(1997-8#2)(2006-10#1)(2007-12#2)(2007-6#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2012-2#1)
rather than any##4##3##(1992-9#1)(2007-11#1)(2010-7#1)(2011-12#1)
rather than as a##9##4##(1990-5#1)(2006-3#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)
rather than as an##4##4##(1996-3#1)(2008-7#1)(2013-1#2)
rather than as the##2##4##(1990-11#1)(1995-8#1)
rather than as##18##3##(1990-11#1)(1990-5#1)(1995-8#1)(1996-3#1)(2005-10#1)(2006-3#1)(2006-8#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2013-1#2)
rather than assessing the##2##4##(2008-7#1)(2009-9#1)
rather than at##7##3##(1990-10#1)(1994-3#1)(1995-1#1)(1995-11#1)(2005-10#1)(2008-5#1)(2008-8#1)
rather than being##14##3##(1990-5#1)(1991-8#1)(1994-9#1)(1995-3#1)(2006-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-6#1)(2010-12#1)(2012-3#1)
rather than better##2##3##(1990-9#1)(1991-11#1)
rather than between##3##3##(2008-10#2)(2010-10#1)
rather than by a##4##4##(1995-12#2)(1996-12#1)(2008-10#1)
rather than by direct##2##4##(1994-2#1)(1996-11#1)
rather than by##26##3##(1990-11#1)(1990-3#1)(1992-6#1)(1994-2#1)(1994-3#2)(1995-12#2)(1996-11#1)(1996-12#1)(1996-5#1)(1996-7#1)(2006-10#1)(2006-5#2)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-8#2)(2009-6#1)(2010-1#1)(2010-2#1)(2012-12#1)(2013-7#1)
rather than causing##2##3##(1991-7#1)(2008-5#1)
rather than chronic##2##3##(2005-7#1)(2010-3#1)
rather than clinical resources##2##4##(2013-1#2)
rather than clinical##4##3##(1997-3#1)(2010-1#1)(2013-1#2)
rather than continuous##2##3##(2007-9#2)
rather than conventional##3##3##(2008-11#1)(2008-5#1)(2011-2#1)
rather than curative##2##3##(1993-9#1)(2012-3#1)
rather than current##2##3##(1993-6#1)(1997-4#1)
rather than decreased##2##3##(1994-8#1)(2008-11#1)
rather than direct##5##3##(1991-12#1)(1992-3#1)(2008-2#1)(2008-5#1)(2008-9#1)
rather than directly##2##3##(2008-1#1)(2009-5#1)
rather than enhanced##2##3##(2008-1#1)(2008-4#1)
rather than favouring##2##3##(1992-10#1)(2005-7#1)
rather than for##4##3##(1994-8#1)(2006-5#1)(2008-9#1)(2013-8#1)
rather than four##3##3##(1994-12#1)(2012-12#2)
rather than from##9##3##(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-8#1)(2008-9#1)(2010-2#1)(2011-1#1)
rather than genetic##2##3##(2005-12#1)(2008-8#1)
rather than having##2##3##(1995-1#1)(2013-1#1)
rather than hours##2##3##(2008-10#1)(2008-6#1)
rather than human##2##3##(2007-11#1)(2008-7#1)
rather than improving##2##3##(1995-3#1)(2012-2#1)
rather than in a##3##4##(1996-7#1)(2007-12#1)(2008-11#1)
rather than in the##19##4##(1990-11#1)(1991-8#1)(1992-11#1)(1992-4#1)(1993-12#2)(1995-3#1)(1995-7#1)(1997-2#1)(2006-10#2)(2008-2#2)(2008-3#2)(2008-4#1)(2012-3#2)(2013-1#1)
rather than in##39##3##(1990-10#1)(1990-11#1)(1990-7#1)(1991-8#1)(1992-11#1)(1992-4#1)(1993-12#2)(1993-7#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-5#1)(1996-7#2)(1997-2#1)(2006-10#2)(2007-12#1)(2007-9#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-9#2)(2009-6#1)(2010-2#1)(2010-9#1)(2011-1#1)(2012-3#2)(2013-1#1)
rather than increase##2##3##(2008-10#1)(2013-1#1)
rather than individual##3##3##(2007-12#1)(2010-4#1)(2012-2#1)
rather than individually##2##3##(2005-10#1)(2008-3#1)
rather than individuals##2##3##(1996-8#1)(2007-4#1)
rather than inhibition##2##3##(1995-11#1)(2006-4#1)
rather than intensity##2##3##(2007-12#1)(2008-3#1)
rather than its##6##3##(1990-7#1)(1991-12#1)(1994-8#1)(2007-11#1)(2008-4#1)(2008-7#1)
rather than just the##2##4##(1993-12#1)(2009-8#1)
rather than just##9##3##(1990-9#1)(1993-12#1)(1994-2#2)(1994-3#1)(1997-8#1)(2008-11#1)(2009-2#1)(2009-8#1)
rather than later##2##3##(2012-1#1)(2012-3#1)
rather than less##2##3##(1997-1#1)(2005-10#1)
rather than low##2##3##(1994-6#1)(2006-3#1)
rather than making##3##3##(1995-12#1)(2006-5#1)(2008-9#1)
rather than mass##2##3##(1990-12#1)(2008-7#1)
rather than maximize##2##3##(1997-3#2)
rather than merely##3##3##(2006-3#1)(2008-10#1)(2009-5#1)
rather than neuronal##2##3##(1996-5#1)(1997-1#1)
rather than of##2##3##(2008-2#1)(2008-3#1)
rather than on its##2##4##(1991-11#1)(2008-1#1)
rather than on more##2##4##(1990-11#1)(2012-2#1)
rather than on the##8##4##(1991-7#1)(1993-2#1)(1994-10#1)(1994-9#1)(1997-8#1)(2006-4#1)(2008-10#1)(2011-2#1)
rather than on##27##3##(1990-11#1)(1991-11#1)(1991-7#1)(1991-8#1)(1993-2#1)(1994-10#1)(1994-9#1)(1997-1#2)(1997-8#1)(2005-8#1)(2006-4#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
rather than one##9##3##(1994-12#1)(1995-6#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-9#2)(2011-12#1)(2012-3#1)
rather than only##3##3##(2008-4#1)(2009-8#1)(2010-11#1)
rather than peripheral##2##3##(1997-8#1)(2006-10#1)
rather than physical##4##3##(1995-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
rather than primary##2##3##(1996-5#1)(2011-12#1)
rather than promoting##2##3##(1990-7#1)(1995-8#1)
rather than pure##2##3##(2009-8#1)(2010-5#1)
rather than recognition##2##3##(1993-3#1)(1997-8#1)
rather than relying##2##3##(2008-10#1)(2008-7#1)
rather than resistance##2##3##(1990-5#1)(2007-12#1)
rather than routine##2##3##(2011-2#1)(2013-8#1)
rather than seeing##2##3##(2009-4#1)(2012-1#1)
rather than seeking to##2##4##(2006-2#1)(2008-2#1)
rather than sexual##2##3##(2008-10#1)(2012-3#1)
rather than simply##6##3##(1994-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)(2012-3#1)
rather than sleep##2##3##(2008-3#1)(2012-2#1)
rather than solely on##2##4##(2006-10#1)(2006-7#1)
rather than solely##7##3##(1995-2#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-4#1)(2008-11#1)(2008-7#1)
rather than species-specific##2##3##(2007-12#1)(2008-10#1)
rather than specific##3##3##(1995-6#1)(2008-11#1)(2010-2#1)
rather than structural##2##3##(2006-8#1)(2010-12#1)
rather than that of##2##4##(2008-10#1)(2011-1#1)
rather than the expected##2##4##(2007-11#1)(2009-7#1)
rather than the more##2##4##(1994-5#1)(2008-2#1)
rather than the number of##5##5##(1990-4#1)(1993-12#1)(2008-3#1)(2011-2#1)(2013-1#1)
rather than the number##6##4##(1990-4#1)(1993-12#1)(2008-3#1)(2009-5#1)(2011-2#1)(2013-1#1)
rather than the result of##2##5##(1990-10#1)(2010-7#1)
rather than the traditional##3##4##(2008-10#2)(2008-3#1)
rather than the usual##2##4##(1993-8#1)(2009-12#1)
rather than the value##2##4##(2008-11#1)(2012-2#1)
rather than the##122##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-3#1)(1990-4#3)(1990-7#1)(1990-8#1)(1991-11#2)(1991-2#2)(1991-8#1)(1991-9#2)(1992-3#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-4#1)(2007-7#1)(2008-10#12)(2008-11#3)(2008-2#9)(2008-3#8)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-4#2)(2010-5#1)(2010-7#3)(2011-2#1)(2012-12#4)(2012-2#2)(2013-1#2)(2013-8#1)
rather than their##7##3##(1997-6#1)(2005-10#1)(2005-11#1)(2008-10#1)(2008-11#1)(2012-11#1)(2012-3#1)
rather than those##5##3##(1993-3#1)(1994-1#1)(1994-3#1)(1997-3#1)(2008-7#1)
rather than through##6##3##(1994-1#2)(1994-10#1)(1995-6#1)(2008-11#1)(2008-4#1)
rather than to a##4##4##(1991-2#1)(1992-6#1)(1993-8#1)(2008-10#1)
rather than to differences##2##4##(2008-9#1)(2010-10#1)
rather than to its##3##4##(1990-10#1)(2006-10#1)(2008-5#1)
rather than to the##6##4##(1990-5#1)(1991-3#1)(1991-5#1)(1992-12#1)(2004-12#1)(2006-12#1)
rather than to##41##3##(1990-10#2)(1990-12#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#2)(1993-8#1)(1994-3#1)(1995-3#1)(1996-1#1)(1997-2#1)(2004-12#1)(2006-10#1)(2006-12#1)(2006-6#2)(2006-7#2)(2007-12#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)
rather than traditional##2##3##(1994-2#1)(1997-8#1)
rather than true##2##3##(2012-12#1)(2013-7#1)
rather than trying to##2##4##(2008-1#1)(2010-9#1)
rather than using a##2##4##(1996-4#1)(2013-7#1)
rather than using##4##3##(1996-4#1)(2008-10#1)(2008-6#1)(2013-7#1)
rather than via##2##3##(1992-11#1)(2012-1#1)
rather than with##6##3##(1990-5#1)(1996-1#1)(1996-12#1)(2008-10#1)(2008-8#1)(2009-2#1)
rather than##1106##2##(1990-10#7)(1990-11#7)(1990-12#6)(1990-2#3)(1990-3#3)(1990-4#3)(1990-5#8)(1990-6#2)(1990-7#5)(1990-8#6)(1990-9#5)(1991-11#7)(1991-12#7)(1991-2#7)(1991-3#1)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#8)(1991-9#3)(1992-1#2)(1992-10#2)(1992-11#4)(1992-12#2)(1992-2#3)(1992-3#4)(1992-4#3)(1992-5#1)(1992-6#5)(1992-8#3)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#7)(1993-2#6)(1993-3#8)(1993-4#1)(1993-6#5)(1993-7#4)(1993-8#6)(1993-9#7)(1994-1#5)(1994-10#4)(1994-11#2)(1994-12#8)(1994-2#6)(1994-3#9)(1994-5#4)(1994-6#2)(1994-8#11)(1994-9#9)(1995-1#7)(1995-10#2)(1995-11#7)(1995-12#9)(1995-2#2)(1995-3#7)(1995-4#1)(1995-5#3)(1995-6#6)(1995-7#1)(1995-8#5)(1995-9#2)(1996-1#3)(1996-10#1)(1996-11#6)(1996-12#6)(1996-2#2)(1996-3#4)(1996-4#5)(1996-5#7)(1996-7#6)(1996-8#4)(1996-9#4)(1997-1#6)(1997-2#5)(1997-3#8)(1997-4#5)(1997-5#4)(1997-6#7)(1997-7#4)(1997-8#14)(2004-1#1)(2004-10#1)(2004-11#2)(2004-12#4)(2004-2#1)(2004-4#1)(2004-9#1)(2005-10#11)(2005-11#5)(2005-12#2)(2005-7#6)(2005-8#4)(2005-9#1)(2006-10#30)(2006-12#5)(2006-2#2)(2006-3#6)(2006-4#4)(2006-5#5)(2006-6#3)(2006-7#8)(2006-8#11)(2006-9#1)(2007-1#3)(2007-10#4)(2007-11#13)(2007-12#26)(2007-2#1)(2007-3#2)(2007-4#4)(2007-5#1)(2007-6#3)(2007-7#3)(2007-8#3)(2007-9#9)(2008-1#13)(2008-10#70)(2008-11#22)(2008-12#7)(2008-2#24)(2008-3#34)(2008-4#22)(2008-5#16)(2008-6#7)(2008-7#26)(2008-8#18)(2008-9#16)(2009-10#2)(2009-11#3)(2009-12#5)(2009-2#3)(2009-3#1)(2009-4#7)(2009-5#7)(2009-6#8)(2009-7#4)(2009-8#7)(2009-9#5)(2010-1#2)(2010-10#4)(2010-11#4)(2010-12#8)(2010-2#10)(2010-3#3)(2010-4#5)(2010-5#3)(2010-6#1)(2010-7#9)(2010-8#7)(2010-9#2)(2011-1#6)(2011-12#6)(2011-2#20)(2012-1#10)(2012-11#7)(2012-12#13)(2012-2#28)(2012-3#17)(2013-1#24)(2013-7#6)(2013-8#10)
rather that the##3##3##(1990-11#1)(1995-2#1)(2008-9#1)
rather that##6##2##(1990-11#1)(1995-2#1)(2007-4#1)(2008-10#1)(2008-9#1)(2012-2#1)
rather the##8##2##(1992-1#1)(1993-11#1)(1994-11#1)(1995-1#1)(1995-6#1)(2010-3#1)(2010-7#1)(2011-2#1)
rather then##2##2##(2008-1#1)(2013-1#1)
rather uncommon##3##2##(1990-5#1)(2005-11#1)(2011-2#1)
rather uniform##2##2##(1990-2#1)(2008-2#1)
rather weak##5##2##(1991-4#1)(1997-1#1)(2004-12#1)(2005-11#1)(2008-8#1)
rather well##2##2##(2005-11#1)(2011-2#1)
rather##1558##1##(1990-10#9)(1990-11#8)(1990-12#9)(1990-2#6)(1990-3#3)(1990-4#5)(1990-5#13)(1990-6#5)(1990-7#6)(1990-8#6)(1990-9#6)(1991-1#3)(1991-11#11)(1991-12#9)(1991-2#8)(1991-3#2)(1991-4#1)(1991-5#8)(1991-6#4)(1991-7#5)(1991-8#8)(1991-9#3)(1992-1#4)(1992-10#4)(1992-11#6)(1992-12#5)(1992-2#5)(1992-3#5)(1992-4#4)(1992-5#2)(1992-6#6)(1992-8#4)(1992-9#3)(1993-1#2)(1993-10#2)(1993-11#6)(1993-12#10)(1993-2#8)(1993-3#9)(1993-4#1)(1993-6#8)(1993-7#4)(1993-8#8)(1993-9#8)(1994-1#6)(1994-10#4)(1994-11#5)(1994-12#10)(1994-2#8)(1994-3#11)(1994-4#1)(1994-5#4)(1994-6#3)(1994-8#13)(1994-9#9)(1995-1#8)(1995-10#2)(1995-11#8)(1995-12#10)(1995-2#6)(1995-3#9)(1995-4#1)(1995-5#6)(1995-6#10)(1995-7#2)(1995-8#7)(1995-9#2)(1996-1#4)(1996-10#3)(1996-11#9)(1996-12#10)(1996-2#4)(1996-3#6)(1996-4#5)(1996-5#12)(1996-6#1)(1996-7#6)(1996-8#5)(1996-9#5)(1997-1#8)(1997-2#7)(1997-3#8)(1997-4#9)(1997-5#4)(1997-6#8)(1997-7#5)(1997-8#16)(2003-11#1)(2004-1#1)(2004-10#1)(2004-11#2)(2004-12#6)(2004-2#1)(2004-4#1)(2004-9#1)(2005-10#13)(2005-11#16)(2005-12#2)(2005-4#1)(2005-6#1)(2005-7#8)(2005-8#7)(2005-9#1)(2006-1#1)(2006-10#37)(2006-11#1)(2006-12#10)(2006-2#5)(2006-3#6)(2006-4#4)(2006-5#6)(2006-6#4)(2006-7#9)(2006-8#12)(2006-9#2)(2007-1#6)(2007-10#7)(2007-11#20)(2007-12#36)(2007-2#6)(2007-3#4)(2007-4#7)(2007-5#2)(2007-6#3)(2007-7#5)(2007-8#9)(2007-9#9)(2008-1#18)(2008-10#99)(2008-11#27)(2008-12#10)(2008-2#35)(2008-3#41)(2008-4#26)(2008-5#30)(2008-6#12)(2008-7#34)(2008-8#24)(2008-9#27)(2009-10#5)(2009-11#4)(2009-12#6)(2009-2#6)(2009-3#1)(2009-4#9)(2009-5#9)(2009-6#12)(2009-7#7)(2009-8#10)(2009-9#7)(2010-1#3)(2010-10#4)(2010-11#6)(2010-12#14)(2010-2#10)(2010-3#4)(2010-4#12)(2010-5#3)(2010-6#2)(2010-7#13)(2010-8#10)(2010-9#3)(2011-1#10)(2011-12#9)(2011-2#31)(2012-1#11)(2012-11#11)(2012-12#15)(2012-2#40)(2012-3#21)(2012-8#1)(2013-1#36)(2013-7#9)(2013-8#15)
ratification of the##2##3##(2009-12#2)
ratification##5##1##(2009-12#4)(2011-12#1)
ratified##2##1##(2006-7#1)(2007-3#1)
ratify##2##1##(2007-8#1)(2008-9#1)
rating and##8##2##(1994-2#1)(1996-7#1)(2008-10#3)(2010-8#1)(2012-12#2)
rating by##2##2##(1994-6#1)(2011-2#1)
rating categories##2##2##(2011-2#2)
rating for##3##2##(1991-12#1)(2008-10#1)(2013-1#1)
rating of 1##2##3##(2008-7#1)(2012-2#1)
rating of perceived exertion (RPE)##3##5##(2006-10#1)(2013-1#1)(2013-7#1)
rating of the##2##3##(2007-12#1)(2007-4#1)
rating of their##2##3##(1990-8#1)(2012-2#1)
rating of##27##2##(1990-8#1)(1992-7#1)(1993-3#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(2006-10#3)(2006-11#1)(2007-12#3)(2007-4#2)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
rating or##2##2##(2008-10#1)(2008-9#1)
rating questionnaire##2##2##(2007-4#1)(2008-8#1)
rating scale and##2##3##(2007-7#1)(2008-12#1)
rating scale for##3##3##(2006-12#1)(2011-2#1)(2011-8#1)
rating scale in##3##3##(2007-12#1)(2008-7#1)(2012-2#1)
rating scale of##3##3##(1993-2#1)(2007-11#1)(2013-8#1)
rating scale was##4##3##(1991-12#1)(2008-1#1)(2008-10#1)(2011-2#1)
rating scale were used to assess##2##6##(1991-6#1)(2007-2#1)
rating scale##40##2##(1990-3#1)(1991-12#1)(1991-6#1)(1993-2#1)(1996-12#1)(1996-7#1)(1997-3#1)(2004-11#1)(2006-12#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-12#2)(2008-3#1)(2008-7#3)(2011-2#5)(2011-8#1)(2012-2#4)(2013-1#1)(2013-7#1)(2013-8#1)
rating scales are##2##3##(2007-12#2)
rating scales for assessing##2##4##(1996-7#1)(2008-6#1)
rating scales or##2##3##(2008-11#1)(2008-7#1)
rating scales##23##2##(1996-12#1)(1996-7#2)(1997-8#1)(2006-10#1)(2007-12#6)(2007-8#1)(2008-1#1)(2008-11#1)(2008-6#2)(2008-7#5)(2010-8#1)(2012-2#1)
rating scores##2##2##(2008-6#1)(2010-2#1)
rating survey##2##2##(2011-1#2)
rating system##4##2##(1996-5#1)(2010-8#1)(2011-2#2)
rating systems##3##2##(1997-8#1)(2008-10#1)(2008-9#1)
rating the##3##2##(2008-11#1)(2008-9#2)
rating their##2##2##(2006-10#1)(2007-9#1)
rating was##2##2##(2008-4#1)(2008-9#1)
rating were##2##2##(2008-10#2)
rating##183##1##(1990-3#1)(1990-8#2)(1991-12#2)(1991-6#1)(1992-1#3)(1992-7#1)(1993-2#1)(1993-3#2)(1994-2#1)(1994-6#1)(1995-1#1)(1995-9#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#4)(1997-3#3)(1997-7#1)(1997-8#5)(2004-10#1)(2004-11#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#13)(2007-2#1)(2007-4#4)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#23)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#12)(2008-8#3)(2008-9#7)(2009-10#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-8#4)(2011-1#2)(2011-2#15)(2011-8#1)(2012-1#1)(2012-12#2)(2012-2#10)(2012-3#1)(2013-1#3)(2013-7#4)(2013-8#2)
rating)##4##1##(2007-12#3)(2008-10#1)
ratings (r =##3##3##(2004-3#2)(2006-12#1)
ratings and performance##2##3##(1997-3#1)(2012-12#1)
ratings and##16##2##(1991-3#1)(1994-2#1)(1996-7#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-6#1)(2010-2#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
ratings are##5##2##(1992-2#1)(1997-8#3)(2009-7#1)
ratings as well as##2##4##(2006-12#1)(2008-10#1)
ratings as##3##2##(1993-3#1)(2006-12#1)(2008-10#1)
ratings based on##3##3##(1995-1#1)(2008-10#1)(2011-1#1)
ratings by##3##2##(1995-12#1)(1996-1#1)(2008-10#1)
ratings for##6##2##(1992-3#1)(1993-12#1)(2004-3#1)(2008-5#1)(2008-9#1)(2010-8#1)
ratings from##2##2##(1997-2#1)(2011-1#1)
ratings in the##4##3##(1996-3#1)(2007-12#3)
ratings in##11##2##(1990-5#1)(1995-12#1)(1996-3#1)(2006-12#1)(2007-12#3)(2008-10#4)
ratings of a##2##3##(1993-1#1)(1994-3#1)
ratings of academic##2##3##(2009-7#1)(2013-7#1)
ratings of care##2##3##(1991-3#1)(2011-2#1)
ratings of child##2##3##(1996-2#1)(2006-3#1)
ratings of perceived exertion (RPE)##2##5##(2013-8#2)
ratings of perceived exertion##3##4##(2013-8#3)
ratings of problem##2##3##(1995-12#1)(2008-12#1)
ratings of the condition##2##4##(1992-4#2)
ratings of the##15##3##(1991-12#1)(1991-6#1)(1992-4#2)(1996-2#1)(2004-12#1)(2006-11#1)(2007-12#2)(2008-10#2)(2008-4#1)(2009-7#1)(2012-2#2)
ratings of their##2##3##(1995-12#1)(2012-12#1)
ratings of##63##2##(1991-12#1)(1991-3#2)(1991-6#1)(1992-4#2)(1993-1#1)(1993-5#1)(1994-3#2)(1995-12#4)(1996-2#2)(1996-3#1)(1997-8#2)(2004-11#1)(2004-12#1)(2006-11#1)(2006-3#1)(2007-12#5)(2007-5#1)(2008-10#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-7#2)(2009-8#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#4)
ratings on##3##2##(1990-12#1)(1993-11#1)(2011-2#1)
ratings than the##2##3##(2008-10#2)
ratings to their##2##3##(1993-2#2)
ratings to##3##2##(1993-2#2)(2012-2#1)
ratings were collected##2##3##(2008-10#1)(2011-2#1)
ratings were not##2##3##(1995-12#1)(2010-2#1)
ratings were significantly##2##3##(2008-10#1)(2009-11#1)
ratings were used##2##3##(2006-7#1)(2008-10#1)
ratings were##22##2##(1995-1#1)(1995-12#1)(1996-7#1)(2006-12#1)(2006-7#1)(2008-10#6)(2008-4#1)(2008-6#1)(2008-9#2)(2009-11#2)(2009-12#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)
ratings with##3##2##(2008-2#1)(2008-9#2)
ratings##217##1##(1990-12#1)(1990-5#1)(1991-12#1)(1991-3#5)(1991-6#1)(1992-2#2)(1992-3#1)(1992-4#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1994-10#1)(1994-2#1)(1994-3#2)(1995-1#2)(1995-12#9)(1996-1#2)(1996-2#2)(1996-3#2)(1996-7#2)(1997-2#1)(1997-3#4)(1997-8#5)(2004-10#1)(2004-11#1)(2004-12#2)(2004-3#3)(2005-10#1)(2006-10#1)(2006-11#1)(2006-12#6)(2006-3#1)(2006-7#2)(2006-8#1)(2007-12#13)(2007-2#1)(2007-5#1)(2007-6#1)(2008-10#33)(2008-11#2)(2008-12#2)(2008-2#7)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#6)(2009-11#2)(2009-12#2)(2009-5#1)(2009-7#4)(2009-8#3)(2010-12#2)(2010-2#2)(2010-4#2)(2010-8#3)(2011-1#8)(2011-2#9)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#4)(2013-7#4)(2013-8#6)
ratio &gt##11##2##(1992-6#1)(1992-9#2)(1994-3#1)(1994-6#1)(1997-1#1)(1997-6#1)(2007-10#1)(2008-10#2)(2011-2#1)
ratio (0##8##2##(1990-8#1)(1995-6#1)(1996-2#1)(1996-9#1)(2008-5#2)(2008-7#1)(2011-2#1)
ratio (1##5##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
ratio (2##2##2##(1990-4#1)(2008-2#1)
ratio (3##3##2##(1997-3#1)(2008-5#1)(2011-2#1)
ratio (OR) 1##2##3##(2012-12#1)(2013-1#1)
ratio (OR) = 4##2##4##(2004-10#1)(2008-4#1)
ratio (OR) =##4##3##(1992-10#1)(2004-10#1)(2008-4#1)(2011-1#1)
ratio (OR) for##7##3##(1991-5#1)(2006-2#1)(2008-3#1)(2008-6#1)(2009-9#1)(2011-2#1)(2012-3#1)
ratio (OR)##21##2##(1991-5#1)(1992-10#1)(2004-10#1)(2006-2#1)(2007-10#1)(2008-3#1)(2008-4#1)(2008-6#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
ratio (P &lt##3##3##(1996-9#3)
ratio (P= 0##2##3##(2011-1#2)
ratio (RR)##2##2##(1991-9#1)(1997-8#1)
ratio (SMR)##4##2##(1993-7#1)(1995-2#1)(2008-7#1)(2008-8#1)
ratio (SNR) of##5##3##(2007-12#1)(2008-10#2)(2010-8#1)(2013-8#1)
ratio (SNR)##23##2##(2007-12#3)(2008-10#3)(2008-2#4)(2008-3#5)(2008-9#1)(2009-5#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
ratio (VBR) and prefrontal sulcal prominence (PSP)##3##7##(1996-7#3)
ratio (WHR) and##2##3##(2006-9#1)(2011-1#1)
ratio (WHR)##6##2##(2006-9#1)(2007-12#3)(2008-3#1)(2011-1#1)
ratio (both##2##2##(1990-12#1)(1993-7#1)
ratio (n =##2##3##(1990-2#2)
ratio (p##3##2##(2008-12#2)(2008-3#1)
ratio (r = 0##2##4##(1995-12#1)(2008-11#1)
ratio (r =##3##3##(1995-12#1)(2008-11#1)(2011-2#1)
ratio (the ratio of the##2##5##(2008-1#1)(2008-3#1)
ratio (the##3##2##(2008-1#1)(2008-3#1)(2008-6#1)
ratio 0##6##2##(1994-6#2)(1995-9#1)(2009-4#1)(2010-6#1)(2012-3#1)
ratio 1##34##2##(1990-2#1)(1992-3#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-9#1)(2006-10#1)(2007-10#1)(2008-10#11)(2008-3#2)(2008-7#1)(2008-8#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
ratio 10##4##2##(1992-9#1)(2007-2#1)(2008-10#1)(2008-5#1)
ratio 2##10##2##(1991-12#1)(1991-2#1)(1996-12#1)(2007-10#3)(2008-10#2)(2008-3#1)(2011-1#1)
ratio 3##8##2##(1991-8#1)(1993-4#1)(1997-3#1)(2007-10#1)(2007-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
ratio 4##4##2##(1990-6#1)(2010-5#1)(2011-2#1)(2012-3#1)
ratio 6##3##2##(1994-4#1)(2008-1#1)(2008-10#1)
ratio 83%##2##2##(1997-8#2)
ratio = 0##12##3##(1991-9#1)(1992-12#1)(1996-12#2)(2006-5#2)(2007-10#1)(2008-12#1)(2008-3#1)(2010-2#2)(2012-2#1)
ratio = 2##7##3##(1990-4#1)(1990-5#1)(2005-10#4)(2013-8#1)
ratio = 2)##3##3##(2007-8#1)(2008-10#2)
ratio = 3##3##3##(1991-2#1)(2011-1#1)(2012-2#1)
ratio = 4##2##3##(2008-12#1)(2013-8#1)
ratio =##36##2##(1990-4#2)(1990-5#1)(1990-8#1)(1991-2#1)(1991-9#1)(1992-12#2)(1993-2#1)(1996-12#2)(2005-10#4)(2006-5#2)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-3#2)(2008-6#1)(2010-2#2)(2011-1#1)(2012-2#2)(2013-8#2)
ratio C26##2##2##(1990-11#2)
ratio LOA##2##2##(2009-1#2)
ratio [HR]##5##2##(2007-8#1)(2008-3#2)(2012-6#1)(2013-8#1)
ratio [OR] = 2##3##4##(2007-10#2)(2008-3#1)
ratio [OR] =##8##3##(2006-10#1)(2007-10#3)(2008-3#3)(2010-10#1)
ratio [OR]##17##2##(2005-8#1)(2006-10#1)(2007-10#7)(2007-8#1)(2008-3#3)(2008-7#1)(2010-10#1)(2011-12#1)(2011-2#1)
ratio after##2##2##(2011-2#1)(2013-1#1)
ratio among##3##2##(1990-12#1)(1993-10#1)(2011-1#1)
ratio analysis##3##2##(2008-10#2)(2008-3#1)
ratio and a##3##3##(1991-12#1)(2008-10#1)(2008-3#1)
ratio and erythrocyte sedimentation rate##2##5##(2008-5#1)(2013-1#1)
ratio and heavy metals##2##4##(2008-12#2)
ratio and heavy##3##3##(2008-12#3)
ratio and high##2##3##(2005-4#1)(2007-8#1)
ratio and in##2##3##(2010-2#1)(2013-1#1)
ratio and rate ratio##2##4##(1993-9#2)
ratio and strain##2##3##(2007-4#1)(2008-3#1)
ratio and the##26##3##(1990-11#1)(1990-9#1)(1994-12#1)(1995-2#1)(2004-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-2#1)(2012-2#1)(2012-3#1)
ratio and their##2##3##(2008-10#1)(2012-1#1)
ratio and varied pH##3##4##(2008-10#3)
ratio and##153##2##(1990-11#1)(1990-12#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-6#2)(1993-5#1)(1993-9#3)(1994-12#2)(1994-2#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-7#1)(1997-1#1)(1997-6#2)(2004-12#1)(2004-9#2)(2005-11#1)(2005-4#1)(2006-10#2)(2006-6#1)(2006-7#1)(2007-11#4)(2007-12#5)(2007-3#3)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#5)(2008-2#7)(2008-3#21)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#1)(2009-2#2)(2009-9#2)(2010-12#1)(2010-2#4)(2010-5#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#5)(2013-8#4)
ratio appears##2##2##(2006-8#1)(2009-5#1)
ratio approach##2##2##(2008-10#1)(2013-1#1)
ratio are##12##2##(2007-12#2)(2007-3#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2013-1#1)(2013-8#2)
ratio as a function of##4##5##(1996-5#1)(2007-5#1)(2008-2#1)(2008-3#1)
ratio as a predictor##2##4##(2008-5#1)(2012-12#1)
ratio as a##11##3##(1991-12#1)(1996-3#1)(1996-5#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-12#1)
ratio as an##2##3##(2008-2#1)(2012-11#1)
ratio as the##5##3##(1994-5#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-5#1)
ratio as well as the##2##5##(1990-3#1)(2007-10#1)
ratio as well as their##2##5##(1990-11#1)(1993-9#1)
ratio as well as##6##4##(1990-11#1)(1990-3#1)(1993-9#1)(1994-2#1)(2007-10#1)(2011-2#1)
ratio as##29##2##(1990-11#1)(1990-3#1)(1991-12#1)(1993-9#1)(1994-2#1)(1994-5#1)(1996-3#1)(1996-5#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-9#1)(2008-2#3)(2008-3#3)(2008-5#2)(2009-5#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-7#1)
ratio associated with the##2##4##(2005-11#1)(2008-3#1)
ratio associated with##3##3##(2005-11#1)(2008-3#1)(2010-8#1)
ratio at birth##2##3##(2006-10#2)
ratio at the##3##3##(2006-9#1)(2007-11#1)(2008-2#1)
ratio at two##2##3##(2008-2#1)(2010-5#1)
ratio at##15##2##(1993-8#1)(1994-12#1)(2006-10#2)(2006-9#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2010-5#2)(2012-2#1)
ratio before##3##2##(2008-2#2)(2012-12#1)
ratio being##5##2##(2006-8#1)(2007-7#1)(2008-7#1)(2010-8#1)(2012-3#1)
ratio between the two##2##4##(2008-2#2)
ratio between the##31##3##(1991-2#1)(1991-5#1)(1997-2#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-12#4)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2012-12#1)(2013-1#1)(2013-8#1)
ratio between these two##2##4##(1992-12#1)(2013-1#1)
ratio between##58##2##(1990-12#1)(1991-2#2)(1991-5#1)(1992-12#1)(1992-4#1)(1993-2#1)(1994-6#2)(1995-11#1)(1995-12#1)(1997-2#1)(2004-9#1)(2005-11#3)(2006-10#2)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#4)(2008-10#11)(2008-11#1)(2008-2#6)(2008-3#2)(2008-5#2)(2008-6#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#2)
ratio but##2##2##(2007-12#1)(2008-1#1)
ratio by a factor##2##4##(2007-8#1)(2008-2#1)
ratio by more than##2##4##(2007-11#1)(2008-2#1)
ratio by##11##2##(1990-11#1)(1990-3#1)(2007-11#1)(2007-8#1)(2008-2#4)(2008-3#1)(2008-7#1)(2011-2#1)
ratio can be##9##3##(1993-10#1)(2006-12#1)(2007-12#1)(2008-2#4)(2008-3#2)
ratio can predict##2##3##(2008-5#1)(2011-1#1)
ratio can##17##2##(1990-9#1)(1993-10#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#5)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-1#1)
ratio compared to##3##3##(1997-6#1)(2006-10#1)(2012-2#1)
ratio compared with##4##3##(2007-12#1)(2008-3#3)
ratio compared##7##2##(1997-6#1)(2006-10#1)(2007-12#1)(2008-3#3)(2012-2#1)
ratio contain##2##2##(1992-8#1)(2010-2#1)
ratio could be##2##3##(2012-12#1)(2013-8#1)
ratio could##3##2##(2008-8#1)(2012-12#1)(2013-8#1)
ratio data##7##2##(2007-12#1)(2008-10#2)(2008-2#2)(2008-7#1)(2009-9#1)
ratio decreased from##2##3##(1992-8#1)(2010-4#1)
ratio decreased with increasing##2##4##(2008-2#1)(2013-8#1)
ratio decreased with##5##3##(2008-10#2)(2008-2#1)(2008-5#1)(2013-8#1)
ratio decreased##10##2##(1992-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2013-8#2)
ratio decreases##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
ratio derivative polarography##2##3##(2008-10#2)
ratio derivative##3##2##(2008-10#3)
ratio determination##3##2##(1996-2#3)
ratio did not##2##3##(1996-2#1)(2008-3#1)
ratio distribution##2##2##(1996-7#1)(2006-10#1)
ratio does not##2##3##(2008-2#1)(2008-3#1)
ratio during the##2##3##(2007-9#1)(2013-8#1)
ratio during##4##2##(2007-9#1)(2009-3#1)(2013-8#2)
ratio equal to 0##3##4##(2008-3#1)(2008-5#2)
ratio estimate##2##2##(1996-6#1)(2012-2#1)
ratio estimation##4##2##(1993-9#1)(1994-2#1)(2010-12#1)(2012-2#1)
ratio for a##4##3##(2008-3#4)
ratio for all##2##3##(1990-4#1)(1995-2#1)
ratio for each##2##3##(2008-2#1)(2008-3#1)
ratio for patients##2##3##(2008-12#1)(2008-9#1)
ratio for the##19##3##(1990-11#1)(1992-6#1)(1993-12#1)(1997-8#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#3)(2010-4#1)(2012-2#1)
ratio for two##2##3##(2008-3#1)(2008-7#1)
ratio for##70##2##(1990-11#1)(1990-4#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-5#1)(1992-10#1)(1992-4#1)(1992-6#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-12#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-5#1)(1997-6#1)(1997-8#1)(2006-10#4)(2006-12#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#13)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
ratio from##10##2##(1992-12#1)(1994-2#1)(1996-3#1)(2004-9#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-2#1)(2010-4#1)
ratio had a##2##3##(1990-8#1)(2012-1#1)
ratio had##7##2##(1990-8#1)(2008-10#1)(2008-3#1)(2009-9#1)(2012-1#1)(2012-2#2)
ratio has been##2##3##(2007-11#1)(2009-3#1)
ratio has##3##2##(2007-11#1)(2008-2#1)(2009-3#1)
ratio in a##4##3##(2007-11#1)(2008-2#1)(2008-8#1)(2011-1#1)
ratio in all##2##3##(2007-12#1)(2008-10#1)
ratio in an##2##3##(2008-3#1)(2012-3#1)
ratio in both##2##3##(1993-12#1)(2007-11#1)
ratio in the##35##3##(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-11#1)(1992-4#1)(1992-6#1)(1993-8#1)(1997-2#2)(2005-11#1)(2005-4#1)(2006-3#2)(2006-9#3)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-8#1)(2009-7#1)(2010-2#1)(2010-4#2)(2010-5#1)(2012-2#2)
ratio in##110##2##(1990-2#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-9#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-3#1)(2005-11#1)(2005-4#1)(2006-12#2)(2006-3#2)(2006-4#1)(2006-9#4)(2007-10#1)(2007-11#5)(2007-12#2)(2007-9#2)(2008-10#7)(2008-12#2)(2008-2#7)(2008-3#5)(2008-5#4)(2008-6#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-1#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-5#2)(2010-7#1)(2011-1#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#3)
ratio increased from##2##3##(1993-6#1)(2010-4#1)
ratio increased with##2##3##(1992-9#1)(2013-8#1)
ratio increased##7##2##(1992-9#1)(1993-6#1)(2010-4#1)(2011-2#1)(2013-8#3)
ratio increases##5##2##(1994-8#1)(1997-4#1)(2008-11#1)(2008-5#1)(2010-4#1)
ratio index##6##2##(1994-5#2)(1996-5#1)(2008-12#2)(2011-2#1)
ratio indicates##4##2##(1992-5#1)(1994-6#1)(2008-12#1)(2008-5#1)
ratio influenced the##2##3##(1997-1#1)(2008-8#1)
ratio is 0##2##3##(1996-5#1)(2008-10#1)
ratio is 1##2##3##(1993-11#1)(2008-10#1)
ratio is a##2##3##(2008-3#1)(2011-12#1)
ratio is about##2##3##(1992-5#1)(2008-8#1)
ratio is also##2##3##(1997-7#1)(2010-12#1)
ratio is an##2##3##(2005-11#1)(2008-10#1)
ratio is approximately 2##2##4##(1993-12#1)(2008-1#1)
ratio is approximately##4##3##(1992-11#1)(1993-12#1)(2008-1#1)(2008-2#1)
ratio is better than##2##4##(2007-11#1)(2008-1#1)
ratio is calculated##2##3##(2008-3#1)(2008-8#1)
ratio is greater than##2##4##(2006-8#1)(2007-8#1)
ratio is higher##2##3##(2008-10#1)(2008-2#1)
ratio is improved##2##3##(2007-12#1)(2007-4#1)
ratio is not##5##3##(1994-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)
ratio is strongly related to the##2##6##(2011-2#1)(2012-1#1)
ratio is suggested to be##2##5##(2008-11#1)(2008-3#1)
ratio is##76##2##(1990-8#2)(1990-9#1)(1991-7#1)(1992-11#1)(1992-5#1)(1993-11#2)(1993-12#2)(1993-9#1)(1994-8#1)(1996-5#2)(1996-9#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-12#4)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#11)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
ratio larger than##2##3##(2007-11#1)(2008-7#1)
ratio less than 1##2##4##(1990-11#1)(2007-4#1)
ratio less than##6##3##(1990-11#1)(1990-9#1)(1995-5#1)(2005-8#1)(2007-4#1)(2013-7#1)
ratio mass spectrometry##3##3##(1993-12#1)(2012-12#2)
ratio mass##4##2##(1993-12#1)(1995-10#1)(2012-12#2)
ratio may be##2##3##(2005-11#1)(2010-4#1)
ratio may##4##2##(2005-11#1)(2005-9#1)(2008-2#1)(2010-4#1)
ratio measurement##3##2##(2008-10#1)(2008-2#1)(2012-2#1)
ratio measurements of##2##3##(2008-2#1)(2009-10#1)
ratio measurements##6##2##(1997-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-10#1)
ratio method##6##2##(1993-9#1)(1994-2#1)(2008-10#4)
ratio methods##3##2##(1994-2#1)(2008-10#2)
ratio must be##2##3##(1991-6#1)(2007-12#1)
ratio must##3##2##(1991-6#1)(2007-12#1)(2008-2#1)
ratio observed in##2##3##(1995-9#1)(2008-9#1)
ratio obtained in##4##3##(1990-8#1)(1993-6#1)(1996-12#1)(2008-10#1)
ratio obtained with##2##3##(2006-5#1)(2008-2#1)
ratio obtained##9##2##(1990-8#1)(1993-6#1)(1996-12#1)(2006-5#1)(2007-8#1)(2008-10#2)(2008-2#2)
ratio of &gt##7##3##(2004-9#1)(2007-12#3)(2008-3#2)(2010-8#1)
ratio of 0##23##3##(1990-3#1)(1991-1#1)(1991-9#1)(1992-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-6#1)(2008-8#1)(2010-4#1)(2010-8#1)(2011-1#1)
ratio of 1##57##3##(1990-10#1)(1990-12#2)(1990-3#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-4#1)(1994-11#1)(1994-3#2)(1995-1#1)(1995-2#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-4#1)(1997-6#2)(2004-12#1)(2004-9#2)(2006-12#1)(2007-10#2)(2007-2#4)(2007-3#1)(2007-7#3)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-9#1)(2010-12#1)(2011-12#1)(2012-2#2)(2013-1#2)
ratio of 1/1##2##3##(1996-2#1)(2009-9#1)
ratio of 10##4##3##(1995-1#1)(2008-10#3)
ratio of 100##3##3##(2008-10#2)(2010-8#1)
ratio of 14##2##3##(2007-12#1)(2008-1#1)
ratio of 15##2##3##(1997-3#1)(2012-2#1)
ratio of 16##3##3##(1992-12#1)(2004-12#1)(2008-2#1)
ratio of 2##14##3##(1990-12#1)(1990-4#1)(1994-5#1)(2005-12#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-8#1)(2010-12#1)
ratio of 20##2##3##(2008-10#1)(2008-3#1)
ratio of 3##30##3##(1990-4#1)(1990-8#1)(1991-5#1)(1993-7#1)(1996-8#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
ratio of 3)##2##3##(2008-10#1)(2008-3#1)
ratio of 4##10##3##(1994-12#1)(2007-4#1)(2007-8#2)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-12#1)(2013-1#1)
ratio of 40##2##3##(2007-12#1)(2011-3#1)
ratio of 45##2##3##(2008-3#1)(2011-1#1)
ratio of 5##12##3##(1990-2#1)(1990-9#1)(1991-4#1)(1993-11#1)(1993-2#1)(2008-10#2)(2008-2#1)(2008-3#2)(2013-1#2)
ratio of 50##2##3##(2007-12#1)(2008-3#1)
ratio of 6##4##3##(2004-8#1)(2005-11#1)(2008-2#1)(2008-3#1)
ratio of 7##3##3##(1993-3#1)(2013-1#1)(2013-8#1)
ratio of HIV-infected##2##3##(1990-3#1)(1992-7#1)
ratio of a##4##3##(2005-11#1)(2008-10#1)(2008-2#1)(2011-2#1)
ratio of about 1##2##4##(1992-6#1)(1993-6#1)
ratio of about##4##3##(1992-6#1)(1993-6#1)(2005-11#1)(2009-4#1)
ratio of an##2##3##(2008-2#1)(2008-3#1)
ratio of approximately 3##2##4##(1992-6#1)(2008-11#1)
ratio of approximately##10##3##(1991-2#1)(1992-6#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#4)
ratio of at least##3##4##(2007-7#1)(2008-3#1)(2010-8#1)
ratio of blood isolates of B##2##6##(2006-8#2)
ratio of cholesterol##3##3##(1991-9#1)(1996-8#1)(1997-1#1)
ratio of dopaminergic versus serotonergic cells in the##2##8##(1997-3#2)
ratio of dopaminergic versus serotonergic cells##3##6##(1997-3#3)
ratio of dopaminergic##4##3##(1997-3#4)
ratio of each##4##3##(2005-4#1)(2007-12#1)(2008-10#1)(2008-5#1)
ratio of ferulic##2##3##(1994-5#1)(2006-8#1)
ratio of hapten##3##3##(2008-11#3)
ratio of insulin##2##3##(1995-5#1)(2008-3#1)
ratio of intensity##2##3##(1995-5#1)(2008-3#1)
ratio of lactic acid to acetic acid and quality score##2##10##(2012-2#2)
ratio of male to female was 1##2##7##(2007-2#1)(2008-3#1)
ratio of male to female##4##5##(1993-9#1)(2007-2#1)(2008-3#1)(2011-2#1)
ratio of medium##2##3##(1993-12#1)(2007-11#1)
ratio of more than##2##4##(2007-12#2)
ratio of one##4##3##(1990-3#1)(2008-10#1)(2008-3#1)(2008-5#1)
ratio of patients##3##3##(2006-10#1)(2008-1#1)(2011-1#1)
ratio of polyunsaturated to saturated fatty acids##2##7##(1997-7#1)(2010-4#1)
ratio of polyunsaturated##4##3##(1997-7#1)(2010-4#3)
ratio of the CH(2)##2##4##(2008-10#2)
ratio of the difference##2##4##(2008-2#1)(2008-5#1)
ratio of the dose at 100 cm##2##7##(2010-9#2)
ratio of the in##2##4##(2004-12#2)
ratio of the ion##2##4##(2008-10#2)
ratio of the metal##2##4##(2008-10#2)
ratio of the number of##5##5##(1993-9#1)(1997-7#1)(2008-11#1)(2010-8#1)(2013-8#1)
ratio of the optical##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
ratio of the particle##3##4##(2005-11#2)(2009-5#1)
ratio of the population##2##4##(2008-10#1)(2012-2#1)
ratio of the rates of##2##5##(1990-11#1)(1991-5#1)
ratio of the scatter##2##4##(2012-1#2)
ratio of the two##5##4##(1996-5#1)(2007-12#1)(2008-2#1)(2008-3#2)
ratio of the##180##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1991-12#1)(1991-2#3)(1991-5#1)(1991-8#1)(1991-9#2)(1992-6#2)(1992-7#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-8#2)(1994-9#1)(1995-5#2)(1995-8#1)(1996-2#1)(1996-5#2)(1996-9#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-12#4)(2004-4#1)(2005-10#1)(2005-11#6)(2006-10#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-11#6)(2007-12#15)(2007-2#1)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#26)(2008-11#2)(2008-12#1)(2008-2#18)(2008-3#26)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-8#2)(2010-9#2)(2012-1#4)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
ratio of these##6##3##(1990-8#1)(1991-1#1)(2005-4#1)(2006-6#1)(2008-3#1)(2009-10#1)
ratio of this##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
ratio of three##4##3##(2008-10#3)(2008-5#1)
ratio of total##4##3##(1990-5#1)(2006-9#1)(2008-11#1)(2008-3#1)
ratio of two##2##3##(1992-7#1)(2008-2#1)
ratio of unsaturated to saturated##2##5##(1995-7#1)(2010-4#1)
ratio of unsaturated to##4##4##(1994-3#1)(1995-7#1)(2010-4#2)
ratio of##928##2##(1990-10#2)(1990-11#1)(1990-12#5)(1990-2#3)(1990-3#6)(1990-4#2)(1990-5#4)(1990-7#1)(1990-8#5)(1990-9#3)(1991-1#5)(1991-10#4)(1991-11#2)(1991-12#5)(1991-2#6)(1991-4#2)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#5)(1992-11#3)(1992-12#2)(1992-3#2)(1992-6#6)(1992-7#7)(1992-8#1)(1992-9#2)(1993-11#3)(1993-12#3)(1993-2#3)(1993-3#1)(1993-4#4)(1993-6#3)(1993-7#2)(1993-8#2)(1993-9#5)(1994-10#1)(1994-11#2)(1994-12#10)(1994-2#2)(1994-3#5)(1994-4#1)(1994-5#4)(1994-6#4)(1994-8#5)(1994-9#4)(1995-1#3)(1995-10#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#5)(1995-5#7)(1995-6#2)(1995-7#2)(1995-8#4)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#4)(1996-3#6)(1996-4#4)(1996-5#3)(1996-6#1)(1996-8#3)(1996-9#2)(1997-1#6)(1997-2#4)(1997-3#6)(1997-5#1)(1997-6#5)(1997-7#4)(1997-8#3)(2004-11#1)(2004-12#6)(2004-4#2)(2004-8#2)(2004-9#4)(2005-10#3)(2005-11#18)(2005-12#3)(2005-3#1)(2005-4#8)(2005-7#1)(2005-8#3)(2006-10#6)(2006-11#1)(2006-12#4)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#10)(2006-9#5)(2007-1#1)(2007-10#3)(2007-11#15)(2007-12#39)(2007-2#9)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#7)(2007-8#14)(2007-9#5)(2008-1#10)(2008-10#129)(2008-11#21)(2008-12#8)(2008-2#48)(2008-3#77)(2008-4#7)(2008-5#32)(2008-6#5)(2008-7#5)(2008-8#7)(2008-9#8)(2009-10#1)(2009-11#3)(2009-2#1)(2009-4#5)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-4#11)(2010-5#1)(2010-6#1)(2010-8#9)(2010-9#3)(2011-1#17)(2011-12#4)(2011-2#12)(2011-3#2)(2012-1#8)(2012-11#2)(2012-12#6)(2012-2#11)(2012-3#6)(2012-7#1)(2013-1#15)(2013-7#1)(2013-8#8)
ratio on the##4##3##(2004-9#1)(2005-11#2)(2011-2#1)
ratio on##14##2##(2004-9#1)(2005-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#3)(2008-3#1)(2009-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
ratio or##7##2##(1993-11#1)(1994-9#1)(2008-2#2)(2008-5#1)(2009-4#1)(2010-1#1)
ratio over##2##2##(1994-5#1)(2007-12#1)
ratio produced##3##2##(2008-2#1)(2012-3#2)
ratio profile##2##2##(2008-3#2)
ratio profiles##3##2##(2008-3#3)
ratio ranged between##2##3##(2010-2#2)
ratio ranged##3##2##(1993-8#1)(2010-2#2)
ratio rather than##2##3##(2007-11#1)(2007-4#1)
ratio relative to##2##3##(1990-10#1)(2013-8#1)
ratio remains##2##2##(1990-2#1)(2008-2#1)
ratio represents a unique context for selection on attractive traits##2##10##(2008-8#2)
ratio should##3##2##(2006-10#1)(2007-11#1)(2007-8#1)
ratio showed a##3##3##(1994-8#1)(1994-9#1)(2006-8#1)
ratio showed that##3##3##(1990-5#1)(2010-2#2)
ratio showed##7##2##(1990-5#1)(1994-8#1)(1994-9#1)(2006-8#1)(2008-11#1)(2010-2#2)
ratio significantly##5##2##(1992-6#1)(1996-3#1)(2010-5#1)(2012-1#1)(2013-8#1)
ratio spectra derivative spectrophotometry##2##4##(2008-10#2)
ratio spectra##15##2##(2008-10#14)(2011-1#1)
ratio statistic##3##2##(2008-10#1)(2008-12#1)(2012-12#1)
ratio technique##2##2##(2008-3#2)
ratio test is##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
ratio test##17##2##(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2010-2#1)(2011-2#2)(2012-2#1)(2013-1#2)
ratio tests##4##2##(1994-11#1)(1996-12#1)(2008-9#2)
ratio than that of the##2##5##(2008-10#1)(2009-7#1)
ratio than the##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
ratio than##11##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)(2009-7#1)(2011-2#1)(2012-3#1)
ratio that is##4##3##(1993-11#1)(2008-3#3)
ratio that##6##2##(1993-11#1)(2008-2#1)(2008-3#4)
ratio to a##2##3##(1994-6#1)(2008-3#1)
ratio to be##4##3##(2007-12#2)(2008-2#1)(2010-4#1)
ratio to the##4##3##(1996-3#1)(2008-3#1)(2012-2#1)(2013-1#1)
ratio to##32##2##(1992-5#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-9#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
ratio under##3##2##(1996-7#1)(2008-1#1)(2008-5#1)
ratio using##2##2##(2007-2#1)(2012-12#1)
ratio values##8##2##(1990-8#1)(1990-9#1)(1996-2#1)(2008-10#4)(2008-5#1)
ratio variance##2##2##(2008-3#1)(2008-9#1)
ratio variation##2##2##(2008-10#1)(2008-9#1)
ratio varied##2##2##(2008-5#1)(2011-2#1)
ratio varying between##2##3##(2007-3#2)
ratio was 0##5##3##(1991-1#1)(2008-10#1)(2008-8#1)(2012-12#1)(2012-2#1)
ratio was 1##14##3##(1994-12#1)(1994-8#1)(1995-7#1)(2006-2#1)(2006-7#1)(2007-2#1)(2007-3#1)(2007-7#2)(2008-5#2)(2011-11#1)(2012-2#1)(2013-1#1)
ratio was 2##5##3##(2005-8#1)(2007-2#1)(2007-7#2)(2011-2#1)
ratio was 3##4##3##(1996-3#1)(2007-7#1)(2007-8#1)(2008-3#1)
ratio was 4##2##3##(2009-5#1)(2013-1#1)
ratio was 5##3##3##(2006-8#1)(2007-3#2)
ratio was 6##2##3##(1991-11#1)(2008-7#1)
ratio was 7##2##3##(2007-8#1)(2008-10#1)
ratio was also##4##3##(1993-12#1)(1994-8#1)(1996-2#1)(2013-1#1)
ratio was approximately##2##3##(1994-10#1)(2008-10#1)
ratio was calculated##3##3##(2008-12#1)(2010-12#1)(2011-1#1)
ratio was decreased##2##3##(2009-8#1)(2013-8#1)
ratio was elevated##2##3##(2006-8#1)(2008-9#1)
ratio was found to be significantly##2##6##(1994-3#1)(2008-10#1)
ratio was found to be##4##5##(1994-3#1)(2008-10#1)(2008-5#1)(2010-4#1)
ratio was found to##5##4##(1994-3#1)(2008-10#1)(2008-5#1)(2010-4#2)
ratio was found##6##3##(1994-3#1)(2008-10#2)(2008-5#1)(2010-4#2)
ratio was high##3##3##(1997-3#1)(2007-7#1)(2008-5#1)
ratio was higher among##2##4##(1997-1#1)(2008-7#1)
ratio was higher in##3##4##(1992-7#1)(2008-10#1)(2008-12#1)
ratio was higher##6##3##(1992-7#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)
ratio was in Angle Class II##2##6##(2010-2#2)
ratio was lower##2##3##(1997-4#1)(2006-9#1)
ratio was normal##2##3##(2008-1#1)(2008-7#1)
ratio was not significantly##3##4##(1990-12#1)(2008-1#1)(2008-12#1)
ratio was observed##3##3##(1996-5#1)(2008-5#1)(2013-1#1)
ratio was obtained##4##3##(2007-11#2)(2008-10#1)(2013-8#1)
ratio was of 1##2##4##(2007-8#1)(2013-7#1)
ratio was of##3##3##(2007-8#1)(2013-7#2)
ratio was optimized##2##3##(2008-10#1)(2011-2#1)
ratio was significantly decreased in##2##5##(2008-7#1)(2011-2#1)
ratio was significantly decreased##3##4##(2008-7#1)(2011-2#1)(2013-8#1)
ratio was significantly higher in##2##5##(2008-5#1)(2011-2#1)
ratio was significantly reduced##2##4##(1993-8#1)(1994-7#1)
ratio was significantly##9##3##(1993-8#1)(1994-7#1)(2008-5#1)(2008-7#2)(2010-8#1)(2011-2#2)(2013-8#1)
ratio was very##2##3##(2008-10#1)(2009-5#1)
ratio was##155##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-1#1)(1991-11#2)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-7#1)(1993-8#2)(1994-10#1)(1994-12#2)(1994-3#2)(1994-6#2)(1994-7#1)(1994-8#3)(1995-7#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#2)(2005-11#2)(2005-8#1)(2006-10#1)(2006-2#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-11#4)(2007-12#1)(2007-2#2)(2007-3#3)(2007-7#6)(2007-8#5)(2008-1#4)(2008-10#14)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#3)(2008-5#8)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-5#2)(2009-8#1)(2010-12#1)(2010-2#2)(2010-4#3)(2010-8#1)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#5)(2011-3#1)(2012-11#1)(2012-12#1)(2012-2#4)(2013-1#6)(2013-7#2)(2013-8#6)
ratio were 0##3##3##(1996-3#1)(2008-5#1)(2010-8#1)
ratio were also##2##3##(1996-7#1)(2008-4#1)
ratio were measured in##2##4##(1990-2#1)(2012-12#1)
ratio were obtained##2##3##(2008-10#1)(2010-12#1)
ratio were the##2##3##(2010-12#1)(2012-12#1)
ratio were##25##2##(1990-2#1)(1990-5#1)(1996-3#1)(1996-7#1)(2007-1#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-12#1)(2010-12#2)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#2)
ratio when##3##2##(1990-3#1)(2008-3#1)(2010-12#1)
ratio which##5##2##(1991-3#1)(1992-12#1)(2008-10#1)(2008-11#1)(2008-12#1)
ratio with a##3##3##(1993-8#1)(1996-12#1)(2004-11#1)
ratio with an##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
ratio with the##4##3##(1991-5#1)(2008-12#1)(2008-3#1)(2009-10#1)
ratio with##20##2##(1991-5#1)(1993-8#1)(1996-12#1)(1996-9#1)(2004-11#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#7)(2008-9#1)(2009-10#1)(2012-2#1)(2012-3#1)
ratio within##2##2##(2007-7#1)(2008-3#1)
ratio without##3##2##(1993-9#1)(1997-1#1)(2008-7#1)
ratio would##2##2##(2005-11#1)(2012-2#1)
ratio##3166##1##(1990-10#4)(1990-11#10)(1990-12#15)(1990-2#18)(1990-3#12)(1990-4#6)(1990-5#10)(1990-6#1)(1990-7#1)(1990-8#17)(1990-9#12)(1991-1#9)(1991-10#8)(1991-11#6)(1991-12#11)(1991-2#14)(1991-3#2)(1991-4#3)(1991-5#16)(1991-6#5)(1991-7#3)(1991-8#9)(1991-9#8)(1992-1#1)(1992-10#2)(1992-11#6)(1992-12#16)(1992-2#6)(1992-3#5)(1992-4#4)(1992-5#5)(1992-6#15)(1992-7#13)(1992-8#6)(1992-9#9)(1993-10#2)(1993-11#12)(1993-12#11)(1993-2#6)(1993-3#4)(1993-4#6)(1993-5#2)(1993-6#8)(1993-7#6)(1993-8#10)(1993-9#19)(1994-10#2)(1994-11#9)(1994-12#22)(1994-2#9)(1994-3#14)(1994-4#2)(1994-5#11)(1994-6#18)(1994-7#1)(1994-8#17)(1994-9#16)(1995-1#8)(1995-10#7)(1995-11#4)(1995-12#6)(1995-2#7)(1995-3#6)(1995-4#1)(1995-5#9)(1995-6#5)(1995-7#6)(1995-8#9)(1995-9#6)(1996-1#2)(1996-11#3)(1996-12#19)(1996-2#12)(1996-3#22)(1996-4#6)(1996-5#10)(1996-6#4)(1996-7#12)(1996-8#4)(1996-9#12)(1997-1#16)(1997-2#12)(1997-3#12)(1997-4#4)(1997-5#2)(1997-6#12)(1997-7#9)(1997-8#16)(2004-10#1)(2004-11#3)(2004-12#7)(2004-2#1)(2004-4#2)(2004-8#2)(2004-9#10)(2005-1#2)(2005-10#9)(2005-11#46)(2005-12#3)(2005-3#1)(2005-4#11)(2005-7#1)(2005-8#9)(2005-9#2)(2006-10#31)(2006-11#2)(2006-12#13)(2006-2#3)(2006-3#6)(2006-4#5)(2006-5#6)(2006-6#7)(2006-7#10)(2006-8#22)(2006-9#14)(2007-1#2)(2007-10#28)(2007-11#51)(2007-12#106)(2007-2#21)(2007-3#17)(2007-4#8)(2007-5#4)(2007-6#2)(2007-7#26)(2007-8#43)(2007-9#11)(2008-1#30)(2008-10#364)(2008-11#46)(2008-12#44)(2008-2#195)(2008-3#267)(2008-4#12)(2008-5#107)(2008-6#20)(2008-7#43)(2008-8#49)(2008-9#32)(2009-1#4)(2009-10#4)(2009-11#4)(2009-12#5)(2009-2#4)(2009-3#3)(2009-4#14)(2009-5#13)(2009-6#5)(2009-7#4)(2009-8#3)(2009-9#9)(2010-1#6)(2010-10#2)(2010-11#4)(2010-12#25)(2010-2#25)(2010-4#36)(2010-5#10)(2010-6#3)(2010-7#2)(2010-8#22)(2010-9#6)(2011-1#54)(2011-11#1)(2011-12#12)(2011-2#67)(2011-3#3)(2012-1#21)(2012-11#5)(2012-12#41)(2012-2#57)(2012-3#35)(2012-6#1)(2012-7#1)(2013-1#69)(2013-7#10)(2013-8#61)
ratio'##3##1##(2008-10#2)(2008-7#1)
ratio) and##4##2##(1990-3#1)(2008-12#1)(2008-2#1)(2010-8#1)
ratio) are##2##2##(2008-5#1)(2010-2#1)
ratio) in##2##2##(2008-10#1)(2008-5#1)
ratio) is##2##2##(2007-11#1)(2011-1#1)
ratio) of##3##2##(1995-1#1)(2008-10#1)(2011-12#1)
ratio) was##3##2##(1993-12#1)(2008-5#1)(2008-7#1)
ratio) were##3##2##(1993-7#1)(2007-8#1)(2008-10#1)
ratio) with a##3##3##(2005-12#1)(2008-2#1)(2008-3#1)
ratio) with##4##2##(2005-12#1)(2008-2#2)(2008-3#1)
ratio)##50##1##(1990-2#1)(1990-3#1)(1993-12#1)(1993-7#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-5#1)(1997-2#1)(2005-12#3)(2006-3#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#1)(2009-7#1)(2010-2#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
ratio=1##3##1##(2004-9#1)(2007-9#1)(2010-6#1)
ratio=2) and the##3##3##(2008-10#3)
ratio=2)##4##1##(2008-10#4)
ratio=3##2##1##(2008-10#1)(2011-2#1)
ratio=3)##3##1##(2008-10#3)
ratiometric##7##1##(2007-10#1)(2008-10#4)(2008-3#1)(2008-4#1)
ratiometry is##2##2##(2008-10#2)
ratiometry##9##1##(2008-10#9)
ration and##3##2##(2010-8#3)
ration of##3##2##(1996-12#1)(2010-8#1)(2011-2#1)
ration with 0##2##3##(2010-12#2)
ration with##3##2##(2010-12#2)(2011-2#1)
ration##33##1##(1996-12#1)(2006-12#1)(2007-8#3)(2008-12#1)(2008-5#3)(2010-12#2)(2010-8#15)(2011-1#3)(2011-2#4)
rational and##11##2##(1993-12#1)(1996-3#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-9#2)(2010-10#2)(2012-2#1)
rational approach to the treatment of##2##6##(1996-3#1)(2008-7#1)
rational approach to the##4##4##(1996-3#1)(2006-10#1)(2008-7#1)(2011-2#1)
rational approach to##10##3##(1996-3#1)(2005-6#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-5#1)(2011-2#1)
rational approach##16##2##(1994-9#1)(1995-5#1)(1996-3#1)(1996-6#1)(2005-6#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-3#1)(2008-7#1)(2009-5#1)(2009-7#1)(2011-2#1)(2012-12#1)
rational approaches to##2##3##(1995-3#1)(2008-7#1)
rational basis for##5##3##(1990-3#1)(1996-10#1)(2008-1#1)(2008-3#1)(2008-9#1)
rational basis##6##2##(1990-3#1)(1996-10#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-9#1)
rational choice##5##2##(1992-5#1)(2006-7#2)(2007-11#1)(2010-11#1)
rational choices in##2##3##(2006-10#1)(2008-1#1)
rational choices##3##2##(1993-11#1)(2006-10#1)(2008-1#1)
rational clinical##3##2##(1990-10#1)(1992-5#1)(2010-11#1)
rational decision##2##2##(1993-11#1)(2008-7#1)
rational decision-making##2##2##(2006-7#1)(2012-11#1)
rational decisions##2##2##(2009-6#1)(2011-2#1)
rational design of the##2##4##(1997-1#1)(2007-8#1)
rational design of##21##3##(1992-10#1)(1995-1#1)(1995-11#1)(1997-1#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-9#1)(2010-11#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
rational design##26##2##(1992-10#1)(1995-1#1)(1995-11#1)(1997-1#1)(1997-4#2)(1997-6#1)(2006-10#2)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-11#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-7#1)
rational diagnostic evaluation##2##3##(1991-11#1)(1993-4#1)
rational drug design##7##3##(1992-9#1)(1994-2#1)(2005-8#1)(2008-5#1)(2009-7#1)(2011-3#2)
rational drug prescribing##2##3##(2008-7#1)(2011-2#1)
rational drug##11##2##(1992-9#1)(1994-2#1)(2005-8#2)(2006-6#1)(2008-5#1)(2008-7#1)(2009-7#1)(2011-2#1)(2011-3#2)
rational engineering##2##2##(2012-3#2)
rational explanation of##2##3##(1995-1#1)(2008-4#1)
rational explanation##4##2##(1995-1#1)(2007-11#1)(2008-4#1)(2013-1#1)
rational for##2##2##(1997-6#1)(2011-2#1)
rational harmonic mode-locked##3##3##(2007-12#3)
rational process##2##2##(1990-12#1)(2008-11#1)
rational protein design##2##3##(1991-7#1)(1994-11#1)
rational protein##3##2##(1991-7#1)(1994-11#1)(1994-8#1)
rational strategies for##2##3##(2008-11#1)(2008-6#1)
rational strategies##3##2##(2007-7#1)(2008-11#1)(2008-6#1)
rational therapeutic##3##2##(1991-12#1)(1993-11#1)(1997-8#1)
rational therapy##4##2##(1990-12#1)(1991-11#1)(1992-1#1)(2005-10#1)
rational treatment of##4##3##(1993-9#1)(1996-3#1)(2006-5#1)(2007-7#1)
rational treatment##10##2##(1990-11#1)(1990-6#1)(1993-9#1)(1996-3#2)(1997-8#1)(2006-5#2)(2006-9#1)(2007-7#1)
rational use of the##2##4##(2006-10#1)(2011-2#1)
rational use of##18##3##(1990-5#1)(1993-9#1)(1995-2#1)(1995-9#1)(1996-1#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-2#4)(2007-7#3)(2008-3#1)(2010-1#1)(2011-2#1)
rational vaccine design##2##3##(1995-5#1)(2012-12#1)
rational##226##1##(1990-10#2)(1990-11#1)(1990-12#3)(1990-3#1)(1990-5#1)(1990-6#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-7#1)(1992-1#2)(1992-10#1)(1992-3#1)(1992-5#3)(1992-9#2)(1993-11#4)(1993-12#2)(1993-2#2)(1993-4#1)(1993-5#1)(1993-9#2)(1994-11#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#3)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-3#6)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#2)(2005-10#1)(2005-6#1)(2005-8#2)(2006-10#7)(2006-12#1)(2006-2#4)(2006-5#2)(2006-6#2)(2006-7#6)(2006-9#3)(2007-10#1)(2007-11#7)(2007-12#5)(2007-4#2)(2007-6#2)(2007-7#7)(2007-8#2)(2008-1#2)(2008-10#5)(2008-11#10)(2008-12#2)(2008-3#3)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#3)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#4)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#4)(2010-12#2)(2010-5#2)(2011-1#4)(2011-2#8)(2011-3#3)(2012-11#3)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
rational&quot##3##1##(1993-7#1)(2007-11#1)(2008-7#1)
rational-choice##2##1##(2006-7#2)
rational-harmonic mode-locking regime##2##3##(2007-12#2)
rational-harmonic##6##1##(2007-12#6)
rationale and design of the##2##5##(2008-8#2)
rationale and design of##3##4##(2008-8#3)
rationale and design##5##3##(2007-8#1)(2008-8#3)(2008-9#1)
rationale and##22##2##(1990-11#1)(2005-10#1)(2005-7#1)(2005-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-7#2)(2008-8#3)(2008-9#1)(2010-11#1)(2011-1#1)(2012-2#1)(2012-3#1)
rationale are##3##2##(1990-12#1)(2008-2#1)(2008-3#1)
rationale behind the##4##3##(1995-2#1)(2007-10#1)(2008-12#1)(2008-9#1)
rationale behind##12##2##(1995-2#1)(2007-10#1)(2008-12#2)(2008-3#2)(2008-7#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#2)
rationale for a##7##3##(1991-6#1)(1992-9#1)(1996-10#1)(2008-6#1)(2009-3#1)(2010-11#1)(2010-5#1)
rationale for an##2##3##(1992-12#1)(2008-7#1)
rationale for establishing##2##3##(1993-1#1)(1995-12#1)
rationale for its##4##3##(1996-9#1)(2005-11#1)(2006-12#1)(2010-2#1)
rationale for testing mTOR inhibitors in##2##6##(2008-5#2)
rationale for the clinical development of##2##6##(2008-3#1)(2009-4#1)
rationale for the development of##4##5##(2006-10#1)(2006-6#1)(2007-7#1)(2008-3#1)
rationale for the project##2##4##(2008-8#1)(2010-8#1)
rationale for the selection of##2##5##(2005-8#1)(2006-10#1)
rationale for the use of##7##5##(1990-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-11#1)(2010-6#1)(2011-2#1)
rationale for the##39##3##(1990-3#1)(1991-12#1)(1992-11#1)(1993-8#1)(1994-6#2)(1995-6#1)(1995-8#1)(1996-8#1)(2004-12#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#3)(2008-8#1)(2008-9#2)(2009-2#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
rationale for their use##2##4##(2006-10#1)(2008-4#1)
rationale for their##3##3##(1993-8#1)(2006-10#1)(2008-4#1)
rationale for this approach is##2##5##(2010-4#1)(2011-2#1)
rationale for this##6##3##(1992-9#1)(2007-2#1)(2007-4#1)(2010-4#2)(2011-2#1)
rationale for treatment##2##3##(1996-9#1)(1997-3#1)
rationale for use of##3##4##(1994-9#1)(1996-9#1)(2010-12#1)
rationale for use##5##3##(1994-9#1)(1996-9#1)(1997-2#1)(2007-10#1)(2010-12#1)
rationale for using this##2##4##(2008-11#1)(2008-5#1)
rationale for using##7##3##(2007-10#1)(2007-11#1)(2008-11#1)(2008-5#1)(2009-5#1)(2011-2#1)(2012-1#1)
rationale for##146##2##(1990-10#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-9#2)(1993-1#2)(1993-8#2)(1994-2#1)(1994-6#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#1)(2004-12#1)(2005-10#1)(2005-11#3)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#3)(2006-12#2)(2006-6#1)(2006-8#1)(2006-9#2)(2007-10#2)(2007-11#7)(2007-2#1)(2007-4#2)(2007-5#2)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#6)(2008-3#4)(2008-4#3)(2008-5#4)(2008-6#5)(2008-7#3)(2008-8#1)(2008-9#3)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#2)(2011-2#5)(2011-7#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#3)
rationale is that the##2##4##(2008-9#2)
rationale is##7##2##(2004-7#1)(2007-1#1)(2007-11#1)(2008-8#1)(2008-9#2)(2009-7#1)
rationale of the##2##3##(2008-10#1)(2008-7#1)
rationale of##8##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#1)(2009-9#1)
rationale that##5##2##(1992-5#1)(1993-7#1)(1994-9#1)(2008-2#1)(2010-12#1)
rationale to##4##2##(1995-4#1)(2006-5#1)(2006-8#1)(2012-12#1)
rationale##249##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-9#2)(1993-1#2)(1993-7#1)(1993-8#2)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#2)(1995-4#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#1)(2004-12#1)(2004-7#1)(2005-10#2)(2005-11#4)(2005-7#4)(2005-8#3)(2005-9#1)(2006-10#4)(2006-12#2)(2006-3#1)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#6)(2006-9#2)(2007-1#1)(2007-10#5)(2007-11#10)(2007-12#4)(2007-2#1)(2007-4#3)(2007-5#2)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#7)(2008-12#2)(2008-2#3)(2008-3#13)(2008-4#3)(2008-5#7)(2008-6#7)(2008-7#7)(2008-8#6)(2008-9#7)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-10#2)(2010-11#3)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#3)(2010-8#3)(2011-1#4)(2011-2#9)(2011-7#1)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#3)
rationales and##2##2##(2006-6#1)(2008-3#1)
rationales for##3##2##(2006-10#1)(2010-2#1)(2012-11#1)
rationales##9##1##(1997-2#1)(2006-10#1)(2006-6#1)(2007-4#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-2#1)(2012-11#1)
rationalisation of##2##2##(2008-1#1)(2013-1#1)
rationalisation##3##1##(2007-8#1)(2008-1#1)(2013-1#1)
rationalise##2##1##(1996-11#1)(2005-5#1)
rationalised in##2##2##(2008-5#1)(2010-2#1)
rationalist##2##1##(1996-6#1)(2010-12#1)
rationality and##2##2##(2006-7#1)(2008-5#1)
rationality of##3##2##(2008-9#1)(2009-2#1)(2010-7#1)
rationality##13##1##(2006-7#5)(2007-7#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-7#1)(2011-3#1)
rationalization of##4##2##(1991-11#1)(1997-3#1)(2008-11#1)(2008-7#1)
rationalization##8##1##(1991-11#1)(1992-3#1)(1996-5#1)(1997-3#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-2#1)
rationalize the observed##2##3##(1996-8#1)(2008-11#1)
rationalize the##10##2##(1996-5#1)(1996-8#1)(1997-7#1)(2006-10#2)(2008-10#2)(2008-11#1)(2008-7#1)(2013-7#1)
rationalize##17##1##(1990-12#1)(1990-8#1)(1995-3#1)(1996-5#1)(1996-8#2)(1997-7#1)(2006-10#2)(2006-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2010-12#1)(2013-7#1)
rationalized as a##2##3##(1996-2#1)(1996-6#1)
rationalized by##5##2##(1991-7#1)(1992-9#1)(1994-5#1)(2008-12#1)(2010-12#1)
rationalized in terms of##7##4##(1991-8#1)(1993-3#1)(1995-10#1)(1997-3#1)(2008-10#2)(2011-1#1)
rationalized in terms##8##3##(1991-8#1)(1993-3#1)(1995-10#1)(1997-3#1)(2008-10#2)(2008-5#1)(2011-1#1)
rationalized in##9##2##(1991-8#1)(1993-3#1)(1995-10#1)(1997-3#1)(2007-6#1)(2008-10#2)(2008-5#1)(2011-1#1)
rationalized on the basis of##2##5##(1992-1#1)(2007-12#1)
rationalized##26##1##(1991-7#1)(1991-8#1)(1992-1#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-10#1)(1996-2#2)(1996-6#1)(1997-3#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-7#1)(2010-12#1)(2010-6#1)(2011-1#1)
rationalizes##2##1##(1993-11#1)(2009-4#1)
rationalizing the##4##2##(1993-8#1)(2005-11#1)(2010-5#1)(2012-2#1)
rationalizing##6##1##(1993-8#1)(1997-2#1)(1997-3#1)(2005-11#1)(2010-5#1)(2012-2#1)
rationally designed##4##2##(1995-2#1)(1995-6#1)(2007-2#1)(2009-4#1)
rationally##25##1##(1990-3#1)(1993-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-7#2)(1997-4#1)(2004-12#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-4#1)(2011-1#1)(2012-3#2)(2013-7#1)(2013-8#1)
rationed##2##1##(1996-8#1)(2010-4#1)
rationing decisions##3##2##(1992-3#1)(1997-3#2)
rationing in##2##2##(1992-2#1)(1996-8#1)
rationing##27##1##(1991-12#1)(1992-12#1)(1992-2#3)(1992-3#3)(1993-12#1)(1993-3#3)(1993-7#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-8#2)(1997-3#4)(2004-12#1)(2006-5#1)(2008-4#1)(2008-7#1)(2012-3#1)
rations T1##2##2##(2007-8#2)
rations at##3##2##(2006-8#1)(2010-4#1)(2012-2#1)
rations of##2##2##(2007-8#1)(2010-8#1)
rations##23##1##(2006-8#1)(2007-8#9)(2008-10#1)(2008-12#1)(2010-11#1)(2010-4#1)(2010-7#1)(2010-8#6)(2012-2#2)
ratios &gt##2##2##(1994-9#1)(2007-8#1)
ratios (0##2##2##(1995-8#1)(2009-11#1)
ratios (1##4##2##(1996-2#1)(2008-10#1)(2008-5#1)(2011-2#1)
ratios (3##2##2##(2008-10#1)(2012-2#1)
ratios (4##2##2##(1997-8#1)(2010-4#1)
ratios (5 min##2##3##(1992-2#2)
ratios (HR)##5##2##(2007-8#1)(2009-3#1)(2010-12#1)(2011-2#1)(2013-1#1)
ratios (OR) were calculated##2##4##(2006-7#1)(2011-2#1)
ratios (OR) were##4##3##(2006-7#1)(2007-6#1)(2011-2#2)
ratios (OR)##8##2##(1995-5#1)(2006-7#1)(2007-6#1)(2009-6#1)(2011-2#3)(2013-1#1)
ratios (ORs) and##2##3##(2011-2#2)
ratios (ORs)##4##2##(2007-7#1)(2008-8#1)(2011-2#2)
ratios (P##2##2##(2007-8#1)(2010-2#1)
ratios (RR)##2##2##(2011-2#1)(2013-8#1)
ratios (from##2##2##(2008-10#1)(2012-2#1)
ratios 1##3##2##(1991-7#1)(2008-10#1)(2008-2#1)
ratios among the##2##3##(2010-8#1)(2013-8#1)
ratios among##5##2##(2008-10#2)(2009-4#1)(2010-8#1)(2013-8#1)
ratios and 95% confidence intervals##4##5##(2007-10#1)(2007-3#1)(2011-2#1)(2013-1#1)
ratios and 95%##5##3##(2007-10#1)(2007-3#1)(2011-2#2)(2013-1#1)
ratios and a##2##3##(1992-2#1)(2008-6#1)
ratios and higher##2##3##(1991-9#1)(2008-7#1)
ratios and in##2##3##(1990-10#1)(2008-10#1)
ratios and##46##2##(1990-10#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-2#1)(1993-11#1)(1995-9#1)(1996-8#1)(1996-9#1)(2006-10#2)(2007-10#1)(2007-3#1)(2008-10#6)(2008-2#2)(2008-3#7)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2010-4#2)(2011-1#1)(2011-2#5)(2013-1#2)(2013-8#1)
ratios are##16##2##(1992-8#1)(1994-8#1)(1996-5#1)(2007-12#1)(2008-10#4)(2008-2#3)(2008-3#3)(2009-12#1)(2011-12#1)
ratios as high as 50##2##5##(2008-10#1)(2008-3#1)
ratios as high as##4##4##(2008-10#2)(2008-2#1)(2008-3#1)
ratios as well as##3##4##(2010-4#1)(2012-11#1)(2013-8#1)
ratios as##12##2##(1992-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2010-4#1)(2012-11#1)(2013-8#2)
ratios at the##7##3##(1993-11#1)(2004-11#1)(2005-11#1)(2007-3#1)(2008-10#1)(2008-3#1)(2011-2#1)
ratios at##13##2##(1993-11#1)(1993-9#1)(1997-5#1)(1997-8#1)(2004-11#1)(2005-11#1)(2007-3#1)(2008-10#2)(2008-3#2)(2011-1#1)(2011-2#1)
ratios between the##2##3##(1997-8#1)(2010-11#1)
ratios between##8##2##(1994-8#1)(1997-8#1)(2004-9#1)(2008-10#3)(2008-7#1)(2010-11#1)
ratios by##6##2##(1990-12#1)(2007-12#1)(2008-10#2)(2008-3#1)(2011-2#1)
ratios can be used##2##4##(2008-10#1)(2012-2#1)
ratios can be##3##3##(1996-6#1)(2008-10#1)(2012-2#1)
ratios change##2##2##(2007-11#1)(2008-1#1)
ratios could##2##2##(1993-1#1)(2008-10#1)
ratios did not##2##3##(2008-5#1)(2008-7#1)
ratios estimated with##2##3##(2007-8#1)(2008-3#1)
ratios estimated##3##2##(2007-8#1)(2008-3#1)(2010-12#1)
ratios for a##2##3##(1992-12#1)(1993-12#1)
ratios for each##2##3##(2007-3#1)(2008-4#1)
ratios for primary prevention in##2##5##(1993-9#2)
ratios for the##9##3##(1990-9#1)(1995-7#1)(2007-11#2)(2008-10#1)(2008-3#1)(2011-2#1)(2012-12#2)
ratios for##37##2##(1990-10#1)(1990-12#1)(1990-9#2)(1991-12#1)(1992-12#1)(1993-12#1)(1993-9#3)(1994-2#1)(1995-1#1)(1995-7#1)(2007-11#2)(2007-3#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-9#1)(2010-12#1)(2011-2#3)(2012-12#2)(2013-1#1)(2013-4#1)
ratios from##7##2##(1992-3#1)(1997-7#1)(2008-10#1)(2008-3#2)(2008-7#1)(2010-12#1)
ratios greater than##2##3##(1991-12#1)(2006-7#1)
ratios had##3##2##(2008-10#2)(2012-1#1)
ratios has##3##2##(1997-2#1)(2008-10#1)(2012-3#1)
ratios have been##2##3##(1995-11#1)(2008-5#1)
ratios have##3##2##(1995-11#1)(2007-12#1)(2008-5#1)
ratios in blood from##2##4##(1996-3#1)(1996-8#1)
ratios in both##2##3##(2008-10#1)(2008-3#1)
ratios in brain##2##3##(1994-11#1)(1997-3#1)
ratios in the##11##3##(1990-10#2)(1990-4#1)(1991-8#1)(1995-3#2)(1997-4#1)(2006-10#1)(2010-5#2)(2010-8#1)
ratios in##55##2##(1990-10#4)(1990-4#1)(1990-9#1)(1991-12#1)(1991-8#1)(1992-3#3)(1993-12#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-11#2)(1995-3#2)(1996-3#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-3#2)(2008-8#1)(2010-12#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
ratios increased##3##2##(1997-8#1)(2008-3#1)(2013-8#1)
ratios indicated##4##2##(2008-10#1)(2009-4#2)(2010-5#1)
ratios is##4##2##(2006-6#1)(2007-11#1)(2008-3#1)(2008-5#1)
ratios less than##4##3##(2008-2#2)(2008-3#2)
ratios measured##2##2##(1992-3#1)(2008-2#1)
ratios obtained##2##2##(2006-12#1)(2008-10#1)
ratios of &gt##2##3##(2007-12#1)(2008-3#1)
ratios of 0##8##3##(1994-8#1)(1996-12#1)(1997-2#1)(2006-11#3)(2007-11#1)(2008-11#1)
ratios of 1##6##3##(1990-5#1)(1992-4#1)(1992-6#1)(2008-10#1)(2010-12#1)(2012-3#1)
ratios of 2##2##3##(1990-7#1)(2007-11#1)
ratios of a synthetic##2##4##(2008-10#1)(2009-4#1)
ratios of approximately##5##3##(1995-2#2)(2008-10#1)(2008-11#1)(2008-3#1)
ratios of slopes to standard deviations of measurements##2##8##(1993-6#2)
ratios of the three##2##4##(1993-2#1)(2008-10#1)
ratios of the##28##3##(1991-9#1)(1993-2#2)(1993-3#1)(1996-12#1)(1996-3#2)(1997-7#1)(2005-11#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-2#3)(2008-3#4)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
ratios of##190##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-5#3)(1991-9#2)(1992-11#1)(1992-3#1)(1992-4#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#3)(1996-3#5)(1996-4#1)(1996-5#1)(1996-8#4)(1997-1#1)(1997-2#1)(1997-3#3)(1997-6#2)(1997-7#2)(1997-8#1)(2005-11#2)(2005-12#1)(2006-10#1)(2006-11#3)(2006-12#3)(2006-7#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-5#1)(2007-7#1)(2007-8#6)(2008-10#27)(2008-11#5)(2008-2#6)(2008-3#11)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#2)(2010-12#2)(2010-8#3)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
ratios on##4##2##(2009-8#1)(2010-5#1)(2011-1#1)(2013-1#1)
ratios or##2##2##(2008-3#2)
ratios ranged from##3##3##(1990-12#1)(2008-7#1)(2009-3#1)
ratios ranged##4##2##(1990-12#1)(2008-12#1)(2008-7#1)(2009-3#1)
ratios ranging from 0##3##4##(1992-9#2)(2008-3#1)
ratios ranging from##8##3##(1990-12#1)(1992-9#2)(1994-5#1)(2006-10#1)(2008-3#2)(2008-9#1)
ratios ranging##9##2##(1990-12#1)(1992-9#2)(1994-5#1)(2006-10#1)(2008-3#3)(2008-9#1)
ratios should##3##2##(1995-1#1)(2008-9#2)
ratios showed##3##2##(1990-12#1)(2010-12#1)(2013-8#1)
ratios similar to those of##2##5##(1992-3#1)(1994-8#1)
ratios suggested that the##2##4##(2010-5#1)(2011-2#1)
ratios than##4##2##(1997-4#1)(2007-8#1)(2008-10#1)(2013-8#1)
ratios that##5##2##(2008-10#1)(2008-3#2)(2008-5#1)(2008-8#1)
ratios to##7##2##(1994-2#1)(1995-1#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-8#1)(2013-8#1)
ratios up to 1##2##4##(2008-10#2)
ratios up to 20##2##4##(1990-2#1)(2008-3#1)
ratios up to##6##3##(1990-2#1)(2007-11#1)(2008-10#3)(2008-3#1)
ratios was##6##2##(1992-7#1)(2005-11#1)(2008-10#2)(2008-12#1)(2008-3#1)
ratios were 0##4##3##(1990-10#1)(1994-7#1)(2006-11#1)(2008-3#1)
ratios were calculated and##2##4##(2011-2#1)(2012-2#1)
ratios were calculated##8##3##(2007-3#1)(2008-3#1)(2008-7#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
ratios were determined##3##3##(1992-3#1)(2012-12#2)
ratios were evaluated##3##3##(2008-10#1)(2012-12#2)
ratios were found##3##3##(1993-11#1)(2007-7#1)(2008-10#1)
ratios were higher in##2##4##(2008-5#1)(2013-1#1)
ratios were lower##2##3##(1995-3#1)(2006-12#1)
ratios were not##2##3##(1990-11#1)(2008-10#1)
ratios were observed##3##3##(2008-3#2)(2011-2#1)
ratios were shown##2##3##(2007-8#1)(2008-11#1)
ratios were significantly increased in##2##5##(1997-1#1)(2008-10#1)
ratios were significantly##8##3##(1994-8#1)(1996-8#1)(1997-1#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)
ratios were##80##2##(1990-10#2)(1990-11#2)(1990-9#1)(1992-1#2)(1992-2#2)(1992-3#1)(1992-9#2)(1993-11#2)(1994-7#1)(1994-8#1)(1995-1#1)(1995-3#2)(1996-12#3)(1996-2#2)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-6#1)(2006-11#1)(2006-12#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#10)(2008-11#2)(2008-3#5)(2008-5#3)(2008-7#2)(2009-4#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#9)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
ratios when##2##2##(2008-8#1)(2010-4#1)
ratios with##6##2##(1992-7#1)(1993-3#1)(2008-2#1)(2008-3#2)(2010-12#1)
ratios within##2##2##(1992-2#1)(2012-2#1)
ratios##917##1##(1990-10#8)(1990-11#4)(1990-12#9)(1990-2#4)(1990-3#2)(1990-4#2)(1990-5#2)(1990-7#1)(1990-9#4)(1991-10#1)(1991-12#10)(1991-2#2)(1991-3#1)(1991-5#5)(1991-7#2)(1991-8#1)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#6)(1992-3#10)(1992-4#2)(1992-5#1)(1992-6#4)(1992-7#4)(1992-8#2)(1992-9#4)(1993-1#2)(1993-11#7)(1993-12#2)(1993-2#2)(1993-3#6)(1993-5#2)(1993-6#2)(1993-8#1)(1993-9#8)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#3)(1994-5#3)(1994-7#1)(1994-8#5)(1994-9#3)(1995-1#6)(1995-10#2)(1995-11#6)(1995-12#3)(1995-2#5)(1995-3#9)(1995-4#1)(1995-5#2)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#2)(1996-11#1)(1996-12#9)(1996-2#4)(1996-3#8)(1996-4#1)(1996-5#5)(1996-6#1)(1996-7#2)(1996-8#7)(1996-9#3)(1997-1#2)(1997-2#3)(1997-3#6)(1997-4#5)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#8)(2004-11#1)(2004-9#2)(2005-10#1)(2005-11#11)(2005-12#1)(2005-7#1)(2005-9#1)(2006-10#6)(2006-11#4)(2006-12#11)(2006-6#2)(2006-7#3)(2007-10#4)(2007-11#13)(2007-12#13)(2007-2#2)(2007-3#5)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#23)(2007-9#3)(2008-1#2)(2008-10#124)(2008-11#18)(2008-12#7)(2008-2#35)(2008-3#74)(2008-4#9)(2008-5#25)(2008-6#3)(2008-7#13)(2008-8#14)(2008-9#10)(2009-10#1)(2009-11#4)(2009-12#3)(2009-3#2)(2009-4#7)(2009-5#2)(2009-6#3)(2009-8#4)(2009-9#4)(2010-1#1)(2010-11#1)(2010-12#12)(2010-2#3)(2010-3#2)(2010-4#9)(2010-5#6)(2010-7#1)(2010-8#8)(2010-9#1)(2011-1#9)(2011-12#7)(2011-2#32)(2012-1#2)(2012-11#1)(2012-12#20)(2012-2#14)(2012-3#9)(2012-8#1)(2013-1#13)(2013-4#1)(2013-7#3)(2013-8#16)
ratios) of##2##2##(1993-9#1)(2008-10#1)
ratios)##5##1##(1993-9#2)(2008-10#1)(2008-3#1)(2008-7#1)
ratites##3##1##(2013-1#3)
ratoon##2##1##(2007-1#1)(2008-10#1)
rats (0##7##2##(1991-9#1)(1992-3#1)(1992-8#1)(1996-12#2)(1997-2#1)(2009-4#1)
rats (22##2##2##(1997-5#1)(2008-4#1)
rats (24 months old)##2##4##(1995-9#1)(2009-5#1)
rats (24##3##2##(1995-7#1)(1995-9#1)(2009-5#1)
rats (25##2##2##(1992-3#1)(2009-10#1)
rats (3 months##2##3##(1996-5#1)(2008-8#1)
rats (3##4##2##(1993-7#1)(1995-7#1)(1996-5#1)(2008-8#1)
rats (4 months old)##2##4##(1995-9#1)(2009-5#1)
rats (4##4##2##(1995-5#1)(1995-9#1)(2007-8#1)(2009-5#1)
rats (6##4##2##(1995-7#3)(2008-7#1)
rats (7##2##2##(2007-1#1)(2008-4#1)
rats (P &lt##2##3##(1994-10#1)(1995-1#1)
rats (P less than 0##3##5##(1991-12#1)(1991-2#1)(1992-3#1)
rats (P##6##2##(1991-12#1)(1991-2#1)(1992-3#1)(1994-10#1)(1995-1#2)
rats (Rattus norvegicus)##5##3##(1993-2#1)(2008-10#1)(2008-12#1)(2012-12#1)(2013-1#1)
rats (Rattus##6##2##(1993-2#1)(2008-10#1)(2008-12#1)(2009-5#1)(2012-12#1)(2013-1#1)
rats (SER)##2##2##(1991-9#1)(2011-2#1)
rats (control)##2##2##(1990-9#1)(2010-12#1)
rats (group##2##2##(1990-5#1)(1996-12#1)
rats (i##3##2##(1997-2#2)(2010-5#1)
rats (n = 3)##2##4##(1992-3#1)(1993-8#1)
rats (n = 5)##3##4##(2008-5#2)(2009-6#1)
rats (n =##17##3##(1992-3#1)(1993-12#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-5#1)(1995-5#1)(1997-8#1)(2007-10#2)(2007-8#1)(2008-11#1)(2008-5#2)(2009-6#1)(2010-10#1)
rats (p &lt##2##3##(1994-11#1)(2008-9#1)
rats (p&lt##2##2##(2008-4#2)
rats -##2##2##(1995-12#1)(2011-2#1)
rats 2##3##2##(1990-12#1)(1991-12#1)(2010-12#1)
rats 24##2##2##(1994-6#1)(2008-10#1)
rats 7##2##2##(1990-2#1)(1997-6#1)
rats Rattus norvegicus##2##3##(2008-12#1)(2010-2#1)
rats [P &lt##2##3##(2007-1#1)(2008-4#1)
rats a diet containing##3##4##(1993-7#2)(2004-11#1)
rats a##6##2##(1993-7#2)(1995-3#1)(1996-9#1)(1997-5#1)(2004-11#1)
rats acquired##2##2##(1993-12#1)(1994-2#1)
rats adapted to##4##3##(1997-6#2)(2013-1#2)
rats administered with##3##3##(1996-3#2)(2008-10#1)
rats administered##8##2##(1990-3#2)(1991-2#1)(1996-10#1)(1996-3#2)(2008-10#1)(2008-9#1)
rats after intravenous##2##3##(1997-2#1)(2011-2#1)
rats after##38##2##(1990-12#1)(1991-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-7#1)(1993-8#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-3#1)(1997-2#2)(1997-8#2)(2005-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-2#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#2)(2013-1#3)
rats against##3##2##(1990-4#1)(2005-11#1)(2008-11#1)
rats aged##8##2##(1994-2#1)(1995-1#1)(1995-5#1)(1995-8#1)(2008-7#1)(2009-2#1)(2009-5#2)
rats also had##3##3##(1995-5#1)(1997-1#1)(2008-10#1)
rats also##7##2##(1991-8#1)(1994-6#1)(1995-12#1)(1995-5#1)(1997-1#1)(2008-10#1)(2010-5#1)
rats and a##3##3##(1992-11#1)(1995-11#1)(2009-8#1)
rats and at##2##3##(1995-11#1)(2008-4#1)
rats and compared##2##3##(1991-4#1)(1993-11#1)
rats and dogs##7##3##(1991-12#1)(1992-6#1)(1995-12#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-5#1)
rats and guinea pigs##2##4##(1995-12#1)(2006-10#1)
rats and humans##8##3##(1993-9#2)(1994-10#1)(1996-10#1)(1996-4#1)(1996-5#1)(2007-8#1)(2008-1#1)
rats and in rats##3##4##(1991-2#1)(1992-7#1)(1995-12#1)
rats and in##6##3##(1990-7#1)(1991-2#1)(1992-7#1)(1993-6#1)(1995-1#1)(1995-12#1)
rats and its##3##3##(1995-6#1)(2010-11#1)(2013-8#1)
rats and may##3##3##(1993-12#1)(2007-1#1)(2009-4#1)
rats and mice and##2##4##(2008-4#1)(2008-7#1)
rats and mice were##2##4##(1996-5#1)(1997-8#1)
rats and mice##32##3##(1991-1#1)(1991-12#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-5#1)(1997-2#2)(1997-8#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-4#10)(2008-7#2)(2008-9#2)(2009-11#2)(2010-7#1)
rats and no##2##3##(1991-5#1)(1992-11#1)
rats and other##2##3##(1990-12#1)(2008-4#1)
rats and rabbits##6##3##(1990-11#3)(1992-7#1)(1996-5#1)(1996-8#1)
rats and rats##4##3##(1995-7#1)(1997-3#1)(1997-7#1)(2013-1#1)
rats and significantly##2##3##(1996-4#1)(2012-2#1)
rats and that##4##3##(1991-2#1)(1993-3#1)(1995-5#1)(2010-1#1)
rats and the##6##3##(1993-2#1)(1994-10#1)(2005-11#1)(2010-12#1)(2013-7#2)
rats and their##3##3##(1990-8#1)(1995-3#1)(2008-11#1)
rats and those##2##3##(1991-10#1)(1995-3#1)
rats and three##2##3##(1993-6#1)(2006-9#1)
rats and thus##2##3##(1990-8#1)(1992-7#1)
rats and was##4##3##(1991-4#1)(1993-4#1)(1995-1#1)(1996-5#1)
rats and##194##2##(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-6#2)(1990-7#1)(1990-8#3)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#3)(1991-4#2)(1991-5#3)(1991-9#1)(1992-1#1)(1992-11#2)(1992-3#1)(1992-6#1)(1992-7#4)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#2)(1993-6#2)(1993-7#1)(1993-9#2)(1994-10#2)(1994-11#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#4)(1995-12#5)(1995-2#4)(1995-3#3)(1995-5#2)(1995-6#1)(1995-7#1)(1995-9#2)(1996-1#2)(1996-10#3)(1996-11#1)(1996-12#6)(1996-3#1)(1996-4#3)(1996-5#4)(1996-8#1)(1996-9#1)(1997-2#7)(1997-3#2)(1997-7#1)(1997-8#4)(2004-9#1)(2005-11#1)(2006-10#2)(2006-12#3)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-4#15)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#5)(2009-11#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#2)
rats anesthetized with urethane##2##4##(1997-7#1)(2008-10#1)
rats anesthetized with##3##3##(1997-2#1)(1997-7#1)(2008-10#1)
rats are not##2##3##(1994-8#1)(1996-12#1)
rats are resistant to##2##4##(1993-3#1)(1994-11#1)
rats are used##2##3##(2008-4#2)
rats are##24##2##(1990-2#1)(1990-5#1)(1991-5#1)(1992-5#1)(1993-3#1)(1993-4#1)(1994-10#1)(1994-11#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#1)(1997-2#2)(2008-4#6)(2009-5#2)(2012-11#1)
rats as a##2##3##(1991-2#1)(1994-5#1)
rats as compared to the control##2##6##(1990-8#1)(2008-11#1)
rats as compared to##7##4##(1990-8#1)(1994-2#2)(1995-12#1)(1997-5#1)(2008-11#1)(2012-2#1)
rats as compared with##4##4##(1993-12#1)(1996-10#1)(1996-4#1)(2008-7#1)
rats as compared##11##3##(1990-8#1)(1993-12#1)(1994-2#2)(1995-12#1)(1996-10#1)(1996-4#1)(1997-5#1)(2008-11#1)(2008-7#1)(2012-2#1)
rats as well as##2##4##(1994-11#1)(1994-6#1)
rats as well##3##3##(1994-11#2)(1994-6#1)
rats as##27##2##(1990-8#1)(1991-12#1)(1991-2#1)(1992-9#1)(1993-12#1)(1994-11#2)(1994-2#2)(1994-5#1)(1994-6#1)(1995-12#2)(1996-10#1)(1996-12#1)(1996-4#1)(1996-7#1)(1997-5#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2012-2#1)
rats at 10##2##3##(1992-7#1)(2006-1#1)
rats at a dose of 0##2##6##(1994-6#1)(1995-3#1)
rats at a dose of##3##5##(1992-2#1)(1994-6#1)(1995-3#1)
rats at a##4##3##(1992-2#1)(1994-6#1)(1995-3#1)(2012-2#1)
rats at any time##2##4##(1994-5#2)
rats at different ages##2##4##(1993-12#1)(1993-9#1)
rats at different##3##3##(1993-12#1)(1993-9#1)(1997-2#1)
rats at postnatal##2##3##(1996-4#1)(1996-5#1)
rats at rest##3##3##(2013-1#3)
rats at the age of##2##5##(1994-11#1)(2012-1#1)
rats at the##10##3##(1991-8#1)(1993-7#1)(1994-11#1)(2008-3#1)(2009-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
rats at two##2##3##(1997-5#1)(2012-12#1)
rats at##50##2##(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-2#1)(1992-7#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#3)(1994-6#1)(1995-3#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-5#1)(2006-1#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-2#1)(2010-1#1)(2010-6#2)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#4)
rats bearing##7##2##(1991-10#1)(1993-12#1)(1993-6#1)(1993-8#3)(1994-8#1)
rats before##2##2##(1993-7#1)(1995-11#1)
rats behave##2##2##(1993-2#1)(1993-3#1)
rats behaviorally sensitized to AMPH##2##5##(1997-8#2)
rats behaviorally sensitized to MA##2##5##(1997-8#2)
rats behaviorally sensitized to methamphetamine##2##5##(1997-8#2)
rats behaviorally sensitized to##6##4##(1997-8#6)
rats but not in##2##4##(2008-10#1)(2008-7#1)
rats but not##3##3##(1992-9#1)(2008-10#1)(2008-7#1)
rats but##9##2##(1991-10#1)(1992-9#1)(1994-2#2)(1995-12#1)(1997-1#1)(2008-10#1)(2008-7#1)(2009-11#1)
rats by a##4##3##(1990-4#1)(1994-12#1)(2012-2#1)(2013-8#1)
rats by daily##2##3##(1997-2#2)
rats by in situ hybridization##2##5##(1997-4#1)(2008-5#1)
rats by intraperitoneal##2##3##(2007-9#1)(2011-3#1)
rats by measuring##2##3##(1993-7#1)(2008-10#1)
rats by the##2##3##(1990-7#1)(2009-2#1)
rats by##64##2##(1990-11#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-2#2)(1992-10#1)(1992-11#2)(1992-8#1)(1993-12#1)(1993-7#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-11#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#2)(1997-7#1)(1997-8#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
rats can be##4##3##(1996-10#1)(1997-3#1)(2008-10#1)(2011-2#1)
rats can##6##2##(1993-12#1)(1996-10#1)(1997-3#1)(2008-10#1)(2009-11#1)(2011-2#1)
rats cannot##2##2##(1990-6#1)(1994-5#1)
rats carrying##4##2##(1990-2#1)(1990-4#2)(2012-12#1)
rats catalyzed##2##2##(1991-8#1)(1993-4#1)
rats caused a##4##3##(1992-2#1)(1994-8#1)(1995-5#2)
rats caused##6##2##(1992-2#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-5#2)
rats causes##4##2##(1990-5#1)(1995-12#1)(2006-9#1)(2008-4#1)
rats chronically intoxicated with ethanol##2##5##(2009-8#2)
rats chronically##4##2##(1993-12#1)(1996-10#1)(2009-8#2)
rats compared to the##2##4##(2008-8#1)(2011-2#1)
rats compared to##9##3##(1990-8#1)(1993-7#1)(1994-2#1)(1995-12#1)(1996-5#1)(1997-3#1)(1997-5#1)(2008-8#1)(2011-2#1)
rats compared with young##2##4##(1995-7#1)(2008-7#1)
rats compared with##9##3##(1993-12#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-7#1)(1997-1#1)(2007-1#1)(2008-7#1)(2013-8#1)
rats compared##18##2##(1990-8#1)(1993-12#1)(1993-7#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-7#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-5#1)(2007-1#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
rats could be##2##3##(1993-5#1)(1994-11#1)
rats could##8##2##(1990-7#2)(1992-10#1)(1993-5#1)(1994-11#1)(2008-10#1)(2012-1#1)(2012-2#1)
rats decreased##4##2##(1995-12#1)(1995-8#1)(1996-10#1)(2008-8#1)
rats delayed##2##2##(1994-8#1)(1995-12#1)
rats demonstrated a##2##3##(1990-10#1)(1994-10#1)
rats demonstrated that##2##3##(1990-8#1)(1997-1#1)
rats demonstrated##6##2##(1990-10#1)(1990-8#1)(1994-10#1)(1995-12#1)(1997-1#1)(2007-9#1)
rats depleted of##2##3##(1997-4#1)(2012-12#1)
rats depleted##3##2##(1994-3#1)(1997-4#1)(2012-12#1)
rats deprived of##2##3##(1992-3#1)(1997-2#1)
rats develop##2##2##(1993-6#1)(1995-12#1)
rats did not##8##3##(1991-9#1)(1992-12#1)(1993-12#1)(1995-3#1)(1996-1#1)(1997-2#1)(2008-10#1)(2008-7#1)
rats differ in##2##3##(1990-11#1)(1993-6#1)
rats differ##3##2##(1990-11#1)(1993-5#1)(1993-6#1)
rats displayed a##2##3##(1992-11#1)(2007-9#1)
rats displayed##4##2##(1992-11#1)(1995-12#1)(1996-12#1)(2007-9#1)
rats divided##2##2##(2007-1#1)(2008-9#1)
rats dosed with##2##3##(1994-8#1)(2008-9#1)
rats during early##2##3##(2008-4#1)(2013-8#1)
rats during their first##3##4##(1992-5#1)(1993-7#2)
rats during##23##2##(1991-12#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-2#1)(1993-7#2)(1994-11#1)(1994-6#1)(1997-6#1)(1997-7#2)(2008-4#2)(2010-12#1)(2010-9#1)(2011-2#1)(2013-1#3)(2013-8#3)
rats each##5##2##(2007-1#1)(2008-4#2)(2009-5#1)(2012-2#1)
rats elicited##3##2##(1994-11#1)(1997-2#1)(1997-3#1)
rats established by##2##3##(1992-7#1)(2008-10#1)
rats even##2##2##(1993-12#1)(1997-2#1)
rats every##2##2##(1994-2#1)(1995-12#1)
rats exhibit##3##2##(1994-11#1)(1994-5#1)(1995-12#1)
rats exhibited a##2##3##(1993-6#1)(1995-8#1)
rats exhibited significantly##2##3##(1993-7#1)(2009-12#1)
rats exhibited##10##2##(1990-2#1)(1993-6#1)(1993-7#1)(1994-3#1)(1995-8#2)(1997-2#1)(2008-4#1)(2009-12#1)(2013-7#1)
rats exposed prenatally to##3##4##(1994-10#1)(1996-10#1)(2006-3#1)
rats exposed prenatally##4##3##(1994-10#1)(1996-10#2)(2006-3#1)
rats exposed to a##2##4##(2008-10#1)(2008-12#1)
rats exposed to##25##3##(1990-5#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-12#1)(1994-11#1)(1994-5#2)(1994-6#1)(1995-12#1)(1995-8#2)(1996-12#1)(1997-2#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)
rats exposed##30##2##(1990-5#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-12#1)(1994-10#2)(1994-11#1)(1994-5#2)(1994-6#1)(1995-12#1)(1995-8#2)(1996-10#2)(1996-12#1)(1997-2#2)(2006-3#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)
rats expressing##3##2##(1990-11#1)(1991-3#1)(1995-2#1)
rats fasted overnight##2##3##(1995-11#1)(1995-12#1)
rats fasted##3##2##(1994-8#1)(1995-11#1)(1995-12#1)
rats fed a diet##2##4##(1991-12#1)(1995-11#1)
rats fed a fat-free diet##3##5##(1991-2#3)
rats fed a##9##3##(1991-12#1)(1991-2#3)(1992-7#1)(1994-11#1)(1995-11#1)(1995-3#1)(2004-11#1)
rats fed an##4##3##(1991-7#1)(1993-6#1)(2007-8#1)(2010-12#1)
rats fed ethanol##4##3##(1990-8#1)(1995-3#1)(2008-11#2)
rats fed on##3##3##(1991-12#1)(2009-5#1)(2010-2#1)
rats fed the##2##3##(1993-12#1)(1994-6#1)
rats fed vitamin E##3##4##(1994-5#3)
rats fed vitamin##4##3##(1993-12#1)(1994-5#3)
rats fed with a##2##4##(1996-6#1)(2012-2#1)
rats fed with##7##3##(1996-6#1)(2006-9#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#2)
rats fed##43##2##(1990-8#1)(1991-12#2)(1991-2#3)(1991-7#1)(1992-11#1)(1992-7#1)(1993-12#3)(1993-6#1)(1994-11#1)(1994-2#1)(1994-5#3)(1994-6#1)(1995-11#1)(1995-3#2)(1996-6#1)(1997-5#1)(2004-11#1)(2006-9#1)(2007-8#3)(2007-9#1)(2008-11#2)(2008-5#1)(2009-5#1)(2010-12#1)(2010-2#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
rats following a##2##3##(1990-4#1)(2008-5#1)
rats following administration##2##3##(2008-10#1)(2008-4#1)
rats following bilateral##2##3##(1994-3#1)(1997-5#1)
rats following chronic##3##3##(1991-8#1)(1993-2#1)(2009-5#1)
rats following i##3##3##(1991-9#1)(1992-8#1)(1995-3#1)
rats following oral##2##3##(1995-11#1)(2008-5#1)
rats following##25##2##(1990-4#1)(1991-3#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#2)(1994-10#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-3#1)(1997-5#1)(2008-10#1)(2008-4#1)(2008-5#2)(2009-2#1)(2009-5#1)(2010-2#1)
rats for a period of##2##5##(2004-11#1)(2012-2#1)
rats for a##3##3##(2004-11#1)(2009-12#1)(2012-2#1)
rats for##20##2##(1990-5#1)(1991-11#1)(1991-9#1)(1992-5#1)(1993-11#1)(1993-7#1)(1995-8#1)(2004-11#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-8#1)(2009-12#1)(2009-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
rats from a##3##3##(1993-11#1)(1993-7#1)(1996-10#1)
rats from each##2##3##(1993-12#1)(2011-2#1)
rats from##13##2##(1991-12#1)(1991-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-6#2)(1995-11#1)(1996-10#1)(1996-4#1)(2008-10#1)(2011-2#1)
rats given Ni3S2 +##2##4##(1994-5#2)
rats given ethanol##2##3##(1995-3#1)(2008-11#1)
rats given##12##2##(1991-4#1)(1993-2#1)(1993-9#1)(1994-5#2)(1995-12#1)(1995-3#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-3#1)(2012-1#1)
rats had a##4##3##(1991-2#1)(1991-6#1)(1993-2#1)(1993-8#1)
rats had significantly##2##3##(1993-3#1)(2010-2#1)
rats had##19##2##(1991-2#1)(1991-6#1)(1993-2#1)(1993-3#2)(1993-8#2)(1996-5#1)(2007-9#2)(2008-5#1)(2008-7#2)(2008-9#2)(2010-2#1)(2013-1#2)(2013-7#1)
rats has been##3##3##(1992-1#1)(1994-10#1)(1996-1#1)
rats has##6##2##(1992-1#1)(1994-10#1)(1996-1#1)(2011-1#2)(2011-2#1)
rats have shown that##2##4##(1994-2#1)(2008-10#1)
rats have shown##3##3##(1994-2#1)(2008-10#1)(2008-7#1)
rats have##11##2##(1993-12#1)(1994-11#1)(1994-2#2)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)
rats housed##3##2##(1993-7#1)(2013-8#2)
rats immunized with##2##3##(1995-12#1)(2006-10#1)
rats implanted with##3##3##(1997-2#1)(1997-5#1)(2008-8#1)
rats in a##9##3##(1991-2#1)(1992-1#1)(1992-11#1)(1994-10#1)(1994-2#1)(1996-12#1)(1997-2#1)(2012-1#1)(2013-1#1)
rats in all##2##3##(1991-3#1)(1996-12#1)
rats in comparison with##5##4##(1990-7#1)(1994-6#1)(1995-8#1)(2007-6#1)(2008-10#1)
rats in comparison##6##3##(1990-7#1)(1994-6#1)(1995-1#1)(1995-8#1)(2007-6#1)(2008-10#1)
rats in group##3##3##(1997-2#1)(2008-8#2)
rats in order to##4##4##(1991-1#1)(1992-3#1)(1997-2#1)(2008-10#1)
rats in response to##5##4##(1990-6#1)(1993-2#1)(1993-4#1)(1996-5#1)(1996-7#1)
rats in the frontal cortex##2##5##(1993-4#1)(1997-2#1)
rats in the presence of##4##5##(1994-2#1)(1997-2#1)(2007-8#1)(2009-4#1)
rats in the##20##3##(1990-10#1)(1990-5#1)(1991-5#1)(1992-11#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-2#1)(1994-7#1)(1997-2#3)(2007-8#1)(2009-4#1)(2011-2#3)(2013-1#2)
rats in vivo and##3##4##(1994-3#2)(1997-5#1)
rats in vivo##8##3##(1994-3#4)(1995-3#1)(1996-1#1)(1997-5#1)(2009-8#1)
rats in which DSIP was injected##2##6##(1995-12#2)
rats in which##6##3##(1993-11#1)(1993-3#1)(1994-6#1)(1995-12#2)(2006-6#1)
rats in##83##2##(1990-10#1)(1990-5#1)(1990-6#1)(1990-7#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-5#2)(1993-9#1)(1994-10#2)(1994-2#4)(1994-3#5)(1994-6#3)(1994-7#2)(1995-1#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-5#1)(1996-7#1)(1997-2#6)(1997-5#1)(2006-10#1)(2006-6#1)(2007-6#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#3)(2009-4#1)(2009-8#1)(2011-2#3)(2012-1#1)(2013-1#3)
rats increased the##3##3##(1993-2#1)(1993-4#1)(1996-3#1)
rats increased##7##2##(1993-2#1)(1993-4#1)(1994-10#1)(1996-3#1)(2008-8#1)(2011-2#1)(2012-1#1)
rats increases the##2##3##(1995-7#1)(2004-11#1)
rats increases##4##2##(1993-6#1)(1995-12#1)(1995-7#1)(2004-11#1)
rats indicate##2##2##(1996-4#1)(2008-12#1)
rats induced by##5##3##(1991-2#1)(1995-3#1)(2005-9#1)(2010-12#1)(2013-1#1)
rats induced##7##2##(1991-2#1)(1992-3#1)(1994-8#1)(1995-3#1)(2005-9#1)(2010-12#1)(2013-1#1)
rats induces##3##2##(1995-3#1)(1996-5#1)(2007-10#1)
rats infused##2##2##(1990-11#1)(1995-11#1)
rats injected with##8##3##(1992-11#1)(1993-11#1)(1996-7#1)(1996-9#1)(1997-7#1)(2008-11#1)(2013-7#2)
rats injected##9##2##(1992-11#1)(1993-11#1)(1996-7#1)(1996-9#1)(1997-7#1)(2007-11#1)(2008-11#1)(2013-7#2)
rats into##3##2##(2007-5#1)(2008-4#1)(2012-2#1)
rats intoxicated with##2##3##(1994-7#2)
rats irradiated##3##2##(1992-9#2)(1995-6#1)
rats is##25##2##(1990-11#1)(1990-7#1)(1992-5#1)(1992-7#1)(1993-5#1)(1994-11#1)(1994-6#1)(1995-12#2)(1995-3#1)(1996-1#1)(1996-11#2)(2007-10#1)(2008-10#2)(2008-11#2)(2008-4#3)(2008-5#1)(2010-1#1)(2011-2#1)(2013-8#1)
rats it decreased##2##3##(2008-4#1)(2008-7#1)
rats it##6##2##(1996-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2013-1#1)
rats leads to##2##3##(1993-7#1)(2006-9#1)
rats learned to##2##3##(1991-9#1)(1993-6#1)
rats learned##4##2##(1991-9#1)(1993-2#1)(1993-6#1)(2008-7#1)
rats made##2##2##(1992-12#1)(1994-3#1)
rats maintained##4##2##(1992-1#1)(1993-2#1)(2004-11#1)(2008-4#1)
rats markedly##2##2##(1991-2#1)(1996-10#1)
rats may be##3##3##(1990-2#1)(1992-12#1)(1993-12#1)
rats may##8##2##(1990-2#1)(1991-12#1)(1992-1#1)(1992-12#1)(1993-12#1)(1993-9#1)(1996-2#1)(2010-7#1)
rats might##3##2##(1990-7#1)(2008-7#1)(2013-1#1)
rats more resistant to experimental gastric mucosal injury##2##8##(1996-7#2)
rats more##3##2##(1992-11#1)(1996-7#2)
rats of 12 months##2##4##(1994-2#1)(1995-1#1)
rats of 12##3##3##(1994-2#1)(1995-1#1)(2012-2#1)
rats of 3##2##3##(1994-2#1)(1995-3#1)
rats of Koletsky type##2##4##(1991-10#1)(1991-12#1)
rats of Wistar strain for##2##5##(2008-4#1)(2008-6#1)
rats of Wistar strain##4##4##(1991-10#1)(2007-1#1)(2008-4#1)(2008-6#1)
rats of Wistar##5##3##(1991-10#1)(2007-1#1)(2008-4#1)(2008-6#1)(2008-7#1)
rats of a##2##3##(1993-3#1)(2008-6#1)
rats of both sexes##15##4##(1991-10#1)(1993-12#1)(1993-9#2)(1995-1#1)(1995-8#1)(1996-10#1)(2008-10#1)(2008-12#2)(2008-7#4)(2009-11#1)
rats of both##18##3##(1991-10#1)(1993-12#1)(1993-5#1)(1993-9#2)(1995-1#1)(1995-8#1)(1996-10#1)(1996-4#2)(2008-10#1)(2008-12#2)(2008-7#4)(2009-11#1)
rats of different ages##5##4##(1991-2#1)(1995-6#1)(1997-1#1)(1997-6#1)(2009-2#1)
rats of different##7##3##(1990-2#1)(1991-2#1)(1995-6#1)(1997-1#1)(1997-6#1)(2009-2#1)(2012-1#1)
rats of increasing age##2##4##(1995-12#1)(1996-5#1)
rats of the Milan strain##2##5##(1991-6#1)(1992-2#1)
rats of the##14##3##(1991-6#1)(1992-2#1)(1993-11#1)(1993-5#1)(1994-6#1)(1995-11#2)(1996-4#1)(1997-3#1)(2006-12#1)(2006-4#1)(2008-1#1)(2012-1#1)(2013-8#1)
rats of various##4##3##(1993-7#1)(2010-12#3)
rats of##78##2##(1990-2#1)(1990-3#1)(1991-10#3)(1991-12#1)(1991-2#1)(1991-6#1)(1992-10#2)(1992-2#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#2)(1993-7#1)(1993-9#2)(1994-10#2)(1994-2#2)(1994-6#2)(1995-1#2)(1995-11#2)(1995-12#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-4#5)(1996-5#2)(1997-1#1)(1997-3#1)(1997-6#1)(2006-12#1)(2006-4#3)(2007-1#1)(2008-1#1)(2008-10#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#5)(2009-11#1)(2009-2#1)(2010-12#4)(2011-12#1)(2012-1#2)(2012-2#1)(2013-1#2)(2013-8#1)
rats on day##2##3##(1993-12#1)(1994-2#1)
rats on the##2##3##(1997-3#1)(2008-11#1)
rats on##16##2##(1992-9#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-2#2)(1997-3#1)(2008-10#2)(2008-11#2)(2008-3#1)(2009-2#1)(2013-8#2)
rats once##2##2##(1996-10#1)(2009-8#1)
rats only##4##2##(1994-10#1)(2008-10#2)(2012-2#1)
rats or##7##2##(1990-11#1)(1991-12#1)(1992-1#1)(1996-1#1)(1996-10#1)(1996-4#1)(2011-1#1)
rats orally##4##2##(1993-3#1)(2008-11#2)(2012-2#1)
rats over##2##2##(1997-2#1)(2004-11#1)
rats per group##4##3##(2007-1#1)(2008-4#2)(2009-5#1)
rats performed##2##2##(1993-6#1)(1995-12#1)
rats prenatally exposed to ethanol##3##5##(1995-3#1)(2013-1#2)
rats prenatally exposed to##4##4##(1995-3#1)(1996-10#1)(2013-1#2)
rats presented##3##2##(1994-5#1)(2007-9#1)(2013-8#1)
rats pretreated with##9##3##(1990-7#1)(1991-5#1)(1992-11#1)(1993-12#1)(1994-9#1)(1995-12#2)(2008-6#2)
rats pretreated##10##2##(1990-7#1)(1991-3#1)(1991-5#1)(1992-11#1)(1993-12#1)(1994-9#1)(1995-12#2)(2008-6#2)
rats previously##4##2##(1993-5#1)(1993-7#1)(1994-2#1)(2008-3#1)
rats produce##3##2##(1993-6#1)(1995-9#1)(2008-10#1)
rats produced a significant##2##4##(2008-12#1)(2010-5#1)
rats produced a##3##3##(1996-12#1)(2008-12#1)(2010-5#1)
rats produced##7##2##(1994-2#1)(1996-12#1)(2004-11#1)(2008-12#1)(2008-4#1)(2010-5#1)(2012-2#1)
rats reared under##2##3##(1992-9#1)(1994-11#1)
rats received 0##2##3##(2008-10#1)(2011-2#1)
rats received a single##2##4##(1992-12#1)(2008-12#1)
rats received a##5##3##(1992-12#1)(1993-12#1)(1996-1#1)(2008-12#1)(2012-7#1)
rats received an injection of##2##5##(1993-7#1)(2007-10#1)
rats received an intraperitoneal##2##4##(1994-6#1)(2013-1#1)
rats received an##6##3##(1991-12#1)(1993-7#1)(1994-6#1)(1994-8#1)(2007-10#1)(2013-1#1)
rats received bilateral##2##3##(1993-3#1)(1994-3#1)
rats received either unilateral##2##4##(1990-5#1)(2009-10#1)
rats received either##3##3##(1990-5#1)(1996-9#1)(2009-10#1)
rats received##47##2##(1990-5#2)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-12#3)(1993-3#1)(1993-7#1)(1994-3#1)(1994-6#1)(1994-7#2)(1994-8#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-9#1)(1997-3#1)(1997-7#1)(2004-11#1)(2007-10#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#2)(2013-8#1)
rats receiving either##3##3##(1992-9#1)(1996-12#1)(2006-9#1)
rats receiving##18##2##(1990-5#1)(1991-2#1)(1992-9#1)(1993-4#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-8#1)(2004-12#1)(2006-9#2)(2010-12#1)(2012-12#1)
rats reduces##2##2##(1993-9#2)
rats relative to##5##3##(1991-2#1)(1991-3#1)(1992-5#1)(1994-11#1)(1995-10#1)
rats resulted in a##2##4##(1991-8#1)(1995-12#1)
rats resulted in##6##3##(1991-8#1)(1993-12#1)(1995-12#1)(1995-2#1)(1996-4#1)(2009-4#1)
rats results in##4##3##(1992-6#1)(1992-9#1)(1993-8#1)(1996-10#1)
rats results##5##2##(1992-6#1)(1992-9#1)(1993-8#1)(1996-10#1)(2008-10#1)
rats revealed##4##2##(1990-5#1)(1992-11#1)(1994-6#1)(1996-12#1)
rats show##7##2##(1990-11#2)(1990-7#1)(1992-3#1)(1994-3#1)(2005-7#1)(2007-5#1)
rats showed a significant increase in##2##6##(1994-3#1)(1997-2#1)
rats showed a significant increase##3##5##(1992-9#1)(1994-3#1)(1997-2#1)
rats showed a significant##5##4##(1992-10#1)(1992-9#1)(1994-11#1)(1994-3#1)(1997-2#1)
rats showed a##15##3##(1992-10#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-11#1)(1994-3#1)(1997-2#2)(2009-12#1)(2013-1#1)
rats showed an##2##3##(1991-5#1)(1996-4#1)
rats showed higher##3##3##(1994-6#1)(2013-1#1)(2013-8#1)
rats showed less##2##3##(1995-5#1)(2013-8#1)
rats showed no##2##3##(1993-2#1)(2008-4#1)
rats showed significantly lower##2##4##(2008-12#1)(2013-8#1)
rats showed significantly##5##3##(1993-12#1)(1993-6#1)(2008-12#1)(2008-9#1)(2013-8#1)
rats showed that the##2##4##(1994-2#1)(2012-1#1)
rats showed that##5##3##(1994-2#1)(2010-12#1)(2012-1#2)(2012-3#1)
rats showed the##2##3##(1993-9#1)(1995-10#1)
rats showed##43##2##(1990-11#1)(1991-5#1)(1992-10#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-5#1)(1996-4#1)(1997-2#2)(2008-12#1)(2008-4#1)(2008-9#1)(2009-12#1)(2010-1#1)(2010-12#1)(2012-1#2)(2012-3#1)(2013-1#3)(2013-8#3)
rats still##2##2##(1993-3#2)
rats subjected to porta-caval anastomosis##3##5##(1993-3#3)
rats subjected to##16##3##(1990-5#1)(1991-12#1)(1993-3#3)(1993-4#1)(1995-7#1)(1996-1#1)(1996-3#1)(1997-7#1)(2005-8#1)(2007-9#2)(2012-1#2)(2013-7#1)
rats submitted to##6##3##(1992-7#2)(1994-10#1)(1996-12#1)(2007-9#1)(2008-5#1)
rats subsequently##4##2##(1992-8#1)(1993-6#2)(2012-2#1)
rats suggests that##2##3##(1993-12#1)(1997-2#1)
rats suggests##3##2##(1993-12#1)(1994-11#1)(1997-2#1)
rats tested##4##2##(1992-9#1)(1994-2#1)(1995-7#1)(2013-7#1)
rats than in Wistar rats##2##5##(1993-12#1)(2008-4#1)
rats than in control rats##3##5##(1990-7#1)(1995-12#1)(2009-5#1)
rats than in control##4##4##(1990-3#1)(1990-7#1)(1995-12#1)(2009-5#1)
rats than in mice##2##4##(1997-2#1)(2006-9#1)
rats than in the##2##4##(1990-5#1)(1997-2#1)
rats than in##22##3##(1990-3#2)(1990-5#1)(1990-7#2)(1991-12#2)(1993-12#2)(1993-6#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#2)(1996-10#1)(1997-2#2)(2006-9#1)(2008-4#1)(2009-5#1)(2013-8#1)
rats than##27##2##(1990-3#2)(1990-5#1)(1990-7#2)(1991-12#2)(1992-11#1)(1993-12#2)(1993-6#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#2)(1996-10#1)(1997-2#2)(2006-9#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-11#1)(2009-5#1)(2013-8#1)
rats that are resistant to##2##5##(2009-11#1)(2012-12#1)
rats that had been##3##4##(1992-1#1)(1995-10#1)(2011-2#1)
rats that had received##2##4##(1993-6#1)(1996-5#1)
rats that had##7##3##(1990-10#1)(1992-1#1)(1993-6#1)(1995-10#1)(1996-5#1)(2008-11#1)(2011-2#1)
rats that inhaled oxygen-17 gas##2##5##(1990-5#2)
rats that received##7##3##(1993-2#1)(1995-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
rats that were##7##3##(1993-11#1)(1993-12#1)(1993-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2013-1#1)
rats that##34##2##(1990-10#1)(1990-5#2)(1992-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-6#1)(1995-10#1)(1995-12#1)(1996-1#1)(1996-5#1)(1996-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-5#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
rats the##16##2##(1990-11#1)(1991-10#1)(1991-2#3)(1992-10#1)(1994-11#1)(1994-2#2)(1994-8#1)(1995-12#2)(2008-4#1)(2008-7#1)(2011-2#2)
rats through##5##2##(1992-6#1)(1997-4#1)(2008-11#1)(2008-4#1)(2010-12#1)
rats to a##5##3##(1995-12#2)(1995-3#1)(1997-5#1)(2008-4#1)
rats to determine if##2##4##(1994-2#1)(1994-6#1)
rats to determine the##2##4##(1990-5#1)(1996-5#1)
rats to determine##5##3##(1990-5#1)(1992-5#1)(1994-2#1)(1994-6#1)(1996-5#1)
rats to elucidate##2##3##(1995-1#1)(2010-11#1)
rats to examine##2##3##(1995-12#1)(1995-5#1)
rats to study##2##3##(1996-3#1)(2008-10#1)
rats to the##6##3##(1991-10#2)(1993-4#1)(1993-7#1)(1996-3#1)(2010-5#1)
rats to##67##2##(1990-5#1)(1990-7#1)(1991-10#2)(1991-6#1)(1992-11#1)(1992-5#1)(1993-12#3)(1993-3#2)(1993-4#2)(1993-6#1)(1993-7#3)(1993-8#2)(1993-9#2)(1994-2#1)(1994-6#1)(1995-1#2)(1995-12#6)(1995-3#1)(1995-5#2)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#2)(1997-2#1)(1997-5#2)(1997-8#1)(2005-10#1)(2007-10#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#1)(2009-3#2)(2009-4#1)(2010-11#1)(2010-12#1)(2010-5#1)(2012-1#2)(2012-2#3)(2013-8#2)
rats trained in##2##3##(2008-7#1)(2009-2#1)
rats trained to discriminate ethanol from vehicle##2##7##(1997-7#2)
rats trained to discriminate##3##4##(1996-10#1)(1997-7#2)
rats trained to##5##3##(1992-9#1)(1995-12#1)(1996-10#1)(1997-7#2)
rats trained##7##2##(1992-9#1)(1995-12#1)(1996-10#1)(1997-7#2)(2008-7#1)(2009-2#1)
rats treated as##2##3##(1991-3#1)(1995-12#1)
rats treated with a##2##4##(1994-3#1)(2009-8#1)
rats treated with ethanol##2##4##(1995-3#1)(2012-2#1)
rats treated with menthol cigarette and##2##6##(2011-1#2)
rats treated with normal cigarette##2##5##(2011-1#2)
rats treated with repeated##2##4##(1991-5#1)(1996-10#1)
rats treated with##68##3##(1990-12#1)(1990-2#3)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#3)(1992-2#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-7#1)(1994-10#1)(1994-2#1)(1994-3#2)(1994-5#5)(1994-6#2)(1994-8#1)(1995-12#2)(1995-3#4)(1996-10#2)(1996-11#2)(1996-12#1)(1996-5#1)(1997-1#1)(1997-3#1)(2007-10#2)(2008-10#3)(2008-5#2)(2008-6#2)(2008-8#1)(2009-4#1)(2009-8#1)(2010-12#2)(2011-1#5)(2011-2#1)(2012-1#2)(2012-2#2)(2013-1#1)(2013-8#1)
rats treated##74##2##(1990-12#2)(1990-2#3)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#2)(1991-5#3)(1992-2#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-7#1)(1994-10#1)(1994-2#1)(1994-3#2)(1994-5#5)(1994-6#2)(1994-8#1)(1995-12#3)(1995-3#4)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-10#2)(2008-10#3)(2008-5#2)(2008-6#2)(2008-8#1)(2009-4#1)(2009-8#1)(2010-12#2)(2011-1#5)(2011-2#1)(2012-1#2)(2012-2#2)(2013-1#1)(2013-8#1)
rats under a##2##3##(1991-5#1)(1997-1#1)
rats under##9##2##(1991-12#1)(1991-5#1)(1992-8#1)(1993-6#1)(1995-12#1)(1996-3#1)(1997-1#2)(2008-4#1)
rats undergoing##3##2##(1992-1#1)(1995-12#1)(2006-6#1)
rats underwent either##3##3##(1993-5#1)(1996-3#1)(2007-9#1)
rats underwent##7##2##(1993-3#1)(1993-5#1)(1995-2#1)(1996-3#1)(2007-5#1)(2007-9#1)(2011-2#1)
rats up to##5##3##(1995-5#1)(2008-1#1)(2008-3#1)(2009-2#1)(2012-1#1)
rats used##4##2##(1992-11#1)(1992-9#1)(1996-7#1)(2012-1#1)
rats using a##7##3##(1991-11#1)(1993-4#2)(1994-10#1)(1994-2#1)(2007-11#1)(2007-8#1)
rats using an##2##3##(1995-9#1)(2009-11#1)
rats using##19##2##(1991-11#1)(1991-8#1)(1993-4#2)(1994-10#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-10#1)(1997-5#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-11#2)(2012-3#1)
rats via##4##2##(1993-11#1)(1996-1#1)(2011-2#1)(2012-2#1)
rats vs##3##2##(1996-1#2)(2004-11#1)
rats was associated with##2##4##(1992-3#1)(1993-4#1)
rats was decreased##2##3##(1993-3#1)(2009-6#1)
rats was determined##2##3##(2008-5#1)(2009-8#1)
rats was due to##2##4##(1991-2#1)(1997-8#1)
rats was examined##5##3##(1990-9#1)(1991-9#1)(1993-11#1)(1997-8#1)(2007-1#1)
rats was higher##2##3##(2008-7#1)(2010-12#1)
rats was increased##2##3##(1993-11#1)(1997-3#1)
rats was investigated##10##3##(1990-10#1)(1990-9#1)(1991-5#1)(1992-2#1)(1993-8#1)(1995-12#1)(1997-2#1)(2007-9#1)(2009-5#1)(2012-2#1)
rats was lower than##2##4##(1992-5#1)(2010-12#1)
rats was lower##4##3##(1992-5#1)(1995-1#1)(1995-9#1)(2010-12#1)
rats was markedly reduced##2##4##(1993-12#1)(1997-2#1)
rats was markedly##4##3##(1993-12#1)(1994-9#1)(1997-1#1)(1997-2#1)
rats was measured by##4##4##(1991-2#1)(1992-3#1)(1993-3#1)(2007-8#1)
rats was noted##2##3##(1991-5#1)(2008-12#1)
rats was reduced in##2##4##(1994-2#1)(1995-7#1)
rats was reduced##3##3##(1994-2#1)(1994-3#1)(1995-7#1)
rats was significantly##4##3##(1990-11#1)(1991-1#1)(1992-9#1)(1995-3#1)
rats was studied by##2##4##(2008-8#1)(2012-1#1)
rats was studied using##2##4##(1996-1#1)(2012-3#1)
rats was studied##13##3##(1994-12#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-6#1)(2008-4#3)(2008-8#2)(2012-1#2)(2012-3#1)
rats was used as##2##4##(1991-8#1)(1994-6#1)
rats was used##4##3##(1991-12#2)(1991-8#1)(1994-6#1)
rats was##112##2##(1990-10#1)(1990-11#1)(1990-9#2)(1991-1#4)(1991-11#1)(1991-12#4)(1991-2#2)(1991-5#2)(1991-8#1)(1991-9#1)(1992-2#3)(1992-3#2)(1992-5#2)(1992-7#1)(1992-9#3)(1993-11#2)(1993-12#4)(1993-3#2)(1993-4#1)(1993-7#4)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-12#3)(1995-3#3)(1995-5#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-8#2)(2007-1#2)(2007-10#1)(2007-11#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#2)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#2)(2009-2#2)(2009-5#2)(2009-6#1)(2009-8#1)(2010-12#5)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)
rats we##3##2##(1995-3#1)(2007-10#1)(2008-12#1)
rats weighing between##5##3##(2007-1#1)(2008-11#1)(2008-4#1)(2009-5#2)
rats weighing##11##2##(2007-1#2)(2008-11#1)(2008-12#1)(2008-4#2)(2009-5#3)(2011-2#1)(2013-1#1)
rats were administered##11##3##(1991-12#1)(1993-7#1)(1995-3#1)(2008-10#2)(2008-9#5)(2012-2#1)
rats were allocated to##2##4##(2009-8#1)(2011-2#1)
rats were also##3##3##(1994-5#2)(2008-10#1)
rats were anaesthetized##2##3##(2007-8#1)(2008-4#1)
rats were analyzed##2##3##(1996-3#1)(2011-1#1)
rats were assigned##2##3##(2004-11#1)(2012-3#1)
rats were challenged with##2##4##(1995-12#1)(1997-8#1)
rats were challenged##3##3##(1993-12#1)(1995-12#1)(1997-8#1)
rats were compared##2##3##(1993-2#1)(1993-4#1)
rats were cultured##2##3##(1995-3#1)(1996-5#1)
rats were decapitated and##3##4##(1995-6#1)(1996-10#1)(2008-7#1)
rats were decapitated##4##3##(1995-6#1)(1996-10#1)(2008-7#1)(2009-2#1)
rats were dermally administered 0##2##5##(2008-9#2)
rats were determined##4##3##(1990-3#1)(1990-5#2)(1995-1#1)
rats were divided into 4 groups##2##6##(2007-10#1)(2013-8#1)
rats were divided into five groups##2##6##(2007-1#1)(2011-2#1)
rats were divided into four groups##4##6##(1997-2#1)(2008-7#1)(2010-4#1)(2011-1#1)
rats were divided into three groups##3##6##(2008-8#1)(2009-5#1)(2012-2#1)
rats were divided into two groups##2##6##(2008-12#1)(2008-7#1)
rats were divided into##20##4##(1995-6#1)(1997-2#2)(2007-1#1)(2007-10#1)(2008-12#1)(2008-4#2)(2008-7#2)(2008-8#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-7#1)(2013-8#1)
rats were euthanized##2##3##(1995-11#1)(2011-2#1)
rats were examined##6##3##(1991-1#1)(1991-12#1)(1992-10#1)(1992-11#1)(1994-10#1)(2008-10#1)
rats were exposed to a##2##5##(1992-6#1)(2013-7#1)
rats were exposed to##10##4##(1990-3#1)(1990-5#1)(1992-6#1)(1992-7#1)(2006-6#1)(2008-12#2)(2010-8#1)(2013-1#1)(2013-7#1)
rats were exposed##11##3##(1990-3#1)(1990-5#1)(1992-6#1)(1992-7#1)(1996-12#1)(2006-6#1)(2008-12#2)(2010-8#1)(2013-1#1)(2013-7#1)
rats were fed a diet##2##5##(1991-7#1)(2007-8#1)
rats were fed the##2##4##(1993-11#1)(2004-11#1)
rats were fed##20##3##(1991-2#3)(1991-7#1)(1993-11#1)(1993-9#1)(1994-10#1)(1994-2#2)(1996-12#1)(1997-1#1)(2004-11#1)(2007-8#1)(2007-9#2)(2008-9#1)(2012-2#1)(2013-1#2)(2013-7#1)
rats were found to be##2##5##(1991-11#1)(1996-11#1)
rats were found##3##3##(1991-11#1)(1994-5#1)(1996-11#1)
rats were given a single##2##5##(1993-7#1)(2013-1#1)
rats were given a##3##4##(1992-3#1)(1993-7#1)(2013-1#1)
rats were given drinking water containing 0##2##7##(2008-10#2)
rats were given##21##3##(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-7#2)(1994-5#3)(1995-12#1)(1995-2#1)(1996-5#1)(2008-10#3)(2008-4#1)(2008-9#1)(2010-12#1)(2013-1#1)
rats were higher than##2##4##(2010-7#1)(2013-1#1)
rats were implanted with##4##4##(1991-3#1)(1993-12#1)(1995-5#1)(1996-8#1)
rats were implanted##5##3##(1991-3#1)(1993-12#1)(1995-5#1)(1996-8#1)(2004-11#1)
rats were injected intraperitoneally with##4##5##(1992-11#1)(1996-11#1)(2008-11#1)(2008-5#1)
rats were injected with##3##4##(1991-8#1)(1997-3#1)(2011-2#1)
rats were injected##9##3##(1991-8#2)(1992-11#1)(1995-2#1)(1996-11#1)(1997-3#1)(2008-11#1)(2008-5#1)(2011-2#1)
rats were intratracheally##2##3##(2008-10#2)
rats were investigated using##2##4##(2008-4#1)(2012-1#1)
rats were investigated##8##3##(1990-11#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-5#1)(1996-2#1)(2008-4#1)(2012-1#1)
rats were killed by decapitation##2##5##(1990-2#1)(2008-8#1)
rats were killed by##3##4##(1990-2#1)(1995-12#1)(2008-8#1)
rats were killed##11##3##(1990-2#1)(1991-2#1)(1995-12#1)(2006-6#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#1)(2013-8#1)
rats were measured##2##3##(1990-3#1)(2008-3#1)
rats were more sensitive##2##4##(2008-10#1)(2013-1#1)
rats were more susceptible##2##4##(1991-10#1)(1994-6#1)
rats were more##4##3##(1991-10#1)(1994-6#1)(2008-10#1)(2013-1#1)
rats were pair-fed##2##3##(1996-10#1)(2004-11#1)
rats were perfused in##2##4##(1992-2#1)(1996-12#1)
rats were pretreated with##3##4##(1995-1#1)(1996-10#1)(1996-12#1)
rats were pretreated##4##3##(1995-1#1)(1996-10#1)(1996-12#2)
rats were randomized##2##3##(2006-6#1)(2013-1#1)
rats were randomly assigned to##3##5##(1996-9#1)(2007-8#1)(2007-9#1)
rats were randomly assigned##4##4##(1996-9#1)(2007-8#1)(2007-9#1)(2012-12#1)
rats were randomly divided into five groups##2##7##(2010-1#1)(2011-3#1)
rats were randomly divided into four groups##4##7##(2008-10#1)(2008-4#2)(2010-12#1)
rats were randomly divided into##10##5##(2007-10#1)(2008-10#1)(2008-4#2)(2010-1#1)(2010-12#1)(2010-2#1)(2011-2#1)(2011-3#1)(2012-12#1)
rats were randomly##17##3##(1994-10#1)(1996-9#1)(2007-10#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-4#2)(2010-1#1)(2010-12#1)(2010-2#1)(2011-2#1)(2011-3#1)(2012-12#2)(2013-1#1)
rats were received##2##3##(2012-2#2)
rats were sacrificed at##2##4##(1994-6#1)(1995-11#1)
rats were sacrificed##4##3##(1993-4#1)(1994-6#1)(1995-11#1)(2013-8#1)
rats were sequentially##3##3##(1993-7#1)(1994-6#1)(2008-10#1)
rats were significantly##2##3##(1997-2#1)(1997-6#1)
rats were studied for##2##4##(1995-12#1)(1996-9#1)
rats were studied##9##3##(1990-11#1)(1990-5#1)(1994-5#1)(1995-12#2)(1995-3#1)(1996-8#1)(1996-9#1)(2012-2#1)
rats were subjected to##12##4##(1993-3#1)(1995-3#1)(1997-1#1)(1997-2#1)(2007-1#1)(2007-10#1)(2008-11#1)(2008-7#1)(2010-2#1)(2013-1#2)(2013-7#1)
rats were submitted to##2##4##(1992-11#1)(2011-12#1)
rats were tested##6##3##(1992-7#1)(1993-12#2)(1993-3#1)(2008-11#1)(2011-2#1)
rats were then##3##3##(1990-10#2)(2010-2#1)
rats were trained in an##2##5##(1990-7#1)(1993-5#1)
rats were trained on##2##4##(1993-12#1)(1997-2#1)
rats were trained to discriminate##3##5##(1991-12#1)(1992-10#1)(1997-5#1)
rats were trained to##5##4##(1991-12#1)(1992-10#1)(1992-11#1)(1997-5#1)(2008-10#1)
rats were trained##11##3##(1990-7#1)(1991-12#1)(1992-10#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-5#1)(1997-2#1)(1997-5#1)(2008-10#1)
rats were treated with 0##3##5##(2007-9#1)(2008-1#1)(2010-8#1)
rats were treated with the##3##5##(1991-8#1)(1997-5#1)(2008-10#1)
rats were treated with##14##4##(1991-8#1)(1993-12#1)(1996-10#1)(1997-5#1)(1997-7#1)(2005-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-5#2)(2010-8#1)(2011-2#1)
rats were treated##20##3##(1991-8#1)(1993-12#2)(1996-1#1)(1996-10#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-7#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2010-8#1)(2011-2#1)
rats were used as##2##4##(2008-7#1)(2008-8#1)
rats were used for##4##4##(1993-3#1)(1997-2#1)(2007-10#1)(2010-4#1)
rats were used in this study##2##6##(2007-1#1)(2008-8#1)
rats were used in##5##4##(1996-4#1)(2007-1#1)(2008-8#1)(2010-8#1)(2011-1#1)
rats were used##15##3##(1993-2#1)(1993-3#1)(1996-4#1)(1997-2#1)(2007-1#1)(2007-10#1)(2008-2#1)(2008-7#1)(2008-8#3)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)
rats were##370##2##(1990-10#4)(1990-11#2)(1990-2#2)(1990-3#3)(1990-5#4)(1990-7#7)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#5)(1991-2#6)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#3)(1992-10#2)(1992-11#6)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-7#2)(1992-8#2)(1993-11#3)(1993-12#9)(1993-2#8)(1993-3#7)(1993-4#5)(1993-5#1)(1993-7#4)(1993-8#1)(1993-9#3)(1994-10#3)(1994-12#2)(1994-2#3)(1994-5#8)(1994-6#4)(1994-8#1)(1995-1#3)(1995-11#2)(1995-12#11)(1995-2#3)(1995-3#4)(1995-5#1)(1995-6#2)(1996-1#1)(1996-10#7)(1996-11#3)(1996-12#6)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#2)(1996-9#3)(1997-1#3)(1997-2#9)(1997-3#3)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#6)(2005-7#1)(2006-6#3)(2007-1#3)(2007-10#5)(2007-11#1)(2007-8#4)(2007-9#5)(2008-1#1)(2008-10#19)(2008-11#5)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#9)(2008-5#5)(2008-7#7)(2008-8#5)(2008-9#9)(2009-2#1)(2009-4#1)(2009-5#2)(2009-8#2)(2010-1#1)(2010-12#6)(2010-2#3)(2010-4#3)(2010-7#1)(2010-8#3)(2011-1#5)(2011-12#1)(2011-2#8)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#16)(2013-7#4)(2013-8#3)
rats when##5##2##(1990-2#1)(1992-5#1)(1996-4#1)(2011-1#1)(2011-12#1)
rats whereas##2##2##(1996-9#1)(2008-10#1)
rats which received##2##3##(1994-3#1)(2007-1#1)
rats which##15##2##(1990-10#1)(1991-10#1)(1993-12#2)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1996-10#1)(1996-9#1)(1997-1#1)(1997-3#1)(2007-1#1)(2008-4#1)(2011-2#1)
rats while the##2##3##(1994-2#1)(2008-6#1)
rats while##4##2##(1992-7#1)(1994-2#1)(2008-6#1)(2013-7#1)
rats whose##6##2##(1994-10#1)(1994-2#1)(1995-1#1)(1995-5#1)(2008-5#1)(2013-1#1)
rats with BDL##2##3##(2007-6#2)
rats with a##14##3##(1991-11#1)(1991-2#2)(1991-5#1)(1993-2#1)(1993-3#3)(1994-10#1)(1994-2#1)(1995-12#1)(1996-9#2)(2008-4#1)
rats with acute cerebral##2##4##(2012-3#1)(2013-8#1)
rats with acute##3##3##(1992-9#1)(2012-3#1)(2013-8#1)
rats with an##5##3##(1993-3#1)(1994-11#1)(1996-5#1)(1997-2#1)(2008-8#1)
rats with bilateral##4##3##(1991-1#1)(1991-5#1)(1993-7#1)(1997-6#1)
rats with chronic##5##3##(1994-2#1)(1995-11#1)(1996-9#1)(2007-10#1)(2008-5#1)
rats with dexamethasone##2##3##(1992-5#1)(1993-2#1)
rats with endotoxic shock##2##4##(2010-12#2)
rats with excitotoxic##2##3##(1992-10#1)(2008-10#1)
rats with experimental##8##3##(1992-3#1)(2008-4#2)(2010-12#2)(2012-1#3)
rats with hepatic encephalopathy were##2##5##(1990-4#2)
rats with higher innate##2##4##(2012-3#2)
rats with myocardial infarction##3##4##(1996-2#2)(2012-12#1)
rats with myocardial##4##3##(1996-2#2)(2010-12#1)(2012-12#1)
rats with nephrotic syndrome##2##4##(2009-6#2)
rats with severe##3##3##(1993-11#1)(2012-1#1)(2013-8#1)
rats with the##10##3##(1990-5#1)(1991-2#1)(1991-6#2)(1997-4#2)(1997-7#1)(1997-8#1)(2006-5#1)(2011-1#1)
rats with thermal hyperalgesia##2##4##(1995-11#1)(1996-5#1)
rats with unilateral##2##3##(1994-2#1)(1995-5#1)
rats with##203##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-4#3)(1990-5#2)(1990-7#1)(1990-9#1)(1991-1#5)(1991-11#1)(1991-2#3)(1991-5#3)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#3)(1992-10#2)(1992-11#1)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#8)(1993-4#1)(1993-6#2)(1993-7#4)(1994-10#3)(1994-11#3)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-11#2)(1995-12#5)(1995-3#1)(1995-5#1)(1996-10#1)(1996-2#2)(1996-3#1)(1996-5#3)(1996-9#3)(1997-1#2)(1997-2#2)(1997-4#4)(1997-6#1)(1997-7#1)(1997-8#2)(2005-12#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-6#2)(2008-10#3)(2008-11#5)(2008-4#10)(2008-5#5)(2008-8#6)(2009-4#1)(2009-6#3)(2009-8#1)(2010-12#9)(2010-5#1)(2011-1#3)(2011-3#1)(2012-1#8)(2012-12#2)(2012-2#3)(2012-3#7)(2013-1#10)(2013-7#1)(2013-8#4)
rats without##7##2##(1991-12#1)(1991-3#1)(1993-2#1)(1997-2#1)(2008-4#1)(2009-6#1)(2011-2#1)
rats would##3##2##(1993-6#1)(2006-9#1)(2008-3#1)
rats##4751##1##(1990-10#13)(1990-11#28)(1990-12#14)(1990-2#41)(1990-3#33)(1990-4#19)(1990-5#39)(1990-6#7)(1990-7#43)(1990-8#16)(1990-9#7)(1991-1#23)(1991-10#25)(1991-11#5)(1991-12#65)(1991-2#60)(1991-3#22)(1991-4#4)(1991-5#28)(1991-6#22)(1991-7#3)(1991-8#21)(1991-9#28)(1992-1#15)(1992-10#21)(1992-11#52)(1992-12#29)(1992-2#15)(1992-3#35)(1992-4#2)(1992-5#19)(1992-6#11)(1992-7#33)(1992-8#33)(1992-9#50)(1993-11#41)(1993-12#119)(1993-2#55)(1993-3#56)(1993-4#46)(1993-5#20)(1993-6#38)(1993-7#60)(1993-8#17)(1993-9#34)(1994-10#54)(1994-11#59)(1994-12#19)(1994-2#87)(1994-3#42)(1994-5#51)(1994-6#67)(1994-7#7)(1994-8#44)(1994-9#11)(1995-1#35)(1995-10#17)(1995-11#48)(1995-12#149)(1995-2#28)(1995-3#70)(1995-5#33)(1995-6#10)(1995-7#23)(1995-8#16)(1995-9#18)(1996-1#26)(1996-10#63)(1996-11#26)(1996-12#71)(1996-2#20)(1996-3#20)(1996-4#42)(1996-5#40)(1996-6#11)(1996-7#15)(1996-8#7)(1996-9#29)(1997-1#26)(1997-2#99)(1997-3#29)(1997-4#15)(1997-5#52)(1997-6#24)(1997-7#29)(1997-8#36)(2004-11#36)(2004-12#1)(2004-9#1)(2005-10#10)(2005-11#4)(2005-12#1)(2005-7#3)(2005-8#3)(2005-9#1)(2006-1#4)(2006-10#11)(2006-12#11)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#3)(2006-6#5)(2006-8#1)(2006-9#19)(2007-1#35)(2007-10#31)(2007-11#12)(2007-12#5)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#5)(2007-6#14)(2007-7#1)(2007-8#27)(2007-9#29)(2008-1#14)(2008-10#121)(2008-11#75)(2008-12#54)(2008-2#3)(2008-3#23)(2008-4#156)(2008-5#66)(2008-6#19)(2008-7#76)(2008-8#47)(2008-9#39)(2009-10#6)(2009-11#18)(2009-12#9)(2009-2#15)(2009-3#8)(2009-4#20)(2009-5#40)(2009-6#18)(2009-7#1)(2009-8#18)(2010-1#8)(2010-10#13)(2010-11#5)(2010-12#65)(2010-2#14)(2010-3#5)(2010-4#7)(2010-5#13)(2010-6#3)(2010-7#11)(2010-8#13)(2010-9#2)(2011-1#38)(2011-12#10)(2011-2#83)(2011-3#9)(2012-1#56)(2012-11#7)(2012-12#21)(2012-2#68)(2012-3#25)(2012-7#2)(2013-1#122)(2013-7#37)(2013-8#51)
rats' skin##6##2##(2011-3#6)
rats'##15##1##(1991-1#1)(1992-7#1)(1993-9#1)(1994-6#1)(1994-8#1)(2006-12#1)(2010-12#1)(2011-3#7)(2013-1#1)
rats) is associated with##2##4##(2012-3#2)
rats) was##3##2##(1992-9#3)
rats)##30##1##(1990-2#2)(1991-12#1)(1992-12#1)(1992-9#4)(1993-12#1)(1994-8#2)(1995-5#2)(1995-7#2)(1997-7#2)(2004-11#1)(2006-6#1)(2008-10#1)(2008-11#2)(2011-2#2)(2012-3#6)
rats/group)##2##1##(1993-11#1)(1997-2#1)
rats]##43##1##(1992-10#1)(2005-10#4)(2009-2#1)(2010-12#9)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#5)(2012-2#3)(2012-3#5)(2013-1#2)(2013-7#2)(2013-8#7)
rattlesnake (Crotalus##3##2##(1994-6#1)(2007-2#2)
rattlesnake Crotalus atrox##2##3##(1992-8#1)(1994-8#1)
rattlesnake##13##1##(1991-9#1)(1992-8#4)(1994-6#2)(1994-8#1)(2007-2#2)(2012-2#3)
rattlesnakes##2##1##(1994-6#1)(2012-2#1)
raubitschekii##3##1##(2009-2#3)
ravages##2##1##(1997-6#1)(2008-5#1)
raw IR##2##2##(2008-10#2)
raw and cooked hamburgers##2##4##(2010-4#2)
raw and cooked##5##3##(2010-4#5)
raw and pasteurized##2##3##(2008-12#2)
raw and##17##2##(2007-8#1)(2008-10#2)(2008-12#4)(2009-2#1)(2010-4#6)(2012-12#1)(2013-1#2)
raw beef patties##3##3##(2010-4#3)
raw beef##4##2##(2010-4#4)
raw bit-error rate (BER)##2##4##(2007-11#1)(2008-2#1)
raw bit-error rate##6##3##(2007-11#2)(2008-1#2)(2008-2#2)
raw data from##2##3##(2008-3#1)(2011-7#1)
raw data or##2##3##(1996-12#1)(2008-8#1)
raw data##24##2##(1993-12#1)(1995-7#1)(1995-9#1)(1996-12#1)(1996-7#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-8#1)(2009-3#1)(2011-7#1)(2012-12#2)(2013-1#4)
raw honey samples##2##3##(2008-5#2)
raw images##2##2##(2008-3#1)(2010-2#1)
raw material and from##2##4##(2008-10#2)
raw material and##5##3##(2008-10#5)
raw material for the##2##4##(2008-10#1)(2008-5#1)
raw material for##4##3##(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
raw material to##2##3##(2008-6#1)(2013-1#1)
raw material was##3##3##(2008-5#1)(2008-6#1)(2013-1#1)
raw material##32##2##(1997-2#1)(2008-10#10)(2008-4#1)(2008-5#8)(2008-6#3)(2009-8#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#4)
raw materials and##6##3##(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#2)
raw materials in##4##3##(2006-12#1)(2008-10#1)(2009-5#1)(2012-3#1)
raw materials used for the##2##5##(2008-10#2)
raw materials used in##2##4##(2008-10#1)(2012-3#1)
raw materials used##4##3##(2008-10#3)(2012-3#1)
raw materials with##2##3##(2008-10#1)(2008-11#1)
raw materials##45##2##(1994-3#3)(2006-12#3)(2007-11#2)(2007-8#1)(2008-10#14)(2008-11#4)(2008-5#4)(2008-6#5)(2009-11#1)(2009-5#2)(2009-7#1)(2011-2#1)(2012-3#3)(2013-8#1)
raw milk##10##2##(2008-10#5)(2010-2#4)(2011-1#1)
raw mucilaginous gel##2##3##(2012-11#2)
raw or##4##2##(2004-8#1)(2007-2#1)(2007-7#1)(2010-4#1)
raw plant drugs##2##3##(2005-4#2)
raw pork meat##4##3##(1997-4#2)(2010-4#2)
raw pork##11##2##(1997-4#3)(2010-2#6)(2010-4#2)
raw scores##3##2##(1995-1#1)(2006-10#2)
raw seeds##2##2##(2011-2#2)
raw speckle##2##2##(2008-2#1)(2010-11#1)
raw vegan##6##2##(2008-2#6)
raw wastewater##2##2##(2010-5#1)(2012-12#1)
raw water##3##2##(1992-5#1)(2006-4#1)(2008-10#1)
raw##265##1##(1990-5#1)(1992-5#3)(1993-12#1)(1994-3#5)(1994-4#2)(1995-1#1)(1995-7#1)(1995-9#1)(1996-12#1)(1996-3#3)(1996-7#1)(1996-8#2)(1997-2#1)(1997-4#4)(2004-8#1)(2005-11#5)(2005-4#2)(2005-8#1)(2006-10#4)(2006-12#3)(2006-4#1)(2006-5#1)(2007-11#4)(2007-12#3)(2007-2#4)(2007-3#2)(2007-7#2)(2007-8#6)(2008-1#2)(2008-10#51)(2008-11#4)(2008-12#5)(2008-2#13)(2008-3#4)(2008-4#2)(2008-5#16)(2008-6#8)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#12)(2010-4#16)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#11)(2011-7#1)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#2)(2012-3#6)(2013-1#13)(2013-8#3)
rawinsonde##2##1##(2007-12#2)
ray aberration##2##2##(2008-3#2)
ray amputations##2##2##(2006-3#1)(2006-4#1)
ray and##3##2##(2008-10#1)(2008-3#2)
ray at##2##2##(2008-2#1)(2008-8#1)
ray bending##2##2##(2008-3#2)
ray blight##8##2##(2008-10#8)
ray deflections##2##2##(2008-2#1)(2008-3#1)
ray density##2##2##(2008-2#2)
ray distribution##2##2##(2008-3#2)
ray in the##2##3##(2007-12#1)(2008-3#1)
ray in##3##2##(2007-12#1)(2008-3#1)(2008-5#1)
ray of light##2##3##(1990-11#1)(2008-7#1)
ray of##5##2##(1990-11#1)(2007-7#1)(2007-9#1)(2008-7#1)(2008-8#1)
ray optics and##2##3##(2008-3#2)
ray optics model is##2##4##(2008-3#2)
ray optics model##7##3##(2008-3#7)
ray optics##16##2##(2007-11#1)(2008-2#2)(2008-3#12)(2011-1#1)
ray path##2##2##(2008-3#2)
ray paths##5##2##(2008-2#3)(2008-3#2)
ray propagation##3##2##(2008-2#2)(2008-3#1)
ray rejection can be##2##4##(2008-2#2)
ray rejection##3##2##(2008-2#3)
ray to##2##2##(2007-12#1)(2008-2#1)
ray trace to##2##3##(2008-3#2)
ray trace##7##2##(2008-2#2)(2008-3#5)
ray tracing for##2##3##(2008-3#2)
ray tracing is##2##3##(2008-2#1)(2008-3#1)
ray tracing to##2##3##(2008-2#2)
ray tracing##36##2##(2007-12#2)(2008-2#24)(2008-3#10)
ray##164##1##(1990-11#1)(1993-12#1)(1997-8#2)(2006-3#4)(2006-4#1)(2007-11#2)(2007-12#6)(2007-7#1)(2007-8#3)(2007-9#3)(2008-1#3)(2008-10#11)(2008-2#57)(2008-3#51)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#2)(2009-12#1)(2010-7#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
ray)##2##1##(1995-12#1)(2007-12#1)
ray-finned fishes##2##2##(1997-4#1)(2008-1#1)
ray-finned##3##1##(1991-5#1)(1997-4#1)(2008-1#1)
ray-optics approach##2##2##(2008-3#2)
ray-optics approximation##2##2##(2008-2#1)(2008-3#1)
ray-optics model##5##2##(2007-11#1)(2008-1#1)(2008-2#2)(2008-3#1)
ray-optics##13##1##(2007-11#1)(2008-1#1)(2008-2#3)(2008-3#8)
ray-trace##2##1##(2008-2#1)(2008-3#1)
ray-tracing and##2##2##(2008-3#2)
ray-tracing approach##2##2##(2008-2#1)(2008-3#1)
ray-tracing method for##2##3##(2007-12#1)(2008-3#1)
ray-tracing method to##2##3##(2007-12#1)(2008-3#1)
ray-tracing method##9##2##(2007-12#3)(2008-2#3)(2008-3#3)
ray-tracing simulation##2##2##(2007-12#1)(2008-2#1)
ray-tracing simulations##6##2##(2007-12#1)(2008-2#2)(2008-3#3)
ray-tracing technique##2##2##(2008-3#2)
ray-tracing##44##1##(2007-12#8)(2008-2#14)(2008-3#22)
rayleigh##2##1##(2008-2#1)(2008-3#1)
rayon-based activated carbon fibers##3##4##(2005-11#3)
rayon-based##5##1##(2005-11#5)
rays and##3##2##(1994-5#1)(2008-2#1)(2008-3#1)
rays are parallel##2##3##(2007-12#1)(2008-3#1)
rays are used##2##3##(2008-2#1)(2008-3#1)
rays are##11##2##(1997-6#1)(2007-12#1)(2007-9#1)(2008-2#6)(2008-3#2)
rays at##2##2##(2007-11#1)(2013-1#1)
rays by##2##2##(2008-2#2)
rays from##4##2##(2008-2#2)(2008-3#1)(2008-5#1)
rays in the dorsal fin##2##5##(2008-5#1)(2013-7#1)
rays in the##6##3##(2007-12#1)(2008-3#2)(2008-5#1)(2013-7#2)
rays in##14##2##(1997-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-2#2)(2008-3#4)(2008-5#1)(2013-7#2)
rays of##3##2##(2008-2#1)(2008-5#1)(2013-7#1)
rays that are incident upon##2##5##(2007-12#2)
rays that are##3##3##(2007-11#1)(2007-12#2)
rays that##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
rays through##4##2##(2008-3#3)(2013-8#1)
rays to##3##2##(1995-12#1)(2008-2#1)(2013-1#1)
rays with##4##2##(2007-12#1)(2008-3#2)(2012-2#1)
rays##112##1##(1990-6#1)(1991-12#1)(1992-4#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-6#2)(2007-11#5)(2007-12#15)(2007-7#3)(2007-9#1)(2008-10#1)(2008-2#25)(2008-3#24)(2008-5#6)(2008-6#1)(2008-7#4)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#5)(2013-8#1)
rays&quot##2##1##(1997-6#2)
razor##4##1##(2008-5#2)(2009-9#1)(2012-12#1)
rb##2##1##(2006-2#1)(2008-2#1)
rbE-II##2##1##(1997-4#2)
rbFGF##4##1##(1994-12#4)
rbFGF/ACS significantly increased the incidence of complete wound closure##2##9##(2008-5#2)
rbFGF/ACS##5##1##(2008-5#5)
rbNOS##3##1##(1994-11#3)
rbcL##3##1##(1991-9#1)(2006-12#1)(2012-2#1)
rbcS genes##3##2##(1993-12#3)
rbcS##5##1##(1993-12#4)(1994-8#1)
rbcS-m3##4##1##(1994-8#4)
rbsA##2##1##(2011-1#2)
rcsB gene##3##2##(1991-7#3)
rdgB##5##1##(1997-7#5)
rdo##5##1##(2008-9#5)
rds1 is##2##2##(1995-8#2)
rds1##7##1##(1995-8#7)
re##16##1##(1991-7#2)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-1#1)(1996-2#1)(2005-11#1)(2008-1#1)(2008-10#1)(2010-7#1)(2012-1#1)(2013-8#2)
re-Ad##2##1##(1997-4#2)
re-acquisition of##2##2##(1994-8#1)(2012-1#1)
re-addition of serum##2##3##(1996-2#2)
re-addition of##3##2##(1996-2#2)(2008-8#1)
re-admission##3##1##(1997-7#1)(2007-2#1)(2012-3#1)
re-admissions##6##1##(1996-2#3)(1997-4#1)(2006-9#1)(2011-2#1)
re-admitted##3##1##(1996-2#1)(2007-8#1)(2008-2#1)
re-affirm##2##1##(1994-9#1)(2008-1#1)
re-alignment##2##1##(2007-7#1)(2013-1#1)
re-analysis of##3##2##(2006-9#1)(2008-7#1)(2008-9#1)
re-analysis##4##1##(2006-9#1)(2008-7#1)(2008-9#1)(2010-11#1)
re-analyzed##4##1##(2006-6#1)(2008-10#1)(2009-4#1)(2012-2#1)
re-arrangements##2##1##(1997-6#1)(2009-10#1)
re-assessed##2##1##(2008-10#1)(2011-1#1)
re-assignment in complex with the galectin-like domain##2##7##(2009-7#2)
re-bleeding##4##1##(2013-1#4)
re-calibration##2##1##(2008-10#2)
re-canalization##3##1##(2007-7#3)
re-create##2##1##(2008-8#1)(2011-2#1)
re-creating##2##1##(1990-11#1)(2013-7#1)
re-cycling##2##1##(1996-3#2)
re-design##2##1##(2008-10#1)(2013-7#1)
re-designed##2##1##(2007-1#2)
re-dislocation##2##1##(2009-3#2)
re-dissolved##3##1##(2008-10#2)(2008-5#1)
re-do##2##1##(2006-4#1)(2007-9#1)
re-education##2##1##(2008-12#1)(2008-5#1)
re-emergence of a##2##3##(2008-1#1)(2013-1#1)
re-emergence of##8##2##(2007-6#1)(2007-7#1)(2008-1#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
re-emergent##3##1##(2010-4#2)(2013-8#1)
re-emerging infectious##2##2##(2009-2#1)(2012-12#1)
re-emerging##10##1##(2007-2#1)(2008-1#1)(2009-2#1)(2009-8#1)(2010-12#1)(2011-1#2)(2012-12#2)(2012-2#1)
re-encoding errors##3##2##(2008-2#3)
re-engagement##6##1##(2010-2#6)
re-engineer##3##1##(1996-2#1)(2007-12#1)(2008-11#1)
re-engineered##3##1##(1996-1#1)(1996-2#1)(2006-10#1)
re-engineering of##2##2##(2008-11#1)(2008-7#1)
re-engineering##14##1##(1995-12#1)(1995-2#2)(1996-1#2)(1996-2#5)(1996-3#1)(2007-12#1)(2008-11#1)(2008-7#1)
re-entrant##2##1##(1996-4#1)(2006-9#1)
re-entry into the##2##3##(1991-9#1)(2008-11#1)
re-entry##10##1##(1991-9#1)(2007-8#2)(2008-11#3)(2008-4#1)(2010-5#1)(2012-3#1)(2013-1#1)
re-epithelialization##2##1##(2009-12#1)(2012-3#1)
re-equilibration time##2##2##(1990-9#1)(1992-2#1)
re-establish##7##1##(1996-8#1)(2006-6#1)(2007-5#1)(2008-1#1)(2008-6#1)(2012-12#1)(2013-1#1)
re-established in##3##2##(1991-9#1)(2007-8#1)(2008-6#1)
re-established##15##1##(1991-9#1)(1992-8#1)(1993-5#1)(1994-3#2)(1997-5#1)(2007-11#1)(2007-8#1)(2008-6#2)(2010-12#1)(2012-12#1)(2012-2#1)(2012-4#1)(2013-1#1)
re-establishing##5##1##(1995-12#1)(2006-11#1)(2007-7#1)(2008-6#1)(2008-8#1)
re-establishment of the##2##3##(1995-3#1)(2012-12#1)
re-establishment of##7##2##(1994-11#1)(1995-3#1)(2008-11#1)(2008-5#1)(2008-6#1)(2012-12#1)(2013-1#1)
re-establishment##9##1##(1994-11#1)(1995-3#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2012-12#2)(2013-1#1)
re-estimation is##2##2##(2008-5#1)(2012-2#1)
re-estimation of##2##2##(2008-5#1)(2008-6#1)
re-estimation##6##1##(2008-5#2)(2008-6#1)(2012-2#3)
re-evaluate##10##1##(1995-6#1)(1995-7#1)(2006-8#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-7#1)(2009-11#1)(2009-5#1)
re-evaluated at##2##2##(2006-10#2)
re-evaluated in##2##2##(2006-8#1)(2010-12#1)
re-evaluated##18##1##(1990-11#1)(1995-3#1)(2006-10#2)(2006-8#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-2#1)(2011-12#1)(2012-2#1)(2013-1#1)
re-evaluation of the##5##3##(1993-11#1)(1993-12#1)(1993-2#1)(2008-8#1)(2013-8#1)
re-evaluation of##10##2##(1993-11#1)(1993-12#1)(1993-2#1)(2006-10#1)(2006-12#1)(2006-9#1)(2008-8#1)(2013-1#2)(2013-8#1)
re-evaluation##18##1##(1990-11#1)(1993-11#1)(1993-12#1)(1993-2#1)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
re-exacerbation##3##1##(2011-2#3)
re-examination of the##4##3##(1990-12#1)(1991-2#1)(2006-9#1)(2009-3#1)
re-examination of##7##2##(1990-12#1)(1991-2#1)(2005-8#1)(2006-9#2)(2008-11#1)(2009-3#1)
re-examination##14##1##(1990-12#1)(1991-2#2)(1991-5#1)(1991-8#1)(1992-7#1)(1994-5#1)(2005-8#2)(2006-9#2)(2008-11#1)(2008-12#1)(2009-3#1)
re-examine the##3##2##(2005-11#1)(2008-11#1)(2010-12#1)
re-examine##10##1##(1992-12#1)(1994-6#1)(1996-3#1)(2005-11#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-7#1)(2010-12#1)
re-examined and##4##2##(2007-4#1)(2007-5#1)(2008-11#1)(2008-7#1)
re-examined the##3##2##(1991-9#1)(1993-7#1)(2009-12#1)
re-examined to##2##2##(1996-7#1)(2008-10#1)
re-examined##21##1##(1991-8#1)(1991-9#1)(1992-2#1)(1992-5#1)(1993-7#1)(1995-12#1)(1996-12#1)(1996-7#1)(2005-10#1)(2006-7#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-2#1)(2010-4#1)
re-examines##4##1##(1993-12#1)(2006-12#1)(2008-12#1)(2008-9#1)
re-excised##2##1##(1995-4#1)(2004-2#1)
re-excision##3##1##(1996-12#1)(2013-1#2)
re-excisions##4##1##(2004-2#4)
re-excretion##2##1##(1997-6#2)
re-expansion pulmonary##2##2##(2006-10#1)(2007-8#1)
re-exploration##4##1##(1991-3#1)(2007-8#1)(2008-7#1)(2009-8#1)
re-exposed to##2##2##(1993-4#1)(2012-2#1)
re-exposure to the##4##3##(2008-11#1)(2012-2#3)
re-exposure to##7##2##(1993-12#1)(2008-11#1)(2012-2#5)
re-exposure##14##1##(1993-12#2)(1993-5#1)(2007-5#2)(2008-11#1)(2012-2#7)(2013-1#1)
re-expressed##4##1##(1993-3#1)(1997-6#1)(2008-3#1)(2013-1#1)
re-formed##3##1##(1991-6#1)(1991-9#1)(1995-5#1)
re-growth##4##1##(2006-2#2)(2012-2#1)(2013-7#1)
re-hFKBP-12 produced##2##2##(1993-6#2)
re-hFKBP-12##3##1##(1993-6#3)
re-implantation##4##1##(2008-10#2)(2008-4#1)(2013-1#1)
re-infarction or death##2##3##(2009-6#2)
re-infarction##6##1##(1991-6#1)(2009-6#5)
re-infection##3##1##(2007-7#1)(2008-1#1)(2012-12#1)
re-infused##2##1##(2007-8#1)(2010-12#1)
re-initiates DNA replication##2##3##(1997-6#2)
re-initiation of##3##2##(1997-6#1)(2012-12#1)(2012-2#1)
re-initiation##5##1##(1997-6#2)(2012-12#2)(2012-2#1)
re-injuries##2##1##(2009-6#1)(2010-2#1)
re-injury##2##1##(2009-6#1)(2011-1#1)
re-integration##2##1##(2008-10#2)
re-intervention##3##1##(1990-12#1)(2009-6#1)(2013-8#1)
re-introduced##4##1##(1996-8#1)(2010-10#1)(2011-1#1)(2012-1#1)
re-introduction of##4##2##(2008-4#1)(2008-8#1)(2009-9#1)(2011-2#1)
re-introduction##5##1##(2008-4#1)(2008-8#1)(2009-9#1)(2010-12#1)(2011-2#1)
re-intussusception##3##1##(2010-12#3)
re-investigate##2##1##(2007-11#1)(2008-7#1)
re-investigated##3##1##(1992-3#1)(1995-4#1)(2007-12#1)
re-irradiation##3##1##(2007-11#2)(2008-6#1)
re-leptin##2##1##(1997-4#2)
re-mapping##2##1##(1994-2#2)
re-mineralization##2##1##(2011-1#1)(2011-12#1)
re-occurrence of##4##2##(2006-10#1)(2008-10#1)(2008-6#1)(2008-8#1)
re-operated##6##1##(1993-11#1)(1994-5#3)(1996-2#1)(2007-8#1)
re-operation for##2##2##(2007-4#1)(2007-8#1)
re-operation##14##1##(1991-3#1)(1993-5#1)(2007-4#1)(2007-7#1)(2007-8#6)(2009-4#1)(2010-8#1)(2011-2#2)
re-operative##4##1##(2007-8#3)(2009-5#1)
re-organize into##2##2##(2008-5#2)
re-orientation of##2##2##(2007-4#1)(2009-5#1)
re-oxidation of the##2##3##(2008-10#2)
re-oxidation of##3##2##(2008-10#3)
re-oxidation##5##1##(1994-8#1)(2008-10#3)(2008-5#1)
re-randomized##2##1##(2008-5#1)(2012-3#1)
re-resection of colorectal liver metastases in##2##6##(2006-10#2)
re-resection of##3##2##(2006-10#2)(2008-9#1)
re-resection##4##1##(2006-10#2)(2008-6#1)(2008-9#1)
re-rupture rates##2##2##(2009-5#2)
re-sequencing##3##1##(1991-7#1)(2010-4#1)(2012-1#1)
re-stenosis##3##1##(2007-5#1)(2011-2#1)(2013-1#1)
re-surgery##2##1##(1997-8#1)(2013-7#1)
re-suspended##3##1##(2008-11#2)(2008-8#1)
re-tested on##2##2##(1997-8#1)(2007-5#1)
re-tested##6##1##(1991-10#1)(1991-9#1)(1994-8#1)(1997-8#1)(2007-5#1)(2011-2#1)
re-testing##2##1##(2008-12#2)
re-thoracotomy##2##1##(2007-8#2)
re-training##5##1##(2007-5#2)(2007-6#1)(2011-1#1)(2013-1#1)
re-transplantation##6##1##(2007-8#4)(2008-1#1)(2008-10#1)
re-treated with##2##2##(2007-11#1)(2012-1#1)
re-treated##3##1##(2007-11#1)(2012-1#1)(2013-1#1)
re-treatment with##3##2##(2007-11#2)(2010-7#1)
re-treatment##16##1##(1991-3#1)(2006-6#1)(2007-11#4)(2008-6#5)(2009-8#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
re-uptake##9##1##(1994-10#2)(1995-12#3)(1996-12#2)(2012-2#1)(2012-3#1)
re-use##8##1##(1992-8#1)(1994-11#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-3#1)
re-used rockwool##2##2##(2008-10#2)
re-used##7##1##(1994-5#2)(2008-10#3)(2013-1#2)
re-virus##4##1##(1993-6#4)
re-visited##2##1##(2007-2#1)(2008-10#1)
re-watering##5##1##(2013-8#5)
reCsnSN##3##1##(1994-12#3)
reGP63##6##1##(1993-11#6)
reabsorbed by##2##2##(1990-11#1)(1995-3#1)
reabsorbed##3##1##(1990-11#1)(1995-3#1)(2007-5#1)
reabsorption and##3##2##(1996-11#1)(2012-12#2)
reabsorption in the kidney##2##4##(1995-12#1)(2012-12#1)
reabsorption in##3##2##(1992-7#1)(1995-12#1)(2012-12#1)
reabsorption loss##3##2##(2007-12#1)(2008-2#2)
reabsorption of##7##2##(1992-9#1)(1993-4#1)(2006-10#4)(2008-7#1)
reabsorption##28##1##(1990-2#1)(1990-7#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-4#1)(1995-12#1)(1996-10#1)(1996-11#1)(1997-8#1)(2006-10#5)(2007-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-9#1)(2012-12#3)(2012-2#1)(2013-8#1)
reabsorptive##2##1##(1995-12#1)(2008-11#1)
reaccumulation of##2##2##(1993-3#1)(2008-5#1)
reaccumulation##3##1##(1991-2#1)(1993-3#1)(2008-5#1)
reach 1##3##2##(1993-9#1)(2007-11#1)(2008-11#1)
reach 8##2##2##(2006-4#1)(2008-10#1)
reach a better##3##3##(2006-2#1)(2007-11#1)(2012-1#1)
reach a consensus##2##3##(1993-1#1)(2008-7#1)
reach a critical##3##3##(2006-10#1)(2008-7#1)(2008-8#1)
reach a diagnosis##2##3##(2006-10#1)(2009-11#1)
reach a maximum##8##3##(1990-7#1)(1991-7#1)(1992-11#1)(1993-7#1)(1996-5#1)(2006-7#1)(2008-5#2)
reach a peak##3##3##(1992-9#1)(1993-12#1)(2007-9#1)
reach a plateau##3##3##(1993-9#1)(2008-10#2)
reach a##62##2##(1990-7#1)(1991-7#1)(1992-11#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-10#1)(1996-5#1)(2005-10#1)(2005-7#3)(2006-10#3)(2006-2#2)(2006-6#1)(2006-7#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-6#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#1)(2009-11#1)(2009-2#1)(2011-1#1)(2012-1#2)(2012-3#1)(2013-1#3)
reach adulthood##3##2##(1996-6#1)(2006-10#1)(2011-2#1)
reach an##8##2##(1992-12#1)(1996-3#1)(2006-2#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-8#1)
reach and##9##2##(1990-12#1)(1993-7#2)(1994-9#1)(1996-1#2)(1996-3#1)(2008-4#1)(2008-8#1)
reach as high as##2##4##(2008-9#1)(2009-11#1)
reach as##6##2##(1994-1#1)(2007-12#1)(2008-2#1)(2008-9#1)(2009-11#1)(2011-1#1)
reach at##2##2##(1993-11#1)(2008-10#1)
reach conclusions##3##2##(1992-11#1)(2005-5#1)(2011-2#1)
reach considerable##2##2##(2011-2#1)(2013-1#1)
reach equilibrium##3##2##(1992-6#1)(2006-6#1)(2008-10#1)
reach greater##2##2##(2006-9#1)(2007-3#1)
reach high##4##2##(1991-1#1)(2005-11#1)(2008-10#1)(2008-5#1)
reach its full potential##3##4##(2008-10#1)(2008-11#1)(2012-2#1)
reach its##8##2##(1992-11#1)(1992-3#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-3#2)(2012-2#1)
reach large##2##2##(1994-3#1)(2006-10#1)
reach levels##2##2##(1994-2#1)(1997-6#1)
reach maximal##2##2##(1992-5#1)(1996-2#1)
reach more than##3##3##(2005-11#1)(2008-5#1)(2011-12#1)
reach of the##7##3##(2007-12#1)(2007-7#1)(2008-1#1)(2008-3#1)(2010-8#2)(2011-11#1)
reach of##18##2##(1996-1#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-8#2)(2011-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
reach out to##3##3##(1992-3#1)(2010-8#1)(2011-2#1)
reach out##4##2##(1992-3#1)(1997-2#1)(2010-8#1)(2011-2#1)
reach peak##3##2##(2004-12#1)(2005-9#1)(2008-11#1)
reach significance##5##2##(1992-11#1)(1995-12#1)(1997-5#1)(2007-2#1)(2012-3#1)
reach statistical significance##19##3##(1991-12#1)(1991-2#1)(1994-10#1)(1994-12#1)(1994-5#1)(1995-6#1)(1997-8#1)(2005-10#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-1#1)
reach statistical##20##2##(1991-12#1)(1991-2#1)(1994-10#1)(1994-12#1)(1994-5#1)(1995-6#1)(1997-8#1)(2005-10#1)(2006-8#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-1#1)
reach steady state##3##3##(2008-10#2)(2009-5#1)
reach such##3##2##(2007-10#1)(2007-12#1)(2013-8#1)
reach test##2##2##(2006-10#1)(2010-1#1)
reach the hypothalamus##2##3##(1996-9#2)
reach the level of##2##4##(1996-5#1)(2007-10#1)
reach the tumor##2##3##(2008-11#2)
reach the##85##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-2#1)(1992-5#1)(1994-10#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-3#2)(1997-6#1)(1997-7#1)(2005-11#1)(2005-8#2)(2006-1#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#2)(2007-9#1)(2008-1#3)(2008-10#12)(2008-11#3)(2008-2#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
reach their peak##2##3##(2008-10#1)(2008-5#1)
reach their target##2##3##(1995-2#1)(1996-3#1)
reach their##11##2##(1991-3#1)(1995-2#1)(1996-3#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-5#1)(2012-2#1)
reach these##3##2##(1991-3#1)(2010-8#1)(2012-2#1)
reach this goal##4##3##(1997-3#1)(2007-2#1)(2007-7#1)(2011-2#1)
reach this##10##2##(1997-3#1)(2006-2#1)(2007-2#1)(2007-7#1)(2008-10#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#1)
reach those who##2##3##(1996-1#1)(2006-8#1)
reach to##4##2##(1993-7#2)(2006-5#1)(2008-10#1)
reach up to##4##3##(2007-9#1)(2008-10#1)(2009-8#1)(2012-3#1)
reach values of##2##3##(2007-8#1)(2013-1#1)
reach##469##1##(1990-11#1)(1990-12#2)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#2)(1991-7#1)(1992-11#4)(1992-12#3)(1992-2#1)(1992-3#3)(1992-5#3)(1992-6#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-7#6)(1993-8#1)(1993-9#2)(1994-1#1)(1994-10#2)(1994-12#3)(1994-2#2)(1994-3#6)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#2)(1996-1#6)(1996-10#2)(1996-12#2)(1996-2#1)(1996-3#6)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#3)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#1)(2004-12#1)(2004-3#1)(2005-10#2)(2005-11#5)(2005-5#2)(2005-7#3)(2005-8#3)(2005-9#2)(2006-1#1)(2006-10#10)(2006-12#3)(2006-2#5)(2006-4#2)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#6)(2007-11#9)(2007-12#6)(2007-2#5)(2007-3#3)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#4)(2007-9#5)(2008-1#12)(2008-10#46)(2008-11#12)(2008-12#2)(2008-2#11)(2008-3#5)(2008-4#4)(2008-5#15)(2008-6#4)(2008-7#8)(2008-8#8)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#3)(2009-4#3)(2009-5#3)(2009-6#2)(2009-8#3)(2009-9#3)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#3)(2011-11#1)(2011-12#2)(2011-2#17)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#7)(2012-2#10)(2012-3#6)(2013-1#12)(2013-7#3)(2013-8#9)
reachability##3##1##(2006-10#1)(2006-6#1)(2008-5#1)
reachable sets##2##2##(2006-10#2)
reachable##5##1##(2006-10#3)(2008-10#1)(2008-6#1)
reached 0##5##2##(1993-1#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-8#1)
reached 1##3##2##(2007-8#1)(2012-1#2)
reached 100##3##2##(2008-1#2)(2012-12#1)
reached 100% in##2##3##(2008-10#1)(2008-5#1)
reached 100%##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
reached 150##2##2##(2004-9#1)(2008-6#1)
reached 18 years##2##3##(2007-8#1)(2011-2#1)
reached 18##4##2##(2007-8#1)(2008-10#1)(2011-2#1)(2012-12#1)
reached 2##3##2##(1997-8#1)(2008-9#1)(2011-1#1)
reached 20##2##2##(1994-5#1)(1996-2#1)
reached 31##2##2##(2008-12#1)(2008-5#1)
reached 35%##2##2##(2007-12#1)(2008-10#1)
reached 36##2##2##(1992-2#1)(2007-12#1)
reached 5##2##2##(2008-8#1)(2010-12#1)
reached 7##2##2##(2008-11#1)(2009-4#1)
reached 71##2##2##(2007-11#1)(2013-1#1)
reached 83%##2##2##(1991-4#1)(2012-3#1)
reached 97##2##2##(2008-5#1)(2013-1#1)
reached a consensus##2##3##(1994-2#1)(1997-3#1)
reached a critical##3##3##(2006-10#1)(2008-3#1)(2011-2#1)
reached a high##2##3##(2006-10#1)(2009-6#1)
reached a level of##4##4##(1991-12#1)(1991-3#1)(1991-7#1)(1997-7#1)
reached a level##5##3##(1991-12#1)(1991-3#1)(1991-7#1)(1997-7#1)(2007-1#1)
reached a maximal level##4##4##(1990-4#1)(1994-2#1)(1997-7#1)(2008-10#1)
reached a maximal##7##3##(1990-4#1)(1991-11#1)(1994-2#1)(1995-3#1)(1997-7#1)(2008-10#1)(2008-8#1)
reached a maximum 1##2##4##(2008-10#2)
reached a maximum at##5##4##(1991-5#1)(1993-11#1)(1993-8#1)(1995-6#1)(2013-1#1)
reached a maximum cell##2##4##(2008-11#2)
reached a maximum in##3##4##(1997-8#1)(2005-11#1)(2008-10#1)
reached a maximum of##2##4##(1991-1#1)(1996-6#1)
reached a maximum on##2##4##(1990-8#1)(2008-10#1)
reached a maximum##25##3##(1990-10#1)(1990-8#1)(1991-1#1)(1991-5#1)(1992-3#1)(1993-11#2)(1993-8#1)(1994-12#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-8#1)(2005-11#1)(2008-10#4)(2008-11#3)(2012-2#1)(2013-1#1)(2013-8#1)
reached a mean##3##3##(1990-6#1)(1993-12#1)(2008-7#1)
reached a peak at##2##4##(1990-3#1)(1991-2#1)
reached a peak##6##3##(1990-3#1)(1991-2#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-12#1)
reached a plateau##12##3##(1990-11#1)(1990-12#1)(1994-11#1)(1997-6#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-3#2)(2011-2#1)
reached a steady##2##3##(1990-7#1)(2008-5#1)
reached a value of##3##4##(2006-5#1)(2008-11#1)(2008-2#1)
reached a##97##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-3#1)(1993-11#2)(1993-12#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-11#3)(2006-10#3)(2006-11#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#9)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-6#1)(2010-3#2)(2010-4#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
reached about##3##2##(2005-11#1)(2008-10#1)(2008-7#1)
reached after the##2##3##(2006-8#1)(2011-1#1)
reached after##10##2##(1991-10#1)(1995-12#1)(2006-8#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-5#1)(2011-1#1)(2013-1#1)
reached an equilibrium##2##3##(1995-6#1)(2008-10#1)
reached an important milestone##2##4##(2006-10#1)(2008-2#1)
reached an important##3##3##(2006-10#1)(2008-2#1)(2008-7#1)
reached an##16##2##(1991-10#1)(1995-6#1)(1997-2#1)(2006-10#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
reached and a##2##3##(1993-2#1)(2013-1#1)
reached and the##2##3##(1993-12#1)(2008-10#1)
reached and##9##2##(1993-12#1)(1993-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-1#1)(2011-2#1)(2013-1#1)
reached approximately##2##2##(1992-9#1)(2011-2#1)
reached around##2##2##(1992-3#1)(2008-11#1)
reached as##3##2##(1994-6#1)(1995-2#1)(2013-8#1)
reached at 50##2##3##(2006-8#1)(2008-10#1)
reached at the##2##3##(1991-6#1)(2008-11#1)
reached at##17##2##(1990-12#1)(1990-5#1)(1991-3#1)(1991-6#1)(1991-9#1)(1993-11#1)(1993-4#2)(1996-11#1)(2006-8#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-4#1)
reached between##3##2##(1994-11#1)(2007-12#1)(2012-2#1)
reached by other##2##3##(2008-2#1)(2013-8#1)
reached by subjects##2##3##(2007-6#2)
reached by the##3##3##(1996-4#1)(2008-10#1)(2013-7#1)
reached by using##2##3##(2005-4#1)(2008-10#1)
reached by##25##2##(1990-6#1)(1991-8#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-6#1)(2005-4#1)(2006-10#1)(2006-5#1)(2007-6#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
reached confluence##2##2##(2008-11#2)
reached consensus on##2##3##(2007-2#1)(2010-9#1)
reached consensus##7##2##(2007-2#1)(2007-6#4)(2008-7#1)(2010-9#1)
reached during the##2##3##(2007-12#1)(2013-1#1)
reached during##4##2##(1990-8#1)(2007-12#1)(2007-6#1)(2013-1#1)
reached earlier##2##2##(2008-3#1)(2010-12#1)
reached epidemic proportions##4##3##(2007-1#1)(2008-1#1)(2008-10#1)(2010-3#1)
reached epidemic##5##2##(1991-6#1)(2007-1#1)(2008-1#1)(2008-10#1)(2010-3#1)
reached equilibrium in##2##3##(1997-1#1)(2008-10#1)
reached equilibrium##4##2##(1990-5#1)(1995-1#1)(1997-1#1)(2008-10#1)
reached for the##2##3##(2008-10#2)
reached for##7##2##(1992-9#1)(2008-10#4)(2008-3#1)(2013-1#1)
reached full coverage##2##3##(2008-10#2)
reached higher##2##2##(2008-10#1)(2013-8#1)
reached in a##2##3##(2012-12#1)(2013-1#1)
reached in the##4##3##(2007-12#1)(2009-10#2)(2011-2#1)
reached in##25##2##(2004-1#2)(2004-2#1)(2005-8#1)(2006-9#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2009-10#2)(2011-1#3)(2011-2#3)(2012-12#2)(2013-1#1)(2013-8#1)
reached is##3##2##(2008-2#1)(2008-5#1)(2008-6#1)
reached its maximum after##2##4##(2008-10#2)
reached its maximum##6##3##(1991-2#1)(1992-7#1)(2007-3#1)(2008-10#2)(2012-1#1)
reached its peak on the day##2##6##(2007-10#2)
reached its peak##4##3##(1991-5#1)(1991-7#1)(2007-10#2)
reached its##14##2##(1990-3#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-7#1)(2007-10#2)(2007-2#1)(2007-3#1)(2008-10#2)(2008-7#1)(2009-8#1)(2012-1#1)
reached maturity##2##2##(2006-10#1)(2010-3#1)
reached maximal levels at##2##4##(1992-8#1)(1994-11#1)
reached maximal levels##3##3##(1990-12#1)(1992-8#1)(1994-11#1)
reached maximal##5##2##(1990-12#1)(1992-8#1)(1994-11#1)(1994-9#1)(1997-6#1)
reached maximum levels##3##3##(1990-3#1)(1995-11#1)(1996-10#1)
reached maximum##6##2##(1990-3#1)(1993-9#1)(1995-11#1)(1996-10#1)(1996-11#1)(1996-6#1)
reached near##2##2##(1990-2#1)(2008-11#1)
reached normal##4##2##(1994-5#1)(1994-6#1)(2006-11#1)(2012-12#1)
reached on the##2##3##(1993-12#1)(1996-12#1)
reached on##3##2##(1993-12#1)(1996-12#1)(2008-5#1)
reached or##2##2##(2006-10#1)(2008-10#1)
reached out to##2##3##(2008-6#1)(2012-12#1)
reached over##2##2##(2008-10#1)(2010-3#1)
reached significance##3##2##(1993-12#1)(1993-9#1)(1997-1#1)
reached skeletal maturity##2##3##(2007-8#1)(2008-6#1)
reached statistical significance when##2##4##(1992-11#1)(1997-2#1)
reached statistical significance##4##3##(1990-6#1)(1992-11#1)(1997-2#1)(2006-12#1)
reached the clinic##2##3##(2007-11#1)(2008-5#1)
reached the highest##3##3##(2007-9#1)(2008-10#1)(2008-11#1)
reached the level of##2##4##(1997-5#1)(2012-12#1)
reached the maximal level##2##4##(1993-6#1)(2008-9#1)
reached the maximum at##2##4##(2008-4#1)(2008-9#1)
reached the maximum level at##2##5##(1990-2#1)(1993-12#1)
reached the maximum level##5##4##(1990-2#1)(1990-3#1)(1993-12#1)(1994-6#1)(2008-9#1)
reached the maximum##10##3##(1990-2#1)(1990-3#1)(1991-1#1)(1993-12#1)(1994-6#1)(1997-2#1)(2008-4#1)(2008-9#2)(2012-12#1)
reached the peak##3##3##(2006-8#1)(2008-6#1)(2010-12#1)
reached the primary##2##3##(1992-2#1)(2007-8#1)
reached the recommended levels##2##4##(2011-2#2)
reached the stage of clinical trials##2##6##(2005-7#1)(2007-11#1)
reached the target##2##3##(1995-12#1)(2007-10#1)
reached the##81##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1991-1#1)(1991-2#1)(1991-9#2)(1992-2#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-5#3)(1997-6#1)(2005-4#1)(2005-7#3)(2006-10#2)(2006-12#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-3#1)(2007-8#1)(2007-9#3)(2008-10#10)(2008-11#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#3)(2009-6#1)(2010-1#1)(2010-12#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
reached their maxima##2##3##(1991-7#1)(1994-12#1)
reached their peak##2##3##(2012-2#1)(2012-3#1)
reached their##9##2##(1991-7#1)(1992-7#1)(1994-12#1)(2007-5#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)
reached this##2##2##(1990-3#1)(2010-6#1)
reached three##2##2##(1990-12#1)(2008-11#1)
reached to 2##2##3##(1992-7#1)(2008-10#1)
reached to grasp an object using##2##6##(1993-7#2)
reached to the##2##3##(1994-11#1)(2008-6#1)
reached to##11##2##(1992-11#1)(1992-7#1)(1993-7#2)(1994-11#1)(2005-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2011-2#1)
reached two##2##2##(1992-3#1)(2010-5#1)
reached using##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
reached values of##2##3##(1994-7#1)(2008-10#1)
reached values##4##2##(1994-12#1)(1994-7#1)(2005-11#1)(2008-10#1)
reached very high##2##3##(1997-7#1)(2007-5#1)
reached very##4##2##(1997-7#1)(2007-5#1)(2013-1#2)
reached was##2##2##(2006-5#1)(2006-6#1)
reached when##4##2##(1991-4#1)(2008-5#1)(2008-8#1)(2013-8#1)
reached with##8##2##(1990-12#1)(2004-8#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-2#1)(2012-12#1)
reached##694##1##(1990-10#2)(1990-11#1)(1990-12#8)(1990-2#2)(1990-3#5)(1990-4#1)(1990-5#2)(1990-6#3)(1990-7#3)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#2)(1991-4#2)(1991-5#3)(1991-6#4)(1991-7#3)(1991-8#1)(1991-9#3)(1992-10#2)(1992-11#3)(1992-2#2)(1992-3#7)(1992-5#1)(1992-7#5)(1992-8#3)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#5)(1993-12#7)(1993-2#2)(1993-4#2)(1993-6#1)(1993-7#2)(1993-8#2)(1993-9#4)(1994-11#4)(1994-12#4)(1994-2#2)(1994-3#3)(1994-5#4)(1994-6#4)(1994-7#2)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#3)(1996-1#1)(1996-10#1)(1996-11#4)(1996-12#3)(1996-2#3)(1996-3#4)(1996-4#1)(1996-5#2)(1996-6#3)(1996-7#1)(1996-8#3)(1997-1#3)(1997-2#4)(1997-3#2)(1997-4#1)(1997-5#4)(1997-6#5)(1997-7#6)(1997-8#2)(2004-1#2)(2004-2#1)(2004-8#1)(2004-9#1)(2005-11#8)(2005-4#2)(2005-7#3)(2005-8#1)(2005-9#1)(2006-10#13)(2006-11#2)(2006-12#3)(2006-5#3)(2006-6#5)(2006-8#6)(2006-9#3)(2007-1#2)(2007-10#5)(2007-11#5)(2007-12#12)(2007-2#2)(2007-3#3)(2007-4#4)(2007-5#6)(2007-6#8)(2007-7#4)(2007-8#13)(2007-9#3)(2008-1#10)(2008-10#86)(2008-11#28)(2008-12#4)(2008-2#12)(2008-3#14)(2008-4#7)(2008-5#24)(2008-6#9)(2008-7#13)(2008-8#10)(2008-9#9)(2009-1#1)(2009-10#2)(2009-12#1)(2009-4#2)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#6)(2010-3#6)(2010-4#5)(2010-5#3)(2010-6#3)(2010-8#1)(2010-9#2)(2011-1#9)(2011-12#2)(2011-2#23)(2012-1#5)(2012-12#15)(2012-2#10)(2012-3#8)(2013-1#18)(2013-7#2)(2013-8#9)
reached)##2##1##(1990-10#1)(1997-6#1)
reaches 1##2##2##(2008-9#1)(2012-1#1)
reaches a maximum at##6##4##(1991-2#2)(2008-2#1)(2008-8#1)(2012-12#2)
reaches a maximum##14##3##(1991-2#3)(1991-5#1)(1992-7#1)(1993-9#1)(1996-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-12#2)
reaches a minimum##2##3##(2007-12#1)(2008-3#1)
reaches a peak##3##3##(1995-2#1)(2006-8#1)(2007-11#1)
reaches a plateau at##2##4##(1991-10#1)(2012-2#1)
reaches a plateau##3##3##(1991-10#1)(2008-5#1)(2012-2#1)
reaches a##33##2##(1991-10#1)(1991-2#3)(1991-5#1)(1992-7#1)(1993-9#1)(1994-6#1)(1995-2#1)(1996-11#1)(1996-3#1)(1997-2#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#4)(2008-8#1)(2012-12#2)(2012-2#1)
reaches about##2##2##(2007-2#1)(2008-5#1)
reaches an##2##2##(1993-8#1)(2008-3#1)
reaches as high as##2##4##(2011-2#2)
reaches its maximum when##2##4##(1995-8#1)(2007-11#1)
reaches its maximum##3##3##(1995-8#1)(2007-11#1)(2013-8#1)
reaches its##7##2##(1995-1#1)(1995-8#1)(1996-9#1)(2007-11#1)(2007-9#1)(2008-9#1)(2013-8#1)
reaches of the##3##3##(2007-9#1)(2012-12#1)(2013-8#1)
reaches out##2##2##(1992-3#1)(1996-12#1)
reaches the brain##2##3##(2008-5#1)(2011-1#1)
reaches the peak##2##3##(2008-9#2)
reaches the##23##2##(1990-7#1)(1992-3#1)(1994-3#1)(1997-1#1)(2005-11#1)(2005-12#1)(2005-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-9#2)(2009-5#1)(2010-10#1)(2011-1#1)(2012-12#1)
reaches##138##1##(1990-12#1)(1990-7#1)(1991-10#1)(1991-2#4)(1991-5#1)(1991-7#1)(1992-10#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#3)(1994-5#1)(1994-6#2)(1995-1#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(2005-11#1)(2005-12#1)(2005-3#1)(2006-10#2)(2006-2#2)(2006-7#1)(2006-8#1)(2007-11#5)(2007-12#5)(2007-2#1)(2007-3#2)(2007-5#2)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#7)(2008-3#10)(2008-5#11)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#1)(2009-5#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#5)(2012-1#3)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
reaching 0##2##2##(2008-5#1)(2013-1#1)
reaching 1##2##2##(1992-3#1)(1994-3#1)
reaching a maximal##3##3##(1991-5#1)(1991-8#1)(1992-7#1)
reaching a maximum after##2##4##(1990-7#1)(1997-7#1)
reaching a maximum at##5##4##(1994-9#1)(1995-2#1)(1995-6#1)(1997-2#1)(2011-2#1)
reaching a maximum in##3##4##(1994-9#1)(2008-10#1)(2013-7#1)
reaching a maximum##18##3##(1990-7#1)(1991-8#1)(1992-12#1)(1992-6#1)(1994-9#2)(1995-2#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2011-2#1)(2013-7#1)
reaching a minimum##2##3##(1992-12#1)(2008-3#1)
reaching a peak at##4##4##(1990-2#1)(1994-5#1)(2007-9#1)(2009-12#1)
reaching a peak##7##3##(1990-2#1)(1991-9#1)(1992-6#1)(1994-5#1)(2006-10#1)(2007-9#1)(2009-12#1)
reaching a plateau##3##3##(1990-7#1)(1996-7#1)(1997-5#1)
reaching a##53##2##(1990-12#1)(1990-2#1)(1990-7#3)(1990-9#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-5#1)(1992-6#2)(1992-7#1)(1994-5#1)(1994-9#2)(1995-2#1)(1995-4#1)(1995-6#1)(1996-5#1)(1996-7#2)(1997-1#1)(1997-2#2)(1997-5#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-7#1)(2013-8#1)
reaching an##8##2##(1994-5#1)(1996-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-12#1)
reaching and grasping##4##3##(1996-1#2)(1996-2#1)(2008-11#1)
reaching and##9##2##(1991-1#1)(1996-1#2)(1996-2#1)(2008-11#1)(2008-8#1)(2012-2#2)(2013-1#1)
reaching deficits##2##2##(1992-10#1)(2008-4#1)
reaching epidemic proportions##5##3##(2007-5#1)(2008-3#1)(2011-12#1)(2013-1#1)(2013-8#1)
reaching equilibrium##5##2##(1990-2#1)(1995-11#1)(2006-6#1)(2008-10#1)(2012-2#1)
reaching for food##2##3##(1992-11#1)(1994-3#1)
reaching for##3##2##(1992-11#1)(1993-9#1)(1994-3#1)
reaching its maximum##2##3##(1992-11#1)(2009-5#1)
reaching maximal##2##2##(1991-10#1)(1994-6#1)
reaching movements in##2##3##(1995-12#1)(2008-6#1)
reaching movements##8##2##(1995-12#2)(2008-11#1)(2008-6#3)(2012-1#2)
reaching normal##2##2##(1995-11#1)(2007-8#1)
reaching out to##3##3##(1992-3#1)(1993-3#1)(2005-12#1)
reaching out##5##2##(1992-3#2)(1993-3#1)(2005-12#1)(2007-10#1)
reaching peak##3##2##(1990-5#1)(2008-10#1)(2008-5#1)
reaching statistical significance for##2##4##(2007-2#1)(2012-3#1)
reaching statistical significance in##2##4##(1991-8#1)(1997-5#1)
reaching statistical significance##6##3##(1991-2#1)(1991-8#1)(1997-5#1)(2006-5#1)(2007-2#1)(2012-3#1)
reaching success##4##2##(1991-1#1)(1992-11#1)(1992-9#1)(1994-3#1)
reaching target##3##2##(1991-6#2)(1995-5#1)
reaching task##5##2##(1992-9#1)(1994-5#1)(1997-2#1)(2012-1#2)
reaching tasks##2##2##(1992-9#1)(2012-1#1)
reaching the highest##2##3##(1997-2#1)(2011-2#1)
reaching the liver##2##3##(1994-5#2)
reaching the lowest level##2##4##(2008-10#1)(2013-1#1)
reaching the same##2##3##(2008-10#1)(2008-5#1)
reaching the##47##2##(1990-4#1)(1990-5#1)(1993-5#1)(1994-5#2)(1994-6#2)(1997-2#2)(2005-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-12#3)(2009-2#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#1)(2011-12#2)(2011-2#5)(2012-2#1)(2013-1#1)
reaching their##4##2##(2008-1#1)(2008-9#1)(2010-12#1)(2012-2#1)
reaching to##3##2##(1993-7#1)(1996-4#1)(2008-5#1)
reaching up to##3##3##(2007-3#1)(2008-12#1)(2009-4#1)
reaching up##4##2##(2007-3#1)(2008-12#1)(2009-4#1)(2011-1#1)
reaching values##2##2##(1991-5#1)(2006-11#1)
reaching work area##2##3##(2010-7#2)
reaching##301##1##(1990-10#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#2)(1990-7#3)(1990-9#1)(1991-1#2)(1991-10#1)(1991-2#2)(1991-5#3)(1991-6#2)(1991-8#3)(1991-9#1)(1992-10#2)(1992-11#7)(1992-12#2)(1992-3#4)(1992-5#1)(1992-6#5)(1992-7#1)(1992-9#6)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-1#1)(1994-3#5)(1994-5#5)(1994-6#3)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#2)(1996-1#3)(1996-10#1)(1996-11#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#6)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#2)(2006-10#9)(2006-11#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#4)(2007-11#3)(2007-12#6)(2007-2#2)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#4)(2008-1#1)(2008-10#15)(2008-11#5)(2008-12#3)(2008-2#5)(2008-3#7)(2008-4#8)(2008-5#8)(2008-6#7)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#4)(2009-2#2)(2009-4#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-7#6)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#3)(2011-2#10)(2012-1#10)(2012-11#1)(2012-12#2)(2012-2#12)(2012-3#3)(2013-1#6)(2013-7#2)(2013-8#2)
reacquired the##2##2##(1990-11#1)(1994-8#1)
reacquisition of##2##2##(1993-2#1)(2007-12#1)
reacquisition##5##1##(1993-2#1)(1994-8#1)(2007-12#1)(2008-5#2)
react against##4##2##(1990-11#1)(1990-8#1)(2006-5#1)(2013-7#1)
react at##3##2##(2005-11#1)(2008-10#2)
react by##3##2##(1994-6#1)(2005-9#1)(2006-10#1)
react in##3##2##(1991-12#1)(2006-2#1)(2008-10#1)
react more strongly to##2##4##(2010-4#2)
react more##6##2##(1996-11#1)(1997-8#2)(2008-10#1)(2010-4#2)
react on##2##2##(1990-11#1)(2005-4#1)
react preferentially##2##2##(2008-10#1)(2008-8#1)
react rapidly with##2##3##(1991-9#1)(1996-2#1)
react rapidly##3##2##(1991-9#2)(1996-2#1)
react strongly with##2##3##(1991-4#1)(1994-6#1)
react to##20##2##(1990-3#2)(1991-12#1)(1993-12#1)(1993-3#1)(1995-12#2)(1995-2#1)(1995-6#1)(2006-10#2)(2006-8#1)(2007-8#1)(2008-2#1)(2008-5#1)(2009-11#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#1)
react with a##7##3##(1990-11#1)(1991-7#1)(1995-2#1)(2005-9#1)(2006-8#1)(2008-10#1)(2010-4#1)
react with both##4##3##(1993-11#1)(1996-1#1)(2012-12#2)
react with common##2##3##(2008-10#2)
react with free##2##3##(1992-9#1)(2008-10#1)
react with protein##2##3##(2008-10#1)(2011-12#1)
react with specific##2##3##(1996-5#1)(2008-10#1)
react with the antibody##2##4##(1990-4#1)(2008-8#1)
react with the##25##3##(1990-4#1)(1990-5#1)(1990-8#1)(1991-2#2)(1992-8#1)(1993-11#1)(1993-9#1)(1994-11#1)(1995-2#1)(1996-2#1)(2005-11#1)(2006-6#1)(2008-10#7)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-9#1)
react with this##2##3##(1991-8#1)(2008-5#1)
react with##148##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#2)(1991-11#1)(1991-2#4)(1991-4#1)(1991-7#1)(1991-8#3)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#4)(1993-11#2)(1993-6#4)(1993-9#1)(1994-11#1)(1994-9#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#3)(1997-4#2)(1997-7#4)(2005-11#5)(2005-9#1)(2006-10#2)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#4)(2007-5#1)(2007-9#1)(2008-10#47)(2008-11#2)(2008-3#2)(2008-4#5)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-9#1)(2010-4#3)(2011-1#1)(2011-12#1)(2012-12#2)(2012-2#1)
react##228##1##(1990-11#3)(1990-3#3)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#3)(1991-11#1)(1991-12#2)(1991-2#4)(1991-4#2)(1991-7#2)(1991-8#3)(1991-9#2)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#4)(1993-11#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#5)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-6#2)(1994-9#5)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#5)(1996-5#3)(1997-4#2)(1997-7#4)(1997-8#2)(2005-11#8)(2005-4#1)(2005-5#1)(2005-9#3)(2006-10#5)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#2)(2007-10#1)(2007-11#4)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#55)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#6)(2008-5#6)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#5)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#2)(2013-7#1)
reactant addition##3##2##(2004-9#3)
reactant and##4##2##(1996-5#1)(2006-3#1)(2008-10#1)(2008-5#1)
reactant concentration##2##2##(1996-5#1)(2005-11#1)
reactant ion chemistry##3##3##(2008-10#3)
reactant ion##6##2##(2008-10#6)
reactant ions and##2##3##(2008-10#2)
reactant ions##6##2##(2008-10#6)
reactant population##2##2##(2006-12#1)(2013-8#1)
reactant##45##1##(1993-3#1)(1993-6#1)(1996-11#1)(1996-5#2)(1997-8#1)(2004-12#1)(2004-9#3)(2005-11#4)(2006-12#2)(2006-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#14)(2008-3#1)(2008-4#1)(2008-5#3)(2013-8#5)
reactants and##6##2##(1990-7#1)(1995-2#1)(2005-10#1)(2007-5#1)(2008-10#1)(2013-8#1)
reactants are##8##2##(1990-5#1)(1990-7#1)(1996-9#1)(2008-10#2)(2008-4#3)
reactants but##2##2##(1997-1#1)(2007-11#1)
reactants in##3##2##(1995-12#1)(2008-11#1)(2010-12#1)
reactants were##2##2##(1995-6#1)(2008-10#1)
reactants##48##1##(1990-11#1)(1990-5#1)(1990-7#3)(1991-9#1)(1993-6#2)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(2005-10#1)(2005-11#1)(2007-11#3)(2007-5#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#5)(2009-11#1)(2010-12#2)(2010-5#1)(2012-3#1)(2013-8#2)
reactants)##3##1##(2006-10#1)(2008-10#2)
reacted by##2##2##(2006-5#1)(2011-1#1)
reacted exclusively##3##2##(1990-12#1)(1994-12#2)
reacted in a##2##3##(1990-7#1)(2007-11#1)
reacted in the##3##3##(1994-9#2)(1995-12#1)
reacted in vitro##2##3##(1991-7#1)(2008-7#1)
reacted in##11##2##(1990-7#1)(1991-7#1)(1994-9#2)(1995-12#1)(2007-11#3)(2008-10#1)(2008-7#1)(2010-8#1)
reacted less##2##2##(1991-7#1)(1994-6#1)
reacted more##2##2##(1994-12#1)(2004-9#1)
reacted on the##2##3##(2005-4#1)(2008-10#1)
reacted on##5##2##(1992-2#1)(1992-3#1)(1995-6#1)(2005-4#1)(2008-10#1)
reacted only weakly with##2##4##(1991-7#1)(1992-11#1)
reacted only weakly##4##3##(1991-7#2)(1992-11#1)(1994-9#1)
reacted only##6##2##(1991-7#2)(1992-11#1)(1993-6#1)(1994-9#1)(2008-10#1)
reacted positively to##3##3##(2007-2#1)(2007-5#1)(2008-10#1)
reacted positively##5##2##(1990-3#1)(2007-2#1)(2007-5#1)(2008-10#2)
reacted readily with##2##3##(2007-10#1)(2012-12#1)
reacted specifically with##3##3##(1996-8#1)(2008-10#2)
reacted specifically##4##2##(1990-12#1)(1996-8#1)(2008-10#2)
reacted stronger with##3##3##(1993-6#2)(2008-10#1)
reacted strongly with all##2##4##(1995-2#1)(2008-10#1)
reacted strongly with the##2##4##(1991-2#1)(1991-4#1)
reacted strongly with##6##3##(1991-2#1)(1991-4#2)(1992-12#1)(1995-2#1)(2008-10#1)
reacted strongly##7##2##(1991-2#2)(1991-4#2)(1992-12#1)(1995-2#1)(2008-10#1)
reacted subsequently with##2##3##(2008-10#2)
reacted to nine polypeptides##2##4##(2008-5#2)
reacted to##17##2##(1990-3#1)(1990-6#1)(1991-8#1)(1992-1#1)(1993-4#2)(1994-6#1)(1996-3#1)(2005-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#4)
reacted very##3##2##(1994-3#1)(2005-10#1)(2008-10#1)
reacted with a##18##3##(1991-4#1)(1991-7#2)(1991-8#1)(1992-3#1)(1993-3#1)(1993-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1996-5#1)(2008-10#5)(2008-2#1)(2008-5#1)
reacted with an antibody##2##4##(1992-4#1)(1992-7#1)
reacted with an enzyme##2##4##(1993-6#2)
reacted with an##4##3##(1992-4#1)(1992-7#1)(1993-6#2)
reacted with anti-A beta##3##4##(1995-12#3)
reacted with antibodies##3##3##(1993-6#1)(1996-5#1)(2008-5#1)
reacted with both##5##3##(1991-9#1)(1994-3#1)(1996-1#1)(1996-12#1)(1997-8#1)
reacted with hydrazine##2##3##(2008-10#1)(2008-11#1)
reacted with iodide##2##3##(2008-10#2)
reacted with the##27##3##(1990-2#1)(1990-7#2)(1991-2#1)(1991-7#1)(1991-9#2)(1992-8#1)(1993-11#2)(1993-3#1)(1993-9#1)(1994-3#1)(1995-3#1)(1996-7#1)(2008-10#8)(2008-11#2)(2008-5#2)
reacted with this##3##3##(1990-3#1)(1991-7#1)(2007-8#1)
reacted with three##2##3##(1990-12#1)(2008-5#1)
reacted with two##3##3##(1990-4#1)(1990-7#1)(1994-11#1)
reacted with undifferentiated and intermediate neuroblasts##2##6##(1991-9#2)
reacted with undifferentiated and##3##4##(1991-9#2)(1994-6#1)
reacted with various##2##3##(1990-2#1)(2008-10#1)
reacted with##184##2##(1990-11#1)(1990-12#3)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#3)(1990-9#1)(1991-1#3)(1991-2#3)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#4)(1991-8#1)(1991-9#6)(1992-1#1)(1992-11#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#3)(1993-3#2)(1993-5#2)(1993-6#3)(1993-9#2)(1994-11#2)(1994-3#3)(1994-6#5)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#3)(1995-3#1)(1995-6#2)(1996-1#2)(1996-12#3)(1996-2#1)(1996-5#5)(1996-7#1)(1997-2#3)(1997-4#2)(1997-8#1)(2004-9#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#13)(2007-8#2)(2008-10#39)(2008-11#7)(2008-12#1)(2008-2#1)(2008-5#9)(2011-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
reacted##291##1##(1990-11#1)(1990-12#6)(1990-2#3)(1990-3#4)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#4)(1990-9#1)(1991-1#3)(1991-2#6)(1991-4#3)(1991-5#2)(1991-6#1)(1991-7#8)(1991-8#2)(1991-9#6)(1992-1#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#2)(1992-9#3)(1993-11#3)(1993-12#1)(1993-3#2)(1993-4#2)(1993-5#4)(1993-6#6)(1993-9#2)(1994-11#2)(1994-12#3)(1994-3#7)(1994-6#7)(1994-8#2)(1994-9#5)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#5)(1995-2#1)(1995-3#1)(1995-6#4)(1995-8#1)(1996-1#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#5)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#2)(1997-8#1)(2004-9#3)(2005-10#1)(2005-12#1)(2005-4#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#16)(2007-2#1)(2007-5#2)(2007-8#3)(2008-10#61)(2008-11#10)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#13)(2008-7#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-12#2)(2012-3#2)(2013-1#1)
reacting at##2##2##(1994-12#1)(1995-1#1)
reacting by##2##2##(1994-12#2)
reacting for##2##2##(1992-3#1)(2012-3#1)
reacting material##2##2##(1997-8#1)(2008-10#1)
reacting on##2##2##(2005-4#2)
reacting the##4##2##(1992-9#1)(1995-3#1)(2008-7#1)(2010-3#1)
reacting to the##2##3##(2008-11#1)(2008-3#1)
reacting to##5##2##(1991-1#1)(1993-12#1)(2008-11#1)(2008-3#1)(2008-8#1)
reacting with a##2##3##(2007-11#1)(2008-10#1)
reacting with anti-MYC antisera##2##4##(1991-10#2)
reacting with the##2##3##(1991-3#1)(2008-10#1)
reacting with##31##2##(1990-12#3)(1990-2#1)(1990-3#1)(1990-8#1)(1991-10#3)(1991-2#1)(1991-3#1)(1992-1#1)(1992-8#1)(1993-5#1)(1994-3#1)(1994-8#1)(1995-11#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-10#5)(2008-5#2)(2008-8#1)(2011-2#1)
reacting##87##1##(1990-12#3)(1990-2#1)(1990-3#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#3)(1991-2#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-3#2)(1992-8#1)(1992-9#2)(1993-12#1)(1993-5#1)(1993-9#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#2)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2005-11#2)(2005-4#2)(2006-10#2)(2006-7#1)(2007-10#2)(2007-11#3)(2008-10#13)(2008-11#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#4)(2010-12#2)(2010-3#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
reaction (2)##2##2##(2008-10#2)
reaction (AR)##2##2##(1992-8#1)(2008-8#1)
reaction -##2##2##(1991-10#1)(2008-11#1)
reaction 2 and##2##3##(1992-6#2)
reaction 2##3##2##(1992-6#3)
reaction a##2##2##(1991-6#1)(2008-10#1)
reaction after##7##2##(1994-9#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-10#2)(2012-1#1)
reaction against the##2##3##(1990-8#1)(1991-11#1)
reaction against##3##2##(1990-8#1)(1991-11#1)(1991-12#1)
reaction alone##2##2##(2008-10#2)
reaction also##4##2##(1993-8#1)(2006-10#1)(2008-11#1)(2008-5#1)
reaction among##3##2##(2006-9#1)(2008-10#2)
reaction and a##9##3##(1993-5#1)(1993-8#1)(1997-2#1)(1997-4#1)(2005-8#1)(2008-10#2)(2008-5#2)
reaction and an##4##3##(1993-10#1)(1996-11#1)(2007-12#1)(2008-7#1)
reaction and chemiluminescence detection##2##4##(2008-10#2)
reaction and chemiluminescence##3##3##(2008-10#3)
reaction and fluorescence##3##3##(2007-12#2)(2008-10#1)
reaction and further##2##3##(2007-11#1)(2008-10#1)
reaction and its##3##3##(1993-3#1)(2006-10#1)(2007-2#1)
reaction and no##2##3##(1993-8#1)(2008-10#1)
reaction and possibly##2##3##(2008-5#1)(2008-8#1)
reaction and that the##2##4##(1991-7#1)(1995-2#1)
reaction and that##3##3##(1991-7#1)(1995-2#1)(2009-2#1)
reaction and the##20##3##(1990-12#1)(1990-2#1)(1992-3#2)(1992-8#1)(1993-11#2)(1995-11#1)(1995-2#1)(2005-4#1)(2006-9#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-8#1)(2011-2#1)(2013-1#1)
reaction and to##4##3##(1995-3#1)(2008-11#1)(2009-3#1)(2012-11#1)
reaction and used##2##3##(1996-10#1)(2008-10#1)
reaction and##184##2##(1990-12#3)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#2)(1991-1#2)(1991-11#1)(1991-12#1)(1991-5#3)(1991-7#2)(1991-9#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#2)(1993-10#1)(1993-11#3)(1993-3#1)(1993-5#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-11#2)(1996-2#2)(1996-5#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#2)(2004-11#1)(2004-9#1)(2005-12#2)(2005-4#2)(2005-8#2)(2006-10#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-2#2)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#45)(2008-11#3)(2008-12#2)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#3)(2008-8#6)(2009-2#1)(2009-3#2)(2009-5#1)(2009-9#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-11#1)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#1)(2013-1#5)(2013-7#1)(2013-8#1)
reaction apparatus to study synchrotron-radiation-stimulated processes##2##6##(2006-5#2)
reaction appears##2##2##(1991-4#1)(1991-7#1)
reaction are##15##2##(1990-1#1)(1990-11#1)(1991-7#1)(1992-1#1)(1992-6#1)(1992-8#1)(1993-4#1)(2004-9#1)(2006-10#1)(2008-10#3)(2008-7#1)(2009-10#1)(2010-6#1)
reaction around##2##2##(1991-11#1)(1996-12#1)
reaction as a##3##3##(1992-6#1)(2007-7#1)(2010-6#1)
reaction as well as##3##4##(1994-8#1)(2009-2#1)(2009-4#1)
reaction as##11##2##(1992-6#1)(1994-8#1)(2004-9#1)(2007-7#2)(2008-10#3)(2009-2#1)(2009-4#1)(2010-6#1)
reaction assay##18##2##(1992-12#2)(1994-8#1)(1995-11#1)(1996-12#1)(1997-3#1)(2004-11#2)(2007-2#1)(2007-6#1)(2008-10#5)(2011-2#1)(2012-2#1)(2012-3#1)
reaction at a##2##3##(1997-3#1)(2010-5#1)
reaction at low pH##2##4##(1993-8#1)(2010-4#1)
reaction at pH 5##2##4##(1990-2#2)
reaction at pH 7##2##4##(1990-2#1)(1994-8#1)
reaction at pH##5##3##(1990-2#3)(1994-8#1)(2008-10#1)
reaction at the##8##3##(1990-6#1)(1992-11#1)(1994-6#1)(1996-5#1)(2006-11#2)(2008-10#2)
reaction at##33##2##(1990-2#3)(1990-6#1)(1990-8#1)(1992-11#1)(1993-8#3)(1994-6#1)(1994-8#1)(1996-5#1)(1997-3#1)(2004-9#1)(2005-11#2)(2006-11#2)(2006-12#1)(2006-5#1)(2008-10#8)(2010-4#2)(2010-5#1)(2010-7#1)(2012-3#1)
reaction barrier##2##2##(2008-11#1)(2013-8#1)
reaction became##2##2##(2007-10#1)(2008-4#1)
reaction because##2##2##(1992-12#1)(2008-10#1)
reaction before##2##2##(2008-8#1)(2013-1#1)
reaction being##2##2##(1990-3#1)(2008-10#1)
reaction between 1##3##3##(2008-10#1)(2010-12#1)(2010-7#1)
reaction between a##3##3##(2008-10#2)(2009-9#1)
reaction between an##2##3##(2005-11#1)(2008-6#1)
reaction between ascorbic acid and##2##5##(2008-10#2)
reaction between diaminomaleonitrile##2##3##(2007-11#2)
reaction between hydrogen peroxide and##2##5##(2008-10#2)
reaction between hydrogen peroxide##3##4##(2008-10#3)
reaction between iron(III)##2##3##(2008-10#2)
reaction between luminol and periodate##2##5##(2008-10#2)
reaction between luminol and##5##4##(2008-10#5)
reaction between luminol##6##3##(2008-10#6)
reaction between nitrite##2##3##(2008-10#2)
reaction between tetrabutylammonium periodate and phenothiazine in##2##7##(2008-10#2)
reaction between the##19##3##(1995-3#1)(1997-4#1)(1997-7#1)(2007-11#2)(2007-9#1)(2008-10#11)(2008-5#2)
reaction between##142##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-12#1)(1992-6#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-5#2)(1996-5#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-9#1)(2005-11#2)(2006-12#2)(2006-4#2)(2006-8#1)(2007-11#6)(2007-3#1)(2007-9#1)(2008-10#87)(2008-12#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-9#2)(2010-12#1)(2010-4#3)(2010-7#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-7#1)
reaction buffer##3##2##(2006-10#1)(2008-10#1)(2008-4#1)
reaction but##3##2##(1990-10#1)(1993-6#1)(1996-5#1)
reaction by##25##2##(1991-12#1)(1991-2#3)(1991-5#1)(1992-1#1)(1992-6#1)(1993-3#1)(1993-6#1)(1995-1#1)(1995-11#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-3#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-9#1)
reaction by-products##2##2##(2007-8#1)(2008-10#1)
reaction can be##14##3##(1990-11#1)(1991-1#1)(1991-9#1)(1992-5#1)(1992-6#1)(1995-8#1)(1996-5#1)(1997-1#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-9#1)
reaction can complete##2##3##(2008-10#2)
reaction can##20##2##(1990-11#1)(1991-1#1)(1991-9#1)(1992-5#1)(1992-6#1)(1994-9#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-7#1)(2007-4#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-9#1)(2011-2#1)
reaction carried out in##2##4##(1991-9#1)(2008-10#1)
reaction catalyzed by T4##2##4##(1993-11#1)(1994-8#1)
reaction catalyzed by the##2##4##(1995-2#1)(1997-4#1)
reaction catalyzed by##18##3##(1991-12#1)(1991-4#1)(1992-12#1)(1992-3#2)(1992-5#1)(1993-11#1)(1994-8#2)(1995-1#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-4#1)(2008-10#2)
reaction catalyzed##20##2##(1991-12#1)(1991-4#1)(1992-12#1)(1992-3#2)(1992-5#1)(1993-11#1)(1994-8#3)(1995-1#2)(1995-10#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-4#1)(2008-10#2)
reaction caused by##2##3##(1993-2#1)(2012-2#1)
reaction cell and##3##3##(2008-10#3)
reaction cell##12##2##(2007-8#4)(2008-10#8)
reaction center (RC)##3##3##(1993-11#1)(2008-8#1)(2010-2#1)
reaction center associated##2##3##(1993-8#2)
reaction center complex##3##3##(1991-7#1)(1994-12#1)(1997-7#1)
reaction center core complex##2##4##(1994-10#2)
reaction center core##3##3##(1994-10#2)(1994-12#1)
reaction center of##3##3##(1993-8#1)(1997-4#1)(1997-7#1)
reaction center##33##2##(1991-3#2)(1991-7#1)(1991-8#2)(1992-3#2)(1992-6#2)(1993-11#1)(1993-8#3)(1994-10#2)(1994-12#3)(1994-8#3)(1995-8#3)(1997-4#1)(1997-6#1)(1997-7#2)(2006-10#1)(2008-8#3)(2010-2#1)
reaction centers and##4##3##(1991-6#1)(2010-2#2)(2010-4#1)
reaction centers from Rhodobacter sphaeroides RS601##2##6##(2008-9#2)
reaction centers from##5##3##(1991-3#1)(1991-7#1)(1997-4#1)(2008-9#2)
reaction centers of##2##3##(1991-7#1)(1993-11#1)
reaction centers was##3##3##(1994-8#1)(2008-8#1)(2008-9#1)
reaction centers##30##2##(1991-3#2)(1991-4#1)(1991-6#2)(1991-7#5)(1992-6#1)(1993-11#3)(1994-8#1)(1997-4#2)(2008-10#1)(2008-8#2)(2008-9#6)(2010-2#2)(2010-4#1)(2013-1#1)
reaction chamber##2##2##(2008-10#1)(2008-6#1)
reaction characterized by a##2##4##(1995-10#1)(1996-12#1)
reaction characterized by an##2##4##(2008-10#1)(2010-6#1)
reaction characterized by##4##3##(1995-10#1)(1996-12#1)(2008-10#1)(2010-6#1)
reaction chemistry##2##2##(1990-7#1)(2012-2#1)
reaction coil and##3##3##(1990-6#1)(2008-10#2)
reaction coil length##3##3##(2008-10#3)
reaction coil to##3##3##(2008-10#3)
reaction coil was##3##3##(2008-10#3)
reaction coil##22##2##(1990-6#1)(1990-8#1)(2008-10#20)
reaction coils and##2##3##(2007-8#1)(2008-10#1)
reaction coils##3##2##(2007-8#1)(2008-10#2)
reaction compared with##2##3##(1997-7#1)(2004-9#1)
reaction components##3##2##(2008-10#2)(2008-4#1)
reaction condition)##2##2##(2008-6#2)
reaction conditions and the##3##4##(1997-2#1)(2008-10#2)
reaction conditions and##7##3##(1997-2#1)(2008-10#5)(2009-10#1)
reaction conditions are##3##3##(2007-11#1)(2008-10#2)
reaction conditions for the##2##4##(2010-5#1)(2011-1#1)
reaction conditions for##6##3##(1995-10#1)(2008-10#1)(2010-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
reaction conditions of##3##3##(1991-5#1)(2008-4#1)(2012-3#1)
reaction conditions the##3##3##(1997-4#1)(2008-10#1)(2008-9#1)
reaction conditions to##3##3##(2005-7#1)(2007-11#1)(2008-10#1)
reaction conditions was required##2##4##(1993-4#1)(1996-2#1)
reaction conditions were##12##3##(2008-10#6)(2008-3#1)(2008-5#1)(2009-12#1)(2009-7#1)(2012-3#1)(2013-8#1)
reaction conditions with##2##3##(1996-5#1)(2008-10#1)
reaction conditions##79##2##(1990-7#1)(1991-5#1)(1992-12#1)(1993-4#1)(1995-10#1)(1996-11#1)(1996-2#2)(1996-5#2)(1997-2#1)(1997-4#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-4#1)(2007-11#6)(2008-10#28)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-3#3)(2013-1#2)(2013-8#2)
reaction consists##2##2##(1996-5#1)(1997-4#1)
reaction constants##2##2##(1994-5#2)
reaction controlled##2##2##(2006-10#1)(2007-8#1)
reaction coordinate##3##2##(1991-8#1)(2009-8#1)(2012-2#1)
reaction could##4##2##(1990-12#1)(1990-7#1)(1994-8#1)(2008-10#1)
reaction coupled to##2##3##(1995-3#1)(2006-10#1)
reaction cycle##4##2##(1995-5#1)(1995-6#1)(1997-4#1)(2009-9#1)
reaction deadtimes##2##2##(2011-12#2)
reaction depends##2##2##(1995-1#1)(2008-10#1)
reaction developed##2##2##(2008-10#1)(2008-7#1)
reaction development##2##2##(2007-10#1)(2007-8#1)
reaction directly from##2##3##(1990-7#1)(2008-9#1)
reaction discovery##2##2##(2010-6#2)
reaction does not##2##3##(1992-8#1)(1996-2#1)
reaction does##3##2##(1992-8#1)(1996-2#1)(2008-10#1)
reaction due to##2##3##(2007-5#1)(2010-12#1)
reaction during##2##2##(1995-12#1)(2006-4#1)
reaction dynamics##3##2##(2006-4#1)(2007-11#1)(2011-1#1)
reaction employing##3##2##(2008-2#1)(2008-5#1)(2010-5#1)
reaction enthalpies##2##2##(1992-2#1)(2010-7#1)
reaction equilibrium##2##2##(2008-10#1)(2008-9#1)
reaction events##5##2##(1995-6#3)(2006-10#2)
reaction field##9##2##(1995-10#1)(2007-11#2)(2008-10#2)(2010-12#2)(2013-1#2)
reaction followed by##7##3##(1990-12#1)(1992-2#1)(1993-3#1)(1994-2#1)(1994-8#1)(1997-5#1)(2008-4#1)
reaction followed##8##2##(1990-12#1)(1992-2#1)(1993-3#1)(1994-2#1)(1994-8#1)(1997-5#1)(2008-10#1)(2008-4#1)
reaction following the##2##3##(1993-3#1)(2008-5#1)
reaction following##5##2##(1992-12#1)(1993-3#1)(2008-5#2)(2010-12#1)
reaction follows##3##2##(1991-12#1)(1995-1#2)
reaction for direct##2##3##(2008-10#1)(2013-1#1)
reaction for the determination of##2##5##(2008-10#2)
reaction for the##16##3##(1991-10#1)(1996-11#1)(2005-4#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-4#2)(2010-12#1)(2010-4#1)(2012-3#1)(2013-8#1)
reaction for##42##2##(1990-11#1)(1991-10#1)(1991-3#1)(1994-5#1)(1996-11#1)(1996-3#1)(2005-4#1)(2006-10#1)(2006-8#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-4#3)(2010-12#4)(2010-4#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
reaction force was##2##3##(2007-7#2)
reaction force##9##2##(1993-9#1)(2007-7#6)(2008-6#1)(2012-1#1)
reaction forces and##2##3##(2007-1#1)(2007-7#1)
reaction forces##8##2##(2007-1#1)(2007-7#2)(2010-3#1)(2010-9#1)(2012-1#2)(2013-1#1)
reaction from a##2##3##(1994-12#1)(1994-8#1)
reaction from the##4##3##(1995-12#1)(2007-11#1)(2008-4#1)(2012-1#1)
reaction from two##2##3##(1994-11#1)(2012-3#1)
reaction from##20##2##(1991-7#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1996-5#1)(2007-11#1)(2008-10#5)(2008-4#2)(2008-8#1)(2012-1#1)(2012-3#1)(2013-1#1)
reaction gave##3##2##(1994-6#1)(2006-12#1)(2010-5#1)
reaction has been proposed##2##4##(2008-10#1)(2008-8#1)
reaction has been##11##3##(1990-10#1)(1991-12#1)(1992-7#1)(1995-11#1)(1995-6#1)(1996-5#1)(2008-10#4)(2008-8#1)
reaction has##19##2##(1990-10#2)(1991-12#1)(1992-7#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-5#1)(2006-10#1)(2008-1#1)(2008-10#6)(2008-4#1)(2008-8#1)(2010-5#1)
reaction have been##3##3##(1991-12#1)(2008-10#2)
reaction have##4##2##(1991-11#1)(1991-12#1)(2008-10#2)
reaction in a##7##3##(1995-12#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#2)
reaction in all##2##3##(1990-8#1)(2008-8#1)
reaction in both cases##2##4##(1992-10#1)(2008-10#1)
reaction in both##3##3##(1992-10#1)(1994-3#1)(2008-10#1)
reaction in living cells##3##4##(2010-12#1)(2013-1#2)
reaction in patients with##3##4##(1991-12#1)(2006-10#1)(2008-7#1)
reaction in patients##4##3##(1991-12#1)(2006-10#1)(2008-7#1)(2011-1#1)
reaction in the presence of##2##5##(1994-3#1)(2008-10#1)
reaction in the##28##3##(1990-2#1)(1991-10#1)(1991-11#1)(1992-4#2)(1992-6#1)(1992-8#1)(1993-12#1)(1994-3#1)(1995-3#1)(2005-4#1)(2006-10#2)(2008-10#7)(2008-5#1)(2008-6#2)(2008-7#1)(2009-6#1)(2010-8#1)(2012-12#1)(2012-2#1)
reaction in vivo##5##3##(1993-5#1)(1994-6#1)(1995-1#1)(1996-9#1)(2006-10#1)
reaction in which##3##3##(1990-12#1)(1995-3#1)(2008-10#1)
reaction in##111##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1992-10#1)(1992-3#1)(1992-4#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-7#1)(1995-1#1)(1995-12#2)(1995-3#2)(1995-9#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-9#1)(1997-6#1)(1997-7#2)(2005-11#1)(2005-4#1)(2006-10#5)(2007-10#1)(2007-11#1)(2007-12#4)(2007-7#1)(2008-10#22)(2008-11#2)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#3)(2008-8#5)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#7)
reaction including##2##2##(1992-6#1)(1995-11#1)
reaction indicates that the##2##4##(1990-7#1)(1994-5#1)
reaction induced by##4##3##(1991-4#1)(2008-3#1)(2008-8#2)
reaction induces##2##2##(2008-4#1)(2008-5#1)
reaction interface##5##2##(2008-10#5)
reaction intermediate##5##2##(1990-5#1)(1990-7#1)(1994-9#1)(1995-1#1)(1997-6#1)
reaction intermediates##6##2##(1991-9#1)(2006-10#2)(2006-5#1)(2009-9#1)(2011-12#1)
reaction into##2##2##(1995-8#1)(2008-4#1)
reaction involved##4##2##(1995-3#1)(1995-5#1)(2006-12#1)(2008-10#1)
reaction involving##9##2##(2005-11#1)(2008-10#2)(2008-5#2)(2009-11#1)(2010-3#1)(2011-1#1)(2013-8#1)
reaction ion monitoring-mass spectrometry##2##4##(1996-3#2)
reaction is a##8##3##(1991-6#1)(1996-2#1)(1996-5#1)(2006-10#1)(2008-10#3)(2008-8#1)
reaction is also##3##3##(2008-10#2)(2008-5#1)
reaction is associated with##2##4##(1995-5#1)(2007-11#1)
reaction is carried out##3##4##(1990-2#1)(1991-7#1)(2008-10#1)
reaction is catalyzed by##2##4##(1994-8#1)(2008-4#1)
reaction is coupled with##2##4##(1995-3#1)(2008-10#1)
reaction is coupled##3##3##(1992-6#1)(1995-3#1)(2008-10#1)
reaction is decreased##2##3##(1991-7#1)(1992-1#1)
reaction is discussed##2##3##(2008-10#1)(2010-4#1)
reaction is inhibited by##2##4##(2010-5#1)(2013-8#1)
reaction is involved in##2##4##(1990-4#1)(2008-10#1)
reaction is monitored spectrophotometrically by measuring the decrease in##2##9##(2008-10#2)
reaction is monitored spectrophotometrically##3##4##(2008-10#3)
reaction is monitored##4##3##(2008-10#4)
reaction is not##4##3##(1990-6#1)(1991-8#1)(2008-10#1)(2011-1#1)
reaction is performed in##2##4##(2008-10#1)(2008-4#1)
reaction is proposed##7##3##(1991-7#1)(1995-2#1)(2007-10#1)(2007-8#1)(2008-10#3)
reaction is selective for the##2##5##(1992-3#1)(2008-4#1)
reaction is selective for##3##4##(1992-3#1)(2008-10#1)(2008-4#1)
reaction is the##4##3##(1990-2#1)(1991-6#1)(2007-10#1)(2008-10#1)
reaction is to##2##3##(1990-8#1)(1991-7#1)
reaction is used to##2##4##(2008-10#1)(2011-2#1)
reaction is used##3##3##(2007-8#1)(2008-10#1)(2011-2#1)
reaction is##134##2##(1990-11#1)(1990-2#2)(1990-4#1)(1990-6#2)(1990-7#4)(1990-8#2)(1991-6#2)(1991-7#4)(1991-8#1)(1991-9#1)(1992-1#2)(1992-3#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#3)(1994-9#3)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-2#3)(1996-5#4)(1996-6#1)(1996-9#1)(1997-2#1)(1997-7#1)(2004-9#1)(2005-12#1)(2006-10#3)(2007-10#2)(2007-11#2)(2007-8#2)(2008-10#40)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-4#2)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
reaction kinetics was##2##3##(2005-4#1)(2008-10#1)
reaction kinetics##13##2##(1990-5#1)(1994-2#1)(1995-3#1)(2005-4#1)(2008-10#4)(2008-5#2)(2009-12#1)(2010-4#1)(2013-1#1)
reaction leading to##4##3##(1995-5#1)(2007-11#1)(2008-3#1)(2009-3#1)
reaction leads to the##2##4##(2007-11#1)(2010-5#1)
reaction loads were##3##3##(2007-1#3)
reaction loads##4##2##(2007-1#3)(2007-4#1)
reaction markers in##2##3##(2011-2#1)(2012-1#1)
reaction markers##4##2##(2008-10#1)(2011-2#2)(2012-1#1)
reaction may be##2##3##(1992-3#1)(2013-1#1)
reaction may##9##2##(1990-3#1)(1990-5#1)(1991-12#1)(1992-3#1)(1994-3#1)(2007-10#1)(2013-1#3)
reaction mechanism for the##2##4##(1991-12#1)(2008-10#1)
reaction mechanism for##4##3##(1991-12#1)(1995-1#1)(2008-10#2)
reaction mechanism in##2##3##(2008-10#1)(2009-11#1)
reaction mechanism is discussed##2##4##(2008-10#1)(2010-5#1)
reaction mechanism is##5##3##(2007-12#1)(2008-10#2)(2008-12#1)(2010-5#1)
reaction mechanism of the##3##4##(1990-5#1)(1995-3#1)(2008-10#1)
reaction mechanism of##8##3##(1990-5#1)(1991-1#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(2008-10#1)
reaction mechanism was discussed##2##4##(2005-11#1)(2008-10#1)
reaction mechanism was##5##3##(1990-3#1)(2005-11#1)(2008-10#3)
reaction mechanism##39##2##(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1991-1#2)(1991-12#2)(1994-2#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#14)(2008-11#1)(2008-12#2)(2009-11#1)(2010-5#1)(2010-7#1)
reaction mechanisms and##2##3##(2007-12#1)(2011-1#1)
reaction mechanisms for##2##3##(1994-8#1)(2007-11#1)
reaction mechanisms of##2##3##(2006-5#1)(2008-10#1)
reaction mechanisms##17##2##(1990-11#1)(1992-8#1)(1994-6#1)(1994-8#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#4)(2008-10#4)(2008-7#1)(2011-1#1)
reaction media##5##2##(2008-10#3)(2008-6#1)(2013-1#1)
reaction mediated by##2##3##(1995-4#1)(2008-11#1)
reaction medium##23##2##(1991-7#1)(1995-1#1)(1996-5#1)(2007-6#1)(2008-10#14)(2008-7#3)(2010-5#1)(2013-1#1)
reaction method##7##2##(1996-12#1)(1997-6#2)(1997-8#1)(2005-4#1)(2008-10#2)
reaction mix##2##2##(1992-2#1)(2008-4#1)
reaction mixture containing##6##3##(1990-4#1)(1993-3#1)(1994-5#1)(1997-4#1)(2008-5#1)(2013-1#1)
reaction mixture is##2##3##(1991-5#1)(2008-10#1)
reaction mixture was##5##3##(1993-2#1)(1994-2#1)(2007-11#1)(2008-10#1)(2010-4#1)
reaction mixture with##2##3##(1992-9#1)(1997-4#1)
reaction mixture##48##2##(1990-4#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#3)(1992-1#1)(1992-11#1)(1992-9#1)(1993-2#2)(1993-3#1)(1994-12#1)(1994-2#2)(1994-5#2)(1994-9#1)(1996-8#1)(1997-4#2)(2005-12#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-4#2)(2008-5#7)(2008-8#1)(2009-12#1)(2010-4#1)(2013-1#1)(2013-8#2)
reaction mixtures of##2##3##(1991-10#1)(2008-10#1)
reaction mixtures was##2##3##(1992-11#1)(2008-10#1)
reaction mixtures##16##2##(1990-12#1)(1990-8#1)(1991-10#2)(1992-11#1)(1992-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#5)(2008-7#1)
reaction model was##2##3##(2005-11#1)(2008-7#1)
reaction model##9##2##(1990-10#3)(1996-9#1)(2005-11#1)(2006-10#2)(2008-5#1)(2008-7#1)
reaction monitoring (MRM) mode##9##4##(2011-1#3)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
reaction monitoring (MRM)##15##3##(2007-8#2)(2008-10#1)(2010-12#1)(2011-1#3)(2011-3#2)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
reaction monitoring##27##2##(1996-6#1)(1997-3#1)(2007-8#3)(2008-10#7)(2010-12#1)(2011-1#4)(2011-2#1)(2011-3#2)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
reaction network##5##2##(2006-10#1)(2008-11#1)(2010-5#1)(2010-9#2)
reaction networks##5##2##(2006-10#3)(2006-12#1)(2011-2#1)
reaction norm##4##2##(2008-10#1)(2008-8#2)(2011-12#1)
reaction norms for##2##3##(2008-8#2)
reaction norms##8##2##(2008-8#7)(2011-12#1)
reaction observed##3##2##(1995-2#1)(2008-10#1)(2009-6#1)
reaction occurred between##2##3##(1991-1#1)(1995-5#1)
reaction occurred in##2##3##(1991-8#1)(2007-8#1)
reaction occurred##8##2##(1991-1#1)(1991-8#1)(1995-2#1)(1995-5#1)(2005-5#1)(2007-2#1)(2007-8#1)(2010-11#1)
reaction occurs##9##2##(1993-11#1)(1995-5#1)(2006-10#1)(2006-6#1)(2008-1#1)(2008-10#3)(2008-7#1)
reaction of 1##8##3##(1996-2#1)(2007-10#1)(2008-10#1)(2008-5#1)(2009-3#1)(2010-3#1)(2010-5#1)(2010-6#1)
reaction of 2##5##3##(1991-7#1)(1996-5#1)(1997-7#1)(2006-12#1)(2008-5#1)
reaction of 3##4##3##(2007-11#2)(2008-10#2)
reaction of 4 with##3##4##(1996-5#2)(2005-7#1)
reaction of 5 with##4##4##(1996-5#2)(2005-7#2)
reaction of 5##6##3##(1996-5#3)(2005-7#2)(2008-10#1)
reaction of Cr(VI) with##2##4##(2008-10#2)
reaction of Cu(II) with##7##4##(2006-11#2)(2008-10#5)
reaction of H(2)O(2) with##2##4##(2008-10#1)(2010-5#1)
reaction of HRP with hydrogen peroxide and p-iodophenol##2##8##(2008-10#2)
reaction of HRP##3##3##(2008-10#3)
reaction of N##3##3##(1991-9#1)(2007-11#2)
reaction of a##11##3##(1993-6#1)(2005-11#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-6#1)(2009-6#1)(2009-8#1)(2011-2#1)(2013-1#1)
reaction of an##7##3##(1996-5#1)(2006-9#1)(2007-11#1)(2007-8#1)(2009-2#1)(2012-11#1)(2013-7#1)
reaction of aromatic##2##3##(2008-10#1)(2012-3#1)
reaction of ascorbic acid##2##4##(2008-10#2)
reaction of bilirubin##2##3##(2008-10#2)
reaction of closo-1##2##3##(1996-2#2)
reaction of cobalt(II)##2##3##(2008-10#2)
reaction of cyclopentylamine##2##3##(2008-6#2)
reaction of enzyme##3##3##(1990-2#1)(1990-7#2)
reaction of equimolar##2##3##(1996-2#1)(2007-11#1)
reaction of ethyl##2##3##(2007-11#1)(2012-3#1)
reaction of free##3##3##(1997-2#1)(1997-8#1)(2007-11#1)
reaction of glucose##2##3##(2008-10#2)
reaction of human##3##3##(1991-2#1)(1994-3#1)(1997-4#1)
reaction of inflammation##2##3##(2013-1#2)
reaction of l-cysteine with##2##4##(2008-10#2)
reaction of luminol with hydrogen peroxide##3##6##(2008-10#3)
reaction of luminol with##7##4##(2008-10#7)
reaction of luminol##8##3##(2008-10#8)
reaction of mercury##3##3##(2005-11#1)(2008-10#2)
reaction of methyl##2##3##(1996-5#1)(2008-10#1)
reaction of metoclopramide##2##3##(2008-10#2)
reaction of oxygen with##2##4##(1995-11#1)(2008-10#1)
reaction of protein##2##3##(1997-6#1)(2008-10#1)
reaction of pyruvate##3##3##(1993-11#1)(1995-10#2)
reaction of silica##2##3##(2008-10#1)(2008-3#1)
reaction of silver##2##3##(2008-10#2)
reaction of sulfide with##2##4##(2008-10#2)
reaction of sulfide##3##3##(2008-10#3)
reaction of tert-butyl##2##3##(2007-11#1)(2009-8#1)
reaction of the analyte with##2##5##(2008-10#2)
reaction of the organism##3##4##(1996-9#2)(2011-2#1)
reaction of the produced##2##4##(2008-10#2)
reaction of the##85##3##(1990-5#1)(1990-7#3)(1990-8#1)(1991-11#2)(1991-5#2)(1991-6#1)(1991-7#2)(1991-9#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-4#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-5#2)(1996-2#1)(1996-5#2)(1996-9#2)(1997-4#1)(1997-6#1)(2005-11#2)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#5)(2007-8#1)(2008-1#1)(2008-10#21)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-9#1)(2009-12#2)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#1)(2013-1#2)(2013-8#1)
reaction of these##4##3##(2007-10#1)(2008-10#3)
reaction of this##4##3##(1994-9#1)(2008-10#3)
reaction of xanthine oxidase with##2##5##(1994-8#1)(1996-9#1)
reaction of##557##2##(1990-10#1)(1990-11#1)(1990-2#4)(1990-4#1)(1990-5#4)(1990-7#6)(1990-8#1)(1991-10#1)(1991-11#2)(1991-2#2)(1991-3#2)(1991-5#4)(1991-6#3)(1991-7#4)(1991-9#6)(1992-2#1)(1992-3#1)(1992-5#3)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-3#1)(1993-4#1)(1993-6#3)(1993-8#2)(1994-10#3)(1994-11#4)(1994-12#2)(1994-3#1)(1994-4#1)(1994-5#6)(1994-6#4)(1994-8#2)(1994-9#2)(1995-1#5)(1995-10#2)(1995-11#1)(1995-3#1)(1995-5#4)(1995-6#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-2#9)(1996-3#2)(1996-5#20)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#2)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#5)(2004-2#1)(2004-9#5)(2005-10#1)(2005-11#7)(2005-4#7)(2005-7#3)(2005-8#1)(2006-10#2)(2006-11#2)(2006-12#2)(2006-3#1)(2006-5#3)(2006-6#1)(2006-9#2)(2007-1#1)(2007-10#6)(2007-11#34)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#8)(2008-1#2)(2008-10#200)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#7)(2008-5#18)(2008-6#6)(2008-7#3)(2008-8#7)(2008-9#4)(2009-10#3)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#2)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#5)(2010-6#1)(2010-7#1)(2011-1#6)(2011-2#3)(2012-1#3)(2012-11#3)(2012-2#1)(2012-3#4)(2013-1#6)(2013-7#3)(2013-8#3)
reaction on the##7##3##(1991-3#1)(1994-8#1)(1995-12#1)(2007-7#1)(2007-8#1)(2010-4#1)(2010-5#1)
reaction on tobacco##2##3##(2008-10#2)
reaction on##15##2##(1991-3#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-9#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#5)(2010-4#1)(2010-5#1)
reaction operates##2##2##(1994-3#1)(1995-1#1)
reaction or##10##2##(1991-9#1)(1992-11#1)(1993-3#1)(1994-8#1)(1997-2#1)(2006-10#1)(2008-10#1)(2010-4#1)(2011-1#1)(2012-12#1)
reaction parameters##4##2##(2008-5#1)(2008-6#1)(2010-8#1)(2011-2#1)
reaction participants##2##2##(2006-10#1)(2008-7#1)
reaction pathway##16##2##(1990-12#1)(1991-3#1)(1991-9#1)(1992-12#1)(1994-12#1)(1995-2#1)(2005-11#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-3#1)(2010-2#1)(2010-6#2)
reaction pathways##8##2##(1990-12#1)(1997-6#1)(1997-7#1)(2005-11#1)(2008-10#1)(2009-11#1)(2009-7#1)(2010-2#1)
reaction pattern##7##2##(1996-5#1)(2007-8#1)(2008-10#1)(2010-6#1)(2012-2#3)
reaction patterns##4##2##(2007-8#1)(2008-5#1)(2008-6#1)(2012-3#1)
reaction proceeds through##2##3##(2008-10#1)(2009-10#1)
reaction proceeds##6##2##(1992-9#1)(1995-4#1)(1996-5#1)(2008-10#1)(2009-10#1)(2010-8#1)
reaction process##6##2##(2006-12#1)(2008-10#3)(2008-2#1)(2010-7#1)
reaction produced a##2##3##(1995-5#1)(2008-10#1)
reaction producing##2##2##(2006-4#1)(2008-7#1)
reaction product and##2##3##(2007-8#1)(2008-10#1)
reaction product in##2##3##(1996-4#1)(2008-10#1)
reaction product is##6##3##(1990-8#1)(1991-5#1)(1996-8#1)(2008-10#3)
reaction product was##6##3##(1990-5#1)(1991-9#1)(1992-1#1)(1992-3#1)(2006-6#1)(2008-6#1)
reaction product##38##2##(1990-1#1)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-5#2)(1991-9#1)(1992-1#1)(1992-3#1)(1993-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-4#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(2006-6#1)(2007-8#1)(2007-9#1)(2008-10#12)(2008-6#1)
reaction products and##3##3##(1991-1#1)(2008-10#1)(2010-12#1)
reaction products are##2##3##(1993-11#1)(1996-3#1)
reaction products by##4##3##(1991-8#1)(1992-6#1)(1994-11#1)(2008-4#1)
reaction products in the##2##4##(1990-5#1)(1994-5#1)
reaction products in##3##3##(1990-5#1)(1994-5#1)(1996-5#1)
reaction products of##3##3##(1993-4#1)(2008-10#2)
reaction products was##3##3##(1996-6#1)(2008-10#1)(2008-4#1)
reaction products were##8##3##(1991-5#1)(1991-7#1)(1994-6#1)(1994-8#1)(2007-10#1)(2008-11#2)(2010-4#1)
reaction products##50##2##(1990-1#1)(1990-5#1)(1990-7#2)(1991-1#1)(1991-12#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-4#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1996-10#1)(1996-12#2)(1996-3#1)(1996-5#3)(1996-6#1)(2004-9#1)(2007-10#1)(2008-10#6)(2008-11#3)(2008-4#5)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2013-7#1)
reaction profile of##2##3##(2006-5#1)(2010-5#1)
reaction profile##6##2##(1991-8#1)(2006-5#1)(2007-2#1)(2008-10#1)(2010-5#1)(2013-8#1)
reaction profiles##4##2##(2008-10#3)(2013-8#1)
reaction progress##3##2##(1994-5#1)(2008-10#1)(2010-8#1)
reaction promoted by##2##3##(1994-8#1)(2007-11#1)
reaction provides a##2##3##(1996-7#1)(2009-3#1)
reaction provides an##2##3##(1996-4#2)
reaction provides##4##2##(1996-4#2)(1996-7#1)(2009-3#1)
reaction ranged from##2##3##(1994-12#1)(2011-2#1)
reaction rate and the##2##4##(2008-10#1)(2009-12#1)
reaction rate and##4##3##(2007-11#1)(2008-10#2)(2009-12#1)
reaction rate constant##4##3##(1990-7#1)(2008-10#2)(2008-8#1)
reaction rate constants of##3##4##(2006-10#1)(2007-11#2)
reaction rate constants were determined##2##5##(1997-8#1)(2008-9#1)
reaction rate constants##7##3##(1997-8#1)(2006-10#1)(2007-11#3)(2008-10#1)(2008-9#1)
reaction rate is##5##3##(2006-11#2)(2008-10#1)(2008-7#2)
reaction rate of##4##3##(1991-12#1)(2008-10#2)(2008-5#1)
reaction rate was found to increase with##2##7##(2007-5#1)(2008-7#1)
reaction rate was##6##3##(1991-2#1)(2007-5#1)(2008-10#3)(2008-7#1)
reaction rate##47##2##(1990-7#1)(1991-12#1)(1991-2#1)(1992-6#2)(1994-8#1)(1995-1#1)(1997-8#1)(2006-10#1)(2006-11#2)(2006-12#1)(2007-10#1)(2007-11#5)(2007-5#1)(2008-10#13)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#1)
reaction rates and activation energy in aerobic composting processes for yard waste##2##12##(2008-5#2)
reaction rates and activation energy##3##5##(2008-5#3)
reaction rates and##6##3##(1995-11#1)(2008-5#5)
reaction rates##22##2##(1995-11#1)(2006-10#2)(2006-12#1)(2007-10#1)(2008-10#3)(2008-5#7)(2008-7#4)(2008-9#1)(2011-2#2)
reaction reported##3##2##(2006-10#1)(2008-11#1)(2010-5#1)
reaction reporting##3##2##(2006-10#1)(2008-3#1)(2013-8#1)
reaction required##2##2##(1994-6#1)(1995-2#1)
reaction resulted in##2##3##(1990-10#1)(1996-5#1)
reaction results in##2##3##(2009-12#1)(2011-2#1)
reaction scheme##8##2##(1991-2#2)(1992-9#1)(1993-6#1)(1994-2#2)(1997-2#1)(2008-2#1)
reaction screening##2##2##(1997-4#1)(2010-6#1)
reaction secondary to##2##3##(1993-4#1)(2008-6#1)
reaction sequence is##2##3##(1990-3#1)(2010-1#1)
reaction sequence##18##2##(1990-3#4)(1991-10#1)(1991-9#1)(1992-1#1)(1995-11#1)(1996-5#3)(1997-3#1)(2008-10#1)(2008-4#1)(2010-1#1)(2010-5#1)(2010-6#1)(2013-7#1)
reaction sequences##3##2##(2004-4#1)(2008-10#1)(2008-7#1)
reaction should##2##2##(1995-12#1)(2007-8#1)
reaction showed##4##2##(1991-2#1)(1994-11#1)(2008-10#1)(2009-8#1)
reaction shows##2##2##(1992-9#1)(2007-8#1)
reaction sites##3##2##(1990-3#1)(1991-5#1)(1994-8#1)
reaction sizes##2##2##(2011-1#2)
reaction solution##5##2##(2008-10#2)(2008-5#1)(2012-12#1)(2013-8#1)
reaction step##5##2##(1991-2#2)(2008-10#2)(2009-5#1)
reaction steps##4##2##(1997-3#1)(1997-6#1)(2006-10#1)(2007-12#1)
reaction strength##2##2##(1993-12#1)(2010-4#1)
reaction system was##2##3##(2008-10#2)
reaction system##26##2##(1990-3#1)(1991-8#1)(2005-12#1)(2006-10#1)(2007-8#2)(2008-10#15)(2008-7#1)(2009-7#1)(2009-8#1)(2011-1#1)(2013-1#1)
reaction systems##8##2##(1992-3#1)(1996-8#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-6#1)(2012-2#1)
reaction takes place##3##3##(1995-8#1)(2008-10#1)(2008-4#1)
reaction takes##4##2##(1992-12#1)(1995-8#1)(2008-10#1)(2008-4#1)
reaction taking place##2##3##(2008-11#1)(2008-8#1)
reaction technique##8##2##(1990-12#1)(1990-2#1)(1991-9#1)(1993-2#1)(1993-9#1)(1994-12#1)(2008-12#1)(2010-4#1)
reaction techniques##7##2##(1991-8#1)(1992-5#1)(1995-1#1)(1996-7#1)(2006-10#1)(2006-8#1)(2008-10#1)
reaction temperature and##6##3##(2004-9#1)(2007-10#1)(2008-10#3)(2011-2#1)
reaction temperature##16##2##(2004-9#1)(2007-10#1)(2008-10#5)(2008-5#3)(2010-4#2)(2011-2#2)(2013-1#2)
reaction than##3##2##(1991-5#1)(1994-8#1)(2005-4#1)
reaction that can##2##3##(2008-4#1)(2012-2#1)
reaction that may##2##3##(1992-2#1)(2007-2#1)
reaction that##24##2##(1990-3#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-12#1)(1992-2#1)(1993-2#1)(1995-8#1)(1996-8#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-4#5)(2009-3#1)(2009-6#1)(2011-1#1)(2012-12#1)(2012-2#1)
reaction the K(m) for the##2##5##(2008-7#2)
reaction the##5##2##(1990-10#1)(2008-10#1)(2008-7#2)(2013-1#1)
reaction time (RT)##6##3##(1993-2#1)(1996-1#1)(2008-11#1)(2008-7#1)(2010-1#1)(2013-7#1)
reaction time and##9##3##(1995-12#1)(2008-10#6)(2008-4#1)(2009-2#1)
reaction time in the##3##4##(1990-5#1)(2013-1#2)
reaction time in##4##3##(1990-5#1)(2006-3#1)(2013-1#2)
reaction time of##10##3##(1995-1#1)(1996-2#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-6#1)(2010-6#1)(2012-11#1)
reaction time task##8##3##(1992-11#2)(1994-2#1)(2008-4#3)(2009-10#1)(2012-1#1)
reaction time variance contributed by base time##2##7##(2008-8#2)
reaction time variance##3##3##(2008-8#3)
reaction time was##4##3##(2006-12#1)(2008-10#1)(2008-5#1)(2010-12#1)
reaction time were##2##3##(2007-11#1)(2007-5#1)
reaction time##85##2##(1990-10#2)(1990-5#1)(1991-6#1)(1992-11#2)(1993-2#2)(1994-2#2)(1995-1#1)(1995-12#2)(1996-1#1)(1996-2#1)(1996-5#3)(1996-7#1)(1997-2#1)(1997-4#1)(2004-9#1)(2006-12#1)(2006-3#1)(2007-11#2)(2007-5#1)(2007-8#3)(2008-10#20)(2008-11#1)(2008-4#4)(2008-5#7)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#3)(2010-1#2)(2010-12#2)(2010-6#1)(2011-2#2)(2012-1#1)(2012-11#1)(2013-1#2)(2013-7#1)
reaction time)##2##2##(2008-10#2)
reaction times and##4##3##(2008-12#1)(2008-5#1)(2011-1#1)(2012-1#1)
reaction times for##4##3##(1997-7#1)(2008-11#1)(2010-6#2)
reaction times of##2##3##(2007-11#1)(2008-10#1)
reaction times##35##2##(1990-3#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-4#2)(1996-6#1)(1997-7#1)(2007-11#7)(2007-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2010-12#1)(2010-2#1)(2010-6#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)
reaction to N-acetylcysteine after##2##4##(1997-5#2)
reaction to P##2##3##(2008-10#2)
reaction to Physiogel SRK##2##4##(1991-11#2)
reaction to a##8##3##(1990-2#1)(2007-8#2)(2008-10#2)(2008-8#1)(2012-1#1)(2013-7#1)
reaction to an##4##3##(2007-12#1)(2007-9#1)(2012-12#2)
reaction to be##3##3##(1990-9#1)(1991-7#1)(1993-11#1)
reaction to biodegradable##2##3##(2008-6#2)
reaction to form the##2##4##(2007-8#1)(2010-2#1)
reaction to form##6##3##(1990-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-2#1)(2010-4#1)
reaction to give##3##3##(2007-10#1)(2007-11#1)(2008-5#1)
reaction to isolates##2##3##(2008-10#2)
reaction to occur##2##3##(2006-11#1)(2008-10#1)
reaction to stress##2##3##(2006-12#1)(2013-1#1)
reaction to the##17##3##(1991-1#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-9#1)(1996-12#1)(2004-9#2)(2005-8#1)(2006-8#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-3#1)(2013-1#1)(2013-8#1)
reaction to trauma##2##3##(1992-3#1)(1992-4#1)
reaction to tuberculin##2##3##(1990-6#2)
reaction to##149##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-6#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-5#2)(1991-6#1)(1991-7#2)(1991-9#2)(1992-12#1)(1992-3#1)(1992-4#2)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-5#1)(1995-1#1)(1995-9#1)(1996-12#2)(1996-6#2)(1996-9#1)(1997-5#2)(1997-6#1)(2004-9#2)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#4)(2007-3#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#23)(2008-11#5)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#3)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#2)(2011-2#7)(2012-1#5)(2012-12#2)(2012-2#1)(2013-1#4)(2013-7#3)(2013-8#1)
reaction took place##2##3##(2008-10#1)(2008-4#1)
reaction types##2##2##(2010-10#2)
reaction under##4##2##(1995-10#1)(1996-2#1)(2007-11#1)(2008-10#1)
reaction using the analyte pulse perturbation technique##2##7##(2008-10#2)
reaction using the##3##3##(1997-7#1)(2008-10#2)
reaction using##34##2##(1990-7#1)(1990-8#2)(1991-12#1)(1992-11#1)(1992-6#1)(1993-2#1)(1993-9#1)(1994-11#1)(1996-2#1)(1996-7#1)(1997-4#1)(1997-6#1)(1997-7#2)(2006-9#1)(2007-12#1)(2008-10#11)(2008-7#2)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#1)
reaction vessel of##2##3##(2006-5#1)(2008-10#1)
reaction vessel##4##2##(2006-5#1)(2008-10#2)(2008-7#1)
reaction volume##2##2##(1994-12#1)(2008-10#1)
reaction was also discussed##3##4##(2008-10#3)
reaction was also##6##3##(1994-2#1)(2008-10#5)
reaction was applied to the##2##5##(2008-10#2)
reaction was applied to##3##4##(2008-10#3)
reaction was associated with##2##4##(1992-9#1)(1995-6#1)
reaction was carried out at##2##5##(1994-9#1)(2008-7#1)
reaction was carried out in##2##5##(2004-8#1)(2004-9#1)
reaction was carried out using##2##5##(1991-5#1)(2008-10#1)
reaction was carried out##8##4##(1991-5#1)(1994-9#1)(2004-8#1)(2004-9#1)(2008-10#2)(2008-7#1)(2010-11#1)
reaction was confirmed##2##3##(1990-6#1)(2007-11#1)
reaction was developed##2##3##(2008-10#2)
reaction was employed##2##3##(1991-9#1)(2008-5#1)
reaction was examined##2##3##(1992-6#1)(1996-12#1)
reaction was first##2##3##(1995-6#1)(2008-10#1)
reaction was followed by##2##4##(2004-9#1)(2010-5#1)
reaction was found to be##4##5##(1991-1#1)(1991-7#1)(2004-9#1)(2008-10#1)
reaction was found to##5##4##(1991-1#1)(1991-7#1)(2004-9#1)(2008-10#2)
reaction was found##8##3##(1991-1#1)(1991-7#1)(1993-6#1)(1994-12#1)(2004-9#1)(2007-10#1)(2008-10#2)
reaction was induced##2##3##(1996-12#1)(1997-1#1)
reaction was inhibited##2##3##(1991-2#1)(2005-12#1)
reaction was investigated by##3##4##(1991-7#1)(1993-8#1)(2004-9#1)
reaction was investigated##6##3##(1991-7#1)(1993-8#1)(2004-9#2)(2008-10#2)
reaction was monitored by##2##4##(2008-10#1)(2010-5#1)
reaction was monitored##8##3##(2008-10#6)(2008-3#1)(2010-5#1)
reaction was most##2##3##(1990-7#1)(1997-5#1)
reaction was not##3##3##(1992-7#1)(1996-2#1)(2008-10#1)
reaction was observed between##2##4##(2008-10#1)(2010-4#1)
reaction was observed##8##3##(1990-3#1)(1990-6#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#1)(2010-4#1)
reaction was run##2##3##(2005-12#1)(2013-1#1)
reaction was shown by##2##4##(1992-5#1)(1996-5#1)
reaction was studied##6##3##(1995-10#1)(2006-3#1)(2008-10#4)
reaction was the##2##3##(1992-11#1)(1997-2#1)
reaction was used to##15##4##(1990-12#1)(1991-12#1)(1991-7#1)(1992-6#1)(1992-8#1)(1995-6#1)(1996-5#1)(1997-2#1)(2007-10#1)(2007-6#1)(2008-10#1)(2009-2#1)(2010-4#1)(2012-3#1)(2013-1#1)
reaction was used##17##3##(1990-12#1)(1991-12#1)(1991-7#1)(1992-6#1)(1992-8#1)(1994-2#1)(1995-6#1)(1996-5#1)(1997-2#1)(2007-10#1)(2007-6#1)(2008-10#2)(2009-2#1)(2010-4#1)(2012-3#1)(2013-1#1)
reaction was##170##2##(1990-1#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#4)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-6#2)(1993-8#2)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-6#3)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-5#2)(1997-1#1)(1997-2#2)(1997-5#1)(1997-6#1)(2004-8#1)(2004-9#5)(2005-11#1)(2005-12#2)(2005-8#1)(2006-12#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-10#4)(2007-11#5)(2007-6#1)(2007-8#1)(2008-10#50)(2008-11#1)(2008-3#1)(2008-5#5)(2008-7#2)(2008-8#2)(2009-2#1)(2009-8#1)(2010-11#1)(2010-4#2)(2010-5#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
reaction we##2##2##(1992-11#2)
reaction were detected##2##3##(1995-11#1)(2008-8#1)
reaction were determined##2##3##(2005-4#1)(2008-10#1)
reaction were investigated##3##3##(2004-9#1)(2008-10#2)
reaction were##28##2##(1990-10#1)(1991-12#1)(1992-4#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-8#1)(1997-2#1)(2004-8#1)(2004-9#1)(2005-11#1)(2005-4#1)(2007-11#1)(2008-10#11)(2008-11#1)(2008-8#1)(2011-2#1)
reaction when##7##2##(1991-12#2)(1991-2#1)(2004-9#1)(2005-11#1)(2008-10#2)
reaction where the##2##3##(2006-10#1)(2008-10#1)
reaction where##3##2##(2006-10#1)(2008-10#1)(2009-8#1)
reaction wherein##2##2##(2008-10#2)
reaction which is##3##3##(1994-9#1)(2007-7#1)(2008-10#1)
reaction which occurs##2##3##(1996-7#1)(2008-10#1)
reaction which##13##2##(1990-11#1)(1990-8#1)(1991-1#1)(1992-12#1)(1994-9#1)(1995-4#1)(1996-7#1)(2006-5#1)(2007-7#1)(2008-10#3)(2008-4#1)
reaction will##2##2##(2008-11#1)(2008-6#1)
reaction with 1##2##3##(2005-11#1)(2007-10#1)
reaction with 2##2##3##(2007-11#1)(2008-10#1)
reaction with Co(II) and##2##4##(2008-10#1)(2008-5#1)
reaction with O6-benzylguanine##2##3##(1995-5#2)
reaction with a##8##3##(1990-3#1)(1992-12#1)(1992-2#1)(1994-9#1)(1997-1#1)(1997-7#1)(2008-10#2)
reaction with alkaline##2##3##(2007-8#1)(2008-10#1)
reaction with an##2##3##(2004-12#1)(2008-10#1)
reaction with cysteine##2##3##(1997-8#2)
reaction with hydroxylamine##2##3##(1995-8#1)(2009-9#1)
reaction with luminol##2##3##(1995-3#1)(2008-10#1)
reaction with methyl##2##3##(2008-10#1)(2010-8#1)
reaction with potassium##3##3##(2008-10#3)
reaction with sodium##2##3##(2007-10#1)(2008-10#1)
reaction with the formation of##2##5##(2006-12#1)(2010-5#1)
reaction with the studied##2##4##(2008-10#2)
reaction with the##19##3##(1991-3#1)(1993-8#1)(1994-9#1)(1996-8#1)(1997-1#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#8)(2010-12#1)(2010-4#1)(2010-5#1)
reaction with##204##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-2#1)(1993-3#1)(1993-8#3)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#2)(1994-8#1)(1994-9#3)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-5#2)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2004-12#1)(2005-11#3)(2005-9#1)(2006-10#3)(2006-12#2)(2007-1#1)(2007-10#2)(2007-11#7)(2007-2#1)(2007-3#1)(2007-8#6)(2007-9#1)(2008-10#84)(2008-11#3)(2008-12#1)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#1)(2009-10#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#3)(2013-8#1)
reaction within the##3##3##(1990-2#1)(1992-11#1)(2008-4#1)
reaction without##3##2##(1994-6#1)(2008-10#1)(2009-11#1)
reaction yield##3##2##(2008-10#1)(2008-5#1)(2012-3#1)
reaction yielded##2##2##(2008-10#1)(2011-1#1)
reaction yields##2##2##(2008-10#1)(2008-6#1)
reaction zone##2##2##(2008-10#1)(2008-2#1)
reaction zones##4##2##(2008-10#1)(2008-3#3)
reaction##4799##1##(1990-1#5)(1990-10#14)(1990-11#13)(1990-12#25)(1990-2#29)(1990-3#23)(1990-4#6)(1990-5#22)(1990-6#14)(1990-7#36)(1990-8#21)(1990-9#7)(1991-1#13)(1991-10#14)(1991-11#13)(1991-12#27)(1991-2#21)(1991-3#16)(1991-4#6)(1991-5#37)(1991-6#16)(1991-7#34)(1991-8#12)(1991-9#30)(1992-1#12)(1992-10#5)(1992-11#16)(1992-12#20)(1992-2#10)(1992-3#21)(1992-4#10)(1992-5#12)(1992-6#29)(1992-7#12)(1992-8#22)(1992-9#21)(1993-1#3)(1993-10#2)(1993-11#18)(1993-12#16)(1993-2#17)(1993-3#16)(1993-4#11)(1993-5#10)(1993-6#18)(1993-7#3)(1993-8#31)(1993-9#11)(1994-1#2)(1994-10#7)(1994-11#20)(1994-12#38)(1994-2#20)(1994-3#21)(1994-4#1)(1994-5#26)(1994-6#22)(1994-7#2)(1994-8#38)(1994-9#28)(1995-1#26)(1995-10#20)(1995-11#14)(1995-12#17)(1995-2#13)(1995-3#16)(1995-4#7)(1995-5#30)(1995-6#24)(1995-8#23)(1995-9#5)(1996-1#2)(1996-10#6)(1996-11#16)(1996-12#21)(1996-2#35)(1996-3#7)(1996-4#5)(1996-5#64)(1996-6#12)(1996-7#15)(1996-8#11)(1996-9#12)(1997-1#10)(1997-2#22)(1997-3#13)(1997-4#26)(1997-5#8)(1997-6#31)(1997-7#28)(1997-8#22)(1997-9#1)(2004-11#7)(2004-12#1)(2004-2#1)(2004-4#2)(2004-7#1)(2004-8#2)(2004-9#28)(2005-10#6)(2005-11#38)(2005-12#10)(2005-4#15)(2005-5#1)(2005-7#8)(2005-8#7)(2005-9#3)(2006-10#63)(2006-11#8)(2006-12#26)(2006-2#1)(2006-3#9)(2006-4#11)(2006-5#16)(2006-6#6)(2006-7#1)(2006-8#11)(2006-9#8)(2007-1#8)(2007-10#35)(2007-11#121)(2007-12#31)(2007-2#18)(2007-3#4)(2007-4#4)(2007-5#8)(2007-6#4)(2007-7#26)(2007-8#88)(2007-9#11)(2008-1#10)(2008-10#1358)(2008-11#50)(2008-12#15)(2008-2#19)(2008-3#20)(2008-4#98)(2008-5#141)(2008-6#38)(2008-7#66)(2008-8#68)(2008-9#26)(2009-10#20)(2009-11#4)(2009-12#9)(2009-2#10)(2009-3#13)(2009-4#4)(2009-5#10)(2009-6#7)(2009-7#3)(2009-8#17)(2009-9#9)(2010-1#4)(2010-10#4)(2010-11#3)(2010-12#30)(2010-2#11)(2010-3#5)(2010-4#34)(2010-5#34)(2010-6#26)(2010-7#16)(2010-8#10)(2010-9#4)(2011-1#37)(2011-11#1)(2011-12#8)(2011-2#61)(2011-3#3)(2012-1#24)(2012-11#7)(2012-12#23)(2012-2#33)(2012-3#30)(2013-1#85)(2013-7#15)(2013-8#41)
reaction&quot##2##1##(1991-12#1)(2011-2#1)
reaction'##2##1##(1991-5#1)(1993-12#1)
reaction) and##2##2##(1996-12#1)(2008-5#1)
reaction) in##2##2##(1997-6#1)(2012-3#1)
reaction)##24##1##(1990-6#1)(1991-5#1)(1991-7#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-8#1)(1996-12#1)(1996-4#1)(1997-6#1)(2005-12#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-3#1)
reaction-diffusion model##2##2##(2008-8#2)
reaction-diffusion models and##2##3##(2007-9#1)(2008-8#1)
reaction-diffusion models##4##2##(2007-9#2)(2008-8#1)(2008-9#1)
reaction-diffusion system##2##2##(2006-10#1)(2007-9#1)
reaction-diffusion##19##1##(1991-1#1)(2006-10#1)(2006-2#1)(2007-9#3)(2008-10#1)(2008-2#3)(2008-8#5)(2008-9#1)(2009-8#1)(2013-8#2)
reaction-driven scaffold-hopping##2##2##(2012-2#2)
reaction-rate##2##1##(1996-5#1)(2008-10#1)
reaction?##3##1##(1990-9#1)(2009-5#1)(2013-1#1)
reaction]##8##1##(1990-8#1)(1991-12#1)(1994-3#1)(1996-2#1)(1996-8#1)(2005-12#1)(2005-4#1)(2011-2#1)
reactional##13##1##(1991-11#1)(2007-7#2)(2008-10#1)(2011-2#8)(2013-8#1)
reactions across##2##2##(2012-2#2)
reactions after##5##2##(1991-12#1)(1996-8#1)(2005-11#1)(2008-10#1)(2013-1#1)
reactions against##3##2##(1997-4#1)(2005-11#1)(2012-2#1)
reactions among##2##2##(2008-10#2)
reactions and drug##2##3##(2007-12#1)(2011-2#1)
reactions and the##3##3##(1997-7#1)(2006-10#1)(2008-10#1)
reactions and their##3##3##(2006-10#1)(2008-3#1)(2012-12#1)
reactions and##72##2##(1991-1#1)(1991-11#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-9#1)(1995-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-7#1)(2005-8#1)(2006-10#5)(2006-12#2)(2006-6#1)(2007-11#4)(2007-12#1)(2007-5#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#3)(2012-12#1)(2013-1#1)
reactions are common and##3##4##(2006-12#1)(2008-10#1)(2008-8#1)
reactions are common##5##3##(1992-8#1)(1997-8#1)(2006-12#1)(2008-10#1)(2008-8#1)
reactions are discussed##2##3##(2005-11#1)(2008-10#1)
reactions are proposed##2##3##(2007-11#1)(2008-8#1)
reactions are related##2##3##(2004-11#1)(2008-10#1)
reactions are the##2##3##(2007-11#1)(2008-10#1)
reactions are usually##2##3##(2007-11#1)(2008-7#1)
reactions are##69##2##(1990-12#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-3#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-6#1)(1995-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-5#1)(1997-8#1)(2004-11#1)(2005-11#1)(2005-8#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-6#1)(2007-11#5)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#11)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#4)(2009-8#1)(2010-12#2)(2010-7#1)(2010-8#1)(2012-2#2)
reactions as key steps##2##4##(2007-11#1)(2011-2#1)
reactions as well as in##2##5##(1993-12#1)(2010-12#1)
reactions as well as##5##4##(1993-12#1)(1994-8#1)(2006-2#1)(2008-6#1)(2010-12#1)
reactions as##9##2##(1993-12#1)(1994-8#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-6#1)(2010-12#2)(2011-2#1)
reactions associated with##7##3##(2005-10#1)(2007-2#1)(2008-8#1)(2009-8#2)(2010-5#1)(2012-12#1)
reactions at the injection site##3##5##(1990-6#1)(2005-11#1)(2008-4#1)
reactions at the site of##2##5##(2006-9#1)(2008-11#1)
reactions at the##9##3##(1990-6#1)(1997-2#1)(2005-11#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-6#1)(2013-8#1)
reactions at##16##2##(1990-2#1)(1990-6#1)(1993-12#1)(1997-2#1)(2005-11#1)(2006-2#1)(2006-9#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-6#1)(2013-8#1)
reactions between 1##2##3##(2007-10#1)(2009-11#1)
reactions between a##2##3##(1992-9#1)(1997-6#1)
reactions between the##4##3##(1996-11#1)(1996-2#1)(1997-7#1)(2008-10#1)
reactions between##30##2##(1991-4#1)(1992-6#1)(1992-9#1)(1994-5#1)(1995-1#2)(1995-8#2)(1996-11#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#2)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-5#1)(2008-7#2)(2009-11#1)
reactions but##4##2##(1996-5#1)(1996-9#1)(1997-3#1)(2009-8#1)
reactions by##15##2##(1991-10#1)(1991-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-2#1)(1997-8#1)(2006-8#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-9#1)
reactions can also##2##3##(1996-5#1)(2005-11#1)
reactions can be prevented by##2##5##(1990-3#2)
reactions can be##7##3##(1990-3#2)(1992-2#1)(1994-9#1)(2008-10#1)(2008-8#2)
reactions can have##2##3##(2008-10#2)
reactions can##15##2##(1990-3#2)(1992-2#1)(1994-9#1)(1996-5#1)(2005-11#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-8#2)(2009-11#1)(2012-2#1)
reactions catalysed by##3##3##(1991-2#1)(1991-6#1)(2010-5#1)
reactions catalyzed by##12##3##(1990-3#1)(1990-5#1)(1990-8#1)(1991-4#1)(1991-7#1)(1992-3#1)(1994-2#1)(1994-8#1)(2005-11#1)(2006-12#1)(2006-4#1)(2008-7#1)
reactions caused by##2##3##(1991-11#1)(2007-8#1)
reactions characteristic of##2##3##(1996-1#1)(2008-10#1)
reactions commonly##2##2##(2008-10#1)(2009-12#1)
reactions due to##4##3##(1994-12#1)(1995-1#1)(2008-1#1)(2008-12#1)
reactions during the##4##3##(1993-5#1)(1995-8#1)(2008-10#1)(2008-8#1)
reactions during##11##2##(1990-1#1)(1990-11#1)(1991-2#1)(1991-5#1)(1992-10#1)(1993-5#1)(1995-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-8#1)
reactions following##2##2##(2008-10#1)(2011-2#1)
reactions for##14##2##(1993-5#1)(1994-3#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-10#3)(2009-10#1)(2010-12#2)(2011-1#1)(2013-8#2)
reactions from##8##2##(1992-11#1)(1993-2#1)(1994-6#1)(1996-8#1)(1997-2#1)(2007-12#1)(2008-10#1)(2010-2#1)
reactions has been##4##3##(1994-5#1)(1996-11#1)(2008-10#1)(2010-5#1)
reactions has##5##2##(1994-5#1)(1996-11#1)(1996-2#1)(2008-10#1)(2010-5#1)
reactions have been##7##3##(2007-11#2)(2008-10#2)(2008-9#1)(2009-12#1)(2012-3#1)
reactions have##9##2##(2006-10#1)(2007-11#2)(2008-10#2)(2008-9#1)(2009-12#2)(2012-3#1)
reactions in a##5##3##(1992-6#1)(2006-4#1)(2006-8#1)(2009-1#1)(2009-3#1)
reactions in an##2##3##(2008-8#1)(2011-2#1)
reactions in blood coagulation##2##4##(1990-11#1)(1994-11#1)
reactions in children##2##3##(2006-8#1)(2010-11#1)
reactions in parallel##2##3##(1994-6#1)(2011-2#1)
reactions in patients##3##3##(2011-1#1)(2011-2#1)(2013-1#1)
reactions in small##2##3##(2006-10#1)(2006-3#1)
reactions in solution##3##3##(1995-6#1)(1997-2#1)(2009-9#1)
reactions in the field##2##4##(2008-10#2)
reactions in the presence of##4##5##(1992-8#1)(2008-10#1)(2009-8#1)(2013-8#1)
reactions in the##25##3##(1990-7#1)(1991-9#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-6#1)(1994-11#1)(1995-8#1)(1996-2#1)(1996-5#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-8#2)
reactions in these##2##3##(2012-12#1)(2013-1#1)
reactions in which##4##3##(1992-6#1)(2008-10#1)(2008-11#1)(2010-7#1)
reactions in##112##2##(1990-11#1)(1990-12#2)(1990-5#1)(1990-7#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-5#1)(1994-6#1)(1995-2#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-2#2)(2004-12#1)(2005-10#1)(2005-11#1)(2005-4#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-4#1)(2006-8#2)(2007-11#1)(2007-2#2)(2007-8#1)(2008-10#15)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#1)(2009-3#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#7)(2013-8#2)
reactions include##2##2##(2008-8#1)(2012-1#1)
reactions included##2##2##(1990-2#1)(1994-12#1)
reactions including##9##2##(1991-9#1)(1993-6#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-2#1)(2012-12#1)
reactions indicate##2##2##(2007-3#1)(2008-12#1)
reactions induced by##2##3##(2009-11#1)(2013-1#1)
reactions induced##3##2##(1992-11#1)(2009-11#1)(2013-1#1)
reactions initiated by##3##3##(1990-11#1)(2008-5#1)(2011-2#1)
reactions involved##2##2##(2008-10#2)
reactions involving##12##2##(1993-4#1)(1994-11#1)(1995-6#1)(1995-8#2)(2006-4#1)(2008-4#1)(2009-10#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-3#1)
reactions is##19##2##(1990-12#1)(1993-12#1)(1994-9#1)(1995-12#1)(2006-10#2)(2007-10#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-12#1)(2013-8#2)
reactions lead to##2##3##(2008-10#1)(2008-4#1)
reactions leading to the##2##4##(1994-11#1)(1994-8#1)
reactions leading to##3##3##(1994-11#1)(1994-8#1)(2006-6#1)
reactions linked to##2##3##(2006-12#1)(2011-2#1)
reactions may be##5##3##(1990-3#1)(2005-12#1)(2007-7#1)(2008-4#1)(2008-5#1)
reactions may occur##2##3##(1991-9#1)(2012-2#1)
reactions may result in##2##4##(2004-4#1)(2010-5#1)
reactions may##11##2##(1990-3#1)(1991-9#1)(2004-4#1)(2005-12#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-10#1)(2010-5#1)(2012-2#1)
reactions measured##2##2##(1996-5#1)(2006-12#1)
reactions mediated by##2##3##(1997-1#1)(2008-4#1)
reactions monitored by##2##3##(1994-11#1)(2008-10#1)
reactions not only##2##3##(2005-11#1)(2007-11#1)
reactions observed##2##2##(1992-3#1)(2008-10#1)
reactions occur##5##2##(2008-10#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-1#1)
reactions occurred##3##2##(1991-11#1)(2007-10#1)(2010-5#1)
reactions occurring##3##2##(2004-9#1)(2005-11#1)(2012-2#1)
reactions of 1##4##3##(2006-4#1)(2009-3#2)(2010-5#1)
reactions of ATP##2##3##(1994-8#1)(1996-2#1)
reactions of a##2##3##(2007-11#1)(2010-5#1)
reactions of an##2##3##(1992-9#1)(2008-5#1)
reactions of iodine##2##3##(2008-10#2)
reactions of soybean##2##3##(2012-11#1)(2013-1#1)
reactions of the##32##3##(1990-10#1)(1990-2#1)(1990-8#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-6#2)(1993-6#1)(1994-9#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-7#1)(2007-11#2)(2007-8#1)(2008-10#9)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-2#1)
reactions of these##4##3##(1992-6#1)(2008-8#1)(2009-10#1)(2009-8#1)
reactions of thioisatin with thiazolidine-2-carboxylic acid##2##6##(2012-3#2)
reactions of three##2##3##(1992-11#1)(1992-6#1)
reactions of##192##2##(1990-10#4)(1990-2#1)(1990-5#3)(1990-8#3)(1991-1#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-11#2)(1992-12#1)(1992-6#6)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#3)(1993-6#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#2)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-7#2)(2005-4#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#22)(2007-12#4)(2007-6#1)(2007-8#3)(2008-10#36)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#2)(2009-3#2)(2009-8#3)(2010-12#1)(2010-2#1)(2010-5#5)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#3)(2013-1#1)
reactions on solid##2##3##(1997-4#1)(2008-10#1)
reactions on the##5##3##(1995-12#1)(1995-6#1)(1997-1#1)(2007-8#1)(2008-6#1)
reactions on##17##2##(1990-3#1)(1991-5#1)(1995-12#1)(1995-6#1)(1997-1#1)(1997-4#1)(2007-11#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-6#1)
reactions or##5##2##(1995-8#1)(2005-10#2)(2008-10#1)(2011-2#1)
reactions per##2##2##(2008-10#1)(2008-2#1)
reactions performed##2##2##(1994-9#1)(2008-10#1)
reactions previously##2##2##(2010-12#2)
reactions ranged from 8 mm to 18 mm (mean =##2##10##(2011-1#2)
reactions ranged from##3##3##(2011-1#2)(2013-8#1)
reactions related to the##2##4##(2007-1#1)(2012-1#1)
reactions related to##4##3##(1997-5#2)(2007-1#1)(2012-1#1)
reactions required##2##2##(1996-2#1)(1997-3#1)
reactions such as pain##2##4##(2007-11#2)
reactions such as##6##3##(2006-10#1)(2007-11#3)(2008-5#1)(2011-2#1)
reactions taking place at the##2##5##(2007-11#1)(2010-7#1)
reactions than##4##2##(1991-12#1)(2004-11#1)(2005-10#1)(2007-11#1)
reactions that are believed to be##2##6##(1996-10#1)(2008-11#1)
reactions that are##8##3##(1990-8#1)(1994-12#1)(1996-10#1)(2004-4#1)(2006-4#1)(2008-11#1)(2008-8#1)(2012-12#1)
reactions that can##2##3##(2008-10#1)(2010-6#1)
reactions that may##3##3##(2007-11#1)(2008-11#1)(2012-1#1)
reactions that occur##2##3##(2006-10#1)(2008-10#1)
reactions that require##2##3##(1994-3#1)(2008-1#1)
reactions that##27##2##(1990-12#1)(1990-8#1)(1991-8#1)(1994-12#1)(1994-3#1)(1995-8#1)(1996-10#1)(2004-4#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)
reactions through##4##2##(1994-11#1)(2010-11#1)(2010-12#1)(2013-8#1)
reactions to a number of##2##5##(2006-10#1)(2012-2#1)
reactions to be##4##3##(1991-7#1)(1994-11#1)(2007-8#1)(2010-11#1)
reactions to drugs##5##3##(1990-12#1)(1993-10#1)(1994-9#1)(2008-10#1)(2008-8#1)
reactions to mosquito bites in##2##5##(2011-1#2)
reactions to mosquito bites##5##4##(2011-1#5)
reactions to stress##2##3##(1996-5#1)(2007-6#1)
reactions to the##15##3##(1990-2#1)(1996-3#1)(2004-2#1)(2005-12#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)
reactions to trauma##2##3##(2011-2#2)
reactions to##102##2##(1990-12#2)(1990-2#1)(1990-3#1)(1991-7#2)(1993-1#1)(1993-10#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-11#1)(1996-3#3)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(2004-2#1)(2004-9#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-10#2)(2007-11#3)(2007-12#1)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#2)(2008-7#2)(2008-8#5)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#3)(2011-1#9)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#3)
reactions towards##4##2##(1994-12#2)(1994-9#2)
reactions under##3##2##(1992-11#1)(2008-10#1)(2010-6#1)
reactions using##8##2##(1994-3#1)(2008-10#3)(2008-4#2)(2009-6#1)(2013-1#1)
reactions was##15##2##(1993-6#1)(1994-3#1)(1994-8#1)(2005-1#1)(2008-10#6)(2008-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
reactions were carried out##7##4##(1991-11#1)(1995-8#1)(1996-9#1)(2007-11#2)(2008-6#1)(2010-9#1)
reactions were conducted in##2##4##(1993-8#1)(2010-6#1)
reactions were conducted##3##3##(1993-8#1)(2010-2#1)(2010-6#1)
reactions were determined##2##3##(1994-5#1)(1996-9#1)
reactions were enhanced by##2##4##(2007-8#1)(2011-2#1)
reactions were inhibited by##2##4##(1992-9#1)(1993-4#1)
reactions were mild##2##3##(2007-6#1)(2012-12#1)
reactions were not##2##3##(1990-7#1)(2008-10#1)
reactions were observed in##4##4##(2008-10#1)(2010-5#1)(2013-1#1)(2013-8#1)
reactions were observed##12##3##(1990-2#1)(1992-1#1)(1992-9#1)(1996-1#1)(1996-8#1)(1997-1#1)(2005-12#1)(2005-8#1)(2008-10#1)(2010-5#1)(2013-1#1)(2013-8#1)
reactions were performed under##2##4##(1992-7#1)(2008-5#1)
reactions were performed##3##3##(1992-7#1)(2008-10#1)(2008-5#1)
reactions were reported in##2##4##(1991-11#1)(2011-2#1)
reactions were reported##3##3##(1991-11#1)(2008-2#1)(2011-2#1)
reactions were studied##3##3##(1992-6#1)(2008-10#2)
reactions were##76##2##(1990-2#2)(1990-7#1)(1991-11#2)(1992-1#1)(1992-4#1)(1992-6#2)(1992-7#1)(1992-9#2)(1993-12#1)(1993-4#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-4#1)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#1)(2004-9#1)(2005-12#1)(2005-8#1)(2006-12#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#11)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
reactions when##3##2##(1994-9#1)(2008-5#1)(2008-6#1)
reactions which were##3##3##(2008-6#1)(2010-2#1)(2012-12#1)
reactions which##7##2##(1991-3#1)(1992-6#1)(1997-2#1)(2008-11#1)(2008-6#1)(2010-2#1)(2012-12#1)
reactions will##4##2##(1991-2#1)(2008-10#1)(2010-7#1)(2012-6#1)
reactions with a##2##3##(2007-11#1)(2009-10#1)
reactions with different##3##3##(2007-11#2)(2008-10#1)
reactions with the##11##3##(1994-9#1)(1995-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2010-5#3)
reactions with##65##2##(1990-12#1)(1992-3#1)(1993-12#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-7#1)(1996-2#4)(1996-5#2)(1997-6#2)(1997-7#1)(2006-10#1)(2006-3#1)(2007-11#3)(2007-8#2)(2008-10#11)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2010-5#5)(2010-6#1)(2011-1#2)(2011-2#1)(2012-3#3)
reactions within the##4##3##(2008-7#1)(2009-12#1)(2009-9#1)(2012-2#1)
reactions within##7##2##(2008-10#1)(2008-7#1)(2009-12#1)(2009-8#1)(2009-9#2)(2012-2#1)
reactions##1697##1##(1990-1#1)(1990-10#5)(1990-11#5)(1990-12#12)(1990-2#8)(1990-3#6)(1990-4#2)(1990-5#6)(1990-6#2)(1990-7#5)(1990-8#10)(1990-9#4)(1991-1#2)(1991-10#2)(1991-11#7)(1991-12#7)(1991-2#7)(1991-3#6)(1991-4#4)(1991-5#5)(1991-6#2)(1991-7#10)(1991-8#3)(1991-9#8)(1992-1#3)(1992-10#3)(1992-11#7)(1992-12#6)(1992-2#4)(1992-3#7)(1992-4#3)(1992-5#2)(1992-6#19)(1992-7#2)(1992-8#7)(1992-9#10)(1993-1#3)(1993-10#1)(1993-11#1)(1993-12#12)(1993-2#4)(1993-3#4)(1993-4#6)(1993-5#3)(1993-6#7)(1993-8#4)(1993-9#3)(1994-11#10)(1994-12#10)(1994-2#6)(1994-3#13)(1994-5#8)(1994-6#9)(1994-8#9)(1994-9#15)(1995-1#7)(1995-10#3)(1995-11#4)(1995-12#4)(1995-2#8)(1995-3#7)(1995-4#3)(1995-5#1)(1995-6#9)(1995-7#2)(1995-8#15)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#5)(1996-12#2)(1996-2#12)(1996-3#12)(1996-4#2)(1996-5#16)(1996-6#5)(1996-7#3)(1996-8#9)(1996-9#8)(1997-1#9)(1997-2#17)(1997-3#9)(1997-4#8)(1997-5#6)(1997-6#8)(1997-7#8)(1997-8#6)(2004-11#2)(2004-12#1)(2004-2#1)(2004-4#4)(2004-9#4)(2005-1#1)(2005-10#5)(2005-11#12)(2005-12#3)(2005-4#2)(2005-7#2)(2005-8#7)(2005-9#3)(2006-1#1)(2006-10#30)(2006-11#1)(2006-12#18)(2006-2#7)(2006-3#8)(2006-4#5)(2006-5#1)(2006-6#4)(2006-8#8)(2006-9#1)(2007-1#3)(2007-10#10)(2007-11#78)(2007-12#12)(2007-2#6)(2007-3#3)(2007-5#7)(2007-6#5)(2007-7#12)(2007-8#22)(2007-9#4)(2008-1#4)(2008-10#242)(2008-11#31)(2008-12#9)(2008-2#13)(2008-3#19)(2008-4#33)(2008-5#41)(2008-6#12)(2008-7#38)(2008-8#43)(2008-9#9)(2009-1#1)(2009-10#13)(2009-11#4)(2009-12#9)(2009-2#4)(2009-3#5)(2009-4#1)(2009-5#5)(2009-6#7)(2009-7#2)(2009-8#17)(2009-9#6)(2010-10#5)(2010-11#3)(2010-12#17)(2010-2#6)(2010-3#1)(2010-4#9)(2010-5#27)(2010-6#12)(2010-7#12)(2010-8#13)(2010-9#2)(2011-1#29)(2011-12#3)(2011-2#47)(2012-1#10)(2012-11#3)(2012-12#21)(2012-2#19)(2012-3#11)(2012-6#1)(2013-1#23)(2013-7#1)(2013-8#18)
reactions)##3##1##(2006-12#1)(2008-11#1)(2008-8#1)
reactions?##2##1##(2009-8#1)(2010-12#1)
reactivate HIV from latency##2##4##(2012-12#2)
reactivate##17##1##(1990-5#1)(1992-7#1)(1995-1#1)(1995-6#2)(1997-4#1)(1997-7#1)(2008-5#3)(2008-9#1)(2009-4#1)(2009-9#1)(2011-2#1)(2012-12#2)(2013-8#1)
reactivated by incubation with##3##4##(1992-12#1)(1993-11#1)(1994-12#1)
reactivated by##9##2##(1991-9#1)(1992-11#1)(1992-12#1)(1993-11#2)(1994-12#1)(1995-1#1)(1995-8#1)(2007-8#1)
reactivated during##2##2##(1992-12#1)(2012-2#1)
reactivated the##2##2##(1990-7#1)(1996-3#1)
reactivated with##4##2##(1990-11#1)(1993-6#1)(1995-8#1)(2008-5#1)
reactivated##28##1##(1990-11#1)(1990-7#1)(1991-9#1)(1992-11#1)(1992-12#3)(1993-11#2)(1993-6#1)(1993-8#1)(1994-12#1)(1995-1#1)(1995-8#2)(1996-3#1)(1997-4#2)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
reactivates##4##1##(1995-6#1)(2008-1#1)(2008-10#2)
reactivating##2##1##(2007-11#1)(2009-9#1)
reactivation and##5##2##(1990-7#1)(2006-10#1)(2008-5#1)(2009-4#1)(2012-12#1)
reactivation by the##2##3##(1991-1#1)(2013-8#1)
reactivation by##4##2##(1991-1#1)(1993-11#1)(2007-11#1)(2013-8#1)
reactivation can be##2##3##(1992-9#1)(2006-10#1)
reactivation from##2##2##(1994-6#1)(2006-10#1)
reactivation in##4##2##(2006-10#1)(2009-3#1)(2011-1#1)(2013-1#1)
reactivation of a latent infection##2##5##(1993-5#1)(2010-12#1)
reactivation of a latent##3##4##(1993-5#1)(2010-12#2)
reactivation of inhibited##2##3##(1995-1#1)(1997-7#1)
reactivation of the##7##3##(1991-5#1)(1992-10#1)(1994-11#1)(1996-1#1)(2008-7#2)(2009-2#1)
reactivation of##34##2##(1990-7#2)(1991-5#1)(1992-10#1)(1993-5#1)(1993-8#2)(1994-10#1)(1994-11#1)(1995-1#2)(1996-1#1)(1997-7#1)(2005-7#1)(2006-10#3)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-3#1)(2010-12#2)(2011-2#1)(2012-12#1)(2013-1#1)
reactivation##84##1##(1990-11#1)(1990-5#1)(1990-7#3)(1991-1#1)(1991-10#1)(1991-3#1)(1991-5#1)(1992-10#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#2)(1994-3#1)(1994-6#1)(1995-1#3)(1995-6#2)(1995-8#1)(1996-1#1)(1997-7#1)(2004-1#1)(2005-7#1)(2006-10#11)(2007-10#1)(2007-11#5)(2007-12#1)(2008-1#1)(2008-10#4)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#2)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#2)(2010-1#1)(2010-10#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#3)(2013-1#2)(2013-7#1)(2013-8#1)
reactivations##4##1##(2008-1#2)(2008-12#1)(2012-2#1)
reactive IgM##2##2##(1992-9#1)(2007-11#1)
reactive against##4##2##(1990-11#1)(1997-5#1)(2007-11#1)(2008-4#1)
reactive aldehyde##2##2##(1994-8#1)(2008-12#1)
reactive aldehydes##2##2##(1993-3#1)(2008-7#1)
reactive amino##2##2##(1990-12#1)(1995-2#1)
reactive and##17##2##(1990-3#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-4#1)(2011-2#1)(2012-12#1)
reactive antibodies##3##2##(1997-6#1)(2007-2#1)(2008-1#1)
reactive arthritis caused by##2##4##(1990-6#1)(2007-11#1)
reactive arthritis##16##2##(1990-6#5)(1993-9#1)(1994-8#3)(2006-10#3)(2007-11#2)(2008-7#1)(2012-2#1)
reactive astrocytes may##2##3##(1995-12#1)(2013-7#1)
reactive astrocytes##8##2##(1994-2#1)(1995-12#3)(1995-7#1)(1996-11#1)(2007-3#1)(2013-7#1)
reactive blending##3##2##(2008-10#3)
reactive blue 2##3##3##(1995-12#1)(1997-1#1)(2008-4#1)
reactive carbonyl##7##2##(2004-11#5)(2008-5#2)
reactive cells##2##2##(1990-2#1)(2008-9#1)
reactive cellular##2##2##(1992-8#1)(2012-12#1)
reactive centers##2##2##(1994-5#2)
reactive changes##4##2##(1997-3#1)(2010-3#1)(2010-9#1)(2011-2#1)
reactive control##5##2##(2009-8#1)(2011-2#4)
reactive disease##2##2##(1990-10#1)(1995-11#1)
reactive dye bath##2##3##(2008-1#2)
reactive dye##5##2##(2005-12#1)(2008-1#2)(2008-10#2)
reactive dyes and##2##3##(2008-1#1)(2008-10#1)
reactive dyes##6##2##(2008-1#4)(2008-10#2)
reactive electrophilic##3##2##(1995-12#1)(1997-8#1)(2006-12#1)
reactive for NADPH-diaphorase##2##3##(1995-6#2)
reactive for cytokeratin AE1/3##2##4##(1994-8#2)
reactive for##7##2##(1994-8#2)(1995-2#1)(1995-6#2)(2007-7#1)(2007-9#1)
reactive forms of##2##3##(1996-11#1)(2009-8#1)
reactive gas##2##2##(2005-11#1)(2008-10#1)
reactive gingival##2##2##(2007-12#1)(2012-12#1)
reactive glia##2##2##(1990-7#1)(2013-7#1)
reactive glial cells in##2##4##(1990-2#2)
reactive glial cells##4##3##(1990-2#4)
reactive gliosis##4##2##(1994-2#2)(1996-10#1)(1996-3#1)
reactive group##5##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
reactive groups##3##2##(1991-9#1)(1995-6#1)(2008-4#1)
reactive hyperaemia##3##2##(1997-6#1)(2006-7#1)(2008-3#1)
reactive hyperemia in##2##3##(2008-4#2)
reactive hyperemia##5##2##(1997-2#1)(2008-4#4)
reactive in the##2##3##(1991-7#1)(2006-10#1)
reactive in##12##2##(1990-12#1)(1991-7#1)(1993-6#1)(2006-10#1)(2007-8#2)(2008-12#1)(2008-3#1)(2010-8#1)(2011-11#2)(2012-3#1)
reactive intermediate##7##2##(1990-12#1)(1990-7#1)(1995-6#3)(2005-7#1)(2008-5#1)
reactive intermediates that##2##3##(1995-7#2)
reactive intermediates##12##2##(1991-9#1)(1995-7#6)(1996-12#1)(2008-10#2)(2008-7#1)(2013-8#1)
reactive ion etching (RIE)##3##4##(2008-1#1)(2009-11#2)
reactive ion etching##10##3##(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#3)(2009-11#2)(2010-4#1)
reactive ion##11##2##(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#3)(2009-11#3)(2010-4#1)
reactive iron##3##2##(2008-10#3)
reactive lesions##2##2##(1990-3#1)(2007-12#1)
reactive lymphoid##2##2##(1992-6#1)(2005-8#1)
reactive mechanism##3##2##(2004-9#1)(2008-10#2)
reactive metabolite of##2##3##(1997-8#1)(2010-8#1)
reactive metabolite##5##2##(1991-9#1)(1997-2#1)(1997-8#1)(2008-10#1)(2010-8#1)
reactive metabolites to##2##3##(1991-1#1)(1994-5#1)
reactive metabolites##7##2##(1990-9#1)(1991-1#1)(1994-5#1)(1996-11#1)(2005-7#1)(2008-10#1)(2008-3#1)
reactive metal##2##2##(1997-2#1)(2008-3#1)
reactive microglia##2##2##(1995-12#2)
reactive microgliosis##2##2##(1996-5#1)(2008-7#1)
reactive moieties##2##2##(1993-8#1)(2010-12#1)
reactive molecules##2##2##(1994-2#1)(2009-12#1)
reactive nature##4##2##(1995-1#1)(2012-3#1)(2013-1#2)
reactive nitrogen species (RNS)##3##4##(2008-5#1)(2011-1#1)(2011-2#1)
reactive nitrogen species##4##3##(2008-5#1)(2009-8#1)(2011-1#1)(2011-2#1)
reactive nitrogen##10##2##(1991-6#1)(1992-7#2)(1996-11#1)(2007-11#1)(2008-4#1)(2008-5#1)(2009-8#1)(2011-1#1)(2011-2#1)
reactive nurses who##2##3##(1996-2#2)
reactive or secondary##2##3##(2007-9#1)(2008-5#1)
reactive or##4##2##(1992-8#1)(2007-9#1)(2008-3#1)(2008-5#1)
reactive oxidant##2##2##(2008-10#1)(2012-12#1)
reactive oxygen and nitrogen species)##2##5##(2008-5#1)(2008-7#1)
reactive oxygen and nitrogen##3##4##(2008-5#1)(2008-7#1)(2011-2#1)
reactive oxygen and##6##3##(2008-5#1)(2008-7#2)(2009-8#2)(2011-2#1)
reactive oxygen generation##3##3##(1994-3#1)(1994-8#1)(2008-7#1)
reactive oxygen intermediates (ROIs)##2##4##(1993-7#1)(2008-7#1)
reactive oxygen intermediates##6##3##(1991-9#1)(1993-7#2)(1995-8#1)(2006-10#1)(2008-7#1)
reactive oxygen metabolites and paraoxonase 1##2##6##(2012-12#2)
reactive oxygen metabolites and##3##4##(2012-12#2)(2012-3#1)
reactive oxygen metabolites produced by##2##5##(1993-6#2)
reactive oxygen metabolites##7##3##(1993-6#2)(2010-8#1)(2012-12#3)(2012-3#1)
reactive oxygen radicals##2##3##(1991-9#1)(1995-8#1)
reactive oxygen species (ROS) and##4##5##(2009-5#1)(2010-5#1)(2010-7#1)(2012-2#1)
reactive oxygen species (ROS) are##4##5##(2008-10#2)(2012-12#2)
reactive oxygen species (ROS) as##2##5##(1994-11#1)(2010-1#1)
reactive oxygen species (ROS) formation##2##5##(1994-6#1)(2012-12#1)
reactive oxygen species (ROS) production##4##5##(2008-1#1)(2008-10#1)(2008-4#1)(2012-1#1)
reactive oxygen species (ROS) superoxide##2##5##(2008-10#1)(2011-2#1)
reactive oxygen species (ROS) which##2##5##(2008-10#1)(2008-11#1)
reactive oxygen species (ROS)##80##4##(1992-12#1)(1992-3#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-1#4)(2008-10#10)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#2)(2009-5#2)(2009-6#1)(2009-8#7)(2010-1#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#6)(2012-1#2)(2012-12#4)(2012-2#2)(2012-6#1)(2013-1#2)(2013-8#2)
reactive oxygen species and serine proteases##2##6##(1990-9#2)
reactive oxygen species and##15##4##(1990-9#2)(2006-2#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-4#3)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
reactive oxygen species by##6##4##(1992-6#1)(2006-10#1)(2008-10#1)(2008-11#1)(2009-3#1)(2010-1#1)
reactive oxygen species generated by##2##5##(1993-11#1)(2008-4#1)
reactive oxygen species generation##2##4##(2008-4#1)(2009-12#1)
reactive oxygen species have been##4##5##(1995-7#1)(1996-8#1)(2008-10#1)(2009-6#1)
reactive oxygen species in the##9##5##(1992-6#1)(1994-3#1)(1997-4#1)(2008-4#2)(2008-5#1)(2009-12#1)(2009-8#1)(2010-10#1)
reactive oxygen species in##13##4##(1992-6#3)(1994-2#1)(1994-3#1)(1994-6#1)(1997-4#1)(2008-4#2)(2008-5#1)(2009-12#1)(2009-8#1)(2010-10#1)
reactive oxygen species production##6##4##(1991-9#1)(2010-12#2)(2010-4#1)(2010-7#1)(2011-1#1)
reactive oxygen species that##4##4##(1993-3#1)(2005-7#1)(2008-8#1)(2011-1#1)
reactive oxygen species##209##3##(1990-11#1)(1990-3#1)(1990-9#3)(1991-9#4)(1992-12#2)(1992-3#1)(1992-6#7)(1992-7#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#2)(1995-1#1)(1995-7#2)(1995-8#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#4)(1997-6#2)(1997-8#2)(2005-10#1)(2005-7#2)(2005-8#1)(2006-10#3)(2006-2#2)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#8)(2008-10#19)(2008-11#9)(2008-2#1)(2008-3#2)(2008-4#12)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#1)(2009-10#2)(2009-12#4)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#10)(2010-1#2)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#2)(2011-1#7)(2011-10#1)(2011-12#2)(2011-2#7)(2012-1#2)(2012-12#4)(2012-2#3)(2012-6#1)(2013-1#6)(2013-8#4)
reactive oxygen species-potentiated invasive capacity by simultaneously treating AH109A cells with##2##11##(2008-11#2)
reactive oxygen##243##2##(1990-11#1)(1990-3#1)(1990-9#3)(1991-6#1)(1991-9#6)(1992-12#2)(1992-3#1)(1992-6#7)(1992-7#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-6#2)(1993-7#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#1)(1995-1#1)(1995-6#1)(1995-7#2)(1995-8#3)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#4)(1997-6#2)(1997-8#2)(2005-10#1)(2005-7#2)(2005-8#1)(2006-10#4)(2006-2#2)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#8)(2008-10#20)(2008-11#11)(2008-2#1)(2008-3#2)(2008-4#13)(2008-5#7)(2008-6#1)(2008-7#9)(2008-8#5)(2008-9#1)(2009-10#2)(2009-12#4)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#12)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#7)(2011-10#1)(2011-12#2)(2011-2#8)(2012-1#2)(2012-12#7)(2012-2#3)(2012-3#1)(2012-6#1)(2013-1#6)(2013-8#4)
reactive periostitis ossificans of the distal ulna##2##7##(2009-3#2)
reactive periostitis ossificans##3##3##(2009-3#3)
reactive periostitis##7##2##(2009-3#7)
reactive phosphate##2##2##(2008-10#2)
reactive phosphorus (DRP)##3##3##(2008-10#3)
reactive phosphorus##4##2##(2007-8#1)(2008-10#3)
reactive products##2##2##(1992-5#1)(2010-5#1)
reactive protein##10##2##(1990-11#1)(1996-1#1)(2008-10#3)(2008-3#3)(2013-1#1)(2013-8#1)
reactive response##2##2##(1997-3#1)(2009-8#1)
reactive site loop of maspin##2##5##(1995-6#2)
reactive site##8##2##(1991-8#3)(1995-1#1)(1995-6#2)(2009-4#1)(2010-4#1)
reactive sites##3##2##(1990-8#1)(1996-9#1)(2010-4#1)
reactive species production##2##3##(2008-1#2)
reactive species##18##2##(1991-10#1)(1992-12#1)(1994-8#1)(1995-1#1)(1996-6#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-4#1)(2013-1#1)
reactive strains##2##2##(1995-8#2)
reactive strongly with##2##3##(1993-12#1)(2008-8#1)
reactive substances##26##2##(1992-3#2)(1992-8#1)(1993-2#1)(1995-1#1)(1995-3#2)(1995-6#1)(1997-8#1)(2004-12#1)(2005-1#1)(2005-8#1)(2006-2#1)(2007-9#2)(2008-10#3)(2008-4#1)(2011-2#5)(2012-2#1)(2013-8#1)
reactive sulfhydryl##3##2##(1990-12#2)(1996-2#1)
reactive surface##3##2##(2008-10#2)(2008-5#1)
reactive syphilis serology##2##3##(2012-3#2)
reactive systems##3##2##(2007-12#1)(2008-2#1)(2012-1#1)
reactive to the##3##3##(1991-12#1)(1995-12#1)(2006-8#1)
reactive to##18##2##(1990-10#1)(1991-12#1)(1991-5#1)(1991-6#1)(1993-12#1)(1994-11#1)(1995-12#1)(1995-8#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-11#4)(2010-6#1)
reactive transport##2##2##(2005-11#1)(2012-12#1)
reactive with a##3##3##(1990-10#1)(1995-9#1)(2008-10#1)
reactive with different##3##3##(1997-7#2)(2008-5#1)
reactive with the##4##3##(1990-7#1)(1991-7#1)(1995-12#1)(1997-7#1)
reactive with##35##2##(1990-10#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-7#3)(1991-9#1)(1992-3#1)(1992-9#1)(1993-12#2)(1993-8#1)(1993-9#1)(1994-12#2)(1994-9#2)(1995-1#1)(1995-12#1)(1995-9#1)(1996-12#1)(1997-6#1)(1997-7#4)(2008-10#4)(2008-4#2)(2008-5#1)(2008-6#1)
reactive##858##1##(1990-10#3)(1990-11#4)(1990-12#10)(1990-2#5)(1990-3#3)(1990-6#9)(1990-7#3)(1990-8#1)(1990-9#4)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#2)(1991-3#2)(1991-5#2)(1991-6#4)(1991-7#4)(1991-8#3)(1991-9#11)(1992-1#1)(1992-11#2)(1992-12#4)(1992-3#7)(1992-5#1)(1992-6#8)(1992-7#3)(1992-8#6)(1992-9#5)(1993-1#3)(1993-11#4)(1993-12#8)(1993-2#1)(1993-3#2)(1993-4#2)(1993-6#4)(1993-7#4)(1993-8#4)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#4)(1994-2#7)(1994-3#5)(1994-5#5)(1994-6#3)(1994-8#10)(1994-9#5)(1995-1#9)(1995-11#1)(1995-12#10)(1995-2#4)(1995-3#4)(1995-6#10)(1995-7#12)(1995-8#10)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#5)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#5)(1997-1#5)(1997-2#6)(1997-3#4)(1997-4#6)(1997-5#3)(1997-6#5)(1997-7#5)(1997-8#5)(2004-11#5)(2004-12#1)(2004-9#2)(2005-1#1)(2005-10#2)(2005-11#3)(2005-12#1)(2005-7#4)(2005-8#4)(2006-10#11)(2006-12#3)(2006-2#3)(2006-3#5)(2006-5#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#8)(2007-12#14)(2007-2#3)(2007-3#1)(2007-7#4)(2007-8#6)(2007-9#7)(2008-1#25)(2008-10#80)(2008-11#24)(2008-12#3)(2008-2#9)(2008-3#23)(2008-4#31)(2008-5#21)(2008-6#3)(2008-7#18)(2008-8#9)(2008-9#6)(2009-10#2)(2009-11#3)(2009-12#7)(2009-3#12)(2009-4#3)(2009-5#4)(2009-6#3)(2009-7#3)(2009-8#23)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#9)(2010-5#2)(2010-6#2)(2010-7#4)(2010-8#3)(2010-9#5)(2011-1#8)(2011-10#1)(2011-11#2)(2011-12#3)(2011-2#20)(2012-1#4)(2012-12#15)(2012-2#11)(2012-3#6)(2012-6#1)(2013-1#17)(2013-7#2)(2013-8#7)
reactive-appearing &quot##2##2##(1992-8#2)
reactive-ion etching##6##2##(2007-12#1)(2008-3#5)
reactivities during##2##2##(1992-6#1)(2010-4#1)
reactivities of patients with##2##4##(2009-8#2)
reactivities of##8##2##(1992-6#1)(1997-6#1)(2008-10#1)(2009-8#2)(2010-4#1)(2010-8#1)(2012-3#1)
reactivities were##2##2##(1992-6#1)(2010-12#1)
reactivities##22##1##(1990-11#1)(1992-6#3)(1992-8#1)(1994-4#1)(1995-6#1)(1997-4#1)(1997-6#2)(2005-11#1)(2007-3#1)(2008-10#1)(2008-11#1)(2009-8#2)(2010-12#1)(2010-4#2)(2010-5#1)(2010-8#1)(2012-3#1)
reactivity after##4##2##(1994-11#1)(1996-10#1)(2008-4#1)(2008-8#1)
reactivity against##6##2##(1990-12#1)(1992-8#1)(1994-5#1)(1995-12#1)(2008-9#1)(2012-12#1)
reactivity and selectivity##2##3##(2010-12#1)(2012-1#1)
reactivity and##29##2##(1991-12#1)(1992-4#1)(1993-9#1)(1994-6#2)(1995-8#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-7#1)(2006-12#2)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#3)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#1)
reactivity are##3##2##(2005-11#1)(2008-10#1)(2008-8#1)
reactivity as##3##2##(1993-6#1)(1997-2#1)(2008-7#1)
reactivity behavior##2##2##(1992-6#2)
reactivity between##7##2##(1993-3#1)(1995-5#1)(2006-8#1)(2007-8#1)(2008-8#1)(2010-6#1)(2011-2#1)
reactivity by##3##2##(2007-2#1)(2008-5#1)(2009-4#1)
reactivity during the Valsalva maneuver##2##5##(2012-3#2)
reactivity during##5##2##(1992-1#1)(2008-11#1)(2010-3#1)(2012-3#2)
reactivity for##7##2##(1991-7#1)(1991-9#1)(1993-12#1)(2006-12#1)(2008-5#1)(2010-2#1)(2010-4#1)
reactivity has been##2##3##(1992-8#1)(2009-5#1)
reactivity has##3##2##(1992-8#1)(2006-12#1)(2009-5#1)
reactivity in Gujarati Indian##2##4##(2012-2#2)
reactivity in a##2##3##(1990-9#1)(2010-12#1)
reactivity in aqueous##2##3##(2005-11#1)(2008-10#1)
reactivity in patients##2##3##(2006-10#1)(2013-7#1)
reactivity in the##7##3##(1991-11#1)(1995-12#2)(1995-8#1)(2008-10#1)(2008-7#1)(2012-2#1)
reactivity in these##2##3##(2005-8#1)(2012-12#1)
reactivity in##38##2##(1990-9#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#1)(1993-12#1)(1993-2#1)(1994-11#2)(1994-12#1)(1994-6#1)(1995-12#2)(1995-8#2)(1996-1#1)(1996-9#1)(1997-4#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-7#1)
reactivity is impaired##2##3##(1996-9#1)(2013-1#1)
reactivity is##10##2##(1995-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-12#1)(2008-7#2)(2008-8#1)(2013-1#1)
reactivity level##2##2##(1995-8#2)
reactivity of a##2##3##(1994-5#1)(2010-5#1)
reactivity of all##2##3##(1993-9#1)(1997-3#1)
reactivity of the two##4##4##(1991-8#1)(1994-12#1)(1996-2#1)(2007-11#1)
reactivity of the##38##3##(1990-11#1)(1990-12#1)(1991-8#2)(1992-9#1)(1994-12#2)(1994-3#1)(1995-12#2)(1996-2#5)(1996-5#1)(1997-2#1)(1997-7#3)(1997-8#3)(2005-11#2)(2007-11#2)(2008-10#5)(2008-3#1)(2008-5#1)(2010-4#1)(2010-5#1)(2012-2#1)(2013-1#1)
reactivity of these##4##3##(1992-2#1)(1992-7#1)(1993-2#1)(2008-10#1)
reactivity of two##4##3##(1990-12#1)(1992-8#1)(1994-11#1)(2008-4#1)
reactivity of##118##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#1)(1991-4#1)(1991-7#1)(1991-8#2)(1992-2#1)(1992-7#4)(1992-8#2)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#3)(1996-2#6)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-7#3)(1997-8#4)(2005-11#2)(2006-12#3)(2006-3#1)(2006-9#1)(2007-11#10)(2007-12#1)(2008-10#13)(2008-11#1)(2008-3#3)(2008-4#3)(2008-5#5)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-4#2)(2010-5#4)(2012-2#3)(2013-1#2)
reactivity on##2##2##(1990-12#1)(2013-1#1)
reactivity or##4##2##(1993-12#1)(1995-2#1)(2007-11#1)(2007-9#1)
reactivity ratios for the copolymerization of AGE and EGVGE with EO could be determined by analysis of the (1)H NMR spectroscopy for the resulting copolymer##2##25##(2012-12#2)
reactivity ratios##6##2##(2012-12#6)
reactivity than##2##2##(1990-2#1)(2012-2#1)
reactivity through Mcl-1/Bim##2##3##(2013-1#2)
reactivity to a##2##3##(1993-8#1)(2011-2#1)
reactivity to both##2##3##(2009-11#2)
reactivity to stress##2##3##(1993-12#1)(2008-11#1)
reactivity to the##3##3##(1992-12#1)(2005-7#1)(2011-2#1)
reactivity to tumor antigens##2##4##(1991-12#1)(2008-5#1)
reactivity to##50##2##(1990-2#1)(1990-3#1)(1991-1#2)(1991-11#1)(1991-12#1)(1992-12#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-5#2)(1993-8#1)(1994-11#1)(1995-1#2)(1995-5#2)(1996-4#1)(2005-7#1)(2006-12#1)(2006-8#2)(2007-2#3)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#4)(2009-11#3)(2010-3#3)(2010-4#1)(2010-5#1)(2011-2#6)(2012-12#1)(2012-2#1)
reactivity toward##3##2##(1990-2#1)(1992-9#1)(1994-6#1)
reactivity towards the##3##3##(1991-3#1)(1997-7#1)(1997-8#1)
reactivity towards##8##2##(1991-3#1)(1992-9#1)(1993-3#1)(1997-7#1)(1997-8#1)(2008-10#1)(2010-5#1)(2010-7#1)
reactivity was assessed by##2##4##(1991-5#1)(2008-4#1)
reactivity was not##2##3##(1995-1#1)(2006-10#1)
reactivity was observed with##3##4##(1991-9#1)(1993-2#1)(1996-4#1)
reactivity was##24##2##(1990-11#1)(1990-12#1)(1991-1#1)(1991-5#1)(1991-7#1)(1991-9#2)(1993-2#1)(1993-3#1)(1995-1#2)(1996-4#1)(1996-7#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-7#3)(2011-2#2)
reactivity were##4##2##(1996-5#1)(2006-12#1)(2008-12#1)(2008-3#1)
reactivity with all##2##3##(1995-12#1)(2008-5#1)
reactivity with both##2##3##(1990-12#1)(2012-1#1)
reactivity with the##4##3##(1990-3#1)(1992-2#1)(1994-5#1)(2007-2#1)
reactivity with this##2##3##(1991-7#1)(2010-11#1)
reactivity with##27##2##(1990-12#2)(1990-3#1)(1991-11#1)(1991-7#2)(1991-8#1)(1992-2#1)(1992-7#1)(1992-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(1996-2#1)(2007-2#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-11#1)(2012-1#1)
reactivity within##2##2##(1995-5#1)(1996-7#1)
reactivity without##2##2##(2008-10#1)(2008-7#1)
reactivity##517##1##(1990-10#1)(1990-11#2)(1990-12#11)(1990-2#4)(1990-3#2)(1990-5#1)(1990-9#1)(1991-1#3)(1991-11#3)(1991-12#3)(1991-3#2)(1991-4#2)(1991-5#4)(1991-7#5)(1991-8#5)(1991-9#3)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#6)(1992-8#5)(1992-9#5)(1993-1#1)(1993-12#6)(1993-2#3)(1993-3#5)(1993-5#3)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#2)(1994-11#6)(1994-12#6)(1994-2#1)(1994-3#4)(1994-5#3)(1994-6#7)(1994-8#1)(1994-9#8)(1995-1#7)(1995-11#1)(1995-12#7)(1995-2#7)(1995-5#6)(1995-7#1)(1995-8#9)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#7)(1996-3#5)(1996-4#2)(1996-5#2)(1996-7#3)(1996-9#5)(1997-1#3)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#5)(1997-8#8)(2004-9#1)(2005-11#6)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#4)(2006-12#13)(2006-2#2)(2006-3#1)(2006-6#2)(2006-8#5)(2006-9#1)(2007-10#1)(2007-11#16)(2007-12#3)(2007-2#7)(2007-7#3)(2007-8#4)(2007-9#3)(2008-1#3)(2008-10#33)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#9)(2008-5#18)(2008-7#13)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#5)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#5)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#7)(2010-2#3)(2010-3#4)(2010-4#7)(2010-5#6)(2010-6#3)(2010-7#2)(2011-11#2)(2011-2#14)(2012-1#2)(2012-12#14)(2012-2#13)(2012-3#4)(2013-1#10)(2013-7#1)
reactivity)##2##1##(1996-2#1)(2007-2#1)
reactor (KR)##2##2##(2008-10#2)
reactor 1##3##2##(2008-10#2)(2011-1#1)
reactor 2##4##2##(2008-10#2)(2011-1#2)
reactor and a##3##3##(2008-10#3)
reactor and##14##2##(1991-5#1)(2004-4#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)
reactor are##2##2##(1994-2#1)(2008-10#1)
reactor at##9##2##(1995-3#1)(2004-8#3)(2007-9#2)(2008-11#1)(2008-7#1)(2009-6#1)
reactor coil##2##2##(2008-10#2)
reactor column##4##2##(2008-10#4)
reactor containing##2##2##(2008-10#2)
reactor for the##2##3##(1995-3#1)(2004-8#1)
reactor for##11##2##(1991-5#1)(1995-3#1)(2004-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
reactor in a##2##3##(2007-8#1)(2008-10#1)
reactor in the##2##3##(2008-10#2)
reactor in##5##2##(2007-8#2)(2008-10#3)
reactor is##8##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2013-1#1)
reactor length##3##2##(2008-10#3)
reactor operation##2##2##(2006-8#1)(2008-7#1)
reactor performance##4##2##(1990-9#1)(2006-8#1)(2008-11#1)(2008-7#1)
reactor productivity##2##2##(2008-11#1)(2008-7#1)
reactor system##7##2##(2006-10#4)(2008-1#1)(2008-10#2)
reactor temperature##2##2##(2009-2#1)(2013-1#1)
reactor types##3##2##(2004-4#1)(2008-11#1)(2010-5#1)
reactor under##2##2##(2007-10#1)(2013-1#1)
reactor used##2##2##(2008-3#1)(2008-7#1)
reactor using##4##2##(2004-8#1)(2008-10#2)(2008-7#1)
reactor volume##2##2##(2008-10#1)(2008-11#1)
reactor was operated under##2##4##(2007-10#1)(2013-1#1)
reactor was used##2##3##(1994-5#1)(2008-10#1)
reactor was##12##2##(1994-5#1)(2007-10#1)(2007-12#2)(2008-10#5)(2008-5#1)(2008-6#1)(2013-1#1)
reactor were##2##2##(1994-2#1)(2008-10#1)
reactor with a##2##3##(2008-11#1)(2008-7#1)
reactor with##10##2##(1991-5#1)(1994-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#3)(2008-7#1)
reactor##275##1##(1990-3#1)(1990-9#2)(1991-5#6)(1992-1#3)(1992-11#2)(1994-11#1)(1994-2#2)(1994-5#2)(1995-3#3)(1996-6#2)(1997-2#1)(1997-3#1)(2004-4#3)(2004-8#6)(2006-10#7)(2006-7#1)(2006-8#6)(2007-10#9)(2007-11#1)(2007-12#13)(2007-8#7)(2007-9#2)(2008-1#3)(2008-10#84)(2008-11#23)(2008-12#2)(2008-2#3)(2008-3#1)(2008-5#9)(2008-6#17)(2008-7#18)(2008-9#2)(2009-2#3)(2009-6#3)(2010-5#3)(2011-1#3)(2011-2#2)(2013-1#15)(2013-8#3)
reactors and##6##2##(2006-2#1)(2008-10#3)(2008-12#2)
reactors for the determination of##3##5##(2008-10#3)
reactors for##6##2##(2004-4#1)(2008-10#3)(2008-6#1)(2008-7#1)
reactors have##3##2##(1997-6#1)(2008-12#1)(2008-5#1)
reactors in##3##2##(2007-12#1)(2008-10#2)
reactors that are##2##3##(2008-5#1)(2008-6#1)
reactors using##2##2##(2008-10#1)(2008-7#1)
reactors was##5##2##(2008-10#3)(2008-7#2)
reactors with##3##2##(2005-11#1)(2008-10#1)(2008-12#1)
reactors##80##1##(1992-11#1)(1997-3#1)(1997-6#1)(2004-4#1)(2005-11#2)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-10#30)(2008-11#3)(2008-12#6)(2008-2#2)(2008-5#7)(2008-6#3)(2008-7#13)(2009-6#1)(2011-2#2)(2013-1#1)
reacts directly##2##2##(1990-5#1)(1990-7#1)
reacts in a##3##3##(1991-3#1)(1991-7#1)(2008-10#1)
reacts in slightly acidic (0##2##5##(2008-10#2)
reacts in the##2##3##(1990-5#1)(2008-10#1)
reacts in##9##2##(1990-5#1)(1991-3#1)(1991-7#1)(1997-7#1)(2008-10#5)
reacts on Western blots with##2##5##(1992-8#1)(1995-12#1)
reacts on##4##2##(1991-8#1)(1992-8#1)(1995-12#1)(2005-4#1)
reacts rapidly with##3##3##(1997-4#1)(1997-7#1)(2008-10#1)
reacts to form a##2##4##(1991-3#1)(2010-4#1)
reacts to##10##2##(1991-3#1)(1992-2#1)(1993-5#1)(1995-5#1)(2007-5#1)(2008-5#1)(2009-6#1)(2009-8#1)(2010-4#1)(2010-5#1)
reacts with 2##3##3##(1990-5#1)(2006-4#1)(2008-10#1)
reacts with Fe(III)##2##3##(2008-10#2)
reacts with a variety of##3##5##(1997-8#1)(2008-10#1)(2010-6#1)
reacts with a##6##3##(1991-5#1)(1996-7#1)(1997-8#1)(2008-10#1)(2008-8#1)(2010-6#1)
reacts with all##2##3##(1993-9#1)(2010-5#1)
reacts with copper(II) to##2##4##(1996-2#1)(2007-8#1)
reacts with excess##4##3##(2008-10#3)(2008-8#1)
reacts with silylated##2##3##(1996-5#2)
reacts with the##10##3##(1992-9#1)(1994-8#1)(1997-1#1)(1997-4#1)(1997-8#1)(2008-10#4)(2010-2#1)
reacts with##130##2##(1990-2#5)(1990-5#2)(1990-6#1)(1990-7#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-9#1)(1994-2#1)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#1)(1995-12#2)(1996-2#6)(1996-3#1)(1996-5#3)(1996-7#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#2)(2005-11#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#57)(2008-4#1)(2008-5#4)(2008-8#2)(2009-2#1)(2010-1#1)(2010-12#1)(2010-2#4)(2010-5#5)(2010-6#1)(2011-12#1)
reacts##175##1##(1990-2#5)(1990-5#5)(1990-6#1)(1990-7#3)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-5#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#1)(1995-10#1)(1995-12#3)(1995-3#1)(1995-5#1)(1996-2#6)(1996-3#1)(1996-4#1)(1996-5#4)(1996-7#1)(1997-1#2)(1997-2#1)(1997-4#2)(1997-7#3)(1997-8#2)(2005-11#1)(2005-4#2)(2006-2#1)(2006-4#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#64)(2008-4#1)(2008-5#5)(2008-8#2)(2009-2#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#4)(2010-4#1)(2010-5#6)(2010-6#1)(2011-12#1)(2013-1#1)
reacylated##2##1##(1991-7#2)
reacylation of##2##2##(1990-2#1)(1991-9#1)
reacylation##5##1##(1990-2#1)(1991-7#3)(1991-9#1)
read &quot##2##2##(2006-3#1)(2010-12#1)
read about##2##2##(1996-8#1)(2007-9#1)
read and write##7##3##(2007-9#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2013-8#2)
read and##10##2##(2007-9#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-4#1)(2011-2#1)(2013-8#2)
read as##9##2##(2006-3#1)(2006-5#1)(2007-12#6)(2007-8#1)
read at##3##2##(2008-10#2)(2008-2#1)
read by##7##2##(1996-12#1)(2007-6#1)(2008-10#2)(2008-3#1)(2009-8#1)(2010-8#1)
read data##2##2##(2012-3#2)
read lengths##2##2##(2012-3#2)
read noise##2##2##(2007-12#1)(2008-3#1)
read out by##5##3##(2007-11#1)(2008-1#1)(2008-3#2)(2012-12#1)
read out##11##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#6)(2012-12#1)
read sentences##3##2##(2008-11#1)(2008-4#2)
read signal is##2##3##(2008-3#2)
read the##15##2##(1992-10#1)(1993-2#1)(2006-10#1)(2006-4#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
read##147##1##(1990-12#3)(1990-3#2)(1990-9#1)(1991-12#1)(1992-10#2)(1993-2#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-8#1)(1997-8#1)(2005-9#1)(2006-10#3)(2006-3#2)(2006-4#1)(2006-5#1)(2007-11#2)(2007-12#13)(2007-2#1)(2007-6#1)(2007-8#2)(2007-9#5)(2008-1#2)(2008-10#8)(2008-11#3)(2008-12#3)(2008-2#7)(2008-3#14)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-11#1)(2009-12#2)(2009-4#4)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-12#2)(2012-2#5)(2012-3#6)(2013-1#2)(2013-7#3)(2013-8#3)
read-only##5##1##(2008-2#4)(2008-3#1)
read-out##6##1##(2005-9#2)(2008-3#1)(2008-9#1)(2013-8#2)
read-through##9##1##(1990-7#1)(1991-7#1)(1994-12#1)(1994-8#1)(1997-2#1)(2008-7#2)(2012-2#1)(2012-3#1)
read-write sliders##3##2##(2008-2#3)
read-write##5##1##(2008-2#5)
read-write-erase##3##1##(2008-2#3)
readability and comprehensiveness of consumer##2##5##(2011-1#2)
readability and comprehensiveness of##3##4##(2011-1#3)
readability and##6##2##(2011-1#3)(2012-3#1)(2013-1#2)
readability index##2##2##(1992-8#2)
readability of##3##2##(2011-2#1)(2013-7#2)
readability##22##1##(1992-8#2)(2007-5#2)(2008-12#2)(2011-1#4)(2011-2#1)(2012-3#2)(2013-1#6)(2013-7#3)
readable format##2##2##(2008-4#1)(2010-8#1)
readable##11##1##(1996-4#1)(2006-10#1)(2008-10#1)(2008-4#2)(2010-3#1)(2010-4#1)(2010-8#3)(2013-7#1)
readdress the##2##2##(2007-12#1)(2008-3#1)
reader and##3##2##(1990-11#1)(2008-10#1)(2009-2#1)
reader is##7##2##(2006-1#1)(2007-2#1)(2007-4#1)(2008-4#1)(2008-5#1)(2009-3#1)(2011-12#1)
reader to the##4##3##(1992-8#1)(2007-2#1)(2008-9#1)(2010-11#1)
reader to##11##2##(1992-8#1)(2005-7#1)(2006-10#1)(2007-2#1)(2008-4#2)(2008-9#2)(2010-11#1)(2011-1#1)(2011-12#1)
reader##79##1##(1990-11#1)(1990-12#1)(1992-2#2)(1992-8#1)(1994-8#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-3#1)(2005-7#1)(2006-1#2)(2006-10#3)(2006-9#1)(2007-12#1)(2007-2#3)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#5)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-3#2)(2013-8#2)
reader's##4##1##(1997-3#1)(2007-2#2)(2012-11#1)
readers are##5##2##(2007-4#1)(2007-9#1)(2008-3#1)(2009-6#1)(2010-2#1)
readers can##2##2##(2008-1#1)(2008-6#1)
readers in##4##2##(1996-2#1)(2007-9#2)(2008-9#1)
readers of English as a foreign language##2##7##(2007-9#2)
readers of##4##2##(1991-3#1)(2007-9#2)(2008-10#1)
readers on##2##2##(2008-6#1)(2009-9#1)
readers should be aware of##2##5##(2006-1#1)(2008-12#1)
readers should##5##2##(2006-1#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-9#1)
readers some##3##2##(2005-7#1)(2008-4#2)
readers through##2##2##(1995-2#1)(2008-12#1)
readers to some of the##3##5##(2008-4#2)(2010-8#1)
readers to##15##2##(2005-7#1)(2006-5#1)(2007-2#1)(2008-11#1)(2008-2#2)(2008-4#4)(2008-8#1)(2009-4#2)(2010-7#1)(2010-8#1)
readers were##2##2##(2007-9#1)(2008-10#1)
readers who##3##2##(2004-10#2)(2005-10#1)
readers with a##3##3##(2008-4#1)(2008-7#1)(2012-2#1)
readers with an##2##3##(1991-4#1)(2012-12#1)
readers with the##3##3##(1993-9#1)(2007-4#1)(2009-5#1)
readers with##10##2##(1991-4#1)(1993-9#1)(2007-12#1)(2007-4#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-5#1)(2012-12#1)(2012-2#1)
readers would##2##2##(2011-2#1)(2013-7#1)
readers##115##1##(1991-3#1)(1991-4#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-9#1)(1995-2#1)(1996-2#1)(2004-10#4)(2005-10#1)(2005-7#2)(2006-1#1)(2006-5#1)(2007-10#3)(2007-12#2)(2007-2#2)(2007-4#4)(2007-5#2)(2007-8#1)(2007-9#11)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#7)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#2)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-9#5)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-12#3)(2012-2#3)(2012-3#6)(2013-7#2)
readers'##3##1##(2007-11#1)(2011-2#2)
readership of##5##2##(2006-7#1)(2007-11#1)(2008-4#2)(2012-2#1)
readership##11##1##(1995-1#1)(1995-12#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-8#1)(2011-2#1)(2012-2#1)
readily absorbed##2##2##(1994-3#1)(2008-4#1)
readily accept##3##2##(2007-2#1)(2008-7#1)(2010-8#1)
readily accepted##3##2##(1995-3#1)(2008-9#1)(2010-11#1)
readily accessible for##2##3##(1995-2#1)(2005-8#1)
readily accessible##13##2##(1991-7#1)(1995-2#1)(2005-8#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-7#3)(2012-3#1)(2013-8#1)
readily achieved by##3##3##(2007-11#1)(2008-10#1)(2008-6#1)
readily achieved##7##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)
readily adaptable to other##2##4##(2008-2#1)(2008-3#1)
readily adaptable to##7##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-5#1)(2012-12#2)
readily adaptable##9##2##(2007-12#1)(2007-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-5#1)(2012-12#2)
readily adapted to##4##3##(2008-1#1)(2008-4#1)(2008-6#1)(2010-7#1)
readily amenable to##3##3##(2007-9#1)(2008-10#1)(2008-8#1)
readily and##6##2##(1990-2#1)(1993-6#1)(1994-11#1)(2008-1#1)(2008-4#1)(2008-9#1)
readily apparent##7##2##(1990-1#1)(1996-12#1)(2004-11#1)(2006-4#1)(2007-12#1)(2008-3#1)(2010-12#1)
readily applicable to other##2##4##(2006-12#1)(2007-12#1)
readily applicable to##7##3##(1990-11#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-11#1)(2011-1#1)
readily applicable##9##2##(1990-11#1)(1997-6#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-2#1)(2010-11#1)(2011-1#1)
readily as##5##2##(2008-10#2)(2008-11#1)(2008-12#1)(2012-3#1)
readily attainable##2##2##(2005-10#1)(2008-11#1)
readily available and##12##3##(1996-1#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-2#1)(2012-2#1)
readily available components##3##3##(2007-12#1)(2008-10#1)(2008-4#1)
readily available data##2##3##(1997-2#1)(2009-8#1)
readily available for##5##3##(2004-11#1)(2006-2#1)(2006-3#1)(2011-12#1)(2012-12#1)
readily available in##4##3##(2008-11#2)(2008-4#1)(2008-9#1)
readily available reagents##2##3##(2008-10#1)(2008-4#1)
readily available software##2##3##(1992-9#1)(1994-8#1)
readily available starting materials##2##4##(2008-10#1)(2008-8#1)
readily available to the##2##4##(2007-12#1)(2008-5#1)
readily available to##4##3##(1991-7#1)(2007-12#1)(2008-11#1)(2008-5#1)
readily available##90##2##(1991-1#1)(1991-7#1)(1992-10#1)(1992-9#1)(1993-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-2#1)(1997-2#2)(2004-11#2)(2005-10#2)(2006-2#1)(2006-3#1)(2006-6#1)(2007-11#4)(2007-12#3)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#7)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-3#2)(2009-4#2)(2009-8#1)(2009-9#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2013-1#2)
readily be adapted to##2##4##(2008-4#2)
readily be##21##2##(1990-3#1)(1992-12#1)(1994-8#1)(1995-10#1)(1995-8#1)(1997-3#1)(2004-9#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-4#5)(2008-9#1)(2009-9#1)(2011-1#2)
readily cleaved by##2##3##(1990-5#1)(1997-4#1)
readily cleaved##4##2##(1990-5#1)(1997-4#2)(2010-5#1)
readily comparable##2##2##(2007-10#1)(2008-7#1)
readily converted to##2##3##(1995-6#1)(1996-5#1)
readily converted##3##2##(1995-2#1)(1995-6#1)(1996-5#1)
readily decarboxylated by heating in##2##5##(1997-1#2)
readily degraded by##2##3##(1994-11#1)(2008-2#1)
readily degraded##4##2##(1990-3#1)(1994-11#1)(1996-2#1)(2008-2#1)
readily derived from##2##3##(1991-10#1)(2008-2#1)
readily described##2##2##(1993-3#1)(2009-5#1)
readily detectable##8##2##(1994-3#1)(1996-11#1)(1996-12#1)(1996-5#1)(2007-8#1)(2008-3#2)(2011-2#1)
readily detected by##3##3##(1991-5#1)(1993-2#1)(1995-10#1)
readily detected in##5##3##(1995-2#3)(1995-8#1)(2008-10#1)
readily detected with##2##3##(2008-10#2)
readily detected##14##2##(1991-12#1)(1991-5#1)(1993-2#1)(1995-10#1)(1995-2#3)(1995-8#1)(1996-5#1)(2007-7#1)(2008-10#4)
readily determined##6##2##(1995-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-11#1)
readily diagnosed##4##2##(2005-11#1)(2006-10#2)(2011-2#1)
readily distinguishable from##2##3##(2005-8#1)(2007-8#1)
readily distinguishable##5##2##(1995-3#1)(2005-8#1)(2007-8#1)(2008-5#2)
readily distinguished##4##2##(1996-9#1)(1997-6#1)(2008-10#2)
readily elicits##2##2##(1990-7#1)(1995-3#1)
readily established##2##2##(2009-11#1)(2013-8#1)
readily explained by##3##3##(2008-4#1)(2008-7#1)(2009-8#1)
readily extended##2##2##(2008-10#1)(2008-9#1)
readily fermentable##2##2##(2008-5#2)
readily for##2##2##(2008-2#1)(2008-4#1)
readily formed##2##2##(2007-12#1)(2008-10#1)
readily from##2##2##(1990-3#1)(2007-6#1)
readily hydrolyzed##2##2##(1990-5#1)(1996-3#1)
readily identifiable##4##2##(1991-3#1)(1993-11#1)(2007-10#1)(2009-1#1)
readily identified by##3##3##(1995-1#1)(2007-12#1)(2007-7#1)
readily identified##9##2##(1995-1#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-3#2)(2009-8#1)(2010-6#1)
readily identify##3##2##(2007-3#1)(2010-2#1)(2013-8#1)
readily in the##3##3##(2005-12#1)(2008-10#2)
readily in##7##2##(1991-8#1)(2005-12#1)(2008-10#4)(2009-10#1)
readily incorporated into##2##3##(1990-4#1)(1992-6#1)
readily incorporated##3##2##(1990-4#1)(1992-6#1)(2006-2#1)
readily inhibited by##2##3##(1991-8#1)(1993-3#1)
readily interpreted##2##2##(1995-8#1)(2008-3#1)
readily into the##2##3##(1990-3#1)(2008-8#1)
readily into##3##2##(1990-3#1)(1991-9#1)(2008-8#1)
readily isolable##2##2##(1992-9#1)(2006-12#1)
readily isolated##2##2##(1995-2#1)(1995-8#1)
readily managed with##2##3##(2007-11#1)(2012-12#1)
readily measurable##2##2##(1995-2#1)(2008-4#1)
readily modifiable##2##2##(1995-11#1)(2009-8#1)
readily modified##3##2##(1991-2#1)(1994-3#1)(2008-4#1)
readily observable in##2##3##(1996-5#1)(2007-12#1)
readily observable##3##2##(1996-5#1)(2007-12#1)(2008-9#1)
readily observed by##2##3##(1995-10#1)(2007-6#1)
readily observed in##4##3##(1991-2#1)(1995-9#1)(1996-5#1)(2008-10#1)
readily observed##8##2##(1991-2#1)(1995-10#1)(1995-9#1)(1996-5#1)(2007-12#1)(2007-6#1)(2008-10#2)
readily obtained from the##2##4##(1991-5#1)(2008-5#1)
readily obtained from##3##3##(1991-5#1)(1997-4#1)(2008-5#1)
readily obtained##7##2##(1991-5#2)(1997-2#1)(1997-4#1)(2008-3#1)(2008-5#1)(2010-6#1)
readily on##3##2##(2008-10#1)(2013-1#2)
readily oxidizable carbon##2##3##(2013-8#2)
readily performed##4##2##(1990-8#1)(2006-3#1)(2008-1#1)(2008-10#1)
readily prepared##5##2##(1990-11#1)(1993-11#1)(1996-5#1)(2008-10#1)(2012-2#1)
readily reacted in anhydrous##2##4##(2007-11#2)
readily reacted##3##2##(2007-11#2)(2008-10#1)
readily recognized by##2##3##(2007-2#1)(2008-4#1)
readily reduced##2##2##(2008-5#1)(2010-6#1)
readily regenerated with##2##3##(2008-10#2)
readily releasable pool##2##3##(1995-1#1)(2007-10#1)
readily releasable##3##2##(1995-1#2)(2007-10#1)
readily remediated##2##2##(2004-10#2)
readily removed by##3##3##(1997-4#1)(2008-4#2)
readily resolved##2##2##(1990-8#1)(1996-8#1)
readily reversible upon##2##3##(1992-11#1)(2005-7#1)
readily reversible##5##2##(1992-11#1)(1992-8#1)(1997-2#1)(2005-7#1)(2008-10#1)
readily soluble in##2##3##(1991-5#1)(2008-10#1)
readily taken up by##3##4##(2008-4#1)(2012-11#2)
readily taken up##4##3##(2008-4#1)(2008-5#1)(2012-11#2)
readily than the##2##3##(1995-1#1)(2008-4#1)
readily than##5##2##(1990-12#1)(1994-2#1)(1995-1#1)(2008-4#1)(2008-7#1)
readily to the##2##3##(2008-11#1)(2010-8#1)
readily to##8##2##(1992-10#1)(1992-6#1)(1995-2#1)(1997-7#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-8#1)
readily treated##2##2##(2009-5#1)(2012-12#1)
readily understood##2##2##(1994-2#1)(2010-12#1)
readily utilized##3##2##(1990-11#1)(2006-9#1)(2013-1#1)
readily visible in##2##3##(1990-7#1)(1994-12#1)
readily visible##4##2##(1990-7#1)(1992-4#1)(1994-12#1)(2010-6#1)
readily with##5##2##(1997-2#1)(2007-10#1)(2008-11#2)(2012-12#1)
readily##584##1##(1990-1#1)(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#4)(1990-4#1)(1990-5#2)(1990-7#4)(1990-8#2)(1990-9#2)(1991-1#2)(1991-10#4)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#5)(1991-7#2)(1991-8#2)(1991-9#1)(1992-10#3)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#5)(1992-8#3)(1992-9#3)(1993-11#2)(1993-2#3)(1993-3#2)(1993-6#1)(1993-9#3)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#4)(1994-3#5)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#5)(1995-10#3)(1995-11#1)(1995-12#3)(1995-2#14)(1995-3#5)(1995-5#1)(1995-6#2)(1995-8#5)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#9)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#5)(1997-3#3)(1997-4#5)(1997-6#4)(1997-7#2)(1997-8#1)(2004-10#2)(2004-11#3)(2004-2#1)(2004-9#1)(2005-10#4)(2005-11#3)(2005-12#1)(2005-7#1)(2005-8#3)(2006-10#2)(2006-12#3)(2006-2#2)(2006-3#2)(2006-4#1)(2006-6#3)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#14)(2007-12#18)(2007-2#4)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#5)(2007-9#4)(2008-1#7)(2008-10#67)(2008-11#15)(2008-12#4)(2008-2#12)(2008-3#17)(2008-4#31)(2008-5#17)(2008-6#5)(2008-7#17)(2008-8#10)(2008-9#11)(2009-1#1)(2009-10#1)(2009-11#3)(2009-2#2)(2009-3#5)(2009-4#2)(2009-5#3)(2009-6#1)(2009-8#6)(2009-9#3)(2010-11#2)(2010-12#4)(2010-2#2)(2010-4#1)(2010-5#5)(2010-6#4)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#4)(2012-12#8)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#7)
readiness and##3##2##(2008-3#1)(2010-9#1)(2012-3#1)
readiness assessment##3##2##(1996-1#1)(2013-1#2)
readiness for##10##2##(1994-2#1)(1995-12#1)(2008-11#2)(2008-2#1)(2008-4#3)(2010-2#1)(2011-2#1)
readiness of##2##2##(2006-10#1)(2012-3#1)
readiness to change health behaviors##2##5##(2012-2#2)
readiness to change in##2##4##(2007-9#1)(2008-11#1)
readiness to change##10##3##(2007-9#3)(2008-11#3)(2012-2#3)(2013-8#1)
readiness to engage in research##2##5##(2012-3#2)
readiness to engage in##3##4##(2012-3#3)
readiness to##22##2##(1991-2#1)(1992-12#1)(1994-2#1)(1995-12#1)(2007-2#1)(2007-9#3)(2008-11#3)(2008-4#1)(2010-2#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#1)
readiness##61##1##(1991-2#1)(1992-12#1)(1994-2#2)(1995-12#2)(1996-1#2)(1997-1#2)(2006-10#2)(2007-2#1)(2007-9#4)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#4)(2009-10#1)(2009-6#1)(2010-2#2)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#9)(2013-1#4)(2013-8#1)
reading abilities##2##2##(2011-2#1)(2012-3#1)
reading ability##6##2##(2004-10#1)(2007-3#1)(2008-9#1)(2012-2#3)
reading accuracy##2##2##(2010-7#2)
reading achievement##5##2##(2007-9#4)(2010-3#1)
reading acquisition##2##2##(2008-11#2)
reading aloud##5##2##(1995-2#1)(2008-4#2)(2008-9#1)(2009-2#1)
reading and spelling##3##3##(2007-9#2)(2011-1#1)
reading and writing##3##3##(2008-12#2)(2012-12#1)
reading and##36##2##(2006-10#8)(2007-12#1)(2007-2#1)(2007-9#4)(2008-1#2)(2008-12#4)(2008-4#2)(2008-7#1)(2008-9#2)(2009-4#1)(2011-1#1)(2011-2#4)(2012-12#2)(2013-1#1)(2013-7#2)
reading at##2##2##(2008-2#1)(2008-5#1)
reading by##2##2##(2007-12#1)(2008-4#1)
reading comprehension##9##2##(2007-9#3)(2008-12#3)(2011-2#2)(2013-1#1)
reading data##3##2##(2007-12#1)(2008-2#1)(2013-1#1)
reading difficulties##4##2##(2007-9#2)(2008-4#1)(2011-12#1)
reading disabilities##5##2##(2004-10#4)(2008-12#1)
reading disability##7##2##(2004-10#5)(2008-11#1)(2011-2#1)
reading disorders##2##2##(2004-10#2)
reading efficiency in##3##3##(2012-2#3)
reading efficiency##7##2##(2007-9#1)(2008-4#1)(2012-2#5)
reading experience##3##2##(2005-10#1)(2011-2#2)
reading failure##2##2##(2007-3#1)(2013-8#1)
reading fluency skill##3##3##(2010-3#3)
reading fluency##15##2##(2004-10#1)(2007-3#3)(2007-9#1)(2008-12#4)(2010-2#1)(2010-3#5)
reading for##3##2##(2008-9#2)(2012-3#1)
reading frame 1##2##3##(1990-11#1)(1995-2#1)
reading frame and##5##3##(1990-11#1)(1991-2#1)(1993-12#1)(1994-12#2)
reading frame by##2##3##(1994-9#1)(1995-9#1)
reading frame in##6##3##(1993-4#1)(1994-11#1)(1995-9#1)(1997-2#1)(1997-7#1)(2005-11#1)
reading frame of human##3##4##(1990-5#1)(1994-5#1)(2008-4#1)
reading frame of the##11##4##(1990-2#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-6#1)(1994-12#2)(1995-12#1)(2005-11#1)(2008-10#1)
reading frame of##87##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#4)(1990-5#4)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#3)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#2)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-10#2)(1996-12#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-6#2)(1997-7#1)(1997-9#1)(2005-11#1)(2005-6#1)(2008-10#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#2)(2011-2#1)
reading frame was##9##3##(1990-12#1)(1992-9#1)(1993-3#2)(1994-8#1)(1997-6#2)(2008-10#1)(2008-4#1)
reading frame were found##2##4##(1991-7#1)(1997-4#1)
reading frame were##4##3##(1991-7#1)(1993-11#1)(1997-4#1)(2008-10#1)
reading frame##337##2##(1990-1#2)(1990-11#9)(1990-12#2)(1990-2#2)(1990-3#3)(1990-4#8)(1990-5#7)(1990-7#4)(1990-9#8)(1991-1#2)(1991-10#3)(1991-11#1)(1991-12#7)(1991-2#4)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#4)(1991-8#1)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#5)(1992-9#3)(1993-11#5)(1993-12#9)(1993-2#2)(1993-3#4)(1993-4#2)(1993-5#1)(1993-6#6)(1993-7#1)(1993-8#2)(1993-9#2)(1994-11#5)(1994-12#15)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#4)(1994-8#6)(1994-9#9)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#8)(1995-3#1)(1995-6#5)(1995-8#14)(1995-9#3)(1996-10#6)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-7#4)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#10)(1997-3#4)(1997-4#6)(1997-5#4)(1997-6#6)(1997-7#5)(1997-9#1)(2005-11#2)(2005-6#1)(2006-5#1)(2006-8#1)(2008-10#22)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#10)(2008-9#6)(2009-5#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
reading frames (ORFs) in##4##4##(1995-4#1)(2008-10#2)(2012-2#1)
reading frames (ORFs)##46##3##(1990-9#1)(1991-7#1)(1991-9#1)(1993-12#1)(1993-9#1)(1994-12#2)(1995-12#1)(1995-4#2)(1995-6#2)(1995-9#3)(1996-3#5)(1996-6#4)(1997-2#1)(1997-3#6)(1997-4#2)(1997-6#1)(2008-10#10)(2008-7#1)(2012-2#1)
reading frames are##2##3##(1991-7#1)(1994-9#1)
reading frames flanking##2##3##(1993-9#1)(1994-12#1)
reading frames in##5##3##(1991-8#1)(1996-3#1)(1996-7#1)(2008-10#1)(2008-7#1)
reading frames of the##3##4##(1991-7#1)(1991-8#1)(2008-10#1)
reading frames of##7##3##(1990-1#1)(1990-7#1)(1991-7#1)(1991-8#1)(1993-9#1)(1994-11#1)(2008-10#1)
reading frames##144##2##(1990-1#1)(1990-10#1)(1990-11#2)(1990-3#2)(1990-5#2)(1990-7#3)(1990-8#1)(1990-9#1)(1991-7#5)(1991-8#2)(1991-9#2)(1992-3#1)(1992-6#1)(1993-12#2)(1993-9#3)(1994-11#2)(1994-12#4)(1994-3#1)(1994-9#1)(1995-12#2)(1995-3#2)(1995-4#4)(1995-6#4)(1995-8#2)(1995-9#6)(1996-10#1)(1996-12#2)(1996-3#8)(1996-4#1)(1996-6#8)(1996-7#2)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#13)(1997-4#3)(1997-6#1)(1997-7#1)(1997-9#1)(2005-11#2)(2006-12#1)(2008-10#23)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#3)(2011-1#2)(2012-2#1)(2013-8#2)
reading in magneto-optical##2##3##(2007-12#2)
reading in the##4##3##(1991-1#1)(2006-10#1)(2007-9#1)(2008-9#1)
reading in##14##2##(1991-1#1)(2006-10#1)(2007-12#3)(2007-8#1)(2007-9#2)(2008-12#2)(2008-4#1)(2008-9#2)(2011-2#1)
reading instruction in##3##3##(2007-3#1)(2011-12#1)(2013-1#1)
reading instruction##8##2##(2004-10#1)(2007-3#1)(2008-12#1)(2010-2#3)(2011-12#1)(2013-1#1)
reading intervention##2##2##(2004-10#2)
reading interventions##4##2##(2004-10#3)(2012-2#1)
reading light##4##2##(2008-3#4)
reading measures##2##2##(2004-10#1)(2008-12#1)
reading of the##10##3##(1990-12#1)(1991-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-2#1)(2009-4#1)(2011-2#2)(2012-2#1)
reading of##29##2##(1990-12#1)(1991-12#1)(1992-3#1)(1995-11#1)(1996-3#1)(2004-10#2)(2007-12#3)(2007-5#1)(2007-9#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-2#1)(2009-4#1)(2010-3#1)(2010-6#2)(2010-7#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
reading passage##2##2##(2004-10#1)(2011-1#1)
reading passages##2##2##(2008-12#1)(2012-12#1)
reading pattern is##2##3##(1996-2#1)(2008-3#1)
reading patterns##2##2##(2008-3#1)(2012-1#1)
reading performance in##2##3##(2008-12#1)(2008-4#1)
reading performance of##2##3##(2004-10#1)(2008-4#1)
reading performance##6##2##(1995-1#1)(2004-10#1)(2008-11#1)(2008-12#1)(2008-4#2)
reading problems##3##2##(2007-9#1)(2008-12#1)(2013-1#1)
reading scores##5##2##(2004-10#2)(2008-12#2)(2008-2#1)
reading self-concept##6##2##(2010-3#6)
reading sentences##2##2##(2008-9#1)(2013-8#1)
reading skills were##2##3##(2007-9#1)(2008-12#1)
reading skills##10##2##(2004-10#1)(2007-3#1)(2007-9#1)(2008-12#5)(2011-2#2)
reading speed##6##2##(2008-1#5)(2013-1#1)
reading speeds##2##2##(2008-1#2)
reading tests##2##2##(2008-11#1)(2012-2#1)
reading the##9##2##(2006-10#1)(2007-11#1)(2007-6#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-12#1)
reading this##4##2##(2005-9#1)(2008-7#3)
reading times##2##2##(2007-12#1)(2013-1#1)
reading was##2##2##(1996-12#1)(2007-9#1)
reading were##3##2##(2007-9#1)(2010-3#1)(2012-1#1)
reading words##2##2##(2009-2#1)(2010-7#1)
reading##873##1##(1990-1#3)(1990-10#1)(1990-11#11)(1990-12#4)(1990-2#2)(1990-3#5)(1990-4#8)(1990-5#9)(1990-7#7)(1990-8#1)(1990-9#9)(1991-1#3)(1991-10#3)(1991-11#1)(1991-12#9)(1991-2#4)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#9)(1991-8#3)(1991-9#6)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#7)(1992-9#3)(1993-11#5)(1993-12#12)(1993-2#3)(1993-3#4)(1993-4#2)(1993-5#1)(1993-6#6)(1993-7#1)(1993-8#2)(1993-9#5)(1994-11#8)(1994-12#19)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#4)(1994-8#6)(1994-9#10)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#9)(1995-3#3)(1995-4#4)(1995-6#9)(1995-7#1)(1995-8#16)(1995-9#9)(1996-10#7)(1996-11#1)(1996-12#4)(1996-2#4)(1996-3#10)(1996-4#1)(1996-5#1)(1996-6#10)(1996-7#6)(1996-8#1)(1996-9#2)(1997-1#7)(1997-2#13)(1997-3#18)(1997-4#9)(1997-5#4)(1997-6#7)(1997-7#6)(1997-8#2)(1997-9#2)(2004-10#36)(2005-10#1)(2005-11#5)(2005-6#1)(2005-7#2)(2005-9#1)(2006-10#11)(2006-12#1)(2006-5#2)(2006-8#1)(2007-11#2)(2007-12#18)(2007-2#2)(2007-3#9)(2007-5#1)(2007-6#1)(2007-8#3)(2007-9#40)(2008-1#11)(2008-10#50)(2008-11#7)(2008-12#30)(2008-2#12)(2008-3#11)(2008-4#19)(2008-5#6)(2008-6#1)(2008-7#15)(2008-8#11)(2008-9#25)(2009-1#2)(2009-10#1)(2009-2#3)(2009-4#6)(2009-5#5)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#7)(2010-3#15)(2010-4#1)(2010-6#3)(2010-7#11)(2011-1#9)(2011-12#2)(2011-2#17)(2012-1#3)(2012-12#7)(2012-2#12)(2012-3#4)(2013-1#14)(2013-7#2)(2013-8#8)
reading&quot##2##1##(2008-1#1)(2013-8#1)
reading-aloud##4##1##(2008-4#4)
readings and##5##2##(1994-3#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#1)
readings are##2##2##(1993-12#1)(2008-10#1)
readings at##4##2##(1996-5#1)(2008-10#3)
readings for##4##2##(1993-2#1)(2007-2#1)(2008-7#1)(2013-1#1)
readings in##5##2##(1994-11#1)(2008-10#2)(2008-5#1)(2011-2#1)
readings of the same##2##4##(2008-10#1)(2012-2#1)
readings of the##4##3##(2008-10#3)(2012-2#1)
readings of##7##2##(2007-3#1)(2007-8#1)(2008-10#3)(2010-3#1)(2012-2#1)
readings on##3##2##(1995-1#2)(2007-3#1)
readings was##6##2##(1990-8#1)(2008-11#1)(2010-8#4)
readings were taken##2##3##(2008-5#1)(2008-8#1)
readings were##5##2##(2008-5#1)(2008-8#1)(2010-8#3)
readings##72##1##(1990-8#2)(1991-12#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-11#2)(1994-3#1)(1995-1#4)(1995-5#1)(1996-12#1)(1996-5#1)(1997-3#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-3#4)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#3)(2008-5#7)(2008-7#1)(2008-8#1)(2009-9#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#7)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
readings) when the BG rate of change is##2##8##(2009-9#2)
readings)##4##1##(1992-4#1)(2008-10#1)(2009-9#2)
readjustment of the##2##3##(1990-8#1)(2006-5#1)
readjustment##3##1##(1990-8#1)(2006-5#1)(2007-12#1)
readministered##3##1##(1996-10#1)(2012-12#2)
readministration##2##1##(1997-4#1)(2005-7#1)
readmission and##2##2##(2007-8#1)(2011-2#1)
readmission is##2##2##(1992-6#1)(2011-2#1)
readmission of##3##2##(1990-7#1)(1997-1#1)(2009-7#1)
readmission on##2##2##(2006-10#1)(2011-2#1)
readmission rates##5##2##(1996-1#2)(1997-2#1)(2008-11#1)(2013-1#1)
readmission to hospital##2##3##(2006-10#2)
readmission was##2##2##(1992-6#1)(1996-2#1)
readmission within 30 days##5##4##(2006-1#3)(2013-1#2)
readmission within##6##2##(2006-1#3)(2011-2#1)(2013-1#2)
readmission##47##1##(1990-7#1)(1992-6#2)(1993-7#1)(1996-1#3)(1996-2#1)(1997-1#1)(1997-2#1)(2006-1#4)(2006-10#3)(2007-10#1)(2007-12#1)(2007-8#3)(2008-11#1)(2008-3#2)(2009-7#2)(2011-1#1)(2011-2#6)(2013-1#13)
readmissions during##2##2##(1990-12#1)(2011-2#1)
readmissions to##2##2##(2009-7#2)
readmissions were##3##2##(2011-2#1)(2012-2#1)(2013-1#1)
readmissions##30##1##(1990-12#1)(1992-6#2)(1996-2#1)(1997-2#1)(1997-5#2)(2005-10#1)(2009-7#3)(2011-2#4)(2012-2#1)(2013-1#13)(2013-8#1)
readmitted in##2##2##(1992-6#1)(2009-3#1)
readmitted to##4##2##(1992-6#2)(2010-2#1)(2012-12#1)
readmitted within##3##2##(2006-1#1)(2011-2#2)
readmitted##15##1##(1992-6#4)(2006-1#1)(2006-5#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-2#3)(2012-12#1)
readout beam##6##2##(2008-1#1)(2008-2#2)(2008-3#3)
readout beams##2##2##(2008-2#1)(2008-3#1)
readout by##2##2##(2008-2#1)(2010-9#1)
readout for optical storage with phase jump##2##7##(2008-3#2)
readout for##5##2##(2007-12#1)(2008-2#1)(2008-3#2)(2008-8#1)
readout in##2##2##(2008-2#1)(2010-12#1)
readout is##3##2##(2008-3#3)
readout light##2##2##(2008-2#1)(2008-3#1)
readout mechanism for match##2##4##(2013-8#2)
readout method##2##2##(2008-2#1)(2009-12#1)
readout of a##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
readout of the##2##3##(2008-1#1)(2008-3#1)
readout of##13##2##(1995-10#1)(2007-12#3)(2008-1#2)(2008-10#1)(2008-2#3)(2008-3#3)
readout optical modulator##6##3##(2008-2#6)
readout scheme##2##2##(2008-3#2)
readout signal and##2##3##(2008-3#2)
readout signal is##2##3##(2008-3#2)
readout signal##9##2##(2008-2#2)(2008-3#7)
readout system for##3##3##(2007-12#3)
readout system##6##2##(2006-5#1)(2007-11#1)(2007-12#3)(2008-3#1)
readout systems##2##2##(2008-3#1)(2008-4#1)
readout technique##2##2##(2007-11#1)(2008-2#1)
readout the##2##2##(2008-3#2)
readout with##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
readout##136##1##(1995-10#1)(2006-5#3)(2007-11#3)(2007-12#18)(2008-1#5)(2008-10#1)(2008-2#45)(2008-3#48)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#1)(2013-1#2)(2013-8#2)
readouts of##2##2##(2008-4#1)(2011-2#1)
readouts##6##1##(2008-3#1)(2008-4#1)(2008-9#1)(2011-2#2)(2013-1#1)
reads the##2##2##(2008-3#1)(2012-2#1)
reads were##2##2##(2011-2#1)(2012-3#1)
reads##20##1##(1995-8#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#3)(2012-2#2)(2012-3#4)(2013-8#5)
reads)##3##1##(2011-2#2)(2012-2#1)
readthrough protein##3##2##(1994-3#1)(2008-10#2)
readthrough transcription##2##2##(1991-7#1)(1996-7#1)
readthrough##9##1##(1991-7#1)(1993-11#1)(1994-3#2)(1996-7#2)(2008-10#3)
ready access to##2##3##(1993-12#1)(2010-4#1)
ready access##3##2##(1993-12#1)(2008-5#1)(2010-4#1)
ready application of##2##3##(2007-11#1)(2008-10#1)
ready availability##2##2##(2010-12#1)(2013-7#1)
ready for a##3##3##(1992-2#1)(2008-12#1)(2013-8#1)
ready for prime time##3##4##(2007-9#1)(2009-12#1)(2011-2#1)
ready for prime time?##4##4##(2007-4#1)(2009-4#1)(2010-5#1)(2013-8#1)
ready for prime##7##3##(2007-4#1)(2007-9#1)(2009-12#1)(2009-4#1)(2010-5#1)(2011-2#1)(2013-8#1)
ready for the##3##3##(2008-10#2)(2011-2#1)
ready for use##5##3##(2007-7#1)(2008-10#1)(2008-11#2)(2010-12#1)
ready for##43##2##(1991-9#1)(1992-2#1)(1994-12#1)(1994-3#1)(1995-11#1)(1997-2#1)(2004-8#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#4)(2008-4#2)(2009-12#1)(2009-4#2)(2010-12#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
ready to be used in a new assay##2##8##(2008-10#2)
ready to be##4##3##(2006-6#1)(2008-10#2)(2009-10#1)
ready to eat##2##3##(2010-4#1)(2010-7#1)
ready to##22##2##(1991-10#1)(1995-5#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-4#1)(2010-7#2)(2010-8#1)(2012-2#2)
ready##96##1##(1991-10#1)(1991-9#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#2)(1996-3#1)(1997-2#1)(2004-8#1)(2006-10#2)(2006-4#1)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#6)(2008-12#4)(2008-2#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-4#3)(2009-8#1)(2010-12#3)(2010-4#3)(2010-5#1)(2010-7#2)(2010-8#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#2)
ready-made##2##1##(2005-12#1)(2008-7#1)
ready-to-eat foods in##2##3##(2008-1#2)
ready-to-eat##10##1##(1997-4#2)(2008-1#2)(2010-2#1)(2010-4#1)(2011-2#4)
ready?##4##1##(1995-12#2)(2007-6#1)(2010-12#1)
reaffirmed##2##1##(2006-4#1)(2012-2#1)
reaffirms that##2##2##(1994-3#1)(1995-9#1)
reaffirms##4##1##(1994-3#1)(1995-9#1)(2004-12#1)(2011-2#1)
reagent 1##5##2##(2008-10#5)
reagent RBCs##2##2##(1994-6#2)
reagent addition##4##2##(2008-10#4)
reagent amounts and##2##3##(2008-10#2)
reagent amounts##5##2##(2008-10#5)
reagent and ammonium tetraphenylborate##2##4##(2008-10#2)
reagent and organic solvent##2##4##(2008-10#2)
reagent and sample##3##3##(2008-10#3)
reagent and the##3##3##(2008-10#3)
reagent and their##2##3##(2008-10#2)
reagent and##42##2##(1994-3#1)(1995-7#1)(2004-12#1)(2007-8#1)(2008-10#35)(2008-4#1)(2008-7#1)(2013-1#1)
reagent because##2##2##(2008-10#2)
reagent blank##8##2##(2008-10#8)
reagent blanks of microwave digestion system##2##6##(2008-10#2)
reagent carrier##2##2##(2008-10#2)
reagent channel##2##2##(2008-10#2)
reagent chemical##2##2##(2008-10#2)
reagent chemistry##2##2##(2008-10#2)
reagent composition##2##2##(2008-10#2)
reagent concentration and of various foreign ions##2##7##(2008-10#2)
reagent concentration gradient##2##3##(2008-10#2)
reagent concentration##14##2##(1990-7#1)(2008-10#13)
reagent concentrations and##2##3##(2007-8#1)(2008-10#1)
reagent concentrations##6##2##(1997-3#1)(2007-8#1)(2008-10#4)
reagent consumption and the##2##4##(2008-10#2)
reagent consumption and##4##3##(2008-10#4)
reagent consumption of##3##3##(2008-10#3)
reagent consumption##17##2##(2008-10#15)(2011-1#1)(2011-2#1)
reagent containing##4##2##(1993-2#1)(1993-9#1)(1995-8#1)(2008-10#1)
reagent cost##2##2##(2008-9#1)(2009-12#1)
reagent could##2##2##(2007-8#1)(2008-10#1)
reagent diethyl pyrocarbonate##4##3##(1990-11#1)(1991-7#1)(1992-6#1)(1995-3#1)
reagent flow##2##2##(2008-10#2)
reagent for determination of##3##4##(2008-10#3)
reagent for selective##2##3##(2008-10#2)
reagent for spectrophotometric determination of boron##2##6##(2008-10#2)
reagent for spectrophotometric determination of##3##5##(2008-10#3)
reagent for the determination of##2##5##(2008-10#1)(2008-3#1)
reagent for the direct##2##4##(1995-11#1)(2008-10#1)
reagent for the spectrophotometric determination of cobalt##2##7##(2008-10#2)
reagent for the spectrophotometric determination of##3##6##(2008-10#3)
reagent for the##17##3##(1993-2#1)(1995-11#1)(1995-3#1)(2007-8#1)(2008-10#9)(2008-3#1)(2008-5#1)(2009-12#1)(2010-5#1)
reagent for##57##2##(1990-8#1)(1991-7#1)(1991-8#1)(1992-9#2)(1993-2#1)(1995-11#1)(1995-3#1)(2006-12#1)(2007-8#2)(2008-10#36)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-5#3)(2011-2#1)(2013-1#1)
reagent gas##4##2##(1990-9#1)(1997-3#1)(2008-10#2)
reagent gives##4##2##(1993-4#1)(2008-10#2)(2008-8#1)
reagent has been investigated by measuring the##2##7##(2007-8#1)(2008-10#1)
reagent has been##3##3##(2007-8#1)(2008-10#1)(2008-4#1)
reagent has##4##2##(2007-8#1)(2008-10#2)(2008-4#1)
reagent in a##3##3##(2008-10#3)
reagent in alkaline medium##3##4##(2008-10#3)
reagent in the presence of##2##5##(2007-8#1)(2008-10#1)
reagent in the##11##3##(1992-1#1)(1996-11#1)(2007-8#1)(2008-10#7)(2008-5#1)
reagent in xylene from 0##2##5##(2008-10#2)
reagent in xylene from##3##4##(2008-10#3)
reagent in##33##2##(1990-8#1)(1991-7#1)(1992-1#1)(1992-7#1)(1996-11#1)(1997-8#1)(2007-8#1)(2008-10#25)(2008-5#1)
reagent is described##3##3##(1990-2#1)(1996-11#1)(2007-10#1)
reagent is##11##2##(1990-2#1)(1990-8#1)(1991-8#1)(1991-9#1)(1992-8#1)(1996-11#1)(2007-10#1)(2008-10#2)(2008-4#1)(2012-2#1)
reagent mixing in the##2##4##(2006-10#1)(2008-10#1)
reagent mixture##2##2##(2008-10#2)
reagent of##3##2##(2008-10#2)(2008-8#1)
reagent on the##6##3##(1990-12#1)(2008-10#4)(2008-11#1)
reagent or##2##2##(2008-10#2)
reagent reacts with##3##3##(2008-10#3)
reagent reacts##4##2##(2008-10#4)
reagent red cells##3##3##(1992-3#2)(1993-3#1)
reagent red##4##2##(1992-3#2)(1993-3#1)(1994-6#1)
reagent regeneration##2##2##(2008-10#2)
reagent solution in##3##3##(2007-10#1)(2008-10#2)
reagent solution##11##2##(2007-10#1)(2008-10#10)
reagent solutions##5##2##(2007-8#1)(2008-10#4)
reagent stream containing##2##3##(2008-10#2)
reagent stream##8##2##(1992-1#1)(2008-10#7)
reagent strip##5##2##(1996-1#1)(1996-12#3)(2007-7#1)
reagent strips for##2##3##(1996-1#1)(1996-12#1)
reagent strips##4##2##(1996-1#1)(1996-12#2)(2008-10#1)
reagent that##3##2##(1997-6#1)(2007-11#1)(2008-10#1)
reagent to form##3##3##(1994-9#1)(2008-10#2)
reagent to##12##2##(1994-9#1)(1995-1#1)(1997-3#1)(2008-10#7)(2008-4#2)
reagent used in##2##3##(2008-4#2)
reagent used##6##2##(2008-10#4)(2008-4#2)
reagent volumes##4##2##(2008-10#4)
reagent was replaced by 1##2##5##(2008-10#2)
reagent was##15##2##(1992-3#1)(1993-11#1)(2005-4#1)(2008-10#9)(2010-3#1)(2012-2#2)
reagent with##4##2##(1990-8#1)(1991-3#1)(1994-6#1)(2008-10#1)
reagent zones##4##2##(1993-12#1)(2008-10#3)
reagent##685##1##(1990-1#1)(1990-11#1)(1990-12#6)(1990-2#4)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#10)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#3)(1991-5#1)(1991-7#4)(1991-8#4)(1991-9#1)(1992-1#3)(1992-10#1)(1992-11#3)(1992-3#4)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#3)(1993-11#7)(1993-12#2)(1993-2#4)(1993-3#2)(1993-4#2)(1993-6#1)(1993-9#2)(1994-11#2)(1994-3#3)(1994-5#1)(1994-6#4)(1994-8#1)(1994-9#5)(1995-1#2)(1995-11#1)(1995-2#2)(1995-3#3)(1995-6#3)(1995-7#1)(1995-8#3)(1996-1#3)(1996-10#1)(1996-11#3)(1996-12#5)(1996-2#1)(1996-5#2)(1997-3#6)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-12#2)(2005-4#6)(2006-10#2)(2006-12#4)(2007-10#3)(2007-11#9)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#19)(2008-10#415)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#15)(2008-5#8)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#5)(2009-10#1)(2009-12#4)(2010-1#1)(2010-3#1)(2010-5#6)(2011-1#2)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#7)(2013-1#2)(2013-8#2)
reagent)##5##1##(1993-11#1)(2007-10#1)(2008-10#2)(2012-3#1)
reagent-injection FI method##3##3##(2008-10#3)
reagent-injection flow injection photometric method##2##5##(2008-10#2)
reagent-injection flow injection technique##2##4##(2008-10#2)
reagent-injection flow injection##5##3##(2008-10#5)
reagent-injection##8##1##(2008-10#8)
reagentless pH sensors##2##3##(2008-10#2)
reagentless##13##1##(2008-10#10)(2008-3#1)(2008-7#1)(2009-8#1)
reagents and a##3##3##(1990-12#1)(1995-1#1)(2008-10#1)
reagents and sample##3##3##(2008-10#3)
reagents and their##3##3##(2008-4#1)(2013-7#1)(2013-8#1)
reagents and##46##2##(1990-12#1)(1991-7#1)(1992-12#1)(1993-4#1)(1995-1#1)(1997-4#1)(2005-4#1)(2007-11#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-3#1)(2010-6#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
reagents are frequently##2##3##(2008-10#1)(2008-9#1)
reagents are not##2##3##(1992-8#1)(1993-12#1)
reagents are used##2##3##(1990-2#1)(2008-10#1)
reagents are##19##2##(1990-2#1)(1992-11#1)(1992-8#1)(1993-12#1)(1994-3#1)(1996-8#1)(2008-1#1)(2008-10#8)(2008-4#3)(2008-9#1)
reagents but##2##2##(1990-10#1)(2008-10#1)
reagents for detecting##2##3##(1994-3#1)(2008-4#1)
reagents for the##7##3##(1990-2#1)(1992-2#1)(1995-2#1)(2008-10#4)
reagents for use in immunoassays##2##5##(2008-10#2)
reagents for use in##3##4##(2005-7#1)(2008-10#2)
reagents for##27##2##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1992-2#1)(1994-3#2)(1995-2#1)(2005-7#1)(2008-10#12)(2008-11#1)(2008-4#4)(2012-2#1)
reagents gave##3##2##(1990-12#1)(1994-3#1)(2008-10#1)
reagents has been##2##3##(2008-10#2)
reagents has##4##2##(2008-10#2)(2008-11#1)(2008-4#1)
reagents have been used##2##4##(1992-12#1)(1993-9#1)
reagents have been##7##3##(1992-12#1)(1993-11#1)(1993-9#1)(2008-11#1)(2008-4#1)(2008-9#2)
reagents have##8##2##(1992-12#1)(1993-11#1)(1993-9#1)(2008-11#2)(2008-4#1)(2008-9#2)
reagents in the##3##3##(1995-6#1)(2008-10#1)(2008-11#1)
reagents in##14##2##(1994-3#1)(1995-6#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#2)(2010-7#1)
reagents including##2##2##(1994-9#1)(2008-1#1)
reagents into the##2##3##(2008-11#1)(2008-4#1)
reagents into##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
reagents is##5##2##(2008-10#3)(2008-11#1)(2008-4#1)
reagents like##3##2##(2008-1#1)(2008-10#1)(2010-11#1)
reagents may##2##2##(2005-7#1)(2012-2#1)
reagents of##8##2##(1991-12#1)(1997-1#1)(2008-10#4)(2008-4#1)(2008-9#1)
reagents on the##3##3##(1991-7#1)(2005-11#1)(2008-10#1)
reagents on##5##2##(1991-7#1)(1993-4#1)(2005-11#1)(2005-12#1)(2008-10#1)
reagents or##4##2##(1996-5#1)(2008-10#3)
reagents showed##2##2##(1991-7#1)(1994-3#1)
reagents such as##5##3##(1990-2#1)(1994-2#1)(2008-11#1)(2008-4#1)(2009-12#1)
reagents tested##2##2##(1994-3#1)(2008-10#1)
reagents that##6##2##(1993-4#1)(2008-10#2)(2008-4#2)(2008-9#1)
reagents to##12##2##(1996-12#1)(2008-10#4)(2008-4#2)(2008-5#1)(2008-9#1)(2009-10#2)(2009-3#1)
reagents used for##2##3##(1996-6#1)(2008-9#1)
reagents used in the##3##4##(1992-3#1)(1992-4#1)(2008-10#1)
reagents used in this##2##4##(2008-4#2)
reagents used in##5##3##(1992-3#1)(1992-4#1)(2008-10#1)(2008-4#2)
reagents used##9##2##(1992-3#1)(1992-4#1)(1996-6#1)(2008-10#2)(2008-4#3)(2008-9#1)
reagents was also##2##3##(2008-10#2)
reagents was##11##2##(1992-9#1)(1995-10#1)(2008-10#7)(2010-6#1)(2011-1#1)
reagents were added in##2##4##(2007-8#1)(2008-10#1)
reagents were compared for##2##4##(1992-8#1)(2008-10#1)
reagents were used##2##3##(1993-9#1)(1995-2#1)
reagents were##18##2##(1990-10#1)(1990-12#1)(1992-8#1)(1993-6#1)(1993-9#1)(1994-3#1)(1995-2#1)(2007-8#3)(2008-10#7)(2013-1#1)
reagents which##2##2##(1996-5#1)(2008-10#1)
reagents with which to##2##4##(2008-9#2)
reagents with##7##2##(1994-3#2)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#2)
reagents without##2##2##(1991-3#1)(2008-10#1)
reagents##467##1##(1990-10#5)(1990-12#9)(1990-2#4)(1990-5#1)(1990-7#6)(1990-8#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#4)(1991-8#1)(1992-11#4)(1992-12#4)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#2)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#2)(1993-4#3)(1993-6#1)(1993-9#2)(1994-11#2)(1994-2#1)(1994-3#17)(1994-4#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#4)(1996-6#1)(1996-8#3)(1997-1#2)(1997-3#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-4#1)(2005-7#2)(2005-8#1)(2006-10#2)(2006-12#6)(2007-10#1)(2007-11#5)(2007-12#1)(2007-7#1)(2007-8#10)(2007-9#2)(2008-1#8)(2008-10#165)(2008-11#16)(2008-2#3)(2008-3#2)(2008-4#44)(2008-5#9)(2008-7#2)(2008-8#2)(2008-9#21)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#4)(2009-6#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-6#3)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#4)(2012-2#6)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#4)
reagents)##2##1##(2008-10#1)(2008-4#1)
reaggregate##2##1##(2008-4#1)(2008-8#1)
reaggregation##2##1##(1993-3#1)(2008-7#1)
real 3D##2##2##(2007-12#2)
real and artificial##2##3##(1996-2#1)(2008-10#1)
real and imaginary parts of the refractive index##2##8##(2008-2#2)
real and imaginary parts of the##4##6##(2008-2#4)
real and imaginary##5##3##(2008-2#5)
real and perceived##3##3##(1996-3#1)(1997-7#1)(2005-10#1)
real and synthetic##3##3##(2008-10#1)(2008-2#1)(2008-6#1)
real and the imaginary parts of the complex refractive##2##9##(2007-11#1)(2008-2#1)
real and the imaginary parts of the complex##3##8##(2007-11#1)(2008-2#2)
real and the imaginary parts of the##13##7##(2007-11#2)(2007-12#4)(2008-2#3)(2008-3#4)
real and the imaginary parts of##15##6##(2007-11#3)(2007-12#5)(2008-2#3)(2008-3#4)
real and the imaginary##18##4##(2007-11#3)(2007-12#6)(2008-1#1)(2008-2#3)(2008-3#5)
real and the##19##3##(2007-11#3)(2007-12#6)(2008-1#1)(2008-2#3)(2008-3#6)
real and##42##2##(1991-11#1)(1991-3#1)(1992-2#1)(1996-2#1)(1996-3#1)(1997-7#1)(2005-10#1)(2007-11#3)(2007-12#6)(2007-3#1)(2008-1#1)(2008-10#2)(2008-2#9)(2008-3#7)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)(2009-9#1)(2012-2#1)
real applications##2##2##(2008-10#1)(2008-7#1)
real atmospheric##2##2##(2008-2#1)(2008-3#1)
real benefit##4##2##(1996-1#1)(1997-1#1)(2005-10#1)(2008-10#1)
real benefits##2##2##(1997-6#1)(2008-7#1)
real biological samples##2##3##(1992-2#1)(1996-5#1)
real biological##4##2##(1992-2#1)(1996-5#1)(2008-8#1)(2012-3#1)
real biomarkers for##2##3##(2010-12#2)
real but##3##2##(2007-3#1)(2007-9#1)(2013-8#1)
real car##2##2##(2006-11#1)(2007-4#1)
real change in##2##3##(1994-1#1)(2013-8#1)
real changes##2##2##(1994-12#1)(1997-6#1)
real clinical##3##2##(1997-6#1)(2008-3#1)(2010-12#1)
real communities##2##2##(2008-9#2)
real complex samples##2##3##(1994-9#1)(2012-12#1)
real complex##3##2##(1994-9#1)(2012-12#1)(2013-8#1)
real conditions##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
real contaminated##2##2##(2008-10#2)
real crystals##2##2##(2008-3#2)
real danger of##3##3##(1994-2#1)(1995-12#1)(1996-11#1)
real danger##5##2##(1994-2#1)(1995-12#1)(1996-11#1)(2005-7#1)(2008-6#1)
real data analysis##2##3##(2012-1#2)
real data are##2##3##(2008-5#1)(2011-2#1)
real data examples##3##3##(2010-1#1)(2010-12#1)(2013-1#1)
real data sets##6##3##(2007-10#1)(2008-2#1)(2008-6#1)(2009-9#1)(2013-1#2)
real data##38##2##(1991-12#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-3#1)(2013-1#5)(2013-8#1)
real difference##3##2##(1996-2#1)(2008-11#1)(2010-8#1)
real effectiveness##2##2##(2009-3#1)(2011-2#1)
real environmental samples##3##3##(2007-8#2)(2008-10#1)
real environmental##4##2##(2007-8#2)(2008-10#1)(2009-11#1)
real example##4##2##(2008-10#1)(2010-2#1)(2011-1#1)(2012-12#1)
real examples##2##2##(2006-10#1)(2011-1#1)
real extent of##2##3##(2010-9#1)(2013-1#1)
real habitat patch##2##3##(2008-8#2)
real hope##2##2##(2007-12#1)(2008-7#1)
real human##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
real image of##2##3##(2008-2#1)(2008-3#1)
real image sequences##2##3##(2008-3#1)(2008-6#1)
real image##5##2##(2007-12#1)(2008-2#1)(2008-3#2)(2008-6#1)
real images##8##2##(2008-2#7)(2008-3#1)
real impact of##2##3##(1993-9#1)(2012-12#1)
real impact##3##2##(1993-9#1)(2006-10#1)(2012-12#1)
real increase in##2##3##(1990-6#1)(1992-12#1)
real interactions##2##2##(1991-11#1)(2010-11#1)
real life##13##2##(1997-4#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-11#3)(2009-1#1)(2010-2#1)(2010-3#1)(2010-4#1)(2012-1#1)(2012-3#1)
real need for##2##3##(1991-2#1)(2010-11#1)
real need##5##2##(1991-2#1)(1993-12#1)(2006-2#1)(2008-11#1)(2010-11#1)
real numbers##2##2##(2008-10#1)(2008-2#1)
real objects##2##2##(2012-2#2)
real one##2##2##(2008-10#1)(2008-2#1)
real optical##2##2##(2008-2#1)(2008-3#1)
real or apparent##2##3##(1990-5#1)(2012-3#1)
real or##8##2##(1990-5#1)(1997-7#1)(2006-4#1)(2007-12#1)(2008-2#2)(2008-3#1)(2012-3#1)
real part of the complex refractive index was##2##8##(2008-3#2)
real part of the complex refractive index##4##7##(2008-3#4)
real part of the refractive index##5##6##(2008-2#1)(2008-3#4)
real part of the##15##4##(2005-11#1)(2008-2#2)(2008-3#12)
real part of##16##3##(2005-11#1)(2007-11#1)(2008-2#2)(2008-3#12)
real part##21##2##(2005-11#3)(2007-11#2)(2008-2#2)(2008-3#14)
real patient##4##2##(1995-12#1)(2008-3#1)(2013-1#2)
real patients##2##2##(2008-10#1)(2011-2#1)
real possibilities of##2##3##(1991-9#1)(2013-1#1)
real possibility for##2##3##(1992-12#1)(2011-2#1)
real possibility##6##2##(1992-12#1)(1993-9#1)(1996-2#1)(2005-9#1)(2010-12#1)(2011-2#1)
real power##2##2##(2007-10#1)(2008-2#1)
real problem##9##2##(1994-1#1)(2005-9#1)(2006-6#1)(2006-9#1)(2007-4#1)(2007-8#1)(2008-5#1)(2009-4#1)(2011-2#1)
real progress##2##2##(1994-5#1)(2007-11#1)
real protein##2##2##(1991-4#1)(2006-10#1)
real quality##2##2##(2008-10#1)(2012-3#1)
real rTMS##2##2##(2013-1#2)
real refractive index##3##3##(2008-3#2)(2011-1#1)
real risk of##2##3##(1996-8#1)(2007-12#1)
real sample analysis##8##3##(2008-10#8)
real sample##22##2##(2007-8#1)(2008-10#21)
real samples (pharmaceutical preparations)##2##4##(2008-10#2)
real samples analysis##2##3##(2008-10#2)
real samples and##5##3##(2008-10#5)
real samples are##2##3##(2008-10#2)
real samples by##4##3##(2008-10#4)
real samples from##5##3##(2008-10#5)
real samples like##2##3##(1996-5#1)(2008-10#1)
real samples of water##2##4##(2008-10#2)
real samples of##6##3##(2008-10#5)(2008-3#1)
real samples such as##6##4##(2008-10#6)
real samples to##2##3##(2008-10#1)(2008-5#1)
real samples was##4##3##(2007-8#1)(2008-10#3)
real samples were also##2##4##(2008-10#2)
real samples were##6##3##(2005-4#1)(2008-10#5)
real samples with##4##3##(2008-10#4)
real samples##131##2##(1996-5#1)(1997-2#1)(2005-11#1)(2005-4#1)(2007-8#9)(2008-10#112)(2008-3#1)(2008-5#2)(2010-11#1)(2012-11#1)(2012-12#1)
real sediment##2##2##(2008-10#2)
real sequence data##3##3##(2012-3#3)
real soil samples##2##3##(2008-10#2)
real soil##3##2##(2008-10#3)
real solution##5##2##(1994-1#1)(2008-10#3)(2011-2#1)
real space##6##2##(2007-11#1)(2008-1#1)(2008-8#1)(2008-9#1)(2012-1#2)
real spectra##3##2##(2008-10#2)(2008-3#1)
real spectral##2##2##(2005-4#1)(2008-10#1)
real time PCR##9##3##(2008-11#1)(2008-8#1)(2010-12#1)(2010-2#1)(2011-2#2)(2013-1#3)
real time and with##3##4##(2006-12#1)(2008-3#2)
real time and##8##3##(2006-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-3#2)(2011-1#1)
real time determination##2##3##(2008-10#2)
real time in##6##3##(2007-5#1)(2008-2#1)(2008-3#1)(2008-4#1)(2013-1#2)
real time monitoring##2##3##(2008-10#1)(2011-2#1)
real time quantitative PCR##3##4##(2008-10#2)(2008-11#1)
real time##163##2##(1993-4#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#2)(1997-6#1)(2005-5#1)(2006-12#1)(2006-3#1)(2007-11#3)(2007-12#9)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#18)(2008-11#5)(2008-2#21)(2008-3#25)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-8#3)(2011-1#2)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#8)(2013-7#4)(2013-8#3)
real time&quot##2##2##(2008-1#1)(2011-2#1)
real urine samples were##2##4##(2008-10#2)
real urine samples##3##3##(2008-10#3)
real urine##4##2##(2008-10#4)
real value of##2##3##(2007-4#1)(2010-12#1)
real value##6##2##(1991-12#1)(2006-10#1)(2007-3#1)(2007-4#1)(2008-3#1)(2010-12#1)
real water samples and##2##4##(2008-10#1)(2012-1#1)
real water samples##12##3##(2008-10#11)(2012-1#1)
real water##15##2##(2008-10#13)(2010-4#1)(2012-1#1)
real words##3##2##(1996-2#1)(2008-4#1)(2010-7#1)
real world in##3##3##(2006-5#1)(2013-1#1)(2013-8#1)
real world samples##4##3##(2007-8#1)(2008-10#3)
real world##42##2##(1993-2#1)(1994-1#4)(1994-12#2)(1995-6#2)(1996-2#1)(1996-4#1)(1997-1#1)(2006-10#1)(2006-2#1)(2006-5#3)(2006-7#1)(2007-4#1)(2007-8#2)(2008-10#7)(2008-11#1)(2008-3#1)(2008-8#1)(2009-12#1)(2009-9#1)(2011-1#1)(2012-2#3)(2013-1#3)(2013-8#2)
real world&quot##6##2##(1994-11#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#2)
real##1018##1##(1990-12#2)(1990-3#1)(1990-5#2)(1990-6#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-6#1)(1991-9#1)(1992-1#2)(1992-10#4)(1992-12#2)(1992-2#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#3)(1994-1#10)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#4)(1994-9#2)(1995-11#1)(1995-12#3)(1995-2#3)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#3)(1996-11#5)(1996-12#2)(1996-2#8)(1996-3#2)(1996-4#2)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#5)(1997-7#3)(1997-8#1)(2004-12#1)(2004-7#1)(2005-10#2)(2005-11#6)(2005-4#2)(2005-5#1)(2005-7#2)(2005-9#3)(2006-10#12)(2006-11#1)(2006-12#2)(2006-2#6)(2006-3#1)(2006-4#1)(2006-5#5)(2006-6#4)(2006-7#4)(2006-9#1)(2007-10#4)(2007-11#14)(2007-12#32)(2007-2#4)(2007-3#5)(2007-4#8)(2007-5#4)(2007-6#1)(2007-7#3)(2007-8#23)(2007-9#7)(2008-1#8)(2008-10#249)(2008-11#18)(2008-12#6)(2008-2#88)(2008-3#94)(2008-4#11)(2008-5#15)(2008-6#6)(2008-7#18)(2008-8#13)(2008-9#8)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#3)(2009-4#4)(2009-5#3)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#5)(2010-1#1)(2010-11#4)(2010-12#15)(2010-2#4)(2010-3#2)(2010-4#5)(2010-5#1)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#14)(2011-2#17)(2012-1#14)(2012-11#1)(2012-12#13)(2012-2#16)(2012-3#13)(2013-1#31)(2013-7#5)(2013-8#14)
real&quot##2##1##(2009-5#1)(2010-8#1)
real-life applications##2##2##(2008-10#1)(2008-2#1)
real-life situations##3##2##(2012-3#1)(2013-1#2)
real-life##19##1##(1991-12#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2009-1#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#4)
real-life&quot##4##1##(2008-3#1)(2008-9#1)(2009-4#1)(2010-12#1)
real-plane##2##1##(2008-2#2)
real-space##2##1##(2007-11#1)(2012-2#1)
real-time 3-dimensional##2##2##(2008-4#1)(2010-8#1)
real-time IP##3##2##(2008-2#3)
real-time PCR (RT-PCR)##2##3##(2012-3#1)(2013-8#1)
real-time PCR (qPCR)##2##3##(2011-2#1)(2013-8#1)
real-time PCR and Western blot##2##5##(2011-2#1)(2012-2#1)
real-time PCR and the##2##4##(2012-2#1)(2012-3#1)
real-time PCR and##8##3##(2007-12#1)(2008-10#2)(2009-2#1)(2011-2#1)(2012-2#2)(2012-3#1)
real-time PCR assay##8##3##(2008-10#4)(2008-4#1)(2010-4#2)(2011-2#1)
real-time PCR assays##7##3##(2008-10#6)(2008-9#1)
real-time PCR for##2##3##(2007-8#1)(2013-8#1)
real-time PCR instrument##4##3##(2008-10#1)(2008-2#1)(2011-2#2)
real-time PCR method##2##3##(2010-6#1)(2013-8#1)
real-time PCR technique##2##3##(2008-10#2)
real-time PCR to##4##3##(2008-2#1)(2008-4#1)(2010-7#1)(2012-3#1)
real-time PCR with##2##3##(2008-10#1)(2010-5#1)
real-time PCR##91##2##(2007-10#3)(2007-12#2)(2007-8#1)(2008-10#28)(2008-2#2)(2008-4#5)(2008-7#2)(2008-9#1)(2009-2#2)(2009-4#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-4#3)(2010-5#2)(2010-6#3)(2010-7#1)(2011-1#1)(2011-2#8)(2012-1#1)(2012-2#2)(2012-3#9)(2013-1#5)(2013-8#6)
real-time PCRs##2##2##(2011-2#1)(2013-8#1)
real-time RT-PCR##10##2##(2008-6#1)(2008-8#1)(2010-1#1)(2010-4#1)(2010-7#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
real-time Raman sensing##2##3##(2008-2#2)
real-time adaptive-optics##2##2##(2007-12#2)
real-time analysis##3##2##(2006-2#1)(2008-10#1)(2008-4#1)
real-time analytical##3##2##(2007-8#2)(2008-10#1)
real-time and##7##2##(2008-10#2)(2008-11#1)(2008-2#1)(2011-1#1)(2013-1#2)
real-time applications##3##2##(2008-2#2)(2008-3#1)
real-time characterization of##2##3##(2007-12#1)(2008-2#1)
real-time characterization##3##2##(2007-12#1)(2008-2#1)(2009-7#1)
real-time clinical##2##2##(2008-7#1)(2010-8#1)
real-time compensation for##2##3##(2007-11#1)(2008-2#1)
real-time control of the##2##4##(2006-5#1)(2011-2#1)
real-time conversion of##2##3##(2007-12#1)(2008-3#1)
real-time data acquisition##2##3##(2008-4#1)(2009-6#1)
real-time data##10##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2013-1#3)
real-time detection of##7##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-12#1)(2009-2#1)(2009-6#1)
real-time detection##8##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-12#1)(2009-2#1)(2009-6#1)
real-time determination of tissue optical properties##2##6##(2008-3#2)
real-time digital signal##2##3##(2008-2#1)(2008-3#1)
real-time display##3##2##(2007-11#2)(2008-3#1)
real-time dynamic##2##2##(2006-3#1)(2008-3#1)
real-time feedback##5##2##(2007-5#3)(2011-1#1)(2011-2#1)
real-time fluorescent##3##2##(2007-11#1)(2008-10#2)
real-time glucose##2##2##(2009-2#2)
real-time gray-scale##2##2##(2007-11#2)
real-time hologram recording##2##3##(2008-2#1)(2008-3#1)
real-time hologram##3##2##(2008-2#1)(2008-3#2)
real-time holographic##4##2##(2008-2#2)(2008-3#2)
real-time image processing##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
real-time image##10##2##(2006-12#1)(2006-6#1)(2007-12#2)(2008-2#2)(2008-3#2)(2011-1#1)(2012-2#1)
real-time imaging of##2##3##(2008-8#1)(2011-7#1)
real-time imaging##4##2##(2008-8#1)(2009-7#1)(2011-1#1)(2011-7#1)
real-time implementation##2##2##(2008-2#1)(2012-1#1)
real-time information on##2##3##(2006-10#1)(2009-8#1)
real-time interaction with##2##3##(2008-11#1)(2008-7#1)
real-time joint##2##2##(2008-2#1)(2008-3#1)
real-time measurement of##3##3##(2008-10#1)(2008-2#2)
real-time measurements of##2##3##(2008-3#1)(2008-4#1)
real-time measurements##4##2##(1993-4#1)(2008-3#2)(2008-4#1)
real-time monitor##3##2##(2008-2#3)
real-time monitoring of the##2##4##(2006-7#1)(2010-5#1)
real-time monitoring of##14##3##(2006-7#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-3#1)(2010-12#2)(2010-5#2)(2013-1#1)(2013-8#1)
real-time monitoring##17##2##(2006-7#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-3#1)(2010-12#2)(2010-5#2)(2013-1#1)(2013-8#2)
real-time multiplex PCR##2##3##(2013-8#2)
real-time myocardial contrast echocardiography##2##4##(2009-4#1)(2010-8#1)
real-time operation##6##2##(2007-12#2)(2008-3#1)(2013-1#3)
real-time optical spectrum##2##3##(2008-3#2)
real-time optical##3##2##(2008-3#3)
real-time patient##2##2##(1996-1#1)(2008-8#1)
real-time performances##3##2##(2008-2#2)(2008-3#1)
real-time phase-difference amplification##2##3##(2008-3#2)
real-time polarization measurement##2##3##(2007-11#1)(2007-12#1)
real-time polymerase chain reaction (PCR) assay was developed for##2##9##(2008-10#2)
real-time polymerase chain reaction (PCR) assay was developed to##2##9##(2008-10#2)
real-time polymerase chain reaction (PCR) assay was developed##4##8##(2008-10#4)
real-time polymerase chain reaction (PCR) assay##6##6##(2008-10#6)
real-time polymerase chain reaction (PCR)##14##5##(2008-10#12)(2012-12#1)(2012-3#1)
real-time polymerase chain reaction (qPCR)##2##5##(2009-6#1)(2012-3#1)
real-time polymerase chain reaction assay##3##5##(2011-2#1)(2012-2#1)(2012-3#1)
real-time polymerase chain reaction assays##2##5##(2008-10#2)
real-time polymerase chain reaction for##2##5##(2008-10#1)(2012-3#1)
real-time polymerase chain reaction##45##4##(2008-10#22)(2008-4#1)(2008-6#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#3)(2013-8#1)
real-time polymerase chain##47##3##(2008-10#23)(2008-4#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#3)(2013-8#1)
real-time processing of the##2##4##(2007-12#1)(2011-1#1)
real-time processing##4##2##(2007-12#1)(2008-2#1)(2009-6#1)(2011-1#1)
real-time q-PCR##2##2##(2013-8#2)
real-time quantitative PCR##5##3##(2008-10#2)(2008-4#1)(2013-8#2)
real-time quantitative RT-PCR##2##3##(2008-11#1)(2008-5#1)
real-time quantitative polymerase chain reaction (PCR)##3##6##(2008-10#3)
real-time quantitative polymerase chain reaction##11##5##(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#1)(2010-7#1)(2013-1#1)
real-time quantitative reverse##3##3##(2008-10#1)(2008-2#1)(2008-9#1)
real-time quantitative##23##2##(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-9#1)(2010-4#1)(2010-7#1)(2013-1#2)(2013-8#2)
real-time reconfigurable##2##2##(2008-2#2)
real-time reverse transcription PCR##2##4##(2010-5#1)(2011-2#1)
real-time reverse transcription##3##3##(2010-5#1)(2011-2#1)(2012-2#1)
real-time reverse transcription-PCR##2##3##(2010-11#1)(2011-2#1)
real-time reverse transcription-polymerase chain reaction (RT-PCR)##2##6##(2008-10#2)
real-time reverse transcription-polymerase chain reaction##6##5##(2008-10#5)(2013-1#1)
real-time reverse##12##2##(2008-10#5)(2010-11#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#2)
real-time reverse-transcription polymerase chain reaction##2##5##(2008-10#1)(2011-1#1)
real-time sampling and display in##2##5##(2012-3#2)
real-time sampling##3##2##(1992-3#1)(2012-3#2)
real-time three-dimensional echocardiography##3##3##(2007-8#2)(2008-4#1)
real-time three-dimensional##6##2##(2007-11#1)(2007-8#3)(2008-3#1)(2008-4#1)
real-time tracking tools with visible results for patients could improve health outcomes and communication with clinicians##2##16##(2013-1#2)
real-time tracking tools##4##3##(2013-1#4)
real-time tracking##8##2##(2013-1#8)
real-time ultrasound guidance for##2##4##(2007-7#1)(2008-1#1)
real-time ultrasound guidance##5##3##(2007-7#3)(2008-1#1)(2012-2#1)
real-time ultrasound##8##2##(1991-6#1)(1994-4#1)(2007-4#1)(2007-7#3)(2008-1#1)(2012-2#1)
real-time ultrasound-guided##2##2##(2008-1#2)
real-time video##3##2##(2008-2#1)(2008-3#1)(2011-1#1)
real-time visual##2##2##(2007-5#1)(2007-9#1)
real-time visualization of##2##3##(2007-12#1)(2008-2#1)
real-time##606##1##(1990-4#1)(1991-2#1)(1991-6#3)(1992-3#1)(1993-4#1)(1994-4#1)(1995-1#1)(1995-5#1)(1996-1#1)(1996-12#1)(1997-6#1)(1997-8#2)(2004-9#1)(2005-10#1)(2005-11#3)(2005-12#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#4)(2006-7#1)(2006-9#1)(2007-10#3)(2007-11#25)(2007-12#41)(2007-4#1)(2007-5#5)(2007-7#3)(2007-8#8)(2007-9#1)(2008-1#6)(2008-10#99)(2008-11#12)(2008-12#2)(2008-2#65)(2008-3#48)(2008-4#15)(2008-5#2)(2008-6#12)(2008-7#12)(2008-8#6)(2008-9#5)(2009-10#4)(2009-12#1)(2009-2#7)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#7)(2009-7#3)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-4#5)(2010-5#5)(2010-6#5)(2010-7#5)(2010-8#5)(2011-1#16)(2011-12#1)(2011-2#17)(2011-7#2)(2012-1#5)(2012-12#1)(2012-2#15)(2012-3#19)(2013-1#38)(2013-8#23)
real-time&quot##2##1##(2008-10#1)(2008-4#1)
real-valued function optimization##2##3##(2008-2#2)
real-valued##6##1##(2008-2#4)(2008-3#2)
real-world applications##5##2##(2007-11#2)(2008-2#1)(2008-3#1)(2010-7#1)
real-world clinical settings##2##3##(2007-10#1)(2011-2#1)
real-world practice##2##2##(2011-2#1)(2013-1#1)
real-world samples##4##2##(2008-10#2)(2010-5#2)
real-world situations##2##2##(2006-5#1)(2008-11#1)
real-world##51##1##(1994-3#1)(1995-11#1)(1996-2#1)(2006-11#3)(2006-5#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-4#3)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#4)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-5#2)(2010-7#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-2#2)(2013-1#4)
realign##3##1##(1995-3#1)(2007-12#1)(2009-8#1)
realigned the##2##2##(2007-12#1)(2008-3#1)
realigned##6##1##(1993-3#1)(1995-8#1)(2007-12#1)(2007-5#1)(2008-3#1)(2009-3#1)
realignment and##2##2##(2006-12#1)(2008-1#1)
realignment is##3##2##(2008-3#1)(2008-6#1)(2013-8#1)
realignment of pelvic fracture urethral injuries##2##6##(2013-8#2)
realignment of the##2##3##(1995-8#1)(2006-5#1)
realignment of##7##2##(1991-2#1)(1991-3#1)(1995-3#1)(1995-8#1)(2006-5#1)(2013-8#2)
realignment##20##1##(1991-2#1)(1991-3#2)(1993-3#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-11#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-7#3)(2008-1#1)(2008-3#1)(2008-6#1)(2013-8#3)
realisation of##2##2##(2007-10#1)(2012-3#1)
realisation##3##1##(2006-2#1)(2007-10#1)(2012-3#1)
realise the##4##2##(1997-8#1)(2008-11#2)(2008-12#1)
realise##13##1##(1991-5#1)(1997-8#1)(2006-2#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#1)(2010-3#1)
realised by##2##2##(2008-1#1)(2008-2#1)
realised from##3##2##(2008-12#1)(2008-3#1)(2011-2#1)
realised in##7##2##(2006-2#1)(2007-11#1)(2007-6#3)(2008-11#1)(2008-5#1)
realised only##2##2##(1991-3#1)(2008-5#1)
realised##25##1##(1991-3#1)(1996-11#1)(1996-12#1)(2006-2#3)(2007-11#1)(2007-12#1)(2007-6#3)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-1#1)(2011-2#1)
realising##3##1##(1997-3#1)(2007-7#1)(2012-2#1)
realism and##6##2##(2005-5#1)(2008-8#1)(2010-2#1)(2011-2#3)
realism of sexually threatening role plays##2##6##(2009-11#2)
realism of##5##2##(2009-11#4)(2012-2#1)
realism##19##1##(1991-5#1)(2004-3#2)(2005-5#1)(2006-10#1)(2008-8#1)(2009-11#5)(2010-2#2)(2011-2#5)(2012-2#1)
realistic and##7##2##(1995-1#1)(1996-2#1)(2006-6#1)(2008-10#1)(2008-12#1)(2009-8#1)(2011-2#1)
realistic application##2##2##(2008-5#2)
realistic boundary##2##2##(2008-3#1)(2010-12#1)
realistic computer##2##2##(1991-11#1)(2009-8#1)
realistic conditions##5##2##(2008-2#2)(2008-3#2)(2010-6#1)
realistic estimates##2##2##(2008-3#1)(2009-2#1)
realistic expectations##2##2##(2007-11#1)(2007-9#1)
realistic experimental##2##2##(2008-3#2)
realistic geometries##2##2##(2008-3#1)(2013-8#1)
realistic in##2##2##(1991-12#1)(2009-7#1)
realistic model##2##2##(2009-8#1)(2013-1#1)
realistic models##2##2##(1996-8#1)(2013-8#1)
realistic objective##2##2##(2008-7#2)
realistic option in##2##3##(2006-1#1)(2007-2#1)
realistic option##3##2##(2006-1#1)(2007-2#1)(2008-5#1)
realistic parameters##2##2##(2007-12#1)(2008-3#1)
realistic population##2##2##(2007-9#1)(2013-1#1)
realistic scenarios##2##2##(2008-7#1)(2012-2#1)
realistic simulation of##3##3##(2007-5#1)(2008-11#1)(2008-3#1)
realistic simulation##5##2##(2007-5#1)(2008-11#1)(2008-3#1)(2010-12#1)(2010-6#1)
realistic simulations##2##2##(1995-2#1)(1997-6#1)
realistic visual##2##2##(2012-1#2)
realistic way##2##2##(1991-4#1)(2008-3#1)
realistic##212##1##(1990-4#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-2#2)(1994-12#1)(1994-3#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#2)(1996-4#2)(1996-8#1)(1997-2#2)(1997-3#2)(1997-6#1)(2004-12#1)(2005-12#1)(2005-5#1)(2005-9#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#1)(2006-6#1)(2007-1#1)(2007-11#5)(2007-12#11)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#1)(2007-9#4)(2008-10#7)(2008-11#10)(2008-12#2)(2008-2#17)(2008-3#27)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#1)(2009-10#3)(2009-2#2)(2009-7#1)(2009-8#5)(2009-9#1)(2010-10#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#3)(2011-1#2)(2011-2#3)(2012-1#5)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#7)(2013-8#3)
realistically be##3##2##(1995-6#1)(1997-6#1)(2006-7#1)
realistically##15##1##(1995-6#1)(1996-2#1)(1996-7#1)(1997-6#1)(2006-7#1)(2007-12#1)(2007-7#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#2)
realities and##5##2##(1995-2#1)(1995-3#1)(2008-11#1)(2008-4#1)(2012-3#1)
realities of##14##2##(1993-7#1)(1995-3#1)(2007-4#1)(2007-5#3)(2008-10#1)(2008-11#2)(2009-2#1)(2010-4#1)(2010-6#1)(2013-1#1)(2013-8#1)
realities##47##1##(1990-6#1)(1991-3#1)(1992-12#1)(1992-4#1)(1993-1#2)(1993-7#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-3#2)(2006-10#2)(2006-2#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-4#2)(2007-5#3)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-2#1)(2008-4#2)(2008-9#1)(2009-2#1)(2009-4#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
reality and the##2##3##(1997-5#1)(2005-7#1)
reality and##8##2##(1997-5#1)(2005-7#1)(2006-3#1)(2007-5#1)(2008-1#1)(2008-6#1)(2008-9#1)(2011-2#1)
reality for the##3##3##(1995-2#1)(2006-6#1)(2011-2#1)
reality for##6##2##(1994-12#1)(1995-2#1)(2006-6#1)(2007-12#1)(2007-4#1)(2011-2#1)
reality in the##7##3##(1990-11#1)(1996-1#1)(2006-3#1)(2006-6#1)(2009-10#1)(2011-2#1)(2013-8#1)
reality in##15##2##(1990-11#1)(1991-3#1)(1996-1#1)(2006-3#1)(2006-6#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
reality is that##3##3##(2006-10#1)(2008-11#1)(2010-8#1)
reality is##5##2##(1994-2#1)(2006-10#1)(2008-11#1)(2010-8#1)(2013-8#1)
reality of a new tool in psychiatry##3##7##(2007-9#3)
reality of a##4##3##(2007-9#3)(2010-7#1)
reality of the##8##3##(1993-2#1)(1997-2#1)(2006-4#1)(2006-7#1)(2007-10#1)(2008-11#2)(2012-12#1)
reality of##32##2##(1993-2#1)(1994-12#2)(1994-6#1)(1995-11#1)(1997-2#1)(2005-2#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-9#3)(2008-11#3)(2008-2#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)
reality or##3##2##(1996-3#1)(2007-4#1)(2010-7#1)
reality to##4##2##(1993-3#1)(2010-1#1)(2010-8#1)(2012-1#1)
reality with##2##2##(1991-3#1)(2008-10#1)
reality##218##1##(1990-11#1)(1990-5#1)(1990-6#1)(1991-11#2)(1991-3#2)(1991-8#1)(1992-1#1)(1992-12#2)(1992-2#2)(1993-2#1)(1993-3#4)(1993-5#1)(1994-1#3)(1994-11#1)(1994-12#5)(1994-2#1)(1994-3#1)(1994-6#3)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1996-1#2)(1996-12#2)(1996-3#3)(1996-5#1)(1997-2#2)(1997-5#1)(1997-8#1)(2004-8#1)(2005-2#1)(2005-7#2)(2006-10#2)(2006-3#3)(2006-4#1)(2006-6#7)(2006-7#2)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#3)(2007-8#3)(2007-9#7)(2008-1#2)(2008-10#7)(2008-11#11)(2008-12#4)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#5)(2008-9#5)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#2)(2010-7#2)(2010-8#5)(2010-9#1)(2011-2#9)(2011-7#2)(2011-9#1)(2012-1#4)(2012-12#3)(2012-2#3)(2012-3#6)(2013-1#9)(2013-8#5)
reality&quot##2##1##(1993-5#1)(2007-2#1)
reality?##13##1##(1991-1#1)(1991-8#1)(1994-1#1)(1996-1#1)(2004-10#1)(2006-10#1)(2006-3#1)(2006-9#1)(2008-11#2)(2008-7#1)(2009-7#1)(2012-12#1)
reality]##6##1##(1993-10#1)(1994-11#1)(2008-9#1)(2009-9#1)(2012-1#1)(2012-12#1)
realizable##7##1##(1990-5#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2013-8#1)
realization in##3##2##(2007-12#1)(2008-2#2)
realization of a##18##3##(2007-11#2)(2007-12#3)(2008-2#4)(2008-3#6)(2008-7#1)(2009-12#1)(2011-2#1)
realization of an integrated##2##4##(2007-12#1)(2011-1#1)
realization of an##5##3##(2007-12#3)(2011-1#1)(2013-1#1)
realization of the##13##3##(1992-3#1)(1992-5#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2012-1#1)(2012-2#1)
realization of these##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
realization of this##4##3##(2007-11#1)(2008-11#1)(2008-2#1)(2012-2#1)
realization of##79##2##(1992-3#1)(1992-5#1)(1995-1#1)(1995-9#1)(1996-5#2)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-11#7)(2007-12#9)(2007-9#2)(2008-10#3)(2008-11#2)(2008-2#9)(2008-3#12)(2008-7#3)(2008-8#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#1)
realization that the##3##3##(1991-12#1)(2006-10#1)(2007-8#1)
realization that##13##2##(1991-12#1)(1993-11#1)(1994-12#1)(2005-10#1)(2006-10#2)(2007-12#2)(2007-8#1)(2008-10#1)(2008-2#1)(2013-1#2)
realization##111##1##(1991-12#1)(1992-3#1)(1992-5#1)(1993-11#1)(1994-12#1)(1995-1#1)(1995-3#1)(1995-9#1)(1996-5#2)(1997-6#1)(2005-10#1)(2006-10#3)(2006-12#2)(2006-4#1)(2006-5#1)(2007-11#7)(2007-12#14)(2007-8#1)(2007-9#3)(2008-10#5)(2008-11#2)(2008-2#15)(2008-3#13)(2008-7#3)(2008-8#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#8)(2013-7#2)
realizations and##2##2##(2005-11#1)(2008-3#1)
realizations of the##2##3##(2009-9#1)(2011-12#1)
realizations of##5##2##(2007-12#1)(2008-3#2)(2009-9#1)(2011-12#1)
realizations##13##1##(1992-6#1)(2005-11#1)(2007-12#2)(2008-2#2)(2008-3#5)(2009-9#1)(2011-12#1)
realize a##12##2##(2007-12#2)(2008-2#1)(2008-3#3)(2008-5#1)(2009-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
realize an##3##2##(2007-11#1)(2008-2#1)(2012-3#1)
realize that##17##2##(1991-10#1)(1991-2#1)(1992-1#1)(1994-12#1)(1994-2#1)(1994-9#1)(1997-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
realize the goals of##3##4##(2009-8#1)(2013-1#2)
realize the##29##2##(1994-3#1)(1996-3#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#5)(2008-3#3)(2008-7#3)(2008-9#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#4)
realize their##7##2##(2006-4#1)(2008-10#1)(2008-9#1)(2010-12#2)(2012-12#1)(2012-2#1)
realize##113##1##(1991-10#1)(1991-2#1)(1992-1#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1996-3#2)(1997-1#1)(1997-5#1)(1997-8#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#7)(2007-8#3)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#15)(2008-3#10)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-4#2)(2009-6#2)(2009-8#1)(2010-11#1)(2010-12#2)(2010-5#2)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#4)(2012-1#2)(2012-11#3)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#2)
realized a##7##2##(1995-1#1)(2007-11#1)(2007-12#4)(2008-3#1)
realized after##3##2##(2007-8#1)(2008-10#1)(2010-2#1)
realized and##3##2##(2008-2#1)(2008-8#1)(2010-3#1)
realized as a##2##3##(2007-11#1)(2008-3#1)
realized as##4##2##(1997-3#1)(2007-11#1)(2008-10#1)(2008-3#1)
realized at the##2##3##(1992-1#1)(2008-2#1)
realized at##4##2##(1992-1#1)(2008-2#1)(2008-3#1)(2010-5#1)
realized based on##2##3##(2008-2#1)(2012-3#1)
realized but##2##2##(2010-11#1)(2012-2#1)
realized by a##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
realized by means of##3##4##(2008-1#1)(2008-2#1)(2008-3#1)
realized by the##3##3##(2007-10#1)(2008-10#1)(2008-11#1)
realized by use of##7##4##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#1)
realized by##43##2##(1994-9#1)(2007-10#1)(2007-11#6)(2007-12#6)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#6)(2008-3#3)(2008-8#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
realized cluster##2##2##(2009-10#2)
realized during the##2##3##(2008-2#1)(2012-1#1)
realized during##3##2##(2008-2#2)(2012-1#1)
realized experimentally##2##2##(2007-12#1)(2008-1#1)
realized for##7##2##(1994-12#1)(2007-12#1)(2007-9#1)(2008-2#3)(2010-9#1)
realized in a##2##3##(2007-11#1)(2008-2#1)
realized in the##5##3##(2008-3#2)(2009-9#1)(2011-2#1)(2013-8#1)
realized in##18##2##(1994-2#1)(1997-6#2)(2005-11#1)(2005-2#1)(2007-11#1)(2008-2#2)(2008-3#4)(2009-9#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
realized on the##2##3##(2007-8#1)(2008-10#1)
realized on##3##2##(2007-8#1)(2008-10#1)(2008-3#1)
realized over##3##2##(1994-1#1)(2007-12#1)(2008-2#1)
realized simultaneously##2##2##(2007-12#1)(2008-3#1)
realized that##10##2##(1997-1#1)(2005-12#1)(2006-6#2)(2007-12#1)(2008-2#1)(2008-4#1)(2010-2#1)(2011-2#1)(2013-1#1)
realized the##2##2##(2008-3#1)(2009-10#1)
realized their##2##2##(2010-8#1)(2012-3#1)
realized through##4##2##(1994-2#1)(2008-4#1)(2008-5#1)(2012-3#1)
realized to##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2009-8#1)
realized under##4##2##(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)
realized when##3##2##(2007-12#1)(2008-2#1)(2008-8#1)
realized with a##4##3##(2007-12#2)(2008-3#2)
realized with##12##2##(1993-9#1)(2007-12#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2013-1#1)
realized without##2##2##(2008-3#2)
realized##229##1##(1992-1#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-4#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-3#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-6#2)(2005-11#1)(2005-12#1)(2005-2#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#2)(2007-10#1)(2007-11#14)(2007-12#34)(2007-4#1)(2007-7#1)(2007-8#6)(2007-9#2)(2008-1#6)(2008-10#18)(2008-11#1)(2008-12#1)(2008-2#26)(2008-3#23)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#7)(2008-9#1)(2009-10#4)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#4)(2013-8#2)
realizes the##2##2##(2008-3#1)(2008-4#1)
realizes##7##1##(1997-1#1)(2007-12#1)(2008-3#3)(2008-4#1)(2008-7#1)
realizing the##6##2##(1991-3#1)(1996-3#1)(2008-10#2)(2008-5#1)(2013-8#1)
realizing##24##1##(1991-3#1)(1994-1#2)(1994-12#1)(1995-1#1)(1996-3#1)(2006-2#1)(2007-12#2)(2007-4#1)(2008-10#2)(2008-3#5)(2008-4#1)(2008-5#1)(2009-10#1)(2010-12#1)(2010-8#1)(2012-1#1)(2013-8#1)
reallocate##3##1##(1990-12#2)(2013-8#1)
reallocating##2##1##(2008-10#1)(2009-8#1)
reallocation of resources##2##3##(1994-2#1)(2010-7#1)
reallocation of##4##2##(1994-2#1)(2010-10#1)(2010-7#1)(2011-2#1)
reallocation##8##1##(1994-2#1)(2008-8#1)(2010-10#1)(2010-7#1)(2011-2#2)(2012-3#2)
really a##7##2##(1994-1#1)(1996-7#1)(1996-8#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-8#1)
really helps##2##2##(1991-7#1)(2008-4#1)
really high##2##2##(2008-10#1)(2011-2#1)
really important##2##2##(1992-10#1)(2013-8#1)
really is##2##2##(2006-10#1)(2011-2#1)
really know##3##2##(1991-12#1)(1992-3#1)(1994-6#1)
really make a difference##2##4##(2011-2#1)(2013-7#1)
really matter##2##2##(1995-12#1)(2008-7#1)
really superior to##2##3##(1994-3#1)(2011-1#1)
really tell##2##2##(1997-4#1)(2008-8#1)
really the##3##2##(1995-1#1)(2006-10#1)(2008-10#1)
really##123##1##(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-3#4)(1994-6#1)(1995-1#3)(1995-12#1)(1995-3#1)(1995-6#2)(1995-7#1)(1996-1#1)(1996-7#1)(1996-8#2)(1997-4#1)(1997-6#1)(2005-10#1)(2005-11#1)(2006-10#4)(2006-12#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#3)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-2#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#9)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#3)
realm of possibility##2##3##(1990-12#1)(2010-5#1)
realm of##18##2##(1990-12#1)(1996-9#1)(1997-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-2#1)(2010-5#1)(2010-7#2)(2010-8#1)
realm##27##1##(1990-12#1)(1990-6#1)(1996-9#1)(1997-1#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2013-7#1)
realms##7##1##(1997-6#1)(2007-4#1)(2008-11#1)(2009-4#1)(2010-12#1)(2010-7#1)(2010-9#1)
realtime##2##1##(2010-12#1)(2012-1#1)
reaming##3##1##(2008-4#1)(2009-3#1)(2013-1#1)
reamplification of##3##2##(1996-7#1)(1997-4#1)(2008-1#1)
reamplification##4##1##(1991-10#1)(1996-7#1)(1997-4#1)(2008-1#1)
reanalysed in##2##2##(2008-10#1)(2008-5#1)
reanalysed##3##1##(2008-10#2)(2008-5#1)
reanalysis of the data##2##4##(2008-2#1)(2008-9#1)
reanalysis of the##4##3##(1991-2#1)(1995-8#1)(2008-2#1)(2008-9#1)
reanalysis of##7##2##(1991-2#1)(1995-8#1)(1996-8#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-9#1)
reanalysis##11##1##(1991-2#1)(1995-8#1)(1996-8#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-6#1)(2008-9#1)(2011-2#1)
reanalyze##3##1##(1996-12#1)(2008-3#1)(2013-1#1)
reanalyzed the data##2##3##(1992-11#1)(2008-8#1)
reanalyzed##4##1##(1992-11#1)(2007-4#1)(2008-8#1)(2011-2#1)
reanastomosis of##2##2##(1996-2#1)(2008-10#1)
reanastomosis##5##1##(1995-1#1)(1996-2#3)(2008-10#1)
reanimation##9##1##(2007-10#1)(2008-10#1)(2008-8#4)(2010-4#1)(2010-8#1)(2013-1#1)
reap the benefits of##2##4##(1991-2#1)(1996-1#1)
reap the##4##2##(1991-2#1)(1996-1#1)(2006-11#1)(2008-10#1)
reap##9##1##(1991-2#1)(1994-1#1)(1996-1#1)(1996-3#1)(1997-1#1)(2006-10#1)(2006-11#1)(2008-10#1)(2008-11#1)
reappear##3##1##(1992-10#1)(1996-11#1)(1996-5#1)
reappearance of##12##2##(1990-10#1)(1992-6#1)(1993-10#2)(1993-2#1)(1994-12#1)(1994-2#1)(1996-11#1)(2006-10#1)(2007-11#1)(2008-8#1)(2013-7#1)
reappearance##14##1##(1990-10#1)(1992-6#1)(1993-10#2)(1993-2#1)(1994-12#2)(1994-2#1)(1996-11#1)(2006-10#1)(2007-11#1)(2008-4#1)(2008-8#1)(2013-7#1)
reappeared in the##2##3##(2006-4#1)(2012-12#1)
reappeared in##3##2##(1990-12#1)(2006-4#1)(2012-12#1)
reappeared##9##1##(1990-12#1)(1991-11#1)(2006-2#1)(2006-4#1)(2008-11#1)(2008-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
reappears in##3##2##(1994-10#1)(2007-12#2)
reappears##4##1##(1994-10#1)(1994-12#1)(2007-12#2)
reapplication of##2##2##(1992-6#1)(2005-11#1)
reappointment##4##1##(1994-12#1)(1994-3#1)(2007-5#2)
reappraisal of the##3##3##(1991-12#1)(2008-3#1)(2013-8#1)
reappraisal of##8##2##(1991-12#1)(1995-3#1)(2006-10#2)(2008-3#2)(2008-6#1)(2013-8#1)
reappraisal##17##1##(1990-5#1)(1991-12#1)(1992-10#1)(1992-9#1)(1993-12#1)(1995-3#1)(2005-8#1)(2006-10#2)(2006-9#1)(2008-11#2)(2008-3#2)(2008-6#1)(2008-8#1)(2013-8#1)
reappraised##3##1##(1996-11#2)(2006-11#1)
rear bridges##8##2##(1996-11#8)
rear crossbridges##2##2##(1996-11#2)
rear end impact##2##3##(2007-1#2)
rear end##3##2##(2007-1#2)(2007-4#1)
rear impact##9##2##(2006-11#5)(2007-1#1)(2007-4#3)
rear impacts##2##2##(2007-4#2)
rear mirror##3##2##(2008-10#1)(2008-3#2)
rear##51##1##(1991-2#1)(1996-11#11)(1996-12#1)(1996-8#1)(2005-11#1)(2006-10#1)(2006-11#5)(2007-1#5)(2007-12#6)(2007-4#8)(2008-10#3)(2008-3#5)(2009-2#1)(2012-3#1)(2013-1#1)
rear-end collision##2##2##(2007-1#2)
rear-end collisions##4##2##(2007-1#1)(2007-11#1)(2007-4#2)
rear-end impact##3##2##(2006-11#3)
rear-end impacts##5##2##(2007-4#5)
rear-end##14##1##(2006-11#3)(2007-1#3)(2007-11#1)(2007-4#7)
rear-impact##2##1##(2007-4#2)
reared as##3##2##(2007-7#1)(2008-1#1)(2008-5#1)
reared at##2##2##(2007-6#1)(2008-9#1)
reared by##2##2##(2008-8#1)(2008-9#1)
reared controls##2##2##(1992-11#1)(1996-5#1)
reared following##2##2##(2010-4#2)
reared from##4##2##(2008-6#1)(2010-4#1)(2010-8#1)(2013-1#1)
reared in the##2##3##(1992-11#1)(2007-6#1)
reared in##10##2##(1992-11#2)(2007-6#1)(2008-12#4)(2008-8#1)(2010-4#2)
reared on##12##2##(1995-9#1)(2004-2#2)(2007-6#1)(2008-10#1)(2008-6#4)(2008-9#1)(2010-4#1)(2013-1#1)
reared or##2##2##(1996-3#1)(1996-5#1)
reared under low##2##3##(2010-8#2)
reared under##11##2##(1992-9#1)(1994-11#1)(2007-3#1)(2008-3#1)(2008-8#1)(2010-4#1)(2010-8#4)(2012-1#1)
reared##70##1##(1992-11#3)(1992-9#1)(1994-11#1)(1994-2#1)(1995-9#1)(1996-3#1)(1996-5#5)(1997-7#1)(2004-2#3)(2004-4#1)(2007-12#1)(2007-3#1)(2007-6#4)(2007-7#2)(2008-1#1)(2008-10#5)(2008-12#4)(2008-3#2)(2008-5#1)(2008-6#5)(2008-8#3)(2008-9#3)(2009-3#1)(2009-9#1)(2010-4#8)(2010-8#6)(2012-1#1)(2013-1#2)(2013-8#1)
rearing activity##2##2##(1994-2#1)(2012-2#1)
rearing and##6##2##(1990-3#1)(1991-1#1)(1991-11#1)(1994-6#1)(1997-2#1)(2007-3#1)
rearing behavior##4##2##(1994-10#1)(1995-12#2)(2004-11#1)
rearing conditions and##3##3##(1991-2#1)(2010-4#1)(2012-1#1)
rearing conditions##7##2##(1991-2#3)(2010-4#1)(2012-1#2)(2013-7#1)
rearing have##2##2##(1991-1#1)(2010-4#1)
rearing history##2##2##(2007-12#1)(2008-1#1)
rearing in the##2##3##(1992-11#1)(2008-11#1)
rearing in##4##2##(1992-10#1)(1992-11#1)(2007-2#1)(2008-11#1)
rearing of##2##2##(2005-9#1)(2008-5#1)
rearing system##3##2##(2010-2#1)(2010-4#2)
rearing systems and##2##3##(2010-4#1)(2010-8#1)
rearing systems##4##2##(2010-4#3)(2010-8#1)
rearing##78##1##(1990-10#1)(1990-3#2)(1991-1#3)(1991-11#1)(1991-2#5)(1992-10#1)(1992-11#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-6#2)(1995-12#3)(1997-2#2)(2004-11#5)(2005-11#1)(2005-9#1)(2007-12#4)(2007-2#3)(2007-3#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-11#5)(2008-4#1)(2008-5#5)(2008-6#1)(2008-9#2)(2009-9#1)(2010-2#1)(2010-4#8)(2010-8#4)(2011-1#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
rearings##4##1##(1992-8#1)(1993-2#1)(1995-11#1)(1995-2#1)
rearrange##4##1##(1994-12#1)(2007-11#1)(2007-12#1)(2008-3#1)
rearrangeable nonblocking##2##2##(2008-2#2)
rearrangeable##3##1##(2008-2#2)(2008-3#1)
rearranged human##2##2##(1995-2#2)
rearranged in##2##2##(2007-12#1)(2008-7#1)
rearranged into##3##2##(1996-6#2)(2008-5#1)
rearranged transcripts##2##2##(2008-4#2)
rearranged with##2##2##(1991-9#1)(2007-8#1)
rearranged##35##1##(1990-6#1)(1991-9#2)(1992-3#1)(1995-2#5)(1996-5#1)(1996-6#2)(1997-4#1)(1997-9#1)(2005-7#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#3)(2008-4#6)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
rearrangement and##8##2##(1993-6#1)(1995-6#1)(1996-2#1)(1996-6#1)(1997-4#1)(2005-11#1)(2007-4#1)(2010-2#1)
rearrangement are##2##2##(1990-5#1)(1994-11#1)
rearrangement during##3##2##(2005-11#1)(2006-2#1)(2008-10#1)
rearrangement in the##5##3##(1990-10#1)(1991-12#1)(1993-10#1)(1993-3#1)(2008-6#1)
rearrangement in##13##2##(1990-10#1)(1990-6#1)(1991-12#1)(1993-10#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-7#1)(1996-4#1)(1997-1#1)(2007-2#1)(2008-4#1)(2008-6#1)
rearrangement occurs##3##2##(1994-3#1)(1995-8#1)(1996-5#1)
rearrangement of N-allylhydrazones##2##3##(2010-12#2)
rearrangement of a##3##3##(1995-1#2)(2010-10#1)
rearrangement of prenyl phenyl##2##4##(2009-11#2)
rearrangement of the actin cytoskeleton##2##5##(2008-11#1)(2008-7#1)
rearrangement of the##13##3##(1994-8#1)(1994-9#1)(1995-10#1)(1995-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-6#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
rearrangement of##50##2##(1990-4#1)(1990-8#1)(1993-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-3#1)(1995-6#2)(1996-5#5)(1996-6#1)(1996-7#3)(1997-3#1)(1997-6#1)(2006-12#1)(2007-1#1)(2007-11#7)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-11#3)(2009-12#2)(2010-10#1)(2010-12#2)(2012-2#1)(2013-8#1)
rearrangement on##2##2##(1993-5#1)(2008-4#1)
rearrangement or##2##2##(1993-2#1)(2010-12#1)
rearrangement product##4##2##(1990-2#1)(1995-3#2)(1996-5#1)
rearrangement reaction##2##2##(1993-11#1)(1996-5#1)
rearrangement that##2##2##(1990-5#1)(2005-11#1)
rearrangement to##6##2##(1993-11#1)(1995-8#1)(1996-2#1)(1996-5#1)(2010-6#1)(2012-12#1)
rearrangement under##2##2##(1996-5#1)(2007-11#1)
rearrangement was##3##2##(1995-8#1)(2007-2#1)(2010-7#1)
rearrangement within##2##2##(1990-6#1)(1992-12#1)
rearrangement##171##1##(1990-10#1)(1990-2#2)(1990-4#1)(1990-5#5)(1990-6#2)(1990-7#1)(1990-8#2)(1991-12#1)(1991-7#1)(1992-12#1)(1992-6#1)(1993-10#1)(1993-11#4)(1993-2#1)(1993-3#2)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-3#2)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#3)(1995-1#2)(1995-10#1)(1995-3#3)(1995-5#1)(1995-6#3)(1995-8#4)(1996-2#4)(1996-4#1)(1996-5#13)(1996-6#2)(1996-7#3)(1997-1#3)(1997-3#1)(1997-4#1)(1997-6#1)(1997-9#1)(2005-11#3)(2005-8#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-11#13)(2007-12#4)(2007-2#4)(2007-4#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-4#7)(2008-5#1)(2008-6#2)(2008-7#4)(2008-9#2)(2009-11#4)(2009-12#2)(2009-2#1)(2009-5#1)(2009-8#4)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#2)
rearrangements and##7##2##(1990-9#1)(1994-8#1)(2006-2#1)(2006-5#1)(2008-7#1)(2010-3#1)(2010-8#1)
rearrangements are##7##2##(1996-6#1)(1997-4#1)(2008-7#1)(2008-8#2)(2009-12#1)(2012-3#1)
rearrangements as##2##2##(2006-11#1)(2012-3#1)
rearrangements between##3##2##(2008-10#1)(2012-12#2)
rearrangements common##2##2##(2009-12#1)(2010-2#1)
rearrangements have##3##2##(2006-5#1)(2007-11#1)(2009-12#1)
rearrangements in the##3##3##(1991-12#1)(2010-3#2)
rearrangements in these##2##3##(1994-9#1)(2008-9#1)
rearrangements in##12##2##(1991-12#1)(1994-9#1)(1995-1#1)(2006-9#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-3#2)(2013-7#2)
rearrangements of the##2##3##(1994-2#1)(2009-8#1)
rearrangements of##8##2##(1994-2#1)(1994-3#1)(1994-4#1)(1994-8#1)(1995-5#1)(1996-6#1)(2008-2#1)(2009-8#1)
rearrangements that##4##2##(1995-1#1)(1997-6#1)(2008-8#2)
rearrangements were##5##2##(1993-6#1)(1993-9#1)(1994-4#1)(1997-9#1)(2012-12#1)
rearrangements within the##2##3##(1996-10#1)(2008-7#1)
rearrangements##115##1##(1990-11#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-7#1)(1992-11#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-4#2)(1994-8#2)(1994-9#1)(1995-1#3)(1995-11#2)(1995-4#1)(1995-5#1)(1996-10#1)(1996-6#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-9#3)(2006-10#1)(2006-11#1)(2006-2#1)(2006-5#3)(2006-9#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#9)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#7)(2009-2#1)(2009-5#1)(2009-8#3)(2010-2#1)(2010-3#5)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#9)(2012-2#1)(2012-3#6)(2013-7#3)
rearranges the##3##2##(1990-5#1)(1992-5#1)(2008-2#1)
rearranges##7##1##(1990-2#1)(1990-5#1)(1990-7#1)(1992-5#1)(1996-5#2)(2008-2#1)
rearranging##3##1##(1990-2#1)(2006-10#1)(2007-7#1)
rears##2##1##(1994-12#1)(2011-2#1)
reason and##4##2##(2006-4#1)(2007-9#1)(2008-6#1)(2009-4#1)
reason being that##2##3##(2006-7#1)(2008-3#1)
reason being##4##2##(1990-10#1)(2006-7#1)(2006-8#1)(2008-3#1)
reason for a##2##3##(1991-12#1)(2012-3#1)
reason for admission to##3##4##(1995-5#1)(2007-12#2)
reason for admission##6##3##(1990-10#2)(1995-5#1)(2007-12#2)(2013-1#1)
reason for decreased##2##3##(1996-1#1)(2008-11#1)
reason for disability##2##3##(1995-12#1)(1997-6#1)
reason for encounter in general practice##2##6##(2012-3#2)
reason for higher##2##3##(2008-5#1)(2008-8#1)
reason for its##3##3##(2008-10#1)(2008-5#1)(2012-12#1)
reason for not##3##3##(1990-4#1)(1992-2#1)(2007-2#1)
reason for optimism##2##3##(2004-9#1)(2006-10#1)
reason for referral##2##3##(2007-2#1)(2008-7#1)
reason for revision##2##3##(2008-8#1)(2013-1#1)
reason for seeking##2##3##(1995-9#1)(2011-1#1)
reason for the increase##2##4##(1994-6#1)(2006-10#1)
reason for the low rate of##2##6##(1991-9#1)(2007-3#1)
reason for the low##3##4##(1991-9#1)(1997-7#1)(2007-3#1)
reason for the##45##3##(1990-7#1)(1991-9#2)(1992-12#1)(1992-2#2)(1992-9#1)(1993-9#1)(1994-3#1)(1994-6#1)(1996-6#1)(1997-7#1)(2006-10#4)(2007-11#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
reason for these##2##3##(2007-10#1)(2007-11#1)
reason for this apparent##2##4##(2007-11#1)(2008-1#1)
reason for this difference##2##4##(1993-4#1)(2008-10#1)
reason for this improvement##2##4##(2008-10#1)(2008-2#1)
reason for this is that the##3##6##(2008-2#1)(2010-12#1)(2012-3#1)
reason for this is that##5##5##(2008-2#2)(2009-8#1)(2010-12#1)(2012-3#1)
reason for this is the##3##5##(2007-11#1)(2008-3#1)(2009-7#1)
reason for this is##9##4##(1992-1#1)(2007-11#1)(2008-2#2)(2008-3#1)(2009-7#1)(2009-8#1)(2010-12#1)(2012-3#1)
reason for this may be##2##5##(1992-3#1)(1996-12#1)
reason for this##31##3##(1991-11#1)(1992-1#1)(1992-3#1)(1993-4#1)(1993-9#1)(1995-8#1)(1996-12#2)(1996-4#1)(1996-8#1)(2005-11#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-2#4)(2008-3#1)(2008-7#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#1)(2012-1#1)(2012-3#2)(2013-1#1)
reason for##189##2##(1990-10#3)(1990-2#1)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-9#4)(1992-1#1)(1992-12#1)(1992-2#4)(1992-3#1)(1992-9#1)(1993-11#1)(1993-4#1)(1993-9#2)(1994-3#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#4)(1996-4#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(2004-2#1)(2004-9#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#10)(2006-7#2)(2006-8#1)(2007-10#1)(2007-11#6)(2007-12#6)(2007-2#6)(2007-3#3)(2007-7#2)(2007-9#2)(2008-1#4)(2008-10#6)(2008-11#4)(2008-2#5)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#3)(2009-1#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-7#2)(2009-8#4)(2010-11#2)(2010-12#2)(2010-2#4)(2010-3#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#5)(2013-1#4)(2013-8#4)
reason is that the##3##4##(2005-4#1)(2008-9#1)(2013-1#1)
reason is that##6##3##(2005-4#1)(2006-5#1)(2008-4#1)(2008-9#1)(2010-12#1)(2013-1#1)
reason is the##3##3##(1993-8#1)(2010-7#1)(2012-2#1)
reason is##13##2##(1992-8#1)(1993-8#1)(2005-4#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-1#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-1#1)
reason may be##2##3##(1995-2#1)(2010-11#1)
reason of##14##2##(1993-11#1)(2004-12#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
reason that the##3##3##(2005-12#1)(2006-10#1)(2008-10#1)
reason that##17##2##(1990-9#1)(1991-5#1)(1992-8#1)(2005-12#1)(2006-10#3)(2006-12#2)(2006-4#1)(2008-10#1)(2008-11#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
reason the##8##2##(1992-1#1)(1992-10#1)(1993-10#1)(1995-9#1)(2005-1#1)(2007-11#1)(2008-1#1)(2010-4#1)
reason to believe that##5##4##(1993-12#1)(1994-6#1)(2009-4#1)(2010-4#1)(2012-2#1)
reason to consider##2##3##(2008-12#1)(2012-3#1)
reason to##28##2##(1990-8#1)(1991-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-4#1)(1994-6#1)(1996-3#1)(1996-5#1)(1997-5#1)(2005-11#3)(2006-7#1)(2007-10#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#2)(2009-4#1)(2010-4#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)
reason was##6##2##(1990-6#1)(2005-4#1)(2007-3#1)(2008-10#1)(2010-4#1)(2010-8#1)
reason why the##5##3##(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2012-2#1)
reason why##17##2##(1994-8#1)(2006-10#1)(2006-5#1)(2006-6#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-9#1)(2010-2#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-8#1)
reason##430##1##(1990-10#4)(1990-2#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#5)(1992-1#4)(1992-10#1)(1992-12#1)(1992-2#5)(1992-3#2)(1992-5#2)(1992-6#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#1)(1993-4#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#2)(1996-1#2)(1996-12#5)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-9#1)(2005-1#1)(2005-11#4)(2005-12#1)(2005-4#2)(2005-5#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#15)(2006-12#2)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#3)(2006-7#5)(2006-8#3)(2007-1#2)(2007-10#2)(2007-11#14)(2007-12#9)(2007-2#11)(2007-3#6)(2007-5#2)(2007-6#2)(2007-7#5)(2007-8#2)(2007-9#5)(2008-1#14)(2008-10#19)(2008-11#10)(2008-12#2)(2008-2#7)(2008-3#7)(2008-4#4)(2008-5#13)(2008-6#3)(2008-7#8)(2008-8#8)(2008-9#8)(2009-1#2)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-11#3)(2010-12#9)(2010-2#5)(2010-3#1)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#7)(2011-1#6)(2011-12#1)(2011-2#7)(2011-3#1)(2011-7#1)(2012-1#2)(2012-11#1)(2012-12#7)(2012-2#11)(2012-3#8)(2013-1#9)(2013-7#2)(2013-8#9)
reasonable accommodation##4##2##(1995-6#2)(1996-2#1)(2004-9#1)
reasonable accommodations##3##2##(1992-12#1)(1995-12#1)(2004-9#1)
reasonable agreement with the##6##4##(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)
reasonable agreement with##15##3##(1991-9#1)(1995-4#1)(1997-4#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#2)(2012-11#1)
reasonable agreement##19##2##(1991-9#1)(1995-4#1)(1997-4#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#2)(2012-11#1)
reasonable and##5##2##(1994-8#1)(2008-10#4)
reasonable approach is to##2##4##(2007-11#1)(2012-12#1)
reasonable approach##7##2##(2006-10#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-12#1)(2012-12#1)(2013-1#1)
reasonable assumption that##2##3##(2008-3#1)(2008-7#1)
reasonable assumptions##2##2##(1991-12#1)(2013-8#1)
reasonable cost##8##2##(1991-1#1)(1992-1#1)(1996-3#1)(2006-10#1)(2008-10#3)(2008-6#1)
reasonable explanation##2##2##(1993-3#1)(1993-8#1)
reasonable explanations##2##2##(2008-8#1)(2013-1#1)
reasonable in##4##2##(1994-11#1)(2005-9#1)(2011-2#1)(2013-1#1)
reasonable models##2##2##(2008-2#1)(2008-4#1)
reasonable number of##2##3##(1997-2#1)(2008-10#1)
reasonable number##3##2##(1997-2#1)(2008-10#1)(2008-8#1)
reasonable quality##2##2##(1997-6#1)(2008-3#1)
reasonable response##2##2##(2005-10#1)(2008-10#1)
reasonable results##2##2##(2005-4#1)(2013-8#1)
reasonable selectivity##2##2##(2008-10#2)
reasonable separation##2##2##(2008-10#2)
reasonable to assume that##3##4##(1991-6#2)(1996-6#1)
reasonable to assume##4##3##(1991-6#2)(1996-6#1)(1997-7#1)
reasonable to consider##3##3##(2007-2#1)(2008-6#1)(2013-1#1)
reasonable to propose##2##3##(2006-12#1)(2009-10#1)
reasonable to##41##2##(1990-6#1)(1990-8#1)(1990-9#1)(1991-6#2)(1992-3#1)(1993-11#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-11#2)(2007-2#2)(2007-8#1)(2008-10#2)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#1)
reasonable values##2##2##(1997-1#1)(2012-3#1)
reasonable##274##1##(1990-3#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-6#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-1#1)(1993-11#2)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-4#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#1)(2004-9#2)(2005-10#2)(2005-11#1)(2005-4#2)(2005-8#1)(2005-9#1)(2006-10#8)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#4)(2006-9#1)(2007-10#2)(2007-11#7)(2007-12#5)(2007-2#4)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#2)(2007-8#3)(2008-10#25)(2008-11#4)(2008-12#4)(2008-2#10)(2008-3#21)(2008-4#6)(2008-5#7)(2008-6#4)(2008-7#6)(2008-8#3)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2010-12#4)(2010-2#2)(2010-4#4)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#3)(2011-2#3)(2011-7#1)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#5)(2013-1#7)(2013-7#2)(2013-8#4)
reasonableness##6##1##(1992-2#2)(1993-12#1)(1995-9#1)(2005-11#1)(2008-7#1)
reasonably accurate estimates of##2##4##(2006-4#1)(2008-2#1)
reasonably accurate##7##2##(1996-1#1)(1996-4#1)(2006-4#1)(2008-2#1)(2013-1#3)
reasonably approximated##2##2##(2008-2#1)(2009-7#1)
reasonably close##2##2##(2008-8#1)(2010-8#1)
reasonably constant##2##2##(1991-6#1)(2008-11#1)
reasonably controlled##2##2##(1993-9#1)(2012-3#1)
reasonably good agreement with##3##4##(2005-11#1)(2007-11#1)(2008-10#1)
reasonably good##7##2##(2005-11#1)(2007-11#1)(2007-4#1)(2008-10#3)(2008-2#1)
reasonably high##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
reasonably low##4##2##(2007-12#1)(2008-10#1)(2011-2#1)(2012-3#1)
reasonably strong##3##2##(1990-12#1)(2008-1#1)(2008-9#1)
reasonably well by##2##3##(2005-11#1)(2008-10#1)
reasonably well with the##5##4##(1992-3#1)(2007-11#1)(2008-10#2)(2008-2#1)
reasonably well with##6##3##(1992-3#1)(2007-11#1)(2008-10#2)(2008-2#1)(2011-1#1)
reasonably well##19##2##(1992-3#1)(1994-3#1)(1994-9#1)(2005-11#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)
reasonably##108##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-8#1)(1991-6#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-5#1)(1993-9#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-1#1)(2005-11#3)(2006-10#1)(2006-3#1)(2006-4#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-6#1)(2007-8#2)(2008-1#3)(2008-10#17)(2008-11#3)(2008-12#1)(2008-2#9)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#4)(2009-3#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-3#2)(2013-1#4)
reasoned action##4##2##(2008-3#1)(2012-12#3)
reasoned that##10##2##(1991-10#1)(1993-3#1)(1995-11#1)(1996-1#1)(1996-6#1)(2009-4#1)(2009-6#1)(2012-12#3)
reasoned##21##1##(1991-10#1)(1992-12#1)(1993-3#1)(1993-7#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-6#1)(2006-9#1)(2008-3#1)(2008-7#2)(2009-4#1)(2009-6#1)(2012-12#7)
reasoning ability##2##2##(2008-2#1)(2012-1#1)
reasoning about##4##2##(2006-7#1)(2008-11#1)(2012-1#2)
reasoning and##9##2##(2005-10#1)(2006-3#1)(2008-11#1)(2008-12#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
reasoning in the##2##3##(2008-12#1)(2010-11#1)
reasoning in##8##2##(2006-3#2)(2008-10#1)(2008-12#1)(2010-11#1)(2010-9#2)(2012-2#1)
reasoning of##3##2##(1990-3#1)(2008-11#1)(2010-9#1)
reasoning on##3##2##(1992-12#1)(2013-1#2)
reasoning support##2##2##(2008-7#2)
reasoning that##3##2##(2009-11#1)(2009-8#1)(2012-1#1)
reasoning was##2##2##(1990-3#1)(2012-2#1)
reasoning were##2##2##(2009-11#1)(2010-11#1)
reasoning with##4##2##(2008-11#1)(2008-9#1)(2013-1#2)
reasoning##89##1##(1990-3#4)(1992-1#1)(1992-12#1)(1995-8#1)(1997-2#1)(2004-12#1)(2005-10#1)(2006-3#4)(2006-7#2)(2006-8#1)(2008-10#1)(2008-11#14)(2008-12#4)(2008-2#3)(2008-7#4)(2008-9#2)(2009-11#4)(2009-12#1)(2009-3#2)(2009-6#1)(2009-8#4)(2009-9#1)(2010-11#2)(2010-9#3)(2011-2#1)(2012-1#6)(2012-11#1)(2012-12#3)(2012-2#5)(2013-1#5)(2013-7#5)
reasons a##2##2##(1993-12#1)(2008-3#1)
reasons against##2##2##(2006-10#1)(2007-3#1)
reasons and##15##2##(1990-12#1)(1990-5#1)(1993-10#1)(1997-1#1)(2005-7#1)(2007-11#1)(2007-2#1)(2007-3#2)(2007-7#1)(2008-12#1)(2009-4#1)(2009-5#1)(2012-1#1)(2013-7#1)
reasons are discussed##2##3##(2007-11#1)(2008-12#1)
reasons are##16##2##(1990-3#1)(1992-9#1)(2005-8#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-5#1)(2010-4#1)(2010-8#1)(2013-8#2)
reasons behind the##2##3##(2010-11#1)(2012-3#1)
reasons behind##10##2##(1993-2#1)(2007-12#1)(2008-12#1)(2009-4#1)(2010-11#1)(2010-12#1)(2012-11#1)(2012-2#2)(2012-3#1)
reasons but##2##2##(1990-12#1)(1992-6#1)
reasons for a##4##3##(1993-10#1)(1993-6#1)(2009-4#1)(2010-9#1)
reasons for admission##2##3##(2006-10#1)(2009-6#1)
reasons for and##2##3##(1990-2#1)(2010-3#1)
reasons for atypical sequelae of knee arthroscopy##2##7##(2007-11#2)
reasons for avoiding##2##3##(2011-2#1)(2012-3#1)
reasons for cessation of##2##4##(2006-7#1)(2008-8#1)
reasons for contacting##2##3##(1991-9#1)(1996-6#1)
reasons for drop-out##2##3##(1992-5#1)(2007-12#1)
reasons for enrolling##2##3##(1995-12#1)(2010-9#1)
reasons for failure of##3##4##(2007-4#1)(2008-7#1)(2012-12#1)
reasons for failure##5##3##(2007-4#1)(2008-7#1)(2012-12#1)(2013-1#2)
reasons for hospitalization##3##3##(1995-12#1)(2013-1#2)
reasons for increased##2##3##(2005-10#1)(2008-2#1)
reasons for its##3##3##(2006-10#1)(2008-7#2)
reasons for lack of##4##4##(2006-12#1)(2007-12#1)(2012-2#1)(2013-7#1)
reasons for not##5##3##(1993-1#1)(2007-10#2)(2007-3#1)(2011-2#1)
reasons for poor##2##3##(2008-3#2)
reasons for referral##3##3##(1990-4#1)(2006-8#1)(2012-2#1)
reasons for selecting##2##3##(1992-11#1)(2012-1#1)
reasons for such##2##3##(2006-10#1)(2012-2#1)
reasons for the current##3##4##(2006-10#1)(2012-12#2)
reasons for the different##2##4##(1996-5#1)(2004-3#1)
reasons for the failure of##4##5##(2005-8#1)(2008-8#1)(2010-10#1)(2012-2#1)
reasons for the lack of success##2##6##(2006-10#1)(2006-8#1)
reasons for the lack of##4##5##(2006-10#1)(2006-8#1)(2008-7#1)(2012-3#1)
reasons for the rarity of##2##5##(2007-10#1)(2008-9#1)
reasons for the##55##3##(1992-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-7#1)(2004-12#1)(2004-3#1)(2004-4#1)(2005-11#2)(2005-7#1)(2005-8#2)(2006-10#3)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#1)(2007-7#2)(2008-1#1)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-12#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
reasons for these differences##2##4##(1993-11#1)(2008-1#1)
reasons for these effects##2##4##(1990-7#1)(2006-12#1)
reasons for these##12##3##(1990-7#1)(1991-9#1)(1993-11#1)(2004-2#1)(2006-12#1)(2006-3#1)(2006-5#1)(2008-1#3)(2009-4#1)(2013-1#1)
reasons for this are discussed##2##5##(1991-4#1)(1994-8#1)
reasons for this are##5##4##(1991-4#1)(1994-8#1)(2007-7#1)(2008-3#1)(2012-12#1)
reasons for this failure##2##4##(2004-10#1)(2008-9#1)
reasons for this##31##3##(1991-4#1)(1992-12#1)(1994-8#1)(1997-7#1)(2004-10#1)(2005-8#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-7#3)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#2)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)
reasons for tooth loss##3##4##(2008-9#3)
reasons for tooth##4##3##(2008-9#4)
reasons for unmet need##2##4##(2010-8#2)
reasons for use##2##3##(1995-3#1)(2008-11#1)
reasons for use&quot##2##3##(2013-1#2)
reasons for wanting to##2##4##(2006-10#1)(2006-4#1)
reasons for which##2##3##(1991-6#1)(2009-2#1)
reasons for##257##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-7#1)(1991-4#1)(1991-6#3)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#2)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-6#1)(1996-12#4)(1996-2#2)(1996-5#1)(1996-6#2)(1997-1#1)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#1)(2004-10#2)(2004-12#1)(2004-2#1)(2004-3#1)(2004-4#1)(2005-10#2)(2005-11#2)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#7)(2006-12#2)(2006-3#1)(2006-4#3)(2006-5#1)(2006-7#4)(2006-8#5)(2006-9#1)(2007-10#5)(2007-11#8)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#6)(2007-8#1)(2008-1#5)(2008-10#10)(2008-11#3)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#6)(2008-8#5)(2008-9#12)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#1)(2011-12#2)(2011-2#7)(2012-1#3)(2012-11#1)(2012-12#6)(2012-2#8)(2012-3#5)(2013-1#15)(2013-7#1)(2013-8#3)
reasons include##2##2##(2006-10#1)(2008-8#1)
reasons included##3##2##(2007-7#1)(2008-9#1)(2009-2#1)
reasons independent of the##2##4##(1994-4#1)(2008-8#1)
reasons of the##2##3##(2006-6#1)(2008-10#1)
reasons of##18##2##(1996-12#1)(2005-11#1)(2005-4#1)(2006-6#1)(2007-11#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-8#1)
reasons that the##2##3##(2007-11#1)(2008-7#1)
reasons that##14##2##(2006-4#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-12#1)(2011-2#2)(2013-1#4)
reasons the##2##2##(1995-6#1)(2009-11#1)
reasons they##3##2##(2008-12#1)(2008-2#1)(2013-8#1)
reasons to##20##2##(1994-3#1)(1997-3#1)(2006-2#2)(2007-11#1)(2007-2#2)(2008-5#1)(2008-7#3)(2008-9#2)(2010-10#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#1)
reasons were##3##2##(1991-9#1)(2013-1#2)
reasons which##2##2##(2008-7#1)(2009-6#1)
reasons why academic people##2##4##(2009-11#2)
reasons why classical##2##3##(1993-11#1)(2010-11#1)
reasons why patients##2##3##(1991-9#1)(2005-11#1)
reasons why people##3##3##(2009-6#2)(2012-12#1)
reasons why some##2##3##(2006-10#1)(2008-12#1)
reasons why the##7##3##(1993-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-4#1)(2011-12#1)
reasons why they##2##3##(1997-5#1)(2004-10#1)
reasons why##41##2##(1990-12#1)(1991-2#1)(1991-9#1)(1993-11#1)(1993-12#1)(1994-6#1)(1995-12#1)(1997-5#1)(2004-10#1)(2005-10#1)(2005-11#1)(2005-5#1)(2006-10#1)(2006-11#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#2)(2009-6#3)(2009-9#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
reasons##657##1##(1990-12#4)(1990-2#2)(1990-3#2)(1990-4#2)(1990-5#4)(1990-7#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-4#1)(1991-5#1)(1991-6#4)(1991-8#5)(1991-9#6)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-9#2)(1993-1#3)(1993-10#3)(1993-11#4)(1993-12#4)(1993-2#3)(1993-3#2)(1993-5#3)(1993-6#2)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-4#2)(1994-5#4)(1994-6#2)(1994-7#1)(1994-8#2)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#2)(1996-1#4)(1996-11#1)(1996-12#5)(1996-2#7)(1996-3#1)(1996-5#2)(1996-6#2)(1996-9#3)(1997-1#4)(1997-2#1)(1997-3#4)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#1)(2004-1#1)(2004-10#3)(2004-12#1)(2004-2#1)(2004-3#1)(2004-4#1)(2005-10#5)(2005-11#6)(2005-4#1)(2005-5#1)(2005-7#6)(2005-8#4)(2006-1#2)(2006-10#15)(2006-11#1)(2006-12#5)(2006-2#4)(2006-3#1)(2006-4#5)(2006-5#3)(2006-6#3)(2006-7#5)(2006-8#6)(2006-9#2)(2007-10#8)(2007-11#15)(2007-12#7)(2007-2#5)(2007-3#5)(2007-4#6)(2007-5#1)(2007-6#3)(2007-7#13)(2007-8#8)(2007-9#1)(2008-1#8)(2008-10#24)(2008-11#13)(2008-12#5)(2008-2#9)(2008-3#15)(2008-4#6)(2008-5#7)(2008-6#2)(2008-7#15)(2008-8#12)(2008-9#20)(2009-10#1)(2009-11#4)(2009-12#3)(2009-2#4)(2009-3#1)(2009-4#4)(2009-5#5)(2009-6#7)(2009-7#3)(2009-8#2)(2009-9#4)(2010-10#2)(2010-11#6)(2010-12#7)(2010-2#3)(2010-3#2)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#8)(2010-9#2)(2011-1#8)(2011-12#6)(2011-2#25)(2012-1#5)(2012-11#5)(2012-12#11)(2012-2#18)(2012-3#12)(2013-1#32)(2013-7#4)(2013-8#15)
reasons)##3##1##(1992-4#1)(2005-10#1)(2007-2#1)
reassemble##2##1##(1994-9#1)(1995-2#1)
reassembled in##3##2##(1994-9#1)(2008-2#1)(2012-2#1)
reassembled##7##1##(1994-9#1)(1997-4#1)(2008-1#1)(2008-2#1)(2008-8#1)(2012-2#2)
reassembly of##3##2##(1993-8#1)(2008-9#1)(2011-2#1)
reassembly##7##1##(1993-8#1)(2008-8#4)(2008-9#1)(2011-2#1)
reassess their##3##2##(1991-3#1)(2007-11#1)(2008-3#1)
reassess##8##1##(1991-3#1)(1996-3#1)(2007-11#1)(2008-3#1)(2008-5#1)(2009-8#1)(2012-2#1)(2013-1#1)
reassessed on##2##2##(2007-1#1)(2013-1#1)
reassessed##14##1##(1995-2#1)(1997-1#1)(2006-7#1)(2006-9#1)(2007-1#2)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2011-1#1)(2013-1#1)
reassessment of the##6##3##(2006-12#1)(2008-11#1)(2009-12#1)(2009-9#1)(2010-12#1)(2011-12#1)
reassessment of##12##2##(1991-2#1)(1997-1#1)(2005-9#1)(2006-12#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-12#1)(2011-12#1)
reassessment##27##1##(1990-5#1)(1991-2#1)(1993-6#2)(1994-9#2)(1997-1#2)(2005-12#1)(2005-9#2)(2006-12#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
reassignment##4##1##(1995-3#1)(2007-10#1)(2008-1#1)(2009-10#1)
reassociation of##3##2##(1992-8#1)(1992-9#1)(1993-6#1)
reassociation##8##1##(1992-8#2)(1992-9#1)(1993-6#1)(1995-10#2)(1995-5#1)(1995-8#1)
reassortant rotavirus##4##2##(2007-11#4)
reassortant strain##4##2##(2008-10#4)
reassortant##17##1##(2007-11#6)(2008-10#9)(2011-2#1)(2013-8#1)
reassortants among##3##2##(2008-10#1)(2012-12#2)
reassortants between the two##2##4##(2008-10#2)
reassortants of##3##2##(2008-10#1)(2012-12#2)
reassortants##18##1##(2008-10#4)(2012-12#14)
reassortment##12##1##(2005-11#1)(2007-12#1)(2008-10#4)(2011-2#1)(2012-12#4)(2013-8#1)
reassurance##10##1##(2006-10#2)(2007-6#1)(2008-11#1)(2009-9#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
reassure##3##1##(1996-1#1)(2006-10#1)(2007-2#1)
reassured and##2##2##(2008-7#1)(2011-1#1)
reassured##7##1##(2007-6#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-1#1)
reassuring##8##1##(1990-6#1)(1995-2#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-9#1)(2009-11#1)
reattach##2##1##(2007-7#1)(2008-11#1)
reattached##2##1##(1995-1#1)(2006-3#1)
reattachment##3##1##(1991-4#1)(2010-2#1)(2011-1#1)
reauthorization##2##1##(1996-11#1)(2012-2#1)
rebagliati##2##1##(2013-1#2)
rebalanced hemostasis##2##2##(2013-1#2)
rebalanced##3##1##(2007-7#1)(2013-1#2)
rebalancing##2##1##(2011-2#1)(2013-1#1)
rebased##2##1##(1992-1#2)
rebasing##2##1##(1993-12#2)
rebaudioside A (0##2##3##(2007-5#2)
rebaudioside A##4##2##(2007-5#4)
rebaudioside##5##1##(2007-5#4)(2013-1#1)
rebinding of##2##2##(1996-4#1)(2008-10#1)
rebinding to##2##2##(1994-11#1)(1994-5#1)
rebinding##6##1##(1994-11#1)(1994-5#1)(1996-4#1)(2008-10#3)
rebirth##3##1##(2004-12#1)(2008-10#1)(2008-8#1)
rebled##3##1##(1997-6#1)(2007-8#1)(2008-7#1)
rebleed##3##1##(1995-11#1)(2006-10#1)(2007-10#1)
rebleeding and##3##2##(2006-10#1)(2008-7#1)(2013-1#1)
rebleeding from the##2##3##(2007-10#1)(2008-7#1)
rebleeding from##3##2##(2007-10#1)(2008-7#1)(2012-2#1)
rebleeding rate##3##2##(1995-5#1)(2008-7#2)
rebleeding rates##2##2##(1992-10#1)(1995-9#1)
rebleeding##24##1##(1992-10#3)(1995-11#1)(1995-5#1)(1995-9#3)(1997-3#1)(2006-10#2)(2007-10#1)(2008-7#7)(2012-2#1)(2013-1#3)(2013-8#1)
rebleeds##2##1##(2007-10#2)
rebound after##4##2##(1997-6#1)(1997-8#1)(2006-10#2)
rebound following##2##2##(1992-3#1)(2008-5#1)
rebound insomnia##2##2##(2004-3#1)(2013-1#1)
rebound mechanism##3##2##(1997-7#2)(2010-5#1)
rebound of##3##2##(2008-4#3)
rebound to NPR-GC##2##3##(1995-3#2)
rebound to##4##2##(1991-2#1)(1994-5#1)(1995-3#2)
rebound was##3##2##(1990-5#1)(1991-5#1)(2009-8#1)
rebound##40##1##(1990-5#2)(1991-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1993-12#1)(1994-5#1)(1995-12#1)(1995-3#3)(1997-6#2)(1997-7#2)(1997-8#1)(2004-12#1)(2004-3#2)(2006-1#1)(2006-10#3)(2006-4#1)(2007-11#1)(2008-2#1)(2008-4#5)(2008-5#1)(2009-5#1)(2009-8#1)(2010-5#1)(2012-2#2)(2013-1#1)(2013-7#1)
rebounded##2##1##(1992-3#1)(1997-8#1)
reboxetine##5##1##(2008-4#1)(2011-1#3)(2011-2#1)
rebuffed##2##1##(2007-9#1)(2009-10#1)
rebuffs##2##1##(1993-3#1)(2010-8#1)
rebuild##7##1##(1992-2#1)(1997-7#1)(2007-11#3)(2007-8#1)(2009-11#1)
rebuilding of the##2##3##(2007-11#1)(2008-4#1)
rebuilding of##4##2##(1992-11#1)(2007-11#1)(2007-7#1)(2008-4#1)
rebuilding##11##1##(1992-10#1)(1992-11#1)(1992-12#1)(2006-10#1)(2007-11#3)(2007-7#1)(2008-4#1)(2008-8#1)(2012-3#1)
rebuilt##3##1##(2006-4#1)(2008-11#1)(2010-8#1)
rebut##2##1##(1996-11#1)(2008-9#1)
rebuttal##2##1##(2007-3#1)(2008-3#1)
rec##4##1##(1990-11#3)(1991-10#1)
recA gene in##2##3##(1990-9#2)
recA gene##15##2##(1990-9#10)(1993-9#2)(1995-8#2)(2012-2#1)
recA mutant##2##2##(1995-8#2)
recA##32##1##(1990-9#11)(1991-10#2)(1993-9#5)(1995-2#1)(1995-3#1)(1995-8#6)(1997-7#2)(2008-10#3)(2012-2#1)
recA-##6##1##(1990-11#1)(1990-9#2)(1993-9#3)
recA-like gene##3##2##(1993-9#2)(1995-6#1)
recA-like genes##4##2##(1995-6#2)(1995-8#2)
recA-like proteins##2##2##(1995-6#1)(1995-8#1)
recA-like##9##1##(1993-9#2)(1995-6#4)(1995-8#3)
recB##2##1##(1991-10#2)
recF gene##3##2##(1994-12#1)(1995-8#2)
recF##8##1##(1991-10#2)(1994-12#1)(1995-8#5)
recJ##2##1##(1991-10#2)
recQ##3##1##(1991-10#2)(2012-2#1)
recalcification time##3##2##(2004-11#3)
recalcified##3##1##(1990-11#2)(1991-7#1)
recalcitrance##3##1##(2008-5#3)
recalcitrant PG##2##2##(2012-12#2)
recalcitrant cases##2##2##(2006-10#2)
recalcitrant coronary artery spasm##2##4##(2008-7#2)
recalcitrant facial plane warts##2##4##(2013-1#2)
recalcitrant rural smokers##2##3##(2013-1#2)
recalcitrant to##5##2##(2005-11#1)(2006-10#1)(2008-9#1)(2012-11#2)
recalcitrant##39##1##(1991-12#1)(2004-4#1)(2005-11#1)(2005-12#3)(2006-10#6)(2006-3#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-6#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-12#2)(2012-3#1)(2013-1#5)
recalculated##3##1##(1994-1#1)(2008-10#2)
recalculation of##2##2##(2006-10#1)(2008-2#1)
recalculation##3##1##(2006-10#1)(2007-8#1)(2008-2#1)
recalibrated##5##1##(1993-1#1)(2007-8#2)(2008-12#1)(2013-8#1)
recalibration of the##2##3##(1990-12#1)(1992-2#1)
recalibration##10##1##(1990-12#2)(1992-12#1)(1992-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-5#1)(2011-2#1)
recall after mammography##2##3##(2004-2#2)
recall and##11##2##(1991-2#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-8#1)(2011-1#1)(2013-1#4)
recall bias##5##2##(2007-4#3)(2010-11#1)(2011-2#1)
recall data##3##2##(1992-2#1)(2006-4#1)(2008-1#1)
recall for##2##2##(2008-4#1)(2011-2#1)
recall of 69##2##3##(2013-1#2)
recall of 78%##2##3##(2013-1#2)
recall of 85##2##3##(2013-1#2)
recall of##20##2##(1991-2#1)(1996-3#1)(2006-10#1)(2007-4#1)(2008-2#1)(2008-4#2)(2011-12#1)(2011-2#2)(2013-1#10)
recall performance##3##2##(1997-8#1)(2008-9#1)(2009-4#1)
recall processes##2##2##(1994-8#2)
recall significantly##2##2##(2008-12#1)(2009-10#1)
recall skills in##2##3##(2009-4#2)
recall skills##3##2##(2009-4#3)
recall system##2##2##(1994-12#1)(1995-2#1)
recall that##4##2##(2006-7#1)(2007-2#1)(2011-12#1)(2011-2#1)
recall the##3##2##(2007-7#1)(2008-1#1)(2008-10#1)
recall visits##2##2##(2008-5#1)(2012-3#1)
recall was##3##2##(2008-1#1)(2013-1#2)
recall when context is increased##2##5##(1997-8#2)
recall##128##1##(1991-10#1)(1991-11#1)(1991-2#2)(1992-2#1)(1994-12#1)(1994-8#2)(1995-11#1)(1995-2#1)(1996-10#1)(1996-3#2)(1997-8#4)(2004-2#4)(2006-10#4)(2006-3#1)(2006-4#4)(2006-7#1)(2007-12#2)(2007-2#3)(2007-4#4)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#3)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#3)(2009-10#2)(2009-2#1)(2009-4#4)(2009-5#1)(2010-1#2)(2010-11#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-12#2)(2011-2#9)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#20)(2013-8#1)
recalled the##2##2##(2007-2#1)(2009-4#1)
recalled##18##1##(1990-3#1)(1990-4#1)(1992-1#1)(1993-12#2)(1994-2#1)(1996-3#1)(2006-10#1)(2006-12#2)(2006-6#1)(2007-2#1)(2008-1#1)(2008-3#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
recalling##6##1##(1996-11#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)
recalls##12##1##(1990-5#1)(1991-12#2)(2005-12#1)(2006-5#2)(2007-9#1)(2009-2#1)(2011-1#1)(2011-2#1)(2013-1#2)
recanalisation##5##1##(2006-4#3)(2011-2#2)
recanalization and##2##2##(1990-5#1)(2006-10#1)
recanalization during##2##2##(2013-1#2)
recanalization in##3##2##(1990-10#1)(2006-7#1)(2013-7#1)
recanalization of a##2##3##(1991-6#1)(2012-2#1)
recanalization of chronic total##2##4##(2008-12#1)(2009-12#1)
recanalization of the MCA##2##4##(2007-10#2)
recanalization of the##8##3##(2007-10#3)(2007-9#1)(2008-3#1)(2008-7#1)(2009-9#2)
recanalization of##19##2##(1990-6#1)(1991-3#1)(1991-4#1)(1991-6#1)(1997-6#1)(2007-10#3)(2007-9#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-9#3)(2012-2#2)(2013-7#1)
recanalization or##2##2##(2007-8#1)(2008-12#1)
recanalization##46##1##(1990-10#2)(1990-5#1)(1990-6#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-6#1)(1992-7#1)(1993-10#1)(1993-9#1)(1994-5#1)(1997-6#1)(2006-10#1)(2006-11#1)(2006-7#2)(2007-10#4)(2007-8#1)(2007-9#2)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-9#3)(2012-2#2)(2013-1#6)(2013-7#2)(2013-8#1)
recanalized by##2##2##(1991-6#1)(2008-7#1)
recanalized##5##1##(1991-6#1)(1997-8#1)(2005-1#1)(2007-10#1)(2008-7#1)
recapitulate in vivo##2##3##(2008-4#1)(2009-12#1)
recapitulate in##3##2##(1996-4#1)(2008-4#1)(2009-12#1)
recapitulate many##2##2##(2007-11#1)(2008-4#1)
recapitulate the expression of##2##4##(1997-4#1)(2007-12#1)
recapitulate the##9##2##(1990-6#1)(1994-3#1)(1997-4#1)(2007-12#1)(2009-3#2)(2012-1#1)(2012-2#1)(2013-1#1)
recapitulate##20##1##(1990-6#1)(1994-3#1)(1996-4#1)(1997-4#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-4#2)(2008-5#1)(2009-12#1)(2009-3#2)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#2)
recapitulated in##3##2##(2010-3#1)(2011-2#1)(2012-3#1)
recapitulated##4##1##(1993-12#1)(2010-3#1)(2011-2#1)(2012-3#1)
recapitulates the normal##2##3##(2006-3#1)(2008-4#1)
recapitulates the##9##2##(2006-3#1)(2008-11#2)(2008-4#1)(2009-3#1)(2011-1#1)(2012-12#3)
recapitulates##14##1##(1992-2#1)(2006-3#1)(2008-11#2)(2008-4#2)(2008-7#1)(2009-3#1)(2011-1#1)(2012-12#4)(2012-2#1)
recapitulating the##2##2##(1995-11#1)(2012-12#1)
recapitulation of##2##2##(1997-4#1)(2012-12#1)
recapture##5##1##(2004-11#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-8#1)
recaptured##4##1##(1997-7#1)(2004-11#1)(2008-5#1)(2010-8#1)
recaptures##3##1##(2008-5#1)(2009-10#1)(2010-8#1)
recast##3##1##(1990-12#1)(2009-2#1)(2010-7#1)
recatheterization##2##1##(1994-11#1)(2007-9#1)
recedes##2##1##(1990-3#1)(1990-8#1)
receding contact angle##2##3##(2005-11#2)
receding contact angles##5##3##(2005-11#5)
receding contact##7##2##(2005-11#7)
receding##10##1##(2005-11#7)(2008-10#1)(2008-9#1)(2012-12#1)
receipt of a##8##3##(1991-2#1)(1993-9#1)(2008-8#1)(2012-12#4)(2013-1#1)
receipt of the##2##3##(2008-11#1)(2012-12#1)
receipt of##25##2##(1990-11#1)(1990-4#1)(1991-2#1)(1993-9#1)(1995-12#1)(1996-1#1)(2004-9#1)(2006-11#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2012-12#5)(2013-1#7)
receipt##31##1##(1990-11#1)(1990-4#1)(1991-2#1)(1993-9#1)(1995-12#1)(1996-1#1)(2004-9#1)(2006-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#3)(2011-12#1)(2012-12#5)(2013-1#7)
receipts##2##1##(1992-3#1)(2012-3#1)
receivable##6##1##(1993-1#1)(1994-2#1)(1994-3#1)(1996-3#1)(2007-1#1)(2007-9#1)
receivables##5##1##(1990-2#1)(1990-7#1)(1992-3#1)(1993-1#1)(1993-8#1)
receive 100 mg##2##3##(2008-5#1)(2011-2#1)
receive 20##4##2##(2007-11#1)(2011-12#1)(2012-2#2)
receive a diagnosis of##2##4##(2006-9#1)(2012-3#1)
receive a##31##2##(1990-4#1)(1992-10#1)(1994-3#1)(1994-5#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-8#1)(2005-8#1)(2006-2#1)(2006-9#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#5)
receive adequate treatment##2##3##(1993-1#1)(1996-12#1)
receive adequate##6##2##(1993-1#1)(1996-12#1)(1997-5#1)(1997-8#1)(2011-2#1)(2012-3#1)
receive adjuvant chemotherapy##3##3##(2006-9#3)
receive adjuvant therapy##2##3##(1995-10#1)(2013-1#1)
receive adjuvant##5##2##(1995-10#1)(2006-9#3)(2013-1#1)
receive advice##2##2##(1992-2#1)(2006-10#1)
receive an##6##2##(1990-3#1)(1995-6#1)(1996-12#1)(2008-9#1)(2013-1#1)(2013-8#1)
receive and##6##2##(2004-9#1)(2007-9#1)(2008-7#1)(2009-5#1)(2013-1#1)(2013-8#1)
receive any##12##2##(1992-5#1)(1995-8#1)(2007-10#2)(2007-5#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2012-2#1)(2012-3#1)
receive appropriate##2##2##(1991-4#1)(2008-3#1)
receive as##2##2##(1993-12#1)(2007-12#1)
receive care in##2##3##(1996-12#1)(2006-12#1)
receive care##11##2##(1994-3#1)(1995-8#1)(1996-12#3)(2006-12#1)(2008-4#1)(2008-7#1)(2012-12#3)
receive clinical##2##2##(1994-12#1)(2006-5#1)
receive direct##2##2##(1993-2#1)(1993-9#1)
receive either##23##2##(1990-9#1)(1992-4#1)(1993-4#1)(1996-2#1)(2006-10#2)(2007-10#1)(2007-2#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-7#1)(2010-8#1)(2013-1#2)(2013-7#1)
receive excitatory##2##2##(1996-2#1)(2013-8#1)
receive feedback##2##2##(2009-10#2)
receive first-line##2##2##(2010-7#1)(2011-2#1)
receive from##3##2##(1995-1#1)(2011-1#1)(2012-2#1)
receive greater##4##2##(1997-8#1)(2011-2#1)(2013-1#2)
receive help##3##2##(1992-2#1)(1992-4#1)(1996-3#1)
receive in##2##2##(2008-6#1)(2013-1#1)
receive inadequate##2##2##(1996-7#1)(2008-7#1)
receive information from##2##3##(1995-8#1)(2007-8#1)
receive information##6##2##(1995-4#1)(1995-8#1)(1996-1#1)(2007-8#1)(2008-1#1)(2009-5#1)
receive injections of##2##3##(2011-2#1)(2012-2#1)
receive input from##3##3##(1991-5#1)(1995-11#1)(2007-12#1)
receive inputs##3##2##(1993-12#1)(1993-2#1)(2008-4#1)
receive less##2##2##(2009-11#1)(2012-2#1)
receive little##4##2##(1990-12#1)(2004-3#1)(2008-9#1)(2012-1#1)
receive local##2##2##(1993-12#1)(2008-6#1)
receive medical##3##2##(1993-7#1)(1994-2#1)(2006-8#1)
receive more##2##2##(1991-6#1)(2007-10#1)
receive much##2##2##(2006-12#1)(2006-4#1)
receive one##2##2##(1992-8#1)(2009-2#1)
receive optimal##2##2##(2008-5#1)(2011-2#1)
receive postanesthesia##2##2##(1993-1#2)
receive preventive##2##2##(1994-2#2)
receive relevant##2##2##(2008-7#1)(2010-11#1)
receive rt-PA##2##2##(2007-10#1)(2007-9#1)
receive services##3##2##(1994-2#1)(2006-5#1)(2009-6#1)
receive signals##2##2##(1996-8#1)(2008-11#1)
receive support##3##2##(1996-2#1)(2005-5#1)(2009-3#1)
receive t-PA##3##2##(2007-9#2)(2010-12#1)
receive the appropriate##2##3##(2011-12#1)(2012-1#1)
receive the most##2##3##(1992-2#1)(2008-3#1)
receive the vaccine##3##3##(1994-9#1)(2011-2#2)
receive the##29##2##(1990-2#1)(1990-6#1)(1991-10#2)(1992-2#1)(1993-3#1)(1994-12#1)(1994-6#1)(1994-9#2)(1995-6#1)(1996-12#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-3#1)(2010-9#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)
receive their##4##2##(2006-2#1)(2008-11#1)(2009-2#1)(2009-5#1)
receive these##2##2##(2008-4#1)(2008-5#1)
receive this##5##2##(1995-1#2)(1996-12#1)(2008-11#1)(2009-8#1)
receive three doses of##2##4##(2007-2#1)(2013-1#1)
receive treatment##6##2##(1992-5#1)(2007-11#1)(2008-7#2)(2010-8#1)(2013-1#1)
receive##497##1##(1990-12#5)(1990-2#2)(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#3)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-10#3)(1992-12#3)(1992-2#4)(1992-3#1)(1992-4#3)(1992-5#2)(1992-7#1)(1992-8#2)(1993-1#4)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#1)(1993-4#2)(1993-7#3)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#7)(1994-3#2)(1994-4#1)(1994-5#2)(1994-6#3)(1994-9#2)(1995-1#5)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#4)(1995-4#1)(1995-6#4)(1995-8#3)(1995-9#1)(1996-1#3)(1996-12#9)(1996-2#5)(1996-3#4)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#6)(2004-1#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-3#2)(2004-9#2)(2005-10#1)(2005-5#1)(2005-8#1)(2006-10#8)(2006-11#2)(2006-12#4)(2006-2#4)(2006-4#2)(2006-5#3)(2006-6#2)(2006-8#2)(2006-9#6)(2007-1#4)(2007-10#10)(2007-11#9)(2007-12#6)(2007-2#6)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#7)(2007-9#7)(2008-1#7)(2008-10#1)(2008-11#6)(2008-12#4)(2008-2#7)(2008-3#11)(2008-4#9)(2008-5#9)(2008-6#7)(2008-7#14)(2008-8#7)(2008-9#5)(2009-10#3)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#3)(2009-5#5)(2009-6#2)(2009-7#1)(2009-8#4)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#3)(2010-4#4)(2010-6#1)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#2)(2011-12#4)(2011-2#21)(2012-1#8)(2012-11#1)(2012-12#8)(2012-2#13)(2012-3#8)(2013-1#31)(2013-7#4)(2013-8#8)
receive?##2##1##(1994-3#1)(2010-2#1)
received &gt##5##2##(2008-6#2)(2008-7#3)
received 0##14##2##(1993-4#1)(1996-12#1)(1996-5#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-5#3)(2010-7#3)(2011-2#2)
received 1##4##2##(1992-2#1)(2007-2#1)(2007-7#1)(2008-7#1)
received 10##3##2##(2007-11#1)(2011-2#2)
received 100 mg##2##3##(1991-3#1)(2008-12#1)
received 100##3##2##(1991-3#1)(2006-9#1)(2008-12#1)
received 1000 mg##2##3##(1991-3#1)(2007-10#1)
received 1200##2##2##(1996-8#1)(2013-1#1)
received 15##3##2##(1990-2#1)(1996-8#1)(2008-8#1)
received 16 weeks of##2##4##(2009-11#2)
received 2 mg/kg##2##3##(2008-4#1)(2012-2#1)
received 2##7##2##(1990-6#1)(1991-6#1)(2004-11#1)(2007-9#1)(2008-4#1)(2008-7#1)(2012-2#1)
received 20##2##2##(2011-2#1)(2012-2#1)
received 200##3##2##(1996-12#1)(2007-1#1)(2008-1#1)
received 3 doses of##2##4##(1994-9#1)(2008-7#1)
received 3 mT EMF during 2 months##2##7##(2012-2#2)
received 3##6##2##(1992-10#1)(1994-9#1)(2008-5#1)(2008-7#1)(2012-2#2)
received 5##2##2##(1994-3#1)(2011-2#1)
received 50##2##2##(1995-10#1)(2012-2#1)
received 6##3##2##(2007-10#1)(2011-2#1)(2013-1#1)
received 60 Gy##2##3##(1991-4#1)(1992-11#1)
received 60##4##2##(1991-4#1)(1992-11#1)(2007-9#1)(2011-2#1)
received 8##2##2##(2007-10#1)(2008-9#1)
received AP##2##2##(1996-12#2)
received CsA##2##2##(1993-11#1)(1995-2#1)
received FDA approval##2##3##(2005-7#1)(2005-8#1)
received IV##3##2##(1993-1#1)(2007-9#1)(2011-12#1)
received LST##2##2##(2005-8#2)
received PCT##2##2##(2007-7#2)
received PD##2##2##(2007-7#1)(2009-4#1)
received a 2% cholesterol diet##2##5##(2005-12#2)
received a Nucleus##2##3##(2008-9#2)
received a combination of##7##4##(1991-11#1)(1992-10#1)(2006-11#1)(2007-6#1)(2007-8#1)(2012-3#1)(2013-1#1)
received a combination##8##3##(1991-11#1)(1991-9#1)(1992-10#1)(2006-11#1)(2007-6#1)(2007-8#1)(2012-3#1)(2013-1#1)
received a diagnosis of##5##4##(2007-8#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)
received a local anesthetic##2##4##(1996-1#1)(2006-12#1)
received a mean##2##3##(2006-10#1)(2007-8#1)
received a median of##2##4##(1991-3#1)(2008-6#1)
received a median##3##3##(1991-3#1)(2007-2#1)(2008-6#1)
received a placebo##6##3##(1993-1#1)(2005-8#1)(2006-12#2)(2008-5#1)(2012-12#1)
received a postal##2##3##(1993-10#1)(1997-6#1)
received a questionnaire##2##3##(1992-3#1)(1994-2#1)
received a series of##2##4##(1996-1#1)(2006-7#1)
received a single dose of##3##5##(2006-11#1)(2011-2#2)
received a single intraperitoneal injection of##2##6##(1992-12#1)(2008-10#1)
received a single oral dose of##3##6##(2008-12#1)(2009-4#1)(2013-1#1)
received a single oral##4##4##(2008-12#1)(2009-4#1)(2010-12#1)(2013-1#1)
received a single##13##3##(1992-12#1)(1996-1#1)(1997-3#1)(2006-11#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-12#1)(2009-4#1)(2010-12#1)(2011-2#2)(2013-1#1)
received a specific##2##3##(2010-4#1)(2012-1#1)
received a standard dose of##2##5##(2007-11#1)(2008-7#1)
received a total daily dose of##2##6##(2007-2#2)
received a total of##4##4##(2006-12#1)(2008-10#1)(2008-7#1)(2012-1#1)
received a total##7##3##(2006-12#1)(2007-2#2)(2008-10#1)(2008-7#1)(2010-7#1)(2012-1#1)
received a transplant##2##3##(2007-8#1)(2010-5#1)
received a##153##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-12#1)(1992-3#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-12#2)(1993-4#2)(1993-5#1)(1994-2#2)(1994-6#3)(1994-7#1)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#4)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-4#1)(2005-12#2)(2005-6#1)(2005-8#1)(2006-10#5)(2006-11#2)(2006-12#5)(2006-2#2)(2006-7#1)(2006-8#3)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#5)(2007-6#1)(2007-7#2)(2007-8#9)(2007-9#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#4)(2009-10#1)(2009-4#1)(2010-10#2)(2010-12#2)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#3)(2012-7#1)(2013-1#3)(2013-7#1)(2013-8#3)
received additional##3##2##(2007-8#1)(2008-10#1)(2010-7#1)
received adjuvant chemotherapy##3##3##(2004-1#1)(2008-10#1)(2010-3#1)
received adjuvant##5##2##(2004-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2010-3#1)
received after##2##2##(2007-9#1)(2013-1#1)
received amlodipine##2##2##(2007-10#1)(2008-3#1)
received an additional##2##3##(1991-10#1)(2008-7#1)
received an average##3##3##(1995-11#1)(2008-7#2)
received an equal volume of##2##5##(1991-12#1)(2008-12#1)
received an equal##3##3##(1991-12#1)(2008-10#1)(2008-12#1)
received an i##3##3##(1991-12#2)(2008-12#1)
received an injection of the##2##5##(1993-7#1)(1996-9#1)
received an injection of##3##4##(1993-7#1)(1996-9#1)(2007-10#1)
received an injection##4##3##(1993-7#1)(1996-9#1)(2007-10#1)(2008-5#1)
received an intravenous##3##3##(1990-12#1)(2007-10#1)(2012-12#1)
received an oral##2##3##(1991-3#1)(1994-6#1)
received an undesirable gift and##2##5##(2008-11#2)
received an undesirable gift##3##4##(2008-11#3)
received an##56##2##(1990-12#1)(1990-6#1)(1991-10#1)(1991-12#3)(1991-3#1)(1992-3#1)(1993-12#1)(1993-7#2)(1994-6#2)(1994-8#1)(1995-11#1)(1995-4#1)(1995-5#2)(1995-8#1)(1996-9#1)(2005-11#1)(2005-7#1)(2006-11#1)(2006-7#2)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#3)(2008-10#2)(2008-11#3)(2008-12#2)(2008-5#1)(2008-7#4)(2009-9#1)(2010-4#2)(2012-12#1)(2012-2#2)(2013-1#1)
received and##5##2##(1993-10#1)(1996-2#1)(1996-3#1)(2007-7#1)(2010-1#1)
received antenatal care##3##3##(1990-12#1)(2004-10#1)(2010-8#1)
received antibiotics##2##2##(2006-8#1)(2013-8#1)
received antiplatelets##2##2##(2007-10#2)
received any##7##2##(1997-7#1)(2006-10#2)(2006-7#2)(2007-8#1)(2008-1#1)
received approximately##2##2##(1991-6#1)(1991-8#1)
received as##3##2##(2008-10#3)
received at least three##2##4##(1992-8#1)(2007-2#1)
received at least##4##3##(1992-8#1)(2007-2#1)(2011-2#1)(2012-1#1)
received at##9##2##(1992-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-1#1)(2012-3#1)
received attention as##2##3##(2008-10#1)(2012-2#1)
received attention##6##2##(1993-6#1)(2006-10#1)(2008-10#1)(2009-11#1)(2012-2#2)
received azathioprine##2##2##(1990-11#1)(2007-8#1)
received barbiturate therapy##2##3##(2007-10#2)
received between##3##2##(1993-6#1)(2007-2#1)(2008-12#1)
received bilateral destruction of##2##4##(1993-3#1)(1994-3#1)
received bilateral##5##2##(1993-3#1)(1994-3#3)(1997-5#1)
received blood##4##2##(1991-3#1)(1991-7#1)(1992-6#1)(2007-7#1)
received bone marrow transplantation##2##4##(2006-10#1)(2011-2#1)
received both##7##2##(1992-1#1)(1993-1#1)(1997-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-6#1)
received botulinum toxin A##2##4##(2006-10#1)(2007-11#1)
received by each##2##3##(1992-2#1)(2012-2#1)
received by the plants##2##4##(2008-10#2)
received by the students##3##4##(2005-10#1)(2008-11#1)(2010-3#1)
received by the##21##3##(1990-4#1)(1991-12#1)(1991-2#1)(1997-6#1)(1997-8#1)(2005-10#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2009-11#1)(2009-4#1)(2010-3#1)(2011-12#1)(2011-2#1)
received by these##3##3##(1990-12#1)(1995-12#1)(2011-2#1)
received by##44##2##(1990-12#1)(1990-4#1)(1991-12#1)(1991-2#1)(1992-2#1)(1993-1#2)(1994-2#1)(1994-9#1)(1995-12#1)(1995-8#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-9#1)(2008-1#4)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-8#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-3#1)(2011-12#1)(2011-2#3)(2012-2#1)(2013-1#1)
received chemotherapy in##2##3##(2010-3#1)(2011-1#1)
received chemotherapy##14##2##(1990-2#1)(1993-10#1)(1994-2#1)(2007-2#1)(2007-6#1)(2008-6#1)(2008-7#3)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)
received clonidine##3##2##(1993-12#1)(2006-12#2)
received cochlear implants##4##3##(2008-9#4)
received combination##2##2##(2011-2#1)(2012-2#1)
received combined##2##2##(2006-10#1)(2008-10#1)
received concomitant##2##2##(2007-11#1)(2010-7#1)
received considerable attention##4##3##(1997-5#1)(2006-10#1)(2008-11#1)(2013-1#1)
received considerable##6##2##(1997-5#1)(2006-10#1)(2008-11#1)(2008-7#1)(2009-6#1)(2013-1#1)
received continuous##4##2##(1995-6#1)(2006-10#1)(2007-7#1)(2012-12#1)
received conventional##2##2##(2012-1#1)(2012-3#1)
received convergent##2##2##(1991-6#1)(1992-2#1)
received corticosteroids##2##2##(1990-9#1)(2006-10#1)
received daily##5##2##(1995-10#1)(1995-9#1)(1997-5#1)(2006-2#1)(2009-10#1)
received data##3##2##(1991-11#1)(2007-11#1)(2008-2#1)
received deionized water##2##3##(1997-3#1)(2008-10#1)
received dermal applications of##5##4##(2008-9#5)
received dietary##2##2##(2007-8#1)(2008-5#1)
received different forms of##2##4##(1994-3#1)(1994-9#1)
received different##3##2##(1994-3#1)(1994-9#1)(2010-4#1)
received disability pension and##2##4##(2006-8#2)
received distilled water##2##3##(2007-8#1)(2009-5#1)
received during##3##2##(1997-5#1)(2007-10#1)(2009-7#1)
received either a##4##3##(1992-5#1)(1996-9#1)(2007-10#1)(2008-10#1)
received either an##2##3##(1995-9#1)(2009-12#1)
received either placebo or##3##4##(2008-5#1)(2008-6#1)(2010-1#1)
received either##23##2##(1990-11#1)(1990-5#1)(1992-5#1)(1994-8#2)(1995-12#2)(1995-9#1)(1996-9#1)(1997-2#1)(1997-5#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-10#1)(2009-12#1)(2010-1#1)(2010-7#1)
received epidural##2##2##(1993-10#1)(2006-12#1)
received equal volume of##2##4##(2006-4#1)(2012-2#1)
received equal##4##2##(1993-12#1)(2006-4#1)(2008-12#1)(2012-2#1)
received extensive##3##2##(1996-9#1)(2007-12#1)(2008-2#1)
received external##3##2##(2007-3#1)(2008-6#1)(2008-7#1)
received far##3##2##(1996-1#1)(2009-5#1)(2012-12#1)
received fasciectomies##2##2##(2008-9#2)
received fluconazole##2##2##(2006-8#2)
received for##3##2##(1995-2#1)(2010-12#1)(2013-8#1)
received four cycles of##2##4##(2009-8#1)(2013-1#1)
received four##4##2##(1992-9#1)(1994-12#1)(2009-8#1)(2013-1#1)
received from the##7##3##(1991-1#1)(1997-8#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)
received from##26##2##(1990-10#1)(1991-1#1)(1992-11#1)(1993-9#1)(1994-2#1)(1994-3#1)(1997-8#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
received further##2##2##(1992-11#1)(1992-6#1)
received general anesthesia##2##3##(1993-1#1)(1993-4#1)
received general##3##2##(1993-1#1)(1993-4#1)(2010-7#1)
received good quality of care##2##5##(2012-2#2)
received good##3##2##(2009-4#1)(2012-2#2)
received grafts from##2##3##(2007-11#1)(2012-12#1)
received grafts##3##2##(2007-11#1)(2008-8#1)(2012-12#1)
received great attention##2##3##(2007-9#1)(2010-3#1)
received high##2##2##(2007-7#1)(2009-9#1)
received home care in the##2##5##(2006-7#1)(2011-2#1)
received home care##4##3##(2006-7#2)(2011-2#2)
received home##6##2##(1997-4#1)(2006-7#2)(2011-2#2)(2012-12#1)
received i##9##2##(1990-5#1)(1991-9#1)(2007-7#6)(2010-7#1)
received in a##3##3##(1991-9#1)(2011-2#1)(2012-12#1)
received in the##5##3##(2008-11#1)(2008-2#1)(2008-5#1)(2012-1#1)(2013-8#1)
received in##15##2##(1990-9#1)(1991-9#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
received increased attention##7##3##(1991-12#1)(1992-1#1)(1996-3#1)(2007-7#1)(2008-10#1)(2011-1#1)(2012-3#1)
received increasing attention as a##3##5##(2006-10#1)(2008-8#2)
received increasing attention as##4##4##(2005-7#1)(2006-10#1)(2008-8#2)
received increasing attention because##2##4##(1997-8#1)(2008-11#1)
received increasing attention##14##3##(1994-2#1)(1995-6#1)(1997-8#1)(2005-7#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-8#1)(2011-2#2)
received increasing##16##2##(1994-2#1)(1995-6#1)(1997-8#1)(2005-7#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-3#1)(2010-8#1)(2011-2#2)
received individual##2##2##(2007-10#1)(2012-2#1)
received information from##2##3##(2008-11#1)(2011-1#1)
received information##4##2##(1990-10#1)(1994-2#1)(2008-11#1)(2011-1#1)
received injection##8##2##(2011-12#4)(2012-1#1)(2013-1#3)
received injections of##3##3##(1991-6#1)(1994-5#1)(1995-11#1)
received input from the##6##4##(1991-11#3)(1995-11#2)(2006-7#1)
received input from##7##3##(1991-11#4)(1995-11#2)(2006-7#1)
received intensive##2##2##(1993-3#1)(2006-12#1)
received intracerebroventricular##2##2##(1994-8#1)(1995-12#1)
received intraperitoneal injections of##2##4##(1996-10#1)(2013-1#1)
received intraperitoneal##4##2##(1996-10#1)(1996-5#1)(2011-2#1)(2013-1#1)
received intrastriatal##2##2##(2008-7#2)
received intravenous antibiotics##2##3##(2006-10#1)(2007-8#1)
received intravenous##8##2##(1991-2#2)(2006-10#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-7#1)(2012-11#1)
received ketamine##2##2##(2007-2#1)(2012-2#1)
received less attention##2##3##(2008-2#1)(2012-12#1)
received less##6##2##(1994-1#1)(1996-2#1)(1997-6#1)(2008-2#1)(2008-9#1)(2012-12#1)
received little attention in##7##4##(1995-1#1)(2006-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-3#1)(2011-12#1)
received little attention##21##3##(1995-1#1)(1995-4#1)(2006-1#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#1)(2010-1#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#1)
received little##27##2##(1995-1#1)(1995-4#1)(2005-11#1)(2006-1#1)(2006-12#1)(2006-2#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-3#1)(2009-8#1)(2010-1#2)(2010-3#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#1)
received local therapy##2##3##(2008-6#2)
received local##3##2##(2007-11#1)(2008-6#2)
received lonidamine##2##2##(1991-2#1)(1992-4#1)
received mandibular##3##2##(2013-1#3)
received melatonin##2##2##(2008-8#2)
received more than##4##3##(1992-8#1)(2005-8#1)(2008-10#1)(2011-2#1)
received more##8##2##(1992-8#1)(1997-6#1)(2005-8#1)(2008-10#2)(2011-2#1)(2012-12#1)(2013-8#1)
received morphine##2##2##(1995-12#1)(2008-7#1)
received much attention in the##2##5##(2008-5#1)(2011-2#1)
received much attention##5##3##(2008-1#1)(2008-3#1)(2008-5#1)(2009-3#1)(2011-2#1)
received much##8##2##(1990-6#1)(2008-1#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-3#1)(2011-2#1)
received multiple##5##2##(2006-12#1)(2007-11#3)(2008-5#1)
received neoadjuvant##2##2##(2004-2#1)(2012-3#1)
received no further##2##3##(1996-3#1)(2008-5#1)
received no medication##2##3##(2007-8#1)(2008-5#1)
received no social insurance benefits at all##2##7##(2006-8#2)
received no treatment##2##3##(2007-11#1)(2013-8#1)
received no##33##2##(1990-10#1)(1990-2#1)(1990-4#1)(1991-5#1)(1992-11#1)(1994-2#1)(1995-5#1)(1995-6#3)(1996-3#1)(1997-2#1)(2006-2#1)(2006-5#1)(2006-8#2)(2007-11#1)(2007-8#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2010-11#1)(2010-3#1)(2011-1#1)(2012-11#1)(2013-1#2)(2013-7#1)(2013-8#1)
received normal saline##2##3##(2009-5#2)
received normal##4##2##(2008-5#1)(2009-5#3)
received nystatin##2##2##(2006-8#2)
received one dose of##3##4##(1993-7#1)(1994-7#1)(2012-2#1)
received one of three doses of##2##6##(1992-9#1)(2011-2#1)
received one of three##4##4##(1991-1#1)(1992-9#1)(2007-2#1)(2011-2#1)
received one of##6##3##(1991-1#1)(1992-9#1)(2007-2#1)(2008-3#1)(2008-9#1)(2011-2#1)
received one##16##2##(1991-1#1)(1992-9#1)(1993-7#1)(1994-7#1)(1997-2#1)(2007-2#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)
received only##19##2##(1991-3#1)(1992-10#1)(1992-5#1)(1993-1#2)(1994-2#1)(1995-2#1)(1996-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-12#1)(2012-2#1)(2013-8#1)
received optical signal##2##3##(2008-3#1)(2008-9#1)
received optical##3##2##(2008-2#1)(2008-3#1)(2008-9#1)
received oral naltrexone##2##3##(2007-2#2)
received oral##7##2##(2005-11#1)(2006-12#1)(2007-2#2)(2008-5#1)(2011-12#1)(2013-8#1)
received other##2##2##(1995-5#1)(2006-8#1)
received palliative##2##2##(1992-10#1)(2009-8#1)
received peritoneal dialysis##2##3##(2007-7#2)
received piroxicam##2##2##(1992-3#1)(2007-9#1)
received placebo or##2##3##(2008-5#1)(2010-7#1)
received placebo##9##2##(1996-3#1)(2004-3#1)(2006-10#1)(2007-8#1)(2008-5#3)(2010-7#1)(2012-2#1)
received positive##2##2##(2007-8#1)(2008-11#1)
received postoperative##6##2##(1990-3#1)(1993-8#1)(2007-6#2)(2007-9#1)(2010-7#1)
received power##3##2##(2008-2#2)(2010-12#1)
received pre- and##2##3##(2008-12#1)(2010-2#1)
received prenatal care##2##3##(1993-6#1)(1995-2#1)
received preoperative##3##2##(2007-8#2)(2011-2#1)
received previous chemotherapy##2##3##(1992-10#1)(2008-6#1)
received previous treatment##3##3##(1990-4#1)(1992-8#1)(2012-12#1)
received previous##8##2##(1990-4#1)(1992-10#1)(1992-8#1)(2007-6#1)(2007-8#1)(2008-6#1)(2008-9#1)(2012-12#1)
received primary##2##2##(2007-8#1)(2011-2#1)
received prior chemotherapy##3##3##(1990-12#1)(1990-6#1)(1991-3#1)
received prior##5##2##(1990-12#1)(1990-6#1)(1991-3#1)(1991-4#1)(1996-1#1)
received proper##3##2##(1996-11#1)(1996-6#1)(2008-12#1)
received prophylactic##4##2##(1995-4#1)(2006-11#1)(2007-12#1)(2008-5#1)
received prophylaxis##3##2##(1990-12#1)(2007-7#2)
received propofol##2##2##(2010-7#1)(2013-1#1)
received psychiatric##2##2##(2007-1#1)(2010-12#1)
received radiation therapy##5##3##(1990-12#1)(1996-3#2)(2006-12#2)
received radiation##7##2##(1990-12#1)(1991-2#1)(1996-3#2)(2006-12#2)(2009-10#1)
received radiotherapy and##2##3##(1992-12#1)(2011-1#1)
received radiotherapy##8##2##(1992-10#1)(1992-12#1)(2008-6#4)(2009-11#1)(2011-1#1)
received rasburicase##2##2##(2008-7#2)
received regulatory approval##3##3##(2005-11#1)(2008-7#1)(2010-5#1)
received regulatory##4##2##(2005-11#1)(2005-8#1)(2008-7#1)(2010-5#1)
received relatively little##4##3##(2009-12#1)(2009-4#1)(2009-8#1)(2012-12#1)
received relatively##5##2##(1993-2#1)(2009-12#1)(2009-4#1)(2009-8#1)(2012-12#1)
received renal transplantation##2##3##(2007-7#1)(2008-4#1)
received renal##3##2##(2007-7#1)(2008-1#1)(2008-4#1)
received renewed attention##2##3##(1992-12#1)(2007-8#1)
received repeated##2##2##(1997-8#1)(2008-8#1)
received reports##2##2##(1992-1#1)(1997-5#1)
received right##2##2##(2007-9#2)
received routine##5##2##(1991-12#1)(1994-7#1)(2006-8#1)(2009-12#1)(2010-12#1)
received rt-PA##4##2##(2007-10#3)(2008-8#1)
received saline##3##2##(1994-10#1)(2011-1#1)(2012-2#1)
received several##2##2##(1991-3#1)(1991-8#1)
received signal##2##2##(2008-2#2)
received significantly##3##2##(1991-2#1)(2007-9#1)(2010-7#1)
received similar##2##2##(1995-12#1)(2011-12#1)
received six##2##2##(2007-8#1)(2008-6#1)
received some##4##2##(1993-3#1)(2004-11#1)(2006-10#1)(2012-2#1)
received special##3##2##(1994-6#1)(1995-6#1)(2006-6#1)
received specific##3##2##(2007-2#1)(2008-11#1)(2010-3#1)
received standard care##3##3##(2008-4#1)(2010-4#2)
received standard##7##2##(1992-10#1)(2008-4#1)(2008-6#1)(2010-4#2)(2012-3#1)(2013-1#1)
received subcutaneous injections of##2##4##(1996-5#1)(2008-5#1)
received subcutaneous##4##2##(1992-5#1)(1996-5#1)(2008-3#1)(2008-5#1)
received successful##2##2##(2007-8#2)
received supplemental oxygen##2##3##(1993-1#2)
received support and##2##3##(2007-2#1)(2010-3#1)
received support##4##2##(2007-2#1)(2010-10#1)(2010-3#1)(2013-1#1)
received surgery or##2##3##(2008-7#1)(2011-2#1)
received surgical treatment##2##3##(1990-4#1)(2008-6#1)
received surgical##5##2##(1990-4#1)(2008-6#1)(2012-12#1)(2012-2#1)(2013-1#1)
received t-PA##3##2##(2007-9#2)(2010-12#1)
received thalidomide##2##2##(2008-5#2)
received the combination##4##3##(2007-8#3)(2013-1#1)
received the fortified##2##3##(2006-10#2)
received the infiltration with a solution of bupivacaine 0##2##9##(1996-8#2)
received the intervention##3##3##(2008-12#1)(2010-3#1)(2012-3#1)
received the most##2##3##(2008-8#1)(2010-4#1)
received the new##2##3##(2006-7#1)(2007-11#1)
received the placebo##2##3##(2006-10#1)(2008-5#1)
received the same dose of##2##5##(1995-3#1)(2007-1#1)
received the same##8##3##(1995-3#1)(2006-6#1)(2007-1#1)(2007-7#1)(2007-8#1)(2007-9#1)(2009-6#1)(2013-1#1)
received the##63##2##(1990-2#1)(1992-6#1)(1993-12#1)(1995-3#1)(1996-8#2)(1997-4#1)(1997-6#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-3#2)(2006-6#1)(2006-7#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-4#3)(2010-5#1)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
received their##3##2##(1992-9#1)(2007-2#1)(2008-4#1)
received these##2##2##(1995-2#1)(2008-2#1)
received this diagnosis##2##3##(1991-9#2)
received this##4##2##(1991-9#2)(1997-6#1)(2008-1#1)
received three doses of##2##4##(1994-7#1)(1995-9#1)
received three##5##2##(1994-3#1)(1994-7#1)(1995-9#1)(1996-5#1)(2008-8#1)
received thrombolytic therapy##3##3##(1995-9#1)(2007-9#1)(2008-7#1)
received thrombolytic##4##2##(1995-9#1)(2007-10#1)(2007-9#1)(2008-7#1)
received training in##3##3##(1993-8#1)(2008-4#1)(2012-12#1)
received training##5##2##(1993-8#1)(1995-6#1)(2008-4#1)(2012-12#1)(2012-3#1)
received treatment for##3##3##(1992-12#1)(2007-1#1)(2007-2#1)
received treatment with##6##3##(1991-11#1)(1991-3#1)(2007-11#1)(2007-7#1)(2007-8#2)
received treatment##11##2##(1991-11#1)(1991-3#1)(1992-12#1)(2007-1#2)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2010-12#1)
received two##5##2##(1994-3#1)(2012-2#1)(2013-1#3)
received unilateral##3##2##(1992-11#1)(1993-6#1)(1995-5#1)
received various##5##2##(1995-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
received vehicle##3##2##(1992-9#1)(2012-2#1)(2012-3#1)
received via oral route a placebo##4##6##(2008-4#3)(2009-5#1)
received warfarin##4##2##(2007-10#3)(2011-2#1)
received was##7##2##(1991-3#1)(1992-2#1)(1993-6#1)(1994-5#1)(2008-9#1)(2009-5#1)(2012-2#1)
received were##2##2##(1990-2#1)(2008-10#1)
received widespread##2##2##(2005-7#1)(2008-6#1)
received##1694##1##(1990-10#3)(1990-11#2)(1990-12#12)(1990-2#7)(1990-3#1)(1990-4#5)(1990-5#7)(1990-6#8)(1990-8#1)(1990-9#3)(1991-1#3)(1991-10#3)(1991-11#10)(1991-12#9)(1991-2#6)(1991-3#15)(1991-4#2)(1991-5#2)(1991-6#4)(1991-7#1)(1991-8#7)(1991-9#6)(1992-1#4)(1992-10#10)(1992-11#6)(1992-12#6)(1992-2#5)(1992-3#5)(1992-4#1)(1992-5#7)(1992-6#5)(1992-7#1)(1992-8#4)(1992-9#6)(1993-1#17)(1993-10#6)(1993-11#2)(1993-12#10)(1993-2#3)(1993-3#5)(1993-4#7)(1993-5#4)(1993-6#8)(1993-7#4)(1993-8#3)(1993-9#2)(1994-1#1)(1994-10#2)(1994-11#1)(1994-12#4)(1994-2#9)(1994-3#9)(1994-4#1)(1994-5#2)(1994-6#8)(1994-7#4)(1994-8#4)(1994-9#3)(1995-1#2)(1995-10#2)(1995-11#6)(1995-12#8)(1995-2#7)(1995-3#5)(1995-4#3)(1995-5#11)(1995-6#9)(1995-8#5)(1995-9#5)(1996-1#9)(1996-10#1)(1996-11#3)(1996-12#9)(1996-2#4)(1996-3#7)(1996-4#2)(1996-5#6)(1996-6#3)(1996-8#5)(1996-9#7)(1997-1#2)(1997-2#7)(1997-3#6)(1997-4#4)(1997-5#7)(1997-6#9)(1997-7#3)(1997-8#6)(2004-1#2)(2004-10#1)(2004-11#3)(2004-12#1)(2004-2#3)(2004-3#1)(2004-4#1)(2004-9#2)(2005-10#4)(2005-11#4)(2005-12#3)(2005-6#4)(2005-7#8)(2005-8#10)(2006-1#1)(2006-10#32)(2006-11#6)(2006-12#19)(2006-2#6)(2006-3#3)(2006-4#1)(2006-5#5)(2006-6#4)(2006-7#10)(2006-8#19)(2006-9#3)(2007-1#6)(2007-10#29)(2007-11#27)(2007-12#19)(2007-2#29)(2007-3#6)(2007-4#2)(2007-5#2)(2007-6#7)(2007-7#43)(2007-8#60)(2007-9#23)(2008-1#20)(2008-10#51)(2008-11#30)(2008-12#25)(2008-2#19)(2008-3#31)(2008-4#17)(2008-5#50)(2008-6#38)(2008-7#56)(2008-8#19)(2008-9#35)(2009-10#6)(2009-11#6)(2009-12#5)(2009-2#2)(2009-3#3)(2009-4#8)(2009-5#10)(2009-6#4)(2009-7#4)(2009-8#8)(2009-9#2)(2010-1#5)(2010-10#5)(2010-11#4)(2010-12#12)(2010-2#1)(2010-3#16)(2010-4#16)(2010-5#3)(2010-6#2)(2010-7#16)(2010-8#5)(2010-9#2)(2011-1#18)(2011-11#1)(2011-12#13)(2011-2#54)(2012-1#12)(2012-11#4)(2012-12#25)(2012-2#55)(2012-3#17)(2012-7#1)(2013-1#59)(2013-7#8)(2013-8#23)
receiver and the##2##3##(2008-3#1)(2013-7#1)
receiver and##4##2##(2008-3#1)(2009-10#2)(2013-7#1)
receiver aperture##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
receiver are##2##2##(2007-12#1)(2008-3#1)
receiver array##3##2##(2008-2#1)(2008-3#2)
receiver domain##5##2##(1995-1#5)
receiver field of view##3##4##(2008-3#3)
receiver for##6##2##(2007-11#2)(2008-2#3)(2008-8#1)
receiver front end##2##3##(2008-3#2)
receiver is##10##2##(2007-11#1)(2007-12#2)(2008-2#6)(2008-3#1)
receiver operating characteristic (ROC) analysis##2##5##(2010-9#1)(2011-1#1)
receiver operating characteristic (ROC) curve##4##5##(2007-8#1)(2008-10#1)(2010-2#1)(2012-1#1)
receiver operating characteristic (ROC)##9##4##(1995-10#1)(1996-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-2#1)(2010-9#1)(2011-1#1)(2012-1#1)
receiver operating characteristic curve analysis##3##5##(2008-10#3)
receiver operating characteristic curve##11##4##(1990-12#1)(2006-6#1)(2007-8#1)(2008-10#3)(2008-3#1)(2010-2#2)(2011-1#1)(2012-2#1)
receiver operating characteristic curves##2##4##(1996-9#1)(2013-7#1)
receiver operating characteristic##25##3##(1990-12#1)(1995-10#1)(1996-7#1)(1996-9#1)(2006-6#1)(2007-8#2)(2008-10#4)(2008-2#1)(2008-3#1)(2010-1#1)(2010-2#3)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
receiver operating characteristics##5##3##(2007-4#1)(2007-8#1)(2008-2#1)(2010-8#1)(2011-2#1)
receiver operating##33##2##(1990-12#1)(1995-10#1)(1996-7#1)(1996-9#1)(2006-6#1)(2007-4#1)(2007-8#3)(2008-10#4)(2008-2#2)(2008-3#2)(2010-1#1)(2010-2#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
receiver operator##2##2##(2012-12#1)(2013-1#1)
receiver performance##2##2##(2008-2#1)(2008-3#1)
receiver response##2##2##(2007-12#1)(2008-2#1)
receiver sensitivities##2##2##(2007-12#2)
receiver with##2##2##(2008-2#2)
receiver##174##1##(1990-12#1)(1991-8#1)(1995-1#6)(1995-10#1)(1995-5#2)(1996-12#1)(1996-7#1)(1996-9#1)(1997-4#1)(2006-6#1)(2007-11#11)(2007-12#14)(2007-3#2)(2007-4#1)(2007-8#3)(2008-1#2)(2008-10#8)(2008-2#51)(2008-3#31)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#3)(2009-4#1)(2010-1#1)(2010-12#2)(2010-2#3)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#3)
receiver's##5##1##(2007-12#2)(2008-2#1)(2008-3#2)
receiver-operating characteristic (ROC)##2##3##(2010-8#1)(2011-1#1)
receiver-operating characteristic##4##2##(1995-6#1)(1997-2#1)(2010-8#1)(2011-1#1)
receiver-operating##5##1##(1995-6#1)(1997-2#1)(2008-7#1)(2010-8#1)(2011-1#1)
receiver-stimulator package##3##2##(2012-2#3)
receiver-stimulator##7##1##(2008-9#4)(2012-2#3)
receivers for##2##2##(2008-2#1)(2008-3#1)
receivers on##2##2##(2008-2#1)(2009-8#1)
receivers that are##2##3##(2008-2#1)(2008-3#1)
receivers that##3##2##(2008-2#2)(2008-3#1)
receivers were##2##2##(2008-8#1)(2009-4#1)
receivers with##2##2##(2007-12#1)(2008-2#1)
receivers##44##1##(1995-5#4)(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#10)(2008-3#13)(2008-8#2)(2009-12#1)(2009-4#1)(2009-8#1)(2010-8#1)(2012-12#2)(2013-1#3)
receives a##10##2##(1990-2#1)(1994-6#1)(1995-11#1)(1995-5#1)(1996-5#1)(2006-8#1)(2007-1#1)(2008-10#1)(2012-1#1)(2012-2#1)
receives an##3##2##(1996-8#1)(2008-1#1)(2008-10#1)
receives direct##2##2##(1995-12#1)(1996-3#1)
receives input##2##2##(1994-3#2)
receives its##2##2##(1994-12#1)(2007-8#1)
receives##57##1##(1990-2#1)(1990-4#1)(1991-12#1)(1992-5#1)(1992-8#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#2)(1995-11#2)(1995-12#1)(1995-5#2)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-3#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#2)
receiving 1##2##2##(2007-5#1)(2008-5#1)
receiving 6##2##2##(1996-12#1)(2012-3#1)
receiving 60##2##2##(1997-6#1)(2007-10#1)
receiving BCT##2##2##(1995-4#1)(2008-6#1)
receiving a single##4##3##(2007-2#1)(2008-10#1)(2009-4#1)(2012-2#1)
receiving a total##2##3##(1990-6#1)(2013-1#1)
receiving a transplant##2##3##(2007-8#2)
receiving a##30##2##(1990-6#1)(1991-11#1)(1992-10#1)(1993-2#1)(1993-9#1)(1994-3#1)(1995-11#1)(1995-3#1)(1995-5#1)(2007-11#2)(2007-2#1)(2007-8#4)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#1)(2012-2#1)(2013-1#1)
receiving an##9##2##(1992-2#1)(1993-12#1)(1995-1#1)(1996-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-8#1)
receiving and##4##2##(1995-1#1)(2007-12#1)(2007-4#1)(2010-4#1)
receiving anticoagulants##2##2##(2013-1#2)
receiving any##3##2##(1990-12#1)(2006-10#1)(2007-11#1)
receiving appropriate##2##2##(2007-2#1)(2010-12#1)
receiving area of##2##3##(2007-12#1)(2008-2#1)
receiving aspirin##2##2##(1993-7#1)(2008-5#1)
receiving bevacizumab##2##2##(2009-8#1)(2011-2#1)
receiving bone##3##2##(1991-2#1)(2011-1#2)
receiving care##6##2##(2010-8#1)(2011-2#3)(2012-12#1)(2013-8#1)
receiving chemotherapy for##4##3##(1991-10#1)(2004-1#1)(2008-6#1)(2008-7#1)
receiving chemotherapy in##4##3##(2007-12#2)(2010-8#1)(2013-1#1)
receiving chemotherapy##28##2##(1991-10#1)(1991-4#1)(1995-9#1)(2004-1#2)(2007-12#2)(2007-4#1)(2008-6#1)(2008-7#16)(2010-2#1)(2010-8#1)(2013-1#1)
receiving concomitant##2##2##(2006-10#1)(2007-11#1)
receiving concurrent##2##2##(2006-10#1)(2013-1#1)
receiving continuous##2##2##(2007-8#1)(2011-2#1)
receiving corticosteroids##3##2##(2007-10#1)(2007-11#1)(2007-7#1)
receiving craniospinal##2##2##(2011-2#2)
receiving dexmedetomidine##2##2##(2013-8#2)
receiving dialysis treatment##2##3##(1996-2#1)(2011-1#1)
receiving dialysis##5##2##(1990-6#1)(1996-2#1)(1996-8#1)(2005-12#1)(2011-1#1)
receiving direct##2##2##(1993-9#1)(2008-8#1)
receiving echocardiography##5##2##(2007-10#5)
receiving either##8##2##(1990-6#1)(1992-2#1)(1992-9#1)(1995-1#1)(1996-12#1)(2004-1#1)(2006-9#1)(2007-11#1)
receiving erythropoietin##3##2##(1993-2#1)(2008-1#2)
receiving esomeprazole##2##2##(2011-2#2)
receiving every other day injections of beta-carotene (400 mg##2##9##(2006-5#2)
receiving glucocorticoids##3##2##(1993-12#1)(2006-10#2)
receiving hemodialysis##5##2##(2007-8#1)(2010-3#1)(2011-1#1)(2013-1#1)(2013-8#1)
receiving high##2##2##(2007-6#1)(2008-10#1)
receiving high-dose##5##2##(2007-11#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)
receiving highly active antiretroviral therapy##3##5##(2006-10#1)(2007-12#1)(2013-8#1)
receiving highly active antiretroviral##4##4##(2006-10#2)(2007-12#1)(2013-8#1)
receiving highly emetogenic chemotherapy##2##4##(2008-7#2)
receiving highly##6##2##(2006-10#2)(2007-12#1)(2008-7#2)(2013-8#1)
receiving home##3##2##(1995-3#1)(2012-12#1)(2013-1#1)
receiving hormonal##3##2##(1992-1#1)(2008-6#1)(2013-1#1)
receiving immunosuppressive drugs##2##3##(2005-7#1)(2011-2#1)
receiving immunosuppressive##4##2##(1996-12#1)(2005-7#1)(2007-11#1)(2011-2#1)
receiving inadequate##2##2##(1993-3#1)(2007-12#1)
receiving increasing attention as a##2##5##(2007-10#1)(2013-1#1)
receiving increasing attention as##3##4##(2007-10#1)(2010-5#1)(2013-1#1)
receiving increasing attention##10##3##(1993-1#1)(2006-10#1)(2007-10#1)(2007-11#1)(2010-2#1)(2010-5#1)(2013-1#2)(2013-8#2)
receiving increasing##12##2##(1993-1#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-2#1)(2009-5#1)(2010-2#1)(2010-5#1)(2013-1#2)(2013-8#2)
receiving information##2##2##(1994-3#1)(2008-10#1)
receiving informed consent##2##3##(2007-8#1)(2008-12#1)
receiving inpatient##2##2##(1991-2#1)(1993-1#1)
receiving intensive##2##2##(1991-12#1)(2008-7#1)
receiving long term cyclosporin##2##4##(2007-11#2)
receiving long-term##5##2##(1995-9#1)(2005-10#3)(2012-12#1)
receiving maintenance##2##2##(2011-1#1)(2012-12#1)
receiving massage##2##2##(2008-10#1)(2009-1#1)
receiving mechanical ventilation##3##3##(2005-8#1)(2008-9#1)(2011-1#1)
receiving medical##2##2##(1994-2#1)(2010-10#1)
receiving more##2##2##(2010-5#1)(2011-2#1)
receiving much attention##2##3##(2007-8#1)(2008-12#1)
receiving much##3##2##(2007-8#1)(2008-1#1)(2008-12#1)
receiving no hormone##2##3##(1994-2#2)
receiving no##5##2##(1994-2#2)(2007-12#1)(2010-6#1)(2011-1#1)
receiving occupational therapy##2##3##(2013-7#2)
receiving one or more##2##4##(2009-9#1)(2010-5#1)
receiving only##3##2##(1992-9#1)(2008-10#1)(2008-6#1)
receiving oral##3##2##(2009-8#1)(2010-12#1)(2013-7#1)
receiving other##5##2##(1991-12#1)(1996-12#1)(2005-8#1)(2006-10#1)(2008-11#1)
receiving placebo##5##2##(2006-10#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-12#1)
receiving recombinant##2##2##(1991-8#1)(2007-7#1)
receiving routine##2##2##(2006-9#1)(2007-11#1)
receiving services from the##2##4##(2007-2#1)(2011-1#1)
receiving services##4##2##(1994-3#1)(2007-2#1)(2011-1#1)(2011-2#1)
receiving single fraction##2##3##(2008-10#2)
receiving single##4##2##(1996-8#1)(2008-10#3)
receiving steroids##2##2##(2008-7#1)(2013-1#1)
receiving such##4##2##(1991-8#1)(1992-3#1)(2007-4#1)(2010-3#1)
receiving support##2##2##(1997-3#1)(2010-2#1)
receiving synthetic##2##2##(2008-10#2)
receiving systemic##2##2##(1993-6#1)(1994-2#1)
receiving tamoxifen##2##2##(1997-3#1)(2008-7#1)
receiving the combined##2##3##(2007-11#1)(2008-10#1)
receiving the fish-oil##2##3##(2006-8#2)
receiving the##34##2##(1990-10#1)(1990-5#1)(1992-12#1)(1993-3#1)(1993-4#1)(1995-4#1)(1995-5#1)(1995-8#1)(1997-3#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#3)(2008-1#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-12#2)(2013-1#7)(2013-8#1)
receiving their##2##2##(2005-10#1)(2010-9#1)
receiving theophylline##2##2##(1992-2#1)(2007-2#1)
receiving these agents##3##3##(2006-10#1)(2007-12#1)(2007-2#1)
receiving these##4##2##(2006-10#1)(2007-12#1)(2007-2#1)(2009-2#1)
receiving this treatment##2##3##(2005-7#1)(2007-4#1)
receiving this##4##2##(1990-12#1)(2005-7#1)(2007-4#1)(2008-3#1)
receiving total##2##2##(1992-3#1)(2006-7#1)
receiving trastuzumab##2##2##(2007-11#2)
receiving treatment at##4##3##(1996-2#1)(2007-2#1)(2012-2#1)(2013-8#1)
receiving treatment for##4##3##(1996-3#1)(2008-7#1)(2009-6#1)(2011-1#1)
receiving treatment with##3##3##(1992-2#1)(2007-11#2)
receiving treatment##13##2##(1992-2#1)(1996-2#1)(1996-3#1)(2007-11#2)(2007-2#1)(2008-6#1)(2008-7#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
receiving vehicle##2##2##(1995-2#1)(1996-1#1)
receiving welfare##2##2##(1996-11#1)(2007-12#1)
receiving##717##1##(1990-10#1)(1990-12#5)(1990-3#1)(1990-5#3)(1990-6#4)(1990-7#1)(1990-8#4)(1991-1#3)(1991-10#2)(1991-11#2)(1991-12#3)(1991-2#9)(1991-3#1)(1991-4#3)(1991-8#3)(1992-1#1)(1992-10#2)(1992-12#2)(1992-2#4)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#2)(1993-1#2)(1993-10#2)(1993-12#3)(1993-2#2)(1993-3#3)(1993-4#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-10#1)(1994-12#1)(1994-2#7)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#4)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#3)(1995-4#4)(1995-5#3)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#4)(1996-10#1)(1996-11#1)(1996-12#8)(1996-2#3)(1996-3#4)(1996-6#1)(1996-8#4)(1996-9#2)(1997-1#2)(1997-3#4)(1997-5#1)(1997-6#1)(1997-8#1)(2004-1#6)(2004-11#1)(2004-12#1)(2004-2#2)(2004-3#2)(2005-10#5)(2005-11#1)(2005-12#1)(2005-7#6)(2005-8#3)(2005-9#1)(2006-1#2)(2006-10#26)(2006-12#4)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#5)(2006-8#10)(2006-9#3)(2007-1#1)(2007-10#13)(2007-11#34)(2007-12#12)(2007-2#12)(2007-3#1)(2007-4#5)(2007-5#3)(2007-6#2)(2007-7#5)(2007-8#19)(2007-9#1)(2008-1#7)(2008-10#25)(2008-11#5)(2008-12#5)(2008-2#11)(2008-3#15)(2008-4#2)(2008-5#16)(2008-6#9)(2008-7#49)(2008-8#8)(2008-9#7)(2009-1#1)(2009-10#3)(2009-11#3)(2009-2#5)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-8#5)(2009-9#2)(2010-10#1)(2010-12#13)(2010-2#5)(2010-3#3)(2010-4#2)(2010-5#6)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#14)(2011-12#1)(2011-2#28)(2012-1#3)(2012-12#20)(2012-2#11)(2012-3#5)(2013-1#42)(2013-7#3)(2013-8#15)
recency effect##2##2##(2009-2#2)
recency of##2##2##(1990-12#1)(1992-11#1)
recency##8##1##(1990-12#1)(1992-10#1)(1992-11#3)(1993-3#1)(2009-2#2)
recent American##2##2##(2008-3#1)(2008-4#1)
recent Canadian##2##2##(1997-3#1)(2008-11#1)
recent Consensus##2##2##(2008-2#1)(2013-8#1)
recent Food and Drug##2##4##(2007-7#1)(2011-2#1)
recent German##2##2##(2008-5#2)
recent Health##2##2##(1997-2#1)(2007-11#1)
recent Japanese##2##2##(2010-12#1)(2012-11#1)
recent Letter##6##2##(2007-11#1)(2007-12#4)(2008-10#1)
recent NMR##2##2##(1991-2#1)(1992-10#1)
recent National##2##2##(2006-8#1)(2007-8#1)
recent Ne##2##2##(1996-8#2)
recent United##2##2##(1992-1#1)(1992-2#1)
recent X-ray structural##2##3##(2009-2#1)(2009-3#1)
recent X-ray##3##2##(1991-4#1)(2009-2#1)(2009-3#1)
recent achievements in##4##3##(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#1)
recent achievements##6##2##(2006-10#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-7#1)
recent addition##8##2##(1994-8#1)(2006-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-5#1)(2012-2#1)
recent adoption of##2##3##(2010-11#2)
recent advancement in##2##3##(1991-8#1)(2009-8#1)
recent advancement##3##2##(1991-8#1)(2008-7#1)(2009-8#1)
recent advancements in our understanding of##2##6##(2012-1#1)(2012-2#1)
recent advancements in the##4##4##(2006-10#1)(2008-10#1)(2009-3#1)(2010-6#1)
recent advancements in##6##3##(2006-10#1)(2008-10#1)(2009-3#1)(2010-6#1)(2012-1#1)(2012-2#1)
recent advancements##7##2##(2006-10#1)(2008-10#1)(2009-3#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-2#1)
recent advances and the key strategies##2##6##(2008-10#1)(2012-3#1)
recent advances and##11##3##(2005-6#1)(2006-10#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-4#1)(2012-12#2)(2012-3#1)
recent advances have##2##3##(2005-7#1)(2006-10#1)
recent advances in both##2##4##(2010-2#1)(2010-7#1)
recent advances in characterizing##2##4##(2006-11#1)(2010-5#1)
recent advances in health information technologies##2##6##(2013-1#2)
recent advances in health information##3##5##(2009-7#1)(2013-1#2)
recent advances in medical##2##4##(2007-7#1)(2012-12#1)
recent advances in our knowledge of##2##6##(2006-10#1)(2013-8#1)
recent advances in our understanding of how##2##7##(2006-10#1)(2008-8#1)
recent advances in our understanding of the##4##7##(2006-10#1)(2008-1#1)(2008-10#1)(2011-1#1)
recent advances in our understanding of##10##6##(2006-10#2)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-1#3)
recent advances in our##13##4##(2006-10#3)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#1)(2012-1#3)(2013-8#1)
recent advances in the area of##3##6##(2005-7#1)(2007-9#1)(2008-10#1)
recent advances in the care of##2##6##(2006-10#1)(2008-6#1)
recent advances in the development##2##5##(2007-8#1)(2013-1#1)
recent advances in the field of##4##6##(2007-11#1)(2008-3#1)(2008-5#1)(2010-2#1)
recent advances in the field##7##5##(2007-11#1)(2008-3#1)(2008-5#2)(2008-9#1)(2010-12#1)(2010-2#1)
recent advances in the treatment of##3##6##(2006-10#1)(2008-9#1)(2013-7#1)
recent advances in the use of##2##6##(2006-11#1)(2008-7#1)
recent advances in the##43##4##(2005-10#1)(2005-2#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-8#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#2)(2009-12#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
recent advances in these##2##4##(1993-12#1)(2011-2#1)
recent advances in this field##4##5##(2006-10#1)(2008-1#1)(2008-4#1)(2010-11#1)
recent advances in this##6##4##(2005-8#1)(2006-10#1)(2008-1#1)(2008-4#1)(2010-11#1)(2012-2#1)
recent advances in understanding of##2##5##(2005-8#1)(2006-9#1)
recent advances in understanding the##5##5##(2006-8#1)(2008-1#1)(2008-5#1)(2010-12#1)(2012-2#1)
recent advances in understanding##10##4##(2005-8#2)(2006-8#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-5#1)(2010-12#1)(2012-1#1)(2012-2#1)
recent advances in##128##3##(1993-12#1)(1994-2#1)(1994-3#1)(1997-4#1)(2005-10#1)(2005-2#1)(2005-7#1)(2005-8#4)(2006-10#15)(2006-11#2)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#2)(2007-7#2)(2007-8#3)(2007-9#3)(2008-1#4)(2008-10#3)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#2)(2009-12#1)(2009-5#2)(2009-7#2)(2009-8#2)(2010-10#1)(2010-11#3)(2010-12#3)(2010-2#3)(2010-5#2)(2010-7#2)(2011-1#3)(2011-2#3)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#5)(2012-2#6)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#2)
recent advances of the##2##4##(2007-7#1)(2013-1#1)
recent advances of##5##3##(2007-7#1)(2008-10#1)(2008-8#1)(2011-1#1)(2013-1#1)
recent advances on##2##3##(2008-5#1)(2010-12#1)
recent advances that have##2##4##(2007-6#1)(2010-12#1)
recent advances toward##2##3##(2007-9#1)(2011-7#1)
recent advances##169##2##(1990-9#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1997-4#1)(2004-8#1)(2005-10#1)(2005-2#1)(2005-6#1)(2005-7#2)(2005-8#4)(2006-10#18)(2006-11#3)(2006-8#2)(2006-9#2)(2007-11#2)(2007-12#1)(2007-4#1)(2007-6#3)(2007-7#3)(2007-8#3)(2007-9#4)(2008-1#5)(2008-10#6)(2008-3#3)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#8)(2008-8#5)(2008-9#3)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#3)(2010-10#1)(2010-11#3)(2010-12#5)(2010-2#3)(2010-5#2)(2010-7#2)(2011-1#5)(2011-2#4)(2011-3#1)(2011-7#1)(2012-1#5)(2012-11#1)(2012-12#7)(2012-2#6)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#2)
recent advent of##3##3##(2008-3#1)(2009-5#1)(2010-8#1)
recent analysis##3##2##(1997-5#1)(2005-3#1)(2007-2#1)
recent analytical##2##2##(2008-11#1)(2010-7#1)
recent and promising##3##3##(2006-7#1)(2008-5#1)(2008-7#1)
recent and rapid##2##3##(1994-2#1)(2005-7#1)
recent and##23##2##(1991-12#1)(1991-9#1)(1994-2#1)(1996-8#1)(2005-7#1)(2006-10#1)(2006-7#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-11#1)(2010-4#1)(2011-2#2)(2012-1#1)(2013-1#2)(2013-7#1)
recent antibiotic##3##2##(2008-5#1)(2012-2#1)(2013-8#1)
recent antibiotics##2##2##(1994-11#1)(2010-4#1)
recent applications of##3##3##(2008-10#1)(2010-5#1)(2010-9#1)
recent applications to##2##3##(1994-9#1)(2008-9#1)
recent applications##7##2##(1994-9#1)(2006-6#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-5#1)(2010-9#1)
recent approaches##5##2##(2005-11#1)(2007-10#1)(2010-8#1)(2013-7#2)
recent article by##2##3##(2010-12#1)(2010-3#1)
recent article##3##2##(2010-12#1)(2010-3#1)(2011-1#1)
recent articles have##2##3##(2006-10#2)
recent articles##5##2##(1991-4#1)(2006-10#2)(2006-5#1)(2008-2#1)
recent asthma guidelines##2##3##(2007-2#2)
recent attempts to##5##3##(1992-1#1)(1994-6#1)(2006-6#1)(2008-3#1)(2011-1#1)
recent attempts##7##2##(1992-1#1)(1994-6#1)(1995-1#1)(2006-6#1)(2008-3#1)(2008-4#1)(2011-1#1)
recent attention to##2##3##(2006-10#1)(2012-12#1)
recent attention##3##2##(2006-10#1)(2009-8#1)(2012-12#1)
recent availability##5##2##(2005-7#1)(2005-9#1)(2008-10#1)(2008-4#1)(2012-12#1)
recent balloon flights##2##3##(2008-3#2)
recent birth##3##2##(1995-5#2)(2012-3#1)
recent breakthroughs in##2##3##(2007-12#1)(2009-2#1)
recent case of##5##3##(1990-9#1)(1991-12#1)(2006-1#1)(2007-12#1)(2008-1#1)
recent case reports##2##3##(2008-7#1)(2009-11#1)
recent case study##2##3##(1996-2#1)(2008-7#1)
recent case##12##2##(1990-9#2)(1991-12#1)(1996-2#1)(2006-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-7#2)(2008-9#1)(2009-11#1)
recent case-control##2##2##(2008-7#2)
recent cases of##3##3##(2007-12#1)(2007-8#1)(2010-4#1)
recent cases##8##2##(1990-9#1)(1992-12#1)(2005-8#1)(2007-12#2)(2007-8#1)(2008-7#1)(2010-4#1)
recent change##2##2##(2007-3#1)(2008-10#1)
recent changes in the##2##4##(1992-12#1)(2012-3#1)
recent changes in##6##3##(1990-8#1)(1992-12#1)(2006-10#2)(2006-8#1)(2012-3#1)
recent changes##8##2##(1990-8#1)(1992-12#1)(2005-9#1)(2006-10#2)(2006-8#1)(2012-3#1)(2013-7#1)
recent characterization of##3##3##(2004-11#1)(2008-4#1)(2009-8#1)
recent claims##5##2##(2006-5#1)(2007-10#1)(2007-11#1)(2010-4#1)(2010-7#1)
recent clinical and##2##3##(2005-11#1)(2006-9#1)
recent clinical data##3##3##(2008-5#1)(2008-8#1)(2009-4#1)
recent clinical guidelines##2##3##(2005-3#1)(2010-12#1)
recent clinical studies##3##3##(1996-11#1)(2005-7#1)(2011-1#1)
recent clinical success of##2##4##(1993-11#1)(2008-6#1)
recent clinical trial##3##3##(1996-8#1)(2008-1#1)(2008-7#1)
recent clinical trials in the##2##5##(2008-11#1)(2009-3#1)
recent clinical trials in##3##4##(2008-11#1)(2008-5#1)(2009-3#1)
recent clinical trials of##4##4##(2005-7#1)(2005-8#1)(2012-12#1)(2012-3#1)
recent clinical trials##22##3##(1991-7#1)(1996-7#1)(2005-10#1)(2005-7#1)(2005-8#1)(2005-9#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-5#2)(2008-9#2)(2009-3#2)(2010-12#1)(2010-5#1)(2012-12#3)(2012-3#1)(2013-1#1)
recent clinical##48##2##(1991-7#1)(1993-11#1)(1996-11#1)(1996-7#1)(1996-8#1)(1997-7#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-3#1)(2005-7#2)(2005-8#1)(2005-9#2)(2006-10#1)(2006-11#1)(2006-9#1)(2007-10#2)(2007-11#2)(2008-1#2)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#2)(2009-4#1)(2010-12#2)(2010-5#1)(2010-6#1)(2011-1#1)(2012-12#4)(2012-3#1)(2013-1#1)
recent common ancestor with##5##4##(1995-11#1)(2008-10#4)
recent common ancestor##7##3##(1995-11#1)(1995-8#1)(2008-10#5)
recent comparative##3##2##(2005-11#1)(2006-10#1)(2010-8#1)
recent completion of the##2##4##(2006-10#1)(2008-9#1)
recent comprehensive##3##2##(1996-2#1)(2006-10#1)(2008-7#1)
recent computational##2##2##(2007-3#1)(2008-7#1)
recent conceptual syntheses##2##3##(2008-9#2)
recent conceptual##3##2##(2008-9#2)(2009-4#1)
recent concerns##2##2##(2007-8#1)(2008-11#1)
recent cost-effectiveness##2##2##(2010-4#1)(2013-1#1)
recent crystal##2##2##(2008-8#1)(2010-5#1)
recent data are##2##3##(2006-6#1)(2008-8#1)
recent data from##6##3##(2005-8#1)(2006-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
recent data have##3##3##(1996-9#1)(2006-9#1)(2008-5#1)
recent data indicate that##4##4##(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
recent data on the##4##4##(1993-6#1)(2006-10#1)(2008-10#1)(2008-6#1)
recent data on##11##3##(1993-6#1)(2006-10#3)(2008-1#1)(2008-10#1)(2008-3#2)(2008-6#1)(2008-9#1)(2012-1#1)
recent data show that##4##4##(1993-12#1)(2008-3#1)(2010-12#1)(2013-1#1)
recent data showing that##2##4##(2007-5#1)(2010-3#1)
recent data suggest that the##4##5##(2004-11#1)(2007-4#1)(2007-8#1)(2009-8#1)
recent data suggest that##12##4##(1990-10#1)(1996-3#1)(2004-11#1)(2005-8#1)(2006-10#2)(2007-11#2)(2007-4#1)(2007-8#1)(2009-10#1)(2009-8#1)
recent data suggests that##2##4##(2006-8#1)(2008-3#1)
recent data##69##2##(1990-10#1)(1993-12#1)(1993-3#1)(1993-6#1)(1996-3#1)(1996-9#1)(1997-5#1)(2004-11#1)(2005-8#2)(2005-9#1)(2006-10#8)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-4#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#6)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#2)(2009-8#1)(2010-12#1)(2010-3#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-3#2)(2013-1#2)
recent debate##2##2##(2006-10#1)(2008-9#1)
recent debates##2##2##(2008-9#1)(2012-12#1)
recent decades##24##2##(1990-3#1)(1993-6#1)(1997-5#1)(2006-6#1)(2007-2#1)(2007-3#1)(2008-1#2)(2008-11#1)(2008-7#3)(2008-9#1)(2009-3#1)(2010-10#1)(2010-2#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
recent decision##2##2##(2010-12#1)(2011-12#1)
recent decisions##2##2##(2005-11#1)(2013-8#1)
recent declines in##2##3##(1997-2#1)(2008-1#1)
recent demonstration of##3##3##(1995-6#1)(2006-10#1)(2007-9#1)
recent demonstration that##2##3##(1991-8#1)(2009-5#1)
recent demonstration##6##2##(1991-8#1)(1995-6#1)(1996-2#1)(2006-10#1)(2007-9#1)(2009-5#1)
recent description##2##2##(2006-10#1)(2013-1#1)
recent development and##3##3##(1995-2#1)(2008-6#1)(2008-7#1)
recent development in##4##3##(2006-6#1)(2009-7#1)(2010-12#1)(2010-8#1)
recent development of a##4##4##(1990-2#1)(1997-2#1)(2008-4#1)(2010-1#1)
recent development of##28##3##(1990-12#1)(1990-2#1)(1992-8#1)(1993-11#1)(1997-2#1)(2004-2#1)(2006-10#4)(2007-1#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-12#2)(2010-7#1)(2010-8#1)(2012-11#1)
recent development##40##2##(1990-12#1)(1990-2#1)(1992-8#1)(1993-11#1)(1995-2#1)(1997-2#1)(2004-2#1)(2006-10#4)(2006-11#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-12#3)(2010-6#2)(2010-7#1)(2010-8#2)(2012-11#1)
recent developmental##4##2##(2007-12#2)(2008-10#1)(2012-12#1)
recent developments and##6##3##(1991-11#1)(2005-8#1)(2006-9#1)(2007-8#1)(2008-10#1)(2010-5#1)
recent developments in molecular##3##4##(2006-10#1)(2009-5#1)(2011-2#1)
recent developments in the application of##2##6##(2008-1#1)(2008-10#1)
recent developments in the design##2##5##(2005-7#1)(2008-10#1)
recent developments in the field of##4##6##(1994-9#1)(2006-10#1)(2008-4#1)(2012-11#1)
recent developments in the field##5##5##(1994-9#1)(2006-10#2)(2008-4#1)(2012-11#1)
recent developments in the study of##2##6##(2006-12#1)(2008-10#1)
recent developments in the##25##4##(1992-12#1)(1994-9#1)(1996-3#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-8#1)(2008-1#3)(2008-10#4)(2008-4#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-11#1)(2010-4#1)(2012-11#1)
recent developments in this field##2##5##(1993-6#1)(2010-7#1)
recent developments in this##3##4##(1993-6#1)(2006-10#1)(2010-7#1)
recent developments in##68##3##(1990-8#1)(1992-12#1)(1993-6#2)(1994-9#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-9#1)(2005-7#1)(2005-8#2)(2006-10#12)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-5#1)(2007-6#1)(2008-1#6)(2008-10#8)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-3#1)(2009-5#1)(2009-7#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-11#1)
recent developments of##4##3##(2006-12#1)(2007-11#1)(2008-3#1)(2013-8#1)
recent developments on cost-effective flow-based analysis##2##6##(2008-10#2)
recent developments on##4##3##(2008-10#2)(2008-11#1)(2009-10#1)
recent developments regarding the##2##4##(2009-10#1)(2013-1#1)
recent developments regarding##3##3##(2009-10#1)(2011-2#1)(2013-1#1)
recent developments that##3##3##(1991-7#1)(2006-10#1)(2006-12#1)
recent developments with##3##3##(1997-4#1)(2007-8#1)(2010-7#1)
recent developments##108##2##(1990-8#1)(1991-11#1)(1991-2#1)(1991-7#1)(1992-11#1)(1992-12#1)(1993-6#2)(1994-9#1)(1995-6#1)(1996-1#1)(1996-3#2)(1996-9#1)(1997-4#1)(2005-7#2)(2005-8#3)(2006-10#17)(2006-12#3)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-2#2)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#6)(2008-10#11)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#2)(2009-3#1)(2009-5#1)(2009-7#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#5)(2012-1#1)(2012-11#1)(2013-1#1)(2013-8#1)
recent discoveries in the##2##4##(2006-10#1)(2006-2#1)
recent discoveries of##2##3##(2008-10#1)(2012-2#1)
recent discoveries##9##2##(1996-12#1)(2006-10#1)(2006-2#1)(2008-10#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#1)(2012-2#1)
recent discovery of a##2##4##(1996-4#1)(2006-12#1)
recent discovery of##13##3##(1990-6#1)(1993-5#1)(1994-4#1)(1995-4#1)(1996-4#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-12#1)
recent discovery##18##2##(1990-6#1)(1993-5#1)(1994-4#1)(1995-4#1)(1996-4#1)(2006-12#2)(2007-10#1)(2007-11#1)(2007-6#1)(2008-11#1)(2008-4#3)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)
recent discussions##2##2##(2006-10#1)(2008-11#1)
recent duplication##2##2##(1993-3#2)
recent efforts have##2##3##(2008-4#1)(2010-9#1)
recent efforts to##5##3##(1993-6#1)(1996-1#1)(2005-8#1)(2006-10#1)(2007-8#1)
recent efforts##9##2##(1993-3#1)(1993-6#1)(1996-1#1)(2005-8#1)(2006-10#1)(2007-8#2)(2008-4#1)(2010-9#1)
recent emergence of##4##3##(2005-6#1)(2008-10#1)(2008-12#1)(2009-12#1)
recent emerging##2##2##(2008-9#1)(2009-2#1)
recent empirical##4##2##(1996-11#1)(2007-2#1)(2008-8#1)(2012-2#1)
recent epidemiologic##2##2##(2006-10#2)
recent epidemiological studies have##2##4##(1991-4#1)(2011-2#1)
recent epidemiological studies##3##3##(1991-4#1)(1994-6#1)(2011-2#1)
recent epidemiological##7##2##(1991-4#1)(1994-6#1)(1997-7#1)(2005-10#1)(2007-1#1)(2011-2#1)(2012-2#1)
recent episodes##2##2##(1995-3#1)(2006-10#1)
recent evidence from##4##3##(2008-2#2)(2008-7#2)
recent evidence has indicated##2##4##(1996-11#1)(2008-5#1)
recent evidence suggests that##5##4##(1995-6#1)(1996-10#1)(2005-10#1)(2008-11#1)(2008-5#1)
recent evidence that##8##3##(1992-9#2)(1996-4#1)(2006-10#1)(2008-8#1)(2012-1#1)(2012-2#1)(2012-3#1)
recent evidence##35##2##(1992-9#2)(1995-6#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-4#1)(2005-10#1)(2006-10#2)(2006-3#1)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#2)(2010-12#1)(2010-3#1)(2011-1#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
recent evolution of##3##3##(1993-2#1)(2006-5#1)(2006-7#1)
recent examples of##3##3##(1997-4#1)(2008-7#1)(2009-12#1)
recent examples##4##2##(1996-6#1)(1997-4#1)(2008-7#1)(2009-12#1)
recent experience of the##2##4##(2007-4#1)(2008-11#1)
recent experience of##3##3##(2007-4#1)(2008-11#2)
recent experience##8##2##(2004-9#1)(2006-6#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-11#2)(2008-7#1)
recent experiences##3##2##(2005-8#1)(2007-12#1)(2009-10#1)
recent experiment##3##2##(1992-9#1)(2007-11#1)(2007-12#1)
recent experimental data##2##3##(2006-10#1)(2007-1#1)
recent experimental results##4##3##(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)
recent experimental##15##2##(1996-8#1)(1997-3#1)(2005-10#1)(2006-10#2)(2006-4#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-7#1)
recent experiments in which##2##4##(2007-11#1)(2007-12#1)
recent experiments in##3##3##(1991-11#1)(2007-11#1)(2007-12#1)
recent experiments on the##2##4##(1995-4#1)(2008-7#1)
recent experiments on##3##3##(1995-4#1)(2007-12#1)(2008-7#1)
recent experiments##16##2##(1991-11#1)(1991-3#1)(1995-4#1)(1996-5#1)(2004-12#1)(2006-4#1)(2007-11#1)(2007-12#4)(2008-10#2)(2008-7#2)(2012-1#1)
recent exposure##3##2##(1991-7#1)(1994-6#1)(2008-11#1)
recent extensive##2##2##(2008-7#1)(2008-8#1)
recent finding of##2##3##(1996-3#1)(2007-10#1)
recent finding that##5##3##(1992-5#1)(2006-9#1)(2008-8#1)(2009-8#2)
recent finding##10##2##(1990-8#1)(1992-5#1)(1996-3#1)(2006-9#1)(2007-10#1)(2008-10#1)(2008-8#1)(2009-8#2)(2010-11#1)
recent findings (focusing on papers published between##2##7##(2006-10#2)
recent findings about##2##3##(2006-2#1)(2008-3#1)
recent findings and##5##3##(2006-9#1)(2008-10#1)(2008-8#1)(2009-8#1)(2011-1#1)
recent findings concerning##2##3##(2008-11#1)(2008-4#1)
recent findings from##2##3##(2006-10#1)(2008-11#1)
recent findings have##2##3##(2008-4#1)(2010-8#1)
recent findings in the##3##4##(2006-10#1)(2011-1#1)(2012-2#1)
recent findings in this field##2##5##(2008-4#1)(2009-10#1)
recent findings in this##3##4##(2008-1#1)(2008-4#1)(2009-10#1)
recent findings in##11##3##(2006-1#1)(2006-10#1)(2008-1#2)(2008-4#1)(2009-10#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
recent findings of##3##3##(2008-6#1)(2009-4#1)(2010-9#1)
recent findings on the molecular##2##5##(2008-7#1)(2012-12#1)
recent findings on the##7##4##(1996-4#1)(2006-10#1)(2008-7#1)(2009-1#1)(2010-3#1)(2011-1#1)(2012-12#1)
recent findings on##18##3##(1990-2#1)(1996-4#1)(1997-7#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-7#1)(2009-1#1)(2009-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
recent findings regarding##6##3##(1996-11#1)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#2)
recent findings showing that##2##4##(2008-7#1)(2013-7#1)
recent findings suggest that##4##4##(2003-11#1)(2008-8#1)(2009-8#1)(2011-2#1)
recent findings suggest##5##3##(2003-11#1)(2007-8#1)(2008-8#1)(2009-8#1)(2011-2#1)
recent findings that suggest##2##4##(2008-11#1)(2008-7#1)
recent findings that##9##3##(1994-8#1)(2006-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-6#1)(2011-1#1)(2012-2#1)
recent findings##89##2##(1990-2#1)(1991-2#1)(1991-3#1)(1994-8#1)(1995-8#1)(1996-11#1)(1996-4#1)(1997-7#1)(2003-11#1)(2006-1#1)(2006-10#7)(2006-2#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#1)(2008-11#5)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#4)(2009-1#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-2#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#5)(2011-7#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-7#1)(2013-8#4)
recent focus##2##2##(2006-10#1)(2009-3#1)
recent gene##2##2##(2009-10#1)(2009-12#1)
recent genetic##3##2##(1995-6#1)(2011-1#1)(2011-2#1)
recent government##2##2##(2008-11#2)
recent graduates##2##2##(1994-3#1)(2011-2#1)
recent guidelines##3##2##(2006-10#1)(2007-8#1)(2011-2#1)
recent health##2##2##(1994-1#1)(2012-3#1)
recent high-resolution##4##2##(1990-5#1)(1996-4#1)(2008-2#1)(2012-2#1)
recent history of##9##3##(2005-7#1)(2006-5#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-2#1)(2012-2#2)(2013-1#1)
recent history##12##2##(1991-1#1)(1996-5#1)(2005-7#1)(2006-5#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-2#1)(2012-2#2)(2013-1#1)
recent human##2##2##(2006-12#1)(2006-5#1)
recent identification of multiple##3##4##(1996-8#1)(2008-10#1)(2010-12#1)
recent identification of the##4##4##(1996-2#1)(1996-7#1)(1997-4#1)(2012-12#1)
recent identification of##17##3##(1990-8#1)(1996-10#1)(1996-2#2)(1996-7#1)(1996-8#1)(1997-4#1)(2006-10#3)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)
recent immunological##2##2##(1990-6#1)(2007-11#1)
recent improvement##2##2##(1996-3#1)(2008-7#1)
recent improvements in##3##3##(2007-11#1)(2007-5#1)(2008-10#1)
recent improvements##7##2##(2007-11#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-3#1)(2012-8#1)
recent in##2##2##(2005-10#1)(2008-7#1)
recent incident##2##2##(1991-2#1)(2008-10#1)
recent increase in the##2##4##(2008-10#1)(2010-7#1)
recent increase in##7##3##(1993-1#1)(1994-4#1)(2005-11#1)(2006-10#1)(2008-10#1)(2010-1#1)(2010-7#1)
recent increase of##3##3##(2006-10#1)(2008-10#1)(2013-8#1)
recent increase##10##2##(1993-1#1)(1994-4#1)(2005-11#1)(2006-10#2)(2008-10#2)(2010-1#1)(2010-7#1)(2013-8#1)
recent increases in##2##3##(2007-4#1)(2010-3#1)
recent infection##4##2##(1990-3#1)(2007-2#1)(2007-8#1)(2008-12#1)
recent information on##2##3##(1997-2#1)(2008-4#1)
recent information##4##2##(1997-2#1)(2006-10#1)(2008-4#1)(2009-1#1)
recent innovation##2##2##(2007-12#1)(2010-5#1)
recent innovations in##3##3##(2008-10#1)(2008-8#1)(2010-1#1)
recent innovations##4##2##(2008-10#1)(2008-8#1)(2009-12#1)(2010-1#1)
recent insights into the pathogenesis of##2##6##(2006-10#1)(2008-7#1)
recent insights into the##4##4##(2006-10#1)(2008-1#1)(2008-7#1)(2010-9#1)
recent insights into##6##3##(2006-10#1)(2008-1#1)(2008-7#1)(2010-9#1)(2011-2#1)(2013-1#1)
recent insights##9##2##(2006-10#1)(2008-1#2)(2008-7#2)(2010-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
recent interest in the use of##3##6##(1995-5#1)(2005-8#1)(2011-12#1)
recent interest in the##5##4##(1995-5#1)(2005-8#2)(2007-11#1)(2011-12#1)
recent interest in##9##3##(1995-5#1)(1997-7#1)(2005-8#2)(2007-1#1)(2007-11#1)(2008-3#1)(2009-5#1)(2011-12#1)
recent interest##11##2##(1995-5#1)(1997-7#1)(2005-8#2)(2006-10#1)(2007-1#1)(2007-11#1)(2008-3#1)(2009-5#1)(2010-7#1)(2011-12#1)
recent introduction of the##2##4##(1993-12#1)(2008-10#1)
recent introduction of##14##3##(1991-2#1)(1993-12#1)(1996-5#1)(1997-4#1)(1997-8#1)(2004-11#1)(2006-4#1)(2007-11#1)(2008-10#2)(2008-3#1)(2009-4#1)(2011-2#1)(2013-1#1)
recent introduction##15##2##(1991-2#1)(1993-12#1)(1996-5#1)(1997-4#1)(1997-8#1)(2004-11#1)(2006-4#1)(2007-11#1)(2008-10#3)(2008-3#1)(2009-4#1)(2011-2#1)(2013-1#1)
recent investigation##3##2##(1993-2#1)(2006-10#1)(2007-12#1)
recent investigations have##3##3##(1992-3#1)(2006-10#1)(2008-2#1)
recent investigations##9##2##(1992-3#1)(2005-9#1)(2006-10#2)(2006-3#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)
recent isolates##2##2##(2007-6#1)(2008-5#1)
recent issue of##3##3##(2005-7#1)(2010-8#1)(2012-2#1)
recent knowledge of##2##3##(2007-12#1)(2008-2#1)
recent knowledge##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2010-4#1)
recent laboratory evidence##2##3##(1991-9#1)(2008-10#1)
recent laboratory##3##2##(1991-9#1)(2008-10#1)(2010-4#1)
recent landmark##2##2##(2008-5#1)(2009-7#1)
recent large##6##2##(1992-6#1)(2007-10#1)(2010-12#1)(2011-2#1)(2013-1#2)
recent legal##5##2##(2008-11#4)(2009-11#1)
recent life events##2##3##(2007-6#2)
recent literature and##4##3##(2006-10#3)(2008-8#1)
recent literature concerning##7##3##(1997-7#1)(2006-10#3)(2008-8#1)(2010-9#1)(2011-2#1)
recent literature has##2##3##(2007-7#1)(2008-7#1)
recent literature in##3##3##(2006-10#1)(2010-2#1)(2013-1#1)
recent literature on the##7##4##(1991-12#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-8#1)(2009-6#1)(2011-1#1)
recent literature on this##2##4##(2008-4#1)(2011-1#1)
recent literature on##15##3##(1991-12#1)(1994-6#1)(1996-1#1)(2006-10#2)(2006-2#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-8#2)(2009-5#1)(2009-6#1)(2011-1#2)
recent literature related to##2##4##(2006-10#1)(2012-2#1)
recent literature suggests a##2##4##(2007-4#1)(2011-2#1)
recent literature that##2##3##(2005-10#1)(2006-10#1)
recent literature##78##2##(1990-6#1)(1991-12#1)(1991-2#1)(1991-4#1)(1993-10#1)(1993-5#1)(1994-6#1)(1996-1#1)(1997-7#1)(2005-10#1)(2006-10#21)(2006-11#1)(2006-2#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
recent major##3##2##(2006-10#1)(2007-11#2)
recent material##2##2##(2007-3#1)(2008-3#1)
recent mathematical##2##2##(2008-9#1)(2009-5#1)
recent measles##2##2##(1991-8#1)(2007-2#1)
recent mechanistic##2##2##(2009-4#1)(2010-12#1)
recent meta-analysis##4##2##(1993-6#1)(2006-9#1)(2007-8#1)(2010-1#1)
recent method##2##2##(2008-7#1)(2013-8#1)
recent methodological##2##2##(2007-12#1)(2008-8#1)
recent methods##4##2##(1997-4#1)(2007-6#1)(2008-1#1)(2008-11#1)
recent migrants##2##2##(2008-6#1)(2012-12#1)
recent model##3##2##(1994-5#1)(2007-12#1)(2012-2#1)
recent models of##2##3##(2008-4#2)
recent modifications of##2##3##(2005-8#1)(2008-4#1)
recent modifications##5##2##(1996-1#1)(2005-8#1)(2006-9#1)(2008-10#1)(2008-4#1)
recent molecular cloning of##2##4##(1994-11#1)(2008-4#1)
recent molecular##5##2##(1992-3#1)(1994-11#1)(2007-12#2)(2008-4#1)
recent myocardial##2##2##(1990-5#1)(2007-9#1)
recent neuroimaging##4##2##(2006-9#1)(2008-11#2)(2008-6#1)
recent neurological##2##2##(2006-11#1)(2006-7#1)
recent nosocomial##2##2##(2006-10#2)
recent observation of##2##3##(1990-2#1)(2007-12#1)
recent observation##4##2##(1990-2#1)(1997-1#1)(2006-2#1)(2007-12#1)
recent observations##9##2##(1992-5#1)(2006-10#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#2)(2009-11#1)
recent ongoing##2##2##(2008-11#1)(2010-5#1)
recent onset and##3##3##(1991-11#1)(2007-8#1)(2008-3#1)
recent onset of##5##3##(2008-10#1)(2009-4#1)(2012-12#1)(2013-1#2)
recent onset schizophrenia##2##3##(1997-8#2)
recent onset##15##2##(1991-11#1)(1997-8#2)(2007-5#2)(2007-8#2)(2008-10#1)(2008-3#1)(2009-4#1)(2011-1#1)(2012-12#1)(2013-1#3)
recent or##3##2##(1992-1#1)(1994-6#1)(2008-10#1)
recent origin##2##2##(1995-8#1)(2010-6#1)
recent outbreak of##3##3##(1997-1#1)(2007-12#1)(2008-10#1)
recent outbreak##4##2##(1997-1#1)(2007-12#1)(2008-10#1)(2008-3#1)
recent outbreaks##4##2##(2007-6#3)(2008-10#1)
recent paper by##3##3##(2008-3#2)(2013-1#1)
recent paper in##8##3##(2009-6#1)(2009-8#7)
recent paper##23##2##(1994-11#1)(2006-5#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-6#2)(2009-8#11)(2010-12#1)(2013-1#1)
recent papers on##2##3##(2006-10#1)(2007-8#1)
recent papers##10##2##(1994-6#1)(1995-3#1)(2006-10#5)(2006-8#1)(2007-3#1)(2007-8#1)
recent past##17##2##(1991-3#2)(1994-12#1)(2006-10#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-9#1)(2012-12#1)(2012-2#1)(2012-5#1)
recent patent##7##2##(2005-7#2)(2005-8#2)(2008-1#3)
recent patents and##2##3##(2008-1#1)(2010-7#1)
recent patents in this field##3##5##(2008-1#3)
recent patents in##4##3##(2008-1#4)
recent patents##15##2##(2008-1#13)(2008-2#1)(2010-7#1)
recent perspectives##2##2##(2012-1#1)(2012-12#1)
recent pharmacological##2##2##(2005-7#1)(2006-10#1)
recent phase##2##2##(2008-6#1)(2010-12#1)
recent physiological##2##2##(1996-5#1)(2006-10#1)
recent population##4##2##(2008-10#1)(2009-2#1)(2010-8#2)
recent practice##2##2##(2008-11#1)(2013-1#1)
recent preclinical##3##2##(2005-7#1)(2005-9#1)(2008-3#1)
recent predictions of##2##3##(2007-12#1)(2011-1#1)
recent progress has been made##2##5##(1993-10#1)(2010-11#1)
recent progress in the application of##2##6##(2010-11#1)(2011-1#1)
recent progress in the development and##2##6##(1994-3#1)(2013-1#1)
recent progress in the development of##4##6##(2007-8#1)(2011-2#1)(2011-3#1)(2013-1#1)
recent progress in the development##6##5##(1994-3#1)(2007-8#1)(2011-2#1)(2011-3#1)(2013-1#2)
recent progress in the field##2##5##(2009-10#1)(2011-1#1)
recent progress in the##17##4##(1991-2#1)(1994-3#1)(2005-7#1)(2007-8#1)(2008-11#1)(2008-2#1)(2009-10#2)(2010-11#1)(2011-1#2)(2011-2#3)(2011-3#1)(2013-1#2)
recent progress in understanding##2##4##(2006-10#1)(2007-8#1)
recent progress in##35##3##(1990-6#1)(1991-2#1)(1993-3#1)(1994-3#1)(2005-7#1)(2006-10#2)(2006-11#1)(2007-12#1)(2007-8#2)(2008-1#2)(2008-11#1)(2008-2#1)(2008-3#1)(2009-10#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-1#4)(2011-2#4)(2011-3#1)(2013-1#2)
recent progress is##2##3##(2006-10#1)(2011-1#1)
recent progress made in##2##4##(2008-10#1)(2012-12#1)
recent progress of##2##3##(2006-7#1)(2008-3#1)
recent progress on the##2##4##(2006-10#1)(2011-2#1)
recent progress on##6##3##(2006-10#1)(2009-7#1)(2010-2#1)(2011-1#2)(2011-2#1)
recent progress that##2##3##(2008-1#1)(2008-11#1)
recent progress##59##2##(1990-6#1)(1991-2#1)(1993-10#1)(1993-3#1)(1994-3#1)(1996-11#1)(2005-7#1)(2006-10#4)(2006-11#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-1#3)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-10#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-11#2)(2010-12#1)(2010-2#1)(2011-1#8)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)
recent progresses in the##2##4##(2008-1#1)(2008-8#1)
recent proliferation of##3##3##(2007-12#1)(2009-6#1)(2013-1#1)
recent proposal##3##2##(1995-11#1)(2006-10#1)(2007-12#1)
recent proposals for##2##3##(1993-3#1)(1996-6#1)
recent proposals##5##2##(1993-3#1)(1993-4#1)(1994-9#1)(1996-6#1)(2006-9#1)
recent prospective studies##2##3##(2006-2#1)(2008-3#1)
recent prospective study##2##3##(2005-7#1)(2007-7#1)
recent prospective##5##2##(2005-7#1)(2006-2#1)(2007-7#1)(2008-3#1)(2012-12#1)
recent publication of##2##3##(2008-8#1)(2012-2#1)
recent publication##9##2##(1993-10#1)(2007-12#1)(2008-10#1)(2008-8#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
recent publications have##2##3##(2006-10#1)(2008-7#1)
recent publications in##3##3##(2006-10#1)(2007-4#1)(2008-4#1)
recent publications on##2##3##(2006-10#1)(2010-12#1)
recent publications##22##2##(1993-3#1)(1996-8#1)(2006-10#8)(2006-7#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
recent published##8##2##(1995-11#1)(1995-12#1)(1995-3#1)(2006-6#1)(2008-10#1)(2008-8#1)(2010-12#1)(2012-2#1)
recent randomized controlled##2##3##(2006-5#1)(2011-2#1)
recent randomized##6##2##(1993-2#1)(2006-10#1)(2006-5#1)(2009-11#1)(2011-2#1)(2013-1#1)
recent recognition##3##2##(2007-3#1)(2010-5#1)(2012-12#1)
recent recommendations##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
recent release of##2##3##(2006-12#1)(2008-10#1)
recent relevant##2##2##(2007-7#1)(2009-5#1)
recent report by##2##3##(1992-3#1)(2007-4#1)
recent report of a##2##4##(1991-9#1)(2008-6#1)
recent report on##3##3##(1995-11#1)(1997-6#1)(2009-8#1)
recent report that##3##3##(2005-8#1)(2009-8#1)(2012-2#1)
recent report##22##2##(1990-9#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#3)(1992-9#1)(1995-11#1)(1995-8#1)(1997-6#1)(2005-8#1)(2006-10#2)(2007-4#1)(2008-6#1)(2009-2#1)(2009-5#1)(2009-8#2)(2010-12#1)(2012-2#1)
recent reports have##4##3##(1992-12#1)(2007-12#1)(2008-8#1)(2009-10#1)
recent reports in the literature##2##5##(1991-2#1)(2008-2#1)
recent reports in##3##3##(1991-2#1)(2006-10#1)(2008-2#1)
recent reports indicate##2##3##(2006-2#1)(2008-3#1)
recent reports of##6##3##(1997-5#1)(2007-7#1)(2007-8#1)(2009-5#1)(2009-9#1)(2011-2#1)
recent reports on##4##3##(2006-10#2)(2007-8#1)(2008-11#1)
recent reports suggest that##2##4##(1993-9#1)(2007-11#1)
recent reports using##2##3##(2009-3#1)(2012-1#1)
recent reports##39##2##(1990-5#1)(1991-2#1)(1991-4#1)(1992-12#1)(1993-12#1)(1993-9#1)(1997-5#1)(2005-8#1)(2006-10#6)(2006-2#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-8#2)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
recent research findings##4##3##(1991-2#2)(2008-11#1)(2010-2#1)
recent research has shown that##2##5##(2008-11#1)(2008-2#1)
recent research has suggested##2##4##(2012-3#1)(2013-8#1)
recent research has##9##3##(2004-3#1)(2007-11#1)(2008-11#2)(2008-2#2)(2008-8#1)(2012-3#1)(2013-8#1)
recent research in this area##2##5##(2007-7#1)(2008-10#1)
recent research in this##3##4##(2006-10#1)(2007-7#1)(2008-10#1)
recent research in##4##3##(2005-8#1)(2006-10#1)(2007-7#1)(2008-10#1)
recent research into the##2##4##(2008-5#1)(2011-1#1)
recent research on the##3##4##(2008-10#1)(2008-7#1)(2008-9#1)
recent research on##4##3##(2008-10#1)(2008-7#2)(2008-9#1)
recent research shows that##2##4##(2008-1#1)(2009-8#1)
recent research suggests##3##3##(2006-10#1)(2008-8#1)(2013-1#1)
recent research##51##2##(1990-12#1)(1990-4#1)(1991-2#2)(1991-6#1)(1994-3#1)(2004-3#1)(2005-1#1)(2005-8#2)(2006-10#5)(2007-11#2)(2007-12#1)(2007-2#2)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#4)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-8#1)(2010-2#2)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
recent research]##2##2##(1991-6#1)(1997-6#1)
recent results from##3##3##(2008-1#1)(2008-10#1)(2009-8#1)
recent results in##5##3##(2005-7#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-5#1)
recent results obtained##2##3##(2008-5#1)(2011-2#1)
recent results of##8##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-3#1)
recent results on the##3##4##(1992-11#1)(1994-8#1)(2008-5#1)
recent results showing that##2##4##(1996-9#1)(2010-4#1)
recent results suggest that##2##4##(2008-10#1)(2008-3#1)
recent results##35##2##(1992-11#1)(1994-8#1)(1995-9#1)(1996-9#1)(1997-6#1)(2005-7#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#3)(2008-3#3)(2008-4#2)(2008-5#6)(2008-7#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#2)
recent resurgence##2##2##(2008-7#1)(2008-8#1)
recent review##5##2##(2004-12#1)(2007-3#1)(2010-12#1)(2010-6#1)(2011-2#1)
recent reviews and##3##3##(1993-6#2)(2012-1#1)
recent reviews##5##2##(1993-6#2)(2007-1#1)(2010-4#1)(2012-1#1)
recent scientific##4##2##(1997-3#1)(2007-11#1)(2008-1#1)(2010-12#1)
recent series##4##2##(2006-10#1)(2007-8#2)(2008-10#1)
recent smoking##4##2##(2008-8#4)
recent speciation##2##2##(2006-5#1)(2008-6#1)
recent state##2##2##(1993-2#1)(2008-11#1)
recent strategies##3##2##(1993-2#1)(2005-8#1)(2009-10#1)
recent structural study##2##3##(2009-8#1)(2010-12#1)
recent structural##3##2##(2008-8#1)(2009-8#1)(2010-12#1)
recent studies and##4##3##(2007-10#1)(2007-8#1)(2008-1#1)(2008-3#1)
recent studies are##2##3##(1996-4#1)(2010-12#1)
recent studies conducted in##2##4##(1996-1#1)(2009-1#1)
recent studies examining##2##3##(2006-9#1)(2012-12#1)
recent studies from##3##3##(2006-11#1)(2008-2#1)(2012-12#1)
recent studies have also##2##4##(2006-9#1)(2011-1#1)
recent studies have compared##2##4##(2006-9#1)(2011-2#1)
recent studies have demonstrated that##4##5##(2008-1#1)(2011-2#2)(2012-12#1)
recent studies have demonstrated##7##4##(2007-11#1)(2008-1#1)(2008-8#1)(2011-2#3)(2012-12#1)
recent studies have implicated##2##4##(1993-11#1)(1997-7#1)
recent studies have indicated that##2##5##(2006-10#1)(2012-2#1)
recent studies have provided##3##4##(2007-8#1)(2008-1#1)(2008-3#1)
recent studies have revealed##2##4##(2008-7#1)(2012-2#1)
recent studies have shown that the##2##6##(1996-2#1)(2008-8#1)
recent studies have shown that##7##5##(1996-2#1)(2006-7#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-4#1)(2012-11#1)
recent studies have shown##13##4##(1996-2#1)(2006-10#2)(2006-7#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-11#1)
recent studies have suggested a##2##5##(1997-6#1)(2013-1#1)
recent studies have suggested that##5##5##(1995-12#1)(1995-3#1)(1997-8#1)(2010-12#1)(2013-1#1)
recent studies have suggested##7##4##(1995-12#1)(1995-3#1)(1997-6#1)(1997-8#1)(2010-12#1)(2013-1#2)
recent studies have used##2##4##(2006-8#1)(2007-6#1)
recent studies have##54##3##(1993-11#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-8#1)(2006-10#6)(2006-12#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-11#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#3)
recent studies in which the##2##5##(2007-2#1)(2013-1#1)
recent studies in which##3##4##(2007-2#1)(2008-3#1)(2013-1#1)
recent studies in##11##3##(1994-2#1)(1994-8#1)(2006-10#2)(2007-2#1)(2007-5#1)(2008-3#2)(2010-2#1)(2010-7#1)(2013-1#1)
recent studies indicate that##4##4##(1990-5#1)(1992-5#1)(2006-10#1)(2009-4#1)
recent studies indicate##5##3##(1990-5#1)(1992-5#1)(2006-10#1)(2008-3#1)(2009-4#1)
recent studies of the##5##4##(1992-6#1)(2006-10#1)(2008-5#1)(2008-8#1)(2012-2#1)
recent studies of##13##3##(1992-6#1)(2006-10#4)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-5#1)(2012-2#1)(2013-1#1)
recent studies on the structure##2##5##(2008-1#1)(2008-4#1)
recent studies on the##7##4##(1994-2#1)(2004-11#1)(2008-1#1)(2008-4#1)(2008-5#1)(2009-6#1)(2011-2#1)
recent studies on this##2##4##(1997-8#1)(2012-1#1)
recent studies on##18##3##(1994-2#1)(1996-6#1)(1997-8#1)(2004-11#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-1#2)(2012-11#1)
recent studies reported##2##3##(2009-5#1)(2011-1#1)
recent studies show that##3##4##(2006-10#1)(2008-3#1)(2008-8#1)
recent studies show##4##3##(2006-10#1)(2007-11#1)(2008-3#1)(2008-8#1)
recent studies showed that##3##4##(1995-8#1)(2010-5#1)(2013-8#1)
recent studies showing##3##3##(2007-6#1)(2008-1#1)(2010-8#1)
recent studies suggest that##11##4##(1993-11#1)(1993-6#1)(1994-8#1)(1995-12#1)(2005-8#1)(2006-10#1)(2007-10#1)(2008-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
recent studies that have##2##4##(2004-11#1)(2008-10#1)
recent studies that##12##3##(1994-2#1)(1997-1#1)(2004-11#1)(2006-11#1)(2006-7#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-9#1)(2010-4#1)(2011-2#1)(2013-8#1)
recent studies using##4##3##(2008-11#1)(2008-3#1)(2011-2#1)(2012-3#1)
recent studies##205##2##(1990-10#1)(1990-5#2)(1991-7#1)(1992-4#1)(1992-5#1)(1992-6#2)(1993-1#1)(1993-11#3)(1993-6#1)(1994-2#3)(1994-8#3)(1995-12#2)(1995-3#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-2#2)(1996-4#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-1#1)(2004-10#1)(2004-11#2)(2005-11#1)(2005-8#2)(2006-10#22)(2006-11#2)(2006-12#1)(2006-3#1)(2006-7#2)(2006-8#2)(2006-9#3)(2007-10#2)(2007-11#2)(2007-2#3)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#5)(2008-1#11)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#8)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#4)(2008-9#1)(2009-1#1)(2009-10#2)(2009-11#2)(2009-2#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-4#3)(2010-5#4)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#12)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#7)(2013-8#4)
recent study has##4##3##(2007-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
recent study of the##3##4##(1991-12#1)(1992-12#1)(2007-3#1)
recent study of##10##3##(1991-12#1)(1992-12#1)(1997-7#1)(2005-9#1)(2006-10#1)(2007-11#2)(2007-3#1)(2008-1#1)(2011-12#1)
recent study showed##2##3##(2008-5#1)(2013-1#1)
recent study using##2##3##(2008-11#1)(2009-8#1)
recent study##55##2##(1990-11#1)(1991-10#1)(1991-12#1)(1992-12#1)(1996-12#1)(1997-2#1)(1997-7#1)(2004-12#1)(2005-9#1)(2006-10#2)(2006-5#1)(2007-11#3)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#2)(2008-8#2)(2009-3#1)(2009-5#1)(2009-8#5)(2010-11#3)(2010-12#3)(2010-4#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
recent success##3##2##(2005-7#1)(2006-2#1)(2012-12#1)
recent suggestion##2##2##(1992-3#1)(2007-12#1)
recent suggestions that##2##3##(1997-7#1)(2009-8#1)
recent surge in##3##3##(2008-1#1)(2008-10#1)(2008-11#1)
recent surge of##2##3##(2009-4#1)(2012-11#1)
recent surge##6##2##(2008-1#2)(2008-10#1)(2008-11#1)(2009-4#1)(2012-11#1)
recent surgery and certain forms of thrombophilia##2##7##(2010-12#2)
recent surgery##4##2##(2006-4#1)(2009-3#1)(2010-12#2)
recent survey of##5##3##(1994-3#1)(1995-1#1)(1995-2#1)(2008-3#1)(2008-6#1)
recent survey##11##2##(1992-3#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-2#1)(2006-12#1)(2007-6#1)(2008-1#1)(2008-3#2)(2008-6#1)
recent surveys##4##2##(2006-10#1)(2008-8#1)(2008-9#1)(2010-12#1)
recent synaptic##2##2##(2008-11#2)
recent technical##3##2##(1996-4#1)(2008-4#1)(2010-2#1)
recent technique##2##2##(2010-7#1)(2013-1#1)
recent technological advances##2##3##(2006-10#1)(2008-11#1)
recent technological##5##2##(2006-10#1)(2007-8#1)(2008-11#1)(2010-7#1)(2012-2#1)
recent ten years##2##3##(2012-3#2)
recent theoretical##8##2##(2007-12#5)(2007-5#1)(2008-3#1)(2012-3#1)
recent therapeutic##4##2##(1993-2#1)(2005-7#1)(2007-11#1)(2007-8#1)
recent thoughts##2##2##(2009-7#1)(2013-1#1)
recent times##10##2##(1996-1#1)(2007-7#1)(2008-11#1)(2008-3#1)(2009-12#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#2)
recent topics##2##2##(1996-6#1)(2012-2#1)
recent transfers##2##2##(1995-11#1)(2013-1#1)
recent transformation##2##2##(2008-2#1)(2008-9#1)
recent trauma##3##2##(1990-9#1)(2006-7#1)(2007-7#1)
recent traumatic##2##2##(1990-12#1)(1995-9#1)
recent travel##2##2##(2007-2#1)(2011-2#1)
recent treatment##2##2##(1991-6#1)(2011-2#1)
recent trend of##3##3##(2008-11#1)(2009-12#1)(2012-12#1)
recent trend##8##2##(2007-11#1)(2007-12#1)(2007-5#2)(2008-11#1)(2008-4#1)(2009-12#1)(2012-12#1)
recent trends in the##4##4##(1991-1#1)(1992-12#1)(2006-5#1)(2009-9#1)
recent trends in##12##3##(1990-10#1)(1991-1#1)(1992-12#1)(1994-6#1)(2006-5#1)(2006-9#1)(2007-7#1)(2008-1#1)(2009-9#1)(2011-2#2)(2013-1#1)
recent trends##17##2##(1990-10#1)(1990-12#1)(1991-1#1)(1992-12#1)(1994-6#1)(2006-5#1)(2006-9#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#2)(2009-9#1)(2011-2#2)(2013-1#1)
recent trial##2##2##(2007-11#1)(2008-7#1)
recent trials and##2##3##(2008-8#1)(2009-10#1)
recent trials##6##2##(2007-11#1)(2007-4#1)(2007-8#1)(2008-8#1)(2009-10#1)(2010-2#1)
recent use of##3##3##(1992-9#1)(2006-10#1)(2008-11#1)
recent vaccine##2##2##(2006-10#1)(2010-12#1)
recent vector developments##2##3##(2005-7#1)(2006-10#1)
recent viral##2##2##(1992-3#1)(2008-1#1)
recent work has identified##2##4##(1991-3#1)(2008-11#1)
recent work has shown that##3##5##(1996-2#1)(2006-10#1)(2006-7#1)
recent work has##7##3##(1991-3#1)(1996-2#1)(2005-11#1)(2006-10#1)(2006-7#1)(2008-11#1)(2012-12#1)
recent work in the##2##4##(2005-10#1)(2007-10#1)
recent work in##3##3##(1997-8#1)(2005-10#1)(2007-10#1)
recent work on the##3##4##(1990-9#1)(2006-3#1)(2007-5#1)
recent work on##7##3##(1990-9#1)(2006-3#1)(2007-5#1)(2008-2#1)(2009-9#1)(2012-3#1)(2013-8#1)
recent work suggests that##3##4##(2006-10#1)(2008-1#1)(2008-10#1)
recent work that##3##3##(2006-10#1)(2007-9#1)(2009-2#1)
recent work with##2##3##(2008-9#1)(2009-3#1)
recent work##46##2##(1990-9#1)(1991-3#1)(1994-11#1)(1996-2#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#5)(2006-3#1)(2006-7#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#5)(2009-9#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
recent works that##2##3##(2008-4#1)(2010-12#1)
recent works##5##2##(1996-10#1)(2008-4#1)(2009-8#2)(2010-12#1)
recent workshop##2##2##(2006-10#1)(2009-3#1)
recent world##2##2##(2006-10#2)
recent years about##2##3##(1993-11#1)(2007-11#1)
recent years advances in##2##4##(2006-7#1)(2011-2#1)
recent years as a##2##4##(1996-1#1)(2010-8#1)
recent years as##9##3##(1996-1#1)(1997-2#1)(2007-7#1)(2008-10#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)
recent years has been##2##4##(1997-4#1)(2007-1#1)
recent years has##10##3##(1992-11#1)(1997-4#1)(2005-5#1)(2005-8#1)(2006-12#1)(2007-1#1)(2007-2#1)(2008-4#1)(2008-7#1)(2013-1#1)
recent years have seen a##2##5##(2008-5#1)(2012-12#1)
recent years have shown##2##4##(1993-9#1)(2008-3#1)
recent years have##10##3##(1991-12#1)(1993-9#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-12#2)
recent years in##5##3##(1992-1#1)(2006-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
recent years it has been##4##5##(1990-11#1)(1994-11#1)(2006-1#1)(2008-12#1)
recent years it has##5##4##(1990-11#1)(1994-11#1)(2006-1#1)(2008-12#1)(2008-7#1)
recent years regarding##2##3##(2005-8#1)(2012-12#1)
recent years several studies have shown##2##6##(1995-4#1)(2008-3#1)
recent years several##3##3##(1995-4#1)(2008-3#1)(2010-12#1)
recent years some##2##3##(2006-10#1)(2008-1#1)
recent years the##13##3##(1990-7#1)(1991-6#1)(1991-8#1)(1992-2#1)(1994-8#1)(1995-5#1)(2005-11#1)(2007-5#1)(2008-11#1)(2008-5#2)(2009-6#1)(2012-12#1)
recent years there has been a growing interest##3##8##(2006-7#1)(2008-1#1)(2010-2#1)
recent years there has been a##5##6##(2006-7#1)(2007-11#1)(2008-1#1)(2008-2#1)(2010-2#1)
recent years there has been an increasing##2##7##(1992-8#1)(1993-5#1)
recent years there has been an##3##6##(1992-8#1)(1993-5#1)(2012-12#1)
recent years there has been##14##5##(1992-8#1)(1993-5#1)(2006-7#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#2)(2010-2#1)(2012-12#1)
recent years there have been##3##5##(1990-11#1)(2008-11#1)(2011-2#1)
recent years there##17##3##(1990-11#1)(1992-8#1)(1993-5#1)(2006-7#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2010-2#1)(2011-2#1)(2012-12#1)
recent years##468##2##(1990-11#3)(1990-5#1)(1990-7#1)(1991-12#4)(1991-2#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#2)(1992-11#2)(1992-2#2)(1992-6#2)(1992-8#1)(1993-1#2)(1993-10#2)(1993-11#3)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-10#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-4#1)(1995-5#3)(1996-1#2)(1996-11#2)(1996-12#2)(1996-2#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#2)(1997-7#3)(1997-8#1)(2005-1#1)(2005-10#4)(2005-11#4)(2005-2#1)(2005-4#1)(2005-5#1)(2005-6#1)(2005-7#3)(2005-8#6)(2005-9#4)(2006-1#1)(2006-10#15)(2006-11#4)(2006-12#3)(2006-2#2)(2006-4#3)(2006-5#3)(2006-6#2)(2006-7#2)(2006-8#8)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#10)(2007-12#5)(2007-2#3)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#11)(2007-8#9)(2007-9#1)(2008-1#12)(2008-10#18)(2008-11#14)(2008-12#5)(2008-2#6)(2008-3#9)(2008-4#5)(2008-5#11)(2008-6#1)(2008-7#21)(2008-8#6)(2008-9#8)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#2)(2010-1#2)(2010-12#14)(2010-2#4)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#5)(2010-8#5)(2010-9#1)(2011-1#9)(2011-12#4)(2011-2#18)(2011-3#5)(2011-7#1)(2012-1#5)(2012-11#2)(2012-12#11)(2012-2#9)(2012-3#12)(2013-1#16)(2013-7#2)(2013-8#12)
recent##3180##1##(1990-10#3)(1990-11#6)(1990-12#5)(1990-2#3)(1990-3#3)(1990-4#3)(1990-5#9)(1990-6#7)(1990-7#1)(1990-8#6)(1990-9#8)(1991-1#2)(1991-10#2)(1991-11#5)(1991-12#11)(1991-2#13)(1991-3#7)(1991-4#9)(1991-5#2)(1991-6#8)(1991-7#5)(1991-8#5)(1991-9#7)(1992-1#9)(1992-10#3)(1992-11#5)(1992-12#9)(1992-2#4)(1992-3#7)(1992-4#3)(1992-5#4)(1992-6#6)(1992-8#8)(1992-9#6)(1993-1#6)(1993-10#6)(1993-11#9)(1993-12#7)(1993-2#9)(1993-3#10)(1993-4#2)(1993-5#4)(1993-6#11)(1993-7#1)(1993-8#3)(1993-9#2)(1994-1#1)(1994-10#2)(1994-11#8)(1994-12#4)(1994-2#9)(1994-3#10)(1994-4#2)(1994-5#2)(1994-6#9)(1994-8#8)(1994-9#3)(1995-1#7)(1995-11#8)(1995-12#4)(1995-2#3)(1995-3#7)(1995-4#3)(1995-5#7)(1995-6#9)(1995-7#2)(1995-8#7)(1995-9#2)(1996-1#10)(1996-10#4)(1996-11#9)(1996-12#4)(1996-2#13)(1996-3#11)(1996-4#8)(1996-5#4)(1996-6#5)(1996-7#3)(1996-8#7)(1996-9#8)(1997-1#4)(1997-2#9)(1997-3#5)(1997-4#10)(1997-5#6)(1997-6#10)(1997-7#11)(1997-8#11)(2003-11#1)(2004-1#2)(2004-10#1)(2004-11#5)(2004-12#5)(2004-2#1)(2004-3#1)(2004-8#1)(2004-9#1)(2005-1#2)(2005-10#14)(2005-11#12)(2005-12#1)(2005-2#3)(2005-3#2)(2005-4#1)(2005-5#1)(2005-6#4)(2005-7#24)(2005-8#36)(2005-9#12)(2006-1#4)(2006-10#226)(2006-11#15)(2006-12#13)(2006-2#15)(2006-3#6)(2006-4#8)(2006-5#17)(2006-6#16)(2006-7#15)(2006-8#22)(2006-9#21)(2007-1#8)(2007-10#17)(2007-11#62)(2007-12#61)(2007-2#26)(2007-3#13)(2007-4#18)(2007-5#19)(2007-6#20)(2007-7#31)(2007-8#63)(2007-9#29)(2008-1#95)(2008-10#135)(2008-11#83)(2008-12#11)(2008-2#36)(2008-3#64)(2008-4#52)(2008-5#67)(2008-6#18)(2008-7#98)(2008-8#68)(2008-9#41)(2009-1#3)(2009-10#19)(2009-11#10)(2009-12#14)(2009-2#18)(2009-3#18)(2009-4#18)(2009-5#26)(2009-6#16)(2009-7#13)(2009-8#52)(2009-9#10)(2010-1#10)(2010-10#3)(2010-11#19)(2010-12#67)(2010-2#21)(2010-3#11)(2010-4#17)(2010-5#28)(2010-6#15)(2010-7#22)(2010-8#22)(2010-9#10)(2011-1#61)(2011-12#11)(2011-2#111)(2011-3#9)(2011-7#4)(2012-1#26)(2012-11#11)(2012-12#55)(2012-2#60)(2012-3#49)(2012-5#1)(2012-8#1)(2013-1#85)(2013-7#12)(2013-8#46)
recent-onset##6##1##(2005-12#1)(2007-5#1)(2007-7#1)(2008-11#2)(2008-8#1)
recently a##3##2##(2007-3#1)(2008-12#1)(2011-2#1)
recently accumulated##2##2##(1991-9#1)(2010-3#1)
recently acquired##6##2##(1990-5#1)(2008-2#1)(2008-4#1)(2009-8#1)(2011-2#1)(2012-12#1)
recently added##2##2##(2008-11#1)(2008-12#1)
recently adopted by the##2##4##(1992-2#1)(1995-12#1)
recently adopted##4##2##(1992-2#1)(1994-2#1)(1995-12#1)(2012-11#1)
recently also##3##2##(1991-9#1)(2009-5#1)(2012-12#1)
recently an##2##2##(2011-2#1)(2012-12#1)
recently analyzed##2##2##(2008-9#1)(2009-8#1)
recently and presented##2##3##(1993-6#1)(2008-3#1)
recently and##12##2##(1992-3#1)(1993-3#1)(1993-6#1)(1994-9#1)(2007-1#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#2)(2009-12#1)
recently applied to##2##3##(2009-6#1)(2010-7#1)
recently appointed##2##2##(1997-6#1)(2008-11#1)
recently approved for the##2##4##(2006-10#1)(2008-5#1)
recently approved for##5##3##(1992-8#1)(1996-7#1)(2006-10#1)(2008-4#1)(2008-5#1)
recently approved##19##2##(1992-8#1)(1996-7#1)(2005-6#1)(2006-10#3)(2007-11#2)(2007-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#2)(2009-4#1)(2010-12#1)(2011-2#1)
recently arrived##2##2##(2008-12#1)(2012-12#1)
recently as a##7##3##(1995-8#1)(2004-11#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-7#1)(2009-10#1)
recently as the##2##3##(2008-10#1)(2011-1#1)
recently as##13##2##(1990-10#1)(1994-1#1)(1995-6#1)(1995-8#1)(2004-11#1)(2006-6#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-10#1)(2011-1#1)
recently available data##3##3##(1992-3#1)(1993-2#1)(2009-10#1)
recently available##6##2##(1992-3#1)(1993-2#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-10#1)
recently became##2##2##(2006-6#1)(2009-7#1)
recently become widespread##2##3##(2005-8#1)(2011-2#1)
recently become##15##2##(1992-8#1)(1993-1#1)(1993-3#1)(1996-6#1)(2005-8#1)(2006-2#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)
recently been adapted##2##3##(2007-7#1)(2008-4#1)
recently been approved by the##2##5##(2007-11#1)(2008-6#1)
recently been approved for use in##2##6##(2007-11#1)(2007-7#1)
recently been approved for use##3##5##(2007-11#2)(2007-7#1)
recently been approved##6##3##(2007-11#3)(2007-7#1)(2008-6#1)(2011-2#1)
recently been associated with##4##4##(1995-2#1)(2006-9#1)(2007-8#1)(2013-8#1)
recently been challenged by##2##4##(2006-10#1)(2008-5#1)
recently been challenged##3##3##(2006-10#2)(2008-5#1)
recently been characterized##6##3##(1991-12#1)(1991-6#1)(1992-11#1)(1995-6#1)(2009-10#1)(2011-1#1)
recently been cloned and sequenced##2##5##(1991-12#1)(2006-2#1)
recently been cloned and##5##4##(1991-12#1)(1993-3#1)(1993-9#1)(1995-10#1)(2006-2#1)
recently been cloned##7##3##(1991-12#1)(1992-8#1)(1993-3#1)(1993-9#1)(1995-10#1)(1997-7#1)(2006-2#1)
recently been completed##2##3##(2008-7#1)(2010-12#1)
recently been demonstrated in##2##4##(1993-9#1)(2012-2#1)
recently been demonstrated to##3##4##(1991-6#1)(2008-1#1)(2008-6#1)
recently been demonstrated##7##3##(1991-11#1)(1991-6#1)(1993-9#1)(2008-1#1)(2008-2#1)(2008-6#1)(2012-2#1)
recently been described as##2##4##(1990-7#1)(2012-3#1)
recently been described##9##3##(1990-5#1)(1990-7#2)(1992-9#1)(2005-12#1)(2006-10#1)(2010-12#1)(2012-3#1)(2013-1#1)
recently been developed to##3##4##(2008-2#1)(2008-3#1)(2010-12#1)
recently been developed##12##3##(2006-10#1)(2007-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
recently been discovered##2##3##(2008-5#1)(2013-7#1)
recently been documented##2##3##(2006-7#1)(2007-5#1)
recently been explored##2##3##(1997-6#1)(2006-10#1)
recently been found to be##2##5##(2005-11#1)(2008-10#1)
recently been found to##4##4##(2005-11#1)(2008-10#1)(2009-8#1)(2012-12#1)
recently been found##8##3##(1995-5#1)(2005-11#2)(2007-8#1)(2008-10#1)(2009-4#1)(2009-8#1)(2012-12#1)
recently been identified as a##4##5##(1994-11#1)(1994-12#1)(1995-2#1)(2008-5#1)
recently been identified as##8##4##(1994-11#1)(1994-12#1)(1995-2#1)(1996-10#1)(1996-2#1)(2007-2#1)(2008-5#1)(2012-1#1)
recently been identified in##3##4##(1994-9#1)(1996-5#1)(2013-1#1)
recently been identified##18##3##(1990-8#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-2#1)(1996-10#1)(1996-2#1)(1996-5#1)(2004-12#1)(2006-10#2)(2007-2#1)(2008-11#1)(2008-5#1)(2012-1#1)(2013-1#1)
recently been implicated in##5##4##(1994-3#1)(2007-2#1)(2008-10#1)(2010-12#1)(2011-2#1)
recently been introduced as a##2##5##(1996-8#1)(2008-7#1)
recently been introduced for##2##4##(1994-2#1)(2007-11#1)
recently been introduced##7##3##(1994-2#1)(1996-1#1)(1996-8#1)(2006-12#1)(2007-11#1)(2008-7#1)(2012-2#1)
recently been investigated##2##3##(2011-1#1)(2012-4#1)
recently been made##4##3##(1993-1#1)(1993-3#1)(2010-6#1)(2011-1#1)
recently been observed##2##3##(2008-10#1)(2012-2#1)
recently been performed##3##3##(1991-9#1)(2006-11#1)(2008-7#1)
recently been proposed##9##3##(1991-2#1)(1994-6#1)(1995-12#1)(1997-6#1)(2007-12#1)(2008-2#1)(2013-1#3)
recently been reported in##2##4##(2008-5#1)(2009-8#1)
recently been reported that##2##4##(1990-4#1)(2006-12#1)
recently been reported to##4##4##(1991-6#1)(1991-7#1)(2007-11#1)(2010-11#1)
recently been reported##16##3##(1990-4#1)(1991-6#1)(1991-7#1)(1992-5#1)(1992-8#1)(1993-3#1)(1994-5#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-11#1)(2011-2#1)
recently been shown to be a##2##6##(2006-10#1)(2008-8#1)
recently been shown to be##12##5##(1992-8#1)(1995-2#1)(1996-4#1)(1996-6#1)(2006-10#1)(2006-9#1)(2007-8#1)(2008-3#1)(2008-8#1)(2009-5#1)(2012-2#1)(2013-1#1)
recently been shown to possess##2##5##(1991-5#1)(1996-9#1)
recently been shown to##30##4##(1990-12#1)(1991-5#1)(1992-8#1)(1993-8#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-4#1)(1996-6#1)(1996-9#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#3)(2008-5#3)(2008-8#1)(2009-3#1)(2009-5#1)(2010-11#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
recently been shown##36##3##(1990-12#1)(1991-10#1)(1991-5#1)(1992-8#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-4#1)(1996-6#1)(1996-9#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#3)(2008-5#3)(2008-8#1)(2009-3#1)(2009-5#1)(2010-11#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
recently been studied##3##3##(1997-6#1)(2008-11#1)(2011-1#1)
recently been suggested##6##3##(1990-3#1)(1993-4#1)(1994-12#1)(1997-1#1)(2010-12#1)(2013-1#1)
recently been used in##2##4##(2008-12#1)(2009-7#1)
recently been used##4##3##(2006-9#1)(2008-12#1)(2008-7#1)(2009-7#1)
recently been##269##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-5#1)(1991-6#4)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#4)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#6)(1993-4#1)(1993-8#1)(1993-9#3)(1994-11#2)(1994-12#5)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-6#3)(1997-7#3)(1997-8#2)(2004-12#1)(2005-10#1)(2005-11#2)(2005-12#3)(2005-7#2)(2005-8#1)(2006-10#11)(2006-11#1)(2006-12#2)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#3)(2007-11#9)(2007-12#4)(2007-2#2)(2007-5#1)(2007-7#3)(2007-8#4)(2008-1#2)(2008-10#8)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#4)(2008-5#9)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#2)(2010-11#5)(2010-12#6)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#4)(2011-2#5)(2012-1#2)(2012-10#1)(2012-11#1)(2012-12#5)(2012-2#9)(2012-3#2)(2012-4#1)(2013-1#10)(2013-7#2)(2013-8#1)
recently begun to##2##3##(2008-1#1)(2008-9#1)
recently begun##4##2##(2008-1#1)(2008-11#1)(2008-9#1)(2013-8#1)
recently by the##3##3##(1992-12#1)(2005-11#1)(2012-2#1)
recently by##5##2##(1992-12#1)(2005-11#1)(2006-10#1)(2008-2#1)(2012-2#1)
recently changed##3##2##(1993-2#1)(1996-12#1)(2009-10#1)
recently characterized the##2##3##(2004-1#1)(2009-8#1)
recently characterized##11##2##(1990-7#1)(1992-7#1)(1993-3#1)(1995-3#2)(1996-6#1)(2004-1#1)(2008-10#1)(2009-8#2)(2011-2#1)
recently cloned from##3##3##(1997-2#1)(1997-7#1)(2008-10#1)
recently cloned the rat##2##4##(1992-11#1)(2008-5#1)
recently cloned the##6##3##(1992-11#2)(1994-2#1)(1994-5#1)(1995-10#1)(2008-5#1)
recently cloned##22##2##(1990-12#1)(1991-9#1)(1992-11#2)(1992-6#1)(1992-8#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-8#2)(1996-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)
recently come##2##2##(2008-4#1)(2009-8#1)
recently completed a##3##3##(1996-11#1)(1997-2#1)(2007-7#1)
recently completed##14##2##(1994-7#1)(1995-6#1)(1996-1#1)(1996-11#1)(1997-2#1)(2004-10#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-7#1)(2010-11#1)(2010-5#1)
recently conducted##3##2##(1997-4#1)(2006-10#1)(2010-3#1)
recently created##4##2##(1994-12#1)(2007-7#1)(2011-2#1)(2012-3#1)
recently deceased##2##2##(1990-4#1)(1993-2#1)
recently defined##5##2##(1997-7#1)(2008-2#1)(2008-5#1)(2009-3#1)(2012-3#1)
recently demonstrated in##4##3##(1994-12#1)(2008-11#2)(2008-2#1)
recently demonstrated that a##2##4##(2008-3#1)(2009-8#1)
recently demonstrated that##21##3##(1990-2#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-10#1)(1995-2#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-8#5)(2010-11#1)(2010-3#1)(2010-7#1)(2011-1#1)
recently demonstrated the##3##3##(2008-2#1)(2008-5#1)(2012-2#1)
recently demonstrated##35##2##(1990-2#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-10#1)(1995-2#1)(1996-5#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#6)(2010-11#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
recently derived##3##2##(2008-8#2)(2011-12#1)
recently described S##2##3##(2008-10#1)(2009-6#1)
recently described a##4##3##(1990-11#1)(1991-12#1)(1995-1#1)(1996-9#1)
recently described an##3##3##(1990-8#1)(1994-5#1)(2011-2#1)
recently described by##2##3##(2006-12#1)(2012-12#1)
recently described in the##2##4##(1991-11#1)(2008-11#1)
recently described in##4##3##(1990-11#1)(1991-11#1)(2008-11#1)(2010-10#1)
recently described##63##2##(1990-11#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-7#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-6#1)(2005-3#1)(2006-10#1)(2006-12#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-4#1)(2008-5#2)(2008-6#1)(2009-6#1)(2010-10#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#1)
recently designed##2##2##(1991-6#1)(2010-6#1)
recently detected##4##2##(1990-5#1)(2006-4#1)(2008-10#1)(2012-2#1)
recently determined##7##2##(1990-5#1)(1995-12#1)(1996-12#1)(1997-3#1)(1997-4#1)(2007-9#1)(2012-2#1)
recently detoxified##2##2##(1996-7#2)
recently developed a##6##3##(1996-7#1)(2008-11#1)(2008-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
recently developed an##3##3##(1994-2#1)(2008-3#1)(2011-1#1)
recently developed and##4##3##(2006-11#1)(2008-3#2)(2008-5#1)
recently developed at##2##3##(2007-5#1)(2008-3#1)
recently developed by##4##3##(1993-11#1)(2008-10#1)(2008-3#1)(2011-2#1)
recently developed computer-based##2##3##(2007-6#1)(2008-9#1)
recently developed for the##2##4##(1994-6#1)(2008-3#1)
recently developed for##6##3##(1992-6#1)(1994-6#1)(2008-11#2)(2008-3#1)(2009-9#1)
recently developed in our##3##4##(1990-3#1)(2012-12#2)
recently developed method##4##3##(1997-4#1)(2008-10#1)(2008-3#2)
recently developed methods for##2##4##(2008-7#1)(2012-3#1)
recently developed methods##4##3##(1996-2#1)(2008-7#1)(2012-3#2)
recently developed statistical##2##3##(1996-3#1)(2008-10#1)
recently developed technique of##3##4##(2006-12#1)(2007-12#2)
recently developed technique##4##3##(2006-12#1)(2007-12#2)(2008-9#1)
recently developed to##4##3##(2007-12#1)(2007-8#1)(2008-4#1)(2009-5#1)
recently developed##134##2##(1990-3#1)(1990-5#1)(1991-1#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-6#2)(1993-11#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-4#2)(2006-9#2)(2007-12#6)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#5)(2008-10#7)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#13)(2008-4#6)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-5#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#8)(2013-8#2)
recently diagnosed with##3##3##(2008-10#1)(2009-9#1)(2010-3#1)
recently diagnosed##13##2##(1994-12#1)(1994-2#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-4#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-2#1)
recently disclosed##2##2##(2005-8#1)(2008-1#1)
recently discovered endogenous##2##3##(1992-6#1)(1995-10#1)
recently discovered in##2##3##(1997-3#1)(2013-1#1)
recently discovered that the##4##4##(1990-6#1)(2009-6#1)(2011-2#2)
recently discovered that##6##3##(1990-6#1)(2008-8#1)(2009-6#1)(2010-7#1)(2011-2#2)
recently discovered##50##2##(1990-3#2)(1990-5#1)(1990-6#1)(1991-12#1)(1991-5#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-4#1)(1996-6#1)(1997-3#1)(2005-11#2)(2006-2#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
recently diverged##3##2##(2008-10#1)(2010-6#1)(2013-1#1)
recently documented in##2##3##(2009-8#1)(2010-10#1)
recently emerged as an##2##4##(2008-11#1)(2010-9#1)
recently emerged as##11##3##(1996-2#1)(2004-12#1)(2008-11#2)(2008-3#1)(2010-11#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
recently emerged##18##2##(1996-2#1)(2004-12#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-11#1)(2010-3#1)(2010-9#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#1)
recently employed##2##2##(2009-12#1)(2011-2#1)
recently enacted##2##2##(1991-2#2)
recently encountered##4##2##(1995-4#1)(2006-10#1)(2008-10#1)(2008-6#1)
recently entered##3##2##(2006-10#1)(2008-1#1)(2013-1#1)
recently established by##2##3##(1996-7#1)(2008-3#1)
recently established##12##2##(1994-12#1)(1996-7#1)(1997-4#1)(1997-7#1)(2006-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-8#1)(2010-8#1)
recently evolved##5##2##(1997-4#1)(2008-10#3)(2011-2#1)
recently experienced##4##2##(1991-10#1)(2005-6#1)(2009-7#1)(2010-7#1)
recently explored##3##2##(2008-4#1)(2013-1#2)
recently exposed##2##2##(2008-9#1)(2009-3#1)
recently fabricated##2##2##(2007-11#1)(2008-3#1)
recently for the treatment of##2##5##(2007-11#1)(2008-11#1)
recently for the##3##3##(2005-11#1)(2007-11#1)(2008-11#1)
recently for##11##2##(2005-11#1)(2007-11#2)(2008-11#1)(2008-2#2)(2008-7#2)(2010-6#1)(2013-1#1)(2013-7#1)
recently found in##4##3##(1995-11#1)(1997-7#1)(2008-10#1)(2008-5#1)
recently found that the##2##4##(1990-12#1)(2008-5#1)
recently found that##11##3##(1990-12#1)(1990-7#1)(1991-12#1)(1991-7#1)(1992-4#1)(1993-11#1)(1994-12#1)(1994-3#1)(2008-5#1)(2010-12#1)(2011-2#1)
recently found to be##3##4##(1992-3#1)(1994-11#1)(2006-10#1)
recently found to##5##3##(1992-3#1)(1994-11#1)(1996-2#1)(2006-10#1)(2012-12#1)
recently found##22##2##(1990-12#1)(1990-7#1)(1991-12#1)(1991-7#1)(1992-3#1)(1992-4#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-11#1)(1996-2#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2010-12#1)(2011-2#1)(2012-12#1)
recently gained a##2##3##(2008-10#1)(2008-5#1)
recently gained##8##2##(1997-4#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-5#1)(2012-2#1)
recently generated##3##2##(1995-2#1)(2009-10#1)(2009-8#1)
recently had##4##2##(2009-3#1)(2010-12#1)(2010-6#1)(2013-7#1)
recently has been##6##3##(2005-10#1)(2007-11#1)(2007-12#1)(2011-7#1)(2013-7#1)(2013-8#1)
recently has the##2##3##(2006-2#1)(2012-1#1)
recently has##14##2##(1994-11#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-9#1)(2010-12#1)(2011-7#1)(2012-1#1)(2013-7#1)(2013-8#1)
recently have been##4##3##(2006-10#1)(2008-10#1)(2008-8#1)(2010-8#1)
recently have##15##2##(1991-3#1)(2006-10#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2013-7#1)(2013-8#1)
recently homeless veterans##2##3##(2007-5#2)
recently identified a##4##3##(1993-11#1)(1994-2#1)(1994-9#1)(2008-8#1)
recently identified as a##6##4##(1990-11#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-9#1)(2011-1#1)
recently identified as the##3##4##(1994-11#1)(1997-5#1)(2008-5#1)
recently identified as##12##3##(1990-11#1)(1994-11#2)(1996-12#1)(1996-8#1)(1997-4#1)(1997-5#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-1#1)
recently identified in porcine brain##2##5##(1990-7#1)(1991-3#1)
recently identified in the##3##4##(1991-5#1)(1994-11#1)(2011-1#1)
recently identified in##7##3##(1990-7#1)(1991-3#1)(1991-5#1)(1992-5#1)(1994-11#1)(1996-11#1)(2011-1#1)
recently identified tumor##2##3##(1994-6#1)(2008-5#1)
recently identified##63##2##(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#1)(1991-3#1)(1991-5#1)(1992-5#1)(1993-11#2)(1993-6#1)(1994-11#3)(1994-2#1)(1994-6#1)(1994-9#2)(1995-3#1)(1995-6#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-10#3)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#2)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
recently implemented##4##2##(1990-10#1)(2008-3#1)(2013-1#2)
recently improved##2##2##(2006-12#1)(2007-11#1)
recently in the##9##3##(1993-3#1)(1994-3#1)(1994-8#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2011-1#1)
recently in##25##2##(1990-11#1)(1991-12#1)(1993-3#1)(1994-3#1)(1994-8#1)(1997-3#1)(2005-7#1)(2006-10#2)(2006-2#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2011-1#1)(2012-11#1)(2012-12#1)
recently increased##6##2##(1991-3#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-7#1)(2008-6#1)
recently integrated##2##2##(2008-12#1)(2008-7#1)
recently introduced##37##2##(1990-6#1)(1991-9#1)(1992-2#1)(1992-4#1)(1996-3#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)
recently investigated##2##2##(2009-8#1)(2010-3#1)
recently is##2##2##(1993-3#1)(1997-6#1)
recently isolated from rat and human##2##6##(1995-5#1)(2006-10#1)
recently isolated from##4##3##(1992-6#1)(1994-12#1)(1995-5#1)(2006-10#1)
recently isolated viruses##2##3##(2013-8#2)
recently isolated##16##2##(1990-2#1)(1991-2#1)(1991-8#1)(1992-6#1)(1994-12#2)(1995-12#2)(1995-5#2)(2006-10#1)(2008-5#1)(2009-8#1)(2012-2#1)(2013-8#2)
recently issued##2##2##(2008-1#1)(2009-11#1)
recently it has been##2##4##(1990-9#1)(2008-4#1)
recently it has##3##3##(1990-9#1)(1997-8#1)(2008-4#1)
recently it##6##2##(1990-9#1)(1997-8#1)(2007-9#1)(2008-4#1)(2008-8#1)(2011-2#1)
recently joined##2##2##(1991-1#1)(2011-2#1)
recently laid##2##2##(1996-11#1)(2008-5#1)
recently led to the##2##4##(1995-5#1)(2008-5#1)
recently led to##4##3##(1995-5#1)(2007-6#1)(2008-5#1)(2011-2#1)
recently licensed##2##2##(2008-3#1)(2011-2#1)
recently made in##2##3##(2007-7#1)(2007-8#1)
recently made##6##2##(1992-6#1)(1997-2#1)(2005-7#1)(2007-7#1)(2007-8#1)(2008-11#1)
recently mapped the##2##3##(1996-8#1)(2008-7#1)
recently mapped##5##2##(1994-12#1)(1996-8#1)(2006-10#1)(2007-7#1)(2008-7#1)
recently marketed##3##2##(2007-11#2)(2009-2#1)
recently observed in##2##3##(2008-10#1)(2008-3#1)
recently observed that##5##3##(1990-5#1)(1994-10#1)(1997-7#1)(2008-10#1)(2011-12#1)
recently observed##12##2##(1990-5#1)(1992-9#1)(1993-9#1)(1994-10#1)(1996-4#1)(1997-7#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2011-12#1)
recently obtained##5##2##(2005-11#1)(2007-11#1)(2008-2#1)(2009-3#1)(2011-2#1)
recently on##3##2##(1995-9#1)(1997-2#1)(2007-8#1)
recently patented##3##2##(2008-1#3)
recently predicted##4##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)
recently presented with##2##3##(2007-8#1)(2010-6#1)
recently presented##7##2##(2007-8#2)(2008-3#2)(2008-7#1)(2009-8#1)(2010-6#1)
recently progressed##2##2##(2007-11#1)(2013-7#1)
recently proposed and##3##3##(2007-8#1)(2008-2#2)
recently proposed as a##2##4##(1997-8#1)(2013-7#1)
recently proposed as##4##3##(1991-10#1)(1995-12#1)(1997-8#1)(2013-7#1)
recently proposed by the##3##4##(2006-11#1)(2008-3#1)(2011-1#1)
recently proposed by##8##3##(1995-11#1)(2005-11#1)(2006-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2011-1#1)
recently proposed for##5##3##(2008-10#2)(2010-8#1)(2012-2#1)(2012-3#1)
recently proposed method of##2##4##(2007-12#1)(2008-2#1)
recently proposed method##4##3##(2007-12#1)(2008-2#1)(2008-7#2)
recently proposed rare variant methods##2##5##(2012-3#2)
recently proposed simplified##2##3##(2005-11#1)(2008-10#1)
recently proposed that the##2##4##(2008-10#1)(2008-11#1)
recently proposed that##5##3##(1991-6#1)(2006-5#1)(2008-10#1)(2008-11#1)(2009-8#1)
recently proposed to##2##3##(1990-8#1)(2012-3#1)
recently proposed##69##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-5#2)(1994-9#1)(1995-11#1)(1995-12#2)(1996-11#1)(1997-8#1)(2005-11#2)(2006-10#2)(2006-11#1)(2006-5#1)(2007-11#1)(2007-12#5)(2007-8#2)(2008-10#9)(2008-11#1)(2008-2#8)(2008-3#4)(2008-5#2)(2008-7#3)(2009-8#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#4)(2013-1#2)(2013-7#1)
recently provided##3##2##(1994-4#1)(1995-12#1)(2007-7#1)
recently published articles##2##3##(2006-10#2)
recently published data##5##3##(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
recently published findings##2##3##(2007-12#1)(2012-2#1)
recently published in##2##3##(1995-2#1)(2010-5#1)
recently published model##2##3##(2008-3#1)(2012-3#1)
recently published studies##4##3##(2006-8#1)(2007-8#1)(2008-12#1)(2012-3#1)
recently published##66##2##(1992-12#1)(1992-4#1)(1992-6#1)(1993-3#1)(1994-12#1)(1995-2#1)(1996-1#1)(1996-8#1)(2004-10#1)(2005-11#1)(2005-8#1)(2006-10#6)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#4)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#1)(2009-8#3)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#3)
recently purified##5##2##(1991-1#2)(1991-2#1)(1992-12#1)(1993-9#1)
recently reached the##2##3##(2005-7#1)(2006-10#1)
recently reached##3##2##(2005-7#1)(2006-10#1)(2008-10#1)
recently received##7##2##(1992-1#1)(1992-12#1)(2006-10#1)(2007-9#1)(2008-11#2)(2010-10#1)
recently recognised##2##2##(2007-11#1)(2007-7#1)
recently recognized##3##2##(1994-9#1)(2008-11#1)(2009-3#1)
recently released##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
recently removed##2##2##(2006-10#1)(2007-2#1)
recently reported for##2##3##(1991-6#1)(2009-8#1)
recently reported from##3##3##(1992-9#1)(1995-11#1)(1995-12#1)
recently reported in the##2##4##(1991-4#1)(2012-2#1)
recently reported in##6##3##(1990-11#1)(1991-4#1)(2007-8#1)(2008-5#1)(2008-7#1)(2012-2#1)
recently reported on the##2##4##(2007-8#1)(2008-11#1)
recently reported on##3##3##(2007-8#1)(2008-11#1)(2011-2#1)
recently reported that the##5##4##(1993-6#1)(1994-12#1)(1995-6#1)(2008-2#1)(2013-8#1)
recently reported that##22##3##(1990-11#1)(1990-7#1)(1992-6#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-3#1)(1997-6#1)(2006-10#1)(2008-2#1)(2008-8#1)(2009-8#3)(2012-2#1)(2013-8#1)
recently reported the##8##3##(1991-2#1)(1991-8#1)(1995-8#1)(2008-8#1)(2009-8#2)(2010-5#1)(2013-1#1)
recently reported##90##2##(1990-11#2)(1990-7#1)(1991-1#1)(1991-2#2)(1991-4#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#3)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-6#2)(2005-8#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-12#3)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-8#6)(2009-9#1)(2010-1#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#1)(2013-8#2)
recently revealed that##2##3##(1992-11#1)(2008-8#1)
recently reviewed##2##2##(2008-2#1)(2008-5#1)
recently revised##6##2##(1994-5#1)(2005-11#1)(2008-5#1)(2009-4#1)(2012-2#1)(2013-1#1)
recently revived##2##2##(2008-10#1)(2012-3#1)
recently seen##3##2##(1990-6#1)(1991-11#1)(2012-3#1)
recently set##2##2##(2008-11#1)(2011-1#1)
recently showed that##6##3##(1994-2#1)(1997-4#1)(2006-12#1)(2008-10#1)(2009-2#1)(2010-4#1)
recently shown that the##3##4##(1990-10#1)(2008-11#1)(2009-5#1)
recently shown that##27##3##(1990-10#1)(1990-5#1)(1992-9#1)(1993-12#1)(1994-5#1)(1995-2#1)(1996-10#1)(1996-5#2)(1996-8#1)(1997-4#1)(1997-6#1)(2008-1#2)(2008-10#1)(2008-11#1)(2009-5#1)(2009-8#7)(2011-2#2)(2013-8#1)
recently shown to be##8##4##(1993-12#1)(1994-5#1)(1997-1#1)(2005-11#1)(2008-4#1)(2009-4#1)(2009-8#1)(2013-8#1)
recently shown to##19##3##(1991-5#1)(1991-8#1)(1993-12#2)(1993-3#1)(1994-5#1)(1997-1#1)(2005-11#1)(2005-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#2)(2009-4#1)(2009-8#1)(2013-8#1)
recently shown##49##2##(1990-10#1)(1990-5#1)(1990-9#1)(1991-5#1)(1991-8#1)(1992-9#1)(1993-12#3)(1993-3#1)(1994-5#2)(1995-2#1)(1996-10#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-4#1)(1997-6#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-10#2)(2009-4#1)(2009-5#2)(2009-8#8)(2011-2#2)(2013-8#2)
recently started##2##2##(2008-7#1)(2012-2#1)
recently studied##2##2##(1993-6#1)(2011-2#1)
recently studies have##2##3##(2008-3#1)(2008-7#1)
recently suggested by##3##3##(2008-5#3)
recently suggested that##3##3##(1995-1#1)(1995-8#1)(2008-10#1)
recently suggested to##2##3##(2008-8#1)(2010-12#1)
recently suggested##9##2##(1995-1#1)(1995-8#1)(2007-4#1)(2008-10#1)(2008-5#3)(2008-8#1)(2010-12#1)
recently summarized in##2##3##(2008-10#1)(2009-4#1)
recently synthesized 1##2##3##(2008-10#2)
recently synthesized##17##2##(1990-11#1)(1995-6#1)(2008-10#14)(2008-2#1)
recently taken##2##2##(1991-1#1)(1997-3#1)
recently tested##2##2##(1991-6#1)(2009-8#1)
recently that the##3##3##(1997-4#1)(2006-12#1)(2012-2#1)
recently that##14##2##(1994-3#1)(1995-12#1)(1997-4#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-6#1)(2012-2#1)(2013-1#1)
recently the##7##2##(1996-6#1)(2006-7#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#1)
recently there has been##3##4##(2009-4#1)(2012-1#1)(2013-1#1)
recently these##2##2##(2004-9#1)(2009-2#1)
recently this##4##2##(1994-6#1)(1995-2#1)(2010-8#1)(2013-1#1)
recently to be##3##3##(1992-3#1)(1997-4#1)(2008-8#1)
recently to measure##2##3##(2008-4#1)(2012-1#1)
recently to the##2##3##(2008-10#2)
recently to##13##2##(1992-3#1)(1993-2#1)(1997-4#1)(1997-6#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2012-1#1)
recently treated##2##2##(2008-6#1)(2010-5#1)
recently two##2##2##(2008-10#1)(2008-4#1)
recently under##3##2##(2006-10#1)(2008-10#2)
recently undergone##6##2##(1995-3#1)(1996-3#1)(2006-10#1)(2007-12#1)(2008-6#1)(2009-12#1)
recently updated##4##2##(2005-8#1)(2008-4#1)(2011-2#1)(2012-1#1)
recently used##7##2##(1995-12#1)(2006-12#1)(2008-10#1)(2009-8#1)(2010-7#1)(2012-3#1)(2013-8#1)
recently utilized##3##2##(2008-10#1)(2008-12#1)(2008-9#1)
recently was found##2##3##(2004-3#1)(2010-4#1)
recently was##3##2##(1997-4#1)(2004-3#1)(2010-4#1)
recently we##3##2##(1995-3#1)(1996-6#1)(2008-8#1)
recently with the##3##3##(1993-3#1)(2006-10#1)(2008-8#1)
recently with##7##2##(1993-3#1)(2006-10#1)(2008-2#2)(2008-8#1)(2010-4#1)(2012-2#1)
recently yielded##2##2##(1993-9#1)(2012-1#1)
recently##2058##1##(1990-10#3)(1990-11#9)(1990-12#7)(1990-2#3)(1990-3#5)(1990-4#2)(1990-5#11)(1990-6#6)(1990-7#6)(1990-8#6)(1990-9#2)(1991-1#6)(1991-10#5)(1991-11#4)(1991-12#10)(1991-2#11)(1991-3#6)(1991-4#1)(1991-5#6)(1991-6#9)(1991-7#6)(1991-8#4)(1991-9#11)(1992-1#2)(1992-10#3)(1992-11#6)(1992-12#5)(1992-2#3)(1992-3#6)(1992-4#7)(1992-5#4)(1992-6#10)(1992-7#1)(1992-8#9)(1992-9#7)(1993-1#2)(1993-11#7)(1993-12#5)(1993-2#9)(1993-3#15)(1993-4#2)(1993-6#11)(1993-7#1)(1993-8#2)(1993-9#9)(1994-1#3)(1994-10#1)(1994-11#8)(1994-12#18)(1994-2#12)(1994-3#10)(1994-4#2)(1994-5#9)(1994-6#7)(1994-7#1)(1994-8#7)(1994-9#8)(1995-1#3)(1995-10#5)(1995-11#9)(1995-12#15)(1995-2#13)(1995-3#13)(1995-4#1)(1995-5#8)(1995-6#13)(1995-8#6)(1995-9#1)(1996-1#5)(1996-10#4)(1996-11#4)(1996-12#5)(1996-2#9)(1996-3#4)(1996-4#5)(1996-5#6)(1996-6#6)(1996-7#6)(1996-8#6)(1996-9#2)(1997-1#8)(1997-2#5)(1997-3#9)(1997-4#15)(1997-5#2)(1997-6#11)(1997-7#11)(1997-8#5)(1997-9#1)(2003-11#1)(2004-1#1)(2004-10#2)(2004-11#1)(2004-12#3)(2004-3#1)(2004-4#1)(2004-9#1)(2005-1#1)(2005-10#5)(2005-11#16)(2005-12#3)(2005-3#1)(2005-4#1)(2005-6#2)(2005-7#10)(2005-8#13)(2005-9#1)(2006-1#2)(2006-10#73)(2006-11#5)(2006-12#14)(2006-2#6)(2006-4#4)(2006-5#4)(2006-6#9)(2006-7#7)(2006-8#9)(2006-9#7)(2007-1#4)(2007-10#6)(2007-11#36)(2007-12#36)(2007-2#14)(2007-3#4)(2007-4#4)(2007-5#12)(2007-6#4)(2007-7#17)(2007-8#34)(2007-9#15)(2008-1#30)(2008-10#128)(2008-11#55)(2008-12#14)(2008-2#45)(2008-3#67)(2008-4#44)(2008-5#60)(2008-6#16)(2008-7#49)(2008-8#35)(2008-9#18)(2009-10#15)(2009-11#6)(2009-12#5)(2009-2#5)(2009-3#15)(2009-4#10)(2009-5#9)(2009-6#6)(2009-7#8)(2009-8#47)(2009-9#6)(2010-1#2)(2010-10#4)(2010-11#14)(2010-12#22)(2010-2#6)(2010-3#9)(2010-4#6)(2010-5#9)(2010-6#8)(2010-7#8)(2010-8#12)(2010-9#9)(2011-1#25)(2011-12#7)(2011-2#62)(2011-3#1)(2011-7#2)(2012-1#13)(2012-10#1)(2012-11#7)(2012-12#27)(2012-2#44)(2012-3#25)(2012-4#1)(2013-1#48)(2013-7#12)(2013-8#24)
recently)##2##1##(2006-10#1)(2013-1#1)
recently-developed##2##1##(1996-11#1)(2013-8#1)
recents##2##1##(1993-9#1)(2008-1#1)
receptacle area##8##2##(2008-10#8)
receptacle of##2##2##(2007-12#1)(2008-7#1)
receptacle##19##1##(1996-9#1)(2007-12#2)(2008-10#11)(2008-7#5)
receptacles##2##1##(2007-10#1)(2008-10#1)
reception and##2##2##(1994-6#1)(2009-6#1)
reception of the##3##3##(2008-11#1)(2008-2#1)(2012-2#1)
reception of##8##2##(2008-11#2)(2008-2#3)(2008-9#1)(2012-2#2)
reception##23##1##(1994-5#1)(1994-6#1)(1996-1#1)(2004-7#1)(2007-12#1)(2008-11#2)(2008-2#4)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#2)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)
receptive and expressive##5##3##(2007-9#3)(2011-1#1)(2012-2#1)
receptive area##2##2##(1996-1#2)
receptive female##7##2##(1993-7#2)(2008-11#1)(2009-6#1)(2013-8#3)
receptive field borders##2##3##(1990-4#2)
receptive field of##2##3##(1991-11#1)(1992-9#1)
receptive field properties##2##3##(1995-11#1)(2008-8#1)
receptive field##23##2##(1990-4#3)(1991-11#1)(1992-3#1)(1992-9#1)(1994-3#1)(1995-11#3)(1995-12#1)(1996-12#2)(1996-2#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-8#4)(2012-2#1)
receptive fields (RFs)##2##3##(1995-5#1)(1996-9#1)
receptive fields in area##2##4##(1995-11#1)(2008-8#1)
receptive fields in rat primary somatosensory cortex##2##7##(1991-11#1)(1996-1#1)
receptive fields in##7##3##(1991-11#1)(1994-2#1)(1995-11#1)(1995-12#2)(1996-1#1)(2008-8#1)
receptive fields of simple cells in the##2##7##(1996-2#1)(2008-11#1)
receptive fields of##6##3##(1995-12#2)(1996-1#1)(1996-2#1)(2007-12#1)(2008-11#1)
receptive fields##33##2##(1991-11#1)(1991-8#1)(1994-2#4)(1995-11#2)(1995-12#8)(1995-5#1)(1996-1#5)(1996-2#1)(1996-9#2)(2007-12#2)(2008-11#3)(2008-8#3)
receptive language##4##2##(2008-9#2)(2009-4#1)(2010-4#1)
receptive neurons in the##2##4##(1992-3#2)
receptive neurons##3##2##(1992-3#3)
receptive stage##4##2##(1994-9#4)
receptive to##7##2##(1991-6#1)(1996-11#1)(2004-3#1)(2007-4#1)(2008-10#1)(2010-11#1)(2012-12#1)
receptive##108##1##(1990-4#3)(1991-1#1)(1991-11#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-3#4)(1992-9#1)(1993-1#1)(1993-7#4)(1994-2#4)(1994-3#1)(1994-9#5)(1995-11#5)(1995-12#9)(1995-5#1)(1996-1#7)(1996-11#1)(1996-12#2)(1996-2#2)(1996-4#1)(1996-9#2)(1997-1#1)(2004-3#1)(2005-8#1)(2006-4#1)(2007-12#4)(2007-4#1)(2007-9#4)(2008-10#2)(2008-11#6)(2008-12#2)(2008-2#2)(2008-8#7)(2008-9#2)(2009-4#1)(2009-6#1)(2010-11#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#3)
receptivity is##2##2##(1994-9#1)(2009-6#1)
receptivity of##2##2##(2008-10#1)(2012-3#1)
receptivity##18##1##(1993-2#4)(1994-9#3)(2008-10#1)(2008-9#2)(2009-6#4)(2009-8#1)(2012-3#2)(2013-8#1)
receptor &quot##2##2##(1990-2#1)(1993-12#1)
receptor (AR)##17##2##(1990-11#2)(1990-8#1)(1992-5#1)(1993-7#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-7#1)(2004-1#1)(2011-2#3)(2012-12#1)
receptor (AT1R)##2##2##(2008-1#1)(2013-8#1)
receptor (AT2R)##2##2##(1994-9#1)(2013-8#1)
receptor (AhR)##5##2##(1993-11#1)(2008-10#3)(2009-3#1)
receptor (EGF-R)##6##2##(1992-9#1)(1994-8#2)(1994-9#1)(1995-6#1)(2005-7#1)
receptor (EGFR) and##5##3##(1992-8#1)(1995-11#1)(1996-3#1)(1997-7#1)(2012-1#1)
receptor (EGFR) was##3##3##(1991-12#1)(1992-12#2)
receptor (EGFR)##36##2##(1990-7#1)(1990-9#1)(1991-12#1)(1992-12#2)(1992-8#1)(1993-3#1)(1995-11#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-7#1)(2005-11#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#4)(2010-12#1)(2010-5#1)(2012-1#3)(2012-12#2)(2012-3#1)(2013-1#4)(2013-8#1)
receptor (EGFr)##2##2##(1992-8#1)(1994-9#1)
receptor (ER) and##5##3##(1995-4#1)(1996-11#1)(1997-7#1)(2008-11#1)(2011-2#1)
receptor (ER) content##2##3##(1993-1#1)(2007-10#1)
receptor (ER)##25##2##(1990-11#1)(1990-12#1)(1992-6#1)(1992-7#1)(1993-1#2)(1994-12#1)(1995-11#1)(1995-2#1)(1995-4#1)(1996-11#3)(1996-2#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-5#2)(2008-10#1)(2008-11#3)(2008-6#1)(2011-2#1)
receptor (FGFR)##5##2##(1994-8#1)(1995-10#1)(2007-12#1)(2009-7#1)(2012-12#1)
receptor (FR)##2##2##(2011-1#1)(2013-8#1)
receptor (GHR) and##2##3##(1995-8#1)(2008-4#1)
receptor (GHR) in##2##3##(2010-5#1)(2012-1#1)
receptor (GHR)##6##2##(1995-3#1)(1995-8#1)(2008-4#1)(2008-9#1)(2010-5#1)(2012-1#1)
receptor (GPCR)##3##2##(1996-2#1)(2008-4#1)(2008-7#1)
receptor (GR)##13##2##(1991-6#1)(1993-12#1)(1994-11#2)(1994-3#1)(1995-7#1)(1996-4#1)(1996-5#1)(1996-7#1)(2006-10#1)(2008-11#1)(2009-8#1)(2010-10#1)
receptor (GR)-mediated##2##2##(1991-6#1)(1994-11#1)
receptor (IP3R)##2##2##(1995-2#1)(1997-4#1)
receptor (Ki = 0##2##4##(1995-12#2)
receptor (Ki =##3##3##(1994-8#1)(1995-12#2)
receptor (LDLR)##2##2##(1995-2#1)(2013-1#1)
receptor (LHR)##3##2##(1991-9#1)(2008-8#2)
receptor (MR)##3##2##(1991-6#1)(1994-11#1)(1996-4#1)
receptor (NMDAR)##4##2##(1996-9#1)(2010-2#1)(2012-2#1)(2013-1#1)
receptor (PPAR) in##2##3##(1992-8#1)(2008-1#1)
receptor (PPAR)##7##2##(1992-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(2008-1#2)(2008-5#1)
receptor (PR)##4##2##(1995-11#1)(1996-5#1)(1997-7#1)(2007-5#1)
receptor (R)##2##2##(1996-5#1)(1997-7#1)
receptor (RXR) alpha##2##3##(1992-12#1)(1995-8#1)
receptor (RXR)##8##2##(1992-12#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-8#1)(2012-12#1)
receptor (TCR) and##2##3##(1991-10#1)(2011-1#1)
receptor (TCR) gene##4##3##(1990-11#1)(2007-2#1)(2009-8#1)(2010-7#1)
receptor (TCR) transgenic mice##2##4##(2008-11#2)
receptor (TCR) transgenic##3##3##(2008-11#2)(2009-9#1)
receptor (TCR)##27##2##(1990-11#1)(1990-9#1)(1991-10#1)(1991-12#1)(1992-5#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-7#1)(2004-12#1)(2007-2#2)(2008-11#3)(2008-4#3)(2009-10#1)(2009-8#1)(2009-9#1)(2010-7#1)(2011-1#1)(2012-3#1)
receptor (TCR)-mediated##2##2##(1994-6#1)(1995-3#1)
receptor (TR)##3##2##(1990-8#1)(1995-10#1)(1995-8#1)
receptor (V2R)##2##2##(1993-6#1)(1994-8#1)
receptor (VDR) and##3##3##(1996-3#1)(2010-7#1)(2012-12#1)
receptor (VDR)##16##2##(1992-12#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-2#1)(1996-3#1)(2005-11#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-7#1)(2012-12#3)(2012-2#1)
receptor (alpha##2##2##(1990-4#1)(1995-3#1)
receptor (and##2##2##(1990-3#1)(1993-6#1)
receptor (hGR)##2##2##(1995-10#1)(1995-3#1)
receptor (hIL-6R)##2##2##(2008-8#2)
receptor (mAChR)##2##2##(1995-7#1)(2008-8#1)
receptor (nAChR)##5##2##(1992-9#1)(1994-5#1)(1997-1#1)(1997-5#1)(2008-8#1)
receptor (type##2##2##(1994-9#1)(2006-10#1)
receptor (u-PAR)##2##2##(1993-12#1)(1993-3#1)
receptor (uPAR)##2##2##(1995-5#1)(1997-7#1)
receptor 1##10##2##(1992-2#1)(1995-2#1)(1997-1#1)(2006-11#1)(2008-11#1)(2009-4#1)(2012-2#1)(2013-1#2)(2013-8#1)
receptor 2##17##2##(1994-2#3)(2005-10#1)(2008-5#2)(2009-8#1)(2010-3#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-3#3)(2013-1#2)
receptor 3##9##2##(1992-8#1)(1996-5#1)(2008-3#2)(2009-9#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
receptor 4 as##2##3##(1997-7#1)(2010-11#1)
receptor 4##7##2##(1997-7#1)(2008-3#2)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#1)
receptor 5##4##2##(1994-12#2)(2012-2#2)
receptor 6##2##2##(1995-2#1)(2010-3#1)
receptor A##2##2##(1995-10#1)(2013-7#1)
receptor EP3 subtype##5##3##(1993-7#1)(1994-5#2)(1994-9#2)
receptor EP3##6##2##(1993-7#2)(1994-5#2)(1994-9#2)
receptor Flt-1##2##2##(2008-8#2)
receptor II##2##2##(1996-5#1)(2007-11#1)
receptor LIN-12##2##2##(1994-12#1)(2007-12#1)
receptor PD-1##2##2##(2011-1#1)(2012-3#1)
receptor TKs##2##2##(2012-12#2)
receptor V beta##3##3##(1990-12#2)(1994-12#1)
receptor accessory protein##2##3##(2011-1#1)(2013-1#1)
receptor action##3##2##(1997-5#1)(2011-2#1)(2013-8#1)
receptor activated by##3##3##(2008-4#3)
receptor activated##6##2##(1993-7#1)(1997-8#2)(2008-4#3)
receptor activates##2##2##(1996-5#1)(2008-7#1)
receptor activation by##4##3##(1990-5#1)(1994-6#1)(2008-10#1)(2008-4#1)
receptor activation in##5##3##(1993-4#1)(2007-8#1)(2008-4#2)(2011-2#1)
receptor activation is##7##3##(1991-3#3)(1993-8#1)(1994-2#1)(1996-12#1)(1997-2#1)
receptor activation may be##2##4##(1993-6#1)(1995-11#1)
receptor activation may##3##3##(1993-6#1)(1995-11#1)(1996-5#1)
receptor activation suppresses##2##3##(1990-2#1)(1997-2#1)
receptor activation##73##2##(1990-2#3)(1990-5#2)(1991-3#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-4#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#3)(1995-5#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#2)(1997-2#2)(1997-4#1)(1997-5#7)(2005-8#1)(2006-10#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#6)(2008-5#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-12#1)(2011-2#2)(2013-1#1)
receptor activator of nuclear factor kappa B ligand (RANKL)##2##9##(2011-1#2)
receptor activator of nuclear factor kappa B ligand##3##8##(2010-10#1)(2011-1#2)
receptor activator of nuclear factor kappaB ligand##2##7##(2005-3#1)(2010-10#1)
receptor activator of nuclear factor##6##5##(2005-3#1)(2007-8#1)(2010-10#2)(2011-1#2)
receptor activator of nuclear##8##4##(2005-3#1)(2007-8#1)(2008-7#1)(2010-10#3)(2011-1#2)
receptor activator of##11##3##(2005-3#1)(2007-8#1)(2008-11#2)(2008-7#1)(2010-10#3)(2011-1#2)(2013-1#1)
receptor activator##13##2##(1991-2#1)(2005-3#1)(2007-8#1)(2008-11#2)(2008-7#1)(2010-10#3)(2010-4#1)(2011-1#2)(2013-1#1)
receptor active##2##2##(1997-5#1)(2012-2#1)
receptor activities##2##2##(1996-3#1)(2008-10#1)
receptor activity and##3##3##(1992-12#1)(1994-8#1)(2008-4#1)
receptor activity##26##2##(1991-2#3)(1991-3#1)(1991-5#1)(1992-12#1)(1994-10#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-6#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-1#3)(2008-4#4)(2010-4#2)(2011-2#1)
receptor affinities##2##2##(1992-3#1)(1995-6#1)
receptor affinity and##3##3##(1994-5#1)(1996-8#1)(2008-11#1)
receptor affinity for##2##3##(1992-12#1)(1996-2#1)
receptor affinity in##2##3##(1997-2#1)(1997-5#1)
receptor affinity was##2##3##(1994-9#1)(2007-11#1)
receptor affinity##22##2##(1990-2#1)(1991-7#1)(1992-10#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-5#1)(1994-9#2)(1996-2#1)(1996-5#2)(1996-8#2)(1997-1#1)(1997-2#2)(1997-5#1)(2004-3#1)(2007-11#1)(2008-11#1)
receptor aggregation##3##2##(1991-3#2)(1993-8#1)
receptor agonism and##3##3##(1995-3#1)(2006-8#1)(2011-1#1)
receptor agonism##6##2##(1995-3#1)(1996-8#1)(1997-8#1)(2006-8#1)(2007-11#1)(2011-1#1)
receptor agonist 1S##2##3##(1993-11#1)(1995-12#1)
receptor agonist and##3##3##(1991-9#1)(2008-2#1)(2008-4#1)
receptor agonist for the##2##4##(2005-7#2)
receptor agonist in##2##3##(2005-7#1)(2012-12#1)
receptor agonist is##2##3##(1996-2#1)(2013-1#1)
receptor agonist on##2##3##(1997-5#1)(2012-2#1)
receptor agonist peptide##2##3##(1994-3#1)(1996-8#1)
receptor agonist sumatriptan##2##3##(1996-12#1)(2007-9#1)
receptor agonist##134##2##(1990-2#5)(1991-11#1)(1991-9#1)(1992-1#1)(1992-2#2)(1993-11#6)(1993-3#9)(1993-4#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-11#2)(1994-2#3)(1994-3#2)(1994-9#1)(1995-11#1)(1995-12#15)(1995-2#1)(1995-3#1)(1996-1#2)(1996-10#3)(1996-11#2)(1996-12#13)(1996-2#6)(1996-3#2)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#4)(1997-5#5)(1997-8#2)(2004-1#1)(2004-12#2)(2005-7#3)(2006-10#1)(2007-8#1)(2007-9#2)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-6#2)(2008-8#1)(2010-12#2)(2010-6#1)(2010-8#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
receptor agonist)##6##2##(1992-3#1)(1993-3#5)
receptor agonist-induced##3##2##(1992-9#1)(1993-11#1)(1996-2#1)
receptor agonistic##2##2##(1995-12#1)(2008-1#1)
receptor agonists and antagonists##6##4##(1990-2#1)(1991-5#1)(1996-12#1)(2004-12#1)(2008-4#1)(2009-7#1)
receptor agonists and##14##3##(1990-2#1)(1991-5#1)(1993-11#1)(1993-12#1)(1995-5#1)(1996-12#2)(1997-2#1)(2004-12#1)(2007-11#1)(2008-4#1)(2009-7#1)(2010-6#1)(2011-2#1)
receptor agonists can##2##3##(1993-11#1)(2008-4#1)
receptor agonists have##2##3##(2008-7#1)(2013-1#1)
receptor agonists in mice##2##4##(1993-11#1)(1993-3#1)
receptor agonists in##8##3##(1993-11#2)(1993-3#1)(1996-2#1)(1996-5#1)(1997-5#1)(1997-7#1)(2010-2#1)
receptor agonists on food intake##2##5##(1992-2#2)
receptor agonists on the##3##4##(1990-2#1)(1995-12#1)(2008-12#1)
receptor agonists on##8##3##(1990-2#1)(1992-2#2)(1992-9#1)(1995-12#2)(1995-3#1)(2008-12#1)
receptor agonists or##2##3##(1990-3#1)(1996-5#1)
receptor agonists to##2##3##(1990-7#1)(2008-7#1)
receptor agonists##93##2##(1990-2#4)(1990-3#2)(1990-7#1)(1991-4#2)(1991-5#2)(1992-2#2)(1992-9#3)(1993-11#9)(1993-12#2)(1993-3#3)(1994-2#4)(1994-9#1)(1995-12#7)(1995-3#1)(1995-5#1)(1995-7#3)(1995-8#1)(1996-10#1)(1996-12#6)(1996-2#5)(1996-5#3)(1996-9#1)(1997-2#1)(1997-5#2)(1997-7#1)(2004-12#1)(2005-7#1)(2005-9#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#2)(2009-4#1)(2009-7#1)(2009-9#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#2)(2010-7#1)(2011-2#1)(2013-1#1)
receptor alpha and beta##2##4##(1997-2#1)(2013-8#1)
receptor alpha and##4##3##(1995-10#1)(1995-3#1)(1997-2#1)(2013-8#1)
receptor alpha chain##4##3##(1994-9#2)(1997-9#2)
receptor alpha gene##3##3##(1990-9#1)(1994-2#2)
receptor alpha in##3##3##(1995-2#1)(1995-3#1)(2009-4#1)
receptor alpha subunit##8##3##(1991-2#2)(1993-12#1)(1993-4#1)(1994-2#1)(1995-1#1)(1995-6#1)(1996-4#1)
receptor alpha##53##2##(1990-9#1)(1991-11#1)(1991-2#2)(1991-9#1)(1993-12#2)(1993-4#1)(1994-12#1)(1994-2#3)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-7#3)(1997-9#2)(2004-12#1)(2007-12#1)(2008-11#2)(2008-12#2)(2008-7#2)(2009-4#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
receptor alpha-chain##3##2##(1991-9#1)(1995-6#1)(1997-7#1)
receptor also mediates##2##3##(2008-4#1)(2008-5#1)
receptor also##7##2##(1992-6#1)(1993-4#1)(2007-9#1)(2008-4#2)(2008-5#1)(2010-3#1)
receptor amino acid##2##3##(1994-12#2)
receptor analysis##3##2##(1990-2#1)(1990-9#1)(1995-9#1)
receptor and a##8##3##(1991-11#1)(1992-3#1)(1993-3#1)(1994-2#1)(1995-8#1)(2006-10#1)(2006-12#1)(2008-11#1)
receptor and adrenoreceptor##2##3##(2013-1#2)
receptor and an##2##3##(1994-9#1)(2008-3#1)
receptor and by##2##3##(1991-9#1)(1993-9#1)
receptor and for##2##3##(1992-8#1)(1996-2#1)
receptor and in##5##3##(1993-3#1)(1996-7#1)(1997-2#1)(1997-6#1)(2008-4#1)
receptor and inhibit##2##3##(1993-9#1)(2008-11#1)
receptor and is##7##3##(1990-12#1)(1991-10#1)(1994-12#1)(1996-12#1)(2006-10#1)(2008-10#1)(2008-4#1)
receptor and its ligands##2##4##(1995-10#1)(2007-8#1)
receptor and its##8##3##(1992-8#1)(1993-6#1)(1995-10#1)(1995-11#1)(1995-3#1)(2007-8#1)(2008-8#1)(2012-2#1)
receptor and may be##2##4##(1991-9#1)(1995-10#1)
receptor and may##3##3##(1991-9#1)(1995-10#1)(1996-2#1)
receptor and of##2##3##(1990-5#1)(1993-4#1)
receptor and plasminogen activator activity by estrogen are related to the##2##11##(2008-11#2)
receptor and prolactin##2##3##(1992-1#1)(1994-12#1)
receptor and subsequent##4##3##(1995-6#1)(2008-11#1)(2011-2#1)(2013-7#1)
receptor and that##5##3##(1991-12#1)(1991-2#1)(1992-4#1)(1997-6#2)
receptor and the##18##3##(1990-12#1)(1992-8#2)(1993-12#1)(1994-12#1)(1994-2#1)(1996-1#1)(1996-11#2)(1996-8#1)(1997-8#1)(2008-11#1)(2008-4#2)(2008-7#1)(2010-3#2)(2011-1#1)
receptor and to##3##3##(1996-11#1)(2008-4#1)(2008-9#1)
receptor and was##2##3##(1991-11#1)(1995-9#1)
receptor and with the##2##4##(1996-2#2)
receptor and with##3##3##(1994-9#1)(1996-2#2)
receptor and##209##2##(1990-10#1)(1990-12#2)(1990-5#2)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#4)(1992-1#2)(1992-11#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-8#6)(1992-9#1)(1993-11#2)(1993-12#2)(1993-3#3)(1993-4#1)(1993-6#2)(1993-9#2)(1994-12#5)(1994-2#5)(1994-3#2)(1994-6#1)(1994-8#2)(1994-9#6)(1995-10#3)(1995-11#3)(1995-12#3)(1995-2#1)(1995-3#5)(1995-6#3)(1995-8#3)(1995-9#3)(1996-1#1)(1996-11#4)(1996-12#1)(1996-2#6)(1996-3#1)(1996-4#1)(1996-5#6)(1996-7#4)(1996-8#2)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#7)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-5#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#10)(2008-3#3)(2008-4#12)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-12#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#3)(2010-8#1)(2011-1#2)(2011-2#7)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
receptor and/or##2##2##(1994-9#1)(1996-2#1)
receptor antagonism have##2##3##(2007-8#1)(2008-2#1)
receptor antagonism in##2##3##(2005-7#1)(2005-8#1)
receptor antagonism##14##2##(1992-3#1)(1992-9#1)(1995-7#1)(1996-10#1)(1996-6#1)(2005-7#1)(2005-8#1)(2007-8#3)(2008-1#1)(2008-2#1)(2013-7#1)(2013-8#1)
receptor antagonist (IL-1ra)##7##3##(1992-9#1)(1994-3#1)(1995-2#1)(2007-11#2)(2008-5#1)(2011-1#1)
receptor antagonist 2-amino-5-phosphonovalerate (APV)##2##4##(1992-3#1)(1994-2#1)
receptor antagonist CP-99##4##3##(1993-11#2)(1995-5#1)(1996-3#1)
receptor antagonist L-365##3##3##(1996-12#2)(1996-2#1)
receptor antagonist Ro##2##3##(1994-2#1)(1996-12#1)
receptor antagonist SCH 23390##2##4##(1996-12#1)(1996-2#1)
receptor antagonist activity##2##3##(1994-9#1)(2012-12#1)
receptor antagonist and an##3##4##(1995-8#1)(2008-6#2)
receptor antagonist and dexamethasone##2##4##(2008-7#2)
receptor antagonist and##9##3##(1995-12#1)(1995-8#1)(2007-9#1)(2008-6#2)(2008-7#2)(2009-3#1)(2012-12#1)
receptor antagonist bicuculline##3##3##(1994-2#1)(1997-2#2)
receptor antagonist devazepide##3##3##(1993-6#1)(1995-12#1)(1996-12#1)
receptor antagonist in##4##3##(1994-9#1)(1995-12#1)(1996-10#1)(1997-3#1)
receptor antagonist loxiglumide##2##3##(1991-2#1)(1993-11#1)
receptor antagonist nalmefene##2##3##(1993-12#2)
receptor antagonist on##3##3##(1992-3#1)(1995-10#1)(1995-12#1)
receptor antagonist protein##2##3##(2006-9#1)(2007-11#1)
receptor antagonist raclopride##3##3##(1996-12#1)(2008-6#2)
receptor antagonist that##3##3##(1997-3#1)(2005-7#1)(2008-11#1)
receptor antagonist to##2##3##(1996-10#1)(1997-5#1)
receptor antagonist was##2##3##(1994-11#1)(2005-8#1)
receptor antagonist with##5##3##(1993-11#1)(1995-12#2)(1996-2#1)(2009-3#1)
receptor antagonist##382##2##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#7)(1990-4#1)(1990-5#5)(1990-6#1)(1990-7#4)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#7)(1991-6#4)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#2)(1992-3#8)(1992-4#1)(1992-6#2)(1992-8#4)(1992-9#4)(1993-11#24)(1993-12#3)(1993-3#15)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-10#2)(1994-11#3)(1994-12#1)(1994-2#14)(1994-3#2)(1994-5#3)(1994-8#2)(1994-9#7)(1995-1#1)(1995-10#5)(1995-11#2)(1995-12#25)(1995-2#3)(1995-3#3)(1995-5#4)(1995-7#3)(1995-8#1)(1996-1#1)(1996-10#15)(1996-11#3)(1996-12#30)(1996-2#8)(1996-3#4)(1996-5#3)(1996-8#5)(1996-9#5)(1997-1#2)(1997-2#5)(1997-3#3)(1997-4#4)(1997-5#11)(1997-7#9)(1997-8#1)(2004-12#2)(2005-11#1)(2005-6#1)(2005-7#2)(2005-8#3)(2005-9#2)(2006-1#1)(2006-10#1)(2006-2#1)(2006-6#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#5)(2008-8#5)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-8#1)(2010-12#9)(2010-6#1)(2011-1#1)(2011-12#1)(2012-12#3)(2013-1#4)
receptor antagonist)##9##2##(1991-5#2)(1993-3#1)(1995-12#2)(2008-1#1)(2008-5#1)(2010-12#1)(2012-2#1)
receptor antagonistic##2##2##(2005-9#1)(2008-1#1)
receptor antagonists and their##2##4##(2008-1#1)(2008-7#1)
receptor antagonists and##9##3##(1993-11#1)(1995-10#2)(1995-12#1)(1996-10#1)(2005-7#1)(2008-1#1)(2008-7#1)(2010-3#1)
receptor antagonists are a new class of##3##7##(2005-7#1)(2008-2#1)(2008-7#1)
receptor antagonists are effective##2##4##(2005-7#1)(2009-2#1)
receptor antagonists are##7##3##(2005-7#2)(2005-8#1)(2007-11#1)(2008-2#1)(2008-7#1)(2009-2#1)
receptor antagonists as##3##3##(2005-7#1)(2005-9#1)(2008-1#1)
receptor antagonists for##2##3##(1991-5#1)(2008-8#1)
receptor antagonists from##2##3##(1993-4#1)(2005-8#1)
receptor antagonists have been##2##4##(2005-10#1)(2010-12#1)
receptor antagonists have##6##3##(2005-10#1)(2007-11#2)(2008-7#2)(2010-12#1)
receptor antagonists in the treatment of##2##6##(2005-7#1)(2012-2#1)
receptor antagonists in the##5##4##(1996-12#1)(2005-7#3)(2012-2#1)
receptor antagonists in##13##3##(1992-11#1)(1993-12#1)(1996-12#1)(1996-3#1)(2005-7#3)(2008-1#1)(2008-2#1)(2009-2#2)(2011-12#1)(2012-2#1)
receptor antagonists is##6##3##(1993-11#1)(1993-4#1)(2005-7#1)(2005-8#1)(2007-8#1)(2008-2#1)
receptor antagonists may be##2##4##(1996-2#1)(2008-2#1)
receptor antagonists may##6##3##(1995-12#1)(1996-10#1)(1996-2#1)(2005-7#1)(2008-1#1)(2008-2#1)
receptor antagonists on the##3##4##(1994-2#1)(1996-12#2)
receptor antagonists on##7##3##(1991-5#1)(1992-3#1)(1994-2#1)(1996-12#2)(1996-3#1)(2009-2#1)
receptor antagonists the##3##3##(1993-11#1)(1996-10#1)(1996-3#1)
receptor antagonists to##4##3##(1992-3#1)(1994-11#1)(1994-2#1)(1996-10#1)
receptor antagonists were##5##3##(1995-12#1)(1996-12#1)(2007-11#1)(2008-5#1)(2009-2#1)
receptor antagonists with##3##3##(1995-7#1)(1996-12#1)(2008-7#1)
receptor antagonists##211##2##(1990-2#2)(1991-3#1)(1991-5#4)(1991-8#2)(1991-9#1)(1992-11#1)(1992-3#8)(1992-4#1)(1992-8#2)(1993-11#10)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#6)(1994-11#3)(1994-2#2)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-10#2)(1995-11#4)(1995-12#7)(1995-3#1)(1995-7#2)(1995-8#1)(1996-10#4)(1996-12#7)(1996-2#2)(1996-3#5)(1996-8#2)(1996-9#3)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-7#2)(1997-8#1)(2005-10#1)(2005-6#1)(2005-7#19)(2005-8#7)(2005-9#4)(2006-10#3)(2007-11#10)(2007-8#1)(2007-9#1)(2008-1#11)(2008-10#1)(2008-11#2)(2008-2#5)(2008-3#3)(2008-4#5)(2008-5#1)(2008-7#15)(2008-8#1)(2009-2#6)(2009-7#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#2)(2010-7#1)(2011-12#1)(2012-12#1)(2012-2#1)
receptor antibodies and##4##3##(1991-12#1)(2006-10#1)(2007-11#1)(2008-4#1)
receptor antibodies in patients with##3##5##(1991-9#1)(2006-10#2)
receptor antibodies##20##2##(1991-12#2)(1991-5#1)(1991-9#1)(1994-3#1)(1995-6#1)(2006-10#10)(2007-11#2)(2008-4#1)(2009-11#1)
receptor antibody##10##2##(1991-10#1)(1991-5#1)(1992-4#1)(1994-2#1)(1994-3#1)(2004-1#1)(2008-11#1)(2008-5#1)(2012-2#1)(2013-1#1)
receptor antisense##3##2##(1995-3#1)(1996-7#1)(2005-8#1)
receptor appears to be##5##4##(1990-7#1)(1990-8#1)(1995-3#1)(1995-8#1)(1997-5#1)
receptor appears to##6##3##(1990-2#1)(1990-7#1)(1990-8#1)(1995-3#1)(1995-8#1)(1997-5#1)
receptor are expressed##2##3##(1995-12#1)(2010-3#1)
receptor are identified##2##3##(1991-8#1)(1993-3#1)
receptor are##15##2##(1990-10#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-3#2)(1994-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(2009-5#1)(2010-3#1)
receptor as a therapeutic target in##2##6##(2005-9#1)(2008-1#1)
receptor as a##7##3##(1992-9#1)(1994-12#1)(1996-8#1)(1997-6#1)(2005-9#1)(2008-1#1)(2009-6#1)
receptor as well as##3##4##(1991-9#1)(1994-12#1)(1995-2#1)
receptor as##18##2##(1991-9#1)(1992-9#1)(1994-12#2)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#1)(1996-8#1)(1997-1#1)(1997-6#1)(2005-9#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-6#1)
receptor assays##2##2##(1995-7#1)(2008-10#1)
receptor associated##2##2##(1991-1#2)
receptor at a##2##3##(1991-5#1)(1993-6#1)
receptor at the##4##3##(1990-2#1)(1993-7#1)(1994-5#1)(1997-2#1)
receptor at##11##2##(1990-2#1)(1991-5#1)(1992-12#1)(1993-1#1)(1993-6#1)(1993-7#1)(1994-5#1)(1995-6#2)(1997-2#1)(2008-8#1)
receptor autoantibodies##3##2##(1992-12#1)(2012-3#2)
receptor autophosphorylation in##2##3##(1994-6#1)(1996-6#1)
receptor autophosphorylation sites##3##3##(1991-1#1)(1993-6#2)
receptor autophosphorylation##11##2##(1990-12#1)(1990-3#2)(1991-1#1)(1992-10#1)(1993-6#2)(1994-6#2)(1996-6#2)
receptor autoradiography##12##2##(1990-2#1)(1991-6#1)(1991-9#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-5#1)(1995-7#1)(1996-7#1)(1997-5#1)
receptor availability##2##2##(1996-5#1)(2011-1#1)
receptor axons##2##2##(2007-12#2)
receptor background##2##2##(1994-3#1)(1996-8#1)
receptor based on##2##3##(1991-1#1)(2008-4#1)
receptor bears##2##2##(1990-7#1)(1994-9#1)
receptor behavior##2##2##(2008-10#1)(2008-5#1)
receptor belongs to the##2##4##(1993-12#1)(2010-3#1)
receptor beta chain##4##3##(1992-6#1)(1997-5#2)(2008-4#1)
receptor beta gene##2##3##(1991-7#1)(1995-10#1)
receptor beta subunit##2##3##(1996-10#1)(1996-2#1)
receptor beta##18##2##(1991-7#1)(1992-6#1)(1994-8#1)(1995-10#2)(1995-3#1)(1995-8#2)(1996-10#1)(1996-2#1)(1997-5#2)(1997-7#1)(2005-8#1)(2007-11#1)(2008-4#2)(2008-7#1)
receptor beta-chain##3##2##(1994-11#2)(1995-6#1)
receptor beta-subunits##2##2##(1995-3#1)(1995-6#1)
receptor between##2##2##(1991-12#1)(1996-12#1)
receptor binding activity of##2##4##(1992-2#2)
receptor binding activity##4##3##(1991-10#1)(1992-2#2)(1994-12#1)
receptor binding affinity and##2##4##(1990-7#1)(1996-8#1)
receptor binding affinity##6##3##(1990-2#1)(1990-7#1)(1992-8#1)(1993-1#1)(1996-8#1)(1997-4#1)
receptor binding and Nb2 cell proliferation##2##6##(1994-11#2)
receptor binding and activation##2##4##(1994-12#1)(1994-6#1)
receptor binding and##18##3##(1990-11#1)(1990-2#1)(1993-3#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-12#2)(1996-5#1)(2008-4#1)(2013-8#1)
receptor binding are##2##3##(1990-2#1)(1991-6#1)
receptor binding assay##2##3##(1990-3#1)(2007-1#1)
receptor binding assays##7##3##(1991-12#1)(1992-12#1)(1994-5#1)(1995-3#1)(1995-7#1)(1995-8#1)(2005-8#1)
receptor binding capacity and##2##4##(1992-7#1)(1997-6#1)
receptor binding capacity##6##3##(1992-7#2)(1997-6#1)(2008-9#2)(2013-8#1)
receptor binding domain##4##3##(1991-10#1)(1991-2#1)(1996-5#1)(1997-1#1)
receptor binding in the##5##4##(1991-9#1)(1995-5#1)(1996-10#1)(1996-5#1)(1996-8#1)
receptor binding in##16##3##(1990-11#1)(1991-4#2)(1991-5#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-11#1)(1995-5#1)(1995-7#1)(1996-10#2)(1996-5#2)(1996-8#1)
receptor binding is##4##3##(1994-12#1)(1995-3#1)(1996-10#1)(1996-5#1)
receptor binding kinetics##2##3##(2004-2#1)(2006-5#1)
receptor binding of the##2##4##(1996-12#1)(2011-1#1)
receptor binding of##9##3##(1991-1#1)(1992-2#1)(1994-12#1)(1994-9#1)(1995-5#1)(1996-12#1)(2006-11#1)(2008-4#1)(2011-1#1)
receptor binding regions of##2##4##(1991-8#2)
receptor binding regions##4##3##(1991-8#3)(1992-8#1)
receptor binding site##8##3##(1990-2#1)(1991-2#3)(1993-3#1)(1994-11#1)(1994-8#2)
receptor binding sites and##2##4##(1990-12#1)(1993-11#1)
receptor binding sites for##2##4##(1990-12#1)(1991-8#1)
receptor binding sites in rat##2##5##(1990-6#1)(1993-11#1)
receptor binding sites in the##2##5##(1992-6#1)(1994-2#1)
receptor binding sites in##5##4##(1990-6#1)(1992-6#1)(1993-11#1)(1994-2#1)(2012-2#1)
receptor binding sites##19##3##(1990-12#3)(1990-6#1)(1990-7#1)(1991-2#2)(1991-3#2)(1991-8#1)(1992-6#1)(1993-11#3)(1994-2#1)(1995-11#1)(1995-7#1)(2005-8#1)(2012-2#1)
receptor binding studies##4##3##(1992-3#1)(1996-11#1)(1996-9#1)(2007-11#1)
receptor binding to calf thymus DNA##3##6##(1990-2#3)
receptor binding to##6##3##(1990-11#1)(1990-2#3)(1993-11#1)(1995-12#1)
receptor binding using##2##3##(1995-6#1)(1995-7#1)
receptor binding was not##2##4##(1994-12#1)(1996-10#1)
receptor binding was##9##3##(1993-12#1)(1994-12#2)(1995-5#3)(1996-10#1)(1996-12#1)(1996-2#1)
receptor binding within the##2##4##(1995-5#2)
receptor binding##195##2##(1990-11#3)(1990-12#3)(1990-2#9)(1990-3#1)(1990-6#1)(1990-7#2)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#6)(1991-3#4)(1991-4#3)(1991-5#1)(1991-6#1)(1991-8#4)(1991-9#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-6#2)(1992-7#2)(1992-8#6)(1992-9#2)(1993-1#1)(1993-11#4)(1993-12#5)(1993-3#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-11#5)(1994-12#11)(1994-2#2)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#4)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#4)(1995-5#7)(1995-6#3)(1995-7#5)(1995-8#1)(1996-10#4)(1996-11#2)(1996-12#6)(1996-2#1)(1996-4#1)(1996-5#6)(1996-8#4)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(2004-2#1)(2004-3#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-5#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-4#3)(2008-8#1)(2008-9#4)(2009-2#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-8#4)
receptor binds and##2##3##(1995-2#1)(1995-6#1)
receptor binds##7##2##(1990-5#1)(1991-11#1)(1991-2#1)(1992-9#1)(1994-11#1)(1995-2#1)(1995-6#1)
receptor biology##3##2##(1993-12#1)(2006-10#1)(2007-11#1)
receptor blockade in##2##3##(1996-12#1)(1996-9#1)
receptor blockade on##3##3##(1993-2#1)(1995-12#1)(2012-1#1)
receptor blockade##19##2##(1992-3#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-9#1)(1995-12#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-9#1)(2005-6#1)(2007-1#1)(2007-8#2)(2008-4#1)(2010-4#1)(2011-2#1)(2012-1#2)
receptor blocker therapy##3##3##(2007-1#3)
receptor blocker##30##2##(1990-2#1)(1991-3#1)(1992-8#1)(1993-7#1)(1993-9#1)(1994-2#4)(1995-12#1)(1996-12#1)(1996-2#1)(1997-3#1)(2006-9#1)(2007-1#9)(2007-10#1)(2007-8#1)(2008-4#3)(2008-9#1)(2012-3#1)
receptor blockers (ARB)##2##3##(2008-1#2)
receptor blockers (ARBs)##8##3##(2007-1#6)(2008-8#1)(2010-6#1)
receptor blockers and##3##3##(1996-12#1)(1996-3#1)(2008-11#1)
receptor blockers in##2##3##(2008-11#1)(2008-8#1)
receptor blockers##32##2##(1993-8#3)(1996-12#1)(1996-3#1)(1996-6#3)(2006-10#1)(2007-1#7)(2007-10#1)(2007-8#2)(2008-1#2)(2008-11#3)(2008-7#1)(2008-8#2)(2010-12#2)(2010-6#1)(2011-2#1)(2013-1#1)
receptor blocking drug##2##3##(1990-11#2)
receptor blocking##6##2##(1990-11#3)(1990-6#1)(1997-5#1)(2005-7#1)
receptor both##2##2##(2003-11#1)(2005-7#1)
receptor but##6##2##(1990-11#2)(1990-8#1)(1994-9#1)(1997-1#1)(1997-8#1)
receptor by a##2##3##(1990-7#1)(1992-2#1)
receptor by in situ hybridization histochemistry##2##6##(1990-7#2)
receptor by protein kinase C##3##5##(1992-11#1)(1995-6#1)(1996-5#1)
receptor by the##3##3##(1993-8#1)(1994-3#1)(1996-8#1)
receptor by trypsin##2##3##(1992-11#1)(1996-5#1)
receptor by using the##2##4##(1991-4#1)(1994-11#1)
receptor by##50##2##(1990-10#2)(1990-2#1)(1990-5#1)(1990-7#5)(1990-8#2)(1991-12#1)(1991-3#2)(1991-4#2)(1991-5#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-6#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-12#1)(1996-5#3)(1996-8#1)(1997-7#1)(2008-8#1)(2011-2#1)
receptor c-KIT##2##2##(2008-6#1)(2013-1#1)
receptor c-Mpl##2##2##(2008-8#2)
receptor cDNA as a probe##2##5##(1994-11#1)(1995-6#1)
receptor cDNA coding##2##3##(1992-3#1)(1993-3#1)
receptor cDNA fragment##2##3##(1991-5#1)(1993-3#1)
receptor cDNA was##4##3##(1990-9#1)(1992-3#1)(1992-8#1)(1995-12#1)
receptor cDNA##44##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-9#2)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-11#3)(1992-2#3)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-3#3)(1993-4#1)(1994-11#2)(1994-5#2)(1994-8#2)(1994-9#2)(1995-12#2)(1995-2#1)(1995-6#4)(1997-9#1)(2008-5#1)(2008-8#1)
receptor cDNAs##3##2##(1992-9#1)(1995-12#1)(1997-2#1)
receptor calcium##4##2##(1995-2#1)(1995-7#1)(2006-10#1)(2008-4#1)
receptor can be##4##3##(1993-9#1)(1994-2#1)(1995-11#1)(1995-2#1)
receptor can##15##2##(1992-3#1)(1992-7#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-5#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-12#1)
receptor capacity##2##2##(1994-11#1)(1996-4#1)
receptor cell##4##2##(2007-12#2)(2008-10#1)(2008-7#1)
receptor cells in taste buds##2##5##(2013-1#2)
receptor cells in##3##3##(1994-2#1)(2013-1#2)
receptor cells##11##2##(1991-5#1)(1994-2#1)(2007-12#4)(2008-7#1)(2012-2#1)(2013-1#3)
receptor chains##5##2##(1995-6#1)(1995-8#1)(1996-5#1)(2008-10#1)(2008-11#1)
receptor channel##7##2##(1990-7#1)(1992-3#1)(1995-1#1)(1996-4#1)(2008-4#3)
receptor channels expressed in Xenopus oocytes##2##6##(1995-3#2)
receptor channels##11##2##(1990-7#1)(1993-5#1)(1995-3#3)(1995-7#2)(1997-3#1)(2008-8#3)
receptor chimeras##5##2##(1990-12#1)(1991-8#2)(1995-3#2)
receptor class##4##2##(1993-12#1)(1995-11#1)(2010-4#1)(2013-1#1)
receptor classes##2##2##(1996-5#1)(2008-5#1)
receptor clustering and##2##3##(1996-8#1)(1997-6#1)
receptor clustering##7##2##(1990-8#1)(1991-11#2)(1996-8#1)(1997-6#1)(2006-10#1)(2008-10#1)
receptor compared##2##2##(1994-5#1)(1996-3#1)
receptor complex appears to##2##4##(1994-9#1)(1995-11#1)
receptor complex in##3##3##(1990-10#1)(1991-9#1)(1996-7#1)
receptor complex is##3##3##(1991-9#1)(1995-8#1)(2012-3#1)
receptor complex to##2##3##(1993-11#1)(1996-4#1)
receptor complex##46##2##(1990-10#1)(1990-7#2)(1991-1#2)(1991-9#2)(1992-11#3)(1992-9#1)(1993-11#1)(1993-9#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#2)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#3)(1997-2#1)(1997-3#3)(1997-5#2)(2009-8#1)(2010-5#1)(2012-3#1)
receptor complexes##16##2##(1990-5#3)(1992-11#5)(1992-9#1)(1993-9#1)(1995-11#1)(1995-12#2)(1996-2#1)(1997-4#1)(2008-9#1)
receptor component##2##2##(1991-6#1)(1996-10#1)
receptor concentration)##2##2##(1991-11#2)
receptor concentrations in the##3##4##(1991-11#1)(1992-12#1)(2006-5#1)
receptor concentrations in##4##3##(1991-11#1)(1992-12#1)(2006-5#2)
receptor concentrations##9##2##(1991-11#2)(1992-12#1)(2006-5#6)
receptor conformation##3##2##(1991-5#1)(1992-9#1)(1993-3#1)
receptor consists of 359##2##4##(1991-3#1)(1991-5#1)
receptor consists of##5##3##(1991-3#1)(1991-5#1)(1992-6#1)(1995-6#1)(2007-12#1)
receptor contact##2##2##(1994-5#2)
receptor contacts##2##2##(1996-11#2)
receptor containing##3##2##(1990-2#1)(1991-10#1)(1991-4#1)
receptor content of##2##3##(1990-10#1)(1991-12#1)
receptor content##7##2##(1990-10#1)(1990-2#1)(1991-12#1)(1993-1#1)(1994-9#1)(2008-11#2)
receptor could be a##2##4##(1993-9#1)(1996-12#1)
receptor could be##6##3##(1992-5#1)(1993-9#1)(1996-1#1)(1996-12#1)(2008-4#1)(2008-8#1)
receptor could##9##2##(1991-8#1)(1992-5#1)(1993-9#1)(1996-1#1)(1996-12#1)(2007-9#1)(2008-4#1)(2008-8#2)
receptor coupled to##2##3##(1991-2#1)(1993-8#1)
receptor coupled##5##2##(1990-2#1)(1991-2#1)(1993-8#1)(1995-3#1)(1996-5#1)
receptor couples##2##2##(1992-7#1)(1997-2#1)
receptor coupling to##3##3##(1995-6#1)(1997-7#1)(1997-8#1)
receptor coupling##4##2##(1995-3#1)(1995-6#1)(1997-7#1)(1997-8#1)
receptor crosslinking##3##2##(1991-5#2)(1995-2#1)
receptor current##3##2##(1990-7#2)(1995-2#1)
receptor cytoplasmic##2##2##(1994-9#1)(1995-3#1)
receptor declines##2##2##(1992-8#1)(1996-12#1)
receptor decreased##2##2##(1994-9#2)
receptor deficiency##2##2##(2007-9#1)(2013-8#1)
receptor deficient mice##3##3##(1995-11#1)(2008-6#2)
receptor deficient##5##2##(1994-8#1)(1995-11#1)(1996-10#1)(2008-6#2)
receptor degradation##2##2##(1993-8#1)(1997-5#1)
receptor densities and##4##3##(1991-6#1)(1994-10#1)(1994-2#2)
receptor densities##14##2##(1990-2#1)(1990-8#1)(1991-6#1)(1994-10#2)(1994-12#1)(1994-2#4)(1996-7#1)(2008-11#3)
receptor density (Bmax)##3##3##(1992-8#1)(1995-10#1)(1996-7#1)
receptor density and mRNA##3##4##(1995-2#3)
receptor density and##6##3##(1992-5#1)(1995-10#1)(1995-12#1)(1995-2#3)
receptor density in the striatum##2##5##(1993-12#1)(1993-2#1)
receptor density in the##6##4##(1991-8#1)(1992-5#3)(1993-12#1)(1993-2#1)
receptor density in##9##3##(1991-8#1)(1991-9#1)(1992-5#3)(1993-12#2)(1993-2#1)(1997-5#1)
receptor density is##2##3##(1992-10#1)(1993-2#1)
receptor density on##2##3##(1992-12#1)(1995-2#1)
receptor density or##2##3##(1995-3#1)(2008-4#1)
receptor density was##7##3##(1991-4#1)(1992-5#4)(1993-12#1)(1997-5#1)
receptor density##49##2##(1990-7#2)(1991-4#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-5#8)(1992-8#1)(1993-12#7)(1993-2#2)(1995-10#3)(1995-12#1)(1995-2#4)(1995-3#1)(1995-6#3)(1996-7#3)(1997-5#4)(1997-8#1)(2008-11#2)(2008-4#1)
receptor dependent##3##2##(1990-11#1)(1994-6#1)(2007-11#1)
receptor desensitization and##2##3##(2008-4#1)(2008-5#1)
receptor desensitization##8##2##(1995-12#1)(1996-5#1)(1997-1#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-5#1)
receptor did not##3##3##(1990-2#1)(1993-9#1)(2008-4#1)
receptor dimerization##2##2##(1992-6#1)(1997-6#1)
receptor distribution##4##2##(1990-2#1)(1996-12#1)(2012-1#1)(2013-1#1)
receptor do not##2##3##(1990-8#1)(1994-2#1)
receptor does not affect the##2##5##(1996-10#1)(2009-4#1)
receptor does not##3##3##(1996-10#1)(2009-4#1)(2009-8#1)
receptor domain of##3##3##(1996-11#2)(1997-1#1)
receptor domain##8##2##(1996-11#2)(1997-1#2)(1997-6#1)(1997-7#3)
receptor domains##7##2##(1991-4#1)(1993-6#3)(1994-5#1)(1994-6#1)(1996-2#1)
receptor down-regulation##3##2##(1994-11#1)(1995-3#1)(1996-8#1)
receptor downregulation##2##2##(1994-10#1)(2012-12#1)
receptor dysfunction##2##2##(1995-12#1)(2008-6#1)
receptor encoded by the##4##4##(1991-9#1)(1993-6#1)(1997-2#1)(2008-4#1)
receptor encoded by##5##3##(1991-9#2)(1993-6#1)(1997-2#1)(2008-4#1)
receptor engagement##3##2##(1991-10#1)(1994-3#1)(2008-4#1)
receptor enhances##3##2##(1992-7#1)(1996-4#1)(2007-8#1)
receptor exhibited##2##2##(1994-12#1)(1995-6#1)
receptor exhibits##3##2##(1992-7#1)(1994-3#1)(1994-8#1)
receptor expressed in Xenopus oocytes##2##5##(1990-2#1)(2008-4#1)
receptor expressed in Xenopus##3##4##(1990-2#1)(1992-3#1)(2008-4#1)
receptor expressed in##10##3##(1990-2#1)(1990-9#1)(1992-3#2)(1994-12#1)(1995-11#1)(1997-8#1)(2008-4#1)(2008-5#1)(2009-12#1)
receptor expressed on##3##3##(1992-12#1)(1994-9#1)(1997-2#1)
receptor expressed##17##2##(1990-2#1)(1990-9#1)(1992-12#1)(1992-3#2)(1993-3#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-11#1)(1996-8#1)(1997-2#1)(1997-8#1)(2008-4#2)(2008-5#1)(2009-12#1)
receptor expressing##4##2##(1991-2#1)(1996-10#1)(1996-5#1)(2008-1#1)
receptor expression and function##2##4##(1990-9#1)(1996-11#1)
receptor expression and##12##3##(1990-9#1)(1991-9#1)(1994-10#1)(1994-9#1)(1995-3#1)(1996-11#1)(2006-12#1)(2008-11#1)(2008-3#1)(2010-8#1)(2011-2#2)
receptor expression by##5##3##(1991-5#1)(1992-1#1)(1992-5#1)(1994-5#1)(2008-5#1)
receptor expression during##2##3##(1995-11#1)(1997-5#1)
receptor expression in human##3##4##(1994-11#1)(1995-5#1)(1996-2#1)
receptor expression in the##7##4##(1991-11#1)(1991-9#1)(1995-7#2)(1997-6#1)(2006-5#1)(2008-4#1)
receptor expression in vivo##2##4##(1994-11#2)
receptor expression in##24##3##(1991-11#1)(1991-2#1)(1991-5#2)(1991-9#1)(1994-11#3)(1994-3#1)(1995-12#1)(1995-5#1)(1995-7#2)(1996-2#1)(1996-8#1)(1997-6#1)(2006-5#2)(2007-2#1)(2008-4#2)(2010-11#1)(2012-3#1)(2013-7#1)
receptor expression is regulated##2##4##(1994-11#1)(2008-4#1)
receptor expression is##3##3##(1994-11#1)(2008-4#1)(2008-8#1)
receptor expression levels##3##3##(1997-8#1)(2007-11#1)(2008-11#1)
receptor expression on##5##3##(1994-12#1)(1997-2#1)(2008-4#2)(2008-5#1)
receptor expression suggests##2##3##(1995-2#1)(1996-5#1)
receptor expression vector##2##3##(1991-1#1)(1993-6#1)
receptor expression was##3##3##(1996-5#1)(1997-5#1)(2006-5#1)
receptor expression##102##2##(1990-3#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#3)(1991-9#2)(1992-1#1)(1992-5#3)(1993-12#1)(1993-6#1)(1993-7#1)(1994-10#1)(1994-11#5)(1994-12#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#2)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#1)(1997-2#2)(1997-5#5)(1997-6#1)(1997-8#2)(2006-12#1)(2006-5#3)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#7)(2008-5#2)(2008-8#2)(2009-2#1)(2010-11#3)(2010-8#2)(2010-9#1)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#1)
receptor extracellular domain##2##3##(1990-12#1)(1995-11#1)
receptor families##2##2##(2008-7#1)(2011-1#1)
receptor family and##2##3##(1995-2#1)(2008-1#1)
receptor family are##2##3##(1996-12#1)(2005-11#1)
receptor family from mammals##2##4##(1993-12#2)
receptor family of proteins##2##4##(1994-9#1)(1996-5#1)
receptor family of##5##3##(1994-9#1)(1995-3#1)(1995-8#1)(1996-5#1)(2008-4#1)
receptor family##38##2##(1992-5#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-2#1)(1995-3#1)(1995-8#4)(1996-11#1)(1996-12#1)(1996-5#4)(1997-4#1)(2005-11#1)(2008-1#2)(2008-4#3)(2010-3#2)(2012-12#1)(2013-1#3)(2013-8#1)
receptor following##2##2##(1996-8#1)(1997-5#1)
receptor for BDNF##2##3##(1991-5#1)(1996-12#1)
receptor for IgE (Fc epsilon RI)##2##6##(1991-10#1)(1994-8#1)
receptor for IgE (Fc epsilon##3##5##(1991-10#1)(1994-6#1)(1994-8#1)
receptor for VEGF##2##3##(1992-9#2)
receptor for advanced glycation end##2##5##(2009-10#1)(2009-3#1)
receptor for binding to##2##4##(1995-3#1)(1997-2#1)
receptor for immunoglobulin G##3##4##(1990-8#2)(1991-10#1)
receptor for immunoglobulin##4##3##(1990-8#2)(1991-10#2)
receptor for sperm##2##3##(1994-5#1)(1995-6#1)
receptor for the neuropeptide gastrin-releasing peptide##2##6##(1990-5#2)
receptor for the##14##3##(1990-5#2)(1991-10#1)(1993-4#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#1)(2008-4#2)(2009-8#1)(2010-5#1)(2011-2#1)
receptor for these##2##3##(1994-9#1)(1995-3#1)
receptor for##103##2##(1990-11#4)(1990-2#1)(1990-5#4)(1990-7#2)(1990-8#4)(1991-10#4)(1991-12#2)(1991-3#2)(1991-4#1)(1991-5#3)(1991-8#1)(1992-11#1)(1992-12#2)(1992-6#1)(1992-8#1)(1992-9#4)(1993-11#1)(1993-12#1)(1993-4#1)(1993-5#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#3)(1994-6#3)(1994-8#1)(1994-9#4)(1995-10#1)(1995-2#3)(1995-3#6)(1995-5#1)(1995-6#2)(1995-7#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-5#1)(2005-8#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-4#4)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)
receptor forms when receptor-insulin complexes were##2##6##(1990-7#2)
receptor forms##7##2##(1990-7#2)(1993-6#1)(1997-6#1)(2008-4#2)(2010-12#1)
receptor fragment##2##2##(1990-11#1)(1996-1#1)
receptor from a##3##3##(1993-8#1)(1994-12#1)(1996-7#1)
receptor from both##2##3##(1992-11#1)(1994-9#1)
receptor from human placenta##3##4##(1990-2#2)(1991-4#1)
receptor from human##7##3##(1990-2#2)(1990-7#1)(1991-4#1)(1992-11#1)(1992-8#1)(1994-8#1)
receptor from rat##3##3##(1991-5#2)(1993-12#1)
receptor from sea anemones##3##4##(1993-12#3)
receptor from the##5##3##(1990-12#2)(1990-7#1)(1990-8#1)(2006-1#1)
receptor from##29##2##(1990-12#2)(1990-2#3)(1990-7#3)(1990-8#1)(1991-12#1)(1991-4#1)(1991-5#2)(1992-11#2)(1992-8#1)(1993-12#4)(1993-8#1)(1994-12#2)(1994-8#1)(1994-9#1)(1996-7#1)(2006-1#1)(2008-11#1)(2008-4#1)
receptor function by##4##3##(1993-12#1)(1994-5#1)(1995-11#1)(1995-5#1)
receptor function in##5##3##(1994-11#1)(1994-5#1)(1996-1#1)(2008-4#1)(2010-10#1)
receptor function is##2##3##(1995-5#1)(2007-9#1)
receptor function using##2##3##(1993-12#1)(1995-5#1)
receptor function was##2##3##(1992-3#1)(2008-5#1)
receptor function##37##2##(1990-12#2)(1991-1#1)(1991-5#1)(1992-3#2)(1993-12#2)(1994-10#1)(1994-11#2)(1994-5#2)(1994-9#1)(1995-11#3)(1995-12#1)(1995-3#1)(1995-5#4)(1996-1#1)(1996-10#1)(1996-5#1)(1997-2#1)(1997-5#1)(2007-11#1)(2007-9#1)(2008-4#2)(2008-5#1)(2008-8#2)(2010-10#1)(2011-1#1)
receptor functionally##3##2##(1994-5#1)(1995-2#1)(1997-7#1)
receptor functions##5##2##(1991-9#1)(1995-10#1)(1996-2#1)(1997-2#1)(2009-3#1)
receptor fusion protein##3##3##(1995-3#1)(2005-7#1)(2006-10#1)
receptor fusion##5##2##(1995-3#1)(2005-7#1)(2006-10#1)(2008-11#1)(2008-4#1)
receptor gamma 2 subunit subtype##3##5##(1995-11#3)
receptor gamma 2 subunit##5##4##(1994-12#1)(1995-11#3)(1995-12#1)
receptor gamma 2##6##3##(1994-12#2)(1995-11#3)(1995-12#1)
receptor gamma chain##2##3##(1995-3#2)
receptor gamma##11##2##(1994-12#2)(1995-11#3)(1995-12#1)(1995-3#2)(2007-10#1)(2008-4#1)(2009-8#1)
receptor gene (EDNRB)##2##3##(1994-12#1)(1996-4#1)
receptor gene and##6##3##(1990-12#2)(1994-8#1)(1997-5#1)(2008-4#1)(2008-9#1)
receptor gene by##2##3##(1990-10#1)(1991-1#1)
receptor gene expression by##3##4##(1992-6#1)(1994-11#1)(2008-4#1)
receptor gene expression during##2##4##(1994-10#1)(1995-10#1)
receptor gene expression in##5##4##(1990-11#1)(1991-1#1)(1994-9#1)(1995-3#1)(2007-11#1)
receptor gene expression is##2##4##(1992-1#1)(1993-6#1)
receptor gene expression##25##3##(1990-11#3)(1991-1#1)(1991-12#2)(1992-1#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-3#4)(2007-11#2)(2008-4#1)(2010-5#1)
receptor gene family##5##3##(1994-3#1)(1994-9#2)(1996-10#2)
receptor gene for##2##3##(1992-9#1)(1993-3#1)
receptor gene has##2##3##(1993-11#1)(1993-9#1)
receptor gene in the##6##4##(1990-11#1)(1991-2#1)(1991-5#1)(1995-6#1)(1996-5#1)(2009-5#1)
receptor gene in##18##3##(1990-11#1)(1990-5#2)(1991-2#1)(1991-5#1)(1992-1#1)(1992-5#1)(1992-7#1)(1993-7#1)(1994-11#1)(1994-12#2)(1995-6#1)(1996-4#1)(1996-5#1)(2008-11#1)(2009-5#1)(2010-11#1)
receptor gene is##5##3##(1991-12#1)(1991-9#1)(1992-2#1)(1995-3#1)(2005-1#1)
receptor gene promoter##3##3##(1994-8#1)(1995-3#1)(1996-5#1)
receptor gene that##2##3##(1993-11#1)(1994-8#1)
receptor gene transcription##2##3##(1994-11#1)(1995-3#1)
receptor gene transfer##5##3##(2005-10#3)(2012-2#2)
receptor gene was isolated##2##4##(1994-2#1)(1994-8#1)
receptor gene was performed in##2##5##(2006-10#1)(2008-1#1)
receptor gene was##8##3##(1991-5#3)(1992-2#1)(1994-2#1)(1994-8#1)(2006-10#1)(2008-1#1)
receptor gene##180##2##(1990-10#1)(1990-11#4)(1990-12#3)(1990-3#1)(1990-5#2)(1991-1#3)(1991-12#4)(1991-2#1)(1991-5#7)(1991-7#1)(1991-9#2)(1992-1#3)(1992-11#1)(1992-2#3)(1992-3#2)(1992-5#3)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#5)(1993-11#2)(1993-12#5)(1993-3#3)(1993-6#2)(1993-7#2)(1993-9#4)(1994-10#1)(1994-11#4)(1994-12#7)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#4)(1994-9#4)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#7)(1995-6#2)(1996-10#3)(1996-11#2)(1996-12#1)(1996-2#2)(1996-4#3)(1996-5#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-7#4)(1997-8#1)(2005-1#2)(2005-10#4)(2006-10#3)(2006-9#2)(2007-11#3)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#7)(2008-7#1)(2008-8#1)(2008-9#6)(2009-5#1)(2010-11#1)(2010-5#1)(2011-2#3)(2012-1#3)(2012-12#2)(2012-2#2)(2013-8#1)
receptor genes and##2##3##(2007-12#1)(2012-2#1)
receptor genes by##2##3##(1993-12#1)(1997-2#1)
receptor genes##38##2##(1991-2#2)(1991-5#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-7#1)(1993-12#2)(1993-6#1)(1993-9#1)(1994-12#3)(1995-1#1)(1996-10#1)(1996-2#1)(1997-2#2)(1997-4#1)(1997-5#2)(1997-7#1)(2007-12#1)(2007-2#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-6#1)(2010-9#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)
receptor genotype##3##2##(1995-9#1)(2007-2#1)(2010-4#1)
receptor guanylyl cyclases##2##3##(1992-3#1)(1995-3#1)
receptor guanylyl##3##2##(1992-3#1)(1995-3#2)
receptor had##3##2##(1993-4#1)(1993-9#1)(2008-4#1)
receptor has a role in##2##5##(1995-7#1)(2006-10#1)
receptor has a##4##3##(1993-11#1)(1995-7#1)(1996-11#1)(2006-10#1)
receptor has been characterized##2##4##(1991-7#1)(1994-12#1)
receptor has been identified##2##4##(1992-12#1)(2008-7#1)
receptor has been##15##3##(1991-7#1)(1991-9#1)(1992-12#1)(1992-9#1)(1994-12#1)(1994-8#1)(1995-11#3)(1995-2#1)(1996-11#1)(1996-5#1)(2008-4#1)(2008-7#1)(2008-8#1)
receptor has##28##2##(1991-10#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-8#1)(1995-11#3)(1995-2#2)(1995-7#1)(1996-11#2)(1996-5#1)(2006-10#2)(2008-4#1)(2008-7#1)(2008-8#2)(2009-6#1)
receptor have been##9##3##(1990-3#1)(1990-5#1)(1990-7#1)(1991-7#1)(1995-3#1)(2006-10#2)(2008-11#1)(2008-4#1)
receptor have##11##2##(1990-3#1)(1990-5#1)(1990-7#1)(1991-7#1)(1995-3#1)(1995-5#1)(2006-10#2)(2007-12#1)(2008-11#1)(2008-4#1)
receptor heterogeneity##2##2##(1990-2#1)(1994-10#1)
receptor homologue##3##2##(1992-11#1)(1996-12#2)
receptor identified##2##2##(1992-8#1)(1993-12#1)
receptor imaging##2##2##(1997-8#1)(2009-10#1)
receptor immunoreactive##2##2##(1994-11#1)(1994-8#1)
receptor immunoreactivity in##2##3##(1992-8#1)(1993-12#1)
receptor immunoreactivity##5##2##(1992-8#1)(1993-12#2)(1993-4#1)(1994-10#1)
receptor in CHO##2##3##(1990-9#1)(1995-12#1)
receptor in K562 cells##2##4##(1994-6#2)
receptor in K562##3##3##(1992-8#1)(1994-6#2)
receptor in a human##3##4##(1992-6#2)(1993-3#1)
receptor in a##11##3##(1992-12#2)(1992-6#2)(1993-3#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-11#1)(2008-1#1)(2008-4#1)
receptor in an##2##3##(1994-12#1)(1994-2#1)
receptor in both##2##3##(1990-5#1)(1996-11#1)
receptor in breast##2##3##(1993-11#1)(1995-5#1)
receptor in human##7##3##(1990-2#2)(1991-12#1)(1991-3#1)(1992-12#1)(2008-10#1)(2008-5#1)
receptor in intact cells##2##4##(1990-9#2)
receptor in intact##3##3##(1990-9#2)(1997-6#1)
receptor in membranes from##2##4##(1990-3#1)(1996-8#1)
receptor in mouse##4##3##(1991-8#1)(1995-3#1)(1995-6#1)(2008-5#1)
receptor in normal##3##3##(1990-11#1)(1992-12#1)(1994-3#1)
receptor in plasma##2##3##(1990-10#1)(1994-2#1)
receptor in rat##11##3##(1990-11#1)(1991-4#1)(1992-12#1)(1993-11#1)(1994-9#1)(1995-12#3)(1996-1#1)(1996-11#1)(1997-8#1)
receptor in the control of##2##5##(1996-1#1)(2008-4#1)
receptor in the human##2##4##(1993-6#1)(1994-8#1)
receptor in the maintenance of thermal hyperalgesia induced by unilateral constriction injury to the sciatic nerve in the rat##2##19##(1995-12#2)
receptor in the presence##2##4##(1990-5#1)(1996-8#1)
receptor in the spinal cord##2##5##(1994-8#1)(1996-11#1)
receptor in the##47##3##(1990-11#1)(1990-5#2)(1990-7#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-8#3)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-2#1)(1996-8#1)(1997-4#2)(1997-6#1)(1997-8#1)(2007-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2010-12#2)(2011-2#1)(2012-3#1)
receptor in these##4##3##(1994-12#2)(1994-8#1)(2008-4#1)
receptor in this##2##3##(1991-9#1)(1995-3#1)
receptor in vitro##4##3##(1990-11#1)(1995-3#1)(1996-11#1)(1997-6#1)
receptor in##195##2##(1990-10#2)(1990-11#4)(1990-12#1)(1990-2#4)(1990-3#1)(1990-5#3)(1990-6#2)(1990-7#4)(1990-8#1)(1990-9#4)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#3)(1991-9#2)(1992-10#1)(1992-12#6)(1992-2#1)(1992-6#4)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#4)(1993-3#3)(1993-4#1)(1993-6#1)(1993-8#5)(1993-9#1)(1994-11#3)(1994-12#6)(1994-2#3)(1994-3#4)(1994-5#1)(1994-6#2)(1994-8#6)(1994-9#2)(1995-10#4)(1995-11#2)(1995-12#7)(1995-2#2)(1995-3#5)(1995-5#1)(1995-6#2)(1995-8#2)(1996-1#3)(1996-10#2)(1996-11#4)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-7#1)(1996-8#3)(1997-1#1)(1997-4#2)(1997-6#3)(1997-7#2)(1997-8#2)(2005-7#1)(2005-8#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#5)(2008-5#4)(2008-7#1)(2008-8#4)(2009-2#1)(2009-5#1)(2010-1#1)(2010-12#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
receptor increased with##2##3##(1992-8#1)(1996-3#1)
receptor independent##2##2##(2009-8#2)
receptor induced##2##2##(1990-9#1)(1993-8#1)
receptor induces##5##2##(1994-12#1)(1994-3#1)(1995-8#1)(2007-10#1)(2008-5#1)
receptor inhibition##4##2##(1993-3#1)(2007-11#2)(2008-8#1)
receptor inhibitor##2##2##(2006-6#1)(2008-6#1)
receptor inhibitors in##3##3##(2008-1#1)(2009-4#1)(2012-1#1)
receptor inhibitors##5##2##(2005-7#1)(2006-6#1)(2008-1#1)(2009-4#1)(2012-1#1)
receptor inhibits the##3##3##(1992-7#1)(2007-11#1)(2008-8#1)
receptor inhibits##5##2##(1992-7#1)(1996-1#1)(1996-8#1)(2007-11#1)(2008-8#1)
receptor interacting##2##2##(2012-12#1)(2013-1#1)
receptor interaction##8##2##(1993-3#1)(1993-8#1)(1995-2#1)(1995-6#2)(1995-8#1)(2005-8#1)(2013-8#1)
receptor interactions with##3##3##(1990-2#1)(2008-11#1)(2009-12#1)
receptor interactions##13##2##(1990-2#2)(1990-4#1)(1994-5#1)(1996-2#1)(1996-8#3)(2008-11#1)(2008-4#2)(2008-9#1)(2009-12#1)
receptor interacts with##3##3##(1993-6#1)(1993-8#1)(1994-12#1)
receptor internalization##11##2##(1990-11#2)(1991-3#2)(1994-11#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-2#1)(2008-5#1)
receptor into##2##2##(1993-3#1)(2006-11#1)
receptor intrinsic kinase activity##2##4##(1994-12#2)
receptor involved in##3##3##(1994-9#1)(2008-4#1)(2008-7#1)
receptor involved##4##2##(1990-2#1)(1994-9#1)(2008-4#1)(2008-7#1)
receptor involvement in##2##3##(1994-11#1)(1996-11#1)
receptor involvement##4##2##(1991-11#1)(1991-2#1)(1994-11#1)(1996-11#1)
receptor is a##12##3##(1991-2#1)(1992-8#1)(1993-3#2)(1993-6#2)(1994-12#1)(1995-11#1)(1995-8#1)(2007-8#1)(2008-3#1)(2011-2#1)
receptor is also##2##3##(1992-8#1)(2008-4#1)
receptor is an##5##3##(1991-4#1)(1993-3#1)(1994-8#1)(1996-7#1)(2008-4#1)
receptor is associated with##2##4##(1991-9#1)(2011-2#1)
receptor is currently##2##3##(2008-4#1)(2008-5#1)
receptor is essential for##2##4##(1994-12#1)(2007-11#1)
receptor is essential##3##3##(1994-12#2)(2007-11#1)
receptor is expressed in##2##4##(1997-2#1)(2013-8#1)
receptor is expressed on##2##4##(1991-12#1)(2006-1#1)
receptor is expressed##5##3##(1991-12#1)(1997-2#1)(1997-6#1)(2006-1#1)(2013-8#1)
receptor is important for##2##4##(1991-7#1)(1994-3#1)
receptor is involved in the##3##5##(1995-11#1)(2008-4#1)(2008-5#1)
receptor is involved in##5##4##(1995-11#1)(2008-4#2)(2008-5#1)(2008-8#1)
receptor is linked##2##3##(1994-12#1)(1994-9#1)
receptor is much##2##3##(1995-6#1)(2008-4#1)
receptor is necessary for##4##4##(1990-11#2)(1995-1#1)(1995-2#1)
receptor is necessary##5##3##(1990-11#2)(1995-1#1)(1995-2#1)(1996-8#1)
receptor is normally##2##3##(1992-12#1)(2007-9#1)
receptor is not required for##2##5##(1991-8#1)(1995-8#1)
receptor is not##4##3##(1991-8#1)(1995-3#1)(1995-8#1)(1996-10#1)
receptor is suggested##3##3##(1994-11#1)(1994-9#1)(1996-9#1)
receptor is the primary##2##4##(1992-12#1)(1996-5#1)
receptor is the##6##3##(1990-6#1)(1992-11#1)(1992-12#1)(1996-5#1)(2007-8#1)(2008-4#1)
receptor is##115##2##(1990-11#5)(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-2#4)(1991-4#1)(1991-5#3)(1991-7#1)(1991-8#2)(1991-9#3)(1992-11#1)(1992-12#2)(1992-3#2)(1992-8#2)(1993-3#4)(1993-6#2)(1994-11#2)(1994-12#5)(1994-2#1)(1994-3#2)(1994-8#5)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#5)(1995-3#1)(1995-6#3)(1995-8#2)(1996-10#1)(1996-5#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-5#1)(1997-6#2)(1997-7#1)(2005-9#1)(2006-1#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-8#2)(2007-9#1)(2008-11#2)(2008-3#2)(2008-4#11)(2008-5#3)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#2)(2013-8#1)
receptor isoform##5##2##(1994-12#1)(1994-5#1)(2005-8#1)(2007-10#1)(2010-10#1)
receptor isoforms##6##2##(1992-5#1)(1993-4#1)(1994-9#1)(1997-1#1)(2005-10#1)(2008-10#1)
receptor itself##3##2##(1995-3#1)(2008-3#1)(2009-12#1)
receptor kinase activity##5##3##(1990-3#1)(1993-12#2)(1994-12#1)(1994-5#1)
receptor kinase and##3##3##(1994-8#2)(2009-3#1)
receptor kinase in##3##3##(1993-12#2)(1995-3#1)
receptor kinase##23##2##(1990-3#2)(1991-12#2)(1992-12#1)(1992-3#1)(1993-12#6)(1994-12#1)(1994-5#1)(1994-8#2)(1995-3#2)(1997-4#2)(2009-3#1)(2009-4#1)(2011-2#1)
receptor kinases (GRKs)##2##3##(1996-5#1)(2005-7#1)
receptor kinases##7##2##(1995-2#1)(1996-5#2)(2005-7#2)(2006-10#1)(2009-8#1)
receptor knockout mice##2##3##(1996-8#1)(2008-11#1)
receptor knockout##4##2##(1996-8#1)(2008-11#1)(2008-4#1)(2008-5#1)
receptor labeling##2##2##(1991-5#1)(2006-5#1)
receptor leads to the##2##4##(1995-3#1)(2013-8#1)
receptor leads to##4##3##(1995-3#2)(1996-5#1)(2013-8#1)
receptor led to##3##3##(1993-7#1)(1994-9#1)(2009-8#1)
receptor level as well as plasminogen activator activity in MCF-7 cells##3##11##(2008-11#3)
receptor level##8##2##(1990-7#1)(1991-9#1)(1993-6#1)(1995-1#1)(2008-11#3)(2008-7#1)
receptor levels and the##2##4##(1991-2#1)(1993-11#1)
receptor levels and##3##3##(1991-2#1)(1993-11#1)(1996-11#1)
receptor levels in##4##3##(1991-11#1)(1993-12#1)(1995-7#1)(2013-1#1)
receptor levels##19##2##(1991-11#1)(1991-2#1)(1992-1#1)(1992-2#1)(1993-11#1)(1993-12#2)(1994-2#2)(1994-5#1)(1995-12#1)(1995-7#1)(1996-11#2)(1996-12#3)(1996-3#1)(2013-1#1)
receptor ligand binding##2##3##(1994-5#1)(1997-7#1)
receptor ligand##21##2##(1991-5#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-12#4)(1996-2#1)(1997-1#2)(1997-5#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-7#2)(2009-8#1)
receptor ligand)##2##2##(1995-5#2)
receptor ligands and##2##3##(1995-3#1)(2010-12#1)
receptor ligands in##5##3##(1995-10#1)(1995-12#1)(1996-10#1)(2008-10#1)(2013-1#1)
receptor ligands including##2##3##(1995-6#1)(2009-8#1)
receptor ligands on##2##3##(1994-2#1)(1996-12#1)
receptor ligands##50##2##(1990-10#1)(1990-2#1)(1991-3#1)(1992-10#1)(1992-3#1)(1992-5#2)(1992-8#1)(1993-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#2)(1995-10#1)(1995-11#2)(1995-12#3)(1995-3#3)(1995-6#1)(1996-10#1)(1996-12#2)(1996-8#2)(1997-2#3)(1997-8#1)(2006-1#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-8#1)(2010-12#1)(2010-3#1)(2013-1#1)(2013-8#1)
receptor loci##4##2##(1995-6#1)(2012-1#3)
receptor locus##3##2##(1990-12#1)(1993-10#1)(2005-8#1)
receptor loss##3##2##(1992-8#1)(1996-5#2)
receptor mRNA and protein##3##4##(1991-5#1)(1995-3#1)(1997-5#1)
receptor mRNA and##13##3##(1991-5#1)(1992-1#1)(1992-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1995-3#2)(1995-7#1)(1996-2#2)(1997-5#1)(1997-8#1)
receptor mRNA expression in the##2##5##(1995-6#1)(2010-12#1)
receptor mRNA expression in##5##4##(1993-3#1)(1994-12#1)(1995-6#2)(2010-12#1)
receptor mRNA expression##14##3##(1993-3#2)(1994-10#1)(1994-12#1)(1995-6#5)(1996-2#1)(1997-5#1)(2008-5#2)(2010-12#1)
receptor mRNA from##3##3##(1994-9#1)(1997-5#1)(2008-7#1)
receptor mRNA in rat##3##4##(1994-12#1)(1995-5#1)(1996-12#1)
receptor mRNA in the##6##4##(1994-11#1)(1994-12#1)(1995-12#1)(1996-5#1)(1997-5#1)(2008-5#1)
receptor mRNA in these cells##2##5##(1994-6#1)(1997-5#1)
receptor mRNA in##19##3##(1993-5#1)(1994-11#1)(1994-12#3)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-5#2)(1997-8#1)(2008-5#1)
receptor mRNA is expressed in##2##5##(1993-8#1)(1994-12#1)
receptor mRNA is expressed##3##4##(1993-8#1)(1994-12#2)
receptor mRNA is present in##2##5##(1993-12#1)(1995-1#1)
receptor mRNA is##7##3##(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#3)(1995-1#1)
receptor mRNA level##3##3##(1991-5#1)(1994-12#1)(1995-2#1)
receptor mRNA levels in##2##4##(1994-8#1)(1995-6#1)
receptor mRNA levels was##2##4##(1994-5#1)(1995-6#1)
receptor mRNA levels were##3##4##(1992-12#1)(1994-11#1)(1997-8#1)
receptor mRNA levels##12##3##(1992-1#1)(1992-12#1)(1994-10#1)(1994-11#1)(1994-5#1)(1994-8#2)(1995-6#3)(1996-4#1)(1997-8#1)
receptor mRNA was expressed in##2##5##(1994-2#1)(2008-5#1)
receptor mRNA was expressed intensely in laminae I##2##8##(1994-2#2)
receptor mRNA was expressed##4##4##(1994-2#3)(2008-5#1)
receptor mRNA was not##3##4##(1994-12#1)(1994-8#1)(1995-3#1)
receptor mRNA was##10##3##(1994-12#2)(1994-2#4)(1994-8#2)(1995-3#1)(2008-5#1)
receptor mRNA were##6##3##(1990-7#1)(1992-8#1)(1993-3#1)(1994-11#1)(1996-1#1)(2008-5#1)
receptor mRNA##114##2##(1990-7#1)(1991-12#1)(1991-5#3)(1992-1#2)(1992-12#1)(1992-2#2)(1992-8#3)(1993-11#1)(1993-12#2)(1993-3#4)(1993-5#2)(1993-6#1)(1993-8#1)(1994-10#2)(1994-11#3)(1994-12#10)(1994-2#6)(1994-5#3)(1994-6#1)(1994-8#5)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#5)(1995-3#4)(1995-5#1)(1995-6#9)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#6)(1996-4#2)(1996-5#3)(1997-5#6)(1997-8#3)(2008-4#2)(2008-5#6)(2008-7#1)(2009-4#1)(2010-12#1)
receptor mRNAs in the rat##2##5##(1993-12#1)(1994-2#1)
receptor mRNAs in the##3##4##(1993-12#1)(1994-2#2)
receptor mRNAs in##5##3##(1993-12#1)(1994-2#2)(1995-12#1)(1996-11#1)
receptor mRNAs were##4##3##(1991-7#1)(1993-2#1)(1994-8#1)(1996-11#1)
receptor mRNAs##13##2##(1991-7#1)(1993-12#2)(1993-2#1)(1994-2#2)(1994-8#1)(1995-12#1)(1996-11#3)(1996-2#1)(2008-6#1)
receptor may be involved##2##4##(1996-2#1)(2008-3#1)
receptor may be##5##3##(1995-2#1)(1996-2#1)(2008-10#2)(2008-3#1)
receptor may play a role in##2##6##(1990-11#1)(1991-3#1)
receptor may play a##3##4##(1990-11#1)(1991-3#1)(2008-4#1)
receptor may play##4##3##(1990-11#1)(1991-3#1)(1997-8#1)(2008-4#1)
receptor may##20##2##(1990-11#1)(1991-3#1)(1992-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-8#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)
receptor mechanism##4##2##(1993-9#2)(1995-3#1)(2010-7#1)
receptor mechanisms##2##2##(1991-5#1)(1992-8#1)
receptor mediated##19##2##(1991-1#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-3#1)(1993-2#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-4#1)(1997-2#2)(2007-11#1)(2008-10#1)(2008-8#1)(2013-8#1)
receptor mediates the##2##3##(1994-12#1)(1994-2#1)
receptor mediates##4##2##(1993-11#1)(1994-12#1)(1994-2#1)(1994-3#1)
receptor mediating##2##2##(1995-12#1)(1997-7#1)
receptor membranes##3##2##(1993-3#2)(1994-5#1)
receptor message##2##2##(1992-9#1)(1994-3#1)
receptor messenger RNA in##2##4##(1992-8#1)(1997-5#1)
receptor messenger RNA##4##3##(1991-5#1)(1992-8#1)(1994-6#1)(1997-5#1)
receptor messenger##6##2##(1990-10#1)(1991-5#1)(1992-8#1)(1994-6#1)(1996-11#1)(1997-5#1)
receptor might be##3##3##(1990-5#1)(1993-3#1)(1996-12#1)
receptor modulates##2##2##(1995-2#1)(1996-5#1)
receptor modulation##4##2##(1994-11#1)(1997-7#1)(2004-12#1)(2008-4#1)
receptor modulators in##3##3##(2012-12#3)
receptor modulators with##2##3##(2007-12#1)(2008-4#1)
receptor modulators##10##2##(2005-12#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2012-12#4)
receptor molecule##10##2##(1991-4#1)(1994-11#1)(1994-3#2)(1994-9#1)(1997-6#1)(2006-12#2)(2008-1#1)(2012-2#1)
receptor molecules and##3##3##(1996-12#2)(2008-5#1)
receptor molecules in##2##3##(1993-8#1)(1996-12#1)
receptor molecules##18##2##(1992-11#1)(1992-12#2)(1992-7#1)(1993-8#3)(1994-9#1)(1996-12#5)(2008-1#2)(2008-4#1)(2008-5#1)(2009-8#1)
receptor monoclonal antibody##2##3##(1996-12#1)(2008-5#1)
receptor monoclonal##3##2##(1996-12#1)(2008-1#1)(2008-5#1)
receptor must be##2##3##(1996-5#1)(2011-2#1)
receptor mutant mice##4##3##(1996-10#3)(1996-3#1)
receptor mutant##6##2##(1996-10#3)(1996-3#1)(1997-6#1)(2011-1#1)
receptor mutation##2##2##(1995-11#1)(1995-6#1)
receptor mutations##2##2##(1997-4#1)(2008-6#1)
receptor negative##7##2##(2004-2#3)(2008-2#1)(2011-1#2)(2011-2#1)
receptor neurones##2##2##(2007-12#2)
receptor neurons in##2##3##(2007-12#2)
receptor neurons##13##2##(1992-5#1)(2007-12#10)(2008-7#1)(2009-12#1)
receptor nor the##2##3##(1990-12#1)(2008-11#1)
receptor nor##5##2##(1990-12#1)(1992-8#1)(1994-6#1)(1995-12#1)(2008-11#1)
receptor not##2##2##(1992-4#1)(1996-8#1)
receptor nuclear translocator##2##3##(1997-4#1)(2008-7#1)
receptor number or##2##3##(1990-2#1)(1992-9#1)
receptor number##8##2##(1990-2#1)(1990-5#1)(1992-8#1)(1992-9#1)(1993-6#1)(1995-10#1)(1996-10#1)(1996-11#1)
receptor occupancy##2##2##(1991-12#1)(1994-11#1)
receptor occurs in##2##3##(1992-9#1)(1993-12#1)
receptor occurs##4##2##(1991-4#1)(1992-8#1)(1992-9#1)(1993-12#1)
receptor of bacterial chemotaxis##2##4##(1992-8#1)(1994-5#1)
receptor of the##12##3##(1992-1#1)(1993-4#1)(1994-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-5#4)(1997-6#1)(2011-2#1)
receptor of##39##2##(1990-7#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-8#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-8#2)(1994-2#1)(1994-5#2)(1995-2#1)(1995-3#2)(1995-8#1)(1996-2#1)(1997-4#1)(1997-5#6)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-8#2)(2010-4#1)(2011-2#1)(2013-8#1)
receptor on the##9##3##(1990-5#2)(1993-12#1)(1994-11#1)(2006-10#2)(2008-1#1)(2008-11#1)(2008-5#1)
receptor on##33##2##(1990-5#2)(1990-7#2)(1990-8#1)(1992-10#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-4#1)(2005-10#1)(2006-10#2)(2007-11#1)(2008-1#1)(2008-11#3)(2008-5#1)(2012-2#1)(2013-1#1)(2013-7#1)
receptor operated##2##2##(1993-8#1)(1995-5#1)
receptor or the##2##3##(1997-6#1)(2008-4#1)
receptor or##12##2##(1990-8#1)(1991-7#1)(1993-9#1)(1994-6#1)(1995-10#1)(1995-3#1)(1995-7#1)(1997-6#1)(2007-11#1)(2008-4#1)(2013-1#2)
receptor organ##3##2##(1995-8#1)(2012-12#2)
receptor partial agonist##5##3##(1996-11#1)(1996-12#1)(1997-5#2)(2005-9#1)
receptor partial cDNA##2##3##(1992-5#1)(1993-3#1)
receptor partial##8##2##(1992-5#1)(1993-11#1)(1993-3#1)(1996-11#1)(1996-12#1)(1997-5#2)(2005-9#1)
receptor pathway##8##2##(1995-11#1)(2008-4#2)(2010-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
receptor patterns in the plasma membrane of##2##7##(2006-10#2)
receptor patterns##3##2##(2006-10#3)
receptor peptide##6##2##(1991-5#1)(1991-7#1)(1994-12#2)(1994-6#1)(1995-3#1)
receptor pharmacology##2##2##(1994-2#1)(2007-11#1)
receptor phosphatase##3##2##(1995-8#3)
receptor phosphorylation and##2##3##(1990-10#1)(1996-8#1)
receptor phosphorylation by##3##3##(1995-6#2)(1996-5#1)
receptor phosphorylation##13##2##(1990-10#1)(1991-3#1)(1992-3#1)(1993-3#1)(1995-6#2)(1995-7#1)(1996-12#1)(1996-5#2)(1996-8#1)(2010-12#1)(2013-7#1)
receptor physiology and##2##3##(2006-10#1)(2010-5#1)
receptor plays a##6##3##(1993-3#1)(1995-2#1)(1995-6#1)(1996-12#1)(2008-11#1)(2008-4#1)
receptor plays##7##2##(1993-3#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-12#1)(2008-11#1)(2008-4#1)
receptor polymorphism##2##2##(2008-1#1)(2008-3#1)
receptor polymorphisms##2##2##(2007-7#1)(2009-7#1)
receptor population##4##2##(1992-12#1)(1994-9#1)(1997-5#1)(2008-3#1)
receptor populations in##3##3##(1994-10#3)
receptor populations##9##2##(1990-8#2)(1991-12#1)(1991-4#1)(1994-10#3)(1994-11#1)(1994-9#1)
receptor positive fibres##2##3##(1992-8#1)(1993-9#1)
receptor positive##13##2##(1991-8#1)(1992-8#1)(1993-9#2)(1995-9#2)(1996-11#1)(2004-2#1)(2008-12#1)(2008-5#1)(2010-1#1)(2012-1#1)(2013-1#1)
receptor positivity##2##2##(1996-4#1)(2009-7#1)
receptor potential##7##2##(1995-3#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-9#1)(2011-2#1)(2013-1#1)
receptor preparations##5##2##(1990-11#1)(1990-7#1)(1991-1#1)(1992-11#1)(1994-3#1)
receptor present on##2##3##(1994-11#1)(1995-1#1)
receptor present##4##2##(1992-12#1)(1993-6#1)(1994-11#1)(1995-1#1)
receptor probe##3##2##(1992-4#1)(1993-12#1)(1996-2#1)
receptor production##2##2##(2008-11#2)
receptor promoter##4##2##(1991-7#1)(1994-11#1)(1996-5#1)(2008-6#1)
receptor properties##6##2##(1992-1#1)(1995-11#2)(1995-12#1)(1996-1#1)(1996-5#1)
receptor protein in##3##3##(1992-8#1)(1995-10#1)(2006-12#1)
receptor protein is##2##3##(1997-7#1)(2006-12#1)
receptor protein tyrosine kinase##5##4##(1993-8#2)(1995-3#1)(1997-7#1)(2012-12#1)
receptor protein was##4##3##(1992-12#1)(1994-11#1)(1996-5#1)(2008-11#1)
receptor protein##50##2##(1990-12#1)(1990-4#1)(1990-8#2)(1991-3#1)(1991-4#1)(1991-7#1)(1992-12#3)(1992-6#1)(1992-8#2)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-3#1)(1994-5#1)(1995-10#4)(1995-3#2)(1995-7#1)(1995-8#2)(1996-1#1)(1996-5#1)(1997-6#1)(1997-7#2)(2005-8#2)(2006-12#3)(2007-11#1)(2008-10#1)(2008-11#2)(2008-4#3)(2008-9#1)(2012-12#1)
receptor protein-tyrosine##3##2##(1991-1#2)(1993-6#1)
receptor proteins##14##2##(1990-11#1)(1992-2#1)(1992-3#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-8#2)(1996-9#1)(2006-12#1)(2009-12#1)(2010-2#1)(2012-12#1)
receptor pseudogene##2##2##(1993-12#1)(1993-2#1)
receptor purified from##2##3##(1991-9#1)(1992-11#1)
receptor purified##3##2##(1991-12#1)(1991-9#1)(1992-11#1)
receptor radioligand##5##2##(1994-8#1)(1995-11#1)(1995-12#1)(1997-2#2)
receptor rearrangement##2##2##(1995-6#1)(1997-9#1)
receptor recognition site##3##3##(1991-2#1)(1995-12#1)(1995-3#1)
receptor recognition##9##2##(1991-2#1)(1991-4#1)(1991-7#1)(1995-12#1)(1995-3#2)(1996-4#1)(2008-8#1)(2010-2#1)
receptor reconstituted##2##2##(1994-3#1)(1995-8#1)
receptor regulated by##2##3##(1997-4#1)(2008-8#1)
receptor regulated##4##2##(1993-6#1)(1994-12#1)(1997-4#1)(2008-8#1)
receptor regulation and##2##3##(2008-4#2)
receptor regulation##7##2##(1993-6#1)(2007-8#1)(2008-4#3)(2008-8#1)(2009-8#1)
receptor remains a##2##3##(1995-8#1)(2011-1#1)
receptor remains##4##2##(1994-8#1)(1995-6#1)(1995-8#1)(2011-1#1)
receptor represents a##2##3##(1995-11#1)(1996-12#1)
receptor responsible for##5##3##(1990-11#1)(1991-1#1)(1995-2#1)(1996-6#1)(1996-8#1)
receptor results in##2##3##(1993-6#1)(1996-8#1)
receptor results##3##2##(1992-12#1)(1993-6#1)(1996-8#1)
receptor retained its##2##3##(1990-7#1)(1995-3#1)
receptor rose to##2##3##(1993-2#2)
receptor selective ligands##2##3##(1994-12#1)(1996-10#1)
receptor selective##10##2##(1991-1#1)(1991-12#1)(1994-11#1)(1994-12#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-8#1)(1996-9#1)(2008-8#1)
receptor selectively##2##2##(1993-11#1)(1995-6#1)
receptor selectivity##3##2##(1992-3#1)(2004-3#1)(2011-2#1)
receptor sequence##3##2##(1994-3#1)(1995-6#1)(2011-2#1)
receptor sequences##2##2##(1992-2#1)(2008-4#1)
receptor showed that##2##3##(1993-6#1)(1996-12#1)
receptor showed##5##2##(1992-8#1)(1993-6#1)(1995-11#1)(1996-12#1)(1997-2#1)
receptor shows a##2##3##(1991-11#1)(1993-12#1)
receptor shows##4##2##(1991-11#1)(1991-2#1)(1993-12#1)(1994-5#1)
receptor signal##6##2##(1992-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-2#1)
receptor signaling in##7##3##(2005-10#1)(2008-11#1)(2008-6#1)(2010-11#2)(2012-2#2)
receptor signaling pathways##2##3##(1991-9#1)(1994-12#1)
receptor signaling##23##2##(1991-9#1)(1992-3#1)(1994-12#1)(2005-10#1)(2007-11#1)(2008-11#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-11#4)(2010-3#1)(2012-2#3)(2013-1#1)
receptor signalling##7##2##(1991-1#1)(2006-10#1)(2006-11#1)(2008-4#4)
receptor signals##2##2##(1994-3#1)(1995-2#1)
receptor since##2##2##(1993-1#1)(1995-6#1)
receptor site##9##2##(1990-5#1)(1991-3#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-8#1)(1997-2#1)(2005-9#1)(2007-11#1)
receptor sites in##4##3##(1990-3#1)(1992-6#1)(1994-11#1)(1995-7#1)
receptor sites on##3##3##(1990-7#1)(1991-2#1)(1995-11#1)
receptor sites##18##2##(1990-2#1)(1990-3#1)(1990-7#2)(1991-2#1)(1991-7#1)(1991-9#1)(1992-6#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-7#1)(1996-10#1)(1996-12#1)(2007-11#1)(2008-5#1)(2008-9#1)
receptor species##4##2##(1990-7#1)(1991-9#2)(2008-1#1)
receptor specific##4##2##(1997-7#1)(2004-10#1)(2008-3#1)(2013-8#1)
receptor specifically binds##2##3##(1994-11#1)(1994-12#1)
receptor specifically##3##2##(1994-11#1)(1994-12#1)(1995-6#1)
receptor specificity##3##2##(1994-12#1)(2007-9#2)
receptor staining##2##2##(1994-10#1)(2012-2#1)
receptor status and##4##3##(1990-5#1)(1991-12#1)(2007-11#1)(2013-1#1)
receptor status of##3##3##(1993-6#1)(2007-2#1)(2009-12#1)
receptor status##23##2##(1990-2#1)(1990-5#1)(1991-12#1)(1992-2#1)(1992-8#1)(1993-11#2)(1993-6#1)(1994-7#1)(1995-10#1)(1995-4#2)(1995-9#1)(1996-11#1)(2004-2#2)(2007-11#1)(2007-2#3)(2007-4#1)(2009-12#1)(2013-1#1)
receptor stimulates##4##2##(1994-6#1)(1995-1#1)(1997-7#1)(2007-12#1)
receptor stimulation is##2##3##(1994-2#1)(1995-11#1)
receptor stimulation on##4##3##(1996-12#1)(1996-8#1)(1997-5#2)
receptor stimulation with##4##3##(1990-5#2)(1991-12#1)(1995-11#1)
receptor stimulation##31##2##(1990-5#2)(1991-10#1)(1991-12#1)(1992-6#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#2)(1995-2#1)(1996-1#1)(1996-12#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#2)(1997-6#1)(2008-4#5)(2010-12#2)(2012-1#1)
receptor structural gene##2##3##(1993-6#1)(1995-12#1)
receptor study##3##2##(1991-7#2)(2007-2#1)
receptor sub-type##2##2##(1991-12#1)(1992-3#1)
receptor subfamily##2##2##(1994-12#1)(1997-4#1)
receptor substrate-1 (IRS-1) is##2##4##(1995-8#1)(1996-8#1)
receptor substrate-1 (IRS-1)##6##3##(1995-6#1)(1995-8#1)(1996-10#1)(1996-5#1)(1996-8#1)(1997-7#1)
receptor substrate-1##10##2##(1995-6#2)(1995-8#1)(1996-10#1)(1996-5#1)(1996-8#1)(1997-7#2)(2013-1#2)
receptor substrates##2##2##(1992-10#1)(2008-6#1)
receptor subtype activation)##2##3##(1995-12#2)
receptor subtype and##2##3##(1994-2#1)(2008-10#1)
receptor subtype antagonists##2##3##(1991-9#1)(1997-8#1)
receptor subtype in the##3##4##(1991-5#1)(1993-12#1)(1997-1#1)
receptor subtype in##4##3##(1991-5#1)(1993-12#1)(1995-11#1)(1997-1#1)
receptor subtype involved in##2##4##(1996-12#1)(1996-2#1)
receptor subtype may##2##3##(1994-9#1)(1996-12#1)
receptor subtype of##2##3##(1991-5#1)(1993-2#1)
receptor subtype selectivity##3##3##(1991-9#1)(1995-7#1)(1997-1#1)
receptor subtype that##2##3##(1994-9#1)(1995-5#1)
receptor subtype##75##2##(1991-5#2)(1991-9#4)(1992-11#1)(1992-12#1)(1992-3#4)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#5)(1993-5#1)(1993-6#1)(1993-9#1)(1994-2#2)(1994-3#5)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#4)(1995-5#1)(1995-7#1)(1996-10#1)(1996-12#5)(1996-2#2)(1996-5#1)(1996-9#1)(1997-1#3)(1997-5#4)(1997-6#1)(1997-8#2)(2006-10#1)(2008-10#1)(2008-4#5)(2012-12#1)
receptor subtypes and##3##3##(1994-12#1)(2005-8#1)(2010-3#1)
receptor subtypes are##5##3##(1990-5#1)(1995-12#1)(1996-12#2)(2005-9#1)
receptor subtypes as##2##3##(1994-12#1)(1994-9#1)
receptor subtypes have been##2##4##(1993-12#1)(1995-11#1)
receptor subtypes have##3##3##(1993-12#1)(1994-6#1)(1995-11#1)
receptor subtypes in rat brain##2##5##(1991-1#1)(1996-3#1)
receptor subtypes in rat##3##4##(1991-1#1)(1996-3#1)(1996-5#1)
receptor subtypes in the##8##4##(1990-11#1)(1990-5#1)(1991-9#1)(1995-10#2)(1996-1#1)(1996-5#1)(1997-5#1)
receptor subtypes in##17##3##(1990-11#2)(1990-5#1)(1991-1#1)(1991-11#1)(1991-9#1)(1995-10#2)(1995-11#1)(1996-1#1)(1996-3#1)(1996-5#2)(1997-5#2)(2008-11#1)(2011-2#1)
receptor subtypes were assessed by##2##5##(1994-9#1)(1995-10#1)
receptor subtypes were##3##3##(1993-12#1)(1994-9#1)(1995-10#1)
receptor subtypes with##3##3##(1990-6#1)(1997-1#1)(2008-8#1)
receptor subtypes##104##2##(1990-11#3)(1990-3#1)(1990-5#3)(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#4)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-6#4)(1994-9#6)(1995-10#4)(1995-11#4)(1995-12#4)(1995-2#2)(1995-3#3)(1995-7#2)(1996-1#1)(1996-12#6)(1996-2#1)(1996-3#4)(1996-5#3)(1997-1#1)(1997-3#1)(1997-5#2)(1997-7#1)(1997-8#1)(2004-12#1)(2005-6#2)(2005-8#2)(2005-9#2)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-5#1)(2011-2#1)
receptor subunit gene##2##3##(1993-11#1)(1995-3#1)
receptor subunit genes##2##3##(1990-8#1)(1996-2#1)
receptor subunit in the##2##4##(1995-12#2)
receptor subunit is##2##3##(1995-3#1)(1996-12#1)
receptor subunit mRNA expression in##2##5##(1997-8#1)(2008-4#1)
receptor subunit mRNA##3##3##(1996-12#1)(1997-8#1)(2008-4#1)
receptor subunit mRNAs##2##3##(1995-11#1)(1996-12#1)
receptor subunit##36##2##(1990-8#1)(1993-11#2)(1993-12#2)(1994-5#2)(1994-9#1)(1995-11#2)(1995-12#5)(1995-3#2)(1995-5#1)(1996-12#5)(1996-2#1)(1996-5#2)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2008-4#1)(2008-7#1)
receptor subunits are##2##3##(1995-5#1)(1997-7#1)
receptor subunits in the##2##4##(1995-11#1)(1995-5#1)
receptor subunits##29##2##(1990-7#1)(1990-8#2)(1993-9#2)(1994-2#2)(1995-11#1)(1995-12#2)(1995-5#3)(1996-10#1)(1996-5#2)(1997-2#2)(1997-6#2)(1997-7#4)(2008-4#2)(2010-8#1)(2012-12#1)(2013-1#1)
receptor suggests that##2##3##(1994-9#1)(2006-12#1)
receptor super family##2##3##(2008-7#1)(2013-8#1)
receptor superfamily##34##2##(1991-5#1)(1991-9#1)(1992-2#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#4)(1994-5#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-6#1)(1995-8#1)(1996-10#2)(1996-2#2)(1996-5#2)(1997-1#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-3#1)(2009-4#1)(2010-12#1)(2013-8#1)
receptor synthesis##5##2##(1992-9#1)(1993-8#1)(1994-5#1)(1995-3#1)(2007-11#1)
receptor system##15##2##(1990-12#2)(1991-10#1)(1993-6#2)(1995-11#2)(1995-3#1)(1996-9#1)(1997-5#1)(2006-10#1)(2008-11#1)(2008-4#1)(2012-1#1)(2013-7#1)
receptor systems##12##2##(1990-3#1)(1992-10#2)(1992-4#1)(1994-11#1)(1994-2#1)(1996-4#1)(1996-5#1)(2008-1#2)(2008-4#1)(2009-3#1)
receptor targeting##2##2##(1993-8#1)(2011-1#1)
receptor targets##2##2##(1995-11#1)(2005-8#1)
receptor than##2##2##(1995-1#1)(2006-5#1)
receptor that could##2##3##(1991-6#1)(1994-8#1)
receptor that is##6##3##(1993-3#1)(1994-5#1)(1996-12#1)(1997-2#1)(2008-4#1)(2012-1#1)
receptor that mediates##2##3##(1995-6#1)(2007-11#1)
receptor that recognizes OxLDL##2##4##(1995-2#2)
receptor that recognizes##3##3##(1992-6#1)(1995-2#2)
receptor that##30##2##(1990-6#2)(1991-6#1)(1991-7#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-12#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-12#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-3#1)(2008-4#3)(2012-1#2)
receptor through##4##2##(1992-8#1)(1994-8#1)(1996-5#2)
receptor to DNA##2##3##(1995-2#1)(2008-4#1)
receptor to be##6##3##(1990-5#1)(1990-9#1)(1991-1#1)(1991-3#1)(2008-4#2)
receptor to the plasma membrane##2##5##(1990-7#1)(1993-4#1)
receptor to the##9##3##(1990-7#1)(1991-3#1)(1993-4#1)(1993-6#1)(1994-11#1)(1995-11#1)(1995-3#1)(1996-5#1)(2006-10#1)
receptor to##47##2##(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#2)(1991-1#1)(1991-3#2)(1992-3#1)(1992-6#2)(1992-9#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#3)(1996-11#1)(1996-5#3)(1996-8#2)(1997-7#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-4#5)(2009-4#1)(2012-2#1)
receptor transcripts##3##2##(1993-3#1)(1994-9#1)(1995-10#1)
receptor transfected cells was##2##4##(1993-9#2)
receptor transgenic mice##4##3##(1990-12#1)(1996-10#1)(2008-11#2)
receptor transgenic##5##2##(1990-12#1)(1996-10#1)(2008-11#3)
receptor translocation##2##2##(1990-12#1)(2008-3#1)
receptor type 2##3##3##(2007-11#1)(2009-3#1)(2011-2#1)
receptor type I##2##3##(1996-12#1)(2011-1#1)
receptor type II##5##3##(1995-7#1)(1996-5#1)(2007-12#3)
receptor type##20##2##(1990-6#1)(1991-4#1)(1994-6#1)(1995-5#2)(1995-7#1)(1996-12#1)(1996-5#1)(1997-5#1)(2005-8#1)(2007-11#1)(2007-12#3)(2008-4#1)(2009-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-8#1)
receptor types##4##2##(1992-9#1)(1993-4#1)(1994-2#1)(1994-5#1)
receptor tyrosine kinase Axl##2##4##(2013-1#2)
receptor tyrosine kinase activity##6##4##(1990-12#2)(1990-4#1)(1991-12#1)(1996-11#1)(1997-1#1)
receptor tyrosine kinase and##5##4##(1993-12#1)(1994-9#1)(1995-3#1)(2010-4#1)(2012-2#1)
receptor tyrosine kinase domain##3##4##(1990-4#1)(1992-12#2)
receptor tyrosine kinase gene##2##4##(1992-9#1)(2008-7#1)
receptor tyrosine kinase genes##2##4##(1993-8#1)(2008-7#1)
receptor tyrosine kinase inhibitor##3##4##(2008-5#1)(2008-6#1)(2010-7#1)
receptor tyrosine kinase inhibitors##5##4##(1996-6#3)(2008-5#1)(2012-1#1)
receptor tyrosine kinase that##2##4##(1995-10#1)(2008-5#1)
receptor tyrosine kinase##59##3##(1990-11#1)(1990-12#2)(1990-4#3)(1991-12#1)(1991-5#1)(1992-12#2)(1992-7#1)(1992-9#2)(1993-12#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-3#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-5#3)(1996-6#8)(1996-9#1)(1997-1#1)(2007-10#1)(2008-5#4)(2008-6#1)(2008-7#3)(2009-4#2)(2010-4#2)(2010-7#1)(2012-1#1)(2012-2#1)(2013-1#2)
receptor tyrosine kinases (RTKs)##2##4##(1993-8#1)(2009-9#1)
receptor tyrosine kinases##24##3##(1990-7#1)(1992-1#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-3#1)(1996-8#3)(1996-9#1)(2007-10#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-8#1)(2012-12#1)
receptor tyrosine##87##2##(1990-11#1)(1990-12#2)(1990-4#3)(1990-7#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-12#2)(1992-7#1)(1992-9#2)(1993-12#1)(1993-6#3)(1993-8#2)(1994-11#1)(1994-12#2)(1994-3#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#3)(1995-8#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-5#3)(1996-6#8)(1996-8#3)(1996-9#2)(1997-1#1)(2007-10#2)(2008-1#1)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-4#2)(2010-7#1)(2010-8#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#2)
receptor under feedback control##2##4##(1996-8#2)
receptor under##3##2##(1996-5#1)(1996-8#2)
receptor using the##2##3##(1996-1#1)(1997-5#1)
receptor using##4##2##(1992-11#1)(1992-9#1)(1996-1#1)(1997-5#1)
receptor values##2##2##(1990-5#1)(1991-2#1)
receptor variant##3##2##(1993-12#1)(1994-12#2)
receptor variants in isolated adipocytes##2##5##(1991-12#2)
receptor variants##3##2##(1991-12#2)(2012-2#1)
receptor varies##2##2##(1995-12#1)(1996-2#1)
receptor via a##2##3##(1990-12#1)(1995-11#1)
receptor via both the##2##4##(1994-5#1)(1995-6#1)
receptor via##8##2##(1990-12#1)(1991-2#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-6#1)(2008-8#1)
receptor was also##2##3##(1997-5#1)(2006-9#1)
receptor was detected##2##3##(1990-8#1)(1992-8#1)
receptor was determined##2##3##(1994-9#1)(2008-4#1)
receptor was expressed in##3##4##(1990-11#1)(1991-9#1)(1992-9#1)
receptor was investigated in##2##4##(1993-3#1)(1996-3#1)
receptor was involved in##3##4##(1994-12#1)(2008-4#1)(2008-8#1)
receptor was isolated by##2##4##(1993-3#1)(1996-10#1)
receptor was isolated from a##2##5##(1991-5#1)(1992-2#1)
receptor was isolated from##3##4##(1991-3#1)(1991-5#1)(1992-2#1)
receptor was isolated##7##3##(1991-3#1)(1991-5#1)(1992-2#1)(1993-3#1)(1994-12#1)(1996-10#2)
receptor was more##2##3##(1992-11#1)(1994-8#1)
receptor was purified in##2##4##(1992-6#1)(1993-6#1)
receptor was purified##3##3##(1992-6#1)(1993-6#1)(2008-8#1)
receptor was##73##2##(1990-11#1)(1990-2#2)(1990-4#1)(1990-7#2)(1990-8#1)(1991-3#2)(1991-5#4)(1991-7#1)(1991-9#2)(1992-11#4)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#3)(1993-12#1)(1993-3#2)(1993-6#1)(1993-7#1)(1994-12#3)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#4)(1995-10#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-10#2)(1996-3#1)(1996-4#1)(1997-2#1)(1997-5#1)(2006-9#1)(2007-2#1)(2008-11#3)(2008-4#6)(2008-8#3)(2008-9#1)(2011-2#1)(2013-7#1)
receptor were isolated##2##3##(1991-5#1)(1992-12#1)
receptor were measured in##2##4##(1994-9#1)(1996-4#1)
receptor were used##2##3##(1995-11#1)(2006-5#1)
receptor were##22##2##(1990-7#2)(1990-8#1)(1991-11#1)(1991-5#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-9#1)(1993-6#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1996-4#1)(2006-4#1)(2006-5#1)(2008-11#1)(2008-8#1)
receptor when##2##2##(1992-3#1)(2013-8#1)
receptor which is##3##3##(1991-4#1)(1996-5#1)(2008-11#1)
receptor which##11##2##(1990-7#1)(1991-2#1)(1991-4#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-9#1)(1996-5#1)(2008-11#1)(2008-3#1)
receptor while##2##2##(1991-9#1)(1992-3#1)
receptor with a##6##3##(1990-12#1)(1993-3#2)(1994-12#1)(1995-1#1)(1995-11#1)
receptor with an##2##3##(1992-9#1)(2007-2#1)
receptor with high##2##3##(1995-3#1)(2008-8#1)
receptor with its##2##3##(1994-8#1)(1995-10#1)
receptor with no##2##3##(1991-2#1)(1994-8#1)
receptor with the##6##3##(1990-5#1)(1990-8#1)(1991-8#1)(1993-3#1)(1996-11#1)(1996-8#1)
receptor with##39##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-9#1)(1993-3#3)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-10#3)(1995-11#2)(1995-3#2)(1996-11#1)(1996-8#3)(1997-6#1)(2007-2#1)(2008-4#1)(2008-8#1)(2013-7#1)
receptor without##2##2##(1990-9#1)(1995-3#1)
receptor would##2##2##(1990-7#1)(1995-3#1)
receptor##7022##1##(1990-10#19)(1990-11#66)(1990-12#49)(1990-2#80)(1990-3#17)(1990-4#11)(1990-5#55)(1990-6#14)(1990-7#74)(1990-8#38)(1990-9#20)(1991-1#35)(1991-10#26)(1991-11#25)(1991-12#53)(1991-2#53)(1991-3#49)(1991-4#31)(1991-5#92)(1991-6#23)(1991-7#30)(1991-8#33)(1991-9#72)(1992-1#15)(1992-10#13)(1992-11#53)(1992-12#65)(1992-2#33)(1992-3#78)(1992-4#15)(1992-5#39)(1992-6#42)(1992-7#19)(1992-8#69)(1992-9#70)(1993-1#7)(1993-10#2)(1993-11#96)(1993-12#102)(1993-2#17)(1993-3#125)(1993-4#24)(1993-5#12)(1993-6#57)(1993-7#20)(1993-8#54)(1993-9#45)(1994-10#21)(1994-11#99)(1994-12#150)(1994-2#100)(1994-3#78)(1994-5#86)(1994-6#50)(1994-7#1)(1994-8#94)(1994-9#124)(1995-1#25)(1995-10#76)(1995-11#108)(1995-12#147)(1995-2#99)(1995-3#167)(1995-4#4)(1995-5#48)(1995-6#100)(1995-7#41)(1995-8#54)(1995-9#10)(1996-1#27)(1996-10#72)(1996-11#59)(1996-12#148)(1996-2#83)(1996-3#35)(1996-4#31)(1996-5#148)(1996-6#33)(1996-7#25)(1996-8#99)(1996-9#27)(1997-1#40)(1997-2#78)(1997-3#19)(1997-4#45)(1997-5#109)(1997-6#44)(1997-7#77)(1997-8#39)(1997-9#5)(2003-11#1)(2004-1#4)(2004-10#2)(2004-12#11)(2004-2#7)(2004-3#3)(2004-9#1)(2005-1#2)(2005-10#11)(2005-11#11)(2005-12#1)(2005-3#1)(2005-6#9)(2005-7#44)(2005-8#36)(2005-9#15)(2006-1#5)(2006-10#68)(2006-11#4)(2006-12#16)(2006-2#2)(2006-4#2)(2006-5#15)(2006-6#11)(2006-8#4)(2006-9#8)(2007-1#19)(2007-10#12)(2007-11#69)(2007-12#46)(2007-2#13)(2007-3#1)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#2)(2007-8#28)(2007-9#16)(2008-1#67)(2008-10#45)(2008-11#115)(2008-12#7)(2008-2#16)(2008-3#38)(2008-4#273)(2008-5#69)(2008-6#28)(2008-7#76)(2008-8#91)(2008-9#43)(2009-10#3)(2009-11#2)(2009-12#16)(2009-2#13)(2009-3#14)(2009-4#20)(2009-5#4)(2009-6#5)(2009-7#7)(2009-8#37)(2009-9#11)(2010-1#3)(2010-10#10)(2010-11#11)(2010-12#37)(2010-2#6)(2010-3#20)(2010-4#12)(2010-5#11)(2010-6#11)(2010-7#8)(2010-8#14)(2010-9#3)(2011-1#32)(2011-12#6)(2011-2#63)(2011-3#2)(2012-1#37)(2012-11#4)(2012-12#57)(2012-2#53)(2012-3#22)(2013-1#81)(2013-7#14)(2013-8#37)
receptor&quot##3##1##(1990-11#1)(1990-3#1)(1995-2#1)
receptor'##2##1##(2008-11#1)(2012-12#1)
receptor's##7##1##(1991-2#1)(1994-6#1)(1996-8#1)(1997-7#1)(2005-11#1)(2011-2#1)(2012-3#1)
receptor(s) and##2##2##(1993-3#1)(2006-1#1)
receptor(s) in##2##2##(2008-10#1)(2013-1#1)
receptor(s)##12##1##(1990-2#1)(1990-5#2)(1993-12#1)(1993-3#1)(1994-9#1)(1997-2#1)(2006-1#1)(2006-10#1)(2008-10#1)(2010-12#1)(2013-1#1)
receptor) and##7##2##(1990-10#1)(1990-2#1)(1996-5#1)(2006-10#1)(2008-4#1)(2010-6#1)(2011-2#1)
receptor) are##2##2##(2008-5#1)(2010-12#1)
receptor) were##2##2##(1990-2#1)(1992-11#1)
receptor)##31##1##(1990-10#1)(1990-2#2)(1990-3#1)(1991-2#1)(1992-11#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-6#1)(1996-5#1)(2006-10#1)(2008-1#1)(2008-11#2)(2008-4#3)(2008-5#1)(2008-8#1)(2009-2#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-2#1)(2012-11#1)
receptor- and##2##2##(1990-7#1)(1994-12#1)
receptor-##5##1##(1990-7#1)(1994-12#2)(2008-7#1)(2013-1#1)
receptor-1##6##1##(1993-6#2)(1994-8#1)(1995-8#1)(2009-3#1)(2010-5#1)
receptor-2##4##1##(2008-5#1)(2010-2#1)(2012-12#1)(2012-3#1)
receptor-CD3 complex##3##2##(1990-3#1)(1992-2#1)(1996-7#1)
receptor-activated##6##1##(1994-10#1)(1996-2#1)(1997-5#1)(2006-10#2)(2008-4#1)
receptor-alpha and##2##2##(1997-7#1)(2009-10#1)
receptor-alpha##9##1##(1995-2#2)(1997-7#1)(2009-10#1)(2009-11#2)(2011-2#2)(2013-1#1)
receptor-associated ion##2##2##(1994-2#1)(1994-5#1)
receptor-associated##12##1##(1991-5#1)(1994-2#1)(1994-5#1)(1995-8#1)(1996-5#2)(1997-6#3)(2008-8#1)(2013-1#2)
receptor-bearing neurons##3##2##(1991-12#3)
receptor-bearing##4##1##(1991-12#4)
receptor-binding affinity##4##2##(2012-2#4)
receptor-binding potency##2##2##(1991-7#1)(1992-3#1)
receptor-binding region of the##2##4##(1992-6#1)(1993-3#1)
receptor-binding region of##5##3##(1990-4#1)(1991-10#1)(1992-11#1)(1992-6#1)(1993-3#1)
receptor-binding region##9##2##(1990-4#2)(1991-10#1)(1992-11#2)(1992-6#2)(1993-3#2)
receptor-binding site##4##2##(1991-11#1)(1992-9#1)(1996-7#1)(2012-2#1)
receptor-binding sites##2##2##(1994-6#1)(2012-2#1)
receptor-binding##43##1##(1990-4#2)(1991-10#1)(1991-11#1)(1991-2#1)(1991-6#2)(1991-7#3)(1991-9#1)(1992-11#4)(1992-3#3)(1992-6#3)(1992-9#2)(1993-3#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-10#2)(1996-7#2)(1997-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2012-2#6)
receptor-blocking##2##1##(2006-9#1)(2008-3#1)
receptor-bound##12##1##(1991-7#3)(1992-12#1)(1993-8#3)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#1)(2009-8#1)
receptor-centered gene networks##4##3##(2013-1#4)
receptor-containing##4##1##(1993-11#1)(1994-5#1)(1995-3#2)
receptor-coupled second messenger systems##4##4##(1990-10#4)
receptor-coupled##5##1##(1990-10#4)(1993-9#1)
receptor-deficient rabbits with homologous##2##4##(1995-1#2)
receptor-deficient##5##1##(1991-1#1)(1995-1#2)(1995-10#1)(1995-2#1)
receptor-dependent mechanism##2##2##(1992-8#1)(1995-8#1)
receptor-dependent signaling##2##2##(1995-6#1)(1996-5#1)
receptor-dependent specificities##2##2##(1994-8#2)
receptor-dependent##24##1##(1991-2#1)(1991-6#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-8#2)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-1#1)(2007-11#1)(2008-3#1)(2009-5#2)(2009-8#1)(2010-4#1)(2012-1#1)(2013-1#3)
receptor-derived##4##1##(1992-4#1)(1996-8#1)(2008-11#2)
receptor-effector##2##1##(1990-5#1)(1995-6#1)
receptor-encoding gene##2##2##(1993-6#1)(2013-8#1)
receptor-expressing cells##6##2##(1991-6#1)(1996-1#1)(1997-6#2)(2008-5#2)
receptor-gamma##4##1##(2008-10#1)(2008-7#2)(2012-12#1)
receptor-glucocorticoid complexes##2##2##(1990-2#2)
receptor-hormone##2##1##(1990-7#1)(2008-1#1)
receptor-immunoreactive##2##1##(1991-11#1)(1996-12#1)
receptor-independent##7##1##(1991-2#1)(1992-3#1)(1993-12#1)(1995-2#1)(1995-3#1)(1996-9#1)(2007-12#1)
receptor-induced cyclic##2##2##(1993-6#1)(1995-5#1)
receptor-induced##5##1##(1992-6#1)(1993-6#1)(1995-5#1)(2008-4#1)(2011-2#1)
receptor-ion channel##2##2##(1991-4#1)(1993-2#1)
receptor-ionophore complex##2##2##(1991-11#2)
receptor-ligand binding##4##2##(1994-11#1)(2008-1#1)(2008-4#1)(2009-2#1)
receptor-ligand interaction##2##2##(1996-1#1)(2009-10#1)
receptor-ligand interactions##4##2##(1990-4#1)(1995-11#1)(2008-4#2)
receptor-ligand pair##2##2##(2005-7#1)(2009-3#1)
receptor-ligand##19##1##(1990-4#1)(1992-9#1)(1994-11#1)(1994-12#1)(1995-11#1)(1996-1#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-4#4)(2009-10#1)(2009-2#1)(2009-3#1)(2011-1#1)
receptor-like immunoreactivity##2##2##(1992-8#1)(1993-12#1)
receptor-like kinases##2##2##(2007-12#1)(2009-10#1)
receptor-like protein tyrosine phosphatases##2##4##(1994-10#2)
receptor-like protein##6##2##(1994-10#2)(2008-11#1)(2009-8#1)(2010-4#2)
receptor-like proteins##2##2##(1991-5#1)(2009-8#1)
receptor-like##25##1##(1991-5#2)(1992-7#1)(1992-8#1)(1993-12#1)(1994-10#2)(1996-10#1)(1996-11#1)(1996-2#2)(1997-4#3)(2007-12#1)(2008-10#1)(2008-11#2)(2009-10#2)(2009-8#2)(2010-4#2)(2013-7#1)
receptor-mediated Ca2+ entry in##2##4##(1991-6#2)
receptor-mediated Ca2+ entry##3##3##(1991-6#2)(1993-3#1)
receptor-mediated Ca2+##4##2##(1991-6#2)(1993-11#1)(1993-3#1)
receptor-mediated IPSP##2##2##(1994-2#2)
receptor-mediated IPSPs##2##2##(1994-2#2)
receptor-mediated PKA##2##2##(1997-5#1)(2008-10#1)
receptor-mediated actions##2##2##(1995-7#1)(1996-2#1)
receptor-mediated activation of##5##3##(1990-3#1)(1992-6#1)(1997-4#1)(2008-4#1)(2008-7#1)
receptor-mediated antigen delivery and incorporation system##2##6##(1993-3#2)
receptor-mediated calcium##2##2##(1991-6#1)(1996-5#1)
receptor-mediated currents##6##2##(1992-8#2)(1993-12#1)(1995-5#2)(1997-5#1)
receptor-mediated endocytosis##12##2##(1990-7#1)(1992-11#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-2#1)(2008-10#1)(2008-11#2)
receptor-mediated event##2##2##(1992-6#1)(1995-8#1)
receptor-mediated functions##2##2##(1994-6#1)(1996-12#1)
receptor-mediated gene##3##2##(1993-3#1)(1993-6#1)(2007-11#1)
receptor-mediated glutamatergic##4##2##(1994-5#1)(1995-11#1)(1995-12#1)(2008-4#1)
receptor-mediated inhibition of adenylate cyclase##2##5##(1990-10#2)
receptor-mediated inhibition of adenylyl cyclase##2##5##(1995-12#1)(1997-1#1)
receptor-mediated inhibition of##4##3##(1990-10#2)(1995-12#1)(1997-1#1)
receptor-mediated inhibition##6##2##(1990-10#2)(1995-12#1)(1997-1#1)(2011-2#2)
receptor-mediated inositol##2##2##(1995-11#1)(1997-1#1)
receptor-mediated inward current##2##3##(1995-11#2)
receptor-mediated inward currents evoked##2##4##(1995-11#2)
receptor-mediated inward currents##4##3##(1995-11#4)
receptor-mediated inward##6##2##(1995-11#6)
receptor-mediated mechanisms##3##2##(1992-3#1)(1994-11#1)(1996-12#1)
receptor-mediated pathways##2##2##(1995-8#1)(2010-1#1)
receptor-mediated phagocytosis in##3##3##(1993-6#1)(1994-6#1)(2006-10#1)
receptor-mediated phagocytosis##5##2##(1993-4#2)(1993-6#1)(1994-6#1)(2006-10#1)
receptor-mediated process##4##2##(1990-10#1)(1993-2#1)(1995-2#1)(1997-8#1)
receptor-mediated response##2##2##(1997-1#1)(1997-4#1)
receptor-mediated responses##5##2##(1990-10#1)(1990-12#1)(1991-3#1)(1997-6#1)(2008-4#1)
receptor-mediated signal transduction##3##3##(1993-7#1)(1994-12#1)(1995-7#1)
receptor-mediated stimulation of##3##3##(1992-3#1)(1995-10#1)(1996-9#1)
receptor-mediated uptake##2##2##(1991-6#1)(1995-8#1)
receptor-mediated##179##1##(1990-10#4)(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#1)(1990-7#3)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-6#6)(1991-8#2)(1992-11#1)(1992-3#2)(1992-6#3)(1992-8#4)(1992-9#3)(1993-11#4)(1993-12#2)(1993-2#1)(1993-3#7)(1993-4#2)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#7)(1994-12#3)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#4)(1994-9#1)(1995-10#1)(1995-11#13)(1995-12#4)(1995-2#2)(1995-3#2)(1995-5#4)(1995-6#1)(1995-7#2)(1995-8#4)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-8#2)(1996-9#3)(1997-1#3)(1997-2#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#2)(2006-10#4)(2007-11#3)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#9)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-1#1)(2010-12#1)(2011-2#3)(2013-1#1)(2013-8#2)
receptor-negative##4##1##(1990-8#1)(1995-1#1)(1997-7#1)(2011-1#1)
receptor-operated Ca2+ channels##2##3##(1993-11#1)(1994-3#1)
receptor-operated Ca2+##3##2##(1991-4#1)(1993-11#1)(1994-3#1)
receptor-operated##7##1##(1991-4#1)(1993-11#1)(1993-8#1)(1994-3#1)(2008-8#2)(2010-2#1)
receptor-positive breast##2##2##(1993-4#1)(2011-1#1)
receptor-positive tumors##3##2##(1993-4#1)(1995-10#1)(1997-8#1)
receptor-positive##16##1##(1990-9#2)(1991-12#1)(1992-4#1)(1993-11#1)(1993-4#2)(1994-6#1)(1995-10#1)(1997-7#1)(1997-8#1)(2007-11#2)(2008-11#1)(2008-5#1)(2011-1#1)
receptor-receptor interactions##2##2##(1994-10#2)
receptor-regulated SMAD##2##2##(2011-2#2)
receptor-regulated##3##1##(1990-2#1)(2011-2#2)
receptor-related protein##7##2##(1991-2#2)(1993-3#1)(1994-9#1)(1996-5#1)(2007-8#1)(2008-8#1)
receptor-related##10##1##(1991-2#2)(1992-7#1)(1993-3#1)(1994-9#1)(1996-10#2)(1996-5#1)(2007-8#1)(2008-8#1)
receptor-selective agonist##5##2##(1992-10#1)(1997-5#4)
receptor-selective agonists##2##2##(1991-9#1)(1997-5#1)
receptor-selective antagonist##2##2##(1995-12#1)(2007-11#1)
receptor-selective##13##1##(1991-1#1)(1991-9#1)(1992-10#1)(1994-11#1)(1995-12#1)(1997-5#5)(1997-7#1)(2007-11#1)(2008-8#1)
receptor-simulating environments##3##2##(1990-9#2)(1991-5#1)
receptor-specific regulation of the##2##4##(1993-6#2)
receptor-specific##12##1##(1992-12#2)(1993-1#1)(1993-6#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-3#1)(2005-11#1)(2008-4#1)(2010-5#1)
receptor-steroid complex##2##2##(1990-2#2)
receptor-steroid complexes##2##2##(1990-2#2)
receptor-steroid##4##1##(1990-2#4)
receptor-stimulated phosphoinositide##2##2##(1992-10#1)(1996-5#1)
receptor-stimulated##9##1##(1992-10#1)(1992-3#1)(1994-11#2)(1995-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#1)
receptor-targeted##3##1##(1997-7#1)(2008-8#1)(2013-8#1)
receptor-type##3##1##(1997-7#2)(2012-12#1)
receptor/CD3 complex##2##2##(1990-11#1)(1992-4#1)
receptor/channel complex##4##2##(1992-3#1)(1994-8#1)(1996-12#1)(1996-9#1)
receptor/channel##6##1##(1992-3#1)(1994-8#1)(1996-12#2)(1996-9#2)
receptor/ligand interactions##2##2##(2006-5#1)(2008-4#1)
receptor/ligand##3##1##(1997-7#1)(2006-5#1)(2008-4#1)
receptor/tyrosine kinases##2##2##(1994-8#1)(1995-3#1)
receptor?##2##1##(1991-1#1)(1995-11#1)
receptors (ARs)##2##2##(1994-11#1)(2010-12#1)
receptors (ER##2##2##(1990-5#1)(1990-9#1)
receptors (ER) and##2##3##(1990-5#1)(1996-3#1)
receptors (ER) are##2##3##(1996-4#1)(2012-2#1)
receptors (ER)##7##2##(1990-5#1)(1994-9#1)(1995-1#1)(1996-3#1)(1996-4#1)(2012-2#1)(2013-8#1)
receptors (GPCR)##4##2##(1995-8#1)(2005-7#1)(2008-1#1)(2011-1#1)
receptors (GPCRs) are##2##3##(1997-2#1)(2007-12#1)
receptors (GPCRs)##5##2##(1997-2#1)(2005-7#1)(2007-12#1)(2008-11#1)(2009-4#1)
receptors (K(i)##2##2##(1997-5#2)
receptors (KI =##2##3##(1990-2#2)
receptors (Ki##2##2##(1995-12#1)(2005-8#1)
receptors (LDLRs)##2##2##(1991-12#1)(2009-8#1)
receptors (PPARs)##7##2##(1997-4#1)(2005-7#1)(2008-1#2)(2008-3#1)(2010-12#1)(2013-7#1)
receptors (PR)##3##2##(1993-9#1)(2004-2#1)(2013-8#1)
receptors (RARs)##3##2##(1991-2#1)(2007-11#1)(2012-2#1)
receptors (RXR)##2##2##(1995-8#1)(2008-5#1)
receptors (TCR)##4##2##(1995-2#1)(2008-4#1)(2008-9#1)(2012-2#1)
receptors (TRs)##2##2##(1994-3#1)(1996-4#1)
receptors (alpha and beta isotypes)##2##5##(2010-3#2)
receptors (alpha##3##2##(1994-2#1)(2010-3#2)
receptors (i##2##2##(1994-12#1)(2008-4#1)
receptors (isotypes alpha##3##3##(2010-3#3)
receptors (labelled##2##2##(1991-9#1)(1993-9#1)
receptors (nAChRs)##6##2##(1994-2#1)(1995-11#1)(2005-8#1)(2007-8#1)(2008-8#1)(2011-2#1)
receptors (α7##2##2##(2011-1#1)(2012-1#1)
receptors 1 and 2##3##4##(2008-4#1)(2010-3#2)
receptors 1 and##4##3##(2008-4#1)(2008-7#1)(2010-3#2)
receptors activate##2##2##(1996-2#1)(2008-7#1)
receptors after##3##2##(1992-4#1)(1997-6#1)(2009-4#1)
receptors agonists##2##2##(1994-11#1)(2013-1#1)
receptors alpha and beta##2##4##(1994-9#1)(2008-4#1)
receptors alpha and##4##3##(1994-9#1)(1997-4#2)(2008-4#1)
receptors alpha##6##2##(1994-6#1)(1994-9#1)(1997-4#2)(2008-4#2)
receptors also##7##2##(1991-1#1)(1995-12#1)(2005-10#1)(2007-3#1)(2008-4#3)
receptors although##2##2##(1993-11#1)(1995-8#1)
receptors and GABA receptors##2##4##(1996-12#1)(2008-3#1)
receptors and MHC##3##3##(2008-2#1)(2008-4#1)(2008-7#1)
receptors and a##3##3##(1991-9#1)(1995-7#1)(2007-11#1)
receptors and activate##2##3##(1995-3#1)(2006-10#1)
receptors and additional##2##3##(2008-11#1)(2010-6#1)
receptors and an##3##3##(1991-9#1)(1992-4#1)(2008-5#1)
receptors and are##4##3##(1993-8#1)(2008-1#1)(2008-8#1)(2009-12#1)
receptors and beta-adrenoceptors in##3##4##(1995-12#3)
receptors and beta-adrenoceptors##5##3##(1995-12#5)
receptors and can##2##3##(1993-11#1)(1995-5#1)
receptors and cell##2##3##(2006-10#1)(2008-4#1)
receptors and channels##2##3##(1995-8#2)
receptors and for##3##3##(1990-2#1)(1996-8#1)(1997-6#1)
receptors and has been##2##4##(1990-5#1)(2008-7#1)
receptors and has##4##3##(1990-5#1)(1991-2#1)(2008-7#1)(2011-2#1)
receptors and indirectly##2##3##(2006-10#2)
receptors and is##6##3##(1991-10#1)(1992-11#1)(1996-10#2)(1996-7#1)(1997-7#1)
receptors and its##2##3##(1992-12#1)(2009-7#1)
receptors and ligands##2##3##(2009-11#1)(2009-8#1)
receptors and may##3##3##(1990-6#1)(1995-2#1)(2009-10#1)
receptors and of##4##3##(1990-12#1)(1992-9#1)(2007-11#1)(2007-12#1)
receptors and other##3##3##(1994-9#1)(2008-4#1)(2008-9#1)
receptors and signaling pathways##2##4##(2006-10#1)(2008-5#1)
receptors and signaling##5##3##(2006-10#2)(2007-11#1)(2008-5#1)(2009-8#1)
receptors and that the##2##4##(1991-5#1)(1994-12#1)
receptors and that##7##3##(1990-7#1)(1991-5#1)(1993-2#1)(1994-12#1)(1996-1#1)(1996-2#1)(2010-10#1)
receptors and the role##2##4##(1991-4#1)(2006-10#1)
receptors and the##26##3##(1991-4#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-4#1)(1993-2#1)(1994-2#1)(1995-12#3)(1995-2#1)(1996-12#1)(1996-5#2)(2006-10#1)(2007-8#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-3#2)(2009-8#1)(2011-1#2)(2012-3#1)
receptors and their ligands##3##4##(2008-4#2)(2011-2#1)
receptors and their mRNAs##3##4##(1993-2#3)
receptors and their##17##3##(1991-4#1)(1991-5#1)(1993-2#3)(1994-2#1)(1996-3#1)(1996-5#1)(2006-12#1)(2007-12#1)(2008-2#1)(2008-4#2)(2009-6#1)(2009-7#1)(2009-8#1)(2011-2#1)
receptors and thus might##2##4##(1990-2#1)(1993-11#1)
receptors and thus##3##3##(1990-2#1)(1993-11#1)(1995-12#1)
receptors and transporters##3##3##(2008-7#1)(2013-1#2)
receptors and was##2##3##(1995-3#2)
receptors and##264##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#4)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#4)(1991-3#1)(1991-4#2)(1991-5#5)(1991-6#3)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#2)(1992-4#2)(1992-9#1)(1993-11#4)(1993-12#2)(1993-2#6)(1993-3#1)(1993-4#2)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-5#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#3)(1995-12#11)(1995-2#2)(1995-3#6)(1995-5#1)(1995-6#1)(1995-7#5)(1995-8#2)(1996-1#2)(1996-10#2)(1996-12#3)(1996-2#4)(1996-3#1)(1996-5#3)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#2)(2005-10#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#11)(2006-11#1)(2006-12#1)(2006-5#1)(2007-11#4)(2007-12#3)(2007-3#1)(2007-8#2)(2008-1#4)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#21)(2008-5#2)(2008-7#8)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#2)(2009-6#2)(2009-7#2)(2009-8#10)(2010-10#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#3)
receptors appear to be##3##4##(1990-7#1)(2008-5#2)
receptors appear to##6##3##(1990-7#1)(1994-11#1)(2005-8#1)(2006-10#1)(2008-5#2)
receptors appear##7##2##(1990-7#1)(1994-11#1)(1997-8#1)(2005-8#1)(2006-10#1)(2008-5#2)
receptors are a##2##3##(1993-12#1)(2008-4#1)
receptors are activated by##2##4##(1993-6#1)(1997-5#1)
receptors are already##2##3##(2005-8#1)(2012-1#1)
receptors are also##6##3##(1992-3#1)(1995-2#1)(1996-10#1)(1997-3#1)(2009-8#1)(2012-2#1)
receptors are critical##2##3##(2006-10#1)(2008-4#1)
receptors are crucial##2##3##(2008-4#2)
receptors are differentially##2##3##(2008-4#2)
receptors are discussed##2##3##(2007-11#1)(2008-4#1)
receptors are expressed by##2##4##(1990-7#1)(2008-4#1)
receptors are expressed in the##3##5##(1992-9#1)(2008-4#2)
receptors are expressed in##4##4##(1992-9#1)(2008-4#2)(2008-6#1)
receptors are expressed##9##3##(1990-7#1)(1992-9#1)(1993-7#1)(1996-10#1)(2008-4#4)(2008-6#1)
receptors are highly expressed##2##4##(2008-3#1)(2008-8#1)
receptors are involved in the##4##5##(1993-3#1)(1995-10#1)(2008-4#1)(2010-8#1)
receptors are involved in##12##4##(1993-3#1)(1993-5#1)(1994-8#1)(1995-10#2)(1996-12#1)(1997-3#1)(2007-11#1)(2008-4#2)(2008-8#1)(2010-8#1)
receptors are involved##13##3##(1993-3#1)(1993-5#1)(1994-8#1)(1995-10#2)(1996-12#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-4#2)(2008-8#1)(2010-8#1)
receptors are known to##5##4##(1990-7#1)(1991-12#1)(1996-1#1)(1996-8#1)(2011-1#1)
receptors are ligand-gated##2##3##(2008-4#1)(2008-8#1)
receptors are likely to be##3##5##(1991-5#1)(2008-4#2)
receptors are localized##3##3##(1996-12#1)(2008-3#1)(2008-4#1)
receptors are members of the##2##5##(1994-5#1)(2008-4#1)
receptors are more##2##3##(2008-4#1)(2008-6#1)
receptors are not involved in the##2##6##(1996-12#1)(1997-3#1)
receptors are not involved in##3##5##(1996-12#1)(1996-2#1)(1997-3#1)
receptors are not##6##3##(1990-2#1)(1996-10#1)(1996-12#1)(1996-2#1)(1997-3#1)(2012-2#1)
receptors are predominantly##2##3##(1997-5#1)(2008-3#1)
receptors are present in##5##4##(1991-6#1)(1991-9#1)(1993-3#1)(1994-2#1)(2008-6#1)
receptors are present on##2##4##(1992-9#1)(2007-11#1)
receptors are present##8##3##(1991-6#1)(1991-9#2)(1992-9#1)(1993-3#1)(1994-2#1)(2007-11#1)(2008-6#1)
receptors are reviewed##2##3##(2005-7#1)(2005-8#1)
receptors are the##2##3##(2008-4#1)(2009-3#1)
receptors are widely##2##3##(2008-3#1)(2011-2#1)
receptors are##162##2##(1990-2#4)(1990-7#3)(1990-8#1)(1991-12#2)(1991-2#1)(1991-5#4)(1991-6#1)(1991-7#1)(1991-9#3)(1992-10#1)(1992-12#1)(1992-3#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-7#2)(1995-8#1)(1996-1#2)(1996-10#3)(1996-11#1)(1996-12#5)(1996-2#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#3)(1997-7#2)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-5#1)(2007-11#4)(2007-9#1)(2008-1#6)(2008-3#6)(2008-4#34)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-8#1)
receptors as determined##2##3##(1994-2#1)(2006-2#1)
receptors as targets##2##3##(2005-8#1)(2008-8#1)
receptors as well as the##2##5##(1990-7#1)(2013-8#1)
receptors as well as##10##4##(1990-2#1)(1990-7#1)(1993-8#1)(1995-11#1)(1996-12#1)(2005-8#1)(2008-1#1)(2008-4#2)(2013-8#1)
receptors as well##11##3##(1990-2#1)(1990-7#1)(1993-8#1)(1995-11#1)(1996-12#1)(2005-8#1)(2006-6#1)(2008-1#1)(2008-4#2)(2013-8#1)
receptors as##29##2##(1990-2#1)(1990-7#1)(1992-11#1)(1993-12#1)(1993-8#1)(1994-10#1)(1994-2#1)(1995-11#1)(1995-8#2)(1996-12#2)(1997-7#1)(2005-8#2)(2006-2#1)(2006-6#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#4)(2008-7#1)(2008-8#1)(2010-10#1)(2013-8#1)
receptors associated with##4##3##(1991-5#1)(1992-9#1)(1994-8#1)(2010-5#1)
receptors at the##6##3##(1991-12#1)(1992-12#1)(1995-7#1)(1997-5#1)(2008-3#1)(2008-4#1)
receptors at##11##2##(1990-2#1)(1991-12#1)(1992-12#1)(1995-7#1)(1996-10#1)(1996-3#1)(1997-5#1)(2005-8#1)(2008-3#1)(2008-4#1)(2009-9#1)
receptors become##4##2##(1991-12#1)(1991-5#1)(1995-3#1)(1996-10#1)
receptors between##2##2##(1992-4#1)(1997-2#1)
receptors both##4##2##(1993-2#1)(1994-8#1)(1995-10#1)(1995-12#1)
receptors but also##2##3##(1990-10#1)(1996-8#1)
receptors but not with##2##4##(1997-7#2)
receptors but not##4##3##(1995-11#1)(1997-4#1)(1997-7#2)
receptors but##14##2##(1990-10#1)(1990-12#1)(1992-12#1)(1992-8#1)(1993-11#1)(1994-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-8#1)(1997-4#1)(1997-7#2)
receptors by a##2##3##(1995-11#1)(1995-12#1)
receptors by both##2##3##(1995-11#1)(1995-6#1)
receptors by the##4##3##(1991-1#1)(1992-2#1)(1992-3#1)(1996-4#1)
receptors by their##4##3##(1991-9#1)(1993-6#1)(1997-4#1)(2013-1#1)
receptors by##51##2##(1990-11#1)(1990-7#1)(1991-1#3)(1991-12#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-7#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-11#3)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-2#2)(1996-4#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(2005-10#1)(2005-8#1)(2008-1#1)(2008-4#5)(2008-8#1)(2010-2#1)(2013-1#1)
receptors called##2##2##(1993-2#1)(2005-7#1)
receptors can be##8##3##(1990-3#1)(1991-9#1)(1993-5#1)(1994-6#1)(1995-11#1)(1996-10#1)(2008-11#1)(2008-4#1)
receptors can##20##2##(1990-11#1)(1990-3#1)(1991-9#1)(1993-5#1)(1994-10#1)(1994-6#1)(1995-11#1)(1996-10#1)(1996-12#1)(1997-5#1)(2005-10#1)(2007-12#2)(2008-11#1)(2008-4#2)(2009-12#1)(2010-12#1)(2011-1#1)(2013-1#1)
receptors compared##2##2##(1990-2#1)(1994-2#1)
receptors composed of##2##3##(1990-7#1)(1993-9#1)
receptors contain##2##2##(1990-11#1)(1994-11#1)
receptors containing the##6##3##(1990-7#2)(1994-12#1)(1995-12#1)(1997-3#1)(2008-4#1)
receptors containing##11##2##(1990-7#2)(1991-10#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-12#2)(1996-8#1)(1997-3#1)(2008-4#1)
receptors contribute to##2##3##(1997-5#1)(2006-11#1)
receptors contributes to the##2##4##(1991-9#1)(2012-12#1)
receptors contributes to##3##3##(1991-9#1)(1994-6#1)(2012-12#1)
receptors control##2##2##(1990-11#1)(2008-4#1)
receptors could be##5##3##(1994-6#1)(1997-5#1)(1997-7#1)(2008-7#1)(2010-5#1)
receptors could not be##2##4##(1993-11#1)(1997-5#1)
receptors could##11##2##(1993-11#1)(1994-6#1)(1994-9#1)(1997-5#2)(1997-7#1)(1997-8#1)(2008-7#2)(2010-5#1)(2012-12#1)
receptors coupled to##7##3##(1990-10#1)(1991-2#2)(1993-6#1)(2006-10#3)
receptors differ##2##2##(1993-3#1)(1993-6#1)
receptors display##2##2##(1990-12#1)(1995-11#1)
receptors displayed##2##2##(1991-12#1)(1994-12#1)
receptors do not##6##3##(1992-3#1)(1993-11#2)(1997-2#1)(2006-10#1)(2008-7#1)
receptors does not##4##3##(1993-2#1)(1996-12#2)(1997-5#1)
receptors during##5##2##(1996-3#1)(2005-10#1)(2006-5#1)(2008-1#1)(2010-3#1)
receptors enhances##2##2##(1994-2#1)(1995-3#1)
receptors exist##2##2##(1993-3#1)(2006-10#1)
receptors expressed by##3##3##(1994-8#1)(2008-2#1)(2008-4#1)
receptors expressed in Xenopus oocytes were examined##2##7##(1995-7#1)(1996-8#1)
receptors expressed in Xenopus oocytes##4##5##(1995-11#2)(1995-7#1)(1996-8#1)
receptors expressed in the##2##4##(1991-9#1)(1997-5#1)
receptors expressed in##18##3##(1991-9#1)(1994-2#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-7#1)(1996-8#1)(1997-3#1)(1997-5#3)(1997-6#1)(2008-4#1)(2008-8#1)(2010-3#1)(2012-1#1)
receptors expressed on##7##3##(1994-5#1)(1995-11#1)(1995-6#1)(1997-2#1)(2007-11#1)(2008-4#1)(2009-3#1)
receptors expressed##28##2##(1991-9#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#3)(1995-12#1)(1995-6#1)(1995-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#3)(1997-6#1)(2007-11#1)(2008-2#1)(2008-4#3)(2008-8#1)(2009-3#1)(2010-3#1)(2012-1#1)
receptors expression##6##2##(2008-4#1)(2008-8#1)(2009-3#1)(2011-2#3)
receptors failed to##2##3##(1997-5#2)
receptors for BDNF and##2##4##(1993-9#1)(1995-11#1)
receptors for immunoglobulin E (IgE)##2##5##(1994-8#1)(1996-5#1)
receptors for prolactin##2##3##(1994-3#1)(2008-4#1)
receptors for the Fc##2##4##(1990-7#1)(2008-4#1)
receptors for the specific##2##4##(1991-12#1)(2007-8#1)
receptors for the##16##3##(1990-7#1)(1991-12#1)(1991-5#1)(1992-11#1)(1993-5#1)(1995-3#1)(1995-8#1)(1996-12#2)(1996-3#1)(2007-8#1)(2008-1#2)(2008-4#1)(2010-4#1)(2011-2#1)
receptors for these##3##3##(1990-7#1)(1993-9#1)(2008-5#1)
receptors for this##2##3##(1990-7#1)(1996-11#1)
receptors for##106##2##(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#3)(1991-12#6)(1991-3#1)(1991-4#1)(1991-5#1)(1992-11#2)(1992-12#3)(1992-4#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-5#2)(1993-6#2)(1993-8#2)(1993-9#3)(1994-11#4)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#3)(1996-11#3)(1996-12#3)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#2)(1997-6#1)(1997-7#1)(2006-11#1)(2006-12#2)(2006-6#2)(2007-12#2)(2007-8#2)(2008-1#3)(2008-10#1)(2008-11#2)(2008-4#6)(2008-5#1)(2008-7#2)(2009-3#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
receptors found##2##2##(1997-4#1)(2008-4#1)
receptors from human##2##3##(1994-6#1)(1996-6#1)
receptors from rat and##2##4##(1994-9#1)(1996-12#1)
receptors from rat##3##3##(1994-9#1)(1996-12#1)(1997-1#1)
receptors from the##3##3##(1994-3#1)(2008-7#1)(2012-12#1)
receptors from##20##2##(1993-4#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-7#1)(2006-12#1)(2006-5#1)(2008-7#1)(2012-12#1)
receptors function##2##2##(1994-12#1)(2012-2#1)
receptors functionally##2##2##(1993-6#1)(2008-4#1)
receptors generates##2##2##(1996-2#1)(2006-10#1)
receptors genes##2##2##(1997-5#1)(2007-2#1)
receptors had been##2##3##(1991-6#1)(2012-12#1)
receptors had no effect##2##4##(1994-8#2)
receptors had no##3##3##(1994-8#2)(1996-12#1)
receptors had##10##2##(1991-6#1)(1993-8#1)(1994-12#1)(1994-8#2)(1996-12#1)(1996-3#1)(2008-4#1)(2012-12#1)(2012-2#1)
receptors has been##7##3##(1993-6#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-9#1)(2007-10#1)(2007-7#1)
receptors has led to the##2##5##(2006-10#1)(2008-4#1)
receptors has##15##2##(1993-2#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-9#1)(1996-11#1)(1997-5#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-7#1)(2008-4#2)
receptors have a##2##3##(1993-2#1)(1994-8#1)
receptors have also been found in##2##6##(2008-4#1)(2011-12#1)
receptors have also been##3##4##(1990-7#1)(2008-4#1)(2011-12#1)
receptors have an##2##3##(1994-2#1)(2009-3#1)
receptors have been characterized##2##4##(2008-4#2)
receptors have been described##2##4##(1992-11#1)(1996-5#1)
receptors have been identified on##2##5##(2006-10#1)(2008-4#1)
receptors have been identified##7##4##(1995-12#1)(1995-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-4#1)
receptors have been shown to##4##5##(1996-12#1)(1996-3#1)(2007-11#1)(2009-6#1)
receptors have been##31##3##(1990-10#1)(1990-7#1)(1992-11#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-7#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-4#3)(2008-7#1)(2009-6#1)(2010-5#1)
receptors have##46##2##(1990-10#1)(1990-7#2)(1992-11#1)(1993-11#1)(1993-2#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-7#1)(2005-7#2)(2005-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-1#2)(2008-4#4)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-12#1)
receptors having##2##2##(1990-3#1)(1994-6#1)
receptors identified##2##2##(1995-12#1)(1995-6#1)
receptors in NHEKs##3##3##(2008-4#3)
receptors in T##2##3##(2005-10#1)(2007-11#1)
receptors in Xenopus oocytes##4##4##(1993-6#2)(1994-3#1)(1997-3#1)
receptors in a##8##3##(1991-1#1)(1992-3#1)(1994-3#1)(1996-12#1)(1997-1#1)(2006-10#1)(2008-4#1)(2013-7#1)
receptors in bone##2##3##(1991-5#1)(2008-5#1)
receptors in bovine##3##3##(1990-3#1)(1991-6#1)(1995-3#1)
receptors in brain##4##3##(1990-10#1)(1994-10#1)(1995-12#1)(2008-8#1)
receptors in breast cancer##3##4##(1996-4#2)(1996-7#1)
receptors in breast##6##3##(1994-2#1)(1995-9#1)(1996-4#2)(1996-7#1)(1997-7#1)
receptors in developing##3##3##(1995-11#1)(1996-3#2)
receptors in development##2##3##(1993-9#1)(2008-3#1)
receptors in diabetic##2##3##(1994-11#1)(1996-9#1)
receptors in different##4##3##(1994-5#1)(2008-9#1)(2009-7#1)(2010-5#1)
receptors in female##2##3##(1992-5#1)(2006-5#1)
receptors in guinea-pig##2##3##(1990-5#1)(1993-12#1)
receptors in human neutrophils##2##4##(1994-6#1)(2008-4#1)
receptors in human##18##3##(1992-3#2)(1992-6#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#2)(1996-5#1)(1997-5#1)(2008-4#2)(2008-5#2)(2009-7#1)(2010-5#1)
receptors in isolated##2##3##(1993-6#1)(2006-10#1)
receptors in learning and memory##2##5##(1993-2#1)(2008-5#1)
receptors in lymphocytes##2##3##(2007-2#2)
receptors in mediating##6##3##(1993-7#1)(1994-2#1)(1995-12#1)(1996-1#1)(1997-7#2)
receptors in modulation of##2##4##(1994-2#1)(2008-11#1)
receptors in neonatal##2##3##(1994-12#1)(1994-2#1)
receptors in normal##2##3##(1995-10#1)(2009-3#1)
receptors in porcine##2##3##(1992-6#1)(1996-10#1)
receptors in primary##3##3##(1990-2#1)(1994-11#1)(2008-11#1)
receptors in quisqualic##2##3##(1992-8#2)
receptors in rabbit##5##3##(1990-11#1)(1997-7#2)(2008-4#2)
receptors in rat and##2##4##(1994-2#1)(1994-5#1)
receptors in rat brain by##2##5##(1994-10#1)(1997-1#1)
receptors in rat brain##6##4##(1992-9#2)(1993-11#1)(1994-10#2)(1997-1#1)
receptors in rat heart##2##4##(1990-9#1)(1995-11#1)
receptors in rat##19##3##(1990-10#1)(1990-9#1)(1992-9#3)(1993-11#1)(1994-10#2)(1994-2#1)(1994-5#3)(1995-10#1)(1995-11#1)(1995-12#1)(1997-1#1)(1997-5#1)(1997-8#1)(2008-4#1)
receptors in rats##5##3##(1991-1#1)(1994-3#1)(1995-12#1)(1996-5#1)(2007-1#1)
receptors in regulation of##2##4##(1993-11#1)(2013-1#1)
receptors in skeletal##2##3##(1991-7#1)(1993-5#1)
receptors in the CNS##4##4##(1990-11#1)(1991-3#1)(1992-10#2)
receptors in the adult##2##4##(1990-2#1)(1993-3#1)
receptors in the brain##2##4##(1991-3#1)(1996-2#1)
receptors in the central nervous system##2##6##(1997-4#1)(2007-1#1)
receptors in the development##2##4##(1996-3#1)(1997-6#1)
receptors in the frontal cortex##2##5##(1990-7#1)(1995-3#1)
receptors in the heart##2##4##(1990-5#1)(2012-12#1)
receptors in the hippocampus##4##4##(1993-11#2)(1996-12#1)(2008-11#1)
receptors in the human##2##4##(1990-4#1)(1996-5#1)
receptors in the hypothalamus##3##4##(1993-12#1)(1995-10#1)(1997-5#1)
receptors in the liver##2##4##(1990-11#1)(1990-4#1)
receptors in the mechanism of##2##5##(1991-6#1)(1997-2#1)
receptors in the medial prefrontal cortex##2##6##(1991-9#2)
receptors in the medial##5##4##(1991-9#2)(1992-9#1)(1993-12#1)(1994-5#1)
receptors in the median raphe nucleus##2##6##(1993-12#1)(1994-12#1)
receptors in the modulation of##2##5##(1993-6#1)(2008-4#1)
receptors in the nervous system##2##5##(2008-5#1)(2008-7#1)
receptors in the nucleus##2##4##(1993-7#1)(1995-10#1)
receptors in the obese Zucker rat which##2##7##(1997-5#2)
receptors in the pathophysiology of##2##5##(1993-2#1)(1997-7#1)
receptors in the pituitary##2##4##(1997-5#1)(2008-4#1)
receptors in the rat eye##2##5##(1997-2#1)(2008-4#1)
receptors in the rat##9##4##(1991-5#2)(1995-11#2)(1995-12#2)(1997-2#1)(1997-8#1)(2008-4#1)
receptors in the spinal cord##4##5##(1993-11#1)(1994-2#1)(1995-7#1)(2008-4#1)
receptors in the striatum##7##4##(1990-7#1)(1991-4#1)(1991-9#2)(1993-2#1)(1994-2#1)(1995-12#1)
receptors in the substantia nigra##3##5##(1995-2#3)
receptors in the substantia##4##4##(1991-9#1)(1995-2#3)
receptors in the##152##3##(1990-11#2)(1990-2#3)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#3)(1991-3#3)(1991-4#3)(1991-5#4)(1991-6#3)(1991-9#7)(1992-10#2)(1992-12#1)(1992-3#3)(1992-8#3)(1992-9#2)(1993-11#6)(1993-12#5)(1993-2#2)(1993-3#1)(1993-6#3)(1993-7#1)(1993-8#2)(1994-10#2)(1994-12#1)(1994-2#2)(1994-5#1)(1994-9#1)(1995-10#4)(1995-11#2)(1995-12#6)(1995-2#3)(1995-3#1)(1995-5#1)(1995-7#2)(1996-1#1)(1996-10#3)(1996-12#4)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#3)(1997-2#2)(1997-4#1)(1997-5#4)(1997-6#1)(1997-7#1)(1997-8#2)(2004-12#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#7)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-5#1)(2012-1#2)(2012-12#1)(2012-2#1)
receptors in these cells##2##4##(1991-12#1)(2008-4#1)
receptors in these##5##3##(1991-10#1)(1991-12#1)(1997-1#1)(2008-4#1)(2009-7#1)
receptors in this##2##3##(1990-3#1)(1993-7#1)
receptors in uterine##2##3##(1990-11#1)(2007-2#1)
receptors in various##3##3##(2005-8#1)(2010-10#1)(2010-5#1)
receptors in vitro##7##3##(1993-11#1)(1993-5#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-5#1)(1996-8#1)
receptors in vivo##2##3##(1996-8#1)(2008-4#1)
receptors in which##2##3##(1991-5#1)(1994-12#1)
receptors in##434##2##(1990-10#2)(1990-11#4)(1990-2#4)(1990-3#2)(1990-4#2)(1990-5#5)(1990-6#1)(1990-7#3)(1990-9#1)(1991-1#3)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#3)(1991-4#3)(1991-5#7)(1991-6#5)(1991-7#2)(1991-9#9)(1992-10#2)(1992-11#1)(1992-12#1)(1992-3#7)(1992-5#2)(1992-6#3)(1992-8#8)(1992-9#7)(1993-11#12)(1993-12#9)(1993-2#3)(1993-3#2)(1993-4#1)(1993-5#3)(1993-6#9)(1993-7#3)(1993-8#3)(1993-9#4)(1994-10#9)(1994-11#4)(1994-12#6)(1994-2#14)(1994-3#4)(1994-5#5)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#7)(1995-11#5)(1995-12#13)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#2)(1995-7#3)(1995-8#2)(1995-9#1)(1996-1#4)(1996-10#4)(1996-11#2)(1996-12#6)(1996-2#4)(1996-3#4)(1996-4#5)(1996-5#8)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#3)(1997-2#5)(1997-3#2)(1997-4#2)(1997-5#10)(1997-6#2)(1997-7#7)(1997-8#3)(2004-12#1)(2005-10#1)(2005-12#1)(2005-6#2)(2005-7#3)(2005-8#4)(2006-10#5)(2006-5#3)(2007-1#2)(2007-10#4)(2007-11#1)(2007-12#2)(2007-2#5)(2007-4#1)(2008-1#3)(2008-10#4)(2008-11#5)(2008-2#1)(2008-3#3)(2008-4#30)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#2)(2009-10#1)(2009-3#2)(2009-6#1)(2009-7#5)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#4)(2011-1#1)(2011-12#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
receptors including the##2##3##(1991-8#1)(2005-11#1)
receptors including##7##2##(1991-8#1)(1994-2#1)(2005-11#1)(2008-4#3)(2013-7#1)
receptors increases##3##2##(1990-9#1)(1996-10#1)(1996-12#1)
receptors induced by##4##3##(1990-10#1)(1991-3#1)(1995-12#1)(2008-8#1)
receptors induced##5##2##(1990-10#1)(1991-3#1)(1995-12#1)(1995-6#1)(2008-8#1)
receptors inhibit##3##2##(1994-11#1)(2008-7#2)
receptors inhibits##2##2##(1996-12#1)(1997-4#1)
receptors initiate##2##2##(1997-8#1)(2009-12#1)
receptors interact with##3##3##(1990-3#1)(1996-8#1)(2008-4#1)
receptors interact##4##2##(1990-3#1)(1996-8#1)(2008-4#1)(2012-2#1)
receptors involved in the##4##4##(1995-12#1)(1995-2#1)(1996-12#2)
receptors involved in##12##3##(1992-8#2)(1995-12#1)(1995-2#1)(1996-12#2)(1996-8#1)(1996-9#1)(1997-6#1)(2005-8#1)(2008-4#1)(2008-8#1)
receptors involved##15##2##(1992-8#2)(1993-4#1)(1995-12#1)(1995-2#1)(1996-12#3)(1996-8#1)(1996-9#1)(1997-6#1)(2005-8#1)(2008-4#1)(2008-7#1)(2008-8#1)
receptors is a##3##3##(1996-3#1)(2008-3#1)(2009-3#1)
receptors is an##2##3##(1991-2#1)(1997-7#1)
receptors is increased##2##3##(1990-5#1)(1993-2#1)
receptors is not##2##3##(1994-2#1)(1995-12#1)
receptors is responsible for##2##4##(1996-2#1)(2008-4#1)
receptors is##44##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#1)(1992-1#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-12#4)(1995-2#2)(1995-3#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1997-6#1)(1997-7#1)(2007-2#1)(2008-3#1)(2008-4#6)(2008-7#1)(2009-3#1)(2010-2#1)(2011-2#2)
receptors isolated from##2##3##(1996-12#1)(1996-2#1)
receptors known to be##2##4##(1991-11#1)(1994-3#1)
receptors known##3##2##(1991-11#1)(1994-3#1)(1996-7#1)
receptors labeled with##2##3##(1991-5#1)(1994-2#1)
receptors leading to##2##3##(1990-5#1)(2011-12#1)
receptors leads to##4##3##(1991-10#1)(1995-12#1)(2007-9#1)(2010-11#1)
receptors like the##2##3##(2010-6#1)(2012-12#1)
receptors like##3##2##(2010-6#1)(2011-2#1)(2012-12#1)
receptors located in##2##3##(1995-12#1)(2008-7#1)
receptors located on##5##3##(1995-7#1)(1996-12#2)(2008-7#1)(2010-12#1)
receptors located##8##2##(1993-12#1)(1995-12#1)(1995-7#1)(1996-12#2)(2008-7#2)(2010-12#1)
receptors may also##2##3##(1990-7#1)(2008-5#1)
receptors may be a##3##4##(1996-5#1)(2008-4#2)
receptors may be coupled##2##4##(1992-1#1)(1997-8#1)
receptors may be important##2##4##(1990-7#1)(1995-12#1)
receptors may be located on##2##5##(1991-9#1)(1996-5#1)
receptors may be##15##3##(1990-7#1)(1991-12#1)(1991-9#1)(1992-1#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-5#2)(1997-8#1)(2005-7#1)(2006-10#1)(2008-4#2)(2008-9#1)
receptors may have##3##3##(1990-2#1)(1996-2#1)(2007-12#1)
receptors may lead to##2##4##(2008-4#1)(2012-3#1)
receptors may mediate##3##3##(1991-3#1)(1994-8#1)(1995-3#1)
receptors may not##2##3##(1992-9#1)(1996-12#1)
receptors may play a##2##4##(1993-3#1)(1995-12#1)
receptors may play##3##3##(1993-3#1)(1995-12#1)(2008-4#1)
receptors may##50##2##(1990-11#1)(1990-2#1)(1990-7#2)(1991-1#1)(1991-12#1)(1991-3#1)(1991-9#3)(1992-1#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-7#1)(1994-8#1)(1995-11#1)(1995-12#5)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-5#2)(1997-8#1)(2005-7#1)(2005-9#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-4#7)(2008-5#1)(2008-9#1)(2009-6#1)(2012-3#1)
receptors mediate contraction##4##3##(1994-11#1)(1995-12#1)(1995-5#1)(1997-5#1)
receptors mediate the##3##3##(1990-7#1)(1992-7#1)(1993-11#1)
receptors mediate##13##2##(1990-5#1)(1990-7#1)(1991-5#1)(1992-7#1)(1993-11#1)(1994-11#1)(1995-12#2)(1995-5#1)(1997-5#1)(2008-4#3)
receptors mediated##2##2##(1997-7#1)(2005-10#1)
receptors mediating contraction of##2##4##(1995-5#1)(1997-7#1)
receptors mediating these##3##3##(1991-6#1)(1997-5#2)
receptors mediating##12##2##(1991-5#1)(1991-6#1)(1993-6#1)(1995-3#3)(1995-5#1)(1997-4#1)(1997-5#3)(1997-7#1)
receptors might be important##2##4##(1994-10#1)(2006-12#1)
receptors might be##6##3##(1992-8#1)(1994-10#1)(2006-12#1)(2006-9#1)(2008-4#1)(2011-1#1)
receptors might##9##2##(1992-4#1)(1992-8#1)(1994-10#2)(2006-12#1)(2006-9#1)(2008-3#1)(2008-4#1)(2011-1#1)
receptors modulate##5##2##(1990-2#1)(1996-8#1)(1997-1#1)(2005-8#1)(2013-8#1)
receptors nor##2##2##(1992-6#1)(1996-12#1)
receptors of a##2##3##(1993-2#1)(1995-3#1)
receptors of the##16##3##(1990-2#1)(1990-5#1)(1991-3#1)(1991-6#1)(1994-6#2)(1994-9#1)(1996-2#1)(1996-5#1)(1997-5#1)(2005-10#1)(2007-11#1)(2008-4#1)(2009-8#1)(2012-1#1)(2013-1#1)
receptors of##48##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-3#2)(1991-6#1)(1992-11#1)(1993-2#3)(1993-3#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-3#2)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-5#2)(1997-7#1)(1997-9#1)(2005-10#1)(2007-11#1)(2007-7#2)(2008-11#2)(2008-4#3)(2009-12#1)(2009-8#1)(2011-2#1)(2012-1#1)(2013-1#2)
receptors on cells##2##3##(1994-3#1)(2008-1#1)
receptors on cholinergic neurones##2##4##(1996-3#2)
receptors on hematopoietic cells##2##4##(1994-12#1)(2012-2#1)
receptors on human fibroblasts##2##4##(1990-4#1)(1992-2#1)
receptors on human##9##3##(1990-4#1)(1992-2#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#2)(2008-4#1)
receptors on parietal cells##2##4##(2006-10#2)
receptors on sensory neurons##2##4##(1996-3#1)(2007-11#1)
receptors on target cells##2##4##(2008-5#1)(2011-2#1)
receptors on the plasma##2##4##(1991-12#1)(2005-8#1)
receptors on the##25##3##(1991-1#1)(1991-10#1)(1991-12#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-7#1)(1994-3#1)(1995-6#1)(1996-11#1)(1996-3#1)(1997-2#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-12#2)(2008-2#1)(2008-4#2)(2008-7#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-7#1)
receptors on these cells##2##4##(1993-5#1)(1997-7#1)
receptors on various##2##3##(2007-11#1)(2007-2#1)
receptors on##111##2##(1990-10#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#2)(1991-10#1)(1991-12#1)(1991-4#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-11#3)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#5)(1994-9#1)(1995-10#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#1)(1995-7#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#4)(1997-2#1)(1997-3#1)(1997-7#1)(2004-12#1)(2005-12#1)(2005-6#1)(2005-8#1)(2006-10#7)(2006-12#2)(2006-3#1)(2007-11#3)(2007-12#2)(2007-2#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-4#10)(2008-5#2)(2008-7#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-7#2)
receptors or##16##2##(1991-1#1)(1991-6#1)(1993-7#1)(1993-9#1)(1994-6#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-7#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#2)
receptors per cell##4##3##(1990-2#1)(1995-6#1)(2008-11#2)
receptors per##6##2##(1990-2#1)(1995-6#1)(2008-11#2)(2008-3#1)(2008-4#1)
receptors play a role in##4##5##(1995-3#1)(2008-4#1)(2008-5#1)(2010-5#1)
receptors play a##9##3##(1995-3#1)(1996-10#1)(2007-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-7#1)(2010-5#1)
receptors play an important role in the##2##7##(1994-3#1)(1995-3#1)
receptors play an important role in##4##6##(1994-3#1)(1995-12#1)(1995-3#1)(1996-12#1)
receptors play an##5##3##(1994-3#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-12#1)
receptors play##15##2##(1994-3#1)(1995-12#1)(1995-3#2)(1996-10#2)(1996-12#1)(2007-11#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-7#1)(2010-5#1)
receptors plays an##2##3##(1995-12#1)(1995-8#1)
receptors prepared##4##2##(1994-6#3)(1997-1#1)
receptors present in##2##3##(1990-7#1)(1995-5#1)
receptors present on##2##3##(2009-2#1)(2010-4#1)
receptors present##5##2##(1990-7#1)(1995-5#1)(2009-2#1)(2010-4#1)(2011-1#1)
receptors produce##2##2##(1997-5#1)(2008-4#1)
receptors purified on##2##3##(1990-5#2)
receptors purified##3##2##(1990-5#2)(1991-1#1)
receptors regulate##2##2##(1990-2#1)(2012-2#1)
receptors responsible for##2##3##(2006-10#1)(2008-4#1)
receptors results in##4##3##(1990-4#1)(1991-5#1)(2008-2#1)(2010-3#1)
receptors revealed that##3##3##(1992-5#1)(1995-11#1)(2008-5#1)
receptors revealed##5##2##(1992-12#1)(1992-5#1)(1993-12#1)(1995-11#1)(2008-5#1)
receptors reveals##2##2##(1994-3#1)(1995-11#1)
receptors seem to##2##3##(2006-10#1)(2008-1#1)
receptors show##2##2##(1996-1#1)(1996-11#1)
receptors showed##4##2##(1990-3#1)(1990-7#1)(1994-12#1)(1995-12#1)
receptors since they##2##3##(1991-4#1)(2008-4#1)
receptors since##4##2##(1991-4#1)(1991-5#1)(1991-8#1)(2008-4#1)
receptors stimulated##2##2##(1995-11#1)(1996-2#1)
receptors stimulates##2##2##(1992-9#1)(2008-4#1)
receptors such as##5##3##(1992-6#1)(2006-2#1)(2008-7#1)(2010-12#1)(2011-2#1)
receptors termed##2##2##(2008-4#1)(2012-1#1)
receptors than HaCaT cells##2##4##(1992-9#2)
receptors than##7##2##(1990-4#1)(1992-9#2)(1994-9#1)(1995-11#1)(2006-1#1)(2008-8#1)
receptors that are##6##3##(1992-3#1)(1994-3#1)(1995-8#1)(2008-1#1)(2008-4#1)(2008-8#1)
receptors that bind##2##3##(2007-12#1)(2012-3#1)
receptors that can##2##3##(2009-8#1)(2012-1#1)
receptors that deliver##2##3##(2007-11#1)(2007-8#1)
receptors that exhibit##3##3##(1991-4#1)(1995-6#1)(2009-12#1)
receptors that play important roles in##2##6##(2008-1#1)(2009-8#1)
receptors that play##4##3##(2005-10#1)(2008-1#1)(2009-8#1)(2009-9#1)
receptors that recognize##3##3##(1991-9#1)(2008-4#1)(2011-2#1)
receptors that respond##2##3##(1991-6#1)(2008-4#1)
receptors that##50##2##(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#3)(1996-5#1)(1996-8#1)(1997-4#1)(1997-5#1)(2005-10#1)(2005-11#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-1#4)(2008-10#1)(2008-4#5)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#2)(2009-9#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
receptors then##2##2##(1993-8#1)(2008-8#1)
receptors through##3##2##(1991-7#1)(2008-11#1)(2011-1#1)
receptors to a##3##3##(1995-11#1)(1997-7#1)(2007-12#1)
receptors to mediate##3##3##(1994-12#1)(2008-4#1)(2009-8#1)
receptors to other##2##3##(1991-10#1)(1992-9#1)
receptors to the##7##3##(1992-8#1)(1992-9#1)(1993-6#2)(1994-10#1)(1994-5#1)(1994-6#1)
receptors to their##4##3##(1990-3#1)(1993-6#1)(1995-7#1)(2008-10#1)
receptors to which##2##3##(1997-6#1)(2010-10#1)
receptors to##45##2##(1990-3#1)(1990-7#1)(1991-10#1)(1991-8#1)(1992-2#1)(1992-8#1)(1992-9#2)(1993-6#3)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-4#1)(1997-6#2)(1997-7#2)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-8#1)(2010-10#1)(2012-2#1)
receptors undergo##2##2##(1990-2#1)(1991-6#1)
receptors using##5##2##(1994-9#1)(1996-5#1)(1997-2#1)(1997-5#2)
receptors via##2##2##(1997-8#1)(2008-7#1)
receptors was also altered##2##4##(1996-4#2)
receptors was also##5##3##(1991-4#1)(1991-5#1)(1996-1#1)(1996-4#2)
receptors was determined by##2##4##(1993-4#1)(2008-4#1)
receptors was determined##3##3##(1993-4#1)(1997-2#1)(2008-4#1)
receptors was increased##2##3##(1994-12#1)(1995-12#1)
receptors was not##2##3##(1991-9#1)(1993-12#1)
receptors was observed in##2##4##(1995-7#1)(1997-1#1)
receptors was performed##2##3##(2007-11#1)(2008-4#1)
receptors was studied##4##3##(1991-1#1)(1992-6#1)(1995-11#1)(1996-2#1)
receptors was##44##2##(1991-1#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#4)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#3)(1994-12#2)(1994-9#2)(1995-11#1)(1995-12#2)(1995-3#1)(1995-7#1)(1996-1#1)(1996-2#2)(1996-4#2)(1996-5#1)(1996-8#2)(1997-1#2)(1997-2#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-4#3)(2008-6#1)(2012-2#1)
receptors were also##5##3##(1990-12#1)(1993-12#1)(1995-11#1)(1996-5#1)(2007-2#1)
receptors were blocked##2##3##(1992-9#1)(1996-2#1)
receptors were compared##2##3##(1990-2#1)(1994-9#1)
receptors were detected##3##3##(1991-9#1)(1994-6#1)(1996-5#1)
receptors were expressed in Xenopus oocytes##3##6##(1993-6#1)(1995-5#1)(2008-4#1)
receptors were expressed in##5##4##(1991-5#1)(1993-6#1)(1995-3#1)(1995-5#1)(2008-4#1)
receptors were expressed##6##3##(1991-5#1)(1992-9#1)(1993-6#1)(1995-3#1)(1995-5#1)(2008-4#1)
receptors were found##3##3##(1995-1#1)(1996-5#1)(2008-4#1)
receptors were investigated##2##3##(1993-12#1)(2008-6#1)
receptors were less##2##3##(1993-12#1)(1994-2#1)
receptors were mainly##2##3##(1995-7#2)
receptors were measured##3##3##(1994-12#1)(1996-5#2)
receptors were not affected##2##4##(1994-12#1)(1996-2#1)
receptors were not##3##3##(1993-2#1)(1994-12#1)(1996-2#1)
receptors were observed##3##3##(1993-4#1)(1995-10#1)(2012-2#1)
receptors were present##3##3##(1992-4#1)(1993-12#1)(2008-4#1)
receptors were purified##2##3##(1994-2#1)(1995-3#1)
receptors were shown to be##2##5##(2008-3#1)(2008-4#1)
receptors were significantly decreased in the##2##6##(1993-12#1)(1995-12#1)
receptors were studied in##4##4##(1990-11#1)(1993-11#1)(1994-2#1)(2006-5#1)
receptors were studied##6##3##(1990-11#1)(1993-11#1)(1994-2#1)(1997-5#1)(2006-5#1)(2008-4#1)
receptors were undetectable in##2##4##(1990-11#2)
receptors were used to##3##4##(1993-12#1)(1994-10#1)(1996-12#1)
receptors were used##4##3##(1991-9#1)(1993-12#1)(1994-10#1)(1996-12#1)
receptors were##95##2##(1990-11#3)(1990-12#1)(1990-2#2)(1991-1#2)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#3)(1992-11#2)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#6)(1993-2#1)(1993-4#1)(1993-6#2)(1994-10#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#3)(1995-11#5)(1995-12#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-7#4)(1996-12#1)(1996-2#4)(1996-5#5)(1996-8#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-6#1)(2004-2#1)(2005-8#1)(2006-5#1)(2007-2#1)(2008-3#1)(2008-4#8)(2008-6#1)(2008-8#1)(2012-12#1)(2012-2#2)
receptors when##4##2##(1991-11#1)(1994-10#1)(1995-3#1)(1996-10#1)
receptors which are##4##3##(1990-3#1)(1991-3#1)(1995-10#1)(2007-12#1)
receptors which have##2##3##(1996-10#1)(2008-7#1)
receptors which may##2##3##(1994-3#1)(2008-3#1)
receptors which##23##2##(1990-3#1)(1991-3#1)(1991-5#2)(1992-7#1)(1993-9#1)(1994-10#1)(1994-3#1)(1994-8#1)(1995-10#1)(1996-10#3)(1996-12#3)(1996-2#2)(1996-5#1)(1997-5#1)(2007-12#1)(2008-3#1)(2008-7#1)
receptors will help##2##3##(1991-12#1)(1995-12#1)
receptors with a##4##3##(1990-7#1)(1991-4#1)(1996-7#1)(2007-1#1)
receptors with high affinity##2##4##(1990-2#1)(1995-11#1)
receptors with the##6##3##(1995-11#1)(1995-3#1)(1996-10#1)(2008-4#2)(2010-12#1)
receptors with##46##2##(1990-10#1)(1990-2#3)(1990-5#1)(1990-7#1)(1991-10#4)(1991-4#1)(1991-6#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-3#4)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-7#1)(2004-12#1)(2007-1#2)(2007-2#1)(2008-4#3)(2008-5#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
receptors within the##2##3##(1990-7#1)(1993-12#1)
receptors within##4##2##(1990-7#1)(1993-12#1)(1994-2#1)(1995-11#1)
receptors would##2##2##(1992-11#1)(2012-2#1)
receptors##3717##1##(1990-10#16)(1990-11#20)(1990-12#8)(1990-2#41)(1990-3#18)(1990-4#8)(1990-5#23)(1990-6#2)(1990-7#44)(1990-8#8)(1990-9#6)(1991-1#27)(1991-10#12)(1991-11#9)(1991-12#33)(1991-2#24)(1991-3#16)(1991-4#15)(1991-5#42)(1991-6#24)(1991-7#6)(1991-8#9)(1991-9#50)(1992-1#3)(1992-10#6)(1992-11#17)(1992-12#20)(1992-2#3)(1992-3#24)(1992-4#11)(1992-5#7)(1992-6#13)(1992-7#4)(1992-8#32)(1992-9#36)(1993-1#2)(1993-10#3)(1993-11#47)(1993-12#42)(1993-2#28)(1993-3#34)(1993-4#18)(1993-5#11)(1993-6#38)(1993-7#13)(1993-8#21)(1993-9#23)(1994-10#32)(1994-11#39)(1994-12#47)(1994-2#63)(1994-3#29)(1994-5#20)(1994-6#30)(1994-8#40)(1994-9#43)(1995-1#9)(1995-10#25)(1995-11#63)(1995-12#121)(1995-2#34)(1995-3#68)(1995-4#1)(1995-5#23)(1995-6#22)(1995-7#34)(1995-8#32)(1995-9#2)(1996-1#14)(1996-10#36)(1996-11#16)(1996-12#77)(1996-2#55)(1996-3#25)(1996-4#18)(1996-5#60)(1996-6#2)(1996-7#8)(1996-8#39)(1996-9#7)(1997-1#22)(1997-2#38)(1997-3#11)(1997-4#20)(1997-5#64)(1997-6#28)(1997-7#46)(1997-8#14)(1997-9#1)(2004-12#4)(2004-2#3)(2005-10#15)(2005-11#6)(2005-12#2)(2005-6#3)(2005-7#26)(2005-8#33)(2005-9#4)(2006-1#6)(2006-10#65)(2006-11#6)(2006-12#14)(2006-2#3)(2006-3#5)(2006-4#1)(2006-5#8)(2006-6#6)(2006-9#3)(2007-1#5)(2007-10#9)(2007-11#45)(2007-12#29)(2007-2#18)(2007-3#3)(2007-4#1)(2007-6#2)(2007-7#4)(2007-8#13)(2007-9#8)(2008-1#49)(2008-10#23)(2008-11#37)(2008-12#2)(2008-2#12)(2008-3#33)(2008-4#329)(2008-5#47)(2008-6#12)(2008-7#64)(2008-8#39)(2008-9#13)(2009-1#1)(2009-10#3)(2009-11#4)(2009-12#17)(2009-2#3)(2009-3#21)(2009-4#4)(2009-5#1)(2009-6#7)(2009-7#13)(2009-8#29)(2009-9#4)(2010-1#1)(2010-10#12)(2010-11#4)(2010-12#17)(2010-2#4)(2010-3#24)(2010-4#7)(2010-5#13)(2010-6#3)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#23)(2011-12#3)(2011-2#44)(2012-1#20)(2012-12#31)(2012-2#35)(2012-3#7)(2013-1#28)(2013-7#9)(2013-8#12)
receptors'##2##1##(1995-12#1)(2007-5#1)
receptors) and##3##2##(1993-12#1)(1994-3#1)(2008-3#1)
receptors) are##3##2##(1996-2#1)(2008-10#1)(2009-12#1)
receptors) was##2##2##(1993-12#1)(1997-5#1)
receptors) with a Ki of 3##2##6##(1996-12#2)
receptors)##38##1##(1991-7#1)(1991-8#1)(1992-5#1)(1993-12#3)(1994-11#2)(1994-2#1)(1994-3#1)(1995-11#1)(1996-10#2)(1996-12#2)(1996-2#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-5#4)(2004-12#1)(2006-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#3)(2008-5#2)(2009-12#1)(2009-8#1)(2009-9#1)(2010-4#1)
receptors]##2##1##(1990-2#1)(1992-10#1)
recertification by##2##2##(1994-12#1)(2006-5#1)
recertification##3##1##(1994-12#1)(1996-9#1)(2006-5#1)
recess and##3##2##(2006-5#1)(2008-1#1)(2011-2#1)
recess##24##1##(1990-5#1)(2006-12#1)(2006-5#1)(2007-11#2)(2008-1#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#6)(2012-2#2)(2013-1#2)(2013-8#5)
recessed##4##1##(1990-2#1)(1994-5#1)(1994-7#1)(2008-10#1)
recession along with##2##3##(2013-7#2)
recession is##3##2##(2012-12#1)(2012-3#1)(2013-7#1)
recession of##2##2##(2010-4#1)(2011-7#1)
recession##34##1##(1992-2#1)(1993-12#1)(1993-3#1)(2005-11#1)(2008-1#1)(2008-12#2)(2008-2#1)(2009-8#1)(2010-12#1)(2010-4#3)(2011-1#1)(2011-7#1)(2012-12#4)(2012-3#3)(2013-1#1)(2013-7#11)
recessions##4##1##(1993-5#1)(2010-4#1)(2013-7#2)
recessive allele##3##2##(1990-5#1)(2006-10#1)(2008-10#1)
recessive alleles##2##2##(2013-1#2)
recessive and##4##2##(1996-3#1)(1997-4#1)(2008-5#1)(2011-2#1)
recessive autosomal##3##2##(1992-5#1)(2008-1#1)(2009-1#1)
recessive disease##6##2##(1995-6#1)(1997-1#1)(2005-10#1)(2007-7#1)(2008-8#1)(2011-1#1)
recessive disorder characterized by##6##4##(1992-4#1)(1997-1#1)(2007-7#1)(2009-5#1)(2011-1#2)
recessive disorder that##3##3##(1991-8#1)(2011-1#1)(2012-12#1)
recessive disorder##28##2##(1991-8#1)(1991-9#1)(1992-4#1)(1996-2#1)(1996-6#2)(1997-1#2)(2006-10#1)(2006-9#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-7#1)(2009-5#1)(2010-3#1)(2011-1#4)(2012-12#4)(2013-1#1)(2013-8#1)
recessive disorders and##2##3##(1993-1#1)(2006-6#1)
recessive disorders##4##2##(1993-1#1)(2006-6#1)(2012-11#1)(2012-12#1)
recessive dystrophic epidermolysis bullosa##6##4##(2006-3#1)(2007-8#2)(2012-3#3)
recessive fashion##3##2##(1997-1#1)(2007-7#1)(2011-2#1)
recessive form of##3##3##(1997-1#1)(1997-7#1)(2008-11#1)
recessive form##5##2##(1996-6#1)(1997-1#1)(1997-7#1)(2008-11#2)
recessive gene controlled resistance to##2##5##(2008-10#2)
recessive gene for##3##3##(2008-10#3)
recessive gene##26##2##(1990-9#1)(1996-4#1)(2006-11#1)(2008-10#17)(2008-5#1)(2008-8#1)(2008-9#4)
recessive genes were detected in##4##5##(2008-10#4)
recessive genes were##5##3##(2008-10#5)
recessive genes##11##2##(1996-6#1)(2008-10#10)
recessive genetic disorder##2##3##(2008-8#1)(2011-3#1)
recessive genetic##6##2##(2006-7#1)(2007-7#1)(2008-10#1)(2008-8#2)(2011-3#1)
recessive hearing##2##2##(2006-10#1)(2011-1#1)
recessive inheritance of##3##3##(1994-11#1)(2008-10#2)
recessive inheritance##10##2##(1994-11#1)(1997-5#1)(2005-7#1)(2007-7#1)(2008-10#2)(2008-7#2)(2011-1#1)(2012-12#1)
recessive inherited disorder##2##3##(1993-6#1)(2008-3#1)
recessive inherited##3##2##(1993-6#1)(2008-3#1)(2013-1#1)
recessive juvenile parkinsonism (AR-JP)##2##4##(2008-7#2)
recessive lethal##2##2##(1991-11#1)(1992-1#1)
recessive manner##3##2##(1994-8#1)(1997-4#1)(2005-11#1)
recessive model##2##2##(2009-4#2)
recessive mutation##6##2##(1990-5#1)(1991-11#1)(1994-12#1)(1996-9#1)(1997-4#1)(2008-10#1)
recessive or additive##2##3##(2012-3#2)
recessive phenotype##2##2##(1994-12#2)
recessive to##2##2##(1996-5#1)(2008-8#1)
recessive trait##9##2##(1993-12#1)(1994-9#1)(1995-6#1)(1996-3#1)(1996-6#2)(2006-11#1)(2007-7#1)(2010-2#1)
recessive##246##1##(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-2#1)(1992-4#1)(1992-5#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-6#2)(1993-7#1)(1994-11#1)(1994-12#4)(1994-3#2)(1994-8#2)(1994-9#1)(1995-10#1)(1995-6#2)(1996-12#1)(1996-2#3)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#7)(1996-8#2)(1996-9#1)(1997-1#6)(1997-3#1)(1997-4#4)(1997-5#4)(1997-7#2)(1997-8#1)(2005-10#2)(2005-11#1)(2005-7#1)(2006-10#3)(2006-11#2)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-2#2)(2007-3#2)(2007-7#7)(2007-8#6)(2008-1#3)(2008-10#42)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#6)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#5)(2009-1#1)(2009-10#2)(2009-4#3)(2009-5#1)(2009-9#1)(2010-10#2)(2010-2#2)(2010-3#2)(2011-1#10)(2011-2#4)(2011-3#1)(2012-11#1)(2012-12#8)(2012-2#1)(2012-3#8)(2013-1#4)(2013-8#3)
recessively inherited##4##2##(1990-8#1)(2008-1#1)(2008-11#1)(2008-8#1)
recessively##5##1##(1990-8#1)(2008-1#2)(2008-11#1)(2008-8#1)
rechallenge with##3##2##(1991-3#1)(1997-2#1)(2012-2#1)
rechallenge##6##1##(1991-3#1)(1997-2#1)(2012-2#3)(2013-8#1)
recharge##4##1##(2008-2#1)(2008-5#1)(2009-12#1)(2009-6#1)
recherchées##2##1##(2012-2#1)(2013-1#1)
recidivation##2##1##(2005-10#1)(2007-11#1)
recidive##6##1##(1994-2#2)(1997-4#1)(2008-9#1)(2011-2#2)
recidivism##4##1##(2007-8#1)(2008-6#1)(2009-11#1)(2011-2#1)
recidivisms##2##1##(2011-2#2)
recipe for##2##2##(2008-9#1)(2012-12#1)
recipe##8##1##(1993-3#1)(1994-12#1)(2008-9#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
recipes and##2##2##(1995-7#1)(2008-10#1)
recipes for##3##2##(1995-7#1)(2008-2#1)(2008-9#1)
recipes in##2##2##(1995-7#2)
recipes##17##1##(1995-7#6)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#2)(2012-2#2)
recipient (host)##2##2##(2007-11#1)(2009-10#1)
recipient age##6##2##(1991-11#1)(2007-11#2)(2007-8#2)(2008-1#1)
recipient and donor##4##3##(1992-6#1)(1995-2#1)(2008-10#1)(2008-4#1)
recipient and the donor##2##4##(2008-9#1)(2011-2#1)
recipient and the##4##3##(1991-11#1)(2008-9#1)(2011-2#2)
recipient and##15##2##(1990-3#1)(1991-11#1)(1992-6#1)(1995-12#1)(1995-2#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#6)
recipient animals##3##2##(2006-5#1)(2008-4#1)(2008-9#1)
recipient cell##2##2##(1990-10#1)(1991-8#1)
recipient cells in##2##3##(2008-4#2)
recipient cells##6##2##(1995-2#1)(2008-4#3)(2013-1#2)
recipient embryos##2##2##(2008-11#2)
recipient is##3##2##(2006-10#1)(2007-11#1)(2011-2#1)
recipient may##2##2##(2007-11#1)(2011-3#1)
recipient mice##4##2##(1991-12#1)(1996-10#1)(2010-11#1)(2010-12#1)
recipient morbidity##2##2##(2006-10#1)(2009-8#1)
recipient of the##4##3##(1994-12#1)(1996-2#2)(2011-6#1)
recipient of##10##2##(1994-12#1)(1995-5#1)(1996-2#2)(1997-4#1)(2005-12#1)(2007-10#1)(2007-12#1)(2010-12#1)(2011-6#1)
recipient selection and##2##3##(2006-10#1)(2007-11#1)
recipient site##4##2##(2004-9#1)(2007-7#2)(2010-6#1)
recipient sites##2##2##(2008-5#1)(2012-2#1)
recipient species##2##2##(1996-10#2)
recipient strain##5##2##(1991-7#1)(1991-9#1)(1997-3#1)(2008-10#2)
recipient vessels##2##2##(2011-2#1)(2012-12#1)
recipient with##3##2##(1995-5#1)(2007-11#1)(2008-1#1)
recipient##207##1##(1990-10#1)(1990-3#1)(1991-11#4)(1991-12#2)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-3#2)(1995-11#1)(1995-12#1)(1995-2#9)(1995-5#2)(1995-6#2)(1996-1#1)(1996-10#3)(1996-12#1)(1996-2#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(2004-4#1)(2004-9#1)(2005-12#2)(2006-10#11)(2006-12#1)(2006-5#3)(2007-10#1)(2007-11#9)(2007-12#1)(2007-7#8)(2007-8#6)(2008-1#10)(2008-10#9)(2008-11#9)(2008-12#1)(2008-4#11)(2008-5#3)(2008-6#1)(2008-8#5)(2008-9#9)(2009-10#1)(2009-2#2)(2009-5#1)(2009-8#3)(2010-10#2)(2010-11#4)(2010-12#3)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#18)(2011-3#4)(2011-6#1)(2012-12#4)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#2)
recipient's age##2##2##(2008-1#2)
recipient's##11##1##(1990-3#1)(1992-12#2)(1997-5#2)(2005-12#1)(2006-10#2)(2007-10#1)(2008-1#2)
recipient)##3##1##(1995-2#1)(2008-1#1)(2011-2#1)
recipient]##3##1##(1990-9#1)(1991-3#1)(2011-2#1)
recipients (n =##2##3##(1996-3#1)(1996-8#1)
recipients and the##2##3##(1996-12#1)(2006-7#1)
recipients and##22##2##(1990-10#1)(1991-12#1)(1992-10#1)(1995-2#1)(1996-12#1)(1996-2#1)(2006-7#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-4#1)(2008-5#1)(2008-9#3)(2010-12#2)(2012-12#1)(2012-2#2)
recipients are also##2##3##(2008-3#1)(2012-12#1)
recipients are at increased risk##2##5##(2005-10#1)(2008-10#1)
recipients are discussed##2##3##(2006-10#2)
recipients are##13##2##(2005-10#1)(2006-10#2)(2007-11#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-12#2)
recipients at##6##2##(1992-12#1)(1996-8#1)(2007-10#1)(2008-1#1)(2009-4#1)(2013-1#1)
recipients by##3##2##(1991-12#1)(1991-9#1)(1994-9#1)
recipients compared to##2##3##(2007-7#1)(2013-8#1)
recipients compared##3##2##(1992-2#1)(2007-7#1)(2013-8#1)
recipients developed##2##2##(1995-2#1)(2007-7#1)
recipients during the##2##3##(1996-8#1)(2007-12#1)
recipients during##4##2##(1995-2#1)(1995-3#1)(1996-8#1)(2007-12#1)
recipients for##2##2##(1990-5#1)(2008-4#1)
recipients from the##3##3##(2007-12#1)(2008-9#1)(2012-12#1)
recipients have##4##2##(1991-12#1)(1995-12#2)(2007-11#1)
recipients in a##3##3##(1994-9#2)(2007-11#1)
recipients in the##2##3##(1993-3#1)(2006-7#1)
recipients in##13##2##(1991-1#1)(1991-2#1)(1992-2#1)(1993-3#1)(1994-9#2)(1995-2#2)(1996-6#1)(2006-7#1)(2007-11#1)(2007-7#2)
recipients is##7##2##(2007-11#3)(2007-8#1)(2008-3#2)(2010-9#1)
recipients of allogeneic##2##3##(2008-1#1)(2013-8#1)
recipients of##24##2##(1990-5#1)(1991-12#2)(1991-7#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#3)(1996-12#1)(1996-5#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#1)(2010-5#1)(2011-2#2)(2013-8#1)
recipients receiving##3##2##(1995-2#1)(2007-11#2)
recipients showed##3##2##(1995-2#1)(2006-10#1)(2008-9#1)
recipients such##2##2##(2008-1#1)(2008-10#1)
recipients than in##2##3##(1993-7#1)(2008-1#1)
recipients that##3##2##(1995-12#1)(2008-4#1)(2008-6#1)
recipients to##8##2##(1991-12#1)(1994-9#1)(1995-2#2)(2008-11#1)(2008-12#1)(2008-4#1)(2012-2#1)
recipients was##3##2##(1994-9#1)(1995-2#1)(2007-11#1)
recipients were treated##2##3##(1993-11#1)(1995-2#1)
recipients were##15##2##(1993-11#1)(1994-2#1)(1995-2#5)(1996-6#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-4#1)(2008-6#1)(2008-9#2)
recipients who##8##2##(1994-3#1)(2007-11#1)(2007-8#2)(2008-4#1)(2010-2#1)(2010-8#1)(2012-2#1)
recipients with##16##2##(1991-12#1)(1994-2#1)(1995-12#1)(1995-2#3)(1997-2#1)(1997-4#1)(2005-10#1)(2007-11#2)(2011-2#2)(2012-2#1)(2013-1#2)
recipients without##2##2##(2007-11#2)
recipients##407##1##(1990-10#1)(1990-5#2)(1991-1#1)(1991-11#3)(1991-12#15)(1991-2#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#4)(1993-11#4)(1993-12#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-2#3)(1994-3#4)(1994-9#12)(1995-1#3)(1995-12#7)(1995-2#55)(1995-3#3)(1995-5#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#3)(1996-3#3)(1996-5#2)(1996-6#2)(1996-8#5)(1997-2#4)(1997-4#1)(2005-10#2)(2005-12#1)(2006-10#14)(2006-2#1)(2006-5#1)(2006-7#6)(2007-10#1)(2007-11#43)(2007-12#10)(2007-2#2)(2007-5#2)(2007-7#12)(2007-8#17)(2007-9#3)(2008-1#25)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#8)(2008-4#13)(2008-5#1)(2008-6#5)(2008-7#1)(2008-8#1)(2008-9#14)(2009-10#1)(2009-2#2)(2009-4#2)(2009-5#4)(2010-10#2)(2010-12#8)(2010-2#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-12#1)(2011-2#13)(2012-1#1)(2012-12#5)(2012-2#7)(2013-1#6)(2013-7#1)(2013-8#5)
recipients'##3##1##(2007-12#1)(2007-2#1)(2010-10#1)
recipients)##2##1##(1991-3#1)(2008-6#1)
reciprocal actions##2##2##(1995-12#1)(2013-7#1)
reciprocal altruism##4##2##(2008-8#2)(2012-3#2)
reciprocal and##5##2##(2006-8#1)(2007-12#1)(2008-5#1)(2009-7#2)
reciprocal cross##2##2##(2008-10#1)(2008-9#1)
reciprocal crosses between##2##3##(1990-10#1)(2009-12#1)
reciprocal crosses in##2##3##(2008-12#1)(2009-12#1)
reciprocal crosses were made between##2##5##(2008-10#1)(2009-12#1)
reciprocal crosses##9##2##(1990-10#1)(2008-10#1)(2008-12#2)(2008-5#1)(2009-12#3)(2012-3#1)
reciprocal effects##4##2##(1992-9#1)(1995-12#1)(1997-7#1)(2010-3#1)
reciprocal exchange##2##2##(1996-4#1)(2013-1#1)
reciprocal exchanges##2##2##(1993-12#1)(2006-5#1)
reciprocal friends##3##2##(2009-7#3)
reciprocal influences##2##2##(1995-3#1)(2007-10#1)
reciprocal inhibition##2##2##(1993-3#2)
reciprocal interaction##2##2##(2007-10#1)(2010-3#1)
reciprocal interactions between##3##3##(2006-10#1)(2008-7#1)(2012-1#1)
reciprocal interactions##7##2##(1990-11#1)(2006-10#1)(2008-5#2)(2008-7#2)(2012-1#1)
reciprocal of##8##2##(1990-11#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-4#1)
reciprocal pair##2##2##(2008-3#1)(2011-2#1)
reciprocal phase##3##2##(2008-3#3)
reciprocal populations##2##2##(2008-10#2)
reciprocal relationship between##3##3##(2007-9#1)(2009-3#1)(2009-7#1)
reciprocal relationship##7##2##(2005-12#1)(2007-9#1)(2008-3#1)(2009-3#1)(2009-7#2)(2011-2#1)
reciprocal relationships##2##2##(1991-12#1)(2013-8#1)
reciprocal social interaction##2##3##(2009-4#1)(2011-2#1)
reciprocal social##4##2##(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
reciprocal space##3##2##(1994-8#1)(2006-5#1)(2007-11#1)
reciprocal translocation between##2##3##(1990-9#1)(2012-12#1)
reciprocal translocation##4##2##(1990-9#1)(2007-11#2)(2012-12#1)
reciprocal velocity##2##2##(1992-3#2)
reciprocal##160##1##(1990-10#1)(1990-11#5)(1990-5#2)(1990-9#1)(1991-10#1)(1991-12#1)(1991-3#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#5)(1995-2#1)(1995-3#1)(1995-8#2)(1996-12#2)(1996-3#1)(1996-4#1)(1996-7#1)(1997-3#1)(1997-7#4)(2004-12#1)(2004-2#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-5#3)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#14)(2008-12#2)(2008-2#3)(2008-3#12)(2008-4#1)(2008-5#9)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-12#3)(2009-3#1)(2009-4#2)(2009-7#8)(2009-8#1)(2010-1#2)(2010-12#1)(2010-3#3)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#6)(2012-7#1)(2013-1#1)(2013-7#1)(2013-8#2)
reciprocally connected##3##2##(1996-5#1)(1996-6#1)(2008-11#1)
reciprocally##17##1##(1990-2#1)(1992-8#1)(1994-3#2)(1994-9#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-11#2)(2008-9#2)(2012-2#1)
reciprocating##3##1##(2008-10#1)(2008-8#1)(2009-4#1)
reciprocation##2##1##(1997-3#2)
reciprocity and##3##2##(1997-3#1)(2008-11#1)(2008-2#1)
reciprocity as##2##2##(2005-12#1)(2012-11#1)
reciprocity inequality##3##2##(2007-12#3)
reciprocity of the##2##3##(1996-4#1)(2008-2#1)
reciprocity of##4##2##(1996-4#1)(2008-2#1)(2013-1#2)
reciprocity principle is##2##3##(2008-2#1)(2008-3#1)
reciprocity principle##3##2##(2008-2#1)(2008-3#2)
reciprocity theorem##6##2##(2008-2#1)(2008-3#5)
reciprocity##43##1##(1992-3#1)(1993-3#1)(1994-3#1)(1996-4#1)(1997-3#1)(2005-12#2)(2007-11#1)(2007-12#5)(2007-8#1)(2008-11#1)(2008-2#9)(2008-3#8)(2008-7#1)(2008-9#1)(2010-9#1)(2012-11#1)(2012-3#5)(2013-1#2)
recirculated##4##1##(1995-3#1)(2008-10#1)(2008-3#1)(2008-6#1)
recirculating##11##1##(1996-11#2)(1996-12#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#2)
recirculation and##3##2##(1992-10#1)(1994-10#1)(2007-7#1)
recirculation in##2##2##(1995-12#1)(2009-4#1)
recirculation of##4##2##(1997-4#1)(2007-10#1)(2008-3#1)(2009-7#1)
recirculation##32##1##(1990-5#1)(1991-11#1)(1991-5#1)(1992-10#1)(1993-2#4)(1994-10#3)(1995-12#2)(1997-4#1)(2007-10#1)(2007-7#8)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2009-7#1)(2011-2#1)
reckless##3##1##(1996-12#1)(1996-5#1)(1997-5#1)
reclaim and##2##2##(2008-4#2)
reclaim##7##1##(2008-1#1)(2008-4#5)(2008-6#1)
reclaimed##3##1##(2009-5#1)(2010-5#1)(2010-9#1)
reclaiming##2##1##(1997-3#1)(2012-2#1)
reclassification of the##2##3##(2006-8#1)(2008-5#1)
reclassification of##7##2##(1993-1#1)(1997-8#1)(2006-8#2)(2008-10#1)(2008-5#1)(2009-12#1)
reclassification##8##1##(1993-1#1)(1995-8#1)(1997-8#1)(2006-8#2)(2008-10#1)(2008-5#1)(2009-12#1)
reclassified as##5##2##(1991-9#1)(1997-6#1)(2006-12#1)(2010-7#2)
reclassified##10##1##(1991-9#1)(1997-6#1)(2006-12#2)(2006-8#1)(2009-8#1)(2010-7#2)(2013-8#2)
recloned in the Bluescript vector##2##5##(1990-3#2)
recloned##3##1##(1990-11#1)(1990-3#2)
recoded and nonrecoded##3##3##(2008-2#3)
recoded and##5##2##(2008-2#4)(2011-2#1)
recoded##8##1##(2005-8#1)(2008-2#6)(2011-2#1)
recoding##2##1##(1997-8#1)(2009-8#1)
recognise and##4##2##(2008-11#1)(2008-6#1)(2012-12#1)(2012-2#1)
recognise rodent##2##2##(1993-2#2)
recognise that the##3##3##(2005-5#1)(2007-11#1)(2012-12#1)
recognise that##5##2##(1996-11#1)(2005-5#1)(2007-11#1)(2008-8#1)(2012-12#1)
recognise the##9##2##(1991-6#1)(1994-8#1)(1995-10#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#2)
recognise their##2##2##(2006-2#1)(2008-9#1)
recognise these##2##2##(2007-3#1)(2012-2#1)
recognise##41##1##(1991-6#1)(1993-2#2)(1994-2#1)(1994-8#1)(1995-10#2)(1996-11#1)(1996-8#1)(1997-1#1)(1997-7#1)(2005-5#1)(2006-2#2)(2006-3#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#2)(2011-2#3)(2012-12#3)(2012-2#3)(2013-1#1)(2013-8#1)
recognised and##5##2##(1994-7#1)(2008-11#2)(2011-1#1)(2012-2#1)
recognised as a##10##3##(1994-2#1)(2006-2#1)(2006-3#1)(2006-8#1)(2007-7#1)(2008-11#1)(2008-12#1)(2012-12#1)(2012-2#2)
recognised as an essential##2##4##(2007-10#1)(2011-1#1)
recognised as an important##3##4##(2007-7#1)(2008-11#1)(2009-5#1)
recognised as an##7##3##(1997-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-11#1)(2009-5#1)(2011-1#1)
recognised as the##2##3##(2005-12#1)(2007-11#1)
recognised as##27##2##(1993-2#1)(1994-2#1)(1997-8#1)(2005-11#1)(2005-12#1)(2006-2#2)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-7#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)
recognised but##2##2##(2007-8#1)(2013-7#1)
recognised by a##4##3##(1992-11#1)(1994-11#1)(1995-3#1)(1996-6#1)
recognised by the##3##3##(1991-2#1)(1992-8#1)(2005-5#1)
recognised by##24##2##(1990-11#1)(1990-7#1)(1991-2#1)(1992-11#1)(1992-8#1)(1993-8#1)(1994-11#1)(1995-3#1)(1995-8#2)(1996-6#1)(1996-7#1)(2005-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-7#1)(2010-3#1)(2012-1#1)(2012-12#1)
recognised in##7##2##(1991-3#1)(1992-6#1)(1997-2#1)(2005-8#1)(2007-11#1)(2008-10#2)
recognised risk factors##2##3##(2007-2#1)(2010-7#1)
recognised that##6##2##(1990-4#1)(2006-8#1)(2007-11#1)(2008-11#2)(2008-8#1)
recognised the##2##2##(1992-11#1)(2008-10#1)
recognised to be##2##3##(2008-8#1)(2010-4#1)
recognised to##4##2##(2008-8#1)(2010-4#1)(2012-2#1)(2012-3#1)
recognised##132##1##(1990-11#1)(1990-4#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-11#2)(1992-6#1)(1992-8#2)(1993-12#1)(1993-2#3)(1993-8#2)(1994-11#1)(1994-2#1)(1994-6#1)(1994-7#1)(1995-10#1)(1995-3#2)(1995-8#2)(1996-6#2)(1996-7#1)(1997-2#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-5#5)(2005-7#1)(2005-8#1)(2006-2#2)(2006-3#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#14)(2007-12#3)(2007-2#2)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#5)(2008-11#10)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-5#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#2)(2013-7#1)
recognises a##2##2##(1995-12#1)(2005-7#1)
recognises the##3##2##(2008-12#1)(2010-5#1)(2013-8#1)
recognises##12##1##(1990-2#1)(1990-7#3)(1992-8#1)(1995-12#1)(1997-1#1)(2005-7#1)(2005-8#1)(2008-12#1)(2010-5#1)(2013-8#1)
recognising that##3##2##(2006-10#1)(2008-7#1)(2012-3#1)
recognising the importance of##2##4##(1996-3#1)(2006-2#1)
recognising the##8##2##(1991-6#1)(1992-8#1)(1996-3#1)(2006-2#2)(2006-3#1)(2008-11#2)
recognising##20##1##(1990-4#1)(1991-6#1)(1992-8#2)(1996-1#1)(1996-11#1)(1996-3#1)(2006-10#2)(2006-2#2)(2006-3#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-11#2)(2008-7#1)(2012-3#1)(2013-8#1)
recognition ability##4##2##(2008-10#2)(2010-5#1)(2012-2#1)
recognition algorithm##3##2##(2010-8#1)(2012-2#2)
recognition analysis##2##2##(2008-10#2)
recognition and aggressive treatment##2##4##(2006-10#1)(2012-3#1)
recognition and aggressive##4##3##(2006-10#2)(2007-3#1)(2012-3#1)
recognition and are##2##3##(2008-4#1)(2013-1#1)
recognition and binding of##2##4##(1997-7#1)(2011-1#1)
recognition and binding##4##3##(1995-6#1)(1997-7#1)(2011-1#1)(2013-8#1)
recognition and clearance##2##3##(2011-1#2)
recognition and diagnosis##2##3##(2005-10#1)(2009-2#1)
recognition and management of##6##4##(2006-10#1)(2008-1#1)(2008-3#2)(2010-7#1)(2013-1#1)
recognition and management##10##3##(2006-10#1)(2006-9#1)(2007-11#2)(2008-1#1)(2008-3#2)(2010-10#1)(2010-7#1)(2013-1#1)
recognition and prompt##2##3##(2007-1#1)(2011-2#1)
recognition and removal of##2##4##(2007-12#1)(2008-12#1)
recognition and signaling##2##3##(2008-10#1)(2012-2#1)
recognition and the##2##3##(2006-10#1)(2009-4#1)
recognition and treatment are##2##4##(2010-9#1)(2013-8#1)
recognition and treatment of this##2##5##(2007-7#1)(2013-1#1)
recognition and treatment of##6##4##(2006-8#1)(2007-7#1)(2008-1#1)(2010-7#1)(2012-3#1)(2013-1#1)
recognition and treatment##14##3##(1991-2#1)(2004-3#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-7#1)(2009-4#1)(2010-7#1)(2010-9#1)(2012-3#2)(2013-1#1)(2013-8#1)
recognition and##127##2##(1990-1#1)(1990-5#1)(1990-6#2)(1991-2#2)(1991-8#1)(1991-9#1)(1992-4#2)(1992-6#1)(1993-5#1)(1994-9#2)(1995-5#1)(1995-6#3)(1996-4#1)(1996-5#1)(1997-1#1)(1997-7#1)(1997-8#1)(2004-3#1)(2005-10#2)(2005-7#2)(2006-10#5)(2006-12#1)(2006-4#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-11#4)(2007-12#3)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#3)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#4)(2009-12#1)(2009-2#1)(2009-4#4)(2009-8#1)(2010-10#2)(2010-12#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#10)(2013-8#2)
recognition are discussed##2##3##(1991-7#1)(2007-7#1)
recognition are##8##2##(1991-7#1)(1995-1#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)
recognition as a##4##3##(1993-2#1)(1994-12#1)(2008-10#1)(2013-1#1)
recognition as an##2##3##(2008-2#1)(2010-3#1)
recognition as##10##2##(1993-2#1)(1994-12#1)(1996-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-3#1)(2012-2#1)(2013-1#1)
recognition at the##2##3##(2008-7#1)(2008-8#1)
recognition at##4##2##(1995-5#1)(2008-2#1)(2008-7#1)(2008-8#1)
recognition based on##8##3##(2007-12#3)(2007-8#1)(2008-2#1)(2008-3#2)(2008-8#1)
recognition between##5##2##(1992-6#1)(2007-11#1)(2008-10#2)(2009-3#1)
recognition but##2##2##(1993-11#1)(2007-9#1)
recognition by a##4##3##(1996-9#1)(1997-4#1)(1997-8#1)(2006-12#1)
recognition by means of##2##4##(2008-3#2)
recognition by monoclonal antibodies##2##4##(1994-8#1)(1997-8#1)
recognition by the ileal bile acid transport system##2##8##(1994-9#2)
recognition by the immune system##3##5##(1990-12#1)(2010-12#1)(2013-1#1)
recognition by the##19##3##(1990-12#1)(1991-6#2)(1991-8#1)(1992-4#2)(1993-12#1)(1994-3#1)(1994-9#2)(1995-8#1)(1996-1#1)(1996-12#1)(2005-10#1)(2006-10#1)(2009-10#1)(2010-12#1)(2012-3#1)(2013-1#1)
recognition by use of a##3##5##(2007-12#2)(2008-3#1)
recognition by use of##9##4##(2007-12#6)(2008-1#1)(2008-3#2)
recognition by##77##2##(1990-11#1)(1990-12#1)(1991-6#2)(1991-8#1)(1992-11#1)(1992-3#1)(1992-4#3)(1992-8#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-7#1)(1994-8#3)(1994-9#4)(1995-1#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-5#1)(1996-9#2)(1997-1#2)(1997-4#1)(1997-8#2)(2005-10#1)(2006-10#2)(2006-12#3)(2007-11#1)(2007-12#6)(2008-1#3)(2008-10#3)(2008-3#8)(2008-9#1)(2009-10#3)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
recognition can be##2##3##(2008-4#1)(2012-2#1)
recognition can##3##2##(2006-10#1)(2008-4#1)(2012-2#1)
recognition capability##2##2##(2008-10#2)
recognition domain with##2##3##(1997-2#1)(2006-10#1)
recognition domain##11##2##(1990-6#1)(1990-8#1)(1993-12#1)(1997-2#4)(1997-7#1)(2006-10#1)(2011-1#1)(2012-3#1)
recognition during##3##2##(2008-4#1)(2009-3#1)(2011-1#1)
recognition element##4##2##(2008-10#4)
recognition elements##6##2##(1993-11#1)(1996-9#1)(2007-8#1)(2008-10#3)
recognition event##4##2##(1990-12#1)(1994-12#1)(2009-3#2)
recognition following##2##2##(1995-12#1)(2009-4#1)
recognition for##11##2##(1991-3#1)(1994-1#1)(1994-2#1)(2007-7#1)(2008-10#2)(2008-9#1)(2009-4#1)(2012-2#1)(2012-3#2)
recognition from##2##2##(1994-3#1)(2008-2#1)
recognition function##2##2##(1996-10#1)(2012-3#1)
recognition has been##2##3##(2007-12#1)(2009-4#1)
recognition helix##2##2##(1990-11#1)(1992-4#1)
recognition impairments##3##2##(2008-4#2)(2009-4#1)
recognition in a##2##3##(2008-4#1)(2009-1#1)
recognition in cochlear implant##2##4##(2008-9#2)
recognition in mice##2##3##(2008-11#1)(2008-4#1)
recognition in the##12##3##(1990-12#1)(1992-4#1)(1993-1#1)(1995-6#1)(2006-10#1)(2006-4#1)(2006-9#1)(2008-7#3)(2008-8#1)(2009-3#1)
recognition in##55##2##(1990-12#1)(1991-6#1)(1992-4#1)(1993-1#1)(1993-2#1)(1993-7#1)(1994-9#1)(1995-6#1)(1995-8#2)(1996-2#1)(1997-5#1)(2004-12#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-3#2)(2006-4#1)(2006-9#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#6)(2008-7#3)(2008-8#2)(2008-9#6)(2009-1#4)(2009-3#1)(2009-4#2)(2009-5#2)
recognition is discussed##2##3##(1997-4#1)(2006-12#1)
recognition is not##2##3##(2006-7#1)(2009-4#1)
recognition is proposed##6##3##(2008-10#1)(2008-3#4)(2008-6#1)
recognition is##22##2##(1992-6#1)(1994-5#1)(1995-2#1)(1996-5#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-12#2)(2006-7#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-6#1)(2009-4#1)(2011-12#1)(2013-1#1)
recognition judgments to##4##3##(2008-10#4)
recognition material##2##2##(2008-10#2)
recognition mechanism##3##2##(2008-10#1)(2012-3#2)
recognition mechanisms##2##2##(2008-10#1)(2010-12#1)
recognition memory and##3##3##(1990-10#1)(1997-5#1)(2006-5#1)
recognition memory in##2##3##(1991-11#1)(1991-2#1)
recognition memory of##2##3##(1996-1#1)(1997-7#1)
recognition memory##30##2##(1990-10#1)(1990-11#1)(1991-11#1)(1991-2#1)(1992-10#1)(1993-3#2)(1994-3#1)(1996-1#3)(1996-7#2)(1997-5#1)(1997-7#1)(2006-5#2)(2006-9#3)(2007-12#2)(2008-11#1)(2008-6#2)(2008-9#1)(2009-10#2)(2009-2#1)(2012-2#1)
recognition method##2##2##(2010-2#1)(2012-2#1)
recognition methods##3##2##(2008-10#2)(2010-7#1)
recognition molecule##3##2##(1993-6#1)(2010-4#2)
recognition motif and##2##3##(1995-3#1)(2010-11#1)
recognition motif for##2##3##(1990-11#2)
recognition motif##12##2##(1990-11#2)(1993-12#1)(1994-12#1)(1995-1#1)(1995-3#1)(1996-8#1)(1997-4#1)(2006-12#1)(2010-11#1)(2010-12#1)(2012-2#1)
recognition motifs##4##2##(1994-3#1)(1997-5#1)(2012-2#1)(2013-8#1)
recognition must##2##2##(2008-1#1)(2008-2#1)
recognition of MHC##2##3##(2008-8#2)
recognition of PHI##3##3##(1996-5#3)
recognition of a##14##3##(1991-10#1)(1992-9#1)(1994-11#1)(1994-2#1)(1995-8#1)(1996-5#1)(1997-8#1)(2007-12#1)(2007-3#1)(2008-11#1)(2008-3#2)(2010-5#1)(2011-1#1)
recognition of an##2##3##(1996-5#1)(2013-7#1)
recognition of certain##2##3##(1995-3#1)(2010-7#1)
recognition of co-therapies that could reduce##2##6##(2006-10#2)
recognition of contour objects##2##4##(2008-3#2)
recognition of damaged and apoptotic cells##2##6##(1995-2#2)
recognition of damaged##3##3##(1993-3#1)(1995-2#2)
recognition of danger signs##2##4##(2012-12#2)
recognition of delirium##2##3##(1991-4#1)(2013-1#1)
recognition of each##3##3##(2005-7#1)(2008-10#1)(2010-4#1)
recognition of either##2##3##(1993-3#1)(2012-1#1)
recognition of emotional##2##3##(1990-10#1)(2006-3#1)
recognition of emotionally##2##3##(2006-3#1)(2013-7#1)
recognition of evolving##2##3##(2007-7#1)(2011-1#1)
recognition of faces##3##3##(1991-11#1)(1997-8#1)(2009-4#1)
recognition of facial##3##3##(2008-1#1)(2008-11#1)(2008-5#1)
recognition of host cells##2##4##(2007-7#1)(2012-1#1)
recognition of host##3##3##(2007-7#1)(2009-8#1)(2012-1#1)
recognition of low##3##3##(1994-9#1)(1997-2#1)(2010-7#1)
recognition of mRNA##2##3##(1994-12#1)(2006-12#1)
recognition of new##2##3##(1997-3#1)(2008-10#1)
recognition of objects##3##3##(2008-3#1)(2008-4#1)(2011-12#1)
recognition of pathogens and##2##4##(2009-3#1)(2009-8#1)
recognition of peptide##2##3##(1996-5#1)(2008-4#1)
recognition of potential complications##2##4##(2006-10#1)(2007-6#1)
recognition of specific##5##3##(1991-4#1)(2007-2#1)(2008-1#1)(2008-3#1)(2012-1#1)
recognition of such##2##3##(2010-11#1)(2010-5#1)
recognition of the disease##2##4##(1992-6#1)(1992-8#1)
recognition of the importance of##4##5##(1995-1#1)(2007-8#1)(2009-11#1)(2010-10#1)
recognition of the need for##2##5##(1996-7#1)(2008-11#1)
recognition of the role of##2##5##(2006-10#1)(2013-1#1)
recognition of the##80##3##(1990-12#1)(1990-6#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-9#1)(1996-2#2)(1996-3#2)(1996-7#1)(1997-2#1)(1997-5#1)(2005-7#1)(2006-10#5)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-1#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)
recognition of their##6##3##(1990-2#1)(1996-5#1)(2006-7#1)(2008-11#1)(2008-3#1)(2011-1#1)
recognition of these##6##3##(1991-7#1)(2006-10#1)(2006-2#1)(2008-11#1)(2010-5#1)(2011-1#1)
recognition of this syndrome##2##4##(1997-3#1)(2006-10#1)
recognition of this uncommon condition##2##5##(2005-9#1)(2013-7#1)
recognition of this##20##3##(1991-3#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-5#1)(2005-9#1)(2006-10#2)(2006-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-7#1)(2012-3#1)(2013-1#2)(2013-7#1)
recognition of three-dimensional objects##2##4##(2008-2#1)(2008-3#1)
recognition of three-dimensional##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
recognition of two##2##3##(1995-3#1)(2008-7#1)
recognition of##386##2##(1990-10#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#1)(1990-6#2)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-3#1)(1991-4#2)(1991-5#2)(1991-7#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#4)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#12)(1995-3#6)(1995-5#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#9)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#4)(1997-6#1)(1997-7#3)(1997-8#2)(2004-11#1)(2005-5#1)(2005-7#5)(2005-8#1)(2005-9#1)(2006-10#16)(2006-12#2)(2006-2#2)(2006-3#2)(2006-5#3)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#2)(2007-12#11)(2007-2#1)(2007-3#1)(2007-6#2)(2007-7#8)(2007-8#5)(2008-1#5)(2008-10#21)(2008-11#7)(2008-12#4)(2008-2#9)(2008-3#12)(2008-4#14)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#8)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#7)(2009-6#1)(2009-8#4)(2009-9#1)(2010-10#4)(2010-11#1)(2010-12#5)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#8)(2011-12#3)(2011-2#6)(2012-1#3)(2012-11#5)(2012-12#3)(2012-2#5)(2012-3#6)(2013-1#11)(2013-7#4)(2013-8#1)
recognition on##4##2##(1991-5#1)(1993-2#1)(2008-10#2)
recognition or##5##2##(1996-8#1)(2007-11#1)(2008-4#1)(2013-1#1)(2013-8#1)
recognition pattern of this##2##4##(1995-2#1)(2012-3#1)
recognition pattern of##3##3##(1995-2#1)(2012-3#2)
recognition pattern##4##2##(1995-2#1)(1996-12#1)(2012-3#2)
recognition performance##3##2##(2007-8#1)(2008-2#1)(2009-8#1)
recognition procedures##6##2##(2008-10#5)(2010-5#1)
recognition process##9##2##(1991-5#1)(1994-3#1)(1995-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-5#1)(2013-1#1)(2013-7#1)
recognition processes##2##2##(1996-11#1)(2007-12#1)
recognition programs##2##2##(2008-8#1)(2011-2#1)
recognition properties of##2##3##(2008-10#1)(2012-3#1)
recognition properties##7##2##(1997-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-7#1)(2012-3#1)
recognition protein##4##2##(1992-5#1)(1993-3#2)(1994-10#1)
recognition proteins##2##2##(1993-8#1)(2006-10#1)
recognition rate##2##2##(2008-3#1)(2010-8#1)
recognition receptors that##3##3##(2005-10#1)(2009-8#1)(2013-1#1)
recognition receptors##13##2##(2005-10#1)(2008-1#1)(2008-4#1)(2009-6#1)(2009-8#2)(2010-12#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
recognition requires a##2##3##(2007-8#1)(2012-3#1)
recognition requires##3##2##(1991-4#1)(2007-8#1)(2012-3#1)
recognition research##3##2##(2008-4#2)(2009-4#1)
recognition results##2##2##(2008-2#1)(2009-8#1)
recognition scores##2##2##(2008-9#2)
recognition sequence of##3##3##(1994-12#1)(1995-8#1)(1997-4#1)
recognition sequence##25##2##(1990-3#1)(1990-7#1)(1991-11#1)(1992-10#1)(1992-2#1)(1992-8#1)(1993-12#1)(1994-12#4)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#1)(1995-8#6)(1996-4#1)(1997-2#1)(1997-4#1)
recognition sequences##6##2##(1990-12#1)(1991-9#1)(1992-3#1)(1994-12#1)(2008-4#1)(2012-1#1)
recognition signal##2##2##(1991-6#1)(1996-5#1)
recognition site as##2##3##(1992-1#1)(1995-6#1)
recognition site for the##2##4##(1991-7#1)(1995-6#1)
recognition site for##3##3##(1991-7#1)(1995-6#2)
recognition site in##3##3##(1991-6#1)(1994-11#1)(1995-12#1)
recognition site of the##2##4##(1991-11#1)(1993-7#1)
recognition site of##5##3##(1990-5#1)(1991-11#1)(1993-2#1)(1993-7#1)(1994-5#1)
recognition site on the##3##4##(1991-12#1)(1991-5#1)(1995-1#1)
recognition site was##2##3##(1995-1#1)(1996-7#1)
recognition site##39##2##(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#2)(1991-7#1)(1992-1#1)(1992-6#1)(1993-11#1)(1993-2#2)(1993-7#1)(1994-11#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-1#4)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#5)(1996-7#1)(1997-2#1)(1997-5#1)(2008-4#1)(2013-1#1)
recognition sites for the##2##4##(1996-10#1)(2008-4#1)
recognition sites for##5##3##(1990-8#1)(1991-8#1)(1996-10#1)(2008-10#1)(2008-4#1)
recognition sites in##4##3##(1990-12#1)(1993-11#1)(1994-3#1)(1995-1#1)
recognition sites of##3##3##(1991-2#1)(1991-6#1)(1997-2#1)
recognition sites##28##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-8#1)(1991-2#2)(1991-5#1)(1991-6#2)(1991-8#2)(1992-8#1)(1993-11#1)(1994-11#1)(1994-3#1)(1995-1#3)(1995-3#1)(1995-5#1)(1996-10#2)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-4#1)(2010-12#1)
recognition step##2##2##(1994-8#1)(2008-10#1)
recognition structure##2##2##(1995-6#1)(2005-11#1)
recognition structures at##3##3##(2005-11#3)
recognition structures##4##2##(1994-9#1)(2005-11#3)
recognition system is##2##3##(2004-9#1)(2008-2#1)
recognition system that is##2##4##(2006-4#1)(2007-11#1)
recognition system that##3##3##(2006-4#1)(2007-11#1)(2008-2#1)
recognition system##21##2##(2004-9#2)(2006-12#1)(2006-4#1)(2007-11#1)(2007-4#1)(2008-2#7)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#3)(2010-5#1)(2013-8#1)
recognition systems##8##2##(2007-12#2)(2008-2#2)(2008-8#2)(2008-9#1)(2009-4#1)
recognition task##13##2##(1992-11#1)(1993-3#1)(1993-5#1)(1994-3#3)(2006-7#1)(2008-4#2)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)
recognition tasks##4##2##(2008-3#1)(2010-2#1)(2013-1#2)
recognition techniques##8##2##(2008-10#7)(2009-3#1)
recognition technology##2##2##(2004-9#1)(2008-11#1)
recognition test##4##2##(1992-10#1)(2008-9#1)(2012-2#1)(2013-1#1)
recognition tests##4##2##(1992-10#1)(2008-9#1)(2009-8#2)
recognition that chronic##2##3##(2007-11#1)(2011-2#1)
recognition that the##2##3##(2008-3#1)(2008-4#1)
recognition that##29##2##(1991-12#1)(1992-9#1)(1995-3#1)(2005-10#1)(2006-10#3)(2006-9#2)(2007-11#1)(2007-12#4)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-12#1)(2009-3#1)(2009-8#1)(2011-2#2)(2013-8#1)
recognition through##3##2##(1994-4#1)(2008-10#1)(2012-3#1)
recognition to the##3##3##(1990-8#1)(2008-10#1)(2012-3#1)
recognition to##7##2##(1990-8#1)(2008-10#1)(2008-2#1)(2009-1#3)(2012-3#1)
recognition using##2##2##(1995-11#1)(2008-2#1)
recognition was##6##2##(1991-2#1)(1991-5#1)(1995-12#1)(2008-10#1)(2008-2#1)(2008-9#1)
recognition will##2##2##(2006-10#1)(2012-3#1)
recognition with##10##2##(2006-10#1)(2008-2#2)(2008-3#7)
recognition within##3##2##(1994-12#1)(2008-9#1)(2009-4#1)
recognition without identification for##2##4##(2009-10#2)
recognition without##3##2##(2007-11#1)(2009-10#2)
recognition would##2##2##(2009-1#1)(2012-2#1)
recognition##1478##1##(1990-1#1)(1990-10#3)(1990-11#8)(1990-12#9)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#5)(1990-7#2)(1990-8#5)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#5)(1991-12#4)(1991-2#10)(1991-3#6)(1991-4#6)(1991-5#8)(1991-6#9)(1991-7#5)(1991-8#6)(1991-9#3)(1992-1#2)(1992-10#5)(1992-11#3)(1992-12#3)(1992-2#3)(1992-3#2)(1992-4#9)(1992-5#1)(1992-6#9)(1992-8#4)(1992-9#5)(1993-1#2)(1993-10#1)(1993-11#6)(1993-12#4)(1993-2#8)(1993-3#11)(1993-5#3)(1993-6#4)(1993-7#3)(1993-8#6)(1994-1#1)(1994-10#1)(1994-11#6)(1994-12#15)(1994-2#4)(1994-3#10)(1994-4#1)(1994-5#5)(1994-6#2)(1994-7#2)(1994-8#10)(1994-9#16)(1995-1#14)(1995-10#2)(1995-11#4)(1995-12#3)(1995-2#17)(1995-3#14)(1995-5#4)(1995-6#17)(1995-8#17)(1995-9#1)(1996-1#6)(1996-10#3)(1996-11#4)(1996-12#4)(1996-2#4)(1996-3#2)(1996-4#4)(1996-5#22)(1996-6#2)(1996-7#4)(1996-8#5)(1996-9#6)(1997-1#3)(1997-2#9)(1997-3#4)(1997-4#12)(1997-5#12)(1997-6#2)(1997-7#7)(1997-8#12)(2004-10#2)(2004-11#1)(2004-12#1)(2004-3#1)(2004-9#4)(2005-10#5)(2005-11#4)(2005-5#2)(2005-7#10)(2005-8#1)(2005-9#1)(2006-10#33)(2006-12#19)(2006-2#2)(2006-3#5)(2006-4#3)(2006-5#5)(2006-7#7)(2006-8#3)(2006-9#10)(2007-1#1)(2007-10#6)(2007-11#17)(2007-12#38)(2007-2#2)(2007-3#3)(2007-4#3)(2007-6#2)(2007-7#16)(2007-8#18)(2007-9#7)(2008-1#19)(2008-10#102)(2008-11#21)(2008-12#5)(2008-2#49)(2008-3#67)(2008-4#43)(2008-5#7)(2008-6#18)(2008-7#26)(2008-8#24)(2008-9#34)(2009-1#9)(2009-10#9)(2009-11#2)(2009-12#3)(2009-2#4)(2009-3#12)(2009-4#33)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#13)(2009-9#1)(2010-10#6)(2010-11#2)(2010-12#16)(2010-2#5)(2010-3#1)(2010-4#8)(2010-5#8)(2010-6#3)(2010-7#9)(2010-8#8)(2010-9#2)(2011-1#18)(2011-12#4)(2011-2#20)(2011-3#1)(2012-1#9)(2012-11#5)(2012-12#8)(2012-2#27)(2012-3#28)(2013-1#39)(2013-7#7)(2013-8#11)
recognitions##4##1##(2006-11#1)(2007-11#1)(2008-2#1)(2010-7#1)
recognizable and##4##2##(2004-3#1)(2006-3#1)(2006-5#1)(2007-12#1)
recognizable by##3##2##(1994-11#1)(1997-4#1)(2009-2#1)
recognizable histologic##2##2##(1995-4#1)(2010-9#1)
recognizable syndromes##2##2##(1996-12#2)
recognizable##31##1##(1990-5#1)(1991-5#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-4#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-4#3)(1997-6#1)(2004-3#1)(2006-10#1)(2006-3#1)(2006-5#1)(2007-12#2)(2007-9#2)(2008-1#1)(2008-5#1)(2009-2#1)(2009-3#2)(2010-3#1)(2010-9#1)
recognize RNA##2##2##(2008-8#1)(2011-1#1)
recognize a previously seen object##2##5##(1991-2#1)(1997-8#1)
recognize a previously seen##3##4##(1991-2#1)(1997-8#1)(2010-2#1)
recognize a##20##2##(1990-10#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-8#1)(1994-12#1)(1995-2#1)(1997-1#1)(1997-8#1)(2005-12#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-2#1)(2012-11#1)
recognize all##3##2##(1997-2#1)(2008-4#1)(2008-5#1)
recognize an##2##2##(1991-9#1)(1995-2#1)
recognize and bind to the##2##5##(1992-8#1)(2008-9#1)
recognize and bind to##3##4##(1992-8#1)(2008-9#1)(2009-7#1)
recognize and bind##4##3##(1992-8#1)(2008-9#1)(2009-7#1)(2011-1#1)
recognize and cleave##2##3##(2009-2#1)(2012-1#1)
recognize and react to##2##4##(1995-12#1)(2006-10#1)
recognize and react##3##3##(1995-12#1)(2006-10#1)(2013-7#1)
recognize and reject##2##3##(2006-10#1)(2008-9#1)
recognize and##43##2##(1992-8#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-5#1)(2004-2#1)(2004-3#1)(2006-10#3)(2006-12#1)(2006-4#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#3)(2009-2#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#4)(2013-7#1)
recognize antigens##4##2##(1990-11#1)(1992-4#1)(2008-5#1)(2010-8#1)
recognize cell surface##2##3##(1995-6#1)(2008-10#1)
recognize different##5##2##(1996-12#1)(1996-7#1)(1996-8#1)(2008-2#1)(2011-1#1)
recognize each##2##2##(1996-12#1)(2008-3#1)
recognize epitopes##2##2##(1990-11#1)(1991-2#1)
recognize features##2##2##(1991-7#1)(2008-10#1)
recognize how##2##2##(1996-3#1)(2008-5#1)
recognize individual integrin chains in Western blots and in flow cytometry##2##11##(2012-12#2)
recognize intact##7##2##(1995-2#1)(2008-2#2)(2008-4#4)
recognize its##2##2##(2006-12#1)(2008-4#1)
recognize molecules##2##2##(1994-12#1)(2013-1#1)
recognize or##2##2##(2008-5#1)(2010-9#1)
recognize other##2##2##(1995-2#1)(2008-4#1)
recognize peptide##3##2##(1991-12#1)(1994-11#1)(1996-5#1)
recognize primary##2##2##(1994-4#1)(1995-6#1)
recognize similar##2##2##(1996-11#1)(1996-7#1)
recognize some##2##2##(2008-9#1)(2009-4#1)
recognize specific##6##2##(1992-8#1)(1995-10#1)(2008-1#2)(2008-4#2)
recognize such##2##2##(1995-6#1)(2008-1#1)
recognize taste stimuli##2##3##(2008-7#2)
recognize that it##2##3##(2008-2#1)(2009-8#1)
recognize that the##7##3##(1992-6#1)(1994-3#1)(1995-12#1)(1996-6#1)(2006-2#1)(2008-2#1)(2008-7#1)
recognize that they##2##3##(1996-2#1)(2013-8#1)
recognize that##24##2##(1992-6#1)(1992-8#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(2006-10#1)(2006-2#2)(2007-11#2)(2007-2#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-8#1)(2010-8#1)(2013-8#1)
recognize the characteristics of##2##4##(2008-2#1)(2013-1#1)
recognize the illness##2##3##(2011-2#2)
recognize the importance of##4##4##(1993-1#1)(2009-9#1)(2010-1#1)(2013-1#1)
recognize the need for##3##4##(1995-1#1)(1996-1#1)(2012-12#1)
recognize the need##4##3##(1995-1#1)(1996-1#1)(2009-4#1)(2012-12#1)
recognize the potential##2##3##(1992-3#1)(2009-9#1)
recognize the presence##2##3##(2008-3#2)
recognize the same##2##3##(1992-2#1)(2008-10#1)
recognize the symptoms##2##3##(2006-8#1)(2011-3#1)
recognize the value of##3##4##(1992-5#1)(1994-1#1)(2013-8#1)
recognize the##102##2##(1990-12#1)(1990-2#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1993-1#2)(1993-11#1)(1993-2#2)(1993-3#1)(1993-7#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-1#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-5#2)(1996-7#1)(1996-9#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#2)(2005-8#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#2)(2008-9#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-9#3)(2010-1#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
recognize their##7##2##(1993-2#1)(1993-6#1)(1995-2#1)(1995-3#1)(1995-6#1)(2006-1#1)(2012-1#1)
recognize them##4##2##(2007-12#1)(2007-5#1)(2008-1#1)(2011-1#1)
recognize these##4##2##(1991-4#1)(2008-11#1)(2008-4#1)(2010-1#1)
recognize this##6##2##(1991-5#1)(1991-8#1)(2007-12#1)(2008-9#1)(2011-2#1)(2013-7#1)
recognize two##4##2##(1995-2#1)(1996-12#1)(1996-5#1)(1997-4#1)
recognize various##3##2##(1996-12#1)(2013-1#2)
recognize##425##1##(1990-10#1)(1990-11#3)(1990-12#4)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-11#2)(1991-12#5)(1991-2#3)(1991-3#2)(1991-4#2)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#3)(1992-5#2)(1992-6#2)(1992-8#4)(1993-1#4)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#3)(1993-6#2)(1993-7#1)(1994-1#2)(1994-11#2)(1994-12#5)(1994-2#4)(1994-3#3)(1994-4#1)(1994-6#4)(1994-8#1)(1994-9#2)(1995-1#3)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#12)(1995-3#5)(1995-5#1)(1995-6#8)(1995-8#4)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#5)(1996-2#4)(1996-3#3)(1996-4#1)(1996-5#6)(1996-6#1)(1996-7#4)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#4)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#4)(2004-2#2)(2004-3#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-8#2)(2006-1#1)(2006-10#10)(2006-12#3)(2006-2#2)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#2)(2007-11#4)(2007-12#6)(2007-2#4)(2007-3#2)(2007-4#1)(2007-5#3)(2007-7#1)(2007-8#2)(2008-1#7)(2008-10#10)(2008-11#8)(2008-12#1)(2008-2#8)(2008-3#6)(2008-4#18)(2008-5#7)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#13)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#5)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#8)(2010-1#3)(2010-11#1)(2010-12#4)(2010-2#3)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#4)(2011-1#6)(2011-2#15)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#6)(2012-2#3)(2012-3#3)(2013-1#10)(2013-7#3)(2013-8#3)
recognized a band##2##3##(1991-12#1)(1997-7#1)
recognized a single band##2##4##(1991-9#1)(1993-2#1)
recognized a single##5##3##(1991-9#1)(1993-2#1)(1995-6#1)(1996-5#1)(1997-7#1)
recognized a##21##2##(1990-8#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-12#1)(1993-2#2)(1993-9#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-5#1)(1997-7#2)(2006-8#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-10#1)(2011-2#1)
recognized all##4##2##(1995-1#1)(2008-10#1)(2008-5#2)
recognized amoeboid##2##2##(1993-11#2)
recognized among##3##2##(2005-10#1)(2008-1#1)(2010-6#1)
recognized and treated##2##3##(2008-8#1)(2012-12#1)
recognized and##29##2##(1991-2#1)(1993-5#1)(1994-6#1)(1994-8#1)(1995-6#1)(1997-1#1)(1997-3#1)(1997-7#1)(2003-11#1)(2005-7#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-3#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-8#1)
recognized antigens##3##2##(1990-12#1)(1997-7#1)(2008-5#1)
recognized as a cause of##4##5##(1997-1#1)(2006-10#1)(2008-7#1)(2012-3#1)
recognized as a critical##2##4##(2009-3#1)(2013-1#1)
recognized as a key##3##4##(2005-11#1)(2008-11#1)(2008-8#1)
recognized as a major cause of##2##6##(1995-2#1)(1997-1#1)
recognized as a major##9##4##(1995-2#1)(1997-1#1)(2007-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-3#1)(2010-3#1)(2013-8#1)
recognized as a public health##2##5##(2008-10#1)(2011-2#1)
recognized as a##58##3##(1990-9#1)(1991-4#1)(1992-1#1)(1992-11#1)(1995-2#1)(1995-6#1)(1996-3#1)(1997-1#2)(1997-5#1)(2005-11#2)(2005-8#2)(2006-1#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-10#2)(2007-2#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#2)(2009-8#1)(2010-12#2)(2010-3#1)(2011-11#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
recognized as an important source of##2##6##(2006-8#1)(2009-2#1)
recognized as an important##10##4##(2006-8#1)(2007-1#1)(2007-6#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-11#1)
recognized as an opportunistic##2##4##(1993-6#1)(2007-12#1)
recognized as an##19##3##(1992-4#1)(1993-6#1)(1997-1#1)(1997-2#1)(2005-7#1)(2006-8#1)(2007-1#1)(2007-12#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-11#1)
recognized as being##4##3##(1993-8#1)(2008-4#2)(2011-2#1)
recognized as critical##2##3##(2007-8#1)(2010-6#1)
recognized as important##6##3##(2005-10#1)(2006-10#3)(2008-1#1)(2011-1#1)
recognized as one of the most common##2##7##(2007-7#1)(2008-10#1)
recognized as one of the##5##5##(2007-7#2)(2008-10#2)(2010-4#1)
recognized as safe##2##3##(2008-10#1)(2012-12#1)
recognized as the major##2##4##(2008-7#1)(2010-9#1)
recognized as the most common##2##5##(2008-12#1)(2010-12#1)
recognized as the most##4##4##(1992-2#1)(2008-12#1)(2010-12#1)(2011-1#1)
recognized as the primary##2##4##(2008-10#1)(2012-11#1)
recognized as the##24##3##(1992-2#1)(1992-6#1)(1993-8#1)(1994-2#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-12#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#3)(2010-9#1)(2011-1#1)(2012-11#1)
recognized as##176##2##(1990-10#1)(1990-3#1)(1990-9#1)(1991-4#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1993-6#1)(1993-8#2)(1994-2#1)(1994-3#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-5#1)(2005-10#1)(2005-11#2)(2005-7#2)(2005-8#3)(2006-1#1)(2006-10#5)(2006-2#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#4)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#7)(2007-8#1)(2008-1#7)(2008-10#10)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#4)(2009-10#1)(2009-2#1)(2009-3#3)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#6)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-9#3)(2011-1#3)(2011-11#1)(2011-12#2)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#7)(2013-8#3)
recognized at##6##2##(1995-2#1)(1997-2#1)(2006-2#1)(2008-5#1)(2011-1#1)(2011-2#1)
recognized both##3##2##(1990-12#1)(1993-11#1)(1996-1#1)
recognized by RNA polymerase##2##4##(1993-9#2)
recognized by a monoclonal antibody##4##5##(1991-7#1)(1994-10#1)(1995-3#2)
recognized by a monoclonal##5##4##(1991-7#1)(1994-10#1)(1994-12#1)(1995-3#2)
recognized by a##13##3##(1990-6#1)(1991-7#1)(1992-7#1)(1994-10#1)(1994-12#2)(1995-2#1)(1995-3#2)(1995-6#1)(2008-3#1)(2008-5#2)
recognized by an antibody against##2##5##(1993-11#1)(1994-8#1)
recognized by an antibody##3##4##(1992-11#1)(1993-11#1)(1994-8#1)
recognized by an##7##3##(1992-11#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#1)(1997-8#1)
recognized by antibodies in##2##4##(1990-11#2)
recognized by antibodies##8##3##(1990-11#2)(1990-12#1)(1994-11#1)(1994-12#1)(2008-4#1)(2011-2#1)(2013-1#1)
recognized by mAbs##2##3##(2008-4#2)
recognized by monoclonal antibody##3##4##(1990-7#1)(1992-12#1)(2008-8#1)
recognized by polyclonal##4##3##(1991-2#1)(2008-2#1)(2008-4#2)
recognized by sera from##2##4##(1990-5#1)(2009-6#1)
recognized by several##3##3##(1992-2#1)(1994-6#1)(2011-2#1)
recognized by sigma##2##3##(1993-11#1)(1995-6#1)
recognized by specific##2##3##(2008-11#1)(2010-2#1)
recognized by the monoclonal antibody##2##5##(1990-7#1)(1991-9#1)
recognized by the monoclonal##3##4##(1990-7#1)(1991-5#1)(1991-9#1)
recognized by the##52##3##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#2)(1991-7#2)(1991-9#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-12#1)(1995-2#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-4#2)(2008-5#2)(2008-8#1)(2009-6#1)(2010-12#1)(2013-1#1)(2013-8#1)
recognized by their##2##3##(1997-6#1)(2008-4#1)
recognized by this antibody##2##4##(1994-9#1)(1995-11#1)
recognized by this##3##3##(1994-9#1)(1995-11#1)(1995-3#1)
recognized by##173##2##(1990-10#1)(1990-11#5)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#2)(1990-7#2)(1990-9#1)(1991-1#1)(1991-2#4)(1991-4#1)(1991-5#4)(1991-6#1)(1991-7#3)(1991-9#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#3)(1993-3#2)(1993-6#1)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#4)(1994-3#2)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#5)(1995-4#1)(1995-6#3)(1995-8#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-8#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2003-11#1)(2005-11#1)(2005-12#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#7)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#10)(2008-5#6)(2008-7#1)(2008-8#4)(2008-9#1)(2009-6#3)(2010-1#1)(2010-12#1)(2010-2#2)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
recognized cause of stroke##2##4##(1996-2#1)(2011-1#1)
recognized cause of##5##3##(1996-2#1)(2007-9#1)(2008-7#1)(2011-1#1)(2011-2#1)
recognized complication of##2##3##(2007-8#1)(2008-7#1)
recognized complication##3##2##(2007-8#1)(2008-7#1)(2009-7#1)
recognized during##2##2##(2008-3#1)(2012-2#1)
recognized early##3##2##(1995-11#1)(2008-12#1)(2008-8#1)
recognized for its role in##2##5##(1995-2#1)(2012-2#1)
recognized for its role##3##4##(1990-4#1)(1995-2#1)(2012-2#1)
recognized for its##4##3##(1990-4#1)(1995-12#1)(1995-2#1)(2012-2#1)
recognized for##12##2##(1990-4#1)(1995-12#1)(1995-2#1)(1996-3#1)(2005-10#1)(2006-12#1)(2009-10#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#2)
recognized from##3##2##(1996-4#1)(2008-2#1)(2008-4#1)
recognized human##3##2##(1990-5#1)(1994-9#1)(2008-5#1)
recognized in both##2##3##(2006-10#1)(2008-5#1)
recognized in recent##2##3##(2007-7#1)(2013-8#1)
recognized in the##11##3##(2006-7#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#1)(2011-1#1)(2012-1#1)
recognized in vivo##2##3##(1994-12#1)(2005-12#1)
recognized in##53##2##(1990-11#1)(1991-5#1)(1994-12#1)(1995-10#1)(1995-8#1)(1996-9#2)(1997-2#1)(2005-12#1)(2006-10#4)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#5)(2008-7#2)(2009-12#2)(2009-7#1)(2009-8#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
recognized is##3##2##(1995-1#1)(2008-11#1)(2008-2#1)
recognized more##3##2##(1995-1#1)(2008-5#1)(2012-2#1)
recognized not only##2##3##(1996-6#1)(2012-1#1)
recognized on Western##2##3##(1991-2#1)(1993-12#1)
recognized on##6##2##(1991-2#1)(1993-12#1)(1995-12#1)(1997-8#1)(2008-10#1)(2008-9#1)
recognized only##2##2##(2009-9#1)(2011-1#1)
recognized pathogenic##2##2##(2008-1#1)(2012-12#1)
recognized phenomenon##2##2##(2004-11#1)(2007-8#1)
recognized purified##2##2##(1992-3#1)(1995-8#1)
recognized risk factors##2##3##(2005-10#1)(2011-2#1)
recognized role##2##2##(2008-10#1)(2010-5#1)
recognized species##3##2##(2006-5#1)(2007-12#1)(2008-9#1)
recognized that a##4##3##(1995-12#1)(2008-11#1)(2012-2#1)(2013-7#1)
recognized that the##4##3##(1995-12#1)(2008-5#1)(2008-7#1)(2011-1#1)
recognized that there##2##3##(1995-2#1)(2012-12#1)
recognized that they##2##3##(2008-12#1)(2012-1#1)
recognized that##47##2##(1990-9#1)(1992-5#1)(1993-12#1)(1994-3#1)(1994-9#1)(1995-12#4)(1995-2#1)(1996-2#1)(1996-3#2)(1996-9#1)(2004-11#1)(2006-10#4)(2006-3#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#2)(2009-9#1)(2010-1#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-7#1)
recognized the 65 kDa##2##4##(1992-12#1)(1994-2#1)
recognized the importance of##4##4##(1994-8#1)(2007-10#1)(2008-1#1)(2008-5#1)
recognized the need to##5##4##(1991-3#1)(1996-2#1)(1996-3#1)(1997-2#1)(2012-3#1)
recognized the protein##2##3##(1990-5#1)(1991-5#1)
recognized the##39##2##(1990-3#1)(1990-5#2)(1991-3#2)(1991-5#1)(1992-12#1)(1992-7#1)(1993-2#1)(1994-11#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-3#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1997-2#2)(1997-6#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-7#1)(2010-12#1)(2012-3#2)
recognized this##2##2##(1994-11#1)(2013-8#1)
recognized three##2##2##(1991-3#1)(1997-4#1)
recognized to be a##4##4##(1993-12#1)(1993-9#1)(2008-10#1)(2013-1#1)
recognized to be##12##3##(1990-6#1)(1991-5#1)(1992-4#1)(1992-5#1)(1993-12#1)(1993-9#1)(2007-3#1)(2008-10#1)(2008-7#2)(2010-4#1)(2013-1#1)
recognized to have a##2##4##(2005-8#1)(2008-7#1)
recognized to have##4##3##(1997-1#1)(2005-8#1)(2008-11#1)(2008-7#1)
recognized to play a##2##4##(2012-12#1)(2013-7#1)
recognized to play##3##3##(2010-12#1)(2012-12#1)(2013-7#1)
recognized to##25##2##(1990-6#1)(1991-5#1)(1992-4#1)(1992-5#1)(1993-12#2)(1993-9#1)(1997-1#1)(2005-8#1)(2007-3#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-7#3)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
recognized with the##2##3##(1997-2#1)(2008-6#1)
recognized with##5##2##(1995-11#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-6#1)
recognized worldwide as##2##3##(2008-10#1)(2010-6#1)
recognized worldwide##3##2##(2008-10#1)(2009-3#1)(2010-6#1)
recognized##912##1##(1990-10#3)(1990-11#6)(1990-12#6)(1990-2#3)(1990-3#3)(1990-4#2)(1990-5#7)(1990-6#4)(1990-7#3)(1990-8#4)(1990-9#4)(1991-1#1)(1991-10#1)(1991-12#7)(1991-2#10)(1991-3#3)(1991-4#3)(1991-5#7)(1991-6#1)(1991-7#5)(1991-8#3)(1991-9#4)(1992-1#1)(1992-11#2)(1992-12#6)(1992-2#2)(1992-3#5)(1992-4#2)(1992-5#6)(1992-6#3)(1992-7#4)(1992-8#2)(1992-9#2)(1993-10#1)(1993-11#9)(1993-12#4)(1993-2#4)(1993-3#4)(1993-5#1)(1993-6#2)(1993-8#5)(1993-9#6)(1994-10#1)(1994-11#8)(1994-12#9)(1994-2#3)(1994-3#5)(1994-4#1)(1994-6#4)(1994-8#5)(1994-9#3)(1995-1#4)(1995-10#2)(1995-11#4)(1995-12#9)(1995-2#6)(1995-3#11)(1995-4#1)(1995-5#2)(1995-6#10)(1995-7#1)(1995-8#9)(1995-9#1)(1996-1#3)(1996-11#2)(1996-12#10)(1996-2#4)(1996-3#7)(1996-4#2)(1996-5#5)(1996-6#2)(1996-8#3)(1996-9#5)(1997-1#8)(1997-2#7)(1997-3#4)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#5)(1997-8#4)(2003-11#3)(2004-11#4)(2005-10#6)(2005-11#4)(2005-12#5)(2005-5#1)(2005-7#4)(2005-8#6)(2006-1#1)(2006-10#27)(2006-11#2)(2006-12#2)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#3)(2006-7#4)(2006-8#4)(2006-9#4)(2007-1#2)(2007-10#9)(2007-11#4)(2007-12#11)(2007-2#7)(2007-3#3)(2007-5#2)(2007-6#1)(2007-7#10)(2007-8#9)(2007-9#2)(2008-1#17)(2008-10#49)(2008-11#24)(2008-12#6)(2008-2#7)(2008-3#10)(2008-4#21)(2008-5#34)(2008-6#5)(2008-7#24)(2008-8#16)(2008-9#9)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#5)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#3)(2009-8#7)(2009-9#5)(2010-1#2)(2010-11#2)(2010-12#10)(2010-2#4)(2010-3#4)(2010-4#3)(2010-5#4)(2010-6#5)(2010-7#4)(2010-8#2)(2010-9#4)(2011-1#12)(2011-11#1)(2011-12#2)(2011-2#28)(2012-1#5)(2012-11#2)(2012-12#18)(2012-2#11)(2012-3#15)(2013-1#21)(2013-7#5)(2013-8#8)
recognizes a conformational epitope##3##4##(1995-10#1)(1997-7#1)(2009-8#1)
recognizes a peptide##2##3##(1995-8#1)(1997-8#1)
recognizes a##16##2##(1991-9#1)(1992-2#1)(1992-4#1)(1993-12#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-8#2)(1997-7#3)(1997-8#1)(2007-7#1)(2008-11#1)(2009-8#1)
recognizes an epitope##3##3##(1990-8#1)(1997-7#1)(2007-8#1)
recognizes an##5##2##(1990-8#1)(1996-2#1)(1997-7#1)(2007-8#1)(2008-10#1)
recognizes and##4##2##(1990-5#1)(2004-10#1)(2007-9#1)(2008-6#1)
recognizes both##5##2##(1990-12#1)(1994-8#1)(1995-10#1)(1995-6#1)(2008-11#1)
recognizes human##4##2##(1992-6#1)(1994-12#2)(1995-3#1)
recognizes specifically##3##2##(1994-8#1)(1995-12#1)(2008-11#1)
recognizes that##4##2##(1995-2#1)(1997-3#1)(2007-11#1)(2012-12#1)
recognizes the sequence##2##3##(1993-9#1)(1994-5#1)
recognizes the##33##2##(1990-10#1)(1990-3#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-7#1)(1992-9#2)(1993-7#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1997-4#1)(1997-7#1)(2006-4#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-8#1)(2010-6#1)(2011-1#1)(2012-2#1)
recognizes this##2##2##(2008-4#1)(2012-2#1)
recognizes##111##1##(1990-10#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#2)(1992-7#1)(1992-9#2)(1993-12#1)(1993-7#1)(1993-9#1)(1994-12#3)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-10#2)(1995-12#1)(1995-2#5)(1995-3#4)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-2#1)(1996-5#1)(1997-3#2)(1997-4#2)(1997-7#5)(1997-8#3)(2004-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#2)(2009-8#2)(2010-11#1)(2010-6#1)(2011-1#4)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
recognizing a##13##2##(1990-12#1)(1991-3#1)(1995-2#1)(1997-8#1)(2006-10#1)(2007-12#2)(2007-5#1)(2008-10#1)(2008-3#1)(2008-4#2)(2011-2#1)
recognizing an event as a work accident##2##7##(2009-4#2)
recognizing an##4##2##(1992-7#1)(1993-2#1)(2009-4#2)
recognizing and cleaving at##2##4##(1993-9#2)
recognizing and##8##2##(1992-3#1)(1993-9#2)(2006-1#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-4#1)
recognizing external epitopes of the human MDR1 P-glycoprotein##2##8##(1993-9#2)
recognizing restriction##2##2##(2006-8#2)
recognizing that##7##2##(1993-11#1)(1994-1#1)(1995-12#1)(2005-7#1)(2007-12#1)(2008-5#1)(2013-8#1)
recognizing the Tn antigen##2##4##(1992-8#2)
recognizing the benefits of##2##4##(2006-10#1)(2007-12#1)
recognizing the benefits##3##3##(1990-2#1)(2006-10#1)(2007-12#1)
recognizing the importance of##3##4##(2008-1#1)(2009-4#1)(2013-1#1)
recognizing the##50##2##(1990-2#1)(1991-12#1)(1991-5#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#2)(1995-1#1)(1996-8#1)(2005-8#2)(2006-10#3)(2006-12#1)(2006-8#1)(2007-10#2)(2007-12#3)(2008-1#1)(2008-10#3)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#4)(2013-7#1)
recognizing these##2##2##(2008-8#1)(2009-9#1)
recognizing this##2##2##(2008-7#1)(2011-2#1)
recognizing##163##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#3)(1991-7#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#6)(1994-1#1)(1994-2#1)(1994-3#3)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-6#2)(1995-8#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-8#2)(2005-11#1)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#4)(2006-12#2)(2006-4#1)(2006-8#4)(2007-10#2)(2007-12#7)(2007-5#2)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#4)(2008-12#1)(2008-3#5)(2008-4#9)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#6)(2009-5#1)(2009-7#1)(2009-9#3)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
recoil of##2##2##(2009-4#1)(2010-12#1)
recoil##11##1##(1991-12#1)(1992-9#1)(2008-1#1)(2008-7#3)(2009-4#1)(2009-7#1)(2010-12#1)(2013-1#1)(2013-7#1)
recollection and##2##2##(2008-7#2)
recollection of##3##2##(2004-11#1)(2008-7#1)(2010-8#1)
recollection##11##1##(2004-11#1)(2008-11#1)(2008-7#7)(2010-8#1)(2011-1#1)
recollective experience##2##2##(2008-9#2)
recolonization in##2##2##(2004-9#1)(2008-10#1)
recolonization##7##1##(2004-9#1)(2008-1#1)(2008-10#3)(2008-8#1)(2008-9#1)
recombinant (r)##2##2##(1993-8#1)(2013-1#1)
recombinant (re-) protein was##2##4##(1995-2#1)(1997-4#1)
recombinant 21-hydroxylase##2##2##(1992-8#2)
recombinant APP695##2##2##(1992-6#2)
recombinant Autographa californica##2##3##(1995-1#1)(2008-11#1)
recombinant BHK-21 cells##2##3##(1995-5#1)(2008-11#1)
recombinant BHK-21##3##2##(1995-5#1)(2008-11#2)
recombinant BV##2##2##(1997-4#2)
recombinant BmNPV harboring##2##3##(1997-4#2)
recombinant BmNPV##4##2##(1997-4#3)(2008-11#1)
recombinant C-terminal##2##2##(2008-11#1)(2011-2#1)
recombinant C3a##3##2##(1991-3#3)
recombinant CEA vaccinia construct##2##4##(1991-7#2)
recombinant CHO and BHK##2##4##(2008-11#2)
recombinant CHO cell line##7##4##(2008-11#7)
recombinant CHO cell lines##3##4##(2008-11#3)
recombinant CHO cell##11##3##(2008-11#11)
recombinant CHO cells##2##3##(2008-11#2)
recombinant CHO##16##2##(2008-11#16)
recombinant CR##2##2##(1995-11#2)
recombinant Chinese hamster ovary (rCHO) cells##2##6##(2008-11#2)
recombinant Chinese hamster ovary cell##2##5##(2008-11#2)
recombinant Chinese hamster ovary cells##2##5##(2008-11#2)
recombinant Chinese hamster ovary##9##4##(2008-11#9)
recombinant Chinese##10##2##(2008-11#10)
recombinant DNA cloning##2##3##(2009-2#2)
recombinant DNA derived##2##3##(1990-5#1)(2008-7#1)
recombinant DNA molecules##2##3##(1990-11#1)(2009-2#1)
recombinant DNA research##2##3##(2009-2#2)
recombinant DNA techniques##4##3##(1990-8#1)(1992-2#1)(1994-2#1)(2013-1#1)
recombinant DNA technology and##4##4##(1994-2#1)(2006-6#1)(2009-2#2)
recombinant DNA technology##15##3##(1994-2#1)(2006-6#1)(2007-11#5)(2007-7#1)(2009-2#4)(2009-9#1)(2011-2#1)(2013-8#1)
recombinant DNA##43##2##(1990-11#1)(1990-5#2)(1990-8#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-8#1)(1994-2#2)(1994-5#1)(1995-8#1)(1996-12#1)(2006-6#1)(2007-11#6)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#10)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
recombinant DNA-derived##2##2##(1990-12#1)(2007-11#1)
recombinant DNAs##2##2##(1993-4#1)(1994-8#1)
recombinant E##15##2##(1990-8#2)(1992-11#1)(1992-5#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-7#1)(2008-6#2)(2008-7#3)(2011-1#1)(2011-2#1)
recombinant EBV DNase exhibited##2##4##(1991-7#2)
recombinant EBV DNase##3##3##(1991-7#3)
recombinant EBV-DNase##2##2##(1991-7#2)
recombinant EPO##2##2##(2007-7#1)(2008-11#1)
recombinant Escherichia coli strain##2##4##(1994-12#1)(2011-1#1)
recombinant Escherichia coli##16##3##(1991-7#1)(1994-12#2)(1994-2#1)(1995-2#2)(1996-7#1)(2005-11#1)(2008-10#1)(2008-5#1)(2008-7#4)(2011-1#1)(2013-1#1)
recombinant HCII##2##2##(1995-5#2)
recombinant HGF##2##2##(1991-10#1)(1991-4#1)
recombinant HIV-1##2##2##(1994-6#1)(2011-2#1)
recombinant HMM was##3##3##(1995-1#3)
recombinant HMM##4##2##(1995-1#4)
recombinant IFN-gamma##2##2##(2008-11#2)
recombinant IFN-γ produced by##2##4##(2011-2#1)(2012-3#1)
recombinant IFN-γ##5##2##(2010-12#1)(2011-2#2)(2012-3#2)
recombinant IL-1##4##2##(1991-10#1)(1993-9#1)(1994-9#1)(2007-11#1)
recombinant IL-12##2##2##(1996-10#1)(2008-11#1)
recombinant M##2##2##(2008-10#1)(2011-2#1)
recombinant MAP2c##2##2##(1994-12#2)
recombinant MIF##2##2##(1994-11#1)(1997-4#1)
recombinant N-methyl-D-aspartate##2##2##(1996-8#2)
recombinant NMDA receptors##2##3##(1993-9#1)(1996-8#1)
recombinant NS0##2##2##(2008-11#1)(2008-7#1)
recombinant NSE##2##2##(1990-11#2)
recombinant P1 phage##2##3##(1997-5#1)(2007-3#1)
recombinant PVX##4##2##(2008-10#4)
recombinant Potato virus X (PVX)##2##5##(2008-10#2)
recombinant Pseudomonas##2##2##(1993-11#1)(2008-10#1)
recombinant RNA1s were##2##3##(2008-10#2)
recombinant RNA1s##3##2##(2008-10#3)
recombinant SIV-PR##2##2##(1991-9#2)
recombinant XFGFR-1##2##2##(1993-6#2)
recombinant Zymomonas##2##2##(2008-6#2)
recombinant adeno-associated viral vector##2##4##(2008-9#2)
recombinant adeno-associated viral vectors##3##4##(2008-4#2)(2008-9#1)
recombinant adeno-associated viral##5##3##(2008-4#2)(2008-9#3)
recombinant adeno-associated virus (rAAV)##2##4##(2008-8#2)
recombinant adeno-associated virus vector##2##4##(2008-8#1)(2008-9#1)
recombinant adeno-associated virus##8##3##(1993-2#1)(2005-7#1)(2008-8#4)(2008-9#1)(2012-12#1)
recombinant adeno-associated##13##2##(1993-2#1)(2005-7#1)(2008-4#2)(2008-8#4)(2008-9#4)(2012-12#1)
recombinant adenoviral vector##5##3##(1996-1#1)(2008-11#1)(2008-8#1)(2010-1#2)
recombinant adenoviral vectors##2##3##(2008-11#2)
recombinant adenoviral##7##2##(1996-1#1)(2008-11#3)(2008-8#1)(2010-1#2)
recombinant adenovirus could##2##3##(2008-8#2)
recombinant adenovirus vector##3##3##(1997-7#1)(2007-3#1)(2008-9#1)
recombinant adenovirus##20##2##(1994-9#2)(1995-2#1)(1995-3#1)(1996-1#1)(1996-4#1)(1997-4#2)(1997-7#1)(2007-3#1)(2008-8#2)(2008-9#1)(2010-1#1)(2011-2#5)(2013-7#1)
recombinant adenoviruses##7##2##(1992-9#1)(1994-9#2)(1995-12#1)(2008-11#1)(2008-4#2)
recombinant alpha##2##2##(1990-7#1)(1991-10#1)
recombinant alpha-toxin##3##2##(2010-6#3)
recombinant and native human##2##4##(1991-10#1)(1994-8#1)
recombinant and native##6##3##(1991-10#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-6#1)(2008-8#1)
recombinant and##12##2##(1991-10#1)(1993-12#1)(1993-4#2)(1994-11#1)(1994-8#1)(1995-6#1)(2007-2#1)(2008-10#2)(2008-8#1)(2009-5#1)
recombinant antibodies against the##2##4##(2008-11#2)
recombinant antibodies##11##2##(1992-7#2)(1997-4#1)(2005-7#1)(2008-10#2)(2008-11#2)(2008-4#2)(2013-8#1)
recombinant antibody##8##2##(1994-11#1)(1994-8#1)(1997-2#1)(2008-11#5)
recombinant antigen##10##2##(1991-3#1)(1992-3#1)(1992-4#2)(1994-3#1)(2005-8#2)(2006-10#1)(2008-4#1)(2010-6#1)
recombinant antigens K39##2##3##(2005-8#2)
recombinant antigens##5##2##(1995-5#1)(1997-7#1)(2005-8#2)(2007-11#1)
recombinant antithrombin##2##2##(1994-11#1)(2010-11#1)
recombinant bacteria##4##2##(2005-11#2)(2008-11#1)(2008-4#1)
recombinant bacterial##2##2##(1994-3#1)(1997-1#1)
recombinant baculovirus containing##5##3##(1993-12#1)(1994-10#1)(1995-8#1)(1997-4#1)(2008-11#1)
recombinant baculovirus expressing##2##3##(1993-6#1)(1993-8#1)
recombinant baculovirus with an##2##4##(2008-11#1)(2008-7#1)
recombinant baculovirus##29##2##(1992-3#1)(1993-12#2)(1993-6#1)(1993-8#3)(1994-10#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-5#1)(1995-8#1)(1997-2#1)(1997-4#2)(2005-11#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-4#1)(2008-7#2)(2010-2#1)
recombinant baculovirus-infected##3##2##(1991-2#1)(1993-12#1)(1995-2#1)
recombinant baculoviruses with##2##3##(1994-8#1)(2010-2#1)
recombinant baculoviruses##15##2##(1992-8#1)(1993-12#2)(1994-8#3)(1997-8#2)(2008-2#4)(2008-7#1)(2010-2#1)(2011-2#1)
recombinant basic FGF##2##3##(1991-2#1)(1994-12#1)
recombinant basic fibroblast growth factor##4##5##(1990-2#1)(1994-12#1)(2008-5#2)
recombinant basic##6##2##(1990-2#1)(1991-2#1)(1994-12#2)(2008-5#2)
recombinant binding##2##2##(1991-7#1)(1991-8#1)
recombinant cDNA##11##2##(1990-5#1)(1990-9#1)(1991-7#1)(1992-5#1)(1992-8#1)(1993-4#3)(1997-2#1)(2008-4#2)
recombinant cell line##2##3##(2008-10#1)(2008-11#1)
recombinant cell lines##6##3##(2008-11#5)(2012-3#1)
recombinant cell##8##2##(2008-10#1)(2008-11#6)(2012-3#1)
recombinant cells##2##2##(2008-11#2)
recombinant chicken PTH-(1-88)##2##3##(1991-3#2)
recombinant chicken##4##2##(1991-3#2)(1994-9#1)(2008-11#1)
recombinant clones can be##2##4##(1990-11#1)(1991-9#1)
recombinant clones##8##2##(1990-11#1)(1990-5#1)(1990-6#1)(1991-9#1)(1992-12#1)(1994-3#1)(1995-3#1)(2008-10#1)
recombinant clotting factor concentrates has##2##5##(2007-11#2)
recombinant clotting factor concentrates##3##4##(2007-11#3)
recombinant constructs##4##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-3#1)
recombinant cosmid##2##2##(2008-6#2)
recombinant cutinase##3##2##(1995-3#1)(2008-7#2)
recombinant cytokines##2##2##(1992-8#1)(2011-2#1)
recombinant eel growth hormone##2##4##(1990-8#2)
recombinant enzyme##10##2##(1992-12#1)(1992-8#2)(1994-3#1)(1994-6#1)(1995-3#1)(2006-10#1)(2006-12#2)(2011-1#1)
recombinant enzymes##5##2##(1992-4#1)(1995-2#1)(2006-8#1)(2011-1#1)(2011-2#1)
recombinant erythropoietin##2##2##(2008-11#1)(2010-7#1)
recombinant eukaryotic expression plasmid##2##4##(2005-6#2)
recombinant eukaryotic expression##3##3##(2005-6#2)(2008-8#1)
recombinant eukaryotic##4##2##(2005-10#1)(2005-6#2)(2008-8#1)
recombinant expression of##2##3##(1997-6#1)(2006-11#1)
recombinant expression systems##2##3##(1994-9#1)(2006-12#1)
recombinant expression##7##2##(1991-9#1)(1994-9#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-11#1)(2006-12#1)
recombinant factor VIIa##11##3##(1995-6#1)(2005-10#1)(2006-10#1)(2007-11#3)(2007-2#1)(2007-8#2)(2011-2#1)(2013-1#1)
recombinant factor##17##2##(1992-2#1)(1995-6#1)(2005-10#1)(2006-10#1)(2007-11#5)(2007-2#1)(2007-8#2)(2008-11#1)(2008-8#1)(2009-7#1)(2011-2#1)(2013-1#1)
recombinant flagella##2##2##(2006-10#2)
recombinant form##7##2##(1993-8#1)(1995-3#1)(2007-11#2)(2008-3#1)(2008-6#1)(2009-3#1)
recombinant forms of##5##3##(2007-11#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)
recombinant forms##7##2##(2005-11#1)(2005-7#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)
recombinant fragments##6##2##(1995-11#2)(1995-12#1)(1995-6#2)(2008-4#1)
recombinant from##2##2##(1990-12#1)(1995-2#1)
recombinant fungal##2##2##(1995-1#1)(2008-10#1)
recombinant fusion proteins for##2##4##(1995-12#1)(2012-2#1)
recombinant fusion proteins##4##3##(1994-2#1)(1995-12#1)(1996-7#1)(2012-2#1)
recombinant fusion##8##2##(1994-2#1)(1995-12#1)(1996-7#1)(1997-2#1)(2005-7#1)(2007-8#1)(2010-12#1)(2012-2#1)
recombinant gamma##3##2##(1990-9#1)(1992-1#1)(1995-5#1)
recombinant gene##4##2##(1990-12#1)(1994-2#1)(1994-9#1)(2008-11#1)
recombinant genes into##2##3##(1994-5#1)(2008-4#1)
recombinant genes##6##2##(1990-9#1)(1994-5#2)(2008-4#1)(2008-7#1)(2011-1#1)
recombinant genotypes##2##2##(2008-10#2)
recombinant glycoprotein##7##2##(2008-11#2)(2008-7#4)(2011-2#1)
recombinant glycoproteins##2##2##(2008-11#2)
recombinant gp120##3##2##(1994-9#2)(1995-5#1)
recombinant green fluorescent protein (GFP) in##2##6##(2008-5#2)
recombinant green fluorescent protein (GFP)##3##5##(2008-11#1)(2008-5#2)
recombinant hFGF-10 adenovirus##3##3##(2011-3#3)
recombinant hIGFBP-3##2##2##(1991-7#2)
recombinant hNGF or mouse NGF##2##5##(1993-12#2)
recombinant hNGF##4##2##(1993-12#4)
recombinant heat shock protein##2##4##(1991-11#1)(1994-3#1)
recombinant hemoglobin containing##2##3##(1994-9#2)
recombinant hepatitis B surface antigen##2##5##(1997-4#1)(2008-11#1)
recombinant hepatitis B virus surface antigen##2##6##(1994-11#1)(1997-4#1)
recombinant hepatitis B##8##3##(1994-11#1)(1994-4#1)(1997-4#2)(2005-12#1)(2007-11#1)(2008-11#1)(2012-2#1)
recombinant hirudin##10##2##(1990-11#1)(1993-3#1)(1994-2#3)(2007-11#2)(2009-8#1)(2013-8#2)
recombinant human GH##2##3##(2006-9#1)(2007-11#1)
recombinant human IGF II##2##4##(1990-6#2)
recombinant human IL-1 alpha##2##4##(1990-11#1)(1996-11#1)
recombinant human IL-1##3##3##(1990-11#1)(1992-9#1)(1996-11#1)
recombinant human NGF was##3##4##(1990-8#3)
recombinant human activated protein C (rhAPC) has been reported to significantly reduce mortality and morbidity in patients with severe sepsis and##2##21##(2006-4#1)(2011-1#1)
recombinant human activated protein C##5##5##(2006-4#1)(2007-12#1)(2011-1#2)(2012-2#1)
recombinant human alpha##4##3##(1990-12#1)(1990-2#2)(1995-11#1)
recombinant human and##3##3##(1993-8#2)(1995-11#1)
recombinant human bone morphogenetic protein-2##2##5##(2011-2#1)(2013-8#1)
recombinant human bone morphogenetic##4##4##(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
recombinant human erythropoietin (r-HuEPO) in##2##5##(2007-7#2)
recombinant human erythropoietin (r-HuEPO)##3##4##(2007-7#2)(2008-1#1)
recombinant human erythropoietin##16##3##(1991-4#1)(1995-5#1)(2005-10#1)(2007-11#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2010-12#2)(2011-2#1)
recombinant human fibroblast growth factor-2 in the##2##7##(2006-9#2)
recombinant human fibroblast growth factor-2##5##5##(2006-9#5)
recombinant human fibroblast growth##6##4##(2006-9#5)(2008-7#1)
recombinant human glucagon##4##3##(2008-8#4)
recombinant human growth hormone##5##4##(1994-6#1)(1997-2#1)(1997-8#1)(2005-10#1)(2007-11#1)
recombinant human growth##6##3##(1994-6#1)(1997-2#1)(1997-8#1)(2005-10#1)(2006-11#1)(2007-11#1)
recombinant human interleukin-1 beta##3##4##(1990-12#3)
recombinant human interleukin-1##6##3##(1990-12#3)(1992-1#3)
recombinant human interleukin-6##2##3##(1990-5#1)(2008-11#1)
recombinant human monoclonal antibody##2##4##(2008-11#2)
recombinant human nerve growth factor##2##5##(1990-8#1)(1993-12#1)
recombinant human plasminogen##2##3##(1995-6#2)
recombinant human prion-free##2##3##(1996-11#1)(2007-11#1)
recombinant human thyrotropin##7##3##(1993-12#1)(1995-12#1)(2006-9#1)(2013-1#4)
recombinant human tissue plasminogen activator##2##5##(1992-12#1)(2008-7#1)
recombinant human tissue##3##3##(1992-12#1)(2008-11#1)(2008-7#1)
recombinant human transferrin produced##2##4##(2008-11#2)
recombinant human transferrin##3##3##(2008-11#3)
recombinant human tumor necrosis factor##3##5##(1991-2#1)(1991-8#1)(1992-9#1)
recombinant human tumor necrosis##4##4##(1991-2#1)(1991-8#1)(1992-9#1)(1995-4#1)
recombinant human uPA##4##3##(2008-11#4)
recombinant human##180##2##(1990-11#1)(1990-12#4)(1990-2#2)(1990-5#4)(1990-6#2)(1990-8#6)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#4)(1992-11#1)(1992-12#2)(1992-5#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-12#2)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#5)(1994-6#2)(1994-9#1)(1995-10#2)(1995-11#3)(1995-12#3)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#6)(1996-10#1)(1996-11#2)(1996-5#2)(1996-7#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-8#2)(2005-10#3)(2005-8#1)(2006-11#2)(2006-4#1)(2006-9#8)(2007-11#7)(2007-12#2)(2007-7#2)(2008-1#3)(2008-10#1)(2008-11#21)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#5)(2008-8#5)(2010-11#1)(2010-12#2)(2011-1#2)(2011-11#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
recombinant immunoglobulin##2##2##(2008-11#1)(2008-3#1)
recombinant inbred (RI) strains##2##4##(1994-8#1)(2008-12#1)
recombinant inbred (RI)##4##3##(1994-8#1)(2008-10#2)(2008-12#1)
recombinant inbred line population##4##4##(2008-10#4)
recombinant inbred line##6##3##(2008-10#6)
recombinant inbred lines (RILs) derived##2##5##(2008-10#2)
recombinant inbred lines (RILs) from##2##5##(2008-10#1)(2008-8#1)
recombinant inbred lines (RILs)##10##4##(2008-10#7)(2008-8#1)(2012-11#1)(2012-3#1)
recombinant inbred lines derived from##2##5##(2008-10#2)
recombinant inbred lines from the cross##2##6##(2008-10#2)
recombinant inbred lines of the##2##5##(2008-10#1)(2012-3#1)
recombinant inbred lines of##3##4##(2008-10#2)(2012-3#1)
recombinant inbred lines##22##3##(1997-7#1)(2008-10#15)(2008-8#1)(2011-2#1)(2012-11#2)(2012-3#2)
recombinant inbred population derived from##2##5##(2008-10#1)(2012-11#1)
recombinant inbred population##5##3##(2008-10#4)(2012-11#1)
recombinant inbred##38##2##(1990-7#1)(1994-8#1)(1997-7#1)(2008-10#27)(2008-12#1)(2008-8#1)(2011-2#1)(2012-11#3)(2012-3#2)
recombinant inhibin##2##2##(1995-9#2)
recombinant insulin##4##2##(1996-7#1)(2008-11#2)(2012-12#1)
recombinant interferon##6##2##(1991-2#1)(1991-8#1)(1995-5#1)(2007-11#3)
recombinant interferon-alpha##3##2##(2007-11#2)(2012-3#1)
recombinant interferon-gamma##2##2##(2008-11#2)
recombinant interleukin 2##3##3##(1990-12#1)(1995-12#1)(2008-11#1)
recombinant interleukin##4##2##(1990-12#1)(1992-11#1)(1995-12#1)(2008-11#1)
recombinant interleukin-1 alpha##2##3##(1992-4#1)(1994-8#1)
recombinant interleukin-2##4##2##(1991-10#2)(1991-8#1)(2007-11#1)
recombinant isolates##4##2##(2008-10#4)
recombinant line##3##2##(2008-10#3)
recombinant lines##2##2##(2008-10#2)
recombinant mammalian cell cultures##2##4##(2008-11#2)
recombinant mammalian cell lines##3##4##(2008-11#3)
recombinant mammalian cell##5##3##(2008-11#5)
recombinant mammalian##7##2##(2008-11#7)
recombinant monoclonal##2##2##(2008-11#1)(2008-5#1)
recombinant mouse##13##2##(1993-6#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#2)(1995-3#1)(1996-12#1)(2008-10#2)(2008-4#1)
recombinant murine angiostatin##2##3##(1997-7#2)
recombinant murine##8##2##(1992-1#1)(1993-8#1)(1994-12#1)(1995-2#1)(1996-10#1)(1997-4#1)(1997-7#2)
recombinant mutant##2##2##(1990-12#1)(1997-7#1)
recombinant mycobacterial##3##2##(1991-11#1)(1995-2#1)(2007-11#1)
recombinant non-glycosylated##2##2##(1995-3#1)(1995-8#1)
recombinant non-myristoylated recoverin##2##3##(1994-8#2)
recombinant peptides##3##2##(1990-10#1)(1994-2#1)(2011-2#1)
recombinant phage containing the##2##4##(1993-11#1)(1993-8#1)
recombinant phage##5##2##(1991-9#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-5#1)
recombinant phosphatase 2A##2##3##(1992-9#2)
recombinant plasmid carrying##2##3##(1990-9#1)(1997-6#1)
recombinant plasmid containing a##2##4##(1990-5#1)(1997-1#1)
recombinant plasmid containing##3##3##(1990-5#1)(1993-5#1)(1997-1#1)
recombinant plasmid was##4##3##(1994-3#1)(2005-11#2)(2005-6#1)
recombinant plasmid##32##2##(1990-1#1)(1990-5#1)(1990-9#2)(1991-12#1)(1991-4#1)(1991-7#2)(1992-9#1)(1993-5#1)(1994-3#3)(1994-6#1)(1997-1#1)(1997-2#1)(1997-6#1)(2005-11#4)(2005-6#2)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#2)(2013-1#1)
recombinant plasmids containing##3##3##(1993-3#1)(1995-1#1)(2008-8#1)
recombinant plasmids were##2##3##(2008-8#1)(2013-1#1)
recombinant plasmids##19##2##(1990-1#1)(1990-9#1)(1991-7#1)(1993-3#1)(1994-2#2)(1995-1#1)(1995-2#1)(1995-8#1)(1997-2#1)(1997-6#2)(2005-11#2)(2008-10#1)(2008-8#2)(2013-1#2)
recombinant polymerase chain reaction##3##4##(1991-5#3)
recombinant polypeptide##3##2##(1990-3#1)(1992-6#1)(1997-6#1)
recombinant populations##2##2##(2006-5#1)(2008-8#1)
recombinant porcine growth hormone##3##4##(1992-9#2)(2008-9#1)
recombinant porcine##4##2##(1992-9#2)(2008-7#1)(2008-9#1)
recombinant precursor##2##2##(2008-9#1)(2011-2#1)
recombinant proTNF##2##2##(1991-8#2)
recombinant product##6##2##(1994-11#1)(1994-2#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-11#1)
recombinant production of##3##3##(1995-5#1)(1996-11#1)(2011-1#1)
recombinant production##4##2##(1995-5#1)(1996-11#1)(2011-1#1)(2013-8#1)
recombinant products##4##2##(1995-8#1)(2007-11#2)(2008-7#1)
recombinant protein C##2##3##(1995-1#2)
recombinant protein and##3##3##(2008-11#1)(2008-4#2)
recombinant protein by##2##3##(2008-11#2)
recombinant protein containing##2##3##(1990-7#1)(2008-4#1)
recombinant protein expression in##3##4##(2008-11#3)
recombinant protein expression##7##3##(2008-11#6)(2008-7#1)
recombinant protein from##2##3##(1991-8#1)(1997-4#1)
recombinant protein has##3##3##(1990-11#1)(1992-3#2)
recombinant protein hyper-producing##2##3##(2008-11#2)
recombinant protein in a##2##4##(1994-2#1)(2008-11#1)
recombinant protein in##4##3##(1994-2#1)(2008-1#1)(2008-11#2)
recombinant protein is##6##3##(1993-2#1)(1994-8#1)(2005-11#1)(2008-11#1)(2008-8#2)
recombinant protein produced in##2##4##(1990-3#1)(1993-4#1)
recombinant protein production and##2##4##(2008-11#1)(2012-2#1)
recombinant protein production from##2##4##(2008-11#1)(2012-3#1)
recombinant protein production in plants##2##5##(2008-7#2)
recombinant protein production in##8##4##(2008-11#3)(2008-7#3)(2011-2#2)
recombinant protein production of##2##4##(2008-11#2)
recombinant protein production##31##3##(1992-12#1)(2007-6#1)(2008-11#15)(2008-2#1)(2008-5#1)(2008-7#5)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)
recombinant protein purification##2##3##(2008-4#2)
recombinant protein showed that it was##2##6##(1994-8#1)(1995-8#1)
recombinant protein showed##5##3##(1994-8#1)(1995-2#1)(1995-8#1)(1997-7#1)(2010-12#1)
recombinant protein was biologically active##2##5##(1993-3#1)(1994-12#1)
recombinant protein was purified##2##4##(1990-8#1)(1993-9#1)
recombinant protein was##13##3##(1990-11#1)(1990-3#1)(1990-8#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(2008-11#4)(2008-8#1)
recombinant protein##136##2##(1990-11#3)(1990-3#3)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-8#1)(1992-12#1)(1992-3#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-8#3)(1995-1#2)(1995-2#1)(1995-8#1)(1996-11#1)(1996-5#2)(1997-4#4)(1997-6#1)(1997-7#2)(2005-11#2)(2006-12#1)(2007-11#1)(2007-6#3)(2008-1#1)(2008-10#1)(2008-11#45)(2008-2#1)(2008-4#5)(2008-5#2)(2008-7#10)(2008-8#3)(2008-9#1)(2010-12#1)(2011-1#2)(2011-2#6)(2012-2#1)(2012-3#2)
recombinant proteins at##2##3##(1993-9#1)(1997-3#1)
recombinant proteins expressed in##2##4##(1994-11#1)(2008-4#1)
recombinant proteins expressed##3##3##(1991-10#1)(1994-11#1)(2008-4#1)
recombinant proteins for research##2##4##(2008-11#1)(2012-2#1)
recombinant proteins for##9##3##(1994-5#1)(1995-5#1)(1997-4#1)(2008-11#5)(2012-2#1)
recombinant proteins has been##2##4##(1996-11#1)(2006-12#1)
recombinant proteins have##2##3##(2006-2#1)(2008-10#1)
recombinant proteins in Escherichia coli##2##5##(1995-11#1)(2008-4#1)
recombinant proteins in the##3##4##(2007-11#1)(2008-11#2)
recombinant proteins in transgenic plants##2##5##(2008-7#2)
recombinant proteins in##15##3##(1992-12#1)(1995-11#1)(2006-12#1)(2007-11#1)(2007-6#1)(2008-11#5)(2008-2#1)(2008-4#2)(2008-7#2)
recombinant proteins on the##3##4##(1994-11#3)
recombinant proteins produced by##2##4##(2008-11#1)(2011-2#1)
recombinant proteins produced in##2##4##(2008-4#1)(2008-7#1)
recombinant proteins produced##5##3##(1994-5#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)
recombinant proteins using##4##3##(2008-11#1)(2008-2#1)(2008-4#2)
recombinant proteins was##2##3##(2006-12#2)
recombinant proteins were purified and##2##5##(1991-10#1)(2005-11#1)
recombinant proteins were purified##3##4##(1991-10#1)(2005-11#1)(2006-8#1)
recombinant proteins were##6##3##(1990-11#1)(1991-10#1)(1994-8#1)(1997-4#1)(2005-11#1)(2006-8#1)
recombinant proteins with##3##3##(1995-5#1)(2008-11#1)(2012-2#1)
recombinant proteins##118##2##(1990-11#1)(1990-4#1)(1990-9#1)(1991-10#2)(1991-2#1)(1991-5#1)(1992-12#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#5)(1994-12#2)(1994-5#5)(1994-8#1)(1995-1#1)(1995-11#1)(1995-5#2)(1995-8#2)(1996-10#1)(1996-11#1)(1996-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2005-11#2)(2006-10#2)(2006-12#5)(2006-2#1)(2006-8#1)(2007-11#2)(2007-6#2)(2008-1#2)(2008-10#1)(2008-11#28)(2008-2#4)(2008-4#15)(2008-5#1)(2008-7#4)(2009-10#1)(2009-8#1)(2010-2#1)(2011-2#3)(2012-2#2)(2013-8#1)
recombinant rabbit##3##2##(1991-7#2)(1994-3#1)
recombinant rat##14##2##(1990-5#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-8#1)(1997-8#1)(2008-11#4)(2008-4#1)(2008-8#2)
recombinant receptor##5##2##(1992-7#1)(1995-11#3)(2008-4#1)
recombinant receptors##2##2##(1995-11#1)(1995-3#1)
recombinant retrovirus##6##2##(1990-5#1)(1995-5#1)(1997-8#1)(2009-10#3)
recombinant retroviruses##4##2##(1990-5#2)(1991-12#1)(2007-6#1)
recombinant reverse##2##2##(1992-8#1)(1994-6#1)
recombinant silkworm eclosion hormone##2##4##(1990-12#2)
recombinant single-chain##5##2##(1990-11#1)(1992-2#1)(1995-8#1)(2008-10#1)(2009-8#1)
recombinant soluble CD4##2##3##(1992-4#1)(2005-7#1)
recombinant soluble and non-fusion angiogenesis inhibitor Kringle 5##3##8##(2012-12#3)
recombinant soluble and##4##3##(1995-3#1)(2012-12#3)
recombinant soluble##14##2##(1992-4#2)(1992-6#2)(1994-8#1)(1995-1#1)(1995-3#2)(1997-7#1)(2005-7#1)(2007-11#1)(2012-12#3)
recombinant staphylokinase##2##2##(2012-2#2)
recombinant strain was##2##3##(1994-2#1)(2008-8#1)
recombinant strain##14##2##(1994-2#2)(1994-9#1)(2008-3#1)(2008-8#4)(2013-1#6)
recombinant strains##6##2##(2008-4#1)(2011-1#1)(2012-3#1)(2013-1#3)
recombinant subunit##2##2##(2009-7#1)(2009-8#1)
recombinant tPA##2##2##(2008-11#2)
recombinant techniques##2##2##(2007-11#2)
recombinant technology##3##2##(2006-9#1)(2007-11#1)(2008-10#1)
recombinant therapeutic proteins##2##3##(2008-10#2)
recombinant therapeutic##6##2##(2008-10#2)(2008-11#2)(2010-7#1)(2011-2#1)
recombinant thrombolytic##3##2##(2007-11#3)
recombinant tissue plasminogen activator (rt-PA)##3##5##(2007-10#1)(2007-9#1)(2008-7#1)
recombinant tissue plasminogen activator for##2##5##(2006-12#1)(2008-7#1)
recombinant tissue plasminogen activator##14##4##(1993-2#1)(2006-12#1)(2007-10#3)(2007-7#1)(2007-9#3)(2008-7#2)(2009-11#1)(2009-6#1)(2013-7#1)
recombinant tissue-type plasminogen activator##3##4##(1990-11#1)(1992-10#1)(2013-7#1)
recombinant tissular plasminogen activator (t-PA)##2##5##(2008-11#2)
recombinant transforming growth##2##3##(1992-8#1)(2009-4#1)
recombinant tropomyosin##2##2##(1994-9#2)
recombinant tumor necrosis factor##3##4##(1991-12#2)(1994-8#1)
recombinant tumor necrosis##4##3##(1991-12#2)(1994-8#2)
recombinant type##3##2##(1995-2#1)(1997-2#1)(1997-4#1)
recombinant uPA##5##2##(2008-11#5)
recombinant vaccine##4##2##(1993-6#1)(1995-5#1)(2007-11#1)(2008-8#1)
recombinant vaccines##7##2##(1996-3#1)(1997-4#2)(2007-11#2)(2007-6#1)(2008-4#1)
recombinant vaccinia virus expressing##2##4##(1991-7#1)(2007-2#1)
recombinant vaccinia virus was##2##4##(1991-12#1)(1995-8#1)
recombinant vaccinia virus##12##3##(1991-12#1)(1991-5#2)(1991-7#1)(1991-9#2)(1995-6#1)(1995-8#1)(2007-2#1)(2008-8#3)
recombinant vaccinia viruses##2##3##(2007-2#1)(2008-8#1)
recombinant vaccinia##14##2##(1991-12#1)(1991-5#2)(1991-7#1)(1991-9#2)(1995-6#1)(1995-8#1)(2007-2#2)(2008-8#4)
recombinant vector##7##2##(1992-12#1)(1994-5#1)(2005-10#2)(2008-9#1)(2010-4#1)(2011-2#1)
recombinant vectors##3##2##(2008-1#2)(2008-5#1)
recombinant version##2##2##(2007-11#1)(2008-8#1)
recombinant viral vector##2##3##(2009-12#1)(2013-8#1)
recombinant viral vectors##2##3##(2007-11#1)(2008-4#1)
recombinant viral##7##2##(1997-4#1)(2007-11#2)(2008-4#1)(2009-12#1)(2010-4#1)(2013-8#1)
recombinant virus containing the##2##4##(1996-4#1)(1997-8#1)
recombinant virus was##2##3##(1991-1#1)(2012-3#1)
recombinant virus##18##2##(1990-3#1)(1991-1#1)(1991-7#1)(1994-11#1)(1994-12#1)(1994-6#1)(1996-11#1)(1996-4#2)(1997-4#1)(1997-8#1)(2005-11#1)(2008-10#3)(2008-11#1)(2012-3#2)
recombinant viruses##13##2##(1990-11#1)(1991-5#1)(1993-12#1)(1993-6#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)
recombinant von Willebrand##2##3##(2007-11#1)(2008-11#1)
recombinant wild-type##5##2##(1992-9#1)(1994-8#2)(1995-6#1)(1995-8#1)
recombinant yeast##11##2##(1992-5#1)(1993-9#1)(1994-3#1)(1995-2#1)(1997-2#1)(2008-7#3)(2008-8#1)(2009-2#1)(2011-1#1)
recombinant zebrafish FSH##2##3##(2010-5#2)
recombinant zebrafish##3##2##(2010-5#3)
recombinant##1866##1##(1990-1#2)(1990-10#3)(1990-11#19)(1990-12#13)(1990-2#4)(1990-3#5)(1990-4#2)(1990-5#18)(1990-6#5)(1990-7#5)(1990-8#16)(1990-9#11)(1991-1#3)(1991-10#12)(1991-11#4)(1991-12#8)(1991-2#6)(1991-3#12)(1991-4#5)(1991-5#12)(1991-7#25)(1991-8#8)(1991-9#11)(1992-1#6)(1992-10#3)(1992-11#6)(1992-12#8)(1992-2#3)(1992-3#9)(1992-4#8)(1992-5#4)(1992-6#5)(1992-7#6)(1992-8#20)(1992-9#12)(1993-1#1)(1993-11#6)(1993-12#20)(1993-2#4)(1993-3#3)(1993-4#11)(1993-5#2)(1993-6#10)(1993-7#1)(1993-8#12)(1993-9#10)(1994-10#1)(1994-11#24)(1994-12#17)(1994-2#19)(1994-3#19)(1994-4#1)(1994-5#22)(1994-6#14)(1994-7#1)(1994-8#29)(1994-9#21)(1995-1#18)(1995-10#5)(1995-11#18)(1995-12#8)(1995-2#24)(1995-3#21)(1995-4#1)(1995-5#18)(1995-6#17)(1995-8#16)(1995-9#2)(1996-1#2)(1996-10#6)(1996-11#7)(1996-12#4)(1996-2#3)(1996-3#2)(1996-4#4)(1996-5#10)(1996-6#1)(1996-7#8)(1996-8#5)(1996-9#1)(1997-1#5)(1997-2#12)(1997-3#6)(1997-4#48)(1997-5#2)(1997-6#9)(1997-7#15)(1997-8#12)(2004-1#1)(2005-10#7)(2005-11#18)(2005-12#3)(2005-6#4)(2005-7#12)(2005-8#6)(2006-10#10)(2006-11#5)(2006-12#13)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#10)(2007-10#4)(2007-11#71)(2007-12#3)(2007-2#5)(2007-3#2)(2007-6#8)(2007-7#6)(2007-8#4)(2007-9#3)(2008-1#13)(2008-10#95)(2008-11#233)(2008-12#3)(2008-2#12)(2008-3#5)(2008-4#65)(2008-5#22)(2008-6#13)(2008-7#54)(2008-8#50)(2008-9#16)(2009-10#5)(2009-11#2)(2009-12#1)(2009-2#12)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#4)(2009-9#4)(2010-1#3)(2010-11#4)(2010-12#10)(2010-2#3)(2010-4#4)(2010-5#5)(2010-6#5)(2010-7#2)(2010-8#1)(2011-1#13)(2011-11#1)(2011-12#1)(2011-2#44)(2011-3#3)(2012-1#2)(2012-11#3)(2012-12#6)(2012-2#12)(2012-3#21)(2013-1#27)(2013-7#4)(2013-8#12)
recombinant-inbred lines (RILs)##2##3##(2008-10#2)
recombinantantibody##2##1##(2008-11#2)
recombinantly expressed##4##2##(1995-2#1)(1995-6#1)(1996-9#1)(2008-4#1)
recombinantly synthesized##2##2##(1991-2#1)(2006-10#1)
recombinantly##8##1##(1991-2#1)(1995-2#1)(1995-6#1)(1996-9#1)(2005-7#1)(2006-10#1)(2008-4#1)(2013-1#1)
recombinants and their##2##3##(2008-10#2)
recombinants and##5##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)
recombinants from##3##2##(1994-11#1)(2008-10#2)
recombinants in##3##2##(1991-7#1)(1997-4#1)(2008-10#1)
recombinants is##3##2##(1995-8#1)(2008-4#1)(2013-1#1)
recombinants might##2##2##(2008-10#1)(2013-8#1)
recombinants of##2##2##(2008-10#2)
recombinants to##2##2##(1992-6#1)(1994-12#1)
recombinants were##8##2##(1991-6#1)(1994-3#1)(1994-8#1)(1995-2#1)(2005-11#1)(2008-10#3)
recombinants##60##1##(1990-11#1)(1990-12#1)(1990-6#1)(1991-1#1)(1991-6#2)(1991-7#2)(1991-9#2)(1992-6#3)(1994-11#1)(1994-12#2)(1994-3#3)(1994-8#3)(1995-2#2)(1995-3#1)(1995-8#1)(1995-9#1)(1997-3#2)(1997-4#2)(2005-11#1)(2008-10#18)(2008-11#1)(2008-2#2)(2008-4#3)(2008-6#1)(2013-1#1)(2013-8#2)
recombinase target##2##2##(2008-11#2)
recombinase##22##1##(1991-9#1)(1994-11#2)(1994-12#1)(1994-3#1)(1995-1#3)(1996-4#1)(1997-4#1)(2006-12#1)(2007-9#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#2)(2012-12#1)(2012-2#1)
recombinases##8##1##(1997-2#1)(2008-11#4)(2008-6#1)(2011-2#1)(2012-3#1)
recombination among##7##2##(2008-10#5)(2012-11#1)(2012-2#1)
recombination and duplication of a limited set of domains##2##9##(2009-5#1)(2011-2#1)
recombination and repair##4##3##(1991-7#1)(1994-9#2)(1997-2#1)
recombination and##33##2##(1990-11#1)(1991-7#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-8#3)(1996-10#1)(1997-2#1)(1997-7#2)(2006-12#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#3)(2009-5#2)(2010-10#1)(2010-4#1)(2011-2#1)(2013-8#1)
recombination are##3##2##(1995-8#1)(2009-8#1)(2010-2#1)
recombination as a##2##3##(1990-11#1)(1994-3#1)
recombination as##4##2##(1990-11#1)(1990-8#1)(1994-11#1)(1994-3#1)
recombination at##3##2##(1990-2#1)(1991-3#1)(1995-8#1)
recombination between EV71##2##3##(2013-8#2)
recombination between attP and attB##2##5##(2007-12#2)
recombination between the##6##3##(1996-10#1)(1996-4#1)(1997-3#1)(2008-10#2)(2009-2#1)
recombination between##26##2##(1990-11#1)(1991-12#1)(1993-12#1)(1995-1#1)(1995-8#3)(1996-10#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-4#1)(2007-12#3)(2008-10#5)(2008-7#1)(2008-8#1)(2009-2#1)(2013-8#2)
recombination by##2##2##(1990-5#1)(2007-12#1)
recombination can##2##2##(1990-9#1)(1997-7#1)
recombination during##2##2##(1995-8#1)(2008-8#1)
recombination event between##2##3##(1996-10#1)(2008-10#1)
recombination event##9##2##(1991-12#1)(1994-12#1)(1996-10#2)(1997-3#1)(2008-10#2)(2008-7#1)(2013-1#1)
recombination events between##3##3##(1990-11#1)(2008-10#1)(2013-8#1)
recombination events in##2##3##(1995-8#1)(2006-10#1)
recombination events was##2##3##(2008-10#1)(2008-12#1)
recombination events##24##2##(1990-11#1)(1990-5#1)(1993-11#1)(1994-3#2)(1994-9#1)(1995-8#1)(1997-4#1)(2006-10#2)(2006-12#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-4#1)(2013-1#1)(2013-8#1)
recombination experiments##3##2##(1992-6#1)(2008-10#1)(2008-6#1)
recombination for##2##2##(1995-2#1)(1995-8#1)
recombination fraction##2##2##(1992-5#1)(2010-2#1)
recombination frequencies##2##2##(2008-10#1)(2008-5#1)
recombination frequency##2##2##(1995-12#1)(2008-4#1)
recombination had##2##2##(1990-4#1)(2005-6#1)
recombination has been##2##3##(2008-10#2)
recombination has##3##2##(1990-10#1)(2008-10#2)
recombination hot##2##2##(2008-10#2)
recombination hotspots and##2##3##(2006-10#1)(2008-10#1)
recombination in human##2##3##(1993-12#1)(2007-9#1)
recombination in mouse embryonic stem cells##3##6##(1995-1#1)(1995-2#1)(1995-8#1)
recombination in the##11##3##(1990-11#2)(1991-8#1)(1993-12#1)(1997-4#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#2)
recombination in##49##2##(1990-11#2)(1991-3#1)(1991-8#1)(1993-11#3)(1993-12#4)(1994-3#2)(1994-8#1)(1995-1#3)(1995-11#3)(1995-2#2)(1995-6#2)(1995-8#1)(1996-10#1)(1996-2#1)(1996-6#1)(1997-4#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-4#4)(2008-5#1)(2008-8#3)(2008-9#2)(2010-1#1)(2012-2#1)
recombination intermediates##2##2##(1991-5#1)(1994-9#1)
recombination is achieved by##2##4##(2007-11#1)(2008-4#1)
recombination is##13##2##(1990-11#1)(1990-5#1)(1994-8#1)(1995-8#1)(1997-7#1)(2007-11#1)(2008-10#3)(2008-4#1)(2008-8#1)(2009-3#1)(2010-12#1)
recombination machinery##2##2##(2007-6#1)(2008-7#1)
recombination may##5##2##(2008-10#4)(2013-1#1)
recombination nodules##3##2##(2006-5#3)
recombination occurred between##2##3##(2008-10#1)(2013-8#1)
recombination occurred##5##2##(1993-9#1)(1995-1#1)(1995-8#1)(2008-10#1)(2013-8#1)
recombination of the##10##3##(1991-6#1)(1991-7#1)(1994-12#1)(1995-2#2)(1996-10#1)(2005-6#1)(2008-9#1)(2009-8#1)(2010-4#1)
recombination of##33##2##(1990-11#1)(1990-8#1)(1991-3#1)(1991-6#1)(1991-7#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#2)(1995-7#2)(1995-8#1)(1996-10#1)(1996-2#1)(1996-7#1)(2005-6#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-4#1)(2011-1#1)(2012-1#1)(2013-8#1)
recombination or##2##2##(2008-10#1)(2012-2#1)
recombination process##5##2##(1990-5#2)(2008-4#1)(2009-3#1)(2013-1#1)
recombination products##4##2##(1994-8#1)(2008-4#3)
recombination rate##8##2##(2008-12#1)(2008-8#5)(2010-3#1)(2012-3#1)
recombination rates##3##2##(2012-3#3)
recombination reaction in##2##3##(1997-7#1)(2008-10#1)
recombination reaction##4##2##(1997-7#2)(2008-10#1)(2012-1#1)
recombination signal##3##2##(1995-1#1)(1997-7#1)(2008-7#1)
recombination site##2##2##(1997-2#1)(2013-1#1)
recombination sites##3##2##(1994-12#1)(1995-8#1)(2008-4#1)
recombination system##4##2##(1990-3#1)(1995-2#1)(2007-9#1)(2008-9#1)
recombination systems##2##2##(1994-8#1)(2008-8#1)
recombination that##3##2##(1995-8#1)(2008-12#1)(2008-2#1)
recombination time##2##2##(2007-11#2)
recombination to##5##2##(1990-3#1)(1992-7#1)(1993-11#1)(1995-1#1)(1996-10#1)
recombination using a##2##3##(2008-6#1)(2013-8#1)
recombination using##5##2##(1990-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2013-8#1)
recombination vectors##2##2##(1993-12#2)
recombination was found##2##3##(2008-10#2)
recombination was observed##2##3##(1990-8#1)(1995-1#1)
recombination was##6##2##(1990-5#1)(1990-8#1)(1991-3#1)(1995-1#1)(2008-10#2)
recombination were##3##2##(1990-8#1)(1994-8#1)(2008-10#1)
recombination with a##2##3##(1990-5#1)(1991-9#1)
recombination with the##2##3##(1992-12#1)(2009-2#1)
recombination with##10##2##(1990-5#2)(1991-12#1)(1991-9#2)(1992-12#1)(1994-8#1)(1995-2#1)(2008-3#1)(2009-2#1)
recombination within##5##2##(1996-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2013-8#1)
recombination##516##1##(1990-10#4)(1990-11#8)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#12)(1990-8#5)(1990-9#3)(1991-10#1)(1991-11#1)(1991-12#4)(1991-3#4)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#3)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#6)(1993-12#12)(1993-2#1)(1993-3#2)(1993-9#3)(1994-11#3)(1994-12#5)(1994-3#6)(1994-8#12)(1994-9#4)(1995-1#12)(1995-11#5)(1995-12#1)(1995-2#8)(1995-3#1)(1995-6#5)(1995-7#3)(1995-8#21)(1995-9#2)(1996-10#9)(1996-2#6)(1996-4#3)(1996-6#3)(1996-7#3)(1997-1#1)(1997-2#7)(1997-3#3)(1997-4#7)(1997-7#11)(2005-11#1)(2005-6#2)(2006-10#4)(2006-12#4)(2006-5#4)(2007-11#5)(2007-12#4)(2007-6#2)(2007-9#2)(2008-1#1)(2008-10#82)(2008-11#11)(2008-12#5)(2008-2#3)(2008-3#4)(2008-4#25)(2008-5#3)(2008-6#2)(2008-7#16)(2008-8#30)(2008-9#11)(2009-10#3)(2009-2#4)(2009-3#3)(2009-5#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#3)(2011-1#3)(2011-12#2)(2011-2#2)(2012-1#2)(2012-11#1)(2012-2#4)(2012-3#5)(2012-5#1)(2013-1#11)(2013-8#12)
recombination)##4##1##(1995-8#1)(2008-10#2)(2008-2#1)
recombination-activating gene##2##2##(1991-9#1)(1995-2#1)
recombination-activating##4##1##(1991-9#1)(1994-3#2)(1995-2#1)
recombination-based screening##4##2##(1991-9#4)
recombination-based##6##1##(1991-9#5)(2012-2#1)
recombination-mediated##2##1##(1994-12#1)(2011-1#1)
recombinational##8##1##(1990-9#1)(1992-6#1)(1993-12#1)(1993-2#1)(1995-1#1)(1995-3#1)(2008-2#1)(2008-8#1)
recombinations##5##1##(1993-11#1)(1996-10#1)(2006-10#2)(2012-12#1)
recombine between the##2##3##(1990-11#1)(2008-8#1)
recombine with the##2##3##(1992-3#1)(2008-9#1)
recombine with##3##2##(1992-12#1)(1992-3#1)(2008-9#1)
recombine##10##1##(1990-11#1)(1991-3#1)(1992-12#1)(1992-3#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)
recombined and##2##2##(2008-1#1)(2008-3#1)
recombined embryos##2##2##(2008-5#2)
recombined single chain insulin##5##4##(2008-9#5)
recombined with a quartet of micromeres##2##6##(2008-5#2)
recombined with##6##2##(1991-4#1)(1992-3#1)(1995-2#1)(2008-5#3)
recombined##28##1##(1991-4#1)(1991-8#1)(1992-1#1)(1992-3#1)(1994-12#1)(1995-2#1)(1996-5#1)(2005-11#1)(2006-9#1)(2007-12#3)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#7)(2008-9#6)
recombineering##5##1##(2008-7#2)(2012-2#3)
recombining the##2##2##(2007-12#1)(2008-3#1)
recombining##10##1##(1994-8#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2012-1#1)
recombinogenic##4##1##(1994-8#2)(2008-11#1)(2008-8#1)
recomend##2##1##(2007-11#1)(2007-9#1)
recomendations##2##1##(2006-6#1)(2008-5#1)
recommenced##2##1##(2006-4#1)(2009-6#1)
recommend a##15##2##(1993-3#1)(1996-8#1)(1997-8#1)(2006-10#1)(2006-9#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-5#1)(2011-12#1)
recommend acupuncture##2##2##(1993-3#2)
recommend aggressive##2##2##(1997-5#1)(2005-7#1)
recommend directions for##2##3##(1991-2#1)(2010-9#1)
recommend for##2##2##(2006-2#1)(2011-2#1)
recommend further research in this##2##5##(2007-2#1)(2007-8#1)
recommend further##3##2##(2006-10#1)(2007-2#1)(2007-8#1)
recommend in##2##2##(1990-11#1)(2008-9#1)
recommend it for##2##3##(2008-7#1)(2012-3#1)
recommend it##5##2##(1992-12#1)(1992-3#1)(1996-2#1)(2008-7#1)(2012-3#1)
recommend its use##2##3##(2008-10#1)(2011-2#1)
recommend its##3##2##(1991-10#1)(2008-10#1)(2011-2#1)
recommend more##2##2##(1991-5#1)(2012-2#1)
recommend performing##4##2##(1994-8#1)(2007-3#1)(2007-7#1)(2010-12#1)
recommend prophylactic##2##2##(1992-12#1)(2013-1#1)
recommend that a##2##3##(2005-7#1)(2007-2#1)
recommend that an##2##3##(1995-3#1)(2008-7#1)
recommend that at least##2##4##(2007-8#1)(2012-11#1)
recommend that every##2##3##(2007-11#1)(2007-8#1)
recommend that future##2##3##(2011-12#1)(2012-12#1)
recommend that patients with##3##4##(1996-11#1)(2007-10#1)(2007-7#1)
recommend that patients##4##3##(1996-11#1)(2007-10#1)(2007-7#1)(2008-3#1)
recommend that the##6##3##(2005-11#1)(2006-2#1)(2006-9#1)(2008-10#2)(2009-8#1)
recommend that this##3##3##(2007-2#1)(2008-5#1)(2010-8#1)
recommend that##54##2##(1990-3#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-2#1)(1994-9#1)(1995-3#1)(1996-11#2)(1996-9#1)(1997-2#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#4)(2006-2#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#3)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-4#1)(2010-5#2)(2010-8#2)(2010-9#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#4)(2013-1#1)(2013-7#1)
recommend the use of##9##4##(1994-9#1)(2006-5#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-6#1)(2008-8#1)(2009-2#1)
recommend the##31##2##(1990-8#1)(1991-3#1)(1993-12#3)(1994-2#1)(1994-9#1)(1995-4#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-2#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-1#1)(2013-7#1)
recommend their##2##2##(1996-12#1)(2007-2#1)
recommend this##10##2##(1991-12#1)(1992-12#1)(1995-4#1)(1996-1#1)(2005-9#1)(2007-11#1)(2007-8#1)(2008-11#1)(2011-2#1)(2012-1#1)
recommend to use##2##3##(1991-7#1)(2006-10#1)
recommend to##8##2##(1990-6#1)(1991-7#1)(2005-1#1)(2006-10#1)(2006-6#1)(2007-8#1)(2011-1#1)(2013-7#1)
recommend treatment##2##2##(1990-12#1)(2007-11#1)
recommend use of##2##3##(2008-7#1)(2008-9#1)
recommend using##5##2##(1994-8#1)(2006-3#1)(2007-1#1)(2008-9#1)(2010-4#1)
recommend##265##1##(1990-11#2)(1990-12#2)(1990-3#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-12#3)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#4)(1993-5#2)(1994-2#2)(1994-8#2)(1994-9#2)(1995-3#1)(1995-4#2)(1995-8#1)(1996-1#1)(1996-11#3)(1996-12#1)(1996-2#2)(1996-3#2)(1996-6#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-5#2)(1997-8#1)(2004-2#1)(2004-9#1)(2005-1#2)(2005-10#2)(2005-11#2)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#11)(2006-11#1)(2006-12#3)(2006-2#2)(2006-3#1)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#5)(2007-2#7)(2007-3#1)(2007-5#5)(2007-7#5)(2007-8#10)(2007-9#2)(2008-1#4)(2008-10#10)(2008-11#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#10)(2008-8#3)(2008-9#8)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-8#1)(2009-9#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#5)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#5)(2011-12#2)(2011-2#8)(2012-1#3)(2012-11#2)(2012-12#7)(2012-2#2)(2012-3#4)(2013-1#5)(2013-7#5)(2013-8#2)
recommendable##6##1##(1990-6#1)(1993-11#1)(1993-3#1)(2007-8#1)(2008-7#1)(2008-8#1)
recommendation and##2##2##(2007-2#1)(2012-12#1)
recommendation as##3##2##(2007-11#1)(2009-8#1)(2013-7#1)
recommendation by the##2##3##(2006-10#1)(2008-3#1)
recommendation for the##2##3##(2007-9#1)(2009-10#1)
recommendation for##17##2##(1996-12#1)(1997-1#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2010-4#2)(2010-8#1)(2010-9#1)(2012-11#1)(2012-2#1)(2013-1#1)
recommendation in##2##2##(1992-10#1)(2009-8#1)
recommendation is based on##2##4##(2007-10#1)(2011-2#1)
recommendation is##6##2##(1992-8#1)(1993-12#1)(2007-10#1)(2007-7#1)(2010-5#1)(2011-2#1)
recommendation of the##3##3##(1996-6#1)(2006-2#1)(2008-8#1)
recommendation of##13##2##(1993-2#1)(1996-6#1)(1997-6#1)(2006-2#1)(2007-2#1)(2008-12#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-12#1)(2013-1#2)
recommendation on##2##2##(2012-2#1)(2013-7#1)
recommendation that##7##2##(1991-10#1)(1991-8#1)(1993-5#1)(2005-7#1)(2007-11#1)(2008-6#1)(2011-12#1)
recommendation to##4##2##(1990-8#1)(1994-2#1)(1996-11#1)(2012-12#1)
recommendation##88##1##(1990-8#1)(1991-10#1)(1991-8#1)(1992-10#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-2#1)(1996-11#2)(1996-12#1)(1996-6#1)(1997-1#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-2#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#4)(2008-3#3)(2008-5#1)(2008-6#4)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-12#4)(2010-4#2)(2010-5#1)(2010-8#2)(2010-9#2)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#3)(2012-2#2)(2013-1#6)(2013-7#2)
recommendations 1995##2##2##(1996-2#2)
recommendations about the##4##3##(2007-12#1)(2008-10#1)(2011-2#1)(2013-1#1)
recommendations about##8##2##(1992-3#1)(1995-1#1)(1995-2#1)(2007-12#1)(2007-3#1)(2008-10#1)(2011-2#1)(2013-1#1)
recommendations address##2##2##(2006-10#1)(2008-12#1)
recommendations against##2##2##(2009-4#1)(2009-5#1)
recommendations and future##2##3##(2007-11#1)(2010-3#1)
recommendations and##16##2##(1996-1#1)(2005-11#2)(2006-12#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-6#1)(2010-7#1)(2012-12#1)(2013-1#3)
recommendations apply to##3##3##(2008-6#2)(2011-2#1)
recommendations are based on##5##4##(2008-11#1)(2010-11#1)(2013-1#3)
recommendations are based##6##3##(2007-8#1)(2008-11#1)(2010-11#1)(2013-1#3)
recommendations are discussed##3##3##(1996-2#1)(1997-3#1)(2007-10#1)
recommendations are made##6##3##(1992-12#1)(1992-9#1)(2008-11#1)(2008-12#1)(2012-11#2)
recommendations are not##2##3##(2007-2#1)(2008-11#1)
recommendations are offered for##3##4##(1990-9#1)(2006-11#1)(2010-9#1)
recommendations are offered to##2##4##(2007-12#1)(2012-3#1)
recommendations are offered##6##3##(1990-9#1)(2006-11#1)(2007-12#1)(2008-12#1)(2010-9#1)(2012-3#1)
recommendations are presented##2##3##(2007-2#1)(2008-12#1)
recommendations are proposed##3##3##(2012-12#2)(2012-3#1)
recommendations are provided for##2##4##(1993-2#1)(2009-5#1)
recommendations are provided##4##3##(1993-2#1)(2009-5#1)(2011-2#1)(2013-8#1)
recommendations are##49##2##(1990-9#1)(1992-12#1)(1992-9#1)(1993-2#1)(1993-5#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-3#1)(2006-10#2)(2006-11#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-8#2)(2008-10#1)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#1)(2009-4#1)(2009-5#2)(2010-11#1)(2010-12#2)(2010-9#1)(2011-2#3)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
recommendations as to the##2##4##(2007-8#1)(2009-3#1)
recommendations as##3##2##(2005-1#1)(2007-8#1)(2009-3#1)
recommendations based on the##5##4##(1995-5#1)(2006-12#1)(2008-12#1)(2008-8#1)(2012-11#1)
recommendations based on##13##3##(1993-1#1)(1993-12#2)(1995-5#1)(2006-12#1)(2008-12#1)(2008-8#2)(2010-9#2)(2012-11#1)(2012-12#1)(2013-1#1)
recommendations by the##4##3##(1994-12#1)(2007-12#2)(2007-4#1)
recommendations by##6##2##(1994-12#1)(2007-12#2)(2007-4#1)(2008-5#1)(2010-12#1)
recommendations concerning##4##2##(1994-4#1)(2008-10#1)(2009-5#1)(2012-1#1)
recommendations detail##2##2##(2007-8#1)(2010-4#1)
recommendations developed by the##2##4##(1995-12#1)(2008-4#1)
recommendations developed##3##2##(1995-12#1)(2008-4#1)(2011-2#1)
recommendations focus##2##2##(2008-12#1)(2008-7#1)
recommendations for calcium##2##3##(2005-3#1)(2013-8#1)
recommendations for children##2##3##(1995-1#1)(2012-2#1)
recommendations for clinical##2##3##(2008-11#1)(2012-3#1)
recommendations for further research##3##4##(1996-8#1)(2008-4#1)(2012-1#1)
recommendations for further##5##3##(1996-8#1)(2008-11#1)(2008-12#1)(2008-4#1)(2012-1#1)
recommendations for future practice##2##4##(1994-7#1)(2008-11#1)
recommendations for future research are##2##5##(2009-4#1)(2012-1#1)
recommendations for future research in this area##2##7##(2012-12#1)(2013-1#1)
recommendations for future research##9##4##(2006-1#1)(2008-8#1)(2009-4#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
recommendations for future##19##3##(1992-3#1)(1994-7#1)(1996-12#1)(2006-1#1)(2008-11#1)(2008-8#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
recommendations for good##2##3##(2008-1#1)(2012-3#1)
recommendations for improving##4##3##(1996-2#1)(2007-4#1)(2009-5#1)(2010-12#1)
recommendations for management of##2##4##(1992-10#1)(2008-6#1)
recommendations for management##3##3##(1992-10#1)(2007-12#1)(2008-6#1)
recommendations for optimal use##2##4##(2007-11#2)
recommendations for physicians##2##3##(2008-11#1)(2010-9#1)
recommendations for practice##2##3##(2008-1#1)(2010-7#1)
recommendations for prevention and control of##2##6##(1991-8#1)(1993-7#1)
recommendations for prevention##3##3##(1991-8#1)(1993-7#1)(2007-9#1)
recommendations for research##3##3##(1996-3#1)(2006-10#1)(2011-2#1)
recommendations for screening##3##3##(2004-11#1)(2007-12#1)(2008-8#1)
recommendations for the future##2##4##(2006-10#1)(2008-3#1)
recommendations for the long-term##2##4##(1990-2#1)(2008-8#1)
recommendations for the management of##5##5##(2007-11#1)(2008-3#1)(2010-12#2)(2011-2#1)
recommendations for the treatment of##2##5##(1996-9#1)(2013-1#1)
recommendations for the use of##9##5##(1996-6#1)(2008-11#1)(2008-3#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-11#1)
recommendations for the##44##3##(1990-2#1)(1993-12#1)(1993-4#1)(1994-3#1)(1995-2#2)(1996-6#1)(1996-9#2)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-11#2)(2008-3#7)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#2)(2010-12#2)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
recommendations for their##4##3##(2007-12#1)(2008-6#1)(2009-7#1)(2010-11#1)
recommendations for those##2##3##(2012-12#1)(2012-2#1)
recommendations for travelers##3##3##(2011-2#3)
recommendations for treatment##4##3##(1994-6#1)(2006-12#1)(2007-3#1)(2012-2#1)
recommendations for using##2##3##(2008-11#1)(2010-3#1)
recommendations for vaccination of##2##4##(2007-11#1)(2008-4#1)
recommendations for##229##2##(1990-2#1)(1990-8#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-3#2)(1992-8#1)(1993-12#4)(1993-4#1)(1993-7#4)(1993-9#2)(1994-12#2)(1994-3#1)(1994-6#2)(1994-7#1)(1995-1#1)(1995-2#3)(1995-3#2)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#2)(1996-9#2)(1997-2#1)(1997-3#2)(2004-11#1)(2005-11#1)(2005-3#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#2)(2006-12#2)(2006-5#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-11#4)(2007-12#7)(2007-3#1)(2007-4#4)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#5)(2008-10#1)(2008-11#13)(2008-12#1)(2008-2#2)(2008-3#8)(2008-4#7)(2008-5#2)(2008-6#5)(2008-7#1)(2008-8#6)(2008-9#6)(2009-10#1)(2009-11#4)(2009-12#1)(2009-4#2)(2009-5#1)(2009-7#3)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#5)(2010-3#2)(2010-5#5)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#8)(2011-1#2)(2011-12#2)(2011-2#10)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#7)(2012-3#5)(2013-1#9)(2013-8#4)
recommendations from a##2##3##(1990-11#1)(2006-10#1)
recommendations from the##8##3##(1996-6#1)(1997-2#1)(2007-3#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-5#1)(2013-1#1)
recommendations from##19##2##(1990-11#1)(1993-9#1)(1996-6#1)(1997-2#1)(2005-8#1)(2006-10#2)(2007-3#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-11#2)(2009-4#1)(2009-5#1)(2010-12#1)(2011-3#1)(2013-1#1)
recommendations generated by##3##3##(2007-4#1)(2013-1#2)
recommendations have been##2##3##(2008-2#1)(2008-8#1)
recommendations have##4##2##(1992-9#1)(2008-2#1)(2008-3#1)(2008-8#1)
recommendations in performing##2##3##(2012-3#1)(2013-8#1)
recommendations in the##5##3##(1990-6#1)(1992-3#1)(2008-10#3)
recommendations in##20##2##(1990-6#1)(1992-3#1)(1993-12#1)(2007-11#2)(2008-10#3)(2008-12#1)(2008-9#2)(2009-9#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#2)
recommendations include##2##2##(2005-9#1)(2007-12#1)
recommendations into##2##2##(2007-7#1)(2008-3#1)
recommendations is##3##2##(1993-8#1)(2006-10#1)(2008-9#1)
recommendations issued by the##2##4##(2010-12#1)(2011-2#1)
recommendations made by##2##3##(2011-1#1)(2013-1#1)
recommendations made##4##2##(1992-1#1)(1996-3#1)(2011-1#1)(2013-1#1)
recommendations may help to##2##4##(2008-1#1)(2012-1#1)
recommendations may##4##2##(2007-12#1)(2008-1#1)(2008-10#1)(2012-1#1)
recommendations of the Advisory Committee on Immunization Practices (ACIP)##2##9##(2004-12#2)
recommendations of the European##2##4##(1996-1#1)(2013-1#1)
recommendations of the##34##3##(1990-3#1)(1993-6#1)(1996-1#1)(1996-9#1)(2004-12#2)(2006-11#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-12#3)(2012-3#2)(2013-1#4)
recommendations of##45##2##(1990-3#1)(1993-6#1)(1994-12#1)(1995-2#1)(1996-1#1)(1996-9#1)(1997-4#1)(2004-12#2)(2006-11#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#4)
recommendations on how to improve the##2##6##(2007-3#1)(2009-7#1)
recommendations on how to##4##4##(2007-3#1)(2007-5#1)(2009-7#1)(2012-2#1)
recommendations on how##7##3##(2007-3#1)(2007-5#1)(2009-7#1)(2010-11#1)(2012-12#1)(2012-2#1)(2013-8#1)
recommendations on the investigation and##2##5##(2007-12#2)
recommendations on the##8##3##(1990-12#1)(1996-2#1)(2007-12#2)(2008-12#1)(2008-3#1)(2009-4#1)(2011-2#1)
recommendations on##29##2##(1990-12#1)(1990-5#1)(1991-1#1)(1991-11#1)(1996-2#1)(2006-8#2)(2006-9#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#1)(2008-12#1)(2008-3#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
recommendations or##3##2##(2006-2#1)(2011-2#2)
recommendations regarding the use of##2##5##(1993-9#1)(2013-1#1)
recommendations regarding the##10##3##(1993-9#1)(2006-9#1)(2007-4#2)(2008-1#1)(2008-3#1)(2008-9#1)(2012-12#2)(2013-1#1)
recommendations regarding##24##2##(1993-9#1)(2005-7#1)(2006-10#2)(2006-9#1)(2007-11#1)(2007-2#1)(2007-4#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-11#1)(2012-12#3)(2012-3#1)(2013-1#1)
recommendations should be##2##3##(2007-4#1)(2008-12#1)
recommendations should##3##2##(2007-4#1)(2008-1#1)(2008-12#1)
recommendations that are##2##3##(2009-5#1)(2013-1#1)
recommendations that emerged from the##2##5##(2007-10#1)(2008-5#1)
recommendations that have##2##3##(1991-1#1)(2007-8#1)
recommendations that may help##2##4##(2010-12#1)(2012-1#1)
recommendations that may##4##3##(1993-12#1)(2006-10#1)(2010-12#1)(2012-1#1)
recommendations that##23##2##(1991-1#1)(1993-12#1)(1995-6#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-5#1)(2009-6#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-1#2)(2013-1#1)
recommendations to address##2##3##(1991-3#1)(2012-12#1)
recommendations to help##4##3##(1996-3#1)(2009-7#1)(2011-2#1)(2013-1#1)
recommendations to improve##2##3##(2006-10#1)(2010-12#1)
recommendations to increase##2##3##(2008-3#1)(2010-8#1)
recommendations to minimize the##2##4##(2005-12#1)(2007-7#1)
recommendations to the##4##3##(1996-1#1)(2008-12#1)(2010-5#1)(2010-8#1)
recommendations to##30##2##(1991-3#1)(1996-1#1)(1996-3#1)(1997-3#1)(2005-12#1)(2006-10#1)(2006-3#1)(2007-7#1)(2008-12#2)(2008-3#2)(2009-12#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-12#4)(2012-3#1)(2013-1#4)
recommendations using the##2##3##(2010-4#1)(2013-8#1)
recommendations using##3##2##(2008-9#1)(2010-4#1)(2013-8#1)
recommendations was##5##2##(1990-6#1)(2008-1#1)(2008-12#1)(2011-1#1)(2011-2#1)
recommendations were made##2##3##(1994-2#1)(2013-1#1)
recommendations were##16##2##(1992-3#1)(1994-2#1)(1996-1#1)(2006-1#1)(2006-11#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-6#1)(2010-10#1)(2010-2#1)(2011-2#1)(2013-1#4)
recommendations with##3##2##(1990-12#1)(2008-6#1)(2010-11#1)
recommendations##777##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-3#2)(1991-8#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#3)(1992-3#5)(1992-4#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-12#9)(1993-2#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#4)(1993-8#1)(1993-9#5)(1994-12#4)(1994-2#2)(1994-3#1)(1994-4#1)(1994-6#2)(1994-7#1)(1995-1#4)(1995-12#1)(1995-2#5)(1995-3#2)(1995-4#2)(1995-5#1)(1995-6#1)(1996-1#6)(1996-12#2)(1996-2#6)(1996-3#4)(1996-4#1)(1996-6#3)(1996-8#3)(1996-9#4)(1997-1#2)(1997-2#3)(1997-3#4)(1997-4#1)(1997-5#1)(1997-7#1)(2004-11#1)(2004-12#3)(2005-1#1)(2005-11#3)(2005-12#1)(2005-3#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#2)(2006-10#18)(2006-11#5)(2006-12#4)(2006-2#3)(2006-3#1)(2006-5#2)(2006-6#1)(2006-8#6)(2006-9#4)(2007-1#2)(2007-10#2)(2007-11#14)(2007-12#20)(2007-2#6)(2007-3#4)(2007-4#16)(2007-5#1)(2007-6#3)(2007-7#6)(2007-8#10)(2007-9#4)(2008-1#17)(2008-10#19)(2008-11#24)(2008-12#20)(2008-2#5)(2008-3#19)(2008-4#13)(2008-5#9)(2008-6#10)(2008-7#10)(2008-8#18)(2008-9#14)(2009-10#4)(2009-11#7)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#12)(2009-5#7)(2009-6#1)(2009-7#6)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#3)(2010-11#10)(2010-12#15)(2010-2#4)(2010-3#6)(2010-4#4)(2010-5#10)(2010-6#4)(2010-7#2)(2010-8#7)(2010-9#19)(2011-1#11)(2011-12#3)(2011-2#43)(2011-3#2)(2012-1#8)(2012-11#6)(2012-12#26)(2012-2#12)(2012-3#17)(2013-1#47)(2013-8#13)
recommendations]##3##1##(1997-8#1)(2009-5#1)(2011-2#1)
recommended ABC approach##2##3##(2012-3#2)
recommended a##9##2##(1993-12#1)(1994-11#1)(1994-4#1)(1996-6#3)(1997-1#1)(2007-8#1)(2007-9#1)
recommended against##2##2##(1995-6#1)(1995-9#1)
recommended and##6##2##(1994-1#1)(2007-11#1)(2007-6#1)(2008-6#1)(2011-2#1)(2012-11#1)
recommended approach##2##2##(2008-10#1)(2009-11#1)
recommended as a first-line treatment##2##5##(2008-10#1)(2008-3#1)
recommended as a first-line##3##4##(2008-10#1)(2008-3#1)(2013-1#1)
recommended as a##14##3##(1990-10#1)(1991-3#1)(1994-3#1)(2006-10#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2010-5#1)(2011-1#1)(2012-1#1)(2013-1#2)
recommended as an additional##2##4##(1991-3#1)(2013-1#1)
recommended as an##7##3##(1991-3#1)(2006-11#1)(2007-7#1)(2008-10#1)(2011-1#1)(2013-1#2)
recommended as first choice##2##4##(1991-6#1)(2008-3#1)
recommended as first-line##2##3##(2006-6#1)(2008-9#1)
recommended as primary##2##3##(1995-9#1)(2011-2#1)
recommended as the##6##3##(1990-6#1)(1996-2#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-4#1)
recommended as##45##2##(1990-10#1)(1990-6#1)(1990-8#1)(1991-3#2)(1991-6#1)(1991-8#1)(1992-3#1)(1994-3#1)(1995-2#1)(1995-9#1)(1996-2#1)(1996-9#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-3#3)(2008-4#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-6#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-1#1)(2013-1#4)
recommended at##3##2##(1997-8#1)(2006-2#1)(2008-6#1)
recommended because of the##3##4##(1993-8#1)(2006-10#1)(2007-12#1)
recommended because of##4##3##(1993-12#1)(1993-8#1)(2006-10#1)(2007-12#1)
recommended because##8##2##(1991-12#1)(1993-12#1)(1993-8#1)(1996-8#1)(2006-10#1)(2007-12#2)(2008-2#1)
recommended by World Health Organization##2##5##(2007-2#1)(2007-8#1)
recommended by health##2##3##(2005-11#1)(2011-2#1)
recommended by some##3##3##(1993-10#1)(1995-1#1)(2006-10#1)
recommended by the American##3##4##(2008-10#1)(2010-8#1)(2012-12#1)
recommended by the Association##2##4##(1990-6#1)(2008-10#1)
recommended by the Cochrane##2##4##(2007-2#1)(2013-1#1)
recommended by the International##2##4##(2006-10#1)(2008-10#1)
recommended by the National##2##4##(2008-10#1)(2011-2#1)
recommended by the US##2##4##(2006-2#1)(2008-10#1)
recommended by the World Health Organization##3##6##(1991-9#1)(2008-1#1)(2011-2#1)
recommended by the World##4##4##(1991-9#1)(2008-1#1)(2011-2#2)
recommended by the##36##3##(1990-4#2)(1990-6#1)(1991-9#1)(1993-1#1)(1994-3#1)(1996-11#1)(1996-9#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-4#1)(2009-10#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
recommended by##65##2##(1990-4#3)(1990-6#1)(1991-9#1)(1993-1#1)(1993-10#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-11#1)(1996-3#1)(1996-9#1)(2005-11#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#3)(2007-2#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
recommended changes##2##2##(1994-3#1)(2006-2#1)
recommended concentrations##2##2##(2008-10#1)(2008-5#1)
recommended daily allowances##2##3##(1992-9#1)(2010-6#1)
recommended daily intake##2##3##(2011-2#1)(2012-2#1)
recommended daily##11##2##(1992-9#1)(1997-4#2)(2008-5#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#3)
recommended diagnostic##2##2##(1996-9#1)(2013-8#1)
recommended dietary allowances##4##3##(1992-2#1)(2005-3#2)(2006-10#1)
recommended dietary##6##2##(1992-2#1)(1992-9#1)(2005-3#2)(2006-10#1)(2006-4#1)
recommended dosage of##3##3##(1991-12#1)(1994-2#1)(2007-11#1)
recommended dosage##6##2##(1990-10#1)(1991-12#1)(1994-2#1)(1995-7#1)(2007-11#1)(2007-2#1)
recommended dose is##2##3##(2007-2#1)(2007-7#1)
recommended dose##6##2##(2004-1#1)(2005-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2012-2#1)
recommended doses##2##2##(1997-6#1)(2008-10#1)
recommended drugs##3##2##(1995-1#1)(1997-3#1)(2011-2#1)
recommended for a##4##3##(1990-12#1)(1992-8#1)(2008-7#1)(2012-11#1)
recommended for children##2##3##(1993-5#1)(2007-8#1)
recommended for future##2##3##(2010-7#1)(2010-8#1)
recommended for inclusion in##2##4##(2008-7#1)(2012-12#1)
recommended for patients with a##2##5##(1994-12#1)(2007-8#1)
recommended for patients with##9##4##(1990-12#1)(1990-8#1)(1994-12#1)(2007-8#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
recommended for patients##12##3##(1990-12#1)(1990-8#1)(1994-12#1)(2006-10#1)(2007-8#2)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
recommended for persons##2##3##(1993-5#1)(2012-3#1)
recommended for the treatment of##4##5##(1995-12#1)(2004-11#1)(2006-10#1)(2007-12#1)
recommended for the treatment##5##4##(1995-12#1)(2004-11#1)(2006-10#1)(2007-12#1)(2008-5#1)
recommended for the##19##3##(1990-8#1)(1995-12#1)(1995-9#1)(2004-11#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-9#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
recommended for use as##2##4##(1996-3#1)(2012-1#1)
recommended for use in##2##4##(2007-7#1)(2008-8#1)
recommended for use##5##3##(1991-2#1)(1996-3#1)(2007-7#1)(2008-8#1)(2012-1#1)
recommended for##124##2##(1990-12#3)(1990-8#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-12#1)(1993-2#2)(1993-5#2)(1993-6#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-9#1)(1996-3#1)(1996-8#1)(1997-7#1)(2004-11#1)(2005-4#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-5#2)(2007-11#2)(2007-12#3)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#3)(2007-8#8)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#4)(2008-7#5)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-4#2)(2010-12#1)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#1)(2011-2#9)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#3)
recommended guidelines for##3##3##(1996-7#1)(2008-4#1)(2010-5#1)
recommended guidelines##5##2##(1996-7#1)(2005-10#1)(2006-2#1)(2008-4#1)(2010-5#1)
recommended in all##3##3##(2007-12#1)(2007-7#1)(2011-1#1)
recommended in most cases##2##4##(2006-10#1)(2011-2#1)
recommended in patients##2##3##(1990-3#1)(2007-11#1)
recommended in the##7##3##(1991-12#1)(2006-5#1)(2007-3#1)(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)
recommended in this##3##3##(2006-7#1)(2007-2#1)(2008-8#1)
recommended in##45##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-12#1)(1993-8#1)(1997-4#1)(2005-12#1)(2005-3#1)(2006-10#2)(2006-3#1)(2006-5#1)(2006-7#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#2)(2008-10#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#2)
recommended intake##2##2##(2005-9#1)(2012-2#1)
recommended intakes##2##2##(2010-6#1)(2012-2#1)
recommended is##2##2##(2013-1#1)(2013-8#1)
recommended levels of##4##3##(2011-2#4)
recommended levels##13##2##(1997-3#1)(2008-5#5)(2010-11#1)(2010-8#1)(2011-2#5)
recommended method for##2##3##(2008-10#1)(2009-11#1)
recommended method was##3##3##(2008-10#3)
recommended method##8##2##(2008-10#7)(2009-11#1)
recommended on a##2##3##(2008-1#1)(2009-7#1)
recommended on the basis of##4##5##(1990-2#1)(1994-6#1)(2011-2#1)(2012-2#1)
recommended on the##5##3##(1990-2#1)(1994-6#1)(1996-1#1)(2011-2#1)(2012-2#1)
recommended on##8##2##(1990-2#1)(1994-6#1)(1996-1#1)(2004-12#1)(2008-1#1)(2009-7#1)(2011-2#1)(2012-2#1)
recommended only##3##2##(1990-2#1)(1994-3#1)(2011-12#1)
recommended other##2##2##(1992-6#1)(1993-3#1)
recommended over##4##2##(2007-7#1)(2013-7#3)
recommended prior to##2##3##(2009-5#1)(2012-12#1)
recommended procedure was##2##3##(2008-10#1)(2012-11#1)
recommended procedure##9##2##(2006-6#1)(2008-10#6)(2008-3#1)(2012-11#1)
recommended procedures##2##2##(2008-10#1)(2008-11#1)
recommended regimen##2##2##(1997-5#1)(2007-11#1)
recommended standard##2##2##(1992-5#1)(2008-10#1)
recommended starting##2##2##(2005-7#1)(2013-1#1)
recommended target##2##2##(2007-9#1)(2011-2#1)
recommended that a##3##3##(2008-11#1)(2008-4#1)(2012-2#1)
recommended that blood##2##3##(1995-6#1)(2011-2#1)
recommended that patients with##2##4##(2006-10#1)(2006-2#1)
recommended that patients##4##3##(1997-3#1)(2006-10#1)(2006-2#1)(2010-8#1)
recommended that the##13##3##(1994-3#1)(2006-12#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#3)(2013-8#1)
recommended that##77##2##(1990-4#2)(1991-3#3)(1991-4#1)(1992-8#1)(1993-12#2)(1993-3#1)(1994-11#1)(1994-3#2)(1994-4#1)(1995-4#2)(1995-6#2)(1996-12#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-8#1)(2005-5#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-7#3)(2007-9#3)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#3)(2012-2#3)(2013-1#1)(2013-8#1)
recommended the##6##2##(2004-2#1)(2006-2#1)(2007-10#1)(2008-7#1)(2011-2#2)
recommended therapeutic##2##2##(1991-11#1)(2007-11#1)
recommended time##3##2##(2006-4#1)(2012-1#1)(2013-1#1)
recommended to be##4##3##(2005-11#1)(2008-5#1)(2009-4#1)(2011-2#1)
recommended to consider##2##3##(2007-2#1)(2008-8#1)
recommended to correct##2##3##(1993-1#1)(2008-10#1)
recommended to evaluate the##2##4##(2007-2#1)(2008-10#1)
recommended to evaluate##4##3##(1994-2#1)(2007-11#1)(2007-2#1)(2008-10#1)
recommended to identify##2##3##(2008-10#1)(2008-4#1)
recommended to improve##5##3##(2007-7#1)(2008-5#1)(2008-9#1)(2010-4#1)(2010-9#1)
recommended to reduce the##2##4##(2008-12#1)(2009-11#1)
recommended to reduce##3##3##(2008-12#1)(2009-11#1)(2009-2#1)
recommended to the##2##3##(2008-5#1)(2008-6#1)
recommended to##61##2##(1990-12#2)(1992-11#1)(1992-3#1)(1993-1#1)(1994-11#1)(1994-2#1)(1995-4#1)(2004-12#1)(2005-11#2)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#4)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2013-1#1)
recommended today##2##2##(1990-10#1)(2009-6#1)
recommended treatment is##5##3##(1997-5#1)(2009-3#1)(2010-12#1)(2012-12#1)(2013-8#1)
recommended treatment##8##2##(1997-5#1)(2008-3#1)(2008-5#1)(2009-3#1)(2009-8#1)(2010-12#1)(2012-12#1)(2013-8#1)
recommended treatments##4##2##(1993-9#1)(2010-10#1)(2013-1#2)
recommended use##2##2##(2008-6#1)(2008-8#1)
recommended value of##2##3##(2009-8#1)(2010-9#1)
recommended values##4##2##(2008-10#4)
recommended when##3##2##(1990-4#1)(1991-5#1)(2007-8#1)
recommended with##4##2##(1997-7#1)(2009-2#2)(2009-4#1)
recommended##953##1##(1990-10#6)(1990-12#8)(1990-2#4)(1990-3#1)(1990-4#7)(1990-6#5)(1990-8#5)(1990-9#1)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#5)(1991-4#1)(1991-5#3)(1991-6#5)(1991-7#1)(1991-8#2)(1991-9#4)(1992-11#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#3)(1992-7#1)(1992-8#3)(1992-9#4)(1993-1#5)(1993-10#2)(1993-12#6)(1993-2#3)(1993-3#5)(1993-5#4)(1993-6#2)(1993-8#4)(1993-9#1)(1994-1#1)(1994-11#4)(1994-12#2)(1994-2#2)(1994-3#7)(1994-4#2)(1994-6#3)(1994-9#2)(1995-1#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-4#4)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#1)(1995-9#4)(1996-1#1)(1996-11#2)(1996-12#6)(1996-2#4)(1996-3#2)(1996-6#4)(1996-7#1)(1996-8#2)(1996-9#5)(1997-1#3)(1997-2#5)(1997-3#5)(1997-4#5)(1997-5#3)(1997-6#2)(1997-7#2)(1997-8#6)(2004-1#1)(2004-11#1)(2004-12#3)(2004-2#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-3#5)(2005-4#1)(2005-5#1)(2005-7#1)(2005-8#3)(2005-9#4)(2006-1#2)(2006-10#19)(2006-11#5)(2006-12#5)(2006-2#13)(2006-3#1)(2006-4#3)(2006-5#7)(2006-6#5)(2006-7#2)(2006-8#6)(2006-9#2)(2007-1#2)(2007-10#6)(2007-11#17)(2007-12#15)(2007-2#19)(2007-3#5)(2007-4#3)(2007-6#5)(2007-7#25)(2007-8#17)(2007-9#8)(2008-1#14)(2008-10#79)(2008-11#13)(2008-12#5)(2008-2#2)(2008-3#12)(2008-4#12)(2008-5#20)(2008-6#11)(2008-7#14)(2008-8#15)(2008-9#7)(2009-10#1)(2009-11#6)(2009-12#2)(2009-2#5)(2009-3#2)(2009-4#6)(2009-5#2)(2009-6#4)(2009-7#4)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#7)(2010-2#11)(2010-3#2)(2010-4#6)(2010-5#5)(2010-6#4)(2010-7#3)(2010-8#11)(2010-9#5)(2011-1#15)(2011-12#5)(2011-2#65)(2011-3#1)(2012-1#7)(2012-11#4)(2012-12#15)(2012-2#27)(2012-3#7)(2013-1#42)(2013-7#6)(2013-8#19)
recommending that##3##2##(1996-2#1)(2010-1#1)(2011-2#1)
recommending the hospital to potential patients##2##6##(2008-8#2)
recommending the##6##2##(2006-10#1)(2007-1#1)(2008-10#1)(2008-8#2)(2009-4#1)
recommending this##2##2##(2007-8#1)(2008-8#1)
recommending##32##1##(1992-12#2)(1992-3#1)(1992-8#1)(1994-12#1)(1996-2#1)(1996-3#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#3)(2009-4#1)(2009-5#1)(2010-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
recommends a##3##2##(2005-11#1)(2008-7#1)(2010-5#1)
recommends against##3##2##(2006-2#1)(2010-9#1)(2011-1#1)
recommends exclusive##2##2##(2004-12#1)(2012-2#1)
recommends strategies##3##2##(2009-5#1)(2010-7#1)(2011-1#1)
recommends that all##3##3##(1990-12#1)(1996-12#1)(1996-2#1)
recommends that the##2##3##(2008-10#1)(2008-11#1)
recommends that##25##2##(1990-12#1)(1995-3#1)(1995-9#2)(1996-12#1)(1996-2#1)(2005-5#1)(2007-10#1)(2007-12#1)(2007-2#4)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
recommends the##5##2##(1992-10#1)(1995-12#1)(2008-10#1)(2009-10#1)(2011-3#1)
recommends##64##1##(1990-12#1)(1990-9#1)(1991-3#1)(1992-10#1)(1995-12#1)(1995-3#1)(1995-9#2)(1996-12#1)(1996-2#1)(1997-2#1)(2004-12#1)(2005-11#1)(2005-5#1)(2006-2#1)(2007-10#2)(2007-12#1)(2007-2#5)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-5#2)(2009-6#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#4)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#3)(2013-1#1)
recomposition##2##1##(2007-11#2)
recompressed##2##1##(1991-6#1)(2008-3#1)
recompression##4##1##(1991-6#2)(2007-11#1)(2007-12#1)
recomputed##2##1##(1991-2#1)(2013-8#1)
reconceptualize##2##1##(1993-2#1)(2006-3#1)
reconcile the##13##2##(1992-3#1)(1993-11#1)(1994-11#1)(2005-11#1)(2006-2#1)(2006-5#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-1#1)
reconcile this##2##2##(2007-12#1)(2007-8#1)
reconcile##26##1##(1990-2#1)(1992-3#1)(1993-11#1)(1994-11#1)(1995-5#1)(1996-10#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-9#1)(2011-1#1)(2013-8#1)
reconciled with##3##2##(1990-12#1)(2008-2#1)(2008-3#1)
reconciled##11##1##(1990-12#1)(1995-3#1)(1995-5#1)(1997-2#1)(2005-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-12#1)
reconciles##3##1##(2007-12#1)(2007-9#1)(2008-11#1)
reconciliation analysis##2##2##(2008-1#2)
reconciliation in##2##2##(2010-6#1)(2013-1#1)
reconciliation of##2##2##(1993-7#1)(2006-12#1)
reconciliation##17##1##(1993-7#1)(2004-3#1)(2006-12#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#2)(2008-8#1)(2010-6#3)(2013-1#2)
reconciliation-based orthology analysis##2##3##(2010-6#2)
reconciliation-based orthology##3##2##(2010-6#3)
reconciling the##3##2##(2008-4#1)(2012-3#1)(2013-8#1)
reconciling##7##1##(2007-11#1)(2008-4#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
recondita f##7##2##(2008-10#7)
recondita##10##1##(2008-10#10)
reconditioned##2##1##(1996-3#1)(2008-5#1)
reconditioning program##3##2##(2006-3#3)
reconditioning##9##1##(2006-3#5)(2007-8#1)(2008-10#2)(2011-3#1)
reconfigurability##3##1##(2008-2#1)(2013-1#2)
reconfigurable binary optical##2##3##(2007-11#1)(2007-12#1)
reconfigurable linear threshold elements implemented in floating-gate##2##7##(2008-2#2)
reconfigurable optical##2##2##(2007-12#1)(2008-2#1)
reconfigurable##21##1##(2007-11#1)(2007-12#7)(2008-2#10)(2008-3#2)(2009-3#1)
reconfiguration of the##4##3##(1992-2#1)(2007-12#1)(2008-10#1)(2008-3#1)
reconfiguration of##5##2##(1992-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-6#1)
reconfiguration##12##1##(1991-1#2)(1992-2#1)(1993-2#1)(1994-2#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-6#1)
reconfigured##2##1##(2010-7#1)(2012-1#1)
reconfiguring##5##1##(1992-2#1)(1994-12#1)(2008-7#1)(2012-3#1)(2013-1#1)
reconfirmed that##2##2##(1993-12#1)(1997-3#1)
reconfirmed##7##1##(1993-12#1)(1996-5#1)(1997-3#1)(2007-12#1)(2007-3#1)(2011-2#1)(2013-8#1)
reconnaissance and##2##2##(2006-12#2)
reconnaissance##3##1##(2006-12#3)
reconnection in##2##2##(1991-10#1)(1993-8#1)
reconnection of interdisciplinary knowledge in##2##5##(2012-12#2)
reconnection of interdisciplinary knowledge##3##4##(2012-12#3)
reconnection of##5##2##(1991-10#1)(2008-4#1)(2012-12#3)
reconnection##13##1##(1991-10#3)(1993-8#1)(2007-11#3)(2008-4#1)(2008-7#1)(2012-12#4)
reconsider##11##1##(1991-1#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-2#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-12#1)(2010-8#1)
reconsideration and##2##2##(1993-12#1)(2007-9#1)
reconsideration of the##6##3##(1992-12#1)(2005-6#1)(2006-10#1)(2008-4#1)(2009-3#1)(2010-3#1)
reconsideration of##8##2##(1992-12#1)(2005-6#1)(2006-10#1)(2008-1#1)(2008-4#1)(2009-3#1)(2009-7#1)(2010-3#1)
reconsideration##13##1##(1992-12#1)(1993-12#1)(1996-11#1)(2005-6#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-4#1)(2009-3#1)(2009-7#1)(2010-1#2)(2010-3#1)
reconsidered##18##1##(1990-6#1)(1990-8#1)(1991-10#1)(1991-2#1)(1994-9#1)(1995-11#1)(2006-11#1)(2007-12#3)(2008-11#1)(2008-4#2)(2008-9#1)(2009-7#1)(2011-2#1)(2013-7#1)(2013-8#1)
reconsidering##3##1##(1997-5#1)(2005-12#1)(2013-1#1)
reconsiders##3##1##(1991-1#1)(1995-2#1)(2010-10#1)
reconstitute the##10##2##(1990-2#1)(1990-3#1)(1992-3#1)(1995-12#1)(1996-5#1)(1997-7#1)(2006-3#1)(2007-8#3)
reconstitute##23##1##(1990-12#1)(1990-2#1)(1990-3#1)(1991-2#1)(1992-3#1)(1992-6#1)(1993-6#2)(1994-9#1)(1995-12#1)(1996-5#1)(1997-4#1)(1997-7#1)(2005-8#1)(2006-3#1)(2007-8#3)(2008-10#1)(2008-4#2)(2009-2#1)(2012-2#1)
reconstituted HDL particles##3##3##(1991-8#1)(1994-11#1)(1995-5#1)
reconstituted HDL##4##2##(1991-8#1)(1994-11#1)(1995-5#1)(2008-10#1)
reconstituted InsP(3) receptor##4##3##(2008-8#4)
reconstituted a##2##2##(1992-7#1)(2008-4#1)
reconstituted assay##2##2##(1993-12#1)(1996-5#1)
reconstituted basement membrane (Matrigel)##3##4##(1991-12#1)(2008-11#1)(2008-4#1)
reconstituted basement membrane##9##3##(1991-12#1)(1992-9#1)(1993-7#1)(2006-11#1)(2008-11#4)(2008-4#1)
reconstituted by##5##2##(1990-10#1)(1995-8#2)(2008-1#1)(2008-5#1)
reconstituted channels##2##2##(1996-9#1)(2008-8#1)
reconstituted complexes##3##2##(1990-5#1)(1993-8#2)
reconstituted enzyme system##4##3##(1991-10#1)(1993-12#1)(1994-5#1)(1995-10#1)
reconstituted enzyme##6##2##(1991-10#1)(1993-12#1)(1994-12#1)(1994-5#1)(1995-10#1)(1997-7#1)
reconstituted from the alpha and beta subunits of##2##8##(1990-9#1)(1992-11#1)
reconstituted from the##3##3##(1990-9#1)(1992-11#1)(1997-6#1)
reconstituted from##8##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-10#1)(1992-11#1)(1993-3#1)(1996-5#1)(1997-6#1)
reconstituted high density##2##3##(1994-11#1)(1995-5#1)
reconstituted human##3##2##(1990-12#1)(2008-5#2)
reconstituted in lipid##2##3##(1994-3#1)(2008-8#1)
reconstituted in liposomes##3##3##(1991-4#1)(1993-7#1)(2008-8#1)
reconstituted in the##3##3##(1990-12#1)(1994-10#1)(1997-1#1)
reconstituted in vitro##7##3##(1992-12#1)(1992-5#1)(1993-8#1)(1994-11#1)(1994-8#1)(1996-11#1)(2008-4#1)
reconstituted in##28##2##(1990-11#1)(1990-12#2)(1990-3#1)(1991-4#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-11#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-4#2)(2008-8#2)
reconstituted into liposomes##5##3##(1990-2#1)(1991-4#1)(1994-12#1)(1995-2#1)(2008-8#1)
reconstituted into phospholipid vesicles##2##4##(1990-3#1)(1991-2#1)
reconstituted into proteoliposomes##3##3##(1992-1#1)(1992-12#1)(1995-8#1)
reconstituted into##17##2##(1990-11#1)(1990-2#1)(1990-3#1)(1991-2#1)(1991-4#1)(1992-1#1)(1992-12#1)(1992-6#2)(1992-7#1)(1994-10#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-8#1)(2008-8#2)
reconstituted membrane##2##2##(1991-8#1)(1994-6#1)
reconstituted monooxygenase##2##2##(1993-4#1)(1994-8#1)
reconstituted proteins##2##2##(1991-4#1)(1992-8#1)
reconstituted serum##3##2##(2008-10#3)
reconstituted system containing##3##3##(1995-3#1)(1995-6#1)(1996-3#1)
reconstituted system##12##2##(1990-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-1#3)(1995-3#1)(1995-6#1)(1995-8#1)(1996-3#1)(2010-12#1)
reconstituted systems are##2##3##(1990-12#1)(1995-1#1)
reconstituted systems##6##2##(1990-12#1)(1992-9#1)(1995-1#3)(1997-2#1)
reconstituted the##4##2##(1994-12#2)(1994-9#1)(1995-12#1)
reconstituted with a##2##3##(1990-8#1)(1997-4#1)
reconstituted with the##2##3##(1994-9#1)(1997-8#1)
reconstituted with##38##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#3)(1991-12#1)(1991-4#3)(1991-9#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-2#2)(1995-5#1)(1995-6#2)(1996-5#1)(1997-4#4)(1997-7#1)(1997-8#2)(2004-11#2)(2008-4#2)(2008-8#1)(2011-2#1)
reconstituted##235##1##(1990-10#2)(1990-11#3)(1990-12#7)(1990-2#2)(1990-3#4)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#3)(1990-8#4)(1990-9#1)(1991-10#2)(1991-12#3)(1991-2#1)(1991-4#9)(1991-5#1)(1991-8#2)(1991-9#3)(1992-1#3)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#5)(1992-8#4)(1992-9#3)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#2)(1993-6#1)(1993-7#2)(1993-8#4)(1993-9#2)(1994-10#3)(1994-11#5)(1994-12#9)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#6)(1995-10#1)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#4)(1995-6#4)(1995-8#6)(1996-11#1)(1996-3#1)(1996-5#4)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#6)(1997-6#2)(1997-7#2)(1997-8#2)(2004-11#2)(2006-11#1)(2008-1#1)(2008-10#7)(2008-11#6)(2008-4#9)(2008-5#4)(2008-6#1)(2008-8#15)(2008-9#2)(2009-8#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#2)
reconstitutes##2##1##(1994-5#1)(2008-1#1)
reconstituting##8##1##(1991-2#1)(1991-9#1)(1992-7#1)(1995-12#1)(2006-3#1)(2008-1#1)(2008-9#1)(2013-1#1)
reconstitution after##4##2##(2008-10#1)(2012-12#1)(2012-2#2)
reconstitution and##4##2##(1992-4#1)(1995-8#1)(2008-8#1)(2009-9#1)
reconstitution assay##2##2##(1995-6#1)(1996-9#1)
reconstitution assays##2##2##(1993-6#1)(1996-8#1)
reconstitution experiments##10##2##(1990-3#1)(1991-4#1)(1992-12#1)(1992-6#1)(1994-3#1)(1994-9#1)(1995-8#1)(1996-6#1)(1996-9#1)(1997-2#1)
reconstitution in##6##2##(1992-1#1)(1993-2#1)(1995-12#1)(2008-7#1)(2008-8#1)(2009-12#1)
reconstitution inflammatory syndrome##7##3##(2008-10#1)(2009-7#1)(2010-5#2)(2010-6#1)(2010-9#1)(2012-2#1)
reconstitution inflammatory##8##2##(2008-10#1)(2009-7#1)(2010-5#2)(2010-6#1)(2010-9#1)(2012-2#2)
reconstitution into##2##2##(1995-2#1)(1995-8#1)
reconstitution of a##4##3##(1991-9#1)(1992-8#1)(1996-9#1)(2008-2#1)
reconstitution of the##10##3##(1990-5#1)(1991-5#1)(1992-6#1)(1992-9#1)(1994-8#1)(1996-5#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)
reconstitution of##49##2##(1990-5#1)(1990-8#1)(1991-11#1)(1991-4#2)(1991-5#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-8#3)(1996-10#2)(1996-5#2)(1996-9#2)(1997-4#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#2)(2012-2#1)(2013-7#1)
reconstitution process##2##2##(1990-8#1)(1992-6#1)
reconstitution reaction##2##2##(1991-7#2)
reconstitution system##3##2##(1990-7#1)(1991-5#1)(2008-4#1)
reconstitution to##2##2##(1994-2#1)(2012-2#1)
reconstitution was##4##2##(1992-6#1)(1994-12#1)(1994-3#1)(2010-12#1)
reconstitution with##6##2##(1991-5#1)(1993-3#1)(1994-2#1)(1994-3#1)(2008-4#2)
reconstitution##135##1##(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#3)(1991-11#1)(1991-2#1)(1991-4#4)(1991-5#5)(1991-7#2)(1991-9#1)(1992-1#3)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#8)(1992-8#2)(1992-9#2)(1993-2#1)(1993-3#2)(1993-6#1)(1994-12#3)(1994-2#3)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#7)(1996-10#2)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#4)(1997-2#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-12#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-9#1)(2012-10#1)(2012-12#1)(2012-2#7)(2013-1#1)(2013-7#1)
reconstruct a##8##2##(2006-11#1)(2007-4#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-6#1)(2011-1#1)
reconstruct evolutionary##2##2##(2007-12#1)(2008-4#1)
reconstruct the defect##2##3##(2008-4#1)(2011-12#1)
reconstruct the wave front##2##4##(2008-3#2)
reconstruct the##44##2##(2006-3#1)(2007-11#1)(2007-12#12)(2007-8#2)(2008-1#1)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-11#1)(2010-6#1)(2011-12#1)(2012-12#1)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
reconstruct##103##1##(1992-1#1)(1994-6#1)(1995-5#1)(1997-6#1)(2006-11#1)(2006-3#1)(2007-11#6)(2007-12#18)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-12#1)(2008-2#7)(2008-3#15)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#2)(2009-5#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-6#4)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#6)(2013-1#3)(2013-7#1)(2013-8#1)
reconstructed a##2##2##(2006-10#1)(2007-11#1)
reconstructed absorption##2##2##(2006-12#1)(2008-3#1)
reconstructed and##4##2##(2007-11#2)(2008-2#1)(2008-3#1)
reconstructed at any##2##3##(2008-10#1)(2008-2#1)
reconstructed at##3##2##(2008-10#1)(2008-2#2)
reconstructed blastocyst##2##2##(2008-9#2)
reconstructed breast##2##2##(2013-1#2)
reconstructed by an##3##3##(2007-12#1)(2007-8#1)(2008-2#1)
reconstructed by means of##3##4##(2008-2#1)(2008-3#2)
reconstructed by optical##2##3##(2007-12#2)
reconstructed by the##2##3##(2007-12#1)(2008-3#1)
reconstructed by using##3##3##(2007-12#1)(2009-3#1)(2011-2#1)
reconstructed by##27##2##(1992-3#1)(2007-11#2)(2007-12#8)(2007-8#2)(2008-2#2)(2008-3#8)(2008-9#1)(2009-3#1)(2009-9#1)(2011-2#1)
reconstructed data##2##2##(2008-11#1)(2008-3#1)
reconstructed embryos were##3##3##(2008-9#2)(2012-2#1)
reconstructed embryos##6##2##(2008-9#2)(2012-2#4)
reconstructed epidermis##9##2##(2008-5#9)
reconstructed from computer-generated holograms##2##4##(2008-3#2)
reconstructed from the##2##3##(2008-3#2)
reconstructed from##24##2##(1994-9#1)(1997-3#1)(2006-12#1)(2007-8#1)(2008-2#6)(2008-3#11)(2008-7#2)(2008-9#1)
reconstructed human epidermis##3##3##(2008-5#3)
reconstructed image fidelity is##2##4##(2008-3#2)
reconstructed image was##2##3##(2008-1#1)(2008-2#1)
reconstructed image##20##2##(2007-11#3)(2007-12#1)(2008-1#1)(2008-2#3)(2008-3#10)(2012-12#2)
reconstructed images is##2##3##(2008-2#2)
reconstructed images##20##2##(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#3)(2008-2#5)(2008-3#6)(2009-10#1)(2010-8#1)(2011-2#1)
reconstructed in##4##2##(1990-5#1)(2008-2#1)(2008-3#2)
reconstructed on##4##2##(1994-12#1)(2008-3#1)(2008-5#1)(2011-1#1)
reconstructed skin model##2##3##(2008-5#2)
reconstructed skin##4##2##(2008-5#4)
reconstructed the##4##2##(1994-4#1)(2007-12#1)(2011-2#1)(2013-1#1)
reconstructed to##2##2##(2010-10#1)(2013-8#1)
reconstructed using a##3##3##(2006-8#1)(2008-7#1)(2009-9#1)
reconstructed using##11##2##(2006-8#2)(2007-4#1)(2008-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-8#1)(2013-1#2)
reconstructed wave##4##2##(2008-2#2)(2008-3#2)
reconstructed with a##7##3##(1996-2#1)(2007-12#1)(2008-3#4)(2011-2#1)
reconstructed with an##3##3##(2007-8#1)(2008-2#1)(2008-3#1)
reconstructed with the##3##3##(2008-2#1)(2008-3#1)(2009-5#1)
reconstructed with##26##2##(1996-2#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-8#1)(2008-2#2)(2008-3#6)(2008-6#1)(2008-7#1)(2009-4#1)(2009-5#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#1)
reconstructed##290##1##(1990-12#2)(1990-5#1)(1990-7#1)(1991-5#1)(1991-7#3)(1992-1#1)(1992-3#2)(1993-12#1)(1993-5#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-4#1)(1994-9#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-8#1)(2005-12#1)(2006-10#1)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-11#14)(2007-12#32)(2007-4#1)(2007-5#2)(2007-8#5)(2008-1#4)(2008-10#3)(2008-11#3)(2008-2#29)(2008-3#65)(2008-4#2)(2008-5#19)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#11)(2009-1#1)(2009-10#3)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-2#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#7)(2012-1#3)(2012-12#3)(2012-2#9)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#1)
reconstructing a##4##2##(1995-6#1)(2008-2#1)(2011-3#1)(2012-12#1)
reconstructing an##2##2##(2008-3#1)(2012-12#1)
reconstructing ancestral##2##2##(2008-8#1)(2010-6#1)
reconstructing large##2##2##(2007-12#1)(2007-7#1)
reconstructing the profiles##2##3##(2008-3#2)
reconstructing the##15##2##(1993-5#1)(1996-5#1)(2006-5#1)(2006-8#1)(2007-12#3)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#1)
reconstructing##60##1##(1993-5#1)(1995-6#2)(1996-3#1)(1996-5#1)(2006-5#2)(2006-8#1)(2007-11#1)(2007-12#6)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#9)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-2#1)(2009-9#1)(2010-10#1)(2010-6#1)(2011-3#1)(2011-7#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
reconstruction across the field##2##4##(2012-12#2)
reconstruction after##17##2##(1991-4#1)(1996-3#1)(2006-10#2)(2006-6#2)(2007-7#2)(2008-2#1)(2008-8#2)(2009-7#1)(2010-6#1)(2011-2#1)(2012-2#2)(2012-8#1)
reconstruction algorithm for##3##3##(2007-12#1)(2008-2#1)(2011-1#1)
reconstruction algorithm that##2##3##(2008-2#1)(2011-1#1)
reconstruction algorithm##16##2##(2007-11#2)(2007-12#2)(2008-2#4)(2008-3#5)(2011-1#3)
reconstruction algorithms for##3##3##(2007-12#1)(2008-3#2)
reconstruction algorithms##10##2##(2007-12#2)(2008-2#1)(2008-3#4)(2010-2#1)(2012-1#2)
reconstruction and segmentation of##2##4##(2009-10#1)(2011-7#1)
reconstruction and segmentation##4##3##(2009-10#3)(2011-7#1)
reconstruction and that##2##3##(2008-3#2)
reconstruction and the##3##3##(2007-12#1)(2008-8#1)(2009-10#1)
reconstruction and##39##2##(1996-2#1)(2005-11#1)(2006-11#1)(2006-12#1)(2007-1#2)(2007-12#2)(2008-2#3)(2008-3#3)(2008-6#3)(2008-7#1)(2008-8#2)(2009-10#4)(2009-2#1)(2009-5#1)(2009-9#2)(2010-8#1)(2011-2#2)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
reconstruction are##7##2##(2006-3#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-7#1)(2011-2#2)
reconstruction as a##2##3##(2007-8#1)(2008-11#1)
reconstruction as##3##2##(2007-8#1)(2008-11#1)(2012-12#1)
reconstruction based on##3##3##(2007-12#1)(2008-2#1)(2008-6#1)
reconstruction but##2##2##(2008-9#1)(2013-1#1)
reconstruction by the##2##3##(2005-5#1)(2007-7#1)
reconstruction by##13##2##(2005-5#1)(2006-10#1)(2007-11#3)(2007-7#1)(2007-8#3)(2008-2#2)(2008-3#2)
reconstruction can be##5##3##(2006-8#1)(2007-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
reconstruction can##6##2##(2006-8#1)(2007-11#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
reconstruction combined with##2##3##(2008-6#1)(2013-7#1)
reconstruction during##2##2##(2007-8#1)(2009-7#1)
reconstruction error and##2##3##(2008-3#1)(2009-10#1)
reconstruction error##9##2##(1995-9#1)(2008-3#7)(2009-10#1)
reconstruction errors##4##2##(2007-12#1)(2008-2#2)(2008-7#1)
reconstruction even##3##2##(2008-3#3)
reconstruction experiments##2##2##(1994-8#1)(2008-9#1)
reconstruction filters##2##2##(2008-2#1)(2012-1#1)
reconstruction following##4##2##(1990-9#1)(1992-9#1)(2008-6#1)(2009-9#1)
reconstruction for the##2##3##(2007-12#1)(2010-4#1)
reconstruction for##18##2##(1990-6#1)(1997-6#1)(2006-12#2)(2006-3#1)(2007-12#1)(2008-1#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
reconstruction from electron micrographs##2##4##(1990-12#1)(1990-5#1)
reconstruction from noisy##3##3##(2007-12#2)(2008-3#1)
reconstruction from##18##2##(1990-12#1)(1990-5#1)(1991-12#1)(2007-12#4)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-7#2)(2012-1#1)(2012-3#1)
reconstruction geometry##2##2##(2005-10#2)
reconstruction has become##3##3##(2007-1#1)(2007-12#1)(2011-2#1)
reconstruction has##10##2##(2007-1#1)(2007-12#1)(2008-1#1)(2008-3#2)(2009-5#1)(2009-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
reconstruction have##3##2##(1991-6#1)(2009-5#1)(2013-1#1)
reconstruction image##2##2##(2007-11#1)(2012-1#1)
reconstruction in all##2##3##(2006-8#1)(2011-2#1)
reconstruction in patients##3##3##(2007-12#1)(2008-10#1)(2012-2#1)
reconstruction in the female athlete##2##5##(2006-3#2)
reconstruction in the presence of severe anamorphism##2##7##(2007-11#2)
reconstruction in the##8##3##(2006-3#3)(2007-11#2)(2007-8#1)(2008-6#1)(2011-1#1)
reconstruction in these##2##3##(2008-2#1)(2008-6#1)
reconstruction in turbid media##3##4##(2007-12#2)(2011-1#1)
reconstruction in##40##2##(1990-3#1)(1992-5#1)(1996-3#1)(1997-6#1)(2006-3#3)(2006-4#1)(2006-8#1)(2007-11#4)(2007-12#4)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#3)(2008-9#1)(2011-1#3)(2011-2#3)(2012-2#1)(2013-1#2)
reconstruction is a##2##3##(2008-2#1)(2008-4#1)
reconstruction is necessary##2##3##(2006-10#1)(2011-2#1)
reconstruction is performed##2##3##(2005-12#1)(2010-3#1)
reconstruction is usually##2##3##(1992-5#1)(2012-2#1)
reconstruction is##29##2##(1991-4#2)(1992-5#1)(2004-1#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-7#2)(2008-1#1)(2008-2#3)(2008-3#3)(2008-4#1)(2009-7#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
reconstruction may be##3##3##(2007-12#1)(2008-3#1)(2008-7#1)
reconstruction may##4##2##(2007-12#1)(2008-3#1)(2008-7#1)(2009-7#1)
reconstruction method is##2##3##(2008-2#1)(2008-3#1)
reconstruction method##11##2##(2007-11#1)(2008-2#3)(2008-3#4)(2009-5#1)(2011-1#1)(2013-1#1)
reconstruction methods in##2##3##(2008-2#1)(2011-1#1)
reconstruction methods##11##2##(1997-6#1)(2006-3#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-3#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
reconstruction model##2##2##(2008-2#1)(2013-1#1)
reconstruction of AMPPNP##2##3##(1996-11#2)
reconstruction of a simulated##2##4##(2008-3#2)
reconstruction of a two-dimensional##2##4##(2007-11#1)(2008-3#1)
reconstruction of a##17##3##(2007-11#3)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#5)(2010-9#1)(2012-12#2)
reconstruction of absorption and scattering##3##5##(2007-12#1)(2008-2#1)(2011-1#1)
reconstruction of an##7##3##(1990-3#1)(2006-3#1)(2008-3#3)(2009-8#1)(2010-7#1)
reconstruction of anterior##2##3##(2007-11#1)(2013-1#1)
reconstruction of any##2##3##(2007-7#1)(2008-9#1)
reconstruction of biological##2##3##(2009-4#1)(2012-2#1)
reconstruction of bone defects after##2##5##(2011-2#2)
reconstruction of bone##4##3##(2007-11#2)(2011-2#2)
reconstruction of complex##2##3##(2011-2#1)(2012-2#1)
reconstruction of defects##4##3##(1991-5#1)(2007-11#2)(2007-12#1)
reconstruction of joint##2##3##(2007-11#1)(2007-12#1)
reconstruction of large##2##3##(2007-8#1)(2009-4#1)
reconstruction of lower##3##3##(2009-9#1)(2013-8#2)
reconstruction of the ACL##2##4##(1996-11#1)(2013-1#1)
reconstruction of the anterior cruciate ligament##6##6##(2007-5#1)(2007-7#1)(2007-8#3)(2013-1#1)
reconstruction of the anterior##9##4##(2006-2#1)(2007-5#1)(2007-7#1)(2007-8#4)(2009-3#1)(2013-1#1)
reconstruction of the distal##2##4##(2010-11#1)(2012-2#1)
reconstruction of the femoral##2##4##(2007-7#2)
reconstruction of the knee##2##4##(1996-11#1)(2012-3#1)
reconstruction of the proximal##2##4##(2008-6#1)(2013-8#1)
reconstruction of the underlying##2##4##(2008-3#1)(2010-10#1)
reconstruction of the##98##3##(1990-3#1)(1990-6#1)(1991-5#1)(1992-3#3)(1996-11#2)(1996-3#1)(2005-11#1)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#10)(2007-5#1)(2007-7#3)(2007-8#6)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-3#4)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#4)(2013-8#4)
reconstruction of three-dimensional##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
reconstruction of tissue optical##2##4##(2008-3#1)(2011-1#1)
reconstruction of##249##2##(1990-3#2)(1990-5#1)(1990-6#1)(1991-5#2)(1992-3#3)(1993-6#2)(1993-9#1)(1994-3#1)(1996-11#5)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(2005-11#1)(2005-5#2)(2006-11#1)(2006-2#1)(2006-3#3)(2006-4#3)(2006-5#2)(2006-8#1)(2007-11#16)(2007-12#20)(2007-3#1)(2007-5#2)(2007-7#5)(2007-8#13)(2008-10#4)(2008-11#1)(2008-2#19)(2008-3#27)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#5)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#6)(2009-4#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-6#4)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#11)(2012-1#2)(2012-12#5)(2012-2#6)(2012-3#6)(2013-1#8)(2013-7#1)(2013-8#9)
reconstruction on the##4##3##(2005-10#1)(2008-3#1)(2008-5#1)(2013-1#1)
reconstruction on##8##2##(2005-10#2)(2008-3#2)(2008-5#1)(2009-2#1)(2009-9#1)(2013-1#1)
reconstruction operations##2##2##(1990-8#1)(2008-6#1)
reconstruction or##2##2##(1991-4#1)(2008-2#1)
reconstruction patients##2##2##(2006-3#1)(2007-12#1)
reconstruction people from schistosomiasis endemic areas##2##6##(2012-3#2)
reconstruction problem##6##2##(2006-10#3)(2008-2#1)(2008-3#1)(2009-4#1)
reconstruction problems##3##2##(2008-2#2)(2008-6#1)
reconstruction procedure##4##2##(2008-2#1)(2008-3#2)(2011-1#1)
reconstruction procedures##2##2##(2009-10#1)(2011-2#1)
reconstruction process##5##2##(1995-6#1)(2007-11#2)(2008-3#2)
reconstruction quality of##2##3##(2008-2#1)(2008-3#1)
reconstruction quality##4##2##(2008-2#2)(2008-3#2)
reconstruction results##2##2##(2008-2#2)
reconstruction software##2##2##(2008-3#1)(2009-3#1)
reconstruction surgery##5##2##(2008-12#1)(2008-4#2)(2012-2#1)(2013-1#1)
reconstruction system##2##2##(1995-6#1)(2008-2#1)
reconstruction technique##10##2##(1997-1#1)(2007-12#1)(2008-3#6)(2008-6#1)(2011-2#1)
reconstruction techniques##7##2##(1992-3#1)(1994-9#1)(2007-12#1)(2008-3#1)(2008-8#2)(2009-7#1)
reconstruction that##2##2##(2007-12#1)(2007-8#1)
reconstruction to##9##2##(1995-4#1)(2007-11#1)(2008-2#1)(2008-3#2)(2009-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
reconstruction using a##11##3##(1992-3#1)(1996-3#1)(2006-3#2)(2007-11#1)(2008-2#2)(2008-3#1)(2009-1#1)(2009-3#1)(2013-1#1)
reconstruction using the##6##3##(1990-9#1)(2007-7#2)(2011-2#2)(2013-7#1)
reconstruction using##28##2##(1990-9#1)(1992-3#1)(1996-3#2)(2006-10#1)(2006-3#2)(2006-9#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-12#1)(2008-2#3)(2008-3#1)(2009-1#1)(2009-3#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#2)(2013-7#1)
reconstruction was carried out##2##4##(2006-2#1)(2006-6#1)
reconstruction was found##2##3##(2007-7#1)(2008-11#1)
reconstruction was performed##4##3##(1996-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
reconstruction was##13##2##(1996-11#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-7#1)(2007-8#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
reconstruction wavelength##2##2##(2008-2#2)
reconstruction were identified##2##3##(2013-1#2)
reconstruction were##5##2##(1991-10#1)(1996-8#1)(2007-12#1)(2013-1#2)
reconstruction will##2##2##(1995-6#1)(2008-7#1)
reconstruction with a##14##3##(2007-11#3)(2007-12#2)(2008-2#2)(2008-3#2)(2008-7#2)(2008-9#1)(2009-3#1)(2013-1#1)
reconstruction with an##3##3##(2008-1#1)(2013-1#1)(2013-7#1)
reconstruction with bone-patellar tendon-bone graft##2##5##(2008-6#2)
reconstruction with hamstrings##5##3##(2008-6#1)(2013-1#4)
reconstruction with patellar tendon or hamstring##2##6##(2009-9#2)
reconstruction with the forehead flap##2##5##(2008-8#2)
reconstruction with the##5##3##(2008-8#2)(2008-9#1)(2011-1#1)(2011-2#1)
reconstruction with##59##2##(1993-11#1)(1993-9#1)(1996-3#1)(2006-3#1)(2006-4#1)(2007-11#5)(2007-12#5)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-6#4)(2008-7#3)(2008-8#2)(2008-9#3)(2009-1#2)(2009-12#1)(2009-3#1)(2009-9#2)(2010-12#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#9)(2013-7#1)(2013-8#1)
reconstruction without##3##2##(2006-3#1)(2007-12#1)(2009-4#1)
reconstruction##1104##1##(1990-12#2)(1990-3#4)(1990-5#2)(1990-6#3)(1990-8#1)(1990-9#4)(1991-10#1)(1991-11#1)(1991-12#1)(1991-4#4)(1991-5#2)(1991-6#1)(1991-7#1)(1992-3#5)(1992-5#3)(1992-9#1)(1993-11#2)(1993-12#1)(1993-6#2)(1993-9#2)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-4#1)(1995-6#4)(1995-9#1)(1996-11#8)(1996-2#1)(1996-3#9)(1996-4#1)(1996-5#2)(1996-8#2)(1997-1#2)(1997-6#3)(2004-1#1)(2005-10#7)(2005-11#3)(2005-12#1)(2005-5#3)(2005-8#1)(2006-10#10)(2006-11#5)(2006-12#5)(2006-2#2)(2006-3#19)(2006-4#5)(2006-5#2)(2006-6#5)(2006-8#5)(2006-9#1)(2007-1#3)(2007-11#47)(2007-12#94)(2007-3#1)(2007-5#4)(2007-7#16)(2007-8#34)(2007-9#1)(2008-1#7)(2008-10#16)(2008-11#5)(2008-12#3)(2008-2#91)(2008-3#123)(2008-4#15)(2008-5#8)(2008-6#23)(2008-7#24)(2008-8#21)(2008-9#17)(2009-1#4)(2009-10#12)(2009-11#3)(2009-12#3)(2009-2#6)(2009-3#18)(2009-4#4)(2009-5#5)(2009-6#8)(2009-7#11)(2009-8#7)(2009-9#13)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#7)(2010-7#5)(2010-8#4)(2010-9#1)(2011-1#28)(2011-12#4)(2011-2#54)(2011-3#1)(2011-7#1)(2012-1#15)(2012-12#20)(2012-2#37)(2012-3#19)(2012-8#1)(2013-1#61)(2013-7#10)(2013-8#17)
reconstruction)##2##1##(2007-6#1)(2007-8#1)
reconstruction]##6##1##(1990-5#1)(2008-12#1)(2009-9#2)(2013-1#1)(2013-7#1)
reconstructions and##4##2##(2006-6#1)(2007-12#1)(2011-2#1)(2012-2#1)
reconstructions are##8##2##(2007-11#1)(2007-7#1)(2008-3#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-7#1)
reconstructions based on##2##3##(2010-9#1)(2011-1#1)
reconstructions by##2##2##(1996-11#1)(2013-1#1)
reconstructions can be##2##3##(2008-3#1)(2008-4#1)
reconstructions for##8##2##(2008-10#1)(2008-2#1)(2008-3#4)(2011-1#1)(2013-1#1)
reconstructions from serial##2##3##(1995-7#1)(1995-8#1)
reconstructions from##4##2##(1995-7#1)(1995-8#1)(2008-10#1)(2008-9#1)
reconstructions have##5##2##(2007-11#1)(2008-7#1)(2010-9#1)(2012-1#1)(2012-2#1)
reconstructions in diffraction tomography##2##4##(2008-3#2)
reconstructions in##5##2##(1992-5#1)(2007-11#1)(2008-3#2)(2012-2#1)
reconstructions may be##2##3##(2008-2#1)(2008-4#1)
reconstructions of the##4##3##(2006-10#1)(2007-12#1)(2008-3#1)(2010-9#1)
reconstructions of##18##2##(1996-11#1)(1997-6#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2009-4#1)(2010-5#1)(2010-9#1)
reconstructions showed##2##2##(2009-4#1)(2012-2#1)
reconstructions using##3##2##(1991-6#1)(2012-2#2)
reconstructions with##2##2##(2008-2#1)(2009-9#1)
reconstructions##119##1##(1991-5#1)(1991-6#1)(1992-5#1)(1993-12#1)(1995-7#1)(1995-8#2)(1996-11#5)(1997-6#1)(2006-10#1)(2006-5#1)(2006-6#2)(2006-7#1)(2007-11#3)(2007-12#5)(2007-5#1)(2007-7#5)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#12)(2008-3#12)(2008-4#8)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#4)(2009-4#2)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-9#3)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#9)(2012-7#1)(2013-1#6)(2013-7#1)
reconstructive challenge##3##2##(2010-9#1)(2012-12#1)(2012-2#1)
reconstructive efforts##2##2##(2007-12#2)
reconstructive hand##2##2##(2008-7#1)(2011-2#1)
reconstructive options for##4##3##(2006-3#1)(2007-12#1)(2008-9#1)(2011-2#1)
reconstructive options##8##2##(2006-3#2)(2007-12#1)(2008-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
reconstructive plastic surgery##2##3##(1991-4#1)(1992-2#1)
reconstructive plastic##3##2##(1991-4#1)(1992-2#1)(2012-2#1)
reconstructive procedure##3##2##(1991-4#1)(2008-7#1)(2011-12#1)
reconstructive procedures##5##2##(1990-4#1)(2008-12#1)(2008-6#1)(2008-9#1)(2011-12#1)
reconstructive surgeon##7##2##(2007-12#2)(2008-9#1)(2011-12#1)(2011-2#2)(2012-2#1)
reconstructive surgeons##4##2##(2006-6#1)(2009-3#1)(2011-2#1)(2012-2#1)
reconstructive surgeries##3##2##(2007-12#1)(2013-1#2)
reconstructive surgery in##4##3##(1993-11#1)(2007-11#1)(2008-4#1)(2011-2#1)
reconstructive surgery of the##3##4##(1992-9#1)(1996-8#1)(2006-10#1)
reconstructive surgery of##5##3##(1992-9#1)(1996-8#1)(2006-10#1)(2007-11#1)(2011-2#1)
reconstructive surgery using##3##3##(2007-11#1)(2013-1#2)
reconstructive surgery##37##2##(1990-9#1)(1991-6#1)(1992-5#1)(1992-9#1)(1993-11#1)(1996-6#1)(1996-8#1)(1997-6#1)(2006-10#1)(2007-11#5)(2007-4#1)(2007-7#1)(2008-11#3)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-5#1)(2011-2#3)(2012-2#1)(2013-1#7)
reconstructive surgical##4##2##(1992-5#1)(2007-12#1)(2007-7#1)(2011-2#1)
reconstructive technique##2##2##(2010-12#1)(2013-1#1)
reconstructive techniques##5##2##(1994-12#1)(2007-12#2)(2010-3#1)(2013-8#1)
reconstructive treatment##3##2##(1992-1#1)(1992-3#1)(2011-2#1)
reconstructive##126##1##(1990-3#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-4#2)(1991-6#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-9#2)(1993-11#1)(1993-3#1)(1994-12#1)(1994-2#1)(1996-6#1)(1996-8#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-3#2)(2006-6#1)(2006-8#1)(2007-11#7)(2007-12#17)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-4#2)(2008-6#3)(2008-7#3)(2008-9#5)(2009-2#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-6#2)(2010-9#1)(2011-1#1)(2011-12#3)(2011-2#16)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#11)(2013-8#3)
reconstructor##3##1##(2008-2#1)(2010-5#2)
reconstructs the##8##2##(1993-3#1)(2007-12#2)(2008-2#1)(2008-3#2)(2008-9#1)(2013-7#1)
reconstructs##14##1##(1993-3#1)(2007-11#1)(2007-12#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-9#1)(2013-7#1)
recontamination with##2##2##(2008-9#1)(2013-1#1)
recontamination##6##1##(1991-11#1)(2008-9#1)(2013-1#2)(2013-8#2)
recontouring of the##2##3##(2008-6#1)(2010-8#1)
recontouring##3##1##(2007-8#1)(2008-6#1)(2010-8#1)
reconvalescence##3##1##(1996-2#1)(1997-6#1)(2007-11#1)
reconversion##2##1##(1991-6#1)(2008-10#1)
record (EMR)##4##2##(2009-12#1)(2011-2#1)(2013-1#2)
record a##3##2##(1994-2#1)(2008-11#1)(2008-3#1)
record and##9##2##(1994-3#1)(2006-6#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#1)(2012-3#1)(2013-7#1)
record as##2##2##(2008-4#1)(2012-2#1)
record data##3##2##(2011-2#1)(2012-2#1)(2012-3#1)
record documentation##3##2##(2006-8#2)(2010-8#1)
record for the##3##3##(1992-3#1)(2008-5#1)(2008-6#1)
record for##6##2##(1992-3#1)(2007-12#1)(2008-5#1)(2008-6#1)(2011-1#1)(2012-12#1)
record high##2##2##(2007-12#2)
record in##5##2##(1994-6#1)(2008-10#2)(2008-2#1)(2010-8#1)
record is##9##2##(1992-2#1)(1997-5#4)(2008-1#1)(2008-5#1)(2013-1#2)
record keeping is##2##3##(1994-3#1)(2011-2#1)
record keeping##9##2##(1992-12#1)(1994-3#1)(1995-1#1)(2007-12#1)(2008-12#1)(2008-6#1)(2010-1#1)(2011-2#1)(2012-1#1)
record linkage to##2##3##(1997-8#1)(2008-8#1)
record linkage##6##2##(1990-9#1)(1993-9#1)(1996-7#1)(1997-8#1)(2008-8#1)(2011-2#1)
record low##2##2##(2007-12#1)(2013-8#1)
record of a##2##3##(1995-3#1)(2008-10#1)
record of the##7##3##(1991-6#1)(2005-9#1)(2007-7#1)(2008-4#1)(2008-5#1)(2010-8#1)(2012-12#1)
record of##41##2##(1990-8#1)(1990-9#1)(1991-6#2)(1992-12#1)(1995-3#1)(1997-3#1)(1997-4#1)(1997-5#1)(2005-9#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-3#2)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-3#1)(2010-2#1)(2010-5#1)(2010-8#3)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#2)
record on##3##2##(2008-11#1)(2013-1#2)
record review of all##2##4##(1997-8#1)(2009-7#1)
record review##7##2##(1997-8#1)(2006-10#1)(2006-11#1)(2007-10#1)(2008-6#1)(2009-7#1)(2012-2#1)
record system for##2##3##(1991-3#1)(1995-4#1)
record system##13##2##(1991-3#2)(1995-4#1)(2008-8#4)(2009-10#1)(2012-3#1)(2013-1#4)
record systems is##3##3##(2013-1#3)
record systems##11##2##(1991-1#1)(1993-12#1)(2010-4#1)(2011-2#1)(2013-1#7)
record temperature##2##2##(2008-10#1)(2012-12#1)
record that##2##2##(1993-12#1)(1995-12#1)
record the##33##2##(1994-2#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-6#1)(2010-8#1)(2011-3#1)(2012-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
record their##3##2##(2007-2#1)(2007-6#1)(2008-12#1)
record to##3##2##(1990-12#1)(2008-3#1)(2011-2#1)
record was reviewed##2##3##(2007-10#2)
record was##9##2##(2004-12#1)(2007-10#2)(2008-11#1)(2008-4#1)(2010-6#1)(2013-1#3)
record were##2##2##(2007-10#1)(2011-1#1)
record##412##1##(1990-12#2)(1990-2#1)(1990-8#1)(1990-9#3)(1991-1#1)(1991-3#4)(1991-6#5)(1991-9#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-12#4)(1993-2#1)(1993-5#3)(1993-9#4)(1994-12#1)(1994-2#3)(1994-3#4)(1994-6#3)(1995-1#1)(1995-10#1)(1995-12#2)(1995-3#1)(1995-4#1)(1996-12#1)(1996-2#3)(1996-3#5)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#9)(1997-8#2)(2004-11#1)(2004-12#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-6#4)(2006-7#2)(2006-8#8)(2007-1#1)(2007-10#5)(2007-11#5)(2007-12#24)(2007-2#3)(2007-3#4)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#4)(2008-1#4)(2008-10#8)(2008-11#9)(2008-12#3)(2008-2#9)(2008-3#19)(2008-4#9)(2008-5#14)(2008-6#5)(2008-7#4)(2008-8#10)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#3)(2010-8#12)(2011-1#8)(2011-2#11)(2011-3#1)(2011-9#1)(2012-1#2)(2012-11#4)(2012-12#6)(2012-2#3)(2012-3#6)(2013-1#67)(2013-7#5)(2013-8#4)
record-keeping systems##2##2##(1994-3#1)(2012-11#1)
record-keeping##9##1##(1992-12#2)(1993-6#1)(1994-12#1)(1994-3#1)(1995-1#1)(1997-8#1)(2009-7#1)(2012-11#1)
recordable compact##5##2##(2008-10#2)(2008-2#1)(2008-3#2)
recordable##18##1##(1991-1#1)(1993-8#1)(1995-6#1)(1997-3#1)(2006-12#1)(2006-6#2)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#4)(2008-9#1)
recorded a##10##2##(1991-6#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-8#2)(2013-1#2)(2013-7#1)
recorded across the##2##3##(2006-5#1)(2007-8#1)
recorded activity##3##2##(1993-9#1)(1997-7#1)(2012-2#1)
recorded after the##4##3##(1993-9#1)(1997-8#1)(2007-11#1)(2008-10#1)
recorded after##8##2##(1990-10#1)(1993-9#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
recorded along the##2##3##(2007-11#1)(2011-2#1)
recorded among the##2##3##(2008-10#1)(2009-7#1)
recorded among##6##2##(1990-3#1)(2006-1#1)(2006-2#1)(2008-10#2)(2009-7#1)
recorded an##2##2##(1990-9#1)(2012-2#1)
recorded and analysed using##2##4##(2008-11#1)(2008-12#1)
recorded and analysed##6##3##(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-6#1)(2010-3#1)
recorded and analyzed##7##3##(1990-10#1)(1990-7#1)(2007-10#1)(2008-3#1)(2008-6#1)(2009-11#1)(2012-1#1)
recorded and compared with##3##4##(1990-3#1)(2008-12#1)(2008-2#1)
recorded and discussed##2##3##(2008-10#1)(2011-1#1)
recorded and displayed##2##3##(1992-10#1)(2006-6#1)
recorded and examined##2##3##(2007-4#1)(2008-10#1)
recorded and reconstructed##3##3##(2007-12#2)(2008-1#1)
recorded and retrieved##2##3##(2007-12#2)
recorded and the##5##3##(1993-5#1)(1996-3#1)(2004-9#1)(2008-8#1)(2013-8#1)
recorded and then transcribed##2##4##(2007-10#1)(2013-1#1)
recorded and used to##2##4##(1997-8#1)(2007-11#1)
recorded and##58##2##(1990-10#1)(1990-3#1)(1990-7#1)(1992-10#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-3#1)(1996-12#1)(1996-3#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-10#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#6)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-1#1)(2013-1#3)(2013-7#1)(2013-8#1)
recorded as a##6##3##(1995-10#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)
recorded as an##4##3##(2006-12#1)(2007-12#1)(2008-6#1)(2013-8#1)
recorded as new species from Costa Rica and most of them are endemic to particular regions##2##16##(2007-3#2)
recorded as the##2##3##(2008-3#1)(2010-2#1)
recorded as##28##2##(1990-6#1)(1994-2#1)(1995-10#1)(1996-2#1)(2006-12#1)(2007-11#3)(2007-12#2)(2007-3#2)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-2#2)(2013-8#1)
recorded at a##5##3##(2007-12#1)(2008-4#1)(2008-8#1)(2009-4#1)(2013-8#1)
recorded at different##4##3##(2008-10#1)(2008-3#3)
recorded at the##10##3##(1994-2#1)(1997-5#1)(2005-8#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2013-7#2)
recorded at##62##2##(1990-7#1)(1994-2#1)(1994-8#1)(1996-7#1)(1997-5#1)(2004-11#1)(2005-11#1)(2005-8#1)(2006-12#1)(2007-12#2)(2007-5#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#12)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#5)(2009-4#2)(2009-5#1)(2009-6#2)(2009-9#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-7#2)(2013-8#1)
recorded before and after##6##4##(1995-11#1)(1995-7#1)(2007-2#1)(2008-3#1)(2008-5#1)(2012-12#1)
recorded before and##8##3##(1993-1#1)(1995-11#1)(1995-7#1)(2007-2#2)(2008-3#1)(2008-5#1)(2012-12#1)
recorded before##14##2##(1990-6#1)(1992-12#1)(1993-1#1)(1995-11#1)(1995-12#1)(1995-7#1)(2006-12#1)(2007-2#3)(2008-3#1)(2008-5#1)(2012-12#1)(2013-8#1)
recorded between##10##2##(1995-12#1)(2007-5#1)(2008-10#4)(2008-12#2)(2010-8#1)(2013-8#1)
recorded both from##2##3##(1991-5#1)(1997-4#1)
recorded both##3##2##(1991-5#1)(1997-4#1)(2008-9#1)
recorded by a digital##2##4##(2007-1#1)(2009-8#1)
recorded by a##11##3##(1990-9#1)(1993-9#1)(1996-8#1)(2007-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)
recorded by an image sensor##2##5##(2008-3#2)
recorded by an##4##3##(1993-7#1)(2008-1#1)(2008-3#2)
recorded by conventional##2##3##(1994-2#1)(2004-11#1)
recorded by the##9##3##(1995-2#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)
recorded by use of a##10##5##(1996-5#1)(2007-12#4)(2008-2#4)(2008-3#1)
recorded by use of##12##4##(1996-5#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#4)(2008-3#1)
recorded by using a##2##4##(2007-11#1)(2008-7#1)
recorded by##68##2##(1990-9#1)(1993-7#1)(1993-9#1)(1994-2#1)(1995-2#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-5#1)(2004-11#1)(2005-1#1)(2007-1#2)(2007-11#3)(2007-12#8)(2007-7#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#9)(2008-3#9)(2008-5#3)(2008-7#3)(2008-8#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)
recorded case of##2##3##(2007-2#1)(2011-2#1)
recorded cells##3##2##(1993-12#1)(1995-11#1)(1996-1#1)
recorded continuously##4##2##(1991-10#1)(1995-12#1)(2007-9#1)(2008-7#1)
recorded daily##2##2##(1997-3#1)(2008-5#1)
recorded data##4##2##(1993-3#1)(2007-12#1)(2008-2#1)(2008-3#1)
recorded directly##2##2##(2008-2#2)
recorded during a##2##3##(2008-11#1)(2011-12#1)
recorded during five##2##3##(1993-2#1)(2008-3#1)
recorded during the##7##3##(1990-10#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-2#1)(2013-8#1)
recorded during##37##2##(1990-10#1)(1991-4#1)(1992-1#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-6#2)(1994-6#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-1#1)(2006-5#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2010-5#1)(2010-8#1)(2011-12#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
recorded electrophysiologically##2##2##(1995-11#1)(1996-1#1)
recorded every##6##2##(1993-6#1)(2008-12#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-7#1)
recorded extracellularly##3##2##(1994-10#1)(1995-3#1)(2008-6#1)
recorded for a##3##3##(1994-8#1)(2007-10#1)(2008-10#1)
recorded for all##2##3##(2009-8#1)(2009-9#1)
recorded for each##5##3##(1993-5#1)(1993-9#1)(1997-4#1)(2007-2#1)(2008-3#1)
recorded for the first time from##2##6##(2007-3#1)(2013-1#1)
recorded for the first time##7##5##(2006-4#1)(2007-3#1)(2007-7#1)(2012-12#1)(2013-1#3)
recorded for the first##8##4##(1991-5#1)(2006-4#1)(2007-3#1)(2007-7#1)(2012-12#1)(2013-1#3)
recorded for the wild-type##2##4##(2008-10#2)
recorded for the##14##3##(1991-5#2)(2006-4#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#2)(2010-12#1)(2012-12#1)(2013-1#3)(2013-8#1)
recorded for##50##2##(1991-5#2)(1991-9#1)(1993-11#1)(1993-5#1)(1993-9#1)(1994-7#1)(1994-8#1)(1996-7#1)(1997-4#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#8)(2008-11#1)(2008-3#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#3)
recorded from a##4##3##(1997-5#1)(2007-12#1)(2008-3#1)(2009-5#1)
recorded from an##2##3##(1992-7#1)(2008-3#1)
recorded from several##2##3##(1992-8#1)(2013-8#1)
recorded from single##3##3##(1996-12#1)(1997-8#1)(2008-7#1)
recorded from the central##2##4##(1995-11#1)(1996-1#1)
recorded from the gastrocnemius muscle##2##5##(1991-3#1)(1992-8#1)
recorded from the same##3##4##(1994-10#1)(1997-3#1)(2009-4#1)
recorded from the##33##3##(1990-4#2)(1990-7#1)(1991-11#1)(1991-3#3)(1991-9#1)(1992-8#2)(1992-9#2)(1993-12#1)(1993-2#1)(1994-10#1)(1994-5#1)(1995-11#2)(1995-12#1)(1996-1#1)(1996-6#1)(1996-9#1)(1997-3#1)(2006-12#1)(2007-11#1)(2007-3#1)(2009-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-7#1)(2013-7#1)
recorded from##87##2##(1990-2#1)(1990-4#2)(1990-7#1)(1991-11#3)(1991-3#4)(1991-9#1)(1992-3#1)(1992-7#1)(1992-8#4)(1992-9#2)(1993-12#1)(1993-2#2)(1993-7#1)(1994-10#1)(1994-3#1)(1994-5#2)(1995-11#4)(1995-12#2)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-5#3)(1996-6#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-12#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#4)(2008-5#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-7#1)(2013-1#3)(2013-7#1)(2013-8#2)
recorded here for the first time##2##6##(2007-5#1)(2010-8#1)
recorded here##3##2##(1992-10#1)(2007-5#1)(2010-8#1)
recorded higher##2##2##(2008-5#1)(2011-1#1)
recorded holograms are##2##3##(2007-12#1)(2008-1#1)
recorded holograms##5##2##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)
recorded images of##2##3##(2008-3#1)(2008-9#1)
recorded images##3##2##(2007-11#1)(2008-3#1)(2008-9#1)
recorded in 10##2##3##(1993-7#1)(2007-4#1)
recorded in 11 patients##2##4##(2006-6#2)
recorded in 11##4##3##(1994-8#1)(2006-6#2)(2007-7#1)
recorded in 12##2##3##(1992-7#1)(1993-12#1)
recorded in 2##2##3##(1992-1#1)(2008-10#1)
recorded in 7##2##3##(1993-2#1)(2013-8#1)
recorded in a photorefractive##3##4##(2008-2#3)
recorded in a##17##3##(1993-6#1)(1994-6#1)(1995-6#1)(1996-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#4)(2008-3#2)(2008-9#1)(2011-2#1)
recorded in all##9##3##(1991-11#1)(2006-12#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-12#1)(2013-1#1)
recorded in an##4##3##(2007-12#1)(2008-10#1)(2010-8#1)(2013-8#1)
recorded in both groups##4##4##(2006-5#1)(2010-4#1)(2013-7#2)
recorded in both##6##3##(2006-5#1)(2007-12#1)(2010-4#1)(2011-2#1)(2013-7#2)
recorded in different##3##3##(1992-6#1)(1995-12#1)(2008-2#1)
recorded in liver##3##3##(1991-2#1)(2009-6#1)(2010-10#1)
recorded in one##2##3##(2007-12#1)(2007-3#1)
recorded in patients with##2##4##(1994-10#1)(2010-7#1)
recorded in plants with##2##4##(1994-6#2)
recorded in the course of##2##5##(2008-10#1)(2011-12#1)
recorded in the medical##2##4##(1991-7#1)(2007-10#1)
recorded in the primary##2##4##(1993-2#1)(2008-3#1)
recorded in the##62##3##(1990-10#1)(1990-3#1)(1990-7#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-7#2)(1991-8#1)(1992-10#1)(1993-12#1)(1993-2#2)(1994-12#2)(1994-8#1)(1995-11#1)(1995-12#1)(1997-8#1)(2006-11#1)(2006-2#1)(2007-10#1)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#3)(2008-9#1)(2009-4#2)(2009-8#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
recorded in their##3##3##(1994-6#1)(2013-1#2)
recorded in these##2##3##(2008-1#1)(2008-3#1)
recorded in this##2##3##(1992-7#1)(2007-9#1)
recorded in three##4##3##(1990-8#1)(1991-12#1)(1996-12#1)(2010-4#1)
recorded in veins##2##3##(1995-12#2)
recorded in vitro##2##3##(1990-7#1)(1993-2#1)
recorded in##269##2##(1990-10#2)(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#4)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#5)(1991-4#1)(1991-5#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-1#3)(1992-10#1)(1992-2#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-12#4)(1993-2#5)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-12#4)(1994-6#4)(1994-8#2)(1995-11#2)(1995-12#5)(1995-6#1)(1996-1#3)(1996-12#1)(1997-6#1)(1997-8#6)(2004-10#2)(2005-1#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#6)(2006-8#3)(2006-9#1)(2007-10#3)(2007-11#2)(2007-12#8)(2007-3#4)(2007-4#1)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#6)(2008-10#21)(2008-11#3)(2008-12#4)(2008-2#13)(2008-3#14)(2008-4#5)(2008-5#7)(2008-7#3)(2008-9#2)(2009-12#1)(2009-4#2)(2009-6#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#2)(2011-12#2)(2011-2#12)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#6)(2013-7#3)(2013-8#6)
recorded marginal increases that were not significant##2##7##(2008-4#2)
recorded marks##2##2##(2008-3#2)
recorded mean##3##2##(1990-8#1)(1993-5#1)(2007-2#1)
recorded neurons##2##2##(1991-3#1)(1997-5#1)
recorded of##2##2##(2006-6#1)(2008-3#1)
recorded on a##14##3##(1996-7#1)(2006-5#1)(2007-12#1)(2008-2#5)(2008-3#4)(2008-5#1)(2008-7#1)
recorded on an##6##3##(1995-6#1)(1996-7#1)(2007-6#1)(2008-2#1)(2008-3#1)(2008-5#1)
recorded on each##2##3##(2008-2#1)(2008-7#1)
recorded on the##4##3##(2006-4#1)(2007-2#1)(2008-1#1)(2008-3#1)
recorded on##44##2##(1991-3#1)(1992-7#1)(1994-3#1)(1995-6#1)(1996-7#2)(2006-4#1)(2006-5#2)(2007-11#1)(2007-12#2)(2007-2#2)(2007-6#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#8)(2008-3#7)(2008-5#2)(2008-7#2)(2011-12#1)(2012-12#2)
recorded only##3##2##(1994-8#1)(2012-3#1)(2013-8#1)
recorded output##2##2##(2007-12#2)
recorded outside the##2##3##(2008-10#1)(2008-8#1)
recorded over a##3##3##(2007-11#1)(2008-3#2)
recorded over##8##2##(1993-9#2)(1994-3#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-7#1)
recorded responses##2##2##(1993-2#1)(2007-12#1)
recorded sensory##2##2##(1993-12#2)
recorded signal##3##2##(1997-6#1)(2008-10#1)(2008-2#1)
recorded signals##3##2##(2008-2#1)(2008-3#1)(2011-1#1)
recorded simultaneously from##2##3##(1991-3#1)(2008-3#1)
recorded simultaneously on##2##3##(2008-3#1)(2008-4#1)
recorded simultaneously with##3##3##(1992-8#1)(1995-11#1)(2005-11#1)
recorded simultaneously##10##2##(1991-3#1)(1992-8#1)(1995-11#1)(1997-5#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-3#2)(2008-4#1)
recorded species##2##2##(2012-12#2)
recorded the highest##2##3##(2007-2#2)
recorded the lowest##3##3##(2008-4#1)(2008-5#1)(2011-12#1)
recorded the##20##2##(1997-3#1)(2007-11#1)(2007-2#2)(2007-4#1)(2007-7#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-9#1)(2011-12#1)(2012-1#1)(2012-3#1)
recorded their##4##2##(2006-10#1)(2006-12#1)(2007-10#1)(2008-11#1)
recorded through the##2##3##(2007-12#1)(2008-3#1)
recorded through##5##2##(2007-12#1)(2008-3#1)(2008-6#1)(2010-8#1)(2013-1#1)
recorded to##7##2##(1997-3#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-3#2)(2008-7#1)
recorded under##3##2##(1996-6#1)(2011-2#1)(2013-8#1)
recorded up to##2##3##(2010-5#1)(2013-1#1)
recorded using the##4##3##(1991-1#1)(2005-10#1)(2008-10#1)(2008-11#1)
recorded using##21##2##(1990-10#1)(1991-1#1)(1992-6#1)(1994-2#1)(2004-11#1)(2005-10#1)(2006-11#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-7#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
recorded via##2##2##(1993-1#1)(2008-10#1)
recorded was##6##2##(1992-4#1)(1994-4#1)(1995-6#1)(2008-11#1)(2008-3#1)(2008-8#1)
recorded weekly##3##2##(1995-3#1)(2008-10#2)
recorded were##2##2##(2007-1#1)(2008-5#1)
recorded when##4##2##(1995-12#1)(2008-11#1)(2008-12#1)(2008-3#1)
recorded while the##2##3##(2008-2#1)(2013-1#1)
recorded while##5##2##(1994-3#1)(1996-1#1)(2006-3#1)(2008-2#1)(2013-1#1)
recorded with a CCD camera##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
recorded with a CCD##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
recorded with a spectrograph and##2##5##(2007-12#1)(2008-10#1)
recorded with a##28##3##(1991-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1997-1#1)(2006-4#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#8)(2008-3#7)(2008-4#1)
recorded with an##6##3##(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2011-2#1)
recorded with electrodes##2##3##(1992-1#1)(2009-3#1)
recorded with the goal of equal hologram##2##7##(2008-2#2)
recorded with the##7##3##(1995-7#1)(1996-12#1)(2007-10#2)(2008-2#2)(2008-8#1)
recorded with two##2##3##(2008-3#1)(2008-9#1)
recorded with##65##2##(1991-3#1)(1992-1#1)(1993-9#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#1)(1997-1#1)(1997-8#1)(2005-8#1)(2006-4#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#8)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#12)(2008-3#13)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
recorded within##3##2##(1990-8#1)(1997-2#1)(2008-3#1)
recorded##1453##1##(1990-10#10)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#6)(1990-4#5)(1990-5#3)(1990-6#3)(1990-7#7)(1990-8#6)(1990-9#3)(1991-1#1)(1991-10#2)(1991-11#5)(1991-12#3)(1991-2#2)(1991-3#16)(1991-4#3)(1991-5#5)(1991-6#2)(1991-7#3)(1991-8#1)(1991-9#5)(1992-1#11)(1992-10#5)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#3)(1992-5#1)(1992-6#2)(1992-7#6)(1992-8#9)(1992-9#5)(1993-1#2)(1993-11#2)(1993-12#13)(1993-2#10)(1993-3#2)(1993-5#4)(1993-6#4)(1993-7#4)(1993-9#8)(1994-10#4)(1994-12#6)(1994-2#7)(1994-3#5)(1994-4#1)(1994-5#3)(1994-6#6)(1994-7#1)(1994-8#7)(1994-9#1)(1995-10#1)(1995-11#12)(1995-12#13)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#6)(1995-7#2)(1995-8#2)(1995-9#1)(1996-1#8)(1996-10#1)(1996-12#10)(1996-2#3)(1996-3#3)(1996-5#6)(1996-6#5)(1996-7#4)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#7)(1997-4#2)(1997-5#6)(1997-6#4)(1997-7#4)(1997-8#10)(2004-10#4)(2004-11#3)(2004-2#1)(2004-9#1)(2005-1#2)(2005-10#5)(2005-11#5)(2005-12#1)(2005-5#2)(2005-7#1)(2005-8#3)(2006-1#3)(2006-10#10)(2006-11#6)(2006-12#12)(2006-2#5)(2006-3#1)(2006-4#4)(2006-5#7)(2006-6#12)(2006-8#6)(2006-9#3)(2007-1#6)(2007-10#12)(2007-11#25)(2007-12#61)(2007-2#14)(2007-3#18)(2007-4#4)(2007-5#14)(2007-6#4)(2007-7#20)(2007-8#21)(2007-9#7)(2008-1#23)(2008-10#112)(2008-11#21)(2008-12#25)(2008-2#62)(2008-3#107)(2008-4#26)(2008-5#52)(2008-6#5)(2008-7#31)(2008-8#15)(2008-9#11)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#7)(2009-5#4)(2009-6#6)(2009-7#3)(2009-8#6)(2009-9#2)(2010-10#3)(2010-11#2)(2010-12#5)(2010-2#4)(2010-3#3)(2010-4#7)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#21)(2010-9#5)(2011-1#16)(2011-12#11)(2011-2#36)(2011-3#1)(2012-1#6)(2012-11#1)(2012-12#17)(2012-2#23)(2012-3#8)(2012-7#1)(2013-1#47)(2013-7#11)(2013-8#27)
recorder##10##1##(1992-1#1)(1995-6#1)(2004-11#1)(2007-2#1)(2008-10#2)(2008-2#1)(2011-1#1)(2012-12#1)(2012-3#1)
recorders##4##1##(2006-9#1)(2007-4#3)
recording a##6##2##(2007-8#1)(2008-2#2)(2008-3#1)(2008-7#2)
recording and numerical##2##3##(2008-3#2)
recording and reading of##2##4##(2007-12#2)
recording and reading##5##3##(2007-12#3)(2008-1#1)(2008-2#1)
recording and readout of##2##4##(2007-12#1)(2008-3#1)
recording and readout##8##3##(2007-12#3)(2008-2#4)(2008-3#1)
recording and reconstruction##5##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
recording and the reconstruction processes##2##5##(2007-12#1)(2008-3#1)
recording and the reconstruction##3##4##(2007-12#2)(2008-3#1)
recording and the##5##3##(2007-12#4)(2008-3#1)
recording and thermal fixing##2##4##(2008-2#1)(2008-3#1)
recording and##46##2##(1993-12#1)(1994-2#1)(1996-12#1)(2007-11#2)(2007-12#16)(2008-1#1)(2008-10#1)(2008-2#10)(2008-3#10)(2009-10#1)(2010-8#1)(2013-7#1)
recording at the##2##3##(2008-11#1)(2008-2#1)
recording at##4##2##(1997-8#1)(2007-12#1)(2008-11#1)(2008-2#1)
recording beams##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
recording by##4##2##(2007-11#1)(2007-12#1)(2008-2#2)
recording can be##2##3##(2008-3#1)(2008-4#1)
recording chamber##3##2##(2008-11#1)(2009-9#1)(2013-1#1)
recording characteristics of##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
recording characteristics##8##2##(2007-12#2)(2008-2#2)(2008-3#4)
recording conditions##2##2##(2008-2#1)(2008-3#1)
recording configuration##3##2##(1995-6#1)(1996-1#1)(2008-8#1)
recording data##2##2##(2007-12#1)(2009-2#1)
recording density##3##2##(2008-2#3)
recording device##4##2##(1991-10#1)(2008-3#2)(2008-5#1)
recording during##2##2##(1990-10#1)(2006-6#1)
recording experiments##2##2##(1990-5#1)(2008-11#1)
recording for##3##2##(2008-7#2)(2011-1#1)
recording from neuronal dendrites##2##4##(2008-4#2)
recording from neurons##2##3##(2007-12#1)(2008-4#1)
recording from single##3##3##(1992-9#1)(2008-11#2)
recording from##9##2##(1992-9#1)(2007-12#3)(2008-11#2)(2008-4#3)
recording geometry##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
recording in DuPont##2##3##(2008-1#2)
recording in LiNbO(3)##3##3##(2007-11#1)(2007-12#2)
recording in a##6##3##(2007-12#3)(2008-2#1)(2008-3#1)(2008-7#1)
recording in the##6##3##(1991-1#1)(1992-3#1)(1994-2#1)(2007-12#1)(2008-2#1)(2011-2#1)
recording in##41##2##(1991-1#2)(1991-6#1)(1992-3#1)(1992-5#1)(1993-12#1)(1994-11#1)(1994-2#1)(1995-4#1)(1996-7#1)(2007-11#2)(2007-12#11)(2008-1#2)(2008-2#8)(2008-3#3)(2008-7#1)(2011-2#3)(2013-1#1)
recording is##4##2##(2007-12#1)(2008-2#2)(2013-1#1)
recording layers##3##2##(2008-2#1)(2008-3#2)
recording material and##2##3##(2008-2#2)
recording material is##2##3##(2007-12#1)(2008-2#1)
recording material##8##2##(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#1)
recording materials##2##2##(2007-12#1)(2008-2#1)
recording media##8##2##(2007-12#1)(2008-2#4)(2008-3#3)
recording medium in##2##3##(2007-12#1)(2008-3#1)
recording medium##14##2##(2007-11#1)(2007-12#7)(2008-3#5)(2008-4#1)
recording method##8##2##(2007-12#1)(2008-11#1)(2008-3#5)(2013-1#1)
recording methods##3##2##(2007-12#1)(2008-2#1)(2008-4#1)
recording of a##3##3##(2005-11#1)(2007-12#2)
recording of an##4##3##(2007-11#3)(2007-12#1)
recording of brain activity during the performance of a specific behavioral task##2##12##(2008-4#2)
recording of each##2##3##(2007-12#1)(2008-2#1)
recording of holograms##2##3##(2007-12#1)(2008-3#1)
recording of somatosensory##2##3##(2006-10#1)(2010-7#1)
recording of the##20##3##(1994-2#1)(1994-6#1)(1997-2#1)(2005-10#1)(2007-11#4)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#1)(2010-11#1)(2010-4#1)(2013-1#2)
recording of two##3##3##(1997-4#1)(2007-12#1)(2008-3#1)
recording of vaccination rates##2##4##(2008-4#2)
recording of volume holographic memories##2##5##(2008-2#2)
recording of volume##3##3##(2008-2#2)(2008-3#1)
recording of##96##2##(1990-6#1)(1991-8#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#2)(1996-10#1)(1996-4#1)(1996-6#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-11#10)(2007-12#12)(2008-1#3)(2008-10#4)(2008-11#2)(2008-2#8)(2008-3#14)(2008-4#10)(2008-5#2)(2008-7#1)(2009-12#1)(2010-11#2)(2010-4#1)(2010-7#1)(2011-2#1)(2013-1#3)(2013-8#1)
recording parameters##4##2##(2008-2#1)(2008-3#3)
recording period##3##2##(1990-11#1)(1996-1#1)(1997-8#1)
recording procedures##2##2##(1992-7#1)(2008-2#1)
recording process in##2##3##(2008-1#1)(2008-3#1)
recording process##8##2##(2007-12#2)(2008-1#2)(2008-3#4)
recording schedule##5##2##(2007-12#5)
recording scheme in##2##3##(2008-2#1)(2008-3#1)
recording scheme##4##2##(2008-1#1)(2008-2#2)(2008-3#1)
recording sensitivity##4##2##(2007-12#3)(2008-3#1)
recording session##3##2##(1993-12#1)(1995-7#2)
recording sites##6##2##(1990-7#1)(1991-11#2)(1991-3#1)(1994-4#1)(1995-11#1)
recording sources##2##2##(2008-3#2)
recording spatial and spectral data##2##5##(2008-2#1)(2008-3#1)
recording speed##3##2##(2008-2#1)(2008-3#2)
recording system##7##2##(1992-11#1)(1993-3#1)(2007-11#1)(2008-10#1)(2008-3#2)(2010-8#1)
recording systems##4##2##(2008-2#2)(2008-3#1)(2010-12#1)
recording technique##10##2##(1991-8#1)(1996-5#1)(1997-1#2)(1997-5#1)(2007-12#3)(2008-3#2)
recording techniques were used##2##4##(1993-12#1)(1996-2#1)
recording techniques were##3##3##(1993-12#1)(1996-2#1)(1996-7#1)
recording techniques##8##2##(1990-7#1)(1993-12#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-1#1)(2009-10#1)
recording the##31##2##(1993-3#1)(1994-10#1)(1997-5#1)(2005-7#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-12#2)(2007-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#5)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-4#1)(2010-8#1)(2012-2#3)(2013-7#1)(2013-8#1)
recording time##7##2##(1992-8#1)(1993-9#1)(2005-4#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-7#1)
recording two-dimensional##2##2##(1997-7#1)(2007-12#1)
recording was##5##2##(1995-3#1)(1996-1#1)(2006-4#1)(2007-11#1)(2008-5#1)
recording waves##2##2##(2008-2#2)
recording were##2##2##(1991-12#1)(2008-3#1)
recording with a##4##3##(2007-12#2)(2008-3#1)(2008-4#1)
recording with red light##2##4##(2007-12#2)
recording with##17##2##(1990-7#1)(1993-2#1)(1996-12#1)(2007-12#7)(2008-2#2)(2008-3#4)(2008-4#1)
recording##636##1##(1990-10#1)(1990-11#2)(1990-5#2)(1990-6#1)(1990-7#3)(1990-9#1)(1991-1#3)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#1)(1991-3#3)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-7#5)(1992-8#1)(1992-9#1)(1993-12#5)(1993-2#1)(1993-3#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-4#1)(1994-6#1)(1994-8#2)(1995-11#2)(1995-12#8)(1995-3#1)(1995-4#1)(1995-6#1)(1995-7#5)(1995-9#1)(1996-1#3)(1996-10#1)(1996-12#5)(1996-2#1)(1996-4#2)(1996-5#1)(1996-6#2)(1996-7#2)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#3)(2005-10#1)(2005-11#1)(2005-4#2)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#4)(2006-4#3)(2006-5#1)(2006-6#2)(2006-9#1)(2007-1#1)(2007-11#21)(2007-12#115)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#10)(2008-10#21)(2008-11#13)(2008-12#4)(2008-2#83)(2008-3#120)(2008-4#20)(2008-5#10)(2008-7#10)(2008-8#5)(2008-9#3)(2009-10#4)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-4#3)(2010-7#3)(2010-8#6)(2011-1#5)(2011-2#8)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#10)(2013-7#3)(2013-8#3)
recording)##2##1##(2008-1#1)(2008-5#1)
recordings and##10##2##(1994-4#1)(1996-12#2)(1996-5#1)(2007-1#1)(2008-11#1)(2008-4#2)(2011-1#1)(2012-2#1)
recordings are##6##2##(1993-10#1)(1996-12#1)(2008-11#1)(2008-3#1)(2010-8#1)(2011-12#1)
recordings at the##2##3##(2008-11#1)(2010-7#1)
recordings at##5##2##(1995-12#1)(1997-8#1)(2007-11#1)(2008-11#1)(2010-7#1)
recordings carried out##3##3##(1991-2#1)(1991-9#1)(1995-11#1)
recordings during##2##2##(1993-1#1)(2010-8#1)
recordings from the##6##3##(1997-8#1)(2007-12#3)(2008-11#2)
recordings from##24##2##(1990-5#1)(1991-3#1)(1992-3#1)(1992-7#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-7#1)(1996-11#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-12#4)(2008-11#4)(2009-8#1)(2012-1#1)(2013-1#1)
recordings have##3##2##(1997-7#1)(2008-11#1)(2010-8#1)
recordings in the##3##3##(1990-2#1)(1991-9#1)(2007-8#1)
recordings in##10##2##(1990-2#1)(1990-4#1)(1991-5#1)(1991-9#1)(1992-4#1)(1995-11#1)(1995-12#1)(2007-8#1)(2008-1#1)(2008-8#1)
recordings indicate that##2##3##(2008-11#1)(2008-4#1)
recordings obtained from##2##3##(1994-10#1)(1997-3#1)
recordings obtained##3##2##(1994-10#1)(1997-3#1)(2008-1#1)
recordings of the##4##3##(1993-8#1)(1994-10#1)(2006-6#1)(2008-5#1)
recordings of##28##2##(1990-7#1)(1990-8#1)(1991-6#1)(1992-7#1)(1992-8#1)(1993-4#1)(1993-8#1)(1994-10#2)(1994-4#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-5#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2009-9#1)
recordings performed##2##2##(1992-4#1)(1994-3#1)
recordings revealed##4##2##(1993-9#1)(1995-5#1)(1996-3#1)(2008-4#1)
recordings show##2##2##(1995-9#1)(2007-12#1)
recordings showed that##2##3##(1992-3#1)(2008-1#1)
recordings showed##4##2##(1990-8#1)(1992-3#1)(1995-11#1)(2008-1#1)
recordings that##2##2##(2006-4#1)(2008-12#1)
recordings to##2##2##(1992-4#1)(2008-11#1)
recordings under##2##2##(1996-6#1)(2009-2#1)
recordings were made from the##2##5##(1995-12#2)
recordings were made from##14##4##(1991-6#1)(1991-8#2)(1992-1#1)(1992-8#2)(1993-12#1)(1995-12#3)(1995-7#1)(1996-3#1)(2008-8#1)(2008-9#1)
recordings were made##15##3##(1991-6#1)(1991-8#2)(1992-1#1)(1992-8#2)(1993-12#1)(1995-12#3)(1995-7#1)(1996-3#1)(2008-7#1)(2008-8#1)(2008-9#1)
recordings were obtained from##7##4##(1990-7#1)(1991-8#1)(1992-11#1)(1993-4#1)(1995-8#1)(1997-5#2)
recordings were obtained in##3##4##(1992-1#1)(1995-12#1)(1996-1#1)
recordings were obtained##10##3##(1990-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1993-4#1)(1995-12#1)(1995-8#1)(1996-1#1)(1997-5#2)
recordings were performed##2##3##(1995-12#1)(1995-7#1)
recordings were##34##2##(1990-7#1)(1991-6#1)(1991-8#3)(1992-1#2)(1992-11#1)(1992-8#3)(1993-12#1)(1993-4#1)(1995-12#5)(1995-6#1)(1995-7#2)(1995-8#1)(1996-1#1)(1996-3#1)(1996-8#1)(1997-5#2)(2006-4#1)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)
recordings##209##1##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#3)(1990-8#4)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#2)(1991-8#3)(1991-9#2)(1992-1#2)(1992-11#2)(1992-2#1)(1992-3#2)(1992-4#3)(1992-7#3)(1992-8#4)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-4#2)(1993-8#1)(1993-9#1)(1994-10#3)(1994-2#2)(1994-3#2)(1994-4#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#4)(1995-12#8)(1995-5#1)(1995-6#4)(1995-7#3)(1995-8#2)(1995-9#1)(1996-1#5)(1996-11#1)(1996-12#6)(1996-3#2)(1996-5#3)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-7#2)(1997-8#4)(2006-10#1)(2006-3#1)(2006-4#3)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#7)(2007-8#2)(2008-1#3)(2008-10#1)(2008-11#14)(2008-12#1)(2008-2#2)(2008-3#8)(2008-4#10)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-7#1)(2010-8#3)(2011-1#3)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#2)
recordkeeping##4##1##(1992-6#1)(1993-12#2)(2006-2#1)
records a##2##2##(2008-3#1)(2009-10#1)
records analysis##2##2##(1995-12#1)(2012-3#1)
records and National##2##3##(2012-12#1)(2013-8#1)
records and by##2##3##(1995-5#1)(1997-5#1)
records and provide##2##3##(1993-2#1)(2008-7#1)
records and radiographs of##2##4##(2007-7#1)(2008-8#1)
records and radiographs##3##3##(2007-7#1)(2007-8#1)(2008-8#1)
records and radiological##3##3##(1996-6#1)(2006-8#1)(2012-2#1)
records and the##3##3##(1993-1#1)(2006-10#1)(2008-1#1)
records and to##2##3##(2008-5#1)(2010-8#1)
records and##59##2##(1990-4#1)(1990-9#2)(1993-1#1)(1993-2#1)(1994-12#1)(1994-3#2)(1995-3#1)(1995-5#1)(1996-2#2)(1996-6#1)(1997-2#1)(1997-5#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-8#3)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#12)(2013-8#1)
records are##6##2##(1994-12#1)(1996-12#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-2#1)
records as##3##2##(2007-9#1)(2008-6#1)(2012-3#1)
records at##2##2##(1993-3#1)(2006-7#1)
records by##2##2##(1994-3#1)(2007-12#1)
records can be##3##3##(2008-6#1)(2008-7#1)(2010-8#1)
records can provide##2##3##(2007-12#1)(2008-8#1)
records can##6##2##(1997-1#1)(2007-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-8#1)
records collected##2##2##(1996-5#1)(2008-10#1)
records data##4##2##(2006-10#1)(2008-12#1)(2012-3#1)(2013-1#1)
records department##3##2##(1991-1#1)(1993-1#1)(2009-5#1)
records for Guam and##2##4##(2008-10#2)
records for the##16##3##(1990-12#1)(1990-6#1)(2007-3#1)(2007-5#7)(2008-5#4)(2012-2#1)(2012-9#1)
records for this##2##3##(1990-6#1)(2012-2#1)
records for##47##2##(1990-12#1)(1990-6#2)(1992-3#1)(1992-8#1)(1993-12#1)(1994-3#1)(1995-2#1)(1996-12#1)(1996-2#1)(2006-7#1)(2007-10#1)(2007-3#3)(2007-5#9)(2008-10#2)(2008-3#1)(2008-5#4)(2008-6#1)(2010-2#1)(2011-1#3)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2012-9#1)(2013-1#4)
records from the##8##3##(1993-6#1)(2009-4#1)(2009-8#1)(2010-8#1)(2013-1#4)
records from##30##2##(1990-6#1)(1992-1#1)(1992-9#1)(1993-6#1)(1994-3#2)(2005-10#1)(2006-8#1)(2007-2#2)(2007-8#1)(2008-1#1)(2009-3#1)(2009-4#2)(2009-8#1)(2010-2#1)(2010-8#2)(2012-1#1)(2012-12#2)(2013-1#6)(2013-8#2)
records have been##3##3##(2008-7#1)(2013-1#2)
records have##4##2##(2008-7#2)(2013-1#2)
records in the##3##3##(1994-1#1)(2006-10#1)(2011-2#1)
records in##13##2##(1993-1#1)(1993-11#3)(1994-1#1)(1994-6#2)(2006-10#1)(2007-11#1)(2009-6#1)(2011-2#2)(2012-11#1)
records included##2##2##(2008-1#1)(2008-5#1)
records information##2##2##(2010-8#1)(2012-3#1)
records is##4##2##(1991-3#1)(1993-12#1)(1995-1#1)(2007-8#1)
records obtained##2##2##(2005-10#1)(2013-1#1)
records of 19##2##3##(2006-4#1)(2007-2#1)
records of 200##2##3##(2008-1#1)(2009-5#1)
records of a##2##3##(2008-6#1)(2013-8#1)
records of all patients##2##4##(1996-2#1)(2007-8#1)
records of all##4##3##(1994-7#1)(1996-2#1)(2007-3#1)(2007-8#1)
records of consumption##2##3##(2012-2#2)
records of each##2##3##(2007-11#1)(2013-1#1)
records of patients who had##2##5##(1992-3#1)(1993-11#1)
records of patients who##3##4##(1992-3#1)(1993-11#1)(2007-10#1)
records of patients with##7##4##(1996-11#1)(2008-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
records of patients##15##3##(1992-3#1)(1993-11#1)(1996-1#1)(1996-11#1)(1996-12#1)(2007-10#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#4)
records of physicians##2##3##(1990-5#1)(2007-4#1)
records of the##30##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-12#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-2#1)(1997-7#1)(2006-8#1)(2008-1#4)(2008-11#1)(2008-2#1)(2008-3#1)(2010-4#1)(2013-7#1)
records of these patients were reviewed retrospectively##2##7##(2006-10#1)(2007-8#1)
records of these patients were reviewed##3##6##(2006-10#1)(2007-7#1)(2007-8#1)
records of these patients##4##4##(1990-10#1)(2006-10#1)(2007-7#1)(2007-8#1)
records of##174##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#3)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-12#2)(1993-5#1)(1993-6#2)(1993-9#1)(1994-3#1)(1994-6#2)(1994-7#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-7#1)(2004-10#1)(2004-11#1)(2005-6#1)(2005-7#1)(2006-10#6)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-8#4)(2006-9#1)(2007-10#4)(2007-11#1)(2007-2#4)(2007-3#5)(2007-4#1)(2007-6#2)(2007-7#5)(2007-8#3)(2007-9#2)(2008-1#11)(2008-10#3)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-4#2)(2010-9#1)(2011-1#3)(2011-11#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#8)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#4)
records on##2##2##(2006-10#1)(2010-3#1)
records several##2##2##(1994-10#1)(2008-3#1)
records showed##3##2##(1990-12#1)(1994-8#1)(2004-9#1)
records shows##2##2##(2009-3#1)(2010-8#1)
records studied##2##2##(1992-3#1)(2007-3#1)
records that##2##2##(2008-9#1)(2011-2#1)
records the##7##2##(2004-9#1)(2007-11#1)(2007-7#1)(2008-2#2)(2008-3#1)(2011-2#1)
records to identify##3##3##(2008-11#1)(2008-9#1)(2012-12#1)
records to##13##2##(1994-3#2)(1996-11#1)(2007-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
records was##6##2##(2006-10#1)(2008-6#2)(2008-9#1)(2013-1#2)
records were examined##2##3##(1991-2#1)(1993-10#1)
records were missing##2##3##(1992-11#1)(2009-3#1)
records were reviewed for##2##4##(2008-1#1)(2008-9#1)
records were reviewed##8##3##(1993-5#1)(1996-1#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-9#2)
records were used for##2##4##(1990-2#1)(2011-12#1)
records were used##3##3##(1990-2#1)(1996-2#1)(2011-12#1)
records were##28##2##(1990-2#1)(1991-2#1)(1992-11#1)(1993-10#1)(1993-12#1)(1993-5#1)(1996-1#1)(1996-2#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-8#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
records which were##2##3##(2007-7#1)(2011-1#1)
records with a##2##3##(1990-9#2)
records with##5##2##(1990-9#2)(2006-1#1)(2011-2#2)
records##686##1##(1990-10#1)(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#3)(1990-6#4)(1990-8#1)(1990-9#5)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#7)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#4)(1993-10#1)(1993-11#4)(1993-12#10)(1993-2#1)(1993-3#2)(1993-5#2)(1993-6#3)(1993-9#1)(1994-1#2)(1994-10#1)(1994-11#1)(1994-12#6)(1994-3#14)(1994-6#4)(1994-7#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#4)(1996-12#4)(1996-2#8)(1996-3#4)(1996-5#2)(1996-6#4)(1996-9#3)(1997-1#3)(1997-2#5)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2004-1#1)(2004-10#1)(2004-11#1)(2004-9#2)(2005-10#2)(2005-6#1)(2005-7#1)(2005-9#2)(2006-1#1)(2006-10#14)(2006-11#1)(2006-12#3)(2006-2#2)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#11)(2006-9#1)(2007-1#2)(2007-10#10)(2007-11#3)(2007-12#9)(2007-2#8)(2007-3#12)(2007-4#1)(2007-5#13)(2007-6#2)(2007-7#8)(2007-8#10)(2007-9#5)(2008-1#19)(2008-10#13)(2008-11#11)(2008-12#7)(2008-2#7)(2008-3#7)(2008-4#2)(2008-5#13)(2008-6#9)(2008-7#17)(2008-8#12)(2008-9#11)(2009-10#6)(2009-11#1)(2009-3#3)(2009-4#4)(2009-5#3)(2009-6#3)(2009-7#2)(2009-8#4)(2009-9#1)(2010-11#4)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#7)(2010-5#1)(2010-6#1)(2010-8#17)(2010-9#1)(2011-1#9)(2011-11#1)(2011-12#2)(2011-2#20)(2012-1#4)(2012-11#3)(2012-12#15)(2012-2#20)(2012-3#16)(2012-7#1)(2012-9#1)(2013-1#87)(2013-7#1)(2013-8#8)
records)##2##1##(2012-12#1)(2013-7#1)
records?##2##1##(2008-1#1)(2008-9#1)
records?]##2##1##(1993-1#1)(2011-12#1)
records]##4##1##(1994-4#1)(1994-6#1)(1995-9#1)(2007-8#1)
recount the##2##2##(1996-2#1)(2008-6#1)
recount##6##1##(1996-2#1)(2007-9#1)(2008-12#1)(2008-6#2)(2011-2#1)
recounting##2##1##(1992-3#1)(1994-1#1)
recounts the##4##2##(1994-2#1)(2005-11#1)(2007-2#1)(2008-9#1)
recounts##6##1##(1994-2#1)(2005-11#1)(2007-2#1)(2007-9#2)(2008-9#1)
recouplings in##2##2##(2007-11#2)
recourse to nasogastric tube placement##2##5##(1990-8#2)
recourse to the##4##3##(2007-8#1)(2008-3#1)(2009-2#1)(2012-2#1)
recourse to##20##2##(1990-8#2)(1996-8#1)(1997-2#1)(2007-11#3)(2007-7#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
recourse##22##1##(1990-8#2)(1996-8#1)(1997-2#1)(2007-11#3)(2007-7#1)(2007-8#4)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
recover after a##2##3##(2010-12#1)(2013-1#1)
recover after##6##2##(1991-9#1)(1995-8#1)(2008-10#1)(2010-12#1)(2010-2#1)(2013-1#1)
recover and##5##2##(1996-11#1)(2006-8#1)(2008-7#1)(2013-1#2)
recover but##2##2##(2007-12#1)(2012-1#1)
recover damages##3##2##(1993-7#1)(1995-6#1)(1996-11#1)
recover during##2##2##(1991-9#1)(2005-8#1)
recover from the##2##3##(2008-10#1)(2013-8#1)
recover from##16##2##(1991-3#1)(1991-5#1)(2005-10#1)(2006-10#2)(2007-5#2)(2008-1#1)(2008-10#2)(2008-2#2)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
recover the original##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
recover the phase##2##3##(2008-2#1)(2008-3#1)
recover the##35##2##(1991-2#1)(1995-12#1)(1997-4#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-6#1)(2008-10#2)(2008-2#7)(2008-3#4)(2008-4#2)(2008-5#2)(2008-8#3)(2009-5#1)(2010-9#1)(2011-1#1)(2013-1#2)(2013-8#1)
recover with##3##2##(2006-10#1)(2010-11#1)(2010-12#1)
recover##148##1##(1990-10#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-9#2)(1992-12#2)(1993-11#1)(1993-12#1)(1993-5#1)(1993-7#1)(1994-6#1)(1995-12#2)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-11#5)(1997-4#2)(1997-8#2)(2005-10#1)(2005-8#1)(2006-10#5)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#11)(2008-12#1)(2008-2#12)(2008-3#7)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-6#1)(2010-9#1)(2011-1#1)(2012-1#4)(2012-12#1)(2012-2#2)(2013-1#8)(2013-8#5)
recoverable##7##1##(1991-9#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-3#1)(2009-7#1)
recovered about##2##2##(1995-3#1)(2008-10#1)
recovered accurately##3##2##(2008-2#3)
recovered after the treatment##2##4##(2008-8#1)(2008-9#1)
recovered after the##4##3##(2006-10#1)(2008-10#1)(2008-8#1)(2008-9#1)
recovered after##17##2##(1991-2#1)(1995-12#2)(2006-10#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#1)(2013-1#3)(2013-8#1)
recovered and nonrecovered patients##2##4##(1996-7#2)
recovered and reused##2##3##(1996-11#1)(2007-10#1)
recovered and the##3##3##(1990-3#1)(1996-7#1)(1997-8#1)
recovered and##23##2##(1990-10#1)(1990-3#1)(1994-9#1)(1996-11#1)(1996-7#4)(1996-8#1)(1997-8#1)(2005-9#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
recovered apple trees##2##3##(2008-10#2)
recovered as##5##2##(1991-12#1)(2005-11#1)(2006-8#1)(2007-11#1)(2008-5#1)
recovered at##8##2##(1990-7#1)(1991-12#1)(1996-12#1)(2008-10#4)(2013-8#1)
recovered between years##2##3##(2008-10#2)
recovered between##4##2##(2007-9#1)(2008-10#3)
recovered by a##3##3##(2007-11#1)(2008-2#1)(2008-7#1)
recovered by co-treatment with##2##4##(1997-4#1)(2008-4#1)
recovered by measurement##2##3##(2007-12#1)(2008-3#1)
recovered by the##2##3##(1991-12#1)(2005-12#1)
recovered by##32##2##(1991-12#2)(1992-8#1)(1993-12#1)(1993-9#1)(1994-12#1)(1995-8#1)(1996-6#1)(1997-4#1)(2005-12#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
recovered cells were##2##3##(2006-8#1)(2008-10#1)
recovered cells##5##2##(2006-8#3)(2008-10#1)(2008-4#1)
recovered completely after##2##3##(2012-2#1)(2013-1#1)
recovered completely and##2##3##(1993-7#1)(2012-2#1)
recovered completely##13##2##(1993-7#1)(1994-8#1)(1996-6#1)(2006-12#1)(2007-7#4)(2008-1#2)(2012-2#2)(2013-1#1)
recovered fluorescence##2##2##(2008-10#1)(2008-12#1)
recovered following##5##2##(1991-4#1)(1992-4#1)(2008-10#1)(2008-5#1)(2010-5#1)
recovered for##3##2##(1990-4#1)(2006-12#1)(2008-7#1)
recovered four##2##2##(2008-10#1)(2010-4#1)
recovered from PD after the following winter##2##7##(2008-10#2)
recovered from PD##3##3##(2008-10#3)
recovered from a POI##2##4##(2008-10#2)
recovered from a##12##3##(1995-8#1)(2005-7#1)(2008-10#8)(2008-7#1)(2012-3#1)
recovered from all of the##2##5##(2011-2#1)(2012-3#1)
recovered from all##5##3##(1990-12#1)(2008-10#2)(2011-2#1)(2012-3#1)
recovered from digital dermatitis lesions##2##5##(2006-8#2)
recovered from digital##3##3##(2006-8#2)(2008-6#1)
recovered from diseased lettuce and tomato plants##2##7##(2008-10#2)
recovered from diseased##8##3##(2008-10#8)
recovered from individual##2##3##(2008-10#2)
recovered from more than##2##4##(2005-7#1)(2008-10#1)
recovered from noncultivated hosts##4##4##(2008-10#4)
recovered from noncultivated##5##3##(2008-10#5)
recovered from plasma##2##3##(1992-8#1)(2008-10#1)
recovered from soil samples##3##4##(2008-10#3)
recovered from the##46##3##(1990-9#1)(1991-11#1)(1994-9#2)(1996-12#2)(1996-9#1)(1997-7#1)(2005-9#1)(2006-3#1)(2006-5#1)(2007-12#1)(2007-2#1)(2008-10#18)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#3)(2008-7#3)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
recovered from these##4##3##(2008-10#3)(2013-8#1)
recovered from this##2##3##(2006-10#1)(2011-2#1)
recovered from two##3##3##(1992-4#1)(2007-7#1)(2008-10#1)
recovered from##208##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-9#1)(1992-4#2)(1992-7#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-5#1)(1994-9#2)(1995-8#1)(1996-12#3)(1996-4#1)(1996-8#1)(1996-9#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2005-7#3)(2005-8#1)(2005-9#2)(2006-10#1)(2006-3#1)(2006-5#1)(2006-8#6)(2007-11#1)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#96)(2008-11#1)(2008-12#5)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#11)(2008-6#2)(2008-7#5)(2008-8#2)(2009-3#1)(2009-5#1)(2010-12#2)(2010-3#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
recovered full##2##2##(1991-4#1)(2008-9#1)
recovered fully##2##2##(1996-11#1)(2007-7#1)
recovered fungi##2##2##(2008-10#1)(2010-6#1)
recovered in a##4##3##(1990-3#1)(1996-6#1)(2008-10#1)(2008-5#1)
recovered in the first##2##4##(1990-12#1)(2013-1#1)
recovered in the##24##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-3#1)(1991-7#2)(1992-2#1)(1992-9#1)(1993-8#2)(1994-11#1)(1995-7#2)(1995-8#2)(1996-8#1)(1997-4#1)(1997-6#1)(2008-2#1)(2010-3#1)(2013-1#1)(2013-8#1)
recovered in##48##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1991-3#1)(1991-7#2)(1991-9#3)(1992-1#1)(1992-10#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-2#1)(1993-8#2)(1994-11#1)(1994-5#1)(1995-1#1)(1995-7#2)(1995-8#2)(1996-6#1)(1996-8#2)(1997-4#1)(1997-5#1)(1997-6#1)(2007-8#2)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#2)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
recovered increase in##2##3##(2008-5#2)
recovered is##2##2##(2008-10#1)(2008-4#1)
recovered its##2##2##(1993-6#1)(2008-5#1)
recovered less##2##2##(1995-6#1)(2008-5#1)
recovered more quickly##2##3##(2011-1#1)(2013-8#1)
recovered more slowly##2##3##(1994-7#1)(2011-1#1)
recovered more##5##2##(1994-7#1)(2007-12#1)(2011-1#2)(2013-8#1)
recovered most##2##2##(1991-2#1)(2008-10#1)
recovered motor function##2##3##(1996-1#1)(2008-11#1)
recovered much##2##2##(1993-12#1)(2013-1#1)
recovered on##8##2##(2007-8#1)(2008-10#6)(2008-12#1)
recovered only from##3##3##(1990-11#1)(2007-6#1)(2008-10#1)
recovered only##6##2##(1990-11#1)(1994-2#1)(2007-6#1)(2008-10#1)(2008-5#1)(2012-3#1)
recovered or##3##2##(2008-10#1)(2010-12#1)(2012-1#1)
recovered patients##2##2##(2006-10#1)(2012-2#1)
recovered per##2##2##(2006-5#1)(2008-9#1)
recovered plants##2##2##(2008-10#2)
recovered quantitatively##5##2##(2008-10#5)
recovered rapidly##4##2##(1990-8#1)(2006-12#1)(2008-7#1)(2013-8#1)
recovered spectral images##2##3##(2013-8#2)
recovered the##6##2##(1994-5#1)(1995-6#1)(1997-2#1)(2006-8#1)(2010-4#1)(2011-2#1)
recovered their##3##2##(2008-11#1)(2008-4#1)(2013-8#1)
recovered to baseline##2##3##(1995-7#1)(2013-8#1)
recovered to immediate preoperative##2##4##(2013-1#2)
recovered to the##5##3##(1990-3#1)(1991-4#1)(1992-1#1)(1997-2#1)(2008-7#1)
recovered to##15##2##(1990-3#1)(1991-4#1)(1992-1#1)(1992-6#1)(1993-11#1)(1995-7#1)(1997-2#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#2)(2013-8#1)
recovered trees##3##2##(2008-10#3)
recovered uneventfully and##3##3##(2011-1#1)(2012-2#1)(2013-1#1)
recovered uneventfully##6##2##(2007-8#2)(2011-1#1)(2012-2#2)(2013-1#1)
recovered well and##2##3##(1990-4#1)(2012-2#1)
recovered well without##2##3##(2007-8#1)(2013-1#1)
recovered well##13##2##(1990-4#1)(2007-8#2)(2008-12#1)(2009-10#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
recovered were##3##2##(1996-12#1)(2006-8#1)(2007-6#1)
recovered when##2##2##(2008-11#1)(2008-5#1)
recovered with high##2##3##(1996-7#1)(2008-10#1)
recovered with the##3##3##(2008-10#2)(2008-3#1)
recovered with##16##2##(1990-8#1)(1996-7#1)(1997-3#1)(2005-10#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-2#1)
recovered within##6##2##(1991-8#1)(1993-12#1)(1993-2#1)(1995-11#1)(2010-3#1)(2011-2#1)
recovered without##6##2##(1990-5#1)(1997-6#1)(2007-10#1)(2007-8#1)(2009-6#1)(2012-2#1)
recovered##695##1##(1990-10#3)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#5)(1990-4#4)(1990-5#3)(1990-6#1)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#2)(1991-4#3)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#4)(1992-1#3)(1992-10#1)(1992-2#1)(1992-4#5)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#5)(1993-2#2)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#3)(1994-5#4)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#5)(1995-1#1)(1995-11#2)(1995-12#2)(1995-3#1)(1995-6#3)(1995-7#5)(1995-8#5)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#8)(1996-2#1)(1996-3#1)(1996-4#2)(1996-6#3)(1996-7#6)(1996-8#4)(1996-9#1)(1997-1#1)(1997-2#6)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#3)(2004-11#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#4)(2005-8#2)(2005-9#4)(2006-10#3)(2006-12#4)(2006-3#1)(2006-4#1)(2006-5#5)(2006-7#2)(2006-8#14)(2007-10#3)(2007-11#11)(2007-12#8)(2007-2#4)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#8)(2007-8#16)(2007-9#2)(2008-1#3)(2008-10#187)(2008-11#5)(2008-12#9)(2008-2#17)(2008-3#11)(2008-4#11)(2008-5#32)(2008-6#4)(2008-7#19)(2008-8#6)(2008-9#5)(2009-10#2)(2009-2#1)(2009-3#1)(2009-5#3)(2009-6#2)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#6)(2010-3#4)(2010-4#4)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#11)(2011-2#12)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#10)(2012-3#6)(2013-1#17)(2013-8#17)
recovered)##4##1##(2008-10#4)
recoveries (&gt##5##2##(2008-10#5)
recoveries (mean##3##2##(1993-11#1)(2012-12#2)
recoveries (n =##2##3##(2012-3#1)(2013-8#1)
recoveries and the##2##3##(1992-1#1)(2012-12#1)
recoveries and##11##2##(1992-1#1)(1992-2#1)(1993-2#1)(1996-8#1)(2007-8#1)(2008-10#4)(2011-1#1)(2012-12#1)
recoveries are in the range of##4##6##(2005-4#1)(2008-10#3)
recoveries are##10##2##(2005-4#1)(2008-10#9)
recoveries at three##2##3##(2007-8#2)
recoveries at##3##2##(2007-8#2)(2012-12#1)
recoveries between 95##2##3##(2008-10#2)
recoveries between 98##2##3##(2008-10#2)
recoveries between##11##2##(2005-12#1)(2008-10#10)
recoveries for all##2##3##(2008-10#2)
recoveries for both##3##3##(2008-10#3)
recoveries for the spiked##2##4##(2008-10#2)
recoveries for the##7##3##(1997-2#1)(2008-10#6)
recoveries for##34##2##(1990-12#1)(1990-9#1)(1996-8#2)(1997-2#1)(2004-11#1)(2005-12#1)(2008-10#26)(2010-3#1)
recoveries from spiked##2##3##(2008-10#2)
recoveries from the##3##3##(2008-10#3)
recoveries from##14##2##(1996-6#1)(2007-8#2)(2008-10#10)(2012-3#1)
recoveries in the range of##2##5##(2007-8#1)(2008-10#1)
recoveries in the range##3##4##(2007-8#2)(2008-10#1)
recoveries in the##4##3##(2007-8#2)(2008-10#2)
recoveries in##9##2##(1997-3#1)(2007-8#2)(2008-10#5)(2008-5#1)
recoveries obtained by##3##3##(2008-10#3)
recoveries obtained for##2##3##(2008-10#2)
recoveries obtained in##2##3##(1997-6#1)(2008-10#1)
recoveries obtained ranged from##2##4##(2007-8#1)(2008-10#1)
recoveries obtained##16##2##(1990-9#1)(1997-6#1)(2007-8#1)(2008-10#13)
recoveries of &gt##3##3##(2008-10#1)(2013-8#2)
recoveries of 101##4##3##(2008-10#4)
recoveries of PAHs from##2##4##(2008-10#2)
recoveries of analytes##2##3##(2008-10#2)
recoveries of certified values##2##4##(2008-10#2)
recoveries of protein##2##3##(1990-3#1)(2013-8#1)
recoveries of spiked##2##3##(2008-10#2)
recoveries of the analytes##2##4##(2008-10#2)
recoveries of the spiked##2##4##(2007-1#1)(2008-10#1)
recoveries of the three##2##4##(1997-5#1)(2012-12#1)
recoveries of the two##2##4##(2008-10#2)
recoveries of the##25##3##(1995-6#1)(1997-2#1)(1997-5#1)(2005-4#1)(2007-1#1)(2008-10#12)(2008-7#1)(2011-1#1)(2012-12#5)(2013-1#1)
recoveries of these##3##3##(2008-10#3)
recoveries of total##2##3##(2008-10#1)(2012-12#1)
recoveries of##134##2##(1990-2#1)(1990-3#1)(1991-3#1)(1991-8#1)(1992-11#2)(1992-7#1)(1993-1#1)(1995-6#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-12#2)(2005-4#1)(2007-1#1)(2007-5#1)(2007-8#2)(2008-10#84)(2008-11#1)(2008-5#1)(2008-7#2)(2010-2#1)(2011-1#7)(2011-2#1)(2012-12#10)(2013-1#1)(2013-8#3)
recoveries range from##3##3##(2008-10#3)
recoveries range##4##2##(2008-10#4)
recoveries ranged between##4##3##(2008-10#4)
recoveries ranged from 96##2##4##(2008-10#2)
recoveries ranged from##11##3##(2008-10#7)(2009-3#1)(2011-1#1)(2012-12#1)(2013-8#1)
recoveries ranged##15##2##(2008-10#11)(2009-3#1)(2011-1#1)(2012-12#1)(2013-8#1)
recoveries ranging from 90##2##4##(2005-4#1)(2008-10#1)
recoveries ranging from##3##3##(2005-4#1)(2008-10#2)
recoveries ranging##4##2##(2005-4#1)(2008-10#3)
recoveries than##3##2##(2008-10#2)(2012-12#1)
recoveries was##2##2##(2007-8#1)(2008-10#1)
recoveries were 95##2##3##(2008-10#1)(2011-1#1)
recoveries were 97##2##3##(2005-12#1)(2005-4#1)
recoveries were 98##2##3##(2008-10#1)(2011-1#1)
recoveries were between##8##3##(1995-1#1)(2008-10#3)(2012-1#1)(2012-12#2)(2012-3#1)
recoveries were found to be &gt##2##6##(2008-10#2)
recoveries were found to be##4##5##(2008-10#4)
recoveries were in the range of 99##2##7##(2008-10#2)
recoveries were in the range of##4##6##(2005-4#1)(2008-10#3)
recoveries were in the##5##4##(2005-4#1)(2008-10#4)
recoveries were in##6##3##(2005-4#1)(2008-10#5)
recoveries were observed##2##3##(2008-10#2)
recoveries were obtained in##3##4##(2008-10#3)
recoveries were obtained##6##3##(2008-10#6)
recoveries were reached##2##3##(2008-10#2)
recoveries were similar##3##3##(1997-8#2)(2008-10#1)
recoveries were##66##2##(1990-9#1)(1991-11#1)(1991-8#1)(1992-11#1)(1993-2#1)(1995-1#1)(1997-8#2)(2005-12#3)(2005-4#2)(2007-8#2)(2008-10#38)(2011-1#5)(2012-1#1)(2012-12#3)(2012-3#1)(2013-8#3)
recoveries with##3##2##(2007-8#1)(2008-10#1)(2008-6#1)
recoveries##406##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-9#3)(1991-11#1)(1991-3#1)(1991-8#2)(1992-1#1)(1992-11#3)(1992-2#1)(1992-7#1)(1993-1#1)(1993-11#2)(1993-2#3)(1994-5#1)(1995-1#1)(1995-6#1)(1996-6#2)(1996-8#5)(1997-2#3)(1997-3#4)(1997-5#1)(1997-6#2)(1997-8#3)(2004-11#1)(2005-11#1)(2005-12#7)(2005-4#5)(2006-9#1)(2007-1#1)(2007-5#1)(2007-8#16)(2008-10#268)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#3)(2009-3#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#14)(2011-2#1)(2012-1#2)(2012-12#20)(2012-3#3)(2013-1#1)(2013-8#8)
recoverin family##4##2##(1992-11#4)
recoverin in##2##2##(1994-8#1)(1995-6#1)
recoverin##24##1##(1992-11#4)(1992-2#4)(1992-5#1)(1992-8#3)(1994-8#7)(1995-6#5)
recoverin-like##2##1##(1992-2#1)(1992-5#1)
recovering alcoholics##2##2##(1991-12#1)(2012-1#1)
recovering clusters##2##2##(2008-7#2)
recovering from such##2##3##(2007-11#2)
recovering from##20##2##(1990-5#1)(1997-6#1)(2006-10#1)(2007-11#6)(2007-7#2)(2007-8#1)(2008-5#1)(2009-10#2)(2009-8#1)(2010-4#1)(2010-7#1)(2013-1#2)
recovering its##2##2##(1997-4#1)(2008-11#1)
recovering of##3##2##(2008-8#2)(2008-9#1)
recovering the##4##2##(1991-6#1)(2006-4#1)(2008-6#1)(2010-5#1)
recovering##65##1##(1990-3#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-6#1)(1992-9#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-4#1)(2007-11#8)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#2)(2009-12#2)(2009-8#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-12#1)(2012-1#2)(2013-1#4)
recoverins##2##1##(1995-2#2)
recovers from##2##2##(1996-11#1)(2010-7#1)
recovers with##2##2##(1996-4#1)(2007-1#1)
recovers##17##1##(1993-3#1)(1995-2#1)(1996-11#1)(1996-4#1)(1996-9#1)(2005-11#1)(2005-8#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)(2010-7#1)(2011-2#1)(2013-7#1)
recovery (&gt##2##2##(2008-10#2)
recovery achieved for##2##3##(2008-10#2)
recovery after hip fracture##3##4##(2008-8#3)
recovery after photobleaching##10##3##(1995-12#1)(1997-4#1)(1997-6#1)(2005-11#1)(2008-1#3)(2008-7#1)(2008-9#1)(2011-1#1)
recovery after the transplantation of##2##5##(2010-2#2)
recovery after treatment with##2##4##(1994-6#1)(2007-12#1)
recovery after##49##2##(1990-2#1)(1991-6#1)(1993-2#1)(1993-7#1)(1994-10#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-9#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-3#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-8#2)(2010-2#3)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2013-1#2)(2013-7#1)(2013-8#2)
recovery and a##2##3##(1995-5#1)(2006-10#1)
recovery and high##4##3##(2008-10#2)(2013-1#2)
recovery and its##2##3##(2008-10#2)
recovery and linearity##2##3##(1996-6#1)(2007-11#1)
recovery and neurorehabilitation##2##3##(2008-8#2)
recovery and optimal##2##3##(2007-8#1)(2008-10#1)
recovery and precision##3##3##(2005-4#2)(2008-10#1)
recovery and shorter hospital##2##4##(1993-2#1)(2006-10#1)
recovery and survival##2##3##(1995-5#1)(2007-8#1)
recovery and the##6##3##(2005-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-9#1)
recovery and was discharged##3##4##(2006-4#1)(2010-12#1)(2011-1#1)
recovery and was##6##3##(2006-4#1)(2007-8#1)(2009-4#1)(2010-12#1)(2011-1#1)(2013-1#1)
recovery and##117##2##(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-7#1)(1994-10#1)(1994-3#1)(1995-11#1)(1995-5#3)(1996-6#2)(1996-8#1)(1996-9#1)(1997-5#1)(2005-4#4)(2006-10#4)(2006-2#1)(2006-4#1)(2007-11#2)(2007-7#2)(2007-8#10)(2007-9#2)(2008-1#3)(2008-10#24)(2008-11#2)(2008-2#4)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-11#2)(2012-12#4)(2012-2#2)(2013-1#8)(2013-7#1)(2013-8#2)
recovery are##4##2##(2005-4#1)(2006-10#1)(2008-8#1)(2010-3#1)
recovery as##3##2##(1990-4#1)(2008-10#1)(2012-11#1)
recovery assay based on standard additions method##2##7##(2008-10#2)
recovery assay##3##2##(2008-10#3)
recovery at a##2##3##(2008-10#1)(2008-8#1)
recovery at##12##2##(2007-8#2)(2008-1#1)(2008-10#4)(2008-6#1)(2008-8#1)(2009-2#1)(2013-1#2)
recovery based on the##2##4##(2007-7#1)(2008-10#1)
recovery because##2##2##(1995-6#1)(2006-10#1)
recovery both##3##2##(1996-5#1)(2013-1#2)
recovery by the##2##3##(1992-10#1)(2013-8#1)
recovery by##9##2##(1992-10#1)(1995-7#1)(2005-11#1)(2008-10#1)(2008-6#1)(2008-8#3)(2013-8#1)
recovery can be##3##3##(1994-5#1)(2006-10#1)(2012-2#1)
recovery can##5##2##(1994-5#1)(2006-10#1)(2008-4#1)(2012-2#1)(2013-1#1)
recovery compared to##2##3##(2008-10#2)
recovery compared with##2##3##(2007-9#1)(2013-1#1)
recovery compared##5##2##(2007-9#1)(2008-10#2)(2008-9#1)(2013-1#1)
recovery could be##2##3##(2008-10#1)(2008-5#1)
recovery does not##2##3##(1991-2#1)(2008-2#1)
recovery due to##2##3##(2012-2#1)(2012-3#1)
recovery during the##2##3##(2008-5#1)(2008-7#1)
recovery during##6##2##(1996-9#1)(1997-3#1)(2008-11#1)(2008-5#1)(2008-7#2)
recovery efficiency##2##2##(2008-10#1)(2013-1#1)
recovery efforts##2##2##(2008-8#1)(2012-2#1)
recovery experiment and##2##3##(2008-10#1)(2008-5#1)
recovery experiment##5##2##(2008-10#1)(2008-5#2)(2013-8#2)
recovery experiments##5##2##(2008-10#4)(2012-1#1)
recovery factor##3##2##(2008-10#3)
recovery following##9##2##(1993-2#1)(1996-12#1)(2005-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
recovery for all##3##3##(1991-12#1)(2008-10#2)
recovery for##23##2##(1991-12#1)(1994-9#1)(2005-4#1)(2007-12#1)(2008-10#13)(2008-5#3)(2008-6#1)(2008-8#1)(2013-1#1)
recovery from activity limitations due to acute injury##2##8##(2010-3#2)
recovery from activity limitations##6##4##(2010-3#6)
recovery from acute##2##3##(1991-6#1)(2012-1#1)
recovery from an##2##3##(2005-9#1)(2006-8#1)
recovery from chronic acidosis##2##4##(1991-7#2)
recovery from eating disorders##3##4##(2006-7#2)(2012-2#1)
recovery from mild##2##3##(2008-6#1)(2013-8#1)
recovery from nervous system##2##4##(1993-7#2)
recovery from neuromuscular blockade##3##4##(2006-10#1)(2010-7#2)
recovery from psychosis##4##3##(2012-11#4)
recovery from refractoriness in##2##4##(1991-2#2)
recovery from refractoriness was##2##4##(1991-2#1)(1994-2#1)
recovery from refractoriness##4##3##(1991-2#3)(1994-2#1)
recovery from stroke##2##3##(2008-2#1)(2008-8#1)
recovery from surgery##2##3##(1993-4#1)(2007-8#1)
recovery from the disease##2##4##(2008-7#1)(2011-1#1)
recovery from the##11##3##(1996-6#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-7#1)(2010-7#1)(2011-1#1)(2011-12#1)
recovery from this##2##3##(2011-12#1)(2011-2#1)
recovery from##117##2##(1990-5#1)(1990-7#2)(1991-2#3)(1991-5#1)(1991-6#1)(1991-7#2)(1992-10#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-4#1)(1993-7#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#2)(1995-7#2)(1996-10#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-2#1)(2006-7#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#4)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#4)(2009-6#3)(2009-8#2)(2009-9#1)(2010-1#1)(2010-3#8)(2010-7#3)(2011-1#1)(2011-12#2)(2011-2#1)(2012-1#2)(2012-11#4)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#3)
recovery has##2##2##(1993-1#1)(2006-4#1)
recovery in a##5##3##(1993-9#1)(2006-10#1)(2008-2#1)(2010-3#1)(2012-12#1)
recovery in children and##2##4##(2006-10#1)(2013-8#1)
recovery in patients with##2##4##(2009-2#1)(2012-1#1)
recovery in patients##5##3##(1996-3#1)(2008-4#1)(2009-2#1)(2012-1#1)(2013-1#1)
recovery in the##11##3##(1990-3#1)(1990-5#1)(1992-9#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#2)(2008-7#1)(2013-1#2)
recovery in##61##2##(1990-3#2)(1990-5#1)(1992-10#1)(1992-3#1)(1992-9#2)(1993-9#3)(1995-2#1)(1995-3#2)(1996-3#1)(1997-3#1)(1997-8#1)(2004-4#1)(2006-10#3)(2007-8#3)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#1)
recovery intervals##2##2##(1994-2#2)
recovery is from##2##3##(2008-10#2)
recovery is in the range##2##5##(2008-10#2)
recovery is in##3##3##(2008-10#2)(2008-6#1)
recovery is possible##2##3##(2008-7#1)(2011-1#1)
recovery is##42##2##(1991-9#1)(1993-2#1)(1993-5#1)(1993-9#1)(1996-9#1)(1997-6#1)(2004-12#1)(2005-4#6)(2006-6#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#9)(2008-2#5)(2008-5#1)(2008-6#1)(2008-7#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#2)
recovery kinetics##2##2##(2008-8#2)
recovery level##2##2##(1992-1#1)(2008-10#1)
recovery marker##2##2##(1996-3#1)(1996-4#1)
recovery may be##2##3##(1994-10#1)(2008-10#1)
recovery measurements##5##2##(1995-3#1)(2007-8#1)(2008-10#3)
recovery method##3##2##(2008-10#2)(2012-12#1)
recovery needs##2##2##(2007-11#1)(2007-8#1)
recovery occurred##3##2##(1991-6#1)(1997-8#1)(2008-6#1)
recovery of &gt##2##3##(2008-10#2)
recovery of 0##2##3##(2008-10#2)
recovery of 100##3##3##(2008-10#3)
recovery of 101%##2##3##(2008-10#2)
recovery of 95##2##3##(2008-10#2)
recovery of 99##5##3##(2005-4#1)(2008-10#4)
recovery of ATP##3##3##(1990-7#1)(1994-10#2)
recovery of DTH##2##3##(1991-12#1)(1996-10#1)
recovery of LVDP and##2##4##(2010-7#2)
recovery of RGC function##2##4##(2012-12#2)
recovery of U(VI)##2##3##(2008-10#2)
recovery of a##12##3##(1993-5#1)(1994-12#1)(1997-5#1)(2006-11#2)(2007-7#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)
recovery of active drug from##2##5##(2010-7#2)
recovery of activity##7##3##(1991-2#1)(1992-3#2)(1992-7#1)(1995-1#1)(1996-7#1)(2011-2#1)
recovery of added##4##3##(1990-11#1)(1995-2#1)(2007-10#1)(2008-10#1)
recovery of all the##2##4##(1994-8#1)(2008-10#1)
recovery of all##5##3##(1994-8#1)(1996-8#1)(2008-10#3)
recovery of anaerobic##2##3##(2006-8#2)
recovery of autonomic function following MCAO##2##6##(2007-10#2)
recovery of both##2##3##(2008-10#2)
recovery of brain##2##3##(2008-8#1)(2011-1#1)
recovery of cells##2##3##(1992-9#1)(2011-2#1)
recovery of cerebral##2##3##(1993-2#1)(1994-6#1)
recovery of compounds##2##3##(1996-5#1)(2008-10#1)
recovery of copper was##2##4##(2008-10#2)
recovery of copper##7##3##(2008-10#7)
recovery of dopamine##2##3##(1990-5#1)(2008-10#1)
recovery of each##4##3##(2007-8#1)(2008-10#2)(2008-5#1)
recovery of function compared to##2##5##(2007-8#1)(2009-10#1)
recovery of function following##4##4##(1991-2#3)(1993-7#1)
recovery of function is##2##4##(1992-10#1)(2008-2#1)
recovery of function##18##3##(1991-1#1)(1991-2#3)(1992-10#3)(1993-7#1)(1993-9#2)(1994-10#1)(1995-11#1)(1997-5#1)(2007-8#1)(2008-11#1)(2008-2#2)(2009-10#1)
recovery of human##3##3##(1995-6#1)(2008-12#1)(2008-7#1)
recovery of infectious##2##3##(1995-8#1)(2013-8#1)
recovery of left ventricular##3##4##(2007-9#1)(2008-11#1)(2010-7#1)
recovery of lysozyme##2##3##(2008-7#1)(2011-2#1)
recovery of mechanical##2##3##(1996-10#1)(2008-3#1)
recovery of motor##2##3##(2012-1#1)(2013-7#1)
recovery of patients##2##3##(1994-6#1)(2012-1#1)
recovery of perchlorate##2##3##(2008-10#2)
recovery of protein##3##3##(1990-4#1)(1991-5#1)(1994-6#1)
recovery of rat brain##2##4##(1993-4#1)(1995-7#1)
recovery of rat##3##3##(1993-4#1)(1995-7#1)(2008-12#1)
recovery of recombinant##2##3##(1994-5#1)(2008-11#1)
recovery of renal function##5##4##(2006-10#2)(2006-7#1)(2008-1#1)(2008-4#1)
recovery of renal##6##3##(2006-10#2)(2006-7#1)(2007-7#1)(2008-1#1)(2008-4#1)
recovery of responding to the extinguished stimulus during##2##8##(2008-5#2)
recovery of spatial learning following##2##5##(1997-5#2)
recovery of spiked##9##3##(1992-8#2)(1997-2#1)(2007-8#1)(2008-10#4)(2008-7#1)
recovery of spikes##2##3##(2008-10#2)
recovery of sporamin##2##3##(2008-6#2)
recovery of standard##2##3##(2008-10#1)(2012-2#1)
recovery of target##3##3##(2006-11#1)(2007-8#1)(2008-10#1)
recovery of the analyte##5##4##(2008-10#4)(2012-12#1)
recovery of the animal##3##4##(2005-10#1)(2008-4#2)
recovery of the assay##3##4##(1992-6#1)(1993-1#1)(2008-10#1)
recovery of the dark##2##4##(1992-8#1)(1997-4#1)
recovery of the drug##2##4##(2008-10#1)(2010-2#1)
recovery of the method was##2##5##(2008-10#1)(2011-1#1)
recovery of the method##3##4##(2008-10#2)(2011-1#1)
recovery of the patient was##2##5##(2008-9#1)(2009-6#1)
recovery of the patient##3##4##(2006-10#1)(2008-9#1)(2009-6#1)
recovery of the patients##2##4##(2009-2#1)(2012-2#1)
recovery of the rare##3##4##(2008-10#1)(2010-10#2)
recovery of the spiked##3##4##(1992-8#1)(2008-10#2)
recovery of the##117##3##(1990-10#1)(1990-3#1)(1990-5#2)(1990-7#3)(1991-12#1)(1991-5#1)(1992-11#3)(1992-12#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-1#1)(1995-10#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-1#2)(1997-4#1)(2004-4#1)(2005-10#1)(2005-4#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-8#2)(2008-10#26)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#3)(2008-7#3)(2008-9#2)(2009-2#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-4#3)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#2)
recovery of these##4##3##(1991-5#1)(2008-10#2)(2008-5#1)
recovery of this##2##3##(2010-10#1)(2013-8#1)
recovery of total##2##3##(2008-10#2)
recovery of viable##2##3##(2006-5#1)(2012-2#1)
recovery of walking ability##2##4##(2007-10#2)
recovery of##571##2##(1990-10#2)(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#5)(1990-7#5)(1990-8#1)(1990-9#2)(1991-1#3)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#5)(1991-5#4)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#3)(1992-11#3)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#4)(1992-8#5)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#4)(1993-3#2)(1993-4#1)(1993-5#1)(1993-7#2)(1993-8#1)(1993-9#4)(1994-10#3)(1994-11#5)(1994-12#2)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#5)(1994-8#1)(1995-1#4)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#4)(1995-5#1)(1995-6#2)(1995-7#2)(1995-8#3)(1996-1#1)(1996-10#2)(1996-12#4)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#4)(1997-6#1)(1997-7#2)(1997-8#1)(2004-4#3)(2005-10#1)(2005-11#2)(2005-12#1)(2005-4#4)(2005-8#1)(2006-10#5)(2006-11#4)(2006-2#1)(2006-3#1)(2006-5#2)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#6)(2007-11#3)(2007-12#11)(2007-3#1)(2007-6#1)(2007-7#5)(2007-8#9)(2007-9#1)(2008-1#2)(2008-10#164)(2008-11#13)(2008-12#6)(2008-2#9)(2008-3#15)(2008-4#6)(2008-5#15)(2008-6#4)(2008-7#13)(2008-8#1)(2008-9#6)(2009-10#1)(2009-11#1)(2009-2#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-10#4)(2010-11#1)(2010-12#5)(2010-2#3)(2010-4#5)(2010-5#1)(2010-7#5)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#7)(2011-3#1)(2012-1#10)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#7)(2013-7#7)(2013-8#4)
recovery on##4##2##(1996-11#1)(2008-10#2)(2012-3#1)
recovery or##11##2##(1990-11#1)(1993-7#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)(2012-12#1)
recovery percentage##3##2##(2007-8#1)(2008-10#2)
recovery percentages##4##2##(2008-10#4)
recovery performance##2##2##(2005-11#1)(2008-10#1)
recovery period after##2##3##(2007-11#1)(2007-9#1)
recovery period and##2##3##(1992-3#1)(1995-7#1)
recovery period##21##2##(1990-2#1)(1992-3#1)(1995-3#1)(1995-7#3)(2006-1#1)(2007-11#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-2#1)(2010-5#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
recovery periods##3##2##(1993-2#1)(2008-1#1)(2008-5#1)
recovery phase##6##2##(1994-10#1)(1996-2#2)(2004-4#1)(2010-7#1)(2013-1#1)
recovery phenotype##2##2##(2008-10#2)
recovery problems##3##2##(2008-2#2)(2010-9#1)
recovery procedure##2##2##(2008-2#2)
recovery process##19##2##(1991-2#1)(1994-6#1)(2005-11#1)(2006-10#2)(2007-4#1)(2008-10#1)(2008-9#2)(2011-2#2)(2012-2#4)(2013-1#4)
recovery processes##9##2##(1990-3#1)(1994-10#1)(1995-5#1)(2004-4#1)(2007-11#1)(2007-12#2)(2008-11#1)(2012-2#1)
recovery profile##3##2##(2005-11#1)(2007-9#1)(2008-10#1)
recovery profiles##2##2##(2006-10#1)(2008-10#1)
recovery range of##3##3##(2008-10#2)(2008-5#1)
recovery range##6##2##(2007-11#1)(2008-10#4)(2008-5#1)
recovery ranged##2##2##(1991-3#1)(2008-10#1)
recovery rate (RR)##2##3##(2008-10#2)
recovery rate of##5##3##(1993-9#1)(1996-12#1)(2007-8#1)(2008-10#2)
recovery rate was##10##3##(1996-12#1)(2005-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2013-8#2)
recovery rate##23##2##(1993-9#1)(1996-12#2)(2005-4#3)(2007-8#3)(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#1)(2013-8#2)
recovery rates were##5##3##(2005-4#1)(2008-10#4)
recovery rates##18##2##(1996-12#1)(2005-4#1)(2006-8#1)(2007-8#1)(2008-10#13)(2008-12#1)
recovery ratio of##4##3##(2005-4#4)
recovery requirements##2##2##(2008-10#2)
recovery results##3##2##(2008-10#3)
recovery room##6##2##(2008-7#1)(2010-7#2)(2011-2#1)(2012-2#2)
recovery studies were##2##3##(2008-10#1)(2011-2#1)
recovery studies##17##2##(2008-10#7)(2008-8#1)(2010-12#1)(2010-2#2)(2010-5#4)(2011-2#2)
recovery study##5##2##(2008-10#3)(2009-6#1)(2010-2#1)
recovery term##2##2##(2008-10#2)
recovery test was performed##2##4##(2008-10#2)
recovery test##8##2##(1995-1#1)(2008-10#6)(2013-8#1)
recovery tests##6##2##(2007-10#1)(2008-10#5)
recovery that##2##2##(2008-2#1)(2009-12#1)
recovery the##2##2##(1991-2#1)(2008-10#1)
recovery through##3##2##(2008-11#1)(2012-12#2)
recovery time and##4##3##(2006-10#1)(2006-6#1)(2010-11#1)(2011-2#1)
recovery time in semiconductor optical amplifiers##2##6##(2007-11#2)
recovery time in##4##3##(2007-11#2)(2008-1#1)(2008-9#1)
recovery time of##3##3##(2008-3#1)(2010-8#1)(2013-1#1)
recovery time was##4##3##(2008-1#3)(2012-2#1)
recovery time were##2##3##(2012-2#2)
recovery time##30##2##(1990-11#1)(1996-3#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#1)(2008-1#5)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-2#4)(2013-1#1)
recovery times and##3##3##(2007-8#1)(2010-7#1)(2013-1#1)
recovery times##9##2##(1996-2#1)(2007-2#2)(2007-8#2)(2008-10#2)(2010-7#1)(2013-1#1)
recovery to the##2##3##(2008-3#2)
recovery to##10##2##(1990-4#1)(1991-1#1)(1995-12#3)(2008-10#1)(2008-3#2)(2008-9#1)(2012-2#1)
recovery under isothermal##2##3##(2009-7#2)
recovery under##6##2##(2005-11#1)(2009-7#2)(2013-8#3)
recovery up to##2##3##(2007-8#1)(2008-10#1)
recovery using##3##2##(2008-10#1)(2008-4#1)(2008-6#1)
recovery value##2##2##(2008-10#2)
recovery values are##4##3##(2008-10#4)
recovery values from##2##3##(2008-10#2)
recovery values obtained##4##3##(2008-10#4)
recovery values were obtained##2##4##(2008-10#1)(2011-2#1)
recovery values were##5##3##(2008-10#4)(2011-2#1)
recovery values##24##2##(2008-10#23)(2011-2#1)
recovery varied from##2##3##(1997-8#1)(2008-10#1)
recovery was 0##2##3##(1995-3#1)(2008-10#1)
recovery was 100%##2##3##(1997-3#1)(2006-3#1)
recovery was above##2##3##(2008-5#1)(2011-3#1)
recovery was achieved##5##3##(2007-7#2)(2009-4#1)(2011-2#1)(2012-3#1)
recovery was ca##2##3##(1990-12#1)(1993-2#1)
recovery was calculated##2##3##(2008-10#2)
recovery was evaluated##2##3##(1996-12#1)(2012-3#1)
recovery was faster##2##3##(2007-9#1)(2012-2#1)
recovery was found in##2##4##(2008-10#1)(2008-5#1)
recovery was found to be##3##5##(1997-8#1)(2008-10#1)(2010-2#1)
recovery was found##6##3##(1997-8#1)(2008-10#2)(2008-5#1)(2009-9#1)(2010-2#1)
recovery was higher##2##3##(2008-10#1)(2009-3#1)
recovery was made##2##3##(2010-3#1)(2011-2#1)
recovery was observed in##4##4##(1993-4#1)(2007-2#1)(2007-7#1)(2011-1#1)
recovery was observed##10##3##(1991-3#1)(1993-2#1)(1993-4#2)(1996-8#1)(2007-2#1)(2007-7#1)(2011-1#1)(2011-12#1)(2013-8#1)
recovery was obtained in##2##4##(2007-11#1)(2007-8#1)
recovery was obtained##5##3##(1992-12#1)(2007-11#1)(2007-8#1)(2008-10#2)
recovery was seen##2##3##(2011-2#1)(2012-2#1)
recovery was similar##2##3##(1991-5#1)(2009-3#1)
recovery was uneventful##3##3##(2007-8#1)(2011-2#1)(2012-12#1)
recovery was##110##2##(1990-12#1)(1990-2#3)(1990-4#1)(1990-8#2)(1991-1#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-4#2)(1993-9#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-12#2)(1996-3#1)(1996-8#2)(1997-3#2)(1997-8#3)(2005-12#1)(2005-3#1)(2005-4#4)(2006-3#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-10#24)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-8#1)(2009-3#2)(2009-4#1)(2009-9#3)(2010-2#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#4)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#3)
recovery were obtained for##2##4##(2008-10#2)
recovery were obtained##3##3##(2007-8#1)(2008-10#2)
recovery were##20##2##(1990-8#1)(1991-10#1)(1994-8#1)(1996-12#1)(1997-8#1)(2007-10#1)(2007-8#2)(2007-9#1)(2008-10#6)(2008-2#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-3#1)
recovery when##3##2##(2008-4#1)(2008-5#1)(2010-7#1)
recovery with the##2##3##(2006-7#1)(2008-6#1)
recovery with##11##2##(1994-10#1)(1995-5#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-1#2)(2008-3#1)(2008-6#1)(2010-5#1)(2012-12#1)
recovery within##3##2##(1991-8#1)(1997-6#1)(2013-8#1)
recovery without##5##2##(1996-6#1)(2007-10#1)(2007-2#1)(2011-2#1)(2012-2#1)
recovery yield##6##2##(1991-8#1)(2008-5#3)(2011-2#1)(2013-1#1)
recovery##1981##1##(1990-10#2)(1990-11#4)(1990-12#5)(1990-2#8)(1990-3#4)(1990-4#4)(1990-5#10)(1990-7#8)(1990-8#5)(1990-9#3)(1991-1#6)(1991-10#3)(1991-11#4)(1991-12#6)(1991-2#13)(1991-3#3)(1991-4#2)(1991-5#8)(1991-6#5)(1991-7#2)(1991-8#6)(1991-9#5)(1992-1#2)(1992-10#8)(1992-11#5)(1992-12#5)(1992-2#4)(1992-3#8)(1992-5#2)(1992-6#2)(1992-7#5)(1992-8#6)(1992-9#4)(1993-1#4)(1993-11#1)(1993-12#3)(1993-2#17)(1993-3#2)(1993-4#4)(1993-5#3)(1993-7#8)(1993-8#2)(1993-9#12)(1994-10#11)(1994-11#6)(1994-12#5)(1994-2#6)(1994-3#5)(1994-4#2)(1994-5#3)(1994-6#10)(1994-8#6)(1994-9#2)(1995-1#5)(1995-10#1)(1995-11#5)(1995-12#9)(1995-2#7)(1995-3#5)(1995-4#1)(1995-5#6)(1995-6#4)(1995-7#9)(1995-8#3)(1995-9#1)(1996-1#2)(1996-10#3)(1996-11#1)(1996-12#11)(1996-2#4)(1996-3#5)(1996-4#3)(1996-5#4)(1996-6#6)(1996-7#3)(1996-8#7)(1996-9#7)(1997-1#2)(1997-2#4)(1997-3#9)(1997-4#5)(1997-5#5)(1997-6#7)(1997-7#2)(1997-8#10)(2004-12#1)(2004-3#2)(2004-4#7)(2004-9#1)(2005-10#3)(2005-11#12)(2005-12#4)(2005-3#1)(2005-4#28)(2005-7#1)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#37)(2006-11#5)(2006-12#2)(2006-2#3)(2006-3#5)(2006-4#7)(2006-5#4)(2006-6#2)(2006-7#11)(2006-8#6)(2006-9#4)(2007-1#3)(2007-10#14)(2007-11#22)(2007-12#22)(2007-2#7)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#18)(2007-8#55)(2007-9#16)(2008-1#21)(2008-10#450)(2008-11#29)(2008-12#16)(2008-2#48)(2008-3#26)(2008-4#15)(2008-5#48)(2008-6#29)(2008-7#31)(2008-8#36)(2008-9#18)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#4)(2009-3#4)(2009-4#4)(2009-5#1)(2009-6#7)(2009-7#7)(2009-8#11)(2009-9#7)(2010-1#2)(2010-10#5)(2010-11#3)(2010-12#15)(2010-2#16)(2010-3#11)(2010-4#11)(2010-5#10)(2010-6#3)(2010-7#17)(2010-8#6)(2010-9#3)(2011-1#17)(2011-12#8)(2011-2#42)(2011-3#3)(2012-1#21)(2012-11#12)(2012-12#32)(2012-2#40)(2012-3#18)(2013-1#67)(2013-7#14)(2013-8#40)
recovery&quot##2##1##(2007-8#1)(2008-10#1)
recovery)##9##1##(1993-3#1)(2008-10#2)(2011-2#1)(2012-12#5)
recreated##6##1##(2005-7#1)(2008-11#1)(2009-11#1)(2012-1#3)
recreates##3##1##(1993-3#1)(2006-12#1)(2008-7#1)
recreating the##4##2##(2009-10#1)(2009-4#1)(2013-1#2)
recreation and leisure activities##2##4##(2012-12#2)
recreation and##4##2##(2007-11#1)(2009-6#1)(2012-12#2)
recreation of elbow spasticity##2##4##(2012-1#2)
recreation of##3##2##(2006-6#1)(2012-1#2)
recreation therapy##3##2##(1993-2#2)(2007-7#1)
recreation##14##1##(1993-2#2)(1994-3#1)(2004-11#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-4#1)(2009-6#1)(2012-1#3)(2012-12#2)
recreational activities##9##2##(1992-12#1)(1997-3#1)(2007-10#1)(2011-2#3)(2012-12#2)(2012-2#1)
recreational and##2##2##(2008-8#1)(2013-1#1)
recreational areas##2##2##(1990-2#1)(1992-2#1)
recreational athlete##2##2##(2006-3#1)(2011-2#1)
recreational drugs##5##2##(1991-1#1)(2007-11#1)(2011-2#1)(2013-7#2)
recreational facilities##2##2##(2011-2#1)(2013-1#1)
recreational screen-based##2##2##(2013-1#2)
recreational soccer player##2##3##(2011-2#2)
recreational sports##3##2##(2012-12#3)
recreational waters##2##2##(2009-6#2)
recreational##55##1##(1990-2#1)(1991-1#1)(1992-12#1)(1992-2#1)(1994-4#1)(1997-3#1)(2005-8#1)(2006-10#1)(2006-3#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#2)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-6#3)(2009-7#1)(2011-2#8)(2012-12#9)(2012-2#1)(2013-1#4)(2013-7#3)(2013-8#1)
recrossing##2##1##(1996-1#1)(2008-2#1)
recrudescence of##2##2##(1991-5#1)(2011-2#1)
recrudescence##11##1##(1990-7#1)(1991-5#1)(2005-7#1)(2006-10#3)(2008-2#1)(2008-5#2)(2011-12#1)(2011-2#1)
recruit adult##2##2##(2012-3#1)(2013-1#1)
recruit and activate##3##3##(2007-7#1)(2007-8#1)(2008-5#1)
recruit and retain##4##3##(1991-3#1)(2007-10#1)(2007-4#1)(2008-5#1)
recruit and##9##2##(1991-3#1)(2007-10#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-5#2)(2011-2#1)
recruit other##3##2##(1995-6#1)(2005-11#1)(2008-4#1)
recruit targets for##2##3##(2009-8#1)(2013-8#1)
recruit the##7##2##(1994-8#1)(1996-4#1)(2007-12#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
recruit##73##1##(1991-3#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-4#2)(1996-5#2)(1997-4#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-10#2)(2007-10#4)(2007-11#1)(2007-12#1)(2007-3#2)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#3)(2008-11#5)(2008-4#2)(2008-5#5)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#3)(2009-8#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
recruited a##5##2##(2008-11#2)(2010-10#1)(2013-1#2)
recruited and followed##2##3##(1992-2#1)(2007-8#1)
recruited and##11##2##(1992-2#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-2#2)(2013-1#3)(2013-8#1)
recruited as##2##2##(2012-2#1)(2013-1#1)
recruited at a##3##3##(2006-10#1)(2008-5#1)(2011-2#1)
recruited at##8##2##(2006-10#1)(2007-10#1)(2007-9#1)(2008-5#1)(2008-7#1)(2010-3#1)(2010-8#1)(2011-2#1)
recruited by the##2##3##(2008-11#1)(2012-1#1)
recruited by##10##2##(1996-8#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2009-3#1)(2009-5#1)(2012-1#1)
recruited during##5##2##(1993-1#2)(2007-2#1)(2007-5#1)(2013-1#1)
recruited for the study##5##4##(2007-1#1)(2008-3#1)(2010-8#1)(2011-2#1)(2012-12#1)
recruited for the##8##3##(2007-1#1)(2008-11#1)(2008-3#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)
recruited for this study##6##4##(1995-3#1)(2007-3#1)(2008-1#1)(2008-12#1)(2008-8#1)(2013-1#1)
recruited for this##8##3##(1995-3#1)(2007-3#1)(2008-1#1)(2008-12#1)(2008-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
recruited for##19##2##(1995-3#1)(2007-1#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2013-1#2)(2013-8#1)
recruited from a##6##3##(2007-8#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#2)
recruited from an##2##3##(1993-10#1)(2004-3#1)
recruited from the##13##3##(1995-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-3#1)(2009-10#1)(2010-11#1)(2010-2#1)(2011-11#1)(2011-2#2)(2013-1#1)(2013-8#1)
recruited from three##2##3##(2008-4#1)(2012-1#1)
recruited from two##3##3##(2008-9#1)(2011-11#1)(2013-1#1)
recruited from##62##2##(1993-10#1)(1995-1#1)(1995-4#1)(2004-3#1)(2005-1#1)(2006-7#5)(2007-12#1)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-5#3)(2009-6#1)(2009-7#1)(2010-11#2)(2010-2#1)(2010-7#1)(2011-1#3)(2011-11#2)(2011-2#4)(2012-1#1)(2012-2#1)(2013-1#9)(2013-8#1)
recruited in a##2##3##(2007-8#1)(2013-1#1)
recruited in##11##2##(2006-12#1)(2007-8#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-8#1)(2012-2#2)(2013-1#1)(2013-8#1)
recruited into the study##3##4##(2007-2#1)(2008-4#1)(2011-1#1)
recruited into the##4##3##(2007-2#1)(2008-1#1)(2008-4#1)(2011-1#1)
recruited into##12##2##(1994-3#1)(2006-4#1)(2007-2#1)(2008-1#1)(2008-4#1)(2009-3#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
recruited over##4##2##(2007-2#1)(2009-10#1)(2010-7#1)(2011-1#1)
recruited the##2##2##(2008-11#2)
recruited to participate in a##2##5##(2008-5#1)(2011-1#1)
recruited to participate in##4##4##(2007-10#1)(2008-5#1)(2008-6#1)(2011-1#1)
recruited to the study##3##4##(2006-10#1)(2008-7#1)(2011-12#1)
recruited to the##7##3##(1997-8#1)(2006-10#1)(2007-5#1)(2008-2#1)(2008-7#1)(2011-12#1)(2012-2#1)
recruited to##29##2##(1992-6#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-8#1)(2006-10#2)(2006-2#2)(2007-10#1)(2007-12#1)(2007-5#1)(2008-1#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#1)
recruited via##3##2##(2011-1#1)(2013-1#2)
recruited when subjects##2##3##(2008-11#1)(2012-12#1)
recruited##242##1##(1990-5#1)(1992-2#2)(1992-6#1)(1993-1#2)(1993-10#1)(1994-3#2)(1994-6#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-4#1)(1996-2#1)(1996-8#2)(1997-4#1)(1997-8#1)(2004-3#1)(2004-9#1)(2005-1#1)(2006-10#4)(2006-12#1)(2006-2#2)(2006-4#1)(2006-7#6)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#4)(2007-2#5)(2007-3#2)(2007-5#3)(2007-7#1)(2007-8#6)(2007-9#2)(2008-1#7)(2008-10#4)(2008-11#15)(2008-12#4)(2008-2#1)(2008-3#5)(2008-4#6)(2008-5#5)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#2)(2009-10#2)(2009-2#1)(2009-3#4)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#4)(2011-1#12)(2011-11#2)(2011-12#2)(2011-2#12)(2012-1#6)(2012-11#2)(2012-12#3)(2012-2#8)(2012-3#1)(2013-1#29)(2013-7#1)(2013-8#9)
recruiters##3##1##(1993-2#1)(2008-12#1)(2012-3#1)
recruiting and##3##2##(1991-2#1)(2008-5#1)(2012-2#1)
recruiting of##4##2##(1994-1#1)(1995-8#1)(2008-5#1)(2010-2#1)
recruiting patients##4##2##(2008-11#1)(2010-5#1)(2011-1#1)(2012-3#1)
recruiting radiologists##2##2##(2007-4#2)
recruiting##42##1##(1990-2#1)(1991-2#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-1#2)(1995-5#1)(1995-8#1)(1996-3#2)(1996-5#1)(1997-4#1)(1997-6#1)(2005-7#1)(2006-5#1)(2007-1#1)(2007-4#3)(2007-5#1)(2007-8#1)(2008-11#2)(2008-5#3)(2008-8#1)(2009-4#1)(2009-7#1)(2010-2#2)(2010-5#1)(2011-1#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
recruitment and activation of##4##4##(1995-2#1)(2006-10#1)(2006-11#1)(2007-9#1)
recruitment and activation##6##3##(1995-2#1)(2006-10#1)(2006-11#1)(2007-9#1)(2008-8#1)(2009-11#1)
recruitment and development of##2##4##(2007-3#1)(2007-4#1)
recruitment and retention initiatives##2##4##(2007-4#1)(2008-11#1)
recruitment and retention of##6##4##(1994-3#1)(2005-9#1)(2007-4#1)(2008-12#1)(2009-5#1)(2012-3#1)
recruitment and retention strategies##4##4##(1995-2#1)(2007-10#1)(2012-11#2)
recruitment and retention##26##3##(1991-2#1)(1994-3#2)(1995-2#1)(2005-9#2)(2007-10#1)(2007-4#3)(2008-1#1)(2008-11#3)(2008-12#2)(2008-8#1)(2009-5#1)(2010-11#2)(2011-1#2)(2012-11#2)(2012-3#2)
recruitment and##67##2##(1990-2#2)(1991-11#1)(1991-2#1)(1991-6#1)(1993-9#1)(1994-2#2)(1994-3#3)(1995-2#2)(1996-1#1)(2005-8#1)(2005-9#2)(2006-10#1)(2006-11#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-4#4)(2007-9#1)(2008-1#4)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#2)(2008-8#6)(2009-1#1)(2009-11#1)(2009-5#1)(2010-10#1)(2010-11#3)(2010-12#1)(2011-1#2)(2012-1#1)(2012-11#2)(2012-2#2)(2012-3#2)(2013-7#1)
recruitment at##2##2##(2008-1#1)(2012-3#1)
recruitment by##7##2##(2008-3#1)(2012-1#5)(2012-2#1)
recruitment challenges##4##2##(2007-10#2)(2010-10#1)(2010-11#1)
recruitment difficulties##2##2##(1990-2#1)(2007-4#1)
recruitment efforts##5##2##(1996-3#1)(2008-10#1)(2008-11#1)(2012-3#2)
recruitment for##3##2##(2008-10#1)(2008-5#1)(2013-7#1)
recruitment from##5##2##(1992-1#1)(2008-11#1)(2012-12#1)(2012-3#1)(2013-8#1)
recruitment in##5##2##(1993-11#1)(1994-2#1)(2005-7#1)(2008-5#1)(2008-8#1)
recruitment maneuver##2##2##(2009-4#1)(2011-1#1)
recruitment method##4##2##(1995-1#3)(2007-12#1)
recruitment methods##3##2##(2007-10#1)(2007-12#1)(2008-1#1)
recruitment of T cells to the##2##6##(2008-5#1)(2013-1#1)
recruitment of T cells##3##4##(2006-10#1)(2008-5#1)(2013-1#1)
recruitment of a##2##3##(2005-12#1)(2008-4#1)
recruitment of additional##2##3##(1994-2#1)(2009-6#1)
recruitment of blood flow##2##4##(2008-7#1)(2010-11#1)
recruitment of blood##5##3##(1997-8#1)(2006-9#1)(2008-12#1)(2008-7#1)(2010-11#1)
recruitment of immune cells##2##4##(2007-1#1)(2008-3#1)
recruitment of new##3##3##(1993-1#1)(1996-10#1)(2007-4#1)
recruitment of participants##2##3##(2008-4#1)(2010-3#1)
recruitment of small-diameter fibers by the long-duration pulses##2##8##(1991-2#2)
recruitment of##81##2##(1990-10#1)(1990-12#1)(1991-10#1)(1991-2#2)(1992-1#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#2)(1994-8#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-5#2)(2008-1#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#1)(2009-10#2)(2009-3#1)(2009-4#1)(2009-6#4)(2009-8#1)(2010-11#3)(2010-3#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#6)(2012-2#2)(2013-1#5)(2013-8#1)
recruitment patterns in the Florida Keys##2##6##(2007-5#2)
recruitment patterns in the##3##4##(2007-5#2)(2012-2#1)
recruitment patterns of##2##3##(2007-3#1)(2007-5#1)
recruitment patterns##6##2##(2007-3#1)(2007-5#3)(2011-2#1)(2012-2#1)
recruitment process for##2##3##(2007-5#1)(2010-11#1)
recruitment strategies##2##2##(1993-2#1)(2007-10#1)
recruitment strategy was##2##3##(2007-10#2)
recruitment strategy##3##2##(2007-10#2)(2010-11#1)
recruitment to clinical trials##3##4##(2010-11#1)(2012-3#1)(2013-1#1)
recruitment to the##8##3##(1997-2#1)(1997-6#1)(2008-10#1)(2009-10#1)(2012-12#2)(2013-1#1)(2013-7#1)
recruitment to##18##2##(1994-11#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-11#1)(2012-12#2)(2012-3#4)(2013-1#2)(2013-7#1)
recruitment tool##2##2##(2012-3#2)
recruitment was##2##2##(2007-10#1)(2007-5#1)
recruitment were##2##2##(1990-2#1)(2011-1#1)
recruitment##335##1##(1990-10#1)(1990-12#1)(1990-2#4)(1991-10#1)(1991-11#1)(1991-2#4)(1991-6#1)(1992-1#4)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#4)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-2#5)(1994-3#4)(1994-4#1)(1994-8#1)(1995-1#4)(1995-12#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#2)(1996-3#2)(1996-5#2)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#3)(1997-8#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-7#1)(2005-8#3)(2005-9#2)(2006-10#4)(2006-11#2)(2006-5#2)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#12)(2007-12#8)(2007-2#1)(2007-3#5)(2007-4#7)(2007-5#8)(2007-8#1)(2007-9#1)(2008-1#9)(2008-10#6)(2008-11#11)(2008-12#4)(2008-3#4)(2008-4#5)(2008-5#10)(2008-7#2)(2008-8#10)(2008-9#3)(2009-1#1)(2009-10#3)(2009-11#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#4)(2009-8#1)(2010-10#4)(2010-11#11)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#7)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#5)(2012-1#8)(2012-11#2)(2012-12#11)(2012-2#10)(2012-3#18)(2013-1#14)(2013-7#5)(2013-8#3)
recruits and blood donors##2##4##(1996-11#2)
recruits and##3##2##(1990-2#1)(1996-11#2)
recruits in##4##2##(2007-5#1)(2008-12#1)(2013-1#2)
recruits is##2##2##(2010-8#1)(2011-2#1)
recruits of##2##2##(2007-5#1)(2011-2#1)
recruits were##2##2##(2007-5#2)
recruits who##2##2##(2008-12#1)(2013-1#1)
recruits##38##1##(1990-2#1)(1990-3#1)(1991-1#1)(1991-6#1)(1994-11#1)(1996-11#2)(1996-5#1)(1997-2#1)(1997-4#1)(2005-9#1)(2007-3#1)(2007-5#6)(2007-8#1)(2008-11#1)(2008-12#4)(2008-8#1)(2009-3#2)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#4)(2013-8#1)
recrystallization of##2##2##(2008-3#2)
recrystallization##5##1##(2008-3#2)(2010-2#1)(2010-4#1)(2013-8#1)
recrystallized##3##1##(2008-10#2)(2008-3#1)
rectal adenocarcinoma##2##2##(2006-8#1)(2007-10#1)
rectal administration##3##2##(2007-2#1)(2008-10#1)(2012-3#1)
rectal and sacral tumor##2##4##(2013-8#2)
rectal and##9##2##(1991-12#1)(1994-5#1)(2009-11#2)(2011-2#1)(2012-11#1)(2012-12#1)(2013-8#2)
rectal bleeding and##2##3##(2007-10#1)(2011-2#1)
rectal bleeding##9##2##(1993-9#1)(2006-8#1)(2007-10#2)(2011-11#1)(2011-2#3)(2013-1#1)
rectal cancer and##6##3##(1991-9#1)(1993-5#1)(1993-9#1)(2010-11#1)(2010-12#1)(2013-8#1)
rectal cancer are##3##3##(2008-10#2)(2010-11#1)
rectal cancer by##2##3##(2011-3#1)(2012-1#1)
rectal cancer in##5##3##(1992-10#1)(2007-4#2)(2009-12#1)(2011-12#1)
rectal cancer is##9##3##(2006-2#1)(2006-8#1)(2008-10#3)(2008-8#1)(2009-12#1)(2011-2#2)
rectal cancer patients##3##3##(2008-10#1)(2009-12#1)(2013-1#1)
rectal cancer surgery##3##3##(2006-8#1)(2010-11#1)(2012-12#1)
rectal cancer with##3##3##(2007-4#1)(2009-8#1)(2013-8#1)
rectal cancer##89##2##(1990-10#2)(1990-9#6)(1991-12#1)(1991-9#4)(1992-10#1)(1992-4#1)(1992-8#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-4#1)(1994-8#1)(1995-4#3)(1996-1#1)(1997-7#3)(1997-8#1)(2006-2#1)(2006-6#4)(2006-8#3)(2006-9#1)(2007-4#5)(2008-1#1)(2008-10#7)(2008-8#1)(2009-12#4)(2009-4#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#3)(2010-12#1)(2010-6#2)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#6)
rectal cancer]##11##2##(2008-10#2)(2008-8#2)(2012-1#6)(2013-7#1)
rectal cancers##4##2##(1991-6#1)(1996-1#1)(2007-8#1)(2011-2#1)
rectal carcinoid##7##2##(2008-5#3)(2010-12#4)
rectal carcinoma##12##2##(1990-4#1)(1990-9#1)(1993-5#1)(1994-10#1)(1995-4#1)(1996-1#1)(2007-10#1)(2008-11#1)(2008-8#1)(2012-12#3)
rectal carcinoma]##4##2##(1990-3#1)(1990-9#1)(1996-8#1)(1997-3#1)
rectal diaphragm##2##2##(2010-2#2)
rectal examination (DRE)##3##3##(2007-3#1)(2008-7#1)(2009-5#1)
rectal examination and##3##3##(2007-11#1)(2008-7#1)(2012-12#1)
rectal examination in##2##3##(2008-7#2)
rectal examination##10##2##(1991-7#1)(2007-11#1)(2007-3#1)(2008-7#4)(2009-5#1)(2011-11#1)(2012-12#1)
rectal examinations##6##2##(1991-7#4)(1994-12#1)(2008-4#1)
rectal lumen##3##2##(2013-1#3)
rectal mucosa following its topical##2##5##(2010-12#2)
rectal mucosa##5##2##(2010-12#4)(2012-1#1)
rectal mucosal prolapse and##3##4##(2013-1#3)
rectal mucosal prolapse##7##3##(2006-6#1)(2013-1#6)
rectal pain##3##2##(2010-12#3)
rectal polypoid##5##2##(2013-1#4)(2013-8#1)
rectal prolapse##3##2##(2006-6#1)(2011-2#1)(2012-2#1)
rectal pull-through##2##2##(2013-1#2)
rectal stump##6##2##(1990-4#3)(2008-8#3)
rectal surgery##3##2##(1990-4#1)(2010-11#2)
rectal temperature and##2##3##(1991-2#1)(1991-3#1)
rectal temperature of##2##3##(1990-9#1)(1993-4#1)
rectal temperature was##2##3##(1990-2#2)
rectal temperature##17##2##(1990-2#3)(1990-5#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#2)(1992-1#1)(1993-4#1)(1995-6#1)(1996-8#1)(2013-1#1)(2013-7#2)
rectal temperatures##3##2##(1990-2#2)(2007-8#1)
rectal toxicity##2##2##(2008-7#2)
rectal tube##5##2##(2005-12#2)(2006-6#3)
rectal tumor##5##2##(2010-12#3)(2013-8#2)
rectal tumour##2##2##(2006-6#1)(2012-12#1)
rectal vs##2##2##(2012-12#2)
rectal##323##1##(1990-10#2)(1990-12#1)(1990-2#5)(1990-3#1)(1990-4#6)(1990-5#3)(1990-6#1)(1990-8#1)(1990-9#10)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#6)(1991-9#4)(1992-1#1)(1992-10#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-4#1)(1993-5#4)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#4)(1994-10#1)(1994-12#1)(1994-3#1)(1994-4#3)(1994-5#1)(1994-8#1)(1995-4#4)(1995-6#1)(1996-1#5)(1996-2#1)(1996-3#1)(1996-8#2)(1997-3#1)(1997-7#3)(1997-8#1)(2005-12#2)(2006-2#3)(2006-6#12)(2006-8#6)(2006-9#1)(2007-10#4)(2007-11#2)(2007-2#1)(2007-3#1)(2007-4#5)(2007-8#2)(2008-1#1)(2008-10#13)(2008-11#1)(2008-3#6)(2008-4#4)(2008-5#3)(2008-7#8)(2008-8#9)(2009-10#1)(2009-11#4)(2009-12#8)(2009-3#1)(2009-4#1)(2009-5#4)(2009-8#2)(2009-9#2)(2010-1#1)(2010-11#7)(2010-12#20)(2010-2#4)(2010-5#1)(2010-6#3)(2011-11#2)(2011-12#2)(2011-2#15)(2011-3#1)(2012-1#9)(2012-11#1)(2012-12#12)(2012-2#1)(2012-3#2)(2013-1#18)(2013-7#4)(2013-8#12)
rectally##3##1##(1991-8#1)(1997-6#1)(2009-10#1)
rectangle##4##1##(1996-2#1)(2008-2#1)(2010-12#1)(2012-2#1)
rectangle-packing##2##1##(2008-6#2)
rectangles can be##2##3##(2008-3#1)(2008-6#1)
rectangles or##2##2##(2008-4#1)(2012-1#1)
rectangles##12##1##(2008-3#1)(2008-4#1)(2008-6#9)(2012-1#1)
rectangular formats##2##2##(2008-2#2)
rectangular lattice arrays##2##3##(2010-1#2)
rectangular lattice##4##2##(1995-3#1)(2008-2#1)(2010-1#2)
rectangular pulses##2##2##(1990-3#1)(2006-5#1)
rectangular shape##3##2##(2007-12#1)(2012-1#1)(2012-2#1)
rectangular symmetry##2##2##(2007-11#1)(2008-3#1)
rectangular##80##1##(1990-3#1)(1991-2#1)(1992-12#1)(1992-7#1)(1995-12#1)(1995-3#1)(1996-2#2)(2005-11#1)(2006-5#3)(2007-1#1)(2007-11#2)(2007-12#7)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#17)(2008-3#14)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-5#1)(2010-9#2)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)
rectangular-shaped##2##1##(2008-3#2)
rectification (type##2##2##(1996-2#2)
rectification and the##4##3##(1994-2#1)(2007-12#3)
rectification and##5##2##(1994-2#1)(2007-11#1)(2007-12#3)
rectification behavior##2##2##(2005-11#2)
rectification in##3##2##(2007-11#2)(2007-12#1)
rectification of##6##2##(1993-4#1)(2007-11#2)(2007-12#1)(2008-6#1)(2008-8#1)
rectification that##2##2##(1994-3#1)(2008-8#1)
rectification##41##1##(1991-8#1)(1993-4#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-2#5)(2005-11#3)(2007-11#7)(2007-12#10)(2007-9#1)(2008-4#1)(2008-6#1)(2008-8#5)(2010-2#1)(2011-2#1)
rectified##10##1##(1997-7#1)(2005-5#1)(2007-11#4)(2008-3#1)(2008-7#1)(2008-8#2)
rectifier K(+)##4##2##(2008-8#3)(2009-12#1)
rectifier K(+)-channel##2##2##(1993-3#2)
rectifier K+ channels##2##3##(2010-12#2)
rectifier K+##5##2##(1995-2#2)(1996-5#1)(2010-12#2)
rectifier##18##1##(1993-12#3)(1993-3#2)(1993-9#1)(1995-2#3)(1996-5#1)(2008-8#4)(2009-12#1)(2010-12#2)(2013-7#1)
rectifiers##2##1##(2007-9#2)
rectify the##2##2##(1996-1#1)(2006-12#1)
rectify this problem##2##3##(1993-8#1)(2008-3#1)
rectify##7##1##(1993-8#1)(1996-1#1)(2006-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2012-12#1)
rectifying K+##9##2##(1994-3#2)(1995-12#2)(1995-2#1)(1997-4#2)(1997-7#1)(2008-8#1)
rectifying potassium channel##2##3##(1994-2#1)(1997-4#1)
rectifying potassium##7##2##(1994-2#4)(1996-2#1)(1997-4#1)(2008-8#1)
rectifying##28##1##(1992-2#1)(1993-12#1)(1994-2#4)(1994-3#2)(1994-9#1)(1995-12#2)(1995-2#1)(1995-6#2)(1996-2#1)(1997-4#3)(1997-7#1)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-4#3)(2011-2#1)
rectilinear in the##2##3##(2008-10#2)
rectilinear over the##6##3##(2008-10#6)
rectilinear##14##1##(2007-12#1)(2007-8#1)(2008-10#12)
recto-anal##2##1##(2011-2#2)
recto-sigmoid##2##1##(1997-3#1)(2008-10#1)
recto-vaginal fistulae##2##2##(2004-10#2)
recto-vaginal##4##1##(1992-3#1)(2004-10#2)(2008-7#1)
rectoanal##2##1##(1994-4#1)(2006-6#1)
rectocolitis##7##1##(1990-3#1)(1992-3#3)(1996-6#1)(2006-2#1)(2008-4#1)
rectorrhagia##2##1##(1993-10#2)
rectoscopy and cystoscopy##2##3##(1992-12#2)
rectoscopy and##3##2##(1992-12#2)(1997-8#1)
rectoscopy##4##1##(1992-12#3)(1997-8#1)
rectosigmoid##8##1##(1993-12#2)(2006-10#1)(2007-3#1)(2007-4#1)(2008-10#1)(2010-2#1)(2013-1#1)
rectosigmoidoscopy with##2##2##(2008-7#2)
rectosigmoidoscopy##4##1##(1991-5#1)(1995-9#1)(2008-7#2)
rectovaginal tears##2##2##(2012-2#2)
rectovaginal##5##1##(2007-8#1)(2008-12#1)(2012-2#3)
rectum (8 cases)##2##3##(1991-10#1)(2007-12#1)
rectum and the##2##3##(2009-12#1)(2011-2#1)
rectum and##22##2##(1991-8#1)(1991-9#2)(1992-3#1)(1992-5#1)(1992-8#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-7#1)(2008-8#1)(2009-12#2)(2009-5#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-1#2)(2012-12#2)
rectum are##3##2##(1993-10#1)(1996-12#1)(2008-3#1)
rectum in##2##2##(1992-8#1)(1994-4#1)
rectum is##4##2##(1990-6#1)(2006-7#1)(2008-7#1)(2012-1#1)
rectum of##3##2##(1996-2#1)(2006-7#1)(2007-12#1)
rectum presenting##2##2##(2008-12#1)(2013-8#1)
rectum that##2##2##(1990-4#1)(2013-8#1)
rectum wall##4##2##(2007-12#1)(2012-1#1)(2012-12#2)
rectum were##2##2##(1991-6#1)(1993-5#1)
rectum with##3##2##(2006-6#1)(2007-2#1)(2008-3#1)
rectum##134##1##(1990-10#1)(1990-2#1)(1990-3#1)(1990-4#3)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#3)(1991-6#3)(1991-8#2)(1991-9#3)(1992-3#2)(1992-4#2)(1992-5#3)(1992-8#2)(1993-10#2)(1993-5#1)(1993-8#4)(1993-9#4)(1994-2#1)(1994-4#1)(1996-12#1)(1996-2#1)(2006-2#2)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#3)(2007-10#1)(2007-12#4)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-5#3)(2009-8#1)(2010-12#4)(2010-5#1)(2011-11#1)(2011-2#7)(2012-1#6)(2012-12#9)(2012-3#2)(2013-1#2)(2013-7#3)(2013-8#5)
rectum)##2##1##(1995-8#1)(2010-8#1)
rectum]##5##1##(1991-12#1)(1992-8#1)(1993-5#1)(2007-8#1)(2008-8#1)
rectus abdominis flap##2##3##(1991-5#1)(2008-4#1)
rectus abdominis muscle##4##3##(1993-12#1)(2006-10#1)(2011-1#1)(2012-2#1)
rectus abdominis myocutaneous flap##3##4##(1990-9#1)(2013-1#2)
rectus abdominis##16##2##(1990-9#1)(1991-5#1)(1993-12#1)(2005-10#1)(2006-10#1)(2008-4#1)(2009-6#1)(2010-4#2)(2011-1#1)(2012-12#1)(2012-2#3)(2013-1#2)
rectus abdominus##2##2##(2012-2#1)(2013-1#1)
rectus femoris muscle length##3##4##(2008-12#3)
rectus femoris muscle##6##3##(2008-12#4)(2011-2#2)
rectus femoris##12##2##(2008-12#5)(2008-6#1)(2010-4#1)(2011-2#3)(2012-1#2)
rectus muscle##8##2##(1990-4#1)(1991-12#1)(1991-3#2)(1993-12#2)(2007-2#1)(2012-3#1)
rectus##47##1##(1990-10#2)(1990-4#1)(1990-9#1)(1991-12#1)(1991-3#3)(1991-5#1)(1992-12#1)(1993-10#2)(1993-12#3)(2005-10#1)(2006-10#1)(2007-2#1)(2008-12#5)(2008-4#1)(2008-6#2)(2009-6#1)(2010-4#3)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
recumbency##5##1##(1994-7#2)(1995-2#1)(2010-10#1)(2011-1#1)
recumbent##5##1##(1996-11#1)(2004-2#4)
recuperate##3##1##(1993-4#1)(2006-10#1)(2008-11#1)
recuperation period##2##2##(1996-1#1)(1997-4#1)
recuperation##4##1##(1996-1#1)(1997-4#1)(2008-1#1)(2008-10#1)
recur after##5##2##(2005-5#1)(2006-10#1)(2010-3#1)(2011-2#1)(2013-1#1)
recur##26##1##(1990-8#1)(1993-11#1)(1993-3#1)(1994-11#1)(2005-5#1)(2006-10#2)(2006-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-12#2)(2010-3#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#4)
recurred after##5##2##(2006-12#1)(2007-8#1)(2008-6#1)(2011-2#1)(2013-8#1)
recurred and##3##2##(2007-12#1)(2008-4#1)(2011-2#1)
recurred as a##2##3##(2008-6#1)(2011-1#1)
recurred as##3##2##(2006-4#1)(2008-6#1)(2011-1#1)
recurred following##2##2##(1994-11#1)(2008-8#1)
recurred in##7##2##(1991-4#1)(1997-6#1)(1997-7#1)(2006-6#1)(2008-10#1)(2008-6#1)(2013-1#1)
recurred locally##2##2##(1990-9#1)(1991-6#1)
recurred within##2##2##(1990-9#1)(2011-1#1)
recurred##49##1##(1990-9#2)(1991-2#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-5#2)(1993-2#1)(1993-6#1)(1994-1#1)(1994-11#1)(1996-12#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#2)(2006-9#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-6#3)(2008-8#1)(2009-1#1)(2009-3#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
recurrence (n =##2##3##(1993-1#1)(1995-10#1)
recurrence (p##2##2##(1993-11#1)(2006-10#1)
recurrence 30##2##2##(2008-7#1)(2013-1#1)
recurrence after a##3##3##(1993-3#1)(2006-11#1)(2008-5#1)
recurrence after primary surgery##2##4##(1990-6#1)(1993-9#1)
recurrence after primary##3##3##(1990-6#1)(1991-8#1)(1993-9#1)
recurrence after resection##2##3##(1991-11#1)(2008-3#1)
recurrence after surgery##5##3##(2007-10#1)(2007-7#2)(2010-12#1)(2012-3#1)
recurrence after surgical##4##3##(2008-7#1)(2009-1#1)(2010-3#1)(2013-1#1)
recurrence after treatment##3##3##(2007-11#1)(2008-1#1)(2010-6#1)
recurrence after##44##2##(1990-3#1)(1990-6#1)(1991-11#2)(1991-8#1)(1992-10#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-9#1)(2004-1#1)(2004-11#1)(2005-1#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#3)(2007-8#2)(2008-1#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-1#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-6#2)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
recurrence along##2##2##(2010-11#1)(2011-2#1)
recurrence among##3##2##(2007-11#3)
recurrence and 15##2##3##(1996-6#1)(2008-6#1)
recurrence and 2##2##3##(1995-10#1)(2007-6#1)
recurrence and a##2##3##(2008-1#1)(2012-12#1)
recurrence and dissemination##2##3##(2007-7#1)(2008-7#1)
recurrence and metastasis##5##3##(2008-11#1)(2008-6#1)(2008-7#1)(2010-12#1)(2012-2#1)
recurrence and the patient##2##4##(2008-12#1)(2012-3#1)
recurrence and the##6##3##(2007-10#1)(2007-8#2)(2008-12#1)(2010-6#1)(2012-3#1)
recurrence and##64##2##(1990-12#1)(1991-8#2)(1995-10#1)(1995-4#2)(1995-8#1)(1996-11#1)(1996-6#2)(2004-2#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#5)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
recurrence are##3##2##(2006-10#1)(2008-2#1)(2008-9#1)
recurrence as well as##2##4##(2008-6#1)(2009-2#1)
recurrence as##5##2##(2008-10#1)(2008-6#1)(2009-2#1)(2011-1#1)(2011-12#1)
recurrence at the same##2##4##(2010-7#1)(2011-1#1)
recurrence at the##4##3##(2007-2#1)(2010-7#1)(2011-1#2)
recurrence at##9##2##(2007-2#1)(2008-6#1)(2010-7#1)(2011-1#2)(2012-2#2)(2012-3#2)
recurrence by##3##2##(2007-5#1)(2010-12#1)(2013-8#1)
recurrence could be##2##3##(2007-8#1)(2008-8#1)
recurrence during the follow-up period##2##5##(2004-10#1)(2006-12#1)
recurrence during##4##2##(2004-10#1)(2006-12#1)(2007-8#1)(2010-12#1)
recurrence even after##2##3##(2008-6#1)(2011-2#1)
recurrence following##6##2##(1994-8#1)(2006-9#2)(2007-8#1)(2008-10#1)(2012-12#1)
recurrence for more than##2##4##(1991-8#1)(1995-10#1)
recurrence for##9##2##(1991-8#1)(1992-4#1)(1995-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-1#1)(2013-1#2)
recurrence free##2##2##(1996-3#1)(2011-12#1)
recurrence from##3##2##(1990-12#1)(2008-10#1)(2010-6#1)
recurrence has been noted##2##4##(2009-10#1)(2010-8#1)
recurrence has been observed##4##4##(2008-10#1)(2008-5#1)(2011-2#2)
recurrence has been reported in##2##5##(2008-8#1)(2011-2#1)
recurrence has been##9##3##(2006-10#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-8#1)(2011-2#3)
recurrence has##11##2##(2006-10#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-8#2)(2009-10#1)(2010-8#1)(2011-2#3)
recurrence in 11##2##3##(2010-3#1)(2011-2#1)
recurrence in patients with##3##4##(1990-10#1)(2012-3#1)(2013-1#1)
recurrence in patients##4##3##(1990-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
recurrence in the##5##3##(1990-12#1)(1996-6#1)(2006-10#1)(2007-11#1)(2008-10#1)
recurrence in##26##2##(1990-10#1)(1990-12#1)(1992-3#1)(1996-6#1)(1997-7#1)(2006-10#2)(2007-11#3)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-6#2)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
recurrence is a##3##3##(2006-8#1)(2007-8#1)(2010-6#1)
recurrence is also##2##3##(2005-11#1)(2008-6#1)
recurrence is common##3##3##(2005-9#1)(2007-8#1)(2008-2#1)
recurrence is##14##2##(2005-11#1)(2005-9#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-6#1)(2007-8#3)(2008-2#1)(2008-6#1)(2010-6#1)(2012-12#1)
recurrence it is##2##3##(2008-1#1)(2013-8#1)
recurrence may##3##2##(2006-11#1)(2008-7#1)(2010-12#1)
recurrence nor##3##2##(1990-1#1)(2009-8#1)(2010-7#1)
recurrence occurred in##4##3##(1995-10#1)(1996-3#1)(1996-6#1)(2010-3#1)
recurrence of a##3##3##(1993-10#1)(2004-10#1)(2008-6#1)
recurrence of bleeding##3##3##(1996-11#2)(2013-8#1)
recurrence of breast##2##3##(1992-2#1)(1996-4#1)
recurrence of cancer##2##3##(1990-11#1)(1992-2#1)
recurrence of colorectal##2##3##(2008-11#1)(2011-2#1)
recurrence of disease##4##3##(2008-6#1)(2009-3#1)(2011-2#1)(2013-8#1)
recurrence of infection##3##3##(2007-11#1)(2007-12#1)(2008-8#1)
recurrence of melanoma##2##3##(1993-12#1)(2008-9#1)
recurrence of stenosis##2##3##(2008-1#2)
recurrence of symptoms##5##3##(1992-8#1)(2005-10#1)(2006-5#1)(2007-1#1)(2008-7#1)
recurrence of the disease##8##4##(1992-10#1)(1995-4#1)(2006-11#1)(2007-3#1)(2008-10#1)(2009-5#1)(2010-9#1)(2013-8#1)
recurrence of the lesion##3##4##(2005-12#1)(2008-5#1)(2010-5#1)
recurrence of the same##2##4##(2006-10#1)(2008-7#1)
recurrence of the tumor##3##4##(2007-8#1)(2008-11#1)(2009-3#1)
recurrence of the tumour##3##4##(2008-6#3)
recurrence of the##33##3##(1992-10#1)(1995-4#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-4#1)(2007-3#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#2)(2009-3#1)(2009-5#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
recurrence of tuberculosis##3##3##(2013-1#3)
recurrence of tumor after##2##4##(2010-8#1)(2011-1#1)
recurrence of##137##2##(1990-11#1)(1990-4#1)(1990-8#1)(1991-10#1)(1991-4#1)(1992-10#3)(1992-2#2)(1992-6#1)(1992-8#1)(1993-10#1)(1993-12#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-10#2)(1996-11#2)(1996-4#1)(1996-6#1)(1996-7#2)(1997-8#1)(2004-10#1)(2004-11#2)(2005-10#1)(2005-12#1)(2006-10#3)(2006-11#1)(2006-2#2)(2006-3#2)(2006-4#2)(2006-5#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#7)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#4)(2007-8#7)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#6)(2008-7#4)(2008-8#3)(2008-9#1)(2009-3#3)(2009-5#1)(2009-6#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#5)
recurrence on##3##2##(2008-5#1)(2008-6#1)(2009-3#1)
recurrence or complications##2##3##(2006-12#1)(2007-9#1)
recurrence or metastasis##3##3##(2006-10#1)(2008-6#1)(2011-2#1)
recurrence or metastatic disease##2##4##(2007-11#1)(2008-6#1)
recurrence or metastatic##3##3##(2007-11#1)(2008-1#1)(2008-6#1)
recurrence or##16##2##(1993-11#1)(1993-2#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-6#2)(2011-2#1)(2013-8#1)
recurrence plots##3##2##(2008-11#3)
recurrence post##2##2##(2013-1#2)
recurrence rate after##3##3##(2006-11#1)(2010-12#2)
recurrence rate and##9##3##(2006-10#1)(2006-6#1)(2007-11#2)(2007-4#1)(2011-2#3)(2012-2#1)
recurrence rate in##2##3##(1992-11#1)(2007-9#1)
recurrence rate of##8##3##(1992-6#1)(1995-3#1)(2006-3#1)(2006-9#1)(2007-11#1)(2007-12#1)(2009-2#1)(2010-9#1)
recurrence rate was##9##3##(1990-12#1)(1991-4#1)(1993-11#1)(1995-5#1)(1996-9#1)(2007-8#1)(2008-5#1)(2009-10#1)(2013-1#1)
recurrence rate##51##2##(1990-12#1)(1991-4#1)(1992-11#1)(1992-6#1)(1993-11#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-9#1)(1997-7#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-3#1)(2006-6#1)(2006-9#2)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2010-12#2)(2010-3#1)(2010-9#1)(2011-2#6)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
recurrence rates and##3##3##(1997-5#1)(1997-6#1)(2007-9#1)
recurrence rates of##2##3##(1993-1#1)(2012-1#1)
recurrence rates to##3##3##(2009-12#1)(2010-8#1)(2011-2#1)
recurrence rates##29##2##(1993-1#1)(1997-5#1)(1997-6#2)(2006-1#1)(2006-11#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-6#2)(2009-12#1)(2010-12#1)(2010-8#2)(2011-2#5)(2012-1#1)(2012-3#1)(2013-1#3)
recurrence reported##2##2##(2008-10#1)(2012-3#1)
recurrence risk of##3##3##(1996-6#1)(2011-2#1)(2012-2#1)
recurrence risk##4##2##(1996-6#2)(2011-2#1)(2012-2#1)
recurrence that##2##2##(2007-12#1)(2008-6#1)
recurrence usually##2##2##(2012-12#1)(2013-8#1)
recurrence was detected##3##3##(1990-2#1)(2008-12#1)(2013-7#1)
recurrence was found##2##3##(1992-2#1)(2008-10#1)
recurrence was observed##9##3##(1992-3#1)(1995-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2010-11#1)(2011-1#1)(2012-12#2)
recurrence was seen in##2##4##(1990-12#1)(2004-1#1)
recurrence was seen##6##3##(1990-12#1)(2004-1#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-12#1)
recurrence was##44##2##(1990-12#1)(1990-2#1)(1991-8#1)(1992-10#1)(1992-2#1)(1992-3#2)(1993-9#1)(1994-12#1)(1995-10#1)(1997-3#2)(2004-1#1)(2004-11#1)(2005-5#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-6#2)(2010-11#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#4)(2013-7#1)
recurrence were##8##2##(1995-10#1)(1996-6#1)(2007-9#1)(2008-7#1)(2012-1#1)(2012-12#1)(2013-8#2)
recurrence with##6##2##(2006-10#1)(2006-9#3)(2007-2#1)(2007-7#1)
recurrence within##5##2##(1996-12#1)(2006-11#1)(2006-4#1)(2007-10#1)(2008-6#1)
recurrence##822##1##(1990-1#1)(1990-10#2)(1990-11#3)(1990-12#7)(1990-2#1)(1990-3#1)(1990-4#2)(1990-6#2)(1990-8#2)(1990-9#2)(1991-10#2)(1991-11#3)(1991-4#4)(1991-8#5)(1991-9#1)(1992-1#1)(1992-10#6)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#4)(1992-4#1)(1992-6#2)(1992-8#2)(1993-1#3)(1993-10#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#1)(1993-9#3)(1994-12#3)(1994-2#1)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#2)(1995-10#7)(1995-2#1)(1995-3#3)(1995-4#5)(1995-5#1)(1995-8#2)(1996-1#1)(1996-10#2)(1996-11#5)(1996-12#2)(1996-3#3)(1996-4#1)(1996-6#12)(1996-7#2)(1996-9#2)(1997-3#2)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#1)(2004-1#3)(2004-10#3)(2004-11#4)(2004-2#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-3#1)(2005-5#3)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#19)(2006-11#6)(2006-12#9)(2006-2#2)(2006-3#4)(2006-4#3)(2006-5#2)(2006-6#9)(2006-8#4)(2006-9#18)(2007-1#3)(2007-10#5)(2007-11#27)(2007-12#21)(2007-2#7)(2007-3#2)(2007-4#4)(2007-5#4)(2007-6#3)(2007-7#18)(2007-8#39)(2007-9#9)(2008-1#11)(2008-10#17)(2008-11#8)(2008-12#2)(2008-2#4)(2008-3#9)(2008-4#5)(2008-5#17)(2008-6#47)(2008-7#19)(2008-8#15)(2008-9#4)(2009-1#1)(2009-10#2)(2009-12#1)(2009-2#3)(2009-3#5)(2009-4#1)(2009-5#5)(2009-6#1)(2009-7#2)(2009-8#4)(2010-10#3)(2010-11#4)(2010-12#16)(2010-3#12)(2010-4#1)(2010-5#1)(2010-6#7)(2010-7#8)(2010-8#4)(2010-9#3)(2011-1#12)(2011-12#2)(2011-2#46)(2012-1#7)(2012-12#25)(2012-2#18)(2012-3#14)(2013-1#39)(2013-7#6)(2013-8#25)
recurrence)##4##1##(1992-10#1)(2006-10#1)(2007-7#1)(2012-1#1)
recurrence-free survival##8##2##(2007-11#1)(2007-6#2)(2008-6#4)(2011-2#1)
recurrence-free##11##1##(1995-8#1)(2007-11#1)(2007-6#2)(2008-6#5)(2011-1#1)(2011-2#1)
recurrence?##2##1##(2009-3#1)(2011-2#1)
recurrence]##2##1##(1992-4#1)(2012-2#1)
recurrences after##5##2##(2006-6#2)(2007-5#1)(2013-1#1)(2013-8#1)
recurrences and##12##2##(1990-9#1)(1995-10#1)(1996-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-7#1)(2012-2#2)(2013-8#1)
recurrences by##3##2##(1990-6#1)(1992-5#2)
recurrences during##2##2##(2006-3#1)(2009-8#1)
recurrences following##2##2##(1990-6#1)(2013-1#1)
recurrences have been observed##2##4##(2007-12#1)(2011-1#1)
recurrences in patients with##2##4##(2010-3#1)(2011-2#1)
recurrences in##9##2##(1992-12#1)(1993-5#1)(1995-2#1)(1996-6#1)(2007-5#1)(2007-7#1)(2010-3#1)(2010-7#1)(2011-2#1)
recurrences is##3##2##(1991-9#1)(2007-11#1)(2007-8#1)
recurrences occurred in##2##3##(1993-5#1)(2011-1#1)
recurrences occurred##4##2##(1990-12#1)(1993-5#1)(1996-9#1)(2011-1#1)
recurrences of the##6##3##(1997-4#1)(2006-10#1)(2007-8#1)(2008-6#1)(2013-1#2)
recurrences of##19##2##(1990-4#1)(1991-2#1)(1991-6#1)(1995-9#1)(1996-12#1)(1997-4#1)(2006-10#1)(2006-6#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-6#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#3)
recurrences on the##2##3##(1991-6#1)(2013-7#1)
recurrences or##4##2##(2009-4#1)(2010-3#1)(2011-2#1)(2012-12#1)
recurrences were detected##2##3##(1990-12#1)(1992-2#1)
recurrences were not##2##3##(1990-9#1)(1993-9#1)
recurrences were observed##2##3##(1990-12#1)(2008-8#1)
recurrences were##7##2##(1990-12#2)(1990-9#1)(1992-2#1)(1993-9#1)(2008-8#1)(2013-1#1)
recurrences##140##1##(1990-12#5)(1990-3#1)(1990-4#1)(1990-6#6)(1990-9#4)(1991-12#2)(1991-2#1)(1991-4#2)(1991-6#3)(1991-9#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-5#2)(1993-3#1)(1993-5#4)(1993-9#2)(1994-1#1)(1995-10#1)(1995-2#3)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-8#3)(2004-1#1)(2004-2#1)(2006-10#5)(2006-11#1)(2006-3#1)(2006-6#7)(2006-8#2)(2007-11#1)(2007-12#1)(2007-5#3)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#4)(2008-6#8)(2008-7#2)(2008-8#3)(2009-10#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-3#2)(2010-7#2)(2011-1#4)(2011-2#5)(2012-12#2)(2012-2#3)(2013-1#8)(2013-7#1)(2013-8#2)
recurrent GBM##2##2##(2006-6#1)(2006-7#1)
recurrent GCToB##2##2##(2012-2#2)
recurrent abdominal pain and##2##4##(1991-10#1)(2011-12#1)
recurrent abdominal pain in##4##4##(1992-5#2)(1993-8#1)(2012-1#1)
recurrent abdominal pain##11##3##(1990-8#1)(1991-10#1)(1992-5#2)(1993-1#1)(1993-8#2)(2005-12#1)(2011-12#1)(2011-2#1)(2012-1#1)
recurrent abdominal##12##2##(1990-8#1)(1991-10#1)(1992-5#2)(1993-1#1)(1993-8#2)(2005-12#1)(2006-4#1)(2011-12#1)(2011-2#1)(2012-1#1)
recurrent abortion##3##2##(1992-12#2)(2007-2#1)
recurrent acute otitis media and##7##5##(2007-9#6)(2013-8#1)
recurrent acute otitis media##10##4##(2007-10#1)(2007-9#8)(2013-8#1)
recurrent acute otitis##11##3##(2007-10#1)(2007-9#9)(2013-8#1)
recurrent acute pancreatitis##2##3##(1995-4#2)
recurrent acute##15##2##(1995-4#2)(2007-10#1)(2007-7#1)(2007-9#9)(2010-7#1)(2013-8#1)
recurrent adverse##2##2##(1997-4#1)(2008-3#1)
recurrent and metastatic disease##2##4##(1996-1#1)(1997-5#1)
recurrent and refractory##2##3##(2008-12#1)(2013-7#1)
recurrent and severe##2##3##(1992-9#1)(2007-11#1)
recurrent and##19##2##(1992-9#1)(1994-6#1)(1996-1#1)(1997-4#1)(1997-5#1)(2006-10#2)(2006-11#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2013-7#1)
recurrent angina##5##2##(1990-4#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-6#1)
recurrent angina-like chest pain##2##4##(1996-3#1)(2012-2#1)
recurrent aphthous stomatitis##2##3##(2007-12#1)(2010-1#1)
recurrent attacks of##2##3##(1997-5#1)(2006-10#1)
recurrent attacks##5##2##(1997-5#1)(2006-10#1)(2007-2#1)(2007-3#2)
recurrent bacteremia##2##2##(2007-2#2)
recurrent bacterial infections##3##3##(2007-11#1)(2008-1#1)(2011-2#1)
recurrent bacterial##4##2##(2006-10#1)(2007-11#1)(2008-1#1)(2011-2#1)
recurrent biliary##2##2##(1991-3#1)(2007-5#1)
recurrent bladder tumours##3##3##(1991-6#3)
recurrent bladder##6##2##(1991-6#4)(2007-12#1)(2013-8#1)
recurrent bleeding in##2##3##(2007-8#2)
recurrent bleeding##6##2##(1996-11#2)(2007-8#4)
recurrent breast cancer##8##3##(1993-1#2)(1994-12#2)(1994-7#2)(1995-10#2)
recurrent cancer##3##2##(2007-7#1)(2008-2#1)(2009-10#1)
recurrent cancers##2##2##(1991-6#1)(2006-6#1)
recurrent carcinoma##2##2##(1994-1#1)(2013-1#1)
recurrent carcinomas##3##2##(1991-4#3)
recurrent cardiac tamponade##2##3##(2010-5#2)
recurrent carpal tunnel syndrome##3##4##(2008-9#3)
recurrent cases##2##2##(2008-11#1)(2009-3#1)
recurrent cellulitis##2##2##(2010-6#2)
recurrent chest##2##2##(2008-12#1)(2009-3#1)
recurrent chronic##2##2##(1991-5#1)(2008-9#1)
recurrent coarctation##2##2##(2007-8#2)
recurrent collaterals of##2##3##(1996-5#2)
recurrent cutaneous##3##2##(1996-2#1)(2010-12#2)
recurrent cyanotic episodes##3##3##(1992-5#3)
recurrent cytogenetic##2##2##(2007-12#1)(2011-2#1)
recurrent disc herniation##2##3##(2006-8#1)(2007-1#1)
recurrent disc##3##2##(2006-8#1)(2007-1#1)(2007-11#1)
recurrent disease after##3##3##(1994-5#1)(1997-4#1)(2010-5#1)
recurrent disease and##2##3##(2007-7#1)(2010-3#1)
recurrent disease in##2##3##(2009-11#1)(2010-5#1)
recurrent disease was##2##3##(1991-8#1)(2006-9#1)
recurrent disease##35##2##(1991-6#1)(1991-8#1)(1991-9#1)(1994-5#1)(1997-3#1)(1997-4#1)(2006-10#8)(2006-9#2)(2007-7#1)(2007-8#1)(2008-12#1)(2008-6#2)(2009-11#1)(2009-2#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
recurrent dislocation##3##2##(2009-3#2)(2011-12#1)
recurrent dislocations##2##2##(2007-7#1)(2009-3#1)
recurrent embolic##2##2##(1996-6#1)(2012-1#1)
recurrent epididymo-orchitis##2##2##(2010-2#2)
recurrent epigastric pain##3##3##(1995-4#2)(2006-10#1)
recurrent episodes of##21##3##(1990-12#1)(1990-2#1)(1994-2#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-11#2)(2006-8#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#2)
recurrent episodes##24##2##(1990-12#1)(1990-2#1)(1994-2#1)(1996-7#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-11#2)(2006-8#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-7#1)(2011-1#2)(2012-12#1)(2013-1#2)
recurrent epistaxis##6##2##(2007-10#2)(2008-7#1)(2010-6#1)(2011-1#1)(2012-1#1)
recurrent erysipelas##2##2##(2007-8#2)
recurrent erythema nodosum##3##3##(2011-1#3)
recurrent event##3##2##(1997-4#3)
recurrent events##8##2##(1997-4#2)(2007-10#3)(2008-11#1)(2008-3#1)(2008-8#1)
recurrent extra-abdominal desmoid##3##3##(2008-6#3)
recurrent fetal loss##4##3##(2004-10#3)(2007-2#1)
recurrent forms##2##2##(2008-4#1)(2012-1#1)
recurrent gastric cancer##3##3##(2006-2#1)(2008-4#1)(2009-8#1)
recurrent gastric##4##2##(1992-10#1)(2006-2#1)(2008-4#1)(2009-8#1)
recurrent giant cell##3##3##(2006-12#1)(2012-2#2)
recurrent haemoptysis##3##2##(1991-11#1)(1992-9#2)
recurrent head and neck cancer##2##5##(1990-12#1)(2007-7#1)
recurrent head and neck tumors##2##5##(2008-5#2)
recurrent head and neck##5##4##(1990-12#1)(2007-7#1)(2008-5#3)
recurrent hematoma##2##2##(2008-7#2)
recurrent hematuria##2##2##(2008-1#2)
recurrent hemoptysis##2##2##(2005-11#1)(2012-3#1)
recurrent hepatitis C##3##3##(2006-10#1)(2007-11#1)(2008-3#1)
recurrent hepatitis##4##2##(2006-10#2)(2007-11#1)(2008-3#1)
recurrent hernias##2##2##(1996-9#2)
recurrent hernias)##2##2##(1992-5#2)
recurrent herpes simplex##2##3##(2005-11#2)
recurrent herpes##3##2##(2005-11#2)(2013-1#1)
recurrent hypoglycemia##3##2##(1997-2#1)(2006-1#2)
recurrent illness##3##2##(2007-11#2)(2008-3#1)
recurrent infection##11##2##(1992-11#1)(1992-9#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-8#2)(2011-2#1)(2011-3#1)
recurrent infections at##2##3##(2007-2#1)(2011-2#1)
recurrent infections of the##2##4##(1992-11#1)(2007-2#1)
recurrent infections##15##2##(1991-6#1)(1992-11#1)(2005-11#1)(2007-11#1)(2007-2#6)(2007-7#1)(2010-5#1)(2011-1#1)(2011-2#2)
recurrent instability##3##2##(2008-8#1)(2009-3#1)(2011-12#1)
recurrent intracranial##2##2##(2006-5#1)(2008-12#1)
recurrent intrahepatic cholangiocarcinoma##2##3##(2008-8#2)
recurrent intrahepatic##4##2##(2005-10#2)(2008-8#2)
recurrent ischemic events##2##3##(1993-2#1)(2007-10#1)
recurrent ischemic##3##2##(1993-2#1)(2007-10#2)
recurrent laryngeal nerve palsy##2##4##(2009-9#2)
recurrent laryngeal nerve##4##3##(2008-2#1)(2009-9#2)(2012-2#1)
recurrent laryngeal nerves##3##3##(1995-6#1)(2005-7#1)(2006-10#1)
recurrent laryngeal##8##2##(1995-6#1)(2005-7#1)(2006-10#1)(2008-2#2)(2009-9#2)(2012-2#1)
recurrent lesions##2##2##(1997-8#1)(2010-5#1)
recurrent limb melanoma##2##3##(2006-6#2)
recurrent lower##3##2##(2007-8#1)(2009-9#1)(2010-7#1)
recurrent major##5##2##(1995-11#1)(1996-3#1)(1996-7#2)(2011-2#1)
recurrent malignancies of the##2##4##(1993-6#1)(1994-1#1)
recurrent malignant glioma##2##3##(2006-12#1)(2006-7#1)
recurrent malignant##5##2##(1990-9#2)(1992-1#1)(2006-12#1)(2006-7#1)
recurrent melanoma##2##2##(1996-2#1)(2008-9#1)
recurrent myocardial infarction##2##3##(1991-3#1)(2008-3#1)
recurrent nerve##4##2##(1990-4#2)(1991-11#1)(2008-2#1)
recurrent network of##2##3##(2008-2#1)(2013-8#1)
recurrent network##5##2##(2008-2#3)(2013-8#2)
recurrent neural networks##5##3##(2010-8#5)
recurrent neural##10##2##(2008-11#4)(2008-2#1)(2010-8#5)
recurrent non-small cell lung cancer##2##5##(2006-6#2)
recurrent or chronic##2##3##(2006-8#1)(2013-1#1)
recurrent or metastatic disease##2##4##(2008-6#2)
recurrent or metastatic##3##3##(2008-6#3)
recurrent or persistent##2##3##(1992-6#1)(2010-12#1)
recurrent or progressive##2##3##(2005-5#1)(2008-5#1)
recurrent or radiation-induced stenosis##2##4##(2006-11#2)
recurrent or##15##2##(1992-6#1)(1995-12#1)(2005-5#1)(2006-11#2)(2006-8#1)(2008-1#2)(2008-5#1)(2008-6#3)(2010-12#1)(2010-5#1)(2013-1#1)
recurrent oral##3##2##(1997-8#1)(2007-7#1)(2012-3#1)
recurrent orbital inflammation##2##3##(2011-1#2)
recurrent osteomyelitis##2##2##(1992-6#1)(2008-9#1)
recurrent osteosarcoma##3##2##(2008-6#2)(2010-3#1)
recurrent pain is##2##3##(2008-11#1)(2009-12#1)
recurrent pain##6##2##(2008-11#4)(2009-12#1)(2010-3#1)
recurrent pancreatitis##4##2##(2006-2#1)(2007-5#1)(2009-12#1)(2011-2#1)
recurrent parent##6##2##(2008-10#5)(2008-9#1)
recurrent patterns##2##2##(2007-12#1)(2008-10#1)
recurrent pelvic and limb melanoma##2##5##(2006-6#2)
recurrent pelvic##3##2##(1994-12#1)(2006-6#2)
recurrent pericarditis##4##2##(2009-10#4)
recurrent pleural effusions##2##3##(2006-12#2)
recurrent pleural##3##2##(1990-10#1)(2006-12#2)
recurrent pneumonia##5##2##(2006-8#1)(2007-2#1)(2007-8#1)(2008-5#1)(2012-2#1)
recurrent post-bronchiolitis##2##2##(2008-1#2)
recurrent pregnancy loss and##2##4##(2011-2#1)(2012-2#1)
recurrent pregnancy loss##6##3##(2009-6#2)(2011-2#3)(2012-2#1)
recurrent prolapse##2##2##(2007-4#1)(2011-2#1)
recurrent prostate cancer##4##3##(2006-10#1)(2007-11#1)(2013-1#2)
recurrent pulmonary##2##2##(2008-4#1)(2011-2#1)
recurrent rectal##3##2##(2006-6#1)(2012-1#2)
recurrent renal##2##2##(1990-12#1)(2007-7#1)
recurrent respiratory infections##7##3##(2005-11#3)(2008-3#2)(2011-2#2)
recurrent respiratory tract infections##3##4##(2008-7#1)(2009-9#1)(2011-2#1)
recurrent respiratory tract##4##3##(2006-2#1)(2008-7#1)(2009-9#1)(2011-2#1)
recurrent respiratory##15##2##(1997-1#1)(1997-2#1)(2005-11#4)(2006-2#1)(2008-3#2)(2008-7#1)(2009-9#1)(2011-2#3)(2013-8#1)
recurrent seizures##5##2##(2007-11#1)(2008-3#1)(2008-7#1)(2009-8#1)(2011-2#1)
recurrent severe##4##2##(2007-11#1)(2007-7#1)(2007-8#1)(2012-12#1)
recurrent sinusitis##2##2##(1993-2#1)(2012-1#1)
recurrent skin##2##2##(2011-2#1)(2013-1#1)
recurrent spontaneous abortion##5##3##(1991-3#1)(1991-8#1)(2010-12#2)(2012-2#1)
recurrent spontaneous##8##2##(1991-3#1)(1991-8#1)(2008-7#1)(2010-12#2)(2012-2#2)(2013-1#1)
recurrent stasis ulcers##4##3##(2013-1#4)
recurrent stenosis##5##2##(1994-4#1)(2005-10#2)(2006-11#1)(2007-10#1)
recurrent stroke in##3##3##(2007-10#1)(2007-9#2)
recurrent stroke prevention##5##3##(2007-10#4)(2007-9#1)
recurrent stroke##34##2##(1991-11#1)(2007-10#13)(2007-9#8)(2008-8#3)(2010-12#1)(2010-9#7)(2012-12#1)
recurrent strokes and##2##3##(2007-10#2)
recurrent strokes##4##2##(2007-10#3)(2010-10#1)
recurrent stupor##2##2##(1994-2#1)(1996-11#1)
recurrent superficial bladder tumours##2##4##(1991-6#2)
recurrent swelling##2##2##(2007-7#2)
recurrent theme##2##2##(2006-3#1)(2010-8#1)
recurrent thrombosis in the antiphospholipid##2##5##(2006-10#2)
recurrent thrombosis##5##2##(1994-11#1)(2004-10#2)(2006-10#2)
recurrent thyroid cancer##3##3##(2012-12#3)
recurrent transient##3##2##(2007-8#1)(2012-3#1)(2013-8#1)
recurrent tumor##5##2##(1992-4#1)(1993-10#1)(1994-8#1)(2007-8#1)(2012-2#1)
recurrent tumors##4##2##(2006-12#2)(2006-2#1)(2007-12#1)
recurrent tumour is##2##3##(2008-1#1)(2008-6#1)
recurrent tumour##5##2##(1993-8#1)(2008-1#2)(2008-6#2)
recurrent tumours##2##2##(2008-6#1)(2009-4#1)
recurrent ulcer##3##2##(1992-11#1)(1992-5#1)(2012-2#1)
recurrent unexplained##2##2##(2006-10#1)(2008-4#1)
recurrent urinary tract infection##2##4##(1990-11#1)(2009-5#1)
recurrent urinary tract infections and##3##5##(2012-2#1)(2012-3#1)(2013-1#1)
recurrent urinary tract infections##5##4##(2008-10#1)(2012-2#2)(2012-3#1)(2013-1#1)
recurrent urinary tract##7##3##(1990-11#1)(2008-10#1)(2009-5#1)(2012-2#2)(2012-3#1)(2013-1#1)
recurrent urinary##8##2##(1990-11#1)(1992-12#1)(2008-10#1)(2009-5#1)(2012-2#2)(2012-3#1)(2013-1#1)
recurrent urosepsis##2##2##(2013-1#2)
recurrent vascular events##2##3##(2007-10#1)(2008-8#1)
recurrent vascular##3##2##(2007-10#1)(2008-8#2)
recurrent venous##2##2##(1994-12#1)(2013-1#1)
recurrent ventricular arrhythmias##3##3##(1993-8#1)(2007-9#1)(2008-12#1)
recurrent ventricular##4##2##(1993-8#1)(2007-9#1)(2008-12#2)
recurrent vomiting##2##2##(1990-3#1)(1996-1#1)
recurrent vulvovaginal candidiasis##3##3##(1994-12#1)(2008-5#1)(2012-3#1)
recurrent vulvovaginal##4##2##(1994-12#1)(2007-10#1)(2008-5#1)(2012-3#1)
recurrent wheals##2##2##(2010-6#2)
recurrent wheezing##2##2##(2008-1#1)(2009-8#1)
recurrent##929##1##(1990-10#3)(1990-11#3)(1990-12#3)(1990-2#2)(1990-3#3)(1990-4#4)(1990-5#2)(1990-6#2)(1990-8#1)(1990-9#6)(1991-10#3)(1991-11#5)(1991-2#2)(1991-3#4)(1991-4#3)(1991-5#1)(1991-6#12)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#3)(1992-2#1)(1992-4#2)(1992-5#10)(1992-6#4)(1992-8#1)(1992-9#6)(1993-1#5)(1993-10#1)(1993-12#1)(1993-2#4)(1993-6#1)(1993-7#1)(1993-8#5)(1994-1#2)(1994-11#1)(1994-12#5)(1994-2#2)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#2)(1994-8#2)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#6)(1995-2#1)(1995-4#4)(1995-6#1)(1995-8#1)(1996-1#2)(1996-11#4)(1996-2#2)(1996-3#2)(1996-5#2)(1996-6#1)(1996-7#3)(1996-9#3)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#8)(1997-5#4)(1997-8#5)(2004-10#5)(2004-11#2)(2004-12#1)(2004-3#1)(2005-10#4)(2005-11#10)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#3)(2006-10#31)(2006-11#8)(2006-12#7)(2006-2#4)(2006-3#1)(2006-4#5)(2006-5#2)(2006-6#13)(2006-7#6)(2006-8#7)(2006-9#5)(2007-1#1)(2007-10#31)(2007-11#19)(2007-12#10)(2007-2#21)(2007-3#4)(2007-4#1)(2007-5#3)(2007-7#22)(2007-8#33)(2007-9#19)(2008-1#14)(2008-10#17)(2008-11#16)(2008-12#8)(2008-2#11)(2008-3#12)(2008-4#10)(2008-5#14)(2008-6#25)(2008-7#19)(2008-8#18)(2008-9#12)(2009-10#5)(2009-11#1)(2009-12#3)(2009-2#3)(2009-3#9)(2009-4#1)(2009-5#3)(2009-6#2)(2009-8#7)(2009-9#5)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#14)(2010-2#3)(2010-3#5)(2010-4#1)(2010-5#7)(2010-6#10)(2010-7#4)(2010-8#6)(2010-9#9)(2011-1#20)(2011-12#5)(2011-2#36)(2011-3#1)(2012-1#12)(2012-11#1)(2012-12#14)(2012-2#24)(2012-3#18)(2013-1#29)(2013-7#5)(2013-8#10)
recurrently##7##1##(1992-6#1)(1996-2#1)(1997-5#1)(2004-11#1)(2008-4#1)(2008-5#1)(2013-1#1)
recurring abdominal##2##2##(1993-7#1)(2008-3#1)
recurring and##3##2##(1997-4#2)(2004-11#1)
recurring infection##2##2##(2007-8#1)(2008-6#1)
recurring issues##2##2##(2007-2#1)(2007-4#1)
recurring outcome##2##2##(1997-4#2)
recurring themes##4##2##(2005-7#1)(2008-12#1)(2008-5#1)(2010-7#1)
recurring##45##1##(1991-3#2)(1993-1#1)(1993-7#1)(1993-9#1)(1994-12#1)(1996-2#1)(1997-4#5)(2004-11#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-2#1)(2013-7#1)
recurs##10##1##(1995-12#1)(1996-12#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-6#1)(2010-2#1)(2011-2#1)
recursion##2##1##(2007-11#1)(2008-2#1)
recursions##2##1##(1994-6#2)
recursive algorithm##2##2##(1992-2#1)(2008-2#1)
recursive least-squares algorithm##2##3##(2008-1#1)(2008-2#1)
recursive partitioning analysis##2##3##(1991-12#1)(2008-3#1)
recursive partitioning##6##2##(1991-12#2)(1992-2#1)(1995-2#1)(2008-3#1)(2013-1#1)
recursive procedure##2##2##(2008-3#2)
recursive##27##1##(1991-12#2)(1992-2#3)(1995-12#1)(1995-2#1)(1997-3#1)(2006-10#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-2#5)(2008-3#6)(2008-6#1)(2010-12#1)(2013-1#1)
recursively##3##1##(2007-3#1)(2008-2#1)(2013-1#1)
recurva##4##1##(2006-10#2)(2007-7#2)
recurved##2##1##(2008-5#2)
recyclability##3##1##(1994-3#1)(2010-12#1)(2010-6#1)
recyclable##3##1##(1996-1#1)(2007-11#1)(2008-10#1)
recycle batch##5##2##(2008-11#1)(2008-7#4)
recycle##18##1##(1994-9#1)(1995-6#1)(2005-8#1)(2006-12#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-9#1)(2011-1#1)(2012-12#1)
recycled HDPE##5##2##(2009-3#5)
recycled back##2##2##(1991-9#1)(1996-2#1)
recycled bone##2##2##(2008-6#2)
recycled in##3##2##(1990-8#1)(1994-9#1)(2007-11#1)
recycled plates##3##2##(1996-11#3)
recycled##36##1##(1990-8#1)(1991-9#1)(1994-9#1)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-4#1)(2008-6#2)(2008-7#1)(2009-3#6)(2011-2#3)(2012-2#2)(2013-1#2)
recycles##3##1##(2006-10#1)(2006-11#1)(2012-1#1)
recycling and##2##2##(1996-3#1)(2012-11#1)
recycling from##3##2##(1996-12#1)(1996-3#1)(2011-1#1)
recycling hypothesis##4##2##(1997-1#3)(2007-8#1)
recycling of a##2##3##(2008-3#1)(2008-8#1)
recycling of eIF-2##2##3##(1991-12#2)
recycling of internalized##2##3##(1994-8#1)(1997-7#1)
recycling of the##2##3##(1990-11#1)(2008-11#1)
recycling of##25##2##(1990-11#1)(1991-12#2)(1991-9#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-8#1)(1997-7#2)(2005-8#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-6#2)(2008-8#1)(2008-9#1)(2012-2#1)
recycling or##2##2##(2007-3#1)(2012-2#1)
recycling organic##2##2##(2005-11#1)(2008-5#1)
recycling site##2##2##(2008-10#2)
recycling was##2##2##(1997-7#1)(2008-3#1)
recycling with##3##2##(1996-11#1)(2008-2#2)
recycling##96##1##(1990-11#2)(1991-12#2)(1991-9#1)(1992-11#1)(1992-12#1)(1993-11#4)(1993-3#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-8#1)(1996-1#2)(1996-11#4)(1996-12#4)(1996-3#5)(1997-1#4)(1997-7#5)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-8#2)(2008-1#3)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2011-1#3)(2012-11#1)(2012-2#3)(2013-1#2)
recycling)##2##1##(2008-10#1)(2009-10#1)
red (10 microM)##2##3##(1992-8#1)(2008-8#1)
red (MR)##2##2##(2008-10#1)(2010-5#1)
red (NR)##4##2##(1993-9#1)(2008-10#2)(2010-5#1)
red S##6##2##(2008-10#4)(2013-7#2)
red alga##9##2##(1997-3#2)(1997-6#1)(2006-12#1)(2008-10#2)(2008-11#3)
red algae##9##2##(1997-4#3)(2007-3#2)(2008-10#1)(2008-8#1)(2011-10#1)(2012-1#1)
red algal##2##2##(1994-12#1)(2009-6#1)
red and blue##3##3##(2006-11#1)(2008-3#1)(2008-8#1)
red and green##4##3##(1997-4#1)(2007-8#1)(2008-10#1)(2008-3#1)
red and white##4##3##(2008-10#3)(2009-4#1)
red and##27##2##(1992-11#1)(1994-12#1)(1995-3#1)(1997-4#1)(2006-11#1)(2007-11#1)(2007-8#3)(2008-10#8)(2008-11#1)(2008-3#6)(2008-8#1)(2009-4#1)(2010-5#1)
red areas of the##2##4##(1990-1#1)(1990-10#1)
red areas##3##2##(1990-1#1)(1990-10#1)(2008-7#1)
red beds##6##2##(2013-8#6)
red beet##3##2##(1990-3#1)(1994-8#1)(2008-10#1)
red blood cell (RBC) transfusion##3##5##(2008-5#1)(2011-1#1)(2012-3#1)
red blood cell (RBC)##13##4##(1990-4#1)(1992-1#2)(1992-3#1)(1996-3#1)(2008-3#1)(2008-5#2)(2009-4#1)(2011-1#1)(2012-3#2)(2013-1#1)
red blood cell count##2##4##(2006-4#1)(2007-2#1)
red blood cell counts##2##4##(1993-4#1)(2013-7#1)
red blood cell membrane##5##4##(1994-12#2)(1994-6#1)(1997-1#2)
red blood cell membranes##2##4##(1991-10#1)(1992-1#1)
red blood cell scintigraphy##3##4##(2009-2#3)
red blood cell transfusion##6##4##(2006-10#1)(2008-3#1)(2008-7#2)(2012-2#2)
red blood cell transfusions during the study##2##7##(2008-7#2)
red blood cell transfusions##6##4##(2006-10#1)(2006-4#1)(2008-7#2)(2012-2#2)
red blood cell units##2##4##(2007-11#1)(2013-1#1)
red blood cell velocity##2##4##(1993-11#2)
red blood cell##78##3##(1990-4#1)(1990-8#1)(1991-10#1)(1991-3#1)(1992-1#3)(1992-3#1)(1993-11#2)(1993-12#1)(1993-3#3)(1993-4#1)(1994-12#3)(1994-2#2)(1994-6#2)(1995-8#1)(1996-3#2)(1996-6#2)(1996-8#1)(1997-1#2)(1997-6#2)(2006-10#2)(2006-12#1)(2006-4#2)(2006-5#3)(2007-11#2)(2007-2#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#3)(2008-7#4)(2008-8#1)(2009-2#3)(2009-4#1)(2009-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#1)
red blood cells (RBC) of##2##5##(1992-1#1)(2008-8#1)
red blood cells (RBC) was##2##5##(1996-3#1)(2010-8#1)
red blood cells (RBC)##13##4##(1992-1#1)(1993-3#1)(1994-2#1)(1994-5#1)(1995-1#1)(1996-3#1)(1996-7#1)(2005-10#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-8#1)(2011-12#1)
red blood cells (RBCs) and##2##5##(1993-6#1)(2009-4#1)
red blood cells (RBCs) in##2##5##(1994-6#1)(2005-7#1)
red blood cells (RBCs) tested##2##5##(1993-9#1)(1994-12#1)
red blood cells (RBCs) were##2##5##(1994-9#1)(2010-9#1)
red blood cells (RBCs)##19##4##(1990-3#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-12#5)(1994-3#1)(1994-6#2)(1994-9#1)(2005-7#1)(2008-10#1)(2009-11#1)(2009-4#1)(2010-9#1)
red blood cells and##11##4##(1995-3#1)(1997-8#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-4#1)(2010-12#1)(2012-12#2)(2013-1#1)
red blood cells by##5##4##(1993-11#1)(1993-3#1)(1993-8#1)(2006-10#1)(2008-11#1)
red blood cells for##2##4##(1994-3#1)(2009-2#1)
red blood cells from##6##4##(1994-2#1)(1996-12#1)(2007-8#1)(2008-3#1)(2008-4#1)(2010-8#1)
red blood cells in##4##4##(2008-10#1)(2008-9#1)(2009-2#1)(2012-2#1)
red blood cells is##3##4##(1990-1#1)(1996-3#1)(2012-3#1)
red blood cells of patients##2##5##(1993-11#1)(1997-6#1)
red blood cells of the##3##5##(2007-9#1)(2008-8#1)(2012-2#1)
red blood cells of##6##4##(1993-11#1)(1994-12#1)(1997-6#1)(2007-9#1)(2008-8#1)(2012-2#1)
red blood cells to##3##4##(1990-12#1)(2008-10#1)(2012-2#1)
red blood cells was##5##4##(1990-2#2)(1994-6#1)(2007-9#2)
red blood cells##188##3##(1990-1#2)(1990-12#4)(1990-2#2)(1990-3#1)(1990-7#1)(1990-8#2)(1991-12#2)(1991-4#1)(1991-5#1)(1991-8#3)(1992-1#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-11#2)(1993-12#2)(1993-3#5)(1993-4#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#7)(1994-2#7)(1994-3#2)(1994-5#2)(1994-6#6)(1994-8#2)(1994-9#2)(1995-1#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-12#3)(1996-3#3)(1996-7#1)(1997-6#1)(1997-8#4)(2005-10#2)(2005-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#3)(2007-9#3)(2008-10#15)(2008-11#2)(2008-2#5)(2008-3#4)(2008-4#7)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-11#1)(2009-2#4)(2009-4#2)(2009-8#1)(2010-12#3)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#6)
red blood##269##2##(1990-1#2)(1990-12#4)(1990-2#2)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#3)(1991-10#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#3)(1992-1#4)(1992-11#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-11#4)(1993-12#3)(1993-3#8)(1993-4#3)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#10)(1994-2#9)(1994-3#2)(1994-5#2)(1994-6#8)(1994-8#2)(1994-9#2)(1995-1#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#3)(1996-3#5)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#2)(1997-6#3)(1997-8#5)(2005-10#2)(2005-7#1)(2006-10#3)(2006-12#1)(2006-4#2)(2006-5#3)(2006-6#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-8#4)(2007-9#3)(2008-10#18)(2008-11#2)(2008-2#6)(2008-3#7)(2008-4#7)(2008-5#8)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#3)(2009-11#1)(2009-2#7)(2009-4#3)(2009-5#1)(2009-8#1)(2010-12#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#9)(2012-3#4)(2013-1#9)(2013-7#1)
red blotchiness##2##2##(2008-5#2)
red cell adherence##2##3##(1993-3#1)(2012-2#1)
red cell and##2##3##(1990-12#1)(1993-3#1)
red cell antigens##5##3##(1992-9#2)(1993-12#1)(1994-3#2)
red cell aplasia (PRCA)##3##4##(2007-10#1)(2008-10#1)(2008-12#1)
red cell aplasia##6##3##(2007-10#2)(2008-10#1)(2008-12#1)(2008-6#1)(2013-1#1)
red cell aplasia]##2##3##(1994-3#1)(2013-1#1)
red cell destruction##2##3##(1992-6#1)(1992-7#1)
red cell distribution width##2##4##(2005-10#1)(2011-12#1)
red cell mass##2##3##(2008-4#2)
red cell membrane##8##3##(1990-5#1)(1991-5#2)(1993-6#1)(1994-12#1)(1996-1#1)(1997-6#1)(2008-11#1)
red cell phenotype##2##3##(1993-12#1)(1994-12#1)
red cell samples##2##3##(1993-3#1)(1994-3#1)
red cell units##2##3##(1994-12#1)(1994-9#1)
red cell##87##2##(1990-11#2)(1990-12#2)(1990-5#1)(1990-8#1)(1991-10#1)(1991-3#1)(1991-5#3)(1991-8#1)(1991-9#2)(1992-12#2)(1992-2#1)(1992-6#3)(1992-7#1)(1992-9#4)(1993-12#2)(1993-3#5)(1993-6#1)(1994-12#4)(1994-3#5)(1994-5#2)(1994-6#1)(1994-9#5)(1995-1#2)(1995-11#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-6#2)(1996-7#1)(1997-6#1)(2005-10#2)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-10#2)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#2)(2008-6#1)(2008-7#1)(2009-5#1)(2011-12#2)(2011-3#1)(2012-2#1)(2013-1#2)
red cells and##4##3##(1992-12#1)(1993-9#1)(1994-3#1)(2008-4#1)
red cells are##3##3##(1991-5#1)(1994-3#1)(2006-10#1)
red cells collected##2##3##(1993-12#1)(1994-3#1)
red cells from the proposita##3##5##(1992-12#3)
red cells from##7##3##(1992-12#5)(1993-12#1)(1994-12#1)
red cells in##4##3##(1992-3#1)(1993-3#1)(2005-10#1)(2006-6#1)
red cells lack##2##3##(1995-6#2)
red cells of different age##2##5##(1995-1#2)
red cells of##4##3##(1990-9#1)(1994-12#1)(1995-1#2)
red cells or##2##3##(1992-12#1)(1993-3#1)
red cells treated with##2##4##(1992-9#1)(1994-12#1)
red cells were##5##3##(1993-12#2)(1994-3#1)(2008-10#1)(2008-3#1)
red cells##69##2##(1990-11#2)(1990-12#2)(1990-8#2)(1990-9#1)(1991-5#1)(1992-12#8)(1992-3#2)(1992-9#2)(1993-12#6)(1993-3#9)(1993-9#2)(1994-12#3)(1994-3#8)(1994-5#1)(1995-1#2)(1995-6#2)(1997-1#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-9#1)(2008-10#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#1)(2010-11#1)(2011-1#1)(2013-1#2)
red clover mottle##2##3##(1995-12#2)
red clover##4##2##(1995-12#2)(2004-4#1)(2008-10#1)
red color##4##2##(1992-1#1)(2008-10#1)(2010-4#2)
red colour##3##2##(2006-12#2)(2008-5#1)
red coloured##4##2##(2008-10#3)(2008-5#1)
red complex with##2##3##(2008-10#2)
red complex##8##2##(2008-10#8)
red compound##2##2##(2005-4#1)(2008-10#1)
red deer (Cervus elaphus) in Ireland##2##6##(1993-2#2)
red deer (Cervus elaphus)##3##4##(1993-2#2)(2005-7#1)
red deer##9##2##(1993-2#2)(2005-7#7)
red disarrayed&quot##2##2##(1990-3#2)
red discoloration of##2##3##(1995-11#1)(2013-1#1)
red dyes##2##2##(2008-10#2)
red emission##4##2##(2007-12#2)(2007-8#1)(2008-10#1)
red flag documentation##2##3##(2008-12#2)
red flag items##3##3##(2008-12#3)
red flag##6##2##(2008-12#5)(2013-1#1)
red flags##6##2##(1997-4#1)(2008-12#3)(2010-9#1)(2013-7#1)
red flour beetle##2##3##(1992-8#1)(2008-12#1)
red fluorescence##3##2##(2006-10#1)(2008-4#1)(2008-5#1)
red fluorescent##5##2##(1990-5#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)
red for##2##2##(2008-3#1)(2013-7#1)
red fruits##2##2##(2008-10#2)
red in the##2##3##(1994-5#1)(2008-10#1)
red in##4##2##(1994-5#1)(2008-10#3)
red laser light##2##3##(2008-3#1)(2012-2#1)
red laser##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2012-2#1)
red leading edges stimulated an ETR under##2##7##(2011-2#2)
red light and##5##3##(1990-5#1)(2008-4#2)(2009-6#1)(2013-1#1)
red light emitting diode##2##4##(2007-8#2)
red light is##2##3##(2007-11#1)(2007-12#1)
red light##36##2##(1990-11#1)(1990-5#4)(1992-1#1)(1992-6#1)(1995-9#1)(2007-11#2)(2007-12#8)(2007-8#3)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#2)(2008-8#1)(2008-9#1)(2009-6#1)(2012-2#2)(2013-1#1)
red light-induced amaranthin##2##3##(2008-4#2)
red mangrove (Rhizophora mangle)##3##4##(2007-5#1)(2008-5#1)(2011-2#1)
red mangrove##5##2##(2007-5#1)(2008-5#2)(2011-2#2)
red marrow##2##2##(2008-6#2)
red meat##8##2##(2004-9#1)(2011-2#5)(2012-12#1)(2012-2#1)
red mud##5##2##(2005-11#2)(2007-8#3)
red muscle##3##2##(1997-7#2)(2005-8#1)
red nucleus##20##2##(1990-2#2)(1991-9#2)(1992-11#11)(1992-7#1)(1992-8#1)(1994-10#1)(1996-6#1)(1997-2#1)
red ochre##3##2##(2008-10#3)
red or green##2##3##(1992-12#1)(2011-2#1)
red or##4##2##(1992-12#1)(2008-3#2)(2011-2#1)
red orange extract##2##3##(2008-5#2)
red pacu##2##2##(2008-7#2)
red pepper##5##2##(1997-6#1)(2004-11#1)(2008-10#2)(2012-3#1)
red pigments##3##2##(1990-7#1)(2008-5#1)(2013-7#1)
red pine##3##2##(2008-10#3)
red raspberry and ellagic acid##2##5##(2009-3#2)
red raspberry##3##2##(2009-3#3)
red resinous exudates##2##3##(2008-10#2)
red sea urchin##3##3##(2007-5#3)
red sea##5##2##(2007-5#4)(2009-5#1)
red seaweed##2##2##(2006-12#1)(2008-11#1)
red shift in the##2##4##(1990-5#1)(1991-2#1)
red shift in##3##3##(1990-5#1)(1991-2#1)(2008-10#1)
red shift of##7##3##(1992-12#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)
red shift##16##2##(1990-5#1)(1991-2#1)(1992-12#1)(1994-8#1)(1995-2#1)(2005-11#2)(2006-12#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#4)(2011-1#1)
red shifts##2##2##(1997-5#1)(2008-10#1)
red showed##2##2##(2006-8#1)(2008-5#1)
red soil region##2##3##(2013-8#2)
red soil##6##2##(2008-10#1)(2013-8#5)
red staining of##2##3##(2006-8#1)(2010-2#1)
red staining##3##2##(2006-8#1)(2010-2#1)(2011-2#1)
red tape##2##2##(2008-7#1)(2009-4#1)
red thrombi##4##2##(2008-5#4)
red tilapia##3##2##(2008-12#3)
red to blue##3##3##(2008-10#2)(2010-1#1)
red to##5##2##(2008-1#1)(2008-10#2)(2008-5#1)(2010-1#1)
red wine consumption##2##3##(2008-7#2)
red wine may##2##3##(1995-3#1)(2008-7#1)
red wine might##2##3##(2008-10#2)
red wine or##3##3##(2011-2#2)(2012-12#1)
red wine polyphenols##2##3##(2009-3#2)
red wine samples##4##3##(2007-8#1)(2008-10#3)
red wine##43##2##(1995-3#3)(1996-1#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-7#9)(2009-3#3)(2010-12#1)(2010-2#1)(2011-2#6)(2012-12#1)(2013-1#1)
red wines using##2##3##(2008-10#2)
red wines##13##2##(1995-3#2)(2007-8#1)(2008-10#10)
red winter wheat##4##3##(2008-10#2)(2008-5#2)
red with##4##2##(2006-10#1)(2006-11#1)(2008-10#2)
red##1018##1##(1990-1#3)(1990-10#1)(1990-11#7)(1990-12#9)(1990-2#4)(1990-3#4)(1990-4#1)(1990-5#11)(1990-7#2)(1990-8#6)(1990-9#1)(1991-10#3)(1991-12#2)(1991-2#1)(1991-3#4)(1991-4#1)(1991-5#5)(1991-8#4)(1991-9#5)(1992-1#7)(1992-11#18)(1992-12#12)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#6)(1992-7#2)(1992-8#3)(1992-9#7)(1993-10#1)(1993-11#4)(1993-12#11)(1993-2#3)(1993-3#22)(1993-4#3)(1993-6#2)(1993-8#1)(1993-9#5)(1994-10#1)(1994-11#3)(1994-12#20)(1994-2#10)(1994-3#17)(1994-4#1)(1994-5#8)(1994-6#9)(1994-8#6)(1994-9#7)(1995-1#5)(1995-11#5)(1995-12#4)(1995-2#4)(1995-3#7)(1995-5#2)(1995-6#3)(1995-8#3)(1995-9#1)(1996-1#2)(1996-12#3)(1996-2#1)(1996-3#5)(1996-4#1)(1996-6#5)(1996-7#2)(1996-8#1)(1997-1#4)(1997-2#1)(1997-3#2)(1997-4#7)(1997-5#3)(1997-6#6)(1997-7#2)(1997-8#5)(2004-11#1)(2004-4#1)(2004-9#1)(2005-10#5)(2005-11#4)(2005-4#1)(2005-6#1)(2005-7#10)(2005-8#1)(2006-10#7)(2006-11#2)(2006-12#8)(2006-2#1)(2006-4#3)(2006-5#6)(2006-6#3)(2006-8#2)(2007-10#2)(2007-11#9)(2007-12#23)(2007-2#3)(2007-3#3)(2007-5#6)(2007-7#1)(2007-8#23)(2007-9#5)(2008-1#6)(2008-10#145)(2008-11#15)(2008-12#14)(2008-2#16)(2008-3#27)(2008-4#20)(2008-5#38)(2008-6#5)(2008-7#23)(2008-8#17)(2008-9#7)(2009-11#2)(2009-12#2)(2009-2#8)(2009-3#6)(2009-4#5)(2009-5#3)(2009-6#4)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#3)(2010-4#6)(2010-5#8)(2010-6#2)(2010-7#3)(2010-8#7)(2010-9#2)(2011-1#6)(2011-10#1)(2011-12#8)(2011-2#29)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#8)(2012-2#20)(2012-3#6)(2013-1#23)(2013-7#6)(2013-8#15)
red)##2##1##(2008-10#1)(2008-9#1)
red-##3##1##(1993-9#1)(1994-3#1)(2008-8#1)
red-absorbing##2##1##(1990-12#2)
red-bellied newt##2##2##(2008-6#2)
red-bellied##3##1##(1997-4#1)(2008-6#2)
red-cell reinfusion##2##2##(2008-8#2)
red-cell##4##1##(1992-9#1)(1997-5#1)(2008-8#2)
red-colored##4##1##(2008-3#1)(2009-11#1)(2011-12#1)(2011-2#1)
red-coloured##2##1##(1990-12#1)(2008-10#1)
red-emitting CdTe quantum dots##2##4##(2008-10#2)
red-green##2##1##(2008-1#1)(2010-4#1)
red-green-blue##3##1##(2008-3#1)(2009-11#1)(2010-4#1)
red-haired##3##1##(2012-11#3)
red-legged partridges##2##2##(2008-5#2)
red-light##3##1##(2009-8#3)
red-ox##3##1##(1991-1#2)(2008-10#1)
red-region fluorescent reagent##2##3##(2008-10#2)
red-region fluorescent##3##2##(2008-10#3)
red-sensitive##10##1##(1990-10#2)(1990-12#4)(1992-8#1)(2008-2#1)(2008-8#1)(2011-12#1)
red-shift##5##1##(1991-7#1)(1992-12#1)(1994-10#1)(1996-12#2)
red-shifted emission##2##2##(1991-7#1)(2009-2#1)
red-shifted intermediates of##2##3##(1997-4#2)
red-shifted intermediates##3##2##(1997-4#3)
red-shifted to##2##2##(2008-10#2)
red-shifted##18##1##(1991-7#1)(1993-11#1)(1995-5#1)(1997-4#5)(2005-4#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-2#1)(2010-2#2)
red-smear##3##1##(2012-2#3)
red-tailed##3##1##(2008-5#3)
red-tape##2##1##(1994-2#1)(1995-7#1)
red-violet##3##1##(2008-10#2)(2008-5#1)
red/infrared irradiation had##2##3##(2008-10#2)
redactable##8##1##(2013-1#8)
redacting##4##1##(2013-1#4)
reddened##2##1##(1992-3#1)(2008-10#1)
reddening##4##1##(1991-8#1)(2005-7#1)(2008-3#1)(2008-5#1)
redder##5##1##(2010-4#4)(2011-2#1)
reddish spot##3##2##(2004-2#3)
reddish##12##1##(2004-2#6)(2008-10#1)(2008-5#1)(2010-12#1)(2012-3#1)(2013-8#2)
reddish-brown##3##1##(2008-10#2)(2008-2#1)
redefine the##6##2##(1994-1#1)(1994-3#1)(1995-2#1)(1996-1#1)(2011-2#1)(2012-12#1)
redefine##13##1##(1994-1#1)(1994-3#1)(1995-2#2)(1996-1#1)(1996-6#1)(2005-7#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-6#1)(2011-2#1)(2012-12#1)
redefined to##2##2##(2005-9#1)(2006-7#1)
redefined##11##1##(1995-1#1)(1995-12#1)(1995-3#2)(1997-1#1)(2005-9#1)(2006-7#2)(2008-10#1)(2008-12#1)(2010-6#1)
redefining the##6##2##(1993-7#1)(1994-2#1)(1995-12#1)(2008-10#1)(2008-3#1)(2011-3#1)
redefining##14##1##(1993-3#1)(1993-7#1)(1994-2#1)(1995-12#1)(2006-2#1)(2007-4#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-2#1)(2009-4#1)(2011-3#1)
redefinition of the##3##3##(2006-10#1)(2008-3#1)(2013-8#1)
redefinition of##7##2##(1997-8#1)(2006-10#2)(2006-4#1)(2008-3#1)(2011-2#1)(2013-8#1)
redefinition##8##1##(1997-8#1)(2006-10#2)(2006-4#1)(2006-9#1)(2008-3#1)(2011-2#1)(2013-8#1)
redeployment##8##1##(1993-1#3)(1994-2#1)(1995-1#3)(1995-2#1)
redesign and##2##2##(1996-1#1)(2007-12#1)
redesign of the##3##3##(1996-3#1)(1997-3#1)(2008-7#1)
redesign of##6##2##(1996-3#1)(1997-2#2)(1997-3#1)(2007-3#1)(2008-7#1)
redesign process##3##2##(1996-12#1)(1996-3#2)
redesign##41##1##(1992-12#2)(1993-12#2)(1993-3#2)(1994-1#2)(1994-7#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#7)(1997-1#2)(1997-2#3)(1997-3#1)(2004-10#2)(2007-12#1)(2007-3#1)(2008-1#2)(2008-12#1)(2008-7#1)(2010-11#1)(2012-1#1)
redesigned its##2##2##(1995-12#1)(1996-1#1)
redesigned side airbag##2##3##(2007-1#2)
redesigned to achieve##2##3##(1994-12#1)(2013-8#1)
redesigned to##4##2##(1994-12#1)(1995-1#1)(2008-6#1)(2013-8#1)
redesigned##15##1##(1994-12#1)(1995-1#1)(1995-12#1)(1996-1#1)(1997-2#1)(2007-1#2)(2007-5#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)(2012-10#1)(2013-8#2)
redesigning of##2##2##(1992-3#1)(2008-11#1)
redesigning the##6##2##(1995-12#1)(1995-3#1)(1996-1#1)(1997-3#2)(2008-2#1)
redesigning##20##1##(1992-3#2)(1993-2#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-7#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-4#1)(2010-7#1)
redhorse (Moxostoma##4##2##(2009-4#4)
redhorse##7##1##(2009-4#7)
redhorse)##2##1##(2009-4#2)
redifferentiated##3##1##(2007-1#2)(2008-11#1)
redifferentiation##4##1##(2008-8#1)(2009-3#1)(2009-8#1)(2010-7#1)
redirect the##5##2##(1996-10#1)(2005-10#1)(2008-2#2)(2011-1#1)
redirect##10##1##(1996-10#1)(1997-7#1)(2005-10#2)(2007-4#1)(2007-6#1)(2008-2#2)(2011-1#1)(2012-2#1)
redirected to##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
redirected##5##1##(1991-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-8#1)
redirection and frequency filtering##2##4##(2008-3#2)
redirection of the##3##3##(2007-7#1)(2007-8#1)(2008-11#1)
redirection of##5##2##(2007-7#1)(2007-8#2)(2008-11#2)
redirection##12##1##(2007-11#1)(2007-7#1)(2007-8#2)(2008-11#4)(2008-3#2)(2011-2#1)(2012-2#1)
redirects##5##1##(1994-3#1)(1994-5#1)(2008-11#1)(2012-1#1)(2012-2#1)
rediscovered in the##3##3##(2007-3#1)(2008-6#1)(2012-1#1)
rediscovered in##4##2##(2007-3#1)(2008-6#1)(2008-9#1)(2012-1#1)
rediscovered##9##1##(1993-7#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-1#1)
rediscovery##3##1##(2006-2#1)(2007-7#1)(2008-8#1)
redisplacement##6##1##(1991-9#1)(2011-2#5)
redissolution##3##1##(2008-10#3)
redissolved in##2##2##(1992-7#1)(2007-6#1)
redistribute##4##1##(1996-11#1)(1997-1#1)(2008-5#1)(2012-1#1)
redistributed to##3##2##(1991-3#1)(1992-11#1)(1992-2#1)
redistributed##8##1##(1990-12#1)(1991-3#1)(1992-11#1)(1992-2#1)(1996-11#1)(1996-5#1)(2007-12#1)(2011-2#1)
redistributing##3##1##(1992-6#1)(2011-1#1)(2011-2#1)
redistribution in the##4##3##(2008-5#2)(2009-10#1)(2010-7#1)
redistribution in##9##2##(1990-4#1)(1991-5#1)(1992-5#1)(1995-8#1)(2006-10#1)(2008-5#2)(2009-10#1)(2010-7#1)
redistribution is##2##2##(1990-11#1)(2007-12#1)
redistribution of PKC##2##3##(1996-8#1)(1996-9#1)
redistribution of TIAR##2##3##(1995-2#2)
redistribution of energy##2##3##(2007-12#2)
redistribution of the##8##3##(1994-6#1)(1995-1#1)(1995-6#1)(1997-3#1)(2005-11#1)(2007-9#1)(2008-10#1)(2012-3#1)
redistribution of##51##2##(1990-10#1)(1991-10#1)(1991-8#1)(1992-11#1)(1992-6#2)(1992-7#1)(1993-11#1)(1993-8#1)(1994-12#2)(1994-6#3)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#2)(1995-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#2)(2005-11#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-12#4)(2007-9#1)(2008-10#1)(2008-3#1)(2008-8#3)(2009-8#2)(2010-12#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
redistribution under gravi-stimulation##2##3##(2009-10#2)
redistribution was##3##2##(1990-10#1)(1992-5#2)
redistribution within the##2##3##(2008-7#1)(2013-7#1)
redistribution##104##1##(1990-10#2)(1990-11#1)(1990-4#2)(1991-10#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-5#3)(1992-6#3)(1992-7#1)(1993-11#1)(1993-8#1)(1994-12#2)(1994-6#3)(1994-9#3)(1995-1#1)(1995-11#1)(1995-2#2)(1995-6#2)(1995-8#1)(1996-11#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-3#1)(1997-6#2)(2005-10#2)(2005-11#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-9#1)(2008-10#2)(2008-3#3)(2008-5#3)(2008-7#1)(2008-8#4)(2009-10#4)(2009-8#2)(2010-12#2)(2010-7#2)(2011-12#2)(2011-2#4)(2012-1#3)(2012-2#2)(2012-3#1)(2013-7#5)
redistributions##2##1##(1995-12#1)(2008-5#1)
redistributive policies##2##2##(1990-12#1)(1997-2#1)
redistributive##3##1##(1990-12#1)(1997-2#2)
redness and swelling##3##3##(2007-11#2)(2008-11#1)
redness and##4##2##(2007-11#2)(2008-11#1)(2010-4#1)
redness of##3##2##(2008-5#1)(2008-8#1)(2010-3#1)
redness##17##1##(2005-11#1)(2007-11#2)(2008-11#1)(2008-5#5)(2008-8#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#1)
redness)##2##1##(2012-12#1)(2013-1#1)
redo cardiac surgery##2##3##(2007-8#1)(2007-9#1)
redo coronary artery bypass##2##4##(1996-8#1)(2007-8#1)
redo surgery##2##2##(2007-8#1)(2007-9#1)
redo##9##1##(1996-8#1)(2007-8#4)(2007-9#2)(2009-3#1)(2011-2#1)
redolens f##2##2##(2008-10#2)
redolens##6##1##(2007-7#1)(2008-10#5)
redolens-F##3##1##(2008-10#3)
redoubled##3##1##(2008-8#1)(2013-8#2)
redox active##3##2##(1990-12#1)(1995-6#1)(1997-6#1)
redox activity##3##2##(1993-4#1)(2008-5#1)(2010-7#1)
redox agents##2##2##(2008-8#1)(2011-2#1)
redox and##3##2##(1990-8#1)(2009-9#1)(2010-4#1)
redox behavior of##2##3##(2008-10#2)
redox behavior##6##2##(2008-10#6)
redox catalyst##2##2##(2008-10#2)
redox centers##2##2##(1990-3#1)(1995-6#1)
redox centres##2##2##(2007-8#1)(2008-10#1)
redox changes##2##2##(1997-4#1)(2008-10#1)
redox chemistry##6##2##(2008-10#1)(2009-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2013-1#1)
redox component##4##2##(1995-8#4)
redox couple due to##2##4##(2008-10#2)
redox couple with##2##3##(2008-10#1)(2008-5#1)
redox couple##16##2##(1995-10#1)(1997-1#1)(2005-11#1)(2006-12#1)(2008-10#9)(2008-5#1)(2008-7#1)(2010-6#1)
redox couples##3##2##(1996-2#1)(1997-1#1)(2008-10#1)
redox cycle##7##2##(1992-8#3)(1996-2#2)(2008-10#1)(2013-8#1)
redox cyclers##2##2##(1997-8#2)
redox cycling in##2##3##(1995-6#1)(1997-2#1)
redox cycling of##8##3##(1994-12#2)(1994-3#3)(1995-6#2)(2008-11#1)
redox cycling##17##2##(1992-11#2)(1992-8#2)(1994-12#2)(1994-3#3)(1995-6#4)(1997-2#1)(2008-10#1)(2008-11#1)(2010-8#1)
redox disproportionation##2##2##(1996-2#2)
redox electrochemistry of ferrocene monocarboxylic acid##3##6##(2007-11#3)
redox electrochemistry of ferrocene##4##4##(2007-11#4)
redox electrochemistry of##5##3##(2007-11#5)
redox electrode detector##3##3##(2008-10#3)
redox electrode##6##2##(2008-10#6)
redox environment##4##2##(2008-10#1)(2008-7#1)(2010-12#2)
redox enzymes##2##2##(1997-7#1)(2008-10#1)
redox equilibrium##3##2##(2008-10#1)(2008-7#1)(2009-10#1)
redox forms of##2##3##(1996-6#1)(2008-10#1)
redox forms##3##2##(1996-6#1)(2008-10#1)(2010-4#1)
redox homeostasis##6##2##(1994-8#2)(2009-6#1)(2009-9#1)(2012-12#1)(2012-2#1)
redox imbalances##2##2##(2009-8#1)(2010-4#1)
redox indicator##4##2##(1996-12#1)(2008-10#3)
redox indicators##3##2##(2008-10#3)
redox initiation polymerization##2##3##(2008-10#2)
redox initiation##3##2##(2008-10#3)
redox labels##2##2##(2008-12#2)
redox mechanism##4##2##(1994-9#1)(2008-10#3)
redox mediator##10##2##(2008-10#10)
redox mediators##2##2##(1992-12#1)(2008-10#1)
redox microarray##4##2##(2006-2#4)
redox midpoint potentials##2##3##(1993-8#1)(1997-3#1)
redox midpoint##3##2##(1990-7#1)(1993-8#1)(1997-3#1)
redox or##2##2##(1990-8#1)(2008-10#1)
redox pairs##2##2##(1997-1#1)(2008-8#1)
redox partner##3##2##(1994-5#1)(1994-9#1)(1995-1#1)
redox partners##3##2##(1990-5#2)(1995-2#1)
redox peak##3##2##(2008-10#2)(2008-8#1)
redox peaks##5##2##(2008-10#4)(2008-11#1)
redox polymer##5##2##(1996-6#1)(2008-10#4)
redox potential and##3##3##(1991-4#1)(2008-10#1)(2008-7#1)
redox potential of the##2##4##(1995-2#1)(1997-1#1)
redox potential of##3##3##(1995-10#1)(1995-2#1)(1997-1#1)
redox potential##27##2##(1990-3#1)(1991-4#2)(1993-11#1)(1994-11#1)(1995-10#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-9#1)(1997-1#1)(1997-4#1)(2008-10#6)(2008-11#3)(2008-4#1)(2008-7#4)(2010-7#1)
redox potentials and##3##3##(1991-4#2)(2008-10#1)
redox potentials of the##4##4##(1990-7#1)(1991-4#1)(1992-3#1)(2008-10#1)
redox potentials of##6##3##(1990-7#1)(1991-4#1)(1992-3#1)(1994-3#1)(1995-10#1)(2008-10#1)
redox potentials##17##2##(1990-7#1)(1991-4#3)(1992-11#1)(1992-3#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-8#1)(1997-4#1)(2008-10#5)
redox process##5##2##(1996-2#1)(2008-10#4)
redox processes##4##2##(1994-8#1)(2008-10#2)(2009-9#1)
redox properties of##8##3##(1993-11#1)(1995-10#2)(1995-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-6#1)
redox properties##12##2##(1991-4#1)(1993-11#1)(1994-5#1)(1994-8#1)(1995-10#2)(1995-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-6#1)(2013-8#1)
redox protein##3##2##(1993-9#1)(1995-2#1)(2009-9#1)
redox proteins##3##2##(1990-5#1)(1995-5#1)(2010-12#1)
redox ratio##3##2##(1995-12#1)(2008-11#1)(2011-2#1)
redox reaction and##2##3##(2008-1#1)(2008-10#1)
redox reaction between bromate and##3##5##(2008-10#3)
redox reaction between##8##3##(2008-10#8)
redox reaction is##2##3##(2005-12#1)(2008-10#1)
redox reaction of cysteine with iron(III)##2##6##(2008-10#2)
redox reaction of##8##3##(2005-4#2)(2008-10#6)
redox reaction with##2##3##(2008-10#2)
redox reaction##29##2##(2005-12#1)(2005-4#2)(2008-1#1)(2008-10#24)(2013-8#1)
redox reactions in##2##3##(1994-11#1)(2008-10#1)
redox reactions##12##2##(1994-11#3)(1994-2#1)(1995-1#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-7#1)(2009-10#1)
redox regulation##2##2##(2006-2#1)(2009-10#1)
redox sensitive##2##2##(1994-2#1)(2010-10#1)
redox signals##2##2##(2008-10#1)(2009-10#1)
redox site##3##2##(1994-2#2)(2006-10#1)
redox slip##3##2##(1990-8#2)(1994-8#1)
redox speciation##2##2##(2008-10#2)
redox species##2##2##(2008-10#2)
redox state in##2##3##(1993-6#1)(1997-6#1)
redox state of the##3##4##(1991-2#1)(1994-12#1)(2008-11#1)
redox state of##13##3##(1990-8#1)(1991-2#1)(1994-12#2)(1994-3#1)(1994-8#2)(1995-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)
redox state##30##2##(1990-8#2)(1991-2#1)(1992-8#1)(1993-6#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-8#2)(1995-8#2)(1997-6#4)(2006-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-10#3)(2009-4#1)(2010-12#1)
redox states of the##2##4##(1992-4#1)(1994-8#1)
redox states of##3##3##(1992-4#1)(1994-8#1)(1997-2#1)
redox states##9##2##(1992-3#1)(1992-4#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-8#2)(1997-2#1)(2008-3#1)
redox status and##2##3##(1993-4#1)(2011-1#1)
redox status of##3##3##(1997-2#1)(2008-7#1)(2009-10#1)
redox status##9##2##(1993-4#1)(1997-2#1)(2007-9#2)(2008-10#1)(2008-7#1)(2009-10#1)(2011-1#2)
redox stress and remodeling##2##4##(2011-2#2)
redox stress##5##2##(2011-2#5)
redox system##9##2##(1993-4#2)(1994-11#1)(2005-8#1)(2008-10#4)(2009-3#1)
redox waves##4##2##(1996-5#1)(2008-10#3)
redox##460##1##(1990-12#1)(1990-3#2)(1990-5#3)(1990-7#4)(1990-8#8)(1991-2#2)(1991-3#3)(1991-4#6)(1992-11#5)(1992-12#2)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#7)(1993-11#2)(1993-4#6)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#7)(1994-12#5)(1994-2#6)(1994-3#7)(1994-5#2)(1994-8#10)(1994-9#2)(1995-1#3)(1995-10#5)(1995-11#1)(1995-12#1)(1995-2#4)(1995-5#4)(1995-6#7)(1995-8#11)(1996-12#1)(1996-2#12)(1996-5#1)(1996-6#4)(1996-9#2)(1997-1#4)(1997-2#4)(1997-3#1)(1997-4#3)(1997-6#10)(1997-7#3)(1997-8#3)(2005-11#1)(2005-12#1)(2005-4#2)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#6)(2007-11#6)(2007-12#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#144)(2008-11#13)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#10)(2008-8#3)(2008-9#1)(2009-10#12)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#4)(2009-9#5)(2010-10#2)(2010-12#5)(2010-4#5)(2010-5#2)(2010-6#3)(2010-7#4)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#7)(2012-11#2)(2012-12#5)(2012-2#1)(2013-1#1)(2013-8#3)
redox- and light-sensitive##2##3##(2010-2#2)
redox-active mediator##2##2##(2008-10#2)
redox-active metal##2##2##(1997-8#1)(2009-10#1)
redox-active molecules##2##2##(2006-2#1)(2007-11#1)
redox-active tyrosine residue##2##3##(1994-8#2)
redox-active##21##1##(1991-7#1)(1992-9#1)(1993-9#1)(1994-2#1)(1994-8#2)(1995-5#1)(1997-2#1)(1997-8#1)(2006-2#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-7#1)(2009-10#3)
redox-cycling quinones##3##2##(2009-9#3)
redox-cycling##5##1##(2009-9#5)
redox-dependent assembly##2##2##(1994-11#2)
redox-dependent##6##1##(1994-11#2)(1994-5#1)(2009-10#2)(2012-12#1)
redox-mediated##2##1##(2008-8#1)(2010-12#1)
redox-potentiometric##2##1##(2008-10#2)
redox-reagent solution##2##2##(2007-8#2)
redox-reagent##3##1##(2007-8#3)
redox-reductive screen mode using a series of##2##7##(1990-8#2)
redox-reductive screen mode##5##3##(1990-8#5)
redox-reductive screen##6##2##(1990-8#6)
redox-related##2##1##(2008-8#1)(2012-12#1)
redox-sensitive##3##1##(2008-4#1)(2008-5#1)(2009-10#1)
redox-status##2##1##(2008-8#1)(2009-8#1)
redoxal and BNID##2##3##(1995-3#2)
redoxal##3##1##(1995-3#3)
redress##12##1##(1996-12#1)(2005-8#1)(2006-12#1)(2006-4#1)(2007-5#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-12#2)(2011-2#1)
redressing##2##1##(2007-11#1)(2007-8#1)
redshift##4##1##(1990-12#1)(2007-11#1)(2007-4#1)(2008-1#1)
reduce CVD##4##2##(2009-4#1)(2010-12#1)(2011-1#1)(2012-12#1)
reduce FBS##2##2##(2008-11#2)
reduce Fusarium##2##2##(2008-10#2)
reduce HIV##2##2##(1995-9#1)(2011-2#1)
reduce LDL concentrations##2##3##(1993-9#2)
reduce O2##2##2##(1991-3#1)(1994-11#1)
reduce a##9##2##(1991-5#1)(1993-1#1)(1995-6#1)(2008-10#2)(2008-8#1)(2012-1#1)(2013-1#2)
reduce abnormal##3##2##(1995-7#1)(1996-8#2)
reduce adverse effects##3##3##(2006-10#2)(2013-1#1)
reduce adverse##6##2##(2006-10#2)(2007-12#1)(2013-1#3)
reduce aflatoxin##2##2##(2008-10#2)
reduce alcohol##3##2##(2008-1#1)(2011-12#1)(2012-12#1)
reduce all##2##2##(2008-11#1)(2009-11#1)
reduce an##2##2##(1994-11#1)(2008-8#1)
reduce and##4##2##(1993-8#1)(2007-10#1)(2012-2#1)(2012-3#1)
reduce binding of##2##3##(1996-11#1)(2008-12#1)
reduce bleeding##4##2##(2005-10#1)(2006-10#1)(2007-8#2)
reduce blood loss##2##3##(2006-12#1)(2007-7#1)
reduce blood pressure##5##3##(1990-11#1)(1993-2#1)(1995-2#1)(1996-9#1)(2008-8#1)
reduce blood##12##2##(1990-11#1)(1993-2#1)(1995-2#1)(1996-9#2)(2005-10#2)(2006-12#1)(2007-7#1)(2007-8#1)(2008-8#1)(2010-4#1)
reduce bone##3##2##(2006-10#1)(2007-11#1)(2009-3#1)
reduce both##3##2##(2007-12#1)(2008-7#1)(2012-2#1)
reduce brain##4##2##(1996-9#1)(2010-12#1)(2010-2#1)(2011-2#1)
reduce cardiovascular morbidity and mortality##2##5##(2012-12#2)
reduce cardiovascular morbidity and##3##4##(1996-9#1)(2012-12#2)
reduce cardiovascular morbidity##4##3##(1993-11#1)(1996-9#1)(2012-12#2)
reduce cardiovascular risk in##2##4##(2005-10#1)(2009-11#1)
reduce cardiovascular risk##4##3##(2005-10#1)(2008-6#1)(2009-11#1)(2010-12#1)
reduce cardiovascular##9##2##(1993-11#1)(1996-9#1)(2005-10#1)(2008-6#1)(2009-11#1)(2010-12#1)(2010-9#1)(2012-12#2)
reduce cell##2##2##(2010-11#1)(2011-2#1)
reduce child##3##2##(2008-11#1)(2009-7#1)(2010-12#1)
reduce cholesterol levels##2##3##(2006-12#1)(2008-5#1)
reduce cholesterol##4##2##(1991-6#1)(2006-10#1)(2006-12#1)(2008-5#1)
reduce chronic##3##2##(1994-7#1)(1997-5#1)(2008-1#1)
reduce complications and##2##3##(2007-8#1)(2012-12#1)
reduce cost##4##2##(1997-3#1)(2007-8#1)(2008-7#1)(2012-2#1)
reduce costs and##5##3##(1995-2#1)(1997-1#1)(2006-6#1)(2010-9#1)(2012-1#1)
reduce costs in##2##3##(1990-4#1)(2006-10#1)
reduce costs##25##2##(1990-4#1)(1991-12#1)(1994-3#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-1#1)(1996-2#2)(1997-1#2)(1997-2#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-2#1)(2008-10#1)(2009-4#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)
reduce crashes##2##2##(2009-8#1)(2012-12#1)
reduce damage##4##2##(2006-6#1)(2008-10#1)(2008-7#1)(2012-11#1)
reduce delays##2##2##(1993-3#1)(2007-12#1)
reduce disease##7##2##(2008-10#5)(2011-2#1)(2012-12#1)
reduce disparities in##2##3##(2008-3#1)(2012-3#1)
reduce disparities##4##2##(2008-3#1)(2009-5#1)(2012-3#1)(2013-1#1)
reduce drinking##2##2##(1994-2#1)(2008-11#1)
reduce emergency##2##2##(2007-7#1)(2013-8#1)
reduce endogenous oxidative DNA damage##2##5##(2009-3#2)
reduce energy##2##2##(1997-7#1)(2013-1#1)
reduce expenses##4##2##(1991-4#2)(1994-2#1)(1995-3#1)
reduce exposure to##4##3##(2008-11#1)(2008-5#1)(2009-3#1)(2010-9#1)
reduce false positive##2##3##(2006-7#1)(2010-1#1)
reduce fracture risk##2##3##(1993-11#1)(2012-12#1)
reduce growth##2##2##(1995-6#1)(2008-12#1)
reduce health care##3##3##(1994-12#1)(1996-2#1)(2006-8#1)
reduce health##7##2##(1994-12#1)(1994-4#1)(1996-2#1)(2006-8#1)(2010-5#1)(2012-1#1)(2012-2#1)
reduce hepatic##2##2##(1991-7#1)(1995-3#1)
reduce host##2##2##(2008-8#1)(2008-9#1)
reduce hot flashes##2##3##(2008-7#2)
reduce hydrophobicity##2##2##(1996-6#2)
reduce imports##2##2##(1996-3#2)
reduce in the##2##3##(1990-9#1)(2013-1#1)
reduce in##3##2##(1990-9#1)(2012-2#1)(2013-1#1)
reduce incidence of##3##3##(2005-12#1)(2006-8#1)(2008-7#1)
reduce incidence##4##2##(2005-12#1)(2006-10#1)(2006-8#1)(2008-7#1)
reduce infarct##2##2##(1990-12#1)(2008-2#1)
reduce inflammation and##5##3##(1992-11#1)(1993-9#1)(2007-11#1)(2011-2#1)(2013-1#1)
reduce inflammation##8##2##(1992-11#1)(1993-9#1)(2006-8#1)(2007-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
reduce inflammatory##2##2##(2008-7#1)(2011-2#1)
reduce intake##2##2##(1997-8#1)(2007-8#1)
reduce intracellular##2##2##(1995-7#1)(2008-10#1)
reduce its##11##2##(1991-7#1)(1992-8#1)(1997-5#1)(2005-11#1)(2007-9#1)(2008-3#1)(2008-7#1)(2009-7#1)(2012-1#1)(2012-12#1)(2012-3#1)
reduce left ventricular##2##3##(1992-4#1)(2011-2#1)
reduce length of stay and##3##5##(1993-3#1)(1995-3#1)(2012-3#1)
reduce length of stay in##2##5##(2006-10#1)(2008-3#1)
reduce length of stay##10##4##(1993-3#2)(1995-3#1)(2006-10#2)(2008-3#1)(2010-11#1)(2012-2#2)(2012-3#1)
reduce levels of##2##3##(2007-5#1)(2008-9#1)
reduce levels##3##2##(2007-5#1)(2008-1#1)(2008-9#1)
reduce life##2##2##(1997-4#1)(2008-8#1)
reduce lipid peroxidation##2##3##(2004-11#1)(2008-5#1)
reduce local##3##2##(2004-4#1)(2007-11#2)
reduce long-term##4##2##(2008-2#1)(2008-3#1)(2013-1#2)
reduce losses##3##2##(2008-1#1)(2008-7#1)(2009-3#1)
reduce maternal mortality##4##3##(1994-3#1)(2008-11#2)(2013-1#1)
reduce maternal##6##2##(1994-3#1)(2006-10#1)(2008-11#2)(2013-1#2)
reduce medical costs##2##3##(1991-1#1)(2010-8#1)
reduce medical##4##2##(1991-1#1)(2008-3#1)(2008-7#1)(2010-8#1)
reduce medication errors##4##3##(2011-1#2)(2013-1#2)
reduce medication##5##2##(2010-10#1)(2011-1#2)(2013-1#2)
reduce morbidity and mortality in##3##5##(2006-4#1)(2008-9#1)(2011-1#1)
reduce morbidity and mortality of##2##5##(1990-2#1)(2009-2#1)
reduce morbidity and mortality##9##4##(1990-2#1)(2006-10#1)(2006-4#1)(2008-1#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
reduce morbidity and##11##3##(1990-2#1)(2006-10#2)(2006-4#1)(2006-8#1)(2008-1#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
reduce morbidity##14##2##(1990-2#1)(2004-9#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
reduce mortality and morbidity##7##4##(2006-10#2)(2006-2#1)(2006-4#1)(2011-1#1)(2013-1#2)
reduce mortality and##9##3##(2006-10#3)(2006-2#2)(2006-4#1)(2011-1#1)(2013-1#2)
reduce mortality in ARDS##2##4##(1997-1#1)(2005-8#1)
reduce mortality in##3##3##(1997-1#1)(2005-8#1)(2008-3#1)
reduce mortality##24##2##(1990-5#1)(1992-8#1)(1997-1#1)(2005-8#1)(2006-10#3)(2006-2#3)(2006-4#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#2)(2008-8#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#2)
reduce most##2##2##(2005-8#1)(2010-4#1)
reduce myocardial##2##2##(2006-10#1)(2006-4#1)
reduce negative##3##2##(2006-10#1)(2006-6#1)(2012-12#1)
reduce neurological##2##2##(2007-8#1)(2010-12#1)
reduce neuronal##2##2##(1996-1#1)(2007-9#1)
reduce noise##3##2##(2008-1#1)(2012-1#1)(2013-1#1)
reduce occupational##2##2##(2008-11#1)(2009-2#1)
reduce or even##2##3##(2007-1#1)(2009-10#1)
reduce or##22##2##(1992-2#1)(1997-4#1)(2006-2#1)(2006-3#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-5#1)(2010-1#1)(2010-5#2)(2012-3#1)(2013-1#2)
reduce overall##4##2##(2003-11#1)(2006-2#1)(2008-10#1)(2011-2#1)
reduce oxidative stress##2##3##(2008-11#1)(2008-7#1)
reduce oxidative##3##2##(2008-11#1)(2008-4#1)(2008-7#1)
reduce pain and improve##3##4##(2006-10#1)(2006-8#1)(2007-11#1)
reduce pain and##4##3##(2006-10#1)(2006-8#1)(2007-11#1)(2008-7#1)
reduce pain##18##2##(2006-10#2)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-7#1)(2009-3#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
reduce patient anxiety##2##3##(1993-11#1)(1996-2#1)
reduce patient##9##2##(1993-11#1)(1996-2#2)(2004-3#1)(2007-6#1)(2008-3#1)(2009-9#1)(2010-12#1)(2011-7#1)
reduce peak##3##2##(1992-5#1)(1997-3#1)(2006-10#1)
reduce plasma##3##2##(2005-9#2)(2010-12#1)
reduce polypharmacy##2##2##(2005-1#1)(2012-2#1)
reduce population##2##2##(2008-9#1)(2013-1#1)
reduce possible##2##2##(1995-5#1)(2007-10#1)
reduce post-operative##3##2##(2007-8#3)
reduce postoperative bleeding##2##3##(2007-8#1)(2007-9#1)
reduce postoperative pain##2##3##(2006-8#1)(2008-8#1)
reduce postoperative##6##2##(2006-10#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-8#1)
reduce potential##2##2##(1991-7#1)(2011-2#1)
reduce potentially##2##2##(2007-8#1)(2012-2#1)
reduce power##2##2##(2008-2#1)(2008-8#1)
reduce professional##2##2##(2006-10#1)(2009-9#1)
reduce protein##3##2##(1994-12#1)(2007-1#1)(2008-3#1)
reduce pulmonary##2##2##(2007-8#1)(2008-3#1)
reduce quality of life##2##4##(2008-6#1)(2012-12#1)
reduce quality##3##2##(2008-6#1)(2010-7#1)(2012-12#1)
reduce rates of##2##3##(2008-1#1)(2009-1#1)
reduce recurrence##5##2##(1997-6#1)(2006-11#1)(2007-8#1)(2011-2#2)
reduce redundancy##2##2##(1996-2#1)(2010-8#1)
reduce relapse##2##2##(2006-9#1)(2012-2#1)
reduce risk factors##2##3##(2008-3#1)(2008-5#1)
reduce risk in##2##3##(1997-1#1)(2008-7#1)
reduce risk of##9##3##(1992-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2009-5#1)(2011-1#1)(2012-12#1)(2013-8#1)
reduce risk##23##2##(1992-2#1)(1997-1#1)(1997-3#1)(2005-12#1)(2005-9#1)(2007-1#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#4)(2009-5#1)(2011-1#1)(2012-12#1)(2013-8#1)
reduce risks from##2##3##(1991-3#1)(2008-9#1)
reduce risks of##2##3##(2006-10#1)(2007-2#1)
reduce risks##7##2##(1991-3#2)(2005-10#1)(2005-5#1)(2006-10#1)(2007-2#1)(2008-9#1)
reduce root disease severity##2##4##(2008-10#2)
reduce serum##5##2##(1991-6#1)(1994-9#1)(2005-8#1)(2010-12#1)(2011-2#1)
reduce significantly the##7##3##(1993-11#1)(1996-6#1)(2007-12#1)(2008-2#2)(2008-3#1)(2013-8#1)
reduce significantly##8##2##(1993-11#1)(1996-6#1)(2007-12#1)(2008-2#2)(2008-3#1)(2013-1#1)(2013-8#1)
reduce social##2##2##(1994-4#1)(2006-1#1)
reduce some of the##2##4##(2006-12#1)(2008-11#1)
reduce some##3##2##(2006-12#1)(2007-8#1)(2008-11#1)
reduce stock farmers'##2##3##(2006-12#2)
reduce stroke##2##2##(2007-8#1)(2008-8#1)
reduce substantially the##3##3##(1994-9#1)(2007-12#1)(2010-9#1)
reduce such##2##2##(2007-2#1)(2008-12#1)
reduce sympathetic activation##2##3##(2005-10#1)(2006-10#1)
reduce sympathetic drive##2##3##(1995-12#1)(2005-10#1)
reduce sympathetic##7##2##(1995-12#1)(2005-10#4)(2006-10#1)(2008-10#1)
reduce symptoms and##3##3##(2006-9#1)(2008-12#1)(2010-10#1)
reduce symptoms##5##2##(2006-9#1)(2008-10#1)(2008-12#1)(2010-10#1)(2011-2#1)
reduce systematic error##2##3##(1993-2#1)(2008-2#1)
reduce the adverse##3##3##(2012-1#1)(2012-3#1)(2013-7#1)
reduce the amount of##11##4##(2006-12#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-4#1)(2009-3#1)(2011-2#1)(2012-11#1)
reduce the average##2##3##(2008-2#1)(2008-7#1)
reduce the binding of##2##4##(1990-12#1)(1994-8#1)
reduce the biological##2##3##(1991-12#1)(2008-7#1)
reduce the burden of##9##4##(2006-11#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-11#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
reduce the cell water content##2##5##(2008-5#2)
reduce the cell##3##3##(2008-5#2)(2010-2#1)
reduce the chance of##4##4##(1995-6#1)(2006-9#1)(2007-8#1)(2013-1#1)
reduce the chance##5##3##(1995-6#1)(2006-9#1)(2007-8#1)(2008-7#1)(2013-1#1)
reduce the clinical and##2##4##(2008-8#1)(2011-2#1)
reduce the clinical##3##3##(2008-8#1)(2011-2#1)(2013-1#1)
reduce the coherent##2##3##(2007-11#1)(2008-3#1)
reduce the complication##2##3##(2008-10#1)(2010-8#1)
reduce the complications##2##3##(2007-5#1)(2009-10#1)
reduce the computation time##4##4##(2008-3#3)(2010-2#1)
reduce the computation##5##3##(2008-2#1)(2008-3#3)(2010-2#1)
reduce the computational##2##3##(2008-2#2)
reduce the concentration of##2##4##(1996-12#1)(2008-9#1)
reduce the cost and##2##4##(1996-12#1)(2008-3#1)
reduce the cost for##2##4##(2006-6#1)(2008-7#1)
reduce the cost of health care##2##6##(2006-10#1)(2013-8#1)
reduce the cost of##5##4##(1997-4#1)(2006-10#1)(2008-2#1)(2013-1#1)(2013-8#1)
reduce the cost##10##3##(1996-12#1)(1997-4#1)(2006-10#1)(2006-6#1)(2008-2#2)(2008-3#1)(2008-7#1)(2013-1#1)(2013-8#1)
reduce the costs associated with##2##5##(2008-10#1)(2008-6#1)
reduce the costs of##3##4##(1997-1#1)(2008-1#1)(2008-11#1)
reduce the costs##5##3##(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)
reduce the degree of##3##4##(1997-3#2)(2009-11#1)
reduce the degrees of##2##4##(2006-6#1)(2008-10#1)
reduce the density of##2##4##(1997-6#1)(2008-10#1)
reduce the development of##2##4##(2007-8#1)(2008-8#1)
reduce the discomfort##2##3##(1995-6#1)(2007-7#1)
reduce the dose of##2##4##(1992-12#1)(2005-9#1)
reduce the dose##4##3##(1992-12#1)(2005-9#1)(2008-7#1)(2013-1#1)
reduce the effectiveness of##2##4##(1997-7#1)(2006-11#1)
reduce the expression of##3##4##(2008-12#1)(2008-6#1)(2009-12#1)
reduce the extent of##3##4##(2007-8#1)(2008-5#1)(2012-11#1)
reduce the frequency of##7##4##(1994-4#1)(1995-2#1)(1995-6#1)(1996-11#1)(2006-5#1)(2007-4#1)(2008-5#1)
reduce the frequency##9##3##(1994-4#1)(1995-2#1)(1995-6#1)(1996-11#1)(2005-7#1)(2006-5#1)(2007-4#1)(2008-5#1)(2010-2#1)
reduce the gradient in##2##4##(1990-8#1)(1992-9#1)
reduce the growth in##2##4##(1991-7#1)(1995-6#1)
reduce the growth##4##3##(1990-11#1)(1991-7#1)(1995-6#1)(2009-10#1)
reduce the harm associated with##2##5##(2006-10#1)(2008-11#1)
reduce the harm##3##3##(2006-10#1)(2008-11#1)(2013-8#1)
reduce the high mortality rate##2##5##(2007-8#1)(2011-12#1)
reduce the high mortality##3##4##(2007-11#1)(2007-8#1)(2011-12#1)
reduce the high##6##3##(2007-11#1)(2007-8#1)(2008-12#1)(2011-1#1)(2011-12#1)(2012-12#1)
reduce the impact of##7##4##(1991-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#2)
reduce the impact##8##3##(1991-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-8#1)(2011-1#1)(2011-2#2)
reduce the incidence and##3##4##(2004-10#1)(2006-10#1)(2008-5#1)
reduce the incidence of atrial fibrillation##2##6##(2007-8#2)
reduce the incidence of both##2##5##(2008-12#1)(2008-8#1)
reduce the incidence of instrument damage and##2##7##(2006-6#2)
reduce the incidence of postoperative##2##5##(2006-10#1)(2007-8#1)
reduce the incidence of stroke##3##5##(1993-12#1)(2007-8#1)(2008-1#1)
reduce the incidence of surgical site infections##2##7##(2006-6#1)(2013-1#1)
reduce the incidence of##66##4##(1990-6#1)(1991-12#1)(1992-12#2)(1993-12#1)(1993-3#1)(1995-6#1)(1996-1#1)(1997-8#1)(2004-12#1)(2006-10#4)(2006-11#2)(2006-2#1)(2006-5#1)(2006-6#3)(2006-8#2)(2007-1#3)(2007-10#1)(2007-11#5)(2007-2#1)(2007-8#10)(2008-1#1)(2008-10#2)(2008-12#1)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#1)(2009-6#1)(2010-12#1)(2011-12#2)(2011-2#2)(2012-3#1)(2013-1#3)
reduce the incidence##72##3##(1990-6#1)(1991-12#1)(1992-12#2)(1993-12#1)(1993-3#1)(1995-6#1)(1996-1#1)(1997-8#1)(2004-10#1)(2004-12#1)(2005-11#1)(2006-10#5)(2006-11#2)(2006-2#1)(2006-5#1)(2006-6#3)(2006-8#2)(2007-1#3)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-8#10)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#1)(2009-6#1)(2010-12#1)(2011-12#2)(2011-2#3)(2012-3#1)(2013-1#3)
reduce the influence of##3##4##(2008-2#2)(2008-3#1)
reduce the influence##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
reduce the latter##2##3##(1992-8#1)(2008-3#1)
reduce the length of##2##4##(1995-3#1)(2007-11#1)
reduce the level of contamination##2##5##(2008-1#1)(2008-10#1)
reduce the level of##7##4##(1991-1#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)
reduce the levels of##3##4##(2008-3#1)(2008-5#1)(2012-3#1)
reduce the likelihood of##7##4##(2006-7#1)(2007-2#1)(2008-3#1)(2010-12#1)(2010-9#1)(2011-2#2)
reduce the lipid##2##3##(2009-7#1)(2011-11#1)
reduce the matrix##2##3##(2009-8#1)(2010-11#1)
reduce the morbidity and mortality associated with##2##7##(1996-9#1)(2008-3#1)
reduce the morbidity and mortality due to##2##7##(2009-4#1)(2009-6#1)
reduce the morbidity and mortality##5##5##(1996-9#1)(2008-3#1)(2009-4#1)(2009-6#1)(2012-12#1)
reduce the morbidity associated with##3##5##(2006-5#1)(2006-8#1)(2008-7#1)
reduce the morbidity of##2##4##(2007-3#1)(2010-12#1)
reduce the morbidity##10##3##(1996-9#1)(2006-5#1)(2006-8#1)(2007-3#1)(2008-3#1)(2008-7#1)(2009-4#1)(2009-6#1)(2010-12#1)(2012-12#1)
reduce the mortality##6##3##(1993-10#1)(1993-3#1)(1993-8#1)(2007-10#1)(2012-12#1)(2013-1#1)
reduce the need for##10##4##(1996-8#1)(2006-8#1)(2007-7#2)(2008-6#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-12#1)(2010-9#1)
reduce the need of##2##4##(1992-3#1)(2008-11#1)
reduce the need##12##3##(1992-3#1)(1996-8#1)(2006-8#1)(2007-7#2)(2008-11#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-12#1)(2010-9#1)
reduce the negative##3##3##(1990-6#1)(2007-5#1)(2007-8#1)
reduce the number and##3##4##(1990-9#1)(2007-12#1)(2012-12#1)
reduce the number of patients##2##5##(2006-10#1)(2011-2#1)
reduce the number of##48##4##(1990-11#1)(1992-8#1)(1993-12#1)(1993-7#1)(1994-3#1)(1994-5#1)(1995-7#1)(1996-6#1)(1997-5#1)(1997-7#1)(2006-10#4)(2006-4#1)(2007-11#3)(2007-12#1)(2007-4#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#1)(2010-11#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#1)(2013-7#2)(2013-8#1)
reduce the number##51##3##(1990-11#1)(1990-9#1)(1992-8#1)(1993-12#1)(1993-7#1)(1994-3#1)(1994-5#1)(1995-7#1)(1996-6#1)(1997-5#1)(1997-7#1)(2006-10#4)(2006-4#1)(2007-11#3)(2007-12#2)(2007-4#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#1)(2010-11#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#2)(2013-8#1)
reduce the occurrence of##6##4##(1995-11#1)(2006-11#1)(2007-8#1)(2008-12#1)(2010-7#1)(2011-1#1)
reduce the overall##6##3##(1997-2#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-9#1)(2013-1#1)
reduce the pain##3##3##(2007-8#1)(2008-8#1)(2013-1#1)
reduce the peak power##2##4##(2007-12#1)(2012-1#1)
reduce the peak##5##3##(2007-12#1)(2008-2#2)(2012-1#2)
reduce the physical##2##3##(1995-1#1)(2008-5#1)
reduce the possibility of##3##4##(2007-12#1)(2008-3#1)(2013-8#1)
reduce the potential for physical##2##5##(1992-3#1)(2011-2#1)
reduce the potential for##6##4##(1992-3#1)(1993-10#1)(2007-9#1)(2008-10#1)(2011-2#1)(2013-1#1)
reduce the potential##9##3##(1992-3#1)(1993-10#1)(1995-10#1)(2006-2#1)(2007-9#1)(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
reduce the prevalence and severity of##2##6##(2006-4#1)(2008-1#1)
reduce the prevalence of##7##4##(2006-4#1)(2007-6#1)(2008-3#1)(2010-4#1)(2012-1#1)(2012-12#2)
reduce the prevalence##9##3##(2006-4#2)(2007-6#1)(2008-1#1)(2008-3#1)(2010-4#1)(2012-1#1)(2012-12#2)
reduce the probability of##5##4##(1997-4#1)(2008-10#1)(2010-5#1)(2012-1#1)(2012-3#1)
reduce the probability##6##3##(1991-12#1)(1997-4#1)(2008-10#1)(2010-5#1)(2012-1#1)(2012-3#1)
reduce the production of pro-inflammatory mediators##2##6##(2007-11#1)(2008-10#1)
reduce the production of##7##4##(1992-5#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-9#1)(2011-1#1)
reduce the proportion of##4##4##(1993-9#1)(2005-7#1)(2007-7#1)(2008-10#1)
reduce the quality of life##2##5##(1990-9#1)(2008-7#1)
reduce the quality of##4##4##(1990-9#1)(2007-7#1)(2008-7#1)(2010-4#1)
reduce the range of##2##4##(2008-8#2)
reduce the range##3##3##(2008-10#1)(2008-8#2)
reduce the rate of##10##4##(1994-11#1)(1994-12#1)(2006-6#1)(2007-11#1)(2008-2#1)(2008-5#1)(2010-2#1)(2010-7#1)(2010-8#1)(2013-1#1)
reduce the rate##11##3##(1992-1#1)(1994-11#1)(1994-12#1)(2006-6#1)(2007-11#1)(2008-2#1)(2008-5#1)(2010-2#1)(2010-7#1)(2010-8#1)(2013-1#1)
reduce the relative##2##3##(1990-7#1)(2008-4#1)
reduce the required##4##3##(2006-11#1)(2008-2#2)(2008-3#1)
reduce the restenosis rate##2##4##(1991-3#1)(1992-9#1)
reduce the risk for##4##4##(2006-10#2)(2010-12#1)(2013-1#1)
reduce the risk of a##3##5##(1992-2#1)(2008-4#1)(2012-2#1)
reduce the risk of adverse reactions##3##6##(1991-9#1)(1997-5#1)(2008-8#1)
reduce the risk of cardiovascular disease##2##6##(1993-11#1)(2012-2#1)
reduce the risk of cardiovascular##3##5##(1993-11#1)(2008-3#1)(2012-2#1)
reduce the risk of coronary artery##2##6##(1991-8#1)(2013-8#1)
reduce the risk of coronary##3##5##(1991-8#1)(1996-3#1)(2013-8#1)
reduce the risk of developing##2##5##(2009-6#1)(2010-2#1)
reduce the risk of fractures##2##5##(2007-8#1)(2008-4#1)
reduce the risk of nosocomial##2##5##(1992-10#1)(2007-12#1)
reduce the risk of relapse##2##5##(2009-11#1)(2011-2#1)
reduce the risk of transmission##4##5##(1994-12#1)(2006-10#1)(2006-8#1)(2012-1#1)
reduce the risk of##84##4##(1990-2#1)(1990-8#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-2#2)(1993-11#2)(1993-7#1)(1993-9#1)(1994-12#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-5#1)(1997-7#1)(2005-10#2)(2006-10#4)(2006-11#1)(2006-5#1)(2006-6#1)(2006-8#3)(2007-10#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-6#1)(2007-8#6)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#3)(2009-4#1)(2009-6#2)(2009-7#1)(2010-1#2)(2010-12#2)(2010-2#1)(2010-4#1)(2011-2#2)(2012-1#2)(2012-2#3)(2013-8#6)
reduce the risk##91##3##(1990-2#1)(1990-8#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-2#2)(1993-11#2)(1993-7#1)(1993-9#1)(1994-12#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-5#1)(1997-7#1)(2005-10#2)(2006-10#6)(2006-11#1)(2006-5#1)(2006-6#1)(2006-8#3)(2007-10#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-6#1)(2007-8#6)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-11#3)(2009-4#1)(2009-6#2)(2009-7#1)(2010-1#2)(2010-12#3)(2010-2#1)(2010-4#1)(2011-2#2)(2012-1#2)(2012-2#3)(2013-1#1)(2013-8#7)
reduce the risks associated with##2##5##(2007-2#1)(2008-10#1)
reduce the risks associated##3##4##(2007-2#1)(2008-10#1)(2013-1#1)
reduce the risks of##4##4##(2005-10#1)(2008-11#1)(2008-12#1)(2008-9#1)
reduce the risks##11##3##(2005-10#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-9#1)(2013-1#2)
reduce the sensitivity of##2##4##(2008-2#1)(2013-7#1)
reduce the severity of the disease##2##6##(2008-10#1)(2012-3#1)
reduce the severity of##8##4##(1991-3#1)(2008-10#4)(2008-5#1)(2010-1#1)(2012-3#1)
reduce the severity##9##3##(1991-3#1)(2008-10#4)(2008-12#1)(2008-5#1)(2010-1#1)(2012-3#1)
reduce the side effects##2##4##(2007-8#1)(2013-8#1)
reduce the size of the##3##5##(1996-3#1)(2008-5#1)(2010-10#1)
reduce the size of##5##4##(1994-11#1)(1996-3#1)(2008-5#1)(2010-10#1)(2010-11#1)
reduce the size##6##3##(1994-11#1)(1996-3#1)(2008-5#1)(2008-8#1)(2010-10#1)(2010-11#1)
reduce the spatial##3##3##(1994-5#1)(2008-3#1)(2009-5#1)
reduce the spread of##4##4##(1996-6#1)(2007-7#2)(2010-12#1)
reduce the surface##7##3##(2004-9#1)(2005-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2010-4#1)
reduce the time and##2##4##(2008-10#1)(2013-1#1)
reduce the time needed for##2##5##(2008-10#1)(2008-3#1)
reduce the time required to develop##2##6##(2008-11#2)
reduce the time required to##3##5##(2008-10#1)(2008-11#2)
reduce the time to##2##4##(2010-12#1)(2012-12#1)
reduce the time##12##3##(2006-10#1)(2006-3#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2010-12#1)(2012-12#1)(2013-1#1)
reduce the total number of##2##5##(2008-2#1)(2013-1#1)
reduce the toxicity##2##3##(2007-11#1)(2008-10#1)
reduce the uncorrected higher-order aberrations##2##5##(2008-3#2)
reduce the use of##3##4##(1991-1#1)(2007-4#1)(2012-3#1)
reduce the variability of##3##4##(2008-10#2)(2008-2#1)
reduce the variance##3##3##(2007-10#1)(2008-2#1)(2009-3#1)
reduce the volume of the##2##5##(1995-12#1)(2009-5#1)
reduce the##866##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#3)(1990-4#2)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#2)(1991-10#1)(1991-12#4)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#4)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#4)(1992-9#3)(1993-10#2)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#3)(1993-7#2)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#4)(1994-12#2)(1994-3#1)(1994-4#1)(1994-5#3)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#6)(1995-7#2)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#3)(1996-6#3)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#5)(1997-5#5)(1997-6#3)(1997-7#3)(1997-8#3)(2004-1#1)(2004-10#1)(2004-12#1)(2004-7#1)(2004-9#1)(2005-10#6)(2005-11#5)(2005-7#4)(2005-8#1)(2005-9#1)(2006-10#21)(2006-11#8)(2006-12#4)(2006-2#2)(2006-3#2)(2006-4#4)(2006-5#8)(2006-6#7)(2006-7#3)(2006-8#8)(2006-9#1)(2007-1#4)(2007-10#6)(2007-11#23)(2007-12#19)(2007-2#6)(2007-3#5)(2007-4#6)(2007-5#2)(2007-6#2)(2007-7#9)(2007-8#31)(2007-9#4)(2008-1#14)(2008-10#61)(2008-11#20)(2008-12#8)(2008-2#41)(2008-3#49)(2008-4#8)(2008-5#22)(2008-6#7)(2008-7#19)(2008-8#15)(2008-9#11)(2009-10#5)(2009-11#5)(2009-12#2)(2009-3#3)(2009-4#3)(2009-5#7)(2009-6#5)(2009-7#3)(2009-8#2)(2009-9#2)(2010-1#4)(2010-10#2)(2010-11#4)(2010-12#15)(2010-2#6)(2010-4#6)(2010-5#2)(2010-7#5)(2010-8#6)(2010-9#6)(2011-1#9)(2011-11#1)(2011-12#6)(2011-2#21)(2011-3#1)(2011-7#1)(2012-1#11)(2012-11#2)(2012-12#13)(2012-2#9)(2012-3#8)(2013-1#26)(2013-7#5)(2013-8#21)
reduce their##20##2##(1991-11#1)(1991-6#1)(1992-1#1)(1996-8#1)(1996-9#1)(2005-10#1)(2006-11#1)(2007-7#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2011-2#2)(2012-1#1)(2013-1#1)
reduce these##7##2##(1993-1#1)(2008-11#1)(2008-8#1)(2009-10#1)(2010-4#1)(2011-1#1)(2013-7#1)
reduce this complication##2##3##(2007-3#1)(2008-7#1)
reduce this risk##5##3##(1994-12#1)(2008-1#1)(2009-11#1)(2010-9#2)
reduce this##15##2##(1994-12#1)(1994-2#1)(2007-11#2)(2007-3#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-3#1)(2010-9#2)(2011-1#1)(2013-8#1)
reduce those##2##2##(2005-10#1)(2008-2#1)
reduce time##2##2##(2008-3#1)(2012-2#1)
reduce tissue##3##2##(2008-10#1)(2009-4#1)(2010-8#1)
reduce to the##3##3##(1993-9#1)(2006-7#1)(2007-11#1)
reduce to##11##2##(1993-9#1)(1994-5#1)(1997-6#1)(2006-7#1)(2007-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2009-11#1)
reduce tobacco##2##2##(2009-7#1)(2013-1#1)
reduce total##5##2##(1990-7#1)(2005-10#1)(2007-8#1)(2008-5#1)(2011-2#1)
reduce toughness##3##2##(2004-9#1)(2013-1#2)
reduce transmission##2##2##(2006-10#1)(2008-4#1)
reduce uncertainties##3##2##(2008-2#2)(2008-5#1)
reduce unnecessary##3##2##(1997-2#1)(2007-1#1)(2008-9#1)
reduce unwanted##3##2##(2007-3#1)(2008-4#2)
reduce variation in##2##3##(1993-3#1)(1994-12#1)
reduce variation##4##2##(1993-3#1)(1994-12#1)(1996-1#1)(1996-12#1)
reduce viral##3##2##(1994-6#1)(1997-1#1)(2013-8#1)
reduce waiting##3##2##(2006-10#1)(2006-12#1)(2008-11#1)
reduce waste##3##2##(1997-3#1)(2007-4#1)(2008-6#1)
reduce##2085##1##(1990-1#1)(1990-10#2)(1990-11#4)(1990-12#3)(1990-2#5)(1990-3#6)(1990-4#3)(1990-5#1)(1990-6#2)(1990-7#4)(1990-8#3)(1990-9#4)(1991-1#5)(1991-10#3)(1991-11#3)(1991-12#5)(1991-2#3)(1991-3#7)(1991-4#3)(1991-5#3)(1991-6#7)(1991-7#6)(1991-8#2)(1991-9#3)(1992-1#3)(1992-10#2)(1992-11#2)(1992-12#3)(1992-2#6)(1992-3#3)(1992-4#3)(1992-5#5)(1992-6#2)(1992-7#2)(1992-8#6)(1992-9#6)(1993-1#3)(1993-10#2)(1993-11#8)(1993-12#2)(1993-2#7)(1993-3#9)(1993-4#1)(1993-5#2)(1993-6#2)(1993-7#4)(1993-8#3)(1993-9#8)(1994-10#1)(1994-11#8)(1994-12#8)(1994-2#6)(1994-3#4)(1994-4#5)(1994-5#4)(1994-6#5)(1994-7#3)(1994-8#5)(1994-9#5)(1995-1#3)(1995-10#1)(1995-11#3)(1995-12#9)(1995-2#8)(1995-3#8)(1995-5#5)(1995-6#10)(1995-7#7)(1995-8#3)(1995-9#1)(1996-1#9)(1996-10#1)(1996-11#4)(1996-12#5)(1996-2#9)(1996-3#8)(1996-4#1)(1996-6#7)(1996-7#1)(1996-8#7)(1996-9#8)(1997-1#11)(1997-2#10)(1997-3#7)(1997-4#10)(1997-5#9)(1997-6#6)(1997-7#4)(1997-8#5)(2003-11#1)(2004-1#1)(2004-10#1)(2004-11#3)(2004-12#2)(2004-3#1)(2004-4#1)(2004-7#1)(2004-9#4)(2005-1#1)(2005-10#21)(2005-11#6)(2005-12#4)(2005-5#2)(2005-7#5)(2005-8#6)(2005-9#6)(2006-1#1)(2006-10#66)(2006-11#11)(2006-12#13)(2006-2#7)(2006-3#4)(2006-4#12)(2006-5#9)(2006-6#12)(2006-7#7)(2006-8#18)(2006-9#3)(2007-1#9)(2007-10#10)(2007-11#53)(2007-12#39)(2007-2#15)(2007-3#8)(2007-4#10)(2007-5#4)(2007-6#4)(2007-7#16)(2007-8#59)(2007-9#9)(2008-1#32)(2008-10#142)(2008-11#48)(2008-12#15)(2008-2#67)(2008-3#89)(2008-4#21)(2008-5#51)(2008-6#18)(2008-7#52)(2008-8#45)(2008-9#25)(2009-1#1)(2009-10#9)(2009-11#10)(2009-12#4)(2009-2#4)(2009-3#11)(2009-4#13)(2009-5#12)(2009-6#7)(2009-7#10)(2009-8#9)(2009-9#5)(2010-1#9)(2010-10#10)(2010-11#8)(2010-12#26)(2010-2#9)(2010-3#5)(2010-4#16)(2010-5#9)(2010-6#1)(2010-7#9)(2010-8#17)(2010-9#19)(2011-1#32)(2011-11#2)(2011-12#11)(2011-2#57)(2011-3#2)(2011-7#2)(2012-1#24)(2012-11#4)(2012-12#37)(2012-2#35)(2012-3#26)(2013-1#91)(2013-7#9)(2013-8#34)
reduced (&gt##2##2##(1995-1#1)(1997-3#1)
reduced (P &lt##5##3##(1992-12#2)(2008-5#1)(2010-2#1)(2011-3#1)
reduced (P less than 0##2##5##(1990-2#1)(1992-5#1)
reduced (P##7##2##(1990-2#1)(1992-12#2)(1992-5#1)(2008-5#1)(2010-2#1)(2011-3#1)
reduced (P&lt##4##2##(2007-6#1)(2008-6#1)(2010-4#2)
reduced (by##2##2##(1991-4#1)(1995-2#1)
reduced (from##3##2##(1995-12#1)(2007-8#1)(2008-5#1)
reduced (p &lt##4##3##(2006-8#1)(2008-9#1)(2010-4#1)(2010-5#1)
reduced (p##5##2##(1991-7#1)(2006-8#1)(2008-9#1)(2010-4#1)(2010-5#1)
reduced 13##2##2##(2008-10#2)
reduced 2##2##2##(1995-3#1)(2010-9#1)
reduced BPTI##2##2##(1995-10#2)
reduced CO##2##2##(1993-11#1)(1997-2#1)
reduced CoQ##2##2##(2008-4#2)
reduced DLCO##3##2##(1994-6#3)
reduced DNA synthesis##2##3##(1996-6#1)(2008-5#1)
reduced DNA##5##2##(1995-1#1)(1996-6#1)(2008-5#2)(2012-3#1)
reduced FHB##2##2##(2008-10#2)
reduced Fusarium##2##2##(2008-10#2)
reduced GSH##4##2##(1995-1#1)(2007-6#1)(2008-7#2)
reduced H##2##2##(2008-10#2)
reduced IAPP##2##2##(1995-10#2)
reduced IGF-I##3##2##(1990-12#1)(2007-7#2)
reduced IL-2##2##2##(1990-2#1)(2008-11#1)
reduced IL-6##2##2##(2011-2#1)(2012-12#1)
reduced IS##2##2##(2013-1#1)(2013-7#1)
reduced LDL cholesterol in##2##4##(2005-12#2)
reduced LDL cholesterol##3##3##(2005-12#2)(2012-2#1)
reduced MR image artifact##2##4##(2009-7#2)
reduced TAT specific activity##2##4##(1997-4#2)
reduced ability of the##3##4##(1996-5#1)(2006-12#1)(2008-10#1)
reduced ability of##6##3##(1991-7#1)(1995-1#1)(1996-5#1)(1997-4#1)(2006-12#1)(2008-10#1)
reduced ability to##9##3##(1991-12#1)(1991-4#1)(1992-10#1)(1994-11#2)(1997-7#2)(2011-12#1)(2012-2#1)
reduced ability##15##2##(1991-12#1)(1991-4#1)(1991-7#1)(1992-10#1)(1994-11#2)(1995-1#1)(1996-5#1)(1997-4#1)(1997-7#2)(2006-12#1)(2008-10#1)(2011-12#1)(2012-2#1)
reduced about##3##2##(1990-1#1)(1992-1#1)(2008-12#1)
reduced acceptance##2##2##(2008-2#1)(2008-3#1)
reduced access##3##2##(1991-1#1)(2011-2#2)
reduced activation##3##2##(1994-11#1)(2010-12#1)(2011-2#1)
reduced activities of the##2##4##(1990-3#1)(2012-1#1)
reduced activity and##2##3##(2006-9#1)(2007-10#1)
reduced activity of##5##3##(1992-6#1)(1994-12#1)(2009-6#1)(2012-2#1)(2012-3#1)
reduced activity toward##2##3##(1995-5#1)(1997-2#1)
reduced activity with##2##3##(1994-11#1)(1995-8#1)
reduced activity##24##2##(1990-12#1)(1990-4#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-12#1)(1995-2#2)(1995-5#1)(1995-8#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-12#1)(2006-9#1)(2007-10#1)(2008-11#2)(2009-10#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
reduced adhesion to##2##3##(2006-5#1)(2008-5#1)
reduced adhesion##3##2##(1990-9#1)(2006-5#1)(2008-5#1)
reduced affinity and##2##3##(1993-8#1)(1997-1#1)
reduced affinity for##5##3##(1991-7#1)(1992-6#1)(1994-11#2)(1994-9#1)
reduced affinity##12##2##(1990-11#1)(1991-7#1)(1992-6#1)(1993-8#1)(1994-11#2)(1994-9#3)(1997-1#1)(1997-2#1)(2013-7#1)
reduced after the##2##3##(1990-9#1)(2009-4#1)
reduced after treatment with##2##4##(1992-8#1)(1996-11#1)
reduced after treatment##3##3##(1992-8#1)(1996-11#1)(2013-1#1)
reduced after##21##2##(1990-12#1)(1990-9#1)(1991-2#1)(1992-8#1)(1993-3#1)(1994-12#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-9#1)(1997-2#1)(2004-9#1)(2008-10#2)(2008-11#1)(2009-4#1)(2010-5#1)(2013-1#3)(2013-7#1)
reduced all##3##2##(1996-5#1)(2008-12#1)(2012-2#1)
reduced among##2##2##(2010-1#1)(2012-2#1)
reduced amount of##7##3##(1990-3#1)(1992-1#1)(2006-12#1)(2008-10#1)(2012-1#1)(2012-11#1)(2012-12#1)
reduced amount##8##2##(1990-3#1)(1992-1#1)(2006-12#1)(2008-10#1)(2008-5#1)(2012-1#1)(2012-11#1)(2012-12#1)
reduced amounts of##3##3##(1995-6#1)(2008-5#1)(2012-12#1)
reduced amounts##5##2##(1993-9#1)(1995-6#1)(2008-5#2)(2012-12#1)
reduced analogs##2##2##(1994-11#2)
reduced and a##2##3##(2008-10#1)(2008-11#1)
reduced and alkylated##2##3##(1990-6#1)(2008-4#1)
reduced and more##2##3##(1991-5#1)(2007-11#1)
reduced and oxidized glutathione##2##4##(1995-1#1)(1996-9#1)
reduced and oxidized states##2##4##(1993-11#1)(1996-2#1)
reduced and oxidized##10##3##(1991-4#1)(1993-11#1)(1993-3#1)(1995-1#1)(1996-2#1)(1996-9#1)(2006-12#1)(2009-7#2)(2011-1#1)
reduced and that the##2##4##(1992-1#1)(2008-2#1)
reduced and that##3##3##(1992-1#1)(1997-5#1)(2008-2#1)
reduced and the##10##3##(1991-5#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-12#1)(2012-12#1)
reduced and was##2##3##(1991-6#1)(1992-1#1)
reduced and##73##2##(1990-4#1)(1990-6#2)(1990-8#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-3#1)(1995-1#1)(1995-10#1)(1995-5#1)(1996-2#1)(1996-9#2)(1997-2#1)(1997-5#1)(1997-8#1)(2005-11#2)(2006-12#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-6#2)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
reduced antioxidant##4##2##(1997-2#1)(2008-11#1)(2010-8#1)(2013-1#1)
reduced anxiety##5##2##(1995-8#1)(2007-11#1)(2008-12#1)(2011-2#1)(2012-1#1)
reduced approximately 50%##3##3##(1994-11#1)(2006-10#1)(2008-10#1)
reduced as a result of##3##5##(1990-5#1)(2007-12#1)(2008-10#1)
reduced as a##4##3##(1990-5#1)(1994-2#1)(2007-12#1)(2008-10#1)
reduced as compared##2##3##(1992-6#1)(1995-12#1)
reduced as the##3##3##(1997-2#1)(2007-12#1)(2010-2#1)
reduced as well##2##3##(1992-4#1)(1994-3#1)
reduced as##17##2##(1990-5#1)(1992-4#1)(1992-6#1)(1994-2#1)(1994-3#1)(1995-12#1)(1997-2#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-7#1)(2010-2#1)(2010-5#1)
reduced at -0##2##3##(2008-10#2)
reduced at a##6##3##(1990-8#1)(2008-10#5)
reduced at low##2##3##(1997-6#1)(2008-2#1)
reduced at the##8##3##(1994-9#1)(1995-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-12#2)
reduced at##37##2##(1990-8#1)(1992-3#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-6#1)(2006-3#1)(2006-9#1)(2007-11#1)(2007-6#1)(2008-10#15)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-12#2)
reduced availability of##4##3##(1994-5#1)(2006-2#1)(2011-2#2)
reduced bacterial##5##2##(2008-10#3)(2012-2#1)(2013-1#1)
reduced barrier function##3##3##(2008-5#3)
reduced because of the##2##4##(2008-2#1)(2010-4#1)
reduced because of##3##3##(2008-2#1)(2010-4#2)
reduced because##4##2##(2008-2#1)(2010-4#2)(2011-2#1)
reduced below##2##2##(2008-3#1)(2008-8#1)
reduced binding affinity##2##3##(1992-9#1)(2011-2#1)
reduced binding##5##2##(1992-12#1)(1992-9#1)(1996-12#1)(2006-11#1)(2011-2#1)
reduced biofilm##2##2##(2008-10#1)(2011-12#1)
reduced biological##2##2##(1993-8#1)(2008-8#1)
reduced blood flow in##2##4##(1992-7#1)(2012-3#1)
reduced blood flow##4##3##(1992-7#1)(2007-10#1)(2007-9#1)(2012-3#1)
reduced blood##7##2##(1992-7#1)(2006-6#1)(2007-10#1)(2007-9#1)(2008-4#1)(2009-10#1)(2012-3#1)
reduced body image dissatisfaction##2##4##(2007-12#2)
reduced body mass##2##3##(1997-4#1)(2012-3#1)
reduced body weight##2##3##(1995-3#1)(2006-2#1)
reduced body weights##3##3##(1997-6#1)(2005-7#1)(2008-9#1)
reduced body##12##2##(1991-2#1)(1995-3#1)(1997-4#1)(1997-6#1)(2005-7#1)(2006-2#1)(2007-12#2)(2008-4#1)(2008-9#1)(2010-8#1)(2012-3#1)
reduced bone mineral density##2##4##(2006-9#1)(2012-2#1)
reduced bone##10##2##(1997-8#1)(2006-9#1)(2007-8#1)(2009-3#1)(2009-4#1)(2009-7#1)(2011-1#1)(2012-2#1)(2013-1#2)
reduced both the##4##3##(1990-5#1)(1995-12#1)(1997-5#1)(2008-10#1)
reduced both##11##2##(1990-5#1)(1991-6#1)(1994-3#1)(1995-12#1)(1997-5#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-7#1)
reduced but did not##2##4##(1990-5#1)(1997-4#1)
reduced but not abolished##2##4##(1997-5#1)(2010-4#1)
reduced but##11##2##(1990-5#1)(1990-8#1)(1994-4#1)(1997-4#1)(1997-5#1)(2008-10#1)(2008-7#1)(2009-12#1)(2010-4#1)(2010-5#1)(2012-2#1)
reduced by 0##3##3##(2008-10#1)(2010-2#1)(2012-2#1)
reduced by 1##3##3##(1994-10#1)(2007-10#1)(2008-1#1)
reduced by 10%##4##3##(1992-6#1)(1996-7#1)(2008-10#1)(2008-2#1)
reduced by 17%##2##3##(1991-2#1)(2008-7#1)
reduced by 20%##2##3##(1995-12#1)(2008-2#1)
reduced by 30%##2##3##(1990-8#1)(2013-7#1)
reduced by 36%##2##3##(2008-3#1)(2012-1#1)
reduced by 40%##5##3##(1992-9#1)(1994-2#1)(1995-8#1)(2008-10#1)(2008-3#1)
reduced by 40-50%##2##3##(1990-3#1)(1996-5#1)
reduced by 50##2##3##(1993-4#1)(2007-11#1)
reduced by 50%##5##3##(1994-2#1)(1995-8#1)(2008-1#1)(2008-10#1)(2008-2#1)
reduced by 85%##2##3##(1992-8#1)(2008-4#1)
reduced by NADPH##2##3##(1990-12#1)(2009-10#1)
reduced by a factor of 2##3##6##(1995-3#1)(2007-11#1)(2008-10#1)
reduced by a factor of##11##5##(1990-12#1)(1995-3#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)
reduced by a##20##3##(1990-12#1)(1991-10#1)(1991-5#1)(1994-2#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-2#1)(2006-1#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)
reduced by about 50%##3##4##(2008-2#2)(2013-8#1)
reduced by about##12##3##(1994-4#1)(1995-5#1)(1995-7#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-6#1)(2009-8#1)(2012-12#1)(2013-8#1)
reduced by adding##2##3##(2007-4#1)(2010-4#1)
reduced by addition of the##3##5##(2008-3#2)(2008-5#1)
reduced by an##3##3##(1995-12#1)(2008-10#2)
reduced by applying##2##3##(2008-10#2)
reduced by approximately##6##3##(1990-3#1)(1991-8#1)(1992-11#1)(1992-6#1)(1996-11#1)(2008-6#1)
reduced by as much as##2##5##(2007-11#1)(2013-8#1)
reduced by blocking##2##3##(1992-7#1)(1993-7#1)
reduced by both##2##3##(1995-12#1)(1997-8#1)
reduced by dithiothreitol##2##3##(1995-10#2)
reduced by early##2##3##(2006-9#1)(2013-1#1)
reduced by exposure to##2##4##(1991-8#1)(1991-9#1)
reduced by heat treatment##2##4##(2008-10#1)(2008-2#1)
reduced by high##3##3##(1997-8#2)(2009-10#1)
reduced by increasing the##4##4##(1991-2#1)(1996-11#1)(1997-8#1)(2009-5#1)
reduced by increasing##6##3##(1991-2#1)(1992-4#1)(1996-11#1)(1997-8#1)(2008-8#1)(2009-5#1)
reduced by more than##5##4##(1995-3#1)(1997-2#1)(2008-10#1)(2008-3#1)(2010-3#1)
reduced by only##3##3##(1995-5#1)(2008-3#1)(2009-8#1)
reduced by over##3##3##(1990-6#1)(1997-1#1)(2008-5#1)
reduced by pretreatment##2##3##(1993-11#1)(2008-10#1)
reduced by the addition of##3##5##(1990-2#1)(1991-4#1)(1996-12#1)
reduced by the presence of##3##5##(1990-2#1)(1995-3#1)(2008-3#1)
reduced by the same##3##4##(1990-3#1)(1992-2#1)(2009-11#1)
reduced by the use of##2##5##(1994-3#1)(2011-2#1)
reduced by the##36##3##(1990-12#1)(1990-2#3)(1990-3#2)(1991-10#1)(1991-4#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-8#1)(2006-10#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2009-11#1)(2009-4#1)(2011-2#1)
reduced by treatment with##2##4##(1991-6#1)(1995-11#1)
reduced by use of##3##4##(2008-2#2)(2008-3#1)
reduced by##407##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#5)(1990-3#6)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#7)(1991-4#1)(1991-5#6)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#2)(1992-6#4)(1992-7#1)(1992-8#3)(1992-9#2)(1993-11#3)(1993-12#3)(1993-2#3)(1993-3#3)(1993-4#1)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#5)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-10#2)(1995-11#2)(1995-12#5)(1995-2#2)(1995-3#7)(1995-5#4)(1995-6#1)(1995-7#3)(1995-8#5)(1996-1#1)(1996-11#3)(1996-12#6)(1996-2#5)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#4)(1996-9#2)(1997-1#6)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#6)(2004-11#1)(2005-10#1)(2005-12#1)(2005-4#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-8#2)(2006-9#2)(2007-10#2)(2007-11#4)(2007-12#8)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#6)(2007-9#2)(2008-1#3)(2008-10#55)(2008-11#4)(2008-12#5)(2008-2#13)(2008-3#18)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#6)(2008-8#7)(2009-10#3)(2009-11#2)(2009-12#1)(2009-4#3)(2009-5#1)(2009-8#4)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#6)
reduced capacity for##2##3##(1996-11#1)(2006-12#1)
reduced capacity to##3##3##(1992-6#1)(2008-7#2)
reduced capacity##6##2##(1992-12#1)(1992-6#1)(1996-11#1)(2006-12#1)(2008-7#2)
reduced carbohydrate##3##2##(2008-10#1)(2008-5#1)(2012-11#1)
reduced cardiovascular##2##2##(1992-4#1)(2012-11#1)
reduced catalytic##2##2##(1991-7#1)(1997-7#1)
reduced cell death##2##3##(1995-11#1)(1996-1#1)
reduced cell growth##2##3##(2008-11#2)
reduced cell viability##5##3##(1993-12#1)(1995-12#1)(1996-3#1)(2010-8#1)(2011-12#1)
reduced cell##15##2##(1993-12#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-3#1)(2007-5#1)(2008-10#3)(2008-11#3)(2010-8#1)(2011-12#1)(2012-12#1)
reduced cellular##2##2##(1990-2#1)(2008-11#1)
reduced central##2##2##(1990-10#1)(2007-10#1)
reduced cerebral##3##2##(1990-9#1)(2006-10#1)(2006-4#1)
reduced cholinergic##2##2##(1994-12#1)(1996-8#1)
reduced clearance##2##2##(2008-3#1)(2010-12#1)
reduced clusters##2##2##(1994-11#1)(2010-2#1)
reduced colonization of##2##3##(2008-10#2)
reduced colonization##3##2##(2008-10#3)
reduced compared to controls##2##4##(1993-5#1)(2008-5#1)
reduced compared to that of##2##5##(1992-10#1)(1995-1#1)
reduced compared to that##3##4##(1992-10#1)(1995-1#1)(2008-5#1)
reduced compared to the##4##4##(2005-11#1)(2010-12#1)(2012-12#2)
reduced compared to##13##3##(1990-2#1)(1992-10#1)(1993-5#1)(1993-6#1)(1995-1#1)(2005-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-12#1)(2012-12#2)
reduced compared with that on##2##5##(2006-5#1)(2008-10#1)
reduced compared with that##4##4##(2006-5#1)(2007-12#1)(2008-10#1)(2008-2#1)
reduced compared with the##7##4##(1994-9#1)(1995-12#1)(1996-11#1)(2006-5#1)(2008-10#1)(2008-3#1)(2011-2#1)
reduced compared with##19##3##(1994-12#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-11#1)(2006-5#2)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-4#1)(2011-2#1)(2012-12#1)
reduced compared##32##2##(1990-2#1)(1992-10#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-11#1)(2005-11#1)(2006-5#2)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#3)
reduced competition##2##2##(1996-8#1)(2008-9#1)
reduced complexity##2##2##(2007-12#1)(2008-2#1)
reduced complication rates##3##3##(2007-7#1)(2008-1#1)(2010-6#1)
reduced compounds##3##2##(1993-4#1)(2008-10#1)(2010-5#1)
reduced computational##3##2##(2008-2#1)(2008-6#1)(2012-3#1)
reduced concentration of##3##3##(1992-8#1)(1993-1#1)(2012-1#1)
reduced concentration##4##2##(1992-8#1)(1993-1#1)(2008-11#1)(2012-1#1)
reduced concentrations of##3##3##(1992-12#1)(1995-8#1)(2011-2#1)
reduced concreteness##3##2##(2008-8#3)
reduced considerably##10##2##(1990-11#1)(1990-12#1)(1996-2#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2012-12#1)
reduced contact##2##2##(1991-8#1)(2008-5#1)
reduced coronary##3##2##(1996-9#1)(2005-12#1)(2006-10#1)
reduced correspondingly##2##2##(1996-1#1)(2012-2#1)
reduced cortical##4##2##(1991-6#2)(1992-7#1)(1994-12#1)
reduced cost of##3##3##(2007-7#1)(2008-11#1)(2008-6#1)
reduced cost to##2##3##(1996-2#1)(2005-9#1)
reduced cost##14##2##(1990-10#2)(1996-1#1)(1996-2#1)(2005-10#1)(2005-9#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)
reduced costs and##2##3##(2006-6#1)(2008-11#1)
reduced costs##8##2##(1992-2#1)(1993-8#1)(1997-1#1)(2006-10#1)(2006-5#1)(2006-6#1)(2008-10#1)(2008-11#1)
reduced counterpart##2##2##(2008-10#2)
reduced crystal##2##2##(2007-11#1)(2008-3#1)
reduced cytochrome##4##2##(1991-2#1)(1992-12#1)(1994-8#1)(1994-9#1)
reduced cytotoxicity##3##2##(1991-10#1)(1994-2#1)(2009-2#1)
reduced damage##5##2##(1994-10#2)(1996-1#1)(2007-12#1)(2008-9#1)
reduced datasets##3##2##(2007-8#3)
reduced decay caused by all three##2##6##(2008-10#2)
reduced decay##3##2##(2008-10#3)
reduced degradation##2##2##(1996-9#1)(2013-1#1)
reduced diameter##2##2##(2012-1#2)
reduced dietary##2##2##(2005-12#1)(2008-1#1)
reduced disability pension##3##3##(2006-8#3)
reduced disease development##2##3##(2008-10#2)
reduced disease in##3##3##(2008-10#3)
reduced disease incidence and##2##4##(2008-10#2)
reduced disease incidence in the##2##5##(2008-10#2)
reduced disease incidence##9##3##(2007-11#1)(2008-10#8)
reduced disease severity by##2##4##(2008-10#2)
reduced disease severity##7##3##(2007-12#1)(2008-10#6)
reduced disease symptoms##2##3##(2008-10#1)(2011-1#1)
reduced disease##32##2##(2007-11#1)(2007-12#1)(2008-10#28)(2008-5#1)(2011-1#1)
reduced dorsal##2##2##(1990-10#1)(1996-5#1)
reduced doses of##4##3##(1993-8#1)(2007-11#1)(2008-10#1)(2011-1#1)
reduced doses##6##2##(1993-8#1)(2005-9#1)(2007-11#1)(2008-10#2)(2011-1#1)
reduced drastically##2##2##(2008-10#1)(2009-7#1)
reduced drug accumulation##3##3##(1990-5#1)(2008-11#2)
reduced drug##4##2##(1990-5#1)(2008-11#2)(2008-6#1)
reduced due to##2##3##(2006-1#1)(2008-10#1)
reduced during the##5##3##(1990-2#1)(1997-7#1)(2008-1#2)(2012-2#1)
reduced during##12##2##(1990-2#1)(1994-5#1)(1997-3#1)(1997-7#1)(2004-4#1)(2007-12#1)(2008-1#2)(2008-10#1)(2009-3#1)(2011-2#1)(2012-2#1)
reduced effect of##4##3##(1991-9#1)(2007-11#1)(2008-12#1)(2008-3#1)
reduced effect##5##2##(1991-9#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-8#1)
reduced effectiveness or##2##3##(2010-1#1)(2012-2#1)
reduced effectiveness##4##2##(1993-10#1)(2004-3#1)(2010-1#1)(2012-2#1)
reduced efficacy##2##2##(2008-10#1)(2008-2#1)
reduced efficiency##2##2##(1990-5#1)(2007-12#1)
reduced ejection fraction##2##3##(2008-10#1)(2011-2#1)
reduced electrophoretic mobility##2##3##(1994-12#1)(1997-7#1)
reduced electrophoretic##3##2##(1991-4#1)(1994-12#1)(1997-7#1)
reduced energetic##2##2##(2008-9#1)(2012-2#1)
reduced energy##3##2##(1996-9#1)(2008-11#1)(2008-5#1)
reduced enzyme##5##2##(1990-10#2)(1992-3#1)(1994-9#1)(1996-6#1)
reduced epidermal##2##2##(2008-5#2)
reduced even##2##2##(2006-5#1)(2008-2#1)
reduced exercise capacity##2##3##(2010-10#1)(2012-2#1)
reduced exposure to##2##3##(1995-12#1)(2008-1#1)
reduced exposure##3##2##(1995-12#1)(2008-1#1)(2008-8#1)
reduced expression in the##2##4##(2010-12#1)(2011-12#1)
reduced expression in##3##3##(1997-2#1)(2010-12#1)(2011-12#1)
reduced expression of the##3##4##(1997-6#1)(1997-7#1)(2008-5#1)
reduced expression of##17##3##(1991-11#1)(1992-1#1)(1992-8#1)(1996-3#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2010-11#1)(2010-7#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
reduced expression##21##2##(1991-11#1)(1992-1#1)(1992-8#1)(1993-12#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-12#2)(2012-12#1)(2012-2#1)(2013-1#1)
reduced fasting##2##2##(1995-6#1)(2008-1#1)
reduced ferredoxin##2##2##(1991-7#2)
reduced fertility##3##2##(1994-2#1)(2012-3#2)
reduced fish##2##2##(2009-4#1)(2009-5#1)
reduced flavin##4##2##(1994-11#1)(1996-7#3)
reduced folded##2##2##(1994-8#1)(1997-4#1)
reduced following treatment##2##3##(1994-11#1)(2010-12#1)
reduced following##4##2##(1994-11#1)(2006-9#1)(2008-10#1)(2010-12#1)
reduced food intake##6##3##(1991-2#1)(1993-12#1)(1996-2#1)(2004-11#1)(2008-7#1)(2011-2#1)
reduced food##8##2##(1991-2#1)(1992-2#1)(1993-12#1)(1996-2#1)(2004-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
reduced for the##4##3##(1991-2#1)(1992-6#1)(2005-10#1)(2008-10#1)
reduced for##15##2##(1991-2#1)(1992-6#1)(1992-7#1)(1993-7#1)(1993-8#1)(2005-10#1)(2006-11#1)(2007-1#1)(2008-10#4)(2008-2#1)(2008-5#1)(2011-2#1)
reduced form of the##2##4##(2008-10#1)(2009-7#1)
reduced form of##9##3##(1991-3#1)(1994-5#1)(1996-7#1)(1997-2#1)(2008-10#4)(2009-7#1)
reduced form##20##2##(1991-3#1)(1992-1#1)(1992-6#1)(1994-5#1)(1996-7#1)(1997-2#1)(1997-7#1)(2006-12#2)(2007-12#1)(2008-10#6)(2009-7#1)(2010-2#1)(2011-2#1)(2013-8#1)
reduced formation of##4##3##(1991-9#1)(1995-12#1)(2008-10#1)(2009-5#1)
reduced forms##2##2##(1996-8#1)(2009-7#1)
reduced fracture##3##2##(2007-8#1)(2013-1#2)
reduced frequency of##3##3##(1992-8#1)(2010-4#1)(2012-12#1)
reduced frequency##4##2##(1992-8#1)(2005-11#1)(2010-4#1)(2012-12#1)
reduced friction##3##2##(2008-5#1)(2010-10#2)
reduced from 0##4##3##(2004-2#1)(2007-11#1)(2008-10#1)(2011-12#1)
reduced from 1##2##3##(1993-5#1)(2008-5#1)
reduced from 3##2##3##(1995-6#1)(2012-3#1)
reduced from 47##3##3##(1992-1#1)(1997-8#1)(2012-12#1)
reduced from 94%##2##3##(1991-3#1)(2013-8#1)
reduced from a##3##3##(2007-11#1)(2007-12#1)(2008-5#1)
reduced from the##4##3##(1994-12#1)(1996-8#1)(2004-9#1)(2007-12#1)
reduced from##61##2##(1990-8#1)(1991-3#1)(1992-1#1)(1992-2#1)(1993-5#1)(1993-7#3)(1993-8#1)(1994-12#1)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-8#1)(1997-4#2)(1997-8#3)(2004-2#1)(2004-9#2)(2007-11#2)(2007-12#5)(2008-10#8)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#4)(2008-7#1)(2008-9#2)(2011-12#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
reduced function##5##2##(1994-3#1)(1996-6#1)(2006-10#1)(2007-10#1)(2008-7#1)
reduced functional##3##2##(2005-9#1)(2006-10#1)(2007-9#1)
reduced gastric##2##2##(1993-11#1)(2011-2#1)
reduced gene expression##2##3##(1996-5#1)(1997-8#1)
reduced gene##3##2##(1996-5#1)(1997-8#1)(2010-10#1)
reduced general condition##2##3##(1990-6#1)(1991-2#1)
reduced germination##4##2##(2008-10#3)(2011-2#1)
reduced glutathione (GSH)##19##3##(1990-2#1)(1991-9#1)(1995-2#1)(2007-11#1)(2007-9#2)(2008-10#4)(2008-12#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-11#1)(2010-4#2)(2011-2#1)(2013-1#1)
reduced glutathione and##4##3##(1992-7#1)(1992-8#1)(1993-4#1)(2013-1#1)
reduced glutathione as##2##3##(1990-12#1)(1993-2#1)
reduced glutathione in##4##3##(1994-5#1)(2008-10#3)
reduced glutathione##53##2##(1990-12#1)(1990-2#1)(1991-9#3)(1992-11#1)(1992-12#1)(1992-7#2)(1992-8#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#3)(1996-7#3)(1997-1#2)(1997-2#1)(1997-8#1)(2004-11#1)(2005-12#1)(2007-11#1)(2007-8#1)(2007-9#2)(2008-10#7)(2008-12#1)(2008-6#1)(2008-7#2)(2009-6#1)(2010-11#1)(2010-4#2)(2011-2#2)(2012-2#2)(2013-1#2)
reduced gradually##3##2##(1990-11#1)(2009-6#1)(2013-8#1)
reduced growth and development##2##4##(2008-8#2)
reduced growth and##5##3##(2008-11#1)(2008-12#1)(2008-8#2)(2012-3#1)
reduced growth of##2##3##(2008-10#2)
reduced growth rate##7##3##(1993-9#1)(2005-7#1)(2006-9#1)(2008-11#1)(2010-10#1)(2010-4#1)(2010-8#1)
reduced growth rates##4##3##(2006-12#1)(2008-11#2)(2010-2#1)
reduced growth##26##2##(1993-9#1)(1995-5#1)(1997-2#1)(2004-4#1)(2005-7#1)(2006-12#1)(2006-9#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-8#2)(2009-8#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
reduced haloperidol##2##2##(1990-2#2)
reduced health##2##2##(1997-1#1)(2007-2#1)
reduced heart rate variability##2##4##(2006-11#1)(2008-7#1)
reduced heart rate##3##3##(1997-4#1)(2006-11#1)(2008-7#1)
reduced height##2##2##(2007-11#1)(2007-7#1)
reduced hepatic##4##2##(1993-12#1)(1994-6#1)(2008-4#1)(2009-10#1)
reduced host cell reactivation of damaged plasmid##2##7##(1990-7#2)
reduced host##4##2##(1990-7#2)(2007-12#1)(2008-7#1)
reduced human##2##2##(1995-2#2)
reduced hyphal##3##2##(2008-10#3)
reduced if the drug was##2##5##(2008-7#1)(2012-1#1)
reduced if the##4##3##(2008-10#1)(2008-7#2)(2012-1#1)
reduced if##14##2##(1992-11#1)(1996-8#1)(2006-8#1)(2008-10#5)(2008-3#1)(2008-7#3)(2009-1#1)(2012-1#1)
reduced immediately##2##2##(1993-8#1)(2005-5#1)
reduced immune response##2##3##(2008-9#1)(2013-1#1)
reduced immune##3##2##(2008-9#2)(2013-1#1)
reduced in 1998##2##3##(2008-10#1)(2008-5#1)
reduced in Alzheimer's disease##3##4##(1991-9#1)(1995-5#1)(1996-12#1)
reduced in Gadd45(as)/MCF-7##2##3##(2008-9#2)
reduced in KB##2##3##(1991-10#2)
reduced in a dose-dependent##4##4##(1992-12#1)(2008-10#1)(2008-5#1)(2010-12#1)
reduced in a##11##3##(1990-5#1)(1992-12#1)(2007-12#1)(2008-10#4)(2008-5#1)(2010-12#1)(2012-12#2)
reduced in all the##2##4##(1992-2#1)(2008-3#1)
reduced in all##8##3##(1992-2#1)(1995-3#1)(1996-12#1)(1997-4#1)(2006-10#1)(2006-11#1)(2007-8#1)(2008-3#1)
reduced in both the##2##4##(1993-12#1)(1995-7#1)
reduced in both##7##3##(1992-12#1)(1993-12#1)(1995-7#1)(2006-1#1)(2009-5#1)(2012-2#2)
reduced in cells##3##3##(1995-8#1)(1996-5#1)(2008-4#1)
reduced in comparison to##3##4##(1994-12#1)(2005-11#1)(2008-5#1)
reduced in comparison with##5##4##(1994-12#1)(1996-7#1)(2008-12#1)(2008-4#1)(2008-8#1)
reduced in comparison##8##3##(1994-12#2)(1996-7#1)(2005-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)
reduced in diabetic##2##3##(1992-3#1)(2008-1#1)
reduced in infected##2##3##(2008-10#2)
reduced in its ability to##2##5##(2008-10#2)
reduced in most##2##3##(2007-11#1)(2011-2#1)
reduced in number and##2##4##(1993-12#1)(1995-12#1)
reduced in number##4##3##(1993-12#1)(1994-2#1)(1995-12#1)(2008-7#1)
reduced in obese##2##3##(1997-5#1)(2011-2#1)
reduced in one##3##3##(2008-10#1)(2008-7#2)
reduced in patients with##7##4##(1991-7#1)(1995-3#2)(1996-12#1)(2007-8#1)(2009-9#1)(2012-2#1)
reduced in patients##9##3##(1991-7#1)(1995-3#2)(1996-12#1)(2007-8#1)(2008-5#1)(2009-9#1)(2012-2#1)(2013-1#1)
reduced in proportion##2##3##(1992-12#1)(1996-9#1)
reduced in size##5##3##(1996-2#1)(2004-1#1)(2004-9#1)(2007-11#1)(2012-2#1)
reduced in smokers compared##3##4##(2009-5#3)
reduced in the absence of##5##5##(1993-6#1)(1997-6#1)(2008-4#1)(2011-1#1)(2012-12#1)
reduced in the presence of an##2##6##(1997-7#1)(2012-11#1)
reduced in the presence of##9##5##(1991-6#1)(1992-7#1)(1993-9#2)(1994-2#1)(1995-11#1)(1997-7#1)(1997-8#1)(2012-11#1)
reduced in the##73##3##(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-5#1)(1997-1#2)(1997-2#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#3)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#3)(2008-7#2)(2008-8#1)(2009-2#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#2)(2013-1#4)
reduced in these##2##3##(1997-5#1)(2008-3#1)
reduced in vitro##4##3##(1990-8#1)(1993-12#1)(1996-7#1)(2008-10#1)
reduced in##298##2##(1990-10#1)(1990-11#3)(1990-12#2)(1990-5#4)(1990-7#3)(1990-8#2)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#2)(1991-9#3)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#2)(1992-5#2)(1992-7#1)(1993-11#2)(1993-12#7)(1993-2#2)(1993-3#3)(1993-6#1)(1993-7#1)(1993-9#4)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#1)(1994-4#1)(1994-5#3)(1994-7#1)(1994-9#1)(1995-11#2)(1995-12#3)(1995-3#6)(1995-5#2)(1995-6#1)(1995-7#3)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#9)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#2)(1996-9#2)(1997-1#2)(1997-2#2)(1997-4#2)(1997-5#7)(1997-6#1)(1997-7#2)(1997-8#3)(2004-1#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-8#2)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#31)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#6)(2008-5#7)(2008-7#13)(2008-8#4)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#7)(2012-2#10)(2013-1#6)(2013-7#1)(2013-8#3)
reduced incidence of##12##3##(1996-1#1)(1997-3#1)(2005-9#1)(2006-11#1)(2007-2#1)(2007-5#1)(2008-10#4)(2009-4#1)(2010-1#1)
reduced incidence##16##2##(1990-2#1)(1996-1#1)(1996-4#1)(1997-3#1)(2005-9#1)(2006-11#1)(2007-2#1)(2007-5#1)(2008-10#5)(2009-4#1)(2010-1#1)(2012-12#1)
reduced incorporation of##2##3##(2007-8#1)(2012-2#1)
reduced infarct size##3##3##(1995-7#1)(1996-9#1)(2012-2#1)
reduced infarct##4##2##(1995-7#1)(1996-9#1)(2012-2#1)(2013-7#1)
reduced infection by##2##3##(2008-10#2)
reduced infection##5##2##(2008-10#5)
reduced inflammatory##2##2##(2010-10#1)(2012-2#1)
reduced influence of##2##3##(2009-4#2)
reduced inhibition##2##2##(1993-4#1)(1996-5#1)
reduced initial##2##2##(1991-12#1)(2008-3#1)
reduced inorganic sulfur##2##3##(2006-3#1)(2008-10#1)
reduced inorganic##3##2##(2006-3#2)(2008-10#1)
reduced insulin secretion##3##3##(1990-12#2)(1991-7#1)
reduced insulin##5##2##(1990-12#2)(1991-7#1)(2008-4#1)(2009-9#1)
reduced intake##2##2##(2008-1#2)
reduced interest in##2##3##(1996-2#2)
reduced into##3##2##(1991-5#1)(2005-4#1)(2008-10#1)
reduced intracellular##3##2##(1995-8#1)(1996-8#1)(2007-11#1)
reduced intron content##2##3##(2008-7#2)
reduced invasion of both##2##4##(2008-10#1)(2012-2#1)
reduced iron##3##2##(1993-9#1)(1994-5#1)(2008-10#1)
reduced ischemic##3##2##(1996-9#1)(2005-12#1)(2008-8#1)
reduced islet cell##2##3##(1997-4#1)(2010-11#1)
reduced islet##3##2##(1993-11#1)(1997-4#1)(2010-11#1)
reduced it##8##2##(1990-2#1)(1992-7#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-4#1)(1995-8#1)(2010-10#1)
reduced its##2##2##(2008-12#1)(2012-2#1)
reduced laccase##2##2##(1992-12#1)(2008-10#1)
reduced leaf##4##2##(2008-10#3)(2013-1#1)
reduced lean body mass##2##4##(1997-8#1)(2007-7#1)
reduced left ventricular function##3##4##(2006-10#1)(2010-7#1)(2013-1#1)
reduced left ventricular##5##3##(1993-3#1)(2006-10#1)(2010-7#1)(2012-2#1)(2013-1#1)
reduced left##6##2##(1993-3#1)(2006-10#1)(2010-11#1)(2010-7#1)(2012-2#1)(2013-1#1)
reduced length of##2##3##(1991-12#1)(2012-2#1)
reduced leptin levels##2##3##(2007-7#1)(2013-1#1)
reduced lesion frequency##2##3##(2008-10#2)
reduced lesion##5##2##(1995-12#1)(2008-10#4)
reduced level of##9##3##(1996-6#1)(2006-12#1)(2007-2#1)(2008-5#1)(2008-6#1)(2010-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
reduced level##11##2##(1995-11#1)(1996-6#1)(2006-12#1)(2007-2#1)(2008-5#2)(2008-6#1)(2010-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
reduced levels of the##2##4##(1994-8#1)(1996-5#1)
reduced levels of##25##3##(1990-12#1)(1990-8#1)(1994-3#1)(1994-8#1)(1994-9#1)(1996-12#1)(1996-5#1)(1996-7#1)(2005-10#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)
reduced levels##27##2##(1990-12#1)(1990-8#1)(1992-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1996-12#1)(1996-5#1)(1996-7#1)(2005-10#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)
reduced life##2##2##(1993-8#1)(1996-6#1)
reduced likelihood of##3##3##(2007-12#1)(2012-3#1)(2013-7#1)
reduced lipid##4##2##(2008-1#2)(2008-9#1)(2012-11#1)
reduced liver##4##2##(1992-5#1)(1995-5#1)(2007-8#1)(2012-2#1)
reduced local##2##2##(1992-9#1)(1996-11#1)
reduced losses##2##2##(2008-10#1)(2013-8#1)
reduced lung function##2##3##(1992-9#1)(1996-3#1)
reduced lung##4##2##(1992-9#1)(1996-3#1)(2007-8#1)(2008-10#1)
reduced mRNA##2##2##(1996-12#1)(2006-12#1)
reduced markedly##3##2##(1990-12#1)(1994-6#1)(1995-7#1)
reduced medical costs by##2##4##(1995-1#2)
reduced medical##3##2##(1995-1#3)
reduced mobilities were##2##3##(1996-7#1)(2010-9#1)
reduced mobilities##3##2##(1991-4#1)(1996-7#1)(2010-9#1)
reduced mobility constants##2##3##(2008-10#2)
reduced model##7##2##(2007-11#1)(2007-12#2)(2008-6#3)(2010-2#1)
reduced molecular##3##2##(1994-3#1)(1996-8#1)(2008-10#1)
reduced morbidity and mortality##4##4##(2008-1#1)(2009-4#1)(2010-12#1)(2012-2#1)
reduced morbidity and##6##3##(2007-1#1)(2008-1#1)(2008-7#1)(2009-4#1)(2010-12#1)(2012-2#1)
reduced morbidity##9##2##(2007-1#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)
reduced more##4##2##(1997-7#1)(1997-8#1)(2008-10#2)
reduced morphine##2##2##(1990-7#1)(2008-7#1)
reduced mortality and##2##3##(2008-8#1)(2012-2#1)
reduced mortality rate##2##3##(2006-10#1)(2012-2#1)
reduced mortality##10##2##(1995-2#1)(1996-6#1)(2005-12#1)(2006-10#1)(2007-1#1)(2008-5#1)(2008-8#1)(2012-2#2)(2013-8#1)
reduced near-stoichiometric##2##2##(2007-11#1)(2008-2#1)
reduced need for##2##3##(1991-9#1)(2012-2#1)
reduced need##3##2##(1991-9#1)(1995-5#1)(2012-2#1)
reduced net insulin-stimulated glucose uptake by##2##6##(2010-10#2)
reduced net##3##2##(2008-10#1)(2010-10#2)
reduced neurite length##2##3##(2013-1#2)
reduced neurite##3##2##(2008-10#1)(2013-1#2)
reduced neuroinflammation##2##2##(2010-2#1)(2012-3#1)
reduced neuronal##2##2##(1994-3#1)(2006-8#1)
reduced new##2##2##(2005-3#1)(2008-5#1)
reduced nicotinamide adenine dinucleotide##2##4##(1994-6#1)(2010-8#1)
reduced noise##2##2##(2008-4#1)(2009-10#1)
reduced nor##2##2##(1990-8#1)(1992-8#1)
reduced number of##20##3##(1991-11#1)(1992-10#1)(1995-12#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-5#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-11#1)(2010-8#1)(2012-12#2)(2012-2#2)
reduced numbers of astrocytes##2##4##(2009-3#2)
reduced numbers of the##2##4##(2007-6#1)(2013-1#1)
reduced numbers of##10##3##(1991-5#1)(1996-2#1)(2007-11#1)(2007-6#1)(2008-10#2)(2009-3#2)(2011-2#1)(2013-1#1)
reduced ocelli##2##2##(2008-9#2)
reduced odds of##3##3##(2008-10#2)(2012-12#1)
reduced oligosaccharide##2##2##(1995-2#1)(1995-3#1)
reduced on the##8##3##(1990-5#1)(1992-1#1)(1993-11#1)(2008-10#4)(2008-5#1)
reduced on##12##2##(1990-5#1)(1992-1#1)(1993-11#1)(2004-2#1)(2008-10#6)(2008-5#1)(2008-7#1)
reduced only at##3##3##(1990-2#1)(1995-3#1)(2006-8#1)
reduced only in##4##3##(1995-3#2)(1996-12#1)(1997-2#1)
reduced only##13##2##(1990-2#2)(1992-4#1)(1993-12#1)(1994-11#1)(1995-3#3)(1996-12#1)(1997-2#2)(2006-8#1)(2008-10#1)
reduced operative##2##2##(1994-12#1)(2008-3#1)
reduced opportunities for##2##3##(2008-10#1)(2013-1#1)
reduced optical##3##2##(2008-10#1)(2008-3#1)(2010-12#1)
reduced or abolished##2##3##(1990-11#1)(1996-11#1)
reduced or absent##2##3##(2008-4#1)(2008-6#1)
reduced or eliminated by##2##4##(1991-4#1)(2007-12#1)
reduced or eliminated##6##3##(1991-4#1)(1993-12#1)(1995-1#1)(2007-12#1)(2008-9#1)(2013-8#1)
reduced or even##2##3##(1997-7#1)(2005-7#1)
reduced or lost##2##3##(2008-1#1)(2011-3#1)
reduced or##24##2##(1990-11#1)(1991-4#1)(1993-12#1)(1994-3#1)(1995-1#1)(1996-11#1)(1996-12#1)(1997-7#1)(2005-7#1)(2006-3#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#1)(2011-3#1)(2013-8#2)
reduced organ##2##2##(1994-3#1)(2006-8#1)
reduced output##2##2##(2008-1#1)(2008-2#1)
reduced overall##2##2##(1992-10#1)(2008-10#1)
reduced oxidative stress##4##3##(2006-9#1)(2008-7#1)(2009-6#1)(2013-7#1)
reduced oxygen tension of the##2##5##(2007-2#1)(2011-2#1)
reduced oxygen tension##3##3##(2007-2#1)(2011-1#1)(2011-2#1)
reduced oxygen##7##2##(2006-9#2)(2007-2#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
reduced pain in##2##3##(2006-3#1)(2013-1#1)
reduced pain scores##2##3##(2008-7#2)
reduced pain##10##2##(1990-6#1)(1995-9#1)(2006-3#1)(2007-11#2)(2007-8#1)(2008-12#1)(2008-7#2)(2013-1#1)
reduced pathogen populations##2##3##(2008-10#2)
reduced pathogen##3##2##(2008-10#3)
reduced penetrance##2##2##(1996-5#1)(2008-10#1)
reduced perfusion##2##2##(1990-8#1)(2008-11#1)
reduced phosphorus##3##2##(2008-10#3)
reduced physical##3##2##(1996-2#1)(1997-8#1)(2006-9#1)
reduced pineal activity and##2##4##(1992-8#2)
reduced plant##3##2##(2008-8#2)(2013-1#1)
reduced plasma leakage##2##3##(1995-7#2)
reduced plasma##7##2##(1992-5#1)(1994-11#1)(1995-2#1)(1995-6#1)(1995-7#2)(2004-11#1)
reduced platelet##4##2##(1995-12#1)(1997-6#1)(1997-7#1)(2008-3#1)
reduced population##4##2##(2008-10#2)(2008-9#2)
reduced potency##2##2##(1994-6#1)(1997-6#1)
reduced potential for##3##3##(2007-11#1)(2010-3#1)(2011-2#1)
reduced power##3##2##(2007-12#1)(2008-11#1)(2010-11#1)
reduced pregnenolone production&quot##2##3##(2012-2#2)
reduced presence of##3##3##(2008-10#2)(2010-12#1)
reduced pressure to##2##3##(2008-11#1)(2008-5#1)
reduced pressure##9##2##(1992-2#1)(2006-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2010-4#1)(2013-7#1)
reduced presynaptic##2##2##(1993-11#2)
reduced prior to##2##3##(1995-8#1)(2007-1#1)
reduced product of##2##3##(1997-2#1)(2008-10#1)
reduced production of##7##3##(1990-5#1)(1991-8#1)(1994-6#1)(1995-6#1)(2006-10#1)(2008-10#1)(2009-6#1)
reduced production##9##2##(1990-2#1)(1990-5#1)(1991-8#1)(1994-6#1)(1995-6#1)(2006-10#1)(2008-10#1)(2008-11#1)(2009-6#1)
reduced productivity##3##2##(2007-10#1)(2008-11#1)(2010-2#1)
reduced proliferation of##2##3##(2011-2#1)(2012-4#1)
reduced proliferation##3##2##(2011-2#1)(2012-12#1)(2012-4#1)
reduced protein##7##2##(1990-12#1)(1991-6#1)(1993-8#1)(1995-12#1)(1997-4#1)(2008-3#2)
reduced pulmonary##2##2##(2008-8#1)(2010-10#1)
reduced pyridine nucleotides##2##3##(1995-6#1)(1996-2#1)
reduced pyridine##4##2##(1995-2#1)(1995-6#1)(1996-2#2)
reduced quality of life##6##4##(1995-8#1)(1996-2#1)(2006-10#1)(2007-11#1)(2008-5#1)(2008-7#1)
reduced quality##8##2##(1994-7#1)(1995-8#1)(1996-2#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)
reduced radial##2##2##(2008-10#1)(2008-4#1)
reduced range of motion##4##4##(2007-11#1)(2011-2#1)(2012-1#1)(2013-7#1)
reduced rate of##5##3##(1990-12#1)(1997-8#1)(2007-2#1)(2008-10#1)(2008-9#1)
reduced rates of##4##3##(1994-5#1)(1997-7#1)(2008-9#1)(2009-5#1)
reduced rates##6##2##(1993-6#1)(1994-5#1)(1995-2#1)(1997-7#1)(2008-9#1)(2009-5#1)
reduced reactivity in##2##3##(2010-12#2)
reduced reactivity##4##2##(1994-12#1)(1995-8#1)(2010-12#2)
reduced relative to##4##3##(1994-5#1)(1995-1#1)(1997-4#1)(2010-8#1)
reduced relative##6##2##(1994-11#1)(1994-5#1)(1995-1#1)(1996-6#1)(1997-4#1)(2010-8#1)
reduced renal blood flow##3##4##(1995-5#1)(2012-2#2)
reduced renal##6##2##(1995-5#1)(1996-8#1)(2006-2#1)(2012-2#3)
reduced replication##3##2##(2011-2#2)(2013-1#1)
reduced reproduction##2##2##(2007-3#1)(2008-11#1)
reduced reproductive success##2##3##(2004-4#1)(2008-10#1)
reduced requirement for##2##3##(2006-5#1)(2007-8#1)
reduced respiration##2##2##(2008-9#1)(2011-2#1)
reduced responses to the##3##4##(1996-1#1)(1997-8#2)
reduced responses to##4##3##(1996-1#2)(1997-8#2)
reduced responsiveness##2##2##(2008-10#1)(2008-3#1)
reduced risk of cardiovascular##3##4##(2010-12#1)(2012-1#1)(2013-1#1)
reduced risk of##26##3##(1991-8#1)(1992-10#1)(1993-9#1)(1995-12#1)(1997-7#1)(2005-10#2)(2006-10#2)(2007-2#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#3)
reduced risk##32##2##(1990-7#1)(1991-8#1)(1992-10#1)(1992-9#1)(1993-9#1)(1995-12#1)(1997-7#1)(2005-10#4)(2006-10#3)(2007-2#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-1#2)(2012-2#1)(2013-1#3)
reduced root galling##2##3##(2008-10#2)
reduced root rot severity##3##4##(2008-10#3)
reduced root##5##2##(2008-10#5)
reduced sample##4##2##(1997-4#1)(2007-8#1)(2008-10#1)(2008-7#1)
reduced scattering and absorption coefficients##4##5##(2007-12#1)(2008-2#2)(2008-3#1)
reduced scattering and##5##3##(2007-12#1)(2008-2#3)(2008-3#1)
reduced scattering coefficient and##2##4##(2007-11#1)(2008-2#1)
reduced scattering coefficient##12##3##(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#4)(2011-1#1)
reduced scattering coefficients of##3##4##(2008-2#1)(2008-3#2)
reduced scattering coefficients##12##3##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#6)
reduced scattering##39##2##(1997-6#1)(2007-11#2)(2007-12#5)(2008-2#13)(2008-3#16)(2011-1#2)
reduced sclerotia##2##2##(2008-10#2)
reduced secondary spectrum##3##3##(2008-3#3)
reduced secondary##4##2##(2008-3#3)(2012-5#1)
reduced secretion##2##2##(1994-11#1)(2013-8#1)
reduced seed##2##2##(2008-10#1)(2012-11#1)
reduced seizure##2##2##(1996-1#1)(2008-1#1)
reduced sensitive##3##2##(2007-6#3)
reduced sensitivity and##2##3##(2008-10#2)
reduced sensitivity of##2##3##(1996-9#1)(2008-11#1)
reduced sensitivity to the##3##4##(1994-9#1)(2007-2#1)(2008-1#1)
reduced sensitivity to##8##3##(1991-3#1)(1991-9#1)(1994-9#1)(2007-2#1)(2008-1#2)(2008-2#1)(2009-4#1)
reduced sensitivity##15##2##(1991-3#1)(1991-9#1)(1994-9#1)(1996-9#1)(2007-2#1)(2007-6#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2009-4#1)(2012-2#1)
reduced serum IGF-I##2##3##(1994-8#2)
reduced serum free##2##3##(1993-12#1)(1996-12#1)
reduced serum levels of##2##4##(1994-6#1)(2007-11#1)
reduced serum##20##2##(1991-1#2)(1992-3#1)(1992-8#1)(1993-12#1)(1994-10#1)(1994-6#1)(1994-8#2)(1996-12#1)(1996-9#2)(2004-11#1)(2005-1#1)(2007-11#1)(2008-11#1)(2008-7#2)(2009-9#1)(2012-12#1)
reduced shear##2##2##(2008-11#1)(2008-12#1)
reduced sialylation##2##2##(1992-6#1)(1993-4#1)
reduced significantly (P##2##3##(2010-2#2)
reduced significantly by##4##3##(1995-3#1)(2004-11#1)(2008-10#1)(2010-2#1)
reduced significantly in##4##3##(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)
reduced significantly the##5##3##(1996-5#1)(1997-7#1)(2008-10#1)(2011-2#1)(2013-7#1)
reduced significantly##40##2##(1990-12#1)(1991-4#1)(1994-9#1)(1995-3#1)(1996-10#1)(1996-5#2)(1997-2#1)(1997-7#1)(2004-11#2)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-2#3)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
reduced size##3##2##(2007-12#1)(2008-10#1)(2009-2#1)
reduced sleep latency##2##3##(2004-3#2)
reduced sleep##3##2##(2004-3#2)(2008-12#1)
reduced smoking##2##2##(2008-1#1)(2008-8#1)
reduced social##2##2##(2008-6#1)(2012-1#1)
reduced specific##2##2##(1990-12#1)(2008-10#1)
reduced speck severity##2##3##(2008-10#2)
reduced spinal##2##2##(1993-4#1)(2005-8#1)
reduced splenic##2##2##(1995-2#1)(2008-11#1)
reduced sporulation##4##2##(2008-10#4)
reduced stability##3##2##(1993-6#1)(1994-11#1)(1994-6#1)
reduced state and##2##3##(1990-3#1)(2008-10#1)
reduced state##10##2##(1990-2#1)(1990-3#1)(1990-7#1)(1991-4#1)(1994-11#1)(1994-8#1)(1996-5#1)(2008-10#1)(2010-2#2)
reduced stress##2##2##(1995-12#1)(2013-8#1)
reduced stress-induced##4##2##(2008-4#2)(2011-2#2)
reduced subsets##3##2##(2007-8#2)(2008-12#1)
reduced substantially##6##2##(1990-1#1)(1996-8#1)(2008-2#1)(2008-3#2)(2009-10#1)
reduced sulfur compounds (RSC)##3##4##(2008-10#3)
reduced sulfur compounds##5##3##(2008-10#5)
reduced sulfur##8##2##(2008-10#8)
reduced superoxide##2##2##(2005-8#1)(2008-10#1)
reduced support vector##2##3##(2008-2#2)
reduced surface area##2##3##(1997-4#1)(2005-11#1)
reduced surface##3##2##(1997-4#1)(2005-11#1)(2010-4#1)
reduced survival during##2##3##(2008-6#1)(2008-7#1)
reduced survival##13##2##(1993-1#1)(1993-11#2)(1994-10#1)(1996-11#1)(2006-8#1)(2007-12#1)(2008-6#1)(2008-7#2)(2012-2#2)(2012-3#1)
reduced susceptibility to##6##3##(1997-2#1)(2005-8#1)(2007-12#1)(2010-12#1)(2011-2#1)(2012-12#1)
reduced susceptibility##7##2##(1997-2#1)(2005-8#1)(2007-12#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#1)
reduced symptoms of##5##3##(2008-10#4)(2008-6#1)
reduced synthesis of the##2##4##(2008-5#1)(2013-8#1)
reduced synthesis of##3##3##(2006-10#1)(2008-5#1)(2013-8#1)
reduced systemic##2##2##(1997-1#1)(2005-10#1)
reduced temperature##3##2##(1992-6#1)(1996-2#1)(2008-11#1)
reduced temporal##3##2##(1996-7#1)(2008-9#1)(2011-1#1)
reduced that##2##2##(1992-12#1)(2012-2#1)
reduced the EFS-evoked##3##3##(2008-2#3)
reduced the EGF##2##3##(1990-4#1)(2008-4#1)
reduced the ability of##3##4##(1995-8#1)(2008-10#1)(2008-5#1)
reduced the ability##4##3##(1995-8#1)(2008-10#1)(2008-5#1)(2012-12#1)
reduced the accumulation of##2##4##(1994-11#1)(2008-10#1)
reduced the activation of##2##4##(2012-3#1)(2013-1#1)
reduced the activity of##2##4##(1993-4#1)(2008-4#1)
reduced the activity##5##3##(1992-3#1)(1993-4#1)(1996-12#1)(2006-8#1)(2008-4#1)
reduced the affinity##3##3##(1992-9#1)(1994-8#1)(1995-5#1)
reduced the amount of##7##4##(1991-8#1)(1992-2#1)(1994-8#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-7#1)
reduced the amplitude and##2##4##(1991-5#1)(1993-12#1)
reduced the amplitude of the##3##5##(1992-8#2)(1997-3#1)
reduced the amplitude of##4##4##(1992-8#2)(1997-3#1)(1997-5#1)
reduced the amplitude##6##3##(1991-5#1)(1992-8#2)(1993-12#1)(1997-3#1)(1997-5#1)
reduced the average##2##3##(1996-11#1)(2012-12#1)
reduced the catalytic##2##3##(1990-5#1)(1992-9#1)
reduced the contractile##2##3##(1995-12#1)(1997-5#1)
reduced the cost of##2##4##(1990-2#1)(2008-6#1)
reduced the degree of##2##4##(2008-2#1)(2012-1#1)
reduced the development of##4##4##(1996-1#1)(2008-10#2)(2008-5#1)
reduced the disease##2##3##(2008-10#2)
reduced the effect of##3##4##(1991-5#1)(1994-2#1)(1995-6#1)
reduced the effectiveness of##2##4##(2008-10#2)
reduced the elevated##3##3##(1990-5#1)(1990-7#1)(2010-5#1)
reduced the enzymatic activity##2##4##(1995-10#1)(2008-10#1)
reduced the enzymatic##3##3##(1991-8#1)(1995-10#1)(2008-10#1)
reduced the enzyme activity##3##4##(1990-5#2)(1991-4#1)
reduced the enzyme##4##3##(1990-5#2)(1991-4#1)(1997-1#1)
reduced the expression of##2##4##(2008-10#2)
reduced the expression##3##3##(1995-1#1)(2008-10#2)
reduced the formation of##6##4##(1991-5#1)(1992-3#1)(1997-8#1)(2005-8#1)(2008-4#1)(2013-7#1)
reduced the frequency of##5##4##(1991-5#1)(1992-8#1)(2006-6#1)(2010-2#1)(2011-2#1)
reduced the growth of soybeans##2##5##(2008-10#2)
reduced the growth of the##2##5##(2008-10#1)(2008-12#1)
reduced the growth of##8##4##(2008-10#6)(2008-12#1)(2010-8#1)
reduced the growth rate##2##4##(1995-6#1)(1996-3#1)
reduced the growth##10##3##(1995-6#1)(1996-3#1)(2008-10#6)(2008-12#1)(2010-8#1)
reduced the incidence and severity of##2##6##(1991-12#1)(2008-10#1)
reduced the incidence of fire blight##2##6##(2008-10#2)
reduced the incidence of##19##4##(1993-2#1)(1996-12#1)(2005-12#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-10#6)(2008-5#2)(2008-6#1)(2009-5#1)(2013-1#1)
reduced the incidence##22##3##(1991-12#1)(1992-5#1)(1993-2#1)(1996-12#1)(2005-12#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-10#7)(2008-5#2)(2008-6#1)(2009-5#1)(2013-1#1)
reduced the increase##2##3##(1995-8#1)(1996-2#1)
reduced the infarct area##2##4##(1995-12#1)(2011-2#1)
reduced the infarct size##3##4##(2010-7#1)(2011-2#2)
reduced the infarct##6##3##(1992-7#1)(1995-12#1)(2010-7#1)(2011-2#3)
reduced the infection##2##3##(2008-10#2)
reduced the inhibitory##4##3##(1991-2#1)(1993-9#1)(1994-9#1)(1995-12#1)
reduced the intensity##2##3##(1994-2#1)(2012-1#1)
reduced the intracellular##3##3##(1994-12#1)(2008-11#2)
reduced the level of lipid peroxides at the surface of UVA-exposed skin##2##12##(2008-5#2)
reduced the level of##9##4##(1992-3#1)(1996-11#1)(1996-12#1)(1996-5#1)(2008-5#2)(2011-1#1)(2012-2#1)(2012-3#1)
reduced the levels of##9##4##(1992-4#1)(1993-6#1)(1994-8#1)(2008-10#1)(2008-11#2)(2012-2#1)(2013-1#2)
reduced the lipid peroxidation##2##4##(1997-8#1)(2010-8#1)
reduced the loss of##2##4##(2008-10#1)(2008-3#1)
reduced the lung##2##3##(1996-6#1)(2011-2#1)
reduced the magnitude of##5##4##(1990-2#1)(1992-7#1)(1993-2#1)(1996-5#1)(2008-2#1)
reduced the need##2##3##(1995-5#1)(2007-7#1)
reduced the number of infected##2##5##(2008-10#2)
reduced the number of##38##4##(1990-3#1)(1990-6#1)(1992-1#1)(1992-11#1)(1993-11#2)(1993-8#1)(1994-8#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-7#1)(2004-12#1)(2005-7#1)(2007-12#1)(2007-4#2)(2007-7#1)(2008-1#1)(2008-10#10)(2008-2#1)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#2)
reduced the number##39##3##(1990-3#1)(1990-6#1)(1992-1#1)(1992-11#1)(1993-11#2)(1993-8#1)(1994-8#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-7#1)(2004-12#1)(2005-7#1)(2007-12#1)(2007-4#2)(2007-7#1)(2008-1#1)(2008-10#10)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#2)
reduced the numbers of##2##4##(2008-10#2)
reduced the occurrence of##5##4##(1992-12#1)(2007-8#1)(2008-7#1)(2010-8#1)(2011-2#1)
reduced the occurrence##6##3##(1992-12#1)(1996-11#1)(2007-8#1)(2008-7#1)(2010-8#1)(2011-2#1)
reduced the overall##3##3##(1992-8#1)(2008-10#1)(2012-2#1)
reduced the peak##3##3##(1992-8#1)(2008-10#1)(2012-2#1)
reduced the population##3##3##(2008-10#1)(2009-3#1)(2010-10#1)
reduced the predictive ability of the##2##6##(2008-10#2)
reduced the pressor response##2##4##(1992-8#1)(1995-1#1)
reduced the pressor##3##3##(1991-5#1)(1992-8#1)(1995-1#1)
reduced the prevalence##2##3##(2006-10#1)(2012-1#1)
reduced the production of##2##4##(2008-4#1)(2010-12#1)
reduced the promoter activity##3##4##(1995-3#1)(1995-6#1)(1997-2#1)
reduced the proportion of##3##4##(1997-1#2)(2008-10#1)
reduced the rate of disease##2##5##(2007-11#1)(2008-10#1)
reduced the rate of##12##4##(1990-11#1)(1990-7#1)(1991-12#1)(1995-12#1)(1996-10#1)(2003-11#1)(2005-12#1)(2007-11#2)(2008-10#3)
reduced the rate##13##3##(1990-11#1)(1990-7#1)(1991-12#1)(1992-6#1)(1995-12#1)(1996-10#1)(2003-11#1)(2005-12#1)(2007-11#2)(2008-10#3)
reduced the release of##3##4##(1995-12#1)(1996-8#1)(1997-8#1)
reduced the resistance##2##3##(1990-6#1)(1992-6#1)
reduced the response##5##3##(1992-8#1)(1994-10#1)(1996-2#1)(1997-3#1)(2004-2#1)
reduced the risk for##2##4##(1997-1#1)(2013-7#1)
reduced the risk of##7##4##(1995-12#1)(2005-12#1)(2006-4#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-6#1)
reduced the risk##9##3##(1995-12#1)(1997-1#1)(2005-12#1)(2006-4#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-6#1)(2013-7#1)
reduced the sensitivity##2##3##(1994-3#1)(2008-4#1)
reduced the severity of##8##4##(2004-4#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-7#1)
reduced the size of##3##4##(1991-11#1)(1994-11#1)(2009-10#1)
reduced the size##5##3##(1991-11#1)(1994-11#1)(2008-10#1)(2008-4#1)(2009-10#1)
reduced the slope of##2##4##(2008-4#1)(2009-12#1)
reduced the survival##2##3##(2007-11#1)(2008-5#1)
reduced the synthesis of##3##4##(1990-7#1)(1993-9#1)(2008-5#1)
reduced the time required to inactivate chlamydospores##2##7##(2008-10#2)
reduced the time required to##3##5##(1993-12#1)(2008-10#2)
reduced the time required##4##4##(1993-12#1)(2008-10#3)
reduced the time to##4##4##(2007-11#1)(2008-9#1)(2010-7#1)(2011-12#1)
reduced the time##9##3##(1993-12#1)(1996-10#1)(2007-11#1)(2008-10#3)(2008-9#1)(2010-7#1)(2011-12#1)
reduced the total amount of##2##5##(2008-10#1)(2008-11#1)
reduced the total##5##3##(1994-5#1)(2004-2#1)(2007-1#1)(2008-10#1)(2008-11#1)
reduced the tumor##3##3##(1994-12#1)(2008-6#1)(2011-2#1)
reduced the variability of##2##4##(2008-10#1)(2012-1#1)
reduced the variability##3##3##(2008-10#2)(2012-1#1)
reduced the weight of##2##4##(1996-6#1)(2008-9#1)
reduced the weights of testes and epididymides##2##7##(2008-3#1)(2008-5#1)
reduced the yield of cv##2##5##(2008-10#2)
reduced the##562##2##(1990-10#1)(1990-11#2)(1990-2#5)(1990-3#3)(1990-4#1)(1990-5#6)(1990-6#3)(1990-7#7)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#4)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#8)(1991-6#1)(1991-8#3)(1992-1#1)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#5)(1992-4#2)(1992-5#2)(1992-6#4)(1992-7#3)(1992-8#8)(1992-9#2)(1993-1#1)(1993-11#7)(1993-12#3)(1993-2#4)(1993-3#1)(1993-4#2)(1993-6#3)(1993-8#2)(1993-9#4)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#3)(1994-6#3)(1994-8#6)(1994-9#2)(1995-1#5)(1995-10#2)(1995-11#1)(1995-12#13)(1995-2#1)(1995-3#3)(1995-5#7)(1995-6#7)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#3)(1996-11#3)(1996-12#5)(1996-2#3)(1996-3#3)(1996-4#2)(1996-5#2)(1996-6#4)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#6)(1997-2#5)(1997-3#2)(1997-4#1)(1997-5#6)(1997-6#2)(1997-7#2)(1997-8#5)(2003-11#1)(2004-12#3)(2004-2#2)(2004-4#1)(2005-11#1)(2005-12#3)(2005-7#1)(2005-8#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#3)(2007-10#2)(2007-11#7)(2007-12#2)(2007-3#2)(2007-4#2)(2007-7#4)(2007-8#4)(2008-1#4)(2008-10#84)(2008-11#12)(2008-12#1)(2008-2#9)(2008-3#5)(2008-4#15)(2008-5#19)(2008-6#5)(2008-7#11)(2008-8#6)(2008-9#4)(2009-1#1)(2009-10#2)(2009-12#2)(2009-3#2)(2009-5#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#15)(2012-1#7)(2012-12#7)(2012-2#8)(2012-3#3)(2012-7#1)(2013-1#13)(2013-7#5)(2013-8#5)
reduced their##13##2##(1990-3#1)(1990-6#2)(1991-11#1)(1995-3#1)(1996-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-11#2)(2012-1#1)(2012-3#1)
reduced thermal##3##2##(2007-12#1)(2008-2#1)(2008-7#1)
reduced these##3##2##(1990-10#1)(2008-10#1)(2013-1#1)
reduced thioredoxin##2##2##(1991-4#2)
reduced this##8##2##(1991-6#1)(1991-8#1)(1994-3#1)(1994-8#1)(2007-8#1)(2008-10#2)(2010-4#1)
reduced through the##2##3##(1993-3#1)(2008-2#1)
reduced through##7##2##(1991-8#1)(1993-3#1)(1994-4#1)(2008-10#1)(2008-2#2)(2009-1#1)
reduced tillage##3##2##(2008-10#3)
reduced time of analysis##2##4##(2008-10#2)
reduced time to exhaustion##2##4##(2013-8#2)
reduced time to##3##3##(1993-11#1)(2013-8#2)
reduced time##8##2##(1993-11#1)(1994-8#1)(2007-11#1)(2008-10#2)(2013-1#1)(2013-8#2)
reduced to &lt##4##3##(2006-5#1)(2007-11#1)(2008-10#1)(2013-1#1)
reduced to 0##10##3##(1990-11#1)(1994-3#1)(1994-5#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-3#3)(2010-12#1)
reduced to 1##2##3##(1993-1#1)(2008-1#1)
reduced to 10##2##3##(1995-10#1)(2012-12#1)
reduced to 27##2##3##(1993-12#1)(1994-10#1)
reduced to 30##2##3##(1996-5#1)(2008-10#1)
reduced to 5##3##3##(1994-2#1)(2007-11#1)(2009-2#1)
reduced to Cr(III)##3##3##(2008-10#2)(2011-2#1)
reduced to Fe(II)##3##3##(2008-10#3)
reduced to a##18##3##(1990-11#1)(1993-12#1)(1995-5#1)(1997-5#1)(2005-11#1)(2005-9#1)(2006-12#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#1)(2009-4#1)(2013-8#1)
reduced to about##7##3##(1994-6#1)(1995-12#1)(1995-5#1)(1996-6#1)(1997-4#1)(2006-8#1)(2010-8#1)
reduced to an##2##3##(1995-4#1)(2007-12#1)
reduced to as##2##3##(2007-11#1)(2010-6#1)
reduced to less than##6##4##(1994-12#1)(1996-7#1)(2007-7#1)(2008-3#2)(2008-5#1)
reduced to one third##2##4##(1993-6#1)(2008-10#1)
reduced to one##3##3##(1993-6#1)(2008-10#1)(2009-4#1)
reduced to only##2##3##(2007-12#1)(2008-10#1)
reduced to produce##2##3##(2008-10#1)(2008-4#1)
reduced to the corresponding##2##4##(1995-3#1)(2005-8#1)
reduced to the##24##3##(1990-12#1)(1990-4#1)(1990-6#1)(1994-6#1)(1995-3#1)(2005-11#1)(2005-8#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-5#1)(2012-2#1)
reduced to two##4##3##(1992-4#1)(1995-5#1)(2007-12#1)(2008-9#1)
reduced to yield##2##3##(1995-6#1)(2007-11#1)
reduced to zero##2##3##(1994-5#1)(2008-3#1)
reduced to##189##2##(1990-11#2)(1990-12#1)(1990-4#2)(1990-5#1)(1990-6#2)(1990-8#1)(1991-10#1)(1991-5#1)(1992-2#1)(1992-4#1)(1992-5#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#3)(1994-6#2)(1994-8#1)(1995-10#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-5#4)(1995-6#2)(1996-11#1)(1996-5#2)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-11#3)(2005-8#1)(2005-9#1)(2006-12#2)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#7)(2007-12#11)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#31)(2008-11#4)(2008-2#7)(2008-3#9)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#2)
reduced total cholesterol##3##3##(1991-2#1)(1992-12#1)(1992-8#1)
reduced total##10##2##(1990-11#1)(1991-2#1)(1992-12#1)(1992-8#1)(1997-7#1)(1997-8#1)(2005-12#1)(2007-7#1)(2007-8#1)(2008-10#1)
reduced toxic##2##2##(2008-3#1)(2009-8#1)
reduced toxicity in##3##3##(2008-8#1)(2008-9#1)(2010-11#1)
reduced toxicity##8##2##(1992-6#1)(1992-8#1)(1995-10#1)(1995-8#1)(2008-8#1)(2008-9#1)(2010-11#1)(2012-11#1)
reduced transcription##2##2##(1997-4#1)(2008-5#1)
reduced tube##2##2##(2007-11#1)(2008-10#1)
reduced tumor##2##2##(2008-11#1)(2013-1#1)
reduced tumour##2##2##(1990-10#1)(2005-11#1)
reduced under##4##2##(2008-10#1)(2012-1#1)(2012-6#1)(2013-1#1)
reduced upon##4##2##(1991-7#1)(1996-2#1)(1997-4#1)(2012-2#1)
reduced upper limb##2##3##(2007-11#1)(2012-1#1)
reduced uptake of##3##3##(1995-11#1)(2008-5#1)(2010-11#1)
reduced uptake##5##2##(1991-8#1)(1993-11#1)(1995-11#1)(2008-5#1)(2010-11#1)
reduced uranium##2##2##(2006-3#2)
reduced urinary##2##2##(1993-11#1)(2007-7#1)
reduced use of##4##3##(2007-8#1)(2008-10#1)(2008-9#1)(2011-2#1)
reduced using a##2##3##(1996-5#1)(2011-12#1)
reduced using##4##2##(1996-5#1)(2008-11#1)(2011-12#1)(2012-3#1)
reduced values of##2##3##(1990-8#1)(1995-11#1)
reduced values##3##2##(1990-8#1)(1995-11#1)(1996-9#1)
reduced via##2##2##(1991-8#1)(2008-10#1)
reduced viability of##2##3##(2008-10#1)(2008-5#1)
reduced viability##5##2##(1997-3#1)(1997-6#1)(2008-10#1)(2008-5#2)
reduced viral replication##2##3##(2013-1#2)
reduced virulence##4##2##(2008-10#1)(2008-9#1)(2011-12#1)(2011-2#1)
reduced visual##4##2##(1997-1#1)(2011-2#1)(2013-1#2)
reduced vital activity##2##3##(2010-9#2)
reduced volume##2##2##(2006-9#2)
reduced water and##3##3##(1995-12#1)(2008-11#1)(2012-3#1)
reduced water##9##2##(1994-9#1)(1995-12#1)(2005-8#1)(2008-11#4)(2010-4#1)(2012-3#1)
reduced weight##4##2##(1994-6#2)(2004-11#1)(2008-3#1)
reduced when a##2##3##(2008-7#1)(2012-1#1)
reduced when compared with##2##4##(1993-3#1)(1997-7#1)
reduced when compared##3##3##(1993-3#1)(1996-3#1)(1997-7#1)
reduced when the##7##3##(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2012-11#1)
reduced when##30##2##(1990-11#1)(1990-7#1)(1993-3#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-5#1)(1997-7#1)(2005-11#1)(2007-11#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#1)
reduced whereas##2##2##(1995-5#1)(2007-6#1)
reduced while##2##2##(2007-9#1)(2009-9#1)
reduced with NaBH4##3##3##(1995-3#1)(2007-11#2)
reduced with a##3##3##(1991-6#1)(2005-10#1)(2005-9#1)
reduced with age##3##3##(1994-10#1)(1995-12#1)(1995-9#1)
reduced with dithiothreitol (DTT)##2##4##(1990-12#1)(2012-2#1)
reduced with##43##2##(1990-12#1)(1990-5#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-6#1)(1993-2#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-1#1)(1997-2#1)(1997-6#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-5#1)(2007-10#1)(2007-11#5)(2007-7#2)(2008-10#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
reduced within##3##2##(1993-12#1)(2008-10#2)
reduced without##2##2##(1991-12#1)(2011-2#1)
reduced yield##5##2##(2008-10#4)(2011-1#1)
reduced##4662##1##(1990-1#2)(1990-10#15)(1990-11#21)(1990-12#29)(1990-2#35)(1990-3#19)(1990-4#6)(1990-5#30)(1990-6#16)(1990-7#25)(1990-8#14)(1990-9#7)(1991-1#6)(1991-10#10)(1991-11#9)(1991-12#15)(1991-2#22)(1991-3#8)(1991-4#13)(1991-5#31)(1991-6#18)(1991-7#15)(1991-8#20)(1991-9#23)(1992-1#15)(1992-10#10)(1992-11#12)(1992-12#25)(1992-2#13)(1992-3#21)(1992-4#11)(1992-5#9)(1992-6#23)(1992-7#16)(1992-8#30)(1992-9#14)(1993-1#6)(1993-10#1)(1993-11#33)(1993-12#30)(1993-2#16)(1993-3#19)(1993-4#13)(1993-5#3)(1993-6#10)(1993-7#7)(1993-8#23)(1993-9#26)(1994-10#9)(1994-11#36)(1994-12#25)(1994-2#24)(1994-3#24)(1994-4#6)(1994-5#25)(1994-6#27)(1994-7#2)(1994-8#30)(1994-9#20)(1995-1#24)(1995-10#14)(1995-11#15)(1995-12#50)(1995-2#34)(1995-3#31)(1995-4#2)(1995-5#33)(1995-6#23)(1995-7#10)(1995-8#30)(1995-9#5)(1996-1#16)(1996-10#6)(1996-11#21)(1996-12#34)(1996-2#26)(1996-3#12)(1996-4#8)(1996-5#26)(1996-6#17)(1996-7#20)(1996-8#21)(1996-9#25)(1997-1#32)(1997-2#36)(1997-3#12)(1997-4#34)(1997-5#28)(1997-6#19)(1997-7#26)(1997-8#37)(2003-11#1)(2004-1#2)(2004-10#1)(2004-11#10)(2004-12#3)(2004-2#5)(2004-3#4)(2004-4#6)(2004-9#4)(2005-1#1)(2005-10#16)(2005-11#20)(2005-12#14)(2005-3#1)(2005-4#3)(2005-5#1)(2005-7#5)(2005-8#12)(2005-9#6)(2006-1#5)(2006-10#32)(2006-11#5)(2006-12#22)(2006-2#5)(2006-3#11)(2006-4#4)(2006-5#15)(2006-6#6)(2006-7#4)(2006-8#19)(2006-9#15)(2007-1#12)(2007-10#19)(2007-11#79)(2007-12#82)(2007-2#13)(2007-3#6)(2007-4#8)(2007-5#3)(2007-6#15)(2007-7#23)(2007-8#53)(2007-9#16)(2008-1#41)(2008-10#625)(2008-11#84)(2008-12#30)(2008-2#97)(2008-3#123)(2008-4#62)(2008-5#119)(2008-6#37)(2008-7#103)(2008-8#61)(2008-9#42)(2009-1#4)(2009-10#20)(2009-11#6)(2009-12#6)(2009-2#7)(2009-3#14)(2009-4#23)(2009-5#14)(2009-6#9)(2009-7#12)(2009-8#11)(2009-9#7)(2010-1#9)(2010-10#17)(2010-11#13)(2010-12#40)(2010-2#23)(2010-3#12)(2010-4#26)(2010-5#18)(2010-6#6)(2010-7#11)(2010-8#25)(2010-9#9)(2011-1#32)(2011-10#1)(2011-11#2)(2011-12#11)(2011-2#93)(2011-3#3)(2012-1#41)(2012-11#9)(2012-12#61)(2012-2#85)(2012-3#35)(2012-4#2)(2012-5#3)(2012-6#2)(2012-7#3)(2012-8#1)(2013-1#104)(2013-7#25)(2013-8#46)
reduced)##2##1##(2008-8#1)(2009-4#1)
reduced-dose radiotherapy##2##2##(2006-8#2)
reduced-pathogenicity##2##1##(2008-10#2)
reduced-resolution filter##2##2##(2008-3#2)
reduced-resolution optical correlators##2##3##(2008-2#1)(2008-3#1)
reduced-resolution optical##3##2##(2008-2#2)(2008-3#1)
reduced-resolution##8##1##(2008-2#3)(2008-3#5)
reduced-scattering coefficients##3##2##(2008-2#2)(2008-3#1)
reduced-scattering##7##1##(2008-2#4)(2008-3#3)
reduced-size drawings##2##2##(2007-12#2)
reduced-size##3##1##(2007-12#2)(2010-4#1)
reduced/denatured RNase A##3##3##(2011-1#3)
reducer##7##1##(1990-3#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-6#1)(2010-4#1)(2012-1#1)
reducers##3##1##(2008-3#2)(2012-2#1)
reduces a##5##2##(1994-9#1)(1997-7#1)(2008-2#1)(2008-8#1)(2013-1#1)
reduces activity##4##2##(1992-3#2)(1995-5#1)(2008-4#1)
reduces adhesion##2##2##(2005-11#1)(2006-7#1)
reduces apoptosis in##2##3##(1995-12#1)(2011-2#1)
reduces as##2##2##(1995-11#1)(2008-3#1)
reduces blood pressure in##3##4##(1995-12#1)(1996-9#2)
reduces blood pressure##5##3##(1995-12#1)(1996-9#2)(2007-10#1)(2008-4#1)
reduces blood##8##2##(1995-12#1)(1996-9#2)(2007-10#1)(2007-8#2)(2008-11#1)(2008-4#1)
reduces bone resorption##2##3##(1994-6#1)(2013-1#1)
reduces bone##3##2##(1994-6#1)(2007-11#1)(2013-1#1)
reduces both the##5##3##(2007-12#1)(2008-10#2)(2008-2#1)(2011-2#1)
reduces both##13##2##(2006-10#1)(2006-2#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
reduces cardiac##5##2##(1993-3#1)(1996-2#1)(1997-4#1)(2008-10#1)(2008-4#1)
reduces cardiovascular risk##3##3##(2008-1#1)(2008-6#1)(2009-11#1)
reduces cardiovascular##7##2##(1996-9#1)(2005-11#1)(2006-2#1)(2008-1#2)(2008-6#1)(2009-11#1)
reduces cell##2##2##(1991-9#1)(2008-11#1)
reduces cerebral##2##2##(1997-6#1)(2007-10#1)
reduces complications##2##2##(2007-11#1)(2007-8#1)
reduces early##2##2##(2007-11#1)(2007-7#1)
reduces expression of##2##3##(1994-3#1)(1997-4#1)
reduces growth##3##2##(1992-7#1)(1994-8#1)(2007-11#1)
reduces hippocampal##2##2##(1995-7#1)(2011-2#1)
reduces hospital##2##2##(2008-3#2)
reduces hospitalization##2##2##(2007-8#1)(2011-2#1)
reduces in##3##2##(1996-7#1)(2006-10#1)(2008-10#1)
reduces infarct size##3##3##(1996-9#1)(2007-10#1)(2012-2#1)
reduces infarct##4##2##(1996-9#1)(2007-10#2)(2012-2#1)
reduces its##7##2##(1991-12#1)(1991-3#1)(1994-9#1)(1996-8#1)(2007-8#1)(2008-8#1)(2010-12#1)
reduces levels of##2##3##(2010-5#1)(2012-12#1)
reduces light levels##2##3##(2007-10#1)(2008-8#1)
reduces morbidity and mortality##2##4##(1993-5#1)(2008-3#1)
reduces morbidity and##3##3##(1993-5#1)(2006-10#1)(2008-3#1)
reduces morbidity##7##2##(1993-5#1)(2006-10#2)(2006-9#1)(2007-11#1)(2008-3#1)(2010-7#1)
reduces mortality##4##2##(2007-10#1)(2010-11#1)(2010-8#1)(2012-2#1)
reduces motor##2##2##(2009-12#1)(2012-1#1)
reduces noise##2##2##(2013-1#2)
reduces or eliminates the##2##4##(1997-7#1)(2008-1#1)
reduces or eliminates##3##3##(1995-11#1)(1997-7#1)(2008-1#1)
reduces or##5##2##(1995-11#2)(1997-7#1)(2008-1#1)(2010-7#1)
reduces oxidative##2##2##(2008-10#1)(2008-11#1)
reduces pain after##2##3##(1995-3#1)(2013-7#1)
reduces pain and improves##2##4##(2007-11#1)(2011-1#1)
reduces pain and##5##3##(2007-11#2)(2008-12#1)(2009-3#1)(2011-1#1)
reduces pain##9##2##(1995-3#1)(2007-11#2)(2008-12#2)(2009-3#1)(2010-4#1)(2011-1#1)(2013-7#1)
reduces plasma##2##2##(1994-4#1)(2009-6#1)
reduces platelet##2##2##(1990-11#1)(2005-1#1)
reduces postoperative##2##2##(2010-7#1)(2013-1#1)
reduces reagent##2##2##(2008-10#1)(2009-12#1)
reduces renal##2##2##(1996-11#1)(2007-11#1)
reduces risk##2##2##(2006-2#1)(2007-1#1)
reduces sample##3##2##(2008-10#2)(2010-11#1)
reduces scratching behaviour in##2##4##(1996-7#2)
reduces significantly the##2##3##(2008-2#1)(2008-5#1)
reduces symptoms##2##2##(2007-8#2)
reduces the ability##2##3##(2004-9#1)(2010-6#1)
reduces the activation energy##2##4##(1996-7#1)(2008-10#1)
reduces the affinity of LA for GT##2##7##(1996-7#2)
reduces the affinity of agonists for##2##6##(1990-5#1)(1996-2#1)
reduces the affinity of##6##4##(1990-5#1)(1992-6#1)(1994-11#1)(1996-2#1)(1996-7#2)
reduces the affinity##7##3##(1990-5#1)(1992-6#1)(1994-11#1)(1995-3#1)(1996-2#1)(1996-7#2)
reduces the average##3##3##(1996-12#1)(2007-11#1)(2008-9#1)
reduces the background##2##3##(2007-12#1)(2008-10#1)
reduces the burden of##2##4##(2010-11#1)(2010-8#1)
reduces the degree of##2##4##(1991-9#1)(1992-10#1)
reduces the duration of##3##4##(1993-1#1)(1993-11#1)(2007-11#1)
reduces the effect of##3##4##(2007-11#1)(2008-2#2)
reduces the effectiveness of the##2##5##(1997-1#1)(2008-2#1)
reduces the effectiveness of##5##4##(1990-9#1)(1997-1#1)(2007-11#1)(2008-2#1)(2008-6#1)
reduces the effects of##6##4##(1995-11#1)(2007-12#1)(2008-2#3)(2013-7#1)
reduces the energy##2##3##(2008-10#1)(2008-3#1)
reduces the frequency of##2##4##(1994-9#1)(2007-2#1)
reduces the incidence and##2##4##(2008-5#1)(2011-2#1)
reduces the incidence of atrial fibrillation post cardiac surgery##2##9##(2007-8#2)
reduces the incidence of atrial fibrillation##4##6##(2007-8#4)
reduces the incidence of post-operative##3##5##(2007-8#3)
reduces the incidence of postoperative atrial fibrillation##2##7##(2007-8#2)
reduces the incidence of vertebral##2##5##(2008-3#1)(2008-8#1)
reduces the incidence of##32##4##(1990-9#1)(1991-9#1)(1992-2#1)(1992-9#1)(1993-10#1)(1994-2#1)(1994-6#1)(2006-10#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-8#16)(2008-1#1)(2008-3#1)(2008-8#1)(2011-12#1)
reduces the incidence##34##3##(1990-9#1)(1991-9#1)(1992-2#1)(1992-9#1)(1993-10#1)(1994-2#1)(1994-6#1)(2006-10#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-8#16)(2008-1#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-12#1)(2011-2#1)
reduces the inhibition##3##3##(1990-12#1)(1990-8#1)(2008-11#1)
reduces the intensity##2##3##(1995-8#1)(2007-8#1)
reduces the lasing threshold to##2##5##(2007-11#1)(2008-1#1)
reduces the level of##4##4##(1993-3#1)(1993-9#1)(1994-8#1)(1997-7#1)
reduces the magnitude of##2##4##(2006-6#1)(2008-2#1)
reduces the need for##3##4##(1990-11#1)(1995-4#1)(2009-3#1)
reduces the need##4##3##(1990-11#1)(1995-4#1)(2009-3#1)(2013-7#1)
reduces the noise##2##3##(1996-12#1)(2008-3#1)
reduces the number of##17##4##(1990-3#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-7#1)(1994-5#1)(1995-1#1)(1995-5#1)(1995-9#1)(2008-10#1)(2008-11#1)(2010-10#1)(2010-12#1)(2010-3#1)(2013-1#2)
reduces the number##18##3##(1990-3#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-7#1)(1994-5#1)(1995-1#1)(1995-5#1)(1995-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-10#1)(2010-12#1)(2010-3#1)(2013-1#2)
reduces the overall##2##3##(1997-5#1)(2008-6#1)
reduces the phosphorylation##2##3##(1992-6#1)(1996-2#1)
reduces the possibility of##2##4##(1991-2#1)(2008-3#1)
reduces the prevalence of##2##4##(2008-10#1)(2013-8#1)
reduces the probability of##4##4##(2007-2#1)(2008-3#1)(2010-4#1)(2010-8#1)
reduces the rate of##8##4##(1991-2#1)(1994-9#1)(1996-11#1)(1996-8#2)(2007-1#1)(2010-12#1)(2013-8#1)
reduces the risk of recurrent##2##5##(2008-3#1)(2010-12#1)
reduces the risk of stroke##4##5##(1991-11#1)(2007-10#1)(2007-4#1)(2008-8#1)
reduces the risk of subsequent##2##5##(1995-9#1)(1997-1#1)
reduces the risk of##26##4##(1991-11#3)(1995-9#1)(1996-1#1)(1997-1#1)(2005-7#1)(2006-2#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-12#2)(2011-2#1)(2012-2#1)(2013-7#1)
reduces the risk##27##3##(1991-11#3)(1995-9#1)(1996-1#1)(1997-1#1)(2005-7#1)(2006-1#1)(2006-2#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-12#2)(2011-2#1)(2012-2#1)(2013-7#1)
reduces the risks of##4##4##(1991-2#1)(2006-12#1)(2008-3#1)(2008-4#1)
reduces the severity of##2##4##(2008-10#1)(2012-2#1)
reduces the severity##3##3##(2008-10#1)(2012-2#1)(2012-3#1)
reduces the time required for##2##5##(2008-10#2)
reduces the time required##3##4##(1997-4#1)(2008-10#2)
reduces the time##6##3##(1994-3#1)(1997-4#1)(2006-10#1)(2008-10#2)(2009-10#1)
reduces the##335##2##(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#4)(1991-12#1)(1991-2#5)(1991-6#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#2)(1993-11#1)(1993-3#2)(1993-9#3)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#6)(1995-1#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#3)(1995-4#2)(1995-5#1)(1995-8#2)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-5#1)(1996-6#1)(1996-7#5)(1996-8#4)(1996-9#4)(1997-1#4)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#3)(2004-3#1)(2004-9#1)(2005-11#3)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#2)(2006-8#2)(2007-1#2)(2007-10#3)(2007-11#11)(2007-12#15)(2007-2#3)(2007-4#1)(2007-7#1)(2007-8#23)(2008-1#3)(2008-10#15)(2008-11#6)(2008-12#1)(2008-2#14)(2008-3#19)(2008-4#2)(2008-5#7)(2008-6#5)(2008-7#3)(2008-8#5)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#2)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#2)(2011-12#4)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#8)(2013-7#3)(2013-8#3)
reduces their##2##2##(1994-9#1)(2009-5#1)
reduces this##2##2##(1990-12#1)(2008-5#1)
reduces time##3##2##(2007-12#1)(2007-3#1)(2009-8#1)
reduces to a##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
reduces to the##5##3##(1993-9#1)(2007-12#2)(2008-2#1)(2009-8#1)
reduces to##9##2##(1993-9#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#2)(2009-8#1)
reduces total##2##2##(2009-10#1)(2012-2#1)
reduces transcription to##2##3##(1991-12#1)(1995-8#1)
reduces transcription##3##2##(1991-12#2)(1995-8#1)
reduces transfusion requirements##2##3##(2008-7#1)(2009-5#1)
reduces waste##2##2##(2008-10#2)
reduces##728##1##(1990-11#4)(1990-12#4)(1990-2#1)(1990-3#2)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#5)(1991-12#5)(1991-2#7)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#2)(1991-8#3)(1991-9#3)(1992-1#2)(1992-10#1)(1992-2#2)(1992-3#6)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#2)(1992-9#2)(1993-1#1)(1993-10#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-5#1)(1993-9#8)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#4)(1994-4#1)(1994-5#1)(1994-6#4)(1994-8#3)(1994-9#9)(1995-1#3)(1995-11#7)(1995-12#7)(1995-2#3)(1995-3#6)(1995-4#2)(1995-5#4)(1995-7#3)(1995-8#5)(1995-9#2)(1996-1#3)(1996-11#3)(1996-12#2)(1996-2#5)(1996-3#1)(1996-5#4)(1996-6#1)(1996-7#8)(1996-8#6)(1996-9#9)(1997-1#5)(1997-2#1)(1997-3#1)(1997-4#6)(1997-5#1)(1997-6#1)(1997-7#6)(1997-8#2)(2004-3#2)(2004-9#1)(2005-1#3)(2005-11#5)(2005-12#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#9)(2006-12#2)(2006-2#7)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#3)(2007-10#12)(2007-11#25)(2007-12#26)(2007-2#3)(2007-3#1)(2007-4#2)(2007-7#3)(2007-8#37)(2008-1#9)(2008-10#41)(2008-11#11)(2008-12#4)(2008-2#25)(2008-3#36)(2008-4#7)(2008-5#14)(2008-6#6)(2008-7#9)(2008-8#14)(2008-9#6)(2009-10#3)(2009-11#2)(2009-12#4)(2009-2#1)(2009-3#4)(2009-5#5)(2009-6#3)(2009-8#6)(2010-1#4)(2010-10#4)(2010-11#4)(2010-12#6)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#6)(2010-8#7)(2010-9#2)(2011-1#9)(2011-12#8)(2011-2#16)(2012-1#5)(2012-12#5)(2012-2#14)(2012-3#9)(2013-1#18)(2013-7#6)(2013-8#6)
reducibility##3##1##(2009-3#2)(2013-1#1)
reducible##17##1##(1994-6#3)(1995-2#1)(1996-5#1)(2006-7#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#2)(2009-9#1)(2011-1#1)(2013-8#1)
reducing HIV##2##2##(2008-4#1)(2009-7#1)
reducing IOP##2##2##(2008-3#1)(2009-8#1)
reducing LDL##2##2##(1993-9#1)(2006-5#1)
reducing LOS##3##2##(1993-12#1)(1995-12#2)
reducing a##4##2##(1995-1#1)(1996-9#1)(2007-5#1)(2008-10#1)
reducing ability of##2##3##(1997-8#1)(2008-11#1)
reducing ability##3##2##(1997-8#1)(2008-11#2)
reducing activity##7##2##(1993-6#1)(1996-2#1)(2006-8#1)(2008-1#1)(2008-7#1)(2010-12#1)(2010-4#1)
reducing agent and##4##3##(1990-9#1)(2008-10#2)(2013-7#1)
reducing agent for##2##3##(1996-5#1)(2008-10#1)
reducing agent##33##2##(1990-2#1)(1990-7#1)(1990-9#1)(1992-11#1)(1993-3#1)(1994-9#1)(1995-1#1)(1995-11#3)(1995-6#1)(1996-2#1)(1996-5#1)(2005-11#1)(2007-8#1)(2008-10#13)(2008-5#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-7#1)
reducing agent)##3##2##(1994-8#1)(2007-11#1)(2008-10#1)
reducing agents and##4##3##(2008-10#1)(2008-5#1)(2009-3#1)(2012-2#1)
reducing agents##21##2##(1990-5#2)(1990-6#1)(1991-2#1)(1992-6#2)(1992-9#1)(1994-12#1)(1997-1#2)(1997-6#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#2)(2009-3#1)(2010-4#1)(2012-2#1)
reducing airway##2##2##(1994-6#2)
reducing alcohol##2##2##(2008-11#1)(2008-2#1)
reducing and non-reducing conditions##2##4##(1995-12#1)(1997-8#1)
reducing and##5##2##(1991-2#1)(1995-12#1)(1997-8#1)(2008-5#1)(2009-4#1)
reducing angiotensin##2##2##(2006-10#1)(2009-4#1)
reducing anisotropic diffusion##3##3##(2008-2#3)
reducing antioxidant##3##2##(2012-1#1)(2012-2#2)
reducing anxiety##2##2##(2009-12#1)(2009-5#1)
reducing any##3##2##(1997-8#1)(2008-11#1)(2008-2#1)
reducing associated##2##2##(2007-7#1)(2012-2#1)
reducing atmosphere##2##2##(2007-12#1)(2010-4#1)
reducing body weight##2##3##(1997-1#1)(2013-1#1)
reducing body##4##2##(1997-1#1)(2008-5#1)(2009-10#1)(2013-1#1)
reducing both the##2##3##(2008-10#2)
reducing both##6##2##(1996-5#1)(2007-5#1)(2008-10#2)(2008-3#1)(2013-8#1)
reducing breast##3##2##(1997-1#1)(2007-4#1)(2013-1#1)
reducing capacity of##2##3##(2008-11#2)
reducing capacity##3##2##(2008-11#3)
reducing cardiovascular disease##2##3##(2012-12#1)(2013-7#1)
reducing cardiovascular risk in##2##4##(2008-8#1)(2009-11#1)
reducing cardiovascular risk##3##3##(1990-2#1)(2008-8#1)(2009-11#1)
reducing cardiovascular##8##2##(1990-2#1)(1992-6#1)(1993-8#1)(1996-9#1)(2008-8#1)(2009-11#1)(2012-12#1)(2013-7#1)
reducing child poverty##2##3##(2008-11#2)
reducing child##3##2##(1996-2#1)(2008-11#2)
reducing complications##2##2##(1996-9#1)(2011-2#1)
reducing conditions##26##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#2)(1991-6#1)(1991-7#1)(1992-12#2)(1993-3#1)(1994-12#1)(1995-12#1)(1995-5#1)(1995-8#2)(1995-9#1)(1996-12#1)(1997-2#2)(1997-8#1)(2004-4#1)(2008-1#1)(2008-10#1)(2009-11#1)
reducing conversion rates to full-blown illness and decreasing symptom severity##2##10##(2009-8#2)
reducing coronary##2##2##(1995-12#1)(2013-1#1)
reducing cost##5##2##(1997-1#1)(2007-4#1)(2007-7#1)(2013-1#2)
reducing costs##7##2##(1996-2#1)(1996-3#1)(1997-2#1)(2006-10#1)(2008-10#1)(2008-11#1)(2012-12#1)
reducing death##2##2##(2006-10#1)(2009-7#1)
reducing disease incidence##2##3##(2008-10#2)
reducing disease##6##2##(2008-10#5)(2008-8#1)
reducing disparities in##2##3##(2013-1#2)
reducing drug##3##2##(1996-2#1)(2008-6#1)(2008-7#1)
reducing effect##2##2##(1993-2#1)(1997-2#1)
reducing efficiency##3##2##(2008-7#1)(2013-1#2)
reducing end of##5##3##(1992-10#1)(1995-11#1)(2007-8#2)(2011-1#1)
reducing end##13##2##(1990-4#1)(1992-10#2)(1992-12#1)(1995-11#3)(1996-2#1)(2005-11#1)(2007-8#3)(2011-1#1)
reducing energy##2##2##(2010-3#1)(2012-2#1)
reducing equivalents from##2##3##(1992-6#1)(2009-9#1)
reducing equivalents to##2##3##(1992-6#1)(2006-8#1)
reducing equivalents##11##2##(1991-2#1)(1992-6#3)(1994-11#1)(1995-3#1)(2004-4#1)(2006-8#1)(2009-4#1)(2009-9#2)
reducing errors##2##2##(1996-2#1)(2013-8#1)
reducing extracellular##2##2##(1996-9#1)(2009-9#1)
reducing food##2##2##(2006-2#1)(2012-2#1)
reducing future##2##2##(1997-7#1)(2010-4#1)
reducing germination of##2##3##(2008-10#2)
reducing health care##2##3##(1996-3#1)(2008-11#1)
reducing health disparities in underserved##2##5##(2011-1#1)(2012-2#1)
reducing health disparities in##3##4##(2008-4#1)(2011-1#1)(2012-2#1)
reducing health risks##2##3##(2008-6#1)(2009-7#1)
reducing health##7##2##(1996-3#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-7#1)(2011-1#1)(2012-2#1)
reducing hepatic##2##2##(2009-2#1)(2012-2#1)
reducing hospital stays##2##3##(2011-12#1)(2013-1#1)
reducing hospital##7##2##(1991-11#1)(1992-12#1)(1992-2#1)(2006-8#1)(2007-7#1)(2011-12#1)(2013-1#1)
reducing incontinence episodes##2##3##(2008-3#2)
reducing inflammation##2##2##(2012-2#1)(2013-7#1)
reducing insulin##2##2##(2007-9#1)(2008-3#1)
reducing intraocular pressure (IOP)##2##4##(2009-8#1)(2011-2#1)
reducing ischemic##2##2##(2007-9#1)(2008-3#1)
reducing its##8##2##(1990-9#1)(1994-6#1)(1994-8#1)(1995-11#1)(2007-12#1)(2008-10#1)(2008-9#1)(2010-12#1)
reducing lesion##2##2##(2012-3#1)(2013-8#1)
reducing levels of##2##3##(2010-11#1)(2011-2#1)
reducing low-density lipoprotein cholesterol##2##4##(1991-2#1)(2008-7#1)
reducing maternal##3##2##(2010-12#1)(2011-1#1)(2011-12#1)
reducing morbidity and mortality##3##4##(2007-2#1)(2011-2#1)(2013-1#1)
reducing morbidity##5##2##(1994-3#1)(2007-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
reducing mortality##4##2##(1994-7#1)(1995-3#1)(2005-11#1)(2007-3#1)
reducing myopia progression to between##2##5##(2012-12#2)
reducing myopia progression to##3##4##(2012-12#3)
reducing negative##3##2##(2008-8#1)(2009-5#1)(2013-7#1)
reducing of the##2##3##(2008-12#1)(2013-8#1)
reducing of##6##2##(1992-5#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-9#1)(2013-8#1)
reducing or eliminating the##3##4##(1990-3#1)(1997-3#1)(2006-3#1)
reducing or eliminating##5##3##(1990-3#1)(1997-3#1)(2006-3#1)(2008-11#1)(2008-2#1)
reducing or##12##2##(1990-3#1)(1992-5#1)(1994-6#1)(1997-3#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-11#1)(2012-3#1)
reducing overall##3##2##(1997-1#1)(2007-8#1)(2013-1#1)
reducing oxidative stress and##2##4##(2008-9#1)(2012-2#1)
reducing oxidative stress##4##3##(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)
reducing oxidative##5##2##(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-2#1)
reducing pain and improving##2##4##(1996-7#1)(2013-1#1)
reducing pain and##3##3##(1996-7#1)(2007-8#1)(2013-1#1)
reducing pain##5##2##(1996-7#1)(2006-6#1)(2006-7#1)(2007-8#1)(2013-1#1)
reducing particle##2##2##(2006-2#1)(2008-8#1)
reducing plasma##2##2##(1993-9#1)(2012-2#1)
reducing populations##2##2##(2008-5#1)(2011-2#1)
reducing postoperative##3##2##(2006-12#1)(2010-7#1)(2012-1#1)
reducing power consumption##2##3##(2008-7#1)(2010-11#1)
reducing power##10##2##(1993-12#1)(2008-10#2)(2008-7#4)(2010-11#1)(2010-5#1)(2013-1#1)
reducing pressure##2##2##(2007-7#1)(2008-10#1)
reducing radiation exposure##2##3##(1996-6#1)(2012-2#1)
reducing radiation##3##2##(1996-6#1)(2012-1#1)(2012-2#1)
reducing reaction##2##2##(1990-7#1)(2007-8#1)
reducing reagent##4##2##(2008-10#3)(2009-12#1)
reducing recurrence##2##2##(2011-2#1)(2012-1#1)
reducing risk##5##2##(1993-11#1)(1995-3#1)(2006-8#1)(2007-2#1)(2011-2#1)
reducing salt intake##3##3##(2013-1#3)
reducing salt##4##2##(2013-1#4)
reducing sample##2##2##(2008-10#1)(2010-1#1)
reducing sequence length##2##3##(2008-9#2)
reducing serum##5##2##(1991-6#1)(2007-11#1)(2008-11#1)(2008-5#1)(2009-3#1)
reducing sexual risk##2##3##(2008-4#1)(2013-1#1)
reducing side##2##2##(1994-8#1)(2011-2#1)
reducing significantly##2##2##(2007-11#1)(2008-3#1)
reducing species##3##2##(1990-2#1)(2008-10#2)
reducing staff##2##2##(1993-1#1)(2007-9#1)
reducing stigma##2##2##(2006-9#1)(2010-8#1)
reducing stress##2##2##(2005-6#1)(2010-10#1)
reducing sudden##2##2##(2010-12#1)(2011-1#1)
reducing sugar in the##2##4##(2008-5#1)(2011-1#1)
reducing sugar##7##2##(2008-10#2)(2008-5#1)(2008-7#1)(2009-3#1)(2011-1#2)
reducing sugars content##2##3##(2008-10#2)
reducing sugars in##4##3##(1997-2#1)(2008-10#3)
reducing sugars##18##2##(1992-12#1)(1994-6#1)(1995-11#1)(1997-2#1)(2007-11#1)(2008-10#10)(2010-12#1)(2013-1#2)
reducing surgical##2##2##(2007-5#1)(2010-5#1)
reducing the ability of##2##4##(1997-7#1)(2008-10#1)
reducing the activity##2##3##(1990-12#1)(2012-12#1)
reducing the amount of plant##2##5##(1991-11#1)(2008-10#1)
reducing the amount of##5##4##(1991-11#1)(1995-1#1)(2007-8#1)(2008-10#1)(2008-3#1)
reducing the burden of##3##4##(2006-10#1)(2008-1#1)(2013-8#1)
reducing the computational##2##3##(2009-9#1)(2011-2#1)
reducing the cost of##3##4##(1994-1#1)(2007-6#1)(2013-8#1)
reducing the cost##4##3##(1994-1#1)(2006-8#1)(2007-6#1)(2013-8#1)
reducing the dose of##3##4##(2008-1#1)(2010-12#1)(2010-2#1)
reducing the dose##6##3##(2005-11#1)(2007-11#1)(2008-1#1)(2009-7#1)(2010-12#1)(2010-2#1)
reducing the effect of##2##4##(2005-3#1)(2008-3#1)
reducing the efficacy of the##2##5##(2008-10#1)(2008-5#1)
reducing the efficacy of##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
reducing the extent##2##3##(2008-10#1)(2008-5#1)
reducing the frequency of##3##4##(2006-2#1)(2008-5#1)(2013-1#1)
reducing the harm##2##3##(1990-9#2)
reducing the impact of##4##4##(2008-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
reducing the incidence of hypertension##2##5##(2006-4#1)(2013-1#1)
reducing the incidence of##21##4##(1993-10#1)(2006-10#2)(2006-2#2)(2006-3#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#4)(2007-7#1)(2007-8#1)(2008-7#1)(2008-8#2)(2011-12#1)(2012-2#1)(2013-1#1)
reducing the incidence##23##3##(1993-10#1)(2006-10#2)(2006-2#2)(2006-3#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#4)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#2)(2008-8#2)(2011-12#1)(2012-2#1)(2013-1#1)
reducing the length of stay##2##5##(1992-12#1)(2006-10#1)
reducing the level of##4##4##(2007-11#1)(2008-10#1)(2008-9#1)(2009-8#1)
reducing the likelihood of##2##4##(2006-5#1)(2007-4#1)
reducing the morbidity and mortality##2##5##(2007-2#1)(2010-9#1)
reducing the mortality##2##3##(1990-12#1)(2009-8#1)
reducing the need for##6##4##(1994-6#1)(2007-11#1)(2007-7#1)(2008-3#1)(2011-12#1)(2012-2#1)
reducing the number of##17##4##(1995-5#1)(1996-12#1)(1996-2#1)(1997-2#2)(2007-11#2)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-3#1)
reducing the number##18##3##(1990-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-2#2)(2007-11#2)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-3#1)
reducing the occurrence of##3##4##(1992-5#1)(2008-10#1)(2009-11#1)
reducing the presence of##2##4##(2008-10#1)(2011-12#1)
reducing the pressure##2##3##(2007-7#1)(2008-3#1)
reducing the prevalence of##2##4##(2007-10#1)(2007-11#1)
reducing the probability##2##3##(2008-3#1)(2008-7#1)
reducing the production of##3##4##(1991-12#1)(2005-7#1)(2008-10#1)
reducing the rate of##5##4##(1990-9#1)(1992-2#1)(2007-11#1)(2007-8#1)(2010-2#1)
reducing the relative##2##3##(2008-1#1)(2013-1#1)
reducing the risk of cardiovascular##2##5##(2006-12#1)(2013-8#1)
reducing the risk of##16##4##(1992-10#1)(1996-3#1)(2006-12#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-8#1)
reducing the risk##20##3##(1991-12#1)(1992-10#1)(1996-3#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-8#1)
reducing the severity of##3##4##(2008-10#3)
reducing the severity##4##3##(2008-10#3)(2008-5#1)
reducing the stiffness coefficient concerning the oophorectomy status and follow-up period##2##11##(2013-1#2)
reducing the time of##2##4##(2008-10#2)
reducing the time##5##3##(2007-7#1)(2008-10#3)(2008-6#1)
reducing the total##3##3##(2007-7#1)(2008-6#1)(2010-5#1)
reducing the transmission##2##3##(2006-4#1)(2008-4#1)
reducing the use of##2##4##(1992-3#1)(2008-11#1)
reducing the volume of##2##4##(2008-10#1)(2008-6#1)
reducing the##338##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#3)(1991-11#1)(1991-12#3)(1991-3#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-10#1)(1993-3#1)(1993-4#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#2)(1997-2#2)(1997-6#2)(1997-7#1)(2004-2#1)(2004-3#1)(2005-10#3)(2005-11#5)(2005-3#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#7)(2006-11#1)(2006-12#2)(2006-2#5)(2006-3#1)(2006-4#4)(2006-5#2)(2006-6#1)(2006-8#3)(2007-10#2)(2007-11#21)(2007-12#5)(2007-2#1)(2007-3#3)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#6)(2007-8#7)(2008-1#6)(2008-10#39)(2008-11#8)(2008-2#13)(2008-3#13)(2008-4#2)(2008-5#16)(2008-6#5)(2008-7#6)(2008-8#8)(2008-9#2)(2009-10#1)(2009-11#2)(2009-2#2)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#2)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#4)(2011-2#6)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#14)(2013-7#1)(2013-8#6)
reducing their##14##2##(1993-5#1)(2006-5#1)(2007-2#2)(2007-9#2)(2008-10#2)(2008-5#1)(2008-8#1)(2010-5#1)(2010-9#1)(2011-12#1)(2012-3#1)
reducing time##2##2##(2008-10#1)(2008-3#1)
reducing tobacco##2##2##(2008-8#1)(2009-7#1)
reducing total##4##2##(1991-6#1)(2006-10#1)(2008-10#1)(2008-8#1)
reducing treatment##2##2##(1997-8#1)(2005-9#1)
reducing urinary##2##2##(2008-3#1)(2013-1#1)
reducing utilization##2##2##(1997-1#1)(2008-8#1)
reducing waste##2##2##(2008-10#1)(2013-7#1)
reducing wound##3##2##(2007-8#1)(2010-12#1)(2012-2#1)
reducing##1205##1##(1990-10#2)(1990-11#2)(1990-12#7)(1990-2#5)(1990-3#4)(1990-4#3)(1990-5#9)(1990-6#4)(1990-7#2)(1990-8#2)(1990-9#6)(1991-11#2)(1991-12#4)(1991-2#5)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#3)(1992-11#2)(1992-12#8)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#4)(1992-6#6)(1992-9#6)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#4)(1993-2#2)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#3)(1993-8#1)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#3)(1994-3#3)(1994-5#4)(1994-6#7)(1994-7#1)(1994-8#3)(1994-9#2)(1995-1#5)(1995-11#10)(1995-12#8)(1995-2#2)(1995-3#4)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#4)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#9)(1996-3#4)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#9)(1997-1#8)(1997-2#7)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#6)(2004-2#1)(2004-3#2)(2004-4#2)(2005-1#1)(2005-10#4)(2005-11#10)(2005-12#1)(2005-3#1)(2005-6#1)(2005-7#5)(2005-8#3)(2005-9#2)(2006-1#1)(2006-10#24)(2006-11#2)(2006-12#6)(2006-2#10)(2006-3#2)(2006-4#7)(2006-5#6)(2006-6#2)(2006-7#4)(2006-8#11)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#35)(2007-12#9)(2007-2#5)(2007-3#7)(2007-4#5)(2007-5#4)(2007-6#4)(2007-7#16)(2007-8#20)(2007-9#7)(2008-1#10)(2008-10#138)(2008-11#29)(2008-12#1)(2008-2#27)(2008-3#31)(2008-4#16)(2008-5#34)(2008-6#12)(2008-7#28)(2008-8#26)(2008-9#9)(2009-10#7)(2009-11#9)(2009-12#3)(2009-2#3)(2009-3#6)(2009-4#7)(2009-5#3)(2009-6#1)(2009-7#5)(2009-8#9)(2009-9#6)(2010-1#4)(2010-10#7)(2010-11#5)(2010-12#17)(2010-2#7)(2010-3#2)(2010-4#12)(2010-5#7)(2010-6#1)(2010-7#4)(2010-8#4)(2010-9#4)(2011-1#15)(2011-11#1)(2011-12#12)(2011-2#34)(2011-3#1)(2012-1#9)(2012-11#1)(2012-12#23)(2012-2#24)(2012-3#12)(2012-6#1)(2013-1#57)(2013-7#11)(2013-8#16)
reductance##2##1##(2008-11#2)
reductant and##3##2##(1994-5#1)(2008-10#1)(2009-3#1)
reductant for##5##2##(1991-8#1)(1995-5#1)(1997-8#1)(2008-10#1)(2009-10#1)
reductant##30##1##(1990-2#5)(1991-8#1)(1992-3#1)(1992-6#2)(1993-11#1)(1993-3#1)(1994-5#1)(1995-5#1)(1997-6#1)(1997-8#1)(2005-11#1)(2008-10#9)(2008-8#1)(2009-10#1)(2009-3#1)(2010-4#1)(2013-1#1)
reductants such as##2##3##(2008-10#1)(2009-3#1)
reductants##15##1##(1990-2#2)(1990-3#1)(1990-5#1)(1991-7#1)(1992-6#2)(1994-8#1)(1997-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-3#1)(2013-1#1)
reductase (EC 1##6##3##(1992-4#1)(1994-3#1)(1994-5#1)(1995-8#2)(1997-7#1)
reductase (FTR)##2##2##(1995-6#1)(2009-10#1)
reductase (MTHFR) gene##2##3##(2007-10#1)(2008-8#1)
reductase (MTHFR)##8##2##(1996-6#1)(2007-10#2)(2008-1#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#1)
reductase (NR)##3##2##(1993-6#1)(1994-5#1)(2008-10#1)
reductase (TR)##2##2##(2008-7#1)(2013-7#1)
reductase C677T##2##2##(2008-5#1)(2012-3#1)
reductase activities##8##2##(1992-3#1)(1994-9#1)(1996-5#1)(1997-3#1)(2008-5#1)(2008-6#1)(2013-1#1)(2013-8#1)
reductase activity and##2##3##(1996-2#1)(2008-10#1)
reductase activity in##6##3##(1990-11#1)(1991-10#1)(1993-6#1)(1994-5#1)(1996-3#1)(2009-8#1)
reductase activity of##4##3##(1993-4#3)(1995-3#1)
reductase activity was##4##3##(1990-11#1)(1992-2#1)(1995-1#1)(2007-8#1)
reductase activity##47##2##(1990-11#4)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-10#2)(1991-2#2)(1992-2#1)(1992-7#3)(1992-8#3)(1993-4#3)(1993-6#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-3#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-1#2)(1997-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-8#1)(2009-9#2)
reductase and a##2##3##(1990-7#1)(1991-2#1)
reductase and both##2##3##(1994-6#1)(1995-1#1)
reductase and other##3##3##(1991-5#1)(1996-7#1)(1997-2#1)
reductase and oxidase##2##3##(1995-2#2)
reductase and sorbitol dehydrogenase##3##4##(1996-2#3)
reductase and the##2##3##(1994-9#1)(2009-3#1)
reductase and##41##2##(1990-12#1)(1990-7#1)(1991-10#1)(1991-2#4)(1991-5#1)(1992-1#1)(1992-5#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-6#2)(1994-6#2)(1994-8#1)(1994-9#4)(1995-1#3)(1995-2#2)(1995-6#1)(1995-8#1)(1996-2#3)(1996-7#1)(1996-8#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-3#1)
reductase are##7##2##(1990-12#1)(1991-3#1)(1992-7#1)(1992-8#1)(1993-6#1)(1994-8#1)(1995-3#1)
reductase as##4##2##(1990-12#1)(1994-3#1)(1994-9#1)(1996-3#1)
reductase but##2##2##(1992-8#1)(2005-7#1)
reductase by##12##2##(1993-11#1)(1994-8#2)(1995-1#1)(1995-3#3)(1996-5#1)(1996-8#2)(2009-8#2)
reductase cDNA##5##2##(1990-3#2)(1990-8#1)(1993-12#1)(1993-3#1)
reductase complex##4##2##(1990-7#2)(1993-2#1)(1995-11#1)
reductase component of##4##3##(2008-11#4)
reductase component##6##2##(1997-4#2)(2008-11#4)
reductase deficiency##3##2##(1993-6#2)(2008-2#1)
reductase domain##2##2##(1994-9#1)(2010-12#1)
reductase enzyme##5##2##(1991-6#1)(2008-6#1)(2009-11#1)(2010-12#2)
reductase enzymes##3##2##(1994-8#1)(2006-8#1)(2010-12#1)
reductase from Escherichia coli##6##4##(1991-2#2)(1991-5#1)(1995-10#2)(2011-1#1)
reductase from Pseudomonas##2##3##(1997-2#1)(1997-7#1)
reductase from human liver##3##4##(1993-12#2)(1994-9#1)
reductase from human##4##3##(1990-3#1)(1993-12#2)(1994-9#1)
reductase from the##2##3##(1992-4#1)(1997-7#1)
reductase from##39##2##(1990-3#3)(1991-2#3)(1991-5#1)(1992-11#1)(1992-3#1)(1992-4#2)(1992-8#2)(1992-9#1)(1993-12#2)(1993-6#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-8#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-7#2)(2008-6#2)(2009-7#1)(2011-1#1)
reductase gene##12##2##(1992-8#3)(1993-6#1)(1994-5#1)(1995-7#1)(2006-12#2)(2008-11#1)(2008-2#1)(2011-1#1)(2013-1#1)
reductase genes##4##2##(2008-6#1)(2013-1#3)
reductase has been##3##3##(1990-12#1)(1991-5#1)(2006-10#1)
reductase has##5##2##(1990-12#1)(1991-5#1)(1991-6#1)(2006-10#1)(2008-11#1)
reductase in rat##3##3##(1993-5#1)(1997-2#2)
reductase in##17##2##(1990-12#1)(1990-2#1)(1991-3#1)(1991-5#2)(1992-7#2)(1993-5#1)(1994-3#1)(1994-8#1)(1997-2#2)(2006-12#1)(2008-11#1)(2009-7#1)(2010-8#1)(2013-1#1)
reductase inhibitor##17##2##(1991-12#2)(1991-5#2)(1992-3#1)(1993-6#1)(1993-9#2)(1994-12#1)(1994-8#3)(1996-5#1)(2005-8#1)(2006-5#1)(2008-5#1)(2009-11#1)
reductase inhibitor)##2##2##(1995-12#1)(2006-12#1)
reductase inhibitors (statins)##3##3##(2006-10#1)(2008-1#1)(2009-5#1)
reductase inhibitors are##2##3##(1991-5#1)(2006-10#1)
reductase inhibitors in##2##3##(2006-5#1)(2008-6#1)
reductase inhibitors such as##2##4##(1994-12#1)(1995-8#1)
reductase inhibitors##42##2##(1991-5#1)(1991-6#2)(1992-2#2)(1992-5#1)(1994-11#6)(1994-12#1)(1994-8#1)(1994-9#2)(1995-5#1)(1995-8#1)(1996-5#1)(1997-2#1)(2005-7#2)(2005-9#1)(2006-10#3)(2006-5#1)(2007-11#4)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-5#1)(2010-4#1)(2011-1#1)(2013-1#1)
reductase into##3##2##(1994-6#2)(1994-8#1)
reductase is##8##2##(1991-10#1)(1991-5#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-12#1)(2009-7#1)(2009-8#1)
reductase isoenzymes##2##2##(1997-6#1)(2010-11#1)
reductase levels##3##2##(1995-1#1)(1995-3#1)(1996-6#1)
reductase may##2##2##(1993-9#1)(1995-3#1)
reductase of P##2##3##(1991-3#1)(1993-2#1)
reductase of##7##2##(1990-3#1)(1990-8#1)(1991-3#1)(1993-2#2)(1997-2#1)(1997-3#1)
reductase or##2##2##(1990-12#1)(1990-8#1)
reductase reaction##3##2##(1990-8#1)(1994-11#2)
reductase subunit##2##2##(1992-10#1)(2013-8#1)
reductase system##3##2##(1991-3#1)(1994-12#2)
reductase that##3##2##(1990-5#1)(2008-5#1)(2008-6#1)
reductase to##6##2##(1991-10#1)(1991-2#2)(1994-11#1)(1994-8#1)(1995-2#1)
reductase under##2##2##(1991-3#1)(1995-6#1)
reductase was detected##2##3##(1996-6#1)(2010-8#1)
reductase was##17##2##(1990-11#1)(1990-8#1)(1991-2#3)(1992-2#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-3#1)(1996-3#3)(1996-6#1)(2008-11#1)(2010-8#1)
reductase were##4##2##(1994-11#1)(1994-9#1)(1995-1#1)(1997-2#1)
reductase with##3##2##(1991-7#1)(1994-8#2)
reductase##634##1##(1990-10#1)(1990-11#6)(1990-12#11)(1990-2#5)(1990-3#24)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#8)(1990-8#10)(1990-9#1)(1991-10#5)(1991-12#3)(1991-2#22)(1991-3#6)(1991-5#13)(1991-6#5)(1991-7#3)(1991-8#3)(1992-1#4)(1992-10#2)(1992-11#2)(1992-2#6)(1992-3#7)(1992-4#6)(1992-5#4)(1992-6#3)(1992-7#6)(1992-8#15)(1992-9#5)(1993-11#5)(1993-12#10)(1993-2#5)(1993-3#2)(1993-4#5)(1993-5#2)(1993-6#21)(1993-8#2)(1993-9#7)(1994-11#15)(1994-12#10)(1994-2#4)(1994-3#10)(1994-5#4)(1994-6#7)(1994-8#26)(1994-9#15)(1995-1#17)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#10)(1995-3#11)(1995-5#1)(1995-6#6)(1995-7#1)(1995-8#10)(1996-11#1)(1996-12#1)(1996-2#6)(1996-3#7)(1996-5#5)(1996-6#9)(1996-7#2)(1996-8#5)(1996-9#4)(1997-1#2)(1997-2#12)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#5)(2005-7#3)(2005-8#1)(2005-9#1)(2006-10#8)(2006-11#1)(2006-12#6)(2006-5#2)(2006-8#3)(2007-10#2)(2007-11#4)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#11)(2008-11#18)(2008-2#4)(2008-3#1)(2008-4#4)(2008-5#9)(2008-6#8)(2008-7#1)(2008-8#3)(2009-10#5)(2009-11#3)(2009-3#3)(2009-5#3)(2009-7#3)(2009-8#5)(2009-9#2)(2010-11#1)(2010-12#5)(2010-4#4)(2010-5#1)(2010-8#2)(2011-1#5)(2011-2#6)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#4)
reductase)##10##1##(1990-3#1)(1990-8#1)(1994-8#1)(1996-12#2)(2006-10#1)(2008-10#1)(2008-4#1)(2008-6#1)(2012-2#1)
reductase-encoding##3##1##(1991-7#1)(1994-12#1)(2008-10#1)
reductase-like protein##3##2##(1996-11#1)(1997-7#2)
reductase-mediated reaction of glyceraldehyde with##2##5##(1991-3#2)
reductases and##3##2##(1992-4#1)(1994-9#1)(1997-4#1)
reductases at##2##2##(1996-8#1)(2009-9#1)
reductases in##3##2##(1990-12#1)(1995-2#1)(2009-10#1)
reductases##36##1##(1990-12#1)(1990-3#3)(1990-5#3)(1991-3#1)(1991-5#3)(1992-3#1)(1992-4#4)(1992-8#2)(1992-9#1)(1993-6#1)(1994-3#1)(1994-9#2)(1995-1#1)(1995-2#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2009-10#3)(2009-9#2)(2012-2#1)
reduction (IC50##2##2##(1992-6#1)(2009-9#1)
reduction (P &lt##4##3##(1992-12#1)(1993-2#1)(1997-2#1)(2009-6#1)
reduction (p less than 0##2##5##(1992-4#1)(1993-1#1)
reduction (p##4##2##(1992-4#1)(1993-1#1)(1997-2#1)(2010-4#1)
reduction (p&lt##3##2##(2007-11#1)(2011-2#1)(2013-1#1)
reduction across##2##2##(2010-7#1)(2011-2#1)
reduction activity##4##2##(2006-3#1)(2013-7#3)
reduction after##4##2##(1995-2#1)(2008-5#1)(2008-7#1)(2013-8#1)
reduction among##4##2##(1991-5#1)(2007-10#1)(2007-11#1)(2010-4#1)
reduction and alkylation of##2##4##(1990-7#1)(1991-2#1)
reduction and alkylation##3##3##(1990-7#1)(1991-2#1)(2008-4#1)
reduction and cast immobilization##2##4##(2006-4#1)(2013-8#1)
reduction and fixation##4##3##(2006-3#1)(2010-11#1)(2011-2#1)(2013-8#1)
reduction and internal fixation of the##2##6##(2006-8#1)(2009-9#1)
reduction and internal fixation of##4##5##(2006-8#1)(2008-12#1)(2009-9#1)(2011-2#1)
reduction and internal fixation with a reamed##2##7##(2009-3#2)
reduction and internal fixation with##3##5##(2009-3#2)(2012-2#1)
reduction and internal fixation##13##4##(2006-8#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-3#3)(2009-9#1)(2011-2#1)(2012-2#2)(2013-1#2)
reduction and its##3##3##(2006-6#1)(2008-10#1)(2013-8#1)
reduction and oxidation of##4##4##(2008-10#2)(2008-3#1)(2012-2#1)
reduction and oxidation##8##3##(2008-10#6)(2008-3#1)(2012-2#1)
reduction and reoxidation of##2##4##(1990-5#2)
reduction and stabilization of the##2##5##(2007-11#1)(2010-3#1)
reduction and the##5##3##(1991-7#1)(1992-3#1)(2007-7#1)(2008-8#1)(2010-7#1)
reduction and uptake##2##3##(2009-9#2)
reduction and##118##2##(1990-5#3)(1990-7#1)(1990-8#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-8#1)(1995-3#1)(1995-7#1)(1995-9#1)(1996-2#1)(1997-8#1)(2004-11#1)(2004-4#1)(2006-10#4)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#3)(2008-10#13)(2008-11#1)(2008-12#6)(2008-2#3)(2008-3#5)(2008-4#3)(2008-7#3)(2008-8#2)(2009-10#1)(2009-12#2)(2009-3#4)(2009-9#3)(2010-11#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#4)(2013-1#3)(2013-7#2)(2013-8#4)
reduction approach##2##2##(2008-2#1)(2008-3#1)
reduction approaches##2##2##(2008-8#1)(2010-3#1)
reduction are##3##2##(1994-12#1)(2006-5#1)(2011-1#1)
reduction as well as##3##4##(1993-4#1)(2007-11#1)(2007-8#1)
reduction as##6##2##(1993-4#1)(2007-11#1)(2007-8#1)(2008-8#1)(2011-2#2)
reduction assay##4##2##(1993-12#1)(1997-2#1)(2008-11#1)(2013-1#1)
reduction assays##4##2##(1992-1#1)(1997-2#1)(2009-6#2)
reduction at -1##4##3##(2008-10#4)
reduction at the##4##3##(1994-12#1)(1996-2#1)(2007-2#1)(2008-5#1)
reduction at##19##2##(1994-12#2)(1995-11#1)(1996-2#1)(1997-7#1)(2007-2#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-6#1)(2009-9#1)(2011-12#1)(2012-12#1)(2012-2#1)
reduction based on##3##3##(2008-10#1)(2012-2#2)
reduction because of##2##3##(1994-8#1)(2007-8#1)
reduction behaviors##3##2##(2005-10#1)(2010-4#1)(2012-2#1)
reduction being##3##2##(2005-10#1)(2005-12#1)(2008-2#1)
reduction below the##2##3##(1993-3#1)(2007-12#1)
reduction below##5##2##(1990-9#1)(1993-3#2)(2007-12#1)(2008-7#1)
reduction both##2##2##(2006-6#1)(2008-11#1)
reduction by a##2##3##(2006-3#1)(2008-10#1)
reduction by the##5##3##(1992-1#1)(1994-11#1)(1994-3#1)(1994-8#1)(2007-1#1)
reduction by##43##2##(1990-2#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-9#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1997-7#1)(2005-3#1)(2006-1#1)(2006-3#2)(2006-8#2)(2007-1#1)(2007-12#2)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#2)(2008-3#2)(2008-9#2)(2009-10#1)(2009-9#2)(2010-6#1)(2012-2#1)
reduction campaign##3##2##(2007-8#3)
reduction can be##9##3##(1994-3#1)(2006-3#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2011-1#1)(2011-2#1)
reduction can##12##2##(1994-3#1)(1995-2#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#1)(2011-1#1)(2011-2#1)
reduction coil##4##2##(2008-10#4)
reduction column##3##2##(2008-10#3)
reduction compared to##2##3##(1994-8#1)(2012-2#1)
reduction compared##3##2##(1994-8#1)(2012-2#1)(2012-3#1)
reduction constant##2##2##(1993-8#2)
reduction could be##3##3##(1995-5#1)(1997-8#1)(2007-1#1)
reduction current of the adsorbed##2##5##(2008-10#2)
reduction current of##4##3##(2008-10#4)
reduction current##8##2##(1993-12#1)(2007-8#1)(2008-10#6)
reduction decreased##2##2##(2006-3#1)(2012-1#1)
reduction dominates over##2##3##(2006-6#2)
reduction due to##4##3##(2008-10#3)(2012-1#1)
reduction during##4##2##(1996-1#1)(2009-10#1)(2009-8#1)(2010-4#1)
reduction effect##3##2##(1991-9#1)(2005-10#1)(2008-9#1)
reduction efficiency##2##2##(2005-11#1)(2008-10#1)
reduction followed by##2##3##(2007-8#1)(2008-10#1)
reduction for the##3##3##(1997-2#1)(2008-10#1)(2008-12#1)
reduction for##14##2##(1991-8#1)(1992-10#1)(1994-8#1)(1997-2#1)(2005-10#1)(2006-10#1)(2007-4#1)(2008-10#2)(2008-12#1)(2008-2#1)(2010-4#1)(2011-1#1)(2012-3#1)
reduction from##10##2##(1993-8#1)(1994-3#1)(1997-3#1)(2006-3#1)(2007-8#1)(2008-3#1)(2008-6#1)(2009-9#1)(2011-1#1)(2012-3#1)
reduction has been##4##3##(2006-2#1)(2008-5#1)(2010-8#1)(2013-1#1)
reduction have been##2##3##(2008-5#1)(2008-7#1)
reduction in %##2##3##(2008-3#1)(2008-5#1)
reduction in Aeromonas hydrophila strain KB1##2##6##(2006-8#2)
reduction in CHD##2##3##(2005-10#2)
reduction in HOMA-IR##2##3##(2008-3#1)(2013-8#1)
reduction in LDL cholesterol##3##4##(2005-10#1)(2008-3#1)(2012-2#1)
reduction in LDL##4##3##(2005-10#1)(2008-3#2)(2012-2#1)
reduction in MAP##2##3##(1991-5#1)(1992-6#1)
reduction in MC##3##3##(1992-11#1)(2013-7#2)
reduction in RH##3##3##(2008-10#3)
reduction in a##2##3##(1995-1#1)(2007-12#1)
reduction in acidic##2##3##(2008-10#2)
reduction in activity##2##3##(1990-2#1)(1994-9#1)
reduction in agonist##2##3##(2008-3#1)(2013-8#1)
reduction in an##2##3##(2007-12#1)(2007-3#1)
reduction in antibiotic##2##3##(1997-5#1)(2008-4#1)
reduction in apple##2##3##(2008-10#2)
reduction in binding##3##3##(1991-9#1)(1995-3#1)(1995-7#1)
reduction in blood pressure##2##4##(1991-2#1)(2007-10#1)
reduction in blood##5##3##(1991-2#1)(2007-10#1)(2007-6#1)(2009-4#1)(2012-2#1)
reduction in body weight##3##4##(1993-8#1)(2006-2#1)(2008-12#1)
reduction in body##5##3##(1993-8#1)(2006-2#1)(2008-12#1)(2009-6#1)(2012-3#1)
reduction in bone##3##3##(1996-9#1)(2008-3#1)(2011-2#1)
reduction in both##11##3##(1990-11#1)(1990-12#1)(1991-8#1)(1993-8#1)(1994-6#1)(1995-12#1)(1997-5#1)(2004-2#1)(2006-2#1)(2008-10#2)
reduction in breast cancer##2##4##(1994-4#1)(2007-2#1)
reduction in breast##3##3##(1994-4#1)(2004-2#1)(2007-2#1)
reduction in cardiovascular##3##3##(1996-9#1)(2006-10#1)(2008-7#1)
reduction in cell number##2##4##(1994-10#1)(1994-12#1)
reduction in cell proliferation##2##4##(1990-12#1)(1990-6#1)
reduction in cell##7##3##(1990-12#1)(1990-6#1)(1993-8#1)(1994-10#1)(1994-12#1)(1996-7#1)(2012-12#1)
reduction in cerebral##4##3##(1990-11#1)(1994-2#1)(1996-9#1)(2007-9#1)
reduction in circulating white blood cells##2##6##(1994-8#2)
reduction in clinical##3##3##(2007-11#1)(2008-3#1)(2013-8#1)
reduction in cost of##2##4##(2007-6#1)(2008-10#1)
reduction in cost##3##3##(2007-6#1)(2008-10#1)(2010-2#1)
reduction in critical spacing##2##4##(2008-1#2)
reduction in cure##2##3##(2008-7#1)(2012-12#1)
reduction in death##2##3##(2007-10#1)(2007-5#1)
reduction in deep##2##3##(2007-8#1)(2008-6#1)
reduction in density of##2##4##(1990-2#1)(1996-6#1)
reduction in density##3##3##(1990-2#1)(1996-6#1)(2008-4#1)
reduction in diastolic##2##3##(1996-3#1)(2008-3#1)
reduction in disease incidence##2##4##(2008-10#2)
reduction in disease severity##4##4##(2008-10#2)(2011-12#1)(2012-2#1)
reduction in disease##11##3##(1994-7#1)(2008-10#8)(2011-12#1)(2012-2#1)
reduction in early##3##3##(2007-7#1)(2008-3#1)(2010-12#1)
reduction in either##2##3##(2008-10#1)(2009-9#1)
reduction in elasticity##2##3##(2008-5#1)(2012-2#1)
reduction in energy##5##3##(1994-5#1)(1997-7#1)(2008-10#1)(2008-5#1)(2012-2#1)
reduction in enzyme##2##3##(1991-12#1)(1997-4#1)
reduction in expression of the##2##5##(1994-8#1)(1997-7#1)
reduction in expression##3##3##(1994-8#1)(1996-7#1)(1997-7#1)
reduction in fat mass##2##4##(2008-3#1)(2008-5#1)
reduction in flow rates with##2##5##(1996-12#2)
reduction in freshwater##2##3##(2010-8#2)
reduction in growth rates##2##4##(1994-2#1)(2008-7#1)
reduction in growth##6##3##(1993-8#1)(1994-2#1)(2008-6#2)(2008-7#1)(2009-9#1)
reduction in heart failure##2##4##(2008-3#1)(2013-8#1)
reduction in hemoglobin##2##3##(1996-9#1)(2008-10#1)
reduction in hospital##2##3##(2007-4#1)(2007-9#1)
reduction in hospitalization##2##3##(2007-7#1)(2011-2#1)
reduction in host density as a result of parasite-induced host##2##10##(2008-9#2)
reduction in hot flash scores##2##5##(2008-7#2)
reduction in hourly dose requirements##2##5##(2006-10#2)
reduction in hypogastric nerve activity##2##5##(1995-12#2)
reduction in hypoglycemic##2##3##(2008-3#1)(2010-10#1)
reduction in incidence of##3##4##(2009-10#1)(2011-1#1)(2013-1#1)
reduction in incidence##4##3##(2007-4#1)(2009-10#1)(2011-1#1)(2013-1#1)
reduction in infarct volume##2##4##(1996-9#1)(2007-10#1)
reduction in infarct##3##3##(1991-9#1)(1996-9#1)(2007-10#1)
reduction in inflammation##2##3##(2008-3#1)(2010-8#1)
reduction in intensity of##3##4##(1995-6#1)(2008-10#2)
reduction in its##6##3##(1992-11#1)(1992-6#1)(1993-12#1)(1995-12#1)(2009-6#1)(2010-12#1)
reduction in kcat##4##3##(1990-2#1)(1992-2#1)(1995-2#1)(1995-5#1)
reduction in length of stay##2##5##(1994-3#1)(2012-2#1)
reduction in luc expression##2##4##(1993-6#2)
reduction in mean##3##3##(1993-11#1)(2007-8#1)(2008-3#1)
reduction in microvascular conductance##2##4##(1995-12#2)
reduction in morbidity and mortality##2##5##(1992-11#1)(2008-3#1)
reduction in morbidity and##3##4##(1992-11#1)(2006-5#1)(2008-3#1)
reduction in morbidity##4##3##(1990-11#1)(1992-11#1)(2006-5#1)(2008-3#1)
reduction in mortality from##2##4##(1995-12#1)(1996-3#1)
reduction in mortality##11##3##(1995-12#1)(1995-5#1)(1996-3#1)(2004-2#1)(2005-10#1)(2006-10#1)(2007-11#1)(2008-7#1)(2009-4#1)(2009-7#1)(2013-1#1)
reduction in neuronal##3##3##(1996-6#1)(2007-9#1)(2013-1#1)
reduction in number of##2##4##(2006-10#1)(2008-5#1)
reduction in numbers of##5##4##(1997-3#1)(2007-10#1)(2007-11#1)(2008-5#1)(2010-1#1)
reduction in overall##2##3##(2005-11#1)(2013-8#1)
reduction in pain##9##3##(1994-3#1)(2005-7#1)(2006-12#1)(2006-3#1)(2006-7#1)(2007-11#1)(2007-8#1)(2010-4#1)(2010-7#1)
reduction in parasite##3##3##(2005-7#1)(2006-10#1)(2008-8#1)
reduction in pathogen##2##3##(2008-10#2)
reduction in peak##2##3##(2006-4#1)(2007-11#1)
reduction in photoplethysmography##2##3##(2008-2#2)
reduction in plant##2##3##(1992-3#1)(2008-10#1)
reduction in plasma##6##3##(1994-11#1)(1995-2#2)(1996-5#1)(2008-10#1)(2010-11#1)
reduction in population##4##3##(1994-5#1)(2006-7#1)(2008-1#1)(2013-1#1)
reduction in postoperative##5##3##(2006-12#2)(2010-7#1)(2012-1#2)
reduction in pressure##2##3##(1996-6#1)(2007-8#1)
reduction in proliferation##2##3##(1997-6#1)(2009-12#1)
reduction in protein##4##3##(1990-5#1)(2007-8#2)(2011-2#1)
reduction in pupil size##3##4##(1993-11#2)(2007-11#1)
reduction in reagent##2##3##(2008-10#1)(2011-2#1)
reduction in receptor binding##2##4##(1990-2#1)(1995-7#1)
reduction in renal plasma flow and glomerular filtration rate and##2##10##(1995-12#2)
reduction in renal##3##3##(1995-12#2)(2008-10#1)
reduction in resistance##2##3##(2004-11#1)(2013-1#1)
reduction in response to##3##4##(1991-1#1)(1993-1#1)(1995-6#1)
reduction in reward magnitude##2##4##(1993-12#2)
reduction in reward##3##3##(1993-12#3)
reduction in risk of##3##4##(1993-11#1)(2005-10#1)(2008-4#1)
reduction in risk##5##3##(1993-11#1)(1996-3#1)(2005-10#1)(2007-11#1)(2008-4#1)
reduction in root lesions)##2##4##(2008-10#2)
reduction in serum##10##3##(1993-12#1)(1995-12#1)(1995-3#1)(2006-10#1)(2008-3#1)(2008-5#2)(2010-8#1)(2011-2#1)(2013-8#1)
reduction in severity##2##3##(1992-5#1)(2004-2#1)
reduction in size of the##3##5##(2008-10#1)(2008-8#1)(2011-1#1)
reduction in size of##4##4##(2008-10#2)(2008-8#1)(2011-1#1)
reduction in size##5##3##(1995-3#1)(2008-10#2)(2008-8#1)(2011-1#1)
reduction in sperm##2##3##(2008-6#1)(2009-6#1)
reduction in stroke incidence##2##4##(1992-4#1)(2007-9#1)
reduction in stroke##3##3##(1992-4#1)(1993-10#1)(2007-9#1)
reduction in surface tension##2##4##(1994-5#1)(2008-5#1)
reduction in survival##2##3##(2005-10#1)(2008-7#1)
reduction in susceptibility##3##3##(1994-2#1)(2005-7#1)(2006-11#1)
reduction in systemic##2##3##(1992-8#1)(1993-12#1)
reduction in temperature##3##3##(1996-2#1)(2006-4#1)(2008-2#1)
reduction in tensile properties##2##4##(1991-10#1)(2008-5#1)
reduction in the LDL##2##4##(1991-1#1)(1997-7#1)
reduction in the ability of##2##5##(1994-11#1)(1994-3#1)
reduction in the ability##3##4##(1994-11#1)(1994-3#1)(1997-5#1)
reduction in the accumulation of##2##5##(1994-8#1)(2008-7#1)
reduction in the activity of##3##5##(1991-6#1)(1997-5#1)(2007-12#1)
reduction in the activity##4##4##(1991-6#1)(1994-6#1)(1997-5#1)(2007-12#1)
reduction in the amount of##7##5##(1990-12#1)(1993-4#1)(2008-10#2)(2008-12#1)(2010-7#1)(2013-1#1)
reduction in the amount##8##4##(1990-12#1)(1993-4#1)(2006-10#1)(2008-10#2)(2008-12#1)(2010-7#1)(2013-1#1)
reduction in the apparent##2##4##(1995-1#1)(1996-5#1)
reduction in the binding##2##4##(1991-9#1)(2006-12#1)
reduction in the cost##2##4##(2008-9#1)(2010-11#1)
reduction in the degree of##2##5##(1992-9#1)(1996-1#1)
reduction in the development of##2##5##(2008-5#1)(2013-8#1)
reduction in the development##3##4##(2008-5#1)(2013-1#1)(2013-8#1)
reduction in the duration of##3##5##(2007-11#2)(2008-9#1)
reduction in the expression of##2##5##(1994-5#1)(1994-8#1)
reduction in the extent of##2##5##(1995-1#1)(1995-5#1)
reduction in the frequency and##2##5##(2007-11#1)(2007-8#1)
reduction in the frequency of##2##5##(2004-2#1)(2009-10#1)
reduction in the frequency##4##4##(2004-2#1)(2007-11#1)(2007-8#1)(2009-10#1)
reduction in the incidence of the composite end-point##2##8##(2007-11#2)
reduction in the incidence of the##3##6##(1992-9#1)(2007-11#2)
reduction in the incidence of##11##5##(1992-9#1)(1993-3#1)(1993-7#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
reduction in the incidence##12##4##(1992-9#1)(1993-3#1)(1993-7#1)(2006-10#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
reduction in the lesion counts##2##5##(2007-7#2)
reduction in the level of##6##5##(1990-5#1)(1994-8#1)(1995-6#1)(2008-6#1)(2010-12#1)(2012-12#1)
reduction in the levels of##9##5##(1994-6#1)(1995-3#1)(1997-4#1)(1997-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2010-5#1)(2013-1#1)
reduction in the levels##10##4##(1994-6#1)(1995-3#2)(1997-4#1)(1997-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2010-5#1)(2013-1#1)
reduction in the mRNA##2##4##(1991-12#1)(2005-10#1)
reduction in the mean##2##4##(1990-9#1)(2012-12#1)
reduction in the number of cases of##2##7##(1992-11#1)(2006-8#1)
reduction in the number of cases##3##6##(1992-11#1)(2006-8#1)(2012-12#1)
reduction in the number of patients##3##6##(1992-1#1)(1996-9#1)(2008-7#1)
reduction in the number of##39##5##(1992-1#1)(1992-11#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#2)(1996-12#2)(1996-9#1)(1997-7#1)(2006-5#1)(2006-8#1)(2007-7#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
reduction in the number##41##4##(1990-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#2)(1996-12#2)(1996-9#1)(1997-7#1)(2006-5#1)(2006-8#1)(2007-7#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
reduction in the overall##2##4##(1993-11#1)(2007-12#1)
reduction in the percentage of##3##5##(2007-9#1)(2008-10#1)(2008-4#1)
reduction in the population of##2##5##(1995-12#1)(2008-10#1)
reduction in the presence of##2##5##(2009-9#2)
reduction in the prevalence of##3##5##(1994-7#1)(2010-12#1)(2013-1#1)
reduction in the production of##2##5##(1991-12#1)(2008-10#1)
reduction in the production##3##4##(1991-12#1)(2008-10#1)(2008-11#1)
reduction in the quantity##2##4##(1994-8#1)(2006-4#1)
reduction in the rate of##13##5##(1990-11#1)(1990-12#1)(1994-6#1)(1995-3#1)(1997-4#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-5#2)(2009-11#1)(2011-2#1)
reduction in the relative##2##4##(1994-8#1)(2007-12#1)
reduction in the risk of##9##5##(1991-8#1)(2007-3#1)(2009-11#1)(2010-12#1)(2010-6#1)(2011-1#2)(2012-2#1)(2013-8#1)
reduction in the serum##3##4##(2007-1#1)(2008-12#1)(2010-4#1)
reduction in the severity of##2##5##(1991-8#1)(2007-7#1)
reduction in the severity##3##4##(1991-8#1)(1995-11#1)(2007-7#1)
reduction in the size of the lesion##2##7##(2008-5#1)(2013-8#1)
reduction in the size of the##7##6##(1992-10#1)(1992-6#1)(2007-1#1)(2008-1#1)(2008-5#1)(2012-2#1)(2013-8#1)
reduction in the size of##8##5##(1992-10#1)(1992-6#1)(2006-5#1)(2007-1#1)(2008-1#1)(2008-5#1)(2012-2#1)(2013-8#1)
reduction in the time##2##4##(1991-12#1)(2011-1#1)
reduction in the total amount of##2##6##(2006-4#1)(2008-8#1)
reduction in the total##4##4##(1994-12#1)(1994-3#1)(2006-4#1)(2008-8#1)
reduction in the treatment of##2##5##(2006-10#1)(2007-8#1)
reduction in the volume of##2##5##(2007-9#2)
reduction in the##345##3##(1990-11#1)(1990-12#4)(1990-2#2)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#5)(1991-2#1)(1991-3#2)(1991-4#2)(1991-6#1)(1991-8#2)(1991-9#5)(1992-1#2)(1992-10#2)(1992-11#1)(1992-3#2)(1992-6#1)(1992-9#4)(1993-11#3)(1993-12#3)(1993-3#3)(1993-4#1)(1993-7#2)(1993-9#1)(1994-11#3)(1994-12#1)(1994-3#4)(1994-5#3)(1994-6#6)(1994-7#1)(1994-8#8)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#5)(1995-2#1)(1995-3#4)(1995-5#3)(1995-6#2)(1995-9#2)(1996-1#2)(1996-10#1)(1996-12#2)(1996-2#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#3)(1997-2#4)(1997-4#2)(1997-5#4)(1997-7#4)(2004-11#1)(2004-2#1)(2005-10#1)(2005-12#1)(2006-10#3)(2006-12#2)(2006-4#3)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-11#9)(2007-12#7)(2007-3#1)(2007-5#1)(2007-7#7)(2007-8#3)(2007-9#3)(2008-1#6)(2008-10#23)(2008-11#3)(2008-12#3)(2008-2#12)(2008-3#9)(2008-4#5)(2008-5#12)(2008-6#6)(2008-7#6)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#3)(2009-12#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#4)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#9)
reduction in their##7##3##(1990-5#1)(1996-12#1)(2008-7#2)(2009-10#1)(2010-12#1)(2011-2#1)
reduction in this##2##3##(1996-7#1)(2005-10#1)
reduction in time##2##3##(2008-10#1)(2008-9#1)
reduction in tissue##2##3##(1993-1#1)(1993-12#1)
reduction in total cholesterol##2##4##(1991-8#1)(2008-3#1)
reduction in total##12##3##(1991-8#1)(1992-2#1)(1993-9#1)(1996-10#1)(1997-3#1)(2008-3#2)(2008-8#3)(2009-6#1)(2012-2#1)
reduction in transmission##2##3##(2007-7#1)(2008-3#1)
reduction in triglycerides##2##3##(2008-3#2)
reduction in tumor##3##3##(1994-12#1)(2006-12#2)
reduction in tumour##2##3##(1997-3#1)(2006-8#1)
reduction in uptake##2##3##(1991-5#1)(1993-11#1)
reduction in viability of##2##4##(2008-10#1)(2009-4#1)
reduction in viability##4##3##(2006-5#1)(2008-10#2)(2009-4#1)
reduction in viral##2##3##(2008-5#1)(2010-12#1)
reduction in volume##3##3##(2006-12#1)(2008-1#2)
reduction in weight##3##3##(1990-11#1)(1992-3#1)(2007-12#1)
reduction in yield##3##3##(2006-12#1)(2008-10#2)
reduction in##1227##2##(1990-11#6)(1990-12#8)(1990-2#8)(1990-3#1)(1990-4#2)(1990-5#8)(1990-6#3)(1990-8#5)(1990-9#1)(1991-1#5)(1991-10#1)(1991-12#8)(1991-2#4)(1991-3#2)(1991-4#5)(1991-5#4)(1991-6#2)(1991-7#2)(1991-8#6)(1991-9#11)(1992-1#3)(1992-10#3)(1992-11#4)(1992-12#3)(1992-2#3)(1992-3#8)(1992-4#3)(1992-5#2)(1992-6#3)(1992-8#3)(1992-9#5)(1993-1#4)(1993-10#1)(1993-11#11)(1993-12#13)(1993-2#1)(1993-3#4)(1993-4#3)(1993-5#2)(1993-6#3)(1993-7#4)(1993-8#5)(1993-9#4)(1994-10#3)(1994-11#5)(1994-12#7)(1994-2#3)(1994-3#8)(1994-4#2)(1994-5#7)(1994-6#8)(1994-7#2)(1994-8#15)(1994-9#6)(1995-1#3)(1995-11#2)(1995-12#19)(1995-2#9)(1995-3#9)(1995-5#7)(1995-6#11)(1995-7#3)(1995-8#2)(1995-9#3)(1996-1#3)(1996-10#2)(1996-11#1)(1996-12#10)(1996-2#4)(1996-3#4)(1996-5#10)(1996-6#5)(1996-7#5)(1996-8#1)(1996-9#14)(1997-1#2)(1997-2#5)(1997-3#3)(1997-4#6)(1997-5#8)(1997-6#3)(1997-7#7)(1997-8#3)(2004-1#1)(2004-11#3)(2004-2#5)(2004-3#2)(2004-9#2)(2005-10#11)(2005-11#6)(2005-12#1)(2005-7#3)(2005-8#2)(2006-10#20)(2006-11#1)(2006-12#11)(2006-2#3)(2006-3#2)(2006-4#7)(2006-5#5)(2006-6#2)(2006-7#4)(2006-8#8)(2006-9#2)(2007-1#5)(2007-10#5)(2007-11#24)(2007-12#20)(2007-2#3)(2007-3#3)(2007-4#2)(2007-5#3)(2007-6#2)(2007-7#15)(2007-8#18)(2007-9#9)(2008-1#15)(2008-10#100)(2008-11#17)(2008-12#7)(2008-2#27)(2008-3#48)(2008-4#16)(2008-5#39)(2008-6#17)(2008-7#33)(2008-8#16)(2008-9#16)(2009-1#1)(2009-10#5)(2009-11#5)(2009-12#4)(2009-4#5)(2009-5#3)(2009-6#6)(2009-7#3)(2009-8#6)(2009-9#6)(2010-1#2)(2010-10#2)(2010-11#4)(2010-12#11)(2010-2#4)(2010-3#2)(2010-4#8)(2010-5#4)(2010-6#2)(2010-7#5)(2010-8#10)(2011-1#12)(2011-10#1)(2011-12#1)(2011-2#19)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#15)(2012-2#28)(2012-3#3)(2012-5#1)(2013-1#29)(2013-7#8)(2013-8#27)
reduction internal fixation##5##3##(2007-12#1)(2008-8#1)(2009-4#1)(2009-9#1)(2013-1#1)
reduction intervention##4##2##(2008-4#2)(2008-6#1)(2011-12#1)
reduction interventions##3##2##(2008-6#1)(2011-11#1)(2012-3#1)
reduction is a##5##3##(1992-8#1)(1995-10#1)(1995-12#1)(2005-10#1)(2013-1#1)
reduction is an##2##3##(2006-8#1)(2007-12#1)
reduction is critical##2##3##(1995-5#1)(2009-12#1)
reduction is not##3##3##(1994-8#1)(2006-10#1)(2006-11#1)
reduction is the##3##3##(1995-2#1)(2006-8#1)(2007-8#1)
reduction is##43##2##(1990-10#1)(1990-7#1)(1991-1#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-4#1)(1996-9#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-8#2)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2009-11#1)(2009-12#1)(2009-6#1)(2010-9#1)(2013-1#3)
reduction kinetics##3##2##(1991-8#1)(1992-6#1)(2008-10#1)
reduction leads to the##2##4##(1992-4#1)(2008-10#1)
reduction mammaplasty##4##2##(1990-5#1)(2006-8#3)
reduction may be##2##3##(1991-4#1)(1992-7#1)
reduction may provide##2##3##(1991-5#1)(2008-5#1)
reduction may##5##2##(1991-4#1)(1991-5#1)(1992-7#1)(2008-11#1)(2008-5#1)
reduction mechanism of##2##3##(2008-10#2)
reduction mechanism##4##2##(2008-10#4)
reduction method##9##2##(2005-11#1)(2008-2#1)(2010-7#1)(2012-2#5)(2013-1#1)
reduction occurred##3##2##(1990-8#1)(1991-6#1)(1994-2#1)
reduction occurs##3##2##(1994-3#1)(2008-10#1)(2009-6#1)
reduction of 0##2##3##(2006-1#1)(2007-3#1)
reduction of 1##3##3##(1994-11#1)(1995-3#2)
reduction of 1-nitro-3-nitrosopyrene##2##3##(1992-7#2)
reduction of 1-nitro-6-nitrosopyrene##2##3##(1992-7#2)
reduction of 18%##2##3##(1991-11#1)(2008-10#1)
reduction of 2##5##3##(1993-4#1)(1994-6#1)(1995-3#1)(2005-10#1)(2005-11#1)
reduction of 2-heptanone##2##3##(2008-10#2)
reduction of 5##3##3##(1992-4#1)(2007-12#1)(2008-5#1)
reduction of CBF and##2##4##(2006-8#1)(2008-7#1)
reduction of Cr(VI)##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
reduction of Cu(2+)##2##3##(2008-10#2)
reduction of Cu(II)##2##3##(1991-8#1)(1997-8#1)
reduction of DCPIP##2##3##(2008-5#2)
reduction of DNA##2##3##(1997-4#1)(2008-5#1)
reduction of Fe(3+)##2##3##(2008-10#2)
reduction of Fe(III) to Fe(II)##3##5##(1995-6#1)(1996-2#1)(2008-10#1)
reduction of Fe(III)##5##3##(1995-6#1)(1996-2#1)(2006-8#1)(2008-10#2)
reduction of GABAergic##2##3##(1997-5#2)
reduction of H(2)O(2)##3##3##(2008-10#3)
reduction of HDL##2##3##(1993-11#1)(2007-1#1)
reduction of Hg(II) ions##2##4##(2008-10#2)
reduction of Hg(II)##3##3##(2008-10#3)
reduction of LDL##2##3##(1995-1#1)(2005-8#1)
reduction of LV##2##3##(2005-10#1)(2007-8#1)
reduction of LVH##2##3##(1992-8#2)
reduction of MTT##2##3##(1992-6#1)(1997-2#1)
reduction of NO by##2##4##(1992-3#1)(2010-6#1)
reduction of NO##3##3##(1992-3#1)(1997-7#1)(2010-6#1)
reduction of NaCl##2##3##(2010-4#2)
reduction of PEPCK activity##2##4##(1993-3#2)
reduction of a variety of##2##5##(1994-8#1)(2011-1#1)
reduction of a##9##3##(1991-7#1)(1993-8#1)(1994-8#1)(2007-12#1)(2008-10#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-3#1)
reduction of about##4##3##(1993-11#1)(1996-6#1)(2008-11#1)(2008-5#1)
reduction of adhesion formation##2##4##(1991-1#1)(1992-1#1)
reduction of adhesion##3##3##(1991-1#1)(1992-1#2)
reduction of affinity##2##3##(1992-9#1)(1997-2#1)
reduction of aldehydes##2##3##(2007-10#2)
reduction of all##2##3##(2006-6#1)(2008-10#1)
reduction of an##6##3##(1992-12#1)(2004-11#1)(2006-4#1)(2008-10#1)(2008-5#1)(2010-7#1)
reduction of antibiotic##2##3##(2008-1#1)(2013-7#1)
reduction of azide##2##3##(1996-4#1)(2006-12#1)
reduction of benzodiazepine##2##3##(1995-11#1)(1995-12#1)
reduction of biliverdin##2##3##(1994-9#2)
reduction of blood pressure##2##4##(2005-6#1)(2007-1#1)
reduction of bone##2##3##(2009-7#1)(2013-1#1)
reduction of both##8##3##(1990-8#1)(1992-1#1)(1992-10#1)(1994-8#1)(1995-1#1)(2008-10#1)(2011-1#1)(2012-12#1)
reduction of breast cancer##3##4##(2011-2#1)(2012-3#2)
reduction of breast##4##3##(1990-5#1)(2011-2#1)(2012-3#2)
reduction of cAMP##2##3##(2010-12#2)
reduction of cardiovascular risk##2##4##(1992-8#1)(2007-11#1)
reduction of cardiovascular##3##3##(1992-8#1)(2007-11#1)(2008-4#1)
reduction of catechin autoxidation intermediate##2##5##(2008-10#2)
reduction of cell##3##3##(1990-2#1)(1993-12#1)(2009-3#1)
reduction of central##3##3##(2008-1#1)(2011-2#1)(2013-1#1)
reduction of coenzyme Q at##2##5##(1995-6#2)
reduction of complement##2##3##(2011-2#1)(2012-1#1)
reduction of copper##2##3##(2008-10#1)(2010-5#1)
reduction of coronary##2##3##(1992-8#1)(2010-2#1)
reduction of cortical##2##3##(2012-1#1)(2013-1#1)
reduction of cytochrome c##2##4##(1991-12#1)(1994-8#1)
reduction of cytochrome##4##3##(1991-12#2)(1991-8#1)(1994-8#1)
reduction of dendritic##2##3##(1996-8#1)(2012-2#1)
reduction of diastolic##2##3##(1991-8#1)(1995-11#1)
reduction of dietary##2##3##(1996-1#1)(2007-7#1)
reduction of dioxygen to water##2##5##(1991-2#1)(1995-8#1)
reduction of disease##3##3##(2008-10#2)(2008-5#1)
reduction of dopamine##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
reduction of electrostatic##2##3##(1991-5#1)(2012-2#1)
reduction of elevated##4##3##(1991-7#1)(2005-10#1)(2006-11#1)(2011-12#1)
reduction of enzyme activity##3##4##(1990-5#1)(1997-2#1)(1997-5#1)
reduction of errors##2##3##(2006-6#1)(2008-2#1)
reduction of extracellular##2##3##(1990-3#1)(1997-4#1)
reduction of fat mass was##2##5##(2008-3#2)
reduction of fat##3##3##(1996-1#1)(2008-3#2)
reduction of ferric##4##3##(1990-12#1)(1995-6#1)(2009-3#1)(2009-8#1)
reduction of glutathione disulfide by##2##5##(1995-3#2)
reduction of glutathione disulfide##3##4##(1995-3#3)
reduction of glutathione##4##3##(1993-3#1)(1995-3#3)
reduction of growth##2##3##(2008-10#1)(2008-11#1)
reduction of hearing##3##3##(1990-12#3)
reduction of hydrogen peroxide##6##4##(2007-10#1)(2008-10#5)
reduction of hydrogen##7##3##(2007-10#1)(2008-10#6)
reduction of iNOS expression and nitrite production##2##7##(1996-12#2)
reduction of iNOS expression##3##4##(1996-12#3)
reduction of imines##2##3##(2010-5#2)
reduction of incidence and mortality##2##5##(1991-6#1)(1992-12#1)
reduction of infectious##2##3##(1990-8#1)(2009-6#1)
reduction of inflammation##2##3##(1995-3#1)(2008-10#1)
reduction of inoculum##2##3##(2008-10#2)
reduction of insulin##3##3##(1990-12#1)(2008-3#1)(2013-8#1)
reduction of intracellular##3##3##(1994-10#1)(1995-1#1)(2010-12#1)
reduction of its##5##3##(1993-6#1)(1995-1#1)(2006-6#1)(2007-2#1)(2008-10#1)
reduction of lateral##2##3##(2007-2#1)(2012-2#1)
reduction of lead##2##3##(2008-10#2)
reduction of malignant##2##3##(1996-11#1)(2006-6#1)
reduction of mortality and##2##4##(2010-12#1)(2011-2#1)
reduction of mortality##7##3##(2006-10#2)(2008-10#1)(2010-12#1)(2011-2#2)(2012-2#1)
reduction of myocardial##2##3##(1996-9#1)(2010-12#1)
reduction of nitrate to nitrite##4##5##(2008-10#4)
reduction of nitrate to##5##4##(2008-10#5)
reduction of nitrate##6##3##(2007-12#1)(2008-10#5)
reduction of one of the##3##5##(1991-5#1)(1995-3#1)(2010-2#1)
reduction of only##2##3##(2008-7#1)(2008-9#1)
reduction of optical##2##3##(2008-2#1)(2008-3#1)
reduction of oral##2##3##(2007-2#1)(2010-2#1)
reduction of organic##2##3##(2006-12#1)(2008-10#1)
reduction of oxygen##5##3##(1995-2#1)(1997-6#1)(2008-10#2)(2013-8#1)
reduction of pain##6##3##(1990-12#1)(1990-9#1)(1992-3#1)(2007-11#1)(2007-7#1)(2007-8#1)
reduction of plasma##6##3##(1990-12#1)(1990-5#1)(1992-9#1)(1994-8#1)(2008-3#1)(2012-1#1)
reduction of postoperative##2##3##(1992-6#1)(2010-12#1)
reduction of prednisone##2##3##(1992-5#1)(2008-7#1)
reduction of protein##4##3##(1992-1#1)(1997-2#1)(2008-11#1)(2010-12#1)
reduction of proteinuria##2##3##(2007-8#1)(2012-12#1)
reduction of quantized kinoforms##2##4##(2008-2#2)
reduction of red blood cell##2##5##(1993-11#1)(2008-3#1)
reduction of residual##2##3##(2007-8#1)(2008-2#1)
reduction of risk##6##3##(1991-5#1)(1991-8#2)(1996-1#1)(2009-4#1)(2012-12#1)
reduction of schistosomiasis transmission##2##4##(2006-10#2)
reduction of serum##5##3##(1995-3#1)(2008-5#1)(2009-7#1)(2009-8#1)(2012-2#1)
reduction of silver nitrate##2##4##(2005-11#1)(2013-1#1)
reduction of silver##4##3##(2005-11#1)(2007-8#1)(2010-4#1)(2013-1#1)
reduction of symptoms##3##3##(2011-10#1)(2011-2#2)
reduction of synaptic##2##3##(2008-7#1)(2013-1#1)
reduction of the activity##3##4##(1990-5#2)(1993-3#1)
reduction of the alpha-2 subunit##2##5##(1997-5#2)
reduction of the amount of##4##5##(1990-10#1)(2007-11#1)(2008-10#1)(2008-12#1)
reduction of the body##2##4##(1990-9#1)(1992-5#1)
reduction of the cardiovascular##2##4##(1995-10#1)(2007-12#1)
reduction of the corresponding##2##4##(2010-5#1)(2010-6#1)
reduction of the coupling##2##4##(2008-2#1)(2008-3#1)
reduction of the data##2##4##(2007-12#1)(2013-8#1)
reduction of the first##3##4##(1995-12#1)(2008-9#1)(2010-12#1)
reduction of the hip##2##4##(2008-8#1)(2013-7#1)
reduction of the horizontal##3##4##(1992-10#3)
reduction of the internal##3##4##(1990-6#1)(1993-12#1)(2010-12#1)
reduction of the medium##2##4##(2008-11#1)(2011-2#1)
reduction of the nidus##3##4##(1991-2#1)(2008-7#2)
reduction of the nitro group##4##5##(1991-3#1)(1995-6#1)(1996-2#1)(2007-11#1)
reduction of the nitro##5##4##(1991-3#1)(1995-6#1)(1996-2#1)(2007-11#1)(2008-10#1)
reduction of the number of##4##5##(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#1)
reduction of the risk factors##2##5##(2006-8#1)(2007-6#1)
reduction of the risk##3##4##(2006-6#1)(2006-8#1)(2007-6#1)
reduction of the size of the##3##6##(1990-2#1)(2007-5#1)(2008-10#1)
reduction of the structurally##2##4##(1993-11#1)(1995-3#1)
reduction of the symptoms##2##4##(1990-11#1)(2008-10#1)
reduction of the time##2##4##(2007-7#1)(2008-4#1)
reduction of the total##2##4##(1994-9#1)(2012-12#1)
reduction of the##269##3##(1990-1#1)(1990-10#2)(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-7#1)(1992-1#2)(1992-10#3)(1992-12#4)(1992-3#6)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-10#3)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-7#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-4#2)(1997-5#3)(1997-7#1)(1997-8#1)(2004-4#1)(2005-11#2)(2006-10#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#3)(2007-11#9)(2007-12#9)(2007-5#2)(2007-6#1)(2007-7#6)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#36)(2008-11#10)(2008-12#2)(2008-2#10)(2008-3#8)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-1#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#4)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#4)(2011-2#7)(2012-12#1)(2012-2#4)(2013-1#1)(2013-7#2)(2013-8#1)
reduction of their##2##3##(2005-10#1)(2006-10#1)
reduction of thermal##2##3##(2007-12#1)(2008-2#1)
reduction of these##3##3##(2009-12#1)(2009-8#1)(2013-1#1)
reduction of this##3##3##(1994-12#1)(2008-4#1)(2011-2#1)
reduction of time##2##3##(2007-8#1)(2010-8#1)
reduction of total##7##3##(1992-8#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-6#1)(2010-5#1)(2013-1#1)
reduction of virus##3##3##(2008-10#2)(2013-8#1)
reduction of##1167##2##(1990-1#2)(1990-10#4)(1990-11#4)(1990-12#10)(1990-2#9)(1990-3#5)(1990-5#8)(1990-6#2)(1990-7#3)(1990-8#6)(1990-9#4)(1991-1#3)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#7)(1991-3#5)(1991-4#2)(1991-5#6)(1991-6#1)(1991-7#4)(1991-8#10)(1992-1#8)(1992-10#4)(1992-11#2)(1992-12#6)(1992-3#8)(1992-4#4)(1992-5#2)(1992-6#6)(1992-7#8)(1992-8#8)(1992-9#7)(1993-1#1)(1993-10#1)(1993-11#8)(1993-12#9)(1993-2#1)(1993-3#6)(1993-4#2)(1993-5#1)(1993-6#4)(1993-8#2)(1993-9#3)(1994-10#2)(1994-11#3)(1994-12#8)(1994-2#2)(1994-3#4)(1994-4#1)(1994-5#1)(1994-6#4)(1994-7#1)(1994-8#9)(1994-9#9)(1995-1#6)(1995-10#4)(1995-11#4)(1995-12#7)(1995-2#5)(1995-3#15)(1995-5#3)(1995-6#11)(1995-7#4)(1995-8#2)(1996-1#5)(1996-10#1)(1996-11#2)(1996-12#8)(1996-2#6)(1996-3#3)(1996-4#4)(1996-5#4)(1996-6#6)(1996-8#5)(1996-9#4)(1997-1#1)(1997-2#9)(1997-3#3)(1997-4#8)(1997-5#9)(1997-6#2)(1997-7#5)(1997-8#4)(2004-11#3)(2004-12#1)(2004-4#1)(2005-10#9)(2005-11#7)(2005-12#1)(2005-3#1)(2005-6#1)(2005-7#1)(2005-8#6)(2006-1#1)(2006-10#13)(2006-11#1)(2006-12#2)(2006-2#3)(2006-3#2)(2006-4#4)(2006-5#2)(2006-6#8)(2006-7#2)(2006-8#6)(2007-1#6)(2007-10#9)(2007-11#27)(2007-12#27)(2007-2#3)(2007-3#5)(2007-4#4)(2007-5#2)(2007-6#2)(2007-7#15)(2007-8#16)(2007-9#5)(2008-1#13)(2008-10#172)(2008-11#26)(2008-12#7)(2008-2#20)(2008-3#34)(2008-4#13)(2008-5#27)(2008-6#7)(2008-7#17)(2008-8#2)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#6)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#4)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#16)(2010-2#8)(2010-4#10)(2010-5#13)(2010-6#3)(2010-7#6)(2010-8#1)(2010-9#3)(2011-1#14)(2011-10#1)(2011-12#4)(2011-2#29)(2012-1#8)(2012-12#12)(2012-2#17)(2012-3#9)(2012-7#1)(2013-1#29)(2013-7#5)(2013-8#13)
reduction on the##7##3##(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-8#1)(2012-1#1)
reduction on##17##2##(1990-12#1)(1997-4#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2009-8#1)(2012-1#1)
reduction only##3##2##(1993-7#2)(2012-2#1)
reduction or complete##3##3##(1990-9#1)(1995-5#1)(2008-11#1)
reduction or elimination of##2##4##(2008-5#1)(2013-1#1)
reduction or##22##2##(1990-9#1)(1991-12#1)(1995-5#1)(2006-4#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#3)(2012-12#1)(2012-2#1)(2013-1#1)
reduction over##3##2##(2007-9#1)(2008-5#1)(2011-2#1)
reduction pathways##2##2##(1994-8#1)(2008-9#1)
reduction peak at -0##2##4##(1990-5#1)(2008-10#1)
reduction peak current of##3##4##(2008-10#3)
reduction peak current##5##3##(2008-10#5)
reduction peak of##2##3##(2008-10#2)
reduction peak##16##2##(1990-5#1)(2008-10#15)
reduction peaks##4##2##(1990-5#1)(2008-10#3)
reduction potential at pH##2##4##(1990-5#1)(1995-6#1)
reduction potential of the##4##4##(1991-11#1)(1995-8#1)(2005-11#1)(2008-10#1)
reduction potential of##7##3##(1991-11#1)(1991-8#2)(1995-8#1)(2005-11#1)(2008-10#2)
reduction potential##17##2##(1990-5#1)(1991-11#1)(1991-8#2)(1992-7#1)(1994-8#3)(1995-6#1)(1995-8#1)(2005-11#1)(2007-11#2)(2008-10#4)
reduction potentials of##3##3##(1991-10#1)(1991-8#1)(1992-7#1)
reduction potentials##14##2##(1990-5#1)(1991-10#3)(1991-8#2)(1992-7#1)(1995-5#2)(1995-8#1)(2007-11#1)(2007-8#3)
reduction process is##2##3##(1996-2#1)(2008-10#1)
reduction process was##4##3##(2006-8#1)(2008-10#3)
reduction process##15##2##(1996-2#1)(2006-8#2)(2008-10#10)(2010-12#1)(2011-2#1)
reduction processes##2##2##(2005-11#1)(2008-2#1)
reduction product of##3##3##(1994-5#1)(2008-10#2)
reduction product##7##2##(1994-5#1)(1997-8#1)(2008-10#5)
reduction products of##2##3##(1995-3#1)(2008-10#1)
reduction products##5##2##(1995-3#1)(1997-8#1)(2008-10#3)
reduction programs are##2##3##(1995-2#1)(2009-2#1)
reduction programs##7##2##(1994-3#1)(1995-2#1)(1996-6#1)(1997-5#1)(2009-2#2)(2013-1#1)
reduction proved to be##2##4##(1992-8#1)(2011-1#1)
reduction rate of##4##3##(1995-8#1)(2008-2#1)(2008-7#1)(2011-1#1)
reduction rate was##2##3##(1993-6#1)(1997-7#1)
reduction rate##8##2##(1993-6#1)(1995-8#2)(1997-7#1)(2006-8#1)(2008-2#1)(2008-7#1)(2011-1#1)
reduction rates of##2##3##(1990-8#1)(1995-2#1)
reduction rates##4##2##(1990-8#2)(1995-2#1)(2006-3#1)
reduction reaction##5##2##(2008-10#3)(2008-8#1)(2010-4#1)
reduction reactions##4##2##(1995-8#1)(2005-4#1)(2008-10#1)(2010-4#1)
reduction relative to##2##3##(1990-2#1)(2008-10#1)
reduction should be##4##3##(1996-11#1)(2007-8#1)(2008-8#1)(2009-3#1)
reduction site##5##2##(1991-3#1)(1994-5#1)(1994-9#3)
reduction step is##2##3##(2008-10#2)
reduction step##5##2##(2008-10#4)(2011-2#1)
reduction strategies##6##2##(1994-2#1)(2005-10#1)(2008-10#2)(2012-1#1)(2012-11#1)
reduction strategy##2##2##(1996-4#1)(2008-2#1)
reduction surgery##12##2##(2005-11#1)(2006-10#4)(2007-8#2)(2008-9#2)(2010-5#2)(2013-1#1)
reduction technique##3##2##(2008-2#1)(2008-3#1)(2011-1#1)
reduction techniques##4##2##(2008-3#1)(2008-6#1)(2008-7#1)(2012-12#1)
reduction test##6##2##(1990-12#1)(2007-2#1)(2007-7#2)(2011-1#2)
reduction than##2##2##(2008-10#1)(2009-8#1)
reduction through##11##2##(1996-3#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-6#3)(2009-7#1)(2013-1#1)(2013-8#1)
reduction to a##2##3##(1996-8#1)(2008-10#1)
reduction to nitrite##2##3##(2008-10#2)
reduction to the##3##3##(1995-6#1)(1996-10#1)(2008-10#1)
reduction to##26##2##(1990-5#1)(1992-8#1)(1993-11#1)(1994-12#1)(1995-6#1)(1996-10#1)(1996-6#1)(1996-8#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-2#2)(2008-6#1)(2009-10#1)(2013-1#2)
reduction treatment##2##2##(2008-3#2)
reduction using a##2##3##(2006-3#1)(2007-2#1)
reduction using##3##2##(1996-1#1)(2006-3#1)(2007-2#1)
reduction via##2##2##(2008-6#1)(2009-10#1)
reduction was also##2##3##(1993-12#1)(2008-10#1)
reduction was associated with##2##4##(1992-2#1)(2008-4#1)
reduction was found to##2##4##(2006-5#1)(2007-12#1)
reduction was found##4##3##(1997-3#1)(2006-5#1)(2007-12#1)(2008-6#1)
reduction was less##2##3##(1994-6#1)(1995-9#1)
reduction was lower##2##3##(1991-6#1)(2010-4#1)
reduction was measured##2##3##(1997-3#1)(2008-10#1)
reduction was more##3##3##(1990-11#1)(2007-1#1)(2012-3#1)
reduction was not##3##3##(2007-6#1)(2010-12#1)(2013-1#1)
reduction was noted in##2##4##(2006-12#1)(2007-9#1)
reduction was observed in##3##4##(1991-8#1)(1993-12#1)(2008-6#1)
reduction was observed##6##3##(1991-8#1)(1992-6#1)(1993-12#1)(1993-4#1)(2008-6#1)(2013-1#1)
reduction was performed##4##3##(1990-10#1)(2007-3#1)(2008-10#1)(2011-2#1)
reduction was significantly##2##3##(1996-10#1)(2007-6#1)
reduction was the##2##3##(1990-6#1)(1994-3#1)
reduction was##78##2##(1990-10#1)(1990-11#2)(1990-2#2)(1990-3#2)(1990-6#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-2#2)(1992-6#2)(1993-12#2)(1993-4#2)(1994-3#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-3#2)(1997-6#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-6#2)(2007-8#3)(2007-9#1)(2008-10#11)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-4#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-1#2)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#1)
reduction wave##3##2##(2008-10#2)(2008-5#1)
reduction were##6##2##(1993-4#1)(1996-3#1)(2005-11#2)(2006-4#1)(2008-5#1)
reduction when##3##2##(1994-8#1)(1996-9#1)(2013-1#1)
reduction will##2##2##(2006-3#1)(2009-4#1)
reduction with a##3##3##(1997-1#1)(2008-3#1)(2008-5#1)
reduction with dithionite##3##3##(1990-3#2)(1993-11#1)
reduction with dithiothreitol##2##3##(1990-12#1)(1994-2#1)
reduction with good##2##3##(2007-8#1)(2008-10#1)
reduction with lithium aluminum##2##4##(1996-5#1)(2007-11#1)
reduction with respect to##2##4##(2008-2#1)(2008-7#1)
reduction with sodium borohydride##4##4##(1990-12#1)(1995-2#1)(2008-10#1)(2008-5#1)
reduction with sodium##6##3##(1990-12#1)(1992-2#1)(1993-11#1)(1995-2#1)(2008-10#1)(2008-5#1)
reduction with##54##2##(1990-12#2)(1990-2#1)(1990-3#3)(1990-8#1)(1992-2#1)(1993-10#1)(1993-11#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-2#1)(1996-4#1)(1996-5#6)(1997-1#1)(1997-6#1)(2006-7#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#3)(2009-6#1)(2009-8#1)(2011-2#1)(2013-1#1)
reduction would##2##2##(1996-9#1)(2009-1#1)
reduction##3615##1##(1990-1#2)(1990-10#6)(1990-11#12)(1990-12#24)(1990-2#24)(1990-3#12)(1990-4#2)(1990-5#25)(1990-6#7)(1990-7#5)(1990-8#17)(1990-9#7)(1991-1#9)(1991-10#6)(1991-11#2)(1991-12#15)(1991-2#16)(1991-3#12)(1991-4#9)(1991-5#13)(1991-6#5)(1991-7#11)(1991-8#24)(1991-9#16)(1992-1#13)(1992-10#9)(1992-11#9)(1992-12#11)(1992-2#7)(1992-3#21)(1992-4#9)(1992-5#4)(1992-6#25)(1992-7#11)(1992-8#15)(1992-9#13)(1993-1#7)(1993-10#3)(1993-11#28)(1993-12#30)(1993-2#3)(1993-3#16)(1993-4#11)(1993-5#3)(1993-6#10)(1993-7#7)(1993-8#13)(1993-9#10)(1994-10#6)(1994-11#10)(1994-12#23)(1994-2#14)(1994-3#20)(1994-4#3)(1994-5#11)(1994-6#15)(1994-7#3)(1994-8#36)(1994-9#19)(1995-1#12)(1995-10#6)(1995-11#10)(1995-12#30)(1995-2#24)(1995-3#29)(1995-5#16)(1995-6#24)(1995-7#8)(1995-8#11)(1995-9#5)(1996-1#13)(1996-10#5)(1996-11#4)(1996-12#18)(1996-2#17)(1996-3#10)(1996-4#8)(1996-5#22)(1996-6#14)(1996-7#6)(1996-8#8)(1996-9#25)(1997-1#5)(1997-2#20)(1997-3#9)(1997-4#17)(1997-5#20)(1997-6#8)(1997-7#15)(1997-8#11)(2004-1#1)(2004-10#1)(2004-11#8)(2004-12#1)(2004-2#5)(2004-3#2)(2004-4#3)(2004-9#2)(2005-10#28)(2005-11#22)(2005-12#4)(2005-3#2)(2005-4#1)(2005-6#1)(2005-7#6)(2005-8#8)(2005-9#1)(2006-1#2)(2006-10#48)(2006-11#5)(2006-12#17)(2006-2#9)(2006-3#18)(2006-4#15)(2006-5#10)(2006-6#16)(2006-7#9)(2006-8#35)(2006-9#4)(2007-1#16)(2007-10#15)(2007-11#75)(2007-12#72)(2007-2#13)(2007-3#12)(2007-4#8)(2007-5#7)(2007-6#6)(2007-7#49)(2007-8#63)(2007-9#18)(2008-1#34)(2008-10#462)(2008-11#61)(2008-12#24)(2008-2#77)(2008-3#109)(2008-4#42)(2008-5#83)(2008-6#42)(2008-7#73)(2008-8#26)(2008-9#30)(2009-1#4)(2009-10#13)(2009-11#14)(2009-12#8)(2009-2#6)(2009-3#12)(2009-4#9)(2009-5#6)(2009-6#16)(2009-7#9)(2009-8#18)(2009-9#20)(2010-1#3)(2010-10#3)(2010-11#6)(2010-12#35)(2010-2#16)(2010-3#6)(2010-4#29)(2010-5#20)(2010-6#6)(2010-7#14)(2010-8#14)(2010-9#5)(2011-1#42)(2011-10#2)(2011-11#1)(2011-12#10)(2011-2#80)(2011-3#1)(2012-1#21)(2012-11#5)(2012-12#34)(2012-2#70)(2012-3#21)(2012-5#3)(2012-7#1)(2013-1#93)(2013-7#20)(2013-8#59)
reduction) and##8##2##(1990-12#1)(1992-8#1)(1994-12#1)(1995-3#2)(1996-2#1)(2008-10#1)(2009-9#1)
reduction) in the CMM group and from 7##2##8##(2008-7#2)
reduction) in the##4##3##(2008-7#4)
reduction) in##6##2##(2008-10#2)(2008-7#4)
reduction)##30##1##(1990-12#1)(1990-4#1)(1990-5#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-3#3)(1996-2#3)(2007-7#1)(2007-8#1)(2008-10#9)(2008-7#4)(2009-9#1)(2010-4#1)
reductionism##4##1##(2006-10#1)(2006-3#1)(2006-9#1)(2007-3#1)
reductionist##10##1##(1997-6#2)(2008-9#1)(2010-12#1)(2011-1#5)(2012-12#1)
reductionistic##2##1##(1995-7#1)(2006-7#1)
reductions (e##2##2##(2008-5#1)(2012-1#1)
reductions and##6##2##(1992-8#1)(2007-7#1)(2008-10#2)(2008-7#2)
reductions are##4##2##(1996-6#1)(2006-9#1)(2008-8#1)(2012-2#1)
reductions by##2##2##(2009-4#1)(2010-4#1)
reductions can be##2##3##(1996-9#1)(2011-11#1)
reductions due to##2##3##(1993-4#1)(2012-3#1)
reductions for the##2##3##(2012-3#1)(2013-8#1)
reductions for##4##2##(1997-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
reductions from##2##2##(1992-4#1)(1994-1#1)
reductions in LDL##2##3##(1991-2#1)(1991-8#1)
reductions in SIDS##2##3##(2007-1#2)
reductions in a##2##3##(1994-12#1)(2008-10#1)
reductions in atmospheric##2##3##(2008-5#1)(2010-5#1)
reductions in blood pressure##2##4##(1996-9#1)(2006-2#1)
reductions in blood##3##3##(1996-9#1)(2006-12#1)(2006-2#1)
reductions in both##6##3##(1991-9#1)(1995-8#1)(2007-10#1)(2008-10#1)(2009-9#1)(2012-12#1)
reductions in carbon##2##3##(2007-8#2)
reductions in cocaine-reinforced behavior##2##4##(2011-12#2)
reductions in costs##2##3##(1996-5#1)(2008-10#1)
reductions in host##2##3##(2008-10#1)(2008-9#1)
reductions in lesion##3##3##(2007-11#1)(2008-10#1)(2012-3#1)
reductions in mortality##4##3##(2005-11#1)(2006-9#1)(2007-7#1)(2010-12#1)
reductions in plasma##2##3##(2005-7#1)(2010-6#1)
reductions in the incidence##2##4##(2005-7#1)(2008-10#1)
reductions in the levels of##3##5##(1995-1#1)(2008-5#2)
reductions in the levels##4##4##(1995-1#1)(2008-5#3)
reductions in the number of##3##5##(1992-3#1)(1996-9#1)(1997-2#1)
reductions in the specific##2##4##(1994-12#1)(2008-7#1)
reductions in the use of##2##5##(1995-12#1)(2008-4#1)
reductions in the##31##3##(1992-3#1)(1994-12#1)(1994-3#1)(1995-1#2)(1995-12#2)(1996-4#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-5#1)(2005-7#1)(2006-9#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#2)(2009-3#1)(2011-11#1)(2011-2#1)(2012-2#1)
reductions in these##2##3##(1996-1#1)(1996-12#1)
reductions in##190##2##(1990-10#1)(1990-9#2)(1991-2#1)(1991-3#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#2)(1993-10#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-12#5)(1995-2#2)(1995-3#1)(1995-8#2)(1996-1#1)(1996-12#2)(1996-4#1)(1996-5#2)(1996-7#1)(1996-9#4)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#3)(1997-7#1)(2004-3#1)(2005-11#1)(2005-7#2)(2006-10#1)(2006-11#2)(2006-12#1)(2006-2#3)(2006-5#1)(2006-7#1)(2006-9#2)(2007-1#3)(2007-10#3)(2007-11#2)(2007-3#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#29)(2008-11#4)(2008-3#4)(2008-4#2)(2008-5#9)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-9#1)(2011-11#2)(2011-12#3)(2011-2#1)(2011-3#1)(2012-1#3)(2012-12#5)(2012-2#5)(2012-3#4)(2013-1#2)(2013-7#2)(2013-8#1)
reductions of the##5##3##(1992-3#1)(1994-2#1)(1996-3#1)(1997-7#1)(2008-10#1)
reductions of##37##2##(1990-12#1)(1991-11#1)(1992-12#4)(1992-3#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-3#1)(1997-6#1)(1997-7#2)(2006-10#1)(2006-8#3)(2007-10#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-5#1)(2011-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
reductions on##2##2##(2008-4#1)(2013-1#1)
reductions or##3##2##(1994-1#1)(1995-9#1)(2008-7#1)
reductions over##2##2##(1996-12#1)(2008-2#1)
reductions ranging from##2##3##(2008-10#1)(2012-1#1)
reductions than##2##2##(2005-7#1)(2008-10#1)
reductions that##2##2##(1996-1#1)(2006-10#1)
reductions were found in the##2##5##(1997-3#1)(2006-9#1)
reductions were found##3##3##(1997-3#1)(2006-9#1)(2008-10#1)
reductions were##21##2##(1994-7#1)(1995-12#1)(1995-3#1)(1997-3#1)(2005-8#1)(2006-9#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#1)(2011-11#3)(2011-2#2)
reductions with##3##2##(1993-2#1)(1996-9#1)(2010-12#1)
reductions##322##1##(1990-10#1)(1990-12#1)(1990-9#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#4)(1992-2#1)(1992-3#2)(1992-4#3)(1992-8#3)(1993-1#1)(1993-10#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-8#1)(1994-1#2)(1994-10#1)(1994-12#5)(1994-2#2)(1994-3#1)(1994-6#1)(1994-7#1)(1995-1#3)(1995-12#8)(1995-2#2)(1995-3#3)(1995-5#2)(1995-8#2)(1995-9#1)(1996-1#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#1)(1996-9#6)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#3)(2004-3#1)(2005-10#1)(2005-11#1)(2005-7#5)(2005-8#1)(2006-10#3)(2006-11#2)(2006-12#1)(2006-2#3)(2006-5#1)(2006-7#1)(2006-8#3)(2006-9#4)(2007-1#3)(2007-10#4)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#47)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#3)(2008-5#11)(2008-6#2)(2008-7#15)(2008-8#3)(2008-9#2)(2009-12#2)(2009-3#2)(2009-4#2)(2009-7#1)(2009-8#1)(2009-9#3)(2010-12#3)(2010-2#1)(2010-4#3)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-11#7)(2011-12#4)(2011-2#4)(2011-3#1)(2012-1#5)(2012-12#5)(2012-2#7)(2012-3#6)(2013-1#5)(2013-7#2)(2013-8#3)
reductive activation of##3##3##(1995-2#1)(2009-10#2)
reductive activation##5##2##(1995-2#1)(1997-7#2)(2009-10#2)
reductive activity##2##2##(1991-10#2)
reductive alkylation of##2##3##(1992-7#1)(1994-9#1)
reductive alkylation##3##2##(1992-7#1)(1994-9#1)(2006-12#1)
reductive amination of##4##3##(1996-5#2)(2005-7#1)(2009-8#1)
reductive amination##9##2##(1994-8#1)(1996-5#3)(2005-7#3)(2009-8#1)(2012-1#1)
reductive and##2##2##(2004-4#1)(2008-10#1)
reductive charge##3##2##(2008-10#3)
reductive cleavage of##3##3##(1992-3#2)(2010-12#1)
reductive cleavage##7##2##(1992-3#4)(2008-4#1)(2010-12#2)
reductive dechlorination##5##2##(2004-4#3)(2011-1#2)
reductive dehalogenation of##4##3##(2006-3#3)(2008-11#1)
reductive dehalogenation##5##2##(2004-4#1)(2006-3#3)(2008-11#1)
reductive desorption of the##2##4##(2008-10#2)
reductive desorption of##3##3##(2008-10#3)
reductive desorption##5##2##(2008-10#5)
reductive elution##2##2##(2008-10#2)
reductive sulphur##6##2##(2008-10#6)
reductive##104##1##(1990-2#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-10#2)(1992-12#1)(1992-3#5)(1992-7#1)(1994-6#1)(1994-8#6)(1994-9#3)(1995-2#1)(1995-3#1)(1995-5#1)(1996-5#3)(1996-9#1)(1997-3#3)(1997-7#2)(2004-4#6)(2005-7#3)(2006-12#2)(2006-3#4)(2006-8#2)(2006-9#1)(2008-1#3)(2008-10#22)(2008-11#5)(2008-3#2)(2008-4#2)(2009-10#3)(2009-3#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#4)(2012-1#1)(2012-2#1)(2013-8#1)
reductively##4##1##(1991-2#1)(1992-3#1)(2004-4#1)(2006-8#1)
reductoisomerase (DXR)##2##2##(2008-11#1)(2012-2#1)
reductor column##4##2##(2008-10#4)
reductor##6##1##(2007-8#1)(2008-10#5)
redundancies##5##1##(1996-3#1)(2008-2#2)(2008-7#1)(2013-1#1)
redundancy and regulation##2##3##(2005-10#2)
redundancy and##6##2##(2005-10#2)(2008-3#1)(2008-5#1)(2011-3#2)
redundancy between##2##2##(2008-10#1)(2012-3#1)
redundancy in the##5##3##(1996-3#1)(2008-2#1)(2008-5#1)(2009-4#1)(2009-6#1)
redundancy in##13##2##(1996-3#1)(1997-8#2)(2007-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-4#1)(2009-6#1)(2010-8#1)(2012-2#1)(2012-3#1)
redundancy of the##3##3##(1993-6#1)(1996-2#1)(2007-5#1)
redundancy of##11##2##(1993-6#1)(1994-10#1)(1995-7#2)(1996-2#2)(1997-6#1)(2007-5#1)(2008-2#2)(2011-12#1)
redundancy or##3##2##(2008-7#1)(2009-10#1)(2009-5#1)
redundancy seems##2##2##(2007-11#1)(2008-1#1)
redundancy##62##1##(1992-8#1)(1993-12#1)(1993-6#1)(1994-10#1)(1994-8#1)(1995-7#4)(1996-2#4)(1996-3#1)(1997-5#1)(1997-6#1)(1997-8#2)(2005-10#2)(2007-11#3)(2007-5#1)(2008-1#1)(2008-10#2)(2008-2#7)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-8#1)(2010-9#1)(2011-12#2)(2011-2#1)(2011-3#2)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#2)
redundant and##4##2##(1996-5#1)(2005-10#1)(2009-5#1)(2009-6#1)
redundant family##2##2##(1991-5#1)(2009-8#1)
redundant information##3##2##(2008-3#2)(2010-4#1)
redundant manipulators##4##2##(2007-8#2)(2008-2#2)
redundant mechanisms##3##2##(1996-4#1)(2008-7#1)(2008-8#1)
redundant navigation##3##2##(2007-5#3)
redundant navigational control##2##3##(2007-5#2)
redundant role in##2##3##(2009-10#1)(2013-1#1)
redundant role##3##2##(2009-10#2)(2013-1#1)
redundant skin##2##2##(2009-5#2)
redundant with##2##2##(1997-1#1)(2012-2#1)
redundant##61##1##(1991-5#1)(1991-7#1)(1992-7#1)(1993-12#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1997-1#1)(1997-6#1)(2005-10#1)(2007-12#1)(2007-5#5)(2007-8#3)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#3)(2009-5#3)(2009-6#1)(2009-8#3)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
redundant-bit##2##1##(2008-2#2)
redundantly with##2##2##(2007-11#1)(2007-12#1)
redundantly##6##1##(1991-2#2)(2007-11#1)(2007-12#1)(2009-10#1)(2012-12#1)
reduplication##2##1##(1990-6#1)(1993-12#1)
redux##4##1##(1990-12#1)(1991-11#1)(1991-5#1)(2007-12#1)
redwater##2##1##(2010-1#2)
redwood##3##1##(2008-10#2)(2008-11#1)
reed canarygrass##5##2##(2008-5#4)(2009-3#1)
reed##9##1##(2005-8#1)(2008-5#6)(2008-6#1)(2009-3#1)
reeducation##8##1##(1990-2#1)(1992-12#1)(2007-7#1)(2007-8#1)(2008-5#1)(2012-2#1)(2013-1#2)
reef and##2##2##(2007-3#1)(2007-5#1)
reef at##3##2##(2007-5#2)(2008-5#1)
reef communities##4##2##(2007-5#3)(2011-2#1)
reef coral##2##2##(2008-6#1)(2012-12#1)
reef corals##2##2##(2008-2#1)(2008-6#1)
reef environments##4##2##(2007-3#1)(2007-5#3)
reef fish##4##2##(2007-5#1)(2008-8#2)(2013-1#1)
reef fishes##3##2##(2007-5#1)(2008-5#1)(2010-8#1)
reef in the##2##3##(2007-5#1)(2011-2#1)
reef in##4##2##(2007-5#1)(2011-2#3)
reef lagoon##2##2##(2007-5#2)
reef localities##2##2##(2007-5#1)(2008-5#1)
reef of##2##2##(2007-3#1)(2008-5#1)
reef restoration##3##2##(2011-2#3)
reef sharks Carcharhinus melanopterus##2##4##(2010-8#2)
reef site##2##2##(2011-2#2)
reef sites##4##2##(2007-5#2)(2011-2#2)
reef status##2##2##(2008-5#2)
reef structures##3##2##(2007-5#2)(2011-2#1)
reef systems##3##2##(2007-5#3)
reef##113##1##(1991-6#1)(2007-3#11)(2007-5#44)(2007-9#1)(2008-2#1)(2008-4#1)(2008-5#14)(2008-6#2)(2008-8#2)(2008-9#2)(2010-8#5)(2011-2#24)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
reef)##2##1##(2011-2#2)
reef-building##5##1##(1992-6#2)(2007-3#1)(2007-5#1)(2008-5#1)
reefs and##5##2##(2007-5#1)(2008-5#1)(2011-2#3)
reefs are##4##2##(2007-5#1)(2008-5#2)(2011-2#1)
reefs at##4##2##(2008-3#1)(2008-5#3)
reefs have been##2##3##(1991-6#1)(2007-5#1)
reefs have##3##2##(1991-6#1)(2007-5#1)(2012-2#1)
reefs in##3##2##(2007-5#2)(2011-2#1)
reefs is##3##2##(1991-6#1)(2007-3#1)(2011-2#1)
reefs of##3##2##(2007-5#2)(2008-5#1)
reefs were surveyed##2##3##(2008-5#2)
reefs##78##1##(1991-6#2)(2006-12#1)(2007-3#8)(2007-5#22)(2007-8#1)(2008-3#1)(2008-5#12)(2008-9#1)(2010-8#2)(2011-2#26)(2012-2#2)
reeler mouse##6##2##(1994-10#5)(2011-2#1)
reeler##15##1##(1991-6#1)(1994-10#7)(1995-11#1)(2011-2#4)(2012-2#2)
reelin and nNOS##3##3##(2011-2#3)
reelin and##5##2##(2009-8#1)(2011-2#4)
reelin immunoreactivity##3##2##(2009-8#3)
reelin is##2##2##(2009-8#2)
reelin##19##1##(2009-8#15)(2011-2#4)
reelin-positive##3##1##(2009-8#1)(2011-2#2)
reemerged in the##2##3##(1992-5#1)(2008-10#1)
reemerged in##3##2##(1992-5#1)(1995-3#1)(2008-10#1)
reemerged##5##1##(1992-5#1)(1995-3#1)(2007-12#1)(2008-10#1)(2011-1#1)
reemergence of##7##2##(1992-3#1)(2008-1#1)(2008-10#1)(2010-2#2)(2012-2#1)(2013-8#1)
reemission of##2##2##(2008-11#1)(2008-3#1)
reenforced##2##1##(2007-2#2)
reengineer##4##1##(1995-1#1)(1996-1#1)(2011-7#1)(2012-2#1)
reengineering is##2##2##(1995-1#1)(1997-3#1)
reengineering may be##2##3##(1994-12#1)(1995-3#1)
reengineering##25##1##(1994-1#1)(1994-12#3)(1995-1#4)(1995-3#4)(1996-1#2)(1997-3#9)(2007-4#1)(2008-1#1)
reenter##2##1##(2008-8#1)(2013-1#1)
reentered the##2##2##(1992-2#1)(1995-11#1)
reentered##3##1##(1992-2#1)(1994-8#1)(1995-11#1)
reentrant tachycardia (1 patient)##2##4##(1995-6#2)
reentrant tachycardia##13##2##(1993-2#3)(1995-6#6)(2006-9#2)(2008-11#1)(2009-11#1)
reentrant##18##1##(1993-2#4)(1993-6#1)(1995-6#6)(2006-9#2)(2007-12#1)(2008-11#1)(2008-2#1)(2009-11#1)(2010-8#1)
reentry tachycardia##3##2##(1993-10#1)(2006-8#1)(2006-9#1)
reentry##9##1##(1990-5#1)(1993-10#1)(1994-9#2)(2006-8#1)(2006-9#1)(2007-8#1)(2008-2#1)(2010-2#1)
reesei##25##1##(1991-9#2)(1993-8#2)(1996-11#3)(2008-10#2)(2008-5#8)(2008-6#3)(2008-9#2)(2011-2#1)(2013-1#2)
reestablish the##2##2##(2010-11#1)(2013-1#1)
reestablish##6##1##(2008-1#1)(2009-3#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
reestablished##6##1##(1991-2#1)(1991-6#1)(2006-4#1)(2007-2#1)(2007-9#1)(2009-8#1)
reestablishes the##2##2##(2009-8#1)(2010-12#1)
reestablishing the##2##2##(1995-12#1)(2011-2#1)
reestablishing##3##1##(1993-12#1)(1995-12#1)(2011-2#1)
reestablishment of##3##2##(1991-12#1)(1995-2#1)(2009-3#1)
reestimated##2##1##(2008-10#1)(2008-5#1)
reevaluate the##2##2##(2008-3#1)(2008-9#1)
reevaluate##6##1##(2005-8#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-4#1)(2010-8#1)
reevaluated##9##1##(1990-5#1)(1991-12#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-5#1)(2007-7#1)(2008-10#1)
reevaluates the##2##2##(1993-10#1)(2009-3#1)
reevaluation of the##4##3##(1990-6#1)(1995-8#1)(2006-8#1)(2008-1#1)
reevaluation of##8##2##(1990-6#1)(1993-12#1)(1995-8#1)(2006-8#1)(2007-7#1)(2008-1#1)(2009-6#1)(2011-2#1)
reevaluation##15##1##(1990-6#1)(1992-1#1)(1992-4#1)(1993-12#1)(1995-8#1)(1996-11#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-7#1)(2008-1#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
reevii Hr##3##2##(1991-10#3)
reevii##5##1##(1991-10#5)
reexamination of the##2##3##(2007-9#2)
reexamination of##9##2##(1993-8#1)(1994-12#1)(1997-4#1)(2007-9#2)(2008-10#1)(2008-8#1)(2008-9#1)(2012-3#1)
reexamination##12##1##(1993-8#1)(1994-12#1)(1997-4#1)(2007-12#1)(2007-9#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-3#1)
reexamine##8##1##(1990-12#1)(1990-5#1)(1995-2#1)(1996-12#1)(2008-8#2)(2008-9#1)(2010-9#1)
reexamined and##2##2##(2007-4#1)(2011-2#1)
reexamined by##2##2##(1991-8#1)(2008-3#1)
reexamined in##2##2##(1996-11#1)(1997-1#1)
reexamined with##2##2##(1993-10#1)(2008-10#1)
reexamined##20##1##(1991-2#1)(1991-3#1)(1991-8#1)(1993-10#1)(1993-11#1)(1996-11#1)(1996-5#2)(1997-1#1)(2007-12#1)(2007-4#2)(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-1#1)
reexamines the##2##2##(2007-1#1)(2008-11#1)
reexamining the##2##2##(2006-3#1)(2013-1#1)
reexcision and oral prednisone##2##4##(2004-1#2)
reexcision##8##1##(1993-5#1)(2004-1#3)(2008-11#1)(2013-1#3)
reexploration##2##1##(2006-11#1)(2008-9#1)
reextraction##2##1##(2008-10#2)
ref##3##1##(1993-9#1)(2008-1#1)(2008-10#1)
refed after##2##2##(1996-11#1)(1997-8#1)
refed##4##1##(1996-11#1)(1996-7#2)(1997-8#1)
refeeding syndrome##6##2##(2005-10#4)(2006-7#1)(2013-1#1)
refeeding##27##1##(1990-3#1)(1990-8#1)(1992-11#1)(1996-1#3)(1996-11#3)(1996-7#1)(2005-10#4)(2006-1#1)(2006-10#1)(2006-7#1)(2008-3#1)(2008-4#1)(2008-7#4)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
refer a##2##2##(1996-1#1)(2008-9#1)
refer as a##2##3##(2007-12#1)(2010-8#1)
refer it##2##2##(2008-2#1)(2008-5#1)
refer patients to##3##3##(1995-9#1)(2010-9#1)(2012-2#1)
refer patients with##2##3##(1993-2#1)(2006-7#1)
refer patients##7##2##(1993-2#1)(1993-3#1)(1995-9#1)(2006-7#1)(2007-6#1)(2010-9#1)(2012-2#1)
refer the##4##2##(1992-5#1)(2008-11#1)(2008-2#2)
refer their patients to##2##4##(2006-10#1)(2007-4#1)
refer their patients##3##3##(2006-10#1)(2007-2#1)(2007-4#1)
refer their##4##2##(2006-10#1)(2007-2#1)(2007-4#1)(2011-1#1)
refer to a##11##3##(1991-9#1)(1995-5#1)(2007-2#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
refer to any##3##3##(1995-2#1)(2006-10#1)(2008-4#1)
refer to as the##4##4##(1990-6#1)(1995-6#1)(1996-4#1)(2012-12#1)
refer to as##11##3##(1990-6#1)(1992-6#1)(1995-6#1)(1996-11#2)(1996-4#1)(2007-4#1)(2008-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
refer to the##7##3##(1993-2#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#1)
refer to this##6##3##(1990-3#1)(1996-4#1)(2008-2#1)(2009-3#1)(2012-2#1)(2013-8#1)
refer to##74##2##(1990-3#1)(1990-6#2)(1991-9#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-11#2)(1996-4#2)(1997-1#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-3#1)(2009-4#1)(2010-3#1)(2010-4#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#4)(2013-1#3)(2013-7#1)(2013-8#4)
refer travellers to##2##3##(2007-2#2)
refer##110##1##(1990-3#1)(1990-6#2)(1991-1#1)(1991-11#1)(1991-9#1)(1992-12#1)(1992-5#2)(1992-6#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-9#2)(1996-1#1)(1996-11#2)(1996-4#2)(1997-1#1)(2005-11#1)(2006-10#2)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#5)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#2)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#6)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#3)(2009-11#1)(2009-3#1)(2009-4#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-11#2)(2012-12#1)(2012-2#5)(2013-1#4)(2013-7#1)(2013-8#4)
referable symptomatology##2##2##(1991-6#1)(2007-9#1)
refered to##2##2##(2008-10#1)(2008-7#1)
refered##3##1##(1994-2#1)(2008-10#1)(2008-7#1)
referees##2##1##(2005-7#2)
reference 3D##2##2##(2008-3#2)
reference DNA##2##2##(2008-12#2)
reference LITA channel##2##3##(2008-2#2)
reference adult##2##2##(1996-7#1)(2008-7#1)
reference and control##2##3##(2007-11#1)(2012-12#1)
reference and the##5##3##(2007-8#1)(2008-2#2)(2008-3#2)
reference and##29##2##(1993-11#3)(1997-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#7)(2008-3#3)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
reference area##6##2##(1996-10#1)(2008-12#1)(2011-2#4)
reference arm and##2##3##(2008-2#1)(2008-3#1)
reference arm of the interferometer##3##5##(2008-1#1)(2008-2#2)
reference arm of##5##3##(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)
reference arm##11##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#5)(2008-3#3)
reference axis##2##2##(2008-2#1)(2008-3#1)
reference beam and##5##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)
reference beam in##2##3##(2008-3#2)
reference beam is##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
reference beam to##3##3##(2008-2#1)(2008-3#2)
reference beam##39##2##(2007-11#2)(2007-12#10)(2008-1#1)(2008-2#8)(2008-3#18)
reference beams is##2##3##(2007-12#1)(2008-3#1)
reference beams##8##2##(2007-12#3)(2008-2#2)(2008-3#3)
reference blood samples##2##3##(1995-11#1)(2009-11#1)
reference blood##3##2##(1995-11#1)(2009-11#1)(2009-9#1)
reference by##3##2##(2007-12#1)(2008-10#2)
reference center##2##2##(2011-2#1)(2013-1#1)
reference code##2##2##(2008-12#1)(2008-3#1)
reference compound##7##2##(1991-12#1)(1995-3#1)(2005-12#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-5#1)
reference compounds##10##2##(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#3)(2009-5#1)(2010-11#1)(2012-12#1)
reference computations##2##2##(2006-11#1)(2008-3#1)
reference curve##2##2##(2005-7#1)(2008-10#1)
reference data##12##2##(1996-12#1)(2004-9#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-4#1)(2011-2#1)(2012-2#1)
reference distribution##2##2##(1995-8#1)(2010-2#1)
reference document for##2##3##(1992-2#1)(2009-5#1)
reference dose##3##2##(1994-3#1)(2007-8#1)(2012-1#1)
reference drug##6##2##(2008-11#1)(2008-3#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
reference drugs##3##2##(2006-12#1)(2009-5#1)(2012-2#1)
reference electrode and a##2##4##(2008-10#2)
reference electrode was##2##3##(2008-10#2)
reference electrode##28##2##(1991-5#1)(2006-10#1)(2006-8#1)(2008-10#24)(2008-9#1)
reference electrode)##8##2##(2007-8#1)(2008-10#7)
reference electrodes##2##2##(2008-10#2)
reference equations##2##2##(2012-2#2)
reference field##6##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#2)
reference food##2##2##(2008-1#2)
reference for a##2##3##(2005-11#1)(2008-2#1)
reference for the##10##3##(1990-12#1)(1995-3#1)(2006-12#1)(2007-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
reference for those##2##3##(2008-11#1)(2008-12#1)
reference for##31##2##(1990-12#1)(1995-3#1)(2005-11#1)(2005-12#1)(2006-12#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
reference formulation##5##2##(1993-6#2)(1995-4#2)(2006-1#1)
reference frame##5##2##(2007-4#1)(2008-2#1)(2008-3#3)
reference frames##2##2##(2008-2#1)(2008-3#1)
reference frequency##3##2##(2007-12#2)(2008-2#1)
reference function##3##2##(2007-11#1)(2008-3#2)
reference genome##4##2##(2008-2#2)(2012-2#1)(2012-3#1)
reference gratings##2##2##(2008-2#2)
reference group##22##2##(1991-5#1)(1994-6#1)(1996-1#1)(2005-11#1)(2006-10#1)(2006-7#9)(2007-7#2)(2007-9#1)(2008-10#1)(2011-2#1)(2012-1#2)(2013-8#1)
reference group) and##2##3##(1991-5#1)(1995-1#1)
reference group)##3##2##(1991-5#1)(1995-1#1)(2004-12#1)
reference groups were##2##3##(2011-2#2)
reference groups##7##2##(1990-4#1)(1991-9#1)(2008-10#1)(2008-5#1)(2011-2#3)
reference guide##2##2##(1997-2#1)(2012-5#1)
reference haplotypes##2##2##(2012-3#2)
reference image and##2##3##(2008-3#2)
reference image##9##2##(2007-12#1)(2008-2#2)(2008-3#6)
reference images for##2##3##(2008-2#1)(2008-3#1)
reference images##6##2##(2008-2#3)(2008-3#3)
reference in the##3##3##(1994-3#2)(2008-3#1)
reference in##11##2##(1994-3#2)(2006-2#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-2#2)(2012-3#1)(2013-8#1)
reference individuals##2##2##(1990-11#1)(2008-10#1)
reference interaction site model##2##4##(2009-10#1)(2010-7#1)
reference interval for##3##3##(1991-1#1)(1991-8#1)(2006-10#1)
reference interval##11##2##(1990-8#1)(1991-1#1)(1991-5#2)(1991-8#1)(1992-3#1)(1992-9#1)(1994-6#1)(2005-12#1)(2006-10#1)(2012-2#1)
reference intervals and##2##3##(2006-10#1)(2011-11#1)
reference intervals for##2##3##(2006-10#1)(2011-1#1)
reference intervals##13##2##(1996-4#1)(2006-10#2)(2008-5#3)(2011-1#1)(2011-11#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
reference into##2##2##(2008-1#1)(2008-10#1)
reference is made to the##2##5##(1994-2#1)(2010-11#1)
reference is made to##4##4##(1994-2#1)(2006-5#1)(2008-10#1)(2010-11#1)
reference is made##5##3##(1994-2#1)(2006-5#1)(2008-10#1)(2009-3#1)(2010-11#1)
reference is##12##2##(1990-2#1)(1994-2#1)(2006-5#1)(2007-11#1)(2008-10#2)(2008-3#1)(2009-3#1)(2010-11#2)(2011-1#1)(2013-8#1)
reference isolates of##2##3##(2008-10#1)(2008-5#1)
reference isolates##4##2##(2008-10#3)(2008-5#1)
reference laboratories in##2##3##(2005-5#1)(2007-12#1)
reference laboratory##3##2##(1994-9#1)(2005-5#1)(2011-2#1)
reference laser##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
reference lead##2##2##(1995-6#1)(2007-7#1)
reference level##2##2##(1997-6#1)(2010-5#1)
reference levels##6##2##(2008-3#3)(2011-2#1)(2012-2#2)
reference librarians to##2##3##(1996-1#1)(1997-3#1)
reference librarians##5##2##(1996-1#4)(1997-3#1)
reference libraries and hybridisation fingerprinting##2##5##(1993-6#1)(1994-6#1)
reference libraries##3##2##(1993-6#1)(1994-6#1)(2008-10#1)
reference library##3##2##(1994-6#1)(2008-9#1)(2010-5#1)
reference light##6##2##(2007-11#4)(2007-12#1)(2008-11#1)
reference limits##3##2##(1990-4#1)(2008-3#1)(2012-1#1)
reference liquid##2##2##(2008-10#1)(2008-2#1)
reference liquids##2##2##(2008-2#2)
reference lists of##7##3##(2012-12#4)(2013-1#1)(2013-8#2)
reference lists##13##2##(2007-11#1)(2007-8#2)(2008-10#1)(2011-2#1)(2012-12#4)(2013-1#1)(2013-8#3)
reference material (CRM) of##2##4##(2008-10#2)
reference material (CRM)##3##3##(2008-10#3)
reference material (GBW##3##3##(2008-10#3)
reference material NIST##3##3##(2008-10#3)
reference material and a##2##4##(2007-8#1)(2008-10#1)
reference material and applied to##2##5##(2008-10#2)
reference material and##13##3##(2007-8#2)(2008-10#11)
reference material for the##2##4##(2008-10#2)
reference material for##5##3##(1996-7#2)(2008-10#2)(2013-8#1)
reference material from##2##3##(2008-10#2)
reference material is##2##3##(1996-7#1)(2008-10#1)
reference material was##2##3##(2007-12#1)(2008-1#1)
reference material##99##2##(1996-7#3)(1996-9#1)(2005-11#1)(2007-12#2)(2007-8#4)(2008-1#1)(2008-10#85)(2011-2#1)(2013-8#1)
reference materials (CRM##2##3##(2008-10#2)
reference materials (CRMs)##7##3##(2008-10#7)
reference materials (whole##2##3##(2008-10#2)
reference materials SRM##2##3##(2008-10#2)
reference materials and comparing the##2##5##(2008-10#2)
reference materials and##21##3##(2007-8#3)(2008-10#18)
reference materials are##4##3##(2008-10#4)
reference materials by##3##3##(2008-10#3)
reference materials of biological origin##2##5##(2008-10#2)
reference materials of##12##3##(2008-10#12)
reference materials were in##2##4##(2008-10#2)
reference materials were##8##3##(2005-4#1)(2008-10#7)
reference materials with##2##3##(2007-8#1)(2008-10#1)
reference materials##157##2##(1994-6#1)(2005-4#1)(2007-8#4)(2008-10#151)
reference materials)##2##2##(2008-10#2)
reference measurement##4##2##(1993-5#1)(2008-3#1)(2011-1#2)
reference measurements##2##2##(2008-10#1)(2008-3#1)
reference medium##3##2##(2007-12#1)(2008-3#2)
reference memory group##2##3##(2008-12#2)
reference memory is##2##3##(1992-9#2)
reference memory performance##2##3##(1993-12#2)
reference memory task##2##3##(1993-12#1)(2013-1#1)
reference memory##25##2##(1991-1#1)(1992-10#1)(1992-9#4)(1993-11#2)(1993-12#5)(1993-3#3)(1994-8#1)(2008-11#1)(2008-12#4)(2008-7#1)(2013-1#2)
reference method and##2##3##(2008-10#2)
reference method at the 95% confidence level##2##7##(2008-10#2)
reference method based on##3##4##(1996-12#1)(2007-8#1)(2008-10#1)
reference method for##7##3##(2008-10#6)(2008-6#1)
reference method is##2##3##(1995-4#1)(2008-10#1)
reference method##63##2##(1990-11#1)(1995-4#1)(1996-12#2)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#48)(2008-2#1)(2008-6#1)(2010-12#1)(2010-5#1)(2011-1#2)(2012-3#1)(2013-1#1)
reference methods at##2##3##(2008-10#2)
reference methods##19##2##(2008-10#15)(2010-4#2)(2011-1#2)
reference mirror##5##2##(2008-2#2)(2008-3#3)
reference models##2##2##(2008-10#1)(2009-12#1)
reference object and##2##3##(2008-2#2)
reference object is##2##3##(2008-2#1)(2008-3#1)
reference object##8##2##(2008-2#5)(2008-3#3)
reference or##5##2##(2008-10#2)(2010-5#1)(2011-2#2)
reference orientations##2##2##(1990-11#2)
reference panel to##2##3##(2012-3#2)
reference panel##3##2##(2012-3#3)
reference patterns were##2##3##(2008-2#2)
reference patterns##5##2##(2006-12#2)(2008-2#3)
reference peptide##2##2##(2008-4#2)
reference phase-encoded JTC##2##3##(2008-3#2)
reference phase-encoded##3##2##(2008-3#3)
reference place##2##2##(1993-2#2)
reference plane##5##2##(2007-11#1)(2008-2#1)(2008-3#2)(2013-8#1)
reference planes##2##2##(2004-3#1)(2008-2#1)
reference plasmid##4##2##(1996-10#4)
reference point##8##2##(1992-7#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2010-10#1)(2011-2#1)(2012-2#1)
reference points##10##2##(1992-2#1)(2007-5#1)(2008-2#3)(2008-3#2)(2008-4#1)(2010-2#1)(2013-8#1)
reference population##14##2##(1990-11#1)(1994-3#1)(1994-6#2)(1996-3#2)(2006-10#2)(2008-11#2)(2009-9#1)(2011-1#1)(2012-1#2)
reference position##2##2##(2006-8#2)
reference preparation##2##2##(1990-11#1)(1993-9#1)
reference preparations##2##2##(1994-3#1)(2007-8#1)
reference procedure##10##2##(2007-8#1)(2008-10#9)
reference procedures##2##2##(2008-10#2)
reference profiles##2##2##(2006-4#2)
reference protein##2##2##(2008-10#1)(2013-1#1)
reference pulse with a##2##4##(2007-12#1)(2008-3#1)
reference pulse with##3##3##(2007-12#2)(2008-3#1)
reference pulse##7##2##(2007-12#2)(2008-2#1)(2008-3#4)
reference range and##4##3##(1992-10#1)(1993-2#1)(2013-1#2)
reference range for##2##3##(1993-2#1)(1994-11#1)
reference range in##3##3##(2006-6#1)(2011-11#1)(2013-1#1)
reference range is##2##3##(2006-6#1)(2012-2#1)
reference range of##2##3##(1990-2#1)(2011-11#1)
reference range##23##2##(1990-2#1)(1991-2#1)(1992-10#1)(1993-2#3)(1994-11#1)(2006-5#3)(2006-6#3)(2008-9#1)(2011-11#2)(2012-2#2)(2013-1#5)
reference ranges are##4##3##(1995-4#1)(2011-1#1)(2013-1#2)
reference ranges for##3##3##(1995-4#1)(2005-7#1)(2008-9#1)
reference ranges##21##2##(1990-1#1)(1993-5#1)(1994-10#1)(1994-11#2)(1994-12#1)(1995-4#2)(1995-7#1)(2005-12#1)(2005-7#1)(2008-9#2)(2010-2#1)(2011-1#2)(2011-11#1)(2013-1#4)
reference sample is##2##3##(1993-1#1)(2008-10#1)
reference sample##10##2##(1993-1#1)(2005-4#1)(2007-8#1)(2008-10#4)(2012-1#1)(2013-1#1)(2013-8#1)
reference samples##10##2##(2005-4#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-3#1)
reference scales##2##2##(2011-2#2)
reference sequence##5##2##(2005-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)
reference serum##3##2##(2007-11#1)(2011-2#2)
reference service##3##2##(1994-12#1)(1994-2#1)(1996-1#1)
reference services in##2##3##(1995-1#1)(1996-3#1)
reference services##5##2##(1994-12#1)(1995-1#1)(1996-3#2)(1997-1#1)
reference set was##2##3##(2008-10#1)(2012-1#1)
reference set##4##2##(2007-11#1)(2008-10#1)(2008-7#1)(2012-1#1)
reference should##3##2##(2005-10#1)(2006-3#1)(2007-12#1)
reference signal and##2##3##(2008-2#1)(2011-1#1)
reference signal##16##2##(2007-12#3)(2007-8#2)(2008-2#5)(2008-3#1)(2010-8#3)(2011-1#1)(2012-1#1)
reference signals##3##2##(2007-8#2)(2008-2#1)
reference sinusoid##2##2##(2008-2#1)(2008-3#1)
reference solid and water materials with##2##6##(2008-10#2)
reference solution##6##2##(2007-8#1)(2008-10#5)
reference solutions in##2##3##(2008-10#1)(2008-5#1)
reference solutions##6##2##(2008-10#5)(2008-5#1)
reference source##3##2##(2008-10#1)(2008-2#2)
reference spectra##4##2##(2006-5#1)(2008-10#1)(2008-3#1)(2012-12#1)
reference spectrophotometer is##2##3##(2008-3#2)
reference spectrophotometer##4##2##(2008-3#4)
reference spectrophotometric##3##2##(2008-10#2)(2008-5#1)
reference standard for##5##3##(1991-9#1)(1994-3#1)(2010-4#1)(2013-1#2)
reference standard##19##2##(1991-5#1)(1991-9#1)(1994-3#1)(1996-9#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#6)(2010-11#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#2)
reference standards##10##2##(1992-4#1)(2006-8#1)(2007-1#1)(2007-8#2)(2008-10#3)(2009-9#1)(2010-3#1)
reference strain B##2##3##(2006-8#1)(2011-2#1)
reference strain##21##2##(1995-4#1)(2006-8#1)(2007-10#1)(2008-10#7)(2008-5#4)(2011-10#1)(2011-2#5)(2013-8#1)
reference strains P##2##3##(2006-8#2)
reference strains and##2##3##(2011-1#1)(2011-2#1)
reference strains for##2##3##(2008-10#2)
reference strains of##10##3##(1996-12#1)(1997-6#1)(2005-8#1)(2008-10#5)(2008-5#1)(2012-12#1)
reference strains were##5##3##(2008-10#2)(2008-5#1)(2011-1#1)(2011-2#1)
reference strains##41##2##(1996-12#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-8#3)(2007-8#1)(2008-10#16)(2008-5#7)(2009-6#1)(2010-3#1)(2011-1#2)(2011-2#5)(2012-12#1)
reference substance##2##2##(1997-3#1)(2005-7#1)
reference substrate for##2##3##(1993-4#1)(2008-5#1)
reference substrate##3##2##(1993-4#2)(2008-5#1)
reference surface and##2##3##(2008-3#2)
reference surface##6##2##(2008-11#1)(2008-3#5)
reference system##5##2##(1993-6#1)(1997-4#1)(2008-7#1)(2012-12#2)
reference technique##2##2##(2008-10#2)
reference test##3##2##(1995-4#3)
reference that was##2##3##(1995-3#1)(2007-6#1)
reference that##4##2##(1995-3#1)(2007-6#1)(2008-10#1)(2008-2#1)
reference to a##6##3##(1992-6#1)(1993-2#1)(1996-12#1)(2006-8#1)(2008-1#1)(2009-9#1)
reference to clinical##2##3##(1991-4#1)(2008-1#1)
reference to its##3##3##(1992-6#1)(2008-7#1)(2011-1#1)
reference to recent##4##3##(1990-5#1)(1992-3#1)(1997-7#1)(2007-12#1)
reference to the##67##3##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-9#1)(1991-12#1)(1991-6#1)(1991-8#1)(1993-10#1)(1993-7#1)(1994-6#2)(1995-1#2)(1995-11#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-5#1)(2004-4#1)(2005-7#1)(2006-11#2)(2006-2#1)(2006-5#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-7#1)(2010-10#1)(2011-12#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
reference to their##4##3##(2007-7#1)(2008-11#1)(2008-7#1)(2008-8#1)
reference to understand the##2##4##(1996-1#1)(2008-10#1)
reference to##212##2##(1990-12#2)(1990-3#2)(1990-4#1)(1990-5#5)(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#2)(1993-1#1)(1993-10#1)(1993-2#2)(1993-7#3)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#4)(1995-1#2)(1995-11#1)(1995-3#1)(1995-4#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-5#2)(1997-7#2)(2004-12#1)(2004-4#2)(2004-7#1)(2005-5#1)(2005-7#2)(2006-10#1)(2006-11#2)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-11#3)(2007-12#5)(2007-4#2)(2007-5#1)(2007-7#8)(2007-8#3)(2007-9#1)(2008-1#7)(2008-10#9)(2008-11#6)(2008-12#4)(2008-2#12)(2008-3#5)(2008-5#3)(2008-7#11)(2008-8#4)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2011-1#4)(2011-12#2)(2011-2#5)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#3)
reference trajectories##3##2##(2012-1#3)
reference transition at##2##3##(2007-12#2)
reference transition##3##2##(2007-12#2)(2008-3#1)
reference treatments##3##2##(1995-9#1)(2007-11#1)(2008-10#1)
reference value##6##2##(1996-1#1)(2007-4#1)(2008-10#2)(2008-3#2)
reference values for the##3##4##(2006-10#1)(2011-2#1)(2013-1#1)
reference values for##16##3##(1992-2#1)(1993-12#1)(1994-5#1)(1996-12#1)(2005-7#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-4#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#2)(2013-1#2)
reference values to##2##3##(2007-12#1)(2008-10#1)
reference values were##2##3##(1996-12#1)(2008-10#1)
reference values##53##2##(1990-12#1)(1991-8#1)(1992-2#2)(1993-12#1)(1993-2#2)(1994-5#1)(1995-2#1)(1996-12#3)(1996-9#1)(2005-4#1)(2005-7#2)(2006-10#1)(2006-11#3)(2006-7#1)(2007-12#2)(2007-4#1)(2008-10#11)(2008-11#1)(2008-3#4)(2008-5#1)(2008-7#1)(2010-3#1)(2010-9#1)(2011-2#3)(2012-2#2)(2013-1#4)
reference variable##2##2##(2013-7#2)
reference vector##2##2##(2008-2#2)
reference vectors##2##2##(2008-2#2)
reference was##2##2##(2006-10#1)(2007-12#1)
reference wave##11##2##(2007-12#2)(2008-2#2)(2008-3#7)
reference wavelength##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
reference waves##3##2##(2007-12#1)(2008-3#2)
reference with##3##2##(2008-1#1)(2008-10#1)(2008-3#1)
reference##1816##1##(1990-1#1)(1990-11#7)(1990-12#6)(1990-2#2)(1990-3#2)(1990-4#4)(1990-5#5)(1990-8#1)(1990-9#2)(1991-1#4)(1991-12#4)(1991-2#4)(1991-3#2)(1991-4#2)(1991-5#8)(1991-6#1)(1991-8#3)(1991-9#4)(1992-10#2)(1992-11#1)(1992-12#4)(1992-2#6)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-9#6)(1993-1#2)(1993-10#2)(1993-11#5)(1993-12#6)(1993-2#9)(1993-3#3)(1993-4#2)(1993-5#4)(1993-6#4)(1993-7#3)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#4)(1994-12#4)(1994-2#3)(1994-3#9)(1994-5#1)(1994-6#11)(1994-8#1)(1994-9#1)(1995-1#5)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#4)(1995-4#12)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#9)(1996-10#6)(1996-11#1)(1996-12#11)(1996-2#3)(1996-3#5)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#4)(1996-9#5)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#3)(2004-12#3)(2004-3#1)(2004-4#2)(2004-7#1)(2004-9#2)(2005-10#3)(2005-11#6)(2005-12#4)(2005-3#1)(2005-4#5)(2005-5#4)(2005-7#8)(2005-8#2)(2006-1#1)(2006-10#13)(2006-11#7)(2006-12#13)(2006-2#4)(2006-3#2)(2006-4#5)(2006-5#6)(2006-6#4)(2006-7#12)(2006-8#19)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#28)(2007-12#76)(2007-4#7)(2007-5#5)(2007-6#1)(2007-7#19)(2007-8#38)(2007-9#4)(2008-1#20)(2008-10#517)(2008-11#23)(2008-12#23)(2008-2#124)(2008-3#147)(2008-4#13)(2008-5#34)(2008-6#2)(2008-7#24)(2008-8#6)(2008-9#10)(2009-10#5)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#5)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#5)(2010-10#2)(2010-11#4)(2010-12#6)(2010-2#4)(2010-3#6)(2010-4#4)(2010-5#5)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#26)(2011-10#1)(2011-11#4)(2011-12#2)(2011-2#52)(2011-3#1)(2012-1#20)(2012-11#3)(2012-12#17)(2012-2#25)(2012-3#19)(2012-5#1)(2013-1#38)(2013-7#6)(2013-8#19)
reference) and##2##2##(2008-10#1)(2010-12#1)
reference)##4##1##(2008-10#2)(2008-5#1)(2010-12#1)
reference-wave accuracy##2##2##(2008-3#2)
reference-wave##3##1##(2007-12#1)(2008-3#2)
referenced polarization##2##2##(2007-12#2)
referenced to the##2##3##(2008-10#1)(2008-2#1)
referenced to##8##2##(1993-7#3)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
referenced##22##1##(1993-7#3)(1997-2#1)(2007-12#3)(2007-6#1)(2007-8#1)(2008-10#6)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#1)(2012-2#1)
references and##5##2##(2005-7#1)(2008-10#1)(2008-4#2)(2010-9#1)
references are##2##2##(2008-10#1)(2008-3#1)
references concerning##2##2##(2005-7#1)(2008-10#1)
references for the##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
references for those##2##3##(2008-9#2)
references for##9##2##(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#2)(2011-1#1)(2011-2#1)(2013-1#1)
references from##5##2##(1992-11#1)(1996-9#1)(2006-10#1)(2006-2#1)(2011-2#1)
references in##3##2##(2005-7#1)(2007-10#1)(2010-5#1)
references is presented##2##3##(2006-2#1)(2008-10#1)
references is##3##2##(1994-1#1)(2006-2#1)(2008-10#1)
references of##4##2##(2006-12#1)(2008-11#1)(2011-1#1)(2013-1#1)
references on##2##2##(2008-1#1)(2008-3#1)
references that##2##2##(2008-3#1)(2009-4#1)
references to the##5##3##(1992-12#1)(2008-10#1)(2008-8#1)(2009-7#1)(2011-2#1)
references to##15##2##(1992-12#1)(1993-6#1)(1996-12#1)(1996-2#1)(2005-7#2)(2007-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-7#1)(2011-2#1)(2012-11#1)(2013-1#1)
references were##2##2##(2009-2#1)(2011-2#1)
references##99##1##(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-11#1)(1992-12#2)(1993-2#1)(1993-6#1)(1994-1#1)(1994-10#1)(1996-12#1)(1996-2#1)(1996-8#1)(1996-9#1)(2005-10#1)(2005-12#1)(2005-4#1)(2005-7#7)(2006-10#1)(2006-12#2)(2006-2#2)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#3)(2007-6#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#4)(2009-2#2)(2009-4#1)(2009-7#1)(2010-3#1)(2010-5#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#4)(2012-11#1)(2013-1#3)(2013-8#3)
references)##2##1##(2008-10#1)(2009-12#1)
referencing##13##1##(1993-5#1)(2006-10#1)(2006-6#1)(2007-12#3)(2007-5#1)(2008-2#2)(2008-4#1)(2009-3#1)(2009-4#1)(2013-1#1)
referendum##3##1##(1997-1#1)(1997-3#1)(2006-7#1)
referent bodies##2##2##(2007-12#2)
referent figures##2##2##(2007-12#2)
referent group##5##2##(1996-6#4)(2008-11#1)
referent##17##1##(1993-2#1)(1994-6#1)(1995-2#1)(1996-6#4)(2006-11#1)(2007-12#4)(2008-11#1)(2008-5#1)(2010-3#1)(2011-2#1)(2013-1#1)
referential constraints##2##2##(2009-2#2)
referential##9##1##(2008-10#1)(2009-2#2)(2010-12#1)(2011-2#2)(2013-8#3)
referents##6##1##(1995-2#1)(2007-3#1)(2008-11#2)(2008-7#1)(2010-6#1)
referral and##8##2##(1991-12#1)(1996-12#1)(2007-3#1)(2008-7#1)(2012-1#1)(2012-2#3)
referral by##3##2##(1992-9#1)(1996-9#1)(2008-1#1)
referral center in##3##3##(2011-12#1)(2012-2#1)(2013-8#1)
referral center##14##2##(2006-8#1)(2007-12#1)(2007-8#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-2#1)(2013-8#2)
referral centers in##3##3##(2007-2#1)(2007-7#1)(2011-2#1)
referral centers##10##2##(2007-2#1)(2007-7#1)(2007-8#1)(2011-2#5)(2013-1#2)
referral centre in##4##3##(2005-12#1)(2007-7#1)(2011-12#2)
referral centre##14##2##(1993-5#1)(2005-12#1)(2007-7#1)(2008-4#1)(2009-10#1)(2010-10#2)(2011-1#2)(2011-12#2)(2011-2#1)(2012-2#1)(2013-8#1)
referral centres for##2##3##(2008-11#1)(2008-9#1)
referral centres##4##2##(1995-10#1)(2005-10#1)(2008-11#1)(2008-9#1)
referral decisions##5##2##(1994-1#4)(2007-2#1)
referral diagnosis##3##2##(2007-7#3)
referral for evaluation of##2##4##(2007-12#1)(2008-12#1)
referral for##13##2##(1991-6#1)(1994-12#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-10#1)(2011-12#1)
referral hospital in##7##3##(2006-2#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
referral hospital##11##2##(2006-2#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#2)(2013-1#1)
referral hospitals##4##2##(1990-11#1)(2008-1#2)(2010-8#1)
referral network##2##2##(1990-12#1)(1996-5#1)
referral of children##2##3##(1990-12#1)(2007-2#1)
referral of patients with##2##4##(2007-7#1)(2008-1#1)
referral of patients##5##3##(1990-3#1)(2007-7#1)(2008-1#2)(2010-1#1)
referral of##13##2##(1990-12#1)(1990-3#1)(1992-12#1)(1996-12#1)(1996-3#1)(2007-2#1)(2007-7#1)(2008-1#2)(2009-11#1)(2010-1#1)(2011-1#1)(2012-2#1)
referral pattern##4##2##(2006-11#1)(2006-8#2)(2011-2#1)
referral patterns##8##2##(1992-1#1)(1993-12#1)(1996-3#1)(2006-7#1)(2006-8#2)(2007-2#1)(2008-6#1)
referral policies##2##2##(1997-3#2)
referral practices of##2##3##(2011-1#2)
referral practices##3##2##(2011-1#3)
referral process##2##2##(1997-3#1)(2008-1#1)
referral rate##2##2##(2007-12#1)(2011-1#1)
referral rates##2##2##(2010-10#2)
referral relationships##2##2##(1990-12#1)(1997-1#1)
referral services##3##2##(1994-1#1)(1994-2#1)(1996-1#1)
referral sources##3##2##(1992-1#1)(1996-1#1)(2007-2#1)
referral system in##3##3##(2007-3#1)(2011-1#2)
referral system##7##2##(1992-2#1)(2007-3#2)(2010-8#1)(2011-1#2)(2011-12#1)
referral to a tertiary cardiac##2##5##(2007-11#1)(2010-12#1)
referral to a##6##3##(2004-12#1)(2007-11#1)(2007-4#1)(2010-12#1)(2010-2#1)(2010-9#1)
referral to the##5##3##(1993-12#1)(2006-8#1)(2008-1#1)(2008-8#1)(2010-8#1)
referral to##29##2##(1992-9#1)(1993-12#1)(2004-12#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#1)(2008-1#3)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-8#1)(2010-9#1)(2012-11#2)(2013-1#2)
referral unit##2##2##(2011-1#2)
referral was##3##2##(2008-11#1)(2010-2#1)(2011-1#1)
referral##285##1##(1990-11#1)(1990-12#3)(1990-3#1)(1990-4#1)(1991-12#1)(1991-6#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-9#6)(1993-10#1)(1993-12#2)(1993-5#2)(1993-9#1)(1994-1#7)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#2)(1995-10#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-6#1)(1996-1#3)(1996-12#2)(1996-2#1)(1996-3#3)(1996-5#1)(1996-9#3)(1997-1#2)(1997-3#3)(2004-12#4)(2004-3#1)(2005-10#2)(2005-12#1)(2005-8#2)(2006-10#2)(2006-11#1)(2006-2#2)(2006-3#2)(2006-5#2)(2006-7#2)(2006-8#8)(2007-11#3)(2007-12#4)(2007-2#10)(2007-3#8)(2007-4#2)(2007-5#2)(2007-7#12)(2007-8#5)(2008-1#17)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#5)(2010-12#1)(2010-2#3)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#19)(2011-12#5)(2011-2#16)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#17)(2012-3#3)(2013-1#12)(2013-8#5)
referral]##2##1##(1993-2#1)(1993-6#1)
referrals and##3##2##(2006-3#1)(2007-10#1)(2013-8#1)
referrals are##2##2##(2007-9#1)(2008-12#1)
referrals for##6##2##(1994-1#1)(1994-2#1)(1994-4#1)(2007-3#1)(2008-1#1)(2008-12#1)
referrals from##6##2##(1993-12#1)(1995-1#1)(2007-3#1)(2007-4#1)(2008-12#1)(2011-2#1)
referrals in##3##2##(1991-8#1)(2006-2#1)(2007-7#1)
referrals made##2##2##(2007-11#1)(2010-10#1)
referrals to a##3##3##(1996-4#1)(2012-2#2)
referrals to the##2##3##(2007-1#1)(2012-2#1)
referrals to##8##2##(1992-9#1)(1994-3#1)(1995-10#1)(1996-4#1)(2007-1#1)(2012-2#3)
referrals##76##1##(1990-12#1)(1991-11#3)(1991-8#3)(1992-9#3)(1993-12#1)(1993-2#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-2#4)(1994-3#1)(1994-4#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-8#1)(2004-12#1)(2004-2#1)(2004-3#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-3#2)(2007-4#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-12#4)(2008-4#1)(2008-9#2)(2010-10#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#7)(2013-8#3)
referred after##2##2##(2007-3#1)(2013-8#1)
referred as##3##2##(2007-12#1)(2008-10#1)(2008-12#1)
referred at##2##2##(2007-11#1)(2008-9#1)
referred back to##2##3##(1994-9#1)(2008-12#1)
referred because of##7##3##(1995-5#1)(2006-10#1)(2007-5#1)(2011-1#2)(2012-3#1)(2013-1#1)
referred by a##2##3##(2007-3#1)(2011-2#1)
referred by teachers##2##3##(2005-10#2)
referred by the##3##3##(1991-8#1)(2010-3#1)(2011-1#1)
referred by their##2##3##(2007-3#1)(2008-12#1)
referred by##16##2##(1990-12#2)(1991-8#1)(2005-10#2)(2006-8#1)(2007-3#2)(2007-6#1)(2007-7#1)(2008-12#2)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
referred cardiac pain and##2##4##(2008-9#2)
referred for a##2##3##(2009-3#1)(2010-8#1)
referred for cardiac##2##3##(2007-8#1)(2011-2#1)
referred for colposcopy##3##3##(1992-3#1)(1992-6#1)(1997-7#1)
referred for coronary##3##3##(2008-12#1)(2008-7#1)(2010-12#1)
referred for evaluation of##3##4##(2006-8#1)(2007-9#1)(2013-8#1)
referred for evaluation##5##3##(1997-3#1)(2006-8#1)(2007-9#1)(2008-10#1)(2013-8#1)
referred for investigation##3##3##(1992-11#1)(1994-6#1)(2007-3#1)
referred for surgery##2##3##(1992-9#1)(2010-8#1)
referred for surgical##2##3##(1990-4#1)(2007-7#1)
referred for therapy##2##3##(1992-3#1)(2010-12#1)
referred for this##2##3##(2007-11#1)(2007-8#1)
referred for thymectomy##2##3##(2007-8#2)
referred for treatment##2##3##(1996-9#1)(2006-9#1)
referred for upper##4##3##(1993-5#1)(2006-10#2)(2008-5#1)
referred for##78##2##(1990-2#1)(1990-4#1)(1991-12#1)(1992-11#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-6#1)(1995-11#1)(1996-3#2)(1996-9#1)(1997-3#1)(1997-7#1)(2006-10#2)(2006-8#2)(2006-9#1)(2007-11#3)(2007-12#1)(2007-3#6)(2007-5#1)(2007-7#3)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-3#2)(2010-12#3)(2010-5#1)(2010-8#2)(2011-1#5)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
referred from other##2##3##(2007-3#1)(2008-9#1)
referred from the emergency department##2##5##(2008-9#1)(2011-2#1)
referred from the##6##3##(2007-7#1)(2008-9#3)(2011-2#1)(2012-12#1)
referred from##13##2##(1996-9#1)(2007-3#2)(2007-7#1)(2008-6#1)(2008-9#4)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
referred here##2##2##(1995-7#1)(2007-12#1)
referred leg pain##5##3##(2006-12#5)
referred pain areas of##2##4##(2010-9#2)
referred pain to##2##3##(2006-1#1)(2008-9#1)
referred pain##15##2##(2006-1#1)(2006-8#2)(2008-12#2)(2008-9#3)(2010-9#7)
referred patients##3##2##(1995-1#1)(2007-6#1)(2008-1#1)
referred the##3##2##(1990-3#1)(1993-12#1)(1995-6#1)
referred their patients to##3##4##(1997-6#1)(2006-10#2)
referred to Children's##2##3##(1995-12#1)(2007-2#1)
referred to a specialist##4##4##(2008-11#1)(2009-11#1)(2013-8#2)
referred to a tertiary##2##4##(2006-10#1)(2012-2#1)
referred to a##22##3##(1990-2#1)(1994-11#1)(1997-3#1)(2006-10#2)(2006-8#2)(2007-3#1)(2007-7#1)(2008-11#1)(2008-12#1)(2009-11#1)(2009-3#1)(2009-7#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
referred to an##5##3##(1990-12#1)(1993-12#1)(2008-7#1)(2010-10#1)(2013-8#1)
referred to as &quot##18##4##(1992-1#1)(1997-5#1)(1997-6#1)(2006-8#2)(2007-4#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-12#1)(2010-3#2)(2010-9#1)(2012-12#1)(2013-7#1)
referred to as 'hedge' phrases##2##5##(2013-1#2)
referred to as a##7##4##(2007-12#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-4#1)
referred to as an##3##4##(2007-8#1)(2008-3#1)(2010-10#1)
referred to as the &quot##8##5##(1991-2#1)(1996-1#1)(1996-12#1)(1997-4#1)(2007-5#1)(2008-11#1)(2011-2#1)(2012-12#1)
referred to as the##24##4##(1990-2#1)(1991-2#1)(1992-1#1)(1992-2#1)(1992-6#1)(1992-9#1)(1994-12#1)(1996-1#1)(1996-12#2)(1997-4#1)(2005-11#1)(2006-10#2)(2006-2#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2010-4#1)(2011-2#1)(2012-12#1)
referred to as##183##3##(1990-11#1)(1990-2#1)(1991-11#1)(1991-2#1)(1992-1#2)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-10#2)(1995-12#1)(1995-2#1)(1995-4#1)(1996-1#1)(1996-10#1)(1996-12#3)(1996-7#1)(1997-1#3)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-11#2)(2005-3#1)(2005-7#2)(2005-9#2)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#3)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#17)(2008-11#4)(2008-12#3)(2008-2#3)(2008-3#10)(2008-4#7)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#3)(2009-5#1)(2010-10#3)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#4)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#1)
referred to in the##3##4##(1993-10#1)(1994-2#1)(2008-10#1)
referred to in##4##3##(1992-11#1)(1993-10#1)(1994-2#1)(2008-10#1)
referred to our center from##2##5##(1991-10#1)(2008-4#1)
referred to our center##4##4##(1991-10#1)(2007-2#1)(2007-7#1)(2008-4#1)
referred to our clinic for##2##5##(2012-12#1)(2013-1#1)
referred to our clinic##5##4##(2007-2#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
referred to our hospital for evaluation##2##6##(2010-12#2)
referred to our hospital for##6##5##(2010-12#2)(2011-2#2)(2013-8#2)
referred to our hospital##8##4##(2008-1#1)(2010-12#2)(2011-2#2)(2012-12#1)(2013-8#2)
referred to our tertiary##3##4##(2007-8#1)(2013-1#2)
referred to our##32##3##(1991-10#1)(1994-1#1)(1997-1#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#2)
referred to the Clinic##2##4##(1994-12#1)(2007-8#1)
referred to the Department of##3##5##(1995-6#1)(1997-8#1)(2008-6#1)
referred to the Department##4##4##(1995-6#1)(1997-8#1)(2007-11#1)(2008-6#1)
referred to the department of##2##5##(2008-6#1)(2012-2#1)
referred to the department##3##4##(1990-12#1)(2008-6#1)(2012-2#1)
referred to the group##2##4##(1993-9#1)(2009-2#1)
referred to the total##2##4##(1990-5#1)(1992-12#1)
referred to the##59##3##(1990-12#1)(1990-3#2)(1990-5#1)(1990-8#1)(1992-1#1)(1992-12#1)(1992-5#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#2)(1994-2#1)(1995-6#1)(1997-8#1)(2004-1#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-8#2)(2007-11#3)(2007-2#2)(2007-4#1)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#1)(2009-10#1)(2009-2#1)(2009-8#3)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
referred to their##2##3##(2006-2#2)
referred to three##3##3##(1992-4#1)(2007-2#1)(2008-7#1)
referred to two##2##3##(1992-6#1)(2008-2#1)
referred to us because##2##4##(2007-12#1)(2009-6#1)
referred to us##10##3##(1992-1#1)(1995-11#1)(2005-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-4#1)(2009-6#1)(2010-8#1)(2011-2#1)
referred to##391##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-9#2)(1992-1#4)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#3)(1992-6#3)(1992-7#1)(1992-9#1)(1993-10#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#4)(1994-1#1)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#3)(1996-6#1)(1996-7#1)(1997-1#4)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2004-1#1)(2005-11#3)(2005-3#2)(2005-7#2)(2005-9#2)(2006-10#13)(2006-11#1)(2006-12#3)(2006-2#6)(2006-3#2)(2006-8#8)(2007-10#2)(2007-11#6)(2007-12#3)(2007-2#13)(2007-3#5)(2007-4#2)(2007-5#2)(2007-7#4)(2007-8#7)(2007-9#3)(2008-1#5)(2008-10#24)(2008-11#5)(2008-12#7)(2008-2#4)(2008-3#10)(2008-4#12)(2008-5#7)(2008-6#5)(2008-7#9)(2008-8#5)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#5)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-10#7)(2010-11#2)(2010-12#5)(2010-2#2)(2010-3#5)(2010-4#2)(2010-8#5)(2010-9#3)(2011-1#7)(2011-2#15)(2012-1#2)(2012-11#2)(2012-12#8)(2012-2#10)(2012-3#3)(2013-1#9)(2013-7#4)(2013-8#7)
referred with a##2##3##(2006-12#1)(2009-8#1)
referred with##5##2##(1990-4#1)(2006-12#1)(2007-2#1)(2009-8#1)(2011-2#1)
referred without ADHD##2##3##(2010-8#2)
referred##601##1##(1990-11#1)(1990-12#7)(1990-2#3)(1990-3#3)(1990-4#3)(1990-5#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#4)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#3)(1992-6#4)(1992-7#1)(1992-9#4)(1993-10#2)(1993-12#2)(1993-2#3)(1993-3#2)(1993-5#1)(1993-6#1)(1993-9#4)(1994-1#1)(1994-11#1)(1994-12#5)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#4)(1995-10#2)(1995-11#2)(1995-12#3)(1995-2#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#3)(1996-3#3)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#4)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2004-1#1)(2005-10#2)(2005-11#3)(2005-12#1)(2005-3#2)(2005-7#2)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#18)(2006-11#1)(2006-12#9)(2006-2#6)(2006-3#3)(2006-8#13)(2006-9#1)(2007-10#2)(2007-11#11)(2007-12#6)(2007-2#16)(2007-3#16)(2007-4#2)(2007-5#4)(2007-6#3)(2007-7#10)(2007-8#13)(2007-9#5)(2008-1#10)(2008-10#27)(2008-11#6)(2008-12#16)(2008-2#4)(2008-3#12)(2008-4#12)(2008-5#8)(2008-6#7)(2008-7#12)(2008-8#6)(2008-9#12)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#3)(2009-4#6)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#5)(2010-10#8)(2010-11#2)(2010-12#8)(2010-2#2)(2010-3#6)(2010-4#2)(2010-5#1)(2010-8#9)(2010-9#11)(2011-1#16)(2011-2#24)(2011-3#1)(2012-1#2)(2012-11#2)(2012-12#10)(2012-2#15)(2012-3#5)(2013-1#16)(2013-7#4)(2013-8#12)
referred)##2##1##(1995-1#2)
referring and##2##2##(2007-9#1)(2008-12#1)
referring clinicians##5##2##(2007-4#1)(2012-2#4)
referring physician##7##2##(1992-3#1)(1993-2#1)(1996-3#1)(2006-10#1)(2006-3#1)(2007-4#1)(2007-8#1)
referring physicians and patients##2##4##(2007-4#2)
referring physicians and##5##3##(1990-12#1)(1993-1#1)(1996-1#1)(2007-4#2)
referring physicians as##2##3##(2007-4#1)(2007-9#1)
referring physicians##22##2##(1990-12#1)(1991-1#1)(1993-1#1)(1993-12#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-3#1)(2006-10#1)(2007-3#1)(2007-4#7)(2007-7#1)(2007-8#1)(2007-9#1)(2011-2#1)(2012-2#1)
referring the##3##2##(2008-10#1)(2009-8#1)(2010-3#1)
referring to the##10##3##(1991-11#1)(1996-1#1)(2005-11#1)(2006-3#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-4#1)(2011-1#1)
referring to##33##2##(1990-4#1)(1991-10#1)(1991-11#1)(1991-3#1)(1996-1#1)(2005-11#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-6#2)(2009-2#1)(2009-9#1)(2010-12#2)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-7#2)
referring##90##1##(1990-12#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-3#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-6#1)(1995-1#1)(1995-12#2)(1995-3#1)(1996-1#3)(1996-3#3)(1997-8#1)(2004-12#1)(2005-11#1)(2006-10#3)(2006-3#2)(2006-8#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-4#9)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#2)(2009-2#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#8)(2013-1#4)(2013-7#2)(2013-8#1)
refers the##2##2##(2008-1#1)(2008-4#1)
refers to a phenomenon in which##2##6##(2008-2#1)(2009-11#1)
refers to a##18##3##(1992-1#1)(2004-12#1)(2005-8#1)(2006-11#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#1)(2009-11#2)(2010-8#1)(2011-1#1)(2012-12#1)
refers to power per unit##2##5##(2008-3#2)
refers to the phenomenon in which##2##6##(2008-1#1)(2009-10#1)
refers to the process##2##4##(2008-10#1)(2008-4#1)
refers to the use##2##4##(2008-4#1)(2010-8#1)
refers to the##37##3##(1992-6#1)(1996-12#1)(1996-2#1)(2006-10#2)(2007-1#3)(2007-4#2)(2007-7#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#1)(2009-10#2)(2009-5#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
refers to##96##2##(1990-10#1)(1990-11#1)(1992-1#1)(1992-6#2)(1993-9#2)(1994-11#2)(1994-3#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-8#2)(2004-12#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-6#1)(2007-1#3)(2007-2#2)(2007-4#2)(2007-7#2)(2007-8#1)(2008-1#5)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#3)(2009-11#2)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#4)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#5)(2013-7#2)
refers##101##1##(1990-10#1)(1990-11#1)(1992-1#1)(1992-6#2)(1993-9#2)(1994-11#2)(1994-3#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-8#2)(2004-12#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-6#1)(2007-1#3)(2007-2#2)(2007-4#2)(2007-7#2)(2007-8#1)(2008-1#6)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#6)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#3)(2009-11#2)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#4)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#6)(2013-7#2)
refill##5##1##(1992-3#1)(1995-1#1)(2009-9#1)(2010-11#1)(2010-7#1)
refilling system of intracellular##2##4##(1990-3#2)
refilling##5##1##(1990-3#2)(1995-3#2)(1997-7#1)
refine the assessment of##2##4##(2008-11#1)(2009-7#1)
refine the##29##2##(1994-8#1)(1996-3#1)(1997-1#1)(2005-11#1)(2006-10#3)(2007-10#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#3)(2010-11#1)(2011-2#2)(2012-11#1)(2012-2#2)(2013-1#1)(2013-8#1)
refine these##2##2##(2008-8#1)(2009-2#1)
refine this##3##2##(2005-7#1)(2006-10#1)(2008-4#1)
refine##56##1##(1994-7#1)(1994-8#1)(1996-3#1)(1997-1#1)(1997-3#1)(2005-11#1)(2005-7#1)(2006-10#8)(2007-10#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#3)(2010-1#1)(2010-11#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
refined and##8##2##(1991-6#1)(1992-4#1)(1995-10#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-7#1)
refined at 1##2##3##(1990-7#1)(1997-4#1)
refined at 2##8##3##(1991-5#1)(1992-4#2)(1993-8#2)(1994-9#1)(1995-11#1)(1995-3#1)
refined at##11##2##(1990-7#1)(1991-5#1)(1992-4#2)(1993-8#2)(1994-9#1)(1995-11#1)(1995-3#1)(1996-6#1)(1997-4#1)
refined by the##3##3##(1992-12#1)(2006-10#1)(2010-11#1)
refined by##6##2##(1992-12#1)(1992-4#1)(1995-2#1)(2006-10#1)(2007-12#1)(2010-11#1)
refined crystal structure##3##3##(1994-9#1)(1995-3#1)(1997-5#1)
refined crystal##4##2##(1994-9#1)(1995-10#1)(1995-3#1)(1997-5#1)
refined in the##3##3##(2006-10#1)(2006-11#1)(2008-8#1)
refined in##7##2##(2006-10#1)(2006-11#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#1)
refined local search##3##3##(2008-2#3)
refined model##2##2##(1994-9#1)(2011-1#1)
refined models##2##2##(1996-12#1)(2007-5#1)
refined over the##2##3##(2006-7#1)(2008-6#1)
refined structure showed##2##3##(1995-1#1)(2008-9#1)
refined structure##3##2##(1995-1#1)(1997-5#1)(2008-9#1)
refined structures and NOE##2##4##(1995-10#2)
refined structures and##3##3##(1995-1#1)(1995-10#2)
refined structures##8##2##(1994-5#2)(1995-1#1)(1995-10#3)(1995-11#1)(2009-3#1)
refined sucrose##2##2##(2005-11#1)(2012-1#1)
refined sugar##2##2##(2005-11#1)(2006-10#1)
refined the##3##2##(2008-5#1)(2011-1#1)(2012-12#1)
refined through the##3##3##(2008-10#2)(2012-2#1)
refined through##5##2##(1994-3#1)(2008-10#2)(2012-2#1)(2013-1#1)
refined to 2##4##3##(1995-10#1)(1995-4#1)(1997-5#2)
refined to R = 0##2##5##(1994-12#1)(2008-5#1)
refined to a conventional##2##4##(1995-3#1)(1996-2#1)
refined to a crystallographic R-factor of 19##2##7##(1993-8#1)(1997-4#1)
refined to a crystallographic R-factor of##4##6##(1993-3#1)(1993-8#1)(1994-8#1)(1997-4#1)
refined to a crystallographic##5##4##(1991-4#1)(1993-3#1)(1993-8#1)(1994-8#1)(1997-4#1)
refined to a##10##3##(1991-4#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-4#1)
refined to an R factor of 0##2##7##(1992-8#1)(1995-11#1)
refined to an R factor of##3##6##(1991-2#1)(1992-8#1)(1995-11#1)
refined to an R##4##4##(1991-2#1)(1992-8#1)(1995-11#1)(1995-6#1)
refined to an##5##3##(1991-12#1)(1991-2#1)(1992-8#1)(1995-11#1)(1995-6#1)
refined to##28##2##(1991-12#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-4#1)(1997-5#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-12#1)
refined using##6##2##(1991-12#1)(1995-10#1)(1995-3#1)(1997-7#1)(2008-11#1)(2008-8#1)
refined with##5##2##(1990-10#2)(1995-8#1)(2008-3#1)(2010-7#1)
refined##183##1##(1990-10#2)(1990-7#1)(1990-8#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#5)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#3)(1993-9#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#3)(1995-1#2)(1995-10#8)(1995-11#3)(1995-2#2)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#7)(1996-6#1)(1997-1#1)(1997-4#2)(1997-5#4)(1997-7#1)(1997-8#1)(2005-11#3)(2005-8#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-12#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#10)(2008-11#5)(2008-2#5)(2008-3#6)(2008-4#2)(2008-5#2)(2008-6#3)(2008-8#4)(2008-9#5)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#4)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#4)(2012-7#1)(2013-1#3)(2013-8#3)
refinement and##11##2##(1992-2#1)(1993-3#1)(1993-8#1)(1996-2#1)(2006-10#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-2#1)(2009-4#1)
refinement are##2##2##(2008-2#1)(2009-3#1)
refinement in##3##2##(1995-10#1)(2006-10#1)(2009-10#1)
refinement is##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
refinement of inhomogeneous films##3##4##(2008-2#1)(2008-3#2)
refinement of risk##2##3##(2011-2#1)(2013-1#1)
refinement of the model##3##4##(1997-7#2)(2007-11#1)
refinement of the##19##3##(1993-2#1)(1994-2#1)(1997-7#2)(2005-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#3)(2009-7#1)(2010-8#1)(2011-2#1)(2013-1#2)
refinement of this##2##3##(2006-12#1)(2013-1#1)
refinement of##44##2##(1991-12#1)(1993-2#1)(1994-2#1)(1995-1#1)(1997-7#3)(2004-8#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#5)(2008-5#3)(2008-7#1)(2009-7#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#5)(2013-7#1)
refinement to the absolute optimum##2##5##(2008-10#2)
refinement to##4##2##(1992-9#1)(2008-10#3)
refinement using##2##2##(1992-2#1)(1995-1#1)
refinement while##2##2##(2010-8#1)(2012-2#1)
refinement##109##1##(1991-12#2)(1992-2#3)(1992-4#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-7#4)(1997-8#1)(2004-8#1)(2005-8#2)(2006-10#4)(2006-12#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#10)(2008-12#1)(2008-2#9)(2008-3#8)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-7#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#3)(2013-1#8)(2013-7#1)
refinements and##3##2##(2008-5#1)(2010-7#1)(2013-1#1)
refinements in the##4##3##(1992-2#2)(2006-10#1)(2012-2#1)
refinements in##9##2##(1992-2#2)(1996-1#1)(2005-5#1)(2006-10#4)(2012-2#1)
refinements of the##2##3##(2008-4#1)(2009-2#1)
refinements of##3##2##(1993-11#1)(2008-4#1)(2009-2#1)
refinements to##4##2##(1992-9#1)(1994-5#1)(2007-11#1)(2012-2#1)
refinements##27##1##(1992-2#3)(1992-9#1)(1993-11#1)(1994-5#1)(1994-6#1)(1994-9#1)(1996-1#1)(1996-6#1)(2005-5#1)(2006-10#5)(2007-11#1)(2008-4#1)(2008-5#1)(2009-2#1)(2010-7#1)(2012-12#1)(2012-2#2)(2013-1#3)
refineries##3##1##(2008-10#1)(2008-8#1)(2009-10#1)
refinery##10##1##(1991-12#2)(2007-10#1)(2007-8#1)(2008-10#3)(2008-5#1)(2011-2#1)(2013-7#1)
refining in##2##2##(2008-1#1)(2008-8#1)
refining our##2##2##(2009-8#1)(2010-3#1)
refining the##8##2##(1993-11#1)(2006-10#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#1)
refining##32##1##(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#2)(1994-2#1)(2004-9#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
refirming##2##1##(2008-5#2)
refixation##2##1##(2013-7#2)
reflaxicon##3##1##(2008-2#3)
reflect a common##2##3##(1996-12#1)(2006-8#1)
reflect a decrease##2##3##(2007-2#1)(2008-10#1)
reflect a different##2##3##(1993-1#1)(1995-2#1)
reflect a general##2##3##(1994-3#1)(1994-9#1)
reflect a lack of##4##4##(2006-10#1)(2007-3#1)(2008-8#1)(2012-1#1)
reflect a##57##2##(1990-7#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-10#2)(1992-12#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#2)(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-8#1)(2006-9#2)(2007-10#2)(2007-2#1)(2007-3#2)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-8#1)
reflect activation of##2##3##(1995-12#1)(2008-4#1)
reflect activation##3##2##(1992-7#1)(1995-12#1)(2008-4#1)
reflect activity##2##2##(1991-9#1)(2012-1#1)
reflect adaptive##2##2##(1995-12#1)(2008-8#1)
reflect an intrinsic##2##3##(1990-8#1)(1997-2#1)
reflect an##10##2##(1990-11#1)(1990-8#1)(1992-1#1)(1996-2#1)(1997-2#1)(2006-12#1)(2007-12#1)(2011-2#1)(2012-2#1)(2013-7#1)
reflect and##2##2##(2008-12#1)(2009-4#1)
reflect both##4##2##(1991-10#1)(2008-3#1)(2010-6#1)(2011-2#1)
reflect changes in the##5##4##(1991-7#1)(1996-12#1)(1996-4#1)(1996-9#1)(2008-7#1)
reflect changes in##13##3##(1991-7#1)(1992-1#1)(1993-12#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-4#2)(1996-9#1)(1997-7#1)(2008-11#1)(2008-7#1)(2013-1#1)
reflect changes##15##2##(1990-7#1)(1991-7#1)(1992-1#1)(1993-12#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-4#2)(1996-9#1)(1997-7#1)(2007-11#1)(2008-11#1)(2008-7#1)(2013-1#1)
reflect clinical##4##2##(1993-12#1)(1993-2#1)(2013-1#2)
reflect common##2##2##(2006-2#1)(2011-2#1)
reflect differences in the##5##4##(1991-4#1)(1992-8#1)(1995-12#1)(2004-11#2)
reflect differences in##11##3##(1990-8#1)(1991-4#1)(1992-8#1)(1993-2#1)(1994-3#1)(1995-12#1)(1996-4#1)(2004-11#2)(2011-2#1)(2013-8#1)
reflect different##9##2##(1994-11#1)(1994-9#1)(2008-11#2)(2008-2#1)(2008-8#3)(2011-1#1)
reflect either##2##2##(1991-7#1)(2008-7#1)
reflect functional##4##2##(1993-2#1)(1994-9#1)(2008-10#1)(2008-6#1)
reflect high##2##2##(1997-3#1)(2011-2#1)
reflect in##3##2##(2008-4#1)(2009-12#1)(2013-8#1)
reflect increased##3##2##(1995-6#1)(1996-10#1)(1996-9#1)
reflect its##2##2##(2006-12#1)(2010-12#1)
reflect more##3##2##(1996-1#1)(2007-11#1)(2010-8#1)
reflect neuronal##2##2##(1996-1#1)(2011-1#1)
reflect on the##10##3##(1994-9#1)(2006-4#1)(2006-9#1)(2008-12#1)(2008-7#1)(2009-4#1)(2011-1#1)(2012-3#3)
reflect on their##3##3##(2008-11#2)(2012-1#1)
reflect on##27##2##(1990-12#1)(1994-9#2)(1995-1#1)(2005-7#1)(2006-4#1)(2006-9#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#5)(2013-1#2)
reflect only the##3##3##(1990-12#1)(1992-9#1)(2008-10#1)
reflect only##4##2##(1990-12#1)(1992-9#1)(2008-10#1)(2011-2#1)
reflect physiological constraints##2##3##(2009-8#1)(2010-8#1)
reflect physiological##3##2##(2008-11#1)(2009-8#1)(2010-8#1)
reflect primarily##2##2##(1995-8#1)(1996-5#1)
reflect realistic##2##2##(1997-3#1)(2007-12#1)
reflect regional##2##2##(1995-2#1)(1997-8#1)
reflect relative##2##2##(2007-11#1)(2008-9#1)
reflect similar changes##2##3##(1995-2#1)(2012-11#1)
reflect similar##4##2##(1995-11#1)(1995-2#1)(2009-12#1)(2012-11#1)
reflect some##5##2##(1990-6#1)(1993-2#1)(1995-12#1)(2004-9#1)(2008-11#1)
reflect structural##2##2##(1991-7#1)(2011-2#1)
reflect that##6##2##(2006-12#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-2#1)(2012-3#1)
reflect the ability of##3##4##(1991-2#1)(2008-10#1)(2012-2#1)
reflect the action of##2##4##(1995-5#1)(2008-10#1)
reflect the balance between##2##4##(2006-10#1)(2006-2#1)
reflect the cellular##2##3##(1997-8#1)(2009-6#1)
reflect the clinical##3##3##(2008-3#1)(2011-2#2)
reflect the combined effects of##2##5##(2008-10#1)(2008-2#1)
reflect the combined##3##3##(2008-10#1)(2008-2#1)(2009-7#1)
reflect the differences in##2##4##(1995-5#1)(2010-8#1)
reflect the effects of##3##4##(1991-3#1)(2008-2#1)(2011-1#1)
reflect the greater##2##3##(1995-2#1)(2013-8#1)
reflect the in vivo##2##4##(1992-8#1)(2009-6#1)
reflect the increased##2##3##(1992-6#1)(2011-2#1)
reflect the level of##3##4##(2008-10#1)(2008-4#1)(2013-8#1)
reflect the loss of##2##4##(1993-2#1)(2008-11#1)
reflect the overall##2##3##(2007-9#1)(2012-2#1)
reflect the presence of##4##4##(1994-9#1)(1997-5#1)(2006-10#1)(2008-7#1)
reflect the presence##5##3##(1994-9#1)(1997-1#1)(1997-5#1)(2006-10#1)(2008-7#1)
reflect the same##3##3##(2006-2#1)(2007-12#1)(2008-7#1)
reflect the severity##2##3##(2008-5#1)(2009-9#1)
reflect the state of##2##4##(2008-11#1)(2009-12#1)
reflect the true##4##3##(1990-10#1)(2006-8#1)(2008-11#1)(2011-2#1)
reflect the##200##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-12#2)(1991-2#1)(1991-3#3)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-2#5)(1993-3#3)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-9#1)(1995-12#3)(1995-2#2)(1995-4#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#4)(2005-8#1)(2005-9#1)(2006-10#5)(2006-12#2)(2006-2#3)(2006-8#2)(2006-9#2)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-3#4)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#5)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-9#3)(2010-1#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#5)
reflect their##10##2##(1992-10#1)(1992-6#1)(1994-3#1)(1994-6#1)(1995-8#1)(2008-10#1)(2009-10#1)(2009-12#1)(2011-1#1)(2013-1#1)
reflect this##4##2##(1996-8#1)(2006-6#1)(2008-10#1)(2010-9#1)
reflect two##2##2##(1991-11#1)(2007-9#1)
reflect upon##2##2##(2011-1#1)(2012-2#1)
reflect variation in##2##3##(1992-12#1)(2010-8#1)
reflect##587##1##(1990-10#1)(1990-11#3)(1990-12#4)(1990-2#3)(1990-3#2)(1990-4#1)(1990-6#1)(1990-7#4)(1990-8#3)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#2)(1991-3#6)(1991-4#1)(1991-7#5)(1991-9#1)(1992-1#4)(1992-10#3)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#3)(1992-4#1)(1992-6#5)(1992-7#2)(1992-8#3)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#4)(1993-2#10)(1993-3#3)(1993-4#1)(1993-6#2)(1993-7#2)(1993-8#2)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#8)(1994-5#1)(1994-6#1)(1994-9#7)(1995-1#1)(1995-11#4)(1995-12#10)(1995-2#10)(1995-4#2)(1995-5#6)(1995-6#1)(1995-7#1)(1995-8#4)(1995-9#1)(1996-1#4)(1996-10#2)(1996-11#3)(1996-12#3)(1996-2#2)(1996-3#3)(1996-4#4)(1996-5#4)(1996-6#5)(1996-7#4)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#7)(2004-11#3)(2004-4#1)(2004-9#1)(2005-10#1)(2005-7#2)(2005-8#3)(2005-9#1)(2006-10#8)(2006-12#7)(2006-2#5)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#2)(2006-8#4)(2006-9#5)(2007-1#2)(2007-10#6)(2007-11#8)(2007-12#7)(2007-2#3)(2007-3#7)(2007-5#1)(2007-7#3)(2007-8#5)(2007-9#3)(2008-1#3)(2008-10#24)(2008-11#21)(2008-12#7)(2008-2#8)(2008-3#11)(2008-4#6)(2008-5#8)(2008-6#8)(2008-7#13)(2008-8#16)(2008-9#8)(2009-10#4)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#3)(2009-9#5)(2010-1#1)(2010-12#3)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#7)(2010-9#2)(2011-1#9)(2011-2#21)(2012-1#5)(2012-11#2)(2012-12#2)(2012-2#7)(2012-3#13)(2013-1#10)(2013-7#2)(2013-8#10)
reflectance (or##2##2##(2008-2#1)(2008-3#1)
reflectance Fourier transform infrared##4##4##(2005-11#1)(2008-10#3)
reflectance NIR##2##2##(2008-10#2)
reflectance and fluorescence##2##3##(2013-1#2)
reflectance and the##6##3##(2008-2#3)(2008-3#2)(2013-8#1)
reflectance and transmittance measurements##4##4##(2008-2#4)
reflectance and transmittance of a slab with a randomly rough boundary##2##11##(2008-3#2)
reflectance and transmittance##8##3##(2008-2#5)(2008-3#3)
reflectance and##36##2##(2007-8#2)(2008-10#2)(2008-2#16)(2008-3#12)(2009-11#1)(2013-1#2)(2013-8#1)
reflectance are##2##2##(2008-2#1)(2008-3#1)
reflectance as a function of##2##5##(2006-12#1)(2008-2#1)
reflectance as##5##2##(2006-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
reflectance at a##2##3##(2008-2#1)(2008-3#1)
reflectance at the sea surface##2##5##(2008-2#2)
reflectance at the##6##3##(2007-12#1)(2008-2#3)(2008-3#2)
reflectance at three##2##3##(2008-2#1)(2008-3#1)
reflectance at##24##2##(1991-2#1)(2007-12#3)(2008-10#2)(2008-2#9)(2008-3#9)
reflectance by##4##2##(2008-2#1)(2008-3#3)
reflectance can be##2##3##(2008-3#2)
reflectance changes##2##2##(1995-12#2)
reflectance components##2##2##(2008-3#2)
reflectance curves##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
reflectance data close to##2##4##(2008-3#2)
reflectance data from##2##3##(2008-3#2)
reflectance data##16##2##(2008-2#7)(2008-3#9)
reflectance distribution##13##2##(2008-2#3)(2008-3#10)
reflectance factor##2##2##(2008-2#1)(2008-3#1)
reflectance for##5##2##(2008-2#2)(2008-3#3)
reflectance from the##2##3##(2008-2#1)(2008-5#1)
reflectance from##7##2##(2008-2#3)(2008-3#3)(2008-5#1)
reflectance imaging of##2##3##(2008-3#1)(2009-8#1)
reflectance imaging##3##2##(2008-2#1)(2008-3#1)(2009-8#1)
reflectance in the##12##3##(2007-10#1)(2008-10#1)(2008-2#5)(2008-3#4)(2010-5#1)
reflectance in##13##2##(2007-10#1)(2008-10#1)(2008-2#6)(2008-3#4)(2010-5#1)
reflectance infrared Fourier transform spectroscopy##4##5##(2005-11#1)(2006-12#1)(2008-10#2)
reflectance infrared Fourier transform##7##4##(2005-11#1)(2006-12#1)(2008-1#1)(2008-10#3)(2010-4#1)
reflectance infrared Fourier##8##3##(2005-11#1)(2006-12#1)(2008-1#1)(2008-10#4)(2010-4#1)
reflectance infrared spectroscopy##3##3##(2008-10#1)(2010-4#2)
reflectance infrared##17##2##(2005-11#2)(2006-12#2)(2008-1#2)(2008-10#8)(2010-4#3)
reflectance into##2##2##(2008-10#1)(2008-3#1)
reflectance is obtained##2##3##(2008-2#2)
reflectance is##16##2##(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#7)
reflectance measurement##3##2##(2008-2#1)(2008-3#2)
reflectance measurements of##2##3##(1992-4#1)(2008-2#1)
reflectance measurements##15##2##(1992-4#1)(2007-12#2)(2008-10#5)(2008-2#2)(2008-3#5)
reflectance method##3##2##(2008-10#2)(2008-3#1)
reflectance methods##2##2##(2008-10#1)(2008-3#1)
reflectance mode##3##2##(2007-8#1)(2010-4#1)(2012-2#1)
reflectance model##3##2##(2008-2#1)(2008-3#2)
reflectance models##2##2##(2008-2#1)(2008-3#1)
reflectance near##4##2##(2008-3#3)(2011-1#1)
reflectance of 0##2##3##(2007-12#1)(2008-2#1)
reflectance of a##7##3##(2008-2#3)(2008-3#3)(2010-5#1)
reflectance of sunlight from##2##4##(2008-10#2)
reflectance of the multilayer coating##4##5##(2008-2#3)(2008-3#1)
reflectance of the##16##3##(2007-11#2)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#6)(2013-8#1)
reflectance of##43##2##(2007-11#6)(2007-12#2)(2008-1#1)(2008-10#3)(2008-2#14)(2008-3#14)(2010-5#2)(2013-8#1)
reflectance on##5##2##(2008-2#2)(2008-3#3)
reflectance or##3##2##(2007-8#1)(2008-2#1)(2008-3#1)
reflectance profiles##2##2##(2008-2#1)(2008-3#1)
reflectance properties##2##2##(2008-2#1)(2008-3#1)
reflectance ratio##3##2##(2008-2#1)(2008-3#2)
reflectance sensor##4##2##(2007-8#2)(2008-10#2)
reflectance spectra and##4##3##(2008-10#4)
reflectance spectra of##2##3##(2008-2#1)(2008-3#1)
reflectance spectra##13##2##(2008-10#5)(2008-2#2)(2008-3#5)(2008-6#1)
reflectance spectrometry and##2##3##(2008-10#1)(2008-8#1)
reflectance spectrometry##5##2##(2008-10#3)(2008-8#1)(2009-12#1)
reflectance spectrophotometry##2##2##(2008-10#1)(2008-5#1)
reflectance spectroscopic##4##2##(2008-10#4)
reflectance spectroscopy (DRS)##2##3##(2008-10#2)
reflectance spectroscopy (NIRS)##3##3##(2008-10#3)
reflectance spectroscopy of the##2##4##(1991-9#1)(2008-5#1)
reflectance spectroscopy of##3##3##(1991-9#1)(2008-3#1)(2008-5#1)
reflectance spectroscopy##24##2##(1991-9#2)(1992-8#1)(2007-12#1)(2008-10#11)(2008-3#5)(2008-5#1)(2010-4#2)(2013-8#1)
reflectance spectrum is##2##3##(2008-2#1)(2008-3#1)
reflectance spectrum##8##2##(2007-11#2)(2008-10#1)(2008-2#3)(2008-3#2)
reflectance ultraviolet-visible##3##2##(2005-4#2)(2007-11#1)
reflectance units##2##2##(2008-2#1)(2008-3#1)
reflectance values##5##2##(2008-10#2)(2008-2#1)(2008-3#2)
reflectance versus##3##2##(2008-10#2)(2008-2#1)
reflectance was##6##2##(2008-10#1)(2008-2#3)(2008-3#2)
reflectance were##4##2##(2008-10#3)(2008-2#1)
reflectance with##2##2##(2007-12#1)(2008-2#1)
reflectance##494##1##(1991-2#1)(1991-9#2)(1992-4#1)(1992-8#1)(1993-3#1)(1995-1#2)(1995-12#2)(2005-11#4)(2005-4#3)(2006-12#6)(2007-10#3)(2007-11#11)(2007-12#25)(2007-7#1)(2007-8#6)(2008-1#4)(2008-10#88)(2008-12#2)(2008-2#126)(2008-3#174)(2008-4#1)(2008-5#5)(2008-6#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-4#8)(2010-5#4)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#4)
reflectances of the##5##3##(2007-5#1)(2008-12#1)(2008-2#2)(2008-3#1)
reflectances of##8##2##(2007-11#1)(2007-5#1)(2008-12#1)(2008-2#2)(2008-3#3)
reflectances were##2##2##(2007-11#1)(2008-3#1)
reflectances##22##1##(2007-11#2)(2007-5#1)(2008-12#1)(2008-2#6)(2008-3#12)
reflected a##8##2##(1991-8#2)(1992-10#1)(2005-11#1)(2008-10#1)(2009-2#1)(2010-1#1)(2012-12#1)
reflected an##2##2##(2004-12#1)(2013-1#1)
reflected and transmitted light##2##4##(2008-3#2)
reflected and##6##2##(2007-11#1)(2008-2#2)(2008-3#2)(2008-5#1)
reflected as##3##2##(1991-9#1)(2007-5#1)(2008-4#1)
reflected at##6##2##(1990-2#1)(1990-5#1)(1994-9#1)(1995-6#1)(2008-3#2)
reflected atmospheric radiance##2##3##(2008-3#2)
reflected back##3##2##(2006-8#1)(2007-12#1)(2008-10#1)
reflected beam is##3##3##(2008-2#2)(2008-3#1)
reflected beam##10##2##(2007-12#1)(2008-2#6)(2008-3#3)
reflected beams##6##2##(2007-12#1)(2008-1#1)(2008-3#4)
reflected both in##2##3##(1992-9#1)(2012-3#1)
reflected both##4##2##(1992-9#1)(1995-5#1)(2008-10#1)(2012-3#1)
reflected by a mirror##3##4##(2008-10#2)(2008-2#1)
reflected by a##15##3##(1991-2#1)(1993-7#1)(1994-2#1)(1996-11#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-2#3)(2008-3#1)
reflected by an##2##3##(1992-3#1)(1993-11#1)
reflected by different##2##3##(1994-11#1)(1996-10#1)
reflected by the formation of##2##5##(1996-6#1)(1997-8#1)
reflected by the ratio of##2##5##(1994-12#1)(2010-8#1)
reflected by the##29##3##(1990-8#1)(1991-7#1)(1992-5#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-3#1)(1996-6#1)(1997-8#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#4)(2008-5#1)(2009-10#1)(2010-8#2)(2013-8#1)
reflected by##72##2##(1990-5#1)(1990-8#1)(1991-2#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-7#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-6#2)(1995-10#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#5)(2008-5#1)(2008-7#2)(2009-10#1)(2009-3#1)(2009-4#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-2#2)(2013-1#2)(2013-8#1)
reflected different##2##2##(1991-8#1)(2006-1#1)
reflected from a##8##3##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#2)
reflected from the##6##3##(2007-12#2)(2008-3#3)(2009-1#1)
reflected from##17##2##(2007-11#2)(2007-12#5)(2008-2#3)(2008-3#5)(2009-1#1)(2010-5#1)
reflected in a##10##3##(1990-4#1)(1993-2#1)(1993-6#1)(1995-2#1)(1996-2#1)(2006-7#1)(2008-10#1)(2008-5#1)(2009-11#1)(2011-2#1)
reflected in an##5##3##(1996-12#1)(1997-5#1)(2008-10#2)(2012-12#1)
reflected in changes in the##2##5##(1995-1#1)(1995-8#1)
reflected in changes in##3##4##(1993-2#1)(1995-1#1)(1995-8#1)
reflected in its##3##3##(2010-9#1)(2011-1#1)(2011-2#1)
reflected in significant##2##3##(2008-5#1)(2013-1#1)
reflected in the circular##2##4##(1991-2#1)(1995-6#1)
reflected in the observed##2##4##(1994-2#1)(2009-7#1)
reflected in the##50##3##(1990-5#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-2#1)(1993-6#1)(1994-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-2#2)(1996-7#1)(1996-9#1)(2005-11#3)(2006-5#2)(2007-1#1)(2007-11#1)(2007-3#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-7#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-8#1)
reflected in their##5##3##(2005-9#1)(2006-7#1)(2007-12#1)(2008-1#1)(2012-11#1)
reflected in##119##2##(1990-4#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#2)(1993-2#3)(1993-6#2)(1994-2#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#3)(1996-7#1)(1996-9#1)(1997-2#1)(1997-5#2)(2004-3#1)(2004-9#2)(2005-11#4)(2005-9#1)(2006-10#1)(2006-5#3)(2006-7#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-1#2)(2008-10#7)(2008-11#6)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#7)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
reflected intensity##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
reflected light from##3##3##(2008-2#1)(2008-3#2)
reflected light is##2##3##(2007-11#1)(2008-2#1)
reflected light##16##2##(1991-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#6)(2008-3#6)
reflected off##3##2##(2008-2#1)(2008-3#2)
reflected on the##4##3##(1992-11#1)(2008-3#2)(2011-2#1)
reflected on##6##2##(1992-11#1)(2007-12#1)(2008-3#2)(2011-2#1)(2012-3#1)
reflected or##3##2##(2008-3#1)(2009-5#2)
reflected photon##2##2##(2008-3#2)
reflected pulses##2##2##(2007-12#1)(2008-1#1)
reflected radiance##2##2##(2008-3#2)
reflected rays are##2##3##(2008-2#2)
reflected rays##5##2##(2007-12#1)(2008-2#4)
reflected solar##3##2##(2008-3#3)
reflected the##39##2##(1990-8#1)(1992-3#1)(1993-12#2)(1994-10#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-2#1)(2005-7#1)(2007-12#1)(2007-3#1)(2007-8#2)(2008-10#5)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-4#1)(2009-5#2)(2009-9#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
reflected their##3##2##(1990-10#1)(1995-11#1)(2008-11#1)
reflected this##2##2##(2008-10#1)(2013-7#1)
reflected through##2##2##(2008-1#1)(2008-12#1)
reflected upon##2##2##(2008-11#1)(2008-2#1)
reflected waves##6##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)
reflected##445##1##(1990-10#1)(1990-11#2)(1990-2#1)(1990-4#1)(1990-5#3)(1990-8#2)(1991-1#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-7#1)(1991-8#4)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#4)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#4)(1993-6#2)(1993-7#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#4)(1994-6#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#5)(1995-8#4)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#4)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-5#2)(1997-7#1)(1997-8#1)(2004-12#1)(2004-3#2)(2004-9#2)(2005-11#6)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#4)(2006-3#1)(2006-5#3)(2006-7#2)(2006-8#1)(2007-1#3)(2007-10#2)(2007-11#10)(2007-12#25)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#1)(2007-8#4)(2007-9#2)(2008-1#5)(2008-10#27)(2008-11#16)(2008-12#3)(2008-2#38)(2008-3#62)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#8)(2008-8#5)(2008-9#2)(2009-1#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#5)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#4)(2010-7#1)(2010-8#7)(2010-9#2)(2011-1#6)(2011-12#2)(2011-2#13)(2012-1#2)(2012-11#2)(2012-12#5)(2012-2#2)(2012-3#5)(2012-5#1)(2013-1#6)(2013-7#2)(2013-8#3)
reflected-light##4##1##(2007-12#2)(2008-2#1)(2008-3#1)
reflecting DNA##2##2##(1994-11#1)(2008-10#1)
reflecting a low##2##3##(1996-4#1)(2013-1#1)
reflecting a##15##2##(1991-4#1)(1996-4#1)(1996-5#2)(2006-2#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-7#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
reflecting an##7##2##(1994-3#1)(1994-9#1)(1996-2#1)(2008-10#1)(2008-11#1)(2010-7#1)(2013-8#1)
reflecting changes in##2##3##(1997-4#1)(1997-8#1)
reflecting different##2##2##(2007-2#1)(2011-2#1)
reflecting in##3##2##(1992-8#1)(2006-6#1)(2013-1#1)
reflecting mirror##3##2##(2008-1#1)(2008-3#2)
reflecting mirrors##2##2##(2007-12#1)(2008-2#1)
reflecting on the##5##3##(2006-10#1)(2008-10#2)(2008-12#2)
reflecting on##9##2##(1992-3#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-9#1)(2012-3#1)
reflecting specific##2##2##(1992-9#1)(2008-11#1)
reflecting surface##4##2##(2007-12#1)(2008-2#3)
reflecting surfaces##9##2##(2007-12#1)(2008-2#3)(2008-3#5)
reflecting the different##2##3##(1994-4#1)(2007-11#1)
reflecting the increasing##2##3##(1997-4#1)(2005-8#1)
reflecting the influence of##2##4##(1997-3#1)(2011-12#1)
reflecting the presence of##3##4##(1993-9#1)(2008-10#1)(2013-8#1)
reflecting the reproducibility and reliability of the developed method##3##9##(2008-10#3)
reflecting the##73##2##(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-11#1)(1993-9#1)(1994-2#2)(1994-4#1)(1995-12#1)(1996-1#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(2005-12#2)(2005-8#3)(2006-6#3)(2006-8#2)(2007-11#2)(2008-10#10)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-7#1)(2013-8#1)
reflecting their##5##2##(1993-1#1)(2007-10#1)(2008-11#1)(2011-1#1)(2013-7#1)
reflecting these##2##2##(2008-10#1)(2011-2#1)
reflecting##252##1##(1990-12#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-9#3)(1994-11#1)(1994-2#3)(1994-3#1)(1994-4#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-8#2)(2004-4#1)(2005-10#1)(2005-12#3)(2005-8#3)(2006-10#1)(2006-2#1)(2006-6#4)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#11)(2007-12#13)(2007-2#1)(2007-4#1)(2008-1#2)(2008-10#19)(2008-11#8)(2008-12#5)(2008-2#13)(2008-3#22)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#4)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-3#2)(2010-5#1)(2010-7#3)(2010-8#2)(2011-1#4)(2011-12#2)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#3)(2012-5#1)(2013-1#5)(2013-7#4)(2013-8#5)
reflection (ATR) spectroscopy##2##3##(1990-2#1)(2007-8#1)
reflection (ATR)##5##2##(1990-2#1)(1993-9#1)(2007-8#1)(2008-10#2)
reflection FTIR##2##2##(2008-10#2)
reflection X-ray fluorescence##2##3##(2008-10#2)
reflection about the##2##3##(2008-7#1)(2013-1#1)
reflection about##4##2##(1992-11#1)(2008-7#1)(2009-8#1)(2013-1#1)
reflection and discussion##2##3##(2011-2#1)(2013-1#1)
reflection and polarization properties##2##4##(2007-12#1)(2008-3#1)
reflection and the##6##3##(2007-11#1)(2008-2#3)(2008-3#2)
reflection and transmission coefficients##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
reflection and transmission##10##3##(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#3)
reflection and##44##2##(1990-8#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-11#7)(2008-12#1)(2008-2#12)(2008-3#12)(2008-9#1)(2011-2#2)(2013-1#1)
reflection appeared at 0##2##4##(2008-8#2)
reflection as a##4##3##(2008-11#1)(2008-12#3)
reflection as an##2##3##(2008-11#1)(2008-12#1)
reflection as##6##2##(2008-11#2)(2008-12#4)
reflection at a nonlinear-linear##3##4##(2007-12#3)
reflection at the interface between the##2##6##(2008-2#1)(2008-3#1)
reflection at the##7##3##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#2)
reflection at##14##2##(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#3)(2008-3#4)(2012-3#1)
reflection based##2##2##(2007-12#1)(2008-11#1)
reflection by##5##2##(2007-12#2)(2008-12#1)(2008-2#2)
reflection can be##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
reflection can##6##2##(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#1)
reflection characteristics##3##2##(2008-3#3)
reflection coefficient of a stratified sea##2##6##(2008-2#2)
reflection coefficient of##3##3##(2008-2#3)
reflection coefficient##12##2##(2007-12#1)(2008-2#9)(2008-3#2)
reflection coefficients and##2##3##(2007-11#1)(2008-3#1)
reflection coefficients of##2##3##(2008-2#2)
reflection coefficients##7##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)
reflection configuration##4##2##(2006-12#1)(2006-5#1)(2007-12#1)(2008-10#1)
reflection confocal optical##2##3##(2008-3#2)
reflection confocal##5##2##(2007-12#2)(2008-3#3)
reflection data##2##2##(1997-5#1)(2008-8#1)
reflection distribution##3##2##(2008-2#2)(2008-3#1)
reflection filter##3##2##(2007-12#2)(2008-3#1)
reflection for##7##2##(2006-7#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)
reflection from a##8##3##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#2)
reflection from the##6##3##(2007-12#1)(2008-2#1)(2008-3#4)
reflection from##23##2##(1991-2#1)(2007-11#2)(2007-12#4)(2008-2#8)(2008-3#8)
reflection geometry##4##2##(2008-1#1)(2008-2#1)(2008-3#2)
reflection grating##6##2##(2007-12#1)(2008-2#3)(2008-3#2)
reflection gratings##8##2##(2006-4#1)(2007-12#2)(2008-2#1)(2008-3#4)
reflection has##4##2##(2005-11#1)(2008-11#1)(2009-8#1)(2012-12#1)
reflection hologram is##2##3##(2008-1#1)(2008-3#1)
reflection hologram recorded##2##3##(2008-3#2)
reflection hologram##4##2##(2008-1#1)(2008-3#3)
reflection holograms##2##2##(2008-2#1)(2008-3#1)
reflection imaging##2##2##(2007-12#1)(2008-2#1)
reflection in a##2##3##(2007-12#1)(2008-12#1)
reflection in the##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
reflection in##18##2##(1995-2#1)(2007-11#2)(2007-12#2)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#3)(2009-5#1)
reflection intensities##2##2##(1996-9#1)(2006-5#1)
reflection interference##2##2##(2007-12#1)(2008-2#1)
reflection is##10##2##(2007-11#1)(2007-12#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2013-1#1)
reflection light##2##2##(2008-2#1)(2013-8#1)
reflection losses##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
reflection matrix##2##2##(2008-2#1)(2008-3#1)
reflection may be instrumental in##2##5##(2008-11#2)
reflection measurements##2##2##(2006-7#1)(2008-2#1)
reflection method##2##2##(2007-12#1)(2008-2#1)
reflection microscope##2##2##(2007-12#1)(2008-3#1)
reflection mode##5##2##(2004-9#1)(2007-12#1)(2008-2#3)
reflection model##4##2##(2008-2#1)(2008-3#3)
reflection occurs##2##2##(2007-11#1)(2007-12#1)
reflection of a##10##3##(1996-9#1)(2007-11#1)(2007-12#3)(2008-3#3)(2008-5#1)(2008-9#1)
reflection of light##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
reflection of the##18##3##(1990-3#1)(1991-5#1)(1992-4#1)(1993-2#1)(1993-9#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#5)(2008-3#1)(2010-2#1)(2012-12#1)
reflection of##64##2##(1990-3#1)(1991-5#1)(1992-4#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-8#1)(1996-11#1)(1996-5#1)(1996-9#1)(2004-4#1)(2005-11#1)(2005-9#1)(2006-12#2)(2006-6#1)(2007-10#3)(2007-11#4)(2007-12#7)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#14)(2008-3#10)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)(2012-12#1)(2012-3#1)
reflection on a##2##3##(2008-11#1)(2008-3#1)
reflection on practice##2##3##(2008-11#2)
reflection on the##11##3##(1993-9#1)(2008-11#1)(2008-2#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#4)
reflection on##28##2##(1993-9#1)(1996-12#1)(2007-8#1)(2008-11#5)(2008-2#2)(2008-3#3)(2008-9#1)(2009-10#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#7)(2013-8#1)
reflection or##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
reflection properties of##2##3##(2008-2#1)(2008-3#1)
reflection properties##4##2##(2008-2#2)(2008-3#2)
reflection spectra##5##2##(2007-11#1)(2008-10#1)(2008-3#3)
reflection spectral##2##2##(2007-12#1)(2008-3#1)
reflection spectroscopy with##2##3##(2007-8#1)(2008-10#1)
reflection spectroscopy##8##2##(2006-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)
reflection spectrum##6##2##(2007-12#3)(2008-2#1)(2008-3#2)
reflection the##2##2##(2008-3#2)
reflection to##2##2##(2008-11#1)(2008-3#1)
reflection upon##3##2##(2008-11#2)(2009-4#1)
reflection was##7##2##(2007-12#2)(2008-11#1)(2008-2#2)(2012-12#1)(2013-1#1)
reflection wavelength##3##2##(2007-12#2)(2008-3#1)
reflection with##3##2##(2008-2#1)(2008-3#2)
reflection##599##1##(1990-2#1)(1990-3#1)(1990-8#1)(1991-2#1)(1991-5#3)(1992-11#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-9#3)(1994-2#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-9#2)(1997-4#1)(1997-5#1)(1997-8#1)(2004-4#1)(2004-9#1)(2005-11#3)(2005-5#1)(2005-9#1)(2006-10#1)(2006-12#5)(2006-3#2)(2006-4#1)(2006-5#7)(2006-6#1)(2006-7#2)(2007-1#2)(2007-10#4)(2007-11#36)(2007-12#81)(2007-2#1)(2007-8#7)(2008-1#11)(2008-10#23)(2008-11#44)(2008-12#15)(2008-2#124)(2008-3#132)(2008-5#5)(2008-7#3)(2008-8#4)(2008-9#3)(2009-1#1)(2009-10#1)(2009-2#1)(2009-4#3)(2009-5#1)(2009-8#3)(2009-9#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#7)(2012-12#6)(2012-2#2)(2012-3#3)(2013-1#14)(2013-8#2)
reflection)##2##1##(2008-2#2)
reflection-absorption##4##1##(2008-10#1)(2008-2#2)(2013-8#1)
reflection-in-learning##3##1##(2013-1#3)
reflection-mode##2##1##(2007-12#1)(2008-2#1)
reflection-on-action##2##1##(2007-10#1)(2008-11#1)
reflection-transmission surface light-scattering##2##3##(2008-2#2)
reflection-type all-optical switch for ultrashort pulses based on a single asymmetrically confined photonic crystal##2##14##(2007-11#2)
reflection-type confocal microscope with a phase-conjugate mirror##2##7##(2008-2#2)
reflection-type confocal microscope##3##3##(2007-12#1)(2008-2#2)
reflection-type##10##1##(2007-11#3)(2007-12#2)(2008-2#5)
reflections (I &gt##4##3##(1997-7#2)(2008-5#2)
reflections and##8##2##(1996-9#1)(2007-12#1)(2008-3#3)(2011-2#1)(2012-2#1)(2013-1#1)
reflections are##4##2##(2006-2#1)(2007-10#1)(2008-2#2)
reflections at the##3##3##(2008-2#1)(2008-3#2)
reflections at##4##2##(2006-4#1)(2008-2#1)(2008-3#2)
reflections between the##2##3##(2007-12#1)(2008-2#1)
reflections between##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
reflections concerning the##2##3##(1991-12#1)(1995-4#1)
reflections from the##3##3##(2007-12#1)(2008-12#1)(2008-2#1)
reflections from##8##2##(2007-12#1)(2008-1#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-7#1)
reflections in the##5##3##(1992-12#1)(1994-9#1)(2007-11#1)(2008-2#2)
reflections in##7##2##(1992-12#1)(1994-6#1)(1994-9#1)(2007-11#1)(2008-2#3)
reflections of a##3##3##(1994-2#1)(1996-8#1)(2005-11#1)
reflections of##11##2##(1994-2#1)(1996-5#1)(1996-8#1)(2005-11#1)(2007-12#1)(2008-11#2)(2008-3#3)(2012-2#1)
reflections off##2##2##(2007-12#1)(2008-2#1)
reflections on cell##2##3##(2008-11#1)(2008-2#1)
reflections on the##19##3##(1993-6#1)(1994-2#1)(1995-2#1)(1995-6#1)(2005-8#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-2#1)(2009-8#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)
reflections on two##2##3##(2008-11#1)(2008-2#1)
reflections on##37##2##(1991-3#1)(1993-6#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-3#1)(2004-8#1)(2005-7#1)(2005-8#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-11#4)(2008-12#1)(2008-2#3)(2008-4#1)(2009-4#1)(2009-8#1)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
reflections that##2##2##(2007-11#1)(2008-3#1)
reflections to##2##2##(1994-9#1)(2008-3#1)
reflections upon##3##2##(2007-12#1)(2008-11#1)(2008-5#1)
reflections were##2##2##(1996-9#2)
reflections with I &gt##5##4##(1996-2#3)(1997-7#2)
reflections with##6##2##(1996-2#3)(1997-4#1)(1997-7#2)
reflections within the##4##3##(2006-4#1)(2007-12#1)(2008-2#1)(2008-3#1)
reflections##154##1##(1991-12#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-7#1)(1993-6#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-9#2)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-2#3)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#4)(1997-4#1)(1997-5#1)(1997-7#5)(2004-8#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-2#1)(2006-4#4)(2006-5#2)(2006-6#1)(2007-10#2)(2007-11#3)(2007-12#12)(2008-1#5)(2008-10#1)(2008-11#8)(2008-12#5)(2008-2#22)(2008-3#19)(2008-4#1)(2008-5#3)(2008-7#2)(2009-1#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
reflective and transmissive##2##3##(2008-3#2)
reflective and##5##2##(2007-11#1)(2007-12#1)(2008-3#2)(2013-1#1)
reflective at the##2##3##(2008-2#2)
reflective at##3##2##(2007-12#1)(2008-2#2)
reflective bistable twisted nematic##2##4##(2007-12#2)
reflective coatings##2##2##(2008-2#1)(2008-3#1)
reflective commentary##2##2##(2007-9#1)(2008-11#1)
reflective dielectric##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
reflective e-portfolio##3##2##(2009-9#3)
reflective grating interferometer##2##3##(2007-11#1)(2008-3#1)
reflective grating##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
reflective journal##3##2##(2007-10#1)(2012-12#2)
reflective learning##2##2##(2008-11#1)(2008-12#1)
reflective liquid-crystal##4##2##(2007-11#2)(2008-3#2)
reflective of a##2##3##(1995-3#1)(2011-2#1)
reflective of the##8##3##(1992-3#1)(1995-3#1)(2005-8#1)(2005-9#1)(2008-4#1)(2009-4#1)(2010-11#2)
reflective of##18##2##(1991-7#1)(1992-3#1)(1995-3#2)(2005-8#1)(2005-9#1)(2006-9#1)(2008-10#1)(2008-12#1)(2008-4#3)(2009-4#1)(2010-11#2)(2011-2#2)(2013-8#1)
reflective optics##2##2##(2008-3#2)
reflective phases##3##2##(2008-11#3)
reflective practice in##3##3##(1997-4#1)(2008-11#2)
reflective practice##14##2##(1997-4#3)(2008-11#8)(2008-12#1)(2012-12#1)(2013-1#1)
reflective practitioners##3##2##(2008-11#1)(2008-12#1)(2008-9#1)
reflective sessions##2##2##(2008-12#2)
reflective speckle##4##2##(2008-3#4)
reflective surface##6##2##(2007-12#3)(2008-2#2)(2008-3#1)
reflective surfaces##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
reflective thinking and practice during##2##5##(2012-12#2)
reflective thinking and practice##4##4##(2012-12#4)
reflective thinking and##6##3##(2006-5#1)(2007-12#1)(2012-12#4)
reflective##171##1##(1990-5#1)(1991-7#1)(1992-3#1)(1994-6#1)(1995-3#2)(1997-4#3)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-5#2)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#17)(2007-9#3)(2008-10#5)(2008-11#24)(2008-12#9)(2008-2#21)(2008-3#39)(2008-4#3)(2008-9#1)(2009-11#1)(2009-4#1)(2009-9#4)(2010-11#2)(2010-3#1)(2010-4#2)(2011-2#3)(2012-12#8)(2013-1#2)(2013-8#1)
reflectively##2##1##(2012-12#1)(2012-3#1)
reflectivities above##3##2##(2007-11#2)(2007-12#1)
reflectivities for##2##2##(2008-3#2)
reflectivities of##7##2##(2007-12#1)(2008-1#1)(2008-2#4)(2008-3#1)
reflectivities##15##1##(2007-11#2)(2007-12#2)(2008-1#1)(2008-2#5)(2008-3#5)
reflectivity and the##5##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
reflectivity and topography images##2##4##(2007-12#2)
reflectivity and topography##3##3##(2007-12#3)
reflectivity and##18##2##(2005-11#1)(2007-11#2)(2007-12#7)(2008-2#3)(2008-3#5)
reflectivity as a function of##2##5##(2007-12#2)
reflectivity at the##2##3##(2008-2#1)(2008-3#1)
reflectivity at##5##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
reflectivity by##2##2##(2008-3#1)(2011-1#1)
reflectivity can##2##2##(2007-11#1)(2008-3#1)
reflectivity change##2##2##(2007-11#2)
reflectivity changes of##2##3##(2008-3#2)
reflectivity changes##3##2##(2007-11#1)(2008-3#2)
reflectivity curves##3##2##(2008-2#3)
reflectivity distribution##2##2##(2008-3#2)
reflectivity for the##2##3##(2007-12#1)(2008-3#1)
reflectivity in the##2##3##(2008-2#2)
reflectivity in##5##2##(2007-11#1)(2007-12#1)(2008-2#3)
reflectivity is##9##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#4)
reflectivity measurements##7##2##(1995-5#1)(2008-2#3)(2008-3#3)
reflectivity mirror##2##2##(2008-2#1)(2008-3#1)
reflectivity mirrors##2##2##(2008-3#2)
reflectivity of a##8##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#4)
reflectivity of approximately##2##3##(2008-2#1)(2008-3#1)
reflectivity of as much as##2##5##(2007-12#2)
reflectivity of the##16##3##(2007-11#1)(2007-12#4)(2008-2#6)(2008-3#5)
reflectivity of this##2##3##(2008-2#2)
reflectivity of##50##2##(2007-11#5)(2007-12#13)(2008-2#15)(2008-3#17)
reflectivity profile in the##2##4##(2008-2#2)
reflectivity profile##3##2##(2008-1#1)(2008-2#2)
reflectivity was measured##3##3##(2007-11#1)(2008-2#2)
reflectivity was##5##2##(2007-11#2)(2007-12#1)(2008-2#2)
reflectivity with##5##2##(2007-11#1)(2008-3#4)
reflectivity##194##1##(1995-5#1)(2005-11#4)(2006-5#1)(2007-11#24)(2007-12#41)(2007-9#1)(2008-1#2)(2008-2#53)(2008-3#66)(2011-1#1)
reflectometer for##3##2##(2007-12#2)(2008-3#1)
reflectometer with##2##2##(2008-2#2)
reflectometer##16##1##(1996-4#1)(2007-11#2)(2007-12#5)(2008-10#1)(2008-2#4)(2008-3#3)
reflectometers for surface anisotropy##2##4##(2008-3#2)
reflectometers##7##1##(1993-9#1)(2008-2#4)(2008-3#2)
reflectometric and ellipsometric##4##3##(2008-3#4)
reflectometric interference spectroscopy (RIfS)##2##4##(1997-2#1)(2008-10#1)
reflectometric interference spectroscopy##3##3##(1997-2#1)(2008-10#2)
reflectometric##9##1##(1997-2#1)(2008-10#3)(2008-3#5)
reflectometry and ellipsometry##2##3##(2007-12#1)(2008-3#1)
reflectometry and##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
reflectometry for##2##2##(2008-2#1)(2008-3#1)
reflectometry in##2##2##(2008-2#1)(2008-3#1)
reflectometry is##3##2##(2007-12#1)(2008-2#2)
reflectometry of##2##2##(2008-2#1)(2008-3#1)
reflectometry##34##1##(2005-11#1)(2006-5#1)(2007-11#2)(2007-12#7)(2007-9#1)(2008-1#2)(2008-10#1)(2008-2#8)(2008-3#8)(2008-7#2)(2011-1#1)
reflector as##3##2##(2007-11#1)(2008-3#2)
reflector for##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
reflector in##2##2##(2008-2#1)(2008-3#1)
reflector is##4##2##(2007-12#2)(2008-3#2)
reflector losses##2##2##(2008-3#2)
reflector with##2##2##(2007-12#1)(2008-2#1)
reflector##65##1##(2007-11#8)(2007-12#14)(2008-2#16)(2008-3#27)
reflectors and##3##2##(2007-11#1)(2008-2#1)(2008-7#1)
reflectors in##2##2##(2008-3#2)
reflectors of##2##2##(2007-11#1)(2008-3#1)
reflectors##28##1##(2007-11#6)(2007-12#4)(2008-1#1)(2008-2#8)(2008-3#8)(2008-7#1)
reflects a deficit in##2##4##(2008-4#1)(2009-2#1)
reflects a deficit##3##3##(2008-4#2)(2009-2#1)
reflects a general##2##3##(1992-6#1)(2012-1#1)
reflects a growing##2##3##(2007-9#1)(2008-2#1)
reflects a lack of##2##4##(2008-4#1)(2009-9#1)
reflects a##30##2##(1990-8#1)(1991-9#1)(1992-6#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-8#1)(1997-2#1)(2006-7#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-9#1)(2010-10#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
reflects alterations##2##2##(2008-5#1)(2009-6#1)
reflects an##11##2##(1990-2#1)(1991-12#1)(1994-5#1)(1995-1#1)(1997-2#1)(1997-7#1)(2006-10#2)(2007-7#1)(2008-1#1)(2010-2#1)
reflects clinical##4##2##(2013-1#4)
reflects its##3##2##(2007-4#1)(2009-5#1)(2011-2#1)
reflects less than##2##3##(2007-2#1)(2008-2#1)
reflects on his##4##3##(1994-12#1)(2004-12#1)(2007-9#2)
reflects on the experience of##2##5##(2008-1#1)(2008-12#1)
reflects on the##3##3##(2008-1#1)(2008-12#1)(2012-3#1)
reflects on##14##2##(1994-12#1)(2004-12#1)(2007-10#1)(2007-2#2)(2007-9#2)(2008-1#1)(2008-12#1)(2010-10#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
reflects recent##2##2##(1994-6#1)(2009-4#1)
reflects some##2##2##(1993-1#1)(2008-7#1)
reflects that##4##2##(1992-8#1)(2008-10#1)(2008-9#1)(2009-8#1)
reflects the amount of##2##4##(1991-8#1)(2008-10#1)
reflects the current##2##3##(2007-4#1)(2008-1#1)
reflects the degree of##3##4##(2004-4#1)(2008-10#1)(2013-1#1)
reflects the development##2##3##(2006-10#2)
reflects the fact that##4##4##(1990-4#1)(1993-3#1)(2006-12#1)(2009-11#1)
reflects the importance##3##3##(1992-6#1)(2007-3#1)(2010-12#1)
reflects the involvement of the##2##5##(1991-11#1)(2008-9#1)
reflects the need##2##3##(1994-9#1)(2007-8#1)
reflects the presence of##3##4##(1997-8#1)(2007-2#1)(2011-1#1)
reflects the rate of##2##4##(1991-2#1)(2011-2#1)
reflects the strong##2##3##(1990-12#1)(2007-12#1)
reflects the total##3##3##(1997-7#1)(2007-11#1)(2008-8#1)
reflects the##123##2##(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-11#2)(1991-2#1)(1991-8#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#2)(1995-1#3)(1995-3#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#2)(1997-6#3)(1997-7#1)(1997-8#2)(2004-3#1)(2004-4#2)(2005-10#1)(2005-11#2)(2005-8#1)(2005-9#1)(2006-10#3)(2006-12#2)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#5)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#2)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#5)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#2)(2009-9#1)(2010-12#3)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
reflects their##4##2##(2008-1#1)(2008-4#1)(2009-8#1)(2011-12#1)
reflects##293##1##(1990-12#6)(1990-2#2)(1990-3#2)(1990-4#1)(1990-7#3)(1990-8#3)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-8#3)(1991-9#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#3)(1993-1#1)(1993-11#1)(1993-2#3)(1993-3#2)(1993-5#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#4)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-7#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#2)(1996-6#1)(1996-8#2)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#3)(2004-11#1)(2004-12#1)(2004-3#1)(2004-4#2)(2005-10#2)(2005-11#3)(2005-4#1)(2005-8#1)(2005-9#1)(2006-10#7)(2006-12#2)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-2#7)(2007-3#1)(2007-4#3)(2007-5#2)(2007-7#2)(2007-8#6)(2007-9#3)(2008-1#8)(2008-10#9)(2008-11#5)(2008-12#4)(2008-2#4)(2008-3#7)(2008-4#7)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#3)(2009-10#3)(2009-11#3)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#3)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#2)(2010-6#1)(2010-9#2)(2011-1#1)(2011-12#2)(2011-2#7)(2012-1#5)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#12)(2013-7#1)(2013-8#3)
reflex activity##5##2##(1993-12#1)(1994-4#2)(1995-7#1)(2008-4#1)
reflex and motor development##2##4##(1991-4#2)
reflex and##16##2##(1990-7#1)(1991-4#2)(1992-7#2)(1993-11#1)(1993-12#1)(1995-11#1)(1996-12#1)(2007-12#1)(2008-4#5)(2010-6#1)
reflex arc##4##2##(2007-1#1)(2008-11#2)(2010-2#1)
reflex arcs##2##2##(1992-8#1)(2008-12#1)
reflex by##4##2##(1990-7#2)(1992-3#1)(1996-1#1)
reflex circuit that##2##3##(2009-10#1)(2012-1#1)
reflex engagement##4##2##(2005-10#4)
reflex from the##2##3##(1991-5#2)
reflex in a##2##3##(1995-3#1)(1996-12#1)
reflex in rats##2##3##(1991-5#2)
reflex in the##4##3##(1994-2#1)(2006-10#1)(2006-4#1)(2008-4#1)
reflex in##18##2##(1990-5#2)(1990-7#1)(1991-5#2)(1993-12#1)(1994-2#2)(1995-3#1)(1996-12#2)(2005-10#1)(2006-10#1)(2006-4#1)(2007-1#1)(2008-4#1)(2011-2#1)(2012-2#1)
reflex irradiation was##2##3##(1995-8#2)
reflex is one of the##2##5##(2005-10#1)(2010-8#1)
reflex is##7##2##(1990-11#1)(1994-2#1)(2005-10#2)(2006-10#1)(2007-1#1)(2010-8#1)
reflex loss##2##2##(1993-9#1)(2005-10#1)
reflex may##2##2##(1996-5#1)(2005-10#1)
reflex modification##2##2##(1991-1#1)(2008-4#1)
reflex of the##3##3##(1995-7#1)(1996-2#1)(2007-10#1)
reflex of##5##2##(1995-7#1)(1996-2#1)(2007-1#1)(2007-10#1)(2007-3#1)
reflex pathway##3##2##(1993-12#1)(1997-2#1)(2010-8#1)
reflex pathways##3##2##(1990-5#1)(2005-10#1)(2008-7#1)
reflex potentials##2##2##(1994-2#1)(2005-8#1)
reflex radiation model##2##3##(2008-2#2)
reflex regulation##2##2##(2005-10#1)(2008-1#1)
reflex responses in##2##3##(1995-8#1)(2013-1#1)
reflex responses##8##2##(1991-10#1)(1992-8#1)(1993-12#2)(1995-12#2)(1995-8#1)(2013-1#1)
reflex sensitivity##2##2##(1991-10#1)(1996-2#1)
reflex sympathetic dystrophy and##3##4##(1992-11#2)(2008-7#1)
reflex sympathetic dystrophy of##2##4##(1992-11#2)
reflex sympathetic dystrophy syndrome##4##4##(1992-11#1)(1992-3#1)(2006-10#1)(2008-4#1)
reflex sympathetic dystrophy##20##3##(1992-11#11)(1992-3#1)(2006-10#2)(2007-11#2)(2008-10#1)(2008-4#1)(2008-7#2)
reflex tests##5##2##(1990-9#1)(1994-3#4)
reflex time##2##2##(2008-4#2)
reflex to##2##2##(1992-7#1)(1992-9#1)
reflex was##8##2##(1993-12#1)(1994-4#1)(1996-1#1)(1996-2#1)(2007-2#1)(2009-12#3)
reflex which##2##2##(1994-2#1)(1995-12#1)
reflex##260##1##(1990-11#1)(1990-4#1)(1990-5#4)(1990-7#10)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#2)(1991-3#1)(1991-4#2)(1991-5#15)(1991-8#1)(1992-11#11)(1992-2#1)(1992-3#5)(1992-4#3)(1992-7#5)(1992-8#2)(1992-9#3)(1993-11#1)(1993-12#8)(1993-9#3)(1994-2#13)(1994-3#4)(1994-4#7)(1994-8#1)(1995-11#1)(1995-12#6)(1995-3#2)(1995-6#1)(1995-7#2)(1995-8#4)(1996-1#4)(1996-12#6)(1996-2#5)(1996-5#1)(1996-6#2)(1997-2#1)(1997-7#2)(1997-8#2)(2004-2#1)(2005-10#17)(2005-8#1)(2006-10#6)(2006-2#1)(2006-3#1)(2006-4#1)(2007-1#8)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#3)(2008-4#18)(2008-7#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#4)(2010-11#3)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#4)(2011-2#4)(2012-1#6)(2012-2#3)(2013-1#2)(2013-8#1)
reflex)##2##1##(2007-9#1)(2012-2#1)
reflex-mediated##2##1##(1995-3#1)(2009-12#1)
reflexes and##10##2##(1993-12#2)(1993-5#1)(1993-9#1)(2007-12#2)(2008-9#1)(2009-5#1)(2013-7#1)(2013-8#1)
reflexes are##2##2##(1996-2#1)(2008-12#1)
reflexes at##2##2##(2009-4#1)(2013-1#1)
reflexes during##2##2##(1991-11#1)(2011-2#1)
reflexes for##2##2##(2010-1#1)(2012-1#1)
reflexes in the##4##3##(1992-12#1)(1997-8#1)(2006-10#1)(2008-7#1)
reflexes in##12##2##(1992-12#1)(1992-8#1)(1996-2#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-7#1)(2009-4#1)(2012-1#2)
reflexes that##2##2##(2008-7#1)(2012-1#1)
reflexes were##3##2##(1995-8#1)(1996-2#1)(2008-7#1)
reflexes##89##1##(1990-2#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-12#6)(1992-8#4)(1993-12#6)(1993-5#1)(1993-8#1)(1993-9#4)(1994-10#1)(1994-2#1)(1994-5#1)(1995-8#2)(1996-1#3)(1996-2#5)(1996-7#3)(1997-8#2)(2005-10#2)(2005-8#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#3)(2009-4#2)(2009-5#1)(2010-1#1)(2010-11#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#6)(2012-2#2)(2013-1#1)(2013-7#3)(2013-8#2)
reflexia##2##1##(2008-4#2)
reflexion##3##1##(1992-11#1)(2009-8#1)(2011-2#1)
reflexive shift of##2##3##(2008-11#2)
reflexive##13##1##(1992-7#1)(2006-4#1)(2007-10#1)(2008-11#4)(2008-12#1)(2009-8#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-8#1)
reflexology##8##1##(1997-6#4)(2008-4#1)(2011-12#1)(2012-2#2)
reflexus##2##1##(2008-12#2)
reflow##8##1##(1990-11#2)(1991-9#1)(1992-11#1)(1993-3#2)(2007-10#1)(2010-3#1)
reflux (GER) is##2##3##(2006-10#1)(2012-2#1)
reflux (GER)##3##2##(2006-10#1)(2009-3#1)(2012-2#1)
reflux (VUR)##5##2##(2006-10#1)(2008-10#2)(2009-5#1)(2012-11#1)
reflux and pulmonary aspiration##3##4##(2010-10#1)(2010-7#2)
reflux and##14##2##(1996-3#3)(2006-10#2)(2006-6#1)(2006-8#1)(2007-3#1)(2008-10#3)(2010-10#1)(2010-7#2)
reflux are##2##2##(2006-9#1)(2010-10#1)
reflux but##3##2##(2006-2#1)(2007-8#1)(2013-8#1)
reflux by##2##2##(2010-10#1)(2012-11#1)
reflux conditions##2##2##(2007-10#1)(2007-11#1)
reflux disease (GERD) has##2##4##(2006-10#1)(2010-12#1)
reflux disease (GERD) is a common disorder##2##7##(2006-2#1)(2010-10#1)
reflux disease (GERD) is a##3##5##(2006-10#1)(2006-2#1)(2010-10#1)
reflux disease (GERD)##18##3##(2006-10#5)(2006-2#2)(2006-6#1)(2007-6#1)(2008-5#2)(2008-8#1)(2010-10#1)(2010-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
reflux disease (GORD)##2##3##(1997-1#1)(2006-2#1)
reflux disease and the##2##4##(2005-1#1)(2010-12#1)
reflux disease and##9##3##(1993-3#1)(2005-1#1)(2006-10#1)(2006-2#1)(2008-12#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
reflux disease in an impoverished##2##5##(2011-2#2)
reflux disease in patients##2##4##(2009-2#1)(2013-8#1)
reflux disease in##6##3##(2009-1#1)(2009-2#1)(2010-11#1)(2011-2#2)(2013-8#1)
reflux disease is a##3##4##(1994-2#1)(2005-1#1)(2006-10#1)
reflux disease is##5##3##(1994-2#1)(2005-1#2)(2006-10#1)(2006-2#1)
reflux disease were##2##3##(1990-10#1)(2013-8#1)
reflux disease##78##2##(1990-10#1)(1990-2#1)(1993-3#1)(1994-2#2)(1997-1#1)(2005-1#6)(2006-10#16)(2006-2#8)(2006-6#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-12#2)(2008-3#4)(2008-5#3)(2008-8#1)(2009-1#1)(2009-11#1)(2009-2#2)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#5)(2011-2#4)(2012-2#2)(2013-1#3)(2013-8#4)
reflux disease]##2##2##(2009-5#1)(2012-2#1)
reflux esophagitis and##2##3##(2007-3#1)(2013-8#1)
reflux esophagitis##14##2##(1996-2#2)(2005-10#1)(2006-8#1)(2007-3#5)(2008-12#2)(2008-3#1)(2008-5#1)(2013-8#1)
reflux gastritis##2##2##(2005-12#1)(2006-8#1)
reflux had##2##2##(2008-4#2)
reflux in childhood##2##3##(1992-11#1)(2007-7#1)
reflux in patients with##2##4##(2008-4#1)(2012-2#1)
reflux in the##2##3##(1991-6#1)(1992-3#1)
reflux in##12##2##(1991-5#1)(1991-6#1)(1992-11#1)(1992-3#1)(1997-5#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-4#1)(2010-11#1)(2012-2#1)(2012-3#1)
reflux is##4##2##(1990-12#1)(2005-1#1)(2008-10#1)(2008-4#1)
reflux may##2##2##(1996-3#1)(2013-1#1)
reflux nephropathy##2##2##(2007-7#1)(2008-1#1)
reflux oesophagitis##3##2##(1994-2#1)(2005-1#2)
reflux of##5##2##(1993-4#1)(1995-1#1)(2007-9#1)(2009-8#1)(2012-3#1)
reflux or##2##2##(1997-1#1)(2007-11#1)
reflux showed##2##2##(2008-4#1)(2012-11#1)
reflux symptoms##5##2##(1990-10#2)(1993-3#1)(2006-2#2)
reflux therapy##2##2##(2005-11#1)(2008-7#1)
reflux using##5##2##(2008-10#2)(2008-4#2)(2009-3#1)
reflux was found##2##3##(1990-8#1)(2008-4#1)
reflux was##6##2##(1990-8#1)(1991-10#1)(1993-2#1)(2008-10#1)(2008-4#1)(2013-1#1)
reflux were##2##2##(2006-10#1)(2008-4#1)
reflux with##4##2##(1991-5#1)(2008-10#1)(2008-6#1)(2012-11#1)
reflux##275##1##(1990-10#3)(1990-12#2)(1990-2#1)(1990-8#1)(1991-10#2)(1991-11#1)(1991-5#4)(1991-6#2)(1992-11#3)(1992-3#2)(1992-9#1)(1993-2#1)(1993-3#2)(1993-4#1)(1994-2#3)(1995-1#1)(1995-10#1)(1995-9#2)(1996-2#2)(1996-3#6)(1996-9#1)(1997-1#2)(1997-5#1)(2005-1#11)(2005-10#1)(2005-11#1)(2005-12#2)(2006-10#28)(2006-2#15)(2006-6#2)(2006-7#2)(2006-8#3)(2006-9#7)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-3#6)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#28)(2008-12#4)(2008-3#5)(2008-4#14)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-2#2)(2009-3#3)(2009-5#3)(2009-8#2)(2010-10#6)(2010-11#2)(2010-12#7)(2010-2#1)(2010-7#5)(2011-1#1)(2011-2#5)(2012-11#8)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#5)(2013-8#9)
reflux-like##2##1##(1993-8#1)(2006-10#1)
refluxed into the##2##3##(1996-9#1)(2008-3#1)
refluxing ureters##3##2##(2008-10#2)(2012-11#1)
refluxing##17##1##(1996-2#1)(2005-4#1)(2005-8#3)(2006-12#1)(2007-11#4)(2008-10#4)(2008-5#1)(2010-12#1)(2012-11#1)
refocus##3##1##(1993-12#1)(2008-11#1)(2012-3#1)
refocused##3##1##(1997-2#1)(2007-12#1)(2008-3#1)
refocusing##5##1##(2008-10#1)(2008-2#2)(2009-10#1)(2011-1#1)
refold##3##1##(1995-3#1)(1995-4#1)(2008-4#1)
refolded and##4##2##(1992-5#1)(1995-11#1)(1995-3#1)(1997-4#1)
refolded by##2##2##(1994-12#1)(2008-1#1)
refolded in vitro##3##3##(1994-12#1)(1995-1#1)(1996-5#1)
refolded into the##2##3##(1990-4#1)(1994-5#1)
refolded to its##2##3##(1995-1#1)(2011-2#1)
refolded to##3##2##(1993-5#1)(1995-1#1)(2011-2#1)
refolded##21##1##(1990-4#1)(1992-5#1)(1993-4#1)(1993-5#1)(1994-12#2)(1994-5#1)(1995-1#2)(1995-11#2)(1995-2#2)(1995-3#1)(1996-5#1)(1997-4#2)(2008-1#1)(2009-3#1)(2011-1#1)(2011-2#1)
refolding and unfolding##2##3##(1995-1#1)(1995-5#1)
refolding and##3##2##(1995-1#1)(1995-3#1)(1995-5#1)
refolding from##2##2##(1992-6#1)(1995-5#1)
refolding of 0##2##3##(2011-2#2)
refolding of the##6##3##(1990-2#1)(1997-4#1)(1997-7#1)(2008-4#1)(2008-8#2)
refolding of##18##2##(1990-2#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-5#2)(1997-4#2)(1997-7#1)(2008-4#1)(2008-8#2)(2009-3#1)(2011-2#3)
refolding phases##2##2##(1990-7#2)
refolding##56##1##(1990-11#1)(1990-2#2)(1990-7#2)(1991-7#2)(1992-5#1)(1992-6#1)(1994-2#1)(1994-5#2)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#4)(1995-5#3)(1995-6#1)(1995-8#3)(1996-5#2)(1997-4#5)(1997-7#2)(2008-10#1)(2008-4#2)(2008-8#3)(2008-9#1)(2009-3#1)(2011-1#2)(2011-2#10)(2012-3#1)
reforestation##5##1##(2008-5#1)(2013-8#4)
reform and the##9##3##(1991-12#1)(1993-12#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-1#1)(2008-2#1)(2008-4#1)(2011-1#1)
reform and##27##2##(1991-12#1)(1992-3#1)(1993-12#3)(1993-2#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-3#1)(1997-1#1)(1997-3#1)(2007-4#1)(2008-2#1)(2008-4#2)(2009-8#1)(2010-8#1)(2011-1#3)
reform are##5##2##(1994-12#1)(1994-2#1)(1996-1#3)
reform bill##2##2##(1996-7#1)(2012-3#1)
reform debate##6##2##(1993-3#1)(1993-5#1)(1994-12#1)(1994-2#1)(1995-3#1)(1997-1#1)
reform efforts##9##2##(1994-1#1)(1996-1#3)(1996-2#1)(2007-2#1)(2012-3#1)(2013-1#2)
reform for the##2##3##(1993-12#1)(2007-2#1)
reform for##6##2##(1993-12#3)(1994-3#1)(2007-2#1)(2007-3#1)
reform has##7##2##(1993-12#1)(1994-1#1)(1995-2#1)(1996-1#1)(1997-1#1)(1997-2#1)(2011-1#1)
reform have##3##2##(1994-8#1)(1996-3#1)(1997-3#1)
reform in a##2##3##(1996-1#1)(2008-5#1)
reform in the##12##3##(1993-12#1)(1994-1#1)(1995-1#2)(1995-12#1)(1996-6#1)(1997-3#1)(2007-7#1)(2008-4#2)(2010-3#1)(2010-8#1)
reform in##34##2##(1991-1#1)(1993-12#1)(1994-1#1)(1995-1#2)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-4#9)(2008-5#1)(2008-8#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-3#2)
reform initiative##2##2##(1995-1#1)(1995-12#1)
reform initiatives##8##2##(1994-1#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-1#1)(1997-3#2)(2013-1#1)
reform is a##3##3##(1996-1#1)(1996-12#1)(1997-2#1)
reform is##16##2##(1992-3#1)(1993-1#1)(1993-3#1)(1994-12#2)(1994-2#1)(1995-12#1)(1995-3#1)(1996-1#3)(1996-12#1)(1997-2#1)(1997-3#1)(2011-2#1)(2013-1#1)
reform legislation##8##2##(1994-8#1)(1995-12#1)(1995-3#1)(1997-3#2)(2007-4#1)(2007-9#1)(2012-3#1)
reform of health care##2##4##(1994-12#1)(1997-2#1)
reform of health##3##3##(1994-12#1)(1997-2#1)(2012-12#1)
reform of the##7##3##(1992-1#1)(1992-12#1)(1993-12#1)(1996-1#1)(1997-2#1)(2007-4#1)(2011-2#1)
reform of##18##2##(1992-1#1)(1992-12#1)(1993-10#1)(1993-12#1)(1994-12#1)(1996-1#1)(1997-2#2)(2005-5#1)(2006-8#1)(2007-4#1)(2008-2#2)(2008-3#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
reform on##5##2##(1994-1#1)(1995-12#2)(2006-10#1)(2010-11#1)
reform plan##3##2##(1992-6#1)(1993-12#1)(1994-2#1)
reform plans##2##2##(1993-12#1)(1996-1#1)
reform policy##2##2##(1994-1#1)(2009-4#1)
reform programme##2##2##(1990-5#1)(2012-3#1)
reform project##3##2##(1994-2#1)(2008-2#1)(2009-4#1)
reform proposal##2##2##(1993-3#1)(1994-2#1)
reform proposals##6##2##(1993-12#3)(1995-1#2)(1996-3#1)
reform that##4##2##(1996-3#1)(1997-5#1)(2008-9#1)(2012-2#1)
reform the##6##2##(1992-5#1)(1994-12#1)(1996-3#1)(1997-1#1)(2007-5#1)(2008-4#1)
reform through##3##2##(1995-1#2)(2010-2#1)
reform to##2##2##(2008-2#1)(2008-7#1)
reform vision##2##2##(1993-3#1)(2011-1#1)
reform was##3##2##(1994-1#1)(2008-10#1)(2008-11#1)
reform will##6##2##(1991-12#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-1#1)
reform would##3##2##(1992-3#1)(2008-8#1)(2010-11#1)
reform##471##1##(1990-10#1)(1990-12#1)(1990-5#1)(1991-1#3)(1991-12#6)(1991-2#3)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#3)(1992-2#2)(1992-3#4)(1992-5#2)(1992-6#1)(1992-8#1)(1993-1#2)(1993-10#1)(1993-12#28)(1993-2#3)(1993-3#9)(1993-5#5)(1993-6#3)(1993-8#1)(1994-1#15)(1994-12#36)(1994-2#13)(1994-3#9)(1994-5#1)(1994-8#5)(1995-1#25)(1995-12#25)(1995-2#17)(1995-3#10)(1995-6#2)(1996-1#32)(1996-12#9)(1996-2#7)(1996-3#13)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#6)(1997-2#6)(1997-3#15)(1997-5#1)(1997-8#3)(2005-5#1)(2006-10#1)(2006-4#1)(2006-8#2)(2006-9#2)(2007-10#1)(2007-12#1)(2007-2#2)(2007-3#4)(2007-4#8)(2007-5#2)(2007-7#2)(2007-9#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#8)(2008-3#1)(2008-4#15)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-8#2)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-8#2)(2010-9#3)(2011-1#8)(2011-12#1)(2011-2#6)(2011-7#1)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#8)(2013-1#7)(2013-7#1)(2013-8#1)
reform?##9##1##(1993-3#1)(1994-7#1)(1995-1#1)(1995-12#2)(1995-2#1)(1996-12#1)(1996-2#1)(1997-2#1)
reform]##4##1##(1990-2#1)(1990-3#1)(1997-8#1)(2007-9#1)
reformation and##2##2##(2009-8#1)(2011-1#1)
reformation of##3##2##(1994-12#1)(2009-2#2)
reformation##16##1##(1991-1#1)(1992-1#5)(1994-12#1)(1994-2#1)(2008-3#1)(2009-2#2)(2009-8#1)(2011-1#3)(2012-12#1)
reformations##2##1##(2008-7#1)(2011-2#1)
reformatted into##2##2##(2006-5#2)
reformatted##3##1##(2006-5#2)(2012-2#1)
reformatting##2##1##(2006-5#1)(2008-7#1)
reformed its##2##2##(1994-12#1)(1995-3#1)
reformed##10##1##(1992-3#1)(1993-8#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-3#2)(1996-1#1)(2007-3#1)(2010-11#1)
reforming the##4##2##(1995-12#1)(2008-10#1)(2008-11#1)(2009-3#1)
reforming##11##1##(1993-3#1)(1994-1#1)(1994-3#1)(1995-12#1)(1996-6#1)(2005-7#1)(2008-10#1)(2008-11#1)(2009-3#1)(2011-1#1)(2012-3#1)
reforms and health##2##3##(1997-1#1)(2013-8#1)
reforms and##7##2##(1997-1#1)(2007-9#1)(2008-11#1)(2008-4#1)(2009-6#1)(2012-12#1)(2013-8#1)
reforms for##2##2##(1993-2#1)(2010-12#1)
reforms from##2##2##(2008-7#1)(2012-3#1)
reforms have##2##2##(2011-1#1)(2012-3#1)
reforms in the##3##3##(1993-2#1)(1997-1#1)(2011-2#1)
reforms in##9##2##(1993-2#1)(1994-12#1)(1996-1#1)(1997-1#2)(2007-4#1)(2008-5#1)(2009-4#1)(2011-2#1)
reforms that##4##2##(1992-3#1)(2007-4#1)(2012-1#1)(2013-1#1)
reforms were##2##2##(2007-12#1)(2011-1#1)
reforms##80##1##(1990-2#1)(1990-5#1)(1991-2#2)(1991-8#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-2#4)(1993-3#1)(1994-12#2)(1994-2#2)(1994-7#1)(1995-12#3)(1995-3#4)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#6)(1997-5#1)(2006-8#1)(2007-12#2)(2007-3#2)(2007-4#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#2)(2011-1#2)(2011-2#2)(2012-1#3)(2012-12#1)(2012-3#7)(2013-1#1)(2013-8#2)
reformulate the##4##2##(1994-11#1)(2007-8#1)(2008-10#1)(2008-2#1)
reformulated##9##1##(1996-1#1)(1996-2#1)(2007-10#1)(2008-2#1)(2008-3#4)(2010-1#1)
reformulating##2##1##(2010-7#1)(2012-2#1)
reformulation##9##1##(1993-1#1)(1993-6#1)(1996-1#1)(1996-2#1)(2008-3#2)(2010-4#2)(2013-8#1)
reformulations of##2##2##(1996-2#1)(2008-3#1)
reformulations##3##1##(1996-2#1)(2008-3#1)(2012-2#1)
refracted and##3##2##(2008-2#2)(2008-3#1)
refracted rays##2##2##(2008-2#1)(2008-3#1)
refracted##16##1##(1991-3#2)(2007-11#1)(2008-2#8)(2008-3#5)
refractile##5##1##(1994-8#1)(1995-11#1)(2008-8#1)(2011-1#1)(2012-2#1)
refracting##5##1##(2008-2#3)(2008-3#2)
refraction and dispersion##2##3##(2007-11#2)
refraction and internal reflection in##2##5##(2008-2#2)
refraction and##20##2##(2007-11#5)(2007-12#2)(2008-2#9)(2008-3#4)
refraction are##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
refraction at##3##2##(2008-1#1)(2008-2#1)(2008-7#1)
refraction halos##4##2##(2008-2#4)
refraction in##11##2##(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2011-1#1)
refraction of the##7##3##(2008-2#3)(2008-3#4)
refraction of##25##2##(2007-12#1)(2008-2#16)(2008-3#7)(2008-4#1)
refraction through##3##2##(2007-11#1)(2008-3#2)
refraction with##2##2##(2008-3#1)(2010-1#1)
refraction##155##1##(1991-9#1)(2005-11#1)(2006-12#1)(2007-1#1)(2007-11#19)(2007-12#18)(2008-1#3)(2008-10#1)(2008-2#58)(2008-3#46)(2008-4#1)(2008-7#2)(2009-6#1)(2010-1#1)(2011-1#1)
refractive and##4##2##(2007-12#1)(2008-3#3)
refractive elements##2##2##(2007-12#1)(2008-2#1)
refractive error was##2##3##(1992-7#1)(2013-7#1)
refractive error##9##2##(1992-7#2)(2007-1#1)(2010-8#1)(2011-1#2)(2012-12#1)(2013-7#2)
refractive errors##7##2##(1992-7#1)(2007-12#1)(2009-8#1)(2009-9#1)(2010-8#2)(2011-1#1)
refractive index (RI)##6##3##(1991-7#1)(2007-11#1)(2008-10#2)(2012-12#1)(2013-1#1)
refractive index accurately##2##3##(2008-2#1)(2008-3#1)
refractive index and extinction coefficient of##2##6##(2008-3#2)
refractive index and extinction##3##4##(2008-2#1)(2008-3#2)
refractive index and the extinction coefficient##4##6##(2008-2#3)(2008-3#1)
refractive index and the size distribution##2##6##(2008-2#2)
refractive index and the size##3##5##(2008-2#3)
refractive index and the thickness##2##5##(2008-3#2)
refractive index and the##15##4##(2008-2#7)(2008-3#7)(2011-1#1)
refractive index and thickness of##3##5##(2007-11#2)(2013-1#1)
refractive index and thickness##4##4##(2007-11#3)(2013-1#1)
refractive index and##34##3##(2007-11#5)(2007-12#1)(2008-2#13)(2008-3#13)(2011-1#1)(2013-1#1)
refractive index are presented##2##4##(2007-12#1)(2008-2#1)
refractive index are##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
refractive index as well as##2##5##(2007-12#1)(2008-2#1)
refractive index as##5##3##(2007-12#2)(2008-2#2)(2008-4#1)
refractive index at##3##3##(2007-12#2)(2008-3#1)
refractive index between##3##3##(2007-1#1)(2008-1#1)(2008-3#1)
refractive index by##3##3##(2007-11#1)(2008-3#2)
refractive index can be##3##4##(2007-12#1)(2008-3#2)
refractive index caused by##2##4##(2006-12#1)(2008-2#1)
refractive index changes##3##3##(2007-12#2)(2008-10#1)
refractive index detection##2##3##(1992-1#1)(2008-10#1)
refractive index for##4##3##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
refractive index gradient##2##3##(2008-10#2)
refractive index higher than that of silica##3##7##(2007-11#1)(2008-2#2)
refractive index in##4##3##(2007-12#1)(2008-10#1)(2008-3#2)
refractive index inside the##2##4##(2008-2#1)(2008-3#1)
refractive index is presented##2##4##(2008-3#2)
refractive index is##25##3##(2007-11#3)(2007-12#5)(2008-1#1)(2008-2#4)(2008-3#12)
refractive index may##2##3##(2007-11#1)(2008-3#1)
refractive index n = 1##2##5##(2008-2#1)(2008-3#1)
refractive index n and the extinction coefficient##2##7##(2008-2#2)
refractive index n and the##4##5##(2008-10#1)(2008-2#2)(2008-3#1)
refractive index n and##5##4##(2008-10#1)(2008-2#2)(2008-3#2)
refractive index n##10##3##(2008-10#1)(2008-2#3)(2008-3#6)
refractive index n(0)##3##3##(2008-3#3)
refractive index n(2) of##2##4##(2007-11#2)
refractive index near##2##3##(2008-2#1)(2008-3#1)
refractive index of a film##2##5##(2008-3#2)
refractive index of a##11##4##(2007-12#1)(2008-2#4)(2008-3#6)
refractive index of air##4##4##(2007-12#2)(2008-2#1)(2008-3#1)
refractive index of an aqueous##2##5##(2007-11#1)(2011-12#1)
refractive index of an##3##4##(2007-11#1)(2008-2#1)(2011-12#1)
refractive index of particles##2##4##(2008-2#2)
refractive index of the film##2##5##(2008-2#2)
refractive index of the##38##4##(2005-11#1)(2007-11#7)(2007-12#4)(2007-8#1)(2008-1#3)(2008-10#1)(2008-2#9)(2008-3#10)(2009-6#1)(2010-2#1)
refractive index of this##2##4##(2008-1#1)(2008-3#1)
refractive index of##99##3##(2005-11#2)(2006-10#1)(2007-11#9)(2007-12#8)(2007-8#2)(2008-1#4)(2008-10#4)(2008-2#29)(2008-3#36)(2009-6#1)(2010-2#1)(2011-12#2)
refractive index on##2##3##(2008-3#2)
refractive index sensitivities##2##3##(2008-7#1)(2010-2#1)
refractive index than##3##3##(2007-12#1)(2011-1#1)(2012-12#1)
refractive index to##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
refractive index was altered##2##4##(2007-11#2)
refractive index was##8##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#3)(2013-8#1)
refractive index were##2##3##(2007-12#1)(2008-3#1)
refractive index with an##2##4##(2008-3#2)
refractive index with temperature##2##4##(2008-2#2)
refractive index with the##2##4##(2008-3#2)
refractive index with##8##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#4)
refractive index##374##2##(1990-12#1)(1991-7#1)(1992-1#2)(1996-2#1)(2005-11#5)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#38)(2007-12#39)(2007-8#2)(2008-1#9)(2008-10#21)(2008-2#98)(2008-3#129)(2008-4#2)(2008-7#2)(2009-4#1)(2009-6#3)(2010-2#2)(2010-8#1)(2011-1#6)(2011-12#3)(2012-12#2)(2013-1#2)(2013-8#1)
refractive index)##3##2##(2008-10#1)(2008-3#2)
refractive indices and thicknesses are##2##5##(2008-2#1)(2008-3#1)
refractive indices and thicknesses of##2##5##(2008-3#2)
refractive indices and thicknesses##5##4##(2008-2#1)(2008-3#4)
refractive indices and##14##3##(2007-12#1)(2008-2#9)(2008-3#4)
refractive indices are measured##2##4##(2007-11#1)(2008-3#1)
refractive indices are##5##3##(2007-11#1)(2008-2#2)(2008-3#2)
refractive indices at which##2##4##(2007-12#1)(2008-3#1)
refractive indices for##2##3##(2006-2#1)(2008-2#1)
refractive indices in##2##3##(2006-10#1)(2007-11#1)
refractive indices is presented##2##4##(2008-2#1)(2008-3#1)
refractive indices is##3##3##(2008-2#1)(2008-3#2)
refractive indices of silicon and##2##5##(2008-2#1)(2008-3#1)
refractive indices of##27##3##(2005-11#1)(2006-2#1)(2007-11#1)(2007-12#5)(2008-1#1)(2008-2#6)(2008-3#12)
refractive indices on##2##3##(2008-3#2)
refractive indices that##2##3##(2008-2#2)
refractive indices were##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
refractive indices##91##2##(2005-11#1)(2006-10#1)(2006-2#2)(2007-11#6)(2007-12#8)(2008-1#2)(2008-2#33)(2008-3#36)(2009-5#1)(2012-12#1)
refractive lens##4##2##(2007-11#2)(2008-3#1)(2011-2#1)
refractive lenses##6##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)
refractive microlens array##2##3##(2008-10#1)(2008-2#1)
refractive microlens##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
refractive sounding##2##2##(2008-2#2)
refractive surgery##8##2##(1991-9#1)(2007-1#1)(2007-3#2)(2012-12#1)(2013-1#1)(2013-8#2)
refractive turbulence on coherent lidar##2##5##(2008-3#2)
refractive turbulence on##4##3##(2008-3#4)
refractive turbulence##6##2##(2008-3#6)
refractive##555##1##(1990-12#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-7#3)(1996-2#2)(2005-11#6)(2006-10#2)(2006-12#1)(2006-2#2)(2007-1#3)(2007-11#50)(2007-12#60)(2007-3#3)(2007-8#2)(2008-1#11)(2008-10#23)(2008-2#146)(2008-3#187)(2008-4#2)(2008-7#2)(2009-4#1)(2009-5#1)(2009-6#3)(2009-8#3)(2009-9#1)(2010-2#2)(2010-8#4)(2011-1#11)(2011-12#3)(2011-2#2)(2012-12#5)(2013-1#3)(2013-7#3)(2013-8#3)
refractive-diffractive##2##1##(2008-2#2)
refractive-index and##3##2##(2007-11#1)(2008-2#2)
refractive-index change in##5##3##(2007-12#1)(2008-3#4)
refractive-index change is##2##3##(2007-12#2)
refractive-index change##20##2##(2007-11#1)(2007-12#8)(2008-2#3)(2008-3#8)
refractive-index changes of##2##3##(2007-11#1)(2007-12#1)
refractive-index changes##12##2##(2007-11#3)(2007-12#6)(2008-3#3)
refractive-index contrast of##2##3##(2007-12#2)
refractive-index contrast##5##2##(2007-11#1)(2007-12#3)(2008-2#1)
refractive-index detection scheme##2##3##(2008-2#2)
refractive-index detection##4##2##(2008-2#4)
refractive-index difference##10##2##(2007-12#4)(2008-2#6)
refractive-index differences##3##2##(2007-12#3)
refractive-index distribution and##2##3##(2008-2#2)
refractive-index distribution##8##2##(2007-12#2)(2008-2#2)(2008-3#4)
refractive-index gradients in##2##3##(2008-2#1)(2008-3#1)
refractive-index gradients##3##2##(2008-2#2)(2008-3#1)
refractive-index grating##3##2##(2007-12#3)
refractive-index gratings##2##2##(2007-11#1)(2008-2#1)
refractive-index increase##3##2##(2008-2#1)(2008-3#2)
refractive-index measurement##2##2##(2008-3#2)
refractive-index mismatch on##2##3##(2008-2#1)(2008-3#1)
refractive-index mismatch##6##2##(2008-2#2)(2008-3#4)
refractive-index modification of fused silica##2##5##(2007-11#2)
refractive-index modification of##3##3##(2007-11#3)
refractive-index modulation of##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
refractive-index modulation##15##2##(2007-11#4)(2007-12#6)(2008-2#1)(2008-3#4)
refractive-index modulations##2##2##(2007-12#1)(2008-3#1)
refractive-index perturbation##3##2##(2007-12#2)(2008-3#1)
refractive-index profile of##7##3##(2007-12#1)(2008-2#6)
refractive-index profile##19##2##(2007-11#2)(2007-12#1)(2008-2#13)(2008-3#3)
refractive-index profiles from##2##3##(2008-3#2)
refractive-index profiles of##3##3##(2008-1#1)(2008-3#2)
refractive-index profiles##12##2##(2008-1#2)(2008-2#3)(2008-3#7)
refractive-index sensitivity of##2##3##(2007-12#1)(2008-3#1)
refractive-index structure##3##2##(2007-12#1)(2008-2#2)
refractive-index turbulence##4##2##(2008-3#4)
refractive-index variation##5##2##(2007-11#1)(2008-3#4)
refractive-index##190##1##(2007-11#25)(2007-12#48)(2008-1#2)(2008-2#56)(2008-3#59)
refractivity of##2##2##(2007-12#1)(2008-3#1)
refractivity##5##1##(2007-12#2)(2008-2#1)(2008-3#2)
refractometer based on##4##3##(2007-11#1)(2008-3#3)
refractometer##10##1##(2007-11#3)(2008-2#2)(2008-3#5)
refractometric prism##2##2##(2008-3#2)
refractometric##7##1##(1990-9#1)(1992-7#1)(2007-8#1)(2008-3#3)(2009-6#1)
refractometry by the rainbow method##2##5##(2008-2#1)(2008-3#1)
refractometry##10##1##(1990-9#1)(2007-8#1)(2008-2#7)(2008-3#1)
refractoriness in##3##2##(1991-2#2)(2013-1#1)
refractoriness of##4##2##(1993-12#1)(1996-6#2)(2013-1#1)
refractoriness##15##1##(1991-2#4)(1992-8#2)(1993-12#1)(1993-2#1)(1994-2#1)(1996-6#2)(2008-1#1)(2013-1#3)
refractory DME##2##2##(2011-2#2)
refractory RA##4##2##(2006-10#1)(2008-8#3)
refractory SLE##2##2##(2013-1#2)
refractory acute lymphocytic##2##3##(2007-8#1)(2012-2#1)
refractory acute##4##2##(2007-11#2)(2007-8#1)(2012-2#1)
refractory and##2##2##(2008-12#1)(2012-3#1)
refractory anemia##2##2##(2007-12#1)(2012-12#1)
refractory angina##5##2##(2006-9#1)(2007-11#1)(2008-12#1)(2008-3#1)(2010-6#1)
refractory ascites##7##2##(2005-11#1)(2007-12#3)(2009-8#1)(2013-1#2)
refractory asthma##5##2##(2010-5#4)(2012-2#1)
refractory benign##2##2##(2007-5#1)(2008-3#1)
refractory cases##4##2##(2005-8#1)(2006-10#1)(2012-2#1)(2013-8#1)
refractory chronic##4##2##(2008-5#1)(2009-3#2)(2010-12#1)
refractory diabetic macular oedema##2##4##(2011-2#2)
refractory disease##6##2##(2008-1#1)(2008-5#1)(2010-4#1)(2010-5#2)(2011-1#1)
refractory epilepsies##2##2##(2007-11#1)(2009-3#1)
refractory epilepsy##4##2##(2005-8#1)(2007-11#1)(2008-7#1)(2013-1#1)
refractory focal##2##2##(1997-3#1)(2006-8#1)
refractory heart failure##4##3##(1995-6#2)(2011-2#2)
refractory hypertension or##2##3##(1995-10#1)(2008-12#1)
refractory hypertension##5##2##(1990-9#1)(1995-10#1)(2008-1#1)(2008-12#1)(2012-2#1)
refractory metastatic breast cancer##2##4##(2009-8#2)
refractory metastatic##3##2##(2009-8#2)(2010-12#1)
refractory multiple myeloma##2##3##(2008-5#1)(2009-4#1)
refractory myeloma##3##2##(1990-10#1)(2010-4#2)
refractory neuropathic pain##2##3##(2006-12#2)
refractory obsessive-compulsive##2##2##(2010-12#1)(2010-2#1)
refractory or relapsed##4##3##(2007-10#2)(2007-11#1)(2008-1#1)
refractory or##6##2##(2006-6#1)(2007-10#2)(2007-11#1)(2008-1#1)(2008-5#1)
refractory patients##8##2##(2007-11#1)(2008-1#1)(2008-3#1)(2009-9#1)(2010-12#1)(2013-1#3)
refractory period and##2##3##(1996-12#1)(2006-9#1)
refractory period##8##2##(1991-2#1)(1992-6#1)(1996-12#1)(2004-11#1)(2006-9#1)(2008-11#3)
refractory periods##6##2##(1991-2#1)(1994-2#1)(1994-3#2)(1997-3#1)(2008-7#1)
refractory pulmonary##2##2##(2008-4#2)
refractory rejection in##2##3##(2007-11#2)
refractory rejection##5##2##(2007-11#5)
refractory rheumatoid arthritis##4##3##(2007-11#3)(2008-8#1)
refractory schizophrenia##2##2##(1993-5#1)(2009-9#1)
refractory seizures##3##2##(1997-3#1)(2008-7#1)(2009-8#1)
refractory strictures##2##2##(2010-12#2)
refractory systemic lupus erythematosus##2##4##(2012-12#1)(2013-1#1)
refractory to aggressive##2##3##(2006-10#2)
refractory to conservative##4##3##(2006-12#1)(2006-8#1)(2009-2#1)(2013-1#1)
refractory to conventional therapy##5##4##(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#1)(2011-2#1)
refractory to conventional##9##3##(1990-6#1)(1991-6#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-11#1)(2011-2#1)
refractory to infliximab##2##3##(2012-3#2)
refractory to medical management##2##4##(2007-9#1)(2011-3#1)
refractory to medical therapy##3##4##(1992-5#1)(2007-8#1)(2010-12#1)
refractory to medical treatment##4##4##(1992-5#1)(2006-3#1)(2007-8#1)(2010-7#1)
refractory to medical##9##3##(1992-5#2)(2006-3#1)(2007-8#2)(2007-9#1)(2010-12#1)(2010-7#1)(2011-3#1)
refractory to or##3##3##(2007-10#1)(2007-8#1)(2012-3#1)
refractory to other##3##3##(2008-5#1)(2012-3#2)
refractory to the conventional##2##4##(2006-6#1)(2012-2#1)
refractory to the##6##3##(1992-9#2)(2006-10#1)(2006-6#1)(2012-12#1)(2012-2#1)
refractory to therapy##2##3##(1994-7#1)(2008-7#1)
refractory to these agents##2##4##(2008-5#1)(2009-8#1)
refractory to treatment##6##3##(1993-8#1)(1995-3#1)(2005-7#1)(2007-7#1)(2012-12#1)(2013-7#1)
refractory to##91##2##(1990-6#1)(1991-6#2)(1992-4#1)(1992-5#3)(1992-9#2)(1993-12#1)(1993-2#1)(1993-8#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-9#1)(1995-3#1)(1995-8#1)(1997-7#1)(2005-7#2)(2005-8#1)(2006-10#7)(2006-12#2)(2006-3#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#2)(2009-11#1)(2009-2#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-7#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#6)(2013-1#4)(2013-7#1)(2013-8#2)
refractory ventricular##2##2##(1991-9#1)(2010-7#1)
refractory yttrium##2##2##(2008-10#2)
refractory##338##1##(1990-10#1)(1990-3#2)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#2)(1991-9#1)(1992-4#1)(1992-5#4)(1992-6#1)(1992-8#1)(1992-9#4)(1993-12#1)(1993-2#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-7#2)(1994-9#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#3)(1996-3#1)(1996-4#1)(1996-5#1)(1997-3#4)(1997-7#1)(2004-11#1)(2004-3#1)(2005-11#2)(2005-7#4)(2005-8#3)(2006-10#15)(2006-12#5)(2006-3#2)(2006-4#3)(2006-6#2)(2006-8#5)(2006-9#3)(2007-1#1)(2007-10#6)(2007-11#18)(2007-12#8)(2007-3#2)(2007-5#1)(2007-7#2)(2007-8#7)(2007-9#2)(2008-1#6)(2008-10#10)(2008-11#9)(2008-12#5)(2008-3#5)(2008-4#4)(2008-5#10)(2008-6#3)(2008-7#10)(2008-8#5)(2008-9#2)(2009-11#2)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#6)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#11)(2010-2#2)(2010-4#3)(2010-5#8)(2010-6#1)(2010-7#3)(2011-1#3)(2011-2#15)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#8)(2012-3#10)(2013-1#15)(2013-7#2)(2013-8#7)
refracture##3##1##(2008-12#1)(2011-12#1)(2012-2#1)
refrain from##4##2##(1996-9#1)(2006-7#1)(2012-12#1)(2012-3#1)
refrain##5##1##(1996-9#1)(2006-7#1)(2008-11#1)(2012-12#1)(2012-3#1)
refrained from##2##2##(1990-4#1)(1992-4#1)
refraining from##4##2##(1993-6#1)(2008-10#1)(2008-3#1)(2008-5#1)
refresh##3##1##(2007-12#1)(2012-11#1)(2012-12#1)
refreshed##2##1##(2005-7#1)(2013-7#1)
refresher course##2##2##(2008-1#1)(2009-3#1)
refresher##4##1##(2008-1#1)(2008-12#1)(2008-9#1)(2009-3#1)
refreshing##2##1##(2008-2#1)(2008-3#1)
refrigerated storage##6##2##(2007-3#2)(2010-4#1)(2012-2#1)(2013-7#2)
refrigerated##18##1##(1994-9#1)(1996-7#1)(2005-10#1)(2006-5#2)(2007-3#3)(2008-10#3)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#3)
refrigeration temperature##2##2##(1997-4#1)(2012-2#1)
refrigeration##15##1##(1992-4#1)(1996-1#1)(1997-4#1)(2005-11#1)(2005-5#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-3#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#2)
refrigerator##6##1##(1993-7#1)(2008-10#1)(2010-4#1)(2010-7#1)(2012-12#2)
refrigerators##2##1##(1996-1#1)(1996-6#1)
refuge for##3##2##(2007-5#1)(2008-5#1)(2013-7#1)
refuge##15##1##(1993-6#3)(1995-6#1)(1996-6#1)(2007-5#2)(2008-5#3)(2009-5#2)(2012-11#1)(2012-2#1)(2013-7#1)
refugee camps in##2##3##(1994-9#1)(2012-12#1)
refugee campuses##2##2##(2011-2#2)
refugee population##2##2##(2010-5#1)(2011-12#1)
refugee##21##1##(1991-10#2)(1994-7#1)(1994-9#1)(1996-3#1)(2007-9#3)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-12#2)(2010-5#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#1)
refugees and##3##2##(1995-11#2)(1997-3#1)
refugees in##6##2##(1990-3#1)(1990-6#1)(2007-2#1)(2008-7#1)(2010-1#1)(2011-2#1)
refugees residing in##2##3##(2008-7#1)(2011-2#1)
refugees##31##1##(1990-3#1)(1990-6#1)(1991-4#2)(1993-5#1)(1993-7#1)(1994-4#1)(1995-11#2)(1995-8#1)(1995-9#1)(1997-3#1)(2006-9#2)(2007-2#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-7#4)(2010-1#1)(2010-12#1)(2011-12#1)(2011-2#3)(2013-1#3)
refugees]##2##1##(1993-10#1)(1997-2#1)
refuges and##2##2##(2008-5#1)(2013-1#1)
refuges##6##1##(2008-10#1)(2008-5#3)(2008-6#1)(2013-1#1)
refusal at##2##2##(2005-10#2)
refusal of##8##2##(1990-5#1)(1991-6#1)(1993-5#1)(1994-8#1)(1995-5#1)(2006-10#1)(2007-8#1)(2009-2#1)
refusal to##9##2##(1992-8#1)(1995-12#1)(1995-6#1)(2007-3#1)(2007-4#1)(2008-11#2)(2009-6#1)(2011-2#1)
refusal##32##1##(1990-12#1)(1990-5#1)(1991-6#2)(1992-2#1)(1992-8#1)(1993-5#2)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#1)(2005-10#6)(2006-10#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2009-2#1)(2009-6#2)(2009-7#1)(2011-2#1)
refusals and##2##2##(2008-7#1)(2009-6#1)
refusals##4##1##(1990-6#1)(2005-10#1)(2008-7#1)(2009-6#1)
refuse piles##4##2##(2008-10#4)
refuse to participate in##2##4##(2009-6#2)
refuse to take part in##2##5##(2009-6#2)
refuse to take##3##3##(2006-10#1)(2009-6#2)
refuse to##12##2##(1997-7#1)(2005-9#1)(2006-10#1)(2006-2#1)(2007-1#1)(2008-7#1)(2009-6#5)(2013-8#1)
refuse treatment##9##2##(1990-5#1)(1995-12#2)(1995-2#1)(1996-12#1)(2006-5#1)(2007-12#2)(2010-9#1)
refuse##45##1##(1990-11#1)(1990-12#2)(1990-5#1)(1991-9#1)(1992-12#2)(1993-5#1)(1994-12#1)(1995-12#2)(1995-2#1)(1996-12#1)(1996-9#1)(1997-7#2)(2004-12#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#6)(2010-9#1)(2013-8#2)
refused a##3##2##(1995-12#1)(2006-10#1)(2010-7#1)
refused further therapy##2##3##(1991-6#1)(1992-10#1)
refused further##3##2##(1991-6#1)(1992-10#1)(2007-3#1)
refused on the basis of##2##5##(1990-2#1)(2006-9#1)
refused or##2##2##(1997-5#1)(2008-11#1)
refused surgery##2##2##(1990-6#1)(2007-8#1)
refused to be tested##2##4##(1996-11#2)
refused to dismiss##3##3##(1995-12#1)(1996-11#1)(1996-5#1)
refused to treat##2##3##(1995-6#1)(1996-11#1)
refused to work with##2##4##(1994-4#1)(1996-12#1)
refused to##30##2##(1991-12#1)(1991-6#1)(1992-12#1)(1994-11#1)(1994-4#1)(1995-12#1)(1995-4#1)(1995-6#4)(1995-9#1)(1996-11#5)(1996-12#2)(1996-5#1)(1996-6#2)(1997-5#1)(2006-7#1)(2007-10#1)(2007-9#1)(2009-6#1)(2010-2#1)(2011-1#1)(2011-2#1)
refused##63##1##(1990-2#1)(1990-6#1)(1991-12#1)(1991-6#3)(1992-10#1)(1992-12#1)(1992-9#1)(1994-11#2)(1994-4#1)(1995-12#4)(1995-4#2)(1995-6#6)(1995-9#1)(1996-11#6)(1996-12#2)(1996-5#2)(1996-6#2)(1997-5#2)(1997-6#1)(2006-10#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-3#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-6#3)(2010-11#1)(2010-2#1)(2010-7#2)(2011-1#1)(2011-2#2)
refusers##7##1##(1990-6#1)(1991-6#6)
refuses to##6##2##(1992-12#1)(1995-6#2)(2007-8#1)(2008-7#1)(2010-8#1)
refuses##8##1##(1992-12#1)(1993-5#1)(1995-6#2)(2007-8#1)(2008-12#1)(2008-7#1)(2010-8#1)
refusing to##4##2##(1995-6#3)(1996-6#1)
refusing##7##1##(1993-6#1)(1995-6#3)(1996-6#1)(1997-5#1)(2008-12#1)
refutations##2##1##(2006-7#1)(2008-8#1)
refute##8##1##(1991-12#1)(1996-3#1)(1997-8#1)(2006-8#1)(2007-6#2)(2008-3#1)(2012-12#1)
refuted##4##1##(2007-7#1)(2008-3#1)(2012-2#1)(2013-7#1)
refuting the refutation of dogma##2##5##(2007-5#2)
refuting the##3##2##(2007-5#2)(2008-10#1)
refuting##5##1##(1995-5#1)(2007-5#3)(2008-10#1)
reg##2##1##(2010-12#2)
reg1 mutation##2##2##(1994-2#2)
regain a##2##2##(2011-1#1)(2011-3#1)
regain of##2##2##(1994-11#1)(2010-6#1)
regain the##4##2##(2008-1#1)(2008-10#1)(2011-2#1)(2012-1#1)
regain their##5##2##(1993-2#1)(2008-10#1)(2012-3#1)(2013-1#2)
regain##27##1##(1992-5#1)(1993-2#1)(1994-11#1)(1995-5#1)(1995-8#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#5)(2008-7#1)(2008-9#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-3#1)(2013-1#3)(2013-8#1)
regained a##2##2##(2008-10#1)(2013-1#1)
regained by the##2##3##(1994-5#1)(1995-2#1)
regained full##2##2##(2009-9#1)(2012-2#1)
regained normal##2##2##(2007-7#1)(2010-12#1)
regained only##2##2##(1995-12#1)(1996-1#1)
regained the ability to walk##2##5##(1996-9#2)
regained the ability to##5##4##(1994-12#1)(1996-9#2)(2007-7#1)(2007-8#1)
regained the##6##2##(1994-12#1)(1996-9#2)(2007-7#1)(2007-8#1)(2008-5#1)
regained their##2##2##(1992-5#1)(2009-3#1)
regained##35##1##(1992-11#1)(1992-5#1)(1994-12#2)(1994-5#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-9#3)(1997-6#2)(2006-6#2)(2007-7#2)(2007-8#3)(2008-10#3)(2008-5#1)(2008-6#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
regaining##8##1##(2006-1#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#1)(2012-1#1)(2012-11#1)(2012-7#1)
regalis##3##1##(2008-5#1)(2010-8#2)
regard and##2##2##(1996-10#1)(2008-6#1)
regard as##2##2##(2006-7#1)(2007-7#1)
regard for personhood##2##3##(2005-7#2)
regard for##5##2##(1992-12#1)(2005-7#2)(2008-12#1)(2008-5#1)
regard the##2##2##(1997-4#1)(1997-5#1)
regard this##2##2##(1990-9#1)(2007-12#1)
regard to a##3##3##(1997-7#1)(2005-11#1)(2007-4#1)
regard to clinical##3##3##(1993-11#1)(1993-8#1)(2007-2#1)
regard to confounding##2##3##(1992-3#1)(2008-9#1)
regard to diagnosis##2##3##(2009-9#1)(2011-2#1)
regard to environmental##2##3##(2006-1#1)(2008-11#1)
regard to its##10##3##(1990-2#1)(1990-5#1)(1990-6#1)(1992-11#1)(1993-4#1)(1993-9#1)(2006-6#1)(2008-2#1)(2012-3#1)(2013-1#1)
regard to possible##2##3##(1991-12#1)(1991-3#1)
regard to sex##2##3##(2010-6#1)(2011-1#1)
regard to the clinical##2##4##(2008-10#1)(2008-11#1)
regard to the development of##2##5##(2007-11#1)(2008-12#1)
regard to the development##3##4##(2007-11#2)(2008-12#1)
regard to the incidence and##2##5##(1990-6#1)(2006-2#1)
regard to the influence##2##4##(2008-10#2)
regard to the possible role##2##5##(2006-10#1)(2008-10#1)
regard to the##119##3##(1990-10#2)(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-8#2)(1993-3#2)(1994-11#2)(1994-12#1)(1994-5#2)(1995-1#1)(1995-10#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-3#3)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-7#2)(1997-8#2)(2004-11#1)(2005-1#1)(2005-4#1)(2006-10#6)(2006-11#2)(2006-2#2)(2006-6#2)(2007-11#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#2)(2009-4#1)(2009-6#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#4)(2010-5#2)(2010-8#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#4)
regard to their##29##3##(1992-3#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-4#1)(1997-1#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-11#1)(2007-1#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#1)
regard to therapeutic##3##3##(2006-10#1)(2006-8#1)(2012-12#1)
regard to these##6##3##(1990-12#1)(1990-6#1)(1995-2#1)(2008-10#1)(2008-9#1)(2011-1#1)
regard to toxicity and##2##4##(2007-11#2)
regard to##487##2##(1990-10#4)(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#4)(1990-8#3)(1990-9#1)(1991-1#1)(1991-12#3)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-3#4)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#5)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#3)(1994-6#2)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#3)(1995-6#1)(1995-9#3)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#3)(1996-3#4)(1996-4#2)(1996-5#1)(1996-6#3)(1996-7#3)(1996-8#4)(1996-9#3)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#2)(1997-7#3)(1997-8#3)(2004-10#1)(2004-11#1)(2004-2#1)(2004-4#1)(2005-1#1)(2005-11#4)(2005-4#1)(2005-8#2)(2006-1#1)(2006-10#20)(2006-11#4)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#5)(2006-7#3)(2006-8#6)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#12)(2007-12#9)(2007-2#4)(2007-3#2)(2007-4#5)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#5)(2007-9#4)(2008-1#4)(2008-10#31)(2008-11#18)(2008-12#13)(2008-2#8)(2008-3#6)(2008-4#6)(2008-5#7)(2008-6#7)(2008-7#8)(2008-8#2)(2008-9#7)(2009-10#1)(2009-11#3)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#2)(2010-11#4)(2010-12#3)(2010-2#2)(2010-3#5)(2010-4#4)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#7)(2011-10#1)(2011-2#16)(2011-3#1)(2012-1#3)(2012-11#2)(2012-12#10)(2012-2#5)(2012-3#5)(2012-9#1)(2013-1#5)(2013-8#9)
regard##588##1##(1990-10#4)(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#4)(1990-6#4)(1990-8#3)(1990-9#2)(1991-1#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#4)(1992-2#2)(1992-3#2)(1992-4#2)(1992-5#3)(1992-6#1)(1992-8#4)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#5)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#3)(1994-6#2)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#3)(1995-6#2)(1995-9#3)(1996-1#1)(1996-10#2)(1996-11#1)(1996-2#3)(1996-3#4)(1996-4#2)(1996-5#1)(1996-6#3)(1996-7#3)(1996-8#4)(1996-9#5)(1997-1#1)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#5)(1997-8#3)(2004-10#1)(2004-11#1)(2004-2#1)(2004-4#1)(2005-1#1)(2005-10#1)(2005-11#4)(2005-4#1)(2005-7#4)(2005-8#2)(2006-1#1)(2006-10#21)(2006-11#4)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#4)(2006-5#2)(2006-6#6)(2006-7#4)(2006-8#8)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#14)(2007-12#12)(2007-2#4)(2007-3#2)(2007-4#5)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#6)(2007-9#4)(2008-1#5)(2008-10#35)(2008-11#25)(2008-12#16)(2008-2#8)(2008-3#7)(2008-4#9)(2008-5#10)(2008-6#10)(2008-7#9)(2008-8#3)(2008-9#8)(2009-10#2)(2009-11#6)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#2)(2009-9#2)(2010-1#3)(2010-11#4)(2010-12#4)(2010-2#2)(2010-3#7)(2010-4#4)(2010-5#6)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#3)(2011-1#8)(2011-10#1)(2011-2#17)(2011-3#1)(2012-1#3)(2012-11#2)(2012-12#10)(2012-2#14)(2012-3#7)(2012-9#1)(2013-1#6)(2013-7#1)(2013-8#11)
regarded as &quot##3##3##(1992-1#1)(2013-1#2)
regarded as a &quot##2##4##(1990-3#1)(2012-11#1)
regarded as a model##2##4##(2008-9#1)(2009-2#1)
regarded as a potential##3##4##(2006-5#1)(2011-12#1)(2012-2#1)
regarded as a risk factor##2##5##(2007-11#1)(2008-3#1)
regarded as a useful##2##4##(2008-3#1)(2011-2#1)
regarded as a##75##3##(1990-11#1)(1990-3#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-5#2)(1993-9#1)(1994-2#1)(1994-7#1)(1995-2#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-6#1)(2004-1#1)(2005-11#2)(2005-9#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#4)(2008-3#6)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
regarded as an important##2##4##(1997-4#1)(2013-1#1)
regarded as an##27##3##(1991-5#1)(1991-6#1)(1992-12#1)(1993-4#1)(1994-3#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-3#1)(1997-4#1)(2003-11#1)(2005-11#1)(2005-8#2)(2006-5#1)(2007-8#1)(2008-11#2)(2008-3#2)(2009-12#1)(2009-5#1)(2010-3#2)(2012-11#1)(2013-1#1)
regarded as being##5##3##(1990-12#1)(1994-6#1)(1996-6#1)(1996-9#1)(2012-2#1)
regarded as complementary##2##3##(2006-7#1)(2008-11#1)
regarded as essential##3##3##(1996-11#1)(2006-2#1)(2010-2#1)
regarded as important##4##3##(1991-6#1)(1995-10#1)(2007-12#1)(2008-11#1)
regarded as its##2##3##(2008-3#1)(2009-2#1)
regarded as one of the most important##2##7##(2006-12#1)(2011-2#1)
regarded as one of the most##3##6##(2006-12#1)(2008-10#1)(2011-2#1)
regarded as one of the##6##5##(1991-4#1)(1994-5#1)(2006-12#1)(2008-10#1)(2011-2#1)(2012-2#1)
regarded as one##7##3##(1991-4#1)(1994-5#1)(2006-12#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
regarded as safe for##2##4##(2008-3#1)(2009-6#1)
regarded as safe##3##3##(2008-3#1)(2009-6#1)(2013-7#1)
regarded as such##2##3##(1994-6#1)(2009-6#1)
regarded as target##2##3##(1993-3#1)(2012-2#1)
regarded as the consequence of##2##5##(1994-12#1)(2012-2#1)
regarded as the gold##2##4##(1996-2#1)(2007-11#1)
regarded as the most##5##4##(1993-2#1)(1994-11#1)(2007-12#1)(2011-1#1)(2012-3#1)
regarded as the##31##3##(1991-5#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1996-2#1)(1996-3#1)(2005-11#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
regarded as very##2##3##(2006-2#1)(2008-10#1)
regarded as##253##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-4#3)(1991-5#3)(1991-6#3)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#4)(1993-3#3)(1993-4#1)(1993-5#3)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-7#2)(1995-10#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-1#1)(1996-11#3)(1996-12#3)(1996-2#3)(1996-3#2)(1996-6#2)(1996-9#1)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#2)(2003-11#1)(2004-1#1)(2005-11#5)(2005-8#3)(2005-9#2)(2006-1#1)(2006-10#3)(2006-12#1)(2006-2#4)(2006-5#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#8)(2007-12#5)(2007-4#2)(2007-8#7)(2007-9#1)(2008-1#3)(2008-10#20)(2008-11#5)(2008-2#2)(2008-3#12)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#2)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#4)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#5)(2012-1#2)(2012-11#4)(2012-12#2)(2012-2#9)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#2)
regarded by##3##2##(1991-3#1)(1991-8#2)
regarded him as##2##3##(1996-12#1)(2007-11#1)
regarded only as##2##3##(1996-11#1)(2008-1#1)
regarded them##2##2##(2008-10#1)(2008-7#1)
regarded to be##2##3##(1994-9#1)(1996-3#1)
regarded to##5##2##(1991-12#1)(1994-9#1)(1996-3#1)(2007-12#1)(2010-7#1)
regarded with##3##2##(1990-2#1)(1994-2#1)(2009-3#1)
regarded##290##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#3)(1991-5#3)(1991-6#3)(1991-8#2)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#4)(1993-3#4)(1993-4#1)(1993-5#3)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#2)(1994-7#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-1#1)(1996-11#5)(1996-12#4)(1996-2#3)(1996-3#3)(1996-6#2)(1996-9#1)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#2)(2003-11#1)(2004-1#1)(2005-11#5)(2005-8#3)(2005-9#2)(2006-1#1)(2006-10#5)(2006-12#1)(2006-2#4)(2006-5#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#10)(2007-12#6)(2007-4#2)(2007-8#8)(2007-9#1)(2008-1#4)(2008-10#21)(2008-11#7)(2008-2#2)(2008-3#12)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#4)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#5)(2012-1#3)(2012-11#4)(2012-12#2)(2012-2#10)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#2)
regarding &quot##2##2##(2005-11#1)(2009-10#1)
regarding HIV/AIDS##3##2##(2007-7#2)(2008-8#1)
regarding a preference for individuals with##2##6##(1994-12#2)
regarding a##11##2##(1990-3#1)(1991-10#1)(1994-12#2)(1996-9#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-10#1)(2009-4#1)(2009-5#1)
regarding access##2##2##(2013-1#2)
regarding adjuvant therapy##2##3##(2008-6#2)
regarding adjuvant##3##2##(2008-6#2)(2011-2#1)
regarding aetiology##2##2##(2007-2#1)(2012-2#1)
regarding age##5##2##(2007-6#1)(2007-7#1)(2010-3#1)(2010-4#1)(2011-2#1)
regarding all##5##2##(1992-8#1)(2006-7#2)(2009-8#1)(2010-4#1)
regarding anatomy##2##2##(2007-11#1)(2012-2#1)
regarding any##2##2##(1997-5#1)(2011-2#1)
regarding application of##2##3##(2008-10#1)(2012-3#1)
regarding appropriate##6##2##(2008-3#1)(2009-2#1)(2010-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
regarding body##2##2##(2006-7#1)(2013-1#1)
regarding both##7##2##(1996-12#1)(2005-8#1)(2006-10#1)(2007-12#2)(2008-8#1)(2010-2#1)
regarding breast##5##2##(1990-8#1)(2007-10#3)(2010-8#1)
regarding cancer##2##2##(2006-2#1)(2009-7#1)
regarding cardiovascular##2##2##(2008-10#1)(2013-1#1)
regarding cigarette smoking##2##3##(1991-5#1)(2009-5#1)
regarding cigarette use##2##3##(2013-1#2)
regarding cigarette##4##2##(1991-5#1)(2009-5#1)(2013-1#2)
regarding clinical##5##2##(1993-8#1)(2006-8#1)(2007-10#1)(2011-3#2)
regarding clopidogrel resistance##2##3##(2011-12#2)
regarding communication##2##2##(1991-2#1)(2008-7#1)
regarding current##2##2##(2008-10#1)(2010-4#1)
regarding data##2##2##(1997-3#1)(2012-11#1)
regarding decision##2##2##(1996-1#1)(2010-2#1)
regarding demographic##2##2##(2007-2#1)(2008-11#1)
regarding dengue##2##2##(2008-1#1)(2012-12#1)
regarding dental##3##2##(1993-1#1)(2006-10#1)(2008-6#1)
regarding diagnosis and##2##3##(1995-10#1)(2008-4#1)
regarding diagnosis##3##2##(1995-10#1)(2005-8#1)(2008-4#1)
regarding dietary##2##2##(2006-8#1)(2009-4#1)
regarding differences between the##2##4##(1996-7#1)(2007-6#1)
regarding disease##3##2##(2008-3#1)(2008-7#1)(2009-11#1)
regarding drug##2##2##(1993-1#1)(2010-5#1)
regarding early##5##2##(1997-1#1)(2008-11#1)(2011-12#1)(2012-3#1)(2013-1#1)
regarding elderly##2##2##(1993-12#1)(2009-5#1)
regarding energy##2##2##(1997-4#1)(2012-2#1)
regarding established##2##2##(2008-11#1)(2010-4#1)
regarding etiology##3##2##(2008-9#1)(2013-1#2)
regarding euthanasia##2##2##(2006-7#1)(2013-7#1)
regarding exercise and##2##3##(1993-11#1)(2010-3#1)
regarding existing##2##2##(1991-5#1)(2008-10#1)
regarding exposure to##2##3##(2006-12#1)(2010-12#1)
regarding factors##2##2##(2008-10#1)(2012-3#1)
regarding fertility and##2##3##(2009-2#1)(2009-6#1)
regarding further##2##2##(2008-10#1)(2012-2#1)
regarding general##2##2##(2006-10#1)(2006-8#1)
regarding health care##2##3##(1994-12#1)(2012-2#1)
regarding health##5##2##(1994-12#1)(2009-9#1)(2011-1#1)(2012-2#2)
regarding his##4##2##(1991-2#1)(2009-2#1)(2011-1#1)(2013-1#1)
regarding home##2##2##(2010-10#1)(2012-11#1)
regarding hospice care##3##3##(2008-6#1)(2012-12#2)
regarding hospital##2##2##(1995-1#1)(2007-2#1)
regarding how to##2##3##(2007-5#1)(2008-12#1)
regarding how##12##2##(1994-12#1)(2006-12#1)(2007-12#2)(2007-5#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-9#1)(2010-11#1)(2012-2#1)
regarding human##4##2##(2006-11#1)(2006-7#1)(2010-11#1)(2011-2#1)
regarding identification##2##2##(2007-8#1)(2011-12#1)
regarding implementation##2##2##(2006-11#1)(2007-12#1)
regarding individual##2##2##(2008-11#1)(2013-1#1)
regarding infection##2##2##(2007-7#1)(2011-2#1)
regarding isolation of##2##3##(2007-7#1)(2008-2#1)
regarding its application##2##3##(2011-2#1)(2012-2#1)
regarding its diagnosis##2##3##(2006-9#1)(2012-3#1)
regarding its etiology##2##3##(2006-9#1)(2008-6#1)
regarding its impact##2##3##(2007-8#1)(2008-7#1)
regarding its possible##2##3##(1997-7#1)(2012-2#1)
regarding its potential##3##3##(2007-1#1)(2008-4#1)(2012-2#1)
regarding its##28##2##(1993-12#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-9#3)(2007-1#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-8#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
regarding larval##2##2##(2008-8#1)(2012-2#1)
regarding long-term##4##2##(1995-12#1)(2008-8#1)(2012-2#1)(2013-1#1)
regarding male##2##2##(2006-10#1)(2012-2#1)
regarding management of##3##3##(2008-10#1)(2008-7#1)(2010-2#1)
regarding management##4##2##(2005-10#1)(2008-10#1)(2008-7#1)(2010-2#1)
regarding mechanisms of##2##3##(1996-9#1)(2008-10#1)
regarding mechanisms##3##2##(1996-9#1)(2008-10#1)(2011-1#1)
regarding medical##3##2##(1992-12#1)(2007-4#1)(2011-2#1)
regarding multiple##2##2##(2006-11#1)(2013-1#1)
regarding natural history##2##3##(2005-8#1)(2007-8#1)
regarding nutrition##3##2##(1991-3#1)(2008-4#1)(2013-7#1)
regarding occupational health##2##3##(2007-1#1)(2011-1#1)
regarding occupational##3##2##(2007-1#1)(2011-1#1)(2013-1#1)
regarding optimal##2##2##(2010-4#1)(2012-12#1)
regarding other##2##2##(2007-3#1)(2008-12#1)
regarding our##2##2##(2007-6#1)(2011-1#1)
regarding outcomes##3##2##(2008-9#1)(2010-5#1)(2011-2#1)
regarding pain##2##2##(2007-7#1)(2012-2#1)
regarding participation in##3##3##(1996-1#1)(2008-11#1)(2008-7#1)
regarding patient characteristics##2##3##(2007-7#1)(2010-7#1)
regarding patient##7##2##(1992-3#1)(2007-7#1)(2010-4#1)(2010-7#1)(2013-1#3)
regarding permeability##3##2##(2005-11#1)(2008-10#1)(2008-5#1)
regarding physician##2##2##(1996-1#2)
regarding positive##2##2##(2007-7#1)(2008-6#1)
regarding possible##4##2##(1996-3#1)(1997-4#1)(2011-1#1)(2011-2#1)
regarding potential mechanisms of##2##4##(2008-4#1)(2011-1#1)
regarding potential##6##2##(2007-8#1)(2008-4#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-2#1)
regarding pregnancy##3##2##(1992-2#1)(2012-11#2)
regarding prevention of##2##3##(1992-2#1)(2008-12#1)
regarding prevention##3##2##(1992-2#1)(2008-12#1)(2012-12#1)
regarding previous genital infection##2##4##(1992-12#2)
regarding previous genital##3##3##(1992-12#3)
regarding previous##4##2##(1992-12#3)(2008-7#1)
regarding protein structure##2##3##(1993-6#1)(2008-4#1)
regarding protein##3##2##(1993-6#1)(2008-4#1)(2010-11#1)
regarding psychiatric##3##2##(2007-9#2)(2012-2#1)
regarding quality##2##2##(1996-3#1)(2008-7#1)
regarding risk##4##2##(2006-10#1)(2008-4#1)(2008-6#1)(2010-12#1)
regarding risks##2##2##(2007-7#1)(2013-8#1)
regarding safety##3##2##(2006-10#1)(2007-9#1)(2008-8#1)
regarding screening for##2##3##(1990-8#1)(2006-10#1)
regarding sensitivity##2##2##(1992-6#1)(2006-10#1)
regarding sex##2##2##(2006-8#1)(2010-5#1)
regarding sexual##7##2##(2008-12#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-12#1)
regarding specific##3##2##(1991-6#1)(1995-1#1)(2008-4#1)
regarding student##3##2##(2008-11#2)(2011-2#1)
regarding substance##2##2##(2008-6#1)(2012-2#1)
regarding such##4##2##(1995-1#1)(2008-6#1)(2012-3#2)
regarding surgical##4##2##(2005-10#1)(2008-9#1)(2011-2#1)(2013-8#1)
regarding surveillance##2##2##(2012-3#1)(2013-1#1)
regarding the &quot##2##3##(1995-11#1)(2010-7#1)
regarding the ability of##4##4##(2008-11#1)(2008-8#1)(2011-2#1)(2013-8#1)
regarding the accuracy of the##2##5##(2008-2#1)(2012-2#1)
regarding the advantages##2##3##(2007-2#1)(2009-5#1)
regarding the analysis of##2##4##(2007-6#1)(2008-10#1)
regarding the analysis##3##3##(2007-6#1)(2008-10#2)
regarding the appropriate##2##3##(2008-10#1)(2008-3#1)
regarding the appropriateness of##2##4##(1996-2#1)(2006-10#1)
regarding the assessment##2##3##(2008-10#1)(2008-6#1)
regarding the association##2##3##(1994-8#1)(2008-7#1)
regarding the benefit of##2##4##(2007-2#1)(2010-5#1)
regarding the benefits##2##3##(1996-12#1)(2008-2#1)
regarding the best management##2##4##(2007-12#1)(2010-3#1)
regarding the best##5##3##(2007-12#1)(2008-7#1)(2010-3#2)(2011-2#1)
regarding the biological##4##3##(1990-9#1)(1995-3#1)(2008-5#1)(2013-1#1)
regarding the biology of##2##4##(2006-10#1)(2007-11#1)
regarding the choice of##2##4##(2011-2#1)(2012-2#1)
regarding the clinical##7##3##(1990-9#1)(2007-8#1)(2008-1#1)(2009-8#1)(2011-2#2)(2013-8#1)
regarding the comparative##2##3##(2008-7#1)(2010-4#1)
regarding the contribution of##3##4##(2008-12#1)(2008-7#1)(2008-8#1)
regarding the correct##2##3##(2008-7#1)(2013-1#1)
regarding the correlation between##2##4##(2008-12#1)(2009-5#1)
regarding the current##3##3##(2008-1#1)(2008-10#1)(2012-12#1)
regarding the degree of##4##4##(1997-3#2)(2012-11#1)(2012-2#1)
regarding the determination of##2##4##(2008-10#2)
regarding the development of##5##4##(2008-12#1)(2008-2#1)(2008-6#1)(2009-9#1)(2012-12#1)
regarding the development##6##3##(2006-8#1)(2008-12#1)(2008-2#1)(2008-6#1)(2009-9#1)(2012-12#1)
regarding the different##3##3##(2009-6#1)(2013-1#2)
regarding the distribution of##2##4##(2012-2#2)
regarding the effect of##7##4##(2007-10#2)(2007-11#1)(2008-10#1)(2008-6#1)(2011-2#1)(2013-8#1)
regarding the effectiveness and##2##4##(2013-1#2)
regarding the effectiveness of##4##4##(2007-10#1)(2007-2#1)(2008-12#1)(2012-2#1)
regarding the effectiveness##6##3##(2007-10#1)(2007-2#1)(2008-12#1)(2012-2#1)(2013-1#2)
regarding the effects of the##2##5##(1991-10#1)(2013-8#1)
regarding the effects of##6##4##(1991-10#1)(1993-3#1)(2008-9#1)(2012-1#1)(2013-8#2)
regarding the effects##7##3##(1991-10#1)(1993-3#1)(2008-9#1)(2009-5#1)(2012-1#1)(2013-8#2)
regarding the efficacy of##3##4##(2006-2#1)(2008-11#1)(2009-5#1)
regarding the efficacy##5##3##(1992-5#1)(2006-2#1)(2008-11#2)(2009-5#1)
regarding the epidemiology##2##3##(2005-8#1)(2007-11#1)
regarding the establishment of##2##4##(2006-10#1)(2013-1#1)
regarding the etiology and##2##4##(2005-8#1)(2008-7#1)
regarding the etiology##4##3##(2005-8#1)(2008-10#1)(2008-7#1)(2009-4#1)
regarding the evolution of##2##4##(2010-6#1)(2012-2#1)
regarding the evolution##3##3##(1996-2#1)(2010-6#1)(2012-2#1)
regarding the expression##2##3##(1995-12#1)(2009-10#1)
regarding the factors##2##3##(2011-2#1)(2012-3#1)
regarding the feasibility##2##3##(2004-9#1)(2012-12#1)
regarding the following##2##3##(2008-1#1)(2011-1#1)
regarding the formation of##2##4##(1991-6#1)(2013-1#1)
regarding the function of##3##4##(1995-11#1)(2008-7#1)(2010-2#1)
regarding the functional role of##2##5##(1991-4#1)(2009-10#1)
regarding the functional##4##3##(1991-4#1)(2008-6#1)(2009-10#2)
regarding the future##2##3##(1996-1#1)(2012-12#1)
regarding the genetic##4##3##(2006-5#1)(2008-4#1)(2009-10#1)(2011-2#1)
regarding the identity##2##3##(2008-11#2)
regarding the impact of##9##4##(2007-9#2)(2008-11#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
regarding the impact##10##3##(1995-5#1)(2007-9#2)(2008-11#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
regarding the implementation of a##3##5##(2007-11#1)(2010-10#2)
regarding the importance of##5##4##(2006-7#1)(2008-1#1)(2009-7#1)(2012-2#1)(2013-8#1)
regarding the importance##6##3##(2006-7#1)(2008-1#1)(2008-3#1)(2009-7#1)(2012-2#1)(2013-8#1)
regarding the incidence of##3##4##(2007-1#1)(2008-10#1)(2008-12#1)
regarding the influence of##2##4##(2007-10#1)(2008-9#1)
regarding the interaction##2##3##(2006-10#1)(2008-7#1)
regarding the interactions between##2##4##(2008-10#1)(2013-1#1)
regarding the interpretation of##2##4##(2007-11#1)(2013-1#1)
regarding the key##2##3##(2006-10#1)(2008-8#1)
regarding the knowledge##2##3##(2008-2#1)(2013-8#1)
regarding the location of##2##4##(2007-7#1)(2012-12#1)
regarding the long term##2##4##(1991-10#1)(2010-4#1)
regarding the long-term##3##3##(2006-10#1)(2006-9#1)(2011-2#1)
regarding the management of##7##4##(2006-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-11#1)(2010-2#1)(2011-2#1)
regarding the mechanism##2##3##(2007-9#1)(2010-2#1)
regarding the mechanisms##3##3##(1994-11#1)(2007-4#1)(2012-12#1)
regarding the medical##3##3##(1993-12#1)(2006-9#1)(2011-2#1)
regarding the molecular mechanisms##2##4##(1994-12#1)(2010-1#1)
regarding the nature of##4##4##(1996-12#1)(2008-11#1)(2008-9#1)(2013-7#1)
regarding the nature##5##3##(1996-12#1)(2008-11#1)(2008-9#2)(2013-7#1)
regarding the need for##2##4##(1995-2#1)(1997-3#1)
regarding the need##3##3##(1995-2#1)(1997-3#1)(2009-7#1)
regarding the number of##2##4##(2008-10#1)(2008-12#1)
regarding the optimal##7##3##(1994-12#1)(1995-5#1)(2005-8#1)(2007-7#2)(2007-8#1)(2011-2#1)
regarding the origin of this##3##5##(2013-1#2)(2013-8#1)
regarding the overall##2##3##(1993-12#1)(2007-1#1)
regarding the pathogenesis of##2##4##(2005-8#1)(2012-2#1)
regarding the pathogenesis##3##3##(2005-8#1)(2006-10#1)(2012-2#1)
regarding the pathogenic##2##3##(2008-5#1)(2010-7#1)
regarding the physiological##2##3##(1994-11#1)(2007-11#1)
regarding the possibility##2##3##(2008-7#1)(2011-2#1)
regarding the possible##6##3##(1995-11#1)(2005-7#2)(2006-10#1)(2006-12#1)(2006-2#1)
regarding the potential for##3##4##(2005-7#2)(2012-12#1)
regarding the potential##9##3##(1992-3#1)(1994-1#2)(2005-7#2)(2007-7#1)(2008-10#1)(2009-11#1)(2012-12#1)
regarding the prevalence##2##3##(2007-2#1)(2010-12#1)
regarding the pros and cons of##2##6##(1996-6#1)(2008-4#1)
regarding the quality of##2##4##(2005-7#1)(2013-1#1)
regarding the regulation of##2##4##(1997-1#1)(2008-1#1)
regarding the relationship between##7##4##(2008-4#1)(2009-10#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
regarding the relationship of##2##4##(1991-2#1)(2007-8#1)
regarding the relationship##9##3##(1991-2#1)(2007-8#1)(2008-4#1)(2009-10#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
regarding the relative##5##3##(1993-2#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-5#1)
regarding the results##2##3##(1991-3#1)(2010-6#1)
regarding the risk of##4##4##(2007-4#1)(2009-11#1)(2012-12#1)(2013-1#1)
regarding the risks and benefits##2##5##(2005-6#1)(2007-9#1)
regarding the risks of##2##4##(1993-2#1)(2010-1#1)
regarding the risks##4##3##(1993-2#1)(2005-6#1)(2007-9#1)(2010-1#1)
regarding the role of the##2##5##(2007-8#1)(2008-8#1)
regarding the role of##17##4##(1992-7#1)(1995-1#1)(1995-12#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-8#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
regarding the safety of##5##4##(2007-11#1)(2007-9#2)(2008-11#1)(2010-12#1)
regarding the significance of##2##4##(2009-10#1)(2012-11#1)
regarding the specific##3##3##(2007-10#1)(2008-4#1)(2012-12#1)
regarding the stability##3##3##(1996-8#1)(2007-6#1)(2008-11#1)
regarding the standard##2##3##(2007-10#1)(2012-3#1)
regarding the structure and##2##4##(1995-1#1)(2007-11#1)
regarding the structure##3##3##(1995-1#1)(2007-11#1)(2010-7#1)
regarding the successful##2##3##(1993-3#1)(1996-12#1)
regarding the surrounding##2##3##(2008-12#1)(2008-7#1)
regarding the therapeutic##2##3##(1992-6#1)(2006-10#1)
regarding the time course##2##4##(2008-4#1)(2010-3#1)
regarding the time##3##3##(2006-6#1)(2008-4#1)(2010-3#1)
regarding the timing##2##3##(2009-6#1)(2010-8#1)
regarding the topic##2##3##(2012-12#1)(2013-8#1)
regarding the transmission of##2##4##(1991-5#1)(2007-12#1)
regarding the treatment of the##2##5##(2007-11#1)(2008-1#1)
regarding the treatment of##6##4##(2007-11#1)(2007-4#1)(2008-1#2)(2011-2#1)(2012-12#1)
regarding the treatment##7##3##(2007-11#1)(2007-4#1)(2007-9#1)(2008-1#2)(2011-2#1)(2012-12#1)
regarding the use of##24##4##(1991-5#1)(1992-9#1)(1993-9#1)(2005-10#1)(2005-11#1)(2005-8#2)(2006-10#2)(2007-10#1)(2007-11#1)(2007-4#1)(2008-12#1)(2009-11#1)(2009-2#1)(2010-12#1)(2010-5#2)(2012-2#2)(2013-1#4)
regarding the use##25##3##(1991-5#1)(1992-9#1)(1993-9#1)(2005-10#1)(2005-11#1)(2005-8#2)(2006-10#2)(2007-10#1)(2007-11#1)(2007-4#1)(2008-12#1)(2008-6#1)(2009-11#1)(2009-2#1)(2010-12#1)(2010-5#2)(2012-2#2)(2013-1#4)
regarding the various types of##2##5##(2006-9#1)(2007-7#1)
regarding the various##3##3##(2006-9#1)(2007-10#1)(2007-7#1)
regarding the##658##2##(1990-3#1)(1990-6#1)(1990-9#2)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#1)(1992-10#1)(1992-12#1)(1992-3#3)(1992-5#1)(1992-6#2)(1992-7#4)(1992-9#1)(1993-10#1)(1993-12#2)(1993-2#3)(1993-3#3)(1993-4#1)(1993-6#2)(1993-9#1)(1994-1#2)(1994-11#4)(1994-12#5)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#5)(1995-11#3)(1995-12#5)(1995-2#3)(1995-3#1)(1995-5#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#5)(1996-2#3)(1996-3#3)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#4)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-3#1)(2004-5#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-6#1)(2005-7#5)(2005-8#8)(2006-10#20)(2006-12#2)(2006-2#3)(2006-3#2)(2006-4#2)(2006-5#3)(2006-6#3)(2006-7#1)(2006-8#5)(2006-9#5)(2007-1#5)(2007-10#9)(2007-11#16)(2007-12#8)(2007-2#10)(2007-4#15)(2007-5#4)(2007-6#2)(2007-7#7)(2007-8#10)(2007-9#8)(2008-1#12)(2008-10#23)(2008-11#28)(2008-12#14)(2008-2#11)(2008-3#12)(2008-4#7)(2008-5#6)(2008-6#7)(2008-7#18)(2008-8#10)(2008-9#7)(2009-10#9)(2009-11#3)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#5)(2009-6#3)(2009-7#5)(2009-8#2)(2009-9#2)(2010-1#4)(2010-10#3)(2010-11#2)(2010-12#9)(2010-2#6)(2010-3#6)(2010-4#4)(2010-5#5)(2010-6#3)(2010-7#4)(2010-8#4)(2010-9#3)(2011-1#6)(2011-12#1)(2011-2#27)(2012-1#3)(2012-11#3)(2012-12#23)(2012-2#21)(2012-3#4)(2013-1#37)(2013-7#2)(2013-8#18)
regarding their current texting practices and the feasibility/acceptability of text messaging as a means of conducting sexual health promotion##2##19##(2013-1#2)
regarding their potential use##2##4##(2006-10#1)(2008-5#1)
regarding their relative##2##3##(2007-8#1)(2009-4#1)
regarding their role in##2##4##(2008-4#1)(2009-7#1)
regarding their use of##2##4##(2007-10#1)(2012-2#1)
regarding their use##3##3##(2007-10#1)(2007-12#1)(2012-2#1)
regarding their##54##2##(1992-12#1)(1992-2#1)(1993-11#1)(1994-12#1)(1994-3#1)(1995-1#2)(1997-2#1)(2004-12#1)(2005-7#1)(2006-10#4)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-12#4)(2012-2#2)(2012-5#1)(2013-1#5)(2013-7#1)
regarding therapeutic##2##2##(1990-2#1)(2005-10#1)
regarding these agents##2##3##(2006-10#1)(2008-8#1)
regarding these##18##2##(1991-12#1)(1996-2#1)(1997-1#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
regarding this issue##2##3##(1990-11#1)(2011-2#1)
regarding this problem##2##3##(2013-1#1)(2013-8#1)
regarding this subject##2##3##(2007-2#1)(2009-3#1)
regarding this topic is##2##4##(2011-12#1)(2012-1#1)
regarding this topic##4##3##(2008-3#1)(2011-12#1)(2012-1#1)(2013-8#1)
regarding this##17##2##(1990-11#1)(1991-10#1)(2007-2#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-3#1)(2010-10#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#2)
regarding to##4##2##(1996-12#1)(2008-10#1)(2013-1#1)(2013-8#1)
regarding treatment of##3##3##(2006-10#1)(2008-5#1)(2012-3#1)
regarding use of##8##3##(1992-5#1)(1996-2#1)(2006-2#1)(2007-10#1)(2008-8#1)(2008-9#1)(2013-1#2)
regarding use##9##2##(1992-5#1)(1996-2#1)(2006-2#1)(2007-10#1)(2008-8#1)(2008-9#1)(2013-1#3)
regarding various##2##2##(2007-11#1)(2012-2#1)
regarding whether##3##2##(1991-3#1)(2006-3#1)(2007-1#1)
regarding which##4##2##(2008-5#1)(2011-8#1)(2012-3#1)(2013-8#1)
regarding workplace##2##2##(1992-1#1)(2010-6#1)
regarding##1598##1##(1990-1#1)(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#4)(1990-6#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-10#5)(1991-11#1)(1991-12#4)(1991-2#4)(1991-3#5)(1991-4#1)(1991-5#7)(1991-6#3)(1991-7#2)(1991-8#2)(1992-1#2)(1992-10#1)(1992-12#9)(1992-2#4)(1992-3#4)(1992-5#2)(1992-6#3)(1992-7#4)(1992-8#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#5)(1993-2#4)(1993-3#5)(1993-4#1)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#1)(1994-1#2)(1994-11#4)(1994-12#10)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#2)(1995-1#11)(1995-10#1)(1995-11#3)(1995-12#6)(1995-2#3)(1995-3#2)(1995-4#3)(1995-5#3)(1995-8#2)(1995-9#3)(1996-1#7)(1996-11#2)(1996-12#11)(1996-2#7)(1996-3#6)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#5)(1997-2#3)(1997-3#6)(1997-4#3)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#8)(2004-11#2)(2004-12#2)(2004-3#1)(2004-5#1)(2004-9#1)(2005-10#6)(2005-11#6)(2005-12#1)(2005-6#1)(2005-7#10)(2005-8#13)(2005-9#1)(2006-10#62)(2006-11#4)(2006-12#9)(2006-2#6)(2006-3#3)(2006-4#2)(2006-5#6)(2006-6#5)(2006-7#12)(2006-8#18)(2006-9#10)(2007-1#10)(2007-10#25)(2007-11#24)(2007-12#23)(2007-2#19)(2007-3#4)(2007-4#26)(2007-5#6)(2007-6#6)(2007-7#24)(2007-8#24)(2007-9#18)(2008-1#21)(2008-10#45)(2008-11#54)(2008-12#28)(2008-2#25)(2008-3#22)(2008-4#23)(2008-5#17)(2008-6#29)(2008-7#38)(2008-8#23)(2008-9#18)(2009-10#11)(2009-11#8)(2009-12#1)(2009-2#5)(2009-3#6)(2009-4#12)(2009-5#11)(2009-6#7)(2009-7#10)(2009-8#5)(2009-9#4)(2010-1#7)(2010-10#6)(2010-11#9)(2010-12#22)(2010-2#12)(2010-3#15)(2010-4#16)(2010-5#10)(2010-6#7)(2010-7#5)(2010-8#9)(2010-9#4)(2011-1#31)(2011-12#9)(2011-2#64)(2011-3#3)(2011-7#1)(2011-8#1)(2012-1#8)(2012-11#10)(2012-12#55)(2012-2#69)(2012-3#23)(2012-5#1)(2013-1#99)(2013-7#7)(2013-8#39)
regardless of BMI##2##3##(1994-12#1)(2008-9#1)
regardless of RH##2##3##(2008-10#2)
regardless of ability to##2##4##(1994-2#1)(2010-12#1)
regardless of affective valence##2##4##(2008-11#2)
regardless of age##10##3##(1992-11#1)(1993-12#2)(2006-10#1)(2007-7#1)(2008-5#2)(2008-7#1)(2011-1#1)(2013-7#1)
regardless of concentration##2##3##(2008-10#1)(2010-4#1)
regardless of diagnosis##2##3##(1994-12#1)(2010-2#1)
regardless of differences in##3##4##(1991-9#1)(2011-1#1)(2013-8#1)
regardless of ethnicity or gender##2##5##(2007-12#2)
regardless of food##2##3##(2010-8#1)(2011-1#1)
regardless of gender and##2##4##(2008-7#1)(2013-1#1)
regardless of gender##4##3##(2007-12#1)(2008-3#1)(2008-7#1)(2013-1#1)
regardless of how##2##3##(1992-2#1)(2008-7#1)
regardless of injury##2##3##(2007-10#1)(2009-4#1)
regardless of its##5##3##(1991-12#1)(2008-7#1)(2009-5#1)(2011-12#1)(2013-1#1)
regardless of race##2##3##(2008-5#2)
regardless of sex##6##3##(2007-11#1)(2008-5#1)(2009-1#1)(2009-11#1)(2009-7#1)(2011-1#1)
regardless of size##4##3##(1996-12#1)(2008-10#1)(2010-12#1)(2011-2#1)
regardless of stage##2##3##(2008-8#1)(2012-3#1)
regardless of the cause of##2##5##(1991-7#1)(2006-10#1)
regardless of the cause##3##4##(1991-7#1)(2006-10#1)(2011-1#1)
regardless of the degree of##4##5##(1992-1#1)(1993-12#1)(2007-12#1)(2007-5#1)
regardless of the etiology of##2##5##(2013-1#1)(2013-8#1)
regardless of the fraction of##2##5##(2005-11#1)(2008-11#1)
regardless of the host##2##4##(2008-10#2)
regardless of the irrigation##2##4##(2008-10#2)
regardless of the method##2##4##(2007-8#1)(2008-10#1)
regardless of the origin of##2##5##(2008-10#2)
regardless of the origin##3##4##(2008-10#3)
regardless of the presence of##6##5##(1992-7#1)(1993-8#1)(1994-9#1)(2008-10#2)(2009-3#1)
regardless of the presence or absence of##5##7##(1992-9#1)(1993-12#1)(1993-3#1)(2008-10#2)
regardless of the presence##11##4##(1992-7#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-9#1)(2008-10#4)(2009-3#1)
regardless of the site of##2##5##(2008-10#1)(2008-9#1)
regardless of the size##2##4##(1996-6#1)(2010-5#1)
regardless of the stage of##3##5##(1991-5#1)(2011-1#1)(2012-3#1)
regardless of the step-to-step transition type used##2##7##(2012-12#2)
regardless of the time of##2##5##(2006-5#1)(2008-10#1)
regardless of the type of##3##5##(1997-1#1)(2008-1#1)(2010-11#1)
regardless of the##137##3##(1990-12#1)(1990-8#1)(1991-11#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-12#3)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-4#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-12#1)(2005-11#3)(2005-8#1)(2006-10#1)(2006-11#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-12#3)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#23)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#4)(2008-5#5)(2008-7#3)(2008-9#3)(2009-3#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#4)(2013-8#6)
regardless of their gender##2##4##(2005-10#1)(2008-2#1)
regardless of their##23##3##(1990-5#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-9#2)(1995-9#2)(1996-2#1)(2005-10#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#2)(2009-12#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
regardless of treatment##2##3##(2007-12#1)(2007-8#1)
regardless of type of##2##4##(2007-12#1)(2008-9#1)
regardless of whether cells##2##4##(1996-5#1)(2009-4#1)
regardless of whether or not Ca2+ was present##2##8##(1994-2#2)
regardless of whether the##13##4##(1990-2#1)(1991-5#1)(1995-11#1)(2005-10#1)(2007-10#1)(2008-10#4)(2008-12#1)(2008-2#1)(2009-3#1)(2010-5#1)
regardless of whether they are##3##5##(1994-9#1)(2007-12#1)(2009-4#1)
regardless of whether they were##2##5##(2008-10#1)(2010-3#1)
regardless of whether they##6##4##(1994-9#1)(1996-4#1)(2007-12#1)(2008-10#1)(2009-4#1)(2010-3#1)
regardless of whether##36##3##(1990-2#1)(1991-5#1)(1994-2#2)(1994-9#1)(1995-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(2005-10#1)(2005-12#1)(2006-2#1)(2007-10#2)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-9#1)(2009-3#1)(2009-4#2)(2010-3#1)(2010-5#1)
regardless of which definition is selected##2##6##(2013-1#2)
regardless of which##4##3##(2007-12#1)(2008-7#1)(2013-1#2)
regardless of year##2##3##(2008-10#2)
regardless of##371##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#3)(1990-8#2)(1991-11#2)(1991-12#1)(1991-4#1)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-7#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#6)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-4#1)(1994-8#1)(1994-9#5)(1995-11#2)(1995-12#1)(1995-2#5)(1995-4#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#3)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1997-1#2)(1997-2#1)(1997-4#4)(1997-5#2)(1997-6#1)(1997-8#2)(2004-12#2)(2005-10#2)(2005-11#4)(2005-12#1)(2005-8#2)(2006-10#3)(2006-11#1)(2006-2#1)(2006-5#3)(2006-6#1)(2006-7#2)(2006-8#2)(2007-10#3)(2007-11#1)(2007-12#12)(2007-4#3)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#7)(2007-9#2)(2008-1#5)(2008-10#48)(2008-11#6)(2008-12#3)(2008-2#11)(2008-3#9)(2008-4#2)(2008-5#12)(2008-7#10)(2008-8#1)(2008-9#11)(2009-1#2)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#3)(2010-7#1)(2010-8#2)(2011-1#8)(2011-12#3)(2011-2#9)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#10)(2012-3#7)(2013-1#15)(2013-7#1)(2013-8#10)
regardless##377##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#3)(1990-8#2)(1990-9#1)(1991-11#2)(1991-12#1)(1991-4#1)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-7#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#6)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-4#1)(1994-8#1)(1994-9#5)(1995-11#2)(1995-12#1)(1995-2#5)(1995-4#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#3)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1997-1#2)(1997-2#1)(1997-4#4)(1997-5#2)(1997-6#1)(1997-8#2)(2004-12#2)(2005-10#2)(2005-11#4)(2005-12#1)(2005-8#2)(2006-10#3)(2006-11#1)(2006-2#1)(2006-5#3)(2006-6#1)(2006-7#2)(2006-8#2)(2007-10#3)(2007-11#1)(2007-12#12)(2007-4#3)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#7)(2007-9#2)(2008-1#5)(2008-10#48)(2008-11#7)(2008-12#3)(2008-2#11)(2008-3#9)(2008-4#2)(2008-5#12)(2008-7#10)(2008-8#1)(2008-9#11)(2009-1#2)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#3)(2010-7#1)(2010-8#2)(2011-1#9)(2011-12#3)(2011-2#9)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#10)(2012-3#7)(2013-1#16)(2013-7#1)(2013-8#10)
regards the##28##2##(1990-2#1)(1990-4#1)(1990-5#3)(1991-12#1)(1992-3#1)(1993-9#1)(1994-4#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-4#1)(1996-5#1)(1996-7#1)(2006-10#1)(2006-12#1)(2006-6#1)(2008-1#1)(2008-10#3)(2008-2#1)(2009-2#1)(2010-12#1)(2011-2#1)(2013-8#1)
regards their##5##2##(1990-2#1)(1995-2#1)(2007-10#1)(2010-12#1)(2010-4#1)
regards to the##16##3##(1996-9#1)(2006-2#1)(2006-8#1)(2007-12#1)(2008-6#1)(2008-8#1)(2009-10#2)(2009-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#1)
regards to their##6##3##(2007-12#1)(2008-10#1)(2008-2#2)(2009-3#1)(2011-1#1)
regards to##55##2##(1993-4#1)(1996-9#1)(2006-2#1)(2006-5#1)(2006-8#3)(2007-11#1)(2007-12#3)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-2#1)(2009-3#2)(2009-5#1)(2009-8#1)(2010-12#2)(2010-8#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#2)
regards##147##1##(1990-2#3)(1990-4#2)(1990-5#3)(1990-6#3)(1990-9#1)(1991-12#1)(1991-4#3)(1991-6#3)(1991-8#4)(1992-10#3)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#2)(1992-9#2)(1993-2#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-4#1)(1994-6#1)(1995-2#1)(1995-5#3)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-7#2)(1996-9#1)(1997-2#1)(2005-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#4)(2006-8#6)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-12#1)(2008-2#7)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#4)(2010-4#1)(2010-8#1)(2011-1#5)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#4)
regenerable chemiluminescent##2##2##(2008-10#2)
regenerable##6##1##(1994-2#1)(2008-1#1)(2008-10#3)(2008-4#1)
regenerants were##2##2##(2008-9#1)(2013-1#1)
regenerants##5##1##(2006-12#1)(2008-10#1)(2008-9#2)(2013-1#1)
regenerate into##2##2##(2007-1#1)(2008-5#1)
regenerate the##8##2##(1995-10#1)(1996-9#1)(2008-10#2)(2008-11#1)(2008-5#2)(2013-1#1)
regenerate was##2##2##(2007-11#1)(2009-3#1)
regenerate##47##1##(1990-2#1)(1991-3#2)(1992-1#1)(1994-2#2)(1995-10#1)(1995-3#1)(1996-9#1)(1997-4#1)(2007-1#1)(2007-11#5)(2008-1#1)(2008-10#3)(2008-11#3)(2008-5#6)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#1)(2010-10#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
regenerated and##3##2##(2006-12#1)(2008-10#2)
regenerated at##2##2##(1991-11#1)(2008-9#1)
regenerated bone##5##2##(2007-11#1)(2007-8#3)(2012-12#1)
regenerated by passing##2##3##(2008-10#1)(2008-12#1)
regenerated by simple polishing##2##4##(2008-10#2)
regenerated by using##2##3##(2008-10#2)
regenerated by##20##2##(1992-6#1)(2008-10#16)(2008-12#1)(2008-5#1)(2008-6#1)
regenerated fiber##2##2##(2007-11#1)(2013-8#1)
regenerated for##2##2##(2007-8#1)(2008-10#1)
regenerated from##4##2##(2008-10#1)(2008-8#2)(2013-1#1)
regenerated grating##2##2##(2007-11#2)
regenerated host##3##2##(2011-2#3)
regenerated in##3##2##(1990-5#1)(1992-9#1)(2013-1#1)
regenerated plants##5##2##(2006-12#1)(2007-1#1)(2008-8#1)(2009-6#1)(2013-1#1)
regenerated to##3##2##(1991-10#2)(2005-11#1)
regenerated using##2##2##(2008-10#2)
regenerated with##3##2##(1991-7#1)(2008-10#2)
regenerated##112##1##(1990-5#1)(1991-10#3)(1991-11#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-6#1)(1992-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-4#1)(2005-11#2)(2006-12#2)(2007-1#1)(2007-11#4)(2007-12#2)(2007-5#1)(2007-8#4)(2008-1#1)(2008-10#32)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#11)(2008-6#1)(2008-8#4)(2008-9#3)(2009-6#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#5)(2011-7#1)(2012-12#2)(2013-1#6)(2013-8#5)
regenerates##6##1##(1991-1#1)(1991-4#1)(2007-11#1)(2007-5#1)(2008-3#1)(2013-1#1)
regenerating axons##3##2##(1993-12#1)(1995-3#1)(1996-3#1)
regenerating bone##2##2##(2008-9#1)(2010-12#1)
regenerating islet-derived##2##2##(2008-10#1)(2010-10#1)
regenerating liver after partial##2##4##(1991-2#1)(2008-8#1)
regenerating liver from##2##3##(1996-11#2)
regenerating liver was##2##3##(1990-5#1)(1994-8#1)
regenerating liver##13##2##(1990-5#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-11#2)(1994-12#1)(1994-8#1)(1996-11#2)(2008-8#1)
regenerating livers of##3##3##(1995-1#2)(1996-11#1)
regenerating livers##6##2##(1991-1#1)(1995-1#3)(1996-11#2)
regenerating muscle##2##2##(2008-1#2)
regenerating peripheral nerves##2##3##(1994-3#2)
regenerating process of collecting ducts and ureters of##2##8##(1997-6#2)
regenerating rabbit liver##3##3##(1994-12#3)
regenerating rat liver##11##3##(1991-5#1)(1991-7#3)(1992-4#3)(1993-9#1)(1994-3#1)(1997-8#2)
regenerating rat##13##2##(1991-5#1)(1991-7#3)(1992-4#3)(1993-9#1)(1994-3#1)(1995-1#2)(1997-8#2)
regenerating the##3##2##(2007-8#1)(2008-10#1)(2012-2#1)
regenerating##86##1##(1990-2#3)(1990-5#2)(1990-7#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#5)(1992-11#3)(1992-4#3)(1993-12#2)(1993-9#1)(1994-12#5)(1994-2#1)(1994-3#3)(1994-8#1)(1995-1#5)(1995-12#1)(1995-3#1)(1995-6#1)(1996-11#5)(1996-2#2)(1996-3#1)(1997-6#3)(1997-8#2)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#4)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2012-2#1)(2013-1#2)(2013-8#2)
regeneration ability##4##2##(2007-5#1)(2008-10#1)(2008-5#1)(2008-8#1)
regeneration after DEX exposure##2##4##(1995-12#2)
regeneration after injury##2##3##(2010-11#1)(2013-8#1)
regeneration after partial hepatectomy##5##4##(1991-5#2)(1995-6#1)(1997-8#1)(2010-1#1)
regeneration after##20##2##(1990-11#2)(1991-3#1)(1991-5#3)(1992-9#1)(1993-2#1)(1995-12#2)(1995-6#1)(1997-8#1)(2008-3#1)(2010-1#1)(2010-11#2)(2012-2#2)(2013-8#2)
regeneration and anatomical plasticity##2##4##(1995-11#2)
regeneration and repair##2##3##(2012-12#1)(2013-1#1)
regeneration and the##3##3##(2008-1#1)(2009-4#1)(2011-2#1)
regeneration and##31##2##(1990-9#1)(1991-11#1)(1991-7#1)(1992-8#1)(1993-2#1)(1993-5#1)(1994-8#3)(1995-11#2)(1995-8#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-8#1)(2008-1#2)(2008-5#1)(2008-8#1)(2009-4#2)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#4)
regeneration applications##3##2##(2007-12#1)(2008-5#1)(2009-12#1)
regeneration as##2##2##(1994-10#1)(2008-5#1)
regeneration at the##2##3##(2006-12#1)(2013-1#1)
regeneration at##3##2##(2006-12#1)(2013-1#1)(2013-8#1)
regeneration by increasing##2##3##(1995-12#2)
regeneration by##8##2##(1995-12#4)(2008-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
regeneration can be##2##3##(1991-3#1)(2012-12#1)
regeneration capacity of##3##3##(2007-3#1)(2008-9#1)(2009-3#1)
regeneration capacity##6##2##(2007-3#1)(2008-1#1)(2008-9#2)(2009-12#1)(2009-3#1)
regeneration cycle##2##2##(2007-8#1)(2008-5#1)
regeneration cycles##2##2##(2008-10#2)
regeneration field##2##2##(2008-5#2)
regeneration following##6##2##(1993-3#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-5#1)(2012-12#1)
regeneration for##2##2##(2006-5#1)(2012-2#1)
regeneration frequency was##2##3##(2010-2#1)(2013-1#1)
regeneration from##3##2##(2007-11#1)(2008-12#1)(2010-10#1)
regeneration have##2##2##(2008-1#1)(2011-2#1)
regeneration in the##5##3##(1991-3#1)(1996-12#1)(1996-3#1)(2006-9#1)(2010-1#1)
regeneration in vivo##3##3##(1992-4#2)(2005-7#1)
regeneration in##27##2##(1990-11#1)(1990-2#1)(1991-3#2)(1992-4#2)(1993-5#1)(1994-2#1)(1995-12#1)(1996-11#2)(1996-12#1)(1996-3#1)(2005-7#1)(2006-9#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2010-1#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#1)
regeneration is##8##2##(1990-2#1)(1991-3#2)(1991-7#1)(1995-12#1)(2006-10#1)(2010-1#1)(2013-1#1)
regeneration of a##2##3##(2008-12#1)(2008-5#1)
regeneration of active##2##3##(1990-5#1)(1993-8#1)
regeneration of articular cartilage##3##4##(2007-11#3)
regeneration of axons and##2##4##(2008-7#1)(2011-1#1)
regeneration of the axons in the injured spinal cord##2##9##(1995-3#2)
regeneration of the central nervous system##2##6##(2008-5#2)
regeneration of the periodontal attachment apparatus##2##6##(2012-3#2)
regeneration of the##34##3##(1991-3#3)(1991-9#1)(1995-12#1)(1995-3#2)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-4#3)(2008-5#6)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-8#1)
regeneration of this##2##3##(1991-4#1)(2008-5#1)
regeneration of tissues##3##3##(2008-8#1)(2008-9#1)(2009-9#1)
regeneration of##87##2##(1990-5#1)(1991-3#3)(1991-4#2)(1991-5#1)(1991-9#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-8#1)(1995-12#1)(1995-3#2)(1995-9#1)(1997-8#1)(2005-11#1)(2006-11#1)(2007-1#1)(2007-11#3)(2007-12#3)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-4#4)(2008-5#11)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-6#1)(2009-9#2)(2010-2#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#5)(2012-2#2)(2012-3#2)(2013-8#2)
regeneration or##3##2##(1994-11#1)(2008-1#1)(2009-9#1)
regeneration process##5##2##(1991-3#1)(1994-2#1)(2008-10#1)(2008-11#1)(2012-2#1)
regeneration properties##2##2##(1994-2#1)(2008-7#1)
regeneration through##4##2##(1993-5#1)(2007-12#1)(2010-10#1)(2013-7#1)
regeneration under##2##2##(2012-1#1)(2013-1#1)
regeneration using a##2##3##(2007-12#1)(2008-1#1)
regeneration using##5##2##(2005-11#1)(2007-12#1)(2008-1#1)(2009-4#1)(2010-6#1)
regeneration was##3##2##(1994-2#1)(2008-10#1)(2008-5#1)
regeneration whole plantlets from root##2##5##(2008-12#2)
regeneration whole plantlets##3##3##(2008-12#3)
regeneration with a##2##3##(1993-8#1)(2007-8#1)
regeneration with##7##2##(1993-8#1)(2007-12#2)(2007-8#1)(2008-5#1)(2009-5#1)(2012-3#1)
regeneration##443##1##(1990-11#4)(1990-2#5)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#2)(1991-11#1)(1991-3#19)(1991-4#2)(1991-5#6)(1991-7#2)(1991-9#1)(1992-11#8)(1992-12#1)(1992-4#5)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#3)(1993-3#2)(1993-5#5)(1993-8#3)(1993-9#1)(1994-10#3)(1994-11#3)(1994-12#1)(1994-2#6)(1994-8#4)(1995-11#2)(1995-12#9)(1995-3#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#3)(1996-12#1)(1996-3#2)(1996-4#1)(1997-3#1)(1997-6#1)(1997-8#3)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#3)(2006-11#2)(2006-12#1)(2006-5#1)(2006-6#2)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#7)(2007-12#15)(2007-3#2)(2007-5#1)(2007-8#9)(2008-1#14)(2008-10#26)(2008-11#6)(2008-12#7)(2008-2#2)(2008-3#5)(2008-4#7)(2008-5#36)(2008-6#1)(2008-7#7)(2008-8#10)(2008-9#5)(2009-10#1)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#6)(2009-5#1)(2009-6#1)(2009-9#5)(2010-1#4)(2010-10#9)(2010-11#5)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#4)(2010-7#4)(2011-1#1)(2011-2#8)(2012-1#3)(2012-11#4)(2012-12#18)(2012-2#10)(2012-3#12)(2012-7#1)(2013-1#17)(2013-7#3)(2013-8#12)
regeneration]##3##1##(2013-1#2)(2013-8#1)
regenerative amplification##2##2##(2007-12#1)(2008-3#1)
regenerative amplifier and an adaptive phase controller##2##7##(2007-11#2)
regenerative amplifier and##3##3##(2007-11#2)(2008-3#1)
regenerative amplifier that is##2##4##(2007-12#1)(2008-2#1)
regenerative amplifier that##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
regenerative amplifier with a##2##4##(2007-11#1)(2008-3#1)
regenerative amplifier##29##2##(2007-11#8)(2007-12#14)(2008-1#2)(2008-2#3)(2008-3#2)
regenerative amplifiers##6##2##(2007-11#3)(2007-12#2)(2008-3#1)
regenerative and plastic insufficiency##2##4##(2010-12#2)
regenerative and##5##2##(2008-11#1)(2008-5#1)(2010-12#2)(2011-1#1)
regenerative capacity of the##2##4##(1992-4#1)(2010-12#1)
regenerative capacity##5##2##(1992-4#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
regenerative cell proliferation##3##3##(1996-11#3)
regenerative cell##4##2##(1996-11#3)(2013-1#1)
regenerative cells##4##2##(2007-12#3)(2009-10#1)
regenerative effects##2##2##(2008-7#1)(2012-12#1)
regenerative mechanisms##2##2##(2008-7#1)(2012-1#1)
regenerative medicine and##4##3##(2007-8#1)(2008-1#1)(2008-11#1)(2011-1#1)
regenerative medicine applications##3##3##(2010-1#1)(2012-5#1)(2012-6#1)
regenerative medicine for the##2##4##(2008-1#1)(2012-12#1)
regenerative medicine to##2##3##(2008-9#1)(2012-12#1)
regenerative medicine##61##2##(2007-1#1)(2007-8#1)(2008-1#6)(2008-11#5)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#6)(2010-3#2)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#11)(2012-5#2)(2012-6#2)(2013-1#1)(2013-7#2)
regenerative potential of##2##3##(2012-12#1)(2012-2#1)
regenerative potential##9##2##(2007-12#1)(2010-8#1)(2011-12#2)(2012-12#3)(2012-2#2)
regenerative process##2##2##(2010-12#1)(2013-8#1)
regenerative processes##3##2##(1991-9#1)(1995-12#1)(2013-8#1)
regenerative sprouting##2##2##(1996-12#1)(1997-3#1)
regenerative therapies##2##2##(2010-6#1)(2012-12#1)
regenerative therapy##2##2##(2012-12#2)
regenerative##179##1##(1991-11#1)(1991-3#1)(1991-9#1)(1992-4#1)(1993-3#1)(1994-5#2)(1995-12#1)(1996-11#3)(1996-12#1)(1997-3#2)(2005-7#2)(2007-1#1)(2007-11#13)(2007-12#24)(2007-8#1)(2008-1#11)(2008-11#6)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#5)(2009-12#2)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#2)(2010-1#2)(2010-10#6)(2010-12#6)(2010-3#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#3)(2011-2#1)(2012-1#2)(2012-11#5)(2012-12#25)(2012-2#4)(2012-5#2)(2012-6#2)(2012-7#1)(2013-1#3)(2013-7#2)(2013-8#2)
regeneratively##3##1##(2007-12#2)(2008-2#1)
regenerator##2##1##(2007-12#1)(2009-7#1)
regia and##3##2##(2008-10#2)(2013-1#1)
regia##17##1##(2008-10#16)(2013-1#1)
regime a##2##2##(2007-11#1)(2007-12#1)
regime against##2##2##(2007-5#2)
regime and the##2##3##(2008-8#1)(2011-1#1)
regime and##15##2##(1995-5#1)(2007-11#1)(2007-12#3)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
regime are##2##2##(2007-12#1)(2011-1#1)
regime by##3##2##(2005-11#1)(2006-4#1)(2007-11#1)
regime compared##2##2##(2008-10#1)(2010-3#1)
regime during##2##2##(2008-2#1)(2009-8#1)
regime for##9##2##(1992-12#1)(2005-10#1)(2008-2#2)(2008-3#2)(2008-5#1)(2012-12#2)
regime have##2##2##(2007-11#1)(2008-5#1)
regime in which the##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
regime in which##6##3##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#1)
regime in##10##2##(1991-6#1)(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#2)(2008-8#1)(2011-1#1)
regime is identified in which##2##5##(2007-11#1)(2007-12#1)
regime is identified##3##3##(2005-11#1)(2007-11#1)(2007-12#1)
regime is##14##2##(1992-8#1)(2005-11#4)(2006-5#1)(2007-11#1)(2007-12#5)(2008-3#1)(2008-6#1)
regime of a##2##3##(1992-11#1)(2007-11#1)
regime of the##2##3##(2008-7#1)(2008-8#1)
regime of##17##2##(1990-11#1)(1992-11#1)(1992-5#1)(2006-6#1)(2007-11#3)(2007-12#2)(2007-9#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2012-2#1)
regime on##3##2##(2005-11#1)(2008-10#1)(2010-4#1)
regime the##2##2##(2005-11#1)(2007-11#1)
regime was##5##2##(2005-11#1)(2006-6#1)(2008-3#1)(2010-10#1)(2013-7#1)
regime where the##3##3##(2005-11#3)
regime where##4##2##(2005-11#3)(2008-3#1)
regime which is##2##3##(2005-11#1)(2009-5#1)
regime which##3##2##(2005-11#1)(2008-8#1)(2009-5#1)
regime with a##2##3##(2007-12#1)(2008-2#1)
regime with##9##2##(2007-11#2)(2007-12#3)(2008-11#1)(2008-2#2)(2008-8#1)
regime##280##1##(1990-11#1)(1991-12#1)(1991-6#2)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#2)(1993-7#1)(1993-8#1)(1994-6#1)(1995-1#1)(1995-11#2)(1995-5#1)(1995-6#1)(1996-3#1)(1996-4#2)(1997-1#1)(1997-6#1)(2004-4#1)(2005-10#1)(2005-11#19)(2006-10#2)(2006-2#1)(2006-4#2)(2006-5#4)(2006-6#2)(2007-11#30)(2007-12#57)(2007-3#2)(2007-5#2)(2007-9#1)(2008-1#3)(2008-10#15)(2008-11#8)(2008-12#1)(2008-2#18)(2008-3#22)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#7)(2008-9#4)(2009-4#2)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-2#1)(2010-3#3)(2010-4#1)(2010-8#3)(2011-1#6)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#6)(2013-1#3)(2013-7#3)(2013-8#1)
regime)##5##1##(2007-12#2)(2008-3#2)(2008-9#1)
regimen (p##2##2##(1994-2#1)(2008-10#1)
regimen A##4##2##(1997-7#4)
regimen B##2##2##(1994-7#1)(1997-7#1)
regimen a##2##2##(1994-12#1)(2012-3#1)
regimen and a##2##3##(1994-3#1)(2010-10#1)
regimen and with##2##3##(2007-8#1)(2010-12#1)
regimen and##15##2##(1990-10#1)(1990-6#1)(1994-3#1)(2006-10#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-5#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-9#1)(2013-1#1)
regimen as##3##2##(1990-4#1)(1993-11#1)(2008-5#1)
regimen at the##2##3##(1992-4#1)(2011-1#1)
regimen between##2##2##(1992-4#1)(2008-11#1)
regimen can be##2##3##(2007-10#1)(2010-2#1)
regimen can##3##2##(2007-10#1)(2008-3#1)(2010-2#1)
regimen comprising##2##2##(1995-8#1)(2010-3#1)
regimen during##2##2##(2008-3#1)(2008-4#1)
regimen for patients with##3##4##(1992-10#1)(2009-4#1)(2013-7#1)
regimen for six months##2##4##(1995-9#1)(2010-4#1)
regimen for the treatment of##2##5##(2012-3#1)(2013-1#1)
regimen for the##7##3##(2007-7#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-9#1)(2012-3#1)(2013-1#1)
regimen for##39##2##(1991-12#1)(1992-10#1)(1992-12#1)(1993-11#1)(1994-6#1)(1995-9#1)(1996-3#1)(1997-1#1)(2005-12#1)(2005-3#1)(2006-10#2)(2007-1#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#2)
regimen given##2##2##(2006-6#2)
regimen has been##3##3##(1993-11#1)(2009-8#1)(2010-12#1)
regimen has##7##2##(1993-11#1)(2004-1#2)(2008-12#1)(2009-8#1)(2010-12#1)(2013-1#1)
regimen in order to##3##4##(1992-12#1)(2008-5#1)(2009-1#1)
regimen in patients with##3##4##(1991-10#1)(2006-10#1)(2010-4#1)
regimen in the treatment of advanced##2##6##(1990-12#2)
regimen in the treatment of##5##5##(1990-12#2)(1990-2#1)(1991-6#1)(2013-1#1)
regimen in the##6##3##(1990-12#2)(1990-2#1)(1991-6#1)(2006-6#1)(2013-1#1)
regimen in##32##2##(1990-12#3)(1990-2#1)(1991-10#1)(1991-6#1)(1992-1#1)(1992-12#1)(1994-3#1)(1997-7#1)(2005-6#1)(2005-9#1)(2006-10#1)(2006-6#1)(2006-9#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-1#1)(2010-12#1)(2010-4#2)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
regimen is associated with##3##4##(2007-11#1)(2007-8#2)
regimen is##27##2##(1990-2#1)(1990-4#2)(1991-12#1)(1992-10#1)(1992-12#1)(1992-8#1)(1993-9#1)(1996-12#2)(2006-12#1)(2006-6#3)(2006-9#1)(2007-11#4)(2007-12#2)(2007-8#2)(2008-5#1)(2008-8#1)(2011-12#1)(2011-2#1)
regimen may be##2##3##(1994-2#1)(2010-12#1)
regimen may##5##2##(1994-2#1)(2005-12#1)(2007-11#1)(2008-11#1)(2010-12#1)
regimen of a##2##3##(1990-4#1)(2008-7#1)
regimen of antitubercular drugs##2##4##(2013-1#2)
regimen of epoetin##4##3##(2007-11#1)(2008-7#3)
regimen of##47##2##(1990-4#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1995-2#1)(1997-4#3)(1997-5#1)(2004-12#1)(2006-10#1)(2006-12#1)(2006-6#2)(2006-8#1)(2007-11#8)(2007-2#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#6)(2009-10#1)(2009-12#2)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
regimen on##3##2##(2005-10#1)(2008-3#1)(2011-2#1)
regimen or##4##2##(2005-8#1)(2006-12#1)(2007-11#1)(2008-7#1)
regimen that##6##2##(1994-2#1)(2007-1#1)(2007-11#1)(2010-4#1)(2011-1#1)(2011-2#1)
regimen to treat##2##3##(2010-12#1)(2012-3#1)
regimen to##5##2##(1992-9#1)(2010-12#2)(2012-2#1)(2012-3#1)
regimen used##3##2##(1990-10#1)(1990-6#1)(2006-10#1)
regimen using##3##2##(2007-10#1)(2008-7#1)(2009-8#1)
regimen was associated with##2##4##(2007-8#1)(2009-9#1)
regimen was changed to##2##4##(2013-8#2)
regimen was effective in##2##4##(1990-12#1)(2009-12#1)
regimen was effective##3##3##(1990-12#1)(2007-2#1)(2009-12#1)
regimen was repeated##2##3##(2007-9#1)(2008-10#1)
regimen was##22##2##(1990-12#1)(1991-12#1)(1991-3#1)(1992-8#1)(1993-2#1)(1994-11#1)(1994-12#1)(2007-11#2)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-6#1)(2009-12#1)(2009-9#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-8#2)
regimen were##6##2##(1990-4#1)(1994-5#1)(1995-3#1)(2007-3#1)(2008-6#1)(2013-8#1)
regimen with##11##2##(1990-10#1)(1991-9#1)(1992-6#1)(1993-2#1)(2004-1#1)(2007-10#1)(2007-11#1)(2008-6#1)(2008-7#1)(2009-11#1)(2012-12#1)
regimen without##2##2##(2010-12#1)(2013-7#1)
regimen##465##1##(1990-10#5)(1990-12#6)(1990-2#2)(1990-4#7)(1990-6#4)(1990-9#1)(1991-10#3)(1991-11#1)(1991-12#7)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#3)(1992-10#9)(1992-12#4)(1992-2#1)(1992-4#2)(1992-6#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#4)(1993-12#2)(1993-2#2)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#6)(1994-3#3)(1994-5#2)(1994-6#3)(1994-7#1)(1994-9#2)(1995-2#2)(1995-3#3)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-3#1)(1996-5#1)(1997-1#2)(1997-4#4)(1997-5#1)(1997-7#8)(2004-1#5)(2004-12#1)(2005-10#3)(2005-11#2)(2005-12#4)(2005-3#1)(2005-6#1)(2005-8#3)(2005-9#3)(2006-1#2)(2006-10#7)(2006-12#3)(2006-5#1)(2006-6#10)(2006-7#1)(2006-8#1)(2006-9#3)(2007-1#4)(2007-10#3)(2007-11#37)(2007-12#8)(2007-2#3)(2007-3#3)(2007-5#1)(2007-7#6)(2007-8#13)(2007-9#2)(2008-1#5)(2008-10#9)(2008-11#11)(2008-12#2)(2008-3#13)(2008-4#1)(2008-5#11)(2008-6#6)(2008-7#14)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#4)(2009-4#1)(2009-6#3)(2009-7#1)(2009-8#8)(2009-9#2)(2010-10#3)(2010-11#4)(2010-12#13)(2010-2#2)(2010-3#4)(2010-4#6)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#15)(2012-1#1)(2012-12#7)(2012-2#8)(2012-3#8)(2013-1#16)(2013-7#3)(2013-8#8)
regimen)##2##1##(1991-9#1)(2010-4#1)
regimen]##3##1##(1990-10#1)(2005-9#2)
regimens administered##3##2##(2009-1#1)(2013-8#2)
regimens and##14##2##(1990-6#1)(1991-3#1)(2007-11#4)(2008-10#1)(2008-7#1)(2010-12#1)(2010-3#2)(2011-2#1)(2012-1#1)(2012-12#1)
regimens are preferred##2##3##(2005-8#1)(2010-11#1)
regimens are##13##2##(2005-12#1)(2005-8#1)(2006-10#2)(2007-11#2)(2008-1#1)(2008-4#1)(2009-10#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-6#1)
regimens as##2##2##(2006-2#1)(2011-2#1)
regimens based on##2##3##(1996-9#1)(2011-2#1)
regimens based##3##2##(1996-9#1)(2008-5#1)(2011-2#1)
regimens but##2##2##(2006-10#1)(2008-10#1)
regimens by##2##2##(1991-3#1)(1992-12#1)
regimens can##4##2##(2005-11#1)(2006-1#1)(2008-1#1)(2008-6#1)
regimens consisting of##3##3##(2007-11#1)(2008-1#1)(2013-1#1)
regimens continue to be##2##4##(1993-11#1)(2004-1#1)
regimens for the##2##3##(2005-6#1)(2006-10#1)
regimens for##19##2##(1991-2#1)(2005-10#1)(2005-6#1)(2006-10#2)(2006-3#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-7#2)(2009-11#1)(2009-12#1)(2009-4#1)(2010-4#1)(2012-12#1)(2012-3#1)(2013-1#1)
regimens has##2##2##(2010-12#1)(2012-1#1)
regimens have been##4##3##(2005-8#1)(2006-10#1)(2007-2#1)(2008-11#1)
regimens have demonstrated##3##3##(2005-7#1)(2007-5#1)(2013-1#1)
regimens have##9##2##(2005-7#1)(2005-8#1)(2006-10#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-4#1)(2013-1#1)
regimens in four##2##3##(2008-5#1)(2008-6#1)
regimens in patients with##2##4##(1991-9#1)(2008-6#1)
regimens in the treatment of##2##5##(1992-3#1)(2013-1#1)
regimens in##19##2##(1991-9#1)(1992-3#1)(1997-8#1)(2007-11#4)(2007-12#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#2)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
regimens include##2##2##(2008-3#1)(2012-3#1)
regimens including##2##2##(2004-1#1)(2011-2#1)
regimens involving##4##2##(1994-2#1)(1996-12#1)(2007-11#2)
regimens is##2##2##(1993-9#1)(2006-12#1)
regimens may be##2##3##(2005-8#1)(2007-11#1)
regimens may require##2##3##(2007-11#2)
regimens may##4##2##(2005-8#1)(2007-11#3)
regimens of chemotherapy##2##3##(2007-8#1)(2010-12#1)
regimens of##14##2##(1990-12#1)(2006-7#1)(2007-11#4)(2007-8#1)(2008-10#1)(2010-12#3)(2011-2#1)(2013-1#1)(2013-7#1)
regimens on survival##2##3##(2006-10#1)(2010-12#1)
regimens on##7##2##(2006-10#1)(2008-1#1)(2008-12#2)(2009-12#1)(2010-12#1)(2012-3#1)
regimens or##3##2##(2008-7#1)(2009-8#1)(2010-6#1)
regimens should be##3##3##(1993-1#1)(2009-6#1)(2012-2#1)
regimens should##4##2##(1993-1#1)(2009-6#1)(2012-1#1)(2012-2#1)
regimens such as##4##3##(2006-10#2)(2007-11#1)(2008-1#1)
regimens that are##3##3##(1993-9#1)(2005-10#1)(2011-2#1)
regimens that result in##2##4##(1991-12#1)(2007-7#1)
regimens that##11##2##(1991-12#1)(1993-9#1)(2005-10#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-3#1)(2008-8#1)(2011-2#1)
regimens to##4##2##(2006-2#1)(2007-11#1)(2008-6#1)(2009-5#1)
regimens used##3##2##(2005-10#1)(2007-4#1)(2008-7#1)
regimens using##2##2##(2006-10#1)(2007-11#1)
regimens were studied##2##3##(2006-10#1)(2012-2#1)
regimens were##12##2##(1991-11#1)(1993-5#1)(2006-10#1)(2007-11#2)(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-2#1)
regimens which are##2##3##(1993-7#1)(2005-7#1)
regimens which##3##2##(1993-7#1)(2005-7#1)(2005-8#1)
regimens will become##2##3##(1993-11#1)(2006-10#1)
regimens will##3##2##(1993-11#1)(2006-10#1)(2007-11#1)
regimens with the##2##3##(2007-11#2)
regimens with##8##2##(1996-11#1)(2006-8#1)(2007-11#2)(2008-6#1)(2008-7#1)(2009-10#1)(2011-2#1)
regimens##362##1##(1990-12#3)(1990-4#1)(1990-6#4)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#3)(1991-6#1)(1991-9#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-1#2)(1993-11#7)(1993-3#1)(1993-5#1)(1993-7#2)(1993-9#2)(1994-10#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-5#1)(1996-11#2)(1996-12#1)(1996-9#1)(1997-7#2)(1997-8#1)(2004-1#3)(2005-10#3)(2005-11#4)(2005-12#1)(2005-6#1)(2005-7#4)(2005-8#7)(2006-1#1)(2006-10#21)(2006-12#2)(2006-2#2)(2006-3#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#46)(2007-12#3)(2007-2#3)(2007-3#3)(2007-4#2)(2007-5#2)(2007-6#4)(2007-7#5)(2007-8#4)(2007-9#2)(2008-1#11)(2008-10#7)(2008-11#6)(2008-12#2)(2008-3#5)(2008-4#2)(2008-5#9)(2008-6#13)(2008-7#20)(2008-8#2)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#4)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-11#4)(2010-12#14)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#1)(2011-2#10)(2011-3#1)(2012-1#4)(2012-12#3)(2012-2#4)(2012-3#7)(2013-1#11)(2013-7#1)(2013-8#2)
regimes and to##2##3##(2007-12#1)(2008-1#1)
regimes and##9##2##(1997-6#1)(2005-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-8#1)(2009-4#2)
regimes are##5##2##(2007-12#2)(2008-2#1)(2008-8#1)(2011-1#1)
regimes as well as##2##4##(1997-1#1)(2012-12#1)
regimes can be##2##3##(2005-11#2)
regimes can##3##2##(2005-11#2)(2008-8#1)
regimes for the##3##3##(2008-2#1)(2008-3#1)(2012-11#1)
regimes for##5##2##(2008-2#1)(2008-3#2)(2009-12#1)(2012-11#1)
regimes has##2##2##(2005-11#1)(2008-10#1)
regimes have been##2##3##(2006-2#1)(2008-3#1)
regimes in the##3##3##(2004-2#1)(2008-10#2)
regimes in which##3##3##(2007-12#1)(2008-11#1)(2008-3#1)
regimes in##15##2##(1994-2#1)(1994-6#1)(2004-10#1)(2004-2#1)(2006-12#1)(2007-12#2)(2008-10#4)(2008-11#2)(2008-3#1)(2012-1#1)
regimes of the##2##3##(2008-11#1)(2008-8#1)
regimes of##13##2##(1997-2#1)(2006-5#1)(2006-6#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#2)(2011-2#1)
regimes on##3##2##(1990-8#1)(2008-12#2)
regimes ranging from##2##3##(2008-10#2)
regimes that##2##2##(2008-10#1)(2008-8#1)
regimes were##3##2##(1996-12#1)(2007-2#1)(2008-10#1)
regimes which##2##2##(2009-7#1)(2010-2#1)
regimes with##6##2##(2007-12#3)(2008-10#2)(2010-3#1)
regimes##156##1##(1990-11#1)(1990-5#1)(1990-8#1)(1991-7#1)(1994-2#1)(1994-6#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-6#1)(2004-1#1)(2004-10#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-11#7)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#3)(2006-6#2)(2007-11#3)(2007-12#15)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#30)(2008-11#7)(2008-12#3)(2008-2#7)(2008-3#15)(2008-7#3)(2008-8#7)(2009-12#1)(2009-2#1)(2009-4#2)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-8#3)(2011-1#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)
regimes)##3##1##(2008-10#2)(2008-7#1)
regio- and stereoselective##5##3##(1990-12#1)(1996-5#2)(2005-8#2)
regio- and##12##2##(1990-12#1)(1990-7#2)(1996-5#3)(2005-8#3)(2006-12#1)(2008-12#1)(2013-8#1)
regio-##13##1##(1990-12#1)(1990-7#2)(1996-5#3)(2005-8#3)(2006-12#1)(2008-12#1)(2010-6#1)(2013-8#1)
regiochemistry##2##1##(1996-5#1)(1996-8#1)
regioisomer##3##1##(1996-5#1)(2006-12#1)(2009-9#1)
regioisomeric dimethoxybenzoylpiperazines##2##2##(2013-7#2)
regioisomeric##5##1##(2013-7#5)
regioisomers##7##1##(1996-4#1)(1996-5#1)(1997-2#1)(2009-10#1)(2009-12#1)(2010-7#1)(2013-7#1)
region (3'UTR)##5##2##(1992-2#1)(1994-3#1)(2008-10#2)(2009-5#1)
region (4##3##2##(1992-10#1)(1992-7#1)(1997-2#1)
region (CR) sequences##3##3##(2008-10#2)(2010-8#1)
region (CR)##6##2##(2008-10#2)(2008-8#1)(2009-5#2)(2010-8#1)
region (Chromosome##2##2##(2006-2#2)
region (France)##2##2##(2008-10#2)
region (Italy)##4##2##(1992-4#1)(2007-1#1)(2012-12#1)(2013-8#1)
region (MAR)##2##2##(1992-10#1)(2008-8#1)
region (NTR)##2##2##(2008-10#1)(2013-8#1)
region (UTR)##11##2##(1990-12#1)(1992-8#1)(1994-12#1)(1996-5#1)(1997-5#1)(1997-7#1)(2005-11#1)(2007-12#1)(2008-10#3)
region (aa##3##2##(1994-12#1)(1995-8#1)(2005-8#1)
region (amino##2##2##(1991-9#1)(1997-4#1)
region (approximately##2##2##(2007-7#1)(2008-3#1)
region (residues##9##2##(1990-7#1)(1991-5#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#1)(1996-5#1)(1997-3#1)
region (the##3##2##(1992-11#1)(1995-2#1)(2008-5#1)
region -##4##2##(1997-8#1)(2007-7#3)
region 1##7##2##(1995-5#2)(1997-8#1)(2008-10#3)(2008-4#1)
region 2##5##2##(1992-4#3)(2008-10#2)
region A##4##2##(1994-9#4)
region B##4##2##(1994-9#4)
region DNA##2##2##(1994-11#1)(2008-10#1)
region I##6##2##(1990-3#3)(1994-9#2)(2005-11#1)
region II##2##2##(1990-9#1)(2005-11#1)
region R##3##2##(1996-2#2)(2008-2#1)
region a##7##2##(1992-12#1)(1993-9#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#1)
region about##2##2##(1991-9#1)(1997-6#1)
region above##3##2##(2008-3#3)
region adjacent to a TATA box##2##6##(1991-12#2)
region adjacent to the##2##4##(1994-3#1)(1996-9#1)
region adjacent to##7##3##(1991-12#2)(1994-3#3)(1996-10#1)(1996-9#1)
region affects##2##2##(2007-9#1)(2012-2#1)
region after##4##2##(1990-7#1)(1993-3#1)(2007-12#1)(2008-4#1)
region allowed##2##2##(1990-5#1)(1991-9#1)
region alone##3##2##(2008-10#3)
region along##2##2##(2007-11#1)(2010-11#1)
region also contains##4##3##(1993-11#1)(1993-6#1)(1997-3#1)(2009-7#1)
region also##8##2##(1992-9#1)(1993-11#1)(1993-6#1)(1994-3#1)(1997-3#1)(2007-12#1)(2008-8#1)(2009-7#1)
region among##6##2##(1991-8#1)(1992-4#1)(1994-3#1)(2007-2#1)(2012-2#1)(2013-8#1)
region and a##18##3##(1990-11#1)(1991-12#1)(1991-7#2)(1993-3#1)(1994-9#1)(1995-8#1)(1997-4#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-7#1)(2010-5#1)(2013-1#1)
region and an##5##3##(1990-6#1)(1991-9#1)(2008-6#1)(2008-8#1)(2009-5#1)
region and are##4##3##(1993-3#1)(2007-11#1)(2010-8#1)(2011-1#1)
region and have##2##3##(2006-10#1)(2007-12#1)
region and in the##5##4##(1992-2#1)(1996-10#1)(1997-1#1)(2005-11#2)
region and in##6##3##(1991-6#1)(1992-2#1)(1996-10#1)(1997-1#1)(2005-11#2)
region and is##2##3##(1990-3#1)(2008-10#1)
region and may##3##3##(1996-7#1)(2008-6#1)(2009-4#1)
region and other##2##3##(2007-12#1)(2013-7#1)
region and some##2##3##(1990-4#1)(1990-9#1)
region and that##3##3##(1997-3#1)(2008-2#1)(2009-10#1)
region and the absorption edge##2##5##(2008-2#2)
region and the##36##3##(1990-1#1)(1990-11#1)(1990-2#1)(1991-1#1)(1991-6#1)(1992-3#1)(1992-4#1)(1994-11#3)(1994-12#2)(1994-3#1)(1994-5#1)(1997-2#1)(1997-8#1)(2005-11#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-2#4)(2008-9#1)(2009-1#1)(2010-5#1)(2011-2#1)(2012-11#1)(2013-7#1)(2013-8#1)
region and their##2##3##(2007-5#1)(2008-10#1)
region and to##3##3##(1994-2#1)(1996-2#1)(2012-12#1)
region and was##2##3##(1990-4#1)(2013-1#1)
region and we##2##3##(1990-5#1)(2008-5#1)
region and were##2##3##(1994-3#1)(2008-10#1)
region and with##3##3##(1991-11#1)(1993-9#1)(2008-2#1)
region and##205##2##(1990-1#2)(1990-11#3)(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#2)(1991-7#4)(1991-9#1)(1992-1#1)(1992-2#3)(1992-3#1)(1992-4#2)(1992-9#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-9#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#2)(1994-9#2)(1995-1#1)(1995-10#2)(1995-11#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#3)(1996-7#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#3)(2005-11#3)(2006-10#2)(2006-4#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#7)(2007-2#2)(2007-3#1)(2007-5#4)(2007-6#1)(2007-7#3)(2008-1#1)(2008-10#17)(2008-11#2)(2008-12#2)(2008-2#13)(2008-3#5)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#6)(2008-9#2)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-5#3)(2010-8#2)(2011-1#2)(2011-2#3)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#1)
region appeared to##2##3##(1997-2#1)(2005-11#1)
region appears to be##2##4##(1995-3#1)(1997-4#1)
region appears to##3##3##(1995-1#1)(1995-3#1)(1997-4#1)
region are not##2##3##(1992-3#1)(2008-7#1)
region are presented##2##3##(1990-6#1)(2008-3#1)
region are##33##2##(1990-6#2)(1991-11#1)(1992-3#1)(1992-7#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-7#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#3)(2008-7#2)(2009-12#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
region around the##6##3##(1990-11#1)(1991-4#1)(1991-9#1)(1995-7#1)(2006-2#1)(2007-7#1)
region around##9##2##(1990-11#1)(1991-4#1)(1991-9#1)(1992-9#1)(1995-7#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-3#1)
region as a result of##2##5##(2008-2#2)
region as a##7##3##(1992-11#1)(1993-3#1)(1993-9#1)(2008-2#2)(2012-12#2)
region as an##3##3##(2007-12#2)(2008-10#1)
region as in##2##3##(2008-2#1)(2008-6#1)
region as the##2##3##(2008-10#2)
region as well as##4##4##(1992-11#1)(1994-6#1)(2008-3#1)(2011-2#1)
region as##23##2##(1991-4#1)(1992-11#2)(1992-4#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-6#1)(2007-12#2)(2008-10#3)(2008-2#3)(2008-3#1)(2008-6#1)(2009-12#1)(2011-2#1)(2012-12#2)
region assay##2##2##(1991-3#1)(2008-12#1)
region at a##2##3##(1992-2#1)(2007-2#1)
region at the##11##3##(1990-5#1)(1991-10#1)(1993-12#1)(1997-4#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-8#1)
region at##29##2##(1990-3#1)(1990-5#1)(1991-10#1)(1992-2#1)(1993-12#1)(1994-11#1)(1994-6#1)(1995-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2012-3#1)(2013-8#1)
region bearing##2##2##(1992-11#1)(1996-10#1)
region because##3##2##(1992-11#1)(2008-2#1)(2008-3#1)
region before##3##2##(1995-2#1)(1997-6#1)(2012-2#1)
region being##2##2##(1990-6#1)(1996-7#1)
region between helices D and##2##5##(1994-8#2)
region between nt##2##3##(1991-12#1)(1994-9#1)
region between nt8306 and nt9021##2##5##(2005-8#2)
region between the catalytic##2##4##(1995-11#1)(1997-2#1)
region between the two##2##4##(1995-10#1)(2012-2#1)
region between the##24##3##(1990-5#1)(1991-6#1)(1992-11#1)(1992-4#1)(1993-11#1)(1993-5#1)(1993-6#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-2#2)(1997-4#1)(2008-10#3)(2008-3#1)(2008-7#2)(2012-2#1)
region between##65##2##(1990-3#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-11#1)(1992-4#1)(1993-11#1)(1993-5#1)(1993-6#3)(1994-11#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#3)(1996-10#2)(1996-12#1)(1996-6#1)(1996-7#1)(1997-2#4)(1997-4#2)(2005-8#2)(2007-12#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-2#4)(2008-3#3)(2008-5#2)(2008-7#2)(2008-9#1)(2012-2#1)
region boundaries##2##2##(2008-2#1)(2011-2#1)
region but##5##2##(1995-2#1)(2007-8#1)(2008-10#2)(2008-7#1)
region by the##2##3##(1995-3#1)(2011-1#1)
region by use of##3##4##(2007-12#1)(2008-3#2)
region by##32##2##(1990-5#1)(1990-7#1)(1991-12#1)(1992-12#1)(1993-8#1)(1994-12#1)(1995-3#1)(1995-5#1)(1996-8#1)(1997-2#1)(1997-8#1)(2007-12#4)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-3#5)(2008-4#2)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)
region can be obtained##2##4##(2006-6#1)(2007-12#1)
region can be used##2##4##(1993-9#1)(2008-3#1)
region can be##8##3##(1993-9#1)(1994-12#1)(2006-6#1)(2007-12#1)(2008-2#1)(2008-3#2)(2012-1#1)
region can##12##2##(1990-3#1)(1992-11#1)(1993-9#1)(1994-12#1)(2006-6#1)(2007-12#1)(2008-2#2)(2008-3#2)(2009-8#1)(2012-1#1)
region centered##2##2##(2008-10#1)(2008-2#1)
region characterized##2##2##(2008-5#1)(2011-1#1)
region close to the GRPR locus on the X chromosome##2##10##(1996-12#2)
region close to the##6##4##(1990-5#1)(1990-7#1)(1996-12#2)(1996-3#1)(2007-12#1)
region close to##8##3##(1990-5#1)(1990-7#1)(1995-10#1)(1996-12#2)(1996-3#1)(2007-12#1)(2008-10#1)
region coding for the##3##4##(1991-6#1)(1994-2#1)(1997-6#1)
region coding for##7##3##(1991-12#2)(1991-6#1)(1994-2#1)(1997-6#1)(1997-7#1)(2013-1#1)
region compared to##2##3##(1992-6#1)(2008-10#1)
region compared with##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
region compared##5##2##(1992-6#1)(2007-12#1)(2008-10#2)(2008-3#1)
region comprises##2##2##(1991-8#1)(1994-12#1)
region comprising the##3##3##(1990-5#1)(1992-11#1)(1996-10#1)
region comprising##5##2##(1990-5#1)(1991-6#1)(1992-11#1)(1994-8#1)(1996-10#1)
region consisting of##2##3##(1994-5#1)(1994-9#1)
region consists of two##2##4##(1997-2#1)(2008-8#1)
region consists of##6##3##(1990-9#1)(1993-7#1)(1994-12#1)(1997-2#1)(2008-7#1)(2008-8#1)
region contained##8##2##(1992-11#1)(1993-9#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-6#1)(2009-10#1)
region containing a##2##3##(2006-10#1)(2008-10#1)
region containing the##6##3##(1990-10#1)(1990-2#1)(1994-12#1)(1996-12#1)(1997-4#1)(1997-7#1)
region containing this##2##3##(1993-10#1)(1996-5#1)
region containing##21##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-7#1)(1993-10#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-5#2)(1997-4#1)(1997-7#1)(2006-10#1)(2008-10#1)(2009-5#1)
region contains a##6##3##(1991-11#1)(1992-11#1)(1994-8#1)(1995-6#1)(1997-7#1)(2008-8#1)
region contains at least##2##4##(1995-8#1)(1996-6#1)
region contains the##2##3##(1991-2#1)(1993-12#1)
region contains##29##2##(1990-11#1)(1991-11#1)(1991-2#1)(1991-7#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1994-11#1)(1994-12#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-6#2)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-8#1)
region contribute to the##2##4##(1993-12#1)(1994-11#1)
region controlling##2##2##(1991-8#1)(1994-12#1)
region corresponding to the##3##4##(1991-2#1)(2006-3#1)(2010-7#1)
region corresponding to##6##3##(1991-2#1)(1996-2#1)(1996-7#2)(2006-3#1)(2010-7#1)
region could be##4##3##(1990-4#1)(1992-9#1)(1995-9#1)(2008-10#1)
region could##12##2##(1990-4#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-9#1)(1994-12#2)(1995-9#1)(2006-6#1)(2007-6#1)(2008-10#2)
region depends on##2##3##(1990-3#1)(1996-3#1)
region depends##4##2##(1990-3#1)(1995-2#2)(1996-3#1)
region derived from the##3##4##(1990-11#1)(1992-6#1)(1996-2#1)
region determined##2##2##(1997-8#1)(2008-10#1)
region did not##4##3##(1994-3#1)(1997-2#1)(1997-4#1)(1997-9#1)
region directly##2##2##(1990-7#1)(2006-9#1)
region displayed##2##2##(1992-12#1)(1995-2#1)
region does##2##2##(1991-11#1)(1993-3#1)
region downstream of the##3##4##(1996-12#1)(1996-7#1)(1997-2#1)
region downstream of##4##3##(1991-7#1)(1996-12#1)(1996-7#1)(1997-2#1)
region downstream##6##2##(1990-5#1)(1991-7#1)(1993-12#1)(1996-12#1)(1996-7#1)(1997-2#1)
region due to##2##3##(1992-9#1)(2009-11#1)
region during the##3##3##(2008-10#2)(2012-3#1)
region during##8##2##(1992-10#1)(1995-11#1)(1996-8#1)(2008-10#3)(2008-2#1)(2012-3#1)
region encodes##3##2##(1992-11#1)(1993-12#1)(1997-2#1)
region encoding the##6##3##(1994-12#1)(1996-10#1)(1996-4#1)(1997-2#2)(2008-10#1)
region encoding##9##2##(1990-9#1)(1994-10#1)(1994-12#2)(1996-10#1)(1996-4#1)(1997-2#2)(2008-10#1)
region encompassing##4##2##(1991-5#1)(2006-10#1)(2008-10#1)(2010-12#1)
region examined##4##2##(1991-9#1)(1996-10#1)(1997-2#1)(2013-1#1)
region extending from##2##3##(1992-12#1)(2013-1#1)
region extending##6##2##(1990-4#1)(1992-12#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-1#1)
region flanking##2##2##(2005-11#1)(2009-9#1)
region followed by##3##3##(1991-7#1)(2010-2#1)(2011-1#1)
region for a##2##3##(1993-11#1)(2008-2#1)
region for membrane##2##3##(1994-12#1)(1996-3#1)
region for the##15##3##(1990-12#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-7#1)(1993-11#1)(1993-4#1)(1996-2#2)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2013-1#1)
region for this##2##3##(1990-7#1)(1994-8#1)
region for##67##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-12#2)(1991-2#1)(1991-4#2)(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-9#2)(1993-11#2)(1993-4#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-8#2)(1996-12#2)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#1)(1997-8#2)(2006-10#1)(2006-4#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-2#2)(2008-3#4)(2008-9#1)(2009-3#1)(2009-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
region forms##2##2##(1990-11#1)(2005-11#1)
region from 25##2##3##(2008-1#1)(2008-10#1)
region from a##2##3##(1993-9#1)(1994-8#1)
region from both##2##3##(2008-10#2)
region from the##9##3##(1990-11#2)(1991-3#1)(1993-2#1)(1994-3#1)(1996-3#1)(1996-4#1)(2005-11#1)(2008-11#1)
region from which##2##3##(2008-10#1)(2008-11#1)
region from##57##2##(1990-11#2)(1990-7#1)(1991-3#1)(1992-9#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-3#1)(1995-8#2)(1996-10#2)(1996-3#1)(1996-4#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#4)(2008-3#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-3#1)(2012-12#1)(2013-8#1)
region functions##2##2##(1994-9#1)(1996-6#1)
region further##2##2##(1997-1#1)(1997-6#1)
region gene##3##2##(1994-8#1)(1997-8#1)(2008-11#1)
region genes##8##2##(1993-5#1)(1994-12#1)(1994-2#1)(1995-2#4)(2008-4#1)
region growing##2##2##(2006-5#1)(2008-3#1)
region had no##2##3##(2008-10#2)
region had##4##2##(1990-9#1)(2008-10#2)(2013-8#1)
region has been developed##3##4##(2008-10#1)(2008-2#2)
region has been measured##2##4##(2008-2#1)(2008-3#1)
region has been##20##3##(1990-11#1)(1991-5#1)(1992-11#1)(1992-9#1)(1993-6#1)(1994-8#1)(1996-10#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-2#5)(2008-3#2)(2008-9#1)(2011-2#1)(2012-12#1)
region has the##3##3##(1993-6#1)(2007-2#1)(2008-12#1)
region has##34##2##(1990-10#1)(1990-11#1)(1990-3#1)(1991-5#1)(1992-11#1)(1992-9#1)(1993-2#1)(1993-6#2)(1994-10#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-10#1)(1996-12#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#6)(2008-3#2)(2008-4#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#2)
region have a##2##3##(1992-7#1)(1997-3#1)
region have been reported##2##4##(2008-5#2)
region have been##6##3##(2006-10#1)(2006-4#1)(2008-12#1)(2008-5#2)(2010-8#1)
region have##8##2##(1992-7#1)(1997-3#1)(2006-10#1)(2006-4#1)(2008-12#1)(2008-5#2)(2010-8#1)
region homologous to##3##3##(1993-6#1)(1995-1#1)(2008-10#1)
region identified##2##2##(1992-2#1)(2008-10#1)
region implicated in##2##3##(1995-2#1)(2013-8#1)
region important##2##2##(1995-6#1)(2008-7#1)
region in a patient with##2##5##(1990-12#1)(1990-5#1)
region in a##8##3##(1990-12#1)(1990-5#1)(1990-8#1)(2007-11#2)(2007-2#1)(2009-4#1)(2011-2#1)
region in addition to##2##4##(1991-5#1)(1996-3#1)
region in an##3##3##(1994-2#1)(1997-1#1)(2008-3#1)
region in human##2##3##(1997-2#1)(1997-7#1)
region in patients with##2##4##(1997-9#1)(2012-3#1)
region in the catalytic domain##2##5##(1990-5#1)(1996-4#1)
region in the extracellular##2##4##(1995-8#1)(2008-8#1)
region in the years##2##4##(2007-1#1)(2009-5#1)
region in the##48##3##(1990-5#1)(1990-7#1)(1990-8#1)(1991-5#1)(1992-11#3)(1992-8#1)(1992-9#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(2005-11#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-5#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#3)(2008-8#1)(2008-9#1)(2009-5#3)(2011-1#2)(2012-2#1)(2012-3#1)(2013-8#1)
region in these##2##3##(1995-2#1)(2010-4#1)
region in which the##2##4##(1991-7#1)(2007-12#1)
region in which##5##3##(1991-5#1)(1991-7#1)(1997-4#1)(2007-12#1)(2008-2#1)
region in##141##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#4)(1991-12#1)(1991-2#2)(1991-5#4)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#3)(1992-8#1)(1992-9#2)(1993-11#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-6#1)(1994-9#3)(1995-1#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-9#1)(2005-11#1)(2006-4#1)(2006-7#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-9#1)(2008-1#3)(2008-10#7)(2008-11#3)(2008-2#4)(2008-3#5)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#3)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#5)
region included##3##2##(1993-11#1)(1997-2#2)
region includes##4##2##(1990-11#1)(1995-6#1)(1996-12#1)(1997-1#1)
region including the##3##3##(1990-3#1)(1996-12#1)(2008-10#1)
region including##6##2##(1990-3#1)(1992-11#1)(1996-12#1)(1997-7#1)(2008-10#1)(2011-1#1)
region increased##2##2##(1991-7#1)(1992-1#1)
region increases##2##2##(2009-6#2)
region indicated that the##2##4##(1990-2#1)(1997-2#1)
region indicated##3##2##(1990-2#1)(1997-2#1)(2005-11#1)
region indicates##2##2##(1994-8#1)(2008-8#1)
region induced by##2##3##(1991-8#1)(2008-3#1)
region inside the##5##3##(2005-11#4)(2009-5#1)
region into the##2##3##(2013-7#1)(2013-8#1)
region into##6##2##(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2013-7#1)(2013-8#1)
region involved in the##2##4##(1994-12#1)(1997-2#1)
region involved in##7##3##(1992-8#1)(1994-12#2)(1995-8#1)(1997-2#1)(1997-4#1)(2008-10#1)
region involved##8##2##(1992-8#1)(1994-12#2)(1995-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#1)
region is a##5##3##(1990-6#1)(1992-9#1)(1996-12#1)(2007-12#1)(2008-7#1)
region is also##4##3##(1994-8#1)(2008-10#1)(2011-1#1)(2012-2#1)
region is an##2##3##(1995-6#1)(2008-9#1)
region is characterized by##2##4##(1993-11#1)(1994-11#1)
region is composed of##2##4##(2007-12#1)(2008-8#1)
region is considered##3##3##(2008-2#2)(2008-5#1)
region is demonstrated by use of##2##6##(2007-11#2)
region is found##2##3##(1990-3#1)(2008-9#1)
region is given##2##3##(2008-11#1)(2008-3#1)
region is highly conserved##2##4##(1994-12#1)(2008-10#1)
region is highly##3##3##(1992-5#1)(1994-12#1)(2008-10#1)
region is involved in the##2##5##(1991-8#1)(2007-12#1)
region is involved in##3##4##(1991-8#1)(1997-7#1)(2007-12#1)
region is known##2##3##(2005-10#1)(2008-4#1)
region is not##6##3##(1990-4#1)(1991-7#1)(1992-4#1)(1994-8#1)(1996-7#1)(2012-2#1)
region is partially##2##3##(1991-6#1)(1994-6#1)
region is phylogenetically##2##3##(1994-8#1)(2008-10#1)
region is presented##3##3##(2008-2#2)(2008-4#1)
region is required for##2##4##(1992-9#1)(2008-7#1)
region is the##3##3##(1990-9#1)(1991-9#1)(1992-12#1)
region is to##2##3##(2007-11#1)(2012-1#1)
region is very##2##3##(1991-6#1)(2007-2#1)
region is well##2##3##(1996-5#1)(2013-8#1)
region is##128##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#3)(1992-12#2)(1992-2#1)(1992-4#1)(1992-5#1)(1992-9#2)(1993-11#2)(1993-12#3)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#4)(1994-9#2)(1995-11#1)(1995-6#3)(1995-8#3)(1996-12#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-7#2)(2005-10#1)(2005-11#1)(2006-9#1)(2007-11#3)(2007-12#10)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#3)
region it##3##2##(1990-5#1)(1992-7#1)(2008-8#1)
region just##3##2##(1991-6#1)(2007-11#1)(2012-2#1)
region known to##2##3##(1996-1#1)(2008-7#1)
region led to the##2##4##(1995-11#1)(2011-3#1)
region level##4##2##(2008-2#1)(2010-11#1)(2013-1#2)
region lies between##4##3##(1991-8#2)(2008-2#1)(2012-12#1)
region linking##2##2##(1994-9#1)(1997-6#1)
region located in the##3##4##(1990-4#1)(2007-2#1)(2012-2#1)
region located##11##2##(1990-10#1)(1990-4#1)(1991-12#1)(1992-11#1)(1993-2#1)(1996-6#1)(1996-7#1)(2006-8#1)(2007-2#1)(2012-12#1)(2012-2#1)
region matching##2##2##(2008-2#2)
region may##6##2##(1994-12#1)(1995-11#1)(1996-4#1)(2008-10#1)(2008-4#1)(2008-5#1)
region might be##2##3##(2008-10#2)
region might##4##2##(2007-3#1)(2008-10#2)(2008-8#1)
region movement##2##2##(2006-10#1)(2008-6#1)
region near 1##2##3##(2007-11#2)
region near the C terminus##2##5##(1993-6#1)(1995-3#1)
region near the##10##3##(1991-12#1)(1993-6#1)(1994-12#1)(1995-3#1)(2005-11#1)(2007-12#2)(2007-5#1)(2011-1#1)(2013-7#1)
region near##19##2##(1991-12#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-3#1)(2005-11#1)(2007-11#3)(2007-12#4)(2007-5#1)(2007-8#1)(2008-3#2)(2011-1#1)(2013-7#1)
region nor##2##2##(1996-7#1)(2012-2#1)
region not##4##2##(1994-8#1)(1995-6#1)(2007-12#1)(2012-12#1)
region of 1##2##3##(2007-12#1)(2008-10#1)
region of 16S##2##3##(2008-12#1)(2011-12#1)
region of 2##3##3##(1994-6#1)(1996-2#1)(2007-8#1)
region of 3##2##3##(2007-7#1)(2012-12#1)
region of 55 bp##2##4##(1990-11#2)
region of Australia##2##3##(1992-2#1)(2012-12#1)
region of Brazil##2##3##(1993-6#1)(2013-8#1)
region of CYP2E1##2##3##(1994-8#1)(1997-3#1)
region of China##2##3##(2008-10#1)(2013-8#1)
region of DNA that##2##4##(1990-5#1)(1994-12#1)
region of DNA##6##3##(1990-5#1)(1990-7#1)(1993-9#1)(1994-12#1)(1995-3#1)(1996-3#1)
region of E##2##3##(1994-3#1)(1995-5#1)
region of El##2##3##(2007-10#1)(2008-5#1)
region of Guatemala##3##3##(2007-2#2)(2007-3#1)
region of HIV-1##4##3##(1990-2#1)(1992-6#1)(1994-9#1)(1997-4#1)
region of Iran##2##3##(2007-2#2)
region of Nepal##3##3##(2008-7#2)(2012-3#1)
region of Nigeria##2##3##(2012-2#2)
region of P##2##3##(2008-10#2)
region of PKI alpha into PKI beta 1##2##8##(1995-3#2)
region of Poland##4##3##(2007-7#1)(2008-12#3)
region of Quebec##2##3##(1992-1#1)(2007-12#1)
region of Saudi Arabia##6##4##(2007-2#1)(2007-3#2)(2008-1#1)(2012-1#2)
region of São Paulo##2##4##(2011-2#1)(2013-8#1)
region of Turkey##3##3##(1997-3#1)(2008-12#1)(2011-1#1)
region of VP1##4##3##(1994-8#1)(2005-11#3)
region of Venezuela##3##3##(2008-10#2)(2008-5#1)
region of WSMoV NSs protein##2##5##(2008-10#2)
region of a##36##3##(1990-10#1)(1990-12#1)(1990-3#1)(1992-12#1)(1992-3#1)(1993-7#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-6#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-11#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-8#2)(2009-10#1)(2009-2#1)(2011-1#1)(2012-1#1)
region of all##4##3##(1993-12#1)(2008-5#1)(2012-2#1)(2012-3#1)
region of alpha 1-AGP gene is##2##6##(1992-12#2)
region of alpha##5##3##(1990-2#1)(1990-7#1)(1992-12#2)(1992-2#1)
region of an##6##3##(1992-11#1)(1992-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
region of bacterial chromosomes##2##4##(1994-12#1)(1995-8#1)
region of beta-tubulin##2##3##(1991-4#1)(1995-5#1)
region of both##3##3##(1993-4#1)(1993-6#1)(1994-3#1)
region of bovine##2##3##(1995-3#1)(2010-4#1)
region of c-myc##2##3##(1993-12#1)(2008-11#1)
region of central##3##3##(2008-3#1)(2010-3#1)(2010-5#1)
region of chromosome 11##2##4##(2008-11#1)(2012-12#1)
region of chromosome 21##2##4##(1993-12#1)(1996-2#1)
region of chromosome 3##2##4##(1990-12#1)(2009-10#1)
region of chromosome 6##2##4##(1994-11#1)(2008-8#1)
region of chromosome##22##3##(1990-12#1)(1990-9#1)(1993-11#1)(1993-12#1)(1994-11#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-5#2)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#3)(2009-10#1)(2012-12#1)
region of cyclin##2##3##(1997-8#1)(2007-8#1)
region of delayed replication##2##4##(1997-4#2)
region of each##8##3##(1991-11#1)(1993-12#1)(1995-12#1)(1995-9#1)(1997-3#1)(2008-10#1)(2008-5#2)
region of exon##3##3##(1990-8#1)(1992-5#2)
region of glycophorin A##2##4##(1990-4#2)
region of healthy##2##3##(2007-5#1)(2012-1#1)
region of helix##2##3##(1997-7#1)(2006-11#1)
region of hepatitis C virus##2##5##(1995-5#2)
region of homology to##3##4##(1993-12#1)(1993-6#1)(2008-6#1)
region of homology##5##3##(1992-8#1)(1993-12#1)(1993-6#2)(2008-6#1)
region of human##21##3##(1990-2#1)(1990-8#1)(1991-12#2)(1991-9#1)(1992-11#1)(1992-2#1)(1994-6#5)(1995-10#1)(1995-12#2)(1996-6#1)(1996-8#1)(2008-4#1)(2009-7#2)(2010-12#1)
region of iNOSox##2##3##(1997-4#2)
region of interest (ROI)##5##4##(2008-2#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-1#1)
region of interest analysis##2##4##(2008-10#1)(2012-12#1)
region of interest##25##3##(1994-3#1)(1995-6#1)(1996-6#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-5#1)(2009-7#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
region of its##2##3##(1990-5#1)(1993-4#1)
region of lambdaN##4##3##(2008-8#4)
region of maximum##2##3##(2008-10#1)(2008-5#1)
region of mitochondrial DNA##3##4##(2007-10#1)(2008-10#2)
region of mouse chromosome##4##4##(1993-2#1)(1995-2#1)(1997-1#1)(1997-2#1)
region of mouse##5##3##(1993-2#1)(1995-2#1)(1997-1#1)(1997-2#1)(1997-5#1)
region of nodD3##2##3##(2008-8#1)(2008-9#1)
region of origin##5##3##(2008-10#4)(2011-12#1)
region of other##2##3##(1991-2#1)(1991-6#1)
region of phenyl cyanate##2##4##(2010-2#2)
region of protein##3##3##(1991-5#1)(1992-12#1)(1992-8#1)
region of rDNA##2##3##(2008-10#2)
region of rat hippocampal slices##4##5##(1992-3#1)(1996-8#2)(1997-5#1)
region of rat##13##3##(1991-2#1)(1991-3#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1994-11#1)(1996-8#2)(1997-5#2)(2008-11#1)
region of rearrangement##2##3##(1997-1#2)
region of residence##3##3##(2007-7#2)(2009-4#1)
region of ribosomal DNA##4##4##(1996-5#1)(2008-10#2)(2009-2#1)
region of sorghumpsbA gene##2##4##(2008-9#2)
region of support##2##3##(2008-2#2)
region of target##3##3##(2008-4#1)(2008-7#1)(2011-2#1)
region of the Bacillus subtilis genome##4##6##(1995-12#1)(1996-8#2)(1997-7#1)
region of the Bacillus subtilis##5##5##(1991-9#1)(1995-12#1)(1996-8#2)(1997-7#1)
region of the EF-1 alpha O gene##2##7##(1992-11#2)
region of the Escherichia coli##3##5##(1990-7#2)(1991-3#1)
region of the HIV-1##3##4##(1991-5#2)(1993-12#1)
region of the MHC##2##4##(1992-4#1)(1997-6#1)
region of the P##2##4##(1990-12#1)(1990-9#1)
region of the TSH##2##4##(1991-7#1)(1993-8#1)
region of the Ti plasmid##2##5##(1990-11#1)(1992-5#1)
region of the United States##16##5##(1997-5#1)(2007-2#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-9#1)(2010-12#1)
region of the alpha 1##3##5##(1994-2#1)(1994-6#1)(1995-2#1)
region of the alpha##5##4##(1990-2#1)(1994-2#1)(1994-6#1)(1995-2#1)(1997-4#1)
region of the body##3##4##(2006-6#1)(2008-2#1)(2008-5#1)
region of the bovine##3##4##(1992-11#1)(1992-12#2)
region of the brachial fascia##2##5##(2009-1#2)
region of the brain##8##4##(1992-8#1)(1995-12#1)(1996-12#1)(1996-5#1)(2007-12#1)(2008-11#1)(2008-6#1)(2010-1#1)
region of the cell##3##4##(1995-7#1)(2008-1#1)(2008-6#1)
region of the chicken##4##4##(1993-6#2)(1993-8#1)(2013-8#1)
region of the chromosome##6##4##(1990-5#1)(1991-7#2)(1995-2#1)(1997-2#1)(2010-8#1)
region of the country##4##4##(2007-3#1)(2009-5#1)(2010-12#1)(2013-7#1)
region of the dorsal##2##4##(1991-3#1)(1995-12#1)
region of the enzyme##5##4##(1991-8#1)(1993-8#1)(1994-9#1)(1996-7#1)(1997-4#1)
region of the extended##2##4##(1993-6#1)(2009-5#1)
region of the extracellular domain of##2##6##(1990-12#1)(1993-6#1)
region of the fiber##2##4##(2007-12#2)
region of the gamma subunit##2##5##(1992-11#2)
region of the gamma##3##4##(1992-11#2)(1995-3#1)
region of the gene was##2##5##(1991-1#1)(2008-8#1)
region of the gene##24##4##(1990-4#1)(1991-1#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-9#1)(1992-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-10#1)(1996-3#1)(1997-2#2)(1997-4#1)(1997-6#2)(1997-7#1)(2008-8#1)
region of the genome##5##4##(1996-2#1)(2008-10#1)(2008-5#1)(2012-12#1)(2012-3#1)
region of the hand##2##4##(2007-7#1)(2008-7#1)
region of the hepatitis##3##4##(1994-11#1)(1997-6#2)
region of the hindlimb and the##4##6##(1994-2#4)
region of the hindlimb##5##4##(1994-2#5)
region of the hippocampus and##2##5##(1997-2#1)(2010-12#1)
region of the hippocampus##8##4##(1994-2#1)(1994-8#1)(1996-1#1)(1996-12#1)(1997-2#1)(2008-7#1)(2009-5#1)(2010-12#1)
region of the hsdSts + d sequence##2##7##(1990-5#2)
region of the human gene##2##5##(1990-7#1)(1991-7#1)
region of the human immunodeficiency virus##2##6##(1991-5#1)(1994-8#1)
region of the human##42##4##(1990-11#1)(1990-7#1)(1991-11#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-7#1)(1994-12#5)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1996-5#1)(1997-2#2)(1997-7#1)(1997-8#1)(2008-4#2)
region of the insulin##4##4##(1992-6#1)(1992-8#2)(2008-4#1)
region of the inverted##3##4##(1992-4#2)(2008-5#1)
region of the larva##2##4##(2008-5#2)
region of the left breast##2##5##(1996-6#2)
region of the left##3##4##(1993-12#1)(1996-6#2)
region of the ligand##2##4##(2008-10#1)(2010-5#1)
region of the long arm##2##5##(2008-10#1)(2008-9#1)
region of the long##3##4##(1991-3#1)(2008-10#1)(2008-9#1)
region of the mRNA##5##4##(1990-3#1)(1992-11#1)(1993-4#1)(1993-6#1)(1997-2#1)
region of the major##3##4##(1994-11#1)(1995-10#1)(1995-6#1)
region of the mandibular angle##2##5##(2010-2#1)(2012-12#1)
region of the maternal allele##2##5##(2010-12#2)
region of the membrane##2##4##(1995-11#1)(1996-1#1)
region of the molecule##7##4##(1991-12#1)(1991-2#2)(1994-9#1)(1995-8#1)(1997-5#1)(2008-5#1)
region of the mouse##7##4##(1990-11#1)(1991-2#1)(1991-6#2)(1995-11#1)(1996-1#1)(1996-11#1)
region of the murine##3##4##(1993-9#1)(1994-9#1)(2008-4#1)
region of the nuclear ribosomal RNA gene##3##7##(2008-10#3)
region of the nuclear ribosomal##4##5##(2008-10#4)
region of the nucleus##3##4##(1992-10#1)(1993-2#1)(1993-6#1)
region of the peptide##6##4##(1990-2#2)(1991-7#1)(1993-3#1)(1994-11#1)(1997-4#1)
region of the predicted##2##4##(1995-10#1)(1995-6#1)
region of the promoter##2##4##(1993-3#1)(1995-2#1)
region of the protein and##2##5##(1992-12#1)(1994-8#1)
region of the protein##16##4##(1990-11#1)(1990-4#1)(1990-5#1)(1991-10#1)(1991-4#1)(1991-8#1)(1992-12#1)(1992-8#1)(1993-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-3#1)(1996-7#1)(2012-12#1)
region of the rDNA##4##4##(2008-10#4)
region of the rat##13##4##(1990-12#1)(1990-5#1)(1991-2#1)(1992-5#2)(1993-3#2)(1993-8#1)(1994-11#1)(1994-5#1)(1997-5#1)(2008-11#1)(2008-9#1)
region of the ribosomal DNA##2##5##(2008-10#2)
region of the ribosomal##4##4##(2008-10#3)(2008-5#1)
region of the solar##2##4##(1996-5#1)(2008-2#1)
region of the spectrum##21##4##(1990-3#1)(1995-11#1)(2007-10#1)(2007-11#4)(2007-12#3)(2008-10#3)(2008-2#4)(2008-3#3)(2011-1#1)
region of the spinal cord##4##5##(1994-9#2)(1995-7#1)(2013-1#1)
region of the state##3##4##(2008-10#1)(2008-8#1)(2011-2#1)
region of the third##2##4##(1991-2#1)(1991-8#1)
region of the upper##3##4##(1997-1#1)(2007-8#1)(2009-1#1)
region of the viral##2##4##(1995-2#1)(1997-2#1)
region of the##702##3##(1990-1#1)(1990-11#9)(1990-12#5)(1990-2#7)(1990-3#5)(1990-4#3)(1990-5#14)(1990-7#8)(1990-8#1)(1990-9#7)(1991-1#3)(1991-10#2)(1991-11#2)(1991-12#4)(1991-2#5)(1991-3#6)(1991-4#4)(1991-5#7)(1991-6#8)(1991-7#10)(1991-8#7)(1991-9#11)(1992-1#1)(1992-10#2)(1992-11#9)(1992-12#8)(1992-2#2)(1992-3#5)(1992-4#7)(1992-5#5)(1992-6#4)(1992-7#3)(1992-8#5)(1992-9#5)(1993-1#2)(1993-11#2)(1993-12#9)(1993-2#2)(1993-3#8)(1993-4#2)(1993-5#4)(1993-6#11)(1993-7#2)(1993-8#6)(1993-9#4)(1994-10#1)(1994-11#7)(1994-12#12)(1994-2#10)(1994-3#6)(1994-5#6)(1994-6#4)(1994-8#11)(1994-9#15)(1995-1#5)(1995-10#4)(1995-11#8)(1995-12#3)(1995-2#10)(1995-3#7)(1995-4#1)(1995-5#1)(1995-6#8)(1995-7#2)(1995-8#6)(1996-1#5)(1996-10#5)(1996-11#3)(1996-12#7)(1996-2#3)(1996-3#3)(1996-4#2)(1996-5#5)(1996-6#4)(1996-7#3)(1996-8#3)(1997-1#5)(1997-2#11)(1997-3#2)(1997-4#7)(1997-5#4)(1997-6#8)(1997-7#12)(1997-8#6)(2004-9#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-12#2)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#16)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#5)(2007-9#3)(2008-1#3)(2008-10#43)(2008-11#7)(2008-12#3)(2008-2#14)(2008-3#8)(2008-4#8)(2008-5#17)(2008-6#3)(2008-7#13)(2008-8#6)(2008-9#5)(2009-1#3)(2009-10#2)(2009-12#1)(2009-4#1)(2009-5#4)(2009-7#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#6)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#5)(2012-12#5)(2012-2#2)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#4)
region of these genes##3##4##(1990-8#1)(1995-3#1)(1997-2#1)
region of these##9##3##(1990-8#1)(1994-11#1)(1995-2#1)(1995-3#1)(1997-2#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-7#1)
region of this gene##8##4##(1992-7#1)(1993-6#1)(1994-6#1)(1995-3#1)(1996-10#1)(1997-7#1)(2006-12#1)(2008-11#1)
region of this##15##3##(1990-12#1)(1990-3#1)(1991-5#1)(1992-7#1)(1993-11#1)(1993-6#1)(1994-6#1)(1995-3#1)(1996-10#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-12#1)(2008-11#1)(2009-8#1)
region of##1464##2##(1990-1#1)(1990-10#2)(1990-11#14)(1990-12#12)(1990-2#16)(1990-3#10)(1990-4#10)(1990-5#21)(1990-6#2)(1990-7#15)(1990-8#5)(1990-9#9)(1991-1#3)(1991-10#6)(1991-11#3)(1991-12#7)(1991-2#10)(1991-3#10)(1991-4#6)(1991-5#12)(1991-6#10)(1991-7#12)(1991-8#11)(1991-9#18)(1992-1#2)(1992-10#2)(1992-11#14)(1992-12#19)(1992-2#7)(1992-3#9)(1992-4#9)(1992-5#9)(1992-6#5)(1992-7#8)(1992-8#9)(1992-9#6)(1993-1#2)(1993-11#7)(1993-12#21)(1993-2#7)(1993-3#12)(1993-4#5)(1993-5#5)(1993-6#20)(1993-7#3)(1993-8#11)(1993-9#6)(1994-10#1)(1994-11#15)(1994-12#23)(1994-2#11)(1994-3#11)(1994-5#12)(1994-6#14)(1994-8#15)(1994-9#25)(1995-1#8)(1995-10#7)(1995-11#12)(1995-12#8)(1995-2#20)(1995-3#19)(1995-4#1)(1995-5#7)(1995-6#20)(1995-7#2)(1995-8#12)(1995-9#1)(1996-1#7)(1996-10#6)(1996-11#5)(1996-12#8)(1996-2#6)(1996-3#8)(1996-4#2)(1996-5#12)(1996-6#12)(1996-7#3)(1996-8#7)(1996-9#2)(1997-1#10)(1997-2#18)(1997-3#9)(1997-4#19)(1997-5#10)(1997-6#14)(1997-7#25)(1997-8#8)(2004-9#2)(2005-10#1)(2005-11#5)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#6)(2006-11#2)(2006-12#4)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#1)(2007-1#1)(2007-10#4)(2007-11#12)(2007-12#32)(2007-2#12)(2007-3#9)(2007-4#1)(2007-5#4)(2007-7#8)(2007-8#8)(2007-9#5)(2008-1#11)(2008-10#103)(2008-11#18)(2008-12#9)(2008-2#31)(2008-3#28)(2008-4#12)(2008-5#31)(2008-6#7)(2008-7#22)(2008-8#23)(2008-9#12)(2009-1#3)(2009-10#6)(2009-12#1)(2009-2#3)(2009-4#5)(2009-5#5)(2009-7#4)(2009-8#6)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#7)(2010-2#4)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#5)(2011-1#7)(2011-12#3)(2011-2#15)(2012-1#6)(2012-12#19)(2012-2#13)(2012-3#10)(2012-7#1)(2013-1#13)(2013-7#1)(2013-8#19)
region on chromosome 6q##2##4##(2009-4#1)(2012-3#1)
region on chromosome##11##3##(1990-9#1)(1996-2#1)(1997-2#1)(2008-1#1)(2009-10#1)(2009-4#1)(2010-3#2)(2012-3#3)
region on the##16##3##(1991-3#1)(1994-9#1)(1996-12#6)(1996-6#2)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#2)
region on##41##2##(1990-9#1)(1991-3#1)(1991-7#1)(1992-4#1)(1993-3#1)(1994-9#1)(1995-3#1)(1996-12#6)(1996-2#1)(1996-6#2)(1996-8#1)(1997-2#1)(1997-4#1)(2007-12#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-4#1)(2010-3#3)(2010-5#1)(2012-1#1)(2012-3#3)
region opens##2##2##(2007-11#1)(2008-3#1)
region or the##2##3##(1991-6#1)(2007-12#1)
region or with the##2##4##(1995-6#1)(2008-11#1)
region or##14##2##(1990-8#1)(1991-6#1)(1992-6#1)(1993-9#1)(1995-6#1)(1996-4#1)(2007-12#1)(2008-10#5)(2008-11#1)(2011-2#1)
region overlapping##2##2##(1993-8#1)(2007-7#1)
region peptide##2##2##(1994-5#1)(2008-11#1)
region plays##2##2##(1992-7#1)(2008-11#1)
region presents a##3##3##(2007-11#1)(2008-10#1)(2008-8#1)
region previously implicated##2##3##(1994-12#1)(2008-11#1)
region previously##5##2##(1991-7#1)(1993-9#1)(1994-12#1)(2008-11#1)(2008-4#1)
region probes##2##2##(1990-5#1)(2012-3#1)
region quasi-phase matches a##2##4##(2007-12#2)
region represent##2##2##(2007-5#1)(2011-2#1)
region represented##2##2##(1997-6#1)(2008-11#1)
region required for##3##3##(1990-11#1)(1994-12#1)(2007-8#1)
region residues##2##2##(1995-8#1)(2013-7#1)
region resolved##2##2##(2008-10#1)(2010-8#1)
region results in##3##3##(1996-11#1)(2008-7#1)(2011-2#1)
region revealed the presence of##2##5##(1993-2#1)(1994-5#1)
region revealed##8##2##(1990-2#1)(1993-2#1)(1993-3#1)(1994-5#1)(1995-8#1)(1997-3#1)(2006-10#1)(2008-10#1)
region rich in##5##3##(1990-10#1)(1990-6#1)(1992-2#1)(1994-3#1)(1997-7#1)
region selection##4##2##(1995-3#2)(2008-10#1)(2008-6#1)
region sequence##2##2##(1990-7#1)(2008-10#1)
region sequenced##4##2##(1990-12#1)(1993-11#1)(1994-8#1)(2008-10#1)
region sequences##3##2##(1997-3#1)(2008-12#2)
region shares##3##2##(1990-9#1)(1992-11#1)(1994-3#1)
region should be##2##3##(1996-11#1)(2008-1#1)
region should##3##2##(1996-11#1)(2008-1#1)(2010-12#1)
region showed a##2##3##(1992-12#1)(1996-7#1)
region showed that the##2##4##(2008-10#1)(2009-5#1)
region showed that##5##3##(2008-10#4)(2009-5#1)
region showed##14##2##(1991-5#1)(1992-12#1)(1993-12#1)(1994-3#1)(1995-4#1)(1995-8#1)(1996-7#1)(2008-10#5)(2009-5#1)(2011-1#1)
region shows a##2##3##(1992-3#1)(1996-10#1)
region shows that the##2##4##(1997-6#1)(2008-7#1)
region shows##6##2##(1992-3#1)(1996-10#1)(1997-6#1)(2008-10#1)(2008-7#1)(2010-2#1)
region spanning residues##2##3##(1992-12#1)(1994-9#1)
region spanning##5##2##(1991-6#1)(1992-12#1)(1994-9#1)(1995-3#1)(2008-10#1)
region specific to##2##3##(1990-7#1)(2008-10#1)
region specific##7##2##(1990-7#1)(1991-3#2)(1994-12#1)(1995-5#1)(1996-8#1)(2008-10#1)
region still##2##2##(2008-5#1)(2012-3#1)
region studied with##2##3##(1990-12#1)(1996-6#1)
region studied##3##2##(1990-12#1)(1996-6#1)(2007-1#1)
region such that##2##3##(1995-3#1)(2008-2#1)
region surrounding the##7##3##(1991-7#1)(1994-2#1)(1997-5#1)(2006-10#1)(2006-6#1)(2007-11#1)(2012-3#1)
region surrounding##9##2##(1991-7#1)(1994-11#1)(1994-2#1)(1997-5#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-3#1)(2012-3#1)
region termed##2##2##(1995-8#1)(1997-1#1)
region than##2##2##(1994-6#1)(2013-1#1)
region that contains##4##3##(1994-9#1)(1997-4#1)(1997-7#1)(2008-10#1)
region that could##2##3##(1994-12#1)(1997-5#1)
region that encodes the##2##4##(1993-2#1)(1995-2#1)
region that has##6##3##(1990-8#1)(1992-9#1)(1994-11#1)(1997-7#1)(2008-10#1)(2008-2#1)
region that is most important##2##5##(1994-3#1)(2008-10#1)
region that is##9##3##(1990-5#1)(1991-12#1)(1993-12#1)(1994-3#1)(1995-6#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#1)
region that may##2##3##(1990-12#1)(2007-11#1)
region that shares##3##3##(1995-8#1)(1997-7#1)(2008-10#1)
region that was##5##3##(1993-12#1)(2008-10#2)(2008-5#2)
region that##59##2##(1990-10#1)(1990-12#2)(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-9#2)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#3)(2006-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)
region the##5##2##(2007-12#1)(2007-5#1)(2008-3#1)(2010-9#1)(2013-1#1)
region then##2##2##(1997-5#1)(2008-8#1)
region there are##3##3##(2008-1#1)(2008-11#1)(2008-7#1)
region there##4##2##(1990-11#1)(2008-1#1)(2008-11#1)(2008-7#1)
region through the##2##3##(1994-12#1)(2008-10#1)
region through##5##2##(1994-12#1)(1997-6#1)(2008-10#1)(2008-5#1)(2012-3#1)
region to another##4##3##(2008-1#1)(2013-1#3)
region to be##4##3##(1990-11#1)(1990-12#1)(1992-1#1)(1997-3#1)
region to the##7##3##(1995-3#1)(2006-10#1)(2006-12#2)(2008-10#1)(2008-3#1)(2011-1#1)
region to##40##2##(1990-11#2)(1990-12#1)(1991-8#1)(1992-1#1)(1992-2#1)(1994-5#1)(1995-3#2)(1996-10#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-12#3)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#2)
region toward the##2##3##(1993-3#1)(2008-3#1)
region treated##2##2##(2008-6#1)(2008-9#1)
region up to##2##3##(1991-7#1)(2008-2#1)
region upstream from the##4##4##(1990-1#1)(1993-9#1)(1995-8#1)(1996-2#1)
region upstream from##6##3##(1990-1#2)(1993-9#1)(1994-11#1)(1995-8#1)(1996-2#1)
region upstream of the##6##4##(1993-8#1)(1994-9#1)(1996-5#1)(1997-7#1)(2008-3#1)(2008-5#1)
region upstream of##7##3##(1993-8#1)(1994-9#1)(1996-5#1)(1997-7#1)(2006-5#1)(2008-3#1)(2008-5#1)
region upstream##13##2##(1990-1#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-7#1)(2006-5#1)(2008-3#1)(2008-5#1)
region usage##2##2##(1995-5#1)(2010-3#1)
region using a##2##3##(2008-2#1)(2008-4#1)
region using the polymerase chain reaction##2##6##(1991-5#1)(1991-9#1)
region using##13##2##(1991-5#2)(1991-9#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2011-12#2)
region was calculated##2##3##(2008-3#1)(2012-2#1)
region was detected##4##3##(1993-3#1)(1995-3#1)(2008-10#1)(2012-12#1)
region was determined##5##3##(1990-10#1)(1991-5#1)(1991-6#1)(1993-6#1)(1994-9#1)
region was examined##2##3##(1992-3#1)(2008-10#1)
region was formed##2##3##(2007-11#1)(2007-12#1)
region was found to##3##4##(1992-3#1)(1994-9#1)(1995-8#1)
region was found##4##3##(1992-3#1)(1994-9#1)(1995-8#1)(1997-2#1)
region was identified##2##3##(1992-7#1)(2008-8#1)
region was separated##2##3##(1990-7#1)(2008-9#1)
region was sequenced##2##3##(1990-7#1)(1994-12#1)
region was shown to##2##4##(1990-5#1)(1991-12#1)
region was similar to##2##4##(1990-4#1)(1991-7#1)
region was subcloned into##2##4##(1991-2#1)(1993-12#1)
region was synthesized and##2##4##(1990-12#1)(2007-8#1)
region was the##2##3##(2007-5#1)(2008-10#1)
region was used as##2##4##(1990-10#1)(2008-10#1)
region was used to##2##4##(1994-5#1)(2008-10#1)
region was used##5##3##(1990-10#1)(1994-5#1)(2008-10#2)(2008-2#1)
region was##99##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#3)(1991-12#3)(1991-2#3)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-7#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#4)(1995-11#2)(1995-12#1)(1995-3#1)(1995-8#2)(1996-12#1)(1996-4#1)(1997-2#4)(1997-5#1)(1997-7#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#10)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-5#1)(2009-6#1)(2010-5#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
region we##2##2##(2008-3#1)(2012-2#1)
region were analyzed##3##3##(1997-7#1)(2007-7#1)(2008-12#1)
region were observed##3##3##(1991-4#1)(1997-2#1)(2005-8#1)
region were sequenced##2##3##(1993-2#1)(2008-10#1)
region were tested for##2##4##(1991-11#1)(2007-2#1)
region were##69##2##(1990-5#2)(1991-11#2)(1991-4#1)(1991-9#1)(1992-7#2)(1992-9#1)(1993-2#2)(1993-5#1)(1993-6#1)(1994-11#2)(1994-3#1)(1994-9#3)(1995-11#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-7#2)(2005-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-12#3)(2008-3#1)(2008-4#3)(2008-5#4)(2009-8#1)(2010-5#1)(2012-11#1)(2012-2#1)(2013-8#3)
region where the##3##3##(1993-11#1)(2008-2#1)(2008-3#1)
region where this##2##3##(2011-2#1)(2012-2#1)
region where##18##2##(1991-4#1)(1993-11#1)(1995-2#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#2)
region which contains the##2##4##(1993-4#1)(1994-12#1)
region which contains##3##3##(1991-12#1)(1993-4#1)(1994-12#1)
region which is##2##3##(1991-9#1)(1992-6#1)
region which was##2##3##(2006-10#1)(2012-2#1)
region which##18##2##(1990-6#1)(1991-12#1)(1991-9#1)(1992-6#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-9#1)(1996-10#1)(1996-12#1)(1997-1#1)(1997-3#1)(2006-10#1)(2007-2#1)(2011-2#1)(2012-2#1)
region while##2##2##(1991-7#1)(2008-3#1)
region whose##2##2##(1997-4#1)(2010-2#1)
region will##3##2##(2008-1#1)(2008-7#1)(2010-8#1)
region with a##13##3##(1990-4#1)(1994-8#1)(1996-11#1)(1997-4#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)(2010-9#1)(2013-1#1)
region with an##2##3##(2008-2#1)(2008-3#1)
region with high##3##3##(1995-3#1)(1995-8#1)(2008-8#1)
region with homology to##2##4##(1993-6#1)(1997-1#1)
region with the##5##3##(1993-11#1)(1996-2#1)(2006-10#1)(2008-10#1)(2012-3#1)
region with three groups of##2##5##(2012-1#2)
region with three##3##3##(2008-10#1)(2012-1#2)
region with##62##2##(1990-4#1)(1991-11#1)(1992-11#1)(1992-2#1)(1992-7#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-2#4)(1996-4#2)(1997-1#1)(1997-4#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#6)(2008-2#5)(2008-3#3)(2008-7#1)(2008-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#3)(2012-2#1)(2012-3#1)(2013-1#3)
region within the##7##3##(1992-3#1)(1995-6#1)(1996-5#1)(2007-11#1)(2008-11#1)(2008-2#1)(2012-12#1)
region within##11##2##(1992-3#1)(1992-8#1)(1995-6#1)(1996-5#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2012-12#1)
region without a##2##3##(2006-10#1)(2012-2#1)
region without##6##2##(1997-3#1)(2006-10#1)(2007-12#2)(2011-1#1)(2012-2#1)
region would##2##2##(1997-5#1)(2008-8#1)
region##5202##1##(1990-1#5)(1990-10#16)(1990-11#44)(1990-12#31)(1990-2#27)(1990-3#32)(1990-4#34)(1990-5#59)(1990-6#20)(1990-7#34)(1990-8#18)(1990-9#24)(1991-1#8)(1991-10#13)(1991-11#15)(1991-12#36)(1991-2#28)(1991-3#25)(1991-4#23)(1991-5#35)(1991-6#28)(1991-7#44)(1991-8#32)(1991-9#38)(1992-1#9)(1992-10#6)(1992-11#41)(1992-12#38)(1992-2#23)(1992-3#25)(1992-4#23)(1992-5#13)(1992-6#20)(1992-7#27)(1992-8#20)(1992-9#32)(1993-1#3)(1993-10#2)(1993-11#29)(1993-12#52)(1993-2#25)(1993-3#34)(1993-4#15)(1993-5#17)(1993-6#46)(1993-7#5)(1993-8#29)(1993-9#24)(1994-10#4)(1994-11#46)(1994-12#82)(1994-2#30)(1994-3#44)(1994-5#27)(1994-6#28)(1994-8#47)(1994-9#78)(1995-1#21)(1995-10#18)(1995-11#30)(1995-12#21)(1995-2#54)(1995-3#49)(1995-4#6)(1995-5#18)(1995-6#51)(1995-7#5)(1995-8#53)(1995-9#2)(1996-1#15)(1996-10#26)(1996-11#15)(1996-12#36)(1996-2#28)(1996-3#21)(1996-4#24)(1996-5#35)(1996-6#33)(1996-7#24)(1996-8#24)(1996-9#9)(1997-1#23)(1997-2#75)(1997-3#32)(1997-4#55)(1997-5#27)(1997-6#33)(1997-7#59)(1997-8#33)(1997-9#7)(2004-9#4)(2005-10#3)(2005-11#42)(2005-5#4)(2005-7#1)(2005-8#12)(2005-9#2)(2006-1#3)(2006-10#31)(2006-11#5)(2006-12#19)(2006-2#5)(2006-3#6)(2006-4#13)(2006-5#10)(2006-6#6)(2006-7#11)(2006-8#2)(2006-9#3)(2007-1#10)(2007-10#13)(2007-11#64)(2007-12#150)(2007-2#30)(2007-3#25)(2007-4#13)(2007-5#17)(2007-6#4)(2007-7#36)(2007-8#30)(2007-9#13)(2008-1#50)(2008-10#395)(2008-11#71)(2008-12#41)(2008-2#173)(2008-3#147)(2008-4#52)(2008-5#98)(2008-6#27)(2008-7#75)(2008-8#91)(2008-9#59)(2009-1#4)(2009-10#21)(2009-11#1)(2009-12#5)(2009-2#7)(2009-3#6)(2009-4#16)(2009-5#21)(2009-6#8)(2009-7#10)(2009-8#15)(2009-9#11)(2010-1#4)(2010-10#6)(2010-11#5)(2010-12#21)(2010-2#7)(2010-3#12)(2010-4#11)(2010-5#23)(2010-6#2)(2010-7#16)(2010-8#23)(2010-9#4)(2011-1#50)(2011-12#7)(2011-2#68)(2011-3#1)(2011-9#1)(2012-1#22)(2012-11#8)(2012-12#76)(2012-2#63)(2012-3#44)(2012-6#1)(2012-7#1)(2013-1#74)(2013-7#21)(2013-8#65)
region&quot##6##1##(1991-4#2)(1991-9#1)(1995-8#1)(2005-11#2)
region'##2##1##(2008-9#1)(2013-8#1)
region's##9##1##(2007-2#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-11#1)(2013-1#2)
region(s) of##3##2##(1991-7#1)(1992-11#1)(2005-8#1)
region(s)##6##1##(1991-7#1)(1992-11#1)(1996-5#1)(1997-5#1)(2005-8#1)(2012-3#1)
region) and##11##2##(1991-5#1)(1991-7#1)(1994-8#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)
region) are##3##2##(1995-8#1)(2008-3#1)(2010-4#1)
region) as a##2##3##(1995-2#2)
region) of the##5##3##(1994-8#1)(2006-12#1)(2008-1#1)(2008-2#1)(2008-5#1)
region) of##8##2##(1994-8#1)(2006-12#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-6#1)(2010-7#1)(2011-2#1)
region) or##2##2##(1995-9#1)(2013-1#1)
region) to##2##2##(2007-12#1)(2008-2#1)
region) were##2##2##(1991-12#1)(1995-9#1)
region)##56##1##(1990-12#1)(1990-4#1)(1991-12#1)(1991-5#3)(1991-7#1)(1992-3#1)(1992-4#1)(1994-8#4)(1995-2#2)(1995-8#1)(1995-9#2)(1996-11#1)(1996-2#1)(1996-7#1)(2005-10#1)(2006-12#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
region-based and pathway-based QTL mappings using a##2##7##(2012-3#2)
region-based methods##2##2##(2008-2#1)(2012-3#1)
region-based##8##1##(2008-2#2)(2008-3#1)(2012-3#5)
region-of-interest##2##1##(2008-3#1)(2011-1#1)
region-specific##17##1##(1992-8#1)(1993-4#1)(1993-9#1)(1994-8#1)(1995-12#1)(1996-6#1)(1996-8#1)(1997-5#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-6#1)(2010-11#1)(2011-2#1)(2012-12#2)
region]##8##1##(1990-9#1)(1992-11#1)(1995-8#1)(2007-5#1)(2008-8#1)(2012-3#1)(2013-8#2)
regional PWV##2##2##(2013-3#2)
regional activation##2##2##(2006-10#1)(2011-1#1)
regional albedo values##2##3##(2008-3#2)
regional albedo##3##2##(2008-3#3)
regional anaesthesia has##3##3##(2006-10#1)(2010-7#1)(2013-1#1)
regional anaesthesia in##7##3##(2006-10#6)(2013-1#1)
regional anaesthesia##27##2##(1990-6#1)(1992-11#1)(2006-10#19)(2010-7#2)(2013-1#4)
regional anaesthetic techniques##5##3##(1994-3#2)(2006-10#3)
regional anaesthetic##7##2##(1994-3#2)(2006-10#4)(2008-8#1)
regional and distant##2##3##(2008-2#1)(2010-2#1)
regional and district##2##3##(1993-10#1)(2011-2#1)
regional and general anaesthesia##6##4##(2006-10#4)(2010-7#1)(2011-1#1)
regional and general##7##3##(2006-10#4)(2008-12#1)(2010-7#1)(2011-1#1)
regional and global##6##3##(1996-12#1)(2007-9#1)(2008-1#1)(2009-10#2)(2011-1#1)
regional and local##3##3##(2008-9#1)(2011-1#1)(2012-3#1)
regional and national##3##3##(1990-7#1)(2007-7#1)(2008-1#1)
regional and systemic##2##3##(2008-3#1)(2009-9#1)
regional and##41##2##(1990-7#1)(1992-5#1)(1993-10#1)(1993-4#1)(1996-12#1)(1996-2#2)(1997-1#1)(2006-10#5)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-7#1)(2011-1#4)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#1)
regional anesthesia and analgesia##2##4##(2006-10#1)(2008-8#1)
regional anesthesia and##3##3##(2006-10#2)(2008-8#1)
regional anesthesia are##2##3##(2006-10#2)
regional anesthesia for##4##3##(2006-10#4)
regional anesthesia in##4##3##(1993-4#1)(2005-12#1)(2006-10#1)(2012-3#1)
regional anesthesia techniques##2##3##(2006-10#2)
regional anesthesia##38##2##(1990-12#3)(1993-4#3)(2005-12#1)(2006-10#20)(2007-2#1)(2008-5#1)(2008-8#2)(2009-5#1)(2012-2#4)(2012-3#1)(2013-7#1)
regional anesthetic##2##2##(2005-12#1)(2006-10#1)
regional areas##3##2##(1996-2#1)(2011-2#2)
regional arterial##2##2##(2008-9#1)(2012-12#1)
regional attrition##5##2##(1994-3#5)
regional authorities or##2##3##(1997-3#1)(2008-7#1)
regional background site##2##3##(2004-4#2)
regional block##5##2##(1993-4#2)(2006-1#2)(2013-1#1)
regional blocks##2##2##(2006-10#1)(2013-1#1)
regional brain syndromes##4##3##(2008-7#4)
regional brain##17##2##(1990-9#1)(1991-10#1)(1995-12#1)(1996-1#1)(1996-9#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-7#5)(2008-9#1)(2009-6#1)(2010-2#1)(2013-8#1)
regional cancer registry##4##3##(2011-2#1)(2013-1#2)(2013-7#1)
regional cancer##7##2##(1996-2#1)(2004-2#1)(2010-3#1)(2011-2#1)(2013-1#2)(2013-7#1)
regional cardiac##2##2##(2007-3#1)(2012-12#1)
regional centers##2##2##(1992-12#1)(2007-9#1)
regional centres##2##2##(1992-2#1)(2005-11#1)
regional cerebral blood flow (CBF)##3##5##(1992-8#1)(2007-10#1)(2008-7#1)
regional cerebral blood flow (rCBF) was##2##6##(1995-5#1)(1996-1#1)
regional cerebral blood flow (rCBF)##8##5##(1992-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-5#2)
regional cerebral blood flow and##2##5##(1993-2#1)(2007-10#1)
regional cerebral blood flow in the##2##6##(1991-9#1)(2006-3#1)
regional cerebral blood flow in##3##5##(1991-9#1)(1996-5#1)(2006-3#1)
regional cerebral blood flow##28##4##(1991-9#2)(1992-8#3)(1993-2#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-5#3)(2006-3#1)(2007-10#3)(2007-8#1)(2007-9#1)(2008-2#1)(2008-7#1)(2009-1#1)(2010-8#1)(2012-12#1)
regional cerebral blood##30##3##(1991-9#2)(1992-8#3)(1993-2#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-5#3)(2006-11#1)(2006-3#1)(2007-10#4)(2007-8#1)(2007-9#1)(2008-2#1)(2008-7#1)(2009-1#1)(2010-8#1)(2012-12#1)
regional cerebral metabolic rate##2##4##(2006-11#1)(2007-10#1)
regional cerebral##36##2##(1991-9#2)(1992-8#3)(1993-2#1)(1993-9#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-5#3)(1997-3#1)(2006-10#1)(2006-11#2)(2006-3#1)(2006-7#1)(2007-10#5)(2007-8#1)(2007-9#1)(2008-2#1)(2008-7#1)(2009-1#1)(2010-8#1)(2012-12#1)
regional changes in the##2##4##(1996-11#1)(1997-5#1)
regional changes in##3##3##(1996-11#1)(1997-5#2)
regional changes of##2##3##(1990-2#1)(1995-12#1)
regional changes##5##2##(1990-2#1)(1995-12#1)(1996-11#1)(1997-5#2)
regional characteristics##2##2##(1997-2#1)(2013-8#1)
regional chemotherapy##3##2##(1990-4#1)(2006-6#1)(2010-12#1)
regional citrate##2##2##(2007-8#2)
regional coexistence##2##2##(2008-8#2)
regional comparison##2##2##(1993-10#1)(2012-2#1)
regional continuity##2##2##(1994-3#2)
regional control##2##2##(2007-11#1)(2011-2#1)
regional coordination##2##2##(1990-12#1)(2012-12#1)
regional cortical##2##2##(2006-9#1)(2009-9#1)
regional difference##3##2##(1990-7#1)(1993-12#1)(2010-3#1)
regional differences and##2##3##(1996-2#1)(2009-10#1)
regional differences are##2##3##(1991-6#1)(2006-10#1)
regional differences between##3##3##(1992-8#1)(1994-2#1)(2011-12#1)
regional differences in the##3##4##(1992-3#1)(1994-2#1)(2013-8#1)
regional differences in##13##3##(1992-3#1)(1994-2#1)(1997-7#1)(2005-10#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-9#1)(2011-12#1)(2011-2#2)(2013-8#1)
regional differences##25##2##(1990-10#1)(1990-7#1)(1991-6#1)(1992-3#1)(1992-8#1)(1994-2#2)(1996-2#1)(1997-7#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-9#1)(2011-12#2)(2011-2#2)(2013-1#1)(2013-8#1)
regional distribution of the##3##4##(1992-3#1)(1995-11#1)(1995-12#1)
regional distribution of##10##3##(1990-7#1)(1992-3#2)(1994-5#1)(1995-11#1)(1995-12#1)(1996-2#1)(2008-3#1)(2010-12#1)(2013-7#1)
regional distribution pattern of##2##4##(1995-5#1)(1997-5#1)
regional distribution pattern##4##3##(1993-9#1)(1995-5#2)(1997-5#1)
regional distribution##17##2##(1990-3#1)(1990-7#1)(1992-3#2)(1993-9#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-5#2)(1996-1#1)(1996-12#1)(1996-2#1)(1997-5#1)(2008-3#1)(2010-12#1)(2013-7#1)
regional distributions in##2##3##(1995-11#1)(1995-5#1)
regional distributions##3##2##(1991-3#1)(1995-11#1)(1995-5#1)
regional dosages delivered##2##3##(1994-12#2)
regional dosages##4##2##(1994-12#4)
regional effect##2##2##(1993-3#1)(2011-1#1)
regional environmental##2##2##(1997-5#1)(2013-8#1)
regional fat##2##2##(2010-6#1)(2010-9#1)
regional function##2##2##(2005-1#1)(2012-2#1)
regional haemodynamic##2##2##(1990-9#1)(1991-5#1)
regional health agencies##2##3##(2007-2#1)(2012-3#1)
regional health authorities##4##3##(1993-10#1)(1994-3#1)(1997-2#1)(2008-11#1)
regional health authority##2##3##(1996-3#1)(1997-1#1)
regional health care##2##3##(1994-12#1)(1995-3#1)
regional health##23##2##(1993-10#1)(1994-12#1)(1994-3#3)(1994-5#2)(1995-3#2)(1995-6#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#2)(2007-10#1)(2007-2#2)(2008-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
regional healthcare##2##2##(2007-1#1)(2007-12#1)
regional hospital in##3##3##(1994-8#1)(1995-5#1)(2007-3#1)
regional hospital##9##2##(1993-12#1)(1994-8#1)(1995-5#3)(2006-1#1)(2007-3#1)(2008-5#1)(2013-1#1)
regional hospital]##2##2##(1992-2#1)(2009-2#1)
regional hospitals and##2##3##(1993-5#1)(1995-1#1)
regional hospitals##12##2##(1993-12#1)(1993-5#1)(1995-1#1)(1995-5#1)(2007-10#1)(2008-1#2)(2010-3#1)(2011-2#4)
regional hyperthermia##3##2##(1993-4#1)(2005-11#1)(2013-8#1)
regional information##2##2##(2006-10#1)(2011-2#1)
regional inhibition of##2##3##(1995-7#1)(1996-2#1)
regional inhomogeneity##2##2##(1997-8#1)(2007-4#1)
regional invasion##2##2##(2008-10#2)
regional laboratories##2##2##(1994-9#1)(2005-9#1)
regional left ventricular##3##3##(1997-8#1)(2008-3#1)(2010-12#1)
regional level with##2##3##(1994-2#1)(2010-12#1)
regional level##11##2##(1990-11#1)(1994-2#1)(2006-10#1)(2007-2#1)(2008-10#3)(2009-7#1)(2010-12#1)(2010-8#1)(2011-1#1)
regional levels##3##2##(1994-12#1)(2008-10#1)(2010-12#1)
regional lymph node metastasis##2##4##(2008-6#1)(2013-8#1)
regional lymph node##6##3##(1995-10#1)(2006-10#1)(2008-6#1)(2010-12#1)(2012-12#1)(2013-8#1)
regional lymph nodes##10##3##(1992-4#1)(1992-8#1)(1997-4#1)(2006-6#1)(2008-1#1)(2008-6#2)(2009-1#1)(2010-2#1)(2010-8#1)
regional lymph##17##2##(1992-4#1)(1992-8#1)(1995-10#1)(1997-4#1)(2006-10#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-6#3)(2009-1#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-12#1)(2013-8#1)
regional lymphadenopathy##2##2##(2011-1#1)(2013-1#1)
regional lymphatics##2##2##(1993-4#1)(2007-12#1)
regional medical center##2##3##(2006-12#1)(2007-5#1)
regional metabolism##2##2##(2008-1#1)(2008-7#1)
regional migratory osteoporosis##3##3##(2006-10#3)
regional myocardial##5##2##(1991-9#1)(1993-12#2)(1996-9#1)(2007-8#1)
regional nodal##2##2##(1993-9#1)(2006-10#1)
regional or national##2##3##(2011-2#1)(2012-3#1)
regional or##8##2##(1992-1#2)(2004-4#1)(2007-4#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-3#1)
regional osteoporosis##3##2##(2006-10#3)
regional oxygen extraction fraction##2##4##(2006-11#1)(2007-10#1)
regional pain syndrome (CRPS)##3##4##(2006-12#2)(2009-2#1)
regional pain syndrome type 1##2##5##(2006-12#1)(2006-7#1)
regional pain syndrome type##5##4##(2006-10#2)(2006-12#1)(2006-7#2)
regional pain syndrome##18##3##(2006-10#4)(2006-12#5)(2006-7#2)(2006-8#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-2#2)(2011-2#1)
regional pain##19##2##(2006-10#5)(2006-12#5)(2006-7#2)(2006-8#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-2#2)(2011-2#1)
regional patterns##2##2##(1991-6#1)(1995-5#1)
regional planning##5##2##(1992-12#1)(1994-12#1)(1994-3#2)(2008-7#1)
regional plans of organization of services##2##6##(2008-2#2)
regional populations##2##2##(2011-2#2)
regional prevalence##2##2##(2008-10#1)(2009-10#1)
regional recurrence##2##2##(1992-10#1)(2007-8#1)
regional reference laboratory##2##3##(1994-9#1)(2005-5#1)
regional reference##3##2##(1994-9#1)(2005-5#1)(2011-2#1)
regional referral##2##2##(2005-8#1)(2013-1#1)
regional rehabilitation##2##2##(2007-10#1)(2007-9#1)
regional right##2##2##(1997-1#1)(2013-8#1)
regional scale##8##2##(2008-10#5)(2008-8#1)(2010-2#1)(2011-2#1)
regional spatial##2##2##(2008-10#1)(2009-2#1)
regional specification##2##2##(2013-1#2)
regional specificity##2##2##(1990-5#1)(1997-6#1)
regional spread of##3##3##(1997-3#1)(2008-10#2)
regional spread##7##2##(1990-4#3)(1997-3#1)(2008-10#3)
regional subclassification of pathological breast tissue##2##6##(2009-11#1)(2009-3#1)
regional surveillance##3##2##(2008-1#1)(2011-12#1)(2011-2#1)
regional system##4##2##(1992-12#3)(2008-3#1)
regional systems##7##2##(1992-12#5)(1997-4#1)(2013-8#1)
regional systolic and##2##3##(2005-1#2)
regional systolic##3##2##(2005-1#2)(2010-5#1)
regional techniques for##2##3##(2006-10#1)(2006-7#1)
regional techniques##5##2##(2006-10#4)(2006-7#1)
regional tissue##2##2##(1990-5#1)(1992-3#1)
regional treatment##2##2##(1991-4#1)(2010-3#1)
regional variability##2##2##(2008-9#2)
regional variation in the##3##4##(2008-10#1)(2008-2#1)(2008-8#1)
regional variation in##9##3##(2007-10#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-8#2)(2010-8#1)(2012-1#1)
regional variation##12##2##(1990-6#1)(2007-10#3)(2008-1#1)(2008-10#1)(2008-2#1)(2008-8#2)(2010-8#1)(2012-1#2)
regional variations were##2##3##(1993-5#1)(2007-3#1)
regional variations##7##2##(1993-5#1)(1996-3#1)(2006-10#1)(2007-3#2)(2010-11#2)
regional vascular##5##2##(1993-3#1)(1996-12#1)(1997-6#1)(2012-12#2)
regional vasculitis##2##2##(2006-10#2)
regional wall motion abnormalities##3##4##(2011-2#1)(2013-1#2)
regional wall motion##4##3##(1997-1#1)(2011-2#1)(2013-1#2)
regional##836##1##(1990-1#1)(1990-10#1)(1990-11#4)(1990-12#5)(1990-2#1)(1990-3#1)(1990-4#4)(1990-5#2)(1990-6#4)(1990-7#4)(1990-9#4)(1991-1#1)(1991-10#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#3)(1991-5#2)(1991-6#4)(1991-9#3)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#11)(1992-2#3)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#6)(1992-9#1)(1993-10#3)(1993-12#6)(1993-2#1)(1993-3#3)(1993-4#9)(1993-5#2)(1993-7#1)(1993-9#3)(1994-10#1)(1994-12#7)(1994-2#3)(1994-3#15)(1994-5#5)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#4)(1995-12#5)(1995-2#2)(1995-3#2)(1995-5#11)(1995-6#2)(1995-7#2)(1995-8#3)(1995-9#1)(1996-1#4)(1996-11#1)(1996-12#7)(1996-2#8)(1996-3#5)(1996-4#1)(1996-5#3)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#5)(1997-1#6)(1997-2#4)(1997-3#4)(1997-4#2)(1997-5#4)(1997-6#3)(1997-7#5)(1997-8#6)(2004-2#2)(2004-4#4)(2005-1#3)(2005-10#1)(2005-11#2)(2005-12#2)(2005-5#5)(2005-8#1)(2005-9#1)(2006-1#3)(2006-10#88)(2006-11#4)(2006-12#8)(2006-3#2)(2006-5#2)(2006-6#4)(2006-7#9)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#14)(2007-11#2)(2007-12#7)(2007-2#9)(2007-3#6)(2007-4#4)(2007-5#6)(2007-7#6)(2007-8#8)(2007-9#6)(2008-1#15)(2008-10#37)(2008-11#13)(2008-12#3)(2008-2#8)(2008-3#10)(2008-4#5)(2008-5#5)(2008-6#4)(2008-7#17)(2008-8#20)(2008-9#13)(2009-1#2)(2009-10#6)(2009-11#2)(2009-12#2)(2009-2#6)(2009-3#2)(2009-4#5)(2009-5#2)(2009-6#2)(2009-7#3)(2009-9#2)(2010-11#2)(2010-12#8)(2010-2#6)(2010-3#6)(2010-5#2)(2010-6#1)(2010-7#5)(2010-8#8)(2010-9#3)(2011-1#10)(2011-12#5)(2011-2#32)(2012-1#3)(2012-11#2)(2012-12#21)(2012-2#12)(2012-3#10)(2013-1#24)(2013-3#4)(2013-7#7)(2013-8#11)
regionalisation##2##1##(1994-3#1)(2007-12#1)
regionalization of##2##2##(1990-11#1)(1996-12#1)
regionalization##3##1##(1990-11#1)(1993-3#1)(1996-12#1)
regionalized##6##1##(1990-5#1)(1994-1#1)(1995-1#1)(2007-2#1)(2007-8#2)
regionally based study was adopted in 2008##2##7##(2013-1#2)
regionally selective##4##2##(1996-2#1)(2005-7#1)(2006-9#1)(2007-12#1)
regionally specific##5##2##(1993-8#1)(1994-10#1)(1996-12#1)(1996-4#1)(2008-4#1)
regionally##28##1##(1991-11#1)(1991-5#1)(1992-4#1)(1993-10#1)(1993-8#1)(1994-10#1)(1995-12#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-6#1)(1997-5#1)(2005-10#1)(2005-7#1)(2006-9#1)(2007-12#2)(2008-10#1)(2008-4#1)(2008-8#2)(2008-9#1)(2010-3#1)(2012-12#2)(2013-1#2)
regions (UTR)##2##2##(1993-12#1)(1997-4#1)
regions (e##2##2##(2006-11#1)(2008-3#1)
regions (including##2##2##(1995-5#1)(2009-7#1)
regions (p &lt##2##3##(1996-1#1)(2006-12#1)
regions (pH##2##2##(2005-11#2)
regions (residues##2##2##(1994-11#1)(1995-8#1)
regions (the##2##2##(1990-4#1)(2004-11#1)
regions 1##2##2##(1995-8#2)
regions affected by the##2##4##(2010-4#1)(2013-1#1)
regions along the##2##3##(1995-8#1)(2012-2#1)
regions along##3##2##(1995-8#1)(1997-4#1)(2012-2#1)
regions among##2##2##(1996-5#1)(2010-3#1)
regions and a##4##3##(1993-8#1)(1994-12#1)(1997-2#1)(2008-2#1)
regions and can##2##3##(1992-9#1)(2007-12#1)
regions and in##5##3##(1996-12#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-3#1)
regions and the##15##3##(1991-8#1)(1993-12#1)(1993-8#1)(1995-12#1)(1995-5#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
regions and their##6##3##(1994-11#1)(1997-2#1)(2007-10#1)(2008-2#1)(2013-1#2)
regions and##107##2##(1990-11#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-7#2)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-8#2)(1995-12#1)(1995-5#2)(1995-8#1)(1996-12#1)(1996-8#1)(1997-2#7)(1997-4#1)(2006-6#1)(2006-7#1)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#6)(2008-8#3)(2009-12#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#5)(2012-11#1)(2012-2#2)(2012-3#5)(2013-1#3)(2013-8#1)
regions appear##2##2##(2008-2#1)(2010-5#1)
regions are also##2##3##(2007-7#1)(2010-5#1)
regions are associated with##3##4##(2008-10#1)(2008-7#1)(2010-2#1)
regions are characterized by##2##4##(2008-10#1)(2008-7#1)
regions are characterized##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
regions are described##2##3##(2008-3#1)(2009-12#1)
regions are discussed##2##3##(1995-5#1)(2007-11#1)
regions are important for the##2##5##(1992-11#1)(1995-6#1)
regions are in##2##3##(1991-11#1)(1991-2#1)
regions are involved##2##3##(1995-8#1)(1997-2#1)
regions are most##2##3##(1997-7#1)(2006-1#1)
regions are related to##2##4##(2008-3#1)(2010-8#1)
regions are the##2##3##(1991-3#1)(1997-4#1)
regions are##77##2##(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#2)(1992-11#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-12#2)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-3#1)(1997-2#2)(1997-4#1)(1997-7#2)(2006-1#1)(2006-10#2)(2006-4#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-7#2)(2008-10#3)(2008-11#3)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-12#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
regions around the##5##3##(1992-3#1)(1992-9#1)(1995-5#1)(2009-5#1)(2011-2#1)
regions as the##4##3##(1993-8#1)(1994-3#1)(2008-3#1)(2008-4#1)
regions as well as##2##4##(1990-3#1)(1992-11#1)
regions as well##3##3##(1990-3#1)(1992-11#1)(1994-12#1)
regions as##13##2##(1990-3#1)(1990-4#1)(1992-11#1)(1993-8#1)(1994-12#1)(1994-3#1)(1997-3#1)(2005-5#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-4#1)(2012-1#1)
regions associated with resistance##2##4##(2008-10#2)
regions associated with##10##3##(1995-12#2)(2008-10#4)(2008-11#1)(2010-2#1)(2012-12#1)(2013-8#1)
regions at the dough stage##2##5##(2008-10#2)
regions at the##9##3##(1991-6#1)(1991-7#1)(1993-12#1)(1996-4#1)(2007-8#1)(2008-10#3)(2008-6#1)
regions at##13##2##(1991-6#1)(1991-7#1)(1993-12#1)(1996-4#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-6#1)(2009-5#1)
regions between the##2##3##(1991-3#1)(1996-7#1)
regions between##9##2##(1991-3#1)(1992-9#1)(1996-7#1)(1997-7#1)(2008-10#2)(2008-9#2)(2013-8#1)
regions but not in the##2##5##(1993-8#1)(2007-10#1)
regions but##6##2##(1993-8#1)(1995-2#1)(1997-4#1)(2005-11#1)(2007-10#1)(2013-1#1)
regions by##12##2##(1991-11#1)(1991-7#1)(1992-9#1)(1994-11#1)(1995-3#1)(1995-5#1)(1997-2#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-8#1)
regions can be##3##3##(1992-7#1)(2006-5#1)(2008-10#1)
regions can##5##2##(1992-7#1)(1997-2#1)(2006-5#1)(2007-11#1)(2008-10#1)
regions characterized by##2##3##(2008-2#1)(2009-7#1)
regions close to the##4##4##(1994-11#1)(1994-9#1)(2006-10#1)(2006-4#1)
regions closer to##3##3##(2013-8#3)
regions common to##2##3##(1993-11#1)(1993-6#1)
regions common##3##2##(1993-11#1)(1993-6#1)(2008-10#1)
regions compared to the##2##4##(2007-9#1)(2011-2#1)
regions compared##3##2##(1996-10#1)(2007-9#1)(2011-2#1)
regions conserved##2##2##(1995-8#1)(1997-2#1)
regions contained##4##2##(1992-9#1)(1993-7#1)(1994-12#1)(1995-1#1)
regions containing##6##2##(1992-11#1)(1993-8#1)(1995-5#1)(2008-8#1)(2012-1#1)(2013-7#1)
regions corresponding to##5##3##(1993-2#1)(1995-7#1)(2008-8#1)(2012-12#1)(2013-1#1)
regions could##5##2##(1990-5#1)(1990-9#1)(1991-6#1)(1995-7#1)(2007-8#1)
regions covering##2##2##(2008-9#1)(2013-8#1)
regions demonstrated##2##2##(2008-10#1)(2008-3#1)
regions derived from the##2##4##(1991-10#2)
regions derived from##3##3##(1991-10#2)(2008-10#1)
regions designated##2##2##(1992-5#1)(1994-9#1)
regions did##2##2##(2008-10#1)(2008-11#1)
regions do not##2##3##(2008-10#1)(2013-1#1)
regions during the##2##3##(1996-11#1)(2008-10#1)
regions during##10##2##(1994-5#1)(1995-12#1)(1996-11#1)(1996-5#1)(2008-10#2)(2008-11#1)(2011-1#2)(2012-2#1)
regions each##2##2##(1991-2#1)(1994-8#1)
regions endemic for##2##3##(2007-7#1)(2010-8#1)
regions examined##11##2##(1991-3#1)(1991-6#1)(1993-12#1)(1994-10#1)(1994-2#2)(1995-2#1)(1996-12#1)(1996-3#2)(1997-7#1)
regions far from##2##3##(1991-9#1)(2008-3#1)
regions flanking the##2##3##(1995-2#1)(2006-3#1)
regions flanking##4##2##(1991-7#1)(1995-1#1)(1995-2#1)(2006-3#1)
regions following##3##2##(1996-5#1)(1997-6#1)(1997-8#1)
regions for##32##2##(1990-8#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-3#1)(1993-5#1)(1993-9#1)(1995-10#2)(1995-12#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-7#1)(2006-12#1)(2006-8#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-4#1)(2009-9#1)(2010-2#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
regions form##2##2##(1995-3#1)(2010-7#1)
regions found##3##2##(1996-8#1)(1997-4#1)(2013-8#1)
regions from the##12##3##(1990-3#1)(1991-7#1)(1992-2#1)(1994-12#1)(1995-3#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-6#1)(2012-3#1)
regions from three##2##3##(2007-11#1)(2008-10#1)
regions from##30##2##(1990-3#1)(1991-7#1)(1992-2#2)(1992-9#1)(1993-4#1)(1994-12#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-7#1)(1997-8#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-3#1)
regions had elevated##2##3##(2009-10#2)
regions had##4##2##(1993-10#1)(2008-10#1)(2009-10#2)
regions has##2##2##(2008-10#1)(2008-9#1)
regions have been shown to##2##5##(1994-12#1)(2013-1#1)
regions have been##6##3##(1993-8#1)(1994-12#1)(2006-10#1)(2006-11#1)(2008-8#1)(2013-1#1)
regions have##14##2##(1991-5#1)(1993-8#1)(1994-12#1)(1994-2#1)(1996-7#1)(2006-10#1)(2006-11#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-1#1)
regions homologous to##3##3##(1990-5#1)(1991-2#1)(1991-6#1)
regions implicated in##5##3##(1992-1#1)(1995-2#1)(2008-4#1)(2009-2#1)(2013-8#1)
regions important for##3##3##(1990-11#1)(1991-3#1)(1996-8#1)
regions important##4##2##(1990-11#1)(1991-3#1)(1996-8#1)(2008-12#1)
regions in South Africa##2##4##(2011-1#2)
regions in a##3##3##(1994-8#1)(2008-11#1)(2009-6#1)
regions in both##2##3##(1997-2#1)(2013-1#1)
regions in human##4##3##(1990-3#1)(1990-8#3)
regions in normal##2##3##(1997-3#1)(2012-2#1)
regions in order to##2##4##(2008-2#1)(2012-3#1)
regions in right##3##3##(1995-12#2)(2009-4#1)
regions in the genome##2##4##(2007-6#1)(2009-6#1)
regions in the human genome##2##5##(2008-1#1)(2009-9#1)
regions in the human##3##4##(1995-3#1)(2008-1#1)(2009-9#1)
regions in the putative##3##4##(1991-2#2)(1992-11#1)
regions in the right hemisphere##2##5##(1995-11#1)(2007-7#1)
regions in the##52##3##(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-6#2)(1992-8#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-11#2)(1995-3#3)(1997-3#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2009-3#1)(2009-6#2)(2009-9#1)(2010-5#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
regions in these##2##3##(2007-12#1)(2008-7#1)
regions in which the##3##4##(1997-6#1)(2006-8#1)(2007-11#1)
regions in which##6##3##(1996-5#1)(1997-6#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-9#1)
regions in##153##2##(1990-11#1)(1990-3#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#3)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-11#2)(1995-12#2)(1995-3#3)(1995-6#2)(1995-7#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#4)(1997-7#1)(2006-10#1)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#4)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2008-1#3)(2008-10#13)(2008-11#5)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-9#1)(2010-5#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-11#1)(2012-12#1)(2012-2#6)(2012-3#7)(2013-1#3)(2013-8#2)
regions including the##2##3##(2008-11#1)(2009-4#1)
regions including##4##2##(1994-2#1)(1996-2#1)(2008-11#1)(2009-4#1)
regions indicated that the presence of##2##6##(1993-5#1)(2008-10#1)
regions indicated that##4##3##(1993-5#1)(2008-10#2)(2013-8#1)
regions inside the##2##3##(2007-11#1)(2007-12#1)
regions involved in the##3##4##(1996-8#1)(2009-3#1)(2009-5#1)
regions involved in##12##3##(1991-2#1)(1991-5#1)(1995-12#1)(1995-6#1)(1996-7#1)(1996-8#1)(1997-7#1)(2008-4#1)(2009-2#1)(2009-3#1)(2009-5#1)(2013-8#1)
regions is a##3##3##(2008-11#1)(2008-2#2)
regions is##25##2##(1990-4#1)(1991-10#1)(1994-9#1)(1995-12#1)(1997-1#1)(2006-5#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#4)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-7#1)
regions joined to##2##3##(1992-5#1)(1992-7#1)
regions just##2##2##(1991-4#1)(2005-8#1)
regions known to be involved in##2##6##(1993-7#1)(1997-6#1)
regions known to be##3##4##(1993-7#1)(1997-6#1)(2008-8#1)
regions known to##5##3##(1993-7#1)(1996-12#1)(1997-6#1)(2008-11#1)(2008-8#1)
regions may be related with##2##5##(1997-7#1)(2008-5#1)
regions may be##5##3##(1991-12#1)(1995-11#1)(1995-12#1)(1997-7#1)(2008-5#1)
regions may##13##2##(1990-7#1)(1991-12#1)(1993-8#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-4#1)(1997-7#1)(2006-2#1)(2008-11#1)(2008-5#1)(2010-8#1)(2013-1#1)
regions most##2##2##(2008-10#1)(2013-8#1)
regions near##4##2##(1996-8#1)(1997-5#1)(2009-11#1)(2009-5#1)
regions normally##3##2##(1991-6#1)(1995-8#1)(2008-9#1)
regions occurred##2##2##(1994-12#1)(2008-9#1)
regions of 1##2##3##(1997-8#1)(2012-12#1)
regions of 25##2##3##(2008-10#1)(2010-10#1)
regions of Asia##2##3##(2007-12#1)(2008-10#1)
regions of Brazil##2##3##(2008-10#2)
regions of California##2##3##(2008-10#1)(2011-2#1)
regions of Canada##2##3##(2009-4#1)(2013-1#1)
regions of China##6##3##(2005-11#1)(2008-10#3)(2011-12#1)(2011-2#1)
regions of DNA##5##3##(1992-2#1)(1993-3#1)(2007-10#1)(2008-11#1)(2011-2#1)
regions of France##2##3##(2008-10#2)
regions of H2B and##2##4##(1992-9#2)
regions of Malawi##2##3##(2008-10#2)
regions of Mexico##2##3##(2008-10#1)(2011-2#1)
regions of North America##2##4##(2008-10#1)(2008-8#1)
regions of North##3##3##(2008-10#2)(2008-8#1)
regions of Poland##2##3##(2007-7#1)(2008-10#1)
regions of RNA##2##3##(1996-5#1)(1997-2#1)
regions of Saudi Arabia##6##4##(2007-3#3)(2007-7#1)(2008-1#2)
regions of South America##3##4##(1991-11#1)(2008-10#1)(2012-12#1)
regions of South##4##3##(1991-11#1)(2007-3#1)(2008-10#1)(2012-12#1)
regions of Spain##3##3##(1990-8#1)(1996-12#1)(2007-7#1)
regions of Turkey##3##3##(1997-8#1)(2007-1#1)(2008-10#1)
regions of a##7##3##(1994-11#1)(1994-12#1)(1995-5#1)(1997-4#1)(2008-2#1)(2008-9#1)(2011-2#1)
regions of an##2##3##(2005-11#1)(2008-3#1)
regions of antibodies##3##3##(1992-8#2)(2008-4#1)
regions of apple pectin with##2##5##(1990-9#2)
regions of beta##2##3##(1994-9#2)
regions of both the##4##4##(1990-5#1)(1990-9#1)(1992-3#1)(1993-5#1)
regions of both##6##3##(1990-5#1)(1990-9#1)(1992-3#1)(1993-5#1)(1994-3#1)(1995-3#1)
regions of chromosomes##3##3##(1991-5#1)(2013-1#2)
regions of conserved sequence##2##4##(1990-3#1)(1995-5#1)
regions of cortical bone##2##4##(1995-6#2)
regions of cortical##4##3##(1995-6#2)(1997-1#1)(2007-10#1)
regions of different##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
regions of equal##2##3##(1996-1#1)(2007-12#1)
regions of equally noticeable chromaticity differences##2##6##(2008-2#2)
regions of eukaryotic##2##3##(1991-11#1)(2011-2#1)
regions of genes##3##3##(1991-9#1)(1995-8#1)(2013-8#1)
regions of genomic DNA##2##4##(1990-3#2)
regions of genomic##3##3##(1990-3#2)(2011-2#1)
regions of high and low##3##5##(2007-11#1)(2013-1#2)
regions of high##11##3##(1992-1#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-5#1)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#2)
regions of homology##4##3##(1990-4#1)(1990-7#1)(1993-6#1)(2008-4#1)
regions of human plasminogen##2##4##(1993-8#2)
regions of human##6##3##(1991-8#1)(1992-9#1)(1993-8#2)(1995-2#1)(1997-5#1)
regions of interest in##3##4##(2008-6#1)(2013-1#2)
regions of interest were##2##4##(1997-5#1)(2007-9#1)
regions of interest##24##3##(1992-1#1)(1997-5#1)(2006-5#1)(2007-10#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-11#1)(2008-3#2)(2008-6#2)(2009-10#1)(2009-8#1)(2011-1#1)(2012-1#3)(2012-3#2)(2013-1#4)
regions of known##3##3##(1994-12#1)(1994-5#1)(2007-10#1)
regions of loss of heterozygosity##2##5##(1990-9#2)
regions of loss##3##3##(1990-9#2)(2008-11#1)
regions of mammalian##2##3##(1993-9#1)(1995-11#1)
regions of many genes##2##4##(1997-2#1)(1997-4#1)
regions of mouse##2##3##(1992-11#1)(1997-2#1)
regions of primary##2##3##(1994-5#1)(2007-12#1)
regions of protein##3##3##(1991-4#1)(1995-1#1)(1997-8#1)
regions of rDNA##2##3##(2008-10#2)
regions of rat brain##5##4##(1991-9#1)(1994-10#1)(1996-12#1)(1996-3#2)
regions of rat##6##3##(1990-7#1)(1991-9#1)(1994-10#1)(1996-12#1)(1996-3#2)
regions of ribosomal DNA##3##4##(2005-9#1)(2008-10#1)(2008-5#1)
regions of rice##2##3##(2008-8#1)(2008-9#1)
regions of sequence conservation##2##4##(1994-6#2)
regions of sequence##3##3##(1994-6#2)(1995-6#1)
regions of significant##2##3##(1992-3#1)(1992-7#1)
regions of similarity##2##3##(1991-9#1)(1995-2#1)
regions of structural##2##3##(1990-4#1)(1993-6#1)
regions of the C##2##4##(1991-7#1)(1994-12#1)
regions of the L genes##2##5##(2008-10#2)
regions of the United States##5##5##(2008-10#2)(2009-12#1)(2009-4#1)(2013-8#1)
regions of the adult##4##4##(1994-12#1)(1995-2#1)(1996-5#1)(2008-7#1)
regions of the amygdala##3##4##(1991-1#1)(1991-10#2)
regions of the beta-subunit of##2##5##(1991-8#1)(1994-8#1)
regions of the body##4##4##(2006-11#1)(2006-12#1)(2007-11#1)(2011-2#1)
regions of the bovine##2##4##(1992-9#1)(2011-2#1)
regions of the brain##19##4##(1991-9#1)(1992-9#1)(1993-7#1)(1994-10#1)(1994-12#1)(1995-1#1)(1995-12#1)(1996-3#1)(1997-2#1)(1997-5#1)(2006-3#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-9#1)(2012-2#1)
regions of the catalytic##2##4##(1994-12#1)(1997-1#1)
regions of the central nervous system##2##6##(1996-12#1)(2008-7#1)
regions of the complex##2##4##(1990-4#1)(1991-3#1)
regions of the country##7##4##(1991-5#1)(2007-12#1)(2008-10#1)(2008-6#1)(2009-6#2)(2012-1#1)
regions of the different##2##4##(1990-5#1)(2013-8#1)
regions of the electromagnetic spectrum##2##5##(2008-2#1)(2012-12#1)
regions of the enzyme##2##4##(1993-9#1)(1994-8#1)
regions of the epithelial##2##4##(1992-3#1)(2007-12#1)
regions of the gene were##2##5##(1990-9#1)(1997-4#1)
regions of the genes##2##4##(2006-11#1)(2010-7#1)
regions of the genome##11##4##(1997-1#1)(2008-10#4)(2008-4#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
regions of the glass##2##4##(2004-9#1)(2008-2#1)
regions of the gut##2##4##(1992-8#1)(1996-5#1)
regions of the human##10##4##(1993-2#2)(1993-3#1)(1993-6#1)(1994-5#1)(1995-12#1)(1997-6#2)(2008-11#1)(2008-7#1)
regions of the measured spectrum##2##5##(2008-2#2)
regions of the molecule##2##4##(1992-12#1)(1995-3#1)
regions of the mouse and human genes are##2##8##(1993-3#1)(1993-6#1)
regions of the mouse##3##4##(1993-3#1)(1993-6#1)(1996-3#1)
regions of the nuclear ribosomal DNA##2##6##(2008-10#2)
regions of the nucleus##3##4##(1993-2#1)(1993-5#1)(1993-6#1)
regions of the peptide##3##4##(1990-2#1)(1995-2#1)(1995-5#1)
regions of the postnatal##2##4##(1997-5#1)(2009-8#1)
regions of the protein that##2##5##(1993-12#1)(2008-4#1)
regions of the protein##10##4##(1992-6#1)(1992-9#2)(1993-11#2)(1993-12#1)(1995-6#1)(1997-2#1)(2008-4#1)(2008-7#1)
regions of the rat brain using##2##6##(1993-8#1)(1995-7#1)
regions of the rat brain##4##5##(1993-8#1)(1994-8#1)(1995-7#1)(1997-8#1)
regions of the rat epididymis##2##5##(1992-3#2)
regions of the rat##9##4##(1992-2#1)(1992-3#2)(1993-8#2)(1994-8#1)(1995-7#1)(1996-5#1)(1997-8#1)
regions of the respiratory tract##2##5##(1994-12#1)(2008-10#1)
regions of the respiratory##3##4##(1994-12#1)(2008-10#1)(2010-9#1)
regions of the spectrum##3##4##(1990-3#1)(2008-2#1)(2008-3#1)
regions of the spinal##2##4##(1991-5#1)(1995-12#1)
regions of the spine##3##4##(2006-7#3)
regions of the structure##2##4##(1991-4#1)(1995-3#1)
regions of the two##2##4##(1993-8#1)(1997-2#1)
regions of the vessel##2##4##(2010-4#1)(2011-1#1)
regions of the world and##2##5##(2010-10#1)(2011-11#1)
regions of the world##27##4##(1996-11#1)(2005-11#1)(2007-2#3)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#1)(2009-8#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-11#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#1)
regions of the##386##3##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#4)(1990-4#3)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#3)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#7)(1993-11#2)(1993-12#4)(1993-2#3)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#6)(1993-7#1)(1993-8#3)(1993-9#1)(1994-10#1)(1994-12#9)(1994-2#3)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#5)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#5)(1995-4#1)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#4)(1996-11#2)(1996-12#5)(1996-2#2)(1996-3#3)(1996-5#7)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#7)(1997-4#4)(1997-5#3)(1997-6#5)(1997-7#1)(1997-8#1)(1997-9#1)(2003-11#1)(2004-9#1)(2005-11#1)(2005-5#1)(2006-10#3)(2006-11#2)(2006-12#3)(2006-3#1)(2006-6#1)(2006-7#3)(2007-11#2)(2007-12#7)(2007-2#4)(2007-3#2)(2007-5#2)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#45)(2008-11#8)(2008-12#2)(2008-2#12)(2008-3#9)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#3)(2009-10#3)(2009-12#3)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#3)(2009-9#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#4)(2011-11#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#7)(2012-3#4)(2013-1#3)(2013-8#2)
regions of their##3##3##(1994-8#1)(1995-2#1)(2011-12#1)
regions of these genes##2##4##(1995-3#1)(2008-11#1)
regions of these##6##3##(1994-9#1)(1995-3#1)(2008-10#1)(2008-11#2)(2010-7#1)
regions of this##7##3##(1991-12#1)(1992-11#1)(1992-8#1)(1994-5#1)(1997-4#1)(2005-8#1)(2008-4#1)
regions of two##2##3##(1997-2#2)
regions of##828##2##(1990-11#4)(1990-12#3)(1990-2#1)(1990-3#9)(1990-4#6)(1990-5#7)(1990-6#1)(1990-7#4)(1990-8#3)(1990-9#8)(1991-1#1)(1991-10#3)(1991-11#3)(1991-12#6)(1991-2#1)(1991-3#2)(1991-4#3)(1991-5#6)(1991-6#3)(1991-7#3)(1991-8#4)(1991-9#8)(1992-1#4)(1992-10#2)(1992-11#3)(1992-12#3)(1992-2#3)(1992-3#5)(1992-5#1)(1992-6#4)(1992-7#2)(1992-8#5)(1992-9#14)(1993-11#4)(1993-12#5)(1993-2#3)(1993-3#5)(1993-4#2)(1993-5#2)(1993-6#10)(1993-7#2)(1993-8#9)(1993-9#2)(1994-10#5)(1994-11#4)(1994-12#14)(1994-2#5)(1994-3#2)(1994-5#7)(1994-6#7)(1994-7#2)(1994-8#10)(1994-9#5)(1995-1#6)(1995-11#3)(1995-12#8)(1995-2#8)(1995-3#8)(1995-4#2)(1995-5#6)(1995-6#10)(1995-7#1)(1995-8#6)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#8)(1996-2#4)(1996-3#5)(1996-4#1)(1996-5#12)(1996-7#4)(1996-8#4)(1996-9#1)(1997-1#3)(1997-2#19)(1997-3#1)(1997-4#9)(1997-5#7)(1997-6#7)(1997-7#3)(1997-8#6)(1997-9#1)(2003-11#1)(2004-9#1)(2005-11#4)(2005-5#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-11#2)(2006-12#3)(2006-3#1)(2006-5#1)(2006-6#2)(2006-7#3)(2007-1#1)(2007-10#4)(2007-11#5)(2007-12#20)(2007-2#4)(2007-3#6)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#4)(2007-8#4)(2007-9#3)(2008-1#8)(2008-10#88)(2008-11#16)(2008-12#5)(2008-2#22)(2008-3#19)(2008-4#12)(2008-5#13)(2008-6#3)(2008-7#11)(2008-8#10)(2008-9#7)(2009-10#8)(2009-12#3)(2009-2#1)(2009-4#4)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#5)(2009-9#2)(2010-10#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#3)(2010-9#3)(2011-1#7)(2011-11#1)(2011-12#3)(2011-2#17)(2011-3#1)(2012-1#7)(2012-11#1)(2012-12#6)(2012-2#10)(2012-3#9)(2013-1#16)(2013-7#1)(2013-8#9)
regions on both sides of the##2##6##(1991-8#1)(1995-8#1)
regions on chromosomes##3##3##(2008-5#1)(2012-3#1)(2013-8#1)
regions on the same##2##4##(1990-10#1)(2008-10#1)
regions on the##15##3##(1990-10#1)(1991-7#1)(1991-8#1)(1993-11#1)(1993-3#1)(1995-2#1)(1995-9#1)(1996-4#1)(1996-5#1)(1997-8#1)(2005-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-7#1)
regions on##28##2##(1990-10#1)(1991-11#1)(1991-7#1)(1991-8#2)(1992-7#1)(1993-11#1)(1993-3#1)(1995-2#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-4#1)(1996-5#1)(1997-8#1)(2005-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
regions or##9##2##(1993-3#1)(1996-6#1)(2008-10#4)(2008-8#1)(2009-10#1)(2010-4#1)
regions outside##3##2##(2008-1#1)(2008-3#1)(2011-1#1)
regions over a period of##2##5##(2008-10#1)(2008-2#1)
regions over##3##2##(1994-3#1)(2008-10#1)(2008-2#1)
regions overlap##2##2##(1990-1#1)(1997-6#1)
regions previously shown to be##2##5##(1992-12#1)(1993-9#1)
regions previously##7##2##(1992-12#1)(1993-9#1)(1994-2#1)(1995-2#1)(2008-10#1)(2012-2#2)
regions properly##2##2##(2008-2#2)
regions required for##3##3##(1990-6#1)(1994-9#1)(2008-10#1)
regions responsible for##3##3##(1991-8#1)(1997-2#1)(2012-1#1)
regions resulted##2##2##(2008-10#1)(2010-4#1)
regions results in##2##3##(2005-6#1)(2008-12#1)
regions revealed a##2##3##(1994-12#1)(2008-11#1)
regions revealed that##2##3##(2007-1#1)(2009-8#1)
regions revealed##9##2##(1994-12#1)(1995-3#1)(2004-11#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-8#1)(2013-8#1)
regions sampled##2##2##(2008-10#1)(2012-3#1)
regions separated##2##2##(2008-10#1)(2008-2#1)
regions sequenced##2##2##(1993-2#1)(1997-8#1)
regions share##3##2##(1991-12#1)(1991-9#1)(1993-2#1)
regions should have##2##3##(2008-4#1)(2012-2#1)
regions should##4##2##(2008-4#1)(2008-6#1)(2008-8#1)(2012-2#1)
regions show##3##2##(1996-7#1)(2008-10#1)(2008-11#1)
regions showed##7##2##(1991-7#1)(1993-12#1)(1995-10#1)(1997-5#1)(1997-8#1)(2007-5#1)(2008-10#1)
regions showing##2##2##(1993-9#1)(1994-6#1)
regions shows a##2##3##(1990-11#1)(1992-8#1)
regions studied##7##2##(1994-12#2)(1996-12#1)(1997-5#1)(2008-10#2)(2008-4#1)
regions such as the##4##4##(1997-7#1)(2007-2#1)(2007-4#1)(2009-10#1)
regions such as##5##3##(1994-6#1)(1997-7#1)(2007-2#1)(2007-4#1)(2009-10#1)
regions suggests##2##2##(2011-2#1)(2012-3#1)
regions surrounding the##2##3##(1996-12#1)(1997-7#1)
regions surrounding##3##2##(1995-1#1)(1996-12#1)(1997-7#1)
regions tested##3##2##(1991-9#1)(2008-10#1)(2008-5#1)
regions than##3##2##(1996-12#1)(2009-5#1)(2013-8#1)
regions that are implicated in social cognition##2##7##(2008-1#1)(2008-11#1)
regions that are##14##3##(1994-8#1)(1996-4#2)(2005-11#1)(2008-1#1)(2008-11#4)(2008-2#2)(2008-3#1)(2012-2#1)(2012-3#1)
regions that correspond##2##3##(2007-12#1)(2009-10#1)
regions that have##5##3##(1994-2#1)(1995-2#1)(1996-10#1)(2008-3#1)(2008-7#1)
regions that lack##2##3##(2007-12#1)(2012-2#1)
regions that may##2##3##(1996-5#1)(2008-4#1)
regions that were##3##3##(1995-6#2)(1996-12#1)
regions that would##2##3##(1991-12#1)(2013-1#1)
regions that##56##2##(1990-8#1)(1991-12#2)(1993-6#1)(1994-2#1)(1994-8#3)(1995-11#1)(1995-2#1)(1995-6#2)(1996-10#1)(1996-12#1)(1996-4#2)(1996-5#1)(2005-11#1)(2007-12#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#2)(2009-10#1)(2009-4#1)(2010-3#1)(2010-4#1)(2011-10#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#1)
regions the##3##2##(1991-5#1)(1997-8#1)(2007-9#1)
regions there##3##2##(1992-1#1)(1996-12#1)(2008-8#1)
regions they##3##2##(2010-10#1)(2010-2#1)(2012-12#1)
regions to be##2##3##(2008-2#1)(2008-6#1)
regions to##14##2##(1991-8#1)(1994-3#1)(1995-2#1)(1997-5#1)(2005-11#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2010-8#1)(2013-1#3)
regions together##2##2##(1995-12#1)(2008-11#1)
regions under##3##2##(2007-12#1)(2007-5#1)(2008-3#1)
regions upstream##2##2##(1994-12#1)(1994-2#1)
regions using a##3##3##(1994-11#1)(2009-4#1)(2010-12#1)
regions using##9##2##(1991-4#1)(1994-11#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-4#1)(2009-9#1)(2010-12#1)(2011-2#1)
regions was determined##2##3##(1990-11#1)(1993-4#1)
regions was##12##2##(1990-11#1)(1992-12#1)(1993-4#1)(1993-7#1)(1994-5#1)(1996-3#1)(1997-8#1)(2008-10#1)(2008-5#1)(2013-7#1)(2013-8#2)
regions we##2##2##(2008-10#1)(2008-7#1)
regions were also##2##3##(1994-12#1)(2008-8#1)
regions were cloned##3##3##(1992-9#1)(2006-9#1)(2008-10#1)
regions were compared##2##3##(1991-9#1)(1997-2#1)
regions were consistent with##2##4##(2006-9#1)(2008-10#1)
regions were identical##2##3##(1991-9#1)(2008-10#1)
regions were identified##3##3##(1992-7#1)(2008-10#2)
regions were in##2##3##(1992-8#1)(2012-3#1)
regions were not##4##3##(1991-12#1)(1997-5#2)(2008-10#1)
regions were obtained##2##3##(1992-11#1)(2006-8#1)
regions were selected##2##3##(1991-11#1)(2008-10#1)
regions were sequenced##2##3##(1991-12#1)(2008-10#1)
regions were tested##2##3##(1996-8#1)(2008-10#1)
regions were##62##2##(1990-4#1)(1990-5#1)(1990-9#1)(1991-11#2)(1991-12#2)(1991-4#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-12#2)(1995-12#1)(1995-2#1)(1996-10#1)(1996-3#2)(1996-8#3)(1997-2#1)(1997-5#2)(1997-6#2)(1997-8#1)(2006-10#2)(2006-8#1)(2006-9#2)(2007-9#1)(2008-1#1)(2008-10#11)(2008-3#1)(2008-8#2)(2009-10#1)(2009-12#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
regions where more##2##3##(2007-10#1)(2008-6#1)
regions where the##10##3##(1994-8#1)(2007-12#1)(2008-3#4)(2008-4#1)(2011-1#1)(2012-3#1)(2013-1#1)
regions where they are##2##4##(2008-8#1)(2009-8#1)
regions where##31##2##(1990-2#1)(1993-9#1)(1994-8#2)(2005-9#1)(2007-10#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-8#3)(2009-6#1)(2009-8#1)(2010-2#2)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
regions which are##7##3##(1992-8#2)(1994-12#1)(1994-3#1)(1996-10#1)(1997-2#1)(2006-10#1)
regions which may##2##3##(1992-9#1)(2006-9#1)
regions which##17##2##(1992-8#2)(1992-9#1)(1993-3#1)(1994-12#1)(1994-3#1)(1996-10#1)(1996-4#1)(1997-2#1)(2006-10#1)(2006-3#1)(2006-9#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
regions whose##2##2##(2008-2#1)(2008-5#1)
regions with different##4##3##(1991-4#1)(2007-2#1)(2008-10#1)(2008-6#1)
regions with high##5##3##(1992-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2012-3#1)
regions with the##4##3##(1994-8#1)(1995-5#1)(2012-1#1)(2013-8#1)
regions with##57##2##(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-1#1)(1994-10#1)(1994-6#1)(1994-8#2)(1995-5#1)(2006-4#1)(2007-12#3)(2007-2#1)(2007-5#2)(2007-7#1)(2008-10#7)(2008-12#1)(2008-2#4)(2008-3#4)(2008-5#2)(2008-6#2)(2008-8#1)(2009-6#1)(2010-2#2)(2010-3#1)(2011-1#2)(2011-12#1)(2012-1#2)(2012-3#1)(2013-1#4)(2013-8#2)
regions within its##2##3##(1991-6#1)(2003-11#1)
regions within the##11##3##(1992-6#1)(1993-12#1)(1993-7#1)(1993-8#1)(1995-12#1)(1996-12#1)(2006-11#1)(2008-10#1)(2011-1#1)(2012-3#1)(2013-7#1)
regions within##20##2##(1991-6#1)(1992-6#2)(1993-12#1)(1993-7#1)(1993-8#1)(1995-10#1)(1995-12#1)(1996-12#1)(1996-5#1)(2003-11#1)(2006-11#1)(2007-5#1)(2008-10#2)(2009-4#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
regions worldwide##5##2##(2008-10#4)(2012-2#1)
regions would##2##2##(1996-3#1)(2012-3#1)
regions##2841##1##(1990-1#2)(1990-10#3)(1990-11#12)(1990-12#4)(1990-2#3)(1990-3#19)(1990-4#17)(1990-5#17)(1990-6#3)(1990-7#12)(1990-8#11)(1990-9#15)(1991-1#2)(1991-10#18)(1991-11#15)(1991-12#18)(1991-2#9)(1991-3#10)(1991-4#12)(1991-5#19)(1991-6#16)(1991-7#18)(1991-8#13)(1991-9#17)(1992-1#11)(1992-10#3)(1992-11#14)(1992-12#14)(1992-2#12)(1992-3#8)(1992-5#4)(1992-6#13)(1992-7#11)(1992-8#15)(1992-9#27)(1993-1#1)(1993-10#3)(1993-11#10)(1993-12#18)(1993-2#12)(1993-3#14)(1993-4#6)(1993-5#6)(1993-6#14)(1993-7#6)(1993-8#24)(1993-9#8)(1994-10#9)(1994-11#13)(1994-12#39)(1994-2#17)(1994-3#10)(1994-4#1)(1994-5#15)(1994-6#15)(1994-7#5)(1994-8#24)(1994-9#19)(1995-1#13)(1995-10#5)(1995-11#16)(1995-12#28)(1995-2#22)(1995-3#20)(1995-4#3)(1995-5#23)(1995-6#27)(1995-7#8)(1995-8#23)(1995-9#1)(1996-1#3)(1996-10#11)(1996-11#5)(1996-12#28)(1996-2#9)(1996-3#18)(1996-4#10)(1996-5#28)(1996-6#6)(1996-7#14)(1996-8#16)(1996-9#3)(1997-1#5)(1997-2#40)(1997-3#7)(1997-4#21)(1997-5#18)(1997-6#24)(1997-7#19)(1997-8#20)(1997-9#2)(2003-11#2)(2004-11#2)(2004-9#2)(2005-10#2)(2005-11#16)(2005-5#2)(2005-6#1)(2005-7#1)(2005-8#4)(2005-9#6)(2006-1#1)(2006-10#25)(2006-11#6)(2006-12#10)(2006-2#3)(2006-3#3)(2006-4#7)(2006-5#5)(2006-6#3)(2006-7#8)(2006-8#7)(2006-9#4)(2007-1#6)(2007-10#12)(2007-11#28)(2007-12#50)(2007-2#10)(2007-3#15)(2007-4#9)(2007-5#13)(2007-6#4)(2007-7#15)(2007-8#17)(2007-9#13)(2008-1#21)(2008-10#270)(2008-11#81)(2008-12#22)(2008-2#81)(2008-3#75)(2008-4#50)(2008-5#42)(2008-6#18)(2008-7#49)(2008-8#43)(2008-9#24)(2009-1#2)(2009-10#23)(2009-11#3)(2009-12#9)(2009-2#5)(2009-3#3)(2009-4#16)(2009-5#15)(2009-6#8)(2009-7#4)(2009-8#9)(2009-9#9)(2010-10#6)(2010-11#1)(2010-12#12)(2010-2#17)(2010-3#8)(2010-4#10)(2010-5#7)(2010-6#6)(2010-7#7)(2010-8#12)(2010-9#4)(2011-1#31)(2011-10#1)(2011-11#1)(2011-12#9)(2011-2#56)(2011-3#3)(2011-7#1)(2012-1#27)(2012-11#5)(2012-12#21)(2012-2#44)(2012-3#48)(2012-7#1)(2013-1#48)(2013-7#12)(2013-8#47)
regions)##8##1##(1995-8#1)(2007-4#1)(2008-10#2)(2008-7#1)(2011-1#1)(2012-1#1)(2012-3#1)
regions]##6##1##(1991-2#1)(1995-4#1)(1997-8#1)(2005-10#1)(2011-12#1)(2012-3#1)
regioselective acylation##2##2##(2008-4#1)(2008-7#1)
regioselective formation of##2##3##(1994-11#1)(2009-8#1)
regioselective ring opening of the oxabicycloheptadienes##2##6##(2008-8#2)
regioselective synthesis of##2##3##(2007-11#1)(2008-2#1)
regioselective##27##1##(1992-3#1)(1994-11#1)(1996-2#1)(1996-5#3)(2005-7#1)(2005-8#2)(2007-11#6)(2008-10#2)(2008-2#1)(2008-4#5)(2008-7#1)(2008-8#2)(2009-8#1)
regioselectively##4##1##(2007-11#1)(2008-4#1)(2008-5#1)(2009-5#1)
regioselectivity and##2##2##(1995-5#1)(2006-9#1)
regioselectivity at the 17 position##2##5##(1994-8#2)
regioselectivity at the##3##3##(1994-8#2)(1996-5#1)
regioselectivity at##4##2##(1994-8#2)(1996-5#1)(2009-8#1)
regioselectivity for##2##2##(1994-11#1)(2005-8#1)
regioselectivity in the##2##3##(1991-7#1)(1992-11#1)
regioselectivity is##2##2##(1990-11#1)(1992-3#1)
regioselectivity##19##1##(1990-11#1)(1991-7#1)(1992-11#1)(1992-3#1)(1994-11#1)(1994-5#1)(1994-8#2)(1995-5#1)(1996-5#2)(1996-9#1)(2005-8#2)(2006-9#1)(2008-8#2)(2009-8#1)(2012-3#1)
regiospecific##5##1##(1991-9#1)(2007-11#2)(2007-12#1)(2011-1#1)
regiospecifically##2##1##(1991-10#1)(1993-3#1)
regiospecificity##5##1##(1991-8#1)(1994-9#2)(1995-10#1)(1996-5#1)
register a##4##2##(2008-11#1)(2008-3#1)(2010-9#1)(2013-7#1)
register is##2##2##(1995-8#1)(1997-6#1)
register of all##2##3##(2008-10#2)
register of##13##2##(1991-2#1)(1995-8#1)(2005-8#1)(2006-10#1)(2006-7#2)(2007-2#2)(2008-10#2)(2008-4#1)(2008-6#1)(2012-3#1)
register on##3##2##(1996-1#1)(2006-10#1)(2006-8#1)
register with the##2##3##(1991-3#1)(2007-7#1)
register with##4##2##(1991-3#1)(2007-7#1)(2008-1#1)(2008-12#1)
register##69##1##(1990-11#1)(1990-2#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-8#7)(1996-1#1)(1996-11#1)(1996-4#2)(1996-6#1)(1996-7#1)(1997-6#1)(1997-8#2)(2005-8#1)(2006-10#2)(2006-7#2)(2006-8#5)(2007-2#3)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-9#1)(2012-2#1)(2012-3#3)(2013-7#1)(2013-8#4)
register&quot##2##1##(1996-11#1)(2008-10#1)
register-based##2##1##(2011-1#2)
registered a##2##2##(1990-4#1)(1991-12#1)
registered an increase of##2##4##(1994-8#1)(1995-4#1)
registered and##10##2##(1990-4#1)(1991-9#1)(1994-12#1)(1996-5#1)(2007-8#1)(2008-10#2)(2008-8#1)(2010-5#1)(2011-2#1)
registered as##8##2##(1993-5#2)(1993-8#1)(2006-8#2)(2008-1#1)(2008-10#1)(2010-9#1)
registered at a##2##3##(2006-10#1)(2008-6#1)
registered at the##5##3##(1996-12#1)(2006-4#2)(2008-9#1)(2012-2#1)
registered at##13##2##(1994-11#1)(1994-4#1)(1996-12#1)(2005-10#1)(2006-10#1)(2006-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2012-2#1)(2013-7#1)(2013-8#1)
registered between##4##2##(1992-3#1)(1995-9#1)(2008-11#1)(2013-1#1)
registered by a##2##3##(1990-6#1)(2008-3#1)
registered by the Ragusa Cancer Registry##2##6##(1991-2#1)(1992-12#1)
registered by##8##2##(1990-4#1)(1990-6#1)(1991-2#1)(1992-12#1)(1992-3#1)(2006-10#1)(2008-3#1)(2011-1#1)
registered cases##2##2##(2010-12#1)(2011-2#1)
registered dietitian##2##2##(1995-3#2)
registered during the##3##3##(2008-5#3)
registered during##8##2##(1990-5#1)(2008-5#4)(2009-10#1)(2011-2#2)
registered for the##6##3##(1994-9#1)(1997-7#1)(2008-1#1)(2008-5#1)(2008-6#1)(2012-2#1)
registered for##14##2##(1994-9#1)(1995-8#1)(1997-7#1)(2007-3#1)(2007-7#2)(2008-1#1)(2008-5#1)(2008-6#1)(2009-3#1)(2011-2#2)(2012-2#1)(2013-1#1)
registered from##2##2##(2007-12#1)(2008-10#1)
registered in a##3##3##(1996-6#1)(2008-7#1)(2012-3#1)
registered in ambulatory##2##3##(2010-4#2)
registered in the Swedish Prescribed Drug Register##2##7##(2010-3#2)
registered in the health##2##4##(1993-8#1)(1994-3#1)
registered in the##23##3##(1990-11#1)(1991-11#1)(1991-6#1)(1993-8#2)(1994-3#1)(1995-6#1)(1997-2#1)(1997-4#2)(1997-7#1)(2006-10#1)(2006-8#1)(2007-10#1)(2008-12#1)(2008-6#2)(2009-6#1)(2010-3#2)(2013-1#1)(2013-8#2)
registered in this##4##3##(1991-10#1)(1995-6#1)(2008-10#1)(2008-5#1)
registered in##76##2##(1990-10#1)(1990-11#1)(1990-2#1)(1991-10#1)(1991-11#1)(1991-6#2)(1992-11#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-3#2)(1993-8#3)(1993-9#1)(1994-3#1)(1994-5#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#2)(1996-12#2)(1996-6#2)(1996-8#1)(1997-2#1)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-8#2)(2007-10#2)(2007-11#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-3#2)(2010-4#3)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#2)
registered mental##2##2##(2008-11#1)(2010-5#1)
registered nurse##7##2##(2005-7#1)(2007-10#1)(2008-11#3)(2008-3#1)(2010-2#1)
registered nurses (RNs)##6##3##(1991-2#1)(2008-12#1)(2010-10#1)(2010-11#1)(2013-1#2)
registered nurses and##2##3##(2008-11#1)(2011-1#1)
registered nurses in##3##3##(2008-11#1)(2010-11#1)(2012-3#1)
registered nurses who##2##3##(2008-1#1)(2008-11#1)
registered nurses working in the##2##5##(2006-1#1)(2011-1#1)
registered nurses##39##2##(1991-2#1)(1994-3#1)(2006-1#2)(2006-7#1)(2007-10#2)(2008-1#1)(2008-11#8)(2008-12#4)(2008-7#1)(2008-9#1)(2010-10#1)(2010-11#3)(2010-3#1)(2011-1#3)(2011-2#1)(2012-3#2)(2013-1#6)
registered nurses'##2##2##(2007-10#1)(2008-12#1)
registered on the##2##3##(1993-12#1)(2010-5#1)
registered on##3##2##(1993-12#1)(2008-6#1)(2010-5#1)
registered prospectively##2##2##(1991-4#1)(2012-2#1)
registered since##2##2##(1994-6#1)(2010-12#1)
registered the##2##2##(1995-4#1)(2008-5#1)
registered to##3##2##(1997-2#1)(2011-2#1)(2012-12#1)
registered together with the##2##4##(1990-4#1)(1997-4#1)
registered when##2##2##(1991-11#1)(2008-11#1)
registered with a##2##3##(2008-1#1)(2010-1#1)
registered with the U##2##4##(2008-10#1)(2008-9#1)
registered with the##5##3##(1995-12#1)(1996-8#1)(2008-10#1)(2008-9#1)(2010-9#1)
registered with##10##2##(1990-10#1)(1995-12#1)(1996-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-1#1)(2010-9#1)
registered##326##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#5)(1990-5#1)(1990-6#1)(1990-8#1)(1991-10#3)(1991-11#2)(1991-12#1)(1991-2#3)(1991-4#1)(1991-6#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#2)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#4)(1993-8#4)(1993-9#5)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-4#4)(1995-5#2)(1995-6#3)(1995-8#4)(1995-9#4)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#2)(1996-8#2)(1997-2#3)(1997-4#4)(1997-6#2)(1997-7#2)(1997-8#2)(2005-10#1)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#4)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#7)(2007-10#8)(2007-11#3)(2007-12#1)(2007-2#3)(2007-3#4)(2007-4#1)(2007-5#3)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#9)(2008-11#17)(2008-12#7)(2008-2#3)(2008-3#4)(2008-5#11)(2008-6#6)(2008-7#2)(2008-8#1)(2008-9#5)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#2)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#3)(2010-2#1)(2010-3#4)(2010-4#3)(2010-5#4)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#7)(2011-2#19)(2011-7#1)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#5)(2013-1#14)(2013-7#3)(2013-8#5)
registering##9##1##(1993-8#1)(1996-9#1)(2007-10#1)(2007-12#1)(2008-11#1)(2009-10#1)(2009-6#1)(2010-8#1)(2012-2#1)
registers of##5##2##(1995-2#1)(2008-10#1)(2011-2#2)(2013-8#1)
registers##20##1##(1991-11#1)(1995-11#1)(1995-2#2)(2006-10#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2011-2#4)(2013-1#3)(2013-8#3)
registrants for the##2##3##(1994-9#2)
registrants##7##1##(1994-9#2)(2005-8#1)(2006-12#1)(2007-4#2)(2007-6#1)
registrar##6##1##(1990-3#1)(1994-7#1)(2006-2#2)(2009-4#1)(2010-12#1)
registrars##5##1##(1990-4#2)(1992-2#1)(2008-11#1)(2011-2#1)
registration accuracy of skin- and bone-implanted fiducials##3##7##(2006-12#3)
registration accuracy of##4##3##(2006-12#4)
registration accuracy##7##2##(2006-12#4)(2007-12#1)(2008-2#1)(2009-12#1)
registration algorithm##5##2##(2008-2#2)(2010-2#1)(2011-2#2)
registration and##23##2##(1990-4#1)(1991-11#1)(1996-7#1)(2005-8#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-11#2)(2008-2#2)(2010-11#1)(2010-12#1)(2012-12#5)(2013-1#1)(2013-7#1)
registration are##2##2##(2008-2#1)(2011-2#1)
registration as##4##2##(1992-1#1)(2008-2#1)(2011-1#2)
registration authorities##4##2##(1992-3#1)(2005-10#1)(2007-8#2)
registration data##2##2##(1992-1#1)(2011-2#1)
registration for##4##2##(1996-3#1)(2007-5#1)(2008-11#1)(2008-3#1)
registration in##5##2##(1990-12#1)(2005-8#1)(2008-10#1)(2008-2#1)(2011-2#1)
registration is##8##2##(1996-8#1)(2006-10#1)(2006-6#1)(2007-5#1)(2008-2#2)(2008-3#1)(2012-12#1)
registration of all##2##3##(1992-3#1)(1993-5#1)
registration of births and deaths##3##5##(2008-11#1)(2010-8#1)(2012-12#1)
registration of births##4##3##(2008-10#1)(2008-11#1)(2010-8#1)(2012-12#1)
registration of drugs##2##3##(1997-6#1)(2011-2#1)
registration of infections]##2##3##(1994-2#2)
registration of pain##2##3##(1991-11#2)
registration of the##6##3##(1993-3#1)(2008-10#1)(2008-3#1)(2009-12#1)(2010-12#1)(2013-8#1)
registration of##45##2##(1990-6#2)(1991-10#2)(1991-11#3)(1992-3#2)(1993-3#1)(1993-5#2)(1993-9#1)(1994-2#2)(1994-6#1)(1997-6#1)(2006-6#3)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#1)(2009-12#2)(2009-2#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
registration on##3##2##(1996-5#1)(2008-2#1)(2008-3#1)
registration process##3##2##(2005-10#1)(2005-7#1)(2006-9#1)
registration system##2##2##(1990-9#1)(2011-2#1)
registration systems##5##2##(1993-12#1)(2012-12#4)
registration technique##2##2##(2008-11#2)
registration techniques##3##2##(1996-7#1)(2008-3#1)(2009-12#1)
registration trials##2##2##(2005-6#1)(2005-8#1)
registration using##2##2##(2009-12#1)(2010-12#1)
registration was##4##2##(2006-12#1)(2007-5#2)(2008-3#1)
registration were##2##2##(2006-12#1)(2010-12#1)
registration##239##1##(1990-12#2)(1990-3#1)(1990-4#1)(1990-6#2)(1990-9#1)(1991-10#2)(1991-11#5)(1991-3#1)(1991-4#1)(1992-1#4)(1992-10#2)(1992-12#1)(1992-3#3)(1993-1#1)(1993-12#1)(1993-3#1)(1993-5#2)(1993-9#2)(1994-12#1)(1994-2#2)(1994-6#1)(1995-3#1)(1995-9#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#2)(1996-8#1)(1997-6#1)(2005-10#2)(2005-12#1)(2005-6#1)(2005-7#1)(2005-8#6)(2006-10#3)(2006-12#9)(2006-3#1)(2006-6#7)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-5#9)(2007-6#1)(2007-8#3)(2007-9#2)(2008-10#4)(2008-11#17)(2008-12#1)(2008-2#29)(2008-3#12)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#7)(2009-2#2)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#8)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#14)(2012-1#2)(2012-12#12)(2012-2#1)(2013-1#1)(2013-7#3)(2013-8#1)
registration)##2##1##(2008-3#1)(2011-2#1)
registrations were##2##2##(2008-7#1)(2009-3#1)
registrations##11##1##(1990-2#1)(1991-6#1)(1995-5#2)(1996-7#1)(2008-2#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-9#1)(2012-12#1)
registries and##6##2##(2007-8#1)(2008-1#1)(2009-12#1)(2010-2#1)(2013-1#2)
registries for##2##2##(1993-12#1)(2011-2#1)
registries have##2##2##(2006-10#1)(2011-2#1)
registries in##2##2##(1996-12#1)(2011-2#1)
registries is a##2##3##(2008-7#1)(2009-1#1)
registries of##2##2##(2005-12#1)(2012-2#1)
registries provide##2##2##(2004-2#1)(2011-2#1)
registries were##4##2##(1996-12#1)(2012-12#1)(2013-1#2)
registries which##3##2##(1993-4#1)(2011-2#1)(2011-3#1)
registries##57##1##(1991-2#1)(1993-12#1)(1993-4#2)(1994-5#1)(1996-12#2)(1997-2#1)(2004-2#1)(2005-12#3)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#6)(2008-8#1)(2009-1#1)(2009-10#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#9)(2011-3#1)(2012-12#3)(2012-2#1)(2013-1#6)
registry and##8##2##(1994-5#1)(1996-12#1)(1997-2#1)(2008-1#1)(2010-11#1)(2012-2#1)(2013-1#2)
registry data##9##2##(1997-2#1)(2004-2#1)(2007-11#1)(2008-3#1)(2009-6#1)(2010-12#1)(2011-2#2)(2012-12#1)
registry for##3##2##(2005-11#1)(2008-1#1)(2012-2#1)
registry in##6##2##(1992-10#1)(2007-10#2)(2007-3#1)(2010-11#1)(2011-2#1)
registry is##4##2##(2005-12#1)(2008-8#1)(2010-11#1)(2013-7#1)
registry of the##5##3##(1993-9#1)(2007-5#1)(2010-11#1)(2012-2#1)(2013-1#1)
registry of##12##2##(1993-9#1)(1996-1#1)(2007-5#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-6#1)(2012-2#1)(2013-1#1)
registry system##3##2##(1993-5#1)(2006-2#1)(2013-1#1)
registry to##3##2##(2007-11#1)(2010-11#1)(2012-11#1)
registry was##2##2##(1992-10#1)(2008-9#1)
registry##124##1##(1992-10#3)(1993-5#1)(1993-9#1)(1994-5#1)(1996-1#1)(1996-12#1)(1997-2#2)(2004-2#1)(2005-11#1)(2005-12#4)(2006-10#2)(2006-12#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-10#4)(2007-11#3)(2007-2#3)(2007-3#1)(2007-5#2)(2007-8#11)(2007-9#2)(2008-1#6)(2008-10#1)(2008-11#4)(2008-3#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-11#11)(2010-12#3)(2010-5#1)(2010-6#4)(2010-8#1)(2011-2#16)(2012-11#1)(2012-12#2)(2012-2#5)(2013-1#8)(2013-7#2)(2013-8#1)
regius##2##1##(2008-10#1)(2009-4#1)
región of##2##2##(2013-8#2)
regolith and##2##2##(1990-8#1)(2013-8#1)
regolith##4##1##(1990-8#3)(2013-8#1)
regraft patients##2##2##(1995-2#2)
regraft##4##1##(1995-2#4)
regress after##2##2##(1991-11#1)(1991-6#1)
regress##13##1##(1991-11#1)(1991-6#1)(1992-5#1)(1995-4#1)(1996-10#1)(1996-9#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-5#1)(2010-9#1)(2011-1#1)
regressed after##2##2##(1995-6#1)(2007-11#1)
regressed against##4##2##(2006-12#1)(2008-10#1)(2013-1#2)
regressed and##4##2##(1990-11#1)(1992-4#1)(1995-3#1)(2010-2#1)
regressed in##3##2##(1997-8#1)(2008-3#2)
regressed onto##4##2##(2004-4#1)(2007-12#1)(2008-10#1)(2013-7#1)
regressed spontaneously##2##2##(1993-7#1)(2008-4#1)
regressed to##2##2##(1991-3#1)(1997-2#1)
regressed with##3##2##(2008-10#1)(2008-5#2)
regressed##38##1##(1990-11#1)(1990-9#1)(1991-3#1)(1992-4#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-7#1)(1995-3#2)(1995-6#1)(1996-4#1)(1997-2#1)(1997-8#1)(2004-4#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#5)(2008-3#3)(2008-4#2)(2008-5#2)(2010-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
regresses##3##1##(1995-11#1)(1997-5#1)(1997-7#1)
regressing out##2##2##(2011-2#2)
regressing##7##1##(1993-5#1)(2008-3#1)(2009-8#1)(2010-12#2)(2011-2#2)
regression (LR)##2##2##(2007-8#1)(2010-8#1)
regression (MLR)##10##2##(2005-12#1)(2008-10#6)(2010-12#1)(2011-2#1)(2012-3#1)
regression (PCR) and partial least squares (PLS)##3##7##(2008-10#2)(2013-8#1)
regression (PCR) and partial least##5##5##(2008-10#2)(2010-4#1)(2011-2#1)(2013-8#1)
regression (PCR) and partial##6##4##(2008-10#3)(2010-4#1)(2011-2#1)(2013-8#1)
regression (PCR)##14##2##(2008-10#11)(2010-4#1)(2011-2#1)(2013-8#1)
regression (PLS) and artificial neural##2##5##(2008-10#2)
regression (PLS)##9##2##(2008-10#8)(2010-4#1)
regression (PLSR)##2##2##(2008-10#1)(2013-8#1)
regression (r##2##2##(1995-2#1)(2008-10#1)
regression after##3##2##(1992-2#1)(2007-8#1)(2011-1#1)
regression analyses and##2##3##(2007-8#1)(2010-8#1)
regression analyses found##2##3##(1996-2#1)(2013-1#1)
regression analyses indicated that##2##4##(2007-7#1)(2011-12#1)
regression analyses indicated##3##3##(2007-7#1)(2008-11#1)(2011-12#1)
regression analyses of the##2##4##(2008-10#2)
regression analyses of##5##3##(1995-4#1)(2007-7#1)(2008-10#2)(2011-2#1)
regression analyses revealed that##6##4##(1995-10#1)(2006-7#1)(2009-5#1)(2010-2#1)(2012-2#1)(2012-3#1)
regression analyses revealed##9##3##(1995-10#1)(2006-7#2)(2007-9#1)(2009-5#1)(2010-11#1)(2010-2#1)(2012-2#1)(2012-3#1)
regression analyses showed that##4##4##(2007-9#1)(2008-8#1)(2010-3#1)(2011-1#1)
regression analyses showed##6##3##(1992-8#1)(2007-9#1)(2008-10#1)(2008-8#1)(2010-3#1)(2011-1#1)
regression analyses were performed to estimate##2##6##(2007-10#1)(2010-11#1)
regression analyses were performed to##4##5##(2007-10#1)(2008-10#1)(2008-3#1)(2010-11#1)
regression analyses were performed##5##4##(2007-10#1)(2008-10#1)(2008-3#1)(2010-11#1)(2012-2#1)
regression analyses were used to##7##5##(1993-12#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-10#1)(2010-4#1)(2012-2#1)
regression analyses were##16##3##(1993-12#1)(2007-1#1)(2007-10#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#1)(2010-11#1)(2010-4#1)(2012-11#1)(2012-2#2)
regression analyses##81##2##(1992-2#1)(1992-8#2)(1993-12#1)(1994-12#1)(1995-1#2)(1995-10#1)(1995-4#1)(1996-12#1)(1996-2#1)(1996-8#1)(2006-7#4)(2007-1#1)(2007-10#3)(2007-12#3)(2007-7#2)(2007-8#3)(2007-9#3)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-9#2)(2010-10#2)(2010-11#2)(2010-2#2)(2010-3#2)(2010-4#3)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#5)(2013-7#1)
regression analysis and##7##3##(1992-8#1)(1996-5#1)(1996-7#1)(2008-10#2)(2008-11#1)(2011-1#1)
regression analysis between##6##3##(2007-11#1)(2008-10#2)(2009-11#1)(2011-2#1)(2013-8#1)
regression analysis demonstrated that##2##4##(2008-7#1)(2010-12#1)
regression analysis for##2##3##(1992-12#1)(1992-8#1)
regression analysis found that##2##4##(2008-7#1)(2010-8#1)
regression analysis identified##3##3##(1996-12#1)(2007-10#1)(2008-10#1)
regression analysis indicated that the##3##5##(1996-3#1)(2008-7#1)(2010-7#1)
regression analysis indicated that##6##4##(1996-3#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-7#1)(2011-1#1)
regression analysis is##2##3##(2010-2#1)(2010-6#1)
regression analysis of potentiometric##2##4##(2008-10#2)
regression analysis of the##6##4##(1992-8#1)(1993-1#1)(1993-3#1)(2008-10#2)(2012-3#1)
regression analysis of##25##3##(1992-8#1)(1993-1#1)(1993-3#1)(1995-1#1)(1995-4#1)(1996-6#1)(2007-11#1)(2008-10#9)(2008-11#2)(2008-5#1)(2009-6#1)(2011-2#1)(2012-12#2)(2012-3#2)
regression analysis on##3##3##(1994-5#1)(1995-6#1)(2010-1#1)
regression analysis revealed a##2##4##(2007-7#1)(2008-10#1)
regression analysis revealed that##15##4##(2006-6#1)(2006-9#1)(2007-10#2)(2007-8#2)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
regression analysis revealed##20##3##(1992-6#1)(1996-7#1)(2006-6#1)(2006-9#1)(2007-10#2)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
regression analysis showed no significant##2##5##(2006-5#1)(2012-2#1)
regression analysis showed no##3##4##(1993-2#1)(2006-5#1)(2012-2#1)
regression analysis showed that the##4##5##(1990-4#1)(2007-12#1)(2008-10#1)(2011-1#1)
regression analysis showed that##17##4##(1990-4#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-7#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)
regression analysis showed##26##3##(1990-4#1)(1993-2#1)(2006-5#1)(2006-9#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)
regression analysis the##3##3##(1994-6#1)(1997-2#1)(2006-9#1)
regression analysis was applied to##2##5##(2011-1#1)(2012-1#1)
regression analysis was carried out##4##5##(2006-11#1)(2007-7#1)(2013-1#2)
regression analysis was performed to determine the##2##7##(2008-10#1)(2013-8#1)
regression analysis was performed##6##4##(2004-12#1)(2008-10#1)(2008-3#1)(2012-1#1)(2013-1#1)(2013-8#1)
regression analysis was used to evaluate the##2##7##(2011-1#1)(2013-1#1)
regression analysis was used to##8##5##(2006-11#1)(2008-3#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#2)
regression analysis was utilized to##2##5##(2008-11#1)(2008-12#1)
regression analysis was##26##3##(1993-8#1)(2004-12#1)(2006-11#2)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2011-1#3)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#5)(2013-8#2)
regression analysis were##4##3##(2008-11#2)(2008-3#1)(2011-1#1)
regression analysis##246##2##(1990-3#1)(1990-4#1)(1991-1#1)(1991-10#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-1#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-8#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-4#1)(1995-6#2)(1996-12#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#3)(1997-2#1)(1997-6#1)(1997-8#3)(2004-10#1)(2004-12#1)(2005-10#1)(2006-10#1)(2006-11#2)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#4)(2007-1#1)(2007-10#7)(2007-11#6)(2007-12#1)(2007-2#1)(2007-3#2)(2007-7#2)(2007-8#6)(2007-9#2)(2008-10#43)(2008-11#11)(2008-12#2)(2008-3#7)(2008-5#2)(2008-7#7)(2008-8#3)(2008-9#1)(2009-11#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#4)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#11)(2011-12#1)(2011-2#11)(2012-1#4)(2012-11#1)(2012-12#7)(2012-2#7)(2012-3#6)(2013-1#7)(2013-7#2)(2013-8#8)
regression analysis)##2##2##(2008-4#2)
regression and a##3##3##(1993-4#1)(2007-11#1)(2009-8#1)
regression and classification##2##3##(2008-10#1)(2010-1#1)
regression and the##6##3##(1992-6#1)(1995-2#1)(2009-9#1)(2012-3#2)(2013-8#1)
regression and##41##2##(1991-8#1)(1992-6#1)(1993-1#1)(1993-4#1)(1993-9#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-4#1)(1995-8#1)(2006-12#1)(2006-8#1)(2007-11#2)(2008-10#10)(2008-3#2)(2008-5#1)(2009-8#3)(2009-9#1)(2010-1#1)(2012-3#6)(2013-8#1)
regression approach on##2##3##(2008-10#1)(2012-3#1)
regression approach##6##2##(1995-2#1)(2008-10#3)(2012-3#2)
regression approaches##3##2##(1994-5#1)(2008-10#2)
regression are##4##2##(1991-8#1)(2008-10#2)(2010-2#1)
regression as well as##2##4##(2004-3#1)(2008-8#1)
regression based##4##2##(2007-10#1)(2009-3#2)(2013-8#1)
regression between the##3##3##(2008-10#1)(2008-3#1)(2010-2#1)
regression between##7##2##(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-4#1)(2010-12#1)(2010-2#1)
regression by apoptosis##2##3##(1994-11#1)(1995-6#1)
regression by##3##2##(1994-11#1)(1995-6#1)(2008-10#1)
regression calibration##2##2##(2007-12#1)(2008-10#1)
regression can be##3##3##(1995-11#1)(2008-10#1)(2012-1#1)
regression can##5##2##(1995-11#1)(1995-2#1)(2008-10#1)(2010-1#1)(2012-1#1)
regression coefficient of 0##3##4##(2008-10#2)(2010-2#1)
regression coefficient of##5##3##(2008-10#3)(2010-2#1)(2012-2#1)
regression coefficient##11##2##(2008-10#7)(2010-12#1)(2010-2#1)(2012-2#1)(2012-3#1)
regression coefficients and##3##3##(2008-12#1)(2012-3#2)
regression coefficients are##3##3##(1994-5#1)(1997-8#1)(2010-11#1)
regression coefficients of##5##3##(1992-1#1)(1995-9#1)(2008-10#3)
regression coefficients##28##2##(1992-1#1)(1994-5#1)(1995-2#1)(1995-4#1)(1995-9#1)(1997-6#2)(1997-8#1)(2008-10#10)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-11#1)(2010-12#1)(2011-12#1)(2012-3#3)
regression curve##2##2##(2008-10#1)(2011-2#1)
regression diagnostics##3##2##(2008-10#3)
regression dilution bias##3##3##(1990-3#2)(2012-12#1)
regression dilution##4##2##(1990-3#2)(1993-10#1)(2012-12#1)
regression equation for##4##3##(1995-6#1)(2008-10#2)(2012-12#1)
regression equation has##2##3##(2008-10#1)(2011-3#1)
regression equation is##2##3##(2005-4#1)(2007-8#1)
regression equation of the calibration graph##4##6##(2008-10#4)
regression equation of##6##3##(2008-10#6)
regression equation##28##2##(1993-9#1)(1995-6#1)(2005-12#1)(2005-4#1)(2007-8#3)(2008-10#17)(2008-7#1)(2009-11#1)(2011-3#1)(2012-12#1)
regression equations##10##2##(1992-12#1)(2004-12#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
regression estimates##2##2##(1993-6#1)(2009-12#1)
regression estimation##2##2##(2008-2#1)(2010-3#1)
regression for##10##2##(1991-1#1)(1993-6#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-6#1)(2008-7#1)(2012-12#1)(2013-7#1)
regression found##2##2##(2006-6#1)(2009-9#1)
regression has##2##2##(2007-8#1)(2012-3#1)
regression identified##3##2##(1997-8#1)(2009-4#1)(2009-6#1)
regression in case-control studies##2##4##(1995-4#2)
regression in the##4##3##(1995-2#1)(2008-10#2)(2012-12#1)
regression in##17##2##(1992-12#1)(1995-2#1)(1995-4#2)(1996-4#1)(2005-1#1)(2006-10#1)(2008-10#3)(2009-4#1)(2009-8#1)(2010-1#1)(2010-3#1)(2011-11#1)(2011-2#1)(2012-12#1)
regression including##2##2##(1996-9#1)(2012-3#1)
regression indicated that##5##3##(1993-12#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-3#1)
regression is a##2##3##(1993-1#1)(1994-5#1)
regression is##8##2##(1993-1#1)(1994-5#1)(1995-4#1)(1996-10#2)(2007-6#1)(2008-10#1)(2012-3#1)
regression line was##3##3##(1993-7#1)(2004-12#1)(2008-10#1)
regression line##10##2##(1990-8#1)(1993-7#1)(2004-12#1)(2006-7#1)(2008-10#6)
regression lines##5##2##(1990-12#1)(1991-2#1)(1992-1#1)(2008-10#2)
regression method and##3##3##(1995-2#1)(2013-1#2)
regression method for##2##3##(2008-3#1)(2012-3#1)
regression method to##4##3##(2008-10#1)(2012-3#2)(2013-8#1)
regression method##32##2##(1995-2#4)(2005-4#1)(2008-10#15)(2008-3#2)(2010-2#1)(2012-3#4)(2013-1#3)(2013-8#2)
regression methodology##2##2##(1996-2#1)(1996-8#1)
regression methods for trend detection##2##5##(1993-6#2)
regression methods for##3##3##(1993-6#2)(1994-2#1)
regression methods to##4##3##(2008-10#2)(2009-8#1)(2012-3#1)
regression methods##20##2##(1993-6#2)(1994-11#1)(1994-2#1)(2007-9#1)(2008-10#10)(2008-6#1)(2009-8#2)(2012-3#2)
regression model and##2##3##(1997-8#1)(2012-3#1)
regression model for bivariate ordered categorical data##2##7##(1995-6#1)(1996-7#1)
regression model for the##3##4##(1993-11#1)(1995-9#1)(2007-10#1)
regression model for##14##3##(1990-12#1)(1992-6#1)(1993-11#1)(1995-2#1)(1995-6#2)(1995-9#1)(1996-7#1)(1997-4#1)(1997-8#1)(2007-10#1)(2008-8#1)(2011-2#1)(2012-2#1)
regression model identified##2##3##(1990-4#1)(2008-11#1)
regression model is proposed##2##4##(1996-8#1)(2007-3#1)
regression model is##4##3##(1996-8#1)(2007-3#1)(2007-6#1)(2012-12#1)
regression model of##2##3##(2011-2#1)(2012-2#1)
regression model that##5##3##(1993-9#1)(2004-9#1)(2006-6#1)(2008-10#1)(2008-3#1)
regression model to predict##2##4##(2007-3#1)(2010-8#1)
regression model to##9##3##(1993-9#1)(1995-2#1)(1996-7#1)(1997-6#1)(1997-8#1)(2007-3#1)(2008-10#1)(2010-8#1)(2012-3#1)
regression model used##3##3##(2007-3#1)(2008-10#1)(2009-7#1)
regression model was developed##4##4##(2008-10#1)(2011-1#1)(2013-1#2)
regression model was used to##4##5##(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)
regression model was used##7##4##(2007-10#1)(2008-10#1)(2008-7#1)(2011-1#2)(2011-2#1)(2012-2#1)
regression model was##12##3##(2007-10#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#2)
regression model when##2##3##(1993-6#1)(2008-10#1)
regression model with##8##3##(1997-2#1)(1997-8#1)(2006-12#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
regression model##127##2##(1990-12#1)(1990-4#1)(1992-1#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-6#1)(1993-7#1)(1993-9#2)(1995-2#2)(1995-4#1)(1995-6#3)(1995-8#1)(1995-9#2)(1996-11#1)(1996-7#2)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#4)(2004-9#1)(2006-12#1)(2006-6#2)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-3#4)(2007-6#1)(2007-8#1)(2008-10#13)(2008-11#4)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#4)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#4)(2011-2#9)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#10)(2013-7#1)(2013-8#1)
regression modeling of##3##3##(2008-10#2)(2012-1#1)
regression modeling##8##2##(2008-10#3)(2008-3#1)(2008-8#2)(2012-1#2)
regression modelling##5##2##(1994-6#1)(1996-7#1)(2007-12#1)(2009-6#1)(2012-12#1)
regression models and##5##3##(1992-9#1)(1994-6#1)(1996-2#1)(2011-1#1)(2013-1#1)
regression models are##3##3##(1996-2#1)(2009-10#1)(2010-11#1)
regression models explained##2##3##(2008-10#2)
regression models fitted##3##3##(1994-2#1)(1994-5#2)
regression models for survival data##2##5##(1994-6#2)
regression models for##11##3##(1991-1#1)(1992-2#1)(1993-5#1)(1994-5#1)(1994-6#2)(1995-8#1)(2008-10#1)(2008-8#1)(2013-1#2)
regression models in##3##3##(1996-8#1)(2008-10#1)(2013-1#1)
regression models of##2##3##(2009-10#1)(2010-12#1)
regression models suggest##2##3##(2008-11#1)(2012-12#1)
regression models that##2##3##(2008-10#1)(2012-3#1)
regression models to examine the##2##5##(2010-9#1)(2012-12#1)
regression models to##9##3##(1995-2#1)(2007-5#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
regression models using##2##3##(1994-5#1)(2007-11#1)
regression models were developed##2##4##(2007-8#1)(2008-10#1)
regression models were used to examine the##2##7##(2006-11#1)(2012-3#1)
regression models were used to##8##5##(2006-11#1)(2008-10#1)(2012-2#1)(2012-3#3)(2013-1#2)
regression models were##20##3##(1994-1#1)(2006-11#1)(2007-3#1)(2007-8#2)(2008-10#4)(2008-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#4)
regression models with##4##3##(1995-2#1)(1997-2#1)(2012-1#1)(2012-12#1)
regression models##116##2##(1990-12#1)(1990-2#1)(1991-1#1)(1992-2#2)(1992-9#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-5#4)(1994-6#3)(1995-2#3)(1995-6#1)(1995-8#1)(1996-2#3)(1996-8#2)(1997-2#1)(2006-11#1)(2006-12#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#3)(2009-12#1)(2009-5#1)(2010-11#2)(2010-12#2)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#10)(2013-1#11)(2013-7#2)(2013-8#1)
regression neural##3##2##(2008-10#2)(2010-2#1)
regression occurs##2##2##(1995-11#1)(2009-8#1)
regression of a##6##3##(1996-2#1)(2007-9#1)(2008-1#2)(2009-4#1)(2011-3#1)
regression of bone marrow fibrosis##2##5##(2012-12#2)
regression of breast cancer##2##4##(1994-3#2)
regression of coronary##3##3##(1991-7#1)(1993-9#1)(1995-8#1)
regression of even##2##3##(1992-3#1)(2008-1#1)
regression of hypertrophy##2##3##(1990-3#1)(2008-7#1)
regression of laryngeal##2##3##(1990-6#2)
regression of metastatic##2##3##(1990-2#1)(2006-8#1)
regression of myocardial##2##3##(1993-8#1)(2010-8#1)
regression of the disease in##2##5##(2007-6#1)(2007-7#1)
regression of the lesions##3##4##(1993-7#1)(2010-12#1)(2013-1#1)
regression of the tumor##3##4##(1996-4#2)(1997-1#1)
regression of the tumour##2##4##(2008-5#1)(2008-7#1)
regression of the##32##3##(1991-12#1)(1992-12#1)(1993-7#1)(1995-11#1)(1996-4#3)(1997-1#1)(2006-11#1)(2006-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)
regression of##106##2##(1990-11#2)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#3)(1991-12#1)(1991-7#1)(1992-12#1)(1992-3#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-3#2)(1994-5#2)(1994-9#1)(1995-11#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-2#1)(1996-4#4)(1996-9#1)(1997-1#1)(1997-2#1)(1997-8#1)(2004-11#1)(2004-3#1)(2005-1#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-6#1)(2006-8#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#8)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
regression on the##3##3##(1990-10#1)(2008-10#1)(2010-5#1)
regression on##8##2##(1990-10#1)(1991-5#1)(2008-10#2)(2010-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
regression or##4##2##(1990-12#1)(1992-9#1)(1993-1#1)(2010-12#1)
regression parameters##5##2##(1992-9#1)(1995-6#1)(1997-8#1)(2008-3#1)(2008-7#1)
regression performed##3##2##(2007-10#1)(2008-5#1)(2012-3#1)
regression problems##2##2##(1997-4#1)(2008-6#1)
regression procedure##2##2##(2006-10#1)(2008-10#1)
regression process##2##2##(1996-10#1)(2005-12#1)
regression rate##3##2##(2006-10#1)(2008-6#1)(2009-11#1)
regression results##9##2##(1996-3#1)(2005-10#1)(2008-10#1)(2008-12#2)(2008-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
regression revealed that##2##3##(2008-11#1)(2008-8#1)
regression revealed##3##2##(2008-11#1)(2008-8#1)(2009-12#1)
regression showed that##2##3##(2011-1#1)(2013-1#1)
regression showed##5##2##(2007-2#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
regression slope##6##2##(1995-4#2)(2008-10#3)(2013-1#1)
regression slopes were##2##3##(1990-7#1)(2008-10#1)
regression slopes##3##2##(1990-7#1)(1996-12#1)(2008-10#1)
regression surface##2##2##(2008-6#2)
regression technique##5##2##(1990-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
regression techniques##7##2##(2005-12#1)(2008-10#3)(2008-2#1)(2008-9#1)(2013-8#1)
regression to identify##2##3##(2013-1#2)
regression to the mean##3##4##(1994-4#2)(2009-8#1)
regression to the##4##3##(1994-4#2)(2008-10#1)(2009-8#1)
regression to##22##2##(1991-1#1)(1994-4#2)(1994-5#1)(1996-3#1)(2006-7#1)(2008-10#6)(2008-6#1)(2008-9#1)(2009-8#1)(2010-5#1)(2012-2#1)(2012-3#2)(2013-1#3)
regression tree##5##2##(2007-8#1)(2008-10#4)
regression triplet##3##2##(2008-10#3)
regression using##4##2##(1995-2#1)(2008-6#1)(2012-12#1)(2012-3#1)
regression was conducted##2##3##(1997-2#1)(2012-12#1)
regression was observed in##2##4##(2006-10#1)(2011-2#1)
regression was performed to##2##4##(2008-10#1)(2012-1#1)
regression was used for##2##4##(2008-10#2)
regression was used to adjust##2##5##(2007-8#1)(2008-3#1)
regression was used to assess##3##5##(2007-8#1)(2011-1#1)(2012-12#1)
regression was used to compare##3##5##(2007-11#1)(2012-1#1)(2012-12#1)
regression was used to estimate##4##5##(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
regression was used to find the straight line that fitted the experimental data##2##13##(2008-10#2)
regression was used to identify##2##5##(2007-1#1)(2013-8#1)
regression was used to test##3##5##(2010-2#1)(2013-1#2)
regression was used to##30##4##(2005-4#1)(2007-1#1)(2007-11#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#2)
regression was used##35##3##(1994-12#1)(2005-4#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#2)
regression was##59##2##(1992-12#1)(1994-12#1)(1996-4#1)(1997-2#1)(2005-4#1)(2006-10#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-8#2)(2008-10#11)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#6)(2012-1#3)(2012-12#3)(2012-3#2)(2013-1#5)(2013-8#3)
regression were##9##2##(1993-1#1)(2009-4#1)(2009-8#1)(2013-1#5)(2013-8#1)
regression with##14##2##(1995-6#1)(1996-7#1)(2007-11#2)(2007-2#1)(2008-10#4)(2009-5#1)(2010-1#1)(2010-5#1)(2011-2#1)(2013-8#1)
regression##1492##1##(1990-10#1)(1990-11#2)(1990-12#5)(1990-2#4)(1990-3#6)(1990-4#2)(1990-5#1)(1990-6#3)(1990-7#1)(1990-8#1)(1991-1#4)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#3)(1992-1#3)(1992-12#5)(1992-2#9)(1992-3#3)(1992-4#1)(1992-6#3)(1992-8#5)(1992-9#8)(1993-1#9)(1993-10#1)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#1)(1993-4#4)(1993-5#2)(1993-6#7)(1993-7#3)(1993-8#2)(1993-9#10)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#4)(1994-4#3)(1994-5#15)(1994-6#6)(1994-8#2)(1994-9#4)(1995-1#5)(1995-10#2)(1995-11#5)(1995-12#2)(1995-2#18)(1995-4#13)(1995-5#1)(1995-6#13)(1995-8#6)(1995-9#7)(1996-1#1)(1996-10#4)(1996-11#1)(1996-12#4)(1996-2#8)(1996-3#3)(1996-4#10)(1996-5#3)(1996-6#1)(1996-7#7)(1996-8#6)(1996-9#2)(1997-1#1)(1997-2#8)(1997-4#2)(1997-6#4)(1997-7#1)(1997-8#12)(2004-10#1)(2004-11#1)(2004-12#3)(2004-3#2)(2004-9#1)(2005-1#2)(2005-10#4)(2005-11#1)(2005-12#5)(2005-4#6)(2006-10#11)(2006-11#5)(2006-12#4)(2006-4#1)(2006-5#1)(2006-6#5)(2006-7#6)(2006-8#6)(2006-9#5)(2007-1#3)(2007-10#19)(2007-11#23)(2007-12#12)(2007-2#4)(2007-3#9)(2007-4#1)(2007-5#1)(2007-6#5)(2007-7#5)(2007-8#32)(2007-9#9)(2008-1#5)(2008-10#305)(2008-11#26)(2008-12#10)(2008-2#10)(2008-3#29)(2008-4#8)(2008-5#13)(2008-6#16)(2008-7#17)(2008-8#20)(2008-9#13)(2009-10#3)(2009-11#3)(2009-12#5)(2009-3#3)(2009-4#5)(2009-5#6)(2009-6#5)(2009-7#8)(2009-8#12)(2009-9#5)(2010-1#10)(2010-10#4)(2010-11#6)(2010-12#21)(2010-2#18)(2010-3#7)(2010-4#16)(2010-5#7)(2010-6#3)(2010-7#4)(2010-8#11)(2010-9#3)(2011-1#30)(2011-11#1)(2011-12#6)(2011-2#53)(2011-3#3)(2012-1#15)(2012-11#4)(2012-12#37)(2012-2#22)(2012-3#68)(2012-7#1)(2013-1#66)(2013-7#9)(2013-8#31)
regression)##4##1##(1991-8#1)(2009-11#1)(2009-2#1)(2012-1#1)
regression-based##3##1##(1997-1#1)(2008-2#1)(2008-3#1)
regressions indicate that##2##3##(2008-9#1)(2009-12#1)
regressions of##4##2##(2004-1#1)(2008-10#2)(2008-5#1)
regressions on##4##2##(2007-11#1)(2009-9#1)(2013-1#2)
regressions were used to##2##4##(2008-8#1)(2012-3#1)
regressions were used##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
regressions were##8##2##(2007-8#1)(2008-10#2)(2008-8#1)(2010-2#1)(2010-4#1)(2012-3#1)(2013-1#1)
regressions##51##1##(1991-2#1)(2004-1#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-8#2)(2008-9#3)(2009-12#3)(2009-3#2)(2009-4#2)(2009-7#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#2)(2011-1#2)(2011-2#3)(2012-3#2)(2013-1#5)(2013-7#1)
regressive##11##1##(1991-3#1)(1993-2#1)(1996-10#2)(1996-6#1)(1996-7#1)(2005-10#1)(2005-11#1)(2008-11#1)(2009-10#1)(2010-12#1)
regressors##2##1##(1993-5#1)(2011-2#1)
regret this##2##2##(2006-3#1)(2008-10#1)
regret##6##1##(2004-10#2)(2006-3#1)(2006-4#1)(2008-10#1)(2009-7#1)
regrets that this article is an accidental duplication of an article that has already been published in##8##17##(2008-11#6)(2008-4#1)(2008-7#1)
regrets that this article is an accidental duplication of an article that has already been published##9##16##(2008-11#6)(2008-4#1)(2008-7#1)(2012-3#1)
regrets that this article##10##4##(2008-11#7)(2008-4#1)(2008-7#1)(2012-3#1)
regrets##11##1##(1991-3#1)(2008-11#7)(2008-4#1)(2008-7#1)(2012-3#1)
regretted##2##1##(2004-10#1)(2006-4#1)
regrew##3##1##(1991-9#1)(2005-10#1)(2007-12#1)
regrow a noticeable amount of hair##2##6##(2008-5#2)
regrow##4##1##(1991-3#2)(2008-5#2)
regrowth of the##2##3##(1991-10#1)(2008-7#1)
regrowth of##8##2##(1991-10#1)(1992-9#1)(1995-11#2)(2007-2#1)(2008-7#2)(2010-9#1)
regrowth than##2##2##(1997-7#1)(2008-7#1)
regrowth was##2##2##(2007-1#1)(2012-11#1)
regrowth##27##1##(1991-10#1)(1992-2#1)(1992-9#4)(1995-11#2)(1997-4#1)(1997-7#1)(2007-1#1)(2007-11#3)(2007-2#1)(2008-10#1)(2008-5#2)(2008-7#6)(2010-9#1)(2011-2#1)(2012-11#1)
regs##2##1##(1995-2#1)(2006-5#1)
regucalcin mRNA in##2##3##(1992-6#2)
regucalcin mRNA##5##2##(1992-6#5)
regucalcin##8##1##(1992-6#7)(1996-7#1)
regular BSE##2##2##(2011-2#2)
regular HAART##2##2##(2012-2#2)
regular and##15##2##(1993-3#1)(2006-4#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-12#2)
regular assessment##2##2##(1996-8#1)(2012-12#1)
regular basis##27##2##(1994-3#1)(1995-2#1)(1997-5#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-2#2)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-9#1)(2011-2#2)
regular blood##2##2##(2006-6#1)(2007-12#1)
regular cellulose##2##2##(2005-7#1)(2008-10#1)
regular clients and##3##3##(2012-3#3)
regular clients##6##2##(2012-3#6)
regular clinical and##2##3##(1990-9#1)(2010-3#1)
regular clinical##4##2##(1990-9#1)(1992-12#1)(2010-3#1)(2012-12#1)
regular communication##2##2##(1997-3#1)(2006-10#1)
regular confocal microscope##2##3##(2008-2#2)
regular consumption of##6##3##(2008-1#1)(2008-5#1)(2009-5#3)(2011-2#1)
regular contact with##2##3##(2008-11#2)
regular control##3##2##(1993-1#1)(2007-11#1)(2011-2#1)
regular cycles##3##2##(2008-10#2)(2013-8#1)
regular delivery of##2##3##(2006-10#1)(2008-1#1)
regular dialysis treatment##7##3##(1995-1#1)(2007-7#2)(2010-12#4)
regular dialysis##10##2##(1995-1#1)(1995-3#1)(2007-7#2)(2008-1#1)(2010-12#4)(2011-2#1)
regular donors who sero-converted##2##4##(2007-12#2)
regular donors##7##2##(1997-7#1)(2007-12#5)(2013-8#1)
regular evaluation of the##2##4##(2007-12#1)(2007-9#1)
regular exercise##9##2##(1995-11#1)(2007-10#1)(2007-9#1)(2008-7#1)(2008-8#1)(2010-2#2)(2011-2#1)(2013-1#1)
regular follow up in##2##4##(2008-8#1)(2011-2#1)
regular follow up##4##3##(2008-8#1)(2011-2#3)
regular follow-up is##2##3##(1993-7#1)(2011-1#1)
regular follow-up was##2##3##(2008-3#1)(2013-1#1)
regular follow-up with##2##3##(1996-7#1)(2007-8#1)
regular follow-up##9##2##(1993-7#1)(1996-7#1)(2005-12#1)(2007-8#1)(2008-3#1)(2011-1#1)(2011-2#2)(2013-1#1)
regular grid##4##2##(2008-10#2)(2008-6#1)(2011-2#1)
regular health##2##2##(1993-8#1)(1995-8#1)
regular hemodialysis (HD)##2##3##(2007-7#1)(2008-1#1)
regular hemodialysis##8##2##(2007-7#6)(2008-1#1)(2012-12#1)
regular insulin##2##2##(2007-11#2)
regular job##2##2##(2007-7#1)(2008-2#1)
regular labeling of##2##3##(2008-10#2)
regular laboratory##2##2##(1990-3#1)(1997-3#1)
regular lattice##3##2##(2007-12#1)(2008-8#1)(2013-8#1)
regular long-term##2##2##(2008-9#1)(2013-8#1)
regular meals##2##2##(1997-4#1)(2011-2#1)
regular medical##5##2##(1991-9#1)(1994-12#1)(2006-7#1)(2008-5#1)(2010-8#1)
regular menstrual cycles##2##3##(1995-12#1)(2011-2#1)
regular menstrual##3##2##(1995-12#1)(2005-8#1)(2011-2#1)
regular monitoring of##6##3##(2006-10#1)(2007-11#1)(2007-6#1)(2008-10#1)(2011-12#2)
regular monitoring##8##2##(2006-10#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-4#1)(2010-12#1)(2011-12#2)
regular night nursing##2##3##(2010-7#2)
regular occurrence##2##2##(2008-5#1)(2012-3#1)
regular or##2##2##(2007-11#1)(2008-3#1)
regular pattern of##2##3##(1994-9#1)(2008-2#1)
regular pattern##4##2##(1994-9#1)(2007-11#1)(2008-2#1)(2009-8#1)
regular patterns of##2##3##(2008-10#1)(2008-7#1)
regular patterns##5##2##(1993-11#1)(2008-10#1)(2008-7#1)(2009-2#2)
regular periodic##3##2##(1991-2#1)(2007-2#1)(2009-2#1)
regular physical activity or##2##4##(2006-2#1)(2009-3#1)
regular physical activity##8##3##(1995-8#1)(2006-2#1)(2007-6#2)(2008-5#1)(2009-3#1)(2011-2#1)(2012-2#1)
regular physical##9##2##(1995-10#1)(1995-8#1)(2006-2#1)(2007-6#2)(2008-5#1)(2009-3#1)(2011-2#1)(2012-2#1)
regular polygon and slit##2##4##(2008-3#2)
regular primary##2##2##(1996-1#1)(2009-3#1)
regular screening colonoscopies##2##3##(1995-9#2)
regular screening of##3##3##(2007-1#1)(2007-2#1)(2013-8#1)
regular screening##6##2##(1990-12#1)(1995-9#2)(2007-1#1)(2007-2#1)(2013-8#1)
regular secondary structure##3##3##(1991-4#1)(1992-12#1)(1997-2#1)
regular secondary##5##2##(1991-4#1)(1992-12#1)(1997-2#1)(2009-7#1)(2012-12#1)
regular sieving structures##2##3##(2008-7#2)
regular smokers##3##2##(1993-10#1)(1994-6#1)(2012-12#1)
regular snus users##2##3##(2012-12#2)
regular solution model##2##3##(1994-12#1)(2005-11#1)
regular solution theory##6##3##(2008-10#6)
regular solution##8##2##(1994-12#1)(2005-11#1)(2008-10#6)
regular structures##2##2##(1993-3#1)(2008-7#1)
regular surveillance##2##2##(2007-8#1)(2009-12#1)
regular suture##2##2##(1991-12#2)
regular time intervals##4##3##(1992-8#1)(2008-10#2)(2008-5#1)
regular toileting##2##2##(1991-8#2)
regular use of these##2##4##(1991-9#1)(2008-5#1)
regular use of##9##3##(1990-9#1)(1991-9#2)(1992-10#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#1)
regular use##10##2##(1990-9#1)(1991-9#2)(1992-10#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)
regular users of the##2##4##(1992-2#1)(2012-1#1)
regular users##3##2##(1992-2#1)(2008-12#1)(2012-1#1)
regular words##2##2##(2009-7#2)
regular##516##1##(1990-11#1)(1990-12#6)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-12#3)(1991-2#5)(1991-3#1)(1991-4#1)(1991-7#1)(1991-8#4)(1991-9#3)(1992-10#2)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-10#2)(1993-11#2)(1993-12#1)(1993-3#4)(1993-7#1)(1993-8#2)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#2)(1995-9#2)(1996-1#3)(1996-11#2)(1996-12#2)(1996-4#1)(1996-6#2)(1996-7#1)(1996-8#5)(1997-2#3)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#1)(2004-10#1)(2004-11#1)(2005-10#1)(2005-11#5)(2005-12#1)(2005-5#1)(2005-7#3)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#8)(2006-12#1)(2006-2#4)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#3)(2007-10#3)(2007-11#10)(2007-12#19)(2007-2#5)(2007-3#4)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#16)(2007-8#8)(2007-9#2)(2008-1#16)(2008-10#33)(2008-11#11)(2008-12#2)(2008-2#13)(2008-3#18)(2008-4#5)(2008-5#16)(2008-6#2)(2008-7#11)(2008-8#6)(2008-9#4)(2009-10#4)(2009-12#2)(2009-2#6)(2009-3#3)(2009-4#4)(2009-5#4)(2009-7#6)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#8)(2010-2#3)(2010-3#3)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#2)(2011-12#3)(2011-2#27)(2011-3#1)(2012-1#3)(2012-12#17)(2012-2#12)(2012-3#14)(2013-1#8)(2013-7#1)(2013-8#9)
regularis##5##1##(2007-1#3)(2012-2#2)
regularities in the##3##3##(2012-1#1)(2012-2#2)
regularities in##4##2##(2012-1#2)(2012-2#2)
regularities of##3##2##(1995-4#1)(2007-11#1)(2010-9#1)
regularities##11##1##(1995-4#1)(2007-11#1)(2008-11#1)(2010-9#1)(2012-1#3)(2012-2#3)(2013-1#1)
regularity of##6##2##(2006-10#1)(2008-11#1)(2008-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
regularity##23##1##(2006-10#1)(2007-12#2)(2008-10#6)(2008-11#2)(2008-2#3)(2010-12#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#4)
regularization is##2##2##(2008-2#1)(2008-3#1)
regularization method##2##2##(2008-3#2)
regularization parameter##12##2##(2008-10#1)(2008-2#5)(2008-3#2)(2010-2#3)(2011-1#1)
regularization parameters##2##2##(2008-3#2)
regularization scheme##3##2##(2008-2#1)(2008-3#2)
regularization solution##2##2##(2008-3#2)
regularization##46##1##(1996-4#1)(2007-11#1)(2008-10#2)(2008-2#10)(2008-3#21)(2008-6#3)(2009-7#1)(2010-2#3)(2011-1#2)(2012-12#2)
regularized functional##2##2##(2008-2#2)
regularized least-squares##2##2##(2008-2#1)(2008-6#1)
regularized phase-tracking (RPT) technique##2##4##(2008-2#1)(2008-3#1)
regularized phase-tracking (RPT)##5##3##(2008-2#1)(2008-3#4)
regularized phase-tracking technique##3##3##(2008-3#3)
regularized phase-tracking##10##2##(2008-2#2)(2008-3#8)
regularized##34##1##(2007-12#2)(2008-2#13)(2008-3#10)(2008-6#5)(2009-3#1)(2010-1#1)(2013-1#2)
regularly and##4##2##(1990-12#1)(2010-10#1)(2011-2#1)(2013-1#1)
regularly assessed##2##2##(2011-2#1)(2012-1#1)
regularly at##2##2##(2007-9#1)(2012-2#1)
regularly but##2##2##(2007-7#1)(2008-10#1)
regularly by##2##2##(1993-8#1)(1997-8#1)
regularly checked##3##2##(1993-1#1)(1993-5#1)(2008-5#1)
regularly distributed##2##2##(2008-10#1)(2008-3#1)
regularly documented included##2##3##(2008-12#2)
regularly during the##2##3##(1992-7#1)(1994-4#1)
regularly for##3##2##(2008-7#1)(2011-2#2)
regularly from##2##2##(1990-12#1)(1996-2#1)
regularly in##4##2##(1997-8#1)(2007-11#1)(2008-5#1)(2013-8#1)
regularly monitored##4##2##(1992-1#1)(2008-11#1)(2011-1#1)(2011-2#1)
regularly observed in##2##3##(1992-3#1)(1993-11#1)
regularly over##2##2##(1992-9#1)(2008-5#1)
regularly scheduled##8##2##(2005-8#3)(2006-10#1)(2008-4#2)(2009-4#1)(2012-12#1)
regularly spaced##5##2##(1990-5#1)(2006-12#1)(2008-10#1)(2008-3#1)(2012-11#1)
regularly to ensure that##2##4##(2005-9#1)(2008-11#1)
regularly to##3##2##(2005-9#1)(2007-8#1)(2008-11#1)
regularly updated##2##2##(2011-2#1)(2013-1#1)
regularly used##3##2##(2008-10#1)(2010-12#1)(2010-8#1)
regularly with##2##2##(1996-2#1)(2008-10#1)
regularly##148##1##(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-1#4)(1993-10#1)(1993-11#2)(1993-5#1)(1993-8#1)(1994-3#1)(1994-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-7#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#4)(2005-8#3)(2005-9#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#6)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#2)(2010-1#2)(2010-10#1)(2010-12#3)(2010-2#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#11)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
regulatable##5##1##(1990-6#2)(1994-2#1)(2008-11#2)
regulate Fp##2##2##(1995-8#2)
regulate P2##2##2##(2008-4#2)
regulate a large number of##2##5##(2008-4#1)(2009-8#1)
regulate a number of##4##4##(1996-12#1)(2006-9#1)(2008-11#1)(2009-5#1)
regulate a variety of##3##4##(1995-2#1)(2008-1#1)(2009-11#1)
regulate a##20##2##(1990-8#1)(1995-2#1)(1996-12#1)(1997-7#1)(2005-7#1)(2006-9#1)(2008-1#1)(2008-11#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-8#3)(2010-7#1)
regulate actin##5##2##(1990-3#1)(1996-2#1)(2012-2#3)
regulate body##2##2##(2008-5#1)(2009-5#1)
regulate bone##3##2##(2007-8#1)(2009-4#2)
regulate both##5##2##(1993-12#1)(1995-6#1)(2008-10#1)(2012-2#1)(2013-8#1)
regulate cell attachment and##2##4##(1994-6#1)(2011-11#1)
regulate cell cycle progression##3##4##(1991-9#1)(1994-8#1)(2008-1#1)
regulate cell cycle##4##3##(1991-9#1)(1994-8#1)(2008-1#1)(2009-3#1)
regulate cell death##2##3##(1996-10#1)(2008-11#1)
regulate cell growth##4##3##(1995-8#1)(2005-11#1)(2005-12#1)(2008-11#1)
regulate cell##17##2##(1991-9#1)(1994-6#1)(1994-8#1)(1995-8#1)(1996-10#1)(1996-3#1)(2005-11#1)(2005-12#1)(2007-4#1)(2008-1#1)(2008-11#2)(2009-3#1)(2011-11#1)(2012-1#1)(2012-12#1)(2012-3#1)
regulate cellular functions##3##3##(1995-3#1)(2005-8#1)(2013-1#1)
regulate cellular responses##2##3##(1997-4#1)(2009-12#1)
regulate cellular##9##2##(1994-9#1)(1995-3#1)(1997-4#1)(2005-7#1)(2005-8#1)(2009-12#1)(2011-12#1)(2012-12#1)(2013-1#1)
regulate development and##2##3##(1993-3#1)(1996-5#1)
regulate development##3##2##(1993-3#1)(1994-12#1)(1996-5#1)
regulate different##4##2##(1994-10#1)(2008-4#1)(2009-10#2)
regulate distinct##2##2##(2008-4#1)(2010-11#1)
regulate diverse processes including cell##2##5##(2005-7#1)(2007-12#1)
regulate diverse##4##2##(2005-7#1)(2007-12#2)(2008-9#1)
regulate expression of the##2##4##(1995-2#1)(2008-7#1)
regulate expression of##3##3##(1995-2#1)(1997-4#1)(2008-7#1)
regulate food intake and##2##4##(1997-4#1)(2008-1#1)
regulate food intake##3##3##(1997-4#1)(2008-1#1)(2008-3#1)
regulate gastric acid secretion##3##4##(1990-2#1)(2006-10#2)
regulate gastric##5##2##(1990-2#1)(2006-10#3)(2013-1#1)
regulate gene expression at##2##4##(2008-1#1)(2008-7#1)
regulate gene expression##17##3##(1993-6#1)(1995-6#1)(1997-4#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-11#1)(2010-7#1)(2011-2#2)(2012-12#2)(2013-8#1)
regulate gene##18##2##(1993-6#1)(1995-6#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-11#1)(2010-7#1)(2011-2#2)(2012-12#2)(2013-8#1)
regulate glucose##3##2##(2005-8#1)(2008-1#1)(2011-2#1)
regulate growth##4##2##(1993-12#1)(1995-5#1)(1996-4#1)(2010-12#1)
regulate immune##2##2##(2007-2#1)(2012-12#1)
regulate inflammation##4##2##(2008-7#1)(2011-2#1)(2012-1#2)
regulate inflammatory##2##2##(1995-12#1)(2006-10#1)
regulate insulin##3##2##(1997-4#1)(2011-1#1)(2013-1#1)
regulate intestinal##2##2##(1992-6#1)(2008-7#1)
regulate intracellular##3##2##(2008-1#1)(2008-7#1)(2010-12#1)
regulate its expression##3##3##(1995-8#1)(2007-12#1)(2012-2#1)
regulate its own##2##3##(1994-3#1)(1997-4#1)
regulate its##10##2##(1993-3#1)(1994-3#1)(1994-9#1)(1995-8#1)(1997-4#1)(2005-9#1)(2007-12#1)(2008-11#1)(2012-2#1)(2013-8#1)
regulate lipid metabolism##2##3##(1990-3#1)(2012-12#1)
regulate many##4##2##(1991-5#1)(2008-4#1)(2008-8#1)(2010-10#1)
regulate market share##2##3##(1996-12#1)(1997-2#1)
regulate molecular##2##2##(2009-2#1)(2009-8#1)
regulate multiple aspects of##3##4##(2005-7#1)(2006-11#1)(2013-1#1)
regulate multiple##4##2##(2005-7#1)(2006-11#1)(2007-12#1)(2013-1#1)
regulate neuronal##8##2##(1990-7#1)(1994-6#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2013-1#1)(2013-8#1)
regulate neurotransmitter release##2##3##(1995-12#1)(2007-10#1)
regulate neurotransmitter##3##2##(1995-12#1)(1996-12#1)(2007-10#1)
regulate oxidative##2##2##(2008-4#1)(2010-3#1)
regulate plant##2##2##(2008-8#1)(2009-6#1)
regulate proliferation of##2##3##(1996-5#1)(2010-3#1)
regulate protein##2##2##(2006-8#1)(2008-1#1)
regulate some##3##2##(1991-1#1)(1994-10#1)(2007-8#1)
regulate specific##2##2##(1995-2#1)(2009-5#1)
regulate such##3##2##(2006-12#1)(2009-8#1)(2011-2#1)
regulate synaptic##2##2##(2008-4#1)(2008-7#1)
regulate the activities of##2##4##(1993-4#1)(1994-9#1)
regulate the activity of the##5##5##(1995-6#1)(1996-5#1)(1996-9#1)(2008-8#1)(2008-9#1)
regulate the activity of##13##4##(1991-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-8#1)(2008-1#1)(2008-8#1)(2008-9#1)(2009-8#1)
regulate the cell##3##3##(1994-11#1)(2008-11#1)(2012-3#1)
regulate the cellular##2##3##(1991-9#1)(1992-8#1)
regulate the development of##3##4##(1991-11#1)(2008-9#1)(2010-5#1)
regulate the expression of a##3##5##(1995-12#1)(2010-8#1)(2012-12#1)
regulate the expression of the##5##5##(1992-6#1)(1992-8#1)(1993-12#1)(1994-5#1)(2008-11#1)
regulate the expression of##24##4##(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-9#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-12#1)(2010-1#1)(2010-8#1)(2011-2#3)(2012-12#3)(2012-3#1)
regulate the function of##2##4##(2007-12#1)(2012-12#1)
regulate the gene expression##3##4##(2008-10#1)(2008-9#1)(2011-2#1)
regulate the gene##4##3##(1995-6#1)(2008-10#1)(2008-9#1)(2011-2#1)
regulate the maintenance of##2##4##(2007-10#1)(2008-7#1)
regulate the rate of##3##4##(1990-8#1)(2008-10#1)(2012-2#1)
regulate the survival##2##3##(1996-12#1)(1996-3#1)
regulate the synthesis##2##3##(1995-3#1)(2010-9#1)
regulate the transcription of##3##4##(1994-9#2)(1996-10#1)
regulate the##146##2##(1990-2#1)(1990-8#3)(1991-1#1)(1991-11#2)(1991-12#2)(1991-3#1)(1991-9#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-5#1)(1994-9#4)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#4)(1995-8#2)(1995-9#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-6#2)(1997-8#2)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#1)(2007-10#2)(2007-12#2)(2007-2#2)(2008-1#3)(2008-10#6)(2008-11#4)(2008-12#1)(2008-4#8)(2008-5#4)(2008-7#2)(2008-8#3)(2008-9#5)(2009-10#2)(2009-12#1)(2009-3#1)(2009-8#3)(2010-1#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-1#1)(2012-12#8)(2012-2#7)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
regulate their##10##2##(1995-12#1)(1995-8#2)(1996-3#1)(2008-10#1)(2009-3#1)(2009-6#1)(2012-12#1)(2012-2#1)(2013-1#1)
regulate these##2##2##(1992-3#1)(2012-2#1)
regulate this process##2##3##(2007-12#1)(2008-7#1)
regulate this##5##2##(2007-12#2)(2008-7#1)(2009-6#1)(2009-8#1)
regulate tissue##2##2##(1991-12#1)(2008-4#1)
regulate tissue-specific##2##2##(1992-1#1)(1993-3#1)
regulate transcription and replication##2##4##(1997-2#1)(1997-4#1)
regulate transcription in myeloid##2##4##(1991-12#1)(1995-1#1)
regulate transcription in##3##3##(1991-12#1)(1991-2#1)(1995-1#1)
regulate transcription##10##2##(1991-12#1)(1991-2#1)(1994-6#1)(1995-1#1)(1995-2#2)(1997-2#1)(1997-4#1)(2008-9#1)(2011-2#1)
regulate transcriptional##2##2##(1995-6#1)(1997-7#1)
regulate vascular tone##3##3##(1995-2#1)(2010-10#1)(2012-4#1)
regulate vascular##4##2##(1995-2#1)(1995-8#1)(2010-10#1)(2012-4#1)
regulate##593##1##(1990-11#3)(1990-2#3)(1990-3#3)(1990-7#3)(1990-8#4)(1991-1#2)(1991-11#3)(1991-12#7)(1991-2#2)(1991-3#4)(1991-5#3)(1991-8#1)(1991-9#3)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#3)(1993-2#1)(1993-3#4)(1993-4#1)(1993-5#2)(1993-6#3)(1993-9#4)(1994-10#2)(1994-11#5)(1994-12#5)(1994-2#3)(1994-3#3)(1994-4#1)(1994-5#2)(1994-6#3)(1994-8#3)(1994-9#7)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#6)(1995-2#10)(1995-3#4)(1995-5#3)(1995-6#9)(1995-7#1)(1995-8#11)(1995-9#1)(1996-10#3)(1996-11#2)(1996-12#4)(1996-2#8)(1996-3#3)(1996-4#1)(1996-5#6)(1996-6#2)(1996-7#1)(1996-8#4)(1996-9#2)(1997-1#1)(1997-2#3)(1997-4#7)(1997-6#5)(1997-7#4)(1997-8#2)(2003-11#1)(2005-1#1)(2005-10#2)(2005-11#4)(2005-12#1)(2005-7#7)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#11)(2006-11#3)(2006-12#2)(2006-2#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#4)(2007-11#1)(2007-12#16)(2007-2#3)(2007-4#1)(2007-7#1)(2007-8#6)(2008-1#11)(2008-10#13)(2008-11#18)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#25)(2008-5#7)(2008-6#2)(2008-7#14)(2008-8#15)(2008-9#11)(2009-10#8)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#5)(2009-4#5)(2009-5#3)(2009-6#4)(2009-7#1)(2009-8#18)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#2)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#3)(2011-11#1)(2011-12#2)(2011-2#13)(2012-1#8)(2012-11#3)(2012-12#26)(2012-2#27)(2012-3#7)(2012-4#1)(2013-1#11)(2013-7#1)(2013-8#7)
regulated alternative##2##2##(1992-6#1)(2007-12#1)
regulated and constitutive secretory##4##4##(1991-1#1)(1992-12#3)
regulated and constitutive##6##3##(1991-1#2)(1992-12#4)
regulated and##25##2##(1990-7#1)(1991-1#2)(1992-12#4)(1992-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-3#1)(2006-10#1)(2006-2#1)(2008-5#1)(2008-7#2)(2009-8#2)(2010-9#1)(2012-12#2)(2012-2#1)(2013-8#1)
regulated are##2##2##(2008-9#1)(2012-2#1)
regulated as##2##2##(1992-3#1)(2009-3#1)
regulated at a##2##3##(1993-2#1)(2010-11#1)
regulated at the level of##3##5##(1990-12#1)(1992-3#1)(2008-1#1)
regulated at the transcriptional level by##3##6##(1993-4#1)(1995-2#1)(2009-8#1)
regulated at the transcriptional level##5##5##(1991-12#1)(1993-4#1)(1993-6#1)(1995-2#1)(2009-8#1)
regulated at the transcriptional##6##4##(1991-12#1)(1993-4#1)(1993-6#1)(1995-2#1)(1997-4#1)(2009-8#1)
regulated at the##15##3##(1990-12#1)(1990-2#1)(1991-12#1)(1992-3#1)(1992-8#1)(1993-4#1)(1993-6#1)(1995-2#1)(1995-3#1)(1997-4#1)(2008-1#1)(2009-6#1)(2009-8#2)(2013-1#1)
regulated at translation level##2##4##(2008-9#2)
regulated at##25##2##(1990-12#1)(1990-2#1)(1991-12#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-11#1)(1995-2#1)(1995-3#1)(1997-4#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-9#2)(2009-6#1)(2009-8#3)(2010-11#1)(2010-12#1)(2013-1#2)
regulated both##4##2##(1992-11#2)(2007-2#1)(2007-7#1)
regulated by 1##2##3##(1993-3#1)(2012-12#1)
regulated by Ca(2+)##4##3##(2004-12#1)(2006-10#1)(2008-8#2)
regulated by Ca2+##3##3##(1992-6#1)(1994-6#1)(1995-6#1)
regulated by RA in##2##4##(1994-8#2)
regulated by Se##2##3##(1991-12#1)(2012-2#1)
regulated by a balance between##2##5##(1990-5#1)(2007-10#1)
regulated by a balance##3##4##(1990-5#1)(2007-10#1)(2013-1#1)
regulated by a complex##4##4##(1992-8#1)(2009-8#1)(2010-8#1)(2012-2#1)
regulated by a number of##3##5##(1990-9#1)(2008-4#1)(2010-2#1)
regulated by a protein kinase##3##5##(1993-3#1)(1997-1#1)(1997-5#1)
regulated by a variety of cellular##2##6##(1993-12#1)(2006-10#1)
regulated by a variety of##3##5##(1993-12#1)(1995-6#1)(2006-10#1)
regulated by a##34##3##(1990-5#2)(1990-9#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-5#1)(1997-1#1)(1997-4#1)(1997-5#2)(2006-10#1)(2007-10#1)(2007-12#2)(2008-11#1)(2008-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-1#2)(2012-2#1)(2013-1#1)
regulated by alternative##2##3##(1996-5#1)(1997-4#1)
regulated by an##6##3##(1995-11#1)(1996-4#1)(2006-10#1)(2008-10#1)(2008-5#1)(2013-7#1)
regulated by androgens##2##3##(1993-6#1)(1995-12#1)
regulated by calcium##3##3##(1992-8#1)(2008-4#1)(2013-8#1)
regulated by carbon sources##2##4##(1991-9#2)
regulated by cell##3##3##(1994-3#1)(1995-8#1)(2010-7#1)
regulated by covalent modification##2##4##(1990-8#2)
regulated by either##2##3##(2007-12#1)(2010-10#1)
regulated by endogenous##3##3##(1994-9#1)(1996-10#1)(2008-1#1)
regulated by environmental factors##2##4##(2008-4#1)(2009-8#1)
regulated by extracellular##2##3##(1992-8#1)(2011-2#1)
regulated by genetic##2##3##(2008-2#1)(2013-1#1)
regulated by glucose##4##3##(1995-5#1)(1995-6#1)(1995-8#1)(1997-4#1)
regulated by hormones##2##3##(1994-6#1)(2009-5#1)
regulated by intracellular##3##3##(1995-11#1)(1995-6#1)(2008-8#1)
regulated by its##2##3##(1991-9#1)(1995-1#1)
regulated by mechanisms##2##3##(1992-5#1)(2009-6#1)
regulated by multiple##8##3##(1995-1#1)(1996-4#1)(1997-7#1)(2007-12#1)(2009-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
regulated by nerve growth factor##2##5##(1992-9#1)(1995-8#1)
regulated by neurotransmitters and##2##4##(2008-1#1)(2008-12#1)
regulated by p53##3##3##(1997-2#2)(2010-12#1)
regulated by phosphorylation of##4##4##(1993-8#1)(1994-3#1)(1996-8#1)(1997-2#1)
regulated by phosphorylation##7##3##(1991-9#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-3#1)(1996-8#1)(1997-2#1)
regulated by protein kinase A##2##5##(1991-2#1)(2008-8#1)
regulated by protein kinase##3##4##(1990-7#1)(1991-2#1)(2008-8#1)
regulated by protein##4##3##(1990-7#1)(1991-2#1)(1993-8#1)(2008-8#1)
regulated by several##2##3##(2008-7#1)(2008-8#1)
regulated by sex##2##3##(1994-3#1)(2010-10#1)
regulated by specific##3##3##(1997-4#1)(2007-1#1)(2011-1#1)
regulated by tetracycline##2##3##(2008-2#1)(2013-1#1)
regulated by the##56##3##(1990-12#1)(1990-4#2)(1990-5#1)(1990-9#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-11#1)(1993-12#1)(1993-6#2)(1994-1#1)(1994-10#1)(1994-12#4)(1994-9#1)(1995-10#1)(1995-2#3)(1995-3#1)(1995-8#1)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(2005-11#2)(2006-1#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-2#1)(2010-4#1)(2010-8#1)(2013-1#1)(2013-8#1)
regulated by these##2##3##(1997-2#1)(1997-7#1)
regulated by thyroid hormone in##2##5##(1992-5#2)
regulated by two##8##3##(1991-4#1)(1992-5#1)(1994-12#1)(1994-5#1)(1995-10#1)(1995-8#1)(2008-9#1)(2011-2#1)
regulated by various##4##3##(1994-8#1)(2006-10#1)(2008-4#2)
regulated by##398##2##(1990-10#2)(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#4)(1990-7#2)(1990-8#3)(1990-9#2)(1991-1#2)(1991-10#1)(1991-12#2)(1991-2#4)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#5)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#5)(1992-6#1)(1992-8#4)(1992-9#2)(1993-11#4)(1993-12#4)(1993-3#4)(1993-5#2)(1993-6#5)(1993-8#4)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#10)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#5)(1994-8#6)(1994-9#2)(1995-1#2)(1995-10#3)(1995-11#7)(1995-12#4)(1995-2#6)(1995-3#9)(1995-5#3)(1995-6#6)(1995-8#10)(1996-1#2)(1996-10#2)(1996-11#2)(1996-12#1)(1996-2#4)(1996-3#3)(1996-4#4)(1996-5#7)(1996-6#1)(1996-7#1)(1996-8#5)(1997-1#1)(1997-2#7)(1997-3#1)(1997-4#7)(1997-5#4)(1997-6#3)(1997-7#4)(2003-11#1)(2004-12#1)(2005-10#1)(2005-11#3)(2005-7#1)(2006-1#1)(2006-10#6)(2006-12#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#10)(2007-3#1)(2007-8#1)(2008-1#8)(2008-10#5)(2008-11#5)(2008-12#1)(2008-2#3)(2008-4#13)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#9)(2008-9#4)(2009-10#1)(2009-3#5)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#14)(2009-9#1)(2010-10#5)(2010-11#1)(2010-12#5)(2010-2#3)(2010-3#1)(2010-4#3)(2010-5#2)(2010-7#1)(2010-8#3)(2011-1#6)(2011-10#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#7)
regulated directly by##3##3##(1991-6#1)(2008-8#1)(2010-3#1)
regulated during oogenesis##2##3##(2009-3#2)
regulated during the##2##3##(1991-9#1)(1994-9#1)
regulated during##19##2##(1990-11#1)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1993-3#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-3#1)(1997-4#1)(2008-4#1)(2008-8#1)(2009-3#3)(2010-10#1)(2010-8#1)
regulated environment##2##2##(1995-1#1)(1997-5#1)
regulated enzyme##3##2##(1996-5#1)(1997-2#1)(2006-10#1)
regulated events##2##2##(1994-8#1)(2005-11#1)
regulated exocytosis##7##2##(1992-8#2)(1993-3#2)(1996-5#1)(2008-1#2)
regulated expression in##2##3##(1995-3#1)(1995-4#1)
regulated expression of the##2##4##(1992-6#1)(2008-11#1)
regulated expression of##7##3##(1992-6#1)(1993-3#1)(1993-9#2)(1997-4#1)(2008-11#2)
regulated expression##11##2##(1992-4#1)(1992-6#1)(1993-3#1)(1993-9#2)(1995-3#1)(1995-4#1)(1997-4#1)(2008-11#3)
regulated gene expression##2##3##(1995-11#1)(2009-8#1)
regulated gene##5##2##(1992-11#1)(1995-1#1)(1995-11#1)(2008-8#1)(2009-8#1)
regulated genes##3##2##(1992-6#1)(1993-6#1)(2008-7#1)
regulated has##2##2##(2008-11#1)(2008-9#1)
regulated health##2##2##(1994-3#1)(2006-2#1)
regulated in a cell cycle-dependent##2##5##(1995-2#1)(1996-1#1)
regulated in a tissue-specific##2##4##(1991-12#2)
regulated in a##10##3##(1991-12#2)(1993-3#2)(1993-8#1)(1995-2#1)(1996-1#1)(1997-2#1)(2005-7#1)(2008-8#1)
regulated in human##3##3##(1991-11#1)(1995-6#1)(2009-4#1)
regulated in part by the##2##5##(2008-4#1)(2012-1#1)
regulated in part by##5##4##(1995-1#1)(1995-3#1)(2008-4#2)(2012-1#1)
regulated in response to##9##4##(1993-6#1)(1994-8#1)(1996-2#1)(2006-3#1)(2007-8#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
regulated in the cell##2##4##(1996-4#1)(2011-2#1)
regulated in the##15##3##(1991-11#1)(1992-3#1)(1993-5#1)(1996-4#2)(1997-2#1)(2005-10#1)(2006-11#1)(2008-10#3)(2008-5#1)(2009-3#1)(2010-12#1)(2011-2#1)
regulated in vitro##3##3##(1991-12#1)(1991-3#1)(1997-6#1)
regulated in vivo##2##3##(1994-11#1)(2012-12#1)
regulated in##65##2##(1990-11#1)(1990-7#1)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#1)(1992-3#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-8#1)(1995-1#1)(1995-10#2)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#1)(1996-2#2)(1996-4#2)(1997-2#2)(1997-4#1)(1997-6#1)(2005-10#1)(2005-7#1)(2006-11#1)(2006-3#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-4#2)(2008-5#1)(2008-8#1)(2009-3#2)(2009-4#1)(2009-8#2)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
regulated independently of the##2##4##(1991-10#1)(2005-8#1)
regulated independently##4##2##(1991-10#1)(1995-9#1)(2005-8#1)(2008-11#1)
regulated insulin##2##2##(1995-1#1)(2010-11#1)
regulated interactions##2##2##(1994-12#1)(2009-12#1)
regulated kinase##3##2##(1996-5#1)(1997-4#1)(2008-4#1)
regulated kinases##2##2##(1994-8#1)(2008-4#1)
regulated mainly##2##2##(1993-6#1)(2008-5#1)
regulated manner##6##2##(1994-9#1)(2008-1#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
regulated membrane fusion##2##3##(2009-7#1)(2012-2#1)
regulated on##2##2##(1991-12#1)(2006-9#1)
regulated or##4##2##(1991-12#1)(2006-2#1)(2008-5#1)(2008-8#1)
regulated primarily##3##2##(1990-12#1)(2007-12#1)(2008-9#1)
regulated process##3##2##(2006-2#1)(2008-1#1)(2012-2#1)
regulated processes##2##2##(2009-8#1)(2011-2#1)
regulated proliferation##2##2##(2009-8#1)(2011-1#1)
regulated protein##5##2##(1990-2#1)(1996-2#1)(1997-6#1)(2008-4#1)(2008-8#1)
regulated proteins##5##2##(1994-12#1)(1996-5#1)(2008-4#1)(2008-8#1)(2009-2#1)
regulated secretion##4##2##(1991-1#2)(1994-12#1)(2010-11#1)
regulated secretory granules##2##3##(1992-12#2)
regulated secretory##9##2##(1990-5#2)(1992-12#2)(1993-5#1)(1994-11#2)(1996-4#1)(2010-11#1)
regulated system##3##2##(1990-4#1)(1990-8#1)(2008-11#1)
regulated the expression of##2##4##(1997-7#1)(2008-11#1)
regulated the##9##2##(1997-7#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)(2009-4#1)(2013-1#1)
regulated through the##5##3##(1995-11#1)(1996-5#1)(2006-10#1)(2012-12#1)(2012-2#1)
regulated through##13##2##(1992-6#1)(1993-6#1)(1993-9#1)(1995-11#1)(1995-3#1)(1996-5#1)(2005-8#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-4#1)(2012-12#1)(2012-2#1)
regulated to##5##2##(1991-11#1)(1993-5#1)(2008-5#1)(2009-9#1)(2013-8#1)
regulated transcription##5##2##(1990-9#1)(1992-12#1)(1995-1#2)(1997-4#1)
regulated under##3##2##(1996-3#1)(2008-5#1)(2009-9#1)
regulated via##6##2##(1990-5#1)(1993-6#1)(1996-7#1)(1997-1#1)(2008-4#1)(2008-9#1)
regulated with##3##2##(1991-9#1)(1997-1#1)(2012-1#1)
regulated##900##1##(1990-10#3)(1990-11#7)(1990-12#3)(1990-2#3)(1990-3#2)(1990-4#4)(1990-5#8)(1990-7#4)(1990-8#4)(1990-9#3)(1991-1#6)(1991-10#2)(1991-11#3)(1991-12#8)(1991-2#5)(1991-3#5)(1991-4#2)(1991-5#4)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#8)(1992-11#7)(1992-12#8)(1992-2#3)(1992-3#6)(1992-4#2)(1992-5#6)(1992-6#6)(1992-8#7)(1992-9#3)(1993-11#4)(1993-12#4)(1993-2#3)(1993-3#11)(1993-4#1)(1993-5#6)(1993-6#13)(1993-8#6)(1993-9#3)(1994-1#2)(1994-10#1)(1994-11#13)(1994-12#23)(1994-2#4)(1994-3#7)(1994-5#2)(1994-6#5)(1994-8#12)(1994-9#12)(1995-1#10)(1995-10#8)(1995-11#10)(1995-12#6)(1995-2#14)(1995-3#18)(1995-4#2)(1995-5#3)(1995-6#11)(1995-8#12)(1995-9#1)(1996-1#3)(1996-10#3)(1996-11#5)(1996-12#1)(1996-2#7)(1996-3#6)(1996-4#8)(1996-5#15)(1996-6#1)(1996-7#2)(1996-8#7)(1997-1#3)(1997-2#12)(1997-3#1)(1997-4#16)(1997-5#6)(1997-6#9)(1997-7#6)(2003-11#2)(2004-12#1)(2005-10#2)(2005-11#5)(2005-3#1)(2005-7#2)(2005-8#3)(2006-1#1)(2006-10#17)(2006-11#2)(2006-12#1)(2006-2#5)(2006-3#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#14)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#17)(2008-10#20)(2008-11#18)(2008-12#3)(2008-2#6)(2008-3#1)(2008-4#34)(2008-5#11)(2008-6#1)(2008-7#9)(2008-8#19)(2008-9#17)(2009-10#3)(2009-12#2)(2009-2#1)(2009-3#11)(2009-4#3)(2009-5#3)(2009-6#5)(2009-7#2)(2009-8#29)(2009-9#3)(2010-10#6)(2010-11#7)(2010-12#10)(2010-2#3)(2010-3#3)(2010-4#4)(2010-5#2)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#11)(2011-10#1)(2011-2#16)(2012-1#4)(2012-11#2)(2012-12#10)(2012-2#17)(2012-3#2)(2013-1#15)(2013-7#1)(2013-8#11)
regulated)##2##1##(1994-12#1)(2008-11#1)
regulated?##4##1##(1991-6#1)(1992-8#1)(1997-6#1)(2009-8#1)
regulates ERK##2##2##(2009-8#1)(2010-10#1)
regulates a##5##2##(1995-12#1)(2008-11#1)(2008-8#1)(2010-9#1)(2011-2#1)
regulates activities of##2##3##(1993-8#1)(2008-4#1)
regulates all##2##2##(2007-12#1)(2011-2#1)
regulates alternative##2##2##(1996-11#1)(1996-5#1)
regulates and##2##2##(2009-10#1)(2011-2#1)
regulates calcium and phosphates homeostasis##2##5##(2010-12#2)
regulates cell division##3##3##(1996-4#1)(2009-8#2)
regulates cell##9##2##(1991-11#1)(1996-4#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-8#3)(2010-12#1)
regulates cellular##2##2##(2008-8#1)(2012-2#1)
regulates diverse##2##2##(2008-5#1)(2012-12#1)
regulates energy balance##4##3##(1995-12#3)(2011-2#1)
regulates gene expression##2##3##(1996-4#1)(1997-4#1)
regulates gene##4##2##(1995-2#1)(1996-4#1)(1997-4#1)(2011-2#1)
regulates human##3##2##(1995-10#1)(2009-3#1)(2012-7#1)
regulates insulin##3##2##(1990-8#1)(1997-4#2)
regulates its expression##2##3##(1990-9#1)(1994-11#1)
regulates its##5##2##(1990-9#1)(1994-11#1)(2006-12#1)(2008-8#1)(2009-9#1)
regulates mammalian##2##2##(2008-9#1)(2012-2#1)
regulates many##3##2##(1990-2#1)(2008-1#1)(2010-7#1)
regulates migration of##3##3##(1995-8#1)(2010-12#1)(2010-8#1)
regulates multiple##3##2##(1995-11#1)(1995-3#1)(2012-3#1)
regulates osteoclast##2##2##(1991-12#1)(2012-3#1)
regulates photoreceptor specification##2##3##(2007-12#2)
regulates protein F1 phosphorylation##2##4##(1990-9#2)
regulates protein##3##2##(1990-9#2)(2006-10#1)
regulates several##2##2##(2008-1#1)(2008-10#1)
regulates the activity of##3##4##(1993-6#1)(1994-10#1)(1996-5#1)
regulates the assembly##2##3##(2007-8#1)(2008-1#1)
regulates the expression of##9##4##(1990-6#1)(1991-9#1)(1992-3#1)(1992-8#1)(1994-12#2)(1994-9#1)(2009-4#1)(2010-7#1)
regulates the growth of##2##4##(1990-7#1)(1994-11#1)
regulates the growth##3##3##(1990-7#1)(1994-11#1)(1995-3#1)
regulates the intracellular##3##3##(1997-6#1)(2008-4#1)(2008-9#1)
regulates the message##2##3##(1994-2#2)
regulates the proliferation and##2##4##(1990-4#1)(2013-1#1)
regulates the stability of##2##4##(1994-9#1)(2009-8#1)
regulates the synthesis##2##3##(1992-11#1)(1997-4#1)
regulates the##78##2##(1990-10#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#2)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#2)(1992-8#1)(1993-6#2)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#2)(1994-9#5)(1995-2#1)(1995-3#1)(1995-7#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-4#5)(1997-6#3)(2005-7#1)(2005-8#1)(2006-10#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#2)(2013-1#3)
regulates transcription of IGF-I mRNAs that contain exon##2##8##(1995-10#2)
regulates transcription of##3##3##(1995-10#2)(2012-12#1)
regulates tumor cell##2##3##(2009-3#1)(2011-1#1)
regulates β-cell function##3##3##(2012-2#3)
regulates##303##1##(1990-10#2)(1990-2#1)(1990-4#2)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#2)(1990-9#3)(1991-10#1)(1991-11#2)(1991-12#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-3#2)(1992-5#1)(1992-7#1)(1992-8#2)(1993-6#3)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#4)(1994-2#3)(1994-3#1)(1994-6#3)(1994-8#2)(1994-9#8)(1995-10#3)(1995-11#3)(1995-12#9)(1995-2#4)(1995-3#4)(1995-6#3)(1995-7#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#3)(1996-5#3)(1996-7#1)(1996-8#1)(1997-4#11)(1997-5#1)(1997-6#5)(1997-7#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#1)(2007-10#1)(2007-12#6)(2007-8#2)(2007-9#2)(2008-1#6)(2008-10#4)(2008-11#4)(2008-4#10)(2008-5#3)(2008-7#3)(2008-8#8)(2008-9#4)(2009-10#2)(2009-3#5)(2009-4#1)(2009-6#5)(2009-7#2)(2009-8#13)(2009-9#2)(2010-10#3)(2010-11#2)(2010-12#10)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#5)(2011-2#12)(2012-11#1)(2012-12#17)(2012-2#13)(2012-3#5)(2012-7#1)(2013-1#6)(2013-8#2)
regulating Notch##2##2##(2010-3#2)
regulating actin##2##2##(2008-1#1)(2009-8#1)
regulating activity of##3##3##(1993-3#1)(1993-8#1)(1996-4#1)
regulating activity##4##2##(1993-3#1)(1993-8#1)(1996-4#1)(2009-5#1)
regulating and##2##2##(1995-5#1)(2009-3#1)
regulating angiogenesis##3##2##(2008-9#2)(2013-1#1)
regulating apoptosis##4##2##(2005-8#1)(2006-2#1)(2007-8#1)(2008-9#1)
regulating biological##2##2##(2009-5#1)(2010-5#1)
regulating body temperature##2##3##(1995-8#1)(2013-1#1)
regulating body weight##2##3##(1996-2#2)
regulating body##4##2##(1995-8#1)(1996-2#2)(2013-1#1)
regulating bone##4##2##(1997-7#1)(2007-7#1)(2009-4#1)(2010-10#1)
regulating both##3##2##(2006-10#1)(2007-10#1)(2009-8#1)
regulating cell growth##3##3##(1992-9#1)(2008-5#1)(2009-9#1)
regulating cell proliferation during wing disc development##2##7##(2012-12#2)
regulating cell proliferation##3##3##(1991-12#1)(2012-12#2)
regulating cell survival##2##3##(1995-12#1)(2011-2#1)
regulating cell##19##2##(1991-12#1)(1992-9#1)(1993-11#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-6#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#2)(2009-9#1)(2010-9#1)(2011-2#1)(2012-12#3)
regulating cellular##4##2##(1995-2#1)(2006-2#1)(2008-1#1)(2009-10#1)
regulating diverse##2##2##(1997-4#1)(2008-7#1)
regulating energy##4##2##(2008-10#1)(2008-3#2)(2011-1#1)
regulating expression of##5##3##(1991-4#1)(1991-6#1)(1992-5#1)(1995-8#1)(2010-8#1)
regulating expression##7##2##(1991-4#1)(1991-6#1)(1992-5#1)(1995-8#1)(2008-11#1)(2008-4#1)(2010-8#1)
regulating factors##2##2##(1996-7#1)(2008-7#1)
regulating gene expression and##2##4##(2007-12#1)(2008-4#1)
regulating gene expression##8##3##(1993-3#1)(1995-2#1)(1996-3#1)(2007-12#2)(2008-4#2)(2010-12#1)
regulating hormone##2##2##(2008-4#1)(2008-5#1)
regulating hospital##2##2##(1993-3#1)(1996-2#1)
regulating insulin secretion##3##3##(2008-1#1)(2008-4#1)(2010-11#1)
regulating its##4##2##(1995-2#1)(1995-6#1)(2010-3#1)(2010-8#1)
regulating lipid metabolism##2##3##(2006-2#1)(2008-9#1)
regulating lipid##4##2##(2006-2#1)(2008-1#1)(2008-9#1)(2010-2#1)
regulating myocardial##2##2##(2010-5#1)(2012-3#1)
regulating pancreatic##2##2##(2006-10#2)
regulating physiological##2##2##(2009-6#1)(2010-10#1)
regulating protein synthesis##2##3##(1996-5#1)(2012-2#1)
regulating protein##3##2##(1996-10#1)(1996-5#1)(2012-2#1)
regulating proteins##4##2##(1994-6#1)(2008-9#2)(2012-2#1)
regulating seed germination##2##3##(2009-8#1)(2011-12#1)
regulating several##2##2##(2013-1#1)(2013-8#1)
regulating stomatal##3##2##(1994-11#1)(2008-8#2)
regulating the activation of##2##4##(2007-11#1)(2008-4#1)
regulating the activity of##4##4##(1995-1#1)(1997-1#1)(1997-2#1)(2003-11#1)
regulating the binding of##2##4##(1996-5#1)(2011-2#1)
regulating the dynamics of##2##4##(2009-8#1)(2012-2#1)
regulating the expression of the##4##5##(1992-6#1)(1997-7#2)(1997-8#1)
regulating the expression of##12##4##(1992-3#1)(1992-6#1)(1997-7#2)(1997-8#1)(2008-8#1)(2009-8#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-12#2)
regulating the functions of##3##4##(1990-3#1)(2009-9#1)(2010-11#1)
regulating the level of##2##4##(1992-6#1)(2009-8#1)
regulating the level##3##3##(1992-6#1)(2008-11#1)(2009-8#1)
regulating the production of##2##4##(1994-5#1)(2011-2#1)
regulating the rate##2##3##(1993-12#1)(2009-5#1)
regulating the response to##2##4##(1997-5#1)(2008-5#1)
regulating the synthesis##2##3##(1997-8#1)(2013-1#1)
regulating the##131##2##(1990-11#1)(1990-3#1)(1991-1#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#1)(1994-11#2)(1994-5#2)(1995-1#2)(1995-2#1)(1995-3#1)(1995-8#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#2)(2003-11#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-6#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#4)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#6)(2009-9#3)(2010-10#1)(2010-11#2)(2010-3#3)(2010-7#1)(2011-1#3)(2011-2#5)(2011-3#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#3)
regulating their##4##2##(1995-8#1)(1996-12#1)(2008-5#1)(2013-1#1)
regulating these processes##4##3##(1997-6#1)(2005-8#1)(2007-11#1)(2008-1#1)
regulating these##7##2##(1997-6#1)(1997-7#1)(2005-8#1)(2007-11#1)(2008-1#1)(2013-1#1)(2013-7#1)
regulating transcription##4##2##(1993-3#1)(1995-2#1)(2008-4#1)(2011-2#1)
regulating various##2##2##(2009-6#1)(2012-12#1)
regulating vascular tone##2##3##(1994-6#1)(1995-12#1)
regulating β-cell mass##2##3##(2010-11#2)
regulating##467##1##(1990-11#2)(1990-2#1)(1990-3#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#3)(1991-6#3)(1991-7#2)(1991-8#1)(1992-1#1)(1992-11#3)(1992-12#3)(1992-3#2)(1992-5#3)(1992-6#3)(1992-8#1)(1992-9#2)(1993-11#4)(1993-12#1)(1993-2#2)(1993-3#4)(1993-4#1)(1993-5#2)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#8)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#3)(1994-9#3)(1995-1#3)(1995-11#1)(1995-12#5)(1995-2#10)(1995-3#5)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#7)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#6)(1996-3#3)(1996-4#2)(1996-5#6)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-5#4)(1997-6#5)(1997-7#6)(1997-8#3)(1997-9#1)(2003-11#1)(2004-2#1)(2005-1#1)(2005-10#3)(2005-11#2)(2005-12#1)(2005-7#3)(2005-8#4)(2006-1#2)(2006-10#7)(2006-2#3)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#8)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#10)(2008-10#5)(2008-11#15)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#16)(2008-5#7)(2008-6#3)(2008-7#6)(2008-8#16)(2008-9#8)(2009-10#6)(2009-11#1)(2009-3#3)(2009-4#3)(2009-5#4)(2009-6#2)(2009-8#16)(2009-9#6)(2010-1#1)(2010-10#3)(2010-11#5)(2010-12#1)(2010-2#3)(2010-3#7)(2010-5#3)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#6)(2011-10#2)(2011-12#2)(2011-2#13)(2011-3#1)(2012-1#2)(2012-11#4)(2012-12#14)(2012-2#11)(2012-3#6)(2013-1#13)(2013-7#4)(2013-8#6)
regulation 21 CFR Part 11##2##5##(2008-10#2)
regulation allowing##2##2##(1995-2#1)(2008-2#1)
regulation among##2##2##(2008-7#1)(2012-2#1)
regulation and apoptosis##5##3##(1995-2#3)(2011-1#1)(2011-2#1)
regulation and control##2##3##(1995-2#1)(2008-9#1)
regulation and expression of the creatine transporter##2##7##(2008-5#2)
regulation and expression of##3##4##(2008-5#2)(2012-12#1)
regulation and function of##4##4##(2008-10#1)(2008-4#1)(2010-9#1)(2011-1#1)
regulation and function##7##3##(2008-10#1)(2008-11#1)(2008-4#2)(2010-9#1)(2011-1#1)(2011-2#1)
regulation and protein##2##3##(2008-8#1)(2011-3#1)
regulation and that##2##3##(1994-10#1)(1996-11#1)
regulation and the##4##3##(2005-8#1)(2008-3#1)(2008-4#1)(2008-8#1)
regulation and to##4##3##(1995-2#1)(2006-10#1)(2008-8#1)(2009-3#1)
regulation and##97##2##(1990-11#1)(1990-12#2)(1990-4#1)(1990-6#1)(1991-9#1)(1992-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-2#6)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-7#1)(1996-9#1)(1997-6#1)(1997-7#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#2)(2008-7#4)(2008-8#4)(2008-9#3)(2009-3#1)(2009-4#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-12#3)(2011-2#4)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#5)
regulation appears to##2##3##(1994-5#1)(1995-1#1)
regulation appears##3##2##(1993-12#1)(1994-5#1)(1995-1#1)
regulation are##6##2##(1992-11#1)(1994-8#1)(2009-12#1)(2009-8#1)(2010-3#1)(2010-4#1)
regulation as a##3##3##(1990-12#1)(1994-8#1)(1996-1#1)
regulation as well as##2##4##(2008-11#1)(2009-8#1)
regulation as well##3##3##(2008-11#1)(2009-8#1)(2011-2#1)
regulation as##10##2##(1990-12#1)(1994-12#1)(1994-8#1)(1995-12#1)(1996-1#1)(1997-1#1)(2008-11#1)(2008-4#1)(2009-8#1)(2011-2#1)
regulation at the##2##3##(1990-8#1)(2011-2#1)
regulation at##5##2##(1990-8#1)(2007-12#1)(2011-2#2)(2012-3#1)
regulation between##3##2##(1993-11#1)(1997-6#1)(2008-7#1)
regulation but##2##2##(1997-6#1)(2010-12#1)
regulation by 1alpha##2##3##(2008-11#2)
regulation by a##3##3##(1990-2#1)(2009-6#1)(2011-1#1)
regulation by glucocorticoids##4##3##(1994-11#3)(1997-6#1)
regulation by growth##2##3##(1995-3#1)(1995-5#1)
regulation by nuclear##2##3##(1997-7#1)(2006-11#1)
regulation by serum of##2##4##(1996-2#2)
regulation by serum##3##3##(1995-9#1)(1996-2#2)
regulation by the##10##3##(1992-7#1)(1993-2#1)(1994-3#1)(1995-12#1)(1996-5#1)(2007-12#1)(2009-8#2)(2012-12#1)(2012-2#1)
regulation by these##3##3##(1992-5#1)(1993-6#1)(1995-3#1)
regulation by various##2##3##(2008-1#2)
regulation by##95##2##(1990-1#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-5#3)(1991-8#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-5#2)(1992-7#2)(1992-9#1)(1993-2#1)(1993-6#4)(1993-8#1)(1994-11#4)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#1)(1995-8#2)(1995-9#2)(1996-10#2)(1996-11#1)(1996-2#2)(1996-4#1)(1996-5#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-7#1)(2003-11#1)(2006-10#2)(2006-11#1)(2007-12#2)(2008-1#2)(2008-10#2)(2008-11#3)(2008-4#3)(2008-8#1)(2009-3#1)(2009-6#1)(2009-8#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-8#1)
regulation can##6##2##(2008-11#1)(2008-8#1)(2010-12#2)(2013-1#2)
regulation could be##2##3##(2008-8#1)(2013-8#1)
regulation did not##2##3##(1995-12#1)(2011-2#1)
regulation during##4##2##(2006-1#1)(2008-8#1)(2009-8#1)(2013-1#1)
regulation effects on##3##3##(2005-11#1)(2008-10#2)
regulation effects##4##2##(2005-11#1)(2008-10#2)(2008-9#1)
regulation factors##2##2##(2008-2#1)(2012-3#1)
regulation for the##2##3##(1993-8#1)(1997-6#1)
regulation for##11##2##(1991-2#1)(1991-3#1)(1993-8#1)(1997-6#1)(2005-10#1)(2005-7#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-8#1)
regulation function##3##2##(2008-8#1)(2011-2#1)(2012-3#1)
regulation has been##2##3##(2007-12#1)(2013-1#1)
regulation has##4##2##(2007-12#1)(2008-7#1)(2009-3#1)(2013-1#1)
regulation have##6##2##(2006-10#1)(2007-7#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#1)
regulation in C##2##3##(2007-12#1)(2010-11#1)
regulation in breast cancer##2##4##(1991-3#1)(2009-4#1)
regulation in flies##3##3##(2007-8#1)(2012-12#2)
regulation in pancreatic##2##3##(2006-10#1)(2013-7#1)
regulation in plants##2##3##(2012-2#1)(2012-3#1)
regulation in the nervous system##2##5##(1994-11#1)(1994-2#1)
regulation in the##22##3##(1990-11#1)(1990-5#1)(1991-1#1)(1992-11#1)(1993-11#1)(1993-5#1)(1994-11#2)(1994-2#1)(1995-2#1)(1997-1#1)(2006-11#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-3#1)(2011-1#1)(2012-2#1)
regulation in##85##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#1)(1991-1#2)(1991-3#1)(1991-9#1)(1992-11#2)(1992-3#2)(1993-11#2)(1993-2#1)(1993-5#1)(1994-10#1)(1994-11#3)(1994-2#2)(1994-3#1)(1994-4#1)(1995-11#1)(1995-2#3)(1995-3#1)(1995-7#1)(1996-11#1)(1996-5#1)(1997-1#1)(1997-5#1)(1997-6#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-3#2)(2008-7#6)(2008-8#3)(2008-9#4)(2009-10#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#1)(2011-1#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-7#1)(2013-8#1)
regulation involving##3##2##(1990-2#1)(2007-12#1)(2008-7#1)
regulation is achieved##2##3##(1991-6#2)
regulation is an##2##3##(1997-3#1)(2011-2#1)
regulation is associated with##2##4##(1990-8#1)(1994-10#1)
regulation is not##3##3##(2008-6#1)(2008-7#1)(2011-2#1)
regulation is##43##2##(1990-10#1)(1990-8#1)(1991-12#2)(1991-3#1)(1991-6#2)(1992-3#1)(1993-5#1)(1993-8#1)(1994-10#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-2#1)(1997-2#2)(1997-3#1)(2005-8#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-11#3)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-8#1)(2010-7#1)(2011-2#2)(2012-12#2)(2013-1#2)
regulation may be##3##3##(2005-8#1)(2008-1#1)(2010-12#1)
regulation may##5##2##(1994-12#1)(1994-2#1)(2005-8#1)(2008-1#1)(2010-12#1)
regulation mechanism of##4##3##(1997-6#1)(1997-8#1)(2008-11#1)(2008-9#1)
regulation mechanism##7##2##(1993-12#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-3#1)
regulation mechanisms of##2##3##(2008-11#1)(2008-7#1)
regulation mechanisms##5##2##(2008-11#1)(2008-7#2)(2008-8#1)(2011-1#1)
regulation might##3##2##(1992-5#1)(2007-5#1)(2012-3#1)
regulation occurs##2##2##(1990-9#1)(2008-4#1)
regulation of APP gene##3##4##(1990-8#1)(1993-11#1)(1994-9#1)
regulation of APP##4##3##(1990-8#1)(1993-11#1)(1994-9#1)(1995-6#1)
regulation of APS reductase by##2##5##(2009-8#2)
regulation of CRH##3##3##(1995-12#1)(2008-11#1)(2008-4#1)
regulation of Ca2+##5##3##(1992-9#1)(1994-2#1)(1995-11#1)(1995-6#1)(1997-7#1)
regulation of Cl-##2##3##(1991-2#1)(1994-9#1)
regulation of DNA synthesis##3##4##(1990-10#1)(1994-8#2)
regulation of DNA##4##3##(1990-10#1)(1994-8#3)
regulation of ER##3##3##(1996-11#2)(1996-3#1)
regulation of G protein##2##4##(2007-12#1)(2013-1#1)
regulation of G-protein##2##3##(1990-3#1)(1994-3#1)
regulation of Kir3 channels by##2##5##(2008-8#2)
regulation of Kir3 channels##3##4##(2008-8#3)
regulation of L1##2##3##(1994-12#2)
regulation of LPL##2##3##(1995-3#2)
regulation of NMDA receptor##2##4##(2008-8#1)(2009-3#1)
regulation of PEPCK gene expression##6##5##(1995-6#4)(1996-2#2)
regulation of PEPCK gene transcription##3##5##(1996-2#3)
regulation of PEPCK gene##9##4##(1995-6#4)(1996-2#5)
regulation of PI3K##2##3##(2010-9#2)
regulation of PLA2 activity##2##4##(1991-5#1)(1994-12#1)
regulation of RNA synthesis##2##4##(1996-2#1)(2011-1#1)
regulation of S-adenosylmethionine##2##3##(1992-8#1)(1993-4#1)
regulation of Src##2##3##(1994-9#1)(2009-7#1)
regulation of T cell##3##4##(1994-8#1)(2008-11#1)(2012-1#1)
regulation of T##5##3##(1994-8#1)(1995-1#1)(1996-10#1)(2008-11#1)(2012-1#1)
regulation of T-type##2##3##(2008-8#2)
regulation of a##13##3##(1990-11#1)(1991-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-6#1)(1997-7#1)(2006-12#1)(2007-11#1)(2007-5#1)(2008-10#1)(2010-12#1)
regulation of acid##3##3##(2006-10#1)(2008-9#2)
regulation of actin##4##3##(2009-10#1)(2009-8#1)(2010-12#1)(2012-2#1)
regulation of alpha##2##3##(1992-11#1)(1994-12#1)
regulation of alternative##2##3##(1993-5#1)(2008-4#1)
regulation of angiogenesis##3##3##(1995-2#1)(2008-1#2)
regulation of apoptosis and##2##4##(1994-10#1)(2008-7#1)
regulation of apoptosis##8##3##(1994-10#1)(1995-8#1)(2004-12#1)(2006-2#1)(2007-1#1)(2008-7#1)(2008-8#2)
regulation of appetite##2##3##(2011-2#2)
regulation of autoimmunity##2##3##(2007-12#1)(2011-2#1)
regulation of basal##7##3##(1991-11#1)(1992-2#1)(1994-11#1)(1994-12#1)(1995-5#1)(1996-5#1)(2013-1#1)
regulation of behavior##3##3##(1991-6#1)(2008-7#1)(2010-4#1)
regulation of bile##2##3##(2006-10#2)
regulation of biological##4##3##(1995-7#1)(1997-6#1)(2008-8#2)
regulation of blood pressure##6##4##(1992-8#1)(1993-12#1)(1996-11#1)(2007-1#1)(2008-1#1)(2013-1#1)
regulation of blood##9##3##(1992-12#1)(1992-8#1)(1993-12#1)(1996-11#1)(2007-1#1)(2007-11#1)(2008-1#1)(2010-11#1)(2013-1#1)
regulation of bone##2##3##(1994-11#1)(2013-1#1)
regulation of both##5##3##(1990-3#1)(1996-7#1)(2006-1#1)(2006-4#1)(2012-3#1)
regulation of brain##6##3##(1991-4#1)(1991-5#1)(1994-12#1)(1996-12#1)(2007-8#1)(2008-1#1)
regulation of cAMP##3##3##(1991-5#1)(1992-3#1)(1994-8#1)
regulation of calcium##4##3##(1990-7#1)(1995-3#1)(1995-7#1)(1997-5#1)
regulation of cancer cell##2##4##(1996-4#1)(2008-11#1)
regulation of cancer##3##3##(1996-4#1)(2008-11#1)(2012-12#1)
regulation of cardiac activity in rats##2##6##(2008-4#2)
regulation of cardiac activity##3##4##(2008-4#3)
regulation of cardiac ion channel##2##5##(2008-8#1)(2010-8#1)
regulation of cardiac##10##3##(1991-4#1)(1992-6#1)(1994-12#1)(2008-4#3)(2008-8#1)(2010-11#1)(2010-12#1)(2010-8#1)
regulation of cardiovascular##2##3##(2008-1#1)(2008-10#1)
regulation of catalysis##2##3##(1992-11#1)(1997-4#1)
regulation of cell cycle##4##4##(1993-6#1)(2009-3#1)(2012-12#1)(2012-3#1)
regulation of cell growth and differentiation##3##6##(1991-10#1)(1994-10#1)(2008-8#1)
regulation of cell growth and##5##5##(1991-10#1)(1994-10#1)(2005-8#1)(2008-4#1)(2008-8#1)
regulation of cell growth##7##4##(1991-10#1)(1994-10#1)(1994-12#1)(2005-8#1)(2007-10#1)(2008-4#1)(2008-8#1)
regulation of cell proliferation##6##4##(1991-8#1)(1993-9#1)(2008-4#3)(2008-5#1)
regulation of cell##31##3##(1991-10#1)(1991-8#1)(1992-7#1)(1992-8#1)(1993-6#1)(1993-9#1)(1994-10#2)(1994-12#1)(1995-6#1)(1996-3#1)(2005-8#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#6)(2008-5#1)(2008-8#2)(2009-3#1)(2009-8#1)(2012-12#3)(2012-3#1)
regulation of cellular proliferation##2##4##(1991-4#1)(1994-9#1)
regulation of cellular##19##3##(1991-4#1)(1991-5#1)(1992-8#1)(1993-6#1)(1994-9#1)(1995-3#1)(2007-1#3)(2007-10#1)(2007-6#1)(2008-1#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2013-7#1)
regulation of channel##2##3##(2008-8#2)
regulation of cholesterol##4##3##(1991-5#1)(1995-12#1)(2010-12#1)(2013-1#1)
regulation of clinical##2##3##(1994-12#1)(2012-3#1)
regulation of collagen synthesis##2##4##(1994-2#1)(2008-9#1)
regulation of collagen##3##3##(1994-2#1)(1996-4#1)(2008-9#1)
regulation of cytochrome##2##3##(1992-12#1)(1995-3#1)
regulation of cytokine##2##3##(1996-12#1)(1997-4#1)
regulation of developmental##2##3##(1996-10#1)(2008-8#1)
regulation of dopamine synthesis##2##4##(1997-1#2)
regulation of endocrine and##2##4##(1995-5#1)(2008-8#1)
regulation of endothelial##3##3##(2008-10#1)(2010-9#1)(2012-3#1)
regulation of energy##8##3##(1994-8#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-8#1)
regulation of eosinophil-specific genes##2##4##(2012-3#2)
regulation of erythroid-specific gene##2##4##(1995-3#1)(1996-2#1)
regulation of estrogen receptor expression in##2##6##(2006-5#2)
regulation of estrogen receptor##5##4##(1991-11#2)(1997-4#1)(2006-5#2)
regulation of estrogen##6##3##(1991-11#2)(1997-4#1)(2006-5#2)(2012-2#1)
regulation of exocrine pancreatic secretion##2##5##(2006-10#2)
regulation of expression of the gene##2##6##(1991-8#1)(2008-7#1)
regulation of expression of the##5##5##(1991-8#1)(1995-2#1)(1996-5#1)(2008-7#1)(2009-9#1)
regulation of expression of##7##4##(1991-10#1)(1991-8#1)(1995-2#1)(1996-5#1)(2007-11#1)(2008-7#1)(2009-9#1)
regulation of expression##9##3##(1991-10#1)(1991-5#1)(1991-8#1)(1995-2#1)(1995-5#1)(1996-5#1)(2007-11#1)(2008-7#1)(2009-9#1)
regulation of fluid##2##3##(2006-10#1)(2008-4#1)
regulation of gastric acid secretion##2##5##(1997-1#1)(2006-10#1)
regulation of gastric function##2##4##(1992-6#2)
regulation of gastric secretion##2##4##(1990-3#1)(1990-5#1)
regulation of gastric##7##3##(1990-3#1)(1990-5#1)(1991-9#1)(1992-6#2)(1997-1#1)(2006-10#1)
regulation of gene expression by##2##5##(2009-4#1)(2013-8#1)
regulation of gene expression in##6##5##(1994-5#1)(1997-2#1)(2007-11#1)(2008-7#1)(2011-2#1)(2012-2#1)
regulation of gene expression is##2##5##(2007-11#1)(2008-7#1)
regulation of gene expression##33##4##(1991-6#1)(1992-5#1)(1992-6#1)(1994-5#2)(1996-4#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-11#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-7#4)(2009-2#1)(2009-4#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
regulation of gene##36##3##(1990-10#1)(1991-6#1)(1992-5#1)(1992-6#1)(1994-5#2)(1996-4#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-11#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-7#4)(2009-2#1)(2009-4#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
regulation of genes involved in##3##5##(2007-8#1)(2008-1#1)(2012-12#1)
regulation of genes##7##3##(1996-12#1)(1996-4#1)(2007-8#1)(2008-1#2)(2009-12#1)(2012-12#1)
regulation of glucocorticoid receptor##2##4##(1996-7#2)
regulation of glucose sensors in##2##5##(2008-1#2)
regulation of glucose transport in##2##5##(1991-5#1)(1994-12#1)
regulation of glucose transport##4##4##(1991-5#1)(1992-11#1)(1994-12#1)(2008-1#1)
regulation of glucose##11##3##(1990-3#1)(1991-3#1)(1991-5#1)(1992-11#1)(1994-12#1)(2008-1#3)(2008-11#2)(2008-4#1)
regulation of growth and differentiation##2##5##(1990-12#1)(1991-4#1)
regulation of growth and##4##4##(1990-12#1)(1991-4#1)(1996-11#1)(1996-5#1)
regulation of growth by##2##4##(1994-10#1)(1994-8#1)
regulation of growth##12##3##(1990-12#1)(1991-1#1)(1991-4#1)(1994-10#1)(1994-8#2)(1995-11#1)(1996-11#1)(1996-5#1)(2006-6#1)(2010-5#1)(2013-1#1)
regulation of hIK1##2##3##(2008-8#2)
regulation of hepatic##2##3##(1990-3#1)(1993-8#1)
regulation of higher##2##3##(1993-11#1)(2009-2#1)
regulation of hippocampal##2##3##(1996-5#1)(2009-8#1)
regulation of hormonal##2##3##(2012-2#1)(2013-1#1)
regulation of human##15##3##(1990-2#2)(1991-12#1)(1993-2#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-6#1)(1995-2#1)(1996-10#1)(2008-1#1)(2008-4#1)
regulation of immune responses##2##4##(2011-2#1)(2013-1#1)
regulation of immune##3##3##(2011-2#1)(2013-1#2)
regulation of inflammatory##2##3##(1991-5#1)(2007-11#1)
regulation of insulin gene##2##4##(2008-1#1)(2010-11#1)
regulation of insulin##7##3##(1991-1#1)(1994-3#1)(2008-1#1)(2010-11#1)(2011-1#1)(2013-1#2)
regulation of intestinal##5##3##(1994-8#1)(1995-12#1)(1996-5#1)(2006-10#1)(2008-4#1)
regulation of intracellular free calcium levels##2##6##(1995-11#2)
regulation of intracellular##12##3##(1990-12#1)(1990-7#1)(1990-8#1)(1995-11#2)(1996-9#1)(2004-11#1)(2007-11#1)(2010-2#1)(2013-1#3)
regulation of ion##2##3##(1990-5#1)(1995-8#1)
regulation of its expression in##2##5##(1996-10#1)(1996-5#1)
regulation of its expression##3##4##(1996-10#1)(1996-5#1)(1997-4#1)
regulation of its##11##3##(1991-3#1)(1992-11#1)(1992-12#1)(1993-12#1)(1995-11#1)(1996-10#1)(1996-2#1)(1996-5#1)(1997-4#1)(2010-12#1)(2011-2#1)
regulation of lipid##2##3##(2011-2#1)(2013-1#1)
regulation of liver##3##3##(1994-3#1)(2011-12#1)(2011-2#1)
regulation of local##3##3##(1991-10#1)(2008-4#1)(2012-12#1)
regulation of mRNA##3##3##(1991-9#1)(1996-2#1)(2007-12#1)
regulation of many cellular##2##4##(2009-4#1)(2009-5#1)
regulation of many##4##3##(1995-8#1)(2008-5#1)(2009-4#1)(2009-5#1)
regulation of membrane##3##3##(1991-1#1)(1997-6#1)(1997-8#1)
regulation of microbial##2##3##(2007-3#1)(2010-12#1)
regulation of microtubule##2##3##(1995-1#1)(2008-5#1)
regulation of mitochondrial##4##3##(2005-8#2)(2008-7#2)
regulation of multiple##3##3##(1995-8#1)(1996-8#1)(2012-12#1)
regulation of muscle##5##3##(1995-2#3)(2009-3#1)(2012-2#1)
regulation of neurite##2##3##(1996-1#1)(2008-11#1)
regulation of nitrogen metabolism##2##4##(1995-2#1)(1997-6#1)
regulation of nuclear##4##3##(1994-5#1)(2006-12#1)(2006-2#1)(2009-6#1)
regulation of ornithine##2##3##(1994-12#1)(1997-8#1)
regulation of other##2##3##(1992-11#1)(1995-5#1)
regulation of pancreatic exocrine secretion##3##5##(2006-10#3)
regulation of pancreatic exocrine##4##4##(1991-5#1)(2006-10#3)
regulation of pancreatic##8##3##(1991-5#1)(2006-10#7)
regulation of phospholipid##2##3##(1992-4#1)(2011-2#1)
regulation of pituitary##4##3##(1993-5#1)(1995-9#2)(1996-11#1)
regulation of plasma##2##3##(1993-6#1)(2007-8#1)
regulation of private health insurance##2##5##(1993-3#1)(2008-7#1)
regulation of proliferation and##3##4##(2008-4#1)(2012-1#1)(2013-1#1)
regulation of proliferation##6##3##(1992-8#1)(2008-4#1)(2008-7#1)(2012-1#1)(2013-1#1)(2013-8#1)
regulation of protein kinase C activity##2##6##(1990-5#1)(1990-8#1)
regulation of protein phosphorylation##2##4##(1994-3#1)(1996-2#1)
regulation of protein##8##3##(1990-5#1)(1990-8#2)(1992-8#1)(1994-3#1)(1996-2#1)(2008-11#1)(2010-2#1)
regulation of rat##2##3##(1992-5#1)(1995-10#1)
regulation of receptor expression##2##4##(1991-3#1)(1994-11#1)
regulation of receptors##5##3##(2005-8#4)(2006-10#1)
regulation of release of##2##4##(1993-5#1)(2007-4#1)
regulation of reproductive##2##3##(2006-10#1)(2008-6#1)
regulation of secondary##2##3##(2008-10#1)(2008-7#1)
regulation of signaling pathways##3##4##(1994-12#1)(2012-12#2)
regulation of specific gene##2##4##(1995-11#1)(1996-11#1)
regulation of specific##4##3##(1995-11#1)(1996-11#1)(1996-8#1)(2007-10#1)
regulation of splicing##2##3##(1991-5#1)(1991-6#1)
regulation of spontaneous release of##2##5##(1997-2#2)
regulation of sympathetic outflow##2##4##(2005-10#1)(2008-1#1)
regulation of sympathetic##3##3##(2005-10#1)(2008-1#1)(2008-2#1)
regulation of synaptic##4##3##(1996-12#1)(2008-7#1)(2009-8#1)(2012-2#1)
regulation of synthesis##2##3##(1994-3#1)(2010-12#1)
regulation of the Na+/H+ exchanger##2##5##(1997-7#2)
regulation of the TH gene##2##5##(1997-2#2)
regulation of the actin cytoskeleton##3##5##(1991-5#1)(2008-5#1)(2011-12#1)
regulation of the brain##2##4##(1995-12#1)(1996-12#1)
regulation of the c-myc gene##2##5##(1993-12#1)(1993-2#1)
regulation of the cell cycle##3##5##(1992-4#1)(2010-12#1)(2012-12#1)
regulation of the cell##5##4##(1992-4#1)(1994-12#1)(2008-7#1)(2010-12#1)(2012-12#1)
regulation of the central##3##4##(1991-2#1)(1994-11#1)(2009-9#1)
regulation of the enhancer##2##4##(1995-8#1)(1996-4#1)
regulation of the enzyme##2##4##(1994-8#1)(2007-10#1)
regulation of the expression of human##2##6##(1992-5#1)(1993-9#1)
regulation of the expression of the##2##6##(1991-3#1)(1997-4#1)
regulation of the expression of##9##5##(1991-3#1)(1992-12#1)(1992-5#1)(1993-9#1)(1994-3#1)(1994-6#1)(1997-1#1)(1997-4#1)(2008-9#1)
regulation of the gene##8##4##(1990-12#1)(1991-5#1)(1991-6#1)(1993-12#1)(1993-9#1)(1995-8#1)(1997-1#1)(1997-2#1)
regulation of the human##8##4##(1990-5#1)(1993-2#1)(1994-8#1)(1995-3#1)(1996-10#1)(1996-11#1)(2008-11#1)(2008-8#1)
regulation of the immune system##4##5##(2007-11#1)(2007-5#1)(2008-4#2)
regulation of the immune##6##4##(1991-2#1)(2007-11#1)(2007-5#1)(2008-4#3)
regulation of the level of##2##5##(1997-3#1)(2009-6#1)
regulation of the metabolism of##2##5##(1992-11#1)(1993-6#1)
regulation of the stress##2##4##(2008-5#1)(2012-12#1)
regulation of the##226##3##(1990-10#2)(1990-12#2)(1990-2#1)(1990-5#2)(1991-1#2)(1991-11#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#3)(1992-11#3)(1992-12#4)(1992-4#1)(1992-5#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#3)(1993-5#2)(1993-6#8)(1993-9#2)(1994-11#6)(1994-12#3)(1994-3#4)(1994-5#5)(1994-6#3)(1994-8#6)(1995-1#2)(1995-11#1)(1995-12#7)(1995-2#4)(1995-3#7)(1995-5#2)(1995-6#1)(1995-8#6)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#4)(1996-12#4)(1996-3#2)(1996-4#2)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#3)(2006-10#3)(2006-11#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#3)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#3)(2010-12#4)(2010-4#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#4)(2012-12#2)(2012-2#3)(2013-1#3)(2013-7#2)(2013-8#2)
regulation of their expression##5##4##(1992-3#1)(1994-11#1)(2006-10#1)(2008-4#1)(2008-8#1)
regulation of their##7##3##(1992-3#1)(1994-11#1)(1997-7#1)(2006-10#1)(2008-4#1)(2008-8#1)(2011-2#1)
regulation of these genes##2##4##(1990-3#1)(1990-5#1)
regulation of these two##4##4##(1991-5#1)(1992-7#1)(1994-6#1)(2009-8#1)
regulation of these##18##3##(1990-3#1)(1990-5#1)(1991-2#1)(1991-5#1)(1992-5#1)(1992-7#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-6#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)
regulation of this##10##3##(1992-4#2)(1994-11#1)(1994-9#1)(1996-5#1)(1996-7#1)(2005-10#1)(2006-10#1)(2009-4#1)(2011-2#1)
regulation of tobacco##2##3##(1991-5#1)(1991-8#1)
regulation of toxin##2##3##(1995-2#1)(2011-2#1)
regulation of transcription##6##3##(1997-1#1)(1997-3#1)(1997-4#1)(2007-12#1)(2010-2#1)(2011-2#1)
regulation of tumor cell##2##4##(2008-4#1)(2012-1#1)
regulation of uterine##3##3##(1994-9#1)(2006-10#1)(2012-3#1)
regulation of various biological##2##4##(2008-11#1)(2008-9#1)
regulation of viral##3##3##(1990-6#1)(2007-8#1)(2009-2#1)
regulation of voluntary##2##3##(1993-12#1)(2006-7#1)
regulation of##1434##2##(1990-10#5)(1990-11#4)(1990-12#5)(1990-2#6)(1990-3#10)(1990-4#1)(1990-5#8)(1990-6#2)(1990-7#8)(1990-8#8)(1990-9#1)(1991-1#5)(1991-10#7)(1991-11#7)(1991-12#9)(1991-2#7)(1991-3#4)(1991-4#5)(1991-5#24)(1991-6#6)(1991-7#5)(1991-8#8)(1991-9#9)(1992-1#5)(1992-10#1)(1992-11#11)(1992-12#7)(1992-2#2)(1992-3#4)(1992-4#6)(1992-5#5)(1992-6#13)(1992-7#3)(1992-8#9)(1992-9#4)(1993-11#6)(1993-12#15)(1993-2#4)(1993-3#4)(1993-4#3)(1993-5#8)(1993-6#16)(1993-7#2)(1993-8#7)(1993-9#4)(1994-10#6)(1994-11#20)(1994-12#23)(1994-2#9)(1994-3#16)(1994-5#14)(1994-6#9)(1994-8#23)(1994-9#12)(1995-1#6)(1995-10#3)(1995-11#12)(1995-12#21)(1995-2#16)(1995-3#22)(1995-4#2)(1995-5#10)(1995-6#12)(1995-7#3)(1995-8#16)(1995-9#3)(1996-1#6)(1996-10#6)(1996-11#13)(1996-12#14)(1996-2#20)(1996-3#7)(1996-4#10)(1996-5#18)(1996-6#3)(1996-7#7)(1996-8#8)(1996-9#2)(1997-1#12)(1997-2#11)(1997-3#5)(1997-4#10)(1997-5#2)(1997-6#6)(1997-7#8)(1997-8#7)(1997-9#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-10#6)(2005-11#1)(2005-7#1)(2005-8#8)(2006-1#3)(2006-10#41)(2006-11#5)(2006-12#5)(2006-2#2)(2006-4#1)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#6)(2007-10#6)(2007-11#16)(2007-12#17)(2007-3#3)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#8)(2007-9#3)(2008-1#25)(2008-10#15)(2008-11#32)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#45)(2008-5#14)(2008-6#8)(2008-7#38)(2008-8#44)(2008-9#17)(2009-10#6)(2009-12#4)(2009-2#4)(2009-3#7)(2009-4#7)(2009-5#6)(2009-6#7)(2009-7#3)(2009-8#22)(2009-9#5)(2010-10#5)(2010-11#11)(2010-12#22)(2010-2#5)(2010-3#2)(2010-4#4)(2010-5#3)(2010-7#1)(2010-8#7)(2010-9#5)(2011-1#12)(2011-11#1)(2011-12#6)(2011-2#30)(2011-3#2)(2012-1#11)(2012-12#33)(2012-2#21)(2012-3#12)(2012-7#1)(2013-1#33)(2013-7#6)(2013-8#7)
regulation on a##2##3##(1995-8#2)
regulation on the##3##3##(1994-10#1)(2008-10#1)(2010-9#1)
regulation on##12##2##(1994-10#1)(1994-12#1)(1995-2#1)(1995-8#2)(2007-4#1)(2008-10#1)(2010-7#1)(2010-9#2)(2011-2#1)(2013-7#1)
regulation or##5##2##(1994-12#1)(2008-4#1)(2010-5#1)(2012-12#2)
regulation plays an important##2##4##(2008-1#1)(2009-10#1)
regulation process##2##2##(1990-5#1)(1996-11#1)
regulation properties##3##2##(2008-10#1)(2009-10#2)
regulation remains to be##2##4##(1995-2#1)(2008-9#1)
regulation requires##2##2##(2008-4#1)(2012-3#1)
regulation should be##2##3##(2008-8#1)(2009-12#1)
regulation systems##4##2##(1991-5#1)(2008-10#1)(2008-11#2)
regulation that##4##2##(1995-9#1)(2008-2#1)(2008-7#1)(2011-2#1)
regulation through##5##2##(1990-2#1)(1992-11#1)(1995-6#1)(2004-9#1)(2007-8#1)
regulation to##7##2##(1992-3#1)(1995-12#1)(1996-3#1)(1997-7#1)(2006-11#1)(2008-7#1)(2012-12#1)
regulation towards##2##2##(2009-4#1)(2013-1#1)
regulation using##2##2##(1995-11#1)(2013-8#1)
regulation via##3##2##(2006-10#1)(2009-5#1)(2011-2#1)
regulation was determined##2##3##(1996-11#1)(2008-8#1)
regulation was investigated##2##3##(1994-12#1)(1996-1#1)
regulation was##9##2##(1994-12#2)(1994-9#1)(1996-1#1)(1996-11#1)(1997-2#1)(2008-11#1)(2008-8#1)(2008-9#1)
regulation which##4##2##(1994-6#1)(2008-1#1)(2008-11#1)(2011-2#1)
regulation will##2##2##(2008-7#1)(2010-3#1)
regulation with##2##2##(2007-12#1)(2011-2#1)
regulation within the##2##3##(2009-8#1)(2010-1#1)
regulation##2324##1##(1990-1#2)(1990-10#8)(1990-11#10)(1990-12#9)(1990-2#11)(1990-3#11)(1990-4#2)(1990-5#19)(1990-6#3)(1990-7#10)(1990-8#14)(1990-9#2)(1991-1#9)(1991-10#8)(1991-11#9)(1991-12#18)(1991-2#10)(1991-3#9)(1991-4#5)(1991-5#32)(1991-6#10)(1991-7#6)(1991-8#9)(1991-9#12)(1992-1#5)(1992-10#2)(1992-11#17)(1992-12#8)(1992-2#3)(1992-3#10)(1992-4#6)(1992-5#11)(1992-6#15)(1992-7#5)(1992-8#12)(1992-9#5)(1993-11#10)(1993-12#20)(1993-2#6)(1993-3#7)(1993-4#3)(1993-5#12)(1993-6#21)(1993-7#3)(1993-8#13)(1993-9#5)(1994-1#1)(1994-10#12)(1994-11#33)(1994-12#31)(1994-2#14)(1994-3#20)(1994-4#1)(1994-5#16)(1994-6#13)(1994-8#28)(1994-9#16)(1995-1#9)(1995-10#3)(1995-11#18)(1995-12#30)(1995-2#30)(1995-3#34)(1995-4#2)(1995-5#15)(1995-6#18)(1995-7#5)(1995-8#25)(1995-9#6)(1996-1#10)(1996-10#10)(1996-11#19)(1996-12#14)(1996-2#29)(1996-3#10)(1996-4#13)(1996-5#20)(1996-6#3)(1996-7#11)(1996-8#9)(1996-9#3)(1997-1#16)(1997-2#16)(1997-3#6)(1997-4#13)(1997-5#4)(1997-6#17)(1997-7#12)(1997-8#9)(1997-9#2)(2003-11#2)(2004-11#2)(2004-12#2)(2004-9#2)(2005-10#11)(2005-11#2)(2005-4#1)(2005-7#2)(2005-8#12)(2006-1#4)(2006-10#53)(2006-11#11)(2006-12#11)(2006-2#6)(2006-4#1)(2006-5#3)(2006-6#5)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#9)(2007-10#8)(2007-11#17)(2007-12#34)(2007-2#1)(2007-3#5)(2007-4#6)(2007-5#4)(2007-6#5)(2007-7#4)(2007-8#13)(2007-9#5)(2008-1#36)(2008-10#37)(2008-11#64)(2008-12#5)(2008-2#9)(2008-3#9)(2008-4#65)(2008-5#23)(2008-6#17)(2008-7#73)(2008-8#74)(2008-9#44)(2009-10#15)(2009-11#2)(2009-12#10)(2009-2#6)(2009-3#16)(2009-4#11)(2009-5#10)(2009-6#12)(2009-7#5)(2009-8#39)(2009-9#7)(2010-1#1)(2010-10#10)(2010-11#14)(2010-12#40)(2010-2#8)(2010-3#6)(2010-4#5)(2010-5#6)(2010-7#5)(2010-8#8)(2010-9#9)(2011-1#20)(2011-11#1)(2011-12#13)(2011-2#57)(2011-3#3)(2012-1#15)(2012-11#1)(2012-12#58)(2012-2#33)(2012-3#29)(2012-7#1)(2013-1#49)(2013-7#12)(2013-8#21)
regulation)##6##1##(1991-1#1)(1993-12#1)(1994-5#1)(2008-11#1)(2008-7#1)(2009-10#1)
regulation]##6##1##(1990-12#1)(2005-8#1)(2007-9#1)(2009-2#1)(2010-11#2)
regulations and controls on safe use of OP particularly in Asian countries are recommended##2##14##(2013-1#2)
regulations and##22##2##(1990-5#1)(1991-1#1)(1991-12#1)(1992-1#1)(1993-12#1)(1995-2#1)(1995-5#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-9#1)(2009-5#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
regulations are considered##2##3##(2006-8#1)(2008-11#1)
regulations are##9##2##(1993-12#1)(1993-3#1)(1995-3#1)(1995-9#1)(2006-11#1)(2006-8#1)(2007-5#1)(2008-11#1)(2012-3#1)
regulations as##2##2##(1994-1#1)(2008-11#1)
regulations concerning##3##2##(1991-11#1)(1992-11#1)(1995-2#1)
regulations do not##2##3##(1996-1#1)(2005-3#1)
regulations for##8##2##(1991-7#1)(1991-8#1)(1992-11#1)(1993-3#1)(1994-1#1)(2005-9#1)(2008-11#1)(2010-2#1)
regulations from##2##2##(2008-11#1)(2011-2#1)
regulations governing the##2##3##(1990-2#1)(2007-11#1)
regulations have##3##2##(2007-12#1)(2009-10#1)(2010-9#1)
regulations in force##2##3##(2009-4#1)(2010-12#1)
regulations in##6##2##(2006-8#1)(2007-12#1)(2007-6#1)(2009-4#1)(2010-12#1)(2012-1#1)
regulations of the##4##3##(2008-1#1)(2008-11#1)(2012-3#1)(2013-8#1)
regulations of##10##2##(1995-6#1)(2006-8#1)(2008-1#1)(2008-11#2)(2009-5#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
regulations on the protection and rights of workers##2##8##(2010-9#2)
regulations on the protection##3##4##(1990-2#1)(2010-9#2)
regulations on##6##2##(1990-2#1)(1991-2#1)(1995-2#2)(2010-9#2)
regulations pertaining to the##2##4##(2012-1#1)(2013-8#1)
regulations regarding##3##2##(2008-10#1)(2010-2#1)(2013-8#1)
regulations require##3##2##(2005-3#1)(2007-4#1)(2013-1#1)
regulations should##2##2##(2005-3#1)(2006-8#1)
regulations such as those imposed by the USP##2##8##(2012-2#2)
regulations that##4##2##(1994-2#1)(1996-8#1)(2006-8#1)(2007-11#1)
regulations to##3##2##(1991-1#1)(2010-12#1)(2010-9#1)
regulations were##5##2##(1991-4#1)(1993-3#1)(2007-12#1)(2010-12#1)(2013-7#1)
regulations##203##1##(1990-10#1)(1990-2#3)(1990-5#1)(1991-1#4)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#2)(1991-4#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#2)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#8)(1994-1#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-2#8)(1995-3#4)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-8#2)(1997-3#1)(1997-7#1)(2005-3#5)(2005-5#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-8#21)(2007-1#2)(2007-11#4)(2007-12#7)(2007-2#1)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#12)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#2)(2010-11#1)(2010-12#4)(2010-2#2)(2010-4#1)(2010-5#1)(2010-9#6)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#3)(2013-8#6)
regulations'##2##1##(1994-2#1)(2008-11#1)
regulations)##2##1##(2007-12#2)
regulative effect of acupuncture on##2##5##(2012-3#2)
regulative effect of##3##3##(2008-9#1)(2012-3#2)
regulative##8##1##(1992-5#1)(2008-11#1)(2008-9#2)(2009-6#1)(2009-9#1)(2012-3#2)
regulator (CFTR) gene##2##3##(2006-10#1)(2011-3#1)
regulator (CFTR)##7##2##(1990-8#1)(1995-11#1)(1995-6#1)(1997-3#1)(2006-10#1)(2008-3#1)(2011-3#1)
regulator (Fur) protein##2##3##(1997-7#1)(2009-6#1)
regulator and##5##2##(1990-10#1)(1991-8#1)(1997-2#1)(1997-4#2)
regulator by##2##2##(1992-2#1)(1997-1#1)
regulator for##6##2##(1990-10#1)(1993-7#1)(2008-1#1)(2008-11#1)(2011-1#1)(2011-2#1)
regulator in the presence of##2##5##(1990-7#1)(1994-11#1)
regulator in the##3##3##(1990-7#1)(1994-11#1)(1994-12#1)
regulator in##14##2##(1990-10#1)(1990-7#1)(1991-10#1)(1991-12#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-8#1)(1996-4#1)(2008-10#1)(2008-11#1)(2009-6#1)(2012-12#1)
regulator is##5##2##(1990-1#1)(1990-7#1)(1991-8#1)(1994-10#1)(2010-12#1)
regulator of Ca2+##2##3##(1994-3#1)(1995-3#1)
regulator of angiogenesis##2##3##(2013-1#1)(2013-8#1)
regulator of both##2##3##(1994-8#1)(2012-12#1)
regulator of calcium##3##3##(1994-9#1)(1996-11#1)(2006-12#1)
regulator of cell cycle##2##4##(2008-4#1)(2012-3#1)
regulator of cell growth##2##4##(2008-1#1)(2013-1#1)
regulator of cell##7##3##(1995-12#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-10#1)(2012-3#1)(2013-1#1)
regulator of cellular##2##3##(1995-2#1)(2012-12#1)
regulator of de novo##2##4##(1995-3#1)(2007-10#1)
regulator of immune##2##3##(1995-12#1)(2009-10#1)
regulator of inflammation and##2##4##(1992-9#1)(2008-7#1)
regulator of inflammation##3##3##(1992-9#1)(2007-7#1)(2008-7#1)
regulator of insulin secretion##4##4##(1996-2#1)(1997-4#1)(2010-11#2)
regulator of insulin##6##3##(1995-1#1)(1996-2#2)(1997-4#1)(2010-11#2)
regulator of intestinal##2##3##(1996-4#1)(2009-9#1)
regulator of macrophage##2##3##(2008-4#1)(2012-2#1)
regulator of progesterone##2##3##(1997-8#2)
regulator of skeletal##2##3##(1994-2#1)(2012-12#1)
regulator of the##17##3##(1990-3#1)(1991-12#1)(1991-9#1)(1993-6#1)(1994-9#1)(1996-7#1)(2004-12#1)(2005-12#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#2)(2010-8#1)
regulator of transcription##4##3##(1996-5#2)(2008-8#1)(2010-12#1)
regulator of vascular##3##3##(1991-10#1)(1995-2#1)(2011-1#1)
regulator of##157##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-6#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-6#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-6#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#2)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#3)(1997-4#3)(1997-6#1)(1997-8#2)(2004-12#1)(2005-12#1)(2006-10#2)(2006-12#4)(2006-2#2)(2007-10#3)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#6)(2008-5#3)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#2)(2009-6#2)(2009-7#1)(2009-8#7)(2009-9#2)(2010-11#6)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#9)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#2)
regulator protein##4##2##(1990-8#1)(1997-2#3)
regulator proteins##2##2##(1991-2#1)(1995-6#1)
regulator that has##2##3##(2009-8#1)(2012-2#1)
regulator that##6##2##(1995-6#1)(2009-8#2)(2012-12#1)(2012-2#2)
regulator which##3##2##(1991-10#1)(1991-12#1)(2008-8#1)
regulator##305##1##(1990-1#1)(1990-10#4)(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#7)(1990-8#2)(1991-10#3)(1991-12#6)(1991-2#4)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#2)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#6)(1995-1#2)(1995-11#2)(1995-12#2)(1995-2#8)(1995-3#3)(1995-5#2)(1995-6#6)(1995-8#3)(1996-10#1)(1996-11#2)(1996-2#2)(1996-4#3)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#3)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#6)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2004-12#1)(2005-11#1)(2005-12#1)(2005-6#1)(2006-10#6)(2006-11#1)(2006-12#5)(2006-2#2)(2006-8#1)(2007-10#3)(2007-11#2)(2007-12#6)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#4)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#7)(2008-5#3)(2008-7#4)(2008-8#5)(2008-9#2)(2009-10#2)(2009-6#7)(2009-7#1)(2009-8#12)(2009-9#3)(2010-10#5)(2010-11#6)(2010-12#4)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#8)(2011-2#2)(2011-3#1)(2012-12#17)(2012-2#8)(2012-3#1)(2012-8#1)(2013-1#6)(2013-8#2)
regulators and##8##2##(2007-7#1)(2008-11#1)(2008-7#1)(2010-5#1)(2012-2#1)(2013-1#3)
regulators for##3##2##(2007-12#1)(2009-8#1)(2012-12#1)
regulators have##3##2##(2007-5#1)(2008-11#1)(2012-1#1)
regulators in##6##2##(1993-5#1)(2007-5#1)(2009-3#1)(2009-8#1)(2013-1#1)(2013-8#1)
regulators is##2##2##(2007-12#1)(2011-2#1)
regulators of a##2##3##(2006-9#1)(2010-4#1)
regulators of cell proliferation##3##4##(2007-4#2)(2008-1#1)
regulators of cell##6##3##(1993-3#1)(2007-4#2)(2008-1#2)(2010-11#1)
regulators of genes involved in##2##5##(2008-7#1)(2009-8#1)
regulators of lipid homeostasis##2##4##(1997-4#1)(2008-3#1)
regulators of the immune response##2##5##(2008-5#1)(2013-1#1)
regulators of the##13##3##(1995-1#1)(1995-8#4)(2005-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-8#1)(2012-12#1)(2013-1#1)
regulators of these##2##3##(1994-12#1)(2010-2#1)
regulators of##96##2##(1992-3#1)(1992-5#1)(1992-9#1)(1993-3#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#6)(1996-2#1)(1996-3#1)(1996-5#1)(1997-4#1)(2004-2#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-9#3)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#2)(2008-1#4)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#2)(2009-7#2)(2009-8#7)(2010-11#1)(2010-2#2)(2010-4#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#8)(2012-2#2)(2013-1#1)(2013-8#1)
regulators or##4##2##(2008-5#1)(2008-9#1)(2012-2#2)
regulators that##3##2##(1995-8#1)(2005-7#1)(2013-7#1)
regulators to##3##2##(2007-12#1)(2009-10#2)
regulators##215##1##(1990-4#1)(1990-6#1)(1991-11#1)(1991-5#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#7)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-1#2)(1997-3#1)(1997-4#6)(1997-7#3)(2004-2#1)(2005-12#2)(2005-3#1)(2005-7#1)(2006-10#2)(2006-11#2)(2006-12#1)(2006-8#1)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#15)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#4)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#7)(2008-11#7)(2008-12#2)(2008-3#2)(2008-4#7)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#3)(2009-10#4)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#9)(2010-10#1)(2010-11#1)(2010-2#2)(2010-4#2)(2010-5#2)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#8)(2012-1#4)(2012-12#12)(2012-2#7)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#3)
regulatory (R)##3##2##(1990-8#1)(1993-6#1)(1994-8#1)
regulatory B cells##3##3##(2010-5#1)(2012-1#1)(2012-3#1)
regulatory B##4##2##(2010-5#1)(2011-2#1)(2012-1#1)(2012-3#1)
regulatory DNA sequences##2##3##(1994-6#1)(2006-10#1)
regulatory DNA##4##2##(1994-6#1)(2006-10#1)(2008-2#1)(2008-7#1)
regulatory RNAs##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2010-7#1)
regulatory T cell##7##3##(2005-10#1)(2007-5#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-7#1)
regulatory T cells (Treg)##4##4##(2007-11#1)(2011-1#1)(2013-1#1)(2013-8#1)
regulatory T cells and##3##4##(2007-5#1)(2010-5#1)(2012-1#1)
regulatory T cells are##2##4##(2008-4#1)(2011-2#1)
regulatory T cells in vivo##2##5##(2007-5#1)(2010-6#1)
regulatory T cells in##5##4##(2006-10#1)(2007-5#1)(2008-4#1)(2010-6#1)(2011-2#1)
regulatory T cells is##2##4##(2007-5#1)(2011-2#1)
regulatory T cells##38##3##(2006-10#1)(2007-11#2)(2007-5#6)(2008-1#1)(2008-4#7)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#3)(2011-1#2)(2011-2#5)(2012-1#2)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
regulatory T cells)##2##3##(2007-5#1)(2010-7#1)
regulatory T##51##2##(2005-10#1)(2006-10#1)(2007-11#2)(2007-5#8)(2008-1#1)(2008-4#7)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#3)(2010-7#1)(2011-1#2)(2011-2#7)(2012-1#5)(2012-3#6)(2013-1#1)(2013-7#2)(2013-8#1)
regulatory T-cells##2##2##(2010-2#1)(2011-1#1)
regulatory action##2##2##(1995-12#1)(2007-9#1)
regulatory activities##2##2##(2008-11#1)(2012-12#1)
regulatory activity in##2##3##(1991-3#1)(1992-8#1)
regulatory activity on##2##3##(1991-3#1)(1995-6#1)
regulatory activity##7##2##(1991-3#3)(1992-8#1)(1995-6#1)(1997-8#1)(2007-11#1)
regulatory agencies in##2##3##(2008-1#1)(2008-10#1)
regulatory agencies such as the##2##5##(2006-5#1)(2012-2#1)
regulatory agencies##22##2##(1992-2#1)(1992-3#1)(1997-2#1)(2005-8#2)(2006-11#1)(2006-5#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#1)(2010-11#1)(2010-9#1)(2012-2#2)(2013-7#1)
regulatory analysis##2##2##(1992-12#1)(2008-11#1)
regulatory and catalytic##4##3##(1991-6#1)(1992-6#1)(1993-6#1)(2008-11#1)
regulatory and##21##2##(1990-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-6#1)(1993-3#1)(1993-6#1)(1996-8#1)(2006-7#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-7#2)(2008-8#1)(2010-11#1)(2010-5#1)(2012-1#1)(2012-3#1)(2013-7#1)
regulatory apparatus##2##2##(2010-4#1)(2012-11#1)
regulatory approach##2##2##(1996-1#1)(1997-1#1)
regulatory approval in##2##3##(2005-11#1)(2009-11#1)
regulatory approval##6##2##(2005-11#1)(2006-11#1)(2008-7#1)(2009-11#1)(2010-5#1)(2011-12#1)
regulatory aspects##2##2##(2008-11#1)(2009-9#1)
regulatory authorities##7##2##(2005-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#2)(2013-8#1)
regulatory authority##4##2##(1991-3#1)(2007-4#1)(2008-11#2)
regulatory barriers##2##2##(1996-7#1)(2011-1#1)
regulatory behaviors##3##2##(2006-12#2)(2012-12#1)
regulatory binding sites##2##3##(1993-8#1)(2008-11#1)
regulatory binding##4##2##(1993-8#1)(2008-10#1)(2008-11#1)(2008-3#1)
regulatory bodies and##2##3##(2008-10#1)(2008-4#1)
regulatory bodies are##2##3##(2006-2#1)(2007-4#1)
regulatory bodies##10##2##(2005-8#1)(2006-2#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-4#1)(2009-11#1)(2011-2#1)
regulatory cascade##3##2##(1994-8#1)(1995-4#1)(2009-9#1)
regulatory cells##5##2##(2006-10#1)(2006-11#2)(2008-4#1)(2010-7#1)
regulatory changes##3##2##(1991-3#1)(2006-2#1)(2008-11#1)
regulatory circuit##5##2##(1997-4#3)(2012-3#1)(2013-1#1)
regulatory circuits##2##2##(1997-4#1)(2013-7#1)
regulatory cis elements##2##3##(1990-3#1)(1993-3#1)
regulatory clearance##2##2##(2005-8#1)(2008-7#1)
regulatory complex##4##2##(1997-7#4)
regulatory complexes##2##2##(2007-12#1)(2008-4#1)
regulatory compliance##4##2##(2006-11#1)(2008-10#3)
regulatory component##5##2##(1991-10#1)(1993-12#1)(1995-1#1)(1996-11#1)(2008-10#1)
regulatory control of the##2##4##(1992-7#1)(1994-11#1)
regulatory control of##4##3##(1992-7#1)(1994-11#1)(2006-8#1)(2007-11#1)
regulatory control##7##2##(1992-7#1)(1994-1#1)(1994-11#1)(1995-10#1)(1996-12#1)(2006-8#1)(2007-11#1)
regulatory controls##2##2##(2008-7#2)
regulatory cytokines##3##2##(2007-2#1)(2007-9#1)(2008-9#1)
regulatory domain of the##3##4##(1990-12#1)(1990-6#1)(1990-7#1)
regulatory domain of##16##3##(1990-12#2)(1990-6#1)(1990-7#1)(1992-11#1)(1993-8#1)(1994-12#2)(1994-2#2)(1994-8#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#2)
regulatory domain##27##2##(1990-12#4)(1990-6#1)(1990-7#1)(1991-1#1)(1992-11#1)(1993-8#1)(1994-12#2)(1994-2#2)(1994-8#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-11#4)(1996-5#1)(1997-6#1)(2011-3#1)(2012-12#1)(2012-2#1)
regulatory domains of##3##3##(1995-11#1)(1995-6#1)(1996-11#1)
regulatory domains##13##2##(1992-5#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-11#2)(1996-5#6)
regulatory effect of##3##3##(2008-10#1)(2008-4#1)(2013-1#1)
regulatory effect on##2##3##(2012-1#1)(2013-1#1)
regulatory effect##8##2##(1994-3#1)(2007-12#1)(2008-10#1)(2008-4#1)(2010-12#1)(2012-1#1)(2013-1#2)
regulatory effects of##6##3##(1991-3#1)(1993-6#1)(1994-5#1)(1996-5#1)(2012-12#2)
regulatory effects on the##2##4##(1991-4#1)(2013-1#1)
regulatory effects on##4##3##(1991-4#1)(1997-4#1)(2008-8#1)(2013-1#1)
regulatory effects##13##2##(1991-3#1)(1991-4#1)(1993-6#1)(1994-5#1)(1995-2#1)(1996-10#1)(1996-5#1)(1997-4#2)(2008-8#1)(2012-12#2)(2013-1#1)
regulatory element (-1430/-1327) of the##2##5##(1991-10#2)
regulatory element binding protein-1##2##4##(2012-12#1)(2012-2#1)
regulatory element binding##3##3##(2006-2#1)(2012-12#1)(2012-2#1)
regulatory element in##2##3##(1995-12#1)(1995-8#1)
regulatory element is##3##3##(1991-11#1)(1995-2#1)(1997-2#1)
regulatory element of##4##3##(1993-6#1)(1997-4#2)(2008-11#1)
regulatory element##34##2##(1990-5#1)(1991-10#2)(1991-11#2)(1991-12#2)(1991-5#2)(1992-5#1)(1993-3#1)(1993-6#2)(1994-8#1)(1995-12#1)(1995-2#4)(1995-5#2)(1995-8#1)(1996-11#2)(1996-7#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(2006-2#1)(2008-11#1)(2012-12#1)(2012-2#1)
regulatory element(s)##2##2##(1991-12#1)(1995-2#1)
regulatory elements and##3##3##(1996-3#1)(1997-7#2)
regulatory elements are##2##3##(1992-7#1)(1993-12#1)
regulatory elements by##3##3##(1995-2#1)(1996-10#1)(2006-12#1)
regulatory elements in the##2##4##(1993-12#1)(1997-7#1)
regulatory elements in##6##3##(1993-12#3)(1993-6#1)(1997-7#1)(2008-7#1)
regulatory elements including##2##3##(1994-8#1)(1995-8#1)
regulatory elements is##3##3##(1991-2#1)(1997-2#1)(1997-7#1)
regulatory elements of##3##3##(1994-5#1)(1995-2#1)(2008-1#1)
regulatory elements that##2##3##(1991-11#1)(2006-10#1)
regulatory elements were##2##3##(1997-7#1)(2009-5#1)
regulatory elements with##2##3##(1995-2#1)(2008-11#1)
regulatory elements within the##2##4##(1992-11#1)(2008-10#1)
regulatory elements##67##2##(1991-11#2)(1991-2#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-7#1)(1993-12#7)(1993-3#2)(1993-5#1)(1993-6#5)(1994-12#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#4)(1995-8#1)(1996-10#2)(1996-3#2)(1997-2#2)(1997-6#1)(1997-7#8)(2006-10#1)(2006-12#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-5#3)(2012-3#2)
regulatory environment##6##2##(2005-10#1)(2007-4#1)(2008-11#1)(2010-7#1)(2012-2#1)(2013-1#1)
regulatory enzyme##2##2##(1995-2#1)(2008-5#1)
regulatory enzymes##5##2##(1991-7#1)(1991-8#1)(2009-10#1)(2010-11#1)(2012-1#1)
regulatory event##3##2##(1991-2#1)(1991-3#1)(1992-7#1)
regulatory events##6##2##(1990-12#1)(1992-4#1)(1994-8#1)(1995-6#1)(2009-3#1)(2010-2#1)
regulatory factor##8##2##(1992-2#1)(1993-3#1)(1994-3#1)(1995-10#1)(2008-10#2)(2010-12#1)(2012-3#1)
regulatory factors on the##2##4##(1991-12#1)(1995-6#1)
regulatory factors##16##2##(1990-6#2)(1991-12#1)(1991-4#1)(1991-5#1)(1992-7#1)(1993-12#1)(1993-9#1)(1995-6#2)(1996-10#1)(1996-11#1)(2006-10#1)(2011-1#1)(2012-3#1)(2013-8#1)
regulatory features##2##2##(1994-11#1)(1994-12#1)
regulatory focus and##2##3##(2009-5#2)
regulatory focus theory##2##3##(2009-6#2)
regulatory focus##6##2##(2009-5#3)(2009-6#3)
regulatory framework for##2##3##(2010-12#1)(2010-6#1)
regulatory framework##6##2##(2005-2#1)(2007-10#1)(2007-4#1)(2010-12#1)(2010-6#1)(2013-1#1)
regulatory frameworks##2##2##(2008-7#1)(2012-3#1)
regulatory function in##2##3##(1990-12#1)(2008-7#1)
regulatory function of this##2##4##(1990-3#1)(1997-8#1)
regulatory function of##8##3##(1990-11#1)(1990-3#1)(1991-12#2)(1991-2#1)(1997-8#1)(2008-8#1)(2008-9#1)
regulatory function##14##2##(1990-11#1)(1990-12#1)(1990-3#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1994-10#1)(1997-8#1)(2008-7#1)(2008-8#1)(2008-9#2)
regulatory functions##11##2##(1990-11#1)(1993-2#1)(1994-12#1)(1994-5#1)(1997-4#1)(2007-11#1)(2009-3#1)(2010-11#1)(2012-1#2)(2013-7#1)
regulatory gene networks##2##3##(2008-1#1)(2008-2#1)
regulatory gene##16##2##(1990-1#1)(1990-9#1)(1991-6#1)(1991-9#1)(1992-3#1)(1993-9#1)(2005-6#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-8#2)(2008-9#1)(2010-11#1)(2011-1#1)
regulatory genes in##2##3##(1991-6#1)(2008-8#1)
regulatory genes##13##2##(1990-5#1)(1991-6#1)(1993-9#2)(1994-11#1)(1994-8#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2012-2#1)
regulatory guidelines##2##2##(1996-12#2)
regulatory hierarchies##2##2##(1997-4#1)(2007-11#1)
regulatory hormone##3##2##(1992-2#1)(1995-12#1)(2013-1#1)
regulatory impacts##2##2##(1996-1#2)
regulatory interactions##5##2##(1990-8#1)(1991-11#1)(1992-4#1)(1997-2#1)(2009-8#1)
regulatory issues##5##2##(1995-5#2)(2006-8#1)(2007-11#1)(2007-4#1)
regulatory level##2##2##(2008-10#2)
regulatory light chain##3##3##(1993-9#1)(1995-1#1)(1996-4#1)
regulatory light chains##3##3##(1990-6#1)(1995-1#1)(1996-4#1)
regulatory light##6##2##(1990-6#1)(1993-9#1)(1995-1#2)(1996-4#2)
regulatory limit##2##2##(2008-10#2)
regulatory locus##3##2##(1990-5#1)(1992-2#2)
regulatory loop##5##2##(1995-6#1)(2011-1#2)(2011-2#2)
regulatory lymphocytes can be##2##4##(2006-11#2)
regulatory lymphocytes##3##2##(2006-11#3)
regulatory machinery##2##2##(1996-4#1)(2009-7#1)
regulatory measures##3##2##(1992-4#1)(1995-2#1)(2012-12#1)
regulatory mechanism by which##3##4##(2008-2#1)(2008-4#1)(2011-2#1)
regulatory mechanism by##5##3##(1991-1#1)(1991-10#1)(2008-2#1)(2008-4#1)(2011-2#1)
regulatory mechanism for##5##3##(1991-5#1)(1995-2#1)(1997-4#1)(2010-11#1)(2011-10#1)
regulatory mechanism of##9##3##(1992-11#1)(1992-8#1)(1996-7#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-4#1)(2009-8#1)(2013-1#1)
regulatory mechanism that##2##3##(2005-12#1)(2010-10#1)
regulatory mechanism##32##2##(1991-1#1)(1991-10#1)(1991-5#1)(1991-7#2)(1992-11#1)(1992-8#2)(1995-2#1)(1995-6#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-12#1)(2006-12#1)(2008-1#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2011-10#1)(2011-2#1)(2012-1#1)(2013-1#1)
regulatory mechanisms are##3##3##(2008-11#1)(2009-3#1)(2013-8#1)
regulatory mechanisms governing##2##3##(1992-7#1)(2008-11#1)
regulatory mechanisms in pancreatic acinar##2##5##(2006-10#2)
regulatory mechanisms in##4##3##(1994-8#1)(2006-10#2)(2008-8#1)
regulatory mechanisms of gene##2##4##(2007-12#1)(2011-2#1)
regulatory mechanisms of##8##3##(1993-11#1)(1993-9#1)(1997-4#1)(2007-12#1)(2008-11#1)(2010-12#1)(2011-2#2)
regulatory mechanisms that are##2##4##(1994-3#1)(2007-12#1)
regulatory mechanisms that##9##3##(1994-3#1)(1994-8#1)(2006-10#1)(2007-12#3)(2011-1#1)(2012-1#1)(2013-1#1)
regulatory mechanisms##53##2##(1992-11#1)(1992-12#1)(1992-7#1)(1993-11#1)(1993-9#1)(1994-12#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1996-10#1)(1996-11#1)(1997-4#3)(2006-10#4)(2006-12#1)(2007-12#6)(2008-11#4)(2008-7#1)(2008-8#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
regulatory model##2##2##(1991-9#1)(2009-8#1)
regulatory module##3##2##(2007-12#2)(2013-8#1)
regulatory modules##2##2##(2012-3#1)(2013-1#1)
regulatory molecule##3##2##(1990-4#1)(2008-10#1)(2011-1#1)
regulatory molecules##10##2##(1990-8#1)(1990-9#1)(1991-2#1)(1991-7#1)(1993-6#1)(1995-12#1)(2006-10#1)(2008-1#1)(2008-11#1)(2013-1#1)
regulatory motifs##4##2##(1992-3#2)(1995-2#1)(2008-11#1)
regulatory mutations##2##2##(1990-9#1)(1996-7#1)
regulatory network of##2##3##(1992-11#1)(2010-10#1)
regulatory network that##2##3##(2007-12#1)(2008-7#1)
regulatory network##16##2##(1992-11#1)(1994-10#1)(1994-3#1)(2006-10#1)(2007-12#1)(2008-5#1)(2008-7#3)(2009-12#1)(2009-4#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-2#2)
regulatory networks and##4##3##(2006-10#1)(2008-11#1)(2008-7#1)(2009-5#1)
regulatory networks in##6##3##(2008-11#1)(2008-7#3)(2009-12#1)(2011-2#1)
regulatory networks is##3##3##(2006-7#1)(2008-8#1)(2011-2#1)
regulatory networks that##2##3##(2008-7#1)(2010-4#1)
regulatory networks##40##2##(2006-10#4)(2006-12#1)(2006-7#2)(2007-12#2)(2008-11#5)(2008-7#11)(2008-8#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#3)(2010-4#1)(2010-7#3)(2011-2#2)(2013-1#1)
regulatory operon##2##2##(1990-4#2)
regulatory or##4##2##(2006-5#1)(2008-7#1)(2011-12#1)(2012-12#1)
regulatory pathway in##2##3##(2007-12#1)(2008-11#1)
regulatory pathway##7##2##(1994-6#1)(1995-2#1)(2006-10#1)(2007-12#2)(2008-11#1)(2010-10#1)
regulatory pathways in the##2##4##(2008-7#1)(2010-11#1)
regulatory pathways in##3##3##(1995-2#1)(2008-7#1)(2010-11#1)
regulatory pathways##18##2##(1994-5#1)(1994-6#1)(1995-2#1)(1997-4#1)(2007-12#2)(2008-7#4)(2010-10#1)(2010-11#1)(2012-12#4)(2012-2#1)(2012-3#1)
regulatory peptide##5##2##(1991-10#1)(1991-4#1)(1992-9#1)(2008-4#1)(2011-1#1)
regulatory peptides##8##2##(1990-11#1)(1991-9#2)(1992-11#1)(1993-3#1)(2005-8#1)(2006-10#1)(2008-4#1)
regulatory perspective##2##2##(2009-4#1)(2013-7#1)
regulatory phosphorylation##4##2##(1990-8#1)(1994-9#1)(1995-2#2)
regulatory physiology##2##2##(1997-1#1)(2008-4#1)
regulatory polymorphisms##2##2##(2010-12#1)(2012-12#1)
regulatory potential of##2##3##(1991-10#1)(1997-2#1)
regulatory potential##3##2##(1991-10#1)(1997-2#1)(2008-11#1)
regulatory process##5##2##(1990-10#1)(1991-4#1)(2007-8#1)(2008-5#1)(2008-7#1)
regulatory processes##13##2##(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-3#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
regulatory promoter##2##2##(1992-12#1)(1994-12#1)
regulatory properties of a##2##4##(1990-12#1)(1994-8#1)
regulatory properties of##6##3##(1990-12#1)(1990-5#1)(1994-6#1)(1994-8#1)(1997-6#1)(2006-10#1)
regulatory properties##10##2##(1990-12#1)(1990-5#1)(1993-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-3#1)(1997-6#1)(1997-7#1)(2006-10#1)
regulatory protein for##2##3##(1990-10#1)(1992-6#1)
regulatory protein in##2##3##(1992-5#1)(2009-8#1)
regulatory protein of##4##3##(1990-10#1)(1992-3#1)(2007-3#1)(2008-8#1)
regulatory protein##45##2##(1990-10#3)(1990-7#6)(1990-8#1)(1991-12#1)(1992-12#1)(1992-3#3)(1992-5#2)(1992-6#1)(1992-7#1)(1993-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#2)(2005-11#1)(2006-9#2)(2007-3#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-8#1)(2011-1#1)(2012-2#1)
regulatory protein)##2##2##(1990-7#1)(1997-7#1)
regulatory proteins (G proteins) are##2##5##(1993-6#1)(1994-3#1)
regulatory proteins (G proteins)##4##4##(1990-3#1)(1993-6#1)(1994-3#1)(1996-10#1)
regulatory proteins (IRPs)##2##3##(1995-6#1)(1996-4#1)
regulatory proteins and transcriptional factors##2##5##(2008-9#2)
regulatory proteins and##11##3##(1990-5#1)(1992-9#1)(1995-6#1)(1996-4#1)(1997-2#1)(1997-8#1)(2005-11#1)(2008-9#2)(2012-12#1)(2012-2#1)
regulatory proteins to##2##3##(2008-4#1)(2012-2#1)
regulatory proteins##62##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1992-9#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-3#2)(1994-9#2)(1995-3#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-10#1)(1996-12#1)(1996-4#4)(1997-2#2)(1997-7#1)(1997-8#1)(2005-11#1)(2006-9#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-7#3)(2008-9#3)(2009-10#1)(2009-3#2)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2013-7#1)
regulatory reforms##2##2##(2006-8#1)(2012-12#1)
regulatory region and##4##3##(1990-11#1)(1991-7#1)(2008-8#1)(2009-5#1)
regulatory region of the human##3##5##(1992-2#1)(1994-9#1)(1995-1#1)
regulatory region of the##7##4##(1992-2#1)(1994-10#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-6#1)(2008-4#1)
regulatory region of##10##3##(1990-7#1)(1992-2#1)(1994-10#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-6#1)(2008-11#1)(2008-4#1)(2009-5#1)
regulatory region was##2##3##(1997-7#1)(2009-6#1)
regulatory region with##2##3##(1993-8#1)(1996-2#1)
regulatory region##38##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-7#1)(1992-2#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-10#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-6#2)(1996-2#7)(1997-2#3)(1997-7#2)(2006-10#1)(2008-11#4)(2008-4#1)(2008-8#1)(2009-5#2)(2009-6#1)
regulatory regions and##3##3##(1997-2#1)(2008-11#1)(2008-8#1)
regulatory regions of the human##3##5##(1995-12#1)(2008-11#1)(2008-7#1)
regulatory regions of the##6##4##(1995-12#2)(1997-4#1)(2008-11#1)(2008-7#1)(2012-2#1)
regulatory regions of##11##3##(1993-6#1)(1994-5#1)(1995-12#2)(1997-4#1)(2008-11#2)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
regulatory regions##27##2##(1992-5#2)(1992-6#1)(1993-3#1)(1993-6#1)(1994-5#1)(1994-6#2)(1995-12#3)(1995-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-11#4)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#2)
regulatory requirement##2##2##(2009-11#1)(2012-3#1)
regulatory requirements and##3##3##(2008-11#1)(2010-11#1)(2011-2#1)
regulatory requirements##6##2##(1991-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-11#1)(2011-2#1)
regulatory response##2##2##(2006-8#1)(2009-9#1)
regulatory risk##2##2##(2011-1#1)(2013-7#1)
regulatory role for the##2##4##(1993-8#1)(1994-9#1)
regulatory role for this##2##4##(1990-9#1)(1995-6#1)
regulatory role for##10##3##(1990-9#1)(1991-5#1)(1991-7#1)(1993-3#1)(1993-8#1)(1994-9#1)(1995-6#1)(1997-6#1)(2008-4#1)(2009-6#1)
regulatory role in the##6##4##(1990-9#1)(1991-10#1)(1993-3#1)(2006-11#1)(2008-2#1)(2008-7#1)
regulatory role in##14##3##(1990-9#1)(1991-10#1)(1991-12#1)(1993-3#1)(1994-10#1)(1994-12#2)(1995-3#1)(2006-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-10#1)(2013-1#1)
regulatory role of##13##3##(1991-12#2)(1992-7#1)(1993-3#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-4#1)(2009-12#1)(2009-8#1)(2011-12#1)(2012-12#1)(2012-2#1)
regulatory role##40##2##(1990-9#2)(1991-10#1)(1991-12#3)(1991-5#1)(1991-7#2)(1992-7#1)(1993-3#3)(1993-8#1)(1994-10#1)(1994-12#2)(1994-9#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-12#1)(1996-4#1)(1997-6#1)(2006-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#2)
regulatory roles for##2##3##(1996-7#1)(2010-5#1)
regulatory roles in##5##3##(1994-8#1)(1995-6#1)(1995-8#1)(2008-7#1)(2011-1#1)
regulatory roles of##3##3##(2011-1#1)(2011-12#1)(2012-12#1)
regulatory roles##14##2##(1994-8#1)(1995-6#1)(1995-8#1)(1996-7#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-5#1)(2011-1#2)(2011-12#2)(2012-12#1)
regulatory sequence##9##2##(1991-12#1)(1991-6#1)(1991-9#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(2008-11#1)(2008-9#1)
regulatory sequences in the##3##4##(1991-3#2)(2007-12#1)
regulatory sequences in##4##3##(1990-12#1)(1991-3#2)(2007-12#1)
regulatory sequences were##2##3##(1992-5#1)(1993-3#1)
regulatory sequences##24##2##(1990-1#1)(1990-12#1)(1991-3#2)(1991-9#1)(1992-5#2)(1993-3#1)(1994-8#1)(1994-9#3)(1995-2#2)(1995-8#1)(1996-10#1)(1997-2#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-12#1)(2008-7#2)(2010-12#1)
regulatory signal##2##2##(1990-5#1)(1991-8#1)
regulatory signals of##2##3##(1991-8#1)(1994-12#1)
regulatory signals##10##2##(1991-11#1)(1991-8#3)(1992-12#1)(1993-12#1)(1993-3#1)(1994-12#1)(1996-10#1)(2007-9#1)
regulatory site of##2##3##(1990-7#1)(1992-12#1)
regulatory site on the##2##4##(1991-12#1)(1991-3#1)
regulatory site##7##2##(1990-4#1)(1990-7#1)(1991-12#1)(1991-3#1)(1992-12#1)(1995-11#1)(2008-10#1)
regulatory sites##9##2##(1990-7#1)(1990-9#1)(1993-3#1)(1993-8#1)(1995-6#1)(1997-7#1)(1997-9#1)(2008-8#2)
regulatory standards##2##2##(2008-10#1)(2008-4#1)
regulatory step in the##2##4##(1995-1#1)(1995-10#1)
regulatory step in##4##3##(1990-8#1)(1995-1#1)(1995-10#1)(1997-6#1)
regulatory step##5##2##(1990-8#1)(1993-11#1)(1995-1#1)(1995-10#1)(1997-6#1)
regulatory subunit (RII)##3##3##(1994-9#2)(1995-11#1)
regulatory subunit of cAMP-dependent protein kinase##3##6##(1990-2#1)(1991-6#1)(1997-5#1)
regulatory subunit of##12##3##(1990-2#1)(1991-6#1)(1992-12#1)(1995-2#2)(1996-11#1)(1996-5#1)(1997-1#3)(1997-5#2)
regulatory subunit that##2##3##(1995-2#1)(1997-4#1)
regulatory subunit##33##2##(1990-10#1)(1990-2#4)(1990-8#1)(1991-6#1)(1992-12#1)(1992-8#1)(1993-6#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#6)(1995-3#1)(1996-11#1)(1996-5#1)(1997-1#4)(1997-4#1)(1997-5#2)(1997-6#1)(2008-8#1)(2011-2#1)
regulatory subunits by##2##3##(1995-11#1)(1995-3#1)
regulatory subunits of##3##3##(1992-8#2)(1996-11#1)
regulatory subunits##10##2##(1990-10#1)(1990-8#2)(1992-8#2)(1993-6#1)(1995-11#1)(1995-3#2)(1996-11#1)
regulatory switch##2##2##(1990-11#2)
regulatory system may be##2##4##(1995-12#1)(2011-1#1)
regulatory system of##4##3##(1997-2#2)(2008-7#1)(2008-9#1)
regulatory system##22##2##(1992-8#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-4#2)(1997-2#2)(1997-4#1)(2005-6#1)(2007-12#2)(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-4#1)(2010-10#1)(2011-1#1)(2012-12#2)
regulatory systems are##2##3##(2006-10#1)(2008-7#1)
regulatory systems that##3##3##(1996-12#1)(2006-10#1)(2012-1#1)
regulatory systems##15##2##(1994-12#2)(1995-1#1)(1995-6#1)(1996-12#1)(1997-1#1)(2006-10#2)(2007-12#1)(2008-11#1)(2008-7#3)(2008-9#1)(2012-1#1)
regulatory volume decrease (RVD)##3##4##(1991-1#1)(1992-8#1)(1997-5#1)
regulatory volume decrease##4##3##(1990-2#1)(1991-1#1)(1992-8#1)(1997-5#1)
regulatory volume increase (RVI)##2##4##(1991-1#1)(1992-8#1)
regulatory volume##6##2##(1990-2#1)(1991-1#2)(1992-8#2)(1997-5#1)
regulatory##1385##1##(1990-1#2)(1990-10#6)(1990-11#9)(1990-12#8)(1990-2#5)(1990-3#4)(1990-4#4)(1990-5#8)(1990-6#5)(1990-7#12)(1990-8#11)(1990-9#6)(1991-1#4)(1991-10#7)(1991-11#8)(1991-12#16)(1991-2#6)(1991-3#12)(1991-4#4)(1991-5#6)(1991-6#5)(1991-7#8)(1991-8#5)(1991-9#8)(1992-1#1)(1992-11#8)(1992-12#8)(1992-2#6)(1992-3#8)(1992-4#3)(1992-5#8)(1992-6#3)(1992-7#8)(1992-8#9)(1992-9#2)(1993-11#3)(1993-12#12)(1993-2#3)(1993-3#15)(1993-5#2)(1993-6#17)(1993-8#8)(1993-9#7)(1994-1#2)(1994-10#5)(1994-11#8)(1994-12#20)(1994-2#3)(1994-3#10)(1994-5#6)(1994-6#8)(1994-8#14)(1994-9#13)(1995-1#6)(1995-10#3)(1995-11#5)(1995-12#13)(1995-2#31)(1995-3#15)(1995-4#1)(1995-5#4)(1995-6#20)(1995-8#8)(1995-9#2)(1996-1#6)(1996-10#11)(1996-11#13)(1996-12#12)(1996-2#8)(1996-3#3)(1996-4#11)(1996-5#10)(1996-7#6)(1996-8#3)(1997-1#8)(1997-2#18)(1997-4#23)(1997-5#4)(1997-6#10)(1997-7#20)(1997-8#3)(1997-9#2)(2004-7#1)(2005-10#2)(2005-11#5)(2005-12#1)(2005-2#1)(2005-5#1)(2005-6#2)(2005-8#9)(2006-10#23)(2006-11#11)(2006-12#11)(2006-2#3)(2006-5#2)(2006-7#3)(2006-8#8)(2006-9#3)(2007-1#1)(2007-10#2)(2007-11#10)(2007-12#27)(2007-2#1)(2007-3#3)(2007-4#6)(2007-5#11)(2007-6#1)(2007-8#3)(2007-9#5)(2008-1#11)(2008-10#39)(2008-11#52)(2008-12#5)(2008-2#7)(2008-3#3)(2008-4#32)(2008-5#8)(2008-6#2)(2008-7#51)(2008-8#22)(2008-9#13)(2009-10#5)(2009-11#4)(2009-12#3)(2009-3#9)(2009-4#5)(2009-5#10)(2009-6#8)(2009-7#3)(2009-8#8)(2009-9#4)(2010-1#1)(2010-10#11)(2010-11#10)(2010-12#14)(2010-2#4)(2010-3#2)(2010-4#4)(2010-5#8)(2010-6#4)(2010-7#10)(2010-9#2)(2011-1#20)(2011-10#1)(2011-12#7)(2011-2#30)(2011-3#1)(2012-1#16)(2012-11#2)(2012-12#27)(2012-2#19)(2012-3#26)(2013-1#18)(2013-7#10)(2013-8#10)
regulon##7##1##(1995-6#1)(2006-8#3)(2011-2#2)(2013-8#1)
regulons in##2##2##(2011-2#1)(2013-8#1)
regulons##5##1##(2011-2#1)(2013-8#4)
regurgitant##4##1##(2005-9#2)(2009-10#1)(2010-12#1)
regurgitated##2##1##(2007-2#1)(2012-2#1)
regurgitation (MR) is##2##3##(2009-4#1)(2010-11#1)
regurgitation (MR)##3##2##(1995-3#1)(2009-4#1)(2010-11#1)
regurgitation and##15##2##(1993-10#1)(1993-2#1)(1995-6#1)(2005-12#1)(2007-8#3)(2008-7#1)(2010-11#1)(2010-5#1)(2012-12#1)(2012-2#2)(2013-8#2)
regurgitation due to##3##3##(2007-8#2)(2009-4#1)
regurgitation in the##2##3##(2007-8#1)(2013-1#1)
regurgitation in##6##2##(2005-8#1)(2007-7#1)(2007-8#2)(2012-3#1)(2013-1#1)
regurgitation is##2##2##(2007-8#2)
regurgitation of the##2##3##(1997-7#1)(2006-10#1)
regurgitation of##6##2##(1997-7#1)(2006-10#1)(2007-8#2)(2010-12#1)(2012-2#1)
regurgitation was not present##2##4##(1995-6#1)(2013-1#1)
regurgitation was##3##2##(1990-3#1)(1995-6#1)(2013-1#1)
regurgitation##111##1##(1990-3#1)(1990-6#2)(1990-8#1)(1993-10#1)(1993-2#1)(1994-3#1)(1995-3#4)(1995-6#4)(1997-5#2)(1997-7#1)(1997-8#5)(2005-12#1)(2005-8#1)(2006-10#3)(2006-2#3)(2006-4#1)(2006-8#1)(2007-7#3)(2007-8#19)(2007-9#9)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#2)(2008-7#3)(2009-10#5)(2009-3#1)(2009-4#3)(2010-11#3)(2010-12#1)(2010-4#1)(2010-5#3)(2010-7#2)(2011-1#1)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#4)(2013-8#3)
regúlate the##2##2##(2013-8#2)
rehab##2##1##(1992-3#1)(1995-2#1)
rehabilitate##6##1##(1993-3#1)(2007-6#1)(2008-1#1)(2008-7#1)(2011-1#1)(2011-2#1)
rehabilitated and##2##2##(2007-2#1)(2008-6#1)
rehabilitated##10##1##(1993-4#1)(1996-6#2)(2007-2#2)(2007-7#1)(2007-8#1)(2008-6#1)(2010-10#1)(2010-5#1)
rehabilitating##2##1##(2012-2#2)
rehabilitation (CR)##3##2##(2007-11#1)(2009-10#1)(2013-1#1)
rehabilitation (PR)##2##2##(2010-1#1)(2013-8#1)
rehabilitation after a##2##3##(1995-5#1)(2006-10#1)
rehabilitation after arthroscopic reconstruction of the anterior cruciate ligament##2##9##(2007-8#2)
rehabilitation after stroke##3##3##(1996-6#1)(2007-10#1)(2012-1#1)
rehabilitation after tenolysis of the flexor tendon##2##7##(2007-7#2)
rehabilitation after##26##2##(1991-12#1)(1994-7#1)(1995-5#1)(1996-6#1)(1997-2#1)(1997-3#2)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#3)(2007-7#2)(2007-8#3)(2008-3#1)(2009-12#1)(2010-10#1)(2010-4#1)(2012-1#1)(2012-3#1)(2013-1#2)
rehabilitation and at##2##3##(2007-10#1)(2011-1#1)
rehabilitation and pain##2##3##(2007-7#1)(2007-8#1)
rehabilitation and reintegration##3##3##(1990-9#1)(1992-3#1)(1996-2#1)
rehabilitation and##48##2##(1990-9#1)(1991-12#2)(1991-7#1)(1992-3#2)(1992-5#1)(1993-12#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-2#1)(2005-1#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-7#2)(2007-8#4)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#6)(2013-8#1)
rehabilitation are described##2##3##(2007-8#1)(2008-5#1)
rehabilitation are discussed##2##3##(1990-2#1)(1993-6#1)
rehabilitation are##9##2##(1990-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(2006-3#1)(2007-7#1)(2007-8#1)(2008-5#1)(2011-2#1)
rehabilitation as##2##2##(1994-5#1)(2013-1#1)
rehabilitation at##3##2##(2007-10#1)(2007-11#1)(2012-1#1)
rehabilitation averaged##2##2##(2008-4#2)
rehabilitation based on##2##3##(2009-8#1)(2010-10#1)
rehabilitation by##3##2##(2007-7#1)(2012-1#2)
rehabilitation center##7##2##(1992-1#1)(1993-1#2)(2007-11#1)(2007-9#2)(2008-2#1)
rehabilitation centers##2##2##(2007-11#1)(2013-1#1)
rehabilitation centre##3##2##(2006-8#2)(2012-12#1)
rehabilitation clinic##4##2##(1995-2#1)(2006-8#2)(2007-7#1)
rehabilitation cycle##2##2##(2011-1#1)(2012-1#1)
rehabilitation department##4##2##(1995-9#1)(2007-7#3)
rehabilitation departments##2##2##(2007-7#2)
rehabilitation devices##4##2##(2012-1#4)
rehabilitation efforts##3##2##(2008-8#1)(2011-2#2)
rehabilitation engineering##4##2##(2007-7#4)
rehabilitation exercises##7##2##(2007-8#1)(2008-10#1)(2008-6#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#1)
rehabilitation facility##3##2##(1995-3#1)(2007-9#1)(2008-7#1)
rehabilitation following##2##2##(2008-6#1)(2011-1#1)
rehabilitation for SCI patients##3##4##(2007-11#3)
rehabilitation for patients with##3##4##(2007-11#1)(2012-3#2)
rehabilitation for patients##5##3##(2007-11#2)(2008-6#1)(2012-3#2)
rehabilitation for##20##2##(2006-10#1)(2006-8#2)(2007-11#6)(2007-7#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-10#1)(2012-2#1)(2012-3#2)(2013-1#2)
rehabilitation has##4##2##(1992-3#1)(1996-9#1)(2012-1#2)
rehabilitation hospital##6##2##(1990-5#2)(2007-10#3)(2007-9#1)
rehabilitation hospitals##2##2##(1993-12#1)(2006-1#1)
rehabilitation improves##3##2##(2007-8#1)(2010-7#2)
rehabilitation in patients with##3##4##(2006-8#1)(2007-10#1)(2008-6#1)
rehabilitation in patients##5##3##(2006-8#1)(2007-10#1)(2008-6#1)(2013-1#2)
rehabilitation in the##2##3##(2007-6#1)(2011-1#1)
rehabilitation in##30##2##(1992-3#1)(1995-10#1)(2005-1#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#6)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-10#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2013-1#3)
rehabilitation is the##2##3##(2007-8#1)(2012-1#1)
rehabilitation is##13##2##(1991-7#1)(2007-11#3)(2007-7#2)(2007-8#4)(2011-2#1)(2012-1#1)(2013-1#1)
rehabilitation may##5##2##(2005-10#1)(2007-10#1)(2007-9#1)(2008-11#1)(2008-6#1)
rehabilitation measures##3##2##(1991-5#1)(1995-5#2)
rehabilitation methods##4##2##(2007-6#1)(2007-8#2)(2012-1#1)
rehabilitation model##2##2##(2008-2#1)(2009-8#1)
rehabilitation of a patient with##2##5##(2012-2#1)(2013-1#1)
rehabilitation of a patient##3##4##(2012-2#2)(2013-1#1)
rehabilitation of a##8##3##(2009-11#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
rehabilitation of lost skills as##2##5##(2007-6#2)
rehabilitation of lost skills##3##4##(2007-6#3)
rehabilitation of older##2##3##(1995-10#1)(2010-10#1)
rehabilitation of patients after##2##4##(2007-8#2)
rehabilitation of patients with spinal##2##5##(2007-8#1)(2008-10#1)
rehabilitation of patients with##13##4##(1995-11#1)(2007-11#5)(2007-8#1)(2008-10#1)(2010-3#1)(2012-1#1)(2013-1#3)
rehabilitation of patients##18##3##(1995-11#1)(2007-11#6)(2007-8#4)(2008-10#1)(2010-3#1)(2012-1#1)(2013-1#4)
rehabilitation of persons with##2##4##(2007-7#1)(2011-2#1)
rehabilitation of the knee##5##4##(2007-11#4)(2007-8#1)
rehabilitation of the patient##2##4##(2008-10#1)(2010-3#1)
rehabilitation of the spine##2##4##(2007-6#2)
rehabilitation of the##22##3##(1992-12#1)(1995-2#1)(1995-5#1)(2006-12#1)(2007-11#6)(2007-6#2)(2007-8#2)(2008-10#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-3#1)(2012-1#3)
rehabilitation of##104##2##(1992-12#1)(1992-3#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-8#1)(1996-9#2)(2005-10#2)(2005-11#1)(2006-12#2)(2007-11#15)(2007-12#2)(2007-3#1)(2007-6#7)(2007-7#1)(2007-8#8)(2007-9#1)(2008-10#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-11#2)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#3)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#3)(2011-7#1)(2012-1#10)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#9)(2013-8#1)
rehabilitation on##8##2##(1993-4#1)(1994-10#2)(1995-5#1)(2009-10#1)(2010-5#1)(2012-2#1)(2013-1#1)
rehabilitation outcome in patients with degenerative##2##6##(2007-11#1)(2007-8#1)
rehabilitation outcome##9##2##(1990-8#1)(1995-3#1)(2007-11#1)(2007-7#1)(2007-8#4)(2012-1#1)
rehabilitation patients##5##2##(1993-12#1)(2007-9#3)(2013-1#1)
rehabilitation period##6##2##(1995-5#1)(1995-9#1)(2008-6#4)
rehabilitation potential##2##2##(1995-5#1)(2006-8#1)
rehabilitation procedures##2##2##(2007-7#1)(2007-8#1)
rehabilitation process##15##2##(1996-3#1)(2006-2#1)(2006-3#1)(2007-11#4)(2007-7#1)(2007-8#1)(2010-10#2)(2011-2#1)(2012-12#1)(2013-1#2)
rehabilitation professionals##6##2##(1992-3#1)(1996-2#2)(2006-10#1)(2008-8#1)(2008-9#1)
rehabilitation program after##2##3##(2006-3#2)
rehabilitation program in##5##3##(2006-8#2)(2008-3#1)(2008-7#1)(2013-7#1)
rehabilitation program is##3##3##(1995-10#1)(2007-11#2)
rehabilitation program##36##2##(1995-10#1)(1995-3#1)(1997-3#1)(2006-12#2)(2006-3#3)(2006-8#3)(2007-11#5)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2012-1#2)(2012-12#1)(2013-1#3)(2013-7#1)
rehabilitation programme for##2##3##(1990-4#1)(2008-9#1)
rehabilitation programme in##3##3##(1995-9#1)(2005-1#1)(2007-11#1)
rehabilitation programme##21##2##(1990-4#1)(1990-8#1)(1995-9#1)(2005-1#4)(2005-8#1)(2006-8#3)(2007-11#2)(2008-10#1)(2008-11#1)(2008-9#2)(2010-10#1)(2013-1#3)
rehabilitation programmes##8##2##(1991-7#1)(1996-11#1)(1996-2#1)(1997-8#1)(2007-6#1)(2011-2#3)
rehabilitation programs for##2##3##(1993-3#1)(2007-11#1)
rehabilitation programs##11##2##(1992-3#1)(1993-3#1)(1996-3#1)(2007-11#2)(2007-2#1)(2007-3#1)(2008-10#1)(2008-2#1)(2009-9#1)(2013-1#1)
rehabilitation protocol##4##2##(2006-3#1)(2008-6#1)(2009-9#1)(2012-1#1)
rehabilitation protocols##2##2##(2006-3#1)(2013-1#1)
rehabilitation psychology##5##2##(2009-8#5)
rehabilitation robot##7##2##(2012-1#7)
rehabilitation robotic##3##2##(2012-1#3)
rehabilitation robotics##4##2##(2012-1#4)
rehabilitation robots##2##2##(2012-1#2)
rehabilitation services as##2##3##(2006-5#1)(2007-9#1)
rehabilitation services in##3##3##(1994-3#1)(1995-12#1)(2011-2#1)
rehabilitation services##11##2##(1991-6#1)(1993-12#1)(1994-3#1)(1995-12#1)(1996-6#1)(2006-5#2)(2007-12#1)(2007-9#1)(2011-2#2)
rehabilitation sessions##3##2##(2008-9#2)(2012-1#1)
rehabilitation should be##5##3##(2005-10#1)(2009-9#1)(2010-10#1)(2012-2#1)(2013-1#1)
rehabilitation should##6##2##(2005-10#1)(2009-12#1)(2009-9#1)(2010-10#1)(2012-2#1)(2013-1#1)
rehabilitation specialists##3##2##(1993-3#1)(2007-11#1)(2013-1#1)
rehabilitation strategies after rotator cuff repair##2##6##(2013-1#2)
rehabilitation strategies##5##2##(2007-6#1)(2008-2#1)(2008-8#1)(2013-1#2)
rehabilitation system##8##2##(1995-5#1)(2012-1#7)
rehabilitation team##5##2##(1991-12#1)(1991-4#1)(2007-11#1)(2007-8#2)
rehabilitation than##2##2##(1990-8#1)(2008-1#1)
rehabilitation therapies##2##2##(1994-12#1)(2008-6#1)
rehabilitation therapy##3##2##(1995-9#1)(2006-10#1)(2011-2#1)
rehabilitation to##5##2##(1995-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2012-1#1)
rehabilitation treatment##7##2##(2007-11#3)(2011-2#1)(2012-1#1)(2013-1#2)
rehabilitation unit##5##2##(1990-5#1)(1991-6#1)(1996-5#1)(2007-9#1)(2009-9#1)
rehabilitation using the##2##3##(2007-11#1)(2012-1#1)
rehabilitation using##3##2##(2007-11#1)(2007-9#1)(2012-1#1)
rehabilitation was##9##2##(2006-8#1)(2007-11#2)(2007-7#2)(2008-9#1)(2010-3#1)(2012-12#1)(2013-1#1)
rehabilitation were##4##2##(1993-10#1)(2007-10#1)(2007-7#1)(2007-8#1)
rehabilitation with elements of active movement##2##6##(2007-7#2)
rehabilitation with##13##2##(2006-11#1)(2006-3#1)(2007-11#1)(2007-7#2)(2008-12#2)(2008-9#1)(2010-10#1)(2011-2#1)(2012-1#2)(2012-2#1)
rehabilitation##927##1##(1990-10#1)(1990-2#1)(1990-4#2)(1990-5#4)(1990-6#1)(1990-8#4)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#7)(1991-2#1)(1991-4#2)(1991-5#1)(1991-6#2)(1991-7#5)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#10)(1992-5#1)(1993-1#4)(1993-10#1)(1993-12#9)(1993-3#4)(1993-4#2)(1993-6#3)(1993-7#4)(1993-9#1)(1994-10#2)(1994-12#2)(1994-3#3)(1994-5#1)(1994-7#1)(1995-1#1)(1995-10#3)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#4)(1995-5#12)(1995-8#1)(1995-9#6)(1996-11#3)(1996-12#1)(1996-2#4)(1996-3#4)(1996-5#1)(1996-6#3)(1996-8#1)(1996-9#4)(1997-2#1)(1997-3#4)(1997-6#1)(1997-8#2)(2005-1#6)(2005-10#4)(2005-11#2)(2005-8#1)(2006-1#1)(2006-10#11)(2006-11#1)(2006-12#6)(2006-2#3)(2006-3#13)(2006-4#2)(2006-5#4)(2006-8#27)(2007-1#1)(2007-10#18)(2007-11#90)(2007-12#8)(2007-2#2)(2007-3#2)(2007-5#1)(2007-6#16)(2007-7#46)(2007-8#59)(2007-9#20)(2008-1#3)(2008-10#12)(2008-11#4)(2008-12#4)(2008-2#10)(2008-3#2)(2008-4#5)(2008-5#3)(2008-6#18)(2008-7#13)(2008-8#12)(2008-9#14)(2009-10#6)(2009-11#4)(2009-12#9)(2009-2#1)(2009-3#1)(2009-4#3)(2009-6#1)(2009-7#1)(2009-8#12)(2009-9#5)(2010-1#2)(2010-10#10)(2010-12#1)(2010-2#4)(2010-3#4)(2010-4#1)(2010-5#5)(2010-6#1)(2010-7#4)(2010-9#3)(2011-1#14)(2011-12#3)(2011-2#38)(2011-3#1)(2011-7#1)(2012-1#90)(2012-11#2)(2012-12#13)(2012-2#16)(2012-3#9)(2013-1#61)(2013-7#1)(2013-8#5)
rehabilitation)##6##1##(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-9#1)(2010-12#1)
rehabilitation]##9##1##(1990-4#1)(1992-5#1)(1993-10#1)(1993-6#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-6#2)
rehabilitational##3##1##(1995-5#1)(2008-11#2)
rehabilitations##2##1##(2011-7#1)(2013-1#1)
rehabilitative programme##4##2##(2008-10#3)(2011-2#1)
rehabilitative treatment##3##2##(1992-3#1)(2007-10#1)(2012-1#1)
rehabilitative##23##1##(1992-3#1)(1994-3#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-9#3)(2009-10#1)(2011-2#1)(2012-1#2)(2013-1#6)
rehabilited##6##1##(2007-11#5)(2011-7#1)
rehearsal##3##1##(2006-6#1)(2008-2#1)(2013-7#1)
rehospitalization##5##1##(2006-7#1)(2008-3#1)(2009-10#1)(2010-2#1)(2013-7#1)
rehospitalized##2##1##(1995-11#1)(2006-4#1)
rehydrated##6##1##(2007-12#2)(2008-10#2)(2008-5#1)(2013-7#1)
rehydrating##2##1##(1994-12#1)(2007-12#1)
rehydration solution (ORS) was##2##4##(1991-9#1)(2008-1#1)
rehydration solution##3##2##(1991-9#2)(2008-1#1)
rehydration therapy##2##2##(1991-11#1)(1991-3#1)
rehydration##18##1##(1990-3#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-9#2)(1992-5#1)(1993-3#1)(2007-12#3)(2007-2#1)(2008-1#1)(2008-10#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#1)
rei##2##1##(2008-10#2)
reification##2##1##(2008-2#1)(2010-8#1)
reify##2##1##(2009-10#1)(2009-9#1)
reign of##2##2##(2008-8#1)(2009-4#1)
reign##3##1##(1996-1#1)(2008-8#1)(2009-4#1)
reimaging camera##2##2##(2008-3#2)
reimaging##5##1##(2008-2#1)(2008-3#4)
reimbursable##3##1##(1995-12#1)(2006-8#2)
reimburse##7##1##(1993-3#1)(1997-2#1)(1997-5#2)(2008-12#3)
reimbursed by the##2##3##(1996-1#1)(2007-8#1)
reimbursed by##3##2##(1996-1#1)(2007-8#1)(2011-12#1)
reimbursed for##2##2##(1995-3#1)(2007-4#1)
reimbursed##16##1##(1990-9#1)(1991-1#1)(1992-3#1)(1995-3#1)(1996-1#2)(1996-11#1)(1997-1#1)(2006-9#1)(2007-4#2)(2007-8#1)(2008-12#2)(2011-12#1)(2012-12#1)
reimbursement and##6##2##(1991-3#1)(1993-3#1)(1994-1#1)(2007-10#1)(2007-4#1)(2012-2#1)
reimbursement are##2##2##(2007-8#1)(2008-6#1)
reimbursement for imaging services##2##4##(1995-12#1)(2007-4#1)
reimbursement for partial##2##3##(1991-1#1)(1992-1#1)
reimbursement for##19##2##(1991-1#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-2#1)(1992-9#1)(1994-2#1)(1995-12#1)(1996-3#1)(1997-1#2)(2007-4#4)(2007-6#1)(2008-10#1)(2008-11#1)(2011-2#1)
reimbursement from Medicare##2##3##(1992-3#1)(2006-10#1)
reimbursement from##3##2##(1992-3#1)(2006-10#1)(2007-4#1)
reimbursement in the##2##3##(1993-3#1)(2006-10#1)
reimbursement in##6##2##(1992-12#1)(1993-3#1)(1994-12#1)(2006-10#1)(2008-7#1)(2011-2#1)
reimbursement is##2##2##(1994-2#1)(1996-12#1)
reimbursement issues##2##2##(1992-11#1)(2007-10#1)
reimbursement methodology##2##2##(1996-12#1)(1996-3#1)
reimbursement of##7##2##(1992-1#1)(1993-12#1)(1995-1#1)(1996-1#1)(2008-12#2)(2011-12#1)
reimbursement patterns##4##2##(1992-2#1)(1995-3#2)(2007-6#1)
reimbursement policies##6##2##(1990-12#2)(1992-1#1)(2008-12#1)(2012-11#1)(2013-1#1)
reimbursement policy##4##2##(2007-12#1)(2008-11#1)(2011-2#1)(2012-3#1)
reimbursement practices##3##2##(1991-12#1)(2013-1#2)
reimbursement process##2##2##(2007-4#2)
reimbursement rate##3##2##(2007-10#3)
reimbursement rates##8##2##(1993-12#3)(1996-12#1)(1997-2#1)(1997-3#1)(2004-9#1)(2007-10#1)
reimbursement system##7##2##(1991-2#1)(1993-12#1)(1994-10#1)(2007-4#3)(2009-4#1)
reimbursement to the prospective payment system##2##6##(1991-2#1)(1991-3#1)
reimbursement to##6##2##(1991-1#2)(1991-2#1)(1991-3#1)(1994-3#1)(1996-3#1)
reimbursement##166##1##(1990-10#3)(1990-12#4)(1990-4#1)(1991-1#4)(1991-12#2)(1991-2#2)(1991-3#4)(1991-4#1)(1992-1#5)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#7)(1993-3#5)(1994-1#3)(1994-10#1)(1994-12#4)(1994-2#4)(1994-3#4)(1995-1#2)(1995-12#2)(1995-3#4)(1996-1#1)(1996-12#4)(1996-2#1)(1996-3#3)(1997-1#4)(1997-2#1)(1997-3#2)(2004-9#1)(2005-10#1)(2006-10#4)(2006-7#1)(2007-10#7)(2007-12#2)(2007-4#17)(2007-6#2)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#4)(2008-12#5)(2008-6#2)(2008-7#1)(2009-11#1)(2009-4#3)(2010-12#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#4)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#1)
reimbursements for##3##2##(1997-2#1)(2008-12#1)(2009-6#1)
reimbursements##13##1##(1991-1#1)(1995-2#1)(1997-2#1)(2006-12#1)(2007-11#1)(2007-4#3)(2008-12#1)(2009-6#1)(2010-9#1)(2011-7#1)(2012-3#1)
reimbursing##4##1##(1996-12#1)(1997-1#1)(2008-12#1)(2011-12#1)
reimplantation and##4##2##(2008-1#1)(2008-8#1)(2008-9#2)
reimplantation for##2##2##(2007-8#1)(2012-2#1)
reimplantation in##3##2##(2008-1#1)(2008-9#2)
reimplantation of the##3##3##(1990-3#1)(2007-8#1)(2008-9#1)
reimplantation of##5##2##(1990-3#1)(2007-8#1)(2008-1#1)(2008-9#2)
reimplantation with a##2##3##(2012-2#2)
reimplantation with##4##2##(2012-2#4)
reimplantation##40##1##(1990-10#3)(1990-3#1)(1991-5#1)(2006-9#2)(2007-8#2)(2008-1#5)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#14)(2012-2#7)(2013-1#2)
reimplanted##5##1##(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#1)
reimposition of##2##2##(1992-10#1)(1997-1#1)
rein in##4##2##(1994-3#1)(2006-2#1)(2008-7#1)(2013-7#1)
reincorporated##2##1##(1995-8#1)(1996-8#1)
reindeer and##2##2##(1992-4#2)
reindeer##16##1##(1990-8#3)(1992-4#7)(1995-6#4)(2009-2#2)
reinfarction##2##1##(2007-11#1)(2008-3#1)
reinfection after##2##2##(2006-10#1)(2007-2#1)
reinfection of##2##2##(1991-2#1)(2007-11#1)
reinfection##6##1##(1991-2#1)(2006-10#2)(2007-11#1)(2007-2#1)(2008-12#1)
reinfestation##2##1##(2011-2#2)
reinforce and##4##2##(1994-2#1)(2007-10#1)(2011-2#1)(2012-2#1)
reinforce each other and##2##4##(2008-8#1)(2010-2#1)
reinforce each other##3##3##(1994-4#1)(2008-8#1)(2010-2#1)
reinforce one another##2##3##(2013-1#2)
reinforce the idea that##3##4##(1995-2#1)(2013-1#2)
reinforce the need##2##3##(2006-8#1)(2008-12#1)
reinforce the view that##2##4##(2007-8#1)(2009-4#1)
reinforce the##24##2##(1992-11#1)(1992-2#1)(1995-1#1)(1995-2#1)(1996-7#1)(1996-9#1)(1997-2#1)(2004-1#1)(2006-10#1)(2006-8#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-9#1)(2012-2#1)(2013-1#2)
reinforce their probability of##2##4##(2007-9#2)
reinforce this##2##2##(2007-5#1)(2008-11#1)
reinforce##63##1##(1992-11#1)(1992-2#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-4#1)(1995-1#1)(1995-2#1)(1996-7#1)(1996-9#1)(1997-2#1)(2004-1#1)(2004-2#1)(2005-5#1)(2006-10#3)(2006-5#1)(2006-8#1)(2007-10#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#4)(2008-10#1)(2008-11#2)(2008-12#3)(2008-5#1)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-9#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-2#2)(2012-3#2)(2013-1#7)(2013-7#2)
reinforced by a##2##3##(1990-3#1)(2008-3#1)
reinforced by the##8##3##(1994-3#1)(1996-2#1)(2006-9#1)(2007-7#1)(2008-4#1)(2008-5#1)(2009-7#1)(2009-8#1)
reinforced by##16##2##(1990-3#1)(1994-3#1)(1996-2#1)(2006-9#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#1)
reinforced learning##2##2##(1994-2#2)
reinforced plastic##2##2##(2007-12#1)(2010-2#1)
reinforced polycarbonate##2##2##(2009-11#2)
reinforced polymers##2##2##(2009-7#2)
reinforced the##6##2##(1993-2#1)(1997-8#1)(2005-8#1)(2007-2#1)(2010-5#1)(2013-7#1)
reinforced through the##2##3##(2008-11#1)(2008-6#1)
reinforced with 20##3##3##(2009-7#1)(2013-8#2)
reinforced with##9##2##(2004-9#3)(2009-7#2)(2010-4#1)(2013-8#3)
reinforced##71##1##(1990-3#3)(1991-12#1)(1992-5#1)(1993-2#1)(1993-3#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#1)(1996-2#2)(1997-8#1)(2004-9#4)(2005-8#1)(2006-11#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#3)(2009-11#2)(2009-2#1)(2009-6#1)(2009-7#8)(2009-8#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#2)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#3)
reinforcement and##5##2##(1993-6#3)(1994-2#1)(2009-7#1)
reinforcement in##3##2##(2006-7#2)(2008-5#1)
reinforcement learning and##2##3##(2011-1#1)(2012-2#1)
reinforcement learning##10##2##(2008-11#1)(2008-2#5)(2011-1#2)(2012-2#2)
reinforcement mechanisms##3##2##(2009-7#2)(2012-3#1)
reinforcement morphology##3##2##(2009-7#3)
reinforcement of the##4##3##(1992-12#1)(1996-10#1)(2005-11#1)(2009-10#1)
reinforcement of##14##2##(1991-1#1)(1992-12#1)(1996-10#1)(1996-5#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2012-12#1)(2013-1#3)(2013-7#1)
reinforcement on##3##2##(2006-7#1)(2012-1#2)
reinforcement processes##2##2##(1994-3#1)(2008-8#1)
reinforcement ring##5##2##(2007-7#2)(2008-3#2)(2009-3#1)
reinforcement schedules##2##2##(1993-12#1)(2006-7#1)
reinforcement sensitivity theory (Gray##2##4##(2012-2#2)
reinforcement sensitivity theory##4##3##(2009-9#1)(2012-2#3)
reinforcement threshold##2##2##(1991-5#2)
reinforcement thresholds for##2##3##(1991-5#2)
reinforcement thresholds##6##2##(1991-5#6)
reinforcement was##2##2##(1993-6#1)(2013-7#1)
reinforcement with##2##2##(1996-12#1)(2012-3#1)
reinforcement##127##1##(1990-10#1)(1990-2#5)(1991-1#1)(1991-12#1)(1991-5#10)(1992-12#2)(1993-12#1)(1993-6#11)(1994-2#3)(1994-3#1)(1996-10#2)(1996-12#1)(1996-5#1)(1997-6#2)(1997-7#1)(2005-10#1)(2005-11#1)(2006-7#5)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#8)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#2)(2009-3#1)(2009-7#9)(2009-8#1)(2009-9#2)(2010-10#1)(2010-7#1)(2011-1#2)(2011-2#5)(2012-1#3)(2012-12#1)(2012-2#9)(2012-3#2)(2013-1#3)(2013-7#6)
reinforcement)##2##1##(2013-7#2)
reinforcement]##2##1##(2010-8#1)(2013-7#1)
reinforcements##2##1##(2011-1#1)(2013-8#1)
reinforcer delivered##2##2##(2008-4#2)
reinforcer##12##1##(1993-6#3)(1996-5#1)(1997-6#1)(1997-7#2)(2008-4#2)(2008-5#1)(2011-2#2)
reinforcers##13##1##(1991-1#1)(1992-10#1)(1993-6#1)(1996-5#1)(2006-7#2)(2007-8#1)(2009-10#1)(2010-2#1)(2010-5#1)(2011-2#3)
reinforces the need##2##3##(2008-10#1)(2008-8#1)
reinforces the##15##2##(1995-12#1)(2005-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2009-6#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
reinforces##22##1##(1993-2#1)(1994-8#1)(1995-12#1)(1995-3#1)(2005-8#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2009-10#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
reinforcing actions##2##2##(1993-6#1)(2008-4#1)
reinforcing and##3##2##(1993-6#1)(1994-2#1)(2013-1#1)
reinforcing effects of##4##3##(1994-2#1)(1995-11#1)(2008-10#1)(2008-4#1)
reinforcing effects##5##2##(1994-2#1)(1994-8#1)(1995-11#1)(2008-10#1)(2008-4#1)
reinforcing or##2##2##(1993-6#1)(2011-1#1)
reinforcing properties##3##2##(1996-10#2)(1997-7#1)
reinforcing the##12##2##(2005-11#1)(2005-12#1)(2006-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-6#1)(2009-10#1)(2009-9#1)(2010-12#1)(2011-12#1)(2011-2#1)
reinforcing##48##1##(1991-1#1)(1993-6#3)(1994-2#2)(1994-8#1)(1995-11#1)(1995-9#1)(1996-10#2)(1996-12#1)(1997-7#1)(2004-9#1)(2005-11#1)(2005-12#1)(2006-11#1)(2006-2#1)(2006-5#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-4#3)(2008-6#1)(2009-10#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
reinfused##3##1##(1996-9#2)(2012-12#1)
reinfusion drains##3##2##(2008-8#3)
reinfusion##15##1##(1991-12#2)(1996-9#2)(2008-6#1)(2008-8#5)(2013-1#4)(2013-8#1)
reinhardti##3##1##(2008-7#2)(2008-9#1)
reinhardtii is a##2##3##(1990-3#1)(2012-3#1)
reinhardtii is##3##2##(1990-3#1)(1991-5#1)(2012-3#1)
reinhardtii##32##1##(1990-3#3)(1991-5#3)(1992-12#4)(1993-11#3)(1994-12#2)(1995-11#1)(1995-8#5)(1996-5#1)(2009-10#7)(2009-6#1)(2012-3#2)
reinitiated##2##1##(2008-1#1)(2012-2#1)
reinitiation of DNA synthesis##2##4##(1994-12#2)
reinitiation of meiosis##2##3##(1994-8#2)
reinitiation of##5##2##(1994-12#2)(1994-8#3)
reinitiation##8##1##(1990-3#2)(1994-12#2)(1994-8#3)(1995-8#1)
reinjection##5##1##(1992-5#3)(2008-3#1)(2013-1#1)
reinjury##2##1##(2006-3#2)
reinnervate##3##1##(1991-10#1)(1991-3#1)(2008-8#1)
reinnervated##4##1##(1991-11#1)(1992-9#2)(1996-8#1)
reinnervation by##2##2##(1991-11#1)(2013-8#1)
reinnervation in the##2##3##(1992-8#2)
reinnervation of CGRP(+) IENFs##2##4##(2013-8#2)
reinnervation of the##2##3##(1992-8#1)(1996-8#1)
reinnervation of##6##2##(1991-10#1)(1992-8#1)(1996-8#1)(2013-8#3)
reinnervation rate##2##2##(1991-11#2)
reinnervation##22##1##(1991-10#1)(1991-11#3)(1992-8#3)(1993-5#1)(1994-10#1)(1996-8#4)(2006-11#1)(2008-3#1)(2008-8#1)(2009-11#1)(2011-2#1)(2013-8#4)
reins##3##1##(1992-5#1)(1994-1#1)(2007-9#1)
reinserted##5##1##(2006-6#1)(2007-11#1)(2007-7#2)(2008-10#1)
reinsertion##8##1##(1995-8#1)(1996-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)
reinstated##2##1##(1994-10#1)(2013-8#1)
reinstatement of##2##2##(1994-11#1)(2008-10#1)
reinstituted##4##1##(2007-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
reinsurance##4##1##(1991-12#1)(1991-6#1)(1993-12#1)(1995-2#1)
reintegration of##3##2##(1992-1#1)(1994-5#1)(2008-2#1)
reintegration##13##1##(1990-9#1)(1992-1#1)(1992-3#1)(1993-1#4)(1994-5#1)(1996-2#1)(2006-9#1)(2008-2#2)(2008-5#1)
reinterpretation##2##1##(1993-8#1)(2008-5#1)
reintervention##6##1##(1996-9#1)(2007-7#1)(2007-9#1)(2011-2#3)
reintroduce##4##1##(1990-5#1)(1995-8#1)(2009-5#1)(2010-4#1)
reintroduced in the##2##3##(1995-10#1)(2008-10#1)
reintroduced in##3##2##(1995-10#1)(2008-10#1)(2010-12#1)
reintroduced into the##3##3##(1994-12#1)(2006-6#2)
reintroduced into##5##2##(1990-3#1)(1991-12#1)(1994-12#1)(2006-6#2)
reintroduced##14##1##(1990-3#1)(1991-12#2)(1994-12#1)(1995-10#1)(2006-6#2)(2007-2#1)(2008-10#1)(2008-7#1)(2010-1#1)(2010-12#2)(2011-1#1)
reintroducing##4##1##(2007-12#1)(2007-2#2)(2012-2#1)
reintroduction of##4##2##(1994-5#1)(1994-8#1)(1997-7#1)(2010-3#1)
reintroduction##10##1##(1994-5#1)(1994-8#1)(1997-7#1)(2007-2#4)(2008-7#1)(2010-12#1)(2010-3#1)
reintubation##9##1##(2007-8#1)(2013-8#8)
reinvaded##2##1##(1990-6#2)
reinvent##3##1##(1994-12#1)(2006-5#1)(2008-1#1)
reinvented##2##1##(1996-2#2)
reinventing##2##1##(2006-1#1)(2008-7#1)
reinvention##2##1##(2008-9#2)
reinvestigated the##2##2##(1995-5#1)(1997-4#1)
reinvestigated##10##1##(1991-5#1)(1992-11#1)(1992-12#1)(1994-11#1)(1995-5#1)(1997-4#1)(2008-10#1)(2008-2#1)(2009-2#1)(2011-2#1)
reinvestigation of##2##2##(1994-6#1)(2007-1#1)
reinvigorate##2##1##(2008-3#1)(2012-2#1)
reirradiation##3##1##(2008-10#2)(2010-7#1)
reisolated from##4##2##(2008-10#4)
reisolated##5##1##(1997-3#1)(2008-10#4)
reisolation##2##1##(2008-10#2)
reiterate the##3##2##(2007-12#1)(2010-8#1)(2013-1#1)
reiterate##4##1##(2006-10#1)(2007-12#1)(2010-8#1)(2013-1#1)
reiterated##6##1##(1991-7#1)(1993-3#1)(1993-9#1)(2008-3#1)(2012-12#1)(2012-3#1)
reiterative motifs##2##2##(1991-2#2)
reiterative##7##1##(1991-2#2)(1997-4#1)(2005-11#1)(2006-9#1)(2008-11#1)(2009-6#1)
reject the##13##2##(1995-5#1)(2006-5#1)(2007-7#1)(2008-10#5)(2008-3#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-7#1)
reject tumor##2##2##(2006-10#1)(2006-7#1)
reject##35##1##(1990-2#1)(1992-1#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-5#1)(1997-4#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-7#2)(2008-10#5)(2008-3#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-11#4)(2010-7#1)(2012-11#1)
rejected an##3##2##(1995-12#1)(1995-6#2)
rejected applicants##2##2##(1995-5#2)
rejected by the##2##3##(2008-2#1)(2009-3#1)
rejected by##5##2##(1995-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-3#1)
rejected children were##2##3##(2008-10#2)
rejected for##3##2##(1991-1#1)(2008-10#1)(2012-3#1)
rejected than##2##2##(2007-12#2)
rejected the##7##2##(1992-6#1)(1995-6#3)(1996-11#1)(1996-5#1)(2008-10#1)
rejected##74##1##(1990-8#2)(1991-1#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-6#1)(1993-12#1)(1994-9#1)(1995-12#4)(1995-2#2)(1995-5#3)(1995-6#5)(1995-8#1)(1995-9#1)(1996-11#3)(1996-5#2)(1996-6#1)(1997-3#1)(1997-4#1)(1997-5#1)(2004-3#1)(2006-12#1)(2006-5#2)(2006-7#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#9)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-3#1)(2010-1#2)(2010-12#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#2)
rejecting and##2##2##(1995-2#1)(2006-9#1)
rejecting the##5##2##(1991-12#1)(1993-1#1)(1995-2#1)(1996-5#1)(2006-7#1)
rejecting##18##1##(1991-12#1)(1993-1#1)(1995-2#6)(1996-5#1)(2004-11#1)(2006-11#1)(2006-5#1)(2006-7#1)(2006-9#1)(2008-2#1)(2008-4#1)(2008-7#1)(2012-12#1)
rejection after liver transplantation##2##4##(1993-2#1)(2007-11#1)
rejection after lung transplantation##2##4##(2007-8#2)
rejection after##8##2##(1993-2#1)(1994-3#1)(2007-11#1)(2007-8#3)(2008-10#1)(2012-3#1)
rejection and is##2##3##(2007-11#1)(2011-2#1)
rejection and social##2##3##(2008-1#1)(2010-4#1)
rejection and##33##2##(1990-12#1)(1995-2#2)(2004-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-11#8)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#1)(2010-3#1)(2010-4#2)(2010-5#1)(2011-2#1)(2011-3#1)(2012-12#1)
rejection as##2##2##(2006-10#1)(2007-11#1)
rejection by##3##2##(1990-12#1)(2007-8#1)(2008-2#1)
rejection can be##4##3##(2007-11#1)(2008-10#1)(2008-2#2)
rejection can##5##2##(2007-11#2)(2008-10#1)(2008-2#2)
rejection during##2##2##(1995-2#1)(1996-12#1)
rejection episode##7##2##(1995-2#4)(2007-11#1)(2008-8#1)(2011-2#1)
rejection episodes and##2##3##(2005-9#1)(2007-11#1)
rejection episodes were##2##3##(2007-11#1)(2007-7#1)
rejection episodes##19##2##(1990-11#1)(1993-11#1)(1994-5#1)(1995-2#2)(1996-3#1)(2005-9#1)(2006-5#1)(2007-11#6)(2007-7#2)(2008-1#2)(2011-2#1)
rejection events##2##2##(1993-2#1)(2009-3#1)
rejection for##2##2##(2007-12#1)(2008-3#1)
rejection has##2##2##(2005-7#1)(2007-11#1)
rejection have been##2##3##(2005-7#1)(2007-11#1)
rejection in the##4##3##(2008-1#1)(2008-12#1)(2008-2#1)(2009-5#1)
rejection in##22##2##(1995-2#3)(2007-11#4)(2007-7#3)(2007-8#3)(2008-1#3)(2008-12#1)(2008-2#1)(2009-5#1)(2010-12#1)(2012-2#1)(2012-3#1)
rejection is a##2##3##(2007-11#1)(2008-4#1)
rejection is##14##2##(1995-2#1)(2005-11#1)(2006-10#2)(2007-11#5)(2007-12#1)(2008-1#1)(2008-4#1)(2012-2#2)
rejection of a##4##3##(1996-1#1)(2007-11#1)(2008-7#1)(2010-3#1)
rejection of kidney##3##3##(1995-2#2)(2006-6#1)
rejection of the hypothesis##3##4##(1995-5#1)(2008-10#1)(2008-9#1)
rejection of the##16##3##(1991-12#1)(1995-5#2)(1997-3#1)(2007-11#2)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
rejection of transplanted organs##2##4##(1991-12#1)(2008-4#1)
rejection of##47##2##(1991-12#2)(1995-2#2)(1995-5#3)(1996-1#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-7#1)(2008-10#6)(2008-2#3)(2008-3#2)(2008-4#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-8#1)(2010-10#1)(2010-3#1)(2012-2#1)(2012-3#2)(2013-7#1)
rejection or suppression##2##3##(2013-7#2)
rejection or##7##2##(2007-11#2)(2007-8#2)(2012-2#1)(2013-7#2)
rejection process##3##2##(1995-2#1)(2005-7#2)
rejection rates##3##2##(1996-8#1)(2007-11#2)
rejection ratio##3##2##(2006-5#1)(2008-2#1)(2008-3#1)
rejection to##2##2##(1995-5#1)(2007-11#1)
rejection transfer function##2##3##(2008-1#1)(2008-2#1)
rejection under##2##2##(2007-11#2)
rejection was found##2##3##(2007-11#1)(2007-8#1)
rejection was##10##2##(1992-1#1)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#2)(2013-8#1)
rejection were##3##2##(1991-12#1)(1995-2#1)(2010-8#1)
rejection when used in combination with cyclosporin##2##7##(2007-11#2)
rejection will##2##2##(2007-11#2)
rejection with##4##2##(1995-2#1)(2007-11#2)(2010-5#1)
rejection##390##1##(1990-11#1)(1990-12#2)(1990-6#1)(1991-11#1)(1991-12#4)(1991-7#1)(1992-1#1)(1993-11#1)(1993-12#1)(1993-2#3)(1994-3#1)(1994-5#1)(1995-2#44)(1995-5#5)(1995-8#1)(1996-1#1)(1996-12#3)(1996-3#1)(1996-8#4)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(2004-11#2)(2005-11#1)(2005-12#1)(2005-7#11)(2005-8#2)(2005-9#2)(2006-10#12)(2006-12#2)(2006-5#3)(2006-6#1)(2007-10#1)(2007-11#80)(2007-12#7)(2007-2#1)(2007-3#1)(2007-7#13)(2007-8#25)(2007-9#2)(2008-1#20)(2008-10#15)(2008-11#6)(2008-12#1)(2008-2#11)(2008-3#10)(2008-4#6)(2008-5#2)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#2)(2009-2#1)(2009-3#6)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#3)(2010-4#2)(2010-5#4)(2010-8#1)(2011-1#3)(2011-2#11)(2011-3#2)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#4)(2013-1#1)(2013-7#4)(2013-8#2)
rejection)##3##1##(1991-12#1)(2007-8#1)(2008-10#1)
rejection-free##2##1##(2007-11#1)(2011-2#1)
rejections and##2##2##(2010-8#1)(2011-1#1)
rejections for##2##2##(1995-2#1)(2011-1#1)
rejections##19##1##(1991-1#1)(1992-6#1)(1995-2#1)(1997-5#1)(2005-11#1)(2005-8#1)(2007-2#1)(2007-9#2)(2008-3#1)(2008-7#1)(2010-3#2)(2010-8#3)(2011-1#2)(2011-2#1)
rejects their##2##2##(2004-12#2)
rejects##12##1##(1994-10#1)(1995-11#1)(1995-6#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-6#1)(2004-12#2)(2007-10#1)(2007-12#1)(2008-10#1)
rejoined products##2##2##(1997-1#2)
rejoined##4##1##(1992-11#1)(1997-1#3)
rejoining of##4##2##(1993-2#1)(1997-1#3)
rejoining##7##1##(1993-2#1)(1997-1#6)
rejuvenation of the##2##3##(2007-12#1)(2010-8#1)
rejuvenation procedures##3##2##(2007-12#1)(2010-11#1)(2012-2#1)
rejuvenation##22##1##(2006-12#2)(2007-12#3)(2007-7#1)(2008-5#1)(2008-7#4)(2009-9#2)(2010-11#4)(2010-8#4)(2012-2#1)
rekindled##2##1##(2005-8#1)(2007-9#1)
rekindles##2##1##(1997-5#1)(2008-7#1)
rel family##2##2##(1994-2#1)(1995-1#1)
rel##3##1##(1994-2#1)(1995-1#1)(1997-1#1)
relA##2##1##(1994-11#1)(2007-12#1)
relabeled##2##1##(2005-4#1)(2012-2#1)
relaparotomy##2##1##(1994-3#1)(2007-5#1)
relapse after discontinuation of##2##4##(2006-5#1)(2009-11#1)
relapse after optimal therapy##2##4##(2005-12#2)
relapse after##12##2##(1991-6#1)(1993-2#1)(1997-8#1)(2005-12#2)(2006-5#1)(2007-10#1)(2007-7#1)(2008-6#1)(2009-11#2)(2011-1#1)
relapse and the##3##3##(1992-3#1)(2008-1#1)(2012-12#1)
relapse and##16##2##(1992-10#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-8#1)(1995-9#1)(1997-5#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-5#1)(2009-11#1)(2009-5#1)(2010-11#1)(2010-12#1)(2012-12#1)
relapse as##2##2##(2008-1#1)(2008-8#1)
relapse at##2##2##(1992-12#1)(2008-6#1)
relapse by##3##2##(2007-11#1)(2009-2#1)(2012-1#1)
relapse could be##2##3##(2007-5#1)(2008-5#1)
relapse experiences of##2##3##(2006-7#2)
relapse following##5##2##(2007-11#1)(2009-5#1)(2010-12#1)(2010-2#1)(2012-2#1)
relapse free##3##2##(1990-10#1)(2007-2#1)(2012-3#1)
relapse has been##3##3##(1990-12#1)(2007-7#1)(2010-12#1)
relapse has##7##2##(1990-12#1)(2004-1#1)(2007-11#1)(2007-7#1)(2008-6#1)(2010-12#2)
relapse in acute##2##3##(1991-4#1)(1996-6#1)
relapse in patients with##2##4##(2004-1#1)(2010-12#1)
relapse in patients##3##3##(1994-5#1)(2004-1#1)(2010-12#1)
relapse in the##6##3##(2004-1#1)(2007-12#1)(2011-1#1)(2011-2#2)(2012-2#1)
relapse in##20##2##(1991-4#2)(1993-2#1)(1994-5#1)(1995-1#1)(1996-1#1)(1996-6#1)(1997-8#1)(2004-1#2)(2007-12#2)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-2#1)
relapse is##2##2##(1991-4#1)(2007-5#1)
relapse occurred in##2##3##(1991-3#1)(2004-1#1)
relapse occurred##3##2##(1991-3#1)(1996-7#1)(2004-1#1)
relapse of symptoms##5##3##(2007-8#5)
relapse of the disease##2##4##(1990-6#1)(1995-4#1)
relapse of the##4##3##(1990-6#1)(1995-4#1)(2008-4#1)(2009-11#1)
relapse of##24##2##(1990-6#1)(1995-4#1)(1997-2#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-11#2)(2007-7#1)(2007-8#7)(2008-4#1)(2008-5#1)(2009-11#1)(2010-7#1)(2013-1#3)(2013-8#1)
relapse on##2##2##(2006-2#1)(2009-3#1)
relapse or##5##2##(1991-1#1)(1993-12#1)(2007-8#1)(2008-1#1)(2010-12#1)
relapse prevention##3##2##(2006-9#2)(2012-2#1)
relapse rate and##2##3##(2005-9#1)(2007-11#1)
relapse rate##12##2##(1996-11#1)(2004-1#2)(2005-7#1)(2005-9#1)(2007-1#1)(2007-11#2)(2008-1#1)(2010-12#1)(2011-2#1)(2013-1#1)
relapse rates##8##2##(1997-8#2)(2004-1#1)(2009-10#1)(2009-3#1)(2011-2#1)(2012-2#2)
relapse triggers##4##2##(2009-9#4)
relapse was observed##2##3##(1991-5#1)(2005-5#1)
relapse was significantly##2##3##(2012-1#1)(2012-3#1)
relapse was##9##2##(1991-4#1)(1991-5#1)(1995-5#1)(2004-1#2)(2005-5#1)(2008-6#1)(2012-1#1)(2012-3#1)
relapse with##3##2##(1994-8#1)(2012-12#1)(2013-1#1)
relapse within##2##2##(2008-5#1)(2011-2#1)
relapse##262##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-4#4)(1991-5#1)(1991-6#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-4#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#3)(1994-5#2)(1994-6#1)(1994-8#3)(1995-1#1)(1995-11#1)(1995-4#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-2#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-5#1)(1997-8#7)(2004-1#9)(2005-12#2)(2005-5#1)(2005-6#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#5)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#3)(2006-9#4)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#6)(2007-8#10)(2008-1#6)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#15)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#6)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#2)(2009-7#2)(2009-9#7)(2010-11#2)(2010-12#9)(2010-2#5)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#21)(2012-1#3)(2012-12#5)(2012-2#6)(2012-3#3)(2013-1#8)(2013-8#2)
relapse)##2##1##(2006-6#1)(2012-2#1)
relapse-free survival and##3##3##(1991-4#1)(2007-11#1)(2012-3#1)
relapse-free survival##16##2##(1990-8#1)(1991-4#2)(1993-1#1)(1993-9#2)(1994-12#1)(2007-11#2)(2008-6#1)(2010-3#3)(2011-1#1)(2011-2#1)(2012-3#1)
relapse-free##18##1##(1990-8#1)(1991-4#2)(1993-1#1)(1993-9#2)(1994-12#1)(1995-12#1)(2007-11#2)(2008-6#1)(2009-2#1)(2010-3#3)(2011-1#1)(2011-2#1)(2012-3#1)
relapsed MCL##2##2##(2010-11#1)(2010-12#1)
relapsed acute myeloid leukemia##2##4##(2010-4#1)(2013-7#1)
relapsed acute myeloid##3##3##(2008-5#1)(2010-4#1)(2013-7#1)
relapsed acute##4##2##(2008-5#1)(2010-11#1)(2010-4#1)(2013-7#1)
relapsed after##6##2##(1990-8#1)(1992-6#1)(2007-10#1)(2007-7#1)(2008-1#1)(2011-2#1)
relapsed and died##3##3##(1991-4#1)(1993-5#1)(2008-10#1)
relapsed and refractory myeloma##2##4##(2010-4#2)
relapsed and refractory##3##3##(2010-4#3)
relapsed and##11##2##(1991-4#1)(1992-6#1)(1993-5#1)(1996-2#1)(1996-7#1)(2007-11#1)(2008-10#1)(2008-4#1)(2010-4#3)
relapsed and/or refractory##2##3##(2009-4#1)(2010-12#1)
relapsed and/or##3##2##(2009-4#1)(2010-12#1)(2010-3#1)
relapsed at##2##2##(1990-12#1)(2007-5#1)
relapsed disease##3##2##(2008-1#1)(2008-6#1)(2010-11#1)
relapsed in the##2##3##(2007-10#1)(2007-8#1)
relapsed into smoking##2##3##(1997-4#2)
relapsed leukemia##2##2##(2005-7#1)(2009-4#1)
relapsed or did not respond to##2##6##(2007-11#1)(2012-12#1)
relapsed or did not respond##3##5##(2007-11#2)(2012-12#1)
relapsed or refractory##4##3##(2007-11#2)(2008-5#1)(2011-2#1)
relapsed or##13##2##(2007-11#4)(2007-4#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-7#1)
relapsed patients are##2##3##(1995-9#1)(2007-11#1)
relapsed patients##5##2##(1992-6#1)(1995-9#1)(2007-11#1)(2007-2#1)(2008-3#1)
relapsed within##2##2##(2007-7#1)(2008-6#1)
relapsed##107##1##(1990-10#2)(1990-12#2)(1990-8#1)(1991-4#2)(1991-6#1)(1992-10#1)(1992-6#3)(1993-5#2)(1994-5#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#2)(2005-7#1)(2005-9#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-10#9)(2007-11#8)(2007-2#2)(2007-4#2)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#4)(2008-10#1)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#5)(2008-6#5)(2008-7#1)(2009-4#2)(2010-10#1)(2010-11#3)(2010-12#4)(2010-3#1)(2010-4#5)(2011-2#6)(2012-12#2)(2013-7#2)
relapsed/refractory CLL##2##2##(2009-12#2)
relapsed/refractory patients##2##2##(2011-2#2)
relapsed/refractory##7##1##(1994-12#1)(1995-9#1)(2009-12#3)(2011-2#2)
relapsers##2##1##(2007-11#1)(2008-1#1)
relapses after##4##2##(1991-4#1)(1997-6#1)(2005-10#1)(2007-8#1)
relapses and treatment failures##2##4##(1996-11#1)(2007-2#1)
relapses and##13##2##(1991-6#1)(1993-5#1)(1996-11#1)(2006-2#1)(2007-11#2)(2007-2#1)(2008-1#1)(2008-11#1)(2008-6#1)(2010-5#1)(2013-7#1)(2013-8#1)
relapses are common##2##3##(1993-11#1)(2006-10#1)
relapses are##5##2##(1993-11#1)(1994-6#1)(2006-10#1)(2011-2#1)(2013-8#1)
relapses has##2##2##(1990-3#1)(1991-6#1)
relapses in##4##2##(1991-5#1)(2007-11#3)
relapses occurred in##4##3##(1991-4#1)(1993-5#1)(2006-2#1)(2008-6#1)
relapses occurred##5##2##(1991-4#1)(1993-5#1)(2006-2#1)(2007-8#1)(2008-6#1)
relapses of multiple sclerosis##2##4##(1997-3#1)(2007-11#1)
relapses of the##2##3##(2007-11#1)(2008-8#1)
relapses of##8##2##(1997-3#2)(2007-11#2)(2008-8#1)(2009-6#1)(2010-12#1)(2011-2#1)
relapses or##3##2##(1990-9#1)(2007-11#1)(2008-2#1)
relapses were##3##2##(1996-11#1)(2009-6#1)(2011-2#1)
relapses with##2##2##(2007-2#1)(2013-1#1)
relapses##81##1##(1990-3#2)(1990-9#1)(1991-12#1)(1991-4#3)(1991-5#1)(1991-6#3)(1992-4#1)(1993-11#2)(1993-2#1)(1993-5#2)(1994-6#1)(1995-4#1)(1995-8#1)(1996-11#2)(1996-9#1)(1997-3#2)(1997-6#1)(2004-2#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-2#3)(2007-11#12)(2007-2#2)(2007-7#2)(2007-8#2)(2008-1#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-8#1)(2009-6#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#2)
relapsing EAE##2##2##(1991-12#1)(1995-12#1)
relapsing MS##2##2##(2007-11#2)
relapsing and demyelinating##2##3##(1995-12#2)
relapsing and remitting##4##3##(2006-1#1)(2006-10#1)(2009-8#1)(2010-12#1)
relapsing and##7##2##(1995-12#2)(2006-1#1)(2006-10#1)(2009-8#1)(2010-12#1)(2010-9#1)
relapsing course##3##2##(1991-2#1)(2010-12#1)(2013-8#1)
relapsing disease##3##2##(1993-8#1)(2007-5#1)(2009-6#1)
relapsing experimental autoimmune encephalomyelitis##2##4##(1991-12#1)(2013-7#1)
relapsing fever##2##2##(1994-2#1)(2011-2#1)
relapsing forms of##2##3##(2007-11#1)(2012-3#1)
relapsing multiple sclerosis##2##3##(2007-11#2)
relapsing multiple##3##2##(2006-6#1)(2007-11#2)
relapsing patients##3##2##(1991-2#3)
relapsing polychondritis##7##2##(2006-10#7)
relapsing remitting##3##2##(2007-11#1)(2010-12#1)(2012-3#1)
relapsing##59##1##(1990-8#1)(1991-12#2)(1991-2#6)(1991-6#1)(1992-2#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-12#3)(2005-8#1)(2006-1#1)(2006-10#9)(2006-6#1)(2007-11#6)(2007-5#1)(2008-1#1)(2008-5#1)(2008-7#2)(2009-2#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#4)(2010-9#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
relapsing-remitting MS##3##2##(2005-7#1)(2007-11#2)
relapsing-remitting multiple sclerosis##7##3##(2007-11#6)(2010-12#1)
relapsing-remitting##14##1##(2005-7#1)(2007-11#10)(2008-11#1)(2010-12#1)(2012-3#1)
relate both##2##2##(2008-10#1)(2009-4#1)
relate directly to the##3##4##(1993-1#1)(1995-9#1)(2008-10#1)
relate directly to##5##3##(1993-1#1)(1995-12#1)(1995-9#1)(2008-10#1)(2008-9#1)
relate information##2##2##(2007-2#1)(2010-9#1)
relate it to the##2##4##(2008-10#1)(2008-7#1)
relate it##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
relate more##2##2##(2006-10#1)(2008-12#1)
relate the##25##2##(1990-3#1)(1995-4#1)(1997-2#1)(2006-10#1)(2007-9#1)(2008-10#4)(2008-2#3)(2008-3#6)(2008-5#3)(2008-9#1)(2009-5#1)(2012-12#1)(2012-2#1)
relate their##4##2##(1996-2#1)(2008-11#1)(2008-7#1)(2008-9#1)
relate them to##5##3##(1997-7#1)(2007-10#1)(2008-12#1)(2008-9#1)(2012-2#1)
relate these##9##2##(1990-12#1)(2007-12#1)(2007-2#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#1)(2010-4#1)(2013-1#1)
relate this##4##2##(1997-4#1)(2007-7#1)(2008-7#1)(2012-2#1)
relate to cancer##2##3##(2007-4#1)(2007-9#1)
relate to one another##2##4##(2006-5#1)(2007-9#1)
relate to physician##2##3##(2007-9#1)(2009-11#1)
relate to the ability##2##4##(1996-10#1)(1996-8#1)
relate to the development of##2##5##(2007-6#1)(2011-1#1)
relate to the##36##3##(1991-2#1)(1992-6#1)(1993-4#1)(1994-6#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-6#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-9#1)(2007-1#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#2)(2010-2#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)
relate to their##2##3##(1994-11#1)(2005-7#1)
relate to##125##2##(1990-5#1)(1990-6#1)(1991-11#1)(1991-2#2)(1992-4#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-6#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-8#1)(2005-10#3)(2005-7#4)(2005-8#2)(2006-10#4)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#2)(2007-6#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#3)(2009-11#1)(2009-5#1)(2009-8#3)(2009-9#1)(2010-2#1)(2010-4#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#2)(2012-11#2)(2012-12#4)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
relate with##2##2##(2006-1#1)(2009-7#1)
relate##240##1##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-2#2)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-2#3)(1994-3#2)(1994-6#2)(1995-12#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-9#2)(1996-10#1)(1996-12#1)(1996-2#3)(1996-5#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-7#1)(2005-10#5)(2005-7#4)(2005-8#2)(2006-1#2)(2006-10#7)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#4)(2007-4#2)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#5)(2008-1#2)(2008-10#16)(2008-11#10)(2008-12#6)(2008-2#7)(2008-3#14)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#9)(2008-8#2)(2008-9#7)(2009-11#1)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#3)(2009-9#1)(2010-2#2)(2010-4#2)(2010-9#3)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#2)(2012-11#2)(2012-12#7)(2012-2#5)(2012-3#1)(2012-5#1)(2013-1#4)(2013-8#2)
related 2##2##2##(1995-12#1)(2008-5#1)
related DNA sequences##3##3##(2008-4#2)(2008-9#1)
related DNA##5##2##(1996-2#1)(2007-11#1)(2008-4#2)(2008-9#1)
related NCA-160##2##2##(1993-8#2)
related P##2##2##(2008-10#1)(2008-5#1)
related Quercus##2##2##(2012-5#2)
related TCAA##2##2##(2008-10#2)
related activities that##2##3##(2008-11#1)(2008-7#1)
related activities##4##2##(1997-6#1)(2008-11#1)(2008-2#1)(2008-7#1)
related acute on chronic liver failure]##2##6##(2010-12#2)
related adverse##3##2##(2007-11#1)(2008-3#1)(2011-2#1)
related agencies##2##2##(1995-3#1)(1996-3#1)
related agents##2##2##(1992-12#1)(1996-8#1)
related alterations##2##2##(2008-6#1)(2013-7#1)
related amino acids##2##3##(1997-7#1)(2008-10#1)
related analogues##7##2##(1992-3#1)(1993-4#2)(1997-3#2)(2006-12#1)(2013-1#1)
related and unrelated##3##3##(1993-11#1)(2007-7#1)(2008-10#1)
related and##28##2##(1990-3#1)(1992-5#1)(1993-1#1)(1993-11#1)(1994-2#1)(1995-1#1)(1995-11#1)(2005-7#1)(2006-11#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#2)(2008-1#1)(2008-10#4)(2008-4#1)(2008-6#2)(2010-7#1)(2013-1#1)(2013-8#1)
related antigens##2##2##(2012-2#1)(2013-7#1)
related anxiety and ethnic identity in##2##6##(2004-12#2)
related anxiety##4##2##(2004-12#4)
related applications##3##2##(2007-9#1)(2008-11#1)(2012-1#1)
related areas##2##2##(2005-7#1)(2010-12#1)
related articles##2##2##(2007-2#1)(2010-8#1)
related as expected to##3##4##(2007-12#3)
related as##4##2##(2007-12#3)(2008-10#1)
related bacteria##2##2##(1995-8#1)(1996-12#1)
related behaviors##2##2##(1996-10#1)(2009-8#1)
related benzodiazepines##2##2##(2008-1#2)
related biochemical##3##2##(2007-7#1)(2007-8#1)(2011-2#1)
related biological##2##2##(1995-2#1)(2008-8#1)
related bone##2##2##(2008-7#1)(2010-12#1)
related brain##2##2##(2005-9#1)(2010-12#1)
related but distinct##3##3##(2008-10#1)(2009-9#1)(2010-8#1)
related but##6##2##(2008-10#2)(2008-9#1)(2009-9#1)(2010-8#1)(2011-2#1)
related by a##6##3##(1991-12#2)(1991-4#1)(2008-4#1)(2008-6#1)(2010-7#1)
related by the##2##3##(1993-8#1)(2008-5#1)
related by##13##2##(1990-6#1)(1991-12#3)(1991-4#1)(1993-8#1)(1994-9#1)(2007-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2010-7#1)
related cardiac glycosides##2##3##(1994-9#2)
related cardiac##3##2##(1993-6#1)(1994-9#2)
related cardiovascular diseases##2##3##(2008-1#2)
related cardiovascular##4##2##(2008-1#3)(2010-9#1)
related categories##3##2##(2008-12#1)(2013-1#2)
related causes of death##2##4##(2006-8#1)(2007-8#1)
related causes of##3##3##(2006-8#1)(2007-8#1)(2008-12#1)
related causes##4##2##(2006-8#2)(2007-8#1)(2008-12#1)
related cerebral##2##2##(2008-8#1)(2009-12#1)
related changes in the##4##4##(1990-11#3)(2010-8#1)
related changes in##9##3##(1990-10#1)(1990-11#3)(1992-4#1)(1992-7#1)(2009-3#1)(2010-8#1)(2011-2#1)
related changes of##2##3##(1994-3#1)(2011-2#1)
related changes##15##2##(1990-10#1)(1990-11#4)(1992-4#1)(1992-7#1)(1994-3#1)(2008-12#1)(2008-7#1)(2009-3#1)(2010-8#2)(2011-2#2)
related characteristics##3##2##(2008-7#1)(2008-8#1)(2012-3#1)
related chemical##2##2##(1994-6#1)(2005-7#1)
related chemicals##2##2##(2008-10#1)(2008-7#1)
related chronic##2##2##(2007-11#1)(2012-2#1)
related clinical##2##2##(1993-9#1)(2008-5#1)
related closely to##2##3##(2008-10#1)(2008-2#1)
related closely##3##2##(1992-7#1)(2008-10#1)(2008-2#1)
related cognitive##3##2##(1991-7#1)(1996-1#1)(2007-12#1)
related communities##2##2##(2007-6#1)(2008-7#1)
related complex##3##2##(1991-5#1)(2008-4#1)(2008-5#1)
related complexes##2##2##(1992-4#1)(2008-10#1)
related complications##12##2##(1993-9#1)(1996-12#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-9#1)(2011-1#2)
related components##4##2##(2008-10#1)(2008-11#3)
related compound##3##2##(1990-8#1)(2008-10#1)(2008-5#1)
related compounds also##2##3##(1992-8#1)(1996-2#1)
related compounds and##3##3##(1997-6#1)(2008-10#1)(2008-5#1)
related compounds in##4##3##(1995-9#1)(2008-10#3)
related compounds on##4##3##(2008-11#4)
related compounds to##2##3##(1993-3#1)(2008-10#1)
related compounds were##4##3##(1990-10#1)(2008-10#1)(2008-11#1)(2008-6#1)
related compounds##55##2##(1990-1#1)(1990-10#1)(1990-8#2)(1991-9#1)(1992-8#1)(1993-3#1)(1993-4#1)(1994-9#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#16)(2008-11#7)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-12#1)(2010-7#1)(2012-2#1)
related concepts##3##2##(2004-12#1)(2007-2#1)(2008-9#1)
related conditions for##2##3##(2006-2#1)(2009-1#1)
related conditions##5##2##(1997-3#1)(2006-10#1)(2006-2#1)(2009-1#1)(2010-12#1)
related constructs##3##2##(2006-6#1)(2006-7#1)(2008-11#1)
related crystal##2##2##(1992-9#1)(2011-1#1)
related cytokines##4##2##(1992-8#1)(1995-12#3)
related data##2##2##(1990-7#1)(1992-2#1)
related deaths in##2##3##(2007-8#1)(2011-1#1)
related deaths##10##2##(1996-8#1)(1997-2#1)(2005-8#1)(2006-10#1)(2007-8#1)(2008-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
related derivatives##4##2##(1991-6#1)(1992-8#1)(1995-4#1)(1997-7#1)
related development of##2##3##(1992-1#1)(2010-8#1)
related directly to the##3##4##(1990-10#1)(1993-6#1)(2012-2#1)
related directly to##5##3##(1990-10#1)(1993-6#1)(2006-10#1)(2007-8#1)(2012-2#1)
related directly##6##2##(1990-10#1)(1993-6#1)(2006-10#1)(2007-8#1)(2012-2#1)(2012-3#1)
related disease##2##2##(2010-12#1)(2010-8#1)
related diseases##20##2##(1991-12#1)(1991-8#1)(1994-7#1)(2005-3#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-6#1)(2008-9#1)(2010-3#1)(2010-5#2)(2010-6#1)(2011-1#2)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
related disorders##30##2##(1992-6#2)(1996-8#1)(1997-8#1)(2006-11#1)(2006-12#1)(2008-1#2)(2008-10#1)(2008-11#9)(2008-12#5)(2008-3#2)(2009-7#1)(2010-5#1)(2011-11#1)(2012-2#2)
related donors##7##2##(2007-11#2)(2007-8#2)(2008-1#1)(2008-10#1)(2009-8#1)
related drug##2##2##(1993-3#1)(1996-5#1)
related drugs##4##2##(1993-7#1)(2006-10#1)(2010-12#1)(2011-1#1)
related effects##4##2##(1997-1#1)(2008-10#1)(2012-12#1)(2012-2#1)
related either to##2##3##(1991-8#1)(1994-3#1)
related either##3##2##(1991-8#1)(1994-3#1)(1996-3#1)
related elements##2##2##(2010-10#1)(2010-2#1)
related enzyme##2##2##(1994-9#1)(1996-9#1)
related enzymes and##2##3##(1994-8#1)(1995-12#1)
related enzymes##6##2##(1991-2#1)(1992-3#1)(1994-8#1)(1995-12#1)(2010-5#1)(2013-8#1)
related especially to##2##3##(1995-11#1)(2004-11#1)
related ethers##2##2##(2005-11#1)(2006-5#1)
related event expressions are also integrated into a supervised machine-learning approach##2##11##(2013-1#2)
related events in the##2##4##(1994-2#1)(2008-7#1)
related events##8##2##(1991-2#2)(1994-2#1)(2005-10#1)(2008-11#1)(2008-7#1)(2013-1#2)
related experimental##2##2##(2006-5#1)(2006-6#1)
related experiments##3##2##(1991-5#1)(2007-12#1)(2013-7#1)
related factors and##3##3##(2011-2#2)(2013-8#1)
related factors##18##2##(1996-11#1)(2007-3#1)(2007-4#1)(2008-7#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#3)
related fashion##2##2##(1993-12#1)(2008-5#1)
related fatalities##3##2##(2010-12#1)(2012-12#1)(2013-7#1)
related features##3##2##(1995-11#1)(2008-2#1)(2009-10#1)
related fields##3##2##(2006-10#1)(2008-7#1)(2010-8#1)
related for the##2##3##(1996-12#1)(2007-12#1)
related for##3##2##(1996-1#1)(1996-12#1)(2007-12#1)
related forms of##2##3##(1990-12#1)(1995-11#1)
related functional##3##2##(1996-1#1)(2007-12#1)(2007-3#1)
related fungi##5##2##(2008-10#4)(2008-5#1)
related future research##2##3##(2010-10#1)(2013-8#1)
related gene (protein)##3##3##(2011-3#3)
related gene expression##2##3##(2008-10#1)(2013-1#1)
related gene##11##2##(1995-2#1)(1996-7#1)(2005-10#1)(2008-10#1)(2008-11#1)(2008-8#2)(2011-3#3)(2013-1#1)
related genera##3##2##(1992-1#1)(2008-10#1)(2008-5#1)
related genes and##3##3##(1994-6#1)(2006-12#1)(2008-4#1)
related genes have##2##3##(1990-9#1)(2005-7#1)
related genes in##4##3##(1992-3#1)(1994-10#1)(2005-7#1)(2012-2#1)
related genes##28##2##(1990-12#1)(1990-8#1)(1990-9#1)(1992-3#1)(1994-10#1)(1994-11#1)(1994-6#1)(1994-8#1)(1996-2#4)(1997-2#1)(1997-4#1)(2005-7#2)(2006-12#1)(2008-11#1)(2008-4#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2012-12#1)(2012-2#1)
related genetic##2##2##(1990-12#1)(2013-1#1)
related genus##2##2##(2008-6#2)
related group##6##2##(1996-1#1)(2006-1#1)(2007-5#1)(2008-10#2)(2011-12#1)
related groups##2##2##(1993-12#1)(1995-5#1)
related growth factors##4##3##(1991-3#2)(2010-8#1)(2013-8#1)
related growth##5##2##(1991-3#2)(1994-12#1)(2010-8#1)(2013-8#1)
related health##2##2##(1997-3#1)(2012-2#1)
related hormone##2##2##(1995-2#1)(2013-8#1)
related hormones##2##2##(1995-12#1)(2011-2#1)
related host##2##2##(2008-8#1)(2013-7#1)
related human##3##2##(1990-4#1)(1991-3#1)(2008-8#1)
related illness##2##2##(2007-7#1)(2009-12#1)
related illnesses##3##2##(1991-6#1)(2004-7#1)(2007-2#1)
related immune##2##2##(1996-4#1)(2005-7#1)
related impairments##8##2##(2011-1#8)
related in a##2##3##(2008-10#1)(2008-9#1)
related in part to##3##4##(1990-8#1)(1994-3#1)(2009-10#1)
related in structure and##2##4##(1991-4#1)(2007-11#1)
related in structure##3##3##(1991-4#1)(1991-7#1)(2007-11#1)
related in##16##2##(1990-8#1)(1991-4#1)(1991-7#1)(1994-3#1)(1995-11#1)(2005-12#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-10#1)(2012-2#1)
related increase in##2##3##(1992-7#1)(2008-5#1)
related indicators##3##2##(2009-10#1)(2011-1#1)(2013-8#1)
related individuals##3##2##(1996-5#1)(2010-8#1)(2012-3#1)
related information##3##2##(2008-2#1)(2008-7#1)(2009-12#1)
related inhibitor##3##2##(1993-11#1)(1997-3#1)(2013-8#1)
related inhibitors##3##2##(1992-12#1)(1997-4#1)(2011-3#1)
related injuries##3##2##(1991-2#1)(2006-6#1)(2007-1#1)
related isolates##4##2##(1992-10#1)(2008-10#1)(2011-2#2)
related issues of##2##3##(2008-11#1)(2013-1#1)
related issues##7##2##(1995-2#1)(1996-1#1)(2008-11#1)(2008-5#1)(2009-9#1)(2012-3#1)(2013-1#1)
related legislation##2##2##(1994-1#1)(2008-9#1)
related literature##8##2##(2006-11#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-1#1)(2012-12#3)
related mainly to##3##3##(2007-3#1)(2008-10#2)
related members of the##3##4##(1994-2#1)(2008-5#1)(2011-1#1)
related members##5##2##(1990-2#1)(1994-2#1)(1997-7#1)(2008-5#1)(2011-1#1)
related metabolic##8##2##(1992-8#1)(2008-1#1)(2008-10#1)(2008-3#3)(2010-5#1)(2012-12#1)
related metabolites##3##2##(1990-8#1)(1995-9#1)(2009-4#1)
related minor##2##2##(2008-10#1)(2013-1#1)
related models##2##2##(2006-10#1)(2008-4#1)
related molecules##2##2##(1994-11#1)(1996-3#1)
related morbidity and mortality##3##4##(2007-3#1)(2009-4#1)(2013-7#1)
related morbidity##5##2##(1994-8#1)(2007-3#2)(2009-4#1)(2013-7#1)
related more to##3##3##(1995-2#1)(1995-9#1)(2009-5#1)
related mortality##9##2##(1994-2#1)(2006-6#1)(2008-5#1)(2009-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
related multiple regression model##2##4##(2009-7#2)
related multiple##3##2##(2008-7#1)(2009-7#2)
related myocardial##2##2##(2006-4#1)(2009-10#1)
related natural##3##2##(1994-6#2)(2008-4#1)
related neoplasms##2##2##(1990-4#1)(1992-5#1)
related not only to##4##4##(1992-6#1)(1993-12#1)(2008-5#1)(2009-7#1)
related not##5##2##(1992-6#1)(1993-12#1)(1995-2#1)(2008-5#1)(2009-7#1)
related only to the##3##4##(1991-2#1)(1992-8#1)(2008-10#1)
related only to##4##3##(1991-2#1)(1992-8#1)(2008-10#1)(2008-3#1)
related or unrelated##3##3##(2008-1#1)(2012-12#2)
related or##6##2##(2007-12#1)(2008-1#2)(2012-12#2)(2013-1#1)
related parameters in Saudi##2##4##(2007-2#2)
related parameters##6##2##(2005-12#1)(2007-2#2)(2008-10#1)(2010-5#1)(2011-3#1)
related patents##2##2##(2005-7#1)(2010-7#1)
related pathology##3##2##(1996-12#1)(2008-1#1)(2008-9#1)
related peptide in##3##3##(1992-9#1)(1994-2#2)
related peptide##17##2##(1990-12#1)(1990-7#2)(1991-3#1)(1991-9#3)(1992-3#1)(1992-9#1)(1994-2#3)(1994-9#1)(1995-12#1)(2008-5#1)(2013-7#2)
related peptides and##2##3##(1992-11#1)(1996-5#1)
related peptides were##2##3##(1992-6#1)(2007-8#1)
related peptides##13##2##(1991-1#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-11#1)(1994-3#1)(1994-9#1)(1996-5#1)(1996-8#1)(1997-1#1)(2007-8#2)
related persons##2##2##(2007-7#1)(2008-10#1)
related phenomena##6##2##(1992-1#1)(1995-5#1)(2008-3#2)(2009-12#2)
related phosphatases##2##2##(1992-9#1)(1995-3#1)
related plant##2##2##(1996-9#1)(1997-5#1)
related polypeptides##2##2##(1990-6#1)(1991-10#1)
related polyphenolic compounds##2##3##(1992-9#1)(2011-2#1)
related populations##3##2##(1996-6#1)(2008-9#1)(2009-5#1)
related potentials##4##2##(1991-10#1)(2008-11#2)(2008-9#1)
related primarily to##2##3##(1994-2#1)(2009-3#1)
related primes##2##2##(2009-9#2)
related problems are##2##3##(1990-4#1)(2008-1#1)
related problems##15##2##(1990-4#1)(1995-3#1)(1996-6#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2010-7#1)(2013-8#1)
related procedures##2##2##(2008-9#1)(2009-5#1)
related programs##2##2##(1996-1#1)(2012-2#1)
related promoters##2##2##(1993-9#1)(1997-4#1)
related protein in rodents)##2##4##(1994-9#2)
related protein in##5##3##(1992-1#1)(1994-9#2)(2008-12#1)(2013-1#1)
related protein##22##2##(1990-11#1)(1990-8#1)(1991-11#1)(1992-1#1)(1992-12#1)(1993-6#1)(1994-12#2)(1994-8#1)(1994-9#2)(1995-6#2)(1996-11#1)(1997-5#1)(1997-7#1)(2008-12#1)(2008-9#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
related proteins that##2##3##(2008-1#1)(2009-8#1)
related proteins##26##2##(1990-5#2)(1991-5#1)(1992-6#1)(1993-11#1)(1993-4#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-7#2)(2009-8#2)(2010-12#2)(2012-12#1)
related quality of life##6##4##(2007-6#2)(2007-7#1)(2008-12#1)(2011-2#2)
related quantities##2##2##(2008-10#1)(2008-7#1)
related question##2##2##(2008-11#1)(2010-7#1)
related receptors##2##2##(2011-1#1)(2011-2#1)
related references##2##2##(2010-5#1)(2013-8#1)
related reforms##3##2##(2008-4#2)(2011-1#1)
related research##4##2##(1990-6#1)(1996-2#1)(2006-10#1)(2008-10#1)
related risk factors##11##3##(2012-1#1)(2013-8#10)
related risk##12##2##(2006-10#1)(2012-1#1)(2013-8#10)
related risks##3##2##(2005-9#1)(2007-10#1)(2008-1#1)
related sepsis##2##2##(2007-8#1)(2008-4#1)
related sequence##4##2##(1992-12#1)(1994-8#1)(1995-6#1)(2008-10#1)
related sequences are##2##3##(1995-4#1)(1996-11#1)
related sequences##11##2##(1990-12#1)(1990-5#1)(1993-2#1)(1994-11#1)(1994-6#1)(1995-4#1)(1996-10#1)(1996-11#1)(2005-10#1)(2008-4#1)(2008-5#1)
related serine/threonine##2##2##(1996-11#1)(1996-5#1)
related services##2##2##(1990-12#1)(2012-3#1)
related side effects##2##3##(2008-1#1)(2011-2#1)
related side-effects##2##2##(2007-8#1)(2008-8#1)
related signaling in##2##3##(2008-11#2)
related signaling##3##2##(2008-11#2)(2013-1#1)
related simple##2##2##(1997-2#1)(2008-12#1)
related site-specific##2##2##(1995-3#1)(1997-2#1)
related social##3##2##(1991-3#1)(2008-9#1)(2012-12#1)
related species and##2##3##(1995-11#1)(2007-3#1)
related species is##2##3##(2008-10#1)(2008-11#1)
related species of##3##3##(2007-3#1)(2008-10#1)(2008-7#1)
related species were##2##3##(2008-10#2)
related species##58##2##(1991-11#1)(1991-5#1)(1993-11#1)(1995-1#1)(1995-11#2)(1996-7#1)(1997-4#2)(1997-6#1)(2006-12#1)(2006-8#1)(2007-12#3)(2007-2#1)(2007-3#3)(2007-8#2)(2008-10#15)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#4)(2009-4#1)(2010-3#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
related strain##3##2##(2006-8#1)(2007-7#1)(2008-10#1)
related strains##7##2##(1994-3#1)(2006-10#1)(2008-4#1)(2008-5#2)(2011-2#1)(2012-11#1)
related strategies##2##2##(1992-10#1)(2009-8#1)
related stress##2##2##(2011-2#1)(2012-1#1)
related structures##8##2##(1992-10#1)(1992-8#1)(1993-6#1)(1995-1#1)(2006-4#1)(2010-11#1)(2010-6#1)(2012-3#1)
related studies##2##2##(1991-7#1)(1996-12#1)
related subjects##2##2##(1997-2#1)(2007-9#1)
related substances in##3##3##(2008-10#1)(2010-12#1)(2013-7#1)
related substances##15##2##(1992-4#1)(1992-8#1)(1995-2#1)(2006-8#1)(2008-10#3)(2010-12#2)(2012-12#3)(2013-7#3)
related symptoms as well as##2##5##(1994-7#1)(2006-7#1)
related symptoms##11##2##(1990-10#1)(1994-7#1)(2005-3#1)(2006-10#1)(2006-7#1)(2007-2#2)(2010-12#1)(2011-2#1)(2012-2#2)
related syndromes##2##2##(1996-4#1)(2007-11#1)
related taxa##3##2##(2006-5#1)(2008-7#1)(2011-2#1)
related taxonomic traits were##3##4##(2008-8#3)
related taxonomic traits##4##3##(2008-8#4)
related techniques##5##2##(1996-5#1)(2007-12#1)(2012-11#2)(2012-3#1)
related terms##5##2##(2012-2#1)(2013-1#4)
related the##2##2##(2008-2#1)(2008-3#1)
related to 1##2##3##(2007-11#1)(2008-7#1)
related to AIDS##3##3##(1990-11#1)(1991-6#1)(2007-2#1)
related to B##2##3##(2006-5#1)(2007-6#1)
related to BMI##2##3##(2011-1#1)(2013-8#1)
related to C##2##3##(2007-12#1)(2008-10#1)
related to DMPM##2##3##(2010-12#2)
related to E##3##3##(2007-3#1)(2008-10#2)
related to EPS##2##3##(2011-2#2)
related to HIV infection##2##4##(1994-6#1)(2011-2#1)
related to HIV##3##3##(1994-6#2)(2011-2#1)
related to HIV/AIDS##3##3##(2007-12#1)(2010-12#1)(2012-12#1)
related to M##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
related to Ménière's disease##2##4##(2008-2#2)
related to P##6##3##(2008-10#1)(2008-4#1)(2008-5#2)(2011-12#1)(2012-3#1)
related to PD##2##3##(2008-11#1)(2008-7#1)
related to SA##2##3##(2008-10#2)
related to YouTube##2##3##(2012-2#2)
related to a decrease in the##3##6##(1990-5#1)(2008-10#1)(2010-4#1)
related to a decrease in##4##5##(1990-5#1)(1993-4#1)(2008-10#1)(2010-4#1)
related to a decrease##5##4##(1990-5#1)(1993-4#1)(1997-1#1)(2008-10#1)(2010-4#1)
related to a deficiency in##6##5##(2013-1#6)
related to a direct##2##4##(1990-5#1)(1992-6#1)
related to a failure##2##4##(1990-7#1)(2012-12#1)
related to a greater##3##4##(2008-5#1)(2010-11#1)(2010-12#1)
related to a higher##2##4##(2006-10#1)(2007-4#1)
related to a large##2##4##(1992-1#1)(2009-4#1)
related to a particular##2##4##(2008-12#1)(2012-12#1)
related to a poor##2##4##(1991-12#1)(2009-3#1)
related to a reduced risk of##2##6##(2006-10#1)(2013-1#1)
related to a reduced##3##4##(2006-10#1)(2013-1#1)(2013-8#1)
related to a reduction of##2##5##(2006-6#1)(2010-12#1)
related to a##93##3##(1990-12#1)(1990-5#2)(1990-7#1)(1991-12#1)(1991-2#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-6#2)(1993-4#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#2)(1994-9#2)(1995-12#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-8#2)(2006-10#3)(2006-12#1)(2006-5#1)(2006-6#2)(2006-9#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2010-11#1)(2010-12#4)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#10)(2013-7#1)(2013-8#2)
related to abdominal##2##3##(2008-10#1)(2010-8#1)
related to abnormal induction of sister chromatid exchanges##2##8##(1997-7#2)
related to acquired##2##3##(1995-2#1)(2008-7#1)
related to activity##3##3##(2006-10#1)(2009-3#2)
related to acute##8##3##(1992-6#1)(1995-9#1)(2008-3#3)(2009-5#2)(2011-2#1)
related to adolescent##3##3##(2009-10#1)(2009-7#1)(2010-2#1)
related to adolescents'##3##3##(2009-11#2)(2009-7#1)
related to age and##3##4##(1992-2#1)(1996-3#1)(2010-12#1)
related to age at##3##4##(1991-9#1)(1994-6#1)(2008-9#1)
related to age##18##3##(1990-3#1)(1991-4#1)(1991-9#1)(1992-2#1)(1994-6#1)(1996-3#2)(1997-3#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-9#1)(2010-12#2)(2013-1#1)
related to aging##2##3##(2009-4#1)(2010-4#1)
related to air##2##3##(2008-1#1)(2008-5#1)
related to alcohol##4##3##(1991-9#1)(1992-12#1)(2013-1#2)
related to all##2##3##(1994-6#1)(1995-12#1)
related to an increase in##3##5##(1993-11#1)(2012-1#2)
related to an increase of##3##5##(1994-10#1)(1995-1#1)(2008-5#1)
related to an increase##6##4##(1993-11#1)(1994-10#1)(1995-1#1)(2008-5#1)(2012-1#2)
related to an increased##4##4##(1990-7#1)(1990-8#1)(2007-8#1)(2010-7#1)
related to an##32##3##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1992-10#1)(1992-4#1)(1993-11#1)(1994-10#1)(1994-11#1)(1994-3#1)(1995-1#1)(1996-6#1)(1997-5#1)(2004-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-6#1)(2009-2#1)(2009-3#1)(2010-7#1)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#1)
related to anaesthesia##2##3##(2006-10#1)(2010-7#1)
related to animal##2##3##(2007-12#1)(2012-1#1)
related to antioxidant##2##3##(1995-5#1)(2008-4#1)
related to any##6##3##(1993-9#1)(1996-7#1)(2006-2#1)(2006-8#1)(2008-10#1)(2011-2#1)
related to appearance##3##3##(2007-12#2)(2008-9#1)
related to areas##2##3##(2008-8#1)(2009-2#1)
related to asbestos##2##3##(1993-9#1)(2010-9#1)
related to at least##2##4##(2008-4#1)(2013-1#1)
related to atherosclerosis##4##3##(1995-8#1)(2008-1#1)(2008-4#1)(2010-12#1)
related to atherosclerotic##2##3##(1993-10#1)(2007-10#1)
related to attitudes##2##3##(2007-12#1)(2011-1#1)
related to average##2##3##(2008-10#1)(2008-9#1)
related to bacteria in##2##4##(2006-8#2)
related to bacterial##2##3##(2008-1#1)(2010-2#1)
related to beam##2##3##(2007-12#1)(2008-3#1)
related to behavioural##2##3##(1990-10#1)(2008-9#1)
related to being a successful##2##5##(2012-3#2)
related to being a##3##4##(2012-12#1)(2012-3#2)
related to being##4##3##(2012-1#1)(2012-12#1)(2012-3#2)
related to benefits##2##3##(2008-3#1)(2013-7#1)
related to better health##2##4##(2010-2#2)
related to better##6##3##(1993-2#1)(1994-9#1)(2007-12#1)(2010-2#2)(2011-2#1)
related to blood##4##3##(1990-12#1)(1996-12#1)(2007-5#1)(2008-11#1)
related to body esteem##2##4##(2007-12#2)
related to body image##3##4##(2007-12#2)(2007-7#1)
related to body##7##3##(2007-12#4)(2007-7#2)(2008-5#1)
related to both the##2##4##(1992-9#1)(1997-7#1)
related to both##19##3##(1991-2#1)(1992-11#1)(1992-9#1)(1997-1#1)(1997-4#1)(1997-5#2)(1997-7#1)(2006-5#1)(2007-9#1)(2008-10#1)(2008-5#2)(2008-7#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#1)(2013-1#1)
related to breast cancer##2##4##(1990-8#1)(1997-1#1)
related to breast##3##3##(1990-8#1)(1997-1#1)(2004-8#1)
related to breastfeeding##2##3##(2007-2#2)
related to cancer##8##3##(1990-12#1)(2007-2#1)(2008-1#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
related to carcinogenesis and##2##4##(2011-2#1)(2013-8#1)
related to carcinogenesis##4##3##(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
related to cardiac##2##3##(2007-4#1)(2007-7#1)
related to cardiovascular##3##3##(2005-8#1)(2010-6#1)(2011-2#1)
related to care##2##3##(1995-3#1)(2009-10#1)
related to carotid##2##3##(1990-7#1)(2008-7#1)
related to cell growth##3##4##(1993-8#1)(2008-6#1)(2011-1#1)
related to cell proliferation##2##4##(1991-2#1)(1993-8#1)
related to cell##13##3##(1990-5#1)(1991-2#1)(1992-11#1)(1993-8#2)(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-1#1)(2010-10#1)(2011-1#1)
related to cellular##2##3##(1994-5#1)(1997-7#1)
related to central venous##2##4##(2006-6#1)(2013-8#1)
related to central##3##3##(2006-6#1)(2013-8#2)
related to cerebral##3##3##(2011-2#1)(2013-1#2)
related to certain##2##3##(1993-12#1)(1995-8#1)
related to change in##2##4##(2011-2#1)(2012-12#1)
related to change##3##3##(1994-6#1)(2011-2#1)(2012-12#1)
related to changes in the##4##5##(1991-3#1)(1994-3#1)(2006-10#1)(2008-10#1)
related to changes in##12##4##(1991-3#1)(1991-8#1)(1994-3#1)(2005-11#1)(2006-10#1)(2006-5#1)(2008-10#2)(2008-6#1)(2009-12#1)(2012-7#1)(2013-1#1)
related to changes##14##3##(1990-8#1)(1991-3#1)(1991-8#1)(1994-3#1)(2005-11#1)(2006-10#1)(2006-5#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-12#1)(2012-7#1)(2013-1#1)
related to chemical##2##3##(1997-2#1)(2008-9#1)
related to chemotherapy##3##3##(2013-1#3)
related to child##2##3##(2007-2#1)(2009-7#1)
related to childbirth##3##3##(1995-1#1)(2007-2#2)
related to children's##3##3##(2007-11#1)(2010-2#1)(2011-2#1)
related to cholesterol##2##3##(1995-12#1)(1996-7#1)
related to chronic##4##3##(1995-1#1)(2007-8#1)(2008-10#1)(2008-5#1)
related to common##2##3##(1994-2#1)(2011-2#1)
related to community##2##3##(2009-4#1)(2012-2#1)
related to concentration of##2##4##(2008-10#2)
related to consumer##2##3##(1993-12#1)(2013-1#1)
related to contact##2##3##(2009-4#1)(2010-6#1)
related to cranial##2##3##(2006-9#1)(2007-12#1)
related to current##3##3##(2007-12#1)(2010-4#1)(2013-8#1)
related to decreased##4##3##(2006-10#2)(2010-1#1)(2011-2#1)
related to delayed##3##3##(2008-7#1)(2008-8#1)(2012-2#1)
related to depressed##2##3##(2006-3#1)(2011-1#1)
related to desired upper body size##2##6##(2007-12#2)
related to desired##4##3##(2007-12#4)
related to diabetes##3##3##(2008-1#1)(2008-5#1)(2012-3#1)
related to diagnosis##2##3##(2008-5#1)(2011-2#1)
related to diagnostic##3##3##(2007-7#1)(2010-9#1)(2013-8#1)
related to dietary##3##3##(2007-8#1)(2008-11#1)(2011-2#1)
related to differences in the##2##5##(2007-8#1)(2008-11#1)
related to differences in##16##4##(1990-4#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(2007-1#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#2)(2009-7#1)(2010-4#1)
related to different##8##3##(1994-6#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-2#1)(2010-12#1)
related to differential##2##3##(1995-5#1)(2006-6#1)
related to differentiation##3##3##(1992-7#1)(2008-8#1)(2010-3#1)
related to discharge planning##3##4##(2010-11#1)(2012-11#2)
related to disease##4##3##(2007-12#1)(2007-2#1)(2008-10#1)(2008-3#1)
related to diverse##3##3##(2010-1#1)(2012-12#1)(2013-8#1)
related to dose##3##3##(1993-4#1)(2008-10#1)(2008-7#1)
related to drought##2##3##(2008-10#1)(2012-7#1)
related to drug development##2##4##(1991-3#1)(2008-5#1)
related to drug##5##3##(1991-3#1)(2007-6#1)(2008-5#1)(2010-12#1)(2012-2#1)
related to duration of follow-up##2##5##(1993-12#2)
related to duration of##3##4##(1992-2#1)(1993-12#2)
related to duration##4##3##(1992-2#1)(1993-12#2)(2006-6#1)
related to dysfunction of##2##4##(1997-5#1)(2009-2#1)
related to each other and##2##5##(2008-10#1)(2008-5#1)
related to each other##13##4##(1993-3#1)(2007-2#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-8#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
related to each##20##3##(1993-3#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2009-7#2)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
related to efficacy##2##3##(1995-5#1)(2007-6#1)
related to either the##2##4##(1995-12#1)(2008-11#1)
related to either##6##3##(1992-6#1)(1995-1#1)(1995-12#1)(2008-11#1)(2010-4#1)(2012-12#1)
related to elevated##3##3##(2006-3#2)(2011-2#1)
related to emotional##2##3##(2006-3#1)(2013-1#1)
related to employees'##2##3##(2011-2#1)(2012-3#1)
related to employment##2##3##(2009-9#1)(2010-2#1)
related to energy##2##3##(2009-8#1)(2012-2#1)
related to epidermal growth factor##2##5##(1991-2#2)
related to establishing##2##3##(1991-5#1)(1997-3#1)
related to estrogen##2##3##(2008-7#1)(2011-2#1)
related to excessive##3##3##(1994-10#1)(1995-12#1)(2006-9#1)
related to experimental##2##3##(2005-11#1)(2011-1#1)
related to exposure to##3##4##(2010-9#2)(2011-2#1)
related to exposure##5##3##(1990-5#1)(1995-2#1)(2010-9#2)(2011-2#1)
related to failure##2##3##(2010-8#1)(2011-2#1)
related to family##4##3##(1995-12#1)(2008-7#1)(2009-10#1)(2010-12#1)
related to feeding and##2##4##(2009-4#1)(2011-2#1)
related to feeding##4##3##(2009-4#1)(2010-6#1)(2011-2#1)(2013-8#1)
related to female##2##3##(1991-6#1)(2008-1#1)
related to fertility##2##3##(2008-9#2)
related to financial##3##3##(2009-7#1)(2010-10#2)
related to flow##2##3##(2008-7#1)(2010-9#1)
related to food##2##3##(2012-2#2)
related to fundamental##3##3##(1996-1#1)(2008-5#1)(2008-9#1)
related to gender and##2##4##(1996-6#1)(2011-1#1)
related to gender or##2##4##(1994-6#1)(2013-1#1)
related to gender##9##3##(1994-6#1)(1996-6#1)(2007-4#1)(2008-9#1)(2009-10#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
related to general##2##3##(1993-6#1)(1995-5#1)
related to genetic##4##3##(2005-10#1)(2008-10#1)(2008-11#1)(2009-3#1)
related to glycidol administration##2##4##(2008-9#2)
related to greater##3##3##(2009-7#1)(2012-1#2)
related to groups based##2##4##(1991-3#1)(2008-10#1)
related to groups##3##3##(1991-3#1)(2008-10#2)
related to growth##4##3##(1994-8#1)(2006-9#1)(2012-5#1)(2013-7#1)
related to having##2##3##(2008-8#1)(2012-1#1)
related to health care##2##4##(2006-8#1)(2010-11#1)
related to health##7##3##(1997-3#2)(2006-8#1)(2010-11#1)(2012-1#1)(2012-3#1)(2013-1#1)
related to hepatic##2##3##(2006-4#1)(2007-5#1)
related to high##5##3##(1995-1#1)(2004-11#1)(2008-10#2)(2009-7#1)
related to higher levels of##2##5##(1991-11#1)(2009-7#1)
related to higher##5##3##(1991-11#1)(1992-3#1)(2007-12#1)(2009-7#2)
related to home##2##3##(1991-12#1)(1995-3#1)
related to hormonal##2##3##(2012-3#1)(2013-8#1)
related to hormone##2##3##(2010-9#1)(2012-3#1)
related to human##10##3##(1993-9#1)(1996-12#1)(2005-11#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-2#1)(2010-5#1)(2013-8#1)
related to hydraulic conductance##2##4##(2008-10#1)(2009-8#1)
related to immunosuppression##2##3##(2007-11#1)(2010-5#1)
related to impaired##2##3##(2007-8#1)(2009-3#1)
related to important##2##3##(1996-2#1)(1997-2#1)
related to improved##3##3##(2008-12#1)(2008-6#1)(2010-9#1)
related to in##2##3##(1996-12#1)(2011-1#1)
related to inadequate##2##3##(2008-1#1)(2012-2#1)
related to income##2##3##(1994-4#1)(2007-6#1)
related to increased##11##3##(1990-7#1)(1993-12#1)(2005-10#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-9#1)(2011-1#1)(2013-7#1)
related to individual##2##3##(2008-11#1)(2010-10#1)
related to infection##2##3##(2008-10#1)(2012-3#1)
related to infectious##2##3##(1993-2#1)(2006-11#1)
related to inflammatory##2##3##(1996-6#1)(2008-5#1)
related to influenza##2##3##(1992-6#1)(2009-12#1)
related to informed consent##2##4##(2006-10#1)(2009-6#1)
related to inhibition of##3##4##(1990-12#1)(2008-7#1)(2009-1#1)
related to initial##3##3##(2006-10#1)(2008-10#1)(2008-9#1)
related to insulin resistance##5##4##(2006-1#1)(2006-9#1)(2008-1#2)(2013-1#1)
related to interactions between##2##4##(1996-6#1)(2005-11#1)
related to internalizing##3##3##(2011-2#1)(2012-12#1)(2013-1#1)
related to it##7##3##(1996-6#1)(2006-12#1)(2006-8#1)(2009-4#1)(2011-2#1)(2012-3#2)
related to its role in##2##5##(2007-8#1)(2008-8#1)
related to its##32##3##(1990-2#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-2#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-8#1)(1997-1#1)(2006-10#1)(2007-1#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#1)
related to language##2##3##(2010-2#2)
related to lifestyle##3##3##(2006-8#1)(2008-1#1)(2008-3#1)
related to lipid##3##3##(2004-11#1)(2007-3#1)(2013-1#1)
related to liver##2##3##(1994-12#1)(1996-8#1)
related to local##3##3##(1997-7#1)(2007-3#1)(2008-3#1)
related to location##2##3##(2008-12#1)(2008-6#1)
related to loss of##4##4##(1992-2#1)(1994-5#1)(1997-4#1)(2008-10#1)
related to lovastatin##2##3##(1991-7#1)(1992-11#1)
related to low##6##3##(2007-9#1)(2008-10#1)(2009-10#1)(2009-7#1)(2010-2#1)(2013-1#1)
related to lower levels of##2##5##(2009-7#2)
related to lower##3##3##(2009-7#2)(2010-12#1)
related to lymph node##2##4##(2004-2#1)(2011-2#1)
related to major##2##3##(1993-1#1)(2007-12#1)
related to male##2##3##(2008-1#1)(2012-3#1)
related to mammalian##4##3##(1991-12#1)(1993-11#1)(1995-6#1)(2006-11#1)
related to managed care##2##4##(1995-12#1)(1997-2#1)
related to management##2##3##(2008-10#1)(2008-9#1)
related to many##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
related to mass##2##3##(2009-5#1)(2012-3#1)
related to maturation##2##3##(1992-7#1)(2006-11#1)
related to measures of##3##4##(2008-10#1)(2010-3#1)(2011-1#1)
related to medical procedures##2##4##(2008-10#2)
related to medical##5##3##(1993-3#1)(2008-10#2)(2008-11#1)(2008-7#1)
related to medication##3##3##(1992-12#1)(1992-3#1)(2007-9#1)
related to members of the##2##5##(1993-12#1)(1994-3#1)
related to memory##2##3##(1991-3#1)(2008-12#1)
related to mental health##3##4##(2006-9#1)(2008-11#1)(2011-2#1)
related to mental##4##3##(2006-9#1)(2008-11#1)(2011-2#1)(2013-8#1)
related to metabolic##3##3##(1996-12#1)(2008-3#1)(2009-5#1)
related to mood##2##3##(1996-1#1)(2010-2#1)
related to more##6##3##(2007-12#1)(2008-3#1)(2008-7#1)(2010-7#1)(2012-12#2)
related to mortality##2##3##(2008-7#1)(2012-12#1)
related to multiple##3##3##(2008-11#2)(2012-2#1)
related to muscle##4##3##(1996-10#1)(2010-4#1)(2010-8#1)(2010-9#1)
related to negative##2##3##(2007-12#1)(2012-1#1)
related to neurodegenerative##2##3##(2009-9#1)(2010-11#1)
related to normal##5##3##(1992-10#1)(1995-5#1)(2007-8#1)(2008-5#1)(2013-1#1)
related to nuclear factor 1##2##5##(1994-9#2)
related to number##2##3##(2006-5#1)(2008-4#1)
related to nursing##5##3##(2007-10#1)(2008-1#2)(2008-11#1)(2008-12#1)
related to nutrition##4##3##(2010-5#1)(2011-2#1)(2012-2#2)
related to obesity##3##3##(2008-9#1)(2010-10#1)(2011-2#1)
related to observed##2##3##(2008-3#1)(2008-7#1)
related to oceanographic conditions##2##4##(2007-5#1)(2012-2#1)
related to other diseases##2##4##(1990-6#1)(1991-5#1)
related to other known##2##4##(1990-10#1)(1995-2#1)
related to other##13##3##(1990-10#1)(1990-6#1)(1991-5#1)(1991-9#1)(1995-2#1)(1996-12#1)(2006-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-3#1)(2013-7#1)
related to our##3##3##(2008-10#1)(2009-9#1)(2011-2#1)
related to oxidative stress##3##4##(1996-9#1)(2007-12#1)(2008-10#1)
related to oxidative##4##3##(1996-9#1)(2007-12#1)(2008-10#1)(2009-3#1)
related to oxygen##2##3##(1990-12#1)(1991-9#1)
related to pain##3##3##(1996-7#1)(2008-3#1)(2010-7#1)
related to parental##2##3##(1996-3#1)(2009-7#1)
related to patient##5##3##(1992-3#1)(1993-12#1)(2007-12#1)(2008-6#1)(2010-3#1)
related to patients##3##3##(1992-10#1)(2011-1#1)(2011-2#1)
related to people's satisfaction##3##4##(2010-2#3)
related to perceptions##2##3##(2011-2#1)(2012-3#1)
related to percutaneous##2##3##(2007-7#1)(2010-12#1)
related to performance rank##2##4##(2012-1#2)
related to performance##4##3##(1992-9#1)(2012-1#2)(2012-12#1)
related to personal##2##3##(1996-3#1)(2012-1#1)
related to physical activity##2##4##(2007-10#1)(2010-12#1)
related to physical##9##3##(2007-10#1)(2008-12#1)(2009-11#1)(2009-4#2)(2009-7#1)(2010-12#1)(2010-3#1)(2010-6#1)
related to plant##3##3##(2008-8#2)(2008-9#1)
related to plaque##2##3##(2006-2#1)(2011-12#1)
related to platelet##2##3##(1990-7#1)(1991-12#1)
related to pollen##2##3##(2009-8#1)(2011-2#1)
related to poor##6##3##(1991-12#1)(2004-1#1)(2006-12#1)(2007-12#1)(2008-9#1)(2013-1#1)
related to population##3##3##(1996-3#1)(2008-10#1)(2008-9#1)
related to positive##4##3##(2004-2#2)(2007-12#1)(2010-6#1)
related to post-operative##2##3##(2007-11#1)(2012-2#1)
related to postoperative##2##3##(2008-7#2)
related to poverty##2##3##(1993-1#1)(1995-9#1)
related to power-law##2##3##(2007-12#2)
related to pregnancy and##2##4##(1990-4#1)(2009-4#1)
related to pregnancy##8##3##(1990-4#1)(1992-7#1)(2006-10#2)(2007-9#1)(2008-5#1)(2009-4#1)(2012-1#1)
related to preventive##2##3##(1990-12#1)(1992-4#1)
related to primary##3##3##(1990-11#1)(2007-5#1)(2008-10#1)
related to processes##2##3##(2007-9#1)(2009-10#1)
related to prolonged##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
related to protein##6##3##(1990-9#1)(1991-11#1)(1992-8#1)(1995-10#1)(1995-2#1)(2008-9#1)
related to psychological##2##3##(1990-6#1)(2010-2#1)
related to public##3##3##(1996-2#1)(2008-7#2)
related to pulmonary##2##3##(1996-12#1)(2010-9#1)
related to quality##2##3##(2006-12#1)(2013-1#1)
related to rainfall##3##3##(2008-10#3)
related to rapid##2##3##(1990-2#1)(1994-2#1)
related to reading##2##3##(2010-3#2)
related to recruitment##2##3##(1995-1#1)(2005-9#1)
related to reduced##3##3##(2011-2#1)(2012-2#1)(2012-3#1)
related to renal function##2##4##(1996-3#1)(2007-11#1)
related to renal##3##3##(1996-3#1)(2007-11#1)(2007-8#1)
related to respiratory##2##3##(2008-10#1)(2010-5#1)
related to response##2##3##(2004-2#1)(2008-11#1)
related to safety##2##3##(1991-3#1)(2010-6#1)
related to sagittal balance and physical ability##2##7##(2011-12#2)
related to salt##3##3##(1997-8#1)(2013-1#2)
related to second##2##3##(2007-9#1)(2011-12#1)
related to self-rated##2##3##(2011-2#1)(2012-3#1)
related to several##6##3##(2008-10#2)(2008-5#1)(2008-7#1)(2009-2#1)(2012-3#1)
related to severity of##3##4##(1994-2#1)(2008-5#1)(2013-1#1)
related to sex##7##3##(2006-12#1)(2008-7#1)(2009-1#1)(2009-4#1)(2010-8#1)(2012-2#1)(2012-3#1)
related to sexual behavior##2##4##(1997-8#1)(2011-1#1)
related to sexual##6##3##(1993-12#1)(1996-12#1)(1997-8#1)(2008-9#1)(2011-1#1)(2013-1#1)
related to size##2##3##(2007-9#1)(2008-9#1)
related to skin##2##3##(2008-5#1)(2010-8#1)
related to smoking##3##3##(1991-9#1)(2010-12#1)(2011-2#1)
related to social##6##3##(2004-11#1)(2008-4#1)(2009-8#1)(2010-1#1)(2012-1#1)(2013-1#1)
related to socio-demographic##2##3##(2006-2#1)(2013-1#1)
related to socioeconomic##2##3##(1994-6#2)
related to some##2##3##(1996-5#1)(2006-10#1)
related to specific##5##3##(1991-6#1)(2008-11#1)(2008-4#1)(2011-1#1)(2011-2#1)
related to state##2##3##(1990-8#1)(2013-1#1)
related to stocking rate##2##4##(1996-12#2)
related to stress and##2##4##(2006-9#1)(2008-7#1)
related to stress##4##3##(1993-7#1)(2006-9#1)(2008-7#1)(2011-1#1)
related to students'##2##3##(2008-12#2)
related to success##2##3##(1996-2#1)(2012-3#1)
related to such##4##3##(2006-9#1)(2008-10#1)(2010-1#1)(2011-1#1)
related to suicidal##2##3##(2010-8#1)(2013-8#1)
related to suicide##2##3##(1996-1#2)
related to surface##3##3##(2007-11#1)(2007-7#1)(2008-3#1)
related to surgical##2##3##(1991-4#1)(2007-7#1)
related to survival##3##3##(1993-4#1)(2008-10#1)(2013-1#1)
related to swallowing motion##3##4##(2010-2#3)
related to swallowing##4##3##(2010-2#4)
related to symptoms##2##3##(2008-6#1)(2008-7#1)
related to target distance##2##4##(1991-3#2)
related to that of##6##4##(1990-7#1)(1993-5#1)(1997-8#1)(2004-12#1)(2008-10#1)(2008-12#1)
related to that##8##3##(1990-7#1)(1992-3#1)(1993-5#1)(1997-8#1)(2004-12#1)(2007-9#1)(2008-10#1)(2008-12#1)
related to the Drosophila segment polarity gene##2##7##(1993-12#2)
related to the ability of the##2##6##(2008-10#2)
related to the ability of##4##5##(1991-2#1)(2008-10#2)(2013-8#1)
related to the ability##5##4##(1991-2#1)(1995-12#1)(2008-10#2)(2013-8#1)
related to the absorption coefficient##2##5##(2008-2#1)(2008-3#1)
related to the absorption##3##4##(2008-2#1)(2008-3#2)
related to the activation of##2##5##(1993-3#1)(2009-1#1)
related to the actual##2##4##(2006-8#1)(2011-1#1)
related to the aetiology of##2##5##(1997-1#1)(2008-9#1)
related to the age of the##2##6##(1995-6#1)(2004-2#1)
related to the amount of##11##5##(1990-2#1)(1993-4#1)(1994-11#1)(1994-3#1)(2006-5#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-2#1)
related to the application of##3##5##(2006-10#1)(2008-10#1)(2011-1#1)
related to the areas##2##4##(2008-10#1)(2008-4#1)
related to the availability of##6##5##(1994-3#1)(1996-6#1)(2006-10#1)(2011-2#1)(2012-1#1)(2012-2#1)
related to the behavioural##3##4##(1990-10#1)(1990-2#1)(1992-9#1)
related to the biological##2##4##(2007-11#1)(2009-5#1)
related to the capacity of##3##5##(1995-3#1)(1996-5#1)(2013-1#1)
related to the changes in the##2##6##(1990-12#1)(1993-9#1)
related to the changes##3##4##(1990-12#1)(1993-9#1)(1994-10#1)
related to the clinical##6##4##(1990-5#1)(1991-6#1)(1996-8#1)(2006-10#1)(2007-6#1)(2013-8#1)
related to the concentration of##11##5##(1990-1#1)(1991-12#1)(2008-10#8)(2008-5#1)
related to the consensus##2##4##(1991-5#1)(1995-8#1)
related to the content of##4##5##(1991-10#1)(2008-10#2)(2011-2#1)
related to the control of##3##5##(1990-7#1)(1992-8#1)(2006-10#1)
related to the corresponding##3##4##(1990-7#1)(1991-12#1)(2008-10#1)
related to the coupling##2##4##(2005-4#1)(2008-2#1)
related to the decrease in##2##5##(1996-11#1)(1996-12#1)
related to the decrease of##3##5##(2005-11#1)(2008-10#2)
related to the decrease##5##4##(1996-11#1)(1996-12#1)(2005-11#1)(2008-10#2)
related to the degree of##8##5##(1990-5#1)(1991-7#1)(2004-11#1)(2007-12#1)(2008-10#2)(2008-7#1)(2013-7#1)
related to the development and##2##5##(2006-5#1)(2009-8#1)
related to the development of the##2##6##(2008-12#1)(2009-12#1)
related to the development of##13##5##(1995-12#1)(1997-6#1)(2006-6#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-2#1)(2011-2#1)
related to the development##16##4##(1995-12#1)(1997-6#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-2#1)(2011-2#1)
related to the diagnosis and therapy of##2##7##(2006-10#2)
related to the different##4##4##(1991-3#1)(1994-6#1)(1997-7#1)(2008-7#1)
related to the disease##2##4##(2008-6#1)(2010-7#1)
related to the dose##2##4##(1992-12#1)(2009-8#1)
related to the duration of##4##5##(2007-12#1)(2008-10#2)(2013-1#1)
related to the duration##5##4##(2007-12#1)(2007-2#1)(2008-10#2)(2013-1#1)
related to the early##4##4##(1994-6#1)(2005-11#1)(2007-11#1)(2008-10#1)
related to the efficacy##2##4##(2011-2#1)(2013-1#1)
related to the electronic##2##4##(2008-10#1)(2010-4#1)
related to the energy transfer##2##5##(2008-10#2)
related to the energy##4##4##(1995-11#1)(2008-10#2)(2008-3#1)
related to the environmental##2##4##(2006-10#1)(2006-6#1)
related to the epidemiology##2##4##(2006-10#1)(2011-2#1)
related to the establishment of##2##5##(1994-5#1)(2008-11#1)
related to the establishment##3##4##(1994-12#1)(1994-5#1)(2008-11#1)
related to the estimated##2##4##(1995-12#1)(1995-3#1)
related to the evolutionary##2##4##(1994-12#1)(2008-6#1)
related to the experimental##2##4##(2007-2#1)(2008-3#1)
related to the exposure to##2##5##(1991-12#1)(2011-2#1)
related to the expression of##2##5##(1992-5#1)(1996-2#1)
related to the extent of##5##5##(1996-12#1)(1997-2#1)(2008-12#1)(2008-8#1)(2010-8#1)
related to the extent##6##4##(1996-12#1)(1997-2#2)(2008-12#1)(2008-8#1)(2010-8#1)
related to the failure of##2##5##(2007-11#1)(2011-2#1)
related to the family##2##4##(2008-2#1)(2012-12#1)
related to the formation and##2##5##(2007-1#1)(2008-11#1)
related to the formation of##3##5##(2008-10#1)(2008-2#1)(2008-7#1)
related to the formation##5##4##(2007-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)
related to the function of the##2##6##(2008-4#1)(2008-7#1)
related to the genesis of##2##5##(1991-12#1)(2008-10#1)
related to the genetic##2##4##(2012-12#1)(2012-2#1)
related to the genus##2##4##(2006-8#1)(2008-10#1)
related to the geometry##3##4##(1990-5#1)(2007-12#1)(2008-3#1)
related to the glucose concentration##3##5##(2008-10#3)
related to the higher##2##4##(2006-10#1)(2011-2#1)
related to the human##2##4##(1992-12#1)(1996-1#1)
related to the hydrophobicity of the##2##6##(1992-3#1)(1995-5#1)
related to the implementation of##3##5##(1993-9#1)(2008-2#2)
related to the increase in##2##5##(1992-6#1)(2006-5#1)
related to the increase of##2##5##(2006-10#1)(2008-12#1)
related to the increase##4##4##(1992-6#1)(2006-10#1)(2006-5#1)(2008-12#1)
related to the increased##4##4##(1994-5#1)(1996-9#1)(2005-10#1)(2008-10#1)
related to the individual##4##4##(1992-8#1)(2006-8#1)(2009-9#1)(2011-2#1)
related to the induction of##2##5##(1990-11#1)(1991-2#1)
related to the inhibition of##2##5##(1992-11#1)(2010-2#1)
related to the initial##4##4##(2006-11#1)(2006-3#2)(2007-10#1)
related to the intake of##2##5##(2006-10#2)
related to the intensity##2##4##(2008-10#1)(2009-8#1)
related to the interaction##3##4##(1994-2#1)(2012-12#1)(2012-2#1)
related to the lack of##2##5##(1995-11#1)(2007-11#1)
related to the length and##2##5##(2008-5#1)(2008-9#1)
related to the length of##2##5##(1996-4#1)(1997-3#1)
related to the length##4##4##(1996-4#1)(1997-3#1)(2008-5#1)(2008-9#1)
related to the level of##5##5##(1990-6#1)(1993-6#1)(1995-2#1)(2006-8#1)(2008-5#1)
related to the level##6##4##(1990-6#1)(1993-6#1)(1995-2#1)(2006-8#1)(2008-11#1)(2008-5#1)
related to the levels of##2##5##(1992-4#1)(1992-8#1)
related to the likelihood##3##4##(1992-2#1)(2008-12#1)(2012-12#1)
related to the location of##2##5##(1991-6#1)(1995-11#1)
related to the loss of##3##5##(1992-11#1)(1993-3#1)(2011-1#1)
related to the low##4##4##(1990-11#1)(1995-3#1)(2005-11#1)(2011-2#1)
related to the magnitude of the##2##6##(1990-5#1)(2013-8#1)
related to the magnitude of##5##5##(1990-11#1)(1990-5#1)(1990-8#1)(2010-5#1)(2013-8#1)
related to the major##3##4##(1996-11#1)(2008-2#2)
related to the mammalian##2##4##(1994-12#1)(1997-3#1)
related to the management of##4##5##(2007-4#1)(2010-12#1)(2013-1#1)(2013-8#1)
related to the management##5##4##(2007-4#1)(2010-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
related to the mean##2##4##(1996-1#1)(2008-10#1)
related to the mechanisms##2##4##(2008-1#1)(2010-12#1)
related to the metabolic syndrome##2##5##(2008-3#2)
related to the method##2##4##(1997-6#1)(2006-10#1)
related to the morphology##3##4##(2006-10#1)(2006-5#2)
related to the most##2##4##(1993-8#1)(2009-2#1)
related to the natural##2##4##(1996-3#1)(2006-12#1)
related to the nature of##2##5##(2007-4#1)(2008-10#1)
related to the number of##6##5##(1992-1#1)(2006-3#1)(2008-10#1)(2009-8#2)(2009-9#1)
related to the occurrence of##5##5##(2007-10#1)(2007-9#1)(2008-10#1)(2009-3#1)(2012-2#1)
related to the onset of##2##5##(1991-8#1)(2008-8#1)
related to the optical##3##4##(2007-12#2)(2008-2#1)
related to the organization##3##4##(1994-2#1)(2010-7#1)(2011-1#1)
related to the original##3##4##(2008-1#1)(2008-10#1)(2009-6#1)
related to the other##2##4##(2007-8#1)(2008-5#1)
related to the patient##2##4##(2011-12#1)(2012-2#1)
related to the phase##3##4##(2007-12#1)(2008-3#1)(2008-5#1)
related to the physical##3##4##(1993-2#1)(1996-4#1)(2008-3#1)
related to the potential##4##4##(1994-9#1)(2005-6#1)(2008-10#2)
related to the pregnancy##2##4##(2007-2#1)(2009-10#1)
related to the presence of##17##5##(1990-12#1)(1994-6#1)(1996-12#1)(2006-6#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-12#1)(2010-4#1)(2011-12#1)(2011-2#1)(2013-7#1)
related to the presence##18##4##(1990-12#1)(1994-6#1)(1996-12#1)(1997-2#1)(2006-6#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-12#1)(2010-4#1)(2011-12#1)(2011-2#1)(2013-7#1)
related to the prevalence of tuberculosis among people living with HIV/AIDS##2##11##(2011-1#2)
related to the prevalence of##5##5##(2008-12#1)(2011-1#2)(2012-3#1)(2013-8#1)
related to the previously##3##4##(1992-12#1)(1993-12#1)(2009-8#1)
related to the problem of##2##5##(2008-7#1)(2010-1#1)
related to the procedure##2##4##(2007-9#1)(2013-1#1)
related to the process##2##4##(2005-11#1)(2008-7#1)
related to the production of##4##5##(1992-4#1)(1994-6#1)(2005-8#1)(2008-7#1)
related to the progression of##2##5##(1994-6#1)(1997-7#1)
related to the properties of##2##5##(1992-3#1)(2008-11#1)
related to the quality##2##4##(1996-2#1)(2007-5#1)
related to the rapid##2##4##(1993-9#1)(2009-5#1)
related to the rate of##2##5##(1991-12#1)(1993-9#1)
related to the reported##2##4##(1990-4#1)(2012-3#1)
related to the ring##2##4##(2007-10#1)(2008-2#1)
related to the risk of ischemic stroke##2##7##(2011-1#2)
related to the risk of##5##5##(1991-4#1)(1992-3#1)(1994-4#1)(2011-1#2)
related to the same##3##4##(2007-5#1)(2008-10#1)(2008-7#1)
related to the secretion of##2##5##(2008-6#1)(2008-8#1)
related to the severity of the##2##6##(2010-12#1)(2011-12#1)
related to the severity of##8##5##(1992-3#1)(1996-3#1)(2007-11#1)(2010-12#1)(2010-8#1)(2011-12#1)(2011-2#1)(2013-8#1)
related to the size of the##3##6##(1991-11#1)(1996-12#1)(2010-8#1)
related to the size of##5##5##(1991-11#1)(1993-10#1)(1996-12#1)(1997-6#1)(2010-8#1)
related to the small##2##4##(2006-4#1)(2013-1#1)
related to the specific##4##4##(1994-2#1)(2007-12#1)(2008-7#2)
related to the standard##2##4##(1996-11#1)(2012-3#1)
related to the structural##2##4##(2010-8#1)(2012-2#1)
related to the structure of the##2##6##(2005-11#1)(2008-10#1)
related to the structure of##4##5##(1990-5#1)(2005-11#1)(2008-10#2)
related to the structure##5##4##(1990-5#1)(2005-11#1)(2008-10#2)(2008-9#1)
related to the study##2##4##(1994-6#1)(2012-12#1)
related to the subject##3##4##(2009-4#1)(2013-7#1)(2013-8#1)
related to the surface##3##4##(2005-11#1)(2007-12#1)(2008-9#1)
related to the surgical procedure##3##5##(2004-2#1)(2006-8#1)(2007-8#1)
related to the surgical##4##4##(2004-2#1)(2006-5#1)(2006-8#1)(2007-8#1)
related to the susceptibility##2##4##(1995-12#1)(2009-7#1)
related to the target##2##4##(2006-11#1)(2012-3#1)
related to the technique##2##4##(1997-3#1)(2006-5#1)
related to the time of##2##5##(2009-2#1)(2012-1#1)
related to the time##4##4##(1992-2#1)(2008-9#1)(2009-2#1)(2012-1#1)
related to the total##6##4##(1991-12#1)(2006-12#1)(2008-2#1)(2008-5#1)(2009-5#1)(2009-9#1)
related to the treatment##2##4##(2008-5#1)(2008-7#1)
related to the type of##2##5##(1990-3#1)(2006-12#1)
related to the type##3##4##(1990-3#1)(2006-12#1)(2012-12#1)
related to the underlying disease##2##5##(2008-7#1)(2010-12#1)
related to the underlying##4##4##(2007-11#1)(2008-4#1)(2008-7#1)(2010-12#1)
related to the unique##3##4##(2007-11#1)(2008-10#1)(2009-11#1)
related to the use of##11##5##(1993-2#1)(2006-8#1)(2007-10#1)(2007-2#1)(2008-6#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
related to the vaccine##2##4##(1990-3#1)(2013-8#1)
related to the variation##2##4##(2004-9#1)(2008-10#1)
related to the work##2##4##(2010-5#1)(2012-3#1)
related to the##1027##3##(1990-1#2)(1990-10#3)(1990-11#4)(1990-12#8)(1990-2#8)(1990-3#3)(1990-4#2)(1990-5#11)(1990-6#3)(1990-7#3)(1990-8#4)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#9)(1991-2#5)(1991-3#4)(1991-4#2)(1991-5#5)(1991-6#4)(1991-7#2)(1991-8#2)(1991-9#4)(1992-1#4)(1992-10#1)(1992-11#4)(1992-12#5)(1992-2#4)(1992-3#6)(1992-4#2)(1992-5#3)(1992-6#5)(1992-7#2)(1992-8#6)(1992-9#3)(1993-10#1)(1993-11#2)(1993-12#5)(1993-2#3)(1993-3#4)(1993-4#1)(1993-5#2)(1993-6#4)(1993-7#1)(1993-8#2)(1993-9#6)(1994-10#2)(1994-11#5)(1994-12#6)(1994-2#7)(1994-3#6)(1994-4#1)(1994-5#3)(1994-6#11)(1994-8#4)(1994-9#6)(1995-1#3)(1995-11#3)(1995-12#7)(1995-2#3)(1995-3#4)(1995-5#2)(1995-6#1)(1995-8#4)(1996-1#3)(1996-11#3)(1996-12#7)(1996-2#3)(1996-3#4)(1996-4#5)(1996-5#4)(1996-6#3)(1996-8#3)(1996-9#3)(1997-1#4)(1997-2#11)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#6)(1997-7#3)(1997-8#1)(2004-10#1)(2004-11#2)(2004-2#2)(2004-9#3)(2005-10#2)(2005-11#10)(2005-12#3)(2005-4#1)(2005-5#5)(2005-6#2)(2005-8#2)(2006-1#1)(2006-10#26)(2006-11#4)(2006-12#9)(2006-2#2)(2006-3#3)(2006-4#5)(2006-5#9)(2006-6#8)(2006-8#10)(2007-1#2)(2007-10#9)(2007-11#13)(2007-12#19)(2007-2#8)(2007-3#3)(2007-4#2)(2007-5#3)(2007-6#2)(2007-7#5)(2007-8#5)(2007-9#4)(2008-1#5)(2008-10#112)(2008-11#17)(2008-12#12)(2008-2#29)(2008-3#26)(2008-4#10)(2008-5#17)(2008-6#12)(2008-7#23)(2008-8#15)(2008-9#19)(2009-1#2)(2009-10#5)(2009-11#3)(2009-12#4)(2009-2#3)(2009-3#2)(2009-4#4)(2009-5#6)(2009-6#1)(2009-7#2)(2009-8#12)(2009-9#5)(2010-1#3)(2010-10#2)(2010-12#10)(2010-2#2)(2010-3#2)(2010-4#5)(2010-5#5)(2010-6#3)(2010-7#3)(2010-8#5)(2010-9#4)(2011-1#14)(2011-12#4)(2011-2#33)(2011-3#2)(2012-1#4)(2012-11#3)(2012-12#15)(2012-2#12)(2012-3#11)(2013-1#20)(2013-7#7)(2013-8#11)
related to their degree of##3##5##(1993-9#1)(1995-3#1)(1997-3#1)
related to their histological and##2##5##(1990-9#1)(2012-2#1)
related to their##52##3##(1990-3#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-6#1)(1992-12#1)(1993-9#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-8#2)(2005-11#2)(2006-1#1)(2006-6#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-7#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#2)
related to thermographic results##2##4##(1993-11#2)
related to these two##2##4##(2008-10#1)(2008-11#1)
related to these##17##3##(1991-5#1)(1991-6#1)(2006-10#1)(2006-11#2)(2007-4#1)(2008-10#2)(2008-11#2)(2008-8#3)(2008-9#1)(2009-5#2)(2011-2#1)
related to this##17##3##(1990-10#1)(1990-7#1)(1991-10#1)(1992-2#1)(1993-3#1)(2004-12#1)(2006-10#2)(2007-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-12#1)(2011-1#1)(2013-7#1)
related to thoracic##2##3##(1992-8#1)(2006-7#1)
related to those from##3##4##(1993-12#1)(1995-4#1)(2008-10#1)
related to those in plasma Fb##2##6##(1995-7#2)
related to those of the##2##5##(1996-2#1)(2008-10#1)
related to those##10##3##(1993-12#1)(1995-4#2)(1995-7#2)(1996-2#1)(2007-4#1)(2008-10#3)
related to three parameters##2##4##(1991-10#1)(2007-11#1)
related to thymus##2##3##(2011-2#2)
related to time##3##3##(2006-11#1)(2006-8#1)(2011-2#1)
related to trauma##2##3##(2008-6#1)(2009-3#1)
related to travel##2##3##(1992-12#1)(2006-10#1)
related to treatment##5##3##(1997-5#1)(2007-11#1)(2008-4#1)(2010-11#1)(2011-2#1)
related to tumor##7##3##(1991-7#1)(1991-9#1)(1993-11#1)(2005-5#1)(2008-8#2)(2013-8#1)
related to type of##2##4##(2008-10#1)(2009-7#1)
related to type##4##3##(1990-8#1)(2005-3#1)(2008-10#1)(2009-7#1)
related to use##3##3##(1992-11#1)(2007-12#1)(2012-11#1)
related to variation in the##3##5##(1990-1#1)(2006-10#1)(2010-8#1)
related to variation in##5##4##(1990-1#1)(2006-10#1)(2008-10#1)(2010-8#1)(2013-1#1)
related to various##6##3##(1994-6#1)(1996-1#1)(1997-2#1)(2007-9#1)(2008-4#1)(2011-12#1)
related to violent behavior##2##4##(2009-7#2)
related to violent##3##3##(2009-7#3)
related to volume##2##3##(1991-2#1)(2008-3#1)
related to water##2##3##(2006-10#1)(2010-8#1)
related to weather variables##2##4##(2008-10#2)
related to women's##2##3##(2007-2#1)(2009-4#1)
related to work##2##3##(2013-1#2)
related to yeast##3##3##(1993-4#2)(1997-8#1)
related to##3393##2##(1990-1#3)(1990-10#7)(1990-11#12)(1990-12#16)(1990-2#13)(1990-3#5)(1990-4#7)(1990-5#19)(1990-6#7)(1990-7#13)(1990-8#12)(1990-9#4)(1991-1#3)(1991-10#3)(1991-11#5)(1991-12#21)(1991-2#17)(1991-3#14)(1991-4#6)(1991-5#12)(1991-6#13)(1991-7#5)(1991-8#7)(1991-9#19)(1992-1#9)(1992-10#6)(1992-11#11)(1992-12#15)(1992-2#10)(1992-3#12)(1992-4#7)(1992-5#5)(1992-6#12)(1992-7#7)(1992-8#11)(1992-9#8)(1993-1#6)(1993-10#3)(1993-11#8)(1993-12#19)(1993-2#8)(1993-3#13)(1993-4#8)(1993-5#5)(1993-6#12)(1993-7#3)(1993-8#6)(1993-9#18)(1994-10#4)(1994-11#9)(1994-12#12)(1994-2#16)(1994-3#18)(1994-4#3)(1994-5#11)(1994-6#29)(1994-8#10)(1994-9#16)(1995-1#19)(1995-10#3)(1995-11#7)(1995-12#21)(1995-2#11)(1995-3#13)(1995-4#3)(1995-5#11)(1995-6#6)(1995-7#4)(1995-8#9)(1995-9#3)(1996-1#12)(1996-10#3)(1996-11#5)(1996-12#26)(1996-2#10)(1996-3#15)(1996-4#6)(1996-5#11)(1996-6#12)(1996-7#8)(1996-8#5)(1996-9#8)(1997-1#11)(1997-2#27)(1997-3#12)(1997-4#5)(1997-5#13)(1997-6#8)(1997-7#10)(1997-8#14)(2004-1#1)(2004-10#1)(2004-11#8)(2004-12#2)(2004-2#8)(2004-4#1)(2004-8#1)(2004-9#3)(2005-10#11)(2005-11#21)(2005-12#4)(2005-3#1)(2005-4#1)(2005-5#7)(2005-6#2)(2005-7#2)(2005-8#8)(2005-9#1)(2006-1#6)(2006-10#69)(2006-11#12)(2006-12#23)(2006-2#12)(2006-3#9)(2006-4#9)(2006-5#20)(2006-6#16)(2006-7#12)(2006-8#28)(2006-9#12)(2007-1#8)(2007-10#24)(2007-11#33)(2007-12#85)(2007-2#29)(2007-3#15)(2007-4#13)(2007-5#13)(2007-6#13)(2007-7#22)(2007-8#27)(2007-9#25)(2008-1#30)(2008-10#287)(2008-11#56)(2008-12#37)(2008-2#51)(2008-3#55)(2008-4#35)(2008-5#72)(2008-6#30)(2008-7#74)(2008-8#52)(2008-9#73)(2009-1#5)(2009-10#19)(2009-11#9)(2009-12#11)(2009-2#14)(2009-3#15)(2009-4#27)(2009-5#19)(2009-6#3)(2009-7#41)(2009-8#23)(2009-9#13)(2010-1#11)(2010-10#17)(2010-11#12)(2010-12#41)(2010-2#29)(2010-3#12)(2010-4#18)(2010-5#15)(2010-6#11)(2010-7#14)(2010-8#27)(2010-9#20)(2011-1#59)(2011-10#1)(2011-12#12)(2011-2#130)(2011-3#3)(2012-1#27)(2012-11#10)(2012-12#54)(2012-2#55)(2012-3#40)(2012-5#1)(2012-7#2)(2013-1#112)(2013-7#26)(2013-8#41)
related topics##2##2##(2007-4#1)(2008-10#1)
related toxicities##2##2##(1991-12#1)(2004-1#1)
related toxicity is##2##3##(2007-11#1)(2012-3#1)
related toxins##2##2##(1990-11#1)(1995-1#1)
related traits##2##2##(2008-9#1)(2012-11#1)
related transcription factors##2##3##(1990-11#1)(1992-6#1)
related transcription##3##2##(1990-11#1)(1992-6#1)(1993-6#1)
related transcripts in##3##3##(1990-5#2)(2013-8#1)
related transcripts##4##2##(1990-5#3)(2013-8#1)
related transmembrane##2##2##(1994-2#1)(1995-3#1)
related variables were##2##3##(2011-2#1)(2012-2#1)
related variables##6##2##(2007-12#1)(2008-10#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)
related with a better working memory##2##6##(2012-3#2)
related with a##8##3##(2009-12#1)(2009-4#1)(2010-11#1)(2011-2#2)(2012-2#1)(2012-3#2)
related with its##3##3##(2008-10#1)(2010-7#1)(2012-2#1)
related with the presence of##2##5##(2008-10#2)
related with the##27##3##(1991-11#1)(1991-6#1)(1992-5#1)(1993-11#1)(1996-9#1)(2005-11#3)(2007-6#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-8#1)(2009-4#2)(2009-8#1)(2010-8#1)(2011-2#2)(2012-3#1)
related with their##2##3##(1997-7#1)(2008-6#1)
related with this##2##3##(2007-11#1)(2009-8#1)
related with##89##2##(1990-6#1)(1991-11#1)(1991-6#1)(1992-10#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-12#2)(1994-6#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-7#1)(2005-11#3)(2006-8#1)(2007-10#1)(2007-11#3)(2007-3#1)(2007-6#2)(2007-8#2)(2008-1#1)(2008-10#15)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-4#3)(2009-5#1)(2009-8#2)(2010-11#1)(2010-12#2)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-2#3)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#2)
related work##2##2##(2008-10#1)(2008-2#1)
related##5282##1##(1990-1#4)(1990-10#13)(1990-11#23)(1990-12#26)(1990-2#15)(1990-3#9)(1990-4#14)(1990-5#26)(1990-6#11)(1990-7#18)(1990-8#19)(1990-9#8)(1991-1#5)(1991-10#7)(1991-11#9)(1991-12#27)(1991-2#26)(1991-3#22)(1991-4#10)(1991-5#19)(1991-6#17)(1991-7#13)(1991-8#11)(1991-9#26)(1992-1#13)(1992-10#12)(1992-11#17)(1992-12#22)(1992-2#14)(1992-3#17)(1992-4#10)(1992-5#9)(1992-6#20)(1992-7#12)(1992-8#21)(1992-9#14)(1993-1#8)(1993-10#3)(1993-11#18)(1993-12#30)(1993-2#10)(1993-3#16)(1993-4#18)(1993-5#6)(1993-6#21)(1993-7#5)(1993-8#12)(1993-9#21)(1994-1#1)(1994-10#6)(1994-11#15)(1994-12#22)(1994-2#31)(1994-3#29)(1994-4#4)(1994-5#14)(1994-6#42)(1994-7#2)(1994-8#20)(1994-9#33)(1995-1#26)(1995-10#3)(1995-11#18)(1995-12#35)(1995-2#23)(1995-3#27)(1995-4#5)(1995-5#19)(1995-6#19)(1995-7#4)(1995-8#17)(1995-9#6)(1996-1#22)(1996-10#5)(1996-11#12)(1996-12#40)(1996-2#22)(1996-3#21)(1996-4#10)(1996-5#24)(1996-6#17)(1996-7#10)(1996-8#10)(1996-9#12)(1997-1#15)(1997-2#35)(1997-3#21)(1997-4#15)(1997-5#20)(1997-6#12)(1997-7#18)(1997-8#18)(1997-9#1)(2004-1#2)(2004-10#1)(2004-11#11)(2004-12#7)(2004-2#9)(2004-3#1)(2004-4#1)(2004-7#2)(2004-8#1)(2004-9#3)(2005-10#17)(2005-11#27)(2005-12#9)(2005-3#3)(2005-4#1)(2005-5#7)(2005-6#2)(2005-7#12)(2005-8#12)(2005-9#4)(2006-1#7)(2006-10#90)(2006-11#17)(2006-12#34)(2006-2#17)(2006-3#10)(2006-4#15)(2006-5#26)(2006-6#22)(2006-7#15)(2006-8#38)(2006-9#13)(2007-1#11)(2007-10#32)(2007-11#56)(2007-12#111)(2007-2#45)(2007-3#30)(2007-4#17)(2007-5#15)(2007-6#24)(2007-7#46)(2007-8#59)(2007-9#30)(2008-1#64)(2008-10#454)(2008-11#105)(2008-12#57)(2008-2#66)(2008-3#83)(2008-4#72)(2008-5#116)(2008-6#45)(2008-7#116)(2008-8#84)(2008-9#100)(2009-1#6)(2009-10#29)(2009-11#11)(2009-12#28)(2009-2#17)(2009-3#18)(2009-4#41)(2009-5#24)(2009-6#4)(2009-7#47)(2009-8#37)(2009-9#18)(2010-1#12)(2010-10#21)(2010-11#16)(2010-12#71)(2010-2#35)(2010-3#18)(2010-4#22)(2010-5#23)(2010-6#18)(2010-7#25)(2010-8#44)(2010-9#24)(2011-1#96)(2011-10#1)(2011-11#1)(2011-12#21)(2011-2#187)(2011-3#10)(2012-1#39)(2012-11#17)(2012-12#78)(2012-2#90)(2012-3#62)(2012-5#4)(2012-7#2)(2013-1#153)(2013-7#47)(2013-8#83)
related) were##2##2##(2005-8#1)(2008-1#1)
related)##8##1##(1995-7#2)(2005-8#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-7#1)
related?##6##1##(2006-10#3)(2008-11#1)(2011-12#1)(2013-1#1)
relatedness among##4##2##(2006-3#1)(2008-8#1)(2013-1#2)
relatedness and##14##2##(2007-11#1)(2007-12#1)(2008-5#1)(2009-10#2)(2009-5#2)(2010-2#1)(2010-4#1)(2011-2#1)(2013-1#4)
relatedness between##5##2##(2008-10#2)(2008-5#1)(2009-5#1)(2011-1#1)
relatedness in##2##2##(2008-8#1)(2010-4#1)
relatedness is##2##2##(2005-11#1)(2008-8#1)
relatedness of##14##2##(1993-11#1)(1994-2#1)(1997-4#1)(2005-7#1)(2006-10#1)(2007-6#1)(2008-10#5)(2009-9#1)(2010-2#1)(2013-8#1)
relatedness to SbDV##2##3##(2008-10#2)
relatedness to##8##2##(1997-4#1)(2007-3#1)(2008-10#2)(2008-4#2)(2009-5#1)(2012-2#1)
relatedness##75##1##(1993-11#1)(1994-2#1)(1995-8#1)(1996-12#1)(1997-4#3)(2005-11#1)(2005-7#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-6#1)(2008-10#10)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#9)(2008-9#6)(2009-10#2)(2009-5#4)(2009-9#1)(2010-2#3)(2010-4#2)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#10)(2013-8#1)
relates directly to the##2##4##(2008-2#1)(2008-7#1)
relates how##4##2##(1992-2#1)(1994-2#1)(2007-2#1)(2010-12#1)
relates the##22##2##(1990-2#1)(1991-11#1)(1992-3#1)(1992-6#1)(1994-9#1)(1995-1#1)(2005-11#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-8#1)(2009-4#1)
relates these##2##2##(2007-5#1)(2008-9#1)
relates to a##4##3##(2008-6#1)(2013-1#3)
relates to an##2##3##(1996-7#1)(1997-8#1)
relates to its##2##3##(1996-7#1)(2004-3#1)
relates to the##28##3##(1992-5#1)(1992-7#1)(1993-9#1)(1996-2#1)(1997-3#1)(2005-10#1)(2006-5#1)(2006-8#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#3)(2008-7#1)(2011-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
relates to##87##2##(1992-5#1)(1992-7#1)(1992-9#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-7#2)(1996-8#2)(1997-1#1)(1997-3#1)(1997-8#1)(2004-3#1)(2005-10#2)(2005-4#1)(2006-10#4)(2006-5#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-9#2)(2008-1#4)(2008-10#2)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#1)(2010-10#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#3)
relates##134##1##(1990-10#1)(1990-2#1)(1990-8#1)(1991-11#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-9#1)(1994-2#2)(1994-5#1)(1994-9#1)(1995-1#2)(1996-11#1)(1996-2#2)(1996-3#1)(1996-7#2)(1996-8#2)(1997-1#1)(1997-3#1)(1997-8#2)(2004-3#1)(2005-10#2)(2005-11#1)(2005-4#1)(2005-8#1)(2006-10#4)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#4)(2008-11#4)(2008-12#4)(2008-2#5)(2008-3#9)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#7)(2013-8#3)
relating the intensity of##2##4##(1990-6#1)(2008-10#1)
relating the##21##2##(1990-6#1)(1991-7#1)(1992-12#1)(1993-5#1)(1996-3#1)(2007-11#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#1)
relating these##2##2##(1992-4#1)(2008-10#1)
relating to a##2##3##(1993-11#1)(2011-2#1)
relating to an##2##3##(2005-7#1)(2006-8#1)
relating to cell##2##3##(1997-4#1)(2012-8#1)
relating to drug##3##3##(2005-8#1)(2006-12#1)(2010-2#1)
relating to human##2##3##(2008-5#1)(2010-4#1)
relating to research##2##3##(1992-12#1)(2007-8#1)
relating to small##2##3##(2006-10#1)(2013-1#1)
relating to the production##2##4##(2006-10#1)(2007-11#1)
relating to the use of##3##5##(2006-10#1)(2006-4#1)(2008-4#1)
relating to the##58##3##(1990-10#1)(1991-1#1)(1991-10#1)(1991-5#1)(1992-1#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-12#1)(1993-6#1)(1994-12#1)(1996-5#1)(1997-5#1)(2004-4#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-4#1)(2007-1#1)(2007-11#2)(2007-3#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-4#2)(2010-12#1)(2010-2#1)(2011-1#3)(2011-2#2)(2012-12#3)(2013-1#1)(2013-7#1)
relating to two##2##3##(2005-8#1)(2008-10#1)
relating to##200##2##(1990-10#1)(1990-11#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-5#2)(1991-8#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-6#1)(1994-1#2)(1994-12#1)(1994-2#1)(1995-12#2)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-7#3)(2005-8#6)(2006-10#9)(2006-11#3)(2006-12#2)(2006-2#3)(2006-4#1)(2006-5#1)(2006-7#3)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#4)(2008-11#8)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#6)(2008-5#3)(2008-7#5)(2008-8#6)(2008-9#2)(2009-1#1)(2009-10#2)(2009-2#1)(2009-4#3)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#4)(2010-4#2)(2010-8#3)(2011-1#4)(2011-2#11)(2012-12#6)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#11)(2013-7#1)(2013-8#2)
relating##277##1##(1990-10#1)(1990-11#2)(1990-2#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-5#2)(1991-7#1)(1991-8#3)(1992-1#2)(1992-12#2)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-1#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-4#1)(1995-12#2)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-10#3)(2005-11#1)(2005-5#1)(2005-7#4)(2005-8#8)(2006-10#12)(2006-11#4)(2006-12#2)(2006-2#3)(2006-4#1)(2006-5#1)(2006-7#3)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#3)(2007-9#4)(2008-1#2)(2008-10#17)(2008-11#8)(2008-12#1)(2008-2#7)(2008-3#6)(2008-4#7)(2008-5#3)(2008-6#1)(2008-7#9)(2008-8#7)(2008-9#4)(2009-1#1)(2009-10#2)(2009-2#1)(2009-4#4)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#4)(2010-4#3)(2010-7#2)(2010-8#3)(2011-1#5)(2011-2#13)(2012-12#6)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#12)(2013-7#2)(2013-8#3)
relation among##5##2##(2007-12#2)(2008-3#1)(2008-5#1)(2008-9#1)
relation and##5##2##(2007-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
relation at##2##2##(1996-4#1)(2008-3#1)
relation between RC teacher practices and child##2##7##(2008-12#2)
relation between RC teacher practices and##3##6##(2008-12#3)
relation between RC##4##3##(2008-12#4)
relation between an##2##3##(1994-12#1)(2008-1#1)
relation between cholesterol##2##3##(2006-2#1)(2013-1#1)
relation between disease activity and QoL##2##6##(2012-1#2)
relation between ethnic identity and##2##5##(2004-12#2)
relation between growth##2##3##(2009-6#2)
relation between histological##2##3##(2008-6#2)
relation between physician and patient##2##5##(1993-11#2)
relation between protein##2##3##(2006-5#1)(2007-12#1)
relation between psychiatric##2##3##(1992-10#1)(2011-1#1)
relation between the concentration of##2##5##(2006-12#1)(2008-10#1)
relation between the incident##2##4##(2007-12#1)(2008-3#1)
relation between the levels##2##4##(2008-8#1)(2009-9#1)
relation between the total##2##4##(1996-1#1)(2008-3#1)
relation between the##69##3##(1990-7#1)(1991-11#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-5#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-5#1)(1995-9#2)(1996-1#1)(1996-12#1)(1997-3#1)(1997-5#1)(2005-4#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#10)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2009-2#2)(2009-6#1)(2009-9#1)(2010-10#1)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#2)
relation between##232##2##(1990-5#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#3)(1993-5#2)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#3)(1994-5#1)(1994-6#2)(1994-7#2)(1994-8#1)(1995-1#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#2)(2004-12#2)(2004-4#1)(2005-10#1)(2005-4#4)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#1)(2007-1#2)(2007-11#4)(2007-12#4)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-12#7)(2008-2#6)(2008-3#17)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#7)(2008-8#8)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#3)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#2)(2010-12#3)(2010-2#4)(2010-3#1)(2010-4#3)(2010-7#3)(2011-1#6)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#10)(2013-1#3)(2013-8#3)
relation exists between the##2##4##(2008-12#1)(2008-3#1)
relation exists between##3##3##(2008-12#1)(2008-3#2)
relation extraction and##2##3##(2008-2#2)
relation for the##2##3##(2007-11#1)(2008-3#1)
relation for##8##2##(1995-3#1)(2007-11#1)(2008-2#3)(2008-3#1)(2013-1#2)
relation from##2##2##(2005-11#1)(2013-8#1)
relation in the##3##3##(2008-10#2)(2009-7#1)
relation in##6##2##(1991-7#1)(1995-6#1)(2008-1#1)(2008-10#2)(2009-7#1)
relation is##8##2##(1990-5#1)(2006-10#3)(2007-4#1)(2008-5#1)(2009-6#1)(2011-1#1)
relation of the##11##3##(1993-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-2#1)(2010-10#1)(2011-2#2)
relation of##51##2##(1990-5#1)(1990-6#1)(1990-7#2)(1992-4#1)(1993-12#2)(1993-4#1)(1993-7#1)(1994-3#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-6#1)(2005-10#1)(2006-1#1)(2006-10#3)(2006-8#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-7#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-4#1)(2011-2#3)(2012-1#2)(2012-12#3)(2013-7#2)(2013-8#1)
relation that##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
relation to a number of##2##5##(1991-12#1)(1991-3#1)
relation to a##18##3##(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-3#1)(1992-6#1)(1996-7#1)(2005-10#1)(2005-11#1)(2006-2#1)(2007-3#1)(2007-5#1)(2008-1#2)(2008-2#1)(2008-3#1)(2009-4#1)(2011-1#1)
relation to an earlier##2##4##(2008-10#1)(2008-4#1)
relation to an##4##3##(2007-8#1)(2008-10#2)(2008-4#1)
relation to certain##2##3##(1993-10#1)(1994-9#1)
relation to changes in##3##4##(1997-2#1)(2007-8#1)(2012-12#1)
relation to changes##5##3##(1994-7#1)(1997-2#1)(2006-6#1)(2007-8#1)(2012-12#1)
relation to clinical##6##3##(1991-6#1)(2006-10#1)(2007-12#1)(2008-7#1)(2009-7#1)(2012-2#1)
relation to different##6##3##(1990-1#1)(1992-8#1)(1993-5#1)(1995-3#1)(1996-6#1)(2008-10#1)
relation to disease##2##3##(2008-10#1)(2008-8#1)
relation to dose##2##3##(1991-4#1)(1993-4#1)
relation to each other##2##4##(1990-4#1)(2012-12#1)
relation to each##3##3##(1990-4#1)(1991-6#1)(2012-12#1)
relation to early##2##3##(2009-7#1)(2011-2#1)
relation to etiology##2##3##(1996-8#1)(2006-12#1)
relation to growth##3##3##(1997-2#1)(2007-1#1)(2011-2#1)
relation to health and##2##4##(1991-11#1)(1996-2#1)
relation to health##4##3##(1991-11#1)(1995-6#1)(1996-2#1)(2012-2#1)
relation to insulin##3##3##(1994-12#1)(2008-3#2)
relation to its##6##3##(1994-8#1)(1995-11#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)
relation to lesion##2##3##(1994-10#1)(2008-10#1)
relation to other##13##3##(1993-11#1)(1994-2#1)(1996-3#1)(1996-6#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-4#2)(2008-5#1)(2009-2#1)(2010-12#1)(2013-8#1)
relation to pretreatment##2##3##(2007-10#2)
relation to recovery##2##3##(1992-10#1)(2012-11#1)
relation to subjective##2##3##(2008-4#1)(2008-9#1)
relation to the adjacent##2##4##(2010-8#1)(2012-12#1)
relation to the genetic##2##4##(1997-2#1)(2008-9#1)
relation to the intracellular Ca2+ concentration##2##6##(1990-7#1)(1992-8#1)
relation to the metabolic syndrome##2##5##(2008-3#2)
relation to the type of##3##5##(1990-3#1)(2007-11#1)(2011-2#1)
relation to the##271##3##(1990-10#2)(1990-11#3)(1990-12#3)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#4)(1990-7#2)(1990-9#1)(1991-10#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#4)(1992-12#1)(1992-2#2)(1992-3#4)(1992-6#1)(1992-8#2)(1993-1#1)(1993-10#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#1)(1994-10#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-6#4)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#2)(1995-6#2)(1996-1#2)(1996-10#1)(1996-11#2)(1996-3#3)(1996-4#1)(1996-7#1)(1996-9#3)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-10#1)(2005-10#1)(2005-11#3)(2005-8#2)(2006-10#3)(2006-11#2)(2006-12#4)(2006-3#1)(2006-4#1)(2006-8#8)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#8)(2007-2#1)(2007-5#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-10#15)(2008-11#7)(2008-12#3)(2008-2#5)(2008-3#6)(2008-4#4)(2008-5#7)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#8)(2009-1#1)(2009-2#1)(2009-4#1)(2009-6#2)(2009-8#3)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#3)(2011-12#2)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#9)(2012-3#1)(2013-1#9)(2013-7#2)(2013-8#1)
relation to their##21##3##(1991-2#1)(1991-3#1)(1993-9#1)(1994-11#2)(2004-12#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2009-12#2)(2009-7#1)(2012-2#1)
relation to total##4##3##(1991-10#1)(1996-4#1)(2008-5#1)(2012-2#1)
relation to##866##2##(1990-1#1)(1990-10#3)(1990-11#5)(1990-12#6)(1990-2#6)(1990-3#3)(1990-4#7)(1990-5#5)(1990-7#4)(1990-9#3)(1991-1#2)(1991-10#4)(1991-11#3)(1991-12#5)(1991-2#3)(1991-3#2)(1991-4#3)(1991-5#3)(1991-6#7)(1991-7#2)(1991-8#2)(1991-9#6)(1992-10#1)(1992-12#2)(1992-2#3)(1992-3#7)(1992-6#2)(1992-8#3)(1993-1#1)(1993-10#4)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#4)(1993-4#1)(1993-5#5)(1993-6#5)(1993-8#4)(1993-9#5)(1994-10#2)(1994-11#4)(1994-12#6)(1994-2#8)(1994-3#4)(1994-4#1)(1994-6#8)(1994-7#1)(1994-8#4)(1994-9#2)(1995-1#3)(1995-11#2)(1995-12#2)(1995-3#4)(1995-5#4)(1995-6#3)(1995-7#2)(1995-8#2)(1995-9#1)(1996-1#5)(1996-10#2)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#5)(1996-4#2)(1996-6#4)(1996-7#4)(1996-8#3)(1996-9#4)(1997-2#4)(1997-3#2)(1997-5#2)(1997-6#4)(1997-7#2)(1997-8#12)(2004-1#1)(2004-10#2)(2004-12#2)(2004-2#1)(2005-10#3)(2005-11#9)(2005-4#1)(2005-7#2)(2005-8#3)(2006-1#1)(2006-10#12)(2006-11#4)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#3)(2006-6#5)(2006-7#2)(2006-8#11)(2006-9#2)(2007-1#5)(2007-10#9)(2007-11#11)(2007-12#23)(2007-2#4)(2007-3#4)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#11)(2007-8#10)(2007-9#3)(2008-1#8)(2008-10#70)(2008-11#24)(2008-12#16)(2008-2#10)(2008-3#15)(2008-4#11)(2008-5#21)(2008-6#7)(2008-7#17)(2008-8#14)(2008-9#12)(2009-1#1)(2009-10#3)(2009-11#3)(2009-12#4)(2009-2#3)(2009-3#2)(2009-4#8)(2009-5#5)(2009-6#2)(2009-7#6)(2009-8#7)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#4)(2010-6#4)(2010-7#2)(2010-8#6)(2010-9#2)(2011-1#20)(2011-12#3)(2011-2#26)(2012-1#9)(2012-11#6)(2012-12#14)(2012-2#18)(2012-3#7)(2013-1#27)(2013-7#9)(2013-8#6)
relation was found between##6##4##(1991-4#1)(1991-5#1)(1991-6#1)(1993-2#1)(2008-10#1)(2013-1#1)
relation was found for##2##4##(1992-3#1)(2005-11#1)
relation was found##9##3##(1991-4#1)(1991-5#1)(1991-6#1)(1992-3#1)(1993-2#1)(2005-11#1)(2008-10#2)(2013-1#1)
relation was##17##2##(1991-4#2)(1991-5#1)(1991-6#1)(1992-3#1)(1993-2#1)(1994-9#1)(1996-8#1)(2005-11#1)(2008-10#2)(2008-5#2)(2010-7#1)(2011-12#1)(2011-2#1)(2013-1#1)
relation with the other variables##2##5##(2008-12#1)(2008-5#1)
relation with the##15##3##(1990-5#1)(1991-9#1)(2006-10#1)(2006-6#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
relation with##48##2##(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-9#1)(1992-7#1)(1993-9#1)(1994-8#1)(1996-10#2)(1996-4#1)(1997-6#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-3#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#4)(2008-9#1)(2009-4#1)(2009-5#2)(2009-9#2)(2010-2#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)
relation##1322##1##(1990-1#1)(1990-10#3)(1990-11#5)(1990-12#6)(1990-2#6)(1990-3#3)(1990-4#7)(1990-5#10)(1990-6#1)(1990-7#8)(1990-8#4)(1990-9#5)(1991-1#3)(1991-10#4)(1991-11#5)(1991-12#6)(1991-2#4)(1991-3#3)(1991-4#6)(1991-5#5)(1991-6#12)(1991-7#3)(1991-8#3)(1991-9#9)(1992-10#2)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#9)(1992-4#1)(1992-6#3)(1992-7#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-10#5)(1993-11#5)(1993-12#5)(1993-2#3)(1993-3#4)(1993-4#2)(1993-5#7)(1993-6#6)(1993-7#1)(1993-8#4)(1993-9#7)(1994-1#1)(1994-10#2)(1994-11#4)(1994-12#8)(1994-2#11)(1994-3#6)(1994-4#1)(1994-5#2)(1994-6#10)(1994-7#3)(1994-8#6)(1994-9#3)(1995-1#4)(1995-11#2)(1995-12#3)(1995-3#5)(1995-4#1)(1995-5#5)(1995-6#4)(1995-7#2)(1995-8#3)(1995-9#3)(1996-1#6)(1996-10#4)(1996-11#2)(1996-12#2)(1996-2#5)(1996-3#5)(1996-4#4)(1996-5#1)(1996-6#6)(1996-7#5)(1996-8#4)(1996-9#5)(1997-1#1)(1997-2#4)(1997-3#5)(1997-4#1)(1997-5#5)(1997-6#9)(1997-7#2)(1997-8#15)(2004-1#1)(2004-10#2)(2004-12#4)(2004-2#1)(2004-4#1)(2005-10#6)(2005-11#11)(2005-4#5)(2005-5#2)(2005-7#3)(2005-8#3)(2006-1#2)(2006-10#21)(2006-11#4)(2006-12#6)(2006-2#4)(2006-3#2)(2006-4#4)(2006-5#2)(2006-6#7)(2006-7#4)(2006-8#13)(2006-9#2)(2007-1#7)(2007-10#9)(2007-11#17)(2007-12#35)(2007-2#6)(2007-3#7)(2007-4#2)(2007-5#3)(2007-6#1)(2007-7#14)(2007-8#12)(2007-9#3)(2008-1#11)(2008-10#92)(2008-11#29)(2008-12#26)(2008-2#33)(2008-3#47)(2008-4#15)(2008-5#37)(2008-6#10)(2008-7#29)(2008-8#26)(2008-9#16)(2009-1#1)(2009-10#5)(2009-11#5)(2009-12#6)(2009-2#7)(2009-3#2)(2009-4#10)(2009-5#10)(2009-6#6)(2009-7#9)(2009-8#8)(2009-9#6)(2010-1#3)(2010-10#5)(2010-12#9)(2010-2#9)(2010-3#2)(2010-4#8)(2010-5#4)(2010-6#4)(2010-7#7)(2010-8#6)(2010-9#2)(2011-1#29)(2011-12#6)(2011-2#36)(2012-1#13)(2012-11#6)(2012-12#22)(2012-2#33)(2012-3#8)(2013-1#35)(2013-7#11)(2013-8#11)
relational aggression and victimization##2##4##(2008-10#2)
relational aggression and##3##3##(2008-10#2)(2010-4#1)
relational aggression##6##2##(2008-10#3)(2008-12#1)(2010-4#2)
relational and##4##2##(2008-10#2)(2010-4#1)(2012-3#1)
relational behavior##3##2##(1990-3#3)
relational climate##2##2##(2008-11#2)
relational colour constancy##3##3##(2007-5#3)
relational contexts##2##2##(2009-7#2)
relational data##3##2##(2008-7#1)(2010-8#2)
relational database management system##2##4##(2007-6#1)(2008-7#1)
relational database management##3##3##(1992-3#1)(2007-6#1)(2008-7#1)
relational database##14##2##(1992-3#1)(1996-2#1)(2007-6#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-7#3)(2012-1#1)
relational databases##5##2##(2008-4#3)(2008-7#1)(2008-9#1)
relational genome analysis##2##3##(1993-6#2)
relational problems##2##2##(2006-8#1)(2008-12#1)
relational responding##3##2##(2006-7#1)(2011-2#2)
relational##91##1##(1990-3#5)(1992-3#1)(1993-2#1)(1993-6#2)(1996-2#4)(2006-7#2)(2006-8#1)(2007-5#3)(2007-6#1)(2007-8#2)(2008-10#5)(2008-11#2)(2008-12#7)(2008-2#2)(2008-3#2)(2008-4#8)(2008-7#9)(2008-9#1)(2009-11#2)(2009-2#1)(2009-4#1)(2009-7#3)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#3)(2010-8#3)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#7)
relations activities##8##2##(2008-12#8)
relations among the##6##3##(1997-8#1)(2007-12#1)(2008-3#2)(2008-6#1)(2008-8#1)
relations among##19##2##(1990-12#1)(1992-9#1)(1997-8#1)(2007-12#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-2#1)(2012-12#2)(2013-1#1)
relations and the##5##3##(1995-7#1)(2007-7#1)(2008-12#1)(2008-6#1)(2011-2#1)
relations and##26##2##(1994-3#1)(1995-7#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-12#5)(2008-3#2)(2008-6#1)(2008-8#1)(2009-8#3)(2011-1#1)(2011-2#2)(2012-3#2)
relations are##11##2##(1991-1#1)(1991-12#1)(1994-8#1)(1996-9#1)(2007-7#1)(2008-2#1)(2008-3#4)(2010-4#1)
relations as##5##2##(1995-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)
relations between medical##4##3##(2013-1#4)
relations between the##11##3##(1990-12#1)(1993-6#2)(1996-1#1)(1996-2#1)(2008-3#2)(2010-1#1)(2010-10#1)(2010-6#1)(2010-8#1)
relations between these##3##3##(2007-8#1)(2008-11#1)(2008-2#1)
relations between##60##2##(1990-12#1)(1993-6#2)(1995-5#1)(1996-1#1)(1996-2#2)(1996-3#1)(1996-6#1)(2005-10#1)(2006-5#2)(2006-7#1)(2007-10#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#2)(2009-4#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-2#2)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-3#2)(2013-1#6)(2013-8#1)
relations extracted from##4##3##(2013-1#4)
relations for the##4##3##(1994-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
relations for##15##2##(1990-9#1)(1991-3#1)(1994-11#1)(1994-8#1)(2007-11#1)(2007-12#1)(2008-12#2)(2008-2#2)(2008-3#4)(2009-3#1)
relations in the##2##3##(1990-8#1)(2008-3#1)
relations in##21##2##(1990-8#1)(1992-11#1)(1993-5#1)(1997-3#1)(2006-2#1)(2006-7#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-4#1)(2013-1#4)
relations obtained##3##2##(2007-11#1)(2013-1#2)
relations of the##2##3##(2008-2#1)(2008-4#1)
relations of trust and##2##4##(2008-1#1)(2012-12#1)
relations of##14##2##(1990-3#1)(1994-7#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-10#1)(2010-12#1)(2012-12#1)(2013-1#1)
relations practitioners##2##2##(2008-12#2)
relations provide a##2##3##(1990-8#1)(1994-7#1)
relations that are##2##3##(1990-8#1)(2007-11#1)
relations that##4##2##(1990-8#1)(2007-11#1)(2008-3#2)
relations to the##3##3##(1993-6#1)(1994-12#1)(2008-10#1)
relations to##14##2##(1993-6#1)(1994-12#1)(1996-12#1)(1997-4#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2009-12#1)(2009-7#1)(2012-2#1)
relations were##7##2##(2005-4#1)(2006-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-2#1)
relations with the##4##3##(1991-8#1)(1997-1#1)(2012-2#1)(2013-1#1)
relations with##13##2##(1991-12#1)(1991-8#1)(1994-2#1)(1997-1#1)(2005-5#1)(2008-9#1)(2010-1#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
relations would be##2##3##(1995-3#1)(2009-4#1)
relations##361##1##(1990-12#4)(1990-3#1)(1990-8#5)(1990-9#1)(1991-1#2)(1991-12#3)(1991-2#3)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-4#1)(1992-9#1)(1993-5#1)(1993-6#4)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-7#2)(1994-8#2)(1995-1#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#4)(1997-4#1)(1997-8#2)(2004-11#1)(2005-10#1)(2005-12#1)(2005-2#1)(2005-4#1)(2005-5#2)(2006-2#6)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#5)(2006-8#1)(2007-10#1)(2007-11#7)(2007-12#5)(2007-2#3)(2007-3#1)(2007-5#2)(2007-7#6)(2007-8#1)(2008-1#4)(2008-10#11)(2008-11#10)(2008-12#36)(2008-2#12)(2008-3#27)(2008-4#3)(2008-5#6)(2008-6#7)(2008-7#14)(2008-8#9)(2008-9#6)(2009-10#3)(2009-12#2)(2009-3#1)(2009-4#4)(2009-5#1)(2009-7#4)(2009-8#5)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#2)(2010-2#7)(2010-4#4)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#6)(2011-2#11)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#27)(2013-7#1)(2013-8#4)
relations&quot##2##1##(1995-12#1)(2011-1#1)
relations)##2##1##(1996-12#1)(2008-7#1)
relationship (3D##2##2##(2010-12#1)(2011-3#1)
relationship (P&lt##2##2##(2007-2#1)(2009-4#1)
relationship (QSAR)##5##2##(1996-8#1)(2007-11#2)(2008-10#2)
relationship (QSPR)##2##2##(2007-12#1)(2008-10#1)
relationship among isolates##3##3##(2008-10#3)
relationship among the##10##3##(1997-4#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2010-9#1)(2011-2#1)
relationship among these##2##3##(2007-12#1)(2013-1#1)
relationship among##41##2##(1990-7#1)(1994-3#1)(1995-11#1)(1997-2#1)(1997-4#1)(2005-10#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#2)(2009-7#1)(2010-9#1)(2011-2#5)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
relationship analysis##3##2##(1994-3#1)(1997-2#1)(2011-1#1)
relationship and a##3##3##(2007-4#1)(2008-10#1)(2011-2#1)
relationship and communication##2##3##(2009-7#2)
relationship and the##10##3##(1993-5#1)(1993-6#1)(1995-5#1)(2007-9#2)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2013-8#1)
relationship and##46##2##(1993-5#1)(1993-6#1)(1995-5#1)(1995-6#1)(1997-1#1)(2006-1#3)(2006-7#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-4#2)(2007-9#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2009-7#3)(2009-9#1)(2010-10#1)(2010-4#1)(2010-5#2)(2011-2#4)(2012-1#1)(2012-3#2)(2013-8#1)
relationship are described##2##3##(1995-1#1)(2005-10#1)
relationship are discussed##3##3##(1995-3#1)(2008-10#1)(2008-2#1)
relationship are##10##2##(1991-7#1)(1995-1#2)(1995-3#1)(1997-2#1)(2005-10#1)(2008-10#2)(2008-2#1)(2012-1#1)
relationship as a##2##3##(2005-12#1)(2009-4#1)
relationship as##10##2##(1991-5#1)(1993-3#1)(1996-1#1)(2005-12#1)(2007-5#1)(2007-7#1)(2008-10#1)(2009-4#1)(2012-12#1)(2013-1#1)
relationship at##2##2##(1996-6#1)(2005-11#1)
relationship between &quot##2##3##(1993-12#1)(1994-2#1)
relationship between Al##2##3##(1996-8#1)(2008-10#1)
relationship between HIV##2##3##(2008-6#1)(2012-2#1)
relationship between HMO##2##3##(1991-3#1)(2008-11#1)
relationship between Helicobacter pylori##3##4##(2005-12#1)(2006-10#1)(2007-7#1)
relationship between I##2##3##(2008-10#1)(2008-11#1)
relationship between a gene##2##4##(2006-12#1)(2012-3#1)
relationship between a##17##3##(1991-3#1)(1992-4#1)(1993-4#1)(1994-1#1)(1996-12#1)(2006-11#1)(2006-12#1)(2006-9#1)(2008-10#1)(2008-12#2)(2008-7#1)(2009-3#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
relationship between absorbance##2##3##(2008-10#2)
relationship between activity##2##3##(1991-11#1)(2006-10#1)
relationship between age and##3##4##(2009-1#1)(2010-12#1)(2013-8#1)
relationship between age##4##3##(2009-1#1)(2010-12#1)(2011-2#1)(2013-8#1)
relationship between alcohol consumption and##2##5##(1994-2#1)(2012-12#1)
relationship between alcohol##4##3##(1994-2#1)(2007-7#1)(2012-12#2)
relationship between aluminum and spontaneous pneumothorax##2##6##(2007-8#2)
relationship between ambient##2##3##(2008-11#1)(2010-12#1)
relationship between an##4##3##(2007-3#1)(2007-6#1)(2012-1#1)(2013-1#1)
relationship between anger##2##3##(2010-11#2)
relationship between assimilation and the well-being of##2##7##(2009-3#2)
relationship between barriers##2##3##(2010-11#2)
relationship between being##2##3##(2009-7#1)(2012-12#1)
relationship between bill##2##3##(2010-2#2)
relationship between blood##3##3##(1992-4#1)(2007-2#1)(2013-8#1)
relationship between body image##6##4##(2006-7#2)(2007-12#2)(2009-5#1)(2012-2#1)
relationship between body mass index##2##5##(2011-1#1)(2011-2#1)
relationship between body##12##3##(2006-7#2)(2007-12#3)(2009-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#3)
relationship between bone##2##3##(1992-5#1)(2007-8#1)
relationship between both##5##3##(1995-12#1)(2008-10#1)(2008-5#1)(2009-5#1)(2013-1#1)
relationship between brain development and feeding##2##6##(2012-2#2)
relationship between brain##4##3##(2008-7#1)(2011-1#1)(2012-2#2)
relationship between breastfeeding##2##3##(2008-10#1)(2010-6#1)
relationship between cancer and##2##4##(1991-3#1)(2007-10#1)
relationship between cancer##4##3##(1991-3#1)(1991-5#1)(2007-10#1)(2008-7#1)
relationship between cardiovascular##2##3##(2013-8#2)
relationship between catenation##2##3##(1994-6#2)
relationship between cell##4##3##(1990-7#1)(1993-3#1)(1993-4#1)(2012-1#1)
relationship between changes in##2##4##(2012-1#1)(2012-3#1)
relationship between chemical##4##3##(1992-6#1)(2005-8#1)(2007-7#1)(2008-10#1)
relationship between child and parent##2##5##(2008-3#2)
relationship between child##3##3##(2008-12#1)(2008-3#2)
relationship between childhood##5##3##(2008-11#1)(2009-2#3)(2009-7#1)
relationship between clinical##3##3##(2006-10#1)(2008-6#1)(2011-3#1)
relationship between cobalt##2##3##(1994-6#2)
relationship between concentration of##2##4##(1996-12#1)(2005-11#1)
relationship between concentration##3##3##(1996-12#1)(2005-11#1)(2010-5#1)
relationship between consumption##2##3##(2008-4#2)
relationship between cortical##2##3##(2009-9#1)(2010-2#1)
relationship between current##2##3##(2008-10#1)(2013-4#1)
relationship between degree of##2##4##(2008-8#1)(2010-4#1)
relationship between detection##2##3##(1995-12#1)(2008-3#1)
relationship between disease##5##3##(2008-10#3)(2012-1#1)(2012-3#1)
relationship between dose and##2##4##(1993-12#1)(2005-7#1)
relationship between each##2##3##(2008-10#1)(2008-2#1)
relationship between early##4##3##(1990-3#1)(1997-4#1)(2008-12#1)(2009-7#1)
relationship between eating##3##3##(2006-7#1)(2011-1#1)(2012-2#1)
relationship between educational level and mortality##4##6##(2006-10#2)(2006-8#2)
relationship between educational level and##5##5##(2006-10#2)(2006-8#3)
relationship between educational level##6##4##(2006-10#2)(2006-8#4)
relationship between educational##8##3##(1996-12#1)(2006-10#2)(2006-8#4)(2008-12#1)
relationship between elevated##2##3##(2007-10#1)(2008-7#1)
relationship between estimated and actual severity##2##6##(2008-10#2)
relationship between experience##2##3##(1992-9#1)(2011-2#1)
relationship between exposure to##2##4##(2012-2#1)(2012-3#1)
relationship between exposure##3##3##(1994-6#1)(2012-2#1)(2012-3#1)
relationship between expression of##2##4##(2008-11#2)
relationship between fatty##2##3##(1995-1#1)(2008-7#1)
relationship between fertility of##2##4##(2006-5#2)
relationship between fertility##3##3##(2006-5#3)
relationship between functional##2##3##(2006-10#1)(2010-8#1)
relationship between genotype and##2##4##(2008-3#1)(2008-7#1)
relationship between ghrelin levels and growth parameters in the##2##9##(2011-1#2)
relationship between government and##2##4##(1995-3#1)(2011-2#1)
relationship between growth##3##3##(2008-10#1)(2008-8#1)(2009-6#1)
relationship between hamstring##2##3##(2012-2#2)
relationship between health##6##3##(1990-8#2)(1991-6#1)(2008-11#1)(2010-12#1)(2010-5#1)
relationship between histological##3##3##(1997-8#1)(2006-2#1)(2008-5#1)
relationship between home range area and##2##6##(2008-8#2)
relationship between home range##3##4##(2008-8#3)
relationship between home##5##3##(1992-2#1)(2008-8#3)(2010-7#1)
relationship between hospital##3##3##(1996-3#2)(2013-1#1)
relationship between host##5##3##(2007-2#1)(2008-10#2)(2009-2#1)(2010-12#1)
relationship between human##2##3##(2006-7#1)(2007-5#1)
relationship between hydrogen##2##3##(2008-7#1)(2009-9#1)
relationship between hypertension##2##3##(1993-11#1)(2008-8#1)
relationship between in vitro##2##4##(1994-2#1)(2008-10#1)
relationship between in##3##3##(1994-2#1)(2008-10#1)(2009-12#1)
relationship between incidence##4##3##(2008-10#4)
relationship between increased##5##3##(1991-3#1)(2008-8#1)(2009-8#1)(2013-8#2)
relationship between increasing##2##3##(2008-10#1)(2008-5#1)
relationship between individual##3##3##(2007-6#1)(2008-3#1)(2010-12#1)
relationship between individuals##2##3##(2007-6#2)
relationship between infection##2##3##(1994-11#1)(2006-10#1)
relationship between innovation and continuous##2##5##(1994-1#1)(1995-1#1)
relationship between insomnia and##2##4##(2012-11#1)(2012-12#1)
relationship between insulin##3##3##(1997-7#1)(2008-1#1)(2011-2#1)
relationship between invasiveness and##2##4##(1997-3#2)
relationship between job satisfaction and job factors##2##7##(2007-4#2)
relationship between job satisfaction##3##4##(2007-4#2)(2010-10#1)
relationship between job##6##3##(1996-2#1)(1997-3#1)(2007-4#2)(2010-10#2)
relationship between laboratory##2##3##(1992-3#1)(2007-12#1)
relationship between lipid##3##3##(1994-5#1)(1996-2#1)(2010-4#1)
relationship between local##4##3##(1994-2#1)(1994-8#1)(1996-10#1)(2008-7#1)
relationship between male and female##2##5##(2008-5#1)(2008-9#1)
relationship between male##3##3##(2008-5#1)(2008-9#1)(2013-1#1)
relationship between mass##2##3##(2005-4#1)(2012-2#1)
relationship between maternal##5##3##(2008-8#1)(2010-2#3)(2011-2#1)
relationship between maximum##2##3##(2004-9#1)(2010-8#1)
relationship between mean##3##3##(2008-10#1)(2008-8#1)(2010-6#1)
relationship between measures of##2##4##(1995-11#1)(2008-10#1)
relationship between medical care costs and##2##6##(2008-11#2)
relationship between medical##4##3##(1991-2#1)(1992-9#1)(2008-11#2)
relationship between negative##2##3##(2009-11#1)(2010-10#1)
relationship between neurons##2##3##(2008-1#1)(2008-7#1)
relationship between number of##2##4##(2008-10#1)(2009-4#1)
relationship between nursing##2##3##(2008-1#1)(2010-3#1)
relationship between oxidative stress and##2##5##(1996-9#1)(2008-3#1)
relationship between oxidative stress##3##4##(1996-9#1)(2006-8#1)(2008-3#1)
relationship between oxidative##4##3##(1996-9#1)(2006-8#1)(2008-3#1)(2010-4#1)
relationship between parental##8##3##(1990-5#1)(1993-2#1)(2007-12#1)(2008-9#1)(2009-12#2)(2009-7#1)(2012-1#1)
relationship between patient##2##3##(2008-12#1)(2008-7#1)
relationship between peak height and##3##5##(2008-10#3)
relationship between peak##6##3##(2008-10#6)
relationship between peer##2##3##(1995-12#1)(2007-12#1)
relationship between perceived##6##3##(2006-9#2)(2007-12#1)(2009-7#1)(2010-7#1)(2013-7#1)
relationship between physical activity and educational level##2##7##(2006-8#2)
relationship between physical activity and##5##5##(2005-10#1)(2006-8#2)(2010-12#1)(2013-1#1)
relationship between physical##8##3##(2005-10#1)(2006-8#2)(2008-10#1)(2010-12#1)(2013-1#3)
relationship between physician and##2##4##(1995-2#1)(2008-3#1)
relationship between physician##3##3##(1995-2#1)(2008-3#1)(2010-8#1)
relationship between physicians and##2##4##(2005-3#1)(2013-8#1)
relationship between plant##2##3##(2006-12#1)(2013-7#1)
relationship between plants and##2##4##(2006-12#1)(2011-10#1)
relationship between plasma##6##3##(1992-9#1)(2007-10#2)(2007-8#1)(2008-6#1)(2012-12#1)
relationship between platelet##3##3##(1990-12#1)(1991-12#1)(1994-12#1)
relationship between prenatal##2##3##(1995-2#1)(2008-11#1)
relationship between professional##2##3##(1990-2#1)(2012-11#1)
relationship between protein kinase C##3##5##(1993-6#1)(2005-10#1)(2008-11#1)
relationship between protein##5##3##(1993-6#1)(2005-10#1)(2008-11#1)(2010-4#1)(2013-8#1)
relationship between proteins##3##3##(2008-2#1)(2008-4#2)
relationship between psoas tension and low back pain##2##8##(2009-4#2)
relationship between quality##2##3##(2007-4#2)
relationship between relative##3##3##(1993-5#1)(2008-3#1)(2013-1#1)
relationship between religion and##2##4##(2009-11#2)
relationship between response to##2##4##(1996-12#1)(2011-1#1)
relationship between rumination and##2##4##(2009-11#1)(2010-10#1)
relationship between serum corticosterone##2##4##(2008-7#2)
relationship between serum levels of##2##5##(1993-12#2)
relationship between serum##6##3##(1993-12#2)(1995-4#1)(2008-7#2)(2013-1#1)
relationship between service##2##3##(1995-1#1)(2006-8#1)
relationship between sex##2##3##(2008-5#1)(2012-12#1)
relationship between sexting and##2##4##(2013-1#2)
relationship between sleep and##2##4##(1995-6#1)(1996-7#1)
relationship between sleep##5##3##(1995-6#1)(1996-7#1)(2006-10#1)(2013-1#2)
relationship between smoking and##4##4##(2006-12#1)(2007-12#1)(2013-4#2)
relationship between smoking##6##3##(1996-3#1)(2006-12#1)(2007-12#1)(2013-1#1)(2013-4#2)
relationship between social support and##2##5##(2009-7#1)(2013-8#1)
relationship between social##6##3##(2006-2#1)(2009-7#1)(2009-8#1)(2010-2#1)(2013-8#2)
relationship between socioeconomic status and health##2##6##(2006-10#1)(2010-2#1)
relationship between socioeconomic status and##3##5##(2006-10#1)(2010-2#1)(2011-1#1)
relationship between socioeconomic##4##3##(2006-10#1)(2010-2#2)(2011-1#1)
relationship between species##3##3##(2008-10#1)(2008-8#2)
relationship between specific##3##3##(2006-10#1)(2010-2#1)(2010-5#1)
relationship between spontaneous##2##3##(1991-7#1)(2013-8#1)
relationship between stroke and##2##4##(2007-10#2)
relationship between structural and functional##3##5##(2007-6#3)
relationship between structural##5##3##(2007-6#3)(2013-1#2)
relationship between structure and##6##4##(1992-6#1)(2005-11#1)(2009-5#2)(2010-4#1)(2012-2#1)
relationship between structure##7##3##(1992-6#1)(1993-4#1)(2005-11#1)(2009-5#2)(2010-4#1)(2012-2#1)
relationship between subjective##4##3##(2007-12#3)(2010-7#1)
relationship between sugars##2##3##(2008-12#1)(2012-1#1)
relationship between survival##2##3##(1996-12#1)(2008-10#1)
relationship between temperature and##2##4##(2008-10#1)(2012-12#1)
relationship between the P-R interval and##2##6##(1994-5#2)
relationship between the age at which##2##6##(2008-8#1)(2009-5#1)
relationship between the bone##2##4##(1991-11#1)(2009-3#1)
relationship between the catalytic current and##2##6##(2008-10#2)
relationship between the changes in##3##5##(2006-8#1)(2008-10#2)
relationship between the concentration of the##3##6##(2004-12#1)(2008-10#2)
relationship between the concentration of##7##5##(2004-12#1)(2008-10#5)(2008-8#1)
relationship between the degree of##5##5##(1990-2#1)(1991-8#1)(2008-2#1)(2008-8#1)(2009-8#1)
relationship between the distribution of##6##5##(1992-6#1)(1994-2#1)(2007-3#1)(2008-10#2)(2011-1#1)
relationship between the electric##2##4##(2008-10#1)(2008-3#1)
relationship between the expression of##3##5##(1996-9#1)(1997-6#1)(2013-8#1)
relationship between the flexion synergy and stretch reflexes in individuals with chronic hemiparetic stroke##2##14##(2012-1#2)
relationship between the frequency shift and the##2##7##(2007-12#1)(2008-10#1)
relationship between the frequency##4##4##(2005-10#1)(2006-10#1)(2007-12#1)(2008-10#1)
relationship between the incidence##2##4##(1995-12#1)(2008-10#1)
relationship between the internal carotid flow and the##2##8##(2007-9#2)
relationship between the level of##4##5##(1992-10#1)(2008-5#1)(2009-9#2)
relationship between the load##2##4##(2009-2#1)(2010-6#1)
relationship between the logarithm of##2##5##(1991-2#1)(2008-10#1)
relationship between the metabolic##2##4##(1996-9#1)(2008-1#1)
relationship between the noise##2##4##(2007-11#1)(2010-12#1)
relationship between the number of audible pops##2##7##(2008-12#2)
relationship between the number of##9##5##(1990-2#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-8#1)(2013-1#1)(2013-8#1)
relationship between the outcome##2##4##(2008-9#1)(2011-2#1)
relationship between the patient's##3##4##(1997-8#1)(2008-9#1)(2013-1#1)
relationship between the peak current and##2##6##(2008-10#2)
relationship between the plateau##2##4##(2005-11#2)
relationship between the potential##2##4##(2005-11#1)(2008-10#1)
relationship between the presence of##6##5##(1991-8#1)(1997-7#1)(2010-12#1)(2010-2#1)(2012-2#1)(2013-8#1)
relationship between the primary##2##4##(2008-10#1)(2011-2#1)
relationship between the rate of##3##5##(1992-8#1)(2008-7#1)(2008-8#1)
relationship between the ratio of the##2##6##(1993-9#1)(2008-10#1)
relationship between the relative##3##4##(2008-10#2)(2008-5#1)
relationship between the severity of coronary artery##2##7##(1993-12#2)
relationship between the severity of##3##5##(1993-12#2)(1993-8#1)
relationship between the size of the##2##6##(1996-12#1)(2008-2#1)
relationship between the size##3##4##(1996-12#1)(2008-2#1)(2012-11#1)
relationship between the specific##2##4##(1994-5#1)(1995-5#1)
relationship between the structural##2##4##(1991-1#1)(2008-10#1)
relationship between the structure and function of##3##7##(1991-5#1)(1997-2#1)(2011-1#1)
relationship between the structure and##5##5##(1991-5#1)(1997-2#1)(2008-8#1)(2009-3#1)(2011-1#1)
relationship between the structure##6##4##(1991-5#1)(1997-2#1)(2008-10#1)(2008-8#1)(2009-3#1)(2011-1#1)
relationship between the two proteins##2##5##(1994-11#1)(2012-2#1)
relationship between the two##11##4##(1993-11#1)(1994-11#1)(1996-2#1)(1996-6#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-6#1)(2012-2#3)
relationship between the use of##6##5##(1996-3#2)(2005-8#1)(2006-2#1)(2008-9#1)(2013-7#1)
relationship between the volume##3##4##(1991-2#1)(2007-3#2)
relationship between the##394##3##(1990-10#1)(1990-12#3)(1990-2#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-2#4)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#3)(1992-10#1)(1992-12#2)(1992-2#4)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#2)(1993-11#2)(1993-12#3)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#3)(1994-5#3)(1994-8#2)(1995-10#1)(1995-11#2)(1995-12#3)(1995-5#3)(1995-6#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#4)(1996-6#3)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#2)(2004-11#1)(2004-12#1)(2004-7#1)(2005-10#1)(2005-11#5)(2005-4#4)(2005-8#1)(2006-1#2)(2006-10#1)(2006-12#2)(2006-2#2)(2006-5#1)(2006-6#2)(2006-8#3)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#7)(2007-3#3)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#5)(2008-1#4)(2008-10#59)(2008-11#9)(2008-12#7)(2008-2#7)(2008-3#15)(2008-4#1)(2008-5#9)(2008-6#4)(2008-7#5)(2008-8#14)(2008-9#11)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#3)(2009-9#2)(2010-10#1)(2010-12#5)(2010-2#6)(2010-3#1)(2010-4#4)(2010-6#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#10)(2011-2#10)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#8)(2012-3#2)(2012-5#1)(2013-1#8)(2013-7#2)(2013-8#14)
relationship between their##3##3##(2007-12#1)(2008-9#1)(2013-8#1)
relationship between them##4##3##(1990-4#1)(1995-4#1)(1996-7#1)(2009-6#1)
relationship between therapists and members##2##5##(2007-10#2)
relationship between these two factors##2##5##(1996-3#1)(2009-6#1)
relationship between these two##7##4##(1992-8#1)(1996-3#1)(2006-1#1)(2007-12#1)(2007-2#1)(2009-6#1)(2012-3#1)
relationship between these##17##3##(1992-8#1)(1994-3#1)(1995-9#1)(1996-3#1)(1997-2#1)(1997-8#1)(2005-11#1)(2006-1#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-2#1)(2008-3#1)(2009-6#1)(2012-3#1)(2013-7#1)
relationship between this##8##3##(1991-11#1)(1994-12#1)(1997-8#1)(2006-2#1)(2007-2#2)(2008-10#1)(2013-7#1)
relationship between total##3##3##(1990-6#1)(1992-9#1)(2006-8#1)
relationship between two##4##3##(1995-3#1)(2007-10#1)(2007-12#1)(2010-2#1)
relationship between virulence and##2##4##(2008-10#1)(2008-9#1)
relationship between vitamin##2##3##(2008-7#1)(2013-7#1)
relationship between water and##2##4##(2010-8#1)(2012-1#1)
relationship between weight##2##3##(2007-9#1)(2009-12#1)
relationship between work engagement##2##4##(2012-1#2)
relationship between##1657##2##(1990-10#2)(1990-11#2)(1990-12#5)(1990-2#3)(1990-3#3)(1990-4#2)(1990-5#5)(1990-6#2)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#3)(1991-10#2)(1991-11#5)(1991-12#6)(1991-2#7)(1991-3#5)(1991-4#1)(1991-5#9)(1991-6#2)(1991-7#4)(1991-8#5)(1991-9#5)(1992-1#3)(1992-10#1)(1992-12#2)(1992-2#6)(1992-3#4)(1992-4#4)(1992-5#3)(1992-6#7)(1992-7#1)(1992-8#3)(1992-9#6)(1993-10#1)(1993-11#5)(1993-12#12)(1993-2#6)(1993-3#9)(1993-4#4)(1993-5#6)(1993-6#3)(1993-7#1)(1993-8#3)(1993-9#7)(1994-1#4)(1994-10#4)(1994-11#6)(1994-12#3)(1994-2#12)(1994-3#10)(1994-4#1)(1994-5#7)(1994-6#8)(1994-7#3)(1994-8#7)(1994-9#2)(1995-1#8)(1995-10#2)(1995-11#4)(1995-12#8)(1995-2#8)(1995-3#4)(1995-4#4)(1995-5#6)(1995-6#5)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#12)(1996-2#8)(1996-3#11)(1996-5#2)(1996-6#5)(1996-7#6)(1996-8#3)(1996-9#4)(1997-1#6)(1997-2#8)(1997-3#6)(1997-4#4)(1997-5#1)(1997-6#4)(1997-7#4)(1997-8#10)(2004-1#1)(2004-11#4)(2004-12#5)(2004-7#1)(2004-9#1)(2005-10#10)(2005-11#13)(2005-12#1)(2005-3#1)(2005-4#8)(2005-7#4)(2005-8#2)(2005-9#1)(2006-1#4)(2006-10#24)(2006-11#2)(2006-12#10)(2006-2#6)(2006-3#2)(2006-4#4)(2006-5#10)(2006-6#5)(2006-7#12)(2006-8#18)(2006-9#4)(2007-1#3)(2007-10#16)(2007-11#7)(2007-12#35)(2007-2#10)(2007-3#10)(2007-4#8)(2007-5#5)(2007-6#9)(2007-7#4)(2007-8#7)(2007-9#14)(2008-1#10)(2008-10#154)(2008-11#37)(2008-12#22)(2008-2#20)(2008-3#31)(2008-4#15)(2008-5#33)(2008-6#13)(2008-7#34)(2008-8#49)(2008-9#29)(2009-1#1)(2009-10#10)(2009-11#12)(2009-12#5)(2009-2#6)(2009-3#7)(2009-4#11)(2009-5#10)(2009-6#4)(2009-7#15)(2009-8#9)(2009-9#7)(2010-1#3)(2010-10#6)(2010-11#7)(2010-12#19)(2010-2#27)(2010-3#7)(2010-4#13)(2010-5#5)(2010-6#8)(2010-7#11)(2010-8#17)(2010-9#6)(2011-1#34)(2011-10#1)(2011-12#3)(2011-2#47)(2011-3#1)(2012-1#24)(2012-11#7)(2012-12#22)(2012-2#41)(2012-3#15)(2012-5#1)(2013-1#49)(2013-4#3)(2013-7#13)(2013-8#44)
relationship building##2##2##(2008-12#1)(2013-1#1)
relationship by##2##2##(2008-7#1)(2009-4#1)
relationship can be##4##3##(1990-7#1)(2008-10#1)(2008-2#2)
relationship can##6##2##(1990-7#1)(2008-10#2)(2008-2#2)(2013-1#1)
relationship cannot be##2##3##(2006-2#1)(2007-4#1)
relationship changes##3##2##(2007-2#2)(2012-2#1)
relationship characteristics##2##2##(2008-10#1)(2012-2#1)
relationship could be established between##2##5##(2008-10#1)(2011-2#1)
relationship could be##7##3##(1995-4#1)(2005-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2011-2#1)
relationship could##9##2##(1995-4#1)(2005-11#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2010-1#1)(2011-2#1)
relationship depends##2##2##(1993-3#1)(2008-3#1)
relationship development##2##2##(2008-11#1)(2012-2#1)
relationship distress and dissolution##2##4##(2009-9#1)(2012-2#1)
relationship distress##7##2##(2008-12#3)(2009-9#1)(2012-2#3)
relationship due to##2##3##(1997-5#1)(2012-2#1)
relationship education programs##3##3##(2012-2#3)
relationship education##11##2##(2010-5#1)(2012-2#10)
relationship emerged##3##2##(1991-5#1)(1991-7#1)(1992-9#1)
relationship existed between the##2##4##(2006-1#1)(2007-2#1)
relationship existed between##5##3##(1992-2#1)(2006-1#1)(2007-2#1)(2008-12#1)(2012-3#1)
relationship existed##7##2##(1992-2#1)(1993-12#1)(2006-1#1)(2007-12#1)(2007-2#1)(2008-12#1)(2012-3#1)
relationship existing between##2##3##(1993-4#1)(2008-11#1)
relationship exists between the##5##4##(1995-8#1)(2005-11#1)(2006-5#1)(2006-8#1)(2008-10#1)
relationship exists between##13##3##(1991-2#1)(1994-3#1)(1995-8#1)(1997-4#1)(2005-11#1)(2006-5#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-7#1)(2012-12#1)(2013-7#1)
relationship exists##15##2##(1991-2#1)(1994-3#1)(1995-8#1)(1997-4#1)(2005-11#1)(2006-5#1)(2006-8#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2009-7#1)(2012-12#1)(2013-7#1)
relationship for the##9##3##(1991-8#1)(1994-2#1)(1996-8#1)(1997-3#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-12#1)
relationship for this##2##3##(1995-3#1)(2008-9#1)
relationship for##27##2##(1990-8#1)(1991-12#1)(1991-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-8#1)(1995-3#1)(1996-10#1)(1996-8#1)(1997-3#2)(1997-5#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#1)
relationship formation behaviors##3##3##(2010-10#3)
relationship formation##5##2##(2010-10#5)
relationship found between the##2##4##(2008-11#1)(2008-2#1)
relationship found between##3##3##(2006-8#1)(2008-11#1)(2008-2#1)
relationship functioning##4##2##(2008-12#1)(2008-9#1)(2012-1#1)(2012-2#1)
relationship has been##7##3##(1990-8#1)(1991-12#1)(1994-6#1)(2005-10#1)(2008-1#1)(2010-7#1)(2012-2#1)
relationship has not been##4##4##(1994-2#1)(2008-9#1)(2010-10#1)(2010-3#1)
relationship has##13##2##(1990-8#1)(1991-12#1)(1994-2#1)(1994-6#1)(2004-12#1)(2005-10#1)(2008-1#1)(2008-5#1)(2008-9#1)(2010-10#1)(2010-3#1)(2010-7#1)(2012-2#1)
relationship in a##3##3##(1994-5#1)(2011-2#2)
relationship in some##3##3##(1993-12#1)(2006-2#1)(2007-12#1)
relationship in the range of##3##5##(2008-10#3)
relationship in the##16##3##(1990-8#1)(1991-9#1)(1992-9#1)(1996-4#1)(2006-2#1)(2008-10#6)(2008-11#1)(2012-3#1)(2013-1#1)(2013-7#2)
relationship in##44##2##(1990-8#1)(1991-9#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-5#1)(1996-2#2)(1996-4#1)(1997-6#1)(2005-11#2)(2006-2#2)(2006-8#1)(2007-12#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-5#2)(2008-7#1)(2009-9#1)(2011-2#3)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
relationship included##2##2##(2006-1#1)(2013-1#1)
relationship involves##2##2##(2008-12#1)(2009-9#1)
relationship is accurate##2##3##(2008-8#1)(2009-2#1)
relationship is established##2##3##(1994-4#1)(2013-1#1)
relationship is not##4##3##(2006-10#1)(2007-8#1)(2008-5#1)(2009-5#1)
relationship is used to##2##4##(2007-4#1)(2008-3#1)
relationship is used##3##3##(2007-12#1)(2007-4#1)(2008-3#1)
relationship is##44##2##(1990-3#1)(1990-6#1)(1991-12#1)(1991-3#1)(1991-4#1)(1993-5#1)(1994-2#1)(1994-4#1)(1995-2#1)(1996-8#1)(2004-11#1)(2005-10#2)(2006-10#1)(2007-11#2)(2007-12#3)(2007-4#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-9#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
relationship management##2##2##(2008-12#2)
relationship may##7##2##(1994-4#1)(2008-10#1)(2008-12#1)(2009-2#1)(2012-12#1)(2013-1#2)
relationship memory##3##2##(2010-8#3)
relationship more##2##2##(1994-6#1)(2010-3#1)
relationship obtained##2##2##(2009-4#1)(2010-3#1)
relationship of a##2##3##(1991-8#1)(1995-3#1)
relationship of body##3##3##(2006-3#1)(2007-12#1)(2008-9#1)
relationship of both##2##3##(1994-11#1)(1996-9#1)
relationship of cardiovascular risk factors measured at different ages to##2##10##(2008-7#2)
relationship of depressive symptoms##2##4##(2009-5#2)
relationship of pain##2##3##(2006-8#1)(2008-9#1)
relationship of political party affiliation to##2##6##(2006-7#2)
relationship of the##36##3##(1990-8#1)(1991-10#1)(1991-2#1)(1991-3#1)(1992-6#1)(1993-10#1)(1995-9#1)(1996-11#1)(1996-5#1)(1997-4#1)(2006-3#1)(2007-12#2)(2007-5#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-7#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
relationship of these factors##2##4##(1995-3#1)(2011-1#1)
relationship of these##15##3##(1990-2#1)(1991-10#1)(1993-3#1)(1994-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-6#1)(2004-3#1)(2006-9#1)(2007-1#1)(2011-1#1)(2011-3#1)(2012-1#2)
relationship of various##2##3##(1996-1#1)(2008-8#1)
relationship of##219##2##(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-7#1)(1991-8#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1995-1#1)(1995-3#2)(1995-4#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#3)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-3#1)(2005-1#1)(2005-11#1)(2005-5#1)(2006-10#4)(2006-12#1)(2006-3#2)(2006-4#2)(2006-5#1)(2006-7#3)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#3)(2007-12#8)(2007-2#2)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#20)(2008-11#3)(2008-12#3)(2008-3#2)(2008-4#4)(2008-5#6)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#7)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#6)(2011-11#1)(2011-12#4)(2011-2#7)(2011-3#3)(2012-1#5)(2012-2#4)(2013-1#4)(2013-7#2)(2013-8#3)
relationship on##5##2##(1997-5#1)(2006-1#1)(2006-8#1)(2009-7#1)(2012-12#1)
relationship or##4##2##(1994-12#1)(2008-6#1)(2008-8#1)(2012-2#1)
relationship outcomes##2##2##(2007-10#1)(2012-2#1)
relationship over the entire##3##4##(2008-10#1)(2013-1#2)
relationship persists after adjusting for##3##5##(1993-12#2)(1994-2#1)
relationship problems##2##2##(2012-2#2)
relationship quality and##2##3##(2008-2#1)(2010-5#1)
relationship quality##5##2##(2008-2#1)(2010-5#1)(2010-8#3)
relationship satisfaction was##2##3##(2009-7#1)(2010-8#1)
relationship satisfaction##15##2##(2007-11#1)(2008-6#1)(2008-9#1)(2009-7#6)(2010-8#2)(2012-2#4)
relationship status##2##2##(2008-12#1)(2010-7#1)
relationship studies indicated that##2##4##(1994-9#1)(1995-3#1)
relationship studies##9##2##(1994-11#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-3#3)(2009-4#1)
relationship study of##3##3##(1996-5#1)(2008-10#1)(2010-12#1)
relationship study##6##2##(1995-3#1)(1996-5#2)(2008-10#2)(2010-12#1)
relationship suggests that##2##3##(1990-7#1)(2009-2#1)
relationship suggests##4##2##(1990-7#1)(1992-8#1)(1993-3#1)(2009-2#1)
relationship that##9##2##(1991-6#1)(1993-3#1)(1995-3#1)(2006-4#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-8#1)
relationship to age##2##3##(2008-1#1)(2009-12#1)
relationship to aging##3##3##(1994-5#1)(1996-7#1)(2007-2#1)
relationship to demographic##2##3##(2007-2#1)(2011-11#1)
relationship to growth##2##3##(1994-5#1)(2008-8#1)
relationship to health##3##3##(2008-7#1)(2012-12#1)(2013-1#1)
relationship to its##2##3##(1992-12#1)(2013-1#1)
relationship to mortality##2##3##(1991-2#1)(2008-7#1)
relationship to other##5##3##(1994-12#1)(1997-4#1)(2008-10#2)(2012-2#1)
relationship to patient##2##3##(2008-9#1)(2012-12#1)
relationship to some##3##3##(1993-7#1)(2006-6#1)(2013-1#1)
relationship to the##38##3##(1991-10#1)(1992-1#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-9#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1996-11#1)(1997-6#1)(1997-7#1)(2005-11#1)(2007-11#2)(2007-4#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2010-11#1)(2012-3#1)(2013-8#1)
relationship to their##2##3##(1997-2#1)(2008-9#1)
relationship to##185##2##(1990-11#1)(1990-9#2)(1991-10#1)(1991-2#2)(1991-8#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-4#1)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#2)(1996-11#1)(1996-5#2)(1996-7#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#3)(2006-6#2)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#2)(2007-9#4)(2008-1#4)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#9)(2008-8#1)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#1)(2011-1#2)(2011-11#1)(2011-2#3)(2011-3#2)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#9)(2013-8#2)
relationship using##2##2##(1997-2#1)(2005-11#1)
relationship varies##2##2##(2008-8#1)(2010-2#1)
relationship was also found##2##4##(2007-7#1)(2008-10#1)
relationship was also##3##3##(2007-7#1)(2008-10#1)(2012-3#1)
relationship was detected between##3##4##(1994-6#1)(2008-10#1)(2012-12#1)
relationship was found between the##7##5##(1991-2#2)(1993-2#1)(2007-2#1)(2008-10#1)(2008-4#1)(2013-8#1)
relationship was found between##28##4##(1990-12#1)(1991-2#2)(1993-12#1)(1993-2#1)(1995-8#1)(1996-11#1)(2006-8#2)(2007-12#1)(2007-2#2)(2007-7#1)(2008-10#7)(2008-4#1)(2008-6#1)(2009-11#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
relationship was found to be##3##5##(2008-10#2)(2013-1#1)
relationship was found to##4##4##(2008-10#3)(2013-1#1)
relationship was found with##2##4##(1991-2#1)(2008-10#1)
relationship was found##35##3##(1990-12#1)(1991-2#3)(1993-12#1)(1993-2#1)(1995-8#1)(1996-11#1)(2006-8#2)(2007-12#1)(2007-2#2)(2007-7#1)(2008-10#12)(2008-4#1)(2008-6#1)(2009-11#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
relationship was not observed##2##4##(2008-10#1)(2012-12#1)
relationship was not##4##3##(1995-12#1)(2008-10#2)(2012-12#1)
relationship was noticed between##2##4##(2011-1#1)(2012-1#1)
relationship was observed between c-erbB-2 protein##2##6##(1990-10#2)
relationship was observed between##10##4##(1990-10#2)(1990-7#1)(1991-2#2)(2004-9#1)(2008-10#3)(2008-2#1)
relationship was observed with##2##4##(1991-11#1)(1996-9#1)
relationship was observed##14##3##(1990-10#2)(1990-7#1)(1991-11#1)(1991-2#2)(1996-9#1)(2004-9#1)(2007-5#1)(2008-10#3)(2008-2#1)(2011-1#1)
relationship was obtained between the##7##5##(1990-2#1)(2007-8#1)(2008-10#5)
relationship was obtained##8##3##(1990-2#1)(2007-8#1)(2008-10#6)
relationship was seen between##2##4##(2006-10#1)(2013-1#1)
relationship was similar in##2##4##(1990-10#1)(2013-8#1)
relationship was##105##2##(1990-10#3)(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-2#5)(1993-12#2)(1993-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-11#1)(1996-9#1)(2004-9#2)(2006-10#1)(2006-12#1)(2006-8#2)(2007-12#2)(2007-2#2)(2007-3#3)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#32)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-7#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#1)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#3)
relationship were##5##2##(1991-2#1)(2006-10#1)(2008-5#1)(2009-11#1)(2009-4#1)
relationship where##2##2##(1997-2#1)(2008-7#1)
relationship with a##5##3##(1990-11#1)(1993-5#1)(2006-1#1)(2008-12#1)(2012-3#1)
relationship with age##2##3##(2008-7#1)(2009-12#1)
relationship with air temperature##2##4##(2013-8#2)
relationship with an##2##3##(2007-12#1)(2012-2#1)
relationship with baseline##2##3##(2011-2#1)(2012-12#1)
relationship with clinical##5##3##(1994-12#1)(2008-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
relationship with depression##2##3##(2007-7#1)(2011-2#1)
relationship with fasting##2##3##(1992-6#1)(1995-6#1)
relationship with health care provider##2##5##(2013-7#2)
relationship with its##2##3##(2008-10#2)
relationship with net radiation and##2##5##(2013-8#2)
relationship with other##3##3##(2008-10#1)(2008-4#1)(2013-1#1)
relationship with patients##2##3##(1997-1#1)(2011-1#1)
relationship with respect to##2##4##(2008-7#1)(2012-2#1)
relationship with some##2##3##(2008-10#1)(2013-7#1)
relationship with the cell##2##4##(2006-10#1)(2008-10#1)
relationship with the##52##3##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-2#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-6#1)(2004-3#1)(2006-10#2)(2006-11#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-3#1)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
relationship with their partner##2##4##(2007-12#1)(2010-9#1)
relationship with their##8##3##(2007-12#1)(2008-10#3)(2009-8#1)(2010-9#1)(2012-3#1)(2013-1#1)
relationship with##211##2##(1990-11#2)(1990-12#1)(1990-4#1)(1990-5#2)(1990-6#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-2#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-1#1)(1994-12#3)(1994-3#2)(1994-5#1)(1994-8#1)(1995-12#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-3#1)(1996-6#2)(1997-1#1)(1997-3#1)(1997-5#2)(1997-7#1)(1997-8#1)(2004-3#1)(2005-11#2)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#3)(2006-5#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#29)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#7)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#4)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#9)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#8)(2012-3#4)(2012-9#1)(2013-1#12)(2013-7#5)(2013-8#5)
relationship within the##3##3##(1992-12#1)(2008-12#1)(2010-10#1)
relationship within##5##2##(1992-12#1)(1997-1#1)(2007-12#1)(2008-12#1)(2010-10#1)
relationship##3185##1##(1990-10#5)(1990-11#7)(1990-12#11)(1990-2#8)(1990-3#4)(1990-4#5)(1990-5#8)(1990-6#6)(1990-7#6)(1990-8#8)(1990-9#5)(1991-1#6)(1991-10#6)(1991-11#7)(1991-12#14)(1991-2#19)(1991-3#7)(1991-4#2)(1991-5#15)(1991-6#5)(1991-7#7)(1991-8#10)(1991-9#6)(1992-1#4)(1992-10#2)(1992-11#1)(1992-12#7)(1992-2#9)(1992-3#6)(1992-4#6)(1992-5#3)(1992-6#12)(1992-7#1)(1992-8#7)(1992-9#11)(1993-1#3)(1993-10#2)(1993-11#11)(1993-12#25)(1993-2#12)(1993-3#16)(1993-4#5)(1993-5#10)(1993-6#7)(1993-7#2)(1993-8#5)(1993-9#10)(1994-1#7)(1994-10#4)(1994-11#10)(1994-12#14)(1994-2#21)(1994-3#22)(1994-4#5)(1994-5#15)(1994-6#16)(1994-7#4)(1994-8#10)(1994-9#6)(1995-1#14)(1995-10#2)(1995-11#6)(1995-12#18)(1995-2#11)(1995-3#17)(1995-4#6)(1995-5#9)(1995-6#8)(1995-7#3)(1995-8#4)(1995-9#5)(1996-1#6)(1996-10#2)(1996-11#5)(1996-12#20)(1996-2#15)(1996-3#16)(1996-4#2)(1996-5#9)(1996-6#9)(1996-7#8)(1996-8#12)(1996-9#7)(1997-1#12)(1997-2#19)(1997-3#10)(1997-4#10)(1997-5#8)(1997-6#11)(1997-7#10)(1997-8#13)(2004-1#1)(2004-11#7)(2004-12#7)(2004-2#1)(2004-3#3)(2004-7#1)(2004-9#3)(2005-1#1)(2005-10#16)(2005-11#30)(2005-12#3)(2005-3#1)(2005-4#9)(2005-5#1)(2005-7#5)(2005-8#3)(2005-9#1)(2006-1#12)(2006-10#46)(2006-11#4)(2006-12#18)(2006-2#15)(2006-3#6)(2006-4#8)(2006-5#16)(2006-6#7)(2006-7#22)(2006-8#33)(2006-9#10)(2007-1#8)(2007-10#26)(2007-11#19)(2007-12#69)(2007-2#22)(2007-3#19)(2007-4#24)(2007-5#11)(2007-6#12)(2007-7#10)(2007-8#19)(2007-9#23)(2008-1#22)(2008-10#312)(2008-11#60)(2008-12#47)(2008-2#42)(2008-3#57)(2008-4#33)(2008-5#58)(2008-6#26)(2008-7#69)(2008-8#71)(2008-9#54)(2009-1#2)(2009-10#15)(2009-11#18)(2009-12#13)(2009-2#11)(2009-3#10)(2009-4#19)(2009-5#18)(2009-6#4)(2009-7#30)(2009-8#12)(2009-9#21)(2010-1#10)(2010-10#19)(2010-11#8)(2010-12#26)(2010-2#35)(2010-3#17)(2010-4#21)(2010-5#10)(2010-6#11)(2010-7#15)(2010-8#33)(2010-9#14)(2011-1#55)(2011-10#1)(2011-11#2)(2011-12#9)(2011-2#88)(2011-3#8)(2012-1#44)(2012-11#10)(2012-12#41)(2012-2#106)(2012-3#33)(2012-5#1)(2012-9#1)(2013-1#97)(2013-4#3)(2013-7#27)(2013-8#69)
relationship&quot##2##1##(1993-12#1)(2013-1#1)
relationship) and##3##2##(1994-12#1)(2005-10#1)(2009-9#1)
relationship)##6##1##(1994-12#2)(2005-10#2)(2008-12#1)(2009-9#1)
relationship?##3##1##(1995-3#1)(2009-8#1)(2011-2#1)
relationship?]##2##1##(1991-3#1)(1994-5#1)
relationship]##2##1##(1997-4#1)(2013-7#1)
relationships among adipogenic genes##2##4##(2010-4#2)
relationships among all##2##3##(2008-8#1)(2008-9#1)
relationships among body##3##3##(2006-10#1)(2007-12#1)(2008-9#1)
relationships among different##2##3##(2008-10#1)(2008-3#1)
relationships among isolates##2##3##(2008-10#2)
relationships among phenotypes##3##3##(2011-1#3)
relationships among seven##2##3##(1994-3#1)(2008-10#1)
relationships among several##2##3##(1997-3#1)(2010-7#1)
relationships among temperature##2##3##(2008-10#2)
relationships among the orders of##2##5##(1993-6#1)(2006-5#1)
relationships among the##24##3##(1993-6#1)(1995-4#1)(1997-4#2)(2006-5#1)(2008-10#5)(2008-6#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2013-1#3)(2013-8#1)
relationships among these##8##3##(1990-9#1)(1992-3#1)(1992-4#1)(2008-10#1)(2008-7#2)(2008-9#1)(2011-2#1)
relationships among##112##2##(1990-9#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-2#2)(1993-6#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-4#1)(1996-1#1)(1996-3#2)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#2)(2006-10#1)(2006-5#2)(2007-10#1)(2007-12#2)(2007-5#1)(2008-10#20)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#6)(2008-9#8)(2009-5#1)(2009-7#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#5)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#3)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#3)
relationships and expectations##2##3##(2007-7#2)
relationships and in##2##3##(1991-5#1)(2010-3#1)
relationships and influence##2##3##(2007-12#1)(2013-7#1)
relationships and provided information on the##2##6##(2008-10#2)
relationships and the##8##3##(1992-12#1)(2006-10#1)(2007-2#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-8#1)(2011-2#1)
relationships and to##5##3##(1996-10#1)(2007-11#1)(2007-2#1)(2010-4#1)(2013-8#1)
relationships and##57##2##(1991-3#1)(1991-5#1)(1992-12#1)(1995-3#1)(1996-10#1)(1996-11#1)(1996-12#1)(2004-12#2)(2005-11#1)(2005-8#1)(2006-10#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#3)(2008-9#3)(2009-5#1)(2009-9#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
relationships are also##2##3##(1993-12#1)(2005-11#1)
relationships are discussed##3##3##(2008-7#1)(2012-1#1)(2012-2#1)
relationships are##27##2##(1991-2#1)(1993-12#1)(2005-11#2)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-9#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#2)
relationships as a##3##3##(1996-12#1)(2005-7#1)(2009-4#1)
relationships as##5##2##(1996-12#1)(1997-2#1)(2005-7#1)(2007-9#1)(2009-4#1)
relationships at the##2##3##(2008-2#1)(2008-7#1)
relationships at##6##2##(1996-1#1)(2008-12#1)(2008-2#1)(2008-7#2)(2011-2#1)
relationships become##2##2##(2008-10#1)(2009-7#1)
relationships between (a)##2##3##(2009-11#1)(2009-9#1)
relationships between blood##2##3##(2005-10#1)(2010-4#1)
relationships between cerebral##2##3##(2006-10#1)(2008-7#1)
relationships between disease incidence##2##4##(2008-10#2)
relationships between disease##5##3##(1996-9#1)(2008-10#4)
relationships between drug##2##3##(1995-2#1)(2008-3#1)
relationships between family members##2##4##(1996-9#1)(2008-11#1)
relationships between family##3##3##(1996-9#1)(2008-11#1)(2011-1#1)
relationships between functional##2##3##(1996-2#1)(2013-7#1)
relationships between genotype##2##3##(2009-2#1)(2010-8#1)
relationships between individual##2##3##(2008-7#1)(2010-8#1)
relationships between local and##2##4##(1991-2#1)(2008-8#1)
relationships between measures of##2##4##(2010-10#1)(2013-7#1)
relationships between parameters##2##3##(1994-3#1)(1996-8#1)
relationships between physical health and spiritual##2##6##(2010-2#2)
relationships between physical##3##3##(2008-9#1)(2010-2#2)
relationships between physicochemical##2##3##(2008-10#1)(2013-1#1)
relationships between plasma Hp and##2##5##(1995-7#2)
relationships between plasma Hp##3##4##(1995-7#3)
relationships between plasma##4##3##(1991-2#1)(1995-7#3)
relationships between risk##2##3##(1991-12#1)(2011-1#1)
relationships between serum##2##3##(1995-3#1)(1996-8#1)
relationships between sleep##2##3##(2006-10#1)(2011-2#1)
relationships between social##3##3##(1992-3#1)(2008-5#1)(2013-8#1)
relationships between species##3##3##(2008-8#2)(2013-7#1)
relationships between stress##2##3##(1992-3#1)(2008-7#1)
relationships between students' reading self-concept##2##5##(2010-3#2)
relationships between the##56##3##(1991-12#1)(1991-6#1)(1992-8#1)(1995-8#1)(1996-2#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-3#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-2#2)(2010-4#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#2)
relationships between these two##2##4##(2008-10#1)(2009-12#1)
relationships between these##11##3##(1992-8#1)(2007-10#1)(2007-6#1)(2008-10#2)(2008-12#1)(2008-9#1)(2009-12#1)(2009-3#1)(2011-2#1)(2012-2#1)
relationships between##320##2##(1991-11#1)(1991-12#4)(1991-2#3)(1991-6#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-5#1)(1992-8#2)(1993-1#2)(1993-12#1)(1993-3#2)(1993-5#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#3)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-7#1)(1996-8#2)(1996-9#3)(1997-2#1)(1997-6#1)(1997-7#2)(1997-8#2)(2005-10#2)(2005-8#3)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-6#3)(2006-7#1)(2007-1#2)(2007-10#4)(2007-11#2)(2007-12#2)(2007-2#2)(2007-4#3)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#39)(2008-11#8)(2008-12#3)(2008-2#4)(2008-3#4)(2008-4#7)(2008-5#5)(2008-6#4)(2008-7#12)(2008-8#13)(2008-9#14)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#3)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#6)(2010-3#3)(2010-4#8)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#5)(2011-1#5)(2011-2#8)(2012-1#3)(2012-11#2)(2012-12#3)(2012-2#5)(2012-3#5)(2012-5#1)(2013-1#10)(2013-7#5)(2013-8#6)
relationships by##4##2##(1995-1#1)(2009-7#1)(2011-2#2)
relationships can be##3##3##(2008-10#1)(2008-8#1)(2010-5#1)
relationships describing##2##2##(2007-4#1)(2008-8#1)
relationships developed in the##2##4##(2008-10#2)
relationships during##2##2##(1997-6#1)(2008-2#1)
relationships for the##7##3##(1995-6#2)(2006-12#1)(2007-11#1)(2008-10#1)(2009-9#1)(2010-12#1)
relationships for##23##2##(1991-1#1)(1991-12#1)(1991-3#1)(1994-9#1)(1995-6#2)(1995-8#1)(1996-8#1)(1997-1#1)(2005-11#1)(2005-12#1)(2006-12#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-2#1)(2008-7#3)(2009-9#1)(2010-12#1)(2011-1#1)
relationships found##3##2##(2008-11#1)(2008-4#1)(2010-8#1)
relationships from the##2##3##(2007-6#1)(2008-8#1)
relationships from##4##2##(2007-10#1)(2007-6#1)(2008-8#1)(2010-2#1)
relationships has##2##2##(2004-12#1)(2009-5#1)
relationships have been identified##2##4##(1993-6#1)(2010-7#1)
relationships have been##5##3##(1993-6#1)(2005-10#1)(2006-12#1)(2007-9#1)(2010-7#1)
relationships have##10##2##(1990-5#1)(1991-9#1)(1993-6#1)(2005-10#1)(2006-12#1)(2007-9#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-7#1)
relationships improve##3##2##(2007-4#1)(2007-9#1)(2008-12#1)
relationships in a##6##3##(2007-4#1)(2008-10#1)(2008-12#1)(2010-8#1)(2013-1#2)
relationships in epidemiologic studies##2##4##(2008-7#2)
relationships in human experimental exposure to##2##6##(2008-7#2)
relationships in human##3##3##(1994-8#1)(2008-7#2)
relationships in psychotherapy##3##3##(2006-11#1)(2009-9#2)
relationships in the##12##3##(1991-3#2)(1992-11#1)(1992-4#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-10#1)
relationships in this##3##3##(1992-5#1)(2008-11#1)(2009-4#1)
relationships in##66##2##(1990-7#1)(1991-3#2)(1992-11#2)(1992-4#1)(1992-5#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-5#1)(1996-10#1)(1996-2#1)(1996-4#1)(1997-1#1)(2006-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-9#4)(2010-10#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#5)(2013-8#1)
relationships involved##2##2##(1993-11#1)(1997-6#1)
relationships involving##5##2##(2007-6#1)(2007-9#1)(2008-4#1)(2009-12#1)(2010-8#1)
relationships is##7##2##(1991-2#1)(1991-3#1)(1995-6#1)(2008-2#1)(2008-8#1)(2009-7#1)(2010-2#1)
relationships may be##3##3##(1993-12#1)(2008-1#1)(2008-10#1)
relationships may##5##2##(1993-12#1)(1997-3#1)(2008-1#1)(2008-10#1)(2009-9#1)
relationships not##3##2##(1997-6#2)(2010-5#1)
relationships of a##2##3##(1996-8#1)(1997-4#1)
relationships of resistance##2##3##(2008-10#2)
relationships of the##20##3##(1991-5#1)(1993-8#1)(1994-8#1)(1995-10#1)(1995-3#1)(2004-9#1)(2006-10#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
relationships of##115##2##(1990-6#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-4#3)(1993-5#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-8#1)(1994-9#4)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-8#3)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#1)(2004-9#1)(2005-7#2)(2005-8#1)(2006-10#2)(2006-12#2)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-3#2)(2010-4#2)(2010-6#4)(2010-9#3)(2011-1#1)(2011-2#1)(2012-11#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#3)
relationships on##3##2##(2006-3#1)(2011-1#1)(2013-7#1)
relationships remain##2##2##(2010-12#1)(2011-2#1)
relationships revealed##3##2##(1995-1#1)(2007-6#1)(2008-6#1)
relationships should be disclosed to research participants##2##7##(2009-4#2)
relationships should be##5##3##(2007-7#1)(2008-11#1)(2009-4#3)
relationships suggest that the##2##4##(1991-5#1)(1995-3#1)
relationships suggest that##3##3##(1991-5#1)(1995-3#1)(2008-10#1)
relationships suggested that##2##3##(2008-10#2)
relationships that exist between##2##4##(2008-10#1)(2013-7#1)
relationships that may##3##3##(2011-7#1)(2013-1#2)
relationships that##18##2##(1993-1#1)(1994-1#1)(1994-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2009-8#1)(2009-9#2)(2011-7#1)(2013-1#5)(2013-7#1)
relationships through##2##2##(1996-3#1)(2007-4#1)
relationships to describe##2##3##(2007-4#1)(2007-6#1)
relationships to each other##2##4##(2008-6#1)(2011-1#1)
relationships to one another##2##4##(2007-12#1)(2008-7#1)
relationships to##27##2##(1993-2#1)(1995-1#1)(1995-7#1)(1997-2#1)(2006-4#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-6#2)(2008-7#3)(2008-8#1)(2009-4#1)(2011-1#2)(2011-2#1)
relationships using##2##2##(2012-2#1)(2012-3#1)
relationships was##3##2##(1997-4#1)(2009-7#1)(2011-1#1)
relationships we##2##2##(2013-1#2)
relationships were developed##2##3##(2006-11#1)(2007-4#1)
relationships were established##2##3##(1991-2#1)(2008-10#1)
relationships were found between##7##4##(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#2)
relationships were found##10##3##(1992-4#1)(1994-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#2)(2013-7#1)
relationships were not observed##2##4##(1991-9#1)(2010-7#1)
relationships were not##3##3##(1991-9#1)(2009-4#1)(2010-7#1)
relationships were observed##4##3##(1991-5#2)(2008-10#1)(2009-4#1)
relationships were similar to the##2##5##(2008-11#1)(2008-8#1)
relationships were similar##3##3##(2004-11#1)(2008-11#1)(2008-8#1)
relationships were##45##2##(1991-2#1)(1991-5#2)(1991-9#1)(1992-4#1)(1993-12#1)(1994-5#1)(1996-1#1)(1996-2#1)(1997-1#1)(2004-11#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#3)(2009-9#1)(2010-1#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-7#1)
relationships which##2##2##(1994-8#1)(2011-2#1)
relationships with both##2##3##(1993-2#1)(2008-2#1)
relationships with each##2##3##(1995-1#1)(1997-6#1)
relationships with managed care##2##4##(1995-12#1)(2007-1#1)
relationships with other##2##3##(1991-12#1)(2013-7#1)
relationships with others##2##3##(2005-7#1)(2008-2#1)
relationships with patients##3##3##(1994-12#1)(2004-5#1)(2007-9#1)
relationships with referring physicians##3##4##(1990-12#1)(1995-1#1)(1995-12#1)
relationships with social workers##2##4##(2010-2#2)
relationships with some##2##3##(2008-12#1)(2012-12#1)
relationships with species##2##3##(2007-5#1)(2013-8#1)
relationships with students##2##3##(2007-12#1)(2008-8#1)
relationships with the##6##3##(2007-3#1)(2008-10#1)(2008-7#2)(2008-8#1)(2013-8#1)
relationships with their parents##3##4##(2008-1#1)(2009-7#2)
relationships with their teachers##2##4##(2008-12#2)
relationships with their##8##3##(1994-12#1)(2006-11#1)(2008-1#1)(2008-12#2)(2009-7#2)(2011-1#1)
relationships with##84##2##(1990-12#2)(1991-12#1)(1991-8#1)(1992-4#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#2)(1995-1#2)(1995-12#2)(1995-2#1)(1995-9#1)(1997-2#1)(1997-6#1)(2004-5#1)(2005-7#1)(2006-11#1)(2006-4#1)(2006-7#1)(2006-9#2)(2007-1#2)(2007-12#3)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-12#6)(2008-2#3)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-4#1)(2009-7#2)(2010-1#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-7#3)(2013-8#4)
relationships within the family##2##4##(1992-11#1)(2008-10#1)
relationships within the genus##3##4##(1996-3#1)(2008-10#1)(2010-4#1)
relationships within the##9##3##(1992-11#1)(1996-3#1)(2007-2#1)(2008-10#2)(2008-6#1)(2008-9#1)(2010-3#1)(2010-4#1)
relationships within##19##2##(1992-1#1)(1992-11#1)(1996-12#1)(1996-3#1)(2007-12#2)(2007-2#1)(2008-10#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#1)
relationships##1338##1##(1990-11#1)(1990-12#4)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-1#2)(1991-11#1)(1991-12#9)(1991-2#9)(1991-3#8)(1991-5#5)(1991-6#3)(1991-8#1)(1991-9#3)(1992-1#4)(1992-10#2)(1992-11#5)(1992-12#3)(1992-2#2)(1992-3#4)(1992-4#7)(1992-5#4)(1992-6#1)(1992-8#3)(1993-1#3)(1993-11#3)(1993-12#12)(1993-2#5)(1993-3#6)(1993-4#6)(1993-5#3)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#6)(1994-10#1)(1994-11#2)(1994-12#8)(1994-2#1)(1994-3#6)(1994-4#1)(1994-5#3)(1994-6#5)(1994-8#3)(1994-9#7)(1995-1#8)(1995-10#2)(1995-11#2)(1995-12#5)(1995-2#6)(1995-3#5)(1995-4#2)(1995-5#3)(1995-6#6)(1995-7#4)(1995-8#4)(1995-9#1)(1996-1#3)(1996-10#4)(1996-11#2)(1996-12#6)(1996-2#9)(1996-3#6)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#8)(1996-9#3)(1997-1#10)(1997-2#8)(1997-3#4)(1997-4#5)(1997-5#3)(1997-6#7)(1997-7#2)(1997-8#4)(2004-11#1)(2004-12#3)(2004-4#1)(2004-5#1)(2004-9#1)(2005-10#3)(2005-11#4)(2005-12#1)(2005-7#4)(2005-8#5)(2006-1#1)(2006-10#11)(2006-11#4)(2006-12#10)(2006-2#2)(2006-3#6)(2006-4#3)(2006-5#5)(2006-6#3)(2006-7#10)(2006-8#2)(2006-9#2)(2007-1#6)(2007-10#9)(2007-11#12)(2007-12#22)(2007-2#5)(2007-3#4)(2007-4#14)(2007-5#4)(2007-6#8)(2007-7#7)(2007-8#6)(2007-9#9)(2008-1#16)(2008-10#142)(2008-11#23)(2008-12#27)(2008-2#18)(2008-3#11)(2008-4#21)(2008-5#20)(2008-6#17)(2008-7#52)(2008-8#44)(2008-9#38)(2009-10#3)(2009-11#3)(2009-12#6)(2009-2#2)(2009-3#4)(2009-4#12)(2009-5#12)(2009-6#1)(2009-7#14)(2009-8#6)(2009-9#17)(2010-1#6)(2010-10#4)(2010-11#2)(2010-12#6)(2010-2#16)(2010-3#10)(2010-4#19)(2010-5#6)(2010-6#8)(2010-7#11)(2010-8#15)(2010-9#6)(2011-1#25)(2011-12#2)(2011-2#37)(2011-7#1)(2012-1#10)(2012-11#7)(2012-12#9)(2012-2#23)(2012-3#16)(2012-5#1)(2013-1#51)(2013-7#15)(2013-8#22)
relationships)##3##1##(1995-4#1)(2011-1#1)(2013-7#1)
relationships?##2##1##(2007-1#1)(2012-2#1)
relative Alpha##2##2##(1997-1#2)
relative BS##2##2##(2007-1#2)
relative EC50/IC50##5##2##(2012-2#5)
relative Mr##2##2##(1991-5#1)(1993-6#1)
relative PKA activity levels##2##4##(2008-10#2)
relative S##8##2##(2008-10#8)
relative abilities##2##2##(2008-10#1)(2009-9#1)
relative ability##2##2##(1990-9#1)(1994-12#1)
relative abundance and##8##3##(1996-8#1)(2008-10#1)(2008-5#1)(2010-8#1)(2012-2#1)(2012-6#3)
relative abundance in##3##3##(2008-8#1)(2012-2#1)(2013-7#1)
relative abundance of C##2##4##(2012-6#2)
relative abundance of an##2##4##(2008-11#1)(2008-4#1)
relative abundance of the##6##4##(1992-12#1)(1993-5#1)(1994-11#1)(1995-1#1)(1995-10#1)(2012-2#1)
relative abundance of##28##3##(1992-12#1)(1993-5#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-1#2)(1995-10#1)(1997-2#1)(2005-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-12#1)(2012-2#2)(2012-6#2)(2013-7#1)
relative abundance patterns##2##3##(2008-8#2)
relative abundance##51##2##(1992-12#1)(1993-5#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-1#2)(1995-10#1)(1996-8#1)(1997-2#1)(1997-6#1)(2005-12#1)(2007-12#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#8)(2008-8#5)(2008-9#1)(2009-12#1)(2010-8#1)(2012-2#6)(2012-6#5)(2013-7#2)
relative abundances of##4##3##(2007-7#1)(2008-10#1)(2008-8#1)(2008-9#1)
relative abundances##5##2##(2007-7#1)(2008-10#1)(2008-8#2)(2008-9#1)
relative accuracy of##2##3##(2008-10#1)(2008-2#1)
relative accuracy##7##2##(1990-5#1)(2008-10#4)(2008-2#1)(2010-11#1)
relative activities##8##2##(1991-8#1)(1992-12#1)(1992-4#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-3#1)
relative activity against##2##3##(1992-3#1)(2008-5#1)
relative activity of##3##3##(2008-10#1)(2008-11#1)(2010-12#1)
relative activity##5##2##(1992-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)
relative advantages##2##2##(2008-10#1)(2008-3#1)
relative affinities of the##2##4##(1990-7#1)(2011-2#1)
relative affinities of##4##3##(1990-7#1)(1991-7#1)(2008-9#1)(2011-2#1)
relative affinity for##4##3##(1991-12#1)(1996-2#1)(1997-4#1)(2008-10#1)
relative affinity of##4##3##(1990-4#1)(1990-7#1)(1990-8#1)(1996-7#1)
relative affinity##10##2##(1990-4#1)(1990-7#1)(1990-8#1)(1991-12#1)(1994-5#1)(1995-10#1)(1996-2#1)(1996-7#1)(1997-4#1)(2008-10#1)
relative amount of HPV DNA##2##5##(1997-7#2)
relative amount of the transcripts containing the##2##7##(1994-12#2)
relative amount of the##6##4##(1990-3#1)(1992-2#1)(1994-12#2)(1997-1#1)(2008-11#1)
relative amount of##17##3##(1990-3#1)(1991-12#1)(1992-2#1)(1992-6#1)(1993-12#1)(1994-12#2)(1994-8#1)(1995-1#1)(1995-2#1)(1997-1#1)(1997-7#2)(2008-11#1)(2009-10#1)(2009-2#1)(2013-1#1)
relative amounts of the metabolites##2##5##(2011-3#2)
relative amounts of the two##2##5##(1996-9#1)(2008-2#1)
relative amounts of the##9##4##(1991-5#1)(1992-11#1)(1996-9#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-3#2)
relative amounts of##24##3##(1990-12#1)(1991-5#2)(1992-11#1)(1992-12#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-9#1)(1996-9#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-3#2)
relative amounts##28##2##(1990-12#1)(1991-5#2)(1992-11#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-9#1)(1996-4#1)(1996-9#1)(1997-7#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-3#2)
relative amplitude##2##2##(2008-4#1)(2008-7#1)
relative and absolute##9##3##(2006-9#1)(2007-10#1)(2008-3#1)(2008-4#2)(2008-8#2)(2010-5#1)(2012-2#1)
relative and attributable risk##2##4##(1995-6#2)
relative and attributable##3##3##(1995-6#3)
relative and##18##2##(1992-2#1)(1995-6#3)(2006-9#1)(2007-1#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-8#2)(2010-10#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
relative area under the disease progress##2##6##(2008-10#2)
relative area under the##5##4##(2008-10#5)
relative area##6##2##(2005-11#1)(2008-10#5)
relative attractiveness##3##2##(2008-10#3)
relative average##2##2##(2008-10#1)(2011-2#1)
relative benefit##2##2##(2005-8#1)(2007-9#1)
relative benefits and##2##3##(2007-10#1)(2007-8#1)
relative benefits of##3##3##(2005-10#1)(2007-10#1)(2008-6#1)
relative benefits##6##2##(2005-10#1)(2006-4#1)(2007-10#2)(2007-8#1)(2008-6#1)
relative binding affinities of##4##4##(1990-11#1)(1990-5#1)(1993-6#1)(2006-12#1)
relative binding affinity##2##3##(1997-2#1)(2010-1#1)
relative binding of##3##3##(1991-3#2)(2008-4#1)
relative binding##14##2##(1990-11#1)(1990-5#1)(1991-3#2)(1993-6#1)(1994-11#1)(1994-12#1)(1996-4#1)(1997-2#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-1#1)
relative bioavailability of##5##3##(1996-6#3)(2010-1#1)(2012-1#1)
relative bioavailability##7##2##(1996-6#3)(2008-5#1)(2010-1#1)(2011-2#1)(2012-1#1)
relative bioequivalence of##2##3##(2012-12#1)(2012-3#1)
relative biological effectiveness##2##3##(1994-3#1)(2008-3#1)
relative biological##3##2##(1990-7#1)(1994-3#1)(2008-3#1)
relative blood flow##2##3##(2005-11#1)(2007-10#1)
relative blood##3##2##(2005-11#1)(2007-10#2)
relative body##6##2##(1992-4#5)(2010-8#1)
relative brain size##2##3##(1991-11#2)
relative brain volume##2##3##(2008-3#2)
relative brain##5##2##(1991-11#2)(2007-4#1)(2008-3#2)
relative carrier-envelope phase##2##3##(2007-11#2)
relative cell counts##2##3##(2011-1#2)
relative cell##3##2##(2008-5#1)(2011-1#2)
relative cerebellar metabolism##2##3##(1996-5#2)
relative cerebellar##3##2##(1995-5#1)(1996-5#2)
relative cerebral blood volume (rCBV)##2##5##(2007-10#1)(2008-7#1)
relative cerebral blood##3##3##(2007-10#2)(2008-7#1)
relative cerebral##4##2##(2007-10#2)(2008-7#1)(2011-1#1)
relative change in##4##3##(2005-10#1)(2007-7#1)(2008-3#2)
relative change was observed##2##4##(1991-5#1)(2011-2#1)
relative change##7##2##(1991-5#1)(2005-10#1)(2007-7#1)(2008-3#2)(2008-6#1)(2011-2#1)
relative changes in##2##3##(1992-2#1)(2008-7#1)
relative changes##6##2##(1990-5#1)(1992-2#1)(1995-1#1)(2008-2#1)(2008-7#2)
relative clauses##3##2##(2006-2#3)
relative collision##2##2##(2008-10#2)
relative comparison with##2##3##(2008-10#1)(2008-3#1)
relative composition of##3##3##(1996-7#1)(2004-2#1)(2008-10#1)
relative concentration of each##2##4##(1992-9#1)(1996-9#1)
relative concentration of##8##3##(1991-12#1)(1992-9#1)(1994-10#1)(1996-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
relative concentration##11##2##(1991-12#1)(1992-9#1)(1994-10#1)(1996-9#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#1)
relative concentrations of the##2##4##(1992-9#1)(2008-2#1)
relative concentrations of##6##3##(1992-12#1)(1992-9#1)(2007-8#1)(2008-12#1)(2008-2#1)(2010-2#1)
relative concentrations##7##2##(1992-12#1)(1992-9#1)(1995-2#1)(2007-8#1)(2008-12#1)(2008-2#1)(2010-2#1)
relative configuration of##2##3##(1997-2#1)(2004-7#1)
relative configuration##4##2##(1997-2#2)(2004-7#2)
relative conformation##2##2##(1991-9#1)(1996-8#1)
relative contents##2##2##(2008-10#1)(2008-2#1)
relative contraindications##4##2##(1991-6#1)(2006-3#1)(2011-2#2)
relative contribution of different leaf layers to##2##7##(2008-10#2)
relative contribution of different##3##4##(2008-10#2)(2013-1#1)
relative contribution of the##5##4##(1992-12#1)(1997-7#1)(2006-5#1)(2008-10#1)(2009-7#1)
relative contribution of##29##3##(1991-2#1)(1992-12#1)(1992-6#2)(1994-2#1)(1996-12#1)(1996-7#1)(1997-7#1)(2006-5#2)(2007-12#3)(2008-10#7)(2008-8#1)(2009-1#1)(2009-2#1)(2009-7#1)(2010-2#1)(2011-2#1)(2013-1#3)
relative contribution to the##2##4##(2008-2#1)(2008-7#1)
relative contribution to##5##3##(1992-9#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-2#1)
relative contribution##35##2##(1991-2#1)(1992-12#1)(1992-6#2)(1992-9#1)(1994-2#1)(1996-12#1)(1996-7#1)(1997-7#1)(2006-5#2)(2007-12#3)(2008-10#7)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-2#2)(2009-7#1)(2010-2#1)(2010-6#1)(2011-2#1)(2013-1#3)
relative contributions of subjective##2##4##(2007-12#2)
relative contributions of these##4##4##(1990-11#1)(1992-2#1)(2008-12#1)(2008-7#1)
relative contributions of##19##3##(1990-11#1)(1990-5#1)(1992-2#1)(1996-1#1)(2006-6#1)(2007-12#3)(2007-9#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-9#1)
relative contributions to##4##3##(1990-8#1)(1991-8#1)(1997-2#1)(1997-5#1)
relative contributions##27##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-8#1)(1992-2#1)(1996-1#1)(1996-11#1)(1997-2#1)(1997-5#1)(2006-6#2)(2007-12#3)(2007-9#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-9#1)(2012-3#1)(2013-8#1)
relative cost of##4##3##(2008-5#3)(2008-8#1)
relative cost##6##2##(1993-2#1)(2005-11#1)(2008-5#3)(2008-8#1)
relative costs##3##2##(1993-2#1)(2008-8#1)(2010-2#1)
relative criteria##2##2##(2008-2#1)(2008-7#1)
relative decline##2##2##(2010-5#1)(2012-1#1)
relative decrease in##8##3##(1990-2#1)(1990-7#1)(1991-9#1)(1995-1#1)(1997-2#1)(2007-11#1)(2007-4#1)(2008-2#1)
relative decrease##10##2##(1990-2#1)(1990-7#1)(1991-10#1)(1991-9#1)(1995-1#1)(1997-2#1)(2007-11#1)(2007-4#1)(2008-2#1)(2013-8#1)
relative degree of##2##3##(2007-10#1)(2009-4#1)
relative degrees##2##2##(1994-6#1)(2008-10#1)
relative density##5##2##(1995-11#1)(1996-9#1)(2004-11#1)(2008-5#1)(2012-2#1)
relative deviations##2##2##(2008-10#2)
relative difference in##5##3##(1995-9#1)(2004-9#1)(2008-2#1)(2008-3#1)(2009-2#1)
relative difference##7##2##(1995-9#1)(2004-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-2#1)(2011-1#1)
relative differences in##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
relative differences##7##2##(2008-10#2)(2008-2#1)(2008-3#3)(2012-2#1)
relative disease##2##2##(2008-10#1)(2012-2#1)
relative displacement between##2##3##(2007-4#1)(2008-3#1)
relative displacement##3##2##(2007-4#2)(2008-3#1)
relative distance of##2##3##(2008-2#1)(2010-10#1)
relative ease of##5##3##(1996-5#1)(2009-12#1)(2010-4#1)(2010-7#1)(2013-8#1)
relative ease with which##3##4##(1993-9#1)(1997-4#1)(2008-5#1)
relative ease##12##2##(1993-9#1)(1996-5#1)(1997-4#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
relative economic##2##2##(2006-10#2)
relative effect of##3##3##(1992-11#1)(1992-8#1)(1996-11#1)
relative effect##4##2##(1992-11#1)(1992-8#1)(1996-11#1)(2008-2#1)
relative effective##2##2##(2007-12#1)(2008-10#1)
relative effects of the##2##4##(1991-1#1)(1994-8#1)
relative effects of##7##3##(1991-1#1)(1992-5#1)(1994-8#1)(1995-12#1)(1997-5#1)(2008-10#1)(2009-4#1)
relative effects##8##2##(1991-1#1)(1992-5#1)(1994-8#1)(1995-12#1)(1997-5#1)(2008-10#1)(2008-2#1)(2009-4#1)
relative efficacy of LAIV##2##4##(2011-2#2)
relative efficacy of##10##3##(1994-12#1)(2007-11#3)(2008-10#1)(2008-6#1)(2011-2#4)
relative efficacy##14##2##(1990-5#1)(1994-12#1)(1995-12#1)(1996-12#1)(2007-11#3)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#4)
relative efficiencies##3##2##(1991-1#1)(1994-12#1)(1994-8#1)
relative efficiency of the##2##4##(1992-3#1)(1992-9#1)
relative efficiency of##3##3##(1990-10#1)(1992-3#1)(1992-9#1)
relative efficiency##6##2##(1990-10#1)(1992-3#1)(1992-9#1)(1995-6#1)(2008-3#1)(2010-10#1)
relative electrophoretic mobilities of##2##4##(1991-7#1)(1995-8#1)
relative electrophoretic mobility##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
relative electrophoretic##5##2##(1991-7#1)(1995-8#1)(2008-10#1)(2008-2#1)(2008-4#1)
relative energies of##3##3##(1997-7#1)(2012-12#2)
relative energies##4##2##(1997-7#1)(2010-5#1)(2012-12#2)
relative energy##3##2##(2007-11#1)(2007-12#1)(2013-8#1)
relative entropy##5##2##(2008-12#2)(2008-2#3)
relative error &lt##3##3##(2008-10#3)
relative error in the##3##4##(2008-10#3)
relative error in##4##3##(2008-10#4)
relative error lower than 10%##2##5##(2008-10#2)
relative error of 5##2##4##(2008-10#2)
relative error of##15##3##(2008-10#12)(2008-2#1)(2010-5#1)(2013-8#1)
relative error##40##2##(1996-8#1)(1997-3#1)(2007-8#1)(2008-10#29)(2008-2#2)(2008-3#2)(2010-5#1)(2011-1#1)(2013-8#2)
relative errors for##3##3##(1997-3#1)(2007-8#1)(2008-10#1)
relative errors in##2##3##(2005-11#1)(2008-10#1)
relative errors of the##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
relative errors of##5##3##(2008-10#2)(2008-2#1)(2008-3#1)(2012-12#1)
relative errors##17##2##(1997-3#1)(2005-11#3)(2007-8#1)(2008-10#9)(2008-2#1)(2008-3#1)(2012-12#1)
relative expression of##7##3##(1993-9#1)(1994-2#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-11#1)
relative expression##10##2##(1993-9#1)(1994-2#1)(1996-6#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-11#1)(2010-12#1)(2011-2#1)
relative fitness cost##2##3##(2008-8#2)
relative fitness##5##2##(2008-10#3)(2008-8#2)
relative fluorescence intensity of##4##4##(2005-4#1)(2008-10#3)
relative fluorescence intensity was##2##4##(2008-10#2)
relative fluorescence intensity##8##3##(2005-4#2)(2008-10#6)
relative fluorescence##16##2##(1997-4#1)(2005-4#2)(2005-8#1)(2008-10#9)(2008-3#2)(2010-7#1)
relative for##3##2##(2008-10#2)(2010-12#1)
relative frequencies of##6##3##(2007-2#1)(2007-6#1)(2008-10#1)(2008-8#2)(2013-7#1)
relative frequencies##8##2##(2006-6#1)(2007-2#1)(2007-6#1)(2008-10#2)(2008-8#2)(2013-7#1)
relative frequency of##9##3##(1995-1#1)(2006-10#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-3#1)
relative frequency##12##2##(1995-1#1)(1997-2#1)(2006-10#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-3#1)
relative functional independence##2##3##(2007-9#2)
relative fuzzy connectedness##2##3##(2008-9#2)
relative growth rate##2##3##(1996-10#1)(2008-8#1)
relative growth rates for##2##4##(2008-7#1)(2013-7#1)
relative growth rates##3##3##(2008-7#2)(2013-7#1)
relative growth##9##2##(1992-12#1)(1996-10#1)(2007-5#1)(2008-10#2)(2008-7#2)(2008-8#1)(2013-7#1)
relative hazards##2##2##(1997-3#2)
relative head##3##2##(2006-8#1)(2008-10#2)
relative high##4##2##(1991-9#1)(1993-12#1)(2005-10#1)(2008-5#1)
relative hippocampal volume##4##3##(1993-2#1)(1994-3#3)
relative humidities##18##2##(1995-1#1)(1996-12#1)(2004-11#1)(2005-11#2)(2008-10#10)(2010-4#2)(2011-2#1)
relative humidity &gt##2##3##(2008-10#2)
relative humidity (RH) on the##2##5##(1996-12#1)(2008-2#1)
relative humidity (RH) on##3##4##(1996-12#1)(2008-10#1)(2008-2#1)
relative humidity (RH)##21##3##(1996-12#1)(2007-11#1)(2008-10#17)(2008-2#1)(2008-5#1)
relative humidity and##6##3##(2008-10#4)(2008-5#1)(2013-1#1)
relative humidity at##5##3##(2008-10#2)(2008-2#2)(2008-5#1)
relative humidity during##2##3##(2008-10#2)
relative humidity for##2##3##(2008-10#1)(2010-2#1)
relative humidity in##3##3##(2008-10#1)(2008-12#1)(2008-2#1)
relative humidity of##3##3##(1995-3#1)(2006-10#1)(2008-2#1)
relative humidity was##4##3##(2008-10#3)(2008-2#1)
relative humidity##100##2##(1995-3#3)(1996-12#1)(2005-11#3)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#57)(2008-12#1)(2008-2#9)(2008-3#2)(2008-5#7)(2008-8#2)(2009-3#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2013-1#2)(2013-8#2)
relative humidity)##3##2##(1996-2#1)(2008-10#2)
relative hybrid stability##2##3##(1995-8#2)
relative hypogonadism##2##2##(2008-1#1)(2008-3#1)
relative impact of##4##3##(2006-10#1)(2008-1#1)(2008-10#1)(2009-8#1)
relative importance and##3##3##(2007-2#1)(2008-5#1)(2010-4#1)
relative importance in##3##3##(2007-3#1)(2008-10#1)(2008-8#1)
relative importance of different##3##4##(2007-11#1)(2007-3#1)(2012-3#1)
relative importance of the two##4##5##(1992-12#1)(1996-5#1)(2008-10#1)(2008-9#1)
relative importance of the##12##4##(1992-12#1)(1992-2#2)(1995-9#1)(1996-5#1)(2006-12#1)(2007-3#1)(2008-10#2)(2008-2#1)(2008-9#1)(2011-1#1)
relative importance of these two##2##5##(1996-8#1)(1996-9#1)
relative importance of these##5##4##(1990-9#1)(1993-7#1)(1996-8#1)(1996-9#1)(2007-1#1)
relative importance of##55##3##(1990-7#1)(1990-9#1)(1991-4#1)(1992-12#1)(1992-2#2)(1993-7#1)(1994-2#1)(1995-9#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-8#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-3#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#5)(2008-9#2)(2009-4#1)(2009-6#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-7#1)
relative importance##68##2##(1990-7#1)(1990-9#1)(1991-4#1)(1992-12#1)(1992-2#2)(1993-12#1)(1993-7#1)(1994-2#1)(1994-3#1)(1995-9#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-8#1)(2006-12#1)(2006-2#1)(2006-6#2)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#5)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#4)(2008-7#2)(2008-8#7)(2008-9#2)(2009-4#1)(2009-6#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-7#1)
relative in the##2##3##(1996-6#1)(2008-2#1)
relative in##5##2##(1990-7#1)(1996-6#1)(2006-12#1)(2008-2#1)(2008-4#1)
relative incidence of diabetes mellitus in ABO/Rhesus blood##2##8##(2009-5#2)
relative incidence of##3##3##(2009-5#2)(2011-2#1)
relative inclusion rate##2##3##(1994-9#2)
relative income##3##2##(2008-5#2)(2010-6#1)
relative increase by##2##3##(1994-9#1)(1995-1#1)
relative increase in cell counts##2##5##(2011-1#2)
relative increase in the##2##4##(1996-11#1)(2008-2#1)
relative increase in##7##3##(1996-11#1)(2006-10#2)(2008-2#1)(2008-7#1)(2011-1#2)
relative increase##13##2##(1991-12#1)(1992-9#1)(1994-9#1)(1995-1#1)(1995-5#1)(1996-11#1)(2006-10#2)(2008-2#1)(2008-7#1)(2011-1#2)(2012-12#1)
relative increases in##3##3##(1993-9#1)(1995-12#1)(2010-2#1)
relative independence##2##2##(1990-12#1)(2013-8#1)
relative ineffectiveness##3##2##(1995-9#1)(1996-2#1)(2005-7#1)
relative influence##4##2##(1996-1#1)(1996-3#1)(2008-10#1)(2010-1#1)
relative influences##2##2##(2008-8#1)(2009-6#1)
relative infrequency##2##2##(2007-5#1)(2009-3#1)
relative inhibition##2##2##(1995-3#1)(1997-8#1)
relative intensities of##2##3##(1995-8#1)(2007-11#1)
relative intensities##3##2##(1993-6#1)(1995-8#1)(2007-11#1)
relative intensity noise of##2##4##(2007-12#1)(2008-2#1)
relative intensity noise##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
relative intensity of##9##3##(2005-10#1)(2005-4#1)(2008-10#3)(2008-3#1)(2008-8#2)(2011-12#1)
relative intensity##16##2##(2005-10#2)(2005-4#2)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#2)(2011-12#1)(2013-7#1)(2013-8#1)
relative interfacial pressure##2##3##(2008-10#2)
relative iron##2##2##(2006-9#1)(2012-12#1)
relative lack of##12##3##(1991-3#1)(1997-8#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
relative leaf##2##2##(2008-12#1)(2008-8#1)
relative level##9##2##(1990-3#1)(1994-8#1)(1996-12#1)(1996-7#1)(1997-5#1)(2008-10#1)(2008-4#1)(2008-5#2)
relative levels of mRNA##3##4##(1993-5#1)(2008-7#2)
relative levels of##14##3##(1990-3#1)(1991-12#1)(1991-7#3)(1992-8#1)(1993-5#2)(1994-3#2)(2008-7#3)(2010-5#1)
relative lipid##2##2##(1990-2#1)(1995-8#1)
relative localization##2##2##(1990-3#2)
relative location of the##3##4##(2008-4#1)(2013-1#2)
relative location of##4##3##(1994-12#1)(2008-4#1)(2013-1#2)
relative location##6##2##(1994-12#1)(1996-12#1)(1996-5#1)(2008-4#1)(2013-1#2)
relative low cost##2##3##(2007-12#2)
relative low##5##2##(1992-4#1)(2007-12#2)(2008-10#1)(2011-1#1)
relative magnitude of the##2##4##(1991-7#1)(2005-11#1)
relative magnitude of##8##3##(1991-7#1)(1992-12#1)(1994-10#1)(2005-11#1)(2007-10#1)(2007-5#1)(2008-8#1)(2013-8#1)
relative measurements of##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
relative measurements##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
relative measures##3##2##(1990-2#1)(2008-10#1)(2008-3#1)
relative merit##2##2##(2009-10#1)(2009-5#1)
relative merits and limitations of##2##5##(2008-11#1)(2008-2#1)
relative merits and##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2009-4#1)
relative merits of##10##3##(1997-5#1)(2006-10#1)(2006-2#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#1)(2011-2#1)
relative merits##16##2##(1997-5#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-7#1)(2009-4#1)(2011-2#1)
relative migration times##2##3##(1992-2#1)(1994-9#1)
relative migration##3##2##(1992-2#2)(1994-9#1)
relative mobilities##2##2##(1991-4#1)(2007-12#1)
relative mobility of##2##3##(1994-3#1)(2006-12#1)
relative molecular mass of##10##4##(1990-3#1)(1991-12#2)(1992-3#1)(1993-8#1)(1995-10#1)(1997-6#1)(2008-10#1)(2008-11#2)
relative molecular mass##19##3##(1990-3#2)(1991-11#3)(1991-12#2)(1991-2#2)(1992-3#1)(1993-4#1)(1993-8#1)(1995-10#1)(1996-7#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#2)
relative molecular weight of the##3##5##(1992-2#1)(1994-2#1)(2008-10#1)
relative molecular weight of##5##4##(1992-2#1)(1994-11#2)(1994-2#1)(2008-10#1)
relative molecular##28##2##(1990-11#1)(1990-3#2)(1990-5#1)(1991-11#3)(1991-12#2)(1991-2#2)(1992-12#1)(1992-2#1)(1992-3#1)(1993-4#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-6#1)(1995-10#1)(1996-7#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-11#2)
relative motion between the##3##4##(2006-11#1)(2008-2#1)(2012-1#1)
relative motion between##4##3##(1997-8#1)(2006-11#1)(2008-2#1)(2012-1#1)
relative motion##10##2##(1997-8#1)(2006-11#3)(2007-12#1)(2008-1#1)(2008-2#1)(2012-1#2)(2012-2#1)
relative neglect of##2##3##(1990-12#1)(1995-9#1)
relative neglect##3##2##(1990-12#1)(1995-9#1)(2008-8#1)
relative noise##2##2##(2008-2#1)(2008-9#1)
relative nuclear DNA content##2##4##(2008-9#2)
relative number of##2##3##(2005-1#1)(2006-10#1)
relative numbers of##2##3##(1997-1#1)(2008-12#1)
relative of the##6##3##(1992-3#1)(1993-12#1)(1994-3#1)(2010-3#1)(2011-2#1)(2012-11#1)
relative of##14##2##(1991-5#1)(1992-3#1)(1993-12#1)(1994-3#1)(1995-2#1)(2008-10#3)(2008-5#1)(2008-8#1)(2010-3#1)(2011-2#2)(2012-11#1)
relative or##3##2##(2006-4#1)(2008-8#1)(2010-9#1)
relative order of##4##3##(1991-5#1)(1995-5#1)(2008-10#1)(2008-4#1)
relative orientation of the##4##4##(1996-7#1)(2008-10#1)(2008-2#1)(2008-3#1)
relative orientation of##6##3##(1991-7#1)(1996-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-7#1)
relative orientation##8##2##(1991-7#1)(1993-9#1)(1996-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-7#1)(2010-2#1)
relative pairs##2##2##(1997-5#1)(2012-3#1)
relative parameters##3##2##(2008-10#1)(2008-5#2)
relative paucity of##2##3##(2008-10#1)(2010-11#1)
relative peak##3##2##(1995-6#1)(2008-10#1)(2010-12#1)
relative penis size index (RPSI)##2##5##(2004-4#1)(2010-5#1)
relative percentage##3##2##(1991-3#1)(2007-8#1)(2008-10#1)
relative percentages of##3##3##(2008-10#2)(2010-4#1)
relative performance of the##3##4##(1994-9#1)(2008-10#1)(2008-2#1)
relative performance of##8##3##(1994-1#1)(1994-9#1)(2008-10#1)(2008-2#2)(2008-5#1)(2011-2#1)(2012-3#1)
relative performance##10##2##(1994-1#1)(1994-9#1)(2008-10#1)(2008-2#2)(2008-5#1)(2010-12#1)(2011-2#1)(2012-3#2)
relative phase shift between the##2##5##(2008-3#2)
relative phase shift##3##3##(2007-12#1)(2008-3#2)
relative phase##16##2##(1996-11#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#6)
relative photodegradation rates##2##3##(2008-10#2)
relative photodynamic oxidation rates of##2##5##(2008-5#2)
relative photosynthetic rate##3##3##(2008-10#3)
relative poor##2##2##(2008-10#1)(2010-12#1)
relative population doubling##2##3##(2011-1#2)
relative populations##3##2##(2008-10#1)(2008-8#1)(2010-10#1)
relative position of##6##3##(1993-6#1)(1997-7#1)(2007-11#1)(2008-2#2)(2008-3#1)
relative position##10##2##(1993-6#1)(1997-7#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#2)
relative positions##6##2##(1991-4#1)(2006-12#1)(2007-12#1)(2008-3#2)(2012-3#1)
relative potencies of##3##3##(1992-9#1)(1994-2#1)(2008-5#1)
relative potencies##4##2##(1992-9#1)(1993-3#1)(1994-2#1)(2008-5#1)
relative potency of##4##3##(1990-2#1)(1992-9#1)(1993-8#1)(1996-9#1)
relative potency##8##2##(1990-2#1)(1992-8#1)(1992-9#1)(1993-8#1)(1995-12#1)(1996-9#1)(2008-10#1)(2008-5#1)
relative power in spectral band##2##5##(2008-7#2)
relative power##10##2##(1993-4#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-3#2)(2008-7#4)
relative prediction error of##2##4##(2008-10#1)(2008-3#1)
relative prediction error##3##3##(2008-10#2)(2008-3#1)
relative prediction##5##2##(2008-10#4)(2008-3#1)
relative predictive error##2##3##(2008-10#2)
relative predictive##3##2##(2008-10#3)
relative preference##2##2##(2007-5#1)(2008-8#1)
relative preferences##3##2##(2008-4#2)(2008-9#1)
relative prevalence of##2##3##(2010-8#2)
relative prevalence##5##2##(2008-8#1)(2010-8#2)(2013-1#2)
relative prices##2##2##(1991-12#2)
relative productivity##2##2##(2007-3#2)
relative proportion##7##2##(1991-2#1)(1994-2#1)(1996-4#1)(1997-7#1)(2004-2#1)(2007-12#1)(2008-10#1)
relative proportions of##11##3##(1991-10#1)(1991-9#1)(1993-9#1)(1994-12#1)(1995-2#1)(2008-10#1)(2008-7#2)(2009-10#1)(2010-12#1)(2010-5#1)
relative proportions##14##2##(1991-1#1)(1991-10#1)(1991-9#1)(1992-4#1)(1993-9#1)(1994-12#1)(1995-2#1)(2008-10#1)(2008-7#2)(2009-10#1)(2010-12#1)(2010-5#1)(2012-2#1)
relative protection from##2##3##(2006-10#1)(2010-8#1)
relative protein##4##2##(1996-3#1)(2008-10#1)(2008-4#1)(2008-7#1)
relative quantification of##2##3##(2008-10#1)(2008-12#1)
relative quantification##4##2##(2008-10#1)(2008-12#1)(2008-9#1)(2009-5#1)
relative quantitation of##3##3##(2008-10#2)(2008-4#1)
relative quantitation##4##2##(2008-10#2)(2008-2#1)(2008-4#1)
relative quantitative##3##2##(1993-12#1)(2008-10#1)(2008-4#1)
relative quantity of##3##3##(1991-12#1)(2007-8#2)
relative rarity of this##2##4##(2007-7#1)(2013-8#1)
relative rarity of##3##3##(2006-10#1)(2007-7#1)(2013-8#1)
relative rate of disease##3##4##(1996-7#1)(2008-10#2)
relative rate of##6##3##(1991-10#1)(1996-7#1)(2007-6#1)(2008-10#2)(2008-11#1)
relative rate##9##2##(1991-10#1)(1996-7#1)(2005-8#1)(2007-6#1)(2008-10#4)(2008-11#1)
relative rates of the##2##4##(1991-12#1)(2008-3#1)
relative rates of##9##3##(1991-12#1)(1991-4#1)(1992-12#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-2#1)
relative rates##13##2##(1991-12#1)(1991-4#1)(1992-12#1)(1995-3#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-2#1)(2010-1#1)(2012-12#2)
relative receptor-binding potencies in the range##2##6##(1992-3#2)
relative recoveries##3##2##(1997-3#1)(2008-10#1)(2012-1#1)
relative reflectivity##2##2##(2005-11#2)
relative resistance of##2##3##(1997-4#1)(2008-10#1)
relative resistance to##6##3##(1991-10#1)(1992-11#1)(1992-4#1)(1994-11#1)(2007-11#1)(2008-4#1)
relative resistance##8##2##(1991-10#1)(1992-11#1)(1992-4#1)(1994-11#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-4#1)
relative resource##2##2##(2008-8#1)(2009-10#1)
relative response##7##2##(1992-5#1)(1994-9#2)(2008-10#1)(2010-12#1)(2011-2#2)
relative rigidity##2##2##(1995-8#1)(2008-10#1)
relative risk (RR) and##2##4##(1993-9#1)(2013-1#1)
relative risk (RR) of##2##4##(1992-11#1)(2011-1#1)
relative risk (RR)##7##3##(1991-7#1)(1992-11#1)(1992-9#1)(1993-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
relative risk 0##2##3##(1991-11#1)(2008-10#1)
relative risk and##3##3##(1995-9#1)(1996-1#1)(1997-5#1)
relative risk approaches##4##3##(1997-5#4)
relative risk estimates##2##3##(1996-3#2)
relative risk for the##2##4##(2007-2#1)(2007-4#1)
relative risk for##10##3##(1993-4#1)(2005-10#1)(2006-10#2)(2007-2#1)(2007-4#1)(2008-6#1)(2010-4#1)(2011-12#1)(2012-12#1)
relative risk in##2##3##(1991-7#1)(1992-6#1)
relative risk is##2##3##(1994-2#1)(1996-7#1)
relative risk of breast cancer##2##5##(1991-7#1)(1994-2#1)
relative risk of death##3##4##(1990-5#1)(2007-12#1)(2008-6#1)
relative risk of developing##3##4##(2006-10#2)(2007-1#1)
relative risk of hospitalization##2##4##(2006-10#1)(2007-4#1)
relative risk of##32##3##(1990-5#2)(1991-7#2)(1992-2#1)(1993-7#1)(1993-9#2)(1994-2#1)(1994-9#2)(1995-6#1)(2006-10#3)(2006-11#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-8#1)(2010-10#1)(2011-1#1)(2013-1#2)(2013-7#1)
relative risk reduction##4##3##(2007-7#1)(2008-3#1)(2009-11#1)(2010-2#1)
relative risk was 1##3##4##(1991-7#1)(2006-10#1)(2009-4#1)
relative risk was##5##3##(1991-2#1)(1991-7#1)(1993-9#1)(2006-10#1)(2009-4#1)
relative risk##96##2##(1990-5#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-7#5)(1992-11#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-4#1)(1993-7#1)(1993-9#5)(1994-2#2)(1994-5#1)(1994-9#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-3#2)(1996-7#2)(1996-9#1)(1997-5#7)(1997-6#2)(1997-8#3)(2005-10#1)(2006-10#6)(2006-11#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#2)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#4)(2008-8#1)(2009-11#1)(2009-4#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#4)(2013-7#1)
relative risks (RR) for subsequent##2##5##(1991-5#1)(1991-9#1)
relative risks (RR)##4##3##(1991-5#1)(1991-9#1)(1993-9#1)(2005-10#1)
relative risks for##2##3##(2008-7#1)(2011-2#1)
relative risks in##2##3##(1990-6#1)(1997-7#1)
relative risks of 1##2##4##(1991-5#2)
relative risks of##5##3##(1991-5#2)(1992-6#1)(2008-11#1)(2013-7#1)
relative risks were##3##3##(1991-3#1)(1992-9#1)(1996-11#1)
relative risks##22##2##(1990-6#1)(1991-3#1)(1991-5#3)(1991-9#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-5#1)(1996-11#1)(1997-7#1)(2005-10#2)(2006-12#1)(2007-4#1)(2008-11#1)(2008-7#1)(2011-2#2)(2013-7#1)
relative rms error##2##3##(2008-2#2)
relative roles of##10##3##(1991-8#1)(1996-1#1)(1996-8#1)(2008-10#1)(2008-8#4)(2010-12#1)(2012-3#1)
relative roles##11##2##(1991-8#1)(1996-1#1)(1996-8#1)(2008-10#1)(2008-8#5)(2010-12#1)(2012-3#1)
relative root mean##2##3##(2008-10#2)
relative rotation##2##2##(2007-4#1)(2008-3#1)
relative safety##2##2##(2005-7#1)(2009-3#1)
relative second-order rate constants of 5##2##6##(1994-8#2)
relative seed##2##2##(2008-10#2)
relative selectivity##2##2##(2008-10#2)
relative sensitivities##3##2##(1996-3#1)(2008-10#1)(2008-3#1)
relative sensitivity and##2##3##(2008-10#1)(2008-4#1)
relative sensitivity of the composite##2##5##(2008-10#2)
relative sensitivity of##5##3##(1990-11#1)(1997-2#1)(2008-10#2)(2008-5#1)
relative sensitivity##9##2##(1990-11#1)(1997-2#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#1)
relative signal##2##2##(2008-10#1)(2008-3#1)
relative simplicity##4##2##(2007-12#1)(2008-1#1)(2008-12#1)(2008-4#1)
relative size of##3##3##(1994-3#1)(1996-5#1)(2005-11#1)
relative size##4##2##(1991-9#1)(1994-3#1)(1996-5#1)(2005-11#1)
relative sparing of##2##3##(2008-5#1)(2008-7#1)
relative spatial##2##2##(1997-8#1)(2008-3#1)
relative species##2##2##(2008-3#1)(2010-6#1)
relative spectral##2##2##(2007-11#1)(2008-3#1)
relative stability of the##4##4##(1990-7#2)(1991-4#1)(2006-12#1)
relative stability of##10##3##(1990-7#2)(1991-4#1)(1991-8#1)(1992-12#1)(1995-6#1)(2006-12#1)(2008-3#1)(2008-8#2)
relative stability##13##2##(1990-7#2)(1991-4#1)(1991-8#1)(1992-12#1)(1995-6#1)(1995-8#1)(2006-10#1)(2006-12#1)(2008-3#1)(2008-8#2)(2012-9#1)
relative standard derivation##2##3##(2008-10#2)
relative standard deviation &lt##2##4##(2008-10#2)
relative standard deviation (%R##2##4##(2008-10#2)
relative standard deviation (R##81##4##(2007-8#4)(2008-10#76)(2008-3#1)
relative standard deviation (RSD) of 0##2##6##(2008-10#2)
relative standard deviation (RSD) of##6##5##(2005-3#1)(2008-10#5)
relative standard deviation (RSD) was##3##5##(2008-10#1)(2013-8#2)
relative standard deviation (RSD)##21##4##(2005-3#1)(2005-4#1)(2008-10#16)(2009-8#1)(2013-8#2)
relative standard deviation (n=10) was##3##5##(2008-10#3)
relative standard deviation (n=10)##4##4##(2008-10#4)
relative standard deviation (n=11)##3##4##(2008-10#3)
relative standard deviation (n=5)##2##4##(2008-10#2)
relative standard deviation 0##2##4##(2008-10#2)
relative standard deviation 1##4##4##(1990-9#1)(2008-10#3)
relative standard deviation at##4##4##(2008-10#4)
relative standard deviation being##2##4##(2007-8#1)(2008-10#1)
relative standard deviation between##3##4##(2008-10#3)
relative standard deviation for eight replicate##4##6##(2008-10#4)
relative standard deviation for eight##5##5##(2008-10#5)
relative standard deviation for six##2##5##(2008-10#2)
relative standard deviation for ten##2##5##(2008-10#2)
relative standard deviation for the determination of##3##7##(2008-10#3)
relative standard deviation for the##8##5##(2008-10#8)
relative standard deviation for##42##4##(1997-8#1)(2008-10#41)
relative standard deviation in the range of##2##7##(2007-8#1)(2008-10#1)
relative standard deviation in the##4##5##(2007-8#1)(2008-10#1)(2008-3#2)
relative standard deviation in##7##4##(2007-8#1)(2008-10#4)(2008-3#2)
relative standard deviation is 2##3##5##(2008-10#3)
relative standard deviation is 3##3##5##(2008-10#3)
relative standard deviation is##21##4##(2005-4#4)(2008-10#17)
relative standard deviation obtained##3##4##(2008-10#3)
relative standard deviation of +/-0##3##5##(2008-10#3)
relative standard deviation of 0##7##5##(2008-10#7)
relative standard deviation of 1##18##5##(2008-10#18)
relative standard deviation of 1%##2##5##(2008-10#2)
relative standard deviation of 2##17##5##(2007-10#1)(2008-10#16)
relative standard deviation of 3##9##5##(2005-4#2)(2007-8#1)(2008-10#6)
relative standard deviation of 5##3##5##(2008-10#2)(2011-1#1)
relative standard deviation of less than##8##6##(2008-10#8)
relative standard deviation of the##11##5##(2008-10#11)
relative standard deviation of three##2##5##(2008-10#2)
relative standard deviation of##116##4##(1994-9#1)(2005-4#2)(2007-10#1)(2007-8#1)(2008-10#110)(2011-1#1)
relative standard deviation ranging from##2##5##(2008-10#2)
relative standard deviation values for intra- and inter-day precision studies##2##10##(2010-12#2)
relative standard deviation values for##5##5##(2008-10#3)(2010-12#2)
relative standard deviation values obtained##2##5##(2007-8#1)(2008-10#1)
relative standard deviation values of##3##5##(2008-10#3)
relative standard deviation values##12##4##(2007-8#1)(2008-10#9)(2010-12#2)
relative standard deviation was 1##6##5##(2008-10#6)
relative standard deviation was 2##7##5##(2008-10#7)
relative standard deviation was 3##4##5##(2008-10#4)
relative standard deviation was 4##3##5##(1990-8#1)(2008-10#2)
relative standard deviation was 5##2##5##(2008-10#2)
relative standard deviation was below##2##5##(2008-10#2)
relative standard deviation was##42##4##(1990-8#1)(1992-2#1)(2005-4#1)(2007-8#1)(2008-10#38)
relative standard deviation were found##2##5##(2008-10#1)(2008-5#1)
relative standard deviation were##5##4##(2008-1#1)(2008-10#3)(2008-5#1)
relative standard deviation##429##3##(1990-8#1)(1990-9#1)(1992-2#1)(1993-2#1)(1994-9#1)(1995-12#1)(1997-8#1)(2005-3#1)(2005-4#10)(2007-10#1)(2007-8#12)(2008-1#1)(2008-10#384)(2008-3#4)(2008-5#2)(2009-8#1)(2010-12#2)(2010-4#1)(2011-1#1)(2013-8#2)
relative standard deviation) of##2##4##(2008-10#2)
relative standard deviation)##3##3##(2008-10#3)
relative standard deviations (R##21##4##(1996-8#2)(2007-8#1)(2008-10#18)
relative standard deviations (RSD) for##2##5##(2008-10#1)(2008-5#1)
relative standard deviations (RSD)##5##4##(2005-4#1)(2008-10#2)(2008-5#1)(2012-1#1)
relative standard deviations (RSDs) for the##2##6##(2008-10#1)(2013-8#1)
relative standard deviations (RSDs) less than##2##6##(2011-1#1)(2012-12#1)
relative standard deviations (RSDs) of##4##5##(2008-10#1)(2012-12#3)
relative standard deviations (RSDs)##15##4##(2005-12#2)(2008-10#2)(2011-1#3)(2012-12#6)(2013-8#2)
relative standard deviations (n = 5)##3##6##(2008-10#3)
relative standard deviations (n =##7##5##(2008-10#4)(2011-1#2)(2012-12#1)
relative standard deviations are##3##4##(2005-4#1)(2008-10#2)
relative standard deviations below##2##4##(2007-8#1)(2008-10#1)
relative standard deviations between 1##2##5##(2008-5#1)(2012-12#1)
relative standard deviations for samples were##2##6##(2008-10#1)(2008-5#1)
relative standard deviations for samples##3##5##(1996-6#1)(2008-10#1)(2008-5#1)
relative standard deviations for the##3##5##(1996-5#1)(2008-10#2)
relative standard deviations for##24##4##(1996-5#1)(1996-6#1)(2005-12#1)(2007-8#2)(2008-10#18)(2008-5#1)
relative standard deviations obtained for##2##5##(2008-10#2)
relative standard deviations obtained##3##4##(2008-10#2)(2008-5#1)
relative standard deviations of 2##4##5##(2008-10#4)
relative standard deviations of less than##5##6##(2007-10#1)(2008-10#4)
relative standard deviations of migration times and##2##7##(2008-10#2)
relative standard deviations of the##12##5##(2005-4#1)(2007-8#1)(2008-10#9)(2008-5#1)
relative standard deviations of##35##4##(1992-1#1)(2005-4#3)(2007-10#1)(2007-8#1)(2008-10#28)(2008-5#1)
relative standard deviations ranging from##2##5##(1997-2#1)(2008-10#1)
relative standard deviations ranging##3##4##(1997-2#1)(2008-10#2)
relative standard deviations were 1##3##5##(1992-2#1)(2008-10#2)
relative standard deviations were 2##2##5##(2008-10#2)
relative standard deviations were less than 3##2##7##(2005-4#1)(2013-7#1)
relative standard deviations were less than##3##6##(2005-4#1)(2008-10#1)(2013-7#1)
relative standard deviations were lower than##2##6##(2008-10#2)
relative standard deviations were##20##4##(1992-2#1)(2005-4#1)(2008-10#14)(2011-1#2)(2012-12#1)(2013-7#1)
relative standard deviations##159##3##(1990-12#1)(1992-1#1)(1992-2#1)(1994-9#1)(1996-5#2)(1996-6#1)(1996-8#2)(1997-2#1)(2005-12#3)(2005-4#6)(2007-10#1)(2007-8#5)(2008-10#105)(2008-5#5)(2010-5#1)(2011-1#9)(2012-1#1)(2012-12#10)(2013-7#1)(2013-8#2)
relative standard error (R##3##4##(2008-10#3)
relative standard error for##2##4##(2008-10#2)
relative standard error##7##3##(2008-10#7)
relative standard##606##2##(1990-12#1)(1990-8#1)(1990-9#1)(1992-1#1)(1992-2#2)(1993-2#1)(1994-9#2)(1995-12#1)(1996-5#2)(1996-6#1)(1996-8#2)(1997-2#1)(1997-8#1)(2005-12#3)(2005-3#1)(2005-4#16)(2007-10#2)(2007-8#18)(2008-1#1)(2008-10#504)(2008-2#2)(2008-3#4)(2008-5#7)(2009-8#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-1#10)(2012-1#1)(2012-12#10)(2013-7#1)(2013-8#4)
relative steady-state##2##2##(1991-12#1)(1995-10#1)
relative strength of the##4##4##(2005-10#1)(2007-12#1)(2008-3#1)(2008-7#1)
relative strength of##9##3##(1996-5#1)(2005-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
relative strengths of the##2##4##(2007-12#1)(2008-2#1)
relative strengths of##4##3##(2007-12#1)(2008-1#1)(2008-2#1)(2012-3#1)
relative strengths##6##2##(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-4#1)(2012-3#1)
relative success of##3##3##(2006-4#1)(2007-3#1)(2008-8#1)
relative superiority##2##2##(2007-8#1)(2012-2#1)
relative surface##3##2##(2008-10#2)(2008-2#1)
relative survival rates for major cancer sites ranged from##2##9##(2011-2#2)
relative survival rates of##2##4##(2011-2#2)
relative survival rates##7##3##(2011-2#7)
relative survival##10##2##(1997-2#1)(2011-2#9)
relative terms##3##2##(1990-8#1)(2005-11#1)(2011-1#1)
relative timing##2##2##(2007-11#1)(2010-6#1)
relative to 1##2##3##(1992-7#1)(2008-10#1)
relative to B##2##3##(2011-2#1)(2012-1#1)
relative to EO baseline than to EC##2##7##(2013-8#2)
relative to a non-imprinted control set##2##6##(2008-7#2)
relative to a number of interfering##2##6##(2008-10#2)
relative to a visual##2##4##(2008-10#2)
relative to a##28##3##(1992-2#1)(1995-2#1)(2007-12#3)(2007-5#1)(2008-10#8)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#2)(2008-7#2)(2009-7#1)(2011-1#2)(2012-1#1)
relative to age-matched##2##3##(1994-11#1)(2009-4#1)
relative to all##2##3##(1991-2#1)(2009-8#1)
relative to an##3##3##(1997-4#1)(2008-11#1)(2008-2#1)
relative to body##2##3##(1994-8#1)(2013-8#1)
relative to both##4##3##(1996-11#1)(1996-12#1)(2008-3#1)(2010-2#1)
relative to clinical##2##3##(2004-3#1)(2012-11#1)
relative to control##10##3##(1990-10#1)(1991-8#1)(1992-5#1)(1995-1#1)(1995-9#1)(1997-6#1)(2008-10#1)(2008-3#2)(2008-4#1)
relative to controls##16##3##(1993-6#1)(1994-3#1)(1994-9#2)(1995-10#1)(1995-2#1)(1997-4#1)(1997-5#1)(2006-12#1)(2006-5#1)(2008-10#2)(2008-11#1)(2009-12#1)(2011-2#2)
relative to conventional##2##3##(2008-10#1)(2008-12#1)
relative to cost weights##2##4##(1990-12#2)
relative to direct##2##3##(2008-8#1)(2008-9#1)
relative to dry##2##3##(2008-10#1)(2013-8#1)
relative to each other##5##4##(1991-12#1)(1995-3#1)(2008-5#1)(2012-12#2)
relative to each##7##3##(1991-12#1)(1995-3#1)(1996-6#1)(2008-10#1)(2008-5#1)(2012-12#2)
relative to either##3##3##(1995-11#1)(2008-10#1)(2008-9#1)
relative to fee-for-service##2##3##(1994-1#2)
relative to females##2##3##(1991-3#1)(2010-8#1)
relative to healthy##3##3##(1994-11#1)(2008-4#1)(2011-2#1)
relative to host##2##3##(2008-4#1)(2008-9#1)
relative to how##3##3##(1991-12#1)(2008-5#1)(2010-2#1)
relative to incongruent associations##2##4##(2012-1#2)
relative to incongruent##3##3##(2012-1#3)
relative to its##5##3##(1992-5#1)(1992-6#1)(2007-4#1)(2008-11#1)(2008-3#1)
relative to levels during morphine dependence##2##6##(2007-11#2)
relative to native##2##3##(1990-7#2)
relative to neutral faces##2##4##(2008-2#1)(2009-3#1)
relative to neutral##3##3##(2008-2#2)(2009-3#1)
relative to one another##4##4##(1992-9#1)(1996-5#1)(1997-8#1)(2008-3#1)
relative to one##5##3##(1992-9#1)(1996-5#1)(1997-8#1)(2007-12#1)(2008-3#1)
relative to other##15##3##(1996-10#1)(1996-3#1)(1996-9#1)(1997-4#2)(2006-8#1)(2008-10#3)(2008-2#1)(2008-9#1)(2009-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
relative to placebo##2##3##(2007-11#1)(2008-3#1)
relative to pregnancy##2##3##(1992-5#2)
relative to pure##3##3##(1990-12#1)(2008-10#2)
relative to rat##2##3##(1994-12#1)(1994-9#1)
relative to saline controls##2##4##(1992-5#1)(2012-3#1)
relative to skull##2##3##(2007-1#2)
relative to standard##2##3##(2006-11#1)(2007-12#1)
relative to that at the##2##5##(2008-3#1)(2010-8#1)
relative to that in##2##4##(1990-2#1)(2008-10#1)
relative to that of a##2##5##(2007-11#2)
relative to that of the##7##5##(1994-5#1)(1995-8#1)(2007-12#3)(2007-9#1)(2008-2#1)
relative to that of##22##4##(1990-7#2)(1991-3#1)(1994-5#1)(1995-6#1)(1995-8#1)(2007-11#2)(2007-12#4)(2007-9#1)(2008-10#1)(2008-2#2)(2008-6#1)(2008-8#1)(2009-9#1)(2010-12#1)(2011-12#1)(2012-12#1)
relative to that##32##3##(1990-2#1)(1990-7#2)(1991-3#1)(1994-11#2)(1994-12#1)(1994-5#1)(1995-2#1)(1995-6#1)(1995-8#1)(2007-11#2)(2007-12#4)(2007-9#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-6#1)(2008-8#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-12#1)(2012-12#1)
relative to the average##2##4##(1997-5#1)(2012-2#1)
relative to the control was##2##5##(1994-11#1)(2008-10#1)
relative to the control##10##4##(1990-6#1)(1994-11#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-3#1)(2010-4#1)
relative to the corresponding##3##4##(1995-11#1)(2007-8#1)(2008-10#1)
relative to the first##2##4##(1990-12#1)(2008-4#1)
relative to the free##2##4##(1995-5#1)(2008-10#1)
relative to the inlet catheter tip##2##6##(2006-8#2)
relative to the mean##4##4##(1997-2#1)(2006-11#2)(2008-10#1)
relative to the native##2##4##(1995-2#1)(2008-10#1)
relative to the noninoculated control##2##5##(2008-10#2)
relative to the normal##3##4##(1990-8#1)(1994-12#1)(1995-11#1)
relative to the number of##2##5##(1994-11#1)(2011-2#1)
relative to the other##7##4##(1997-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-2#1)(2010-3#1)
relative to the proximal##2##4##(1991-12#1)(1995-4#1)
relative to the reference##3##4##(2007-12#2)(2013-8#1)
relative to the rest of the telencephalon##2##7##(1993-2#1)(1994-3#1)
relative to the rest of the##3##6##(1993-2#1)(1994-3#1)(1995-1#1)
relative to the site##2##4##(1991-10#1)(1997-7#1)
relative to the standard##2##4##(2008-3#1)(2010-1#1)
relative to the start##2##4##(1992-8#1)(2005-8#1)
relative to the strength of stabilizing selection##2##7##(2008-8#2)
relative to the strength of##3##5##(2008-8#3)
relative to the total##4##4##(1994-12#1)(2008-10#1)(2008-6#1)(2012-1#1)
relative to the transcription start point##3##6##(1990-11#1)(1991-5#1)(1997-6#1)
relative to the transcription##4##4##(1990-11#1)(1991-5#1)(1992-12#1)(1997-6#1)
relative to the two##3##4##(1994-11#1)(2008-10#1)(2011-2#1)
relative to the value of current reproduction##2##7##(2008-8#2)
relative to the wild-type enzyme##2##5##(1995-2#1)(1997-4#1)
relative to the##261##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#3)(1991-4#2)(1991-5#4)(1991-6#1)(1992-11#1)(1992-12#2)(1992-5#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#3)(1993-8#2)(1994-11#4)(1994-12#3)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-2#2)(1995-3#4)(1995-4#1)(1995-5#3)(1995-6#1)(1995-8#2)(1996-12#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#4)(1997-8#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-11#7)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#2)(2007-11#4)(2007-12#11)(2007-2#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#26)(2008-11#2)(2008-2#19)(2008-3#16)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#3)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-11#3)(2012-12#1)(2012-2#3)(2012-3#1)(2012-6#1)(2013-1#2)(2013-8#4)
relative to their##20##3##(1990-12#1)(1994-6#1)(1995-10#1)(1996-12#1)(1997-1#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-7#1)(2011-12#1)(2012-12#4)(2013-1#2)(2013-8#1)
relative to those obtained##2##4##(2006-5#1)(2013-1#1)
relative to those of##4##4##(1990-2#1)(1997-5#1)(2006-3#1)(2007-11#1)
relative to those##14##3##(1990-2#1)(1991-9#1)(1992-11#1)(1994-11#1)(1995-3#2)(1997-5#1)(1997-6#1)(2006-3#1)(2006-5#1)(2007-11#1)(2008-6#1)(2011-2#1)(2013-1#1)
relative to total##7##3##(1990-4#1)(1993-6#1)(2004-4#1)(2006-10#1)(2008-10#1)(2010-12#1)(2013-1#1)
relative to traditional##3##3##(2009-8#1)(2011-1#1)(2011-2#1)
relative to untreated control##2##4##(1997-4#1)(2007-6#1)
relative to untreated##3##3##(1991-7#1)(1997-4#1)(2007-6#1)
relative to vehicle##2##3##(1990-7#1)(1991-10#1)
relative to what##2##3##(1991-2#1)(2009-9#1)
relative to wild type##3##4##(1995-2#1)(1997-4#1)(2011-1#1)
relative to wild##4##3##(1992-9#1)(1995-2#1)(1997-4#1)(2011-1#1)
relative to wild-type##5##3##(1990-8#1)(1994-11#1)(1994-8#1)(1994-9#1)(2006-12#1)
relative to younger##2##3##(1991-12#1)(2012-1#1)
relative to##752##2##(1990-10#5)(1990-11#1)(1990-12#9)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#10)(1990-8#3)(1991-10#2)(1991-11#1)(1991-12#7)(1991-2#7)(1991-3#4)(1991-4#4)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#7)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#2)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#3)(1993-4#3)(1993-6#3)(1993-8#2)(1993-9#2)(1994-1#2)(1994-11#11)(1994-12#5)(1994-2#2)(1994-3#4)(1994-5#4)(1994-6#3)(1994-8#2)(1994-9#6)(1995-1#5)(1995-10#2)(1995-11#5)(1995-2#7)(1995-3#11)(1995-4#1)(1995-5#5)(1995-6#3)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#5)(1996-4#3)(1996-5#5)(1996-6#3)(1996-9#2)(1997-1#5)(1997-2#2)(1997-3#1)(1997-4#11)(1997-5#3)(1997-6#6)(1997-7#6)(1997-8#5)(2004-11#1)(2004-3#1)(2004-4#1)(2005-11#2)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#3)(2006-11#9)(2006-12#5)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#3)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#14)(2007-12#29)(2007-2#1)(2007-4#5)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#73)(2008-11#10)(2008-12#1)(2008-2#35)(2008-3#31)(2008-4#13)(2008-5#13)(2008-6#5)(2008-7#11)(2008-8#18)(2008-9#14)(2009-10#4)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#2)(2009-4#5)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#5)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#7)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#5)(2010-8#5)(2011-1#8)(2011-12#2)(2011-2#13)(2011-3#1)(2012-1#11)(2012-11#5)(2012-12#11)(2012-2#9)(2012-3#4)(2012-6#1)(2013-1#15)(2013-4#1)(2013-8#9)
relative toxicity##2##2##(2004-4#1)(2011-2#1)
relative true##2##2##(2010-1#2)
relative uncertainty of##6##3##(2007-12#2)(2008-10#1)(2008-3#3)
relative value scales##2##3##(1991-2#2)
relative value system##3##3##(1991-12#2)(2007-4#1)
relative value units##4##3##(1991-12#1)(1992-3#1)(1994-1#1)(2013-1#1)
relative value##19##2##(1991-12#4)(1991-2#2)(1992-1#1)(1992-12#2)(1992-3#1)(1993-2#1)(1994-1#1)(1994-12#2)(1995-8#1)(2006-10#1)(2007-4#1)(2008-4#1)(2013-1#1)
relative values##5##2##(1997-6#1)(2007-4#2)(2008-6#1)(2008-8#1)
relative variability##2##2##(1996-3#1)(2008-10#1)
relative variation##3##2##(2008-8#1)(2009-10#1)(2012-12#1)
relative viscosity##5##2##(1994-11#1)(2007-1#3)(2012-12#1)
relative volume of the##4##4##(1991-11#1)(1993-2#2)(2009-2#1)
relative volume of##6##3##(1991-11#1)(1993-2#2)(2006-12#1)(2007-3#1)(2009-2#1)
relative volume##7##2##(1991-11#1)(1992-8#1)(1993-2#2)(2006-12#1)(2007-3#1)(2009-2#1)
relative water content and##2##4##(2012-7#1)(2013-8#1)
relative weight of the##2##4##(1994-12#1)(1995-3#1)
relative weight of##3##3##(1994-12#1)(1995-3#1)(2008-10#1)
relative weight##6##2##(1990-12#1)(1994-12#1)(1995-3#1)(2007-12#1)(2008-10#1)(2011-2#1)
relative with##6##2##(1993-5#1)(2006-10#1)(2007-8#1)(2010-3#1)(2011-1#1)(2011-2#1)
relative yield##2##2##(2008-10#1)(2012-2#1)
relative yield-per-recruit##2##2##(2013-7#2)
relative yields##2##2##(1992-3#1)(2008-5#1)
relative##3431##1##(1990-10#7)(1990-11#6)(1990-12#16)(1990-2#10)(1990-3#9)(1990-4#3)(1990-5#15)(1990-6#2)(1990-7#19)(1990-8#8)(1990-9#3)(1991-1#4)(1991-10#6)(1991-11#8)(1991-12#23)(1991-2#16)(1991-3#11)(1991-4#10)(1991-5#14)(1991-6#3)(1991-7#14)(1991-8#5)(1991-9#11)(1992-1#5)(1992-10#2)(1992-11#7)(1992-12#20)(1992-2#16)(1992-3#13)(1992-4#10)(1992-5#9)(1992-6#10)(1992-7#1)(1992-8#7)(1992-9#17)(1993-1#3)(1993-11#3)(1993-12#9)(1993-2#11)(1993-3#6)(1993-4#7)(1993-5#5)(1993-6#11)(1993-7#3)(1993-8#6)(1993-9#13)(1994-1#4)(1994-10#2)(1994-11#19)(1994-12#19)(1994-2#11)(1994-3#14)(1994-5#7)(1994-6#5)(1994-7#1)(1994-8#9)(1994-9#20)(1995-1#15)(1995-10#7)(1995-11#7)(1995-12#6)(1995-2#13)(1995-3#19)(1995-4#1)(1995-5#12)(1995-6#11)(1995-7#2)(1995-8#11)(1995-9#6)(1996-1#7)(1996-10#3)(1996-11#6)(1996-12#10)(1996-2#6)(1996-3#11)(1996-4#7)(1996-5#16)(1996-6#10)(1996-7#10)(1996-8#8)(1996-9#10)(1997-1#10)(1997-2#14)(1997-3#11)(1997-4#19)(1997-5#16)(1997-6#12)(1997-7#15)(1997-8#17)(2004-11#4)(2004-2#2)(2004-3#1)(2004-4#3)(2004-7#2)(2004-9#1)(2005-1#1)(2005-10#11)(2005-11#28)(2005-12#5)(2005-3#1)(2005-4#20)(2005-7#5)(2005-8#6)(2005-9#2)(2006-1#2)(2006-10#34)(2006-11#14)(2006-12#15)(2006-2#6)(2006-3#4)(2006-4#4)(2006-5#7)(2006-6#7)(2006-7#1)(2006-8#6)(2006-9#5)(2007-1#13)(2007-10#15)(2007-11#44)(2007-12#78)(2007-2#8)(2007-3#13)(2007-4#18)(2007-5#8)(2007-6#6)(2007-7#10)(2007-8#42)(2007-9#7)(2008-1#20)(2008-10#905)(2008-11#32)(2008-12#18)(2008-2#123)(2008-3#124)(2008-4#52)(2008-5#83)(2008-6#21)(2008-7#51)(2008-8#79)(2008-9#40)(2009-1#1)(2009-10#14)(2009-11#3)(2009-12#8)(2009-2#10)(2009-3#7)(2009-4#12)(2009-5#7)(2009-6#5)(2009-7#4)(2009-8#8)(2009-9#6)(2010-1#11)(2010-10#9)(2010-11#6)(2010-12#22)(2010-2#20)(2010-3#5)(2010-4#16)(2010-5#12)(2010-6#9)(2010-7#8)(2010-8#15)(2010-9#2)(2011-1#39)(2011-12#10)(2011-2#72)(2011-3#3)(2012-1#19)(2012-11#7)(2012-12#37)(2012-2#32)(2012-3#23)(2012-6#7)(2012-7#1)(2012-9#2)(2013-1#43)(2013-4#1)(2013-7#14)(2013-8#38)
relatively &quot##2##2##(1992-3#1)(2009-10#1)
relatively abundant protein##2##3##(1991-1#1)(1996-8#1)
relatively abundant##4##2##(1991-1#1)(1996-8#1)(2008-10#1)(2009-7#1)
relatively avascular and##2##3##(2006-12#1)(2013-1#1)
relatively benign##6##2##(1993-10#1)(2007-11#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
relatively better##3##2##(2006-4#1)(2008-11#1)(2008-3#1)
relatively brief##4##2##(1994-8#1)(1996-12#1)(1997-3#1)(2008-4#1)
relatively broad##7##2##(1991-7#1)(2005-11#1)(2006-5#1)(2008-10#1)(2008-3#2)(2011-2#1)
relatively cheap##4##2##(2005-11#1)(2008-1#2)(2009-5#1)
relatively clean##2##2##(2005-7#1)(2008-2#1)
relatively closed and##2##3##(2008-5#1)(2013-8#1)
relatively common and##3##3##(2006-10#1)(2006-4#1)(2010-7#1)
relatively common problem##3##3##(2005-9#1)(2007-7#1)(2011-2#1)
relatively common##34##2##(1991-12#1)(1991-4#1)(1991-5#1)(1993-3#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-6#1)(2009-9#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
relatively compact##3##2##(1994-8#1)(2007-12#1)(2008-3#1)
relatively complex##5##2##(1994-2#1)(2006-12#1)(2007-12#1)(2008-8#2)
relatively conservative##3##2##(1996-12#1)(2007-12#1)(2011-2#1)
relatively consistent##7##2##(1996-7#1)(2008-10#1)(2008-11#2)(2010-7#1)(2010-8#1)(2012-12#1)
relatively constant during the##2##4##(1990-11#1)(2008-10#1)
relatively constant during##3##3##(1990-11#1)(2007-8#1)(2008-10#1)
relatively constant for the##2##4##(1995-8#1)(2007-8#1)
relatively constant for##4##3##(1995-8#1)(2007-8#1)(2008-10#1)(2008-11#1)
relatively constant in##3##3##(1997-1#1)(2008-10#1)(2012-2#1)
relatively constant##27##2##(1990-11#1)(1991-8#1)(1992-5#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-7#1)(2007-12#1)(2007-3#2)(2007-8#3)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-2#1)
relatively contraindicated in##2##3##(1992-10#1)(1995-2#1)
relatively contraindicated##3##2##(1991-12#1)(1992-10#1)(1995-2#1)
relatively crude##2##2##(1992-3#1)(2008-1#1)
relatively distinct##4##2##(2006-8#1)(2008-4#2)(2009-9#1)
relatively dry##3##2##(1992-6#1)(2008-10#1)(2008-6#1)
relatively early in##3##3##(1993-6#1)(1996-11#1)(1996-5#1)
relatively early##10##2##(1991-10#1)(1991-6#1)(1993-6#1)(1996-11#1)(1996-5#1)(2006-8#1)(2008-9#1)(2011-1#2)(2012-2#1)
relatively easily and##2##3##(2006-10#1)(2008-1#1)
relatively easily##7##2##(2004-9#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-12#1)
relatively easy access##2##3##(2006-5#1)(2006-8#1)
relatively easy to perform##3##4##(2008-4#1)(2009-8#1)(2011-2#1)
relatively easy to##14##3##(1991-3#1)(1996-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
relatively easy##27##2##(1991-3#2)(1996-1#1)(1996-12#1)(1996-3#1)(1997-3#1)(2006-10#1)(2006-5#1)(2006-8#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-7#1)(2008-8#1)(2009-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
relatively effective##4##2##(2008-10#2)(2008-3#1)(2013-1#1)
relatively expensive##3##2##(1996-11#1)(2006-12#1)(2012-2#1)
relatively extended##3##2##(1990-11#2)(2007-2#1)
relatively far from the##2##4##(2012-2#1)(2013-7#1)
relatively far from##3##3##(2006-6#1)(2012-2#1)(2013-7#1)
relatively fast response time and can be used##3##8##(2008-10#3)
relatively fast response time##4##4##(2008-10#4)
relatively fast##12##2##(1993-11#1)(1996-5#1)(2008-10#7)(2008-3#1)(2008-6#1)(2011-2#1)
relatively faster##2##2##(1990-11#1)(1994-9#1)
relatively few cases##2##3##(1991-2#1)(1991-5#1)
relatively few data##2##3##(1996-2#1)(2007-1#1)
relatively few of##3##3##(1995-3#1)(2012-12#2)
relatively few side effects##2##4##(2006-10#1)(2010-5#1)
relatively few##43##2##(1990-10#1)(1991-12#2)(1991-2#1)(1991-5#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-6#1)(2005-1#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#2)(2009-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-12#2)(2012-3#2)(2013-1#2)
relatively free from##3##3##(1996-5#1)(2007-12#1)(2008-10#1)
relatively free of##4##3##(2007-8#1)(2010-4#2)(2012-2#1)
relatively free##8##2##(1996-5#1)(2007-12#1)(2007-8#1)(2008-10#1)(2009-5#1)(2010-4#2)(2012-2#1)
relatively frequent##11##2##(1991-12#1)(2005-8#1)(2006-6#1)(2007-9#1)(2008-11#1)(2008-3#1)(2009-2#1)(2009-3#1)(2010-5#1)(2011-1#1)(2013-1#1)
relatively frequently##3##2##(1993-1#1)(2007-10#1)(2013-7#1)
relatively general##2##2##(2008-8#1)(2009-6#1)
relatively good##13##2##(1992-8#1)(1994-9#1)(2005-10#1)(2005-9#1)(2006-1#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-11#1)(2012-1#1)
relatively greater##3##2##(1992-3#1)(2008-6#2)
relatively healthy older adults aged 50 or above##2##8##(2011-1#2)
relatively healthy older##3##3##(2011-1#3)
relatively healthy##4##2##(2011-1#3)(2013-7#1)
relatively high (0##2##3##(1990-8#1)(2008-10#1)
relatively high HIV##2##3##(2007-12#1)(2013-1#1)
relatively high affinity##2##3##(1990-12#1)(2006-1#1)
relatively high amount of##2##4##(1995-3#1)(2008-1#1)
relatively high concentration of##4##4##(1992-6#1)(1994-6#1)(1996-11#1)(2008-10#1)
relatively high concentration##7##3##(1992-6#1)(1994-6#1)(1996-11#1)(1997-2#1)(2008-10#2)(2008-8#1)
relatively high concentrations of##5##4##(1990-10#1)(1996-1#1)(1997-4#1)(2008-10#1)(2012-12#1)
relatively high concentrations##8##3##(1990-10#1)(1995-6#1)(1996-1#1)(1996-6#1)(1997-4#1)(2008-10#2)(2012-12#1)
relatively high cryoprotective##2##3##(1996-1#2)
relatively high degree of##2##4##(1991-8#1)(2008-5#1)
relatively high doses##2##3##(1996-4#1)(2008-7#1)
relatively high free##2##3##(1992-6#1)(2008-5#1)
relatively high in some##2##4##(1991-6#1)(2012-12#1)
relatively high in the##2##4##(1993-3#1)(2008-9#1)
relatively high in##8##3##(1991-6#1)(1992-2#1)(1993-3#1)(1996-7#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#1)
relatively high incidence##2##3##(1994-12#1)(2004-9#1)
relatively high level of##5##4##(1997-4#2)(2008-10#1)(2008-2#1)(2008-8#1)
relatively high level##6##3##(1997-4#2)(2006-10#1)(2008-10#1)(2008-2#1)(2008-8#1)
relatively high levels of##7##4##(1990-4#1)(1990-5#1)(1994-3#1)(1997-1#1)(2005-7#1)(2008-10#2)
relatively high levels##9##3##(1990-4#1)(1990-5#1)(1993-7#1)(1994-3#1)(1997-1#1)(2005-7#1)(2008-10#2)(2008-11#1)
relatively high morbidity##2##3##(2008-4#1)(2009-4#1)
relatively high number of species##2##5##(2007-5#1)(2008-5#1)
relatively high number of##3##4##(2007-12#1)(2007-5#1)(2008-5#1)
relatively high potency##2##3##(1991-5#1)(1995-3#1)
relatively high prevalence of##2##4##(2007-7#1)(2008-1#1)
relatively high prevalence##3##3##(2007-7#1)(2008-1#1)(2011-2#1)
relatively high proportion of##4##4##(1990-12#1)(2006-10#1)(2008-8#1)(2008-9#1)
relatively high proportion##5##3##(1990-12#1)(1997-2#1)(2006-10#1)(2008-8#1)(2008-9#1)
relatively high rate of##2##4##(1993-11#1)(1997-8#1)
relatively high sensitivity##4##3##(2008-10#3)(2008-2#1)
relatively high threshold##2##3##(1994-10#1)(2008-1#1)
relatively high toxicity##2##3##(1997-2#1)(2008-3#1)
relatively high##183##2##(1990-10#1)(1990-12#2)(1990-4#2)(1990-5#1)(1990-8#1)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#2)(1992-1#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#3)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-7#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#3)(1996-11#2)(1996-2#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#5)(1997-4#4)(1997-6#1)(1997-8#2)(2004-9#1)(2005-11#4)(2005-4#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#26)(2008-11#2)(2008-12#1)(2008-2#8)(2008-3#7)(2008-4#3)(2008-5#5)(2008-7#2)(2008-8#6)(2008-9#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#3)(2010-6#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#2)
relatively higher in##2##3##(1994-2#1)(2007-8#1)
relatively higher##13##2##(1990-3#1)(1994-2#1)(1994-6#1)(1994-8#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2009-2#1)(2012-7#1)(2013-1#1)
relatively highest##2##2##(1992-2#1)(2008-5#1)
relatively homogeneous##6##2##(1995-12#1)(1997-6#1)(2008-10#2)(2008-2#1)(2010-3#1)
relatively hydrophobic##4##2##(1996-12#2)(1997-8#1)(2008-10#1)
relatively inactive##2##2##(1991-8#1)(2005-12#1)
relatively independent##4##2##(2006-4#1)(2008-3#1)(2011-1#1)(2011-2#1)
relatively ineffective##3##2##(1990-9#1)(1991-6#1)(2011-2#1)
relatively inefficient##2##2##(1990-11#1)(1996-5#1)
relatively inexpensive##11##2##(1991-2#1)(2006-12#1)(2008-10#6)(2008-3#1)(2008-8#1)(2012-2#1)
relatively infrequent##2##2##(1994-3#1)(2011-12#1)
relatively insensitive to the##7##4##(1991-4#1)(1994-5#1)(1995-2#1)(2006-11#1)(2006-12#1)(2008-10#1)(2008-9#1)
relatively insensitive to##18##3##(1991-4#3)(1991-8#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-8#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-3#1)(2006-11#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)
relatively insensitive##21##2##(1991-12#1)(1991-4#3)(1991-8#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-8#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-3#1)(2006-11#1)(2006-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
relatively intact##6##2##(1993-12#1)(1996-5#1)(2006-8#1)(2008-10#1)(2008-4#2)
relatively large amounts of##5##4##(1993-7#1)(2008-10#3)(2012-2#1)
relatively large and##3##3##(1992-6#1)(2007-12#1)(2012-2#1)
relatively large number of##7##4##(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-8#1)
relatively large proteins##2##3##(1997-2#2)
relatively large size##3##3##(2006-5#1)(2007-1#1)(2010-10#1)
relatively large variation in##2##4##(2007-11#1)(2013-8#1)
relatively large##69##2##(1990-8#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-6#1)(1993-12#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-12#2)(1996-8#1)(1997-2#2)(1997-5#1)(1997-6#1)(2005-11#3)(2006-12#1)(2006-5#1)(2007-1#2)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#6)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#3)(2013-8#2)
relatively larger##7##2##(1992-1#1)(1996-1#1)(2007-12#1)(2008-2#1)(2008-5#1)(2010-8#1)(2011-2#1)
relatively late in##2##3##(2009-8#1)(2010-2#1)
relatively late##5##2##(1995-11#1)(1996-4#1)(2006-6#1)(2009-8#1)(2010-2#1)
relatively less important##2##3##(1996-8#1)(2009-10#1)
relatively less sensitive##2##3##(1991-1#1)(2008-8#1)
relatively less##16##2##(1990-12#1)(1991-1#1)(1994-8#1)(1996-8#1)(2004-12#1)(2005-4#1)(2006-9#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#1)
relatively limited##5##2##(1992-9#1)(1994-10#1)(2008-7#1)(2009-2#1)(2012-12#1)
relatively little attention##3##3##(2009-4#1)(2009-6#1)(2009-8#1)
relatively little effect on the##2##5##(1995-1#1)(1995-3#1)
relatively little effect on##4##4##(1990-3#1)(1995-1#1)(1995-12#1)(1995-3#1)
relatively little effect##5##3##(1990-3#1)(1992-6#1)(1995-1#1)(1995-12#1)(1995-3#1)
relatively little information##2##3##(2006-9#1)(2008-11#1)
relatively little is known about the##8##6##(1991-11#1)(1992-2#1)(1997-2#1)(1997-8#1)(2005-8#1)(2009-5#1)(2012-12#1)(2013-1#1)
relatively little is known about##13##5##(1991-11#1)(1992-2#1)(1995-2#1)(1997-2#1)(1997-8#1)(2005-8#1)(2007-10#1)(2007-3#1)(2009-2#1)(2009-5#1)(2010-8#1)(2012-12#1)(2013-1#1)
relatively little is known##14##4##(1991-11#1)(1992-2#1)(1995-2#1)(1997-2#1)(1997-8#1)(2005-8#1)(2007-10#1)(2007-3#1)(2009-2#1)(2009-5#1)(2010-8#1)(2011-12#1)(2012-12#1)(2013-1#1)
relatively little is##15##3##(1991-11#1)(1992-2#1)(1995-2#1)(1997-2#1)(1997-8#1)(2005-8#1)(2007-10#1)(2007-3#1)(2007-8#1)(2009-2#1)(2009-5#1)(2010-8#1)(2011-12#1)(2012-12#1)(2013-1#1)
relatively little research has explored use of text messaging as a tool for sexual health promotion##2##16##(2013-1#2)
relatively little research has##3##4##(2008-11#1)(2013-1#2)
relatively little scientific##2##3##(2009-12#1)(2010-9#1)
relatively little to##2##3##(2006-7#1)(2007-5#1)
relatively little work has been##2##5##(2006-8#1)(2008-10#1)
relatively little work##3##3##(2006-8#1)(2008-10#1)(2010-2#1)
relatively little##54##2##(1990-3#1)(1991-11#1)(1992-2#1)(1992-6#1)(1993-2#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-8#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-2#1)(2007-3#2)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-5#2)(2008-8#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-8#1)(2010-9#2)(2011-12#1)(2012-12#2)(2013-1#3)
relatively long and##5##3##(1991-5#1)(1992-12#1)(1996-10#1)(1996-2#1)(2010-8#1)
relatively long##21##2##(1990-2#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-7#1)(1996-10#1)(1996-2#1)(1996-3#1)(1997-4#1)(2007-12#2)(2007-3#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-8#1)(2011-1#1)
relatively long-term##2##2##(2006-5#1)(2009-7#1)
relatively low (0##2##3##(2006-5#1)(2012-12#1)
relatively low affinity##3##3##(1990-12#1)(1991-1#1)(1995-11#1)
relatively low bioavailability##2##3##(2008-5#1)(2013-8#1)
relatively low compared with##2##4##(2010-4#1)(2010-8#1)
relatively low compared##4##3##(2008-5#1)(2010-4#1)(2010-8#1)(2011-2#1)
relatively low concentrations of##4##4##(1990-2#1)(1991-4#1)(1993-3#1)(2008-10#1)
relatively low concentrations##7##3##(1990-2#1)(1991-4#1)(1993-3#1)(2008-10#4)
relatively low cost of##2##4##(2008-1#1)(2008-3#1)
relatively low cost##8##3##(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2009-1#1)
relatively low cytotoxicity##2##3##(2008-11#1)(2008-3#1)
relatively low doses##3##3##(2007-11#1)(2008-7#1)(2009-6#1)
relatively low in the United States##2##6##(1994-2#1)(2010-11#1)
relatively low in##7##3##(1994-2#1)(1995-4#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-7#1)(2010-11#1)
relatively low incidence of##2##4##(1993-9#1)(2008-7#1)
relatively low level##3##3##(1992-9#1)(1995-1#1)(1995-3#1)
relatively low levels of##2##4##(2008-10#1)(2011-2#1)
relatively low overall##2##3##(1997-3#1)(2007-5#1)
relatively low percentage of##2##4##(1994-6#1)(2008-7#1)
relatively low pressure##2##3##(2008-10#1)(2008-6#1)
relatively low rate##3##3##(2006-8#1)(2008-3#1)(2008-7#1)
relatively low rates##2##3##(1994-9#1)(2009-9#1)
relatively low toxicity##2##3##(2005-8#1)(2009-8#1)
relatively low variability of##2##4##(2008-9#1)(2010-12#1)
relatively low##184##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-4#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-2#2)(1993-3#1)(1993-9#1)(1994-2#1)(1994-6#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-8#2)(1995-9#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-8#1)(2005-11#4)(2005-12#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#5)(2007-12#3)(2007-3#2)(2007-4#2)(2007-5#2)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#24)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#13)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#3)(2009-1#2)(2009-11#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#1)(2010-4#2)(2010-5#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
relatively lower##8##2##(1993-8#1)(1994-12#1)(1995-1#1)(1996-8#1)(2005-11#1)(2007-7#1)(2008-10#1)(2010-7#1)
relatively mature##3##2##(1992-7#1)(2008-7#1)(2008-9#1)
relatively mild##10##2##(1995-8#1)(1996-11#1)(1996-2#1)(2005-12#1)(2006-10#1)(2008-3#1)(2009-6#1)(2011-2#1)(2013-8#2)
relatively minor effects on##2##4##(2008-11#1)(2010-2#1)
relatively minor effects##3##3##(1994-8#1)(2008-11#1)(2010-2#1)
relatively minor##13##2##(1993-6#1)(1994-8#1)(1997-8#1)(2006-12#1)(2007-11#1)(2008-10#3)(2008-11#1)(2009-9#1)(2010-2#1)(2012-2#2)
relatively modest##9##2##(1991-11#1)(1992-3#1)(1993-12#1)(2005-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2011-2#1)
relatively more##21##2##(1991-12#1)(1991-5#1)(1992-12#1)(1992-6#1)(1993-12#2)(1995-2#1)(2005-10#1)(2006-8#1)(2007-12#1)(2007-4#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#2)(2012-11#3)
relatively narrow##11##2##(1991-4#1)(1995-10#1)(1995-8#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-11#1)
relatively neglected##2##2##(2008-10#1)(2009-8#1)
relatively new and##3##3##(2008-2#1)(2008-8#1)(2011-2#1)
relatively new class of##2##4##(2008-1#1)(2008-7#1)
relatively new technique##6##3##(2007-1#1)(2007-9#1)(2008-10#1)(2010-1#1)(2010-3#1)(2011-1#1)
relatively new techniques##2##3##(2006-8#1)(2008-10#1)
relatively new##49##2##(1992-5#1)(1992-8#1)(1995-11#1)(1995-3#1)(1997-7#1)(2004-12#1)(2006-10#1)(2006-12#2)(2006-8#2)(2007-1#2)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
relatively non##2##2##(1996-11#1)(2008-1#1)
relatively non-invasive##2##2##(2005-11#1)(2007-8#1)
relatively non-specific##2##2##(1996-6#1)(2009-3#1)
relatively nonspecific##2##2##(1991-4#1)(1992-2#1)
relatively nontoxic##3##2##(1994-6#1)(2006-10#1)(2007-11#1)
relatively normal##3##2##(1997-5#1)(2006-10#1)(2012-2#1)
relatively novel##2##2##(2006-12#1)(2010-12#1)
relatively old##3##2##(2008-10#1)(2013-1#2)
relatively painless##2##2##(2006-10#1)(2012-2#1)
relatively passive##2##2##(1990-9#1)(2010-12#1)
relatively poor in activity against##2##5##(2006-5#2)
relatively poor in activity##3##4##(2006-5#3)
relatively poor##21##2##(1990-11#1)(1992-12#1)(1994-1#1)(1994-3#1)(1996-8#1)(2004-2#1)(2005-11#2)(2006-11#1)(2006-5#3)(2007-9#1)(2008-10#2)(2008-5#1)(2008-6#2)(2009-7#1)(2010-12#1)(2011-2#1)
relatively poorly understood##2##3##(1994-10#1)(2007-5#1)
relatively poorly##5##2##(1991-6#1)(1994-10#1)(2006-8#1)(2007-5#1)(2013-1#1)
relatively preserved##6##2##(1994-6#1)(1997-1#1)(2007-8#1)(2008-9#1)(2010-9#1)(2013-8#1)
relatively prolonged##3##2##(1996-9#1)(2005-7#1)(2008-8#1)
relatively protected##3##2##(1991-5#1)(1995-9#1)(2008-8#1)
relatively pure##3##2##(1992-12#1)(2008-4#1)(2008-5#1)
relatively quick##2##2##(2008-5#1)(2010-4#1)
relatively quickly##4##2##(2008-10#1)(2008-6#1)(2008-7#1)(2012-2#1)
relatively rapid and##4##3##(1992-3#1)(1993-10#1)(1997-3#1)(2011-3#1)
relatively rapid##16##2##(1990-11#1)(1992-3#1)(1992-6#1)(1993-10#1)(1994-5#1)(1994-8#1)(1995-12#1)(1997-3#1)(2006-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-3#1)(2012-12#2)(2013-8#1)
relatively rare and##5##3##(1993-8#1)(2006-10#1)(2007-3#1)(2008-3#1)(2013-1#1)
relatively rare but##5##3##(2007-11#2)(2007-8#1)(2008-7#1)(2009-9#1)
relatively rare in##5##3##(1996-8#1)(2006-10#1)(2007-8#1)(2009-3#1)(2010-5#1)
relatively rare occurrence##2##3##(2008-3#1)(2013-1#1)
relatively rare##63##2##(1991-12#1)(1992-10#1)(1992-5#1)(1993-5#1)(1993-8#1)(1996-8#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-7#1)(2007-11#4)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#6)
relatively rarely##4##2##(1991-3#1)(1995-4#1)(2006-5#1)(2013-8#1)
relatively recent introduction of##2##4##(2004-11#1)(2009-4#1)
relatively recent##14##2##(1991-12#1)(1992-8#1)(1993-3#1)(1997-4#1)(2004-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2009-4#1)(2010-7#1)(2013-1#2)
relatively recently##5##2##(1993-3#1)(1994-9#1)(1995-8#1)(2006-8#1)(2011-12#1)
relatively resistant to##10##3##(1990-12#1)(1991-1#1)(1991-3#1)(1994-11#1)(1995-8#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-7#1)(2010-8#1)
relatively restricted##2##2##(1996-4#1)(2011-1#1)
relatively rich in##4##3##(1990-11#1)(1994-3#1)(1995-6#2)
relatively rich##5##2##(1990-11#1)(1994-3#1)(1995-6#2)(2008-9#1)
relatively rigid##4##2##(1994-3#1)(1995-6#1)(2006-10#1)(2008-7#1)
relatively robust##3##2##(1994-5#1)(2008-10#1)(2010-4#1)
relatively safe and##3##3##(1996-1#1)(2008-9#1)(2012-2#1)
relatively safe in##2##3##(2008-10#1)(2013-1#1)
relatively safe##15##2##(1990-4#1)(1996-1#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-9#1)(2010-9#1)(2012-2#1)(2013-1#2)
relatively scarce##3##2##(1997-2#1)(2007-11#1)(2013-1#1)
relatively selective and##3##3##(1995-11#1)(2008-10#2)
relatively selective##8##2##(1992-9#1)(1994-2#1)(1995-11#1)(1996-3#1)(1997-5#1)(2008-10#3)
relatively sensitive##3##2##(1990-11#1)(1990-12#1)(1991-1#1)
relatively short (&lt##2##3##(1993-2#1)(2006-8#1)
relatively short distances##3##3##(2007-8#1)(2008-10#1)(2013-8#1)
relatively short duration of follow-up##2##5##(2007-7#1)(2008-1#1)
relatively short duration of##3##4##(2007-7#1)(2008-1#1)(2009-8#1)
relatively short duration##4##3##(2006-2#1)(2007-7#1)(2008-1#1)(2009-8#1)
relatively short lasting##3##3##(1994-2#1)(2005-7#1)(2009-10#1)
relatively short periods of##2##4##(2005-10#1)(2007-8#1)
relatively short periods##3##3##(2005-10#1)(2007-8#1)(2008-10#1)
relatively short time##10##3##(1994-3#1)(1995-11#1)(1996-4#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#2)(2010-4#1)
relatively short##52##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-7#1)(1992-12#1)(1993-2#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-5#1)(1996-4#1)(1997-7#1)(2004-9#1)(2005-10#1)(2005-7#1)(2006-2#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-12#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
relatively short-lived##3##2##(1994-8#1)(1996-10#1)(1997-7#1)
relatively short-term and##2##3##(2008-2#1)(2010-12#1)
relatively short-term##3##2##(2007-10#1)(2008-2#1)(2010-12#1)
relatively silent##2##2##(1994-10#1)(2008-5#1)
relatively similar##3##2##(1990-8#1)(1997-2#1)(2011-2#1)
relatively simple and##9##3##(1990-11#1)(1996-3#1)(2006-12#1)(2006-6#1)(2008-3#2)(2008-4#1)(2012-11#1)(2013-7#1)
relatively simple to##2##3##(2008-2#1)(2008-9#1)
relatively simple##55##2##(1990-11#1)(1990-4#1)(1991-3#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-7#1)(1994-6#1)(1995-1#1)(1995-2#1)(1996-3#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#5)(2008-3#6)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#1)(2013-7#1)
relatively slow##18##2##(1992-10#2)(1993-12#1)(1994-5#1)(1997-5#2)(2005-11#1)(2005-9#1)(2006-6#1)(2008-10#3)(2008-2#2)(2008-3#1)(2009-6#1)(2010-8#1)(2012-1#1)
relatively slowly##3##2##(1995-10#1)(1995-3#1)(1997-4#1)
relatively small amounts of##5##4##(1994-12#2)(1997-8#1)(2008-10#1)(2008-4#1)
relatively small amounts##6##3##(1994-12#2)(1997-8#1)(2005-7#1)(2008-10#1)(2008-4#1)
relatively small and##3##3##(1996-10#1)(2009-3#1)(2011-1#1)
relatively small compared##2##3##(2008-10#2)
relatively small domains##2##3##(2006-10#1)(2008-10#1)
relatively small effect##5##3##(1997-8#1)(2005-1#1)(2008-10#1)(2008-8#1)(2012-11#1)
relatively small number of##9##4##(1991-2#1)(1991-6#1)(1992-7#1)(1996-12#1)(1996-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-3#1)
relatively small number##11##3##(1991-2#1)(1991-6#1)(1992-7#1)(1996-12#1)(1996-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-3#1)(2013-1#1)
relatively small proportion of##3##4##(1991-12#1)(2008-10#1)(2013-7#1)
relatively small##115##2##(1990-12#1)(1990-7#1)(1991-12#2)(1991-2#1)(1991-6#2)(1991-9#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-12#2)(1995-11#1)(1995-2#1)(1996-10#1)(1996-12#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-5#2)(1997-6#1)(1997-8#2)(2004-1#1)(2005-1#1)(2005-11#3)(2005-7#2)(2006-10#1)(2006-11#2)(2006-12#1)(2006-2#1)(2006-6#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#4)(2008-7#3)(2008-8#2)(2009-3#1)(2009-5#2)(2009-7#2)(2009-9#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)
relatively smaller##3##2##(1993-5#1)(2007-12#1)(2008-3#1)
relatively smooth##2##2##(1995-4#1)(2011-2#1)
relatively soon after##2##3##(1991-12#1)(2012-12#1)
relatively soon##3##2##(1991-12#1)(1994-2#1)(2012-12#1)
relatively sparse##3##2##(1990-3#1)(1994-1#1)(2005-10#1)
relatively specific for##3##3##(1994-9#1)(1996-6#1)(2010-11#1)
relatively specific##6##2##(1991-12#1)(1994-9#1)(1996-6#1)(1997-2#1)(2007-11#1)(2010-11#1)
relatively stable in##4##3##(2007-7#1)(2008-11#1)(2008-5#1)(2011-2#1)
relatively stable over##2##3##(1997-2#1)(2008-5#1)
relatively stable##37##2##(1990-5#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-11#1)(1993-11#1)(1994-6#1)(1995-5#1)(1996-1#1)(1996-4#1)(1996-9#1)(1997-2#1)(2007-1#1)(2007-11#2)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
relatively standardized##2##2##(2006-10#1)(2011-1#1)
relatively straight##2##2##(1992-9#1)(2008-11#1)
relatively straightforward##2##2##(2007-8#1)(2008-2#1)
relatively strong for##3##3##(1993-9#1)(2008-10#1)(2011-2#1)
relatively strong##7##2##(1993-9#1)(2008-10#2)(2008-2#1)(2009-3#1)(2010-12#1)(2011-2#1)
relatively stronger##2##2##(1996-6#1)(2006-6#1)
relatively strongly##2##2##(1992-3#1)(1994-11#1)
relatively successful##2##2##(2006-8#1)(2010-9#1)
relatively thin##2##2##(2008-10#1)(2009-3#1)
relatively to the##3##3##(2008-2#1)(2011-1#1)(2012-11#1)
relatively to##5##2##(2008-10#1)(2008-2#1)(2011-1#1)(2012-11#1)(2013-1#1)
relatively unaffected##4##2##(1994-6#1)(1995-5#1)(1996-9#1)(2008-6#1)
relatively unchanged##5##2##(1997-7#1)(1997-8#1)(2008-10#1)(2008-8#1)(2012-2#1)
relatively uncommon and##2##3##(2007-2#1)(2007-5#1)
relatively uncommon but##2##3##(2006-8#1)(2013-8#1)
relatively uncommon in the##2##4##(2009-3#1)(2013-1#1)
relatively uncommon in##6##3##(2007-3#1)(2007-8#1)(2008-8#1)(2009-3#1)(2013-1#2)
relatively uncommon##31##2##(1992-4#1)(1994-11#1)(2005-12#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-1#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#2)
relatively undifferentiated cells##2##3##(2008-1#1)(2008-4#1)
relatively undifferentiated##4##2##(1990-6#1)(1991-9#1)(2008-1#1)(2008-4#1)
relatively unexplored##4##2##(2008-10#2)(2010-12#1)(2012-2#1)
relatively uniform##8##2##(1997-5#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2010-3#1)
relatively unimportant for##2##3##(2008-9#1)(2012-3#1)
relatively unimportant##3##2##(2004-11#1)(2008-9#1)(2012-3#1)
relatively unknown##3##2##(2007-4#1)(2008-8#1)(2012-2#1)
relatively unstable##3##2##(1990-5#1)(1991-12#1)(2008-9#1)
relatively volatile##2##2##(2008-10#2)
relatively weak##19##2##(1991-8#1)(1994-3#1)(1996-2#1)(1996-6#1)(1997-1#2)(1997-5#1)(2004-9#1)(2005-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-9#1)(2010-4#1)(2010-8#1)(2012-2#1)(2013-1#1)
relatively well characterized##3##3##(2008-8#2)(2011-1#1)
relatively well##11##2##(1994-12#1)(1996-3#1)(1997-2#1)(2006-12#1)(2007-8#1)(2008-5#1)(2008-8#2)(2010-12#1)(2011-1#1)(2012-2#1)
relatively young patients with unipolar major depression##2##7##(1996-7#2)
relatively young patients with unipolar##3##5##(1996-7#3)
relatively young patients with##4##4##(1996-7#3)(2008-7#1)
relatively young patients##5##3##(1991-8#1)(1996-7#3)(2008-7#1)
relatively young##18##2##(1991-3#1)(1991-8#1)(1995-5#1)(1996-7#3)(2006-10#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2011-2#1)
relatively##1930##1##(1990-10#3)(1990-11#11)(1990-12#9)(1990-2#2)(1990-3#6)(1990-4#5)(1990-5#5)(1990-6#1)(1990-7#3)(1990-8#4)(1990-9#2)(1991-1#5)(1991-10#1)(1991-11#4)(1991-12#20)(1991-2#5)(1991-3#7)(1991-4#8)(1991-5#9)(1991-6#7)(1991-7#1)(1991-8#7)(1991-9#5)(1992-1#3)(1992-10#5)(1992-11#3)(1992-12#10)(1992-2#6)(1992-3#11)(1992-4#4)(1992-5#4)(1992-6#10)(1992-7#5)(1992-8#7)(1992-9#5)(1993-1#1)(1993-10#2)(1993-11#4)(1993-12#10)(1993-2#5)(1993-3#6)(1993-4#1)(1993-5#2)(1993-6#2)(1993-7#5)(1993-8#3)(1993-9#3)(1994-1#3)(1994-10#4)(1994-11#6)(1994-12#10)(1994-2#10)(1994-3#8)(1994-5#5)(1994-6#10)(1994-8#9)(1994-9#8)(1995-1#6)(1995-10#2)(1995-11#7)(1995-12#5)(1995-2#7)(1995-3#10)(1995-4#3)(1995-5#7)(1995-6#5)(1995-8#7)(1995-9#2)(1996-1#9)(1996-10#3)(1996-11#8)(1996-12#10)(1996-2#9)(1996-3#9)(1996-4#5)(1996-5#7)(1996-6#5)(1996-7#6)(1996-8#8)(1996-9#4)(1997-1#9)(1997-2#16)(1997-3#8)(1997-4#12)(1997-5#11)(1997-6#6)(1997-7#6)(1997-8#14)(2004-1#1)(2004-11#2)(2004-12#2)(2004-2#1)(2004-9#4)(2005-1#2)(2005-10#8)(2005-11#27)(2005-12#5)(2005-4#4)(2005-7#8)(2005-8#4)(2005-9#4)(2006-1#3)(2006-10#29)(2006-11#7)(2006-12#18)(2006-2#7)(2006-4#6)(2006-5#13)(2006-6#9)(2006-7#2)(2006-8#19)(2006-9#3)(2007-1#8)(2007-10#8)(2007-11#30)(2007-12#39)(2007-2#7)(2007-3#13)(2007-4#8)(2007-5#11)(2007-6#4)(2007-7#18)(2007-8#32)(2007-9#10)(2008-1#27)(2008-10#188)(2008-11#40)(2008-12#5)(2008-2#48)(2008-3#71)(2008-4#32)(2008-5#49)(2008-6#20)(2008-7#39)(2008-8#39)(2008-9#30)(2009-1#3)(2009-10#8)(2009-11#4)(2009-12#4)(2009-2#6)(2009-3#8)(2009-4#6)(2009-5#12)(2009-6#9)(2009-7#6)(2009-8#10)(2009-9#8)(2010-1#1)(2010-10#4)(2010-11#6)(2010-12#22)(2010-2#8)(2010-3#5)(2010-4#15)(2010-5#9)(2010-6#3)(2010-7#5)(2010-8#11)(2010-9#10)(2011-1#23)(2011-12#8)(2011-2#40)(2011-3#1)(2012-1#7)(2012-11#7)(2012-12#21)(2012-2#38)(2012-3#16)(2012-7#1)(2013-1#49)(2013-7#9)(2013-8#17)
relativement##2##1##(2008-11#1)(2008-5#1)
relatives about##2##2##(1993-8#1)(2012-3#1)
relatives and##12##2##(1990-5#1)(1993-12#1)(1997-8#1)(2006-8#1)(2007-7#1)(2008-2#1)(2008-7#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
relatives are##7##2##(1995-9#1)(1997-8#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
relatives as##2##2##(2008-2#1)(2013-1#1)
relatives at risk##2##3##(1993-5#1)(1996-12#1)
relatives by##2##2##(1990-3#1)(2008-10#1)
relatives from##2##2##(2007-3#1)(2009-4#1)
relatives had##3##2##(1996-6#1)(1997-8#1)(2012-2#1)
relatives in the##3##3##(1992-9#1)(1997-8#2)
relatives in##8##2##(1992-9#1)(1997-8#2)(2008-4#2)(2009-10#1)(2009-6#1)(2011-2#1)
relatives is##3##2##(1991-6#1)(2009-10#1)(2011-1#1)
relatives may be##2##3##(1997-7#1)(2008-7#1)
relatives of individuals with##3##4##(2009-10#1)(2009-4#1)(2012-2#1)
relatives of patients in##2##4##(2008-7#1)(2009-3#1)
relatives of patients with type##2##5##(1996-9#1)(2012-12#1)
relatives of patients with##5##4##(1991-11#1)(1991-3#1)(1996-9#1)(2007-5#1)(2012-12#1)
relatives of patients##9##3##(1991-11#1)(1991-3#1)(1996-9#1)(2006-2#1)(2007-5#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-12#1)
relatives of the patients##2##4##(2007-7#1)(2011-2#1)
relatives of the##5##3##(1990-11#1)(1994-2#2)(2007-7#1)(2011-2#1)
relatives of wheat##3##3##(2006-4#1)(2008-10#2)
relatives of##60##2##(1990-11#1)(1990-5#1)(1991-11#3)(1991-3#3)(1991-5#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-9#4)(1994-2#2)(1994-3#2)(1996-6#1)(1996-9#1)(1997-4#1)(2006-1#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-7#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#4)(2012-2#2)(2013-8#1)
relatives on##2##2##(1995-11#1)(2007-7#1)
relatives or##3##2##(1997-8#1)(2006-10#2)
relatives should be##2##3##(1992-3#1)(2010-4#1)
relatives showed##2##2##(1990-5#1)(1997-3#1)
relatives that##2##2##(2008-10#1)(2012-11#1)
relatives to##7##2##(1993-8#1)(1994-4#1)(1997-3#1)(2009-5#1)(2010-11#3)
relatives was##3##2##(1997-2#1)(2007-2#1)(2011-1#1)
relatives were##4##2##(2007-10#1)(2008-1#1)(2011-2#1)(2012-12#1)
relatives with normal mucosa##2##4##(1991-11#2)
relatives with##9##2##(1990-11#1)(1991-11#3)(2007-7#1)(2011-1#1)(2011-2#2)(2013-7#1)
relatives##241##1##(1990-11#2)(1990-3#1)(1990-4#1)(1990-5#4)(1991-11#7)(1991-3#4)(1991-5#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-8#2)(1992-9#4)(1993-1#1)(1993-11#1)(1993-12#2)(1993-5#2)(1993-8#2)(1993-9#5)(1994-12#2)(1994-2#3)(1994-3#2)(1994-4#1)(1994-7#1)(1995-1#1)(1995-11#2)(1995-9#2)(1996-12#1)(1996-3#1)(1996-5#2)(1996-6#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#5)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#9)(2004-11#1)(2004-3#1)(2005-4#1)(2005-7#1)(2006-1#2)(2006-10#3)(2006-2#1)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#5)(2006-9#1)(2007-10#3)(2007-12#1)(2007-2#2)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#8)(2007-8#3)(2008-1#3)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#1)(2008-4#5)(2008-5#1)(2008-7#9)(2008-8#1)(2008-9#5)(2009-10#4)(2009-11#1)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#4)(2009-8#1)(2010-10#2)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#16)(2012-11#1)(2012-12#8)(2012-2#5)(2012-3#5)(2013-1#1)(2013-7#2)(2013-8#5)
relatives'##4##1##(2007-8#1)(2009-5#1)(2010-10#1)(2012-12#1)
relatives?##3##1##(2006-10#1)(2006-9#1)(2011-2#1)
relatives]##3##1##(1990-11#1)(1993-3#1)(2011-1#1)
relativistic intensity##2##2##(2007-12#2)
relativistic##8##1##(1992-3#1)(1994-10#1)(1995-10#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-2#1)
relativity and##2##2##(1992-8#1)(1995-7#1)
relativity theory##2##2##(2009-3#2)
relativity##12##1##(1990-6#1)(1992-8#1)(1992-9#1)(1995-7#1)(2007-9#1)(2008-3#4)(2009-3#3)
relax the##7##2##(1995-8#1)(2006-1#1)(2007-11#1)(2007-12#2)(2008-1#1)(2010-12#1)
relax##20##1##(1992-7#1)(1993-6#1)(1995-8#1)(1996-10#1)(1996-7#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-2#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-6#1)
relaxant effect##4##2##(1992-9#1)(1996-12#1)(2008-12#1)(2009-5#1)
relaxant##23##1##(1990-11#1)(1992-3#2)(1992-6#1)(1992-8#3)(1992-9#2)(1995-12#1)(1996-10#1)(1996-12#2)(1996-2#2)(1997-4#1)(2006-8#1)(2007-2#1)(2008-12#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-4#1)
relaxants has##2##2##(2006-10#1)(2006-2#1)
relaxants to##2##2##(2006-10#1)(2007-9#1)
relaxants##21##1##(1990-6#1)(2005-9#1)(2006-10#7)(2006-2#1)(2006-8#2)(2007-2#1)(2007-8#1)(2007-9#2)(2008-10#1)(2009-7#1)(2010-12#1)(2010-4#1)(2013-7#1)
relaxase (TraI) of##2##3##(1996-5#2)
relaxase##4##1##(1996-5#4)
relaxation after##4##2##(1992-2#1)(1992-6#1)(1993-8#1)(2007-8#1)
relaxation agents than##2##3##(1991-7#2)
relaxation and meditation##2##3##(2009-10#2)
relaxation and the##2##3##(1994-2#1)(1997-5#1)
relaxation and##24##2##(1990-3#1)(1990-5#1)(1992-1#1)(1992-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1997-5#2)(2004-12#1)(2004-3#1)(2005-11#2)(2006-10#1)(2006-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#2)(2009-4#1)(2012-3#2)
relaxation at a##2##3##(1995-1#1)(1995-11#1)
relaxation at##3##2##(1992-6#1)(1995-1#1)(1995-11#1)
relaxation behavior of##3##3##(1995-1#1)(1995-11#1)(2008-10#1)
relaxation behavior##4##2##(1995-1#1)(1995-11#1)(2007-1#1)(2008-10#1)
relaxation behaviour##2##2##(1997-1#1)(2007-4#1)
relaxation by##3##2##(1990-5#1)(1992-6#1)(2007-12#1)
relaxation correlation time##2##3##(1996-5#2)
relaxation data for##2##3##(1992-9#1)(2008-1#1)
relaxation data##5##2##(1992-9#1)(1994-9#2)(2008-1#1)(2008-10#1)
relaxation during##3##2##(1991-2#1)(2007-2#1)(2008-7#1)
relaxation dynamics of##3##3##(2006-10#1)(2006-5#1)(2007-12#1)
relaxation dynamics##6##2##(1993-3#1)(2006-10#3)(2006-5#1)(2007-12#1)
relaxation effect##4##2##(2008-10#1)(2008-12#1)(2012-11#1)(2012-3#1)
relaxation effects##4##2##(1995-12#1)(2005-11#1)(2008-2#1)(2013-1#1)
relaxation efficiency##2##2##(2012-11#1)(2012-3#1)
relaxation experiments##3##2##(1992-6#1)(1995-5#1)(2007-4#1)
relaxation for##3##2##(1997-7#1)(2004-3#1)(2012-2#1)
relaxation frequency##3##2##(2007-12#2)(2008-5#1)
relaxation imagery##2##2##(2004-12#2)
relaxation in rabbit##2##3##(1992-1#1)(1992-6#1)
relaxation in rat##4##3##(1993-11#3)(1996-10#1)
relaxation in response to##2##4##(1990-7#1)(2010-12#1)
relaxation in the##6##3##(1997-7#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-3#2)
relaxation in##28##2##(1990-6#1)(1990-7#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-11#3)(1993-8#2)(1995-10#1)(1995-7#1)(1996-10#2)(1997-5#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-3#2)(2010-12#1)
relaxation induced by##5##3##(1995-2#1)(1996-10#1)(2004-12#2)(2012-3#1)
relaxation is a##2##3##(1995-8#1)(2007-6#1)
relaxation is not##2##3##(1994-8#1)(1997-1#1)
relaxation is##11##2##(1990-6#1)(1991-12#1)(1991-8#1)(1994-8#1)(1995-8#1)(1997-1#1)(2006-10#2)(2007-6#1)(2008-2#1)(2009-10#1)
relaxation labeling##3##2##(2008-1#1)(2008-2#2)
relaxation matrix approach##3##3##(1993-11#1)(1996-7#2)
relaxation matrix##7##2##(1993-11#1)(1994-11#1)(1995-1#1)(1995-10#2)(1996-7#2)
relaxation measurements of##2##3##(2005-11#1)(2009-11#1)
relaxation measurements##9##2##(1992-9#1)(1993-11#1)(1994-11#1)(1995-2#2)(2005-11#1)(2009-11#3)
relaxation mediated by##2##3##(1990-6#1)(1994-11#1)
relaxation modulus##8##2##(2007-1#2)(2009-7#6)
relaxation of isolated##2##3##(1991-10#1)(2007-8#1)
relaxation of rabbit aortic##2##4##(1997-2#1)(2009-5#1)
relaxation of rabbit##3##3##(1997-2#1)(1997-5#1)(2009-5#1)
relaxation of rat##2##3##(1990-11#1)(1991-5#1)
relaxation of the uterine##2##4##(2008-4#2)
relaxation of the##19##3##(1990-6#1)(1991-5#1)(1991-7#1)(1993-11#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-7#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-4#2)(2009-10#2)(2011-1#1)(2011-2#1)(2013-1#2)
relaxation of##55##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-5#2)(1991-7#1)(1992-11#1)(1993-11#2)(1993-6#2)(1994-5#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-10#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#2)(1997-5#2)(2007-11#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-5#2)(2009-10#2)(2009-5#3)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
relaxation on##2##2##(1991-12#1)(2012-3#1)
relaxation or##2##2##(1990-5#1)(1990-6#1)
relaxation oscillation frequency##5##3##(2007-11#4)(2007-12#1)
relaxation oscillation##10##2##(2007-11#5)(2007-12#5)
relaxation oscillations##2##2##(2007-12#2)
relaxation oscillators##4##2##(2008-2#4)
relaxation parameters##3##2##(1994-11#1)(1994-9#1)(1995-2#1)
relaxation process##4##2##(1997-1#1)(2007-12#1)(2008-3#1)(2008-5#1)
relaxation processes##7##2##(1990-8#1)(1991-8#1)(1995-3#1)(1997-1#1)(2008-10#2)(2008-2#1)
relaxation properties##7##2##(1991-7#4)(2009-6#2)(2012-11#1)
relaxation rate in the##2##4##(1994-8#1)(2007-11#1)
relaxation rate##8##2##(1991-8#2)(1994-5#1)(1994-8#3)(2007-11#1)(2008-7#1)
relaxation rates of##5##3##(1991-7#1)(1995-1#1)(1997-5#1)(1997-7#1)(2009-6#1)
relaxation rates##17##2##(1991-7#1)(1991-8#2)(1995-1#8)(1995-2#1)(1997-5#2)(1997-7#1)(2009-6#2)
relaxation responses to##2##3##(1996-12#1)(2009-11#1)
relaxation responses##4##2##(1996-12#1)(1997-5#1)(2009-11#1)(2009-5#1)
relaxation results##2##2##(2010-8#1)(2012-11#1)
relaxation schedule##2##2##(2007-12#2)
relaxation studies##3##2##(1994-3#1)(1995-6#1)(1997-5#1)
relaxation techniques to##2##3##(2007-2#2)
relaxation techniques##6##2##(1996-6#1)(2005-11#1)(2007-2#2)(2009-12#1)(2010-7#1)
relaxation therapy##3##2##(2006-10#2)(2013-1#1)
relaxation through##2##2##(1997-5#1)(2005-11#1)
relaxation time of the##8##4##(1990-7#1)(2007-11#2)(2008-2#1)(2008-3#3)(2009-11#1)
relaxation time of##14##3##(1990-7#2)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)(2009-11#1)(2012-1#2)
relaxation time results from##2##4##(1997-7#2)
relaxation time##48##2##(1990-7#3)(1991-12#1)(1994-11#2)(1994-8#1)(1995-6#2)(1997-1#2)(1997-7#3)(2005-11#1)(2007-11#3)(2007-12#3)(2008-10#4)(2008-2#2)(2008-3#10)(2008-7#2)(2008-9#1)(2009-11#1)(2010-9#1)(2012-1#2)(2012-2#2)(2012-7#1)(2013-7#1)
relaxation times (T2)##2##3##(1996-7#1)(2011-1#1)
relaxation times for the##2##4##(1995-11#2)
relaxation times for##4##3##(1990-2#1)(1995-11#2)(2008-5#1)
relaxation times have##2##3##(1997-7#1)(2008-5#1)
relaxation times of##3##3##(1991-7#1)(1992-7#1)(2012-7#1)
relaxation times##36##2##(1990-2#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-7#1)(1995-11#5)(1995-3#1)(1996-7#2)(1997-1#1)(1997-5#1)(1997-7#5)(2005-11#2)(2006-10#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-5#3)(2008-7#2)(2011-1#1)(2012-1#1)(2012-7#2)
relaxation to##4##2##(1993-8#1)(2007-9#1)(2013-1#2)
relaxation training##2##2##(1996-2#1)(2008-7#1)
relaxation was not##3##3##(1996-10#1)(1997-5#1)(2011-2#1)
relaxation was observed##3##3##(2008-5#1)(2009-5#2)
relaxation was##14##2##(1991-12#1)(1993-11#1)(1995-12#2)(1996-10#1)(1996-2#1)(1997-5#3)(2007-8#1)(2008-5#1)(2009-5#2)(2011-2#1)
relaxation were##5##2##(1995-12#1)(2007-12#2)(2008-3#1)(2012-2#1)
relaxation which##2##2##(1992-11#1)(2009-11#1)
relaxation with##2##2##(1991-12#1)(2004-3#1)
relaxation##542##1##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#3)(1990-6#10)(1990-7#6)(1990-8#1)(1991-10#1)(1991-12#9)(1991-2#2)(1991-4#1)(1991-5#6)(1991-7#9)(1991-8#6)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#1)(1992-6#8)(1992-7#1)(1992-8#1)(1992-9#5)(1993-11#9)(1993-3#1)(1993-6#4)(1993-8#5)(1994-11#9)(1994-2#2)(1994-3#2)(1994-5#4)(1994-8#8)(1994-9#3)(1995-1#13)(1995-10#3)(1995-11#9)(1995-12#8)(1995-2#6)(1995-3#3)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#2)(1996-10#5)(1996-12#4)(1996-2#3)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#6)(1997-1#7)(1997-2#1)(1997-4#5)(1997-5#14)(1997-7#15)(2004-12#5)(2004-3#4)(2005-1#1)(2005-11#14)(2006-10#16)(2006-5#2)(2006-7#1)(2007-1#6)(2007-11#18)(2007-12#22)(2007-2#6)(2007-3#1)(2007-4#3)(2007-6#4)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#3)(2008-10#15)(2008-11#1)(2008-12#2)(2008-2#16)(2008-3#18)(2008-4#2)(2008-5#10)(2008-7#11)(2008-9#1)(2009-10#5)(2009-11#7)(2009-12#2)(2009-2#2)(2009-4#2)(2009-5#7)(2009-6#7)(2009-7#7)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#8)(2012-1#4)(2012-11#6)(2012-12#1)(2012-2#10)(2012-3#7)(2012-7#3)(2013-1#10)(2013-7#3)
relaxation-oscillation frequency##3##2##(2007-12#3)
relaxation-oscillation##4##1##(2007-12#4)
relaxation]##2##1##(1990-6#1)(1996-9#1)
relaxations and##2##2##(2006-10#1)(2008-10#1)
relaxations in a##2##3##(1997-5#1)(2005-11#1)
relaxations in porcine coronary arteries##2##5##(1992-11#1)(1994-11#1)
relaxations in the##2##3##(1990-6#1)(1991-7#1)
relaxations in##8##2##(1990-6#1)(1991-7#1)(1992-11#1)(1994-11#1)(1995-12#1)(1997-5#1)(2005-11#1)(2008-4#1)
relaxations of the##2##3##(1992-11#1)(2007-12#1)
relaxations of##4##2##(1992-11#1)(2007-12#1)(2008-10#1)(2008-4#1)
relaxations were##2##2##(1992-10#1)(2008-4#1)
relaxations##29##1##(1990-6#1)(1991-7#1)(1992-10#1)(1992-11#2)(1994-11#1)(1995-12#2)(1996-12#5)(1997-5#1)(1997-7#1)(2005-11#1)(2006-10#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#4)(2010-10#1)
relaxed DNA##2##2##(1995-6#1)(2008-9#1)
relaxed and##5##2##(1990-2#1)(1995-6#1)(2006-11#1)(2010-4#1)(2012-2#1)
relaxed by##4##2##(1997-7#1)(2007-12#1)(2008-2#1)(2008-5#1)
relaxed plasmid DNA##2##3##(1990-9#1)(1996-2#1)
relaxed when they were##2##4##(1990-5#2)
relaxed##53##1##(1990-2#1)(1990-5#2)(1990-9#1)(1992-11#2)(1993-8#1)(1995-3#1)(1995-6#8)(1996-10#1)(1996-2#1)(1996-6#1)(1997-4#1)(1997-6#1)(1997-7#3)(2006-11#4)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#3)(2009-10#1)(2009-2#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-2#2)(2012-2#1)(2012-3#1)
relaxed-like or active-like##2##3##(1995-6#2)
relaxed-like##3##1##(1995-6#3)
relaxes in##4##2##(2006-5#1)(2007-1#3)
relaxes the##4##2##(2007-12#1)(2008-3#1)(2008-8#1)(2012-3#1)
relaxes##18##1##(1990-7#1)(1992-12#1)(1994-11#1)(2006-5#1)(2006-6#1)(2007-1#3)(2007-11#3)(2007-12#1)(2007-7#1)(2008-3#2)(2008-7#1)(2008-8#1)(2012-3#1)
relaxin##16##1##(1990-11#1)(1994-9#1)(1995-8#3)(1996-7#3)(1997-2#1)(2005-7#6)(2008-4#1)
relaxin-like##3##1##(1996-7#2)(2009-9#1)
relaxing factor (EDRF)##4##3##(1991-12#1)(1991-9#3)
relaxing factor in##3##3##(1990-11#1)(1990-12#1)(1991-3#1)
relaxing factor##12##2##(1990-11#2)(1990-12#1)(1991-12#1)(1991-3#1)(1991-9#3)(1993-3#2)(1994-9#1)(1996-6#1)
relaxing factors##4##2##(1991-12#1)(1993-3#1)(1994-2#1)(2010-10#1)
relaxing this assumption##2##3##(1997-4#1)(2008-8#1)
relaxing##33##1##(1990-11#4)(1990-12#1)(1991-12#2)(1991-3#1)(1991-9#3)(1992-1#1)(1993-3#4)(1993-8#1)(1994-2#1)(1994-9#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-6#1)(1997-4#1)(1997-7#1)(2007-6#2)(2008-3#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-10#1)
relaxins##2##1##(1996-7#2)
relaxivities##4##1##(2008-7#2)(2012-11#2)
relaxivity contrast agents in MR##2##5##(2008-7#2)
relaxivity contrast agents in##3##4##(2008-7#3)
relaxivity contrast agents##4##3##(2008-7#4)
relaxivity of the entrapped Gd-DTPA##2##5##(1990-2#2)
relaxivity of##7##2##(1990-2#4)(2008-7#2)(2010-2#1)
relaxivity properties##2##2##(2007-10#1)(2009-6#1)
relaxivity##25##1##(1990-2#5)(2007-10#1)(2007-8#1)(2008-3#1)(2008-7#12)(2009-6#2)(2010-2#2)(2012-11#1)
relaxometry##3##1##(1996-9#1)(2010-4#1)(2011-1#1)
relay GRIN is##2##3##(2008-2#2)
relay cells##4##2##(1995-5#3)(1997-7#1)
relay distances##2##2##(2008-2#2)
relay from the##2##3##(1997-6#1)(2010-11#1)
relay in the##4##3##(1990-11#1)(1991-5#1)(1992-3#1)(1997-7#1)
relay in##6##2##(1990-11#1)(1991-5#2)(1992-3#1)(1997-7#1)(2010-11#1)
relay lens##2##2##(2008-2#1)(2008-3#1)
relay neurons and##2##3##(1997-7#1)(2008-2#1)
relay neurons##6##2##(1993-12#2)(1997-7#2)(2008-2#1)(2012-2#1)
relay nucleus##2##2##(1996-2#1)(2009-2#1)
relay of##2##2##(1996-5#1)(2010-10#1)
relay optics##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
relay system##4##2##(2008-2#3)(2008-3#1)
relay##60##1##(1990-11#1)(1990-3#1)(1990-9#1)(1991-11#1)(1991-5#2)(1992-3#1)(1993-12#2)(1995-2#1)(1995-5#3)(1996-2#2)(1996-5#2)(1997-6#2)(1997-7#4)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#16)(2008-3#7)(2009-2#2)(2009-8#1)(2010-10#1)(2010-11#3)(2011-1#1)(2012-2#1)
relayed##6##1##(1991-4#1)(1992-8#1)(1993-12#1)(1994-9#1)(1995-12#1)(2010-1#1)
relays were arranged in a##2##5##(2008-2#2)
relays were##3##2##(2008-2#2)(2009-2#1)
relays##11##1##(1992-3#1)(1995-5#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-2#4)(2008-9#1)(2009-2#1)
relearn##3##1##(1992-9#1)(1993-2#1)(2012-1#1)
relearning of##3##2##(1993-2#1)(1994-8#1)(1995-12#1)
relearning##9##1##(1992-9#1)(1993-2#2)(1994-8#1)(1995-12#5)
releasable quanta##2##2##(1995-1#2)
releasable##7##1##(1995-1#3)(1997-7#1)(2007-10#1)(2008-7#1)(2009-3#1)
release (CICR)##5##2##(1993-2#1)(1993-6#1)(1994-8#1)(2007-9#2)
release (up to##2##3##(1996-8#1)(2008-10#1)
release ATP##3##2##(2008-4#3)
release Ca2+##2##2##(1991-10#1)(1996-8#1)
release GABA##3##2##(1992-8#1)(1993-12#1)(1994-2#1)
release MT##4##2##(2008-11#4)
release NO##4##2##(1993-3#1)(1996-6#1)(2008-5#1)(2008-7#1)
release a soluble##3##3##(1992-7#1)(1994-5#1)(2008-8#1)
release a##8##2##(1992-7#1)(1994-5#1)(1997-1#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-1#1)
release activity##3##2##(1991-3#1)(1997-4#1)(1997-6#1)
release adenosine##2##2##(1994-11#1)(1996-2#1)
release after##3##2##(1996-9#1)(2008-5#1)(2008-6#1)
release also##2##2##(1993-6#1)(2008-11#1)
release and a putative##2##4##(1992-8#1)(2005-8#1)
release and a##7##3##(1991-12#1)(1992-8#1)(1995-11#1)(1996-8#1)(2004-11#1)(2005-8#1)(2007-10#1)
release and antibacterial##2##3##(2008-5#2)
release and calcium##2##3##(2006-10#1)(2010-11#1)
release and consequently##2##3##(2007-11#1)(2008-1#1)
release and floating##2##3##(2012-2#1)(2012-3#1)
release and gene expression##2##4##(1992-12#1)(1995-5#1)
release and heavy metal##2##4##(2008-7#2)
release and neuronal##2##3##(1993-9#1)(2007-10#1)
release and permeation##3##3##(2008-5#3)
release and production##2##3##(1994-6#1)(1996-8#1)
release and subsequent##3##3##(1991-8#1)(2008-11#1)(2008-9#1)
release and that##2##3##(2007-10#1)(2008-10#1)
release and the##6##3##(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-12#2)
release and##120##2##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#3)(1991-6#1)(1991-8#2)(1992-1#1)(1992-12#2)(1992-3#1)(1992-8#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-6#2)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#3)(1995-5#2)(1995-7#2)(1996-5#1)(1996-6#1)(1996-8#3)(1996-9#1)(1997-1#3)(1997-2#2)(1997-4#3)(1997-7#1)(2004-11#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-5#1)(2006-8#2)(2007-10#4)(2007-11#3)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#10)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-12#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-5#2)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
release are being##2##3##(2006-10#1)(2008-4#1)
release are##9##2##(1991-3#1)(1995-12#1)(1995-2#1)(1997-4#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-4#2)
release as a##4##3##(1992-6#1)(1997-5#1)(2005-10#1)(2008-11#1)
release as measured by##2##4##(1997-2#1)(2008-9#1)
release as##13##2##(1990-5#1)(1991-12#1)(1992-6#1)(1996-1#1)(1997-2#1)(1997-5#1)(2005-10#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-5#1)(2013-1#1)
release assay##11##2##(1990-10#1)(1990-12#1)(1991-12#1)(1992-9#1)(1993-11#1)(1994-11#1)(2008-4#2)(2010-12#1)(2013-1#2)
release assays##5##2##(1994-2#1)(1995-1#1)(1995-6#1)(2012-2#2)
release associated with##3##3##(1992-12#1)(2007-11#1)(2008-10#1)
release associated##4##2##(1992-12#1)(2007-11#1)(2008-10#1)(2010-5#1)
release at the##3##3##(1993-5#1)(1994-5#1)(1995-3#1)
release at##8##2##(1990-12#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-5#1)(1994-5#1)(1995-3#1)(2008-10#1)
release before##2##2##(1995-5#1)(2006-7#1)
release behavior##5##2##(1990-8#1)(2011-2#2)(2012-3#2)
release biologically active##2##3##(1991-10#1)(1991-9#1)
release both in vivo and in vitro##2##7##(1994-8#1)(2012-3#1)
release both in##4##3##(1994-8#1)(1995-11#1)(1995-5#1)(2012-3#1)
release but##2##2##(1990-12#1)(1993-9#1)
release by Kupffer cells##3##4##(1997-4#3)
release by a##3##3##(1993-9#1)(1997-7#1)(2008-10#1)
release by human##3##3##(2006-12#1)(2010-4#1)(2012-5#1)
release by intraluminal##2##3##(1990-12#1)(1992-6#1)
release by the##7##3##(1991-7#1)(1993-9#1)(1995-1#1)(1995-6#1)(1997-1#1)(2007-12#1)(2008-5#1)
release by##79##2##(1990-12#4)(1990-4#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-6#4)(1992-7#1)(1993-5#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-11#2)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#3)(1995-9#1)(1996-2#2)(1996-5#1)(1996-8#1)(1997-1#2)(1997-4#4)(1997-7#2)(2004-12#1)(2004-9#1)(2006-10#1)(2006-12#2)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-2#1)(2010-4#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-5#1)
release calcium from##2##3##(1995-11#1)(2007-9#1)
release calcium##3##2##(1992-4#1)(1995-11#1)(2007-9#1)
release can be##3##3##(1997-5#1)(2006-7#1)(2008-10#1)
release can##7##2##(1997-5#1)(1997-6#1)(2006-7#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)
release caused by##2##3##(1992-12#1)(1996-4#1)
release cells##2##2##(2006-2#1)(2008-11#1)
release channel##11##2##(1993-6#1)(1995-2#2)(1995-3#2)(2006-10#4)(2008-8#1)(2008-9#1)
release channels##3##2##(1990-2#1)(1992-1#1)(1995-3#1)
release characteristics##7##2##(2008-11#1)(2010-12#2)(2010-2#2)(2010-3#2)
release could be##2##3##(1997-6#1)(2006-4#1)
release could##3##2##(1992-8#1)(1997-6#1)(2006-4#1)
release cytokines and##3##3##(2005-11#1)(2006-2#1)(2007-11#1)
release data##6##2##(1990-8#1)(1991-2#1)(1992-1#1)(1992-2#1)(2010-5#1)(2012-2#1)
release device##2##2##(1997-4#1)(2010-4#1)
release dosage form of##2##4##(2010-12#1)(2010-5#1)
release dosage form##3##3##(2010-12#2)(2010-5#1)
release due to##2##3##(2005-8#1)(2011-2#1)
release during the early##2##4##(1994-2#1)(1995-8#1)
release during the##6##3##(1990-3#1)(1994-2#1)(1995-11#1)(1995-8#1)(2008-5#1)(2008-7#1)
release during##26##2##(1990-3#1)(1990-6#1)(1991-6#1)(1992-12#1)(1993-12#3)(1994-2#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-1#1)(1997-3#1)(1997-5#2)(1997-8#1)(2005-10#2)(2005-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
release dynamics##3##2##(1996-6#1)(2010-2#2)
release enhancing activities##2##3##(1997-3#2)
release experiments##2##2##(1991-2#1)(2008-5#1)
release factor activity##2##3##(1992-3#2)
release factor##10##2##(1991-12#1)(1992-3#3)(1994-12#3)(1994-3#2)(2008-11#1)
release factors##2##2##(2008-11#2)
release followed##2##2##(1997-2#1)(2008-4#1)
release following the##3##3##(1990-4#1)(1991-5#1)(1994-9#1)
release following##5##2##(1990-4#1)(1991-5#1)(1994-9#1)(1995-6#1)(2008-4#1)
release for##8##2##(1992-8#1)(2004-12#1)(2004-9#1)(2009-7#1)(2010-2#1)(2010-4#1)(2012-2#2)
release formulation of##2##3##(1993-4#1)(2005-8#1)
release formulation##5##2##(1993-4#1)(2005-8#1)(2007-10#1)(2010-12#1)(2012-2#1)
release from PC12 cells##2##4##(1996-12#1)(2008-4#1)
release from a##3##3##(1990-2#1)(1996-6#1)(2008-10#1)
release from activated##2##3##(2007-11#1)(2008-11#1)
release from cells##3##3##(2008-4#3)
release from endothelial cells##2##4##(1991-5#1)(1995-12#1)
release from human neutrophils##2##4##(1992-5#2)
release from human##5##3##(1992-5#2)(1994-10#1)(1994-12#1)(2006-8#1)
release from intracellular stores and##4##5##(1990-12#1)(1992-9#1)(1993-9#1)(2012-2#1)
release from intracellular stores##8##4##(1990-12#1)(1992-9#1)(1993-9#1)(1994-11#2)(1996-12#1)(1996-6#1)(2012-2#1)
release from intracellular##10##3##(1990-12#1)(1992-9#1)(1993-9#1)(1994-11#2)(1994-2#1)(1996-12#1)(1996-2#1)(1996-6#1)(2012-2#1)
release from isolated##6##3##(1990-12#1)(1990-3#2)(1991-8#1)(1995-11#1)(1997-4#1)
release from macrophages##2##3##(2003-11#1)(2008-11#1)
release from masking improves##2##4##(2009-5#2)
release from masking##3##3##(2009-5#3)
release from mouse##2##3##(1991-9#1)(2008-5#1)
release from nerve endings##2##4##(2008-5#1)(2010-12#1)
release from nerve##3##3##(1993-6#1)(2008-5#1)(2010-12#1)
release from rat peritoneal##4##4##(1991-12#2)(2008-11#2)
release from rat##11##3##(1990-2#1)(1990-7#1)(1991-12#2)(1992-3#1)(1993-12#1)(1994-8#1)(1995-12#1)(1996-11#1)(2008-11#2)
release from roots##3##3##(2009-8#2)(2010-5#1)
release from striatal slices from saline-treated##2##6##(1995-12#2)
release from the ER##2##4##(1997-1#1)(2010-11#1)
release from the cells##2##4##(1994-11#1)(1994-3#1)
release from the endoplasmic reticulum and##2##6##(2009-8#1)(2013-1#1)
release from the hypothalamus##2##4##(1991-2#1)(1997-2#1)
release from the intracellular##3##4##(1991-12#1)(1996-2#1)(2004-12#1)
release from the isolated perfused rat pancreas##2##7##(1990-12#1)(1990-3#1)
release from the isolated##3##4##(1990-12#1)(1990-3#1)(1991-2#1)
release from the liver##2##4##(1990-3#1)(2005-10#1)
release from the membrane##4##4##(1993-6#1)(1994-6#1)(1996-8#1)(2008-5#1)
release from the mesenteric##2##4##(1992-3#2)
release from the rat cerebral cortex##2##6##(1995-6#1)(1997-2#1)
release from the rat##3##4##(1992-8#1)(1995-6#1)(1997-2#1)
release from the sarcoplasmic reticulum##2##5##(2007-9#1)(2010-2#1)
release from the##63##3##(1990-12#2)(1990-3#2)(1991-12#1)(1991-2#2)(1991-5#1)(1992-10#1)(1992-3#3)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-4#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-3#2)(1995-6#2)(1995-8#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(2004-12#2)(2005-10#2)(2005-8#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
release from these##2##3##(1994-11#1)(2006-1#1)
release from##219##2##(1990-11#1)(1990-12#5)(1990-2#5)(1990-3#4)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#5)(1992-5#3)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#2)(1993-12#1)(1993-3#1)(1993-4#2)(1993-5#2)(1993-6#3)(1993-8#1)(1993-9#2)(1994-10#2)(1994-11#5)(1994-12#1)(1994-2#2)(1994-3#3)(1994-6#1)(1994-8#4)(1994-9#1)(1995-10#1)(1995-11#4)(1995-12#8)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#7)(1995-7#1)(1995-8#2)(1995-9#2)(1996-11#2)(1996-12#2)(1996-2#3)(1996-5#2)(1996-6#3)(1996-8#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(2003-11#1)(2004-11#1)(2004-12#2)(2005-10#2)(2005-8#1)(2006-1#1)(2006-4#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#6)(2008-11#6)(2008-3#2)(2008-4#12)(2008-5#6)(2008-8#2)(2009-11#3)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-5#4)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#2)
release has##2##2##(2008-10#1)(2013-7#1)
release height##2##2##(2007-10#1)(2008-10#1)
release in a concentration-dependent manner##3##5##(1992-3#1)(1992-6#1)(1995-12#1)
release in a dose dependent manner##2##6##(1994-5#1)(2008-5#1)
release in a dose-dependent manner##3##5##(1991-8#1)(1992-7#1)(1994-3#1)
release in a##11##3##(1990-3#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-7#1)(1994-3#1)(1994-5#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-5#1)
release in an##2##3##(1997-4#1)(2008-7#1)
release in both##3##3##(1992-7#1)(1995-12#1)(2008-6#1)
release in macrophages##2##3##(1996-2#1)(2012-1#1)
release in mouse##2##3##(1995-12#1)(1995-3#1)
release in permeabilized##2##3##(1992-12#1)(1993-8#1)
release in raphe##2##3##(1995-12#1)(2008-7#1)
release in rat brain slices##2##5##(1990-7#1)(1992-7#1)
release in rat striatum##2##4##(1991-1#1)(1996-1#1)
release in rat##10##3##(1990-7#1)(1991-1#1)(1992-7#1)(1994-5#1)(1995-11#1)(1995-12#1)(1996-1#2)(1996-12#1)(1996-5#1)
release in response to##8##4##(1992-12#1)(1995-12#1)(1995-7#1)(1997-5#1)(2008-1#1)(2008-3#1)(2008-4#1)(2011-2#1)
release in the brain##3##4##(1993-3#1)(1995-12#1)(2007-12#1)
release in the hippocampus##3##4##(1992-7#1)(1994-5#1)(2013-8#1)
release in the presence of##3##5##(1992-10#1)(1995-12#1)(2007-6#1)
release in the presence##4##4##(1991-5#1)(1992-10#1)(1995-12#1)(2007-6#1)
release in the##39##3##(1990-2#3)(1990-5#2)(1991-2#1)(1991-5#2)(1992-10#1)(1992-3#1)(1992-7#2)(1993-3#1)(1994-5#1)(1995-11#1)(1995-12#3)(1996-1#1)(1996-6#1)(1997-1#2)(1997-3#1)(2005-8#1)(2006-10#2)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2012-8#1)(2013-1#1)(2013-8#1)
release in these##2##3##(1990-2#1)(2008-10#1)
release in vivo##3##3##(1995-12#2)(2010-11#1)
release in##159##2##(1990-11#1)(1990-2#5)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#6)(1991-4#1)(1991-5#3)(1991-8#1)(1992-10#1)(1992-12#3)(1992-3#2)(1992-6#3)(1992-7#7)(1992-8#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#14)(1995-3#1)(1995-7#2)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#3)(1996-12#3)(1996-2#1)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(2005-11#1)(2005-8#1)(2006-10#2)(2007-10#2)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-3#2)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#5)(2008-9#3)(2009-11#1)(2009-12#1)(2009-9#1)(2010-11#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2012-8#3)(2013-1#1)(2013-8#1)
release increased##7##2##(1990-6#1)(1991-1#1)(1991-12#1)(2008-10#4)
release induced by electroconvulsive therapy##2##5##(1996-2#2)
release induced by##7##3##(1994-11#1)(1994-2#1)(1995-12#1)(1996-2#2)(2008-10#1)(2009-10#1)
release inhibits##2##2##(1995-8#1)(2008-3#1)
release into the medium##4##4##(1994-11#1)(1994-6#1)(1996-2#1)(1997-7#1)
release into the##14##3##(1994-11#1)(1994-6#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-7#1)(2006-6#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-9#1)(2012-3#1)
release into##18##2##(1990-4#1)(1991-5#1)(1991-7#1)(1994-11#1)(1994-6#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-7#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-9#1)(2012-3#1)
release is a##4##3##(1990-7#1)(1991-9#1)(1994-11#1)(2006-10#1)
release is consistent with##2##4##(1993-12#1)(1997-4#1)
release is inhibited by##2##4##(1994-8#1)(1996-11#1)
release is mediated by##2##4##(1996-2#1)(2008-5#1)
release is one of the##2##5##(2011-1#1)(2013-8#1)
release is the##2##3##(1993-12#1)(2013-7#1)
release is##41##2##(1990-12#1)(1990-7#1)(1991-2#1)(1991-9#2)(1993-12#2)(1993-4#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-11#2)(1995-3#1)(1996-1#1)(1996-11#3)(1996-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-10#1)(2006-2#1)(2007-8#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-8#1)(2008-9#2)(2010-3#1)(2011-1#1)(2012-11#2)(2013-7#1)(2013-8#2)
release it##3##2##(1992-8#1)(1995-3#2)
release kinetic##4##2##(2008-7#1)(2010-1#1)(2011-2#2)
release kinetics of the##2##4##(2008-5#1)(2009-12#1)
release kinetics of##3##3##(2008-5#1)(2009-12#1)(2011-2#1)
release kinetics##11##2##(1993-11#1)(2006-1#1)(2008-5#1)(2009-12#1)(2009-4#1)(2010-1#1)(2010-5#2)(2011-2#2)(2013-7#1)
release large amounts of##2##4##(1990-11#1)(2011-1#1)
release maximally##2##2##(1992-5#1)(2008-3#1)
release may be##2##3##(1994-5#1)(1996-9#1)
release may contribute to the##2##5##(1993-12#1)(1995-7#1)
release may##6##2##(1990-12#1)(1993-12#1)(1994-5#1)(1995-7#1)(1996-9#1)(2008-7#1)
release measured##2##2##(1992-11#1)(1996-8#1)
release mechanism was##3##3##(2006-1#1)(2010-1#1)(2010-2#1)
release mechanism##11##2##(1990-7#1)(1995-3#1)(1997-1#1)(2006-1#1)(2008-10#1)(2008-5#1)(2010-1#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)
release mechanisms##2##2##(1993-6#1)(2013-1#1)
release melatonin##2##2##(2008-11#2)
release multiple##3##2##(2004-12#1)(2007-12#1)(2012-11#1)
release neutral##2##2##(1991-1#1)(1994-9#1)
release nifedipine##2##2##(1992-4#1)(1997-8#1)
release nitric oxide##3##3##(1994-12#1)(2008-5#2)
release norepinephrine##2##2##(1992-8#1)(1997-1#1)
release occurs##4##2##(1992-10#1)(1993-4#1)(1996-8#1)(2006-12#1)
release of 43K+##3##3##(1992-11#3)
release of 5-HT##2##3##(1994-10#1)(1995-12#1)
release of AMP##2##3##(1990-3#1)(1995-3#1)
release of ATP from##5##4##(1995-5#1)(2006-1#1)(2008-4#2)(2008-5#1)
release of ATP into the extracellular space##2##7##(2008-4#2)
release of ATP##17##3##(1993-4#3)(1995-5#1)(2006-1#1)(2007-10#1)(2008-4#9)(2008-5#1)(2009-3#1)
release of BDNF##3##3##(2009-3#2)(2009-8#1)
release of C2H2##2##3##(1992-3#2)
release of CGRP from##4##4##(1992-6#4)
release of CGRP##5##3##(1991-8#1)(1992-6#4)
release of Ca(2+) from##2##4##(2007-11#1)(2007-12#1)
release of Ca2+ by##2##4##(1991-8#1)(1996-8#1)
release of Ca2+ from intracellular stores##2##6##(1990-4#1)(1994-12#1)
release of Ca2+ from intracellular##3##5##(1990-4#1)(1991-12#1)(1994-12#1)
release of Ca2+##8##3##(1990-4#1)(1991-12#1)(1991-3#1)(1991-8#1)(1993-8#2)(1994-12#1)(1996-8#1)
release of DA was##2##4##(1996-12#1)(1997-2#1)
release of DA##4##3##(1993-2#1)(1996-12#2)(1997-2#1)
release of DOX##3##3##(2009-11#3)
release of FN##3##3##(1992-6#3)
release of GABA##3##3##(1990-2#1)(1991-5#1)(2008-7#1)
release of Glu##2##3##(1992-3#2)
release of H-FABPc##2##3##(1991-10#2)
release of IL-1##3##3##(1992-5#1)(1992-9#1)(1994-3#1)
release of IL-8##2##3##(2008-5#1)(2010-7#1)
release of K+##2##3##(1990-3#1)(1992-11#1)
release of KC/gro protein from##2##5##(1994-9#2)
release of KC/gro protein##5##4##(1993-11#2)(1994-9#3)
release of LDH##5##3##(1992-11#2)(1992-8#1)(1994-2#1)(2008-11#1)
release of LH from the pituitary##2##6##(1995-3#1)(1997-2#1)
release of NE##4##3##(1993-2#1)(1996-6#2)(2008-2#1)
release of NO from##3##4##(1996-6#1)(2008-1#1)(2008-10#1)
release of NO##7##3##(1993-3#1)(1994-2#1)(1996-2#1)(1996-6#1)(2008-1#1)(2008-10#1)(2008-8#1)
release of NPY##2##3##(1995-12#1)(1997-5#1)
release of Pi##2##3##(1995-11#1)(1997-6#1)
release of Smac/DIABLO##2##3##(2008-11#2)
release of Zn (II)##2##4##(2008-5#2)
release of [14C]-5-HT##2##3##(1992-11#2)
release of [3H]5-HT##3##3##(1990-7#1)(1995-12#2)
release of [3H]acetylcholine##2##3##(1990-7#1)(1995-12#1)
release of a drug##2##4##(2009-5#1)(2010-4#1)
release of a##14##3##(1991-5#1)(1992-7#1)(1992-8#1)(1996-5#1)(2006-8#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-4#1)
release of acetylcholine (ACh)##2##4##(1996-11#1)(2008-8#1)
release of acetylcholine from##3##4##(1990-7#1)(1991-6#1)(1992-3#1)
release of acetylcholine##10##3##(1990-2#1)(1990-7#1)(1991-6#1)(1992-3#1)(1993-12#1)(1995-12#1)(1996-11#1)(1997-5#1)(2008-8#1)(2012-1#1)
release of adenosine from##2##4##(1996-2#2)
release of adenosine##7##3##(1993-4#1)(1996-2#3)(2008-4#3)
release of all three##2##4##(1990-2#1)(1990-5#1)
release of alpha-MSH##2##3##(1990-2#1)(1993-5#1)
release of amino acid##2##4##(1991-5#1)(1995-11#1)
release of amino acids from the##2##6##(1991-7#1)(1997-5#1)
release of amino acids##4##4##(1991-7#1)(1992-2#1)(1993-7#1)(1997-5#1)
release of amino##6##3##(1991-5#1)(1991-7#1)(1992-2#1)(1993-7#1)(1995-11#1)(1997-5#1)
release of ammonia##3##3##(2006-12#1)(2008-10#1)(2013-8#1)
release of an endogenous##2##4##(1991-5#1)(1994-11#1)
release of an##5##3##(1991-5#1)(1992-8#1)(1994-11#1)(2008-5#1)(2013-7#1)
release of approximately##2##3##(1990-2#1)(1991-6#1)
release of arachidonic acid and##3##5##(1990-9#1)(1992-2#1)(1996-2#1)
release of arachidonic acid##8##4##(1990-9#1)(1991-1#1)(1992-2#2)(1995-12#1)(1996-2#1)(2008-1#1)(2011-2#1)
release of ascospores occurred##2##4##(2008-10#2)
release of ascospores##5##3##(2008-10#5)
release of aspartate##4##3##(1990-2#2)(1997-8#2)
release of atrial##3##3##(1990-3#2)(1994-12#1)
release of beta-APP##2##3##(1993-8#2)
release of both##8##3##(1990-5#2)(1991-8#1)(1992-11#1)(1994-10#1)(1994-2#1)(1997-2#1)(2009-3#1)
release of calcium##5##3##(1991-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-3#1)
release of cholecystokinin was##2##4##(1993-9#1)(1994-6#1)
release of cholecystokinin##3##3##(1993-9#1)(1994-6#1)(1996-9#1)
release of copper##2##3##(2009-6#2)
release of creatine kinase##3##4##(1991-1#1)(1995-8#2)
release of creatine##4##3##(1991-1#1)(1995-8#2)(2010-12#1)
release of cytochrome c##2##4##(2008-4#1)(2008-6#1)
release of cytosolic enzymes##3##4##(1991-2#1)(1995-6#1)(2008-1#1)
release of cytosolic##4##3##(1991-2#1)(1995-6#1)(2008-1#1)(2008-7#1)
release of dexamethasone##2##3##(2009-11#2)
release of dopamine (DA)##3##4##(1992-7#1)(1993-2#1)(1997-2#1)
release of dopamine from##3##4##(1992-3#1)(1997-7#1)(2008-4#1)
release of dopamine in the##4##5##(1991-6#1)(1991-9#2)(1997-1#1)
release of dopamine##18##3##(1991-6#1)(1991-9#3)(1992-3#1)(1992-7#1)(1993-2#2)(1993-4#1)(1994-10#1)(1995-3#2)(1997-1#1)(1997-2#2)(1997-7#1)(2008-4#1)(2009-6#1)
release of drug##2##3##(2008-5#1)(2011-2#1)
release of drugs##6##3##(1991-11#2)(1995-11#1)(2010-10#1)(2012-11#2)
release of elastase##2##3##(1991-8#2)
release of endogenous opioids##2##4##(1990-2#1)(1990-4#1)
release of endogenous##11##3##(1990-2#3)(1990-4#1)(1991-9#1)(1995-12#1)(1995-6#1)(1996-3#1)(1997-1#1)(2008-3#1)(2008-4#1)
release of endothelin##2##3##(1990-7#2)
release of endothelin-1##2##3##(1992-3#1)(2008-1#1)
release of endothelium-derived relaxing##3##4##(1990-12#1)(1993-3#2)
release of energy##3##3##(1996-3#1)(2004-9#2)
release of excitatory##3##3##(1993-7#1)(1995-6#1)(2007-11#1)
release of extracellular##2##3##(1990-4#1)(2006-3#1)
release of fluorescent##2##3##(1990-11#1)(2008-5#1)
release of free fatty acids from##2##6##(1990-8#1)(1994-8#1)
release of free##6##3##(1990-8#1)(1994-8#1)(1997-7#1)(1997-8#1)(2005-12#1)(2008-6#1)
release of glucose##3##3##(1994-6#1)(2008-10#2)
release of glutamate and##2##4##(1994-2#1)(2007-9#1)
release of glutamate from glial cells##2##6##(1990-11#2)
release of glutamate from##4##4##(1990-11#2)(1991-9#1)(1993-12#1)
release of glutamate in the##2##5##(1991-11#1)(1996-1#1)
release of glutamate in##4##4##(1991-11#1)(1996-1#1)(1997-4#1)(2008-4#1)
release of glutamate##20##3##(1990-11#2)(1990-2#1)(1990-7#1)(1991-11#1)(1991-9#2)(1992-8#1)(1993-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1996-1#1)(1996-9#1)(1997-4#1)(1997-5#1)(2007-9#2)(2008-4#2)
release of glutamic##2##3##(1994-2#2)
release of histamine##2##3##(1991-12#1)(2006-10#1)
release of hormones##2##3##(2013-7#2)
release of immunoreactive##3##3##(1991-8#1)(1995-11#1)(1996-11#1)
release of inflammatory mediators##2##4##(1996-5#1)(2006-10#1)
release of inositol##2##3##(1990-8#1)(1995-5#1)
release of insulin##8##3##(1990-12#1)(1991-11#1)(1992-6#1)(1994-2#2)(1995-8#1)(2008-11#1)(2011-1#1)
release of interleukin 1##2##4##(1991-8#1)(1997-5#1)
release of intracellular##6##3##(1990-12#1)(1990-8#1)(1993-9#1)(2007-10#1)(2008-11#2)
release of intracellularly##2##3##(1992-7#1)(1994-2#1)
release of lactate dehydrogenase##5##4##(1990-5#1)(1992-8#1)(1995-11#1)(1995-3#1)(2008-7#1)
release of lactic dehydrogenase##2##4##(1990-5#1)(1990-7#1)
release of leuprolide acetate from an##2##6##(2004-1#2)
release of leuprolide##3##3##(2004-1#3)
release of low numbers of##2##5##(2008-10#2)
release of lymphokines##2##3##(1990-7#1)(2008-5#1)
release of mediators of##2##4##(1991-10#1)(2006-10#1)
release of mediators such as##2##5##(1992-2#1)(2011-2#1)
release of mediators##4##3##(1991-10#1)(1992-2#1)(2006-10#1)(2011-2#1)
release of metal##3##3##(2008-10#1)(2012-11#2)
release of multiple drugs##2##4##(2012-11#2)
release of multiple##3##3##(2012-11#2)(2012-12#1)
release of neuropeptides##2##3##(1992-11#1)(2009-12#1)
release of neurotensin##2##3##(1997-7#2)
release of neurotransmitter##2##3##(1990-7#1)(1994-8#1)
release of neurotransmitters##2##3##(1995-3#1)(2008-1#1)
release of newly synthesized##5##4##(1995-11#3)(1996-2#1)(2008-11#1)
release of newly##6##3##(1995-11#3)(1996-2#1)(1997-2#1)(2008-11#1)
release of nitric oxide##4##4##(1990-5#1)(1990-7#1)(1992-11#1)(1997-4#1)
release of noradrenaline from##2##4##(1991-2#1)(1996-10#1)
release of noradrenaline##3##3##(1991-2#1)(1996-10#2)
release of norepinephrine##2##3##(1990-12#1)(1992-7#1)
release of physician-specific##3##3##(1994-2#3)
release of pollutants##3##3##(2007-10#1)(2008-10#2)
release of previously incorporated##2##4##(1995-3#1)(2008-4#1)
release of pro-inflammatory cytokines##3##4##(2008-5#1)(2010-7#1)(2012-2#1)
release of pro-inflammatory mediators##3##4##(2008-11#1)(2008-5#2)
release of pro-inflammatory##10##3##(2008-11#3)(2008-5#3)(2008-7#1)(2009-12#1)(2010-7#1)(2012-2#1)
release of proinflammatory cytokines##4##4##(2006-10#1)(2007-11#1)(2007-12#1)(2007-9#1)
release of radioactive##3##3##(1990-2#1)(1991-6#1)(2012-2#1)
release of radioactivity##3##3##(1995-8#1)(2008-4#2)
release of saturated##2##3##(1990-2#2)
release of serotonin from##2##4##(1990-7#1)(2008-4#1)
release of serotonin##9##3##(1990-12#1)(1990-7#2)(1993-7#1)(1995-12#4)(2008-4#1)
release of soluble##4##3##(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#1)
release of somatostatin##2##3##(1992-6#2)
release of stored##2##3##(1990-11#1)(1996-2#1)
release of the bound ss-DNA##2##5##(2006-12#2)
release of the bound##3##4##(1995-8#1)(2006-12#2)
release of the first##2##4##(1992-8#1)(2008-3#1)
release of the fluorine##2##4##(1990-12#1)(1997-4#1)
release of the hormone##2##4##(1990-2#1)(2010-2#1)
release of the transverse carpal ligament##2##6##(2008-9#1)(2012-2#1)
release of the##73##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#1)(1991-7#1)(1992-5#1)(1992-7#1)(1992-8#1)(1994-11#1)(1994-2#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#2)(1997-4#1)(1997-6#1)(2005-10#1)(2006-12#5)(2006-3#1)(2007-1#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
release of theophylline from##2##4##(2004-12#1)(2006-1#1)
release of theophylline##3##3##(2004-12#2)(2006-1#1)
release of these##3##3##(1995-12#1)(2008-5#1)(2008-9#1)
release of toxic##5##3##(2006-10#1)(2008-10#1)(2009-7#1)(2009-8#1)(2011-2#1)
release of transgenic##3##3##(2006-11#1)(2008-8#1)(2011-2#1)
release of tritium in##2##4##(1990-7#2)
release of tritium##3##3##(1990-7#3)
release of tumor necrosis##2##4##(1992-12#1)(2006-8#1)
release of vasoactive##2##3##(1991-5#1)(2006-10#1)
release of vesicle contents##2##4##(1996-7#2)
release of##866##2##(1990-10#2)(1990-11#5)(1990-12#15)(1990-2#22)(1990-3#5)(1990-4#6)(1990-5#9)(1990-7#18)(1990-8#3)(1990-9#3)(1991-1#3)(1991-10#4)(1991-11#4)(1991-12#3)(1991-2#3)(1991-3#3)(1991-4#4)(1991-5#11)(1991-6#4)(1991-7#6)(1991-8#9)(1991-9#8)(1992-10#1)(1992-11#12)(1992-12#3)(1992-2#6)(1992-3#13)(1992-5#3)(1992-6#13)(1992-7#6)(1992-8#9)(1992-9#1)(1993-11#3)(1993-12#2)(1993-2#4)(1993-3#4)(1993-4#5)(1993-5#2)(1993-6#3)(1993-7#7)(1993-8#4)(1993-9#2)(1994-10#5)(1994-11#7)(1994-12#6)(1994-2#13)(1994-3#5)(1994-5#2)(1994-6#5)(1994-8#4)(1994-9#8)(1995-1#2)(1995-11#16)(1995-12#15)(1995-2#3)(1995-3#11)(1995-5#4)(1995-6#3)(1995-8#5)(1996-1#1)(1996-10#5)(1996-11#2)(1996-12#6)(1996-2#8)(1996-3#4)(1996-4#3)(1996-5#4)(1996-6#3)(1996-7#5)(1996-8#2)(1996-9#3)(1997-1#3)(1997-2#16)(1997-3#1)(1997-4#9)(1997-5#6)(1997-6#6)(1997-7#6)(1997-8#4)(2004-1#3)(2004-11#1)(2004-12#2)(2004-9#3)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#6)(2006-1#2)(2006-10#16)(2006-11#1)(2006-12#8)(2006-2#1)(2006-3#4)(2006-6#3)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#8)(2007-12#4)(2007-4#1)(2007-7#1)(2007-8#6)(2007-9#6)(2008-1#11)(2008-10#52)(2008-11#18)(2008-12#7)(2008-2#2)(2008-3#4)(2008-4#34)(2008-5#24)(2008-6#4)(2008-7#9)(2008-8#8)(2008-9#6)(2009-10#3)(2009-11#5)(2009-12#3)(2009-3#6)(2009-4#2)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#7)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#7)(2010-2#1)(2010-3#3)(2010-4#4)(2010-5#3)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#4)(2011-2#19)(2012-1#1)(2012-11#6)(2012-12#11)(2012-2#7)(2012-3#2)(2012-6#2)(2013-1#6)(2013-7#6)(2013-8#6)
release on##5##2##(1996-4#1)(1996-6#1)(2007-7#1)(2010-12#1)(2010-9#1)
release or its##2##3##(1990-5#1)(1993-3#1)
release or##8##2##(1990-5#1)(1990-8#1)(1993-3#2)(2006-10#1)(2006-5#1)(2008-4#1)(2008-7#1)
release over##5##2##(2008-10#1)(2009-2#1)(2010-12#1)(2010-2#1)(2011-1#1)
release pattern##7##2##(1990-6#1)(2008-5#2)(2010-2#1)(2010-3#2)(2011-2#1)
release phenomena##2##2##(2008-7#1)(2011-2#1)
release play an important role in##2##6##(1995-12#1)(1997-2#1)
release point##2##2##(1995-1#1)(2008-8#1)
release products##2##2##(1994-10#1)(2012-2#1)
release profile of##4##3##(2006-1#2)(2010-4#1)(2012-3#1)
release profile##12##2##(2006-1#3)(2007-8#1)(2008-5#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#2)(2012-6#1)
release profiles of##3##3##(2008-11#1)(2008-5#1)(2013-7#1)
release profiles##7##2##(2008-11#1)(2008-12#1)(2008-5#1)(2010-3#1)(2011-1#1)(2013-7#2)
release properties##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
release rate is##2##3##(1995-1#1)(2013-8#1)
release rate of t-PA##2##4##(1990-11#2)
release rate of##6##3##(1990-11#2)(1995-12#1)(2004-9#1)(2009-12#1)(2010-2#1)
release rate##19##2##(1990-11#2)(1995-1#1)(1995-12#4)(2004-9#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-12#1)(2010-12#2)(2010-2#1)(2012-3#1)(2013-8#1)
release rates##7##2##(1990-11#1)(1996-12#1)(2004-12#2)(2008-10#3)
release reaction##2##2##(1990-5#1)(2008-8#1)
release response##4##2##(1992-3#2)(1993-3#1)(1995-8#1)
release scenario and##2##3##(2006-10#2)
release showed##3##2##(1992-3#1)(1997-2#1)(2006-7#1)
release site protein##2##3##(1995-8#2)
release site##7##2##(1994-8#1)(1995-8#3)(1996-2#1)(2007-12#1)(2008-10#1)
release sites within the##2##4##(1991-8#2)
release sites##8##2##(1991-8#2)(1993-6#1)(1995-8#2)(2008-4#1)(2012-2#2)
release step##2##2##(1991-9#1)(1994-11#1)
release stimulated by##2##3##(1991-8#1)(1994-6#1)
release studies##6##2##(1990-11#1)(2008-5#2)(2010-12#1)(2010-2#1)(2013-7#1)
release study##3##2##(2004-12#1)(2010-1#1)(2012-2#1)
release system##4##2##(1994-11#1)(1994-6#1)(2012-11#2)
release systems##5##2##(1994-6#1)(2004-9#2)(2012-11#2)
release testing of##4##3##(2007-8#3)(2008-10#1)
release tests##3##2##(2007-8#1)(2008-10#2)
release than did##2##3##(1995-1#1)(1995-6#1)
release than##3##2##(1994-8#1)(1995-1#1)(1995-6#1)
release that is##2##3##(1995-9#1)(2009-8#1)
release that##5##2##(1990-11#1)(1995-9#1)(1996-6#1)(1997-5#1)(2009-8#1)
release the cells from##2##4##(1992-6#1)(2008-11#1)
release the##24##2##(1990-10#1)(1990-2#1)(1992-11#1)(1992-5#1)(1992-6#1)(1994-2#1)(1994-8#2)(1995-10#2)(1995-2#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
release their##5##2##(1995-4#1)(2008-4#1)(2011-1#1)(2012-11#2)
release theophylline at a##2##4##(2004-12#2)
release theophylline##3##2##(2004-12#2)(2007-11#1)
release these##2##2##(1990-11#1)(1993-4#1)
release through a small incision using a##2##7##(2006-3#2)
release through a##4##3##(1990-11#1)(2006-3#2)(2008-4#1)
release through the##2##3##(1995-10#1)(1996-9#1)
release through##10##2##(1990-11#1)(1995-10#1)(1996-12#1)(1996-9#1)(2006-3#2)(2008-4#2)(2012-11#2)
release to the##4##3##(1994-2#1)(1996-2#1)(2008-5#1)(2009-2#1)
release to##14##2##(1990-3#1)(1994-2#1)(1995-8#1)(1996-10#1)(1996-2#1)(2005-10#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-11#1)(2009-2#1)(2012-11#2)
release under##3##2##(1992-8#1)(2008-10#1)(2008-7#1)
release varies##2##2##(1993-8#1)(1997-6#1)
release via##4##2##(1992-6#1)(1995-12#1)(1996-9#1)(2008-4#1)
release was also##4##3##(1991-3#1)(1993-8#1)(1994-2#1)(1996-12#1)
release was dependent on##2##4##(1996-6#1)(2008-5#1)
release was detected##2##3##(1992-12#1)(2006-8#1)
release was due to##3##4##(1990-2#1)(2007-10#1)(2008-5#1)
release was found to be##3##5##(1991-9#1)(2008-10#1)(2011-2#1)
release was found##5##3##(1991-9#1)(1996-1#1)(2006-1#1)(2008-10#1)(2011-2#1)
release was greater##2##3##(1991-2#1)(1992-6#1)
release was inhibited##4##3##(1990-3#1)(1990-8#1)(1992-6#1)(1996-12#1)
release was not due to##2##5##(1996-12#1)(1996-6#1)
release was not##8##3##(1990-7#1)(1993-7#1)(1996-12#1)(1996-6#1)(2007-3#1)(2008-4#1)(2008-6#1)(2011-2#1)
release was observed in##2##4##(1995-5#1)(2007-6#1)
release was observed##6##3##(1995-5#1)(1996-6#1)(2006-1#1)(2007-6#1)(2008-5#1)(2010-1#1)
release was performed##2##3##(2006-8#1)(2009-3#1)
release was restored##2##3##(1997-6#1)(2008-7#1)
release was significantly##5##3##(1991-8#1)(1992-12#1)(1994-8#1)(1995-9#1)(2006-1#1)
release was studied by##2##4##(2008-10#1)(2011-1#1)
release was##79##2##(1990-2#3)(1990-3#1)(1990-7#2)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-12#2)(1992-6#3)(1993-7#2)(1993-8#2)(1994-2#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-12#4)(1996-6#4)(1996-9#2)(1997-6#1)(1997-7#1)(2005-8#2)(2006-1#3)(2006-8#2)(2007-10#1)(2007-3#1)(2007-6#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2009-3#1)(2009-4#1)(2010-1#2)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#4)(2013-1#1)
release were also##2##3##(1992-7#1)(1994-10#1)
release were##19##2##(1990-7#2)(1990-8#1)(1992-7#1)(1994-10#1)(1994-3#1)(1995-11#4)(1995-9#1)(1996-12#1)(1997-3#1)(1997-7#2)(2007-4#1)(2008-10#1)(2008-5#1)(2008-7#1)
release when##4##2##(1992-8#1)(1997-3#1)(2008-10#1)(2008-7#1)
release whereas##2##2##(1990-8#1)(1992-6#1)
release which was##3##3##(1990-12#1)(1995-11#1)(2009-10#1)
release which##4##2##(1990-12#1)(1995-11#1)(1997-2#1)(2009-10#1)
release while##3##2##(1991-3#1)(1992-12#1)(1996-4#1)
release with a##3##3##(1990-4#1)(1997-7#1)(2008-5#1)
release with the##2##3##(1993-2#1)(2008-6#1)
release with##10##2##(1990-4#1)(1990-5#1)(1993-12#1)(1993-2#1)(1994-2#1)(1996-6#1)(1997-7#1)(2008-5#1)(2008-6#2)
release within the supraoptic nucleus##2##5##(1996-8#2)
release without##3##2##(1990-7#1)(1994-2#1)(2008-9#1)
release##2765##1##(1990-10#6)(1990-11#22)(1990-12#40)(1990-2#43)(1990-3#14)(1990-4#10)(1990-5#17)(1990-6#6)(1990-7#41)(1990-8#20)(1990-9#4)(1991-1#10)(1991-10#6)(1991-11#7)(1991-12#18)(1991-2#29)(1991-3#19)(1991-4#7)(1991-5#24)(1991-6#9)(1991-7#9)(1991-8#19)(1991-9#22)(1992-1#6)(1992-10#4)(1992-11#15)(1992-12#19)(1992-2#8)(1992-3#32)(1992-4#3)(1992-5#8)(1992-6#37)(1992-7#23)(1992-8#24)(1992-9#5)(1993-11#6)(1993-12#13)(1993-2#8)(1993-3#12)(1993-4#15)(1993-5#7)(1993-6#16)(1993-7#11)(1993-8#13)(1993-9#15)(1994-10#13)(1994-11#30)(1994-12#16)(1994-2#33)(1994-3#17)(1994-5#13)(1994-6#17)(1994-8#29)(1994-9#16)(1995-1#10)(1995-10#8)(1995-11#45)(1995-12#65)(1995-2#10)(1995-3#35)(1995-4#1)(1995-5#16)(1995-6#23)(1995-7#11)(1995-8#25)(1995-9#8)(1996-1#13)(1996-10#9)(1996-11#14)(1996-12#27)(1996-2#26)(1996-3#5)(1996-4#8)(1996-5#12)(1996-6#19)(1996-7#6)(1996-8#20)(1996-9#15)(1997-1#17)(1997-2#31)(1997-3#10)(1997-4#36)(1997-5#18)(1997-6#18)(1997-7#18)(1997-8#9)(2003-11#1)(2004-1#3)(2004-11#3)(2004-12#14)(2004-2#1)(2004-3#1)(2004-9#8)(2005-10#11)(2005-11#5)(2005-12#1)(2005-7#6)(2005-8#8)(2006-1#14)(2006-10#38)(2006-11#3)(2006-12#16)(2006-2#5)(2006-3#10)(2006-4#5)(2006-5#3)(2006-6#6)(2006-7#6)(2006-8#10)(2006-9#1)(2007-1#1)(2007-10#25)(2007-11#20)(2007-12#13)(2007-2#2)(2007-3#1)(2007-4#5)(2007-6#3)(2007-7#8)(2007-8#17)(2007-9#17)(2008-1#20)(2008-10#140)(2008-11#59)(2008-12#9)(2008-2#5)(2008-3#23)(2008-4#88)(2008-5#87)(2008-6#16)(2008-7#41)(2008-8#26)(2008-9#24)(2009-10#9)(2009-11#13)(2009-12#8)(2009-2#7)(2009-3#9)(2009-4#6)(2009-5#6)(2009-6#5)(2009-7#4)(2009-8#13)(2009-9#2)(2010-1#14)(2010-10#5)(2010-11#7)(2010-12#31)(2010-2#18)(2010-3#12)(2010-4#11)(2010-5#24)(2010-6#2)(2010-7#3)(2010-8#6)(2010-9#4)(2011-1#21)(2011-12#3)(2011-2#54)(2011-3#1)(2012-1#4)(2012-11#23)(2012-12#22)(2012-2#32)(2012-3#15)(2012-5#1)(2012-6#3)(2012-8#4)(2013-1#22)(2013-7#19)(2013-8#19)
release)##11##1##(1991-9#1)(1992-8#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-12#1)(2005-10#1)(2007-6#1)(2008-10#1)(2008-12#1)(2010-2#1)
release?##3##1##(1991-3#1)(2007-9#1)(2010-10#1)
released ATP##2##2##(2008-4#2)
released CGRP##3##2##(1992-6#2)(1993-11#1)
released TGF-beta1##3##2##(2009-4#3)
released a##3##2##(1990-3#1)(1992-3#1)(2008-10#1)
released about##2##2##(1994-11#1)(2008-4#1)
released after##6##2##(1992-12#1)(1993-11#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-4#1)
released amount##3##2##(2008-5#3)
released an##2##2##(1991-1#1)(1991-10#1)
released and##10##2##(2004-12#1)(2007-9#1)(2008-4#2)(2009-10#1)(2010-6#1)(2011-12#2)(2013-1#2)
released as a##4##3##(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)
released as an##2##3##(1995-3#1)(2011-1#1)
released as the##2##3##(1991-1#1)(1992-12#1)
released as##9##2##(1991-1#1)(1992-12#1)(1993-11#1)(1995-3#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2011-1#1)
released at a##2##3##(2008-10#1)(2011-12#1)
released at the##2##3##(2004-11#1)(2008-10#1)
released at##7##2##(2004-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2011-12#1)(2011-2#1)
released between##3##2##(2008-10#2)(2009-4#1)
released by PMNs##2##3##(2008-4#2)
released by a##3##3##(2008-10#2)(2008-5#1)
released by activated##2##3##(1991-6#1)(2008-5#1)
released by activation of##2##4##(1996-10#1)(2006-10#1)
released by both##2##3##(1992-9#1)(2008-5#1)
released by enzymatic##2##3##(1990-7#1)(2008-10#1)
released by immune cells##2##4##(1997-4#1)(2013-1#1)
released by proteolysis##2##3##(2008-4#1)(2008-5#1)
released by the##17##3##(1990-7#1)(1990-8#1)(1992-3#1)(1995-1#1)(1995-3#1)(1996-7#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2012-11#2)
released by##92##2##(1990-11#1)(1990-12#3)(1990-7#2)(1990-8#1)(1991-12#2)(1991-5#1)(1991-6#2)(1991-8#2)(1992-12#2)(1992-3#1)(1992-6#2)(1992-9#1)(1993-3#1)(1993-4#1)(1993-7#1)(1994-11#1)(1994-2#1)(1994-8#5)(1994-9#1)(1995-1#1)(1995-3#1)(1995-7#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-7#1)(1997-4#3)(2005-12#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-3#1)(2008-1#2)(2008-10#13)(2008-11#3)(2008-4#3)(2008-5#7)(2008-7#2)(2009-4#1)(2010-4#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-11#2)(2012-2#1)(2012-4#1)(2013-1#1)(2013-8#2)
released completely##2##2##(2008-5#1)(2011-2#1)
released during degranulation##2##3##(2008-4#2)
released during the##6##3##(1990-5#1)(1992-6#1)(1994-12#1)(2007-4#1)(2008-10#1)(2011-2#1)
released during##19##2##(1990-5#1)(1992-12#1)(1992-6#1)(1993-2#1)(1994-12#1)(1994-5#2)(1995-7#1)(1996-2#1)(1997-4#1)(1997-8#1)(2005-11#1)(2007-4#1)(2008-10#1)(2008-4#3)(2008-6#1)(2011-2#1)
released for transplantation##2##3##(2011-2#2)
released for##5##2##(1993-5#1)(1993-9#1)(2008-10#1)(2011-2#2)
released from a point source##2##5##(2008-10#2)
released from a##7##3##(1995-8#2)(2008-10#3)(2008-4#2)
released from activated platelets##2##4##(2010-3#2)
released from activated##4##3##(1996-9#1)(1997-1#1)(2010-3#2)
released from adrenergic##2##3##(1990-5#1)(1993-11#1)
released from an##3##3##(1994-3#1)(2008-10#1)(2008-2#1)
released from astrocytes and##2##4##(1994-6#1)(2008-7#1)
released from astrocytes##5##3##(1994-6#1)(2006-4#1)(2008-4#2)(2008-7#1)
released from cells##2##3##(1990-2#1)(1996-2#1)
released from damaged cells##2##4##(2008-11#1)(2008-4#1)
released from damaged##4##3##(1997-2#1)(2008-11#1)(2008-4#1)(2010-8#1)
released from fungal##2##3##(2008-10#1)(2009-8#1)
released from gastric postganglionic intramural neurons##2##6##(2006-10#2)
released from gastric##3##3##(2006-10#3)
released from human##4##3##(1991-10#1)(1991-4#1)(1993-3#1)(1994-12#1)
released from nerve##2##3##(1995-5#1)(2008-4#1)
released from neurons##2##3##(1992-8#1)(1994-6#1)
released from oxidatively damaged##2##4##(1997-8#2)
released from the carrier protein##2##5##(1993-11#1)(1994-11#1)
released from the cells##3##4##(1993-3#1)(1993-7#1)(1994-11#1)
released from the vesicles##2##4##(1992-6#1)(1994-3#1)
released from the##60##3##(1990-2#1)(1990-4#1)(1990-7#1)(1991-12#1)(1991-5#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-4#2)(1993-7#1)(1994-11#2)(1994-3#2)(1994-5#1)(1994-6#1)(1995-12#1)(1997-4#1)(2005-11#2)(2005-7#1)(2006-10#2)(2006-5#1)(2007-7#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2009-4#1)(2009-8#1)(2011-2#3)(2012-12#1)(2012-2#1)
released from these##2##3##(2008-4#1)(2009-7#1)
released from##184##2##(1990-2#3)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#3)(1991-10#2)(1991-12#4)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-9#1)(1992-12#2)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#4)(1992-7#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#5)(1993-2#1)(1993-3#2)(1993-4#2)(1993-6#1)(1993-7#2)(1994-11#2)(1994-12#1)(1994-3#3)(1994-5#1)(1994-6#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-8#4)(2005-11#3)(2005-7#1)(2006-10#11)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-7#2)(2008-10#16)(2008-11#5)(2008-2#2)(2008-3#1)(2008-4#11)(2008-5#5)(2008-6#2)(2008-7#4)(2009-10#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#3)(2010-12#2)(2010-3#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#5)(2012-2#2)(2013-1#1)
released immediately##2##2##(2010-8#2)
released in November##2##3##(2008-4#1)(2010-12#1)
released in a##5##3##(1991-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2010-5#1)
released in the##13##3##(2004-9#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-12#1)(2011-12#1)(2011-2#1)(2013-1#1)
released in##38##2##(1990-2#1)(1991-1#1)(1991-2#1)(1992-6#1)(1992-8#1)(1995-7#1)(1997-1#1)(1997-6#1)(2004-9#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-4#2)(2008-5#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)
released into conditioned medium##2##4##(1990-11#1)(1993-9#1)
released into the circulation##4##4##(1991-8#1)(1993-11#1)(2008-3#1)(2010-9#1)
released into the culture media##2##5##(1990-10#1)(1992-8#1)
released into the culture medium##2##5##(1993-6#1)(1994-11#1)
released into the culture##4##4##(1990-10#1)(1992-8#1)(1993-6#1)(1994-11#1)
released into the environment##2##4##(1992-1#1)(2011-1#1)
released into the extracellular##2##4##(1996-2#1)(2008-8#1)
released into the medium##7##4##(1990-2#1)(1991-1#1)(1991-7#1)(1993-11#1)(1994-9#1)(1996-7#1)(2013-7#1)
released into the serum##2##4##(1991-9#1)(1995-2#1)
released into the water##2##4##(2010-8#2)
released into the##36##3##(1990-10#1)(1990-2#2)(1991-1#1)(1991-10#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#2)(1993-6#1)(1994-11#1)(1994-9#1)(1995-2#2)(1996-2#1)(1996-7#2)(2007-9#1)(2008-11#4)(2008-3#1)(2008-8#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
released into##47##2##(1990-10#1)(1990-11#1)(1990-2#2)(1991-1#1)(1991-10#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-9#2)(1995-2#2)(1996-2#2)(1996-7#2)(1997-4#1)(2007-9#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#2)(2013-1#1)(2013-7#1)
released its##2##2##(2006-10#1)(2010-2#1)
released last##2##2##(2007-9#2)
released males of##2##3##(2011-2#2)
released more##2##2##(1997-4#1)(2006-4#1)
released most##2##2##(1990-9#1)(2006-3#1)
released not##2##2##(1996-11#1)(2008-4#1)
released on the##2##3##(1990-7#1)(1995-8#1)
released on##7##2##(1990-12#1)(1990-7#1)(1991-11#1)(1995-8#1)(1996-4#1)(2008-10#1)(2011-12#1)
released only##2##2##(1996-7#1)(2006-12#1)
released per##2##2##(2007-6#1)(2008-10#1)
released protease##2##2##(1994-3#1)(1996-9#1)
released substances##2##2##(1994-8#1)(1997-1#1)
released the##7##2##(1990-5#1)(1990-9#1)(1995-10#1)(1995-3#1)(1997-5#1)(2008-7#1)(2013-1#1)
released their##3##2##(2007-8#1)(2008-10#2)
released through##2##2##(2008-10#1)(2011-1#1)
released to the culture medium##2##5##(2006-12#1)(2008-11#1)
released to the##6##3##(1992-3#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-3#1)
released to##10##2##(1991-1#1)(1992-3#1)(1994-12#1)(1996-1#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-3#1)
released together##2##2##(1990-5#1)(2007-12#1)
released under##2##2##(1993-4#1)(2008-10#1)
released upon stimulation of##2##4##(1994-11#1)(1995-12#1)
released upon##7##2##(1992-6#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-6#1)(2008-4#2)
released using##2##2##(1994-9#1)(2008-10#1)
released was##4##2##(1990-2#1)(1995-12#1)(2008-10#2)
released were determined##2##3##(1997-2#1)(2008-10#1)
released when##3##2##(1990-12#1)(2007-8#1)(2008-10#1)
released with##8##2##(1990-5#2)(1992-8#1)(1994-11#1)(1996-8#1)(2008-10#2)(2008-4#1)
released##698##1##(1990-10#3)(1990-11#3)(1990-12#6)(1990-2#8)(1990-3#2)(1990-4#2)(1990-5#7)(1990-6#1)(1990-7#5)(1990-8#4)(1990-9#2)(1991-1#7)(1991-10#6)(1991-11#1)(1991-12#9)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#5)(1991-7#2)(1991-8#8)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#9)(1992-2#1)(1992-3#9)(1992-4#1)(1992-5#2)(1992-6#12)(1992-7#5)(1992-8#8)(1992-9#2)(1993-1#1)(1993-11#11)(1993-2#2)(1993-3#5)(1993-4#4)(1993-5#1)(1993-6#4)(1993-7#4)(1993-9#2)(1994-10#1)(1994-11#7)(1994-12#4)(1994-2#4)(1994-3#4)(1994-5#3)(1994-6#5)(1994-8#9)(1994-9#7)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#5)(1995-2#3)(1995-3#4)(1995-5#3)(1995-6#3)(1995-7#3)(1995-8#4)(1996-1#3)(1996-10#1)(1996-11#3)(1996-12#4)(1996-2#6)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#2)(1996-7#5)(1996-8#3)(1996-9#2)(1997-1#4)(1997-2#2)(1997-4#12)(1997-5#2)(1997-6#6)(1997-7#1)(1997-8#6)(2004-1#1)(2004-11#1)(2004-12#1)(2004-9#2)(2005-10#1)(2005-11#6)(2005-12#2)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#17)(2006-12#3)(2006-3#4)(2006-4#2)(2006-5#1)(2006-8#3)(2007-1#1)(2007-10#3)(2007-12#6)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#7)(2008-1#6)(2008-10#72)(2008-11#20)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#39)(2008-5#28)(2008-6#4)(2008-7#12)(2008-8#3)(2008-9#2)(2009-10#4)(2009-12#3)(2009-3#2)(2009-4#6)(2009-7#1)(2009-8#7)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#5)(2010-4#2)(2010-5#1)(2010-6#3)(2010-8#8)(2010-9#3)(2011-1#9)(2011-10#1)(2011-12#5)(2011-2#14)(2011-3#1)(2012-11#6)(2012-12#5)(2012-2#4)(2012-4#1)(2013-1#9)(2013-7#4)(2013-8#3)
releaser##2##1##(2008-10#1)(2008-7#1)
releasers##3##1##(1995-2#1)(2008-10#1)(2010-7#1)
releases Ca2+ from##2##3##(1993-6#1)(1997-5#1)
releases a##3##2##(1995-1#1)(1996-7#1)(2009-2#1)
releases calcium##2##2##(1992-7#1)(2007-9#1)
releases dopamine##2##2##(1992-7#1)(1996-8#1)
releases from##5##2##(1990-9#1)(1996-6#1)(2007-2#1)(2008-2#1)(2012-2#1)
releases of##10##2##(1990-11#1)(1993-9#1)(1997-5#2)(2006-10#1)(2008-10#2)(2008-4#1)(2008-7#1)(2011-12#1)
releases the##5##2##(1993-10#1)(1996-8#1)(1997-4#1)(2008-10#1)(2008-9#1)
releases##82##1##(1990-11#2)(1990-2#1)(1990-4#1)(1990-9#2)(1991-6#1)(1992-6#1)(1992-7#3)(1993-10#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#1)(1995-1#1)(1995-8#4)(1996-2#2)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#3)(2004-1#1)(2005-7#1)(2006-10#3)(2007-12#3)(2007-2#2)(2007-9#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-4#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-12#3)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
releasing a##3##2##(1990-10#1)(1994-2#1)(2012-2#1)
releasing activity in##3##3##(1990-12#1)(1992-3#2)
releasing activity##5##2##(1990-12#2)(1992-3#2)(1996-4#1)
releasing agent##2##2##(1994-2#1)(2008-10#1)
releasing factor##7##2##(1990-12#1)(1992-12#1)(1996-8#2)(1997-8#1)(2010-4#2)
releasing factors##2##2##(1995-12#1)(2006-10#1)
releasing hormone (CRH)##5##3##(1992-6#1)(1996-3#1)(2006-1#1)(2008-4#1)(2010-3#1)
releasing hormone (GnRH)##4##3##(1990-3#1)(1992-11#1)(1992-6#1)(2006-1#1)
releasing hormone in##2##3##(1992-8#1)(1995-12#1)
releasing hormone##39##2##(1990-12#2)(1990-3#1)(1991-3#4)(1991-4#1)(1992-11#2)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-3#2)(2005-8#1)(2006-1#4)(2007-11#3)(2007-7#3)(2008-1#1)(2008-4#2)(2010-3#2)
releasing hormones##7##2##(1994-3#3)(1994-5#1)(1994-9#2)(2012-1#1)
releasing of##4##2##(2008-10#2)(2009-8#1)(2013-1#1)
releasing products##2##2##(2006-8#1)(2008-5#1)
releasing the##12##2##(1990-3#1)(1994-11#1)(1994-3#1)(1995-6#1)(1996-7#1)(2006-6#1)(2007-7#1)(2008-11#1)(2008-4#1)(2010-11#1)(2011-1#1)(2011-2#1)
releasing##156##1##(1990-10#1)(1990-12#5)(1990-3#2)(1990-4#1)(1990-7#1)(1991-12#1)(1991-3#4)(1991-4#3)(1992-11#2)(1992-12#2)(1992-3#2)(1992-6#4)(1992-7#2)(1992-8#2)(1992-9#3)(1994-1#1)(1994-10#1)(1994-11#1)(1994-2#3)(1994-3#5)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#2)(1995-5#1)(1995-6#2)(1996-11#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#2)(1997-4#2)(1997-7#1)(1997-8#1)(2004-3#1)(2005-8#1)(2006-1#4)(2006-10#4)(2006-6#1)(2006-8#2)(2007-11#4)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#4)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#9)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-6#3)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#3)
relegate##3##1##(2008-11#1)(2008-5#1)(2013-1#1)
relegated to a##2##3##(1994-2#1)(2010-2#1)
relegated to##6##2##(1992-2#1)(1994-2#1)(2006-4#1)(2008-5#1)(2010-2#1)(2012-12#1)
relegated##9##1##(1991-6#1)(1992-2#1)(1994-2#1)(2006-4#1)(2008-12#1)(2008-5#1)(2010-2#1)(2012-12#1)(2012-2#1)
relentless##6##1##(1994-2#1)(1995-2#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-1#1)
relentlessly##3##1##(2007-6#1)(2008-1#1)(2012-3#1)
relevance and significance of##2##4##(1991-2#1)(2011-2#1)
relevance and##14##2##(1991-2#1)(1995-2#1)(1997-3#1)(2006-1#1)(2006-12#1)(2007-2#2)(2008-2#1)(2008-9#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
relevance are##2##2##(1994-11#1)(1995-6#1)
relevance as##5##2##(2007-10#1)(2009-2#1)(2011-2#1)(2013-1#2)
relevance for clinical##2##3##(2005-11#1)(2012-12#1)
relevance for the##11##3##(1992-12#1)(1993-12#1)(1994-2#1)(1994-8#1)(1995-5#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-11#1)(2012-12#1)(2013-1#1)
relevance for understanding##2##3##(1996-2#1)(2009-2#1)
relevance for##38##2##(1992-12#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-6#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#1)
relevance in the##7##3##(1990-5#1)(1991-1#1)(1995-3#1)(2005-7#1)(2007-11#1)(2008-10#1)(2012-12#1)
relevance in##30##2##(1990-5#1)(1990-8#2)(1991-1#1)(1991-6#1)(1993-9#1)(1995-3#1)(2005-7#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-1#1)(2010-7#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#1)
relevance is##5##2##(1991-3#1)(2005-10#1)(2006-2#1)(2008-12#1)(2013-1#1)
relevance of a##3##3##(2006-10#1)(2008-10#1)(2008-8#1)
relevance of apoptosis in##2##4##(2003-11#2)
relevance of each##2##3##(2006-10#1)(2012-3#1)
relevance of low##2##3##(1990-3#1)(2008-7#1)
relevance of such##5##3##(1992-12#1)(1992-3#1)(1993-12#1)(1997-3#1)(2008-8#1)
relevance of the data##2##4##(2008-10#1)(2008-3#1)
relevance of the finding##2##4##(1991-4#1)(2010-12#1)
relevance of the methodology##3##4##(2008-9#1)(2012-12#2)
relevance of the results##3##4##(1997-3#1)(2007-9#1)(2008-5#1)
relevance of the specific##2##4##(2007-12#1)(2008-9#1)
relevance of the##48##3##(1991-2#2)(1991-4#1)(1991-9#1)(1994-11#1)(1994-3#2)(1995-11#1)(1995-8#1)(1997-1#1)(1997-3#1)(2007-1#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#3)(2013-1#4)
relevance of their##2##3##(1995-3#1)(2013-8#1)
relevance of these findings##4##4##(1994-11#1)(2007-12#1)(2008-10#2)
relevance of these observations to##2##5##(1990-9#1)(2008-7#1)
relevance of these observations##3##4##(1990-9#1)(1994-6#1)(2008-7#1)
relevance of these results is##2##5##(1995-2#1)(2006-9#1)
relevance of these results to##2##5##(1995-3#1)(2008-10#1)
relevance of these results##6##4##(1993-11#1)(1995-2#1)(1995-3#1)(2006-9#1)(2008-10#1)(2009-8#1)
relevance of these##31##3##(1990-2#1)(1990-9#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-6#2)(1995-1#1)(1995-2#1)(1995-3#1)(1997-1#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-7#2)(2009-6#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-4#1)(2013-1#1)(2013-8#1)
relevance of this interaction in##2##5##(1996-10#1)(2008-9#1)
relevance of this phenomenon##2##4##(1990-12#1)(2012-3#1)
relevance of this##26##3##(1990-12#1)(1990-2#2)(1992-12#1)(1992-5#1)(1993-12#1)(1994-6#1)(1995-4#1)(1995-9#1)(1996-10#1)(1997-2#1)(2006-10#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-12#2)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-3#1)
relevance of using##2##3##(2008-1#1)(2008-3#1)
relevance of##220##2##(1990-12#2)(1990-2#3)(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#3)(1991-4#1)(1991-9#2)(1992-10#1)(1992-12#3)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1994-11#3)(1994-12#1)(1994-3#3)(1994-6#3)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#3)(1995-3#3)(1995-4#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#1)(2003-11#2)(2004-12#4)(2005-10#1)(2005-3#1)(2005-7#1)(2006-10#5)(2006-11#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-9#2)(2007-1#1)(2007-12#5)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#7)(2008-10#13)(2008-11#1)(2008-12#3)(2008-2#4)(2008-3#6)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#9)(2008-8#6)(2008-9#4)(2009-10#2)(2009-12#2)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#6)(2010-2#2)(2010-3#1)(2010-5#2)(2010-7#2)(2010-8#3)(2011-1#5)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#5)(2012-4#1)(2013-1#6)(2013-7#1)(2013-8#3)
relevance since##2##2##(1990-6#1)(2008-10#1)
relevance to clinical practice##2##4##(2005-11#1)(2008-1#1)
relevance to clinical##4##3##(2005-11#1)(2007-7#1)(2008-1#1)(2012-8#1)
relevance to human##2##3##(2007-11#1)(2008-4#1)
relevance to patients##2##3##(1991-5#1)(2007-7#1)
relevance to protein##2##3##(2007-11#1)(2008-9#1)
relevance to the pathogenesis of##2##5##(2007-12#1)(2008-7#1)
relevance to the use of##3##5##(1993-12#1)(2005-8#1)(2008-2#1)
relevance to the##33##3##(1991-5#1)(1992-12#1)(1993-12#1)(1993-8#1)(1994-8#2)(1995-1#1)(1996-7#1)(2005-7#1)(2005-8#1)(2006-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
relevance to those##2##3##(1993-2#1)(2007-4#1)
relevance to understanding the##2##4##(2007-5#1)(2008-1#1)
relevance to##103##2##(1990-5#1)(1991-5#2)(1991-7#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-8#1)(1996-10#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-3#1)(2006-4#1)(2006-5#1)(2007-11#3)(2007-12#3)(2007-4#2)(2007-5#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#5)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#3)(2012-2#3)(2012-3#1)(2012-8#1)(2013-1#2)(2013-7#1)(2013-8#1)
relevance when##2##2##(2005-11#1)(2007-10#1)
relevance##506##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#4)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#5)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#2)(1991-9#2)(1992-10#1)(1992-12#5)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#4)(1993-2#3)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#3)(1994-8#4)(1995-1#2)(1995-11#2)(1995-2#5)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#2)(1996-1#3)(1996-10#2)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#1)(1997-1#6)(1997-2#3)(1997-3#5)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2003-11#2)(2004-12#5)(2005-10#5)(2005-11#3)(2005-3#1)(2005-7#4)(2005-8#3)(2006-1#1)(2006-10#17)(2006-11#2)(2006-12#1)(2006-2#2)(2006-3#2)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#8)(2007-12#10)(2007-2#3)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#6)(2007-8#4)(2007-9#4)(2008-1#15)(2008-10#20)(2008-11#9)(2008-12#7)(2008-2#6)(2008-3#10)(2008-4#11)(2008-5#9)(2008-6#3)(2008-7#15)(2008-8#10)(2008-9#12)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#4)(2009-6#4)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#9)(2010-2#4)(2010-3#4)(2010-5#3)(2010-6#3)(2010-7#4)(2010-8#5)(2011-1#11)(2011-12#2)(2011-2#12)(2012-1#3)(2012-11#1)(2012-12#15)(2012-2#7)(2012-3#11)(2012-4#1)(2012-8#1)(2013-1#14)(2013-7#3)(2013-8#8)
relevance]##2##1##(1992-3#1)(1997-2#1)
relevancy of this##2##3##(1996-1#1)(2012-2#1)
relevancy of##3##2##(1990-12#1)(1996-1#1)(2012-2#1)
relevancy##7##1##(1990-12#1)(1996-1#1)(2007-5#1)(2008-5#1)(2012-12#2)(2012-2#1)
relevant abstracts##2##2##(2008-8#1)(2013-1#1)
relevant adverse##2##2##(2008-8#1)(2010-12#1)
relevant analytical parameters##2##3##(2008-10#2)
relevant anatomical##4##2##(2006-7#1)(2010-7#1)(2013-1#2)
relevant anatomy##4##2##(2006-8#1)(2009-5#1)(2011-2#1)(2013-8#1)
relevant and irrelevant##2##3##(1991-12#1)(2008-7#1)
relevant and should##2##3##(2008-11#1)(2008-5#1)
relevant and##25##2##(1991-1#1)(1991-12#1)(1993-3#1)(2005-8#1)(2005-9#1)(2006-10#2)(2007-12#1)(2007-2#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-4#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-8#1)
relevant animal models##3##3##(2005-8#1)(2007-12#1)(2008-7#1)
relevant animal##6##2##(1992-4#1)(2005-10#1)(2005-8#1)(2007-12#1)(2008-7#1)(2009-7#1)
relevant answers##2##2##(2007-6#1)(2008-7#1)
relevant applications in##2##3##(2008-10#2)
relevant applications##5##2##(2008-10#4)(2013-1#1)
relevant articles concerning##2##3##(2008-3#1)(2012-12#1)
relevant articles on##2##3##(2004-3#1)(2010-12#1)
relevant articles were##2##3##(2007-8#1)(2008-7#1)
relevant articles##14##2##(1994-3#1)(2004-3#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
relevant as##4##2##(1991-6#1)(2005-8#1)(2006-12#1)(2007-11#1)
relevant aspects##3##2##(2008-4#1)(2009-2#1)(2010-9#1)
relevant available standards were identified##2##5##(2013-1#2)
relevant available##3##2##(2010-11#1)(2013-1#2)
relevant because of##3##3##(2007-8#1)(2010-7#1)(2012-2#1)
relevant because##4##2##(1991-6#1)(2007-8#1)(2010-7#1)(2012-2#1)
relevant binding##2##2##(2008-3#1)(2011-1#1)
relevant biochemical##2##2##(2007-9#1)(2009-10#1)
relevant case reports##2##3##(2008-10#1)(2009-5#1)
relevant case##3##2##(1992-1#1)(2008-10#1)(2009-5#1)
relevant changes in##2##3##(1990-5#1)(1991-6#1)
relevant clinical information##2##3##(2007-12#1)(2011-1#1)
relevant clinical##12##2##(1991-12#1)(1992-4#1)(1992-5#1)(2005-10#1)(2007-12#1)(2008-1#1)(2009-11#1)(2009-2#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-2#1)
relevant colonic##2##2##(1991-6#2)
relevant complication##2##2##(2007-8#1)(2009-1#1)
relevant complications##3##2##(2008-7#1)(2008-8#1)(2013-1#1)
relevant concentration##2##2##(1995-2#1)(2008-11#1)
relevant concentrations of##5##3##(1992-5#1)(1993-2#1)(1993-8#1)(2005-12#1)(2012-12#1)
relevant concentrations##8##2##(1992-11#1)(1992-5#1)(1993-2#1)(1993-8#2)(1995-2#1)(2005-12#1)(2012-12#1)
relevant conditions##3##2##(1995-2#1)(2011-2#1)(2012-12#1)
relevant control measures##2##3##(1991-9#1)(2008-12#1)
relevant covariates##4##2##(1995-4#2)(2012-12#1)(2013-1#1)
relevant criteria##2##2##(2005-5#1)(2007-11#1)
relevant data about##2##3##(1994-6#1)(2008-1#1)
relevant data##18##2##(1990-3#1)(1994-6#2)(1996-12#1)(1997-7#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-2#3)(2011-1#1)(2012-1#1)(2013-1#1)
relevant databases##2##2##(2008-7#1)(2011-2#1)
relevant devices##2##2##(2004-9#1)(2007-12#1)
relevant diagnostic##2##2##(1996-3#1)(2013-1#1)
relevant difference##3##2##(2004-1#1)(2012-1#1)(2012-2#1)
relevant differences in##2##3##(2012-2#1)(2013-7#1)
relevant differences##3##2##(1994-12#1)(2012-2#1)(2013-7#1)
relevant differential##2##2##(1995-6#1)(2008-7#1)
relevant disease##4##2##(2010-11#4)
relevant diseases##2##2##(2005-10#1)(2008-4#1)
relevant documents##3##2##(2008-1#1)(2013-1#2)
relevant domains##2##2##(2007-2#1)(2009-3#1)
relevant dose##2##2##(2008-10#1)(2008-3#1)
relevant doses of##5##3##(1997-8#2)(2008-10#1)(2008-5#1)(2012-3#1)
relevant doses##7##2##(1996-4#1)(1997-8#2)(2008-10#2)(2008-5#1)(2012-3#1)
relevant drugs##2##2##(1996-8#1)(2005-7#1)
relevant effect on the##2##4##(2008-8#1)(2012-1#1)
relevant effect on##3##3##(2008-8#1)(2011-2#1)(2012-1#1)
relevant effect##4##2##(2005-11#1)(2008-8#1)(2011-2#1)(2012-1#1)
relevant elements##2##2##(2008-3#1)(2012-12#1)
relevant endpoints##4##2##(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#1)
relevant environmental##2##2##(2008-10#1)(2011-2#1)
relevant enzymatic##2##2##(2009-11#1)(2010-7#1)
relevant epidemiological##2##2##(1990-5#1)(2004-7#1)
relevant evidence##4##2##(2007-8#1)(2011-2#2)(2012-1#1)
relevant examples of##2##3##(2005-10#1)(2008-11#1)
relevant examples##4##2##(2005-10#1)(2006-10#1)(2008-11#1)(2012-1#1)
relevant factor##2##2##(1995-12#1)(2012-12#1)
relevant factors##5##2##(1996-1#1)(2006-6#1)(2008-10#1)(2008-11#1)(2012-12#1)
relevant features of the##2##4##(1990-11#1)(2012-1#1)
relevant features##3##2##(1990-11#1)(2008-10#1)(2012-1#1)
relevant findings##7##2##(1994-4#1)(2008-7#1)(2011-1#1)(2011-2#3)(2012-2#1)
relevant for a##2##3##(2008-4#1)(2011-2#1)
relevant for further##2##3##(2012-1#1)(2013-1#1)
relevant for the assessment of##2##5##(2008-5#1)(2008-7#1)
relevant for the design of##3##5##(2007-1#1)(2008-3#1)(2012-2#1)
relevant for the##23##3##(1991-1#1)(1993-11#1)(1995-1#1)(1996-5#1)(2006-6#1)(2007-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-9#1)(2012-2#3)
relevant for##73##2##(1991-1#1)(1992-5#1)(1993-11#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-5#3)(1996-5#2)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-12#1)(2006-6#2)(2007-1#2)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#4)(2008-7#4)(2008-8#1)(2009-10#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-3#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#1)
relevant from##2##2##(2008-5#1)(2012-3#1)
relevant fungi##3##2##(2008-11#2)(2008-5#1)
relevant genes in##3##3##(1995-11#1)(2012-1#1)(2012-12#1)
relevant genes##7##2##(1991-9#1)(1995-11#1)(2005-8#1)(2008-7#1)(2009-12#1)(2012-1#1)(2012-12#1)
relevant genetic##2##2##(2007-3#1)(2008-11#1)
relevant health##2##2##(2010-9#2)
relevant human##2##2##(2008-7#1)(2008-9#1)
relevant hypotheses##2##2##(1992-3#1)(2008-10#1)
relevant in a##2##3##(1994-3#1)(1994-8#1)
relevant in the##10##3##(1993-2#2)(2006-10#2)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)
relevant in##32##2##(1990-4#1)(1990-9#1)(1993-2#2)(1993-6#1)(1994-3#1)(1994-8#1)(1996-5#1)(1996-7#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-11#1)(2010-6#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
relevant indicators of##2##3##(1996-3#1)(2010-8#1)
relevant information about##2##3##(1997-3#1)(2010-7#1)
relevant information and##2##3##(1993-12#1)(2012-12#1)
relevant information for##3##3##(2006-9#1)(2007-4#1)(2013-8#1)
relevant information from the##2##4##(2008-4#1)(2008-6#1)
relevant information from##4##3##(2008-4#1)(2008-6#1)(2013-1#2)
relevant information in##3##3##(1993-2#1)(2006-6#1)(2008-12#1)
relevant information on the##3##4##(1997-6#1)(2008-7#1)(2013-1#1)
relevant information on##4##3##(1997-6#1)(2008-7#1)(2010-4#1)(2013-1#1)
relevant information to##2##3##(2008-11#1)(2012-3#1)
relevant information##42##2##(1993-12#1)(1993-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-4#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#5)(2009-9#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#5)(2013-8#1)
relevant intracellular compounds##2##3##(2007-6#2)
relevant issue##2##2##(1994-6#1)(2011-2#1)
relevant issues##5##2##(1994-6#1)(1996-2#1)(1997-2#1)(2006-10#1)(2012-3#1)
relevant knowledge##5##2##(1992-1#1)(1996-3#1)(2012-3#1)(2013-1#2)
relevant laboratory##2##2##(1991-4#1)(2008-10#1)
relevant laws##3##2##(2006-8#1)(2007-2#1)(2012-3#1)
relevant levels##4##2##(1997-1#1)(2008-10#2)(2008-11#1)
relevant literature is discussed##2##4##(2010-3#1)(2013-1#1)
relevant literature is##5##3##(1997-5#1)(2005-8#1)(2007-4#1)(2010-3#1)(2013-1#1)
relevant literature on this##3##4##(2007-7#1)(2007-8#1)(2012-2#1)
relevant literature on##5##3##(2007-5#1)(2007-7#1)(2007-8#1)(2012-12#1)(2012-2#1)
relevant literature##40##2##(1992-3#1)(1994-12#1)(1997-5#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
relevant literatures##3##2##(1990-12#1)(2007-7#1)(2010-6#1)
relevant macromolecules##3##2##(1993-3#1)(2008-12#1)(2008-7#1)
relevant manner##4##2##(1990-8#1)(1992-12#1)(1994-8#1)(2008-1#1)
relevant markers##2##2##(2008-7#1)(2008-9#1)
relevant material##2##2##(2006-6#1)(2010-8#1)
relevant measures##2##2##(1997-5#1)(2007-10#1)
relevant medical##3##2##(2007-12#1)(2012-2#2)
relevant metabolites##2##2##(2006-6#1)(2010-7#1)
relevant metal##2##2##(1994-8#1)(2010-5#1)
relevant method##3##2##(2008-5#1)(2012-1#1)(2012-12#1)
relevant model for##4##3##(1996-2#1)(2008-4#1)(2009-12#1)(2012-3#1)
relevant model##5##2##(1996-2#1)(2005-8#1)(2008-4#1)(2009-12#1)(2012-3#1)
relevant molecular##2##2##(1993-12#1)(2012-2#1)
relevant molecules##2##2##(2008-3#1)(2008-4#1)
relevant new##2##2##(2008-9#1)(2009-8#1)
relevant optical##2##2##(2008-2#2)
relevant or##3##2##(2006-6#2)(2008-5#1)
relevant outcomes and weaknesses were tabulated##6##6##(2007-8#6)
relevant outcomes and##7##3##(2007-8#7)
relevant outcomes##63##2##(2006-2#2)(2007-8#61)
relevant papers##5##2##(2007-8#3)(2008-7#1)(2012-12#1)
relevant parameters for the##2##4##(2007-1#1)(2008-11#1)
relevant parameters for##3##3##(2007-1#1)(2008-11#1)(2008-3#1)
relevant parameters such as##2##4##(2008-10#1)(2008-2#1)
relevant parameters##12##2##(1997-1#1)(2007-1#1)(2007-2#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#2)
relevant part##3##2##(2008-10#1)(2008-7#1)(2012-8#1)
relevant peptide##2##2##(1991-2#1)(2006-12#1)
relevant personality##5##2##(2006-6#4)(2009-8#1)
relevant phenomena##2##2##(2006-3#1)(2008-6#1)
relevant population##2##2##(2008-9#1)(2011-2#1)
relevant pressure##2##2##(2008-7#1)(2010-4#1)
relevant problem##2##2##(2006-2#1)(2008-9#1)
relevant properties of the##2##4##(1994-11#1)(2004-9#1)
relevant proteins##3##2##(2008-1#1)(2008-4#1)(2010-7#1)
relevant provisions##2##2##(1994-3#1)(2008-5#1)
relevant publications##4##2##(2006-2#1)(2008-12#1)(2008-8#1)(2008-9#1)
relevant randomised controlled##2##3##(1993-12#1)(2007-11#1)
relevant research on the##2##4##(1995-2#1)(2007-2#1)
relevant research on##3##3##(1995-2#1)(2007-2#1)(2009-11#1)
relevant research##10##2##(1995-2#1)(2005-7#1)(2007-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-4#1)(2012-12#1)
relevant results##2##2##(1997-4#1)(2010-8#1)
relevant risk factors##3##3##(2013-1#3)
relevant risk##6##2##(2005-12#1)(2008-1#1)(2011-2#1)(2013-1#3)
relevant role in##7##3##(1993-9#1)(1996-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2009-8#1)(2011-2#1)
relevant role of##2##3##(2008-4#1)(2013-7#1)
relevant role##10##2##(1992-9#1)(1993-9#1)(1996-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-8#1)(2011-2#1)(2013-7#1)
relevant roles##2##2##(2007-12#1)(2007-5#1)
relevant samples##2##2##(2006-8#1)(2008-4#1)
relevant scientific data##2##3##(2006-8#2)
relevant scientific##4##2##(1990-10#1)(2006-8#2)(2011-2#1)
relevant species##2##2##(2008-3#1)(2013-7#1)
relevant stimuli##2##2##(1993-6#1)(2008-7#1)
relevant studies and##2##3##(2005-10#1)(2010-12#1)
relevant studies were identified and##2##5##(2008-10#1)(2012-12#1)
relevant studies were identified##3##4##(2008-10#1)(2012-12#1)(2013-1#1)
relevant studies were##4##3##(2008-10#1)(2009-11#1)(2012-12#1)(2013-1#1)
relevant studies##20##2##(1993-6#1)(2005-10#1)(2008-10#3)(2008-12#1)(2009-11#1)(2009-2#2)(2010-12#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2013-1#3)
relevant system##2##2##(2008-2#1)(2008-3#1)
relevant target##3##2##(2006-12#1)(2011-2#1)(2012-3#1)
relevant targets##2##2##(2010-5#1)(2011-2#1)
relevant techniques##2##2##(2006-10#1)(2008-11#1)
relevant temporal##2##2##(2009-8#1)(2013-7#1)
relevant test##2##2##(2008-4#2)
relevant thermodynamic##3##2##(1990-8#1)(1996-11#1)(2009-11#1)
relevant tissue##2##2##(2007-11#1)(2008-1#1)
relevant to a##4##3##(1992-3#1)(1996-2#1)(2008-4#2)
relevant to all##6##3##(2007-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#1)
relevant to both##3##3##(1996-3#1)(2008-10#1)(2008-12#1)
relevant to control##2##3##(2007-5#1)(2010-4#1)
relevant to daily life##2##4##(1996-3#1)(2010-12#1)
relevant to diabetes##2##3##(2008-1#1)(2009-5#1)
relevant to health##2##3##(2005-10#1)(2011-2#1)
relevant to human##2##3##(1997-8#1)(2013-8#1)
relevant to its##4##3##(1991-12#1)(1993-3#1)(2008-2#1)(2012-2#1)
relevant to male##2##3##(1995-5#1)(2012-2#1)
relevant to medical##3##3##(2008-12#1)(2008-3#1)(2011-2#1)
relevant to oral and maxillofacial##2##5##(2007-12#2)
relevant to other##5##3##(1991-10#1)(1995-3#1)(2007-11#1)(2008-5#1)(2012-2#1)
relevant to public##2##3##(2008-10#1)(2008-7#1)
relevant to the design of##3##5##(1994-8#1)(1995-7#1)(2012-1#1)
relevant to the design##4##4##(1994-8#1)(1995-7#1)(2008-3#1)(2012-1#1)
relevant to the function##2##4##(1991-6#1)(2006-10#1)
relevant to the immune system##3##5##(2008-10#3)
relevant to the management of##2##5##(1996-12#1)(2009-6#1)
relevant to the pathogenesis of##2##5##(1991-8#1)(2008-7#1)
relevant to the study of##2##5##(2007-4#1)(2009-9#1)
relevant to the study##3##4##(2007-4#1)(2008-5#1)(2009-9#1)
relevant to the treatment of##2##5##(2008-3#1)(2012-12#1)
relevant to the understanding of##2##5##(2008-2#1)(2008-7#1)
relevant to the use of##2##5##(2006-10#1)(2008-10#1)
relevant to the##76##3##(1990-2#1)(1990-7#1)(1991-10#1)(1991-6#1)(1991-8#1)(1992-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-8#1)(1995-12#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-7#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#3)(2006-2#1)(2006-8#2)(2006-9#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-5#3)(2008-7#4)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)
relevant to their##7##3##(1992-1#1)(1992-3#1)(1995-2#1)(2008-12#1)(2008-2#1)(2013-8#2)
relevant to these##3##3##(1994-5#1)(2008-9#1)(2012-1#1)
relevant to this##3##3##(1997-1#1)(1997-7#1)(2005-9#1)
relevant to##259##2##(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#2)(1992-3#3)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#3)(1996-3#3)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#2)(1997-7#3)(1997-8#1)(2004-1#1)(2004-3#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#3)(2005-8#1)(2005-9#1)(2006-10#5)(2006-2#1)(2006-3#1)(2006-8#4)(2006-9#2)(2007-10#1)(2007-11#5)(2007-12#8)(2007-2#1)(2007-3#2)(2007-4#3)(2007-5#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#5)(2008-12#5)(2008-2#10)(2008-3#10)(2008-4#4)(2008-5#4)(2008-6#4)(2008-7#9)(2008-8#3)(2008-9#3)(2009-10#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#4)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#3)(2009-9#5)(2010-10#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#3)(2011-10#1)(2011-12#1)(2011-2#6)(2012-1#4)(2012-12#2)(2012-2#7)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#4)
relevant treatment##3##2##(1993-9#1)(2007-11#1)(2008-7#1)
relevant variables##5##2##(2005-10#1)(2007-8#1)(2008-10#2)(2008-8#1)
relevant when##2##2##(1996-12#1)(2006-11#1)
relevant##1424##1##(1990-10#2)(1990-11#1)(1990-12#4)(1990-2#2)(1990-3#2)(1990-4#3)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#6)(1990-9#2)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#6)(1991-2#4)(1991-4#2)(1991-5#2)(1991-6#6)(1991-8#3)(1991-9#2)(1992-1#4)(1992-11#3)(1992-12#6)(1992-2#2)(1992-3#5)(1992-4#4)(1992-5#3)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#4)(1993-2#8)(1993-3#7)(1993-4#2)(1993-5#3)(1993-6#3)(1993-8#4)(1993-9#5)(1994-11#3)(1994-12#5)(1994-2#3)(1994-3#6)(1994-4#2)(1994-5#2)(1994-6#6)(1994-7#1)(1994-8#6)(1994-9#1)(1995-1#4)(1995-10#2)(1995-11#1)(1995-12#8)(1995-2#9)(1995-3#1)(1995-4#2)(1995-5#7)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#4)(1996-10#2)(1996-11#3)(1996-12#4)(1996-2#5)(1996-3#9)(1996-4#3)(1996-5#5)(1996-6#1)(1996-7#3)(1996-8#3)(1997-1#10)(1997-2#3)(1997-3#2)(1997-4#3)(1997-5#3)(1997-6#1)(1997-7#5)(1997-8#8)(2004-1#4)(2004-3#3)(2004-7#2)(2004-9#2)(2005-10#9)(2005-11#3)(2005-12#3)(2005-5#2)(2005-7#6)(2005-8#8)(2005-9#2)(2006-1#1)(2006-10#30)(2006-11#6)(2006-12#8)(2006-2#8)(2006-3#2)(2006-4#2)(2006-5#1)(2006-6#13)(2006-7#1)(2006-8#14)(2006-9#6)(2007-1#5)(2007-10#6)(2007-11#23)(2007-12#30)(2007-2#7)(2007-3#5)(2007-4#12)(2007-5#6)(2007-6#6)(2007-7#13)(2007-8#80)(2007-9#6)(2008-1#17)(2008-10#80)(2008-11#35)(2008-12#16)(2008-2#27)(2008-3#43)(2008-4#31)(2008-5#31)(2008-6#9)(2008-7#59)(2008-8#27)(2008-9#13)(2009-1#2)(2009-10#7)(2009-11#9)(2009-12#6)(2009-2#11)(2009-3#7)(2009-4#9)(2009-5#12)(2009-6#5)(2009-7#5)(2009-8#10)(2009-9#7)(2010-1#1)(2010-10#3)(2010-11#9)(2010-12#12)(2010-2#2)(2010-3#7)(2010-4#6)(2010-5#5)(2010-6#8)(2010-7#9)(2010-8#8)(2010-9#8)(2011-1#19)(2011-10#1)(2011-12#3)(2011-2#48)(2011-8#1)(2012-1#18)(2012-11#1)(2012-12#24)(2012-2#33)(2012-3#20)(2012-5#1)(2012-8#2)(2013-1#61)(2013-7#7)(2013-8#16)
relevant)##3##1##(2007-1#1)(2008-10#1)(2009-3#1)
relevant?##4##1##(2005-10#1)(2009-11#1)(2009-9#1)(2011-2#1)
relevantly##3##1##(2007-8#1)(2012-11#1)(2013-8#1)
reliabilities for##2##2##(2007-12#1)(2010-4#1)
reliabilities##5##1##(1995-11#1)(2007-12#2)(2010-4#1)(2012-2#1)
reliability analysis##3##2##(2009-1#1)(2010-10#1)(2010-8#1)
reliability and accuracy##3##3##(2006-4#1)(2008-10#1)(2010-12#1)
reliability and construct validity##3##4##(2007-12#1)(2011-1#1)(2012-1#1)
reliability and reproducibility##3##3##(2006-7#1)(2007-7#1)(2010-11#1)
reliability and stability of##3##4##(1992-12#1)(1996-5#1)(2012-3#1)
reliability and the##4##3##(1991-2#1)(2006-10#1)(2010-12#1)(2011-2#1)
reliability and validity of a##2##5##(1997-5#1)(2004-10#1)
reliability and validity of the##10##5##(1993-3#1)(2006-12#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-6#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#1)
reliability and validity of##19##4##(1992-3#1)(1993-11#1)(1993-3#1)(1997-5#1)(2004-10#1)(2006-12#2)(2007-10#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-9#1)(2010-10#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)
reliability and validity##29##3##(1992-3#1)(1993-11#1)(1993-3#1)(1996-3#1)(1997-5#1)(2004-10#1)(2005-4#1)(2006-12#2)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-12#2)(2008-6#1)(2008-7#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
reliability and##72##2##(1990-5#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-3#1)(1996-3#1)(1996-5#1)(1996-8#2)(1997-5#1)(2004-10#1)(2005-4#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#4)(2009-4#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2011-1#5)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)
reliability are##3##2##(1995-2#1)(2006-9#1)(2012-2#1)
reliability as##2##2##(1993-9#1)(2008-9#1)
reliability assessment##4##2##(2006-6#1)(2007-7#1)(2013-1#2)
reliability but##2##2##(2006-8#1)(2012-2#1)
reliability coefficient##2##2##(1992-9#1)(2007-12#1)
reliability evaluation##2##2##(2011-1#2)
reliability for the##4##3##(1996-3#1)(2010-6#1)(2013-1#2)
reliability for##14##2##(1996-3#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-7#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
reliability in the##3##3##(1991-6#1)(2007-4#1)(2007-7#1)
reliability in##16##2##(1991-6#1)(1996-7#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-7#4)(2010-12#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
reliability is##7##2##(1994-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-7#1)
reliability of 'specialized' physical therapists in##2##6##(1993-12#2)
reliability of 0##2##3##(2006-10#1)(2012-3#1)
reliability of Ti6Al4V modular##2##4##(2010-8#2)
reliability of Ti6Al4V##3##3##(2010-8#3)
reliability of a##16##3##(1991-12#1)(1992-12#1)(1993-12#1)(1994-3#1)(1995-11#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-8#1)(2010-12#1)(2010-9#1)(2012-1#1)
reliability of current##2##3##(2007-2#1)(2008-12#1)
reliability of its##2##3##(2007-12#1)(2009-1#1)
reliability of such##2##3##(1990-3#1)(2005-8#1)
reliability of the audit##2##4##(1993-1#2)
reliability of the data##2##4##(1994-6#1)(2007-1#1)
reliability of the determination was proved##3##6##(2008-10#3)
reliability of the developed method##4##5##(2008-10#4)
reliability of the developed##5##4##(2008-10#5)
reliability of the entire##3##4##(2007-11#1)(2008-10#2)
reliability of the marking process##2##5##(2008-11#2)
reliability of the method##9##4##(1992-2#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-7#1)
reliability of the new##2##4##(1990-9#1)(2007-7#1)
reliability of the process##2##4##(2006-12#1)(2008-6#1)
reliability of the results##2##4##(2008-5#1)(2011-2#1)
reliability of the scale##2##4##(2008-9#1)(2011-2#1)
reliability of the##94##3##(1990-5#1)(1990-9#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-7#1)(1993-1#2)(1993-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-7#3)(2007-9#2)(2008-10#26)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#3)(2012-2#1)(2013-8#4)
reliability of these methods##2##4##(2008-10#2)
reliability of these##6##3##(2008-10#3)(2008-3#1)(2008-4#1)(2012-12#1)
reliability of this##5##3##(1993-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2013-8#1)
reliability of two##2##3##(2007-12#1)(2007-3#1)
reliability of##216##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-1#3)(1993-12#6)(1993-2#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-10#1)(2004-11#2)(2005-10#2)(2005-11#1)(2005-5#1)(2005-8#2)(2006-1#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#10)(2007-2#3)(2007-3#2)(2007-5#1)(2007-7#3)(2007-9#2)(2008-10#43)(2008-11#6)(2008-12#7)(2008-2#2)(2008-3#9)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#3)(2009-11#1)(2009-6#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-1#4)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#6)
reliability on a##2##3##(2008-10#1)(2008-3#1)
reliability over##2##2##(2007-12#1)(2010-11#1)
reliability studies##2##2##(2009-7#1)(2013-1#1)
reliability study##3##2##(1996-7#1)(2006-5#1)(2010-12#1)
reliability testing of the##2##4##(2010-10#2)
reliability testing##5##2##(1996-3#1)(2010-10#3)(2011-1#1)
reliability to##2##2##(2006-3#1)(2008-2#1)
reliability was calculated##2##3##(2010-12#1)(2013-8#1)
reliability was tested by##2##4##(2008-10#2)
reliability was tested##3##3##(2008-10#2)(2010-10#1)
reliability was##17##2##(1996-5#1)(2004-10#1)(2004-11#1)(2006-8#1)(2007-3#1)(2007-8#1)(2008-10#5)(2010-10#1)(2010-12#3)(2013-1#1)(2013-8#1)
reliability were##2##2##(1996-7#1)(2004-8#1)
reliability when##2##2##(2008-12#1)(2012-1#1)
reliability##528##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#2)(1991-9#1)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#9)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-2#3)(1994-3#2)(1994-6#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#8)(1996-8#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#2)(2004-10#3)(2004-11#4)(2004-4#1)(2004-8#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-4#2)(2005-5#1)(2005-8#2)(2006-1#2)(2006-10#9)(2006-12#6)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#3)(2006-6#3)(2006-7#2)(2006-8#7)(2006-9#4)(2007-1#1)(2007-10#8)(2007-11#3)(2007-12#30)(2007-2#4)(2007-3#3)(2007-4#1)(2007-5#2)(2007-7#8)(2007-8#4)(2007-9#4)(2008-1#2)(2008-10#71)(2008-11#12)(2008-12#14)(2008-2#11)(2008-3#15)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#11)(2008-8#2)(2008-9#10)(2009-1#3)(2009-10#3)(2009-11#1)(2009-12#3)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#9)(2010-11#2)(2010-12#11)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#6)(2010-9#1)(2011-1#17)(2011-2#11)(2011-3#1)(2011-7#1)(2012-1#8)(2012-12#7)(2012-2#14)(2012-3#4)(2013-1#21)(2013-7#3)(2013-8#10)
reliability)##2##1##(2008-10#2)
reliable alternative to##4##3##(2006-10#2)(2007-12#1)(2008-9#1)
reliable alternative##7##2##(1993-8#1)(2005-8#1)(2006-10#2)(2007-12#1)(2007-7#1)(2008-9#1)
reliable analytical method##3##3##(2005-4#1)(2008-10#2)
reliable analytical methods##2##3##(2008-10#1)(2010-4#1)
reliable analytical procedures##2##3##(2008-10#1)(2010-11#1)
reliable analytical techniques##2##3##(2008-10#1)(2010-11#1)
reliable analytical##13##2##(1996-12#1)(2005-4#1)(2008-10#8)(2010-11#2)(2010-4#1)
reliable and accurate##3##3##(2007-11#1)(2007-5#1)(2011-2#1)
reliable and can##3##3##(2006-2#1)(2008-10#1)(2008-4#1)
reliable and consistent with##3##4##(2008-10#1)(2008-11#1)(2012-2#1)
reliable and easily##2##3##(1997-4#1)(2010-4#1)
reliable and easy to##2##4##(1990-8#1)(2008-10#1)
reliable and economical##2##3##(2006-6#1)(2013-1#1)
reliable and effective##6##3##(2006-10#1)(2006-2#1)(2008-11#1)(2008-4#1)(2008-9#1)(2012-3#1)
reliable and efficient##5##3##(1993-9#1)(1994-6#1)(2007-12#1)(2008-2#1)(2009-5#1)
reliable and powerful##2##3##(2008-8#1)(2013-1#1)
reliable and precise##2##3##(2007-8#1)(2008-3#1)
reliable and quick##2##3##(2008-10#1)(2010-6#1)
reliable and rapid##2##3##(2008-10#2)
reliable and repeatable##2##3##(2007-2#1)(2011-2#1)
reliable and reproducible##8##3##(1990-11#1)(2006-5#1)(2007-7#1)(2008-10#3)(2008-12#1)(2013-1#1)
reliable and robust##3##3##(1995-11#1)(2008-10#1)(2013-1#1)
reliable and safe##3##3##(2006-9#1)(2008-4#1)(2011-2#1)
reliable and sensitive##8##3##(1991-3#1)(1992-7#1)(1996-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)
reliable and specific##2##3##(2008-10#1)(2013-8#1)
reliable and stable##3##3##(2006-10#1)(2008-12#1)(2010-2#1)
reliable and suitable for##2##4##(2008-10#1)(2012-3#1)
reliable and valid##12##3##(1996-8#1)(1997-5#1)(2004-10#1)(2006-6#1)(2006-9#1)(2007-10#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-9#1)(2013-1#1)
reliable and versatile##2##3##(2007-12#1)(2009-9#1)
reliable and##122##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-7#1)(1993-9#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-4#1)(1996-11#1)(1996-12#2)(1996-8#1)(1997-4#1)(1997-5#1)(2004-10#1)(2005-10#1)(2006-10#6)(2006-2#2)(2006-3#1)(2006-5#1)(2006-6#2)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#26)(2008-11#2)(2008-12#6)(2008-2#3)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#6)(2013-8#2)
reliable as an##2##3##(2005-7#1)(2008-10#1)
reliable as##5##2##(1993-2#1)(1997-7#1)(2005-7#1)(2008-10#1)(2008-4#1)
reliable assay##3##2##(1994-3#1)(2008-10#1)(2008-7#1)
reliable assessment of##2##3##(2008-10#2)
reliable assessment##3##2##(2008-10#2)(2012-12#1)
reliable biological##2##2##(1994-3#1)(2008-10#1)
reliable but##2##2##(1996-3#1)(2012-1#1)
reliable cell##3##2##(1990-7#1)(1997-1#1)(2008-11#1)
reliable clinical##3##2##(1996-3#1)(2006-9#1)(2010-11#1)
reliable data for research##2##4##(2013-1#2)
reliable data for##3##3##(2008-6#1)(2013-1#2)
reliable data in the##3##4##(1993-9#1)(2008-2#1)(2008-3#1)
reliable data on the##4##4##(1996-6#1)(2005-10#1)(2008-1#1)(2008-4#1)
reliable data##17##2##(1991-10#1)(1993-9#1)(1996-6#1)(2005-10#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2012-2#1)(2013-1#3)
reliable detection methods##2##3##(2008-11#2)
reliable detection of##11##3##(1997-2#1)(2008-10#3)(2008-2#2)(2008-4#1)(2011-2#2)(2012-12#1)(2013-8#1)
reliable detection##14##2##(1997-2#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-4#1)(2011-2#2)(2012-12#1)(2013-8#1)
reliable determination of##3##3##(2008-10#2)(2008-9#1)
reliable diagnosis of##4##3##(1993-12#1)(2005-11#1)(2008-6#1)(2008-7#1)
reliable diagnosis##11##2##(1993-12#1)(1993-8#1)(2005-11#1)(2005-9#1)(2007-2#1)(2007-7#1)(2008-6#1)(2008-7#2)(2009-8#1)(2011-3#1)
reliable diagnostic test##2##3##(2007-2#1)(2011-1#1)
reliable diagnostic tool##2##3##(2006-7#1)(2011-1#1)
reliable diagnostic tools##2##3##(1996-6#1)(2010-10#1)
reliable diagnostic##15##2##(1992-3#1)(1993-11#1)(1996-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-10#1)(2011-1#2)(2012-3#1)
reliable estimate of##7##3##(1995-2#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)
reliable estimates of the##5##4##(1993-9#1)(2005-10#1)(2008-10#1)(2008-9#1)(2010-2#1)
reliable estimates of##7##3##(1992-9#1)(1993-9#1)(2005-10#2)(2008-10#1)(2008-9#1)(2010-2#1)
reliable estimates##9##2##(1992-9#1)(1993-9#1)(2005-10#2)(2008-10#2)(2008-9#1)(2010-2#2)
reliable estimation of##3##3##(2008-2#1)(2009-11#1)(2011-2#1)
reliable evaluation of##2##3##(2008-10#1)(2008-7#1)
reliable evidence##2##2##(1991-11#1)(2008-7#1)
reliable external##2##2##(2011-2#1)(2013-7#1)
reliable features##3##2##(1996-3#1)(2008-12#1)(2012-1#1)
reliable for detecting##2##3##(2006-10#1)(2008-10#1)
reliable for the determination of##3##5##(1996-3#1)(2005-10#1)(2008-10#1)
reliable for the##9##3##(1991-8#1)(1996-3#1)(2005-10#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-8#1)
reliable for##26##2##(1990-5#1)(1990-6#1)(1991-8#1)(1994-6#1)(1995-6#1)(1996-3#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#8)(2008-3#2)(2008-5#2)(2008-8#1)(2010-3#1)
reliable identification of##2##3##(2008-10#1)(2011-2#1)
reliable identification##3##2##(2008-10#2)(2011-2#1)
reliable in the##5##3##(1991-4#1)(1993-1#1)(2007-10#1)(2007-7#1)(2007-8#1)
reliable in##14##2##(1991-4#2)(1993-1#1)(1994-3#1)(2006-5#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-5#1)(2013-1#1)(2013-8#1)
reliable indicator of##6##3##(1991-12#1)(1993-12#1)(2007-11#1)(2009-8#1)(2013-7#2)
reliable information on the##3##4##(2006-2#1)(2006-6#1)(2011-1#1)
reliable information on##6##3##(1991-2#1)(2006-2#1)(2006-6#1)(2008-9#1)(2010-12#1)(2011-1#1)
reliable information to##2##3##(2008-7#1)(2012-12#1)
reliable information##14##2##(1991-2#1)(1996-3#1)(1997-3#1)(2006-2#1)(2006-6#1)(2007-2#1)(2008-4#1)(2008-7#1)(2008-9#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
reliable instrument##6##2##(1991-4#1)(2007-12#1)(2008-10#1)(2010-10#1)(2012-11#1)(2013-1#1)
reliable is the##3##3##(1990-12#1)(1995-5#1)(1995-9#1)
reliable is##5##2##(1990-12#1)(1991-6#1)(1992-12#1)(1995-5#1)(1995-9#1)
reliable markers##2##2##(1992-10#1)(2008-7#1)
reliable means of##8##3##(1990-8#1)(1993-12#1)(1997-7#2)(2008-10#1)(2008-4#1)(2008-9#1)(2011-7#1)
reliable means##11##2##(1990-8#1)(1993-11#1)(1993-12#1)(1995-2#1)(1997-7#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-7#1)
reliable measure of##3##3##(1993-2#1)(2007-8#1)(2010-8#1)
reliable measures##3##2##(1996-2#1)(2006-2#1)(2008-7#1)
reliable method for the determination of##2##6##(1997-3#1)(2007-5#1)
reliable method for the##9##4##(1997-3#1)(2006-5#1)(2007-5#1)(2008-10#4)(2010-12#1)(2012-3#1)
reliable method for##27##3##(1993-7#1)(1996-3#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-5#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-12#1)(2012-11#1)(2012-3#1)
reliable method in##2##3##(1993-5#1)(2012-2#1)
reliable method is##3##3##(1997-3#1)(2008-10#1)(2008-5#1)
reliable method of assessing##3##4##(2004-11#1)(2006-10#1)(2010-5#1)
reliable method of##10##3##(1997-6#1)(2004-11#1)(2004-2#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-1#1)(2008-10#1)(2008-9#1)(2010-5#1)
reliable method to identify##2##4##(1997-8#1)(2006-8#1)
reliable method to monitor##2##4##(2006-3#1)(2011-2#1)
reliable method to##14##3##(1997-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-3#1)(2009-12#1)(2011-2#1)(2013-7#1)
reliable method was##3##3##(1996-5#1)(2008-10#2)
reliable method##66##2##(1993-5#1)(1993-7#1)(1996-3#1)(1996-5#1)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2004-2#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-1#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#16)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#2)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-7#1)
reliable methods for the##3##4##(1993-6#1)(2006-12#1)(2008-10#1)
reliable methods for##4##3##(1993-6#1)(2006-12#1)(2008-10#1)(2008-9#1)
reliable methods##7##2##(1993-6#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-9#1)(2012-12#1)
reliable models##3##2##(1990-3#1)(1996-3#1)(2013-8#1)
reliable molecular##3##2##(2007-8#1)(2008-6#1)(2008-9#1)
reliable monitoring##2##2##(1992-8#1)(2006-6#1)
reliable optical##2##2##(2008-10#1)(2009-5#1)
reliable or##3##2##(2006-5#1)(2008-10#1)(2010-10#1)
reliable physical##2##2##(2006-12#1)(2006-7#1)
reliable prediction of##3##3##(2008-11#1)(2010-2#1)(2012-2#1)
reliable predictor of##5##3##(2007-1#1)(2007-6#1)(2007-7#1)(2008-4#1)(2008-7#1)
reliable predictor##6##2##(2007-1#1)(2007-6#1)(2007-7#1)(2008-4#1)(2008-7#1)(2011-1#1)
reliable procedures##3##2##(2008-10#2)(2008-2#1)
reliable protection against##2##3##(1990-6#1)(1996-4#1)
reliable protocols for##3##3##(2008-1#1)(2008-4#2)
reliable quantitation of##2##3##(1990-11#1)(1997-2#1)
reliable quantitative##2##2##(2004-9#1)(2006-5#1)
reliable real-time##2##2##(2008-10#2)
reliable recognition##2##2##(1991-11#1)(2008-1#1)
reliable research##2##2##(1993-12#1)(2012-2#1)
reliable results and##2##3##(2007-8#1)(2008-2#1)
reliable results for a##2##4##(2008-2#1)(2008-9#1)
reliable results for##5##3##(2004-4#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-9#1)
reliable results in##2##3##(2008-10#1)(2009-8#1)
reliable results##20##2##(1996-10#1)(1996-3#1)(2004-4#1)(2007-11#2)(2007-8#2)(2008-10#6)(2008-11#1)(2008-2#2)(2008-9#1)(2009-8#1)(2010-12#1)(2013-8#1)
reliable screening method##3##3##(1993-5#1)(2008-5#1)(2011-2#1)
reliable screening##4##2##(1993-5#1)(2006-10#1)(2008-5#1)(2011-2#1)
reliable surgical##3##2##(2006-3#1)(2009-9#1)(2011-2#1)
reliable technique##9##2##(1996-12#1)(1996-6#1)(2006-6#1)(2007-7#1)(2012-2#4)(2012-3#1)
reliable than##11##2##(1990-10#1)(1990-12#1)(1991-7#1)(1992-1#1)(1992-4#1)(2007-2#1)(2008-10#1)(2008-12#1)(2010-6#1)(2011-2#1)(2012-2#1)
reliable to##5##2##(1990-9#1)(1996-11#1)(2008-3#1)(2011-2#1)(2012-2#1)
reliable tool for##4##3##(2006-5#1)(2008-10#1)(2008-2#1)(2011-2#1)
reliable tool##8##2##(2006-5#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-2#1)
reliable tools##2##2##(2012-1#1)(2012-2#1)
reliable treatment##2##2##(1994-6#1)(2006-3#1)
reliable use of##2##3##(2008-10#1)(2008-6#1)
reliable values##2##2##(2008-2#1)(2009-3#1)
reliable way##4##2##(1993-12#1)(2008-10#2)(2010-8#1)
reliable with##4##2##(2006-3#1)(2008-10#1)(2008-2#1)(2008-5#1)
reliable##917##1##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#2)(1991-3#4)(1991-4#3)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-3#4)(1992-4#2)(1992-7#2)(1992-8#1)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#10)(1993-2#5)(1993-3#1)(1993-5#3)(1993-6#1)(1993-7#2)(1993-8#2)(1993-9#6)(1994-2#2)(1994-3#7)(1994-6#5)(1994-8#2)(1994-9#3)(1995-1#2)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#3)(1995-4#1)(1995-5#2)(1995-6#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#5)(1996-2#1)(1996-3#9)(1996-4#2)(1996-5#3)(1996-6#4)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#3)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#4)(1997-8#5)(2004-10#1)(2004-11#1)(2004-2#2)(2004-4#2)(2004-9#1)(2005-10#6)(2005-11#1)(2005-12#2)(2005-4#2)(2005-5#2)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#20)(2006-12#5)(2006-2#5)(2006-3#8)(2006-4#3)(2006-5#8)(2006-6#8)(2006-7#4)(2006-8#2)(2006-9#6)(2007-1#5)(2007-10#5)(2007-11#12)(2007-12#11)(2007-2#7)(2007-3#4)(2007-4#4)(2007-5#6)(2007-6#1)(2007-7#15)(2007-8#20)(2007-9#2)(2008-1#9)(2008-10#148)(2008-11#11)(2008-12#13)(2008-2#27)(2008-3#24)(2008-4#26)(2008-5#18)(2008-6#8)(2008-7#23)(2008-8#8)(2008-9#25)(2009-1#1)(2009-11#2)(2009-12#4)(2009-2#1)(2009-3#2)(2009-5#4)(2009-8#3)(2009-9#3)(2010-1#1)(2010-10#6)(2010-11#8)(2010-12#11)(2010-2#6)(2010-3#2)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#8)(2010-9#1)(2011-1#9)(2011-12#1)(2011-2#27)(2011-3#1)(2011-7#1)(2012-1#7)(2012-11#2)(2012-12#10)(2012-2#20)(2012-3#9)(2013-1#31)(2013-7#7)(2013-8#10)
reliably a##2##2##(1997-7#1)(2010-5#1)
reliably and rapidly##3##3##(2008-3#1)(2008-4#2)
reliably and##9##2##(1996-9#1)(2007-5#1)(2008-1#1)(2008-3#1)(2008-4#3)(2009-5#1)(2013-8#1)
reliably be##4##2##(1993-8#1)(2008-2#1)(2010-10#1)(2010-8#1)
reliably detect##4##2##(1993-9#1)(2006-2#1)(2008-10#1)(2008-3#1)
reliably detected by##2##3##(1996-4#1)(2011-1#1)
reliably detected##6##2##(1994-3#1)(1996-4#1)(1997-3#2)(2008-7#1)(2011-1#1)
reliably detects##2##2##(2008-1#2)
reliably distinguish between##2##3##(1997-6#1)(2008-10#1)
reliably distinguish##4##2##(1997-6#1)(2004-10#2)(2008-10#1)
reliably distinguished##3##2##(1995-8#1)(2008-10#1)(2009-12#1)
reliably employed for##2##3##(2008-10#1)(2008-11#1)
reliably employed##4##2##(1996-12#1)(2008-10#2)(2008-11#1)
reliably for the##2##3##(2008-10#2)
reliably for##4##2##(2008-10#3)(2013-1#1)
reliably forecast##2##2##(2007-9#1)(2008-6#1)
reliably higher than##2##3##(1992-1#2)
reliably identified##2##2##(2005-8#1)(2008-7#1)
reliably identify##3##2##(2007-9#1)(2008-10#1)(2012-3#1)
reliably in##3##2##(1996-6#1)(2006-12#1)(2008-5#1)
reliably measured by##2##3##(2007-8#1)(2008-4#1)
reliably measured##4##2##(2007-8#1)(2008-12#1)(2008-3#1)(2008-4#1)
reliably monitor##3##2##(2004-9#1)(2008-10#1)(2008-8#1)
reliably predict the##2##3##(1993-6#1)(1995-10#1)
reliably predict##6##2##(1993-6#1)(1995-10#1)(1996-3#1)(2006-10#1)(2009-4#1)(2012-1#1)
reliably predicts the##2##3##(2008-10#1)(2013-1#1)
reliably predicts##3##2##(2008-10#2)(2013-1#1)
reliably produced##3##2##(2007-1#1)(2008-3#1)(2009-7#1)
reliably quantified##2##2##(2007-5#1)(2008-4#1)
reliably the##2##2##(1995-12#1)(1995-2#1)
reliably to##4##2##(1993-12#1)(1995-12#1)(2006-10#1)(2008-10#1)
reliably used by##2##3##(2008-10#1)(2008-7#1)
reliably used for##2##3##(1990-12#1)(2008-10#1)
reliably used to determine the##2##5##(2010-12#2)
reliably used to##3##3##(1997-3#1)(2010-12#2)
reliably used##9##2##(1990-12#1)(1992-3#1)(1997-3#1)(2008-10#3)(2008-7#1)(2010-12#2)
reliably with##3##2##(2008-10#1)(2008-2#1)(2008-9#1)
reliably##181##1##(1990-12#1)(1990-8#1)(1991-3#1)(1992-1#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#2)(1996-7#1)(1996-9#1)(1997-3#3)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2004-10#2)(2004-9#1)(2005-10#1)(2005-5#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-5#2)(2007-8#2)(2007-9#2)(2008-1#7)(2008-10#25)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#8)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#2)
reliance of##4##2##(1996-2#1)(2006-8#1)(2008-1#1)(2008-5#1)
reliance on the##9##3##(1990-12#1)(1991-2#1)(1994-3#1)(2005-12#1)(2006-4#1)(2007-7#1)(2008-3#2)(2009-4#1)
reliance on##37##2##(1990-12#1)(1991-2#3)(1993-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-3#1)(1997-2#1)(2005-12#1)(2006-10#4)(2006-4#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-12#2)(2008-3#2)(2008-6#2)(2009-4#1)(2009-7#1)(2010-12#1)(2010-8#2)(2011-1#1)(2012-3#1)
reliance upon##2##2##(2006-12#1)(2008-10#1)
reliance##47##1##(1990-12#1)(1991-2#3)(1991-5#1)(1992-1#1)(1993-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-2#1)(2005-12#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#1)(2008-6#3)(2009-4#1)(2009-7#1)(2010-12#1)(2010-8#2)(2011-1#1)(2012-3#1)
reliant on##10##2##(2004-9#1)(2005-5#1)(2007-12#2)(2008-12#1)(2008-3#1)(2009-4#1)(2010-2#1)(2011-2#1)(2012-2#1)
reliant##11##1##(2004-9#1)(2005-5#1)(2006-12#1)(2007-12#2)(2008-12#1)(2008-3#1)(2009-4#1)(2010-2#1)(2011-2#1)(2012-2#1)
relic##4##1##(1995-11#1)(2007-5#1)(2009-6#1)(2011-1#1)
relics of##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
relics##5##1##(2007-9#1)(2008-10#1)(2008-7#1)(2011-2#2)
relict##3##1##(2008-6#1)(2009-6#1)(2010-10#1)
relied extensively##2##2##(2007-8#1)(2008-4#1)
relied heavily on##2##3##(1995-1#1)(2008-10#1)
relied on a##4##3##(1993-6#1)(1996-5#1)(1997-1#1)(2005-10#1)
relied on the##5##3##(2005-11#1)(2005-7#1)(2008-7#1)(2010-2#1)(2011-2#1)
relied on##41##2##(1990-8#1)(1991-1#1)(1991-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#2)(1996-5#1)(1997-1#2)(2005-10#1)(2005-11#2)(2005-7#1)(2006-10#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-2#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-8#1)
relied upon the##3##3##(2006-4#1)(2008-7#1)(2012-3#1)
relied upon to##3##3##(1996-7#1)(2009-9#1)(2010-8#1)
relied upon##15##2##(1995-11#1)(1996-7#1)(2006-4#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-9#1)(2010-4#1)(2010-8#1)(2012-3#1)(2013-7#1)
relied##66##1##(1990-8#1)(1991-1#1)(1991-3#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-3#1)(1995-1#2)(1995-11#1)(1995-2#2)(1996-5#1)(1996-7#1)(1997-1#2)(2005-10#1)(2005-11#2)(2005-7#1)(2006-10#2)(2006-4#1)(2007-8#2)(2008-1#3)(2008-10#4)(2008-11#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-8#2)(2010-9#1)(2011-2#4)(2012-2#2)(2012-3#2)(2013-7#1)(2013-8#1)
relief after##11##2##(1990-6#1)(1997-6#1)(2006-12#3)(2006-7#1)(2007-11#1)(2007-2#1)(2007-7#1)(2011-2#1)(2012-12#1)
relief and##19##2##(1993-12#1)(2005-9#1)(2006-10#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-11#3)(2007-2#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-10#1)(2012-12#1)
relief at 6 months##2##4##(2006-8#2)
relief at##4##2##(2006-8#3)(2007-11#1)
relief for patients with##2##4##(2007-8#1)(2013-1#1)
relief for patients##4##3##(2006-10#1)(2007-8#2)(2013-1#1)
relief for the##2##3##(2008-1#1)(2012-2#1)
relief for##11##2##(1992-5#1)(1993-4#1)(2006-10#2)(2007-6#1)(2007-8#2)(2008-1#1)(2008-11#1)(2012-2#1)(2013-1#1)
relief from symptoms##2##3##(2007-8#1)(2011-3#1)
relief from the##4##3##(2005-12#1)(2007-11#1)(2008-9#1)(2013-1#1)
relief from##20##2##(1992-5#2)(1993-2#1)(1997-4#1)(2005-12#1)(2006-12#1)(2006-5#1)(2006-8#2)(2007-11#2)(2007-8#2)(2008-5#1)(2008-9#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
relief gratings##2##2##(2008-1#1)(2008-3#1)
relief has been##3##3##(1994-1#1)(2006-8#1)(2010-11#1)
relief in patients##2##3##(2005-10#1)(2007-8#1)
relief in the##2##3##(2006-10#1)(2008-11#1)
relief in##19##2##(2005-10#2)(2006-10#6)(2006-11#1)(2006-8#2)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#2)(2009-4#1)(2010-7#1)
relief is##7##2##(1992-5#1)(2006-10#2)(2006-8#1)(2007-12#1)(2008-7#2)
relief may##2##2##(2006-3#1)(2007-11#1)
relief of a##2##3##(1996-5#1)(2011-2#1)
relief of dentin hypersensitivity##3##4##(2011-2#3)
relief of pain is##2##4##(2007-10#1)(2008-9#1)
relief of pain##10##3##(1995-5#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-9#2)(2011-2#1)(2013-8#1)
relief of symptomatology##2##3##(1994-6#1)(1996-9#1)
relief of symptoms and##3##4##(2006-2#1)(2006-6#1)(2009-2#1)
relief of symptoms##13##3##(1996-1#1)(1996-9#1)(1997-1#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-11#2)(2007-8#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-2#1)
relief of the patient's##3##4##(2007-6#1)(2008-3#1)(2012-2#1)
relief of the##12##3##(1992-3#1)(1992-8#1)(1996-3#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-1#1)(2010-12#1)(2012-2#1)(2013-1#1)
relief of their##2##3##(1996-7#1)(2008-8#1)
relief of this##3##3##(1995-2#1)(2006-11#1)(2008-12#1)
relief of##83##2##(1992-3#1)(1992-8#2)(1993-1#1)(1993-10#1)(1993-12#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#2)(1997-1#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#5)(2007-10#1)(2007-11#3)(2007-6#1)(2007-7#1)(2007-8#4)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-1#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-2#1)(2013-1#5)(2013-8#1)
relief or##6##2##(1993-4#1)(2007-2#1)(2008-11#1)(2008-3#1)(2009-6#1)(2011-2#1)
relief structure##2##2##(2008-3#2)
relief structures##2##2##(2007-12#1)(2008-2#1)
relief that is##2##3##(2006-12#1)(2008-3#1)
relief that##3##2##(2006-12#1)(2008-10#1)(2008-3#1)
relief to##3##2##(2004-9#1)(2006-2#1)(2007-9#1)
relief was achieved##3##3##(1990-10#1)(2007-11#1)(2007-7#1)
relief was obtained##3##3##(2006-8#1)(2008-3#1)(2008-6#1)
relief was##9##2##(1990-10#1)(2006-8#1)(2007-11#2)(2007-7#1)(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#1)
relief with##8##2##(1994-4#1)(1995-10#2)(2006-10#1)(2006-11#1)(2006-8#1)(2008-3#1)(2008-7#1)
relief##376##1##(1990-10#1)(1990-6#1)(1991-2#2)(1991-3#2)(1992-1#2)(1992-3#1)(1992-5#6)(1992-8#3)(1993-1#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-4#2)(1994-1#1)(1994-4#1)(1994-6#2)(1995-1#1)(1995-10#3)(1995-12#3)(1995-2#3)(1995-5#1)(1996-1#1)(1996-2#3)(1996-3#2)(1996-5#1)(1996-7#4)(1996-9#6)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-10#3)(2005-12#1)(2005-4#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#30)(2006-11#3)(2006-12#9)(2006-2#4)(2006-3#2)(2006-5#2)(2006-6#5)(2006-7#6)(2006-8#25)(2006-9#1)(2007-10#2)(2007-11#29)(2007-12#4)(2007-2#10)(2007-6#3)(2007-7#8)(2007-8#11)(2007-9#3)(2008-1#3)(2008-10#4)(2008-11#8)(2008-12#3)(2008-2#7)(2008-3#16)(2008-5#4)(2008-6#2)(2008-7#13)(2008-8#3)(2008-9#8)(2009-1#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#4)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#3)(2010-4#1)(2010-7#5)(2010-8#1)(2011-1#3)(2011-12#3)(2011-2#13)(2011-3#1)(2012-1#3)(2012-12#2)(2012-2#8)(2013-1#8)(2013-7#3)(2013-8#1)
relief)##3##1##(2008-11#1)(2009-10#1)(2010-2#1)
relies heavily on the##4##4##(1995-12#1)(2006-10#1)(2012-12#2)
relies heavily on##10##3##(1995-12#1)(2006-10#1)(2007-11#1)(2008-4#2)(2008-9#1)(2009-10#1)(2012-1#1)(2012-12#2)
relies heavily upon##2##3##(1996-1#1)(2007-11#1)
relies heavily##12##2##(1995-12#1)(1996-1#1)(2006-10#1)(2007-11#2)(2008-4#2)(2008-9#1)(2009-10#1)(2012-1#1)(2012-12#2)
relies largely on the##2##4##(2007-8#1)(2013-8#1)
relies on a##16##3##(1997-4#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-9#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-10#1)(2013-1#1)(2013-8#1)
relies on accurate##2##3##(2007-12#1)(2008-4#1)
relies on both##2##3##(2006-12#1)(2008-10#1)
relies on good##2##3##(2006-2#1)(2006-8#1)
relies on imports for 70% of its albumin formulations##2##9##(2013-1#2)
relies on its##3##3##(1996-5#1)(2009-3#1)(2011-2#1)
relies on surface##2##3##(2008-2#1)(2012-2#1)
relies on the ability of##2##5##(1997-8#1)(2008-4#1)
relies on the ability to##2##5##(2008-3#1)(2009-11#1)
relies on the ability##4##4##(1997-8#1)(2008-3#1)(2008-4#1)(2009-11#1)
relies on the fact that##2##5##(1991-12#1)(2007-12#1)
relies on the immobilization of##2##5##(2008-10#2)
relies on the measurement of##2##5##(2008-2#1)(2008-3#1)
relies on the use of a##4##6##(1990-5#1)(2007-12#2)(2008-3#1)
relies on the use of##5##5##(1990-5#1)(2007-11#1)(2007-12#2)(2008-3#1)
relies on the##62##3##(1990-5#1)(1991-12#1)(1992-5#1)(1997-4#1)(1997-8#1)(2006-10#2)(2006-11#1)(2007-1#1)(2007-11#4)(2007-12#7)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#3)(2008-3#8)(2008-4#2)(2008-7#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-5#1)(2010-12#2)(2010-4#2)(2012-2#1)(2013-1#1)(2013-8#1)
relies on two##2##3##(2007-12#1)(2008-3#1)
relies on##159##2##(1990-5#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-5#1)(1992-6#1)(1994-2#1)(1995-8#1)(1996-1#1)(1996-5#1)(1997-4#2)(1997-8#1)(2005-10#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#1)(2006-8#2)(2007-1#1)(2007-11#7)(2007-12#19)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#17)(2008-11#3)(2008-2#14)(2008-3#16)(2008-4#8)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#1)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-4#3)(2010-8#2)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#5)(2013-8#2)
relies primarily on##3##3##(2006-7#1)(2008-11#1)(2009-8#1)
relies primarily##4##2##(2006-7#1)(2008-11#1)(2009-8#1)(2010-9#1)
relies upon the##2##3##(2008-10#2)
relies upon##11##2##(1995-3#1)(1996-9#1)(1997-8#1)(2006-5#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-12#1)(2011-1#1)(2012-2#1)
relies##196##1##(1990-5#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-5#1)(1992-6#1)(1994-2#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#2)(1996-5#1)(1996-9#1)(1997-4#2)(1997-8#2)(2005-10#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#10)(2007-12#20)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#20)(2008-11#4)(2008-12#1)(2008-2#14)(2008-3#17)(2008-4#11)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#5)(2009-10#3)(2009-11#1)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-4#3)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#4)(2013-1#5)(2013-8#3)
relieve pain and##2##3##(2007-11#1)(2013-8#1)
relieve pain##16##2##(1990-12#1)(1990-5#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-6#1)(2007-11#3)(2008-7#1)(2008-9#1)(2009-12#1)(2010-7#1)(2011-1#2)(2013-8#1)
relieve patient##2##2##(2007-8#1)(2008-2#1)
relieve suffering##2##2##(1992-5#1)(2012-3#1)
relieve symptoms and##3##3##(2007-11#2)(2010-12#1)
relieve symptoms##5##2##(1993-1#1)(2007-11#2)(2010-12#1)(2011-1#1)
relieve the symptoms##2##3##(2008-4#1)(2013-8#1)
relieve the##14##2##(1990-12#1)(1995-8#1)(2005-10#1)(2005-12#1)(2006-6#1)(2007-11#1)(2008-4#1)(2008-9#1)(2009-6#1)(2010-12#2)(2010-9#1)(2011-2#1)(2013-8#1)
relieve this##2##2##(1991-9#1)(1992-6#1)
relieve##75##1##(1990-12#2)(1990-5#1)(1991-9#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-3#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-6#1)(1996-8#1)(1997-6#1)(2005-10#2)(2005-12#1)(2006-10#2)(2006-12#3)(2006-3#1)(2006-6#3)(2006-8#1)(2007-11#9)(2007-12#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-6#1)(2010-12#3)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
relieved by surgical##2##3##(2007-8#1)(2008-7#1)
relieved by the##3##3##(1995-1#1)(2008-3#1)(2008-5#1)
relieved by##19##2##(1991-5#1)(1992-8#1)(1994-2#1)(1994-5#1)(1995-1#2)(1995-12#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-12#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-12#1)
relieved in the##4##3##(1991-2#1)(2007-11#1)(2008-11#2)
relieved in##5##2##(1991-2#1)(1995-8#1)(2007-11#1)(2008-11#2)
relieved of symptoms##2##3##(2010-12#1)(2010-7#1)
relieved of##5##2##(1990-10#1)(1992-3#1)(2010-12#1)(2010-7#1)(2013-8#1)
relieved only##2##2##(2009-2#1)(2011-2#1)
relieved the##5##2##(1997-7#1)(1997-8#1)(2007-8#1)(2010-12#1)(2012-1#1)
relieved with##4##2##(1994-9#1)(1995-2#1)(1996-10#1)(2007-8#1)
relieved##64##1##(1990-10#1)(1990-9#3)(1991-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-5#1)(1992-8#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-10#1)(1997-7#2)(1997-8#2)(2006-10#2)(2006-12#1)(2007-11#2)(2007-12#1)(2007-8#5)(2008-1#3)(2008-10#2)(2008-11#2)(2008-3#3)(2008-5#2)(2008-7#2)(2009-2#1)(2009-8#1)(2010-12#3)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#3)
reliever and##2##2##(2008-10#1)(2010-9#1)
reliever##3##1##(2008-10#1)(2008-3#1)(2010-9#1)
relievers##5##1##(2006-8#2)(2012-2#1)(2013-1#1)(2013-8#1)
relieves the symptoms##2##3##(2008-1#1)(2010-7#1)
relieves the##5##2##(1990-10#1)(1991-4#1)(1993-8#1)(2008-1#1)(2010-7#1)
relieves##16##1##(1990-10#1)(1991-4#1)(1993-12#1)(1993-8#1)(1996-7#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
relieving of the##2##3##(1997-4#1)(2008-7#1)
relieving of##4##2##(1997-4#1)(2008-7#1)(2010-12#1)(2012-2#1)
relieving pain##5##2##(1994-11#1)(1996-7#1)(2006-8#1)(2008-11#1)(2013-1#1)
relieving the##9##2##(1993-2#1)(1994-12#1)(1994-8#1)(2006-10#2)(2006-8#1)(2011-2#1)(2013-1#2)
relieving##36##1##(1993-2#1)(1994-11#1)(1994-12#1)(1994-8#1)(1996-7#1)(1997-4#1)(2004-12#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-8#4)(2007-11#1)(2008-1#1)(2008-11#1)(2008-7#2)(2009-9#1)(2010-12#1)(2010-5#1)(2011-2#4)(2012-1#2)(2012-2#2)(2013-1#4)
religation kinetics##3##2##(1996-6#3)
religation occurs through a##2##4##(1996-6#2)
religation occurs through##3##3##(1996-6#3)
religation##14##1##(1990-9#1)(1994-8#1)(1995-5#1)(1996-6#8)(1997-4#3)
religion and religious##2##3##(2009-11#1)(2010-2#1)
religion and##14##2##(2008-4#1)(2009-11#5)(2009-6#2)(2009-7#2)(2010-2#3)(2010-8#1)
religion are##4##2##(2008-12#2)(2010-10#1)(2013-1#1)
religion have##2##2##(1992-10#1)(2009-6#1)
religion in##7##2##(2005-5#1)(2008-11#1)(2008-8#1)(2009-5#1)(2009-7#2)(2010-2#1)
religion is##3##2##(2008-12#1)(2009-6#1)(2009-7#1)
religion on##3##2##(2009-6#1)(2009-7#1)(2013-1#1)
religion##64##1##(1991-2#1)(1992-10#1)(2005-5#1)(2006-5#1)(2006-8#1)(2007-4#2)(2007-9#2)(2008-1#1)(2008-11#1)(2008-12#5)(2008-4#3)(2008-5#2)(2008-8#1)(2008-9#1)(2009-11#8)(2009-4#2)(2009-5#2)(2009-6#6)(2009-7#7)(2009-8#1)(2010-10#1)(2010-2#5)(2010-8#2)(2011-2#2)(2012-12#1)(2013-1#4)
religion/spirituality##3##1##(2010-8#3)
religions##8##1##(2006-12#1)(2008-12#1)(2008-4#1)(2009-7#2)(2010-2#3)
religiosity and##4##2##(2009-7#4)
religiosity is##2##2##(2010-12#2)
religiosity were##2##2##(2010-2#1)(2011-1#1)
religiosity##20##1##(2005-10#1)(2008-4#3)(2009-11#2)(2009-7#6)(2010-12#3)(2010-2#2)(2010-8#1)(2011-1#2)
religious activities##3##2##(2009-7#2)(2012-12#1)
religious affiliation of##3##3##(1993-12#1)(2009-6#1)(2009-7#1)
religious affiliation were##2##3##(1993-12#1)(2006-7#1)
religious affiliation##13##2##(1993-12#5)(2006-7#2)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#2)(2010-11#1)
religious and cultural##2##3##(1996-9#1)(2007-12#1)
religious and spiritual##3##3##(2010-2#2)(2011-1#1)
religious and##12##2##(1996-9#1)(2004-12#1)(2006-2#1)(2006-4#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-7#1)(2010-2#2)(2011-1#1)
religious backgrounds##2##2##(1995-9#1)(2008-12#1)
religious behaviors##2##2##(2009-5#1)(2012-2#1)
religious beliefs and##4##3##(2008-12#1)(2009-10#1)(2010-2#1)(2012-12#1)
religious beliefs in##2##3##(2010-2#2)
religious beliefs##12##2##(2008-12#2)(2008-4#1)(2009-10#1)(2010-2#4)(2012-12#4)
religious congregations##3##2##(2013-8#3)
religious convictions##2##2##(2008-12#1)(2013-1#1)
religious coping styles##3##3##(2008-12#1)(2009-11#2)
religious coping##18##2##(2008-12#7)(2008-4#4)(2009-11#7)
religious freedom##2##2##(1997-1#1)(2008-7#1)
religious giving##2##2##(2009-10#2)
religious group##2##2##(1995-3#1)(2009-6#1)
religious groups##6##2##(1993-7#1)(2007-3#2)(2008-12#1)(2009-11#1)(2010-8#1)
religious involvement##6##2##(2009-5#2)(2009-7#3)(2010-10#1)
religious leaders in##2##3##(2008-8#1)(2011-1#1)
religious leaders##3##2##(1993-8#1)(2008-8#1)(2011-1#1)
religious norms##2##2##(2007-10#2)
religious or##2##2##(1994-3#1)(1996-2#1)
religious orientation as a therapy intervention##2##6##(2009-7#2)
religious orientation##4##2##(2006-7#1)(2008-12#1)(2009-7#2)
religious paradigms##2##2##(2008-12#2)
religious participation and##2##3##(2010-10#1)(2010-2#1)
religious participation##4##2##(2010-10#3)(2010-2#1)
religious perspectives##3##2##(2005-12#1)(2008-12#2)
religious practices##2##2##(2010-2#2)
religious reasons##2##2##(2007-3#1)(2013-8#1)
religious service attendance and##2##4##(2009-8#2)
religious service attendance##3##3##(2009-8#3)
religious service##4##2##(2009-8#4)
religious services##4##2##(1991-10#1)(2009-5#1)(2009-8#1)(2010-2#1)
religious support##2##2##(1990-10#1)(2008-4#1)
religious traditions##2##2##(2008-1#1)(2008-12#1)
religious values and beliefs##2##4##(2008-12#2)
religious values and##3##3##(2005-7#1)(2008-12#2)
religious values##4##2##(2005-7#1)(2008-12#2)(2009-7#1)
religious##188##1##(1990-10#1)(1990-3#1)(1990-5#1)(1991-10#1)(1991-3#1)(1991-4#1)(1991-6#1)(1993-12#5)(1993-7#1)(1993-8#1)(1994-3#4)(1995-3#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#2)(1997-6#1)(1997-8#1)(2004-12#1)(2005-12#1)(2005-7#1)(2006-2#2)(2006-4#3)(2006-7#3)(2007-10#4)(2007-12#2)(2007-2#1)(2007-3#4)(2007-4#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#25)(2008-3#1)(2008-4#6)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#7)(2009-11#11)(2009-12#1)(2009-4#2)(2009-5#4)(2009-6#2)(2009-7#17)(2009-8#5)(2010-10#5)(2010-11#1)(2010-2#12)(2010-7#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#1)(2012-12#6)(2012-2#6)(2012-3#1)(2013-1#1)(2013-8#4)
religiously based##2##2##(2006-7#1)(2008-12#1)
religiously##3##1##(2006-7#1)(2008-12#1)(2009-6#1)
religiousness and##2##2##(2006-7#1)(2009-7#1)
religiousness##12##1##(2006-7#2)(2007-10#1)(2009-11#2)(2009-5#4)(2009-7#3)
reline##2##1##(2008-12#2)
relining##3##1##(2012-2#1)(2013-1#2)
relinquish##2##1##(1991-3#1)(2007-7#1)
relinquished##2##1##(2008-12#1)(2009-9#1)
reliving##2##1##(2007-11#1)(2008-1#1)
relocalization of##2##2##(1991-10#1)(1992-1#1)
relocate##3##1##(2008-10#1)(2008-5#1)(2009-4#1)
relocated to##2##2##(1992-7#1)(1994-8#1)
relocated##10##1##(1992-7#1)(1994-8#1)(1995-5#1)(2007-5#2)(2007-8#1)(2008-8#1)(2012-3#1)(2013-7#2)
relocating##4##1##(1995-8#1)(1996-1#1)(2009-12#1)(2012-2#1)
relocation of a posterior dislocation of##2##6##(2012-12#2)
relocation of individuals of E##2##5##(2013-7#2)
relocation of the##3##3##(1991-1#1)(2006-11#1)(2009-9#1)
relocation of##10##2##(1991-1#1)(1994-6#1)(1996-8#1)(2006-11#1)(2008-7#1)(2009-9#1)(2012-12#2)(2013-7#2)
relocation##21##1##(1990-2#1)(1991-1#1)(1992-1#1)(1994-6#1)(1996-8#1)(2006-11#1)(2007-5#2)(2008-10#1)(2008-7#1)(2009-8#2)(2009-9#1)(2012-12#2)(2013-7#6)
reluctance of##2##2##(2007-11#1)(2008-10#1)
reluctance to use##2##3##(2006-8#1)(2010-8#1)
reluctance to##18##2##(1990-6#1)(1992-10#2)(1996-5#1)(1996-7#1)(1997-4#1)(2004-2#1)(2005-7#1)(2006-8#2)(2007-10#1)(2008-5#1)(2008-7#2)(2009-3#1)(2010-8#1)(2010-9#1)(2012-3#1)
reluctance##23##1##(1990-6#1)(1992-10#2)(1996-5#1)(1996-7#1)(1997-4#1)(2004-2#1)(2005-7#1)(2006-10#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-5#2)(2008-10#1)(2008-5#1)(2008-7#2)(2009-3#1)(2010-8#1)(2010-9#1)(2012-3#1)
reluctant to enter##2##3##(1993-10#1)(1996-12#1)
reluctant to##19##2##(1991-2#1)(1991-5#1)(1992-9#1)(1993-10#1)(1996-12#1)(1996-3#1)(1997-5#1)(2005-7#1)(2006-10#1)(2006-7#1)(2007-10#1)(2008-1#1)(2008-12#1)(2008-4#1)(2009-2#1)(2010-8#2)(2012-12#1)(2012-3#1)
reluctant##26##1##(1991-2#1)(1991-5#1)(1992-9#1)(1993-10#1)(1995-1#1)(1996-12#1)(1996-3#1)(1997-5#1)(2005-7#1)(2006-10#2)(2006-7#1)(2007-10#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-2#1)(2009-4#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-3#1)
rely heavily on##8##3##(1996-1#1)(1997-3#1)(2006-10#1)(2007-5#1)(2008-1#1)(2008-8#1)(2009-2#1)(2012-12#1)
rely largely on##3##3##(2008-11#1)(2013-1#2)
rely more##3##2##(1996-3#1)(2008-3#1)(2010-2#1)
rely on a##18##3##(1992-3#1)(1992-6#1)(1997-8#1)(2005-11#1)(2006-5#1)(2006-7#1)(2007-12#2)(2008-11#2)(2008-2#1)(2008-6#1)(2008-8#1)(2010-9#1)(2012-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
rely on commercial##2##3##(2007-11#1)(2008-7#1)
rely on external##2##3##(2008-4#1)(2011-2#1)
rely on its data to inform patient care and determine population coverage of immunizations##2##14##(2013-1#2)
rely on the ability to##2##5##(2006-2#1)(2009-6#1)
rely on the use of##3##5##(1997-7#1)(2006-4#1)(2008-10#1)
rely on the##34##3##(1990-12#1)(1990-8#1)(1994-2#1)(1995-12#1)(1995-7#1)(1995-8#1)(1996-10#1)(1997-7#1)(2006-2#1)(2006-4#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-8#1)
rely on traditional##2##3##(2008-10#1)(2010-2#1)
rely on##146##2##(1990-1#1)(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#2)(1995-2#2)(1995-7#1)(1995-8#2)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-7#1)(1997-8#2)(2005-11#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#7)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#6)(2008-9#3)(2009-10#2)(2009-2#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#4)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#2)
rely primarily on##6##3##(1994-1#2)(2006-10#1)(2008-9#1)(2009-6#1)(2011-1#1)
rely upon##9##2##(1991-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-2#1)(2010-6#1)(2010-8#1)(2012-12#1)
rely##193##1##(1990-1#1)(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1995-12#2)(1995-2#2)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-2#1)(1996-3#2)(1996-4#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#3)(2005-11#1)(2005-4#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#5)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#9)(2008-11#7)(2008-12#2)(2008-2#8)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#8)(2008-9#4)(2009-10#2)(2009-2#3)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-12#2)(2010-2#6)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#4)(2012-1#4)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#10)(2013-7#1)(2013-8#2)
relying on an##2##3##(2007-12#1)(2010-11#1)
relying on the##9##3##(1996-2#1)(1997-6#1)(1997-7#1)(2007-8#1)(2008-3#2)(2009-11#1)(2012-12#1)(2012-3#1)
relying on##46##2##(1992-12#1)(1993-5#1)(1994-2#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
relying upon##2##2##(1995-5#1)(2008-7#1)
relying##53##1##(1992-12#1)(1992-5#1)(1993-5#1)(1994-2#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-12#1)(2006-2#2)(2006-7#1)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#2)(2009-10#1)(2009-11#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)
remain &gt##3##2##(1993-9#2)(2011-2#1)
remain a challenge##5##3##(2006-6#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
remain a frequent##2##3##(2006-10#1)(2008-7#1)
remain a major cause of morbidity and mortality in##2##9##(2008-1#1)(2012-12#1)
remain a major cause of##4##5##(2008-1#1)(2008-11#1)(2010-8#1)(2012-12#1)
remain a major problem##2##4##(1994-3#1)(2005-7#1)
remain a major source of##2##5##(2006-10#1)(2010-8#1)
remain a major##11##3##(1994-3#1)(2005-7#1)(2006-10#2)(2008-1#1)(2008-11#1)(2009-9#1)(2010-8#3)(2012-12#1)
remain a problem##2##3##(2006-10#1)(2007-2#1)
remain a rare##2##3##(2007-8#1)(2012-3#1)
remain a substantial##2##3##(2010-3#1)(2012-12#1)
remain a##45##2##(1994-3#1)(1995-8#1)(1996-8#1)(2005-11#1)(2005-7#2)(2006-10#6)(2006-12#1)(2006-6#2)(2007-12#1)(2007-2#2)(2007-8#1)(2008-1#2)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-3#1)(2010-8#3)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
remain about the##5##3##(1991-11#1)(1997-6#1)(2006-10#1)(2008-11#1)(2012-2#1)
remain about##9##2##(1991-11#1)(1994-3#1)(1997-6#1)(2006-10#1)(2008-11#2)(2012-1#1)(2012-12#1)(2012-2#1)
remain active##3##2##(2006-6#1)(2007-7#1)(2008-5#1)
remain after treatment##2##3##(1991-2#1)(2011-2#1)
remain alive##6##2##(1994-12#1)(2007-6#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
remain amongst the##2##3##(2007-8#1)(2011-2#1)
remain an area##2##3##(2006-10#1)(2008-1#1)
remain an important cause of##2##5##(1992-4#1)(2005-8#1)
remain an important##5##3##(1992-4#1)(2005-8#1)(2008-8#1)(2011-2#1)(2013-1#1)
remain an##12##2##(1991-12#1)(1992-4#1)(2005-8#1)(2006-10#2)(2007-10#1)(2008-1#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-11#1)(2013-1#1)
remain are##2##2##(2007-8#1)(2008-4#1)
remain as the##2##3##(2011-3#2)
remain as to whether##2##4##(1993-9#1)(2007-10#1)
remain as##9##2##(1991-11#1)(1993-9#1)(2007-10#1)(2007-11#1)(2008-2#1)(2008-7#1)(2010-12#1)(2011-3#2)
remain asymptomatic for long##2##4##(1991-5#1)(2011-2#1)
remain asymptomatic for##3##3##(1991-5#1)(2011-2#2)
remain asymptomatic##11##2##(1991-5#1)(2005-10#1)(2008-10#1)(2008-4#1)(2009-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
remain at a local##2##4##(1993-6#2)
remain at a##3##3##(1993-6#2)(2012-2#1)
remain at high risk##2##4##(1995-1#1)(2009-11#1)
remain at the##2##3##(2012-12#1)(2012-2#1)
remain at##14##2##(1992-8#1)(1993-6#2)(1995-1#1)(1996-12#1)(2008-5#1)(2008-8#3)(2009-11#2)(2012-12#1)(2012-2#2)
remain available for##4##3##(1992-3#1)(1996-1#1)(2007-11#1)(2008-10#1)
remain bound to##2##3##(1991-7#1)(1997-1#1)
remain challenging##5##2##(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
remain clinically##3##2##(2006-2#1)(2008-11#1)(2012-2#1)
remain concerning##2##2##(2007-7#1)(2009-6#1)
remain constant##4##2##(1995-7#1)(1995-9#1)(2008-10#1)(2011-12#1)
remain controversial and##2##3##(2006-11#1)(2010-8#1)
remain controversial##21##2##(1993-7#1)(2005-1#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-9#1)(2007-11#1)(2007-4#2)(2008-5#1)(2008-8#2)(2010-8#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
remain difficult##3##2##(2006-3#1)(2007-11#1)(2008-5#1)
remain elevated##2##2##(1997-7#1)(2011-2#1)
remain elusive##13##2##(2006-8#1)(2008-11#2)(2008-2#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)
remain enigmatic##2##2##(2012-2#2)
remain essential##3##2##(1992-3#1)(2006-10#1)(2010-7#1)
remain essentially##2##2##(2006-12#1)(2010-5#1)
remain extremely##2##2##(2006-10#1)(2012-3#1)
remain for the##2##3##(2008-11#1)(2008-7#1)
remain for##4##2##(2007-9#1)(2008-11#1)(2008-7#1)(2010-8#1)
remain free of##3##3##(1991-4#1)(1994-1#1)(2008-10#1)
remain functional##2##2##(2006-11#1)(2008-9#1)
remain functionally##2##2##(1994-5#1)(2012-11#1)
remain high and##2##3##(2006-10#1)(2012-1#1)
remain high##12##2##(1995-6#1)(2005-7#1)(2006-10#2)(2006-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2009-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
remain higher than##2##3##(2008-3#1)(2012-12#1)
remain higher##3##2##(2006-12#1)(2008-3#1)(2012-12#1)
remain highly##3##2##(1996-3#1)(2005-11#1)(2011-2#1)
remain however##2##2##(2006-10#1)(2007-2#1)
remain important##4##2##(2006-10#1)(2008-3#1)(2008-5#1)(2013-1#1)
remain in a##2##3##(2006-11#1)(2007-12#1)
remain in remission##2##3##(2006-2#1)(2008-1#1)
remain in terms of##3##4##(1997-5#1)(2007-11#1)(2013-1#1)
remain in the##12##3##(1991-7#1)(1994-12#1)(1995-9#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-12#2)(2008-6#1)(2008-7#1)(2008-9#1)(2012-2#1)
remain in these##2##3##(2007-5#1)(2011-1#1)
remain in##41##2##(1991-3#1)(1991-7#1)(1994-12#1)(1995-1#1)(1995-9#1)(1996-10#1)(1997-1#1)(1997-5#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-3#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
remain inadequate##2##2##(2008-7#1)(2012-3#1)
remain inadequately##2##2##(2008-4#1)(2008-8#1)
remain incompletely##2##2##(2007-9#1)(2010-12#1)
remain intact##7##2##(1991-5#1)(1991-7#1)(1992-10#1)(1996-3#1)(1996-5#1)(1996-6#1)(2008-4#1)
remain invariant##2##2##(2007-12#1)(2013-8#1)
remain involved##2##2##(2007-12#1)(2007-7#1)
remain largely unexplained##2##3##(2006-10#1)(2012-2#1)
remain largely unknown##7##3##(1995-11#1)(1995-12#1)(1996-9#1)(1997-6#1)(1997-7#1)(2006-8#1)(2011-2#1)
remain largely##12##2##(1993-1#1)(1995-11#1)(1995-12#1)(1996-9#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-8#1)(2010-12#1)(2011-2#1)(2012-2#2)
remain leading##2##2##(2012-12#1)(2012-2#1)
remain limited##6##2##(2006-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-7#1)(2013-1#1)
remain low##5##2##(2007-11#1)(2008-8#1)(2010-3#1)(2011-1#1)(2012-12#1)
remain lower than##2##3##(2011-3#1)(2013-1#1)
remain major##2##2##(2008-11#1)(2008-12#1)
remain many unanswered questions##2##4##(2007-2#1)(2008-4#1)
remain many##4##2##(2007-2#1)(2008-4#2)(2012-3#1)
remain obscure##6##2##(1990-8#1)(1993-9#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-7#1)
remain of##2##2##(2008-3#1)(2008-5#1)
remain on##4##2##(1993-2#1)(2004-3#1)(2006-10#1)(2008-3#1)
remain parallel to##2##3##(1995-8#1)(2013-8#1)
remain poor##3##2##(2007-11#1)(2008-3#2)
remain poorly defined##3##3##(2009-8#1)(2010-11#1)(2011-2#1)
remain poorly understood##13##3##(1991-11#1)(1992-3#1)(1995-6#1)(2007-11#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-2#2)(2013-1#1)
remain poorly##17##2##(1991-11#1)(1992-3#1)(1995-6#1)(1997-4#1)(2007-11#1)(2008-9#1)(2009-11#1)(2009-8#2)(2010-11#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
remain regarding##4##2##(2007-9#1)(2010-6#1)(2011-2#1)(2013-1#1)
remain relatively##9##2##(1993-12#1)(2006-2#1)(2007-5#1)(2007-8#2)(2008-10#2)(2008-2#1)(2010-4#1)
remain relevant##3##2##(1996-3#1)(2011-2#2)
remain responsive to##2##3##(1996-5#1)(1997-1#1)
remain sharp##2##2##(1991-11#1)(1997-4#1)
remain significant##4##2##(2006-4#1)(2007-2#1)(2008-6#2)
remain significantly##3##2##(1994-4#1)(2011-2#1)(2012-12#1)
remain similar##2##2##(1990-8#1)(2010-4#1)
remain speculative##3##2##(2006-10#1)(2007-1#1)(2007-8#1)
remain stable for##6##3##(1993-2#2)(2008-10#4)
remain stable##19##2##(1993-2#2)(1993-3#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-2#1)(2008-10#6)(2008-7#1)(2010-9#1)(2012-12#1)(2013-1#2)(2013-8#1)
remain still##2##2##(2006-12#1)(2011-2#1)
remain strong##2##2##(2007-6#1)(2008-11#1)
remain suboptimal##3##2##(2008-8#1)(2010-11#1)(2012-12#1)
remain susceptible to##3##3##(2005-8#1)(2008-10#2)
remain the best##2##3##(2006-9#1)(2008-10#1)
remain the cornerstone of##2##4##(1993-8#1)(2006-10#1)
remain the main##2##3##(2008-4#1)(2010-3#1)
remain the mainstay of treatment##2##5##(2008-3#1)(2010-2#1)
remain the mainstay of##5##4##(1995-5#1)(2008-3#1)(2010-2#1)(2011-2#1)(2013-7#1)
remain the mainstay##6##3##(1995-5#1)(2008-3#1)(2010-2#1)(2011-2#1)(2013-7#1)(2013-8#1)
remain the most common##2##4##(2006-6#1)(2008-7#1)
remain the most##4##3##(2005-7#1)(2006-6#1)(2008-7#1)(2009-1#1)
remain the primary##2##3##(2006-10#1)(2007-8#1)
remain the principal##3##3##(1991-12#1)(1997-6#1)(2005-11#1)
remain the same or##2##4##(1993-1#1)(2008-4#1)
remain the same##4##3##(1993-1#1)(2007-11#1)(2008-12#1)(2008-4#1)
remain the##49##2##(1990-10#1)(1990-2#1)(1991-12#1)(1993-1#1)(1993-8#1)(1994-2#1)(1995-5#1)(1997-3#1)(1997-6#1)(2004-1#1)(2005-11#1)(2005-7#2)(2006-10#3)(2006-2#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-7#1)(2009-1#1)(2009-6#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-7#1)(2011-2#1)(2011-9#1)(2013-1#1)(2013-7#2)(2013-8#2)
remain to be addressed##2##4##(1996-2#1)(2004-12#1)
remain to be answered##9##4##(1992-11#1)(1993-11#1)(1994-11#1)(2006-10#2)(2008-5#1)(2009-6#1)(2010-7#1)(2012-1#1)
remain to be characterized##2##4##(1996-5#1)(2010-9#1)
remain to be clarified##3##4##(1996-6#1)(2010-2#1)(2011-2#1)
remain to be determined##5##4##(1995-2#1)(2006-10#2)(2011-2#2)
remain to be developed##2##4##(2005-7#1)(2007-11#1)
remain to be discovered##2##4##(2008-10#1)(2008-8#1)
remain to be elucidated##10##4##(1990-5#1)(1993-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(2006-10#1)(2009-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
remain to be established##4##4##(1997-7#1)(2008-7#1)(2009-4#1)(2012-12#1)
remain to be explained##2##4##(1995-4#1)(1997-7#1)
remain to be fully elucidated##2##5##(2008-5#1)(2011-2#1)
remain to be fully##3##4##(2008-12#1)(2008-5#1)(2011-2#1)
remain to be identified##6##4##(1996-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-6#1)
remain to be investigated##3##4##(2008-4#1)(2012-12#1)(2013-8#1)
remain to be studied##2##4##(1991-10#1)(2007-10#1)
remain to be##67##3##(1990-5#1)(1990-8#1)(1991-10#1)(1992-11#1)(1992-5#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-4#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-7#2)(2004-12#1)(2005-7#1)(2006-10#6)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-3#1)(2009-4#1)(2009-6#2)(2010-2#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#2)
remain to##69##2##(1990-5#1)(1990-8#1)(1991-10#1)(1992-11#1)(1992-5#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-4#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-7#2)(2004-12#1)(2005-7#1)(2006-10#6)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2009-3#1)(2009-4#1)(2009-6#2)(2010-2#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#2)
remain unaffected##2##2##(2008-10#2)
remain unaltered##3##2##(1991-12#1)(1991-2#1)(2008-10#1)
remain unanswered##10##2##(1992-2#1)(1995-12#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-4#1)(2008-11#1)(2009-4#1)(2012-1#1)(2013-8#1)
remain uncertain##9##2##(1994-8#1)(2005-10#2)(2006-10#1)(2010-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
remain unchanged by##2##3##(1994-12#1)(2006-5#1)
remain unchanged##15##2##(1990-11#1)(1991-4#1)(1992-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-9#1)(2011-12#1)(2012-2#1)(2013-1#1)
remain unclear##36##2##(1993-7#1)(1995-12#2)(1995-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-7#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#2)(2009-4#1)(2009-8#1)(2011-2#3)(2012-12#3)(2012-2#1)
remain undefined##2##2##(1992-4#1)(1997-3#1)
remain underdiagnosed##3##2##(2007-12#1)(2013-8#2)
remain underused##2##2##(2007-10#1)(2012-11#1)
remain undescribed##2##2##(2008-10#2)
remain undetected##4##2##(2007-6#2)(2008-5#1)(2010-2#1)
remain undetermined##2##2##(2008-1#1)(2008-9#1)
remain undiagnosed##3##2##(1991-11#1)(2007-7#1)(2012-11#1)
remain undiscovered##2##2##(1994-2#1)(2013-8#1)
remain unexplored##2##2##(2012-2#2)
remain unidentified##3##2##(1994-8#1)(2007-6#1)(2008-12#1)
remain unknown##24##2##(1991-4#1)(1993-8#1)(1994-8#1)(1996-2#1)(1997-6#1)(2005-8#1)(2006-2#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-8#1)(2012-12#2)(2013-8#3)
remain unloaded##2##2##(2013-1#2)
remain unresolved##6##2##(1995-8#1)(2006-10#1)(2008-10#1)(2008-7#1)(2010-10#1)(2010-7#1)
remain unsolved##2##2##(2010-3#1)(2013-7#1)
remain unsure##2##2##(1992-10#1)(2008-11#1)
remain untreated##2##2##(2007-10#2)
remain valid##3##2##(2007-11#1)(2008-2#1)(2008-4#1)
remain very##3##2##(1997-1#1)(2008-2#1)(2012-2#1)
remain viable for##5##3##(2007-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
remain viable##11##2##(1994-12#1)(1996-1#1)(1997-3#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-4#1)(2009-5#1)
remain vigilant##3##2##(2006-8#1)(2011-2#2)
remain with##4##2##(1991-1#1)(1996-7#1)(2006-9#1)(2009-4#1)
remain within##2##2##(1990-3#1)(2006-6#1)
remain##950##1##(1990-10#2)(1990-11#1)(1990-2#1)(1990-3#2)(1990-5#2)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#5)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#3)(1991-5#2)(1991-7#3)(1991-8#1)(1992-10#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#4)(1992-4#3)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#1)(1993-5#1)(1993-6#4)(1993-7#2)(1993-8#4)(1993-9#6)(1994-1#1)(1994-11#3)(1994-12#4)(1994-2#5)(1994-3#3)(1994-4#2)(1994-5#5)(1994-6#1)(1994-8#4)(1995-1#3)(1995-11#1)(1995-12#5)(1995-2#2)(1995-4#1)(1995-5#4)(1995-6#2)(1995-7#1)(1995-8#5)(1995-9#3)(1996-1#4)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#3)(1996-3#4)(1996-5#5)(1996-6#3)(1996-7#3)(1996-8#3)(1996-9#3)(1997-1#5)(1997-3#4)(1997-4#3)(1997-5#2)(1997-6#6)(1997-7#6)(1997-8#1)(2004-1#2)(2004-10#1)(2004-12#1)(2004-3#1)(2005-1#1)(2005-10#7)(2005-11#6)(2005-5#1)(2005-7#7)(2005-8#4)(2005-9#1)(2006-10#49)(2006-11#4)(2006-12#4)(2006-2#8)(2006-3#3)(2006-4#3)(2006-5#4)(2006-6#7)(2006-7#3)(2006-8#4)(2006-9#7)(2007-1#3)(2007-10#11)(2007-11#18)(2007-12#18)(2007-2#9)(2007-4#6)(2007-5#3)(2007-6#8)(2007-7#10)(2007-8#13)(2007-9#5)(2008-1#15)(2008-10#50)(2008-11#23)(2008-12#9)(2008-2#12)(2008-3#14)(2008-4#15)(2008-5#18)(2008-6#7)(2008-7#19)(2008-8#23)(2008-9#13)(2009-1#2)(2009-10#6)(2009-11#4)(2009-2#6)(2009-3#2)(2009-4#6)(2009-5#2)(2009-6#6)(2009-7#1)(2009-8#7)(2009-9#4)(2010-1#1)(2010-10#2)(2010-11#5)(2010-12#9)(2010-2#5)(2010-3#5)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#5)(2010-8#8)(2010-9#5)(2011-1#9)(2011-12#3)(2011-2#42)(2011-3#3)(2011-7#1)(2011-9#1)(2012-1#8)(2012-11#4)(2012-12#33)(2012-2#31)(2012-3#10)(2012-5#1)(2013-1#33)(2013-7#5)(2013-8#23)
remainder of the protein is##2##5##(1990-9#1)(1993-12#1)
remainder of the##28##3##(1990-6#1)(1990-9#1)(1991-12#1)(1992-4#1)(1993-1#1)(1993-12#1)(1994-3#2)(1994-9#1)(1996-1#1)(1996-9#1)(1997-1#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-9#3)(2008-10#3)(2008-11#1)(2008-2#1)(2010-10#1)(2011-1#1)(2011-12#2)
remainder of##35##2##(1990-6#1)(1990-9#1)(1991-12#1)(1991-9#1)(1992-4#1)(1993-1#1)(1993-12#1)(1994-3#2)(1994-9#1)(1996-1#1)(1996-9#1)(1997-1#1)(1997-2#1)(2005-8#1)(2006-2#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-9#3)(2008-10#3)(2008-11#1)(2008-2#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-12#2)(2012-2#1)(2013-8#1)
remainder was##3##2##(1990-5#1)(1993-11#1)(1996-8#1)
remainder were##7##2##(1993-7#1)(1997-3#1)(1997-4#3)(2006-3#1)(2008-9#1)
remainder##87##1##(1990-5#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-3#1)(1992-4#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-11#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#4)(2004-2#1)(2005-8#1)(2006-2#1)(2006-3#3)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-10#2)(2009-3#1)(2010-10#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-2#2)(2013-8#3)
remained a mystery##3##3##(2007-8#1)(2007-9#1)(2008-5#1)
remained a##14##2##(1990-9#1)(1993-10#1)(1993-2#1)(1996-12#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-5#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
remained about the same##2##4##(2007-2#1)(2008-10#1)
remained above##4##2##(1993-7#1)(1994-11#1)(2008-10#1)(2013-1#1)
remained active##4##2##(1990-2#1)(1995-11#1)(2006-1#1)(2008-10#1)
remained after adjusting for##3##4##(2008-3#1)(2012-12#1)(2012-3#1)
remained after the##2##3##(1996-12#1)(2007-6#1)
remained after##11##2##(1993-12#1)(1994-6#1)(1996-1#1)(1996-12#1)(2004-9#1)(2007-6#1)(2008-10#1)(2008-3#1)(2010-8#1)(2012-12#1)(2012-3#1)
remained alive##3##2##(2008-11#1)(2008-5#1)(2008-6#1)
remained almost constant##3##3##(1990-10#1)(2007-12#1)(2007-6#1)
remained almost unchanged##3##3##(1990-5#1)(2008-5#1)(2008-7#1)
remained almost##7##2##(1990-10#1)(1990-5#1)(1991-12#1)(2007-12#1)(2007-6#1)(2008-5#1)(2008-7#1)
remained an enigma##3##3##(1994-11#1)(1997-4#1)(2010-12#1)
remained an important##2##3##(2008-5#1)(2012-12#1)
remained an##8##2##(1994-11#1)(1995-11#1)(1997-4#1)(2008-5#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-12#1)
remained approximately##4##2##(1993-9#1)(1997-1#1)(2008-6#1)(2011-2#1)
remained around##2##2##(2006-5#1)(2010-12#1)
remained as such##3##3##(1990-5#1)(1990-8#1)(2007-7#1)
remained as##6##2##(1990-5#1)(1990-8#1)(2005-11#1)(2007-7#1)(2008-10#1)(2011-2#1)
remained associated with##4##3##(1994-12#1)(2007-10#1)(2012-1#2)
remained associated##5##2##(1992-3#1)(1994-12#1)(2007-10#1)(2012-1#2)
remained asymptomatic with no evidence of##2##6##(2008-4#1)(2008-5#1)
remained asymptomatic with##3##3##(2008-4#1)(2008-5#1)(2013-8#1)
remained asymptomatic##5##2##(1991-3#1)(2006-6#1)(2008-4#1)(2008-5#1)(2013-8#1)
remained at 6##2##3##(2008-10#1)(2008-12#1)
remained at a high level##2##5##(1992-11#1)(2012-12#1)
remained at a low level##2##5##(1997-8#1)(2003-11#1)
remained at a low##3##4##(1997-8#1)(2003-11#1)(2008-10#1)
remained at a##7##3##(1992-11#1)(1997-8#1)(2003-11#1)(2006-10#2)(2008-10#1)(2012-12#1)
remained at baseline##2##3##(2006-12#1)(2007-12#1)
remained at its##2##3##(1990-2#1)(1995-1#1)
remained at low##2##3##(1996-11#1)(2007-9#1)
remained at the##6##3##(1990-7#1)(1996-6#1)(2006-12#1)(2007-1#1)(2007-7#1)(2013-1#1)
remained at this##3##3##(1991-7#1)(2007-10#1)(2013-1#1)
remained at##35##2##(1990-2#1)(1990-4#1)(1990-7#1)(1991-7#1)(1992-11#1)(1993-3#1)(1994-11#1)(1995-1#1)(1995-9#1)(1996-11#4)(1996-5#1)(1996-6#1)(1997-8#1)(2003-11#1)(2006-10#2)(2006-12#2)(2007-1#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#2)(2008-7#1)(2012-12#1)(2013-1#2)
remained attached to the##3##4##(1996-7#1)(2008-5#1)(2013-1#1)
remained below the normal level##2##5##(2012-1#2)
remained below the##3##3##(2007-9#1)(2012-1#2)
remained below##8##2##(2007-7#1)(2007-9#1)(2008-1#2)(2009-5#1)(2012-1#2)(2013-1#1)
remained bound##2##2##(1992-6#2)
remained clinically stable##2##3##(2005-7#1)(2006-11#1)
remained comparable to##2##3##(1992-3#1)(2008-10#1)
remained comparable##4##2##(1991-5#1)(1992-3#1)(2008-10#1)(2012-3#1)
remained constant during the##2##4##(1992-12#1)(1995-11#1)
remained constant for##2##3##(1991-3#1)(2008-7#1)
remained constant over the##4##4##(1994-6#1)(2012-2#1)(2013-8#2)
remained constant##36##2##(1990-5#1)(1991-2#1)(1991-3#1)(1991-6#2)(1992-11#1)(1992-12#1)(1992-4#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1995-11#1)(1995-2#1)(1996-10#1)(1997-1#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#3)(2011-2#2)(2012-2#1)(2012-8#1)(2013-8#3)
remained constantly##2##2##(1997-6#1)(2010-1#1)
remained dependent on##2##3##(1993-2#1)(1996-4#1)
remained depleted##2##2##(1991-8#1)(2013-8#1)
remained disease-free##2##2##(1992-6#1)(2008-4#1)
remained dominant##2##2##(2008-10#1)(2008-5#1)
remained effective##2##2##(2008-10#2)
remained elevated above control##2##4##(1992-3#1)(1996-9#1)
remained elevated above##3##3##(1990-5#1)(1992-3#1)(1996-9#1)
remained elevated during the##2##4##(1993-1#1)(1995-1#1)
remained elevated during##3##3##(1993-1#1)(1994-2#1)(1995-1#1)
remained elevated in##5##3##(1994-3#1)(1994-5#1)(1995-12#1)(1996-12#1)(2007-10#1)
remained elevated until##2##3##(1994-10#1)(1997-3#1)
remained elevated##22##2##(1990-5#1)(1991-5#1)(1992-3#1)(1993-1#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1995-1#2)(1995-12#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-3#1)(2006-7#1)(2007-10#1)(2013-1#1)(2013-7#1)
remained elusive##13##2##(1995-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-1#1)(2010-6#1)(2012-12#2)
remained enigmatic##5##2##(1995-8#1)(1996-5#1)(2007-8#1)(2009-8#1)(2010-1#1)
remained essentially constant##3##3##(1991-2#1)(1994-1#1)(1994-10#1)
remained essentially identical##2##3##(2008-10#1)(2008-11#1)
remained essentially unaltered##2##3##(1992-9#1)(1994-11#1)
remained essentially unchanged##4##3##(1992-6#1)(1996-1#1)(1996-11#1)(2008-10#1)
remained essentially##11##2##(1991-2#1)(1992-6#1)(1992-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1996-1#1)(1996-11#1)(2008-10#2)(2008-11#1)
remained even after##2##3##(2008-5#1)(2011-1#1)
remained fairly constant##2##3##(1994-9#1)(2008-10#1)
remained fairly stable##2##3##(1990-12#2)
remained fairly##5##2##(1990-12#2)(1992-6#1)(1994-9#1)(2008-10#1)
remained for the##2##3##(2008-12#1)(2013-8#1)
remained for##5##2##(2006-7#1)(2007-9#1)(2008-10#1)(2008-12#1)(2013-8#1)
remained free of disease##2##4##(2006-11#1)(2010-2#1)
remained free of##5##3##(2005-11#1)(2006-11#1)(2007-7#1)(2008-10#1)(2010-2#1)
remained greater than##2##3##(1992-8#1)(2008-10#1)
remained high at##2##3##(1994-9#1)(2011-2#1)
remained high in the##2##4##(1993-12#1)(2011-2#1)
remained high in##4##3##(1993-12#1)(2008-4#1)(2011-2#1)(2012-3#1)
remained high throughout the##2##4##(2008-10#2)
remained high##18##2##(1992-6#1)(1993-12#1)(1994-6#1)(1994-9#1)(1995-2#1)(1996-12#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)(2011-2#3)(2012-3#2)
remained higher than in##3##4##(1996-3#1)(2007-10#1)(2008-10#1)
remained higher than##4##3##(1991-8#1)(1996-3#1)(2007-10#1)(2008-10#1)
remained higher##8##2##(1991-8#1)(1992-5#1)(1993-7#1)(1994-12#1)(1996-3#1)(2007-10#1)(2007-8#1)(2008-10#1)
remained highly##3##2##(2008-10#2)(2008-7#1)
remained in a##3##3##(1991-11#1)(2010-6#1)(2012-3#1)
remained in place for##2##4##(2006-6#1)(2008-5#1)
remained in place##4##3##(2006-6#1)(2006-8#1)(2008-5#1)(2009-4#1)
remained in the final##2##4##(2008-10#1)(2008-3#1)
remained in the##18##3##(1990-3#1)(1991-8#1)(1993-3#1)(1996-3#1)(2006-12#1)(2007-10#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2010-2#1)(2011-2#2)(2012-2#2)
remained in##46##2##(1990-3#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-6#1)(1991-8#1)(1993-3#1)(1993-7#1)(1994-12#1)(1995-1#1)(1996-3#1)(1997-1#1)(1997-5#1)(1997-6#1)(2004-3#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-4#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)
remained incomplete##2##2##(1994-11#1)(2012-3#1)
remained independent of##2##3##(1990-11#1)(2008-3#1)
remained indeterminate##2##2##(2007-3#2)
remained intact in##2##3##(1997-7#1)(2008-5#1)
remained intact##10##2##(1991-4#1)(1993-3#1)(1994-8#1)(1996-12#1)(1997-7#1)(2006-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2012-12#1)
remained largely unchanged##4##3##(1990-3#1)(1991-8#1)(2006-10#1)(2012-3#1)
remained largely##11##2##(1990-3#1)(1991-8#1)(1996-6#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-9#1)(2010-3#1)(2012-12#1)(2012-3#1)
remained limited##4##2##(2007-8#1)(2008-2#1)(2009-11#1)(2010-1#1)
remained low for##3##3##(2008-10#1)(2009-10#1)(2013-8#1)
remained low in##3##3##(1992-7#1)(2010-1#1)(2010-12#1)
remained low##17##2##(1990-8#1)(1990-9#1)(1992-7#1)(1994-2#1)(1995-3#1)(1997-6#1)(2008-10#2)(2008-4#1)(2009-10#1)(2010-1#1)(2010-12#1)(2010-8#2)(2011-1#1)(2012-12#1)(2013-8#1)
remained lower in##2##3##(2008-10#1)(2008-3#1)
remained lower##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
remained minimal##2##2##(2008-10#1)(2011-2#1)
remained moist##3##2##(2008-10#3)
remained mostly##4##2##(1992-11#1)(1995-10#1)(2011-1#2)
remained negative##8##2##(1990-6#1)(1991-6#1)(1996-11#1)(1997-5#1)(2005-11#1)(2007-12#1)(2008-1#1)(2011-2#1)
remained neurologically intact##2##3##(2008-7#1)(2009-3#1)
remained normal in##2##3##(2006-6#1)(2007-7#1)
remained normal##8##2##(1991-3#1)(1994-5#1)(1996-9#1)(2006-6#1)(2007-7#1)(2008-7#2)(2010-4#1)
remained obscure until##2##3##(1993-9#1)(2009-10#1)
remained obscure##6##2##(1990-3#1)(1993-9#2)(1997-6#1)(2007-9#1)(2009-10#1)
remained on the##6##3##(1992-11#1)(1994-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
remained on##10##2##(1992-11#1)(1994-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-9#1)(2012-12#1)(2013-7#1)
remained positive and the##2##4##(1994-12#1)(1996-12#1)
remained positive##10##2##(1993-11#1)(1993-9#1)(1994-12#1)(1995-5#1)(1996-12#1)(2007-7#1)(2008-1#1)(2008-5#1)(2009-8#1)(2013-8#1)
remained relatively constant##6##3##(1992-5#1)(2008-10#3)(2008-11#1)(2012-2#1)
remained relatively free##2##3##(1996-5#1)(2010-4#1)
remained relatively stable##8##3##(1993-11#1)(1995-5#1)(2007-5#1)(2007-7#2)(2008-8#1)(2008-9#1)(2013-1#1)
remained relatively unchanged##2##3##(2008-10#1)(2008-8#1)
remained relatively##22##2##(1992-5#1)(1993-11#1)(1994-11#1)(1995-5#1)(1996-5#1)(2007-11#1)(2007-5#1)(2007-7#2)(2008-10#4)(2008-11#2)(2008-8#2)(2008-9#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
remained responsive to##3##3##(1990-4#1)(1995-2#1)(1995-3#1)
remained satisfactory##2##2##(1991-8#1)(2007-8#1)
remained significant after adjusting for##2##5##(2012-5#1)(2013-1#1)
remained significant##13##2##(1993-4#1)(1996-1#1)(1997-5#1)(1997-6#1)(2008-10#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-5#1)(2013-1#3)
remained significantly associated with##2##4##(1995-9#1)(2008-7#1)
remained significantly higher##3##3##(1992-8#1)(1997-7#1)(2008-10#1)
remained significantly larger##2##3##(2007-8#1)(2009-2#1)
remained significantly reduced##2##3##(1992-12#1)(2010-9#1)
remained significantly##14##2##(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1995-9#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-7#2)(2009-2#1)(2010-9#1)(2011-2#2)
remained similar##4##2##(2006-10#1)(2008-10#1)(2009-5#1)(2012-12#1)
remained so##5##2##(2007-1#1)(2007-7#2)(2008-10#1)(2010-3#1)
remained stable at##8##3##(1991-8#1)(1993-3#1)(1994-6#1)(2007-6#1)(2008-10#1)(2010-9#1)(2011-1#1)(2012-3#1)
remained stable during the##2##4##(2011-2#1)(2012-1#1)
remained stable for##4##3##(1993-9#1)(1996-9#1)(2006-10#1)(2010-4#1)
remained stable in the##2##4##(1997-7#1)(2008-10#1)
remained stable in##5##3##(1991-6#1)(1993-4#1)(1997-7#1)(2008-1#1)(2008-10#1)
remained stable over 14 years##2##5##(2012-12#2)
remained stable over##5##3##(2012-12#4)(2013-1#1)
remained stable throughout##3##3##(1995-2#1)(2007-8#1)(2007-9#1)
remained stable with##2##3##(2008-1#1)(2012-2#1)
remained stable##55##2##(1991-6#1)(1991-8#1)(1993-3#1)(1993-4#1)(1993-9#2)(1994-2#1)(1994-6#2)(1995-2#1)(1995-5#1)(1996-9#2)(1997-7#1)(2005-12#1)(2006-10#2)(2006-11#1)(2007-12#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-5#3)(2008-7#2)(2010-1#1)(2010-11#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#1)
remained susceptible to##2##3##(2008-10#1)(2013-1#1)
remained susceptible##3##2##(2008-10#2)(2013-1#1)
remained symptomatic##2##2##(2005-7#1)(2012-2#1)
remained the most##3##3##(2006-10#1)(2006-8#1)(2010-1#1)
remained the same in all age groups##2##7##(2008-4#2)
remained the same in##5##4##(2007-8#2)(2008-4#3)
remained the same##11##3##(1992-5#1)(1994-2#1)(1995-6#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#3)
remained the##19##2##(1992-5#1)(1994-2#1)(1995-6#1)(1996-3#1)(2005-8#1)(2006-10#2)(2006-8#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#3)(2010-1#1)(2012-2#1)
remained to be##3##3##(1990-5#1)(2006-8#1)(2008-11#1)
remained unaffected by DEPC##2##4##(1991-9#2)
remained unaffected by##4##3##(1991-9#2)(2008-10#1)(2009-12#1)
remained unaffected##16##2##(1990-12#1)(1990-5#2)(1991-10#1)(1991-9#3)(1992-12#1)(1993-9#1)(1996-1#1)(2005-8#1)(2008-10#2)(2008-8#1)(2009-12#1)(2012-8#1)
remained unaltered##12##2##(1990-7#1)(1991-2#1)(1994-11#1)(1994-2#1)(1994-8#1)(2008-11#3)(2008-3#1)(2008-5#1)(2009-4#1)(2011-2#1)
remained uncertain##5##2##(1992-4#1)(1996-4#1)(2007-12#1)(2008-10#1)(2008-3#1)
remained unchanged after##4##3##(1991-2#1)(1991-8#1)(1996-10#1)(1997-1#1)
remained unchanged during the##3##4##(1990-10#1)(1996-7#1)(2008-5#1)
remained unchanged during##4##3##(1990-10#1)(1991-10#1)(1996-7#1)(2008-5#1)
remained unchanged even##2##3##(1990-8#1)(2009-4#1)
remained unchanged for the##2##4##(1991-11#1)(1995-3#1)
remained unchanged for##6##3##(1991-11#1)(1992-3#1)(1992-6#1)(1995-3#1)(1995-8#1)(2007-7#1)
remained unchanged in the##5##4##(1990-12#1)(1991-6#1)(1996-12#1)(2007-2#1)(2011-2#1)
remained unchanged in##13##3##(1990-12#1)(1991-6#1)(1992-11#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-10#1)(1996-1#1)(1996-12#1)(2006-11#1)(2007-2#1)(2011-2#1)(2013-1#1)
remained unchanged or decreased##2##4##(2007-8#1)(2008-10#1)
remained unchanged over the##2##4##(2007-7#1)(2008-10#1)
remained unchanged over##3##3##(1992-10#1)(2007-7#1)(2008-10#1)
remained unchanged throughout the##4##4##(1991-2#1)(1995-9#1)(2008-7#2)
remained unchanged until##2##3##(1990-2#1)(1992-1#1)
remained unchanged with##4##3##(1995-5#1)(2007-1#1)(2008-7#1)(2011-2#1)
remained unchanged##105##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-6#2)(1991-8#2)(1992-1#2)(1992-10#1)(1992-11#1)(1992-3#1)(1992-6#2)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-10#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#1)(1996-7#1)(1997-1#2)(1997-8#1)(2004-10#1)(2005-11#1)(2006-10#2)(2006-11#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2009-3#2)(2009-4#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#3)
remained unclear##7##2##(1997-4#1)(2007-2#1)(2008-10#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-11#1)
remained under the##3##3##(1993-12#1)(2006-8#1)(2011-2#1)
remained under##7##2##(1993-12#1)(2006-8#1)(2007-10#1)(2008-5#2)(2010-8#1)(2011-2#1)
remained undiagnosed##2##2##(2006-10#1)(2008-5#1)
remained uninfected##2##2##(2008-10#2)
remained unknown##8##2##(1990-4#1)(1992-5#1)(1996-8#1)(2007-11#1)(2008-11#2)(2009-8#1)(2011-2#1)
remained unresolved##2##2##(1993-6#1)(2006-10#1)
remained untreated##3##2##(1992-5#1)(2008-7#1)(2013-8#1)
remained very##2##2##(2005-12#1)(2008-10#1)
remained viable in##3##3##(2004-4#1)(2010-11#1)(2010-9#1)
remained viable##6##2##(2004-4#1)(2008-10#1)(2008-11#2)(2010-11#1)(2010-9#1)
remained virtually unchanged##2##3##(1992-11#1)(2009-12#1)
remained virtually##4##2##(1990-3#1)(1990-5#1)(1992-11#1)(2009-12#1)
remained well##5##2##(1997-5#1)(2006-10#1)(2006-4#1)(2008-7#1)(2012-3#1)
remained with##4##2##(2006-8#1)(2007-3#1)(2008-1#1)(2013-1#1)
remained within normal limits throughout the##2##6##(2007-9#1)(2010-7#1)
remained within normal limits##3##4##(2007-9#1)(2008-1#1)(2010-7#1)
remained within normal##5##3##(1997-5#1)(2007-9#1)(2008-1#1)(2008-5#1)(2010-7#1)
remained within the normal range##2##5##(2008-6#1)(2011-11#1)
remained within the normal reference range##2##6##(2006-5#2)
remained within the normal##4##4##(2006-5#2)(2008-6#1)(2011-11#1)
remained within the##6##3##(2006-5#2)(2006-9#1)(2008-6#1)(2011-11#1)(2013-1#1)
remained within##16##2##(1992-7#1)(1997-5#1)(2006-5#2)(2006-9#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-6#2)(2010-7#1)(2011-11#1)(2012-1#1)(2013-1#1)
remained without##3##2##(1992-11#1)(2004-4#1)(2006-6#1)
remained##963##1##(1990-10#3)(1990-11#4)(1990-12#6)(1990-2#3)(1990-3#5)(1990-4#3)(1990-5#9)(1990-6#3)(1990-7#3)(1990-8#3)(1990-9#5)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#9)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#7)(1991-7#1)(1991-8#8)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#7)(1992-12#3)(1992-3#7)(1992-4#4)(1992-5#6)(1992-6#10)(1992-7#2)(1992-8#3)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#8)(1993-2#4)(1993-3#4)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#4)(1993-8#3)(1993-9#9)(1994-1#1)(1994-10#2)(1994-11#11)(1994-12#7)(1994-2#7)(1994-3#4)(1994-5#4)(1994-6#5)(1994-8#2)(1994-9#3)(1995-1#4)(1995-10#3)(1995-11#4)(1995-12#4)(1995-2#8)(1995-3#4)(1995-5#7)(1995-6#2)(1995-7#1)(1995-8#4)(1995-9#3)(1996-1#6)(1996-10#2)(1996-11#8)(1996-12#12)(1996-2#1)(1996-3#3)(1996-4#3)(1996-5#4)(1996-6#3)(1996-7#2)(1996-8#1)(1996-9#6)(1997-1#6)(1997-3#1)(1997-4#5)(1997-5#5)(1997-6#6)(1997-7#4)(1997-8#3)(2003-11#1)(2004-10#1)(2004-3#1)(2004-4#2)(2004-9#1)(2005-11#4)(2005-12#3)(2005-4#1)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#15)(2006-11#7)(2006-12#8)(2006-3#1)(2006-4#2)(2006-5#4)(2006-6#5)(2006-7#2)(2006-8#5)(2006-9#1)(2007-1#3)(2007-10#10)(2007-11#6)(2007-12#11)(2007-2#6)(2007-3#3)(2007-4#2)(2007-5#1)(2007-6#4)(2007-7#20)(2007-8#22)(2007-9#12)(2008-1#17)(2008-10#83)(2008-11#26)(2008-12#5)(2008-2#3)(2008-3#11)(2008-4#11)(2008-5#27)(2008-6#11)(2008-7#24)(2008-8#4)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#4)(2009-4#4)(2009-5#3)(2009-6#2)(2009-8#7)(2009-9#1)(2010-1#9)(2010-10#2)(2010-11#3)(2010-12#9)(2010-2#2)(2010-3#5)(2010-4#3)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#7)(2010-9#3)(2011-1#13)(2011-11#1)(2011-2#30)(2011-3#1)(2011-9#1)(2012-1#10)(2012-11#1)(2012-12#21)(2012-2#13)(2012-3#12)(2012-5#2)(2012-8#2)(2013-1#21)(2013-7#3)(2013-8#15)
remaining 1##2##2##(1996-6#1)(2013-8#1)
remaining 11 patients##2##3##(1997-4#1)(2006-12#1)
remaining 11##3##2##(1997-4#1)(2006-12#1)(2013-1#1)
remaining 16##2##2##(2006-2#1)(2006-8#1)
remaining 2 patients##2##3##(2007-11#1)(2011-1#1)
remaining 2##7##2##(1994-12#1)(1996-3#1)(2007-11#1)(2008-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
remaining 20##3##2##(1996-2#1)(2008-10#1)(2008-4#1)
remaining 29##2##2##(1990-12#1)(2009-9#1)
remaining 3##8##2##(1993-12#1)(1993-2#1)(2005-8#1)(2007-10#1)(2007-8#1)(2008-4#1)(2008-7#1)(2008-8#1)
remaining 4 patients##2##3##(1996-11#1)(2007-10#1)
remaining 4##9##2##(1993-9#1)(1996-11#2)(1997-6#2)(2007-10#1)(2007-6#1)(2008-11#1)(2008-7#1)
remaining 47 patients##2##3##(2007-11#1)(2008-1#1)
remaining 6 patients##2##3##(1991-9#1)(1992-10#1)
remaining 6##4##2##(1991-9#1)(1992-10#1)(2010-12#1)(2013-1#1)
remaining 81%##2##2##(1995-6#1)(2013-1#1)
remaining 9##3##2##(1991-10#1)(2007-10#1)(2008-8#1)
remaining G##2##2##(2007-12#2)
remaining ORFs##2##2##(1995-6#1)(1997-3#1)
remaining activity)##2##2##(2013-1#2)
remaining after##8##2##(1991-1#1)(1995-6#1)(1997-4#1)(2006-10#1)(2009-3#2)(2009-9#1)(2013-8#1)
remaining as a##2##3##(2006-4#1)(2010-11#1)
remaining asymptomatic##2##2##(2008-1#1)(2008-4#1)
remaining at##3##2##(2008-10#1)(2008-11#1)(2009-10#1)
remaining binding sites are blocked by immersing the membrane in a##2##11##(2008-4#2)
remaining binding##3##2##(1994-2#1)(2008-4#2)
remaining cases##6##2##(1995-11#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-4#1)
remaining cell##2##2##(1993-2#1)(2012-4#1)
remaining cells##3##2##(1990-5#1)(1991-5#1)(2008-10#1)
remaining challenges##5##2##(2009-5#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-11#1)
remaining children##2##2##(1996-8#1)(2011-2#1)
remaining compounds##3##2##(1995-3#1)(2008-10#1)(2008-3#1)
remaining constant##3##2##(1994-4#1)(2008-5#1)(2013-1#1)
remaining coordination sites##2##3##(1997-7#1)(2008-5#1)
remaining dopaminergic##2##2##(1996-12#2)
remaining enzyme activity##4##3##(1991-5#3)(2008-6#1)
remaining females entered the 392-day##3##5##(1997-4#3)
remaining five##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
remaining four patients##3##3##(1990-9#1)(1991-8#1)(2008-7#1)
remaining four##9##2##(1990-9#1)(1991-12#1)(1991-8#1)(1993-12#1)(1993-6#1)(2008-10#2)(2008-5#1)(2008-7#1)
remaining free##3##2##(2006-2#1)(2012-11#2)
remaining from##2##2##(2008-10#1)(2008-3#1)
remaining genes##2##2##(1997-4#1)(2007-12#1)
remaining green leaf area##2##4##(2008-10#2)
remaining high##2##2##(1991-11#1)(1996-11#1)
remaining in the##11##3##(1990-12#1)(1990-8#1)(1995-9#1)(1997-5#1)(1997-8#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-6#1)(2008-10#1)(2008-4#1)
remaining in##21##2##(1990-12#1)(1990-8#1)(1994-6#1)(1995-6#1)(1995-9#1)(1997-3#1)(1997-5#1)(1997-8#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-4#2)(2011-2#2)(2012-2#2)
remaining intact##4##2##(1992-5#1)(1993-3#1)(2006-11#1)(2007-10#1)
remaining isolates were of the US-8 strain##2##7##(2008-10#2)
remaining isolates were##3##3##(2008-10#3)
remaining isolates##6##2##(2008-10#6)
remaining kidney##2##2##(2006-7#1)(2008-8#1)
remaining life expectancy##3##3##(1993-11#1)(1994-6#1)(2006-10#1)
remaining life##5##2##(1993-11#1)(1994-6#1)(2006-10#1)(2006-2#1)(2011-2#1)
remaining neurons##3##2##(1995-10#1)(1995-5#1)(1997-2#1)
remaining nidus and##2##3##(2008-7#2)
remaining nidus##5##2##(2008-7#5)
remaining nine subjects##2##3##(2007-7#1)(2009-1#1)
remaining nine##3##2##(2007-7#1)(2008-11#1)(2009-1#1)
remaining on the##2##3##(1994-12#1)(2008-4#1)
remaining on##3##2##(1994-12#1)(2008-4#1)(2013-7#1)
remaining ones##3##2##(1993-2#1)(2007-11#1)(2012-2#1)
remaining part of the##4##4##(2008-7#2)(2011-2#2)
remaining part of##5##3##(2008-7#2)(2011-2#2)(2012-1#1)
remaining part##6##2##(2008-10#1)(2008-7#2)(2011-2#2)(2012-1#1)
remaining patients have##2##3##(2007-8#1)(2010-10#1)
remaining patients in##2##3##(2007-7#1)(2012-2#1)
remaining patients##25##2##(1990-11#1)(1990-12#1)(1991-12#1)(1992-11#1)(1992-5#1)(1992-9#1)(1995-1#1)(2006-5#1)(2006-8#1)(2007-7#3)(2007-8#2)(2008-3#1)(2008-4#1)(2008-6#2)(2010-10#2)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#2)
remaining questions##3##2##(2006-6#1)(2007-8#1)(2008-4#1)
remaining six##6##2##(1991-6#1)(1995-11#1)(1995-2#1)(1997-2#1)(2007-3#1)(2007-8#1)
remaining solution##2##2##(2008-10#1)(2008-11#1)
remaining species##3##2##(2008-10#1)(2008-2#1)(2013-8#1)
remaining strains##2##2##(2008-10#1)(2009-6#1)
remaining three patients##3##3##(1991-12#1)(2008-1#1)(2008-3#1)
remaining three##9##2##(1991-12#1)(1992-6#1)(1997-3#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-3#1)(2009-2#1)
remaining to be##2##3##(2006-9#1)(2008-10#1)
remaining treatment##2##2##(2007-7#1)(2009-6#1)
remaining two##14##2##(1992-5#1)(1993-2#1)(1993-5#1)(1995-1#1)(1995-3#1)(1997-3#1)(1997-7#1)(2004-7#1)(2006-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2009-2#1)(2012-2#1)
remaining vegetation##2##2##(2008-8#2)
remaining##649##1##(1990-1#1)(1990-10#1)(1990-11#3)(1990-12#5)(1990-4#3)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#2)(1991-10#3)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#4)(1991-4#3)(1991-5#6)(1991-6#2)(1991-8#3)(1991-9#2)(1992-10#4)(1992-11#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#4)(1992-6#2)(1992-8#2)(1992-9#2)(1993-1#2)(1993-11#5)(1993-12#5)(1993-2#6)(1993-3#4)(1993-5#3)(1993-6#4)(1993-7#1)(1993-8#2)(1993-9#1)(1994-12#4)(1994-2#2)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#2)(1995-1#2)(1995-10#2)(1995-11#4)(1995-12#1)(1995-2#3)(1995-3#8)(1995-4#1)(1995-5#1)(1995-6#9)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#2)(1996-11#4)(1996-12#7)(1996-2#4)(1996-3#3)(1996-6#2)(1996-8#4)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#6)(1997-4#8)(1997-5#1)(1997-6#2)(1997-7#5)(1997-8#2)(2004-10#1)(2004-12#3)(2004-7#1)(2004-9#2)(2005-11#5)(2005-8#2)(2006-10#4)(2006-11#4)(2006-12#6)(2006-2#4)(2006-3#1)(2006-4#4)(2006-5#4)(2006-6#2)(2006-7#1)(2006-8#5)(2006-9#2)(2007-1#1)(2007-10#10)(2007-11#7)(2007-12#14)(2007-2#6)(2007-3#3)(2007-4#1)(2007-5#3)(2007-6#8)(2007-7#11)(2007-8#13)(2007-9#5)(2008-1#11)(2008-10#66)(2008-11#9)(2008-12#3)(2008-2#8)(2008-3#11)(2008-4#20)(2008-5#17)(2008-6#8)(2008-7#17)(2008-8#13)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#5)(2009-4#4)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#4)(2009-9#7)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#2)(2010-4#2)(2010-6#1)(2010-8#2)(2011-1#5)(2011-10#1)(2011-2#15)(2012-1#2)(2012-11#3)(2012-12#3)(2012-2#9)(2012-3#6)(2012-4#1)(2013-1#15)(2013-7#3)(2013-8#8)
remains &quot##2##2##(1992-1#1)(2009-10#1)
remains a challenge for the##3##5##(2008-11#2)(2013-8#1)
remains a challenge for##6##4##(1993-7#1)(2008-11#3)(2013-7#1)(2013-8#1)
remains a challenge in##2##4##(2007-12#1)(2011-1#1)
remains a challenge##23##3##(1993-7#1)(1995-12#1)(1997-5#1)(2006-1#1)(2007-12#3)(2008-11#3)(2008-3#1)(2008-7#1)(2009-8#1)(2010-4#1)(2011-1#2)(2011-12#1)(2012-12#3)(2012-2#1)(2013-7#1)(2013-8#1)
remains a challenging clinical##2##4##(2005-8#1)(2010-6#1)
remains a challenging problem##3##4##(2010-4#1)(2010-6#1)(2012-2#1)
remains a challenging task##2##4##(2008-1#1)(2008-9#1)
remains a challenging##10##3##(1997-3#1)(2005-8#1)(2008-1#2)(2008-9#1)(2010-4#1)(2010-6#2)(2011-2#1)(2012-2#1)
remains a clinical##4##3##(2008-5#2)(2008-7#1)(2010-12#1)
remains a common##3##3##(2006-6#1)(2008-5#1)(2010-2#1)
remains a concern##3##3##(2008-5#1)(2011-2#1)(2013-8#1)
remains a constant challenge##2##4##(2006-9#1)(2012-3#1)
remains a contentious issue##2##4##(2010-12#1)(2010-8#1)
remains a contentious##3##3##(1991-9#1)(2010-12#1)(2010-8#1)
remains a crucial##2##3##(2006-2#1)(2007-7#1)
remains a difficult and##2##4##(1994-5#1)(2010-5#1)
remains a difficult challenge##2##4##(2006-7#1)(2008-4#1)
remains a difficult##7##3##(1994-5#1)(2006-10#1)(2006-7#2)(2007-7#1)(2008-4#1)(2010-5#1)
remains a dilemma##2##3##(2006-10#1)(2011-2#1)
remains a formidable challenge to##2##5##(2007-8#1)(2011-2#1)
remains a global health##2##4##(2008-10#1)(2012-2#1)
remains a great challenge##3##4##(2007-8#1)(2008-1#1)(2008-7#1)
remains a great##4##3##(2006-10#1)(2007-8#1)(2008-1#1)(2008-7#1)
remains a high priority##2##4##(1995-8#1)(2006-10#1)
remains a highly##6##3##(1996-8#1)(2006-10#2)(2007-2#1)(2008-12#1)(2010-4#1)
remains a key##3##3##(2008-11#1)(2011-2#1)(2011-3#1)
remains a leading cause of death##3##6##(1995-9#1)(2010-8#1)(2012-1#1)
remains a leading cause of##4##5##(1995-9#1)(2008-5#1)(2010-8#1)(2012-1#1)
remains a major cause of death##2##6##(2010-12#1)(2012-2#1)
remains a major cause of##4##5##(2006-1#1)(2007-7#1)(2010-12#1)(2012-2#1)
remains a major challenge##4##4##(2006-10#1)(2007-9#1)(2008-8#2)
remains a major health problem in the##2##7##(2006-10#1)(2013-8#1)
remains a major health problem##3##5##(2006-10#1)(2008-9#1)(2013-8#1)
remains a major limitation##3##4##(2007-11#1)(2008-5#1)(2012-3#1)
remains a major problem in##3##5##(1997-1#1)(2006-4#1)(2008-11#1)
remains a major problem##6##4##(1997-1#1)(2006-10#1)(2006-4#1)(2008-11#1)(2008-2#1)(2012-12#1)
remains a major public health problem##3##6##(2007-10#1)(2008-1#1)(2011-1#1)
remains a major##30##3##(1997-1#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-4#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
remains a matter of debate##2##5##(1997-5#1)(2010-11#1)
remains a matter of##5##4##(1997-5#1)(2007-9#1)(2008-10#1)(2010-11#1)(2013-8#1)
remains a mystery##4##3##(1996-12#1)(2007-12#1)(2008-7#2)
remains a persistent##2##3##(2007-7#1)(2008-3#1)
remains a point of##2##4##(1990-5#1)(2008-1#1)
remains a priority##2##3##(2007-7#1)(2008-1#1)
remains a problem of##2##4##(2007-12#1)(2008-3#1)
remains a problem##7##3##(1993-12#1)(1994-10#1)(1996-7#1)(2007-12#1)(2008-3#1)(2010-12#1)(2011-1#1)
remains a rare##2##3##(1996-2#1)(2006-10#1)
remains a serious problem##3##4##(1997-5#1)(2005-8#1)(2010-3#1)
remains a serious threat to##2##5##(2005-8#1)(2013-8#1)
remains a serious##8##3##(1997-5#1)(2005-8#2)(2007-4#1)(2008-10#1)(2008-3#1)(2010-3#1)(2013-8#1)
remains a significant cause of##2##5##(2006-10#1)(2009-10#1)
remains a significant problem##3##4##(2006-10#2)(2008-11#1)
remains a significant public health problem##2##6##(1997-1#1)(2011-1#1)
remains a significant##18##3##(1997-1#1)(2005-12#1)(2006-10#5)(2006-11#1)(2006-2#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
remains a useful##2##3##(2007-11#1)(2013-1#1)
remains a work in progress##2##5##(2012-12#2)
remains a##240##2##(1990-5#1)(1991-9#1)(1992-5#1)(1993-12#1)(1993-7#1)(1993-9#2)(1994-10#1)(1994-5#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#2)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-5#3)(1997-6#1)(1997-8#1)(2005-11#2)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#5)(2006-1#2)(2006-10#25)(2006-11#2)(2006-12#2)(2006-2#2)(2006-4#2)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-2#2)(2007-4#1)(2007-7#6)(2007-8#6)(2007-9#2)(2008-1#7)(2008-10#4)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#2)(2009-10#2)(2009-5#2)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#5)(2010-5#1)(2010-6#3)(2010-8#3)(2010-9#1)(2011-1#6)(2011-11#1)(2011-12#2)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#8)(2012-2#8)(2012-3#6)(2013-1#5)(2013-7#1)(2013-8#6)
remains after##4##2##(2005-11#1)(2006-10#2)(2008-10#1)
remains almost##2##2##(2005-11#1)(2007-7#1)
remains an area of##3##4##(2005-10#1)(2006-10#1)(2008-9#1)
remains an attractive##2##3##(2006-10#1)(2008-10#1)
remains an enigma##2##3##(2011-2#1)(2012-2#1)
remains an important cause of morbidity and mortality worldwide##2##9##(2005-11#1)(2011-2#1)
remains an important cause of morbidity and mortality##3##8##(2005-11#1)(2011-2#1)(2012-2#1)
remains an important cause of##5##5##(2005-11#1)(2007-7#1)(2011-2#2)(2012-2#1)
remains an important problem in##2##5##(2006-5#1)(2008-2#1)
remains an important problem##3##4##(2006-5#1)(2007-12#1)(2008-2#1)
remains an important public health##2##5##(2007-12#1)(2009-5#1)
remains an important tool for##2##5##(2008-1#1)(2009-4#1)
remains an important##24##3##(1993-6#1)(1993-7#1)(2005-11#1)(2006-10#2)(2006-5#1)(2006-9#2)(2007-12#2)(2007-2#2)(2007-7#1)(2008-1#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
remains an incurable disease##2##4##(2008-10#1)(2008-6#1)
remains an integral##2##3##(1997-4#1)(2012-3#1)
remains an issue for##2##4##(2008-3#1)(2008-7#1)
remains an issue##3##3##(1994-5#1)(2008-3#1)(2008-7#1)
remains an open question##2##4##(1996-11#1)(2006-5#1)
remains an open##3##3##(1996-11#1)(2006-2#1)(2006-5#1)
remains an##63##2##(1990-11#1)(1992-3#1)(1993-6#1)(1993-7#1)(1994-5#1)(1996-11#1)(1996-3#1)(1997-3#1)(1997-4#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#4)(2006-2#1)(2006-5#2)(2006-9#2)(2007-11#1)(2007-12#2)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#2)(2010-12#1)(2010-7#2)(2011-1#3)(2011-2#3)(2012-2#4)(2012-3#2)(2013-8#2)
remains approximately constant##2##3##(2007-12#1)(2008-11#1)
remains as a##2##3##(2008-4#1)(2011-2#1)
remains as one of the##2##5##(2010-10#1)(2011-2#1)
remains as the##2##3##(2006-10#1)(2006-9#1)
remains as##12##2##(1991-5#1)(2005-12#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-12#1)(2008-11#1)(2008-4#1)(2010-10#1)(2010-11#1)(2011-2#2)
remains associated with the##2##4##(1990-11#1)(1991-5#1)
remains associated with##5##3##(1990-11#1)(1991-5#1)(1992-5#1)(1993-3#1)(2011-11#1)
remains associated##6##2##(1990-11#1)(1991-5#1)(1992-5#1)(1993-3#1)(2011-11#1)(2012-2#1)
remains asymptomatic##9##2##(1991-11#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-6#1)(2008-7#1)(2012-3#1)(2013-1#1)
remains at the##3##3##(2006-10#1)(2008-1#1)(2009-2#1)
remains at##8##2##(1993-6#1)(1996-2#1)(1996-5#1)(2005-8#1)(2006-10#1)(2008-1#1)(2008-3#1)(2009-2#1)
remains below##4##2##(1996-2#1)(2008-3#2)(2012-2#1)
remains bound to the##2##4##(1992-3#1)(1995-8#1)
remains challenging##5##2##(2006-7#1)(2008-6#1)(2009-12#1)(2010-5#1)(2011-1#1)
remains considerable##3##2##(2008-11#1)(2008-7#1)(2012-12#1)
remains constant for##3##3##(2007-1#1)(2008-10#1)(2008-2#1)
remains constant throughout the##2##4##(1992-6#1)(1995-1#1)
remains constant throughout##3##3##(1992-12#1)(1992-6#1)(1995-1#1)
remains constant while the##2##4##(2007-12#1)(2008-10#1)
remains constant##21##2##(1991-10#1)(1992-12#1)(1992-6#1)(1992-7#1)(1994-9#1)(1995-1#1)(1997-7#1)(2005-11#2)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#1)
remains controversial and##5##3##(1995-9#1)(2008-6#1)(2008-7#1)(2011-2#2)
remains controversial as##2##3##(2007-8#2)
remains controversial in the##2##4##(2012-3#1)(2013-1#1)
remains controversial in##5##3##(2008-10#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
remains controversial since##2##3##(2006-10#1)(2010-12#1)
remains controversial whether##2##3##(1994-12#1)(2008-7#1)
remains controversial##62##2##(1992-3#1)(1993-7#1)(1994-12#1)(1995-9#1)(1996-3#1)(1997-7#1)(2006-10#6)(2006-6#2)(2006-7#2)(2006-9#1)(2007-10#3)(2007-11#2)(2007-2#2)(2007-7#3)(2007-8#5)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-8#1)(2010-12#2)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
remains difficult to##9##3##(1997-3#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-4#1)(2011-2#2)
remains difficult##16##2##(1994-12#1)(1997-3#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-4#2)(2010-11#1)(2011-2#2)(2012-11#1)(2012-2#2)(2013-1#1)
remains disappointing##2##2##(2006-10#1)(2008-6#1)
remains disease free##3##3##(2008-6#1)(2010-12#1)(2011-2#1)
remains disease-free##3##2##(2008-6#1)(2011-2#2)
remains dormant##2##2##(2009-3#1)(2010-1#1)
remains elusive##21##2##(1992-9#1)(1994-10#1)(1997-4#1)(2005-8#1)(2006-10#3)(2006-5#1)(2007-11#1)(2008-11#3)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#2)
remains enigmatic##3##2##(2008-7#1)(2008-8#1)(2009-10#1)
remains essential##4##2##(1994-9#1)(2006-10#1)(2006-9#1)(2007-2#1)
remains even##2##2##(1996-8#1)(2011-2#1)
remains extremely poor##2##3##(2011-2#1)(2012-12#1)
remains extremely##3##2##(2008-3#1)(2011-2#1)(2012-12#1)
remains fixed##2##2##(2007-12#1)(2008-2#1)
remains for##3##2##(2008-7#1)(2009-10#1)(2013-1#1)
remains free of##3##3##(2005-5#1)(2008-6#1)(2012-2#1)
remains from##3##2##(1991-11#1)(1991-2#1)(1994-7#1)
remains heterogeneous##2##2##(1997-4#1)(2010-11#1)
remains high in##2##3##(1992-5#1)(2008-8#1)
remains high##15##2##(1992-5#1)(1997-2#1)(1997-4#1)(2004-4#1)(2006-10#1)(2006-11#1)(2006-4#1)(2008-3#1)(2008-8#1)(2009-11#1)(2009-9#1)(2011-2#1)(2013-1#3)
remains highly##5##2##(1994-9#1)(2007-7#1)(2010-7#1)(2012-3#1)(2013-8#1)
remains important to##3##3##(2008-2#1)(2011-2#1)(2013-7#1)
remains important##6##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-8#1)(2011-2#1)(2013-7#1)
remains in a##2##3##(1990-2#1)(2008-11#1)
remains in place##2##3##(2007-12#1)(2008-9#1)
remains in the blood##2##4##(2005-8#1)(2008-11#1)
remains in the cytoplasm##2##4##(1991-11#1)(1993-8#1)
remains in the membrane of the##2##6##(1990-12#2)
remains in the##18##3##(1990-12#2)(1990-8#1)(1991-11#1)(1992-8#1)(1993-8#1)(1996-5#1)(1997-1#1)(2005-11#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-12#1)(2010-5#1)(2011-2#1)
remains in##28##2##(1990-12#2)(1990-2#1)(1990-8#1)(1991-11#1)(1992-4#1)(1992-8#1)(1993-8#1)(1996-5#1)(1997-1#1)(2005-11#1)(2005-8#1)(2007-12#2)(2007-4#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-11#1)
remains incompletely understood##3##3##(2006-10#1)(2008-4#1)(2010-3#1)
remains incompletely##4##2##(2006-10#1)(2006-2#1)(2008-4#1)(2010-3#1)
remains inside##2##2##(2007-1#1)(2012-1#1)
remains intact##4##2##(1995-2#1)(1996-2#2)(2007-12#1)
remains intracellular##2##2##(1990-7#2)
remains invariant##2##2##(2007-12#1)(2008-2#1)
remains justified##2##2##(2007-8#1)(2009-3#1)
remains largely unclear##2##3##(2006-9#1)(2013-1#1)
remains largely unexplored##3##3##(1992-12#1)(2008-8#1)(2011-1#1)
remains largely unknown##12##3##(2007-12#1)(2008-8#1)(2009-2#1)(2009-8#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)
remains largely##27##2##(1992-12#1)(1994-12#1)(1995-12#1)(2005-11#1)(2005-8#1)(2006-9#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#1)
remains less common##2##3##(2007-2#1)(2013-1#1)
remains limited to##2##3##(2008-7#1)(2008-8#1)
remains limited##10##2##(2006-10#1)(2008-6#1)(2008-7#1)(2008-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
remains localized##2##2##(2006-10#1)(2012-2#1)
remains low##5##2##(1994-3#1)(2004-12#1)(2007-7#1)(2008-11#1)(2008-4#1)
remains more##3##2##(2007-2#1)(2007-4#1)(2008-2#1)
remains mostly##2##2##(1992-11#1)(1993-11#1)
remains necessary##3##2##(2004-9#1)(2008-12#1)(2010-10#1)
remains normal##2##2##(1995-1#1)(2008-9#1)
remains not##2##2##(2007-8#1)(2011-2#1)
remains obscure##11##2##(1995-5#1)(1997-2#2)(1997-6#1)(2006-10#1)(2006-11#1)(2008-10#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
remains of a##2##3##(1990-8#1)(1995-6#1)
remains of##8##2##(1990-8#1)(1995-6#1)(2006-10#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-1#1)
remains on the##4##3##(1991-6#1)(1997-8#1)(2005-11#1)(2008-12#1)
remains one of the major##2##5##(2007-12#1)(2011-2#1)
remains one of the most common##2##6##(2006-10#1)(2010-12#1)
remains one of the most important##5##6##(2007-11#1)(2012-2#1)(2013-1#2)(2013-8#1)
remains one of the most##13##5##(2006-10#1)(2007-11#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
remains one of the##22##4##(1996-2#1)(2005-7#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-7#3)(2010-10#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
remains over##2##2##(1992-1#1)(2008-2#1)
remains poor##10##2##(2007-11#1)(2008-3#1)(2008-6#1)(2009-10#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-2#1)(2013-1#1)
remains poorly defined##3##3##(2006-5#1)(2010-5#1)(2010-9#1)
remains poorly known##2##3##(2007-11#1)(2007-5#1)
remains poorly studied##2##3##(2008-9#1)(2012-2#1)
remains poorly understood##14##3##(1996-2#1)(2004-12#1)(2005-10#2)(2006-10#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-9#1)(2010-3#1)(2011-1#1)(2012-12#2)
remains poorly##24##2##(1992-12#1)(1993-9#1)(1996-2#1)(2004-12#1)(2005-10#2)(2006-10#1)(2006-5#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-9#2)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-12#2)(2012-2#2)
remains possible that##2##3##(2007-4#1)(2008-10#1)
remains possible##3##2##(2007-4#1)(2008-10#1)(2010-7#1)
remains practically##2##2##(1990-7#1)(2008-10#1)
remains problematic##6##2##(2005-8#3)(2006-10#1)(2007-11#1)(2008-7#1)
remains questionable##2##2##(1997-4#1)(2006-10#1)
remains quite##3##2##(2006-11#1)(2011-12#1)(2012-2#1)
remains rather limited##2##3##(1996-2#1)(2007-8#1)
remains rather##3##2##(1996-2#1)(2007-11#1)(2007-8#1)
remains relatively constant##2##3##(1996-2#1)(1997-1#1)
remains relatively##7##2##(1996-2#1)(1997-1#2)(2006-12#1)(2007-9#1)(2008-10#1)(2010-11#1)
remains small##5##2##(2007-9#1)(2008-11#1)(2008-3#2)(2012-3#1)
remains sparse##3##2##(2006-1#1)(2011-2#1)(2012-2#1)
remains speculative##3##2##(2006-10#1)(2007-11#1)(2009-3#1)
remains stable for##2##3##(1992-9#1)(2008-10#1)
remains stable##5##2##(1992-9#1)(1996-2#1)(2005-8#1)(2008-10#1)(2008-2#1)
remains still##3##2##(2008-8#1)(2009-5#1)(2012-2#1)
remains that##2##2##(2007-8#1)(2010-12#1)
remains the best##10##3##(1991-9#1)(2005-7#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2012-12#1)
remains the cornerstone of##2##4##(2008-12#1)(2012-12#1)
remains the drug of choice##2##5##(1991-12#1)(2011-2#1)
remains the gold standard for diagnosis##2##6##(2006-10#1)(2011-2#1)
remains the gold standard for the diagnosis##2##7##(2006-2#1)(2012-12#1)
remains the gold standard for##6##5##(2006-10#2)(2006-2#1)(2011-2#1)(2012-12#1)(2012-3#1)
remains the gold standard of##2##5##(2006-10#1)(2011-2#1)
remains the gold standard##14##4##(2006-10#3)(2006-2#1)(2007-8#1)(2008-7#1)(2009-10#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)
remains the leading cause of death##2##6##(1990-12#1)(2008-3#1)
remains the leading cause of##3##5##(1990-12#1)(2008-3#1)(2008-5#1)
remains the leading##4##3##(1990-12#1)(2008-3#1)(2008-5#1)(2008-8#1)
remains the main cause of##3##5##(1993-5#1)(1994-5#1)(2006-6#1)
remains the main##6##3##(1993-5#1)(1994-5#1)(2006-6#2)(2007-7#1)(2010-10#1)
remains the mainstay of treatment for##2##6##(2010-12#2)
remains the mainstay of treatment of##2##6##(2006-10#2)
remains the mainstay of treatment##5##5##(2006-10#2)(2008-12#1)(2010-12#2)
remains the major##4##3##(1995-12#1)(2007-11#1)(2008-4#1)(2011-1#1)
remains the most common##6##4##(2006-10#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2011-12#1)
remains the most effective##3##4##(2006-10#1)(2007-8#1)(2008-7#1)
remains the most important cause of morbidity and mortality##2##9##(2007-11#1)(2010-8#1)
remains the most important##7##4##(2006-10#1)(2007-11#1)(2008-1#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#1)
remains the most reliable##2##4##(1991-4#1)(2007-6#1)
remains the most##31##3##(1991-4#1)(1997-5#1)(2004-11#1)(2005-12#1)(2006-10#5)(2007-11#2)(2007-2#1)(2007-6#1)(2007-8#2)(2008-1#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-3#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
remains the only effective treatment##3##5##(2004-11#1)(2006-10#2)
remains the only effective##5##4##(2004-11#2)(2006-10#3)
remains the only##12##3##(1991-11#1)(1991-8#1)(1992-8#1)(1996-3#1)(2004-11#2)(2006-10#4)(2007-7#1)(2011-1#1)
remains the primary##2##3##(2007-1#1)(2012-12#1)
remains the same##2##3##(1995-1#1)(2012-3#1)
remains the standard of care for##2##6##(2006-10#1)(2007-10#1)
remains the standard of care##4##5##(2006-10#2)(2007-10#1)(2012-1#1)
remains the standard treatment##2##4##(2007-11#1)(2009-6#1)
remains the standard##9##3##(2006-10#2)(2007-10#2)(2007-11#1)(2009-6#3)(2012-1#1)
remains the treatment of choice for##4##6##(1997-3#1)(2006-10#1)(2010-10#1)(2010-8#1)
remains the treatment of choice in##2##6##(1991-9#1)(2012-2#1)
remains the treatment of choice##9##5##(1990-2#1)(1991-9#1)(1997-3#1)(2006-10#1)(2006-12#1)(2010-10#1)(2010-8#1)(2012-2#1)(2013-7#1)
remains the##156##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-8#1)(1991-9#2)(1992-8#1)(1992-9#1)(1993-5#2)(1993-6#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-7#1)(2004-11#3)(2005-1#1)(2005-12#1)(2005-7#1)(2006-10#20)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#2)(2007-1#2)(2007-10#2)(2007-11#5)(2007-2#1)(2007-6#1)(2007-7#7)(2007-8#4)(2008-1#3)(2008-10#3)(2008-12#3)(2008-3#1)(2008-4#4)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#3)(2010-10#2)(2010-11#1)(2010-12#4)(2010-3#1)(2010-5#2)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#6)(2011-3#2)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#4)(2012-3#4)(2013-1#1)(2013-7#3)
remains tightly##2##2##(1990-5#1)(1991-12#1)
remains to be a challenging##2##5##(2009-10#1)(2012-2#1)
remains to be answered##3##4##(1995-12#1)(2008-11#1)(2009-6#1)
remains to be ascertained##2##4##(1991-2#1)(1995-12#1)
remains to be clarified##3##4##(1995-2#1)(2007-11#1)(2007-6#1)
remains to be defined##8##4##(1994-11#1)(1994-5#1)(1996-4#1)(1996-9#2)(1997-4#1)(2008-3#1)(2009-3#1)
remains to be determined whether##8##5##(1990-5#1)(2004-1#1)(2006-10#1)(2007-12#1)(2008-11#1)(2010-12#1)(2010-8#1)(2012-12#1)
remains to be determined##41##4##(1990-3#1)(1990-5#1)(1990-9#1)(1992-1#1)(1992-4#1)(1993-9#1)(1994-4#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-3#1)(1996-8#1)(1997-7#1)(1997-8#1)(2004-1#1)(2005-10#1)(2006-10#6)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)
remains to be discovered##2##4##(2007-12#1)(2011-2#1)
remains to be done to##2##5##(1995-6#1)(2007-8#1)
remains to be done##8##4##(1992-3#1)(1995-6#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-7#1)
remains to be elucidated##26##4##(1991-10#1)(1991-2#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-2#1)(1995-8#1)(1996-4#1)(1997-6#1)(1997-7#2)(2004-2#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-5#2)(2008-9#1)(2009-7#2)(2009-8#1)(2012-2#2)
remains to be established##25##4##(1990-10#1)(1990-12#1)(1991-1#1)(1991-5#1)(1991-9#1)(1992-3#2)(1995-6#1)(1997-1#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-4#1)(2008-8#1)(2009-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
remains to be evaluated##2##4##(2008-4#1)(2012-2#1)
remains to be explored##4##4##(1990-2#1)(1994-2#1)(2006-9#1)(2007-12#1)
remains to be fully elucidated##3##5##(2008-12#1)(2008-4#1)(2009-3#1)
remains to be fully understood##2##5##(2010-2#1)(2011-1#1)
remains to be fully##7##4##(2006-10#1)(2008-12#1)(2008-4#1)(2009-3#1)(2010-2#1)(2011-1#1)(2011-2#1)
remains to be further##2##4##(2008-10#1)(2008-8#1)
remains to be identified##3##4##(1995-12#1)(1995-3#1)(2013-8#1)
remains to be investigated whether##2##5##(2007-8#1)(2009-8#1)
remains to be investigated##9##4##(1990-3#1)(1995-1#1)(1997-4#1)(1997-5#2)(2007-8#1)(2009-8#1)(2011-2#1)(2013-1#1)
remains to be learned about##4##5##(2006-10#1)(2006-2#1)(2008-8#1)(2009-5#1)
remains to be learned##6##4##(1994-3#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-8#1)(2009-5#1)
remains to be one of the##2##6##(2008-11#1)(2008-8#1)
remains to be resolved##3##4##(1990-7#1)(1995-3#1)(1996-6#1)
remains to be seen whether##4##5##(1994-3#1)(2007-4#1)(2008-9#1)(2012-2#1)
remains to be seen which##2##5##(2006-10#1)(2007-11#1)
remains to be seen##9##4##(1994-3#1)(1994-9#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-9#1)(2012-1#1)(2012-2#1)
remains to be shown that##2##5##(2006-10#1)(2013-8#1)
remains to be shown##7##4##(1990-7#1)(2005-8#1)(2006-10#1)(2008-10#2)(2009-6#1)(2013-8#1)
remains to be##194##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-1#1)(1992-3#3)(1992-4#1)(1993-10#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-4#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#3)(1995-6#2)(1995-8#2)(1996-1#1)(1996-3#1)(1996-4#2)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#1)(2004-1#1)(2004-2#1)(2005-10#1)(2005-8#1)(2006-10#10)(2006-11#2)(2006-2#2)(2006-9#1)(2007-10#2)(2007-11#5)(2007-12#3)(2007-2#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-3#4)(2008-4#3)(2008-5#5)(2008-7#2)(2008-8#8)(2008-9#2)(2009-10#1)(2009-12#2)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#2)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#8)(2012-3#1)(2013-1#2)(2013-8#4)
remains to##202##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-1#1)(1992-3#3)(1992-4#1)(1993-10#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-4#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#3)(1995-6#2)(1995-8#2)(1996-1#1)(1996-3#1)(1996-4#2)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#1)(2004-1#1)(2004-2#1)(2005-10#1)(2005-8#1)(2006-10#10)(2006-11#2)(2006-2#2)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#2)(2007-11#5)(2007-12#3)(2007-2#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#2)(2008-3#5)(2008-4#3)(2008-5#5)(2008-7#2)(2008-8#8)(2008-9#2)(2009-10#1)(2009-12#2)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#2)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#8)(2012-3#2)(2013-1#4)(2013-8#4)
remains unaffected##4##2##(1993-7#1)(2009-12#1)(2012-12#2)
remains unaltered##3##2##(1990-2#1)(1995-8#1)(2008-10#1)
remains unanswered##2##2##(2006-10#1)(2009-4#1)
remains uncertain##17##2##(1991-2#1)(1991-9#1)(1992-7#1)(1994-10#1)(1994-9#1)(1997-4#1)(1997-6#1)(2004-1#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)
remains unchanged during##2##3##(1992-12#1)(1995-2#1)
remains unchanged in##2##3##(1994-8#1)(2006-2#1)
remains unchanged##17##2##(1992-12#1)(1992-2#1)(1994-8#1)(1995-2#2)(2006-2#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-5#2)(2008-8#1)(2010-11#1)(2012-3#2)(2013-8#1)
remains unclear and##5##3##(1993-11#1)(2005-10#1)(2006-10#1)(2007-12#1)(2013-8#1)
remains unclear but##2##3##(1996-9#1)(2012-3#1)
remains unclear if##3##3##(2007-8#1)(2010-5#1)(2013-8#1)
remains unclear whether this##3##4##(1990-9#1)(2008-11#1)(2013-1#1)
remains unclear whether##12##3##(1990-9#1)(1995-7#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#3)
remains unclear##104##2##(1990-2#1)(1990-7#1)(1990-9#1)(1991-2#1)(1992-2#1)(1993-11#1)(1993-9#2)(1994-8#1)(1995-1#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-9#1)(1997-4#1)(1997-7#2)(1997-8#1)(2005-10#1)(2005-12#1)(2006-10#3)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#4)(2008-10#2)(2008-11#6)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#8)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-5#2)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#6)(2013-7#2)(2013-8#3)
remains unclearly defined##2##3##(2013-1#2)
remains undefined##3##2##(1990-10#1)(2008-3#1)(2011-2#1)
remains under##4##2##(1995-9#1)(2007-2#1)(2008-7#1)(2010-10#1)
remains undetermined##4##2##(1993-1#1)(2008-11#1)(2008-7#1)(2010-12#1)
remains undiagnosed##3##2##(1996-12#1)(2008-10#1)(2012-12#1)
remains unexplained##6##2##(1992-1#1)(1994-9#1)(2005-10#1)(2008-10#1)(2008-3#1)(2013-1#1)
remains unknown and##3##3##(1995-9#1)(2007-4#1)(2011-2#1)
remains unknown whether##4##3##(2007-2#1)(2010-3#1)(2012-2#1)(2012-3#1)
remains unknown##65##2##(1990-3#1)(1991-10#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-9#1)(1996-11#1)(1996-9#2)(1997-4#1)(2004-12#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-5#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-6#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#7)(2012-3#4)(2013-1#3)(2013-8#4)
remains unproven##5##2##(2005-10#1)(2006-10#1)(2006-3#1)(2007-11#1)(2009-11#1)
remains unresolved##7##2##(1994-12#1)(2006-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-2#1)(2013-1#1)
remains unsolved##3##2##(1993-6#1)(1993-8#1)(2007-8#1)
remains valid##3##2##(2008-2#1)(2008-9#1)(2012-12#1)
remains very low##3##3##(1991-5#1)(2005-9#1)(2013-1#1)
remains very##6##2##(1991-5#1)(2005-9#1)(2006-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
remains viable##2##2##(2006-7#1)(2008-7#1)
remains virtually##2##2##(1994-12#1)(2007-12#1)
remains well and asymptomatic##2##4##(2007-10#1)(2007-6#1)
remains well and##3##3##(2007-10#1)(2007-6#1)(2007-8#1)
remains well##4##2##(2007-10#1)(2007-6#1)(2007-8#1)(2010-7#1)
remains with##3##2##(1996-5#1)(2006-10#1)(2012-2#1)
remains##1639##1##(1990-10#2)(1990-11#3)(1990-12#5)(1990-2#5)(1990-3#3)(1990-4#1)(1990-5#5)(1990-7#6)(1990-8#2)(1990-9#2)(1991-1#1)(1991-10#3)(1991-11#4)(1991-12#2)(1991-2#10)(1991-4#1)(1991-5#4)(1991-6#1)(1991-8#1)(1991-9#6)(1992-1#5)(1992-10#1)(1992-11#2)(1992-12#5)(1992-2#2)(1992-3#7)(1992-4#2)(1992-5#4)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#3)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-5#4)(1993-6#4)(1993-7#4)(1993-8#2)(1993-9#7)(1994-10#3)(1994-11#1)(1994-12#8)(1994-2#3)(1994-3#3)(1994-4#1)(1994-5#7)(1994-6#1)(1994-7#1)(1994-8#4)(1994-9#8)(1995-1#6)(1995-10#1)(1995-11#2)(1995-12#7)(1995-2#6)(1995-3#4)(1995-5#2)(1995-6#5)(1995-7#1)(1995-8#7)(1995-9#4)(1996-1#3)(1996-10#1)(1996-11#4)(1996-12#3)(1996-2#13)(1996-3#5)(1996-4#2)(1996-5#3)(1996-6#1)(1996-7#4)(1996-8#4)(1996-9#5)(1997-1#7)(1997-2#7)(1997-3#6)(1997-4#10)(1997-5#6)(1997-6#6)(1997-7#9)(1997-8#5)(2004-1#4)(2004-11#4)(2004-12#3)(2004-2#1)(2004-3#1)(2004-4#1)(2004-9#1)(2005-1#1)(2005-10#9)(2005-11#12)(2005-12#4)(2005-5#3)(2005-7#6)(2005-8#18)(2005-9#3)(2006-1#4)(2006-10#106)(2006-11#9)(2006-12#7)(2006-2#10)(2006-3#3)(2006-4#3)(2006-5#6)(2006-6#8)(2006-7#8)(2006-8#4)(2006-9#9)(2007-1#4)(2007-10#15)(2007-11#33)(2007-12#34)(2007-2#16)(2007-3#2)(2007-4#9)(2007-5#3)(2007-6#4)(2007-7#26)(2007-8#36)(2007-9#7)(2008-1#27)(2008-10#49)(2008-11#38)(2008-12#13)(2008-2#16)(2008-3#39)(2008-4#21)(2008-5#29)(2008-6#19)(2008-7#45)(2008-8#38)(2008-9#17)(2009-10#11)(2009-11#2)(2009-12#4)(2009-2#4)(2009-3#9)(2009-4#4)(2009-5#8)(2009-6#6)(2009-7#8)(2009-8#9)(2009-9#5)(2010-1#2)(2010-10#10)(2010-11#9)(2010-12#27)(2010-2#6)(2010-3#6)(2010-4#8)(2010-5#12)(2010-6#5)(2010-7#7)(2010-8#8)(2010-9#6)(2011-1#28)(2011-11#2)(2011-12#6)(2011-2#68)(2011-3#4)(2012-1#9)(2012-11#6)(2012-12#39)(2012-2#65)(2012-3#35)(2013-1#48)(2013-7#11)(2013-8#31)
remains)##2##1##(1994-3#1)(2008-10#1)
remanded##5##1##(1996-12#4)(1997-5#1)
remanent polarization##2##2##(2010-4#2)
remanent##4##1##(1992-12#1)(2010-4#3)
remapping##2##1##(2009-8#2)
remark##4##1##(2007-9#1)(2008-11#3)
remarkable ability to##3##3##(2008-11#1)(2010-12#1)(2013-1#1)
remarkable ability##4##2##(2005-8#1)(2008-11#1)(2010-12#1)(2013-1#1)
remarkable activity##3##2##(1992-2#1)(2008-10#1)(2008-5#1)
remarkable and##5##2##(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-7#1)
remarkable antioxidant activity##2##3##(2011-1#1)(2012-11#1)
remarkable as##2##2##(1996-3#1)(2008-5#1)
remarkable change caused by##2##4##(1993-8#1)(2013-8#1)
remarkable change in##4##3##(1992-4#1)(1992-5#1)(1992-9#1)(2008-1#1)
remarkable change##7##2##(1991-3#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-8#1)(2008-1#1)(2013-8#1)
remarkable changes in##2##3##(1992-1#1)(2005-11#1)
remarkable changes##3##2##(1992-1#1)(1994-5#1)(2005-11#1)
remarkable chromosomal##2##2##(2008-5#1)(2010-3#1)
remarkable conservation of##3##3##(1992-5#1)(1994-2#1)(2007-12#1)
remarkable conservation##4##2##(1992-5#1)(1994-2#1)(2006-10#1)(2007-12#1)
remarkable consistency##3##2##(2013-1#3)
remarkable decrease in the##2##4##(1994-3#1)(2008-1#1)
remarkable decrease in##5##3##(1994-3#1)(2007-2#1)(2008-1#1)(2008-11#1)(2010-12#1)
remarkable decrease##7##2##(1991-6#1)(1994-3#1)(2007-2#1)(2008-1#1)(2008-11#1)(2010-12#1)(2011-2#1)
remarkable difference between##4##3##(1993-8#1)(1996-4#1)(2004-9#1)(2005-11#1)
remarkable difference##7##2##(1991-8#1)(1993-8#1)(1996-4#1)(2004-9#1)(2005-11#1)(2007-12#1)(2011-2#1)
remarkable differences in##3##3##(1994-12#1)(2006-8#1)(2008-10#1)
remarkable differences##7##2##(1992-2#1)(1994-12#2)(2006-8#1)(2008-10#1)(2010-12#1)(2011-12#1)
remarkable diversity of##3##3##(1993-9#1)(2008-4#1)(2012-11#1)
remarkable diversity##4##2##(1993-9#1)(2008-4#1)(2010-3#1)(2012-11#1)
remarkable effect on##4##3##(1990-7#1)(1996-2#1)(2004-11#1)(2011-12#1)
remarkable effect##5##2##(1990-7#1)(1996-2#1)(2004-11#1)(2008-7#1)(2011-12#1)
remarkable effects of##3##3##(1997-1#1)(2008-8#1)(2010-8#1)
remarkable effects##6##2##(1993-4#1)(1997-1#1)(2008-1#1)(2008-8#1)(2010-8#1)(2012-3#1)
remarkable feature of the##2##4##(2006-10#1)(2008-10#1)
remarkable feature##4##2##(1992-3#1)(1993-8#1)(2006-10#1)(2008-10#1)
remarkable features of##2##3##(1993-8#1)(2011-1#1)
remarkable for##10##2##(1996-11#1)(2006-10#1)(2008-11#1)(2008-7#2)(2009-2#2)(2011-1#1)(2012-2#2)
remarkable growth##2##2##(1992-9#1)(2007-4#1)
remarkable homology##2##2##(1990-10#1)(2008-9#1)
remarkable improvement in the##2##4##(2008-5#1)(2012-3#1)
remarkable improvement in##8##3##(2008-10#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
remarkable improvement##9##2##(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
remarkable in##5##2##(1991-3#1)(2006-12#1)(2007-6#1)(2008-11#1)(2010-10#1)
remarkable increase in the##6##4##(1991-2#1)(1993-11#1)(1993-3#1)(1996-10#1)(2008-5#1)(2012-3#1)
remarkable increase in##12##3##(1991-2#1)(1991-8#1)(1992-6#1)(1993-11#1)(1993-3#1)(1996-10#1)(1996-11#1)(2006-10#2)(2008-11#1)(2008-5#1)(2012-3#1)
remarkable increase##17##2##(1991-2#1)(1991-8#1)(1992-6#2)(1993-11#1)(1993-3#1)(1996-10#1)(1996-11#1)(2006-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-8#1)
remarkable increases in##2##3##(1997-1#1)(2008-10#1)
remarkable increases##3##2##(1996-2#1)(1997-1#1)(2008-10#1)
remarkable long-term stability##2##3##(2008-10#2)
remarkable mechanical##2##2##(2007-12#1)(2008-7#1)
remarkable new##3##2##(1990-9#1)(2007-12#1)(2008-10#1)
remarkable potential##2##2##(1995-9#1)(2009-3#1)
remarkable progress in our understanding of##2##6##(2007-8#1)(2013-8#1)
remarkable progress in##4##3##(2007-8#2)(2008-11#1)(2013-8#1)
remarkable progress##9##2##(2007-10#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-9#1)(2009-5#1)(2011-1#1)(2013-8#1)
remarkable properties of##4##3##(1994-9#1)(2008-3#1)(2009-8#1)(2011-2#1)
remarkable properties##6##2##(1994-9#1)(2008-3#1)(2009-12#2)(2009-8#1)(2011-2#1)
remarkable property##2##2##(2008-12#1)(2012-1#1)
remarkable recovery##3##2##(2010-3#1)(2010-8#1)(2011-12#1)
remarkable resemblance in##2##3##(2010-12#2)
remarkable result##2##2##(2008-5#1)(2009-7#1)
remarkable results##2##2##(2008-10#1)(2012-2#1)
remarkable sensitivity and##2##3##(2007-8#1)(2008-10#1)
remarkable sensitivity##5##2##(1990-2#1)(2007-8#2)(2008-10#2)
remarkable similarity##2##2##(1993-3#1)(2011-2#1)
remarkable stability in##3##3##(1990-11#1)(2008-10#2)
remarkable stability##9##2##(1990-11#1)(1990-5#1)(1993-12#1)(2008-10#3)(2008-5#1)(2011-2#1)(2012-2#1)
remarkable structure##2##2##(2008-11#1)(2011-12#1)
remarkable success##2##2##(1992-1#1)(2013-7#1)
remarkable that##5##2##(1997-6#1)(2009-2#1)(2011-1#1)(2011-2#1)(2013-7#1)
remarkable therapeutic efficacy##2##3##(1991-6#1)(2008-1#1)
remarkable variation##2##2##(1994-5#1)(2008-5#1)
remarkable##375##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-1#2)(1991-11#1)(1991-2#3)(1991-3#3)(1991-5#1)(1991-6#4)(1991-7#2)(1991-8#2)(1992-1#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#2)(1992-9#3)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#3)(1993-4#2)(1993-8#7)(1993-9#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#4)(1996-2#3)(1996-3#2)(1996-4#2)(1996-5#2)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#1)(2004-11#1)(2004-9#1)(2005-11#3)(2005-12#1)(2005-8#1)(2006-10#13)(2006-11#2)(2006-12#5)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#13)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#7)(2007-9#1)(2008-1#7)(2008-10#26)(2008-11#9)(2008-12#5)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#14)(2008-6#4)(2008-7#10)(2008-8#7)(2008-9#5)(2009-10#1)(2009-12#3)(2009-2#4)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#1)(2010-10#2)(2010-12#7)(2010-3#5)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#6)(2011-12#7)(2011-2#11)(2012-1#1)(2012-11#4)(2012-12#4)(2012-2#9)(2012-3#7)(2013-1#8)(2013-7#3)(2013-8#6)
remarkably conserved##4##2##(1996-5#1)(2006-10#1)(2012-2#1)(2012-3#1)
remarkably constant##3##2##(1995-11#1)(1995-12#1)(2008-5#1)
remarkably decreased##2##2##(1997-4#1)(2005-11#1)
remarkably during##2##2##(1991-10#1)(2008-7#1)
remarkably effective in##2##3##(1990-7#1)(2005-10#1)
remarkably effective##3##2##(1990-7#1)(2005-10#1)(2006-10#1)
remarkably efficient##2##2##(1994-3#1)(2012-3#1)
remarkably elevated##2##2##(2007-8#1)(2008-10#1)
remarkably from##2##2##(1997-4#1)(2008-10#1)
remarkably high##5##2##(1990-4#1)(1990-6#1)(2008-10#1)(2009-2#1)(2010-5#1)
remarkably higher than that##2##4##(2008-9#2)
remarkably higher##4##2##(1990-8#1)(1996-2#1)(2008-9#2)
remarkably improved##3##2##(2006-2#1)(2007-12#1)(2012-1#1)
remarkably in##5##2##(1990-11#1)(1990-6#1)(1994-11#1)(1996-1#1)(2008-8#1)
remarkably increased##5##2##(2006-4#1)(2006-6#1)(2008-9#1)(2010-10#1)(2012-2#1)
remarkably inhibited by##2##3##(1992-12#1)(1994-3#1)
remarkably inhibited##5##2##(1992-12#1)(1994-3#1)(1994-9#1)(2008-8#1)(2008-9#1)
remarkably large##2##2##(1995-8#1)(2012-2#1)
remarkably low compared##2##3##(2008-1#1)(2008-10#1)
remarkably low##8##2##(1996-7#1)(2006-10#1)(2007-2#1)(2008-1#2)(2008-10#3)
remarkably lower##3##2##(1990-10#1)(2008-10#1)(2009-4#1)
remarkably over the##2##3##(2006-10#1)(2008-9#1)
remarkably poor##2##2##(2008-8#1)(2011-2#1)
remarkably reduced##6##2##(1990-7#1)(1995-8#1)(2007-11#1)(2008-10#2)(2012-3#1)
remarkably selective##2##2##(1995-8#1)(2010-7#1)
remarkably similar in##4##3##(1992-12#1)(2007-11#1)(2010-2#1)(2011-1#1)
remarkably similar to##6##3##(1990-10#1)(1990-4#1)(1990-5#1)(1993-3#1)(1995-6#1)(2008-9#1)
remarkably similar##24##2##(1990-10#1)(1990-4#1)(1990-5#2)(1991-1#1)(1991-10#1)(1991-5#1)(1992-12#1)(1993-3#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#1)
remarkably simple##3##2##(2005-11#1)(2006-4#1)(2007-11#1)
remarkably specific##2##2##(1992-3#1)(1995-3#1)
remarkably stable##3##2##(1996-4#1)(2008-5#2)
remarkably successful##4##2##(2006-2#1)(2007-2#1)(2008-7#1)(2011-2#1)
remarkably well with##2##3##(2008-4#1)(2008-6#1)
remarkably well##3##2##(2008-4#1)(2008-6#1)(2012-2#1)
remarkably wide##2##2##(2006-6#1)(2010-5#1)
remarkably with##2##2##(1991-11#1)(1993-11#1)
remarkably##198##1##(1990-10#2)(1990-11#1)(1990-4#2)(1990-5#2)(1990-6#2)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#3)(1991-11#2)(1991-5#1)(1991-7#2)(1992-1#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#3)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#5)(1995-9#1)(1996-1#1)(1996-2#2)(1996-4#1)(1996-5#3)(1996-7#1)(1996-9#2)(1997-4#3)(2005-10#1)(2005-11#7)(2005-3#1)(2006-10#4)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#2)(2006-6#2)(2006-8#1)(2007-11#8)(2007-12#5)(2007-2#2)(2007-8#1)(2008-1#3)(2008-10#17)(2008-11#5)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#7)(2008-9#8)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-8#1)(2010-10#1)(2010-2#2)(2010-5#2)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#2)(2011-7#2)(2012-1#2)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#1)
remarked##3##1##(2005-7#1)(2008-10#1)(2009-2#1)
remarks concerning the##2##3##(2008-2#1)(2010-9#1)
remarks of##3##2##(2007-11#1)(2008-9#1)(2010-12#1)
remarks on the##7##3##(1993-9#1)(1994-12#1)(1995-5#1)(1996-5#1)(2006-7#1)(2007-12#1)(2008-10#1)
remarks on##10##2##(1990-7#1)(1992-4#1)(1993-9#1)(1994-12#1)(1995-5#1)(1996-5#1)(2006-7#1)(2007-10#1)(2007-12#1)(2008-10#1)
remarks##27##1##(1990-7#1)(1991-6#1)(1992-4#1)(1993-5#2)(1993-9#1)(1994-12#1)(1995-5#1)(1996-5#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-9#1)(2011-2#1)
remarriage##2##1##(2007-12#1)(2012-11#1)
remarried individuals##3##2##(2012-11#3)
remarried##4##1##(2012-11#4)
remating##4##1##(2008-5#4)
remediable##3##1##(1995-10#1)(2008-2#1)(2012-1#1)
remedial approach##2##2##(1994-2#1)(1995-11#1)
remedial computer##2##2##(2013-1#2)
remedial effects##2##2##(1995-12#2)
remedial measures##3##2##(2007-10#1)(2007-11#1)(2008-3#1)
remedial##19##1##(1993-1#1)(1993-3#1)(1994-2#1)(1995-11#1)(1995-12#2)(1995-8#1)(1996-6#1)(2005-12#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-3#1)(2010-12#1)(2013-1#2)
remediated##3##1##(2004-10#2)(2004-4#1)
remediation of##8##2##(2004-10#1)(2004-4#1)(2006-12#1)(2007-7#1)(2008-4#2)(2008-5#1)(2013-1#1)
remediation strategies##2##2##(2007-9#1)(2011-1#1)
remediation##21##1##(2004-10#1)(2004-4#3)(2006-12#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-4#1)(2010-5#1)(2011-1#1)(2012-11#1)(2013-1#3)(2013-8#1)
remedied##3##1##(1990-3#1)(1996-6#1)(2008-11#1)
remedies are##2##2##(2006-10#1)(2008-2#1)
remedies for##7##2##(2007-12#1)(2007-4#1)(2007-6#2)(2008-7#2)(2008-9#1)
remedies in##3##2##(1991-1#1)(2006-10#1)(2008-10#1)
remedies under##2##2##(1996-1#1)(2008-11#1)
remedies##42##1##(1990-10#1)(1991-1#1)(1992-2#1)(1994-4#1)(1994-6#2)(1996-1#1)(2005-9#1)(2006-10#2)(2006-9#1)(2007-12#1)(2007-4#3)(2007-6#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#3)(2008-7#2)(2008-9#1)(2009-10#1)(2011-1#2)(2011-2#2)(2013-1#1)
remedy for the treatment of##2##5##(2011-1#1)(2013-7#1)
remedy for##4##2##(1994-12#1)(2008-10#1)(2011-1#1)(2013-7#1)
remedy is##3##2##(2007-1#1)(2010-8#1)(2011-1#1)
remedy this##2##2##(2006-11#1)(2012-2#1)
remedy##37##1##(1993-5#1)(1994-11#1)(1994-12#1)(1995-6#1)(1996-11#1)(1996-12#1)(1997-6#1)(2005-3#1)(2006-11#1)(2006-2#1)(2006-3#1)(2007-1#1)(2007-11#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#2)(2009-7#2)(2010-11#1)(2010-8#1)(2011-1#2)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
remedy) on##2##2##(2008-10#2)
remedy)##3##1##(2008-10#3)
remember that##5##2##(1991-11#1)(1992-1#1)(2007-11#1)(2008-5#1)(2013-1#1)
remember the##6##2##(1994-3#1)(1995-3#1)(2005-10#1)(2008-3#1)(2009-11#1)(2009-2#1)
remember to##2##2##(2007-7#1)(2008-9#1)
remember##34##1##(1991-11#1)(1992-1#1)(1994-3#1)(1994-7#1)(1995-3#1)(1995-4#1)(2005-10#1)(2006-3#1)(2006-7#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#3)(2009-11#2)(2009-2#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#1)
remembered##23##1##(1991-9#1)(1994-9#1)(1996-11#1)(2006-4#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-10#1)(2008-4#1)(2009-6#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-1#3)(2012-2#1)(2013-1#2)(2013-8#1)
remembering the##3##2##(1992-10#1)(2005-10#1)(2008-5#1)
remembering##13##1##(1992-10#1)(1997-3#1)(2005-10#1)(2006-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2011-2#3)(2012-12#1)(2013-7#2)
remembers##2##1##(2007-10#1)(2011-12#1)
remethylation of homocysteine to methionine##2##5##(2008-1#1)(2012-2#1)
remethylation##3##1##(2004-11#1)(2008-1#1)(2012-2#1)
remifentanil are##3##2##(2006-10#3)
remifentanil versus##2##2##(2009-4#1)(2012-12#1)
remifentanil##32##1##(2006-10#13)(2007-9#5)(2008-10#1)(2009-4#1)(2011-2#10)(2012-12#2)
remind physicians##2##2##(1991-4#1)(2006-10#1)
remind that##2##2##(2006-8#1)(2008-12#1)
remind the##3##2##(2007-11#1)(2008-5#1)(2010-5#1)
remind##14##1##(1991-4#1)(1997-3#1)(2006-10#1)(2006-8#2)(2007-11#2)(2008-1#2)(2008-12#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-5#1)
reminded of##2##2##(1992-6#1)(2010-8#1)
reminded that##2##2##(2007-2#1)(2009-6#1)
reminded##6##1##(1992-6#1)(2006-10#1)(2006-7#1)(2007-2#1)(2009-6#1)(2010-8#1)
reminder letter##2##2##(1997-2#1)(2008-1#1)
reminder letters##2##2##(2010-8#1)(2012-3#1)
reminder phone calls on reducing no-show rates in##2##8##(2012-3#2)
reminder system##2##2##(2007-12#1)(2013-1#1)
reminder telephone##2##2##(2007-2#1)(2012-3#1)
reminder to##2##2##(2007-2#1)(2011-1#1)
reminder##32##1##(1994-3#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-6#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-10#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-3#4)(2013-1#4)(2013-7#4)
reminders and##3##2##(2008-7#1)(2013-1#2)
reminders of##3##2##(2008-3#1)(2009-3#2)
reminders to##2##2##(1994-2#1)(2013-1#1)
reminders##11##1##(1994-2#1)(1997-2#1)(2007-2#1)(2008-3#1)(2008-7#1)(2009-3#2)(2011-1#1)(2013-1#3)
reminds us that##2##3##(1995-1#1)(2012-3#1)
reminds us##3##2##(1995-1#1)(2012-3#2)
reminds##9##1##(1995-1#1)(2008-1#1)(2008-4#1)(2012-3#3)(2013-1#3)
remineralization and##2##2##(2011-1#1)(2013-8#1)
remineralization of##5##2##(2010-3#1)(2011-2#1)(2012-2#2)(2013-8#1)
remineralization##10##1##(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#5)
remineralizing##3##1##(2011-2#1)(2013-8#2)
reminiscence therapy##4##2##(2006-1#3)(2007-8#1)
reminiscence##11##1##(1991-6#1)(2006-1#3)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-2#2)(2012-11#1)
reminiscent of the well-known##2##4##(1994-6#1)(2009-12#1)
reminiscent of the##21##3##(1992-11#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-10#1)(1997-2#1)(1997-6#1)(1997-9#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-12#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-6#1)
reminiscent of##46##2##(1990-2#1)(1991-5#1)(1992-11#1)(1992-9#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-3#2)(1994-6#1)(1995-10#1)(1995-2#2)(1995-7#1)(1996-10#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-9#1)(2005-11#1)(2006-10#1)(2006-12#3)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-12#1)(2011-1#1)(2012-2#1)
remission (CR)##9##2##(1991-10#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-6#1)(2008-10#2)(2008-6#1)(2010-4#1)
remission (Phase##3##2##(2011-2#3)
remission after##11##2##(1997-6#1)(2006-2#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-7#1)(2010-12#1)(2012-12#1)
remission and in##3##3##(1993-12#2)(2012-1#1)
remission and the##4##3##(1993-8#1)(2008-8#1)(2009-2#1)(2010-11#1)
remission and##20##2##(1991-2#1)(1993-12#2)(1993-8#1)(1996-11#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-8#2)(2009-2#2)(2010-11#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
remission as##2##2##(2008-8#1)(2013-8#1)
remission but##4##2##(1991-4#1)(1992-6#1)(2007-11#1)(2012-12#1)
remission by##2##2##(2011-1#1)(2012-12#1)
remission could##2##2##(1995-9#1)(1996-6#1)
remission during##2##2##(2011-2#1)(2012-12#1)
remission following##4##2##(2007-7#1)(2009-8#1)(2009-9#1)(2012-12#1)
remission for 3 years##2##4##(1992-5#1)(2006-10#1)
remission for##5##2##(1990-4#1)(1992-5#1)(2006-10#1)(2008-1#1)(2008-10#1)
remission from the##2##3##(2006-10#1)(2007-4#1)
remission from##7##2##(2006-10#1)(2007-4#1)(2009-3#3)(2010-5#1)(2012-2#1)
remission has been##2##3##(2007-7#1)(2008-6#1)
remission in a##3##3##(2005-6#1)(2007-10#1)(2008-1#1)
remission in depression##2##3##(2012-3#2)
remission in patients with##2##4##(2008-10#1)(2008-8#1)
remission in##32##2##(1990-4#1)(1991-6#1)(1992-5#2)(1993-2#1)(1994-8#1)(1996-8#1)(1997-3#1)(1997-5#1)(2005-6#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-12#2)(2010-4#1)(2012-1#2)(2012-2#3)(2012-3#2)
remission is##9##2##(1990-11#2)(1993-2#1)(1995-11#1)(2006-2#1)(2007-10#1)(2007-11#1)(2010-11#1)(2011-2#1)
remission lasting##5##2##(1992-10#2)(2006-10#1)(2006-6#1)(2008-1#1)
remission of disease##2##3##(1991-10#1)(2009-2#1)
remission of nephrotic syndrome##2##4##(2007-11#2)
remission of proteinuria in##2##4##(2007-11#1)(2008-1#1)
remission of symptoms##3##3##(1990-7#1)(1991-8#1)(2006-10#1)
remission of the##6##3##(1990-10#1)(2006-10#2)(2007-7#1)(2008-7#1)(2013-7#1)
remission of##46##2##(1990-10#2)(1990-7#1)(1991-10#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-5#1)(1994-12#1)(1995-10#1)(1995-11#1)(1996-11#1)(1997-2#1)(1997-7#1)(2006-10#5)(2007-11#4)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
remission or##2##2##(1990-8#1)(1992-3#1)
remission rate##3##2##(1990-12#1)(1992-2#1)(2007-3#1)
remission rates are##2##3##(1990-4#1)(2013-8#1)
remission rates were##3##3##(2008-6#1)(2011-2#1)(2012-2#1)
remission rates##9##2##(1990-4#1)(1992-10#1)(2008-10#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-2#2)(2013-8#1)
remission state##4##2##(2007-11#3)(2011-2#1)
remission status##2##2##(1996-8#2)
remission using##2##2##(1994-5#1)(2012-2#1)
remission was achieved in##3##4##(1995-5#1)(1997-3#1)(2007-8#1)
remission was achieved##6##3##(1995-5#1)(1997-3#1)(2007-8#3)(2011-2#1)
remission was observed##2##3##(2008-6#1)(2010-9#1)
remission was##17##2##(1990-10#1)(1990-2#1)(1990-4#1)(1992-2#1)(1995-5#1)(1997-3#1)(2007-7#1)(2007-8#3)(2008-6#3)(2010-9#1)(2011-2#2)(2012-3#1)
remission were##4##2##(1990-11#1)(1993-1#1)(2007-11#1)(2008-8#1)
remission with##10##2##(1991-10#1)(1991-5#1)(1991-9#1)(1993-2#1)(2007-7#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
remission##374##1##(1990-10#4)(1990-11#5)(1990-12#2)(1990-2#1)(1990-3#4)(1990-4#5)(1990-6#3)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#4)(1991-2#6)(1991-4#5)(1991-5#4)(1991-6#6)(1991-7#1)(1991-8#9)(1991-9#3)(1992-10#5)(1992-2#3)(1992-3#1)(1992-5#6)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#6)(1993-3#1)(1993-8#1)(1994-12#3)(1994-5#2)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#2)(1995-3#1)(1995-5#1)(1995-9#4)(1996-11#3)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#4)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#3)(1997-5#1)(1997-6#2)(1997-7#1)(2005-11#1)(2005-6#1)(2006-10#14)(2006-12#1)(2006-2#4)(2006-6#3)(2007-10#2)(2007-11#14)(2007-12#1)(2007-2#1)(2007-3#5)(2007-4#2)(2007-5#3)(2007-6#2)(2007-7#18)(2007-8#14)(2008-1#12)(2008-10#9)(2008-12#1)(2008-3#2)(2008-5#6)(2008-6#10)(2008-7#2)(2008-8#9)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#4)(2009-8#3)(2009-9#1)(2010-10#3)(2010-11#5)(2010-12#6)(2010-2#1)(2010-4#4)(2010-5#2)(2010-6#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#21)(2012-1#3)(2012-12#8)(2012-2#10)(2012-3#9)(2013-1#4)(2013-7#1)(2013-8#5)
remission)##3##1##(1997-3#1)(2004-2#1)(2013-1#1)
remission]##2##1##(1991-5#1)(2005-10#1)
remissions and##2##2##(1991-2#1)(2010-12#1)
remissions in##8##2##(1991-9#1)(1993-4#1)(1993-5#1)(2007-11#2)(2007-8#1)(2008-4#1)(2008-5#1)
remissions##23##1##(1990-2#2)(1991-2#2)(1991-9#1)(1993-4#1)(1993-5#1)(1997-5#1)(2006-10#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-12#1)(2010-5#1)(2013-8#3)
remit of##3##2##(2008-11#2)(2009-10#1)
remit##13##1##(2005-10#1)(2006-3#1)(2007-7#1)(2008-11#5)(2009-10#1)(2010-2#1)(2010-7#1)(2012-12#1)(2012-2#1)
remittance activity##3##2##(2012-12#3)
remittance behavior##2##2##(2012-12#2)
remittance##6##1##(2012-12#6)
remitted after##3##2##(1995-1#1)(2010-7#1)(2011-2#1)
remitted##9##1##(1990-8#1)(1995-1#1)(1995-11#1)(2008-2#1)(2010-7#1)(2011-2#1)(2012-12#2)(2013-8#1)
remitting##10##1##(1995-11#1)(2006-1#1)(2006-10#1)(2007-11#1)(2008-4#1)(2009-8#1)(2010-12#2)(2012-3#1)(2013-8#1)
remnant ablation##5##2##(2012-12#1)(2013-1#4)
remnant in##2##2##(2007-2#1)(2008-5#1)
remnant of Atlantic##2##3##(2008-6#2)
remnant of a##2##3##(2009-4#1)(2009-8#1)
remnant of an ancient##2##4##(1995-8#1)(1997-4#1)
remnant of the##2##3##(1995-5#1)(2008-10#1)
remnant of##12##2##(1995-5#1)(1995-8#1)(1997-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-6#2)(2009-4#1)(2009-6#1)(2009-8#1)(2011-2#1)
remnant##48##1##(1991-1#2)(1991-10#1)(1991-5#4)(1992-12#1)(1992-3#1)(1992-7#2)(1995-5#1)(1995-8#1)(1997-2#1)(1997-4#1)(2006-1#1)(2006-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-5#3)(2008-6#2)(2008-8#1)(2009-4#1)(2009-6#2)(2009-8#1)(2010-12#3)(2011-2#2)(2012-12#1)(2013-1#7)
remnant-like particles##2##2##(1993-11#1)(1993-12#1)
remnant-like##4##1##(1993-11#1)(1993-12#2)(2007-10#1)
remnants are##3##2##(1994-9#1)(1997-6#1)(2008-9#1)
remnants have##2##2##(2008-12#1)(2013-7#1)
remnants of a##2##3##(2010-8#1)(2012-11#1)
remnants of the##3##3##(1995-8#1)(2005-11#1)(2007-5#1)
remnants of triglyceride-rich lipoproteins##2##4##(1995-6#2)
remnants of##16##2##(1990-2#1)(1991-2#1)(1995-6#2)(1995-8#1)(2005-11#1)(2007-5#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-11#2)
remnants##33##1##(1990-2#1)(1991-2#1)(1991-5#1)(1993-9#1)(1994-9#1)(1995-6#2)(1995-8#1)(1996-3#1)(1997-2#1)(1997-6#2)(2005-11#1)(2006-2#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-2#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-7#1)
remobilization##3##1##(2008-10#1)(2008-12#1)(2009-8#1)
remodel##5##1##(2007-11#1)(2007-5#1)(2007-8#1)(2009-7#1)(2012-2#1)
remodeled##4##1##(1996-8#1)(2007-8#1)(2008-10#1)(2008-5#1)
remodeling after##3##2##(2005-10#1)(2007-8#1)(2012-2#1)
remodeling and improved##2##3##(2007-8#1)(2012-12#1)
remodeling and repair##2##3##(2008-1#1)(2012-2#1)
remodeling and##32##2##(1994-9#1)(1996-5#1)(1996-6#1)(1996-8#1)(2007-11#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-8#1)(2009-1#2)(2009-10#2)(2009-6#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#5)(2012-2#1)(2013-1#2)(2013-8#1)
remodeling are the##2##3##(1993-10#1)(2010-10#1)
remodeling are##5##2##(1993-10#1)(2005-8#2)(2009-9#1)(2010-10#1)
remodeling as well##2##3##(2006-10#1)(2007-8#1)
remodeling associated##2##2##(1997-8#1)(2008-1#1)
remodeling at##2##2##(2009-11#1)(2012-3#1)
remodeling by##3##2##(2004-9#1)(2008-11#1)(2012-3#1)
remodeling during##2##2##(2010-5#1)(2012-1#1)
remodeling in Arabidopsis##2##3##(2009-8#2)
remodeling in asthma##2##3##(2005-8#2)
remodeling in the##3##3##(2005-8#1)(2008-7#1)(2012-12#1)
remodeling in##23##2##(1994-11#1)(1994-2#1)(1994-8#1)(1995-8#1)(1996-9#1)(2005-8#3)(2007-3#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#2)(2011-2#2)(2012-1#1)(2012-12#2)(2013-8#2)
remodeling involving##3##2##(1996-9#1)(2012-12#2)
remodeling is a##3##3##(1992-7#1)(2005-8#1)(2011-2#1)
remodeling is##6##2##(1992-7#1)(1996-8#1)(2005-8#1)(2009-1#1)(2011-2#2)
remodeling leading to##2##3##(2005-8#1)(2013-1#1)
remodeling of ECM##2##3##(2009-6#1)(2011-2#1)
remodeling of the extracellular matrix##2##5##(2008-1#1)(2009-8#1)
remodeling of the heart##2##4##(2010-12#2)
remodeling of the hip joint##3##5##(2007-11#1)(2007-8#2)
remodeling of the##23##3##(2004-12#1)(2004-3#1)(2007-11#3)(2007-7#1)(2007-8#4)(2008-1#1)(2008-11#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-12#2)(2012-1#1)(2012-3#1)(2013-1#4)
remodeling of##38##2##(1995-12#1)(1997-4#1)(2004-12#1)(2004-3#1)(2006-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-11#1)(2008-7#1)(2009-11#1)(2009-2#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-12#2)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-3#2)(2013-1#4)
remodeling process##9##2##(1993-10#1)(2006-9#1)(2007-8#1)(2008-1#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-2#1)
remodeling processes in the##3##4##(1993-12#2)(2012-12#1)
remodeling processes##4##2##(1993-12#2)(2009-7#1)(2012-12#1)
remodeling that##2##2##(2005-8#1)(2010-8#1)
remodeling under##2##2##(1997-2#1)(2008-7#1)
remodeling was##2##2##(1991-11#1)(1996-9#1)
remodeling which##2##2##(1991-11#1)(2009-4#1)
remodeling##238##1##(1991-10#1)(1991-11#2)(1991-3#1)(1991-7#1)(1992-5#1)(1992-7#1)(1993-10#4)(1993-11#1)(1993-12#2)(1994-11#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#3)(1996-9#3)(1997-2#1)(1997-4#1)(1997-8#1)(2004-12#1)(2004-3#1)(2004-9#2)(2005-10#1)(2005-8#11)(2006-10#5)(2006-9#2)(2007-10#1)(2007-11#6)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#17)(2007-9#1)(2008-1#5)(2008-10#2)(2008-11#10)(2008-3#2)(2008-4#1)(2008-7#5)(2008-8#1)(2008-9#3)(2009-1#5)(2009-10#3)(2009-11#4)(2009-2#1)(2009-3#5)(2009-4#5)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#6)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#4)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#14)(2011-9#2)(2012-1#4)(2012-12#25)(2012-2#5)(2012-3#5)(2013-1#8)(2013-8#6)
remodelling after##2##2##(1996-8#1)(2010-5#1)
remodelling and##7##2##(1997-5#1)(2006-11#1)(2007-1#1)(2008-11#1)(2008-4#1)(2010-10#1)(2012-3#1)
remodelling are##3##2##(2009-4#1)(2012-12#2)
remodelling in##3##2##(2008-7#1)(2010-8#1)(2012-3#1)
remodelling of PI##2##3##(1991-7#2)
remodelling of the##3##3##(1991-7#1)(2008-7#1)(2010-6#1)
remodelling of##13##2##(1991-7#4)(1996-2#1)(2008-5#2)(2008-6#1)(2008-7#2)(2010-6#2)(2012-2#1)
remodelling pathways##2##2##(2010-10#2)
remodelling response##3##2##(2008-7#1)(2010-10#2)
remodelling technique##2##2##(1997-3#1)(2008-3#1)
remodelling to##5##2##(1991-7#1)(2012-12#4)
remodelling##100##1##(1990-5#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-7#8)(1992-1#1)(1993-3#1)(1993-7#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-8#1)(1997-3#2)(1997-5#1)(2005-6#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-1#3)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#13)(2009-4#1)(2009-5#1)(2010-10#6)(2010-5#1)(2010-6#2)(2010-8#1)(2011-2#2)(2012-12#16)(2012-2#9)(2012-3#3)(2013-1#4)(2013-8#1)
remodels##3##1##(1992-5#1)(2006-11#1)(2009-8#1)
remote and##4##2##(1994-6#1)(2008-1#1)(2008-11#1)(2010-8#1)
remote areas are##2##3##(2008-9#1)(2013-1#1)
remote areas##13##2##(1990-6#1)(1996-12#1)(2005-8#1)(2007-2#2)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#2)(2013-1#1)
remote carbonyl groups##2##3##(1996-5#2)
remote communities##5##2##(1997-4#1)(2005-11#1)(2006-2#1)(2009-4#1)(2010-9#1)
remote consultation##3##2##(2008-1#3)
remote control##4##2##(2004-9#1)(2008-10#1)(2010-12#1)(2011-2#1)
remote data##2##2##(2008-10#2)
remote detection of##4##3##(2008-2#1)(2008-3#3)
remote detection##6##2##(2008-2#2)(2008-3#4)
remote distance sensing##2##3##(2008-2#2)
remote experience to present behavior##2##5##(2007-8#2)
remote experience##3##2##(2007-8#3)
remote eye##2##2##(2007-5#1)(2011-7#1)
remote from the##6##3##(1990-2#1)(1995-2#1)(2007-8#2)(2008-10#1)(2008-9#1)
remote from##12##2##(1990-2#1)(1992-3#1)(1995-2#2)(2007-2#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-5#1)(2008-9#1)
remote health professionals##2##3##(1995-1#1)(1995-3#1)
remote health##3##2##(1993-6#1)(1995-1#1)(1995-3#1)
remote homology detection##2##3##(2007-6#2)
remote homology##3##2##(2007-6#2)(2012-2#1)
remote irradiation##2##2##(2008-2#2)
remote islands##5##2##(2008-1#1)(2013-8#4)
remote location##5##2##(1994-7#1)(1997-3#1)(2006-6#1)(2008-12#1)(2013-1#1)
remote locations##6##2##(1996-5#1)(2007-12#1)(2008-10#2)(2008-3#1)(2012-2#1)
remote measurement of##4##3##(2008-2#1)(2008-3#3)
remote measurements of##2##3##(2007-12#1)(2008-3#1)
remote memory##2##2##(1991-9#1)(2012-2#1)
remote monitoring of##2##3##(2008-10#1)(2012-2#1)
remote monitoring##4##2##(2006-1#2)(2008-10#1)(2012-2#1)
remote organs##4##2##(1996-9#2)(2005-10#2)
remote places##4##2##(1991-11#1)(2007-5#1)(2008-7#1)(2013-1#1)
remote primary##4##2##(1996-2#1)(1997-4#1)(2007-12#1)(2008-10#1)
remote rural##2##2##(1996-12#1)(2006-4#1)
remote sensing and the##2##4##(2008-3#2)
remote sensing and##6##3##(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#1)
remote sensing by##2##3##(2008-3#1)(2013-8#1)
remote sensing imagery##2##3##(2008-10#1)(2008-2#1)
remote sensing of atmospheric ammonia by use of a coherent##2##10##(2008-3#2)
remote sensing of atmospheric##3##4##(2008-3#3)
remote sensing of cirrus clouds##2##5##(2007-12#1)(2008-2#1)
remote sensing of ocean color from space##2##7##(2008-3#2)
remote sensing of ocean color##5##5##(2008-2#1)(2008-3#4)
remote sensing of ocean##6##4##(2008-2#2)(2008-3#4)
remote sensing of the##2##4##(2008-3#2)
remote sensing of water##2##4##(2008-2#1)(2008-3#1)
remote sensing of##22##3##(2007-12#1)(2008-10#1)(2008-2#6)(2008-3#14)
remote sensing reflectance##2##3##(2008-2#1)(2013-8#1)
remote sensing variables##2##3##(2008-8#2)
remote sensing##74##2##(2007-12#2)(2008-10#5)(2008-12#3)(2008-2#21)(2008-3#25)(2008-8#11)(2011-1#1)(2013-8#6)
remote site##4##2##(1990-5#1)(1997-4#2)(2012-12#1)
remote sites##2##2##(1992-6#1)(2008-8#1)
remote sounding##3##2##(2008-3#3)
remote structural similarity to##2##4##(2010-10#2)
remote##293##1##(1990-10#2)(1990-2#1)(1990-5#2)(1990-6#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-3#3)(1993-6#1)(1994-6#2)(1994-7#1)(1995-1#1)(1995-12#1)(1995-2#4)(1995-3#1)(1996-12#2)(1996-2#1)(1996-5#3)(1996-9#3)(1997-3#1)(1997-4#5)(1997-8#2)(2004-4#1)(2004-9#1)(2005-10#2)(2005-11#1)(2005-8#1)(2006-1#2)(2006-2#2)(2006-4#3)(2006-6#3)(2006-9#1)(2007-11#2)(2007-12#9)(2007-2#4)(2007-5#5)(2007-6#2)(2007-7#4)(2007-8#6)(2008-1#5)(2008-10#25)(2008-11#3)(2008-12#4)(2008-2#37)(2008-3#44)(2008-4#3)(2008-5#2)(2008-7#9)(2008-8#13)(2008-9#6)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2011-7#1)(2012-12#6)(2012-2#6)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#11)
remote-control##2##1##(2006-10#1)(2011-2#1)
remote-sensing devices##2##2##(2008-3#2)
remote-sensing reflectance from##2##3##(2008-2#1)(2008-3#1)
remote-sensing reflectance model##2##3##(2008-3#2)
remote-sensing reflectance##17##2##(2008-2#5)(2008-3#12)
remote-sensing system##3##2##(2008-3#3)
remote-sensing##34##1##(2008-2#11)(2008-3#23)
remotely and##4##2##(2008-2#2)(2008-4#2)
remotely from the##2##3##(2008-10#1)(2008-6#1)
remotely from##3##2##(2008-10#1)(2008-6#1)(2008-9#1)
remotely piloted aircraft##2##3##(2008-3#2)
remotely pumped amplifiers##2##3##(2007-12#1)(2008-1#1)
remotely related to the##2##4##(1993-11#2)
remotely related to##3##3##(1993-11#2)(1995-2#1)
remotely sensed images##2##3##(2008-3#2)
remotely sensed##11##2##(2007-5#1)(2008-2#2)(2008-3#6)(2008-8#2)
remotely##46##1##(1990-6#1)(1993-11#2)(1995-2#1)(1996-6#1)(2005-10#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#6)(2008-3#10)(2008-4#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2012-12#1)(2012-2#1)
removable partial denture##4##3##(2008-4#1)(2012-1#1)(2012-12#1)(2012-2#1)
removable partial##6##2##(1990-11#1)(2008-4#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)
removable##22##1##(1990-11#1)(1992-9#1)(1995-5#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#2)(2011-12#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#6)
removal ability##2##2##(2008-12#2)
removal and##24##2##(1992-4#2)(1993-11#1)(1993-2#1)(1994-12#1)(2005-8#1)(2007-12#3)(2007-8#1)(2008-10#2)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#2)(2009-10#1)(2010-5#1)(2011-12#1)(2011-2#1)
removal appeared to##2##3##(2007-8#1)(2008-12#1)
removal are##3##2##(2008-11#1)(2008-4#1)(2008-5#1)
removal as##2##2##(2008-1#1)(2011-1#1)
removal at##2##2##(1994-6#1)(2008-7#1)
removal before##3##2##(2007-12#1)(2007-3#2)
removal by immobilized##2##3##(2007-12#1)(2007-8#1)
removal by means of##2##4##(1992-10#1)(2009-11#1)
removal by##17##2##(1992-10#2)(1992-6#1)(1994-5#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-6#1)(2011-1#2)(2011-2#1)
removal can be##2##3##(2006-10#1)(2006-5#1)
removal can##3##2##(1996-8#1)(2006-10#1)(2006-5#1)
removal capacity##3##2##(2005-11#1)(2007-12#1)(2008-7#1)
removal efficiencies##2##2##(2011-2#1)(2013-1#1)
removal efficiency of##4##3##(2007-12#1)(2008-1#1)(2010-8#1)(2013-1#1)
removal efficiency##8##2##(2007-10#1)(2007-12#1)(2008-1#2)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
removal filters##2##2##(2005-12#1)(2008-2#1)
removal for##5##2##(2007-7#2)(2007-8#1)(2008-4#1)(2012-2#1)
removal from the##13##3##(1991-3#1)(1994-6#1)(1995-8#1)(1996-2#1)(1997-2#2)(2006-5#1)(2007-8#1)(2008-11#1)(2008-6#1)(2010-4#1)(2012-11#1)(2012-3#1)
removal from water##2##3##(2008-10#2)
removal from##37##2##(1990-12#1)(1991-3#1)(1991-5#1)(1992-6#1)(1994-6#2)(1995-2#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#1)(2004-9#1)(2005-11#2)(2006-5#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#1)(2008-6#2)(2010-4#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
removal have been##3##3##(2007-10#1)(2007-7#1)(2008-3#1)
removal in a patient with##2##5##(1996-8#1)(2013-7#1)
removal in a##4##3##(1996-8#1)(2008-2#2)(2013-7#1)
removal in the##3##3##(2006-12#1)(2007-12#1)(2008-7#1)
removal in##19##2##(1990-3#1)(1992-10#1)(1992-2#1)(1996-8#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#2)(2009-6#1)(2013-7#1)
removal is not##2##3##(2007-12#1)(2008-6#1)
removal is##16##2##(1990-1#1)(1993-10#1)(1994-12#1)(2005-3#1)(2006-10#2)(2006-5#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-5#1)(2008-6#1)(2009-6#1)(2013-1#1)
removal mechanism##3##2##(2009-6#1)(2011-2#1)(2013-8#1)
removal mechanisms##2##2##(1990-2#1)(2008-8#1)
removal of 1##2##3##(1993-9#1)(2008-6#1)
removal of 95%##2##3##(2009-11#1)(2013-1#1)
removal of CORT##2##3##(1996-10#2)
removal of DNA alterations##2##4##(2008-7#2)
removal of DNA##3##3##(1997-1#1)(2008-7#2)
removal of IgG##2##3##(1991-5#1)(1992-7#1)
removal of LDL##2##3##(1993-9#1)(2013-8#1)
removal of T##2##3##(2008-4#2)
removal of a##30##3##(1990-12#1)(1991-4#1)(1991-9#1)(1992-10#1)(1992-6#1)(1993-10#1)(1996-6#1)(1997-1#1)(2005-11#1)(2005-5#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-9#2)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#2)(2010-5#1)(2012-12#2)(2012-3#1)(2013-1#1)
removal of acoustic##2##3##(2006-11#1)(2006-5#1)
removal of all##9##3##(1995-9#1)(1996-5#1)(2006-5#1)(2006-9#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2011-12#1)
removal of an##7##3##(1991-11#1)(1994-5#1)(1996-12#1)(2007-8#1)(2008-10#1)(2009-4#1)(2010-12#1)
removal of background##2##3##(2006-12#1)(2009-4#1)
removal of benign##2##3##(2006-12#1)(2006-2#1)
removal of bile duct stones##2##5##(1993-5#1)(2010-12#1)
removal of calcium##2##3##(1995-11#1)(2007-8#1)
removal of cellular##2##3##(1994-6#1)(1994-9#1)
removal of contaminating##2##3##(1995-6#1)(2008-9#1)
removal of cumulus cells##2##4##(2013-1#2)
removal of cysticercal cysts##2##4##(2006-5#2)
removal of debris##2##3##(2008-9#1)(2012-3#1)
removal of endogenous##3##3##(1994-12#1)(1995-3#1)(2008-10#1)
removal of excess##2##3##(2008-8#1)(2011-2#1)
removal of extracellular Mg2+##2##4##(1990-7#1)(1997-6#1)
removal of extracellular##6##3##(1990-2#1)(1990-7#2)(1992-4#1)(1997-6#1)(1997-8#1)
removal of foreign bodies in##2##5##(2007-9#2)
removal of foreign bodies##3##4##(2004-7#1)(2007-9#2)
removal of free##3##3##(1991-2#1)(1991-5#1)(2008-10#1)
removal of histones##2##3##(1995-2#2)
removal of hydrogen sulfide from##2##5##(2005-11#2)
removal of hydrogen sulfide##3##4##(2005-11#2)(2007-12#1)
removal of impacted third molars##2##5##(2007-12#2)
removal of impacted##3##3##(2007-12#2)(2010-12#1)
removal of inflammatory##2##3##(2006-8#1)(2012-12#1)
removal of large amounts##2##4##(1991-10#1)(2008-10#1)
removal of large##5##3##(1991-10#1)(2006-6#1)(2008-10#2)(2008-7#1)
removal of light##2##3##(1993-9#1)(2012-12#1)
removal of matrix##2##3##(2007-8#1)(2008-10#1)
removal of medium##2##3##(1990-7#1)(1992-6#1)
removal of mercury from coal is##2##6##(2008-6#2)
removal of mercury##3##3##(2008-10#1)(2008-6#2)
removal of most of the##3##5##(1990-12#1)(2008-4#1)(2013-1#1)
removal of most of##4##4##(1990-12#1)(1991-8#1)(2008-4#1)(2013-1#1)
removal of nearly##2##3##(1990-9#1)(2008-10#1)
removal of necrotic##2##3##(2011-2#2)
removal of nickel##2##3##(2007-10#1)(2008-6#1)
removal of nitrogen##2##3##(2005-11#1)(2013-1#1)
removal of one##3##3##(1996-2#1)(1997-4#1)(2012-3#1)
removal of organic##2##3##(2008-10#1)(2009-8#1)
removal of precancerous##2##3##(2008-7#1)(2010-11#1)
removal of primary##2##3##(2008-5#1)(2011-2#1)
removal of protecting groups##3##4##(1996-2#1)(2008-7#1)(2009-9#1)
removal of residual yolk sac##2##5##(2008-12#2)
removal of residual##4##3##(2007-11#1)(2008-10#1)(2008-12#2)
removal of sialic acid##3##4##(1990-12#1)(1990-5#1)(1994-12#1)
removal of submucous leiomyomas##2##4##(1991-2#2)
removal of surface##2##3##(2008-10#1)(2008-11#1)
removal of susceptible##2##3##(2008-10#2)
removal of the N-terminal##2##4##(1994-3#1)(2005-7#1)
removal of the biofilm##2##4##(2012-2#1)(2013-1#1)
removal of the calcific deposits##2##5##(2012-12#2)
removal of the catheter##2##4##(2007-12#1)(2011-2#1)
removal of the cells##2##4##(1992-8#1)(2008-11#1)
removal of the cyst##3##4##(2006-10#1)(2006-5#2)
removal of the detergent##2##4##(1990-2#1)(1997-4#1)
removal of the endothelium##3##4##(1997-5#2)(2007-8#1)
removal of the infected##3##4##(2007-12#1)(2007-8#1)(2011-2#1)
removal of the lesion##3##4##(2006-10#1)(2007-12#1)(2010-10#1)
removal of the mass and##2##5##(2009-9#1)(2011-2#1)
removal of the medial##3##4##(1994-5#1)(1994-8#1)(2008-7#1)
removal of the plate##2##4##(1993-8#1)(2006-12#1)
removal of the primary##2##4##(2008-1#1)(2008-4#1)
removal of the pulmonary artery in video-assisted thoracic surgery##2##9##(2013-7#2)
removal of the pulmonary artery##4##5##(2013-7#4)
removal of the pulmonary##5##4##(2010-12#1)(2013-7#4)
removal of the residual yolk sac##2##6##(2008-12#2)
removal of the residual##3##4##(2008-10#1)(2008-12#2)
removal of the salivary glands##2##5##(2008-4#2)
removal of the superficial layers of##2##6##(1992-2#2)
removal of the template##3##4##(2005-11#1)(2006-12#1)(2010-12#1)
removal of the thrombus##3##4##(2007-8#1)(2013-1#2)
removal of the tumor##11##4##(1990-9#1)(1995-7#1)(2006-10#1)(2006-12#1)(2008-12#1)(2009-3#1)(2010-9#1)(2011-2#2)(2012-1#1)(2013-8#1)
removal of the tumour and##2##5##(1992-8#1)(2008-7#1)
removal of the tumour##7##4##(1992-8#1)(1994-4#1)(2006-10#1)(2007-11#1)(2008-7#3)
removal of the two##2##4##(1991-1#1)(2008-5#1)
removal of the type-2 copper from##2##6##(1992-12#2)
removal of the type-2 copper##3##5##(1992-12#3)
removal of the##250##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#5)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#4)(1991-3#1)(1991-8#1)(1992-11#3)(1992-12#5)(1992-2#5)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#2)(1993-11#2)(1993-2#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-3#1)(1994-4#2)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#3)(1995-2#1)(1995-4#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-5#2)(1997-8#1)(2005-10#1)(2005-11#3)(2005-7#1)(2006-10#6)(2006-11#1)(2006-12#8)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#4)(2006-8#1)(2007-11#4)(2007-12#5)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#8)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#10)(2008-5#6)(2008-6#1)(2008-7#12)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#2)(2009-3#4)(2009-6#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#10)(2012-1#1)(2012-12#11)(2012-2#3)(2013-1#11)(2013-7#5)(2013-8#2)
removal of these##5##3##(1994-9#1)(2007-10#1)(2007-5#1)(2008-4#1)(2011-1#1)
removal of third molars##2##4##(1993-1#1)(2007-12#1)
removal of third##3##3##(1993-1#1)(2006-5#1)(2007-12#1)
removal of this##5##3##(1990-5#1)(1995-6#1)(2008-2#1)(2010-12#1)(2012-3#1)
removal of three##3##3##(1992-8#1)(1994-12#1)(2008-7#1)
removal of toxic##2##3##(2007-10#1)(2007-11#1)
removal of tumor##2##3##(1992-8#1)(2011-1#1)
removal of zinc##2##3##(1995-8#1)(1997-3#1)
removal of##713##2##(1990-10#3)(1990-11#1)(1990-12#5)(1990-2#10)(1990-5#4)(1990-6#2)(1990-7#5)(1990-9#2)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#6)(1991-2#6)(1991-3#1)(1991-4#2)(1991-5#3)(1991-7#1)(1991-8#3)(1991-9#1)(1992-10#1)(1992-11#4)(1992-12#5)(1992-2#5)(1992-3#3)(1992-4#4)(1992-5#6)(1992-6#5)(1992-7#1)(1992-8#5)(1993-1#1)(1993-10#2)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#2)(1993-8#4)(1993-9#4)(1994-10#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#5)(1994-4#2)(1994-5#3)(1994-6#3)(1994-8#4)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#6)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#7)(1995-7#3)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#3)(1996-11#2)(1996-12#2)(1996-2#4)(1996-5#4)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#5)(1997-3#3)(1997-4#4)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#3)(2004-7#1)(2005-10#1)(2005-11#15)(2005-12#2)(2005-5#2)(2005-7#1)(2005-8#1)(2006-10#7)(2006-11#2)(2006-12#13)(2006-2#4)(2006-3#2)(2006-4#1)(2006-5#15)(2006-6#7)(2006-7#2)(2006-8#3)(2006-9#3)(2007-10#4)(2007-11#9)(2007-12#15)(2007-3#2)(2007-5#4)(2007-7#2)(2007-8#18)(2007-9#4)(2008-1#8)(2008-10#55)(2008-11#11)(2008-12#9)(2008-2#3)(2008-3#7)(2008-4#21)(2008-5#16)(2008-6#12)(2008-7#30)(2008-8#5)(2008-9#5)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#5)(2009-4#2)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#5)(2010-10#2)(2010-11#3)(2010-12#8)(2010-2#3)(2010-4#2)(2010-5#3)(2010-7#1)(2010-9#1)(2011-1#15)(2011-12#2)(2011-2#23)(2012-1#1)(2012-10#1)(2012-12#18)(2012-2#4)(2012-3#6)(2013-1#30)(2013-7#7)(2013-8#6)
removal on the##3##3##(1992-10#1)(2009-9#1)(2013-1#1)
removal on##6##2##(1992-10#1)(1996-11#1)(2008-5#1)(2009-9#1)(2013-1#1)(2013-7#1)
removal or##13##2##(1993-4#1)(1993-7#1)(1995-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-6#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
removal procedures##2##2##(2011-2#2)
removal process##4##2##(1997-5#1)(2008-2#1)(2011-1#1)(2011-2#1)
removal rate##3##2##(2008-8#1)(2012-3#1)(2013-1#1)
removal rates were##2##3##(2008-12#1)(2013-1#1)
removal rates##4##2##(2005-11#1)(2008-12#1)(2008-5#1)(2013-1#1)
removal sampling##2##2##(2004-11#2)
removal should be##4##3##(2006-12#2)(2007-12#1)(2011-12#1)
removal technique##2##2##(2008-5#2)
removal torque##4##2##(2009-7#4)
removal under##3##2##(2006-5#1)(2007-6#1)(2012-12#1)
removal using##4##2##(2007-10#1)(2008-10#1)(2008-2#1)(2013-1#1)
removal was accomplished##2##3##(2006-12#1)(2008-6#1)
removal was achieved in##2##4##(2006-12#2)
removal was achieved##5##3##(2006-12#2)(2007-1#2)(2008-7#1)
removal was##24##2##(1991-6#1)(1994-3#1)(2006-12#3)(2006-5#1)(2007-1#2)(2007-10#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
removal were##3##2##(1993-5#1)(1997-3#1)(2008-6#1)
removal when##2##2##(1996-3#1)(2007-12#1)
removal with##7##2##(2006-6#1)(2007-1#1)(2008-10#1)(2008-5#1)(2009-4#1)(2011-1#1)(2012-3#1)
removal without##2##2##(1991-2#1)(1996-11#1)
removal##1201##1##(1990-1#1)(1990-10#3)(1990-11#1)(1990-12#6)(1990-2#12)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#5)(1990-7#7)(1990-9#2)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#7)(1991-2#9)(1991-3#3)(1991-4#4)(1991-5#4)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-10#7)(1992-11#4)(1992-12#5)(1992-2#6)(1992-3#3)(1992-4#7)(1992-5#7)(1992-6#9)(1992-7#1)(1992-8#5)(1993-1#1)(1993-10#4)(1993-11#4)(1993-12#3)(1993-2#3)(1993-3#1)(1993-4#3)(1993-5#2)(1993-6#3)(1993-7#1)(1993-8#4)(1993-9#4)(1994-10#3)(1994-11#2)(1994-12#6)(1994-2#1)(1994-3#6)(1994-4#2)(1994-5#6)(1994-6#9)(1994-8#4)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#4)(1995-2#7)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#9)(1995-7#3)(1995-8#5)(1995-9#1)(1996-1#2)(1996-10#3)(1996-11#5)(1996-12#2)(1996-2#5)(1996-3#2)(1996-5#4)(1996-6#2)(1996-7#1)(1996-8#4)(1996-9#2)(1997-1#3)(1997-2#8)(1997-3#5)(1997-4#4)(1997-5#3)(1997-6#2)(1997-7#2)(1997-8#4)(2004-11#3)(2004-2#1)(2004-7#1)(2004-9#2)(2005-10#1)(2005-11#24)(2005-12#5)(2005-3#1)(2005-5#4)(2005-7#1)(2005-8#2)(2006-10#12)(2006-11#2)(2006-12#26)(2006-2#6)(2006-3#3)(2006-4#1)(2006-5#23)(2006-6#8)(2006-7#2)(2006-8#4)(2006-9#3)(2007-1#8)(2007-10#14)(2007-11#13)(2007-12#44)(2007-3#5)(2007-5#6)(2007-6#2)(2007-7#12)(2007-8#34)(2007-9#5)(2008-1#16)(2008-10#79)(2008-11#17)(2008-12#18)(2008-2#18)(2008-3#19)(2008-4#31)(2008-5#40)(2008-6#22)(2008-7#46)(2008-8#17)(2008-9#10)(2009-1#1)(2009-10#5)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#5)(2009-4#4)(2009-5#1)(2009-6#10)(2009-7#7)(2009-8#3)(2009-9#6)(2010-10#2)(2010-11#3)(2010-12#9)(2010-2#6)(2010-4#3)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#21)(2011-12#8)(2011-2#37)(2012-1#4)(2012-10#1)(2012-11#1)(2012-12#27)(2012-2#10)(2012-3#12)(2013-1#47)(2013-7#11)(2013-8#12)
removal)##2##1##(2008-5#2)
removal?##2##1##(2007-12#1)(2007-8#1)
removal]##2##1##(1991-3#1)(1993-5#1)
removals##8##1##(1994-5#1)(2006-5#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-10#1)(2012-2#1)
remove 95##3##2##(1993-10#2)(2010-5#1)
remove a##8##2##(1993-6#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2012-12#2)
remove all##2##2##(2005-12#1)(2008-11#1)
remove and##2##2##(2006-4#1)(2008-10#1)
remove barriers to##2##3##(1994-2#1)(2013-7#1)
remove barriers##3##2##(1994-2#1)(1997-2#1)(2013-7#1)
remove cells##2##2##(2008-8#1)(2008-9#1)
remove contaminating##2##2##(1992-8#1)(2008-2#1)
remove excess##3##2##(2005-7#1)(2008-10#1)(2011-2#1)
remove high##2##2##(2007-8#1)(2008-10#1)
remove interfering##2##2##(2008-10#2)
remove low-molecular-weight contaminants##2##3##(2008-9#2)
remove material##2##2##(2008-3#2)
remove one##2##2##(1994-12#1)(2007-9#1)
remove specific##2##2##(1994-12#1)(2008-10#1)
remove sperm##3##2##(2008-8#1)(2012-12#2)
remove the interference##2##3##(2008-10#1)(2012-12#1)
remove the voxelization##2##3##(2011-2#2)
remove the##87##2##(1990-11#1)(1990-2#1)(1991-1#1)(1992-3#1)(1993-10#2)(1993-3#1)(1994-8#2)(1994-9#1)(1995-12#1)(1996-1#1)(1996-5#1)(1997-2#1)(1997-6#1)(2004-10#1)(2005-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#20)(2008-11#4)(2008-2#4)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-4#2)(2011-12#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-7#2)(2013-8#2)
remove them##3##2##(2007-8#1)(2008-5#1)(2011-1#1)
remove these##3##2##(2007-8#1)(2011-1#1)(2011-2#1)
remove this impurity##2##3##(2007-6#2)
remove this##5##2##(2007-6#2)(2009-3#1)(2010-6#1)(2012-3#1)
remove##296##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-4#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-6#2)(1992-8#1)(1993-10#4)(1993-3#1)(1993-6#1)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-6#1)(1997-8#1)(2004-10#1)(2005-11#4)(2005-12#1)(2005-4#1)(2005-5#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#3)(2006-6#1)(2007-1#1)(2007-10#3)(2007-11#6)(2007-12#6)(2007-6#3)(2007-8#9)(2007-9#3)(2008-1#2)(2008-10#52)(2008-11#6)(2008-12#4)(2008-2#11)(2008-3#12)(2008-4#11)(2008-5#9)(2008-6#8)(2008-7#5)(2008-8#9)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#2)(2009-3#1)(2009-4#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-12#2)(2011-2#10)(2011-3#1)(2012-12#6)(2012-3#2)(2013-1#7)(2013-7#6)(2013-8#4)
removed a##2##2##(2008-2#1)(2011-2#1)
removed after the##3##3##(2006-10#1)(2008-7#1)(2009-10#1)
removed after##17##2##(1993-4#3)(1994-5#2)(2006-10#1)(2006-2#1)(2007-7#2)(2007-8#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
removed all of the##2##4##(1996-12#1)(2011-1#1)
removed all##5##2##(1996-12#1)(1997-2#1)(1997-3#1)(2006-5#1)(2011-1#1)
removed and replaced by##2##4##(1991-7#1)(1992-6#1)
removed and replaced##7##3##(1991-7#1)(1992-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)
removed and the##12##3##(1991-2#1)(1993-8#1)(1995-12#1)(1995-8#1)(2008-11#2)(2008-7#3)(2010-2#1)(2013-7#1)(2013-8#1)
removed and##46##2##(1991-2#1)(1991-7#1)(1991-9#1)(1992-6#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-9#1)(1995-12#1)(1995-8#1)(1997-2#1)(1997-3#1)(2005-10#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#4)(2008-12#3)(2008-5#2)(2008-7#8)(2008-9#1)(2010-2#1)(2011-2#2)(2012-11#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
removed as a##2##3##(2008-7#1)(2011-2#1)
removed as##5##2##(2008-3#1)(2008-7#1)(2011-12#1)(2011-2#2)
removed at autopsy##2##3##(1995-12#1)(2008-7#1)
removed at random##3##3##(1995-2#3)
removed at surgery##3##3##(2007-2#1)(2010-3#1)(2012-3#1)
removed at the##5##3##(1990-11#1)(1994-2#1)(2006-6#1)(2007-8#1)(2011-2#1)
removed at##21##2##(1990-11#1)(1990-8#1)(1992-12#1)(1993-7#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#3)(2006-6#1)(2007-2#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-1#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
removed before##3##2##(2007-10#1)(2008-2#1)(2013-1#1)
removed bilaterally##2##2##(1993-12#1)(1994-8#1)
removed by a##6##3##(1993-12#1)(1995-3#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)
removed by an endoscopic transsphenoidal approach##2##6##(2011-2#2)
removed by an##4##3##(1992-1#1)(2008-3#1)(2011-2#2)
removed by cervical esophagotomy##2##4##(2011-2#2)
removed by dialysis##2##3##(1991-5#1)(2008-4#1)
removed by endoscopic##2##3##(2012-2#1)(2013-8#1)
removed by means of##2##4##(1993-10#1)(2008-4#1)
removed by precipitation with##2##4##(1996-11#1)(2008-10#1)
removed by precipitation##4##3##(1996-11#1)(2008-10#2)(2013-1#1)
removed by subsequent washing##2##4##(1991-9#1)(2008-10#1)
removed by subsequent##3##3##(1991-9#1)(2008-10#1)(2009-11#1)
removed by the##9##3##(1992-3#1)(1997-2#1)(2005-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-1#1)
removed by treatment with##3##4##(1994-5#1)(2008-10#1)(2008-4#1)
removed by use of a##3##5##(2007-12#1)(2008-3#1)(2008-9#1)
removed by##107##2##(1990-10#1)(1990-2#1)(1990-7#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-1#1)(1992-3#1)(1992-5#2)(1992-8#1)(1992-9#2)(1993-10#1)(1993-12#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-4#2)(2005-11#4)(2006-12#3)(2006-5#1)(2007-11#1)(2007-12#4)(2007-5#2)(2007-7#2)(2007-8#2)(2008-10#10)(2008-11#1)(2008-2#5)(2008-3#3)(2008-4#7)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2010-4#2)(2011-1#1)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
removed completely##4##2##(1992-8#1)(2006-12#1)(2007-8#1)(2008-10#1)
removed during a##2##3##(1997-8#1)(2010-12#1)
removed during the##2##3##(1994-10#1)(2012-12#1)
removed during##8##2##(1992-2#1)(1994-10#1)(1995-5#1)(1997-8#1)(2008-2#1)(2010-12#1)(2011-2#1)(2012-12#1)
removed endoscopically after##2##3##(1993-5#1)(2011-2#1)
removed endoscopically##7##2##(1993-5#1)(1993-9#1)(2008-5#1)(2011-2#3)(2013-7#1)
removed except for a##2##4##(2005-11#1)(2008-7#1)
removed for##8##2##(1991-7#1)(1992-11#1)(1993-2#1)(1997-4#1)(2006-6#1)(2006-9#1)(2008-10#1)(2013-1#1)
removed from both##2##3##(1994-12#1)(2008-2#1)
removed from its##2##3##(1992-6#1)(2013-1#1)
removed from patients##2##3##(1991-3#1)(1992-7#1)
removed from solution##2##3##(1990-2#1)(2008-4#1)
removed from the market##2##4##(2006-10#1)(2006-8#1)
removed from the patient##2##4##(2004-11#1)(2011-2#1)
removed from the system##2##4##(1992-2#1)(2005-11#1)
removed from the##72##3##(1990-12#1)(1990-4#1)(1990-7#1)(1991-11#3)(1991-4#1)(1991-5#1)(1992-2#3)(1992-5#1)(1992-7#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-2#1)(1996-11#2)(1996-12#1)(1996-5#1)(1997-1#1)(2004-11#1)(2005-10#1)(2005-11#4)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#2)(2008-10#13)(2008-11#5)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#1)(2010-12#2)(2010-8#1)(2011-12#1)(2011-2#1)(2012-10#1)(2012-2#1)(2012-3#1)(2013-8#1)
removed from##126##2##(1990-1#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-7#1)(1991-10#1)(1991-11#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-2#3)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#1)(1993-11#1)(1993-4#1)(1993-8#1)(1994-10#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#4)(1995-2#1)(1995-5#1)(1995-9#1)(1996-11#2)(1996-12#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-8#2)(2004-11#2)(2005-10#1)(2005-11#4)(2006-10#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-8#1)(2008-10#20)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#7)(2008-7#3)(2008-8#1)(2009-4#1)(2009-9#1)(2010-12#3)(2010-8#1)(2011-12#1)(2011-2#1)(2012-10#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
removed gold-cyanide ion##2##3##(2008-6#2)
removed immediately##3##2##(1991-11#1)(1995-2#1)(2011-2#1)
removed in a##2##3##(1990-8#1)(1997-3#1)
removed in two##2##3##(2005-8#1)(2011-2#1)
removed in##21##2##(1990-4#1)(1990-8#1)(1991-6#1)(1993-3#1)(1994-11#1)(1996-2#1)(1997-3#2)(1997-6#1)(2005-8#1)(2006-5#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-6#1)(2011-2#1)(2013-8#1)
removed more##2##2##(1995-1#1)(2005-11#1)
removed on##7##2##(1990-8#1)(1991-12#1)(2007-9#1)(2011-1#1)(2012-12#2)(2013-1#1)
removed or##7##2##(1993-7#1)(1995-2#1)(1997-3#2)(2007-8#1)(2008-3#1)(2012-12#1)
removed per cleavage/religation cycle##2##4##(1997-4#2)
removed successfully##2##2##(2006-4#1)(2007-8#1)
removed surgically##6##2##(2007-8#1)(2008-8#1)(2010-7#1)(2011-2#2)(2012-2#1)
removed temporarily##2##2##(1990-5#1)(2008-11#1)
removed the right##2##3##(2007-12#1)(2011-1#1)
removed the##14##2##(1990-2#1)(1990-9#1)(1991-8#1)(1993-5#1)(1994-3#1)(1994-8#1)(1997-4#1)(2007-12#2)(2007-8#1)(2008-7#1)(2009-4#1)(2011-1#1)(2012-12#1)
removed through an##3##3##(2006-12#1)(2008-4#1)(2008-7#1)
removed through##5##2##(1994-9#1)(2006-12#1)(2008-4#1)(2008-7#1)(2013-1#1)
removed to a##2##3##(2006-8#1)(2008-10#1)
removed to prevent##2##3##(2008-4#1)(2012-2#1)
removed to##9##2##(1990-5#1)(1993-4#1)(1997-7#1)(2005-7#1)(2006-8#1)(2008-10#1)(2008-4#1)(2008-6#1)(2012-2#1)
removed tumor was##2##3##(1996-12#1)(2008-6#1)
removed under##10##2##(1992-12#1)(1992-8#1)(2005-5#3)(2007-7#1)(2007-8#3)(2010-5#1)
removed using a##2##3##(2007-1#2)
removed using##8##2##(2006-2#1)(2007-1#2)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)
removed via a##4##3##(2006-8#2)(2008-7#1)(2011-2#1)
removed via an##3##3##(1995-3#1)(2006-12#1)(2009-3#1)
removed via##10##2##(1995-3#1)(2006-12#1)(2006-8#2)(2007-8#1)(2008-7#2)(2009-3#1)(2011-2#1)(2012-2#1)
removed was##4##2##(1992-8#1)(2005-5#1)(2007-3#1)(2011-2#1)
removed when the##2##3##(1993-8#1)(2007-7#1)
removed when##4##2##(1993-8#1)(2007-7#1)(2008-12#1)(2008-2#1)
removed with a##3##3##(2008-4#1)(2010-1#1)(2013-8#1)
removed with good##2##3##(2008-10#1)(2008-8#1)
removed with the##4##3##(1990-5#1)(2008-3#1)(2012-2#1)(2012-3#1)
removed with##17##2##(1990-5#1)(1991-8#1)(1994-2#1)(1997-2#1)(2006-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
removed without##5##2##(1991-3#1)(1994-3#1)(2006-12#1)(2008-11#1)(2008-7#1)
removed##728##1##(1990-1#1)(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#7)(1990-4#2)(1990-5#3)(1990-7#2)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#4)(1991-12#2)(1991-2#3)(1991-3#4)(1991-4#1)(1991-5#4)(1991-6#3)(1991-7#2)(1991-8#3)(1991-9#5)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#4)(1992-3#5)(1992-4#1)(1992-5#4)(1992-6#2)(1992-7#5)(1992-8#6)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#6)(1993-2#3)(1993-3#2)(1993-4#5)(1993-5#2)(1993-6#3)(1993-7#2)(1993-8#4)(1993-9#3)(1994-10#2)(1994-11#1)(1994-12#5)(1994-2#3)(1994-3#4)(1994-4#1)(1994-5#4)(1994-6#1)(1994-8#6)(1994-9#8)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#7)(1995-3#3)(1995-5#5)(1995-8#3)(1995-9#1)(1996-10#1)(1996-11#3)(1996-12#6)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#5)(1997-3#6)(1997-4#7)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#4)(2004-11#3)(2005-10#2)(2005-11#12)(2005-12#1)(2005-5#4)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#4)(2006-12#14)(2006-2#2)(2006-4#2)(2006-5#5)(2006-6#3)(2006-7#1)(2006-8#6)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#7)(2007-12#14)(2007-2#2)(2007-3#3)(2007-5#4)(2007-7#12)(2007-8#18)(2007-9#2)(2008-1#3)(2008-10#61)(2008-11#21)(2008-12#6)(2008-2#17)(2008-3#15)(2008-4#20)(2008-5#28)(2008-6#7)(2008-7#29)(2008-8#11)(2008-9#9)(2009-1#1)(2009-10#2)(2009-11#1)(2009-2#3)(2009-3#2)(2009-4#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-12#3)(2011-2#38)(2012-10#1)(2012-11#1)(2012-12#10)(2012-2#9)(2012-3#6)(2013-1#20)(2013-7#2)(2013-8#9)
removed)##5##1##(1992-2#2)(2007-1#2)(2008-8#1)
remover##3##1##(2008-5#1)(2012-3#2)
removes all##2##2##(1994-3#1)(2007-11#1)
removes or##2##2##(1991-2#1)(1996-5#1)
removes some##2##2##(2008-10#1)(2008-8#1)
removes the COOH-terminal##3##3##(1990-2#2)(1992-9#1)
removes the##26##2##(1990-2#2)(1990-3#1)(1990-7#1)(1992-9#1)(1995-10#1)(1995-5#1)(1996-4#1)(1996-8#1)(2005-11#1)(2007-10#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-7#1)(2009-3#1)(2009-6#1)(2011-2#1)
removes##68##1##(1990-2#2)(1990-3#1)(1990-7#2)(1991-2#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-3#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-5#1)(1996-4#2)(1996-5#1)(1996-8#2)(1997-4#1)(1997-5#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-2#1)(2007-10#1)(2007-11#5)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#4)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#1)(2009-3#1)(2009-6#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)
removing Cu(II) ions##2##3##(2008-10#2)
removing a##7##2##(1995-8#1)(2007-5#1)(2008-10#1)(2008-7#1)(2009-9#1)(2012-2#1)(2012-3#1)
removing any##3##2##(1993-10#1)(2007-11#1)(2008-9#1)
removing both the##2##3##(2009-12#1)(2010-6#1)
removing both##3##2##(2008-2#1)(2009-12#1)(2010-6#1)
removing debris from broken instruments from root canals##2##8##(2013-8#2)
removing formulations##2##2##(2008-10#2)
removing noise from##3##3##(2008-2#3)
removing noise##5##2##(2008-10#1)(2008-2#4)
removing of##3##2##(2005-11#1)(2007-8#1)(2008-10#1)
removing one##2##2##(2009-9#1)(2010-5#1)
removing organic##3##2##(1997-2#1)(2008-10#1)(2008-5#1)
removing the lesion and##2##4##(2005-10#1)(2012-12#1)
removing the lesion##3##3##(2005-10#1)(2009-12#1)(2012-12#1)
removing the##53##2##(1990-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-6#2)(1995-5#1)(1996-5#1)(1997-3#1)(1997-4#1)(2005-10#1)(2005-11#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#5)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
removing this##2##2##(2007-12#1)(2008-3#1)
removing##196##1##(1990-12#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-9#3)(1993-10#1)(1993-2#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-6#3)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(2005-10#2)(2005-11#5)(2005-12#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#4)(2007-11#2)(2007-12#4)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#29)(2008-11#2)(2008-2#10)(2008-3#3)(2008-4#6)(2008-5#7)(2008-7#5)(2008-8#5)(2008-9#4)(2009-12#2)(2009-2#2)(2009-3#3)(2009-8#1)(2009-9#3)(2010-12#1)(2010-2#2)(2010-3#2)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#7)(2012-11#2)(2012-12#4)(2012-2#3)(2012-3#2)(2012-4#1)(2013-1#6)(2013-8#4)
remunerated##3##1##(1994-12#3)
remuneration for##2##2##(1991-3#1)(2007-4#1)
remuneration##10##1##(1990-6#1)(1991-3#1)(1992-12#1)(1993-1#1)(1994-3#1)(2007-4#1)(2008-1#2)(2008-7#1)(2010-10#1)
remyelination in##2##2##(2008-12#1)(2012-2#1)
remyelination is##3##2##(2008-12#1)(2008-7#2)
remyelination##16##1##(1990-2#1)(2006-6#1)(2007-11#1)(2008-12#6)(2008-7#5)(2012-2#2)
renaissance for##2##2##(1996-2#1)(2005-12#1)
renaissance in##4##2##(2006-6#1)(2007-5#1)(2008-10#1)(2008-8#1)
renaissance of##5##2##(1990-9#1)(2006-9#1)(2007-11#1)(2008-5#1)(2010-7#1)
renaissance##11##1##(1990-9#1)(1996-2#1)(2005-12#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-7#1)
renal 2E1##3##2##(1992-7#3)
renal Cd concentrations were##2##4##(1997-2#1)(1997-4#1)
renal Cd concentrations##3##3##(1997-2#1)(1997-4#2)
renal ECM accumulation##2##3##(2011-2#2)
renal H(2)O(2)##2##2##(2010-7#2)
renal HSP73##3##2##(1997-2#3)
renal MT mRNA were##2##4##(1997-2#2)
renal MT mRNA##3##3##(1997-2#3)
renal MT##6##2##(1993-12#2)(1997-2#4)
renal Na(+)##3##2##(2011-2#3)
renal TCC##3##2##(2006-9#3)
renal abnormalities##8##2##(2006-8#3)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-9#1)
renal abscesses##2##2##(2012-2#2)
renal accumulation of 67Cu-labelled F(ab')2 fragments##2##6##(1997-7#2)
renal accumulation of##5##3##(1997-2#2)(1997-7#3)
renal actions of##4##3##(1993-3#2)(2011-1#1)(2013-1#1)
renal adenocarcinoma in##2##3##(1994-3#1)(2008-5#1)
renal adenocarcinoma##4##2##(1994-3#1)(2005-10#1)(2007-2#1)(2008-5#1)
renal agenesis##3##2##(1992-6#1)(2004-10#1)(2007-7#1)
renal allograft biopsies##5##3##(1995-2#1)(2007-8#1)(2009-3#2)(2011-2#1)
renal allograft dysfunction##2##3##(2008-1#1)(2008-3#1)
renal allograft loss##2##3##(1995-2#2)
renal allograft recipient##3##3##(2008-1#1)(2011-2#2)
renal allograft recipients##9##3##(1995-2#1)(1996-8#1)(2007-11#1)(2007-8#1)(2008-1#4)(2008-4#1)
renal allograft rejection##7##3##(1995-2#1)(1996-12#1)(2007-11#2)(2009-3#3)
renal allograft##40##2##(1991-3#2)(1993-11#1)(1995-2#8)(1996-12#3)(1996-8#1)(2006-7#1)(2007-11#3)(2007-7#1)(2007-8#3)(2008-1#6)(2008-3#1)(2008-4#1)(2009-3#5)(2011-2#4)
renal allografts##9##2##(1995-2#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-8#2)(2012-12#1)
renal amyloidosis##3##2##(1993-2#1)(2007-7#1)(2010-5#1)
renal and cardiovascular side effects##2##5##(2007-8#2)
renal and extrarenal##3##3##(1994-5#1)(1996-1#1)(2007-8#1)
renal and hepatic impairment##2##4##(2008-8#2)
renal and hepatic##5##3##(1994-11#1)(1994-5#1)(1995-1#1)(2008-8#2)
renal and liver function##2##4##(1996-3#1)(2009-11#1)
renal and liver##4##3##(1996-3#1)(2008-12#1)(2009-11#1)(2013-7#1)
renal and subclavian##2##3##(2011-2#2)
renal and vascular##2##3##(2007-1#1)(2009-8#1)
renal and##37##2##(1990-11#1)(1991-12#1)(1992-10#1)(1992-5#1)(1994-11#1)(1994-5#3)(1995-1#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-3#1)(1997-3#1)(1997-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-8#4)(2008-12#1)(2008-2#1)(2008-8#2)(2009-11#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-7#1)
renal and/or##2##2##(2008-1#1)(2012-3#1)
renal anemia##7##2##(2008-10#1)(2008-5#1)(2008-8#5)
renal angioplasty##2##2##(2006-10#2)
renal anomalies##4##2##(1991-4#1)(1996-3#2)(2011-1#1)
renal apical membranes##4##3##(1990-11#4)
renal apical##5##2##(1990-11#5)
renal aplasia##3##2##(1990-8#1)(2013-1#2)
renal arteries and##2##3##(1997-8#1)(2006-10#1)
renal arteries was##4##3##(1993-10#1)(1997-8#1)(2005-10#1)(2008-7#1)
renal arteries were##3##3##(1993-8#1)(1997-8#1)(2009-11#1)
renal arteries##23##2##(1990-9#2)(1991-6#2)(1993-10#1)(1993-8#2)(1996-2#1)(1997-8#3)(2005-10#1)(2006-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#3)(2009-11#1)(2012-2#1)
renal artery aneurysm##2##3##(2008-1#1)(2010-4#1)
renal artery angioplasty##2##3##(1994-9#1)(1997-3#1)
renal artery is##2##3##(2008-1#2)
renal artery stenosis and##3##4##(1990-2#1)(1997-8#1)(2006-10#1)
renal artery stenosis is##2##4##(1991-10#1)(2008-12#1)
renal artery stenosis should be##2##5##(1995-10#1)(2008-4#1)
renal artery stenosis##27##3##(1990-2#1)(1991-10#1)(1995-10#1)(1997-8#3)(2006-10#7)(2006-8#1)(2007-7#1)(2008-1#3)(2008-12#4)(2008-4#2)(2009-5#2)(2013-8#1)
renal artery##72##2##(1990-2#2)(1991-10#2)(1991-6#3)(1991-8#1)(1992-5#1)(1992-7#3)(1993-3#2)(1994-9#2)(1995-10#1)(1996-7#1)(1996-9#2)(1997-3#1)(1997-8#4)(2006-10#9)(2006-6#1)(2006-8#1)(2007-5#1)(2007-7#3)(2008-1#9)(2008-11#1)(2008-12#5)(2008-4#2)(2009-5#2)(2010-12#1)(2010-4#7)(2011-2#1)(2012-2#2)(2013-8#2)
renal aspergillosis##2##2##(2008-10#2)
renal autotransplantation##3##2##(2008-8#2)(2013-8#1)
renal biopsies at##3##3##(2008-1#1)(2010-4#1)(2012-12#1)
renal biopsies##15##2##(2007-7#3)(2007-8#1)(2008-1#7)(2008-4#1)(2010-4#2)(2012-12#1)
renal biopsy findings##3##3##(1996-1#1)(2007-8#1)(2011-1#1)
renal biopsy is##4##3##(2007-8#2)(2008-1#2)
renal biopsy showed##4##3##(1992-5#1)(2006-10#1)(2013-8#2)
renal biopsy specimen##2##3##(2007-7#1)(2008-7#1)
renal biopsy specimens##3##3##(2007-9#3)
renal biopsy was performed in##2##5##(2007-8#1)(2008-1#1)
renal biopsy was performed##3##4##(2007-8#1)(2008-1#2)
renal biopsy was##5##3##(2007-8#1)(2008-1#4)
renal biopsy##44##2##(1992-5#1)(1994-2#1)(1995-11#1)(1995-5#1)(1996-1#1)(2005-12#1)(2006-10#3)(2007-2#1)(2007-7#3)(2007-8#7)(2007-9#3)(2008-1#9)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-2#1)(2013-1#3)(2013-8#2)
renal blood flow and##2##4##(1993-3#1)(2013-7#1)
renal blood flow rate##3##4##(2007-8#3)
renal blood flow##16##3##(1990-9#1)(1992-8#1)(1993-3#1)(1995-10#1)(1995-5#1)(1996-6#1)(2005-12#1)(2007-8#4)(2010-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
renal brush border membrane##3##4##(1992-2#2)(2008-4#1)
renal calbindin-D28k expression in##2##4##(2007-5#2)
renal calculi##6##2##(1995-8#1)(2006-6#1)(2006-9#2)(2008-1#2)
renal cancer after##2##3##(1993-8#1)(2012-1#1)
renal cancer cell##2##3##(1992-1#1)(2008-5#1)
renal cancer patients##4##3##(1993-8#1)(1993-9#3)
renal cancer##25##2##(1991-6#1)(1992-1#1)(1993-8#2)(1993-9#3)(2006-7#1)(2007-11#5)(2007-7#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-11#3)(2011-2#2)(2012-1#1)
renal cancer]##2##2##(1997-6#1)(2012-2#1)
renal carcinoma##9##2##(1990-12#1)(1992-12#1)(1992-6#3)(2005-10#1)(2007-4#1)(2013-1#2)
renal carcinomas##3##2##(1995-10#2)(1995-2#1)
renal cell cancer (RCC)##3##4##(1993-11#1)(2007-11#1)(2008-6#1)
renal cell cancer and##2##4##(2006-10#2)
renal cell cancer##17##3##(1993-11#2)(2006-10#3)(2006-9#1)(2007-10#2)(2007-11#1)(2008-1#1)(2008-6#3)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
renal cell cancer]##2##3##(1992-8#1)(2009-2#1)
renal cell carcinoma (RCC) cells##2##5##(1992-12#1)(1995-5#1)
renal cell carcinoma (RCC) is##3##5##(2008-3#1)(2009-11#1)(2012-3#1)
renal cell carcinoma (RCC)##25##4##(1990-2#1)(1992-12#1)(1995-5#1)(1997-7#1)(2006-9#3)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-3#2)(2008-6#3)(2009-11#2)(2009-8#1)(2010-12#2)(2011-2#1)(2012-3#1)(2013-1#2)
renal cell carcinoma and##7##4##(1992-8#1)(2008-11#2)(2008-8#1)(2009-5#1)(2010-12#1)(2011-12#1)
renal cell carcinoma cell##2##4##(2008-11#1)(2010-8#1)
renal cell carcinoma cells##3##4##(1992-12#1)(1995-5#1)(2008-8#1)
renal cell carcinoma in##5##4##(1990-8#2)(2007-2#1)(2007-7#1)(2010-12#1)
renal cell carcinoma is a rare##2##6##(2006-8#1)(2007-2#1)
renal cell carcinoma is##5##4##(2006-10#1)(2006-8#1)(2006-9#1)(2007-2#1)(2013-1#1)
renal cell carcinoma of##2##4##(2008-4#1)(2013-7#1)
renal cell carcinoma was##2##4##(1991-8#1)(2010-12#1)
renal cell carcinoma with##2##4##(2007-8#1)(2011-2#1)
renal cell carcinoma##130##3##(1990-2#2)(1990-4#1)(1990-5#1)(1990-8#2)(1991-8#4)(1992-12#2)(1992-3#4)(1992-8#3)(1993-12#1)(1993-8#1)(1994-10#1)(1994-12#1)(1995-12#4)(1995-5#2)(1997-6#1)(1997-7#2)(2005-10#1)(2006-10#2)(2006-2#1)(2006-8#2)(2006-9#11)(2007-2#7)(2007-4#2)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#14)(2008-7#1)(2008-8#2)(2009-11#5)(2009-5#1)(2009-7#1)(2009-8#2)(2010-12#7)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#1)
renal cell carcinoma)##2##3##(1994-3#1)(1994-6#1)
renal cell carcinoma?##2##3##(2009-11#1)(2011-2#1)
renal cell carcinoma]##4##3##(2011-1#1)(2011-3#1)(2012-3#1)(2013-1#1)
renal cell carcinomas with##2##4##(1992-8#1)(2011-2#1)
renal cell carcinomas##9##3##(1992-8#4)(2007-10#1)(2007-2#1)(2009-4#1)(2010-8#1)(2011-2#1)
renal cell tumors##2##3##(1992-8#1)(2007-7#1)
renal cell##173##2##(1990-2#2)(1990-4#1)(1990-5#1)(1990-8#2)(1991-1#1)(1991-8#4)(1992-12#2)(1992-3#4)(1992-5#1)(1992-8#9)(1993-11#2)(1993-12#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#4)(1995-5#2)(1997-6#1)(1997-7#2)(2005-10#1)(2006-10#5)(2006-2#1)(2006-8#2)(2006-9#12)(2007-10#3)(2007-11#1)(2007-2#8)(2007-4#2)(2007-7#4)(2007-8#2)(2008-1#4)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#17)(2008-7#1)(2008-8#2)(2009-11#6)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-12#8)(2010-8#3)(2010-9#2)(2011-1#2)(2011-12#2)(2011-2#6)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#8)(2013-7#1)
renal cells##4##2##(1991-12#1)(1992-5#1)(2007-2#1)(2008-10#1)
renal changes##3##2##(1993-3#1)(2006-1#1)(2007-7#1)
renal clearance of##2##3##(1990-9#1)(1992-8#1)
renal clearance##4##2##(1990-11#1)(1990-9#1)(1992-8#1)(1994-8#1)
renal colic##14##2##(2006-7#6)(2007-10#2)(2007-3#1)(2007-7#1)(2008-1#4)
renal complications##10##2##(1996-12#1)(2005-10#2)(2006-1#1)(2007-3#1)(2007-8#1)(2008-1#2)(2008-3#1)(2009-11#1)
renal concentrating mechanism##2##3##(2013-1#2)
renal concentration##2##2##(1995-9#1)(2013-1#1)
renal cortex##13##2##(1992-2#1)(1994-3#1)(1994-5#1)(1995-1#2)(1997-7#1)(2007-8#1)(2010-7#3)(2011-1#2)(2012-12#1)
renal cortical slices##7##3##(1994-3#2)(1994-5#2)(1997-2#3)
renal cortical##10##2##(1990-11#1)(1994-3#2)(1994-5#2)(1997-2#3)(2007-8#1)(2012-12#1)
renal crisis##10##2##(1992-12#2)(2006-10#7)(2007-7#1)
renal cyst##9##2##(2007-10#1)(2007-7#1)(2007-8#3)(2010-6#1)(2013-1#2)(2013-8#1)
renal cystic disease##2##3##(1990-6#1)(2007-8#1)
renal cystic##3##2##(1990-6#1)(2007-8#1)(2008-1#1)
renal cysts##6##2##(1993-8#1)(2007-8#3)(2008-4#2)
renal damage and end-stage renal disease##2##6##(2006-10#2)
renal damage and##4##3##(2006-10#2)(2007-7#1)(2010-2#1)
renal damage in rats##2##4##(2008-8#2)
renal damage in##8##3##(1995-9#2)(1997-5#1)(2005-10#2)(2008-8#2)(2012-12#1)
renal damage was##2##3##(1995-2#1)(2008-1#1)
renal damage##22##2##(1991-5#1)(1995-2#1)(1995-3#1)(1995-9#2)(1997-5#1)(1997-8#1)(2005-10#2)(2006-1#1)(2006-10#2)(2007-11#1)(2007-7#1)(2008-1#2)(2008-7#1)(2008-8#2)(2009-8#1)(2010-2#1)(2012-12#1)
renal deterioration##2##2##(2007-8#1)(2008-10#1)
renal dialysis##2##2##(1995-12#1)(2007-4#1)
renal disease (ESRD) in##5##4##(2007-7#2)(2008-1#3)
renal disease (ESRD) is##2##4##(2005-7#1)(2007-7#1)
renal disease (ESRD) on regular hemodialysis##2##6##(2007-7#2)
renal disease (ESRD) or##2##4##(2006-10#1)(2012-2#1)
renal disease (ESRD) patients undergoing##2##5##(2007-12#1)(2008-7#1)
renal disease (ESRD) patients##7##4##(1991-3#1)(1995-12#1)(1996-8#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-7#1)
renal disease (ESRD) were##3##4##(2007-2#1)(2008-1#1)(2008-4#1)
renal disease (ESRD)##44##3##(1991-3#1)(1995-1#1)(1995-12#2)(1995-2#1)(1996-2#2)(1996-8#1)(1997-1#1)(2005-7#1)(2006-10#1)(2006-5#2)(2007-12#3)(2007-2#1)(2007-7#15)(2008-1#5)(2008-4#1)(2008-7#1)(2008-8#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-7#1)
renal disease and insulin-dependent diabetes mellitus##2##6##(2005-10#1)(2006-10#1)
renal disease and renal##3##4##(2008-1#2)(2010-11#1)
renal disease and##14##3##(1993-12#1)(1995-10#1)(2005-10#1)(2005-7#1)(2006-10#2)(2007-12#1)(2008-1#3)(2008-4#1)(2010-11#1)(2011-2#1)(2013-1#1)
renal disease are##4##3##(1996-9#1)(2006-10#1)(2007-8#1)(2008-10#1)
renal disease can##3##3##(2007-7#3)
renal disease have##2##3##(2005-7#1)(2008-1#1)
renal disease in the##4##4##(2005-7#1)(2007-12#1)(2008-1#1)(2011-2#1)
renal disease in##12##3##(2005-10#1)(2005-7#2)(2006-5#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-4#1)(2009-11#1)(2010-4#1)(2011-2#1)(2012-2#1)
renal disease is##7##3##(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2011-1#1)(2012-12#1)
renal disease on##2##3##(2007-7#1)(2012-12#1)
renal disease or##2##3##(2006-10#1)(2012-12#1)
renal disease patients##11##3##(2007-12#1)(2007-7#2)(2008-1#1)(2008-2#1)(2008-7#3)(2010-5#2)(2010-7#1)
renal disease was##2##3##(2007-7#1)(2007-8#1)
renal disease who##2##3##(2007-7#1)(2008-1#1)
renal disease without##2##3##(2008-1#2)
renal disease##204##2##(1990-6#1)(1991-3#2)(1992-8#2)(1992-9#1)(1993-12#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#1)(1996-12#1)(1996-2#2)(1996-8#1)(1996-9#1)(1997-1#2)(2005-10#3)(2005-11#1)(2005-7#8)(2006-10#13)(2006-5#3)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#9)(2007-2#2)(2007-3#2)(2007-4#1)(2007-7#37)(2007-8#6)(2007-9#1)(2008-1#33)(2008-10#5)(2008-2#2)(2008-3#1)(2008-4#4)(2008-7#6)(2008-8#1)(2009-11#1)(2009-4#1)(2009-5#2)(2009-6#3)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#3)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#5)(2012-2#2)(2013-1#6)(2013-7#1)(2013-8#3)
renal disease)##2##2##(2007-7#1)(2013-8#1)
renal disease]##3##2##(1991-2#2)(2010-12#1)
renal diseases in children##3##4##(2007-7#1)(2008-4#2)
renal diseases in the##3##4##(1994-5#1)(2007-7#1)(2008-1#1)
renal diseases in##6##3##(1994-5#1)(2007-7#2)(2008-1#1)(2008-4#2)
renal diseases##27##2##(1991-12#1)(1992-3#1)(1992-5#1)(1994-5#1)(1997-5#1)(2006-10#1)(2007-7#5)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#1)(2008-4#2)(2008-8#1)(2009-6#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
renal disorder##3##2##(2006-10#1)(2007-6#1)(2008-11#1)
renal disorders##6##2##(1997-7#2)(2008-1#1)(2008-10#2)(2012-1#1)
renal dysfunction and##10##3##(1997-4#1)(2007-3#1)(2007-4#1)(2008-1#3)(2010-7#2)(2011-1#1)(2012-2#1)
renal dysfunction but##2##3##(2010-7#1)(2012-3#1)
renal dysfunction in##5##3##(1997-4#1)(2008-2#1)(2010-7#1)(2011-2#1)(2013-1#1)
renal dysfunction is##3##3##(2006-10#1)(2007-8#1)(2010-7#1)
renal dysfunction##49##2##(1994-6#1)(1997-3#1)(1997-4#5)(2005-10#2)(2006-10#5)(2006-8#1)(2007-3#1)(2007-4#1)(2007-8#5)(2008-1#3)(2008-2#1)(2008-3#1)(2008-8#1)(2009-4#1)(2009-9#1)(2010-7#6)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#3)(2013-1#3)
renal dysplasia##2##2##(2007-8#1)(2008-10#1)
renal ectopia##3##2##(2005-10#2)(2011-2#1)
renal effects of##5##3##(1990-9#1)(1995-12#1)(2005-1#1)(2008-1#1)(2010-8#1)
renal effects were##2##3##(1997-2#1)(2008-5#1)
renal effects##11##2##(1990-9#1)(1994-6#1)(1995-12#1)(1997-2#1)(2005-1#1)(2005-7#1)(2008-1#2)(2008-4#1)(2008-5#1)(2010-8#1)
renal endothelial alterations##2##3##(2012-12#2)
renal endothelial##3##2##(2012-12#3)
renal epithelia##3##2##(1990-6#1)(1991-2#1)(1992-11#1)
renal epithelial cell line##3##4##(1991-12#1)(1997-4#1)(2008-11#1)
renal epithelial cells##8##3##(1992-1#2)(1994-12#1)(1996-8#1)(2008-3#1)(2012-12#3)
renal epithelial##15##2##(1991-12#1)(1991-9#1)(1992-1#2)(1994-12#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-7#1)(2008-11#1)(2008-3#1)(2012-12#4)
renal excretion capability##2##3##(2012-2#2)
renal excretion of##3##3##(1997-3#2)(2006-2#1)
renal excretion was##2##3##(1990-5#1)(2012-2#1)
renal excretion##12##2##(1990-5#1)(1993-9#1)(1997-3#2)(2006-2#1)(2007-11#1)(2008-5#1)(2009-6#1)(2012-2#4)
renal failure (ARF)##18##3##(1997-2#1)(2006-2#1)(2006-5#1)(2007-12#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-4#5)(2012-1#1)(2012-3#1)
renal failure (CRF)##14##3##(1995-3#1)(2007-11#1)(2007-7#6)(2008-1#4)(2011-2#1)(2012-1#1)
renal failure (Ccr##2##3##(1990-4#2)
renal failure (ESRF)##9##3##(2006-8#1)(2007-7#2)(2008-1#5)(2008-4#1)
renal failure (OR##2##3##(2007-8#2)
renal failure and a##2##4##(1992-5#1)(2012-12#1)
renal failure and death##2##4##(2008-7#1)(2010-9#1)
renal failure and had##3##4##(2013-1#2)(2013-8#1)
renal failure and is##2##4##(1991-8#1)(2011-2#1)
renal failure and renal##2##4##(1996-3#1)(2007-8#1)
renal failure and was##2##4##(2006-4#1)(2008-4#1)
renal failure and##39##3##(1990-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-5#1)(1993-11#1)(1993-3#1)(1994-4#1)(1994-9#1)(1996-3#1)(1997-3#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-4#3)(2007-3#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#1)(2009-6#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-1#3)(2013-8#1)
renal failure are##3##3##(2005-8#1)(2008-4#1)(2012-2#1)
renal failure as##2##3##(2007-7#1)(2008-1#1)
renal failure associated with##4##4##(2006-4#2)(2008-1#1)(2012-2#1)
renal failure at##3##3##(2007-7#2)(2011-2#1)
renal failure by##2##3##(2007-11#1)(2012-12#1)
renal failure continues to##3##4##(2006-10#2)(2008-11#1)
renal failure developed##4##3##(1992-12#1)(1992-5#1)(1996-6#2)
renal failure due to bilateral##2##5##(1991-6#1)(2006-6#1)
renal failure due to##6##4##(1991-6#1)(1992-11#1)(1997-5#1)(1997-8#1)(2006-6#1)(2008-4#1)
renal failure during the##2##4##(2005-12#1)(2008-4#1)
renal failure in a##4##4##(1992-10#1)(2006-8#1)(2007-2#1)(2008-1#1)
renal failure in adults]##2##4##(1991-5#1)(2006-9#1)
renal failure in jordan##2##4##(2008-4#2)
renal failure in patients with##3##5##(1990-4#1)(2008-4#1)(2009-9#1)
renal failure in patients##4##4##(1990-4#1)(2008-4#2)(2009-9#1)
renal failure in the intensive care unit##2##7##(2008-4#2)
renal failure in the##8##4##(2006-8#1)(2007-7#1)(2008-1#2)(2008-4#4)
renal failure in##50##3##(1990-4#1)(1990-8#1)(1991-5#1)(1992-10#1)(1992-4#1)(1995-5#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-2#2)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#12)(2008-3#1)(2008-4#12)(2008-7#1)(2009-9#1)(2011-12#1)(2013-8#1)
renal failure is a frequent##2##5##(2009-9#1)(2012-2#1)
renal failure is a##4##4##(2005-12#1)(2008-3#1)(2009-9#1)(2012-2#1)
renal failure is##14##3##(1994-5#1)(2005-12#1)(2006-4#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-3#1)(2009-9#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-2#1)
renal failure occurs##2##3##(2005-12#1)(2007-11#1)
renal failure of##4##3##(1991-11#1)(2008-1#2)(2010-4#1)
renal failure on the##2##4##(2006-10#2)
renal failure on##6##3##(1995-4#1)(1996-8#1)(2006-10#2)(2013-1#2)
renal failure or##2##3##(1992-6#1)(1996-3#1)
renal failure patients and##5##4##(1992-2#2)(2006-5#1)(2007-7#1)(2008-10#1)
renal failure patients##22##3##(1992-2#2)(2006-5#1)(2007-7#4)(2007-8#2)(2008-1#5)(2008-10#1)(2008-4#2)(2009-9#1)(2011-1#4)
renal failure requiring##3##3##(2005-12#1)(2006-8#1)(2012-2#1)
renal failure secondary to##3##4##(1991-1#1)(2007-12#1)(2011-12#1)
renal failure showed##2##3##(2008-1#2)
renal failure that##2##3##(2008-1#1)(2009-9#1)
renal failure to##3##3##(1995-12#2)(2008-1#1)
renal failure was##6##3##(1996-12#1)(2005-1#1)(2005-9#1)(2007-7#2)(2007-8#1)
renal failure which##2##3##(1997-2#1)(2006-8#1)
renal failure who##4##3##(1993-2#1)(1994-12#1)(2007-2#1)(2013-1#1)
renal failure with##4##3##(1990-6#1)(1990-9#1)(1997-8#1)(2007-8#1)
renal failure##473##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#2)(1990-4#8)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#3)(1991-1#1)(1991-11#2)(1991-12#1)(1991-5#3)(1991-6#2)(1991-8#3)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#4)(1992-4#3)(1992-5#3)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-4#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-3#3)(1996-6#2)(1996-8#4)(1997-1#1)(1997-2#3)(1997-3#1)(1997-5#1)(1997-7#2)(1997-8#3)(2005-1#1)(2005-10#3)(2005-12#6)(2005-7#3)(2005-8#1)(2005-9#1)(2006-10#16)(2006-2#3)(2006-4#8)(2006-5#5)(2006-6#6)(2006-7#5)(2006-8#7)(2006-9#1)(2007-1#3)(2007-11#9)(2007-12#3)(2007-2#5)(2007-3#4)(2007-6#2)(2007-7#39)(2007-8#27)(2007-9#2)(2008-1#66)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#6)(2008-4#40)(2008-5#3)(2008-7#9)(2008-8#2)(2008-9#1)(2009-2#2)(2009-4#2)(2009-6#1)(2009-8#2)(2009-9#4)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#2)(2010-9#1)(2011-1#6)(2011-12#3)(2011-2#13)(2012-1#4)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#16)(2013-8#5)
renal failure)##3##2##(2006-6#1)(2007-7#1)(2008-5#1)
renal failure]##8##2##(1997-2#1)(2006-8#2)(2008-10#1)(2008-7#2)(2009-2#1)(2013-8#1)
renal fibrosis##5##2##(2011-2#1)(2012-12#4)
renal flow##2##2##(2010-4#1)(2013-1#1)
renal fossa recurrence with##2##4##(2006-9#1)(2007-7#1)
renal fossa##6##2##(2006-9#1)(2007-7#1)(2008-1#2)(2010-7#1)(2011-1#1)
renal function after##2##3##(2010-12#2)
renal function among##3##3##(1994-5#1)(1996-9#1)(2012-2#1)
renal function and the incidence of heart failure##2##8##(2010-8#2)
renal function and the##5##4##(1995-9#1)(2006-4#1)(2010-8#2)(2011-2#1)
renal function and##32##3##(1993-3#1)(1993-4#1)(1995-9#1)(1996-1#2)(2006-10#3)(2006-4#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#4)(2008-3#1)(2008-4#1)(2008-7#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#1)
renal function are##4##3##(2006-10#1)(2006-7#1)(2008-1#1)(2011-2#1)
renal function by##3##3##(1993-4#1)(2007-8#1)(2008-9#1)
renal function can be##3##4##(1991-5#1)(2010-12#1)(2012-2#1)
renal function can##4##3##(1991-5#1)(2010-12#1)(2012-2#2)
renal function declined##2##3##(2007-8#1)(2011-2#1)
renal function deteriorated##3##3##(2006-10#1)(2007-12#1)(2012-12#1)
renal function deterioration##2##3##(2007-11#1)(2013-1#1)
renal function has##2##3##(1995-2#1)(2006-10#1)
renal function impairment##4##3##(2007-11#2)(2008-10#1)(2012-12#1)
renal function improved##2##3##(2007-11#1)(2012-2#1)
renal function in patients with##4##5##(2007-11#1)(2008-1#2)(2009-8#1)
renal function in patients##6##4##(2007-11#1)(2008-1#2)(2009-8#1)(2013-1#2)
renal function in##18##3##(1996-1#1)(2005-10#1)(2006-10#3)(2007-11#1)(2007-6#2)(2008-1#3)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)
renal function is##9##3##(1992-4#1)(2005-10#1)(2006-10#1)(2007-11#2)(2008-1#1)(2008-4#1)(2011-2#2)
renal function of##2##3##(2011-3#1)(2012-12#1)
renal function or##3##3##(2008-1#1)(2008-10#1)(2011-1#1)
renal function was##5##3##(1997-2#1)(2007-8#1)(2007-9#1)(2008-4#1)(2012-12#1)
renal function were##2##3##(1993-4#1)(2007-8#1)
renal function with##3##3##(1992-7#1)(2007-11#1)(2011-12#1)
renal function##229##2##(1990-3#1)(1990-6#2)(1991-11#2)(1991-12#2)(1991-5#1)(1991-6#1)(1992-3#1)(1992-4#2)(1992-7#1)(1992-8#4)(1993-3#3)(1993-4#4)(1994-4#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#4)(1995-9#1)(1996-1#3)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-4#1)(2005-10#6)(2006-10#19)(2006-4#1)(2006-5#2)(2006-7#3)(2007-1#1)(2007-10#2)(2007-11#14)(2007-12#6)(2007-2#5)(2007-6#3)(2007-7#2)(2007-8#8)(2007-9#1)(2008-1#19)(2008-10#6)(2008-3#6)(2008-4#4)(2008-5#2)(2008-7#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#5)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#16)(2011-3#2)(2012-1#2)(2012-12#9)(2012-2#11)(2012-3#1)(2013-1#9)(2013-8#2)
renal functional impairment##4##3##(2008-1#2)(2008-4#1)(2010-7#1)
renal functional reserve##3##3##(2008-1#3)
renal functional##8##2##(2008-1#6)(2008-4#1)(2010-7#1)
renal functions and##2##3##(2008-1#2)
renal functions in##2##3##(2007-7#1)(2011-1#1)
renal functions##10##2##(1991-8#1)(1995-9#1)(1997-6#1)(2005-12#1)(2007-7#2)(2008-1#3)(2011-1#1)
renal glomeruli##2##2##(2007-7#1)(2012-1#1)
renal glutaminase##2##2##(1991-7#2)
renal graft##4##2##(1990-9#1)(2007-11#1)(2008-1#1)(2009-5#1)
renal handling of##4##3##(2006-10#3)(2007-1#1)
renal handling##5##2##(1995-1#1)(2006-10#3)(2007-1#1)
renal hemodynamics##4##2##(1992-8#1)(1993-4#2)(2010-9#1)
renal histological##2##2##(2013-1#2)
renal histology##4##2##(1997-3#1)(2008-1#2)(2010-4#1)
renal hydatid disease##3##3##(2007-7#2)(2008-10#1)
renal hydatid##4##2##(2007-7#2)(2008-10#2)
renal hypertensive##4##2##(1991-5#1)(1993-4#1)(2008-11#1)(2012-12#1)
renal hypertrophy and##2##3##(1996-6#1)(2006-1#1)
renal hypertrophy##3##2##(1992-9#1)(1996-6#1)(2006-1#1)
renal impairment or##2##3##(2008-4#1)(2011-2#1)
renal impairment##33##2##(1993-12#3)(1996-2#2)(2005-7#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-7#2)(2008-1#4)(2008-4#1)(2008-8#2)(2009-6#1)(2011-2#1)(2013-1#13)
renal in##3##2##(1990-3#1)(2007-8#1)(2010-12#1)
renal infarction##3##2##(2006-6#1)(2007-7#1)(2008-1#1)
renal inflammatory##2##2##(1991-10#1)(2011-2#1)
renal injuries##4##2##(1990-9#2)(2008-10#1)(2012-2#1)
renal injury and##4##3##(2007-11#1)(2007-8#1)(2008-3#1)(2013-8#1)
renal injury in##3##3##(1995-12#2)(2009-6#1)
renal injury resulting from##3##4##(1990-3#2)(2008-3#1)
renal injury##31##2##(1990-3#3)(1992-9#1)(1994-5#3)(1995-12#2)(1995-2#1)(2007-11#1)(2007-8#3)(2008-1#4)(2008-3#2)(2009-3#1)(2009-6#1)(2010-12#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-8#2)
renal inner medullary collecting duct cells##3##6##(1990-7#2)(1997-1#1)
renal inner medullary collecting duct##4##5##(1990-7#2)(1997-1#1)(2008-8#1)
renal inner medullary##5##3##(1990-7#2)(1992-5#1)(1997-1#1)(2008-8#1)
renal inner##6##2##(1990-7#2)(1992-5#2)(1997-1#1)(2008-8#1)
renal insufficiency and##7##3##(1990-9#1)(2005-11#1)(2007-12#1)(2008-1#1)(2009-3#1)(2011-2#1)(2013-8#1)
renal insufficiency in##3##3##(2005-10#1)(2008-1#1)(2011-2#1)
renal insufficiency or##4##3##(1990-2#1)(2006-10#2)(2007-11#1)
renal insufficiency patients##2##3##(1990-2#1)(1991-8#1)
renal insufficiency was##2##3##(1991-5#1)(2011-1#1)
renal insufficiency with##2##3##(2008-4#1)(2008-7#1)
renal insufficiency##72##2##(1990-1#1)(1990-2#2)(1990-5#1)(1990-9#3)(1991-5#1)(1991-8#1)(1993-10#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-4#1)(1996-8#1)(2005-1#1)(2005-10#4)(2005-11#1)(2005-7#1)(2006-10#6)(2006-6#1)(2006-8#2)(2007-11#2)(2007-12#2)(2007-7#4)(2007-8#2)(2008-1#5)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2009-3#1)(2009-6#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#6)(2011-3#1)(2013-1#3)(2013-8#1)
renal insufficiency]##2##2##(2006-7#1)(2007-6#1)
renal insult##2##2##(2008-4#2)
renal involvement and##2##3##(2008-1#1)(2008-7#1)
renal involvement in##3##3##(1992-5#1)(2007-7#1)(2008-1#1)
renal involvement##20##2##(1992-5#1)(1992-8#1)(1994-8#1)(1996-1#1)(1997-8#1)(2006-10#2)(2006-8#2)(2007-7#3)(2007-8#1)(2008-1#3)(2008-7#1)(2011-1#1)(2011-2#2)
renal ischemia##2##2##(1992-9#1)(1993-3#1)
renal length##4##2##(2007-2#1)(2008-10#3)
renal lesion##3##2##(2007-7#2)(2008-1#1)
renal lesions in##2##3##(2004-11#1)(2013-1#1)
renal lesions were##2##3##(2008-5#2)
renal lesions##12##2##(1990-6#1)(2004-11#2)(2005-10#1)(2008-1#1)(2008-5#3)(2008-6#1)(2012-2#1)(2013-1#2)
renal lithiasis less or equal to 2cm##2##7##(2011-2#2)
renal lithiasis##3##2##(1991-11#1)(2011-2#2)
renal manifestations of HCV infection##2##5##(2008-1#1)(2013-1#1)
renal manifestations of##5##3##(2007-7#1)(2008-1#1)(2008-8#1)(2013-1#2)
renal manifestations##8##2##(2007-2#1)(2007-7#1)(2008-1#1)(2008-8#1)(2010-12#1)(2013-1#3)
renal markers##2##2##(1994-6#1)(2011-1#1)
renal mass##2##2##(2008-7#1)(2011-2#1)
renal masses has##2##3##(2012-2#2)
renal masses##7##2##(2008-6#1)(2012-2#6)
renal measures##2##2##(2013-1#2)
renal medulla##6##2##(1990-2#1)(1993-7#1)(1995-2#1)(2008-1#2)(2008-7#1)
renal medullary carcinoma##3##3##(2008-6#1)(2008-7#2)
renal medullary##10##2##(1991-1#1)(1996-5#2)(2006-10#1)(2008-1#3)(2008-6#1)(2008-7#2)
renal mesenchymal##2##2##(1994-5#1)(2012-12#1)
renal metabolism##3##2##(1990-2#1)(1992-7#1)(2008-7#1)
renal microsomes##2##2##(1990-11#1)(1991-10#1)
renal nerve##2##2##(1995-12#1)(2013-8#1)
renal nurses in##3##3##(2007-10#3)
renal nurses##4##2##(2007-10#4)
renal or hepatic##5##3##(1990-3#1)(1995-11#1)(2005-7#1)(2008-3#1)(2012-3#1)
renal or##11##2##(1990-3#1)(1991-9#1)(1994-6#1)(1995-11#1)(2005-7#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-3#1)
renal ossifying tumor of infancy##2##5##(2008-10#2)
renal ossifying tumor##3##3##(2008-10#3)
renal osteodystrophy (ROD)##3##3##(2008-1#1)(2008-4#1)(2011-2#1)
renal osteodystrophy##9##2##(2006-10#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-4#2)(2008-7#1)(2011-2#2)
renal outcome and##2##3##(2006-10#1)(2007-2#1)
renal outcome##6##2##(1991-8#1)(2006-10#1)(2007-2#3)(2007-8#1)
renal oxidative stress##2##3##(2011-3#1)(2012-2#1)
renal parenchyma##8##2##(1993-2#1)(2006-7#1)(2006-9#1)(2008-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
renal parenchyma-tumor density gradient##2##4##(2008-4#2)
renal parenchymal##5##2##(1993-4#1)(1996-6#1)(2008-1#2)(2010-4#1)
renal pathology##4##2##(2004-11#1)(2007-1#1)(2007-8#2)
renal patients##8##2##(1992-12#2)(2007-12#4)(2007-7#1)(2008-10#1)
renal pedicle##2##2##(1995-2#1)(2007-7#1)
renal pelvic##2##2##(2006-10#1)(2008-10#1)
renal pelvis and##5##3##(1993-7#1)(1994-4#1)(2008-10#1)(2011-2#1)(2012-3#1)
renal pelvis##9##2##(1993-7#1)(1994-4#2)(1995-2#1)(2008-1#2)(2008-10#1)(2011-2#1)(2012-3#1)
renal perfusion##4##2##(1992-8#3)(1995-12#1)
renal phosphate reabsorption and##2##4##(1996-11#1)(2012-12#1)
renal phosphate##4##2##(1996-11#2)(2008-6#1)(2012-12#1)
renal physiology and##2##3##(2012-12#1)(2013-8#1)
renal plasma flow and glomerular filtration rate##3##7##(1995-12#3)
renal plasma flow##6##3##(1995-12#3)(1995-2#2)(2008-5#1)
renal prognosis##3##2##(2006-8#1)(2007-8#1)(2013-1#1)
renal protection##8##2##(1996-6#2)(2006-10#2)(2007-1#1)(2008-6#1)(2009-11#1)(2013-1#1)
renal protective##4##2##(1996-7#1)(2006-10#1)(2007-8#1)(2012-3#1)
renal protein expression in##2##4##(2007-5#1)(2012-12#1)
renal proximal tubule cells##4##4##(1991-5#1)(1992-8#2)(2008-11#1)
renal proximal tubule##5##3##(1991-5#1)(1992-8#2)(1997-1#1)(2008-11#1)
renal proximal tubules##5##3##(1994-3#2)(1997-1#3)
renal proximal##12##2##(1990-4#1)(1991-5#1)(1992-7#1)(1992-8#2)(1994-3#2)(1997-1#4)(2008-11#1)
renal reabsorption##3##2##(1992-9#1)(2009-9#1)(2012-2#1)
renal regulation##2##2##(2008-6#2)
renal replacement therapy (CRRT)##5##4##(2006-5#1)(2007-8#1)(2007-9#1)(2008-4#1)(2011-2#1)
renal replacement therapy (RRT)##3##4##(2007-7#1)(2011-2#1)(2012-3#1)
renal replacement therapy and##2##4##(2006-4#1)(2007-11#1)
renal replacement therapy for##3##4##(2006-5#1)(2007-7#1)(2010-3#1)
renal replacement therapy in the##2##5##(2006-4#1)(2008-3#1)
renal replacement therapy in this##2##5##(2008-11#1)(2008-8#1)
renal replacement therapy in##8##4##(2006-4#2)(2008-1#1)(2008-11#2)(2008-3#1)(2008-8#1)(2010-4#1)
renal replacement therapy##44##3##(2006-10#5)(2006-4#5)(2006-5#3)(2007-11#1)(2007-7#5)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-8#1)(2009-9#1)(2010-3#1)(2010-4#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#1)
renal replacement treatment##2##3##(1993-8#1)(2007-7#1)
renal replacement##53##2##(1993-8#1)(2005-1#3)(2006-10#5)(2006-4#6)(2006-5#3)(2007-11#1)(2007-7#6)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#2)
renal resistive index##2##3##(2008-10#1)(2013-1#1)
renal response to##2##3##(1990-7#1)(1994-8#1)
renal revascularization##2##2##(2006-10#2)
renal risk##5##2##(1993-2#1)(2006-10#1)(2007-12#2)(2008-3#1)
renal rupture##2##2##(1990-6#1)(1991-4#1)
renal salt##2##2##(2006-4#1)(2007-7#1)
renal sarcoma##2##2##(2008-6#2)
renal scan##5##2##(2012-12#3)(2013-1#2)
renal scarring##9##2##(1990-3#1)(2006-10#1)(2008-10#1)(2008-4#5)(2009-5#1)
renal scintigraphy##5##2##(2007-5#2)(2008-1#2)(2013-1#1)
renal sodium##5##2##(1997-3#3)(1997-7#2)
renal stone##2##2##(1990-12#1)(2008-1#1)
renal stones##10##2##(1994-12#1)(2006-10#1)(2006-6#1)(2007-7#3)(2008-1#1)(2008-10#1)(2008-4#1)(2011-2#1)
renal surgery##3##2##(2008-10#1)(2009-2#2)
renal survival##5##2##(1994-5#1)(2007-2#1)(2008-1#1)(2013-1#2)
renal sympathetic denervation##2##3##(2011-2#1)(2013-8#1)
renal symptoms##2##2##(1991-10#1)(2011-2#1)
renal system##2##2##(2005-10#1)(2012-2#1)
renal systems##3##2##(2009-5#1)(2010-9#2)
renal tissue##11##2##(1990-12#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-9#1)(2005-12#1)(2008-8#2)(2011-2#3)
renal tissues##5##2##(1992-7#1)(2009-6#1)(2010-10#1)(2012-1#1)(2012-11#1)
renal toxicity of gold##4##4##(1994-5#4)
renal toxicity##13##2##(1993-3#1)(1994-5#6)(2006-10#1)(2008-6#1)(2012-11#1)(2012-12#3)
renal transplant candidates##2##3##(2007-8#1)(2013-1#1)
renal transplant outcome##2##3##(2007-8#2)
renal transplant patient##6##3##(2007-2#1)(2007-7#1)(2008-1#1)(2013-1#2)(2013-7#1)
renal transplant patients and##2##4##(2007-8#1)(2008-1#1)
renal transplant patients with##3##4##(1995-2#1)(2008-1#1)(2011-2#1)
renal transplant patients##28##3##(1990-3#1)(1995-2#4)(2007-11#1)(2007-8#3)(2008-1#14)(2008-3#1)(2008-4#1)(2009-10#1)(2010-7#1)(2011-2#1)
renal transplant population##2##3##(2007-7#1)(2008-1#1)
renal transplant recipient who##3##4##(1996-12#1)(2008-1#1)(2010-12#1)
renal transplant recipient##13##3##(1996-12#1)(2007-7#3)(2008-1#5)(2010-12#1)(2010-9#1)(2011-2#2)
renal transplant recipients (RTR)##2##4##(2007-7#1)(2007-8#1)
renal transplant recipients in##2##4##(1995-2#1)(2007-7#1)
renal transplant recipients is##4##4##(2007-11#1)(2008-3#2)(2010-9#1)
renal transplant recipients were##2##4##(2007-2#1)(2008-4#1)
renal transplant recipients##35##3##(1991-11#1)(1993-11#1)(1995-2#6)(1996-3#3)(2007-11#1)(2007-2#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-3#7)(2008-4#7)(2008-8#1)(2010-9#1)
renal transplant recipients?##2##3##(1995-9#1)(2007-8#1)
renal transplant##111##2##(1990-3#1)(1991-11#1)(1993-11#1)(1995-2#13)(1995-9#1)(1996-12#1)(1996-3#4)(2005-9#1)(2007-11#2)(2007-2#2)(2007-7#11)(2007-8#9)(2008-1#26)(2008-10#1)(2008-3#8)(2008-4#11)(2008-7#1)(2008-8#2)(2009-10#1)(2010-12#2)(2010-7#2)(2010-9#2)(2011-2#4)(2013-1#3)(2013-7#1)
renal transplantation and##3##3##(1992-6#1)(2007-10#1)(2007-8#1)
renal transplantation as##2##3##(2005-11#1)(2007-7#1)
renal transplantation at##3##3##(2007-8#1)(2008-1#2)
renal transplantation conducted##2##3##(2010-7#1)(2012-12#1)
renal transplantation has been##2##4##(2006-10#1)(2011-2#1)
renal transplantation has##3##3##(2006-10#1)(2008-1#1)(2011-2#1)
renal transplantation in a patient##2##5##(1992-12#1)(2012-12#1)
renal transplantation in patients with##3##5##(1991-11#1)(2007-8#1)(2013-1#1)
renal transplantation in patients##4##4##(1991-11#1)(2004-12#1)(2007-8#1)(2013-1#1)
renal transplantation in the Arab countries##2##6##(2008-4#2)
renal transplantation in the Arab##3##5##(2008-4#3)
renal transplantation in the##5##4##(2008-1#1)(2008-4#4)
renal transplantation in##17##3##(1991-11#1)(1992-12#1)(2004-12#1)(2006-10#1)(2007-12#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-4#4)(2012-12#1)(2013-1#1)
renal transplantation is a##2##4##(2008-1#1)(2010-7#1)
renal transplantation is##5##3##(2004-12#1)(2006-10#1)(2007-8#1)(2008-1#1)(2010-7#1)
renal transplantation was##3##3##(2007-7#2)(2008-4#1)
renal transplantation with##3##3##(1992-6#1)(2008-4#1)(2012-12#1)
renal transplantation##120##2##(1990-11#1)(1991-11#3)(1991-9#1)(1992-12#1)(1992-6#4)(1994-5#2)(1995-2#2)(1996-12#1)(1996-8#1)(1997-3#1)(2004-12#3)(2005-11#2)(2006-10#3)(2007-10#2)(2007-11#4)(2007-12#1)(2007-7#16)(2007-8#10)(2007-9#3)(2008-1#21)(2008-4#9)(2008-6#1)(2008-7#1)(2008-8#3)(2009-10#2)(2009-5#2)(2010-7#4)(2010-9#1)(2011-2#4)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
renal transplantation--a##2##2##(1995-2#1)(2008-10#1)
renal transplantation]##3##2##(1996-12#1)(2005-11#1)(2011-2#1)
renal transplantations##2##2##(2008-1#2)
renal transplants were##2##3##(1991-11#1)(2008-1#1)
renal transplants##13##2##(1990-11#2)(1991-11#1)(1995-2#2)(2006-10#1)(2008-1#4)(2008-4#2)(2011-2#1)
renal transport##5##2##(1997-2#1)(2008-11#1)(2012-12#2)(2013-1#1)
renal trauma##4##2##(2007-7#2)(2013-8#2)
renal tuberculosis##2##2##(2008-1#1)(2011-2#1)
renal tubular acidosis##3##3##(2007-3#1)(2008-1#2)
renal tubular cells##6##3##(1991-4#1)(1991-8#1)(1992-3#1)(1992-7#1)(1996-12#1)(2008-8#1)
renal tubular dysfunction##3##3##(1990-8#1)(1996-6#2)
renal tubular epithelial cells has##2##5##(2009-10#1)(2013-1#1)
renal tubular epithelial cells##6##4##(1992-3#1)(2009-10#3)(2012-2#1)(2013-1#1)
renal tubular##33##2##(1990-10#1)(1990-7#1)(1990-8#1)(1991-11#2)(1991-4#1)(1991-8#5)(1991-9#1)(1992-3#2)(1992-7#1)(1996-12#1)(1996-6#2)(2004-11#1)(2006-10#1)(2007-3#1)(2007-7#2)(2008-1#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#3)(2012-2#1)(2013-1#1)
renal tubule degeneration in 100 mg/kg males##3##7##(2008-9#3)
renal tubule degeneration in 350 and 700 mg/L males##2##9##(2008-9#2)
renal tubule degeneration in##6##4##(2008-9#6)
renal tubule degeneration##7##3##(2008-9#7)
renal tubule dilatation in all exposed groups of males##2##9##(2008-9#2)
renal tubule dilatation in##3##4##(2008-9#3)
renal tubule hypertrophy in##2##4##(2008-9#2)
renal tubule hypertrophy##3##3##(2008-9#3)
renal tubule##15##2##(1991-8#1)(2008-11#1)(2008-9#13)
renal tubules##5##2##(1990-2#1)(1991-8#1)(1991-9#1)(1996-7#1)(2007-8#1)
renal tumor of infancy##2##4##(2008-10#2)
renal tumor##11##2##(1992-2#1)(2007-7#1)(2008-10#3)(2008-4#2)(2010-10#1)(2012-3#1)(2013-1#2)
renal tumors##9##2##(1992-8#2)(1994-5#3)(1995-2#1)(2008-4#2)(2009-5#1)
renal tumours##2##2##(2008-6#1)(2013-1#1)
renal ultrasound##2##2##(2007-7#1)(2008-4#1)
renal unit##6##2##(2007-7#1)(2008-1#1)(2013-8#4)
renal uptake of##2##3##(1997-7#2)
renal uptake##3##2##(1997-7#3)
renal uric acid##2##3##(2006-10#1)(2012-2#1)
renal vascular effects of##2##4##(1995-12#1)(1996-10#1)
renal vascular resistance##2##3##(1995-12#1)(2008-1#1)
renal vascular##6##2##(1995-12#2)(1996-10#1)(2008-1#3)
renal vasculature##2##2##(1990-2#1)(2006-10#1)
renal vasculitis##5##2##(1996-1#2)(2007-8#2)(2008-4#1)
renal vasoconstriction##10##2##(1991-5#1)(1995-12#2)(1995-5#1)(2006-10#3)(2006-8#1)(2008-12#1)(2009-8#1)
renal vasoconstrictor##2##2##(1992-2#1)(1996-10#1)
renal vein and##2##3##(2011-2#1)(2012-2#1)
renal vein##11##2##(1992-7#1)(2007-7#1)(2008-7#2)(2009-3#1)(2010-11#4)(2011-2#1)(2012-2#1)
renal venous thrombosis##2##3##(1992-10#1)(2008-10#1)
renal##3032##1##(1990-1#1)(1990-10#4)(1990-11#16)(1990-12#4)(1990-2#16)(1990-3#12)(1990-4#12)(1990-5#4)(1990-6#8)(1990-7#5)(1990-8#8)(1990-9#19)(1991-1#3)(1991-10#8)(1991-11#14)(1991-12#8)(1991-2#5)(1991-3#6)(1991-4#3)(1991-5#9)(1991-6#11)(1991-7#4)(1991-8#18)(1991-9#6)(1992-1#5)(1992-10#3)(1992-11#3)(1992-12#11)(1992-2#10)(1992-3#9)(1992-4#5)(1992-5#19)(1992-6#9)(1992-7#15)(1992-8#32)(1992-9#7)(1993-1#1)(1993-10#2)(1993-11#7)(1993-12#10)(1993-2#4)(1993-3#14)(1993-4#8)(1993-5#2)(1993-7#3)(1993-8#7)(1993-9#7)(1994-10#1)(1994-11#1)(1994-12#6)(1994-2#3)(1994-3#12)(1994-4#6)(1994-5#27)(1994-6#11)(1994-8#9)(1994-9#5)(1995-1#8)(1995-10#6)(1995-11#7)(1995-12#26)(1995-2#45)(1995-3#5)(1995-4#1)(1995-5#7)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#9)(1996-1#10)(1996-10#3)(1996-11#2)(1996-12#12)(1996-2#5)(1996-3#14)(1996-5#3)(1996-6#12)(1996-7#4)(1996-8#12)(1996-9#6)(1997-1#8)(1997-2#22)(1997-3#15)(1997-4#9)(1997-5#4)(1997-6#4)(1997-7#18)(1997-8#13)(2004-10#1)(2004-11#4)(2004-12#3)(2005-1#7)(2005-10#38)(2005-11#5)(2005-12#10)(2005-7#16)(2005-8#2)(2005-9#2)(2006-1#5)(2006-10#137)(2006-12#1)(2006-2#7)(2006-4#18)(2006-5#13)(2006-6#12)(2006-7#21)(2006-8#25)(2006-9#20)(2007-1#10)(2007-10#22)(2007-11#52)(2007-12#33)(2007-2#36)(2007-3#10)(2007-4#6)(2007-5#8)(2007-6#7)(2007-7#190)(2007-8#125)(2007-9#16)(2008-1#302)(2008-10#60)(2008-11#17)(2008-12#11)(2008-2#6)(2008-3#36)(2008-4#112)(2008-5#26)(2008-6#35)(2008-7#47)(2008-8#37)(2008-9#17)(2009-10#7)(2009-11#14)(2009-2#8)(2009-3#11)(2009-4#5)(2009-5#13)(2009-6#12)(2009-7#2)(2009-8#12)(2009-9#7)(2010-1#1)(2010-10#6)(2010-11#10)(2010-12#28)(2010-2#5)(2010-3#2)(2010-4#18)(2010-5#7)(2010-6#1)(2010-7#27)(2010-8#7)(2010-9#12)(2011-1#29)(2011-12#7)(2011-2#107)(2011-3#7)(2012-1#14)(2012-11#5)(2012-12#65)(2012-2#63)(2012-3#17)(2013-1#117)(2013-7#7)(2013-8#40)
renal&quot##2##1##(2008-1#2)
renal-cell cancer (RCC)##2##3##(1995-5#1)(2008-8#1)
renal-cell cancer##7##2##(1992-10#3)(1995-5#2)(2008-8#2)
renal-cell carcinoma##7##2##(1991-2#1)(1991-9#2)(1993-9#1)(1997-7#3)
renal-cell##14##1##(1991-2#1)(1991-9#2)(1992-10#3)(1993-9#1)(1995-5#2)(1997-7#3)(2008-8#2)
renal-cell-carcinoma cells##3##2##(1993-9#3)
renal-cell-carcinoma##4##1##(1993-9#4)
renalase##5##1##(2013-1#5)
renally##2##1##(2008-3#2)
renamed##10##1##(1990-10#1)(1991-12#1)(1994-3#1)(1994-5#1)(1997-4#2)(2005-7#1)(2005-9#1)(2007-5#1)(2011-1#1)
renaturation and##2##2##(1990-5#1)(2008-4#1)
renaturation of the##2##3##(1995-2#1)(2011-1#1)
renaturation##15##1##(1990-3#1)(1990-4#1)(1990-5#1)(1991-7#1)(1992-9#1)(1994-12#1)(1995-2#1)(1996-7#1)(2008-10#2)(2008-4#3)(2009-3#1)(2011-1#1)
renatured##4##1##(1990-11#1)(1992-8#1)(1995-6#1)(1997-4#1)
renaturing##4##1##(1990-3#1)(1991-4#1)(1995-8#1)(1997-6#1)
rendement scolaire##2##2##(2008-11#2)
rendement##3##1##(2008-11#3)
render a##5##2##(1991-12#1)(1996-12#1)(1997-3#1)(1997-5#1)(2010-3#1)
render high-technological medical##2##3##(2011-2#2)
render more##2##2##(2011-1#1)(2013-7#1)
render the##26##2##(1990-12#1)(1990-3#1)(1990-5#1)(1993-5#1)(1995-8#1)(1996-11#1)(1996-4#1)(1996-7#1)(1997-6#1)(2005-7#1)(2006-12#1)(2007-1#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
render them##3##2##(2008-9#1)(2010-7#2)
render these##3##2##(1990-8#1)(1991-12#1)(2011-2#1)
render this##6##2##(2007-12#1)(2008-2#1)(2009-10#1)(2010-10#1)(2011-2#1)(2012-12#1)
render##78##1##(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#2)(1991-12#2)(1991-2#1)(1993-5#1)(1994-1#1)(1994-2#1)(1995-2#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-4#1)(1996-7#2)(1997-3#2)(1997-5#2)(1997-6#2)(2005-11#2)(2005-7#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-7#3)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#3)(2013-7#1)
rendered by the##2##3##(2006-12#1)(2013-1#1)
rendered by##5##2##(1996-3#1)(2006-12#1)(2007-4#1)(2011-1#1)(2013-1#1)
rendered in##4##2##(1990-12#1)(1995-9#1)(2008-2#1)(2008-6#1)
rendered into##2##2##(2008-11#1)(2011-7#1)
rendered ischemic##2##2##(2007-8#1)(2008-12#1)
rendered it##2##2##(1995-6#1)(2008-10#1)
rendered more##4##2##(1994-3#1)(1997-4#1)(1997-7#1)(2008-3#1)
rendered or##2##2##(1992-12#1)(2008-7#1)
rendered the mutant##2##3##(1995-8#1)(2006-3#1)
rendered the##5##2##(1992-7#1)(1995-8#1)(2006-3#1)(2008-5#1)(2013-1#1)
rendered them##3##2##(1990-12#1)(1991-7#1)(1994-12#1)
rendered this##2##2##(1992-11#1)(2008-10#1)
rendered to the##3##3##(1995-9#1)(1997-2#1)(2011-2#1)
rendered to##4##2##(1995-9#1)(1997-2#1)(2010-9#1)(2011-2#1)
rendered unresponsive to SRBC##2##4##(1991-12#2)
rendered##103##1##(1990-12#2)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#1)(2005-11#2)(2006-1#1)(2006-12#1)(2006-3#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#3)(2013-1#2)
rendering it##6##2##(1990-11#1)(1992-2#1)(2005-8#1)(2006-11#1)(2008-11#1)(2011-1#1)
rendering of the##2##3##(2008-2#1)(2012-1#1)
rendering of##10##2##(2007-11#1)(2008-2#3)(2008-6#4)(2008-8#1)(2012-1#1)
rendering the host at risk for systemic infection##2##8##(2013-1#2)
rendering the method suitable for determination of##2##7##(2008-10#2)
rendering the method suitable for##3##5##(2008-10#3)
rendering the##17##2##(1994-11#1)(1996-9#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-7#2)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#2)
rendering them more##2##3##(2008-3#1)(2008-8#1)
rendering them##7##2##(1991-8#1)(2005-7#1)(2008-3#1)(2008-8#2)(2010-1#1)(2010-12#1)
rendering##93##1##(1990-11#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-2#1)(1994-11#1)(1994-9#1)(1996-9#2)(2005-12#2)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#4)(2007-5#1)(2007-8#1)(2008-10#5)(2008-11#4)(2008-2#7)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#19)(2008-7#3)(2008-8#3)(2009-9#2)(2010-1#1)(2010-12#4)(2010-5#1)(2011-1#2)(2012-1#2)(2012-2#3)(2013-1#5)
renderings##4##1##(2007-1#1)(2011-7#3)
renders a##2##2##(2008-2#2)
renders it a##2##3##(2008-10#1)(2008-7#1)
renders it##8##2##(1995-1#1)(1997-2#1)(2006-3#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-7#1)(2009-12#1)
renders possible##2##2##(2008-11#1)(2012-1#1)
renders the cells more##2##4##(1992-11#1)(2005-7#1)
renders the cells##3##3##(1992-11#1)(1997-7#1)(2005-7#1)
renders the enzyme##2##3##(1995-2#1)(1997-1#1)
renders the surface##2##3##(2009-7#1)(2010-4#1)
renders the##19##2##(1992-11#1)(1995-2#1)(1995-8#1)(1996-10#2)(1996-11#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-10#1)(2008-1#1)(2008-2#2)(2008-5#1)(2009-7#1)(2010-4#1)
renders them##2##2##(1995-10#1)(2010-9#1)
renders this##2##2##(1991-8#1)(2011-1#1)
renders##64##1##(1990-12#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1993-4#2)(1993-5#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-2#2)(1995-8#2)(1996-10#2)(1996-11#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-3#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-4#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-4#2)(2008-5#1)(2008-7#2)(2009-1#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-4#3)(2010-9#1)(2011-1#1)(2012-1#1)
rendezvous##3##1##(2007-5#1)(2007-9#1)(2008-3#1)
rendition of##2##2##(2008-8#1)(2013-1#1)
renew their##2##2##(1992-6#1)(2010-2#1)
renew##4##1##(1992-6#1)(1995-6#1)(2008-3#1)(2010-2#1)
renewable energy##4##2##(2006-7#1)(2008-5#2)(2008-6#1)
renewable microcolumn##2##2##(2008-10#2)
renewable resources##7##2##(2006-12#2)(2008-5#2)(2008-6#2)(2008-8#1)
renewable surface##3##2##(2008-10#3)
renewable##35##1##(1993-3#1)(2006-12#2)(2006-7#2)(2008-10#14)(2008-5#8)(2008-6#4)(2008-8#1)(2011-1#1)(2013-1#2)
renewal and##6##2##(1995-1#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-10#1)(2010-11#1)
renewal of the##3##3##(2006-10#1)(2008-10#1)(2008-5#1)
renewal of##7##2##(1994-12#1)(2006-10#1)(2008-10#2)(2008-5#1)(2011-12#1)(2012-2#1)
renewal##50##1##(1990-11#1)(1993-2#3)(1993-5#1)(1994-12#1)(1995-1#4)(1997-5#1)(2006-10#2)(2007-2#1)(2008-1#5)(2008-10#6)(2008-11#3)(2008-5#3)(2008-8#2)(2008-9#1)(2009-10#1)(2010-11#3)(2010-12#1)(2010-3#1)(2011-1#4)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#2)
renewed at##2##2##(1997-1#1)(2008-10#1)
renewed attention to##2##3##(1996-3#1)(2006-10#1)
renewed attention##6##2##(1992-12#1)(1996-3#1)(2006-10#1)(2007-8#1)(2008-3#1)(2013-1#1)
renewed by##2##2##(2008-10#2)
renewed efforts to##2##3##(1994-3#1)(2007-2#1)
renewed emphasis on##3##3##(1996-12#1)(1996-3#1)(2008-10#1)
renewed focus on##3##3##(2008-11#1)(2008-12#1)(2009-8#1)
renewed focus##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2009-8#1)
renewed interest in the##7##4##(1990-9#1)(2006-10#1)(2007-11#2)(2008-7#1)(2012-1#1)(2013-8#1)
renewed interest in##20##3##(1990-9#1)(1995-6#1)(2005-7#1)(2006-10#2)(2006-9#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-7#1)(2009-11#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#1)
renewed interest##23##2##(1990-9#1)(1995-6#1)(2005-7#1)(2006-10#2)(2006-5#1)(2006-9#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-7#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#1)
renewed##71##1##(1990-9#1)(1991-2#1)(1992-1#2)(1992-12#1)(1992-6#1)(1993-1#2)(1994-3#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-3#3)(1996-9#1)(1997-1#2)(2005-7#1)(2006-10#6)(2006-5#1)(2006-9#1)(2007-11#2)(2007-2#4)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-11#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
renewing##4##1##(1995-6#1)(2008-11#1)(2008-5#1)(2008-8#1)
renews##3##1##(1994-2#1)(2008-1#1)(2012-2#1)
reniform nematode##2##2##(2008-10#2)
reniformis and##2##2##(2008-10#2)
reniformis on cotton##2##3##(2008-10#2)
reniformis on##4##2##(2008-10#4)
reniformis##14##1##(2008-10#11)(2009-3#3)
renin activity##15##2##(1990-5#1)(1991-10#1)(1992-4#1)(1992-5#1)(1993-12#1)(1993-3#1)(1995-10#1)(1995-5#1)(1997-3#1)(1997-7#1)(2006-11#1)(2007-8#1)(2008-7#2)(2012-1#1)
renin and aldosterone in##2##4##(2012-1#2)
renin and aldosterone##4##3##(1992-7#1)(1993-12#1)(2012-1#2)
renin and its##2##3##(1995-9#1)(1996-5#1)
renin and prorenin##2##3##(1996-5#2)
renin and##12##2##(1990-7#1)(1992-7#1)(1993-12#1)(1995-9#1)(1996-5#4)(2008-1#1)(2012-1#2)(2013-1#1)
renin angiotensin system blockade##2##4##(2006-10#1)(2013-1#1)
renin angiotensin system in##3##4##(2005-7#1)(2008-11#2)
renin angiotensin system##10##3##(1990-3#1)(1995-12#1)(2005-7#1)(2006-10#2)(2008-11#3)(2012-3#1)(2013-1#1)
renin expressed in##2##3##(1990-7#1)(1990-8#1)
renin gene transcription##2##3##(1993-6#1)(1995-9#1)
renin gene##8##2##(1993-11#1)(1993-6#1)(1994-2#3)(1995-9#3)
renin genes##2##2##(1990-11#2)
renin hypertension##2##2##(2007-8#1)(2008-7#1)
renin in##5##2##(1990-7#1)(1990-8#2)(1995-1#1)(1996-5#1)
renin inhibitor##8##2##(1991-5#1)(1997-8#2)(2007-8#1)(2008-1#1)(2012-12#1)(2012-3#2)
renin inhibitors##5##2##(2008-1#3)(2012-3#2)
renin is##3##2##(1990-5#1)(1995-9#1)(2005-1#1)
renin levels##5##2##(1992-7#1)(2006-9#1)(2007-7#1)(2007-8#1)(2010-12#1)
renin mRNA in##2##3##(1993-6#1)(1995-9#1)
renin mRNA levels and renin production##2##6##(1993-6#2)
renin mRNA levels##3##3##(1993-6#3)
renin mRNA##10##2##(1991-8#1)(1993-11#1)(1993-6#5)(1995-9#3)
renin messenger RNA##3##3##(1991-8#3)
renin production##3##2##(1993-6#3)
renin promoter##2##2##(1994-2#2)
renin ratio##2##2##(2007-7#1)(2008-1#1)
renin was##5##2##(1990-7#1)(1994-12#1)(1994-2#1)(1996-5#2)
renin##134##1##(1990-11#4)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#11)(1990-8#6)(1991-10#1)(1991-5#3)(1991-8#4)(1991-9#2)(1992-4#1)(1992-5#3)(1992-7#2)(1993-11#2)(1993-12#2)(1993-3#1)(1993-6#11)(1994-12#1)(1994-2#6)(1995-1#1)(1995-10#1)(1995-12#1)(1995-5#1)(1995-9#10)(1996-5#9)(1997-3#1)(1997-7#1)(1997-8#2)(2005-1#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-9#1)(2007-7#2)(2007-8#6)(2008-1#7)(2008-11#3)(2008-7#3)(2010-12#1)(2012-1#3)(2012-12#1)(2012-3#5)(2013-1#5)
renin-angiotensin aldosterone##3##2##(2008-1#2)(2008-10#1)
renin-angiotensin system (RAS) may be##2##5##(1993-12#1)(2008-7#1)
renin-angiotensin system (RAS)##10##3##(1991-5#1)(1993-12#1)(1995-10#1)(2005-7#2)(2008-7#1)(2009-10#1)(2009-4#1)(2013-1#2)
renin-angiotensin system and##3##3##(1993-12#1)(2008-4#1)(2012-3#1)
renin-angiotensin system in##4##3##(1991-5#1)(1992-2#1)(1993-11#1)(1993-12#1)
renin-angiotensin system plays##2##3##(1993-12#1)(2006-8#1)
renin-angiotensin system##41##2##(1990-2#1)(1991-5#2)(1991-8#1)(1992-2#1)(1993-11#2)(1993-12#6)(1994-12#1)(1994-9#1)(1995-10#1)(1995-9#2)(1996-3#1)(1996-5#1)(2005-10#1)(2005-7#4)(2006-8#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-10#2)(2009-4#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
renin-angiotensin systems##2##2##(1993-12#1)(2007-8#1)
renin-angiotensin##49##1##(1990-2#1)(1991-5#2)(1991-8#1)(1992-2#1)(1993-11#2)(1993-12#7)(1994-12#1)(1994-9#1)(1995-10#1)(1995-9#2)(1996-3#1)(1996-5#1)(2005-10#2)(2005-7#4)(2006-8#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2009-10#2)(2009-4#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
renin-angiotensin-aldosterone axis##2##2##(2013-1#2)
renin-angiotensin-aldosterone system has##2##3##(2005-10#1)(2007-8#1)
renin-angiotensin-aldosterone system##17##2##(1992-8#1)(1996-6#1)(2005-10#1)(2005-7#1)(2006-11#1)(2007-1#4)(2007-8#4)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
renin-angiotensin-aldosterone##20##1##(1992-8#1)(1994-7#1)(1996-6#1)(2005-10#1)(2005-7#1)(2006-11#1)(2007-1#4)(2007-8#4)(2010-4#1)(2011-2#1)(2013-1#3)(2013-8#1)
rennet##4##1##(2008-10#1)(2010-2#3)
renocolic fistula##4##2##(2013-1#4)
renogram##4##1##(2008-10#1)(2008-4#1)(2013-1#2)
renography##4##1##(1991-5#1)(1995-5#1)(2008-1#2)
renoprotection##3##1##(2007-1#1)(2010-7#1)(2012-12#1)
renoprotective##5##1##(2005-7#1)(2008-1#1)(2010-7#1)(2012-12#1)(2012-3#1)
renormalization group##3##2##(1993-3#1)(2011-1#2)
renormalization##6##1##(1993-3#1)(1995-5#1)(2008-2#1)(2008-8#1)(2011-1#2)
renovascular disease##6##2##(1990-6#1)(1997-2#1)(2007-7#1)(2010-12#1)(2012-2#2)
renovascular hypertension and##4##3##(1992-5#1)(1994-9#1)(2008-1#2)
renovascular hypertension##20##2##(1990-2#3)(1991-10#1)(1992-5#1)(1994-9#1)(1995-7#2)(2006-10#2)(2007-7#3)(2008-1#4)(2010-4#2)(2010-7#1)
renovascular##30##1##(1990-2#3)(1990-6#1)(1991-10#2)(1992-5#1)(1994-9#1)(1995-7#2)(1997-2#1)(2006-10#2)(2007-7#4)(2008-1#4)(2008-3#1)(2010-12#1)(2010-4#3)(2010-7#1)(2012-2#3)
renovated##2##1##(1994-3#1)(1996-7#1)
renovating##2##1##(1996-2#1)(2008-11#1)
renovation of##5##2##(1994-12#1)(2008-10#1)(2008-11#1)(2012-3#2)
renovation##8##1##(1991-12#1)(1992-2#1)(1994-12#1)(2008-10#2)(2008-11#1)(2012-3#2)
renovations##3##1##(1994-1#1)(1995-1#1)(2010-9#1)
renown##3##1##(2009-4#2)(2012-11#1)
renowned for##3##2##(2010-9#1)(2011-1#1)(2012-3#1)
renowned in##2##2##(2007-11#1)(2007-8#1)
renowned##8##1##(2007-11#1)(2007-8#1)(2009-2#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
rent in##2##2##(2007-8#1)(2013-1#1)
rent##4##1##(1991-3#1)(2007-4#1)(2007-8#1)(2013-1#1)
renta##2##1##(1992-1#2)
rented##3##1##(1992-11#1)(2008-2#1)(2011-2#1)
renutrition##2##1##(2006-1#1)(2012-2#1)
reo##2##1##(1997-1#1)(2008-1#1)
reoccluded within##2##2##(1990-12#2)
reoccluded##3##1##(1990-12#2)(1996-9#1)
reocclusion and##2##2##(1992-9#1)(2006-6#1)
reocclusion in##2##2##(1990-12#1)(1993-1#1)
reocclusion##10##1##(1990-12#3)(1992-9#1)(1993-1#1)(1997-8#1)(2006-6#1)(2007-8#1)(2008-5#1)(2008-6#1)
reoccurring##3##1##(2008-11#1)(2013-1#2)
reopened##4##1##(1996-9#1)(1997-3#1)(2008-11#1)(2012-3#1)
reopens the##2##2##(1992-10#1)(2013-7#1)
reoperated because of##2##3##(2008-10#1)(2008-6#1)
reoperated##9##1##(1992-10#1)(1992-8#1)(2007-8#3)(2008-10#2)(2008-6#2)
reoperation and##2##2##(2007-8#1)(2013-8#1)
reoperation at##2##2##(1995-3#1)(2007-8#1)
reoperation for bleeding##4##3##(2007-8#4)
reoperation for##7##2##(1995-4#1)(2007-8#4)(2007-9#2)
reoperation in##5##2##(2006-12#4)(2007-8#1)
reoperation occurred in##2##3##(2007-7#1)(2007-8#1)
reoperation rate##2##2##(1996-11#1)(2012-12#1)
reoperation was##3##2##(2007-11#1)(2012-12#2)
reoperation were##2##2##(2007-8#2)
reoperation with change of##2##4##(2007-11#2)
reoperation with##4##2##(2007-11#2)(2012-3#2)
reoperation within##2##2##(2006-8#1)(2012-12#1)
reoperation##60##1##(1993-10#2)(1994-5#1)(1994-7#1)(1995-3#1)(1995-4#1)(1996-11#1)(2006-12#7)(2006-5#2)(2006-8#2)(2007-11#5)(2007-7#1)(2007-8#13)(2007-9#2)(2008-6#1)(2008-9#2)(2010-3#1)(2010-6#1)(2011-2#2)(2012-12#9)(2012-3#3)(2013-1#1)(2013-8#1)
reoperations##10##1##(1992-2#1)(1994-4#1)(2007-8#4)(2007-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
reoperative##2##1##(2007-8#1)(2013-8#1)
reordering##5##1##(2008-7#5)
reorganisation energy##3##2##(1996-8#2)(2006-10#1)
reorganisation in##2##2##(1996-5#1)(2010-3#1)
reorganisation of the##4##3##(1990-5#1)(1993-10#1)(2005-5#1)(2011-2#1)
reorganisation##11##1##(1990-5#1)(1991-3#1)(1993-10#1)(1996-5#1)(1996-8#2)(2005-5#1)(2006-10#1)(2010-3#1)(2011-2#1)(2012-12#1)
reorganization and recruitment##3##3##(2012-2#3)
reorganization and##8##2##(1990-2#1)(1994-9#1)(2008-11#1)(2008-7#1)(2012-2#4)
reorganization as##2##2##(1993-8#1)(2012-12#1)
reorganization during##3##2##(1997-8#1)(2008-7#1)(2011-2#1)
reorganization energies##2##2##(1997-4#1)(2013-1#1)
reorganization energy##3##2##(1997-4#2)(2010-4#1)
reorganization in##4##2##(1991-2#1)(1996-12#1)(1997-5#1)(2009-11#1)
reorganization of F-actin##3##3##(1993-8#3)
reorganization of cortical##2##3##(1995-12#1)(2008-3#1)
reorganization of health services##3##4##(1993-6#3)
reorganization of the visual##2##4##(1994-6#1)(2008-9#1)
reorganization of the##19##3##(1990-2#1)(1992-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1996-11#1)(1997-2#1)(1997-4#1)(2008-7#1)(2008-9#4)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-1#2)
reorganization of##48##2##(1990-2#1)(1991-11#1)(1992-2#1)(1993-6#3)(1993-8#3)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#3)(1996-11#2)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-2#1)(2006-6#1)(2008-11#1)(2008-3#1)(2008-7#2)(2008-9#5)(2009-2#1)(2009-8#2)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)
reorganization patterns##2##2##(2008-9#1)(2013-8#1)
reorganization upon##2##2##(2006-10#1)(2008-10#1)
reorganization##112##1##(1990-2#3)(1991-11#1)(1991-2#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-6#3)(1993-8#4)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-5#1)(1996-11#2)(1996-12#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#4)(1997-5#2)(1997-6#1)(1997-8#1)(2004-2#1)(2005-11#1)(2006-10#5)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#1)(2008-7#5)(2008-9#8)(2009-11#1)(2009-2#1)(2009-8#4)(2010-10#1)(2010-12#3)(2010-4#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#4)(2013-8#2)
reorganizations##3##1##(1994-8#1)(1996-2#1)(1996-7#1)
reorganize the##2##2##(1991-9#1)(1992-2#1)
reorganize to##2##2##(1993-3#1)(2006-10#1)
reorganize##10##1##(1991-9#1)(1992-2#1)(1993-3#1)(1996-11#1)(2006-10#1)(2008-1#1)(2008-2#2)(2008-4#1)(2008-9#1)
reorganized the##2##2##(1994-8#1)(2008-3#1)
reorganized##6##1##(1990-2#1)(1994-8#1)(1995-3#1)(2008-3#1)(2011-2#2)
reorganizes##3##1##(1995-2#2)(1996-11#1)
reorganizing##3##1##(2007-9#1)(2008-2#1)(2010-5#1)
reorient the##2##2##(1993-2#1)(2008-1#1)
reorient##7##1##(1990-3#1)(1992-11#1)(1993-2#1)(1995-5#1)(2008-1#2)(2009-5#1)
reorientation and##2##2##(1992-2#1)(2011-1#1)
reorientation in the##2##3##(1990-8#1)(2007-12#1)
reorientation in##3##2##(1990-8#1)(2007-12#2)
reorientation of the nematic##2##4##(2007-12#1)(2008-2#1)
reorientation of the##14##3##(1990-8#1)(1993-1#1)(1995-11#1)(1997-3#1)(2006-12#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2011-2#1)
reorientation of##24##2##(1990-8#1)(1991-4#1)(1993-1#1)(1995-11#1)(1995-5#1)(1997-1#1)(1997-3#1)(2006-12#1)(2007-12#5)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2010-12#1)(2011-1#1)(2011-2#2)
reorientation##48##1##(1990-2#1)(1990-3#1)(1990-8#3)(1991-2#1)(1991-4#1)(1992-2#1)(1993-1#1)(1995-11#1)(1995-5#1)(1997-1#1)(1997-3#2)(2005-11#2)(2006-10#1)(2006-12#1)(2007-11#3)(2007-12#8)(2007-8#1)(2008-1#2)(2008-10#3)(2008-2#2)(2008-3#1)(2008-6#2)(2008-8#1)(2009-8#1)(2010-12#1)(2011-1#3)(2011-2#2)
reorientations in##2##2##(1994-11#1)(2008-2#1)
reorientations##5##1##(1994-11#3)(1996-1#1)(2008-2#1)
reoriented##4##1##(1990-12#1)(1995-5#1)(1996-1#1)(2008-6#1)
reorienting the##2##2##(2007-10#1)(2007-11#1)
reorienting##3##1##(2007-10#1)(2007-11#1)(2010-12#1)
reorients##3##1##(1991-5#2)(1994-5#1)
reovirus in##2##2##(1997-6#1)(2008-10#1)
reovirus##12##1##(1997-4#1)(1997-6#4)(2007-12#1)(2007-6#2)(2008-10#3)(2008-5#1)
reoviruses##3##1##(2007-6#1)(2008-10#1)(2008-5#1)
reoxidation of the##5##3##(1990-10#1)(1990-5#1)(1992-12#1)(1997-4#1)(2008-10#1)
reoxidation of##7##2##(1990-10#1)(1990-5#2)(1992-12#1)(1995-2#1)(1997-4#1)(2008-10#1)
reoxidation rate##3##2##(1991-2#3)
reoxidation##14##1##(1990-10#1)(1990-5#2)(1991-2#3)(1992-12#2)(1995-2#1)(1996-2#1)(1997-4#1)(2008-10#3)
reoxidized##8##1##(1990-10#1)(1990-12#1)(1991-2#1)(1992-12#1)(1995-11#1)(1997-4#1)(2008-10#1)(2012-2#1)
reoxygenated##2##1##(1992-9#1)(1994-9#1)
reoxygenation period##3##2##(2011-12#3)
reoxygenation##19##1##(1990-7#2)(1994-4#1)(1994-9#4)(1996-9#2)(2007-9#2)(2008-11#2)(2010-7#1)(2011-12#5)
rep gene mutants##2##3##(2008-10#2)
rep gene##6##2##(2008-10#6)
rep##11##1##(2006-10#1)(2008-10#8)(2008-8#2)
rep-PCR and##2##2##(2008-10#2)
rep-PCR data##2##2##(2008-10#2)
rep-PCR fingerprints of##2##3##(2008-10#2)
rep-PCR fingerprints##6##2##(2008-10#6)
rep-PCR##25##1##(2008-10#25)
repK mRNA##2##2##(1997-6#2)
repK##4##1##(1997-6#4)
repaglinide##2##1##(2010-4#2)
repair (EVAR)##4##2##(2007-8#1)(2010-12#1)(2012-1#1)(2012-2#1)
repair -##3##2##(2007-8#1)(2012-12#2)
repair a##5##2##(1994-5#1)(2007-7#1)(2007-8#1)(2013-7#2)
repair activities##2##2##(1996-11#1)(2007-10#1)
repair activity##4##2##(1992-3#1)(1993-11#1)(2007-10#1)(2008-8#1)
repair after injury##3##3##(2006-10#1)(2007-11#1)(2012-2#1)
repair after##11##2##(1997-4#1)(2006-10#1)(2007-11#2)(2008-11#1)(2008-4#1)(2010-11#1)(2012-12#1)(2012-2#1)(2013-8#2)
repair also##2##2##(1991-7#1)(1997-3#1)
repair an##2##2##(2007-11#1)(2013-8#1)
repair and V(D)J recombination##5##4##(1995-1#1)(1996-2#2)(2013-1#2)
repair and in##2##3##(1991-4#1)(2009-10#1)
repair and recombination##2##3##(2008-7#1)(2011-2#1)
repair and reconstruction##2##3##(2006-3#2)
repair and regeneration##5##3##(1990-4#1)(2008-1#1)(2008-9#2)(2012-12#1)
repair and related##2##3##(2008-8#1)(2010-12#1)
repair and replacement##2##3##(2008-1#1)(2008-5#1)
repair and replication##2##3##(1995-1#1)(1997-2#1)
repair and the##5##3##(1991-7#1)(2008-5#1)(2009-5#1)(2010-8#1)(2012-12#1)
repair and##78##2##(1990-4#1)(1991-4#1)(1991-7#1)(1992-6#1)(1993-8#2)(1994-5#1)(1994-9#1)(1995-1#2)(1996-2#2)(1997-1#1)(1997-2#2)(1997-4#2)(2005-12#1)(2006-10#2)(2006-3#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#7)(2008-8#3)(2008-9#4)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#8)(2013-7#2)
repair appears to##2##3##(2011-2#2)
repair are discussed##2##3##(1994-8#1)(2010-8#1)
repair are##4##2##(1994-8#1)(1996-11#1)(1996-3#1)(2010-8#1)
repair as a##2##3##(2008-11#1)(2010-7#1)
repair as##5##2##(1997-3#2)(2008-11#1)(2009-5#1)(2010-7#1)
repair at##4##2##(2006-3#1)(2007-8#1)(2008-12#1)(2012-3#1)
repair between##2##2##(2007-8#1)(2011-2#1)
repair but##2##2##(2006-10#1)(2007-5#1)
repair by##10##2##(1991-7#1)(1994-2#1)(1994-7#1)(1994-8#1)(1997-4#1)(2007-8#2)(2008-11#1)(2011-2#1)(2013-7#1)
repair can be##2##3##(2007-8#1)(2013-1#1)
repair can##4##2##(2007-11#1)(2007-8#1)(2008-8#1)(2013-1#1)
repair capacity of##2##3##(1997-1#2)
repair capacity##7##2##(1997-1#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)
repair compared to##3##3##(1994-2#3)
repair damaged##3##2##(2007-11#1)(2007-7#1)(2008-8#1)
repair defect##2##2##(1994-7#1)(1995-6#1)
repair due to##2##3##(2009-5#1)(2011-12#1)
repair enzyme##6##2##(1994-5#1)(1995-2#2)(1997-1#1)(1997-4#1)(2005-11#1)
repair enzymes##12##2##(1994-5#2)(1995-5#1)(1996-11#2)(1996-5#3)(1997-4#1)(2006-10#1)(2006-12#1)(2010-12#1)
repair foci##2##2##(2011-2#2)
repair following trauma##2##3##(2008-5#1)(2013-1#1)
repair following##7##2##(2008-1#1)(2008-5#1)(2008-7#1)(2011-2#2)(2012-12#1)(2013-1#1)
repair for##12##2##(2006-4#1)(2007-5#1)(2007-8#2)(2008-10#1)(2008-12#1)(2009-5#4)(2011-2#1)(2012-1#1)
repair from##3##2##(2009-5#2)(2010-12#1)
repair gene##7##2##(1996-11#1)(1997-1#1)(1997-9#1)(2005-11#1)(2010-8#1)(2011-1#2)
repair genes##13##2##(1990-7#1)(1994-8#1)(1995-6#1)(2005-10#1)(2007-10#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-2#1)
repair has a##2##3##(2009-5#1)(2010-7#1)
repair has been##4##3##(1990-7#1)(2006-1#1)(2008-9#1)(2012-12#1)
repair has##13##2##(1990-7#1)(2006-1#2)(2008-10#1)(2008-9#1)(2009-5#1)(2010-7#1)(2011-2#4)(2012-12#1)(2013-7#1)
repair have##2##2##(2010-8#1)(2011-2#1)
repair in an##3##3##(2006-4#1)(2012-12#1)(2012-2#1)
repair in mammalian cells##3##4##(1995-6#2)(1997-6#1)
repair in patients with##3##4##(1992-5#1)(2007-8#1)(2009-10#1)
repair in the##5##3##(2005-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2013-8#1)
repair in##44##2##(1990-5#1)(1991-7#2)(1992-1#1)(1992-5#2)(1994-7#1)(1995-6#3)(1996-7#2)(1997-1#1)(1997-3#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-8#3)(2008-10#4)(2008-11#2)(2008-5#2)(2008-8#2)(2009-10#1)(2009-3#1)(2009-5#3)(2011-2#1)(2012-12#2)(2012-2#2)(2013-8#1)
repair injured##2##2##(2008-9#1)(2012-12#1)
repair is not##2##3##(1993-3#1)(2007-7#1)
repair is now a##2##4##(1996-8#1)(2011-2#1)
repair is presented in##2##4##(2007-8#1)(2010-7#1)
repair is the##2##3##(2007-8#1)(2008-1#1)
repair is##36##2##(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-8#1)(1996-10#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#2)
repair itself##2##2##(2007-11#1)(2007-3#1)
repair material##2##2##(2012-2#2)
repair materials##3##2##(2010-8#3)
repair may be##2##3##(1991-7#1)(2011-2#1)
repair may contribute##2##3##(1997-3#1)(2011-1#1)
repair may##7##2##(1991-7#1)(1993-8#1)(1997-3#1)(2007-10#1)(2008-7#1)(2011-1#1)(2011-2#1)
repair mechanism##5##2##(2007-12#2)(2008-8#2)(2013-1#1)
repair mechanisms##10##2##(1990-7#1)(1994-6#1)(1996-6#1)(2006-10#2)(2008-1#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-12#1)
repair method##2##2##(2006-12#1)(2007-11#1)
repair molecules##2##2##(1994-2#1)(2009-12#1)
repair of DNA damage##2##4##(1991-7#1)(2009-5#1)
repair of DNA##6##3##(1991-7#1)(1996-5#1)(1997-1#1)(2007-9#1)(2009-5#1)(2011-2#1)
repair of SSBs is##2##4##(1996-5#2)
repair of UV##3##3##(1996-5#1)(1997-1#2)
repair of a##15##3##(1990-6#1)(1991-10#1)(1996-6#1)(2005-10#1)(2006-4#1)(2007-2#1)(2007-8#4)(2009-3#1)(2009-6#1)(2011-2#1)(2012-1#1)(2013-7#1)
repair of abdominal##3##3##(2008-3#1)(2010-12#2)
repair of acquired##2##3##(2006-12#2)
repair of active genes##2##4##(1994-5#2)
repair of all##2##3##(2011-2#1)(2013-1#1)
repair of an##3##3##(2007-8#1)(2008-10#2)
repair of aortic arch##2##4##(2008-8#1)(2011-2#1)
repair of atrial##2##3##(2007-9#1)(2008-11#1)
repair of bladder exstrophy##2##4##(2008-10#2)
repair of coarctation of the aorta##3##6##(2007-3#1)(2007-8#1)(2012-1#1)
repair of complex congenital heart defects##2##6##(1993-10#2)
repair of congenital##3##3##(2007-8#1)(2007-9#1)(2008-9#1)
repair of damage to the##2##5##(2007-8#2)
repair of damaged DNA##3##4##(1991-8#1)(1995-3#1)(2007-10#1)
repair of damaged##5##3##(1991-8#1)(1995-3#1)(2007-10#1)(2007-9#1)(2008-5#1)
repair of distal biceps tendon rupture##2##6##(2006-3#1)(2006-4#1)
repair of distal##7##3##(1993-1#1)(2006-10#1)(2006-3#1)(2006-4#2)(2007-8#1)(2012-3#1)
repair of full-thickness##2##3##(2008-5#1)(2013-7#1)
repair of injured##2##3##(2008-1#1)(2012-12#1)
repair of m7Gua##2##3##(1994-5#2)
repair of pectus excavatum##2##4##(2007-8#2)
repair of proximal hypospadias##2##4##(2008-10#1)(2009-5#1)
repair of proximal##3##3##(2008-10#1)(2008-9#1)(2009-5#1)
repair of tetralogy of Fallot##2##5##(2007-8#2)
repair of the aortic##2##4##(2007-8#1)(2008-8#1)
repair of the injured##2##4##(1991-10#1)(2006-10#1)
repair of the lesion##2##4##(1997-1#1)(2007-11#1)
repair of the##22##3##(1991-10#1)(1997-1#1)(2005-12#2)(2006-10#3)(2006-12#1)(2006-4#1)(2007-11#1)(2007-8#3)(2008-12#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2009-6#1)(2012-2#2)(2013-1#1)
repair of these lesions##2##4##(1997-1#2)
repair of these##7##3##(1991-10#1)(1993-3#1)(1997-1#3)(2008-8#1)(2010-9#1)
repair of thoracoabdominal aortic##2##4##(2005-10#1)(2012-12#1)
repair of traumatic##2##3##(2007-11#1)(2009-8#1)
repair of type A##3##4##(2007-8#1)(2013-1#2)
repair of type##4##3##(2007-8#1)(2008-8#1)(2013-1#2)
repair of ventral##2##3##(2009-7#1)(2011-2#1)
repair of##219##2##(1990-6#1)(1991-10#3)(1991-7#1)(1991-8#1)(1992-2#1)(1992-5#2)(1992-6#3)(1993-1#1)(1993-10#3)(1993-12#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-3#1)(1994-5#5)(1994-7#1)(1994-8#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-5#4)(1996-6#1)(1997-1#17)(1997-2#2)(1997-4#1)(1997-6#1)(2004-9#2)(2005-10#2)(2005-12#3)(2006-10#7)(2006-11#1)(2006-12#5)(2006-3#3)(2006-4#6)(2006-6#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#32)(2007-9#4)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#7)(2008-7#3)(2008-8#6)(2008-9#4)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#3)(2010-12#2)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#12)(2012-1#3)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#1)
repair on##3##2##(1992-3#1)(1994-2#1)(2012-2#1)
repair or replacement##2##3##(2007-9#1)(2011-2#1)
repair or##14##2##(1994-5#1)(1995-8#1)(1996-11#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-9#2)(2009-9#1)(2011-1#1)(2011-2#2)(2012-12#2)
repair pathway##5##2##(1995-9#1)(1997-1#1)(2007-10#2)(2012-12#1)
repair pathways##8##2##(1996-11#1)(2007-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)
repair performed##2##2##(2008-5#1)(2011-1#1)
repair procedures##2##2##(2007-8#1)(2011-2#1)
repair process of##2##3##(1997-2#1)(2012-1#1)
repair process##8##2##(1994-3#1)(1997-2#1)(2007-11#1)(2011-2#2)(2012-1#1)(2012-12#2)
repair processes of##2##3##(2007-8#2)
repair processes##7##2##(1997-1#1)(1997-4#1)(2007-8#2)(2008-11#1)(2010-10#1)(2011-12#1)
repair protein##10##2##(1993-12#1)(1994-8#1)(1995-1#1)(1995-5#1)(1997-1#1)(1997-4#1)(2005-11#1)(2009-3#1)(2012-2#1)(2013-1#1)
repair proteins##4##2##(1994-7#1)(1996-4#1)(2013-1#2)
repair rates##4##2##(1994-5#1)(2008-11#3)
repair remains a clinical and scientific challenge with increasing interest focused on##2##12##(2008-5#2)
repair remains##3##2##(2008-5#2)(2009-5#1)
repair requests##2##2##(2008-9#2)
repair response##5##2##(1993-3#1)(1997-3#3)(2012-12#1)
repair sequences##2##2##(2008-9#2)
repair should be##2##3##(1996-11#1)(2007-8#1)
repair site##4##2##(1994-2#1)(2006-3#3)
repair strategies##3##2##(2008-1#2)(2009-9#1)
repair synthesis##4##2##(1990-5#1)(1990-9#1)(1994-7#1)(1995-8#1)
repair system##6##2##(1995-2#1)(1997-1#2)(2005-11#1)(2009-5#2)
repair systems for##2##3##(1997-1#1)(2007-11#1)
repair systems##3##2##(1997-1#1)(2007-11#1)(2008-11#1)
repair techniques##2##2##(2006-12#1)(2007-8#1)
repair that##3##2##(2008-11#1)(2008-12#1)(2013-7#1)
repair the damage##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
repair the##14##2##(1990-11#1)(1991-10#1)(1992-9#1)(2004-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#3)(2008-7#1)(2009-10#1)(2013-8#1)
repair through##2##2##(2008-11#1)(2008-9#1)
repair tissue##5##2##(2008-1#1)(2012-12#4)
repair to##10##2##(1995-6#3)(2007-12#1)(2007-7#1)(2008-11#2)(2011-1#1)(2011-2#1)(2012-12#1)
repair using a##6##3##(1996-9#1)(2006-3#1)(2007-8#1)(2010-7#1)(2010-8#1)(2012-12#1)
repair using mesh##2##3##(2007-10#1)(2011-2#1)
repair using the##3##3##(2007-8#2)(2008-12#1)
repair using##16##2##(1996-9#1)(2006-3#1)(2007-10#1)(2007-8#7)(2008-12#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)
repair versus##2##2##(2011-12#1)(2013-1#1)
repair was performed##3##3##(1997-6#1)(2007-8#2)
repair was##11##2##(1993-2#1)(1993-5#1)(1994-3#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-8#2)(2009-5#1)(2011-2#1)(2013-1#1)
repair were##4##2##(1994-3#1)(2006-8#1)(2007-8#1)(2010-7#1)
repair when##2##2##(2009-3#1)(2009-4#1)
repair with a##3##3##(2007-8#1)(2008-5#1)(2008-6#1)
repair with the##2##3##(2007-8#1)(2011-2#1)
repair with##23##2##(1997-2#1)(2006-11#1)(2007-10#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-3#1)(2009-7#1)(2010-8#2)(2011-12#1)(2011-2#1)(2012-1#1)
repair##1173##1##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#5)(1990-9#3)(1991-10#4)(1991-11#1)(1991-2#1)(1991-4#1)(1991-7#11)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#5)(1992-6#4)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#3)(1993-11#2)(1993-12#7)(1993-2#2)(1993-3#5)(1993-5#1)(1993-8#6)(1993-9#2)(1994-10#2)(1994-2#12)(1994-3#5)(1994-4#1)(1994-5#14)(1994-6#1)(1994-7#7)(1994-8#10)(1994-9#4)(1995-1#6)(1995-12#1)(1995-2#3)(1995-3#4)(1995-5#7)(1995-6#10)(1995-8#5)(1995-9#2)(1996-10#1)(1996-11#11)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#8)(1996-6#3)(1996-7#3)(1996-8#1)(1996-9#5)(1997-1#37)(1997-2#11)(1997-3#12)(1997-4#15)(1997-6#3)(1997-7#1)(1997-9#1)(2004-9#3)(2005-10#5)(2005-11#6)(2005-12#4)(2005-8#1)(2006-1#2)(2006-10#20)(2006-11#3)(2006-12#10)(2006-2#1)(2006-3#14)(2006-4#11)(2006-5#1)(2006-6#4)(2006-8#5)(2006-9#1)(2007-10#11)(2007-11#23)(2007-12#10)(2007-2#3)(2007-3#2)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#8)(2007-8#89)(2007-9#7)(2008-1#16)(2008-10#32)(2008-11#34)(2008-12#9)(2008-3#2)(2008-4#9)(2008-5#28)(2008-6#4)(2008-7#32)(2008-8#26)(2008-9#27)(2009-10#11)(2009-11#1)(2009-12#6)(2009-2#2)(2009-3#13)(2009-4#4)(2009-5#32)(2009-6#3)(2009-7#5)(2009-8#6)(2009-9#9)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#12)(2010-2#1)(2010-3#2)(2010-4#3)(2010-6#2)(2010-7#11)(2010-8#21)(2010-9#3)(2011-1#15)(2011-12#4)(2011-2#77)(2011-3#1)(2012-1#12)(2012-11#3)(2012-12#46)(2012-2#25)(2012-3#4)(2013-1#42)(2013-7#18)(2013-8#9)
repair&quot##2##1##(1992-12#1)(1993-12#1)
repair)##2##1##(2007-8#1)(2008-7#1)
repair-deficient##6##1##(1991-3#1)(1992-2#1)(1995-1#1)(1997-4#1)(2008-7#2)
repair]##2##1##(2008-10#1)(2011-3#1)
repairable##3##1##(1991-10#1)(1993-3#1)(2009-10#1)
repaired and##2##2##(1992-3#1)(2009-4#1)
repaired by MAS were##2##4##(1996-2#2)
repaired by##16##2##(1992-3#1)(1994-8#1)(1996-2#2)(1996-5#1)(1997-4#1)(2007-7#1)(2007-8#2)(2008-11#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
repaired in the##2##3##(2009-6#1)(2011-2#1)
repaired in##9##2##(1994-3#1)(1997-1#1)(2007-8#1)(2009-10#2)(2009-6#1)(2011-2#3)
repaired the##2##2##(2007-12#1)(2012-1#1)
repaired with a single patch##2##5##(2007-8#2)
repaired with a##4##3##(2007-8#2)(2008-12#1)(2011-2#1)
repaired with the##2##3##(1991-2#1)(2005-5#1)
repaired with##15##2##(1991-10#1)(1991-2#1)(1993-3#1)(1997-1#1)(2005-5#1)(2007-7#1)(2007-8#5)(2008-10#1)(2008-12#1)(2008-4#1)(2011-2#1)
repaired##76##1##(1991-10#1)(1991-2#1)(1991-7#1)(1992-2#1)(1992-3#2)(1993-3#1)(1994-3#1)(1994-8#1)(1996-2#3)(1996-5#2)(1997-1#4)(1997-4#1)(1997-6#1)(2005-5#1)(2006-10#1)(2006-12#3)(2006-4#1)(2007-12#1)(2007-7#2)(2007-8#8)(2008-10#1)(2008-11#3)(2008-12#3)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-7#2)(2011-1#1)(2011-2#6)(2012-1#3)(2012-2#1)(2012-3#3)(2013-1#1)
repairing the##3##2##(1991-9#1)(2007-2#1)(2011-2#1)
repairing these##2##2##(2006-4#1)(2011-2#1)
repairing##24##1##(1990-12#1)(1991-9#1)(1997-6#1)(2005-10#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-11#2)(2007-2#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-3#1)(2012-5#1)(2013-1#2)(2013-7#1)(2013-8#1)
repairs and##2##2##(2008-7#1)(2010-6#1)
repairs in##2##2##(2008-10#1)(2008-9#1)
repairs of##2##2##(2006-12#1)(2008-10#1)
repairs##33##1##(1990-11#2)(1993-1#1)(1995-1#1)(1995-6#1)(1997-4#1)(2004-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-5#4)(2010-6#1)(2011-2#5)(2012-2#2)
repanda##4##1##(2008-10#4)
reparation##5##1##(2008-10#1)(2011-12#1)(2011-2#1)(2013-7#2)
reparative process##3##2##(2006-12#1)(2010-12#1)(2013-1#1)
reparative tissue##6##2##(2006-9#6)
reparative##23##1##(1992-6#2)(2006-12#5)(2006-9#7)(2007-12#1)(2007-8#1)(2008-5#1)(2009-3#1)(2009-9#1)(2010-12#1)(2012-12#2)(2013-1#1)
repartition of##2##2##(2005-11#1)(2008-2#1)
repartition##3##1##(2005-11#1)(2008-2#1)(2009-4#1)
repatriates##3##1##(1994-7#1)(2006-6#2)
repatriation##2##1##(2006-7#2)
repayment##4##1##(1992-5#2)(2008-11#2)
repeal##4##1##(1990-9#1)(1995-5#1)(2006-7#1)(2009-7#1)
repealed##2##1##(1996-5#2)
repeat (LTR)##16##2##(1991-3#1)(1991-5#2)(1992-12#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-8#1)(1996-5#1)(1997-6#1)(1997-8#1)(2008-11#1)(2009-10#1)(2013-8#1)
repeat 2##4##2##(1995-6#1)(1996-8#3)
repeat DNA##3##2##(1995-11#1)(2008-5#1)(2008-8#1)
repeat I##3##2##(1995-2#3)
repeat amplification##4##2##(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)
repeat analysis of pharmacokinetically anomalous samples##2##6##(2010-11#2)
repeat analysis##5##2##(2008-4#1)(2010-11#4)
repeat and a##3##3##(2007-10#1)(2008-11#1)(2008-6#1)
repeat and##9##2##(1990-12#1)(1992-12#1)(1997-5#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-6#2)(2011-1#1)
repeat array##2##2##(1992-11#1)(1997-6#1)
repeat as a##2##3##(1992-8#1)(1995-5#1)
repeat as##3##2##(1990-7#1)(1992-8#1)(1995-5#1)
repeat at the##3##3##(1991-12#1)(2008-10#2)
repeat at##4##2##(1990-7#1)(1991-12#1)(2008-10#2)
repeat biopsy##2##2##(2007-8#1)(2008-1#1)
repeat cesarean##2##2##(1995-12#1)(2006-7#1)
repeat cone biopsy##2##3##(1992-2#2)
repeat domain of##2##3##(1993-12#1)(1995-8#1)
repeat domain##10##2##(1990-11#1)(1993-12#1)(1995-3#2)(1995-8#1)(1996-2#1)(1997-7#1)(2006-10#1)(2008-7#1)(2008-8#1)
repeat duplexes##2##2##(1996-11#2)
repeat element##6##2##(1990-11#3)(1995-1#1)(1995-3#1)(1996-10#1)
repeat expansion##3##2##(1997-3#1)(2004-1#1)(2008-8#1)
repeat expansions in##2##3##(2006-11#1)(2008-8#1)
repeat expansions##4##2##(2006-11#2)(2008-8#2)
repeat found in##3##3##(1991-12#1)(1993-12#1)(1994-9#1)
repeat in the##3##3##(1991-6#1)(1996-7#1)(2008-12#1)
repeat in##9##2##(1990-6#1)(1991-6#1)(1996-4#1)(1996-7#1)(2008-12#1)(2008-6#2)(2008-7#1)(2009-5#1)
repeat instability##2##2##(1997-6#1)(2009-5#1)
repeat is##4##2##(1993-12#1)(1995-1#1)(2008-7#1)(2008-8#1)
repeat length##4##2##(1995-11#2)(1997-3#1)(2012-2#1)
repeat lengths in##3##3##(2004-1#3)
repeat lengths##6##2##(1997-4#1)(2004-1#4)(2012-2#1)
repeat located##2##2##(1993-5#1)(1997-6#1)
repeat measurements##3##2##(2007-8#1)(2009-5#1)(2011-1#1)
repeat median sternotomy##2##3##(2007-8#2)
repeat motif##3##2##(1990-7#1)(1992-7#2)
repeat motifs##6##2##(1990-8#1)(1997-7#1)(2007-6#1)(2012-2#3)
repeat number##5##2##(1997-1#2)(1997-3#1)(2004-1#1)(2013-8#1)
repeat numbers##2##2##(1995-1#1)(1997-3#1)
repeat of human##2##3##(1996-5#1)(2006-10#1)
repeat of the##5##3##(1991-12#1)(1991-2#1)(1992-3#1)(1995-3#1)(2013-8#1)
repeat of##20##2##(1990-6#1)(1991-12#1)(1991-2#1)(1992-3#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-5#1)(2006-10#1)(2006-12#1)(2007-6#1)(2008-10#3)(2008-7#1)(2012-2#1)(2013-8#1)
repeat polymorphism in##2##3##(1997-5#1)(2008-9#1)
repeat polymorphism##5##2##(1995-11#2)(1997-5#2)(2008-9#1)
repeat polymorphisms##3##2##(1994-9#1)(1996-3#2)
repeat prescribing and##2##3##(2008-11#2)
repeat prescribing has not been##2##5##(2008-11#2)
repeat prescribing##5##2##(2008-11#5)
repeat prescription##3##2##(1996-9#1)(2008-11#2)
repeat prescriptions##4##2##(1995-11#1)(2008-11#3)
repeat probe##2##2##(1993-9#1)(1997-7#1)
repeat protein##2##2##(2008-9#1)(2009-8#1)
repeat purchase##2##2##(1993-12#2)
repeat region of the##4##4##(1990-12#1)(1991-7#1)(1992-5#1)(1995-8#1)
repeat region of##5##3##(1990-12#1)(1991-7#1)(1992-5#1)(1995-8#1)(1997-7#1)
repeat region##11##2##(1990-12#1)(1991-7#1)(1991-8#1)(1992-5#1)(1995-8#1)(1997-7#1)(2008-10#3)(2008-6#1)(2010-8#1)
repeat regions##5##2##(1991-8#2)(2008-7#1)(2009-9#1)(2013-8#1)
repeat sequence##12##2##(1993-11#1)(1993-2#1)(1994-8#1)(1995-5#1)(1997-4#2)(1997-7#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)
repeat sequences##14##2##(1991-2#1)(1994-12#1)(1996-4#1)(1997-1#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-8#3)(2009-10#1)(2013-8#1)
repeat smear##2##2##(1992-8#2)
repeat studies##2##2##(2007-10#1)(2009-6#1)
repeat study samples##2##3##(2010-11#2)
repeat study##3##2##(2010-11#3)
repeat surgery for##2##3##(2005-5#1)(2012-3#1)
repeat testing##3##2##(1994-6#2)(2011-2#1)
repeat that##2##2##(1991-5#1)(1997-4#1)
repeat the##6##2##(2006-4#1)(2007-1#2)(2008-2#1)(2012-12#2)
repeat to consultation ratios##2##4##(2008-11#2)
repeat to consultation##3##3##(2008-11#3)
repeat to##5##2##(1992-6#2)(2008-11#3)
repeat unit##6##2##(1993-5#1)(1995-6#1)(1997-2#1)(2008-10#3)
repeat units in##2##3##(1997-6#1)(2008-5#1)
repeat units of##2##3##(2007-12#1)(2009-3#1)
repeat units##14##2##(1994-9#1)(1995-11#1)(1996-7#2)(1997-6#2)(1997-7#2)(2006-10#1)(2007-12#1)(2008-5#2)(2008-7#1)(2009-3#1)
repeat was##2##2##(1992-5#1)(1995-6#1)
repeat were##2##2##(1992-8#2)
repeat which##2##2##(1993-11#1)(1997-1#1)
repeat with##2##2##(1990-11#1)(2008-8#1)
repeat##524##1##(1990-11#5)(1990-12#4)(1990-2#2)(1990-3#1)(1990-4#1)(1990-6#5)(1990-7#3)(1990-8#4)(1991-12#3)(1991-2#5)(1991-3#1)(1991-4#1)(1991-5#5)(1991-6#2)(1991-7#1)(1991-8#4)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#2)(1992-4#2)(1992-5#4)(1992-6#2)(1992-7#3)(1992-8#8)(1992-9#2)(1993-11#4)(1993-12#9)(1993-2#1)(1993-3#2)(1993-5#3)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#4)(1994-12#6)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#5)(1995-1#6)(1995-11#8)(1995-12#1)(1995-2#5)(1995-3#8)(1995-5#2)(1995-6#6)(1995-8#5)(1995-9#1)(1996-1#1)(1996-10#2)(1996-11#4)(1996-12#2)(1996-2#4)(1996-3#5)(1996-4#3)(1996-5#6)(1996-7#7)(1996-8#4)(1996-9#1)(1997-1#4)(1997-2#3)(1997-3#6)(1997-4#6)(1997-5#7)(1997-6#7)(1997-7#11)(1997-8#3)(2004-1#6)(2004-10#1)(2005-11#1)(2005-12#1)(2005-5#2)(2006-10#8)(2006-11#2)(2006-12#2)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#4)(2007-7#1)(2007-8#7)(2007-9#1)(2008-1#4)(2008-10#33)(2008-11#18)(2008-12#14)(2008-2#1)(2008-4#7)(2008-5#11)(2008-6#9)(2008-7#22)(2008-8#14)(2008-9#6)(2009-10#3)(2009-3#2)(2009-5#7)(2009-6#3)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#12)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#11)(2011-12#3)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#8)(2012-3#4)(2013-1#2)(2013-8#6)
repeat)##2##1##(2008-4#1)(2008-7#1)
repeat-containing##5##1##(1992-11#1)(1997-4#3)(2013-8#1)
repeatabilities##4##1##(2007-8#1)(2008-10#2)(2008-3#1)
repeatability (R##4##2##(2007-8#2)(2008-10#2)
repeatability (RSD)##2##2##(2008-10#1)(2012-1#1)
repeatability and recovery##3##3##(2008-10#2)(2013-8#1)
repeatability and reproducibility of the##3##5##(2007-11#1)(2008-10#1)(2008-5#1)
repeatability and reproducibility of##4##4##(2007-11#1)(2008-10#1)(2008-5#2)
repeatability and reproducibility##8##3##(2006-11#3)(2007-11#1)(2008-10#2)(2008-5#2)
repeatability and sensitivity##2##3##(2006-11#1)(2009-11#1)
repeatability and within-laboratory reproducibility##2##4##(2008-10#2)
repeatability and##37##2##(2006-11#4)(2007-11#2)(2007-4#1)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#19)(2008-5#2)(2009-11#1)(2009-4#1)(2012-12#2)(2013-8#1)
repeatability at the##3##3##(2008-10#3)
repeatability coefficients##2##2##(2008-10#1)(2008-4#1)
repeatability for##6##2##(2006-11#1)(2008-10#4)(2008-3#1)
repeatability in##2##2##(2008-10#1)(2013-7#1)
repeatability is##3##2##(2008-10#3)
repeatability of 0##3##3##(2008-10#1)(2008-3#2)
repeatability of determination (R##2##4##(2008-10#2)
repeatability of the measurements##2##4##(2008-10#1)(2008-3#1)
repeatability of the##26##3##(1996-5#1)(2006-11#1)(2007-11#1)(2008-10#19)(2008-2#1)(2008-3#2)(2010-12#1)
repeatability of##54##2##(1996-3#1)(1996-5#1)(2005-12#1)(2006-11#1)(2007-11#1)(2008-10#31)(2008-2#3)(2008-3#7)(2008-5#2)(2008-6#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
repeatability study##2##2##(2008-10#1)(2010-12#1)
repeatability was 0##2##3##(2008-10#2)
repeatability was##6##2##(1994-9#1)(2008-10#5)
repeatability were##4##2##(1997-8#1)(2007-8#1)(2008-10#2)
repeatability with a##2##3##(2007-4#1)(2008-10#1)
repeatability with##3##2##(2007-11#1)(2007-4#1)(2008-10#1)
repeatability##189##1##(1994-9#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-8#1)(2005-12#1)(2006-11#9)(2006-12#1)(2007-1#1)(2007-11#4)(2007-4#4)(2007-5#2)(2007-7#1)(2007-8#7)(2007-9#1)(2008-1#2)(2008-10#113)(2008-2#5)(2008-3#8)(2008-4#1)(2008-5#4)(2008-6#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-12#4)(2010-4#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#2)
repeatable (R##2##2##(2008-10#2)
repeatable and reproducible##6##3##(2008-10#2)(2008-5#2)(2012-2#1)(2012-3#1)
repeatable and##10##2##(1991-5#1)(2005-11#1)(2008-10#2)(2008-5#2)(2008-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
repeatable response##2##2##(2007-4#1)(2007-8#1)
repeatable within##2##2##(2005-11#1)(2008-10#1)
repeatable##41##1##(1991-5#1)(1995-12#1)(2005-11#2)(2006-7#1)(2007-11#2)(2007-2#1)(2007-4#3)(2007-8#4)(2008-10#9)(2008-12#2)(2008-2#3)(2008-5#2)(2008-7#1)(2009-2#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
repeated 6 times##2##3##(1995-8#1)(2012-1#1)
repeated AMPH##2##2##(2013-8#2)
repeated DNA##4##2##(2007-6#1)(2008-10#1)(2008-5#1)(2008-8#1)
repeated MAP##2##2##(1996-10#2)
repeated additions of##2##3##(1994-8#1)(2008-7#1)
repeated administration of##8##3##(1993-2#2)(1994-2#1)(1995-12#1)(1995-5#1)(1996-10#1)(1996-12#1)(1997-5#1)
repeated administration##13##2##(1993-2#2)(1994-2#1)(1995-12#2)(1995-5#1)(1996-10#2)(1996-12#1)(1997-5#1)(2007-1#1)(2008-11#1)(2010-12#1)
repeated administrations of##2##3##(1996-10#1)(2012-1#1)
repeated administrations##4##2##(1996-10#3)(2012-1#1)
repeated after##8##2##(1990-10#1)(1993-7#1)(1995-12#1)(1995-7#1)(2006-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
repeated amphetamine administration##2##3##(1991-5#1)(2008-4#1)
repeated amphetamine##4##2##(1991-5#1)(1993-6#1)(1997-7#1)(2008-4#1)
repeated analysis##3##2##(2007-10#1)(2008-10#2)
repeated and dispersed##2##3##(1996-7#2)
repeated and prolonged##2##3##(2008-10#1)(2010-8#1)
repeated and##9##2##(1996-7#2)(1997-6#1)(1997-7#2)(2004-10#1)(2008-10#1)(2008-7#1)(2010-8#1)
repeated application of##4##3##(2007-12#2)(2008-5#2)
repeated applications of##3##3##(1990-7#1)(2013-1#2)
repeated applications##4##2##(1990-7#1)(2008-8#1)(2013-1#2)
repeated as##4##2##(1990-6#1)(1991-12#1)(2006-10#1)(2009-6#1)
repeated aspirating/dispensing cycles##2##3##(2008-10#2)
repeated assays##2##2##(1992-3#1)(2007-8#1)
repeated at the##4##3##(1992-3#1)(1995-8#1)(2007-9#1)(2012-1#1)
repeated at##9##2##(1991-11#1)(1992-3#1)(1995-8#1)(2006-8#1)(2007-9#1)(2008-10#1)(2012-1#1)(2013-1#2)
repeated attacks of##6##3##(1995-5#1)(2005-8#1)(2006-10#1)(2007-3#1)(2009-7#2)
repeated attacks##7##2##(1995-5#1)(2005-8#1)(2006-10#1)(2007-3#1)(2009-7#3)
repeated attempts##2##2##(2007-7#1)(2010-12#1)
repeated batch cultures##3##3##(2008-11#2)(2008-6#1)
repeated batch##10##2##(1994-5#2)(2008-11#3)(2008-6#2)(2008-7#2)(2013-1#1)
repeated batches##2##2##(1994-5#1)(2011-1#1)
repeated blood transfusions##2##3##(2008-1#1)(2013-8#1)
repeated blood##5##2##(1993-10#1)(2007-12#1)(2008-1#1)(2011-2#1)(2013-8#1)
repeated by##2##2##(2006-10#1)(2008-11#1)
repeated cocaine administration##4##3##(1994-2#1)(1996-12#1)(2011-2#2)
repeated cocaine injections##2##3##(1995-12#1)(1996-10#1)
repeated cocaine##9##2##(1994-2#2)(1994-6#1)(1995-12#2)(1996-10#1)(1996-12#1)(2011-2#2)
repeated contractions##3##2##(2005-1#2)(2008-9#1)
repeated courses##2##2##(1992-8#1)(2008-6#1)
repeated cross-sectional##2##2##(1997-4#1)(2013-1#1)
repeated cycles of##4##3##(1991-6#1)(1992-8#1)(2008-10#1)(2010-7#1)
repeated cycles##6##2##(1991-6#1)(1992-8#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-7#1)
repeated daily administration of##2##4##(1993-2#1)(1997-8#1)
repeated daily for##2##3##(1994-2#1)(2007-10#1)
repeated daily##5##2##(1991-2#1)(1993-2#1)(1994-2#1)(1997-8#1)(2007-10#1)
repeated defeat##2##2##(1994-6#2)
repeated dose oral##2##3##(2013-1#2)
repeated dose##3##2##(2008-5#1)(2013-1#2)
repeated doses of##4##3##(2004-12#3)(2012-2#1)
repeated doses##8##2##(1991-11#1)(2004-12#4)(2005-7#1)(2008-5#1)(2012-2#1)
repeated drainage##2##2##(2010-9#1)(2013-8#1)
repeated episodes of##6##3##(2006-4#1)(2007-2#1)(2007-7#1)(2007-8#1)(2010-12#1)(2012-2#1)
repeated events##3##2##(2007-7#1)(2008-9#1)(2012-1#1)
repeated every 21 days##3##4##(1991-4#1)(2008-10#1)(2008-6#1)
repeated every 3 weeks##4##4##(2004-1#1)(2007-10#1)(2008-10#1)(2008-7#1)
repeated every##12##2##(1990-2#1)(1991-4#1)(1992-2#1)(2004-1#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-6#2)(2008-7#1)
repeated examinations##2##2##(1995-5#1)(2006-11#1)
repeated experience of##2##3##(2013-7#2)
repeated experience##3##2##(2012-1#1)(2013-7#2)
repeated exposure to##9##3##(1993-12#3)(1995-10#1)(2008-7#1)(2012-1#1)(2012-2#3)
repeated exposure##12##2##(1992-6#1)(1993-12#3)(1995-10#1)(2008-10#1)(2008-7#1)(2012-1#1)(2012-2#4)
repeated exposures to##2##3##(2008-10#1)(2012-3#1)
repeated exposures##4##2##(2006-4#1)(2008-10#2)(2012-3#1)
repeated fasting/refeeding##3##2##(2012-3#3)
repeated for##5##2##(1992-7#1)(1995-12#1)(2008-11#1)(2008-5#1)(2011-2#1)
repeated four times##2##3##(2008-11#1)(2010-12#1)
repeated gentle##2##2##(1992-7#2)
repeated haemorrhage##2##2##(1997-6#1)(2008-7#1)
repeated in reverse order##2##4##(1993-2#1)(2008-10#1)
repeated in##14##2##(1991-8#1)(1993-1#1)(1993-2#1)(1994-8#1)(1997-3#1)(2006-9#1)(2007-11#2)(2008-10#2)(2008-5#1)(2008-9#1)(2010-6#1)(2011-1#1)
repeated infections##2##2##(1994-3#1)(1997-4#1)
repeated injection of##3##3##(1993-3#2)(2008-8#1)
repeated injection##5##2##(1993-3#2)(2008-11#1)(2008-12#1)(2008-8#1)
repeated injections of##7##3##(1991-5#1)(1993-3#1)(1997-8#1)(2008-10#2)(2008-4#1)(2009-3#1)
repeated injections##8##2##(1991-5#1)(1993-3#1)(1997-8#1)(2008-10#2)(2008-4#1)(2009-3#1)(2013-8#1)
repeated intermittent##2##2##(1996-10#1)(2013-8#1)
repeated ischemia##2##2##(1996-12#1)(1997-8#1)
repeated isolation of##2##3##(2013-8#2)
repeated measure experiment with nesting factors##2##6##(2013-1#2)
repeated measure##5##2##(2007-10#1)(2009-9#1)(2012-12#1)(2013-1#2)
repeated measurement##5##2##(1994-2#1)(1996-12#1)(2007-7#1)(2012-2#2)
repeated measurements made##2##3##(1990-8#1)(2007-12#1)
repeated measurements of##5##3##(1992-9#1)(2008-10#2)(2008-7#1)(2008-9#1)
repeated measurements on##3##3##(1996-3#2)(2008-3#1)
repeated measurements##21##2##(1990-8#1)(1992-9#2)(1993-2#1)(1993-9#1)(1996-3#2)(2007-12#2)(2008-10#5)(2008-3#1)(2008-7#1)(2008-9#1)(2010-2#2)(2012-2#1)(2013-1#1)
repeated measures ANOVA and##2##4##(2008-5#1)(2009-3#1)
repeated measures ANOVA##5##3##(1994-8#1)(2008-5#3)(2009-3#1)
repeated measures analysis of variance##3##5##(1994-8#1)(2010-9#1)(2013-1#1)
repeated measures analysis##4##3##(1994-8#1)(2008-10#1)(2010-9#1)(2013-1#1)
repeated measures and##4##3##(1994-8#1)(1997-3#1)(2008-12#1)(2008-9#1)
repeated measures data##6##3##(1994-8#3)(1994-9#1)(1995-4#1)(1997-7#1)
repeated measures design##5##3##(1993-3#1)(1996-3#1)(2007-10#1)(2008-10#1)(2010-12#1)
repeated measures studies##3##3##(1992-9#1)(1994-6#2)
repeated measures was##2##3##(1996-2#1)(2013-8#1)
repeated measures with##2##3##(2010-10#1)(2013-1#1)
repeated measures##46##2##(1992-6#2)(1992-9#3)(1993-12#1)(1993-3#1)(1993-5#1)(1994-6#2)(1994-8#7)(1994-9#2)(1995-4#1)(1996-2#3)(1996-3#1)(1997-3#4)(1997-7#1)(2007-10#1)(2008-10#3)(2008-12#1)(2008-5#3)(2008-9#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-9#1)(2013-1#3)(2013-8#1)
repeated mechanical##3##2##(2007-12#1)(2008-10#1)(2008-8#1)
repeated microdialysis##2##2##(1996-12#2)
repeated motifs in the##2##4##(1991-7#1)(2009-5#1)
repeated motifs##5##2##(1990-3#1)(1991-7#1)(2007-6#1)(2009-5#2)
repeated nicotine administration##3##3##(1991-1#1)(1991-11#2)
repeated nicotine##4##2##(1991-1#1)(1991-11#2)(2007-10#1)
repeated observations##3##2##(1996-3#1)(2009-12#1)(2010-2#1)
repeated on##6##2##(1990-2#1)(1994-6#1)(1994-7#1)(1996-3#1)(2008-10#2)
repeated once##3##2##(2007-11#1)(2007-7#1)(2010-8#1)
repeated or chronic##2##3##(2010-12#2)
repeated or##3##2##(1991-11#1)(2010-12#2)
repeated oral administration##3##3##(1995-3#1)(2008-10#1)(2013-1#1)
repeated plasma##2##2##(1993-2#1)(1997-7#1)
repeated pregnancies##2##2##(2007-11#1)(2010-12#1)
repeated psychiatric occupational therapy##2##4##(2012-1#2)
repeated restraint stress##5##3##(1993-2#1)(2010-12#4)
repeated sequence##7##2##(1990-7#1)(1990-8#1)(1991-5#1)(1992-6#1)(1993-11#1)(1994-9#1)(2008-8#1)
repeated sequences##11##2##(1990-1#2)(1990-11#1)(1991-10#1)(1992-7#2)(1995-1#1)(1995-6#1)(1996-6#1)(2008-10#1)(2008-5#1)
repeated sessions of##2##3##(1992-3#1)(1996-8#1)
repeated several times##2##3##(2005-10#1)(2006-6#1)
repeated short##2##2##(1990-10#1)(2008-11#1)
repeated short-term##3##2##(1995-2#1)(1997-2#2)
repeated stereotactic##2##2##(2008-7#2)
repeated stimulation##2##2##(1995-12#1)(2012-2#1)
repeated stress##5##2##(1995-12#2)(2010-12#3)
repeated surgery in##3##3##(1991-6#1)(2007-7#2)
repeated surgery##4##2##(1991-6#1)(2007-7#2)(2010-12#1)
repeated surgical##4##2##(2006-12#1)(2007-8#1)(2011-1#1)(2012-12#1)
repeated testing##4##2##(1993-6#2)(2007-1#1)(2007-4#1)
repeated the##8##2##(1992-7#1)(1997-3#1)(2008-10#1)(2011-2#1)(2013-1#3)(2013-8#1)
repeated three times##5##3##(1990-8#1)(1994-2#1)(1997-2#1)(2005-1#1)(2008-10#1)
repeated three##7##2##(1990-8#1)(1994-2#1)(1997-2#1)(2005-1#1)(2007-11#1)(2008-10#1)(2013-1#1)
repeated to##2##2##(2006-11#1)(2007-9#1)
repeated treatment with##2##3##(1995-12#2)
repeated treatment##5##2##(1990-6#1)(1995-12#2)(2008-7#1)(2011-2#1)
repeated treatments##4##2##(2006-6#1)(2008-10#1)(2008-3#1)(2012-2#1)
repeated twice within##2##3##(1996-6#1)(2009-4#1)
repeated twice##6##2##(1994-9#1)(1996-6#1)(2006-6#1)(2008-5#1)(2009-4#1)(2013-1#1)
repeated until##3##2##(1997-6#1)(2008-1#1)(2008-11#1)
repeated use of##3##3##(2007-2#1)(2008-5#1)(2011-2#1)
repeated use##9##2##(1993-12#1)(1994-3#1)(2007-2#1)(2008-10#3)(2008-5#1)(2011-2#1)(2012-1#1)
repeated using the##2##3##(2012-1#1)(2013-1#1)
repeated using##3##2##(2008-11#1)(2012-1#1)(2013-1#1)
repeated washing##2##2##(1992-7#1)(2008-5#1)
repeated with the##2##3##(2007-3#1)(2012-12#1)
repeated with##6##2##(1992-6#1)(1992-8#1)(2007-2#1)(2007-3#1)(2011-3#1)(2012-12#1)
repeated words##3##2##(2006-3#3)
repeated##776##1##(1990-1#2)(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#4)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#2)(1990-7#3)(1990-8#3)(1991-1#1)(1991-10#1)(1991-11#8)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#6)(1992-4#1)(1992-6#8)(1992-7#11)(1992-8#3)(1992-9#5)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#7)(1993-2#8)(1993-3#5)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#9)(1994-3#4)(1994-5#3)(1994-6#8)(1994-7#2)(1994-8#10)(1994-9#6)(1995-1#1)(1995-10#1)(1995-12#12)(1995-2#4)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#8)(1995-9#3)(1996-10#12)(1996-12#9)(1996-2#5)(1996-3#6)(1996-4#4)(1996-5#1)(1996-6#5)(1996-7#2)(1996-8#3)(1997-2#6)(1997-3#7)(1997-4#7)(1997-5#1)(1997-6#5)(1997-7#7)(1997-8#6)(2004-1#1)(2004-10#1)(2004-12#5)(2005-1#4)(2005-10#2)(2005-11#4)(2005-7#1)(2005-8#1)(2006-10#5)(2006-11#2)(2006-12#3)(2006-3#6)(2006-4#2)(2006-5#2)(2006-6#4)(2006-7#1)(2006-8#5)(2006-9#1)(2007-1#3)(2007-10#11)(2007-11#8)(2007-12#13)(2007-2#7)(2007-3#4)(2007-4#1)(2007-6#2)(2007-7#16)(2007-8#7)(2007-9#3)(2008-1#6)(2008-10#58)(2008-11#16)(2008-12#6)(2008-2#6)(2008-3#9)(2008-4#6)(2008-5#22)(2008-6#8)(2008-7#21)(2008-8#9)(2008-9#9)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#4)(2010-1#1)(2010-10#1)(2010-12#23)(2010-2#8)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#4)(2010-9#3)(2011-1#7)(2011-2#16)(2011-3#1)(2012-1#11)(2012-12#7)(2012-2#19)(2012-3#13)(2013-1#35)(2013-7#3)(2013-8#13)
repeated-measures analysis of##2##3##(2012-2#1)(2013-1#1)
repeated-measures##6##1##(1995-4#1)(2007-4#1)(2008-3#1)(2008-5#1)(2012-2#1)(2013-1#1)
repeated-noun##2##1##(2007-12#2)
repeated-series longitudinal data##2##3##(1997-2#2)
repeatedly administered for##2##3##(1996-10#1)(2012-3#1)
repeatedly and##5##2##(1991-3#1)(1994-6#1)(2007-2#1)(2008-10#1)(2012-3#1)
repeatedly applied##3##2##(2007-12#1)(2008-10#1)(2013-1#1)
repeatedly associated with##2##3##(1992-8#1)(2012-2#1)
repeatedly been linked to##2##4##(2007-1#1)(2008-7#1)
repeatedly been##5##2##(1993-11#1)(1996-3#1)(2007-1#1)(2008-7#1)(2011-2#1)
repeatedly by##3##2##(1990-7#1)(1991-8#1)(1994-8#1)
repeatedly developed##2##2##(2007-7#1)(2012-12#1)
repeatedly exposed to##7##3##(1992-3#1)(1993-12#4)(1995-5#1)(2004-9#1)
repeatedly for##4##2##(2008-10#2)(2008-6#1)(2009-4#1)
repeatedly from##2##2##(1995-1#1)(2008-1#1)
repeatedly implicated##2##2##(2009-8#1)(2012-12#1)
repeatedly in##5##2##(1990-10#1)(1996-3#1)(2008-10#2)(2008-9#1)
repeatedly injected##2##2##(1991-8#1)(2008-10#1)
repeatedly isolated from the##2##4##(2007-12#1)(2008-5#1)
repeatedly negative##2##2##(2005-11#1)(2007-7#1)
repeatedly observed##3##2##(1992-5#1)(2007-9#1)(2008-7#1)
repeatedly over time##3##3##(1994-2#1)(2008-9#1)(2010-1#1)
repeatedly over##5##2##(1991-12#1)(1994-2#1)(2005-11#1)(2008-9#1)(2010-1#1)
repeatedly showed##2##2##(1993-7#1)(1994-12#1)
repeatedly shown##3##2##(1995-12#1)(2008-10#1)(2010-10#1)
repeatedly to##2##2##(1994-9#1)(1996-12#1)
repeatedly with the##2##3##(1993-3#1)(1994-9#1)
repeatedly with##5##2##(1991-6#1)(1993-3#1)(1994-9#1)(2007-12#1)(2008-3#1)
repeatedly##128##1##(1990-10#2)(1990-7#2)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-10#1)(1996-12#3)(1996-3#2)(1997-1#1)(1997-5#1)(1997-8#1)(2004-9#1)(2005-11#2)(2005-4#1)(2006-12#1)(2007-1#1)(2007-12#6)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-4#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-8#1)(2010-9#1)(2011-2#2)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#2)(2013-8#1)
repeaters##2##1##(2008-2#1)(2008-3#1)
repeating pattern of##2##3##(1992-9#1)(2008-7#1)
repeating sequences##2##2##(2006-8#1)(2010-8#1)
repeating the procedure##2##3##(2006-5#1)(2006-6#1)
repeating the##8##2##(2006-5#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-9#1)(2012-3#1)
repeating unit of the antigen from Klebsiella type 2##2##9##(1995-11#2)
repeating unit of the##3##4##(1995-11#2)(1996-2#1)
repeating unit of##4##3##(1990-3#1)(1995-11#2)(1996-2#1)
repeating unit##12##2##(1990-3#1)(1990-4#1)(1991-12#1)(1991-7#1)(1992-12#1)(1994-11#1)(1995-11#2)(1995-4#1)(1996-2#1)(2007-11#1)(2009-7#1)
repeating units of##2##3##(1995-11#1)(1995-6#1)
repeating units there was one##2##5##(2008-10#2)
repeating units##13##2##(1991-10#1)(1992-12#1)(1994-11#1)(1994-9#1)(1995-11#2)(1995-4#1)(1995-6#1)(1996-9#1)(2008-10#2)(2012-12#2)
repeating##59##1##(1990-12#1)(1990-3#1)(1990-4#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-12#3)(1992-4#1)(1992-9#1)(1993-11#1)(1994-11#2)(1994-12#1)(1994-9#1)(1995-11#4)(1995-2#1)(1995-4#2)(1995-6#1)(1996-11#1)(1996-2#1)(1996-9#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-6#1)(2008-10#4)(2008-2#3)(2008-4#2)(2008-7#2)(2008-9#2)(2009-7#1)(2010-8#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)
repeating-unit##2##1##(1991-9#1)(1996-2#1)
repeats and four##2##3##(2006-2#1)(2008-10#1)
repeats and several##2##3##(1993-12#1)(1995-12#1)
repeats and the##2##3##(1990-11#1)(1995-6#1)
repeats and two domains##2##4##(1990-7#1)(2008-7#1)
repeats and##24##2##(1990-11#1)(1990-7#1)(1991-12#1)(1992-5#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-7#1)(2006-2#1)(2008-10#2)(2008-4#2)(2008-7#3)
repeats are present##2##3##(1993-9#2)
repeats are##14##2##(1992-2#1)(1992-7#1)(1993-9#4)(1995-3#1)(1995-8#2)(1996-10#1)(1996-11#1)(1997-6#1)(2008-7#1)(2010-3#1)
repeats as##2##2##(1997-6#1)(2008-10#1)
repeats by##2##2##(1990-5#1)(1996-5#1)
repeats containing##2##2##(1994-12#1)(1995-8#1)
repeats for##2##2##(1996-4#1)(2008-3#1)
repeats in the##12##3##(1990-8#1)(1991-2#1)(1992-1#2)(1992-11#1)(1995-5#1)(1996-8#1)(1997-5#1)(2007-6#2)(2008-7#1)(2011-2#1)
repeats in##25##2##(1990-12#1)(1990-8#1)(1991-2#1)(1992-1#3)(1992-11#2)(1993-12#1)(1993-8#1)(1995-5#1)(1996-8#1)(1997-5#1)(2004-1#1)(2006-12#1)(2007-6#3)(2008-10#1)(2008-7#1)(2009-3#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
repeats is##3##2##(1992-1#1)(1992-10#1)(1995-8#1)
repeats located##2##2##(2008-10#1)(2008-11#1)
repeats may##2##2##(1994-11#1)(2008-8#1)
repeats of a##7##3##(1990-5#1)(1991-5#1)(1992-10#1)(1994-12#1)(1997-7#1)(2007-2#1)(2012-11#1)
repeats of the sequence##2##4##(1991-9#1)(1993-9#1)
repeats of the##10##3##(1991-7#1)(1991-9#1)(1992-11#1)(1993-9#2)(1994-12#1)(1995-2#1)(1995-8#1)(1996-6#1)(2008-10#1)
repeats of##41##2##(1990-5#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-6#2)(1993-9#2)(1994-12#3)(1994-3#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-3#4)(1995-6#1)(1995-8#2)(1996-4#1)(1996-6#1)(1997-2#1)(1997-7#1)(2007-2#1)(2007-6#1)(2008-10#4)(2008-5#2)(2008-8#1)(2011-12#1)(2012-11#1)(2013-8#1)
repeats on##2##2##(2006-10#1)(2010-3#1)
repeats that are##3##3##(1992-12#1)(2012-3#1)(2013-1#1)
repeats that##6##2##(1990-9#1)(1992-12#1)(1995-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
repeats was##4##2##(1992-1#1)(1995-8#1)(2008-10#1)(2008-5#1)
repeats were found in##2##4##(1997-5#1)(2007-6#1)
repeats were identified##2##3##(1992-1#1)(1992-7#1)
repeats were##10##2##(1992-1#1)(1992-3#1)(1992-7#1)(1993-11#1)(1997-5#1)(2006-2#2)(2007-6#1)(2008-10#1)(2011-12#1)
repeats which##2##2##(1990-8#1)(1991-12#1)
repeats with##3##2##(1992-1#1)(1995-8#1)(2008-7#1)
repeats within the##3##3##(1995-6#1)(1997-5#1)(2008-7#1)
repeats within##5##2##(1994-11#1)(1995-2#1)(1995-6#1)(1997-5#1)(2008-7#1)
repeats##310##1##(1990-11#4)(1990-12#2)(1990-3#1)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-11#1)(1991-12#8)(1991-2#3)(1991-5#3)(1991-7#4)(1991-8#1)(1991-9#1)(1992-1#11)(1992-10#2)(1992-11#4)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#4)(1993-11#4)(1993-12#5)(1993-6#2)(1993-8#3)(1993-9#10)(1994-11#6)(1994-12#8)(1994-3#1)(1994-5#2)(1994-8#7)(1994-9#4)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#7)(1995-5#1)(1995-6#5)(1995-8#15)(1996-10#2)(1996-11#5)(1996-2#1)(1996-4#2)(1996-5#2)(1996-6#3)(1996-7#1)(1996-8#4)(1997-2#2)(1997-3#2)(1997-4#3)(1997-5#5)(1997-6#4)(1997-7#2)(2004-1#2)(2004-10#1)(2006-10#1)(2006-12#1)(2006-2#3)(2007-12#1)(2007-2#3)(2007-6#12)(2008-10#21)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#15)(2008-8#6)(2009-3#3)(2009-5#1)(2010-3#3)(2010-7#2)(2011-1#2)(2011-12#2)(2011-2#2)(2012-1#3)(2012-11#1)(2012-2#6)(2012-3#1)(2013-1#2)(2013-8#4)
repeats)##4##1##(1994-3#1)(1997-5#2)(2012-1#1)
repel##3##1##(2004-11#1)(2007-12#2)
repelled from the##2##3##(2008-10#1)(2008-5#1)
repelled##3##1##(2004-11#1)(2008-10#1)(2008-5#1)
repellency##6##1##(2008-2#1)(2008-5#1)(2011-2#4)
repellent formulations##2##2##(2008-5#2)
repellent##11##1##(2004-11#1)(2008-10#3)(2008-2#1)(2008-5#3)(2009-8#2)(2010-8#1)
repellents##14##1##(2004-11#2)(2006-4#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-2#3)(2011-2#3)(2013-8#1)
repens##10##1##(2005-11#2)(2008-10#1)(2011-1#1)(2013-1#6)
repercussion in##3##2##(1991-11#1)(2008-10#1)(2011-2#1)
repercussion##8##1##(1991-11#1)(2008-10#3)(2008-11#2)(2008-9#1)(2011-2#1)
repercussions for##2##2##(2008-11#1)(2012-1#1)
repercussions of##5##2##(2004-3#1)(2006-8#1)(2007-9#1)(2008-1#1)(2008-6#1)
repercussions on##5##2##(1996-3#1)(2006-10#1)(2008-12#1)(2009-7#1)(2011-1#1)
repercussions##17##1##(1991-11#1)(1991-2#1)(1996-3#1)(2004-3#1)(2006-10#1)(2006-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-1#1)
reperfused##13##1##(1991-9#1)(1995-12#1)(1996-5#2)(1996-9#1)(2007-8#3)(2008-12#1)(2009-10#1)(2011-1#1)(2012-12#1)(2013-7#1)
reperfusion and##6##2##(1990-12#1)(1996-12#1)(2007-8#1)(2008-3#1)(2012-3#1)(2013-1#1)
reperfusion damage##4##2##(1991-9#1)(1993-12#1)(1994-3#1)(2008-10#1)
reperfusion following##5##2##(1991-2#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-8#1)
reperfusion for 240 min##2##4##(2010-1#2)
reperfusion for##5##2##(1990-7#1)(1993-3#1)(1995-12#1)(2010-1#2)
reperfusion in the##4##3##(1994-10#1)(1994-5#1)(2007-9#2)
reperfusion in##10##2##(1990-3#1)(1994-10#1)(1994-5#1)(1997-1#1)(2007-10#4)(2007-9#2)
reperfusion induced##3##2##(1995-12#1)(1995-6#1)(2012-3#1)
reperfusion injury and##2##3##(1992-9#1)(2006-10#1)
reperfusion injury in##5##3##(1990-3#1)(2005-8#1)(2006-10#1)(2008-1#1)(2013-1#1)
reperfusion injury is##2##3##(1997-1#1)(2012-2#1)
reperfusion injury##38##2##(1990-3#1)(1991-8#1)(1991-9#3)(1992-9#3)(1993-12#1)(1993-3#1)(1996-2#1)(1997-1#2)(2004-11#1)(2005-8#2)(2005-9#1)(2006-10#6)(2007-10#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-12#1)(2009-6#1)(2010-1#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#4)
reperfusion is##2##2##(1997-1#1)(2008-10#1)
reperfusion may result in##2##4##(1997-1#1)(2006-10#1)
reperfusion may##3##2##(1994-5#1)(1997-1#1)(2006-10#1)
reperfusion of ischaemic##2##3##(1997-1#2)
reperfusion of the##3##3##(1996-9#1)(2007-9#1)(2011-1#1)
reperfusion of##10##2##(1996-5#1)(1996-9#2)(1997-1#2)(2005-8#1)(2007-9#1)(2008-7#1)(2010-12#1)(2011-1#1)
reperfusion period##6##2##(1994-5#1)(2005-8#1)(2007-8#1)(2007-9#1)(2010-12#1)(2013-1#1)
reperfusion provides##2##2##(2008-3#1)(2010-3#1)
reperfusion rates##2##2##(2007-10#1)(2007-11#1)
reperfusion reduced##2##2##(1995-7#1)(2011-2#1)
reperfusion resulted in##2##3##(1992-7#2)
reperfusion therapy for##2##3##(1997-8#1)(2008-3#1)
reperfusion therapy##12##2##(1997-8#1)(2008-3#10)(2009-5#1)
reperfusion was performed##2##3##(1996-9#1)(2010-2#1)
reperfusion was##8##2##(1990-11#1)(1991-9#1)(1993-4#1)(1994-5#2)(1996-9#1)(1997-1#1)(2010-2#1)
reperfusion with##2##2##(2007-11#1)(2013-7#1)
reperfusion##250##1##(1990-11#1)(1990-12#2)(1990-3#3)(1990-7#1)(1991-2#2)(1991-8#1)(1991-9#9)(1992-3#4)(1992-7#5)(1992-9#4)(1993-12#4)(1993-3#3)(1993-4#3)(1993-7#1)(1994-10#2)(1994-3#1)(1994-5#8)(1995-12#5)(1995-6#5)(1995-7#2)(1996-10#2)(1996-12#3)(1996-2#1)(1996-5#6)(1996-8#1)(1996-9#14)(1997-1#10)(1997-5#1)(1997-6#1)(1997-8#6)(2004-11#1)(2005-8#5)(2005-9#1)(2006-10#8)(2006-7#1)(2007-10#11)(2007-11#3)(2007-8#17)(2007-9#13)(2008-1#1)(2008-10#10)(2008-12#2)(2008-3#16)(2008-4#2)(2008-5#1)(2008-7#2)(2009-12#2)(2009-5#1)(2009-6#1)(2010-1#5)(2010-12#8)(2010-2#1)(2010-3#3)(2010-6#1)(2010-7#3)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#1)
reperfusion)##4##1##(1993-7#1)(1995-12#1)(2011-2#1)(2012-2#1)
repertoire and##3##2##(1997-6#1)(2010-8#1)(2012-2#1)
repertoire expansion##3##2##(2013-1#3)
repertoire in##4##2##(1994-11#1)(1995-2#2)(2008-1#1)
repertoire is##2##2##(2010-7#1)(2013-1#1)
repertoire of B cells##3##4##(2008-11#3)
repertoire of behaviors##2##3##(2008-10#1)(2012-2#1)
repertoire of responses##2##3##(2009-12#1)(2012-12#1)
repertoire of the##7##3##(1996-12#1)(1997-9#1)(2006-12#1)(2007-1#1)(2008-11#1)(2011-2#1)(2013-8#1)
repertoire of##40##2##(1991-2#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-12#1)(1997-4#1)(1997-7#2)(1997-9#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-12#1)(2006-9#2)(2007-1#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#6)(2008-3#1)(2008-4#2)(2008-7#1)(2009-12#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#1)
repertoire or##2##2##(1994-2#1)(2010-11#1)
repertoire##89##1##(1990-6#1)(1991-12#1)(1991-2#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-7#1)(1996-11#2)(1996-12#1)(1997-4#3)(1997-6#1)(1997-7#3)(1997-9#1)(2004-12#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-12#2)(2006-9#2)(2007-1#1)(2007-3#1)(2008-1#2)(2008-10#4)(2008-11#8)(2008-3#1)(2008-4#5)(2008-7#5)(2008-9#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#4)
repertoires of##5##2##(1995-2#1)(1995-7#1)(2008-11#2)(2008-7#1)
repertoires that##2##2##(1997-4#1)(2010-3#1)
repertoires##22##1##(1994-12#2)(1995-2#1)(1995-7#4)(1997-4#1)(2006-10#1)(2007-12#1)(2008-11#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2010-2#2)(2010-3#1)
repetition detection##2##2##(2013-8#2)
repetition effects##2##2##(2012-2#2)
repetition frequencies##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
repetition frequency of a##2##4##(2007-12#2)
repetition frequency of##7##3##(2007-12#6)(2008-3#1)
repetition frequency##20##2##(2007-11#2)(2007-12#11)(2008-2#1)(2008-3#5)(2011-1#1)
repetition of the##3##3##(2007-11#1)(2008-7#2)
repetition of##17##2##(1992-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#2)(2009-6#1)(2011-2#2)(2013-1#1)
repetition priming to##2##3##(2010-7#2)
repetition priming##4##2##(2008-4#1)(2010-7#3)
repetition rate and a##2##4##(2007-12#2)
repetition rate and its##2##4##(2007-11#1)(2007-12#1)
repetition rate and##8##3##(2007-11#3)(2007-12#3)(2008-1#1)(2011-1#1)
repetition rate are##5##3##(2007-11#2)(2007-12#2)(2008-2#1)
repetition rate by##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
repetition rate for a##2##4##(2008-3#2)
repetition rate from##2##3##(2007-12#1)(2008-1#1)
repetition rate in##2##3##(2007-12#1)(2008-3#1)
repetition rate is reported##2##4##(2007-12#1)(2008-2#1)
repetition rate is##6##3##(2007-12#5)(2008-2#1)
repetition rate of the##4##4##(2007-11#1)(2008-3#3)
repetition rate of##57##3##(1991-8#1)(2007-11#10)(2007-12#26)(2008-1#3)(2008-2#3)(2008-3#13)(2012-11#1)
repetition rate that##2##3##(2007-11#1)(2007-12#1)
repetition rate with##5##3##(2007-12#2)(2008-2#2)(2008-3#1)
repetition rate##154##2##(1991-8#1)(2007-11#28)(2007-12#77)(2008-1#9)(2008-11#1)(2008-2#12)(2008-3#23)(2010-1#1)(2011-1#1)(2012-11#1)
repetition rates and##3##3##(2007-12#2)(2008-2#1)
repetition rates are##2##3##(2007-11#1)(2007-12#1)
repetition rates in the##2##4##(2007-12#2)
repetition rates of##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
repetition rates##23##2##(2007-11#3)(2007-12#13)(2008-2#2)(2008-3#5)
repetition##247##1##(1991-8#1)(1992-1#1)(1992-2#1)(1995-12#1)(1996-3#1)(1996-4#2)(1996-6#1)(1997-7#1)(1997-8#1)(2005-8#1)(2007-11#36)(2007-12#103)(2008-1#9)(2008-10#3)(2008-11#1)(2008-2#17)(2008-3#37)(2008-4#3)(2008-7#2)(2008-9#2)(2009-11#2)(2009-6#1)(2010-1#1)(2010-4#1)(2010-7#3)(2011-1#3)(2011-2#3)(2012-1#2)(2012-11#1)(2012-2#2)(2013-1#1)(2013-8#3)
repetition-rate##13##1##(2007-11#4)(2007-12#8)(2008-3#1)
repetition-rate-doubling rational-harmonic##3##2##(2007-12#3)
repetitions of the##2##3##(1994-2#1)(2008-11#1)
repetitions of##7##2##(1992-4#1)(1994-2#1)(1995-11#1)(2008-11#1)(2009-3#1)(2010-1#1)(2012-12#1)
repetitions were completed##2##3##(2010-1#2)
repetitions were##3##2##(2008-10#1)(2010-1#2)
repetitions##19##1##(1990-1#1)(1990-11#1)(1992-4#1)(1994-2#1)(1995-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2009-3#1)(2010-1#3)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
repetitious##2##1##(2011-12#1)(2012-11#1)
repetitive Ca2+##2##2##(1990-11#1)(1993-6#1)
repetitive DNA elements##2##3##(1991-9#1)(1995-8#1)
repetitive DNA family##2##3##(1995-2#1)(2008-5#1)
repetitive DNA sequences##11##3##(1990-5#1)(1992-8#2)(1994-9#1)(1997-4#1)(2008-10#3)(2008-9#1)(2011-12#2)
repetitive DNA##24##2##(1990-5#1)(1991-9#1)(1992-8#2)(1993-11#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-4#1)(2008-10#8)(2008-11#1)(2008-5#2)(2008-9#1)(2011-12#2)
repetitive SIB##2##2##(2008-11#2)
repetitive Transcranial Magnetic Stimulation (rTMS)##2##5##(2008-12#1)(2011-2#1)
repetitive and##8##2##(1997-3#1)(2006-10#1)(2007-6#1)(2008-10#4)(2008-4#1)
repetitive applications of Pseudomonas putida 06909-rif/nal##2##6##(2008-10#2)
repetitive behavior##2##2##(2009-4#1)(2011-2#1)
repetitive calcium signals##2##3##(2006-10#2)
repetitive calcium##3##2##(2006-10#3)
repetitive determinations of##2##3##(2008-10#2)
repetitive element of##3##3##(1992-12#1)(1994-3#1)(1995-8#1)
repetitive element##9##2##(1991-2#1)(1992-12#1)(1993-3#1)(1994-3#1)(1995-4#1)(1995-8#1)(1997-2#1)(2008-10#2)
repetitive element-based polymerase chain reaction (rep-PCR)##2##6##(2008-10#2)
repetitive elements and##2##3##(1993-12#1)(2011-12#1)
repetitive elements in nucleotide sequences##2##5##(2008-4#2)
repetitive elements in##6##3##(2008-4#3)(2008-7#1)(2010-3#1)(2012-2#1)
repetitive elements##15##2##(1991-6#1)(1991-9#1)(1993-12#1)(1994-12#1)(2008-10#1)(2008-4#4)(2008-7#1)(2010-3#1)(2011-12#2)(2012-2#2)
repetitive extragenic palindromic polymerase chain reaction##2##6##(2008-10#2)
repetitive extragenic palindromic##5##3##(1990-11#1)(2008-10#4)
repetitive firing of action potentials##2##5##(1993-9#1)(2008-11#1)
repetitive firing##3##2##(1991-9#1)(1993-9#1)(2008-11#1)
repetitive hand use and##2##4##(2008-9#2)
repetitive hand use##5##3##(2008-9#5)
repetitive injections of##2##3##(2008-10#2)
repetitive intrathecal##2##2##(2010-12#2)
repetitive loss##2##2##(1997-4#1)(2011-1#1)
repetitive measurements##3##2##(1996-3#1)(2008-10#1)(2008-2#1)
repetitive mechanical##2##2##(2008-5#1)(2009-8#1)
repetitive peptide with a consensus sequence of##2##7##(1990-8#1)(1991-12#1)
repetitive peptide##3##2##(1990-8#1)(1991-12#1)(1993-8#1)
repetitive pulses (+50 mV/20##2##4##(2008-8#2)
repetitive regions##2##2##(1995-8#1)(2008-10#1)
repetitive sequence##7##2##(1993-11#1)(1995-2#1)(1996-4#1)(1996-7#1)(2008-5#1)(2008-8#1)(2013-1#1)
repetitive sequence-based polymerase chain reaction (rep-PCR)##2##6##(2008-10#2)
repetitive sequence-based polymerase chain reaction##7##5##(2008-10#7)
repetitive sequences##17##2##(1990-11#1)(1991-6#1)(1995-12#1)(1996-12#1)(1996-4#1)(1996-6#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-3#2)(2010-8#1)(2012-2#1)
repetitive stimulation##2##2##(1990-5#1)(2012-3#1)
repetitive structure##4##2##(1990-11#4)
repetitive tasks##6##2##(1991-6#1)(1996-3#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-4#1)
repetitive thinking##5##2##(2010-8#5)
repetitive transcranial magnetic stimulation (rTMS) to##2##6##(2010-5#1)(2011-2#1)
repetitive transcranial magnetic stimulation (rTMS)##7##5##(2008-10#1)(2008-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#2)
repetitive transcranial magnetic stimulation##14##4##(2008-10#1)(2008-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#4)(2011-2#2)(2012-1#1)(2012-2#1)
repetitive##292##1##(1990-11#11)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#3)(1991-9#3)(1992-1#1)(1992-11#2)(1992-12#2)(1992-4#5)(1992-5#1)(1992-8#2)(1993-11#4)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-3#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-4#1)(1995-8#4)(1996-1#1)(1996-12#1)(1996-3#2)(1996-4#2)(1996-6#1)(1996-7#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2006-10#7)(2006-11#1)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-4#2)(2007-6#1)(2007-8#4)(2008-1#1)(2008-10#62)(2008-11#11)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#8)(2008-5#8)(2008-7#6)(2008-8#5)(2008-9#6)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#3)(2009-8#2)(2010-10#1)(2010-12#2)(2010-2#2)(2010-3#5)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#7)(2011-1#6)(2011-12#5)(2011-2#8)(2012-1#4)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#2)(2013-8#1)
repetitive-sequence-based##2##1##(2008-10#2)
repetitively##15##1##(1993-2#1)(1995-12#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#3)(2013-1#1)
repetitiveness##2##1##(2006-10#1)(2008-5#1)
repigmentation by##2##2##(2007-7#2)
repigmentation##7##1##(1992-6#1)(2007-7#6)
replace Ca2+##3##2##(1990-5#1)(1995-11#2)
replace a##10##2##(1990-12#1)(1991-9#1)(2006-12#1)(2007-7#1)(2008-12#1)(2009-10#1)(2009-5#1)(2010-2#1)(2013-7#2)
replace and##3##2##(2008-8#1)(2010-3#2)
replace conventional diagnostic##2##3##(1992-12#1)(2006-10#1)
replace conventional##5##2##(1991-4#1)(1992-12#1)(2006-10#1)(2007-12#1)(2008-7#1)
replace it##3##2##(2007-8#1)(2010-12#1)(2011-2#1)
replace or##2##2##(1990-11#1)(2010-7#1)
replace serum##3##2##(1991-2#1)(1993-6#1)(1996-12#1)
replace the &quot##2##3##(2010-8#1)(2012-1#1)
replace the conventional##3##3##(2008-11#1)(2008-2#1)(2013-8#1)
replace the use of##2##4##(2007-7#1)(2008-10#1)
replace the##57##2##(1990-2#2)(1992-2#1)(1992-3#1)(1993-11#1)(1994-12#1)(1996-10#1)(1997-6#1)(1997-7#1)(2004-1#1)(2005-10#1)(2006-10#1)(2006-4#1)(2007-11#4)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#5)(2008-3#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#2)
replace them##2##2##(2007-12#1)(2008-3#1)
replace these##2##2##(2004-9#1)(2007-8#1)
replace this##5##2##(1993-7#1)(2006-12#1)(2006-7#1)(2007-11#1)(2008-10#1)
replace##206##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#1)(1990-7#2)(1990-8#1)(1991-11#1)(1991-2#1)(1991-4#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-8#1)(1993-11#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-3#2)(1994-4#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-6#1)(1996-10#1)(1996-12#2)(1996-2#2)(1997-6#1)(1997-7#1)(2003-11#1)(2004-1#1)(2004-12#1)(2004-2#1)(2004-9#1)(2005-10#2)(2005-8#2)(2006-1#1)(2006-10#6)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#9)(2007-12#4)(2007-3#1)(2007-4#2)(2007-7#4)(2007-8#5)(2008-1#4)(2008-10#9)(2008-11#5)(2008-12#1)(2008-2#8)(2008-3#9)(2008-4#4)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#4)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#4)(2010-2#2)(2010-3#4)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#3)(2011-7#1)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#7)(2012-3#4)(2013-1#3)(2013-7#2)(2013-8#3)
replaceable##3##1##(2008-10#1)(2008-11#1)(2012-3#1)
replaced Ca(2+))##2##2##(2008-4#2)
replaced a##3##2##(2007-7#1)(2007-8#1)(2013-7#1)
replaced and##3##2##(1992-7#1)(1993-5#1)(2013-8#1)
replaced at##3##2##(1997-7#1)(2006-8#1)(2008-10#1)
replaced by Ala##4##3##(1990-5#1)(1992-6#1)(1994-5#2)
replaced by Phe##3##3##(1992-3#1)(1997-4#1)(1997-7#1)
replaced by Ser##2##3##(1995-10#1)(1997-2#1)
replaced by a single##4##4##(1994-5#1)(1997-7#1)(2008-10#2)
replaced by a water molecule##2##5##(1991-7#1)(1995-5#1)
replaced by a##43##3##(1990-10#1)(1990-12#1)(1990-2#1)(1991-2#1)(1991-7#1)(1992-6#1)(1992-7#1)(1993-5#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-5#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-8#1)(2010-5#1)(2012-12#2)(2012-2#2)
replaced by alanine or glycine##2##5##(1993-6#1)(1995-3#1)
replaced by alanine##4##3##(1990-3#1)(1993-6#1)(1994-9#1)(1995-3#1)
replaced by alpha-amino-n-butyric acid##2##4##(1995-10#1)(1997-2#1)
replaced by an##8##3##(1991-7#2)(1996-11#1)(2006-1#1)(2007-3#1)(2008-3#1)(2008-4#1)(2009-1#1)
replaced by another##2##3##(2008-11#1)(2009-4#1)
replaced by aspartic acid##2##4##(1990-5#1)(1997-7#1)
replaced by azathioprine##2##3##(2007-11#1)(2007-7#1)
replaced by glutamine##2##3##(1994-11#1)(1996-5#1)
replaced by glycine##3##3##(1992-9#1)(1993-3#1)(1995-5#1)
replaced by other##3##3##(1990-5#1)(1996-8#1)(2008-7#1)
replaced by purified##2##3##(1990-6#1)(1996-5#1)
replaced by serine##2##3##(1990-7#1)(1996-11#1)
replaced by that of##2##4##(1995-8#1)(1997-7#1)
replaced by the##26##3##(1990-2#2)(1990-5#1)(1991-4#1)(1993-11#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-8#1)(1997-3#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-12#2)(2007-8#3)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-8#1)(2013-8#2)
replaced by two##2##3##(1992-6#1)(1994-9#1)
replaced by tyrosine##2##3##(1991-2#1)(1996-7#1)
replaced by valine##3##3##(1990-2#1)(1991-5#1)(1993-6#1)
replaced by##235##2##(1990-10#3)(1990-11#1)(1990-12#1)(1990-2#5)(1990-3#1)(1990-5#4)(1990-6#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#4)(1991-4#1)(1991-5#1)(1991-7#5)(1991-9#2)(1992-10#3)(1992-3#2)(1992-5#1)(1992-6#3)(1992-7#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-3#2)(1993-5#1)(1993-6#5)(1994-11#5)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#5)(1994-8#3)(1994-9#5)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#4)(1995-5#2)(1995-6#1)(1995-8#3)(1996-11#7)(1996-2#2)(1996-5#4)(1996-7#1)(1996-8#3)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#3)(1997-7#6)(2004-12#1)(2004-4#1)(2004-9#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-6#4)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-3#1)(2007-6#2)(2007-7#3)(2007-8#6)(2008-1#1)(2008-10#12)(2008-11#4)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#4)(2009-1#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-5#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#3)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#3)
replaced conventional##2##2##(2007-7#1)(2013-8#1)
replaced each##2##2##(1993-6#1)(2008-9#1)
replaced either##2##2##(1993-3#1)(1995-1#1)
replaced in the##2##3##(1996-5#1)(2008-5#1)
replaced in##3##2##(1996-5#1)(2008-5#2)
replaced open##2##2##(1995-8#1)(2006-7#1)
replaced the##18##2##(1991-10#1)(1993-12#1)(1994-12#1)(1995-12#1)(1995-6#1)(2005-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-5#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-3#1)(2013-1#1)
replaced two##2##2##(1997-2#1)(2008-9#1)
replaced with &quot##3##3##(2005-5#1)(2007-12#1)(2013-1#1)
replaced with Cys##2##3##(1993-11#1)(1993-3#1)
replaced with a new##2##4##(2009-5#1)(2011-2#1)
replaced with a##15##3##(1990-12#1)(1991-3#1)(1994-3#1)(1997-2#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-5#1)(2008-6#1)(2009-5#1)(2011-1#1)(2011-2#1)
replaced with alanine##2##3##(1994-11#1)(1994-8#1)
replaced with an##3##3##(1991-2#1)(2008-10#1)(2012-12#1)
replaced with asparagine##2##3##(1995-6#1)(2007-12#1)
replaced with glycine##3##3##(1993-3#1)(1994-11#1)(1994-5#1)
replaced with one##2##3##(1993-2#1)(1993-8#1)
replaced with the corresponding##2##4##(1995-5#1)(2008-4#1)
replaced with the##8##3##(1991-12#1)(1994-11#1)(1995-5#1)(2008-12#1)(2008-4#1)(2010-7#1)(2012-1#1)(2012-10#1)
replaced with valine##3##3##(1995-2#1)(1996-2#2)
replaced with##90##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-8#1)(1994-11#4)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#2)(1996-2#3)(1997-2#1)(1997-6#1)(1997-7#1)(2005-5#1)(2005-8#1)(2007-10#1)(2007-11#1)(2007-12#4)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-10#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
replaced##437##1##(1990-10#3)(1990-11#1)(1990-12#3)(1990-2#7)(1990-3#1)(1990-4#1)(1990-5#6)(1990-6#1)(1990-7#2)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#7)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#5)(1991-9#3)(1992-1#2)(1992-10#4)(1992-3#3)(1992-5#2)(1992-6#5)(1992-7#2)(1992-9#2)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#5)(1993-4#1)(1993-5#3)(1993-6#8)(1993-8#2)(1994-11#10)(1994-12#6)(1994-2#3)(1994-3#5)(1994-5#7)(1994-6#1)(1994-8#4)(1994-9#7)(1995-1#1)(1995-10#3)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#5)(1995-5#5)(1995-6#6)(1995-8#5)(1995-9#1)(1996-1#1)(1996-11#7)(1996-2#6)(1996-3#1)(1996-5#5)(1996-7#2)(1996-8#3)(1996-9#1)(1997-2#5)(1997-3#2)(1997-4#1)(1997-6#4)(1997-7#8)(2004-12#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-12#1)(2005-5#1)(2005-8#2)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-4#1)(2006-6#4)(2006-7#1)(2006-8#4)(2006-9#2)(2007-10#2)(2007-11#5)(2007-12#8)(2007-2#2)(2007-3#1)(2007-5#3)(2007-6#2)(2007-7#9)(2007-8#8)(2008-1#4)(2008-10#22)(2008-11#10)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#11)(2008-5#7)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#9)(2009-1#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#2)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#2)(2012-10#1)(2012-11#2)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#8)(2013-7#2)(2013-8#6)
replacement -##3##2##(2007-8#1)(2011-2#1)(2012-11#1)
replacement after##2##2##(1994-4#1)(2007-7#1)
replacement and the amount##2##4##(2005-1#1)(2007-9#1)
replacement and##29##2##(1990-7#1)(1993-9#4)(1994-8#1)(1996-1#1)(1997-5#1)(2005-1#1)(2006-10#1)(2006-8#2)(2006-9#1)(2007-8#8)(2007-9#2)(2008-1#1)(2009-9#1)(2010-10#1)(2012-12#1)(2013-1#2)
replacement are##2##2##(1993-8#1)(2011-2#1)
replacement arthroplasty##3##2##(2006-3#1)(2008-11#1)(2010-4#1)
replacement at the##3##3##(1997-5#1)(2005-11#1)(2008-11#1)
replacement at##5##2##(1990-11#1)(1997-5#1)(2005-11#1)(2008-11#1)(2008-9#1)
replacement before##2##2##(2008-1#1)(2011-2#1)
replacement by##10##2##(1991-1#1)(1991-2#1)(1992-6#1)(1992-8#1)(1995-12#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-6#1)(2012-2#1)
replacement cassette##2##2##(1996-6#2)
replacement costs##2##2##(1992-3#2)
replacement dose of##2##3##(1994-9#1)(2008-4#1)
replacement doses##3##2##(1995-12#1)(2006-10#1)(2006-5#1)
replacement during##2##2##(1995-12#1)(2007-9#1)
replacement followed by##2##3##(1992-9#1)(2007-8#1)
replacement for chronic##2##3##(2007-9#1)(2008-7#1)
replacement for conventional##2##3##(2006-2#1)(2008-7#1)
replacement for the##7##3##(1992-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)
replacement for##37##2##(1992-3#1)(1994-9#1)(1996-9#1)(1997-2#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-3#1)(2007-12#1)(2007-7#1)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-4#1)(2009-5#1)(2011-2#3)(2013-1#1)
replacement had##3##2##(1991-9#1)(1992-4#1)(1995-7#1)
replacement has been##2##3##(2004-12#1)(2007-8#1)
replacement has##3##2##(2004-12#1)(2007-8#1)(2008-7#1)
replacement have been##2##3##(2006-8#1)(2008-8#1)
replacement in Australia##2##3##(2011-2#2)
replacement in a##3##3##(2007-8#2)(2012-12#1)
replacement in ovariectomized rats##2##4##(2004-11#2)
replacement in the##5##3##(1997-8#2)(2006-12#1)(2007-7#1)(2012-12#1)
replacement in##45##2##(1990-11#1)(1991-10#1)(1994-12#1)(1996-11#1)(1997-5#1)(1997-6#1)(1997-8#2)(2004-11#2)(2006-12#1)(2006-9#1)(2007-10#1)(2007-7#5)(2007-8#4)(2007-9#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-9#1)(2011-2#5)(2012-12#7)(2012-2#1)(2013-1#1)
replacement is a##3##3##(1990-8#1)(2007-11#1)(2010-10#1)
replacement is the##2##3##(1993-9#1)(2009-5#1)
replacement is##16##2##(1990-2#1)(1990-8#1)(1993-9#1)(1996-6#1)(2006-9#2)(2007-11#1)(2007-7#1)(2007-8#1)(2009-4#1)(2009-5#2)(2010-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
replacement materials##4##2##(2008-5#1)(2009-9#2)(2011-2#1)
replacement mechanisms##3##2##(2005-1#1)(2012-12#2)
replacement method##4##2##(1996-6#1)(1997-4#1)(2008-8#1)(2008-9#1)
replacement methods##4##2##(1992-8#1)(1995-11#1)(1995-3#1)(2008-8#1)
replacement modalities##2##2##(2005-11#2)
replacement needs##2##2##(1992-3#1)(2006-5#1)
replacement of BSA with FCS in mSOF significantly increased the##2##10##(2006-5#2)
replacement of BSA with FCS in mSOF##3##7##(2006-5#3)
replacement of Leu##2##3##(1991-2#1)(1995-3#1)
replacement of SO##2##3##(2010-4#2)
replacement of Ser by##2##4##(1990-6#1)(1992-8#1)
replacement of a##5##3##(1990-4#1)(1997-4#1)(2008-3#1)(2008-7#1)(2010-6#1)
replacement of an##3##3##(1991-7#1)(1992-7#1)(2011-3#1)
replacement of basal##2##3##(2006-1#1)(2008-1#1)
replacement of glycine##3##3##(1991-6#1)(2008-10#2)
replacement of histone##2##3##(1994-9#1)(2008-7#1)
replacement of lost##3##3##(2008-6#1)(2008-7#1)(2011-2#1)
replacement of missing##2##3##(2007-3#1)(2012-2#1)
replacement of normal##3##3##(2008-8#1)(2013-1#2)
replacement of one##3##3##(1992-3#1)(2008-10#1)(2008-5#1)
replacement of sodium##3##3##(2010-4#3)
replacement of the aortic valve##2##5##(2009-5#1)(2010-9#1)
replacement of the ascending aorta##6##5##(2007-8#6)
replacement of the maxillary central incisors##2##6##(2009-8#2)
replacement of the other##2##4##(1991-9#1)(2008-6#1)
replacement of the##52##3##(1990-3#1)(1990-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-1#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1996-4#1)(1996-5#1)(1997-4#1)(1997-7#1)(2004-10#1)(2005-7#1)(2006-10#1)(2006-12#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#8)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#2)(2010-9#1)(2012-12#2)(2012-2#2)(2013-1#1)
replacement of this##3##3##(1990-12#1)(1991-9#1)(1993-4#1)
replacement of ticlopidine with cilostazol##2##5##(2007-10#2)
replacement of##197##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#2)(1990-8#2)(1991-1#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#3)(1992-12#1)(1992-3#3)(1992-5#1)(1992-6#5)(1992-7#2)(1992-8#3)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-8#2)(1994-12#2)(1994-3#4)(1994-5#1)(1994-8#2)(1994-9#6)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#3)(1995-7#2)(1996-1#1)(1996-4#3)(1996-5#3)(1996-9#1)(1997-4#3)(1997-7#1)(1997-8#1)(2004-10#1)(2005-12#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-5#3)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#10)(2008-1#2)(2008-10#8)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#2)(2009-2#2)(2009-3#1)(2009-5#1)(2009-8#2)(2010-3#1)(2010-4#7)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-12#5)(2012-2#3)(2012-6#1)(2013-1#6)(2013-8#1)
replacement on##9##2##(1991-8#1)(1992-4#2)(1995-7#1)(1997-1#1)(2007-11#1)(2007-8#1)(2008-11#1)(2010-4#1)
replacement or repair##2##3##(2007-8#2)
replacement or##6##2##(1993-10#1)(2007-2#1)(2007-8#2)(2010-3#1)(2013-7#1)
replacement provides##2##2##(2004-11#1)(2012-2#1)
replacement rates were higher in##2##5##(2011-2#2)
replacement series##3##2##(2004-11#1)(2008-10#1)(2008-8#1)
replacement should##2##2##(2006-6#2)
replacement solution##2##2##(1995-3#1)(2007-8#1)
replacement strategies##5##2##(2008-11#3)(2009-9#1)(2010-12#1)
replacement strategy to##3##3##(1990-2#1)(2012-12#2)
replacement strategy##8##2##(1990-2#1)(1992-12#1)(2008-11#3)(2009-9#1)(2012-12#2)
replacement surgery in##2##3##(2007-8#1)(2012-3#1)
replacement surgery##16##2##(1997-5#2)(2005-12#1)(2007-10#1)(2007-5#2)(2007-7#1)(2007-8#1)(2007-9#4)(2008-10#1)(2008-6#1)(2011-2#1)(2012-3#1)
replacement techniques and refined to##3##5##(1993-8#1)(1994-12#1)(1997-5#1)
replacement techniques##4##2##(1993-8#1)(1994-12#1)(1996-2#1)(1997-5#1)
replacement that##2##2##(2006-10#1)(2011-2#1)
replacement therapies##6##2##(2006-10#1)(2007-8#1)(2010-8#1)(2012-12#2)(2012-2#1)
replacement therapy (ERT)##3##3##(1990-6#1)(2012-12#2)
replacement therapy (HRT)##6##3##(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)(2012-2#1)(2013-8#1)
replacement therapy and##10##3##(1991-3#1)(1996-6#1)(2005-8#1)(2006-4#1)(2006-8#1)(2006-9#3)(2007-11#1)(2010-6#1)
replacement therapy for the##2##4##(2005-8#1)(2006-10#1)
replacement therapy for##8##3##(1993-11#1)(1997-1#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-7#1)(2010-3#1)(2012-12#1)
replacement therapy has been##2##4##(1997-1#1)(2008-1#1)
replacement therapy has##3##3##(1997-1#1)(2006-9#1)(2008-1#1)
replacement therapy in adults was##2##5##(1996-11#1)(2007-11#1)
replacement therapy in postmenopausal##2##4##(2006-10#1)(2012-3#1)
replacement therapy in the aging male##2##6##(2006-6#1)(2006-9#1)
replacement therapy in the intensive care unit##4##7##(2006-4#2)(2008-3#1)(2009-9#1)
replacement therapy in the##8##4##(1993-11#1)(2006-4#2)(2006-6#1)(2006-9#1)(2008-3#2)(2009-9#1)
replacement therapy in women##2##4##(2008-4#1)(2012-3#1)
replacement therapy in##30##3##(1991-6#1)(1993-11#1)(1993-2#1)(1996-11#1)(1997-1#2)(2006-10#1)(2006-4#4)(2006-6#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-3#3)(2008-4#4)(2008-8#1)(2009-9#1)(2010-4#1)(2012-1#1)(2012-3#2)
replacement therapy is##9##3##(2005-10#1)(2005-3#1)(2006-10#1)(2006-4#1)(2007-7#1)(2008-10#1)(2008-3#1)(2009-9#1)(2013-1#1)
replacement therapy should be##2##4##(2006-10#1)(2006-6#1)
replacement therapy should##3##3##(2006-10#2)(2006-6#1)
replacement therapy to##4##3##(1996-6#1)(1997-5#1)(2008-11#1)(2008-6#1)
replacement therapy with imiglucerase##2##4##(2008-10#2)
replacement therapy with##9##3##(2006-1#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-10#3)(2013-1#2)
replacement therapy##177##2##(1990-6#1)(1991-3#2)(1991-6#1)(1992-2#1)(1993-11#3)(1993-2#1)(1994-11#1)(1994-5#1)(1994-9#2)(1996-10#1)(1996-11#3)(1996-12#1)(1996-6#2)(1997-1#5)(1997-5#3)(1997-8#2)(2005-10#2)(2005-3#1)(2005-8#2)(2006-1#1)(2006-10#11)(2006-4#9)(2006-5#3)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#10)(2007-11#5)(2007-7#7)(2007-8#1)(2007-9#2)(2008-1#9)(2008-10#4)(2008-11#6)(2008-3#7)(2008-4#8)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-9#3)(2010-10#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#8)(2012-1#1)(2012-12#7)(2012-2#4)(2012-3#6)(2013-1#4)(2013-8#3)
replacement therapy)##2##2##(2010-12#1)(2012-3#1)
replacement therapy]##2##2##(2005-1#1)(2013-8#1)
replacement to##4##2##(2005-8#1)(2008-7#1)(2009-8#1)(2013-1#1)
replacement treatment##4##2##(1993-8#1)(1996-11#1)(2007-7#2)
replacement under cardiopulmonary bypass##2##4##(2006-12#1)(2007-9#1)
replacement under##3##2##(2006-12#1)(2007-9#1)(2008-7#1)
replacement using the##3##3##(1992-4#1)(1993-8#1)(2011-2#1)
replacement using##9##2##(1992-4#1)(1993-8#1)(1994-3#1)(1995-11#1)(2007-8#2)(2008-10#1)(2011-2#1)(2012-2#1)
replacement vector##3##2##(2008-8#3)
replacement was##7##2##(1990-11#1)(1990-2#1)(1994-2#1)(1996-10#1)(2006-10#1)(2007-9#1)(2010-11#1)
replacement we##2##2##(1990-8#1)(2011-2#1)
replacement were##6##2##(1994-3#1)(1995-12#1)(2007-8#1)(2007-9#1)(2011-2#1)(2013-7#1)
replacement which##3##2##(1990-8#1)(2007-5#1)(2008-1#1)
replacement will become##2##3##(1997-8#1)(2009-5#1)
replacement with Glu##2##3##(1996-5#2)
replacement with a##7##3##(1991-10#1)(2007-7#1)(2007-8#4)(2012-2#1)
replacement with cilostazol##3##3##(2007-10#3)
replacement with the##6##3##(1997-1#1)(2007-8#2)(2008-6#1)(2009-3#1)(2011-2#1)
replacement with##37##2##(1991-10#1)(1993-11#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-5#2)(1996-7#1)(1997-1#1)(1997-2#1)(2005-8#1)(2006-12#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-7#1)(2007-8#10)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-3#1)(2009-9#1)(2011-2#1)(2012-2#1)
replacement##1041##1##(1990-10#1)(1990-11#4)(1990-12#2)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#4)(1990-7#1)(1990-8#6)(1991-1#2)(1991-10#2)(1991-12#2)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#4)(1991-7#1)(1991-8#2)(1991-9#4)(1992-12#2)(1992-2#1)(1992-3#8)(1992-4#5)(1992-5#1)(1992-6#6)(1992-7#2)(1992-8#7)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#5)(1993-12#2)(1993-2#2)(1993-3#3)(1993-4#1)(1993-8#6)(1993-9#5)(1994-11#3)(1994-12#6)(1994-2#1)(1994-3#8)(1994-4#2)(1994-5#3)(1994-6#1)(1994-8#5)(1994-9#10)(1995-1#1)(1995-10#1)(1995-11#4)(1995-12#6)(1995-2#2)(1995-3#9)(1995-7#4)(1995-8#2)(1996-1#4)(1996-10#3)(1996-11#6)(1996-12#4)(1996-2#2)(1996-3#2)(1996-4#3)(1996-5#5)(1996-6#6)(1996-7#1)(1996-8#2)(1996-9#4)(1997-1#7)(1997-2#3)(1997-3#2)(1997-4#4)(1997-5#13)(1997-6#2)(1997-7#2)(1997-8#7)(2004-10#1)(2004-11#7)(2004-12#1)(2004-9#2)(2005-1#3)(2005-10#3)(2005-11#6)(2005-12#2)(2005-3#1)(2005-7#2)(2005-8#7)(2005-9#1)(2006-1#2)(2006-10#24)(2006-11#1)(2006-12#7)(2006-2#1)(2006-3#2)(2006-4#13)(2006-5#9)(2006-6#7)(2006-7#2)(2006-8#7)(2006-9#21)(2007-10#9)(2007-11#23)(2007-12#7)(2007-2#3)(2007-3#1)(2007-5#5)(2007-7#33)(2007-8#88)(2007-9#23)(2008-1#18)(2008-10#27)(2008-11#29)(2008-12#4)(2008-2#2)(2008-3#11)(2008-4#25)(2008-5#12)(2008-6#14)(2008-7#15)(2008-8#24)(2008-9#11)(2009-10#2)(2009-12#2)(2009-2#2)(2009-3#8)(2009-4#5)(2009-5#7)(2009-6#1)(2009-7#2)(2009-8#6)(2009-9#11)(2010-10#10)(2010-11#2)(2010-12#6)(2010-3#3)(2010-4#13)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#4)(2011-2#44)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#44)(2012-2#19)(2012-3#12)(2012-6#1)(2013-1#33)(2013-7#4)(2013-8#9)
replacement&quot##3##1##(2006-8#2)(2008-11#1)
replacement)##5##1##(1993-8#1)(2004-9#1)(2007-11#2)(2008-6#1)
replacement?##3##1##(2006-8#1)(2007-8#1)(2010-12#1)
replacements and##8##2##(1991-5#1)(1992-3#1)(1997-9#1)(2007-8#1)(2008-11#1)(2008-5#1)(2009-8#1)(2012-12#1)
replacements are##3##2##(1991-6#1)(2008-8#1)(2009-7#1)
replacements at##3##2##(1990-11#1)(1992-3#1)(1995-5#1)
replacements for##7##2##(1992-3#1)(1993-11#1)(2005-7#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-2#1)
replacements in the extracellular##2##4##(1994-5#1)(1997-9#1)
replacements in the##4##3##(1994-5#1)(1996-11#1)(1997-1#1)(1997-9#1)
replacements in##7##2##(1994-5#1)(1995-5#1)(1996-11#1)(1997-1#1)(1997-9#1)(2008-10#1)(2008-11#1)
replacements of the##2##3##(1991-6#1)(2008-6#1)
replacements of##3##2##(1991-6#1)(1996-11#1)(2008-6#1)
replacements##73##1##(1990-11#2)(1990-9#1)(1991-5#1)(1991-6#3)(1991-8#1)(1991-9#4)(1992-3#7)(1993-11#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#1)(1994-5#1)(1995-5#4)(1996-1#1)(1996-11#4)(1996-12#1)(1997-1#2)(1997-4#1)(1997-5#1)(1997-9#2)(2005-7#1)(2006-10#2)(2006-8#2)(2007-11#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#2)(2009-7#3)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
replaces a##2##2##(1993-12#1)(2008-11#1)
replaces the##18##2##(1992-5#1)(1994-11#1)(1994-12#1)(1995-6#1)(1996-5#1)(2006-3#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#1)(2012-2#2)(2012-3#1)
replaces##34##1##(1990-3#1)(1992-5#2)(1993-12#1)(1994-11#1)(1994-12#1)(1995-11#2)(1995-2#1)(1995-6#2)(1996-5#1)(1997-7#2)(2006-3#1)(2006-8#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
replacing Trp##2##2##(1993-4#1)(1995-2#1)
replacing a##3##2##(2004-11#1)(2008-11#2)
replacing an##3##2##(1991-1#1)(1991-4#1)(2010-3#1)
replacing archaic##2##2##(1994-3#1)(2009-6#1)
replacing damaged##2##2##(2010-12#1)(2011-2#1)
replacing each##2##2##(1994-9#1)(1997-2#1)
replacing either##2##2##(2006-7#1)(2008-1#1)
replacing it with##3##3##(1990-3#1)(1991-8#1)(2008-3#1)
replacing one or##2##3##(1995-5#1)(2009-2#1)
replacing one##3##2##(1995-5#1)(1996-9#1)(2009-2#1)
replacing oxygen##3##2##(2007-12#1)(2008-10#1)(2009-2#1)
replacing the animal##2##3##(2008-11#1)(2010-4#1)
replacing the##35##2##(1990-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-5#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-4#1)(1996-9#1)(1997-4#1)(1997-8#1)(2004-12#1)(2006-1#1)(2006-11#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-5#3)(2010-10#1)(2010-4#1)(2010-5#1)(2012-11#1)(2013-1#2)
replacing their##2##2##(2008-11#1)(2008-4#1)
replacing##125##1##(1990-12#1)(1990-2#3)(1990-3#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-4#2)(1993-8#2)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-7#1)(1996-9#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-11#1)(2004-12#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-11#1)(2006-6#2)(2006-7#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#8)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-2#2)(2009-6#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#5)(2013-8#1)
replant disease and##2##3##(2008-10#2)
replant disease##11##2##(2008-10#11)
replant orchard soils##3##3##(2008-10#3)
replant orchard##4##2##(2008-10#4)
replant soils with##2##3##(2008-10#2)
replant soils##7##2##(2008-10#7)
replant##24##1##(2008-10#23)(2012-2#1)
replantation and##2##2##(2006-3#1)(2008-9#1)
replantation of##2##2##(2008-9#2)
replantation##17##1##(1993-2#1)(2006-3#7)(2006-4#1)(2008-9#8)
replanted##7##1##(2008-10#3)(2008-9#3)(2010-2#1)
replated##3##1##(1997-7#1)(2008-11#2)
replay##6##1##(1994-3#1)(2007-12#1)(2008-2#1)(2013-1#2)(2013-8#1)
replayed##2##1##(2008-2#2)
replenish##7##1##(1990-12#1)(1996-9#1)(1997-1#1)(2008-1#1)(2008-9#1)(2009-4#1)(2009-6#1)
replenished by##4##2##(2007-12#1)(2008-7#1)(2009-8#1)(2010-12#1)
replenished with##2##2##(1995-1#1)(1995-10#1)
replenished##11##1##(1995-1#1)(1995-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)
replenishment of##6##2##(1990-6#1)(1994-5#1)(1997-7#1)(2007-12#2)(2013-1#1)
replenishment##11##1##(1990-5#1)(1990-6#1)(1993-3#1)(1994-5#1)(1997-7#1)(2006-10#1)(2007-12#2)(2010-4#1)(2010-7#1)(2013-1#1)
replete with##4##2##(1995-8#1)(2007-7#1)(2008-7#1)(2010-11#1)
repletion##8##1##(1992-9#1)(1993-12#1)(1994-11#1)(1995-9#1)(2007-7#1)(2008-1#1)(2012-2#1)(2013-1#1)
replica exchange molecular dynamics##2##4##(2010-2#1)(2012-2#1)
replica exchange##7##2##(2008-12#3)(2010-2#3)(2012-2#1)
replica gratings##2##2##(2008-3#2)
replica molding##3##2##(2008-11#1)(2012-11#2)
replica of the input##2##4##(2007-12#1)(2008-3#1)
replica of the##5##3##(2007-12#1)(2007-8#1)(2008-3#3)
replica of##6##2##(2006-3#1)(2007-12#1)(2007-8#1)(2008-3#3)
replica##33##1##(1994-8#1)(1995-6#1)(2006-12#1)(2006-3#1)(2007-12#1)(2007-8#2)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#5)(2008-5#3)(2008-9#1)(2009-2#1)(2010-2#5)(2010-5#1)(2012-11#2)(2012-2#1)
replicability of##3##2##(1997-7#1)(2008-11#2)
replicas of the##6##3##(2007-11#1)(2008-1#1)(2008-2#2)(2008-3#2)
replicas of##9##2##(1995-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#3)
replicas##18##1##(1990-12#1)(1992-12#1)(1995-6#1)(2007-11#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-5#2)(2011-2#1)
replicase and movement protein##2##4##(2008-9#2)
replicase gene##3##2##(2008-10#2)(2008-9#1)
replicase synthesis##2##2##(1997-4#2)
replicase##23##1##(1995-1#5)(1995-12#3)(1996-9#2)(1997-4#2)(2008-10#6)(2008-9#5)
replicase-based DNA vaccine##3##3##(2013-1#3)
replicase-mediated resistance##2##2##(2008-10#2)
replicase-mediated##3##1##(2008-10#3)
replicate analyses of##6##3##(2008-10#6)
replicate analyses##8##2##(2008-10#7)(2008-5#1)
replicate analysis (n=5) of##2##4##(2008-10#2)
replicate analysis of##3##3##(2008-10#3)
replicate analysis##10##2##(2007-8#1)(2008-10#9)
replicate and##12##2##(1990-11#1)(1994-5#1)(1995-2#2)(2005-9#1)(2006-8#1)(2008-9#2)(2010-6#1)(2012-2#2)(2012-3#1)
replicate assay plates##2##3##(2008-10#2)
replicate data sets##2##3##(2012-3#2)
replicate determination of##4##3##(2008-10#4)
replicate determinations at the 0##2##5##(2008-10#2)
replicate determinations at the##4##4##(2008-10#4)
replicate determinations at##7##3##(2008-10#7)
replicate determinations of 0##2##4##(2008-10#2)
replicate determinations of 1##3##4##(2008-10#3)
replicate determinations of 2##2##4##(2008-10#2)
replicate determinations of 5##2##4##(2008-10#2)
replicate determinations of##21##3##(2008-10#21)
replicate determinations##32##2##(2008-10#32)
replicate human##2##2##(2006-11#1)(2008-11#1)
replicate in the##3##3##(1997-3#1)(2006-11#1)(2008-5#1)
replicate in##14##2##(1990-5#1)(1991-12#1)(1992-2#1)(1993-11#1)(1995-2#2)(1997-3#2)(2006-11#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-8#2)
replicate injections of##4##3##(2008-10#4)
replicate injections##7##2##(2008-10#7)
replicate lines of##2##3##(2008-8#1)(2008-9#1)
replicate lines##3##2##(2008-8#2)(2008-9#1)
replicate measurements is##2##3##(2008-10#2)
replicate measurements of##5##3##(2008-10#5)
replicate measurements##10##2##(2007-12#1)(2008-10#9)
replicate observations##2##2##(1993-1#2)
replicate of##3##2##(2012-3#3)
replicate or##2##2##(1994-6#1)(2008-8#1)
replicate phenotypes##2##2##(2012-3#2)
replicate plots##2##2##(2008-10#1)(2013-7#1)
replicate sample##2##2##(2008-10#2)
replicate samples##3##2##(2008-10#2)(2008-5#1)
replicate the##9##2##(1992-11#1)(1993-2#1)(1995-1#1)(2008-2#1)(2008-3#1)(2008-5#2)(2010-12#1)(2012-3#1)
replicate##196##1##(1990-11#1)(1990-5#1)(1990-8#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-1#2)(1993-11#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#4)(1995-5#1)(1995-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-8#1)(2005-9#1)(2006-11#4)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#2)(2007-8#2)(2008-10#88)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#7)(2008-8#6)(2008-9#5)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#2)(2010-6#1)(2011-1#2)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#16)(2013-7#2)(2013-8#2)
replicated DNA can be##2##4##(2008-9#1)(2012-2#1)
replicated DNA##3##2##(2008-9#1)(2012-2#2)
replicated and##3##2##(1997-3#1)(2008-7#1)(2012-1#1)
replicated at##2##2##(2008-10#1)(2008-2#1)
replicated by Q beta replicase##3##5##(1995-1#3)
replicated by##4##2##(1991-2#1)(1995-1#3)
replicated field trials##4##3##(2008-10#3)(2008-4#1)
replicated field##7##2##(2008-10#5)(2008-4#1)(2008-8#1)
replicated in a##3##3##(1995-12#1)(1997-4#1)(2008-7#1)
replicated in several##2##3##(2008-10#1)(2009-4#1)
replicated in##31##2##(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-6#1)(2007-10#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#3)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-12#1)(2013-8#1)
replicated previous##2##2##(2007-12#2)
replicated the##5##2##(2006-4#1)(2007-12#1)(2009-2#1)(2012-1#1)(2012-3#1)
replicated this##2##2##(2007-12#1)(2010-4#1)
replicated to##3##2##(2008-5#1)(2013-8#2)
replicated well##2##2##(1994-8#1)(2007-6#1)
replicated##116##1##(1990-12#2)(1991-2#1)(1991-7#1)(1991-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-1#4)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-8#1)(1997-3#2)(1997-4#1)(1997-7#1)(2006-3#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-12#7)(2007-3#1)(2007-4#1)(2007-6#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#5)(2008-8#3)(2008-9#2)(2009-2#1)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-12#2)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#1)(2013-8#3)
replicates and extends previous##2##4##(1996-2#1)(2008-12#1)
replicates and##3##2##(1996-2#1)(2008-10#1)(2008-12#1)
replicates for##2##2##(2008-10#1)(2012-3#1)
replicates in##5##2##(1995-2#1)(1996-12#1)(2006-11#1)(2008-9#2)
replicates of a##3##3##(2008-10#2)(2008-4#1)
replicates of the##5##3##(1993-4#1)(2007-1#1)(2008-10#1)(2012-3#2)
replicates of##12##2##(1993-4#1)(1994-5#1)(1996-3#1)(2006-8#1)(2007-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2012-3#2)
replicates per##2##2##(2008-12#1)(2010-2#1)
replicates the phase##2##3##(2008-11#2)
replicates the##5##2##(1994-2#1)(2007-7#1)(2008-11#2)(2008-3#1)
replicates was##3##2##(1994-3#1)(2007-8#1)(2012-3#1)
replicates were##2##2##(2008-10#1)(2012-3#1)
replicates##82##1##(1990-9#1)(1993-4#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-2#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-4#2)(2006-11#1)(2006-8#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-10#26)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#3)(2009-3#1)(2009-4#1)(2009-8#1)(2010-2#2)(2012-3#10)
replicates)##3##1##(2006-8#1)(2008-10#2)
replicating and##3##2##(2008-3#1)(2008-8#1)(2013-1#1)
replicating in##2##2##(1995-2#1)(2012-12#1)
replicating the##2##2##(2008-11#1)(2011-2#1)
replicating##36##1##(1990-10#1)(1990-3#1)(1991-1#1)(1994-8#1)(1995-1#3)(1995-2#3)(1995-6#2)(1996-4#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-12#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#2)(2009-8#1)(2010-6#1)(2011-2#1)(2011-3#2)(2012-12#1)(2013-1#1)(2013-8#1)
replication activity and##2##3##(1991-12#1)(1991-8#1)
replication activity##3##2##(1991-12#1)(1991-8#1)(2008-9#1)
replication after##4##2##(1990-5#1)(1995-12#1)(2006-10#1)(2010-11#1)
replication and differentiation##2##3##(2004-11#1)(2008-1#1)
replication and extension##2##3##(1994-2#1)(2007-12#1)
replication and packaging##2##3##(2008-4#1)(2008-9#1)
replication and repair and##2##4##(1997-2#1)(2009-2#1)
replication and repair##5##3##(1993-3#1)(1997-2#1)(2007-8#1)(2008-5#1)(2009-2#1)
replication and shedding of##2##4##(2013-8#2)
replication and spread##3##3##(1992-8#1)(2012-2#1)(2013-8#1)
replication and the##3##3##(2005-7#1)(2008-7#1)(2012-2#1)
replication and transcription are##2##4##(1996-11#1)(2008-11#1)
replication and transcription##5##3##(1994-8#1)(1996-11#1)(2008-11#1)(2008-7#1)(2010-2#1)
replication and##79##2##(1990-2#1)(1990-5#1)(1991-10#1)(1992-12#1)(1992-8#2)(1993-3#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-7#1)(1994-8#2)(1995-2#2)(1996-11#1)(1996-7#1)(1997-2#2)(1997-3#2)(2004-11#1)(2005-7#1)(2006-8#1)(2007-12#1)(2007-3#2)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#5)(2009-2#1)(2009-3#1)(2009-6#1)(2010-2#1)(2011-1#4)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#5)(2013-1#2)(2013-8#3)
replication apparatus##3##2##(1993-3#1)(1994-8#1)(1994-9#1)
replication are##3##2##(1992-12#1)(1994-12#1)(2009-8#1)
replication as##4##2##(1994-6#1)(1995-3#1)(2008-5#1)(2010-3#1)
replication at the##5##3##(1995-1#2)(1997-8#1)(2008-2#1)(2008-9#1)
replication at##10##2##(1990-11#1)(1991-7#1)(1995-1#3)(1997-8#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-8#1)
replication but##2##2##(2005-7#1)(2008-11#1)
replication by##16##2##(1990-5#2)(1991-12#2)(1991-4#1)(1995-2#2)(1997-1#1)(1997-4#1)(1997-6#1)(2006-11#2)(2008-10#1)(2013-1#2)(2013-7#1)
replication can be##2##3##(1995-2#1)(2011-2#1)
replication capacity of##3##3##(1996-7#1)(2008-1#1)(2013-1#1)
replication capacity##4##2##(1996-7#2)(2008-1#1)(2013-1#1)
replication compared with##2##3##(2008-5#1)(2013-1#1)
replication complex##4##2##(1994-11#2)(2008-11#2)
replication complexes##2##2##(1995-2#1)(1997-4#1)
replication cycle and##4##3##(1997-4#1)(2010-7#1)(2011-3#2)
replication cycle##11##2##(1996-1#1)(1997-4#1)(2008-10#2)(2008-4#1)(2010-7#1)(2011-1#1)(2011-3#4)
replication deficient retrovirus carrying##2##4##(1994-5#1)(2008-11#1)
replication deficient##4##2##(1994-5#2)(1997-7#1)(2008-11#1)
replication during##3##2##(1990-9#1)(1996-5#1)(1997-3#1)
replication efficiency##3##2##(2011-2#1)(2013-1#2)
replication enhancer##3##2##(1993-11#3)
replication fidelity##2##2##(2008-2#1)(2009-9#1)
replication for##2##2##(1990-10#1)(2012-2#1)
replication fork and##2##3##(1991-12#1)(2012-2#1)
replication fork movement##2##3##(1994-12#2)
replication fork progression##3##3##(2012-3#3)
replication fork##22##2##(1990-12#1)(1991-12#3)(1992-3#4)(1994-12#4)(1994-9#2)(1995-5#1)(1996-8#1)(2011-2#1)(2012-2#1)(2012-3#4)
replication forks##9##2##(1992-3#1)(2008-8#2)(2011-2#1)(2012-3#5)
replication from the##4##3##(1997-4#1)(1997-6#1)(2007-12#2)
replication from##7##2##(1997-4#1)(1997-6#2)(2006-10#2)(2007-12#2)
replication has been##2##3##(1995-12#1)(2008-9#1)
replication in Escherichia coli##3##4##(1991-12#1)(1994-11#1)(1995-1#1)
replication in cell culture##2##4##(1997-3#1)(2013-8#1)
replication in human##2##3##(1997-6#1)(2012-2#1)
replication in the##8##3##(1995-5#1)(1996-10#1)(1996-7#1)(1997-4#1)(2007-6#1)(2008-8#1)(2010-7#1)(2011-2#1)
replication in vitro##7##3##(1994-6#1)(1994-9#1)(1995-12#1)(1996-8#1)(1997-3#1)(2011-2#1)(2013-8#1)
replication in vivo and in vitro##3##6##(1991-12#1)(1994-12#2)
replication in vivo##6##3##(1991-12#1)(1994-12#2)(1996-7#1)(1997-5#1)(2009-10#1)
replication in##57##2##(1990-12#1)(1990-8#2)(1991-10#1)(1991-11#1)(1991-12#2)(1992-4#1)(1994-11#1)(1994-12#3)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#2)(2005-9#1)(2007-11#2)(2007-6#1)(2007-8#1)(2008-5#1)(2008-8#2)(2009-10#1)(2010-2#1)(2010-7#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#4)
replication initiation##2##2##(1990-9#1)(1991-8#1)
replication into##2##2##(1993-12#1)(1997-4#1)
replication is the##2##3##(1997-2#1)(2013-8#1)
replication is##20##2##(1990-12#1)(1990-5#1)(1991-8#1)(1995-2#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-2#1)(2010-2#1)(2011-1#2)(2013-8#1)
replication licensing##3##2##(2011-1#3)
replication machinery##3##2##(1994-9#2)(2010-2#1)
replication may##2##2##(1996-10#1)(2011-1#1)
replication occurred##2##2##(2008-10#2)
replication of AZT-resistant strains of HIV-1##2##6##(1994-6#2)
replication of AZT-resistant##3##3##(1994-6#3)
replication of DNA##2##3##(1991-10#1)(2010-4#1)
replication of HCV##2##3##(2012-2#2)
replication of HIV##2##3##(2008-5#1)(2011-3#1)
replication of HIV-1 in##2##4##(1993-9#1)(2007-11#1)
replication of HIV-1##8##3##(1991-10#1)(1991-3#1)(1993-9#1)(1996-4#1)(2007-11#1)(2011-2#1)(2011-3#2)
replication of HSV in##2##4##(2008-5#1)(2008-9#1)
replication of a##4##3##(1991-1#1)(1991-12#1)(1995-2#1)(2010-12#1)
replication of both##2##3##(1994-6#1)(2009-6#1)
replication of human immunodeficiency virus##5##5##(1991-7#1)(1991-9#1)(1995-8#1)(1996-1#1)(2010-2#1)
replication of human##7##3##(1991-7#1)(1991-9#1)(1995-8#1)(1996-1#1)(1996-4#1)(2008-9#1)(2010-2#1)
replication of the virus##4##4##(1995-8#1)(2008-5#2)(2013-8#1)
replication of the##19##3##(1990-11#1)(1990-7#1)(1992-12#1)(1993-3#1)(1993-5#1)(1995-8#2)(1997-1#1)(1997-3#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
replication of these##2##3##(2006-10#1)(2008-10#1)
replication of this##2##3##(1997-3#1)(2012-12#1)
replication of##102##2##(1990-11#2)(1990-3#1)(1990-7#1)(1991-1#3)(1991-10#2)(1991-12#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#1)(1993-3#1)(1993-5#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-6#5)(1994-8#2)(1995-12#1)(1995-2#2)(1995-8#3)(1996-1#1)(1996-2#1)(1996-4#3)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-3#2)(1997-4#1)(2005-12#1)(2006-10#2)(2006-2#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-11#5)(2008-4#1)(2008-5#4)(2008-7#1)(2008-9#6)(2009-6#1)(2009-7#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#2)
replication on the##2##3##(1994-8#1)(2008-12#1)
replication or##3##2##(2006-12#1)(2008-10#1)(2012-3#1)
replication origin region##2##3##(1995-8#2)
replication origin##15##2##(1990-9#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-12#1)(1994-11#1)(1994-12#3)(1994-8#1)(1995-8#2)(1997-4#1)(2008-10#1)
replication origins##6##2##(1990-10#1)(1991-5#1)(2008-7#4)
replication primer##2##2##(1991-10#1)(1991-8#1)
replication process##4##2##(2006-12#1)(2008-3#2)(2010-3#1)
replication protein A##3##3##(1993-3#1)(1994-11#1)(1996-8#1)
replication protein##6##2##(1993-3#1)(1994-11#1)(1996-8#1)(2008-10#2)(2008-5#1)
replication proteins##4##2##(1992-5#1)(2008-7#2)(2012-2#1)
replication region##3##2##(1990-11#2)(1997-4#1)
replication remain##2##2##(2008-8#1)(2008-9#1)
replication should be##2##3##(1996-7#1)(2009-11#1)
replication specificity element##2##3##(2008-10#2)
replication specificity##5##2##(2008-10#5)
replication stress##6##2##(2011-2#5)(2012-3#1)
replication that##2##2##(1994-12#2)
replication time##2##2##(1993-2#1)(2008-12#1)
replication to##2##2##(2008-5#1)(2013-1#1)
replication was##12##2##(1991-9#1)(1997-3#2)(1997-5#1)(1997-6#1)(2007-6#1)(2008-10#4)(2008-11#1)(2008-5#1)
replication were##4##2##(1995-1#1)(1996-4#1)(2007-9#1)(2009-10#1)
replication with a##2##3##(1994-11#1)(2012-2#1)
replication with##7##2##(1993-3#2)(1994-11#1)(2006-10#2)(2007-12#1)(2012-2#1)
replication within##2##2##(2012-11#1)(2013-8#1)
replication##829##1##(1990-10#4)(1990-11#9)(1990-12#8)(1990-2#1)(1990-3#4)(1990-5#7)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#4)(1991-1#4)(1991-10#6)(1991-11#1)(1991-12#9)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#5)(1991-6#1)(1991-7#5)(1991-8#6)(1991-9#3)(1992-11#1)(1992-12#6)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#2)(1992-8#2)(1993-11#5)(1993-12#1)(1993-2#4)(1993-3#7)(1993-5#4)(1993-6#2)(1993-9#8)(1994-11#20)(1994-12#24)(1994-2#3)(1994-3#4)(1994-5#7)(1994-6#9)(1994-7#2)(1994-8#15)(1994-9#13)(1995-1#14)(1995-11#1)(1995-12#4)(1995-2#21)(1995-3#6)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#5)(1995-9#1)(1996-1#2)(1996-10#3)(1996-11#4)(1996-12#2)(1996-2#1)(1996-4#7)(1996-5#4)(1996-6#3)(1996-7#8)(1996-8#7)(1997-1#8)(1997-2#7)(1997-3#18)(1997-4#18)(1997-5#8)(1997-6#11)(1997-7#3)(1997-8#1)(2004-11#1)(2005-12#1)(2005-7#5)(2005-9#1)(2006-10#9)(2006-11#4)(2006-12#2)(2006-2#2)(2006-8#2)(2007-11#6)(2007-12#5)(2007-3#2)(2007-6#3)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#57)(2008-11#19)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#8)(2008-5#20)(2008-6#2)(2008-7#19)(2008-8#15)(2008-9#27)(2009-10#3)(2009-11#4)(2009-12#2)(2009-2#7)(2009-3#1)(2009-6#3)(2009-7#2)(2009-8#4)(2009-9#2)(2010-10#1)(2010-11#3)(2010-12#3)(2010-2#8)(2010-3#3)(2010-4#2)(2010-7#3)(2010-9#1)(2011-1#17)(2011-2#18)(2011-3#11)(2012-1#1)(2012-11#1)(2012-12#8)(2012-2#20)(2012-3#20)(2013-1#30)(2013-7#1)(2013-8#16)
replication-associated protein (Rep)##2##3##(2008-10#2)
replication-associated protein##3##2##(2008-10#3)
replication-associated##5##1##(2008-10#3)(2011-2#2)
replication-competent human##2##2##(2008-4#1)(2012-12#1)
replication-competent##7##1##(1995-2#1)(1996-4#1)(2008-11#1)(2008-4#3)(2012-12#1)
replication-defective adenovirus##3##2##(1993-9#1)(1994-3#1)(1994-9#1)
replication-defective##14##1##(1993-9#1)(1994-3#1)(1994-9#1)(2007-1#1)(2007-6#1)(2008-11#1)(2008-4#4)(2008-5#1)(2008-9#1)(2013-1#1)(2013-7#1)
replication-deficient##4##1##(1994-5#1)(1996-3#1)(2007-3#1)(2008-9#1)
replication-dependent histone genes##2##3##(1996-4#2)
replication-dependent##4##1##(1995-6#1)(1996-4#3)
replication-linked##2##1##(1994-9#2)
replication-related##2##1##(1995-6#2)
replication-unlinked##4##1##(1994-9#4)
replications and##2##2##(2010-9#1)(2012-3#1)
replications for##2##2##(2006-5#1)(2008-10#1)
replications in##4##2##(1994-12#1)(2008-10#1)(2008-12#1)(2012-3#1)
replications##30##1##(1993-2#1)(1994-12#1)(2006-5#1)(2008-10#12)(2008-12#8)(2010-4#1)(2010-9#1)(2012-3#5)
replicative DNA##2##2##(1993-3#1)(1994-12#1)
replicative capacity##4##2##(2006-10#2)(2008-1#1)(2008-4#1)
replicative form##2##2##(1990-9#1)(1991-5#1)
replicative life span##2##3##(1991-8#1)(2008-11#1)
replicative senescence##4##2##(1992-9#2)(1997-7#1)(2011-2#1)
replicative##37##1##(1990-9#1)(1991-1#1)(1991-5#1)(1991-8#1)(1992-9#3)(1993-11#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-8#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-10#3)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2009-4#3)(2010-12#1)(2011-2#2)(2011-3#3)(2012-3#1)
replicator networks##2##2##(1995-9#2)
replicon and##2##2##(1990-9#1)(1991-9#1)
replicon of##2##2##(1990-9#1)(1996-9#1)
replicon##20##1##(1990-9#4)(1991-8#1)(1991-9#2)(1994-12#1)(1996-9#2)(1997-2#1)(2008-4#1)(2008-8#1)(2011-2#5)(2012-2#1)(2012-3#1)
replicons##10##1##(1994-12#1)(1996-9#1)(1997-3#1)(1997-4#1)(2008-4#3)(2011-2#3)
replied to the##2##3##(1992-8#1)(2008-12#1)
replied to##3##2##(1992-8#1)(2008-12#1)(2011-2#1)
replied##8##1##(1990-9#1)(1992-8#1)(1994-2#1)(1996-9#1)(2006-8#1)(2007-7#1)(2008-12#1)(2011-2#1)
replies from##3##2##(1990-9#1)(1996-2#1)(2008-4#1)
replies##9##1##(1990-8#1)(1990-9#1)(1992-8#1)(1993-3#1)(1993-5#2)(1995-7#1)(1996-2#1)(2008-4#1)
reply to##12##2##(1993-12#1)(1993-3#1)(1993-6#1)(1995-5#1)(2004-4#1)(2006-7#1)(2007-12#1)(2008-2#2)(2008-8#1)(2009-4#1)(2012-3#1)
reply##121##1##(1990-11#2)(1990-12#1)(1990-4#2)(1990-6#1)(1990-7#3)(1990-9#2)(1991-12#1)(1991-9#3)(1992-11#1)(1992-3#2)(1992-6#1)(1992-8#3)(1992-9#1)(1993-12#1)(1993-3#3)(1993-6#2)(1993-8#1)(1994-2#2)(1994-5#1)(1995-10#1)(1995-11#2)(1995-2#3)(1995-5#3)(1995-7#5)(1997-8#1)(2004-4#1)(2005-4#1)(2005-7#1)(2006-12#1)(2006-7#3)(2007-12#1)(2007-4#37)(2008-10#2)(2008-11#1)(2008-2#3)(2008-7#1)(2008-8#1)(2009-4#1)(2009-9#2)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#5)(2013-8#3)
repolarization abnormalities##2##2##(2010-8#2)
repolarization in##2##2##(1992-11#1)(2013-7#1)
repolarization of the##2##3##(1996-10#1)(1996-2#1)
repolarization of##4##2##(1996-10#1)(1996-2#1)(2007-12#1)(2007-9#1)
repolarization##38##1##(1991-3#1)(1992-11#1)(1993-12#2)(1994-3#1)(1995-6#2)(1996-10#1)(1996-2#1)(1997-8#3)(2007-12#1)(2007-9#5)(2008-8#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-8#4)(2011-1#1)(2011-2#1)(2012-3#6)(2013-7#1)
repolarizing effect##2##2##(1992-11#2)
repolarizing##4##1##(1992-11#2)(1992-12#1)(2010-8#1)
repolishing procedures##2##2##(2010-2#2)
repolishing##6##1##(2010-2#6)
repopulate the##2##2##(1997-4#1)(2006-6#1)
repopulating##2##1##(2008-9#1)(2009-3#1)
repopulation##3##1##(2007-11#1)(2008-1#2)
repor##2##1##(2008-6#2)
report &quot##5##2##(1990-11#1)(1992-2#1)(2006-8#1)(2007-12#1)(2007-4#1)
report 10 patients##2##3##(2008-1#1)(2008-6#1)
report 10##3##2##(2008-1#1)(2008-6#1)(2012-2#1)
report 2 cases of##4##4##(2006-10#1)(2008-4#2)(2009-3#1)
report 2 cases##5##3##(2006-10#1)(2008-3#1)(2008-4#2)(2009-3#1)
report 2##9##2##(1996-11#1)(2006-10#2)(2007-7#1)(2008-3#1)(2008-4#2)(2009-3#1)(2010-11#1)
report 3 cases of##5##4##(1992-4#1)(2007-10#1)(2009-1#1)(2010-2#1)(2012-2#1)
report 3 cases##6##3##(1992-4#1)(1995-9#1)(2007-10#1)(2009-1#1)(2010-2#1)(2012-2#1)
report 7##3##2##(1990-3#1)(2006-9#1)(2013-8#1)
report a 28-year-old##4##3##(2007-8#1)(2009-6#1)(2013-1#1)(2013-8#1)
report a 30-year-old##5##3##(2007-10#1)(2012-12#1)(2013-1#2)(2013-8#1)
report a 50-year-old man with##2##5##(2008-7#1)(2010-6#1)
report a 50-year-old man##3##4##(2008-7#1)(2010-6#1)(2012-2#1)
report a 50-year-old##4##3##(2008-7#1)(2009-5#1)(2010-6#1)(2012-2#1)
report a 72-year-old female##2##4##(2012-1#1)(2012-12#1)
report a case in which a##2##6##(2007-8#1)(2012-2#1)
report a case in which##6##5##(1990-2#1)(1992-2#1)(2007-7#1)(2007-8#1)(2012-2#2)
report a case in##7##4##(1990-2#1)(1992-2#1)(2007-7#1)(2007-8#1)(2009-9#1)(2012-2#2)
report a case of a 16-year-old##2##6##(2011-1#1)(2012-3#1)
report a case of a 36-year-old man with##2##8##(2006-10#1)(2012-2#1)
report a case of a patient who underwent##2##8##(2007-3#1)(2012-2#1)
report a case of a patient with##6##7##(2006-9#1)(2007-8#1)(2009-8#1)(2010-4#1)(2012-2#1)(2012-3#1)
report a case of a patient##9##6##(2006-9#1)(2007-3#1)(2007-8#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-2#2)(2012-3#1)
report a case of a three##2##6##(2007-7#1)(2009-11#1)
report a case of a##96##5##(1991-11#1)(1991-9#1)(1992-5#1)(1996-12#1)(1997-6#1)(2006-10#5)(2006-4#1)(2006-9#1)(2007-12#1)(2007-3#2)(2007-5#1)(2007-7#3)(2007-8#7)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#3)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#5)(2011-12#2)(2011-2#4)(2012-1#1)(2012-12#8)(2012-2#8)(2012-3#3)(2013-1#5)(2013-8#4)
report a case of acute##10##5##(1992-6#1)(2007-8#2)(2008-10#1)(2009-8#1)(2010-4#2)(2010-6#1)(2013-1#2)
report a case of an elderly##3##6##(2008-6#1)(2010-5#1)(2012-2#1)
report a case of an##16##5##(2006-4#1)(2007-5#1)(2007-8#1)(2008-12#1)(2008-6#1)(2009-4#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#2)
report a case of benign##2##5##(1990-10#1)(2011-1#1)
report a case of chronic##3##5##(2007-12#1)(2007-7#1)(2008-11#1)
report a case of congenital##3##5##(2006-8#1)(2008-12#1)(2010-11#1)
report a case of familial##2##5##(1992-9#1)(2009-12#1)
report a case of inflammatory##3##5##(2006-10#1)(2010-6#1)(2012-2#1)
report a case of leiomyosarcoma of the##2##7##(1991-9#1)(2008-5#1)
report a case of malignant##2##5##(1991-12#1)(1993-10#1)
report a case of massive##2##5##(2006-6#1)(2011-1#1)
report a case of primary##7##5##(1992-2#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-8#1)
report a case of retroperitoneal##2##5##(1990-6#1)(1994-6#1)
report a case of severe##7##5##(1990-10#1)(1991-11#1)(2007-8#2)(2012-2#2)(2013-8#1)
report a case of spontaneous##4##5##(1992-2#1)(2007-8#2)(2008-7#1)
report a case of successful##4##5##(2012-1#1)(2012-12#2)(2013-8#1)
report a case of##386##4##(1990-10#2)(1990-12#1)(1990-6#3)(1990-8#1)(1991-11#2)(1991-12#1)(1991-4#1)(1991-6#1)(1991-9#3)(1992-10#1)(1992-2#3)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#2)(1993-7#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-6#1)(1997-8#1)(2004-7#1)(2005-11#1)(2005-12#1)(2006-1#1)(2006-10#17)(2006-2#1)(2006-4#6)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#5)(2007-2#1)(2007-3#4)(2007-5#3)(2007-6#1)(2007-7#16)(2007-8#31)(2008-1#3)(2008-10#8)(2008-11#6)(2008-12#12)(2008-4#2)(2008-5#5)(2008-6#6)(2008-7#14)(2008-8#6)(2008-9#3)(2009-1#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#5)(2009-5#5)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#3)(2010-10#1)(2010-11#3)(2010-12#7)(2010-2#2)(2010-3#2)(2010-4#6)(2010-5#1)(2010-6#9)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#14)(2011-12#4)(2011-2#15)(2012-1#3)(2012-12#21)(2012-2#26)(2012-3#11)(2013-1#16)(2013-8#13)
report a case that##3##4##(2007-12#1)(2010-4#1)(2012-2#1)
report a case where##8##4##(1991-11#1)(1995-7#1)(2006-4#1)(2007-8#1)(2007-9#1)(2008-9#1)(2010-12#1)(2012-12#1)
report a case##421##3##(1990-10#2)(1990-12#1)(1990-2#1)(1990-6#3)(1990-8#1)(1991-11#3)(1991-12#1)(1991-4#2)(1991-6#1)(1991-9#3)(1992-10#1)(1992-2#4)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#2)(1993-7#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-7#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-6#1)(1997-8#1)(2004-7#1)(2005-11#1)(2005-12#2)(2006-1#1)(2006-10#18)(2006-2#1)(2006-4#7)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#6)(2007-2#1)(2007-3#4)(2007-5#3)(2007-6#1)(2007-7#17)(2007-8#34)(2007-9#1)(2008-1#3)(2008-10#9)(2008-11#6)(2008-12#13)(2008-4#2)(2008-5#6)(2008-6#6)(2008-7#14)(2008-8#6)(2008-9#4)(2009-1#2)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#5)(2009-5#5)(2009-6#4)(2009-7#1)(2009-8#4)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#8)(2010-2#2)(2010-3#2)(2010-4#7)(2010-5#1)(2010-6#9)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#15)(2011-12#4)(2011-2#15)(2012-1#3)(2012-12#22)(2012-2#29)(2012-3#11)(2013-1#18)(2013-8#13)
report a clinical##2##3##(1991-12#1)(1993-10#1)
report a dramatic##2##3##(1993-7#1)(2008-7#1)
report a family##2##3##(2009-10#1)(2012-2#1)
report a fatal case of##3##5##(1995-7#1)(2010-12#1)(2012-3#1)
report a female patient with##3##5##(2012-12#1)(2013-1#2)
report a female patient##4##4##(2012-12#2)(2013-1#2)
report a first##2##3##(2011-1#1)(2012-2#1)
report a method for##2##4##(2007-12#1)(2008-10#1)
report a method##6##3##(1992-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-9#1)
report a modified##2##3##(1993-2#1)(2010-7#1)
report a near complete##2##4##(2007-10#1)(2009-7#1)
report a new case of##2##5##(2007-8#1)(2010-8#1)
report a new case##4##4##(1991-11#1)(2007-8#1)(2009-1#1)(2010-8#1)
report a new method##6##4##(1996-11#1)(2008-2#3)(2008-9#1)(2010-8#1)
report a new##30##3##(1990-8#1)(1991-11#1)(1991-3#1)(1994-3#1)(1996-11#1)(1997-6#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-3#1)(2009-9#1)(2010-8#2)(2012-2#1)
report a novel case of##2##5##(2008-3#1)(2011-1#1)
report a novel method##7##4##(2007-12#2)(2007-8#1)(2008-11#1)(2009-7#1)(2010-12#1)(2013-1#1)
report a novel technique##3##4##(2007-12#1)(2008-3#1)(2011-2#1)
report a novel##29##3##(1994-9#1)(1997-4#1)(2007-11#1)(2007-12#8)(2007-8#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
report a patient who developed##4##5##(2007-7#1)(2008-12#1)(2008-7#1)(2010-12#1)
report a patient who##11##4##(2006-10#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-7#1)(2009-3#1)(2010-12#1)(2011-1#1)(2012-2#1)
report a patient with##16##4##(2005-9#1)(2006-10#2)(2007-10#1)(2008-1#1)(2008-7#3)(2008-8#1)(2009-3#1)(2010-7#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
report a patient##33##3##(2005-9#1)(2006-10#4)(2007-10#3)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-12#1)(2008-7#4)(2008-8#1)(2009-3#2)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
report a practical##2##3##(2007-12#1)(2010-8#1)
report a precision of##4##4##(2013-1#4)
report a precision##5##3##(2006-12#1)(2013-1#4)
report a rare case of a##7##6##(2007-8#1)(2010-12#2)(2010-5#1)(2012-2#1)(2012-3#1)(2013-2#1)
report a rare case of##38##5##(1991-12#1)(1992-12#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#2)(2008-12#4)(2008-6#1)(2008-7#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-12#4)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-2#1)(2013-8#1)
report a rare complication##2##4##(2008-7#1)(2012-3#1)
report a rare##46##3##(1991-12#1)(1992-12#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#2)(2008-12#4)(2008-4#1)(2008-6#1)(2008-7#3)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#4)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#2)(2013-2#1)(2013-8#1)
report a retrospective analysis of##2##5##(2008-5#1)(2011-2#1)
report a retrospective study of##3##5##(1993-5#1)(2007-8#2)
report a retrospective##5##3##(1993-5#1)(2007-8#2)(2008-5#1)(2011-2#1)
report a series of patients##2##5##(2012-12#2)
report a series of##10##4##(1990-10#1)(1993-5#1)(2007-12#1)(2008-12#1)(2008-4#1)(2009-7#1)(2011-1#1)(2012-11#1)(2012-12#2)
report a significant##2##3##(2007-6#1)(2011-2#1)
report a similar##2##3##(1992-12#1)(1996-12#1)
report a simple##7##3##(1990-7#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-2#1)(2008-7#1)
report a single##3##3##(2007-10#1)(2009-10#1)(2013-1#1)
report a synthetic strategy for##2##5##(2007-8#1)(2010-12#1)
report a technique of##4##4##(2006-6#1)(2008-6#1)(2012-12#2)
report a technique##6##3##(2006-6#1)(2007-8#1)(2008-6#1)(2009-2#1)(2012-12#2)
report a unique case of##3##5##(2007-10#2)(2011-1#1)
report a unique##5##3##(2007-10#2)(2008-10#1)(2010-5#1)(2011-1#1)
report a##875##2##(1990-10#3)(1990-12#2)(1990-2#2)(1990-3#1)(1990-6#4)(1990-7#1)(1990-8#2)(1991-11#4)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#2)(1991-6#1)(1991-9#5)(1992-10#1)(1992-12#3)(1992-2#5)(1992-5#2)(1992-6#3)(1992-8#2)(1992-9#2)(1993-10#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-5#2)(1993-7#3)(1993-9#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-5#2)(1995-7#3)(1996-11#1)(1996-12#2)(1996-4#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-4#2)(1997-6#2)(1997-8#3)(2004-2#1)(2004-7#1)(2005-10#1)(2005-11#2)(2005-12#2)(2005-9#1)(2006-1#2)(2006-10#24)(2006-12#4)(2006-2#1)(2006-4#7)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#13)(2007-11#21)(2007-12#45)(2007-2#4)(2007-3#4)(2007-5#4)(2007-6#4)(2007-7#27)(2007-8#57)(2007-9#3)(2008-1#11)(2008-10#16)(2008-11#11)(2008-12#21)(2008-2#10)(2008-3#6)(2008-4#6)(2008-5#11)(2008-6#11)(2008-7#35)(2008-8#9)(2008-9#6)(2009-1#3)(2009-10#4)(2009-11#2)(2009-12#1)(2009-2#5)(2009-3#6)(2009-4#6)(2009-5#9)(2009-6#8)(2009-7#5)(2009-8#4)(2009-9#6)(2010-1#1)(2010-10#1)(2010-11#5)(2010-12#20)(2010-2#4)(2010-3#6)(2010-4#8)(2010-5#7)(2010-6#12)(2010-7#4)(2010-8#7)(2010-9#2)(2011-1#27)(2011-12#4)(2011-2#25)(2012-1#6)(2012-11#5)(2012-12#40)(2012-2#57)(2012-3#17)(2013-1#48)(2013-2#1)(2013-7#1)(2013-8#25)
report about a##6##3##(1990-3#1)(1994-5#1)(2005-1#1)(2007-7#1)(2007-8#2)
report about the##3##3##(1993-5#1)(2004-9#1)(2007-2#1)
report about##14##2##(1990-3#1)(1993-5#1)(1994-5#1)(1997-4#1)(2004-9#1)(2005-1#1)(2007-2#1)(2007-7#1)(2007-8#2)(2009-3#1)(2010-4#1)(2013-1#1)(2013-8#1)
report addresses the##5##3##(2008-5#2)(2011-2#1)(2012-12#1)(2012-2#1)
report adds to the##2##4##(2007-12#1)(2009-2#1)
report adverse##6##2##(2007-2#1)(2009-7#1)(2011-2#1)(2013-1#2)(2013-8#1)
report aims to##7##3##(1997-7#1)(2006-9#1)(2007-1#1)(2007-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
report aims##8##2##(1997-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
report allows##2##2##(1992-10#1)(2013-1#1)
report also##7##2##(1995-12#1)(2006-10#1)(2007-12#1)(2007-9#1)(2010-5#2)(2012-3#1)
report an analytical##2##3##(2007-11#1)(2008-10#1)
report an illustrative case##2##4##(2007-7#1)(2008-4#1)
report an improved##3##3##(1991-9#1)(2007-11#1)(2008-11#1)
report an interesting case of##3##5##(2007-11#1)(2010-6#2)
report an unexpected##2##3##(1996-12#1)(2008-3#1)
report an unusual case of##22##5##(2006-10#2)(2006-8#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2009-10#1)(2010-10#1)(2010-2#1)(2010-9#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
report an unusual case##23##4##(2006-10#2)(2006-8#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2009-10#1)(2010-10#1)(2010-2#1)(2010-9#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
report an unusual##26##3##(2006-10#2)(2006-8#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-7#1)(2009-10#2)(2010-10#1)(2010-2#1)(2010-9#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
report an##99##2##(1990-11#1)(1991-3#1)(1991-9#1)(1994-10#1)(1995-2#1)(1996-12#2)(1997-5#1)(1997-8#2)(2006-10#3)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#6)(2007-12#7)(2007-3#2)(2007-7#5)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-9#1)(2009-10#5)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-2#4)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#1)
report analytical##3##2##(2007-3#1)(2008-10#1)(2008-8#1)
report and a##10##3##(2005-11#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-1#1)(2007-2#1)(2008-1#1)(2013-1#3)
report and brief##4##3##(2006-4#1)(2010-12#1)(2012-3#1)(2013-1#1)
report and discuss the##3##4##(2008-9#1)(2009-10#1)(2010-2#1)
report and discuss##5##3##(2008-10#1)(2008-9#1)(2009-10#1)(2010-2#1)(2012-12#1)
report and literature review##41##4##(2006-12#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-2#1)(2008-1#1)(2008-11#1)(2008-12#6)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#2)(2009-10#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#5)(2012-12#2)(2013-1#5)(2013-8#2)
report and literature review]##8##4##(1993-8#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#4)
report and literature##49##3##(1993-8#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-2#1)(2008-1#1)(2008-11#1)(2008-12#6)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#5)(2012-12#3)(2012-2#4)(2013-1#5)(2013-8#2)
report and management##2##3##(2008-12#1)(2013-1#1)
report and objective##2##3##(1990-8#1)(2008-12#1)
report and review of literature##26##5##(2005-9#1)(2006-10#1)(2006-5#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-6#3)(2009-7#1)(2010-11#1)(2010-12#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
report and review of the literature##90##6##(1992-2#1)(2005-10#1)(2005-12#2)(2005-8#1)(2006-10#5)(2006-12#8)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#4)(2007-2#7)(2007-3#5)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#1)(2008-9#3)(2009-6#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#2)
report and review of the literature]##15##6##(1991-9#1)(1992-9#1)(1993-10#1)(1993-6#1)(1993-9#1)(2008-10#5)(2008-8#1)(2008-9#2)(2010-9#1)(2011-2#1)
report and review of the##107##5##(1991-9#1)(1992-2#1)(1992-9#1)(1993-10#1)(1993-6#1)(1993-9#1)(2005-10#1)(2005-12#2)(2005-8#1)(2006-10#5)(2006-12#8)(2006-7#1)(2006-8#2)(2007-10#1)(2007-12#4)(2007-2#7)(2007-3#5)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#2)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#5)(2009-6#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#2)
report and review of##139##4##(1991-9#1)(1992-2#1)(1992-9#1)(1993-10#1)(1993-6#1)(1993-9#1)(2005-10#1)(2005-12#2)(2005-8#1)(2005-9#1)(2006-10#6)(2006-12#8)(2006-5#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-12#5)(2007-2#7)(2007-3#5)(2007-4#2)(2007-5#2)(2007-6#3)(2007-7#2)(2008-1#3)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#6)(2008-7#1)(2008-8#2)(2008-9#5)(2009-5#1)(2009-6#4)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#2)(2011-2#5)(2012-12#5)(2012-2#3)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#2)
report and review##153##3##(1991-9#1)(1992-2#1)(1992-9#1)(1993-10#1)(1993-6#1)(1993-7#1)(1993-9#1)(2005-10#1)(2005-12#2)(2005-8#1)(2005-9#1)(2006-10#7)(2006-12#8)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#7)(2007-3#5)(2007-4#2)(2007-5#3)(2007-6#3)(2007-7#2)(2008-1#3)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#6)(2008-7#1)(2008-8#2)(2008-9#5)(2009-5#2)(2009-6#4)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#2)(2011-2#5)(2012-12#5)(2012-2#5)(2012-3#3)(2013-1#8)(2013-7#2)(2013-8#2)
report and the##2##3##(1996-2#1)(2009-2#1)
report and##263##2##(1990-8#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-4#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-10#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#1)(1995-2#1)(1996-2#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-8#1)(2005-9#1)(2006-10#7)(2006-12#12)(2006-4#3)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#5)(2007-11#2)(2007-12#5)(2007-2#9)(2007-3#6)(2007-4#3)(2007-5#4)(2007-6#4)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#9)(2008-11#4)(2008-12#10)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#9)(2008-7#3)(2008-8#5)(2008-9#9)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#5)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#2)(2011-12#1)(2011-2#15)(2012-12#10)(2012-2#9)(2012-3#5)(2013-1#18)(2013-7#2)(2013-8#4)
report any##2##2##(2007-4#1)(2008-4#1)
report are##11##2##(1991-12#1)(1993-11#1)(1993-2#1)(2008-10#1)(2008-9#1)(2011-12#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
report as##2##2##(2007-8#1)(2009-5#1)
report being##6##2##(1997-6#1)(2008-9#2)(2010-9#1)(2013-1#2)
report both##2##2##(2007-12#1)(2008-7#1)
report by the##5##3##(1993-3#1)(1994-12#1)(1995-1#1)(1995-2#1)(2007-4#1)
report by##15##2##(1992-3#1)(1992-9#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-2#1)(2007-4#1)(2007-9#5)(2008-12#1)(2010-11#1)(2010-12#1)
report can be##2##3##(1990-10#1)(1994-2#1)
report card on##3##3##(1993-6#1)(2008-12#1)(2010-12#1)
report card##12##2##(1992-3#1)(1993-6#1)(1994-2#1)(1995-2#1)(1997-3#4)(2008-12#1)(2009-10#1)(2010-12#1)(2011-2#1)
report cards for##4##3##(1996-3#1)(1997-2#2)(2011-2#1)
report cards in##2##3##(1996-3#1)(2011-2#1)
report cards on##2##3##(1997-3#2)
report cards##17##2##(1996-3#4)(1997-2#2)(1997-3#4)(2008-11#1)(2011-2#6)
report cases of##2##3##(2008-6#1)(2010-4#1)
report complex##2##2##(2008-11#1)(2008-12#1)
report concerning##5##2##(1992-1#1)(1995-11#1)(2006-12#1)(2008-5#1)(2011-1#1)
report concerns##2##2##(1990-3#1)(2008-4#1)
report confirming##3##2##(2011-2#2)(2013-1#1)
report confirms that##2##3##(2007-7#2)
report confirms##4##2##(1996-9#1)(2007-7#2)(2012-3#1)
report contains##2##2##(1991-2#1)(1993-12#1)
report data on##2##3##(2012-2#1)(2013-1#1)
report data##6##2##(1991-1#1)(1995-8#1)(2008-10#1)(2009-8#1)(2012-2#1)(2013-1#1)
report deals with a##3##4##(1993-5#1)(2006-10#1)(2008-9#1)
report deals with##7##3##(1993-5#2)(2006-10#1)(2008-11#1)(2008-9#1)(2009-10#1)(2009-2#1)
report demonstrated##3##2##(2011-12#1)(2011-2#1)(2013-1#1)
report demonstrates a##2##3##(1994-12#1)(2012-1#1)
report demonstrates that the##2##4##(1994-3#1)(2013-8#1)
report demonstrates that##10##3##(1991-12#1)(1994-3#1)(1997-6#1)(2005-11#1)(2006-8#1)(2007-2#1)(2008-10#1)(2009-4#1)(2010-11#1)(2013-8#1)
report demonstrates the feasibility##3##4##(2006-10#1)(2012-12#2)
report demonstrates the##9##3##(2006-10#1)(2007-8#1)(2008-1#1)(2008-5#1)(2012-12#2)(2012-2#2)(2013-7#1)
report demonstrates##23##2##(1990-12#1)(1991-12#1)(1994-12#1)(1994-3#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-5#1)(2009-4#1)(2010-11#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-7#1)(2013-8#1)
report demonstrating##4##2##(2008-10#2)(2008-11#1)(2008-6#1)
report described##3##2##(2008-10#1)(2012-12#2)
report describes a case of a##3##6##(1994-12#1)(2008-11#1)(2009-1#1)
report describes a case of##14##5##(1994-12#1)(2006-12#1)(2007-12#2)(2007-5#1)(2008-10#1)(2008-11#2)(2008-4#1)(2009-1#1)(2009-4#1)(2010-11#1)(2012-12#1)(2013-8#1)
report describes a method##2##4##(1995-2#1)(2012-2#1)
report describes a new##3##4##(2006-10#1)(2007-11#1)(2007-7#1)
report describes a patient with##4##5##(2006-10#1)(2006-4#1)(2007-4#1)(2012-2#1)
report describes a patient##7##4##(2006-10#1)(2006-4#1)(2007-3#1)(2007-4#1)(2008-7#1)(2011-1#1)(2012-2#1)
report describes a rare##3##4##(2010-4#1)(2010-7#1)(2013-1#1)
report describes a##63##3##(1993-12#1)(1994-12#1)(1995-2#2)(1997-7#1)(1997-8#1)(2005-12#1)(2006-10#6)(2006-12#1)(2006-4#1)(2006-5#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#2)(2009-1#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#5)(2012-2#3)(2013-1#3)(2013-7#2)(2013-8#1)
report describes an##6##3##(1992-5#1)(2006-10#1)(2007-7#1)(2008-5#1)(2013-1#2)
report describes the case of a##3##6##(2007-8#1)(2011-2#2)
report describes the clinical##3##4##(2007-12#1)(2011-1#1)(2012-12#1)
report describes the distribution of##2##5##(1997-3#1)(2008-2#1)
report describes the oral##2##4##(2008-5#1)(2011-2#1)
report describes the presence of##2##5##(2007-12#1)(2012-12#1)
report describes the results from##2##5##(2008-5#1)(2008-9#1)
report describes the results##6##4##(1991-5#1)(1997-7#1)(2006-10#1)(2008-5#1)(2008-9#1)(2013-1#1)
report describes the##75##3##(1990-2#1)(1990-4#1)(1991-10#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-7#1)(1993-12#2)(1994-11#1)(1995-3#2)(1995-6#1)(1995-8#3)(1996-10#1)(1996-11#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#2)(2004-9#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-12#5)(2008-2#1)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-11#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#3)(2013-1#3)(2013-8#1)
report describes##168##2##(1990-12#1)(1990-2#1)(1990-4#1)(1991-10#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-5#1)(1992-7#1)(1993-12#3)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-2#2)(1995-3#3)(1995-6#2)(1995-8#3)(1996-10#1)(1996-11#1)(1996-12#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#3)(1997-8#1)(2004-9#1)(2005-12#1)(2006-1#1)(2006-10#9)(2006-12#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#6)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#6)(2008-1#3)(2008-10#8)(2008-11#4)(2008-12#5)(2008-2#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#4)(2011-2#6)(2012-12#8)(2012-2#7)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#2)
report describing the##3##3##(1997-4#1)(2008-10#1)(2008-8#1)
report describing##8##2##(1994-12#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-11#1)(2010-2#1)
report detailed##2##2##(2008-11#1)(2013-8#1)
report details a##2##3##(2010-12#1)(2012-12#1)
report details##5##2##(1996-8#1)(2008-6#1)(2010-12#1)(2011-2#1)(2012-12#1)
report direct##2##2##(1990-11#1)(2007-12#1)
report discusses the##6##3##(2007-12#1)(2007-9#1)(2008-11#1)(2008-12#1)(2011-12#1)(2011-2#1)
report discusses##11##2##(1991-6#1)(1995-8#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2011-12#1)(2011-2#1)(2013-8#1)
report documents##3##2##(1990-5#1)(1996-12#1)(2005-10#1)
report early##3##2##(2007-8#1)(2009-5#1)(2011-1#1)
report either##2##2##(2007-11#1)(2013-8#1)
report emphasizes that##3##3##(1990-3#1)(2007-12#1)(2012-2#1)
report emphasizes the importance##3##4##(1992-4#1)(2006-10#1)(2011-1#1)
report emphasizes the##6##3##(1991-2#1)(1992-4#1)(2006-10#1)(2010-4#1)(2011-1#1)(2012-12#1)
report emphasizes##9##2##(1990-3#1)(1991-2#1)(1992-4#1)(2006-10#1)(2007-12#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)
report evaluates the##2##3##(1992-7#1)(2008-7#1)
report evaluates##3##2##(1992-7#1)(2008-11#1)(2008-7#1)
report evidence that##3##3##(1994-9#1)(1995-8#1)(2007-9#1)
report evidence##7##2##(1991-5#1)(1994-9#1)(1995-8#2)(2007-9#1)(2008-5#1)(2012-1#1)
report examined at least##2##4##(2008-7#2)
report examines##3##2##(2008-10#1)(2009-10#1)(2013-8#1)
report experience##2##2##(1990-11#1)(1996-3#1)
report experimental##15##2##(1991-11#1)(2007-11#1)(2007-12#9)(2008-2#1)(2008-3#3)
report explains##2##2##(2006-2#1)(2010-5#1)
report extended##2##2##(2007-12#1)(2008-3#1)
report features##2##2##(2013-1#2)
report findings from an##2##4##(1995-3#1)(2006-11#1)
report findings from##3##3##(1994-6#1)(1995-3#1)(2006-11#1)
report findings##4##2##(1994-6#1)(1995-3#1)(2006-11#1)(2012-2#1)
report first results##2##3##(2007-12#1)(2007-9#1)
report first##3##2##(2007-12#1)(2007-9#1)(2008-10#1)
report focuses on the##3##4##(2008-5#1)(2010-11#1)(2012-2#1)
report focuses on##9##3##(1991-4#1)(1992-10#1)(2005-9#1)(2006-12#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-1#1)(2012-2#1)
report focuses##10##2##(1991-4#1)(1992-10#1)(1992-11#1)(2005-9#1)(2006-12#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-1#1)(2012-2#1)
report for the first time on##2##6##(1996-3#1)(2009-2#1)
report for the first time that##3##6##(1990-3#1)(2008-10#1)(2012-12#1)
report for the first time the successful##2##7##(1995-6#1)(2010-12#1)
report for the first time the##5##6##(1994-3#1)(1995-6#1)(1996-4#1)(2008-7#1)(2010-12#1)
report for the first time##12##5##(1990-3#1)(1992-6#1)(1994-3#1)(1995-6#1)(1996-3#1)(1996-4#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-2#1)(2010-12#1)(2012-12#1)
report for the##14##3##(1990-3#1)(1992-6#1)(1994-3#2)(1995-6#1)(1996-3#1)(1996-4#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-12#1)
report for##21##2##(1990-3#1)(1991-3#1)(1992-6#1)(1994-3#2)(1995-6#1)(1996-3#1)(1996-4#1)(1997-4#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-12#1)
report forms##2##2##(1996-1#1)(2007-11#1)
report four cases of##4##4##(1993-11#1)(2007-7#1)(2008-9#1)(2011-2#1)
report four##5##2##(1993-11#1)(2007-7#1)(2008-9#1)(2011-1#1)(2011-2#1)
report from a##2##3##(2007-2#1)(2007-9#1)
report from the International##3##4##(2008-7#1)(2009-5#2)
report from the National Heart##2##5##(2009-12#2)
report from the National##4##4##(2008-1#1)(2009-12#2)(2009-5#1)
report from the##27##3##(1991-1#1)(1993-8#1)(1996-1#1)(2005-11#2)(2005-6#1)(2006-10#1)(2006-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#4)(2009-12#2)(2009-5#3)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
report from##49##2##(1990-5#1)(1991-1#1)(1992-8#1)(1993-8#1)(1994-3#1)(1996-1#1)(1997-2#1)(2005-11#2)(2005-6#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-7#1)(2006-9#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#4)(2009-12#2)(2009-3#1)(2009-5#3)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
report further##3##2##(2008-7#1)(2012-2#1)(2013-1#1)
report gene##3##2##(2008-8#1)(2008-9#2)
report generation##2##2##(2007-11#1)(2011-2#1)
report gives an overview of##2##5##(2008-10#1)(2010-11#1)
report gives an##4##3##(2005-3#1)(2008-10#1)(2008-11#1)(2010-11#1)
report gives##8##2##(2005-3#1)(2008-10#3)(2008-11#1)(2008-6#1)(2010-11#1)(2010-5#1)
report greater##3##2##(2008-6#1)(2010-9#1)(2011-1#1)
report has described the##2##4##(1992-8#1)(2013-8#1)
report has##7##2##(1990-12#1)(1992-8#1)(2008-7#1)(2009-4#1)(2010-5#1)(2012-3#1)(2013-8#1)
report have##2##2##(1993-1#1)(2011-2#1)
report having##9##2##(1990-10#2)(1995-12#2)(1996-6#1)(1997-6#1)(2009-5#2)(2010-2#1)
report here a case of a##2##6##(1992-10#1)(2007-8#1)
report here a case of##14##5##(1992-10#1)(2007-11#1)(2007-7#6)(2007-8#1)(2009-2#1)(2010-1#1)(2012-11#1)(2012-2#1)(2013-8#1)
report here a novel##2##4##(1992-12#1)(2009-9#1)
report here a significant##2##4##(1990-11#1)(2013-1#1)
report here a##43##3##(1990-11#1)(1991-1#1)(1992-1#1)(1992-10#2)(1992-12#1)(1992-2#1)(1993-4#1)(1994-9#1)(1996-4#1)(1997-4#1)(1997-7#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#6)(2007-8#3)(2008-10#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-9#1)(2010-1#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
report here on##24##3##(1991-12#1)(1991-8#1)(1993-12#1)(1994-12#1)(1996-3#1)(2005-10#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#2)(2009-1#1)(2009-8#1)(2010-6#5)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-8#1)
report here that##72##3##(1990-5#1)(1990-6#1)(1990-7#1)(1991-1#3)(1991-10#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#3)(1992-12#1)(1992-6#1)(1992-8#2)(1993-11#3)(1993-2#1)(1993-6#1)(1993-8#2)(1993-9#3)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#4)(1994-9#2)(1995-1#3)(1995-11#3)(1995-2#2)(1995-3#2)(1995-8#2)(1996-2#2)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-7#2)(2006-5#1)(2007-12#1)(2008-11#1)(2008-9#1)(2009-10#1)(2009-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
report here the##61##3##(1990-11#1)(1990-12#1)(1990-4#1)(1991-10#3)(1991-2#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-11#3)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-3#3)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-5#2)(1997-9#1)(2005-8#1)(2006-12#3)(2006-7#1)(2007-2#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#2)(2009-3#1)(2009-7#3)(2010-12#1)(2011-1#1)(2011-2#1)(2011-8#1)(2012-2#1)
report here##232##2##(1990-11#2)(1990-12#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#3)(1991-1#4)(1991-10#5)(1991-12#1)(1991-2#2)(1991-5#3)(1991-7#2)(1991-8#3)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#6)(1992-12#2)(1992-2#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#5)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#4)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#4)(1994-5#3)(1994-8#7)(1994-9#4)(1995-1#3)(1995-11#5)(1995-12#1)(1995-2#3)(1995-3#2)(1995-8#2)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-4#3)(1997-5#3)(1997-7#4)(1997-9#1)(2005-10#1)(2005-8#1)(2006-12#3)(2006-5#2)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#2)(2007-3#2)(2007-6#1)(2007-7#7)(2007-8#5)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-2#2)(2009-3#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-6#5)(2011-1#2)(2011-2#4)(2011-8#1)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
report herein##28##2##(1991-11#1)(1995-1#1)(1996-10#1)(1997-4#1)(2004-11#1)(2006-8#1)(2007-11#2)(2007-8#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#1)
report high##4##2##(2010-11#1)(2012-3#1)(2013-1#2)
report higher levels of burnout than##2##6##(2010-9#2)
report higher levels of##3##4##(2010-9#2)(2011-1#1)
report higher##5##2##(1996-9#1)(2010-2#1)(2010-9#2)(2011-1#1)
report highlights the importance of##6##5##(2006-4#1)(2008-12#1)(2010-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
report highlights the need for##2##5##(2007-11#1)(2008-10#1)
report highlights the need to##2##5##(2007-9#1)(2012-3#1)
report highlights the need##4##4##(2007-11#1)(2007-9#1)(2008-10#1)(2012-3#1)
report highlights the##19##3##(2006-10#2)(2006-4#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-12#1)(2009-3#1)(2010-10#1)(2010-5#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
report highlights##22##2##(2006-10#2)(2006-4#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-12#1)(2009-3#1)(2010-10#1)(2010-5#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
report how##3##2##(1991-3#1)(2010-11#1)(2011-1#1)
report illustrates a##2##3##(2007-10#1)(2009-10#1)
report illustrates how##2##3##(2008-10#1)(2008-4#1)
report illustrates that##2##3##(2006-4#1)(2012-12#1)
report illustrates the##8##3##(1993-5#1)(1996-1#1)(2008-11#1)(2008-12#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
report illustrates##14##2##(1993-5#1)(1996-1#1)(2006-4#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-10#1)(2009-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
report improved##2##2##(2006-10#1)(2012-3#1)
report in a##2##3##(2006-6#1)(2012-2#1)
report in an##3##3##(2007-4#1)(2007-5#1)(2007-7#1)
report in one##2##3##(2007-7#1)(2013-8#1)
report in the English literature##2##5##(2009-3#1)(2011-2#1)
report in the literature of##2##5##(2007-8#1)(2009-3#1)
report in the literature##4##4##(2005-12#1)(2007-8#1)(2009-3#1)(2012-2#1)
report in the veterinary literature##2##5##(2007-2#1)(2012-2#1)
report in the##14##3##(1992-2#1)(1992-8#1)(1996-7#1)(2005-12#1)(2007-10#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-5#1)(2009-3#2)(2011-2#1)(2012-2#2)
report in this##7##3##(1993-2#1)(2005-10#1)(2008-10#1)(2012-3#1)(2013-1#3)
report in which##3##3##(1990-12#1)(2008-7#1)(2012-12#1)
report in##47##2##(1990-12#1)(1992-2#1)(1992-8#1)(1993-2#1)(1996-7#1)(1997-2#1)(2005-10#1)(2005-12#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-5#2)(2008-7#1)(2009-3#2)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#2)
report includes##5##2##(1995-1#1)(1996-6#1)(2007-11#1)(2008-1#1)(2011-2#1)
report indicated##2##2##(2010-12#2)
report indicates that##2##3##(2007-2#1)(2008-12#1)
report indicates##3##2##(2006-10#1)(2007-2#1)(2008-12#1)
report introduces##2##2##(1992-8#1)(2007-11#1)
report involves##2##2##(2006-8#1)(2012-2#1)
report is a rare##2##4##(2012-2#2)
report is a##12##3##(2006-10#1)(2007-12#1)(2007-3#1)(2008-5#1)(2009-12#1)(2009-3#1)(2011-2#1)(2012-2#3)(2013-1#2)
report is not only##2##4##(2008-9#1)(2013-1#1)
report is of a##3##4##(2008-11#1)(2008-12#1)(2012-2#1)
report is of##4##3##(2007-7#1)(2008-11#1)(2008-12#1)(2012-2#1)
report is the first to##3##5##(1990-11#1)(2008-6#1)(2010-9#1)
report is the first##6##4##(1990-11#1)(2007-12#1)(2008-11#2)(2008-6#1)(2010-9#1)
report is to describe a case of##2##7##(2007-3#1)(2011-1#1)
report is to describe a case##3##6##(2007-3#1)(2007-5#1)(2011-1#1)
report is to describe a##4##5##(2006-10#1)(2007-3#1)(2007-5#1)(2011-1#1)
report is to describe##7##4##(2006-10#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-8#1)(2010-9#1)(2011-1#1)
report is to review the##5##5##(2004-1#1)(2007-10#1)(2008-8#1)(2008-9#1)(2012-12#1)
report is to review##6##4##(2004-1#1)(2007-10#1)(2008-1#1)(2008-8#1)(2008-9#1)(2012-12#1)
report is to##24##3##(1992-12#1)(2004-1#1)(2006-10#1)(2007-10#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)
report is written##2##3##(1996-1#1)(2006-11#1)
report is##81##2##(1990-11#2)(1992-1#1)(1992-12#1)(1992-9#1)(1993-8#1)(1996-1#1)(1996-3#1)(2004-1#1)(2005-8#2)(2005-9#1)(2006-10#2)(2006-11#1)(2006-4#1)(2007-10#1)(2007-12#3)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#2)(2009-12#1)(2009-3#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-9#3)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#4)
report less##4##2##(1996-1#1)(1996-2#1)(2007-8#1)(2008-5#1)
report low##2##2##(2010-10#1)(2013-8#1)
report measurements##6##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-7#1)
report mixed##2##2##(2008-1#1)(2012-2#1)
report more##6##2##(1995-3#1)(2006-6#1)(2007-12#1)(2008-6#1)(2010-4#1)(2011-2#1)
report new evidence##2##3##(2008-6#1)(2009-9#1)
report new##3##2##(2008-1#1)(2008-6#1)(2009-9#1)
report observations on the##2##4##(1996-2#1)(2008-11#1)
report observations##4##2##(1996-2#1)(2006-7#1)(2007-11#1)(2008-11#1)
report of 2 cases##6##4##(2006-10#2)(2008-6#1)(2009-5#1)(2013-1#2)
report of 2##7##3##(1992-5#1)(2006-10#2)(2008-6#1)(2009-5#1)(2013-1#2)
report of 25 cases##2##4##(2008-1#1)(2010-11#1)
report of 3 cases##2##4##(2007-5#1)(2010-9#1)
report of 3##3##3##(2007-5#1)(2010-9#1)(2011-2#1)
report of HIV##2##3##(2007-8#1)(2013-1#1)
report of a 27-year-old##2##4##(2008-6#1)(2010-2#1)
report of a case and literature review##2##7##(2007-5#1)(2012-3#1)
report of a case and review of literature##3##8##(2007-11#1)(2008-12#1)(2008-7#1)
report of a case and review of the literature##8##9##(1994-6#1)(2005-9#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-12#1)(2012-2#1)(2013-1#1)
report of a case and review of##11##7##(1994-6#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-12#2)(2008-7#1)(2012-2#1)(2013-1#1)
report of a case and review##12##6##(1994-6#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-12#2)(2008-7#1)(2012-2#1)(2013-1#1)
report of a case and##14##5##(1994-6#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#2)(2008-12#2)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
report of a case of##6##5##(1996-3#1)(2007-8#1)(2007-9#1)(2008-10#2)(2012-3#1)
report of a case with literature review##2##7##(2007-10#2)
report of a case with review of literature##2##8##(2008-11#1)(2008-12#1)
report of a case with review of##3##7##(2007-6#1)(2008-11#1)(2008-12#1)
report of a case with##7##5##(1991-6#1)(1992-5#1)(2007-10#2)(2007-6#1)(2008-11#1)(2008-12#1)
report of a case##41##4##(1991-12#1)(1991-6#1)(1992-5#1)(1994-6#1)(1996-3#1)(1996-9#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#5)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
report of a case]##3##4##(2013-1#3)
report of a case]]##4##4##(2012-2#4)
report of a patient with##6##5##(2006-1#1)(2007-7#1)(2012-12#3)(2012-3#1)
report of a patient##12##4##(2006-1#1)(2007-2#1)(2007-7#1)(2007-8#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-12#4)(2012-3#1)
report of a rare case##3##5##(2006-12#1)(2013-1#2)
report of a rare##6##4##(1995-11#1)(2006-12#1)(2007-11#1)(2010-2#1)(2013-1#2)
report of a##156##3##(1991-12#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-4#1)(1994-10#1)(1994-2#1)(1994-6#1)(1994-7#1)(1995-10#2)(1995-11#1)(1995-5#1)(1995-9#1)(1996-3#1)(1996-6#1)(1996-9#1)(2005-10#2)(2005-9#2)(2006-1#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-7#2)(2006-8#2)(2007-10#3)(2007-11#3)(2007-12#3)(2007-2#4)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#3)(2007-9#2)(2008-10#9)(2008-11#5)(2008-12#10)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#1)(2009-8#2)(2009-9#1)(2010-2#2)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#8)(2012-1#1)(2012-11#2)(2012-12#8)(2012-2#10)(2012-3#4)(2013-1#12)(2013-7#1)(2013-8#1)
report of an asymptomatic##2##4##(2007-8#1)(2012-12#1)
report of an interesting##2##4##(1992-5#1)(2010-11#1)
report of an unusual##4##4##(1993-8#1)(2008-10#1)(2012-12#1)(2013-7#1)
report of an##31##3##(1990-9#1)(1991-9#1)(1992-10#1)(1992-5#1)(1993-8#1)(1993-9#1)(1994-2#1)(2006-10#1)(2006-12#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
report of delayed##2##3##(2010-4#1)(2013-1#1)
report of five cases##6##4##(2006-12#1)(2007-3#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-12#1)
report of four cases##8##4##(1990-12#1)(1991-12#1)(2006-10#1)(2007-2#2)(2007-7#1)(2011-2#2)
report of four##10##3##(1990-12#1)(1991-12#1)(2006-10#1)(2007-2#2)(2007-7#1)(2011-12#1)(2011-2#3)
report of isolation of##2##4##(1997-6#1)(2012-2#1)
report of oligodendroglioma in##2##4##(2011-1#2)
report of one##4##3##(2007-4#1)(2012-11#1)(2013-1#2)
report of such a##3##4##(1995-1#1)(2008-12#1)(2011-1#1)
report of such##5##3##(1995-1#1)(2007-10#1)(2007-12#1)(2008-12#1)(2011-1#1)
report of the 2008-09##2##4##(2010-3#2)
report of the first##3##4##(2005-12#1)(2007-10#1)(2007-9#1)
report of the##66##3##(1990-12#2)(1990-7#1)(1991-2#1)(1992-8#1)(1993-1#1)(1993-9#2)(1994-11#1)(1995-2#1)(1995-6#1)(1996-7#1)(1996-9#2)(1997-2#2)(2005-12#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#13)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-5#2)(2009-7#1)(2010-3#3)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#4)
report of these##2##3##(2007-7#1)(2008-10#1)
report of this neoplasm##2##4##(2006-10#1)(2007-2#1)
report of this organism##2##4##(2009-2#1)(2012-12#1)
report of this##11##3##(1990-6#1)(1991-11#1)(1992-3#1)(1994-9#1)(1996-9#1)(1997-6#1)(2006-10#1)(2007-2#1)(2009-2#1)(2012-12#1)(2013-7#1)
report of three cases##21##4##(1991-6#1)(1996-12#1)(2006-4#2)(2007-2#3)(2007-4#2)(2007-7#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
report of two cases and review of the literature##2##9##(2007-9#1)(2009-4#1)
report of two cases and review of##3##7##(2007-9#1)(2009-4#1)(2010-9#1)
report of two cases and##5##5##(2007-9#1)(2008-7#1)(2009-4#1)(2010-9#1)(2011-2#1)
report of two cases##48##4##(1990-10#1)(1991-6#1)(1992-10#1)(1993-6#1)(2005-10#1)(2006-10#2)(2006-12#5)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-4#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
report of two cases]##3##4##(2008-4#1)(2012-2#1)(2013-1#1)
report of two##59##3##(1990-10#1)(1991-6#1)(1992-10#1)(1993-6#1)(1996-5#1)(2005-10#1)(2006-10#2)(2006-12#5)(2006-4#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-7#3)(2007-8#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-4#1)(2009-8#1)(2010-9#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#1)
report of using##2##3##(2006-12#1)(2009-11#1)
report of water buffalo##2##4##(2008-12#2)
report of##569##2##(1990-10#1)(1990-12#3)(1990-3#2)(1990-6#1)(1990-7#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-6#3)(1991-8#1)(1991-9#3)(1992-10#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#4)(1992-8#2)(1992-9#2)(1993-1#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-6#2)(1994-7#2)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-2#1)(1995-5#2)(1995-6#2)(1995-9#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#4)(1997-2#2)(1997-6#2)(1997-7#1)(2005-1#1)(2005-10#4)(2005-11#3)(2005-12#4)(2005-9#3)(2006-1#1)(2006-10#17)(2006-12#14)(2006-2#1)(2006-4#6)(2006-7#3)(2006-8#3)(2006-9#1)(2007-10#6)(2007-11#8)(2007-12#7)(2007-2#15)(2007-3#2)(2007-4#7)(2007-5#4)(2007-6#2)(2007-7#18)(2007-8#17)(2007-9#4)(2008-1#1)(2008-10#41)(2008-11#10)(2008-12#16)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#8)(2008-6#10)(2008-7#12)(2008-8#4)(2008-9#5)(2009-1#2)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#2)(2009-4#2)(2009-5#5)(2009-7#3)(2009-8#3)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#3)(2010-3#6)(2010-4#2)(2010-6#1)(2010-7#7)(2010-8#1)(2010-9#4)(2011-1#7)(2011-12#4)(2011-2#23)(2011-3#3)(2012-1#2)(2012-11#4)(2012-12#24)(2012-2#24)(2012-3#15)(2013-1#42)(2013-7#6)(2013-8#11)
report on 2##4##3##(1992-10#1)(1992-12#1)(1996-11#1)(2008-5#1)
report on a case of##6##5##(2007-10#1)(2007-4#1)(2007-9#1)(2008-8#1)(2010-6#1)(2013-1#1)
report on a case##9##4##(1997-5#1)(2007-10#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-8#1)(2010-6#1)(2011-2#1)(2013-1#1)
report on a comparative##2##4##(2008-3#1)(2008-9#1)
report on a new##6##4##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#1)
report on a novel##8##4##(1991-11#1)(2007-12#5)(2008-2#1)(2008-3#1)
report on a patient who developed##2##6##(2007-8#1)(2011-2#1)
report on a patient who##4##5##(1996-6#1)(2007-8#1)(2007-9#1)(2011-2#1)
report on a patient with##7##5##(2006-10#1)(2006-12#1)(2007-3#1)(2007-6#1)(2009-4#1)(2011-3#1)(2013-7#1)
report on a patient##13##4##(1996-6#1)(1997-1#1)(1997-3#1)(2006-10#1)(2006-12#1)(2007-3#1)(2007-6#1)(2007-8#1)(2007-9#1)(2009-4#1)(2011-2#1)(2011-3#1)(2013-7#1)
report on a pilot##3##4##(1990-1#1)(1996-2#1)(2008-11#1)
report on a rare case of##3##6##(2007-3#1)(2007-8#1)(2008-2#1)
report on a rare##4##4##(2007-3#1)(2007-8#1)(2008-2#1)(2013-1#1)
report on a simple##3##4##(1996-5#1)(2007-12#1)(2008-8#1)
report on a##131##3##(1990-1#1)(1990-12#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-8#1)(1992-10#1)(1992-8#1)(1993-12#1)(1993-3#1)(1995-1#1)(1996-12#3)(1996-2#2)(1996-3#5)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-5#2)(1997-6#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#2)(2007-11#8)(2007-12#15)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#6)(2008-3#12)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-4#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#1)
report on an infant##3##4##(1996-12#2)(1997-1#1)
report on an initial genome screen##2##6##(1997-5#2)
report on an unusual##2##4##(2007-4#1)(2009-3#1)
report on an##28##3##(1993-12#1)(1993-2#1)(1996-12#2)(1997-1#1)(1997-5#3)(2006-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-2#2)(2008-3#6)(2009-3#1)(2010-10#1)(2010-5#1)(2012-12#1)
report on long-term##2##3##(2011-2#1)(2012-2#1)
report on nursing##3##3##(1990-2#1)(1991-2#1)(2011-1#1)
report on our##7##3##(1991-12#1)(1996-12#1)(1996-8#1)(2006-6#1)(2007-12#1)(2007-6#1)(2008-2#1)
report on recent##3##3##(1993-6#1)(2009-7#1)(2010-3#1)
report on the application of a##2##6##(2008-5#1)(2010-4#1)
report on the application of##3##5##(2008-5#1)(2008-7#1)(2010-4#1)
report on the clinical##2##4##(1993-11#1)(1994-2#1)
report on the current##2##4##(2007-5#1)(2011-2#1)
report on the development and testing of a##2##8##(1996-2#1)(2007-11#1)
report on the development and##3##5##(1996-2#1)(2007-11#1)(2012-2#1)
report on the development of a##2##6##(2008-2#1)(2010-4#1)
report on the development of##4##5##(2007-11#1)(2008-12#1)(2008-2#1)(2010-4#1)
report on the development##7##4##(1996-2#1)(2007-11#2)(2008-12#1)(2008-2#1)(2010-4#1)(2012-2#1)
report on the effects of##2##5##(1992-6#1)(2008-11#1)
report on the fabrication of##3##5##(2008-1#1)(2008-2#1)(2008-3#1)
report on the fabrication##9##4##(2007-12#4)(2008-1#1)(2008-2#2)(2008-3#2)
report on the findings and##3##5##(2007-8#1)(2013-1#2)
report on the identification of##3##5##(1990-7#1)(1991-5#1)(2009-8#1)
report on the identification##4##4##(1990-7#1)(1991-5#1)(1994-3#1)(2009-8#1)
report on the isolation##2##4##(1991-2#1)(2008-10#1)
report on the literature##2##4##(2008-7#1)(2011-2#1)
report on the long-term##2##4##(2006-4#1)(2009-4#1)
report on the measurement of##2##5##(2008-3#2)
report on the presence of##3##5##(1991-5#1)(2007-10#1)(2008-5#1)
report on the presence##4##4##(1991-1#1)(1991-5#1)(2007-10#1)(2008-5#1)
report on the results of##5##5##(2007-10#1)(2008-5#1)(2008-9#1)(2013-1#2)
report on the results##6##4##(2007-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2013-1#2)
report on the use of##13##5##(1990-5#1)(2005-11#1)(2006-7#1)(2007-12#3)(2007-3#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-4#1)(2012-12#1)
report on the##179##3##(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#3)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-11#2)(1993-3#1)(1993-4#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-2#1)(1996-9#1)(2005-11#2)(2006-2#2)(2006-4#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#10)(2007-12#15)(2007-3#1)(2007-4#1)(2007-5#6)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#16)(2008-11#3)(2008-12#2)(2008-2#7)(2008-3#14)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#7)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-4#3)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#9)(2013-7#1)(2013-8#2)
report on their experience##5##4##(1990-10#1)(1990-5#1)(2006-12#1)(2007-7#2)
report on their##9##3##(1990-10#1)(1990-12#1)(1990-5#1)(1994-3#1)(2006-12#1)(2007-7#3)(2008-4#1)
report on this##2##3##(2006-2#1)(2010-6#1)
report on three##3##3##(1993-9#1)(2009-7#1)(2011-2#1)
report on two##7##3##(1990-11#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#1)
report on various##2##3##(2008-3#1)(2011-2#1)
report on what is believed to be the first##3##9##(2007-11#1)(2007-12#2)
report on what is##5##4##(2007-11#2)(2007-12#3)
report on what##9##3##(2007-11#2)(2007-12#4)(2008-3#2)(2009-3#1)
report on##505##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#3)(1991-8#1)(1991-9#1)(1992-10#4)(1992-12#3)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#3)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#2)(1996-1#3)(1996-11#3)(1996-12#10)(1996-2#3)(1996-3#7)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#1)(1997-3#5)(1997-5#5)(1997-6#2)(2005-11#2)(2006-10#2)(2006-12#4)(2006-2#3)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#3)(2007-10#4)(2007-11#25)(2007-12#47)(2007-3#4)(2007-4#3)(2007-5#8)(2007-6#2)(2007-7#8)(2007-8#9)(2007-9#5)(2008-1#6)(2008-10#22)(2008-11#7)(2008-12#2)(2008-2#23)(2008-3#47)(2008-4#6)(2008-5#8)(2008-6#5)(2008-7#11)(2008-8#4)(2008-9#10)(2009-12#1)(2009-2#1)(2009-3#4)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#3)(2010-8#2)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#17)(2011-3#1)(2012-1#1)(2012-12#7)(2012-2#5)(2012-3#2)(2013-1#23)(2013-7#2)(2013-8#3)
report one case of##7##4##(1993-10#1)(1993-5#1)(2007-2#2)(2008-5#1)(2009-5#1)(2012-12#1)
report one such case##7##4##(2007-12#1)(2007-7#2)(2009-10#1)(2009-9#1)(2010-2#1)(2012-12#1)
report one such##8##3##(2007-12#1)(2007-7#2)(2009-10#1)(2009-9#1)(2010-2#1)(2011-1#1)(2012-12#1)
report one##16##2##(1993-10#1)(1993-5#1)(2006-10#1)(2007-12#1)(2007-2#2)(2007-7#2)(2008-5#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-2#1)(2011-1#1)(2012-12#2)
report or not to report##3##5##(1991-2#1)(2011-2#1)(2012-11#1)
report or not##4##3##(1991-2#1)(1995-12#1)(2011-2#1)(2012-11#1)
report or##6##2##(1991-2#1)(1995-12#1)(2006-10#1)(2011-2#1)(2012-11#1)(2012-12#1)
report our data##2##3##(1991-3#1)(2009-8#1)
report our experience in##3##4##(2007-7#1)(2011-2#1)(2013-1#1)
report our experience of##5##4##(1991-9#1)(1995-10#1)(2006-8#1)(2007-8#1)(2009-6#1)
report our experience with##9##4##(1993-10#1)(1993-8#1)(1995-3#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
report our experience##20##3##(1991-9#1)(1993-10#1)(1993-8#1)(1995-10#1)(1995-3#1)(1997-1#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-11#1)(2009-6#1)(2011-2#2)(2013-1#1)
report our results##2##3##(2007-8#1)(2008-6#1)
report our##38##2##(1991-3#1)(1991-9#1)(1993-10#1)(1993-8#1)(1995-10#1)(1995-3#1)(1997-1#1)(1997-3#1)(1997-5#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-7#3)(2007-8#4)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-6#1)(2009-8#1)(2011-2#3)(2012-2#2)(2013-1#2)
report outcome##3##2##(2012-1#1)(2012-3#1)(2013-1#1)
report outlines##4##2##(1994-3#1)(2007-12#1)(2008-7#1)(2008-9#1)
report over##2##2##(2007-1#1)(2013-1#1)
report pain##3##2##(2009-3#1)(2010-11#2)
report poor##2##2##(2009-5#1)(2013-8#1)
report positive##2##2##(1996-6#1)(2005-10#1)
report preliminary results of##2##4##(2008-3#1)(2011-2#1)
report preliminary results##5##3##(2008-2#1)(2008-3#2)(2011-2#1)(2012-1#1)
report presented##2##2##(2006-8#1)(2008-11#1)
report presents a patient with##2##5##(2006-10#1)(2007-3#1)
report presents a##9##3##(2005-12#1)(2006-10#1)(2007-3#1)(2008-11#1)(2009-3#1)(2010-2#1)(2012-1#1)(2012-12#2)
report presents an##5##3##(2007-10#1)(2009-2#1)(2010-9#1)(2012-2#1)(2013-1#1)
report presents the##8##3##(1993-8#1)(1995-3#1)(2008-11#1)(2008-6#1)(2009-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
report presents##34##2##(1991-11#1)(1992-10#1)(1992-7#1)(1993-12#1)(1993-8#1)(1995-3#1)(1997-2#2)(2005-12#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-3#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-6#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#2)(2013-7#1)
report provides a##6##3##(1997-8#1)(2005-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2012-2#1)
report provides##14##2##(1993-7#1)(1996-1#1)(1996-7#1)(1997-8#1)(2005-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2012-2#1)
report recent##2##2##(2011-1#1)(2013-1#1)
report reduced##2##2##(1997-8#1)(2007-8#1)
report refers to a##2##4##(2008-2#1)(2011-1#1)
report represents the first##3##4##(1994-9#1)(2007-2#1)(2008-5#1)
report represents the##5##3##(1991-5#1)(1994-9#1)(2006-10#1)(2007-2#1)(2008-5#1)
report represents##6##2##(1991-5#1)(1994-9#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-5#1)
report results from##6##3##(1997-7#1)(2007-12#1)(2008-3#1)(2009-9#1)(2013-1#2)
report results of##3##3##(2008-11#1)(2008-2#1)(2008-9#1)
report results##13##2##(1992-9#1)(1997-7#1)(2006-5#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-9#1)(2010-5#1)(2013-1#2)
report reviews the##5##3##(2006-10#1)(2007-7#1)(2007-8#2)(2008-3#1)
report reviews##12##2##(1991-2#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-7#1)(2007-8#3)(2008-11#1)(2008-3#1)(2008-4#1)(2011-10#1)
report seven cases of##4##4##(2006-6#1)(2006-8#1)(2011-1#1)(2012-2#1)
report seven cases##5##3##(2006-6#1)(2006-8#1)(2008-7#1)(2011-1#1)(2012-2#1)
report seven##6##2##(2006-6#1)(2006-8#1)(2007-8#1)(2008-7#1)(2011-1#1)(2012-2#1)
report should##5##2##(1992-5#1)(2006-10#2)(2008-12#1)(2011-1#1)
report showed##5##2##(1991-6#1)(2008-10#1)(2008-7#1)(2011-12#1)(2013-8#1)
report showing##7##2##(1991-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1995-6#1)(2009-12#1)(2012-12#1)
report shows that##6##3##(1990-12#1)(1993-3#1)(1994-12#1)(1995-2#1)(1995-5#1)(2008-1#1)
report shows the##3##3##(2007-8#2)(2013-7#1)
report shows##11##2##(1990-12#1)(1993-3#1)(1994-12#1)(1995-2#1)(1995-5#1)(2007-8#2)(2008-1#1)(2008-10#1)(2010-5#1)(2013-7#1)
report significant##4##2##(1995-12#1)(2007-11#2)(2008-9#1)
report some##7##2##(1992-6#1)(1994-8#1)(1995-4#1)(1996-5#1)(2008-11#1)(2008-2#1)(2012-3#1)
report studies##2##2##(1996-6#1)(2007-12#1)
report such a case##4##4##(2009-10#1)(2012-2#1)(2012-3#2)
report such a##6##3##(2007-9#1)(2009-10#1)(2012-2#2)(2012-3#2)
report suggested##2##2##(2013-8#2)
report suggesting##2##2##(2008-6#1)(2012-12#1)
report suggests that a##2##4##(2007-7#1)(2012-2#1)
report suggests that##5##3##(1990-8#1)(2007-7#1)(2012-2#3)
report suggests##8##2##(1990-8#1)(2007-7#1)(2007-9#2)(2012-12#1)(2012-2#3)
report summarizes key##2##3##(2007-12#1)(2010-4#1)
report summarizes the proceedings##2##4##(2008-8#1)(2011-2#1)
report summarizes the##17##3##(1991-3#3)(1991-6#1)(1993-12#1)(1994-9#1)(1996-11#2)(1996-3#1)(2005-8#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-2#2)
report summarizes##39##2##(1991-3#4)(1991-5#1)(1991-6#3)(1991-8#1)(1992-1#1)(1992-5#2)(1992-7#1)(1993-12#1)(1994-9#3)(1995-6#1)(1996-11#2)(1996-3#2)(1996-8#1)(1997-1#2)(1997-2#1)(2005-8#1)(2007-12#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#2)(2010-4#1)(2011-2#2)
report supports##2##2##(2006-10#1)(2013-1#1)
report suspected##2##2##(2006-8#1)(2008-5#1)
report that a##19##3##(1990-5#1)(1992-12#1)(1992-2#1)(1992-9#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-3#2)(1996-2#1)(1997-7#1)(2005-8#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-7#1)(2010-5#1)(2012-2#1)
report that activation##2##3##(1994-3#1)(2008-4#1)
report that after##2##3##(1992-2#1)(2008-11#1)
report that an##2##3##(1994-8#1)(2008-11#1)
report that describes##2##3##(2007-10#1)(2007-8#1)
report that human##3##3##(1990-6#1)(1990-7#1)(1993-6#1)
report that in##5##3##(1994-5#1)(1994-9#1)(1995-2#1)(2006-3#1)(2011-2#1)
report that it is##2##4##(1994-12#1)(1996-1#1)
report that rat##2##3##(1990-2#1)(1994-12#1)
report that recombinant##2##3##(1994-8#1)(1995-3#1)
report that sodium##2##3##(1992-9#1)(2008-11#1)
report that the##41##3##(1990-1#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-4#3)(1992-7#1)(1992-8#1)(1992-9#2)(1993-3#1)(1994-11#2)(1994-5#1)(1994-8#1)(1995-10#1)(1995-8#2)(1996-4#1)(1996-5#1)(1997-2#2)(1997-7#1)(1997-8#2)(2007-12#1)(2008-7#3)(2009-4#1)(2009-6#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
report that these##3##3##(1990-3#1)(1990-7#1)(1990-8#1)
report that they##7##3##(1993-3#1)(1995-6#1)(2005-7#2)(2007-10#1)(2007-9#1)(2008-5#1)
report that this##4##3##(1990-10#1)(1991-2#1)(1993-9#1)(2013-8#1)
report that when##3##3##(1991-3#1)(1995-2#1)(2009-10#1)
report that##246##2##(1990-1#1)(1990-10#1)(1990-11#3)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#3)(1990-8#2)(1990-9#1)(1991-11#2)(1991-12#3)(1991-2#5)(1991-3#3)(1991-4#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#3)(1992-7#2)(1992-8#3)(1992-9#4)(1993-11#2)(1993-12#1)(1993-3#3)(1993-6#5)(1993-7#1)(1993-8#1)(1993-9#4)(1994-11#3)(1994-12#4)(1994-2#2)(1994-3#3)(1994-5#3)(1994-6#3)(1994-8#5)(1994-9#3)(1995-1#2)(1995-10#1)(1995-12#2)(1995-2#2)(1995-3#5)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#5)(1996-1#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#5)(1997-8#2)(2005-11#1)(2005-7#2)(2005-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#3)(2007-3#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#6)(2008-11#9)(2008-4#2)(2008-5#1)(2008-7#5)(2008-8#2)(2009-10#2)(2009-2#1)(2009-4#3)(2009-6#1)(2009-7#2)(2009-8#3)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#6)(2012-12#6)(2012-2#9)(2013-1#3)(2013-8#3)
report the NMR##4##3##(2009-7#4)
report the X-ray##3##3##(1994-8#1)(2007-11#1)(2008-10#1)
report the absence of##3##4##(1994-12#1)(2008-7#1)(2013-1#1)
report the assignment of the##2##5##(1991-12#1)(2009-7#1)
report the assignment of##4##4##(1991-12#1)(2009-7#3)
report the association of##2##4##(2008-1#1)(2010-12#1)
report the available##2##3##(2012-12#1)(2013-1#1)
report the cDNA cloning of##3##5##(1992-5#1)(1994-11#1)(1994-8#1)
report the cDNA##4##3##(1992-5#1)(1994-11#1)(1994-8#1)(1996-10#1)
report the case of a 21-year-old##2##6##(2005-12#1)(2013-1#1)
report the case of a 30-year-old##2##6##(2006-11#1)(2007-2#1)
report the case of a 37-year-old man##2##7##(2006-10#1)(2008-7#1)
report the case of a 51-year-old##3##6##(2006-10#1)(2012-2#1)(2013-1#1)
report the case of a 55-year-old##3##6##(2007-10#1)(2007-8#1)(2011-2#1)
report the case of a 7-year-old boy with##2##8##(2006-10#1)(2008-5#1)
report the case of a 7-year-old girl who presented with##2##10##(2005-10#1)(2008-10#1)
report the case of a 7-year-old##4##6##(2005-10#1)(2006-10#1)(2008-10#1)(2008-5#1)
report the case of a patient who##3##7##(1993-8#1)(2008-6#1)(2011-2#1)
report the case of a patient with a##3##8##(1992-10#1)(2010-12#1)(2010-2#1)
report the case of a patient with##12##7##(1992-10#1)(2005-12#1)(2006-2#1)(2008-6#1)(2010-12#2)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
report the case of a patient##21##6##(1992-10#2)(1993-6#1)(1993-8#1)(2005-12#1)(2006-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2010-12#2)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
report the case of a##126##5##(1991-11#2)(1991-5#1)(1992-10#2)(1993-10#1)(1993-6#1)(1993-8#1)(1994-4#1)(2005-10#1)(2005-11#1)(2005-12#3)(2006-10#9)(2006-11#1)(2006-2#2)(2007-10#2)(2007-11#1)(2007-2#2)(2007-5#1)(2007-6#1)(2007-8#10)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#3)(2008-6#6)(2008-7#6)(2008-9#3)(2009-1#1)(2009-3#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#2)(2011-1#1)(2011-2#8)(2012-1#1)(2012-12#5)(2012-2#7)(2012-3#5)(2013-1#10)(2013-7#3)(2013-8#3)
report the case of an##6##5##(1990-6#1)(2007-4#1)(2008-10#1)(2010-12#1)(2010-2#1)(2010-5#1)
report the case of##142##4##(1990-6#1)(1991-11#2)(1991-5#1)(1991-6#1)(1992-10#2)(1993-10#1)(1993-6#1)(1993-8#1)(1994-4#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-12#3)(2006-10#9)(2006-11#1)(2006-2#2)(2007-10#2)(2007-11#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#10)(2007-9#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#3)(2008-6#6)(2008-7#7)(2008-9#3)(2009-1#1)(2009-3#1)(2010-12#7)(2010-2#2)(2010-3#1)(2010-5#3)(2010-6#2)(2010-9#2)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#5)(2012-2#7)(2012-3#5)(2013-1#12)(2013-7#3)(2013-8#3)
report the case##145##3##(1990-6#1)(1991-11#2)(1991-5#1)(1991-6#1)(1992-10#2)(1993-10#1)(1993-6#1)(1993-8#1)(1994-4#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-12#3)(2006-10#9)(2006-11#1)(2006-2#2)(2007-10#2)(2007-11#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#10)(2007-9#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#3)(2008-6#6)(2008-7#7)(2008-9#3)(2009-1#1)(2009-3#1)(2010-12#7)(2010-2#2)(2010-3#1)(2010-5#3)(2010-6#2)(2010-9#2)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#5)(2012-2#7)(2012-3#5)(2013-1#15)(2013-7#3)(2013-8#3)
report the characterization of a##2##5##(1996-9#1)(1997-4#1)
report the characterization of##4##4##(1995-3#1)(1996-9#1)(1997-4#1)(2009-4#1)
report the clinical case of a##2##6##(2011-2#1)(2013-1#1)
report the clinical##13##3##(1996-3#1)(1996-6#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-2#2)(2013-1#3)
report the cloning and characterization of##3##6##(1995-3#1)(1995-8#1)(1997-4#1)
report the cloning and the##2##5##(1991-12#1)(1993-3#1)
report the cloning and##8##4##(1991-12#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-3#1)(1995-8#1)(1997-4#1)(2008-4#1)
report the cloning of a##4##5##(1991-2#1)(1994-9#1)(1995-8#1)(1996-5#1)
report the cloning of the##3##5##(1990-11#1)(1994-12#1)(1995-11#1)
report the cloning of##10##4##(1990-11#1)(1991-2#1)(1991-7#1)(1993-2#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-5#1)(2008-7#1)
report the cloning##20##3##(1990-11#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-3#2)(1993-2#1)(1993-3#1)(1994-12#2)(1994-9#1)(1995-11#1)(1995-3#1)(1995-8#2)(1996-5#1)(1997-4#1)(2008-4#1)(2008-7#1)(2013-1#1)
report the complete##3##3##(1994-3#1)(1996-10#1)(2007-11#1)
report the complications##2##3##(1996-3#1)(2006-11#1)
report the construction of a##2##5##(1991-6#1)(1997-8#1)
report the construction of##6##4##(1991-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2013-8#1)
report the construction##7##3##(1991-6#1)(1993-9#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2013-8#1)
report the crystal structure of##4##5##(1993-9#1)(2011-1#2)(2012-3#1)
report the crystal##6##3##(1993-9#1)(2011-1#3)(2012-2#1)(2012-3#1)
report the demonstration of##8##4##(2007-11#1)(2007-12#6)(2008-1#1)
report the detailed##3##3##(2009-5#1)(2012-1#1)(2012-2#1)
report the development and##3##4##(1994-10#1)(2008-10#1)(2008-3#1)
report the development of a##5##5##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-10#1)
report the development of##10##4##(1990-12#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#1)(2010-10#1)(2012-2#1)(2013-8#1)
report the development##13##3##(1990-12#1)(1994-10#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#2)(2010-10#1)(2012-2#1)(2013-8#1)
report the effect of##3##4##(1996-2#1)(1997-7#1)(2008-1#1)
report the effects of##7##4##(1992-2#1)(1992-4#1)(1995-9#1)(1997-7#1)(2008-4#1)(2009-5#1)(2010-4#1)
report the efficient##2##3##(1996-2#1)(2008-2#1)
report the existence of##5##4##(1990-2#1)(1992-5#1)(1992-6#1)(1993-8#1)(2013-1#1)
report the existence##6##3##(1990-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-8#1)(2013-1#1)
report the experience of##2##4##(1993-9#1)(2008-7#1)
report the experience##3##3##(1993-9#1)(2008-7#1)(2012-3#1)
report the expression and##2##4##(1996-5#1)(2009-9#1)
report the expression of##3##4##(1992-8#1)(1992-9#1)(1995-8#1)
report the expression##7##3##(1992-8#1)(1992-9#1)(1993-9#1)(1995-8#1)(1996-5#1)(2009-3#1)(2009-9#1)
report the fabrication of##5##4##(2007-12#3)(2010-7#1)(2012-2#1)
report the fabrication##6##3##(2007-12#3)(2008-12#1)(2010-7#1)(2012-2#1)
report the first case of##17##5##(1996-12#1)(2006-9#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-6#1)(2009-3#1)(2010-12#2)(2010-2#1)(2011-2#2)(2012-12#1)(2013-1#2)
report the first case##20##4##(1996-12#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-6#1)(2009-3#1)(2010-11#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)
report the first experimental##3##4##(2008-2#1)(2008-7#1)(2012-2#1)
report the first observation of##4##5##(2007-12#2)(2008-2#1)(2008-7#1)
report the first observation##5##4##(2007-12#2)(2008-2#1)(2008-3#1)(2008-7#1)
report the first##49##3##(1990-6#1)(1991-10#1)(1994-10#1)(1995-3#1)(1995-6#1)(1996-12#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-12#3)(2007-7#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#2)(2008-7#3)(2009-3#1)(2009-7#1)(2010-11#1)(2010-12#3)(2010-2#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
report the generation and##3##4##(2007-11#1)(2007-12#1)(2012-2#1)
report the generation of##3##4##(1994-12#1)(2007-11#1)(2007-12#1)
report the generation##6##3##(1994-12#1)(2007-11#2)(2007-12#2)(2012-2#1)
report the identification of##10##4##(1990-11#1)(1991-8#1)(1993-6#2)(1994-11#1)(2008-10#2)(2009-6#1)(2012-3#2)
report the identification##11##3##(1990-11#1)(1991-8#1)(1993-6#2)(1994-11#1)(2008-10#2)(2009-6#1)(2012-3#2)(2013-8#1)
report the isolation and characterization of a novel##2##8##(1990-12#1)(1991-4#1)
report the isolation and characterization of a##4##7##(1990-12#1)(1991-4#1)(1993-12#1)(1994-6#1)
report the isolation and characterization of##5##6##(1990-12#1)(1991-4#1)(1993-12#1)(1994-6#1)(1995-8#1)
report the isolation and##9##4##(1990-12#1)(1991-4#1)(1991-6#1)(1993-12#1)(1993-6#1)(1994-6#1)(1995-8#1)(1997-7#1)(2006-12#1)
report the isolation of a cDNA##3##6##(1992-11#1)(1994-8#1)(1995-2#1)
report the isolation of a##6##5##(1990-2#1)(1992-11#1)(1994-8#1)(1995-2#1)(1995-8#1)(2008-8#1)
report the isolation of the##4##5##(1991-8#1)(1996-11#1)(1996-4#1)(1997-7#1)
report the isolation of two##2##5##(1990-5#1)(1997-3#1)
report the isolation of##16##4##(1990-2#1)(1990-5#1)(1991-8#1)(1992-11#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-4#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-8#1)(2012-12#1)
report the isolation##28##3##(1990-12#1)(1990-2#1)(1990-5#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-11#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-4#1)(1997-3#1)(1997-7#2)(2006-12#1)(2008-10#2)(2008-8#1)(2010-8#1)(2012-12#1)
report the main##3##3##(2008-2#1)(2008-8#1)(2009-4#1)
report the management##2##3##(2008-7#1)(2011-2#1)
report the molecular characterization of a##2##6##(1990-7#1)(1996-9#1)
report the molecular##3##3##(1990-7#1)(1993-12#1)(1996-9#1)
report the nucleotide sequence of a##2##6##(1997-3#1)(2008-10#1)
report the nucleotide sequence##3##4##(1994-8#1)(1997-3#1)(2008-10#1)
report the observation of##17##4##(2007-11#3)(2007-12#10)(2008-1#1)(2008-3#1)(2008-5#1)(2013-1#1)
report the observation that##2##4##(2008-6#1)(2008-7#1)
report the observation##19##3##(2007-11#3)(2007-12#10)(2008-1#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-1#1)
report the occurrence##5##3##(1993-11#1)(2006-12#1)(2008-5#1)(2010-10#1)(2012-2#1)
report the operation of a##3##5##(2007-11#1)(2007-12#2)
report the operation of##4##4##(2007-11#1)(2007-12#3)
report the phenomenon of##2##4##(2008-6#1)(2009-6#1)
report the preliminary results of##2##5##(2007-8#1)(2011-1#1)
report the presence of##5##4##(1993-12#1)(2006-11#1)(2008-5#1)(2011-12#1)(2011-2#1)
report the purification and characterization of##2##6##(1997-6#1)(1997-7#1)
report the purification and##3##4##(1996-4#1)(1997-6#1)(1997-7#1)
report the purification of##3##4##(1990-7#1)(1992-11#1)(1996-4#1)
report the purification##6##3##(1990-7#1)(1992-11#1)(1996-4#2)(1997-6#1)(1997-7#1)
report the result##3##3##(2007-12#1)(2013-1#2)
report the results obtained##3##4##(1990-10#1)(1990-5#1)(2008-2#1)
report the results of a systematic##2##6##(1994-10#1)(2013-1#1)
report the results of a##13##5##(1990-10#1)(1990-5#1)(1993-12#1)(1994-10#1)(2006-4#1)(2007-11#2)(2008-11#1)(2008-9#1)(2010-12#1)(2012-1#1)(2013-1#1)(2013-8#1)
report the results of an##2##5##(1990-5#1)(2007-11#1)
report the results of our##2##5##(2006-11#1)(2007-12#1)
report the results of the first##3##6##(1996-6#1)(2012-12#2)
report the results of the##4##5##(1996-6#1)(2008-12#1)(2012-12#2)
report the results of##43##4##(1990-10#1)(1990-5#2)(1990-9#1)(1991-6#1)(1993-10#1)(1993-12#1)(1994-10#1)(1995-8#1)(1996-11#1)(1996-6#1)(1997-6#1)(2006-11#1)(2006-4#2)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#3)(2008-5#2)(2008-6#1)(2008-9#2)(2009-9#1)(2010-12#1)(2010-6#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
report the results##48##3##(1990-10#2)(1990-5#3)(1990-9#1)(1991-6#1)(1993-10#1)(1993-12#1)(1994-10#1)(1995-8#1)(1996-11#1)(1996-6#1)(1997-6#1)(2006-11#1)(2006-4#2)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#5)(2008-5#2)(2008-6#1)(2008-9#2)(2009-9#1)(2010-12#1)(2010-6#3)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
report the sequence analysis of##2##5##(1995-1#1)(1997-3#1)
report the sequence of the##2##5##(1990-5#1)(1991-7#1)
report the sequence of##7##4##(1990-5#1)(1991-7#1)(1995-6#1)(1995-9#1)(1997-1#1)(1997-3#2)
report the sequence##9##3##(1990-5#1)(1991-7#1)(1995-1#1)(1995-6#1)(1995-9#1)(1997-1#1)(1997-3#3)
report the structural##2##3##(2010-12#1)(2010-5#1)
report the structure and##3##4##(1991-3#1)(1991-6#1)(2008-10#1)
report the structure of##2##4##(1994-3#1)(1994-6#1)
report the structure##5##3##(1991-3#1)(1991-6#1)(1994-3#1)(1994-6#1)(2008-10#1)
report the study##4##3##(2005-11#1)(2008-7#1)(2011-1#1)(2012-2#1)
report the successful management of a##2##6##(2007-8#2)
report the successful treatment of a##2##6##(1994-6#1)(2012-2#1)
report the successful##8##3##(1994-6#1)(2007-8#3)(2008-7#1)(2010-2#1)(2010-6#1)(2012-2#1)
report the surgical##2##3##(2012-12#1)(2013-8#1)
report the synthesis and characterization of##2##6##(2008-10#2)
report the synthesis and##4##4##(2007-11#1)(2008-10#2)(2010-7#1)
report the synthesis of##9##4##(1995-11#1)(2007-10#1)(2007-11#1)(2008-10#1)(2009-10#1)(2009-11#1)(2009-6#1)(2010-4#1)(2012-2#1)
report the synthesis##13##3##(1995-11#1)(2007-10#1)(2007-11#2)(2008-10#3)(2009-10#1)(2009-11#1)(2009-6#1)(2010-4#1)(2010-7#1)(2012-2#1)
report the technique##3##3##(1994-2#2)(2009-8#1)
report the use of a##7##5##(1991-1#1)(1991-6#1)(1992-3#1)(2007-11#1)(2008-1#1)(2008-7#1)(2012-2#1)
report the use of an##2##5##(2007-12#1)(2008-11#1)
report the use of the##5##5##(2007-12#1)(2007-8#1)(2009-5#1)(2010-5#1)(2011-2#1)
report the use of##27##4##(1991-1#1)(1991-6#1)(1992-3#1)(2006-3#1)(2007-11#1)(2007-12#3)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-2#1)(2009-5#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
report the##750##2##(1990-10#2)(1990-11#2)(1990-12#4)(1990-2#2)(1990-3#1)(1990-5#5)(1990-6#3)(1990-7#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#6)(1991-7#2)(1991-8#2)(1991-9#1)(1992-10#3)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-10#2)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#5)(1993-8#3)(1993-9#5)(1994-10#3)(1994-11#5)(1994-12#4)(1994-2#4)(1994-3#2)(1994-4#1)(1994-6#4)(1994-8#4)(1994-9#2)(1995-1#1)(1995-11#3)(1995-2#3)(1995-3#3)(1995-6#5)(1995-8#8)(1995-9#2)(1996-10#2)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#3)(1996-4#4)(1996-5#2)(1996-6#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#7)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#6)(1997-8#1)(2004-10#1)(2005-1#1)(2005-10#2)(2005-11#2)(2005-12#3)(2006-10#16)(2006-11#5)(2006-12#6)(2006-2#4)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#1)(2006-8#3)(2006-9#1)(2007-10#5)(2007-11#27)(2007-12#50)(2007-2#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#21)(2007-9#3)(2008-1#8)(2008-10#28)(2008-11#6)(2008-12#5)(2008-2#17)(2008-3#11)(2008-4#8)(2008-5#12)(2008-6#15)(2008-7#27)(2008-8#3)(2008-9#8)(2009-1#1)(2009-10#3)(2009-11#1)(2009-2#2)(2009-3#4)(2009-4#2)(2009-5#3)(2009-6#4)(2009-7#18)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#16)(2010-2#6)(2010-3#4)(2010-4#4)(2010-5#5)(2010-6#7)(2010-7#4)(2010-8#1)(2010-9#2)(2011-1#12)(2011-12#1)(2011-2#22)(2012-1#4)(2012-11#1)(2012-12#17)(2012-2#27)(2012-3#16)(2012-4#1)(2013-1#33)(2013-7#4)(2013-8#11)
report their clinical experience in##2##5##(1991-9#1)(1993-9#1)
report their experience about##2##4##(1990-10#1)(1992-5#1)
report their experience in##2##4##(1990-5#1)(1993-5#1)
report their experience of##5##4##(1990-3#1)(1990-9#1)(1992-6#1)(1993-5#1)(1993-9#1)
report their experience##15##3##(1990-10#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-3#1)(1992-5#2)(1992-6#1)(1993-10#1)(1993-11#1)(1993-5#2)(1993-9#2)(2006-8#1)
report their results##2##3##(2006-3#1)(2007-7#1)
report their##28##2##(1990-10#1)(1990-3#1)(1990-5#1)(1990-9#2)(1991-12#1)(1991-3#1)(1991-9#2)(1992-5#2)(1992-6#1)(1993-10#1)(1993-11#1)(1993-5#2)(1993-9#3)(1995-4#1)(2006-3#1)(2006-8#1)(2007-11#2)(2007-7#1)(2007-8#1)(2009-7#1)(2013-1#1)
report these##2##2##(2008-8#1)(2008-9#1)
report they##2##2##(2005-7#1)(2006-8#1)
report this case##12##3##(1992-10#1)(1996-3#1)(2007-8#1)(2008-12#1)(2008-7#2)(2009-3#1)(2009-5#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-1#1)
report this##19##2##(1992-10#1)(1996-3#1)(2006-8#1)(2007-1#1)(2007-7#2)(2007-8#1)(2008-12#2)(2008-7#3)(2009-3#1)(2009-5#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-1#1)(2013-1#1)
report three cases of##7##4##(1991-11#1)(1991-4#1)(1993-10#1)(2007-12#1)(2007-2#1)(2009-9#1)(2012-12#1)
report three cases##9##3##(1991-11#1)(1991-4#1)(1993-10#1)(2007-12#1)(2007-2#1)(2008-7#1)(2009-9#1)(2010-7#1)(2012-12#1)
report three##14##2##(1991-11#1)(1991-4#1)(1993-10#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-7#1)(2012-12#1)(2013-1#2)
report to Congress##2##3##(1990-8#1)(1993-3#1)
report to be##2##3##(2007-3#1)(2010-8#1)
report to our knowledge##2##4##(2009-3#1)(2012-2#1)
report to the##2##3##(1996-11#1)(2007-12#1)
report to##16##2##(1990-5#1)(1990-8#1)(1991-6#1)(1991-8#1)(1992-6#1)(1993-3#1)(1996-11#1)(2007-12#1)(2007-3#2)(2009-12#1)(2009-3#1)(2010-2#1)(2010-8#1)(2012-2#2)
report turnaround time##2##3##(1992-2#1)(1996-3#1)
report two adult##2##3##(2005-2#1)(2010-4#1)
report two cases of##41##4##(1990-5#1)(1992-10#1)(1992-5#1)(1996-3#1)(1996-6#1)(2005-10#1)(2005-12#1)(2006-10#2)(2006-2#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#6)(2008-10#2)(2008-4#1)(2008-7#1)(2009-10#1)(2009-4#2)(2009-6#1)(2009-9#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-12#2)(2013-1#3)(2013-7#1)
report two cases##47##3##(1990-5#1)(1992-10#1)(1992-5#1)(1996-3#1)(1996-6#1)(1997-5#1)(2005-10#1)(2005-12#1)(2006-10#2)(2006-2#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#6)(2008-10#2)(2008-4#1)(2008-7#1)(2009-1#1)(2009-10#1)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-12#2)(2013-1#4)(2013-7#2)
report two clinical cases##3##4##(2008-4#1)(2010-9#1)(2011-2#1)
report two patients with##5##4##(1990-3#1)(2006-12#1)(2008-7#1)(2010-7#1)(2013-1#1)
report two patients##11##3##(1990-3#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-7#1)(2013-1#3)
report two such##3##3##(2007-7#1)(2008-7#1)(2010-7#1)
report two##83##2##(1990-3#1)(1990-5#1)(1992-10#1)(1992-5#1)(1994-2#1)(1996-3#1)(1996-6#1)(1997-5#1)(2005-10#1)(2005-12#1)(2005-2#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#7)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#4)(2009-1#1)(2009-10#2)(2009-4#3)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-2#1)(2010-4#1)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#4)(2012-11#2)(2012-12#3)(2012-3#1)(2013-1#9)(2013-7#3)
report underscores the##2##3##(1997-3#1)(2008-4#1)
report using##4##2##(1994-8#1)(2009-9#1)(2013-1#1)(2013-7#1)
report was published##2##3##(2004-2#1)(2007-2#1)
report was to study##4##4##(2007-2#1)(2007-3#2)(2013-7#1)
report was to##12##3##(2004-9#1)(2006-2#1)(2007-2#1)(2007-3#2)(2008-5#1)(2008-6#1)(2009-4#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
report was##27##2##(1993-12#1)(1993-3#1)(1994-5#1)(2004-2#1)(2004-9#1)(2006-2#1)(2007-2#2)(2007-3#2)(2007-6#4)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
report we demonstrate the##3##4##(1992-2#1)(1992-9#1)(2010-12#1)
report we demonstrate##8##3##(1990-11#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-8#1)(2010-12#1)(2011-1#1)
report we describe a unique##2##5##(1992-11#1)(2007-8#1)
report we describe a##9##4##(1992-11#2)(1992-7#1)(1994-3#1)(1997-3#2)(2007-8#1)(2008-4#1)(2012-3#1)
report we describe the##6##4##(1990-8#1)(1991-7#1)(1994-3#1)(1995-3#1)(2007-1#1)(2012-2#1)
report we describe##24##3##(1990-8#1)(1991-7#1)(1992-11#2)(1992-7#1)(1994-3#3)(1995-3#1)(1997-3#2)(1997-9#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-6#1)(2009-10#1)(2012-2#1)(2012-3#2)
report we discuss##3##3##(2007-11#1)(2008-5#1)(2012-3#1)
report we have##8##3##(1990-5#1)(1990-7#1)(1991-4#1)(1992-9#1)(1995-10#1)(1996-3#1)(2008-4#1)(2011-2#1)
report we present a##4##4##(2007-10#1)(2007-8#1)(2008-7#2)
report we present##9##3##(1991-7#1)(2007-10#1)(2007-8#1)(2008-4#1)(2008-7#2)(2008-9#1)(2012-12#1)(2012-2#1)
report we##78##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-3#1)(1991-4#1)(1991-7#2)(1992-11#2)(1992-2#1)(1992-5#1)(1992-7#2)(1992-9#2)(1993-11#1)(1993-8#1)(1994-3#4)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#2)(1996-10#1)(1996-2#1)(1996-3#1)(1997-3#2)(1997-7#1)(1997-9#1)(2005-7#1)(2006-10#2)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-12#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-8#1)
report where##2##2##(1990-11#1)(2011-1#1)
report which##4##2##(1990-4#1)(1994-1#1)(2009-2#1)(2010-11#1)
report will provide##4##3##(2008-11#1)(2008-9#1)(2012-11#2)
report will##14##2##(1997-8#1)(2005-6#1)(2005-9#1)(2007-8#2)(2008-11#2)(2008-7#1)(2008-9#1)(2009-4#1)(2012-11#2)(2012-3#2)
report with literature review##2##4##(2007-3#1)(2010-11#1)
report with the##2##3##(2012-1#1)(2013-7#1)
report with##20##2##(1994-8#1)(1997-2#1)(2006-12#1)(2007-1#1)(2007-2#1)(2007-3#1)(2008-4#1)(2008-6#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
report##6438##1##(1990-1#2)(1990-10#17)(1990-11#20)(1990-12#28)(1990-2#12)(1990-3#13)(1990-4#9)(1990-5#17)(1990-6#16)(1990-7#13)(1990-8#16)(1990-9#11)(1991-1#16)(1991-10#9)(1991-11#17)(1991-12#18)(1991-2#22)(1991-3#18)(1991-4#15)(1991-5#15)(1991-6#22)(1991-7#6)(1991-8#18)(1991-9#17)(1992-1#7)(1992-10#23)(1992-11#16)(1992-12#17)(1992-2#27)(1992-3#16)(1992-4#13)(1992-5#18)(1992-6#14)(1992-7#9)(1992-8#24)(1992-9#23)(1993-1#11)(1993-10#12)(1993-11#18)(1993-12#28)(1993-2#11)(1993-3#17)(1993-4#5)(1993-5#11)(1993-6#23)(1993-7#9)(1993-8#21)(1993-9#25)(1994-1#5)(1994-10#7)(1994-11#15)(1994-12#26)(1994-2#13)(1994-3#24)(1994-4#1)(1994-5#11)(1994-6#17)(1994-7#4)(1994-8#26)(1994-9#23)(1995-1#16)(1995-10#9)(1995-11#15)(1995-12#14)(1995-2#26)(1995-3#26)(1995-4#5)(1995-5#7)(1995-6#16)(1995-7#4)(1995-8#24)(1995-9#5)(1996-1#18)(1996-10#9)(1996-11#14)(1996-12#26)(1996-2#19)(1996-3#29)(1996-4#10)(1996-5#16)(1996-6#15)(1996-7#5)(1996-8#13)(1996-9#16)(1997-1#14)(1997-2#21)(1997-3#29)(1997-4#16)(1997-5#16)(1997-6#15)(1997-7#24)(1997-8#20)(1997-9#2)(2004-1#3)(2004-10#2)(2004-11#1)(2004-2#3)(2004-5#2)(2004-7#2)(2004-8#1)(2004-9#4)(2005-1#3)(2005-10#24)(2005-11#16)(2005-12#26)(2005-2#1)(2005-3#2)(2005-4#2)(2005-6#2)(2005-7#4)(2005-8#18)(2005-9#10)(2006-1#5)(2006-10#126)(2006-11#13)(2006-12#67)(2006-2#17)(2006-3#11)(2006-4#47)(2006-5#12)(2006-6#14)(2006-7#21)(2006-8#38)(2006-9#10)(2007-1#16)(2007-10#53)(2007-11#149)(2007-12#278)(2007-2#66)(2007-3#38)(2007-4#27)(2007-5#34)(2007-6#27)(2007-7#157)(2007-8#172)(2007-9#50)(2008-1#73)(2008-10#202)(2008-11#112)(2008-12#95)(2008-2#83)(2008-3#93)(2008-4#63)(2008-5#91)(2008-6#78)(2008-7#176)(2008-8#51)(2008-9#80)(2009-1#12)(2009-10#32)(2009-11#13)(2009-12#9)(2009-2#21)(2009-3#34)(2009-4#41)(2009-5#40)(2009-6#26)(2009-7#47)(2009-8#24)(2009-9#39)(2010-1#7)(2010-10#18)(2010-11#33)(2010-12#79)(2010-2#48)(2010-3#38)(2010-4#37)(2010-5#36)(2010-6#38)(2010-7#34)(2010-8#23)(2010-9#42)(2011-1#120)(2011-10#1)(2011-11#2)(2011-12#27)(2011-2#251)(2011-3#4)(2011-7#1)(2011-8#1)(2012-1#35)(2012-11#19)(2012-12#204)(2012-2#229)(2012-3#100)(2012-4#1)(2012-8#2)(2013-1#300)(2013-2#1)(2013-7#43)(2013-8#104)
report's##2##1##(1995-12#1)(2013-1#1)
report)##7##1##(2005-12#1)(2008-7#1)(2011-2#3)(2012-2#1)(2012-3#1)
report?##2##1##(1990-8#1)(2012-2#1)
report]##101##1##(1990-10#1)(1990-5#1)(1990-9#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-6#3)(1992-9#1)(1993-8#1)(1994-11#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-8#1)(2005-1#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-3#8)(2007-8#2)(2007-9#3)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#4)(2009-1#1)(2009-5#8)(2010-12#1)(2010-6#2)(2010-9#2)(2011-1#3)(2011-12#2)(2011-2#5)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#1)
reportable conditions##6##2##(2013-1#6)
reportable##21##1##(1991-6#1)(1997-3#3)(2007-12#1)(2010-11#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#12)
reported &gt##2##2##(2008-7#1)(2013-1#1)
reported &quot##2##2##(2011-2#1)(2012-12#1)
reported 100% adherence##2##3##(2012-2#2)
reported 2##2##2##(1997-2#1)(2009-3#1)
reported 826 cases of AIDS to the World Health Organization##2##10##(1997-6#2)
reported ADRs##2##2##(2011-2#1)(2013-8#1)
reported Salmonella##2##2##(1992-5#1)(1996-8#1)
reported VCGs##2##2##(2008-10#2)
reported VRE occurences##2##3##(2007-12#2)
reported X-ray##2##2##(1995-11#1)(2011-2#1)
reported [Appl##2##2##(2007-12#1)(2008-2#1)
reported a case of an##2##5##(2011-1#1)(2012-3#1)
reported a case of##9##4##(1997-3#1)(2008-1#1)(2008-5#2)(2010-12#1)(2011-1#2)(2012-2#1)(2012-3#1)
reported a case##10##3##(1997-3#1)(2008-1#1)(2008-5#2)(2008-9#1)(2010-12#1)(2011-1#2)(2012-2#1)(2012-3#1)
reported a history of##2##4##(2006-10#1)(2013-8#1)
reported a low##2##3##(2007-8#1)(2009-5#1)
reported a lower##3##3##(2008-6#1)(2009-5#1)(2011-2#1)
reported a positive##3##3##(2005-10#1)(2009-4#1)(2013-1#1)
reported a significantly higher##2##4##(2011-1#1)(2012-12#1)
reported a significantly##6##3##(2007-12#1)(2008-7#1)(2009-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
reported a total of##2##4##(1991-2#1)(2008-8#1)
reported a##91##2##(1991-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-4#1)(1995-2#1)(1996-12#1)(1997-1#1)(1997-3#3)(1997-6#1)(2005-10#2)(2006-10#5)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#3)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-4#2)(2009-5#3)(2009-8#2)(2010-1#1)(2010-12#2)(2010-8#1)(2011-1#6)(2011-12#1)(2011-2#4)(2012-12#6)(2012-2#2)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#4)
reported abnormal##2##2##(1991-7#1)(2012-12#1)
reported about##8##2##(1990-12#2)(1992-3#1)(2008-10#1)(2008-6#1)(2010-4#1)(2012-2#1)(2012-3#1)
reported acquiring##2##2##(1993-1#1)(2008-12#1)
reported adverse effects##4##3##(1997-6#1)(2008-3#1)(2011-2#1)(2012-12#1)
reported adverse event is##2##4##(2008-6#1)(2008-8#1)
reported adverse events##3##3##(2007-11#1)(2008-11#2)
reported adverse reactions##2##3##(2010-11#1)(2011-2#1)
reported adverse##11##2##(1997-6#1)(2007-11#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-8#1)(2010-11#1)(2011-2#2)(2012-12#1)
reported after##15##2##(1990-5#1)(1991-12#2)(1994-5#1)(2004-12#1)(2005-1#1)(2005-11#1)(2006-10#1)(2007-10#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)
reported along with##3##3##(2007-12#1)(2008-10#1)(2011-2#1)
reported along##4##2##(2007-12#1)(2008-10#1)(2008-5#1)(2011-2#1)
reported among the##3##3##(2008-2#1)(2012-12#2)
reported among##14##2##(1991-12#1)(1991-8#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-5#1)(2011-1#1)(2012-1#1)(2012-12#3)
reported an IIEF5##2##3##(2011-2#2)
reported an average##2##3##(2006-3#1)(2008-7#1)
reported an increase in##2##4##(2006-10#1)(2006-7#1)
reported an increased##4##3##(1990-12#1)(1991-2#1)(2006-2#1)(2011-2#1)
reported an##21##2##(1990-12#1)(1990-6#1)(1991-2#1)(1991-5#1)(1994-2#1)(1995-2#1)(1996-7#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-7#2)(2007-8#1)(2008-10#1)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#3)(2012-12#1)
reported and a##2##3##(2008-6#1)(2011-2#1)
reported and compared with available experimental##2##6##(1995-9#1)(2009-3#1)
reported and compared with##5##4##(1995-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-3#1)
reported and discussed##9##3##(1990-12#1)(2006-5#2)(2007-8#1)(2008-2#1)(2008-6#1)(2012-12#3)
reported and it##2##3##(2010-12#1)(2010-6#1)
reported and the##9##3##(1996-3#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)
reported and their##2##3##(2007-11#1)(2008-10#1)
reported and##66##2##(1990-12#2)(1990-6#1)(1991-1#1)(1991-7#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-9#1)(1995-9#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(2004-12#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#2)(2007-11#4)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-12#5)(2013-1#1)
reported annually##3##2##(1990-12#1)(2007-11#1)(2008-11#1)
reported anywhere##2##2##(1992-6#1)(2008-11#1)
reported are##4##2##(2007-10#1)(2008-3#1)(2008-5#1)(2012-2#1)
reported as &quot##3##3##(2008-10#1)(2010-6#1)(2012-3#1)
reported as 1##2##3##(1993-4#1)(2008-10#1)
reported as a complication of##2##5##(2007-7#1)(2012-1#1)
reported as a complication##3##4##(2007-7#1)(2008-7#1)(2012-1#1)
reported as a##21##3##(1990-8#1)(1991-4#1)(1993-4#1)(1995-3#1)(1995-8#1)(1997-1#1)(2006-10#2)(2007-12#2)(2007-7#2)(2008-10#2)(2008-7#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-9#1)(2012-1#1)(2013-1#1)
reported as an##6##3##(1993-4#1)(1993-5#1)(1995-6#1)(2008-10#1)(2009-5#1)(2012-2#1)
reported as being##6##3##(1990-4#1)(1991-8#1)(1996-11#1)(2008-5#1)(2008-9#1)(2011-2#1)
reported as benign##2##3##(2011-1#2)
reported as having##4##3##(1995-6#1)(1996-11#2)(2012-12#1)
reported as low##2##3##(2009-4#1)(2012-12#1)
reported as markers##2##3##(2012-12#1)(2013-8#1)
reported as positive##3##3##(2004-1#1)(2010-4#1)(2010-8#1)
reported as resistant##2##3##(2011-2#2)
reported as the##5##3##(1994-11#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-8#1)
reported as##104##2##(1990-12#1)(1990-4#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-4#3)(1993-5#1)(1993-9#1)(1994-11#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-11#3)(1996-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(2004-1#1)(2004-10#1)(2004-12#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-3#1)(2006-7#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#9)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#2)(2009-4#2)(2009-5#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
reported asking##2##2##(2006-8#2)
reported assaults or presented traumatic injuries##2##6##(2013-7#2)
reported assaults##3##2##(2013-7#3)
reported association with##2##3##(2008-3#1)(2008-8#1)
reported association##3##2##(1997-8#1)(2008-3#1)(2008-8#1)
reported associations##4##2##(1997-1#1)(2007-11#1)(2012-12#1)(2012-6#1)
reported at least one##3##4##(2008-12#1)(2012-3#1)(2013-1#1)
reported at least##5##3##(2007-8#1)(2008-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
reported at the##4##3##(2007-9#1)(2008-5#1)(2008-7#1)(2012-12#1)
reported at##17##2##(1994-11#1)(1996-12#1)(1996-8#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#2)(2012-3#1)(2013-1#1)
reported back##2##2##(2007-11#1)(2008-11#1)
reported because of its##2##4##(2007-7#1)(2010-7#1)
reported because of the##2##4##(1992-6#1)(2007-7#1)
reported because of##4##3##(1992-6#1)(2007-7#2)(2010-7#1)
reported because##5##2##(1992-6#1)(2007-7#2)(2008-10#1)(2010-7#1)
reported before##9##2##(1993-12#1)(1995-2#1)(1997-8#1)(2005-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)
reported behavior##2##2##(1992-2#1)(2008-12#1)
reported being &quot##3##3##(2008-12#3)
reported being##21##2##(1993-1#1)(1993-9#1)(1995-1#1)(2007-12#1)(2008-10#1)(2008-12#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
reported beneficial effects of##3##4##(2007-11#1)(2008-5#1)(2012-2#1)
reported benefit from##2##3##(1997-8#1)(2007-7#1)
reported better##3##2##(2004-1#1)(2010-5#1)(2011-1#1)
reported between##5##2##(1992-6#1)(1994-5#1)(2007-2#1)(2010-6#1)(2013-1#1)
reported bite rate##2##3##(2013-8#2)
reported body##2##2##(2006-7#1)(2007-12#1)
reported both##4##2##(2007-8#1)(2008-11#1)(2011-2#1)(2013-8#1)
reported but##5##2##(2006-10#1)(2008-10#1)(2010-12#1)(2011-2#1)(2012-2#1)
reported by 4 patients##2##4##(2007-8#1)(2008-5#1)
reported by Van##2##3##(1992-7#1)(2006-11#1)
reported by different investigators##2##4##(2008-2#2)
reported by men##2##3##(1993-9#1)(2007-12#1)
reported by other authors##3##4##(1991-2#1)(1992-1#1)(2007-7#1)
reported by other##7##3##(1991-2#1)(1992-1#1)(1996-1#1)(1996-8#1)(2007-7#1)(2008-6#1)(2012-12#1)
reported by others##9##3##(1990-7#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-9#1)(1996-7#1)(2008-5#1)(2011-2#1)
reported by patients##2##3##(1996-1#1)(2013-1#1)
reported by some##3##3##(2004-12#1)(2009-4#1)(2012-2#1)
reported by subjects##2##3##(2008-11#1)(2008-8#1)
reported by the##20##3##(1991-2#1)(1993-9#1)(1994-11#1)(1996-1#1)(1996-11#1)(2006-10#1)(2007-10#1)(2008-10#7)(2008-6#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#2)
reported by this##2##3##(1993-11#1)(2007-10#1)
reported by us##3##3##(1990-2#1)(1995-6#1)(2008-10#1)
reported by women##4##3##(1993-9#1)(1994-2#1)(2013-1#1)(2013-8#1)
reported by##163##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-2#2)(1991-5#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-2#2)(1994-5#2)(1994-9#1)(1995-5#1)(1995-6#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(2004-12#2)(2004-7#1)(2004-8#1)(2005-7#1)(2005-9#1)(2006-10#4)(2006-11#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#2)(2007-4#4)(2007-7#4)(2007-8#6)(2007-9#4)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#2)(2008-5#2)(2008-6#2)(2008-8#2)(2008-9#4)(2009-10#2)(2009-4#2)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#4)
reported cDNA##5##2##(1990-5#1)(1991-7#1)(1991-9#1)(1993-6#1)(1994-8#1)
reported case from##2##3##(1991-2#1)(2012-2#1)
reported case in the##2##4##(2008-11#1)(2012-2#1)
reported case in##6##3##(1991-9#1)(2008-10#1)(2008-11#1)(2010-6#1)(2010-9#1)(2012-2#1)
reported case is##2##3##(2008-7#1)(2011-2#1)
reported case of M bovis BCG##2##6##(2008-4#2)
reported case of a##10##4##(1995-4#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#2)(2010-6#1)(2012-2#1)(2013-1#1)
reported case of this##2##4##(1993-12#1)(2013-1#1)
reported case of##61##3##(1993-12#1)(1995-4#1)(1996-3#1)(2006-10#3)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#3)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2009-1#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#1)
reported case##83##2##(1991-2#1)(1991-9#1)(1993-12#1)(1994-9#1)(1995-4#1)(1996-12#1)(1996-3#1)(2006-10#4)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#3)(2008-10#4)(2008-11#2)(2008-2#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-1#1)(2009-4#3)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#4)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#7)(2012-3#4)(2013-1#4)(2013-8#2)
reported cases are##2##3##(2007-6#1)(2010-12#1)
reported cases have##2##3##(2007-7#1)(2008-1#1)
reported cases in the literature##3##5##(1994-6#1)(2008-3#1)(2008-7#1)
reported cases in the##4##4##(1994-6#1)(2008-3#1)(2008-6#1)(2008-7#1)
reported cases in##6##3##(1991-6#1)(1994-6#1)(2007-12#1)(2008-3#1)(2008-6#1)(2008-7#1)
reported cases indicate that##2##4##(2006-6#1)(2013-1#1)
reported cases of##35##3##(1990-12#1)(1990-6#1)(1992-12#1)(1992-2#1)(1994-6#1)(1994-9#1)(1995-3#1)(1996-3#1)(2006-10#4)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#4)(2007-8#1)(2008-4#1)(2008-6#1)(2009-10#1)(2009-3#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
reported cases were##2##3##(1991-11#1)(2011-2#1)
reported cases##80##2##(1990-12#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-8#1)(1994-6#2)(1994-9#1)(1995-3#1)(1996-3#1)(1996-4#1)(2006-10#6)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#4)(2007-2#1)(2007-6#1)(2007-7#6)(2007-8#2)(2008-1#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2009-1#1)(2009-10#2)(2009-3#2)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#7)(2012-12#1)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#1)
reported cause of##2##3##(2006-10#1)(2007-2#1)
reported changes in the##2##4##(1991-2#1)(1993-11#1)
reported changes##3##2##(1991-2#1)(1993-11#1)(2011-2#1)
reported clinical##7##2##(1993-9#1)(1997-1#1)(2006-10#1)(2008-5#1)(2009-8#1)(2010-6#1)(2012-12#1)
reported complete##2##2##(1990-12#1)(2009-3#1)
reported complication##2##2##(2008-1#1)(2012-12#1)
reported complications of##2##3##(2008-9#1)(2012-12#1)
reported complications##6##2##(2006-6#1)(2006-8#1)(2008-9#3)(2012-12#1)
reported concentration##2##2##(2008-10#1)(2011-2#1)
reported concerning the##2##3##(2009-2#1)(2011-1#1)
reported condom##2##2##(1992-2#1)(2012-3#1)
reported daily##2##2##(1996-12#1)(2006-10#1)
reported data in##2##3##(1996-10#1)(2012-2#1)
reported data##15##2##(1991-1#1)(1991-9#1)(1992-5#1)(1996-10#1)(1996-7#1)(2007-11#1)(2008-10#4)(2008-4#1)(2009-2#1)(2010-3#1)(2012-2#1)(2013-8#1)
reported depressive##2##2##(2006-4#1)(2011-1#1)
reported differential##2##2##(2010-12#1)(2013-8#1)
reported difficulty##2##2##(1993-10#1)(2007-9#1)
reported diminished##2##2##(1996-1#2)
reported due to##4##3##(2006-6#1)(2007-7#1)(2007-9#1)(2009-5#1)
reported during the##4##3##(1990-8#1)(2006-10#2)(2008-4#1)
reported during##13##2##(1990-8#1)(1991-9#1)(1997-1#1)(2006-10#3)(2006-2#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-12#1)
reported earlier in##4##3##(1992-9#1)(1993-4#1)(2007-2#1)(2007-7#1)
reported earlier to##2##3##(1991-2#1)(1992-9#1)
reported earlier##14##2##(1991-2#1)(1992-9#2)(1993-4#1)(1994-8#1)(1995-5#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-8#1)(2013-1#1)
reported eating##2##2##(2012-1#2)
reported effective in the treatment of psoriasis##2##7##(2007-7#2)
reported effects of##4##3##(2005-7#1)(2006-10#1)(2007-12#1)(2010-5#1)
reported effects##5##2##(1993-12#1)(2005-7#1)(2006-10#1)(2007-12#1)(2010-5#1)
reported either##2##2##(1994-8#1)(2010-10#1)
reported elsewhere##7##2##(1992-10#1)(1994-3#1)(1997-4#1)(2005-3#1)(2007-2#1)(2008-10#2)
reported encountering delirium##2##3##(2013-1#2)
reported engaging in##3##3##(2005-10#1)(2007-10#1)(2010-7#1)
reported even##2##2##(2006-10#1)(2012-2#1)
reported ever##3##2##(2007-2#1)(2008-12#1)(2012-12#1)
reported evidence##2##2##(1992-12#1)(2008-10#1)
reported examples##2##2##(1990-4#1)(1997-3#1)
reported experience##2##2##(1991-6#1)(2008-11#1)
reported experiences##2##2##(1991-3#1)(2011-1#1)
reported experimental results##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
reported experimental##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2009-11#1)
reported expression##2##2##(1997-7#1)(2011-2#1)
reported feeling##6##2##(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-9#1)(2011-2#1)
reported fewer##3##2##(2007-1#1)(2009-9#1)(2013-1#1)
reported findings##4##2##(1990-1#1)(1993-1#1)(2007-7#1)(2009-8#1)
reported following##5##2##(1994-6#1)(2007-2#1)(2007-9#1)(2009-6#1)(2013-8#1)
reported for Costa##2##3##(2007-3#1)(2007-5#1)
reported for Cu(II)(2) (3##2##4##(2008-5#2)
reported for a##7##3##(1991-5#1)(1991-7#1)(1994-6#1)(2005-7#1)(2007-12#1)(2008-2#1)(2008-5#1)
reported for any##2##3##(2008-8#1)(2010-3#1)
reported for each##2##3##(2010-11#1)(2013-1#1)
reported for free##2##3##(1992-12#1)(2008-10#1)
reported for its rarity##3##4##(2007-7#1)(2007-8#1)(2010-12#1)
reported for its##5##3##(2007-7#2)(2007-8#1)(2008-12#1)(2010-12#1)
reported for measuring##2##3##(2008-10#1)(2008-3#1)
reported for natural##2##3##(2008-10#1)(2008-8#1)
reported for one##2##3##(2006-10#1)(2008-8#1)
reported for other hemoglobins##2##4##(1990-8#1)(1993-6#1)
reported for other##9##3##(1990-8#1)(1990-9#1)(1991-8#1)(1993-11#1)(1993-6#1)(2004-11#1)(2007-12#1)(2007-3#1)(2008-5#1)
reported for several##3##3##(1993-3#1)(1996-8#1)(2010-6#1)
reported for similar##2##3##(2007-9#1)(2008-3#1)
reported for the analysis##2##4##(2008-10#2)
reported for the conventional##2##4##(2008-10#1)(2008-2#1)
reported for the determination of##4##5##(2008-10#4)
reported for the first time for##2##6##(2007-8#1)(2010-9#1)
reported for the first time from the##2##7##(2007-1#1)(2010-3#1)
reported for the first time from##3##6##(2007-1#1)(2008-5#1)(2010-3#1)
reported for the first time in##8##6##(1994-11#2)(1997-3#1)(2007-1#2)(2007-3#1)(2008-5#1)(2013-8#1)
reported for the first time that##2##6##(1992-3#1)(2008-8#1)
reported for the first time##41##5##(1990-11#1)(1992-3#2)(1994-11#2)(1997-3#1)(2004-11#1)(2005-4#1)(2006-12#1)(2006-4#1)(2007-1#4)(2007-11#1)(2007-12#3)(2007-3#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-9#1)(2012-11#1)(2012-3#1)(2013-8#1)
reported for the first##42##4##(1990-11#1)(1991-12#1)(1992-3#2)(1994-11#2)(1997-3#1)(2004-11#1)(2005-4#1)(2006-12#1)(2006-4#1)(2007-1#4)(2007-11#1)(2007-12#3)(2007-3#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-9#1)(2012-11#1)(2012-3#1)(2013-8#1)
reported for the synthesis of##2##5##(2006-12#1)(2009-9#1)
reported for the use of##2##5##(1995-10#1)(2008-1#1)
reported for the##107##3##(1990-1#1)(1990-11#1)(1990-2#1)(1991-12#1)(1991-6#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#2)(1996-2#1)(1997-1#1)(1997-3#1)(2004-11#1)(2005-11#1)(2005-4#1)(2006-12#3)(2006-4#1)(2007-1#5)(2007-11#1)(2007-12#4)(2007-3#1)(2007-8#4)(2008-1#1)(2008-10#20)(2008-11#3)(2008-2#2)(2008-3#5)(2008-5#7)(2008-6#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
reported for their##2##3##(1992-12#1)(2012-12#1)
reported for this##5##3##(1993-8#1)(1996-12#1)(2007-12#1)(2008-4#1)(2008-6#1)
reported for two##2##3##(1993-8#1)(1995-6#1)
reported for##287##2##(1990-1#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#3)(1991-7#2)(1991-8#2)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#1)(1994-11#4)(1994-12#1)(1994-2#5)(1994-3#1)(1994-6#2)(1994-9#2)(1995-1#3)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#1)(1995-7#1)(1996-10#1)(1996-12#3)(1996-2#2)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#2)(2004-11#2)(2005-11#3)(2005-4#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-12#4)(2006-2#1)(2006-4#2)(2006-5#1)(2006-7#1)(2007-1#6)(2007-11#5)(2007-12#10)(2007-2#2)(2007-3#3)(2007-5#1)(2007-7#3)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#32)(2008-11#5)(2008-12#1)(2008-2#11)(2008-3#11)(2008-4#1)(2008-5#19)(2008-6#4)(2008-7#3)(2008-8#8)(2008-9#1)(2009-11#2)(2009-4#2)(2009-8#3)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-11#1)(2011-2#1)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
reported from India##2##3##(2009-9#1)(2012-2#1)
reported from a##7##3##(1994-3#1)(1996-2#2)(1996-8#1)(2007-12#1)(2008-10#1)(2012-1#1)
reported from analysis of##2##4##(1995-12#1)(1997-4#1)
reported from different##2##3##(2007-3#1)(2008-1#1)
reported from other Nordic countries##3##5##(1995-8#1)(2006-10#2)
reported from other countries##3##4##(1995-8#1)(2008-1#1)(2010-4#1)
reported from other##14##3##(1993-2#1)(1995-8#2)(2006-10#2)(2007-2#2)(2007-7#2)(2008-1#2)(2008-10#1)(2010-4#1)(2010-6#1)
reported from the##12##3##(1990-11#1)(1990-12#1)(1992-6#1)(2005-12#1)(2007-5#2)(2008-5#2)(2008-8#1)(2009-4#1)(2012-12#1)(2013-8#1)
reported from this##3##3##(2007-7#1)(2009-6#1)(2012-2#1)
reported from##78##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-8#1)(1992-1#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-8#2)(1996-2#3)(1996-8#1)(1997-4#1)(2005-10#2)(2005-12#1)(2006-10#2)(2006-2#2)(2006-5#1)(2007-12#1)(2007-2#3)(2007-3#1)(2007-5#2)(2007-7#4)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-8#1)(2009-10#1)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#1)
reported functional##3##2##(1993-12#1)(1993-9#1)(2008-4#1)
reported gene##5##2##(1990-10#1)(2008-10#1)(2008-8#1)(2012-11#2)
reported genes##7##2##(1991-7#1)(1995-8#3)(1996-10#1)(1996-2#1)(1996-6#1)
reported good##2##2##(1990-6#1)(2011-2#1)
reported greater##9##2##(1996-3#1)(2006-10#1)(2007-12#2)(2008-6#2)(2008-9#1)(2009-12#1)(2010-9#1)
reported had##2##2##(2006-10#1)(2013-8#1)
reported having a##4##3##(2006-2#1)(2007-2#1)(2012-3#2)
reported having been vaccinated for##2##5##(2009-5#2)
reported having been##4##3##(2009-5#2)(2012-3#1)(2013-7#1)
reported having prescribed##2##3##(2013-1#2)
reported having##27##2##(1994-2#1)(1995-6#1)(2006-12#1)(2006-2#1)(2007-12#1)(2007-2#5)(2007-3#1)(2008-11#1)(2008-8#1)(2009-5#4)(2011-1#1)(2012-3#4)(2013-1#3)(2013-7#2)
reported here and##2##3##(1995-11#1)(1996-12#1)
reported here are##6##3##(1997-6#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2012-2#1)
reported here for the first time##6##6##(2007-11#1)(2008-10#1)(2008-2#1)(2010-8#1)(2012-12#2)
reported here for##8##3##(2007-11#1)(2008-10#2)(2008-2#1)(2008-5#1)(2010-8#1)(2012-12#2)
reported here have##2##3##(1993-6#1)(1994-6#1)
reported here in detail##2##4##(2008-5#2)
reported here in##3##3##(1993-7#1)(2008-5#2)
reported here indicate that##3##4##(1993-12#1)(2004-11#1)(2008-10#1)
reported here is to##3##4##(1991-2#1)(2008-7#1)(2010-7#1)
reported here is##11##3##(1991-2#1)(1991-4#1)(1992-2#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-5#1)(2010-7#1)(2013-7#1)
reported here may be##2##4##(1991-1#1)(1996-9#1)
reported here may##3##3##(1991-1#1)(1992-11#1)(1996-9#1)
reported here provide##2##3##(2008-12#1)(2009-7#1)
reported here show that##3##4##(1990-5#1)(2008-10#1)(2009-2#1)
reported here shows##2##3##(1990-9#1)(2008-3#1)
reported here suggest that##2##4##(1990-12#1)(2007-12#1)
reported here suggest##3##3##(1990-12#1)(2007-12#1)(2009-5#1)
reported here the##2##3##(1994-8#1)(2011-2#1)
reported here was a##2##4##(1997-8#1)(2008-12#1)
reported here was##8##3##(1991-5#1)(1992-8#1)(1997-8#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-5#2)
reported here we##2##3##(1992-3#1)(2008-7#1)
reported here were##2##3##(2008-5#2)
reported here##144##2##(1990-12#1)(1990-4#1)(1990-5#3)(1990-9#1)(1991-1#1)(1991-10#2)(1991-2#3)(1991-4#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#5)(1996-12#2)(1996-2#1)(1996-6#1)(1996-9#1)(1997-3#2)(1997-6#1)(1997-8#1)(2004-11#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#2)(2007-7#6)(2007-8#2)(2008-1#2)(2008-10#10)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#2)(2008-5#11)(2008-6#2)(2008-7#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#2)(2013-7#1)(2013-8#1)
reported herein##8##2##(1992-11#2)(1996-1#1)(1996-2#1)(2007-2#1)(2008-10#1)(2009-12#1)(2012-2#1)
reported high levels of##3##4##(2008-10#2)(2008-12#1)
reported high##9##2##(2006-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-3#1)
reported higher availability of MLs##2##5##(2011-1#2)
reported higher levels of##7##4##(1994-2#2)(2006-2#1)(2006-7#1)(2008-6#1)(2009-7#1)(2010-1#1)
reported higher rates of##2##4##(2009-5#1)(2010-4#1)
reported higher##21##2##(1991-1#1)(1994-2#2)(1996-8#1)(2006-2#1)(2006-7#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-1#1)
reported highest##2##2##(2009-7#1)(2012-3#1)
reported human##3##2##(1992-10#1)(1993-8#1)(2012-3#1)
reported improved outcomes with##2##4##(2007-8#1)(2009-11#1)
reported improved##5##2##(2006-10#1)(2007-8#1)(2009-11#1)(2011-2#1)(2012-12#1)
reported improvement in##2##3##(2007-11#1)(2012-2#1)
reported improvement##5##2##(1992-5#1)(1997-2#1)(2007-11#1)(2007-7#1)(2012-2#1)
reported in 18##2##3##(1992-11#1)(2011-2#1)
reported in 1992##2##3##(1997-3#1)(2006-6#1)
reported in 2##3##3##(2007-11#1)(2007-2#1)(2008-9#1)
reported in Australia##2##3##(2008-10#1)(2012-12#1)
reported in Caucasian populations##3##4##(1991-1#2)(2009-5#1)
reported in Caucasian##5##3##(1991-1#2)(1997-8#1)(2008-10#1)(2009-5#1)
reported in Europe##2##3##(1997-6#1)(2008-10#1)
reported in a number of##2##5##(2010-3#1)(2012-1#1)
reported in a patient##3##4##(2005-5#1)(2007-7#1)(2007-8#1)
reported in a##36##3##(1990-6#1)(1991-10#1)(1992-11#1)(1992-8#1)(1996-9#1)(2004-12#1)(2005-5#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#5)(2008-5#2)(2008-6#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
reported in adults##3##3##(2012-2#1)(2013-1#2)
reported in aged##2##3##(2006-6#1)(2012-1#1)
reported in almost##3##3##(2006-12#1)(2008-4#1)(2009-7#1)
reported in an earlier##2##4##(1991-3#1)(2008-3#1)
reported in an##3##3##(1991-3#1)(2008-3#1)(2008-6#1)
reported in association with##8##4##(2004-7#1)(2006-10#2)(2007-11#1)(2007-7#1)(2008-1#1)(2008-7#1)(2011-2#1)
reported in both##2##3##(2008-4#1)(2013-1#1)
reported in cases of##2##4##(2007-4#1)(2011-2#1)
reported in children##4##3##(2008-10#1)(2008-5#1)(2008-6#1)(2009-4#1)
reported in clinical##3##3##(2011-2#1)(2013-1#2)
reported in detail##3##3##(2008-10#1)(2009-7#1)(2011-2#1)
reported in different##2##3##(2011-2#1)(2012-2#1)
reported in drinking water##2##4##(2008-10#2)
reported in human##3##3##(1991-10#1)(2007-12#1)(2012-1#1)
reported in humans##4##3##(2007-11#1)(2007-2#1)(2007-7#1)(2009-7#1)
reported in literature for##3##4##(1994-6#1)(2007-8#1)(2008-10#1)
reported in literature of##3##4##(2006-11#1)(2009-10#1)(2010-12#1)
reported in literature were##2##4##(2007-1#1)(2008-4#1)
reported in literature##35##3##(1990-2#1)(1991-4#1)(1991-5#1)(1991-9#1)(1994-6#2)(2006-10#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-7#1)(2007-8#3)(2008-10#7)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-10#1)(2010-12#2)(2010-6#1)(2011-2#1)(2011-7#1)(2012-2#3)(2012-3#1)
reported in many other##4##4##(1995-1#1)(1995-7#1)(2006-10#1)(2012-2#1)
reported in many##6##3##(1995-1#1)(1995-7#1)(1995-8#1)(2006-10#1)(2012-2#2)
reported in medical literature##2##4##(2009-7#1)(2012-2#1)
reported in only one##2##4##(2007-8#1)(2009-1#1)
reported in only##4##3##(1992-8#1)(2006-10#1)(2007-8#1)(2009-1#1)
reported in other cell types##2##5##(1992-4#1)(2004-11#1)
reported in other species##2##4##(1991-3#1)(1997-9#1)
reported in other##22##3##(1991-10#1)(1991-12#1)(1991-3#1)(1992-2#1)(1992-4#1)(1994-7#1)(1995-4#1)(1996-9#1)(1997-1#1)(1997-7#1)(1997-9#1)(2004-11#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#2)(2008-6#1)(2008-7#1)(2010-12#1)(2013-1#1)
reported in patients with##17##4##(1990-11#1)(1994-12#1)(1995-11#1)(1997-7#1)(1997-8#1)(2005-10#1)(2007-10#1)(2007-2#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-1#1)(2012-12#1)(2012-3#1)
reported in patients##20##3##(1990-11#1)(1994-12#1)(1995-11#1)(1997-7#1)(1997-8#1)(2005-10#2)(2006-9#1)(2007-10#1)(2007-2#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-6#1)(2012-12#1)(2012-3#1)
reported in preclinical##3##3##(2010-4#1)(2012-2#1)(2012-3#1)
reported in previous studies##4##4##(1994-12#1)(2007-11#1)(2007-12#1)(2008-10#1)
reported in previous##8##3##(1994-12#1)(1996-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-8#1)(2012-1#1)
reported in recent##3##3##(2007-12#1)(2007-7#1)(2011-2#1)
reported in several##8##3##(1991-12#1)(1994-11#1)(1995-12#1)(2006-10#1)(2007-10#1)(2008-7#1)(2011-2#1)(2013-8#1)
reported in similar##2##3##(2006-10#1)(2008-5#1)
reported in some studies##2##4##(2006-8#1)(2012-2#1)
reported in some##10##3##(1990-7#1)(1992-3#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-7#1)
reported in studies##2##3##(1990-12#1)(2006-8#1)
reported in terms of##3##4##(1996-12#1)(1997-3#1)(2010-8#1)
reported in the English literature##11##5##(2006-12#1)(2008-2#1)(2008-6#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
reported in the English##13##4##(2006-12#1)(2008-2#1)(2008-6#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-6#3)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
reported in the United States##6##5##(1996-6#1)(2004-12#1)(2005-7#1)(2007-12#1)(2008-10#1)(2011-2#1)
reported in the earlier##2##4##(2008-2#1)(2009-6#1)
reported in the included##2##4##(2008-10#1)(2013-1#1)
reported in the international literature##2##5##(1997-8#1)(2011-3#1)
reported in the last##4##4##(1994-3#1)(2006-10#1)(2007-5#1)(2013-1#1)
reported in the literature and##6##5##(2006-2#1)(2008-1#1)(2008-2#2)(2008-7#1)(2011-2#1)
reported in the literature are reviewed##2##6##(2006-12#1)(2008-8#1)
reported in the literature are##5##5##(1994-6#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-8#1)
reported in the literature as a##3##6##(2006-3#1)(2013-1#2)
reported in the literature as##6##5##(2006-3#1)(2007-5#1)(2008-3#1)(2009-5#1)(2013-1#2)
reported in the literature for##10##5##(1991-3#2)(1992-9#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-6#1)(2011-12#1)(2013-1#1)
reported in the literature have##2##5##(2008-8#2)
reported in the literature in##3##5##(1991-3#1)(2006-10#1)(2013-1#1)
reported in the literature shows that##2##6##(1990-8#1)(2008-5#1)
reported in the literature so far##2##6##(2009-9#1)(2013-1#1)
reported in the literature##174##4##(1990-12#1)(1990-2#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#1)(1992-10#1)(1992-12#1)(1992-9#2)(1993-10#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-4#1)(1995-7#1)(1995-9#1)(1996-11#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-8#1)(2005-11#1)(2005-12#2)(2005-5#1)(2006-10#4)(2006-11#5)(2006-12#3)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#7)(2007-9#1)(2008-1#3)(2008-10#12)(2008-11#3)(2008-2#6)(2008-3#3)(2008-5#4)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#4)(2009-7#3)(2009-9#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#5)(2011-12#1)(2011-2#4)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#13)(2013-7#1)(2013-8#1)
reported in the medical literature##9##5##(1990-8#1)(1993-6#1)(1993-9#1)(2007-7#1)(2010-6#3)(2011-2#1)(2013-1#1)
reported in the original##2##4##(2006-6#1)(2007-12#1)
reported in the past##5##4##(1991-12#1)(1992-2#1)(2006-10#1)(2006-12#1)(2006-8#1)
reported in the present##3##4##(1990-6#1)(1996-9#1)(2006-12#1)
reported in the recent##2##4##(2008-1#2)
reported in the scientific literature##2##5##(2008-5#1)(2010-7#1)
reported in the study##2##4##(2008-5#1)(2013-1#1)
reported in the world##4##4##(2007-3#1)(2008-6#2)(2009-3#1)
reported in the##301##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#3)(1991-6#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-9#3)(1993-10#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-12#2)(1995-4#1)(1995-7#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-9#2)(1997-2#3)(1997-8#4)(2004-12#1)(2005-11#1)(2005-12#2)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#9)(2006-11#5)(2006-12#8)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#4)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#2)(2007-7#4)(2007-8#7)(2007-9#1)(2008-1#7)(2008-10#16)(2008-11#3)(2008-12#3)(2008-2#9)(2008-3#4)(2008-4#3)(2008-5#8)(2008-6#7)(2008-7#7)(2008-8#6)(2008-9#2)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#4)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-5#2)(2010-6#10)(2010-7#3)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#9)(2011-3#2)(2012-12#4)(2012-2#7)(2012-3#1)(2013-1#18)(2013-7#2)(2013-8#3)
reported in these patients##2##4##(2008-2#1)(2008-6#1)
reported in these##6##3##(1991-2#1)(1996-5#1)(2007-7#1)(2008-2#1)(2008-6#1)(2011-2#1)
reported in this article##4##4##(1991-1#1)(2006-10#1)(2010-11#1)(2010-3#1)
reported in this paper##15##4##(1992-3#1)(1992-6#1)(1994-2#1)(1995-3#1)(1996-5#1)(2005-4#2)(2008-10#5)(2008-9#1)(2011-12#1)(2012-1#1)
reported in this study were##2##5##(2007-2#1)(2011-2#1)
reported in this study##8##4##(1996-8#1)(2007-2#1)(2008-1#1)(2008-10#1)(2009-11#1)(2011-2#3)
reported in this work##3##4##(2005-11#1)(2008-10#2)
reported in this##46##3##(1990-12#1)(1991-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-5#1)(1996-8#1)(2004-12#1)(2005-11#1)(2005-4#3)(2006-10#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-9#2)(2008-1#1)(2008-10#10)(2008-12#1)(2008-9#1)(2009-11#1)(2010-11#1)(2010-3#1)(2010-6#1)(2011-12#1)(2011-2#4)(2012-1#1)(2013-7#1)(2013-8#1)
reported in three##6##3##(2006-10#1)(2008-10#2)(2008-3#1)(2010-12#1)(2011-2#1)
reported in two##4##3##(2007-8#2)(2008-9#1)(2010-10#1)
reported in various##2##3##(1991-9#1)(2012-2#1)
reported in very##2##3##(1995-3#1)(2009-7#1)
reported in vitro##5##3##(1992-5#1)(1995-12#1)(2004-3#1)(2008-9#1)(2013-8#1)
reported in which##12##3##(1992-12#1)(1995-3#1)(1996-9#1)(1997-8#1)(2007-11#2)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-6#1)(2012-2#1)
reported in##839##2##(1990-11#4)(1990-12#3)(1990-2#4)(1990-3#1)(1990-5#2)(1990-6#6)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#4)(1991-10#5)(1991-11#2)(1991-12#7)(1991-2#3)(1991-3#7)(1991-4#2)(1991-5#4)(1991-6#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#5)(1992-12#3)(1992-2#3)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#4)(1992-8#2)(1992-9#4)(1993-10#2)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#2)(1993-5#2)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#4)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#1)(1994-6#4)(1994-7#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#6)(1995-3#3)(1995-4#4)(1995-7#2)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#5)(1996-3#4)(1996-5#4)(1996-6#2)(1996-7#1)(1996-8#4)(1996-9#6)(1997-1#3)(1997-2#8)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#9)(1997-9#1)(2004-11#3)(2004-12#3)(2004-3#1)(2004-7#1)(2005-10#2)(2005-11#3)(2005-12#2)(2005-4#3)(2005-5#2)(2005-7#2)(2005-8#2)(2006-10#27)(2006-11#8)(2006-12#13)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#5)(2006-7#3)(2006-8#7)(2006-9#1)(2007-1#2)(2007-10#8)(2007-11#12)(2007-12#16)(2007-2#13)(2007-3#5)(2007-4#2)(2007-5#2)(2007-7#13)(2007-8#21)(2007-9#5)(2008-1#16)(2008-10#61)(2008-11#6)(2008-12#6)(2008-2#12)(2008-3#8)(2008-4#12)(2008-5#18)(2008-6#15)(2008-7#19)(2008-8#10)(2008-9#12)(2009-1#1)(2009-10#2)(2009-11#1)(2009-2#3)(2009-3#5)(2009-4#3)(2009-5#8)(2009-6#4)(2009-7#10)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#10)(2010-2#2)(2010-3#4)(2010-4#2)(2010-5#3)(2010-6#16)(2010-7#4)(2010-8#2)(2010-9#4)(2011-1#15)(2011-12#2)(2011-2#30)(2011-3#3)(2011-7#1)(2012-1#5)(2012-11#1)(2012-12#14)(2012-2#28)(2012-3#6)(2012-8#1)(2013-1#33)(2013-7#4)(2013-8#11)
reported incidence of##10##3##(2004-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-7#2)(2012-2#1)(2012-3#1)(2013-8#1)
reported incidence##11##2##(2004-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-7#2)(2010-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
reported incidences of##2##3##(2007-7#1)(2008-1#1)
reported include##2##2##(2007-11#1)(2012-3#1)
reported increased##5##2##(1994-4#1)(2008-12#1)(2010-2#1)(2012-2#1)(2013-1#1)
reported increases in##2##3##(2008-10#1)(2010-3#1)
reported injury##2##2##(2006-11#1)(2013-1#1)
reported instances of##2##3##(1991-12#1)(2008-7#1)
reported intrinsic##2##2##(2012-11#2)
reported is a##2##3##(2007-7#1)(2012-2#1)
reported is##6##2##(1992-12#1)(1994-5#1)(2007-7#1)(2008-10#1)(2009-8#1)(2012-2#1)
reported it to##2##3##(1996-11#1)(2013-8#1)
reported it##3##2##(1996-11#1)(2008-3#1)(2013-8#1)
reported lack of##5##3##(1991-2#1)(1991-3#1)(2008-6#1)(2009-4#1)(2010-2#1)
reported large##2##2##(1997-6#1)(2007-12#1)
reported less##14##2##(2006-4#2)(2006-7#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-12#1)(2009-7#1)(2010-3#1)(2011-1#1)(2013-1#3)
reported levels of##2##3##(2008-4#1)(2009-7#1)
reported levels##3##2##(2008-11#1)(2008-4#1)(2009-7#1)
reported link between##2##3##(1996-2#1)(2006-6#1)
reported linkages##2##2##(1997-5#2)
reported literature##2##2##(2012-2#1)(2013-1#1)
reported loss of##2##3##(1991-3#1)(1991-8#1)
reported loss##3##2##(1991-3#1)(1991-8#1)(2007-12#1)
reported low##4##2##(1991-2#1)(1996-6#1)(2006-8#1)(2009-7#1)
reported lower##3##2##(2006-10#1)(2012-12#1)(2013-1#1)
reported manifestations##2##2##(2006-2#1)(2012-3#1)
reported marked##2##2##(1992-3#1)(2008-6#1)
reported method##2##2##(1997-2#1)(2008-10#1)
reported methods##11##2##(1990-12#1)(2008-10#8)(2008-2#1)(2009-10#1)
reported metrics have been based on pair-wise analyses of co-occurring conditions##2##11##(2013-1#2)
reported missing##2##2##(2004-3#1)(2007-8#1)
reported molecular##2##2##(1994-11#1)(2008-9#1)
reported more frequently##3##3##(1991-5#1)(2005-8#1)(2013-1#1)
reported more severe##2##3##(2008-7#1)(2009-9#1)
reported more than##5##3##(1991-2#1)(1991-6#1)(2010-12#1)(2012-12#1)(2013-1#1)
reported more##35##2##(1991-2#1)(1991-5#1)(1991-6#1)(1996-6#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-12#2)(2007-4#2)(2007-8#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#3)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#1)(2011-2#2)(2012-12#1)(2013-1#3)(2013-7#1)
reported mortality##2##2##(1994-9#1)(2007-9#1)
reported mostly in##2##3##(2011-2#1)(2013-8#1)
reported mutations in##2##3##(1995-5#1)(2011-1#1)
reported mutations##3##2##(1995-4#1)(1995-5#1)(2011-1#1)
reported natriuretic##2##2##(1990-11#2)
reported nausea or vomiting##2##4##(2008-7#2)
reported neck##2##2##(2007-4#2)
reported needing##2##2##(1994-8#1)(2006-12#1)
reported no change##2##3##(2007-7#1)(2008-6#1)
reported no recurrence##2##3##(2008-10#1)(2012-12#1)
reported no use##2##3##(2009-5#2)
reported no##15##2##(1993-1#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-6#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-8#1)(2012-12#2)(2013-1#1)
reported not using condoms during##2##5##(2010-7#2)
reported not##3##2##(2007-2#1)(2010-7#2)
reported number of##3##3##(1991-6#1)(2008-7#1)(2013-1#1)
reported observations##2##2##(2008-5#1)(2013-8#1)
reported occurrence##2##2##(2008-10#1)(2010-8#1)
reported of##15##2##(1990-6#2)(1991-3#1)(1991-7#1)(1992-8#1)(2006-10#2)(2006-4#2)(2006-7#2)(2007-7#1)(2008-2#1)(2008-3#1)(2012-12#1)
reported on a##5##3##(1996-3#1)(2007-2#1)(2008-10#1)(2008-6#1)(2008-7#1)
reported on children's##3##3##(2009-10#1)(2009-4#1)(2010-6#1)
reported on previously##2##3##(2008-2#1)(2012-2#1)
reported on the##22##3##(1990-11#1)(1990-12#1)(1990-8#1)(1994-1#1)(1995-10#1)(1995-9#1)(1996-12#1)(2006-1#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#2)
reported on their##2##3##(2009-7#1)(2009-8#1)
reported on##66##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1994-1#1)(1995-10#1)(1995-9#1)(1996-12#1)(1996-3#1)(2004-12#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#3)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#2)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#5)(2013-8#2)
reported one##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
reported only in##4##3##(1995-3#1)(2007-8#1)(2008-10#1)(2008-8#1)
reported only##16##2##(1991-5#1)(1995-3#1)(1996-3#1)(2005-12#1)(2006-12#1)(2006-4#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-8#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#1)
reported or##4##2##(2007-1#1)(2007-7#1)(2008-3#1)(2011-2#1)
reported outbreaks of culture-confirmed influenza##2##5##(1991-11#2)
reported outbreaks##3##2##(1991-11#2)(2012-2#1)
reported outcomes##2##2##(2010-12#1)(2012-12#1)
reported over##3##2##(2008-11#1)(2008-8#1)(2011-2#1)
reported pain and##2##3##(2010-11#1)(2011-2#1)
reported pain##8##2##(1997-5#1)(2006-6#1)(2007-11#1)(2009-3#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-2#1)
reported patients with##3##3##(1992-11#1)(1996-12#1)(2006-1#1)
reported patients##4##2##(1992-11#1)(1993-2#1)(1996-12#1)(2006-1#1)
reported phase##2##2##(1996-2#1)(2007-11#1)
reported plant##2##2##(2006-12#1)(2013-1#1)
reported poor##4##2##(2007-10#1)(2009-5#1)(2012-12#1)(2013-1#1)
reported positive##2##2##(2007-11#1)(2012-3#1)
reported practice##2##2##(2006-9#1)(2012-2#1)
reported preliminary##2##2##(2005-7#1)(2009-5#1)
reported prevalence##5##2##(2006-8#1)(2008-1#2)(2011-2#1)(2013-7#1)
reported previously as##2##3##(1990-7#1)(1996-5#1)
reported previously by our laboratory##2##5##(1997-2#1)(1997-3#1)
reported previously by##6##3##(1991-2#1)(1993-9#1)(1994-9#1)(1997-2#1)(1997-3#1)(2006-9#1)
reported previously for the##2##4##(1990-10#1)(1995-3#1)
reported previously for##11##3##(1990-10#1)(1990-3#1)(1994-3#1)(1995-10#1)(1995-3#1)(1996-2#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
reported previously in the literature##3##5##(2007-11#1)(2007-8#1)(2009-3#1)
reported previously in the##5##4##(1996-2#1)(1997-4#1)(2007-11#1)(2007-8#1)(2009-3#1)
reported previously in##15##3##(1996-2#1)(1996-3#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2009-3#1)(2011-1#2)(2012-2#1)
reported previously that##11##3##(1992-11#1)(1993-12#1)(1994-10#1)(1994-8#1)(1995-5#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-12#1)
reported previously to##3##3##(1992-3#1)(1995-6#1)(2009-3#1)
reported previously using##2##3##(2008-10#2)
reported previously with##2##3##(1997-3#1)(2007-11#1)
reported previously##111##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-3#3)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#3)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#1)(2004-11#1)(2004-9#1)(2005-12#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-3#2)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
reported procedures##3##2##(1991-5#1)(2007-11#1)(2009-12#1)
reported recent risky##2##3##(2011-12#2)
reported recent##4##2##(2011-1#1)(2011-12#2)(2013-1#1)
reported recently for##2##3##(2007-11#1)(2013-1#1)
reported recently that##3##3##(1994-3#1)(1995-12#1)(2008-11#1)
reported recently##8##2##(1990-11#1)(1991-2#1)(1994-3#1)(1995-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2013-1#1)
reported recombination event##2##3##(1991-12#1)(2008-7#1)
reported regarding##2##2##(2012-1#1)(2013-1#1)
reported regional or widespread##2##4##(1992-1#2)
reported relief##3##2##(1992-8#1)(2008-7#1)(2008-9#1)
reported result##2##2##(1994-3#1)(2010-5#1)
reported results##13##2##(1990-12#1)(1993-9#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2012-2#1)(2013-1#2)
reported risk##3##2##(2006-10#1)(2007-1#1)(2007-7#1)
reported satisfaction##3##2##(2007-10#1)(2013-1#2)
reported search##51##2##(2007-8#51)
reported sequence of##2##3##(1990-12#1)(1996-6#1)
reported sequence##5##2##(1990-12#1)(1991-6#1)(1994-12#1)(1996-6#1)(2008-12#1)
reported sequences of##2##3##(1992-8#1)(2005-11#1)
reported series##4##2##(1992-8#1)(2007-10#1)(2007-12#1)(2009-10#1)
reported serious##3##2##(2006-10#1)(2007-10#1)(2009-10#1)
reported sexual behavior##2##3##(2008-12#2)
reported sexual##4##2##(2008-12#2)(2009-5#1)(2013-1#1)
reported showing##2##2##(1996-3#1)(1997-3#1)
reported side effect of##2##4##(2007-7#1)(2008-8#1)
reported side effect##3##3##(2007-7#1)(2007-8#1)(2008-8#1)
reported side effects##5##3##(1991-3#1)(1993-2#2)(2006-10#1)(2008-3#1)
reported side##8##2##(1991-3#1)(1993-2#2)(2006-10#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-8#1)
reported significant##8##2##(1996-12#1)(2005-10#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-5#1)(2009-7#1)
reported significantly higher##2##3##(2010-9#1)(2011-2#1)
reported significantly lower##3##3##(1995-2#1)(2007-2#1)(2010-10#1)
reported significantly more##5##3##(2006-7#1)(2011-12#2)(2012-1#1)(2013-1#1)
reported significantly##16##2##(1995-2#1)(1997-5#2)(2006-7#1)(2007-2#1)(2008-5#1)(2009-9#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-12#2)(2011-2#1)(2012-1#1)(2013-1#2)
reported similar##2##2##(2008-8#1)(2009-7#1)
reported since##8##2##(1995-12#1)(2005-6#1)(2005-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-1#1)(2013-7#1)
reported smoking##4##2##(1991-9#1)(1993-10#2)(2011-2#1)
reported so far for##2##4##(1994-4#1)(1996-10#1)
reported so far in##5##4##(1997-6#1)(2012-12#1)(2012-2#1)(2013-8#2)
reported so far to##2##4##(2008-2#1)(2008-5#1)
reported so far##29##3##(1990-5#1)(1990-8#1)(1991-11#1)(1992-2#1)(1994-4#1)(1994-9#1)(1995-2#1)(1996-10#1)(1997-6#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#4)
reported some##10##2##(2005-10#1)(2006-7#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-8#1)(2011-1#1)(2013-1#1)
reported specific##2##2##(1992-11#1)(2007-4#1)
reported spectral##2##2##(2008-10#1)(2008-7#1)
reported spending##3##2##(2007-7#1)(2010-8#1)(2012-12#1)
reported statistically significant##2##3##(2012-12#2)
reported structure of##3##3##(1994-9#1)(1995-8#1)(1996-7#1)
reported structures##3##2##(2006-2#1)(2007-11#1)(2011-1#1)
reported studies##11##2##(1992-1#1)(1997-4#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-8#1)(2009-9#1)(2010-6#1)(2013-1#1)
reported study##3##2##(1990-9#2)(1993-3#1)
reported such as##2##3##(2006-12#1)(2010-6#1)
reported survival##4##2##(2010-10#1)(2012-1#1)(2012-2#1)(2013-8#1)
reported symptoms of##2##3##(2009-5#1)(2010-9#1)
reported symptoms##8##2##(1990-5#1)(2006-10#1)(2007-8#1)(2008-6#1)(2009-5#1)(2010-9#1)(2012-1#1)(2012-2#1)
reported technique##2##2##(2006-7#1)(2008-2#1)
reported tests##3##2##(2007-4#1)(2013-1#2)
reported that a##11##3##(1991-2#1)(1992-1#1)(1994-3#2)(1995-3#1)(1996-5#1)(2004-12#1)(2005-6#1)(2010-6#1)(2011-2#1)(2012-3#1)
reported that both##4##3##(2006-10#1)(2008-4#1)(2009-8#1)(2012-2#1)
reported that hematuria was##2##4##(2007-2#2)
reported that hematuria##3##3##(2007-2#3)
reported that human##2##3##(1997-4#1)(2009-4#1)
reported that in rat##2##4##(1993-4#1)(1995-5#1)
reported that in##8##3##(1991-5#1)(1993-4#1)(1995-1#1)(1995-5#1)(1996-12#1)(2008-12#1)(2008-2#1)(2011-2#1)
reported that it##2##3##(2008-12#1)(2011-2#1)
reported that low dose##2##4##(1991-12#1)(2007-10#1)
reported that more##2##3##(1997-6#1)(2008-7#1)
reported that not##2##3##(1997-6#1)(2013-1#1)
reported that one##2##3##(1991-12#1)(2008-5#1)
reported that patients##2##3##(2008-7#1)(2011-2#1)
reported that rice##2##3##(2009-10#1)(2009-8#1)
reported that the group##2##4##(1993-3#2)
reported that the use of##2##5##(2011-2#1)(2013-1#1)
reported that the##54##3##(1990-12#1)(1990-7#1)(1991-4#2)(1992-12#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-6#1)(2005-8#2)(2007-2#1)(2008-1#1)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#2)(2009-11#1)(2009-8#1)(2010-7#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#3)
reported that their parents##2##4##(2010-10#1)(2013-7#1)
reported that their##6##3##(1990-8#1)(2008-11#1)(2009-7#1)(2010-10#1)(2013-1#1)(2013-7#1)
reported that these##2##3##(1997-6#1)(2009-4#1)
reported that they had##4##4##(1995-6#1)(1996-2#1)(2009-3#1)(2012-12#1)
reported that they were &quot##2##5##(2008-7#2)
reported that they were##6##4##(1991-6#1)(2007-2#1)(2008-5#1)(2008-7#2)(2010-9#1)
reported that they would##7##4##(1991-8#1)(2007-12#1)(2007-9#1)(2010-4#4)
reported that they##40##3##(1991-12#1)(1991-6#1)(1991-8#1)(1992-4#1)(1993-1#2)(1995-6#2)(1996-2#1)(1997-2#1)(2007-12#2)(2007-2#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-3#1)(2009-6#2)(2010-4#4)(2010-8#1)(2010-9#1)(2011-1#1)(2012-1#3)(2012-12#4)(2013-1#3)
reported that this##4##3##(1993-4#1)(1994-3#1)(1994-9#1)(2012-3#1)
reported that transformation##2##3##(1991-8#1)(1991-9#1)
reported that##313##2##(1990-11#4)(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#5)(1991-2#2)(1991-4#3)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-12#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#2)(1993-2#1)(1993-3#2)(1993-4#3)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#4)(1994-5#2)(1994-6#3)(1994-8#3)(1994-9#2)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#2)(1995-5#3)(1995-6#3)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#4)(1996-9#3)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#5)(1997-6#4)(1997-7#1)(1997-8#1)(2004-12#3)(2005-11#2)(2005-3#1)(2005-6#2)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#2)(2006-12#2)(2006-5#1)(2006-8#1)(2006-9#2)(2007-10#2)(2007-11#2)(2007-12#5)(2007-2#6)(2007-3#1)(2007-4#1)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#7)(2008-11#11)(2008-12#6)(2008-2#4)(2008-3#4)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#9)(2009-9#1)(2010-10#1)(2010-12#2)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#3)(2011-2#11)(2012-1#3)(2012-12#8)(2012-2#4)(2012-3#5)(2013-1#12)(2013-7#1)(2013-8#5)
reported the case of##3##4##(2008-5#1)(2010-12#1)(2011-2#1)
reported the case##4##3##(2008-12#1)(2008-5#1)(2010-12#1)(2011-2#1)
reported the cloning of a##2##5##(1994-9#1)(2006-10#1)
reported the cloning##3##3##(1993-6#1)(1994-9#1)(2006-10#1)
reported the development of a##2##5##(1990-12#1)(2007-8#1)
reported the development of##3##4##(1990-12#1)(1996-5#1)(2007-8#1)
reported the identification of a##3##5##(1993-12#1)(2008-8#1)(2009-8#1)
reported the identification##4##3##(1993-12#1)(2008-8#1)(2009-8#2)
reported the isolation of##2##4##(1994-12#1)(2006-12#1)
reported the isolation##3##3##(1994-12#1)(1996-2#1)(2006-12#1)
reported the lowest##2##3##(2008-7#1)(2013-1#1)
reported the molecular##2##3##(1991-8#1)(2010-3#1)
reported the occurrence of##2##4##(1997-5#1)(2012-12#1)
reported the occurrence##3##3##(1997-5#1)(2008-10#1)(2012-12#1)
reported the presence of##8##4##(1990-5#1)(1993-10#1)(1993-11#1)(1994-6#1)(1997-5#1)(2007-11#1)(2008-11#1)(2013-8#1)
reported the use of##4##4##(2008-10#1)(2008-2#1)(2012-12#1)(2013-1#1)
reported the##75##2##(1990-12#1)(1990-5#2)(1990-8#1)(1991-2#2)(1991-5#1)(1991-8#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-2#1)(1996-5#2)(1997-5#2)(1997-8#1)(2005-4#1)(2005-6#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#4)(2010-1#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#1)(2011-2#3)(2012-12#4)(2013-1#4)(2013-8#3)
reported their peak##2##3##(2013-8#2)
reported their##16##2##(1994-6#1)(1994-9#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-3#1)(2010-1#1)(2010-11#1)(2012-12#1)(2012-2#1)(2013-8#3)
reported they had##2##3##(2007-9#2)
reported they##5##2##(1994-1#1)(2007-9#2)(2012-12#1)(2012-2#1)
reported thus far##4##3##(1997-1#1)(2005-11#1)(2007-12#1)(2012-12#1)
reported to CDC were##2##4##(1992-6#2)
reported to CDC##4##3##(1991-11#1)(1991-8#1)(1992-6#2)
reported to a##2##3##(2008-11#1)(2012-12#1)
reported to act as a##3##5##(1991-7#1)(1994-12#1)(2009-8#1)
reported to act as##4##4##(1991-7#1)(1994-12#1)(2009-8#1)(2013-8#1)
reported to affect##3##3##(1995-6#1)(2008-7#1)(2012-2#1)
reported to be 0##2##4##(2008-10#1)(2012-11#1)
reported to be a potent##2##5##(1990-10#1)(2008-10#1)
reported to be a risk factor for##2##7##(1991-10#1)(2006-10#1)
reported to be a##12##4##(1990-10#1)(1991-10#1)(1992-6#1)(1997-5#1)(2006-10#1)(2006-8#1)(2008-10#2)(2012-12#2)(2013-1#1)(2013-7#1)
reported to be an##5##4##(1993-9#1)(2007-12#1)(2009-10#1)(2009-6#1)(2011-1#1)
reported to be as high as##2##6##(1992-8#1)(2008-9#1)
reported to be as##4##4##(1992-8#1)(2006-8#1)(2008-9#1)(2012-1#1)
reported to be associated with##9##5##(1994-5#1)(1995-11#1)(2006-10#1)(2007-2#1)(2007-3#1)(2008-1#1)(2011-2#1)(2012-1#1)(2012-11#1)
reported to be beneficial##3##4##(1992-7#1)(2007-11#1)(2007-7#1)
reported to be between##2##4##(2007-12#1)(2011-2#1)
reported to be capable of##2##5##(1991-1#1)(2008-7#1)
reported to be expressed##2##4##(1996-12#1)(2013-8#1)
reported to be good##2##4##(2007-6#1)(2009-4#1)
reported to be highly##3##4##(1990-7#1)(1993-12#1)(2011-1#1)
reported to be important##4##4##(1992-8#1)(1995-7#1)(2008-7#1)(2009-5#1)
reported to be in##3##4##(2005-8#2)(2013-1#1)
reported to be involved in##6##5##(1994-3#1)(1997-2#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#1)
reported to be more##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
reported to be present in##3##5##(1994-12#1)(2008-3#1)(2008-9#1)
reported to be present##4##4##(1994-12#1)(1995-8#1)(2008-3#1)(2008-9#1)
reported to be reduced##2##4##(1997-5#1)(2008-5#1)
reported to be the##6##4##(1994-8#1)(1996-5#1)(2006-10#1)(2007-7#1)(2008-4#1)(2009-10#1)
reported to be##154##3##(1990-10#1)(1990-3#2)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#2)(1991-10#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#2)(1993-8#2)(1993-9#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#2)(1996-12#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-5#3)(1997-6#1)(1997-7#1)(2005-7#1)(2005-8#2)(2006-10#4)(2006-11#1)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#12)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#3)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#2)(2010-12#2)(2010-2#1)(2010-9#1)(2011-1#4)(2011-2#6)(2012-1#3)(2012-11#2)(2012-12#6)(2013-1#4)(2013-7#1)(2013-8#2)
reported to bind##4##3##(1995-3#1)(1997-7#1)(2008-10#1)(2013-7#1)
reported to cause##12##3##(1996-4#1)(2006-10#3)(2006-6#1)(2007-2#1)(2008-10#3)(2009-10#1)(2009-3#1)(2012-3#1)
reported to contain##7##3##(1992-9#1)(1993-11#1)(1993-12#1)(1994-10#1)(1995-12#1)(2008-10#2)
reported to correlate with##3##4##(1993-7#1)(2008-9#1)(2012-2#1)
reported to create##2##3##(2009-10#1)(2012-2#1)
reported to date in##3##4##(1992-6#1)(2007-11#1)(2007-2#1)
reported to date##35##3##(1991-12#1)(1992-6#1)(1994-6#1)(1995-12#1)(1997-5#1)(2005-10#1)(2006-10#1)(2007-11#3)(2007-2#1)(2007-8#1)(2008-1#3)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
reported to decrease##4##3##(2010-9#1)(2011-2#2)(2013-1#1)
reported to exhibit potent##2##4##(2008-5#1)(2009-12#1)
reported to exhibit##6##3##(1995-2#1)(2008-11#1)(2008-5#1)(2009-12#2)(2013-8#1)
reported to have a high##2##5##(2007-10#1)(2011-1#1)
reported to have a##11##4##(1996-9#1)(1997-7#1)(2006-9#1)(2007-10#1)(2008-11#1)(2008-5#2)(2010-11#1)(2011-1#1)(2012-3#1)(2013-8#1)
reported to have adverse##2##4##(2006-5#1)(2008-10#1)
reported to have been##2##4##(2005-8#1)(2012-2#1)
reported to have both##2##4##(1994-12#1)(1996-2#1)
reported to have occurred##2##4##(2007-7#1)(2007-9#1)
reported to have##43##3##(1991-5#1)(1992-11#1)(1992-5#1)(1994-12#1)(1996-2#1)(1996-9#1)(1997-6#1)(1997-7#1)(2005-12#1)(2005-8#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-11#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
reported to highlight the##2##4##(2007-7#2)
reported to increase the##2##4##(1991-4#1)(1992-2#1)
reported to increase##9##3##(1991-4#1)(1992-2#1)(1995-12#1)(1995-8#1)(2008-10#2)(2008-4#1)(2011-2#1)(2012-3#1)
reported to induce##6##3##(1991-8#1)(1995-9#1)(2007-7#1)(2009-12#1)(2011-1#1)(2013-8#1)
reported to influence##2##3##(1995-12#1)(2007-12#1)
reported to limit the##2##4##(1993-3#1)(2009-4#1)
reported to occur in the##3##5##(1995-10#1)(2006-11#1)(2013-1#1)
reported to occur in##10##4##(1995-10#1)(2004-12#1)(2006-11#2)(2007-8#1)(2008-1#1)(2008-7#1)(2009-9#1)(2011-2#1)(2013-1#1)
reported to occur##17##3##(1992-2#1)(1994-12#1)(1995-10#1)(2004-12#1)(2006-11#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-1#1)(2011-2#1)(2013-1#1)
reported to play##8##3##(1992-6#1)(1993-6#1)(1996-8#1)(2007-3#1)(2008-7#1)(2010-3#1)(2012-2#1)(2013-8#1)
reported to possess##6##3##(1992-3#1)(1995-5#1)(2008-10#1)(2008-5#1)(2009-8#1)(2013-1#1)
reported to produce##3##3##(2004-12#1)(2008-8#1)(2011-2#1)
reported to reduce##2##3##(2006-5#1)(2008-10#1)
reported to show##2##3##(2008-5#1)(2012-2#1)
reported to stimulate##3##3##(1991-3#1)(1991-5#1)(1994-12#1)
reported to the police##3##4##(1993-3#1)(1994-4#1)(1997-8#1)
reported to the##21##3##(1991-6#1)(1991-8#1)(1992-2#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-4#1)(1994-9#1)(1995-5#1)(1996-11#1)(1996-3#1)(1997-8#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-12#1)(2012-12#1)
reported to##460##2##(1990-10#1)(1990-3#2)(1990-6#2)(1990-7#2)(1990-8#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#1)(1991-3#2)(1991-4#2)(1991-5#4)(1991-6#2)(1991-7#2)(1991-8#4)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#4)(1992-3#3)(1992-5#2)(1992-6#5)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#4)(1993-3#2)(1993-6#3)(1993-7#1)(1993-8#3)(1993-9#2)(1994-10#3)(1994-12#7)(1994-2#3)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#4)(1994-8#4)(1994-9#1)(1995-10#2)(1995-11#1)(1995-12#5)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-7#1)(1996-8#6)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#4)(1997-6#2)(1997-7#4)(1997-8#2)(2004-11#1)(2004-12#2)(2004-4#1)(2005-10#1)(2005-12#1)(2005-7#2)(2005-8#3)(2006-10#10)(2006-11#3)(2006-12#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#8)(2007-12#3)(2007-2#7)(2007-3#2)(2007-6#3)(2007-7#8)(2007-8#3)(2007-9#2)(2008-1#9)(2008-10#32)(2008-11#9)(2008-12#2)(2008-2#6)(2008-3#6)(2008-4#7)(2008-5#12)(2008-6#5)(2008-7#12)(2008-8#3)(2008-9#3)(2009-10#5)(2009-11#1)(2009-12#4)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#3)(2009-8#4)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#8)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#12)(2011-12#1)(2011-2#19)(2012-1#4)(2012-11#2)(2012-12#8)(2012-2#9)(2012-3#6)(2013-1#10)(2013-7#2)(2013-8#11)
reported trials##3##2##(2005-7#1)(2006-10#1)(2007-3#1)
reported two##2##2##(2006-12#1)(2008-5#1)
reported under##2##2##(2005-4#1)(2007-7#1)
reported use##3##2##(1991-9#1)(2008-10#2)
reported using the##2##3##(2006-10#1)(2009-5#1)
reported using##19##2##(1993-12#2)(1995-2#1)(1995-9#1)(1997-7#1)(2006-10#1)(2006-7#1)(2007-2#2)(2007-5#1)(2007-8#1)(2009-12#2)(2009-5#1)(2010-10#1)(2012-12#2)(2013-1#1)(2013-8#1)
reported value##2##2##(1997-2#1)(2008-10#1)
reported values and##2##3##(2007-11#1)(2008-10#1)
reported values for##3##3##(1990-7#1)(1991-7#1)(2008-10#1)
reported values##14##2##(1990-7#1)(1991-7#1)(1993-2#1)(1997-7#1)(2006-2#1)(2007-11#1)(2008-10#7)(2009-11#1)
reported was##3##2##(1996-2#1)(2005-8#1)(2008-12#1)
reported were##9##2##(1992-6#1)(1995-3#1)(1995-5#1)(1996-3#1)(2005-8#1)(2008-1#1)(2009-10#1)(2009-9#1)(2013-1#1)
reported when##3##2##(1993-11#1)(2008-2#1)(2010-2#1)
reported whether they##2##3##(2007-12#1)(2008-12#1)
reported whether##3##2##(2007-12#1)(2008-12#1)(2008-3#1)
reported which##8##2##(1990-2#1)(1990-5#1)(1997-6#1)(2006-6#1)(2008-11#1)(2008-2#1)(2008-7#1)(2012-2#1)
reported who developed##3##3##(1991-12#1)(2007-10#1)(2008-7#1)
reported who presented with##4##4##(2006-10#1)(2009-4#1)(2009-5#1)(2012-2#1)
reported who##10##2##(1991-12#1)(1991-9#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-7#1)(2009-4#1)(2009-5#1)(2012-2#2)
reported with AIDS##2##3##(1992-2#1)(1997-2#1)
reported with a##3##3##(2008-10#2)(2012-2#1)
reported with complete##2##3##(2007-7#1)(2010-7#1)
reported with the##8##3##(1991-10#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-10#3)(2013-1#1)
reported with use of##2##4##(1990-9#1)(2008-10#1)
reported with##58##2##(1990-4#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-7#1)(1992-2#2)(1993-1#1)(1995-1#1)(1996-11#1)(1997-2#1)(1997-8#1)(2006-10#5)(2007-11#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
reported within##4##2##(1992-8#1)(2007-2#1)(2008-3#1)(2010-2#1)
reported work##2##2##(2006-10#1)(2008-7#1)
reported yet##3##2##(2006-7#1)(2008-8#1)(2008-9#1)
reported##6062##1##(1990-1#3)(1990-10#10)(1990-11#19)(1990-12#31)(1990-2#13)(1990-3#12)(1990-4#11)(1990-5#23)(1990-6#22)(1990-7#14)(1990-8#20)(1990-9#12)(1991-1#14)(1991-10#11)(1991-11#15)(1991-12#31)(1991-2#32)(1991-3#18)(1991-4#14)(1991-5#28)(1991-6#24)(1991-7#22)(1991-8#27)(1991-9#19)(1992-1#12)(1992-10#6)(1992-11#15)(1992-12#16)(1992-2#19)(1992-3#13)(1992-4#9)(1992-5#21)(1992-6#29)(1992-7#9)(1992-8#18)(1992-9#18)(1993-1#12)(1993-10#11)(1993-11#13)(1993-12#30)(1993-2#13)(1993-3#20)(1993-4#15)(1993-5#6)(1993-6#21)(1993-7#8)(1993-8#18)(1993-9#24)(1994-1#3)(1994-10#6)(1994-11#21)(1994-12#29)(1994-2#26)(1994-3#24)(1994-4#3)(1994-5#11)(1994-6#26)(1994-7#1)(1994-8#26)(1994-9#23)(1995-1#15)(1995-10#11)(1995-11#12)(1995-12#32)(1995-2#22)(1995-3#28)(1995-4#8)(1995-5#16)(1995-6#18)(1995-7#5)(1995-8#21)(1995-9#9)(1996-1#13)(1996-10#4)(1996-11#13)(1996-12#34)(1996-2#26)(1996-3#27)(1996-4#7)(1996-5#21)(1996-6#13)(1996-7#13)(1996-8#22)(1996-9#17)(1997-1#27)(1997-2#29)(1997-3#19)(1997-4#20)(1997-5#18)(1997-6#19)(1997-7#17)(1997-8#22)(1997-9#1)(2004-1#2)(2004-10#3)(2004-11#9)(2004-12#15)(2004-3#5)(2004-4#2)(2004-7#2)(2004-8#1)(2004-9#4)(2005-1#1)(2005-10#16)(2005-11#21)(2005-12#11)(2005-3#2)(2005-4#6)(2005-5#3)(2005-6#4)(2005-7#17)(2005-8#21)(2005-9#3)(2006-1#5)(2006-10#157)(2006-11#17)(2006-12#46)(2006-2#24)(2006-3#5)(2006-4#15)(2006-5#20)(2006-6#18)(2006-7#28)(2006-8#30)(2006-9#12)(2007-1#21)(2007-10#50)(2007-11#131)(2007-12#134)(2007-2#93)(2007-3#22)(2007-4#19)(2007-5#11)(2007-6#6)(2007-7#125)(2007-8#169)(2007-9#31)(2008-1#74)(2008-10#509)(2008-11#88)(2008-12#65)(2008-2#116)(2008-3#118)(2008-4#53)(2008-5#143)(2008-6#65)(2008-7#128)(2008-8#58)(2008-9#62)(2009-1#4)(2009-10#23)(2009-11#11)(2009-12#17)(2009-2#12)(2009-3#28)(2009-4#32)(2009-5#45)(2009-6#15)(2009-7#36)(2009-8#41)(2009-9#22)(2010-1#11)(2010-10#17)(2010-11#14)(2010-12#65)(2010-2#24)(2010-3#25)(2010-4#17)(2010-5#20)(2010-6#38)(2010-7#28)(2010-8#28)(2010-9#29)(2011-1#94)(2011-11#2)(2011-12#11)(2011-2#192)(2011-3#6)(2011-7#1)(2011-9#1)(2012-1#36)(2012-11#21)(2012-12#143)(2012-2#137)(2012-3#68)(2012-6#1)(2012-8#1)(2013-1#200)(2013-7#28)(2013-8#103)
reported)##2##1##(2007-12#1)(2008-10#1)
reportedly##33##1##(1990-11#1)(1990-7#1)(1991-12#1)(1992-12#1)(1992-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1996-12#1)(1996-7#1)(1997-7#1)(2006-12#2)(2007-2#2)(2007-7#1)(2007-9#1)(2008-11#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
reporter activity##3##2##(1995-2#1)(2006-12#1)(2008-10#1)
reporter and##3##2##(1997-4#1)(2008-10#1)(2008-9#1)
reporter assay##4##2##(2009-3#1)(2010-5#1)(2011-2#1)(2013-1#1)
reporter assays##4##2##(1997-4#1)(2008-10#1)(2008-8#1)(2008-9#1)
reporter cell line##2##3##(1997-4#2)
reporter cell##3##2##(1997-4#2)(2008-10#1)
reporter construct containing the##2##4##(1996-10#1)(1996-3#1)
reporter construct##5##2##(1995-2#1)(1995-3#1)(1996-10#1)(1996-3#1)(2006-12#1)
reporter constructs containing##2##3##(1993-4#1)(1994-11#1)
reporter constructs##10##2##(1993-4#1)(1994-11#2)(1994-2#3)(1994-3#1)(1996-8#1)(1997-7#1)(2008-11#1)
reporter expression##4##2##(1996-5#3)(2009-6#1)
reporter for##3##2##(1997-8#1)(2008-4#1)(2008-9#1)
reporter gene activation##2##3##(1994-12#1)(2008-4#1)
reporter gene activity was detected##2##5##(1993-4#2)
reporter gene activity##10##3##(1990-8#1)(1993-3#1)(1993-4#2)(1994-12#1)(1995-10#1)(1996-5#1)(2008-3#2)(2010-11#1)
reporter gene and##9##3##(1992-12#1)(1992-9#1)(1993-6#1)(1995-3#1)(1997-4#1)(2006-12#1)(2008-10#2)(2009-10#1)
reporter gene assay for##3##4##(1996-11#1)(2010-2#2)
reporter gene assay##9##3##(1996-11#3)(1997-1#1)(2004-9#1)(2010-2#3)(2010-5#1)
reporter gene by##2##3##(1995-8#1)(1997-7#1)
reporter gene construct##2##3##(2008-10#2)
reporter gene constructs##2##3##(1997-1#1)(1997-2#1)
reporter gene controlled by##2##4##(1996-8#1)(2008-9#1)
reporter gene driven by the##2##5##(1991-1#1)(2008-11#1)
reporter gene driven by##5##4##(1991-1#1)(1995-10#1)(1996-5#1)(2008-11#1)(2008-8#1)
reporter gene encoding chloramphenicol acetyltransferase##2##5##(1994-12#1)(1994-3#1)
reporter gene encoding##3##3##(1994-12#1)(1994-3#1)(2008-8#1)
reporter gene expression in the##2##5##(1991-4#1)(1995-10#1)
reporter gene expression in##7##4##(1991-4#1)(1992-2#1)(1993-5#1)(1995-10#1)(1996-5#1)(2006-12#1)(2008-9#1)
reporter gene expression was##3##4##(1995-2#1)(2006-12#1)(2008-10#1)
reporter gene expression##21##3##(1991-4#1)(1991-7#1)(1992-2#1)(1993-5#1)(1995-1#1)(1995-10#1)(1995-2#1)(1996-5#1)(1997-4#1)(2006-12#2)(2008-10#2)(2008-11#2)(2008-8#4)(2008-9#1)(2009-10#1)
reporter gene flanked by##2##4##(1994-3#1)(2009-8#1)
reporter gene in transgenic##3##4##(1993-4#1)(1994-3#2)
reporter gene in transiently transfected##2##5##(1995-5#1)(1996-5#1)
reporter gene in##12##3##(1990-10#1)(1991-6#2)(1993-4#1)(1993-6#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-5#1)
reporter gene system##2##3##(1997-2#1)(2008-10#1)
reporter gene to##7##3##(1990-5#1)(1990-9#1)(1991-5#1)(1991-9#1)(1997-5#1)(2008-10#1)(2010-5#1)
reporter gene under the control of CaMV35S##2##7##(2008-9#2)
reporter gene under the control of the##2##7##(1994-12#1)(1997-4#1)
reporter gene under the control of##8##6##(1994-12#1)(1994-5#2)(1995-5#1)(1995-8#1)(1997-4#1)(2008-9#2)
reporter gene was expressed in##2##5##(1997-4#1)(2006-12#1)
reporter gene was##9##3##(1991-8#1)(1994-2#2)(1995-5#1)(1996-10#1)(1997-4#2)(2006-12#1)(2008-11#1)
reporter gene were##2##3##(1996-3#1)(2008-8#1)
reporter gene##205##2##(1990-10#1)(1990-11#2)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-12#2)(1993-3#4)(1993-4#3)(1993-5#1)(1993-6#2)(1993-9#2)(1994-11#1)(1994-12#7)(1994-2#4)(1994-3#7)(1994-5#3)(1994-8#4)(1995-1#1)(1995-10#5)(1995-2#2)(1995-3#5)(1995-5#4)(1995-6#1)(1995-8#7)(1996-10#1)(1996-11#4)(1996-3#1)(1996-5#6)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#4)(1997-4#10)(1997-5#3)(1997-6#1)(1997-7#4)(2004-9#1)(2005-11#1)(2005-8#1)(2006-12#6)(2007-12#1)(2008-10#16)(2008-11#10)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-8#8)(2008-9#9)(2009-10#2)(2009-12#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#3)(2010-5#2)(2011-1#1)(2011-3#1)(2012-12#1)
reporter genes and##2##3##(1993-6#1)(1995-10#1)
reporter genes containing##2##3##(1992-12#1)(2008-8#1)
reporter genes have##2##3##(1991-7#1)(2008-11#1)
reporter genes in##2##3##(1995-3#1)(1996-11#1)
reporter genes##24##2##(1990-5#1)(1991-7#4)(1991-9#1)(1992-12#1)(1993-11#2)(1993-6#1)(1994-3#1)(1995-10#2)(1995-3#1)(1996-11#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-8#1)(2008-9#1)
reporter group##2##2##(1990-11#1)(1995-2#1)
reporter groups##5##2##(1991-12#1)(1997-4#1)(2008-1#1)(2008-4#2)
reporter in HeLa cells##3##4##(1995-3#3)
reporter in##4##2##(1995-3#3)(1997-6#1)
reporter molecule##6##2##(1996-6#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#2)
reporter of##6##2##(1992-7#2)(1994-3#1)(1997-5#2)(2005-8#1)
reporter phage##3##2##(2011-12#3)
reporter plasmid containing the##3##4##(1991-12#1)(1996-2#1)(1996-3#1)
reporter plasmid##8##2##(1990-8#1)(1991-12#1)(1992-7#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-2#1)(1996-3#1)
reporter plasmids##4##2##(1993-8#1)(1994-8#1)(1995-3#1)(2012-2#1)
reporter probe##2##2##(2008-10#1)(2009-10#1)
reporter protein##8##2##(1996-3#1)(1997-2#1)(2008-11#5)(2009-5#1)
reporter proteins##2##2##(1997-4#1)(2007-8#1)
reporter strain##2##2##(2008-9#1)(2011-2#1)
reporter system to##2##3##(2008-9#1)(2009-6#1)
reporter system##9##2##(1992-12#1)(1994-2#1)(1997-6#1)(2008-7#1)(2008-9#3)(2009-3#1)(2009-6#1)
reporter systems##2##2##(1991-12#1)(1997-1#1)
reporter under the control of##2##5##(2008-11#1)(2010-2#1)
reporter vector##5##2##(2007-10#4)(2012-12#1)
reporter was##2##2##(1997-6#1)(2012-12#1)
reporter will##2##2##(2008-9#1)(2009-6#1)
reporter##404##1##(1990-10#1)(1990-11#4)(1990-12#1)(1990-5#3)(1990-8#2)(1990-9#1)(1991-1#2)(1991-12#4)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#5)(1991-8#1)(1991-9#2)(1992-12#5)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#4)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#3)(1993-3#4)(1993-4#4)(1993-5#1)(1993-6#5)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#8)(1994-2#8)(1994-3#11)(1994-5#3)(1994-8#7)(1994-9#1)(1995-1#1)(1995-10#8)(1995-2#10)(1995-3#12)(1995-4#1)(1995-5#4)(1995-6#2)(1995-8#7)(1996-10#2)(1996-11#6)(1996-2#1)(1996-3#4)(1996-5#10)(1996-6#1)(1996-7#2)(1996-8#2)(1997-1#4)(1997-2#5)(1997-4#18)(1997-5#5)(1997-6#5)(1997-7#5)(1997-8#1)(2004-9#1)(2005-11#2)(2005-8#2)(2005-9#1)(2006-12#8)(2007-10#4)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#31)(2008-11#26)(2008-2#5)(2008-3#2)(2008-4#6)(2008-5#1)(2008-7#4)(2008-8#11)(2008-9#25)(2009-10#3)(2009-12#1)(2009-3#3)(2009-5#1)(2009-6#4)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#4)(2010-5#3)(2010-7#1)(2011-1#4)(2011-12#3)(2011-2#2)(2011-3#1)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
reporter-gene##3##1##(2008-2#1)(2009-12#2)
reportergene##2##1##(1997-2#2)
reporters have been##2##3##(2007-8#1)(2010-12#1)
reporters of##3##2##(2007-12#1)(2008-11#1)(2012-2#1)
reporters##21##1##(1996-5#1)(1997-8#1)(2007-12#1)(2007-8#4)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-7#1)(2011-1#2)(2012-2#1)(2013-8#1)
reporting a case of##20##4##(2007-9#1)(2008-12#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#10)
reporting a definite response##2##4##(2006-8#2)
reporting a##36##2##(2005-10#1)(2006-10#1)(2006-8#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-12#3)(2008-6#1)(2008-7#2)(2009-5#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#11)
reporting adverse##5##2##(1996-3#1)(2007-3#1)(2007-7#1)(2011-2#1)(2012-11#1)
reporting an epitope enhanced by the binding of an RGD-peptide to αvβ3##2##12##(2012-12#2)
reporting an##8##2##(1995-2#1)(2007-10#1)(2008-11#1)(2009-3#1)(2009-5#1)(2012-12#3)
reporting and the##2##3##(2008-1#1)(2011-2#1)
reporting and##22##2##(1997-3#1)(2005-10#1)(2006-6#1)(2007-3#1)(2007-4#1)(2008-1#3)(2008-10#4)(2008-2#1)(2008-6#1)(2009-9#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
reporting bias##2##2##(2008-11#1)(2008-9#1)
reporting clinical##4##2##(2005-9#1)(2006-7#1)(2007-11#1)(2008-8#1)
reporting diagnostic##2##2##(2010-5#2)
reporting fewer##2##2##(1993-9#1)(1995-12#1)
reporting for##6##2##(1993-3#1)(2008-1#2)(2008-9#1)(2010-11#1)(2010-5#1)
reporting form##2##2##(2012-12#2)
reporting format##2##2##(2011-2#2)
reporting forms##4##2##(2008-10#1)(2012-12#3)
reporting from##2##2##(1997-8#1)(2007-2#1)
reporting guidelines##4##2##(1996-8#1)(2007-11#1)(2013-7#2)
reporting high##2##2##(2006-10#1)(2007-12#1)
reporting higher##3##2##(2006-7#1)(2009-5#1)(2011-2#1)
reporting in the##2##3##(1991-2#1)(2006-5#1)
reporting in##11##2##(1991-2#1)(2006-4#1)(2006-5#1)(2008-3#1)(2009-9#1)(2010-11#2)(2010-7#1)(2011-2#1)(2012-3#2)
reporting increased##3##2##(1995-12#1)(2008-4#1)(2011-2#1)
reporting is##4##2##(1996-1#1)(2008-11#1)(2010-7#1)(2011-2#1)
reporting low##2##2##(2011-2#1)(2013-1#1)
reporting needs to be improved##2##5##(2008-10#1)(2012-2#1)
reporting needs to be##3##4##(1993-9#1)(2008-10#1)(2012-2#1)
reporting no##5##2##(1991-7#2)(2011-3#1)(2012-12#1)(2013-1#1)
reporting of a##2##3##(2005-11#1)(2011-2#1)
reporting of adverse events##5##4##(2007-11#2)(2008-7#1)(2011-2#1)(2012-2#1)
reporting of adverse##7##3##(2007-11#2)(2008-11#1)(2008-7#1)(2011-2#2)(2012-2#1)
reporting of clinical##2##3##(1992-12#1)(1996-9#1)
reporting of data##2##3##(2006-10#1)(2007-12#1)
reporting of health##2##3##(1997-3#1)(2013-7#1)
reporting of quality##2##3##(1996-3#1)(2010-11#1)
reporting of the##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
reporting of##62##2##(1991-11#1)(1992-12#1)(1993-1#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-6#2)(1996-9#1)(1997-3#2)(2005-10#1)(2005-11#1)(2006-10#3)(2007-11#2)(2007-12#1)(2007-4#2)(2007-7#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-3#1)(2010-11#2)(2010-2#1)(2010-5#3)(2010-6#1)(2011-2#7)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
reporting on a##3##3##(2007-10#1)(2007-12#1)(2012-12#1)
reporting on the##4##3##(2006-12#1)(2008-4#1)(2008-7#1)(2010-7#1)
reporting on##12##2##(1991-6#1)(1997-1#1)(1997-2#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-7#1)(2010-7#1)(2012-12#1)(2013-8#1)
reporting outcomes following C-ADR (Bryan disc##2##6##(2012-12#2)
reporting outcomes following C-ADR##3##4##(2012-12#3)
reporting outcomes##4##2##(2012-12#4)
reporting procedures##2##2##(2008-10#1)(2011-2#1)
reporting process##2##2##(2007-4#2)
reporting program##3##2##(2008-3#1)(2008-6#1)(2013-1#1)
reporting quality of##2##3##(2008-10#1)(2011-2#1)
reporting quality##3##2##(2008-10#1)(2011-2#2)
reporting requirements##6##2##(1992-3#2)(1993-3#1)(1994-2#1)(1997-3#1)(2012-2#1)
reporting such##2##2##(2010-8#1)(2011-2#1)
reporting system in##3##3##(1996-2#1)(2007-12#1)(2007-2#1)
reporting system is##3##3##(2007-2#1)(2007-4#1)(2007-7#1)
reporting system to##4##3##(1996-3#1)(2007-12#1)(2013-1#2)
reporting system##23##2##(1991-10#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(2006-10#1)(2007-1#1)(2007-12#2)(2007-2#2)(2007-4#2)(2007-7#1)(2010-5#2)(2010-7#2)(2010-8#1)(2013-1#4)
reporting that##3##2##(2008-1#1)(2008-4#1)(2009-7#1)
reporting the##15##2##(1990-2#1)(1993-10#2)(1994-11#1)(1994-2#1)(1997-2#1)(2005-10#1)(2007-11#1)(2008-12#1)(2008-5#1)(2010-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
reporting their##2##2##(1991-6#1)(2012-2#1)
reporting this##4##2##(2007-11#1)(2008-7#1)(2010-3#1)(2013-8#1)
reporting to the##3##3##(1993-12#1)(2010-3#1)(2012-2#1)
reporting to##8##2##(1993-12#1)(2006-10#1)(2007-7#1)(2008-12#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
reporting two##5##2##(1991-7#1)(2007-8#1)(2010-2#1)(2013-8#2)
reporting will##2##2##(1994-3#1)(2010-9#1)
reporting##511##1##(1990-12#5)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-6#2)(1991-7#4)(1991-8#2)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-1#1)(1993-10#2)(1993-12#5)(1993-2#1)(1993-3#4)(1993-6#1)(1993-9#3)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#6)(1994-3#2)(1994-6#1)(1995-12#4)(1995-2#1)(1995-3#2)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#7)(1996-6#3)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#6)(1997-8#1)(2005-10#7)(2005-11#2)(2005-5#1)(2005-8#1)(2005-9#1)(2006-10#9)(2006-12#1)(2006-4#1)(2006-5#5)(2006-6#1)(2006-7#2)(2006-8#4)(2007-1#1)(2007-10#3)(2007-11#6)(2007-12#8)(2007-2#7)(2007-3#2)(2007-4#10)(2007-5#1)(2007-6#1)(2007-7#8)(2007-8#7)(2007-9#1)(2008-1#13)(2008-10#21)(2008-11#11)(2008-12#9)(2008-2#1)(2008-3#4)(2008-4#10)(2008-5#2)(2008-6#4)(2008-7#8)(2008-8#5)(2008-9#5)(2009-10#1)(2009-3#2)(2009-4#1)(2009-5#6)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-11#9)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#13)(2010-6#2)(2010-7#6)(2010-8#6)(2010-9#4)(2011-1#4)(2011-2#38)(2011-3#1)(2012-1#1)(2012-11#3)(2012-12#23)(2012-2#20)(2012-3#9)(2013-1#30)(2013-7#5)(2013-8#34)
reports -##2##2##(2012-1#1)(2013-8#1)
reports a case of a##2##5##(2008-7#1)(2009-7#1)
reports a case of##20##4##(1990-10#1)(1990-6#2)(1991-10#1)(1991-5#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-10#1)(1994-6#1)(2007-12#1)(2008-7#1)(2009-7#2)(2010-1#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#1)
reports a case##21##3##(1990-10#1)(1990-6#2)(1991-10#1)(1991-5#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-10#1)(1994-6#1)(2007-12#1)(2008-12#1)(2008-7#1)(2009-7#2)(2010-1#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#1)
reports a new##2##3##(2005-4#1)(2008-10#1)
reports a study##4##3##(1991-5#1)(2008-11#1)(2010-4#1)(2011-1#1)
reports a##54##2##(1990-10#1)(1990-6#4)(1991-10#1)(1991-5#2)(1992-3#1)(1992-5#1)(1992-6#2)(1993-10#2)(1994-6#1)(1995-11#1)(1997-8#1)(2004-1#1)(2005-4#1)(2006-7#1)(2006-8#1)(2007-12#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-3#1)(2009-7#2)(2009-9#1)(2010-1#2)(2010-3#1)(2010-4#1)(2010-5#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#2)
reports about the##7##3##(1993-9#1)(2008-10#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-5#1)(2012-2#1)
reports about##16##2##(1990-12#1)(1993-9#1)(1996-3#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-9#1)(2009-2#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
reports also##2##2##(1997-4#1)(2007-5#1)
reports an##15##2##(1992-9#1)(1994-1#1)(1996-12#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
reports and clinical trials##3##4##(2005-7#1)(2007-7#1)(2008-5#1)
reports and clinical##4##3##(2005-7#1)(2007-7#1)(2008-1#1)(2008-5#1)
reports and discusses##2##3##(1997-5#1)(2012-1#1)
reports and literature review##4##4##(2006-12#2)(2007-7#1)(2008-4#1)
reports and literature##5##3##(2005-10#1)(2006-12#2)(2007-7#1)(2008-4#1)
reports and recommendations##2##3##(1994-12#1)(2007-3#1)
reports and##60##2##(1991-2#2)(1991-3#2)(1993-12#1)(1994-12#1)(1994-9#1)(1996-4#1)(1997-5#1)(2005-10#1)(2005-7#2)(2006-10#1)(2006-11#1)(2006-12#2)(2006-8#4)(2007-10#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#3)(2008-1#2)(2008-10#1)(2008-11#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2009-4#1)(2009-8#1)(2010-10#2)(2010-3#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#3)(2013-1#2)(2013-7#1)(2013-8#1)
reports are available##4##3##(2008-10#1)(2008-4#1)(2008-9#1)(2012-2#1)
reports are often##2##3##(2007-11#1)(2012-12#1)
reports are published##2##3##(1993-12#1)(2008-11#1)
reports are##25##2##(1990-6#1)(1990-9#1)(1993-12#1)(1996-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-6#1)(2010-8#1)(2011-7#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-8#2)
reports as well##2##3##(2006-12#1)(2008-2#1)
reports as##3##2##(1993-8#1)(2006-12#1)(2008-2#1)
reports available in##3##3##(2006-1#1)(2007-2#1)(2008-8#1)
reports based##2##2##(2008-5#1)(2013-1#1)
reports by##7##2##(1990-10#1)(1994-5#1)(1996-3#1)(1996-8#1)(2007-9#1)(2008-5#1)(2008-9#1)
reports can be##4##3##(1991-3#1)(1994-3#1)(2007-7#1)(2012-2#1)
reports can##5##2##(1991-3#1)(1994-3#1)(2007-7#1)(2009-4#1)(2012-2#1)
reports claiming that##2##3##(1995-2#1)(2008-11#1)
reports claiming##3##2##(1993-3#1)(1995-2#1)(2008-11#1)
reports concerning the effects of##2##5##(1991-12#1)(1995-12#1)
reports concerning the##4##3##(1991-12#1)(1992-6#1)(1995-12#1)(2008-3#1)
reports concerning##9##2##(1991-12#1)(1992-6#1)(1995-12#1)(2008-1#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-1#2)
reports data from##2##3##(2008-1#1)(2011-2#1)
reports data##3##2##(2008-1#1)(2009-8#1)(2011-2#1)
reports dealing with##2##3##(2006-10#1)(2008-1#1)
reports demonstrate that##2##3##(2006-8#1)(2011-2#1)
reports demonstrate##3##2##(2006-8#1)(2009-8#1)(2011-2#1)
reports demonstrating that##2##3##(1996-11#1)(2005-8#1)
reports demonstrating##3##2##(1996-11#1)(2005-8#1)(2008-2#1)
reports describe##4##2##(1996-3#1)(2008-10#1)(2011-1#1)(2013-1#1)
reports describing the##2##3##(2008-3#1)(2009-12#1)
reports describing##6##2##(2008-3#2)(2008-7#1)(2009-12#1)(2010-6#1)(2012-12#1)
reports did##2##2##(1997-3#1)(2013-1#1)
reports discussing##2##2##(2006-10#1)(2012-3#1)
reports documenting##3##2##(2011-2#1)(2012-2#1)(2013-1#1)
reports exist##4##2##(1997-5#1)(2005-10#1)(2008-11#1)(2008-6#1)
reports experimental##3##2##(2006-12#1)(2008-2#1)(2008-9#1)
reports findings of##3##3##(1996-7#1)(2008-4#1)(2011-2#1)
reports findings##8##2##(1995-11#1)(1996-7#1)(2008-11#2)(2008-4#1)(2010-2#1)(2011-2#1)(2012-11#1)
reports focusing on##2##3##(2007-10#1)(2013-8#1)
reports for the first time##2##5##(1995-6#1)(2009-5#1)
reports for the##10##3##(1995-6#1)(2006-10#1)(2006-8#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#1)
reports for##22##2##(1990-4#1)(1995-6#1)(1996-12#1)(1997-1#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-3#1)(2008-5#4)(2008-7#1)(2009-5#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
reports from Europe##2##3##(2007-7#1)(2008-10#1)
reports from a##2##3##(2009-5#1)(2011-2#1)
reports from all##2##3##(2011-1#1)(2011-2#1)
reports from other##4##3##(2007-3#1)(2007-7#2)(2013-8#1)
reports from the##3##3##(1990-10#1)(2008-1#1)(2012-3#1)
reports from##34##2##(1990-10#1)(1992-11#1)(1993-3#1)(1994-10#1)(1994-11#1)(1996-9#1)(2006-10#1)(2006-5#1)(2007-3#1)(2007-7#5)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-7#2)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
reports have been published on the##2##6##(2008-11#1)(2008-6#1)
reports have been published##8##4##(1991-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2012-2#2)(2013-8#1)
reports have been##11##3##(1991-7#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2012-2#2)(2013-8#1)
reports have demonstrated##3##3##(1991-6#1)(1993-12#1)(2007-10#1)
reports have described the##3##4##(2011-2#1)(2012-12#1)(2012-3#1)
reports have described##8##3##(2006-10#1)(2006-8#1)(2008-10#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
reports have focused on the##3##5##(1994-1#1)(2008-8#1)(2013-7#1)
reports have focused on##4##4##(1994-1#1)(2008-8#1)(2011-1#1)(2013-7#1)
reports have highlighted the##3##4##(2006-10#1)(2013-1#2)
reports have indicated that the##2##5##(1994-8#1)(2012-1#1)
reports have indicated that##5##4##(1993-11#1)(1994-3#1)(1994-8#1)(2008-8#1)(2012-1#1)
reports have indicated##7##3##(1993-11#1)(1994-3#1)(1994-8#1)(2006-10#1)(2008-8#1)(2010-12#1)(2012-1#1)
reports have not##2##3##(2008-3#1)(2008-6#1)
reports have provided##2##3##(2006-10#1)(2008-11#1)
reports have shown that##3##4##(2008-7#3)
reports have shown##5##3##(1992-12#1)(2008-10#1)(2008-7#3)
reports have suggested that##4##4##(2005-10#1)(2007-8#1)(2008-11#1)(2009-10#1)
reports have suggested##6##3##(1992-12#1)(1992-5#1)(2005-10#1)(2007-8#1)(2008-11#1)(2009-10#1)
reports have##72##2##(1991-3#1)(1991-6#1)(1991-7#1)(1992-12#2)(1992-5#1)(1993-11#1)(1993-12#2)(1994-1#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-11#1)(1996-2#1)(2005-10#1)(2006-10#5)(2006-8#2)(2007-10#3)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
reports higher##2##2##(1994-10#1)(2008-1#1)
reports in the literature are##2##5##(1996-7#1)(2008-7#1)
reports in the literature of##4##5##(2008-10#1)(2008-6#1)(2008-9#1)(2010-7#1)
reports in the literature##22##4##(1991-11#1)(1991-2#1)(1993-12#1)(1994-2#1)(1994-6#1)(1996-7#1)(2006-11#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#2)(2010-7#1)(2011-2#1)
reports in the##30##3##(1991-11#1)(1991-2#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-6#1)(1996-7#1)(1997-6#1)(2005-7#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#2)(2010-6#2)(2010-7#1)(2011-2#1)(2012-12#1)
reports in which##4##3##(1992-5#1)(1992-6#1)(2006-10#1)(2011-2#1)
reports in##54##2##(1991-11#1)(1991-2#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-6#1)(1996-7#1)(1997-5#1)(1997-6#1)(2005-7#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-6#3)(2010-7#1)(2011-2#4)(2012-12#1)(2013-1#2)(2013-7#1)
reports indicate that##3##3##(2007-5#1)(2008-3#1)(2012-12#1)
reports indicate the involvement of##2##5##(2008-4#1)(2013-7#1)
reports indicate the##3##3##(2006-10#1)(2008-4#1)(2013-7#1)
reports indicate##8##2##(2006-10#1)(2006-2#1)(2007-5#1)(2008-3#1)(2008-4#1)(2009-3#1)(2012-12#1)(2013-7#1)
reports indicated##3##2##(2004-10#1)(2007-12#1)(2008-4#1)
reports involving##2##2##(2008-10#1)(2010-2#1)
reports is an important##3##4##(2013-1#2)(2013-7#1)
reports is##4##2##(1997-3#1)(2013-1#2)(2013-7#1)
reports it##2##2##(2007-2#1)(2007-8#1)
reports linking##3##2##(2007-11#1)(2008-7#1)(2012-2#1)
reports of a high##2##4##(1991-8#1)(2007-11#1)
reports of a##8##3##(1991-8#1)(1997-5#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-9#1)(2010-4#1)(2012-2#1)
reports of adverse events##2##4##(2008-8#1)(2010-8#1)
reports of cases##2##3##(2007-2#1)(2012-3#1)
reports of complications##2##3##(2009-5#1)(2011-2#1)
reports of fatal and non-fatal incidents involving tourists##3##8##(2007-2#3)
reports of medical##2##3##(2008-1#1)(2013-1#1)
reports of pain##2##3##(2007-5#1)(2010-7#1)
reports of parental##2##3##(2009-7#1)(2010-2#1)
reports of physician quality##2##4##(2013-1#2)
reports of poor sleep##2##4##(2012-12#2)
reports of possible##2##3##(1997-5#2)
reports of psychiatric##2##3##(2004-3#1)(2011-12#1)
reports of recent sexual behavior and contraceptive use##2##8##(2012-11#2)
reports of resistance##3##3##(2006-10#1)(2008-10#1)(2011-2#1)
reports of serious##2##3##(2006-10#1)(2009-9#1)
reports of severe##2##3##(2006-10#1)(2007-11#1)
reports of sexual##2##3##(1993-5#1)(2008-12#1)
reports of successful##2##3##(2007-8#1)(2009-5#1)
reports of such a##2##4##(1996-12#1)(2009-3#1)
reports of such##3##3##(1996-12#1)(1996-8#1)(2009-3#1)
reports of the##18##3##(1992-10#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#2)
reports of their##2##3##(2008-4#1)(2008-6#1)
reports of this##2##3##(2007-7#1)(2013-1#1)
reports of typhus-like illnesses##2##4##(2006-2#2)
reports of viral##3##3##(2011-1#1)(2013-1#2)
reports of which are##2##4##(1990-3#1)(2008-5#1)
reports of##283##2##(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-3#2)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-12#1)(1996-3#1)(1996-4#1)(1996-8#2)(1997-1#1)(1997-3#3)(1997-5#5)(1997-6#1)(1997-8#2)(2004-3#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#15)(2006-12#3)(2006-2#4)(2006-6#1)(2006-7#4)(2006-8#5)(2006-9#1)(2007-10#2)(2007-11#6)(2007-12#4)(2007-2#8)(2007-3#1)(2007-4#1)(2007-5#3)(2007-7#5)(2007-8#6)(2007-9#1)(2008-1#3)(2008-10#10)(2008-11#2)(2008-12#3)(2008-3#3)(2008-4#4)(2008-5#6)(2008-6#6)(2008-7#3)(2008-8#4)(2008-9#4)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#5)(2010-10#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#17)(2012-1#1)(2012-11#2)(2012-12#11)(2012-2#6)(2012-3#3)(2013-1#13)(2013-7#2)(2013-8#1)
reports on a qualitative##2##4##(2009-5#1)(2013-8#1)
reports on a survey of##2##5##(1993-1#1)(1995-1#1)
reports on a##24##3##(1993-1#1)(1993-3#1)(1995-1#1)(1996-11#1)(1996-12#1)(2005-11#1)(2006-6#2)(2007-11#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#1)(2009-5#1)(2010-11#1)(2010-8#1)(2010-9#1)(2012-12#1)(2013-8#1)
reports on an##4##3##(1994-1#1)(2008-10#1)(2008-11#1)(2008-12#1)
reports on its##2##3##(2007-8#1)(2010-1#1)
reports on qualitative##2##3##(2008-3#1)(2009-5#1)
reports on recent developments in the##2##6##(1996-3#1)(2006-10#1)
reports on recent##3##3##(1996-3#1)(2006-10#1)(2007-10#1)
reports on selected##2##3##(2009-10#1)(2010-10#1)
reports on side effects##2##4##(1993-2#1)(2005-11#1)
reports on the application of##2##5##(2007-11#1)(2008-10#1)
reports on the design##3##4##(1996-2#1)(2008-12#1)(2008-2#1)
reports on the development of##3##5##(2006-2#1)(2008-11#1)(2012-1#1)
reports on the findings of##2##5##(1995-2#1)(2007-1#1)
reports on the use of a##3##6##(2008-10#1)(2008-12#1)(2013-8#1)
reports on the use of##9##5##(2006-4#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-8#1)
reports on the##70##3##(1990-12#1)(1990-3#1)(1991-1#1)(1991-3#1)(1991-9#1)(1992-5#1)(1993-1#1)(1993-5#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#3)(1996-2#2)(1996-7#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#3)(2007-8#2)(2008-10#9)(2008-11#3)(2008-12#3)(2008-2#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-7#1)(2013-8#1)
reports on this##3##3##(2007-4#1)(2008-4#1)(2008-7#1)
reports on two##3##3##(1994-2#1)(2010-12#1)(2011-1#1)
reports on##196##2##(1990-12#1)(1990-3#1)(1990-4#1)(1991-1#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-2#2)(1992-5#1)(1993-1#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-1#3)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#1)(1994-6#2)(1995-1#2)(1995-11#1)(1995-2#3)(1995-3#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-5#1)(1997-8#1)(2005-11#3)(2005-2#1)(2006-10#6)(2006-12#3)(2006-2#2)(2006-4#2)(2006-6#3)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-3#2)(2007-4#4)(2007-7#6)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#13)(2008-11#10)(2008-12#6)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#5)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-11#1)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#1)(2013-7#2)(2013-8#3)
reports or##5##2##(2005-11#1)(2008-11#1)(2012-1#1)(2013-1#2)
reports our##2##2##(1990-2#1)(1996-12#1)
reports over the##2##3##(2006-8#1)(2009-6#1)
reports over##3##2##(2006-8#1)(2009-6#1)(2013-1#1)
reports published##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
reports received##2##2##(1991-2#1)(2008-8#1)
reports regarding the##3##3##(2007-2#1)(2008-10#1)(2008-9#1)
reports regarding##5##2##(2007-2#1)(2007-8#1)(2008-10#1)(2008-9#1)(2011-3#1)
reports results from a##3##4##(1994-3#1)(1996-3#1)(2011-2#1)
reports results of##2##3##(1990-12#1)(2009-4#1)
reports results##5##2##(1990-12#1)(1994-3#1)(1996-3#1)(2009-4#1)(2011-2#1)
reports should be##3##3##(1992-8#1)(2012-11#2)
reports should##4##2##(1990-3#1)(1992-8#1)(2012-11#2)
reports show that##4##3##(2008-3#1)(2008-8#1)(2011-2#1)(2013-8#1)
reports show##6##2##(1993-8#1)(2008-1#1)(2008-3#1)(2008-8#1)(2011-2#1)(2013-8#1)
reports showed that##4##3##(2007-8#1)(2008-12#1)(2008-9#1)(2013-8#1)
reports showed##5##2##(2007-8#1)(2008-12#1)(2008-9#1)(2012-2#1)(2013-8#1)
reports showing##4##2##(1990-5#1)(1997-5#1)(2011-2#1)(2012-12#1)
reports so far##3##3##(2007-7#1)(2013-1#2)
reports submitted##3##2##(2006-8#1)(2008-10#1)(2010-2#1)
reports suggest a##3##3##(1994-2#1)(2008-6#1)(2010-3#1)
reports suggest that##20##3##(1993-6#1)(1993-9#1)(1994-11#1)(1994-5#1)(1997-2#1)(2005-3#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-4#1)(2008-6#1)(2010-5#1)(2011-2#2)(2013-8#1)
reports suggest the##2##3##(2008-7#1)(2009-11#1)
reports suggest##27##2##(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1996-12#1)(1997-2#1)(2005-3#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-4#1)(2008-6#2)(2008-7#1)(2009-11#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-8#1)
reports suggested that##3##3##(1995-12#1)(2008-1#1)(2009-7#1)
reports suggested##4##2##(1995-12#1)(2008-1#1)(2008-11#1)(2009-7#1)
reports suggesting that##2##3##(2006-9#1)(2007-11#1)
reports suggesting##3##2##(2006-9#1)(2007-11#1)(2012-2#1)
reports that a##3##3##(1992-7#1)(2006-4#1)(2008-8#1)
reports that provide##3##3##(1991-1#1)(2011-1#2)
reports that the##4##3##(1990-5#1)(1995-2#1)(2006-5#1)(2011-12#1)
reports that two##2##3##(1995-6#1)(2006-2#1)
reports that were##2##3##(2008-11#1)(2011-2#1)
reports that##53##2##(1990-12#1)(1990-5#1)(1991-1#1)(1991-2#1)(1992-12#1)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-9#1)(1997-1#1)(1997-7#2)(1997-8#1)(2005-12#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#2)
reports the case of a##5##5##(1992-6#1)(2006-10#1)(2006-2#1)(2008-12#1)(2011-2#1)
reports the case of##6##4##(1992-6#1)(2006-10#1)(2006-2#1)(2006-8#1)(2008-12#1)(2011-2#1)
reports the clinical##2##3##(1990-12#1)(2008-10#1)
reports the development of a##6##5##(1996-11#1)(1996-6#1)(2008-10#3)(2008-5#1)
reports the development of##9##4##(1996-11#1)(1996-12#1)(1996-6#1)(2005-4#1)(2008-10#3)(2008-5#1)(2009-3#1)
reports the development##11##3##(1994-3#1)(1996-11#1)(1996-12#1)(1996-6#1)(2005-4#1)(2007-12#1)(2008-10#3)(2008-5#1)(2009-3#1)
reports the effects of##3##4##(2004-4#1)(2007-3#1)(2008-6#1)
reports the experience of##2##4##(2008-11#1)(2012-12#1)
reports the findings of a##4##5##(1995-1#1)(2007-9#1)(2008-11#2)
reports the findings of##5##4##(1995-1#1)(2007-9#1)(2008-11#2)(2008-9#1)
reports the findings##6##3##(1995-1#1)(2007-12#1)(2007-9#1)(2008-11#2)(2008-9#1)
reports the isolation##2##3##(1995-1#1)(2013-1#1)
reports the prevalence of##2##4##(2006-7#1)(2007-7#1)
reports the results obtained##3##4##(1990-6#1)(2008-10#1)(2008-11#1)
reports the results of a case##2##6##(1996-1#1)(2010-8#1)
reports the results of a study of##2##7##(1992-1#1)(1992-5#1)
reports the results of a study##5##6##(1992-1#1)(1992-5#1)(1993-3#1)(1996-1#1)(2008-5#1)
reports the results of a survey##2##6##(1994-12#1)(1996-12#1)
reports the results of a##16##5##(1991-6#1)(1992-1#1)(1992-3#1)(1992-5#1)(1993-3#1)(1994-12#1)(1996-1#3)(1996-12#1)(2004-10#1)(2004-9#1)(2005-10#1)(2006-4#1)(2008-5#1)(2010-8#1)
reports the results of an##2##5##(2007-9#1)(2008-6#1)
reports the results of##25##4##(1990-10#1)(1990-6#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-5#1)(1993-3#1)(1994-12#1)(1996-1#3)(1996-12#1)(2004-10#1)(2004-9#1)(2005-10#1)(2006-4#2)(2007-9#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-8#1)(2013-1#1)
reports the results##28##3##(1990-10#1)(1990-6#2)(1991-6#1)(1992-1#1)(1992-3#1)(1992-5#1)(1993-3#1)(1994-12#1)(1996-1#3)(1996-12#1)(2004-10#1)(2004-9#1)(2005-10#1)(2006-4#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-8#1)(2013-1#1)
reports the synthesis of##2##4##(2008-4#1)(2010-4#1)
reports the synthesis##3##3##(2008-4#1)(2010-4#1)(2013-7#1)
reports the use of##7##4##(2006-4#1)(2008-10#4)(2010-4#1)(2013-1#1)
reports the##136##2##(1990-10#1)(1990-12#1)(1990-6#2)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-12#3)(1994-3#1)(1995-1#2)(1995-2#1)(1995-3#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-7#1)(2004-10#1)(2004-4#1)(2004-9#1)(2005-10#2)(2005-4#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-4#4)(2006-5#1)(2006-7#1)(2006-8#2)(2007-12#4)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#19)(2008-11#6)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-6#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-4#3)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#2)(2012-7#1)(2013-1#7)(2013-7#2)
reports to date##2##3##(2007-8#1)(2013-1#1)
reports to the contrary##2##4##(1991-4#1)(1993-6#1)
reports to the##6##3##(1990-9#1)(1991-4#1)(1993-6#1)(1997-5#1)(2008-11#1)(2009-2#1)
reports to##18##2##(1990-9#1)(1991-1#1)(1991-4#1)(1993-12#1)(1993-6#1)(1994-3#1)(1997-5#1)(2005-5#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-6#1)(2009-2#1)(2009-4#1)(2012-12#1)(2013-1#2)(2013-8#1)
reports two##7##2##(1992-8#1)(1993-3#1)(1995-1#1)(2008-5#1)(2009-3#1)(2009-9#1)(2012-1#1)
reports using##8##2##(1997-6#1)(2007-5#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#1)(2012-1#1)
reports was##4##2##(1991-3#1)(1997-3#1)(2011-2#2)
reports were published##2##3##(1990-5#1)(2013-1#1)
reports were reviewed##2##3##(1990-3#1)(2008-7#1)
reports were##16##2##(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#1)(1992-6#1)(2004-3#1)(2006-10#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-5#2)(2008-7#1)(2009-2#1)(2011-2#1)(2013-1#1)
reports what##3##2##(1995-8#1)(1996-1#1)(2013-1#1)
reports where##4##2##(1992-8#1)(2007-11#2)(2012-2#1)
reports which##5##2##(1991-4#1)(1991-6#1)(2008-12#1)(2008-5#1)(2008-7#1)
reports will##2##2##(2008-7#1)(2013-7#1)
reports with##4##2##(2007-8#1)(2008-4#1)(2010-4#1)(2012-2#1)
reports##1663##1##(1990-10#5)(1990-11#1)(1990-12#6)(1990-2#1)(1990-3#8)(1990-4#3)(1990-5#5)(1990-6#9)(1990-7#1)(1990-8#1)(1990-9#3)(1991-1#5)(1991-10#1)(1991-11#3)(1991-12#3)(1991-2#8)(1991-3#9)(1991-4#4)(1991-5#8)(1991-6#4)(1991-7#4)(1991-8#3)(1991-9#3)(1992-1#4)(1992-10#3)(1992-11#3)(1992-12#4)(1992-2#2)(1992-3#5)(1992-4#1)(1992-5#6)(1992-6#9)(1992-7#1)(1992-8#7)(1992-9#2)(1993-1#4)(1993-10#3)(1993-11#4)(1993-12#9)(1993-2#2)(1993-3#8)(1993-5#2)(1993-6#8)(1993-7#1)(1993-8#6)(1993-9#4)(1994-1#5)(1994-10#2)(1994-11#4)(1994-12#7)(1994-2#10)(1994-3#12)(1994-5#2)(1994-6#7)(1994-8#2)(1994-9#3)(1995-1#7)(1995-10#1)(1995-11#3)(1995-12#8)(1995-2#6)(1995-3#5)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#3)(1995-9#2)(1996-1#8)(1996-11#7)(1996-12#8)(1996-2#5)(1996-3#7)(1996-4#2)(1996-5#2)(1996-6#2)(1996-7#5)(1996-8#5)(1996-9#3)(1997-1#3)(1997-2#3)(1997-3#7)(1997-4#2)(1997-5#11)(1997-6#3)(1997-7#5)(1997-8#8)(2004-1#2)(2004-10#2)(2004-12#1)(2004-3#3)(2004-4#1)(2004-9#2)(2005-10#6)(2005-11#6)(2005-12#3)(2005-2#1)(2005-3#2)(2005-4#2)(2005-5#3)(2005-7#5)(2005-8#5)(2005-9#2)(2006-1#3)(2006-10#62)(2006-11#3)(2006-12#27)(2006-2#11)(2006-4#8)(2006-5#5)(2006-6#5)(2006-7#7)(2006-8#26)(2006-9#4)(2007-1#5)(2007-10#16)(2007-11#27)(2007-12#19)(2007-2#15)(2007-3#10)(2007-4#10)(2007-5#10)(2007-6#2)(2007-7#36)(2007-8#27)(2007-9#14)(2008-1#24)(2008-10#81)(2008-11#53)(2008-12#17)(2008-2#17)(2008-3#17)(2008-4#17)(2008-5#35)(2008-6#24)(2008-7#42)(2008-8#18)(2008-9#26)(2009-1#1)(2009-10#4)(2009-11#4)(2009-12#2)(2009-2#6)(2009-3#13)(2009-4#12)(2009-5#12)(2009-6#4)(2009-7#10)(2009-8#8)(2009-9#10)(2010-1#6)(2010-10#6)(2010-11#3)(2010-12#18)(2010-2#7)(2010-3#9)(2010-4#8)(2010-5#8)(2010-6#11)(2010-7#6)(2010-8#11)(2010-9#3)(2011-1#20)(2011-11#1)(2011-12#5)(2011-2#74)(2011-3#1)(2011-7#2)(2012-1#14)(2012-11#6)(2012-12#41)(2012-2#30)(2012-3#24)(2012-7#1)(2013-1#67)(2013-7#15)(2013-8#26)
reports) were##2##2##(2006-12#1)(2011-2#1)
reports)##5##1##(1991-8#1)(2006-12#1)(2008-12#1)(2011-12#1)(2011-2#1)
reports]##11##1##(1991-11#1)(1991-4#1)(1991-5#1)(1992-5#1)(1992-6#1)(1993-8#1)(2008-10#1)(2008-7#2)(2008-8#1)(2011-1#1)
reposition##6##1##(2006-3#1)(2007-7#2)(2007-8#1)(2009-2#1)(2009-8#1)
repositioned##5##1##(1993-10#1)(2006-8#2)(2007-9#1)(2013-7#1)
repositioning in##2##2##(2008-11#1)(2010-7#1)
repositioning of the##8##3##(2006-12#1)(2006-7#1)(2007-4#1)(2007-7#2)(2008-1#1)(2009-4#1)(2012-2#1)
repositioning of##12##2##(1996-5#1)(2006-12#1)(2006-7#1)(2007-4#1)(2007-7#3)(2008-1#1)(2009-4#1)(2010-11#1)(2011-2#1)(2012-2#1)
repositioning##30##1##(1994-12#1)(1996-5#1)(2006-12#2)(2006-7#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#5)(2008-1#1)(2008-11#2)(2008-7#2)(2009-4#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-2#4)(2012-2#1)(2013-1#1)
repositories of##2##2##(2005-7#1)(2008-7#1)
repositories##22##1##(1995-12#1)(2005-7#1)(2006-2#1)(2008-11#1)(2008-7#7)(2009-8#1)(2010-12#3)(2013-1#7)
repository for##4##2##(1991-5#1)(2007-12#1)(2008-7#1)(2010-10#1)
repository in##3##2##(2007-10#1)(2013-1#2)
repository of##6##2##(1991-2#1)(2008-7#1)(2013-1#4)
repository##22##1##(1991-2#1)(1991-5#1)(1996-3#1)(2007-10#1)(2007-12#1)(2008-4#3)(2008-7#5)(2010-10#1)(2010-9#1)(2013-1#6)(2013-8#1)
represent &quot##2##2##(2006-8#1)(2012-12#1)
represent 1##2##2##(1997-8#1)(2011-1#1)
represent a challenge for##3##4##(2006-10#1)(2006-6#1)(2012-12#1)
represent a challenge##4##3##(2006-10#1)(2006-6#1)(2011-1#1)(2012-12#1)
represent a challenging##2##3##(2008-1#1)(2010-7#1)
represent a chronic##2##3##(2006-10#1)(2006-11#1)
represent a class of##4##4##(1995-2#1)(2006-8#1)(2008-3#1)(2008-4#1)
represent a common##3##3##(1995-12#1)(2006-12#1)(2008-10#1)
represent a compensatory mechanism##3##4##(1997-5#1)(2008-7#1)(2011-1#1)
represent a compensatory##4##3##(1993-12#1)(1997-5#1)(2008-7#1)(2011-1#1)
represent a contraindication to##2##4##(1991-9#1)(2008-1#1)
represent a detailed##2##3##(1997-7#1)(2008-7#1)
represent a diagnostic and therapeutic challenge##2##6##(2006-12#1)(2010-5#1)
represent a diagnostic challenge##3##4##(2006-1#1)(2008-7#1)(2013-1#1)
represent a diagnostic##5##3##(2006-1#1)(2006-12#1)(2008-7#1)(2010-5#1)(2013-1#1)
represent a different class of##2##5##(1992-8#1)(1995-1#1)
represent a different##4##3##(1992-8#1)(1995-1#1)(1996-7#1)(1997-3#1)
represent a difficult##2##3##(2008-3#1)(2008-6#1)
represent a direct##2##3##(2006-10#1)(2008-1#1)
represent a distinct##8##3##(1991-7#1)(1992-7#1)(2005-10#1)(2008-10#4)(2009-3#1)
represent a diverse group of##2##5##(2008-4#1)(2011-2#1)
represent a form of##2##4##(1997-1#1)(2004-3#1)
represent a frequent cause of##2##5##(2007-1#1)(2007-9#1)
represent a general##2##3##(1995-8#1)(2008-10#1)
represent a global##2##3##(2008-3#1)(2012-2#1)
represent a great opportunity##2##4##(2008-8#1)(2012-12#1)
represent a great##3##3##(2008-8#1)(2010-11#1)(2012-12#1)
represent a group of##4##4##(1993-6#1)(1995-5#1)(2009-12#1)(2010-6#1)
represent a growing##2##3##(2007-10#1)(2012-2#1)
represent a huge##2##3##(2008-4#1)(2010-1#1)
represent a key##4##3##(1992-12#1)(1997-7#1)(2012-11#1)(2012-12#1)
represent a large##5##3##(1994-11#1)(2008-10#1)(2008-4#1)(2009-11#1)(2009-8#1)
represent a major cause of morbidity##2##6##(2008-1#1)(2008-7#1)
represent a major step forward in##2##6##(2009-3#1)(2012-2#1)
represent a major step toward##2##5##(1993-11#1)(2010-7#1)
represent a major step##4##4##(1993-11#1)(2009-3#1)(2010-7#1)(2012-2#1)
represent a major##18##3##(1990-4#1)(1992-9#1)(1993-11#1)(1995-1#1)(1995-2#1)(2006-4#1)(2007-7#1)(2008-1#1)(2008-7#2)(2009-12#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-7#1)(2012-11#1)(2012-2#1)
represent a model for##2##4##(1995-2#1)(1996-4#1)
represent a more##6##3##(1994-6#1)(1997-3#1)(2005-10#1)(2007-2#1)(2009-8#1)(2012-12#1)
represent a new approach##2##4##(1996-5#1)(2009-7#1)
represent a new class of##8##5##(1991-9#1)(1994-5#1)(2004-12#1)(2005-7#1)(2008-3#1)(2008-5#2)(2009-8#1)
represent a new##27##3##(1991-2#1)(1991-6#1)(1991-9#1)(1993-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1996-5#1)(1996-7#1)(1997-3#1)(2004-12#1)(2005-7#2)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#2)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2012-2#1)
represent a novel mechanism##2##4##(1991-5#1)(2007-12#1)
represent a novel therapeutic strategy##2##5##(2005-7#1)(2008-7#1)
represent a novel##18##3##(1990-5#1)(1991-5#1)(1991-9#1)(1992-4#1)(1994-8#1)(1996-12#1)(1996-9#1)(2005-7#1)(2007-12#2)(2008-1#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
represent a number of##2##4##(2008-11#1)(2008-7#1)
represent a particular##2##3##(2007-2#1)(2008-9#1)
represent a possible##3##3##(1993-6#1)(2008-10#1)(2011-2#1)
represent a potential##6##3##(1990-4#1)(2007-10#1)(2007-12#1)(2008-10#3)
represent a potentially##7##3##(1996-8#1)(2006-10#1)(2008-5#1)(2009-12#1)(2010-1#1)(2012-12#2)
represent a powerful##2##3##(2011-2#1)(2012-12#1)
represent a promising##5##3##(1992-12#1)(2008-10#1)(2008-11#1)(2011-11#1)(2012-12#1)
represent a range of##2##4##(2008-10#1)(2009-11#1)
represent a rare group of##2##5##(2007-11#1)(2010-12#1)
represent a rare##4##3##(1990-6#1)(2007-11#1)(2008-10#1)(2010-12#1)
represent a receptor##2##3##(1995-12#1)(2008-10#1)
represent a relatively simple##2##4##(1996-3#1)(2008-2#1)
represent a relatively##5##3##(1996-3#1)(2008-10#1)(2008-2#1)(2008-5#2)
represent a risk factor##2##4##(2006-2#1)(2008-3#1)
represent a risk##4##3##(2006-2#1)(2008-10#1)(2008-3#1)(2011-2#1)
represent a second##2##3##(2010-12#1)(2010-3#1)
represent a serious##2##3##(1996-2#1)(2008-10#1)
represent a significant decrease##2##4##(1991-5#1)(2008-6#1)
represent a significant##10##3##(1991-5#1)(1994-5#1)(2005-3#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2010-12#1)(2010-6#1)
represent a simple##2##3##(2008-1#1)(2010-11#1)
represent a single##4##3##(2007-11#1)(2008-10#2)(2008-5#1)
represent a small##3##3##(1994-12#1)(2006-11#1)(2007-3#1)
represent a source of##2##4##(1991-3#1)(2008-10#1)
represent a special##3##3##(1990-6#1)(1994-8#1)(1997-6#1)
represent a subgroup of##2##4##(1991-4#1)(2011-2#1)
represent a subgroup##3##3##(1991-4#1)(2007-9#1)(2011-2#1)
represent a substantial##2##3##(1992-8#1)(2008-1#1)
represent a therapeutic##2##3##(2008-11#1)(2012-2#1)
represent a unique##3##3##(1990-4#1)(2008-7#1)(2009-8#1)
represent a useful##6##3##(1990-8#1)(1995-12#1)(1995-6#1)(2006-10#1)(2006-2#1)(2008-11#1)
represent a valid##2##3##(2008-7#1)(2010-8#1)
represent a valuable##3##3##(1994-6#1)(2008-7#1)(2008-8#1)
represent a very##2##3##(1996-3#1)(2008-1#1)
represent a viable##2##3##(2009-5#1)(2013-1#1)
represent a wide##2##3##(2008-10#1)(2008-3#1)
represent a##384##2##(1990-10#1)(1990-2#1)(1990-4#4)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#4)(1992-1#2)(1992-12#2)(1992-4#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-6#3)(1993-7#1)(1993-8#2)(1994-11#2)(1994-12#3)(1994-3#1)(1994-5#2)(1994-6#4)(1994-8#2)(1995-1#3)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#4)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#4)(2004-12#1)(2004-3#2)(2005-10#2)(2005-11#1)(2005-3#1)(2005-7#3)(2006-1#1)(2006-10#9)(2006-11#2)(2006-12#4)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#4)(2007-11#5)(2007-12#10)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#10)(2008-10#30)(2008-11#8)(2008-12#1)(2008-2#3)(2008-3#8)(2008-4#5)(2008-5#13)(2008-6#3)(2008-7#14)(2008-8#3)(2008-9#2)(2009-10#3)(2009-11#2)(2009-12#3)(2009-3#3)(2009-4#1)(2009-5#2)(2009-7#3)(2009-8#6)(2010-1#2)(2010-11#5)(2010-12#7)(2010-2#1)(2010-3#1)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#2)(2011-1#5)(2011-11#1)(2011-2#14)(2012-11#2)(2012-12#12)(2012-2#5)(2012-3#2)(2012-8#1)(2013-1#4)(2013-8#5)
represent about 10% of##2##4##(1996-6#1)(2007-1#1)
represent alternative##5##2##(1993-9#1)(2007-9#1)(2010-2#1)(2012-12#1)(2012-3#1)
represent an additional##4##3##(1991-8#1)(1995-2#1)(1995-5#1)(2008-4#1)
represent an altered##2##3##(1993-1#1)(2011-2#1)
represent an alternative##4##3##(2007-7#1)(2008-10#1)(2008-5#1)(2010-6#1)
represent an attractive##3##3##(2005-7#1)(2008-1#1)(2012-2#1)
represent an average##2##3##(1993-4#1)(2008-2#1)
represent an early##2##3##(1996-9#1)(2008-7#1)
represent an effective##3##3##(2006-10#1)(2008-3#1)(2013-7#1)
represent an emerging##3##3##(2007-4#1)(2010-5#1)(2011-1#1)
represent an important and##2##4##(2008-12#1)(2008-7#1)
represent an important challenge in##2##5##(1994-12#1)(1997-2#1)
represent an important source of##2##5##(1992-8#1)(2008-10#1)
represent an important##23##3##(1991-7#1)(1992-8#1)(1992-9#1)(1994-12#1)(1995-1#1)(1997-2#1)(1997-4#1)(2005-12#1)(2005-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-3#1)(2009-9#1)(2010-12#2)(2013-7#1)
represent an improvement##2##3##(1991-12#1)(2007-4#1)
represent an uncommon##2##3##(1992-6#1)(2012-2#1)
represent an##95##2##(1991-12#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-4#1)(1994-12#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-8#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-12#3)(2007-4#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#6)(2008-9#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#2)(2013-8#3)
represent and##2##2##(2008-6#2)
represent another##2##2##(1994-3#1)(2010-5#1)
represent areas##2##2##(2005-8#1)(2008-10#1)
represent both a##3##3##(1992-5#1)(2007-12#1)(2008-9#1)
represent cellular##2##2##(1996-5#1)(2008-4#1)
represent common##2##2##(2012-2#2)
represent complex##2##2##(2008-6#2)
represent cryptic##2##2##(1997-7#1)(2008-9#1)
represent degradation products##2##3##(1991-10#1)(1996-5#1)
represent different##10##2##(1992-3#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-9#1)(2009-10#1)(2009-12#1)(2011-1#1)
represent distinct##6##2##(2008-10#3)(2008-9#1)(2010-3#1)(2010-6#1)
represent diverse##2##2##(2008-7#1)(2011-1#1)
represent early##5##2##(1991-12#1)(1992-6#1)(2008-9#2)(2009-11#1)
represent emerging##2##2##(2007-7#1)(2008-3#1)
represent endogenous##2##2##(2005-10#1)(2013-8#1)
represent first records##2##3##(2007-3#1)(2010-8#1)
represent functional##2##2##(1991-11#1)(2008-11#1)
represent fundamental##2##2##(2009-11#1)(2011-1#1)
represent good candidates for##2##4##(2008-2#1)(2013-1#1)
represent good##3##2##(1997-6#1)(2008-2#1)(2013-1#1)
represent important factors##2##3##(2006-2#1)(2013-7#1)
represent important##14##2##(1997-3#1)(1997-8#1)(2006-2#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-7#2)(2008-8#1)(2012-1#1)(2012-12#1)(2013-7#2)(2013-8#1)
represent in##2##2##(1991-2#1)(2008-7#1)
represent independent##2##2##(1993-4#1)(1995-4#1)
represent interesting##3##2##(2008-1#1)(2008-8#1)(2012-12#1)
represent its##3##2##(1992-2#1)(2013-1#2)
represent less than 1% of##2##5##(2006-10#1)(2010-12#1)
represent mature##3##2##(1992-3#2)(1995-3#1)
represent members##2##2##(1992-5#1)(1995-5#1)
represent miniaturized##2##2##(2008-10#1)(2010-6#1)
represent molecular##2##2##(1995-11#1)(2009-4#1)
represent more##4##2##(1995-12#1)(2008-5#1)(2008-8#2)
represent new##2##2##(1991-1#1)(2005-8#1)
represent novel##7##2##(1991-5#1)(1996-8#1)(2006-8#1)(2007-11#1)(2009-6#1)(2010-3#1)(2010-4#1)
represent objects##2##2##(1992-5#1)(2010-2#1)
represent one of the largest##2##5##(2008-5#1)(2013-8#1)
represent one of the most##4##5##(1992-5#1)(1995-3#1)(2007-12#1)(2010-11#1)
represent one of the##14##4##(1992-5#1)(1995-3#1)(2006-12#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-11#2)(2010-8#1)(2012-12#1)(2013-8#1)
represent one of##15##3##(1992-5#1)(1995-3#1)(2006-12#1)(2006-6#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-11#2)(2010-8#1)(2012-12#1)(2013-8#1)
represent one##16##2##(1992-5#1)(1995-3#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-11#2)(2010-8#1)(2012-12#1)(2013-8#1)
represent only a##3##3##(2007-7#1)(2008-10#1)(2011-2#1)
represent only##5##2##(1990-8#1)(2007-7#1)(2008-1#1)(2008-10#1)(2011-2#1)
represent output function##2##3##(1991-6#2)
represent possible##3##2##(1995-8#1)(2008-11#1)(2013-1#1)
represent potential therapeutic targets##2##4##(2010-12#1)(2011-1#1)
represent potential##4##2##(2008-4#1)(2010-12#1)(2011-1#1)(2012-12#1)
represent previously##2##2##(1996-4#1)(2008-10#1)
represent primary##2##2##(1995-12#1)(2010-10#1)
represent significant##2##2##(2007-11#1)(2008-2#1)
represent single##2##2##(1993-11#2)
represent some##4##2##(2005-11#2)(2008-7#1)(2013-8#1)
represent such a##2##3##(2008-2#1)(2010-12#1)
represent the &quot##2##3##(2007-1#1)(2011-2#1)
represent the active##2##3##(1991-2#1)(2009-3#1)
represent the beginning of##2##4##(2006-12#1)(2009-10#1)
represent the best##5##3##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)
represent the blood of##2##4##(2008-2#2)
represent the critical##3##3##(2004-4#1)(2012-12#2)
represent the dominant##2##3##(2006-1#1)(2012-12#1)
represent the effects of##2##4##(2008-10#1)(2013-1#1)
represent the entire##2##3##(2008-4#1)(2008-7#1)
represent the first biochemical characterization##2##5##(1991-6#1)(1992-3#1)
represent the first demonstration of##5##5##(1994-3#1)(1994-5#1)(1995-7#1)(1996-1#1)(2007-12#1)
represent the first demonstration##6##4##(1994-3#1)(1994-5#1)(1995-7#1)(1996-1#1)(2007-12#1)(2008-8#1)
represent the first step##2##4##(1991-7#1)(2013-1#1)
represent the first##24##3##(1990-2#1)(1990-5#1)(1991-6#2)(1991-7#2)(1991-8#1)(1992-3#1)(1994-3#1)(1994-5#1)(1995-7#1)(1996-1#1)(1997-1#1)(1997-5#1)(1997-7#1)(2006-6#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-8#1)(2009-10#1)(2011-1#1)(2013-1#1)
represent the fundamental##2##3##(1995-2#1)(2008-10#1)
represent the human##3##3##(1991-7#1)(1995-2#1)(2007-4#1)
represent the initial step##2##4##(1995-8#1)(2008-10#1)
represent the main##3##3##(1994-6#1)(2006-2#1)(2010-11#1)
represent the major source##2##4##(2008-11#1)(2010-11#1)
represent the major##8##3##(1990-12#1)(1992-9#1)(1993-6#1)(2006-3#1)(2008-1#1)(2008-11#1)(2010-11#1)(2012-12#1)
represent the majority of##2##4##(1992-7#1)(2008-7#1)
represent the most common##4##4##(2007-7#1)(2008-4#1)(2009-12#1)(2010-9#1)
represent the most frequent##2##4##(2011-2#1)(2013-8#1)
represent the most severe##2##4##(1997-1#1)(2008-2#1)
represent the most##18##3##(1993-1#1)(1993-3#1)(1996-2#1)(1997-1#1)(1997-6#1)(2005-8#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
represent the net##2##3##(2008-2#1)(2008-8#1)
represent the neural##3##3##(2007-8#1)(2007-9#1)(2008-11#1)
represent the optimal##2##3##(2006-12#1)(2007-12#1)
represent the primary##4##3##(1990-2#1)(1993-9#1)(2008-10#1)(2011-1#1)
represent the putative##2##3##(1992-8#1)(1993-2#1)
represent the results of##2##4##(2008-4#1)(2013-1#1)
represent the same##2##3##(2010-10#1)(2010-6#1)
represent the state of the art in##2##7##(2007-8#1)(2010-9#1)
represent the true##2##3##(1991-1#1)(1995-11#1)
represent the##231##2##(1990-1#1)(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#3)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#2)(1991-7#3)(1991-8#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#2)(1995-2#2)(1995-7#1)(1995-8#2)(1995-9#2)(1996-1#1)(1996-12#3)(1996-2#2)(1996-4#2)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#1)(2004-4#1)(2005-11#1)(2005-8#2)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#4)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#3)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#20)(2008-11#9)(2008-12#2)(2008-2#9)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#6)(2008-9#2)(2009-10#2)(2009-12#3)(2009-3#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#4)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#10)(2013-8#2)
represent this##2##2##(1992-2#1)(1996-5#1)
represent those##2##2##(1996-12#1)(2009-9#1)
represent three##4##2##(2008-10#3)(2011-2#1)
represent two different##2##3##(1996-1#1)(2008-10#1)
represent two distinct##2##3##(1994-8#1)(2006-6#1)
represent two major##2##3##(2008-1#1)(2010-2#1)
represent two##15##2##(1992-10#1)(1994-5#1)(1994-8#2)(1996-1#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-2#1)(2010-3#1)(2012-12#1)(2012-3#1)
represent unique##2##2##(1996-12#1)(2013-8#1)
represent what##3##2##(1993-8#1)(2007-12#1)(2008-2#1)
represent##1134##1##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#4)(1990-4#5)(1990-5#3)(1990-6#2)(1990-7#5)(1990-8#4)(1990-9#1)(1991-1#3)(1991-10#1)(1991-11#3)(1991-12#6)(1991-2#5)(1991-3#2)(1991-4#2)(1991-5#3)(1991-6#7)(1991-7#5)(1991-8#2)(1991-9#5)(1992-1#2)(1992-10#1)(1992-12#2)(1992-2#3)(1992-3#5)(1992-4#1)(1992-5#6)(1992-6#5)(1992-7#5)(1992-8#4)(1992-9#4)(1993-1#2)(1993-11#5)(1993-12#2)(1993-2#2)(1993-3#6)(1993-4#4)(1993-5#3)(1993-6#4)(1993-7#2)(1993-8#3)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#10)(1994-2#3)(1994-3#3)(1994-5#4)(1994-6#8)(1994-8#4)(1995-1#4)(1995-11#8)(1995-12#5)(1995-2#7)(1995-3#7)(1995-4#1)(1995-5#5)(1995-6#1)(1995-7#2)(1995-8#4)(1995-9#3)(1996-1#4)(1996-11#2)(1996-12#8)(1996-2#3)(1996-3#4)(1996-4#9)(1996-5#6)(1996-6#3)(1996-7#2)(1996-8#5)(1996-9#5)(1997-1#4)(1997-2#5)(1997-3#5)(1997-4#4)(1997-5#3)(1997-6#7)(1997-7#8)(1997-8#3)(2004-11#1)(2004-12#1)(2004-2#1)(2004-3#2)(2004-4#1)(2005-10#4)(2005-11#5)(2005-12#1)(2005-3#1)(2005-7#4)(2005-8#6)(2006-1#3)(2006-10#19)(2006-11#6)(2006-12#10)(2006-2#5)(2006-3#2)(2006-4#5)(2006-5#4)(2006-6#5)(2006-7#1)(2006-8#8)(2006-9#3)(2007-1#5)(2007-10#6)(2007-11#11)(2007-12#27)(2007-2#6)(2007-3#6)(2007-4#5)(2007-5#2)(2007-6#1)(2007-7#8)(2007-8#7)(2007-9#6)(2008-1#19)(2008-10#88)(2008-11#29)(2008-12#6)(2008-2#25)(2008-3#18)(2008-4#19)(2008-5#30)(2008-6#14)(2008-7#42)(2008-8#17)(2008-9#12)(2009-10#8)(2009-11#4)(2009-12#10)(2009-3#7)(2009-4#6)(2009-5#2)(2009-6#5)(2009-7#4)(2009-8#10)(2009-9#4)(2010-1#4)(2010-10#2)(2010-11#11)(2010-12#14)(2010-2#4)(2010-3#6)(2010-4#2)(2010-5#8)(2010-6#6)(2010-7#4)(2010-8#6)(2010-9#3)(2011-1#19)(2011-11#1)(2011-12#1)(2011-2#34)(2012-1#3)(2012-11#4)(2012-12#27)(2012-2#17)(2012-3#7)(2012-8#1)(2013-1#39)(2013-7#4)(2013-8#17)
representation across##3##2##(1992-7#1)(2008-7#1)(2012-2#1)
representation also##2##2##(1997-8#1)(2011-2#1)
representation and task analyses##2##4##(2013-1#2)
representation and##13##2##(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#1)(2009-10#1)(2010-8#1)(2011-12#1)(2012-1#1)(2013-1#3)
representation are##3##2##(2010-9#1)(2011-1#1)(2012-1#1)
representation as##2##2##(1992-9#2)
representation at##2##2##(1997-8#1)(2008-2#1)
representation for a##2##3##(2008-6#2)
representation for the##3##3##(1995-9#1)(2008-2#2)
representation for##8##2##(1995-9#1)(1997-8#1)(2008-2#2)(2008-6#3)(2012-2#1)
representation has##3##2##(2008-2#3)
representation in area 3b of the##2##6##(1995-11#2)
representation in the two##2##4##(1996-9#1)(1997-8#1)
representation in the##11##3##(1995-11#2)(1996-5#2)(1996-9#2)(1997-8#1)(2008-2#1)(2008-9#1)(2009-4#1)(2010-3#1)
representation in which##2##3##(2008-11#1)(2009-10#1)
representation in##23##2##(1990-8#1)(1993-3#1)(1995-11#4)(1996-5#2)(1996-9#2)(1997-8#2)(2006-4#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-4#1)(2010-3#1)(2012-2#1)
representation is##6##2##(1995-11#1)(2006-4#1)(2008-2#2)(2008-4#1)(2008-6#1)
representation of DNA sequences##2##4##(2013-8#2)
representation of DNA##3##3##(2007-10#1)(2013-8#2)
representation of a##7##3##(1993-11#1)(1995-5#1)(1996-6#1)(2006-10#1)(2007-1#1)(2008-11#1)(2008-5#1)
representation of cancer##2##3##(2008-9#2)
representation of schistosomiasis##2##3##(1994-3#2)
representation of the contralateral##3##4##(1995-11#3)
representation of the facial##2##4##(1997-8#1)(2007-4#1)
representation of the object##2##4##(1996-2#1)(2008-4#1)
representation of the painful##2##4##(2006-10#1)(2010-7#1)
representation of the shape of##2##5##(2007-9#2)
representation of the structure##2##4##(1993-9#1)(1995-6#1)
representation of the##63##3##(1991-4#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-9#1)(1994-3#1)(1995-11#5)(1995-5#2)(1995-6#2)(1996-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#1)(2007-11#1)(2007-4#2)(2007-5#1)(2007-9#2)(2008-10#1)(2008-11#2)(2008-2#7)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-4#2)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
representation of##147##2##(1990-12#1)(1990-8#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-3#5)(1995-11#5)(1995-12#1)(1995-5#3)(1995-6#2)(1996-1#3)(1996-2#1)(1996-4#1)(1996-6#1)(1997-4#1)(1997-7#1)(1997-8#3)(2005-11#1)(2005-6#1)(2006-10#4)(2006-11#1)(2006-12#3)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-3#2)(2007-4#2)(2007-5#1)(2007-9#3)(2008-1#1)(2008-10#4)(2008-11#6)(2008-2#13)(2008-3#4)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#5)(2009-10#4)(2009-11#1)(2009-4#2)(2009-6#1)(2010-2#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#3)
representation on the Poincaré sphere##2##5##(2008-3#2)
representation on the##3##3##(2008-3#2)(2011-2#1)
representation on##4##2##(1996-12#1)(2008-3#2)(2011-2#1)
representation theory##2##2##(2008-2#1)(2013-7#1)
representation to##4##2##(1997-8#1)(2006-8#1)(2007-12#1)(2008-4#1)
representation where##2##2##(2008-2#2)
representation which##2##2##(1996-5#1)(2009-4#1)
representation with##2##2##(1991-4#1)(2008-10#1)
representation##328##1##(1990-12#1)(1990-8#2)(1991-4#2)(1991-5#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#2)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#8)(1995-11#11)(1995-12#3)(1995-5#3)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#4)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#3)(1996-6#2)(1996-9#2)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#11)(2005-11#1)(2005-6#1)(2006-10#5)(2006-11#1)(2006-12#4)(2006-4#4)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#6)(2007-2#1)(2007-3#2)(2007-4#2)(2007-5#1)(2007-9#4)(2008-1#1)(2008-10#5)(2008-11#10)(2008-2#47)(2008-3#11)(2008-4#11)(2008-5#7)(2008-6#8)(2008-7#15)(2008-8#3)(2008-9#8)(2009-10#8)(2009-11#1)(2009-2#1)(2009-4#5)(2009-6#1)(2009-8#1)(2010-2#5)(2010-3#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#7)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#19)(2013-7#2)(2013-8#5)
representational systems##2##2##(2008-4#1)(2008-5#1)
representational##14##1##(1990-11#1)(1995-12#1)(1997-8#2)(2006-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#2)(2012-2#1)(2012-3#1)(2013-1#2)
representations about##2##2##(1991-12#1)(1993-3#1)
representations and##2##2##(2008-2#1)(2010-1#1)
representations are##9##2##(1995-12#1)(2008-3#1)(2008-6#1)(2009-10#1)(2009-3#1)(2010-1#1)(2010-2#1)(2013-1#2)
representations as##2##2##(1992-3#1)(2013-8#1)
representations for##5##2##(2010-10#1)(2011-12#2)(2013-1#2)
representations in the##2##3##(2006-3#1)(2008-10#1)
representations in##6##2##(1995-12#1)(2006-3#1)(2008-10#1)(2009-10#1)(2013-1#2)
representations is##3##2##(1995-11#1)(2008-2#1)(2008-7#1)
representations of a##2##3##(2013-7#1)(2013-8#1)
representations of motherhood and pregnancy in##2##6##(2012-12#2)
representations of options##2##3##(2009-3#2)
representations of the##19##3##(1991-4#1)(1995-6#1)(1996-4#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-8#2)(2007-9#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-12#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
representations of their##2##3##(1991-8#1)(2008-11#1)
representations of##63##2##(1991-4#1)(1991-8#1)(1992-5#1)(1994-3#1)(1995-11#2)(1995-12#2)(1995-6#1)(1996-4#1)(1996-5#1)(1997-8#2)(2005-10#1)(2006-10#1)(2006-12#1)(2006-4#2)(2007-12#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-12#2)(2009-3#3)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#7)
representations that##3##2##(1997-8#1)(2008-4#1)(2009-11#1)
representations##158##1##(1990-11#1)(1991-12#1)(1991-4#1)(1991-8#1)(1992-3#1)(1992-5#1)(1993-3#1)(1994-3#2)(1994-6#1)(1995-11#4)(1995-12#6)(1995-6#1)(1996-4#1)(1996-5#1)(1997-6#2)(1997-8#8)(2005-10#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-4#2)(2007-12#4)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-2#9)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#2)(2008-9#4)(2009-1#1)(2009-10#7)(2009-11#1)(2009-12#4)(2009-3#6)(2009-4#1)(2009-7#1)(2009-8#3)(2010-1#3)(2010-10#2)(2010-2#3)(2010-5#2)(2010-8#1)(2011-1#6)(2011-12#2)(2011-2#2)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#9)
representative applications##2##2##(2008-1#1)(2008-9#1)
representative areas##2##2##(2008-5#1)(2013-8#1)
representative biopsies##2##2##(1990-11#1)(2008-5#1)
representative cases##2##2##(2011-12#1)(2013-1#1)
representative chemicals##2##2##(2008-11#2)
representative data from##2##3##(2006-12#1)(2012-11#1)
representative data##6##2##(2005-9#1)(2006-12#1)(2007-12#1)(2008-7#1)(2012-11#1)(2013-8#1)
representative disks##3##2##(2008-2#3)
representative examples of##4##3##(2006-12#1)(2007-11#1)(2009-3#1)(2012-3#1)
representative examples##8##2##(1997-6#1)(2006-12#1)(2007-11#1)(2008-10#1)(2009-3#1)(2010-10#1)(2010-7#1)(2012-3#1)
representative for##6##2##(1995-2#1)(2006-11#1)(2008-5#1)(2008-9#1)(2012-2#1)(2013-8#1)
representative genomic##2##2##(1994-8#1)(2008-10#1)
representative images##3##2##(2008-3#1)(2008-8#1)(2012-3#1)
representative in##2##2##(1994-12#1)(1995-1#1)
representative isolates of##5##3##(2008-10#5)
representative isolates##12##2##(2008-10#10)(2011-2#1)(2012-12#1)
representative material##2##2##(1991-11#1)(2012-2#1)
representative members##2##2##(1993-3#1)(1997-8#1)
representative of &quot##2##3##(2009-11#1)(2012-2#1)
representative of a novel##3##4##(1991-2#1)(1996-6#1)(2012-2#1)
representative of a##9##3##(1991-2#1)(1992-6#1)(1996-3#1)(1996-6#1)(2007-4#1)(2008-7#1)(2011-2#2)(2012-2#1)
representative of all##2##3##(1990-6#1)(2009-9#1)
representative of an##2##3##(1996-2#1)(2009-8#1)
representative of natural##2##3##(2005-11#1)(2008-2#1)
representative of the general population##2##5##(1997-3#1)(2006-5#1)
representative of the general##3##4##(1994-6#1)(1997-3#1)(2006-5#1)
representative of the population as a whole##2##7##(1993-11#1)(2012-12#1)
representative of the underlying##2##4##(2008-2#1)(2010-11#1)
representative of the##51##3##(1990-10#1)(1990-11#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-6#1)(1995-10#1)(1997-3#1)(2006-5#1)(2006-9#1)(2007-1#1)(2008-10#8)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-8#1)
representative of##108##2##(1990-10#1)(1990-11#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-10#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-3#1)(2005-10#2)(2005-11#2)(2006-11#2)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-4#2)(2007-5#1)(2007-8#1)(2008-10#12)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#5)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#2)(2012-7#1)(2013-1#3)(2013-8#2)
representative panel##3##2##(1994-3#1)(2008-10#1)(2012-3#1)
representative patients##2##2##(2006-7#1)(2008-5#1)
representative points##2##2##(2008-2#1)(2008-9#1)
representative sample of Norwegian##2##4##(2005-10#1)(2007-12#1)
representative sample of over##2##4##(2008-10#1)(2008-2#1)
representative sample of the##7##4##(2007-2#1)(2008-5#2)(2010-9#1)(2011-2#2)(2013-7#1)
representative sample of this##2##4##(1991-6#1)(2009-7#1)
representative sample of##48##3##(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1993-1#1)(1994-6#1)(1995-8#1)(1996-6#1)(2005-10#1)(2006-12#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#2)(2009-6#1)(2009-7#4)(2009-9#2)(2010-3#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
representative sample##55##2##(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1993-1#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-6#1)(2005-10#1)(2006-12#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#2)(2007-8#2)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#2)(2009-6#1)(2009-7#4)(2009-9#2)(2010-3#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
representative samples of the##2##4##(2008-10#1)(2011-2#1)
representative samples of##5##3##(1991-9#1)(2008-10#1)(2009-5#1)(2011-2#1)(2012-11#1)
representative samples##9##2##(1991-9#1)(2008-10#1)(2008-3#2)(2009-12#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-11#1)
representative sigma##2##2##(1994-3#2)
representative species of##2##3##(2007-12#1)(2008-8#1)
representative strains##6##2##(2008-10#5)(2008-4#1)
representative survey##4##2##(2009-4#1)(2010-1#1)(2013-1#2)
representative surveys##3##2##(1992-1#1)(1993-1#1)(2011-2#1)
representative variables##3##2##(2007-8#3)
representative##415##1##(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#4)(1992-1#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-9#2)(1994-12#2)(1994-2#1)(1994-3#3)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#3)(1996-8#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#3)(2004-11#1)(2005-10#4)(2005-11#4)(2005-6#1)(2005-9#1)(2006-10#1)(2006-11#3)(2006-12#4)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#8)(2007-2#2)(2007-3#3)(2007-4#3)(2007-5#3)(2007-8#7)(2008-1#5)(2008-10#60)(2008-11#6)(2008-12#4)(2008-2#15)(2008-3#14)(2008-4#7)(2008-5#12)(2008-6#2)(2008-7#4)(2008-8#7)(2008-9#11)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#7)(2009-8#1)(2009-9#3)(2010-1#2)(2010-10#8)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#4)(2011-12#2)(2011-2#15)(2012-1#1)(2012-11#3)(2012-12#7)(2012-2#7)(2012-3#7)(2012-7#2)(2013-1#16)(2013-7#1)(2013-8#11)
representativeness of##5##2##(2008-4#1)(2009-11#2)(2010-2#1)(2011-2#1)
representativeness##6##1##(2008-4#1)(2009-11#3)(2010-2#1)(2011-2#1)
representatives and##5##2##(1991-12#1)(2008-4#1)(2009-12#1)(2010-3#1)(2012-12#1)
representatives are##2##2##(2008-7#2)
representatives at##3##2##(1994-3#1)(2008-11#1)(2012-12#1)
representatives from all##3##3##(2007-2#1)(2008-11#1)(2008-12#1)
representatives from both##2##3##(2008-10#1)(2008-5#1)
representatives from several##2##3##(2005-8#1)(2008-7#1)
representatives from the##4##3##(1997-6#1)(2005-8#1)(2008-1#2)
representatives from##20##2##(1996-1#1)(1996-12#1)(1996-2#1)(1997-6#1)(2004-10#1)(2005-7#1)(2005-8#3)(2005-9#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-1#1)
representatives in##3##2##(2006-2#1)(2008-4#1)(2013-1#1)
representatives of diverse##2##3##(1996-4#1)(2011-1#1)
representatives of the major##2##4##(2007-12#1)(2008-8#1)
representatives of the##9##3##(1991-9#1)(2007-11#1)(2007-12#3)(2008-8#2)(2011-2#2)
representatives of these genera##2##4##(2008-10#1)(2008-12#1)
representatives of these##4##3##(1996-6#1)(2008-10#1)(2008-12#1)(2013-1#1)
representatives of##45##2##(1991-6#1)(1991-9#1)(1992-7#1)(1994-1#2)(1994-3#2)(1995-6#1)(1996-1#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-7#1)(2005-8#3)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-6#1)(2008-8#3)(2011-1#1)(2011-12#2)(2011-2#3)(2012-2#1)(2013-1#1)
representatives were##2##2##(2007-12#1)(2008-5#1)
representatives##116##1##(1990-7#1)(1991-1#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-7#1)(1993-3#1)(1994-1#2)(1994-3#3)(1994-7#1)(1995-3#2)(1995-6#1)(1996-1#4)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#2)(2004-10#1)(2005-7#2)(2005-8#8)(2005-9#1)(2006-12#1)(2006-2#2)(2007-10#1)(2007-11#1)(2007-12#6)(2007-2#2)(2007-4#1)(2008-1#3)(2008-10#15)(2008-11#5)(2008-12#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#2)(2009-12#1)(2009-4#1)(2010-3#2)(2011-1#2)(2011-12#2)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#1)
representativity##2##1##(1995-4#1)(2004-11#1)
represented 37##3##2##(1992-1#1)(2006-10#1)(2008-5#1)
represented HEV71##2##2##(2013-8#2)
represented a major##2##3##(2006-10#1)(2006-4#1)
represented a minor##2##3##(1990-3#1)(2009-4#1)
represented a significant##2##3##(1994-2#1)(2008-11#1)
represented a##38##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1991-12#1)(1991-8#1)(1992-3#1)(1992-8#1)(1994-2#2)(1995-1#1)(1995-12#1)(1996-3#1)(1996-9#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-2#1)(2009-4#1)(2010-1#1)(2010-5#1)(2010-6#1)(2011-1#2)(2012-1#1)(2012-2#1)
represented about##7##2##(1990-12#1)(1991-11#1)(1992-4#1)(1996-2#1)(1997-8#1)(2008-10#1)(2009-8#1)
represented all##5##2##(1995-12#1)(2008-10#2)(2008-11#1)(2012-1#1)
represented an##3##2##(2008-4#1)(2010-8#1)(2012-12#1)
represented and##2##2##(1994-2#1)(2006-10#1)
represented another##2##2##(1991-10#1)(2009-6#1)
represented approximately##4##2##(1992-1#1)(1996-4#1)(2007-5#1)(2008-10#1)
represented as a##4##3##(1991-12#1)(1992-3#1)(2008-2#1)(2013-1#1)
represented as##15##2##(1991-12#1)(1992-3#1)(1993-3#1)(1996-2#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-6#1)(2008-9#1)(2009-5#1)(2013-1#1)
represented at least##2##3##(1990-1#1)(1995-10#1)
represented at the##3##3##(1991-9#1)(2008-3#1)(2008-8#1)
represented at##7##2##(1990-1#1)(1991-9#1)(1995-10#1)(2005-6#1)(2008-10#1)(2008-3#1)(2008-8#1)
represented by C##2##3##(2007-7#1)(2011-1#1)
represented by a single##3##4##(1990-7#1)(2008-10#2)
represented by a##30##3##(1990-12#1)(1990-7#1)(1993-1#1)(1995-12#1)(1996-5#1)(1997-8#1)(2005-11#1)(2007-1#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-2#5)(2008-3#1)(2008-4#2)(2008-6#1)(2010-8#1)(2011-1#1)(2012-1#2)(2013-7#1)
represented by an##5##3##(2006-2#1)(2008-11#1)(2008-2#1)(2011-3#1)(2012-2#1)
represented by four##2##3##(1990-8#1)(2006-10#1)
represented by the area##2##4##(2008-3#1)(2012-12#1)
represented by the##53##3##(1990-7#1)(1990-9#1)(1992-4#1)(1992-6#1)(1992-9#2)(1995-12#1)(1996-5#1)(2005-11#3)(2006-1#1)(2006-12#1)(2006-2#2)(2007-10#1)(2007-11#2)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-9#1)(2009-1#2)(2009-2#3)(2009-9#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
represented by these##2##3##(1992-2#1)(2007-4#1)
represented by three##2##3##(2007-12#1)(2008-10#1)
represented by##183##2##(1990-12#1)(1990-4#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-6#2)(1992-9#2)(1993-1#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-6#1)(1996-5#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#2)(2005-11#4)(2006-1#2)(2006-10#3)(2006-12#1)(2006-2#3)(2006-4#1)(2006-6#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#14)(2008-11#6)(2008-2#9)(2008-3#6)(2008-4#13)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#1)(2009-1#2)(2009-11#1)(2009-2#3)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-8#2)(2011-1#4)(2011-11#1)(2011-12#1)(2011-2#8)(2011-3#3)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#1)
represented different##2##2##(2008-5#1)(2011-1#1)
represented each of the##2##4##(2008-12#1)(2012-3#1)
represented each##3##2##(2008-10#1)(2008-12#1)(2012-3#1)
represented graphically##2##2##(2007-1#2)
represented in a##6##3##(1997-8#2)(2008-11#1)(2013-1#2)(2013-7#1)
represented in terms of##3##4##(2008-3#1)(2008-4#1)(2009-8#1)
represented in the form of##2##5##(2008-7#1)(2009-8#1)
represented in the##26##3##(1991-2#2)(1992-3#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-9#1)(1995-12#1)(2005-8#1)(2007-1#1)(2007-8#1)(2008-2#2)(2008-7#2)(2008-9#2)(2009-8#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#3)
represented in this##4##3##(1997-3#1)(2007-9#1)(2008-12#1)(2010-8#1)
represented in##62##2##(1991-2#2)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1997-3#1)(1997-8#2)(2005-8#1)(2007-1#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#3)(2008-9#3)(2009-8#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2013-1#10)(2013-7#1)
represented nearly##3##2##(1992-1#1)(2006-5#1)(2008-10#1)
represented on the##2##3##(2007-12#1)(2009-8#1)
represented on##3##2##(1992-6#1)(2007-12#1)(2009-8#1)
represented one of the most##2##5##(2008-5#1)(2008-7#1)
represented one##3##2##(2008-5#1)(2008-7#1)(2013-7#1)
represented only##3##2##(1993-8#1)(1994-8#1)(2007-12#1)
represented the best evidence on the topic##3##7##(2007-8#3)
represented the best evidence on the##5##6##(2007-8#5)
represented the best evidence on this topic##6##7##(2007-8#6)
represented the best evidence on##11##5##(2007-8#11)
represented the best evidence to answer the clinical question##9##9##(2007-8#9)
represented the best evidence to answer the##10##7##(2007-8#10)
represented the best evidence##22##4##(2007-8#22)
represented the main##2##3##(1994-2#1)(2008-11#1)
represented the major##4##3##(1992-6#1)(1994-2#2)(1995-3#1)
represented the most##4##3##(2008-10#2)(2009-5#1)(2011-1#1)
represented the single##2##3##(2005-12#1)(2009-6#1)
represented the##63##2##(1990-2#1)(1991-4#1)(1992-3#1)(1992-6#1)(1994-2#3)(1995-3#1)(1996-9#1)(1997-6#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-8#22)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-6#2)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
represented two##3##2##(1993-12#1)(2008-10#2)
represented unique##2##2##(2008-10#2)
represented using##2##2##(2010-9#1)(2013-1#1)
represented with##4##2##(1990-8#2)(2007-6#1)(2008-7#1)
represented##523##1##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#2)(1990-7#2)(1990-8#6)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#6)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#3)(1992-12#1)(1992-2#1)(1992-3#6)(1992-4#3)(1992-6#4)(1992-8#1)(1992-9#4)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#1)(1993-7#1)(1993-8#2)(1994-12#3)(1994-2#8)(1994-3#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#6)(1995-2#1)(1995-3#1)(1995-6#2)(1995-7#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-9#3)(1997-1#1)(1997-3#2)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#5)(2004-11#1)(2005-10#1)(2005-11#5)(2005-12#1)(2005-6#1)(2005-8#3)(2006-1#2)(2006-10#8)(2006-12#3)(2006-2#5)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#5)(2007-10#3)(2007-11#2)(2007-12#7)(2007-2#2)(2007-3#4)(2007-4#3)(2007-5#7)(2007-6#1)(2007-7#3)(2007-8#24)(2007-9#4)(2008-1#6)(2008-10#45)(2008-11#14)(2008-12#5)(2008-2#18)(2008-3#9)(2008-4#19)(2008-5#18)(2008-6#7)(2008-7#14)(2008-8#4)(2008-9#6)(2009-1#2)(2009-11#2)(2009-2#4)(2009-4#3)(2009-5#3)(2009-6#3)(2009-8#4)(2009-9#2)(2010-1#3)(2010-11#3)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#5)(2010-9#1)(2011-1#12)(2011-11#1)(2011-12#2)(2011-2#18)(2011-3#3)(2012-1#9)(2012-12#3)(2012-2#5)(2012-3#5)(2013-1#17)(2013-7#5)(2013-8#6)
representing &gt##2##2##(2012-12#1)(2012-2#1)
representing 1##4##2##(1996-8#1)(2005-9#1)(2006-12#1)(2008-6#1)
representing 11##4##2##(2007-12#1)(2008-7#1)(2010-4#1)(2011-12#1)
representing 2##3##2##(2006-9#1)(2008-10#2)
representing 23##2##2##(2005-7#1)(2007-3#1)
representing 56##2##2##(2008-10#1)(2009-9#1)
representing 92##2##2##(2008-11#1)(2008-12#1)
representing a complex##2##3##(2008-10#1)(2008-7#1)
representing a diverse##2##3##(2008-10#1)(2010-10#1)
representing a large##2##3##(1990-5#1)(2013-7#1)
representing a new##2##3##(2008-7#1)(2008-8#1)
representing a range of##4##4##(1995-11#1)(2008-10#2)(2009-9#1)
representing a##49##2##(1990-5#1)(1990-7#1)(1992-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-11#1)(1996-10#1)(1996-5#1)(2006-10#1)(2006-2#2)(2006-4#2)(2007-1#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
representing adducts##2##2##(1992-1#1)(1996-9#1)
representing all##6##2##(1992-2#1)(1995-1#1)(1996-6#1)(2008-10#1)(2010-3#1)(2012-3#1)
representing amino acids##2##3##(1992-11#1)(1995-11#1)
representing an##10##2##(1993-5#1)(1993-6#1)(2007-5#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#1)
representing and##2##2##(2008-7#1)(2011-2#1)
representing approximately##5##2##(2007-2#1)(2008-10#1)(2009-3#1)(2010-5#1)(2013-8#1)
representing both##2##2##(2008-4#1)(2009-3#1)
representing clinical##2##2##(1996-9#1)(2007-8#1)
representing different##9##2##(1995-11#1)(1997-4#3)(2006-2#1)(2007-5#1)(2008-10#1)(2008-8#1)(2013-1#1)
representing distinct##2##2##(1992-8#1)(2008-2#1)
representing five##2##2##(1993-9#1)(2008-10#1)
representing four different##2##3##(1992-7#1)(2008-10#1)
representing four##5##2##(1992-7#1)(1996-1#1)(2004-8#1)(2008-10#2)
representing health professionals from different specialties and interests in the field##2##11##(2013-1#2)
representing health##3##2##(1992-3#1)(2013-1#2)
representing highly##2##2##(1991-11#1)(2006-12#1)
representing more than##3##3##(2007-1#1)(2008-7#1)(2012-12#1)
representing more##5##2##(2006-3#1)(2007-1#1)(2008-10#1)(2008-7#1)(2012-12#1)
representing one##2##2##(1990-3#1)(2007-8#1)
representing only##7##2##(1997-8#1)(2005-8#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-1#1)(2013-1#1)
representing over##2##2##(1996-2#1)(2011-1#1)
representing possible##2##2##(1997-2#1)(2006-12#1)
representing sequences##2##2##(1991-12#1)(2007-11#1)
representing seven##2##2##(2008-5#1)(2010-11#1)
representing situations##4##2##(2013-1#4)
representing the 5'##2##3##(1990-11#1)(1995-3#1)
representing the central##2##3##(1991-12#1)(1996-12#1)
representing the diverse##2##3##(2009-5#1)(2009-7#1)
representing the first##3##3##(1993-11#1)(1995-3#1)(1996-5#1)
representing the known genetic and pathogenic diversity##2##7##(2008-10#2)
representing the known##3##3##(2008-10#3)
representing the main##2##3##(2008-10#1)(2013-1#1)
representing the patient##2##3##(2007-12#1)(2008-3#1)
representing the sequence##2##3##(1997-4#1)(2008-5#1)
representing the two##2##3##(2008-10#2)
representing the##105##2##(1990-11#1)(1991-12#1)(1991-5#1)(1992-1#2)(1992-11#1)(1992-6#1)(1992-9#2)(1993-11#2)(1993-5#2)(1993-6#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-3#2)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-3#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#17)(2008-11#1)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#2)(2009-11#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#3)
representing these##2##2##(1993-6#1)(2008-2#1)
representing three different##2##3##(1992-12#1)(2008-10#1)
representing three##4##2##(1992-12#1)(1993-3#1)(2008-10#2)
representing two##5##2##(1991-6#1)(1994-3#1)(2007-9#1)(2008-2#1)(2008-5#1)
representing unique##2##2##(2008-10#1)(2010-4#1)
representing various##5##2##(1992-3#1)(1993-8#1)(2008-10#2)(2010-11#1)
representing##439##1##(1990-11#2)(1990-3#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#5)(1992-11#4)(1992-12#5)(1992-2#1)(1992-3#3)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#3)(1993-10#1)(1993-11#2)(1993-3#2)(1993-5#3)(1993-6#3)(1993-8#1)(1993-9#1)(1994-12#4)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#2)(1995-1#2)(1995-10#2)(1995-11#4)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#2)(1996-9#3)(1997-2#3)(1997-3#1)(1997-4#4)(1997-6#3)(1997-7#1)(1997-8#4)(2004-4#1)(2004-8#1)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#3)(2006-12#4)(2006-2#3)(2006-3#2)(2006-4#3)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#5)(2007-11#4)(2007-12#7)(2007-2#3)(2007-3#2)(2007-4#4)(2007-5#4)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#64)(2008-11#3)(2008-12#3)(2008-2#13)(2008-3#9)(2008-4#7)(2008-5#13)(2008-6#2)(2008-7#13)(2008-8#6)(2008-9#7)(2009-10#2)(2009-11#5)(2009-3#3)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#2)(2010-10#2)(2010-11#3)(2010-12#4)(2010-2#2)(2010-3#4)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#6)(2013-1#29)(2013-7#3)(2013-8#10)
represents 1##2##2##(2007-10#1)(2012-3#1)
represents 98% of##2##3##(2006-10#1)(2008-2#1)
represents a candidate##2##3##(1993-8#1)(2008-8#1)
represents a challenge for the##3##5##(2008-2#1)(2012-11#1)(2012-12#1)
represents a challenge for##5##4##(2008-2#1)(2008-7#1)(2012-11#1)(2012-12#2)
represents a challenge##6##3##(1996-12#1)(2008-2#1)(2008-7#1)(2012-11#1)(2012-12#2)
represents a common##3##3##(2004-1#1)(2006-3#1)(2008-3#1)
represents a complex##5##3##(1994-11#1)(2007-2#1)(2008-1#1)(2008-2#1)(2009-10#1)
represents a condition##3##3##(2007-11#1)(2013-1#2)
represents a critical##3##3##(1996-11#1)(2007-4#1)(2008-4#1)
represents a difficult##2##3##(2005-12#1)(2006-10#1)
represents a first attempt##2##4##(2006-8#1)(2012-2#1)
represents a first##3##3##(2006-8#1)(2009-7#1)(2012-2#1)
represents a form of##3##4##(1993-3#1)(2009-11#1)(2009-9#1)
represents a fundamental##2##3##(2008-11#1)(2009-6#1)
represents a general##2##3##(1994-8#1)(1995-2#1)
represents a good##3##3##(1990-6#1)(1994-9#1)(2009-8#1)
represents a group of inherited disorders of phagocytic system##2##9##(2007-2#2)
represents a heterogeneous group of##2##5##(2007-2#1)(2009-5#1)
represents a key##7##3##(1990-8#1)(1991-7#1)(2007-12#1)(2008-3#1)(2008-9#1)(2009-10#1)(2011-12#1)
represents a limiting##2##3##(1994-11#1)(2008-11#1)
represents a major advance in the##2##6##(1993-11#1)(2008-5#1)
represents a major advance in##4##5##(1993-11#1)(1997-2#1)(2006-10#1)(2008-5#1)
represents a major cause of morbidity and mortality##2##8##(1991-12#1)(2010-4#1)
represents a major cause of##3##5##(1991-12#1)(2010-4#1)(2011-2#1)
represents a major challenge##2##4##(1991-1#1)(2008-7#1)
represents a major limitation to##2##5##(2008-11#1)(2008-6#1)
represents a major threat to##2##5##(1997-5#1)(2011-2#1)
represents a major##22##3##(1991-1#1)(1991-12#1)(1992-6#1)(1993-11#1)(1997-2#1)(1997-5#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-4#1)(2011-2#2)(2013-8#1)
represents a means##2##3##(1991-3#1)(2013-1#1)
represents a mechanism##3##3##(1993-3#1)(1995-2#1)(1996-12#1)
represents a medical##2##3##(1991-3#1)(2009-6#1)
represents a model##3##3##(1995-8#1)(1997-2#1)(2009-8#1)
represents a new and##2##4##(2006-5#1)(2008-10#1)
represents a new approach to##3##5##(1992-2#1)(2008-1#1)(2008-10#1)
represents a new approach##6##4##(1992-2#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-2#1)
represents a new class of##3##5##(1991-5#1)(1992-3#1)(2008-5#1)
represents a new painless##2##4##(2008-10#2)
represents a new type of##2##5##(1991-2#1)(2006-10#1)
represents a new##26##3##(1991-2#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-4#1)(2006-10#2)(2006-5#1)(2007-7#2)(2008-1#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-2#1)
represents a novel and##5##4##(2007-11#1)(2008-11#2)(2008-8#1)(2011-1#1)
represents a novel class of##2##5##(1996-11#1)(2005-7#1)
represents a novel##18##3##(1990-12#1)(1991-11#1)(1992-11#1)(1992-12#1)(1994-12#1)(1994-8#1)(1996-11#1)(1996-6#1)(2005-7#1)(2007-11#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-1#1)
represents a potential health##2##4##(2007-5#1)(2008-7#1)
represents a potential##8##3##(1991-12#1)(1993-5#1)(1993-8#1)(1995-3#1)(2007-5#1)(2008-4#1)(2008-7#1)(2013-1#1)
represents a potentially##3##3##(1994-5#1)(2008-10#1)(2008-5#1)
represents a powerful##2##3##(2008-11#1)(2012-3#1)
represents a previously##2##3##(1994-8#1)(2010-5#1)
represents a promising new##2##4##(2008-5#1)(2010-4#1)
represents a promising technique##2##4##(2008-3#1)(2010-3#1)
represents a promising therapeutic##3##4##(2012-12#2)(2013-1#1)
represents a promising##12##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
represents a residue##2##3##(2006-10#1)(2008-3#1)
represents a risk factor for##2##5##(2006-2#1)(2011-2#1)
represents a risk##3##3##(2006-2#1)(2007-9#1)(2011-2#1)
represents a safe and##3##4##(1995-11#1)(1995-8#1)(2007-8#1)
represents a safe##4##3##(1995-11#1)(1995-8#1)(2007-8#1)(2008-3#1)
represents a second##2##3##(1994-12#1)(2009-3#1)
represents a serious problem for##2##5##(2011-2#1)(2012-12#1)
represents a serious problem##3##4##(2010-9#1)(2011-2#1)(2012-12#1)
represents a serious##6##3##(1995-10#1)(2008-10#1)(2010-9#1)(2011-2#1)(2012-12#2)
represents a significant advancement##2##4##(2008-10#1)(2008-6#1)
represents a significant drop##2##4##(1994-6#2)
represents a significant improvement in##2##5##(1990-2#1)(2008-11#1)
represents a significant improvement##4##4##(1990-2#1)(2006-11#1)(2008-11#1)(2010-5#1)
represents a significant##22##3##(1990-2#1)(1991-11#1)(1991-2#1)(1991-3#1)(1994-6#2)(1995-3#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2010-5#1)(2012-2#1)
represents a simple and powerful##2##5##(1994-9#1)(1996-8#1)
represents a simple##7##3##(1994-2#1)(1994-9#1)(1996-11#1)(1996-8#1)(2008-10#1)(2008-3#1)(2008-4#1)
represents a small##3##3##(1990-2#1)(1997-7#1)(2010-2#1)
represents a special##3##3##(2008-10#1)(2008-4#1)(2010-4#1)
represents a stable##2##3##(2008-2#1)(2008-5#1)
represents a unique opportunity##2##4##(1990-4#1)(2006-10#1)
represents a unique##13##3##(1990-4#1)(1992-6#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-8#2)(2009-7#1)(2009-8#1)(2010-12#2)(2013-7#1)(2013-8#1)
represents a useful model for##2##5##(1995-12#1)(2008-10#1)
represents a useful model##3##4##(1994-12#1)(1995-12#1)(2008-10#1)
represents a useful##8##3##(1994-12#1)(1995-12#1)(2007-3#1)(2008-10#1)(2009-10#1)(2010-11#1)(2010-12#1)(2012-1#1)
represents a valid alternative for the determination of##2##8##(2008-10#2)
represents a valid alternative##4##4##(1992-6#1)(2008-10#2)(2008-3#1)
represents a valid##6##3##(1990-3#1)(1992-6#1)(2006-6#1)(2008-10#2)(2008-3#1)
represents a valuable##6##3##(1990-2#1)(2006-3#1)(2007-7#1)(2008-11#1)(2009-1#1)(2012-3#1)
represents a very##3##3##(1991-9#1)(2008-9#1)(2012-2#1)
represents a viable##3##3##(1992-2#1)(2008-11#1)(2013-1#1)
represents a##422##2##(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#2)(1990-6#1)(1990-8#3)(1991-1#2)(1991-11#3)(1991-12#3)(1991-2#3)(1991-3#3)(1991-5#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#1)(1992-4#1)(1992-6#4)(1993-11#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#2)(1994-11#3)(1994-12#5)(1994-2#2)(1994-5#1)(1994-6#3)(1994-8#3)(1994-9#3)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#5)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#3)(1996-2#1)(1996-4#1)(1996-6#2)(1996-7#4)(1996-8#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#1)(2004-1#1)(2004-12#1)(2005-10#3)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#11)(2006-11#2)(2006-12#3)(2006-2#1)(2006-3#2)(2006-5#4)(2006-6#2)(2006-8#2)(2006-9#1)(2007-1#2)(2007-11#5)(2007-12#7)(2007-2#4)(2007-3#1)(2007-4#3)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#6)(2007-9#4)(2008-1#9)(2008-10#24)(2008-11#16)(2008-2#9)(2008-3#10)(2008-4#8)(2008-5#13)(2008-6#3)(2008-7#14)(2008-8#7)(2008-9#5)(2009-1#1)(2009-10#4)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#4)(2009-7#2)(2009-8#4)(2009-9#2)(2010-11#2)(2010-12#9)(2010-2#1)(2010-3#2)(2010-4#6)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#3)(2011-1#7)(2011-12#1)(2011-2#15)(2012-1#3)(2012-11#2)(2012-12#9)(2012-2#6)(2012-3#4)(2012-4#1)(2013-1#11)(2013-7#1)(2013-8#3)
represents about##4##2##(1990-9#1)(1991-9#1)(1995-11#1)(2008-8#1)
represents an active problem for medical natural language processing (NLP) systems##2##11##(2013-1#2)
represents an additional##3##3##(2007-1#1)(2008-4#1)(2011-2#1)
represents an advanced##2##3##(1991-6#1)(1996-10#1)
represents an alternative to the##4##5##(1993-10#1)(2008-3#1)(2009-3#1)(2009-6#1)
represents an alternative to##6##4##(1993-10#1)(2006-12#1)(2008-3#1)(2008-4#1)(2009-3#1)(2009-6#1)
represents an alternative##10##3##(1993-10#1)(1993-9#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-3#1)(2009-6#1)(2012-12#1)
represents an approach##2##3##(1995-2#1)(2008-10#1)
represents an attractive target for##3##5##(1995-2#1)(2008-11#1)(2011-2#1)
represents an attractive##5##3##(1995-2#1)(1997-3#1)(2007-5#1)(2008-11#1)(2011-2#1)
represents an early##2##3##(2008-1#1)(2011-12#1)
represents an easy##2##3##(1990-5#1)(1997-7#1)
represents an economic##2##3##(1994-12#1)(2011-2#1)
represents an emerging##3##3##(2008-12#1)(2009-6#1)(2010-12#1)
represents an example of##2##4##(2008-10#1)(2008-3#1)
represents an excellent##2##3##(2007-11#1)(2008-3#1)
represents an exciting new##2##4##(2007-4#1)(2008-4#1)
represents an exciting##5##3##(2007-4#1)(2008-4#1)(2009-5#1)(2009-8#1)(2010-2#1)
represents an extremely##2##3##(2005-8#1)(2008-9#1)
represents an ideal##2##3##(2007-2#1)(2012-3#1)
represents an important pathway for##2##5##(2007-11#1)(2010-9#1)
represents an important step toward##2##5##(2007-7#1)(2012-2#1)
represents an important step##3##4##(2007-7#1)(2010-11#1)(2012-2#1)
represents an important##23##3##(1994-5#1)(1995-12#2)(1996-1#1)(1996-9#1)(2004-3#1)(2005-5#1)(2006-2#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-11#1)(2010-9#1)(2012-2#2)(2013-7#1)
represents an increase of##2##4##(2005-10#1)(2008-11#1)
represents an increase##3##3##(2005-10#1)(2007-11#1)(2008-11#1)
represents an independent##2##3##(2007-12#1)(2009-12#1)
represents an initial##2##3##(2007-2#1)(2008-10#1)
represents an innovative##2##3##(2008-3#1)(2009-4#1)
represents an integration##2##3##(1994-11#1)(1997-5#1)
represents an interesting##7##3##(1993-12#1)(2008-11#1)(2010-10#1)(2010-11#1)(2010-7#1)(2010-8#1)(2012-11#1)
represents an unusual##2##3##(2006-9#1)(2008-6#1)
represents an##134##2##(1990-5#1)(1991-2#1)(1991-6#2)(1992-10#1)(1992-11#2)(1992-3#2)(1992-8#1)(1993-10#1)(1993-12#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-12#3)(1995-2#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#2)(2004-3#2)(2005-10#1)(2005-5#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#4)(2007-2#4)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#6)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#3)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-1#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#3)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#1)
represents another##2##2##(2007-8#1)(2012-2#1)
represents higher##2##2##(2011-2#1)(2013-1#1)
represents more##2##2##(1994-12#1)(2007-12#1)
represents one of the few examples in##2##7##(1990-3#1)(2009-6#1)
represents one of the main##3##5##(2007-5#1)(2011-1#1)(2012-1#1)
represents one of the most difficult##3##6##(2007-7#1)(2011-2#1)(2012-2#1)
represents one of the most important##5##6##(1995-1#1)(2005-8#1)(2006-10#1)(2007-4#1)(2008-10#1)
represents one of the most##11##5##(1995-1#1)(2005-8#1)(2006-10#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-5#1)(2010-8#1)(2011-2#1)(2012-2#1)
represents one of the##26##4##(1990-3#1)(1994-12#1)(1995-1#1)(1995-10#1)(2005-8#1)(2006-10#2)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
represents one of##27##3##(1990-3#1)(1994-12#1)(1995-1#1)(1995-10#1)(2005-8#1)(2006-10#2)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-8#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
represents one##30##2##(1990-3#1)(1992-8#1)(1994-12#1)(1995-1#1)(1995-10#1)(2005-8#2)(2006-10#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-8#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
represents only a small##3##4##(1993-6#1)(2007-11#1)(2008-8#1)
represents only a##5##3##(1993-6#1)(2007-11#1)(2008-8#2)(2011-1#1)
represents only one##2##3##(1997-5#1)(2008-3#1)
represents only##9##2##(1993-6#1)(1997-5#1)(2007-11#1)(2007-3#1)(2008-11#1)(2008-3#1)(2008-8#2)(2011-1#1)
represents substantial##2##2##(2005-8#1)(2008-12#1)
represents that##2##2##(1990-8#1)(1992-3#1)
represents the best##5##3##(1990-5#1)(1997-7#1)(2005-6#1)(2008-1#1)(2008-8#1)
represents the final##2##3##(1993-10#1)(1997-4#1)
represents the first case##2##4##(2008-4#1)(2010-5#1)
represents the first demonstration##2##4##(1993-9#1)(1994-9#1)
represents the first description of##2##5##(2008-5#1)(2009-3#1)
represents the first evidence of##2##5##(1992-8#1)(2008-9#1)
represents the first evidence##3##4##(1992-8#1)(2008-9#1)(2013-8#1)
represents the first example of##2##5##(1995-2#1)(2008-10#1)
represents the first report of##3##5##(2008-10#1)(2008-5#1)(2009-7#1)
represents the first report##5##4##(2008-10#2)(2008-5#1)(2009-7#1)(2012-2#1)
represents the first reported##2##4##(1991-7#1)(1996-3#1)
represents the first##43##3##(1990-10#1)(1991-3#1)(1991-7#1)(1992-8#1)(1993-2#1)(1993-9#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-3#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-2#1)(2008-1#2)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-3#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#2)
represents the folding of##2##4##(1995-4#2)
represents the highest##5##3##(1996-9#1)(1997-2#1)(2006-10#1)(2008-2#2)
represents the last##2##3##(1994-3#1)(2011-3#1)
represents the main##4##3##(2007-9#1)(2008-1#1)(2008-11#1)(2012-12#1)
represents the major##4##3##(1991-10#1)(2008-10#1)(2008-7#1)(2012-12#1)
represents the most common##3##4##(2008-5#1)(2011-2#1)(2012-12#1)
represents the most frequent##3##4##(2012-12#1)(2012-2#1)(2013-1#1)
represents the most important##3##4##(1993-10#1)(2010-9#1)(2012-2#1)
represents the most likely##2##4##(2005-7#1)(2008-10#1)
represents the most##19##3##(1993-10#1)(1993-3#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-6#1)(2008-10#1)(2008-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#1)
represents the opportunity to##2##4##(2010-12#1)(2012-11#1)
represents the primary##2##3##(1990-2#1)(1996-9#1)
represents the ratio##2##3##(2005-11#1)(2008-10#1)
represents the second most common##2##5##(2007-4#1)(2008-6#1)
represents the second##3##3##(1994-12#1)(2007-4#1)(2008-6#1)
represents the slope##2##3##(2008-10#1)(2008-2#1)
represents the source of##2##4##(2007-8#1)(2008-1#1)
represents the typical##2##3##(2008-10#1)(2008-7#1)
represents the##217##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-7#2)(1991-9#1)(1992-10#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#2)(1993-11#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-7#1)(1993-9#2)(1994-12#1)(1994-3#3)(1994-4#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-4#2)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-10#1)(2005-11#4)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#8)(2006-6#3)(2007-10#1)(2007-11#3)(2007-12#7)(2007-2#2)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#7)(2008-10#20)(2008-11#3)(2008-12#1)(2008-2#9)(2008-3#5)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#3)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#2)(2009-7#3)(2010-12#3)(2010-3#1)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#7)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#3)
represents value##2##2##(1994-3#1)(2011-2#1)
represents##926##1##(1990-10#1)(1990-12#2)(1990-2#5)(1990-3#2)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#5)(1990-9#1)(1991-1#3)(1991-10#1)(1991-11#3)(1991-12#4)(1991-2#7)(1991-3#6)(1991-5#4)(1991-6#2)(1991-7#4)(1991-9#5)(1992-1#1)(1992-10#2)(1992-11#4)(1992-12#2)(1992-2#4)(1992-3#4)(1992-4#1)(1992-6#4)(1992-7#2)(1992-8#3)(1992-9#2)(1993-10#3)(1993-11#3)(1993-12#1)(1993-2#3)(1993-3#3)(1993-5#2)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#3)(1994-11#6)(1994-12#10)(1994-2#3)(1994-3#4)(1994-4#1)(1994-5#2)(1994-6#5)(1994-7#1)(1994-8#4)(1994-9#5)(1995-1#3)(1995-10#3)(1995-11#3)(1995-12#5)(1995-2#11)(1995-3#4)(1995-4#2)(1995-5#2)(1995-6#4)(1995-8#6)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#3)(1996-12#4)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#3)(1996-7#5)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#7)(1997-3#4)(1997-4#3)(1997-5#5)(1997-6#1)(1997-7#5)(1997-8#4)(2004-1#1)(2004-12#1)(2004-3#2)(2005-10#5)(2005-11#4)(2005-12#1)(2005-5#1)(2005-6#1)(2005-7#2)(2005-8#6)(2006-10#24)(2006-11#2)(2006-12#4)(2006-2#3)(2006-3#2)(2006-5#4)(2006-6#6)(2006-8#3)(2006-9#2)(2007-1#3)(2007-10#3)(2007-11#17)(2007-12#21)(2007-2#10)(2007-3#2)(2007-4#6)(2007-5#6)(2007-6#2)(2007-7#6)(2007-8#8)(2007-9#6)(2008-1#20)(2008-10#60)(2008-11#24)(2008-12#5)(2008-2#22)(2008-3#22)(2008-4#14)(2008-5#22)(2008-6#10)(2008-7#23)(2008-8#18)(2008-9#12)(2009-1#3)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#4)(2009-4#4)(2009-5#5)(2009-6#10)(2009-7#6)(2009-8#6)(2009-9#2)(2010-10#1)(2010-11#5)(2010-12#17)(2010-2#6)(2010-3#4)(2010-4#7)(2010-5#5)(2010-6#3)(2010-7#3)(2010-8#5)(2010-9#5)(2011-1#14)(2011-12#3)(2011-2#31)(2011-3#1)(2012-1#6)(2012-11#4)(2012-12#17)(2012-2#18)(2012-3#11)(2012-4#1)(2013-1#25)(2013-7#2)(2013-8#7)
repress expression of##3##3##(1997-1#1)(2009-3#1)(2012-12#1)
repress expression##4##2##(1991-11#1)(1997-1#1)(2009-3#1)(2012-12#1)
repress gene expression##2##3##(2008-4#1)(2013-1#1)
repress the##11##2##(1990-11#1)(1992-12#1)(1996-10#1)(1997-4#1)(2007-5#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-1#1)(2013-7#1)
repress transcription##3##2##(1991-5#1)(1993-2#1)(2008-4#1)
repress##31##1##(1990-11#1)(1991-11#1)(1991-5#1)(1992-12#1)(1993-2#1)(1993-9#1)(1996-1#1)(1996-10#1)(1996-7#1)(1997-1#1)(1997-4#2)(2006-12#1)(2007-12#2)(2007-5#1)(2008-11#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-1#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
repressed and inhibited##2##3##(2008-5#2)
repressed and##3##2##(2008-5#2)(2012-12#1)
repressed by glucose##3##3##(1990-1#1)(1995-8#1)(2005-12#1)
repressed by the##2##3##(1990-3#1)(1995-6#1)
repressed by##18##2##(1990-1#1)(1990-3#2)(1992-11#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-3#1)(2005-12#1)(2006-12#1)(2008-3#1)(2008-9#1)(2012-2#1)
repressed expression after pathogen infection##2##5##(2008-9#2)
repressed expression##3##2##(2008-9#2)(2009-10#1)
repressed in the##2##3##(1990-5#1)(1994-12#1)
repressed in##12##2##(1990-5#2)(1991-9#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1996-11#1)(1997-7#1)(2007-11#1)(2008-11#1)
repressed the expression of##2##4##(1993-6#1)(2008-11#1)
repressed the##5##2##(1993-12#1)(1993-6#1)(1996-4#1)(2008-11#1)(2011-2#1)
repressed upon##2##2##(2008-11#1)(2009-8#1)
repressed##72##1##(1990-1#1)(1990-11#1)(1990-3#2)(1990-4#1)(1990-5#2)(1991-1#1)(1991-10#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-4#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-8#2)(1994-9#2)(1995-3#1)(1995-6#2)(1995-8#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-4#3)(1997-7#2)(2005-11#1)(2005-12#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#4)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-4#1)(2009-8#2)(2011-2#1)(2012-12#2)(2012-2#1)
represses the##6##2##(1991-10#1)(1996-4#1)(2008-10#1)(2009-8#2)(2013-1#1)
represses transcription from##3##3##(1996-11#2)(1996-8#1)
represses transcription of a##2##4##(1996-8#1)(2011-1#1)
represses transcription of##3##3##(1995-3#1)(1996-8#1)(2011-1#1)
represses transcription##8##2##(1994-6#1)(1995-3#1)(1996-11#2)(1996-8#2)(2008-11#1)(2011-1#1)
represses##35##1##(1991-10#1)(1991-12#1)(1992-5#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-10#1)(1996-11#2)(1996-4#1)(1996-8#2)(1997-8#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-8#4)(2010-10#1)(2011-1#3)(2012-2#1)(2012-3#1)(2013-1#3)
repressible systems##3##2##(1997-2#3)
repressible##8##1##(1991-2#1)(1991-8#1)(1993-12#1)(1995-3#1)(1997-2#3)(1997-7#1)
repressing genes##2##2##(2008-11#1)(2009-8#1)
repressing the expression of##2##4##(1995-11#1)(2008-11#1)
repressing the##3##2##(1995-11#1)(2008-11#1)(2011-2#1)
repressing##11##1##(1993-3#1)(1995-11#1)(1997-3#1)(2008-11#2)(2009-8#1)(2011-2#2)(2012-12#2)(2013-1#1)
repression activity of##2##3##(1996-2#2)
repression activity##3##2##(1996-2#3)
repression and induction##2##3##(1993-11#1)(1994-2#1)
repression and##4##2##(1993-11#1)(1994-2#2)(2013-1#1)
repression by glucose##4##3##(1990-12#1)(1991-8#1)(1993-12#1)(1994-12#1)
repression by the##2##3##(1994-2#1)(1996-4#1)
repression by##14##2##(1990-12#1)(1991-8#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-3#3)(1995-6#1)(1996-11#1)(1996-4#1)(1997-1#1)(2008-10#2)
repression domain##2##2##(1996-10#1)(2006-12#1)
repression function##2##2##(1991-10#1)(1994-6#1)
repression in##6##2##(1990-10#1)(1991-7#1)(1994-12#1)(1994-9#1)(2012-12#2)
repression is relieved##2##3##(1995-8#1)(1997-7#1)
repression is##3##2##(1995-8#1)(1997-7#1)(2007-10#1)
repression mediated by##2##3##(1991-10#1)(1994-9#1)
repression of 3' alpha##2##4##(1996-4#2)
repression of c-fos gene##2##4##(1994-11#2)
repression of cwINV##2##3##(2009-8#2)
repression of fabA transcription##2##4##(1992-8#2)
repression of metE expression##2##4##(1992-1#2)
repression of the expression of##2##5##(1995-12#2)
repression of the##12##3##(1990-8#1)(1991-10#1)(1993-5#1)(1994-9#1)(1995-12#2)(1995-3#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-12#1)
repression of transcription##2##3##(1996-11#1)(2007-12#1)
repression of##65##2##(1990-5#1)(1990-8#1)(1991-10#1)(1991-6#1)(1992-1#3)(1992-8#3)(1993-12#1)(1993-5#1)(1994-11#3)(1994-12#3)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-11#2)(1996-3#1)(1996-4#4)(1997-1#2)(1997-5#1)(1997-8#1)(2006-3#1)(2007-12#3)(2008-1#2)(2008-10#4)(2008-11#2)(2008-7#1)(2008-9#1)(2009-8#4)(2009-9#1)(2011-2#3)(2012-12#3)
repression that##2##2##(1994-11#1)(2008-10#1)
repression were##2##2##(1994-2#1)(2012-3#1)
repression##159##1##(1990-10#1)(1990-12#1)(1990-5#2)(1990-8#1)(1991-10#3)(1991-6#3)(1991-7#2)(1991-8#1)(1992-1#5)(1992-11#1)(1992-8#4)(1993-11#1)(1993-12#3)(1993-5#1)(1994-11#4)(1994-12#6)(1994-2#5)(1994-5#2)(1994-6#3)(1994-9#5)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#7)(1995-6#4)(1995-8#3)(1996-10#1)(1996-11#5)(1996-2#4)(1996-3#2)(1996-4#7)(1996-5#2)(1996-6#1)(1996-7#2)(1997-1#4)(1997-5#2)(1997-7#1)(1997-8#1)(2006-12#2)(2006-3#1)(2006-7#1)(2007-10#1)(2007-12#4)(2008-1#2)(2008-10#11)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-8#4)(2009-9#1)(2011-2#6)(2012-12#7)(2012-3#3)(2013-1#2)(2013-8#2)
repressive activity##2##2##(1992-6#1)(2008-4#1)
repressive and##3##2##(1994-8#1)(2009-7#2)
repressive##13##1##(1990-6#1)(1991-5#1)(1992-6#1)(1994-8#4)(1996-5#2)(2008-4#1)(2009-7#2)(2012-2#1)
repressor and activator##2##3##(2012-3#2)
repressor and its##2##3##(1991-6#1)(1992-6#1)
repressor and##10##2##(1990-11#1)(1990-5#1)(1991-5#1)(1991-6#1)(1992-6#2)(2007-10#1)(2010-4#1)(2012-3#2)
repressor binding site##2##3##(1990-9#1)(1994-9#1)
repressor binding##6##2##(1990-4#2)(1990-9#1)(1991-6#1)(1994-9#1)(1995-8#1)
repressor complexes##2##2##(2008-7#2)
repressor gene##2##2##(1990-11#1)(1997-1#1)
repressor in##2##2##(1990-9#1)(1996-6#1)
repressor is##4##2##(1995-1#1)(1995-2#1)(1995-3#1)(1996-2#1)
repressor mutant##2##2##(1995-1#1)(1995-3#1)
repressor of##12##2##(1991-10#2)(1992-8#1)(1995-2#2)(1996-5#1)(1997-1#1)(1997-4#1)(2007-12#1)(2009-8#1)(2010-8#1)(2011-2#1)
repressor protein##9##2##(1990-11#1)(1990-9#1)(1994-3#1)(1994-9#3)(1995-8#1)(2008-9#2)
repressor proteins##2##2##(1991-12#1)(1994-6#1)
repressor provides##2##2##(1991-6#1)(1992-8#1)
repressor region##2##2##(1992-11#2)
repressor that##3##2##(1993-6#1)(1995-8#2)
repressor to its##2##3##(2008-11#1)(2008-8#1)
repressor to##3##2##(1995-3#1)(2008-11#1)(2008-8#1)
repressor with##3##2##(1992-6#1)(1995-8#1)(1997-1#1)
repressor##143##1##(1990-11#5)(1990-4#5)(1990-5#3)(1990-9#4)(1991-10#3)(1991-12#2)(1991-5#1)(1991-6#6)(1991-7#1)(1991-8#1)(1992-1#3)(1992-11#2)(1992-4#5)(1992-6#5)(1992-8#4)(1993-11#2)(1993-6#1)(1993-7#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#7)(1995-1#3)(1995-11#1)(1995-2#3)(1995-3#6)(1995-6#1)(1995-8#11)(1996-11#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#6)(1997-1#5)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(2006-12#2)(2007-10#1)(2007-11#2)(2007-12#2)(2008-11#2)(2008-7#3)(2008-8#7)(2008-9#2)(2009-6#1)(2009-8#2)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)
repressor's##2##1##(1995-8#2)
repressor)##2##1##(1995-4#1)(1996-2#1)
repressor-operator##2##1##(1990-4#1)(1994-7#1)
repressor/operator##3##1##(1990-5#1)(1994-3#2)
repressors and##2##2##(1990-11#1)(1990-5#1)
repressors in##2##2##(1991-11#1)(2008-10#1)
repressors of##2##2##(1994-9#1)(2009-8#1)
repressors##16##1##(1990-11#1)(1990-5#1)(1991-11#1)(1991-5#1)(1992-4#1)(1994-9#3)(1995-2#1)(1996-2#1)(1996-8#1)(1997-3#1)(2006-12#1)(2007-12#1)(2008-10#1)(2009-8#1)
reprieve##2##1##(1992-10#1)(2007-9#1)
reprint##2##1##(1991-3#2)
reprinted from##3##2##(1993-1#1)(1995-1#1)(1995-2#1)
reprinted here##9##2##(2007-2#8)(2008-9#1)
reprinted in##3##2##(1994-12#1)(1995-2#1)(1996-2#1)
reprinted##17##1##(1993-1#1)(1994-12#1)(1995-1#1)(1995-2#3)(1996-2#1)(2007-2#8)(2008-1#1)(2008-9#1)
reprobed##3##1##(1992-8#1)(2008-2#1)(2008-4#1)
reprobing##2##1##(2008-4#2)
reprocessing of##2##2##(2008-3#1)(2011-2#1)
reprocessing##12##1##(1995-2#1)(2004-9#1)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-3#1)(2010-5#1)(2011-2#2)
reproduce by##2##2##(1994-6#1)(2008-8#1)
reproduce in##5##2##(2004-4#1)(2006-10#1)(2008-10#1)(2010-8#1)(2013-8#1)
reproduce our##2##2##(2008-10#1)(2008-3#1)
reproduce the behavior##2##3##(2008-11#1)(2008-8#1)
reproduce the effects of##2##4##(1995-5#1)(2012-1#1)
reproduce the experimental##3##3##(1993-11#1)(2008-11#1)(2008-12#1)
reproduce the##46##2##(1993-11#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-7#2)(2005-4#2)(2006-10#1)(2006-4#1)(2007-1#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#4)(2008-5#1)(2008-8#2)(2008-9#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#3)(2013-1#1)(2013-8#1)
reproduce this##5##2##(1996-12#1)(2006-4#1)(2007-8#1)(2008-3#1)(2008-9#1)
reproduce##112##1##(1991-10#1)(1991-5#1)(1992-1#1)(1992-10#1)(1992-7#1)(1992-9#2)(1993-11#3)(1994-6#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#2)(1997-2#1)(1997-4#1)(1997-7#2)(2004-4#1)(2005-10#1)(2005-4#2)(2005-9#1)(2006-10#2)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-3#3)(2007-4#4)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#8)(2008-11#7)(2008-12#1)(2008-2#5)(2008-3#7)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#8)(2008-9#5)(2009-11#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-6#1)(2010-8#2)(2011-2#1)(2012-1#3)(2013-1#1)(2013-7#1)(2013-8#4)
reproduced and##3##2##(2008-10#1)(2008-8#1)(2010-12#1)
reproduced by a##4##3##(1990-2#2)(2006-3#1)(2009-4#1)
reproduced by the##5##3##(2005-11#1)(2006-8#1)(2008-10#1)(2009-8#1)(2010-12#1)
reproduced by##23##2##(1990-2#2)(1990-6#1)(1991-1#1)(1995-1#1)(2005-11#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#2)(2008-2#1)(2008-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-12#1)
reproduced for##2##2##(2007-1#1)(2008-10#1)
reproduced from##2##2##(2007-4#1)(2008-3#1)
reproduced in a##2##3##(1990-11#1)(2012-3#1)
reproduced in the##2##3##(2007-9#1)(2008-3#1)
reproduced in vitro##6##3##(1990-6#1)(1991-5#1)(1992-11#1)(1997-7#1)(2008-11#1)(2008-5#1)
reproduced in##19##2##(1990-11#1)(1990-6#1)(1991-5#1)(1991-9#1)(1992-11#1)(1997-7#1)(1997-8#1)(2007-1#1)(2007-5#2)(2007-9#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2011-2#1)(2012-3#1)
reproduced on the##2##3##(2008-10#2)
reproduced the##10##2##(1990-7#1)(1994-6#1)(1995-7#1)(2006-10#1)(2006-12#1)(2008-2#1)(2008-4#1)(2010-10#1)(2010-2#1)(2011-2#1)
reproduced using##2##2##(1994-12#1)(2006-6#1)
reproduced when##2##2##(2008-10#1)(2011-2#1)
reproduced with a##4##3##(1991-8#1)(1992-3#1)(2008-10#1)(2008-2#1)
reproduced with##8##2##(1991-8#1)(1992-3#1)(1997-4#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-2#1)
reproduced within##2##2##(1996-6#1)(2006-11#1)
reproduced##102##1##(1990-11#2)(1990-2#2)(1990-6#2)(1990-7#1)(1991-1#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-7#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-4#1)(1997-7#2)(1997-8#1)(2004-12#1)(2005-11#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-1#3)(2007-11#1)(2007-12#5)(2007-4#2)(2007-5#2)(2007-8#2)(2007-9#1)(2008-10#13)(2008-11#3)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-9#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
reproduces all##2##2##(2008-10#1)(2013-7#1)
reproduces at##2##2##(2008-10#1)(2008-8#1)
reproduces the in vivo##2##4##(1995-3#1)(2008-5#1)
reproduces the##8##2##(1995-3#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-5#1)(2012-1#1)(2012-2#1)
reproduces##21##1##(1995-2#1)(1995-3#1)(1997-3#1)(1997-7#1)(2007-12#2)(2007-5#1)(2008-10#5)(2008-2#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-7#1)
reproducibilities and##2##2##(1997-5#1)(2008-10#1)
reproducibilities##6##1##(1993-2#1)(1997-5#1)(2008-10#4)
reproducibility ( approximately##2##3##(2008-10#2)
reproducibility (0##2##2##(2008-10#2)
reproducibility (R##8##2##(2007-8#6)(2008-10#2)
reproducibility (S##4##2##(2008-10#4)
reproducibility (coefficient##2##2##(2007-8#1)(2008-10#1)
reproducibility (n=5) of##2##3##(2008-10#2)
reproducibility and a##2##3##(2006-8#1)(2008-10#1)
reproducibility and accuracy of##3##4##(1991-3#1)(2008-10#2)
reproducibility and accuracy##6##3##(1991-3#1)(2005-12#1)(2008-10#3)(2013-1#1)
reproducibility and detection##2##3##(2008-10#2)
reproducibility and good##2##3##(2007-8#2)
reproducibility and high##2##3##(2008-10#2)
reproducibility and lifetime##3##3##(2008-10#3)
reproducibility and recovery##2##3##(2008-10#1)(2012-1#1)
reproducibility and reliability of##4##4##(2008-10#3)(2008-11#1)
reproducibility and reliability##7##3##(2005-12#1)(2008-10#3)(2008-11#1)(2013-1#2)
reproducibility and sensitivity##2##3##(2008-5#1)(2013-8#1)
reproducibility and the##2##3##(2008-10#2)
reproducibility and##56##2##(1990-12#1)(1991-3#1)(1997-8#1)(2005-12#2)(2006-11#2)(2006-12#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#24)(2008-11#2)(2008-5#3)(2009-11#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#4)(2013-8#3)
reproducibility are##3##2##(1991-5#1)(2008-10#2)
reproducibility between##4##2##(2008-10#4)
reproducibility for the##2##3##(2008-10#2)
reproducibility for##6##2##(2007-8#1)(2008-10#4)(2010-9#1)
reproducibility in the##3##3##(2007-10#1)(2008-10#1)(2008-11#1)
reproducibility in##5##2##(2004-11#1)(2007-10#1)(2008-10#1)(2008-11#1)(2009-1#1)
reproducibility is around##2##3##(2008-10#2)
reproducibility is##12##2##(1992-1#1)(1997-2#1)(2004-4#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-5#1)
reproducibility obtained##2##2##(2008-10#2)
reproducibility of 0##2##3##(2008-2#1)(2008-3#1)
reproducibility of 1##4##3##(2008-10#4)
reproducibility of different##2##3##(2008-10#2)
reproducibility of the assay##4##4##(2007-8#1)(2008-10#2)(2013-8#1)
reproducibility of the method##10##4##(1991-5#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2010-7#2)
reproducibility of the results##5##4##(1996-12#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-8#1)
reproducibility of the system##3##4##(2007-11#1)(2008-10#1)(2008-2#1)
reproducibility of the tumor position##2##5##(2009-11#2)
reproducibility of the##60##3##(1991-5#1)(1993-10#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-12#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-8#3)(2008-1#1)(2008-10#20)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#2)(2009-2#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-7#2)(2012-12#1)(2012-2#1)(2013-8#1)
reproducibility of these##3##3##(1993-12#1)(2008-10#1)(2012-2#1)
reproducibility of this##3##3##(1994-3#1)(2007-5#1)(2008-11#1)
reproducibility of##118##2##(1991-11#1)(1991-5#1)(1992-4#1)(1992-5#1)(1993-10#1)(1993-12#1)(1994-3#1)(1994-4#3)(1994-9#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-12#2)(2005-7#1)(2006-5#1)(2007-10#2)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#40)(2008-11#3)(2008-12#2)(2008-2#6)(2008-3#3)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#2)(2009-2#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
reproducibility standard deviation) to that provided by the AOAC 920##2##10##(2008-10#2)
reproducibility than##3##2##(2006-11#1)(2007-7#1)(2008-4#1)
reproducibility to##3##2##(2008-10#2)(2008-2#1)
reproducibility was achieved with the##2##5##(2008-10#1)(2012-12#1)
reproducibility was found by##2##4##(2008-10#1)(2009-8#1)
reproducibility was good and little carryover was found##2##8##(2008-10#2)
reproducibility was obtained##2##3##(2008-10#1)(2009-8#1)
reproducibility was##28##2##(1990-2#2)(1995-9#1)(2007-7#1)(2007-8#1)(2008-10#17)(2008-5#1)(2009-11#1)(2009-8#3)(2012-12#1)
reproducibility were##5##2##(2007-8#1)(2008-10#4)
reproducibility with##8##2##(1993-11#1)(2007-8#1)(2008-10#5)(2012-12#1)
reproducibility##439##1##(1990-12#1)(1990-2#2)(1990-5#1)(1991-11#1)(1991-3#1)(1991-5#2)(1992-1#2)(1992-11#1)(1992-4#2)(1992-5#2)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#1)(1994-3#1)(1994-4#3)(1994-9#2)(1995-1#1)(1995-2#1)(1995-3#2)(1995-8#1)(1995-9#3)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#3)(1997-3#1)(1997-8#6)(2004-11#2)(2004-4#1)(2005-10#1)(2005-12#4)(2005-7#1)(2006-11#6)(2006-12#1)(2006-5#2)(2006-7#1)(2006-8#1)(2007-10#3)(2007-11#2)(2007-12#5)(2007-2#1)(2007-5#2)(2007-7#5)(2007-8#21)(2007-9#1)(2008-1#2)(2008-10#211)(2008-11#7)(2008-12#4)(2008-2#10)(2008-3#3)(2008-4#4)(2008-5#10)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#2)(2009-1#1)(2009-11#4)(2009-2#1)(2009-4#1)(2009-8#9)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#3)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2011-7#1)(2012-1#2)(2012-12#5)(2012-2#4)(2012-3#3)(2013-1#7)(2013-8#10)
reproducible (relative standard##2##3##(2008-10#2)
reproducible analysis of##2##3##(1992-10#1)(2008-10#1)
reproducible and accurate##2##3##(2007-10#1)(2007-12#1)
reproducible and can##2##3##(1993-12#1)(2008-10#1)
reproducible and highly sensitive##2##4##(2008-11#1)(2011-12#1)
reproducible and highly##3##3##(2008-10#1)(2008-11#1)(2011-12#1)
reproducible and reliable##3##3##(1991-5#1)(2007-8#1)(2010-8#1)
reproducible and selective##2##3##(2008-10#2)
reproducible and sensitive##4##3##(1990-12#1)(1996-5#1)(1997-8#1)(2008-10#1)
reproducible and specific##3##3##(1996-5#1)(2008-10#2)
reproducible and stable##2##3##(2008-10#2)
reproducible and useful##2##3##(2007-7#1)(2010-12#1)
reproducible and##63##2##(1990-12#1)(1990-9#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-4#1)(1993-12#1)(1993-2#1)(1996-2#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#19)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-1#1)
reproducible data##2##2##(2007-12#1)(2007-7#1)
reproducible experimental results##2##3##(2008-11#1)(2008-9#1)
reproducible experimental##4##2##(2008-11#3)(2008-9#1)
reproducible flow##2##2##(2007-10#1)(2008-10#1)
reproducible for##6##2##(1993-1#2)(1995-12#1)(1996-8#1)(2007-8#1)(2008-10#1)
reproducible from##3##2##(2005-11#1)(2008-10#1)(2008-3#1)
reproducible generation of##2##3##(2008-11#1)(2012-12#1)
reproducible in vitro##2##3##(1995-10#1)(2008-7#1)
reproducible in##4##2##(1995-10#1)(2008-7#2)(2009-1#1)
reproducible manner##5##2##(2007-8#1)(2008-1#1)(2008-10#1)(2013-1#2)
reproducible method##12##2##(1992-8#1)(1994-6#1)(2008-10#3)(2008-11#3)(2008-9#1)(2010-11#1)(2011-2#1)(2013-1#1)
reproducible model of##4##3##(2007-8#2)(2007-9#1)(2008-7#1)
reproducible model##6##2##(2007-6#1)(2007-8#2)(2007-9#1)(2008-7#1)(2008-9#1)
reproducible over##3##2##(1992-7#1)(2007-8#1)(2008-10#1)
reproducible response of##2##3##(2008-10#2)
reproducible response##4##2##(2008-10#4)
reproducible results and##2##3##(1991-5#1)(2008-10#1)
reproducible results for##2##3##(2008-10#1)(2008-11#1)
reproducible results##11##2##(1990-12#1)(1991-5#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)
reproducible retention##2##2##(2005-12#1)(2008-10#1)
reproducible test##2##2##(2006-5#1)(2010-12#1)
reproducible to within##2##3##(1997-8#1)(2008-3#1)
reproducible to##3##2##(1997-8#1)(2008-3#2)
reproducible with a##2##3##(1993-9#1)(2008-10#1)
reproducible with##4##2##(1993-11#1)(1993-9#1)(2008-10#2)
reproducible within a relative standard deviation of 1##2##8##(2008-10#2)
reproducible within a##3##3##(2008-10#3)
reproducible within##6##2##(2008-10#6)
reproducible wringing##5##2##(2008-2#2)(2008-3#3)
reproducible##368##1##(1990-11#3)(1990-12#2)(1990-2#2)(1990-5#1)(1990-7#2)(1990-9#1)(1991-3#2)(1991-5#3)(1991-7#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-7#1)(1992-8#1)(1993-1#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-6#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-5#3)(1996-6#1)(1996-8#4)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#3)(2005-11#3)(2005-12#3)(2006-11#2)(2006-12#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#3)(2007-11#2)(2007-12#4)(2007-6#1)(2007-7#5)(2007-8#19)(2007-9#2)(2008-1#4)(2008-10#107)(2008-11#15)(2008-12#1)(2008-2#5)(2008-3#9)(2008-4#8)(2008-5#12)(2008-6#1)(2008-7#13)(2008-8#4)(2008-9#10)(2009-1#2)(2009-10#1)(2009-12#2)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#3)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#7)(2013-8#3)
reproducibly by##2##2##(2006-9#1)(2008-1#1)
reproducibly detected in##2##3##(2007-12#1)(2010-12#1)
reproducibly in##2##2##(1991-1#1)(1996-9#1)
reproducibly induced by##3##3##(1996-10#1)(2008-11#1)(2011-2#1)
reproducibly observed##2##2##(2005-11#1)(2006-12#1)
reproducibly##38##1##(1990-11#1)(1990-12#1)(1991-1#1)(1991-11#1)(1992-1#1)(1992-12#1)(1992-4#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-10#1)(1996-4#1)(1996-9#1)(1997-2#1)(2004-9#1)(2005-11#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#2)
reproducing in##2##2##(2008-5#1)(2008-8#1)
reproducing population##2##2##(2008-8#1)(2009-2#1)
reproducing the##5##2##(1992-11#2)(1994-6#1)(2006-12#1)(2008-5#1)
reproducing##30##1##(1990-7#1)(1992-11#2)(1994-6#1)(1994-8#1)(2004-12#1)(2006-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-2#2)(2009-4#1)(2009-7#1)(2012-12#2)(2012-2#1)(2013-8#2)
reproduction among##2##2##(2008-8#2)
reproduction and development##7##3##(2005-7#2)(2006-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#1)
reproduction and feeding##2##3##(2008-5#2)
reproduction and life span##2##4##(2008-3#2)
reproduction and life##3##3##(2008-3#2)(2012-2#1)
reproduction and##33##2##(1995-12#1)(1997-5#1)(2004-4#1)(2005-7#2)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-3#2)(2008-5#4)(2008-8#5)(2008-9#3)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#2)
reproduction are##6##2##(1991-10#1)(1991-11#1)(2008-10#1)(2008-9#1)(2010-4#1)(2010-8#1)
reproduction as##2##2##(2010-2#1)(2012-1#1)
reproduction by##2##2##(2008-10#1)(2008-3#1)
reproduction can##2##2##(2008-8#1)(2012-3#1)
reproduction cycle of##3##3##(2007-5#1)(2008-7#2)
reproduction cycle##4##2##(2007-5#1)(2008-7#2)(2008-8#1)
reproduction for##3##2##(2008-8#1)(2008-9#2)
reproduction has##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
reproduction in a##2##3##(2008-3#1)(2013-1#1)
reproduction in the##9##3##(1996-4#1)(2006-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-4#1)(2012-12#1)(2013-8#1)
reproduction in##28##2##(1990-12#1)(1992-5#1)(1996-4#1)(1997-7#1)(2006-10#2)(2007-1#1)(2008-10#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-5#1)(2009-9#2)(2010-12#1)(2010-4#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
reproduction is##8##2##(1996-11#1)(2006-11#1)(2008-10#1)(2008-5#1)(2008-9#2)(2009-10#1)(2013-1#1)
reproduction may be##2##3##(2008-10#1)(2013-1#1)
reproduction may##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
reproduction medicine##3##2##(1991-11#2)(1996-9#1)
reproduction mode##2##2##(2008-9#2)
reproduction number##3##2##(2008-10#2)(2013-8#1)
reproduction occurs##4##2##(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
reproduction of the##14##3##(2007-11#1)(2007-3#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-9#1)(2009-9#1)
reproduction of##37##2##(1990-7#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-3#2)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#9)(2008-8#3)(2008-9#2)(2009-4#1)(2009-9#1)(2010-4#1)(2011-1#1)(2013-1#1)
reproduction on the##3##3##(2008-10#1)(2010-8#1)(2012-3#1)
reproduction probably##3##2##(2008-10#1)(2008-8#1)(2010-2#1)
reproduction rate##3##2##(2008-10#2)(2009-9#1)
reproduction ratio##2##2##(1997-6#1)(2008-5#1)
reproduction than##2##2##(1992-12#1)(2004-11#1)
reproduction to##2##2##(2008-10#1)(2008-9#1)
reproduction was##6##2##(2007-6#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-9#1)(2012-1#1)
reproduction with##2##2##(2008-9#1)(2010-1#1)
reproduction##370##1##(1990-12#1)(1990-7#1)(1991-10#2)(1991-11#3)(1991-3#2)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1995-12#1)(1995-8#2)(1995-9#1)(1996-11#1)(1996-4#3)(1996-5#1)(1996-9#1)(1997-5#5)(1997-6#1)(1997-7#1)(2004-11#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-10#2)(2005-7#6)(2006-10#10)(2006-11#2)(2006-12#2)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#2)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#7)(2007-3#5)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#50)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#10)(2008-4#4)(2008-5#30)(2008-6#2)(2008-7#9)(2008-8#57)(2008-9#33)(2009-10#1)(2009-4#2)(2009-5#4)(2009-6#2)(2009-8#1)(2009-9#9)(2010-1#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#7)(2010-5#4)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#4)(2011-3#1)(2012-1#5)(2012-12#3)(2012-2#3)(2012-3#7)(2013-1#9)(2013-7#4)(2013-8#2)
reproduction?##2##1##(2008-8#1)(2010-3#1)
reproduction]##2##1##(1991-11#1)(1996-9#1)
reproductive ability##2##2##(2007-7#1)(2008-10#1)
reproductive abnormalities##2##2##(2006-1#1)(2008-3#1)
reproductive activities##3##2##(1995-6#1)(1995-8#1)(2008-5#1)
reproductive activity##2##2##(1992-12#1)(2007-3#1)
reproductive age group##3##3##(2009-6#1)(2010-11#1)(2012-2#1)
reproductive age groups##3##3##(2011-2#3)
reproductive age##32##2##(1993-6#1)(1993-7#1)(1994-9#1)(1995-5#1)(1997-5#1)(2004-1#1)(2005-8#1)(2006-4#1)(2008-3#4)(2009-6#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
reproductive and developmental##4##3##(2005-7#1)(2008-11#1)(2010-1#1)(2012-1#1)
reproductive and metabolic##2##3##(2006-10#1)(2013-8#1)
reproductive and respiratory syndrome virus##4##5##(1997-6#2)(2005-11#2)
reproductive and sexual health##9##4##(2008-11#2)(2008-6#5)(2012-3#2)
reproductive and sexual##10##3##(2007-4#1)(2008-11#2)(2008-6#5)(2012-3#2)
reproductive and##29##2##(1997-4#1)(1997-6#2)(2005-11#2)(2005-7#1)(2006-10#1)(2006-9#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#5)(2010-1#1)(2010-3#1)(2012-1#1)(2012-3#2)(2013-7#1)(2013-8#1)
reproductive apparatus##2##2##(2007-12#1)(2007-9#1)
reproductive assurance##2##2##(2008-9#2)
reproductive axis##3##2##(1995-11#1)(2008-3#1)(2008-4#1)
reproductive behavior in the##2##4##(2006-4#1)(2008-6#1)
reproductive behavior in##3##3##(2006-10#1)(2006-4#1)(2008-6#1)
reproductive behavior##8##2##(1991-6#1)(1991-9#1)(1996-2#1)(2006-10#1)(2006-4#2)(2008-5#1)(2008-6#1)
reproductive behaviour##4##2##(1992-12#1)(2008-5#1)(2010-8#2)
reproductive biology of##2##3##(2007-3#1)(2012-2#1)
reproductive biology##9##2##(1990-6#1)(2006-11#1)(2007-3#1)(2008-12#1)(2009-3#1)(2009-6#1)(2012-2#1)(2013-8#2)
reproductive capacity of##2##3##(2008-10#1)(2009-3#1)
reproductive capacity##4##2##(1996-8#1)(2008-10#1)(2009-3#1)(2013-7#1)
reproductive characteristics##5##2##(1996-11#1)(1996-4#1)(2008-5#2)(2010-8#1)
reproductive cloning##2##2##(2005-7#1)(2008-6#1)
reproductive competition##3##2##(2008-9#3)
reproductive complications##2##2##(2007-12#2)
reproductive condition##3##2##(2009-4#3)
reproductive cost##2##2##(2008-9#2)
reproductive costs##2##2##(2008-8#1)(2008-9#1)
reproductive cycle event##2##3##(2004-3#2)
reproductive cycle events##3##3##(2004-3#3)
reproductive cycle of##3##3##(2007-9#1)(2008-5#2)
reproductive cycle##18##2##(1990-12#2)(2004-3#5)(2007-3#1)(2007-9#3)(2008-5#2)(2009-6#1)(2012-12#4)
reproductive data##2##2##(2008-3#1)(2011-2#1)
reproductive development of##2##3##(2004-11#1)(2008-10#1)
reproductive development##4##2##(2004-11#1)(2008-10#2)(2009-10#1)
reproductive diapause##2##2##(2008-8#2)
reproductive disorders##7##2##(1990-3#1)(1993-1#1)(2007-11#1)(2008-10#2)(2010-3#1)(2012-2#1)
reproductive dormancy##3##2##(2008-8#3)
reproductive dysfunction##2##2##(2007-1#1)(2012-2#1)
reproductive ecology of the##2##4##(2007-3#1)(2010-8#1)
reproductive effects##2##2##(2005-7#1)(2006-12#1)
reproductive effort in##2##3##(2008-8#2)
reproductive effort##16##2##(2008-8#11)(2008-9#1)(2010-8#4)
reproductive events##6##2##(1991-12#1)(2007-3#1)(2008-8#3)(2012-2#1)
reproductive factors and##3##3##(1990-10#1)(1990-6#1)(1992-9#1)
reproductive factors##5##2##(1990-10#1)(1990-6#1)(1991-5#1)(1992-9#1)(2008-10#1)
reproductive failure##3##2##(1992-12#2)(2008-9#1)
reproductive function and##2##3##(2006-2#1)(2008-6#1)
reproductive function in mares##2##4##(2006-5#2)
reproductive function in##4##3##(2005-8#1)(2006-5#3)
reproductive function of##3##3##(2006-1#1)(2006-5#2)
reproductive function##27##2##(1990-4#1)(1992-3#1)(1995-11#1)(2005-8#1)(2006-1#3)(2006-10#2)(2006-2#1)(2006-4#1)(2006-5#6)(2008-4#2)(2008-6#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2012-3#1)(2013-8#2)
reproductive functions##6##2##(1991-4#1)(1994-6#2)(2008-12#1)(2008-3#1)(2009-5#1)
reproductive health and##6##3##(2007-7#1)(2008-9#1)(2012-3#4)
reproductive health in##3##3##(2008-1#1)(2012-12#2)
reproductive health information##3##3##(2008-1#1)(2010-8#2)
reproductive health needs##2##3##(2008-1#1)(2013-1#1)
reproductive health outcomes##2##3##(2013-1#2)
reproductive health programs##2##3##(2008-7#1)(2012-11#1)
reproductive health services is##2##4##(2008-11#1)(2012-3#1)
reproductive health services##7##3##(1995-6#1)(2008-1#1)(2008-11#3)(2012-3#2)
reproductive health##72##2##(1991-5#2)(1994-12#1)(1994-3#1)(1994-9#1)(1995-6#1)(1995-9#1)(1996-12#1)(1997-1#1)(2007-2#1)(2007-3#2)(2007-4#2)(2007-7#2)(2008-1#7)(2008-11#10)(2008-7#1)(2008-9#1)(2010-12#1)(2010-8#4)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#17)(2013-1#4)(2013-8#1)
reproductive history##4##2##(1990-6#1)(1991-9#1)(2008-12#1)(2012-12#1)
reproductive hormones in##4##3##(1993-11#1)(2007-1#1)(2007-2#1)(2011-2#1)
reproductive hormones##7##2##(1993-11#1)(2007-1#2)(2007-11#1)(2007-2#1)(2011-2#1)(2012-2#1)
reproductive intentions##2##2##(2006-4#1)(2010-8#1)
reproductive investment##2##2##(2010-8#2)
reproductive isolation among##2##3##(1994-3#1)(2009-2#1)
reproductive isolation and##2##3##(2008-8#1)(2010-8#1)
reproductive isolation between##5##3##(2008-8#4)(2012-3#1)
reproductive isolation in##3##3##(2008-8#1)(2008-9#1)(2010-8#1)
reproductive isolation is##3##3##(2008-8#1)(2008-9#2)
reproductive isolation##28##2##(1994-3#2)(1996-3#1)(1996-6#1)(2008-8#12)(2008-9#5)(2009-2#1)(2010-8#5)(2012-3#1)
reproductive life##5##2##(1991-9#1)(2009-7#1)(2011-2#1)(2012-12#2)
reproductive lifespan##3##2##(2009-12#3)
reproductive lives##2##2##(2010-7#1)(2011-2#1)
reproductive medicine##2##2##(2006-10#1)(2007-2#1)
reproductive number##10##2##(2007-9#1)(2008-10#6)(2008-8#1)(2011-3#1)(2013-8#1)
reproductive organs of##2##3##(2008-12#1)(2008-3#1)
reproductive organs##15##2##(1992-2#1)(1995-11#1)(2006-10#1)(2008-12#3)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2010-1#1)(2013-8#1)
reproductive outcome##8##2##(1992-3#3)(1994-9#1)(2004-10#1)(2009-5#1)(2011-1#1)(2013-7#1)
reproductive outcomes##3##2##(2005-10#1)(2010-9#1)(2011-2#1)
reproductive output and##2##3##(2008-8#2)
reproductive output of##2##3##(2008-10#1)(2011-2#1)
reproductive output##13##2##(2008-10#1)(2008-8#7)(2008-9#1)(2009-10#1)(2011-2#3)
reproductive parasitism##3##2##(2008-9#2)(2010-8#1)
reproductive partitioning and##2##3##(2010-2#2)
reproductive partitioning##3##2##(2008-9#1)(2010-2#2)
reproductive performance of dairy##2##4##(2005-7#2)
reproductive performance of the##2##4##(2008-10#1)(2010-8#1)
reproductive performance of##9##3##(2005-7#2)(2006-5#1)(2008-10#1)(2008-12#1)(2009-5#2)(2010-8#2)
reproductive performance##13##2##(1996-1#1)(2005-7#2)(2006-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-5#2)(2010-8#2)(2013-1#1)
reproductive period##16##2##(1995-10#1)(1997-4#8)(2007-5#1)(2008-1#1)(2012-11#4)(2013-1#1)
reproductive physiology##6##2##(1996-4#1)(1996-9#1)(2008-7#3)(2010-8#1)
reproductive polyps##2##2##(2009-8#1)(2011-2#1)
reproductive potential##12##2##(2008-10#1)(2008-5#1)(2008-8#3)(2008-9#2)(2009-12#2)(2013-8#3)
reproductive problems##2##2##(2008-11#1)(2013-1#1)
reproductive program##2##2##(2007-10#2)
reproductive rate of##3##3##(2008-9#1)(2012-12#2)
reproductive rate##14##2##(2008-8#3)(2008-9#1)(2011-2#2)(2012-12#6)(2012-2#2)
reproductive rights##7##2##(2006-2#2)(2006-5#1)(2008-7#1)(2012-3#3)
reproductive roles##3##2##(1996-12#1)(2008-9#2)
reproductive rounds##3##2##(1997-4#3)
reproductive season##2##2##(2007-3#1)(2010-8#1)
reproductive skew##9##2##(1995-8#1)(2008-8#3)(2008-9#1)(2010-2#4)
reproductive state##6##2##(1994-10#3)(1995-8#1)(2010-8#2)
reproductive states##2##2##(2007-3#1)(2008-8#1)
reproductive status##6##2##(1994-4#1)(1997-4#3)(2007-3#1)(2009-5#1)
reproductive strategies##2##2##(2008-5#1)(2012-3#1)
reproductive strategy##3##2##(2007-12#1)(2008-10#1)(2013-8#1)
reproductive structure of##2##3##(2011-2#2)
reproductive structure##3##2##(2011-2#3)
reproductive structures##3##2##(2007-12#2)(2007-5#1)
reproductive study##2##2##(2005-7#1)(2010-1#1)
reproductive success and##3##3##(2008-9#2)(2009-12#1)
reproductive success for##2##3##(2008-10#1)(2009-12#1)
reproductive success from##2##3##(2008-9#1)(2009-12#1)
reproductive success in##4##3##(2008-9#2)(2010-8#1)(2012-3#1)
reproductive success of##14##3##(1996-6#1)(2007-3#1)(2008-6#2)(2008-8#1)(2008-9#5)(2009-12#1)(2010-8#1)(2012-2#1)(2012-3#1)
reproductive success than##2##3##(2008-9#2)
reproductive success was positively##2##4##(2008-8#1)(2009-12#1)
reproductive success was##4##3##(2008-10#1)(2008-8#2)(2009-12#1)
reproductive success##61##2##(1996-6#1)(2004-4#1)(2006-7#1)(2007-3#1)(2008-10#2)(2008-6#2)(2008-7#1)(2008-8#13)(2008-9#20)(2009-12#8)(2010-2#1)(2010-8#2)(2011-12#1)(2012-2#1)(2012-3#5)(2013-8#1)
reproductive surgery##3##2##(1992-2#2)(1992-3#1)
reproductive system of##2##3##(2007-12#1)(2007-3#1)
reproductive system##22##2##(1992-12#1)(1993-3#1)(2006-10#3)(2007-10#1)(2007-12#2)(2007-3#2)(2007-7#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-10#1)(2010-8#1)(2011-2#3)(2012-2#3)
reproductive systems##6##2##(1995-11#1)(2005-7#1)(2008-7#1)(2009-11#1)(2009-7#1)(2012-12#1)
reproductive tactic##2##2##(2010-8#1)(2013-8#1)
reproductive tactics##3##2##(2008-8#1)(2010-8#2)
reproductive technologies (ART)##2##3##(1992-2#1)(2010-12#1)
reproductive technologies and##3##3##(2006-11#2)(2010-12#1)
reproductive technologies##10##2##(1992-2#2)(2006-11#3)(2007-2#1)(2008-11#1)(2010-12#2)(2011-1#1)
reproductive technology##13##2##(1996-12#1)(2006-11#2)(2006-9#1)(2007-10#1)(2007-2#1)(2008-3#1)(2008-7#1)(2009-4#2)(2010-12#1)(2012-3#1)(2013-8#1)
reproductive timing and##2##3##(2009-10#2)
reproductive timing##3##2##(2009-10#3)
reproductive tissue##4##2##(1992-4#1)(1996-10#1)(2008-12#1)(2012-11#1)
reproductive tissues##6##2##(1991-12#1)(1996-10#2)(1996-4#1)(2008-10#1)(2008-4#1)
reproductive toxicity##2##2##(2005-7#1)(2008-10#1)
reproductive tract and##3##3##(1996-12#1)(2006-5#2)
reproductive tract including##2##3##(1994-9#1)(2011-1#1)
reproductive tract infections in##2##4##(2006-4#1)(2011-1#1)
reproductive tract infections##10##3##(2006-4#2)(2007-3#2)(2011-1#5)(2011-12#1)
reproductive tract of##2##3##(2013-1#2)
reproductive tract##43##2##(1990-11#1)(1991-12#1)(1993-2#1)(1994-9#2)(1996-12#6)(2004-2#1)(2006-10#1)(2006-4#2)(2006-5#4)(2007-12#1)(2007-3#2)(2008-11#1)(2010-3#1)(2011-1#10)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#4)
reproductive tracts##3##2##(2008-11#1)(2008-5#1)(2011-2#1)
reproductive trait##2##2##(2009-7#1)(2012-1#1)
reproductive traits in different parities##2##5##(2012-1#2)
reproductive traits in##5##3##(2008-8#1)(2010-10#1)(2012-1#3)
reproductive traits of##4##3##(1996-11#1)(2012-12#2)(2012-3#1)
reproductive traits that##2##3##(1995-2#1)(2012-3#1)
reproductive traits##20##2##(1995-2#1)(1996-11#1)(2008-8#1)(2008-9#1)(2009-7#3)(2010-10#1)(2012-1#6)(2012-12#4)(2012-3#2)
reproductive vacancies##3##2##(2008-9#3)
reproductive##883##1##(1990-10#2)(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-6#3)(1991-1#2)(1991-12#4)(1991-4#1)(1991-5#3)(1991-6#3)(1991-9#4)(1992-1#1)(1992-12#6)(1992-2#6)(1992-3#5)(1992-4#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#3)(1994-12#1)(1994-3#4)(1994-4#1)(1994-6#2)(1994-9#5)(1995-10#1)(1995-11#5)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#3)(1995-9#3)(1996-1#2)(1996-10#3)(1996-11#3)(1996-12#9)(1996-2#1)(1996-3#1)(1996-4#5)(1996-6#2)(1996-8#2)(1996-9#3)(1997-1#1)(1997-4#19)(1997-5#2)(1997-6#2)(2004-1#1)(2004-10#1)(2004-11#7)(2004-2#2)(2004-3#5)(2004-4#1)(2004-8#1)(2005-10#2)(2005-11#2)(2005-7#9)(2005-8#2)(2006-1#4)(2006-10#12)(2006-11#7)(2006-12#1)(2006-2#3)(2006-4#10)(2006-5#13)(2006-7#1)(2006-9#2)(2007-1#3)(2007-10#5)(2007-11#2)(2007-12#12)(2007-2#7)(2007-3#18)(2007-4#3)(2007-5#3)(2007-7#6)(2007-9#5)(2008-1#9)(2008-10#29)(2008-11#18)(2008-12#11)(2008-3#13)(2008-4#6)(2008-5#19)(2008-6#14)(2008-7#14)(2008-8#81)(2008-9#55)(2009-10#6)(2009-11#1)(2009-12#13)(2009-2#2)(2009-3#3)(2009-4#6)(2009-5#7)(2009-6#4)(2009-7#8)(2009-8#1)(2009-9#2)(2010-1#3)(2010-10#4)(2010-11#1)(2010-12#7)(2010-2#8)(2010-3#3)(2010-7#2)(2010-8#43)(2010-9#1)(2011-1#18)(2011-12#2)(2011-2#30)(2011-3#1)(2012-1#8)(2012-11#7)(2012-12#28)(2012-2#19)(2012-3#37)(2012-8#2)(2013-1#13)(2013-7#6)(2013-8#23)
reproductive-age women##2##2##(2006-10#1)(2011-2#1)
reproductively active##2##2##(1995-12#1)(2012-3#1)
reproductively isolated##3##2##(2008-10#1)(2008-6#1)(2008-8#1)
reproductively##10##1##(1995-12#1)(2008-10#1)(2008-6#1)(2008-8#3)(2009-12#1)(2009-4#1)(2012-3#1)(2013-1#1)
reproductives##4##1##(2007-12#4)
reproductivity##2##1##(2008-10#2)
reprogram##7##1##(1996-1#1)(2008-9#1)(2009-6#1)(2012-11#2)(2012-12#2)
reprogrammed##2##1##(2006-8#1)(2009-9#1)
reprogramming adjustments were##2##3##(2006-8#2)
reprogramming of somatic cells to##2##5##(2010-7#1)(2012-12#1)
reprogramming of##5##2##(2008-1#1)(2009-3#1)(2010-7#1)(2012-12#2)
reprogramming##35##1##(1990-11#1)(2006-8#3)(2007-10#3)(2008-1#5)(2008-6#1)(2008-8#2)(2008-9#1)(2009-3#3)(2009-6#1)(2010-12#3)(2010-7#1)(2012-11#6)(2012-12#5)
reprotonation of the##2##3##(1993-3#1)(2008-10#1)
reprotonation of##3##2##(1993-3#1)(1995-10#1)(2008-10#1)
reprotonation##7##1##(1993-3#1)(1995-10#1)(1995-11#2)(2008-10#3)
représente##2##1##(2011-2#1)(2012-2#1)
reps during##2##2##(2013-1#2)
reps##6##1##(2006-2#4)(2013-1#2)
reptating##2##1##(1992-11#1)(2005-11#1)
reptile species##2##2##(2008-10#1)(2010-3#1)
reptile##9##1##(1995-3#1)(2007-2#1)(2008-10#1)(2008-8#1)(2010-3#2)(2012-3#2)(2013-7#1)
reptiles and birds##2##3##(1997-8#1)(2010-3#1)
reptiles and##4##2##(1993-12#1)(1997-8#1)(2010-3#2)
reptiles##29##1##(1991-11#1)(1992-1#1)(1992-8#2)(1993-12#1)(1995-11#1)(1997-8#1)(2007-2#1)(2007-3#2)(2008-4#1)(2008-8#1)(2010-3#12)(2011-1#1)(2012-2#4)
reptilian genomes##3##2##(2010-3#3)
reptilian species##3##2##(2008-10#1)(2010-3#2)
reptilian##19##1##(1991-3#1)(1992-12#1)(1993-12#1)(1993-4#1)(1994-3#1)(2008-10#1)(2009-10#1)(2010-3#10)(2011-2#1)(2012-2#1)
republic of##4##2##(2012-2#1)(2013-8#3)
republic##7##1##(1990-6#1)(1993-10#2)(2012-2#1)(2013-8#3)
republics##4##1##(1993-10#1)(2007-8#1)(2007-9#1)(2008-12#1)
repulsion and##3##2##(1990-8#1)(1994-12#1)(2010-1#1)
repulsion between the##3##3##(2005-11#2)(2008-10#1)
repulsion between##11##2##(1997-7#1)(2005-11#5)(2007-12#1)(2008-10#2)(2008-9#2)
repulsion is##3##2##(1993-9#1)(1996-7#1)(1997-1#1)
repulsion of the##2##3##(1997-3#1)(2007-12#1)
repulsion of##4##2##(1997-3#1)(1997-7#1)(2007-12#1)(2012-2#1)
repulsion phase##3##2##(2008-10#3)
repulsion##46##1##(1990-8#1)(1992-6#1)(1993-9#3)(1994-12#1)(1994-8#1)(1995-10#1)(1996-5#1)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-7#3)(2005-11#7)(2007-11#1)(2007-12#3)(2008-10#9)(2008-6#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-1#1)(2012-2#1)
repulsions##4##1##(2005-11#1)(2008-10#1)(2010-5#1)(2012-2#1)
repulsive and attractive##2##3##(2006-10#1)(2010-2#1)
repulsive electrostatic##2##2##(2005-11#2)
repulsive force##2##2##(2005-11#1)(2007-11#1)
repulsive forces##3##2##(2005-11#1)(2008-11#1)(2008-7#1)
repulsive interactions between the##3##4##(2005-11#2)(2006-10#1)
repulsive interactions##4##2##(2005-11#3)(2006-10#1)
repulsive pressure##2##2##(1994-8#2)
repulsive##26##1##(1992-12#1)(1994-8#3)(1995-3#1)(1995-5#1)(2005-11#8)(2006-10#2)(2007-11#2)(2007-2#2)(2008-11#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-2#1)
repurified##2##1##(1990-8#1)(2008-8#1)
repurposing##3##1##(2012-1#3)
reputable##2##1##(2007-6#1)(2008-10#1)
reputation as an##2##3##(2009-2#1)(2009-5#1)
reputation as##4##2##(2008-7#1)(2009-10#1)(2009-2#1)(2009-5#1)
reputation that##2##2##(2009-11#1)(2010-12#1)
reputation##27##1##(1990-4#1)(1992-12#2)(1996-1#7)(2006-4#1)(2006-6#2)(2007-8#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-12#1)(2012-2#1)(2013-8#3)
reputational##2##1##(2009-7#1)(2011-2#1)
reputed##4##1##(2004-12#1)(2007-1#1)(2007-8#1)(2008-10#1)
reputedly##2##1##(2007-12#1)(2007-8#1)
request and##4##2##(1997-6#1)(2013-1#1)(2013-8#2)
request by##2##2##(2008-3#1)(2008-5#1)
request cards##2##2##(1993-12#1)(2011-11#1)
request for a##3##3##(1996-11#1)(1997-6#1)(2007-9#1)
request for treatment##5##3##(2009-6#5)
request for##26##2##(1990-3#1)(1991-5#1)(1994-5#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-11#1)(1996-6#1)(1997-6#1)(2006-4#1)(2007-3#1)(2007-9#1)(2008-1#2)(2008-11#1)(2009-6#5)(2010-11#1)(2011-12#1)(2011-7#1)(2012-12#1)(2013-1#1)
request forms and##2##3##(1994-12#1)(2005-12#1)
request forms##6##2##(1993-12#1)(1994-12#2)(2005-12#1)(2012-1#2)
request from the authors##2##4##(2007-6#1)(2008-7#1)
request in##2##2##(1995-12#1)(2007-8#1)
request of the##14##3##(1990-11#1)(1997-4#1)(1997-6#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-3#1)(2011-2#1)(2012-11#3)
request of##19##2##(1990-11#1)(1991-12#1)(1993-7#1)(1997-4#1)(1997-6#1)(2006-5#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-3#1)(2011-2#1)(2012-1#1)(2012-11#3)(2013-8#1)
request to##3##2##(1995-6#1)(1996-12#1)(2007-8#1)
request##96##1##(1990-11#1)(1990-3#1)(1991-12#2)(1991-3#2)(1991-5#1)(1992-11#1)(1992-12#2)(1992-3#1)(1993-12#2)(1993-7#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-6#3)(1996-11#2)(1996-12#1)(1996-3#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-6#3)(2005-12#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-5#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-6#5)(2010-10#1)(2010-11#1)(2010-2#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#1)(2011-7#1)(2012-1#3)(2012-11#3)(2012-12#2)(2013-1#2)(2013-8#3)
requested a##3##2##(1993-12#1)(1993-7#1)(2007-9#1)
requested by the##3##3##(1991-3#1)(1994-5#1)(2010-3#1)
requested by##6##2##(1991-3#1)(1994-5#2)(1995-1#1)(2010-3#1)(2010-8#1)
requested for##2##2##(2006-2#1)(2012-3#1)
requested from##3##2##(2005-11#1)(2007-4#1)(2012-12#1)
requested in##3##2##(2010-8#1)(2012-12#1)(2012-2#1)
requested it##2##2##(1997-5#1)(2011-1#1)
requested that the##2##3##(1996-11#1)(2006-2#1)
requested that##6##2##(1990-3#1)(1995-1#1)(1996-11#2)(2006-10#1)(2006-2#1)
requested to##11##2##(1990-5#1)(1991-11#1)(1996-8#1)(2005-7#1)(2007-3#1)(2008-1#1)(2008-11#2)(2009-8#1)(2010-1#1)(2012-2#1)
requested##62##1##(1990-3#1)(1990-5#1)(1991-11#1)(1991-3#1)(1993-12#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-5#2)(1995-1#2)(1995-6#1)(1996-11#2)(1996-3#2)(1996-5#1)(1996-8#1)(1997-5#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#2)(2006-2#2)(2006-8#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#2)(2009-8#1)(2010-1#1)(2010-3#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
requesting information about their##2##4##(2005-8#1)(2010-10#1)
requesting information##3##2##(1994-6#1)(2005-8#1)(2010-10#1)
requesting support##2##2##(2012-12#2)
requesting the##2##2##(1996-9#1)(2008-4#1)
requesting##21##1##(1992-1#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-5#1)(1994-6#1)(1996-1#1)(1996-9#1)(2005-8#1)(2008-4#1)(2008-9#1)(2010-10#1)(2010-3#2)(2010-8#2)(2011-2#1)(2012-12#2)
requests and##6##2##(1991-8#1)(1995-12#1)(1996-2#1)(2006-10#1)(2008-9#1)(2013-1#1)
requests are##3##2##(1991-8#1)(1992-2#1)(1992-8#1)
requests for##7##2##(1992-12#1)(1994-1#1)(1994-2#1)(1997-3#1)(2005-2#1)(2008-11#1)(2010-8#1)
requests from##2##2##(1993-1#1)(2006-8#1)
requests information##2##2##(2007-1#1)(2010-3#1)
requests to##3##2##(1997-5#1)(2010-5#1)(2012-2#1)
requests##43##1##(1991-8#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-5#1)(2005-12#1)(2005-2#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-9#3)(2009-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#3)
require Mg2+##2##2##(1994-9#1)(1997-7#1)
require a change in##4##4##(2004-12#1)(2006-4#1)(2012-12#1)(2013-8#1)
require a detailed understanding of##2##5##(2007-11#1)(2008-7#1)
require a detailed##3##3##(2007-11#1)(2008-7#1)(2009-2#1)
require a different##3##3##(1997-8#1)(2013-1#2)
require a divalent##2##3##(1990-7#1)(1991-7#1)
require a great##2##3##(1991-6#1)(2008-10#1)
require a high degree of##2##5##(2006-10#1)(2007-8#1)
require a high##5##3##(2006-10#1)(2007-12#1)(2007-8#1)(2008-9#1)(2011-2#1)
require a knowledge of the##2##5##(1990-12#1)(1995-8#1)
require a major##2##3##(1997-7#1)(2012-1#1)
require a new##2##3##(1994-1#1)(2009-5#1)
require a physical##2##3##(2007-12#1)(2008-4#1)
require a priori knowledge of the##2##6##(2008-2#2)
require a separate##2##3##(1996-11#1)(2009-2#1)
require a significant##2##3##(2008-11#1)(2009-3#1)
require a small##2##3##(2008-2#2)
require a##125##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-3#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-8#2)(1997-7#1)(1997-8#1)(2004-12#1)(2006-10#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#7)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#3)(2009-8#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
require accurate##2##2##(1992-9#1)(2008-3#1)
require action##2##2##(1994-4#1)(1996-3#1)
require activation of##2##3##(1996-2#1)(2008-4#1)
require activation##3##2##(1995-6#1)(1996-2#1)(2008-4#1)
require active participation##2##3##(1996-12#1)(2010-1#1)
require active##7##2##(1994-8#1)(1996-11#1)(1996-12#1)(2008-7#1)(2009-5#1)(2010-1#1)(2012-3#1)
require added##2##2##(1992-6#1)(1994-12#1)
require additional##13##2##(1993-6#1)(1994-2#1)(1996-10#1)(2005-11#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2009-8#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-7#1)
require an integrated##3##3##(2007-7#1)(2008-3#1)(2009-3#1)
require an understanding of##2##4##(2008-8#1)(2008-9#1)
require an##30##2##(1990-12#1)(1990-9#1)(1991-3#1)(1996-2#1)(2005-11#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-8#1)(2008-9#2)(2009-11#2)(2009-3#1)(2009-4#1)(2010-10#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-7#1)
require analysis##2##2##(1997-5#1)(2008-9#1)
require and##4##2##(1994-3#1)(2009-6#1)(2012-12#2)
require anesthesia##3##2##(2006-10#1)(2008-11#1)(2008-5#1)
require any##25##2##(1991-11#1)(1991-2#1)(1993-3#1)(1997-6#1)(2006-5#1)(2008-10#13)(2008-11#1)(2008-3#2)(2008-9#1)(2012-1#1)(2012-2#1)(2013-8#1)
require appropriate##2##2##(2008-4#1)(2008-5#1)
require approximately##2##2##(2008-10#1)(2008-11#1)
require being##2##2##(2008-10#1)(2013-8#1)
require better understanding##2##3##(2011-2#1)(2013-1#1)
require better##3##2##(1997-3#1)(2011-2#1)(2013-1#1)
require both a##2##3##(1996-8#1)(1997-7#1)
require both##7##2##(1990-8#1)(1996-8#1)(1997-7#1)(2007-8#1)(2009-12#1)(2011-2#1)(2012-12#1)
require calcium ion##2##3##(1991-2#1)(2008-8#1)
require calcium##3##2##(1991-2#1)(1991-8#1)(2008-8#1)
require cardiac##3##2##(2007-8#2)(2012-2#1)
require cardiopulmonary##2##2##(2007-3#1)(2011-2#1)
require careful attention##2##3##(1992-3#1)(2008-7#1)
require careful##6##2##(1990-12#1)(1992-3#1)(2006-2#1)(2007-2#1)(2008-11#1)(2008-7#1)
require changes in##2##3##(2008-11#1)(2012-2#1)
require changes##3##2##(2007-9#1)(2008-11#1)(2012-2#1)
require close##5##2##(1991-2#1)(1993-8#1)(2004-10#1)(2008-2#1)(2009-6#1)
require collaboration##2##2##(1996-3#1)(2013-1#1)
require complete##4##2##(1992-6#1)(2007-11#1)(2008-2#1)(2012-3#1)
require complex##7##2##(1995-12#2)(2008-11#1)(2008-3#1)(2010-10#1)(2013-1#2)
require concomitant##2##2##(2007-10#1)(2007-11#1)
require confirmation##2##2##(1996-7#1)(2008-10#1)
require considerable##5##2##(1995-12#1)(2007-11#1)(2008-10#1)(2010-10#1)(2013-1#1)
require consideration##2##2##(2008-7#1)(2010-5#1)
require continued##2##2##(2008-11#1)(2011-2#1)
require continuing##2##2##(1995-9#1)(2011-2#1)
require continuous##2##2##(2006-1#1)(2008-7#1)
require conversion##2##2##(1991-9#1)(2008-4#1)
require different interventions##2##3##(1994-12#1)(2008-5#1)
require different##7##2##(1994-12#1)(2006-4#1)(2008-2#1)(2008-5#1)(2009-9#1)(2011-2#1)(2013-1#1)
require drug##2##2##(1995-11#1)(2009-6#1)
require either##2##2##(1993-12#1)(2007-11#1)
require emergency##2##2##(2008-3#1)(2008-7#1)
require expensive##3##2##(2007-9#2)(2009-6#1)
require extensive training##3##3##(1993-2#1)(2013-1#2)
require extensive##5##2##(1993-2#1)(1994-12#1)(2008-11#1)(2013-1#2)
require extra##2##2##(1997-8#1)(2008-11#1)
require factor##2##2##(1990-2#2)
require functional##2##2##(1996-3#1)(2009-9#1)
require further exploration##3##3##(2008-7#1)(2009-4#1)(2011-1#1)
require further investigation##5##3##(1995-5#1)(2008-10#1)(2010-3#1)(2011-1#1)(2013-8#1)
require further research##2##3##(2008-11#1)(2013-1#1)
require further study##7##3##(1990-11#1)(2006-10#2)(2008-10#1)(2010-8#1)(2011-2#1)(2012-2#1)
require further##30##2##(1990-11#1)(1992-12#1)(1995-5#1)(1996-3#1)(1996-5#1)(1996-8#1)(2006-10#3)(2007-11#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-3#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
require general anesthesia##2##3##(2005-11#1)(2007-12#1)
require greater##4##2##(2005-8#1)(2007-12#1)(2007-9#1)(2008-5#1)
require heightened##2##2##(2013-1#1)(2013-8#1)
require high##6##2##(1994-6#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)
require high-speed##3##2##(2008-1#1)(2008-2#1)(2008-7#1)
require higher##4##2##(2008-10#2)(2011-1#1)(2012-12#1)
require highly##2##2##(1990-6#1)(2008-11#1)
require hospital##2##2##(2009-12#1)(2011-2#1)
require immediate##8##2##(1991-5#1)(2005-8#1)(2007-11#1)(2008-3#1)(2008-6#1)(2009-4#1)(2010-2#1)(2013-1#1)
require in##3##2##(2008-3#1)(2008-4#2)
require increased##3##2##(1991-4#1)(1995-12#1)(2005-8#1)
require information##2##2##(2008-10#1)(2008-4#1)
require initial##2##2##(2007-12#1)(2008-11#1)
require innovative##2##2##(1994-2#1)(2007-1#1)
require integration of##2##3##(2012-2#1)(2013-1#1)
require intensive care##2##3##(2006-1#1)(2007-11#1)
require intensive##8##2##(1996-11#1)(2006-1#1)(2007-11#2)(2008-8#1)(2010-12#1)(2011-1#1)(2012-2#1)
require intervention##3##2##(1993-12#1)(2008-11#1)(2008-6#1)
require investigation##2##2##(2008-10#1)(2013-8#1)
require knowledge of the##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
require knowledge##4##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
require large amounts of##2##4##(2008-10#1)(2008-2#1)
require large##5##2##(1997-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-9#1)
require larger##2##2##(2007-11#1)(2010-3#1)
require less##6##2##(1994-11#1)(1996-2#1)(1997-8#1)(2007-11#1)(2008-7#1)(2012-3#1)
require lifelong##2##2##(2005-8#1)(2008-5#1)
require lithographic##2##2##(2007-12#1)(2008-7#1)
require little##3##2##(2008-2#1)(2008-4#2)
require long##2##2##(1990-9#1)(2009-5#1)
require long-term##6##2##(1990-12#1)(1992-1#1)(1993-6#1)(2007-7#1)(2010-10#1)(2011-2#1)
require mRNA and protein synthesis##2##5##(1993-9#2)
require many##2##2##(2008-2#1)(2008-7#1)
require mechanical##2##2##(2007-11#1)(2009-7#1)
require medical##3##2##(1993-12#1)(2006-10#1)(2013-8#1)
require medication##2##2##(2005-5#1)(2007-8#1)
require metabolic activation##2##3##(1996-2#1)(2008-10#1)
require metabolic##3##2##(1996-2#1)(2004-11#1)(2008-10#1)
require microscopic##2##2##(2008-11#1)(2008-4#1)
require minimal##4##2##(1994-2#1)(2006-11#1)(2011-2#1)(2011-9#1)
require modification##3##2##(2006-10#1)(2008-11#1)(2013-1#1)
require monitoring##2##2##(2008-10#1)(2008-6#1)
require more complex##2##3##(2007-2#1)(2012-11#1)
require more information about##2##4##(2008-5#1)(2012-12#1)
require more information##3##3##(2006-1#1)(2008-5#1)(2012-12#1)
require more research##2##3##(2005-11#1)(2007-4#1)
require more##25##2##(1994-12#1)(1995-4#1)(2005-11#1)(2006-1#1)(2006-7#2)(2007-2#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-5#1)(2009-8#1)(2011-1#3)(2012-11#1)(2012-12#2)(2013-1#2)
require much more##2##3##(2006-10#1)(2008-4#1)
require much##4##2##(1992-6#1)(2005-10#1)(2006-10#1)(2008-4#1)
require new and##2##3##(1990-12#1)(1996-3#1)
require new approaches##3##3##(2007-8#1)(2007-9#1)(2010-12#1)
require new##14##2##(1990-12#1)(1990-3#1)(1992-1#1)(1995-3#1)(1996-3#1)(2005-7#1)(2007-8#1)(2007-9#1)(2008-3#2)(2008-5#1)(2010-12#1)(2010-8#1)(2010-9#1)
require no##2##2##(2007-12#2)
require not only##2##3##(2006-2#1)(2008-12#1)
require nuclear##2##2##(2008-8#1)(2011-2#1)
require ongoing##3##2##(2006-12#1)(2010-2#1)(2012-12#1)
require only one##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
require only##7##2##(1990-2#1)(1993-6#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#2)
require open##2##2##(2007-12#1)(2009-3#1)
require orthopedic##3##2##(2007-11#1)(2008-7#1)(2008-8#1)
require other##3##2##(1991-8#1)(2008-2#1)(2009-8#1)
require policy##3##2##(2009-6#1)(2013-1#2)
require precise##3##2##(2006-4#1)(2010-2#1)(2010-9#1)
require prior##3##2##(2008-10#1)(2008-2#1)(2009-7#1)
require prolonged##2##2##(1997-2#1)(2007-12#1)
require prompt##2##2##(2008-1#1)(2012-2#1)
require public##2##2##(1996-3#1)(2008-12#1)
require rapid##2##2##(2006-10#1)(2008-7#1)
require regular##2##2##(1996-8#1)(2004-10#1)
require rehabilitation##2##2##(1991-7#1)(2007-6#1)
require reliable##2##2##(2008-12#1)(2008-2#1)
require secondary##2##2##(2009-8#1)(2013-1#1)
require several years##2##3##(1992-12#1)(2008-10#1)
require several##5##2##(1990-12#1)(1992-12#1)(2008-10#1)(2008-2#1)(2012-2#1)
require significant##5##2##(1996-11#1)(2005-7#1)(2008-6#1)(2009-3#1)(2012-2#1)
require skills##2##2##(2008-11#1)(2008-9#1)
require smaller##3##2##(2007-7#1)(2008-9#1)(2012-3#1)
require solutions##2##2##(2008-10#1)(2010-7#1)
require some##4##2##(1994-3#1)(2005-7#1)(2006-10#2)
require sophisticated##2##2##(2008-10#1)(2009-5#1)
require special preparation##2##3##(1997-2#1)(2008-4#1)
require special##9##2##(1996-12#1)(1997-2#1)(2007-12#2)(2008-3#2)(2008-4#1)(2008-7#1)(2011-2#1)
require specialized##2##2##(2008-9#2)
require specific##10##2##(1991-2#1)(1991-9#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-2#1)(2009-9#1)(2010-1#1)(2012-2#1)
require substantial##3##2##(1994-12#1)(1994-9#1)(2007-11#1)
require successful##2##2##(2011-2#1)(2013-1#1)
require suitable##2##2##(2008-1#1)(2008-10#1)
require supplementation##2##2##(2006-7#1)(2007-2#1)
require surface##2##2##(2008-10#1)(2008-5#1)
require surgery for##2##3##(2006-10#1)(2007-7#1)
require surgery in##2##3##(2011-12#1)(2012-2#1)
require surgery##16##2##(1991-5#1)(2006-10#3)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-12#1)(2011-12#1)(2012-2#2)(2013-1#2)
require surgical intervention##3##3##(2007-12#1)(2013-1#2)
require surgical repair##2##3##(2008-7#1)(2011-2#1)
require surgical treatment##3##3##(1990-1#1)(1991-2#1)(2007-11#1)
require surgical##11##2##(1990-1#1)(1991-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-7#1)(2011-2#1)(2013-1#3)
require systemic##3##2##(2006-10#1)(2010-9#1)(2012-1#1)
require that the##6##3##(1992-2#1)(2007-4#1)(2008-1#1)(2008-9#1)(2012-1#1)(2012-12#1)
require that##20##2##(1992-1#1)(1992-2#1)(1992-5#1)(1994-3#1)(2007-11#2)(2007-12#1)(2007-4#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#2)(2009-4#1)(2010-4#1)(2012-1#1)(2012-12#1)
require the activation of##2##4##(1996-2#1)(2013-1#1)
require the addition of##5##4##(1992-9#1)(2006-11#1)(2008-3#1)(2008-5#1)(2012-3#1)
require the analysis of##2##4##(1995-8#1)(2008-8#1)
require the application of##2##4##(1997-8#1)(2011-2#1)
require the development of##2##4##(2008-10#1)(2008-2#1)
require the development##3##3##(2008-10#1)(2008-2#1)(2009-12#1)
require the expensive##2##3##(2009-10#1)(2011-2#1)
require the input of##2##4##(2009-11#1)(2011-3#1)
require the presence of##8##4##(1990-11#1)(1992-8#1)(1995-4#1)(1996-9#1)(1997-4#1)(2008-10#1)(2008-3#1)(2009-4#1)
require the use of a##2##5##(2006-5#1)(2008-3#1)
require the use of##12##4##(1995-5#1)(2005-10#1)(2006-5#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)
require the use##14##3##(1995-5#1)(2005-10#1)(2006-5#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2012-12#2)
require the##105##2##(1990-11#1)(1990-7#1)(1991-2#1)(1992-1#2)(1992-12#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-11#2)(1994-7#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-10#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-4#3)(1997-8#2)(2005-10#1)(2006-11#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#4)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#2)(2009-9#1)(2010-10#1)(2010-2#1)(2010-6#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-12#3)(2012-3#4)(2013-1#3)(2013-8#1)
require therapeutic##2##2##(2010-8#1)(2012-12#1)
require to##2##2##(2005-11#1)(2009-5#1)
require treatment##13##2##(1990-6#1)(1990-8#1)(1991-5#1)(2005-2#1)(2007-11#1)(2007-9#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
require two##3##2##(1992-4#1)(2006-12#1)(2008-3#1)
require unique##2##2##(2007-9#1)(2010-7#1)
require urgent surgical##2##3##(2008-7#1)(2008-8#1)
require urgent##4##2##(2008-1#1)(2008-7#1)(2008-8#1)(2011-3#1)
require us to##2##3##(1991-2#1)(2007-5#1)
require use of##2##3##(1994-2#1)(2008-4#1)
require validation##4##2##(2013-1#3)(2013-7#1)
require verification##2##2##(2005-8#1)(2007-7#1)
require very little##3##3##(1996-7#1)(2008-4#1)(2008-9#1)
require very##7##2##(1996-7#1)(2005-10#1)(2008-4#2)(2008-9#3)
require##1231##1##(1990-1#1)(1990-10#1)(1990-11#5)(1990-12#8)(1990-2#6)(1990-3#2)(1990-4#3)(1990-5#4)(1990-6#3)(1990-7#2)(1990-8#3)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#9)(1991-3#3)(1991-4#2)(1991-5#4)(1991-6#1)(1991-7#3)(1991-8#3)(1991-9#4)(1992-1#6)(1992-10#1)(1992-12#5)(1992-2#2)(1992-3#6)(1992-4#1)(1992-5#1)(1992-6#5)(1992-8#1)(1992-9#3)(1993-1#1)(1993-12#6)(1993-2#4)(1993-3#4)(1993-4#1)(1993-5#3)(1993-6#9)(1993-7#1)(1993-8#3)(1993-9#6)(1994-1#1)(1994-11#4)(1994-12#8)(1994-2#5)(1994-3#9)(1994-4#1)(1994-6#2)(1994-7#1)(1994-8#5)(1994-9#5)(1995-1#7)(1995-10#1)(1995-11#2)(1995-12#9)(1995-2#5)(1995-3#2)(1995-4#2)(1995-5#2)(1995-6#5)(1995-8#4)(1995-9#2)(1996-1#3)(1996-10#2)(1996-11#6)(1996-12#6)(1996-2#8)(1996-3#9)(1996-5#2)(1996-6#1)(1996-7#3)(1996-8#6)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#5)(1997-4#10)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#8)(2004-10#3)(2004-11#1)(2004-12#1)(2005-10#3)(2005-11#9)(2005-2#1)(2005-3#1)(2005-5#1)(2005-6#1)(2005-7#5)(2005-8#6)(2006-1#4)(2006-10#31)(2006-11#3)(2006-12#5)(2006-2#4)(2006-3#4)(2006-4#4)(2006-5#6)(2006-6#6)(2006-7#7)(2006-8#3)(2006-9#3)(2007-1#1)(2007-10#4)(2007-11#29)(2007-12#37)(2007-2#6)(2007-3#1)(2007-4#6)(2007-5#5)(2007-6#2)(2007-7#18)(2007-8#18)(2007-9#12)(2008-1#16)(2008-10#73)(2008-11#33)(2008-12#6)(2008-2#31)(2008-3#40)(2008-4#41)(2008-5#17)(2008-6#16)(2008-7#29)(2008-8#15)(2008-9#30)(2009-10#4)(2009-11#4)(2009-12#6)(2009-2#6)(2009-3#8)(2009-4#9)(2009-5#12)(2009-6#5)(2009-7#4)(2009-8#7)(2009-9#4)(2010-1#3)(2010-10#6)(2010-11#1)(2010-12#6)(2010-2#4)(2010-3#3)(2010-4#2)(2010-5#5)(2010-6#2)(2010-7#4)(2010-8#6)(2010-9#4)(2011-1#13)(2011-12#3)(2011-2#33)(2011-3#2)(2011-9#1)(2012-1#12)(2012-11#4)(2012-12#24)(2012-2#27)(2012-3#10)(2013-1#61)(2013-7#4)(2013-8#15)
required 20##2##2##(2008-10#1)(2010-4#1)
required 30 to##2##3##(1993-11#1)(2008-10#1)
required NADPH##3##2##(1990-11#1)(1995-6#1)(2008-11#1)
required a dose##2##3##(1990-8#1)(2008-10#1)
required a second##8##3##(1990-12#1)(1994-9#1)(1995-2#1)(1996-1#1)(2007-1#1)(2007-2#1)(2009-7#1)(2012-12#1)
required a total of##3##4##(2006-4#1)(2011-2#1)(2013-1#1)
required a##58##2##(1990-10#2)(1990-12#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-7#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-2#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-6#1)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-12#2)(2007-2#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-7#2)(2009-7#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#4)
required additional therapy##2##3##(1997-8#1)(2004-10#1)
required additional##6##2##(1993-4#1)(1997-8#1)(2004-10#1)(2008-6#1)(2010-7#1)(2013-1#1)
required adjustment##2##2##(2008-3#1)(2012-1#1)
required admission to the##2##4##(2012-3#1)(2013-1#1)
required admission to##3##3##(2012-3#1)(2013-1#2)
required after##2##2##(2007-11#1)(2008-10#1)
required an additional##2##3##(1996-4#1)(2004-11#1)
required an##8##2##(1994-4#1)(1996-4#1)(2004-11#1)(2008-1#1)(2008-11#1)(2008-8#1)(2010-3#1)(2013-8#1)
required and can##2##3##(1994-12#1)(1994-3#1)
required and the##2##3##(2006-10#1)(2008-10#1)
required and##17##2##(1990-6#1)(1992-7#1)(1994-12#1)(1994-3#1)(2006-10#2)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#2)(2011-1#1)(2011-2#2)
required approximately##3##2##(1994-11#1)(2008-10#2)
required are##3##2##(1994-2#1)(1995-12#1)(2008-11#1)
required as a##3##3##(2008-1#1)(2010-12#1)(2012-1#1)
required as an##2##3##(2008-11#1)(2012-2#1)
required as##14##2##(1990-6#1)(1990-8#1)(1994-11#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2010-10#1)(2010-12#1)(2012-1#1)(2012-2#1)(2012-3#1)
required at least one##2##4##(1995-2#1)(2007-11#1)
required at least##5##3##(1990-4#1)(1995-2#1)(1995-3#1)(2007-11#1)(2007-12#1)
required at##12##2##(1990-4#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2009-3#1)(2009-8#1)(2011-2#1)
required because##3##2##(1995-2#1)(2008-10#1)(2008-4#1)
required before these##2##3##(1992-3#1)(2008-1#1)
required before##16##2##(1991-12#1)(1991-8#1)(1992-3#1)(1994-8#1)(1997-1#1)(1997-3#1)(2004-9#1)(2007-1#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2010-4#1)(2010-7#1)(2013-8#1)
required both##4##2##(1990-3#1)(1994-12#1)(2006-12#1)(2011-10#1)
required by a##2##3##(1995-7#1)(2011-1#1)
required by most##2##3##(1995-6#1)(2007-11#1)
required by other##2##3##(2007-8#1)(2008-6#1)
required by the##25##3##(1990-8#1)(1993-3#1)(1994-2#1)(1995-8#1)(2006-7#1)(2006-8#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-2#2)(2010-7#1)(2012-2#2)(2012-3#2)
required by these##2##3##(2010-5#1)(2012-3#1)
required by##70##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#2)(1994-11#1)(1994-12#1)(1994-2#1)(1995-12#2)(1995-6#1)(1995-7#1)(1995-8#2)(1996-12#1)(1997-4#1)(2005-11#1)(2005-3#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-8#2)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#2)(2009-2#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-8#1)
required cardiopulmonary bypass##2##3##(2008-7#1)(2013-1#1)
required cofactors for##2##3##(2012-12#2)
required conditions for##2##3##(2006-12#1)(2008-10#1)
required conversion to##2##3##(2007-8#2)
required costly equipment##2##3##(2012-2#2)
required daily##3##2##(2008-1#1)(2009-2#1)(2012-2#1)
required data##5##2##(1997-3#1)(2008-11#1)(2008-7#1)(2011-1#2)
required dialysis for##2##3##(2008-1#1)(2013-8#1)
required dialysis##3##2##(2008-1#1)(2008-4#1)(2013-8#1)
required divalent cations such as##2##5##(1994-6#1)(1995-2#1)
required drainage##2##2##(1990-3#1)(2013-8#1)
required due to the##3##4##(2008-10#2)(2012-3#1)
required due to##5##3##(2006-2#1)(2008-10#2)(2008-6#1)(2012-3#1)
required during the##2##3##(1992-12#1)(1996-3#1)
required during##6##2##(1992-12#1)(1996-3#1)(2007-12#1)(2008-2#1)(2010-7#1)(2011-2#1)
required emergency##4##2##(1991-8#1)(2007-9#1)(2013-1#2)
required extraordinary##2##2##(2008-2#1)(2008-3#1)
required fewer##2##2##(1996-11#1)(2008-10#1)
required for 50% inhibition of##2##5##(1996-3#1)(2008-11#1)
required for 50%##3##3##(1994-2#1)(1996-3#1)(2008-11#1)
required for 90% control of the disease##2##7##(2008-10#2)
required for 90%##3##3##(2008-10#3)
required for DNA synthesis and##2##5##(1993-11#1)(1994-8#1)
required for DNA synthesis##4##4##(1993-11#1)(1994-8#1)(1995-11#1)(2004-11#1)
required for DNA##7##3##(1990-12#1)(1993-11#1)(1994-8#1)(1995-11#1)(1995-6#1)(1997-4#1)(2004-11#1)
required for Sp1##2##3##(1990-6#1)(1995-3#1)
required for TNF##2##3##(1990-4#1)(1995-9#1)
required for a high##2##4##(1990-12#1)(2008-10#1)
required for a specific##3##4##(1992-2#1)(2007-12#1)(2011-1#1)
required for a##24##3##(1990-12#1)(1990-7#1)(1991-11#1)(1991-5#1)(1992-2#1)(1992-9#1)(1994-12#1)(1996-3#1)(1997-3#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-9#1)(2010-4#2)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
required for accurate##9##3##(1996-12#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-6#1)(2010-4#1)(2012-12#2)
required for acquisition##2##3##(1993-6#1)(2008-7#1)
required for activation of the##2##5##(1992-7#1)(1993-3#1)
required for activation of##4##4##(1992-7#1)(1993-3#1)(1993-6#1)(1995-3#1)
required for activation##5##3##(1992-7#1)(1993-3#1)(1993-6#1)(1995-3#1)(1996-7#1)
required for activity##6##3##(1994-11#1)(1994-3#1)(1995-1#1)(1996-7#1)(2005-10#1)(2008-4#1)
required for all##3##3##(2008-10#1)(2009-9#1)(2011-2#1)
required for an##7##3##(1992-11#1)(1994-8#1)(1996-10#1)(1997-4#1)(2006-9#1)(2007-9#1)(2008-5#1)
required for analysis##2##3##(2008-10#1)(2008-3#1)
required for appropriate##3##3##(1993-5#1)(2009-3#1)(2011-2#1)
required for axonal transport##2##4##(1991-5#1)(2004-12#1)
required for binding##7##3##(1992-12#1)(1992-7#1)(1994-9#1)(1995-1#1)(1995-3#1)(2008-10#1)(2008-4#1)
required for both##15##3##(1992-3#1)(1993-12#1)(1994-5#1)(1994-9#2)(1995-2#1)(1995-4#1)(1996-4#1)(2005-8#1)(2007-12#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-7#1)
required for catalytic activity##2##4##(1991-7#1)(1994-11#1)
required for cell##4##3##(1991-8#1)(1996-5#2)(2008-5#1)
required for complete##4##3##(1994-12#1)(1996-2#1)(2008-7#1)(2010-7#1)
required for cooperative##2##3##(1993-6#1)(1995-8#1)
required for correct##6##3##(1991-11#1)(1994-9#1)(1995-6#1)(2009-8#1)(2012-12#2)
required for developing##2##3##(2008-10#1)(2009-4#1)
required for development of##3##4##(2008-10#1)(2008-4#1)(2012-12#1)
required for development##4##3##(2008-10#2)(2008-4#1)(2012-12#1)
required for differentiation##2##3##(1995-3#1)(1995-5#1)
required for disease##2##3##(2006-10#1)(2008-10#1)
required for early##2##3##(1991-12#1)(2012-12#1)
required for effective##5##3##(2008-12#1)(2009-10#1)(2011-2#1)(2012-1#1)(2013-1#1)
required for efficient##10##3##(1991-11#1)(1991-9#1)(1992-4#1)(1992-9#1)(1995-6#2)(1996-9#1)(1997-5#1)(2011-1#1)(2013-1#1)
required for either##2##3##(1996-12#1)(2012-12#1)
required for enhanced##2##3##(1992-12#1)(1994-11#1)
required for enzyme activity##2##4##(1995-3#1)(2008-6#1)
required for expression##3##3##(1991-5#1)(2008-5#1)(2010-3#1)
required for extracellular secretion of pullulanase##2##6##(1993-9#2)
required for extracellular secretion of##3##5##(1993-9#3)
required for formation##2##3##(1993-2#1)(2009-8#1)
required for full##8##3##(1993-3#1)(1994-12#1)(1994-9#1)(1995-12#1)(2007-11#1)(2008-10#2)(2009-8#1)
required for function of##2##4##(1996-2#1)(1997-6#1)
required for functional##2##3##(1996-5#1)(1997-7#1)
required for further##2##3##(2008-7#1)(2012-12#1)
required for fusion##2##3##(1996-9#1)(2008-4#1)
required for glioma##2##3##(2006-10#1)(2006-12#1)
required for growth##10##3##(1991-1#1)(1996-8#1)(1996-9#1)(1997-4#2)(2006-8#1)(2007-11#1)(2008-11#1)(2008-7#1)(2011-2#1)
required for half-maximal inhibition##3##4##(1990-5#1)(1990-7#1)(1995-6#1)
required for high##3##3##(1990-6#1)(2008-11#1)(2009-10#1)
required for high-affinity binding##3##4##(1990-2#1)(1997-6#1)(2006-12#1)
required for high-affinity##4##3##(1990-2#1)(1995-11#1)(1997-6#1)(2006-12#1)
required for high-level expression##2##4##(1994-12#1)(1996-3#1)
required for host##2##3##(2008-8#1)(2009-9#1)
required for improving##2##3##(1996-8#1)(2008-5#1)
required for in vitro##2##4##(1991-7#1)(1993-9#1)
required for in vivo##2##4##(1991-3#1)(1992-7#1)
required for in##5##3##(1991-3#1)(1991-7#1)(1992-7#1)(1993-9#1)(2011-1#1)
required for infection and##2##4##(2008-10#2)
required for infection##5##3##(2008-10#5)
required for inhibition of##5##4##(1990-5#1)(1992-1#1)(1995-3#1)(1996-9#1)(1997-5#1)
required for inhibition##7##3##(1990-5#1)(1992-1#1)(1995-3#1)(1996-9#2)(1997-5#1)(2008-10#1)
required for interaction with the##2##5##(1994-8#1)(1994-9#1)
required for interaction with##3##4##(1994-11#1)(1994-8#1)(1994-9#1)
required for its##12##3##(1990-6#1)(1991-10#1)(1992-5#1)(1993-9#1)(1994-3#1)(1994-9#1)(1996-9#1)(2008-10#2)(2011-2#1)(2012-2#1)(2013-8#1)
required for maintenance of##5##4##(1995-2#1)(1996-9#1)(2007-4#1)(2008-11#1)(2010-1#1)
required for male##4##3##(1990-11#1)(2007-12#1)(2008-9#1)(2012-12#1)
required for maturation##2##3##(2010-7#1)(2011-1#1)
required for maximal##5##3##(1991-5#1)(1994-12#1)(1997-3#2)(2008-4#1)
required for mitogenic##3##3##(1994-11#1)(1996-2#1)(1996-5#1)
required for mitotic spindle orientation##2##5##(2012-12#2)
required for modeling the##2##4##(2007-12#1)(2008-2#1)
required for modeling##3##3##(2007-12#2)(2008-2#1)
required for most##3##3##(1996-5#1)(2008-4#2)
required for multiple##2##3##(1994-8#1)(2007-12#1)
required for normal##12##3##(1991-11#1)(1992-3#1)(1994-12#1)(2005-10#1)(2006-10#1)(2007-12#1)(2008-9#1)(2009-3#1)(2010-9#1)(2012-2#2)(2012-3#1)
required for nuclear migration in differentiating##2##6##(2008-9#2)
required for nuclear##5##3##(1993-6#1)(1994-8#1)(1995-2#1)(2008-9#2)
required for nucleotide##2##3##(1991-7#1)(1997-4#1)
required for obtaining reliable##2##4##(2008-10#1)(2008-2#1)
required for obtaining##4##3##(2008-10#2)(2008-11#1)(2008-2#1)
required for optimal##7##3##(1994-11#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-5#1)(2010-7#1)(2012-3#1)
required for pathogen##3##3##(2008-10#2)(2011-2#1)
required for persistence##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
required for pollen##3##3##(2008-10#1)(2009-10#2)
required for processing##2##3##(2008-3#2)
required for proper##11##3##(1991-11#1)(1992-11#1)(1995-11#1)(2007-8#1)(2008-10#2)(2008-7#1)(2009-3#1)(2011-2#1)(2012-12#2)
required for protein##3##3##(1995-3#1)(1996-2#1)(2006-10#1)
required for recognition##3##3##(1993-11#1)(1993-6#1)(1994-9#1)
required for removal of##2##4##(2008-10#1)(2012-12#1)
required for replication##2##3##(1995-1#2)
required for resistance to##2##4##(1990-9#1)(1997-6#1)
required for resistance##3##3##(1990-9#1)(1997-6#1)(2009-6#1)
required for restoration of##2##4##(2008-7#1)(2010-2#1)
required for sample##2##3##(2008-10#2)
required for secretion of##3##4##(1993-9#1)(1995-10#1)(1995-2#1)
required for secretion##4##3##(1993-9#1)(1995-10#1)(1995-2#2)
required for sexual##2##3##(1995-6#1)(2008-10#1)
required for significant##2##3##(2008-10#1)(2009-7#1)
required for sporulation##3##3##(1990-10#1)(1995-9#2)
required for stable##3##3##(1997-7#1)(2007-11#1)(2012-12#1)
required for subsequent##3##3##(1993-3#1)(2004-11#1)(2010-2#1)
required for subunit##2##3##(1994-9#2)
required for successful##5##3##(1991-1#1)(2008-1#2)(2008-11#1)(2009-8#1)
required for such##4##3##(1997-8#1)(2007-12#1)(2008-9#1)(2011-1#1)
required for synthesis of##4##4##(1993-11#1)(1994-12#1)(1995-4#1)(2008-10#1)
required for the activation of##2##5##(1995-11#1)(2008-5#1)
required for the activity##2##4##(1991-5#1)(1997-2#1)
required for the analysis##4##4##(2007-8#1)(2008-10#3)
required for the binding##2##4##(1994-8#1)(2009-7#1)
required for the biogenesis of##2##5##(2007-8#1)(2010-5#1)
required for the completion of##2##5##(1996-4#1)(2008-6#1)
required for the control of##2##5##(1993-9#1)(2008-10#1)
required for the design##2##4##(2008-2#1)(2008-6#1)
required for the detection##2##4##(2007-8#1)(2008-10#1)
required for the determination of##6##5##(1992-2#1)(1993-12#1)(2008-10#2)(2012-11#2)
required for the determination##9##4##(1992-2#1)(1993-12#1)(2005-4#1)(2008-10#3)(2010-11#1)(2012-11#2)
required for the diagnosis of##3##5##(2005-11#1)(2013-1#2)
required for the diagnosis##4##4##(2005-11#1)(2010-8#1)(2013-1#2)
required for the differentiation of##2##5##(1991-11#1)(2007-12#1)
required for the enhanced##2##4##(1997-1#1)(2009-8#1)
required for the enzymatic##2##4##(2008-5#1)(2009-2#1)
required for the expression of the##3##6##(1995-12#1)(1995-3#1)(1996-4#1)
required for the expression of##4##5##(1994-12#1)(1995-12#1)(1995-3#1)(1996-4#1)
required for the expression##5##4##(1994-12#1)(1995-12#1)(1995-3#1)(1996-4#1)(2009-8#1)
required for the first##3##4##(1992-5#1)(2008-9#1)(2010-4#1)
required for the formation of##10##5##(1993-12#1)(1993-2#1)(1994-9#1)(1995-3#2)(1995-4#1)(2008-10#1)(2009-10#1)(2010-7#1)(2013-1#1)
required for the full##2##4##(1995-6#1)(1996-5#1)
required for the growth##2##4##(1991-6#1)(1993-3#1)
required for the induction of##6##5##(1990-8#1)(1991-12#1)(1991-6#1)(1992-10#1)(1994-12#1)(1995-5#1)
required for the induction##7##4##(1990-8#1)(1991-12#1)(1991-6#1)(1992-10#1)(1994-12#1)(1994-8#1)(1995-5#1)
required for the inhibition##3##4##(1993-2#1)(1996-12#1)(1996-7#1)
required for the maintenance##2##4##(1990-7#1)(2007-8#1)
required for the production of##4##5##(1991-5#1)(1991-9#1)(2007-11#1)(2013-1#1)
required for the proper formation of the##2##7##(1993-6#1)(2007-12#1)
required for the proper##6##4##(1993-6#1)(1994-9#1)(2007-12#1)(2012-12#2)(2012-3#1)
required for the regulation of##4##5##(1994-12#1)(1995-6#2)(1996-2#1)
required for the synthesis of##2##5##(1990-7#1)(2008-4#1)
required for the transcriptional##2##4##(1995-8#1)(1996-2#1)
required for the##231##3##(1990-11#2)(1990-2#2)(1990-6#1)(1990-7#4)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-5#3)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#3)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#5)(1994-9#5)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#7)(1995-4#1)(1995-5#1)(1995-6#4)(1995-7#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#3)(1996-4#3)(1996-5#2)(1996-7#3)(1996-8#4)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#2)(2004-11#1)(2005-11#1)(2005-12#1)(2005-4#1)(2005-8#3)(2006-10#2)(2006-11#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#4)(2008-10#14)(2008-11#4)(2008-2#4)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#2)(2009-7#1)(2009-8#3)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#6)(2012-3#3)(2013-1#6)(2013-7#2)(2013-8#1)
required for their##9##3##(1992-7#1)(1995-1#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-4#1)(2012-12#2)
required for these##4##3##(1991-12#1)(2008-3#1)(2008-9#1)(2012-12#1)
required for this##11##3##(1990-5#1)(1992-2#1)(1994-11#1)(1994-9#1)(1996-7#1)(1996-9#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#1)
required for tolerance##2##3##(2012-1#1)(2012-11#1)
required for transcription initiation##2##4##(1991-11#1)(1992-6#1)
required for transcription##5##3##(1991-11#1)(1992-6#1)(1993-12#1)(1997-5#1)(2008-7#1)
required for transport##2##3##(1997-7#1)(2013-1#1)
required for treatment##2##3##(2006-8#1)(2008-7#1)
required for tumor##2##3##(1997-7#1)(2011-2#1)
required for use##2##3##(1997-8#1)(2008-10#1)
required for vesicular transport##2##4##(1997-6#2)
required for viability##2##3##(2007-12#2)
required for viral replication##2##4##(2011-1#1)(2013-8#1)
required for viral##4##3##(1993-3#1)(2008-10#1)(2011-1#1)(2013-8#1)
required for##1134##2##(1990-10#1)(1990-11#4)(1990-12#3)(1990-2#5)(1990-3#1)(1990-4#1)(1990-5#6)(1990-6#6)(1990-7#6)(1990-8#6)(1990-9#2)(1991-1#3)(1991-10#2)(1991-11#12)(1991-12#4)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#6)(1991-6#3)(1991-7#6)(1991-8#4)(1991-9#3)(1992-1#2)(1992-10#2)(1992-11#4)(1992-12#6)(1992-2#4)(1992-3#2)(1992-4#5)(1992-5#6)(1992-6#5)(1992-7#7)(1992-8#2)(1992-9#4)(1993-1#1)(1993-11#9)(1993-12#7)(1993-2#4)(1993-3#10)(1993-4#3)(1993-5#1)(1993-6#11)(1993-8#2)(1993-9#9)(1994-10#1)(1994-11#13)(1994-12#19)(1994-2#4)(1994-3#9)(1994-5#4)(1994-6#2)(1994-7#1)(1994-8#21)(1994-9#19)(1995-1#7)(1995-10#5)(1995-11#10)(1995-12#3)(1995-2#18)(1995-3#24)(1995-4#4)(1995-5#5)(1995-6#22)(1995-7#1)(1995-8#10)(1995-9#3)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#10)(1996-3#5)(1996-4#5)(1996-5#17)(1996-6#1)(1996-7#7)(1996-8#13)(1996-9#10)(1997-1#7)(1997-2#3)(1997-3#7)(1997-4#13)(1997-5#5)(1997-6#9)(1997-7#12)(1997-8#3)(2004-11#3)(2004-12#1)(2005-10#2)(2005-11#3)(2005-12#1)(2005-4#1)(2005-7#1)(2005-8#5)(2006-10#12)(2006-11#2)(2006-12#4)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#3)(2006-6#3)(2006-7#1)(2006-8#2)(2006-9#3)(2007-10#3)(2007-11#8)(2007-12#32)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#8)(2007-9#3)(2008-1#7)(2008-10#84)(2008-11#20)(2008-12#3)(2008-2#23)(2008-3#25)(2008-4#29)(2008-5#11)(2008-6#7)(2008-7#20)(2008-8#10)(2008-9#17)(2009-10#11)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#6)(2009-4#1)(2009-6#3)(2009-7#3)(2009-8#17)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#3)(2010-3#3)(2010-4#5)(2010-5#1)(2010-7#7)(2010-8#2)(2010-9#2)(2011-1#10)(2011-12#1)(2011-2#20)(2012-1#7)(2012-11#3)(2012-12#48)(2012-2#17)(2012-3#13)(2013-1#18)(2013-7#3)(2013-8#10)
required four##2##2##(2008-3#1)(2008-4#1)
required from##7##2##(1992-12#1)(2006-2#1)(2007-8#1)(2010-6#1)(2013-1#3)
required further##3##2##(1990-6#1)(2006-10#1)(2007-8#1)
required ground##2##2##(2008-10#1)(2008-3#1)
required hemodialysis##3##2##(2007-7#1)(2008-7#2)
required high concentrations##2##3##(1990-11#1)(1992-8#1)
required high##5##2##(1990-11#1)(1992-8#1)(1993-9#1)(2007-11#1)(2007-12#1)
required higher##7##2##(1992-3#1)(1992-7#1)(1994-12#1)(2008-10#1)(2008-11#1)(2009-5#1)(2012-2#1)
required hospitalization##3##2##(1992-2#1)(2011-2#1)(2013-1#1)
required if##7##2##(1993-3#1)(1997-6#1)(2004-10#1)(2005-11#1)(2008-3#1)(2008-8#1)(2013-1#1)
required in a##4##3##(2005-11#1)(2006-8#1)(2011-1#1)(2012-12#1)
required in addition to##2##4##(2008-12#1)(2008-2#1)
required in adult##2##3##(1991-6#1)(1995-7#1)
required in both##2##3##(1993-6#1)(2005-10#1)
required in order to achieve##2##5##(1994-5#1)(1995-12#1)
required in order to##15##4##(1994-12#1)(1994-5#1)(1995-12#1)(1996-11#1)(1997-4#1)(2006-7#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-2#1)(2009-6#1)(2010-11#1)(2010-6#1)(2011-1#1)
required in order##16##3##(1994-12#1)(1994-5#1)(1995-12#1)(1996-11#1)(1997-4#1)(2006-7#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-2#1)(2009-6#1)(2010-11#1)(2010-6#1)(2011-1#1)
required in patients with##2##4##(2007-8#1)(2012-2#1)
required in several##2##3##(1990-11#1)(1991-2#1)
required in some##3##3##(2007-11#1)(2011-2#1)(2012-3#1)
required in the absence of##2##5##(1995-10#1)(2012-12#1)
required in the##23##3##(1990-2#1)(1990-9#1)(1991-5#1)(1994-2#1)(1994-8#1)(1995-10#1)(1995-8#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-11#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#2)
required in these##2##3##(1996-12#1)(2008-10#1)
required in this##7##3##(1992-11#1)(2007-8#1)(2008-10#2)(2010-6#1)(2012-3#1)(2013-1#1)
required in##117##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-10#1)(1995-12#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1997-4#2)(1997-8#1)(2004-10#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-5#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-6#2)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#2)(2010-7#1)(2011-1#2)(2011-2#4)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
required intensive care##2##3##(1994-2#1)(2009-10#1)
required intensive##3##2##(1994-2#1)(2009-10#1)(2013-7#1)
required interruption of##2##3##(1991-2#1)(1994-4#1)
required is##6##2##(1993-11#1)(1995-12#1)(1997-8#1)(2007-8#1)(2008-3#1)(2008-4#1)
required less##5##2##(1993-2#1)(1996-3#1)(1997-2#1)(2008-7#1)(2010-9#1)
required long##2##2##(1992-12#1)(2008-9#1)
required longer##3##2##(1993-4#1)(2008-10#1)(2013-1#1)
required mechanical ventilation##4##3##(1994-1#1)(2007-2#1)(2013-1#1)(2013-8#1)
required mechanical##5##2##(1994-1#1)(2007-2#1)(2008-2#1)(2013-1#1)(2013-8#1)
required medical##3##2##(1990-8#1)(1993-12#1)(1995-12#1)
required minimal##4##2##(1996-8#1)(2008-10#2)(2011-2#1)
required modifications##3##2##(2007-3#1)(2007-4#1)(2008-7#1)
required more than##3##3##(1993-12#1)(2008-10#1)(2011-1#1)
required more##6##2##(1993-12#1)(2004-10#1)(2007-8#1)(2008-10#1)(2011-1#1)(2012-12#1)
required much less##2##3##(1993-2#1)(2008-10#1)
required much##4##2##(1993-2#1)(1993-9#1)(1995-5#1)(2008-10#1)
required multiple##2##2##(2006-12#1)(2011-2#1)
required no##7##2##(1994-3#1)(1996-9#1)(2005-11#1)(2006-6#1)(2007-7#1)(2008-10#1)(2010-4#1)
required number of##7##3##(1993-1#1)(1996-3#2)(2006-11#1)(2007-12#1)(2008-11#1)(2012-3#1)
required of the##4##3##(2007-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
required of##16##2##(1994-3#2)(1996-2#1)(2004-3#1)(2005-3#1)(2006-5#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#2)(2011-2#1)(2013-1#2)
required on the##4##3##(1997-5#1)(2008-12#1)(2010-11#1)(2012-1#1)
required on##10##2##(1997-5#1)(2004-10#1)(2006-10#1)(2007-6#1)(2008-12#1)(2008-5#1)(2010-11#2)(2012-1#1)(2013-8#1)
required one##3##2##(1991-3#1)(1993-2#1)(2006-12#1)
required only##17##2##(1990-2#1)(1991-3#1)(1992-5#1)(1994-11#1)(1994-2#1)(1994-8#1)(1996-1#2)(1996-10#1)(1996-11#1)(2008-10#3)(2008-2#1)(2009-10#1)(2012-12#1)(2013-8#1)
required operative treatment##2##3##(2007-11#1)(2007-8#1)
required operative##4##2##(2007-11#1)(2007-8#1)(2008-4#1)(2009-4#1)
required participation##2##2##(1991-12#1)(1995-3#1)
required performance##3##2##(2007-8#1)(2008-10#1)(2008-2#1)
required permanent##2##2##(1996-3#1)(2007-7#1)
required precursor for##2##3##(2009-5#1)(2010-11#1)
required prior to##3##3##(2006-6#1)(2008-10#2)
required properties##3##2##(1996-1#1)(2008-5#1)(2010-4#1)
required protein##2##2##(1995-12#1)(1995-3#1)
required removal##3##2##(2008-6#1)(2008-9#1)(2010-12#1)
required reoperation##3##2##(2006-5#1)(2007-11#1)(2008-6#1)
required resolution##2##2##(2008-10#1)(2008-2#1)
required respirator use##3##3##(2008-12#3)
required revision surgery##2##3##(2007-7#1)(2008-9#1)
required revision##5##2##(2006-7#1)(2007-7#1)(2008-9#1)(2009-3#1)(2012-12#1)
required sample volume##2##3##(2007-9#1)(2008-3#1)
required sample##6##2##(2007-9#1)(2008-3#1)(2012-3#4)
required several##2##2##(2006-11#1)(2011-12#1)
required significantly##5##2##(1993-4#1)(2007-8#1)(2008-10#1)(2010-9#1)(2012-3#1)
required skilled resuscitation including##2##4##(1994-6#2)
required standard##2##2##(1990-11#1)(2008-10#1)
required sternotomy##2##2##(2006-10#1)(2007-8#1)
required subsequent##2##2##(1994-12#1)(2013-1#1)
required suction curettage##2##3##(1995-8#2)
required support##4##2##(1996-3#1)(2005-5#1)(2007-8#2)
required surgery##3##2##(1993-2#1)(2005-10#1)(2012-2#1)
required surgical intervention and##2##4##(1990-8#1)(2006-7#1)
required surgical intervention##4##3##(1990-8#1)(2006-7#1)(2007-11#1)(2007-9#1)
required surgical##9##2##(1990-8#1)(1990-9#1)(1991-8#1)(1997-3#1)(2006-7#1)(2007-11#1)(2007-3#1)(2007-9#1)(2010-7#1)
required than##2##2##(1996-1#1)(2008-2#1)
required that##11##2##(1994-11#1)(1995-11#1)(1996-9#1)(2005-7#1)(2006-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#2)(2013-8#1)
required the addition of##3##4##(1992-4#1)(2008-10#1)(2009-4#1)
required the development of##3##4##(1993-11#1)(1997-1#1)(2011-1#1)
required the intact##2##3##(1997-6#1)(2011-12#1)
required the presence of the##3##5##(1994-8#1)(1996-9#1)(1997-7#1)
required the presence of##7##4##(1991-3#1)(1992-7#1)(1994-8#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-7#1)
required the use of##4##4##(1991-7#1)(2008-10#1)(2008-7#1)(2013-1#1)
required the##40##2##(1990-8#1)(1991-1#1)(1991-3#1)(1991-7#1)(1992-10#1)(1992-4#1)(1992-7#1)(1993-11#1)(1993-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-3#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
required throughout the##2##3##(2006-1#1)(2006-5#1)
required time for##3##3##(1990-8#1)(2008-10#1)(2008-12#1)
required time of##2##3##(2007-8#1)(2008-10#1)
required time##5##2##(1990-8#1)(2007-8#1)(2008-10#2)(2008-12#1)
required to account for the##2##5##(2008-7#1)(2012-12#1)
required to accurately##2##3##(2008-6#1)(2008-7#1)
required to achieve a##3##4##(1996-1#1)(2007-8#1)(2008-8#1)
required to achieve##19##3##(1993-8#1)(1994-12#1)(1996-1#1)(1996-2#1)(2007-11#2)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
required to activate the##2##4##(1990-5#1)(1992-6#1)
required to activate##4##3##(1990-5#1)(1991-7#1)(1992-12#1)(1992-6#1)
required to adapt##2##3##(1996-1#1)(2007-11#1)
required to address the##3##4##(2004-10#1)(2006-5#1)(2011-1#1)
required to address##7##3##(2004-10#1)(2005-10#1)(2006-10#1)(2006-5#1)(2008-10#1)(2011-1#1)(2013-8#1)
required to answer##2##3##(2007-6#1)(2010-3#1)
required to assess the efficacy and safety of##2##8##(2005-11#1)(2007-11#1)
required to assess the##5##4##(1990-7#1)(2005-11#1)(2007-11#2)(2007-9#1)
required to assess##11##3##(1990-7#1)(1995-2#1)(1996-1#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-9#1)(2008-10#1)(2010-10#1)(2012-2#1)
required to avoid##2##3##(2008-3#1)(2009-3#1)
required to be##10##3##(1992-2#1)(1996-2#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#2)(2010-9#1)(2013-1#1)
required to better##3##3##(1990-6#1)(2008-11#1)(2013-1#1)
required to care for##2##4##(2007-12#1)(2010-5#1)
required to carry##2##3##(1994-11#1)(1995-12#1)
required to cause a 50%##2##5##(1994-3#1)(1995-8#1)
required to cause##6##3##(1994-3#2)(1994-9#1)(1995-11#1)(1995-3#1)(1995-8#1)
required to clarify the##6##4##(1992-9#1)(2005-10#1)(2007-11#1)(2010-8#1)(2011-2#1)(2012-2#1)
required to clarify##8##3##(1992-9#1)(1994-9#1)(2005-10#1)(2007-11#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
required to complement##2##3##(1995-5#1)(2012-3#1)
required to complete this##2##4##(2005-10#2)
required to complete##6##3##(1993-12#1)(2005-10#2)(2008-10#1)(2008-12#1)(2013-7#1)
required to comply with the##2##5##(2006-7#1)(2006-8#1)
required to confer##2##3##(1990-9#1)(1992-9#1)
required to confirm the##5##4##(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)
required to confirm##8##3##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2012-3#1)
required to control##3##3##(1990-6#1)(2008-1#1)(2008-10#1)
required to create##3##3##(2008-11#1)(2008-8#1)(2011-2#1)
required to deal with##2##4##(2006-12#1)(2008-10#1)
required to decide whether##2##4##(1993-2#1)(2006-6#1)
required to decrease##2##3##(1992-11#1)(2008-10#1)
required to define the##3##4##(2005-7#1)(2008-3#1)(2010-12#1)
required to demonstrate##3##3##(2008-11#1)(2008-8#1)(2010-4#1)
required to detect these##2##4##(1995-10#1)(2010-9#1)
required to detect##9##3##(1992-9#1)(1994-6#1)(1995-10#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-9#1)
required to determine the##14##4##(1991-4#1)(1993-2#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-12#1)(2010-11#1)(2010-2#1)(2012-12#1)(2012-2#1)
required to determine##22##3##(1991-4#1)(1992-12#1)(1992-7#1)(1993-2#1)(1994-9#1)(1997-5#1)(1997-7#1)(2006-11#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-12#1)(2010-11#1)(2010-2#1)(2012-12#1)(2012-2#1)
required to develop a##2##4##(2008-11#1)(2008-6#1)
required to develop##9##3##(1993-12#1)(2007-11#1)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#1)(2010-3#1)(2013-1#1)
required to do##2##3##(1995-12#1)(2010-4#1)
required to drive##3##3##(1994-6#1)(2008-5#1)(2009-12#1)
required to effect##2##3##(1993-4#1)(1996-1#1)
required to elicit##2##3##(1993-12#1)(1996-6#1)
required to elucidate##4##3##(1997-8#1)(2008-2#1)(2008-6#1)(2012-2#1)
required to enable the##2##4##(1997-4#1)(2008-7#1)
required to enable##3##3##(1997-4#1)(2008-11#1)(2008-7#1)
required to ensure that##8##4##(2008-11#1)(2008-3#1)(2008-5#1)(2009-4#1)(2012-12#2)(2012-3#1)(2013-1#1)
required to ensure the##2##4##(2007-12#1)(2008-11#1)
required to ensure##14##3##(1996-2#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-4#1)(2010-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
required to establish a##2##4##(2006-6#1)(2011-2#1)
required to establish the##5##4##(2007-11#1)(2007-7#1)(2007-8#1)(2012-3#1)(2013-1#1)
required to establish##18##3##(1994-2#1)(1995-12#1)(1996-9#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
required to estimate the##2##4##(1997-7#1)(2008-10#1)
required to estimate##4##3##(1996-11#1)(1997-7#1)(2008-10#2)
required to evaluate##5##3##(1993-11#1)(1995-2#1)(2008-10#1)(2009-4#1)(2011-2#1)
required to evoke##2##3##(1991-2#1)(1993-3#1)
required to exceed a cumulative catch of##2##7##(2008-10#2)
required to explain the##2##4##(1993-11#1)(2006-10#1)
required to explain##3##3##(1993-11#1)(2006-10#1)(2008-7#1)
required to express##2##3##(1991-9#1)(1994-8#1)
required to form a##3##4##(1995-11#1)(1996-5#1)(2005-11#1)
required to form##4##3##(1995-11#1)(1996-5#1)(2005-11#1)(2006-12#1)
required to fully##4##3##(1990-11#1)(2007-8#2)(2008-11#1)
required to gather##3##3##(2011-2#3)
required to generate the##2##4##(1995-2#1)(2008-10#1)
required to generate##5##3##(1994-7#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-4#1)
required to give 50%##2##4##(1997-4#1)(2010-5#1)
required to give a##2##4##(1995-10#1)(2007-8#1)
required to give##7##3##(1995-10#1)(1997-4#1)(2006-5#1)(2007-2#1)(2007-8#1)(2008-1#1)(2010-5#1)
required to guarantee##2##3##(2008-12#1)(2008-7#1)
required to have##7##3##(1990-12#1)(1993-12#1)(2008-10#1)(2008-7#1)(2010-4#1)(2010-8#1)(2013-1#1)
required to identify and##2##4##(1992-6#1)(1997-4#1)
required to identify##10##3##(1990-9#1)(1992-6#1)(1996-5#1)(1997-4#1)(2004-2#1)(2007-11#1)(2008-1#1)(2011-2#2)(2013-1#1)
required to implement##3##3##(2007-11#1)(2008-2#2)
required to improve the##5##4##(1994-6#1)(2006-10#1)(2008-10#2)(2011-1#1)
required to improve##11##3##(1994-6#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-9#1)(2008-10#2)(2008-7#1)(2010-3#1)(2011-1#1)(2011-2#1)
required to increase##2##3##(2004-10#1)(2012-3#1)
required to induce##10##3##(1994-11#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-3#1)(2011-12#1)(2011-2#1)
required to inhibit##4##3##(1990-7#1)(1995-2#1)(1997-2#1)(2011-1#1)
required to initiate##3##3##(1991-9#1)(1995-8#1)(2011-2#1)
required to investigate##5##3##(1995-2#1)(2006-12#1)(2010-7#1)(2012-2#1)(2013-1#1)
required to isolate##2##3##(1990-8#1)(2007-12#1)
required to kill##2##3##(1997-5#1)(2009-3#1)
required to maintain a##2##4##(1990-10#1)(2008-4#1)
required to maintain##12##3##(1990-10#1)(1991-9#1)(1992-2#1)(1994-11#1)(1996-8#1)(2006-10#1)(2006-3#1)(2007-7#1)(2008-4#1)(2012-2#2)(2013-1#1)
required to make##9##3##(1990-8#1)(1991-1#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2013-1#2)
required to manage##4##3##(1993-12#1)(1996-3#1)(1996-7#1)(2007-12#1)
required to maximize the##2##4##(2006-2#1)(2007-10#1)
required to mediate##3##3##(1990-6#1)(1993-9#1)(1997-2#1)
required to meet the##2##4##(1993-10#1)(2013-1#1)
required to meet##5##3##(1993-10#1)(2008-10#1)(2008-2#1)(2009-3#1)(2013-1#1)
required to obtain a##7##4##(1995-11#1)(1995-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)
required to obtain maximum##4##4##(2006-8#1)(2008-4#2)(2008-9#1)
required to obtain##23##3##(1990-11#1)(1991-7#1)(1992-11#1)(1992-12#1)(1995-11#1)(1995-9#1)(1997-4#1)(2005-11#1)(2006-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#3)(2011-2#1)
required to optimize##7##3##(2006-10#1)(2006-2#1)(2008-10#1)(2008-11#1)(2009-5#1)(2011-2#1)(2012-2#1)
required to overcome##2##3##(1996-2#1)(2007-11#1)
required to perform##6##3##(1990-12#1)(1993-2#1)(1995-8#1)(2006-6#1)(2008-4#1)(2010-7#1)
required to prepare##3##3##(2006-12#1)(2008-11#1)(2013-8#1)
required to prevent##5##3##(1991-8#1)(2006-8#1)(2008-3#1)(2009-1#1)(2010-1#1)
required to process##3##3##(2007-12#1)(2012-11#1)(2012-12#1)
required to produce a##7##4##(1990-8#1)(1993-12#1)(1994-6#1)(1995-5#1)(2004-9#1)(2008-11#1)(2008-5#1)
required to produce the##4##4##(1990-12#1)(1995-7#1)(2005-11#1)(2008-11#1)
required to produce##20##3##(1990-12#2)(1990-8#1)(1991-7#1)(1992-9#1)(1993-12#1)(1994-6#1)(1995-3#1)(1995-5#1)(1995-7#1)(2004-9#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-11#3)(2008-5#2)(2008-7#1)
required to properly##3##3##(2006-11#1)(2007-7#1)(2011-2#1)
required to protect the##2##4##(1993-11#1)(1996-9#1)
required to protect##4##3##(1993-11#1)(1996-9#1)(2008-10#1)(2008-11#1)
required to provide the##2##4##(2007-11#1)(2008-2#1)
required to provide##8##3##(1993-11#1)(1993-3#1)(1996-12#1)(2007-11#1)(2008-2#1)(2008-7#1)(2011-1#1)(2011-2#1)
required to reach the##4##4##(1994-9#1)(1996-5#1)(2008-10#1)(2013-8#1)
required to reach##12##3##(1990-11#1)(1991-11#1)(1994-9#1)(1996-1#1)(1996-5#1)(2007-12#1)(2007-9#1)(2008-10#3)(2009-9#1)(2013-8#1)
required to record##2##3##(2006-8#1)(2010-8#1)
required to reduce the##4##4##(1997-4#1)(2007-11#1)(2011-2#1)(2013-8#1)
required to reduce##6##3##(1997-4#1)(2007-11#1)(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
required to remove 95 per cent of the ivermectin-resistant O circumcincta and T colubriformis were##2##15##(1993-10#2)
required to remove##7##3##(1993-10#4)(1994-3#1)(2008-4#1)(2013-1#1)
required to respond##2##3##(2008-9#2)
required to restore##2##3##(2007-7#1)(2008-8#1)
required to return##2##3##(1993-12#1)(2008-3#1)
required to run##2##3##(1991-9#1)(2008-4#1)
required to satisfy the##3##4##(2013-1#3)
required to search##2##3##(1994-3#1)(2008-3#1)
required to separate##2##3##(2008-10#1)(2010-2#1)
required to show whether this##2##5##(1992-2#1)(2012-1#1)
required to show##3##3##(1992-2#1)(1995-5#1)(2012-1#1)
required to stabilize##3##3##(1996-5#1)(2008-5#1)(2009-8#1)
required to stimulate the##2##4##(1994-6#1)(2007-8#1)
required to stimulate##3##3##(1994-6#1)(2007-8#1)(2008-1#1)
required to study##2##3##(1992-6#1)(2013-8#1)
required to successfully##2##3##(2007-11#1)(2008-7#1)
required to support##3##3##(2004-10#1)(2008-7#1)(2010-10#1)
required to suppress##3##3##(2008-10#2)(2008-9#1)
required to sustain##4##3##(1990-11#1)(1991-2#1)(2005-7#1)(2012-3#1)
required to take##2##3##(2004-10#1)(2008-7#1)
required to test##2##3##(2008-6#2)
required to treat the##2##4##(2006-10#1)(2007-12#1)
required to treat##7##3##(1993-1#1)(1993-2#1)(2006-10#1)(2007-12#2)(2008-5#1)(2013-1#1)
required to understand##5##3##(2007-9#1)(2008-10#1)(2009-9#1)(2010-12#1)(2012-1#1)
required to undertake##2##3##(2008-11#2)
required to use the##2##4##(1992-11#1)(2008-3#1)
required to use##7##3##(1992-11#2)(2006-8#2)(2008-11#1)(2008-12#1)(2008-3#1)
required to validate##4##3##(2007-8#1)(2008-1#2)(2011-2#1)
required to verify##2##3##(2007-7#1)(2010-12#1)
required to visit##2##3##(1990-7#1)(2008-7#1)
required to##688##2##(1990-10#1)(1990-11#4)(1990-12#4)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#5)(1990-8#3)(1990-9#3)(1991-1#1)(1991-11#1)(1991-2#4)(1991-4#1)(1991-7#3)(1991-8#1)(1991-9#4)(1992-1#2)(1992-11#4)(1992-12#4)(1992-2#3)(1992-4#1)(1992-6#4)(1992-7#1)(1992-9#5)(1993-1#2)(1993-10#5)(1993-11#5)(1993-12#7)(1993-2#5)(1993-3#2)(1993-4#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#3)(1994-12#5)(1994-2#3)(1994-3#6)(1994-5#1)(1994-6#5)(1994-7#1)(1994-8#3)(1994-9#4)(1995-1#2)(1995-10#2)(1995-11#3)(1995-12#3)(1995-2#6)(1995-3#2)(1995-5#3)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#6)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#4)(1996-3#2)(1996-5#6)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#5)(1997-5#2)(1997-7#3)(1997-8#2)(2004-10#4)(2004-11#1)(2004-2#1)(2004-9#2)(2005-10#4)(2005-11#6)(2005-4#1)(2005-7#2)(2006-1#2)(2006-10#15)(2006-11#3)(2006-12#7)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#4)(2006-7#2)(2006-8#8)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#21)(2007-12#14)(2007-2#4)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#9)(2007-8#12)(2007-9#3)(2008-1#13)(2008-10#45)(2008-11#30)(2008-12#6)(2008-2#11)(2008-3#13)(2008-4#12)(2008-5#9)(2008-6#7)(2008-7#23)(2008-8#6)(2008-9#13)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#3)(2009-3#4)(2009-4#3)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#4)(2010-2#4)(2010-3#3)(2010-4#4)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#7)(2011-12#3)(2011-2#22)(2012-1#3)(2012-11#2)(2012-12#8)(2012-2#11)(2012-3#12)(2013-1#27)(2013-7#1)(2013-8#7)
required training##3##2##(2005-5#1)(2013-1#2)
required treatment##2##2##(1996-12#1)(2007-11#1)
required two##2##2##(2008-7#1)(2013-1#1)
required under HIPAA##2##3##(2006-7#2)
required under##3##2##(2006-7#2)(2012-2#1)
required urgent##2##2##(2008-3#1)(2013-1#1)
required us to##2##3##(1991-5#1)(2008-11#1)
required use of##2##3##(1992-3#1)(2011-2#1)
required ventilation##2##2##(2007-9#1)(2012-2#1)
required ventilatory support##3##3##(2006-10#1)(2007-8#2)
required was##4##2##(2008-11#1)(2010-6#3)
required were##2##2##(1995-12#1)(2007-10#1)
required when assessing the##2##4##(2005-5#1)(2007-8#1)
required when the##2##3##(1994-11#1)(1995-8#1)
required when##7##2##(1992-6#1)(1994-11#1)(1995-8#1)(2005-5#1)(2007-8#1)(2008-6#1)(2013-7#1)
required which##3##2##(1994-8#1)(2005-7#1)(2008-11#1)
required with the##3##3##(1994-3#2)(2013-7#1)
required with##8##2##(1994-3#2)(1994-6#1)(1997-1#1)(2005-8#1)(2009-11#1)(2010-11#1)(2013-7#1)
required would##2##2##(1996-2#1)(2009-5#1)
required##3318##1##(1990-10#6)(1990-11#15)(1990-12#11)(1990-2#10)(1990-3#5)(1990-4#6)(1990-5#10)(1990-6#14)(1990-7#12)(1990-8#22)(1990-9#8)(1991-1#7)(1991-10#5)(1991-11#16)(1991-12#10)(1991-2#11)(1991-3#6)(1991-4#5)(1991-5#12)(1991-6#6)(1991-7#12)(1991-8#9)(1991-9#9)(1992-1#5)(1992-10#3)(1992-11#9)(1992-12#17)(1992-2#11)(1992-3#8)(1992-4#8)(1992-5#9)(1992-6#15)(1992-7#11)(1992-8#3)(1992-9#13)(1993-1#5)(1993-10#7)(1993-11#20)(1993-12#21)(1993-2#16)(1993-3#17)(1993-4#11)(1993-5#1)(1993-6#15)(1993-8#5)(1993-9#14)(1994-1#2)(1994-10#2)(1994-11#25)(1994-12#36)(1994-2#16)(1994-3#25)(1994-4#2)(1994-5#10)(1994-6#15)(1994-7#2)(1994-8#35)(1994-9#26)(1995-1#14)(1995-10#8)(1995-11#15)(1995-12#14)(1995-2#35)(1995-3#31)(1995-4#5)(1995-5#12)(1995-6#27)(1995-7#4)(1995-8#21)(1995-9#6)(1996-1#14)(1996-10#4)(1996-11#9)(1996-12#16)(1996-2#19)(1996-3#19)(1996-4#7)(1996-5#28)(1996-6#6)(1996-7#9)(1996-8#23)(1996-9#19)(1997-1#11)(1997-2#8)(1997-3#20)(1997-4#23)(1997-5#10)(1997-6#14)(1997-7#16)(1997-8#9)(2004-10#10)(2004-11#5)(2004-12#2)(2004-2#2)(2004-3#1)(2004-4#1)(2004-9#4)(2005-10#13)(2005-11#14)(2005-12#2)(2005-2#2)(2005-3#2)(2005-4#2)(2005-5#5)(2005-7#6)(2005-8#6)(2005-9#2)(2006-1#5)(2006-10#51)(2006-11#9)(2006-12#20)(2006-2#6)(2006-3#5)(2006-4#10)(2006-5#12)(2006-6#16)(2006-7#9)(2006-8#19)(2006-9#6)(2007-1#5)(2007-10#9)(2007-11#68)(2007-12#75)(2007-2#13)(2007-3#13)(2007-4#8)(2007-5#6)(2007-6#2)(2007-7#23)(2007-8#64)(2007-9#21)(2008-1#43)(2008-10#260)(2008-11#87)(2008-12#21)(2008-2#81)(2008-3#110)(2008-4#60)(2008-5#35)(2008-6#27)(2008-7#76)(2008-8#25)(2008-9#45)(2009-1#2)(2009-10#26)(2009-11#5)(2009-12#6)(2009-2#8)(2009-3#17)(2009-4#12)(2009-5#8)(2009-6#13)(2009-7#6)(2009-8#25)(2009-9#8)(2010-1#5)(2010-10#8)(2010-11#16)(2010-12#16)(2010-2#12)(2010-3#9)(2010-4#18)(2010-5#9)(2010-6#7)(2010-7#20)(2010-8#8)(2010-9#8)(2011-1#35)(2011-10#1)(2011-12#7)(2011-2#81)(2012-1#18)(2012-11#8)(2012-12#80)(2012-2#59)(2012-3#52)(2012-4#1)(2013-1#95)(2013-7#9)(2013-8#33)
required)##3##1##(2006-11#1)(2007-8#1)(2010-8#1)
requirement and##5##2##(1991-2#1)(1996-12#1)(2007-12#1)(2008-12#1)(2010-2#1)
requirement by##3##2##(1992-11#1)(2008-10#1)(2008-6#1)
requirement for Ca2+ and##2##4##(1990-4#1)(1991-1#1)
requirement for Ca2+##3##3##(1990-4#1)(1991-1#1)(1994-12#1)
requirement for DNA##2##3##(1991-7#1)(1995-8#1)
requirement for Mg2+##3##3##(1990-8#1)(1991-7#1)(2005-9#1)
requirement for a##10##3##(1990-6#1)(1991-2#1)(1993-12#1)(1994-9#1)(1995-6#1)(1996-6#1)(2006-3#1)(2007-12#1)(2008-7#1)(2010-1#1)
requirement for additional##2##3##(1997-1#1)(2010-7#1)
requirement for an##4##3##(1992-8#1)(1993-7#1)(1994-8#1)(2010-3#1)
requirement for blood transfusion##2##4##(2007-8#2)
requirement for high##3##3##(1997-8#1)(2005-10#1)(2010-8#1)
requirement for long-term##2##3##(2008-10#1)(2011-2#1)
requirement for more than##2##4##(1996-1#1)(2011-2#1)
requirement for the presence of##2##5##(1990-5#1)(1995-5#1)
requirement for the##16##3##(1990-5#1)(1991-2#1)(1993-12#1)(1994-3#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-7#1)(2004-9#1)(2005-3#1)(2005-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-4#1)
requirement for these##2##3##(1995-4#1)(2012-12#1)
requirement for this##3##3##(1991-2#1)(1992-2#1)(1996-9#1)
requirement for##198##2##(1990-11#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#4)(1991-5#1)(1991-7#4)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#2)(1992-3#3)(1992-5#1)(1992-6#2)(1992-8#1)(1993-11#2)(1993-12#2)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#4)(1994-3#2)(1994-6#1)(1994-8#3)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#3)(1995-4#2)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-6#2)(1997-8#1)(2004-11#1)(2004-9#1)(2005-10#1)(2005-3#1)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2007-1#1)(2007-11#2)(2007-12#5)(2007-5#2)(2007-8#5)(2008-1#1)(2008-10#8)(2008-11#7)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#8)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#3)(2009-12#1)(2009-4#1)(2009-5#1)(2010-1#3)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#4)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#7)(2012-2#2)(2013-1#3)(2013-8#1)
requirement had##2##2##(2007-5#1)(2008-12#1)
requirement in the##3##3##(2009-8#1)(2011-1#1)(2013-1#1)
requirement in##13##2##(1991-12#1)(1991-2#1)(1994-11#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
requirement is##11##2##(1990-10#1)(1991-4#1)(1995-3#1)(1996-8#1)(1997-6#1)(2005-5#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
requirement of 0##2##3##(2008-7#1)(2013-8#1)
requirement of ATP and extra-ribosomal proteins for##2##7##(1992-1#2)
requirement of a##5##3##(1995-3#1)(2008-10#1)(2008-6#1)(2009-12#1)(2013-8#1)
requirement of protein##3##3##(1990-5#1)(1990-7#1)(2013-8#1)
requirement of specific##2##3##(1994-3#1)(2007-8#1)
requirement of the##11##3##(1990-5#2)(1991-4#1)(1991-8#1)(1994-8#1)(1996-5#1)(2005-8#1)(2005-9#1)(2007-9#1)(2008-3#1)(2011-1#1)
requirement of##76##2##(1990-12#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#1)(1991-4#1)(1991-8#1)(1992-1#2)(1992-10#1)(1992-2#1)(1993-3#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-5#2)(1997-1#1)(1997-2#1)(2005-4#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-8#1)(2007-12#2)(2007-8#1)(2007-9#4)(2008-10#3)(2008-11#3)(2008-2#3)(2008-3#6)(2008-6#1)(2008-7#5)(2009-12#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
requirement or prohibition##2##3##(2006-8#2)
requirement that##13##2##(1992-5#1)(1992-6#1)(1992-9#1)(1993-4#1)(1996-6#1)(1997-8#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-12#1)(2008-1#1)(2010-12#1)(2012-3#1)
requirement to##11##2##(1993-11#1)(1995-12#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2009-10#1)(2009-11#1)(2010-12#1)
requirement was increased##2##3##(1993-6#1)(2011-2#1)
requirement was##11##2##(1990-4#1)(1993-6#1)(1996-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2009-6#2)(2011-1#1)(2011-2#1)(2012-2#1)
requirement will##2##2##(2006-8#1)(2008-3#1)
requirement##432##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#6)(1990-3#2)(1990-4#2)(1990-5#4)(1990-6#2)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#4)(1991-2#6)(1991-4#2)(1991-5#1)(1991-6#2)(1991-7#4)(1991-8#2)(1991-9#1)(1992-1#3)(1992-10#2)(1992-11#2)(1992-2#4)(1992-3#4)(1992-5#2)(1992-6#4)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#2)(1993-3#2)(1993-4#2)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#4)(1994-12#4)(1994-2#1)(1994-3#3)(1994-6#1)(1994-8#4)(1994-9#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#6)(1995-4#2)(1995-5#2)(1995-6#3)(1995-8#2)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#3)(1996-9#2)(1997-1#3)(1997-2#2)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#2)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-3#1)(2005-4#1)(2005-5#1)(2005-7#1)(2005-8#2)(2005-9#3)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#5)(2007-1#2)(2007-11#5)(2007-12#12)(2007-2#2)(2007-4#1)(2007-5#3)(2007-8#9)(2007-9#5)(2008-1#4)(2008-10#23)(2008-11#16)(2008-12#3)(2008-2#15)(2008-3#14)(2008-4#3)(2008-5#3)(2008-6#4)(2008-7#15)(2008-8#6)(2008-9#3)(2009-10#3)(2009-11#4)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#2)(2010-1#3)(2010-11#1)(2010-12#6)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#4)(2010-8#2)(2011-1#7)(2011-12#1)(2011-2#10)(2012-1#1)(2012-12#8)(2012-2#9)(2012-3#3)(2012-8#1)(2013-1#6)(2013-8#7)
requirements and allowing##2##3##(2011-2#1)(2013-1#1)
requirements and limitations imposed by##2##5##(2008-11#1)(2013-7#1)
requirements and limitations##4##3##(2008-11#1)(2008-3#1)(2012-2#1)(2013-7#1)
requirements and solutions##2##3##(2006-6#1)(2010-8#1)
requirements and the##11##3##(1990-10#1)(1992-3#1)(1994-2#1)(1996-11#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-6#1)(2010-11#1)(2013-1#1)
requirements and##80##2##(1990-10#1)(1991-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1994-12#1)(1994-2#2)(1994-8#1)(1996-11#1)(1996-12#1)(1996-3#4)(1997-6#1)(2005-7#1)(2006-10#1)(2006-4#1)(2006-5#2)(2006-6#3)(2006-8#1)(2006-9#2)(2007-11#2)(2007-12#4)(2007-2#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-2#2)(2010-8#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#2)
requirements are increased##2##3##(1995-9#1)(2007-12#1)
requirements are presented##2##3##(2008-5#1)(2010-8#1)
requirements are##24##2##(1994-2#1)(1994-3#1)(1994-6#1)(1995-9#1)(1996-3#1)(1996-8#1)(2006-11#1)(2006-8#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#2)(2010-8#1)(2010-9#1)(2012-1#1)
requirements as well as##2##4##(2008-9#1)(2012-3#1)
requirements as##8##2##(1991-5#1)(1997-3#1)(2005-10#1)(2008-11#1)(2008-8#1)(2008-9#2)(2012-3#1)
requirements at##4##2##(2006-12#3)(2012-12#1)
requirements between##2##2##(2007-11#1)(2010-9#1)
requirements by##4##2##(2007-11#1)(2012-1#1)(2012-2#1)(2013-1#1)
requirements can be##2##3##(1997-1#1)(2011-2#1)
requirements can##3##2##(1997-1#1)(2010-7#1)(2011-2#1)
requirements concerning##2##2##(1992-11#1)(1994-4#1)
requirements control##2##2##(1993-6#1)(2008-10#1)
requirements during##6##2##(2004-11#1)(2007-7#1)(2009-5#1)(2010-2#1)(2010-7#1)(2012-3#1)
requirements for a##13##3##(1991-2#1)(1994-12#1)(1994-6#1)(2004-9#1)(2006-2#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-12#1)
requirements for binding to the##2##5##(1992-8#1)(1997-2#1)
requirements for binding##3##3##(1992-8#1)(1997-2#2)
requirements for effective##2##3##(1997-4#1)(2011-1#1)
requirements for evaluating##2##3##(2005-9#1)(2007-1#1)
requirements for future##2##3##(1994-1#1)(1994-6#1)
requirements for maximal##2##3##(1990-3#1)(1993-8#1)
requirements for obtaining##2##3##(1994-6#1)(2008-4#1)
requirements for oxygen##2##3##(1991-6#1)(2008-9#1)
requirements for signal transduction##2##4##(1990-7#1)(2008-4#1)
requirements for signal##3##3##(1990-7#2)(2008-4#1)
requirements for specific antibodies##2##4##(2012-12#2)
requirements for specific##3##3##(1994-9#1)(2012-12#2)
requirements for such##2##3##(2008-3#1)(2008-8#1)
requirements for the##27##3##(1990-8#1)(1991-12#1)(1991-6#1)(1992-6#1)(1994-12#1)(1994-9#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-4#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#3)(2013-8#1)
requirements for this##3##3##(1993-10#1)(1994-9#1)(2008-7#1)
requirements for zinc##2##3##(2004-11#2)
requirements for##226##2##(1990-11#2)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#3)(1992-6#1)(1992-8#1)(1992-9#2)(1993-10#1)(1993-12#1)(1993-2#3)(1993-3#2)(1993-4#1)(1993-8#2)(1994-1#1)(1994-12#5)(1994-2#2)(1994-3#3)(1994-6#5)(1994-8#3)(1994-9#4)(1995-3#2)(1995-5#1)(1995-7#1)(1996-1#2)(1996-12#1)(1996-2#3)(1997-1#2)(1997-2#3)(1997-4#3)(1997-6#1)(2004-11#2)(2004-9#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#2)(2005-9#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#2)(2007-1#1)(2007-11#4)(2007-12#2)(2007-4#3)(2007-6#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#5)(2008-12#1)(2008-2#11)(2008-3#7)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#2)(2009-10#2)(2009-12#1)(2009-3#2)(2009-5#1)(2009-8#2)(2010-1#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#3)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#2)(2012-4#1)(2013-1#8)(2013-8#1)
requirements from a##2##3##(2007-8#1)(2007-9#1)
requirements from##3##2##(2007-8#1)(2007-9#1)(2010-8#1)
requirements has##2##2##(2006-10#1)(2008-3#1)
requirements have##5##2##(1991-12#1)(1994-3#1)(2007-8#1)(2008-7#1)(2009-3#1)
requirements in a##2##3##(2008-1#1)(2008-2#1)
requirements in patients##3##3##(2007-7#1)(2007-9#2)
requirements in terms of##2##4##(2005-5#1)(2011-1#1)
requirements in the##7##3##(1992-11#1)(1996-12#1)(1996-2#1)(2005-10#1)(2007-5#1)(2008-11#1)(2012-3#1)
requirements in##27##2##(1992-11#1)(1996-12#1)(1996-2#1)(1996-9#1)(2005-10#2)(2005-11#1)(2005-5#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#2)(2009-6#1)(2010-12#1)(2010-8#2)(2011-1#1)(2012-3#1)
requirements is##4##2##(1993-11#1)(2008-2#1)(2008-7#1)(2009-1#1)
requirements must be##4##3##(1993-12#1)(1994-1#1)(1997-2#1)(2008-7#1)
requirements of a##11##3##(1990-9#1)(1993-9#1)(1996-2#1)(1997-2#1)(2008-1#2)(2009-11#1)(2009-5#1)(2012-12#2)(2013-1#1)
requirements of an##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
requirements of many##2##3##(2008-10#1)(2008-2#1)
requirements of the European Pharmacopoeia##2##5##(2007-8#1)(2012-12#1)
requirements of the##47##3##(1991-4#1)(1992-1#1)(1993-10#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-5#3)(1996-12#2)(1996-2#1)(2005-9#1)(2006-11#1)(2006-8#2)(2007-10#1)(2007-12#2)(2007-8#2)(2007-9#1)(2008-11#2)(2008-2#3)(2008-3#5)(2008-4#1)(2008-7#2)(2008-8#1)(2009-6#1)(2011-1#2)(2011-2#1)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#1)
requirements of their##3##3##(1996-3#1)(2009-4#1)(2012-2#1)
requirements of##129##2##(1990-9#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-3#3)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-9#2)(1995-3#1)(1995-5#3)(1995-9#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-5#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-5#2)(2006-7#2)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#9)(2008-3#9)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#2)
requirements on the##4##3##(2008-2#1)(2008-3#1)(2009-10#1)(2011-2#1)
requirements on##12##2##(1990-12#1)(1993-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#2)(2009-10#1)(2010-5#1)(2011-2#1)(2013-1#1)
requirements or##2##2##(2008-7#1)(2011-1#1)
requirements put forth##2##3##(1997-3#1)(2009-12#1)
requirements related to##2##3##(1994-11#1)(2010-8#1)
requirements seem to##2##3##(1992-1#1)(2009-11#1)
requirements set forth by the##2##5##(1993-2#1)(1993-3#1)
requirements such as##4##3##(2007-3#1)(2007-8#1)(2008-5#1)(2008-6#1)
requirements that##10##2##(1993-12#1)(1993-2#2)(1993-3#1)(1994-5#1)(2005-5#1)(2008-2#1)(2008-8#1)(2011-2#1)(2013-1#1)
requirements to form##2##3##(1994-9#1)(2007-6#1)
requirements to##19##2##(1990-12#1)(1994-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-12#1)(2007-11#1)(2007-5#1)(2007-6#1)(2008-3#1)(2008-7#1)(2009-12#1)(2012-1#1)(2013-1#4)(2013-7#1)(2013-8#1)
requirements under the##3##3##(1991-1#1)(1993-1#1)(1994-2#1)
requirements under##4##2##(1991-1#1)(1991-12#1)(1993-1#1)(1994-2#1)
requirements using##4##2##(2006-7#1)(2008-8#1)(2012-1#1)(2013-7#1)
requirements were##7##2##(1990-5#1)(1994-2#1)(1995-1#1)(1996-12#1)(2007-7#1)(2008-7#1)(2013-1#1)
requirements when##2##2##(2006-10#1)(2008-3#1)
requirements will##2##2##(2008-10#1)(2012-1#1)
requirements with##2##2##(1993-2#1)(1995-1#1)
requirements##900##1##(1990-10#2)(1990-11#2)(1990-12#5)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#4)(1990-8#1)(1990-9#2)(1991-1#4)(1991-11#5)(1991-12#8)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#3)(1992-11#4)(1992-12#3)(1992-2#3)(1992-3#7)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#5)(1993-1#4)(1993-10#2)(1993-11#1)(1993-12#8)(1993-2#11)(1993-3#8)(1993-4#1)(1993-6#1)(1993-8#5)(1993-9#1)(1994-1#3)(1994-11#1)(1994-12#11)(1994-2#9)(1994-3#7)(1994-4#2)(1994-5#1)(1994-6#7)(1994-8#4)(1994-9#8)(1995-1#4)(1995-12#1)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#5)(1995-6#1)(1995-7#1)(1995-9#2)(1996-1#5)(1996-11#1)(1996-12#6)(1996-2#7)(1996-3#11)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#6)(1997-3#4)(1997-4#4)(1997-6#2)(2004-1#1)(2004-11#3)(2004-9#3)(2005-10#7)(2005-11#4)(2005-12#1)(2005-5#3)(2005-7#1)(2005-8#2)(2005-9#2)(2006-10#12)(2006-11#7)(2006-12#5)(2006-2#4)(2006-4#3)(2006-5#5)(2006-6#9)(2006-7#6)(2006-8#7)(2006-9#3)(2007-1#3)(2007-10#1)(2007-11#15)(2007-12#13)(2007-2#5)(2007-3#1)(2007-4#14)(2007-5#3)(2007-6#9)(2007-7#7)(2007-8#14)(2007-9#8)(2008-1#8)(2008-10#42)(2008-11#16)(2008-12#10)(2008-2#35)(2008-3#45)(2008-4#11)(2008-5#10)(2008-6#9)(2008-7#30)(2008-8#17)(2008-9#14)(2009-1#1)(2009-10#3)(2009-11#3)(2009-12#4)(2009-3#6)(2009-4#3)(2009-5#4)(2009-6#4)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#4)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#18)(2010-9#4)(2011-1#9)(2011-12#2)(2011-2#17)(2012-1#10)(2012-11#4)(2012-12#18)(2012-2#23)(2012-3#10)(2012-4#1)(2013-1#37)(2013-7#6)(2013-8#10)
requirements)##5##1##(1996-2#1)(2005-10#3)(2007-12#1)
requirements]##3##1##(1997-7#1)(2008-12#1)(2008-8#1)
requires ATP##2##2##(1991-5#1)(1994-12#1)
requires NF-kappa B##2##3##(1993-3#1)(2010-3#1)
requires a better understanding of##2##5##(2007-10#1)(2012-3#1)
requires a clear##2##3##(2009-9#1)(2012-12#1)
requires a combined##2##3##(2007-11#1)(2010-12#1)
requires a complex##2##3##(2005-10#1)(2008-4#1)
requires a comprehensive approach##2##4##(2005-10#1)(2008-3#1)
requires a detailed##3##3##(1992-2#1)(2007-12#1)(2010-8#1)
requires a different##2##3##(2008-11#1)(2013-1#1)
requires a full##2##3##(1996-12#1)(1996-3#1)
requires a good##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
requires a high index of suspicion##4##6##(2010-10#1)(2010-5#1)(2011-2#2)
requires a high level of##2##5##(1995-3#1)(2008-10#1)
requires a high##10##3##(1995-3#1)(2008-10#2)(2008-4#1)(2010-10#1)(2010-5#1)(2011-2#3)(2012-3#1)
requires a knowledge of##2##4##(1996-12#1)(2010-2#1)
requires a large##4##3##(2007-12#1)(2007-7#1)(2011-2#1)(2013-1#1)
requires a long-term##4##3##(1994-1#1)(2006-5#1)(2007-6#1)(2008-7#1)
requires a meticulous##2##3##(2008-10#1)(2008-8#1)
requires a minimum##3##3##(2006-9#1)(2008-10#1)(2008-2#1)
requires a much##2##3##(2008-10#1)(2008-2#1)
requires a multidisciplinary approach##5##4##(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
requires a number of##2##4##(2007-6#1)(2008-7#1)
requires a reliable##2##3##(2007-7#1)(2008-4#1)
requires a reorientation of##2##4##(1997-1#1)(2011-2#1)
requires a search for##2##4##(1996-8#1)(2009-4#1)
requires a significant##2##3##(2006-10#1)(2010-2#1)
requires a sound##2##3##(2008-9#1)(2011-2#1)
requires a source of##2##4##(2004-4#1)(2008-4#1)
requires a specific##2##3##(1991-8#1)(1996-4#1)
requires a suitable##4##3##(2008-11#2)(2012-12#1)(2013-8#1)
requires a systematic##3##3##(2005-8#1)(2007-1#1)(2009-7#1)
requires a team##3##3##(2007-12#1)(2013-1#2)
requires a thorough understanding of the##2##6##(2005-7#1)(2006-12#1)
requires a thorough understanding of##6##5##(2005-7#1)(2006-10#1)(2006-12#1)(2008-5#1)(2008-8#1)(2010-4#1)
requires a thorough##9##3##(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#2)(2008-5#1)(2008-8#1)(2010-4#1)(2010-7#1)
requires a##204##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-2#1)(1993-1#1)(1993-10#1)(1993-3#1)(1993-9#1)(1994-1#3)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#3)(1996-5#1)(1996-7#3)(1996-8#3)(1997-1#1)(1997-4#2)(1997-6#1)(2004-4#1)(2005-10#2)(2005-5#2)(2005-7#1)(2005-8#1)(2006-10#5)(2006-11#2)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#9)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#3)(2008-1#4)(2008-10#14)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#8)(2008-4#5)(2008-5#1)(2008-7#6)(2008-8#4)(2008-9#4)(2009-10#1)(2009-4#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#3)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#9)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#6)(2013-8#2)
requires acceptance of##2##3##(1995-12#1)(2007-4#1)
requires accurate##8##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-9#1)(2010-4#1)(2010-9#1)(2011-2#1)
requires activation##2##2##(1995-3#1)(1997-7#1)
requires active##5##2##(1992-1#1)(1992-9#1)(1993-6#1)(2008-7#1)(2009-7#1)
requires additional steps##2##3##(2008-10#1)(2008-4#1)
requires additional##12##2##(1990-3#1)(1991-11#1)(1996-2#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2010-8#1)(2013-1#2)
requires adequate##6##2##(2005-3#1)(2006-3#1)(2008-5#1)(2010-6#1)(2011-2#1)(2012-2#1)
requires all##2##2##(2008-10#1)(2012-12#1)
requires an additional##3##3##(1991-12#1)(2007-12#1)(2008-4#1)
requires an approach##2##3##(2006-5#1)(2012-12#1)
requires an assessment##2##3##(1996-2#1)(2006-5#1)
requires an efficient##2##3##(1993-8#1)(2011-1#1)
requires an integrated##3##3##(2006-7#1)(2009-4#1)(2012-1#1)
requires an understanding of the##6##5##(2006-10#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-8#1)
requires an understanding of##8##4##(1995-2#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)
requires an understanding##9##3##(1995-2#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-1#1)
requires an##48##2##(1990-3#1)(1991-10#1)(1991-12#2)(1991-9#1)(1992-7#1)(1993-2#1)(1993-8#2)(1994-8#1)(1995-2#2)(1996-10#1)(1996-2#2)(2006-10#2)(2006-5#2)(2006-7#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-3#2)
requires appropriate##3##2##(2006-10#1)(2013-1#2)
requires at least two##3##4##(1995-10#1)(2008-1#1)(2011-2#1)
requires at least##6##3##(1995-10#1)(1995-8#1)(2007-9#1)(2008-1#1)(2011-2#1)(2012-2#1)
requires at##8##2##(1995-10#1)(1995-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
requires attention to the##3##4##(2006-3#1)(2007-11#1)(2011-1#1)
requires attention to##5##3##(2006-3#1)(2007-11#1)(2007-12#1)(2008-9#1)(2011-1#1)
requires attention##7##2##(2006-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-1#1)
requires better##3##2##(1994-3#1)(1996-8#1)(2013-8#1)
requires both a##2##3##(1990-10#1)(2008-7#1)
requires both an##3##3##(1991-5#1)(2007-12#2)
requires both##15##2##(1990-10#1)(1990-8#1)(1991-5#1)(1994-2#1)(1994-9#1)(1995-8#1)(1996-3#2)(2007-12#2)(2007-7#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)
requires careful assessment##2##3##(2007-12#1)(2011-1#1)
requires careful consideration##2##3##(2007-12#1)(2008-4#1)
requires careful##18##2##(1995-5#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-11#1)(2008-4#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
requires certain##2##2##(1997-8#1)(2008-2#1)
requires characterization of the##2##4##(1991-6#1)(1993-9#1)
requires clarification##2##2##(1996-8#1)(2008-11#1)
requires clinical experience##2##3##(2007-12#2)
requires clinical##3##2##(1996-12#1)(2007-12#2)
requires close##4##2##(1997-4#1)(2008-9#1)(2010-6#1)(2012-2#1)
requires collaboration between##2##3##(1992-3#1)(2009-4#1)
requires complex##2##2##(1991-6#1)(1997-7#1)
requires computationally##2##2##(2008-2#1)(2009-8#1)
requires conceptual##2##2##(1996-12#1)(2012-2#1)
requires confirmation##3##2##(2007-9#1)(2009-8#1)(2012-12#1)
requires considerable experience##4##3##(1992-2#1)(2007-11#1)(2007-5#1)(2008-4#1)
requires considerable##8##2##(1992-2#1)(2007-11#1)(2007-5#1)(2008-11#1)(2008-3#1)(2008-4#2)(2013-1#1)
requires consideration of the##2##4##(2007-11#1)(2011-1#1)
requires considering##2##2##(2009-3#1)(2012-3#1)
requires constant##2##2##(2005-8#1)(2013-1#1)
requires continuous##5##2##(1991-12#1)(1992-12#1)(2006-10#2)(2009-11#1)
requires control##2##2##(2009-2#1)(2012-3#1)
requires cooperation##3##2##(1990-7#1)(1996-1#1)(2008-10#1)
requires derivatization##2##2##(2008-10#1)(2013-7#1)
requires detailed knowledge of##2##4##(1991-11#1)(2012-1#1)
requires detailed##5##2##(1991-11#1)(1995-12#1)(2007-8#1)(2009-8#1)(2012-1#1)
requires detection##2##2##(1994-2#1)(2006-10#1)
requires different##4##2##(1995-3#1)(2006-10#1)(2008-9#1)(2013-1#1)
requires direct##3##2##(1993-2#1)(2008-4#1)(2011-2#1)
requires early diagnosis and##2##4##(2010-9#1)(2012-12#1)
requires early##4##2##(2008-4#1)(2009-10#1)(2010-9#1)(2012-12#1)
requires effective##2##2##(2007-11#1)(2009-8#1)
requires efficient and##2##3##(2008-2#1)(2013-7#1)
requires efficient##3##2##(2008-2#2)(2013-7#1)
requires either##4##2##(1992-12#1)(1993-8#1)(2006-10#1)(2006-8#1)
requires elimination##2##2##(2008-4#1)(2008-9#1)
requires employers to##3##3##(2006-8#3)
requires estimation of##2##3##(2007-12#1)(2007-7#1)
requires evidence##2##2##(2005-10#1)(2008-11#1)
requires experience##2##2##(1996-2#1)(2007-4#1)
requires expertise in##2##3##(2007-8#1)(2008-10#1)
requires expertise##3##2##(1994-1#1)(2007-8#1)(2008-10#1)
requires extensive##2##2##(2008-4#1)(2011-2#1)
requires extraction##2##2##(2008-10#2)
requires favorable##2##2##(2005-11#1)(2008-10#1)
requires fewer##5##2##(2006-10#1)(2008-1#1)(2008-2#2)(2013-1#1)
requires first##2##2##(2005-8#1)(2008-11#1)
requires five##2##2##(1990-7#1)(1995-2#1)
requires for##2##2##(2005-10#1)(2008-10#1)
requires further clarification##4##3##(2005-8#1)(2007-11#2)(2008-12#1)
requires further development to##2##4##(1993-12#1)(1996-12#1)
requires further development##6##3##(1993-12#1)(1996-12#1)(1997-4#1)(2008-10#2)(2008-11#1)
requires further evaluation##3##3##(2007-7#1)(2010-10#1)(2010-7#1)
requires further investigation##6##3##(1992-10#1)(1996-5#2)(2006-4#1)(2008-6#1)(2008-7#1)
requires further research##2##3##(2005-3#1)(2010-5#1)
requires further study##7##3##(1990-6#1)(1996-6#1)(2007-11#1)(2007-7#2)(2008-6#1)(2010-4#1)
requires further##40##2##(1990-6#1)(1990-8#1)(1992-10#1)(1993-11#1)(1993-12#1)(1996-12#1)(1996-5#2)(1996-6#1)(1997-4#1)(2005-3#1)(2005-8#1)(2006-4#1)(2007-11#3)(2007-7#3)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-10#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-7#1)
requires genetic##2##2##(2007-11#1)(2008-8#1)
requires good##3##2##(1994-2#1)(1996-12#1)(2007-11#1)
requires high index of suspicion##2##5##(2009-7#1)(2013-8#1)
requires high##10##2##(1993-12#1)(2005-11#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2013-1#1)(2013-8#1)
requires hospitalization##2##2##(2007-12#1)(2010-8#1)
requires host##2##2##(1994-5#1)(1994-8#1)
requires huge##2##2##(1997-8#1)(2010-4#1)
requires identification of##3##3##(1996-3#1)(2007-12#1)(2008-11#1)
requires immediate treatment##2##3##(2006-4#1)(2007-3#1)
requires immediate##5##2##(1993-10#1)(1993-4#1)(2006-4#1)(2007-3#1)(2008-9#1)
requires improved##2##2##(1994-11#1)(2006-8#1)
requires in vitro##2##3##(2008-8#1)(2009-11#1)
requires in##4##2##(2008-11#1)(2008-8#2)(2009-11#1)
requires individuals##2##2##(1994-12#1)(2008-11#1)
requires information##2##2##(2008-10#1)(2010-8#1)
requires intact##2##2##(1993-2#1)(2008-7#1)
requires integration of##2##3##(1990-9#1)(2008-3#1)
requires interaction##2##2##(1991-5#1)(2008-4#1)
requires interactions##2##2##(1994-10#1)(2012-2#1)
requires investigation##3##2##(1996-1#1)(1997-2#1)(2011-2#1)
requires investment in##2##3##(2008-11#1)(2012-3#1)
requires is##2##2##(1994-1#1)(1997-8#1)
requires its##3##2##(1990-3#1)(1996-8#1)(2009-2#1)
requires knowledge of the##9##4##(1990-10#1)(2006-9#1)(2007-1#1)(2007-11#1)(2008-2#4)(2008-4#1)
requires knowledge of their##2##4##(2008-10#1)(2010-2#1)
requires knowledge of##19##3##(1990-10#1)(1996-4#1)(2005-8#1)(2006-9#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-2#4)(2008-3#2)(2008-4#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-2#1)
requires knowledge##20##2##(1990-10#1)(1996-4#1)(2005-8#1)(2006-9#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-2#4)(2008-3#2)(2008-4#1)(2009-4#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-2#1)
requires large##4##2##(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#1)
requires larger##2##2##(2008-4#1)(2008-9#1)
requires less##7##2##(1996-3#1)(2006-3#1)(2008-11#1)(2008-4#1)(2009-4#1)(2010-7#1)(2011-2#1)
requires little##8##2##(1990-5#1)(2005-7#1)(2007-11#1)(2008-10#2)(2008-2#1)(2009-8#1)(2012-1#1)
requires long##2##2##(1994-8#1)(2008-7#1)
requires low##2##2##(1997-2#1)(2008-10#1)
requires many##2##2##(2006-10#2)
requires measurement of##2##3##(1993-11#1)(2007-12#1)
requires minimal##5##2##(1990-1#1)(2008-11#1)(2008-2#1)(2009-10#1)(2013-1#1)
requires more attention##2##3##(1993-9#1)(2012-12#1)
requires more sophisticated##2##3##(1996-12#1)(2008-10#1)
requires more than one##2##4##(1997-1#1)(2008-8#1)
requires more than the##2##4##(2006-7#1)(2008-11#1)
requires more than##6##3##(1990-12#1)(1997-1#1)(2006-7#1)(2008-11#1)(2008-7#1)(2008-8#1)
requires more##19##2##(1990-12#1)(1993-9#1)(1995-4#1)(1996-12#1)(1997-1#1)(1997-2#1)(2006-1#1)(2006-5#1)(2006-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-7#2)(2008-8#1)(2012-12#1)
requires much less##2##3##(2008-2#1)(2008-3#1)
requires much##4##2##(1991-5#1)(1996-4#1)(2008-2#1)(2008-3#1)
requires multiple##7##2##(1994-3#1)(1997-4#1)(2008-1#1)(2008-2#1)(2008-3#3)
requires neither a##2##3##(2008-3#2)
requires new##4##2##(1995-5#1)(1996-2#1)(2008-7#1)(2013-7#1)
requires no additional##3##3##(2007-12#2)(2008-4#1)
requires no specialized##2##3##(2008-11#1)(2010-3#1)
requires no##30##2##(1994-1#1)(1994-3#1)(1996-1#1)(2006-5#1)(2007-11#2)(2007-12#7)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#1)(2010-3#1)(2012-12#1)
requires not only##4##3##(1990-9#1)(1992-9#1)(1994-11#1)(1995-8#1)
requires one##3##2##(1994-9#1)(2008-2#1)(2008-5#1)
requires only a single##7##4##(1996-2#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)
requires only a##15##3##(1996-2#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)
requires only one##2##3##(1990-11#1)(1997-8#1)
requires only that the##2##4##(2007-12#1)(2008-8#1)
requires only the##4##3##(1993-6#1)(1995-1#1)(1997-6#1)(2008-3#1)
requires only two##3##3##(2008-2#2)(2008-3#1)
requires only##47##2##(1990-11#1)(1990-4#1)(1992-12#1)(1992-2#1)(1993-6#1)(1995-1#1)(1995-9#1)(1996-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-9#1)(2007-11#2)(2007-12#4)(2008-1#3)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#4)(2008-7#1)(2008-8#2)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#1)
requires participation of##2##3##(1994-12#1)(1995-8#1)
requires patients to##2##3##(2008-10#1)(2010-4#1)
requires phosphorylation##2##2##(1996-2#1)(1996-5#1)
requires physicians##2##2##(1996-6#1)(2007-12#1)
requires precise##6##2##(2006-6#1)(2007-8#1)(2008-11#1)(2008-2#1)(2009-12#1)(2010-6#1)
requires preoperative planning##2##3##(2007-12#1)(2008-7#1)
requires prior##2##2##(2008-10#1)(2009-5#1)
requires processing##2##2##(2008-2#1)(2012-1#1)
requires prolonged##2##2##(1994-6#1)(2007-9#1)
requires prompt##2##2##(2006-10#1)(2009-4#1)
requires proper##3##2##(1991-11#1)(2007-8#1)(2012-2#1)
requires quantifying##3##2##(2012-2#1)(2013-1#2)
requires rapid##5##2##(1997-3#1)(2007-2#1)(2008-3#1)(2009-9#1)(2011-1#1)
requires relatively##2##2##(2008-10#1)(2008-4#1)
requires reliable##2##2##(2008-11#1)(2010-4#1)
requires repeated##2##2##(1995-12#1)(1997-4#1)
requires selection of the##2##4##(2008-3#1)(2008-4#1)
requires several##2##2##(2008-1#1)(2008-3#1)
requires significant##4##2##(1993-2#1)(2005-11#1)(2008-2#1)(2009-6#1)
requires simple##2##2##(2008-10#2)
requires simultaneous##2##2##(1994-9#1)(2007-12#1)
requires small##3##2##(1994-12#1)(2007-12#1)(2008-10#1)
requires some##7##2##(1992-1#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-9#2)(2012-12#1)
requires sophisticated##3##2##(1992-3#1)(2008-10#1)(2013-8#1)
requires special##5##2##(1996-7#1)(2007-8#1)(2008-8#1)(2011-2#1)(2012-12#1)
requires specific##5##2##(1996-12#1)(2007-12#1)(2008-10#1)(2011-2#1)(2013-1#1)
requires specification of only##2##4##(2007-12#1)(2008-2#1)
requires specification of the##3##4##(1995-6#1)(1997-8#1)(2009-2#1)
requires specification of##5##3##(1995-6#1)(1997-8#1)(2007-12#1)(2008-2#1)(2009-2#1)
requires stable##2##2##(2010-5#1)(2012-2#1)
requires strong##4##2##(1994-3#1)(1995-2#1)(2008-10#1)(2012-2#1)
requires substantial##5##2##(1992-8#1)(2007-7#1)(2008-1#1)(2010-1#1)(2011-1#1)
requires sufficient##3##2##(2008-4#1)(2009-12#2)
requires support##2##2##(1991-12#1)(1992-2#1)
requires surgery##3##2##(1993-10#1)(2006-3#1)(2013-8#1)
requires surgical##4##2##(1991-6#1)(1994-9#1)(2008-4#1)(2009-9#1)
requires taking##2##2##(1994-11#1)(2005-8#1)
requires that a##4##3##(1992-11#1)(1994-3#1)(2006-10#1)(2008-3#1)
requires that the cells##2##4##(1990-7#1)(2008-11#1)
requires that the##21##3##(1990-6#1)(1990-7#1)(1995-12#1)(1996-3#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-8#2)(2008-9#1)(2010-9#1)(2012-1#1)(2012-11#2)
requires that##46##2##(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#1)(1992-11#1)(1993-1#1)(1993-9#1)(1994-1#1)(1994-3#1)(1995-10#1)(1995-12#1)(1995-5#1)(1996-3#3)(1996-9#1)(1997-6#2)(2006-10#2)(2007-11#2)(2007-5#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-8#2)(2008-9#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-11#2)
requires the ability to##3##4##(2007-12#1)(2009-8#1)(2010-10#1)
requires the activation of protein kinase C##2##7##(1990-12#1)(1996-5#1)
requires the assumption that##2##4##(2006-5#1)(2009-11#1)
requires the availability of##2##4##(2008-10#2)
requires the calculation of##2##4##(2008-2#1)(2008-3#1)
requires the demonstration of##2##4##(2005-7#1)(2010-4#1)
requires the development of##2##4##(1997-3#1)(2012-3#1)
requires the efficient##2##3##(1992-8#1)(2008-3#1)
requires the establishment of a##2##5##(2009-9#1)(2010-4#1)
requires the establishment of##3##4##(2009-8#1)(2009-9#1)(2010-4#1)
requires the following##2##3##(1996-12#1)(2008-2#1)
requires the formation of a##2##5##(1995-1#1)(1997-5#1)
requires the formation of##4##4##(1995-1#1)(1997-5#1)(2008-2#1)(2008-4#1)
requires the function of##3##4##(1991-10#1)(1991-5#1)(1992-5#1)
requires the integration of##4##4##(1995-12#1)(2012-12#2)(2012-2#1)
requires the interaction of the##2##5##(1994-12#1)(1995-3#1)
requires the knowledge of the##2##5##(2008-10#1)(2012-11#1)
requires the knowledge of##3##4##(2008-10#1)(2008-7#1)(2012-11#1)
requires the measurement of##2##4##(2008-3#1)(2008-9#1)
requires the participation of##2##4##(1992-5#1)(2006-11#1)
requires the patient's##2##3##(2006-3#1)(2010-12#1)
requires the presence of ATP and##2##6##(1994-9#1)(1995-3#1)
requires the presence of the##3##5##(1991-9#1)(1995-1#1)(1995-3#1)
requires the presence of##15##4##(1990-7#1)(1991-9#1)(1992-11#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#2)(1995-6#1)(1996-4#1)(1996-5#1)(1997-7#1)(2006-12#1)(2008-4#1)
requires the sequential##2##3##(1990-2#1)(1995-2#1)
requires the simultaneous##2##3##(1996-10#1)(2007-11#1)
requires the two##2##3##(2008-8#1)(2010-12#1)
requires the use of a##2##5##(2008-3#1)(2011-2#1)
requires the use of an##2##5##(1990-3#1)(1996-5#1)
requires the use of##16##4##(1990-3#1)(1996-5#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-5#1)(2010-11#2)(2010-2#1)(2011-12#1)(2011-2#1)(2012-12#1)
requires the##160##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#3)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-5#2)(1992-7#1)(1992-8#1)(1993-1#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#3)(1995-6#3)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#4)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-3#2)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#7)(2008-3#5)(2008-4#7)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-4#3)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
requires these##2##2##(1994-7#1)(2007-7#1)
requires this##2##2##(2008-8#1)(2009-8#1)
requires three##3##2##(1995-4#1)(1997-4#1)(2007-7#1)
requires time##2##2##(2008-11#1)(2010-9#1)
requires to##2##2##(2010-1#1)(2011-2#1)
requires two##5##2##(1994-6#1)(1996-7#1)(1997-2#1)(2007-9#1)(2008-3#1)
requires tyrosine phosphorylation##2##3##(1990-3#1)(1990-8#1)
requires tyrosine##3##2##(1990-3#1)(1990-8#1)(2008-3#1)
requires understanding of the##2##4##(2008-3#1)(2011-2#1)
requires understanding##3##2##(2007-11#1)(2008-3#1)(2011-2#1)
requires urgent##3##2##(2006-10#1)(2006-4#1)(2008-9#1)
requires use of##4##3##(2005-12#1)(2005-8#1)(2008-4#1)(2008-9#1)
requires using##2##2##(2004-12#1)(2008-10#1)
requires##1496##1##(1990-1#1)(1990-10#2)(1990-11#3)(1990-12#7)(1990-2#2)(1990-3#10)(1990-4#3)(1990-5#3)(1990-6#3)(1990-7#4)(1990-8#3)(1990-9#4)(1991-1#4)(1991-10#3)(1991-11#5)(1991-12#10)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#8)(1991-6#4)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#5)(1992-2#5)(1992-3#3)(1992-4#2)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#5)(1992-9#8)(1993-1#3)(1993-10#3)(1993-11#3)(1993-12#3)(1993-2#5)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#5)(1993-8#5)(1993-9#4)(1994-1#9)(1994-10#3)(1994-11#5)(1994-12#9)(1994-2#8)(1994-3#8)(1994-5#1)(1994-6#6)(1994-7#1)(1994-8#8)(1994-9#10)(1995-1#8)(1995-10#3)(1995-12#7)(1995-2#12)(1995-3#12)(1995-4#3)(1995-5#6)(1995-6#6)(1995-7#1)(1995-8#16)(1995-9#3)(1996-1#9)(1996-10#2)(1996-12#10)(1996-2#12)(1996-3#10)(1996-4#6)(1996-5#12)(1996-6#2)(1996-7#5)(1996-8#8)(1996-9#1)(1997-1#5)(1997-2#9)(1997-3#3)(1997-4#11)(1997-5#1)(1997-6#9)(1997-7#6)(1997-8#7)(2004-12#1)(2004-3#1)(2004-4#1)(2005-10#4)(2005-11#5)(2005-12#2)(2005-3#2)(2005-5#2)(2005-7#4)(2005-8#9)(2005-9#1)(2006-1#1)(2006-10#33)(2006-11#3)(2006-12#5)(2006-2#1)(2006-3#7)(2006-4#4)(2006-5#10)(2006-6#4)(2006-7#3)(2006-8#7)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#32)(2007-12#55)(2007-2#5)(2007-3#1)(2007-4#5)(2007-5#8)(2007-6#2)(2007-7#17)(2007-8#16)(2007-9#10)(2008-1#20)(2008-10#87)(2008-11#50)(2008-12#10)(2008-2#56)(2008-3#71)(2008-4#48)(2008-5#11)(2008-6#7)(2008-7#28)(2008-8#24)(2008-9#30)(2009-10#5)(2009-11#4)(2009-12#5)(2009-2#3)(2009-3#2)(2009-4#9)(2009-5#3)(2009-6#3)(2009-7#3)(2009-8#15)(2009-9#6)(2010-1#3)(2010-10#5)(2010-11#6)(2010-12#11)(2010-2#9)(2010-3#3)(2010-4#15)(2010-5#6)(2010-6#5)(2010-7#4)(2010-8#8)(2010-9#7)(2011-1#18)(2011-12#2)(2011-2#43)(2012-1#12)(2012-11#4)(2012-12#31)(2012-2#27)(2012-3#15)(2013-1#43)(2013-7#5)(2013-8#11)
requiring a##20##2##(1990-5#1)(1993-5#1)(1993-9#1)(1996-4#1)(1997-4#1)(2004-11#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#3)
requiring additional##6##2##(1995-5#1)(2007-8#1)(2008-10#1)(2009-1#1)(2010-6#1)(2013-7#1)
requiring aggressive##2##2##(2008-1#1)(2008-2#1)
requiring an additional##2##3##(2008-10#1)(2009-5#1)
requiring an##11##2##(1995-2#1)(2005-7#1)(2007-8#2)(2008-10#2)(2008-3#2)(2008-4#1)(2009-5#1)(2012-12#1)
requiring antiretroviral therapy##2##3##(2009-8#1)(2013-1#1)
requiring at least##2##3##(2008-10#1)(2011-2#1)
requiring both##4##2##(1995-2#1)(2005-9#1)(2007-11#1)(2008-10#1)
requiring cardiopulmonary bypass##3##3##(2006-10#1)(2007-8#1)(2008-1#1)
requiring discontinuation##2##2##(1991-7#1)(2008-7#1)
requiring early##2##2##(2007-8#1)(2008-11#1)
requiring endoscopic##2##2##(2008-10#1)(2013-8#1)
requiring extensive##3##2##(2007-8#1)(2008-2#1)(2011-1#1)
requiring follow-up##2##2##(2006-10#1)(2008-4#1)
requiring further##4##2##(1993-10#1)(2007-6#1)(2008-7#1)(2013-1#1)
requiring greater##2##2##(2007-8#1)(2008-4#1)
requiring hemodialysis##5##2##(2005-12#1)(2007-12#1)(2007-7#2)(2012-2#1)
requiring high##2##2##(2008-2#1)(2013-7#1)
requiring hospital admission##3##3##(2007-3#2)(2011-2#1)
requiring hospital##4##2##(2004-10#1)(2007-3#2)(2011-2#1)
requiring hospitalization and##2##3##(2005-10#1)(2012-12#1)
requiring hospitalization##8##2##(2005-10#1)(2006-6#1)(2007-9#1)(2010-10#1)(2012-12#1)(2013-1#3)
requiring hospitals##2##2##(1992-12#1)(1995-12#1)
requiring immediate##9##2##(1994-3#1)(1997-5#1)(2008-8#2)(2010-12#1)(2011-2#2)(2012-1#1)(2012-2#1)
requiring insulin treatment##3##3##(2005-7#2)(2008-1#1)
requiring insulin##4##2##(2005-7#3)(2008-1#1)
requiring intensive care##2##3##(2006-4#1)(2009-10#1)
requiring intervention##3##2##(2007-7#2)(2008-3#1)
requiring invasive##2##2##(2007-8#1)(2008-1#1)
requiring large##2##2##(2006-4#1)(2008-7#1)
requiring local##2##2##(2007-12#1)(2007-8#1)
requiring long-term##3##2##(2006-10#1)(2008-10#1)(2010-12#1)
requiring maintenance##2##2##(2006-10#1)(2006-8#1)
requiring major##2##2##(2006-10#1)(2008-8#1)
requiring mechanical ventilation##4##3##(1996-9#1)(2005-8#1)(2006-10#1)(2013-1#1)
requiring medical##3##2##(1991-9#1)(1993-12#1)(2006-1#1)
requiring minimal##3##2##(2007-11#1)(2007-7#1)(2008-11#1)
requiring more detailed##2##3##(1993-2#1)(2012-3#1)
requiring more##4##2##(1993-11#1)(1993-2#1)(2008-7#1)(2012-3#1)
requiring multiple surgical##2##3##(1991-12#1)(2011-1#1)
requiring multiple##3##2##(1991-12#1)(2008-3#1)(2011-1#1)
requiring no sample##2##3##(2008-10#2)
requiring no##8##2##(1991-6#1)(1993-11#1)(1997-8#1)(2008-10#4)(2008-2#1)
requiring numerous##2##2##(2006-4#1)(2009-6#1)
requiring one less step##2##4##(1992-1#2)
requiring only a single##2##4##(2008-3#1)(2010-5#1)
requiring only a##4##3##(1994-9#1)(2008-2#1)(2008-3#1)(2010-5#1)
requiring only##13##2##(1993-8#1)(1994-9#1)(1996-2#1)(1996-7#1)(2007-5#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-11#1)(2010-4#1)(2010-5#1)
requiring operative##2##2##(2006-3#1)(2007-8#1)
requiring prolonged##2##2##(1993-11#1)(2007-11#1)
requiring re-operation##2##2##(2007-8#1)(2011-2#1)
requiring removal of##3##3##(2009-11#1)(2013-1#2)
requiring reoperation##2##2##(1994-7#1)(2012-12#1)
requiring repeated##2##2##(2007-12#1)(2010-9#1)
requiring revision##2##2##(2007-1#1)(2013-1#1)
requiring some form of##2##4##(1996-7#1)(2007-3#1)
requiring specific##3##2##(2011-2#2)(2012-3#1)
requiring surgery##6##2##(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-8#1)
requiring surgical intervention##2##3##(2007-8#1)(2011-2#1)
requiring surgical resection##2##3##(2010-7#1)(2011-2#1)
requiring surgical treatment##3##3##(2009-3#1)(2010-10#1)(2010-4#1)
requiring surgical##9##2##(1993-5#1)(1996-3#1)(2007-8#1)(2009-3#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-2#2)
requiring that##2##2##(1990-12#1)(2008-7#1)
requiring the use of##4##4##(2007-11#1)(2007-12#1)(2010-4#1)(2012-2#1)
requiring the##18##2##(1992-7#1)(1993-6#1)(1996-11#1)(1997-1#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-7#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)
requiring them to##2##3##(1993-12#1)(1996-11#1)
requiring therapeutic##3##2##(1996-11#1)(2006-9#1)(2007-8#1)
requiring transfusion##2##2##(1994-12#1)(1995-12#1)
requiring treatment in##2##3##(1992-6#1)(2011-1#1)
requiring treatment with##2##3##(1992-5#1)(2007-9#1)
requiring treatment##9##2##(1992-5#1)(1992-6#1)(2007-11#1)(2007-9#1)(2008-5#1)(2011-1#1)(2012-11#1)(2013-1#2)
requiring urgent##2##2##(2006-4#1)(2012-12#1)
requiring##436##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#4)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#3)(1993-10#1)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-7#1)(1994-9#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#3)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#3)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-10#1)(2004-11#1)(2004-9#1)(2005-10#5)(2005-12#2)(2005-7#4)(2005-8#5)(2005-9#1)(2006-1#1)(2006-10#13)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#3)(2006-4#6)(2006-5#2)(2006-6#3)(2006-8#2)(2006-9#2)(2007-1#2)(2007-10#4)(2007-11#12)(2007-12#7)(2007-2#2)(2007-3#3)(2007-5#1)(2007-6#2)(2007-7#15)(2007-8#23)(2007-9#3)(2008-1#12)(2008-10#20)(2008-11#7)(2008-12#4)(2008-2#12)(2008-3#13)(2008-4#8)(2008-5#3)(2008-6#6)(2008-7#11)(2008-8#6)(2008-9#2)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#3)(2010-12#3)(2010-2#4)(2010-3#1)(2010-4#5)(2010-5#3)(2010-6#1)(2010-7#4)(2010-9#2)(2011-1#5)(2011-2#16)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#11)(2012-2#10)(2012-3#6)(2013-1#16)(2013-7#2)(2013-8#2)
requirments##3##1##(2006-8#1)(2007-11#2)
requisite for the##4##3##(1991-5#1)(1995-2#1)(2007-11#1)(2012-11#1)
requisite for##7##2##(1991-5#1)(1992-12#1)(1994-8#1)(1995-11#1)(1995-2#1)(2007-11#1)(2012-11#1)
requisite##32##1##(1991-3#2)(1991-5#1)(1991-7#1)(1992-12#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-2#1)(1997-3#1)(1997-8#1)(2005-10#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
requisites##4##1##(1994-8#1)(2008-10#1)(2010-8#1)(2011-2#1)
rer##8##1##(1996-8#2)(1996-9#2)(1997-2#1)(1997-3#1)(1997-8#2)
rereplication##3##1##(2011-1#3)
rerio##7##1##(1993-12#1)(1997-4#1)(2007-9#1)(2008-11#1)(2012-11#1)(2012-12#1)(2012-3#1)
rerio) as##2##2##(2008-11#1)(2013-1#1)
rerio)##9##1##(1992-9#1)(1997-2#1)(2008-11#1)(2008-7#1)(2008-9#2)(2010-12#2)(2013-1#1)
rerouting was associated with##2##4##(2005-5#2)
rerouting##5##1##(2005-5#4)(2013-8#1)
rerupture##2##1##(1993-11#1)(1997-3#1)
res##4##1##(1993-3#1)(1994-3#1)(2006-4#1)(2008-7#1)
resampled##2##1##(2008-3#2)
resampling method##2##2##(2008-3#1)(2012-3#1)
resampling process##2##2##(1997-2#1)(2008-3#1)
resampling the##2##2##(2008-3#1)(2008-6#1)
resampling##16##1##(1997-2#1)(1997-4#1)(2008-10#2)(2008-12#1)(2008-3#6)(2008-6#1)(2010-2#1)(2012-3#3)
resazurin##5##1##(2007-11#1)(2008-10#1)(2008-11#1)(2013-8#2)
rescaled##2##1##(2008-3#2)
rescaling##6##1##(1994-5#3)(2008-2#1)(2008-3#1)(2008-7#1)
rescheduling##2##1##(1992-5#1)(2012-3#1)
rescreening##2##1##(1991-6#2)
rescue a##2##2##(1994-12#1)(2011-12#1)
rescue agent##2##2##(2005-7#2)
rescue analgesic##2##2##(2007-2#1)(2011-12#1)
rescue and##2##2##(2008-10#1)(2008-4#1)
rescue antiemetics##2##2##(2008-5#2)
rescue breathing##2##2##(2006-10#2)
rescue effects##2##2##(2008-8#1)(2012-2#1)
rescue experiments##4##2##(1993-11#1)(2007-12#1)(2008-11#1)(2012-12#1)
rescue medication use##2##3##(2007-9#1)(2008-7#1)
rescue medication##5##2##(2007-2#1)(2007-9#1)(2008-3#1)(2008-7#1)(2010-7#1)
rescue neurons##2##2##(1997-4#1)(2008-10#1)
rescue of##10##2##(1991-9#1)(1992-3#2)(1993-12#1)(1995-11#1)(1995-3#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-2#1)
rescue procedure for##3##3##(2007-8#1)(2012-2#2)
rescue procedure##4##2##(2007-8#1)(2012-2#2)(2012-3#1)
rescue the##9##2##(1993-9#1)(1994-8#1)(1995-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)(2013-8#1)
rescue therapy##7##2##(2008-11#2)(2008-8#2)(2010-12#1)(2012-12#2)
rescue using##2##2##(1994-4#1)(2008-3#1)
rescue with##2##2##(2006-10#1)(2008-5#1)
rescue##124##1##(1990-9#1)(1991-10#1)(1991-3#1)(1991-9#1)(1992-3#3)(1992-6#3)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-3#1)(1996-11#2)(1996-3#1)(1996-6#1)(1997-4#1)(2005-11#1)(2005-7#3)(2005-8#1)(2006-10#3)(2007-11#3)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#7)(2008-9#2)(2009-10#1)(2009-4#2)(2009-7#1)(2009-8#1)(2009-9#5)(2010-12#2)(2010-2#3)(2010-3#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#3)(2011-12#3)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#4)
rescue)##2##1##(2008-7#1)(2009-9#1)
rescued by##12##2##(1995-2#1)(1995-9#1)(1996-3#1)(2007-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#3)
rescued for##2##2##(1997-1#1)(2009-9#1)
rescued from apoptosis##2##3##(1995-8#1)(1997-8#1)
rescued from##6##2##(1992-3#1)(1994-12#1)(1994-6#1)(1995-8#1)(1997-8#1)(2010-2#1)
rescued in##2##2##(1994-3#1)(1996-7#1)
rescued the##3##2##(1995-11#1)(2005-10#1)(2007-10#1)
rescued##42##1##(1990-2#1)(1992-2#1)(1992-3#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-4#2)(1997-8#1)(2005-10#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-3#1)
rescuers##3##1##(2006-10#2)(2007-9#1)
rescues the##3##2##(1997-1#1)(2008-8#1)(2012-2#1)
rescues##9##1##(1995-1#1)(1997-1#2)(1997-4#1)(1997-8#1)(2008-8#2)(2010-11#1)(2012-2#1)
rescuing effect of##2##3##(1997-8#2)
rescuing patients##2##2##(2006-10#1)(2010-3#1)
rescuing##10##1##(1994-12#1)(1994-5#1)(1995-12#1)(1997-4#1)(1997-8#2)(2006-10#1)(2009-10#1)(2010-3#1)(2012-3#1)
resealed in 60 min)##2##4##(1996-5#2)
resealed##4##1##(1994-2#1)(1995-11#1)(1996-5#2)
research &quot##3##2##(1991-9#1)(1997-3#1)(2010-2#1)
research -##2##2##(2008-11#1)(2010-9#1)
research a simple##2##3##(2008-12#1)(2008-2#1)
research a##5##2##(1990-4#1)(2008-12#1)(2008-2#1)(2008-7#1)(2013-8#1)
research about the##3##3##(2007-1#1)(2007-10#1)(2009-11#1)
research about##5##2##(2007-1#1)(2007-10#1)(2008-6#1)(2009-11#1)(2012-2#1)
research across##2##2##(2007-9#1)(2010-12#1)
research activities and##3##3##(2006-10#1)(2008-10#1)(2012-3#1)
research activities in##2##3##(1993-8#1)(2008-6#1)
research activities that##3##3##(1991-12#1)(1993-3#1)(2009-4#1)
research activities##19##2##(1991-12#1)(1993-3#1)(1993-8#1)(1996-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-4#2)(2010-12#1)(2010-5#1)(2012-1#1)(2012-3#1)
research activity and##2##3##(1997-6#1)(2008-7#1)
research activity##4##2##(1997-6#1)(2006-10#1)(2007-7#1)(2008-7#1)
research addresses##2##2##(2009-8#1)(2013-8#1)
research advances in##2##3##(2012-2#1)(2013-8#1)
research advances##4##2##(2006-9#1)(2008-10#1)(2012-2#1)(2013-8#1)
research agenda for##5##3##(1992-12#1)(2008-12#1)(2008-3#1)(2011-2#2)
research agenda that##2##3##(2009-8#1)(2012-3#1)
research agenda##14##2##(1991-1#1)(1992-12#2)(1994-12#1)(2008-12#2)(2008-3#1)(2008-7#1)(2009-11#1)(2009-3#1)(2009-8#1)(2011-2#2)(2012-3#1)
research agendas##2##2##(2008-12#1)(2013-8#1)
research aimed at identifying##2##4##(2010-10#1)(2013-1#1)
research aimed at obtaining##2##4##(1992-2#1)(2009-10#1)
research aimed at understanding##2##4##(2008-9#1)(2010-3#1)
research aimed at##14##3##(1991-6#2)(1992-2#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-2#1)(2010-3#1)(2013-1#2)
research aimed to##3##3##(1993-6#1)(2006-8#1)(2007-12#1)
research aimed##17##2##(1991-6#2)(1992-2#1)(1993-6#1)(2006-12#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-2#1)(2010-3#1)(2013-1#2)
research all##2##2##(2012-12#1)(2012-2#1)
research also suggests that##2##4##(2007-12#1)(2010-2#1)
research also##5##2##(2004-4#1)(2007-12#1)(2008-7#1)(2010-2#1)(2012-2#1)
research among##3##2##(2005-7#1)(2008-10#1)(2013-1#1)
research and a##2##3##(2008-1#1)(2008-8#1)
research and an##2##3##(1996-2#1)(2008-11#1)
research and applications##4##3##(1997-1#1)(2007-11#2)(2008-7#1)
research and assessment##3##3##(2007-4#1)(2009-12#1)(2013-7#1)
research and capacity building in##2##5##(2006-8#1)(2007-12#1)
research and case work activities of criminalistics in Japan##2##9##(1996-6#2)
research and clinical application##3##4##(2007-1#1)(2007-12#1)(2013-8#1)
research and clinical applications##2##4##(2008-10#1)(2011-2#1)
research and clinical practice##3##4##(1994-12#1)(2008-12#1)(2010-9#1)
research and clinical##27##3##(1994-12#1)(1997-5#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-12#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#1)(2010-2#1)(2010-9#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#2)(2013-8#1)
research and data collection##2##4##(1995-12#1)(2007-2#1)
research and data##3##3##(1995-12#1)(2007-2#1)(2008-1#1)
research and development (R&amp##3##4##(2008-5#1)(2009-5#1)(2010-12#1)
research and development areas##2##4##(2008-8#1)(2013-8#1)
research and development in##4##4##(1992-12#1)(1997-4#1)(2006-10#1)(2007-12#1)
research and development into##2##4##(1996-9#1)(2006-12#1)
research and development of newer##2##5##(1991-1#1)(2013-8#1)
research and development of##13##4##(1991-1#1)(2007-11#2)(2008-10#3)(2008-5#1)(2008-7#1)(2011-3#1)(2013-1#3)(2013-8#1)
research and development##51##3##(1991-1#1)(1992-10#1)(1992-12#1)(1995-1#1)(1995-8#1)(1996-2#1)(1996-9#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-11#3)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-5#2)(2010-12#1)(2011-3#1)(2012-1#1)(2012-11#1)(2013-1#3)(2013-8#2)
research and diagnosis##2##3##(1995-6#1)(2012-3#1)
research and diagnostic applications##2##4##(2007-8#1)(2008-11#1)
research and diagnostic##3##3##(2007-8#1)(2008-11#1)(2008-9#1)
research and drug discovery##2##4##(2008-4#1)(2012-11#1)
research and drug##3##3##(2008-4#1)(2008-5#1)(2012-11#1)
research and education##5##3##(1994-12#1)(2005-12#2)(2007-8#1)(2008-7#1)
research and evaluation##2##3##(2008-12#1)(2008-8#1)
research and examples##2##3##(2011-1#1)(2011-12#1)
research and facilitate##2##3##(2009-4#1)(2012-12#1)
research and family##2##3##(2008-9#1)(2010-4#1)
research and for##4##3##(1992-3#1)(2008-5#2)(2010-12#1)
research and funding##2##3##(2006-3#1)(2010-5#1)
research and future##2##3##(1996-2#1)(2008-8#1)
research and health care##2##4##(1996-12#1)(1997-8#1)
research and health##3##3##(1996-12#1)(1997-8#1)(2004-12#1)
research and in clinical practice##2##5##(2006-10#1)(2012-2#1)
research and in clinical##3##4##(1994-12#1)(2006-10#1)(2012-2#1)
research and in##7##3##(1994-12#1)(2005-11#1)(2006-10#1)(2008-11#1)(2010-7#1)(2010-9#1)(2012-2#1)
research and interventions##2##3##(2008-3#1)(2009-4#1)
research and is##2##3##(1995-12#1)(2008-11#1)
research and its##3##3##(1997-8#1)(2006-11#1)(2008-11#1)
research and management##6##3##(2007-10#2)(2013-8#4)
research and market research##2##4##(2004-12#2)
research and may##3##3##(1995-12#1)(2005-7#1)(2008-11#1)
research and medicine##2##3##(2010-9#1)(2013-1#1)
research and offers##2##3##(2009-5#1)(2010-9#1)
research and other##2##3##(1994-10#1)(2010-2#1)
research and practical##2##3##(2007-1#1)(2008-10#1)
research and practice are##3##4##(2010-10#1)(2013-1#2)
research and practice##27##3##(1990-12#1)(2006-10#1)(2006-3#1)(2006-8#1)(2008-1#1)(2008-12#1)(2008-7#1)(2010-10#11)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#4)
research and prevention##2##3##(1993-6#1)(2008-3#1)
research and production##2##3##(2005-12#1)(2008-10#1)
research and scholarly##2##3##(2007-7#1)(2010-4#1)
research and service##2##3##(1993-3#1)(2013-1#1)
research and teaching##5##3##(2005-10#1)(2007-4#1)(2009-4#1)(2010-1#1)(2011-7#1)
research and technical##2##3##(1994-3#1)(2012-2#1)
research and technology##3##3##(1992-3#1)(1997-7#1)(2009-2#1)
research and the development of##3##5##(1995-4#1)(2006-10#1)(2010-12#1)
research and the##17##3##(1992-6#1)(1995-1#1)(1995-4#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-3#1)(2008-5#1)(2008-7#2)(2009-4#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-7#1)
research and therapeutic##4##3##(2010-12#1)(2011-2#1)(2012-12#2)
research and tissue engineering##2##4##(2008-11#1)(2010-4#1)
research and to##2##3##(2012-1#1)(2013-1#1)
research and training##4##3##(1997-7#1)(2007-6#1)(2008-10#1)(2011-1#1)
research and translation##2##3##(1997-1#1)(2012-12#1)
research and treatment##3##3##(2007-7#1)(2011-1#1)(2012-12#1)
research and will##2##3##(1994-3#1)(2012-3#1)
research and##404##2##(1990-11#2)(1990-12#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-12#3)(1994-2#1)(1994-3#3)(1994-6#1)(1995-1#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#5)(1996-3#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#3)(1997-8#2)(2004-12#3)(2004-3#1)(2005-10#2)(2005-11#4)(2005-12#4)(2005-6#2)(2005-7#5)(2005-8#2)(2006-10#6)(2006-11#3)(2006-12#3)(2006-3#2)(2006-4#2)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#3)(2007-1#4)(2007-10#3)(2007-11#8)(2007-12#11)(2007-2#2)(2007-3#1)(2007-4#2)(2007-6#2)(2007-7#3)(2007-8#7)(2007-9#4)(2008-1#4)(2008-10#18)(2008-11#19)(2008-12#10)(2008-2#1)(2008-3#4)(2008-4#5)(2008-5#13)(2008-6#1)(2008-7#11)(2008-8#6)(2008-9#4)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#7)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#12)(2010-11#2)(2010-12#7)(2010-2#2)(2010-3#1)(2010-4#5)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#4)(2011-1#12)(2011-12#2)(2011-2#7)(2011-3#1)(2011-7#3)(2012-1#3)(2012-11#3)(2012-12#8)(2012-2#13)(2012-3#6)(2013-1#13)(2013-7#2)(2013-8#13)
research angles##2##2##(1992-9#1)(2010-12#1)
research applications in##2##3##(2007-7#1)(2008-4#1)
research applications of##2##3##(2004-11#1)(2008-4#1)
research applications##12##2##(1993-3#1)(2004-11#1)(2005-11#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-4#4)(2010-8#1)(2012-2#1)
research approach to##2##3##(2008-11#1)(2012-12#1)
research approach was adopted##3##4##(2008-11#1)(2008-12#1)(2011-1#1)
research approach##10##2##(1994-3#1)(1995-3#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-12#1)(2011-1#1)(2012-12#1)
research approaches##6##2##(1992-12#1)(1996-12#1)(2006-1#1)(2007-5#1)(2008-8#1)(2012-1#1)
research are also discussed##2##4##(2008-4#1)(2011-1#1)
research are also##3##3##(2007-10#1)(2008-4#1)(2011-1#1)
research are being##2##3##(1997-8#1)(2008-11#1)
research are briefly##2##3##(1993-11#1)(2008-2#1)
research are discussed in##2##4##(2005-10#1)(2009-10#1)
research are discussed##25##3##(1990-12#1)(2005-10#1)(2007-1#1)(2007-12#5)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-4#1)(2011-12#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#1)
research are explored##2##3##(1996-2#1)(2007-10#1)
research are highlighted##3##3##(1995-2#1)(2006-10#1)(2012-1#1)
research are identified##2##3##(2008-11#1)(2008-4#1)
research are presented together##2##4##(1990-2#1)(2013-1#1)
research are presented##7##3##(1990-2#1)(1991-2#1)(1996-8#1)(2007-2#1)(2008-6#1)(2012-12#1)(2013-1#1)
research are proposed##2##3##(2006-5#1)(2008-7#1)
research are provided##6##3##(2006-6#1)(2009-2#1)(2009-5#1)(2010-2#1)(2010-8#1)(2012-12#1)
research are suggested##3##3##(1993-7#1)(1994-3#1)(2008-2#1)
research are the##2##3##(1991-3#1)(2011-2#1)
research are##83##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-2#1)(1991-3#1)(1993-11#1)(1993-7#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-8#1)(2004-12#1)(2005-10#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-1#2)(2007-10#3)(2007-12#5)(2007-2#2)(2007-3#1)(2007-4#2)(2007-7#2)(2008-10#1)(2008-11#3)(2008-12#3)(2008-2#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2011-7#1)(2012-1#2)(2012-12#4)(2012-2#1)(2013-1#2)(2013-7#1)
research area that##3##3##(2008-11#1)(2009-7#1)(2012-1#1)
research area##16##2##(1997-3#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-7#1)
research areas##13##2##(1993-2#2)(1996-12#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-10#1)(2010-5#1)(2011-12#1)(2012-3#1)
research around the concept##2##4##(2009-8#2)
research around the##3##3##(2009-8#2)(2013-1#1)
research articles##5##2##(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
research as a##5##3##(1993-2#1)(2005-8#1)(2008-8#1)(2009-6#1)(2011-2#1)
research as the##2##3##(2008-12#1)(2011-2#1)
research as well as##9##4##(1994-6#1)(2004-11#1)(2005-8#1)(2007-8#1)(2008-2#1)(2008-4#1)(2009-9#1)(2010-11#1)(2010-7#1)
research as well##10##3##(1994-6#1)(2004-11#1)(2005-8#1)(2007-8#1)(2008-2#1)(2008-4#1)(2009-9#1)(2010-11#1)(2010-7#1)(2011-2#1)
research as##25##2##(1993-2#1)(1994-6#1)(2004-11#1)(2005-8#2)(2007-11#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-1#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-7#1)(2011-2#3)(2013-1#1)(2013-8#1)
research assistants##3##2##(2007-8#1)(2009-4#2)
research at a##2##3##(2007-7#1)(2008-11#1)
research at the National##2##4##(1996-6#1)(2007-7#1)
research at the interface of##2##5##(2006-12#1)(2010-12#1)
research at the##10##3##(1996-6#1)(2006-12#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-12#1)
research at##15##2##(1996-6#1)(2006-12#1)(2007-3#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)
research attention##3##2##(2008-6#2)(2008-9#1)
research available##4##2##(1992-1#1)(2007-11#1)(2008-11#2)
research awareness##2##2##(2008-12#2)
research base and##2##3##(1992-10#1)(2011-12#1)
research base##6##2##(1990-6#1)(1992-10#1)(1992-12#1)(2006-8#1)(2009-5#1)(2011-12#1)
research based on##3##3##(1994-2#1)(2008-2#1)(2009-10#1)
research based##4##2##(1994-2#1)(2008-12#1)(2008-2#1)(2009-10#1)
research be conducted into the##2##5##(2007-10#1)(2007-9#1)
research be conducted##3##3##(2006-9#1)(2007-10#1)(2007-9#1)
research because of##2##3##(2006-10#1)(2009-6#1)
research because##4##2##(2006-10#1)(2008-4#1)(2008-7#1)(2009-6#1)
research being##3##2##(2009-6#1)(2012-2#2)
research between##2##2##(2012-2#1)(2012-3#1)
research but##3##2##(1991-12#1)(1997-4#1)(2005-12#1)
research by##17##2##(1993-2#1)(1995-12#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-2#1)(2013-1#3)
research can be##7##3##(1994-3#1)(2006-12#1)(2008-10#1)(2008-3#1)(2010-12#1)(2010-3#1)(2013-1#1)
research can##12##2##(1994-12#1)(1994-3#1)(1997-1#1)(1997-7#1)(2004-12#1)(2005-7#1)(2006-12#1)(2008-10#1)(2008-3#1)(2010-12#1)(2010-3#1)(2013-1#1)
research capacity##6##2##(2006-10#1)(2007-12#1)(2008-2#1)(2010-10#2)(2012-12#1)
research carried out in##3##4##(1991-9#1)(2012-11#1)(2012-3#1)
research carried out##8##3##(1991-9#1)(2006-10#1)(2008-1#1)(2010-1#1)(2012-11#1)(2012-12#2)(2012-3#1)
research centered on##2##3##(2008-10#1)(2012-3#1)
research centers##2##2##(2006-6#1)(2013-8#1)
research centres##3##2##(1997-5#1)(2008-11#2)
research challenge##4##2##(1993-9#1)(2008-3#1)(2010-9#1)(2012-2#1)
research challenges##3##2##(1994-12#1)(2009-11#1)(2010-12#1)
research cigarette##2##2##(2007-8#2)
research clinic##2##2##(1992-4#1)(1995-1#1)
research communities##2##2##(2007-5#1)(2008-10#1)
research community is##4##3##(2008-10#1)(2008-6#1)(2013-1#2)
research community##13##2##(1997-1#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#3)(2009-4#1)(2013-1#2)
research components##3##2##(2008-11#1)(2008-8#1)(2010-4#1)
research concerning the##2##3##(2009-2#1)(2013-1#1)
research concerning##7##2##(1994-6#1)(2007-12#1)(2008-1#1)(2008-11#1)(2009-2#1)(2012-12#1)(2013-1#1)
research conducted by##2##3##(2006-11#1)(2009-4#1)
research conducted in the##2##4##(2008-1#1)(2008-11#1)
research conducted in##12##3##(1993-1#1)(1997-7#1)(2006-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-2#1)(2009-4#1)(2009-9#1)(2011-1#2)
research conducted with##2##3##(2008-3#1)(2008-5#1)
research conducted##22##2##(1993-1#1)(1997-7#1)(2006-11#1)(2006-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-9#2)(2011-1#2)(2013-1#3)
research conference##2##2##(2007-5#1)(2010-8#1)
research continues to##4##3##(2007-11#1)(2007-12#1)(2007-2#1)(2013-8#1)
research continues##5##2##(2007-11#1)(2007-12#2)(2007-2#1)(2013-8#1)
research contributions##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
research coordinators##2##2##(2009-4#1)(2012-12#1)
research costs##2##2##(1991-1#1)(1991-3#1)
research could##2##2##(1996-9#1)(2010-12#1)
research criteria##6##2##(1997-8#1)(2007-9#1)(2008-1#2)(2011-2#2)
research data on##2##3##(1997-2#1)(2006-10#1)
research data##13##2##(1997-2#1)(1997-5#1)(2006-10#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-7#1)(2010-5#1)(2010-8#1)
research dealing with##2##3##(2008-12#1)(2012-12#1)
research demonstrate##2##2##(1991-7#1)(2008-8#1)
research demonstrated that##5##3##(2005-7#1)(2008-8#1)(2009-3#1)(2010-12#1)(2013-8#1)
research demonstrates##3##2##(2008-10#1)(2008-2#1)(2009-7#1)
research demonstrating##2##2##(2008-11#1)(2008-2#1)
research departments##2##2##(2007-4#1)(2008-5#1)
research describing##4##2##(2007-11#1)(2008-4#1)(2010-6#1)(2012-3#1)
research design and##3##3##(1991-3#1)(1995-4#1)(2006-5#1)
research design for the##2##4##(2013-1#2)
research design for##4##3##(2006-10#1)(2013-1#3)
research design was used##3##4##(2007-7#1)(2010-3#1)(2012-12#1)
research design was##7##3##(2006-2#1)(2007-7#1)(2008-1#1)(2008-12#1)(2010-3#1)(2012-12#2)
research design##28##2##(1991-3#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-4#1)(2006-10#1)(2006-2#3)(2006-5#1)(2006-7#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-12#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-3#2)(2012-12#3)(2013-1#5)
research designs are##2##3##(1994-3#1)(2011-2#1)
research designs that##2##3##(1996-3#1)(2012-1#1)
research designs##8##2##(1994-3#1)(1996-3#1)(2006-10#1)(2009-8#1)(2011-2#2)(2012-1#2)
research developments in##2##3##(2008-11#1)(2011-1#1)
research developments##4##2##(2008-1#1)(2008-11#1)(2008-3#1)(2011-1#1)
research direction for##2##3##(1997-1#1)(2008-2#1)
research direction##3##2##(1997-1#1)(2008-2#1)(2013-8#1)
research directions are outlined##2##4##(1994-3#1)(2008-10#1)
research directions are##10##3##(1994-2#1)(1994-3#1)(2007-12#2)(2008-1#1)(2008-10#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-7#1)
research directions that##3##3##(2009-12#1)(2011-12#1)(2011-2#1)
research directions##24##2##(1994-2#1)(1994-3#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-9#2)(2010-4#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-12#2)(2013-8#3)
research disciplines##2##2##(2006-5#1)(2008-7#1)
research discoveries##2##2##(2012-11#1)(2012-3#1)
research does not##3##3##(1991-9#1)(1997-1#1)(2006-8#1)
research does##4##2##(1991-9#1)(1997-1#1)(2006-8#1)(2006-9#1)
research domain##3##2##(2010-5#1)(2013-1#2)
research done##2##2##(1990-3#1)(2008-10#1)
research due to##2##3##(1995-2#1)(2008-10#1)
research during the last decade##2##5##(2010-9#1)(2012-2#1)
research during the last##3##4##(1990-5#1)(2010-9#1)(2012-2#1)
research during##4##2##(1990-5#1)(1992-11#1)(2010-9#1)(2012-2#1)
research education##3##2##(2008-11#2)(2008-12#1)
research effort has been##2##4##(1993-11#1)(2011-2#1)
research effort has##3##3##(1993-11#1)(2007-9#1)(2011-2#1)
research effort##6##2##(1993-11#1)(1996-7#1)(2007-12#2)(2007-9#1)(2011-2#1)
research efforts are focused on##3##5##(1994-9#1)(2007-1#1)(2008-5#1)
research efforts are##9##3##(1994-9#1)(1996-8#1)(1997-1#1)(2005-7#1)(2006-4#1)(2007-1#1)(2008-5#1)(2010-12#1)(2010-8#1)
research efforts have##5##3##(2005-7#1)(2009-11#1)(2010-11#1)(2012-12#2)
research efforts in##2##3##(1993-2#1)(2006-10#1)
research efforts to##6##3##(1996-8#1)(2005-9#1)(2008-5#2)(2010-12#1)(2012-1#1)
research efforts##40##2##(1990-12#1)(1990-6#1)(1993-2#1)(1994-9#1)(1996-8#2)(1997-1#1)(1997-4#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#3)(2006-4#1)(2007-1#1)(2007-10#1)(2007-6#1)(2007-9#1)(2008-11#1)(2008-5#3)(2008-9#1)(2009-11#1)(2010-11#1)(2010-12#3)(2010-5#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#1)
research enterprise##3##2##(2005-11#1)(2007-11#1)(2012-12#1)
research established that##2##3##(1997-7#1)(2009-8#1)
research ethics committee##2##3##(1997-5#1)(2004-12#1)
research ethics committees##4##3##(1996-11#3)(2009-4#1)
research ethics in##4##3##(2009-4#1)(2011-2#2)(2011-3#1)
research ethics review##2##3##(2009-4#2)
research ethics##23##2##(1996-11#3)(1996-8#1)(1997-5#1)(2004-12#1)(2005-7#1)(2006-11#1)(2007-10#2)(2007-12#2)(2007-5#1)(2008-9#1)(2009-4#4)(2011-2#4)(2011-3#1)
research evaluating##2##2##(2007-6#1)(2012-2#1)
research evidence to##3##3##(2006-2#1)(2008-11#1)(2008-12#1)
research evidence##18##2##(1996-1#1)(1997-4#1)(2005-6#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-6#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-11#1)(2012-2#1)
research examined the##5##3##(1997-2#1)(2007-12#1)(2008-1#1)(2011-12#1)(2011-2#1)
research examined##8##2##(1997-2#1)(2007-12#1)(2008-1#1)(2008-12#1)(2009-12#1)(2011-12#1)(2011-2#1)(2012-1#1)
research examines the##2##3##(2008-6#1)(2012-1#1)
research examines##3##2##(2008-11#1)(2008-6#1)(2012-1#1)
research examining the##2##3##(1996-2#1)(2007-12#1)
research examining##7##2##(1996-2#1)(2007-12#1)(2008-12#1)(2008-7#1)(2009-7#1)(2010-10#1)(2013-1#1)
research exists##3##2##(2007-12#1)(2008-12#1)(2008-9#1)
research experience##8##2##(1994-12#1)(2006-4#1)(2009-4#2)(2009-6#1)(2010-7#2)(2012-2#1)
research experiences##2##2##(1997-1#1)(2010-10#1)
research explored##2##2##(2007-12#1)(2008-12#1)
research exploring##3##2##(2009-12#1)(2010-2#1)(2013-1#1)
research facility##2##2##(1993-3#1)(2008-4#1)
research field of##3##3##(2008-5#1)(2008-7#1)(2013-1#1)
research field to##2##3##(1997-4#1)(2009-8#1)
research field##13##2##(1997-4#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-1#2)(2013-1#1)
research fields##6##2##(2007-9#1)(2008-10#2)(2009-2#1)(2011-3#1)(2012-12#1)
research findings and##6##3##(2005-6#1)(2008-12#1)(2013-1#4)
research findings are##4##3##(1993-2#2)(2007-7#1)(2009-12#1)
research findings from the##2##4##(2008-12#1)(2010-10#1)
research findings from##3##3##(2008-12#1)(2009-12#1)(2010-10#1)
research findings in##3##3##(2008-12#1)(2012-12#1)(2013-1#1)
research findings on the##4##4##(1994-1#1)(1996-2#1)(2007-11#1)(2007-5#1)
research findings on##9##3##(1991-2#1)(1991-3#1)(1994-1#1)(1996-2#1)(2007-11#1)(2007-5#1)(2008-3#1)(2008-8#1)(2010-9#1)
research findings that##2##3##(2006-2#1)(2012-2#1)
research findings##46##2##(1991-2#2)(1991-3#1)(1993-2#3)(1994-1#1)(1996-2#1)(2005-6#1)(2005-7#1)(2006-2#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-2#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#5)(2013-1#6)
research foci##2##2##(2008-9#2)
research focus for##2##3##(2010-11#1)(2011-2#1)
research focus on##2##3##(2011-2#1)(2013-1#1)
research focus##4##2##(2010-11#1)(2011-2#2)(2013-1#1)
research focused on##5##3##(2006-10#1)(2008-10#1)(2008-12#1)(2010-9#1)(2013-7#1)
research focused##6##2##(2006-10#2)(2008-10#1)(2008-12#1)(2010-9#1)(2013-7#1)
research focuses on the##2##4##(2007-12#1)(2010-2#1)
research focuses on##7##3##(1990-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2010-2#1)(2011-2#1)(2012-2#1)
research focuses##8##2##(1990-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2010-2#1)(2011-2#1)(2012-2#2)
research focusing on##4##3##(1996-12#1)(1996-3#1)(2007-11#1)(2007-12#1)
research for a##5##3##(2006-4#1)(2007-7#1)(2008-9#1)(2009-6#1)(2013-8#1)
research for many years##2##4##(2008-10#1)(2008-3#1)
research for the##4##3##(2008-10#2)(2009-6#1)(2010-2#1)
research for##33##2##(1991-2#1)(1992-1#1)(1993-2#1)(1997-3#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-9#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#2)(2010-2#1)(2011-1#4)(2011-3#1)(2012-2#1)(2013-8#1)
research found that##2##3##(2009-7#1)(2012-12#1)
research found##4##2##(1996-3#1)(2007-3#1)(2009-7#1)(2012-12#1)
research framework##3##2##(1997-1#1)(2008-8#1)(2011-2#1)
research from a##2##3##(2005-7#1)(2007-12#1)
research from the##2##3##(2010-12#1)(2012-1#1)
research from##8##2##(2005-7#1)(2007-12#1)(2008-2#2)(2008-7#2)(2010-12#1)(2012-1#1)
research funders##3##2##(2009-4#3)
research funding##14##2##(1991-3#1)(1992-10#2)(1996-12#1)(2007-12#1)(2007-4#3)(2008-10#1)(2008-11#1)(2008-8#1)(2009-3#2)(2012-1#1)
research gap##4##2##(2006-4#1)(2006-5#1)(2008-10#1)(2013-7#1)
research gaps##3##2##(2009-3#2)(2010-9#1)
research goals##4##2##(2007-9#1)(2009-12#1)(2012-1#1)(2012-2#1)
research grant##5##2##(2007-12#1)(2007-4#1)(2009-4#1)(2011-1#1)(2013-8#1)
research grants##5##2##(1993-3#1)(2007-8#3)(2012-1#1)
research group##15##2##(2005-7#1)(2006-10#1)(2006-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-6#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-12#3)(2013-1#1)
research groups and##3##3##(1991-6#1)(1992-8#1)(1997-6#1)
research groups are##2##3##(2006-6#1)(2008-2#1)
research groups around the##2##4##(2005-7#1)(2006-10#1)
research groups from##2##3##(2008-7#1)(2011-1#1)
research groups have##4##3##(2010-11#2)(2010-8#1)(2012-11#1)
research groups##32##2##(1991-12#1)(1991-6#1)(1992-8#1)(1996-12#1)(1997-6#1)(2005-7#2)(2006-10#1)(2006-6#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#5)(2009-3#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
research guidelines##3##2##(2008-1#1)(2009-4#2)
research had##3##2##(2007-12#1)(2010-3#1)(2012-12#1)
research has accumulated##2##3##(2008-9#1)(2012-2#1)
research has also##3##3##(2006-10#2)(2006-5#1)
research has been carried out on the##2##7##(2005-9#1)(2007-9#1)
research has been carried out on##3##6##(2005-9#1)(2007-9#1)(2012-1#1)
research has been carried out##5##5##(2005-9#1)(2007-9#1)(2008-1#1)(2012-1#1)(2013-1#1)
research has been conducted on##4##5##(2007-6#1)(2011-2#1)(2012-11#1)(2012-2#1)
research has been conducted to##4##5##(2008-10#1)(2008-11#2)(2008-12#1)
research has been conducted##12##4##(2007-10#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-2#1)
research has been devoted to understanding the##2##7##(2010-6#1)(2011-2#1)
research has been devoted to##4##5##(1993-3#1)(2008-10#1)(2010-6#1)(2011-2#1)
research has been done in##3##5##(2007-7#1)(2013-1#2)
research has been done on the##3##6##(1991-3#1)(2008-10#1)(2010-4#1)
research has been done on##4##5##(1991-3#1)(2008-10#1)(2010-4#1)(2013-8#1)
research has been done##9##4##(1991-3#1)(1994-3#1)(2007-7#1)(2008-10#1)(2008-3#1)(2010-4#1)(2013-1#2)(2013-8#1)
research has been##47##3##(1991-3#1)(1993-1#1)(1993-3#1)(1994-3#1)(2005-1#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-2#1)(2007-10#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#2)(2008-9#1)(2009-9#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-2#1)(2013-1#4)(2013-8#1)
research has begun to##2##4##(2011-9#1)(2013-7#1)
research has demonstrated a##3##4##(1994-2#1)(2008-8#1)(2012-2#1)
research has demonstrated that##4##4##(2008-10#1)(2008-11#1)(2008-7#1)(2010-2#1)
research has demonstrated##11##3##(1990-11#1)(1992-12#1)(1994-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2010-2#1)(2010-3#1)(2012-2#1)
research has emphasized the##2##4##(2008-11#1)(2009-6#1)
research has evaluated##3##3##(2005-9#1)(2008-10#1)(2011-1#1)
research has examined the##2##4##(2008-11#1)(2012-12#1)
research has examined##6##3##(1995-1#1)(2005-10#1)(2007-12#1)(2008-11#2)(2012-12#1)
research has explored##4##3##(2009-7#1)(2012-2#1)(2013-1#2)
research has focused on the##9##5##(1997-6#1)(2005-7#1)(2006-10#2)(2007-12#1)(2008-2#1)(2009-9#1)(2010-7#1)(2013-1#1)
research has focused on##22##4##(1993-12#1)(1997-2#1)(1997-6#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#2)(2009-2#1)(2009-4#1)(2009-9#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
research has focused##25##3##(1993-12#1)(1997-2#1)(1997-6#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#2)(2009-2#1)(2009-4#2)(2009-9#1)(2010-7#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#2)
research has generally##2##3##(2007-12#1)(2010-12#1)
research has generated##2##3##(2009-10#1)(2012-12#1)
research has identified##6##3##(2008-6#1)(2009-3#1)(2009-5#1)(2010-3#1)(2010-8#1)(2012-3#1)
research has indicated##2##3##(2007-12#1)(2008-2#1)
research has investigated##3##3##(2007-11#1)(2008-9#1)(2013-7#1)
research has led to##2##4##(2006-10#1)(2008-12#1)
research has linked##3##3##(2006-7#1)(2007-1#1)(2010-7#1)
research has produced##2##3##(2008-9#1)(2011-1#1)
research has recently##2##3##(2005-7#1)(2010-9#1)
research has revealed a##2##4##(2009-2#1)(2009-4#1)
research has revealed##3##3##(2009-2#1)(2009-4#1)(2013-1#1)
research has shown that##13##4##(1990-11#1)(2004-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-12#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
research has shown##19##3##(1990-11#1)(1994-3#1)(2004-12#1)(2005-10#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
research has suggested that##8##4##(1997-8#1)(2005-10#1)(2007-6#1)(2008-11#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-8#1)
research has suggested##10##3##(1997-8#1)(2005-10#1)(2007-6#1)(2008-11#1)(2010-2#2)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
research has taken##2##3##(1995-3#1)(2012-2#1)
research has the##3##3##(2008-9#1)(2009-4#1)(2013-1#1)
research has##210##2##(1990-11#2)(1991-3#1)(1991-5#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-3#2)(1995-1#2)(1995-12#1)(1995-3#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-12#1)(2004-3#1)(2005-1#1)(2005-10#3)(2005-11#2)(2005-7#2)(2005-8#1)(2005-9#3)(2006-10#10)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#8)(2007-4#1)(2007-6#2)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#10)(2008-12#4)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#5)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#5)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#3)(2010-12#5)(2010-2#5)(2010-3#3)(2010-4#1)(2010-6#1)(2010-7#3)(2010-8#4)(2010-9#2)(2011-1#5)(2011-12#2)(2011-2#5)(2011-9#1)(2012-1#4)(2012-11#1)(2012-12#4)(2012-2#7)(2012-3#4)(2013-1#12)(2013-7#2)(2013-8#2)
research have been##5##3##(2008-12#1)(2008-2#1)(2008-3#2)(2009-4#1)
research have##17##2##(1995-6#1)(1997-1#1)(1997-8#1)(2007-8#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2009-12#1)(2009-4#1)(2010-12#1)(2011-7#1)(2013-1#1)
research help##2##2##(2008-12#1)(2010-9#1)
research highlights the##2##3##(2007-11#1)(2012-2#1)
research highlights##5##2##(1996-1#1)(2007-11#1)(2008-11#1)(2008-12#1)(2012-2#1)
research hospitals##2##2##(1994-3#1)(2007-9#1)
research identified##2##2##(1995-5#1)(2007-12#1)
research implications of##2##3##(2007-6#1)(2010-5#1)
research implications##7##2##(1991-1#1)(2007-6#1)(2008-12#1)(2008-5#1)(2010-5#1)(2012-2#1)(2013-7#1)
research in Canada##6##3##(1993-3#2)(2009-4#3)(2013-1#1)
research in Europe##2##3##(2007-8#1)(2009-4#1)
research in Japan##3##3##(1993-7#1)(2006-5#1)(2012-11#1)
research in New Zealand##2##4##(2005-7#1)(2008-1#1)
research in a manner that##2##5##(2008-9#1)(2013-8#1)
research in a##6##3##(1993-6#1)(1995-3#1)(2008-9#1)(2009-4#1)(2011-1#1)(2013-8#1)
research in child and adolescent partial hospitalization##2##7##(1992-1#2)
research in child and adolescent##3##5##(1992-1#2)(2008-4#1)
research in dynamic light scattering##2##5##(2008-2#1)(2008-3#1)
research in emergency situations should##2##5##(2009-6#2)
research in favor of##2##4##(2007-9#1)(2008-11#1)
research in gastroenterology##2##3##(1995-6#1)(2006-2#1)
research in general##3##3##(2007-12#1)(2007-4#1)(2010-1#1)
research in health##5##3##(1990-12#1)(1993-3#1)(1995-11#1)(2005-7#1)(2012-1#1)
research in home care##2##4##(1996-2#1)(2006-5#1)
research in human##2##3##(1994-9#1)(2010-10#1)
research in humanitarian medical programmes##3##5##(2005-9#3)
research in humanitarian##4##3##(2005-9#3)(2009-6#1)
research in long-term##2##3##(2005-8#1)(2009-4#1)
research in molecular##2##3##(2007-11#1)(2011-2#1)
research in order to##4##4##(2005-7#1)(2008-1#1)(2008-12#1)(2013-1#1)
research in other##2##3##(2005-7#1)(2008-11#1)
research in our##2##3##(1990-12#1)(2007-8#1)
research in primary care##2##4##(1996-9#1)(2008-7#1)
research in primary##4##3##(1993-2#1)(1996-9#1)(2008-7#1)(2010-11#1)
research in psychiatry and##2##4##(2008-2#1)(2008-4#1)
research in psychiatry##3##3##(2004-11#1)(2008-2#1)(2008-4#1)
research in recent years##3##4##(2006-12#1)(2008-9#1)(2010-8#1)
research in recent##5##3##(2005-8#1)(2006-12#1)(2008-1#1)(2008-9#1)(2010-8#1)
research in relation to##3##4##(2008-5#1)(2009-12#1)(2011-2#1)
research in several areas##2##4##(1990-12#1)(2006-4#1)
research in several##3##3##(1990-12#1)(1992-3#1)(2006-4#1)
research in stroke##2##3##(2008-8#2)
research in the Middle Ramu##2##5##(2006-2#2)
research in the area of##8##5##(1995-3#1)(1996-10#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-3#1)
research in the area##9##4##(1995-3#1)(1996-10#1)(2005-11#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-3#1)
research in the field of##4##5##(1993-1#1)(2008-5#1)(2010-10#1)(2012-2#1)
research in the field##12##4##(1990-3#1)(1992-1#1)(1993-1#1)(1994-3#1)(2005-8#1)(2007-11#1)(2008-11#1)(2008-5#1)(2010-10#1)(2010-7#1)(2012-12#1)(2012-2#1)
research in the fields of##2##5##(2007-11#1)(2008-8#1)
research in the health##2##4##(2008-11#1)(2008-6#1)
research in the last##2##4##(2005-8#1)(2008-5#1)
research in the medical##2##4##(1991-12#1)(1992-6#1)
research in the past decades##2##5##(2009-5#1)(2010-10#1)
research in the past##5##4##(2008-11#1)(2009-1#1)(2009-5#1)(2010-10#1)(2011-2#1)
research in the use of##2##5##(2008-1#1)(2008-5#1)
research in the##77##3##(1990-3#1)(1990-4#1)(1990-6#1)(1991-12#1)(1992-1#1)(1992-6#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-10#1)(1996-11#1)(1997-3#1)(2005-11#1)(2005-8#2)(2006-10#1)(2006-2#2)(2007-11#5)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#4)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#2)(2009-1#1)(2009-3#1)(2009-4#2)(2009-5#1)(2010-10#3)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-7#2)
research in these##3##3##(2008-9#1)(2009-4#1)(2013-8#1)
research in this area has##3##5##(2008-10#1)(2012-1#1)(2013-1#1)
research in this area is##2##5##(2006-9#1)(2007-6#1)
research in this area##25##4##(1992-9#1)(1996-12#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-9#2)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#4)(2013-8#2)
research in this direction##2##4##(2010-3#1)(2012-2#1)
research in this field is##4##5##(1996-9#1)(2006-10#1)(2010-12#1)(2012-12#1)
research in this field##16##4##(1996-2#1)(1996-9#1)(2006-10#2)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-7#1)
research in this##48##3##(1992-9#1)(1994-8#1)(1996-12#1)(1996-2#1)(1996-9#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-9#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#4)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#2)
research in which##2##3##(2007-12#1)(2008-12#1)
research in##356##2##(1990-12#3)(1990-3#1)(1990-4#1)(1990-6#1)(1991-12#1)(1991-6#2)(1992-1#3)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-2#5)(1993-3#5)(1993-6#3)(1993-7#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-9#2)(1997-3#2)(1997-8#1)(2004-11#1)(2004-7#1)(2005-10#1)(2005-11#2)(2005-7#6)(2005-8#8)(2005-9#3)(2006-10#10)(2006-11#1)(2006-12#2)(2006-2#3)(2006-4#1)(2006-5#3)(2006-8#1)(2006-9#3)(2007-10#4)(2007-11#9)(2007-12#4)(2007-2#2)(2007-4#5)(2007-5#1)(2007-6#3)(2007-7#5)(2007-8#5)(2007-9#5)(2008-1#6)(2008-10#9)(2008-11#10)(2008-12#5)(2008-2#8)(2008-3#2)(2008-4#5)(2008-5#11)(2008-6#3)(2008-7#5)(2008-8#6)(2008-9#4)(2009-1#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#9)(2009-5#3)(2009-6#5)(2009-7#1)(2009-9#2)(2010-1#2)(2010-10#7)(2010-11#6)(2010-12#2)(2010-3#2)(2010-4#5)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#8)(2011-12#1)(2011-2#9)(2012-1#4)(2012-11#2)(2012-12#10)(2012-2#9)(2012-3#5)(2013-1#9)(2013-7#5)(2013-8#7)
research include##3##2##(2006-6#1)(2008-10#1)(2013-1#1)
research included##2##2##(2009-4#1)(2011-1#1)
research includes##2##2##(1996-12#1)(2006-10#1)
research including the##2##3##(2005-8#1)(2010-12#1)
research including##3##2##(2005-8#1)(2010-12#1)(2013-1#1)
research indicate that##2##3##(1990-10#1)(2008-12#1)
research indicate##4##2##(1990-10#1)(2005-1#1)(2008-12#1)(2013-7#1)
research indicated##2##2##(2005-10#1)(2007-7#1)
research indicates that the##2##4##(2008-6#1)(2011-3#1)
research indicates that##16##3##(1995-6#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-2#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#1)
research indicates##18##2##(1995-6#1)(2006-12#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-2#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#1)
research indicating##2##2##(2006-9#1)(2008-6#1)
research information##3##2##(1992-2#1)(1993-12#1)(2012-11#1)
research initiative##3##2##(2008-10#1)(2010-12#2)
research initiatives##5##2##(2008-7#1)(2009-11#1)(2011-2#2)(2012-1#1)
research institutes and##2##3##(2008-10#1)(2008-7#1)
research institutes in##2##3##(1996-2#1)(2007-6#1)
research institutes##6##2##(1994-2#1)(1996-2#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-7#1)
research institution##2##2##(2009-4#1)(2010-1#1)
research institutions and##2##3##(2006-5#1)(2011-2#1)
research institutions##5##2##(2006-4#1)(2006-5#2)(2007-11#1)(2011-2#1)
research instrument##2##2##(1990-8#1)(2013-8#1)
research instruments##5##2##(1993-2#1)(1994-12#1)(2006-8#2)(2008-9#1)
research interest in this##2##4##(2005-8#1)(2010-3#1)
research interest in##3##3##(2005-8#1)(2006-10#1)(2010-3#1)
research interest##6##2##(2005-10#1)(2005-8#1)(2006-10#1)(2010-3#2)(2010-5#1)
research interests##4##2##(2007-9#1)(2008-12#1)(2008-9#1)(2009-4#1)
research into interventions##3##3##(2009-11#1)(2010-12#1)(2012-12#1)
research into its##2##3##(2008-10#1)(2010-5#1)
research into new##2##3##(1996-11#2)
research into practice##7##3##(1996-1#1)(2006-5#1)(2007-4#1)(2009-11#1)(2010-10#1)(2010-5#1)(2012-12#1)
research into the causes##2##4##(2006-10#1)(2008-10#1)
research into the immunopathogenesis of##2##5##(2007-11#1)(2009-12#1)
research into the mechanism of##3##5##(1996-8#1)(2008-5#1)(2008-9#1)
research into the mechanisms of##2##5##(2008-9#1)(2009-8#1)
research into the role of##2##5##(2005-11#1)(2011-1#1)
research into the##32##3##(1991-12#1)(1991-3#1)(1995-5#1)(1996-8#1)(2005-11#1)(2005-2#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-1#1)(2009-12#1)(2009-8#2)(2010-12#1)(2011-1#1)(2013-1#3)
research into##100##2##(1991-12#1)(1991-2#1)(1991-3#2)(1992-1#1)(1992-8#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-8#1)(1997-7#2)(2005-11#1)(2005-2#1)(2005-7#1)(2005-8#3)(2006-10#3)(2006-12#1)(2006-2#1)(2006-5#1)(2006-9#2)(2007-10#2)(2007-11#4)(2007-4#1)(2007-7#2)(2008-1#2)(2008-10#4)(2008-11#4)(2008-2#2)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-1#1)(2009-11#2)(2009-12#2)(2009-4#1)(2009-7#2)(2009-8#3)(2010-10#2)(2010-11#1)(2010-12#2)(2010-5#3)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#9)
research investigated the##7##3##(2005-11#1)(2007-12#1)(2007-2#1)(2009-9#1)(2010-2#1)(2011-2#2)
research investigated##9##2##(2005-11#1)(2007-12#1)(2007-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-2#2)
research investigates the##2##3##(2005-11#1)(2009-4#1)
research investigates##4##2##(2005-11#1)(2007-11#1)(2008-7#1)(2009-4#1)
research investigating the##3##3##(1993-2#1)(2007-12#1)(2010-2#1)
research investigating##6##2##(1990-4#1)(1992-1#1)(1993-2#1)(2007-12#1)(2008-1#1)(2010-2#1)
research investigations##4##2##(2008-10#1)(2008-11#1)(2008-6#1)(2012-12#1)
research involved##16##2##(2007-11#7)(2007-8#9)
research involves##3##2##(1994-2#1)(2009-2#1)(2011-12#1)
research involving persons with##2##4##(2007-7#1)(2010-11#1)
research involving##16##2##(1996-11#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-5#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-10#1)(2010-11#2)(2012-11#1)(2013-8#1)
research is a##6##3##(1995-2#1)(2006-12#1)(2006-7#1)(2007-4#1)(2008-10#1)(2009-9#1)
research is aimed at##3##4##(1996-3#1)(2005-10#1)(2008-3#1)
research is also##9##3##(1994-9#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-8#1)(2010-2#1)(2012-3#1)(2013-8#1)
research is an##5##3##(2006-5#1)(2007-5#1)(2008-11#1)(2008-5#1)(2009-6#1)
research is based on##4##4##(1990-12#1)(2009-10#1)(2010-6#1)(2013-8#1)
research is being conducted##2##4##(2008-10#1)(2009-7#1)
research is being##5##3##(1997-5#1)(2008-10#1)(2008-2#1)(2009-3#1)(2009-7#1)
research is clearly##2##3##(2009-8#1)(2011-1#1)
research is conducted##3##3##(2008-10#1)(2008-12#1)(2013-8#1)
research is discussed##2##3##(1997-1#1)(2007-11#1)
research is focused##2##3##(2007-11#1)(2012-2#1)
research is imperative##2##3##(2007-2#1)(2008-3#1)
research is important for##2##4##(2007-10#1)(2008-7#1)
research is indicated to##2##4##(2006-10#1)(2006-8#1)
research is indicated##3##3##(2006-10#1)(2006-8#1)(2011-2#1)
research is mainly focused on##2##5##(2008-2#1)(2008-5#1)
research is necessary to##3##4##(2008-3#1)(2012-3#1)(2013-8#1)
research is necessary##5##3##(2007-12#1)(2008-3#1)(2012-3#1)(2013-7#1)(2013-8#1)
research is needed before##2##4##(2006-10#1)(2010-10#1)
research is needed in order to##4##6##(2006-8#1)(2008-5#1)(2008-7#1)(2012-3#1)
research is needed in this field##3##6##(1992-8#1)(2012-11#2)
research is needed in this##4##5##(1992-8#1)(2012-11#2)(2012-3#1)
research is needed in##10##4##(1992-8#1)(1995-3#1)(2006-7#1)(2006-8#1)(2008-5#1)(2008-7#1)(2012-11#2)(2012-3#2)
research is needed into##2##4##(2006-10#1)(2008-3#1)
research is needed on the##4##5##(1993-10#1)(1995-11#1)(2008-11#1)(2010-8#1)
research is needed on##12##4##(1990-9#1)(1993-10#1)(1995-11#1)(2006-4#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-4#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#1)
research is needed to better understand the##3##7##(2009-5#1)(2010-2#1)(2012-12#1)
research is needed to better understand##4##6##(2007-12#1)(2009-5#1)(2010-2#1)(2012-12#1)
research is needed to clarify the##2##6##(1997-8#1)(2005-10#1)
research is needed to determine##11##5##(1994-12#1)(2005-10#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-12#1)(2012-12#1)(2012-2#1)
research is needed to evaluate this##2##6##(2008-11#1)(2009-12#1)
research is needed to evaluate##6##5##(1994-2#1)(1996-8#2)(2008-11#1)(2009-12#1)(2010-7#1)
research is needed to further##3##5##(2008-11#1)(2009-11#1)(2012-2#1)
research is needed to identify##6##5##(2006-2#1)(2007-5#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-12#1)
research is needed to understand the##4##6##(2006-10#1)(2007-3#1)(2012-12#1)(2013-1#1)
research is needed to##53##4##(1994-12#1)(1994-2#1)(1996-8#2)(1997-8#1)(2005-10#3)(2006-10#1)(2006-2#1)(2006-9#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#2)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-7#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#2)(2013-1#2)
research is needed##89##3##(1990-9#1)(1992-8#1)(1993-10#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-3#1)(1996-8#2)(1997-8#1)(2005-10#3)(2005-7#1)(2006-10#3)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2008-11#7)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-7#2)(2010-10#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-11#2)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#2)
research is one##2##3##(2008-5#2)
research is presented##2##3##(2009-4#1)(2011-2#1)
research is recommended##2##3##(1996-1#1)(2007-6#1)
research is required to better understand##2##6##(2008-11#1)(2013-1#1)
research is required to##9##4##(2005-10#1)(2006-10#1)(2007-11#1)(2008-11#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
research is required##13##3##(1990-4#1)(2005-10#1)(2006-10#2)(2007-11#1)(2008-11#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
research is still##3##3##(1994-1#1)(2010-10#1)(2012-2#1)
research is that##3##3##(2007-5#1)(2008-10#1)(2010-8#1)
research is the##10##3##(1994-3#1)(1995-6#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-8#1)(2012-2#1)(2013-1#1)
research is therefore##2##3##(1996-11#1)(2011-2#1)
research is to understand the##2##5##(1994-11#1)(2007-12#1)
research is to##15##3##(1994-11#1)(1994-8#1)(1996-4#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
research is warranted to##2##4##(2009-4#1)(2013-1#1)
research is warranted##5##3##(2009-4#1)(2012-2#1)(2013-1#2)(2013-7#1)
research is##260##2##(1990-12#4)(1990-4#1)(1990-8#1)(1990-9#1)(1991-7#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#2)(1996-3#1)(1996-4#1)(1996-8#2)(1997-1#1)(1997-3#3)(1997-5#1)(1997-8#1)(2005-10#5)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#9)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#2)(2006-5#2)(2006-7#2)(2006-8#3)(2006-9#2)(2007-10#1)(2007-11#7)(2007-12#5)(2007-2#4)(2007-3#1)(2007-4#2)(2007-5#5)(2007-6#2)(2007-7#2)(2007-8#1)(2008-10#7)(2008-11#13)(2008-12#3)(2008-2#4)(2008-3#9)(2008-4#3)(2008-5#6)(2008-7#8)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#2)(2009-7#3)(2009-8#2)(2009-9#1)(2010-10#4)(2010-12#3)(2010-2#4)(2010-3#2)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#4)(2011-2#11)(2012-1#3)(2012-11#3)(2012-12#6)(2012-2#9)(2012-3#5)(2013-1#10)(2013-7#2)(2013-8#7)
research issues in##2##3##(2007-12#1)(2008-6#1)
research issues that##2##3##(1992-12#1)(2007-12#1)
research issues##12##2##(1992-12#1)(1996-8#1)(2007-12#4)(2008-11#1)(2008-6#2)(2010-3#1)(2012-2#1)(2013-1#1)
research it##3##2##(2007-9#1)(2008-2#1)(2010-5#1)
research journals##3##2##(1990-8#1)(2013-1#2)
research knowledge##3##2##(2007-10#1)(2008-11#1)(2008-7#1)
research laboratories##7##2##(2008-10#1)(2008-11#1)(2008-7#2)(2010-10#1)(2011-1#1)(2013-1#1)
research laboratory##5##2##(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
research leads to##3##3##(2004-11#1)(2005-9#1)(2008-3#1)
research linking##5##2##(1994-2#1)(2009-5#2)(2010-2#1)(2010-7#1)
research literature suggests that##2##4##(1995-3#1)(2012-2#1)
research literature to##2##3##(2006-10#1)(2008-4#1)
research literature##18##2##(1992-12#1)(1994-3#1)(1995-3#1)(1997-3#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-2#1)(2007-4#1)(2008-11#1)(2008-4#1)(2009-2#1)(2010-2#1)(2011-10#1)(2012-12#2)(2012-2#1)(2013-1#1)
research mainly##3##2##(1995-7#1)(2008-1#1)(2010-8#1)
research material was##2##3##(2007-7#1)(2012-2#1)
research material##3##2##(2007-11#1)(2007-7#1)(2012-2#1)
research may be##8##3##(1992-6#1)(1993-5#1)(2005-7#1)(2007-1#1)(2008-4#1)(2008-9#1)(2013-1#1)(2013-8#1)
research may##15##2##(1990-12#1)(1990-9#1)(1992-12#1)(1992-6#1)(1993-5#1)(1997-2#1)(2005-7#1)(2007-1#1)(2008-10#1)(2008-4#2)(2008-9#1)(2010-4#1)(2013-1#1)(2013-8#1)
research method##11##2##(1991-3#1)(1993-11#1)(2005-10#1)(2005-11#1)(2007-10#2)(2008-1#2)(2010-2#1)(2012-12#1)(2013-8#1)
research methodologies##2##2##(2006-8#1)(2009-12#1)
research methodology##16##2##(1993-8#1)(1994-2#1)(1995-3#2)(1997-7#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-10#1)(2007-2#1)(2008-11#2)(2008-9#1)(2009-6#1)(2009-9#1)(2010-2#1)
research methods and the##2##4##(2007-11#1)(2008-8#1)
research methods and##3##3##(2007-11#1)(2008-10#1)(2008-8#1)
research methods are##2##3##(2008-12#2)
research methods for##2##3##(2008-11#1)(2008-3#1)
research methods in##2##3##(2008-12#1)(2012-3#1)
research methods##21##2##(1992-5#1)(1996-2#1)(1997-1#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-3#1)(2008-8#2)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
research might##3##2##(1990-6#1)(2007-12#1)(2010-4#1)
research misconception##2##2##(2006-11#2)
research misconduct##2##2##(1996-3#1)(1997-8#1)
research model##5##2##(1991-2#1)(2007-7#1)(2008-8#1)(2010-8#1)(2011-1#1)
research models##2##2##(1991-3#1)(2008-11#1)
research must be##6##3##(1993-6#1)(1995-2#1)(2006-10#2)(2013-1#2)
research must##8##2##(1992-8#1)(1993-6#1)(1995-2#1)(2006-10#2)(2011-2#1)(2013-1#2)
research needs are##3##3##(1992-4#1)(2008-10#1)(2011-1#1)
research needs in##3##3##(1994-12#1)(2009-4#1)(2010-7#1)
research needs that##2##3##(1993-12#1)(2008-6#1)
research needs to be conducted to##3##6##(2009-4#1)(2010-8#1)(2013-8#1)
research needs to be##6##4##(2006-10#1)(2009-4#1)(2009-5#1)(2010-8#1)(2012-12#1)(2013-8#1)
research needs to##11##3##(1994-2#1)(2006-10#1)(2008-1#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
research needs##23##2##(1992-2#1)(1992-4#1)(1993-12#1)(1994-12#1)(1994-2#1)(1996-8#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-4#2)(2009-5#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#2)(2012-12#1)(2013-1#1)(2013-8#1)
research network##5##2##(2006-4#2)(2008-10#1)(2009-2#1)(2011-2#1)
research nurse##3##2##(2008-11#3)
research objective##2##2##(2008-7#1)(2011-2#1)
research of human##3##3##(2008-9#1)(2010-12#1)(2012-12#1)
research of the##17##3##(1994-3#1)(2005-11#2)(2005-4#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2012-2#2)(2012-3#2)(2013-7#1)
research of##62##2##(1991-12#1)(1992-3#1)(1994-12#1)(1994-3#1)(1997-4#1)(2005-10#1)(2005-11#2)(2005-4#2)(2006-10#1)(2006-6#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-8#1)(2008-9#4)(2009-10#1)(2009-4#1)(2009-5#2)(2010-1#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#2)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#2)(2013-7#2)
research often##2##2##(2008-4#1)(2013-1#1)
research on and##2##3##(2006-7#1)(2008-5#1)
research on animals in the wild##2##6##(2013-8#2)
research on biological control of##2##5##(2008-10#2)
research on biological##4##3##(1992-12#2)(2008-10#2)
research on both##3##3##(2008-11#1)(2012-3#2)
research on children##2##3##(2009-4#1)(2011-12#1)
research on epidemiology##2##3##(2008-10#1)(2012-3#1)
research on human subjects##3##4##(1995-2#1)(2005-11#2)
research on human##5##3##(1995-2#1)(2005-11#2)(2007-5#1)(2010-3#1)
research on population##3##3##(2009-4#1)(2010-11#1)(2011-12#1)
research on psychological##2##3##(2007-1#1)(2010-2#1)
research on risky##2##3##(2009-3#1)(2009-4#1)
research on romantic##2##3##(2004-12#1)(2009-7#1)
research on social##2##3##(2010-3#1)(2012-2#1)
research on sport##2##3##(2013-7#2)
research on the causes and consequences of##2##7##(2010-2#2)
research on the causes##3##4##(2010-2#2)(2013-1#1)
research on the effects of##5##5##(1991-2#1)(1995-2#1)(2008-11#1)(2012-3#1)(2013-7#1)
research on the epidemiology##3##4##(2004-9#1)(2008-10#1)(2009-4#1)
research on the etiology and##2##5##(1994-8#1)(2013-8#1)
research on the etiology##3##4##(1994-8#1)(2006-8#1)(2013-8#1)
research on the genetic##2##4##(2008-11#1)(2009-2#1)
research on the immunology of schistosomiasis##2##6##(2006-10#2)
research on the impact of##2##5##(2007-11#1)(2008-2#1)
research on the molecular basis##2##5##(2005-9#1)(2006-10#1)
research on the nature##2##4##(1993-1#1)(2008-10#1)
research on the role of##2##5##(2009-7#1)(2012-1#1)
research on the social##2##4##(2006-2#1)(2009-7#1)
research on the toxicology of##2##5##(2008-7#2)
research on the use of##2##5##(2005-7#1)(2008-1#1)
research on the##98##3##(1990-12#1)(1991-2#1)(1993-1#1)(1993-3#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-6#1)(2004-9#1)(2005-7#1)(2005-9#2)(2006-10#3)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#4)(2008-2#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#3)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#2)(2010-3#1)(2011-2#4)(2012-1#2)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#6)
research on their##3##3##(1990-12#1)(1993-12#1)(2011-1#1)
research on these##6##3##(1992-9#1)(2011-2#1)(2012-1#1)(2013-1#3)
research on this topic##3##4##(1990-11#1)(2011-2#1)(2013-1#1)
research on this##8##3##(1990-11#1)(1997-4#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-11#1)(2011-2#1)(2013-1#1)
research on##313##2##(1990-10#2)(1990-11#1)(1990-12#3)(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-4#1)(1992-12#5)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-7#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-6#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-12#1)(2004-3#1)(2004-9#1)(2005-11#3)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#2)(2006-5#2)(2006-7#2)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#4)(2007-11#7)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#5)(2008-10#17)(2008-11#10)(2008-12#5)(2008-2#8)(2008-3#2)(2008-4#2)(2008-5#9)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#10)(2009-5#1)(2009-6#1)(2009-7#8)(2009-8#2)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#5)(2010-2#6)(2010-3#3)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#7)(2011-12#5)(2011-2#8)(2012-1#4)(2012-11#3)(2012-12#1)(2012-2#5)(2012-3#7)(2013-1#19)(2013-7#5)(2013-8#12)
research opportunities##7##2##(2007-7#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#1)
research or##7##2##(2008-11#2)(2008-4#1)(2009-1#1)(2010-12#1)(2011-2#1)(2013-8#1)
research orchard##2##2##(2008-10#2)
research organization##4##2##(1991-9#1)(1994-1#1)(2008-10#1)(2010-5#1)
research outcomes##4##2##(1996-12#1)(2012-2#1)(2013-1#2)
research output in##2##3##(2007-11#1)(2007-6#1)
research over the last few decades##2##6##(1995-1#1)(2008-5#1)
research over the last few##3##5##(1995-1#1)(2008-5#1)(2010-12#1)
research over the last##4##4##(1995-1#1)(2008-5#1)(2010-12#2)
research over the past decade##2##5##(2006-10#1)(2007-11#1)
research over the past##4##4##(2005-8#1)(2006-10#1)(2007-11#1)(2008-5#1)
research over the##8##3##(1995-1#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-5#2)(2010-12#2)
research over##9##2##(1995-1#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-5#2)(2010-12#2)
research papers on photon correlation and scattering##2##7##(2008-2#1)(2008-3#1)
research papers on##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
research papers##6##2##(2008-2#1)(2008-3#1)(2008-5#2)(2011-1#1)(2013-8#1)
research papers]##2##2##(2010-6#1)(2013-1#1)
research paradigm##4##2##(1997-2#1)(2006-2#1)(2008-11#1)(2008-4#1)
research participants and##2##3##(2007-4#1)(2009-6#1)
research participants are##2##3##(2010-2#1)(2012-2#1)
research participants##19##2##(1995-1#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#2)(2008-8#1)(2009-4#3)(2009-6#2)(2009-9#1)(2010-2#2)(2012-12#1)(2012-2#2)
research participation among##2##3##(2009-4#1)(2013-1#1)
research participation##7##2##(2008-5#1)(2009-4#3)(2009-6#1)(2009-9#1)(2013-1#1)
research partnerships##3##2##(2008-1#1)(2009-4#1)(2012-2#1)
research performed##2##2##(2006-1#1)(2008-1#1)
research perspective##2##2##(2009-5#1)(2010-9#1)
research philosophy##2##2##(2007-7#1)(2013-8#1)
research plan##5##2##(1997-1#1)(2006-6#1)(2007-9#1)(2008-7#1)(2011-2#1)
research plots##2##2##(2008-10#2)
research point of view the hypoxia-inducible factor##2##7##(2009-3#2)
research point##4##2##(1990-12#1)(2008-5#1)(2009-3#2)
research points to##2##3##(2007-1#1)(2010-9#1)
research potential##2##2##(2010-11#1)(2011-2#1)
research practices##2##2##(2008-9#1)(2010-11#1)
research presentations##2##2##(2005-7#1)(2008-10#1)
research presented here##3##3##(2008-3#2)(2008-7#1)
research presented##7##2##(2005-7#1)(2007-12#1)(2008-3#2)(2008-7#1)(2010-12#1)(2010-2#1)
research presents##4##2##(2007-12#1)(2008-3#1)(2008-8#1)(2009-4#1)
research priorities for critical care nursing##2##6##(2007-11#2)
research priorities for critical care##3##5##(2007-11#3)
research priorities for##7##3##(2007-11#5)(2008-10#1)(2010-12#1)
research priorities##12##2##(1997-7#1)(2007-11#7)(2008-10#1)(2010-10#1)(2010-12#1)(2011-2#1)
research problems##3##2##(2006-2#1)(2007-10#1)(2010-1#1)
research process##17##2##(1992-5#1)(1996-3#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-12#2)(2009-4#3)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
research productivity in##3##3##(1997-1#2)(2009-4#1)
research productivity##4##2##(1997-1#2)(2007-4#1)(2009-4#1)
research profile##3##2##(2008-11#3)
research program in##2##3##(2007-4#1)(2008-9#1)
research program of##2##3##(2006-12#1)(2007-12#1)
research program on##2##3##(2008-8#1)(2011-3#1)
research program##23##2##(1992-12#2)(1992-5#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#3)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-3#1)(2012-3#1)
research programme##6##2##(1990-10#1)(1992-8#1)(2004-7#1)(2006-5#1)(2007-6#2)
research programmes##5##2##(1992-6#1)(1993-6#1)(2005-7#1)(2008-7#1)(2013-1#1)
research programs that##4##3##(1996-2#1)(2009-8#2)(2013-1#1)
research programs##16##2##(1996-2#1)(1996-5#1)(2007-12#1)(2007-4#2)(2007-9#1)(2008-11#1)(2008-4#2)(2009-12#1)(2009-8#2)(2010-9#2)(2012-11#1)(2013-1#1)
research progress in the##2##4##(2013-8#2)
research progress in##5##3##(2012-3#1)(2013-8#4)
research progress of##3##3##(2013-1#2)(2013-8#1)
research progress##10##2##(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#6)
research progress]##2##2##(2013-8#2)
research project has##2##3##(2006-6#1)(2013-8#1)
research project is##2##3##(2008-9#1)(2013-8#1)
research project on##2##3##(1990-12#1)(1994-4#1)
research project to improve##2##4##(1996-3#1)(2006-4#1)
research project to##8##3##(1991-6#1)(1996-3#1)(1997-2#1)(2006-10#1)(2006-4#1)(2008-12#1)(2009-8#1)(2010-10#1)
research project undertaken##2##3##(2007-11#1)(2012-3#1)
research project##45##2##(1990-12#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-6#1)(1994-4#1)(1994-9#1)(1995-1#1)(1996-3#2)(1997-2#1)(1997-3#1)(2006-10#1)(2006-4#1)(2006-6#2)(2006-8#2)(2007-11#2)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-8#1)(2010-10#3)(2010-12#1)(2010-4#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#5)
research projects are##2##3##(2005-7#1)(2008-12#1)
research projects in##5##3##(2008-7#2)(2009-4#1)(2009-6#1)(2010-3#1)
research projects that##3##3##(1997-1#1)(2008-6#1)(2012-3#1)
research projects which##2##3##(1992-3#1)(2013-1#1)
research projects##31##2##(1992-3#1)(1992-5#1)(1992-6#1)(1994-9#1)(1997-1#1)(1997-3#2)(1997-5#1)(2005-7#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#3)(2009-6#2)(2010-10#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
research proposals for studies##2##4##(2007-12#2)
research proposals##8##2##(2007-12#5)(2008-1#1)(2010-4#1)(2012-2#1)
research propositions##2##2##(1996-2#1)(2007-12#1)
research prospects##3##2##(2006-8#2)(2012-11#1)
research protocol##4##2##(2005-3#1)(2007-2#1)(2008-9#1)(2011-2#1)
research protocols##12##2##(1992-12#1)(1992-3#2)(1997-1#1)(2005-7#1)(2008-1#1)(2009-4#2)(2011-1#2)(2012-11#1)(2013-8#1)
research provides a##3##3##(2008-2#1)(2011-2#1)(2012-12#1)
research provides##6##2##(2008-2#1)(2008-3#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-12#1)
research publications##3##2##(2012-2#1)(2013-7#2)
research published##2##2##(2006-10#1)(2007-9#1)
research purposes##16##2##(1990-8#1)(1992-4#1)(1993-1#1)(2004-11#1)(2006-2#1)(2007-11#1)(2008-11#1)(2008-7#1)(2009-7#1)(2010-5#3)(2011-1#1)(2012-3#2)(2013-1#1)
research quality##3##2##(2008-4#1)(2010-5#2)
research question that##2##3##(1996-2#1)(2008-11#1)
research question##10##2##(1996-2#1)(1996-8#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-7#1)(2010-4#1)
research questions are##3##3##(2006-6#1)(2008-7#1)(2009-5#1)
research questions guiding##2##3##(1990-10#1)(2006-5#1)
research questions were##2##3##(2008-12#1)(2013-1#1)
research questions##18##2##(1990-10#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-2#1)(2008-11#1)(2008-12#2)(2008-7#1)(2009-5#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
research rather than##3##3##(1997-3#1)(2007-12#1)(2007-9#1)
research reactor##2##2##(2006-7#1)(2007-9#1)
research records##2##2##(1991-3#1)(1997-5#1)
research regarding the##4##3##(2006-9#1)(2008-1#1)(2009-4#1)(2010-12#1)
research regarding##8##2##(2006-9#1)(2008-1#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-1#1)
research registry##5##2##(2010-11#5)
research related to the##2##4##(1992-12#1)(2008-3#1)
research related to##8##3##(1992-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2010-11#1)(2012-2#1)
research relationship##2##2##(1997-1#2)
research relevant to##2##3##(2006-10#1)(2007-11#1)
research remains##2##2##(1995-6#1)(2008-5#1)
research reported here##2##3##(1991-2#1)(2007-10#1)
research reported##5##2##(1991-2#1)(2007-10#1)(2008-2#1)(2010-5#1)(2012-1#1)
research reports##5##2##(1995-12#1)(2005-7#1)(2009-5#1)(2010-2#1)(2011-7#1)
research reputation##2##2##(1996-1#2)
research requirements##3##2##(1996-12#1)(2008-4#2)
research requires##3##2##(1996-2#1)(2012-1#1)(2013-1#1)
research results are##3##3##(2005-10#1)(2007-11#1)(2008-8#1)
research results from##2##3##(1993-6#1)(2008-10#1)
research results in##2##3##(1993-2#1)(2008-10#1)
research results to##2##3##(2009-6#1)(2011-2#1)
research results##34##2##(1992-1#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-3#1)(1995-1#1)(1995-2#1)(1997-8#1)(2005-10#1)(2006-2#2)(2007-11#1)(2007-2#1)(2008-10#3)(2008-4#2)(2008-8#2)(2009-11#1)(2009-4#1)(2009-6#1)(2010-2#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#3)
research review##4##2##(1992-2#2)(2009-6#1)(2013-8#1)
research scientists##5##2##(2005-8#1)(2006-10#1)(2006-12#1)(2008-4#1)(2012-1#1)
research setting##5##2##(2008-6#1)(2009-9#1)(2010-7#1)(2011-2#1)(2012-12#1)
research settings##3##2##(2009-8#1)(2013-1#2)
research should be carried out on the##2##7##(2007-2#1)(2013-8#1)
research should be##8##3##(1996-12#1)(1996-9#1)(2006-12#1)(2007-2#1)(2008-1#1)(2010-11#1)(2013-8#2)
research should examine the##2##4##(2007-7#1)(2010-9#1)
research should focus on##6##4##(2008-3#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)
research should focus##7##3##(2008-3#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2013-1#1)
research should seek to##2##4##(2008-5#1)(2009-4#1)
research should##35##2##(1995-12#1)(1996-12#1)(1996-9#1)(2006-12#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#2)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
research show that##3##3##(1991-2#1)(2008-12#1)(2010-10#1)
research show##4##2##(1991-2#1)(2008-10#1)(2008-12#1)(2010-10#1)
research showed that the##2##4##(1995-12#1)(2008-1#1)
research showed that##7##3##(1995-12#1)(1997-3#1)(2007-9#1)(2008-1#1)(2008-12#2)(2013-1#1)
research showed##8##2##(1995-12#1)(1997-3#1)(2007-9#1)(2008-1#1)(2008-12#2)(2010-2#1)(2013-1#1)
research showing##5##2##(1993-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#1)
research shows that the##4##4##(2007-7#1)(2008-3#1)(2009-8#1)(2013-8#1)
research shows that##15##3##(1991-11#1)(2006-1#1)(2006-7#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-8#2)(2010-12#1)(2012-2#1)(2013-8#2)
research shows##20##2##(1991-11#1)(2004-9#1)(2005-11#1)(2006-1#1)(2006-7#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-8#2)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
research skills##5##2##(2005-12#1)(2007-3#1)(2008-11#2)(2008-4#1)
research sought to##3##3##(1993-12#1)(2007-3#1)(2012-3#1)
research staff##3##2##(2009-12#1)(2009-4#1)(2010-11#1)
research station##3##2##(2008-10#1)(2008-11#1)(2010-5#1)
research stations##2##2##(2008-10#2)
research strategies##5##2##(1995-3#1)(2008-2#1)(2009-4#1)(2010-10#1)(2010-9#1)
research strategy##4##2##(2007-2#1)(2008-10#1)(2008-3#1)(2009-8#1)
research studies and##5##3##(2004-12#1)(2005-7#1)(2010-11#1)(2010-8#1)(2013-1#1)
research studies are##2##3##(2008-10#1)(2013-1#1)
research studies have##4##3##(2005-11#1)(2008-11#1)(2008-12#1)(2011-1#1)
research studies in##2##3##(2008-2#1)(2012-3#1)
research studies on the##3##4##(2008-11#1)(2008-5#1)(2013-1#1)
research studies that##6##3##(2007-2#1)(2008-4#1)(2008-6#1)(2010-12#1)(2013-1#2)
research studies##43##2##(1993-12#1)(2004-12#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-2#1)(2007-4#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-6#2)(2010-11#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2012-3#1)(2013-1#9)(2013-7#1)
research study of##2##3##(2007-8#1)(2008-12#1)
research study was to##3##4##(2007-12#1)(2011-1#1)(2012-12#1)
research study was##4##3##(2007-12#1)(2008-12#1)(2011-1#1)(2012-12#1)
research study##30##2##(1994-2#1)(1996-3#1)(2005-12#1)(2006-8#1)(2007-10#2)(2007-12#2)(2007-8#1)(2008-11#4)(2008-12#3)(2008-4#2)(2009-1#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-12#2)(2012-3#1)(2013-1#2)
research subjects in##2##3##(2006-3#1)(2007-12#1)
research subjects##11##2##(1996-3#2)(2005-3#1)(2006-3#1)(2007-11#1)(2007-12#1)(2008-11#1)(2009-4#3)(2012-12#1)
research suggest that##2##3##(2006-10#1)(2007-12#1)
research suggest##3##2##(2006-10#1)(2007-12#1)(2007-9#1)
research suggested##2##2##(2008-12#1)(2008-9#1)
research suggesting##2##2##(2008-7#1)(2012-12#1)
research suggests that incidental##2##4##(2008-5#2)
research suggests that##22##3##(1994-2#1)(2005-9#1)(2006-10#3)(2006-5#1)(2006-7#1)(2007-12#1)(2007-3#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
research suggests##25##2##(1994-2#1)(2005-9#1)(2006-10#3)(2006-5#1)(2006-7#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#3)(2008-8#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
research support for##2##3##(1995-3#1)(2008-11#1)
research supporting the##2##3##(2011-2#1)(2013-8#1)
research supports the##4##3##(2005-10#1)(2006-9#1)(2008-8#1)(2012-2#1)
research supports##6##2##(2005-10#1)(2006-10#1)(2006-9#2)(2008-8#1)(2012-2#1)
research survey##2##2##(1996-1#1)(1996-9#1)
research synthesis##4##2##(1996-11#1)(1996-6#1)(1996-8#1)(2012-2#1)
research take##2##2##(2008-6#1)(2012-12#1)
research targeting##3##2##(2009-4#1)(2009-5#1)(2011-2#1)
research team members##2##3##(2009-4#1)(2013-1#1)
research team##15##2##(1992-12#1)(1997-1#1)(2007-11#2)(2007-2#1)(2008-2#1)(2008-9#1)(2009-4#2)(2009-5#1)(2010-11#1)(2010-3#1)(2012-3#1)(2013-1#2)
research teams##5##2##(1993-12#1)(1993-2#1)(2007-10#1)(2008-8#1)(2012-12#1)
research technique##2##2##(2007-2#1)(2008-9#1)
research techniques is##2##3##(1995-3#1)(2011-1#1)
research techniques##7##2##(1992-10#1)(1995-2#1)(1995-3#2)(2009-2#1)(2011-1#1)(2013-1#1)
research technology##2##2##(2009-2#1)(2013-8#1)
research tested the##3##3##(2008-8#1)(2009-1#1)(2010-8#1)
research that are##4##3##(2005-10#1)(2008-10#1)(2010-5#1)(2012-2#1)
research that can##3##3##(2007-12#1)(2009-4#1)(2011-1#1)
research that has##3##3##(2007-12#1)(2008-5#1)(2010-7#1)
research that is##5##3##(2005-3#1)(2008-6#1)(2009-11#1)(2010-2#1)(2012-3#1)
research that may##2##3##(2012-12#1)(2013-1#1)
research that the##3##3##(2008-7#1)(2009-4#2)
research that there##2##3##(2009-1#1)(2009-2#1)
research that used##2##3##(2007-12#1)(2012-2#1)
research that was##2##3##(2008-8#1)(2010-3#1)
research that will##2##3##(2007-4#1)(2012-3#1)
research that would##2##3##(1992-12#1)(2011-3#1)
research that##77##2##(1992-12#1)(1992-3#1)(1993-12#1)(1996-3#1)(2005-10#1)(2005-12#1)(2005-3#1)(2005-7#1)(2006-7#1)(2007-12#3)(2007-2#2)(2007-4#2)(2007-6#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#4)(2009-5#3)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)
research the##11##2##(1996-1#1)(2007-11#1)(2008-10#1)(2008-12#2)(2008-2#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-8#1)(2013-8#1)
research through an##2##3##(1993-3#1)(2009-4#1)
research through##8##2##(1993-3#1)(2008-1#1)(2008-9#1)(2009-4#2)(2011-2#1)(2012-11#1)(2013-1#1)
research to be##3##3##(1997-1#1)(2005-9#1)(2009-1#1)
research to clarify the##2##4##(2009-11#1)(2011-1#1)
research to clinical##4##3##(1991-9#1)(2005-8#1)(2007-8#1)(2009-3#1)
research to date##3##3##(2007-6#1)(2008-7#1)(2012-2#1)
research to develop and evaluate##2##5##(2008-11#2)
research to develop##8##3##(1991-12#1)(1996-12#1)(1996-2#1)(2008-11#2)(2008-5#1)(2011-1#1)(2011-2#1)
research to evaluate##4##3##(2007-11#2)(2007-6#1)(2010-9#1)
research to examine##2##3##(1991-10#1)(2006-4#1)
research to identify##4##3##(2007-7#1)(2008-6#1)(2009-6#1)(2012-3#1)
research to improve##2##3##(1991-7#1)(2006-4#1)
research to inform##2##3##(2009-4#1)(2009-9#1)
research to policymakers##3##3##(2010-4#3)
research to practice##6##3##(2006-9#1)(2008-3#1)(2008-5#1)(2008-8#1)(2013-1#2)
research to reach##2##3##(2004-3#1)(2008-11#1)
research to the##7##3##(1993-12#1)(2005-9#1)(2006-8#1)(2007-4#1)(2008-1#1)(2009-4#1)(2010-12#1)
research to understand##2##3##(2008-10#1)(2011-1#1)
research to##108##2##(1991-10#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-10#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-1#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-3#1)(1997-4#1)(2004-3#1)(2005-7#2)(2005-8#1)(2005-9#2)(2006-10#3)(2006-11#2)(2006-4#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#1)(2008-11#7)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-1#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#3)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#4)(2010-7#1)(2010-9#3)(2011-1#3)(2011-2#3)(2012-1#3)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#1)
research tool and##2##3##(2008-1#1)(2010-6#1)
research tool for##5##3##(1997-1#1)(2008-11#3)(2010-7#1)
research tool to##2##3##(2006-11#1)(2009-10#1)
research tool##16##2##(1990-10#1)(1997-1#1)(2006-11#2)(2007-6#1)(2008-1#1)(2008-11#3)(2008-3#1)(2008-9#2)(2009-10#1)(2010-6#1)(2010-7#1)(2011-2#1)
research tools to##2##3##(2008-8#1)(2009-10#1)
research tools##8##2##(2005-12#1)(2007-6#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-10#1)(2010-2#1)
research topics##6##2##(2007-12#1)(2008-7#1)(2009-2#1)(2009-4#1)(2010-12#2)
research toward##2##2##(2008-3#1)(2009-12#1)
research towards##2##2##(2008-11#1)(2012-2#1)
research trainees##3##2##(1992-6#3)
research training##3##2##(1992-6#1)(2008-12#1)(2009-4#1)
research translation##2##2##(2010-2#1)(2012-12#1)
research trends##3##2##(2008-10#1)(2010-7#1)(2013-1#1)
research trial##4##2##(2007-4#1)(2008-8#2)(2012-12#1)
research trials##4##2##(1996-1#1)(2006-11#1)(2009-10#1)(2010-11#1)
research undertaken##2##2##(2007-8#1)(2009-11#1)
research universities##2##2##(2009-4#2)
research uptake as##2##3##(2010-10#2)
research uptake##5##2##(2010-10#5)
research use##4##2##(1992-11#1)(2008-11#1)(2008-4#1)(2008-7#1)
research uses##2##2##(2008-2#2)
research using a##3##3##(2010-3#1)(2010-9#1)(2012-3#1)
research using the##2##3##(2009-9#1)(2012-12#1)
research using this##2##3##(1996-8#1)(2007-8#1)
research using##21##2##(1995-2#1)(1996-8#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-9#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
research utilisation##4##2##(2008-11#4)
research volunteers##2##2##(1996-1#1)(2008-5#1)
research was based on the##2##5##(2008-11#1)(2010-8#1)
research was carried out##4##4##(1991-9#1)(2007-11#1)(2008-12#1)(2008-2#1)
research was carried##5##3##(1991-9#1)(2007-11#1)(2007-9#1)(2008-12#1)(2008-2#1)
research was conducted in##4##4##(1997-6#1)(2007-2#1)(2007-7#1)(2008-12#1)
research was conducted##12##3##(1992-1#1)(1997-6#1)(2005-10#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-12#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
research was made##2##3##(2008-2#1)(2013-1#1)
research was the##6##3##(2007-10#1)(2007-5#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-12#1)
research was to assess the##3##5##(2006-10#1)(2007-7#1)(2008-3#1)
research was to assess##5##4##(2006-10#1)(2007-7#3)(2008-3#1)
research was to compare##3##4##(2007-7#1)(2007-9#1)(2008-12#1)
research was to determine##4##4##(1994-3#1)(2008-10#1)(2008-12#1)(2008-7#1)
research was to evaluate the##9##5##(2007-11#1)(2007-2#2)(2007-7#1)(2007-8#2)(2008-10#1)(2012-2#1)(2013-7#1)
research was to evaluate##13##4##(1996-9#1)(2006-5#1)(2007-11#1)(2007-2#2)(2007-7#2)(2007-8#2)(2008-10#1)(2011-2#1)(2012-2#1)(2013-7#1)
research was to investigate the##3##5##(2006-11#1)(2006-8#1)(2007-8#1)
research was to investigate##4##4##(2006-11#1)(2006-8#1)(2007-8#1)(2012-12#1)
research was to provide##2##4##(2011-1#1)(2012-2#1)
research was to study the##4##5##(1990-9#1)(2006-11#1)(2007-2#1)(2011-2#1)
research was to study##6##4##(1990-9#1)(1993-6#1)(2006-11#1)(2007-2#1)(2010-4#1)(2011-2#1)
research was to##63##3##(1990-5#1)(1990-6#1)(1990-9#1)(1993-6#1)(1994-3#1)(1996-9#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#4)(2007-7#7)(2007-8#4)(2007-9#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-2#1)(2010-4#2)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#1)
research was undertaken##3##3##(1994-3#1)(2008-1#1)(2011-2#1)
research was##118##2##(1990-5#1)(1990-6#1)(1990-9#1)(1991-9#1)(1992-1#1)(1992-12#1)(1993-6#1)(1994-3#2)(1996-2#1)(1996-9#1)(1997-6#2)(2005-10#1)(2005-7#1)(2006-10#2)(2006-11#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#4)(2007-12#1)(2007-2#5)(2007-4#1)(2007-5#1)(2007-7#8)(2007-8#5)(2007-9#3)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#5)(2008-2#3)(2008-3#2)(2008-5#4)(2008-7#4)(2009-2#2)(2009-4#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#5)(2012-12#2)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#2)
research we##7##2##(1993-5#1)(2008-12#2)(2008-2#1)(2008-3#1)(2010-1#1)(2011-2#1)
research were to determine##3##4##(2008-1#1)(2008-10#2)
research were to##6##3##(2008-1#1)(2008-10#4)(2010-3#1)
research were used##3##3##(1995-2#1)(2007-4#1)(2008-10#1)
research were##21##2##(1990-10#1)(1995-2#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#7)(2008-7#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-9#1)(2012-2#1)(2013-7#1)
research which has##2##3##(1990-11#1)(2012-3#1)
research which is##2##3##(1996-11#1)(2009-6#1)
research which##8##2##(1990-11#1)(1996-11#2)(1996-6#1)(2009-6#1)(2009-9#1)(2012-12#1)(2012-3#1)
research while##4##2##(2007-7#1)(2008-11#1)(2008-12#2)
research will be##5##3##(2008-11#2)(2008-5#2)(2008-9#1)
research will better define##2##4##(2007-11#1)(2008-3#1)
research will determine##2##3##(1994-5#1)(2007-11#1)
research will inform##2##3##(2012-11#1)(2012-3#1)
research will##27##2##(1992-8#1)(1994-5#1)(2006-10#1)(2006-2#2)(2007-11#2)(2008-10#2)(2008-11#3)(2008-3#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-1#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-3#1)(2012-11#1)(2012-3#1)(2013-8#1)
research with a##5##3##(2006-6#1)(2009-9#1)(2010-4#1)(2010-8#1)(2012-1#1)
research with children##2##3##(2008-10#1)(2010-5#1)
research with participants who are deaf##2##6##(2006-11#2)
research with the aim##2##4##(1990-3#1)(2012-12#1)
research with the##6##3##(1990-3#1)(2007-9#1)(2009-11#1)(2010-12#1)(2012-12#1)(2012-2#1)
research with##49##2##(1990-3#1)(1993-12#1)(1994-9#1)(1995-12#1)(1996-4#1)(1997-3#1)(1997-5#1)(2005-7#1)(2006-11#3)(2006-4#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#3)(2009-11#1)(2009-12#1)(2009-4#3)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#3)(2012-2#4)
research within the##2##3##(2008-10#1)(2010-2#1)
research within##6##2##(1995-3#1)(1997-3#1)(2008-10#1)(2008-5#1)(2009-4#1)(2010-2#1)
research without an##3##3##(2005-10#1)(2013-1#2)
research without##5##2##(1996-3#1)(2005-10#1)(2011-1#1)(2013-1#2)
research work##14##2##(1993-8#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-4#1)(2010-9#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
research works##2##2##(2008-10#2)
research would##4##2##(1997-3#1)(2008-11#1)(2008-12#1)(2011-2#1)
research##5991##1##(1990-10#8)(1990-11#8)(1990-12#21)(1990-2#3)(1990-3#9)(1990-4#5)(1990-5#3)(1990-6#9)(1990-8#4)(1990-9#6)(1991-1#7)(1991-10#4)(1991-11#2)(1991-12#19)(1991-2#11)(1991-3#15)(1991-4#3)(1991-5#3)(1991-6#9)(1991-7#3)(1991-8#1)(1991-9#9)(1992-1#13)(1992-10#14)(1992-11#4)(1992-12#34)(1992-2#14)(1992-3#14)(1992-4#4)(1992-5#6)(1992-6#16)(1992-7#2)(1992-8#11)(1992-9#4)(1993-1#12)(1993-10#2)(1993-11#8)(1993-12#21)(1993-2#28)(1993-3#21)(1993-4#2)(1993-5#4)(1993-6#12)(1993-7#4)(1993-8#4)(1993-9#6)(1994-1#5)(1994-10#5)(1994-11#5)(1994-12#23)(1994-2#17)(1994-3#25)(1994-4#3)(1994-5#4)(1994-6#8)(1994-7#6)(1994-8#4)(1994-9#6)(1995-1#16)(1995-11#3)(1995-12#15)(1995-2#19)(1995-3#21)(1995-4#2)(1995-5#5)(1995-6#17)(1995-7#2)(1995-8#2)(1995-9#5)(1996-1#21)(1996-10#2)(1996-11#17)(1996-12#18)(1996-2#21)(1996-3#20)(1996-4#4)(1996-5#2)(1996-6#8)(1996-7#2)(1996-8#15)(1996-9#10)(1997-1#40)(1997-2#15)(1997-3#37)(1997-4#10)(1997-5#10)(1997-6#8)(1997-7#11)(1997-8#18)(2004-10#2)(2004-11#5)(2004-12#16)(2004-3#4)(2004-4#2)(2004-7#2)(2004-9#2)(2005-1#3)(2005-10#29)(2005-11#30)(2005-12#11)(2005-2#1)(2005-3#7)(2005-4#2)(2005-6#4)(2005-7#50)(2005-8#44)(2005-9#17)(2006-1#5)(2006-10#122)(2006-11#30)(2006-12#24)(2006-2#31)(2006-3#9)(2006-4#23)(2006-5#35)(2006-6#18)(2006-7#17)(2006-8#33)(2006-9#29)(2007-1#23)(2007-10#63)(2007-11#125)(2007-12#127)(2007-2#46)(2007-3#19)(2007-4#60)(2007-5#23)(2007-6#29)(2007-7#67)(2007-8#65)(2007-9#56)(2008-1#83)(2008-10#215)(2008-11#234)(2008-12#153)(2008-2#90)(2008-3#72)(2008-4#100)(2008-5#117)(2008-6#54)(2008-7#142)(2008-8#93)(2008-9#85)(2009-1#17)(2009-10#19)(2009-11#25)(2009-12#40)(2009-2#29)(2009-3#31)(2009-4#171)(2009-5#48)(2009-6#47)(2009-7#41)(2009-8#33)(2009-9#36)(2010-1#15)(2010-10#60)(2010-11#51)(2010-12#80)(2010-2#73)(2010-3#40)(2010-4#39)(2010-5#51)(2010-6#15)(2010-7#31)(2010-8#54)(2010-9#41)(2011-1#125)(2011-10#1)(2011-12#21)(2011-2#161)(2011-3#9)(2011-7#7)(2011-9#1)(2012-1#66)(2012-11#40)(2012-12#138)(2012-2#164)(2012-3#87)(2012-8#1)(2013-1#237)(2013-7#43)(2013-8#126)
research&quot##9##1##(1991-12#2)(1992-12#1)(1993-3#1)(1993-7#1)(2012-11#4)
research'##2##1##(1996-8#1)(2007-11#1)
research)##7##1##(1997-8#1)(2006-10#1)(2009-11#1)(2010-8#1)(2011-1#1)(2013-1#2)
research-and##2##1##(1995-3#1)(2009-12#1)
research-based interventions##2##2##(2008-12#1)(2012-12#1)
research-based##11##1##(1996-2#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-11#2)(2008-12#2)(2010-12#1)(2010-5#1)(2012-12#1)
research-grade##2##1##(2008-4#2)
research-intensive##3##1##(2007-8#1)(2012-3#2)
research-oriented##2##1##(2008-7#1)(2011-2#1)
research-practice gap##2##2##(2008-11#2)
research-practice##3##1##(2008-11#2)(2008-6#1)
research-related tasks##4##2##(2012-3#4)
research-related##5##1##(2007-12#1)(2012-3#4)
research/practice##2##1##(2010-10#2)
research?##4##1##(2004-12#1)(2009-6#1)(2011-1#1)(2013-8#1)
research?]##3##1##(1995-4#1)(1996-6#1)(2008-12#1)
research]##25##1##(1990-10#1)(1990-6#1)(1991-6#1)(1992-11#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-3#1)(1993-6#1)(1994-6#1)(1996-11#1)(1996-3#1)(1997-4#1)(1997-6#1)(2008-11#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#5)
researchable questions that##2##3##(2009-3#2)
researchable##3##1##(2009-3#2)(2010-11#1)
researched and developed##2##3##(2008-10#1)(2013-8#1)
researched and##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
researched in##2##2##(2011-2#1)(2013-7#1)
researched##33##1##(1992-1#1)(1995-3#1)(2006-10#1)(2007-11#1)(2007-2#2)(2007-9#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#2)(2009-2#1)(2011-2#4)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#4)
researcher and##7##2##(1992-2#1)(1997-1#1)(2005-8#1)(2006-11#1)(2008-7#1)(2008-8#1)(2012-2#1)
researcher can##2##2##(2008-7#2)
researcher malpractice##2##2##(2005-3#2)
researcher on##2##2##(2006-5#1)(2007-11#1)
researcher to##7##2##(1992-11#1)(2008-1#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-7#1)(2013-1#1)
researcher was##2##2##(2008-3#1)(2008-8#1)
researcher who##4##2##(2007-8#1)(2008-4#1)(2008-7#1)(2008-9#1)
researcher##64##1##(1990-12#2)(1992-11#1)(1992-12#1)(1992-2#1)(1993-3#2)(1994-3#2)(1997-1#1)(1997-3#1)(2004-11#2)(2005-11#1)(2005-3#2)(2005-4#1)(2005-8#2)(2006-11#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#4)(2009-5#2)(2009-6#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#4)
researcher's##7##1##(1997-1#1)(1997-6#1)(2008-4#1)(2008-7#3)(2011-1#1)
researcher-developed##2##1##(2005-12#1)(2010-4#1)
researchers across##3##2##(2011-1#1)(2012-12#2)
researchers advocate##2##2##(1993-11#1)(2006-9#1)
researchers and clinicians##10##3##(1992-2#1)(2007-12#2)(2008-2#1)(2008-8#1)(2009-5#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
researchers and health professionals##2##4##(2005-7#1)(2011-2#1)
researchers and health##3##3##(2005-7#1)(2011-1#1)(2011-2#1)
researchers and managers##2##3##(2010-8#1)(2013-8#1)
researchers and practitioners to##2##4##(2010-11#1)(2010-9#1)
researchers and practitioners##7##3##(2010-10#1)(2010-11#1)(2010-9#1)(2012-1#1)(2013-1#2)(2013-7#1)
researchers and the##2##3##(1994-3#1)(1995-1#1)
researchers and those##2##3##(2008-2#1)(2008-5#1)
researchers and##58##2##(1992-2#1)(1994-3#1)(1995-1#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-8#1)(2004-10#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-11#1)(2007-1#2)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#2)(2008-5#3)(2008-7#2)(2008-8#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#3)
researchers are##18##2##(1992-2#1)(2006-5#1)(2007-10#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#1)(2010-7#1)(2011-1#1)(2011-11#1)(2012-1#1)(2012-3#1)(2013-8#1)
researchers as##2##2##(2007-3#1)(2009-2#1)
researchers at the##2##3##(2008-10#1)(2009-4#1)
researchers at##9##2##(1997-2#1)(2005-8#1)(2006-8#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2009-4#1)(2012-1#1)
researchers because##2##2##(1991-4#1)(2010-4#1)
researchers believe##2##2##(2007-8#1)(2010-3#1)
researchers by##2##2##(1997-1#1)(2005-3#1)
researchers can##5##2##(2007-10#1)(2007-9#2)(2008-7#1)(2008-9#1)
researchers compared data on##2##4##(1992-10#1)(1994-5#1)
researchers consider##3##2##(2007-2#1)(2008-1#1)(2012-12#1)
researchers develop##2##2##(1996-2#1)(2013-7#1)
researchers explore##3##2##(2008-8#1)(2013-1#2)
researchers for the##2##3##(2006-12#1)(2013-1#1)
researchers for##7##2##(2006-12#1)(2008-3#1)(2008-9#1)(2011-2#1)(2013-1#3)
researchers found that the##2##4##(1993-2#1)(2009-4#1)
researchers found that##3##3##(1993-2#1)(2007-2#1)(2009-4#1)
researchers found##6##2##(1993-2#1)(2006-10#1)(2007-2#3)(2009-4#1)
researchers from the##2##3##(2009-12#1)(2009-4#1)
researchers from##8##2##(2007-2#1)(2008-1#2)(2008-10#1)(2009-12#1)(2009-4#1)(2012-11#1)(2013-8#1)
researchers has##2##2##(2008-4#1)(2009-4#1)
researchers have applied##2##3##(1997-6#1)(2008-2#1)
researchers have been trying to##2##5##(2007-8#1)(2008-6#1)
researchers have been##5##3##(2006-10#1)(2007-8#1)(2007-9#1)(2008-6#1)(2013-1#1)
researchers have begun to##2##4##(2007-8#1)(2009-3#1)
researchers have developed##3##3##(2008-6#1)(2013-1#2)
researchers have examined##2##3##(2008-10#1)(2013-1#1)
researchers have focused##2##3##(2008-10#1)(2010-10#1)
researchers have made##2##3##(2008-1#1)(2011-3#1)
researchers have shown##2##3##(2011-2#1)(2013-8#1)
researchers have suggested a##2##4##(2007-4#1)(2013-4#1)
researchers have suggested##3##3##(2007-4#1)(2012-12#1)(2013-4#1)
researchers have##49##2##(1992-3#1)(1992-8#1)(1996-11#1)(1996-5#1)(1997-6#1)(2006-10#2)(2006-3#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-10#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#2)(2013-1#7)(2013-4#1)(2013-8#2)
researchers in basic##2##3##(2007-11#1)(2008-9#1)
researchers in designing##2##3##(2010-2#1)(2010-6#1)
researchers in developing##2##3##(2006-10#1)(2013-1#1)
researchers in several##2##3##(2004-12#1)(2006-5#1)
researchers in the field of##4##5##(2007-5#1)(2008-5#1)(2008-8#1)(2010-7#1)
researchers in the field##5##4##(2007-5#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-7#1)
researchers in the##11##3##(1995-1#1)(2005-7#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-8#1)(2010-7#1)(2011-1#1)
researchers in##41##2##(1992-2#1)(1995-1#1)(1995-2#1)(2004-12#1)(2005-7#1)(2006-10#1)(2006-5#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#2)(2013-1#4)
researchers interested in using##2##4##(2010-2#1)(2013-8#1)
researchers interested in##5##3##(2005-10#1)(2008-4#1)(2010-2#1)(2011-2#1)(2013-8#1)
researchers interested##6##2##(2005-10#1)(2007-4#1)(2008-4#1)(2010-2#1)(2011-2#1)(2013-8#1)
researchers investigated##2##2##(2006-10#1)(2011-2#1)
researchers investigating##2##2##(2008-8#1)(2013-1#1)
researchers is##7##2##(2008-4#1)(2008-9#1)(2009-12#1)(2009-8#1)(2011-2#1)(2012-12#2)
researchers may use##2##3##(2008-4#1)(2011-1#1)
researchers may##4##2##(2007-3#1)(2008-4#1)(2011-1#1)(2011-2#1)
researchers must##3##2##(2007-9#1)(2008-2#1)(2008-5#1)
researchers need to##3##3##(2008-10#1)(2013-1#2)
researchers of##4##2##(2006-5#1)(2007-5#1)(2008-12#1)(2008-7#1)
researchers often##2##2##(1996-3#1)(2010-8#1)
researchers on##3##2##(2005-7#1)(2006-8#1)(2009-4#1)
researchers report##2##2##(2007-9#2)
researchers should be##2##3##(1992-3#1)(2006-5#1)
researchers should##6##2##(1992-3#1)(1997-5#1)(2006-10#1)(2006-5#1)(2009-9#1)(2010-6#1)
researchers since their##2##3##(2008-11#1)(2010-5#1)
researchers since##3##2##(2008-11#1)(2009-8#1)(2010-5#1)
researchers the##2##2##(2006-12#1)(2011-1#1)
researchers to conduct##2##3##(1994-3#1)(1996-3#1)
researchers to consider##4##3##(2007-10#1)(2008-7#1)(2010-7#1)(2013-8#1)
researchers to design##3##3##(1997-2#1)(2008-11#1)(2012-3#1)
researchers to develop##3##3##(2008-6#1)(2010-10#1)(2011-2#1)
researchers to engage##2##3##(2007-10#1)(2010-7#1)
researchers to identify##2##3##(2007-6#1)(2009-3#1)
researchers to safeguard##2##3##(2006-11#1)(2007-9#1)
researchers to speculate that##2##4##(1994-2#1)(2008-11#1)
researchers to study##3##3##(2008-7#1)(2009-6#1)(2013-1#1)
researchers to the##2##3##(2005-7#1)(2009-7#1)
researchers to##63##2##(1992-3#1)(1994-2#1)(1994-3#1)(1995-1#1)(1996-3#1)(1996-8#1)(1997-2#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#5)(2008-4#1)(2008-6#1)(2008-7#5)(2009-10#2)(2009-12#2)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
researchers understand##3##2##(2007-9#1)(2008-2#1)(2008-4#1)
researchers use##3##2##(1992-3#1)(2007-11#2)
researchers using##3##2##(2007-4#1)(2008-4#1)(2009-9#1)
researchers were##2##2##(1995-11#1)(2007-5#1)
researchers who are##2##3##(2005-8#1)(2007-11#1)
researchers who##9##2##(2005-8#1)(2005-9#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-4#1)(2009-3#1)(2009-8#1)
researchers will need to##2##4##(2008-7#1)(2011-2#1)
researchers with a##2##3##(2008-2#1)(2008-9#1)
researchers with the##4##3##(1993-2#1)(2007-3#1)(2010-5#1)(2012-12#1)
researchers with##10##2##(1993-2#1)(2007-1#1)(2007-3#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-5#1)(2012-12#1)
researchers working in##3##3##(2005-7#1)(2008-1#1)(2012-2#1)
researchers working on##2##3##(2005-10#1)(2005-7#1)
researchers working##5##2##(2005-10#1)(2005-7#2)(2008-1#1)(2012-2#1)
researchers##583##1##(1991-12#1)(1991-4#1)(1992-10#2)(1992-2#3)(1992-3#4)(1992-5#1)(1992-8#1)(1993-11#1)(1993-2#3)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#2)(1994-9#1)(1995-1#5)(1995-11#1)(1995-2#2)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#3)(1996-3#3)(1996-4#2)(1996-5#1)(1996-8#2)(1997-1#3)(1997-2#2)(1997-3#1)(1997-5#2)(1997-6#1)(1997-8#1)(2004-10#1)(2004-12#1)(2005-10#3)(2005-3#3)(2005-7#10)(2005-8#3)(2005-9#3)(2006-10#8)(2006-11#2)(2006-12#3)(2006-3#2)(2006-5#7)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#5)(2007-10#10)(2007-11#10)(2007-12#11)(2007-2#6)(2007-3#6)(2007-4#5)(2007-5#4)(2007-6#7)(2007-7#2)(2007-8#13)(2007-9#36)(2008-1#9)(2008-10#16)(2008-11#18)(2008-12#10)(2008-2#7)(2008-3#8)(2008-4#18)(2008-5#12)(2008-6#4)(2008-7#17)(2008-8#7)(2008-9#10)(2009-10#2)(2009-11#2)(2009-12#5)(2009-2#1)(2009-3#3)(2009-4#15)(2009-5#2)(2009-6#5)(2009-7#3)(2009-8#6)(2009-9#4)(2010-1#2)(2010-10#5)(2010-11#3)(2010-12#1)(2010-2#3)(2010-3#4)(2010-4#5)(2010-5#8)(2010-6#3)(2010-7#5)(2010-8#5)(2010-9#4)(2011-1#11)(2011-11#1)(2011-12#4)(2011-2#17)(2011-3#1)(2012-1#7)(2012-11#3)(2012-12#19)(2012-2#9)(2012-3#3)(2013-1#37)(2013-4#1)(2013-7#2)(2013-8#10)
researchers'##8##1##(1994-9#1)(1995-6#1)(2005-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2012-2#1)(2013-8#1)
researches and##2##2##(1991-9#1)(2007-11#1)
researches are##3##2##(2011-3#1)(2012-3#1)(2013-7#1)
researches for##2##2##(2009-5#1)(2011-1#1)
researches have##4##2##(1991-6#1)(2008-9#1)(2013-1#2)
researches in a##2##3##(2005-10#1)(2011-1#1)
researches in the##2##3##(2006-10#1)(2013-7#1)
researches in##6##2##(2005-10#1)(2006-10#1)(2011-1#1)(2012-2#1)(2013-7#2)
researches of##9##2##(2005-4#2)(2007-11#1)(2009-2#1)(2013-8#5)
researches on##5##2##(2006-1#1)(2008-6#1)(2011-1#1)(2011-2#1)(2013-7#1)
researches should be##2##3##(2006-2#1)(2012-3#1)
researches##61##1##(1990-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(2005-10#1)(2005-4#2)(2006-1#1)(2006-10#1)(2006-2#2)(2007-11#2)(2008-1#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-2#3)(2009-5#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-9#1)(2011-1#6)(2011-2#2)(2011-3#2)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-7#5)(2013-8#8)
researching and##2##2##(1994-2#1)(2006-10#1)
researching the genetic##2##3##(2009-5#2)
researching the##5##2##(2008-10#1)(2009-5#3)(2009-6#1)
researching##13##1##(1994-2#1)(1994-3#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-4#1)(2009-5#3)(2009-6#1)(2010-1#1)(2010-5#1)
resect tumors##2##2##(2006-7#1)(2010-2#1)
resect##15##1##(1993-10#1)(2006-12#2)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-7#1)(2008-5#1)(2008-6#1)(2010-2#1)(2010-3#1)(2012-12#1)
resectability of the##2##3##(2008-3#1)(2008-7#1)
resectability of##5##2##(1990-10#1)(2006-6#1)(2008-3#2)(2008-7#1)
resectability rates##2##2##(1996-1#1)(2013-8#1)
resectability##16##1##(1990-10#1)(1996-1#1)(2006-6#1)(2008-1#2)(2008-2#1)(2008-3#4)(2008-7#1)(2010-11#2)(2010-12#1)(2013-1#1)(2013-8#1)
resectable lung##2##2##(1990-10#2)
resectable non small-cell lung cancer##2##5##(2004-1#2)
resectable non-small cell lung cancer##2##5##(2007-8#1)(2008-2#1)
resectable non-small cell lung##3##4##(2007-8#2)(2008-2#1)
resectable non-small cell##4##3##(1990-10#1)(2007-8#2)(2008-2#1)
resectable stage##2##2##(2005-11#1)(2007-8#1)
resectable##27##1##(1990-10#4)(1992-10#1)(1992-12#1)(1992-3#1)(2004-1#2)(2005-11#1)(2007-4#2)(2007-8#3)(2008-1#1)(2008-2#1)(2008-3#3)(2008-5#1)(2010-11#1)(2010-12#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
resected after##2##2##(2007-8#1)(2012-2#1)
resected and a##3##3##(2007-5#1)(2012-12#1)(2013-8#1)
resected and the##4##3##(2006-12#1)(2007-8#1)(2008-6#1)(2012-2#1)
resected and##10##2##(2006-12#1)(2007-5#1)(2007-8#1)(2008-12#1)(2008-6#1)(2008-7#1)(2012-12#1)(2012-2#2)(2013-8#1)
resected at##2##2##(2012-12#1)(2013-1#1)
resected by the##2##3##(2006-7#1)(2011-2#1)
resected by##6##2##(2006-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2011-2#1)(2012-2#1)
resected colorectal cancer##2##3##(2010-11#1)(2012-3#1)
resected colorectal##3##2##(2010-11#1)(2012-3#1)(2013-1#1)
resected endoscopically##5##2##(2008-10#1)(2008-5#2)(2011-2#1)(2013-1#1)
resected for##2##2##(1996-6#1)(2008-2#1)
resected from a##2##3##(1996-11#1)(2013-8#1)
resected from the femoral##2##4##(2007-7#1)(2013-1#1)
resected from the##4##3##(2007-12#1)(2007-7#1)(2007-8#1)(2013-1#1)
resected from##8##2##(1995-6#1)(1996-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
resected gastric cancer##4##3##(1993-10#1)(2009-3#1)(2010-12#2)
resected gastric##6##2##(1993-10#1)(2008-7#1)(2009-3#1)(2010-12#2)(2011-2#1)
resected in##2##2##(1991-9#1)(2006-10#1)
resected lung##3##2##(2006-10#2)(2008-5#1)
resected lymph nodes##4##3##(1995-9#2)(2006-9#1)(2007-6#1)
resected or##2##2##(2009-9#1)(2012-2#1)
resected soft tissue sarcomas of the##2##6##(1993-9#1)(2007-4#1)
resected specimen##13##2##(1991-9#1)(1992-6#1)(1996-6#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-5#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
resected specimens##3##2##(2008-3#1)(2008-6#1)(2008-7#1)
resected stage I and II##2##5##(2007-8#2)
resected stage I##3##3##(2007-8#3)
resected through##2##2##(2007-8#2)
resected tissue##2##2##(2007-11#1)(2008-5#1)
resected tumor##5##2##(2007-12#1)(2010-12#1)(2011-12#1)(2012-2#2)
resected tumors##2##2##(2010-12#1)(2011-2#1)
resected with##2##2##(1992-9#1)(2011-1#1)
resected##195##1##(1990-8#1)(1991-9#4)(1992-4#1)(1992-6#2)(1992-9#1)(1993-10#1)(1993-12#1)(1993-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-3#1)(1996-6#2)(1997-3#1)(2005-5#1)(2006-10#4)(2006-12#1)(2006-5#2)(2006-6#6)(2006-7#1)(2006-9#2)(2007-10#2)(2007-11#3)(2007-12#3)(2007-4#4)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#25)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#9)(2008-6#10)(2008-7#8)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#8)(2010-3#1)(2010-5#2)(2010-7#1)(2011-1#3)(2011-12#2)(2011-2#5)(2012-1#3)(2012-12#3)(2012-2#15)(2012-3#1)(2013-1#14)(2013-7#1)(2013-8#7)
resecting the##2##2##(2008-4#1)(2013-1#1)
resecting##5##1##(1997-6#1)(2007-8#1)(2008-4#1)(2013-1#2)
resection after##4##2##(2007-7#1)(2010-8#3)
resection alone for##2##3##(2008-1#1)(2013-1#1)
resection and cardiac##2##3##(2007-8#2)
resection and endoprosthetic##2##3##(2008-2#1)(2008-6#1)
resection and liver transplantation##5##4##(2009-8#1)(2013-8#4)
resection and postoperative##2##3##(2006-10#1)(2012-1#1)
resection and reconstruction is##2##4##(2012-1#1)(2012-2#1)
resection and reconstruction##9##3##(2007-11#1)(2008-1#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
resection and subsequent##3##3##(2007-11#1)(2007-7#2)
resection and##84##2##(1990-6#1)(1990-9#2)(1991-11#1)(1991-6#1)(1992-3#1)(1994-11#1)(1994-12#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-6#3)(2006-8#1)(2007-11#6)(2007-12#2)(2007-7#4)(2007-8#6)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-7#2)(2010-8#2)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#6)
resection and/or##2##2##(2008-8#1)(2012-2#1)
resection are discussed##2##3##(1992-5#1)(2008-8#1)
resection are##7##2##(1992-5#1)(1997-8#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-7#1)(2008-8#1)
resection arthroplasty##10##2##(2006-3#1)(2007-11#4)(2008-9#1)(2009-3#1)(2010-2#1)(2010-7#1)(2013-8#1)
resection as##2##2##(2007-8#1)(2008-10#1)
resection at##2##2##(1992-8#1)(2008-8#1)
resection because of##2##3##(1993-2#1)(2006-12#1)
resection because##3##2##(1993-2#1)(2006-12#1)(2012-2#1)
resection between##3##2##(1993-9#1)(2007-8#2)
resection bone##2##2##(2007-7#2)
resection but##2##2##(2009-4#1)(2012-3#1)
resection by##6##2##(1996-2#1)(2007-8#2)(2008-3#1)(2009-12#1)(2010-12#1)
resection can be##3##3##(2007-4#1)(2008-5#1)(2008-9#1)
resection can##8##2##(1992-3#1)(2005-2#1)(2006-6#1)(2007-4#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-9#1)
resection combined with##4##3##(1990-2#1)(2007-8#1)(2008-3#1)(2012-3#1)
resection during##3##2##(2007-7#1)(2007-8#1)(2008-6#1)
resection followed by##4##3##(2007-8#1)(2008-6#1)(2011-1#1)(2013-1#1)
resection for lung cancer##3##4##(2007-8#1)(2009-12#1)(2012-1#1)
resection for metastatic##2##3##(2008-3#1)(2011-2#1)
resection for non-small cell lung##2##5##(2008-2#1)(2008-5#1)
resection for pancreatic##2##3##(2006-10#1)(2008-3#1)
resection for patients with##3##4##(2008-4#1)(2008-6#1)(2013-7#1)
resection for##42##2##(1993-12#1)(1993-2#1)(1994-12#1)(1994-7#1)(1996-3#1)(2005-12#1)(2006-10#3)(2006-6#1)(2007-8#5)(2007-9#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-10#1)(2009-12#2)(2010-1#1)(2011-2#4)(2012-1#1)(2013-1#4)(2013-7#2)
resection from##3##2##(2007-11#1)(2007-4#1)(2010-12#1)
resection group##2##2##(1990-2#2)
resection had##2##2##(2006-11#1)(2009-4#1)
resection has been##4##3##(1991-6#1)(1992-3#1)(2004-1#1)(2008-10#1)
resection has##8##2##(1991-6#1)(1992-3#1)(2004-1#1)(2008-10#1)(2008-4#1)(2010-12#1)(2011-1#1)(2013-1#1)
resection have##2##2##(1990-8#1)(2009-3#1)
resection in 8 cases##2##4##(1990-10#1)(2007-8#1)
resection in one##2##3##(2006-6#1)(2011-2#1)
resection in patients with##3##4##(1996-3#1)(2010-12#1)(2013-1#1)
resection in the##5##3##(2006-6#1)(2007-7#2)(2007-8#1)(2012-2#1)
resection in##29##2##(1990-10#1)(1996-3#1)(2005-12#1)(2006-12#1)(2006-2#1)(2006-6#2)(2007-1#1)(2007-3#1)(2007-7#2)(2007-8#2)(2008-3#2)(2008-4#2)(2008-7#2)(2010-12#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
resection involving the##2##3##(2008-6#1)(2009-9#1)
resection involving##3##2##(2008-5#1)(2008-6#1)(2009-9#1)
resection is a##3##3##(2007-4#1)(2007-8#1)(2007-9#1)
resection is an##2##3##(2007-4#1)(2007-8#1)
resection is feasible##2##3##(2006-6#1)(2012-2#1)
resection is recommended##2##3##(1991-8#1)(2009-2#1)
resection is the only##2##4##(2006-10#1)(2010-12#1)
resection is the##10##3##(1991-6#1)(1993-9#1)(2006-10#2)(2007-8#1)(2008-1#1)(2010-11#1)(2010-12#1)(2012-11#1)(2012-2#1)
resection is usually##2##3##(1990-9#1)(1994-5#1)
resection is##39##2##(1990-2#1)(1990-9#1)(1991-6#1)(1991-8#1)(1993-9#1)(1994-5#1)(1997-3#1)(2004-12#1)(2006-10#5)(2006-6#2)(2007-4#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-11#1)(2012-12#2)(2012-2#2)
resection line at 2 cm##2##5##(2008-8#2)
resection line##4##2##(2007-8#1)(2008-8#2)(2011-2#1)
resection margin##7##2##(1990-9#1)(1992-3#1)(1995-10#1)(2007-8#2)(2008-10#1)(2009-12#1)
resection margins were##2##3##(2007-8#1)(2008-3#1)
resection margins##11##2##(1996-3#1)(1997-7#1)(2007-8#2)(2008-3#1)(2008-6#1)(2011-1#1)(2011-2#3)(2013-8#1)
resection may be##3##3##(2006-10#1)(2007-8#1)(2011-2#1)
resection may##5##2##(2006-10#1)(2007-11#1)(2007-8#1)(2011-2#1)(2013-1#1)
resection of AVMs##2##3##(2008-7#2)
resection of RCC pulmonary metastases##2##5##(2013-1#2)
resection of a giant##3##4##(2007-8#1)(2011-2#1)(2013-1#1)
resection of a large##2##4##(2006-5#1)(2013-8#1)
resection of a##24##3##(1991-11#1)(1997-6#1)(2005-5#1)(2005-9#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-3#1)(2007-7#1)(2007-8#5)(2008-10#1)(2008-6#2)(2008-7#1)(2009-3#1)(2011-2#3)(2013-1#1)(2013-8#1)
resection of acoustic neuroma##5##4##(2004-12#4)(2011-2#1)
resection of acoustic##6##3##(2004-12#4)(2006-11#1)(2011-2#1)
resection of an acoustic neuroma##2##5##(2004-12#1)(2006-12#1)
resection of an##4##3##(2004-12#1)(2006-12#1)(2008-5#1)(2012-12#1)
resection of bladder##5##3##(1991-11#1)(2006-10#1)(2007-7#1)(2008-10#1)(2011-2#1)
resection of brain##2##3##(2006-12#1)(2008-6#1)
resection of colorectal cancer##4##4##(2006-6#1)(2010-1#1)(2010-11#1)(2011-2#1)
resection of colorectal##5##3##(2006-6#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-12#1)
resection of giant aneurysmal bone cyst (ABC)##2##7##(2011-2#2)
resection of giant##6##3##(2007-2#1)(2010-2#1)(2011-2#3)(2013-1#1)
resection of large hypervascular vestibular schwannomas##2##6##(2006-12#2)
resection of large##5##3##(2006-12#2)(2007-7#1)(2007-8#1)(2008-7#1)
resection of low-grade gliomas##2##4##(2006-12#2)
resection of low-grade##3##3##(2006-12#3)
resection of malignant chest wall##2##5##(2008-6#1)(2012-2#1)
resection of non-small cell lung cancer##2##6##(2007-8#2)
resection of primary and secondary intraaxial supratentorial brain tumors##2##9##(2006-12#2)
resection of primary##3##3##(2006-12#2)(2008-6#1)
resection of prostate##2##3##(2011-1#2)
resection of pulmonary##4##3##(1994-10#1)(2010-11#1)(2012-1#2)
resection of small##2##3##(1993-8#1)(2006-10#1)
resection of such##2##3##(2006-12#1)(2006-9#1)
resection of the affected##2##4##(1992-5#1)(2009-3#1)
resection of the aneurysm##2##4##(1991-6#1)(2010-7#1)
resection of the bladder##2##4##(2006-10#1)(2012-2#1)
resection of the bone##2##4##(2008-1#1)(2013-1#1)
resection of the cyst##2##4##(2009-7#1)(2011-2#1)
resection of the cystic##2##4##(1992-9#1)(2008-5#1)
resection of the gastric##2##4##(2006-6#1)(2007-9#1)
resection of the giant-cell tumour##3##5##(2007-11#3)
resection of the intussusception##2##4##(2005-12#1)(2010-12#1)
resection of the left##2##4##(2007-8#1)(2008-6#1)
resection of the lesion and##2##5##(2007-7#1)(2008-7#1)
resection of the lesion##3##4##(2007-7#1)(2007-8#1)(2008-7#1)
resection of the mass##3##4##(2008-6#1)(2009-3#1)(2009-9#1)
resection of the nasal septum##3##5##(2012-12#3)
resection of the nasal##4##4##(2006-10#1)(2012-12#3)
resection of the primary##4##4##(1992-6#1)(2007-10#1)(2011-3#1)(2013-7#1)
resection of the rectum##5##4##(1990-4#1)(2008-8#1)(2010-5#1)(2012-12#2)
resection of the right##2##4##(2007-8#1)(2012-12#1)
resection of the stomach##2##4##(2009-2#2)
resection of the tumor and##2##5##(2007-11#1)(2007-4#1)
resection of the tumor was##2##5##(2007-7#1)(2013-1#1)
resection of the tumor##12##4##(1995-4#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-12#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-1#1)
resection of the tumour was performed##2##6##(2008-7#1)(2012-12#1)
resection of the tumour##8##4##(1990-9#1)(2007-2#1)(2008-10#1)(2008-7#3)(2012-12#1)(2013-8#1)
resection of the##114##3##(1990-3#2)(1990-4#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-5#1)(1992-6#1)(1992-9#2)(1995-4#1)(1997-6#1)(1997-8#1)(2005-12#1)(2006-10#3)(2006-12#3)(2006-2#2)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#9)(2007-9#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-2#4)(2009-3#2)(2009-7#1)(2009-9#1)(2010-12#3)(2010-5#2)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#7)(2011-3#1)(2012-12#8)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
resection of these##2##3##(2005-5#1)(2007-8#1)
resection of this##2##3##(2008-10#1)(2011-2#1)
resection of tumor and##2##4##(2006-6#1)(2007-7#1)
resection of tumor##5##3##(2006-6#1)(2007-11#2)(2007-7#1)(2008-5#1)
resection of tumors##2##3##(2007-5#1)(2011-1#1)
resection of vascular malformations##2##4##(2007-9#2)
resection of vestibular schwannomas##3##4##(2006-11#1)(2006-12#2)
resection of##303##2##(1990-10#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-4#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-5#1)(1992-6#1)(1992-9#3)(1993-2#1)(1993-8#1)(1994-10#1)(1995-4#1)(1995-9#1)(1997-6#3)(1997-8#1)(2004-10#1)(2004-12#5)(2005-10#1)(2005-12#1)(2005-5#2)(2005-9#1)(2006-10#6)(2006-11#2)(2006-12#18)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#5)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#1)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#7)(2007-8#32)(2007-9#6)(2008-1#2)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#7)(2008-6#12)(2008-7#12)(2008-8#1)(2008-9#5)(2009-2#4)(2009-3#3)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#2)(2010-3#1)(2010-5#2)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#25)(2011-3#1)(2012-1#4)(2012-12#12)(2012-2#5)(2012-3#5)(2013-1#13)(2013-7#1)(2013-8#4)
resection offers##2##2##(2008-3#1)(2009-2#1)
resection on##2##2##(1994-4#1)(2007-7#1)
resection or##17##2##(1990-3#1)(1990-9#1)(1991-5#1)(1992-6#1)(1996-3#1)(2006-12#1)(2006-2#1)(2007-2#1)(2007-8#1)(2008-5#5)(2008-7#1)(2012-8#1)(2013-1#1)
resection performed##2##2##(2005-12#1)(2007-8#1)
resection plus##2##2##(2007-8#1)(2008-6#1)
resection procedure with subsequent joint##2##5##(2007-11#2)
resection procedure##4##2##(2007-11#3)(2009-10#1)
resection rate was##2##3##(1992-9#1)(2005-5#1)
resection rate##4##2##(1992-9#1)(2005-5#1)(2010-12#1)(2010-3#1)
resection remains the treatment of choice##2##6##(2006-10#1)(2006-12#1)
resection remains the##6##3##(2006-10#3)(2006-12#1)(2010-11#1)(2010-12#1)
resection remains##7##2##(2006-10#3)(2006-12#1)(2010-11#2)(2010-12#1)
resection should be the##2##4##(1991-4#1)(2010-12#1)
resection should be##6##3##(1991-4#2)(2006-10#2)(2008-5#1)(2010-12#1)
resection should##7##2##(1991-4#2)(2006-10#2)(2008-5#1)(2010-12#1)(2011-2#1)
resection specimen##3##2##(2006-4#1)(2008-10#1)(2008-5#1)
resection specimens##3##2##(1993-11#1)(2008-6#1)(2008-9#1)
resection surgery##5##2##(2006-10#1)(2007-8#1)(2007-9#1)(2011-2#1)(2012-12#1)
resection that##4##2##(2006-6#1)(2008-8#1)(2009-3#1)(2011-2#1)
resection the##3##2##(1992-3#1)(2007-11#1)(2012-12#1)
resection to##5##2##(1993-10#1)(2008-2#1)(2008-6#1)(2010-12#1)(2010-3#1)
resection using##4##2##(1991-6#1)(1992-3#1)(2007-8#1)(2012-12#1)
resection via##2##2##(2005-5#1)(2006-6#1)
resection was achieved in##5##4##(2005-5#1)(2006-6#1)(2007-1#1)(2008-10#1)(2011-2#1)
resection was achieved##7##3##(2005-5#1)(2006-12#1)(2006-6#1)(2007-1#1)(2008-10#1)(2008-8#1)(2011-2#1)
resection was performed in##3##4##(2007-8#1)(2008-5#1)(2013-8#1)
resection was performed##17##3##(1992-6#1)(2007-12#1)(2007-6#1)(2007-8#3)(2008-10#1)(2008-5#1)(2010-12#2)(2010-2#1)(2011-12#1)(2011-2#3)(2013-8#2)
resection was##49##2##(1990-11#1)(1992-6#1)(1992-8#1)(2005-12#1)(2005-5#1)(2006-12#4)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#5)(2008-10#2)(2008-5#2)(2008-6#2)(2008-8#1)(2009-10#1)(2010-12#4)(2010-2#1)(2010-3#1)(2011-12#1)(2011-2#6)(2012-12#3)(2012-2#1)(2013-8#2)
resection were##6##2##(1990-2#1)(2007-8#1)(2007-9#1)(2008-6#1)(2010-12#1)(2011-2#1)
resection while##2##2##(2006-12#1)(2008-9#1)
resection will##2##2##(2008-3#1)(2010-5#1)
resection with anterior##2##3##(2007-11#2)
resection with subsequent joint exchange procedure##2##6##(2007-11#2)
resection with subsequent##5##3##(2007-11#4)(2007-8#1)
resection with##29##2##(1990-2#1)(1992-5#1)(1992-9#1)(1994-6#1)(2006-10#2)(2006-6#1)(2007-11#7)(2007-8#3)(2008-6#1)(2008-8#1)(2009-10#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
resection without##7##2##(1996-3#1)(2006-12#2)(2006-5#1)(2007-1#1)(2007-8#1)(2008-6#1)
resection would##2##2##(2005-5#1)(2008-8#1)
resection##1099##1##(1990-10#2)(1990-11#3)(1990-2#8)(1990-3#5)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#8)(1991-1#1)(1991-11#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#7)(1991-5#2)(1991-6#6)(1991-7#1)(1991-8#4)(1991-9#3)(1992-10#2)(1992-12#2)(1992-2#1)(1992-3#9)(1992-5#5)(1992-6#4)(1992-8#4)(1992-9#6)(1993-10#2)(1993-11#2)(1993-12#1)(1993-2#4)(1993-6#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#3)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-4#1)(1995-6#1)(1995-9#3)(1996-1#1)(1996-2#5)(1996-3#6)(1996-8#1)(1997-3#3)(1997-6#5)(1997-7#2)(1997-8#2)(2004-1#4)(2004-10#1)(2004-12#6)(2005-10#3)(2005-12#6)(2005-2#1)(2005-5#8)(2005-9#2)(2006-10#45)(2006-11#6)(2006-12#36)(2006-2#9)(2006-3#2)(2006-4#3)(2006-5#7)(2006-6#34)(2006-7#2)(2006-8#5)(2006-9#2)(2007-1#5)(2007-10#2)(2007-11#33)(2007-12#7)(2007-2#4)(2007-3#2)(2007-4#6)(2007-5#1)(2007-6#4)(2007-7#30)(2007-8#108)(2007-9#11)(2008-1#7)(2008-10#22)(2008-11#2)(2008-12#2)(2008-2#8)(2008-3#32)(2008-4#10)(2008-5#24)(2008-6#38)(2008-7#27)(2008-8#16)(2008-9#12)(2009-1#2)(2009-10#5)(2009-12#6)(2009-2#6)(2009-3#9)(2009-4#7)(2009-5#3)(2009-6#1)(2009-7#4)(2009-8#2)(2009-9#2)(2010-1#3)(2010-10#1)(2010-11#8)(2010-12#25)(2010-2#6)(2010-3#7)(2010-5#5)(2010-7#5)(2010-8#8)(2010-9#4)(2011-1#10)(2011-12#6)(2011-2#75)(2011-3#2)(2012-1#7)(2012-11#1)(2012-12#28)(2012-2#21)(2012-3#17)(2012-8#1)(2013-1#35)(2013-7#8)(2013-8#24)
resection)##3##1##(1990-12#1)(2007-2#1)(2009-12#1)
resection-ligation##2##1##(1993-10#1)(2012-2#1)
resection?]##2##1##(1990-11#1)(1990-6#1)
resection]##4##1##(1992-9#1)(2006-4#1)(2008-1#1)(2012-1#1)
resectional##3##1##(1991-6#1)(2008-10#1)(2009-2#1)
resectioning##2##1##(2006-6#1)(2011-1#1)
resections and##8##2##(1990-10#1)(1992-2#1)(1997-3#1)(2006-12#1)(2006-7#1)(2007-8#1)(2008-3#1)(2010-12#1)
resections are##4##2##(2006-7#1)(2010-2#1)(2010-8#2)
resections can be##3##3##(2006-10#1)(2007-7#1)(2013-8#1)
resections for hepatocellular carcinoma (HCC)##2##5##(2006-6#1)(2008-3#1)
resections for hepatocellular carcinoma##3##4##(2006-6#2)(2008-3#1)
resections for##12##2##(1990-2#1)(1990-9#1)(1991-4#1)(2006-2#1)(2006-6#2)(2007-8#1)(2008-3#1)(2008-4#1)(2010-12#2)(2011-1#1)
resections has been##2##3##(2010-12#1)(2010-8#1)
resections have been##2##3##(1995-9#1)(2006-10#1)
resections in##3##2##(2007-8#1)(2008-10#1)(2009-2#1)
resections of the##7##3##(1990-4#1)(1992-6#1)(2006-12#1)(2007-11#2)(2011-2#1)(2012-2#1)
resections of##10##2##(1990-4#1)(1992-6#1)(2006-10#1)(2006-12#1)(2007-11#2)(2011-2#3)(2012-2#1)
resections via##2##2##(2008-10#1)(2011-2#1)
resections were performed for##2##4##(1995-9#1)(2008-3#1)
resections with##2##2##(2007-8#2)
resections##93##1##(1990-10#1)(1990-2#2)(1990-4#2)(1990-9#2)(1991-3#2)(1991-4#1)(1991-8#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-3#1)(1993-9#1)(1995-9#4)(1996-9#1)(1997-3#3)(1997-6#1)(2004-1#1)(2006-10#5)(2006-12#2)(2006-2#1)(2006-5#3)(2006-6#6)(2006-7#2)(2007-11#2)(2007-7#3)(2007-8#9)(2007-9#1)(2008-10#4)(2008-3#6)(2008-4#1)(2008-8#1)(2008-9#2)(2009-2#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-8#3)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#1)(2013-8#1)
resections-anastomoses##2##1##(1993-9#2)
resections]##2##1##(1991-6#1)(2008-8#1)
resective surgery is##2##3##(1990-4#1)(2008-8#1)
resective##4##1##(1990-4#1)(1993-10#1)(2008-5#1)(2008-8#1)
resectoscope##3##1##(1990-12#1)(1994-9#2)
resemblance of##4##2##(1991-12#1)(1992-1#1)(2008-6#1)(2011-2#1)
resemblance to a##2##3##(1995-8#1)(2006-5#1)
resemblance to other##2##3##(1992-8#1)(2007-7#1)
resemblance to the##5##3##(1990-11#1)(2006-9#1)(2007-2#1)(2008-3#1)(2011-2#1)
resemblance to those of##3##4##(1992-11#1)(1993-11#1)(2008-3#1)
resemblance to those##4##3##(1992-11#1)(1993-11#1)(1997-3#1)(2008-3#1)
resemblance to##30##2##(1990-11#1)(1991-12#1)(1991-4#1)(1992-11#1)(1992-5#1)(1992-8#1)(1993-10#1)(1993-11#2)(1993-5#1)(1995-8#1)(1997-3#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-1#1)(2010-12#1)(2011-1#1)(2011-2#1)
resemblance##43##1##(1990-11#1)(1991-12#2)(1991-4#1)(1992-1#1)(1992-11#1)(1992-5#1)(1992-8#1)(1993-10#1)(1993-11#2)(1993-5#1)(1995-8#1)(1997-1#1)(1997-3#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-1#1)(2010-12#3)(2011-1#1)(2011-2#2)(2012-2#2)(2013-8#1)
resemble a##4##2##(2007-8#2)(2008-10#1)(2012-2#1)
resemble native##2##2##(1994-3#1)(2013-1#1)
resemble neural##2##2##(1990-3#1)(2008-8#1)
resemble normal##2##2##(1991-10#1)(2006-11#1)
resemble that of##2##3##(1996-5#1)(2008-12#1)
resemble that##3##2##(1996-5#1)(1997-4#1)(2008-12#1)
resemble the consensus##2##3##(1990-3#1)(1995-6#1)
resemble the effects of##2##4##(1993-3#1)(2008-7#1)
resemble the##27##2##(1990-11#1)(1990-3#1)(1991-3#1)(1991-5#1)(1992-7#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-4#1)(1997-7#1)(2005-10#1)(2008-11#2)(2008-4#1)(2008-7#2)(2009-8#1)(2011-1#2)(2012-2#2)
resemble those of##9##3##(1990-6#1)(1991-3#1)(1991-9#1)(1993-12#1)(1995-11#1)(1995-12#1)(1996-7#1)(1997-6#1)(2007-12#1)
resemble those seen in##2##4##(2008-4#1)(2008-7#1)
resemble those##20##2##(1990-6#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-11#1)(1995-11#1)(1995-12#1)(1996-11#1)(1996-7#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-8#1)
resemble typical##2##2##(1997-5#1)(2008-2#1)
resemble##107##1##(1990-11#1)(1990-3#3)(1990-5#2)(1990-6#2)(1991-10#1)(1991-3#2)(1991-5#2)(1991-9#2)(1992-12#1)(1992-6#1)(1992-7#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-4#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-11#2)(1995-12#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-4#1)(1996-5#2)(1996-7#2)(1996-9#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#4)(2008-4#7)(2008-6#1)(2008-7#4)(2008-8#2)(2009-8#2)(2010-5#1)(2010-8#1)(2011-1#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
resembled a##4##2##(2008-12#1)(2011-2#1)(2013-1#1)(2013-7#1)
resembled that of the##5##4##(1991-7#1)(1993-4#1)(2008-10#1)(2008-5#1)(2008-7#1)
resembled that of##12##3##(1990-11#1)(1991-7#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-4#1)(1996-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
resembled that##18##2##(1990-11#1)(1991-7#2)(1992-7#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-6#1)(1995-5#1)(1995-7#1)(1996-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
resembled the##12##2##(1992-5#1)(1992-7#1)(1994-10#1)(1994-5#1)(1995-7#1)(1996-4#1)(2007-10#1)(2008-10#2)(2008-11#1)(2012-2#1)(2012-3#1)
resembled those of the##2##4##(2008-1#1)(2009-10#1)
resembled those of##3##3##(1992-7#1)(2008-1#1)(2009-10#1)
resembled those##7##2##(1991-3#1)(1992-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-10#1)
resembled##74##1##(1990-11#2)(1991-1#1)(1991-3#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#4)(1993-1#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-10#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-5#2)(1995-7#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-3#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#4)(2008-7#1)(2008-9#1)(2009-10#1)(2011-12#1)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
resembles LDL##2##2##(1993-2#1)(2005-10#1)
resembles a##6##2##(1990-12#1)(1991-8#1)(1994-8#1)(2007-12#1)(2009-10#1)(2011-1#1)
resembles an inverted##2##3##(2007-9#1)(2008-2#1)
resembles an##4##2##(2007-9#1)(2008-2#1)(2008-9#1)(2009-8#1)
resembles closely the##2##3##(1992-9#1)(1993-9#1)
resembles previously##2##2##(1990-11#1)(1996-12#1)
resembles that of the##6##4##(1993-11#1)(1994-12#1)(2007-7#1)(2008-2#1)(2010-4#1)(2011-2#1)
resembles that of##18##3##(1990-10#1)(1990-11#1)(1990-6#1)(1992-6#1)(1993-11#1)(1994-12#2)(1994-2#1)(1996-2#1)(2007-7#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-11#1)(2010-4#1)(2011-2#1)
resembles that##25##2##(1990-10#1)(1990-11#1)(1990-4#1)(1990-6#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-11#1)(1994-12#2)(1994-2#1)(1994-9#1)(1996-2#1)(1997-2#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-11#1)(2010-4#1)(2011-2#1)
resembles the##36##2##(1990-5#1)(1991-11#1)(1991-2#1)(1991-4#3)(1992-1#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-6#2)(1994-12#1)(1994-9#1)(1995-10#1)(1995-3#1)(1996-4#2)(1997-1#1)(1997-6#1)(2005-10#1)(2005-9#1)(2006-10#1)(2007-12#3)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-3#1)
resembles those of##2##3##(1993-2#1)(1995-7#1)
resembles those##3##2##(1991-5#1)(1993-2#1)(1995-7#1)
resembles##115##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-4#3)(1991-5#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-6#3)(1993-9#2)(1994-12#5)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#3)(1995-10#1)(1995-3#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-4#2)(1997-1#2)(1997-2#1)(1997-6#2)(1997-8#1)(2005-10#2)(2005-8#1)(2005-9#1)(2006-10#2)(2006-6#2)(2007-12#6)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#3)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#1)(2009-5#1)(2009-8#2)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-3#1)(2013-1#1)
resembling a##9##2##(1990-11#1)(1993-3#2)(1994-12#1)(2006-10#1)(2007-11#1)(2010-2#1)(2011-2#1)(2012-2#1)
resembling acute##2##2##(1992-10#1)(1995-11#1)
resembling an##4##2##(2006-6#1)(2008-7#1)(2009-11#1)(2010-9#1)
resembling human##4##2##(1994-11#1)(1996-11#1)(2010-8#1)(2012-2#1)
resembling native##2##2##(1995-12#1)(1996-12#1)
resembling rheumatoid arthritis##2##3##(1991-8#2)
resembling that of##4##3##(1996-11#1)(1996-9#1)(2006-8#1)(2012-2#1)
resembling that##7##2##(1990-2#1)(1991-12#1)(1996-11#1)(1996-9#1)(2005-7#1)(2006-8#1)(2012-2#1)
resembling the##17##2##(1991-12#1)(1991-4#1)(1995-5#2)(1996-12#2)(1996-4#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-11#1)(2005-12#1)(2005-9#1)(2008-7#1)(2008-9#1)(2010-10#1)(2012-2#1)
resembling those of the##3##4##(1997-6#1)(2007-12#1)(2009-4#1)
resembling those of##11##3##(1991-8#1)(1994-12#1)(1994-6#1)(1997-2#1)(1997-6#1)(2005-11#1)(2007-12#1)(2008-10#1)(2009-4#1)(2010-11#1)(2010-3#1)
resembling those seen##2##3##(2007-11#1)(2009-4#1)
resembling those##16##2##(1991-8#1)(1994-10#1)(1994-12#1)(1994-6#1)(1997-2#1)(1997-6#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2009-4#2)(2010-11#1)(2010-3#1)(2011-2#1)
resembling##132##1##(1990-11#2)(1990-2#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-4#1)(1991-8#5)(1992-10#1)(1992-6#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#2)(1995-5#2)(1995-6#1)(1996-11#2)(1996-12#3)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-5#1)(1997-6#2)(1997-7#3)(2004-2#1)(2005-11#2)(2005-12#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-12#2)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-9#1)(2009-11#1)(2009-3#2)(2009-4#2)(2009-7#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-2#6)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#2)
resent##2##1##(2008-12#1)(2012-2#1)
resented##2##1##(2008-7#1)(2012-3#1)
resentment##4##1##(2007-2#1)(2007-4#2)(2009-4#1)
resequenced##3##1##(1995-8#1)(2012-2#1)(2012-3#1)
resequencing studies##2##2##(2008-9#1)(2012-3#1)
resequencing##7##1##(2008-10#1)(2008-9#1)(2012-2#2)(2012-3#3)
resequestered##2##1##(1991-8#1)(2008-10#1)
reserach##2##1##(2006-8#1)(2012-2#1)
reserpine pretreatment##2##2##(1992-7#1)(1994-10#1)
reserpine treatment##5##2##(1991-8#5)
reserpine was##2##2##(1996-9#1)(2008-10#1)
reserpine##37##1##(1990-2#3)(1990-5#2)(1991-2#1)(1991-8#7)(1992-7#1)(1993-2#1)(1994-10#1)(1996-2#1)(1996-9#1)(2007-3#5)(2008-10#8)(2008-12#5)(2012-2#1)
reserpine-induced##3##1##(1990-5#1)(2012-2#2)
reserpine-treated##2##1##(1990-5#1)(1991-8#1)
reserpinized##4##1##(1990-5#4)
reservation##7##1##(1990-2#1)(1991-12#1)(1991-2#1)(2007-2#1)(2009-11#1)(2010-2#1)(2011-2#1)
reservations about##2##2##(1993-12#1)(2007-5#1)
reservations##9##1##(1991-3#1)(1991-4#1)(1993-12#1)(2007-5#1)(2010-2#2)(2012-12#2)(2012-2#1)
reserve and##6##2##(1993-10#1)(2007-10#1)(2007-8#1)(2008-7#1)(2012-12#2)
reserve by##2##2##(2007-9#1)(2008-1#1)
reserve capacity of##2##3##(1990-11#1)(1992-12#1)
reserve in##5##2##(1990-3#1)(1992-10#1)(2007-9#1)(2008-7#1)(2012-2#1)
reserve is##2##2##(1992-5#1)(2012-2#1)
reserve of##4##2##(2006-10#1)(2008-10#2)(2008-12#1)
reserve pool##4##2##(2007-10#4)
reserve tests##2##2##(2012-2#2)
reserve##70##1##(1990-11#1)(1990-3#1)(1992-10#3)(1992-12#1)(1992-5#1)(1993-10#2)(1996-10#1)(1996-7#2)(2005-1#1)(2006-10#2)(2007-10#6)(2007-12#1)(2007-8#2)(2007-9#3)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#2)(2008-5#2)(2008-7#5)(2008-8#1)(2009-10#1)(2010-11#1)(2010-12#3)(2010-3#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#6)
reserve)##2##1##(2011-1#1)(2013-8#1)
reserved as a##2##3##(1997-2#1)(2010-12#1)
reserved as##3##2##(1997-2#1)(2006-9#1)(2010-12#1)
reserved for only those##2##4##(2005-8#1)(2006-7#1)
reserved for patients developing##2##4##(2006-9#1)(2007-11#1)
reserved for patients with##8##4##(1991-4#1)(1991-6#1)(2006-10#1)(2008-4#1)(2009-8#1)(2011-2#2)(2012-3#1)
reserved for patients##13##3##(1990-6#1)(1991-4#1)(1991-6#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-4#1)(2008-6#1)(2009-8#1)(2011-2#2)(2012-3#1)
reserved for the##5##3##(1992-5#1)(1993-10#1)(2006-9#2)(2013-8#1)
reserved for those##4##3##(2005-11#1)(2006-8#1)(2006-9#1)(2008-8#1)
reserved for##53##2##(1990-6#1)(1991-4#1)(1991-6#1)(1992-5#1)(1992-9#1)(1993-10#1)(1993-11#1)(1996-2#1)(1997-3#2)(1997-7#1)(2005-11#1)(2005-8#1)(2006-10#5)(2006-2#1)(2006-7#1)(2006-8#1)(2006-9#4)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-8#2)(2009-8#2)(2010-12#1)(2010-7#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
reserved to the##2##3##(1997-8#1)(2006-2#1)
reserved to##3##2##(1997-8#1)(2006-2#1)(2013-1#1)
reserved##64##1##(1990-6#1)(1991-4#1)(1991-6#1)(1992-5#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-3#1)(1996-2#1)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#5)(2006-2#2)(2006-7#1)(2006-8#1)(2006-9#5)(2007-11#2)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-8#2)(2009-8#2)(2010-12#2)(2010-7#2)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
reserves and##3##2##(2008-5#1)(2009-3#1)(2010-7#1)
reserves in the##2##3##(2008-10#1)(2013-1#1)
reserves in##5##2##(2005-8#1)(2008-10#1)(2012-2#2)(2013-1#1)
reserves of the##3##3##(2009-2#1)(2009-5#1)(2012-1#1)
reserves of##4##2##(2009-2#1)(2009-5#1)(2011-2#1)(2012-1#1)
reserves##43##1##(1990-3#2)(1995-3#1)(1997-3#1)(1997-5#1)(2005-8#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-5#4)(2008-7#3)(2008-8#6)(2008-9#2)(2009-2#2)(2009-3#1)(2009-5#1)(2010-10#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)
reserving surgical interventions for those patients who are resistant to conservative care##2##12##(2006-12#2)
reserving##3##1##(1990-3#1)(2006-12#2)
reservoir (H)##3##2##(2008-10#3)
reservoir and a##2##3##(2006-10#1)(2007-12#1)
reservoir and##9##2##(1992-11#1)(2006-10#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-5#1)
reservoir as##2##2##(2006-8#1)(2008-8#1)
reservoir at##3##2##(2008-1#2)(2008-10#1)
reservoir for the##3##3##(1992-9#1)(1997-4#1)(2011-2#1)
reservoir for##9##2##(1992-9#1)(1997-4#1)(1997-5#1)(2006-12#1)(2006-6#1)(2008-10#1)(2008-4#1)(2010-12#1)(2011-2#1)
reservoir host##3##2##(2005-12#2)(2008-12#1)
reservoir hosts##2##2##(2008-10#1)(2008-12#1)
reservoir is##8##2##(2006-10#1)(2007-12#3)(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)
reservoir of cpe-positive C##2##4##(2011-2#2)
reservoir of infection##2##3##(2007-7#2)
reservoir of##26##2##(1994-9#1)(1995-2#1)(1997-6#1)(2004-12#1)(2005-7#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-10#1)(2009-12#1)(2009-6#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#1)(2013-7#1)
reservoir powder inhaler##4##3##(1996-2#4)
reservoir systems##2##2##(1996-2#1)(2008-5#1)
reservoir to##2##2##(2008-1#1)(2008-10#1)
reservoir was##3##2##(2005-11#1)(2012-2#2)
reservoir water##4##2##(2008-10#4)
reservoir##145##1##(1990-9#3)(1992-11#2)(1992-3#1)(1992-9#2)(1994-9#1)(1995-2#1)(1995-4#1)(1996-2#5)(1996-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-12#1)(2005-11#2)(2005-12#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#2)(2006-6#1)(2006-8#2)(2007-11#1)(2007-12#14)(2007-4#1)(2007-7#2)(2007-9#1)(2008-1#6)(2008-10#31)(2008-12#5)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#8)(2008-7#2)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#7)(2013-1#2)(2013-7#1)(2013-8#1)
reservoir)##2##1##(1991-6#1)(2009-6#1)
reservoire##2##1##(1996-3#1)(2006-6#1)
reservoirs and##5##2##(2006-8#2)(2008-10#1)(2010-1#1)(2011-2#1)
reservoirs for the Lyme disease##2##5##(1997-4#1)(2010-6#1)
reservoirs for the##4##3##(1997-4#1)(2008-10#2)(2010-6#1)
reservoirs for##7##2##(1992-5#1)(1997-4#1)(2006-10#1)(2008-10#2)(2008-5#1)(2010-6#1)
reservoirs in the##2##3##(1997-4#1)(2013-1#1)
reservoirs in##4##2##(1997-4#1)(2008-5#1)(2012-12#1)(2013-1#1)
reservoirs of##12##2##(1996-4#1)(2005-8#1)(2007-11#1)(2008-10#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
reservoirs to##2##2##(2005-11#1)(2009-8#1)
reservoirs##58##1##(1992-11#1)(1992-5#1)(1994-3#2)(1994-6#1)(1996-4#1)(1997-4#2)(2005-11#4)(2005-8#1)(2006-10#3)(2006-8#2)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#6)(2009-6#1)(2009-8#1)(2010-1#1)(2010-6#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2013-1#3)(2013-7#1)(2013-8#1)
reset the##2##2##(1991-11#1)(2008-5#1)
reset to##3##2##(2010-2#1)(2013-1#1)(2013-8#1)
reset##16##1##(1991-11#1)(1991-3#1)(2005-8#1)(2008-11#1)(2008-5#2)(2008-6#1)(2009-9#1)(2010-11#2)(2010-2#2)(2011-2#1)(2013-1#1)(2013-8#2)
resetting of the##2##3##(2005-8#1)(2008-9#1)
resetting of##4##2##(1995-6#1)(2005-8#1)(2008-3#1)(2008-9#1)
resetting##7##1##(1995-6#3)(2005-8#1)(2008-3#1)(2008-9#1)(2010-11#1)
resettlement##3##1##(2011-1#2)(2011-2#1)
reshape##6##1##(1991-1#1)(1994-1#1)(1995-3#2)(2005-12#1)(2010-8#1)
reshaped##4##1##(2008-2#2)(2008-3#2)
reshaping of##8##2##(1993-12#1)(2007-12#4)(2008-10#1)(2008-11#1)(2009-7#1)
reshaping the##2##2##(1994-12#1)(2009-8#1)
reshaping##23##1##(1992-6#1)(1993-12#1)(1994-12#1)(2007-12#9)(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-8#1)(2013-7#1)
reside at##3##2##(2012-12#1)(2013-8#2)
reside in a##7##3##(1990-5#1)(1990-7#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#1)(2008-1#1)
reside in the##17##3##(1990-6#3)(1992-12#1)(1992-6#1)(1994-12#1)(1995-1#1)(1995-8#1)(1997-4#1)(2006-4#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-10#1)(2012-11#1)(2012-12#2)
reside in##34##2##(1990-5#1)(1990-6#3)(1990-7#1)(1992-12#1)(1992-6#1)(1994-12#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-8#1)(1995-9#1)(1997-4#1)(2006-2#1)(2006-4#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-4#1)(2012-11#1)(2012-12#2)
reside on the##2##3##(1990-11#1)(1992-4#1)
reside on##7##2##(1990-11#1)(1990-4#1)(1992-1#1)(1992-4#1)(1994-5#1)(1994-8#1)(2008-10#1)
reside outside the##2##3##(1991-9#1)(2010-6#1)
reside primarily##2##2##(2010-4#1)(2012-1#1)
reside within##4##2##(1992-4#1)(1996-4#1)(2008-9#1)(2011-12#1)
reside##67##1##(1990-11#1)(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-4#2)(1992-5#1)(1992-6#1)(1994-12#2)(1994-5#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#1)(1995-3#2)(1995-8#1)(1995-9#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-6#2)(2006-2#1)(2006-4#1)(2007-11#1)(2008-1#2)(2008-10#4)(2008-3#3)(2008-4#2)(2008-7#1)(2008-9#2)(2009-10#2)(2010-11#1)(2010-4#2)(2010-6#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#3)(2013-1#1)(2013-8#2)
resided at##2##2##(1996-7#1)(2010-8#1)
resided in the##6##3##(1990-8#1)(1990-9#1)(1995-6#1)(1995-9#1)(2009-7#1)(2012-3#1)
resided in##10##2##(1990-8#1)(1990-9#1)(1991-7#1)(1995-6#1)(1995-9#1)(2007-10#1)(2008-11#1)(2009-7#1)(2012-3#1)(2013-8#1)
resided within##2##2##(1996-5#1)(2006-10#1)
resided##17##1##(1990-8#1)(1990-9#1)(1991-7#1)(1993-4#1)(1994-6#1)(1995-6#1)(1995-9#1)(1996-5#1)(1996-7#1)(2006-10#1)(2007-10#1)(2008-11#1)(2009-5#1)(2009-7#1)(2010-8#1)(2012-3#1)(2013-8#1)
residence and the##2##3##(1996-11#1)(2007-12#1)
residence and##7##2##(1992-4#1)(1994-6#1)(1996-11#1)(2007-12#1)(2011-2#2)(2012-3#1)
residence in the##4##3##(2005-10#1)(2007-10#1)(2008-8#1)(2010-12#1)
residence in##12##2##(1995-5#2)(2004-4#1)(2005-10#1)(2007-10#1)(2008-8#2)(2008-9#1)(2010-12#2)(2010-8#2)
residence of the##4##3##(1991-10#1)(1991-3#1)(2007-12#1)(2012-12#1)
residence of##6##2##(1991-10#1)(1991-3#1)(2006-10#1)(2007-12#1)(2008-8#1)(2012-12#1)
residence time and##4##3##(2007-9#1)(2010-2#1)(2010-5#2)
residence time in##3##3##(1996-1#1)(2008-12#1)(2008-5#1)
residence time of##5##3##(1990-3#1)(2007-9#1)(2008-10#1)(2008-2#1)(2013-7#1)
residence time on the efficacy of antidandruff shampoos##2##8##(2008-5#2)
residence time##35##2##(1990-3#1)(1992-11#1)(1996-1#1)(2007-10#1)(2007-2#1)(2007-9#5)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#8)(2008-7#2)(2010-2#1)(2010-5#2)(2010-8#1)(2011-2#2)(2013-7#1)
residence times##9##2##(1990-3#2)(1991-12#1)(1995-2#1)(1996-12#1)(2007-8#2)(2008-7#1)(2011-2#1)
residence was##2##2##(2013-1#2)
residence##117##1##(1990-3#3)(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-5#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-2#1)(2004-4#1)(2005-10#2)(2006-10#3)(2006-3#2)(2007-10#3)(2007-12#2)(2007-2#1)(2007-7#3)(2007-8#3)(2007-9#5)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#8)(2008-7#3)(2008-8#3)(2008-9#2)(2009-3#1)(2009-4#2)(2009-7#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#4)(2010-9#2)(2011-1#3)(2011-2#8)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#1)
residences##4##1##(1992-4#1)(1993-9#1)(2008-10#1)(2008-6#1)
residencies in##2##2##(1994-12#1)(2007-9#1)
residencies##10##1##(1993-2#1)(1994-12#1)(1994-3#1)(2004-3#1)(2007-3#3)(2007-7#1)(2007-9#1)(2012-3#1)
residency and##2##2##(1994-12#1)(1994-3#1)
residency directors##2##2##(1991-6#2)
residency in##6##2##(1993-12#1)(1994-2#1)(2008-8#2)(2010-8#1)(2011-2#1)
residency of##2##2##(2010-8#1)(2012-2#1)
residency positions##2##2##(1991-8#1)(2007-7#1)
residency program##14##2##(1991-12#1)(1991-6#1)(1994-12#2)(1995-1#2)(1996-9#1)(2004-3#1)(2007-2#2)(2007-4#1)(2007-7#1)(2009-4#1)(2012-3#1)
residency programs in##2##3##(1991-6#1)(1994-1#1)
residency programs##12##2##(1991-6#1)(1992-3#1)(1994-1#1)(1994-3#1)(2004-3#1)(2007-4#2)(2007-7#1)(2008-11#1)(2008-7#1)(2010-1#1)(2011-2#1)
residency training programs##4##3##(1992-1#2)(2007-4#1)(2011-2#1)
residency training##14##2##(1992-1#3)(2004-3#1)(2007-4#1)(2008-8#1)(2010-4#1)(2011-2#3)(2012-3#2)(2013-1#2)
residency##97##1##(1991-12#1)(1991-6#5)(1991-8#1)(1992-1#3)(1992-3#1)(1993-12#2)(1994-1#1)(1994-12#4)(1994-2#1)(1994-3#3)(1995-1#3)(1995-3#1)(1996-1#1)(1996-12#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(2004-3#3)(2006-10#5)(2007-2#2)(2007-3#2)(2007-4#9)(2007-7#5)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#3)(2009-4#1)(2009-6#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#2)(2011-2#7)(2012-2#1)(2012-3#4)(2013-1#5)
resident RTC##2##2##(2011-2#2)
resident and##11##2##(1990-2#1)(1996-1#1)(1997-1#1)(2007-7#2)(2008-8#1)(2010-8#1)(2011-2#3)(2013-7#1)
resident assessment##4##2##(1993-2#1)(1994-3#1)(1997-1#1)(2012-2#1)
resident bacteria##4##2##(2006-10#1)(2008-5#3)
resident characteristics##2##2##(1991-2#1)(1991-3#1)
resident dependency##2##2##(2012-12#2)
resident doctors##2##2##(2008-7#2)
resident education##7##2##(2004-3#1)(2007-4#4)(2010-4#1)(2011-2#1)
resident epidermal Langerhans cells##2##4##(2008-5#2)
resident flora##3##2##(2008-5#3)
resident in the##3##3##(1991-9#1)(2008-11#1)(2009-4#1)
resident in##16##2##(1990-2#1)(1991-9#1)(1994-2#1)(1995-2#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2009-4#1)(2009-5#2)(2010-12#1)(2010-2#1)
resident macrophages##6##2##(1990-2#1)(1993-4#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-4#1)
resident members##2##2##(2008-4#2)
resident microflora##4##2##(2008-10#3)(2008-5#1)
resident nurses##2##2##(2011-2#2)
resident of##3##2##(1994-12#1)(2007-7#1)(2008-10#1)
resident on##3##2##(2008-1#2)(2008-5#1)
resident peritoneal macrophages##4##3##(1994-9#1)(2008-11#1)(2008-12#1)(2008-4#1)
resident peritoneal##5##2##(1994-9#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-4#1)
resident physicians##3##2##(1991-2#1)(2004-3#1)(2010-4#1)
resident population##5##2##(1991-8#1)(1996-3#1)(2007-9#2)(2010-5#1)
resident positions##2##2##(2007-4#2)
resident protein##5##2##(1994-11#2)(1996-10#1)(1996-9#2)
resident species##2##2##(2007-7#1)(2008-5#1)
resident stem##2##2##(2008-1#1)(2010-12#1)
resident tissue macrophages##2##3##(1990-4#1)(2008-4#1)
resident to##2##2##(2008-10#1)(2011-2#1)
resident training##2##2##(2008-4#1)(2012-3#1)
resident work hours##2##3##(2007-3#1)(2013-1#1)
resident##211##1##(1990-2#4)(1990-4#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-4#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-3#1)(1996-9#2)(1997-1#2)(1997-2#1)(2004-3#3)(2004-4#2)(2005-12#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-11#3)(2007-3#5)(2007-4#13)(2007-7#5)(2007-9#4)(2008-1#6)(2008-10#15)(2008-11#2)(2008-12#2)(2008-2#3)(2008-4#7)(2008-5#16)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-4#4)(2009-5#3)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#7)(2011-1#1)(2011-12#1)(2011-2#17)(2012-12#7)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#3)
resident&quot##2##1##(2008-4#1)(2011-2#1)
resident's perspective##2##2##(2007-4#2)
resident's##7##1##(1996-1#1)(2007-4#3)(2011-1#1)(2011-2#2)
resident-level##2##1##(1996-2#1)(1996-3#1)
residential aged care##3##3##(2010-10#2)(2012-12#1)
residential area##5##2##(2007-10#1)(2007-7#1)(2007-8#1)(2010-3#2)
residential areas of Jharsuguda##2##4##(2007-10#2)
residential areas##7##2##(2007-10#3)(2007-12#1)(2008-10#1)(2012-2#2)
residential care for##3##3##(2007-12#3)
residential care##16##2##(1991-10#1)(1997-1#2)(2007-12#3)(2008-12#1)(2010-8#1)(2011-2#4)(2012-12#2)(2013-1#2)
residential centers##2##2##(1991-10#1)(2008-7#1)
residential distance##2##2##(2013-1#2)
residential histories##3##2##(2008-6#3)
residential homes##2##2##(1996-5#1)(2005-9#1)
residential patterns##2##2##(2011-2#2)
residential segregation##2##2##(2011-2#2)
residential substance abuse treatment##2##4##(2009-9#1)(2010-2#1)
residential treatment##6##2##(2008-6#1)(2013-1#1)(2013-8#4)
residential##92##1##(1991-1#1)(1991-10#2)(1991-12#2)(1991-2#1)(1992-4#1)(1993-1#1)(1993-12#2)(1993-5#1)(1994-2#1)(1995-2#1)(1996-3#3)(1996-5#1)(1997-1#2)(2004-4#1)(2005-11#1)(2005-9#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-10#4)(2007-12#4)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-12#1)(2008-6#5)(2008-7#4)(2009-6#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-8#1)(2011-1#3)(2011-2#9)(2012-12#4)(2012-2#3)(2013-1#10)(2013-8#5)
residentially exposed to asbestos##2##4##(2010-9#2)
residentially exposed to##3##3##(2010-9#3)
residentially##4##1##(2010-9#3)(2011-2#1)
residents (n =##2##3##(1995-2#1)(2013-1#1)
residents -##2##2##(2006-10#1)(2013-8#1)
residents aged##3##2##(1991-6#2)(2008-12#1)
residents and fellows in##2##4##(2006-12#1)(2007-4#1)
residents and fellows##3##3##(2006-12#1)(2007-4#1)(2013-8#1)
residents and livestock##2##3##(2011-12#1)(2012-3#1)
residents and medical##2##3##(2009-4#1)(2011-2#1)
residents and staff##4##3##(1994-7#2)(2007-5#1)(2010-7#1)
residents and##34##2##(1991-6#1)(1994-3#1)(1994-7#2)(1995-3#1)(1997-1#2)(2006-10#1)(2006-12#1)(2007-4#4)(2007-5#1)(2007-7#1)(2008-1#2)(2008-11#2)(2008-4#3)(2008-8#1)(2009-4#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
residents are##3##2##(2009-9#1)(2011-1#1)(2013-1#1)
residents as##2##2##(2007-7#1)(2013-1#1)
residents at the##3##3##(2009-11#1)(2011-1#2)
residents at##5##2##(2006-12#1)(2009-11#1)(2011-1#2)(2012-3#1)
residents from the##4##3##(1992-1#1)(1995-3#1)(2004-12#1)(2008-1#1)
residents from##10##2##(1992-1#1)(1993-7#1)(1995-3#1)(2004-12#2)(2007-4#1)(2008-1#1)(2008-12#1)(2010-10#1)(2013-1#1)
residents had##3##2##(2008-1#2)(2012-1#1)
residents have##3##2##(2007-4#1)(2011-1#1)(2011-2#1)
residents in a##2##3##(1995-3#1)(2011-2#1)
residents in an##2##3##(2004-3#1)(2007-2#1)
residents in family and community##2##5##(1993-3#1)(1994-2#1)
residents in the emergency department##2##5##(2007-5#1)(2007-7#1)
residents in the##5##3##(1994-9#1)(1995-3#1)(1996-9#1)(2007-5#1)(2007-7#1)
residents in training##2##3##(1994-3#1)(2006-10#1)
residents in##38##2##(1991-3#1)(1992-1#1)(1992-2#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-3#4)(1996-5#1)(1996-9#1)(2004-3#1)(2006-10#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#2)(2009-9#1)(2010-12#2)(2011-2#2)(2012-1#1)(2012-3#1)
residents increased by##2##3##(1991-8#2)
residents increased##3##2##(1991-8#2)(2007-8#1)
residents is##2##2##(2007-12#1)(2012-12#1)
residents must##2##2##(2007-5#1)(2010-8#1)
residents of Greater Athens##2##4##(1993-9#2)
residents of Olmsted County##2##4##(2007-10#1)(2007-8#1)
residents of Pokhara##2##3##(2011-2#2)
residents of a community##2##4##(1996-3#2)
residents of a nursing home##2##5##(1992-2#1)(2008-7#1)
residents of a##6##3##(1992-2#1)(1996-3#2)(2008-7#1)(2011-2#1)(2013-1#1)
residents of nursing homes##7##4##(1996-6#6)(2008-12#1)
residents of suburban areas##2##4##(2011-2#2)
residents of the U##2##4##(2011-2#2)
residents of the##8##3##(1991-11#1)(1992-2#1)(1993-3#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)
residents of##65##2##(1990-12#1)(1990-2#3)(1991-11#1)(1991-9#1)(1992-1#1)(1992-2#2)(1992-5#1)(1993-3#1)(1993-9#2)(1995-12#1)(1996-2#1)(1996-3#2)(1996-6#6)(1997-2#1)(1997-8#1)(2006-10#1)(2006-2#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#2)(2008-6#1)(2008-7#1)(2009-4#1)(2009-9#1)(2010-11#1)(2011-1#3)(2011-2#10)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
residents on##2##2##(1997-1#1)(2008-6#1)
residents over##3##2##(2009-12#1)(2011-2#1)(2013-8#1)
residents receiving##2##2##(1991-2#1)(2011-2#1)
residents the##2##2##(1995-12#1)(2007-4#1)
residents to##7##2##(2004-3#1)(2007-4#1)(2008-1#1)(2008-11#3)(2012-1#1)
residents was##5##2##(1991-2#1)(1992-2#1)(2011-2#3)
residents were exposed##2##3##(2008-1#1)(2012-2#1)
residents were##10##2##(1997-2#1)(2008-1#1)(2008-3#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
residents who are##2##3##(1997-1#1)(2011-2#1)
residents who##6##2##(1996-6#1)(1997-1#1)(2008-1#1)(2008-11#1)(2011-2#2)
residents with dementia##7##3##(2006-3#1)(2010-10#3)(2011-1#1)(2011-2#2)
residents with##14##2##(1993-8#1)(1993-9#1)(2006-10#1)(2006-3#1)(2008-2#1)(2010-10#3)(2010-7#1)(2011-1#1)(2011-2#4)
residents##393##1##(1990-12#1)(1990-2#3)(1991-1#1)(1991-11#1)(1991-2#3)(1991-3#2)(1991-6#3)(1991-8#4)(1991-9#1)(1992-1#5)(1992-2#5)(1992-5#2)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-5#1)(1993-7#1)(1993-8#2)(1993-9#3)(1994-12#3)(1994-2#2)(1994-3#3)(1994-4#1)(1994-7#4)(1994-9#1)(1995-12#5)(1995-2#6)(1995-3#12)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#7)(1996-9#1)(1997-1#5)(1997-2#3)(1997-8#1)(2004-12#2)(2004-3#5)(2005-7#1)(2005-8#1)(2006-10#8)(2006-12#2)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#3)(2007-2#3)(2007-3#10)(2007-4#17)(2007-5#4)(2007-7#6)(2007-8#3)(2007-9#1)(2008-1#12)(2008-10#1)(2008-11#11)(2008-12#6)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#3)(2009-10#6)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#3)(2009-9#4)(2010-10#8)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#5)(2010-8#7)(2010-9#1)(2011-1#9)(2011-12#1)(2011-2#47)(2012-1#7)(2012-12#9)(2012-2#9)(2012-3#6)(2013-1#10)(2013-7#2)(2013-8#8)
residents' quality of##2##3##(2007-5#2)
residents'##22##1##(1991-2#1)(1992-1#1)(1993-2#1)(1994-2#1)(1995-3#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-4#3)(2007-5#3)(2008-11#1)(2008-4#1)(2010-7#1)(2011-2#5)
residents]##3##1##(1993-4#1)(1997-3#1)(2010-6#1)
resides at##2##2##(1994-6#1)(2009-5#1)
resides in a##5##3##(1994-9#1)(1995-11#1)(2008-1#1)(2009-8#1)(2010-2#1)
resides in the##19##3##(1990-2#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-6#1)(1997-3#1)(2006-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-9#1)(2010-12#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
resides in##33##2##(1990-2#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(2006-11#1)(2006-7#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#2)(2008-9#1)(2009-8#1)(2010-12#2)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#4)
resides on chromosome##2##3##(1995-8#1)(2008-1#1)
resides on the##2##3##(1994-5#1)(1995-3#1)
resides on##5##2##(1991-9#1)(1994-5#1)(1995-3#1)(1995-8#1)(2008-1#1)
resides predominantly##2##2##(1994-9#1)(2008-8#1)
resides within the##3##3##(1994-11#1)(2008-2#1)(2010-2#1)
resides within##4##2##(1994-11#1)(1994-9#1)(2008-2#1)(2010-2#1)
resides##59##1##(1990-11#1)(1990-2#1)(1991-10#1)(1991-4#1)(1991-9#1)(1992-11#1)(1994-11#2)(1994-5#1)(1994-6#2)(1994-9#3)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1997-1#1)(1997-3#1)(1997-4#1)(2006-11#1)(2006-7#1)(2007-12#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#4)
residing at a##2##3##(2008-7#1)(2012-3#1)
residing at the##2##3##(1990-8#1)(2008-8#1)
residing at##7##2##(1990-8#1)(1991-12#1)(2006-10#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#1)
residing in New##2##3##(2008-11#1)(2012-12#1)
residing in a##5##3##(2006-2#1)(2007-9#2)(2008-3#1)(2013-1#1)
residing in each##2##3##(1990-11#1)(2012-1#1)
residing in long-term care##2##4##(2009-4#1)(2013-8#1)
residing in public housing##2##4##(2008-3#2)
residing in the United States##2##5##(1990-12#1)(2011-2#1)
residing in the##17##3##(1990-12#1)(1990-5#1)(1993-6#1)(1995-12#1)(1995-3#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-4#2)(2011-2#1)(2012-12#2)(2012-7#1)(2013-1#1)(2013-8#1)
residing in this##2##3##(2007-2#1)(2008-7#1)
residing in##66##2##(1990-11#1)(1990-12#2)(1990-5#1)(1992-12#1)(1992-3#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-5#2)(1996-3#1)(1997-1#1)(2006-2#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-2#3)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#3)(2008-7#3)(2008-8#1)(2009-4#4)(2009-5#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#5)(2012-2#2)(2012-7#1)(2013-1#3)(2013-7#1)(2013-8#4)
residing near##2##2##(2006-12#2)
residing on human##2##3##(2013-1#2)
residing on the##5##3##(1991-3#1)(1994-5#1)(1996-7#2)(2008-1#1)
residing on##11##2##(1991-3#1)(1994-5#1)(1994-9#1)(1996-7#2)(2008-1#2)(2008-3#1)(2008-4#1)(2013-1#2)
residing within##3##2##(2012-1#1)(2013-1#1)(2013-7#1)
residing##96##1##(1990-11#1)(1990-12#2)(1990-5#1)(1990-8#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-12#2)(1995-3#1)(1995-5#2)(1996-3#1)(1996-7#2)(1997-1#1)(2005-10#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-2#3)(2007-4#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#4)(2008-4#1)(2008-7#5)(2008-8#2)(2009-4#4)(2009-5#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-12#5)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#7)(2013-7#2)(2013-8#4)
residual C-peptide##2##2##(2007-11#1)(2007-5#1)
residual activity##4##2##(1994-5#1)(1994-8#1)(1996-11#2)
residual amplitude##2##2##(2007-12#1)(2008-3#1)
residual anabolic##3##2##(2008-10#3)
residual and##4##2##(1991-3#1)(1997-2#1)(2008-10#1)(2008-12#1)
residual aneurysm##2##2##(2006-10#1)(2012-12#1)
residual aortic regurgitation##2##3##(2007-8#1)(2013-1#1)
residual binding##2##2##(1990-2#1)(1995-3#1)
residual birefringence##3##2##(2007-12#1)(2008-2#2)
residual blockade##3##2##(1996-9#3)
residual blood##3##2##(2008-8#1)(2009-4#1)(2010-12#1)
residual bodies in##2##3##(1992-5#1)(2007-12#1)
residual bodies##3##2##(1992-5#2)(2007-12#1)
residual bone##2##2##(2005-5#1)(2011-12#1)
residual cancer##4##2##(1994-5#1)(2004-2#1)(2006-9#1)(2009-2#1)
residual capacity##11##2##(1991-12#1)(1996-5#1)(1997-3#3)(1997-4#1)(2005-11#1)(2006-9#1)(2008-7#1)(2011-1#2)
residual carbon##2##2##(2008-10#2)
residual cardiovascular risk in##2##4##(2009-11#2)
residual catabolite repression##2##3##(1994-2#2)
residual cavity##2##2##(2010-12#1)(2013-8#1)
residual cells##3##2##(2009-11#3)
residual changes##2##2##(2006-10#1)(2006-6#1)
residual chlorine in##2##3##(2008-10#2)
residual chlorine##8##2##(2008-10#8)
residual cognitive##2##2##(2008-6#1)(2012-1#1)
residual confounding##9##2##(1992-9#5)(1997-1#1)(2005-7#1)(2012-12#2)
residual coronary artery##2##3##(2007-8#2)
residual curarization##2##2##(2006-10#2)
residual disease after##2##3##(2007-11#1)(2010-5#1)
residual disease and##3##3##(2007-7#1)(2010-11#2)
residual disease in re-excisions##2##4##(2004-2#2)
residual disease in the##2##4##(2011-2#1)(2013-8#1)
residual disease in##6##3##(1995-12#1)(2004-2#2)(2011-2#1)(2012-12#1)(2013-8#1)
residual disease or##2##3##(1996-2#1)(2008-5#1)
residual disease was##2##3##(1992-3#1)(2004-2#1)
residual disease##48##2##(1990-4#1)(1991-4#1)(1992-3#1)(1993-1#1)(1993-3#1)(1995-12#3)(1996-11#1)(1996-2#1)(2004-2#5)(2006-12#1)(2007-11#4)(2007-7#3)(2008-10#1)(2008-5#1)(2008-6#4)(2009-11#1)(2009-12#1)(2010-11#3)(2010-2#2)(2010-5#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#2)(2012-3#2)(2013-8#1)
residual disease)##2##2##(2011-1#1)(2011-2#1)
residual effect of the##2##4##(2005-8#1)(2008-10#1)
residual effect of##3##3##(1996-12#1)(2005-8#1)(2008-10#1)
residual effect##6##2##(1996-12#1)(2005-8#1)(2006-9#1)(2008-10#3)
residual effects of##3##3##(1990-3#1)(2008-8#1)(2009-3#1)
residual effects##7##2##(1990-3#1)(1994-5#2)(2008-10#1)(2008-3#1)(2008-8#1)(2009-3#1)
residual emission##4##2##(2008-2#4)
residual error##6##2##(2008-10#1)(2008-2#3)(2008-3#1)(2010-8#1)
residual flow##2##2##(1992-10#1)(2006-6#1)
residual fraction##2##2##(2007-10#1)(2008-10#1)
residual functional deficit##2##3##(2007-3#1)(2012-12#1)
residual functional##4##2##(2007-10#1)(2007-3#1)(2012-1#1)(2012-12#1)
residual glass##2##2##(2009-7#2)
residual hearing##5##2##(2008-9#1)(2012-2#4)
residual hemodynamic abnormalities##2##3##(2010-12#2)
residual higher-order aberrations##2##3##(2008-2#1)(2008-3#1)
residual higher-order##3##2##(2008-2#2)(2008-3#1)
residual kriging##2##2##(2012-2#2)
residual leak##2##2##(1997-8#1)(2011-2#1)
residual limb##3##2##(2007-7#2)(2012-1#1)
residual liver##2##2##(1997-6#1)(2010-12#1)
residual masses##2##2##(1990-3#2)
residual microscopic##2##2##(2007-8#1)(2012-12#1)
residual neuromuscular##2##2##(1996-9#1)(2006-10#1)
residual noise##2##2##(2007-11#1)(2008-3#1)
residual nutrients##2##2##(2008-10#2)
residual or recurrent##2##3##(2006-6#1)(2011-2#1)
residual or##6##2##(1993-1#1)(2006-12#1)(2006-6#1)(2010-5#1)(2010-6#1)(2011-2#1)
residual organic##3##2##(2004-9#1)(2008-2#1)(2008-4#1)
residual pain##2##2##(1995-9#1)(2010-3#1)
residual phase noise##2##3##(2007-11#1)(2007-12#1)
residual phase##7##2##(2007-11#1)(2007-12#3)(2008-3#3)
residual plots##3##2##(1995-8#1)(1995-9#1)(2008-10#1)
residual potency##2##2##(1991-1#2)
residual primary##2##2##(2004-2#1)(2008-7#1)
residual protein##3##2##(2005-10#1)(2008-2#1)(2008-6#1)
residual rate##4##2##(2012-12#4)
residual renal function##7##3##(2007-11#1)(2007-12#3)(2011-2#3)
residual renal##8##2##(2007-11#1)(2007-12#3)(2008-4#1)(2011-2#3)
residual risk assessment##2##3##(2012-2#2)
residual risk of##5##3##(2012-2#5)
residual risk##11##2##(1990-6#1)(2008-7#1)(2009-11#1)(2012-2#8)
residual shunt##5##2##(1994-9#1)(2007-8#1)(2008-11#2)(2010-8#1)
residual signs##2##2##(1990-6#1)(2012-12#1)
residual solution##2##2##(2008-10#2)
residual soybean oil##2##3##(2008-5#2)
residual standard deviation##2##3##(1996-8#1)(2007-12#1)
residual stenosis at##2##3##(2008-8#1)(2011-2#1)
residual stenosis##6##2##(2006-11#2)(2008-11#1)(2008-6#1)(2008-8#1)(2011-2#1)
residual strains in the##3##4##(2008-9#3)
residual strains in##5##3##(2008-9#5)
residual strains##8##2##(2008-9#7)(2011-1#1)
residual stress can##2##3##(2008-2#1)(2009-7#1)
residual stress near##2##3##(2008-2#2)
residual stress relaxation##2##3##(2007-12#2)
residual stress##17##2##(2006-12#1)(2007-11#5)(2007-12#2)(2008-2#7)(2008-8#1)(2009-7#1)
residual stresses on##2##3##(2008-2#1)(2009-7#1)
residual stresses##8##2##(2005-11#1)(2006-12#2)(2008-2#2)(2008-7#1)(2009-7#2)
residual surface##2##2##(2007-12#1)(2008-3#1)
residual symptoms##2##2##(1991-7#1)(2012-12#1)
residual tilt##2##2##(2008-2#2)
residual triggering##2##2##(2008-9#2)
residual tumor in##2##3##(1994-3#1)(2008-6#1)
residual tumor tissue##2##3##(1994-3#1)(2010-12#1)
residual tumor##15##2##(1994-3#2)(2005-10#1)(2006-12#2)(2006-5#1)(2006-9#1)(2007-6#1)(2008-6#2)(2010-12#2)(2010-3#1)(2012-12#2)
residual tumour##4##2##(1993-3#1)(2007-2#1)(2009-4#2)
residual tumours##2##2##(1990-5#1)(1992-9#1)
residual urine volume##7##3##(1993-2#2)(2006-6#5)
residual urine volumes after##2##4##(1993-2#2)
residual urine##11##2##(1993-2#4)(2006-6#5)(2007-7#1)(2011-2#1)
residual variance##3##2##(1995-12#1)(2008-10#1)(2010-11#1)
residual variances##2##2##(2012-1#2)
residual variation##2##2##(1993-11#1)(2010-4#1)
residual vinyl groups in##2##4##(2008-10#2)
residual vinyl groups##3##3##(2008-10#3)
residual vision##2##2##(1995-8#2)
residual volatile organic solvents in honey##2##6##(2012-12#2)
residual volatile organic solvents##3##4##(2012-12#3)
residual volatile organic##4##3##(2011-1#1)(2012-12#3)
residual volume##5##2##(1993-2#1)(1996-2#1)(2005-10#1)(2007-8#1)(2010-12#1)
residual water##4##2##(2006-12#2)(2006-8#1)(2008-10#1)
residual wave-front##2##2##(2008-2#1)(2008-3#1)
residual white blood cells##2##4##(2008-9#2)
residual yolk sac on growth##2##5##(2008-12#2)
residual yolk sac##9##3##(2008-12#9)
residual##682##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#3)(1990-4#2)(1990-5#1)(1990-6#3)(1990-7#1)(1990-8#1)(1990-9#3)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#4)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#3)(1992-7#1)(1992-8#2)(1992-9#7)(1993-1#2)(1993-10#3)(1993-11#2)(1993-12#2)(1993-2#6)(1993-3#4)(1993-5#1)(1993-9#2)(1994-2#3)(1994-3#2)(1994-5#5)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#4)(1995-3#1)(1995-4#1)(1995-5#3)(1995-8#5)(1995-9#3)(1996-1#2)(1996-11#3)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#3)(1996-8#5)(1996-9#4)(1997-1#2)(1997-2#3)(1997-3#6)(1997-4#1)(1997-6#2)(1997-8#3)(2004-2#7)(2004-9#1)(2005-10#3)(2005-11#7)(2005-5#1)(2005-7#2)(2005-8#2)(2006-10#6)(2006-11#2)(2006-12#10)(2006-5#1)(2006-6#10)(2006-8#6)(2006-9#6)(2007-10#4)(2007-11#21)(2007-12#21)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#3)(2007-7#7)(2007-8#14)(2007-9#1)(2008-1#4)(2008-10#60)(2008-11#8)(2008-12#12)(2008-2#43)(2008-3#27)(2008-4#6)(2008-5#9)(2008-6#12)(2008-7#8)(2008-8#14)(2008-9#15)(2009-10#2)(2009-11#8)(2009-12#1)(2009-2#1)(2009-3#7)(2009-4#3)(2009-5#3)(2009-6#1)(2009-7#6)(2009-8#1)(2009-9#4)(2010-11#4)(2010-12#10)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#6)(2010-6#2)(2010-7#2)(2010-8#4)(2011-1#9)(2011-12#8)(2011-2#23)(2011-3#1)(2012-1#7)(2012-12#22)(2012-2#17)(2012-3#4)(2012-8#1)(2013-1#6)(2013-8#8)
residuals (those who were##2##4##(2007-4#2)
residuals after##2##2##(2009-4#1)(2012-3#1)
residuals against##2##2##(1995-8#1)(1995-9#1)
residuals##41##1##(1992-2#1)(1993-1#1)(1993-5#2)(1994-8#2)(1995-12#1)(1995-8#1)(1995-9#1)(1997-3#1)(2006-12#1)(2007-4#2)(2007-6#1)(2008-10#9)(2008-2#2)(2008-7#1)(2008-8#3)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-2#3)(2012-3#1)(2013-8#1)
residuals)##2##1##(2010-3#1)(2012-3#1)
residue (0##4##2##(1993-11#2)(2011-1#2)
residue (I184Y)##2##2##(1992-1#2)
residue (pKa = 7##2##4##(1994-11#2)
residue 161 is##3##3##(1995-5#3)
residue 161##6##2##(1995-5#6)
residue 22##2##2##(1991-9#1)(2009-2#1)
residue 3##4##2##(1994-12#1)(1995-3#1)(1997-4#1)(2006-12#1)
residue 478##3##2##(1992-9#3)
residue C##3##2##(1990-5#1)(2008-11#2)
residue after##4##2##(1993-11#1)(1994-3#1)(2005-11#1)(2008-10#1)
residue analysis##5##2##(2008-10#2)(2008-11#1)(2011-1#1)(2013-8#1)
residue and a##3##3##(1992-9#1)(1994-12#1)(2008-5#1)
residue and the##5##3##(1995-3#1)(2006-10#1)(2008-10#1)(2008-8#1)(2011-2#1)
residue and##20##2##(1990-12#1)(1992-3#1)(1992-9#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-3#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-8#2)(2009-3#1)(2011-2#1)(2012-2#1)
residue are##5##2##(1991-3#1)(1991-5#1)(1992-12#1)(1994-2#1)(1995-10#1)
residue as the##3##3##(1991-7#1)(1991-9#1)(1995-2#1)
residue as##6##2##(1991-7#1)(1991-9#2)(1992-3#1)(1995-2#1)(2008-12#1)
residue at position##25##3##(1990-4#1)(1991-10#1)(1991-2#3)(1991-7#1)(1991-8#1)(1992-3#1)(1992-6#2)(1992-7#1)(1992-8#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-12#1)(2008-2#1)
residue at the C-terminus of the##2##6##(1994-12#1)(1995-8#1)
residue at the reducing##2##4##(1990-5#1)(1995-11#1)
residue at the##17##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#1)(1992-11#2)(1992-3#2)(1994-12#1)(1995-11#2)(1995-8#2)(2008-10#1)(2008-8#1)(2009-8#1)(2012-2#1)
residue at##51##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#2)(1991-10#1)(1991-2#3)(1991-3#1)(1991-7#1)(1991-8#1)(1992-11#2)(1992-3#3)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1994-11#2)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#2)(1995-8#3)(1996-5#1)(1996-6#2)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-8#1)(2012-2#1)
residue beta##2##2##(1992-11#1)(1992-9#1)
residue but##2##2##(1992-12#1)(1997-3#1)
residue by##10##2##(1990-12#1)(1990-5#1)(1991-3#1)(1991-9#1)(1992-7#1)(1994-12#1)(1995-5#1)(2007-10#1)(2008-10#2)
residue can##4##2##(1990-8#1)(1992-12#1)(1995-6#1)(2008-10#1)
residue corresponding to##3##3##(1991-7#1)(2006-5#1)(2008-4#1)
residue could be##2##3##(1990-6#1)(1994-9#1)
residue could##3##2##(1990-6#1)(1991-6#1)(1994-9#1)
residue decomposition##3##2##(2004-2#1)(2008-11#2)
residue for the##2##3##(1996-7#1)(1996-8#1)
residue for##6##2##(1993-11#1)(1993-4#1)(1995-11#1)(1996-7#1)(1996-8#1)(2005-11#1)
residue from the##6##3##(1991-12#1)(1992-8#1)(1995-4#1)(1995-8#1)(2008-10#2)
residue from##12##2##(1990-4#1)(1991-12#1)(1992-8#1)(1994-11#1)(1995-4#1)(1995-8#1)(2008-10#4)(2008-3#1)(2008-7#1)
residue had##2##2##(1990-2#1)(1991-2#1)
residue has been replaced by##2##5##(1994-11#2)
residue has been##3##3##(1994-11#2)(1997-2#1)
residue has##4##2##(1994-11#2)(1995-5#1)(1997-2#1)
residue in Ras structure and##2##5##(1995-2#2)
residue in each subunit##2##4##(1994-11#1)(1994-5#1)
residue in each##3##3##(1994-11#1)(1994-5#1)(1995-5#1)
residue in human##3##3##(1991-6#1)(1992-2#1)(1997-1#1)
residue in position##4##3##(1990-12#1)(1990-2#1)(1991-9#1)(1996-9#1)
residue in the N-terminal##2##4##(1990-10#1)(1995-2#1)
residue in the amino##2##4##(1992-7#1)(1996-7#1)
residue in the catalytic##2##4##(1990-3#1)(1997-7#1)
residue in the pore##2##4##(1991-9#1)(2005-11#1)
residue in the short##2##4##(1990-11#1)(1993-11#1)
residue in the##47##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#2)(1990-4#2)(1990-6#1)(1990-7#1)(1991-2#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-9#1)(1995-1#1)(1995-2#3)(1995-6#1)(1996-5#1)(1996-7#2)(1997-4#1)(1997-7#2)(2005-11#1)(2006-12#1)(2006-5#1)(2008-10#1)(2008-4#1)(2009-3#1)(2009-9#1)(2011-2#1)
residue in##105##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#2)(1990-6#1)(1990-7#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#4)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-6#2)(1992-7#2)(1992-9#6)(1993-11#2)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#4)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#7)(1995-3#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-2#2)(1996-5#1)(1996-7#4)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#2)(2005-11#2)(2006-12#1)(2006-5#1)(2007-6#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-3#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-12#3)(2013-1#2)
residue involved in##4##3##(1991-5#1)(1992-8#1)(1993-3#1)(1995-6#1)
residue is located##2##3##(1995-8#1)(1996-7#1)
residue is replaced by##2##4##(1994-9#1)(1997-7#1)
residue is the##2##3##(1992-8#2)
residue is##36##2##(1990-3#1)(1990-8#1)(1992-3#1)(1992-6#3)(1992-8#2)(1993-11#1)(1993-6#1)(1993-8#1)(1994-5#2)(1994-9#3)(1995-2#2)(1995-6#1)(1995-8#3)(1996-11#1)(1996-5#1)(1996-7#2)(1996-8#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-1#1)(2008-5#1)(2009-2#1)(2009-3#1)(2012-11#1)
residue levels##3##2##(2007-7#3)
residue linked##2##2##(1992-12#1)(1994-5#1)
residue located in the##2##4##(1991-4#1)(1991-6#1)
residue located##5##2##(1991-4#1)(1991-6#1)(1991-7#1)(1996-5#1)(2008-8#1)
residue may be##3##3##(1990-2#1)(1994-12#1)(1994-8#1)
residue may##8##2##(1990-2#1)(1990-4#1)(1991-11#1)(1991-7#1)(1994-12#1)(1994-8#1)(2005-11#1)(2008-10#1)
residue near the##4##3##(1991-9#1)(1994-9#1)(1995-1#1)(2008-8#1)
residue of a##2##3##(1994-8#1)(2008-5#1)
residue of one##2##3##(1994-12#1)(2012-3#1)
residue of the active##2##4##(1990-8#1)(1994-11#1)
residue of the pentasaccharide##2##4##(1992-1#1)(1992-12#1)
residue of the polypeptide chain##2##5##(1997-6#1)(2008-8#1)
residue of the##21##3##(1990-7#1)(1990-8#1)(1992-1#1)(1992-12#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-9#2)(1995-2#1)(1995-5#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-8#2)(2005-11#1)(2008-5#1)(2008-8#1)(2013-8#1)
residue of##52##2##(1990-7#2)(1990-8#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-2#3)(1995-5#1)(1995-8#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2005-11#1)(2006-10#2)(2007-10#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
residue on the complementary strand##2##5##(1992-9#1)(1994-8#1)
residue on the##8##3##(1992-9#1)(1993-11#1)(1994-8#2)(2008-10#2)(2008-5#1)(2009-5#1)
residue on##12##2##(1990-8#1)(1992-9#1)(1993-11#1)(1994-8#2)(2008-10#4)(2008-5#1)(2008-6#1)(2009-5#1)
residue or the##2##3##(1992-4#1)(1994-11#1)
residue or##5##2##(1992-3#1)(1992-4#1)(1994-11#1)(1994-6#1)(2012-12#1)
residue pairs##2##2##(1992-8#1)(2008-8#1)
residue peptide##5##2##(1990-12#1)(1992-12#1)(1992-6#1)(1994-12#1)(2008-8#1)
residue per##3##2##(1993-11#1)(1994-11#1)(1995-3#1)
residue precursors##2##2##(1992-9#2)
residue present on the##2##4##(2012-11#2)
residue present##4##2##(1995-5#1)(2005-11#1)(2012-11#2)
residue responsible for##3##3##(1997-5#1)(2008-4#2)
residue resulted in##2##3##(1991-2#1)(1995-11#1)
residue situated##2##2##(1996-5#2)
residue size##2##2##(2008-10#2)
residue substitutions in##2##3##(1996-11#1)(1997-5#1)
residue synthetic peptide##2##3##(1991-9#1)(1992-7#1)
residue that is conserved in all##2##6##(1993-11#1)(1993-9#1)
residue that is conserved in##3##5##(1993-11#1)(1993-9#1)(1995-6#1)
residue that is##8##3##(1993-11#1)(1993-9#1)(1994-12#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-7#1)(2009-5#1)
residue that##16##2##(1991-12#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-11#2)(1995-6#1)(1995-8#1)(1996-7#1)(1996-8#1)(1997-5#1)(2008-3#1)(2009-5#1)
residue to the##2##3##(1997-4#1)(2008-10#1)
residue to##15##2##(1992-7#2)(1993-8#1)(1994-12#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-4#1)(1997-4#1)(2008-10#1)(2009-10#1)(2010-4#1)(2012-3#1)
residue type##2##2##(1991-4#1)(2011-2#1)
residue using##3##2##(1992-3#1)(1993-11#1)(2008-10#1)
residue was dissolved in##3##4##(2008-10#2)(2008-11#1)
residue was highly##2##3##(1994-9#1)(1997-7#1)
residue was mutated to##2##4##(1995-2#1)(2008-4#1)
residue was reconstituted in##2##4##(1997-3#1)(2008-10#1)
residue was reconstituted##3##3##(1997-3#1)(1997-8#1)(2008-10#1)
residue was replaced with##2##4##(1994-9#1)(1995-6#1)
residue was replaced##3##3##(1994-9#1)(1995-6#1)(1996-5#1)
residue was##33##2##(1990-5#1)(1991-5#1)(1991-7#1)(1991-8#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-5#2)(1994-9#4)(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-4#1)(2012-2#1)
residue were##6##2##(1991-5#1)(1997-6#1)(2007-10#1)(2008-10#3)
residue which is##2##3##(1992-3#1)(2008-5#1)
residue which##8##2##(1992-12#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-2#1)(1995-3#1)(2008-5#1)(2010-3#1)
residue with a##5##3##(1991-12#1)(1991-4#1)(2006-10#1)(2008-10#1)(2010-6#1)
residue with##13##2##(1990-10#1)(1991-12#1)(1991-4#1)(1992-9#1)(1994-9#1)(1997-7#1)(2006-10#1)(2007-8#1)(2008-10#4)(2010-6#1)
residue within a##2##3##(1992-11#1)(1996-5#1)
residue within##6##2##(1992-11#1)(1994-12#1)(1994-9#1)(1996-5#1)(1996-7#1)(2012-3#1)
residue##954##1##(1990-10#3)(1990-11#2)(1990-12#11)(1990-2#9)(1990-3#4)(1990-4#8)(1990-5#8)(1990-6#3)(1990-7#13)(1990-8#7)(1991-10#5)(1991-11#2)(1991-12#4)(1991-2#17)(1991-3#8)(1991-4#10)(1991-5#8)(1991-6#5)(1991-7#14)(1991-8#7)(1991-9#18)(1992-1#5)(1992-11#9)(1992-12#17)(1992-2#7)(1992-3#15)(1992-4#2)(1992-5#1)(1992-6#19)(1992-7#11)(1992-8#10)(1992-9#23)(1993-11#20)(1993-12#3)(1993-2#3)(1993-3#7)(1993-4#2)(1993-6#13)(1993-8#8)(1993-9#4)(1994-10#1)(1994-11#17)(1994-12#16)(1994-2#4)(1994-3#7)(1994-5#18)(1994-6#5)(1994-8#13)(1994-9#35)(1995-1#4)(1995-10#6)(1995-11#14)(1995-2#30)(1995-3#12)(1995-4#1)(1995-5#17)(1995-6#15)(1995-8#20)(1996-10#4)(1996-11#4)(1996-12#1)(1996-2#6)(1996-4#1)(1996-5#13)(1996-6#3)(1996-7#18)(1996-8#9)(1996-9#2)(1997-1#3)(1997-2#4)(1997-3#8)(1997-4#10)(1997-5#5)(1997-6#9)(1997-7#7)(1997-8#6)(1997-9#1)(2004-2#6)(2005-11#10)(2005-12#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#5)(2006-12#5)(2006-5#2)(2007-10#6)(2007-11#2)(2007-12#1)(2007-6#2)(2007-7#3)(2007-8#3)(2008-10#63)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#6)(2008-4#10)(2008-5#16)(2008-6#1)(2008-7#11)(2008-8#16)(2008-9#4)(2009-10#1)(2009-2#2)(2009-3#8)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-3#1)(2010-4#3)(2010-6#1)(2011-1#7)(2011-2#6)(2012-1#1)(2012-11#4)(2012-12#6)(2012-2#11)(2012-3#4)(2013-1#2)(2013-8#8)
residue(s)##15##1##(1990-10#1)(1990-12#1)(1990-2#1)(1991-12#1)(1991-9#2)(1992-3#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-11#1)(1997-6#1)(2008-4#1)(2008-8#1)
residue) and##2##2##(1990-7#1)(1991-8#1)
residue)##13##1##(1990-7#2)(1991-4#1)(1991-8#2)(1991-9#1)(1993-11#1)(1994-3#1)(1995-1#1)(1997-3#1)(2008-10#1)(2008-4#1)(2011-2#1)
residue-containing##3##1##(1993-12#1)(1994-12#1)(2008-6#1)
residue-specific##4##1##(1993-6#1)(1995-1#1)(2009-12#2)
residues (Del##2##2##(1995-2#2)
residues (M(r)##2##2##(1992-8#1)(1994-12#1)
residues (Mr##4##2##(1991-7#1)(1991-8#1)(1992-2#1)(1996-5#1)
residues (the##2##2##(2008-9#2)
residues 1 to##2##3##(1992-8#1)(2005-12#1)
residues 1##3##2##(1992-8#1)(2005-12#2)
residues 10##2##2##(1990-4#1)(1992-9#1)
residues 117 and 309##2##4##(1995-3#2)
residues 173-204##3##2##(1991-7#1)(1995-1#2)
residues 188 and##2##3##(1995-2#1)(1996-7#1)
residues 20##2##2##(1993-8#2)
residues 25##2##2##(1992-7#1)(1996-7#1)
residues 30-43 of PLC-delta 1##2##5##(1994-12#2)
residues 31 and##2##3##(1994-12#1)(1997-4#1)
residues 37-50##4##2##(2013-7#4)
residues 39##2##2##(1992-4#1)(1993-3#1)
residues 4-14 of myelin basic protein##2##6##(1991-10#1)(1994-8#1)
residues 42 to##2##3##(1991-4#1)(2008-10#1)
residues 42##3##2##(1991-4#1)(1994-9#1)(2008-10#1)
residues 49##2##2##(1995-11#1)(1995-2#1)
residues 6##3##2##(1995-2#3)
residues 79##3##2##(1991-5#1)(1994-9#1)(1995-2#1)
residues 8-165##2##2##(1991-8#2)
residues 94-117##2##2##(1996-11#2)
residues 94-96##5##2##(1996-11#5)
residues A##2##2##(2008-11#2)
residues Gln114##2##2##(1990-12#2)
residues Lys165 and Lys166##2##4##(1995-8#2)
residues N-terminal to##2##3##(1992-10#2)
residues affected##2##2##(1990-3#1)(2008-4#1)
residues along the##3##3##(1992-12#1)(1993-9#1)(1995-10#1)
residues along##4##2##(1992-12#1)(1993-9#1)(1995-10#1)(2008-8#1)
residues also##2##2##(1992-7#1)(2011-2#1)
residues among##2##2##(1995-11#1)(2008-5#1)
residues and a##4##3##(1996-10#1)(1996-7#1)(1996-9#1)(2008-4#1)
residues and contains##3##3##(1991-5#1)(1995-5#1)(1997-4#1)
residues and has a##6##4##(1991-5#2)(1993-2#1)(1996-4#1)(1996-7#1)(2008-10#1)
residues and has##7##3##(1990-10#1)(1991-5#2)(1993-2#1)(1996-4#1)(1996-7#1)(2008-10#1)
residues and in##2##3##(1994-8#1)(2011-2#1)
residues and is##4##3##(1991-9#1)(1992-9#1)(1994-5#1)(1994-9#1)
residues and of##2##3##(1990-12#1)(1993-8#1)
residues and that##2##3##(1991-10#1)(2012-12#1)
residues and the##12##3##(1990-12#1)(1990-4#1)(1990-7#2)(1991-6#1)(1992-6#1)(1992-9#1)(1993-6#1)(1996-7#1)(1997-8#1)(1997-9#1)(2008-5#1)
residues and their##4##3##(1997-1#1)(2004-2#1)(2008-11#1)(2011-2#1)
residues and to##3##3##(1990-9#1)(1992-8#1)(1996-10#1)
residues and with##2##3##(1992-1#1)(1995-2#1)
residues and##91##2##(1990-10#1)(1990-12#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#4)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#4)(1991-6#1)(1991-7#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-6#6)(1992-8#1)(1992-9#2)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#4)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-10#3)(1996-4#1)(1996-7#3)(1996-9#1)(1997-1#1)(1997-4#3)(1997-5#1)(1997-8#2)(1997-9#1)(2004-2#1)(2005-11#1)(2007-6#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-8#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
residues and/or##2##2##(1990-2#1)(2008-10#1)
residues appears to play a role in##2##7##(1990-12#1)(1994-12#1)
residues appears to##3##3##(1990-12#1)(1994-12#1)(1994-8#1)
residues are conserved in##3##4##(1995-2#1)(1995-6#1)(2008-7#1)
residues are critical##2##3##(1995-5#1)(2006-12#1)
residues are encoded by##2##4##(1994-12#1)(1994-3#1)
residues are essential for##2##4##(1993-12#1)(1996-9#1)
residues are important for##2##4##(1990-10#1)(1997-7#1)
residues are in the##2##4##(1990-10#1)(1996-9#1)
residues are in##3##3##(1990-10#1)(1996-10#1)(1996-9#1)
residues are involved in##2##4##(1993-9#1)(1996-9#1)
residues are less##2##3##(1990-8#1)(1994-9#1)
residues are located##2##3##(1994-3#1)(1994-5#1)
residues are present in##2##4##(1997-2#1)(2008-8#1)
residues are present##3##3##(1990-7#1)(1997-2#1)(2008-8#1)
residues are replaced##2##3##(1996-11#1)(2008-4#1)
residues are##73##2##(1990-10#4)(1990-2#2)(1990-7#3)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#3)(1995-2#1)(1995-5#3)(1995-6#3)(1996-10#1)(1996-11#2)(1996-5#2)(1996-8#1)(1996-9#3)(1997-2#1)(1997-3#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2008-10#1)(2008-4#4)(2008-7#2)(2008-8#1)(2010-7#2)(2012-2#1)(2013-1#1)
residues as##11##2##(1990-9#1)(1991-2#1)(1992-12#2)(1994-12#1)(1994-9#1)(1996-4#1)(1996-5#1)(2004-2#1)(2006-12#1)(2008-10#1)
residues associated with##2##3##(1991-2#1)(2008-10#1)
residues at its amino terminus that##2##6##(1992-7#1)(1994-9#1)
residues at position##3##3##(1991-2#1)(1993-11#1)(1997-6#1)
residues at positions##12##3##(1990-3#1)(1991-10#1)(1991-12#1)(1991-2#1)(1994-3#1)(1994-5#4)(1995-3#1)(2008-5#2)
residues at the NS2(Pro) dimer interface that##3##7##(2012-2#3)
residues at the active site##3##5##(1992-2#1)(1994-11#1)(1995-2#1)
residues at the##19##3##(1990-2#1)(1992-2#1)(1992-6#2)(1993-11#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-7#2)(1997-3#1)(1997-5#1)(2008-10#2)(2008-8#1)(2012-2#3)
residues at##43##2##(1990-2#1)(1990-3#2)(1991-10#1)(1991-12#1)(1991-2#3)(1992-2#2)(1992-6#2)(1992-7#1)(1993-11#2)(1993-3#1)(1994-11#1)(1994-3#1)(1994-5#4)(1994-8#1)(1994-9#3)(1995-11#1)(1995-2#1)(1995-3#1)(1996-7#2)(1997-3#1)(1997-5#1)(1997-6#1)(2008-10#3)(2008-5#2)(2008-8#1)(2012-2#3)
residues attached to##3##3##(1995-12#1)(1995-3#1)(1996-10#1)
residues attached##5##2##(1995-12#1)(1995-3#1)(1996-10#1)(2007-1#1)(2008-11#1)
residues being##4##2##(1994-9#3)(1995-12#1)
residues between##5##2##(1990-7#1)(1994-8#1)(1996-7#1)(1997-9#1)(2013-8#1)
residues both##2##2##(1991-7#1)(1996-8#1)
residues by site-directed mutagenesis##4##4##(1990-7#1)(1992-3#1)(1992-6#1)(1995-2#1)
residues by the##2##3##(1993-8#1)(1996-2#1)
residues by##18##2##(1990-5#3)(1990-7#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-8#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-9#1)(2005-4#1)(2006-10#1)(2008-5#1)(2013-7#1)
residues can be identified##2##4##(1997-4#1)(2008-10#1)
residues can be##6##3##(1990-12#1)(1992-2#1)(1992-9#1)(1994-6#1)(1997-4#1)(2008-10#1)
residues can##9##2##(1990-12#1)(1992-2#1)(1992-9#1)(1994-6#1)(1997-4#1)(2006-12#1)(2008-10#1)(2012-2#2)
residues caused##2##2##(1992-6#1)(2008-8#1)
residues causes##2##2##(1991-2#1)(1997-8#1)
residues close in##2##3##(1996-6#1)(1997-2#1)
residues close to the##2##4##(1993-8#1)(2009-7#1)
residues close to##3##3##(1993-8#1)(1993-9#1)(2009-7#1)
residues close##5##2##(1993-8#1)(1993-9#1)(1996-6#1)(1997-2#1)(2009-7#1)
residues common##2##2##(1992-5#1)(2006-5#1)
residues conserved in##2##3##(1994-5#1)(2008-5#1)
residues conserved##5##2##(1991-5#1)(1994-12#1)(1994-5#1)(1995-12#1)(2008-5#1)
residues corresponding to##4##3##(1990-3#1)(1990-7#1)(1995-3#1)(1996-9#1)
residues could##2##2##(1994-9#1)(2008-10#1)
residues critical for##4##3##(1995-11#1)(1996-10#1)(1996-11#1)(2010-11#1)
residues did not##2##3##(1991-8#1)(2008-4#1)
residues do not##2##3##(2008-10#1)(2012-2#1)
residues essential##2##2##(1990-12#1)(1990-2#1)
residues exhibiting##2##2##(1990-3#1)(1997-7#1)
residues exposed on the##2##4##(1995-6#1)(2008-10#1)
residues exposed##3##2##(1990-5#1)(1995-6#1)(2008-10#1)
residues flanking the##2##3##(1994-12#1)(1996-11#1)
residues flanking##3##2##(1991-11#1)(1994-12#1)(1996-11#1)
residues for the##3##3##(1990-12#1)(2007-6#1)(2008-4#1)
residues for##10##2##(1990-12#1)(1991-7#1)(1993-6#1)(1993-8#1)(1994-9#1)(2007-6#1)(2008-4#1)(2008-5#1)(2008-8#2)
residues form a##2##3##(1993-3#1)(1995-5#1)
residues form##3##2##(1993-3#1)(1995-5#2)
residues forming the##2##3##(1990-4#1)(1991-4#1)
residues found in##6##3##(1991-6#1)(1991-8#1)(1993-11#1)(1994-8#1)(2008-3#1)(2011-2#1)
residues found##7##2##(1991-6#1)(1991-8#1)(1993-11#1)(1993-3#1)(1994-8#1)(2008-3#1)(2011-2#1)
residues from the amino terminus##2##5##(1992-5#1)(1995-4#1)
residues from the amino##3##4##(1992-5#1)(1995-4#1)(2005-11#1)
residues from the##16##3##(1990-10#1)(1991-1#1)(1991-12#1)(1991-9#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-9#1)(1995-4#1)(1995-6#1)(1997-6#1)(2005-11#1)(2008-10#2)
residues from##35##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#2)(1997-6#2)(2005-11#1)(2007-5#1)(2008-10#6)(2008-4#1)(2008-5#2)(2008-8#1)
residues had##5##2##(1990-7#1)(1991-1#1)(1991-4#1)(2010-4#1)(2013-1#1)
residues has been##4##3##(1991-9#1)(1992-11#1)(1992-7#1)(1997-7#1)
residues has##5##2##(1991-9#1)(1992-11#1)(1992-7#1)(1997-7#1)(2008-10#1)
residues have been replaced##2##4##(1994-8#1)(1997-4#1)
residues have been##11##3##(1992-2#1)(1992-3#1)(1994-8#1)(1995-8#1)(1996-9#2)(1997-4#1)(1997-7#2)(2008-3#1)(2012-2#1)
residues have##13##2##(1992-2#1)(1992-3#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-8#1)(1996-9#2)(1997-4#1)(1997-7#2)(2008-3#1)(2012-2#1)
residues implicated in the##2##4##(1990-12#1)(1997-2#1)
residues implicated in##5##3##(1990-12#1)(1992-3#1)(1996-6#1)(1997-2#1)(2008-5#1)
residues important for##4##3##(1994-3#1)(1994-9#1)(1995-8#1)(2008-10#1)
residues in E##2##3##(1991-11#1)(1993-6#1)
residues in a protein##2##4##(2008-4#1)(2008-7#1)
residues in a##7##3##(1990-2#1)(1991-9#1)(1995-5#1)(1997-4#1)(2008-4#1)(2008-5#1)(2008-7#1)
residues in all##2##3##(1995-5#1)(2012-3#1)
residues in an##2##3##(1993-6#1)(2008-2#1)
residues in both##4##3##(1993-3#1)(1995-10#1)(1995-5#1)(1997-5#1)
residues in each##4##3##(1990-5#1)(1995-5#1)(1996-5#1)(1997-5#1)
residues in fish##2##3##(1992-6#1)(2008-10#1)
residues in fog-water##2##3##(2008-10#2)
residues in food##4##3##(2007-8#1)(2009-8#1)(2013-8#2)
residues in human##6##3##(1993-8#1)(1996-7#1)(1997-4#1)(1997-8#2)(2009-3#1)
residues in its##2##3##(1990-3#1)(1995-8#1)
residues in length##2##3##(1991-8#1)(1995-3#1)
residues in membrane-spanning##2##3##(1991-3#1)(1995-6#1)
residues in most##3##3##(1992-6#1)(1993-6#1)(1997-4#1)
residues in olive oil##2##4##(2007-8#2)
residues in other##2##3##(1996-2#1)(1997-2#1)
residues in pigs##2##3##(1997-3#2)
residues in proteins##6##3##(1992-6#1)(1995-3#1)(1996-2#1)(2008-10#1)(2010-7#1)(2013-1#1)
residues in the N-terminal arm##2##5##(1994-8#1)(2008-9#1)
residues in the N-terminal##6##4##(1994-12#1)(1994-5#1)(1994-8#1)(1997-4#1)(2008-9#1)(2009-12#1)
residues in the active site##3##5##(1992-9#1)(1994-9#1)(2008-4#1)
residues in the alpha-chain##2##4##(1995-6#2)
residues in the beta##2##4##(1990-7#1)(2008-11#1)
residues in the catalytic mechanism of##2##6##(1994-5#1)(2013-8#1)
residues in the catalytic##6##4##(1992-2#1)(1992-4#1)(1992-9#1)(1994-5#1)(1996-11#1)(2013-8#1)
residues in the folding##2##4##(1994-9#1)(1995-4#1)
residues in the native##3##4##(1994-8#1)(1995-10#1)(2010-7#1)
residues in the protein##6##4##(1990-2#1)(1992-8#1)(1994-9#1)(1997-4#1)(2008-1#1)(2008-10#1)
residues in the putative##2##4##(1995-6#1)(1996-10#1)
residues in the same##2##4##(1992-4#1)(2008-11#1)
residues in the third##2##4##(1993-5#1)(1993-8#1)
residues in the variable##2##4##(1994-9#1)(1996-5#1)
residues in the##131##3##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#3)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-4#4)(1992-7#2)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#3)(1994-12#3)(1994-5#6)(1994-8#2)(1994-9#7)(1995-10#2)(1995-11#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#4)(1995-6#9)(1995-8#1)(1996-10#2)(1996-11#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#3)(1996-9#1)(1997-4#4)(1997-7#3)(1997-8#1)(1997-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-8#4)(2008-9#3)(2009-12#1)(2010-7#2)(2012-11#1)(2013-1#2)(2013-8#1)
residues in this region##6##4##(1992-6#1)(1994-5#1)(1996-5#1)(1996-7#1)(1997-4#1)(2008-10#1)
residues in this##7##3##(1992-12#1)(1992-6#1)(1994-5#1)(1996-5#1)(1996-7#1)(1997-4#1)(2008-10#1)
residues in three##2##3##(2008-10#1)(2008-8#1)
residues in vivo##3##3##(1991-12#1)(1993-8#1)(1995-12#1)
residues in##332##2##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#4)(1990-3#3)(1990-5#3)(1990-6#1)(1990-7#4)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#5)(1991-9#2)(1992-11#1)(1992-12#5)(1992-2#2)(1992-3#1)(1992-4#7)(1992-6#9)(1992-7#4)(1992-8#4)(1992-9#3)(1993-11#2)(1993-12#1)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#5)(1993-8#5)(1993-9#3)(1994-11#6)(1994-12#4)(1994-3#1)(1994-5#7)(1994-8#5)(1994-9#10)(1995-1#1)(1995-10#3)(1995-11#3)(1995-12#1)(1995-2#4)(1995-3#6)(1995-4#1)(1995-5#11)(1995-6#12)(1995-8#6)(1996-10#2)(1996-11#1)(1996-2#2)(1996-4#2)(1996-5#7)(1996-6#2)(1996-7#5)(1996-8#1)(1996-9#2)(1997-2#2)(1997-3#3)(1997-4#9)(1997-5#5)(1997-6#1)(1997-7#5)(1997-8#4)(1997-9#1)(2004-11#5)(2004-4#2)(2005-12#2)(2006-7#1)(2006-9#1)(2007-8#6)(2008-1#1)(2008-10#21)(2008-11#4)(2008-2#1)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#8)(2008-9#4)(2009-12#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-6#1)(2010-7#6)(2011-1#3)(2011-2#2)(2012-11#1)(2012-12#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#6)
residues including a##4##3##(1990-11#1)(1990-4#1)(1994-9#1)(1996-6#1)
residues including##6##2##(1990-11#1)(1990-4#1)(1991-10#1)(1994-2#1)(1994-9#1)(1996-6#1)
residues increased##2##2##(1994-11#1)(2004-2#1)
residues indicated##2##2##(1991-7#1)(1996-5#1)
residues inside##3##2##(2008-10#2)(2008-3#1)
residues into the##4##3##(1992-7#1)(1995-5#1)(2008-10#1)(2008-4#1)
residues into##6##2##(1992-7#1)(1995-4#1)(1995-5#1)(1996-8#1)(2008-10#1)(2008-4#1)
residues introduced##2##2##(1992-8#1)(1994-11#1)
residues involved in binding##3##4##(1991-8#1)(1994-9#1)(2011-1#1)
residues involved in##16##3##(1990-8#1)(1991-4#1)(1991-8#1)(1992-12#2)(1992-4#1)(1994-9#1)(1996-9#1)(1997-8#1)(2006-10#1)(2006-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-1#1)(2012-2#1)
residues involved##17##2##(1990-8#1)(1991-4#1)(1991-8#1)(1992-12#2)(1992-4#1)(1994-9#1)(1995-6#1)(1996-9#1)(1997-8#1)(2006-10#1)(2006-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-1#1)(2012-2#1)
residues is##21##2##(1990-12#1)(1990-5#2)(1990-8#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-4#2)(1993-2#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-5#1)(1996-8#1)(2005-3#1)(2008-1#1)(2008-10#1)
residues known to be##2##4##(1992-5#1)(1993-2#1)
residues known to##4##3##(1992-5#1)(1992-9#1)(1993-2#1)(1995-2#1)
residues located at the##5##4##(1990-8#1)(1995-10#1)(1996-5#1)(2008-8#1)(2011-2#1)
residues located at##8##3##(1990-8#1)(1995-10#1)(1995-5#1)(1996-2#1)(1996-5#2)(2008-8#1)(2011-2#1)
residues located in##4##3##(1991-7#1)(1995-6#1)(1996-5#1)(2008-4#1)
residues located on the##2##4##(1990-7#1)(2009-10#1)
residues located within##2##3##(1991-4#1)(1997-4#1)
residues located##18##2##(1990-6#1)(1990-7#1)(1990-8#1)(1991-4#1)(1991-7#1)(1992-6#1)(1995-10#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-5#3)(1997-4#1)(2008-4#1)(2008-8#1)(2009-10#1)(2011-2#1)
residues long##2##2##(1993-3#1)(1994-12#1)
residues may also##2##3##(1994-11#1)(1996-7#1)
residues may be involved in##3##5##(1992-9#1)(1996-10#2)
residues may be##7##3##(1992-7#1)(1992-9#2)(1994-5#1)(1996-10#2)(2008-11#1)
residues may##11##2##(1991-8#1)(1992-7#1)(1992-9#2)(1994-11#1)(1994-5#1)(1996-10#2)(1996-7#1)(2008-11#1)(2009-3#1)
residues near the##4##3##(1991-4#1)(1995-5#1)(1995-6#1)(1996-9#1)
residues of HPRG##3##3##(1995-2#3)
residues of each##3##3##(1991-9#1)(1994-9#1)(1995-10#1)
residues of human##5##3##(1990-9#1)(1994-8#1)(1995-2#1)(1995-6#2)
residues of organochlorine pesticides##2##4##(2007-7#2)
residues of proteins##2##3##(1990-10#1)(2009-8#1)
residues of the enzyme##2##4##(1993-3#1)(1996-7#1)
residues of the human##3##4##(1994-2#1)(1995-3#1)(1996-11#1)
residues of the native##2##4##(1990-7#1)(1991-9#1)
residues of the protein##3##4##(1992-9#1)(1994-2#1)(2008-9#1)
residues of the##60##3##(1990-11#1)(1990-12#2)(1990-3#3)(1990-5#2)(1990-7#4)(1991-10#2)(1991-12#1)(1991-4#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-6#1)(1992-7#2)(1992-9#1)(1993-11#2)(1993-3#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-11#1)(1996-4#2)(1996-5#3)(1996-7#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)
residues of this##2##3##(1992-11#1)(1995-5#1)
residues of##175##2##(1990-10#4)(1990-11#1)(1990-12#4)(1990-3#4)(1990-5#3)(1990-7#5)(1990-8#2)(1990-9#2)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-6#2)(1991-7#6)(1991-9#4)(1992-11#6)(1992-12#3)(1992-6#1)(1992-7#4)(1992-8#1)(1992-9#3)(1993-11#2)(1993-3#3)(1993-4#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#3)(1994-8#3)(1994-9#6)(1995-1#1)(1995-10#1)(1995-11#2)(1995-2#6)(1995-3#4)(1995-5#2)(1995-6#7)(1995-8#1)(1996-11#1)(1996-4#2)(1996-5#5)(1996-7#3)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#3)(2006-6#1)(2006-8#2)(2007-11#1)(2007-7#3)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-8#1)(2010-12#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
residues on a##3##3##(1995-2#1)(2008-4#1)(2012-2#1)
residues on the##9##3##(1990-2#1)(1990-5#1)(1991-2#1)(1992-12#1)(1993-11#1)(1994-5#1)(1996-4#1)(1996-9#1)(1997-6#1)
residues on##24##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-7#1)(1992-12#1)(1993-11#1)(1994-5#2)(1994-9#1)(1995-2#1)(1996-4#1)(1996-9#1)(1997-6#1)(1997-8#1)(1997-9#1)(2007-6#1)(2008-4#2)(2008-5#1)(2008-8#1)(2012-2#1)(2012-3#2)
residues or##6##2##(1992-12#1)(1993-3#1)(1994-3#1)(1997-7#1)(2008-4#1)(2010-10#1)
residues other than those##2##4##(1994-3#1)(2008-5#1)
residues per enzyme molecule##2##4##(1996-7#2)
residues per subunit##2##3##(1990-5#2)
residues per##8##2##(1990-5#2)(1994-6#1)(1995-8#1)(1996-7#2)(1997-6#1)(2011-1#1)
residues play##2##2##(1997-6#1)(1997-8#1)
residues present in the##4##4##(1993-6#1)(1994-11#1)(1994-12#1)(1994-8#1)
residues present in##9##3##(1991-2#1)(1991-4#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#1)(1997-5#1)(2008-7#1)
residues present##10##2##(1991-10#1)(1991-2#1)(1991-4#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#1)(1997-5#1)(2008-7#1)
residues previously##2##2##(1992-8#1)(1993-3#1)
residues responsible for##3##3##(1990-8#1)(1992-8#1)(2012-2#1)
residues resulted in##4##3##(1990-3#1)(1992-3#1)(1994-6#1)(2008-4#1)
residues results in##2##3##(1995-2#1)(2012-12#1)
residues significantly##2##2##(1994-2#1)(2007-10#1)
residues substituted##2##2##(1995-6#1)(2008-8#1)
residues such as##4##3##(1993-6#1)(1997-8#1)(2008-1#1)(2011-2#1)
residues than in##2##3##(2008-10#2)
residues that are##19##3##(1990-8#1)(1991-2#1)(1992-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-8#1)(1996-7#1)(1997-7#2)(2008-10#2)(2008-4#1)(2008-7#1)(2011-2#1)
residues that binds to##2##4##(1995-2#1)(2010-12#1)
residues that have##2##3##(1996-9#1)(2011-1#1)
residues that participate##2##3##(1990-7#2)
residues that were##5##3##(1992-8#1)(1997-4#1)(2008-10#2)(2010-2#1)
residues that##49##2##(1990-10#1)(1990-4#1)(1990-7#2)(1990-8#1)(1991-2#1)(1991-7#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(2006-12#1)(2008-10#5)(2008-4#3)(2008-7#1)(2008-8#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)
residues to form##2##3##(1991-1#1)(2009-7#1)
residues to the solvent##2##4##(1991-4#1)(2008-6#1)
residues to the##9##3##(1991-4#1)(1994-11#1)(1996-5#2)(1997-2#1)(2006-10#1)(2008-6#1)(2010-7#1)(2011-1#1)
residues to##30##2##(1990-3#1)(1991-1#1)(1991-4#1)(1992-12#1)(1992-6#2)(1992-9#1)(1993-4#1)(1994-11#2)(1994-9#2)(1995-5#1)(1996-11#2)(1996-5#2)(1996-7#1)(1996-8#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-4#1)(2010-7#1)(2011-1#1)
residues upon##3##2##(1991-5#1)(1995-8#1)(2008-4#1)
residues using##5##2##(1994-5#1)(1995-1#1)(2007-8#1)(2008-10#1)(2013-8#1)
residues was##14##2##(1990-10#1)(1990-11#1)(1990-4#1)(1991-10#2)(1991-8#2)(1992-4#1)(1993-11#1)(1993-8#1)(1995-8#1)(1996-8#1)(1997-4#1)(2008-4#1)
residues were detected in##2##4##(2004-4#1)(2011-2#1)
residues were found in##2##4##(2008-10#1)(2013-8#1)
residues were found##3##3##(1996-7#1)(2008-10#1)(2013-8#1)
residues were not##2##3##(2005-11#1)(2011-2#1)
residues were removed##2##3##(1994-9#1)(1995-3#1)
residues were replaced with##2##4##(1994-6#1)(1995-6#1)
residues were replanted into the##2##5##(2008-10#2)
residues were synthesized##2##3##(1992-6#1)(1997-8#1)
residues were##45##2##(1990-10#1)(1990-12#1)(1990-7#1)(1991-5#1)(1991-9#2)(1992-6#3)(1992-8#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-5#3)(1995-6#3)(1996-4#1)(1996-7#2)(1996-8#1)(1997-5#1)(1997-8#2)(2004-2#1)(2004-4#1)(2005-11#2)(2008-10#6)(2008-4#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-8#2)
residues which are##4##3##(1991-5#1)(1993-11#1)(1995-10#1)(2008-11#1)
residues which exhibit##2##3##(1990-12#1)(1992-9#1)
residues which may##4##3##(1994-8#1)(1995-1#1)(1996-10#1)(2012-2#1)
residues which##22##2##(1990-10#1)(1990-12#1)(1990-4#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-5#1)(1992-12#1)(1992-9#1)(1993-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#1)(1996-10#1)(1997-2#1)(2008-11#1)(2012-2#1)(2013-1#1)
residues while##3##2##(1990-5#1)(1993-4#1)(1994-11#1)
residues whose##4##2##(1991-11#1)(1994-12#1)(1995-1#1)(1996-7#1)
residues with a##18##3##(1990-10#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-5#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-6#1)(1997-2#1)(2012-2#1)
residues with high##2##3##(1993-4#1)(2007-6#1)
residues with one##2##3##(1992-12#1)(1994-9#1)
residues with the##2##3##(1990-8#1)(1993-3#1)
residues with##57##2##(1990-10#1)(1990-11#2)(1990-2#3)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-1#1)(1992-12#2)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-3#3)(1993-4#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-3#1)(1994-9#4)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-2#1)(1996-6#1)(1997-2#1)(2007-6#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#2)(2010-11#1)(2012-2#1)(2013-1#1)
residues within the##8##3##(1990-11#1)(1991-3#1)(1991-4#1)(1994-9#1)(1995-5#1)(1996-5#1)(2008-8#1)(2011-1#1)
residues within these##2##3##(1994-11#1)(1994-9#1)
residues within this region##3##4##(1994-6#1)(1995-3#1)(1997-4#1)
residues within this##5##3##(1993-3#1)(1994-6#1)(1995-3#2)(1997-4#1)
residues within##26##2##(1990-11#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-11#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-6#1)(1994-9#3)(1995-3#3)(1995-5#1)(1996-5#2)(1997-4#2)(1997-5#1)(2006-12#1)(2008-8#1)(2010-10#1)(2011-1#1)(2013-7#1)
residues##2287##1##(1990-10#26)(1990-11#16)(1990-12#34)(1990-2#18)(1990-3#19)(1990-4#10)(1990-5#30)(1990-6#9)(1990-7#49)(1990-8#15)(1990-9#10)(1991-1#7)(1991-10#16)(1991-11#9)(1991-12#23)(1991-2#28)(1991-3#8)(1991-4#26)(1991-5#18)(1991-6#8)(1991-7#40)(1991-8#30)(1991-9#20)(1992-1#4)(1992-10#4)(1992-11#23)(1992-12#33)(1992-2#13)(1992-3#22)(1992-4#22)(1992-5#7)(1992-6#33)(1992-7#22)(1992-8#33)(1992-9#25)(1993-11#21)(1993-12#7)(1993-2#6)(1993-3#27)(1993-4#11)(1993-5#2)(1993-6#21)(1993-8#20)(1993-9#16)(1994-11#36)(1994-12#29)(1994-2#11)(1994-3#19)(1994-5#44)(1994-6#11)(1994-8#42)(1994-9#94)(1995-1#20)(1995-10#18)(1995-11#19)(1995-12#6)(1995-2#47)(1995-3#34)(1995-4#4)(1995-5#41)(1995-6#52)(1995-8#32)(1996-10#19)(1996-11#21)(1996-12#1)(1996-2#10)(1996-4#9)(1996-5#42)(1996-6#9)(1996-7#38)(1996-8#15)(1996-9#17)(1997-1#6)(1997-2#14)(1997-3#9)(1997-4#35)(1997-5#20)(1997-6#16)(1997-7#25)(1997-8#23)(1997-9#7)(2004-11#7)(2004-2#10)(2004-4#3)(2005-11#12)(2005-12#4)(2005-3#1)(2005-4#3)(2005-6#2)(2005-7#1)(2005-8#1)(2006-10#10)(2006-12#17)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#1)(2007-5#1)(2007-6#4)(2007-7#4)(2007-8#9)(2008-1#6)(2008-10#104)(2008-11#23)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#43)(2008-5#17)(2008-6#8)(2008-7#12)(2008-8#43)(2008-9#12)(2009-10#1)(2009-12#3)(2009-2#1)(2009-3#5)(2009-7#6)(2009-8#4)(2009-9#1)(2010-10#2)(2010-11#4)(2010-12#4)(2010-2#1)(2010-4#5)(2010-5#5)(2010-6#2)(2010-7#12)(2011-1#11)(2011-2#24)(2012-11#1)(2012-12#6)(2012-2#19)(2012-3#7)(2013-1#14)(2013-7#12)(2013-8#19)
residues) and##5##2##(1991-5#2)(1992-11#1)(1994-8#1)(1996-2#1)
residues) has##2##2##(1991-2#1)(1992-11#1)
residues) is##2##2##(1992-6#1)(1997-2#1)
residues)##40##1##(1990-2#2)(1990-5#1)(1990-7#1)(1991-2#2)(1991-3#1)(1991-5#2)(1992-11#3)(1992-3#2)(1992-6#1)(1992-7#2)(1993-11#1)(1994-12#4)(1994-8#3)(1995-2#2)(1995-8#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-8#1)(1997-9#1)(2008-10#2)(2008-3#2)(2008-5#1)(2009-2#1)(2011-2#1)
residuum##3##1##(2008-10#1)(2011-1#2)
resign##2##1##(1996-6#1)(1997-7#1)
resignation of##2##2##(2008-11#2)
resignation##9##1##(1992-1#1)(1993-1#1)(1995-8#1)(2007-10#1)(2007-4#1)(2008-11#2)(2012-1#2)
resigned as##2##2##(1997-7#2)
resigned##3##1##(1997-7#2)(2013-1#1)
resigns##2##1##(1991-4#1)(1992-7#1)
resilience among##2##2##(2007-12#2)
resilience and##8##2##(2006-6#1)(2007-12#1)(2008-6#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-2#1)
resilience in##3##2##(2008-12#1)(2008-4#1)(2011-1#1)
resilience of##5##2##(1995-9#1)(2007-3#1)(2009-7#2)(2011-1#1)
resilience through##2##2##(2012-2#1)(2013-1#1)
resilience to##3##2##(2007-12#1)(2010-12#1)(2012-4#1)
resilience##47##1##(1995-9#1)(2006-6#1)(2006-9#1)(2007-12#6)(2007-3#1)(2008-12#3)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-7#2)(2009-8#5)(2009-9#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#5)(2012-1#2)(2012-12#1)(2012-2#4)(2012-4#1)(2013-1#3)
resiliency##5##1##(2007-4#1)(2008-12#1)(2008-6#1)(2009-8#1)(2010-1#1)
resilient personality##3##2##(2007-12#3)
resilient to##2##2##(2005-7#1)(2010-12#1)
resilient##17##1##(2005-7#1)(2007-12#3)(2008-11#2)(2008-2#1)(2008-5#1)(2009-11#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#3)
resilin is##3##2##(2007-12#3)
resilin##6##1##(2007-12#6)
resin (Amberlite##2##2##(2008-10#2)
resin Amberlite XAD-7##2##3##(2008-10#2)
resin Amberlite##8##2##(1992-4#1)(2008-10#7)
resin acids##3##2##(1997-2#1)(2008-10#2)
resin and a##2##3##(2008-10#2)
resin and the##6##3##(2008-10#5)(2010-4#1)
resin and##32##2##(1990-11#1)(1990-8#1)(1992-7#1)(2007-8#1)(2007-9#1)(2008-10#20)(2008-3#1)(2008-4#1)(2008-7#2)(2010-4#2)(2012-12#1)
resin are##4##2##(2008-10#3)(2009-7#1)
resin as a##5##3##(1990-8#1)(2008-10#4)
resin as##8##2##(1990-8#1)(2008-10#7)
resin at pH##2##3##(2008-10#2)
resin at##4##2##(2008-10#4)
resin based##3##2##(2008-10#1)(2012-12#2)
resin beads##8##2##(2007-12#2)(2008-10#6)
resin bound##2##2##(1994-9#1)(2008-10#1)
resin by a##2##3##(1996-11#1)(2008-2#1)
resin by##7##2##(1996-11#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-4#1)
resin cement on the##2##4##(2008-8#2)
resin cement yielded##2##3##(2013-8#2)
resin cement##13##2##(2008-8#3)(2009-8#1)(2013-1#1)(2013-8#8)
resin cements to##2##3##(2009-8#2)
resin cements##3##2##(2009-8#2)(2013-8#1)
resin coated with##4##3##(2005-4#1)(2008-10#3)
resin column with##2##3##(2008-10#2)
resin column##9##2##(1990-8#1)(2008-10#6)(2011-1#2)
resin composite##9##2##(2009-8#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#3)
resin composites##9##2##(2010-10#1)(2011-1#1)(2012-2#3)(2013-1#3)(2013-8#1)
resin containing the##2##3##(2008-10#2)
resin containing##11##2##(2008-10#10)(2008-4#1)
resin followed by##2##3##(1992-1#1)(2007-8#1)
resin for the separation of##2##5##(2008-10#2)
resin for the##8##3##(1992-7#1)(2008-10#6)(2013-8#1)
resin for##23##2##(1990-8#1)(1991-1#1)(1992-7#1)(2008-10#17)(2008-11#1)(2008-9#1)(2013-8#1)
resin from##4##2##(2006-12#1)(2008-10#2)(2008-4#1)
resin functionalized with##5##3##(2008-10#5)
resin has been##8##3##(2008-10#8)
resin has##11##2##(2008-10#11)
resin have been##3##3##(2005-11#1)(2008-10#2)
resin in the##4##3##(2005-11#2)(2008-10#2)
resin in##9##2##(2005-11#5)(2008-10#4)
resin is highly##2##3##(2008-10#2)
resin is##17##2##(1997-7#1)(2007-12#2)(2008-10#11)(2008-3#1)(2008-4#1)(2010-1#1)
resin loaded with calmagite##2##4##(2008-10#2)
resin loaded with##10##3##(2008-10#10)
resin loading##2##2##(2008-10#2)
resin luting cement##3##3##(2013-1#3)
resin matrices##2##2##(2011-2#2)
resin matrix was##2##3##(2008-10#2)
resin matrix##7##2##(2005-11#1)(2008-10#4)(2011-2#1)(2013-8#1)
resin mini-column is##2##3##(2008-10#2)
resin mini-column##5##2##(2008-10#5)
resin modified glass ionomer cement##2##5##(2008-5#1)(2013-1#1)
resin modified glass ionomer##3##4##(2004-9#1)(2008-5#1)(2013-1#1)
resin modified with##3##3##(2008-10#3)
resin modified##7##2##(2004-9#2)(2008-10#3)(2008-5#1)(2013-1#1)
resin monomer##4##2##(2013-8#4)
resin of##3##2##(2005-11#1)(2006-12#1)(2008-10#1)
resin or##2##2##(1990-12#1)(2013-1#1)
resin packed##2##2##(2008-10#2)
resin phase##11##2##(2008-10#11)
resin shows##2##2##(2008-10#2)
resin surfaces were##2##3##(2008-12#2)
resin surfaces##3##2##(2008-12#3)
resin that##4##2##(2008-10#1)(2008-3#2)(2008-9#1)
resin to##5##2##(2006-8#1)(2008-10#2)(2008-6#1)(2012-2#1)
resin used in##3##3##(1991-1#1)(1991-10#1)(2008-10#1)
resin used##5##2##(1990-11#1)(1991-1#1)(1991-10#1)(2008-10#2)
resin was also##2##3##(2007-8#1)(2008-10#1)
resin was characterised by##2##4##(2008-10#2)
resin was characterized by##4##4##(2008-10#4)
resin was found to##2##4##(2008-10#2)
resin was found##3##3##(2008-10#3)
resin was prepared by##2##4##(2008-10#2)
resin was prepared##3##3##(2008-10#3)
resin was synthesized by##2##4##(2008-10#2)
resin was synthesized##3##3##(1990-8#1)(2008-10#2)
resin was used as a##2##5##(1990-8#1)(2008-10#1)
resin was used as##4##4##(1990-8#1)(2008-10#3)
resin was used##7##3##(1990-8#1)(2008-10#6)
resin was##49##2##(1990-8#2)(2007-8#1)(2008-10#44)(2008-12#1)(2013-8#1)
resin were##7##2##(2008-10#5)(2013-1#1)(2013-8#1)
resin which is##3##3##(2008-10#3)
resin which##4##2##(1994-6#1)(2008-10#3)
resin with a spacer##2##4##(2008-10#2)
resin with a##4##3##(1992-7#1)(2008-10#2)(2008-4#1)
resin with the##2##3##(2008-10#2)
resin with##13##2##(1992-7#1)(2008-10#10)(2008-4#1)(2008-7#1)
resin##609##1##(1990-11#2)(1990-12#1)(1990-5#1)(1990-8#7)(1991-1#2)(1991-10#1)(1992-1#1)(1992-11#1)(1992-4#1)(1992-7#3)(1993-11#1)(1994-6#1)(1994-9#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-2#3)(1997-3#1)(1997-7#1)(2004-9#3)(2005-11#18)(2005-4#2)(2006-12#2)(2006-8#4)(2007-11#2)(2007-12#5)(2007-8#4)(2007-9#4)(2008-1#1)(2008-10#383)(2008-11#1)(2008-12#16)(2008-2#1)(2008-3#10)(2008-4#10)(2008-5#4)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#2)(2009-3#3)(2009-7#2)(2009-8#7)(2010-1#1)(2010-10#1)(2010-2#2)(2010-4#3)(2010-9#1)(2011-1#6)(2011-2#7)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#21)(2013-8#28)
resin's##2##1##(2008-10#1)(2008-11#1)
resin)##6##1##(2008-10#4)(2008-7#1)(2013-8#1)
resin-based composite##5##2##(2008-5#4)(2013-8#1)
resin-based##8##1##(1990-12#1)(2008-5#4)(2013-1#2)(2013-8#1)
resin-bonded fixed partial dentures##2##4##(2011-2#2)
resin-bonded##3##1##(2008-7#1)(2011-2#2)
resin-composite applications##2##2##(2010-10#2)
resin-dentin##3##1##(2008-12#2)(2013-8#1)
resin-embedded##2##1##(2007-5#1)(2008-5#1)
resin-modified glass ionomer cement##5##4##(2008-12#2)(2012-12#3)
resin-modified glass ionomer##6##3##(2008-12#2)(2009-8#1)(2012-12#3)
resin-resin interfaces##3##2##(2008-12#3)
resinae ZN1##4##2##(2013-1#4)
resinae##5##1##(2013-1#5)
resinifera##8##1##(2008-10#8)
resiniferatoxin##11##1##(1990-7#2)(1992-6#2)(1993-9#2)(1997-6#2)(1997-8#1)(2006-9#1)(2013-8#1)
resiniferatoxin-binding##2##1##(1997-6#2)
resinous##6##1##(2008-10#6)
resins and asphaltenes##2##3##(2005-11#2)
resins and##8##2##(1990-3#1)(1991-11#1)(2005-11#2)(2008-10#3)(2008-2#1)
resins are##7##2##(2008-10#1)(2008-2#1)(2008-4#2)(2013-1#2)(2013-8#1)
resins as a##2##3##(2008-10#2)
resins as##5##2##(1990-3#1)(2008-10#3)(2008-7#1)
resins for##5##2##(2008-10#3)(2008-11#1)(2008-4#1)
resins from##4##2##(2005-11#1)(2008-10#2)(2010-12#1)
resins had##2##2##(2008-10#2)
resins in##4##2##(2006-10#1)(2008-10#1)(2011-1#2)
resins of##3##2##(2008-10#2)(2011-2#1)
resins to##2##2##(1997-4#1)(2008-10#1)
resins was##3##2##(1991-7#1)(2008-10#1)(2012-2#1)
resins were##5##2##(2007-12#1)(2008-10#2)(2008-8#1)(2012-2#1)
resins with##2##2##(2008-10#1)(2013-8#1)
resins##123##1##(1990-2#1)(1990-3#2)(1990-9#2)(1991-11#1)(1991-7#1)(1993-9#1)(1995-5#1)(1997-4#2)(2005-11#7)(2006-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#56)(2008-11#2)(2008-12#4)(2008-2#3)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-7#3)(2010-12#1)(2011-1#3)(2011-2#1)(2012-2#4)(2013-1#4)(2013-8#5)
resist film##2##2##(2007-12#1)(2009-7#1)
resist the##9##2##(1991-8#1)(1996-7#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-10#1)
resist thickness##2##2##(2007-12#2)
resist##68##1##(1991-8#1)(1992-9#1)(1993-8#1)(1996-7#1)(1996-9#1)(1997-2#1)(2004-9#1)(2005-11#2)(2006-10#8)(2007-11#1)(2007-12#15)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#4)(2009-10#1)(2009-11#2)(2009-2#4)(2009-3#2)(2009-7#1)(2010-2#2)(2010-4#1)(2010-7#1)(2012-12#2)(2012-2#1)(2013-1#2)
resistance (&gt##2##2##(2008-5#2)
resistance (APR)##2##2##(2008-10#2)
resistance (AR)##2##2##(2008-3#1)(2012-2#1)
resistance (HOMA-IR)##6##2##(2008-3#1)(2011-1#3)(2013-1#1)(2013-8#1)
resistance (IR)##8##2##(2008-3#3)(2010-4#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#1)
resistance (MDR)##8##2##(1990-8#1)(1994-8#1)(1996-7#1)(1997-1#1)(2008-11#1)(2012-1#1)(2012-3#1)(2013-8#1)
resistance (R) genes##7##3##(2008-10#4)(2008-8#1)(2009-6#1)(2011-2#1)
resistance (R)##11##2##(2008-10#6)(2008-12#1)(2008-8#1)(2009-6#2)(2011-2#1)
resistance -##4##2##(1991-6#1)(2007-12#1)(2008-7#1)(2013-1#1)
resistance QTL were##2##3##(2008-10#2)
resistance QTL##7##2##(2008-10#7)
resistance QTLs##6##2##(2008-9#2)(2009-10#4)
resistance affects##3##2##(1996-2#1)(2008-10#2)
resistance after##6##2##(1996-6#1)(2008-10#1)(2008-5#1)(2010-5#1)(2011-12#1)(2012-3#1)
resistance against CMV##2##3##(2007-12#2)
resistance against Pseudomonas syringae##2##4##(2007-12#1)(2008-10#1)
resistance against a##2##3##(2006-12#1)(2009-6#1)
resistance against all##2##3##(2008-10#1)(2008-8#1)
resistance against fusarium##2##3##(2008-10#2)
resistance against light-induced scattering in##2##5##(2008-1#2)
resistance against powdery mildew##2##4##(2008-10#2)
resistance against the fungal##2##4##(2008-10#1)(2009-8#1)
resistance against the##5##3##(1996-7#1)(2004-2#1)(2008-10#1)(2009-1#1)(2009-8#1)
resistance against##56##2##(1992-7#1)(1993-12#1)(1994-6#1)(1996-12#2)(1996-4#1)(1996-7#1)(2004-2#1)(2006-12#4)(2007-12#5)(2008-1#2)(2008-10#26)(2008-11#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-11#1)
resistance allele##7##2##(2008-10#4)(2010-2#2)(2012-11#1)
resistance alleles##4##2##(2008-10#4)
resistance also##2##2##(2008-10#2)
resistance among clinical isolates of##2##5##(2006-8#1)(2012-2#1)
resistance among the##2##3##(2007-8#2)
resistance among##21##2##(2005-7#1)(2005-8#1)(2006-10#1)(2006-8#3)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-3#1)(2008-4#1)(2010-5#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)
resistance and a##7##3##(2008-10#4)(2008-3#2)(2013-1#1)
resistance and an##2##3##(2008-10#2)
resistance and can be##2##4##(2007-8#1)(2013-8#1)
resistance and capacitance were##2##4##(2005-11#1)(2008-10#1)
resistance and capacitance##3##3##(2005-11#1)(2008-10#1)(2008-11#1)
resistance and days to##2##4##(2008-10#2)
resistance and genetic##3##3##(2012-1#1)(2012-11#1)(2013-1#1)
resistance and high##3##3##(2008-10#1)(2008-3#2)
resistance and higher##2##3##(1997-5#1)(2008-5#1)
resistance and in##2##3##(2008-10#1)(2013-1#1)
resistance and increased##3##3##(2006-10#1)(2008-1#1)(2010-9#1)
resistance and insulin##3##3##(1993-12#1)(2008-1#2)
resistance and its##5##3##(1996-5#2)(2008-1#1)(2008-10#1)(2012-12#1)
resistance and molecular##3##3##(2008-10#2)(2013-1#1)
resistance and obesity##3##3##(2008-11#1)(2011-1#1)(2013-1#1)
resistance and susceptibility of##2##4##(2006-10#1)(2008-10#1)
resistance and susceptibility to##3##4##(2006-10#1)(2008-10#1)(2013-8#1)
resistance and susceptibility##6##3##(2006-10#2)(2008-10#3)(2013-8#1)
resistance and that##2##3##(2008-10#2)
resistance and the##24##3##(1991-8#1)(1993-12#1)(1993-2#1)(1996-3#1)(1997-6#1)(2005-11#1)(2005-8#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-5#1)(2009-3#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
resistance and to##2##3##(2007-2#1)(2008-10#1)
resistance and tolerance profiles##2##4##(2011-10#2)
resistance and tolerance to##3##4##(2008-12#2)(2011-10#1)
resistance and tolerance##6##3##(2008-12#2)(2011-10#4)
resistance and toxicity##2##3##(2005-8#1)(2007-7#1)
resistance and virulence##4##3##(2008-10#3)(2011-2#1)
resistance and was##2##3##(1997-1#1)(2006-11#1)
resistance and##281##2##(1990-1#1)(1990-2#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-7#1)(1994-11#2)(1994-2#1)(1994-8#2)(1994-9#1)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-3#1)(1996-5#2)(1997-1#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#1)(2004-4#1)(2004-9#1)(2005-10#2)(2005-11#4)(2005-7#1)(2005-8#4)(2006-1#3)(2006-10#5)(2006-11#3)(2006-3#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#4)(2007-12#1)(2007-2#2)(2007-5#2)(2007-7#1)(2007-8#3)(2008-1#18)(2008-10#49)(2008-11#5)(2008-12#8)(2008-2#2)(2008-3#20)(2008-4#6)(2008-5#5)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#2)(2009-3#3)(2009-4#1)(2009-6#3)(2009-8#4)(2009-9#1)(2010-10#3)(2010-11#3)(2010-12#5)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#9)(2011-10#4)(2011-12#2)(2011-2#6)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#7)(2012-3#1)(2012-5#1)(2013-1#14)(2013-8#4)
resistance appeared##2##2##(2008-10#1)(2008-2#1)
resistance appears to be##2##4##(2005-8#1)(2010-10#1)
resistance are##17##2##(1997-6#1)(2006-11#1)(2006-8#1)(2008-10#3)(2008-3#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-1#1)
resistance arteries##6##2##(1991-10#1)(1991-5#1)(1994-9#1)(1997-4#2)(2010-4#1)
resistance as a##3##3##(1997-2#1)(2008-3#1)(2008-8#1)
resistance as an##2##3##(2005-10#1)(2008-10#1)
resistance as the##3##3##(1995-1#1)(2006-10#1)(2008-10#1)
resistance as well as##3##4##(2007-9#1)(2008-1#1)(2008-9#1)
resistance as##19##2##(1992-8#1)(1995-1#1)(1997-2#1)(2005-10#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-3#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2012-2#1)
resistance associated with##4##3##(1996-5#1)(2008-10#2)(2011-2#1)
resistance associated##6##2##(1996-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2011-2#1)
resistance at the##3##3##(1993-6#1)(2008-10#2)
resistance at##6##2##(1993-6#1)(2008-10#4)(2011-2#1)
resistance based on##3##3##(2008-10#3)
resistance between##5##2##(2005-10#1)(2007-11#1)(2008-10#1)(2011-12#1)(2013-1#1)
resistance both##2##2##(1994-11#1)(2008-10#1)
resistance breaking##2##2##(2008-10#2)
resistance breeding##5##2##(2006-9#1)(2008-10#4)
resistance but##3##2##(2007-8#1)(2008-10#1)(2012-11#1)
resistance by a##2##3##(2006-6#1)(2008-10#1)
resistance by increasing##2##3##(1990-9#1)(2011-2#1)
resistance by the##2##3##(1990-2#1)(2008-6#1)
resistance by##31##2##(1990-2#1)(1990-9#1)(1992-11#1)(1993-9#1)(1994-11#1)(1995-10#1)(1995-8#1)(1997-5#1)(1997-7#1)(2004-11#1)(2006-11#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-2#1)(2008-6#1)(2009-8#1)(2011-2#2)
resistance can be##10##3##(1993-2#1)(2006-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2009-9#1)
resistance can develop##2##3##(2007-9#1)(2008-10#1)
resistance can##18##2##(1993-2#1)(2006-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-8#3)(2009-9#1)(2011-1#1)
resistance combined with##2##3##(2008-10#2)
resistance components##2##2##(2008-10#2)
resistance concerned##2##2##(2008-10#1)(2011-12#1)
resistance conferred by the##4##4##(2008-10#1)(2008-5#1)(2009-8#1)(2011-2#1)
resistance conferred by##9##3##(2008-10#4)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-11#1)
resistance could be##7##3##(1990-2#1)(1997-2#1)(2006-11#1)(2008-10#1)(2009-8#1)(2012-11#1)(2012-12#1)
resistance could##10##2##(1990-2#1)(1997-2#1)(2006-11#1)(2008-10#4)(2009-8#1)(2012-11#1)(2012-12#1)
resistance data##3##2##(2009-2#2)(2011-2#1)
resistance decreased##2##2##(1993-12#1)(2010-6#1)
resistance decreases##2##2##(2008-10#1)(2012-3#1)
resistance derived from##2##3##(2008-10#2)
resistance described here##2##3##(2008-10#2)
resistance described##3##2##(2008-10#2)(2008-11#1)
resistance determinants##2##2##(1991-7#1)(2008-10#1)
resistance development##6##2##(2007-6#1)(2008-10#3)(2011-2#1)(2012-12#1)
resistance did not##5##3##(2008-10#3)(2008-8#1)(2013-1#1)
resistance does not##4##3##(1995-2#1)(2005-10#1)(2008-3#1)(2008-8#1)
resistance donors##2##2##(2008-10#2)
resistance during##8##2##(1990-11#1)(1990-9#1)(2005-8#1)(2007-12#1)(2008-10#2)(2008-5#1)(2010-5#1)
resistance elicitors providing##2##3##(2008-10#2)
resistance elicitors##5##2##(2008-10#5)
resistance evaluation##2##2##(2008-10#1)(2011-1#1)
resistance even##2##2##(2008-1#1)(2008-10#1)
resistance evolution##2##2##(2011-2#2)
resistance exercise##3##2##(2006-9#1)(2008-5#2)
resistance explained##2##2##(2008-10#1)(2010-4#1)
resistance expressed at the##2##4##(2008-10#2)
resistance expressed in##2##3##(2008-10#2)
resistance expressed##6##2##(2008-10#6)
resistance factor##2##2##(2012-12#1)(2012-2#1)
resistance factors##5##2##(2008-10#5)
resistance following##3##2##(2007-6#1)(2008-10#1)(2013-8#1)
resistance for the##3##3##(1994-7#1)(2007-6#1)(2012-12#1)
resistance for##17##2##(1990-11#1)(1994-7#1)(1995-6#1)(2005-8#1)(2006-8#1)(2007-6#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)(2011-1#2)(2012-12#1)
resistance found##4##2##(2004-4#2)(2008-12#1)(2013-8#1)
resistance from these##2##3##(2008-10#1)(2009-3#1)
resistance from##11##2##(2007-4#1)(2007-9#1)(2008-10#6)(2008-12#1)(2009-3#1)(2013-1#1)
resistance gene Bs2##2##3##(2008-10#2)
resistance gene analog polymorphism (RGAP) markers##2##6##(2008-10#2)
resistance gene analog polymorphism (RGAP)##3##5##(2008-10#3)
resistance gene analogs (RGAs)##2##4##(2008-10#2)
resistance gene analogs##3##3##(2008-10#3)
resistance gene and##2##3##(2008-10#2)
resistance gene at##2##3##(2008-10#2)
resistance gene candidates##2##3##(2006-12#2)
resistance gene from##2##3##(2008-5#1)(2008-8#1)
resistance gene in wheat##2##4##(2008-10#2)
resistance gene in##10##3##(2008-10#9)(2012-11#1)
resistance gene into barley##2##4##(2008-10#2)
resistance gene is##2##3##(2008-10#2)
resistance gene number in##2##4##(2008-10#2)
resistance gene to##3##3##(2008-10#3)
resistance gene was successfully##2##4##(1993-11#1)(2008-10#1)
resistance gene was##7##3##(1993-11#1)(1995-2#1)(2008-10#4)(2008-6#1)
resistance gene were##4##3##(1996-7#1)(2008-10#2)(2008-5#1)
resistance gene##146##2##(1991-12#1)(1991-8#2)(1993-11#1)(1994-11#1)(1994-9#1)(1995-2#1)(1996-7#1)(1997-2#1)(2005-8#1)(2006-12#6)(2006-9#1)(2007-6#1)(2008-10#107)(2008-11#2)(2008-5#4)(2008-6#1)(2008-8#5)(2009-6#1)(2011-1#1)(2012-11#4)(2012-2#1)(2012-3#2)
resistance genes Lr1##2##3##(2008-10#2)
resistance genes and##3##3##(2008-10#3)
resistance genes are##2##3##(2008-10#2)
resistance genes as##2##3##(2008-10#2)
resistance genes for##4##3##(2008-10#4)
resistance genes from A##2##4##(2008-10#2)
resistance genes from##3##3##(2008-10#3)
resistance genes identified##2##3##(2008-10#2)
resistance genes in the##5##4##(2008-10#4)(2012-11#1)
resistance genes in##19##3##(2008-10#14)(2008-11#1)(2011-2#1)(2012-11#2)(2012-2#1)
resistance genes including##2##3##(2008-10#2)
resistance genes on##2##3##(2008-10#2)
resistance genes or##2##3##(2008-10#2)
resistance genes present in cultivar AB 136##2##7##(2008-10#2)
resistance genes present in##4##4##(2008-10#4)
resistance genes that##2##3##(2008-10#2)
resistance genes to powdery mildew##2##5##(2008-10#2)
resistance genes to##6##3##(2008-10#6)
resistance genes using##2##3##(2008-10#2)
resistance genes were##3##3##(2008-10#3)
resistance genes##134##2##(1994-5#1)(2005-11#1)(2006-11#1)(2006-8#1)(2007-6#3)(2008-10#119)(2008-11#2)(2008-8#1)(2011-2#2)(2012-11#2)(2012-2#1)
resistance had##2##2##(2008-10#1)(2008-8#1)
resistance has been##9##3##(2005-10#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-8#1)(2010-2#1)(2012-11#1)(2012-12#1)(2013-1#1)
resistance has developed##2##3##(1995-5#1)(2012-12#1)
resistance has##24##2##(1995-5#1)(2005-10#1)(2005-8#2)(2006-10#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-6#1)(2011-12#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
resistance have been identified##3##4##(2008-10#1)(2009-10#1)(2012-11#1)
resistance have been##7##3##(2008-10#2)(2009-10#1)(2010-11#1)(2011-12#1)(2012-11#2)
resistance have##10##2##(2004-11#1)(2005-11#1)(2008-10#3)(2009-10#1)(2010-11#1)(2011-12#1)(2012-11#2)
resistance identified in##2##3##(2008-10#2)
resistance in A##2##3##(2008-10#1)(2008-11#1)
resistance in Arabidopsis##2##3##(2008-10#1)(2009-8#1)
resistance in Campylobacter##2##3##(1990-3#1)(1990-9#1)
resistance in Canada##4##3##(2007-12#4)
resistance in Candida##2##3##(2008-5#1)(2011-2#1)
resistance in DZA045##2##3##(2009-3#2)
resistance in Enterococcus faecium BM4147##2##5##(1991-2#1)(1995-2#1)
resistance in Enterococcus faecium##3##4##(1991-2#1)(1995-2#2)
resistance in M##3##3##(2007-7#1)(2008-10#1)(2011-12#1)
resistance in S##3##3##(2007-2#1)(2011-2#2)
resistance in a##9##3##(1993-7#1)(1993-9#1)(2008-10#6)(2008-11#1)
resistance in adult##2##3##(2007-12#1)(2008-10#1)
resistance in bacteria##6##3##(2008-3#1)(2010-4#4)(2013-8#1)
resistance in barley##6##3##(2008-10#6)
resistance in both##5##3##(1994-12#1)(1995-8#1)(2008-10#3)
resistance in cancer##3##3##(2008-11#1)(2009-4#1)(2010-2#1)
resistance in childhood##2##3##(1992-8#2)
resistance in clinical isolates of##2##5##(2007-7#1)(2008-8#1)
resistance in cucumber##4##3##(2008-10#4)
resistance in cv##2##3##(2008-10#2)
resistance in four##2##3##(2008-10#2)
resistance in greenhouse##3##3##(2008-10#3)
resistance in head lice##2##4##(2010-2#2)
resistance in host##2##3##(2008-10#2)
resistance in human##5##3##(1990-5#1)(1990-7#1)(1992-2#1)(2008-1#1)(2008-11#1)
resistance in humans##2##3##(1994-11#2)
resistance in maize##2##3##(2008-10#2)
resistance in many##2##3##(2006-10#1)(2007-12#1)
resistance in oat##3##3##(2008-10#3)
resistance in other##2##3##(2011-12#1)(2012-12#1)
resistance in patients with##4##4##(1997-3#1)(2007-10#1)(2010-7#1)(2011-2#1)
resistance in patients##5##3##(1997-3#1)(2007-10#1)(2010-7#1)(2011-2#1)(2012-12#1)
resistance in pea##2##3##(2006-9#1)(2008-10#1)
resistance in persons##2##3##(2008-3#1)(2011-1#1)
resistance in plants by##2##4##(2008-10#2)
resistance in plants##12##3##(2006-12#2)(2008-10#7)(2009-8#3)
resistance in radish##2##3##(2008-10#2)
resistance in replicated##2##3##(2008-10#2)
resistance in rice##4##3##(2008-10#2)(2008-9#1)(2009-10#1)
resistance in sheep##3##3##(1991-6#1)(2005-7#1)(2012-1#1)
resistance in six##2##3##(2008-10#2)
resistance in skeletal muscle##2##4##(2008-1#2)
resistance in soft##2##3##(2008-5#1)(2008-6#1)
resistance in some##6##3##(1990-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-8#1)(2013-7#1)
resistance in soybean##2##3##(2008-10#1)(2012-11#1)
resistance in staphylococci##2##3##(2006-10#1)(2006-11#1)
resistance in sugar##2##3##(2008-10#2)
resistance in the field##4##4##(2008-10#4)
resistance in the host##3##4##(2008-10#3)
resistance in the more##2##4##(2006-10#1)(2008-10#1)
resistance in the slash pine-fusiform rust pathosystem##2##7##(2008-10#2)
resistance in the stable fly##2##5##(2011-2#2)
resistance in the##44##3##(1993-8#1)(1995-11#1)(1996-5#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-6#1)(2007-7#1)(2008-10#26)(2008-6#1)(2008-9#2)(2009-6#2)(2011-1#2)(2011-2#3)
resistance in these strains was##2##5##(2006-11#1)(2008-10#1)
resistance in these##6##3##(2006-11#1)(2008-10#4)(2012-11#1)
resistance in this##5##3##(1991-7#1)(2008-10#3)(2008-5#1)
resistance in tobacco##3##3##(2008-10#3)
resistance in tomato##3##3##(2008-10#2)(2009-3#1)
resistance in transgenic plants##2##4##(2006-12#1)(2008-10#1)
resistance in transgenic##5##3##(2006-12#2)(2008-10#2)(2008-9#1)
resistance in tumor cells##2##4##(2008-11#2)
resistance in tumors]##2##3##(1994-3#1)(2005-10#1)
resistance in two##2##3##(2008-10#2)
resistance in vitro and in vivo##2##6##(1994-5#1)(2012-12#1)
resistance in vitro and in##3##5##(1994-5#1)(2008-11#1)(2012-12#1)
resistance in vitro and##5##4##(1994-5#1)(2006-11#1)(2008-11#1)(2008-4#1)(2012-12#1)
resistance in vitro##7##3##(1991-2#1)(1993-7#1)(1994-5#1)(2006-11#1)(2008-11#1)(2008-4#1)(2012-12#1)
resistance in vivo##2##3##(2005-10#1)(2012-2#1)
resistance in wheat##8##3##(2008-10#5)(2011-2#3)
resistance in##419##2##(1990-10#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-9#2)(1991-2#3)(1991-6#2)(1991-7#2)(1991-8#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#1)(1993-7#2)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#3)(2004-4#1)(2004-9#1)(2005-10#2)(2005-7#2)(2005-8#6)(2006-1#1)(2006-10#6)(2006-11#4)(2006-12#6)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#9)(2007-2#2)(2007-6#1)(2007-7#5)(2007-8#1)(2007-9#1)(2008-1#9)(2008-10#169)(2008-11#12)(2008-3#6)(2008-4#5)(2008-5#8)(2008-6#4)(2008-7#2)(2008-8#3)(2008-9#6)(2009-10#1)(2009-11#1)(2009-3#5)(2009-4#1)(2009-6#2)(2009-8#5)(2010-10#3)(2010-11#1)(2010-2#5)(2010-4#4)(2010-7#1)(2010-9#1)(2011-1#3)(2011-10#1)(2011-12#8)(2011-2#14)(2012-1#1)(2012-11#4)(2012-12#6)(2012-2#6)(2012-3#1)(2012-5#1)(2013-1#3)(2013-7#2)(2013-8#1)
resistance include##3##2##(2006-12#1)(2008-1#1)(2008-10#1)
resistance increased##6##2##(2005-11#1)(2006-8#1)(2008-10#2)(2010-8#1)(2012-2#1)
resistance increases##2##2##(1997-4#1)(2008-3#1)
resistance index was##2##3##(1992-6#1)(2007-8#1)
resistance index##14##2##(1992-6#2)(1994-4#1)(1996-6#1)(2004-10#2)(2007-8#3)(2008-7#1)(2012-3#2)(2013-1#1)(2013-8#1)
resistance induced by##5##3##(1995-3#1)(2008-10#2)(2008-3#1)(2008-4#1)
resistance induced##7##2##(1995-3#1)(2008-10#3)(2008-3#1)(2008-4#1)(2009-8#1)
resistance into##4##2##(2008-10#4)
resistance is a major##2##4##(2007-7#1)(2008-10#1)
resistance is a##10##3##(1991-7#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2010-4#1)(2012-1#1)
resistance is also discussed##2##4##(1997-3#1)(2008-10#1)
resistance is an##5##3##(2008-10#4)(2010-12#1)
resistance is associated with##4##4##(1995-7#1)(2008-10#1)(2010-10#1)(2012-5#1)
resistance is conditioned by##2##4##(2006-12#1)(2008-10#1)
resistance is conferred by##2##4##(2008-10#2)
resistance is considered to be##2##5##(2007-7#1)(2008-3#1)
resistance is discussed##2##3##(2008-10#2)
resistance is increased##2##3##(2005-8#1)(2010-8#1)
resistance is increasing##2##3##(2006-11#1)(2012-2#1)
resistance is not##6##3##(1994-12#1)(1994-7#1)(2008-10#3)(2008-8#1)
resistance is now##2##3##(1993-5#1)(2012-12#1)
resistance is often##2##3##(2005-8#1)(2013-1#1)
resistance is overcome by##2##4##(2008-10#1)(2008-5#1)
resistance is relatively##2##3##(2008-10#1)(2010-2#1)
resistance is still##2##3##(2008-10#1)(2008-5#1)
resistance is the##6##3##(1990-2#1)(2008-10#4)(2008-7#1)
resistance is unstable##2##3##(2008-10#2)
resistance is##113##2##(1990-2#1)(1990-9#1)(1991-7#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-7#1)(1997-3#1)(1997-6#1)(2005-8#3)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-8#1)(2007-2#3)(2007-5#1)(2007-7#2)(2008-1#3)(2008-10#45)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#3)(2008-7#1)(2008-8#4)(2009-3#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#3)
resistance level of##3##3##(2008-12#1)(2011-2#2)
resistance level##6##2##(2008-10#2)(2008-12#1)(2008-3#1)(2011-2#2)
resistance levels##7##2##(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-8#1)
resistance limits the##2##3##(2008-10#1)(2009-6#1)
resistance limits##3##2##(2008-10#1)(2009-6#1)(2010-11#1)
resistance loci in##3##3##(2008-10#2)(2008-9#1)
resistance loci were##2##3##(2008-10#2)
resistance loci##9##2##(2008-10#7)(2008-8#1)(2008-9#1)
resistance locus##6##2##(1990-8#1)(2008-10#3)(2012-3#2)
resistance management##6##2##(2004-11#1)(2007-6#1)(2008-10#3)(2011-2#1)
resistance marker##3##2##(1994-12#1)(1997-2#1)(2008-11#1)
resistance markers##7##2##(2005-8#3)(2008-10#2)(2008-9#2)
resistance may be an##2##4##(2006-10#1)(2007-8#1)
resistance may be##13##3##(1997-7#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-8#1)(2009-11#1)(2009-5#1)(2009-6#1)
resistance may operate at##2##4##(2006-11#1)(2008-10#1)
resistance may##21##2##(1994-12#1)(1997-7#1)(2005-12#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-12#2)(2008-8#1)(2009-11#1)(2009-5#1)(2009-6#1)(2012-2#1)
resistance measured by##4##3##(1996-3#1)(2008-1#2)(2008-10#1)
resistance measured##5##2##(1996-3#1)(2008-1#2)(2008-10#1)(2008-3#1)
resistance measurement##2##2##(2011-2#2)
resistance measurements were##2##3##(2007-12#1)(2010-8#1)
resistance measurements##3##2##(2007-12#1)(2010-8#1)(2011-2#1)
resistance mechanism##8##2##(2005-7#1)(2008-10#5)(2009-2#2)
resistance mechanisms and##3##3##(2007-7#1)(2008-11#1)(2012-12#1)
resistance mechanisms in##2##3##(2008-10#1)(2012-2#1)
resistance mechanisms involved##2##3##(2008-11#1)(2012-1#1)
resistance mechanisms to##4##3##(2005-8#1)(2006-10#1)(2008-8#1)(2011-2#1)
resistance mechanisms##27##2##(1996-10#1)(2005-7#2)(2005-8#1)(2006-10#2)(2007-7#1)(2008-10#5)(2008-11#4)(2008-4#1)(2008-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
resistance mediated by##3##3##(1997-4#1)(2008-10#1)(2008-11#1)
resistance might be##3##3##(2008-10#1)(2008-7#1)(2012-12#1)
resistance might##4##2##(2008-10#2)(2008-7#1)(2012-12#1)
resistance modes##2##2##(2008-10#2)
resistance monitoring##7##2##(2008-10#1)(2010-2#3)(2010-4#1)(2011-2#2)
resistance mutation##4##2##(1996-7#2)(2012-2#1)(2013-1#1)
resistance mutations##9##2##(1993-9#2)(2012-1#1)(2012-2#1)(2013-1#5)
resistance observed in##2##3##(1994-8#1)(2006-4#1)
resistance observed##5##2##(1994-8#1)(2005-11#1)(2006-4#1)(2008-10#1)(2010-9#1)
resistance occurred##2##2##(1993-12#1)(1997-4#1)
resistance occurs##3##2##(2008-10#1)(2008-3#1)(2010-2#1)
resistance of Escherichia coli to##2##5##(1994-6#1)(2010-8#1)
resistance of Escherichia coli##3##4##(1994-6#1)(1994-9#1)(2010-8#1)
resistance of H##3##3##(1997-7#1)(2012-12#2)
resistance of LDL to##4##4##(1995-12#1)(1996-3#1)(1997-6#1)(1997-7#1)
resistance of M##2##3##(2008-10#1)(2011-12#1)
resistance of S##5##3##(1994-8#1)(2004-2#1)(2008-10#1)(2008-5#1)(2010-5#1)
resistance of Schistosoma##3##3##(2012-3#3)
resistance of Y##2##3##(2005-12#2)
resistance of a##5##3##(1996-5#1)(2006-5#1)(2008-10#3)
resistance of bermudagrass genotypes to##2##5##(2008-10#2)
resistance of bermudagrass genotypes##3##4##(2008-10#3)
resistance of blood##2##3##(2007-7#1)(2009-5#1)
resistance of certain##2##3##(1994-11#1)(2008-10#1)
resistance of cucumber##3##3##(2008-10#3)
resistance of human##2##3##(1993-3#1)(2008-9#1)
resistance of maize##3##3##(2008-10#3)
resistance of muscle##2##3##(2005-10#1)(2008-1#1)
resistance of neurons in##2##4##(1993-12#1)(2010-8#1)
resistance of some##2##3##(2008-5#1)(2009-3#1)
resistance of sunscreen##2##3##(2008-5#1)(2012-12#1)
resistance of the heart##2##4##(1994-11#1)(2008-4#1)
resistance of the host##2##4##(2008-10#2)
resistance of the most##2##4##(2005-7#1)(2008-8#1)
resistance of the organism##2##4##(2007-12#1)(2008-1#1)
resistance of the small##2##4##(2006-10#1)(2008-6#1)
resistance of the##51##3##(1990-5#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-6#1)(1993-8#1)(1994-11#1)(1994-9#2)(1995-11#1)(1995-5#1)(2004-9#2)(2005-11#3)(2005-7#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#3)
resistance of these##4##3##(1990-2#1)(1997-4#1)(2008-10#2)
resistance of this##3##3##(1994-2#1)(2008-4#1)(2008-5#1)
resistance of topical sunscreens##2##4##(2008-5#2)
resistance of tumor cells to##3##5##(1991-2#1)(2008-10#1)(2008-11#1)
resistance of tumor cells##4##4##(1991-2#1)(2008-10#1)(2008-11#1)(2008-4#1)
resistance of##247##2##(1990-2#1)(1990-5#2)(1990-7#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-9#2)(1992-6#1)(1992-8#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-6#1)(1994-8#3)(1994-9#4)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-11#1)(1996-3#1)(1996-4#2)(1996-5#1)(1997-2#1)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#2)(2004-2#1)(2004-4#2)(2004-9#2)(2005-10#1)(2005-11#5)(2005-12#2)(2005-7#1)(2005-9#1)(2006-10#2)(2006-12#3)(2006-4#1)(2006-5#3)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#47)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#12)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#4)(2009-11#1)(2009-2#1)(2009-3#4)(2009-5#2)(2009-6#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-4#5)(2010-5#1)(2010-6#1)(2010-8#5)(2010-9#2)(2011-1#5)(2011-12#2)(2011-2#10)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#4)(2012-3#5)(2013-1#2)(2013-8#5)
resistance on chromosome##2##3##(2008-10#2)
resistance on the##3##3##(2008-10#3)
resistance on##14##2##(1990-11#1)(1992-8#1)(2008-10#6)(2008-3#1)(2008-8#1)(2009-1#1)(2009-3#1)(2011-1#1)(2011-12#1)
resistance only##2##2##(2008-10#2)
resistance or susceptibility of##2##4##(2008-10#1)(2008-5#1)
resistance or susceptibility##3##3##(2006-10#1)(2008-10#1)(2008-5#1)
resistance or the##2##3##(1991-5#1)(2008-10#1)
resistance or tolerance##2##3##(2008-10#1)(2011-10#1)
resistance or##27##2##(1991-5#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-8#1)(1994-5#1)(2005-8#1)(2006-10#1)(2008-1#1)(2008-10#9)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2011-10#1)(2012-12#1)(2013-1#1)
resistance originated##2##2##(2008-10#1)(2012-11#1)
resistance parameters##2##2##(2008-4#1)(2011-2#1)
resistance pattern of the##3##4##(2007-7#1)(2008-5#1)(2013-8#1)
resistance pattern of##7##3##(2006-8#1)(2007-7#2)(2008-5#1)(2009-5#1)(2012-2#1)(2013-8#1)
resistance pattern##13##2##(2006-8#1)(2007-6#1)(2007-7#3)(2008-5#1)(2009-5#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
resistance patterns of S##2##4##(2010-8#1)(2013-8#1)
resistance patterns of##7##3##(1991-8#1)(2007-6#1)(2007-7#2)(2010-8#1)(2013-8#2)
resistance patterns##14##2##(1991-8#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-7#1)(2009-3#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-8#3)
resistance phenotype##7##2##(2008-10#4)(2008-11#2)(2010-9#1)
resistance phenotypes##9##2##(1992-8#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#1)(2012-3#1)
resistance plays a##2##3##(2008-10#1)(2008-11#1)
resistance plays##3##2##(2008-1#1)(2008-10#1)(2008-11#1)
resistance probably##2##2##(2008-10#2)
resistance problems##3##2##(2005-8#1)(2008-4#1)(2012-12#1)
resistance profile##6##2##(1994-11#1)(2008-5#1)(2009-1#1)(2009-6#1)(2010-12#1)(2012-2#1)
resistance profiles and##2##3##(2008-10#1)(2008-2#1)
resistance profiles in##2##3##(2012-1#1)(2013-1#1)
resistance profiles of##5##3##(1994-11#1)(2006-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
resistance profiles##13##2##(1994-11#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
resistance protein##6##2##(1991-2#1)(1996-8#2)(2008-11#2)(2012-3#1)
resistance proteins##3##2##(2008-5#1)(2009-8#2)
resistance quantitative trait locus (QTL)##2##5##(2008-10#2)
resistance quantitative trait##3##3##(2006-12#1)(2008-10#2)
resistance rate against##2##3##(2007-7#1)(2008-12#1)
resistance rate of E##2##4##(2008-12#1)(2013-1#1)
resistance rate of##3##3##(2008-12#1)(2013-1#2)
resistance rate##8##2##(1996-11#1)(1996-12#1)(2007-7#2)(2008-12#2)(2013-1#2)
resistance rates to##4##3##(2006-8#2)(2007-7#1)(2013-8#1)
resistance rates##10##2##(2006-8#3)(2007-7#3)(2010-11#1)(2013-8#3)
resistance rating##3##2##(2008-10#3)
resistance ratio of##2##3##(2008-12#2)
resistance reactions##2##2##(2008-10#2)
resistance remains a##2##3##(2006-10#1)(2012-12#1)
resistance remains##4##2##(2006-10#1)(2008-1#1)(2008-10#1)(2012-12#1)
resistance requires##2##2##(2005-8#1)(2008-10#1)
resistance resources##2##2##(2008-10#1)(2012-11#1)
resistance response##6##2##(2008-10#4)(2008-9#1)(2009-3#1)
resistance responses##3##2##(2008-10#2)(2009-6#1)
resistance resulted in a##2##4##(2008-10#2)
resistance resulted in lower population growth rates and stronger density dependence than##2##12##(2008-8#2)
resistance resulted in##4##3##(2008-10#2)(2008-8#2)
resistance revealed that##2##3##(2008-10#1)(2010-11#1)
resistance seems to be##2##4##(2006-2#1)(2008-10#1)
resistance seen in##2##3##(2006-8#1)(2008-3#1)
resistance should be##3##3##(2006-10#1)(2006-8#1)(2008-7#1)
resistance should##6##2##(2006-10#1)(2006-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#1)
resistance showed##2##2##(2007-9#1)(2008-10#1)
resistance sources##2##2##(2008-10#2)
resistance status##5##2##(2008-10#5)
resistance strategies##2##2##(2008-10#1)(2010-11#1)
resistance suggests##2##2##(1994-9#1)(2008-7#1)
resistance syndrome (IRS)##3##3##(2008-1#1)(2008-3#2)
resistance syndrome##16##2##(1992-11#1)(1997-2#1)(2005-10#3)(2007-1#1)(2008-1#1)(2008-3#5)(2008-9#1)(2009-7#1)(2013-1#2)
resistance test##5##2##(2008-10#1)(2008-5#1)(2008-8#2)(2013-1#1)
resistance testing##3##2##(2006-10#3)
resistance tests##2##2##(2006-10#1)(2011-3#1)
resistance than that##3##3##(1995-8#1)(2008-10#1)(2012-2#1)
resistance than the##2##3##(2008-10#2)
resistance than##9##2##(1993-12#1)(1995-8#1)(2007-12#1)(2008-10#3)(2012-2#1)(2012-5#1)(2013-1#1)
resistance that is##2##3##(2008-10#1)(2008-11#1)
resistance that results##2##3##(2010-10#1)(2013-1#1)
resistance that##12##2##(2006-11#1)(2008-10#4)(2008-11#1)(2008-6#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-12#1)(2013-1#1)
resistance through##6##2##(2006-11#1)(2008-10#3)(2008-3#1)(2009-6#1)
resistance to 5-methyltryptophan##2##3##(1994-6#2)
resistance to A##4##3##(1996-12#1)(2008-10#3)
resistance to Adriamycin##3##3##(1995-11#3)
resistance to Aphanomyces root rot##3##5##(2008-10#3)
resistance to Aspergillus ear rot and aflatoxin production##3##8##(2008-10#3)
resistance to Aspergillus ear rot and aflatoxin##4##7##(2008-10#4)
resistance to B##5##3##(2004-11#3)(2008-10#2)
resistance to C##2##3##(2008-10#1)(2011-2#1)
resistance to CCW##2##3##(2012-11#2)
resistance to CMV##2##3##(1991-12#1)(2008-10#1)
resistance to Colletotrichum##2##3##(2008-10#2)
resistance to E##6##3##(1993-9#1)(2008-10#5)
resistance to F##7##3##(2008-10#7)
resistance to FHB##7##3##(2008-10#5)(2011-10#2)
resistance to Fusarium wilt##5##4##(2008-10#5)
resistance to Fusarium##9##3##(2008-10#9)
resistance to HER2-targeted therapies##3##4##(2013-1#3)
resistance to HER2-targeted##4##3##(2010-7#1)(2013-1#3)
resistance to IB-49##2##3##(2008-10#2)
resistance to IC-17 was##2##4##(2008-10#2)
resistance to Leptosphaeria maculans##2##4##(2008-10#2)
resistance to M##12##3##(2008-10#9)(2011-10#1)(2012-2#2)
resistance to MStV##3##3##(2008-10#3)
resistance to MTX##2##3##(1995-7#2)
resistance to Magnaporthe##2##3##(2008-10#1)(2013-8#1)
resistance to Melampsora larici-populina leaf rust##2##6##(2008-10#2)
resistance to P##12##3##(2008-10#11)(2009-6#1)
resistance to Phytophthora##3##3##(2008-10#2)(2012-11#1)
resistance to R##3##3##(2008-10#3)
resistance to SLB##2##3##(2008-10#2)
resistance to STB in##2##4##(2008-10#2)
resistance to STB is##2##4##(2008-10#2)
resistance to STB##9##3##(2008-10#9)
resistance to Sclerotinia trifoliorum and Sclerotium rolfsii##2##7##(2008-10#2)
resistance to Sclerotinia trifoliorum##6##4##(2008-10#6)
resistance to Sclerotinia##7##3##(2008-10#7)
resistance to Sclerotium rolfsii as expressed in excised leaf tissues and whole plants##2##13##(2008-10#2)
resistance to Sclerotium rolfsii##4##4##(2008-10#4)
resistance to Septoria tritici blotch (STB)##2##6##(2008-10#2)
resistance to Septoria tritici blotch##3##5##(2008-10#3)
resistance to Septoria##4##3##(2008-10#4)
resistance to Stewart's wilt##2##4##(2008-10#2)
resistance to TNF cytotoxicity##3##4##(1990-9#1)(1992-7#1)(1995-3#1)
resistance to TNF##4##3##(1990-9#1)(1992-7#1)(1994-10#1)(1995-3#1)
resistance to Tobacco mosaic virus (TMV)##2##6##(2008-10#2)
resistance to TuMV##3##3##(2008-10#3)
resistance to UA##2##3##(1997-2#2)
resistance to V##2##3##(2008-10#2)
resistance to Verticillium wilt##2##4##(2008-10#2)
resistance to WB##3##3##(2008-10#3)
resistance to X##2##3##(2008-10#2)
resistance to a broad range of##2##6##(2008-10#1)(2008-11#1)
resistance to a broad##3##4##(2008-10#2)(2008-11#1)
resistance to a variety of##2##5##(2008-11#1)(2008-7#1)
resistance to a wide range of##2##6##(2008-4#1)(2011-2#1)
resistance to a##15##3##(1992-5#1)(1997-5#1)(2006-12#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)
resistance to adriamycin##2##3##(1992-11#1)(1993-8#1)
resistance to aflatoxin production and##2##5##(2008-10#2)
resistance to aflatoxin production in##2##5##(2008-10#2)
resistance to aflatoxin production##5##4##(2008-10#5)
resistance to aflatoxin##6##3##(2008-10#6)
resistance to all four##2##4##(1994-11#1)(2008-10#1)
resistance to all##6##3##(1994-11#1)(2007-6#1)(2008-10#3)(2012-2#1)
resistance to amoxicillin-clavulanic acid##2##4##(2006-8#2)
resistance to ampicillin##3##3##(1990-6#2)(2012-3#1)
resistance to anthracnose in the cultivar TO##2##7##(2008-10#2)
resistance to anthracnose##5##3##(2008-10#5)
resistance to anti-leprosy drugs##2##4##(2008-2#2)
resistance to antibacterial##2##3##(1991-3#1)(2008-7#1)
resistance to antibiotics##9##3##(2006-10#2)(2008-1#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
resistance to anticancer drugs##4##4##(2006-11#1)(2008-11#2)(2008-5#1)
resistance to anticancer##5##3##(2006-11#1)(2008-11#3)(2008-5#1)
resistance to antimicrobial agents##2##4##(1991-2#1)(2008-6#1)
resistance to antimicrobial##3##3##(1991-2#1)(1993-10#1)(2008-6#1)
resistance to antimicrobials and##2##4##(2005-11#1)(2008-11#1)
resistance to antimicrobials##3##3##(2005-11#1)(2008-11#1)(2010-4#1)
resistance to antimonials##3##3##(1997-7#1)(2005-9#2)
resistance to apoptosis in##2##4##(1994-10#1)(2005-10#1)
resistance to apoptosis##8##3##(1994-10#1)(1997-2#1)(2005-10#2)(2009-8#1)(2009-9#1)(2011-2#1)(2013-1#1)
resistance to arsenic and##2##4##(2006-11#1)(2008-3#1)
resistance to arsenic##3##3##(2006-11#1)(2008-3#2)
resistance to arsenite and chromium-VI##2##5##(2011-12#2)
resistance to bacterial blight##3##4##(2008-10#3)
resistance to bacterial##12##3##(1994-2#1)(2008-10#8)(2012-2#1)(2013-8#2)
resistance to barley##3##3##(2008-10#2)(2008-8#1)
resistance to be##3##3##(2008-12#1)(2012-12#1)(2012-3#1)
resistance to blast##6##3##(2008-10#5)(2012-2#1)
resistance to both##12##3##(2006-12#2)(2008-10#5)(2008-4#1)(2008-5#2)(2011-2#1)(2012-11#1)
resistance to cells##2##3##(1995-2#1)(2011-1#1)
resistance to change##8##3##(2006-7#2)(2006-8#1)(2007-7#1)(2008-7#1)(2009-4#1)(2010-10#1)(2011-2#1)
resistance to chemo- and##3##4##(2008-11#1)(2012-12#2)
resistance to chemotherapy##3##3##(2008-11#1)(2010-3#1)(2011-2#1)
resistance to cisplatin and##2##4##(1993-1#1)(2008-4#1)
resistance to cisplatin##5##3##(1993-1#1)(1996-11#3)(2008-4#1)
resistance to citrus##2##3##(2008-10#1)(2008-5#1)
resistance to clarithromycin##2##3##(2006-6#2)
resistance to colchicine##2##3##(1994-11#2)
resistance to colonization of the##2##5##(2008-10#2)
resistance to colonization##4##3##(2007-6#1)(2008-10#3)
resistance to commonly##2##3##(2007-8#1)(2012-3#1)
resistance to conventional##3##3##(2008-1#1)(2011-1#1)(2013-1#1)
resistance to copper##2##3##(2004-4#1)(2008-10#1)
resistance to current##3##3##(2008-4#1)(2009-2#1)(2009-5#1)
resistance to cytotoxic drugs##2##4##(1994-11#1)(2008-11#1)
resistance to cytotoxic##3##3##(1994-11#1)(2008-11#2)
resistance to deer##2##3##(2008-8#2)
resistance to detrimental factors##3##4##(2012-3#3)
resistance to different##5##3##(2006-12#1)(2008-10#1)(2008-5#1)(2010-4#1)(2011-1#1)
resistance to disease##3##3##(2008-10#2)(2008-8#1)
resistance to diseases##2##3##(2008-5#1)(2008-8#1)
resistance to downy mildew##2##4##(2008-10#2)
resistance to each##3##3##(1993-8#1)(2008-10#1)(2013-7#1)
resistance to emotional stress##3##4##(1995-12#3)
resistance to erythromycin##2##3##(2008-11#2)
resistance to established##2##3##(2005-7#1)(2005-8#1)
resistance to ethanol##2##3##(1993-4#1)(2008-7#1)
resistance to eyespot##3##3##(2008-10#3)
resistance to fenbuconazole##2##3##(2011-12#2)
resistance to fluconazole##2##3##(2008-5#2)
resistance to fluoroquinolones##2##3##(2006-10#1)(2008-4#1)
resistance to fungal##3##3##(2008-10#3)
resistance to fusarium head blight##2##5##(2008-10#2)
resistance to fusarium##3##3##(2008-10#3)
resistance to gastric##2##3##(1993-3#1)(2012-11#1)
resistance to gastro-intestinal strongylids##2##4##(2008-4#2)
resistance to gentamicin##2##3##(1995-8#1)(2007-7#1)
resistance to glycopeptides##2##3##(1993-5#1)(2006-10#1)
resistance to gray leaf spot##3##5##(2008-10#3)
resistance to gray##4##3##(2008-10#4)
resistance to growth inhibition elicited by the oxidant##2##8##(1994-3#2)
resistance to heat##2##3##(2008-7#1)(2010-9#1)
resistance to high##2##3##(2008-10#1)(2012-1#1)
resistance to hydrolysis##3##3##(2005-11#1)(2012-11#2)
resistance to hygromycin B##2##4##(2008-10#2)
resistance to hygromycin##3##3##(2008-10#3)
resistance to hyperosmotic stress in##2##5##(2006-5#2)
resistance to imatinib##2##3##(2008-6#1)(2012-12#1)
resistance to imipenem##2##3##(2005-8#1)(2012-2#1)
resistance to infection and##3##4##(2006-10#1)(2007-8#1)(2008-10#1)
resistance to infection by schistosomes##2##5##(2009-5#2)
resistance to infection by##4##4##(2008-10#2)(2009-5#2)
resistance to infection##14##3##(1990-6#1)(1994-9#1)(2006-10#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#4)(2009-5#2)
resistance to infections##3##3##(2007-2#1)(2008-10#1)(2008-7#1)
resistance to infectious diseases##3##4##(2008-10#3)
resistance to inhibition by##2##4##(1994-8#1)(1995-11#1)
resistance to insecticides##4##3##(2007-10#1)(2011-2#1)(2012-12#1)(2013-7#1)
resistance to insulin##3##3##(1996-2#1)(2006-2#1)(2010-10#1)
resistance to iprodione and##2##4##(2008-10#2)
resistance to iprodione##4##3##(2008-10#4)
resistance to isolate##4##3##(2008-10#4)
resistance to isolates##2##3##(2008-10#2)
resistance to kanamycin##2##3##(1994-12#1)(2008-10#1)
resistance to killing by free radicals##2##6##(2008-5#2)
resistance to late blight##2##4##(2008-10#2)
resistance to leaf rust and##3##5##(2008-10#3)
resistance to leaf rust##9##4##(2008-10#9)
resistance to leaf##10##3##(2008-10#10)
resistance to local##2##3##(1995-12#1)(2007-7#1)
resistance to malaria##2##3##(1995-12#1)(2013-8#1)
resistance to many##3##3##(2008-10#2)(2011-10#1)
resistance to methotrexate##3##3##(1990-8#1)(1994-3#1)(1995-7#1)
resistance to most##2##3##(2008-10#1)(2013-1#1)
resistance to multiple##2##3##(2005-8#1)(2007-8#1)
resistance to necrosis induced by##3##5##(2008-10#3)
resistance to one or more##2##5##(2008-10#1)(2013-8#1)
resistance to other##6##3##(1997-6#1)(2006-11#1)(2008-10#1)(2009-11#2)(2011-1#1)
resistance to oxidative stress##9##4##(1997-6#1)(2005-8#1)(2006-12#1)(2006-8#1)(2006-9#1)(2008-3#2)(2008-4#1)(2010-4#1)
resistance to pathogen##2##3##(2008-10#2)
resistance to pathogens##2##3##(1997-7#1)(2008-10#1)
resistance to pathotype##2##3##(2008-10#2)
resistance to penicillin##2##3##(2006-10#1)(2006-8#1)
resistance to penicillins##3##3##(1993-5#1)(2008-4#1)(2010-4#1)
resistance to permethrin##2##3##(2011-2#1)(2012-2#1)
resistance to plant##2##3##(2008-10#1)(2009-8#1)
resistance to platinum##2##3##(2008-4#2)
resistance to powdery mildew in##2##5##(2008-10#2)
resistance to powdery mildew##6##4##(2008-10#6)
resistance to proteolysis##3##3##(1990-5#2)(1995-8#1)
resistance to race 2##4##4##(2008-10#4)
resistance to race##9##3##(2008-10#9)
resistance to races 1 and 4##3##6##(2008-10#3)
resistance to races 1##5##4##(2008-10#5)
resistance to races##7##3##(2008-10#7)
resistance to rice blast##6##4##(2008-10#6)
resistance to septoria speckled leaf blotch in barley##2##8##(2008-10#2)
resistance to septoria##3##3##(2008-10#3)
resistance to several##4##3##(1994-6#1)(2008-10#1)(2008-8#2)
resistance to sliding##2##3##(2010-10#2)
resistance to some of the##2##5##(2006-10#1)(2008-10#1)
resistance to spread of scab within a spike##2##8##(2008-10#2)
resistance to stem rust and##2##5##(2008-10#2)
resistance to stripe rust##8##4##(2008-10#8)
resistance to tan spot##3##4##(2008-10#3)
resistance to the antibiotic##2##4##(1993-2#1)(1993-5#1)
resistance to the different##2##4##(2008-5#2)
resistance to the disease##2##4##(1991-2#1)(2008-10#1)
resistance to the drug##3##4##(1995-4#1)(2005-8#1)(2010-12#1)
resistance to the fungus##2##4##(2008-10#1)(2011-10#1)
resistance to the heterologous##2##4##(2008-10#2)
resistance to the inappropriate rust species##2##6##(2008-10#2)
resistance to the isolate IPO323##2##5##(2008-10#2)
resistance to the root-lesion nematode##2##5##(2008-10#2)
resistance to the same isolate##2##5##(2008-10#2)
resistance to the three##3##4##(2007-2#1)(2008-10#2)
resistance to the toxic##2##4##(2006-8#1)(2008-5#1)
resistance to the##83##3##(1990-10#1)(1990-12#1)(1990-7#1)(1991-1#3)(1991-2#1)(1991-3#1)(1993-2#1)(1993-5#1)(1994-10#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-4#1)(1996-7#1)(1997-8#1)(2005-11#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-8#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#26)(2008-11#1)(2008-12#1)(2008-5#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-10#2)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#4)
resistance to therapy##3##3##(1995-2#1)(2006-10#1)(2012-3#1)
resistance to these pathogens##3##4##(2008-10#2)(2009-10#1)
resistance to these##15##3##(1991-12#1)(1993-6#1)(2006-12#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#5)(2009-10#1)(2012-1#1)(2013-1#1)
resistance to third generation##2##4##(2007-7#1)(2012-2#1)
resistance to this class of##2##5##(2008-11#1)(2011-2#1)
resistance to this##8##3##(1994-10#1)(1997-4#1)(2006-8#1)(2008-10#3)(2008-11#1)(2011-2#1)
resistance to three##4##3##(2008-10#2)(2008-8#1)(2011-1#1)
resistance to thyroid hormone##5##4##(1995-10#2)(1995-8#3)
resistance to trastuzumab##2##3##(2008-5#1)(2013-1#1)
resistance to two##6##3##(2008-10#5)(2011-3#1)
resistance to vancomycin##2##3##(2007-12#1)(2010-8#1)
resistance to various anticancer##2##4##(1997-4#1)(2008-7#1)
resistance to various##7##3##(1994-8#1)(1997-4#2)(2007-7#1)(2008-12#1)(2008-7#1)(2008-8#1)
resistance to vector pathogens##3##4##(2008-11#3)
resistance to vinblastine##2##3##(1994-11#2)
resistance to vincristine##2##3##(1993-8#2)
resistance to virus infection##2##4##(2008-10#2)
resistance to water##2##3##(2008-5#1)(2013-1#1)
resistance to wheat##2##3##(2008-10#2)
resistance to white pine blister rust##6##6##(2008-10#6)
resistance to white pine blister##7##5##(2008-10#7)
resistance to##1111##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#3)(1990-6#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#3)(1991-10#2)(1991-12#3)(1991-2#3)(1991-3#3)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#3)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#3)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#3)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#2)(1993-5#4)(1993-6#1)(1993-8#4)(1993-9#3)(1994-10#5)(1994-11#7)(1994-12#2)(1994-2#2)(1994-3#6)(1994-6#6)(1994-8#6)(1994-9#2)(1995-1#1)(1995-10#2)(1995-11#4)(1995-12#7)(1995-2#5)(1995-3#2)(1995-4#2)(1995-6#6)(1995-7#4)(1995-8#5)(1996-1#1)(1996-10#1)(1996-11#4)(1996-12#1)(1996-2#1)(1996-7#3)(1996-9#1)(1997-1#2)(1997-2#8)(1997-3#3)(1997-4#3)(1997-5#3)(1997-6#3)(1997-7#4)(1997-8#1)(2004-11#3)(2004-12#1)(2004-4#2)(2005-10#5)(2005-11#7)(2005-7#6)(2005-8#9)(2005-9#3)(2006-10#20)(2006-11#5)(2006-12#8)(2006-2#1)(2006-4#2)(2006-5#3)(2006-6#2)(2006-7#3)(2006-8#9)(2006-9#2)(2007-10#6)(2007-11#6)(2007-12#4)(2007-2#2)(2007-3#2)(2007-6#5)(2007-7#11)(2007-8#4)(2007-9#2)(2008-1#8)(2008-10#445)(2008-11#28)(2008-12#8)(2008-2#5)(2008-3#8)(2008-4#19)(2008-5#31)(2008-6#4)(2008-7#13)(2008-8#16)(2008-9#7)(2009-10#1)(2009-11#5)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#10)(2009-6#7)(2009-7#1)(2009-8#6)(2009-9#2)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#5)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#8)(2011-10#6)(2011-12#6)(2011-2#32)(2011-3#4)(2012-1#7)(2012-11#9)(2012-12#11)(2012-2#11)(2012-3#17)(2013-1#22)(2013-7#4)(2013-8#12)
resistance toward##3##2##(2008-10#2)(2008-11#1)
resistance towards##5##2##(1990-12#1)(1995-9#1)(2008-4#1)(2010-2#1)(2011-2#1)
resistance trained##5##2##(2008-5#5)
resistance training group##2##3##(2013-1#2)
resistance training program##2##3##(2007-12#1)(2008-5#1)
resistance training##18##2##(2007-12#1)(2008-5#10)(2010-1#1)(2012-12#1)(2013-1#5)
resistance trait##4##2##(1994-3#2)(2008-10#2)
resistance traits in##2##3##(2008-10#2)
resistance traits##6##2##(2008-10#4)(2008-8#2)
resistance transferred##2##2##(2008-10#2)
resistance triggered by##2##3##(1995-7#1)(2008-10#1)
resistance types##2##2##(2008-8#2)
resistance under field conditions##3##4##(2008-10#3)
resistance under##4##2##(2007-12#1)(2008-10#3)
resistance used in##2##3##(2008-10#2)
resistance using a##2##3##(2007-7#1)(2008-10#1)
resistance using##9##2##(2005-11#1)(2007-7#1)(2008-10#5)(2008-11#1)(2012-2#1)
resistance varied##3##2##(2008-10#1)(2008-5#1)(2009-2#1)
resistance vessels of##2##3##(1990-6#1)(2008-4#1)
resistance vessels##6##2##(1990-6#1)(1991-5#1)(1993-11#1)(2007-8#1)(2008-4#1)(2008-7#1)
resistance via##3##2##(1995-3#1)(2008-10#2)
resistance was also##3##3##(1995-7#1)(2008-10#2)
resistance was confirmed by##2##4##(2008-10#1)(2012-2#1)
resistance was detected in##2##4##(1993-8#1)(2008-11#1)
resistance was determined##2##3##(2008-10#1)(2008-3#1)
resistance was estimated by##2##4##(2008-10#1)(2008-3#1)
resistance was estimated##3##3##(2008-10#2)(2008-3#1)
resistance was evaluated##4##3##(1995-7#1)(2008-10#3)
resistance was found to be##3##5##(2008-10#2)(2011-1#1)
resistance was found##5##3##(2008-10#3)(2009-6#1)(2011-1#1)
resistance was high##2##3##(2007-7#1)(2008-10#1)
resistance was identified##2##3##(2008-10#2)
resistance was induced##2##3##(2008-10#2)
resistance was less##2##3##(1993-12#1)(1994-7#1)
resistance was manifested##2##3##(2008-10#2)
resistance was measured##3##3##(2007-8#1)(2008-1#1)(2008-10#1)
resistance was more##2##3##(2008-10#1)(2008-3#1)
resistance was not found##2##4##(1991-8#1)(2006-8#1)
resistance was not##6##3##(1991-8#1)(1992-1#1)(1993-12#1)(2006-8#1)(2008-10#2)
resistance was observed among##2##4##(2008-10#1)(2010-9#1)
resistance was observed in##6##4##(1995-6#1)(2006-10#1)(2008-10#3)(2008-5#1)
resistance was observed##12##3##(1991-12#1)(1995-6#1)(2006-10#1)(2007-8#1)(2008-10#6)(2008-5#1)(2010-9#1)
resistance was obtained##2##3##(2008-10#2)
resistance was seen##2##3##(2008-10#1)(2012-2#1)
resistance was significantly##2##3##(1991-8#1)(2008-3#1)
resistance was studied##2##3##(2008-10#2)
resistance was##102##2##(1991-12#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-5#1)(1992-6#1)(1993-12#2)(1993-8#1)(1994-7#1)(1995-6#1)(1995-7#2)(2006-10#1)(2006-8#2)(2006-9#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#58)(2008-11#1)(2008-3#5)(2008-5#2)(2009-10#1)(2009-6#1)(2010-9#1)(2011-1#1)(2011-12#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#1)
resistance were identified##4##3##(2008-10#3)(2013-8#1)
resistance were not##4##3##(2008-10#3)(2008-11#1)
resistance were observed in##2##4##(2008-10#1)(2012-2#1)
resistance were positive for the##2##5##(2011-2#2)
resistance were studied in##2##4##(1997-5#1)(2004-4#1)
resistance were studied##4##3##(1997-5#1)(2004-4#1)(2008-10#2)
resistance were##37##2##(1992-3#1)(1994-9#1)(1997-5#1)(2004-4#1)(2005-8#1)(2006-8#1)(2007-7#1)(2007-9#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
resistance when present##2##3##(1994-9#1)(2008-10#1)
resistance when##4##2##(1990-9#1)(1994-9#1)(2008-10#2)
resistance will##6##2##(1995-9#1)(1997-7#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-10#1)
resistance with##9##2##(1994-12#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-7#1)(2010-8#1)(2013-1#1)
resistance within##5##2##(2005-7#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)
resistance##4677##1##(1990-1#1)(1990-10#2)(1990-11#5)(1990-12#2)(1990-2#9)(1990-3#1)(1990-5#8)(1990-6#8)(1990-7#7)(1990-8#3)(1990-9#8)(1991-1#4)(1991-10#4)(1991-12#7)(1991-2#14)(1991-3#6)(1991-4#2)(1991-5#6)(1991-6#3)(1991-7#11)(1991-8#12)(1991-9#9)(1992-1#5)(1992-10#1)(1992-11#7)(1992-12#2)(1992-2#4)(1992-3#8)(1992-4#1)(1992-5#5)(1992-6#5)(1992-7#2)(1992-8#15)(1992-9#3)(1993-1#3)(1993-10#3)(1993-11#6)(1993-12#13)(1993-2#5)(1993-3#4)(1993-4#3)(1993-5#6)(1993-6#5)(1993-7#5)(1993-8#12)(1993-9#14)(1994-10#5)(1994-11#24)(1994-12#9)(1994-2#6)(1994-3#16)(1994-4#1)(1994-5#5)(1994-6#14)(1994-7#8)(1994-8#19)(1994-9#18)(1995-1#5)(1995-10#3)(1995-11#7)(1995-12#11)(1995-2#12)(1995-3#6)(1995-4#5)(1995-5#9)(1995-6#14)(1995-7#12)(1995-8#13)(1995-9#4)(1996-1#2)(1996-10#4)(1996-11#10)(1996-12#7)(1996-2#5)(1996-3#4)(1996-4#6)(1996-5#7)(1996-6#2)(1996-7#11)(1996-8#4)(1996-9#3)(1997-1#4)(1997-2#18)(1997-3#7)(1997-4#12)(1997-5#16)(1997-6#15)(1997-7#19)(1997-8#1)(2004-10#2)(2004-11#7)(2004-12#2)(2004-2#2)(2004-4#9)(2004-9#7)(2005-1#5)(2005-10#22)(2005-11#24)(2005-12#3)(2005-4#1)(2005-6#2)(2005-7#18)(2005-8#51)(2005-9#5)(2006-1#6)(2006-10#66)(2006-11#31)(2006-12#39)(2006-2#5)(2006-3#2)(2006-4#6)(2006-5#6)(2006-6#5)(2006-7#4)(2006-8#33)(2006-9#13)(2007-1#2)(2007-10#12)(2007-11#22)(2007-12#38)(2007-2#16)(2007-3#4)(2007-4#1)(2007-5#6)(2007-6#19)(2007-7#52)(2007-8#30)(2007-9#16)(2008-1#96)(2008-10#1687)(2008-11#108)(2008-12#38)(2008-2#20)(2008-3#119)(2008-4#60)(2008-5#109)(2008-6#17)(2008-7#47)(2008-8#90)(2008-9#33)(2009-1#5)(2009-10#14)(2009-11#15)(2009-2#13)(2009-3#32)(2009-4#6)(2009-5#18)(2009-6#31)(2009-7#2)(2009-8#37)(2009-9#5)(2010-1#3)(2010-10#20)(2010-11#21)(2010-12#20)(2010-2#24)(2010-3#1)(2010-4#24)(2010-5#6)(2010-6#6)(2010-7#4)(2010-8#19)(2010-9#9)(2011-1#60)(2011-10#15)(2011-12#36)(2011-2#134)(2011-3#7)(2012-1#27)(2012-11#45)(2012-12#55)(2012-2#67)(2012-3#54)(2012-5#5)(2013-1#109)(2013-7#8)(2013-8#50)
resistance&quot##8##1##(1991-2#1)(2006-8#1)(2007-8#1)(2008-3#1)(2011-2#2)(2012-11#1)(2013-1#1)
resistance) and##3##2##(2006-10#1)(2008-10#1)(2008-5#1)
resistance) were##2##2##(1995-3#1)(2006-10#1)
resistance)##18##1##(1991-8#1)(1994-12#1)(1995-3#1)(2006-10#3)(2006-12#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2011-1#1)(2012-2#1)
resistance-associated protein 1##2##3##(2008-5#2)
resistance-associated protein##7##2##(1997-4#1)(1997-7#1)(2005-8#1)(2008-11#2)(2008-5#2)
resistance-associated proteins##2##2##(2008-10#2)
resistance-associated##13##1##(1997-4#1)(1997-7#1)(2005-8#1)(2008-10#2)(2008-11#4)(2008-5#2)(2012-2#1)(2013-8#1)
resistance-breaking (RB)##2##2##(2008-10#2)
resistance-breaking strains##2##2##(2008-10#2)
resistance-breaking##7##1##(2008-10#7)
resistance-correlated oligonucleotides##6##2##(2011-2#6)
resistance-encoding##2##1##(1993-5#1)(1995-8#1)
resistance-inducing##3##1##(2008-10#2)(2008-11#1)
resistance-related##3##1##(2010-12#2)(2010-8#1)
resistance-trained males##3##2##(2008-5#3)
resistance-trained##5##1##(2008-5#5)
resistance-training##4##1##(2008-5#4)
resistance]##5##1##(1991-6#1)(1995-4#1)(2005-1#1)(2005-11#1)(2013-1#1)
resistances and virulence##2##3##(2012-3#2)
resistances and##5##2##(2004-12#1)(2007-9#1)(2008-10#1)(2012-3#2)
resistances in##6##2##(1995-3#1)(1997-5#2)(1997-7#1)(2004-12#1)(2008-8#1)
resistances to##9##2##(1992-2#1)(2005-10#1)(2008-10#6)(2013-7#1)
resistances##35##1##(1990-12#1)(1992-2#1)(1992-8#1)(1995-3#1)(1997-5#3)(1997-7#1)(2004-12#2)(2005-10#1)(2005-8#2)(2007-9#1)(2008-10#9)(2008-12#1)(2008-8#2)(2009-3#2)(2010-12#1)(2010-4#1)(2012-3#2)(2013-1#1)(2013-7#2)
resistant 'Burley 21' transgenic lines##2##5##(2008-10#2)
resistant (MDR)##6##2##(1996-1#1)(1996-8#1)(1996-9#1)(2007-6#1)(2007-7#1)(2010-2#1)
resistant (R)##2##2##(1992-11#2)
resistant A(549)/DDP cells##3##3##(2008-9#3)
resistant B##3##2##(2006-8#1)(2008-10#2)
resistant E##2##2##(2007-7#1)(2008-12#1)
resistant Gram-positive##6##2##(1994-9#1)(2006-10#3)(2008-3#2)
resistant HIV-1##4##2##(1996-7#2)(2009-11#1)(2011-2#1)
resistant HeLa cells##2##3##(1990-7#1)(1994-10#1)
resistant MHC##2##2##(2013-8#2)
resistant P##2##2##(2005-8#1)(2008-10#1)
resistant Pseudomonas aeruginosa##2##3##(2009-5#1)(2012-2#1)
resistant QTL##2##2##(2012-3#2)
resistant RBC mode##2##3##(2008-10#2)
resistant S##7##2##(1994-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2012-2#2)(2012-3#1)
resistant Salmonella##3##2##(1993-8#1)(1996-6#1)(2010-4#1)
resistant Staphylococcus aureus (MRSA) strains##2##5##(2007-7#1)(2010-8#1)
resistant Staphylococcus aureus (MRSA)##7##4##(1992-4#1)(1996-7#1)(2005-8#1)(2007-7#2)(2010-2#1)(2010-8#1)
resistant Staphylococcus aureus##15##3##(1992-4#2)(1996-7#2)(2005-8#1)(2006-4#1)(2007-7#3)(2007-8#1)(2009-4#1)(2009-7#1)(2010-2#1)(2010-8#2)
resistant Staphylococcus##17##2##(1991-3#1)(1992-4#2)(1996-7#2)(2005-8#1)(2006-4#1)(2007-7#3)(2007-8#2)(2009-4#1)(2009-7#1)(2010-2#1)(2010-8#2)
resistant TB (XDR-TB)##2##3##(2008-10#1)(2010-5#1)
resistant TB##3##2##(2008-10#1)(2010-5#1)(2013-8#1)
resistant accession##5##2##(2008-10#3)(2009-3#2)
resistant accessions##5##2##(2008-10#5)
resistant against##3##2##(1991-2#1)(1991-5#1)(1994-9#1)
resistant and sensitive pathogen strains##3##5##(2008-10#3)
resistant and sensitive strains##2##4##(2008-10#1)(2010-12#1)
resistant and sensitive##9##3##(2008-10#5)(2009-4#1)(2010-12#2)(2010-8#1)
resistant and susceptible accessions##2##4##(2009-3#2)
resistant and susceptible barley##2##4##(2008-10#2)
resistant and susceptible cultivar##2##4##(2008-10#2)
resistant and susceptible cultivars##3##4##(2008-10#3)
resistant and susceptible families##2##4##(2008-10#1)(2011-10#1)
resistant and susceptible genotypes##2##4##(2008-10#2)
resistant and susceptible plants##2##4##(2008-10#2)
resistant and susceptible to##2##4##(2008-10#2)
resistant and susceptible##31##3##(1996-12#1)(2008-10#26)(2009-3#2)(2011-10#1)(2012-3#1)
resistant and##57##2##(1992-9#1)(1996-12#1)(1997-8#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#37)(2008-3#1)(2008-5#1)(2009-3#2)(2009-4#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-10#1)(2012-3#1)(2013-8#1)
resistant animal##2##2##(1991-3#1)(2006-10#1)
resistant apple fruits##2##3##(2008-10#2)
resistant apple##4##2##(2008-10#4)
resistant at the adult##2##4##(2008-10#2)
resistant at##6##2##(2008-10#6)
resistant atrial arrhythmias##2##3##(2006-12#2)
resistant bacteria##10##2##(2005-7#2)(2008-5#3)(2012-12#1)(2012-2#1)(2013-1#3)
resistant bacterial strains##2##3##(2008-5#1)(2010-11#1)
resistant bacterial##3##2##(2007-11#1)(2008-5#1)(2010-11#1)
resistant bean##2##2##(2008-10#1)(2011-1#1)
resistant berries##8##2##(2008-10#8)
resistant but##2##2##(2007-7#1)(2008-10#1)
resistant by resistant##2##3##(2008-10#2)
resistant by##3##2##(2008-10#3)
resistant cactus##4##2##(2008-10#4)
resistant cancer##2##2##(2008-11#1)(2008-5#1)
resistant cases##2##2##(1996-3#1)(2012-1#1)
resistant cell line##2##3##(1990-5#1)(2008-11#1)
resistant cell lines##9##3##(1990-2#1)(1992-2#1)(1994-8#1)(1995-5#1)(1995-8#2)(2008-11#1)(2010-5#2)
resistant cell##12##2##(1990-12#1)(1990-2#1)(1990-5#1)(1992-2#1)(1994-8#1)(1995-5#1)(1995-8#2)(2008-11#2)(2010-5#2)
resistant cells and##2##3##(2008-1#1)(2008-11#1)
resistant cells##28##2##(1990-10#1)(1990-2#2)(1990-7#2)(1991-4#1)(1992-11#1)(1992-2#4)(1992-9#1)(1994-11#1)(1994-3#2)(1994-8#2)(1995-5#1)(2008-1#1)(2008-11#8)(2008-4#1)
resistant check##3##2##(2008-10#3)
resistant clinical isolates of Pseudomonas aeruginosa##2##6##(2012-2#2)
resistant clinical isolates of##3##4##(2010-12#1)(2012-2#2)
resistant clinical isolates##6##3##(2010-12#2)(2011-1#1)(2012-2#3)
resistant clones##3##2##(1994-9#1)(1995-11#1)(2008-10#1)
resistant colonies##2##2##(1995-7#1)(1996-10#1)
resistant corn genotypes##3##3##(2008-10#3)
resistant corn##4##2##(2008-10#4)
resistant crosses##2##2##(2008-10#2)
resistant cultivar##22##2##(2008-10#19)(2011-10#1)(2012-11#2)
resistant cultivars is the##2##4##(2008-10#2)
resistant cultivars of##4##3##(2008-10#4)
resistant cultivars would be##2##4##(2008-10#2)
resistant cultivars##49##2##(2008-10#47)(2008-12#1)(2012-11#1)
resistant cv##9##2##(2008-10#8)(2008-6#1)
resistant cvs##3##2##(2008-10#3)
resistant disease##8##2##(1990-10#1)(1995-12#1)(2006-10#2)(2008-5#1)(2009-3#1)(2010-7#1)(2013-7#1)
resistant ecotype S96##2##3##(2008-10#2)
resistant ecotypes##2##2##(2008-10#2)
resistant efflux##2##2##(2006-8#2)
resistant families##3##2##(2008-10#3)
resistant field##2##2##(2008-10#2)
resistant fruit##3##2##(2008-10#3)
resistant gene##4##2##(1993-8#1)(1997-8#1)(2008-11#1)(2008-8#1)
resistant genes##3##2##(1995-11#1)(2006-8#2)
resistant genotype##8##2##(2008-10#7)(2008-8#1)
resistant genotypes and##2##3##(2008-10#2)
resistant genotypes##24##2##(2008-10#23)(2008-12#1)
resistant host##4##2##(2008-10#3)(2008-8#1)
resistant human##3##2##(1990-5#1)(1991-7#1)(2012-2#1)
resistant hypertension##3##2##(2010-6#2)(2013-8#1)
resistant in the##2##3##(1990-12#1)(2008-10#1)
resistant in##4##2##(1990-12#1)(2007-7#1)(2008-10#2)
resistant inbred##3##2##(2008-10#3)
resistant individuals##5##2##(2008-1#1)(2008-10#3)(2011-2#1)
resistant isolate##2##2##(1993-8#1)(2010-12#1)
resistant isolates of##5##3##(2008-10#4)(2010-3#1)
resistant isolates##29##2##(2006-10#1)(2006-4#1)(2007-7#2)(2008-10#22)(2008-5#1)(2010-3#1)(2012-2#1)
resistant line##11##2##(1991-2#1)(1992-2#1)(1994-11#1)(1997-6#1)(2008-10#6)(2008-5#1)
resistant lines compared with##2##4##(2008-10#2)
resistant lines##17##2##(1990-2#1)(2006-12#1)(2008-10#14)(2008-5#1)
resistant maize lines##2##3##(2008-10#2)
resistant maize##3##2##(2008-10#3)
resistant malaria##3##2##(2006-4#1)(2007-6#1)(2008-11#1)
resistant mutant##3##2##(1996-7#1)(2006-11#1)(2006-8#1)
resistant mutations##3##2##(1997-4#1)(2010-11#1)(2012-1#1)
resistant only to one##2##4##(2008-5#2)
resistant only to vinclozolin (S(T)R(V))##2##5##(2008-10#2)
resistant only to##4##3##(2008-10#2)(2008-5#2)
resistant or recurrent##2##3##(2007-7#1)(2009-11#1)
resistant or susceptible to##3##4##(2008-10#3)
resistant or susceptible##6##3##(2008-10#6)
resistant or##12##2##(2007-7#1)(2008-10#8)(2009-11#1)(2010-4#1)(2012-12#1)
resistant organisms##7##2##(2005-8#1)(2007-12#1)(2008-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
resistant ovary syndrome##2##3##(1996-2#2)
resistant ovary##3##2##(1996-2#2)(2012-3#1)
resistant parent##7##2##(2008-10#7)
resistant pathogens##6##2##(2005-11#1)(2005-7#2)(2006-10#1)(2009-4#1)(2011-1#1)
resistant pepper##4##2##(2008-10#4)
resistant phenotype of##2##3##(1995-6#1)(2006-8#1)
resistant phenotype was##2##3##(1997-4#1)(2008-10#1)
resistant phenotype##6##2##(1992-2#1)(1995-6#1)(1996-9#1)(1997-4#1)(2006-8#1)(2008-10#1)
resistant plant##2##2##(2008-10#1)(2008-12#1)
resistant plants and##2##3##(2008-10#1)(2008-8#1)
resistant plants showed##2##3##(2008-10#2)
resistant plants##21##2##(1991-7#1)(2008-10#18)(2008-8#1)(2012-11#1)
resistant population##2##2##(2004-11#1)(2008-10#1)
resistant potato##2##2##(2008-10#2)
resistant reactions##2##2##(2008-10#2)
resistant respiration is##2##3##(1990-4#2)
resistant respiration##5##2##(1990-4#5)
resistant roots##4##2##(2008-10#4)
resistant seedlings##5##2##(2008-10#5)
resistant sorghum##2##2##(2008-10#2)
resistant soybean##2##2##(2008-10#1)(2009-3#1)
resistant species##3##2##(1996-5#1)(2008-1#1)(2008-10#1)
resistant starch##3##2##(2006-10#2)(2010-8#1)
resistant starches##3##2##(2006-10#2)(2012-1#1)
resistant states##2##2##(1994-3#1)(2008-1#1)
resistant stems##3##2##(2008-10#3)
resistant strain of##2##3##(2010-12#1)(2011-2#1)
resistant strain##5##2##(2008-10#1)(2010-12#1)(2011-2#3)
resistant strains could be##2##4##(2008-1#1)(2008-10#1)
resistant strains of##4##3##(2007-7#1)(2008-10#1)(2013-8#2)
resistant strains were##3##3##(2007-8#1)(2008-10#1)(2011-12#1)
resistant strains##38##2##(1990-5#1)(1993-5#3)(1996-12#1)(1997-3#1)(1997-7#1)(2005-8#2)(2006-10#1)(2006-11#2)(2006-2#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-11#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#2)
resistant subline##2##2##(1990-2#2)
resistant sublines of##3##3##(1990-10#1)(1994-3#1)(1997-4#1)
resistant sublines##7##2##(1990-10#1)(1994-3#2)(1997-4#2)(2008-4#2)
resistant than##16##2##(1990-12#1)(1990-2#1)(1991-5#1)(1994-11#1)(1994-9#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
resistant to 0##2##3##(1991-2#1)(1992-11#1)
resistant to A##2##3##(2008-10#2)
resistant to CAV/PE alternating##2##4##(1991-12#2)
resistant to CCCP##2##3##(1991-8#2)
resistant to DDT##2##3##(2012-2#1)(2013-1#1)
resistant to Fusarium##2##3##(2008-10#2)
resistant to P##4##3##(2008-10#3)(2008-8#1)
resistant to TNF##2##3##(1992-7#1)(1992-9#1)
resistant to TRAIL##2##3##(2009-9#1)(2012-2#1)
resistant to Verticillium##2##3##(2008-10#2)
resistant to a##4##3##(1993-9#1)(1996-7#1)(1997-2#1)(2005-8#1)
resistant to activation-induced apoptosis##2##4##(2008-10#2)
resistant to all tested##3##4##(2008-10#1)(2008-5#1)(2010-5#1)
resistant to all three##3##4##(2008-10#1)(2008-5#1)(2009-3#1)
resistant to all##15##3##(2005-8#1)(2007-6#1)(2008-10#5)(2008-5#3)(2009-3#1)(2009-5#1)(2010-10#1)(2010-5#1)(2012-2#1)
resistant to ampicillin##4##3##(1993-1#1)(1993-8#1)(2007-7#1)(2010-8#1)
resistant to an##2##3##(2008-10#1)(2008-5#1)
resistant to antibiotics##5##3##(1995-3#1)(1997-4#1)(2006-8#1)(2008-5#1)(2009-10#1)
resistant to antifungal##2##3##(2006-11#1)(2011-2#1)
resistant to apoptosis induced by##2##5##(1995-3#1)(1995-8#1)
resistant to apoptosis##4##3##(1995-3#1)(1995-8#1)(2008-8#1)(2009-9#1)
resistant to at least##3##4##(1993-8#1)(2008-6#1)(2011-2#1)
resistant to attack##2##3##(2008-10#1)(2011-10#1)
resistant to azoxystrobin and##2##4##(2008-10#2)
resistant to bacterial##3##3##(2006-11#1)(2008-8#1)(2009-10#1)
resistant to both fungicides (R(T)R(V))##3##5##(2008-10#3)
resistant to both##14##3##(1991-2#1)(1992-9#1)(2006-10#1)(2008-10#10)(2008-5#1)
resistant to calcification##2##3##(2004-9#1)(2013-1#1)
resistant to cephalosporins##2##3##(2011-2#2)
resistant to chemotherapy##2##3##(2009-11#1)(2013-8#1)
resistant to ciprofloxacin##2##3##(2005-7#1)(2008-7#1)
resistant to cisplatin##2##3##(1992-2#1)(1994-8#1)
resistant to common##2##3##(1990-5#1)(2007-11#1)
resistant to conservative##6##3##(2006-12#2)(2008-9#1)(2010-3#1)(2013-1#2)
resistant to conventional therapies##2##4##(2010-12#1)(2010-9#1)
resistant to conventional therapy##4##4##(1993-8#2)(2007-2#1)(2011-2#1)
resistant to conventional##9##3##(1993-8#2)(1995-12#1)(2007-2#1)(2010-12#2)(2010-2#1)(2010-9#1)(2011-2#1)
resistant to crown rust##2##4##(2008-10#2)
resistant to currently##2##3##(2008-4#1)(2008-5#1)
resistant to digestion##2##3##(1990-9#1)(2008-9#1)
resistant to either##2##3##(2008-10#1)(2010-4#1)
resistant to enzymatic degradation##2##4##(1993-2#1)(2008-5#1)
resistant to enzymatic##3##3##(1993-2#1)(2008-5#1)(2009-8#1)
resistant to erythromycin and##3##4##(2007-7#1)(2008-11#1)(2008-5#1)
resistant to erythromycin##4##3##(2007-12#1)(2007-7#1)(2008-11#1)(2008-5#1)
resistant to fluconazole and##2##4##(2007-7#1)(2008-5#1)
resistant to fluconazole##5##3##(2007-7#1)(2008-10#1)(2008-5#3)
resistant to fluorouracil##3##3##(1990-2#3)
resistant to high##2##3##(1994-11#1)(2009-2#1)
resistant to hydrolysis##2##3##(1994-11#2)
resistant to imatinib or nilotinib##2##5##(2012-12#2)
resistant to imatinib##4##3##(2007-12#1)(2009-3#1)(2012-12#2)
resistant to immunosuppressive##2##3##(2006-10#2)
resistant to infection by##2##4##(2008-10#1)(2010-7#1)
resistant to infection##5##3##(1993-5#1)(2008-10#2)(2010-7#1)(2011-2#1)
resistant to leaf##2##3##(2008-10#2)
resistant to many##2##3##(2005-8#1)(2010-11#1)
resistant to methicillin##2##3##(1991-4#1)(2008-1#1)
resistant to metronidazole##2##3##(2006-8#2)
resistant to most of the##2##5##(2005-8#1)(2008-10#1)
resistant to most##8##3##(2005-8#2)(2006-11#1)(2008-10#2)(2008-11#1)(2013-1#2)
resistant to one or more##2##5##(2007-11#1)(2013-8#1)
resistant to one or##3##4##(2007-11#1)(2008-10#1)(2013-8#1)
resistant to one##4##3##(2007-11#1)(2008-10#2)(2013-8#1)
resistant to other therapies##2##4##(1990-5#1)(2006-12#1)
resistant to other##8##3##(1990-5#1)(1991-12#1)(2005-7#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)
resistant to penicillin##9##3##(1995-3#1)(2007-7#1)(2007-8#2)(2008-12#2)(2009-5#1)(2011-2#1)(2013-8#1)
resistant to powdery mildew##3##4##(2008-10#3)
resistant to proteolysis##5##3##(1990-5#1)(1992-11#1)(1992-3#1)(1996-7#1)(2010-6#1)
resistant to proteolytic##2##3##(1992-9#1)(1996-9#1)
resistant to race 1##2##4##(2008-10#2)
resistant to race##3##3##(2008-10#3)
resistant to repeated##2##3##(2007-8#1)(2010-2#1)
resistant to several##2##3##(2011-2#1)(2012-2#1)
resistant to strain GMI1000##2##4##(2008-10#2)
resistant to stress##2##3##(1996-2#2)
resistant to stripe rust##2##4##(2008-10#2)
resistant to tamoxifen##4##3##(1992-8#1)(1993-1#2)(1994-6#1)
resistant to the action of IGF-1##2##6##(1994-11#2)
resistant to the action of##4##5##(1992-11#1)(1994-11#2)(1995-2#1)
resistant to the cytotoxic effects of##2##6##(1995-3#1)(1996-9#1)
resistant to the effects of##2##5##(1996-4#1)(1996-5#1)
resistant to the inhibitory effect of##2##6##(1994-6#1)(2006-10#1)
resistant to the##49##3##(1991-4#1)(1991-7#2)(1991-8#1)(1992-10#1)(1992-11#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-11#2)(1994-12#1)(1994-6#1)(1995-2#3)(1995-3#1)(1995-8#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2006-9#2)(2008-10#8)(2008-11#1)(2008-7#1)(2009-11#1)(2010-4#1)(2011-1#1)(2011-10#1)(2011-2#1)(2013-1#1)
resistant to therapy##2##3##(1995-12#1)(2008-5#1)
resistant to thiophanate-methy1##2##3##(2008-10#2)
resistant to thiophanate-methyl##3##3##(2008-10#3)
resistant to this##3##3##(1991-12#1)(1992-5#1)(1994-10#1)
resistant to three##2##3##(1991-6#1)(2011-2#1)
resistant to thrombin##2##3##(1991-6#2)
resistant to topical##3##3##(2005-11#1)(2007-7#1)(2007-8#1)
resistant to treatment##6##3##(1992-6#1)(2004-11#1)(2007-11#1)(2007-7#1)(2011-3#1)(2013-8#1)
resistant to two##3##3##(2008-10#2)(2011-2#1)
resistant to vinclozolin (S(T)R(V))##2##4##(2008-10#2)
resistant to vinclozolin##3##3##(2008-10#3)
resistant to##586##2##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#4)(1990-5#3)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#3)(1991-3#2)(1991-4#3)(1991-5#2)(1991-6#3)(1991-7#5)(1991-8#4)(1991-9#1)(1992-1#2)(1992-10#2)(1992-11#4)(1992-12#2)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#6)(1993-1#3)(1993-10#2)(1993-11#3)(1993-12#4)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#3)(1993-8#8)(1993-9#4)(1994-10#1)(1994-11#8)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#4)(1994-9#2)(1995-1#3)(1995-10#3)(1995-12#2)(1995-2#3)(1995-3#6)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#4)(1995-9#1)(1996-12#2)(1996-2#2)(1996-4#2)(1996-5#6)(1996-7#8)(1996-9#4)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#6)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#2)(2004-11#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-12#2)(2005-7#2)(2005-8#5)(2006-10#9)(2006-11#6)(2006-12#7)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#5)(2006-9#2)(2007-10#2)(2007-11#5)(2007-12#5)(2007-2#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#12)(2007-8#5)(2008-1#2)(2008-10#117)(2008-11#13)(2008-12#5)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#23)(2008-6#3)(2008-7#5)(2008-8#6)(2008-9#4)(2009-10#4)(2009-11#2)(2009-2#3)(2009-3#4)(2009-4#1)(2009-5#3)(2009-8#2)(2009-9#3)(2010-10#3)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#5)(2011-1#4)(2011-10#2)(2011-2#22)(2011-3#1)(2012-1#2)(2012-11#2)(2012-12#6)(2012-2#10)(2012-3#3)(2013-1#11)(2013-8#8)
resistant tomato##2##2##(2008-10#2)
resistant towards##2##2##(2006-9#1)(2011-2#1)
resistant transgenic##2##2##(2008-8#2)
resistant tuberculosis##2##2##(1996-6#1)(2013-8#1)
resistant varieties##3##2##(2008-10#2)(2011-2#1)
resistant variety##2##2##(2007-7#1)(2011-2#1)
resistant virus##3##2##(1995-5#1)(2005-10#1)(2005-7#1)
resistant viruses##2##2##(2009-6#1)(2011-2#1)
resistant wheat cultivars##2##3##(2008-10#2)
resistant wheat##6##2##(2008-10#6)
resistant x##2##2##(2008-10#2)
resistant##1603##1##(1990-10#6)(1990-11#4)(1990-12#5)(1990-2#13)(1990-3#1)(1990-4#5)(1990-5#7)(1990-7#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#9)(1991-2#6)(1991-3#6)(1991-4#6)(1991-5#4)(1991-6#4)(1991-7#9)(1991-8#4)(1991-9#1)(1992-1#3)(1992-10#2)(1992-11#8)(1992-12#2)(1992-2#9)(1992-3#3)(1992-4#3)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#4)(1992-9#8)(1993-1#3)(1993-10#3)(1993-11#3)(1993-12#6)(1993-2#2)(1993-3#2)(1993-4#3)(1993-5#7)(1993-6#2)(1993-7#3)(1993-8#11)(1993-9#5)(1994-10#2)(1994-11#12)(1994-12#3)(1994-2#2)(1994-3#10)(1994-5#3)(1994-6#4)(1994-7#1)(1994-8#8)(1994-9#6)(1995-1#3)(1995-10#3)(1995-11#2)(1995-12#4)(1995-2#3)(1995-3#6)(1995-5#6)(1995-6#6)(1995-7#3)(1995-8#7)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#11)(1996-2#4)(1996-3#2)(1996-4#2)(1996-5#8)(1996-6#2)(1996-7#13)(1996-8#1)(1996-9#9)(1997-1#1)(1997-2#2)(1997-3#5)(1997-4#11)(1997-5#2)(1997-6#4)(1997-7#4)(1997-8#6)(2004-11#4)(2004-4#1)(2004-9#1)(2005-10#2)(2005-11#4)(2005-12#4)(2005-7#7)(2005-8#12)(2006-10#28)(2006-11#10)(2006-12#10)(2006-2#1)(2006-3#1)(2006-4#4)(2006-5#1)(2006-6#1)(2006-8#15)(2006-9#5)(2007-10#3)(2007-11#8)(2007-12#7)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#3)(2007-7#39)(2007-8#18)(2008-1#13)(2008-10#573)(2008-11#33)(2008-12#9)(2008-2#2)(2008-3#10)(2008-4#11)(2008-5#43)(2008-6#6)(2008-7#12)(2008-8#16)(2008-9#8)(2009-10#4)(2009-11#5)(2009-12#1)(2009-2#4)(2009-3#11)(2009-4#5)(2009-5#5)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#4)(2010-10#3)(2010-11#4)(2010-12#13)(2010-2#4)(2010-3#4)(2010-4#4)(2010-5#6)(2010-6#4)(2010-7#2)(2010-8#8)(2010-9#5)(2011-1#9)(2011-10#4)(2011-12#3)(2011-2#54)(2011-3#1)(2012-1#8)(2012-11#7)(2012-12#14)(2012-2#24)(2012-3#16)(2012-5#1)(2012-6#1)(2013-1#23)(2013-7#3)(2013-8#22)
resistant&quot##6##1##(1994-8#2)(2008-10#1)(2011-12#2)(2012-12#1)
resistant)##10##1##(2006-10#1)(2007-11#1)(2008-10#7)(2011-2#1)
resisted medical treatment##2##3##(1993-10#1)(1996-3#1)
resisted removal##2##2##(2008-10#1)(2011-2#1)
resisted treatment##2##2##(1991-11#1)(1995-3#1)
resisted##20##1##(1991-11#2)(1992-12#1)(1993-10#1)(1993-12#1)(1995-1#2)(1995-3#1)(1996-3#1)(1996-9#1)(1997-5#1)(2006-8#1)(2008-10#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-2#3)(2013-1#1)
resistence##2##1##(2005-1#1)(2006-9#1)
resistentiae##2##1##(1992-1#1)(1996-1#1)
resistin and RELMs##2##3##(2008-1#2)
resistin and##5##2##(2008-1#4)(2008-10#1)
resistin in##3##2##(2007-12#1)(2008-1#2)
resistin##18##1##(2007-12#1)(2008-1#14)(2008-10#1)(2008-3#1)(2012-12#1)
resistin-like molecules##2##2##(2008-1#2)
resisting the disclosure of##2##4##(1992-3#2)
resisting the##4##2##(1992-3#2)(2010-4#1)(2013-8#1)
resisting##12##1##(1991-12#2)(1992-3#2)(1996-3#1)(2006-11#1)(2008-5#1)(2009-2#1)(2010-4#1)(2011-3#1)(2013-8#2)
resistive and##2##2##(1995-3#1)(1996-4#1)
resistive feedback##2##2##(2013-7#2)
resistive index##4##2##(2008-10#1)(2013-1#3)
resistive loads##3##2##(1993-9#2)(1996-5#1)
resistive network##2##2##(2008-2#2)
resistive strain##2##2##(2007-12#1)(2008-2#1)
resistive##30##1##(1993-9#2)(1995-3#1)(1996-4#2)(1996-5#2)(2006-12#1)(2006-6#1)(2006-9#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#5)(2013-7#2)
resistiveness to care##3##3##(2011-2#3)
resistivity and##3##2##(1992-2#1)(2008-2#1)(2011-2#1)
resistivity in##2##2##(1990-4#1)(1992-12#1)
resistivity of##2##2##(2008-3#1)(2013-8#1)
resistivity##25##1##(1990-4#1)(1990-7#1)(1992-12#1)(1992-2#2)(1996-5#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-2#2)(2008-3#1)(2010-8#4)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#3)
resistor electrodes##2##2##(2008-10#2)
resistor##6##1##(2005-11#2)(2006-12#1)(2008-10#2)(2008-2#1)
resistors##7##1##(2006-12#1)(2007-10#1)(2007-9#1)(2008-10#4)
resists##6##1##(2006-12#2)(2006-3#1)(2007-12#2)(2009-10#1)
resolution (&lt##3##2##(2006-12#1)(2008-3#1)(2008-7#1)
resolution (distance between##2##3##(2007-12#2)
resolution 0##2##2##(2013-8#2)
resolution after##2##2##(2006-10#1)(2006-8#1)
resolution and &lt##2##3##(2006-5#1)(2008-1#1)
resolution and a##6##3##(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)
resolution and accuracy##5##3##(2007-11#1)(2008-11#1)(2008-3#3)
resolution and an##2##3##(2008-3#2)
resolution and can##2##3##(2006-6#1)(2008-2#1)
resolution and contrast##7##3##(2006-4#1)(2007-12#1)(2008-3#3)(2009-5#1)(2012-2#1)
resolution and dynamic range##2##4##(2007-11#1)(2008-3#1)
resolution and efficiency##2##3##(2007-12#1)(2008-10#1)
resolution and high##2##3##(2008-10#1)(2008-3#1)
resolution and refined to a##2##5##(1992-3#1)(1994-8#1)
resolution and refined to##3##4##(1992-3#1)(1994-8#1)(1995-5#1)
resolution and reproducibility##4##3##(1996-5#1)(2009-1#1)(2009-4#1)(2010-5#1)
resolution and selectivity##2##3##(2007-12#1)(2008-10#1)
resolution and sensitivity##7##3##(1991-7#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)
resolution and signal-to-noise ratio##4##4##(1997-8#1)(2008-2#1)(2010-9#1)(2013-8#1)
resolution and the##9##3##(1991-2#1)(1994-1#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)
resolution and##148##2##(1991-12#2)(1991-2#1)(1991-7#2)(1992-2#1)(1992-3#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-5#1)(1996-8#2)(1997-4#1)(1997-8#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-4#2)(2006-5#2)(2006-6#2)(2007-11#7)(2007-12#16)(2008-1#3)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#12)(2008-3#24)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#3)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-8#1)
resolution are also##2##3##(2008-3#1)(2008-4#1)
resolution are##15##2##(1996-6#1)(2006-5#1)(2007-12#5)(2007-4#1)(2008-2#1)(2008-3#3)(2008-4#1)(2011-12#1)(2012-2#1)
resolution as##4##2##(2008-2#2)(2008-3#2)
resolution at##9##2##(2006-5#1)(2008-10#1)(2008-3#3)(2008-6#1)(2009-5#1)(2010-4#1)(2012-2#1)
resolution because of##2##3##(2008-2#1)(2010-6#1)
resolution better than##4##3##(2007-8#1)(2008-3#2)(2008-7#1)
resolution between##6##2##(2005-11#1)(2008-10#4)(2009-9#1)
resolution by the##2##3##(1991-9#1)(2007-12#1)
resolution by use of a##2##5##(2007-11#1)(2008-2#1)
resolution by use of##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
resolution by using##4##3##(1992-4#1)(2005-4#1)(2007-12#1)(2008-8#1)
resolution by x-ray##2##3##(1991-6#1)(1994-8#1)
resolution by##25##2##(1990-5#1)(1991-6#1)(1991-9#1)(1992-4#1)(1993-8#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(2005-4#1)(2007-11#3)(2007-12#4)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)
resolution can be improved##2##4##(2007-11#2)
resolution can be obtained##4##4##(2007-12#1)(2008-2#1)(2008-4#1)(2008-9#1)
resolution can be##11##3##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-9#1)
resolution capability##2##2##(2008-2#1)(2008-3#1)
resolution close to 1 microm##2##5##(2007-11#1)(2012-2#1)
resolution close to##3##3##(2007-11#1)(2008-2#1)(2012-2#1)
resolution compared to##2##3##(2008-10#1)(2009-10#1)
resolution compared with##4##3##(2007-9#1)(2008-2#1)(2008-3#2)
resolution compared##6##2##(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-10#1)
resolution computed pulmonary##2##3##(2007-8#2)
resolution computed tomography (HRCT)##3##4##(2005-8#1)(2007-8#1)(2012-1#1)
resolution computed##5##2##(2005-8#1)(2007-8#3)(2012-1#1)
resolution computerized tomography (HRCT)##2##4##(2007-2#1)(2008-7#1)
resolution crystal structure of the##3##5##(1995-5#1)(2011-1#1)(2013-8#1)
resolution crystal structure of##5##4##(1995-5#1)(1997-6#1)(2011-1#2)(2013-8#1)
resolution data##2##2##(1997-2#1)(2008-2#1)
resolution demonstrated to date for##2##5##(2007-11#1)(2007-12#1)
resolution depend on the##2##4##(2006-5#1)(2008-3#1)
resolution due to the##2##4##(1993-10#1)(2011-1#1)
resolution due to##3##3##(1993-10#1)(2010-8#1)(2011-1#1)
resolution enhancement##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)
resolution factors##2##2##(2008-10#2)
resolution for the##8##3##(1996-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)(2009-11#1)
resolution for this##2##3##(2011-1#1)(2012-3#1)
resolution for##31##2##(1994-1#1)(1996-11#1)(1996-8#1)(2006-4#1)(2007-12#4)(2008-10#6)(2008-2#3)(2008-3#6)(2009-11#1)(2009-3#1)(2010-2#1)(2011-1#1)(2011-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
resolution from the##2##3##(1997-2#1)(2008-3#1)
resolution from##6##2##(1997-2#1)(2008-2#2)(2008-3#2)(2010-6#1)
resolution gel electrophoresis##2##3##(1994-6#1)(2008-4#1)
resolution gels used##2##3##(1990-12#2)
resolution gels##4##2##(1990-12#4)
resolution has been##2##3##(2006-10#1)(2008-2#1)
resolution has##4##2##(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)
resolution high##2##2##(1997-2#1)(2010-12#1)
resolution images of##2##3##(1997-4#1)(2012-1#1)
resolution images##4##2##(1997-4#1)(2012-1#2)(2012-2#1)
resolution imaging of the##2##4##(1993-5#1)(2011-7#1)
resolution imaging of##3##3##(1990-11#1)(1993-5#1)(2011-7#1)
resolution imaging##5##2##(1990-11#1)(1993-5#1)(2008-3#1)(2011-1#1)(2011-7#1)
resolution in HPLC##2##3##(2008-10#2)
resolution in a##5##3##(1991-2#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
resolution in near-field##2##3##(2007-12#1)(2008-3#1)
resolution in order to##2##4##(2010-3#1)(2011-2#1)
resolution in the vertical direction##2##5##(2008-2#1)(2008-3#1)
resolution in the##18##3##(1993-12#1)(1996-12#2)(2004-9#1)(2006-10#2)(2007-11#2)(2007-12#3)(2008-2#3)(2008-3#3)(2008-5#1)
resolution in three dimensions##3##4##(2007-11#1)(2007-12#1)(2011-1#1)
resolution in two-photon microscopy is##2##5##(2008-3#2)
resolution in##73##2##(1991-2#1)(1991-9#1)(1992-7#1)(1993-12#1)(1994-3#1)(1994-8#1)(1996-12#3)(1996-5#1)(1996-8#1)(2004-2#1)(2004-9#1)(2005-8#1)(2006-10#3)(2006-4#1)(2006-5#1)(2007-11#6)(2007-12#8)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#5)(2008-3#14)(2008-4#1)(2008-5#2)(2008-7#2)(2009-2#1)(2009-6#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#3)(2013-8#1)
resolution increased##2##2##(2008-3#1)(2013-8#1)
resolution inductively##2##2##(2008-10#2)
resolution inherent in##2##3##(1991-2#1)(2008-7#1)
resolution is 0##3##3##(1993-8#1)(2008-2#1)(2008-3#1)
resolution is achieved by##2##4##(2008-4#1)(2012-1#1)
resolution is achieved##6##3##(2007-1#1)(2008-2#1)(2008-3#2)(2008-4#1)(2012-1#1)
resolution is better than##2##4##(2008-3#2)
resolution is demonstrated by##3##4##(1991-11#1)(2006-5#1)(2007-12#1)
resolution is demonstrated##4##3##(1991-11#1)(2006-5#1)(2007-12#2)
resolution is determined by the##2##5##(2007-12#1)(2008-3#1)
resolution is increased##3##3##(2007-12#1)(2008-2#1)(2010-12#1)
resolution is limited by the##3##5##(2007-12#1)(2008-3#2)
resolution is limited##5##3##(2007-12#1)(2008-3#4)
resolution is not##4##3##(2006-5#1)(2008-10#1)(2008-2#1)(2008-3#1)
resolution is used to##2##4##(2007-11#1)(2008-2#1)
resolution is##67##2##(1990-2#1)(1991-11#2)(1993-8#1)(1996-12#1)(2005-9#1)(2006-4#1)(2006-5#3)(2007-1#1)(2007-11#2)(2007-12#11)(2008-10#1)(2008-2#9)(2008-3#25)(2008-4#2)(2008-7#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#2)
resolution limit and##2##3##(2005-4#2)
resolution limit of##3##3##(2007-12#2)(2009-11#1)
resolution limit##8##2##(2005-4#2)(2007-11#1)(2007-12#3)(2008-3#1)(2009-11#1)
resolution limits are##2##3##(2006-5#1)(2009-7#1)
resolution limits of##2##3##(2007-12#2)
resolution limits##7##2##(2006-5#1)(2007-12#2)(2008-10#1)(2008-3#1)(2009-7#1)(2010-4#1)
resolution makes##3##2##(2008-4#1)(2008-9#1)(2010-7#1)
resolution mass spectrometry##12##3##(2007-11#1)(2008-10#7)(2008-11#1)(2010-5#2)(2013-7#1)
resolution mass##13##2##(2007-11#1)(2008-10#8)(2008-11#1)(2010-5#2)(2013-7#1)
resolution may##2##2##(2008-10#1)(2012-2#1)
resolution measurements##2##2##(2006-10#1)(2008-3#1)
resolution mechanisms##2##2##(1996-5#1)(2008-11#1)
resolution method##3##2##(2008-10#2)(2008-3#1)
resolution methods##4##2##(2008-10#3)(2009-11#1)
resolution near 100 nm##2##4##(2007-12#2)
resolution near##3##2##(2007-12#3)
resolution obtained##2##2##(1996-12#1)(1997-8#1)
resolution of &lt##3##3##(2006-12#1)(2008-2#2)
resolution of 0##23##3##(2007-11#3)(2007-12#4)(2008-1#1)(2008-2#7)(2008-3#8)
resolution of 1 microm##2##4##(2008-3#2)
resolution of 1##13##3##(1995-3#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#4)(2010-10#1)
resolution of 10##3##3##(2007-12#1)(2008-3#2)
resolution of 100##2##3##(2008-3#2)
resolution of 13##2##3##(2007-11#1)(2009-11#1)
resolution of 2##10##3##(1991-4#1)(1991-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)
resolution of 20 mum##3##4##(2008-2#1)(2008-3#2)
resolution of 20##7##3##(2007-11#1)(2008-2#1)(2008-3#4)(2009-5#1)
resolution of 200##2##3##(2007-12#1)(2008-3#1)
resolution of 3##5##3##(2008-3#4)(2010-3#1)
resolution of 30##2##3##(1996-7#1)(2008-3#1)
resolution of 4##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
resolution of 50##3##3##(2007-12#1)(2008-3#2)
resolution of 7##4##3##(2007-12#1)(2008-11#1)(2011-1#1)(2013-8#1)
resolution of a few##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
resolution of a##13##3##(1993-2#1)(1996-5#1)(2006-12#1)(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#3)(2008-9#1)
resolution of about##2##3##(1992-6#1)(2006-5#1)
resolution of acute##3##3##(2008-8#1)(2009-6#1)(2011-2#1)
resolution of all##2##3##(2007-7#1)(2008-10#1)
resolution of approximately 0##5##4##(2005-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
resolution of approximately##13##3##(1994-5#1)(1994-9#1)(2005-11#1)(2006-5#1)(2007-12#2)(2008-2#3)(2008-3#4)
resolution of at least##4##4##(1997-6#1)(2007-12#1)(2008-10#1)(2008-3#1)
resolution of better than 1##2##5##(2006-4#1)(2007-12#1)
resolution of better than##7##4##(2006-4#2)(2007-11#1)(2007-12#2)(2008-2#2)
resolution of binary##4##3##(2008-10#4)
resolution of both##3##3##(1994-12#1)(2010-4#1)(2012-3#1)
resolution of clinical signs##2##4##(1990-3#1)(2008-1#1)
resolution of clinical##4##3##(1990-3#1)(2006-8#1)(2008-1#1)(2008-2#1)
resolution of far-field##2##3##(2007-11#1)(2009-5#1)
resolution of genetic##2##3##(2007-7#1)(2012-3#1)
resolution of glucose and urea##2##5##(2008-3#2)
resolution of her symptoms##5##4##(2007-8#1)(2008-7#2)(2013-1#1)(2013-8#1)
resolution of her##7##3##(2006-10#1)(2006-8#1)(2007-8#1)(2008-7#2)(2013-1#1)(2013-8#1)
resolution of his symptoms##3##4##(2007-6#1)(2010-1#1)(2012-2#1)
resolution of his##6##3##(2006-12#1)(2007-6#1)(2008-7#1)(2010-1#1)(2011-2#1)(2012-2#1)
resolution of images##2##3##(2008-3#1)(2010-4#1)
resolution of inflammation##3##3##(2008-5#2)(2010-1#1)
resolution of optical coherence tomography##2##5##(2007-11#2)
resolution of optical##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
resolution of several##3##3##(2007-12#1)(2008-11#1)(2008-3#1)
resolution of single-band##2##3##(2008-3#2)
resolution of some##3##3##(1991-12#1)(2008-3#1)(2008-4#1)
resolution of symptoms##4##3##(2007-6#1)(2009-10#1)(2012-12#1)(2013-1#1)
resolution of tens of##2##4##(2007-12#1)(2008-2#1)
resolution of the analytes##3##4##(2008-10#3)
resolution of the data##3##4##(2008-3#1)(2008-8#1)(2009-9#1)
resolution of the infection##2##4##(2007-3#1)(2009-6#1)
resolution of the instrument##3##4##(2006-5#1)(2008-10#1)(2008-3#1)
resolution of the lesion##4##4##(2006-10#1)(2007-7#1)(2008-7#1)(2012-2#1)
resolution of the method##2##4##(1997-6#1)(2007-12#1)
resolution of the order of##4##5##(2007-12#3)(2008-3#1)
resolution of the patient's##2##4##(2007-10#1)(2012-2#1)
resolution of the polarization##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
resolution of the reconstructed##3##4##(2008-2#2)(2008-3#1)
resolution of the sensor##2##4##(2007-11#1)(2007-8#1)
resolution of the system is##5##5##(2007-12#2)(2008-2#1)(2008-3#2)
resolution of the system##7##4##(2007-12#2)(2008-2#2)(2008-3#2)(2013-8#1)
resolution of the##147##3##(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-11#1)(1993-12#1)(1993-6#1)(1993-8#3)(1994-8#1)(1994-9#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-5#2)(1996-6#1)(1997-2#4)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#2)(2006-10#2)(2006-5#1)(2006-6#1)(2007-10#2)(2007-11#5)(2007-12#16)(2007-3#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#16)(2008-11#3)(2008-2#13)(2008-3#27)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#2)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-8#2)(2010-9#2)(2011-1#1)(2012-2#2)(2012-8#1)(2013-1#2)(2013-8#2)
resolution of these##3##3##(2005-11#1)(2005-8#1)(2008-8#1)
resolution of this technique##3##4##(1993-2#1)(2006-10#1)(2007-12#1)
resolution of this##9##3##(1991-1#1)(1993-2#1)(1995-5#1)(2006-10#1)(2006-12#1)(2007-12#2)(2008-10#1)(2008-2#1)
resolution of three-dimensional##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
resolution of##557##2##(1990-10#1)(1990-12#3)(1990-3#2)(1990-6#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#2)(1991-8#1)(1992-1#1)(1992-11#2)(1992-6#1)(1993-12#1)(1993-2#3)(1993-6#1)(1993-8#3)(1994-10#1)(1994-11#1)(1994-12#2)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#4)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#3)(1995-9#2)(1996-12#1)(1996-2#2)(1996-5#5)(1996-6#2)(1996-7#2)(1997-1#1)(1997-2#5)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#4)(2005-10#2)(2005-11#2)(2005-4#1)(2005-5#1)(2005-7#3)(2005-8#1)(2006-10#9)(2006-11#1)(2006-12#5)(2006-2#1)(2006-4#3)(2006-5#6)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#3)(2007-11#28)(2007-12#60)(2007-2#1)(2007-3#1)(2007-6#2)(2007-7#5)(2007-8#7)(2008-1#6)(2008-10#53)(2008-11#6)(2008-2#49)(2008-3#92)(2008-4#7)(2008-5#7)(2008-7#9)(2008-8#7)(2008-9#7)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#2)(2010-8#2)(2010-9#3)(2011-1#7)(2011-2#9)(2012-11#3)(2012-12#7)(2012-2#4)(2012-3#4)(2012-8#1)(2013-1#6)(2013-7#1)(2013-8#6)
resolution on the order of##2##5##(2009-12#1)(2009-5#1)
resolution on the##3##3##(2009-12#1)(2009-5#1)(2012-1#1)
resolution on##9##2##(1990-12#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-6#1)(2012-1#1)
resolution or##5##2##(1996-11#1)(2006-4#1)(2007-8#1)(2008-4#1)(2008-6#1)
resolution over a##7##3##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)(2009-8#1)
resolution over##9##2##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#1)(2009-8#1)(2010-12#1)
resolution performance##2##2##(2007-12#1)(2010-9#1)
resolution produced by##2##3##(2008-10#1)(2008-3#1)
resolution range from##2##3##(2006-4#1)(2008-3#1)
resolution range##4##2##(1994-9#1)(2006-4#1)(2008-3#1)(2008-8#1)
resolution relative to##2##3##(2008-3#1)(2011-1#1)
resolution results##2##2##(2008-10#2)
resolution reveals##3##2##(1990-11#1)(1993-8#1)(2010-10#1)
resolution similar to that##2##4##(2008-10#1)(2010-2#1)
resolution sufficient##2##2##(2008-10#1)(2008-3#1)
resolution than the##3##3##(1997-4#1)(2008-2#2)
resolution than##10##2##(1997-4#1)(2008-10#1)(2008-2#3)(2008-4#1)(2008-7#1)(2009-5#1)(2012-12#2)
resolution that can be achieved##2##5##(2008-1#1)(2008-10#1)
resolution that is##6##3##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)
resolution that##12##2##(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#1)
resolution through a##2##3##(2007-12#1)(2011-2#1)
resolution through##5##2##(2007-12#1)(2008-2#3)(2011-2#1)
resolution to a##2##3##(1990-7#1)(1995-8#1)
resolution to the##2##3##(2006-10#1)(2007-12#1)
resolution to##20##2##(1990-7#1)(1992-9#1)(1995-8#1)(1997-2#1)(2006-10#2)(2007-12#3)(2008-10#2)(2008-3#3)(2008-6#2)(2010-11#1)(2012-2#2)(2013-1#1)
resolution ultrasound and##2##3##(2011-2#1)(2012-1#1)
resolution ultrasound##4##2##(1997-2#1)(2011-2#1)(2012-1#1)(2012-2#1)
resolution using##9##2##(1997-6#1)(1997-7#1)(2006-5#1)(2007-9#1)(2008-10#1)(2009-8#1)(2012-12#1)(2012-3#2)
resolution values were shown in the extraction##2##7##(2008-10#2)
resolution values##4##2##(2008-10#2)(2008-3#1)(2009-4#1)
resolution was achieved##6##3##(1993-12#1)(1997-2#1)(2006-5#1)(2007-2#1)(2008-3#2)
resolution was limited by the##3##5##(2007-12#1)(2008-2#1)(2009-5#1)
resolution was obtained for##2##4##(1997-8#1)(2008-10#1)
resolution was obtained##4##3##(1990-11#1)(1997-8#1)(2007-12#1)(2008-10#1)
resolution was##25##2##(1990-11#1)(1993-12#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-4#2)(2006-5#1)(2007-11#1)(2007-12#3)(2007-2#1)(2008-10#2)(2008-2#2)(2008-3#4)(2009-5#1)(2010-4#1)
resolution were achieved##2##3##(2007-12#1)(2008-10#1)
resolution were observed##2##3##(1996-8#1)(2008-3#1)
resolution were obtained##3##3##(1994-8#1)(1995-3#1)(2011-3#1)
resolution were##14##2##(1994-8#1)(1995-3#1)(1996-8#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-8#1)(2010-9#1)(2011-3#1)(2013-7#1)
resolution with a##6##3##(1991-3#1)(1993-8#1)(2007-12#1)(2008-2#2)(2008-3#1)
resolution with##18##2##(1991-3#1)(1992-1#1)(1993-8#1)(1996-7#1)(1997-5#1)(2006-3#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#1)
resolution within##3##2##(2006-8#1)(2008-2#1)(2011-2#1)
resolution without##5##2##(2007-12#2)(2008-10#1)(2008-3#1)(2008-7#1)
resolution##1919##1##(1990-10#2)(1990-11#4)(1990-12#10)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#4)(1991-1#1)(1991-10#1)(1991-11#4)(1991-12#7)(1991-2#8)(1991-3#2)(1991-4#3)(1991-5#5)(1991-6#3)(1991-7#3)(1991-8#2)(1991-9#2)(1992-1#2)(1992-11#4)(1992-12#2)(1992-2#2)(1992-3#3)(1992-4#4)(1992-5#1)(1992-6#1)(1992-7#5)(1992-8#3)(1992-9#3)(1993-10#1)(1993-11#1)(1993-12#5)(1993-2#5)(1993-3#4)(1993-5#1)(1993-6#3)(1993-8#7)(1993-9#2)(1994-1#2)(1994-10#1)(1994-11#2)(1994-12#5)(1994-2#3)(1994-3#5)(1994-5#2)(1994-6#3)(1994-8#6)(1994-9#17)(1995-1#2)(1995-11#7)(1995-12#2)(1995-2#5)(1995-3#12)(1995-4#1)(1995-5#4)(1995-6#5)(1995-7#1)(1995-8#5)(1995-9#2)(1996-11#6)(1996-12#8)(1996-2#3)(1996-4#1)(1996-5#11)(1996-6#5)(1996-7#4)(1996-8#6)(1996-9#2)(1997-1#2)(1997-2#15)(1997-3#5)(1997-4#9)(1997-5#5)(1997-6#4)(1997-7#6)(1997-8#7)(2004-12#1)(2004-2#1)(2004-3#1)(2004-9#2)(2005-10#2)(2005-11#5)(2005-12#1)(2005-4#4)(2005-5#1)(2005-7#4)(2005-8#6)(2005-9#1)(2006-10#22)(2006-11#1)(2006-12#12)(2006-2#2)(2006-3#1)(2006-4#14)(2006-5#21)(2006-6#5)(2006-7#2)(2006-8#4)(2006-9#1)(2007-1#7)(2007-10#3)(2007-11#78)(2007-12#200)(2007-2#3)(2007-3#2)(2007-4#3)(2007-5#2)(2007-6#2)(2007-7#6)(2007-8#17)(2007-9#4)(2008-1#18)(2008-10#178)(2008-11#16)(2008-12#3)(2008-2#192)(2008-3#287)(2008-4#35)(2008-5#16)(2008-6#8)(2008-7#43)(2008-8#17)(2008-9#27)(2009-1#2)(2009-10#3)(2009-11#9)(2009-12#3)(2009-2#2)(2009-3#4)(2009-4#8)(2009-5#12)(2009-6#6)(2009-7#2)(2009-8#6)(2009-9#3)(2010-1#2)(2010-10#6)(2010-11#3)(2010-12#12)(2010-2#12)(2010-3#3)(2010-4#12)(2010-5#7)(2010-6#6)(2010-7#3)(2010-8#6)(2010-9#9)(2011-1#35)(2011-12#4)(2011-2#25)(2011-3#1)(2011-7#6)(2012-1#10)(2012-11#6)(2012-12#21)(2012-2#24)(2012-3#10)(2012-8#2)(2013-1#15)(2013-7#4)(2013-8#15)
resolution)##4##1##(1991-2#1)(2007-5#1)(2008-2#1)(2008-3#1)
resolutions are determined##2##3##(2007-11#2)
resolutions are##7##2##(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#1)
resolutions in##4##2##(2008-2#1)(2008-3#1)(2011-1#1)(2013-1#1)
resolutions of the##4##3##(2007-12#2)(2008-2#1)(2012-2#1)
resolutions of##15##2##(1994-8#1)(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-6#1)(2012-2#1)
resolutions##53##1##(1994-1#2)(1994-8#1)(1994-9#1)(1995-3#1)(1996-5#1)(2006-3#1)(2006-7#1)(2007-11#2)(2007-12#4)(2007-5#2)(2008-10#6)(2008-2#12)(2008-3#9)(2008-4#1)(2008-6#3)(2008-8#2)(2009-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
resolvable by##3##2##(1995-11#1)(1997-6#1)(2008-7#1)
resolvable from##2##2##(2008-9#2)
resolvable##15##1##(1995-11#1)(1997-6#1)(1997-7#2)(2007-11#2)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#2)
resolvase and##2##2##(1993-3#2)
resolvase##12##1##(1993-3#6)(1994-3#3)(1995-2#2)(2011-12#1)
resolve a debate##2##3##(1995-11#1)(2007-8#1)
resolve a##3##2##(1995-11#1)(2007-8#1)(2008-10#1)
resolve as##2##2##(2008-7#1)(2011-1#1)
resolve in##2##2##(2006-8#1)(2010-5#1)
resolve issues##2##2##(1992-1#1)(2007-12#1)
resolve problems##3##2##(1994-1#1)(1995-5#1)(2008-10#1)
resolve spontaneously##2##2##(2008-7#1)(2012-2#1)
resolve the apparent##2##3##(1993-9#1)(2008-8#1)
resolve the##39##2##(1990-5#1)(1990-6#1)(1990-8#1)(1991-8#1)(1992-9#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-12#1)(1995-5#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-10#1)(2007-12#2)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#1)(2009-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
resolve these inconsistencies##2##3##(1996-3#1)(2008-8#1)
resolve these problems##2##3##(2007-2#1)(2011-2#1)
resolve these##9##2##(1993-12#1)(1996-3#1)(2005-7#1)(2007-2#1)(2007-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
resolve this##13##2##(1995-5#1)(1996-3#1)(1997-4#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-9#1)(2009-11#1)(2011-1#1)(2013-1#3)(2013-8#1)
resolve very##2##2##(1995-3#1)(2008-4#1)
resolve with##7##2##(2006-10#2)(2006-4#1)(2007-8#1)(2007-9#1)(2011-12#1)(2011-2#1)
resolve within##3##2##(1995-9#1)(2008-7#1)(2011-2#1)
resolve##199##1##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-7#2)(1991-8#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-1#3)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#3)(1995-9#2)(1996-3#3)(1996-5#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#3)(2005-10#2)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#6)(2007-12#10)(2007-2#2)(2007-4#3)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#18)(2008-11#3)(2008-12#2)(2008-2#6)(2008-3#8)(2008-4#5)(2008-5#2)(2008-7#4)(2008-8#5)(2008-9#6)(2009-10#2)(2009-11#1)(2009-2#5)(2009-3#1)(2009-5#2)(2009-6#1)(2009-9#1)(2010-12#4)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#6)(2011-12#1)(2011-2#5)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#2)
resolved a##2##2##(2007-12#1)(2008-10#1)
resolved after the##2##3##(2007-12#1)(2013-8#1)
resolved after##17##2##(1992-11#1)(1992-12#1)(1996-12#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-2#1)(2010-3#1)(2010-7#1)(2013-8#1)
resolved and unresolved harmonics##2##4##(2008-2#2)
resolved and##17##2##(1990-7#1)(1996-12#1)(1997-7#1)(2006-5#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-6#1)(2011-2#1)
resolved at##4##2##(1994-8#1)(2007-11#1)(2008-10#2)
resolved by SDS-PAGE into##2##4##(1991-9#1)(1993-3#1)
resolved by the##3##3##(1996-2#1)(2008-10#1)(2011-1#1)
resolved by two-dimensional##2##3##(1994-12#1)(1996-8#1)
resolved by use of##2##4##(2007-8#1)(2008-2#1)
resolved by##62##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#2)(1996-5#2)(1996-8#1)(1997-4#1)(1997-8#1)(2005-12#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-2#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-7#1)(2009-9#1)(2010-2#1)(2011-1#2)(2012-12#3)(2012-2#2)(2013-7#1)
resolved completely after##2##3##(2006-12#1)(2007-3#1)
resolved completely with##2##3##(2006-10#1)(2010-10#1)
resolved completely##8##2##(1992-11#1)(2006-10#1)(2006-12#2)(2006-5#1)(2007-3#1)(2008-10#1)(2010-10#1)
resolved depth steps##2##3##(2008-3#2)
resolved detection of##2##3##(2008-2#1)(2008-3#1)
resolved fluorescence##4##2##(2008-12#1)(2008-2#2)(2008-3#1)
resolved following##5##2##(2006-4#1)(2008-7#1)(2008-8#1)(2010-9#1)(2013-8#1)
resolved for##3##2##(1995-1#1)(1997-8#1)(2013-1#1)
resolved four##2##2##(1990-2#1)(1990-4#1)
resolved from each other##4##4##(1991-5#1)(1992-11#1)(1994-9#1)(2008-1#1)
resolved from the##5##3##(1995-1#1)(2008-10#3)(2010-2#1)
resolved from##13##2##(1990-7#1)(1991-5#2)(1992-11#1)(1994-5#1)(1994-9#1)(1995-1#1)(2008-1#1)(2008-10#3)(2010-2#1)(2011-1#1)
resolved images##2##2##(2007-12#1)(2008-7#1)
resolved in both##2##3##(2006-12#1)(2008-10#1)
resolved in the##4##3##(1992-3#1)(1996-7#1)(2008-2#1)(2008-8#1)
resolved in two##2##3##(1997-8#1)(2008-3#1)
resolved in##25##2##(1992-3#1)(1993-3#1)(1994-2#1)(1996-7#1)(1996-8#1)(1997-6#1)(1997-8#1)(2006-11#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-2#2)(2013-1#2)
resolved into a##2##3##(1990-2#1)(2008-3#1)
resolved into two##4##3##(1990-7#1)(1990-8#1)(1992-5#1)(1996-9#1)
resolved into##16##2##(1990-2#1)(1990-7#1)(1990-8#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-5#1)(1994-9#1)(1995-8#1)(1996-9#1)(2005-10#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)
resolved on a##2##3##(1991-9#1)(1996-5#1)
resolved on the basis of##2##5##(1993-9#1)(2008-10#1)
resolved on the##4##3##(1993-9#1)(2008-10#3)
resolved on##11##2##(1990-12#1)(1991-9#1)(1993-9#1)(1996-5#1)(2006-8#1)(2008-10#4)(2008-4#1)(2008-7#1)
resolved only by##3##3##(1991-3#1)(1997-7#1)(2013-1#1)
resolved only##5##2##(1991-3#1)(1994-9#1)(1997-7#1)(2007-2#1)(2013-1#1)
resolved or improved in##2##4##(2008-10#1)(2012-3#1)
resolved or##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
resolved peaks##4##2##(1991-2#1)(2008-10#1)(2010-4#1)(2011-1#1)
resolved reflectance measurements##2##3##(2007-12#2)
resolved reflectance##6##2##(2007-12#3)(2008-2#1)(2008-3#2)
resolved several##2##2##(1992-7#1)(1997-3#1)
resolved spectra##3##2##(2007-12#2)(2008-3#1)
resolved spectral##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
resolved spontaneously after##3##3##(2006-10#1)(2007-8#2)
resolved spontaneously##8##2##(1994-7#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-8#2)(2009-11#1)(2009-3#1)
resolved sum-frequency generation##2##3##(2007-12#2)
resolved the##9##2##(1991-4#1)(1993-11#1)(1996-5#1)(1997-3#1)(2008-1#1)(2008-3#1)(2009-8#1)(2011-2#1)(2012-2#1)
resolved their MetS status##2##4##(2008-3#2)
resolved their##4##2##(2006-2#1)(2007-12#1)(2008-3#2)
resolved to##3##2##(1995-11#1)(2008-11#1)(2008-3#1)
resolved two##2##2##(1990-12#1)(2010-8#1)
resolved via##4##2##(1993-4#1)(1995-3#1)(1996-8#1)(2008-10#1)
resolved when##2##2##(1994-5#1)(2008-9#1)
resolved with a##3##3##(1994-2#1)(2006-10#1)(2011-2#1)
resolved with no##2##3##(2011-2#1)(2013-8#1)
resolved with the##3##3##(2007-12#1)(2013-1#2)
resolved with##27##2##(1990-8#1)(1994-2#1)(1996-9#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2009-10#2)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
resolved within 2##2##3##(2006-10#1)(2006-12#1)
resolved within a##2##3##(2007-10#1)(2011-2#1)
resolved within##6##2##(1992-11#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2011-2#1)
resolved without##5##2##(1992-10#1)(2006-8#1)(2008-4#1)(2009-3#1)(2012-12#1)
resolved##517##1##(1990-10#2)(1990-11#1)(1990-12#4)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#2)(1990-7#5)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#4)(1991-4#3)(1991-5#2)(1991-6#1)(1991-8#3)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#5)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#1)(1992-7#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-9#2)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#4)(1994-7#1)(1994-8#1)(1994-9#8)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#6)(1995-6#1)(1995-8#3)(1995-9#1)(1996-12#2)(1996-2#2)(1996-5#5)(1996-6#1)(1996-7#1)(1996-8#4)(1996-9#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#6)(1997-7#3)(1997-8#3)(2005-10#2)(2005-12#1)(2005-6#1)(2005-8#1)(2006-1#1)(2006-10#10)(2006-11#1)(2006-12#9)(2006-2#4)(2006-4#4)(2006-5#5)(2006-6#1)(2006-7#1)(2006-8#5)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#12)(2007-12#32)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#11)(2007-9#2)(2008-1#7)(2008-10#54)(2008-11#5)(2008-12#1)(2008-2#32)(2008-3#33)(2008-4#11)(2008-5#5)(2008-6#2)(2008-7#10)(2008-8#6)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#4)(2009-4#1)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#2)(2009-9#4)(2010-10#1)(2010-12#3)(2010-2#3)(2010-3#3)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#11)(2011-2#10)(2012-1#1)(2012-12#5)(2012-2#10)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#4)
resolves all##2##2##(1993-2#1)(2008-10#1)
resolves into##2##2##(2010-3#1)(2012-2#1)
resolves spontaneously##4##2##(2005-11#1)(2007-8#1)(2011-1#1)(2012-2#1)
resolves the##4##2##(1991-2#1)(2006-12#1)(2008-3#1)(2010-8#1)
resolves##23##1##(1991-11#1)(1991-2#1)(1993-2#1)(1996-5#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-5#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#2)(2013-7#1)
resolving both##2##2##(2007-8#1)(2008-3#1)
resolving chemical mixed signals##2##4##(2008-10#2)
resolving chemical##3##2##(2008-10#3)
resolving power and resolution##2##4##(2008-10#2)
resolving power and##5##3##(1996-5#1)(2008-10#2)(2008-2#1)(2008-3#1)
resolving power of approximately##2##4##(1996-8#1)(2006-4#1)
resolving power of the spectrometer##2##5##(2008-10#1)(2008-3#1)
resolving power of the##4##4##(2008-10#2)(2008-3#2)
resolving power of##9##3##(1996-8#1)(2006-4#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-3#3)
resolving power than##2##3##(1993-11#1)(2008-10#1)
resolving power##28##2##(1993-11#1)(1996-5#1)(1996-8#1)(2006-4#2)(2007-12#3)(2007-5#1)(2008-10#10)(2008-2#3)(2008-3#5)(2011-2#1)
resolving problems##2##2##(1994-2#1)(1996-2#1)
resolving specific##2##2##(2007-12#1)(2012-12#1)
resolving the complex##2##3##(2008-2#1)(2011-1#1)
resolving the issue of##2##4##(2008-2#1)(2008-9#1)
resolving the issue##3##3##(2008-2#1)(2008-9#1)(2011-2#1)
resolving the##21##2##(1990-12#1)(1991-8#1)(1997-7#1)(2004-10#1)(2007-11#1)(2008-1#2)(2008-11#1)(2008-2#4)(2008-3#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
resolving this##3##2##(2007-8#1)(2007-9#1)(2008-7#1)
resolving##106##1##(1990-12#1)(1991-8#1)(1993-11#1)(1994-2#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-7#1)(2004-10#1)(2005-10#1)(2005-5#3)(2006-10#1)(2006-4#2)(2007-11#1)(2007-12#7)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#25)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#12)(2008-5#1)(2008-7#3)(2008-9#3)(2009-10#1)(2009-4#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#2)(2013-8#1)
resolvins and protectins##2##3##(2012-1#1)(2012-12#1)
resonance &quot##2##2##(1994-8#1)(1995-5#1)
resonance (MR) imaging and MR##2##5##(2006-12#1)(2008-5#1)
resonance (MR) imaging and##3##4##(2006-12#1)(2006-4#1)(2008-5#1)
resonance (MR) imaging showed##2##4##(2006-12#1)(2006-8#1)
resonance (MR) imaging was##2##4##(1994-8#1)(2006-5#1)
resonance (MR) imaging##26##3##(1990-10#1)(1994-8#1)(1996-2#1)(1997-8#1)(2005-10#2)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#4)(2006-8#2)(2006-9#1)(2007-12#1)(2007-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-12#1)(2011-2#2)
resonance (MR)##48##2##(1990-10#1)(1994-8#1)(1995-11#1)(1995-4#1)(1995-5#1)(1996-2#1)(1997-8#1)(2005-10#2)(2006-12#4)(2006-3#1)(2006-4#1)(2006-5#5)(2006-6#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-5#2)(2008-7#3)(2008-8#2)(2010-12#1)(2010-8#1)(2011-2#2)(2012-11#1)(2012-2#2)
resonance (SPR) is presented##2##4##(2008-2#1)(2008-3#1)
resonance (SPR) technique##2##3##(2008-10#1)(2008-3#1)
resonance (SPR)##31##2##(2005-11#1)(2008-10#16)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#3)(2008-9#1)(2011-1#1)(2012-11#1)
resonance NMR spectroscopy##2##3##(1997-6#1)(2009-7#1)
resonance Raman (RR) spectra##2##4##(1994-11#1)(1994-12#1)
resonance Raman (RR)##3##3##(1994-11#1)(1994-12#1)(1995-5#1)
resonance Raman scattering##6##3##(1993-6#1)(1995-11#1)(2007-12#1)(2008-10#3)
resonance Raman spectra of##3##4##(1995-5#1)(2006-6#1)(2007-1#1)
resonance Raman spectra##7##3##(1990-10#1)(1990-7#1)(1990-8#1)(1991-7#1)(1995-5#1)(2006-6#1)(2007-1#1)
resonance Raman spectroscopy##7##3##(1990-10#1)(1990-5#2)(1992-9#1)(1995-5#1)(2006-6#1)(2008-3#1)
resonance Raman spectrum##2##3##(1990-10#1)(1995-5#1)
resonance Raman##35##2##(1990-10#3)(1990-5#2)(1990-7#1)(1990-8#2)(1991-7#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-5#4)(2006-6#2)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#2)(2009-5#2)
resonance Rayleigh scattering (RRS)##4##4##(2007-8#1)(2008-10#3)
resonance Rayleigh scattering##5##3##(2007-8#1)(2008-10#4)
resonance and the##5##3##(1991-6#1)(2007-12#2)(2008-3#2)
resonance and##28##2##(1990-10#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-9#1)(1995-1#2)(1995-4#1)(1996-11#1)(1997-8#1)(2004-9#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#4)(2008-3#2)(2009-10#2)(2009-5#1)(2010-1#1)(2010-5#1)(2012-11#1)(2012-2#1)
resonance angiography (MRA)##8##3##(1997-8#1)(2008-12#1)(2008-7#4)(2010-12#1)(2012-2#1)
resonance angiography and##4##3##(2006-10#2)(2008-9#1)(2013-1#1)
resonance angiography for##2##3##(2007-9#1)(2008-7#1)
resonance angiography in##2##3##(1996-2#1)(2013-1#1)
resonance angiography of the##2##4##(1997-8#1)(2006-10#1)
resonance angiography revealed##3##3##(2008-1#1)(2008-12#2)
resonance angiography##41##2##(1996-2#1)(1997-4#1)(1997-8#2)(2006-10#10)(2007-10#3)(2007-8#2)(2007-9#2)(2008-1#2)(2008-12#3)(2008-6#1)(2008-7#6)(2008-9#1)(2009-4#1)(2009-8#1)(2010-12#2)(2012-2#1)(2013-1#2)
resonance angle##3##2##(2008-10#2)(2008-2#1)
resonance area##3##2##(1993-6#3)
resonance assignment of Urm1 from Trypanosoma brucei##2##7##(2009-7#2)
resonance assignment of the##10##4##(1991-7#1)(2009-7#9)
resonance assignment of##16##3##(1991-7#1)(2009-7#15)
resonance assignment##18##2##(1991-11#1)(1991-7#1)(2009-7#16)
resonance assignments for the##3##4##(1991-2#1)(1994-5#1)(2009-7#1)
resonance assignments have been made for##2##6##(1995-11#1)(1997-4#1)
resonance assignments have been##3##4##(1995-11#1)(1997-4#1)(2009-7#1)
resonance assignments of Hahellin##2##4##(2009-7#2)
resonance assignments of the##8##4##(1993-6#1)(2009-7#7)
resonance assignments of##18##3##(1993-6#1)(2009-7#17)
resonance assignments were##3##3##(1997-4#2)(2009-7#1)
resonance assignments##33##2##(1991-11#1)(1991-2#1)(1991-4#1)(1993-6#1)(1994-10#1)(1994-5#1)(1995-11#2)(1997-4#4)(2009-7#21)
resonance at##6##2##(1990-8#2)(1992-9#1)(2007-11#1)(2008-10#1)(2008-2#1)
resonance between##2##2##(2008-3#1)(2012-2#1)
resonance condition##3##2##(2007-11#2)(2008-2#1)
resonance conditions##9##2##(2006-12#1)(2007-11#1)(2007-12#6)(2008-2#1)
resonance energy transfer (BRET)##3##4##(2008-4#2)(2011-3#1)
resonance energy transfer (FRET) between##2##5##(2008-1#1)(2008-10#1)
resonance energy transfer (FRET)##17##4##(1992-7#1)(1994-11#1)(1997-7#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-4#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2012-2#1)(2013-7#1)
resonance energy transfer and##2##4##(1996-11#1)(2008-10#1)
resonance energy transfer between##2##4##(1993-8#1)(1996-1#1)
resonance energy transfer measurements##3##4##(1991-2#1)(1994-8#2)
resonance energy transfer to##2##4##(1994-8#1)(1995-6#1)
resonance energy transfer##45##3##(1991-2#1)(1992-3#2)(1992-7#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#3)(1995-10#1)(1995-6#1)(1996-1#1)(1996-11#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-4#5)(2008-9#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-3#1)(2012-2#1)(2013-7#1)(2013-8#1)
resonance energy##48##2##(1991-2#1)(1992-3#2)(1992-7#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#3)(1995-10#1)(1995-6#1)(1996-1#1)(1996-11#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-4#5)(2008-9#3)(2009-4#1)(2009-8#1)(2009-9#2)(2010-12#2)(2010-2#1)(2010-5#1)(2011-3#1)(2012-2#1)(2013-7#1)(2013-8#1)
resonance energy-transfer##2##2##(1990-4#1)(2009-9#1)
resonance experiments##4##2##(2004-9#1)(2008-8#1)(2009-7#1)(2011-1#1)
resonance fluorescence monochromator with##2##4##(2007-12#2)
resonance fluorescence##4##2##(1993-2#1)(1993-8#1)(2007-12#2)
resonance for the##5##3##(2007-12#1)(2008-10#1)(2008-3#2)(2009-10#1)
resonance for##12##2##(1994-8#1)(2006-4#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-7#1)(2009-10#2)
resonance frequency and##3##3##(2008-2#1)(2008-3#1)(2010-4#1)
resonance frequency of##3##3##(1995-1#1)(2008-2#1)(2008-3#1)
resonance frequency shift##5##3##(2009-5#4)(2012-2#1)
resonance frequency##19##2##(1995-1#1)(2006-6#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)(2009-5#4)(2010-4#1)(2012-12#1)(2012-2#1)(2013-8#2)
resonance image (MRI)##5##3##(2006-10#1)(2006-6#1)(2007-12#1)(2008-7#1)(2013-8#1)
resonance image##11##2##(2006-10#2)(2006-12#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-12#1)(2008-7#2)(2010-8#1)(2013-8#1)
resonance images (MRI)##4##3##(2007-1#1)(2008-2#1)(2010-7#1)(2012-3#1)
resonance images were##4##3##(1995-8#1)(2006-10#1)(2007-10#1)(2008-2#1)
resonance images##36##2##(1995-8#1)(1996-1#1)(1996-5#2)(1996-7#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-2#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-4#1)(2008-1#1)(2008-2#6)(2008-3#2)(2008-7#2)(2009-7#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
resonance imaging (MRI) and##10##4##(1994-7#1)(1996-7#1)(2004-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-7#1)(2012-12#1)(2012-2#1)
resonance imaging (MRI) findings##5##4##(1996-11#1)(2008-6#1)(2012-12#2)(2012-3#1)
resonance imaging (MRI) has been##3##5##(2006-10#1)(2007-4#2)
resonance imaging (MRI) has##7##4##(1994-2#1)(2006-10#1)(2007-4#2)(2010-8#1)(2011-1#1)(2013-1#1)
resonance imaging (MRI) is a##4##5##(2008-7#1)(2009-4#1)(2010-12#1)(2012-12#1)
resonance imaging (MRI) is the##3##5##(2009-6#1)(2010-4#1)(2012-2#1)
resonance imaging (MRI) is##14##4##(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-4#1)(2012-12#1)(2012-2#4)(2013-7#1)
resonance imaging (MRI) of the lumbar spine##2##7##(2008-12#1)(2012-2#1)
resonance imaging (MRI) of the##5##5##(2008-12#1)(2008-7#1)(2010-12#1)(2010-9#1)(2012-2#1)
resonance imaging (MRI) of##6##4##(2004-2#1)(2008-12#1)(2008-7#1)(2010-12#1)(2010-9#1)(2012-2#1)
resonance imaging (MRI) showed##5##4##(2008-7#1)(2011-1#1)(2013-1#1)(2013-8#2)
resonance imaging (MRI) shows##2##4##(2005-9#1)(2012-12#1)
resonance imaging (MRI) was##3##4##(2006-12#1)(2008-3#1)(2008-7#1)
resonance imaging (MRI) with##3##4##(1991-12#1)(2008-7#1)(2010-9#1)
resonance imaging (MRI)##136##3##(1991-12#1)(1992-7#1)(1994-2#1)(1994-7#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-7#3)(1996-8#1)(1996-9#1)(2004-11#1)(2004-2#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-12#2)(2006-6#2)(2006-9#2)(2007-10#5)(2007-11#5)(2007-12#2)(2007-3#1)(2007-4#4)(2007-6#1)(2007-8#2)(2007-9#4)(2008-1#4)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#11)(2008-8#1)(2008-9#3)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#5)(2011-1#2)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#6)(2012-2#17)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#2)
resonance imaging (PC-MRI)##2##3##(2008-7#1)(2012-3#1)
resonance imaging and multidetector computed tomography##2##6##(2012-2#2)
resonance imaging and##44##3##(1992-3#1)(1994-7#1)(1997-6#1)(2004-11#2)(2006-10#3)(2006-11#1)(2006-3#1)(2007-10#1)(2007-4#2)(2007-8#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-6#2)(2008-7#4)(2008-9#2)(2009-10#1)(2009-4#1)(2010-12#2)(2010-5#1)(2010-7#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#2)(2013-8#2)
resonance imaging at 3##2##4##(2007-4#1)(2010-8#1)
resonance imaging at##3##3##(2007-4#1)(2008-9#1)(2010-8#1)
resonance imaging can##4##3##(1997-6#1)(2006-10#1)(2006-12#1)(2008-9#1)
resonance imaging confirmed##2##3##(2006-12#1)(2007-10#1)
resonance imaging demonstrated a##3##4##(2008-7#1)(2009-8#1)(2011-2#1)
resonance imaging demonstrated##6##3##(2006-10#1)(2007-10#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#1)
resonance imaging findings of a##2##5##(1997-8#1)(2006-1#1)
resonance imaging findings of##3##4##(1997-8#1)(2006-1#1)(2012-12#1)
resonance imaging findings##4##3##(1997-8#1)(2006-1#1)(2008-7#1)(2012-12#1)
resonance imaging for##4##3##(1994-7#1)(2010-12#1)(2010-7#1)(2012-3#1)
resonance imaging has been##2##4##(1997-8#1)(2010-3#1)
resonance imaging has##3##3##(1997-8#1)(2010-3#1)(2010-4#1)
resonance imaging in a##2##4##(2011-2#1)(2013-3#1)
resonance imaging in the detection##2##5##(2008-1#1)(2008-4#1)
resonance imaging in the diagnosis of##2##6##(1991-5#1)(2008-7#1)
resonance imaging in the diagnosis##4##5##(1990-12#1)(1991-5#1)(2008-7#2)
resonance imaging in the##9##4##(1990-12#1)(1991-5#1)(2006-10#1)(2008-1#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-12#1)
resonance imaging in##27##3##(1990-12#1)(1990-5#1)(1991-5#1)(1995-8#1)(1996-7#1)(1997-5#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#2)(2010-12#2)(2011-2#1)(2012-12#2)(2013-3#1)
resonance imaging is the most##3##5##(2006-10#1)(2010-3#1)(2010-6#1)
resonance imaging is the##5##4##(2006-10#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#1)
resonance imaging is##16##3##(1990-12#1)(1994-11#1)(1996-3#1)(2006-10#1)(2006-7#1)(2006-8#1)(2008-6#1)(2010-3#1)(2010-4#2)(2010-6#1)(2011-2#2)(2012-12#2)(2012-3#1)
resonance imaging may be##3##4##(2006-10#1)(2009-3#1)(2012-2#1)
resonance imaging of brain##2##4##(2012-2#2)
resonance imaging of the abdomen##2##5##(2009-8#1)(2011-2#1)
resonance imaging of the brain##2##5##(2006-10#1)(2009-3#1)
resonance imaging of the##15##4##(1996-3#3)(2006-10#1)(2007-10#1)(2009-3#2)(2009-8#1)(2010-12#1)(2010-4#2)(2010-9#1)(2011-2#2)(2012-11#1)
resonance imaging of##39##3##(1991-11#1)(1994-5#1)(1994-7#1)(1994-8#1)(1996-3#3)(1997-8#1)(2006-10#2)(2006-5#1)(2007-10#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-3#2)(2009-8#1)(2010-12#5)(2010-4#3)(2010-9#1)(2011-12#1)(2011-2#3)(2012-11#2)(2012-2#5)(2013-1#1)
resonance imaging revealed a large##3##5##(2005-5#1)(2006-12#1)(2008-11#1)
resonance imaging revealed a##8##4##(2005-5#1)(2006-12#1)(2006-5#1)(2006-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-9#1)
resonance imaging revealed##19##3##(2005-5#1)(2006-10#1)(2006-12#1)(2006-5#2)(2006-8#1)(2007-10#3)(2008-11#1)(2008-12#3)(2008-5#1)(2009-3#1)(2009-9#1)(2012-2#2)(2013-8#1)
resonance imaging scans were##2##4##(2007-10#1)(2011-2#1)
resonance imaging scans##8##3##(1996-5#1)(1997-8#1)(2007-10#1)(2007-9#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
resonance imaging should be##3##4##(1996-3#1)(2008-8#1)(2010-3#1)
resonance imaging showed a##5##4##(2006-1#1)(2007-8#1)(2008-7#1)(2009-3#1)(2011-2#1)
resonance imaging showed the##2##4##(2006-10#1)(2013-7#1)
resonance imaging showed##15##3##(2005-5#1)(2006-1#1)(2006-10#1)(2007-8#1)(2008-7#2)(2009-3#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-7#1)(2013-8#2)
resonance imaging using##2##3##(2012-12#1)(2012-3#1)
resonance imaging was performed##3##4##(2011-2#1)(2012-12#2)
resonance imaging was##11##3##(1990-6#1)(1996-2#1)(2008-11#1)(2008-4#1)(2009-2#1)(2009-5#1)(2011-2#2)(2012-12#2)(2013-1#1)
resonance imaging##600##2##(1990-11#1)(1990-12#3)(1990-5#1)(1990-6#1)(1991-11#1)(1991-12#2)(1991-5#1)(1991-7#3)(1991-8#1)(1992-12#1)(1992-2#2)(1992-3#5)(1992-7#1)(1993-1#1)(1993-10#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-7#5)(1994-8#1)(1995-1#1)(1995-12#3)(1995-5#3)(1995-6#1)(1995-8#2)(1996-11#1)(1996-2#4)(1996-3#6)(1996-5#3)(1996-7#4)(1996-8#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#7)(2004-11#4)(2004-2#1)(2005-10#3)(2005-2#1)(2005-5#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#21)(2006-11#1)(2006-12#11)(2006-2#1)(2006-3#1)(2006-5#5)(2006-6#4)(2006-7#3)(2006-8#5)(2006-9#5)(2007-10#24)(2007-11#15)(2007-12#3)(2007-3#3)(2007-4#14)(2007-6#1)(2007-8#6)(2007-9#14)(2008-1#6)(2008-10#2)(2008-11#16)(2008-12#4)(2008-2#6)(2008-3#3)(2008-4#10)(2008-5#6)(2008-6#9)(2008-7#38)(2008-8#8)(2008-9#15)(2009-1#2)(2009-10#2)(2009-11#3)(2009-2#5)(2009-3#8)(2009-4#8)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#4)(2010-10#1)(2010-11#2)(2010-12#20)(2010-2#4)(2010-3#4)(2010-4#10)(2010-5#3)(2010-6#4)(2010-7#4)(2010-8#4)(2010-9#7)(2011-1#7)(2011-12#5)(2011-2#24)(2012-1#4)(2012-11#4)(2012-12#19)(2012-2#38)(2012-3#10)(2013-1#10)(2013-3#2)(2013-7#8)(2013-8#8)
resonance in a##2##3##(1990-4#1)(2007-11#1)
resonance in such##2##3##(2007-11#1)(2008-3#1)
resonance in the##2##3##(1991-5#1)(2007-12#1)
resonance in##17##2##(1990-4#1)(1991-5#1)(1992-6#1)(1992-8#1)(1993-7#1)(1993-8#1)(1995-1#1)(2007-11#3)(2007-12#4)(2008-10#1)(2008-3#1)(2009-4#1)
resonance intensities##2##2##(1992-4#1)(1997-7#1)
resonance interferometry##3##2##(2008-2#3)
resonance ionization imaging detector##2##4##(2008-3#2)
resonance ionization imaging##3##3##(2007-12#1)(2008-3#2)
resonance ionization##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
resonance is the##2##3##(2008-10#1)(2008-2#1)
resonance is##10##2##(1991-7#1)(2007-11#2)(2007-12#2)(2008-1#2)(2008-10#2)(2008-2#1)
resonance light scattering (RLS) signals##2##5##(2008-10#2)
resonance light scattering (RLS)##7##4##(2008-10#6)(2008-3#1)
resonance light scattering of##3##4##(2008-10#3)
resonance light scattering ratiometry##2##4##(2008-10#2)
resonance light scattering technique##2##4##(2008-10#2)
resonance light scattering##16##3##(2008-10#15)(2008-3#1)
resonance light##17##2##(2008-10#16)(2008-3#1)
resonance light-scattering (RLS)##2##3##(2008-10#2)
resonance light-scattering##3##2##(2008-10#3)
resonance line of##2##3##(2007-11#1)(2008-3#1)
resonance line##5##2##(1993-6#1)(2007-11#1)(2008-2#2)(2008-3#1)
resonance linewidth##5##2##(1995-5#1)(2007-12#1)(2008-2#1)(2008-3#2)
resonance measurements##8##2##(1990-12#1)(1994-9#1)(1996-1#1)(1996-5#1)(1997-7#1)(1997-8#1)(2008-11#1)(2010-8#1)
resonance methods##3##2##(1992-3#1)(1995-4#1)(2007-11#1)
resonance microscopy##3##2##(1997-5#1)(2008-10#1)(2008-7#1)
resonance modes##5##2##(2007-11#1)(2008-1#2)(2008-2#1)(2008-3#1)
resonance multiphoton##2##2##(2005-4#2)
resonance of the##6##3##(1990-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
resonance of##11##2##(1990-7#1)(1990-8#1)(1994-2#1)(1995-2#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)
resonance peak##5##2##(2007-12#2)(2008-1#1)(2008-3#1)(2009-12#1)
resonance peaks##3##2##(2007-12#1)(2008-5#1)(2008-9#1)
resonance phenomena##3##2##(2007-9#1)(2008-3#1)(2009-8#1)
resonance phenomenon##3##2##(1995-12#1)(2008-2#1)(2010-7#1)
resonance position##3##2##(2006-1#1)(2008-3#2)
resonance scattering (RS) effect##2##4##(2008-10#2)
resonance scattering effect##2##3##(2008-10#2)
resonance scattering spectral method for##2##5##(2008-10#2)
resonance scattering spectral method##3##4##(2008-10#3)
resonance scattering spectral##4##3##(2008-10#4)
resonance scattering##13##2##(2006-4#1)(2008-10#12)
resonance shift##2##2##(2008-10#1)(2008-2#1)
resonance spectra and##2##3##(2008-2#1)(2008-5#1)
resonance spectra of##4##3##(1990-5#1)(2005-4#1)(2008-6#1)(2010-7#1)
resonance spectra##10##2##(1990-10#1)(1990-5#1)(2005-4#1)(2008-2#2)(2008-5#1)(2008-6#2)(2009-6#1)(2010-7#1)
resonance spectrometry##4##2##(1996-1#1)(2006-3#1)(2007-1#1)(2008-3#1)
resonance spectroscopy and##11##3##(1990-7#1)(1992-1#1)(1994-12#1)(1996-6#1)(1997-5#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-7#1)(2010-5#2)
resonance spectroscopy of the brain##2##5##(1995-12#1)(2010-11#1)
resonance spectroscopy of##3##3##(1995-12#1)(2010-11#1)(2012-2#1)
resonance spectroscopy was##2##3##(1996-2#1)(2008-11#1)
resonance spectroscopy##96##2##(1990-10#2)(1990-2#2)(1990-3#1)(1990-7#2)(1991-1#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-7#1)(1993-11#4)(1993-4#1)(1993-6#3)(1994-12#3)(1994-2#1)(1994-5#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-2#1)(1996-5#1)(1996-6#2)(1997-1#3)(1997-5#1)(2005-11#2)(2006-10#1)(2006-12#4)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2008-10#8)(2008-11#4)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#4)(2009-12#1)(2009-4#2)(2010-11#1)(2010-12#2)(2010-5#2)(2010-7#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
resonance spectrum##4##2##(1990-12#1)(1993-11#1)(1994-8#1)(2007-12#1)
resonance structure##3##2##(2006-7#1)(2007-12#1)(2008-2#1)
resonance studies of the##2##4##(1991-5#1)(1994-11#1)
resonance studies of##7##3##(1990-4#1)(1990-5#1)(1991-5#1)(1991-6#1)(1994-11#1)(1997-7#1)(2008-3#1)
resonance studies##10##2##(1990-4#1)(1990-5#1)(1991-5#1)(1991-6#1)(1994-11#1)(1995-11#1)(1997-7#1)(2008-10#1)(2008-3#1)(2011-1#1)
resonance study on##2##3##(1994-5#1)(2008-10#1)
resonance study##10##2##(1991-5#1)(1992-11#1)(1992-4#1)(1994-5#1)(1996-5#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-3#1)
resonance systems##2##2##(2011-2#2)
resonance technique##7##2##(1994-8#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-8#1)
resonance techniques in##2##3##(2007-7#1)(2008-4#1)
resonance techniques##4##2##(1990-2#1)(2007-7#1)(2008-10#1)(2008-4#1)
resonance that##2##2##(2007-12#1)(2007-4#1)
resonance to##4##2##(1994-11#1)(2007-12#2)(2008-3#1)
resonance tomography##5##2##(2007-11#1)(2007-5#1)(2008-4#1)(2009-2#2)
resonance wavelength##7##2##(2007-11#1)(2007-12#3)(2008-10#1)(2008-3#1)(2011-1#1)
resonance wavelengths##2##2##(2008-4#2)
resonance were##2##2##(2005-11#1)(2007-12#1)
resonance with the##2##3##(2008-2#1)(2008-3#1)
resonance with##6##2##(1990-7#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
resonance##1706##1##(1990-10#12)(1990-11#1)(1990-12#5)(1990-2#6)(1990-3#4)(1990-4#4)(1990-5#7)(1990-6#2)(1990-7#10)(1990-8#5)(1991-1#1)(1991-11#4)(1991-12#2)(1991-2#3)(1991-4#5)(1991-5#7)(1991-6#3)(1991-7#9)(1991-8#5)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#4)(1992-12#6)(1992-2#3)(1992-3#17)(1992-4#3)(1992-6#2)(1992-7#3)(1992-8#2)(1992-9#5)(1993-1#1)(1993-10#1)(1993-11#10)(1993-12#1)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#13)(1993-7#2)(1993-8#6)(1993-9#1)(1994-10#1)(1994-11#8)(1994-12#5)(1994-2#7)(1994-3#4)(1994-5#8)(1994-7#5)(1994-8#10)(1994-9#2)(1995-1#8)(1995-10#4)(1995-11#5)(1995-12#6)(1995-2#6)(1995-4#4)(1995-5#14)(1995-6#3)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#4)(1996-11#4)(1996-2#8)(1996-3#6)(1996-5#9)(1996-6#2)(1996-7#6)(1996-8#3)(1996-9#1)(1997-1#4)(1997-2#2)(1997-4#9)(1997-5#5)(1997-6#4)(1997-7#6)(1997-8#13)(2004-11#4)(2004-2#1)(2004-9#3)(2005-10#6)(2005-11#7)(2005-12#2)(2005-2#1)(2005-4#5)(2005-5#2)(2005-7#2)(2005-8#1)(2005-9#1)(2006-1#4)(2006-10#43)(2006-11#4)(2006-12#25)(2006-2#3)(2006-3#3)(2006-4#3)(2006-5#13)(2006-6#12)(2006-7#4)(2006-8#9)(2006-9#7)(2007-1#4)(2007-10#33)(2007-11#54)(2007-12#73)(2007-3#5)(2007-4#19)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#18)(2007-9#24)(2008-1#18)(2008-10#144)(2008-11#25)(2008-12#12)(2008-2#53)(2008-3#65)(2008-4#31)(2008-5#20)(2008-6#16)(2008-7#64)(2008-8#15)(2008-9#25)(2009-1#4)(2009-10#9)(2009-11#3)(2009-12#5)(2009-2#9)(2009-3#9)(2009-4#17)(2009-5#14)(2009-6#4)(2009-7#41)(2009-8#6)(2009-9#8)(2010-1#4)(2010-10#1)(2010-11#4)(2010-12#28)(2010-2#6)(2010-3#4)(2010-4#13)(2010-5#8)(2010-6#4)(2010-7#9)(2010-8#13)(2010-9#8)(2011-1#16)(2011-12#6)(2011-2#37)(2011-3#1)(2012-1#6)(2012-11#11)(2012-12#26)(2012-2#50)(2012-3#15)(2013-1#16)(2013-3#2)(2013-7#9)(2013-8#14)
resonance)##9##1##(1990-9#1)(1991-7#1)(1992-8#1)(2006-6#1)(2007-11#1)(2008-1#2)(2012-12#2)
resonance-ionization and##2##2##(2007-12#2)
resonances and##7##2##(1991-2#1)(1991-4#1)(1995-2#1)(2007-11#1)(2007-12#2)(2008-2#1)
resonances are observed at##2##4##(1991-8#1)(2008-10#1)
resonances are observed##3##3##(1991-8#1)(2008-10#1)(2008-5#1)
resonances are##11##2##(1991-11#1)(1991-8#1)(1995-11#1)(1995-3#1)(1996-2#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-5#1)
resonances as##2##2##(1997-4#1)(2008-1#1)
resonances at##3##2##(1991-8#1)(1996-2#1)(2007-12#1)
resonances by##2##2##(1991-5#1)(2008-3#1)
resonances for the##4##3##(1991-11#3)(2009-7#1)
resonances for##6##2##(1991-11#3)(1994-3#1)(1996-7#1)(2009-7#1)
resonances from the##2##3##(1992-9#1)(1994-10#1)
resonances from##5##2##(1991-4#1)(1992-9#1)(1994-10#2)(1997-4#1)
resonances have been##2##3##(1995-5#1)(2007-12#1)
resonances have##3##2##(1992-8#1)(1995-5#1)(2007-12#1)
resonances in a##2##3##(1991-2#1)(1992-4#1)
resonances in cylindrical microparticles##2##4##(2008-3#2)
resonances in the NMR spectrum##2##5##(1991-2#1)(1997-4#1)
resonances in the##8##3##(1991-2#2)(1993-11#1)(1997-4#1)(2006-5#1)(2007-11#1)(2008-2#2)
resonances in##24##2##(1990-4#1)(1990-7#1)(1991-2#4)(1992-4#1)(1993-11#1)(1994-5#1)(1997-4#1)(2006-5#1)(2007-11#3)(2007-12#4)(2008-2#3)(2008-3#2)(2010-4#1)
resonances is##2##2##(1997-4#1)(2008-3#1)
resonances of the##11##3##(1995-1#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-7#1)(2008-3#1)(2009-7#4)
resonances of##23##2##(1991-4#2)(1991-7#1)(1994-10#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-2#2)(1996-5#1)(1997-7#2)(2008-2#2)(2008-3#4)(2009-7#4)(2010-2#1)
resonances on the##2##3##(2008-3#1)(2008-6#1)
resonances on##3##2##(1990-7#1)(2008-3#1)(2008-6#1)
resonances to##4##2##(1990-10#1)(1991-4#1)(2007-11#1)(2007-8#1)
resonances were assigned by##2##4##(1991-4#1)(1992-3#1)
resonances were assigned##3##3##(1991-4#1)(1992-12#1)(1992-3#1)
resonances were##8##2##(1991-2#1)(1991-4#1)(1992-12#1)(1992-3#1)(1993-11#1)(1995-10#1)(2006-5#1)(2008-9#1)
resonances which##2##2##(1991-2#1)(1994-5#1)
resonances with##3##2##(1990-5#1)(1991-7#1)(2006-7#1)
resonances within a##2##3##(1994-5#1)(2009-6#1)
resonances within##4##2##(1994-5#1)(2007-11#1)(2007-12#1)(2009-6#1)
resonances##166##1##(1990-10#3)(1990-2#1)(1990-4#1)(1990-5#2)(1990-7#3)(1991-11#4)(1991-2#10)(1991-4#9)(1991-5#3)(1991-7#2)(1991-8#2)(1992-12#2)(1992-3#1)(1992-4#2)(1992-8#1)(1992-9#1)(1993-11#3)(1994-10#3)(1994-11#1)(1994-3#1)(1994-5#3)(1995-1#1)(1995-10#3)(1995-11#2)(1995-2#1)(1995-3#2)(1995-5#4)(1995-7#1)(1996-2#7)(1996-5#1)(1996-7#1)(1997-1#1)(1997-4#4)(1997-7#3)(2006-12#1)(2006-5#2)(2006-7#1)(2007-11#10)(2007-12#20)(2007-4#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#8)(2008-3#12)(2008-5#1)(2008-6#3)(2008-7#2)(2008-9#1)(2009-3#1)(2009-6#1)(2009-7#5)(2010-2#2)(2010-4#1)(2010-7#1)
resonant Bragg##2##2##(2006-4#1)(2008-1#1)
resonant Faraday##3##2##(2007-12#3)
resonant OPO generates##2##3##(2007-11#1)(2007-12#1)
resonant OPO is pumped by a##2##6##(2007-11#1)(2007-12#1)
resonant OPO##7##2##(2007-11#3)(2007-12#4)
resonant Raman##2##2##(2007-11#2)
resonant and nonresonant##2##3##(2008-10#1)(2012-2#1)
resonant and##3##2##(2007-12#1)(2008-10#1)(2012-2#1)
resonant at##3##2##(2007-12#2)(2008-2#1)
resonant cavities##3##2##(2007-11#2)(2007-12#1)
resonant cavity##8##2##(2007-11#1)(2007-12#5)(2008-3#2)
resonant continuous-wave optical parametric oscillator pumped by a##2##8##(2007-12#2)
resonant continuous-wave optical parametric oscillator##4##5##(2007-12#4)
resonant continuous-wave##7##2##(2007-11#1)(2007-12#4)(2008-1#2)
resonant coupling##2##2##(2007-12#1)(2008-7#1)
resonant device##3##2##(2007-12#2)(2008-1#1)
resonant enhancement of the##3##4##(1996-2#1)(2007-12#1)(2008-10#1)
resonant enhancement##4##2##(1992-9#1)(1996-2#1)(2007-12#1)(2008-10#1)
resonant features##2##2##(2007-12#2)
resonant filter##3##2##(2008-3#3)
resonant frequencies##5##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)
resonant frequency of the quartz crystal##2##6##(2008-10#2)
resonant frequency of the quartz##3##5##(2005-11#1)(2008-10#2)
resonant frequency of the##6##4##(2005-11#1)(2007-11#1)(2008-10#3)(2008-2#1)
resonant frequency of##7##3##(1990-8#1)(2005-11#1)(2007-11#1)(2008-10#3)(2008-2#1)
resonant frequency##9##2##(1990-8#1)(2005-11#1)(2007-11#1)(2008-10#3)(2008-2#2)(2009-5#1)
resonant grating##4##2##(2007-12#2)(2008-3#2)
resonant interaction with##2##3##(1991-8#1)(1992-9#1)
resonant interaction##3##2##(1991-8#1)(1992-9#1)(2007-11#1)
resonant interference##3##2##(2008-2#2)(2008-3#1)
resonant ionization mass##2##3##(2005-4#2)
resonant ionization##4##2##(2005-4#3)(2008-3#1)
resonant laser ablation##2##3##(2008-3#2)
resonant mirror biosensor##2##3##(2008-4#2)
resonant mirror##7##2##(1997-2#2)(2008-10#1)(2008-4#3)(2010-1#1)
resonant modes of##2##3##(1996-5#1)(2007-12#1)
resonant modes##5##2##(1996-5#1)(2007-11#1)(2007-12#3)
resonant optical parametric oscillator (OPO)##4##5##(2007-12#3)(2008-3#1)
resonant optical parametric oscillator##22##4##(2007-11#4)(2007-12#16)(2008-1#1)(2008-3#1)
resonant optical parametric oscillators##4##4##(2007-11#1)(2007-12#2)(2008-3#1)
resonant optical parametric##26##3##(2007-11#5)(2007-12#18)(2008-1#1)(2008-3#2)
resonant optical##30##2##(2007-11#6)(2007-12#20)(2008-1#1)(2008-2#1)(2008-3#2)
resonant peaks##3##2##(2008-1#2)(2008-3#1)
resonant photoacoustic##2##2##(2007-12#1)(2008-10#1)
resonant pump##2##2##(2007-12#2)
resonant second-harmonic generation##2##3##(2007-11#1)(2007-12#1)
resonant sequential##2##2##(2007-12#2)
resonant sideband extraction##4##3##(2008-2#4)
resonant sideband##5##2##(2007-12#1)(2008-2#4)
resonant tunneling##4##2##(1992-11#1)(1995-11#1)(2007-12#2)
resonant with##3##2##(2007-11#1)(2007-12#2)
resonant##254##1##(1990-8#1)(1991-8#1)(1992-11#1)(1992-9#2)(1995-11#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#2)(1997-4#1)(2005-11#1)(2005-4#3)(2006-4#3)(2007-11#36)(2007-12#92)(2007-8#3)(2007-9#1)(2008-1#15)(2008-10#8)(2008-11#3)(2008-2#27)(2008-3#37)(2008-4#3)(2008-7#3)(2009-11#1)(2009-5#1)(2010-1#1)(2010-5#1)(2011-2#1)(2012-2#1)
resonant-cavity##2##1##(2007-12#2)
resonantly enhanced phase##2##3##(2007-12#1)(2008-3#1)
resonantly enhanced##7##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)
resonantly excited##2##2##(2007-12#2)
resonantly##15##1##(2007-11#2)(2007-12#8)(2008-2#1)(2008-3#4)
resonate##2##1##(1997-1#1)(2008-3#1)
resonated##3##1##(2007-12#1)(2008-3#2)
resonates##4##1##(2007-12#1)(2007-9#1)(2008-2#1)(2012-12#1)
resonating the##2##2##(2007-12#1)(2008-1#1)
resonating##3##1##(2007-12#1)(2008-1#1)(2008-3#1)
resonator and a##3##3##(2007-12#2)(2008-3#1)
resonator and the##3##3##(2007-11#1)(2008-2#1)(2008-7#1)
resonator and##10##2##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#3)(2008-7#1)
resonator as##2##2##(2007-11#1)(2008-3#1)
resonator based on##4##3##(2007-11#1)(2008-3#3)
resonator by##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
resonator configuration##3##2##(2007-12#1)(2008-3#2)
resonator design for##3##3##(2007-11#1)(2008-1#1)(2008-3#1)
resonator design##5##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#2)
resonator for##3##2##(2007-12#1)(2008-3#1)(2011-1#1)
resonator formed by##2##3##(2007-12#2)
resonator geometries such as##2##4##(2008-2#1)(2008-7#1)
resonator in a##2##3##(2007-11#1)(2008-3#1)
resonator in the##2##3##(2007-12#2)
resonator in##5##2##(1991-12#1)(2007-11#1)(2007-12#2)(2008-3#1)
resonator is##10##2##(2007-11#1)(2007-12#6)(2008-3#3)
resonator length##3##2##(2007-12#2)(2008-1#1)
resonator mirror##2##2##(2007-12#1)(2008-3#1)
resonator mirrors##3##2##(2008-1#1)(2008-2#2)
resonator mode##2##2##(2007-12#1)(2008-3#1)
resonator model##2##2##(2007-12#1)(2008-2#1)
resonator of the##2##3##(2007-11#1)(2007-12#1)
resonator of##3##2##(2007-11#1)(2007-12#1)(2008-1#1)
resonator operating at##2##3##(2007-11#1)(2008-2#1)
resonator parameters##2##2##(2007-12#1)(2008-3#1)
resonator scheme##2##2##(2007-11#1)(2008-2#1)
resonator that is##2##3##(2007-12#1)(2008-2#1)
resonator that##6##2##(2007-12#2)(2008-2#2)(2008-3#2)
resonator was##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
resonator when##2##2##(2007-11#1)(2008-3#1)
resonator with a##3##3##(2008-2#1)(2008-3#2)
resonator with an##2##3##(2008-2#1)(2008-3#1)
resonator with the##3##3##(2008-2#1)(2008-3#1)(2011-1#1)
resonator with##11##2##(2008-2#3)(2008-3#6)(2011-1#1)(2013-8#1)
resonator without cavity dumping##2##4##(2007-11#1)(2007-12#1)
resonator without##3##2##(2007-11#1)(2007-12#2)
resonator##223##1##(1991-12#1)(2007-11#26)(2007-12#63)(2008-1#9)(2008-10#1)(2008-2#44)(2008-3#64)(2008-7#4)(2009-5#3)(2010-4#2)(2011-1#3)(2012-2#1)(2013-8#2)
resonators and##2##2##(2007-12#1)(2008-2#1)
resonators are##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
resonators based on##3##3##(2007-11#1)(2008-1#1)(2008-3#1)
resonators by##2##2##(2008-1#1)(2008-3#1)
resonators for##4##2##(2007-12#1)(2008-3#1)(2009-5#2)
resonators in##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
resonators is##2##2##(2007-12#2)
resonators show##2##2##(2007-11#2)
resonators that##4##2##(2007-11#1)(2008-3#3)
resonators with a##3##3##(2008-3#2)(2009-5#1)
resonators with##8##2##(2007-11#1)(2008-3#6)(2009-5#1)
resonators##82##1##(2007-11#18)(2007-12#18)(2008-1#4)(2008-2#9)(2008-3#29)(2009-5#4)
resorb bone##2##2##(1993-9#2)
resorb##5##1##(1991-11#1)(1993-9#2)(2005-3#1)(2007-12#1)
resorbable membranes##2##2##(2007-12#2)
resorbable##10##1##(2004-9#3)(2007-12#2)(2008-5#2)(2010-5#1)(2011-1#1)(2012-3#1)
resorbed by##3##2##(1995-2#1)(2007-7#1)(2008-12#1)
resorbed from##3##2##(1997-5#1)(2012-12#2)
resorbed##16##1##(1993-4#1)(1995-2#1)(1997-5#1)(2004-9#1)(2007-7#1)(2007-8#1)(2008-12#2)(2008-5#1)(2009-3#1)(2009-7#1)(2012-12#2)(2013-1#3)
resorbing##8##1##(1991-8#1)(1993-11#1)(1993-12#3)(1993-8#1)(2012-12#2)
resorcin##2##1##(2005-4#2)
resorcinarene##2##1##(2012-11#2)
resorcinol (PAR) and##2##3##(2008-10#2)
resorcinol (PAR)##6##2##(2008-10#6)
resorcinol and hydroquinone##2##3##(2008-10#2)
resorcinol and##6##2##(2008-10#6)
resorcinol##31##1##(1991-8#1)(1992-3#1)(2006-12#1)(2006-9#2)(2007-11#1)(2008-10#21)(2008-11#1)(2008-6#1)(2011-1#1)(2012-1#1)
resorption and formation##3##3##(1992-5#1)(1993-11#1)(2007-11#1)
resorption and increase##2##3##(1990-9#1)(1992-8#1)
resorption and##26##2##(1990-9#1)(1991-3#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#3)(1996-9#1)(1997-7#1)(2004-9#1)(2005-3#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-12#1)(2009-8#2)(2011-12#1)(2013-1#2)
resorption are##3##2##(2007-11#2)(2009-8#1)
resorption around##2##2##(2008-9#2)
resorption associated with##2##3##(2008-5#1)(2009-3#1)
resorption by##17##2##(1990-6#1)(1991-8#1)(1992-3#1)(1992-7#1)(1993-9#3)(1994-6#1)(1997-6#4)(2008-11#2)(2010-10#2)(2013-1#1)
resorption capacity increased##2##3##(2013-8#2)
resorption capacity##3##2##(2013-8#3)
resorption from##2##2##(2008-4#1)(2008-5#1)
resorption in Quercus brantii##2##4##(2008-12#2)
resorption in the##3##3##(1991-3#1)(1993-9#1)(2007-2#1)
resorption in##22##2##(1991-3#1)(1991-7#2)(1992-3#1)(1993-6#2)(1993-9#3)(1995-2#2)(1995-3#1)(1996-9#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-12#2)(2009-3#2)(2011-1#1)
resorption is##6##2##(1993-6#1)(1996-8#1)(1996-9#1)(2009-8#1)(2013-1#2)
resorption marker##4##2##(1992-5#1)(2008-10#1)(2008-5#1)(2013-8#1)
resorption markers##2##2##(2008-10#2)
resorption of bone##2##3##(2007-11#1)(2008-8#1)
resorption of the##11##3##(2004-9#1)(2005-3#2)(2008-4#1)(2008-5#1)(2009-3#1)(2013-1#5)
resorption of##18##2##(1993-7#1)(2004-9#1)(2005-3#2)(2007-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#1)(2013-1#6)
resorption over##2##2##(1995-1#1)(2010-2#1)
resorption process##3##2##(1991-7#2)(2008-12#1)
resorption using##3##2##(2013-1#3)
resorption villi in the experimental than in the control group (p &lt##2##12##(2011-1#2)
resorption villi##8##2##(2011-1#8)
resorption was lowest at##2##4##(2008-12#2)
resorption was##10##2##(1991-11#1)(1991-7#1)(1992-3#1)(1995-3#2)(2008-12#2)(2008-7#2)(2012-2#1)
resorption were##2##2##(1990-7#1)(1991-11#1)
resorption##251##1##(1990-2#2)(1990-6#1)(1990-7#2)(1990-9#1)(1991-10#1)(1991-11#4)(1991-3#2)(1991-4#1)(1991-7#7)(1991-8#2)(1992-10#1)(1992-3#5)(1992-5#2)(1992-7#3)(1992-8#2)(1993-11#8)(1993-6#10)(1993-7#3)(1993-8#1)(1993-9#10)(1994-3#5)(1994-6#2)(1995-1#1)(1995-2#3)(1995-3#7)(1996-2#1)(1996-8#2)(1996-9#3)(1997-6#4)(1997-7#2)(2004-9#2)(2005-3#11)(2005-7#1)(2006-10#3)(2006-6#1)(2007-1#1)(2007-11#11)(2007-12#3)(2007-2#6)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#7)(2008-12#8)(2008-3#3)(2008-4#2)(2008-5#11)(2008-7#7)(2008-8#2)(2008-9#2)(2009-3#5)(2009-4#1)(2009-8#4)(2010-10#3)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#9)(2011-12#1)(2011-2#3)(2011-7#1)(2012-12#1)(2012-2#2)(2013-1#26)(2013-8#6)
resorption)##2##1##(1990-7#1)(1991-11#1)
resorptive activity##2##2##(1994-12#1)(2012-2#1)
resorptive defect##2##2##(2007-2#2)
resorptive process itself##2##3##(1993-9#1)(1994-3#1)
resorptive##13##1##(1991-12#3)(1993-9#1)(1994-12#1)(1994-3#1)(2006-10#1)(2007-2#2)(2011-2#3)(2012-2#1)
resort to##13##2##(1990-5#1)(1991-1#1)(1993-12#1)(1996-8#1)(2005-8#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-12#1)(2012-2#1)(2013-1#1)
resort##25##1##(1990-5#1)(1991-1#1)(1993-12#1)(1994-3#1)(1996-8#1)(1997-2#1)(2005-11#1)(2005-8#2)(2006-4#1)(2006-8#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-8#2)(2009-12#1)(2009-8#1)(2010-10#1)(2012-2#2)(2013-1#1)(2013-8#2)
resorted to##4##2##(1997-5#1)(2006-4#1)(2008-10#1)(2008-12#1)
resorting to##13##2##(1992-7#1)(1995-6#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-6#1)(2010-6#1)(2011-1#1)(2013-1#1)
resorts##2##1##(1993-10#1)(2008-5#1)
resorufin##4##1##(1994-8#1)(2008-10#2)(2011-2#1)
resource abundance##2##2##(2008-9#2)
resource acquisition##3##2##(1991-8#1)(2008-8#2)
resource allocation and##3##3##(1992-3#1)(1995-1#1)(2011-2#1)
resource allocation decisions##2##3##(1995-1#1)(1997-1#1)
resource allocation planning##2##3##(1992-2#2)
resource allocation##25##2##(1992-1#1)(1992-2#2)(1992-3#2)(1995-1#2)(1995-2#1)(1997-1#1)(2005-8#1)(2006-1#1)(2007-4#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#3)(2010-2#2)(2011-2#1)(2013-1#2)(2013-8#1)
resource and a##2##3##(1993-2#1)(2008-8#1)
resource and##10##2##(1991-3#1)(1993-2#1)(2007-10#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2013-1#2)
resource at##2##2##(2007-5#1)(2008-9#1)
resource availability can##2##3##(2008-8#1)(2008-9#1)
resource availability##7##2##(2008-8#4)(2008-9#1)(2012-2#2)
resource competition##6##2##(2004-11#1)(2007-7#1)(2008-8#3)(2008-9#1)
resource conservation##2##2##(1992-2#1)(2008-2#1)
resource constrained environment##2##3##(2008-1#1)(2008-10#1)
resource constrained##5##2##(2008-1#1)(2008-10#1)(2010-8#1)(2012-2#2)
resource constraints##3##2##(2006-1#1)(2008-11#1)(2008-12#1)
resource consumption##6##2##(1991-12#2)(1995-2#1)(1995-3#1)(2007-2#1)(2008-8#1)
resource costs##2##2##(2008-8#1)(2009-8#1)
resource defense##2##2##(2008-8#1)(2012-2#1)
resource densities##3##2##(2008-8#1)(2008-9#2)
resource density##2##2##(2008-8#2)
resource development##4##2##(2007-12#1)(2008-1#2)(2012-3#1)
resource distribution##2##2##(1995-1#1)(2008-8#1)
resource dynamics##3##2##(2008-8#3)
resource extraction rate is##2##4##(2008-8#2)
resource extraction##3##2##(2008-8#3)
resource for research##4##3##(1995-9#1)(2008-7#1)(2013-1#2)
resource for studying##2##3##(2010-7#1)(2011-1#1)
resource for the##5##3##(1993-2#1)(1997-5#1)(2007-4#1)(2008-10#1)(2008-4#1)
resource for those##2##3##(1995-12#1)(2006-3#1)
resource for##57##2##(1990-5#1)(1991-11#1)(1992-1#1)(1992-3#1)(1993-2#2)(1994-12#1)(1994-9#1)(1995-12#1)(1995-9#1)(1996-2#1)(1997-5#1)(2004-11#4)(2006-12#2)(2006-3#1)(2006-9#1)(2007-2#1)(2007-4#1)(2007-5#4)(2008-10#3)(2008-12#2)(2008-4#3)(2008-7#7)(2008-8#2)(2008-9#2)(2009-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#4)(2013-1#2)(2013-8#1)
resource in the##2##3##(1991-3#1)(2008-8#1)
resource in##4##2##(1991-3#1)(2007-6#1)(2008-12#1)(2008-8#1)
resource information##2##2##(2007-2#1)(2010-8#1)
resource intensive and##2##3##(1993-12#1)(2013-1#1)
resource intensive##3##2##(1993-12#1)(2008-12#1)(2013-1#1)
resource is##3##2##(1997-2#1)(2005-7#1)(2008-12#1)
resource limitation##2##2##(2012-2#2)
resource limited##4##2##(1995-12#1)(2010-8#1)(2011-1#1)(2012-2#1)
resource list##2##2##(2008-9#1)(2010-12#1)
resource management##15##2##(1991-1#1)(1993-2#1)(1995-3#4)(1996-12#1)(1996-2#1)(1997-3#1)(2007-5#1)(2009-2#1)(2011-2#3)(2012-12#1)
resource of##6##2##(1995-2#1)(1996-3#1)(2008-4#2)(2008-7#1)(2008-8#1)
resource partitioning##2##2##(2008-5#1)(2010-8#1)
resource patches##6##2##(2008-11#2)(2008-9#4)
resource planning##5##2##(1997-3#1)(2010-5#1)(2010-8#1)(2013-1#2)
resource poor##10##2##(1995-9#1)(2007-2#2)(2007-4#2)(2008-2#1)(2008-4#1)(2009-4#1)(2010-8#1)(2012-2#1)
resource productivity##2##2##(2008-8#1)(2013-8#1)
resource providing##2##2##(2008-10#1)(2013-8#1)
resource requirements##4##2##(2008-8#2)(2008-9#1)(2010-2#1)
resource settings##7##2##(2009-6#4)(2010-8#1)(2011-2#2)
resource sharing##3##2##(1995-2#1)(2011-12#1)(2011-2#1)
resource shortages##2##2##(1997-1#1)(2011-1#1)
resource supply##3##2##(2008-8#3)
resource that##9##2##(2008-12#2)(2008-4#3)(2008-5#1)(2008-9#1)(2010-11#1)(2012-2#1)
resource to##7##2##(1993-2#1)(1994-10#1)(2007-2#1)(2007-6#1)(2008-3#1)(2008-7#1)(2008-9#1)
resource use during##2##3##(1991-12#1)(2007-10#1)
resource use for##2##3##(1994-3#1)(2009-3#1)
resource use##22##2##(1991-12#2)(1991-2#1)(1993-12#2)(1993-2#1)(1994-3#3)(1995-3#2)(1996-9#1)(1997-2#1)(1997-3#1)(2006-7#1)(2007-10#2)(2007-12#1)(2008-11#1)(2008-9#2)(2009-3#1)
resource utilization and##2##3##(1993-3#1)(2009-11#1)
resource utilization in##2##3##(1994-3#1)(2008-3#1)
resource utilization##24##2##(1992-4#1)(1993-3#1)(1994-3#3)(1995-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(2006-1#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#2)(2009-9#1)(2013-1#2)
resource will##2##2##(2008-7#1)(2008-8#1)
resource within##2##2##(2008-11#1)(2008-9#1)
resource##470##1##(1990-11#1)(1990-12#1)(1990-5#1)(1991-1#2)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#2)(1991-8#2)(1992-1#3)(1992-2#3)(1992-3#3)(1992-4#1)(1993-12#4)(1993-2#7)(1993-3#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#6)(1994-8#1)(1994-9#1)(1995-1#3)(1995-12#6)(1995-2#6)(1995-3#8)(1995-9#2)(1996-1#2)(1996-12#1)(1996-2#3)(1996-3#3)(1996-9#2)(1997-1#3)(1997-2#4)(1997-3#4)(1997-5#1)(2004-11#6)(2004-4#1)(2005-5#4)(2005-7#2)(2005-8#3)(2006-1#3)(2006-10#2)(2006-12#2)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-9#2)(2007-10#4)(2007-11#1)(2007-12#4)(2007-2#7)(2007-3#2)(2007-4#6)(2007-5#6)(2007-6#2)(2007-7#4)(2007-8#5)(2007-9#2)(2008-1#3)(2008-10#12)(2008-11#12)(2008-12#10)(2008-2#3)(2008-3#2)(2008-4#17)(2008-5#6)(2008-6#2)(2008-7#17)(2008-8#59)(2008-9#35)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#3)(2009-4#3)(2009-6#7)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#3)(2010-4#4)(2010-5#4)(2010-7#1)(2010-8#15)(2011-1#4)(2011-12#1)(2011-2#11)(2012-12#3)(2012-2#14)(2012-3#8)(2013-1#24)(2013-7#1)(2013-8#5)
resource-based model##3##2##(2008-8#3)
resource-based relative value scale##6##4##(1991-12#1)(1992-1#1)(1992-12#2)(1994-12#2)
resource-based relative value##7##3##(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#2)(1994-12#2)
resource-based##16##1##(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#2)(1994-1#2)(1994-12#2)(1996-1#1)(2007-5#1)(2008-4#1)(2008-8#3)(2012-2#1)
resource-constrained##6##1##(2006-10#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-2#2)
resource-limited settings##4##2##(2009-4#1)(2010-7#1)(2011-1#1)(2012-2#1)
resource-limited##6##1##(2009-4#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-2#1)
resource-poor settings##2##2##(2009-6#1)(2012-12#1)
resource-poor##11##1##(2006-2#1)(2007-12#1)(2008-11#1)(2008-9#1)(2009-6#2)(2009-8#1)(2012-12#1)(2012-2#2)(2013-1#1)
resource-rich##2##1##(2008-9#2)
resourcefulness##5##1##(2007-2#1)(2008-12#4)
resources (i##2##2##(2010-8#1)(2011-2#1)
resources allocated##2##2##(2008-10#1)(2008-9#1)
resources and a##2##3##(1993-6#1)(1997-3#1)
resources and can##2##3##(1997-3#1)(2008-4#1)
resources and expertise to##2##4##(1995-1#1)(2010-8#1)
resources and expertise##3##3##(1995-1#1)(2010-8#1)(2011-1#1)
resources and had##2##3##(1991-12#1)(1995-1#1)
resources and infrastructure##2##3##(2010-12#1)(2011-1#1)
resources and personnel##3##3##(1993-12#1)(2006-10#1)(2008-10#1)
resources and services##3##3##(1993-1#3)
resources and systems##2##3##(1993-12#1)(2009-8#1)
resources and technologies##2##3##(2006-4#2)
resources and the##6##3##(1996-8#1)(1997-2#1)(1997-3#1)(2008-7#1)(2011-1#1)(2013-1#1)
resources and time##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
resources and to##4##3##(2006-12#1)(2007-5#1)(2008-1#1)(2008-10#1)
resources and##114##2##(1990-12#1)(1991-12#1)(1991-3#1)(1992-2#1)(1993-1#3)(1993-12#2)(1993-6#1)(1994-12#2)(1994-3#2)(1995-1#3)(1995-12#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-8#1)(1997-2#2)(1997-3#4)(2006-10#2)(2006-12#1)(2006-4#2)(2007-4#1)(2007-5#3)(2007-7#2)(2008-1#3)(2008-10#7)(2008-11#1)(2008-12#2)(2008-4#2)(2008-7#6)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#2)(2009-4#1)(2009-6#2)(2009-8#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#3)(2012-11#3)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#3)
resources are allocated##2##3##(1997-3#1)(2008-6#1)
resources are available##2##3##(2008-9#1)(2010-9#1)
resources are currently##2##3##(2008-10#1)(2008-7#1)
resources are limited##2##3##(2009-10#1)(2012-2#1)
resources are scarce##3##3##(2008-12#1)(2008-9#1)(2012-2#1)
resources are##35##2##(1994-3#2)(1995-9#1)(1996-2#1)(1996-4#1)(1997-3#1)(2007-4#2)(2007-7#1)(2008-10#1)(2008-12#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#5)(2009-10#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
resources as well as the##2##5##(2007-1#1)(2009-4#1)
resources as well as##4##4##(1993-2#1)(2007-1#1)(2008-4#1)(2009-4#1)
resources as well##6##3##(1993-2#1)(2007-1#1)(2008-12#1)(2008-4#1)(2009-4#1)(2013-8#1)
resources as##7##2##(1993-2#1)(2006-12#1)(2007-1#1)(2008-12#1)(2008-4#1)(2009-4#1)(2013-8#1)
resources at##3##2##(2009-10#2)(2013-8#1)
resources availability##2##2##(2013-7#2)
resources available and the##2##4##(2007-11#1)(2012-2#1)
resources available for##5##3##(2006-6#1)(2008-4#1)(2008-8#1)(2009-1#1)(2009-10#1)
resources available to##6##3##(1994-1#1)(1996-2#1)(2006-1#1)(2008-4#1)(2010-9#1)(2011-2#1)
resources available##18##2##(1994-1#1)(1996-2#1)(2005-5#1)(2006-1#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-2#1)(2008-4#3)(2008-8#1)(2009-1#1)(2009-10#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-2#1)
resources between##4##2##(2007-7#1)(2008-8#1)(2013-1#2)
resources but##5##2##(2006-6#1)(2008-8#1)(2008-9#2)(2013-8#1)
resources by##8##2##(1996-1#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-8#1)(2013-1#2)
resources can be##3##3##(2006-5#1)(2008-9#1)(2010-2#1)
resources can##4##2##(1996-4#1)(2006-5#1)(2008-9#1)(2010-2#1)
resources conservation##2##2##(2009-7#1)(2013-8#1)
resources devoted to##2##3##(2006-11#1)(2010-11#1)
resources for childbirth educators and##2##5##(2010-9#2)
resources for health##2##3##(1991-6#1)(1997-2#1)
resources for improving##3##3##(2012-11#1)(2013-1#2)
resources for information##2##3##(1996-12#1)(2008-4#1)
resources for more information are provided in the Literature Cited and Key References sections and in URLs given text and within the Internet Resources section##2##25##(2008-4#1)(2008-9#1)
resources for nursing##2##3##(2008-11#2)
resources for physicians##2##3##(2007-7#1)(2008-11#1)
resources for public health##2##4##(1995-12#1)(1997-3#1)
resources for radiology##2##3##(1996-2#1)(2007-4#1)
resources for the##7##3##(1996-4#1)(2006-9#1)(2008-7#1)(2011-2#3)(2012-12#1)
resources for their##2##3##(1992-5#1)(2008-1#1)
resources for treatment##2##3##(2006-10#1)(2008-10#1)
resources for##69##2##(1991-3#1)(1991-6#1)(1992-3#4)(1992-5#1)(1994-2#1)(1995-12#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-12#2)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#5)(2008-7#4)(2008-8#2)(2008-9#1)(2010-12#1)(2010-9#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#8)
resources from the##2##3##(2008-8#1)(2012-3#1)
resources from##12##2##(1991-3#1)(1991-4#1)(1991-8#1)(1994-2#2)(1995-1#1)(1997-1#1)(2007-5#1)(2007-9#1)(2008-11#1)(2008-8#1)(2012-3#1)
resources has##4##2##(2006-11#1)(2012-12#1)(2012-2#1)(2013-8#1)
resources have##3##2##(2008-8#1)(2009-12#1)(2009-2#1)
resources in a##2##3##(2008-7#1)(2010-11#1)
resources in order to##2##4##(2007-2#1)(2008-2#1)
resources in terms of##2##4##(1990-6#1)(2006-10#1)
resources in the health##2##4##(1991-6#1)(2013-1#1)
resources in the##14##3##(1990-9#1)(1991-3#1)(1991-6#1)(2006-9#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
resources in their##2##3##(1993-2#1)(2011-2#1)
resources in this##4##3##(1990-12#1)(1991-11#1)(1997-3#1)(2010-10#1)
resources in##62##2##(1990-12#1)(1990-6#2)(1990-9#1)(1991-11#2)(1991-3#1)(1991-6#1)(1993-2#2)(1997-3#2)(2006-10#1)(2006-9#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2009-3#1)(2009-6#2)(2009-7#2)(2010-10#1)(2010-11#1)(2010-5#1)(2010-9#3)(2011-1#1)(2011-2#2)(2011-7#1)(2012-11#1)(2012-12#4)(2012-2#1)(2013-1#2)(2013-8#3)
resources intensifies##2##2##(2008-1#1)(2009-2#1)
resources into##3##2##(2007-4#1)(2007-7#1)(2008-9#1)
resources is a##2##3##(2009-3#1)(2012-12#1)
resources is##10##2##(1992-12#1)(1995-4#1)(1997-1#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-8#1)(2012-12#1)(2013-7#1)
resources it##2##2##(2008-10#1)(2008-8#1)
resources led to##2##3##(1992-2#1)(2011-3#1)
resources may##2##2##(2007-3#1)(2012-2#1)
resources might be##2##3##(2008-11#1)(2009-5#1)
resources might##3##2##(2008-11#1)(2008-8#1)(2009-5#1)
resources must##3##2##(1995-2#1)(2007-12#1)(2008-11#1)
resources need##2##2##(2006-4#1)(2013-8#1)
resources needed for##4##3##(2008-2#1)(2008-4#1)(2010-3#1)(2013-1#1)
resources needed to meet##2##4##(1991-8#1)(2008-3#1)
resources needed to##3##3##(1991-8#1)(2007-7#1)(2008-3#1)
resources needed##8##2##(1991-8#1)(2007-7#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-3#1)(2013-1#1)
resources of Veterinary Services##2##4##(2005-5#2)
resources of the##9##3##(1990-12#1)(1992-12#1)(1996-2#1)(2008-10#1)(2009-7#1)(2011-2#2)(2012-2#1)(2013-7#1)
resources of##24##2##(1990-12#2)(1990-2#1)(1991-3#1)(1992-12#1)(1995-1#1)(1996-2#2)(1997-3#1)(2005-5#2)(2005-9#1)(2006-5#1)(2008-10#3)(2009-11#1)(2009-7#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-7#1)
resources often##3##2##(2008-8#1)(2008-9#1)(2012-1#1)
resources on the##3##3##(1996-12#1)(2011-2#2)
resources on##17##2##(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-2#2)(2007-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-7#1)(2011-2#4)
resources or##5##2##(2004-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2013-1#1)
resources required to##3##3##(2006-12#1)(2010-5#1)(2011-1#1)
resources required##7##2##(2006-1#1)(2006-12#1)(2008-9#1)(2010-5#1)(2011-1#1)(2012-2#2)
resources should##6##2##(1995-6#1)(2008-7#1)(2008-9#1)(2010-7#1)(2013-1#2)
resources such as the##3##4##(2008-9#1)(2013-1#2)
resources such as##8##3##(2008-7#2)(2008-9#1)(2009-7#1)(2013-1#4)
resources that can##2##3##(2008-4#1)(2008-8#1)
resources that may be useful##2##5##(2007-2#1)(2008-7#1)
resources that may##3##3##(2007-2#1)(2008-7#1)(2012-2#1)
resources that would be##2##4##(1996-1#1)(2012-2#1)
resources that##20##2##(1996-1#1)(2006-2#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-2#1)(2010-9#1)(2011-1#1)(2012-2#3)(2013-1#1)
resources they had##2##3##(2006-8#1)(2009-10#1)
resources they##4##2##(2006-8#1)(2008-11#1)(2008-12#1)(2009-10#1)
resources to a##3##3##(1990-12#1)(1994-12#1)(2009-3#1)
resources to address##3##3##(2010-11#1)(2013-1#2)
resources to an##2##3##(1993-12#1)(1995-2#1)
resources to identify##2##3##(2008-4#1)(2013-1#1)
resources to improve##4##3##(1995-2#1)(2009-3#1)(2010-5#1)(2010-8#1)
resources to meet##6##3##(1990-12#1)(1992-12#1)(1995-3#1)(2010-1#1)(2010-4#1)(2012-12#1)
resources to provide##3##3##(1993-12#1)(1996-3#1)(2013-8#1)
resources to support##2##3##(1997-3#1)(2011-12#1)
resources to the##7##3##(1990-12#1)(1992-5#1)(1994-1#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-3#1)
resources to##73##2##(1990-12#3)(1992-1#1)(1992-12#1)(1992-5#1)(1993-12#3)(1994-1#1)(1994-12#1)(1994-9#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-2#1)(2007-9#1)(2008-10#3)(2008-11#5)(2008-4#1)(2008-7#3)(2008-8#3)(2008-9#4)(2009-3#2)(2009-4#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#2)
resources use##3##2##(2008-11#2)(2008-4#1)
resources used in##2##3##(1990-10#1)(1997-4#1)
resources used##6##2##(1990-10#1)(1996-11#1)(1997-4#1)(2007-2#1)(2008-2#1)(2008-8#1)
resources utilization##3##2##(1991-12#1)(2013-1#2)
resources was##3##2##(1994-1#1)(2007-8#1)(2012-2#1)
resources we##2##2##(2007-6#1)(2010-2#1)
resources were##6##2##(1991-3#1)(2006-6#1)(2008-6#2)(2008-9#1)(2011-2#1)
resources which##3##2##(1994-12#1)(1996-2#1)(2010-2#1)
resources will##4##2##(1990-12#1)(1994-2#1)(1996-11#1)(1996-3#1)
resources with the##2##3##(1996-3#1)(2007-9#1)
resources with##4##2##(1996-3#1)(2007-9#1)(2008-10#1)(2013-8#1)
resources within the##4##3##(2007-7#1)(2008-6#1)(2012-2#1)(2013-8#1)
resources within##5##2##(1993-2#1)(2007-7#1)(2008-6#1)(2012-2#1)(2013-8#1)
resources without##2##2##(2008-8#1)(2008-9#1)
resources would##2##2##(1996-1#1)(2011-1#1)
resources##1051##1##(1990-10#2)(1990-12#9)(1990-2#2)(1990-4#1)(1990-6#3)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#4)(1991-2#1)(1991-3#8)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#2)(1992-1#1)(1992-12#3)(1992-2#4)(1992-3#12)(1992-5#4)(1992-8#1)(1993-1#4)(1993-11#1)(1993-12#8)(1993-2#6)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-1#4)(1994-12#8)(1994-2#4)(1994-3#6)(1994-6#1)(1994-9#1)(1995-1#8)(1995-12#5)(1995-2#8)(1995-3#5)(1995-4#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#10)(1996-11#2)(1996-12#11)(1996-2#8)(1996-3#8)(1996-4#3)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#9)(1997-2#8)(1997-3#18)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#6)(2005-11#3)(2005-5#9)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#5)(2006-10#7)(2006-11#2)(2006-12#9)(2006-2#3)(2006-4#4)(2006-5#3)(2006-6#3)(2006-7#3)(2006-8#3)(2006-9#4)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#6)(2007-2#12)(2007-3#6)(2007-4#15)(2007-5#14)(2007-6#4)(2007-7#18)(2007-8#6)(2007-9#7)(2008-1#19)(2008-10#39)(2008-11#43)(2008-12#11)(2008-2#9)(2008-3#6)(2008-4#28)(2008-5#12)(2008-6#10)(2008-7#41)(2008-8#41)(2008-9#39)(2009-1#2)(2009-10#7)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#5)(2009-4#8)(2009-5#2)(2009-6#6)(2009-7#8)(2009-8#7)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#5)(2010-12#4)(2010-2#12)(2010-3#3)(2010-4#2)(2010-5#5)(2010-7#7)(2010-8#10)(2010-9#11)(2011-1#19)(2011-10#1)(2011-12#3)(2011-2#36)(2011-3#2)(2011-7#1)(2012-1#6)(2012-11#15)(2012-12#18)(2012-2#35)(2012-3#14)(2013-1#60)(2013-7#10)(2013-8#25)
resources) and##2##2##(2009-4#1)(2011-1#1)
resources)##4##1##(1992-12#1)(1996-9#1)(2009-4#1)(2011-1#1)
resources?##3##1##(1997-3#1)(2006-7#1)(2007-7#1)
resources]##3##1##(1994-10#1)(1995-5#1)(2011-1#1)
resourcing##3##1##(2008-11#1)(2012-12#1)(2013-8#1)
resp##19##1##(1990-6#1)(1992-8#1)(1993-3#2)(1995-5#1)(2005-1#3)(2006-12#6)(2006-6#1)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
respect and##8##2##(1990-4#1)(1991-3#1)(1995-5#1)(2008-12#1)(2009-10#1)(2009-8#1)(2011-2#2)
respect for autonomy in##3##4##(2005-7#3)
respect for autonomy##6##3##(1997-8#1)(2005-7#4)(2009-6#1)
respect for personal autonomy##2##4##(2005-7#2)
respect for persons##6##3##(1992-3#1)(2007-11#1)(2007-12#2)(2008-9#1)(2009-6#1)
respect for the##5##3##(1992-2#1)(1992-3#1)(1997-3#1)(2006-2#1)(2007-6#1)
respect for##34##2##(1992-2#1)(1992-3#2)(1996-1#1)(1996-3#1)(1997-3#1)(1997-8#2)(2005-7#6)(2006-10#2)(2006-2#1)(2006-7#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#2)(2009-4#2)(2009-6#2)(2011-2#1)
respect of the##3##3##(1995-6#1)(2010-12#1)(2013-8#1)
respect of##25##2##(1990-12#1)(1991-3#1)(1992-1#1)(1992-10#1)(1992-6#1)(1995-4#1)(1995-6#1)(1997-8#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-12#1)(2011-2#1)(2013-8#1)
respect the##3##2##(1990-4#1)(1993-10#1)(2008-11#1)
respect to baseline##3##3##(2006-6#1)(2008-7#2)
respect to control##7##3##(1992-3#1)(1993-12#1)(2006-6#1)(2009-4#1)(2009-5#1)(2010-8#1)(2013-1#1)
respect to conventional##2##3##(2008-1#1)(2012-2#1)
respect to different##6##3##(1993-8#1)(2008-6#2)(2008-7#1)(2010-12#1)(2013-8#1)
respect to drug##4##3##(1995-5#1)(2005-8#1)(2008-10#1)(2008-4#1)
respect to growth##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
respect to human##4##3##(1992-3#1)(2008-10#2)(2012-2#1)
respect to its##20##3##(1990-12#1)(1991-2#1)(1992-12#2)(1993-8#2)(1995-12#1)(1995-7#1)(1996-2#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
respect to memory##2##3##(1993-12#1)(2008-11#1)
respect to morphology##2##3##(1995-9#1)(2008-5#1)
respect to noise##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
respect to other##3##3##(2006-10#1)(2008-10#1)(2008-3#1)
respect to practical applications##2##4##(2008-10#1)(2008-2#1)
respect to retention##2##3##(1996-9#1)(2008-10#1)
respect to some##2##3##(1992-3#1)(2008-2#1)
respect to that of##4##4##(1990-4#1)(2007-12#1)(2008-10#1)(2008-3#1)
respect to that##5##3##(1990-4#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-3#1)
respect to the conventional##2##4##(2008-10#1)(2013-1#1)
respect to the diagnosis##2##4##(2008-2#1)(2010-2#1)
respect to the effect of##2##5##(1991-6#1)(1992-9#1)
respect to the first##3##4##(1997-2#1)(2006-11#1)(2008-2#1)
respect to the initial##5##4##(2007-10#2)(2008-3#1)(2010-8#1)(2012-1#1)
respect to the launched pump##2##5##(2007-12#2)
respect to the original##3##4##(2007-11#1)(2008-3#1)(2012-12#1)
respect to the primary##3##4##(1990-3#1)(1993-9#1)(2008-5#1)
respect to the structure##2##4##(1990-7#1)(1997-3#1)
respect to the time##2##4##(1995-1#1)(2008-2#1)
respect to the##422##3##(1990-11#4)(1990-12#4)(1990-3#3)(1990-5#2)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#4)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#6)(1992-7#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#2)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#2)(1995-1#1)(1995-10#4)(1995-11#2)(1995-12#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#2)(1995-9#1)(1996-12#2)(1996-2#4)(1996-5#2)(1996-6#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#3)(1997-9#1)(2004-9#1)(2005-10#2)(2005-11#4)(2005-7#1)(2005-8#1)(2006-10#6)(2006-11#4)(2006-12#6)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#13)(2007-12#22)(2007-2#2)(2007-4#4)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#4)(2008-10#36)(2008-11#4)(2008-12#1)(2008-2#42)(2008-3#45)(2008-4#5)(2008-5#9)(2008-7#5)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#2)(2009-2#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#6)(2012-1#4)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#4)(2013-1#4)(2013-8#7)
respect to these##7##3##(1993-4#1)(1995-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-1#1)(2012-2#1)
respect to treatment##2##3##(2006-10#1)(2006-2#1)
respect to weight##2##3##(2008-2#1)(2008-4#1)
respect to##1162##2##(1990-10#1)(1990-11#5)(1990-12#15)(1990-2#3)(1990-3#5)(1990-4#4)(1990-5#2)(1990-7#2)(1990-8#2)(1990-9#1)(1991-10#2)(1991-11#3)(1991-12#7)(1991-2#9)(1991-3#5)(1991-4#4)(1991-5#5)(1991-6#4)(1991-7#4)(1991-8#1)(1991-9#1)(1992-10#3)(1992-11#3)(1992-12#4)(1992-2#2)(1992-3#8)(1992-4#2)(1992-5#4)(1992-6#7)(1992-7#2)(1992-8#4)(1992-9#3)(1993-1#3)(1993-10#2)(1993-12#4)(1993-2#1)(1993-3#6)(1993-4#3)(1993-5#1)(1993-6#3)(1993-7#2)(1993-8#8)(1993-9#3)(1994-10#1)(1994-11#5)(1994-12#7)(1994-2#8)(1994-3#7)(1994-5#4)(1994-6#3)(1994-7#1)(1994-8#7)(1994-9#5)(1995-1#4)(1995-10#7)(1995-11#4)(1995-12#8)(1995-2#3)(1995-3#6)(1995-4#1)(1995-5#7)(1995-6#2)(1995-7#3)(1995-8#3)(1995-9#2)(1996-1#2)(1996-11#1)(1996-12#5)(1996-2#10)(1996-3#3)(1996-5#5)(1996-6#3)(1996-7#4)(1996-8#6)(1996-9#3)(1997-1#2)(1997-2#5)(1997-3#7)(1997-4#8)(1997-5#2)(1997-6#7)(1997-7#4)(1997-8#2)(1997-9#1)(2004-1#1)(2004-10#1)(2004-11#1)(2004-9#3)(2005-10#3)(2005-11#8)(2005-7#1)(2005-8#3)(2006-1#2)(2006-10#18)(2006-11#8)(2006-12#11)(2006-2#4)(2006-3#2)(2006-4#1)(2006-5#2)(2006-6#5)(2006-7#3)(2006-8#6)(2006-9#1)(2007-1#7)(2007-10#3)(2007-11#32)(2007-12#40)(2007-2#4)(2007-3#1)(2007-4#6)(2007-5#2)(2007-6#5)(2007-7#4)(2007-8#12)(2007-9#6)(2008-1#11)(2008-10#118)(2008-11#20)(2008-12#8)(2008-2#81)(2008-3#65)(2008-4#13)(2008-5#28)(2008-6#8)(2008-7#25)(2008-8#12)(2008-9#10)(2009-1#1)(2009-10#7)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#7)(2009-5#3)(2009-6#4)(2009-7#4)(2009-8#5)(2009-9#2)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#6)(2010-2#8)(2010-3#2)(2010-4#5)(2010-5#1)(2010-6#2)(2010-7#5)(2010-8#6)(2010-9#3)(2011-1#12)(2011-12#1)(2011-2#29)(2012-1#8)(2012-11#2)(2012-12#15)(2012-2#15)(2012-3#10)(2012-5#1)(2012-7#1)(2013-1#22)(2013-8#13)
respect##1332##1##(1990-10#1)(1990-11#6)(1990-12#17)(1990-2#3)(1990-3#5)(1990-4#6)(1990-5#2)(1990-7#2)(1990-8#2)(1990-9#1)(1991-10#2)(1991-11#3)(1991-12#7)(1991-2#9)(1991-3#7)(1991-4#4)(1991-5#5)(1991-6#5)(1991-7#4)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#5)(1992-11#3)(1992-12#4)(1992-2#3)(1992-3#11)(1992-4#2)(1992-5#6)(1992-6#8)(1992-7#2)(1992-8#5)(1992-9#4)(1993-1#3)(1993-10#3)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#6)(1993-4#3)(1993-5#1)(1993-6#4)(1993-7#2)(1993-8#8)(1993-9#3)(1994-1#2)(1994-10#1)(1994-11#5)(1994-12#7)(1994-2#8)(1994-3#8)(1994-4#1)(1994-5#5)(1994-6#3)(1994-7#1)(1994-8#7)(1994-9#6)(1995-1#4)(1995-10#8)(1995-11#4)(1995-12#10)(1995-2#3)(1995-3#6)(1995-4#2)(1995-5#9)(1995-6#3)(1995-7#3)(1995-8#3)(1995-9#2)(1996-1#3)(1996-11#1)(1996-12#6)(1996-2#10)(1996-3#4)(1996-5#5)(1996-6#3)(1996-7#5)(1996-8#6)(1996-9#4)(1997-1#2)(1997-2#5)(1997-3#8)(1997-4#9)(1997-5#2)(1997-6#7)(1997-7#4)(1997-8#6)(1997-9#1)(2004-1#1)(2004-10#1)(2004-11#1)(2004-4#1)(2004-9#3)(2005-10#3)(2005-11#10)(2005-7#8)(2005-8#4)(2006-1#3)(2006-10#22)(2006-11#9)(2006-12#11)(2006-2#6)(2006-3#2)(2006-4#2)(2006-5#2)(2006-6#6)(2006-7#5)(2006-8#8)(2006-9#2)(2007-1#7)(2007-10#4)(2007-11#34)(2007-12#42)(2007-2#8)(2007-3#1)(2007-4#6)(2007-5#2)(2007-6#6)(2007-7#5)(2007-8#15)(2007-9#6)(2008-1#15)(2008-10#126)(2008-11#24)(2008-12#9)(2008-2#83)(2008-3#67)(2008-4#17)(2008-5#33)(2008-6#8)(2008-7#28)(2008-8#14)(2008-9#12)(2009-1#1)(2009-10#9)(2009-11#4)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#10)(2009-5#4)(2009-6#8)(2009-7#4)(2009-8#6)(2009-9#3)(2010-1#2)(2010-10#5)(2010-11#2)(2010-12#7)(2010-2#9)(2010-3#2)(2010-4#6)(2010-5#3)(2010-6#2)(2010-7#6)(2010-8#7)(2010-9#3)(2011-1#12)(2011-12#1)(2011-2#37)(2011-7#1)(2012-1#8)(2012-11#2)(2012-12#21)(2012-2#18)(2012-3#10)(2012-5#1)(2012-7#1)(2013-1#24)(2013-8#14)
respectability##2##1##(1995-10#1)(2007-9#1)
respectable##5##1##(1992-8#1)(2005-11#1)(2006-7#1)(2010-6#1)(2012-3#1)
respected and##3##2##(1991-3#1)(1996-4#1)(2006-10#1)
respected by##3##2##(1993-3#1)(2005-7#1)(2012-3#1)
respected##23##1##(1991-11#1)(1991-3#1)(1993-3#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#1)(2004-4#1)(2005-7#1)(2006-10#2)(2006-8#2)(2008-10#1)(2008-3#1)(2008-9#2)(2009-5#1)(2010-5#1)(2011-3#1)(2012-3#2)(2013-7#1)
respectful manner##2##2##(1990-6#1)(1996-3#1)
respectful of##3##2##(2008-2#1)(2008-5#1)(2008-9#1)
respectful##7##1##(1990-6#1)(1996-3#1)(2008-2#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)
respectfully with##2##2##(2007-10#1)(2008-4#1)
respectfully##4##1##(2007-10#1)(2008-4#1)(2009-9#2)
respecting the##2##2##(2005-7#1)(2010-8#1)
respecting##6##1##(2005-7#1)(2009-4#1)(2010-8#1)(2011-1#1)(2012-2#2)
respective 27 kDa and 28 kDa##2##6##(1990-4#2)
respective E##2##2##(1997-2#1)(1997-6#1)
respective calibration##2##2##(2008-10#2)
respective control groups##2##3##(1993-1#1)(2011-2#1)
respective control##5##2##(1993-1#1)(2008-12#1)(2009-6#1)(2011-2#1)(2012-2#1)
respective controls##8##2##(1991-12#1)(1994-5#1)(1994-6#1)(2007-6#2)(2008-10#1)(2008-8#1)(2010-10#1)
respective distances##2##2##(1993-3#1)(1993-4#1)
respective enzymes##5##2##(1990-6#1)(1991-12#1)(1991-3#1)(2010-7#1)(2011-2#1)
respective fractions##2##2##(1993-4#1)(2008-11#1)
respective gene products##2##3##(1994-8#1)(2006-10#1)
respective gene##5##2##(1994-8#1)(2006-10#1)(2008-8#1)(2010-12#1)(2013-8#1)
respective groups##4##2##(1991-7#1)(1997-4#1)(2006-1#1)(2009-5#1)
respective hosts##2##2##(2008-10#2)
respective in##2##2##(1994-9#1)(2008-4#1)
respective increases in##2##3##(1996-3#1)(2008-10#1)
respective ligands##3##2##(1992-8#1)(1994-2#1)(1997-4#1)
respective mRNA##2##2##(1990-5#1)(1992-6#1)
respective maximum##2##2##(2005-11#1)(2009-5#1)
respective molecular##2##2##(2008-10#1)(2008-3#1)
respective normal groups##2##3##(2008-7#2)
respective normal##3##2##(2008-7#2)(2011-12#1)
respective pathogens##3##2##(2008-10#3)
respective potential protective GST genotypes##2##5##(2008-10#2)
respective potential##4##2##(2006-10#2)(2008-10#2)
respective probes##2##2##(1992-12#1)(1994-6#1)
respective protein##2##2##(1992-3#1)(1995-3#1)
respective receptors##3##2##(1995-11#1)(2007-2#1)(2008-8#1)
respective reference##2##2##(2008-10#2)
respective results##5##2##(2007-7#1)(2008-10#1)(2008-5#3)
respective role##2##2##(1996-9#1)(2012-12#1)
respective roles of##4##3##(1992-12#1)(2009-7#1)(2009-8#1)(2010-3#1)
respective roles##7##2##(1992-12#1)(1995-2#1)(1997-3#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-4#1)
respective sequences##2##2##(1990-12#1)(2008-10#1)
respective state##2##2##(1995-12#1)(2012-3#1)
respective strengths and##2##3##(2009-5#2)
respective target##4##2##(1996-9#1)(2008-1#1)(2008-5#1)(2008-6#1)
respective temperatures##2##2##(2008-10#1)(2012-2#1)
respective values of##2##3##(1994-11#1)(1997-7#1)
respective values##9##2##(1990-7#1)(1991-10#1)(1994-11#1)(1995-4#1)(1996-5#1)(1997-7#1)(2008-5#1)(2009-6#1)(2011-2#1)
respective##416##1##(1990-11#2)(1990-12#5)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#5)(1990-6#1)(1990-7#5)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#3)(1991-3#3)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#4)(1992-10#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#2)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-3#4)(1993-4#2)(1993-5#1)(1993-6#1)(1993-9#4)(1994-1#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#7)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#5)(1995-12#2)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#4)(1995-6#3)(1995-7#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#6)(1996-4#1)(1996-5#4)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#4)(1997-3#1)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#1)(2004-10#1)(2004-11#1)(2004-2#1)(2004-9#1)(2005-11#3)(2005-4#2)(2006-1#2)(2006-10#7)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#4)(2007-2#4)(2007-4#1)(2007-6#4)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#6)(2008-10#52)(2008-11#8)(2008-12#2)(2008-2#4)(2008-3#6)(2008-4#5)(2008-5#16)(2008-6#2)(2008-7#10)(2008-8#5)(2008-9#1)(2009-2#1)(2009-5#4)(2009-6#5)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#5)(2011-12#2)(2011-2#11)(2011-4#1)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#9)(2013-7#3)(2013-8#4)
respectively (P &lt##8##3##(1994-2#1)(1997-8#1)(2006-5#3)(2008-5#1)(2010-8#1)(2012-3#1)
respectively (P = 0##2##4##(2005-8#1)(2008-6#1)
respectively (P =##5##3##(2005-8#1)(2008-6#1)(2010-8#1)(2011-2#1)(2013-1#1)
respectively (P less than 0##3##5##(1991-6#1)(1992-5#1)(1992-8#1)
respectively (P##18##2##(1991-6#1)(1992-5#1)(1992-8#1)(1994-2#1)(1997-8#1)(2005-8#1)(2006-5#3)(2008-4#1)(2008-5#1)(2008-6#1)(2010-8#2)(2011-2#1)(2012-3#2)(2013-1#1)
respectively (P&lt##2##2##(2011-2#1)(2012-2#1)
respectively (P=0##2##2##(2007-8#1)(2011-2#1)
respectively (all##2##2##(1992-4#1)(1995-10#1)
respectively (n##2##2##(1990-9#1)(2008-10#1)
respectively (p &lt##13##3##(1995-3#1)(1997-8#2)(2007-3#1)(2007-8#3)(2007-9#1)(2008-1#1)(2013-1#4)
respectively (p = 0##9##4##(1991-12#1)(1993-3#1)(1997-2#1)(2005-10#4)(2005-12#1)(2012-2#1)
respectively (p = NS)##2##4##(1994-12#2)
respectively (p =##11##3##(1991-12#1)(1993-3#1)(1994-12#2)(1997-2#1)(2005-10#4)(2005-12#1)(2012-2#1)
respectively (p##26##2##(1991-12#1)(1993-3#1)(1994-1#1)(1994-12#2)(1995-3#1)(1997-2#1)(1997-8#2)(2005-10#4)(2005-12#1)(2007-3#1)(2007-8#4)(2007-9#1)(2008-1#1)(2012-2#1)(2013-1#4)
respectively (p&lt##8##2##(2007-2#1)(2008-1#1)(2008-6#1)(2009-12#4)(2010-3#1)
respectively (p=0##8##2##(2006-10#1)(2008-1#1)(2008-6#1)(2010-12#1)(2011-1#3)(2011-11#1)
respectively 1##2##2##(2005-11#1)(2007-7#1)
respectively 13##2##2##(1992-2#1)(2011-2#1)
respectively 2 months##2##3##(1992-10#1)(1992-4#1)
respectively 2##4##2##(1991-2#1)(1992-10#1)(1992-4#1)(2013-1#1)
respectively about##2##2##(1991-5#1)(2008-10#1)
respectively after##8##2##(1992-2#1)(1993-9#1)(1994-2#1)(1994-6#1)(2004-2#1)(2007-11#1)(2007-7#1)(2008-12#1)
respectively and a##3##3##(1993-12#1)(2008-5#1)(2011-12#1)
respectively and for##3##3##(2010-2#1)(2010-3#1)(2012-2#1)
respectively and the##7##3##(1994-3#1)(2007-2#2)(2007-8#1)(2008-12#1)(2009-5#1)(2013-1#1)
respectively and their##2##3##(2008-9#1)(2013-8#1)
respectively and then##2##3##(1992-7#1)(2008-8#1)
respectively and this difference was statistically##2##6##(2008-8#2)
respectively and this difference was##3##5##(2008-8#3)
respectively and##41##2##(1991-6#1)(1992-7#1)(1993-11#1)(1993-12#1)(1994-3#1)(1994-5#1)(1995-11#1)(1996-2#1)(2005-4#1)(2006-10#1)(2007-10#1)(2007-2#2)(2007-8#1)(2008-10#3)(2008-12#3)(2008-5#1)(2008-8#4)(2008-9#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#4)(2013-8#1)
respectively as##8##2##(1991-9#1)(1992-12#1)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2012-3#1)
respectively at 1##2##3##(2011-12#2)
respectively at a##2##3##(2008-10#1)(2008-5#1)
respectively at the##4##3##(1996-6#1)(2008-10#1)(2009-10#1)(2011-1#1)
respectively at##19##2##(1990-12#1)(1993-11#1)(1996-6#1)(2007-2#2)(2007-3#1)(2008-10#4)(2008-12#1)(2008-5#1)(2009-10#1)(2011-1#1)(2011-12#3)(2012-12#1)(2013-1#1)
respectively by the##2##3##(2008-8#1)(2011-2#1)
respectively by##12##2##(1990-7#1)(1991-5#1)(1997-2#1)(1997-8#1)(2005-4#1)(2007-1#1)(2008-6#1)(2008-8#3)(2011-2#1)(2012-2#1)
respectively could be##3##3##(2004-10#1)(2007-7#1)(2013-1#1)
respectively during##7##2##(1990-3#2)(2007-10#2)(2008-12#1)(2011-1#1)(2012-2#1)
respectively for both##3##3##(1990-3#1)(1994-2#1)(2011-2#1)
respectively for the two##2##4##(1993-8#1)(1996-11#1)
respectively for the##9##3##(1991-10#1)(1993-8#1)(1996-11#1)(2008-6#1)(2009-4#2)(2010-2#1)(2011-1#1)(2012-12#1)
respectively for women##2##3##(1992-9#2)
respectively for##35##2##(1990-3#1)(1991-10#1)(1992-9#2)(1993-8#1)(1994-12#1)(1994-2#1)(1995-5#1)(1996-1#1)(1996-11#1)(2005-12#1)(2006-10#1)(2007-10#2)(2007-7#1)(2008-10#4)(2008-4#1)(2008-6#1)(2009-4#2)(2010-1#1)(2010-11#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2013-7#1)(2013-8#1)
respectively from##6##2##(1990-4#1)(2006-2#1)(2007-1#1)(2012-1#1)(2012-3#1)(2013-1#1)
respectively had##3##2##(2006-6#1)(2007-2#1)(2011-2#1)
respectively have been##2##3##(2008-1#1)(2008-10#1)
respectively in comparison##2##3##(1990-1#1)(1997-4#1)
respectively in the##16##3##(1991-3#1)(1991-5#1)(1993-8#1)(1994-12#1)(1994-6#1)(2007-2#1)(2007-7#2)(2008-10#1)(2008-5#1)(2008-8#2)(2010-4#1)(2011-2#2)(2012-3#1)
respectively in##42##2##(1990-1#1)(1990-12#1)(1990-7#1)(1991-3#1)(1991-5#2)(1992-11#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-6#1)(1997-4#1)(2004-12#2)(2005-11#1)(2005-8#1)(2007-2#2)(2007-7#3)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#3)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#2)
respectively lower##2##2##(1997-6#1)(2010-12#1)
respectively of##9##2##(1991-2#1)(2006-6#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2009-5#1)(2013-7#1)
respectively on the##3##3##(1993-12#1)(1996-8#1)(2008-10#1)
respectively show##2##2##(1996-10#1)(2005-11#1)
respectively showed a##2##3##(1996-5#1)(2006-9#1)
respectively the##4##2##(1990-2#1)(1990-8#1)(2008-10#1)(2008-5#1)
respectively to the##2##3##(1994-11#1)(2008-10#1)
respectively to##8##2##(1990-3#2)(1990-6#1)(1994-11#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-6#1)
respectively were able to correctly identify##2##6##(2011-2#2)
respectively were studied##3##3##(2008-5#1)(2013-8#2)
respectively were##18##2##(1990-11#1)(1996-6#1)(2006-8#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2011-2#2)(2012-3#1)(2013-8#3)
respectively when compared to##2##4##(2008-4#1)(2009-10#1)
respectively when the##3##3##(1994-12#1)(2005-10#1)(2008-3#1)
respectively when##9##2##(1994-12#1)(1996-12#1)(1997-3#1)(2005-10#1)(2008-3#1)(2008-4#1)(2009-10#1)(2011-12#1)(2011-3#1)
respectively whereas##2##2##(2010-11#1)(2013-1#1)
respectively which##3##2##(1994-11#1)(2011-1#1)(2013-1#1)
respectively while the##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
respectively with a##2##3##(2007-2#1)(2008-10#1)
respectively with##13##2##(1991-5#1)(1992-3#1)(1995-12#1)(1996-2#1)(2007-2#1)(2008-10#6)(2010-12#1)(2013-1#1)
respectively##6270##1##(1990-1#5)(1990-10#17)(1990-11#27)(1990-12#27)(1990-2#30)(1990-3#25)(1990-4#13)(1990-5#21)(1990-6#17)(1990-7#20)(1990-8#17)(1990-9#10)(1991-1#7)(1991-10#15)(1991-11#8)(1991-12#23)(1991-2#30)(1991-3#9)(1991-4#17)(1991-5#29)(1991-6#15)(1991-7#26)(1991-8#32)(1991-9#27)(1992-1#7)(1992-10#7)(1992-11#23)(1992-12#18)(1992-2#18)(1992-3#28)(1992-4#20)(1992-5#5)(1992-6#26)(1992-7#18)(1992-8#28)(1992-9#16)(1993-1#4)(1993-10#7)(1993-11#34)(1993-12#23)(1993-2#21)(1993-3#19)(1993-4#15)(1993-5#3)(1993-6#11)(1993-7#2)(1993-8#26)(1993-9#28)(1994-1#2)(1994-10#4)(1994-11#32)(1994-12#36)(1994-2#23)(1994-3#30)(1994-4#1)(1994-5#21)(1994-6#22)(1994-7#5)(1994-8#34)(1994-9#35)(1995-1#21)(1995-10#18)(1995-11#34)(1995-12#29)(1995-2#32)(1995-3#33)(1995-4#5)(1995-5#22)(1995-6#22)(1995-7#10)(1995-8#12)(1995-9#4)(1996-1#6)(1996-10#14)(1996-11#16)(1996-12#36)(1996-2#38)(1996-3#10)(1996-4#14)(1996-5#47)(1996-6#27)(1996-7#19)(1996-8#32)(1996-9#13)(1997-1#21)(1997-2#53)(1997-3#33)(1997-4#28)(1997-5#14)(1997-6#26)(1997-7#40)(1997-8#36)(2003-11#1)(2004-1#7)(2004-10#2)(2004-11#11)(2004-12#3)(2004-2#7)(2004-3#1)(2004-4#6)(2004-8#3)(2004-9#7)(2005-10#14)(2005-11#66)(2005-12#12)(2005-4#21)(2005-5#1)(2005-6#3)(2005-7#8)(2005-8#8)(2005-9#1)(2006-1#4)(2006-10#40)(2006-11#6)(2006-12#37)(2006-2#7)(2006-3#1)(2006-4#6)(2006-5#19)(2006-6#17)(2006-7#7)(2006-8#35)(2006-9#8)(2007-1#32)(2007-10#23)(2007-11#74)(2007-12#83)(2007-2#54)(2007-3#30)(2007-4#7)(2007-5#8)(2007-6#9)(2007-7#59)(2007-8#133)(2007-9#16)(2008-1#34)(2008-10#1428)(2008-11#102)(2008-12#86)(2008-2#70)(2008-3#147)(2008-4#57)(2008-5#128)(2008-6#46)(2008-7#64)(2008-8#91)(2008-9#60)(2009-1#1)(2009-10#20)(2009-11#8)(2009-12#12)(2009-2#9)(2009-3#17)(2009-4#16)(2009-5#11)(2009-6#12)(2009-7#6)(2009-8#15)(2009-9#15)(2010-1#6)(2010-10#3)(2010-11#10)(2010-12#48)(2010-2#25)(2010-3#20)(2010-4#41)(2010-5#23)(2010-6#13)(2010-7#13)(2010-8#20)(2010-9#6)(2011-1#105)(2011-10#1)(2011-11#8)(2011-12#17)(2011-2#149)(2011-3#9)(2012-1#30)(2012-11#16)(2012-12#64)(2012-2#79)(2012-3#47)(2012-7#2)(2012-8#1)(2013-1#151)(2013-7#18)(2013-8#109)
respectively) after##2##2##(2008-10#1)(2008-12#1)
respectively) and by##3##3##(1991-2#1)(1995-10#1)(2008-10#1)
respectively) and is##3##3##(1992-1#1)(2008-10#1)(2008-4#1)
respectively) and relative standard deviation of 1##2##7##(2008-10#2)
respectively) and the##5##3##(1995-10#1)(1995-11#1)(2008-10#1)(2010-8#1)(2012-1#1)
respectively) and##52##2##(1990-12#1)(1991-2#2)(1991-6#2)(1992-1#1)(1992-2#1)(1995-10#2)(1995-11#6)(1995-2#1)(1997-8#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#1)(2009-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-7#1)(2013-8#1)
respectively) are##4##2##(1990-7#1)(1997-8#1)(2005-11#1)(2013-1#1)
respectively) as##3##2##(1990-7#1)(1992-7#1)(2008-10#1)
respectively) at##4##2##(1990-3#1)(1997-5#1)(2010-4#1)(2012-2#1)
respectively) but##5##2##(1995-2#1)(2006-7#1)(2008-5#2)(2011-2#1)
respectively) by##3##2##(1996-3#1)(1997-6#1)(2008-10#1)
respectively) compared to those with##2##5##(2008-4#1)(2011-1#1)
respectively) compared##3##2##(2006-5#1)(2008-4#1)(2011-1#1)
respectively) for the##2##3##(2008-10#2)
respectively) for##6##2##(1990-12#1)(1995-3#1)(2008-10#3)(2013-8#1)
respectively) from##3##2##(2004-2#1)(2008-11#1)(2008-6#1)
respectively) have no##2##3##(1994-9#1)(2008-8#1)
respectively) have##5##2##(1994-9#1)(2005-8#1)(2008-4#1)(2008-8#1)(2010-5#1)
respectively) in the##4##3##(1994-3#1)(1996-1#1)(2008-10#1)(2013-8#1)
respectively) in##12##2##(1990-12#1)(1990-2#1)(1992-12#1)(1992-3#1)(1994-12#1)(1994-3#1)(1996-1#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
respectively) of##4##2##(1996-5#1)(1997-8#1)(2008-11#1)(2008-2#1)
respectively) on##3##2##(1996-5#1)(2008-12#1)(2011-10#1)
respectively) or##3##2##(1991-12#1)(1993-7#1)(1994-8#1)
respectively) than in##2##3##(1994-9#1)(2006-5#1)
respectively) than##7##2##(1994-9#1)(1997-8#1)(2005-10#1)(2006-4#1)(2006-5#1)(2008-10#1)(2013-8#1)
respectively) the##3##2##(2007-12#1)(2008-10#1)(2008-6#1)
respectively) versus##2##2##(1994-9#1)(2009-10#1)
respectively) was significantly##2##3##(1995-8#1)(2013-8#1)
respectively) was##10##2##(1995-8#2)(2008-10#3)(2008-3#1)(2009-2#1)(2009-7#1)(2013-3#1)(2013-8#1)
respectively) were generated##2##3##(1994-12#1)(2008-10#1)
respectively) were given##2##3##(1991-12#1)(2009-2#1)
respectively) were observed##3##3##(1996-2#1)(2007-5#1)(2008-8#1)
respectively) were obtained##2##3##(2008-10#1)(2008-9#1)
respectively) were##33##2##(1990-2#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-7#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-4#1)
respectively) which##3##2##(2007-2#1)(2011-2#1)(2013-8#1)
respectively) with##4##2##(1997-1#1)(1997-4#1)(2008-10#1)(2008-9#1)
respectively)##682##1##(1990-12#9)(1990-2#6)(1990-3#4)(1990-4#3)(1990-5#5)(1990-6#2)(1990-7#4)(1990-9#1)(1991-12#6)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#4)(1991-9#4)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-7#3)(1992-8#5)(1992-9#2)(1993-1#2)(1993-12#5)(1993-2#1)(1993-3#2)(1993-4#2)(1993-6#1)(1993-7#2)(1993-8#2)(1993-9#1)(1994-10#2)(1994-11#7)(1994-12#4)(1994-3#5)(1994-5#4)(1994-6#3)(1994-8#6)(1994-9#12)(1995-10#2)(1995-11#10)(1995-12#11)(1995-2#5)(1995-3#9)(1995-5#3)(1995-6#4)(1995-7#2)(1995-8#5)(1996-1#3)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#5)(1996-9#2)(1997-1#3)(1997-2#7)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#8)(2004-11#1)(2004-2#3)(2004-9#1)(2005-10#3)(2005-11#5)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#6)(2006-6#1)(2006-7#4)(2006-8#6)(2006-9#3)(2007-1#2)(2007-10#6)(2007-11#7)(2007-12#4)(2007-2#6)(2007-3#1)(2007-4#1)(2007-5#7)(2007-7#7)(2007-8#10)(2007-9#3)(2008-1#12)(2008-10#80)(2008-11#10)(2008-12#17)(2008-2#2)(2008-3#5)(2008-4#8)(2008-5#17)(2008-6#9)(2008-7#7)(2008-8#8)(2008-9#4)(2009-1#1)(2009-10#4)(2009-11#1)(2009-2#4)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#3)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#8)(2010-5#1)(2010-7#2)(2010-8#5)(2010-9#2)(2011-1#14)(2011-10#2)(2011-12#3)(2011-2#32)(2011-3#2)(2012-1#2)(2012-12#5)(2012-2#8)(2012-3#3)(2012-5#2)(2013-1#15)(2013-3#1)(2013-7#4)(2013-8#17)
respectively] and##2##2##(1997-8#1)(2007-11#1)
respectively]##12##1##(1991-9#1)(1996-6#1)(1997-8#2)(2007-11#2)(2008-10#2)(2008-5#1)(2008-7#1)(2010-8#1)(2012-1#1)
respects and##4##2##(2007-8#1)(2009-8#1)(2010-8#1)(2011-2#1)
respects the##6##2##(1991-7#1)(1997-5#1)(2006-5#1)(2007-2#1)(2007-8#1)(2013-1#1)
respects to##3##2##(1991-5#1)(1995-2#1)(2009-9#1)
respects##46##1##(1990-11#1)(1990-12#1)(1990-3#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-8#1)(1997-5#1)(1997-6#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-12#2)(2007-2#1)(2007-8#3)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
respirable dust##2##2##(1991-12#2)
respirable fibers##4##2##(1991-12#1)(2010-8#3)
respirable##15##1##(1991-12#5)(1995-3#1)(1996-1#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-3#1)(2010-8#4)
respirable-sized protein##2##2##(1996-1#2)
respirable-sized##3##1##(1996-1#3)
respiration and heart##3##3##(1996-2#2)(2005-7#1)
respiration and oxidative phosphorylation##2##4##(1997-8#2)
respiration and production##2##3##(2012-2#2)
respiration and##29##2##(1990-4#1)(1991-3#1)(1994-12#2)(1994-8#2)(1996-2#3)(1996-6#1)(1996-7#1)(1996-9#1)(1997-8#2)(2005-7#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-9#1)(2011-12#1)(2012-12#2)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#1)
respiration as##3##2##(1990-4#1)(1996-6#1)(2013-1#1)
respiration by##5##2##(1990-5#2)(2005-8#1)(2008-12#1)(2008-7#1)
respiration decreased in##2##3##(2004-4#1)(2008-10#1)
respiration in the##2##3##(1990-4#1)(1996-7#1)
respiration in##9##2##(1990-4#2)(1993-12#1)(1993-8#1)(1994-12#1)(1996-7#1)(2007-10#1)(2011-1#1)(2012-2#1)
respiration is##5##2##(1990-4#2)(1996-6#1)(2008-7#2)
respiration of##10##2##(1990-8#2)(2008-10#1)(2008-12#1)(2008-5#3)(2008-9#1)(2011-1#1)(2011-2#1)
respiration rate and##5##3##(1994-11#1)(1994-8#1)(2004-12#1)(2011-2#2)
respiration rate increased##2##3##(2007-10#1)(2008-10#1)
respiration rate of##2##3##(1994-8#1)(2011-2#1)
respiration rate##20##2##(1994-11#1)(1994-8#2)(1995-6#2)(2004-12#1)(2005-8#1)(2006-3#1)(2007-10#2)(2008-10#2)(2008-6#1)(2008-7#2)(2011-2#4)(2013-8#1)
respiration rates##7##2##(1990-5#1)(1994-8#2)(2005-8#2)(2008-10#1)(2011-12#1)
respiration was##8##2##(1994-12#2)(1996-9#1)(2004-4#1)(2007-12#1)(2008-7#2)(2011-2#1)
respiration were##5##2##(1990-2#1)(1991-10#2)(2004-12#1)(2008-5#1)
respiration with##2##2##(1994-8#1)(2011-1#1)
respiration##189##1##(1990-2#2)(1990-4#6)(1990-5#4)(1990-7#1)(1990-8#3)(1991-10#3)(1991-3#2)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#6)(1994-5#1)(1994-6#1)(1994-8#9)(1995-2#2)(1995-6#4)(1996-1#1)(1996-12#1)(1996-2#4)(1996-5#1)(1996-6#9)(1996-7#2)(1996-9#2)(1997-1#1)(1997-4#4)(1997-8#4)(2004-12#2)(2004-4#2)(2005-12#1)(2005-7#2)(2005-8#6)(2006-3#2)(2007-10#5)(2007-12#2)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#11)(2008-11#2)(2008-12#3)(2008-5#5)(2008-6#1)(2008-7#11)(2008-9#4)(2009-10#1)(2009-5#2)(2009-8#1)(2011-1#6)(2011-12#4)(2011-2#9)(2012-12#2)(2012-2#6)(2012-3#5)(2012-5#1)(2013-1#6)(2013-8#3)
respiration)##2##1##(2008-10#1)(2009-8#1)
respiration-deficient##2##1##(1995-6#1)(1997-2#1)
respirations##3##1##(1996-6#2)(2007-12#1)
respirator training##2##2##(2008-12#2)
respirator treatment of##3##3##(1991-9#3)
respirator use##4##2##(2008-12#4)
respirator##20##1##(1991-6#1)(1991-9#3)(1994-6#1)(1996-2#1)(1997-4#1)(2005-9#1)(2008-12#9)(2008-4#1)(2008-5#1)(2010-8#1)
respirators##6##1##(1992-10#1)(2005-9#1)(2008-12#3)(2008-4#1)
respiratory abnormality##2##2##(2007-6#1)(2008-12#1)
respiratory acidosis##3##2##(2007-2#1)(2010-1#1)(2012-2#1)
respiratory activity of the##2##4##(1994-12#1)(2008-10#1)
respiratory activity of##4##3##(1994-12#1)(2008-10#1)(2008-5#2)
respiratory activity##11##2##(1991-1#1)(1992-8#1)(1994-12#1)(1997-2#1)(2004-12#3)(2008-10#1)(2008-5#2)(2008-9#1)
respiratory afferents##3##2##(1993-2#1)(1996-5#2)
respiratory ailments##2##2##(2006-12#1)(2013-1#1)
respiratory alkalosis##3##2##(2007-11#1)(2012-3#1)(2013-1#1)
respiratory allergies##3##2##(2012-3#1)(2013-1#2)
respiratory allergy##3##2##(1991-2#1)(1997-2#1)(2007-3#1)
respiratory and cardiac##2##3##(1997-2#1)(2007-11#1)
respiratory and cardiovascular##3##3##(1993-7#1)(2010-6#1)(2013-8#1)
respiratory and circulatory##2##3##(2008-5#1)(2012-2#1)
respiratory and contact##2##3##(2008-10#2)
respiratory and gastrointestinal tract##2##4##(1996-2#1)(2010-9#1)
respiratory and gastrointestinal##4##3##(1996-2#1)(2005-11#1)(2008-8#1)(2010-9#1)
respiratory and photosynthetic##2##3##(1994-3#1)(2009-8#1)
respiratory and renal##2##3##(1994-8#1)(2012-1#1)
respiratory and urinary tract infections##2##5##(2005-9#1)(2012-2#1)
respiratory and##38##2##(1992-8#1)(1993-7#1)(1994-3#1)(1994-8#1)(1996-12#1)(1996-2#1)(1997-2#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
respiratory and/or##2##2##(2010-8#1)(2012-2#1)
respiratory arrest and##2##3##(1991-11#1)(2012-2#1)
respiratory arrest##3##2##(1990-11#1)(1991-11#1)(2012-2#1)
respiratory bronchioles##2##2##(1995-8#1)(2011-2#1)
respiratory bronchiolitis##4##2##(2005-8#3)(2010-12#1)
respiratory burst and##2##3##(1991-2#1)(2012-3#1)
respiratory burst in##2##3##(1991-6#1)(2008-8#1)
respiratory burst is##2##3##(1992-1#1)(1993-6#1)
respiratory burst oxidase##3##3##(1994-3#3)
respiratory burst response to##2##4##(1992-1#1)(1992-7#1)
respiratory burst##33##2##(1990-2#2)(1990-8#1)(1990-9#1)(1991-2#2)(1991-6#3)(1992-1#3)(1992-7#1)(1992-9#1)(1993-6#2)(1993-7#2)(1994-3#3)(1994-6#4)(2008-5#1)(2008-8#4)(2009-7#1)(2012-2#1)(2012-3#1)
respiratory bursts##2##2##(1990-9#1)(1997-3#1)
respiratory cancer##3##2##(2010-8#3)
respiratory care##6##2##(1997-4#3)(2007-12#1)(2011-1#1)(2013-8#1)
respiratory chain NADH dehydrogenase##2##4##(1990-9#1)(1996-5#1)
respiratory chain complex I##3##4##(1997-6#1)(2006-8#1)(2011-1#1)
respiratory chain complex##4##3##(1997-6#1)(1997-7#1)(2006-8#1)(2011-1#1)
respiratory chain deficiency##3##3##(1996-12#2)(1997-7#1)
respiratory chain enzyme activities##4##4##(1994-11#3)(1997-7#1)
respiratory chain enzyme##5##3##(1994-11#3)(1997-7#1)(2013-8#1)
respiratory chain enzymes in##2##4##(1996-3#1)(2005-8#1)
respiratory chain enzymes##5##3##(1996-3#2)(2005-8#3)
respiratory chain function##2##3##(2005-8#1)(2008-10#1)
respiratory chain inhibitors##3##3##(1994-8#1)(2006-8#2)
respiratory chain##58##2##(1990-11#1)(1990-9#1)(1994-11#5)(1994-8#2)(1995-1#1)(1995-11#2)(1995-2#1)(1995-6#3)(1996-12#3)(1996-3#4)(1996-5#2)(1997-1#1)(1997-6#2)(1997-7#4)(1997-8#2)(2005-8#10)(2006-10#1)(2006-8#3)(2007-11#1)(2008-10#1)(2008-7#2)(2009-5#1)(2011-1#1)(2011-2#2)(2012-11#1)(2013-8#1)
respiratory changes##3##2##(1991-10#2)(1994-10#1)
respiratory clinical##2##2##(2010-5#1)(2011-1#1)
respiratory complaints##2##2##(1994-6#1)(2010-5#1)
respiratory complex I##2##3##(1993-12#2)
respiratory complex##3##2##(1993-12#2)(2008-10#1)
respiratory complications in##2##3##(2008-4#1)(2011-2#1)
respiratory complications##12##2##(1996-9#1)(2006-10#2)(2006-12#1)(2007-8#1)(2008-12#1)(2008-4#1)(2009-11#1)(2009-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
respiratory compromise##5##2##(2006-2#1)(2006-7#1)(2007-12#1)(2009-3#1)(2012-1#1)
respiratory conditions among##2##3##(2008-12#2)
respiratory conditions##6##2##(1993-7#1)(1996-3#1)(2008-12#3)(2012-12#1)
respiratory control ratio (RCR)##2##4##(2005-8#1)(2008-10#1)
respiratory control ratio##5##3##(1994-11#1)(1994-12#2)(2005-8#1)(2008-10#1)
respiratory control##11##2##(1990-10#1)(1992-4#1)(1994-11#1)(1994-12#2)(1995-7#2)(1997-8#1)(2005-8#1)(2008-10#1)(2009-10#1)
respiratory coronavirus##2##2##(1992-5#1)(2012-2#1)
respiratory depression and##5##3##(1993-1#1)(1993-3#1)(2005-8#1)(2006-10#2)
respiratory depression in##2##3##(1996-2#1)(2010-7#1)
respiratory depression was##2##3##(2007-2#2)
respiratory depression were##2##3##(1993-12#1)(1996-2#1)
respiratory depression##15##2##(1992-5#1)(1993-1#1)(1993-12#1)(1993-3#1)(1995-5#1)(1996-2#2)(1996-7#1)(2005-8#1)(2006-10#3)(2007-2#2)(2010-7#1)
respiratory difficulty with wheeze##2##4##(2012-3#2)
respiratory disease and associated##2##4##(2009-10#1)(2013-8#1)
respiratory disease and##7##3##(2007-8#2)(2009-10#1)(2012-12#2)(2012-2#1)(2013-8#1)
respiratory disease in##7##3##(1991-8#1)(1996-9#2)(1997-1#1)(1997-6#1)(2005-7#1)(2008-5#1)
respiratory disease or##2##3##(2008-5#1)(2010-7#1)
respiratory disease that##2##3##(1993-5#1)(2005-8#1)
respiratory disease##50##2##(1991-11#1)(1991-8#1)(1993-5#1)(1994-10#1)(1994-6#1)(1996-9#3)(1997-1#2)(1997-6#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-4#2)(2007-8#3)(2008-12#3)(2008-5#4)(2008-7#3)(2009-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-12#4)(2012-2#3)(2013-1#1)(2013-8#2)
respiratory diseases and##2##3##(2006-8#1)(2013-8#1)
respiratory diseases in##4##3##(1997-2#1)(2005-7#1)(2008-11#1)(2008-12#1)
respiratory diseases with##2##3##(2006-8#1)(2013-8#1)
respiratory diseases##36##2##(1996-3#4)(1997-2#1)(2005-7#1)(2006-12#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-3#1)(2008-11#1)(2008-12#2)(2008-5#1)(2009-12#1)(2010-12#2)(2010-2#1)(2010-9#3)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#6)(2013-8#2)
respiratory disorders and##2##3##(1990-3#1)(2008-7#1)
respiratory disorders##10##2##(1990-3#1)(1990-9#1)(1995-8#1)(1996-2#1)(2005-11#1)(2007-3#1)(2008-5#1)(2008-7#3)
respiratory distress and##7##3##(1990-3#1)(2006-2#1)(2006-8#1)(2009-6#1)(2010-1#1)(2011-2#1)(2012-2#1)
respiratory distress associated with##2##4##(2013-1#2)
respiratory distress in##2##3##(2008-7#1)(2013-1#1)
respiratory distress syndrome (ARDS) and##2##5##(2005-8#1)(2006-4#1)
respiratory distress syndrome (ARDS) is a##3##6##(2005-11#1)(2005-8#1)(2012-3#1)
respiratory distress syndrome (ARDS) is##6##5##(2005-11#1)(2005-8#3)(2009-6#1)(2012-3#1)
respiratory distress syndrome (ARDS) remains a##2##6##(1997-1#1)(2005-8#1)
respiratory distress syndrome (ARDS)##19##4##(1991-9#1)(1993-2#1)(1997-1#1)(2005-11#2)(2005-8#8)(2006-4#1)(2009-6#1)(2011-2#2)(2012-1#1)(2012-3#1)
respiratory distress syndrome (ARDS)]##2##4##(1994-3#1)(2010-12#1)
respiratory distress syndrome (RDS)##6##4##(1993-5#1)(1995-5#1)(2006-2#1)(2007-11#1)(2008-6#1)(2009-2#1)
respiratory distress syndrome and##5##4##(1992-2#1)(2007-9#1)(2008-12#1)(2008-4#1)(2009-7#1)
respiratory distress syndrome in##3##4##(1990-12#1)(1993-5#1)(1994-6#1)
respiratory distress syndrome##73##3##(1990-11#1)(1990-12#2)(1990-2#2)(1991-9#4)(1992-2#3)(1993-2#1)(1993-5#3)(1994-11#1)(1994-3#1)(1994-6#2)(1995-5#1)(1997-1#2)(2005-11#2)(2005-7#1)(2005-8#12)(2005-9#1)(2006-10#9)(2006-2#2)(2006-4#2)(2007-11#1)(2007-9#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-2#1)(2009-6#3)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#3)
respiratory distress syndrome' (ARDS)##2##4##(2010-5#2)
respiratory distress syndrome]##4##3##(1990-11#1)(1994-4#1)(1996-6#1)(2012-3#1)
respiratory distress##126##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#1)(1991-3#1)(1991-9#5)(1992-2#4)(1992-4#1)(1993-2#1)(1993-5#3)(1994-11#1)(1994-3#1)(1994-4#2)(1994-6#2)(1995-5#1)(1996-12#1)(1996-6#1)(1997-1#2)(2004-3#1)(2005-11#2)(2005-7#1)(2005-8#12)(2005-9#1)(2006-10#10)(2006-2#3)(2006-4#3)(2006-8#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-2#1)(2009-6#5)(2009-7#1)(2010-1#1)(2010-12#3)(2010-5#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#6)(2013-1#7)
respiratory disturbances##2##2##(2007-1#1)(2010-5#1)
respiratory drive##3##2##(1990-7#1)(2006-10#1)(2012-1#1)
respiratory electron transport##2##3##(1990-11#1)(1997-6#1)
respiratory electron##3##2##(1990-11#1)(1994-5#1)(1997-6#1)
respiratory embarrassment##2##2##(2006-10#1)(2008-12#1)
respiratory enzyme##3##2##(1991-1#1)(1994-11#1)(1996-12#1)
respiratory enzymes##3##2##(2008-10#2)(2012-2#1)
respiratory epithelial adenomatoid hamartoma##2##4##(2008-2#2)
respiratory epithelial cells##4##3##(2008-10#3)(2012-12#1)
respiratory epithelial##6##2##(2008-10#3)(2008-2#2)(2012-12#1)
respiratory epithelium and##3##3##(2008-4#1)(2012-3#2)
respiratory epithelium##7##2##(1990-6#1)(1992-3#1)(2008-1#1)(2008-2#1)(2008-4#1)(2012-3#2)
respiratory events##4##2##(1997-4#1)(2007-2#1)(2008-5#1)(2010-7#1)
respiratory exchange ratio (RER)##4##4##(1992-12#1)(2008-3#1)(2008-5#1)(2013-8#1)
respiratory excursions##2##2##(2009-6#1)(2012-3#1)
respiratory failure and death##2##4##(1993-10#1)(2006-4#1)
respiratory failure and##16##3##(1993-10#1)(1995-4#1)(1997-4#2)(2005-8#2)(2006-4#2)(2007-8#1)(2008-1#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#2)
respiratory failure due to##3##4##(2007-8#1)(2008-6#1)(2012-2#1)
respiratory failure from##2##3##(1990-10#1)(1996-12#1)
respiratory failure is##2##3##(1992-2#1)(2008-1#1)
respiratory failure requiring mechanical ventilation##2##5##(2006-10#1)(2013-1#1)
respiratory failure requiring##3##3##(2006-10#1)(2011-1#1)(2013-1#1)
respiratory failure who have##2##4##(2005-8#1)(2006-10#1)
respiratory failure with##3##3##(2006-10#1)(2013-1#2)
respiratory failure##97##2##(1990-10#1)(1991-6#1)(1992-2#1)(1992-3#1)(1993-10#1)(1994-3#1)(1995-3#2)(1995-4#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-3#1)(1997-4#6)(2005-7#1)(2005-8#5)(2006-10#9)(2006-4#4)(2006-9#3)(2007-2#2)(2007-8#6)(2008-1#5)(2008-2#1)(2008-6#2)(2008-7#1)(2009-5#2)(2009-7#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#4)(2012-2#8)(2012-3#1)(2013-1#11)(2013-8#1)
respiratory failure]##4##2##(1994-3#1)(1995-4#2)(2008-1#1)
respiratory frequency##4##2##(1992-8#2)(1996-2#1)(1996-5#1)
respiratory function and##5##3##(1991-12#1)(2008-10#1)(2012-2#1)(2013-1#2)
respiratory function in##2##3##(1990-5#1)(2008-1#1)
respiratory function test##3##3##(2013-1#3)
respiratory function##28##2##(1990-5#1)(1991-12#2)(1992-8#1)(1993-12#1)(1993-7#1)(2005-8#1)(2006-2#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#2)(2009-3#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#8)
respiratory functions in##2##3##(1994-10#1)(1994-11#1)
respiratory functions##5##2##(1994-10#1)(1994-11#1)(1997-8#1)(2006-10#1)(2007-10#1)
respiratory gases##4##2##(1997-1#2)(1997-4#1)(2010-12#1)
respiratory health in longitudinal social science surveys##2##7##(2010-2#2)
respiratory health to##2##3##(2010-2#2)
respiratory health##8##2##(2008-1#1)(2008-11#1)(2008-12#1)(2010-2#5)
respiratory horns##2##2##(2007-12#2)
respiratory illness and##2##3##(2007-10#1)(2008-10#1)
respiratory illness##11##2##(1994-2#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-8#1)(2012-1#1)(2012-12#2)(2013-8#1)
respiratory illnesses##6##2##(2008-11#1)(2008-4#1)(2009-5#1)(2011-12#1)(2012-12#1)(2013-1#1)
respiratory impairment##2##2##(1991-8#1)(2009-9#1)
respiratory incompetence##2##2##(1997-7#1)(2006-6#1)
respiratory infection and##2##3##(2008-1#1)(2008-7#1)
respiratory infection in##3##3##(1992-10#1)(1993-5#1)(2013-1#1)
respiratory infection##17##2##(1991-9#1)(1992-10#1)(1993-2#1)(1993-5#1)(2005-11#1)(2006-10#3)(2008-1#1)(2008-5#1)(2008-7#2)(2010-12#2)(2012-2#2)(2013-1#1)
respiratory infections and##2##3##(1990-12#1)(2011-2#1)
respiratory infections have been##2##4##(2006-10#1)(2011-1#1)
respiratory infections in##7##3##(2008-3#1)(2010-4#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#2)
respiratory infections is##2##3##(2005-11#1)(2011-2#1)
respiratory infections with##2##3##(2008-4#1)(2013-1#1)
respiratory infections##52##2##(1990-12#1)(1990-5#1)(1991-12#2)(1991-4#1)(1992-1#1)(1994-9#1)(1995-9#1)(1996-1#1)(1997-3#1)(1997-6#1)(2005-11#4)(2005-8#1)(2006-10#4)(2007-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#3)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#5)(2013-1#4)(2013-8#3)
respiratory infectious##2##2##(2010-12#2)
respiratory insufficiency and##3##3##(1996-3#1)(2008-4#1)(2010-12#1)
respiratory insufficiency in patients##2##4##(1997-4#1)(2006-6#1)
respiratory insufficiency##17##2##(1991-9#2)(1995-7#1)(1996-3#1)(1997-4#5)(2006-6#1)(2007-3#1)(2007-7#1)(2008-4#1)(2010-12#1)(2010-7#2)(2010-9#1)
respiratory insufficiency]##9##2##(1990-10#1)(1991-6#1)(1997-4#7)
respiratory irregularities##2##2##(2011-12#2)
respiratory lesions##3##2##(1991-8#1)(1997-3#2)
respiratory manifestations of##4##3##(1994-5#1)(2008-5#1)(2012-1#2)
respiratory manifestations##8##2##(1994-5#1)(2007-2#1)(2007-8#1)(2008-5#2)(2009-8#1)(2012-1#2)
respiratory mechanics##7##2##(2005-8#1)(2006-4#1)(2010-2#1)(2012-2#3)(2013-7#1)
respiratory metabolism##2##2##(2007-7#1)(2011-2#1)
respiratory motion##6##2##(1997-8#1)(2009-5#3)(2011-1#1)(2012-12#1)
respiratory movements##3##2##(1991-10#1)(1993-5#1)(1995-12#1)
respiratory mucosa##3##2##(1991-2#1)(1993-8#1)(1997-5#1)
respiratory muscle fatigue##3##3##(1992-2#1)(1997-4#1)(2013-7#1)
respiratory muscle function##3##3##(1991-6#1)(1997-4#1)(2006-10#1)
respiratory muscle strength##3##3##(1993-7#1)(2013-1#2)
respiratory muscle##17##2##(1991-6#2)(1992-2#3)(1993-7#1)(1994-3#2)(1997-4#2)(2006-10#1)(2012-2#2)(2013-1#3)(2013-7#1)
respiratory muscles##8##2##(1990-10#1)(1991-6#1)(1997-3#1)(1997-4#1)(2007-9#1)(2010-11#1)(2012-2#1)(2012-3#1)
respiratory or cardiovascular##2##3##(2007-7#1)(2007-8#1)
respiratory or##4##2##(2007-5#1)(2007-7#1)(2007-8#1)(2009-3#1)
respiratory organs]##2##2##(1992-3#1)(2006-6#1)
respiratory outcomes##7##2##(2010-6#7)
respiratory parameters at##2##3##(1991-4#1)(2011-2#1)
respiratory parameters##8##2##(1991-4#1)(2008-9#1)(2009-5#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
respiratory pathogen##2##2##(1996-10#1)(2005-12#1)
respiratory pathogens##16##2##(1991-12#9)(2005-11#1)(2006-10#1)(2007-11#1)(2010-11#1)(2011-2#2)(2013-8#1)
respiratory pathology##2##2##(1990-9#1)(2007-6#1)
respiratory pattern##2##2##(1991-10#1)(1997-3#1)
respiratory patterning in##2##3##(1990-7#2)
respiratory patterning##3##2##(1990-7#3)
respiratory phase##3##2##(2010-9#2)(2011-1#1)
respiratory phases##2##2##(2009-5#1)(2011-1#1)
respiratory physiology##3##2##(2005-10#1)(2010-10#1)(2012-2#1)
respiratory problems in##2##3##(2004-4#1)(2012-1#1)
respiratory problems##7##2##(1996-3#1)(2004-4#1)(2005-11#1)(2007-2#1)(2010-12#1)(2010-5#1)(2012-1#1)
respiratory protection program##2##3##(2008-12#2)
respiratory protection programs in the##2##5##(2008-12#2)
respiratory protection##7##2##(1996-12#1)(2008-12#5)(2010-5#1)
respiratory quotient (RQ)##2##3##(2005-1#1)(2006-7#1)
respiratory quotient##3##2##(2005-1#1)(2006-7#1)(2008-4#1)
respiratory rate (RR)##2##3##(1992-12#1)(2012-2#1)
respiratory rate and##6##3##(1991-10#1)(1993-5#1)(2007-8#1)(2013-1#2)(2013-8#1)
respiratory rate than##2##3##(2007-2#2)
respiratory rate##34##2##(1990-2#1)(1991-10#1)(1992-12#1)(1993-5#1)(1994-11#1)(1995-11#1)(1996-3#1)(1997-7#2)(2006-2#1)(2007-11#1)(2007-2#4)(2007-8#2)(2008-4#2)(2008-5#1)(2008-7#1)(2009-6#2)(2010-3#2)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
respiratory rates##4##2##(2006-10#1)(2007-2#1)(2009-8#1)(2012-3#1)
respiratory rehabilitation##3##2##(1990-6#1)(2007-6#1)(2007-8#1)
respiratory responses##3##2##(1996-5#2)(2006-2#1)
respiratory rhythm##4##2##(1992-8#2)(1995-12#2)
respiratory secretions##2##2##(2006-10#1)(2007-11#1)
respiratory signs##2##2##(2008-5#1)(2011-2#1)
respiratory status##2##2##(2007-12#1)(2013-1#1)
respiratory substrates##3##2##(1997-7#1)(2005-8#1)(2008-7#1)
respiratory support##6##2##(1994-4#1)(2006-10#1)(2007-8#1)(2010-6#1)(2013-1#2)
respiratory symptoms and##4##3##(2007-2#1)(2009-9#1)(2010-12#1)(2012-12#1)
respiratory symptoms in##6##3##(1995-8#1)(1996-3#1)(1997-1#1)(2007-2#1)(2008-1#1)(2011-1#1)
respiratory symptoms were##3##3##(2010-9#1)(2011-1#1)(2013-8#1)
respiratory symptoms##46##2##(1992-5#1)(1995-6#1)(1995-8#2)(1996-3#1)(1997-1#1)(1997-3#1)(1997-5#2)(2005-11#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-1#1)(2007-2#3)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#4)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#3)
respiratory syncytial virus (RSV)##10##4##(1992-10#1)(1996-3#1)(2007-11#1)(2008-11#1)(2009-8#2)(2010-5#1)(2011-2#2)(2012-2#1)
respiratory syncytial virus##23##3##(1992-10#3)(1994-6#3)(1995-5#1)(1996-11#1)(1996-3#1)(2006-8#2)(2007-11#1)(2008-1#2)(2008-11#1)(2009-8#2)(2010-10#1)(2010-5#1)(2011-2#3)(2012-2#1)
respiratory syncytial##25##2##(1992-10#3)(1994-6#3)(1995-5#1)(1996-11#1)(1996-3#1)(2006-8#2)(2007-11#1)(2007-3#1)(2008-1#2)(2008-11#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-5#1)(2011-2#3)(2012-2#1)
respiratory syndrome##26##2##(1992-2#1)(1997-6#2)(2005-10#1)(2005-11#2)(2006-9#1)(2007-12#4)(2007-7#3)(2008-1#1)(2008-10#1)(2008-5#5)(2008-7#2)(2009-5#1)(2010-2#1)(2011-1#1)
respiratory syndromes##7##2##(2007-11#1)(2010-12#6)
respiratory system of the##2##4##(2007-12#2)
respiratory system of##3##3##(1994-4#1)(2007-12#2)
respiratory system##37##2##(1990-9#3)(1992-12#1)(1992-2#1)(1994-4#1)(1995-6#1)(1996-3#2)(1996-8#1)(1997-3#1)(2006-10#1)(2006-11#1)(2007-12#3)(2007-2#1)(2007-6#1)(2007-8#2)(2008-5#3)(2009-12#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2013-7#4)
respiratory timing##2##2##(1997-8#2)
respiratory tissues##2##2##(2008-5#1)(2011-2#1)
respiratory toxicity##2##2##(2008-4#2)
respiratory tract and the##2##4##(2008-11#1)(2011-1#1)
respiratory tract and##7##3##(1992-4#1)(2008-11#1)(2008-5#2)(2011-1#1)(2012-12#1)(2013-8#1)
respiratory tract are##4##3##(1992-3#1)(1993-5#1)(1994-12#1)(2007-8#1)
respiratory tract can be##2##4##(1994-6#1)(2013-1#1)
respiratory tract disease##5##3##(1996-9#2)(2009-3#1)(2010-12#1)(2011-2#1)
respiratory tract diseases##2##3##(1992-6#1)(2012-12#1)
respiratory tract has##2##3##(2005-8#1)(2011-1#1)
respiratory tract in##4##3##(1994-12#1)(2007-2#1)(2008-10#1)(2008-5#1)
respiratory tract infection and##2##4##(2008-7#1)(2010-12#1)
respiratory tract infection in##3##4##(2006-4#1)(2010-10#1)(2013-1#1)
respiratory tract infection##25##3##(1991-4#1)(1994-3#1)(1996-3#1)(2005-7#2)(2006-10#1)(2006-2#1)(2006-4#1)(2007-2#2)(2007-3#1)(2008-3#2)(2008-7#2)(2010-10#1)(2010-12#2)(2011-1#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#2)
respiratory tract infections in children##2##5##(2009-5#1)(2012-12#1)
respiratory tract infections in##9##4##(1997-2#2)(2008-1#1)(2008-11#1)(2009-2#1)(2009-5#1)(2010-11#1)(2012-12#2)
respiratory tract infections##34##3##(1990-7#1)(1991-12#2)(1991-4#1)(1996-12#2)(1997-2#2)(2005-11#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-2#2)(2009-3#2)(2009-5#1)(2009-9#2)(2010-11#1)(2010-12#3)(2010-5#2)(2011-2#2)(2012-12#2)
respiratory tract is##4##3##(1990-8#1)(1996-1#1)(2005-11#1)(2006-10#1)
respiratory tract lesions##3##3##(2008-5#3)
respiratory tract of##6##3##(1994-10#1)(1997-6#1)(2007-2#1)(2008-4#1)(2008-5#2)
respiratory tract or##2##3##(2008-11#1)(2008-5#1)
respiratory tract##174##2##(1990-7#1)(1990-8#1)(1991-12#4)(1991-4#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-3#3)(1992-4#2)(1992-6#1)(1992-9#1)(1993-5#1)(1994-10#1)(1994-12#3)(1994-3#1)(1994-6#2)(1995-12#2)(1995-3#1)(1995-6#2)(1995-7#1)(1996-1#3)(1996-12#3)(1996-3#3)(1996-7#1)(1996-9#3)(1997-1#2)(1997-2#2)(1997-4#1)(1997-6#1)(2005-1#1)(2005-11#6)(2005-7#2)(2005-8#1)(2006-10#3)(2006-2#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#8)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-3#3)(2008-4#2)(2008-5#13)(2008-7#3)(2009-2#2)(2009-3#4)(2009-5#2)(2009-6#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#7)(2010-5#2)(2010-8#2)(2011-1#3)(2011-2#9)(2012-12#8)(2012-2#2)(2013-1#7)(2013-7#1)(2013-8#5)
respiratory viral infection in##2##4##(2007-12#1)(2007-8#1)
respiratory viral##5##2##(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)
respiratory virus##4##2##(1995-5#1)(2012-1#1)(2013-1#1)(2013-8#1)
respiratory viruses in##4##3##(2005-7#1)(2010-5#1)(2011-2#2)
respiratory viruses##10##2##(1991-12#1)(2005-7#1)(2006-10#2)(2008-5#1)(2010-5#1)(2011-2#2)(2013-8#2)
respiratory washings##5##2##(2008-5#5)
respiratory##1520##1##(1990-10#5)(1990-11#5)(1990-12#3)(1990-2#6)(1990-3#2)(1990-5#3)(1990-6#5)(1990-7#9)(1990-8#2)(1990-9#9)(1991-1#2)(1991-10#5)(1991-11#2)(1991-12#18)(1991-2#4)(1991-3#3)(1991-4#6)(1991-5#1)(1991-6#9)(1991-8#3)(1991-9#9)(1992-1#4)(1992-10#4)(1992-11#2)(1992-12#3)(1992-2#12)(1992-3#7)(1992-4#6)(1992-5#3)(1992-6#3)(1992-7#2)(1992-8#8)(1992-9#2)(1993-1#1)(1993-10#1)(1993-12#4)(1993-2#3)(1993-3#1)(1993-5#9)(1993-6#2)(1993-7#7)(1993-8#2)(1994-10#5)(1994-11#10)(1994-12#6)(1994-2#4)(1994-3#14)(1994-4#4)(1994-5#2)(1994-6#15)(1994-8#6)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#5)(1995-2#1)(1995-3#3)(1995-4#5)(1995-5#4)(1995-6#7)(1995-7#4)(1995-8#6)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#1)(1996-12#12)(1996-2#6)(1996-3#22)(1996-4#1)(1996-5#8)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#8)(1997-1#10)(1997-2#8)(1997-3#9)(1997-4#34)(1997-5#3)(1997-6#9)(1997-7#12)(1997-8#9)(2004-12#3)(2004-3#1)(2004-4#1)(2005-1#2)(2005-10#2)(2005-11#25)(2005-12#2)(2005-7#7)(2005-8#47)(2005-9#3)(2006-10#52)(2006-11#2)(2006-12#5)(2006-2#11)(2006-4#10)(2006-5#1)(2006-6#5)(2006-7#3)(2006-8#10)(2006-9#4)(2007-1#5)(2007-10#3)(2007-11#15)(2007-12#18)(2007-2#29)(2007-3#7)(2007-4#5)(2007-5#1)(2007-6#4)(2007-7#10)(2007-8#31)(2007-9#6)(2008-1#18)(2008-10#27)(2008-11#13)(2008-12#19)(2008-2#5)(2008-3#8)(2008-4#18)(2008-5#58)(2008-6#3)(2008-7#26)(2008-8#6)(2008-9#2)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#5)(2009-3#9)(2009-4#1)(2009-5#13)(2009-6#10)(2009-7#3)(2009-8#6)(2009-9#4)(2010-1#4)(2010-10#4)(2010-11#3)(2010-12#39)(2010-2#10)(2010-3#3)(2010-4#2)(2010-5#16)(2010-6#11)(2010-7#13)(2010-8#15)(2010-9#11)(2011-1#26)(2011-12#7)(2011-2#58)(2011-3#1)(2012-1#15)(2012-11#2)(2012-12#36)(2012-2#49)(2012-3#25)(2013-1#74)(2013-7#8)(2013-8#30)
respiratory-deficient mutant##2##2##(1994-10#1)(2008-6#1)
respiratory-deficient##4##1##(1994-10#1)(1997-6#1)(2008-6#2)
respiratory-related facial nerve activity##2##4##(1997-6#2)
respiratory-related##4##1##(1995-7#2)(1997-6#2)
respire##2##1##(1995-6#1)(2005-8#1)
respiring cells##2##2##(2008-7#2)
respiring##6##1##(1991-4#1)(2005-8#1)(2008-7#3)(2011-2#1)
respirometry##3##1##(2007-8#2)(2011-1#1)
respite care##8##2##(1990-3#1)(1992-3#1)(1995-12#2)(2005-12#4)
respite services##2##2##(1995-12#1)(2009-6#1)
respite##15##1##(1990-3#1)(1992-3#4)(1995-12#4)(2005-12#4)(2009-6#1)(2010-3#1)
respond adequately##3##2##(1990-12#1)(1993-11#1)(2007-11#1)
respond and adapt##2##3##(2004-2#1)(2011-2#1)
respond and##4##2##(1997-5#1)(2004-2#1)(2011-2#1)(2012-2#1)
respond appropriately##4##2##(2007-2#1)(2008-12#1)(2008-6#1)(2009-9#1)
respond at##3##2##(1995-8#1)(2006-12#1)(2010-4#1)
respond better to##4##3##(1992-1#1)(2005-1#1)(2008-7#1)(2013-1#1)
respond by##2##2##(1990-11#1)(2009-9#1)
respond differentially to##2##3##(1996-5#1)(2008-8#1)
respond differently to the##2##4##(1991-5#1)(1995-8#1)
respond differently to##8##3##(1991-5#1)(1993-10#1)(1993-4#1)(1995-8#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-5#1)
respond differently##10##2##(1991-5#1)(1993-10#1)(1993-4#1)(1995-8#1)(1997-2#1)(1997-8#2)(2008-10#1)(2008-3#1)(2008-5#1)
respond in a##2##3##(1996-4#1)(2008-10#1)
respond in the##3##3##(1991-3#1)(1995-2#1)(2007-11#1)
respond in##11##2##(1991-3#1)(1995-11#1)(1995-2#1)(1996-3#1)(1996-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2013-1#2)(2013-8#1)
respond poorly to##4##3##(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)
respond positively to##2##3##(1992-3#1)(2005-10#1)
respond positively##3##2##(1992-3#1)(2005-10#1)(2012-3#1)
respond quickly to##2##3##(2011-2#1)(2013-7#1)
respond rapidly to##2##3##(2006-7#1)(2008-5#1)
respond selectively to##4##3##(1991-5#1)(1992-2#1)(2008-10#1)(2009-3#1)
respond similarly to##3##3##(1994-5#1)(1996-12#1)(2008-10#1)
respond similarly##4##2##(1994-5#1)(1996-12#1)(2008-10#1)(2008-2#1)
respond to &quot##2##3##(2009-2#2)
respond to ATP##2##3##(1990-5#1)(2008-4#1)
respond to E##2##3##(1995-10#1)(2011-1#1)
respond to ET-1 with##3##4##(1994-12#2)(1994-5#1)
respond to NGF##2##3##(1996-1#1)(1997-6#1)
respond to SP##2##3##(1995-12#1)(1997-4#1)
respond to a variety of##2##5##(1993-3#1)(2008-3#1)
respond to a##17##3##(1990-11#1)(1992-7#1)(1992-8#1)(1993-3#3)(1995-2#1)(2006-10#1)(2006-8#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2012-1#1)
respond to an##3##3##(1993-6#1)(1996-9#1)(2008-4#1)
respond to antigen##6##3##(1992-4#2)(1992-5#1)(1994-3#1)(2007-3#1)(2008-3#1)
respond to both##4##3##(1992-9#1)(1996-11#1)(1996-5#1)(2008-2#1)
respond to certain##2##3##(1992-2#1)(2008-4#1)
respond to changes in##3##4##(2009-2#1)(2013-1#1)(2013-8#1)
respond to changing##2##3##(2006-12#1)(2010-3#1)
respond to conservative##3##3##(2006-7#1)(2006-8#1)(2007-10#1)
respond to conventional##8##3##(2006-10#1)(2006-6#1)(2007-2#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
respond to electrical stimulation of the##2##6##(1992-8#1)(1992-9#1)
respond to environmental##7##3##(1992-6#1)(2007-3#1)(2008-8#1)(2012-12#1)(2012-3#1)(2013-8#2)
respond to estrogen##2##3##(1991-2#1)(1996-4#1)
respond to exogenous##2##3##(1990-9#1)(1997-7#1)
respond to extracellular ATP##2##4##(2008-4#2)
respond to extracellular##3##3##(2008-4#3)
respond to further##3##3##(1994-3#1)(1996-5#1)(2005-10#1)
respond to infection##2##3##(2007-11#1)(2009-8#1)
respond to inflammatory##2##3##(2006-10#1)(2009-12#1)
respond to initial##2##3##(1993-2#1)(2007-11#1)
respond to medical##3##3##(1991-11#1)(1996-11#1)(1997-8#1)
respond to multiple##2##3##(1997-4#1)(2009-8#1)
respond to new therapies##2##4##(2008-6#2)
respond to new##5##3##(2008-1#1)(2008-6#2)(2011-2#1)(2012-12#1)
respond to other##5##3##(2006-8#3)(2007-12#1)(2010-12#1)
respond to oxidative##2##3##(2008-11#1)(2011-1#1)
respond to previous##2##3##(2012-12#2)
respond to standard##3##3##(2007-2#1)(2012-11#1)(2012-12#1)
respond to stimulation##2##3##(1992-1#1)(1992-3#1)
respond to such##2##3##(2008-11#1)(2011-2#1)
respond to surgery##2##3##(2007-7#1)(2010-7#1)
respond to the environment##2##4##(1994-12#1)(2012-2#1)
respond to the##44##3##(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1994-12#1)(1994-3#1)(1995-1#2)(1995-12#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-3#2)(1997-4#1)(2006-10#2)(2006-4#1)(2006-7#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-3#1)(2010-4#2)(2011-2#2)(2012-12#3)(2012-2#1)
respond to their##2##3##(1996-2#1)(2007-2#1)
respond to them##3##3##(1990-12#1)(1992-12#1)(1994-12#1)
respond to these challenges##2##4##(1994-12#1)(1995-1#1)
respond to these needs##2##4##(1991-12#1)(1992-3#1)
respond to these##18##3##(1991-12#1)(1992-3#1)(1994-12#3)(1995-1#1)(1996-4#1)(2005-5#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-4#1)(2010-12#1)
respond to this##5##3##(1992-9#1)(1994-6#1)(2006-10#1)(2007-7#1)(2008-10#1)
respond to traditional##2##3##(2004-3#1)(2008-1#1)
respond to treatment with##2##4##(1990-2#1)(2006-10#1)
respond to treatment##7##3##(1990-12#1)(1990-2#1)(2004-11#1)(2006-10#1)(2007-2#1)(2007-4#1)(2008-11#1)
respond to various##3##3##(1991-2#1)(1992-6#1)(2013-1#1)
respond to##421##2##(1990-11#4)(1990-12#2)(1990-2#3)(1990-5#2)(1990-7#3)(1990-8#3)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#3)(1991-2#4)(1991-3#2)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#2)(1992-11#3)(1992-12#3)(1992-2#2)(1992-3#4)(1992-4#2)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#5)(1992-9#4)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-12#12)(1994-2#1)(1994-3#5)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#5)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#5)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2004-11#1)(2004-3#1)(2005-1#1)(2005-10#2)(2005-11#1)(2005-5#2)(2005-6#1)(2005-8#3)(2006-10#14)(2006-12#4)(2006-2#3)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#8)(2007-10#3)(2007-11#4)(2007-12#4)(2007-2#5)(2007-3#4)(2007-4#2)(2007-7#6)(2007-8#5)(2007-9#3)(2008-1#6)(2008-10#10)(2008-11#10)(2008-12#3)(2008-2#7)(2008-3#6)(2008-4#13)(2008-5#1)(2008-6#4)(2008-7#6)(2008-8#14)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#5)(2009-3#2)(2009-4#2)(2009-6#1)(2009-8#9)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#5)(2010-3#3)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#3)(2011-2#8)(2012-1#5)(2012-11#1)(2012-12#17)(2012-2#6)(2012-3#3)(2012-5#1)(2013-1#6)(2013-7#2)(2013-8#7)
respond well to##8##3##(1990-1#1)(1995-2#1)(1997-6#1)(2006-3#1)(2007-11#1)(2009-4#1)(2010-5#1)(2012-3#1)
respond well##9##2##(1990-1#1)(1995-2#1)(1997-6#1)(2006-12#1)(2006-3#1)(2007-11#1)(2009-4#1)(2010-5#1)(2012-3#1)
respond with##6##2##(1995-12#1)(2005-10#1)(2008-9#1)(2009-8#1)(2010-2#1)(2012-2#1)
respond##560##1##(1990-1#1)(1990-11#6)(1990-12#3)(1990-2#3)(1990-5#2)(1990-7#3)(1990-8#4)(1990-9#2)(1991-1#1)(1991-10#3)(1991-11#2)(1991-12#4)(1991-2#4)(1991-3#4)(1991-5#3)(1991-6#2)(1991-9#3)(1992-1#3)(1992-11#4)(1992-12#3)(1992-2#3)(1992-3#5)(1992-4#2)(1992-5#2)(1992-6#2)(1992-7#3)(1992-8#5)(1992-9#4)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-12#12)(1994-2#1)(1994-3#5)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#5)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#2)(1996-11#2)(1996-12#2)(1996-2#5)(1996-3#3)(1996-4#4)(1996-5#6)(1996-6#1)(1996-7#1)(1996-9#3)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#5)(1997-7#1)(1997-8#4)(2004-11#1)(2004-12#1)(2004-2#1)(2004-3#2)(2005-1#2)(2005-10#4)(2005-11#1)(2005-5#2)(2005-6#1)(2005-8#3)(2006-10#17)(2006-11#1)(2006-12#7)(2006-2#3)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#9)(2007-10#3)(2007-11#8)(2007-12#6)(2007-2#7)(2007-3#4)(2007-4#3)(2007-7#6)(2007-8#6)(2007-9#3)(2008-1#7)(2008-10#17)(2008-11#18)(2008-12#5)(2008-2#8)(2008-3#7)(2008-4#13)(2008-5#4)(2008-6#5)(2008-7#9)(2008-8#16)(2008-9#5)(2009-11#1)(2009-12#1)(2009-2#5)(2009-3#3)(2009-4#4)(2009-6#1)(2009-8#10)(2009-9#3)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#1)(2010-3#3)(2010-4#4)(2010-5#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-12#3)(2011-2#13)(2012-1#7)(2012-11#1)(2012-12#19)(2012-2#11)(2012-3#5)(2012-5#1)(2013-1#10)(2013-7#4)(2013-8#8)
respondants' answers##2##2##(2012-2#2)
responded adequately to##2##3##(1997-2#1)(2013-1#1)
responded and##2##2##(2009-9#1)(2012-3#1)
responded by##5##2##(1995-1#1)(2006-4#1)(2007-4#1)(2008-10#1)(2010-8#1)
responded differentially to the##2##4##(1996-10#1)(2008-10#1)
responded differently to##3##3##(1991-7#1)(1997-1#1)(2008-10#1)
responded differently##7##2##(1991-7#1)(1992-6#1)(1995-7#1)(1997-1#1)(2006-10#1)(2008-10#1)(2010-8#1)
responded dramatically##2##2##(1994-5#1)(2012-2#1)
responded during the##2##3##(1993-2#2)
responded during##3##2##(1993-2#3)
responded excellently to##2##3##(2007-2#1)(2012-2#1)
responded favorably to the##2##4##(2007-8#1)(2011-2#1)
responded favorably to##4##3##(2006-10#1)(2007-5#1)(2007-8#1)(2011-2#1)
responded favorably##5##2##(2006-10#1)(2007-5#1)(2007-8#1)(2008-1#1)(2011-2#1)
responded favourably to##3##3##(1992-5#1)(2007-12#1)(2007-7#1)
responded favourably##5##2##(1992-5#1)(2007-12#1)(2007-7#2)(2012-2#1)
responded immediately##2##2##(2007-8#1)(2008-11#1)
responded in a similar manner##2##5##(1991-7#1)(2007-11#1)
responded in a##4##3##(1991-7#1)(1994-2#1)(1996-2#1)(2007-11#1)
responded in##8##2##(1991-7#1)(1993-2#1)(1994-2#1)(1995-2#1)(1996-2#1)(2007-11#1)(2007-9#2)
responded initially to##2##3##(1991-5#1)(2009-8#1)
responded linearly to##2##3##(2008-10#2)
responded more frequently##3##3##(1991-3#2)(1995-10#1)
responded more##6##2##(1991-3#2)(1995-10#1)(2007-8#1)(2008-5#1)(2008-8#1)
responded normally to##3##3##(1993-6#1)(1996-5#1)(1996-8#1)
responded poorly to##3##3##(1990-8#1)(2008-10#1)(2013-1#1)
responded positively to##3##3##(1994-12#1)(2007-7#1)(2008-11#1)
responded positively##5##2##(1990-2#1)(1994-12#1)(2007-7#1)(2008-11#1)(2013-1#1)
responded promptly to##2##3##(2007-7#1)(2008-11#1)
responded significantly##3##2##(2004-11#1)(2007-12#1)(2012-2#1)
responded similarly to##3##3##(1994-5#1)(2008-10#1)(2008-8#1)
responded similarly##4##2##(1994-5#1)(2008-10#1)(2008-8#1)(2012-1#1)
responded that it was &quot##2##5##(1990-2#2)
responded that they would##2##4##(2007-7#1)(2012-2#1)
responded that they##4##3##(1992-2#1)(2007-7#1)(2012-12#1)(2012-2#1)
responded that##6##2##(1990-2#2)(1992-2#1)(2007-7#1)(2012-12#1)(2012-2#1)
responded to CRH##2##3##(1992-6#1)(1994-3#1)
responded to Ki##2##3##(2008-10#2)
responded to PACAP38##2##3##(1994-10#2)
responded to a combination of##2##5##(2006-10#1)(2007-10#1)
responded to a questionnaire##2##4##(2008-9#1)(2011-1#1)
responded to a##9##3##(1990-2#1)(1993-1#1)(1993-2#1)(2006-10#2)(2007-10#1)(2008-9#1)(2011-1#1)(2012-11#1)
responded to activin A##2##4##(1992-6#2)
responded to both##3##3##(1992-6#1)(2008-4#1)(2008-5#1)
responded to combination##2##3##(1994-3#1)(2010-11#1)
responded to conventional therapy##2##4##(2010-12#1)(2010-3#1)
responded to conventional##4##3##(2008-12#1)(2010-12#1)(2010-3#1)(2013-7#1)
responded to dopamine##2##3##(1996-11#1)(2010-10#1)
responded to nanomolar concentrations of##2##5##(1990-12#1)(1994-12#1)
responded to predation##2##3##(2010-8#2)
responded to stimulation##2##3##(1990-4#1)(1991-10#1)
responded to target words##2##4##(2009-8#1)(2012-12#1)
responded to the questionnaire##3##4##(2007-3#1)(2011-1#1)(2012-1#1)
responded to the survey##8##4##(1995-1#1)(1995-12#1)(1995-3#1)(2007-9#1)(2008-12#1)(2012-2#1)(2013-1#2)
responded to the treatment and##2##5##(2006-4#1)(2007-8#1)
responded to the treatment##6##4##(1991-2#1)(1996-4#1)(2006-4#1)(2007-7#1)(2007-8#1)(2011-2#1)
responded to the##41##3##(1990-2#2)(1991-2#1)(1991-7#1)(1992-12#1)(1992-8#1)(1993-6#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-4#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-4#1)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-5#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-9#1)(2013-1#3)
responded to this##3##3##(2004-2#1)(2008-9#1)(2012-2#1)
responded to treatment with##3##4##(2007-7#2)(2008-7#1)
responded to treatment##9##3##(1990-2#1)(1996-4#1)(2007-2#1)(2007-7#2)(2008-4#1)(2008-7#1)(2010-11#1)(2010-4#1)
responded to##202##2##(1990-11#1)(1990-12#1)(1990-2#4)(1990-4#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#2)(1991-7#2)(1991-8#1)(1992-12#2)(1992-2#1)(1992-6#6)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-10#2)(1994-12#1)(1994-2#7)(1994-3#3)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-7#1)(1996-1#2)(1996-11#3)(1996-4#2)(1996-9#2)(1997-3#3)(1997-7#2)(1997-8#2)(2004-2#1)(2005-10#1)(2006-10#6)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#6)(2007-8#2)(2007-9#2)(2008-10#11)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#4)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#7)(2012-3#1)(2012-7#1)(2012-9#1)(2013-1#5)(2013-7#2)(2013-8#1)
responded very well to##2##4##(2007-6#1)(2007-7#1)
responded well to intravenous##2##4##(2006-10#2)
responded well to the##4##4##(2007-7#1)(2008-10#1)(2012-2#1)(2013-8#1)
responded well to treatment##2##4##(2006-7#1)(2013-1#1)
responded well to##22##3##(1991-2#1)(1995-10#1)(2006-10#5)(2006-7#1)(2007-7#6)(2007-8#1)(2008-10#1)(2008-4#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
responded well##24##2##(1991-2#1)(1995-10#1)(1995-11#1)(2006-10#5)(2006-7#1)(2007-7#7)(2007-8#1)(2008-10#1)(2008-4#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
responded with a##5##3##(1994-3#1)(1995-5#1)(1996-5#1)(2008-10#1)(2009-9#1)
responded with an increased rate##2##5##(1992-7#1)(1997-6#1)
responded with an##4##3##(1992-7#1)(1996-12#2)(1997-6#1)
responded with##19##2##(1990-4#1)(1992-7#1)(1994-3#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-5#1)(1997-3#1)(1997-6#1)(2006-10#1)(2008-10#2)(2009-9#1)(2010-12#1)(2010-5#1)(2012-1#2)(2012-3#1)
responded##393##1##(1990-10#6)(1990-11#1)(1990-12#1)(1990-2#7)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#4)(1991-3#3)(1991-4#1)(1991-5#3)(1991-7#5)(1991-8#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-5#1)(1992-6#7)(1992-7#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#6)(1993-3#1)(1993-6#4)(1993-8#1)(1993-9#1)(1994-10#2)(1994-12#2)(1994-2#8)(1994-3#5)(1994-5#3)(1994-8#2)(1994-9#1)(1995-1#2)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#2)(1995-7#2)(1995-8#1)(1995-9#2)(1996-1#3)(1996-10#1)(1996-11#3)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-1#1)(2004-11#1)(2004-2#1)(2004-3#1)(2005-10#1)(2005-11#1)(2006-10#15)(2006-12#2)(2006-4#2)(2006-6#1)(2006-7#3)(2006-8#5)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-2#3)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#20)(2007-8#7)(2007-9#5)(2008-1#4)(2008-10#24)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#6)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#9)(2008-9#5)(2009-4#1)(2009-5#1)(2009-8#3)(2009-9#5)(2010-10#2)(2010-11#3)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#6)(2010-9#2)(2011-1#4)(2011-2#6)(2012-1#5)(2012-11#1)(2012-12#3)(2012-2#15)(2012-3#4)(2012-7#1)(2012-9#1)(2013-1#10)(2013-7#2)(2013-8#3)
respondent driven sampling (RDS)##2##4##(2012-3#1)(2013-1#1)
respondent##12##1##(1993-2#1)(2006-8#1)(2008-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
respondent's##2##1##(2011-1#1)(2013-7#1)
respondents agreed that##2##3##(2008-8#1)(2010-5#1)
respondents and##7##2##(1990-9#1)(1996-2#1)(2006-10#1)(2007-2#1)(2008-12#1)(2008-3#1)(2009-5#1)
respondents answered##2##2##(1992-5#1)(2008-12#1)
respondents are##4##2##(1991-6#1)(2009-12#1)(2011-1#1)(2012-2#1)
respondents attributed##2##2##(1996-9#1)(2008-2#1)
respondents believed that the##2##4##(2008-4#1)(2012-12#1)
respondents believed that##4##3##(2007-7#1)(2008-4#1)(2012-12#2)
respondents considered##2##2##(2006-8#1)(2011-1#1)
respondents did not##2##3##(1991-6#1)(2007-12#1)
respondents expressed##3##2##(1993-12#1)(1996-1#1)(2007-7#1)
respondents felt that##3##3##(1996-1#1)(1997-3#1)(2011-2#1)
respondents felt##6##2##(1995-12#1)(1996-1#1)(1997-3#1)(2007-12#1)(2011-2#1)(2013-1#1)
respondents for##2##2##(2008-1#1)(2012-2#1)
respondents found the##2##3##(2010-5#1)(2012-12#1)
respondents from the##2##3##(2008-4#1)(2009-4#1)
respondents from##8##2##(1991-2#1)(1993-1#1)(1995-3#1)(1995-6#1)(2008-4#1)(2009-4#1)(2010-4#1)(2012-1#1)
respondents had##16##2##(1990-12#1)(1993-1#1)(1996-9#1)(2004-10#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-9#1)(2008-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
respondents have##2##2##(1996-1#2)
respondents in the##4##3##(1990-6#1)(1991-12#1)(2008-4#1)(2010-8#1)
respondents in##12##2##(1990-6#1)(1991-12#1)(1997-2#1)(1997-3#1)(2008-4#1)(2010-8#1)(2011-1#2)(2012-3#3)(2013-8#1)
respondents indicating##2##2##(2007-7#1)(2008-12#1)
respondents knew that##2##3##(2008-2#1)(2009-10#1)
respondents of the##3##3##(2007-12#1)(2009-7#1)(2013-1#1)
respondents of##4##2##(2007-12#1)(2008-9#1)(2009-7#1)(2013-1#1)
respondents on##2##2##(2010-8#1)(2011-1#1)
respondents report that they perceive managed care organizations as certifying them##2##11##(2005-7#2)
respondents report##3##2##(2005-7#3)
respondents reported being very satisfied with push HIE more often than pull HIE (p &lt##2##15##(2013-1#2)
respondents reported that they##2##4##(2010-8#1)(2012-1#1)
respondents reported that##3##3##(2008-12#1)(2010-8#1)(2012-1#1)
respondents reported to##2##3##(1990-6#1)(2008-2#1)
respondents reported##15##2##(1990-6#1)(2006-2#1)(2008-1#1)(2008-12#1)(2008-2#3)(2009-4#1)(2009-7#1)(2010-8#2)(2011-1#1)(2012-1#1)(2013-1#2)
respondents reporting##3##2##(1993-9#1)(1996-3#1)(2007-10#1)
respondents showed##4##2##(1996-2#1)(2008-11#1)(2011-2#2)
respondents stated that##2##3##(1996-1#1)(2008-11#1)
respondents to the##2##3##(2008-11#1)(2010-4#1)
respondents to##4##2##(1992-9#1)(2008-11#1)(2010-4#1)(2010-8#1)
respondents used##4##2##(1991-6#1)(1993-2#1)(2012-2#1)(2012-3#1)
respondents was##3##2##(2007-10#1)(2007-12#1)(2007-3#1)
respondents were asked to##3##4##(1995-11#1)(2010-8#1)(2011-2#1)
respondents were asked##4##3##(1995-11#1)(2010-8#1)(2011-2#1)(2013-8#1)
respondents were aware of##3##4##(1996-1#1)(2009-10#1)(2010-8#1)
respondents were aware##5##3##(1996-1#1)(2004-10#2)(2009-10#1)(2010-8#1)
respondents were divided into##2##4##(2008-8#1)(2012-12#1)
respondents were in##2##3##(1996-1#1)(2007-6#1)
respondents were more likely to be##2##6##(2013-1#2)
respondents were most##2##3##(1993-3#1)(1995-3#1)
respondents were recruited##2##3##(2011-1#1)(2011-2#1)
respondents were##43##2##(1993-1#1)(1993-3#2)(1995-11#1)(1995-3#1)(1996-1#2)(1996-2#1)(1997-2#1)(1997-3#1)(2004-10#2)(2006-12#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-6#1)(2008-2#1)(2008-8#1)(2008-9#3)(2009-10#1)(2010-2#2)(2010-8#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#4)(2013-1#5)(2013-8#1)
respondents when##3##2##(1993-12#1)(1995-3#1)(2011-2#1)
respondents who would##2##3##(2008-1#2)
respondents who##9##2##(1993-6#1)(1995-1#1)(1997-3#1)(2005-10#1)(2008-1#2)(2009-5#1)(2011-1#1)(2012-3#1)
respondents with##3##2##(2011-2#1)(2012-12#1)(2013-1#1)
respondents working##2##2##(2012-12#1)(2012-3#1)
respondents would##4##2##(1993-1#1)(2007-7#2)(2011-1#1)
respondents##344##1##(1990-12#1)(1990-6#2)(1990-9#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-6#3)(1992-1#1)(1992-12#1)(1992-5#6)(1992-6#1)(1992-9#1)(1993-1#5)(1993-12#2)(1993-2#1)(1993-3#4)(1993-6#1)(1993-9#1)(1994-1#1)(1995-1#4)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-6#1)(1996-1#8)(1996-2#4)(1996-3#4)(1996-9#3)(1997-2#3)(1997-3#4)(1997-5#1)(1997-8#1)(2004-10#4)(2005-10#2)(2005-7#4)(2006-10#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#10)(2007-10#7)(2007-12#12)(2007-2#7)(2007-3#4)(2007-6#1)(2007-7#12)(2007-9#1)(2008-1#7)(2008-10#1)(2008-11#6)(2008-12#8)(2008-2#13)(2008-3#1)(2008-4#5)(2008-8#4)(2008-9#6)(2009-10#6)(2009-11#2)(2009-12#2)(2009-4#3)(2009-5#2)(2009-7#5)(2009-9#1)(2010-1#1)(2010-10#1)(2010-2#2)(2010-4#2)(2010-5#5)(2010-8#9)(2010-9#1)(2011-1#19)(2011-12#1)(2011-2#14)(2012-1#7)(2012-12#17)(2012-2#8)(2012-3#11)(2013-1#20)(2013-8#6)
respondents' knowledge##2##2##(2009-10#1)(2013-1#1)
respondents' perceptions##2##2##(2007-12#1)(2013-1#1)
respondents'##16##1##(1991-2#1)(1997-1#1)(2007-12#1)(2007-6#2)(2007-9#1)(2009-10#1)(2009-4#2)(2009-7#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
respondents)##3##1##(2007-2#1)(2009-7#1)(2012-2#1)
responder analysis of##2##3##(2011-2#2)
responder cells##2##2##(2008-4#1)(2008-9#1)
responder group##3##2##(1992-5#2)(2010-4#1)
responder rates##2##2##(2006-6#1)(2008-9#1)
responder strains##3##2##(1995-2#2)(1997-4#1)
responder##27##1##(1990-2#1)(1992-5#3)(1994-3#1)(1995-2#3)(1997-4#1)(2006-6#1)(2007-8#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-4#1)(2011-2#4)(2012-2#2)(2013-1#1)
responders and non-responders##8##3##(1995-10#1)(2006-8#1)(2007-10#1)(2010-12#1)(2012-12#4)
responders and##13##2##(1994-2#1)(1994-8#1)(1995-10#1)(2006-8#1)(2007-10#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#5)
responders as##2##2##(2004-12#1)(2013-1#1)
responders had##2##2##(1997-8#1)(2006-12#1)
responders in the##2##3##(2007-12#1)(2008-3#1)
responders in##5##2##(2006-4#1)(2007-12#1)(2007-7#1)(2008-3#1)(2011-1#1)
responders stated that the##2##4##(1996-9#1)(1997-8#1)
responders to##8##2##(1993-9#1)(2006-10#1)(2007-7#1)(2008-5#1)(2009-3#1)(2009-6#1)(2010-3#1)(2012-2#1)
responders undergoing##2##2##(2011-1#1)(2012-3#1)
responders was##2##2##(1990-2#2)
responders were##2##2##(1991-2#1)(2008-12#1)
responders##89##1##(1990-10#1)(1990-12#1)(1990-2#2)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-10#1)(1992-4#1)(1992-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-10#1)(1995-12#1)(1996-12#1)(1996-9#1)(1997-8#2)(2004-1#2)(2004-12#1)(2004-3#1)(2006-10#3)(2006-12#3)(2006-2#1)(2006-4#1)(2006-7#2)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#2)(2008-7#2)(2009-10#1)(2009-3#1)(2009-6#1)(2010-12#2)(2010-3#3)(2011-1#2)(2011-2#2)(2012-12#6)(2012-2#1)(2012-3#2)(2013-1#5)
responders&quot##3##1##(2006-12#1)(2010-3#2)
responders)##4##1##(1990-6#1)(1991-8#2)(1993-7#1)
responding and##8##2##(1992-11#1)(1992-12#1)(1992-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2012-2#1)
responding by##2##2##(2007-11#1)(2008-5#1)
responding cells was##2##3##(1992-12#1)(1994-9#1)
responding cells##7##2##(1992-12#1)(1994-9#1)(1997-8#1)(2006-10#1)(2008-2#3)
responding for food##2##3##(1992-9#1)(2009-8#1)
responding for##6##2##(1992-9#1)(1993-10#1)(1993-6#2)(2009-8#2)
responding in##5##2##(1991-11#1)(1992-10#1)(2007-1#1)(2008-4#1)(2011-1#1)
responding on##3##2##(1993-6#2)(2006-6#1)
responding that##2##2##(1993-12#1)(1997-2#1)
responding to a target##2##4##(2008-2#1)(2012-1#1)
responding to a##5##3##(1996-3#1)(2008-10#1)(2008-2#1)(2009-8#1)(2012-1#1)
responding to an##2##3##(1994-2#1)(2006-10#1)
responding to chemotherapy##2##3##(2012-3#1)(2013-7#1)
responding to public##2##3##(2008-8#1)(2010-12#1)
responding to questions##2##3##(2005-7#1)(2008-1#1)
responding to several##2##3##(2011-2#1)(2012-2#1)
responding to the survey##2##4##(1991-2#1)(2012-12#1)
responding to the##23##3##(1990-11#1)(1991-2#1)(1994-2#1)(1995-10#1)(1997-5#1)(2005-7#1)(2006-9#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-9#1)(2012-12#1)(2012-2#1)
responding to this##3##3##(2006-10#1)(2007-3#1)(2009-4#1)
responding to##97##2##(1990-11#2)(1991-1#1)(1991-2#1)(1991-8#1)(1992-3#1)(1992-6#2)(1993-1#2)(1993-2#1)(1994-2#3)(1994-3#2)(1994-9#3)(1995-10#1)(1995-12#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-5#1)(1997-8#1)(2004-11#1)(2005-10#3)(2005-7#2)(2006-10#4)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-4#2)(2009-6#1)(2009-8#3)(2009-9#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-7#2)(2013-8#1)
responding was##2##2##(1993-2#1)(1993-6#1)
responding with##6##2##(1991-1#1)(1991-7#1)(1993-6#2)(2012-2#2)
responding##213##1##(1990-11#5)(1991-1#6)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#13)(1993-7#4)(1993-8#1)(1994-2#3)(1994-3#3)(1994-9#4)(1995-10#1)(1995-12#1)(1995-3#2)(1995-4#1)(1996-10#1)(1996-2#1)(1996-3#2)(1996-8#1)(1996-9#2)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#3)(2004-11#1)(2005-10#3)(2005-7#3)(2006-10#6)(2006-4#1)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#2)(2007-3#2)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#7)(2008-10#4)(2008-11#4)(2008-2#4)(2008-3#1)(2008-4#4)(2008-5#9)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#2)(2009-12#1)(2009-4#2)(2009-6#1)(2009-8#7)(2009-9#3)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#4)(2012-12#2)(2012-2#9)(2012-3#4)(2013-7#2)(2013-8#1)
responding)##2##1##(1996-9#2)
responds linearly to##2##3##(1991-1#1)(2008-10#1)
responds linearly##4##2##(1991-1#1)(2008-10#3)
responds only to##2##3##(2007-12#1)(2008-2#1)
responds preferentially to##2##3##(1990-12#1)(2009-8#1)
responds rapidly##2##2##(2006-8#1)(2008-10#1)
responds sensitively to##2##3##(2006-12#1)(2007-8#1)
responds to Ca2+##2##3##(1990-9#1)(1994-8#1)
responds to a##3##3##(1995-11#1)(1995-2#1)(2010-10#1)
responds to environmental##2##3##(1994-3#1)(2010-8#1)
responds to the##13##3##(1993-6#1)(1994-9#1)(1995-12#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-9#1)(2009-12#1)(2009-5#1)(2011-2#1)
responds to##75##2##(1990-5#1)(1990-8#1)(1990-9#1)(1993-2#2)(1993-6#1)(1994-11#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#3)(1996-12#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-5#1)(2005-10#1)(2005-11#2)(2006-10#2)(2006-6#1)(2007-10#1)(2007-12#1)(2007-5#2)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#2)(2009-5#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#3)
responds well to##4##3##(2006-10#1)(2007-7#1)(2008-4#1)(2010-12#1)
responds##113##1##(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1992-10#1)(1992-5#1)(1992-6#1)(1993-2#2)(1993-6#1)(1994-11#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#3)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-5#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#4)(2006-12#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#4)(2007-3#1)(2007-4#1)(2007-5#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#20)(2008-11#3)(2008-12#2)(2008-2#3)(2008-4#4)(2008-8#5)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-5#1)(2009-6#2)(2009-8#4)(2010-10#1)(2010-12#2)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#3)
response (&lt##3##2##(2008-10#2)(2010-3#1)
response (3##2##2##(1992-8#1)(2007-1#1)
response (30##2##2##(2008-10#2)
response (CAR)##4##2##(2008-6#2)(2013-1#2)
response (CR##2##2##(1992-10#1)(1992-2#1)
response (CR)##10##2##(1990-10#1)(1991-4#1)(1997-7#1)(2006-6#2)(2007-10#1)(2007-6#1)(2008-10#1)(2008-5#1)(2012-12#1)
response (Hb increase &gt##3##4##(2008-7#3)
response (P =##2##3##(2011-2#1)(2012-3#1)
response (SVR) was achieved in##2##5##(2012-12#1)(2013-1#1)
response (SVR)##4##2##(2012-1#1)(2012-12#1)(2013-1#2)
response (TDAR)##6##2##(2008-10#6)
response (complete##2##2##(1997-3#1)(2006-6#1)
response (i##3##2##(2008-10#3)
response (p##2##2##(1992-2#1)(2007-10#1)
response 1##2##2##(1991-2#1)(2009-8#1)
response a##2##2##(1994-9#1)(1997-2#1)
response above basal##2##3##(1994-3#2)
response above##4##2##(1994-3#2)(2008-10#1)(2008-8#1)
response accuracy and##2##3##(2008-4#1)(2009-2#1)
response accuracy##4##2##(1993-9#1)(2008-4#1)(2008-8#1)(2009-2#1)
response after the first##2##4##(1993-2#1)(1994-10#1)
response after##19##2##(1990-10#1)(1991-11#1)(1991-2#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-10#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-12#3)(2012-2#2)(2013-1#1)
response against an##2##3##(1995-12#1)(1995-2#1)
response against the##5##3##(1994-3#1)(2006-10#1)(2006-7#1)(2008-11#1)(2012-2#1)
response against##25##2##(1991-12#1)(1991-7#1)(1992-7#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#1)(1997-4#1)(2006-10#2)(2006-7#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#3)(2010-4#1)(2010-9#1)(2012-2#2)(2013-1#2)
response alternatives##3##2##(2007-4#1)(2009-10#1)(2011-2#1)
response among##8##2##(1994-9#1)(1997-6#1)(2007-10#2)(2008-2#1)(2009-10#1)(2010-12#1)(2012-2#1)
response amplitudes##2##2##(1991-3#1)(2010-9#1)
response analysis##2##2##(1991-1#1)(2008-5#1)
response and a##8##3##(1992-9#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-3#1)(2012-2#1)(2013-1#2)
response and abolished the##2##4##(1990-5#1)(1992-7#1)
response and also##3##3##(1992-12#1)(2011-1#1)(2013-1#1)
response and an##3##3##(1996-7#1)(2008-10#1)(2010-4#1)
response and disease##3##3##(1992-9#1)(2011-2#1)(2012-2#1)
response and exhibit##2##3##(1995-8#1)(2009-11#1)
response and good##2##3##(2008-10#1)(2011-2#1)
response and improved##2##3##(1996-5#1)(2013-1#1)
response and in the##2##4##(2007-11#1)(2012-12#1)
response and in##3##3##(2007-11#1)(2008-6#1)(2012-12#1)
response and injury tolerance of the##2##6##(2007-1#1)(2007-4#1)
response and injury##5##3##(2006-11#1)(2007-1#3)(2007-4#1)
response and is##2##3##(1990-11#1)(1992-10#1)
response and its##2##3##(2007-10#1)(2008-4#1)
response and on##2##3##(2008-1#1)(2008-3#1)
response and pathogenicity##2##3##(2006-10#1)(2008-10#1)
response and presence of##2##4##(1995-2#1)(2008-8#1)
response and recovery times##3##4##(2007-8#1)(2008-10#2)
response and recovery##6##3##(2007-8#1)(2008-10#4)(2013-1#1)
response and selectivity of the##2##5##(2007-8#1)(2008-10#1)
response and side effects##2##4##(2007-7#1)(2012-1#1)
response and survival##2##3##(2006-10#1)(2007-6#1)
response and that##2##3##(2008-10#1)(2009-8#1)
response and the##24##3##(1992-6#1)(1997-2#1)(1997-7#1)(2004-2#1)(2006-10#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#1)(2009-11#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-3#1)(2012-4#1)(2013-7#1)
response and tolerance to##2##4##(2006-11#1)(2009-6#1)
response and tolerance##3##3##(2006-11#1)(2007-4#1)(2009-6#1)
response and toxicity##4##3##(2008-6#2)(2008-7#1)(2010-8#1)
response and was##3##3##(2010-3#1)(2010-8#1)(2013-8#1)
response and were##3##3##(1993-9#1)(1997-4#1)(2009-10#1)
response and##242##2##(1990-10#1)(1990-11#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-12#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-5#1)(1993-6#1)(1993-9#4)(1994-11#1)(1994-3#1)(1994-6#1)(1995-12#2)(1995-2#2)(1995-8#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#2)(1996-7#1)(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#1)(2004-12#2)(2004-2#2)(2005-11#1)(2005-8#1)(2006-10#9)(2006-11#4)(2006-12#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-9#1)(2007-1#4)(2007-10#2)(2007-11#3)(2007-12#3)(2007-4#3)(2007-6#1)(2007-7#2)(2007-8#6)(2008-1#2)(2008-10#27)(2008-11#3)(2008-12#2)(2008-2#6)(2008-3#4)(2008-4#6)(2008-5#4)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#6)(2009-12#1)(2009-6#1)(2009-8#3)(2010-10#1)(2010-12#5)(2010-2#4)(2010-3#1)(2010-4#4)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#8)(2012-1#2)(2012-12#8)(2012-2#3)(2012-3#7)(2012-4#1)(2013-1#13)(2013-7#2)(2013-8#1)
response appears to be##4##4##(1992-1#1)(1992-2#1)(1995-5#1)(2008-5#1)
response appears to require##2##4##(1993-4#1)(2008-7#1)
response appears to##6##3##(1992-1#1)(1992-2#1)(1993-4#1)(1995-5#1)(2008-5#1)(2008-7#1)
response are considered##2##3##(2007-1#1)(2008-10#1)
response are discussed##3##3##(1997-7#1)(2008-10#1)(2010-12#1)
response are generally##2##3##(1996-12#1)(2007-11#1)
response are not##2##3##(2006-2#1)(2012-3#1)
response are##26##2##(1991-2#1)(1992-2#1)(1996-12#1)(1997-4#1)(1997-7#1)(2005-10#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-9#1)(2008-10#4)(2008-2#2)(2008-4#1)(2010-12#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-3#1)
response as a function of##3##5##(2008-10#1)(2008-2#1)(2010-3#1)
response as a##6##3##(1991-12#1)(1996-12#1)(2008-10#1)(2008-2#1)(2009-8#1)(2010-3#1)
response as compared to##2##4##(2008-10#1)(2009-10#1)
response as well as the##2##5##(2007-8#1)(2008-10#1)
response as well as##4##4##(1993-7#1)(1996-10#1)(2007-8#1)(2008-10#1)
response as##19##2##(1991-12#1)(1993-7#1)(1994-8#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-9#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-2#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-3#1)(2011-1#1)(2012-2#1)
response assessed##2##2##(2007-8#1)(2011-2#1)
response assessment##3##2##(2008-1#1)(2011-2#1)(2012-2#1)
response associated with the##3##4##(1991-2#1)(2008-11#1)(2011-2#1)
response associated with##7##3##(1991-2#1)(1997-5#1)(2006-10#1)(2008-11#1)(2008-4#1)(2010-12#1)(2011-2#1)
response at different##2##3##(1992-12#1)(1992-3#1)
response at pH 5##3##4##(2008-10#2)(2009-10#1)
response at pH##4##3##(2008-10#3)(2009-10#1)
response at the end of the##2##6##(1991-8#1)(2008-7#1)
response at the end of##3##5##(1991-8#1)(2008-7#1)(2013-1#1)
response at the##9##3##(1991-8#1)(1992-12#1)(1994-12#1)(2007-12#1)(2008-10#3)(2008-7#1)(2013-1#1)
response at various##2##3##(2007-12#1)(2008-10#1)
response at##35##2##(1991-8#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-6#1)(1994-1#1)(1994-12#1)(1994-9#1)(1995-11#1)(1996-1#1)(1996-12#1)(1997-7#1)(2004-11#1)(2006-10#1)(2006-4#1)(2007-12#2)(2008-10#12)(2008-2#1)(2008-7#1)(2009-10#1)(2013-1#2)
response based on the##2##4##(2008-10#2)
response based on##5##3##(2007-12#1)(2008-10#2)(2008-2#1)(2011-2#1)
response based##6##2##(1996-10#1)(2007-12#1)(2008-10#2)(2008-2#1)(2011-2#1)
response became##2##2##(1991-9#1)(1996-12#1)
response because of##2##3##(1991-11#1)(2008-10#1)
response because##4##2##(1991-11#1)(2008-10#2)(2009-6#1)
response behavior is##2##3##(2006-10#2)
response behavior of the##2##4##(2008-10#2)
response behavior of##3##3##(2008-10#3)
response behavior##7##2##(2006-10#2)(2007-11#1)(2007-8#1)(2008-10#3)
response being##5##2##(1992-9#1)(2008-10#2)(2008-2#1)(2008-4#1)
response between the##5##3##(1990-6#1)(2006-5#1)(2007-4#1)(2008-5#1)(2009-10#1)
response between##10##2##(1990-6#1)(1992-2#1)(1994-6#1)(2006-5#1)(2007-4#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-4#1)(2010-10#1)
response bias in##2##3##(1996-1#1)(2007-9#1)
response bias##14##2##(1994-6#1)(1996-1#2)(2006-1#1)(2007-9#1)(2008-11#2)(2011-2#4)(2012-2#3)
response both##2##2##(1990-8#1)(2008-10#1)
response but did##2##3##(1990-2#1)(1990-4#1)
response but not##4##3##(1996-11#1)(1996-9#1)(1997-4#1)(2004-12#1)
response but##11##2##(1990-2#1)(1990-4#1)(1995-6#1)(1996-11#1)(1996-9#1)(1997-4#2)(2004-12#1)(2008-12#1)(2008-6#1)(2009-6#1)
response by a##2##3##(2006-6#1)(2008-4#1)
response by changing the##2##4##(2008-3#1)(2010-4#1)
response by the##4##3##(2006-12#1)(2007-10#1)(2008-7#1)(2010-4#1)
response by##60##2##(1991-3#1)(1991-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-9#1)(1995-12#1)(1996-5#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-8#3)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#2)(2007-10#1)(2007-11#4)(2007-12#2)(2007-9#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-6#1)(2010-12#1)(2010-4#3)(2012-1#1)(2012-12#1)(2013-1#2)
response can also##2##3##(2006-8#1)(2011-2#1)
response can be obtained by##3##5##(1995-7#1)(2007-7#1)(2007-8#1)
response can be##15##3##(1994-5#1)(1995-7#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
response can cause##2##3##(2009-5#1)(2012-1#1)
response can##27##2##(1994-5#1)(1994-8#1)(1995-7#1)(1997-7#1)(2004-7#1)(2005-8#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#1)
response capability##2##2##(2007-12#1)(2011-1#1)
response categories##6##2##(2008-5#1)(2010-1#2)(2012-2#3)
response caused by##5##3##(1990-5#1)(1991-5#1)(1996-2#1)(1997-3#1)(2006-5#1)
response changes##4##2##(1992-3#1)(1994-10#1)(1995-1#1)(1997-5#1)
response characteristics and injury##2##4##(2007-4#2)
response characteristics and##4##3##(2007-4#2)(2008-10#2)
response characteristics of the electrode##2##5##(2008-10#2)
response characteristics of the##5##4##(2008-10#4)(2008-3#1)
response characteristics of##14##3##(2008-10#12)(2008-3#2)
response characteristics##33##2##(1994-11#1)(2006-3#1)(2007-4#2)(2007-8#1)(2008-10#23)(2008-3#4)(2010-4#1)
response characterized by##3##3##(1991-8#1)(1994-5#1)(2006-2#1)
response choice##2##2##(1997-1#1)(2008-4#1)
response compared to the##4##4##(1996-6#1)(2008-10#2)(2011-1#1)
response compared to##7##3##(1996-6#1)(2007-5#1)(2008-10#3)(2008-7#1)(2011-1#1)
response compared with##2##3##(1992-6#1)(2011-12#1)
response compared##9##2##(1992-6#1)(1996-6#1)(2007-5#1)(2008-10#3)(2008-7#1)(2011-1#1)(2011-12#1)
response completely##2##2##(1996-10#2)
response components##2##2##(2008-11#1)(2009-5#1)
response correctness##5##2##(2008-11#5)
response correlated with the##2##4##(2008-10#1)(2008-5#1)
response correlated with##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
response correlated##5##2##(2007-1#1)(2008-10#2)(2008-5#1)(2008-9#1)
response correlates with##2##3##(2008-10#1)(2012-3#1)
response corridors for##2##3##(2006-11#1)(2007-1#1)
response corridors##7##2##(2006-11#1)(2007-1#2)(2007-4#4)
response could be evoked##2##4##(1990-7#2)
response could be##8##3##(1990-7#2)(1991-11#1)(1991-12#1)(1994-12#1)(2007-11#1)(2008-10#2)
response could##10##2##(1990-7#2)(1991-11#1)(1991-12#1)(1994-12#1)(1994-3#1)(2007-11#1)(2008-10#2)(2008-9#1)
response criteria##5##2##(2006-12#1)(2006-9#1)(2007-11#2)(2012-3#1)
response criterion##3##2##(1997-5#1)(2012-3#2)
response current##3##2##(2008-10#3)
response curve for##2##3##(1996-10#1)(2004-12#1)
response curve is##3##3##(1995-9#1)(2008-10#1)(2012-12#1)
response curve of the##2##4##(2007-12#1)(2010-2#1)
response curve of##5##3##(1994-11#1)(1995-7#1)(2007-12#1)(2010-2#1)(2012-1#1)
response curve to##3##3##(1990-12#1)(1996-10#1)(1997-2#1)
response curve##26##2##(1990-12#1)(1994-11#2)(1995-7#1)(1995-9#2)(1996-10#2)(1996-11#1)(1997-2#1)(2004-12#1)(2004-2#1)(2007-12#1)(2008-10#5)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2012-1#1)(2012-12#1)(2013-8#1)
response curves for##2##3##(2008-7#1)(2012-2#1)
response curves were##2##3##(2008-11#1)(2013-1#1)
response curves##13##2##(1994-2#1)(1995-2#1)(1997-7#1)(2006-7#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#2)(2012-2#1)(2013-1#1)
response data from##3##3##(1995-4#1)(2006-11#1)(2007-4#1)
response data was##2##3##(1993-2#1)(2008-10#1)
response data were obtained##3##4##(1990-8#1)(1997-2#1)(2006-11#1)
response data##18##2##(1990-8#1)(1993-2#1)(1995-4#2)(1997-2#1)(2006-11#2)(2007-4#1)(2008-10#4)(2008-5#1)(2008-6#1)(2009-5#1)(2010-1#2)(2010-2#1)
response depended on##3##3##(1995-12#1)(2008-7#2)
response depends linearly on##5##4##(2008-10#5)
response depends on##2##3##(1997-2#1)(2006-10#1)
response depends##9##2##(1997-2#1)(2006-10#1)(2007-9#1)(2008-10#6)
response despite##2##2##(1994-3#1)(2008-7#1)
response detected##2##2##(2008-5#1)(2013-1#1)
response determines the##2##3##(1996-8#1)(2008-10#1)
response differed##3##2##(1990-12#1)(1992-12#1)(2008-8#1)
response due to##2##3##(2006-11#1)(2010-9#1)
response duration##5##2##(1994-8#1)(2005-7#1)(2009-8#1)(2010-9#1)(2012-2#1)
response during the##9##3##(1990-7#1)(1993-2#1)(1997-2#2)(2006-11#1)(2006-12#1)(2008-12#1)(2012-2#1)(2012-3#1)
response during##32##2##(1990-5#4)(1990-7#1)(1991-1#1)(1991-12#1)(1993-2#1)(1994-3#1)(1994-9#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-2#2)(2006-11#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
response dynamics##3##2##(1993-2#1)(2008-11#1)(2013-7#1)
response efficacy##2##2##(2008-7#1)(2010-3#1)
response element (PPRE)##2##3##(1995-2#1)(2011-3#1)
response element (RARE)##2##3##(1992-9#1)(1995-3#1)
response element (TRE)##4##3##(1993-12#1)(1993-8#1)(1994-3#1)(1996-8#1)
response element binding##6##3##(1991-2#1)(1995-3#2)(1996-10#1)(1997-4#2)
response element consensus##2##3##(1990-5#1)(1997-6#1)
response element in the##3##4##(1993-6#1)(1995-1#1)(1995-3#1)
response element in##8##3##(1990-8#1)(1993-6#1)(1995-1#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-8#1)(2012-3#1)
response element was##3##3##(1991-7#3)
response element##77##2##(1990-5#1)(1990-8#1)(1991-2#4)(1991-5#1)(1991-7#7)(1991-9#1)(1992-12#1)(1992-6#3)(1992-8#1)(1992-9#4)(1993-12#2)(1993-3#1)(1993-6#4)(1993-8#1)(1994-11#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#5)(1995-6#2)(1995-8#2)(1996-10#1)(1996-5#1)(1996-8#9)(1997-1#2)(1997-2#3)(1997-4#3)(1997-6#1)(1997-7#1)(2008-7#2)(2008-9#1)(2009-8#1)(2011-3#1)(2012-12#2)(2012-3#1)
response element-binding protein (CREB)##2##4##(2008-7#1)(2009-3#1)
response element-binding protein##6##3##(1994-9#2)(2008-7#1)(2009-3#1)(2013-1#2)
response element-binding##7##2##(1994-9#2)(2008-7#1)(2009-3#1)(2012-3#1)(2013-1#2)
response elements in the##4##4##(1992-6#1)(1995-10#1)(1995-3#1)(2008-1#1)
response elements in##7##3##(1992-6#1)(1994-11#1)(1994-8#1)(1995-10#1)(1995-3#1)(2005-11#1)(2008-1#1)
response elements of##2##3##(1991-2#1)(1995-12#1)
response elements##38##2##(1990-11#1)(1991-11#1)(1991-2#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#4)(1994-11#1)(1994-12#3)(1994-8#3)(1995-10#1)(1995-12#1)(1995-3#1)(1995-8#3)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-8#2)(2005-11#1)(2008-1#1)(2008-9#1)(2009-4#1)(2010-2#1)(2012-3#1)
response elements)##2##2##(1995-6#1)(2006-11#1)
response elicited by##6##3##(1994-10#1)(1995-12#1)(1997-1#1)(2009-2#1)(2009-8#1)(2012-2#1)
response errors##3##2##(2008-1#1)(2008-2#1)(2012-3#1)
response evaluation and prediction in##2##5##(2010-12#2)
response evaluation and##3##3##(2010-12#3)
response evaluation##4##2##(2010-12#4)
response evoked by##5##3##(1992-3#2)(1996-7#1)(2008-4#2)
response exhibited##2##2##(1993-2#2)
response extends##2##2##(2008-10#1)(2008-2#1)
response factor##5##2##(1993-6#1)(1994-6#1)(1996-5#2)(2008-10#1)
response factors##2##2##(2008-6#1)(2010-12#1)
response failure##2##2##(2008-7#1)(2011-2#1)
response following X-ray-induced apoptosis in the neonatal rat brain##2##9##(1995-6#2)
response following##13##2##(1993-11#1)(1995-6#2)(2004-2#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-7#1)(2009-11#1)(2010-6#1)(2012-2#1)
response for Cu(2+)##2##3##(2008-10#2)
response for H(2)O(2) in the##2##5##(2008-10#2)
response for Pb(2+) over a wide##2##6##(2008-10#2)
response for UO(2)(2+)##2##3##(2008-10#2)
response for a##3##3##(1996-3#1)(2008-2#1)(2009-5#1)
response for both##4##3##(2008-10#4)
response for each##3##3##(2008-10#3)
response for the clinical##2##4##(1990-2#1)(2009-5#1)
response for the##8##3##(1990-2#1)(1990-8#1)(1992-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-5#1)
response for##75##2##(1990-2#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-2#1)(1996-3#2)(1996-5#1)(2008-10#53)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-9#1)(2009-5#2)(2011-2#1)(2012-2#1)(2013-8#2)
response format##2##2##(2005-4#1)(2012-2#1)
response found##2##2##(2006-5#1)(2008-10#1)
response from the##10##3##(1996-2#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#2)(2011-1#1)(2012-12#1)(2012-3#1)
response from##25##2##(1991-1#1)(1992-9#1)(1996-2#2)(1997-5#1)(2007-1#1)(2007-12#1)(2007-9#2)(2008-10#5)(2008-11#1)(2008-3#4)(2010-5#2)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
response function##16##2##(2007-1#1)(2007-12#3)(2008-10#8)(2008-2#2)(2008-3#2)
response functions of the##2##4##(2008-3#2)
response functions of##4##3##(2008-2#2)(2008-3#2)
response functions##6##2##(2007-12#2)(2008-2#2)(2008-3#2)
response gain##4##2##(1992-10#2)(1997-2#1)(2009-9#1)
response gene##7##2##(1992-12#1)(1992-7#1)(1994-8#1)(1994-9#1)(1995-2#1)(1997-7#1)(2006-10#1)
response generally##2##2##(1994-10#1)(2007-11#1)
response genes##18##2##(1992-12#1)(1992-7#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(2006-10#1)(2008-10#2)(2008-11#1)(2010-12#1)(2010-5#1)(2012-2#1)(2013-1#2)(2013-8#2)
response group##2##2##(2013-1#2)
response guidelines##2##2##(2006-11#1)(2007-4#1)
response had##3##2##(1995-12#1)(2004-12#1)(2008-12#1)
response has been demonstrated to##2##5##(2007-11#1)(2013-1#1)
response has been##12##3##(1994-5#1)(1995-12#1)(1996-12#1)(1997-3#1)(2005-8#1)(2006-10#1)(2007-11#2)(2008-1#1)(2008-2#1)(2012-2#1)(2013-1#1)
response has##16##2##(1990-4#1)(1994-5#1)(1995-12#1)(1996-12#1)(1997-3#1)(2005-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
response have been##4##3##(1994-12#1)(2008-10#2)(2010-4#1)
response have##6##2##(1994-12#1)(1995-1#1)(2006-10#1)(2008-10#2)(2010-4#1)
response if##2##2##(1997-1#1)(2009-4#1)
response in 100% of##2##4##(2005-7#1)(2008-4#1)
response in Escherichia coli##2##4##(1994-8#1)(2007-12#1)
response in WKY##2##3##(1994-2#1)(2008-2#1)
response in a##15##3##(1992-11#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-4#1)(1995-6#1)(1996-1#1)(1997-7#1)(2004-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2013-7#1)
response in an##5##3##(1996-12#1)(2006-11#1)(2007-11#1)(2008-11#1)(2008-8#1)
response in animals##2##3##(1993-6#1)(2005-7#1)
response in both##4##3##(1991-10#1)(1993-2#1)(2008-2#1)(2013-1#1)
response in cellular##2##3##(2008-7#1)(2011-2#1)
response in chronic##3##3##(1996-8#1)(2010-5#1)(2012-1#1)
response in cultured##2##3##(1991-9#1)(1997-4#1)
response in human##2##3##(1997-5#1)(2007-7#1)
response in humans##3##3##(1992-4#1)(2006-3#1)(2007-11#1)
response in mammalian cells##3##4##(2007-1#1)(2008-11#2)
response in mammalian##5##3##(1991-8#1)(2007-1#1)(2008-11#3)
response in mice##4##3##(1990-12#1)(2008-4#1)(2008-5#1)(2010-12#1)
response in old rats##2##4##(2008-7#2)
response in one##2##3##(2008-10#1)(2008-9#1)
response in pancreatic cancer##3##4##(2008-9#1)(2012-12#2)
response in patients after cardiac##2##5##(2006-4#1)(2012-2#1)
response in patients with##5##4##(2006-2#1)(2008-10#1)(2010-1#1)(2010-6#1)(2013-7#1)
response in patients##10##3##(2006-2#1)(2006-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-1#1)(2010-3#1)(2010-6#1)(2012-2#1)(2013-7#1)
response in primary##2##3##(1997-7#1)(2008-10#1)
response in rats##3##3##(1993-12#1)(1993-7#1)(2008-12#1)
response in rheumatoid##2##3##(2007-11#1)(2009-2#1)
response in terms of##5##4##(2008-10#2)(2008-2#2)(2008-7#1)
response in the absence of##3##5##(1993-5#1)(1996-10#1)(1997-5#1)
response in the bovine adrenal gland##2##6##(1993-3#2)
response in the brain##2##4##(1995-11#1)(2011-2#1)
response in the concentration range of##5##6##(2008-10#4)(2010-12#1)
response in the concentration range##7##5##(2008-10#6)(2010-12#1)
response in the form of##2##5##(1992-1#1)(2008-11#1)
response in the range of##2##5##(1996-12#1)(2008-10#1)
response in the range##4##4##(1990-6#1)(1996-12#1)(2008-10#2)
response in the rat##4##4##(1990-2#1)(1993-11#1)(2004-9#1)(2008-7#1)
response in the##93##3##(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-11#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#4)(1993-3#2)(1993-5#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-6#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-5#1)(1997-3#2)(1997-5#1)(1997-7#1)(2004-9#1)(2005-11#1)(2006-11#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#4)(2008-9#2)(2010-12#5)(2010-9#1)(2011-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
response in these##4##3##(2007-10#1)(2008-1#1)(2008-7#1)(2012-1#1)
response in time##2##3##(2008-2#1)(2013-7#1)
response in two##2##3##(2006-12#1)(2008-3#1)
response in vitro##4##3##(1990-5#1)(1991-1#1)(1997-6#1)(2008-11#1)
response in vivo##6##3##(1992-8#1)(1995-2#1)(1996-12#1)(1996-2#1)(2007-11#1)(2010-12#1)
response in which##2##3##(1992-9#1)(2008-10#1)
response in yeast##2##3##(1994-12#1)(2012-2#1)
response in##347##2##(1990-12#2)(1990-2#2)(1990-5#5)(1990-6#1)(1990-7#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-3#2)(1992-4#2)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#5)(1993-2#2)(1993-3#3)(1993-5#1)(1993-6#2)(1993-7#1)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#5)(1994-3#1)(1994-6#3)(1994-8#3)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#1)(1996-1#4)(1996-10#2)(1996-11#1)(1996-12#6)(1996-2#3)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#4)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#5)(2004-11#1)(2004-12#1)(2004-9#1)(2005-11#1)(2005-7#3)(2005-8#1)(2006-10#6)(2006-11#2)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#2)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#12)(2007-12#15)(2007-2#3)(2007-4#1)(2007-5#1)(2007-7#6)(2007-8#1)(2008-1#3)(2008-10#34)(2008-11#10)(2008-12#1)(2008-2#7)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#13)(2008-8#2)(2008-9#8)(2009-10#2)(2009-2#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-12#11)(2010-2#1)(2010-3#1)(2010-5#3)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#10)(2012-1#3)(2012-12#7)(2012-2#8)(2012-3#1)(2013-1#4)(2013-7#5)(2013-8#2)
response includes##2##2##(2006-10#1)(2008-10#1)
response including##3##2##(1995-1#1)(1995-11#1)(2009-8#1)
response increase##2##2##(2008-10#1)(2008-7#1)
response increases##2##2##(2008-3#1)(2012-3#1)
response induced by immunising##2##4##(1995-12#2)
response induced by the##3##4##(1991-5#1)(2004-4#1)(2007-8#1)
response induced by##26##3##(1990-8#1)(1991-5#1)(1992-10#1)(1992-7#1)(1992-8#2)(1993-11#1)(1994-12#1)(1995-12#2)(1996-12#1)(1996-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-4#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-4#1)(2009-8#1)(2012-2#1)
response induced##28##2##(1990-8#1)(1991-5#1)(1992-10#2)(1992-7#1)(1992-8#2)(1993-11#1)(1994-12#1)(1995-12#3)(1996-12#1)(1996-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-4#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-4#1)(2009-8#1)(2012-2#1)
response inhibition##7##2##(1992-12#2)(2008-12#1)(2009-10#2)(2010-12#1)(2013-1#1)
response initiated by##3##3##(2006-10#1)(2008-10#2)
response initiated##4##2##(2006-10#1)(2008-10#2)(2008-8#1)
response involving##4##2##(2006-10#1)(2007-11#1)(2008-7#1)(2012-3#1)
response is a##7##3##(1992-10#1)(1994-11#1)(1996-12#1)(2005-12#1)(2008-3#1)(2008-4#1)(2012-1#1)
response is achieved##3##3##(2007-12#1)(2008-12#1)(2010-2#1)
response is also##2##3##(1993-4#1)(2008-10#1)
response is an##4##3##(2006-4#1)(2008-4#1)(2008-7#1)(2009-12#1)
response is associated with##2##4##(1993-8#1)(1997-6#1)
response is determined##3##3##(1997-2#1)(2007-4#1)(2008-10#1)
response is directly mediated by##2##5##(1997-2#1)(2007-11#1)
response is evaluated##3##3##(1996-9#1)(2008-10#2)
response is explained##2##3##(2008-10#2)
response is independent of pH##2##5##(2008-10#2)
response is independent of##3##4##(2008-10#3)
response is induced##2##3##(1991-5#1)(1994-11#1)
response is linear up to##2##5##(2008-10#2)
response is linear##9##3##(1997-2#1)(2007-12#1)(2008-10#6)(2008-3#1)
response is maintained##2##3##(2010-2#1)(2013-8#1)
response is mediated by##4##4##(1996-10#1)(2007-11#1)(2008-10#1)(2011-2#1)
response is more##2##3##(2007-12#1)(2008-8#1)
response is much##2##3##(2008-2#1)(2008-6#1)
response is not due to a##2##6##(1991-7#1)(2008-10#1)
response is not sensitive to##2##5##(1992-8#1)(2008-10#1)
response is not sensitive##3##4##(1992-8#1)(2008-10#2)
response is not##12##3##(1991-5#1)(1991-7#1)(1992-6#1)(1992-8#1)(1997-1#1)(2008-10#4)(2008-8#1)(2010-11#1)(2010-9#1)
response is observed##4##3##(2007-11#1)(2008-10#3)
response is obtained##4##3##(2008-10#2)(2008-3#1)(2010-4#1)
response is of##2##3##(2008-8#1)(2010-12#1)
response is probably##2##3##(1995-2#1)(1997-1#1)
response is proportional to the##2##5##(2007-12#1)(2008-3#1)
response is proportional to##4##4##(2007-12#1)(2008-3#1)(2008-7#2)
response is stable##2##3##(2008-10#2)
response is the activation of##2##5##(1994-8#1)(2012-12#1)
response is the##10##3##(1994-8#1)(1995-2#1)(1996-9#1)(2006-8#1)(2008-7#2)(2011-1#1)(2012-12#3)
response is very##2##3##(2008-10#1)(2011-1#1)
response is##174##2##(1990-2#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-5#2)(1991-7#1)(1992-1#3)(1992-10#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-11#3)(1994-3#1)(1994-8#2)(1995-2#2)(1995-3#1)(1995-5#1)(1996-10#1)(1996-12#2)(1996-4#1)(1996-9#2)(1997-1#2)(1997-2#4)(1997-3#1)(1997-6#1)(2004-2#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-9#1)(2006-10#3)(2006-4#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#7)(2007-4#1)(2008-1#1)(2008-10#42)(2008-12#1)(2008-2#5)(2008-3#10)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#5)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#3)(2013-8#1)
response it##2##2##(2006-8#1)(2008-5#1)
response known##2##2##(2013-1#2)
response latencies##6##2##(1992-11#1)(1992-7#2)(1993-12#1)(2009-9#1)(2012-3#1)
response latency##5##2##(1990-2#1)(1990-7#1)(1991-1#1)(2008-11#2)
response leading to##4##3##(1996-6#1)(2008-1#1)(2010-4#1)(2012-3#1)
response learning##2##2##(1993-2#1)(1995-12#1)
response limited##2##2##(1995-8#1)(2006-12#1)
response linearity##3##2##(2008-10#3)
response matrix##3##2##(2006-12#1)(2007-12#1)(2012-2#1)
response may be##13##3##(1990-10#1)(1990-12#1)(1993-12#1)(1993-9#1)(1996-6#1)(2006-7#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-4#1)(2012-2#1)(2013-1#1)
response may##20##2##(1990-10#1)(1990-12#1)(1993-12#1)(1993-9#1)(1995-2#1)(1996-6#1)(1997-2#1)(2006-10#2)(2006-7#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-4#1)(2012-2#1)(2013-1#2)
response measured with##2##3##(2007-12#1)(2008-4#1)
response measured##5##2##(1993-7#1)(2007-12#1)(2008-4#1)(2010-12#1)(2013-1#1)
response measures##4##2##(2008-12#1)(2009-10#1)(2009-12#1)(2011-1#1)
response mechanism is##2##3##(2007-8#1)(2008-10#1)
response mechanism of##4##3##(2007-8#2)(2008-10#2)
response mechanism##10##2##(2007-8#3)(2008-10#6)(2010-2#1)
response mechanisms##8##2##(1994-6#1)(2005-8#1)(2008-10#1)(2008-2#1)(2008-7#2)(2011-1#1)(2012-2#1)
response mediated by##4##3##(1990-7#1)(1992-1#1)(1994-2#1)(2012-2#1)
response might##2##2##(2008-7#1)(2008-8#1)
response model for##3##3##(2008-10#3)
response model##11##2##(1997-7#2)(2007-12#1)(2008-10#7)(2008-7#1)
response modelling##2##2##(2008-10#1)(2008-5#1)
response modifier##4##2##(1990-9#1)(1991-12#1)(1997-4#1)(2008-5#1)
response modifiers and##2##3##(2007-11#1)(2010-5#1)
response modifiers##8##2##(2006-10#1)(2007-11#1)(2007-3#1)(2008-5#1)(2009-2#1)(2010-12#1)(2010-5#2)
response modifiers&quot##2##2##(1990-4#1)(2008-1#1)
response modulation##2##2##(1991-11#1)(2008-4#1)
response modulator in##2##3##(1990-2#1)(2010-4#1)
response must be##2##3##(1996-12#1)(2008-1#1)
response must##3##2##(1996-12#1)(2008-1#1)(2008-2#1)
response needs more##2##3##(1997-2#1)(2011-1#1)
response nor##2##2##(2004-12#1)(2008-4#1)
response observed after##2##3##(1994-2#2)
response observed in##2##3##(2004-11#1)(2008-10#1)
response observed was##2##3##(2007-9#1)(2013-8#1)
response observed##7##2##(1994-2#2)(1996-4#1)(2004-11#1)(2007-9#1)(2008-10#1)(2013-8#1)
response obtained##4##2##(1995-12#1)(2008-10#3)
response occurred##3##2##(1991-8#1)(1993-4#1)(2008-10#1)
response occurring##2##2##(1991-4#1)(2010-1#1)
response occurs##2##2##(1990-6#1)(2011-2#1)
response of 1##2##3##(2007-11#1)(2008-10#1)
response of 30##2##3##(2008-10#1)(2008-3#1)
response of A##2##3##(2008-10#1)(2012-12#1)
response of Arabidopsis roots to##2##5##(2009-10#2)
response of Arabidopsis##4##3##(2009-10#3)(2009-8#1)
response of B##3##3##(1995-8#1)(2011-2#2)
response of M##3##3##(2008-10#2)(2008-7#1)
response of ON##2##3##(2007-12#1)(2008-9#1)
response of Th clones induced by##2##6##(1991-12#1)(1992-7#1)
response of VSMC to##2##4##(1994-9#2)
response of Y##2##3##(1997-4#1)(2008-10#1)
response of a##39##3##(1992-3#1)(1993-4#1)(1994-5#1)(1995-8#1)(1996-2#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-11#1)(2007-12#9)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#5)(2008-3#3)(2008-5#1)(2008-8#1)(2009-5#2)(2010-2#1)
response of aged##3##3##(2008-3#2)(2010-7#1)
response of all three##2##4##(1996-6#1)(2008-10#1)
response of all##4##3##(1996-6#1)(2008-10#2)(2008-9#1)
response of allopurinol was##2##4##(2008-10#2)
response of an optical##2##4##(2007-12#1)(2008-3#1)
response of an##10##3##(2006-11#1)(2006-5#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-3#1)(2008-4#1)
response of antenna-coupled##2##3##(2007-12#1)(2008-3#1)
response of approximately##2##3##(2008-10#1)(2010-5#1)
response of ascorbic acid##2##4##(2008-10#2)
response of asymmetric-spiral infrared antennas##2##5##(2007-12#1)(2008-2#1)
response of bone##2##3##(2008-1#2)
response of brain##2##3##(1990-10#1)(2009-7#1)
response of breast##2##3##(1990-2#1)(1997-6#1)
response of cells to##4##4##(2007-12#1)(2008-9#2)(2011-2#1)
response of cells##7##3##(1990-6#1)(1994-10#1)(2007-12#1)(2008-2#1)(2008-9#2)(2011-2#1)
response of coronary##2##3##(1991-12#1)(1996-12#1)
response of different##2##3##(2007-8#1)(2008-5#1)
response of each##2##3##(2008-10#2)
response of endothelial cells to##3##5##(2008-11#1)(2010-1#1)(2011-2#1)
response of endothelial cells##4##4##(2008-11#2)(2010-1#1)(2011-2#1)
response of extrinsic photoconductors##2##4##(2008-3#2)
response of health care workers##2##5##(2005-2#1)(2012-2#1)
response of health care##3##4##(2005-2#1)(2007-12#1)(2012-2#1)
response of health##4##3##(1992-12#1)(2005-2#1)(2007-12#1)(2012-2#1)
response of hepatocytes in gamma-glutamyl transferase positive foci##3##8##(1994-6#3)
response of human##9##3##(1992-10#1)(1992-12#1)(1992-2#1)(1992-9#1)(1994-8#1)(1995-12#2)(1996-7#1)(2008-7#1)
response of in##3##3##(1995-2#1)(1996-11#1)(2008-1#1)
response of individual##2##3##(1996-3#1)(2007-12#1)
response of isolated##2##3##(2007-2#1)(2010-5#1)
response of large##2##3##(1993-3#1)(2007-7#1)
response of lead(II)##3##3##(2008-10#3)
response of lymphocytes##3##3##(1995-8#1)(2008-10#1)(2008-4#1)
response of metastatic##2##3##(1990-2#1)(1992-10#1)
response of muscle##2##3##(2006-11#1)(2009-3#1)
response of negative##2##3##(2008-4#1)(2008-9#1)
response of norepinephrine##2##3##(2008-10#2)
response of plants to herbivore removal##2##6##(2008-8#2)
response of plants to##5##4##(2008-10#1)(2008-8#2)(2009-10#1)(2009-8#1)
response of plants##6##3##(1992-8#1)(2008-10#1)(2008-8#2)(2009-10#1)(2009-8#1)
response of populations##3##3##(2008-9#2)(2010-8#1)
response of rat##2##3##(1994-8#1)(1995-6#1)
response of rats##2##3##(1991-10#1)(1992-9#1)
response of splenic CD4 T cells##2##6##(2008-11#2)
response of splenic##3##3##(1995-10#1)(2008-11#2)
response of standard and planar PDA systems##2##7##(2008-2#2)
response of such##2##3##(2008-10#1)(2010-2#1)
response of the Fabry-Perot##2##4##(2007-12#1)(2008-3#1)
response of the brain##3##4##(2006-11#1)(2007-1#2)
response of the composite##2##4##(2009-6#1)(2009-7#1)
response of the device##2##4##(2007-12#1)(2008-2#1)
response of the electrode##5##4##(2007-8#1)(2008-10#4)
response of the film##2##4##(2008-10#2)
response of the instrument##2##4##(2007-8#1)(2008-2#1)
response of the knee##2##4##(2007-1#1)(2007-4#1)
response of the laser##3##4##(2008-3#3)
response of the method##2##4##(2008-10#2)
response of the nematode##2##4##(2008-10#1)(2010-12#1)
response of the new##3##4##(2006-11#2)(2007-4#1)
response of the rat##2##4##(1994-4#1)(2008-7#1)
response of the same##2##4##(2007-1#1)(2008-7#1)
response of the sensor is##2##5##(2007-12#1)(2008-10#1)
response of the sensor to##4##5##(2008-10#4)
response of the sensor##9##4##(2007-12#1)(2008-10#8)
response of the shoulder##2##4##(2006-11#1)(2007-4#1)
response of the skin to##3##5##(2008-5#3)
response of the skin##4##4##(2008-5#3)(2009-9#1)
response of the spinal cord##2##5##(2006-8#2)
response of the system##3##4##(2006-10#1)(2007-12#1)(2008-10#1)
response of the tectorial membrane##2##5##(1995-5#2)
response of the tissue to##2##5##(1990-5#1)(2008-3#1)
response of the tumor##2##4##(1992-10#1)(1995-5#1)
response of the tumour to##2##5##(1990-2#1)(2008-1#1)
response of the##226##3##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-6#4)(1992-8#1)(1992-9#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#3)(1995-6#3)(1996-1#1)(1996-2#2)(1996-3#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-8#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#2)(2006-1#1)(2006-10#5)(2006-11#5)(2006-12#1)(2006-3#1)(2006-5#1)(2006-8#2)(2007-1#7)(2007-10#1)(2007-11#3)(2007-12#10)(2007-4#13)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#49)(2008-2#14)(2008-3#12)(2008-5#8)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
response of these##7##3##(1990-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2012-7#1)
response of this##7##3##(1992-8#1)(1993-9#1)(1996-1#1)(2007-1#1)(2007-12#1)(2008-2#1)(2008-3#1)
response of tissue##2##3##(1997-7#1)(2012-2#1)
response of vascular##2##3##(1990-8#1)(1994-8#1)
response of young##2##3##(2012-9#1)(2013-7#1)
response of##723##2##(1990-10#2)(1990-11#1)(1990-2#3)(1990-5#3)(1990-6#2)(1990-7#3)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#4)(1991-11#3)(1991-12#6)(1991-2#1)(1991-3#2)(1991-5#1)(1991-7#3)(1992-1#1)(1992-10#4)(1992-12#5)(1992-2#1)(1992-3#3)(1992-6#5)(1992-7#1)(1992-8#3)(1992-9#5)(1993-12#5)(1993-3#5)(1993-4#1)(1993-6#1)(1993-7#3)(1993-8#2)(1993-9#1)(1994-10#3)(1994-11#2)(1994-12#3)(1994-2#3)(1994-3#4)(1994-4#1)(1994-5#1)(1994-6#10)(1994-8#8)(1994-9#5)(1995-1#3)(1995-10#1)(1995-12#3)(1995-2#3)(1995-3#2)(1995-5#4)(1995-6#6)(1995-7#2)(1995-8#5)(1995-9#2)(1996-1#4)(1996-11#3)(1996-12#2)(1996-2#5)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#3)(1997-2#2)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#3)(2004-2#4)(2004-9#1)(2005-10#1)(2005-11#3)(2005-2#1)(2006-1#2)(2006-10#9)(2006-11#9)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#2)(2006-8#4)(2007-1#9)(2007-10#1)(2007-11#15)(2007-12#37)(2007-2#1)(2007-4#14)(2007-5#1)(2007-7#6)(2007-8#8)(2007-9#1)(2008-1#8)(2008-10#135)(2008-11#14)(2008-12#1)(2008-2#36)(2008-3#28)(2008-4#6)(2008-5#14)(2008-6#2)(2008-7#16)(2008-8#12)(2008-9#9)(2009-10#7)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#6)(2010-2#3)(2010-3#1)(2010-4#4)(2010-5#4)(2010-7#3)(2010-8#4)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#4)(2012-2#10)(2012-3#4)(2012-7#1)(2012-9#1)(2013-1#9)(2013-7#8)(2013-8#2)
response on a##4##3##(1995-9#1)(1996-2#1)(2007-11#1)(2008-3#1)
response on the##7##3##(1992-11#1)(1993-12#1)(1993-6#1)(1997-1#1)(2006-4#1)(2007-2#1)(2008-6#1)
response on##21##2##(1992-11#2)(1993-12#1)(1993-6#1)(1994-11#1)(1995-9#1)(1996-2#1)(1997-1#1)(2005-10#1)(2006-4#1)(2007-11#3)(2007-2#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2012-3#1)
response only##3##2##(1995-11#1)(2004-12#1)(2008-10#1)
response or the##2##3##(2006-10#1)(2007-11#1)
response or##25##2##(1990-8#1)(1991-11#1)(1991-5#1)(1992-6#1)(1993-11#1)(1993-5#1)(1993-8#1)(1995-10#1)(1996-4#1)(1996-6#1)(1996-9#2)(2006-1#1)(2006-10#1)(2007-11#1)(2007-6#1)(2008-3#2)(2008-9#1)(2009-3#1)(2009-4#1)(2010-10#1)(2012-1#1)(2012-3#2)
response outcome##3##2##(2005-8#1)(2005-9#1)(2010-4#1)
response over a wide concentration range##3##6##(2008-10#3)
response over a wide##6##4##(2008-10#5)(2008-3#1)
response over a##10##3##(2008-10#6)(2008-3#3)(2010-3#1)
response over the concentration range##3##5##(2008-10#3)
response over the concentration##4##4##(2008-10#4)
response over the entire##2##4##(2007-9#1)(2008-7#1)
response over the range##2##4##(2008-10#2)
response over the##11##3##(2007-12#1)(2007-9#1)(2008-10#8)(2008-7#1)
response over##25##2##(1996-2#2)(2007-12#1)(2007-9#1)(2008-10#16)(2008-3#3)(2008-7#1)(2010-3#1)
response parameters##6##2##(2006-10#1)(2007-12#1)(2008-3#1)(2010-2#2)(2012-12#1)
response pathway##7##2##(1996-2#1)(2006-12#1)(2008-8#1)(2009-8#2)(2010-2#1)(2012-2#1)
response pathways##4##2##(1996-2#1)(2007-11#1)(2008-10#1)(2008-7#1)
response pattern to##2##3##(1990-10#1)(1990-4#1)
response pattern##6##2##(1990-10#1)(1990-4#1)(2008-11#2)(2009-8#2)
response patterns for##3##3##(2008-10#3)
response patterns of##2##3##(1993-2#1)(2008-11#1)
response patterns to##2##3##(1993-2#1)(2012-1#1)
response patterns##16##2##(1990-4#1)(1993-12#1)(1993-2#2)(2008-10#4)(2008-11#2)(2008-7#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
response persists##2##2##(1994-2#1)(2009-5#1)
response potential##2##2##(1990-3#1)(1991-1#1)
response prediction##2##2##(2010-11#1)(2010-12#1)
response prevention##2##2##(2006-4#1)(2012-1#1)
response procedure##2##2##(1993-6#1)(2007-4#1)
response profile##3##2##(1990-7#1)(1990-9#1)(1996-5#1)
response profiles of##2##3##(1990-9#1)(2007-3#1)
response properties of the##4##4##(1990-4#1)(2008-10#2)(2008-8#1)
response properties of##9##3##(1990-4#2)(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)(2009-8#1)
response properties##14##2##(1990-4#2)(1992-7#1)(2008-10#3)(2008-11#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#2)(2013-8#1)
response protein##5##2##(1997-7#2)(2007-12#1)(2008-10#1)(2011-2#1)
response proteins##2##2##(1996-9#1)(2012-12#1)
response provides##3##2##(2006-8#1)(2007-11#1)(2008-2#1)
response raised##2##2##(1991-12#1)(2013-1#1)
response range and##2##3##(2008-10#2)
response range of the sensor##2##5##(2008-10#2)
response range of##9##3##(1997-8#1)(2007-8#1)(2008-10#7)
response range##23##2##(1997-8#1)(2007-8#2)(2008-10#20)
response ranges##3##2##(2008-10#1)(2010-7#1)(2013-8#1)
response rate =##2##3##(2007-12#2)
response rate and##7##3##(2006-12#1)(2007-11#2)(2007-6#1)(2008-11#1)(2008-3#1)(2008-6#1)
response rate in the##4##4##(1993-8#1)(2008-4#1)(2010-3#1)(2012-3#1)
response rate in##7##3##(1993-8#1)(2006-12#1)(2007-11#1)(2008-4#1)(2009-8#1)(2010-3#1)(2012-3#1)
response rate is##2##3##(2005-11#1)(2010-8#1)
response rate of 50%##2##4##(1993-12#1)(2013-8#1)
response rate of 62%##3##4##(1990-4#1)(2005-7#1)(2007-2#1)
response rate of 86%##2##4##(2007-11#2)
response rate of patients##2##4##(1997-8#2)
response rate of the##2##4##(2010-8#1)(2013-8#1)
response rate of##46##3##(1990-10#1)(1990-4#1)(1991-12#2)(1992-2#2)(1993-12#1)(1995-1#1)(1997-8#2)(2004-10#1)(2005-7#4)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-11#7)(2007-2#1)(2008-10#1)(2008-11#1)(2008-6#3)(2009-6#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-11#1)(2011-2#1)(2012-2#2)(2013-8#3)
response rate to##4##3##(1993-6#1)(1996-9#1)(2006-10#1)(2006-12#1)
response rate was 61%##2##4##(1992-10#1)(2006-10#1)
response rate was observed in##2##5##(1990-10#1)(2005-7#1)
response rate was##50##3##(1990-10#2)(1990-6#1)(1990-9#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-10#2)(1992-8#1)(1993-1#1)(1994-2#1)(1994-7#1)(1995-4#1)(1995-8#1)(1997-6#1)(1997-8#1)(2004-1#1)(2004-10#2)(2005-10#1)(2005-7#3)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-8#1)(2009-5#1)(2010-12#2)(2010-9#1)(2011-2#1)(2012-2#2)(2013-7#1)
response rate with##3##3##(2007-11#2)(2008-6#1)
response rate##171##2##(1990-10#4)(1990-2#2)(1990-4#1)(1990-6#2)(1990-9#1)(1991-12#4)(1991-3#2)(1991-4#1)(1991-6#1)(1991-8#3)(1992-10#2)(1992-2#2)(1992-8#2)(1993-1#3)(1993-12#1)(1993-6#2)(1993-8#1)(1994-2#1)(1994-7#1)(1995-1#1)(1995-12#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-10#2)(1996-3#1)(1996-9#1)(1997-6#1)(1997-8#4)(2004-1#1)(2004-10#3)(2005-10#1)(2005-11#1)(2005-7#7)(2006-10#6)(2006-12#5)(2006-2#1)(2006-6#4)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-11#17)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#8)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-11#1)(2010-12#3)(2010-3#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-11#1)(2011-2#5)(2012-12#1)(2012-2#5)(2012-3#4)(2013-7#2)(2013-8#3)
response rate) and safe for bone pain palliation in patients with multiple##2##12##(2007-11#2)
response rate) and##3##3##(2006-8#1)(2007-11#2)
response rate) from##2##3##(2007-10#1)(2007-9#1)
response rate)##15##2##(1994-2#1)(1995-2#1)(1996-3#1)(2005-7#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-9#1)(2008-8#1)(2011-1#2)(2013-1#1)
response rates and##7##3##(1994-7#1)(2006-7#1)(2008-5#2)(2010-12#2)(2012-2#1)
response rates between##2##3##(2007-9#1)(2009-3#1)
response rates from##2##3##(2008-12#1)(2008-8#1)
response rates in the##2##4##(2007-7#2)
response rates in##5##3##(2007-10#1)(2007-11#2)(2007-7#2)
response rates of##11##3##(1991-4#1)(1997-5#1)(2006-10#1)(2007-11#2)(2008-3#3)(2008-5#1)(2012-12#1)(2013-1#1)
response rates than##2##3##(2007-11#1)(2013-1#1)
response rates to##4##3##(1990-2#1)(2007-11#2)(2012-3#1)
response rates were##6##3##(1990-6#1)(1991-8#1)(1993-6#1)(2004-1#1)(2007-11#2)
response rates with##2##3##(2008-5#1)(2010-12#1)
response rates##78##2##(1990-2#1)(1990-6#1)(1991-10#1)(1991-4#1)(1991-8#1)(1993-11#1)(1993-6#3)(1994-7#1)(1995-1#1)(1995-4#1)(1997-5#1)(2004-1#1)(2005-11#1)(2005-7#3)(2005-8#1)(2006-10#3)(2006-11#2)(2006-6#1)(2006-7#1)(2007-10#5)(2007-11#12)(2007-6#1)(2007-7#2)(2007-9#1)(2008-12#1)(2008-3#3)(2008-5#6)(2008-6#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-7#1)(2010-11#1)(2010-12#3)(2010-3#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)
response rather than##2##3##(1993-3#1)(1997-8#1)
response regime##2##2##(2007-12#1)(2008-10#1)
response region##4##2##(1997-2#2)(2008-10#2)
response regulator and##2##3##(1997-4#2)
response regulator##6##2##(1994-8#1)(1997-4#2)(2008-10#1)(2009-6#1)(2010-10#1)
response related to##5##3##(1995-1#1)(2008-9#4)
response related##6##2##(1995-1#1)(2008-1#1)(2008-9#4)
response relationships##4##2##(2008-10#1)(2008-7#3)
response relative to the mean##2##5##(2006-11#2)
response relative to##3##3##(2006-11#2)(2008-3#1)
response required##3##2##(1993-6#1)(2007-12#1)(2009-9#1)
response requirement##3##2##(2006-11#1)(2011-2#2)
response requirements##4##2##(2006-11#2)(2006-7#1)(2011-2#1)
response resulting from##2##3##(1995-12#1)(2008-10#1)
response results##2##2##(2008-7#1)(2010-8#1)
response rules##3##2##(1991-1#1)(2012-2#2)
response seems##2##2##(1990-12#1)(2007-11#1)
response seen##2##2##(1995-3#1)(2006-6#1)
response selection##3##2##(1997-1#2)(2008-7#1)
response sensitivity##2##2##(1993-11#1)(2008-5#1)
response should be##3##3##(1993-12#1)(2006-10#1)(2008-2#1)
response should##4##2##(1993-12#1)(1996-9#1)(2006-10#1)(2008-2#1)
response showed a##3##3##(1996-1#2)(2008-10#1)
response signal##3##2##(1993-2#1)(2007-8#1)(2008-10#1)
response similar to##2##3##(1992-10#1)(2008-10#1)
response slope of##2##3##(2008-10#2)
response slope##5##2##(2008-10#5)
response so##3##2##(2004-2#1)(2007-8#1)(2011-2#1)
response stability##2##2##(2008-10#2)
response statistics##2##2##(2007-4#1)(2010-3#1)
response strategies##3##2##(2008-11#1)(2008-3#1)(2010-2#1)
response strength##2##2##(1996-5#1)(2013-7#1)
response studies##2##2##(1990-6#1)(2009-5#1)
response study##2##2##(2008-5#2)
response style##4##2##(2010-1#3)(2012-1#1)
response such as##2##3##(2009-4#1)(2010-12#1)
response suggested that##2##3##(1995-12#1)(2008-10#1)
response surface analysis##2##3##(2008-5#1)(2011-12#1)
response surface methodology was applied to##2##6##(2007-12#1)(2008-5#1)
response surface methodology was##3##4##(2007-12#1)(2008-5#2)
response surface methodology##17##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#11)(2013-1#3)
response surface methodology]##2##3##(2012-12#1)(2012-3#1)
response surface##37##2##(1994-11#1)(2004-12#1)(2007-12#1)(2008-10#11)(2008-3#1)(2008-5#15)(2009-9#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-1#3)
response surfaces##3##2##(2008-10#3)
response system##7##2##(2007-1#1)(2007-12#1)(2008-11#1)(2010-3#3)(2012-12#1)
response systems##3##2##(1994-6#1)(2008-1#1)(2012-12#1)
response targets##3##2##(2007-1#2)(2007-4#1)
response telemetry##5##2##(2008-9#5)
response tendencies##2##2##(2009-10#1)(2009-8#1)
response test##2##2##(2008-10#1)(2008-8#1)
response than that of##2##4##(2008-2#1)(2009-8#1)
response than##10##2##(1990-12#1)(1990-5#1)(1990-8#1)(1995-12#1)(1995-8#1)(2008-10#2)(2008-2#1)(2009-8#1)(2012-3#1)
response that is##13##3##(1991-6#1)(1995-11#1)(1995-5#1)(1996-10#1)(2007-11#3)(2007-12#1)(2007-9#1)(2008-11#1)(2008-3#1)(2009-5#1)(2012-2#1)
response that occurs##2##3##(2006-3#1)(2007-11#1)
response that was##3##3##(1990-6#1)(1996-3#1)(2008-11#1)
response that##46##2##(1990-6#1)(1991-6#1)(1993-8#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-10#1)(1996-3#1)(1996-9#1)(2006-10#2)(2006-11#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#5)(2007-12#3)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-8#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)
response the##2##2##(1992-2#1)(2008-8#1)
response theory##3##2##(2007-12#2)(2009-11#1)
response thresholds##3##2##(1991-11#1)(1993-2#2)
response through the##3##3##(2008-11#1)(2009-6#1)(2013-1#1)
response through##10##2##(1992-3#1)(1994-8#1)(1996-4#1)(2008-11#1)(2008-4#1)(2009-6#2)(2010-5#1)(2012-12#1)(2013-1#1)
response time &lt##3##3##(2007-8#1)(2008-10#2)
response time (&lt##4##3##(2008-10#4)
response time (RT)##2##3##(2008-6#1)(2010-2#1)
response time (within##3##3##(2008-10#3)
response time and##13##3##(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-2#1)(2010-8#1)
response time are##3##3##(2007-11#1)(2008-1#1)(2008-10#1)
response time for##7##3##(1993-6#1)(2006-9#1)(2008-10#2)(2010-5#1)(2010-8#1)(2013-8#1)
response time is##7##3##(2006-5#1)(2007-12#2)(2008-10#3)(2008-2#1)
response time of &lt##8##4##(2007-11#1)(2008-10#7)
response time of 30##2##4##(2007-12#1)(2008-10#1)
response time of about##8##4##(2007-9#1)(2008-10#7)
response time of less than##5##5##(2007-11#1)(2008-10#3)(2013-1#1)
response time of sensor is##2##5##(2008-10#2)
response time of the electrode is##4##6##(2008-10#4)
response time of the electrode was##3##6##(2008-10#3)
response time of the electrode##7##5##(2008-10#7)
response time of the sensor is##3##6##(2008-10#3)
response time of the sensor##4##5##(2008-10#4)
response time of the##22##4##(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#13)(2008-2#2)
response time of##74##3##(2007-11#5)(2007-12#9)(2007-9#1)(2008-1#1)(2008-10#52)(2008-2#4)(2008-3#1)(2013-1#1)
response time to##2##3##(2008-10#1)(2010-2#1)
response time was##5##3##(2006-10#2)(2008-10#2)(2008-2#1)
response time were##3##3##(2006-9#1)(2008-10#2)
response time##181##2##(1992-4#1)(1993-6#1)(1996-12#1)(1996-3#1)(2006-10#3)(2006-2#1)(2006-5#1)(2006-9#2)(2007-11#7)(2007-12#13)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#114)(2008-2#10)(2008-3#3)(2008-6#1)(2010-2#4)(2010-5#2)(2010-7#1)(2010-8#2)(2012-3#1)(2013-1#4)(2013-8#1)
response times and##4##3##(1994-3#1)(2010-3#1)(2011-1#1)(2012-1#1)
response times of ambulances##2##4##(2010-3#2)
response times of##4##3##(2007-8#1)(2008-10#1)(2010-3#2)
response times on##3##3##(2005-10#1)(2008-2#1)(2009-12#1)
response times to##3##3##(2008-10#1)(2010-3#1)(2012-1#1)
response times##34##2##(1994-3#2)(1995-4#1)(2005-10#1)(2006-9#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-7#1)(2009-12#1)(2009-8#1)(2010-2#3)(2010-3#8)(2010-8#1)(2011-1#1)(2012-1#2)(2012-12#1)
response to &quot##2##3##(1994-8#1)(2011-2#1)
response to 1##6##3##(1990-2#2)(1991-2#1)(1991-4#1)(1995-3#2)
response to 1%##2##3##(2007-7#1)(2008-10#1)
response to 1-24 corticotropin at 20##2##6##(2006-2#2)
response to 1-24 corticotropin##4##4##(2006-2#4)
response to 100 nM##2##4##(1995-11#1)(1995-6#1)
response to 2DG was##2##4##(2012-11#2)
response to 5-HT##3##3##(1992-7#1)(1995-3#1)(1997-5#1)
response to ACTH##3##3##(1993-11#1)(1995-10#1)(1996-11#1)
response to AIDS##2##3##(1990-3#1)(1993-3#1)
response to ANF##2##3##(1990-7#2)
response to ATP binding##2##4##(1995-2#2)
response to ATP##5##3##(1993-9#1)(1994-12#1)(1994-8#1)(1995-2#2)
response to CMV##2##3##(1991-12#2)
response to Ca2+##2##3##(1992-8#1)(1997-5#1)
response to Cd##2##3##(1990-5#1)(2008-7#1)
response to Cu(II) over##2##4##(2008-10#2)
response to Cu(II)##3##3##(2008-10#3)
response to DNA damage##11##4##(1992-4#1)(1994-2#1)(1995-2#3)(1995-8#1)(2008-8#2)(2009-5#1)(2011-2#2)
response to DNA##13##3##(1992-4#1)(1994-2#1)(1995-2#3)(1995-8#1)(2008-1#1)(2008-8#2)(2009-5#1)(2011-2#2)(2012-3#1)
response to E2##3##3##(1990-11#3)
response to ET-1##2##3##(1994-12#1)(1996-2#1)
response to GH##4##3##(1994-2#1)(2006-9#1)(2008-3#1)(2008-4#1)
response to GM-CSF##2##3##(1995-2#1)(1996-5#1)
response to GTP##2##3##(1994-12#2)
response to GnRH##5##3##(1993-3#1)(1995-10#1)(1995-9#1)(2006-10#1)(2006-5#1)
response to H(2)O(2)##2##3##(2008-10#1)(2008-4#1)
response to HIV-1##3##3##(2007-11#1)(2009-4#1)(2013-1#1)
response to IGF-I is##2##4##(1991-5#1)(1996-11#1)
response to IGF-I##6##3##(1991-5#1)(1993-6#1)(1996-11#1)(1997-1#1)(2008-11#2)
response to IL-2##2##3##(1992-5#1)(1996-10#1)
response to IL1##2##3##(1990-3#1)(1991-5#1)
response to KLH was##2##4##(2008-10#2)
response to KLH##6##3##(2008-10#6)
response to L-Glu##2##3##(1997-2#2)
response to M##3##3##(2005-7#1)(2008-10#2)
response to NGF##3##3##(1991-7#1)(1994-2#2)
response to NMDA in##2##4##(1992-8#1)(1996-5#1)
response to PHA##2##3##(1990-10#1)(2007-2#1)
response to PTH##3##3##(1990-11#2)(2012-3#1)
response to Paillard (2011)##2##4##(2013-7#2)
response to RA##2##3##(1997-7#1)(2006-12#1)
response to S##4##3##(2008-10#2)(2011-2#2)
response to S-1##2##3##(2008-1#2)
response to SP##2##3##(1991-8#1)(1993-12#1)
response to SRBC##3##3##(1991-12#1)(2004-12#1)(2008-10#1)
response to TPA##2##3##(1995-7#1)(1996-5#1)
response to TSH stimulation##2##4##(1990-12#1)(1993-3#1)
response to TSH##4##3##(1990-12#1)(1991-8#1)(1992-12#1)(1993-3#1)
response to UV##3##3##(2008-1#1)(2008-3#1)(2008-5#1)
response to a T-dependent antigen##2##5##(1994-5#1)(2008-10#1)
response to a certain##2##4##(2009-6#1)(2012-12#1)
response to a fire##2##4##(1993-12#1)(1994-12#1)
response to a given##3##4##(2008-11#1)(2008-4#1)(2012-2#1)
response to a noxious stimulus##2##5##(1993-9#1)(2008-6#1)
response to a number of##2##5##(1992-1#1)(2009-8#1)
response to a particular environment##2##5##(1994-11#1)(2009-7#1)
response to a particular##7##4##(1994-11#1)(1995-10#1)(1995-2#1)(2006-10#1)(2008-1#1)(2008-12#1)(2009-7#1)
response to a plasma cholesterol-lowering diet##2##6##(2012-2#2)
response to a range of##3##5##(1990-12#1)(1992-6#1)(2007-4#1)
response to a second##2##4##(1996-5#1)(2013-1#1)
response to a single##4##4##(1993-11#1)(1995-11#1)(2008-3#1)(2011-10#1)
response to a specific##3##4##(1990-7#1)(2013-8#2)
response to a sudden##2##4##(2006-12#1)(2008-11#1)
response to a variety of insults##2##6##(2008-11#1)(2008-5#1)
response to a variety of##7##5##(2006-8#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2011-2#1)
response to a##127##3##(1990-12#1)(1990-2#2)(1990-7#3)(1990-8#2)(1991-9#1)(1992-1#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#2)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(2005-10#1)(2005-6#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-8#3)(2007-12#1)(2007-2#3)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-10#1)(2011-2#2)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#2)(2013-1#1)(2013-8#4)
response to abnormal##2##3##(1994-9#1)(2006-10#1)
response to acetylcholine was##2##4##(1992-1#1)(1994-7#1)
response to acetylcholine##3##3##(1992-1#1)(1994-7#1)(2008-4#1)
response to acid##2##3##(1992-6#1)(1994-11#1)
response to activation of##5##4##(1994-6#1)(1996-2#1)(1997-6#1)(2008-11#2)
response to activation##8##3##(1993-6#2)(1994-6#1)(1996-2#1)(1997-6#1)(2006-3#1)(2008-11#2)
response to acute stress##4##4##(2013-1#4)
response to acute##15##3##(1991-7#1)(1991-8#1)(1993-2#1)(1995-12#2)(1995-6#1)(1996-2#1)(1996-8#1)(2006-10#1)(2008-5#1)(2010-10#1)(2013-1#4)
response to adenosine##4##3##(1993-11#1)(1997-7#1)(2012-2#1)(2012-3#1)
response to administration of##2##4##(2006-8#1)(2008-10#1)
response to all##7##3##(1995-5#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-5#1)(2011-2#1)
response to alloantigen##2##3##(1991-12#2)
response to altered##3##3##(1990-2#1)(2006-5#1)(2007-11#1)
response to an external##3##4##(1990-3#1)(1993-3#1)(2008-7#1)
response to an increase in##5##5##(1993-3#1)(2005-12#1)(2008-5#1)(2008-7#1)(2009-1#1)
response to an##33##3##(1990-10#1)(1990-3#1)(1991-10#1)(1991-11#1)(1991-9#1)(1993-3#2)(1993-7#1)(1994-12#1)(1995-2#1)(2005-12#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#2)(2009-11#1)(2009-5#1)(2009-8#1)(2010-5#1)(2011-1#2)
response to androgens##2##3##(1995-12#1)(2012-12#1)
response to angiotensinogen##4##3##(1991-5#4)
response to anti-TB treatment##2##4##(1996-3#1)(2012-2#1)
response to antibiotic##2##3##(2011-1#1)(2012-1#1)
response to antibiotics##3##3##(2007-7#1)(2012-3#2)
response to anticancer##2##3##(1997-4#1)(2006-11#1)
response to antidepressants##2##3##(2008-8#1)(2010-6#1)
response to antigen##3##3##(1995-2#2)(1996-8#1)
response to antihypertensive##3##3##(1993-8#1)(1996-9#1)(2012-12#1)
response to any##3##3##(1992-7#1)(1996-9#1)(2008-2#1)
response to arachidonic acid##2##4##(1993-8#1)(1995-11#1)
response to auditory##3##3##(1992-7#2)(2007-10#1)
response to bacterial##4##3##(1997-6#1)(2009-12#1)(2010-12#1)(2012-2#1)
response to basic##2##3##(1991-9#1)(1995-1#1)
response to big endothelin-1 in##2##5##(1992-7#2)
response to big endothelin-1##3##4##(1991-6#1)(1992-7#2)
response to big##5##3##(1991-6#1)(1992-7#2)(1995-1#2)
response to biological##2##3##(1995-8#1)(2010-9#1)
response to both##13##3##(1992-4#1)(1992-8#1)(1993-3#1)(1995-2#1)(1996-8#1)(2005-8#2)(2006-8#1)(2007-12#1)(2007-3#1)(2008-3#1)(2008-5#1)(2009-3#1)
response to cAMP##4##3##(1991-2#1)(1994-12#1)(1996-12#1)(1996-2#1)
response to cage transfer##3##4##(2008-11#3)
response to cancer##7##3##(1994-11#1)(1994-2#1)(1997-1#1)(2005-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
response to carbachol##5##3##(1990-7#1)(1993-7#1)(1995-3#1)(2004-12#2)
response to cardiac##2##3##(2007-9#1)(2012-2#1)
response to carotid sinus massage##2##5##(1993-12#2)
response to cell##4##3##(1991-10#1)(2008-7#1)(2008-9#1)(2009-5#1)
response to cellular##4##3##(1993-9#1)(1996-2#1)(2009-5#1)(2010-7#1)
response to challenge##3##3##(1990-11#1)(1991-3#1)(1997-3#1)
response to changes in the##4##5##(1991-11#1)(1995-11#1)(2007-3#1)(2008-10#1)
response to changes in##17##4##(1990-6#1)(1990-8#1)(1991-11#2)(1992-12#1)(1995-11#2)(2004-9#1)(2005-10#1)(2005-12#1)(2007-10#1)(2007-3#1)(2008-10#2)(2008-3#1)(2009-8#1)(2010-12#1)
response to changes##18##3##(1990-6#1)(1990-8#1)(1991-11#2)(1992-12#1)(1995-11#2)(2004-9#1)(2005-10#1)(2005-12#1)(2007-10#1)(2007-3#1)(2008-10#2)(2008-3#1)(2009-8#1)(2010-12#1)(2011-2#1)
response to changing environmental##2##4##(2007-12#1)(2008-9#1)
response to changing##7##3##(1992-2#1)(1997-6#1)(2007-12#1)(2008-7#1)(2008-9#1)(2009-6#1)(2012-2#1)
response to chemical carcinogens##2##4##(2010-12#2)
response to chemotherapy was##2##4##(1990-12#1)(2008-6#1)
response to chemotherapy##15##3##(1990-12#1)(1990-8#1)(1991-4#2)(1992-10#1)(1992-6#1)(1994-2#1)(1997-7#1)(2005-10#1)(2008-6#1)(2010-3#3)(2012-3#1)(2013-1#1)
response to chlordiazepoxide##3##3##(1992-7#3)
response to chronic##3##3##(1991-7#1)(2008-10#1)(2010-4#1)
response to clenbuterol##2##3##(2010-6#2)
response to climate##2##3##(2008-8#1)(2012-7#1)
response to clopidogrel##2##3##(2008-3#1)(2008-4#1)
response to clozapine##4##3##(1995-12#1)(1995-9#2)(2008-9#1)
response to cocaine##3##3##(1991-2#1)(1996-10#1)(2010-2#1)
response to cognitive assessment##2##4##(2011-2#2)
response to cold##7##3##(1991-2#2)(1997-7#2)(2006-10#1)(2006-12#1)(2008-7#1)
response to combination##2##3##(2006-10#1)(2008-12#1)
response to concerns##2##3##(1996-3#1)(2013-1#1)
response to contact sensitizers##2##4##(2008-10#2)
response to copper##2##3##(2005-7#1)(2007-11#1)
response to cyclic##3##3##(1994-6#1)(1995-1#1)(2010-4#1)
response to cytotoxic therapy##2##4##(1995-5#1)(2006-11#1)
response to cytotoxic##3##3##(1990-1#1)(1995-5#1)(2006-11#1)
response to daily##4##3##(1996-8#1)(1997-7#1)(2005-12#1)(2010-11#1)
response to decreased##2##3##(2006-10#1)(2011-1#1)
response to demolitive surgery##2##4##(1993-10#2)
response to dietary vitamin E##2##5##(2007-8#2)
response to dietary##7##3##(1991-2#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-7#1)(2012-2#1)
response to different##18##3##(1993-6#1)(1994-12#1)(1996-10#1)(1996-12#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-10#5)(2008-9#1)(2009-10#1)(2010-10#1)(2010-11#2)(2012-2#1)
response to dilute tropicamide##2##4##(2008-7#2)
response to disturbance##2##3##(2008-8#2)
response to diverse stimuli##3##4##(1996-5#1)(2012-12#2)
response to diverse##4##3##(1996-5#1)(2008-11#1)(2012-12#2)
response to drought##4##3##(2009-8#1)(2012-5#1)(2012-8#2)
response to drug treatment##2##4##(1995-12#1)(2008-9#1)
response to drugs##6##3##(1993-11#1)(2007-3#1)(2008-7#1)(2008-8#2)(2013-8#1)
response to each of##2##4##(1995-5#1)(1996-3#1)
response to each##3##3##(1995-5#1)(1996-3#1)(2007-12#1)
response to either##7##3##(1991-6#1)(1992-7#1)(1993-2#1)(1994-10#2)(2008-9#1)(2009-5#1)
response to electrical field stimulation##3##5##(1990-7#1)(1993-11#2)
response to electrical field##4##4##(1990-7#1)(1993-11#2)(1993-12#1)
response to electrical stimulation##4##4##(1990-5#1)(1990-7#1)(1996-12#1)(2008-7#1)
response to electrical##8##3##(1990-5#1)(1990-7#2)(1993-11#2)(1993-12#1)(1996-12#1)(2008-7#1)
response to elevated##6##3##(1990-2#1)(1992-8#1)(1994-11#1)(2009-4#1)(2009-5#1)(2010-11#1)
response to emerging##2##3##(2007-12#1)(2010-3#1)
response to endogenous##3##3##(1992-12#1)(1994-12#1)(2007-11#1)
response to endothelin-1##5##3##(1990-8#2)(1995-12#3)
response to environmental conditions##4##4##(1994-9#1)(1995-8#1)(2012-2#1)(2013-7#1)
response to environmental stimuli##2##4##(2008-7#1)(2009-11#1)
response to environmental##15##3##(1994-9#1)(1995-8#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-6#2)(2009-9#1)(2010-4#1)(2011-1#1)(2012-1#2)(2012-2#1)(2013-7#1)(2013-8#1)
response to ethanol##2##3##(1995-6#1)(2012-3#1)
response to ethylene##2##3##(2009-8#2)
response to exercise##3##3##(1997-7#1)(2008-7#1)(2013-8#1)
response to exogenous##8##3##(1992-9#1)(1994-3#1)(1996-8#1)(1997-1#1)(2005-7#1)(2006-5#1)(2008-10#1)(2008-7#1)
response to external##9##3##(2005-11#1)(2006-7#1)(2006-8#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-10#1)(2010-12#1)(2013-8#1)
response to extracellular stimuli##3##4##(1996-2#2)(2009-4#1)
response to extracellular##5##3##(1996-2#2)(1996-5#1)(2008-4#1)(2009-4#1)
response to eye##2##3##(2008-11#1)(2008-7#1)
response to food##3##3##(1990-9#1)(2007-10#1)(2008-7#1)
response to forskolin##2##3##(1995-8#1)(1996-6#1)
response to fungal##2##3##(1990-6#1)(2008-8#1)
response to gaze##2##3##(2008-11#2)
response to general##2##3##(2008-7#1)(2008-9#1)
response to genotoxic##2##3##(2008-5#1)(2011-2#1)
response to global##2##3##(2012-12#1)(2013-8#1)
response to glucocorticoid##4##3##(1994-10#1)(1997-4#1)(2008-11#1)(2008-7#1)
response to glucocorticoids##4##3##(1990-11#1)(1994-11#1)(2006-10#1)(2008-11#1)
response to glucose##11##3##(1992-7#1)(1995-7#2)(1995-8#2)(1996-3#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-11#1)
response to graded##2##3##(1995-12#1)(2008-4#1)
response to growth factors and##3##5##(1991-10#1)(1992-10#1)(1992-11#1)
response to growth factors##11##4##(1990-12#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-10#1)(1992-11#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-3#1)(2011-2#1)
response to growth##17##3##(1990-12#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-10#1)(1992-11#1)(1993-3#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-3#1)(2005-12#2)(2008-5#1)(2008-7#1)(2011-2#1)
response to heat shock##3##4##(1990-12#1)(2006-10#1)(2008-7#1)
response to heat##5##3##(1990-12#1)(1992-1#1)(2006-10#1)(2008-7#1)(2008-8#1)
response to hepatitis C virus##2##5##(2007-7#1)(2008-8#1)
response to hepatitis##4##3##(2007-7#1)(2008-8#1)(2009-12#1)(2013-1#1)
response to high##7##3##(1994-8#1)(1995-5#1)(2008-10#2)(2008-12#1)(2008-4#1)(2012-2#1)
response to histamine##4##3##(1992-9#1)(1995-3#1)(2008-5#1)(2012-12#1)
response to hormones##2##3##(1993-8#1)(1996-11#1)
response to human##2##3##(1997-5#1)(2004-11#1)
response to hydrogen##2##3##(2007-10#1)(2008-10#1)
response to hypertension##2##3##(2009-7#2)
response to hypoglycemia##2##3##(1995-6#1)(2010-11#1)
response to hypoxia##10##3##(1990-6#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#1)(2008-1#2)(2010-11#1)(2010-4#1)(2012-2#1)
response to i##4##3##(1990-7#1)(1992-8#2)(1994-2#1)
response to immunization with##2##4##(1991-5#1)(1996-10#1)
response to immunization##4##3##(1991-11#1)(1991-5#1)(1996-10#1)(2006-10#1)
response to in situ conditions##3##5##(2013-8#3)
response to in##4##3##(2008-4#1)(2013-8#3)
response to increased LA content##2##5##(1990-11#2)
response to increased##5##3##(1990-11#3)(1996-2#1)(2010-10#1)
response to individual##3##3##(1993-12#1)(2008-8#1)(2012-12#1)
response to infection by##2##4##(2008-10#2)
response to infection in##2##4##(2005-7#1)(2008-10#1)
response to infection was##2##4##(2008-10#2)
response to infection##17##3##(1990-8#1)(1993-12#1)(2005-7#1)(2008-10#10)(2008-2#1)(2010-12#2)(2010-6#1)
response to infectious##2##3##(2006-10#1)(2012-2#1)
response to inflammation##4##3##(1990-5#2)(1995-1#1)(2012-12#1)
response to inflammatory##2##3##(2006-2#1)(2009-5#1)
response to inhibitors of##2##4##(1990-7#1)(2013-1#1)
response to initial##3##3##(1996-1#1)(2008-6#1)(2010-11#1)
response to injury##17##3##(1990-7#2)(1991-2#1)(1992-7#1)(1995-1#1)(1995-12#1)(2005-10#1)(2006-10#1)(2007-11#1)(2008-1#3)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)
response to innocuous##2##3##(1996-12#2)
response to insulin##5##3##(1994-9#1)(1995-11#1)(2008-3#1)(2010-11#1)(2010-4#1)
response to integrated treatment##2##4##(2012-3#2)
response to interferon treatment##2##4##(2006-10#2)
response to interferon##5##3##(2006-10#2)(2007-11#2)(2009-8#1)
response to interleukin-2##2##3##(1991-12#1)(1994-12#1)
response to interleukin-6##2##3##(1995-3#1)(1996-5#1)
response to interventions##2##3##(2008-1#1)(2008-6#1)
response to intravenous##8##3##(1990-12#1)(1992-2#1)(1992-8#1)(1995-12#1)(1997-2#1)(2006-10#2)(2006-4#1)
response to ischemic##2##3##(2010-7#1)(2013-7#1)
response to isoproterenol##3##3##(1991-2#1)(1992-6#1)(1994-12#1)
response to its##2##3##(1994-1#1)(2009-6#1)
response to landscape change##2##4##(2008-8#2)
response to leupeptin##2##3##(1995-9#2)
response to light in PD patients##2##6##(2006-9#2)
response to light##5##3##(1992-9#1)(1995-3#1)(2006-9#2)(2008-7#1)
response to lipopolysaccharide##4##3##(1991-5#1)(1992-7#1)(1997-1#1)(1997-5#1)
response to lithium##2##3##(2004-11#2)
response to loading##2##3##(2010-12#1)(2012-2#1)
response to local##4##3##(1991-5#1)(1992-9#1)(2006-10#1)(2006-7#1)
response to long-term##3##3##(1994-5#1)(1997-2#1)(2012-2#1)
response to low##11##3##(2005-12#1)(2008-7#7)(2009-8#1)(2010-8#1)(2013-1#1)
response to lung##2##3##(1994-3#1)(2006-10#1)
response to magnesium##2##3##(1990-9#1)(2008-10#1)
response to malignancy##2##3##(1990-12#1)(2008-4#1)
response to management##2##3##(2008-10#1)(2008-7#1)
response to mechanical##5##3##(1993-2#1)(1997-3#1)(2008-9#1)(2009-8#2)
response to medical##3##3##(1996-2#1)(2006-2#1)(2010-12#1)
response to membrane##3##3##(1992-3#1)(1995-8#1)(2008-4#1)
response to mirtazapine in##2##4##(2008-6#2)
response to movement##2##3##(2006-7#2)
response to myelin##2##3##(1991-12#1)(1995-6#1)
response to natural stimuli##2##4##(2007-1#1)(2008-7#1)
response to natural##3##3##(2007-1#1)(2008-7#1)(2008-8#1)
response to neoadjuvant chemotherapy##3##4##(1993-11#1)(2008-12#1)(2010-12#1)
response to neoadjuvant##5##3##(1993-11#1)(2008-12#2)(2010-12#1)(2010-7#1)
response to new##3##3##(1996-3#1)(2007-12#1)(2008-8#1)
response to nicotine##3##3##(1994-2#2)(2013-1#1)
response to noise and background clutter in the input scene##2##10##(2008-2#2)
response to norepinephrine##3##3##(1992-1#1)(1994-8#2)
response to normal##2##3##(1991-5#1)(2012-12#1)
response to novelty##6##3##(1993-6#5)(1994-2#1)
response to one##2##3##(2007-11#1)(2011-12#1)
response to oral administration##2##4##(1992-2#1)(2007-7#1)
response to oral##6##3##(1992-2#1)(2005-11#1)(2006-10#3)(2007-7#1)
response to osmotic##2##3##(2008-4#1)(2008-7#1)
response to other##4##3##(1994-11#1)(1995-5#1)(2007-11#1)(2012-12#1)
response to oxidative stress##4##4##(1994-3#2)(2006-9#2)
response to oxidative##5##3##(1994-3#2)(2006-9#2)(2012-2#1)
response to oxygen##3##3##(1990-8#1)(1995-11#1)(2008-10#1)
response to pH change##2##4##(2007-10#1)(2008-5#1)
response to pH##6##3##(1993-12#1)(2007-10#1)(2008-10#3)(2008-5#1)
response to pain##2##3##(2004-3#1)(2006-10#1)
response to parasite##2##3##(1996-10#1)(2007-2#1)
response to parasitism##2##3##(2008-8#2)
response to pathogen##2##3##(1997-2#1)(2008-10#1)
response to pathogens##2##3##(2008-10#1)(2012-2#1)
response to penicillin##2##3##(1993-3#1)(2008-10#1)
response to phorbol##4##3##(1992-7#1)(1994-11#1)(1994-2#1)(1994-8#1)
response to physiological##4##3##(1995-3#1)(1997-5#1)(2008-4#1)(2010-1#1)
response to platelet##2##3##(1994-6#1)(2009-12#1)
response to pramipexole##2##3##(2013-8#2)
response to predation##2##3##(2008-9#1)(2010-8#1)
response to preoperative chemotherapy was##2##5##(2010-3#2)
response to preoperative chemotherapy##3##4##(2010-3#3)
response to preoperative##4##3##(1995-4#1)(2010-3#3)
response to primary##2##3##(1993-8#1)(2010-7#1)
response to protein##2##3##(2008-4#1)(2010-4#1)
response to psychosocial stress##2##4##(1995-12#2)
response to public health emergencies##2##5##(2012-2#2)
response to public health##3##4##(2008-1#1)(2012-2#2)
response to radiation therapy##2##4##(2010-12#1)(2012-1#1)
response to radiation##5##3##(2006-12#3)(2010-12#1)(2012-1#1)
response to radiotherapy and##2##4##(2007-4#1)(2010-12#1)
response to radiotherapy##6##3##(2006-12#1)(2007-4#1)(2008-6#2)(2010-12#1)(2010-3#1)
response to recombinant##3##3##(1997-4#2)(2007-11#1)
response to reduced##2##3##(1990-2#1)(2008-7#1)
response to repeated##6##3##(1992-7#2)(2005-11#1)(2007-10#2)(2008-10#1)
response to repetitive##2##3##(2006-10#1)(2010-12#1)
response to retinoic acid##6##4##(1990-12#1)(1991-9#2)(1994-10#1)(1996-11#1)(2008-9#1)
response to retinoids##3##3##(1994-8#1)(2006-12#2)
response to reward##2##3##(1993-12#1)(2008-2#1)
response to salicylate##2##3##(2008-10#2)
response to salvage##2##3##(2006-9#1)(2008-6#1)
response to selection for##3##4##(2008-7#1)(2008-8#1)(2008-9#1)
response to selection in##2##4##(2008-8#2)
response to selection##13##3##(1995-8#1)(2008-7#1)(2008-8#9)(2008-9#1)(2009-2#1)
response to serotonin##2##3##(1996-3#1)(1997-6#1)
response to shear stress##3##4##(1993-11#1)(2008-11#1)(2010-1#1)
response to sheep erythrocytes##2##4##(2008-10#1)(2008-4#1)
response to sheep red blood cells##4##6##(1993-12#1)(2008-10#3)
response to sheep##6##3##(1993-12#1)(2008-10#4)(2008-4#1)
response to signals that##2##4##(1997-4#1)(2006-10#1)
response to single##3##3##(1995-5#1)(2009-8#1)(2010-3#1)
response to skin##3##3##(1992-8#2)(2010-8#1)
response to social##5##3##(1996-3#1)(1997-5#2)(2012-2#1)(2012-3#1)
response to sodium##4##3##(1993-12#2)(2008-10#1)(2012-2#1)
response to some##6##3##(1994-3#1)(2006-10#1)(2008-4#1)(2009-7#1)(2010-3#1)(2012-12#1)
response to specific##6##3##(1994-3#1)(2006-10#1)(2008-10#1)(2009-12#1)(2010-11#1)(2012-12#1)
response to standard##3##3##(2009-2#1)(2009-5#1)(2013-7#1)
response to standing and to hyperventilation##2##6##(2008-7#2)
response to standing##3##3##(2008-7#3)
response to statin therapy in the##2##6##(1997-2#1)(2009-12#1)
response to statin therapy in##3##5##(1997-2#2)(2009-12#1)
response to sterile##2##3##(2011-1#1)(2011-2#1)
response to steroid##2##3##(2008-4#2)
response to stimuli##2##3##(1995-8#1)(2010-1#1)
response to stress and##3##4##(1994-6#1)(2008-3#1)(2010-12#1)
response to stress in##2##4##(2008-11#1)(2008-7#1)
response to stress stimuli##2##4##(1995-12#1)(2008-11#1)
response to stress##20##3##(1994-11#1)(1994-6#1)(1994-8#1)(1995-12#2)(1997-4#1)(1997-5#1)(2008-11#3)(2008-3#1)(2008-7#2)(2009-8#2)(2010-12#1)(2011-2#1)(2012-2#2)(2013-8#1)
response to stressful stimuli##2##4##(1994-2#1)(2013-1#1)
response to stressful##3##3##(1994-2#1)(2013-1#2)
response to stressors##2##3##(1995-12#1)(2011-2#1)
response to subsequent##3##3##(2008-10#1)(2008-7#1)(2010-8#1)
response to such##6##3##(2006-10#2)(2008-11#1)(2008-9#1)(2009-8#1)(2010-8#1)
response to surgery##3##3##(2012-1#1)(2013-1#2)
response to surgical stimulation##2##4##(2011-2#2)
response to surgical stress##3##4##(1993-9#1)(2006-10#1)(2007-11#1)
response to surgical##8##3##(1993-9#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-12#1)(2011-2#3)
response to sympathetic##2##3##(1992-8#1)(2006-10#1)
response to systemic steroid##2##4##(2007-7#2)
response to systemic##3##3##(2007-7#2)(2008-6#1)
response to tamoxifen##2##3##(1991-8#1)(1993-11#1)
response to taste stimuli##6##4##(1996-8#2)(2012-12#2)(2013-1#2)
response to taste##7##3##(1996-8#3)(2012-12#2)(2013-1#2)
response to temperature##4##3##(2008-10#1)(2008-11#1)(2012-2#1)(2013-8#1)
response to that##2##3##(1995-7#1)(2008-8#1)
response to the HIV epidemic##2##5##(1993-12#1)(2009-7#1)
response to the antigen##3##4##(1994-11#1)(2005-7#1)(2007-2#1)
response to the carotid##3##4##(1993-12#2)(1994-10#1)
response to the challenge of##2##5##(1994-7#1)(2008-10#1)
response to the culture pond water##2##6##(2008-5#2)
response to the current##3##4##(1996-1#1)(1996-12#1)(2008-12#1)
response to the disease##2##4##(2006-4#1)(2008-10#1)
response to the drug##3##4##(1994-12#1)(1995-12#1)(2008-10#1)
response to the fungicides##2##4##(2008-10#2)
response to the growing##3##4##(2006-10#1)(2011-1#1)(2012-1#1)
response to the human##2##4##(1996-5#1)(2006-11#1)
response to the infection##3##4##(2008-4#1)(2008-9#1)(2009-8#1)
response to the initial##2##4##(2005-7#1)(2007-6#1)
response to the islands##2##4##(2006-5#2)
response to the local##2##4##(1995-9#1)(2008-11#1)
response to the pathogen##2##4##(2008-10#2)
response to the presence of##5##5##(1993-11#1)(1994-1#1)(2007-3#1)(2008-8#1)(2008-9#1)
response to the protein##2##4##(1995-2#1)(2008-11#1)
response to the questions##2##4##(2010-4#1)(2013-8#1)
response to the second stimulus##2##5##(1992-7#1)(1993-2#1)
response to the second##3##4##(1991-6#1)(1992-7#1)(1993-2#1)
response to the specific##4##4##(2007-12#1)(2008-10#1)(2012-12#1)(2013-7#1)
response to the therapy##2##4##(2010-4#1)(2011-1#1)
response to the treatment##4##4##(1992-8#1)(2006-6#1)(2010-12#1)(2012-12#1)
response to the vaccine##2##4##(2005-7#1)(2010-12#1)
response to the##236##3##(1990-11#1)(1990-12#2)(1991-10#1)(1991-12#3)(1991-2#2)(1991-5#3)(1991-6#2)(1991-8#2)(1992-1#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#8)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-10#1)(1994-11#6)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#2)(1995-12#3)(1995-2#3)(1995-3#3)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#2)(1996-10#2)(1996-12#4)(1996-2#3)(1996-5#4)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#4)(1997-3#1)(1997-6#1)(1997-7#1)(2004-10#1)(2004-2#1)(2005-10#1)(2005-11#1)(2005-7#3)(2006-10#9)(2006-11#1)(2006-4#1)(2006-5#7)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#4)(2007-2#3)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#4)(2008-1#3)(2008-10#16)(2008-11#3)(2008-12#3)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#6)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#5)(2009-9#1)(2010-12#4)(2010-4#2)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#8)(2012-1#3)(2012-12#4)(2012-2#2)(2012-3#2)(2012-9#1)(2013-1#1)(2013-7#3)(2013-8#2)
response to therapies##3##3##(2012-3#1)(2013-1#2)
response to therapy among chronic hepatitis C patients with HCV genotype 4##2##12##(2012-12#2)
response to therapy and prognosis##2##5##(2005-8#1)(2007-7#1)
response to therapy and##8##4##(1995-10#1)(2005-8#1)(2007-3#1)(2007-7#1)(2011-1#3)(2011-2#1)
response to therapy in##5##4##(1995-1#2)(2007-3#1)(2007-7#1)(2010-11#1)
response to therapy of##2##4##(2004-2#1)(2006-8#1)
response to therapy was##2##4##(2005-8#1)(2006-12#1)
response to therapy with##3##4##(2006-9#1)(2011-1#2)
response to therapy##54##3##(1991-2#1)(1992-8#1)(1993-9#1)(1994-7#1)(1995-1#2)(1995-10#1)(1997-2#1)(2004-1#1)(2004-2#2)(2005-8#3)(2006-10#1)(2006-12#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-3#2)(2007-7#4)(2008-1#3)(2008-11#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-2#1)(2010-6#2)(2011-1#6)(2011-12#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#1)
response to these agents##2##4##(1990-2#2)
response to these##15##3##(1990-12#1)(1990-2#2)(1991-5#1)(1992-4#1)(1992-5#1)(1993-9#1)(2005-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#2)(2010-12#1)
response to this challenge##3##4##(1993-12#1)(1994-12#1)(2007-12#1)
response to this##16##3##(1993-12#1)(1994-12#1)(1995-2#1)(1997-5#1)(2004-7#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-9#1)(2012-3#1)
response to those##2##3##(2007-4#1)(2007-8#1)
response to thyroid##2##3##(1991-9#1)(1992-12#1)
response to thyrotropin##4##3##(1990-9#2)(1992-2#1)(2006-1#1)
response to thyrotropin-releasing hormone##2##4##(1994-2#1)(2008-4#1)
response to tissue injury##2##4##(1994-9#1)(2006-10#1)
response to toxic##2##3##(1992-12#1)(1997-3#1)
response to trauma##2##3##(2006-10#1)(2010-12#1)
response to treatment among##2##4##(2011-2#1)(2012-12#1)
response to treatment and survival##2##5##(1996-12#1)(2007-8#1)
response to treatment and##10##4##(1996-12#1)(2006-12#1)(2007-8#2)(2008-4#1)(2008-9#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-8#1)
response to treatment are##2##4##(1996-8#1)(2013-8#1)
response to treatment for##2##4##(1997-2#1)(2012-2#1)
response to treatment in rheumatoid arthritis##2##6##(2007-3#2)
response to treatment in##6##4##(1993-2#1)(2007-2#1)(2007-3#2)(2009-4#1)(2012-2#1)
response to treatment is##4##4##(1997-2#1)(2008-1#1)(2008-3#1)(2009-5#1)
response to treatment of##4##4##(2008-10#1)(2010-3#1)(2011-7#1)(2013-8#1)
response to treatment was##6##4##(1996-6#1)(2007-7#2)(2008-6#1)(2009-8#1)(2013-1#1)
response to treatment with##7##4##(1996-9#1)(2004-11#1)(2005-7#1)(2007-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
response to treatment##71##3##(1992-3#1)(1993-1#1)(1993-2#1)(1996-12#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(2004-11#1)(2005-11#1)(2005-7#1)(2006-12#2)(2006-5#1)(2007-1#1)(2007-11#3)(2007-2#1)(2007-3#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-2#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2011-7#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-8#5)
response to tumor##2##3##(2006-10#1)(2010-7#1)
response to tumors##3##3##(1995-5#1)(2008-4#1)(2008-5#1)
response to two##2##3##(1997-1#1)(2008-3#1)
response to uric acid##2##4##(2008-10#2)
response to vaccination##3##3##(1997-3#1)(2012-3#1)(2013-1#1)
response to vaccines##2##3##(2007-11#1)(2009-4#1)
response to various##14##3##(1990-3#1)(1995-8#2)(1997-4#1)(2008-1#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-3#1)(2011-1#1)(2012-2#2)
response to vasopressin##2##3##(1990-12#1)(1995-5#1)
response to water##6##3##(1994-10#1)(2008-10#1)(2009-8#3)(2012-1#1)
response to which##2##3##(2007-12#1)(2010-12#1)
response to wounding and##2##4##(2008-10#1)(2009-8#1)
response to your##2##3##(2006-2#1)(2008-6#1)
response to##2616##2##(1990-1#1)(1990-10#7)(1990-11#19)(1990-12#20)(1990-2#14)(1990-3#5)(1990-5#7)(1990-6#5)(1990-7#18)(1990-8#8)(1990-9#4)(1991-1#3)(1991-10#5)(1991-11#10)(1991-12#20)(1991-2#17)(1991-3#2)(1991-4#5)(1991-5#25)(1991-6#5)(1991-7#8)(1991-8#13)(1991-9#9)(1992-1#6)(1992-10#2)(1992-11#7)(1992-12#9)(1992-2#9)(1992-3#10)(1992-4#5)(1992-5#3)(1992-6#9)(1992-7#20)(1992-8#29)(1992-9#13)(1993-1#1)(1993-10#2)(1993-11#15)(1993-12#36)(1993-2#12)(1993-3#15)(1993-4#3)(1993-5#2)(1993-6#21)(1993-7#3)(1993-8#8)(1993-9#7)(1994-1#3)(1994-10#8)(1994-11#24)(1994-12#22)(1994-2#31)(1994-3#17)(1994-5#12)(1994-6#10)(1994-7#3)(1994-8#15)(1994-9#5)(1995-1#12)(1995-10#5)(1995-11#11)(1995-12#29)(1995-2#26)(1995-3#17)(1995-4#2)(1995-5#17)(1995-6#10)(1995-7#6)(1995-8#18)(1995-9#9)(1996-1#5)(1996-10#17)(1996-11#7)(1996-12#25)(1996-2#19)(1996-3#12)(1996-4#2)(1996-5#23)(1996-6#4)(1996-7#3)(1996-8#16)(1996-9#5)(1997-1#11)(1997-2#23)(1997-3#10)(1997-4#11)(1997-5#13)(1997-6#9)(1997-7#11)(1997-8#7)(2004-1#1)(2004-10#1)(2004-11#5)(2004-12#4)(2004-2#5)(2004-3#2)(2004-7#1)(2004-9#1)(2005-10#11)(2005-11#8)(2005-12#8)(2005-2#1)(2005-6#1)(2005-7#11)(2005-8#6)(2005-9#1)(2006-1#4)(2006-10#64)(2006-11#5)(2006-12#16)(2006-2#9)(2006-3#3)(2006-4#4)(2006-5#16)(2006-6#1)(2006-7#9)(2006-8#12)(2006-9#8)(2007-1#3)(2007-10#13)(2007-11#36)(2007-12#23)(2007-2#21)(2007-3#11)(2007-4#5)(2007-5#4)(2007-6#1)(2007-7#19)(2007-8#14)(2007-9#14)(2008-1#31)(2008-10#184)(2008-11#51)(2008-12#20)(2008-2#21)(2008-3#22)(2008-4#53)(2008-5#32)(2008-6#28)(2008-7#78)(2008-8#59)(2008-9#42)(2009-1#4)(2009-10#9)(2009-11#7)(2009-12#8)(2009-2#6)(2009-3#4)(2009-4#9)(2009-5#19)(2009-6#17)(2009-7#8)(2009-8#38)(2009-9#8)(2010-1#6)(2010-10#8)(2010-11#14)(2010-12#33)(2010-2#6)(2010-3#15)(2010-4#10)(2010-5#7)(2010-6#7)(2010-7#12)(2010-8#10)(2010-9#8)(2011-1#28)(2011-10#1)(2011-12#5)(2011-2#50)(2011-7#1)(2012-1#19)(2012-11#6)(2012-12#40)(2012-2#47)(2012-3#23)(2012-4#1)(2012-5#1)(2012-7#1)(2012-8#2)(2012-9#2)(2013-1#44)(2013-7#14)(2013-8#33)
response toTGF-beta##2##2##(2008-6#2)
response toward fluoride##2##3##(2008-10#2)
response toward##13##2##(2007-11#1)(2007-8#2)(2008-10#7)(2010-11#1)(2012-12#1)(2013-7#1)
response towards##10##2##(1994-3#1)(2007-2#1)(2007-8#1)(2008-10#7)
response types##2##2##(1992-9#1)(2006-7#1)
response under conditions of##2##4##(2010-12#2)
response under##8##2##(1995-12#1)(2007-11#1)(2008-10#3)(2010-12#2)(2011-2#1)
response upon##2##2##(1995-5#1)(2012-3#1)
response using an##2##3##(2008-4#1)(2012-2#1)
response using##6##2##(1990-11#1)(1994-3#1)(2006-11#1)(2008-4#1)(2008-7#1)(2012-2#1)
response values##2##2##(2004-12#1)(2008-10#1)
response variability##2##2##(2006-10#1)(2008-2#1)
response variable Y##2##3##(2008-7#1)(2012-12#1)
response variable and##2##3##(2008-7#1)(2012-12#1)
response variable##12##2##(1993-7#1)(1994-6#1)(1997-7#1)(2008-10#4)(2008-6#1)(2008-7#2)(2012-12#2)
response variables to##3##3##(2007-4#1)(2008-10#2)
response variables##12##2##(1993-5#1)(1995-12#2)(1997-7#1)(2007-4#1)(2008-10#3)(2008-7#1)(2009-9#1)(2010-12#1)(2010-2#1)
response varied##2##2##(2009-9#1)(2010-12#1)
response varies##2##2##(2006-10#1)(2008-10#1)
response versus##3##2##(2008-10#3)
response was abolished by##2##4##(1992-10#1)(1994-12#1)
response was achieved in the##2##5##(2006-12#2)
response was achieved in##7##4##(1991-6#1)(1992-4#1)(2005-10#1)(2006-12#3)(2008-10#1)
response was achieved##11##3##(1991-6#1)(1992-4#1)(2005-10#1)(2006-12#4)(2008-10#2)(2010-12#1)(2012-12#1)
response was also##8##3##(1991-3#1)(1991-5#1)(1993-7#1)(1995-12#1)(1996-3#1)(2007-2#1)(2007-9#1)(2008-10#1)
response was antagonized by##2##4##(1994-8#1)(1996-12#1)
response was associated with an##2##5##(2007-8#1)(2008-11#1)
response was associated with##4##4##(1991-5#1)(1994-5#1)(2007-8#1)(2008-11#1)
response was blocked by##2##4##(1995-3#1)(2008-8#1)
response was characterized##2##3##(2007-1#1)(2008-10#1)
response was close to the##2##5##(1994-2#1)(2006-11#1)
response was defined as##3##4##(2006-8#1)(2007-8#2)
response was determined##2##3##(1996-6#1)(2010-12#1)
response was due to##2##4##(1990-2#1)(2010-8#1)
response was due##3##3##(1990-2#1)(2008-10#1)(2010-8#1)
response was elicited by##3##4##(1991-2#1)(1992-8#1)(1997-8#1)
response was elicited##6##3##(1991-2#1)(1991-9#1)(1992-8#1)(1995-5#1)(1997-8#1)(2008-4#1)
response was evaluated##6##3##(1992-4#1)(2008-10#2)(2008-12#1)(2008-5#1)(2013-1#1)
response was found##3##3##(1991-1#1)(2005-6#1)(2006-11#1)
response was further##2##3##(1995-1#1)(2008-10#1)
response was in##2##3##(2007-12#1)(2008-2#1)
response was inhibited by the##2##5##(1994-12#1)(1997-2#1)
response was inhibited##3##3##(1994-12#1)(1996-10#1)(1997-2#1)
response was investigated in##2##4##(1990-5#1)(2006-11#1)
response was investigated##4##3##(1990-5#1)(2006-11#1)(2008-10#2)
response was linear for##2##4##(1996-12#1)(2010-2#1)
response was linear from##2##4##(1993-2#1)(1997-2#1)
response was linear##11##3##(1993-2#1)(1996-12#2)(1997-2#1)(2008-10#6)(2010-2#1)
response was markedly##3##3##(1991-6#1)(1994-3#1)(1996-5#1)
response was monitored##2##3##(1995-12#1)(2008-10#1)
response was more##2##3##(1990-2#1)(1996-10#1)
response was not affected by##2##5##(1990-5#1)(1994-2#1)
response was not affected##4##4##(1990-5#1)(1994-12#1)(1994-2#1)(1997-4#1)
response was not altered by##2##5##(1990-7#1)(1994-3#1)
response was not significantly##2##4##(1997-8#1)(2008-10#1)
response was not##16##3##(1990-5#1)(1990-7#1)(1991-10#1)(1991-8#1)(1992-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-2#1)(1996-7#1)(1997-4#1)(1997-8#1)(2008-10#1)(2009-9#1)(2012-2#1)
response was observed for##3##4##(1996-12#1)(2008-10#1)(2009-3#1)
response was observed from##2##4##(2007-8#1)(2008-12#1)
response was observed in the##4##5##(1992-8#1)(1996-5#1)(2008-10#1)(2009-3#1)
response was observed in##17##4##(1990-10#1)(1990-2#1)(1990-6#1)(1991-2#1)(1992-8#1)(1993-9#1)(1995-12#2)(1996-5#1)(2005-7#1)(2006-6#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-3#1)
response was observed to##2##4##(2004-11#1)(2006-10#1)
response was observed##32##3##(1990-10#1)(1990-2#2)(1990-6#1)(1990-9#1)(1991-2#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-9#1)(1995-12#2)(1996-12#1)(1996-5#1)(2004-11#2)(2005-7#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#2)
response was obtained by##2##4##(2008-10#1)(2008-2#1)
response was obtained for##2##4##(2008-10#1)(2008-5#1)
response was obtained in the##4##5##(1992-4#1)(2008-10#3)
response was obtained in##6##4##(1992-12#1)(1992-4#1)(2008-10#3)(2008-5#1)
response was obtained over##2##4##(1997-3#1)(2008-10#1)
response was obtained##21##3##(1992-12#2)(1992-4#1)(1992-8#1)(1993-12#1)(1997-3#1)(2008-1#1)(2008-10#11)(2008-2#1)(2008-5#2)
response was of##3##3##(1996-11#1)(2006-11#1)(2006-6#1)
response was only##2##3##(1997-2#1)(2004-4#1)
response was potentiated by##2##4##(1991-9#1)(2012-12#1)
response was recorded##4##3##(1992-7#1)(2008-1#1)(2008-10#1)(2008-6#1)
response was reduced##3##3##(1991-9#1)(1994-10#1)(2008-4#1)
response was required only to##2##5##(1996-1#2)
response was seen in##2##4##(1991-3#1)(2007-11#1)
response was seen##5##3##(1991-12#1)(1991-3#1)(1995-12#1)(2007-11#1)(2008-10#1)
response was significantly delayed and##2##5##(1997-3#2)
response was significantly##5##3##(1997-3#2)(2008-11#1)(2008-12#1)(2008-4#1)
response was similar in both##2##5##(1991-10#1)(2006-6#1)
response was similar to the##2##5##(2007-1#1)(2009-10#1)
response was similar##5##3##(1991-10#1)(2006-6#1)(2007-1#1)(2009-10#1)(2009-3#1)
response was still##2##3##(1992-6#1)(2007-2#1)
response was studied in##2##4##(1997-1#1)(1997-2#1)
response was studied##4##3##(1997-1#1)(1997-2#1)(2008-10#2)
response was typically##3##3##(1990-7#1)(2007-12#1)(2013-8#1)
response was##285##2##(1990-10#3)(1990-2#6)(1990-5#3)(1990-6#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#4)(1991-2#2)(1991-3#2)(1991-5#3)(1991-6#4)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#3)(1992-6#3)(1992-7#2)(1992-8#4)(1993-12#5)(1993-2#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#3)(1994-2#2)(1994-3#4)(1994-5#1)(1994-8#2)(1995-1#2)(1995-12#6)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#4)(1997-4#1)(1997-7#1)(1997-8#2)(2004-11#2)(2004-4#1)(2005-10#1)(2005-6#1)(2005-7#1)(2006-10#1)(2006-11#5)(2006-12#6)(2006-2#1)(2006-6#3)(2006-7#1)(2006-8#1)(2007-1#3)(2007-11#3)(2007-12#2)(2007-2#4)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#56)(2008-11#4)(2008-12#5)(2008-2#2)(2008-4#4)(2008-5#6)(2008-6#2)(2008-8#4)(2008-9#1)(2009-10#3)(2009-3#3)(2009-4#1)(2009-9#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
response were also##3##3##(2005-12#1)(2008-10#1)(2010-11#1)
response were examined in##2##4##(1993-11#1)(2008-2#1)
response were found##3##3##(1991-2#1)(1992-9#1)(2008-6#1)
response were observed##2##3##(1993-2#1)(2008-6#1)
response were##26##2##(1991-2#1)(1991-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1995-5#1)(1995-6#1)(2005-11#1)(2005-12#1)(2006-6#3)(2007-11#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-6#3)(2010-11#1)(2012-12#2)(2012-2#1)(2013-1#1)
response when a##2##3##(1990-5#1)(2008-9#1)
response when it is##2##4##(2007-12#2)
response when tested##2##3##(1992-2#1)(1994-5#1)
response when the##2##3##(1993-2#1)(2006-10#1)
response when##24##2##(1990-5#1)(1991-5#1)(1992-2#1)(1993-2#2)(1994-3#1)(1994-5#1)(1994-9#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-2#2)(2008-7#1)(2008-9#1)(2009-6#1)(2011-2#1)
response which is##4##3##(1994-11#1)(1996-2#1)(1997-6#1)(2007-4#1)
response which was##2##3##(1991-7#1)(2008-9#1)
response which##10##2##(1991-7#1)(1992-7#1)(1994-11#1)(1996-2#1)(1997-6#1)(2007-4#1)(2008-11#1)(2008-9#2)(2010-9#1)
response while##5##2##(1990-5#1)(1990-7#1)(2008-10#2)(2010-12#1)
response will be##3##3##(1990-4#1)(2008-11#1)(2008-7#1)
response will##7##2##(1990-4#1)(2006-8#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-7#2)
response with a good##2##4##(1993-4#1)(2008-10#1)
response with a slope of##2##5##(2008-10#2)
response with a##10##3##(1990-12#1)(1990-7#1)(1993-4#1)(2006-8#1)(2008-10#4)(2009-4#1)(2010-4#1)
response with an##4##3##(1990-11#2)(1991-12#1)(2008-10#1)
response with no##2##3##(1993-11#1)(1995-6#1)
response with the##4##3##(1990-5#1)(1995-5#1)(2006-10#1)(2010-12#1)
response with##53##2##(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#1)(1992-4#1)(1992-9#2)(1993-11#1)(1993-4#2)(1993-6#1)(1994-2#1)(1994-3#2)(1995-5#1)(1995-6#1)(1995-7#1)(1996-5#1)(1996-9#1)(2006-10#2)(2006-11#1)(2006-8#2)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#9)(2008-2#2)(2008-3#1)(2008-7#3)(2009-4#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#2)(2013-7#1)
response within the##2##3##(1995-2#1)(1996-4#1)
response within##6##2##(1990-10#1)(1995-2#1)(1996-4#1)(2007-8#1)(2008-10#1)(2008-4#1)
response without##2##2##(1997-5#1)(2007-11#1)
response would be##3##3##(1992-12#1)(2005-7#1)(2013-7#1)
response would##6##2##(1991-5#1)(1992-12#1)(2005-7#1)(2005-9#1)(2007-12#1)(2013-7#1)
response##8150##1##(1990-1#1)(1990-10#26)(1990-11#28)(1990-12#33)(1990-2#41)(1990-3#7)(1990-4#10)(1990-5#34)(1990-6#20)(1990-7#35)(1990-8#24)(1990-9#13)(1991-1#19)(1991-10#15)(1991-11#27)(1991-12#64)(1991-2#36)(1991-3#15)(1991-4#11)(1991-5#45)(1991-6#16)(1991-7#24)(1991-8#32)(1991-9#19)(1992-1#21)(1992-10#22)(1992-11#11)(1992-12#37)(1992-2#23)(1992-3#30)(1992-4#17)(1992-5#4)(1992-6#32)(1992-7#35)(1992-8#46)(1992-9#34)(1993-1#6)(1993-10#2)(1993-11#29)(1993-12#73)(1993-2#38)(1993-3#33)(1993-4#12)(1993-5#9)(1993-6#45)(1993-7#19)(1993-8#20)(1993-9#25)(1994-1#5)(1994-10#23)(1994-11#46)(1994-12#45)(1994-2#58)(1994-3#47)(1994-4#1)(1994-5#25)(1994-6#38)(1994-7#5)(1994-8#48)(1994-9#24)(1995-1#29)(1995-10#8)(1995-11#21)(1995-12#86)(1995-2#52)(1995-3#37)(1995-4#9)(1995-5#37)(1995-6#36)(1995-7#11)(1995-8#43)(1995-9#14)(1996-1#27)(1996-10#43)(1996-11#17)(1996-12#63)(1996-2#48)(1996-3#25)(1996-4#15)(1996-5#53)(1996-6#14)(1996-7#9)(1996-8#33)(1996-9#30)(1997-1#32)(1997-2#59)(1997-3#33)(1997-4#32)(1997-5#32)(1997-6#27)(1997-7#41)(1997-8#30)(2004-1#4)(2004-10#4)(2004-11#11)(2004-12#20)(2004-2#17)(2004-3#3)(2004-4#2)(2004-7#3)(2004-9#4)(2005-10#19)(2005-11#20)(2005-12#13)(2005-2#2)(2005-4#2)(2005-6#2)(2005-7#30)(2005-8#15)(2005-9#6)(2006-1#11)(2006-10#183)(2006-11#57)(2006-12#46)(2006-2#31)(2006-3#9)(2006-4#12)(2006-5#31)(2006-6#37)(2006-7#27)(2006-8#38)(2006-9#22)(2007-1#41)(2007-10#40)(2007-11#180)(2007-12#159)(2007-2#45)(2007-3#15)(2007-4#51)(2007-5#10)(2007-6#11)(2007-7#47)(2007-8#62)(2007-9#44)(2008-1#84)(2008-10#1109)(2008-11#141)(2008-12#50)(2008-2#142)(2008-3#140)(2008-4#133)(2008-5#138)(2008-6#79)(2008-7#208)(2008-8#123)(2008-9#111)(2009-1#4)(2009-10#38)(2009-11#21)(2009-12#23)(2009-2#13)(2009-3#14)(2009-4#24)(2009-5#39)(2009-6#33)(2009-7#12)(2009-8#82)(2009-9#25)(2010-1#24)(2010-10#18)(2010-11#24)(2010-12#115)(2010-2#40)(2010-3#47)(2010-4#41)(2010-5#29)(2010-6#11)(2010-7#19)(2010-8#31)(2010-9#19)(2011-1#82)(2011-10#1)(2011-11#1)(2011-12#10)(2011-2#152)(2011-3#1)(2011-7#1)(2012-1#51)(2012-11#10)(2012-12#110)(2012-2#141)(2012-3#91)(2012-4#2)(2012-5#1)(2012-6#2)(2012-7#2)(2012-8#2)(2012-9#3)(2013-1#157)(2013-7#42)(2013-8#69)
response&quot##5##1##(1995-2#1)(1995-3#1)(2008-10#1)(2008-8#2)
response(s)##2##1##(2008-1#2)
response) and##3##2##(1994-12#1)(2007-7#1)(2013-1#1)
response) was##2##2##(2008-10#2)
response)##30##1##(1990-11#1)(1990-12#1)(1990-8#3)(1991-5#1)(1992-10#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-11#1)(1997-2#1)(2004-12#1)(2007-6#1)(2007-7#2)(2008-10#4)(2008-3#1)(2009-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#3)
response)/(untreated control response)##2##3##(2008-10#2)
response-adaptive randomization##2##2##(2012-2#2)
response-related activity##2##2##(1990-10#2)
response-related neurons##2##2##(1990-10#2)
response-related##9##1##(1990-10#5)(1995-3#1)(2009-10#1)(2012-2#2)
response]##4##1##(1996-6#1)(2008-2#1)(2008-4#1)(2012-2#1)
responses (CR)##2##2##(1991-2#1)(2008-5#1)
responses (defined as##2##3##(2007-11#2)
responses (e##2##2##(1996-2#1)(2008-1#1)
responses (i##3##2##(1994-2#1)(2007-10#2)
responses [##2##2##(1995-10#2)
responses above##2##2##(2008-10#2)
responses across##2##2##(2008-2#1)(2010-4#1)
responses after vaccination##2##3##(2006-10#1)(2007-2#1)
responses after##17##2##(1990-4#1)(1992-9#1)(1995-5#1)(1996-8#1)(1997-2#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-7#2)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
responses against a##3##3##(1991-4#1)(2008-11#1)(2009-6#1)
responses against bacterial##3##3##(1992-5#1)(2008-10#1)(2012-12#1)
responses against the##3##3##(1991-9#1)(2011-2#1)(2012-3#1)
responses against##23##2##(1991-4#1)(1991-9#1)(1992-5#1)(1995-2#2)(1995-5#1)(1997-4#1)(2006-10#2)(2007-5#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
responses among##2##2##(2007-11#1)(2012-5#1)
responses and a##4##3##(1991-3#1)(2004-12#1)(2008-3#1)(2008-9#1)
responses and chronic##2##3##(1991-3#1)(2010-5#1)
responses and injuries in##2##4##(2006-11#2)
responses and injuries##3##3##(2006-11#3)
responses and provide##3##3##(1991-12#1)(2012-1#1)(2013-7#1)
responses and the##7##3##(1990-11#1)(2007-1#1)(2007-4#1)(2008-1#1)(2008-9#2)(2012-1#1)
responses and##118##2##(1990-11#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-8#1)(1992-3#3)(1992-6#1)(1992-7#2)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1995-1#1)(1995-2#2)(1995-5#2)(1995-7#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-4#1)(1997-6#1)(2004-12#1)(2004-4#1)(2005-10#1)(2005-11#2)(2005-5#1)(2006-10#3)(2006-11#4)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#6)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#5)(2009-12#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
responses appear to be##2##4##(2009-5#1)(2010-10#1)
responses appear##3##2##(1994-3#1)(2009-5#1)(2010-10#1)
responses are involved##2##3##(1994-11#1)(2011-1#1)
responses are limited##2##3##(2006-10#1)(2010-7#1)
responses are mediated by the##2##5##(1995-12#2)
responses are mediated by##3##4##(1995-12#3)
responses are observed##3##3##(2006-11#1)(2007-11#1)(2008-10#1)
responses are##58##2##(1990-4#1)(1991-2#1)(1993-12#1)(1993-4#1)(1994-11#1)(1995-12#4)(1995-5#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-4#1)(2006-10#3)(2006-11#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#2)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#4)(2010-12#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
responses as a function of##3##5##(2008-11#1)(2008-5#1)(2008-6#1)
responses as a##4##3##(1994-5#1)(2008-11#1)(2008-5#1)(2008-6#1)
responses as compared to##2##4##(1995-5#1)(2013-1#1)
responses as##14##2##(1991-12#1)(1991-2#1)(1994-11#1)(1994-5#1)(1995-5#1)(1997-1#1)(2006-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-2#1)(2012-2#1)(2013-1#1)
responses associated with##7##3##(1995-9#1)(1997-5#1)(1997-6#1)(2008-10#1)(2008-3#1)(2009-10#1)(2011-1#1)
responses associated##8##2##(1995-9#1)(1997-5#1)(1997-6#1)(2008-10#1)(2008-3#1)(2009-10#1)(2011-1#1)(2012-12#1)
responses at all##2##3##(1991-3#1)(1994-5#1)
responses at an##2##3##(2005-8#1)(2008-10#1)
responses at each##2##3##(2008-12#1)(2011-1#1)
responses at the##4##3##(1990-12#1)(2009-8#1)(2012-1#1)(2013-8#1)
responses at##16##2##(1990-12#1)(1991-3#1)(1993-2#1)(1994-10#1)(1994-5#1)(2005-8#1)(2008-10#3)(2008-12#1)(2009-5#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-1#1)(2013-8#1)
responses attributed##2##2##(1997-5#1)(2008-4#1)
responses based on##3##3##(2008-1#1)(2008-5#1)(2008-8#1)
responses before and after##2##4##(1993-6#1)(1996-5#1)
responses before##3##2##(1993-6#1)(1996-5#1)(2006-2#1)
responses between##2##2##(2006-10#1)(2008-10#1)
responses but also##2##3##(2006-10#1)(2010-5#1)
responses but blocked##2##3##(1996-12#1)(1996-5#1)
responses but##8##2##(1994-8#1)(1996-12#1)(1996-5#1)(2006-10#1)(2008-11#1)(2008-9#1)(2010-2#1)(2010-5#1)
responses by a##2##3##(1990-5#1)(2009-8#1)
responses by binding to##2##4##(1993-12#1)(2008-4#1)
responses by sensitization of##2##4##(1991-5#2)
responses by the##4##3##(1994-10#1)(2004-11#1)(2011-2#1)(2012-3#1)
responses by##38##2##(1990-2#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-5#2)(1991-9#1)(1992-6#1)(1993-12#2)(1994-10#1)(1994-12#1)(1994-2#2)(1995-2#1)(1995-8#1)(1996-11#1)(2004-11#1)(2006-10#2)(2006-2#1)(2007-11#1)(2008-10#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#2)
responses can be##9##3##(1995-11#1)(1995-12#1)(1997-7#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-2#1)(2012-1#1)
responses can##11##2##(1994-9#1)(1995-11#1)(1995-12#1)(1996-10#1)(1997-7#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-2#1)(2012-1#1)
responses compared to##5##3##(1994-3#1)(1996-10#1)(2008-10#1)(2008-11#1)(2008-5#1)
responses compared##6##2##(1994-3#1)(1995-11#1)(1996-10#1)(2008-10#1)(2008-11#1)(2008-5#1)
responses could be##6##3##(1994-2#1)(1995-11#1)(1995-5#1)(2008-10#2)(2008-5#1)
responses depended on##2##3##(2007-9#1)(2012-6#1)
responses depending on the##3##4##(1993-11#1)(1993-6#1)(1997-5#1)
responses depends##2##2##(1993-7#1)(2008-11#1)
responses derived##2##2##(2008-7#1)(2009-5#1)
responses did not##2##3##(2007-5#1)(2012-2#1)
responses differ##2##2##(1994-11#1)(2007-8#1)
responses differed##4##2##(1991-2#1)(2008-8#1)(2009-12#1)(2012-2#1)
responses during the##4##3##(1990-10#1)(1993-11#1)(2007-6#1)(2011-2#1)
responses during##23##2##(1990-10#1)(1991-6#3)(1993-11#1)(1993-2#1)(1993-3#1)(1994-6#1)(1995-2#1)(2005-8#1)(2007-11#1)(2007-6#1)(2008-7#1)(2009-12#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#4)
responses either##2##2##(1990-2#1)(1995-9#1)
responses elicited by the##4##4##(1993-11#1)(1993-3#1)(1993-9#1)(2006-10#1)
responses elicited by##12##3##(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-8#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-10#2)(2008-11#1)
responses elicited##13##2##(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-8#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-10#2)(2008-11#1)
responses even##2##2##(2008-5#1)(2008-7#1)
responses evoked by electrical stimulation of the##2##7##(1991-8#1)(1993-12#1)
responses evoked by##9##3##(1991-11#1)(1991-8#2)(1992-3#1)(1992-8#1)(1993-12#1)(1996-9#1)(2005-11#2)
responses evoked in the nucleus tractus solitarii##2##7##(1992-3#2)
responses evoked in the##3##4##(1992-3#2)(1996-5#1)
responses evoked##12##2##(1991-11#1)(1991-8#2)(1992-3#3)(1992-8#1)(1993-12#1)(1996-5#1)(1996-9#1)(2005-11#2)
responses following vaccination##2##3##(1995-4#1)(1995-5#1)
responses following##11##2##(1995-12#1)(1995-4#1)(1995-5#2)(1996-1#1)(1997-4#1)(2003-11#1)(2004-4#1)(2008-4#3)
responses for a##2##3##(1995-7#1)(2007-12#1)
responses for all##3##3##(1991-8#1)(2008-10#1)(2008-2#1)
responses for at least 1##2##5##(2007-10#2)
responses for both##4##3##(1990-4#1)(2008-10#1)(2008-11#1)(2009-3#1)
responses for each##3##3##(2010-11#2)(2013-1#1)
responses for the##3##3##(2007-4#1)(2008-10#2)
responses for##38##2##(1990-4#1)(1991-8#1)(1995-7#1)(2004-12#1)(2006-11#1)(2007-10#2)(2007-12#2)(2007-4#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-2#1)(2009-3#1)(2010-10#1)(2010-11#2)(2011-1#1)(2012-1#1)(2012-2#3)(2013-1#1)
responses from a##4##3##(1993-11#1)(1995-4#1)(2007-9#1)(2012-3#1)
responses from the##3##3##(1993-12#1)(1995-12#1)(2007-3#1)
responses from##29##2##(1991-8#1)(1992-7#1)(1993-11#1)(1993-12#2)(1994-2#1)(1995-12#2)(1995-4#1)(1996-1#1)(1996-3#1)(1996-6#1)(2004-4#1)(2006-11#1)(2006-5#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-4#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
responses generated by##2##3##(2005-7#1)(2009-4#1)
responses has been##2##3##(2007-7#1)(2008-10#1)
responses has##3##2##(2007-4#1)(2007-7#1)(2008-10#1)
responses have been##5##3##(2005-7#1)(2006-2#1)(2007-12#1)(2008-3#1)(2008-7#1)
responses have not been##2##4##(1991-6#1)(2012-2#1)
responses have##13##2##(1991-6#1)(2005-7#2)(2006-10#2)(2006-2#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#1)(2012-2#2)
responses in Arabidopsis##4##3##(1997-8#2)(2009-8#2)
responses in HIV##2##3##(2009-4#1)(2012-12#1)
responses in a##8##3##(1991-5#1)(1992-3#1)(1993-12#1)(1996-2#1)(1996-5#1)(2008-11#1)(2008-7#1)(2013-1#1)
responses in both##5##3##(1990-7#1)(1993-3#1)(1995-5#1)(1996-10#1)(2008-4#1)
responses in conscious rabbits##2##4##(1997-8#2)
responses in conscious##3##3##(1990-2#1)(1997-8#2)
responses in corpora cavernosa from##2##5##(2009-11#2)
responses in human##3##3##(1992-3#1)(1994-12#1)(2008-7#1)
responses in male rats##2##4##(2008-10#1)(2013-8#1)
responses in mice##6##3##(1996-2#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-4#2)
responses in muscles##2##3##(1995-8#2)
responses in patients with metastatic##2##5##(2007-11#1)(2013-1#1)
responses in patients with##5##4##(2006-8#1)(2007-11#3)(2013-1#1)
responses in peripheral##2##3##(2006-10#1)(2011-2#1)
responses in primary##4##3##(1993-7#1)(1997-8#1)(2008-11#1)(2008-9#1)
responses in rat##3##3##(1991-3#1)(1995-12#1)(1996-2#1)
responses in rice##2##3##(2008-10#1)(2008-7#1)
responses in some##2##3##(2007-3#1)(2010-12#1)
responses in that##2##3##(1992-1#1)(1995-12#1)
responses in the anterior##2##4##(2009-2#1)(2013-1#1)
responses in the elderly##2##4##(1995-12#1)(2007-11#1)
responses in the presence##2##4##(1990-2#1)(2008-11#1)
responses in the rat##5##4##(1991-8#1)(1992-1#1)(1994-2#1)(1996-5#1)(2008-10#1)
responses in the spleen##2##4##(2013-1#1)(2013-8#1)
responses in the two##2##4##(2006-10#1)(2012-3#1)
responses in the##55##3##(1990-11#1)(1990-2#1)(1991-8#3)(1992-1#2)(1993-12#1)(1993-6#2)(1994-2#3)(1995-12#5)(1995-5#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-6#1)(2004-11#1)(2005-10#1)(2006-10#2)(2007-11#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2010-2#1)(2010-4#1)(2012-3#1)(2013-1#2)(2013-8#3)
responses in these cells##3##4##(1994-2#1)(1994-9#1)(1995-7#1)
responses in these##5##3##(1994-2#1)(1994-9#1)(1995-7#1)(2007-11#1)(2008-5#1)
responses in this##2##3##(1990-11#1)(2008-10#1)
responses in various##3##3##(1993-11#1)(2005-12#1)(2009-4#1)
responses in vitro##8##3##(1994-11#1)(1994-9#1)(1995-12#1)(1995-2#2)(1996-10#1)(2007-11#1)(2008-11#1)
responses in vivo##8##3##(1993-11#1)(1995-8#1)(1996-10#2)(2008-11#1)(2008-7#1)(2012-12#2)
responses in##293##2##(1990-11#3)(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#2)(1991-10#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-5#3)(1991-6#1)(1991-8#3)(1991-9#1)(1992-1#4)(1992-3#3)(1992-4#1)(1992-8#1)(1992-9#1)(1993-11#4)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-7#2)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#5)(1994-3#1)(1994-6#3)(1994-8#1)(1994-9#3)(1995-11#3)(1995-12#11)(1995-2#3)(1995-3#3)(1995-5#2)(1995-7#2)(1995-8#4)(1996-10#4)(1996-11#1)(1996-12#1)(1996-2#3)(1996-5#2)(1996-7#1)(1996-8#2)(1996-9#3)(1997-2#1)(1997-4#2)(1997-5#3)(1997-6#3)(1997-8#6)(2004-11#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-9#1)(2006-10#5)(2006-3#1)(2006-8#2)(2007-11#11)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#29)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#9)(2008-5#5)(2008-6#2)(2008-7#9)(2008-8#4)(2008-9#9)(2009-11#4)(2009-2#2)(2009-4#4)(2009-5#1)(2009-8#3)(2010-10#1)(2010-12#3)(2010-2#3)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#4)(2012-12#3)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#8)(2013-7#1)(2013-8#7)
responses include an##2##3##(2008-4#1)(2009-6#1)
responses include##3##2##(2008-4#1)(2009-6#1)(2009-8#1)
responses included##5##2##(1997-7#1)(2007-10#1)(2008-10#1)(2011-2#2)
responses including##6##2##(1990-2#1)(2006-2#1)(2008-10#1)(2009-12#1)(2009-8#1)(2012-1#1)
responses increased with##2##3##(1996-1#1)(2012-1#1)
responses increased##5##2##(1996-1#1)(2007-11#1)(2008-12#2)(2012-1#1)
responses indicate##2##2##(1991-2#1)(1993-12#1)
responses indicated that##2##3##(2007-12#1)(2008-6#1)
responses induced by##22##3##(1990-3#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-8#3)(1993-11#2)(1993-12#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-8#1)(2006-5#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-5#3)
responses into##2##2##(2008-2#1)(2011-1#1)
responses involved in##2##3##(2005-6#1)(2007-11#1)
responses involving##2##2##(1991-6#1)(1992-12#1)
responses is##8##2##(1993-6#1)(1995-2#1)(1996-1#1)(1996-2#1)(2006-10#1)(2008-4#2)(2010-7#1)
responses leading to##5##3##(2005-8#1)(2006-10#1)(2008-10#1)(2008-9#1)(2010-4#1)
responses may be##8##3##(1994-11#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2013-8#1)
responses may have##4##3##(1995-12#2)(2007-3#1)(2008-8#1)
responses may not##3##3##(2006-10#2)(2008-12#1)
responses may##25##2##(1991-9#1)(1994-11#1)(1994-6#1)(1995-12#3)(1996-12#1)(1997-2#1)(2006-10#3)(2007-3#1)(2007-9#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2012-5#1)(2013-8#1)
responses mediated by##11##3##(1992-2#1)(1992-8#1)(1994-10#1)(1994-6#1)(1995-11#1)(1995-8#1)(2005-7#1)(2006-10#1)(2008-1#1)(2011-12#1)(2012-12#1)
responses must be##2##3##(2007-12#1)(2012-12#1)
responses observed in##3##3##(1993-2#1)(2008-10#1)(2009-7#1)
responses observed##6##2##(1993-2#1)(1997-4#1)(2007-1#1)(2008-10#1)(2008-7#1)(2009-7#1)
responses obtained from##2##3##(1996-1#1)(2007-11#1)
responses obtained in##2##3##(1991-3#1)(2008-10#1)
responses obtained##8##2##(1990-8#1)(1991-2#1)(1991-3#1)(1996-1#1)(1996-5#1)(2007-11#1)(2008-10#1)(2013-8#1)
responses occur##3##2##(1996-12#1)(2006-12#1)(2008-5#1)
responses occurred##3##2##(2007-11#1)(2008-10#2)
responses of 1x10(-5) to##2##4##(2008-10#2)
responses of European##2##3##(2008-9#1)(2012-7#1)
responses of P##2##3##(1993-11#1)(2013-7#1)
responses of T cells to##2##5##(1996-10#1)(2008-4#1)
responses of T cells##3##4##(1995-12#1)(1996-10#1)(2008-4#1)
responses of T##4##3##(1995-12#1)(1996-10#1)(2008-4#1)(2012-5#1)
responses of Xenopus oocytes##2##4##(1990-7#2)
responses of a##4##3##(1991-2#1)(1992-7#1)(2007-11#1)(2008-11#1)
responses of adult##2##3##(2004-11#1)(2007-6#1)
responses of both##4##3##(1990-10#1)(1995-9#1)(2006-11#1)(2007-4#1)
responses of cells in##2##4##(1994-10#1)(2008-11#1)
responses of cells##4##3##(1994-10#1)(1996-12#1)(1997-4#1)(2008-11#1)
responses of different##2##3##(2008-10#1)(2011-12#1)
responses of four##2##3##(1992-10#1)(2008-10#1)
responses of high and low body satisfied##2##7##(2006-7#2)
responses of human##7##3##(1993-11#2)(1997-7#1)(2007-4#1)(2008-4#1)(2013-1#2)
responses of hybridoma and yeast cells to##2##7##(1994-11#2)
responses of hybridoma and yeast##3##5##(1994-11#3)
responses of individual species##2##4##(2008-6#1)(2009-8#1)
responses of injured##2##3##(1991-3#1)(2007-4#1)
responses of juvenile##2##3##(2010-8#2)
responses of living cells##2##4##(2007-12#2)
responses of male##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
responses of neurons in##2##4##(2008-7#1)(2008-8#1)
responses of organisms to##3##4##(1995-12#1)(2008-7#1)(2011-12#1)
responses of patients##3##3##(1992-3#2)(2008-7#1)
responses of plant##5##3##(1997-8#1)(2008-8#1)(2009-8#1)(2012-2#1)(2012-6#1)
responses of plants to##4##4##(1995-8#1)(2008-10#1)(2008-8#1)(2012-5#1)
responses of rat##5##3##(1990-11#1)(1990-12#1)(1995-6#1)(1995-7#2)
responses of the anal canal##2##5##(2011-2#2)
responses of the three##2##4##(2004-4#1)(2007-6#1)
responses of the two##4##4##(1990-11#1)(1991-11#1)(1993-2#1)(2008-7#1)
responses of the##68##3##(1990-11#1)(1990-12#1)(1990-4#2)(1990-5#2)(1990-9#1)(1991-11#1)(1991-9#1)(1992-11#1)(1992-4#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#5)(1995-8#1)(1996-12#1)(1996-9#1)(1997-2#3)(1997-4#1)(2004-4#1)(2004-9#1)(2005-7#1)(2006-11#4)(2007-11#1)(2007-12#1)(2007-4#3)(2007-6#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-5#1)(2011-12#1)(2011-2#3)(2012-12#1)(2013-1#1)
responses of these neurons##2##4##(1991-3#1)(2008-11#1)
responses of these##8##3##(1991-3#1)(1991-6#1)(1994-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2013-1#1)
responses of this##2##3##(2007-4#1)(2008-10#1)
responses of those##2##3##(1995-12#1)(2010-4#1)
responses of three##2##3##(2010-5#1)(2012-2#1)
responses of two##2##3##(1991-11#1)(1996-11#1)
responses of##320##2##(1990-10#1)(1990-11#4)(1990-12#3)(1990-2#1)(1990-4#5)(1990-5#3)(1990-7#4)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#4)(1991-3#3)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-3#4)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#5)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-10#2)(1994-11#4)(1994-12#4)(1994-2#4)(1994-4#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-11#2)(1995-12#5)(1995-3#6)(1995-6#2)(1995-7#3)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-8#1)(1996-9#2)(1997-2#4)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#2)(2004-4#1)(2004-9#1)(2005-7#3)(2006-10#1)(2006-11#5)(2006-12#2)(2006-2#1)(2006-7#2)(2006-8#1)(2007-11#8)(2007-12#5)(2007-2#2)(2007-4#7)(2007-6#2)(2007-7#2)(2008-10#29)(2008-11#9)(2008-12#4)(2008-2#2)(2008-3#4)(2008-4#6)(2008-5#10)(2008-6#1)(2008-7#5)(2008-8#11)(2008-9#5)(2009-10#3)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#9)(2010-1#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-8#2)(2011-1#3)(2011-12#4)(2011-2#5)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#2)(2012-5#4)(2012-6#3)(2012-7#2)(2012-9#1)(2013-1#8)(2013-7#2)
responses on the##2##3##(1996-7#1)(2008-7#1)
responses on##18##2##(1990-10#1)(1991-3#1)(1992-10#2)(1992-9#2)(1993-3#1)(1996-7#1)(2006-6#1)(2007-1#1)(2008-1#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-1#1)(2013-8#1)
responses or##6##2##(1991-3#1)(1994-8#1)(2008-11#1)(2008-7#2)(2009-11#1)
responses over a wide##2##4##(2007-11#1)(2008-10#1)
responses over the##2##3##(2008-10#1)(2010-10#1)
responses over##6##2##(2007-11#1)(2008-10#2)(2008-4#1)(2008-9#1)(2010-10#1)
responses persisted##2##2##(1991-3#1)(1997-2#1)
responses produced by##5##3##(1991-12#1)(1991-5#1)(1992-7#2)(1995-12#1)
responses provided a##2##3##(1993-12#1)(2009-7#1)
responses provided by##3##3##(1995-12#1)(2007-12#1)(2008-6#1)
responses provided##7##2##(1993-12#1)(1995-12#1)(2007-12#1)(2008-12#1)(2008-6#1)(2009-7#1)(2013-1#1)
responses recorded in##2##3##(1990-10#1)(1990-7#1)
responses recorded##3##2##(1990-10#1)(1990-7#1)(2007-5#1)
responses regulated##2##2##(1993-6#1)(2008-11#1)
responses related to##2##3##(1996-1#1)(2008-7#1)
responses resulting from##2##3##(1996-5#1)(2010-5#1)
responses revealed##2##2##(2008-10#1)(2011-2#1)
responses seen in##3##3##(1996-10#1)(2008-12#1)(2008-5#1)
responses seen##5##2##(1991-11#1)(1991-8#1)(1996-10#1)(2008-12#1)(2008-5#1)
responses should##2##2##(1994-2#1)(2007-11#1)
responses showed##2##2##(1997-5#1)(2013-1#1)
responses similar to those##2##4##(1993-7#1)(2007-12#1)
responses such as##6##3##(1993-3#1)(1995-12#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-3#1)
responses tended to##2##3##(2008-4#1)(2008-8#1)
responses than the##3##3##(1996-9#1)(2007-6#1)(2008-10#1)
responses than##11##2##(1995-12#1)(1996-9#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-4#1)(2008-9#3)(2013-7#1)
responses that are##9##3##(1994-11#2)(1994-2#1)(1995-12#1)(2006-11#1)(2008-10#2)(2009-10#1)(2009-8#1)
responses that may##2##3##(2006-10#1)(2008-10#1)
responses that were significantly##2##4##(1991-12#1)(2008-10#1)
responses that were##4##3##(1991-12#1)(2008-10#2)(2008-6#1)
responses that##44##2##(1991-12#1)(1991-8#2)(1992-7#1)(1993-4#1)(1994-11#3)(1994-2#1)(1995-1#1)(1995-12#1)(1996-6#1)(1996-7#1)(1997-6#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#2)(2007-12#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-5#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-3#1)
responses through the##5##3##(1995-3#1)(2008-11#1)(2008-3#1)(2008-4#2)
responses through##9##2##(1995-3#2)(2006-10#1)(2008-11#1)(2008-3#1)(2008-4#3)(2009-8#1)
responses throughout##2##2##(1991-3#1)(2010-4#1)
responses to &quot##2##3##(1994-1#1)(2010-4#1)
responses to CBA/j##2##3##(1991-12#2)
responses to D-amphetamine##3##3##(1996-8#3)
responses to GABA##2##3##(1995-6#1)(1995-7#1)
responses to HIV/AIDS##5##3##(1995-2#1)(2007-7#4)
responses to IBV##2##3##(1997-3#1)(2008-5#1)
responses to L-glutamate##2##3##(1996-5#1)(1997-2#1)
responses to NMDA and##2##4##(1992-6#1)(1996-5#1)
responses to NMDA##4##3##(1991-6#1)(1992-6#1)(1996-5#2)
responses to SRBC and##2##4##(2005-9#1)(2008-10#1)
responses to TPA##2##3##(1990-4#1)(1994-6#1)
responses to VIP##3##3##(1994-8#1)(1995-11#2)
responses to a thermogenic nutritional supplement at rest##2##8##(2013-8#2)
responses to a wide##2##4##(1997-2#1)(2011-1#1)
responses to a##19##3##(1991-5#1)(1994-11#1)(1994-12#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-2#1)(1997-2#1)(1997-5#1)(2006-12#1)(2006-4#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-1#1)(2013-8#2)
responses to acetylcholine##2##3##(1994-7#1)(1996-12#1)
responses to acute##4##3##(1991-8#1)(2008-11#1)(2008-7#1)(2009-4#1)
responses to adrenergic##2##3##(1991-12#1)(1996-10#1)
responses to all##2##3##(2008-10#1)(2012-3#1)
responses to alpha##2##3##(1990-11#1)(1996-12#1)
responses to an##5##3##(1991-6#1)(1997-1#1)(2008-10#1)(2012-2#1)(2012-3#1)
responses to angiotensin##4##3##(1991-12#2)(1993-3#1)(1994-2#1)
responses to angiotensinogen##2##3##(1991-5#2)
responses to any##2##3##(2004-11#1)(2008-5#1)
responses to both##3##3##(1991-5#1)(2006-12#1)(2009-11#1)
responses to certain##3##3##(1990-5#1)(1990-7#1)(2008-10#1)
responses to changes in##6##4##(1991-9#1)(1993-1#1)(1995-6#1)(2008-10#1)(2008-2#1)(2008-7#1)
responses to cholinergic and##2##4##(1992-8#1)(1993-9#1)
responses to different##3##3##(1995-12#1)(2012-2#1)(2013-1#1)
responses to drought##2##3##(2006-12#1)(2008-7#1)
responses to drugs##2##3##(2006-10#1)(2008-5#1)
responses to either##3##3##(1991-6#1)(1992-1#1)(1995-2#1)
responses to electrical and##2##4##(1991-5#1)(1996-5#1)
responses to emerging##2##3##(2007-12#1)(2012-2#1)
responses to endothelin-1##5##3##(1991-6#3)(1995-12#1)(2009-11#1)
responses to enteric##3##3##(1990-5#1)(2006-10#2)
responses to environmental changes##2##4##(1995-1#1)(2009-8#1)
responses to environmental##5##3##(1995-1#1)(1996-8#1)(2008-8#1)(2009-8#1)(2013-8#1)
responses to exercise##5##3##(2009-1#1)(2010-8#1)(2012-12#2)(2013-8#1)
responses to exogenous##4##3##(1990-10#1)(1993-3#1)(1997-5#1)(2007-11#1)
responses to glucose##2##3##(1995-8#1)(2007-7#1)
responses to high##2##3##(2010-11#1)(2013-8#1)
responses to hypothalamic releasing hormones##3##5##(1994-3#2)(1994-9#1)
responses to increasing##2##3##(1995-2#1)(2008-10#1)
responses to individual##2##3##(2006-10#1)(2009-8#1)
responses to induce##2##3##(2006-10#1)(2006-6#1)
responses to infection##3##3##(1991-11#1)(2008-10#2)
responses to infrequent##2##3##(1993-9#1)(1995-11#1)
responses to inhaled##2##3##(1992-4#1)(1994-2#1)
responses to injury##3##3##(2006-8#1)(2012-12#1)(2012-2#1)
responses to insulin##2##3##(1996-2#1)(1996-8#1)
responses to intravenous sermorelin##2##4##(2007-11#2)
responses to iron deficiency##3##4##(2009-8#3)
responses to isoprenaline##2##3##(1990-9#1)(1995-12#1)
responses to low dose radiation##2##5##(2008-7#2)
responses to low doses of##2##5##(1995-10#1)(2008-7#1)
responses to low##5##3##(1992-11#1)(1995-10#1)(2008-7#3)
responses to morphine in the##2##5##(1993-2#2)
responses to natural##2##3##(2012-12#1)(2012-3#1)
responses to neoadjuvant therapy##2##4##(2007-8#1)(2010-12#1)
responses to nerve stimulation##2##4##(1990-10#2)
responses to nicotine and##3##4##(1990-7#1)(2009-6#1)(2011-2#1)
responses to noise##2##3##(2008-11#1)(2008-9#1)
responses to noradrenaline##5##3##(1990-10#1)(1993-11#3)(2009-5#1)
responses to noxious stimuli##2##4##(1990-4#1)(1993-2#1)
responses to noxious##5##3##(1990-4#1)(1993-2#1)(2008-5#2)(2008-7#1)
responses to oral##3##3##(1993-1#1)(1994-12#1)(1996-3#1)
responses to other##2##3##(2008-10#1)(2008-5#1)
responses to peer rejection##2##4##(2012-2#2)
responses to peer##3##3##(2012-2#3)
responses to phenylephrine##2##3##(1995-12#1)(2013-8#1)
responses to physiological##2##3##(2005-12#1)(2009-9#1)
responses to questionnaires##2##3##(1992-6#1)(2008-2#1)
responses to questions about##2##4##(1992-12#1)(2013-1#1)
responses to right##2##3##(1993-7#1)(1996-2#1)
responses to selection##2##3##(2008-8#1)(2012-3#1)
responses to sensory##2##3##(1992-7#1)(2008-4#1)
responses to sheep red blood cells##2##6##(2008-10#2)
responses to sodium##3##3##(1995-11#1)(2004-4#1)(2008-10#1)
responses to specific##2##3##(2008-5#1)(2009-8#1)
responses to stimulation of the##2##5##(1992-7#1)(1992-8#1)
responses to stimulation of their##2##5##(1991-8#1)(1996-1#1)
responses to stimulation of##5##4##(1991-8#1)(1992-7#1)(1992-8#1)(1993-12#1)(1996-1#1)
responses to stimulation##7##3##(1991-8#1)(1992-7#1)(1992-8#1)(1993-12#1)(1996-1#1)(1996-12#1)(2011-1#1)
responses to stimuli##2##3##(1991-8#1)(1994-11#1)
responses to stress and##3##4##(1994-11#1)(1995-12#1)(2007-10#1)
responses to stress##13##3##(1994-11#1)(1994-2#1)(1995-11#1)(1995-12#6)(1995-8#1)(2004-2#1)(2007-10#1)(2008-4#1)
responses to stressors##2##3##(1995-12#1)(2010-5#1)
responses to substance P##3##4##(1990-11#1)(1996-12#1)(2007-8#1)
responses to tetanus toxoid##2##4##(2011-2#2)
responses to the challenge##2##4##(1994-7#1)(2005-8#1)
responses to the compound stimulus##2##5##(1997-8#2)
responses to the major##2##4##(1990-12#1)(2012-1#1)
responses to the same##2##4##(1991-5#1)(2008-10#1)
responses to the stimulation of##4##5##(1993-7#3)(1995-12#1)
responses to the stimulus##2##4##(1994-2#1)(2006-7#1)
responses to the virus##2##4##(2008-11#1)(2011-1#1)
responses to the##69##3##(1990-12#1)(1990-5#1)(1991-5#1)(1992-1#1)(1993-6#2)(1993-7#3)(1993-9#1)(1994-10#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#2)(1996-1#2)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#3)(2005-7#1)(2005-8#1)(2006-10#2)(2006-7#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-3#1)(2009-6#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#4)(2013-1#1)(2013-8#1)
responses to their##3##3##(1996-12#1)(1997-4#1)(2011-2#1)
responses to therapy##3##3##(1991-2#1)(2005-10#1)(2010-6#1)
responses to these##7##3##(1996-8#1)(2006-10#1)(2007-11#2)(2007-4#1)(2008-7#1)(2008-9#1)
responses to this##6##3##(1991-3#1)(1995-1#1)(1995-3#1)(1997-4#1)(2006-10#1)(2012-12#1)
responses to treatment##7##3##(2005-7#1)(2008-6#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
responses to vaccines##2##3##(2007-11#1)(2013-1#1)
responses to various stimuli##2##4##(2008-4#1)(2010-12#1)
responses to various##6##3##(1991-12#1)(1995-12#1)(1996-9#1)(2006-10#1)(2008-4#1)(2010-12#1)
responses to visual##2##3##(1990-4#1)(1997-7#1)
responses to##757##2##(1990-10#6)(1990-11#5)(1990-12#2)(1990-2#1)(1990-4#6)(1990-5#6)(1990-7#8)(1990-9#2)(1991-1#4)(1991-11#2)(1991-12#12)(1991-2#2)(1991-3#3)(1991-5#8)(1991-6#8)(1991-7#1)(1991-8#7)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#7)(1992-2#3)(1992-3#2)(1992-4#3)(1992-6#3)(1992-7#2)(1992-8#3)(1992-9#1)(1993-1#2)(1993-11#5)(1993-12#5)(1993-2#5)(1993-3#6)(1993-4#1)(1993-6#3)(1993-7#6)(1993-9#4)(1994-1#1)(1994-10#3)(1994-11#6)(1994-12#4)(1994-2#7)(1994-3#3)(1994-5#6)(1994-6#2)(1994-7#4)(1994-8#3)(1994-9#2)(1995-1#2)(1995-10#2)(1995-11#8)(1995-12#23)(1995-2#7)(1995-3#5)(1995-5#9)(1995-6#2)(1995-7#1)(1995-8#5)(1996-1#5)(1996-10#7)(1996-12#8)(1996-2#5)(1996-3#2)(1996-5#6)(1996-6#2)(1996-8#8)(1996-9#4)(1997-1#1)(1997-2#5)(1997-3#3)(1997-4#6)(1997-5#5)(1997-6#1)(1997-7#7)(1997-8#8)(2004-11#1)(2004-2#1)(2004-3#1)(2004-4#2)(2005-10#1)(2005-12#1)(2005-7#4)(2005-8#2)(2005-9#1)(2006-10#16)(2006-12#6)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#3)(2007-11#9)(2007-12#7)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#7)(2007-9#2)(2008-1#1)(2008-10#35)(2008-11#13)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#23)(2008-5#15)(2008-6#3)(2008-7#17)(2008-8#20)(2008-9#10)(2009-1#1)(2009-11#6)(2009-12#2)(2009-2#3)(2009-3#6)(2009-4#2)(2009-5#2)(2009-6#7)(2009-7#2)(2009-8#17)(2009-9#7)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#2)(2010-5#5)(2010-6#1)(2010-7#1)(2010-8#8)(2011-1#10)(2011-11#1)(2011-12#2)(2011-2#16)(2012-1#8)(2012-11#2)(2012-12#15)(2012-2#20)(2012-3#8)(2012-5#1)(2013-1#10)(2013-7#3)(2013-8#11)
responses toward##2##2##(2007-11#1)(2010-10#1)
responses towards the##2##3##(1995-5#1)(2007-12#1)
responses towards##6##2##(1993-7#1)(1995-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)
responses triggered by##2##3##(2008-4#1)(2011-1#1)
responses under##6##2##(1995-12#1)(1996-9#1)(2006-10#1)(2006-11#1)(2012-12#1)(2013-8#1)
responses upon##2##2##(1991-9#1)(2010-12#1)
responses using##4##2##(1991-12#1)(2008-10#1)(2008-4#1)(2010-2#1)
responses varied##2##2##(1993-12#1)(2009-2#1)
responses via##6##2##(1992-12#1)(1994-5#1)(1994-8#1)(2008-11#1)(2009-8#1)(2012-3#1)
responses was##13##2##(1990-11#1)(1990-6#1)(1992-1#1)(1993-12#1)(1995-12#1)(1996-1#1)(1996-5#1)(2006-10#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)
responses were achieved##2##3##(2007-8#1)(2008-10#1)
responses were also##2##3##(1994-6#1)(2008-10#1)
responses were analysed##2##3##(1993-12#1)(2007-9#1)
responses were at##2##3##(1992-10#1)(1996-2#1)
responses were characterized##2##3##(2008-10#1)(2012-12#1)
responses were compared between##2##4##(2007-4#1)(2013-1#1)
responses were compared with those##2##5##(1992-12#1)(1997-8#1)
responses were compared with##5##4##(1992-12#1)(1997-8#1)(2006-11#2)(2008-11#1)
responses were compared##8##3##(1992-12#1)(1997-8#1)(2006-10#1)(2006-11#2)(2007-4#1)(2008-11#1)(2013-1#1)
responses were dose-dependent##2##3##(1994-9#1)(2008-10#1)
responses were evoked##2##3##(1995-11#1)(2011-2#1)
responses were identified##2##3##(2006-2#1)(2010-9#1)
responses were induced by##2##4##(2008-10#1)(2008-5#1)
responses were inhibited by##2##4##(1992-11#1)(1996-2#1)
responses were internally coherent##2##4##(2013-8#2)
responses were investigated##2##3##(1994-2#1)(2007-10#1)
responses were linear over a wide##2##6##(1993-2#1)(2008-10#1)
responses were linear##3##3##(1993-2#1)(2008-10#2)
responses were located##3##3##(2008-12#2)(2008-5#1)
responses were measured##4##3##(1993-12#1)(2007-1#1)(2008-7#1)(2009-4#1)
responses were not##8##3##(1990-5#1)(1991-11#1)(1993-2#1)(1997-5#1)(2007-10#1)(2008-10#2)(2009-5#1)
responses were observed for##2##4##(1996-6#1)(1996-8#1)
responses were observed in patients with##2##6##(2008-6#1)(2010-2#1)
responses were observed in##6##4##(2008-10#1)(2008-6#1)(2009-8#1)(2010-2#1)(2011-1#1)(2013-8#1)
responses were observed##19##3##(1990-10#1)(1990-12#1)(1990-2#1)(1991-9#1)(1992-10#1)(1996-6#1)(1996-8#1)(2007-1#1)(2008-10#5)(2008-6#1)(2009-8#1)(2010-2#1)(2011-1#1)(2012-1#1)(2013-8#1)
responses were obtained in##2##4##(1991-6#1)(1997-3#1)
responses were obtained##7##3##(1991-6#1)(1992-11#1)(1993-2#1)(1997-3#1)(2008-10#1)(2008-2#1)(2009-3#1)
responses were only##3##3##(1993-2#1)(2008-7#1)(2008-8#1)
responses were potentiated##2##3##(1991-3#1)(2007-10#1)
responses were rapid and transient and##2##6##(1994-9#1)(2008-5#1)
responses were received##2##3##(2008-10#1)(2012-12#1)
responses were recorded before##2##4##(1992-12#1)(1995-12#1)
responses were recorded##5##3##(1991-3#1)(1992-12#1)(1994-8#1)(1995-12#1)(2009-11#1)
responses were seen in##5##4##(1990-12#1)(1991-4#1)(2008-10#1)(2008-5#1)(2008-9#1)
responses were seen##6##3##(1990-12#1)(1991-4#1)(1997-1#1)(2008-10#1)(2008-5#1)(2008-9#1)
responses were significantly##5##3##(1994-2#1)(1995-5#1)(1996-5#1)(2008-11#1)(2008-5#1)
responses were studied##2##3##(2007-4#1)(2011-10#1)
responses were unchanged##2##3##(1996-8#2)
responses were##168##2##(1990-10#3)(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-10#4)(1992-11#3)(1992-12#2)(1992-6#2)(1993-12#2)(1993-2#5)(1993-4#1)(1993-7#1)(1994-1#1)(1994-2#2)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#3)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#4)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-8#1)(2004-12#1)(2005-8#1)(2006-10#1)(2006-11#3)(2006-2#1)(2006-6#2)(2006-8#1)(2007-1#2)(2007-10#3)(2007-4#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#22)(2008-11#5)(2008-12#2)(2008-2#1)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-2#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-10#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#3)
responses when##6##2##(2006-7#1)(2007-11#1)(2008-6#1)(2009-8#1)(2010-7#1)(2013-8#1)
responses which were##2##3##(1990-12#1)(1991-3#1)
responses which##9##2##(1990-12#1)(1991-3#1)(1994-11#1)(1996-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-2#1)(2013-7#1)
responses will##2##2##(2006-11#1)(2007-11#1)
responses with a##3##3##(1991-2#1)(1992-7#1)(1996-9#1)
responses with the##3##3##(2006-2#1)(2007-4#1)(2010-5#1)
responses with##16##2##(1990-7#1)(1991-2#1)(1992-7#1)(1996-9#1)(1997-4#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-4#1)(2008-10#3)(2008-9#1)(2010-12#1)(2010-5#1)(2011-1#1)
responses within##3##2##(2004-12#1)(2008-11#1)(2012-2#1)
responses would##2##2##(1993-7#1)(2008-7#1)
responses##3222##1##(1990-10#21)(1990-11#16)(1990-12#15)(1990-2#12)(1990-3#2)(1990-4#18)(1990-5#14)(1990-6#1)(1990-7#20)(1990-8#4)(1990-9#4)(1991-1#8)(1991-10#3)(1991-11#8)(1991-12#31)(1991-2#21)(1991-3#28)(1991-4#3)(1991-5#17)(1991-6#20)(1991-7#1)(1991-8#22)(1991-9#13)(1992-1#9)(1992-10#10)(1992-11#9)(1992-12#15)(1992-2#6)(1992-3#17)(1992-4#8)(1992-5#1)(1992-6#8)(1992-7#14)(1992-8#16)(1992-9#7)(1993-1#3)(1993-11#26)(1993-12#25)(1993-2#21)(1993-3#15)(1993-4#4)(1993-5#3)(1993-6#12)(1993-7#14)(1993-8#1)(1993-9#13)(1994-1#4)(1994-10#12)(1994-11#24)(1994-12#14)(1994-2#31)(1994-3#12)(1994-4#1)(1994-5#13)(1994-6#21)(1994-7#4)(1994-8#10)(1994-9#11)(1995-1#5)(1995-10#5)(1995-11#25)(1995-12#74)(1995-2#24)(1995-3#19)(1995-4#6)(1995-5#32)(1995-6#5)(1995-7#9)(1995-8#16)(1995-9#4)(1996-1#17)(1996-10#26)(1996-11#4)(1996-12#20)(1996-2#21)(1996-3#9)(1996-4#5)(1996-5#24)(1996-6#6)(1996-7#6)(1996-8#18)(1996-9#20)(1997-1#5)(1997-2#17)(1997-3#7)(1997-4#25)(1997-5#23)(1997-6#11)(1997-7#13)(1997-8#18)(2003-11#2)(2004-11#7)(2004-12#4)(2004-2#3)(2004-3#1)(2004-4#8)(2004-9#1)(2005-10#4)(2005-11#10)(2005-12#3)(2005-5#1)(2005-6#1)(2005-7#18)(2005-8#10)(2005-9#2)(2006-10#75)(2006-11#25)(2006-12#11)(2006-2#7)(2006-3#1)(2006-4#3)(2006-5#5)(2006-6#12)(2006-7#7)(2006-8#7)(2006-9#3)(2007-1#10)(2007-10#14)(2007-11#65)(2007-12#41)(2007-2#7)(2007-3#4)(2007-4#24)(2007-5#6)(2007-6#7)(2007-7#12)(2007-8#27)(2007-9#7)(2008-1#21)(2008-10#252)(2008-11#82)(2008-12#26)(2008-2#17)(2008-3#35)(2008-4#106)(2008-5#67)(2008-6#20)(2008-7#85)(2008-8#65)(2008-9#67)(2009-1#1)(2009-10#15)(2009-11#16)(2009-12#13)(2009-2#11)(2009-3#11)(2009-4#9)(2009-5#15)(2009-6#24)(2009-7#6)(2009-8#56)(2009-9#17)(2010-1#5)(2010-10#10)(2010-11#5)(2010-12#15)(2010-2#17)(2010-4#10)(2010-5#17)(2010-6#4)(2010-7#9)(2010-8#15)(2010-9#3)(2011-1#35)(2011-10#1)(2011-11#2)(2011-12#8)(2011-2#55)(2012-1#34)(2012-11#4)(2012-12#54)(2012-2#56)(2012-3#22)(2012-5#9)(2012-6#5)(2012-7#2)(2012-9#1)(2013-1#45)(2013-7#14)(2013-8#38)
responses) and##4##2##(1992-7#1)(2005-5#1)(2008-10#1)(2008-9#1)
responses)##11##1##(1990-11#1)(1990-7#1)(1992-7#1)(2005-5#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-9#2)(2012-1#1)
responses?##3##1##(1990-4#1)(1995-12#1)(1996-9#1)
responsibilities and##10##2##(1991-2#1)(1992-6#1)(1994-1#1)(2006-2#1)(2006-8#1)(2007-2#1)(2008-1#1)(2008-2#1)(2010-2#1)(2010-4#1)
responsibilities are##2##2##(1993-12#1)(2011-1#1)
responsibilities for##9##2##(1991-2#1)(1995-12#3)(2007-5#2)(2012-12#1)(2013-1#2)
responsibilities in##10##2##(1990-10#1)(1990-4#1)(1991-12#1)(1992-2#1)(2005-5#1)(2007-5#1)(2008-1#1)(2010-11#1)(2011-2#1)(2012-3#1)
responsibilities is##2##2##(1992-10#1)(2007-12#1)
responsibilities of the##8##3##(1993-2#1)(1995-6#1)(2005-5#1)(2007-4#3)(2008-7#1)(2012-12#1)
responsibilities of##24##2##(1991-2#1)(1992-12#1)(1993-2#2)(1994-1#2)(1994-3#1)(1995-2#1)(1995-6#1)(1996-1#1)(1997-2#1)(2005-5#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-4#3)(2007-8#1)(2008-3#1)(2008-7#1)(2010-3#1)(2012-12#2)
responsibilities on##2##2##(1993-5#1)(2008-9#1)
responsibilities through##2##2##(1996-1#1)(2013-1#1)
responsibilities to##4##2##(1992-1#1)(1996-1#1)(2007-2#1)(2011-2#1)
responsibilities##121##1##(1990-10#1)(1990-12#1)(1990-4#1)(1991-12#2)(1991-2#4)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#3)(1993-5#1)(1994-1#4)(1994-3#1)(1995-1#1)(1995-12#5)(1995-2#2)(1995-3#2)(1995-6#1)(1996-1#3)(1996-2#1)(1997-2#2)(1997-4#1)(2005-5#2)(2006-10#1)(2006-2#4)(2006-6#1)(2006-7#1)(2006-8#2)(2007-12#3)(2007-2#4)(2007-4#5)(2007-5#3)(2007-8#1)(2008-1#4)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-4#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-9#2)(2011-1#3)(2011-2#2)(2012-11#1)(2012-12#7)(2012-3#5)(2013-1#4)(2013-8#2)
responsibility and accountability##2##3##(2006-2#1)(2007-10#1)
responsibility and##16##2##(1992-2#1)(1994-2#1)(1995-6#1)(2006-2#2)(2007-10#2)(2008-11#1)(2008-6#1)(2010-12#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-3#2)(2013-8#1)
responsibility between##2##2##(2011-1#1)(2013-1#1)
responsibility can##2##2##(2010-12#1)(2012-3#1)
responsibility for care of a child with##2##7##(2009-5#2)
responsibility for care of##3##4##(2009-5#3)
responsibility for health care##3##4##(1993-3#1)(1994-2#2)
responsibility for health##4##3##(1993-3#2)(1994-2#2)
responsibility for his##2##3##(2008-5#1)(2009-2#1)
responsibility for medical##2##3##(1992-5#1)(2006-6#1)
responsibility for planning##2##3##(1993-2#1)(2009-4#1)
responsibility for quality##3##3##(1991-12#1)(1995-3#1)(1996-2#1)
responsibility for the health##2##4##(1996-3#1)(2004-7#1)
responsibility for the management of##2##5##(1992-12#1)(1992-3#1)
responsibility for the patient##2##4##(1993-3#1)(2007-7#1)
responsibility for the##21##3##(1990-3#1)(1991-1#1)(1991-12#2)(1992-12#1)(1992-3#2)(1992-5#1)(1993-3#2)(1994-3#1)(1995-1#1)(1996-2#1)(1996-3#1)(2004-7#1)(2005-5#1)(2007-7#1)(2007-9#1)(2008-11#1)(2009-10#1)(2009-5#1)
responsibility for their health##2##4##(1994-3#1)(2005-10#1)
responsibility for their##6##3##(1991-4#1)(1994-3#1)(1997-3#1)(2005-10#1)(2007-11#1)(2008-6#1)
responsibility for##87##2##(1990-10#1)(1990-3#1)(1991-1#1)(1991-12#5)(1991-4#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#1)(1993-11#1)(1993-2#2)(1993-3#4)(1993-5#1)(1994-12#1)(1994-2#2)(1994-3#3)(1995-1#3)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-2#2)(1996-3#2)(1997-3#1)(2004-7#1)(2005-10#1)(2005-5#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-4#2)(2009-5#5)(2009-9#1)(2010-2#2)(2010-7#1)(2010-8#1)(2012-2#1)(2012-3#2)
responsibility in the##4##3##(2007-11#1)(2008-10#1)(2008-3#2)
responsibility in##17##2##(1991-5#1)(1993-12#1)(1995-1#1)(1997-2#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-3#2)(2009-4#1)(2010-5#1)(2011-2#3)(2012-3#1)(2013-1#1)
responsibility is##4##2##(1990-8#1)(1993-2#1)(2007-11#1)(2011-12#1)
responsibility of cysteine synthase##2##4##(1993-12#2)
responsibility of the##14##3##(1991-3#2)(1991-6#1)(1993-5#1)(1995-9#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-9#2)(2011-1#1)(2012-12#1)(2012-2#1)
responsibility of##38##2##(1991-3#2)(1991-4#2)(1991-6#1)(1992-1#1)(1993-1#1)(1993-12#2)(1993-5#1)(1994-3#1)(1995-9#1)(1996-3#1)(2005-7#1)(2006-1#1)(2007-2#1)(2007-4#1)(2007-9#2)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)
responsibility to ensure##3##3##(1992-1#1)(2008-10#1)(2012-12#1)
responsibility to##18##2##(1992-1#1)(1992-11#1)(1993-3#1)(1994-2#1)(1996-1#1)(2006-10#2)(2007-8#1)(2008-10#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
responsibility when##2##2##(2008-11#1)(2008-5#1)
responsibility##246##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-3#1)(1990-8#1)(1991-1#2)(1991-12#7)(1991-2#1)(1991-3#2)(1991-4#3)(1991-5#1)(1991-6#1)(1992-1#6)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-5#2)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#3)(1993-2#4)(1993-3#9)(1993-5#2)(1994-1#2)(1994-12#1)(1994-2#5)(1994-3#5)(1994-7#1)(1995-1#4)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#3)(1996-2#4)(1996-3#3)(1996-4#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-12#1)(2004-7#1)(2005-10#1)(2005-5#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-2#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#1)(2007-2#1)(2007-4#4)(2007-7#1)(2007-8#2)(2007-9#4)(2008-10#4)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#2)(2009-10#2)(2009-2#1)(2009-4#3)(2009-5#7)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#5)(2010-2#3)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#3)(2011-12#3)(2011-2#9)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#4)(2012-3#8)(2013-1#3)(2013-7#1)(2013-8#1)
responsibility]##3##1##(1995-4#1)(1996-1#1)(1997-2#1)
responsible authorities##2##2##(1992-11#1)(1993-11#1)
responsible enzyme##2##2##(1993-11#1)(2006-10#1)
responsible factor##2##2##(2008-10#1)(2008-7#1)
responsible for Batten's disease##2##4##(1997-6#2)
responsible for CO##2##3##(1992-12#1)(2008-4#1)
responsible for DNA##2##3##(1993-2#1)(1997-4#1)
responsible for a higher##2##4##(2009-1#1)(2009-12#1)
responsible for a low##2##4##(1992-2#1)(1993-12#1)
responsible for a significant proportion of##2##6##(2007-11#1)(2007-2#1)
responsible for a significant##4##4##(1992-6#1)(2007-11#1)(2007-2#1)(2008-1#1)
responsible for a substantial##3##4##(1997-6#1)(2005-7#1)(2011-2#1)
responsible for a variety of##3##5##(2011-12#1)(2011-2#1)(2012-2#1)
responsible for a##45##3##(1991-1#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-9#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-6#1)(2005-7#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-2#1)(2009-7#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)
responsible for about##3##3##(1995-1#1)(2005-10#1)(2008-6#1)
responsible for activation of##4##4##(1990-4#1)(1990-5#1)(1997-4#1)(2006-2#1)
responsible for acute diarrhea##2##4##(1990-11#1)(2011-2#1)
responsible for acute##4##3##(1990-11#1)(2007-11#1)(2011-2#2)
responsible for alteration##2##3##(1990-6#1)(2012-2#1)
responsible for an##8##3##(1990-8#2)(1992-6#1)(2006-7#1)(2006-8#1)(2007-3#1)(2008-5#1)(2013-1#1)
responsible for approximately##4##3##(1992-6#1)(2006-12#1)(2008-3#1)(2011-1#1)
responsible for better##3##3##(2007-12#1)(2008-3#1)(2013-7#1)
responsible for binding##2##3##(1991-2#1)(2008-9#1)
responsible for both the##4##4##(1997-8#1)(2007-12#1)(2008-7#1)(2010-5#1)
responsible for both##9##3##(1990-8#1)(1991-8#1)(1997-1#1)(1997-8#1)(2005-5#1)(2007-11#1)(2007-12#1)(2008-7#1)(2010-5#1)
responsible for catalyzing the##3##4##(1993-12#1)(2011-1#1)(2012-2#1)
responsible for catalyzing##4##3##(1993-12#1)(1997-4#1)(2011-1#1)(2012-2#1)
responsible for cell##6##3##(1991-12#1)(2007-11#1)(2008-11#2)(2008-4#1)(2012-2#1)
responsible for chronic pain##2##4##(2006-8#1)(2009-4#1)
responsible for chronic##6##3##(1991-4#1)(2006-10#1)(2006-8#1)(2009-4#1)(2012-12#2)
responsible for complementation of##2##4##(1993-9#1)(1997-4#1)
responsible for complex##2##3##(2006-12#1)(2012-3#1)
responsible for conferring##2##3##(1996-2#1)(2008-4#1)
responsible for controlling the##2##4##(2008-10#1)(2010-1#1)
responsible for creating##2##3##(2008-8#2)
responsible for cutaneous##2##3##(2007-12#1)(2008-5#1)
responsible for decreased##4##3##(1995-5#1)(2007-7#1)(2008-3#1)(2011-2#1)
responsible for degradation of##2##4##(1994-5#1)(2010-4#1)
responsible for determining the##2##4##(2006-10#1)(2011-2#1)
responsible for different##3##3##(2006-2#1)(2008-10#1)(2012-2#1)
responsible for directing##2##3##(1993-3#1)(1994-9#1)
responsible for disease suppression##2##4##(2008-10#2)
responsible for disease##6##3##(1993-10#1)(2008-10#2)(2010-11#1)(2010-4#1)(2011-2#1)
responsible for epithelial##2##3##(1991-11#1)(2008-1#1)
responsible for expression of##3##4##(1990-5#1)(1991-4#1)(2008-11#1)
responsible for food##2##3##(2005-5#2)
responsible for formation##2##3##(1991-4#1)(1994-8#1)
responsible for free##3##3##(1990-8#1)(2009-3#1)(2012-2#1)
responsible for generating the##3##4##(1994-9#1)(1996-2#1)(2008-8#1)
responsible for generating##7##3##(1991-6#1)(1994-9#1)(1996-2#1)(2006-8#1)(2008-11#1)(2008-8#1)(2012-11#1)
responsible for generation of##3##4##(1993-2#1)(1996-6#1)(2008-4#1)
responsible for glaucoma##3##3##(2011-1#3)
responsible for heat##2##3##(2007-7#1)(2009-8#1)
responsible for important##2##3##(2007-2#1)(2008-10#1)
responsible for increased##4##3##(1995-11#1)(2008-10#1)(2008-3#1)(2011-2#1)
responsible for individual##2##3##(1994-11#1)(2012-12#1)
responsible for inducing##5##3##(1995-12#1)(1995-2#1)(1996-5#1)(2008-10#1)(2008-3#1)
responsible for induction of##2##4##(2008-10#2)
responsible for induction##3##3##(2005-10#1)(2008-10#2)
responsible for infantile neuronal ceroid lipofuscinosis##2##6##(1996-4#2)
responsible for infection##2##3##(2006-10#1)(2012-3#1)
responsible for inhibiting##2##3##(1990-11#1)(2008-4#1)
responsible for inhibition##2##3##(1990-7#1)(1996-2#1)
responsible for initiating##3##3##(1990-11#1)(1991-10#1)(2008-8#1)
responsible for interconversion of##2##4##(1992-10#1)(1994-8#1)
responsible for iron##2##3##(1995-10#1)(2009-2#1)
responsible for it##2##3##(1991-6#1)(2013-8#1)
responsible for its##20##3##(1990-7#1)(1991-10#2)(1992-11#1)(1993-11#1)(1994-8#2)(1995-1#1)(1995-8#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
responsible for light##2##3##(2008-10#2)
responsible for liver##2##3##(1990-8#1)(1994-3#1)
responsible for maintaining##4##3##(1992-8#1)(2007-11#1)(2008-10#1)(2009-2#1)
responsible for major##2##3##(2008-8#1)(2013-1#1)
responsible for many##3##3##(1994-7#1)(2007-10#1)(2008-2#1)
responsible for maternal##2##3##(1992-5#1)(2011-1#1)
responsible for mediating##2##3##(1997-6#1)(2008-10#1)
responsible for membranoproliferative glomerulonephritis##2##4##(2012-2#2)
responsible for metabolizing##2##3##(1995-9#1)(2010-7#1)
responsible for monitoring##2##3##(2006-5#1)(2008-11#1)
responsible for more than##4##4##(1990-12#1)(2010-3#1)(2012-1#1)(2013-1#1)
responsible for most of the##3##5##(2006-12#1)(2008-12#1)(2013-8#1)
responsible for most##4##3##(2006-12#1)(2008-12#1)(2010-5#1)(2013-8#1)
responsible for multidrug resistance##2##4##(1996-7#1)(2008-11#1)
responsible for nearly##4##3##(2005-7#2)(2009-10#1)(2009-8#1)
responsible for neonatal##2##3##(1991-11#1)(2011-2#1)
responsible for neuronal##2##3##(1995-7#1)(2008-4#1)
responsible for normal##2##3##(2008-3#1)(2009-10#1)
responsible for not##2##3##(2011-2#1)(2013-7#1)
responsible for numerous##2##3##(2008-10#1)(2011-2#1)
responsible for olfactory##2##3##(1991-2#1)(2011-1#1)
responsible for other##2##3##(2006-10#1)(2009-9#1)
responsible for plaque disruption##2##4##(2007-10#2)
responsible for poor##2##3##(2007-9#1)(2009-5#1)
responsible for providing##2##3##(2006-12#1)(2007-4#1)
responsible for rapid##3##3##(1995-5#1)(2008-12#1)(2008-2#1)
responsible for regulating the##2##4##(2007-6#1)(2011-2#1)
responsible for regulating##3##3##(2007-6#1)(2010-3#1)(2011-2#1)
responsible for regulation of##3##4##(1992-8#1)(2008-4#1)(2010-5#1)
responsible for resistance to##2##4##(2008-10#1)(2009-5#1)
responsible for resistance##4##3##(2008-10#3)(2009-5#1)
responsible for several##3##3##(2008-10#1)(2010-12#1)(2013-8#1)
responsible for severe##4##3##(1994-5#1)(2008-4#1)(2011-2#1)(2013-1#1)
responsible for significant morbidity##2##4##(2006-10#1)(2011-2#1)
responsible for significant##9##3##(2006-10#1)(2006-9#1)(2008-10#2)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
responsible for some##6##3##(1991-12#1)(1996-12#1)(1996-3#1)(2007-12#1)(2012-2#1)(2012-3#1)
responsible for specific##3##3##(1995-11#1)(2008-4#1)(2011-2#1)
responsible for stabilizing##2##3##(1995-12#1)(2010-4#1)
responsible for such##7##3##(1990-12#1)(1995-7#1)(1996-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)
responsible for suppression of##2##4##(2008-10#1)(2008-9#1)
responsible for systemic##2##3##(2008-10#1)(2009-11#1)
responsible for the DS##2##4##(1996-2#2)
responsible for the TCR##2##4##(2011-1#2)
responsible for the activation of##4##5##(1995-2#1)(2006-12#1)(2008-5#1)(2013-8#1)
responsible for the activity##2##4##(1997-7#1)(2011-2#1)
responsible for the addition##2##4##(1991-10#1)(2008-2#1)
responsible for the apparent##2##4##(1992-11#1)(2008-10#1)
responsible for the appearance of##2##5##(1991-2#1)(2009-2#1)
responsible for the autofluorescence of the##2##6##(1990-4#1)(1995-9#1)
responsible for the binding of##3##5##(1994-12#1)(1997-9#1)(2008-10#1)
responsible for the biological activity of##2##6##(1990-12#1)(1992-2#1)
responsible for the biological activity##5##5##(1990-12#1)(1992-1#1)(1992-2#1)(1992-8#1)(2010-12#1)
responsible for the biological##6##4##(1990-12#1)(1992-1#1)(1992-2#1)(1992-8#1)(2010-12#1)(2010-8#1)
responsible for the changes in##2##5##(2008-6#1)(2011-2#1)
responsible for the changes##3##4##(2008-6#1)(2008-7#1)(2011-2#1)
responsible for the clinical##3##4##(1991-9#1)(2005-8#1)(2008-11#1)
responsible for the control of##2##5##(1990-6#1)(1991-8#1)
responsible for the conversion of##4##5##(1992-6#1)(1994-8#1)(1995-1#1)(2006-5#1)
responsible for the decrease of##2##5##(2011-2#1)(2013-1#1)
responsible for the degradation of##3##5##(1995-6#1)(1995-8#1)(2008-4#1)
responsible for the degradation##4##4##(1995-1#1)(1995-6#1)(1995-8#1)(2008-4#1)
responsible for the destruction of##2##5##(1991-1#1)(1994-6#1)
responsible for the development of##4##5##(1996-9#1)(2006-2#1)(2008-7#1)(2011-2#1)
responsible for the development##5##4##(1996-9#1)(2006-2#1)(2008-7#1)(2010-12#1)(2011-2#1)
responsible for the difference in##2##5##(1993-12#1)(1997-4#1)
responsible for the differences in##3##5##(1994-5#1)(1997-2#1)(1997-7#1)
responsible for the differences##4##4##(1994-5#1)(1997-2#1)(1997-7#1)(1997-9#1)
responsible for the different##5##4##(1995-11#1)(2008-6#1)(2008-8#1)(2013-1#2)
responsible for the differential##2##4##(1992-7#1)(1997-7#1)
responsible for the effects##2##4##(1994-11#1)(2012-11#1)
responsible for the enhanced##5##4##(1997-2#1)(2006-12#1)(2008-11#1)(2008-8#1)(2009-9#1)
responsible for the enhancement##2##4##(1990-6#1)(1992-8#1)
responsible for the expression of##3##5##(1995-6#1)(1997-8#1)(2009-3#1)
responsible for the failure of##2##5##(1992-7#1)(2013-8#1)
responsible for the formation of##7##5##(1993-3#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-4#1)(2011-2#1)
responsible for the generation of the##3##6##(1990-2#1)(1996-7#1)(2012-3#1)
responsible for the generation of##6##5##(1990-2#1)(1994-5#1)(1996-10#1)(1996-7#1)(2009-5#1)(2012-3#1)
responsible for the health##2##4##(2008-1#1)(2012-1#1)
responsible for the high expression of the##2##7##(1991-5#1)(1996-12#1)
responsible for the high##9##4##(1991-5#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-7#1)(2007-10#1)(2008-8#1)(2010-4#1)(2012-1#1)
responsible for the higher##3##4##(1993-9#1)(2007-12#1)(2008-5#1)
responsible for the increase in##4##5##(2008-12#2)(2008-4#1)(2012-3#1)
responsible for the increase##5##4##(2008-12#2)(2008-3#1)(2008-4#1)(2012-3#1)
responsible for the increased##7##4##(1990-5#1)(1990-8#1)(1996-8#1)(2004-4#1)(2008-4#1)(2008-7#1)(2010-11#1)
responsible for the induction of##2##5##(1994-8#1)(2009-8#1)
responsible for the inhibition of##4##5##(1990-3#1)(1991-2#1)(1991-4#1)(2008-8#1)
responsible for the initial##2##4##(1991-7#1)(1992-12#1)
responsible for the introduction##2##4##(1990-3#1)(1997-4#1)
responsible for the largest##3##4##(2004-7#1)(2008-10#1)(2011-2#1)
responsible for the loss of the##2##6##(1990-12#1)(2009-12#1)
responsible for the loss of##4##5##(1990-12#1)(1996-5#1)(1997-7#1)(2009-12#1)
responsible for the low##4##4##(1993-3#1)(1994-8#1)(2008-2#1)(2008-7#1)
responsible for the maintenance of##2##5##(1997-2#1)(2008-7#1)
responsible for the majority of the##2##6##(1990-4#1)(2007-3#1)
responsible for the majority of##9##5##(1990-4#1)(1991-7#1)(1995-12#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-1#1)(2009-5#1)(2009-8#1)
responsible for the metabolism of##5##5##(1994-3#3)(2008-10#1)(2011-1#1)
responsible for the observed##16##4##(1990-5#1)(1990-8#1)(1991-7#1)(1993-11#1)(1993-6#1)(1994-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(2006-9#1)(2007-12#1)(2008-10#2)(2008-4#1)(2009-4#1)
responsible for the occurrence of##2##5##(2007-12#1)(2013-8#1)
responsible for the onset or persistence of rhinogenic deafness##2##9##(2008-4#2)
responsible for the origin of##2##5##(1996-6#1)(2008-8#1)
responsible for the phenomenon of##2##5##(1991-9#1)(2005-11#1)
responsible for the production of##6##5##(1990-8#1)(1991-10#1)(1996-12#1)(1997-2#1)(2008-2#1)(2009-8#1)
responsible for the protective##2##4##(2008-10#1)(2011-1#1)
responsible for the rapid##3##4##(1991-2#1)(1996-9#1)(2013-1#1)
responsible for the recent##2##4##(1996-3#1)(2008-10#1)
responsible for the recovery of##2##5##(2007-6#1)(2008-9#1)
responsible for the reduced##3##4##(1994-8#1)(2008-10#1)(2008-5#1)
responsible for the reduction of##3##5##(1993-11#1)(1997-5#1)(2006-8#1)
responsible for the reduction##4##4##(1993-11#1)(1997-5#1)(2006-8#1)(2011-2#1)
responsible for the regulation of##4##5##(1992-1#1)(1996-5#1)(2006-10#1)(2012-12#1)
responsible for the resistance of##3##5##(1991-2#1)(2008-10#1)(2010-12#1)
responsible for the resistance##4##4##(1990-5#1)(1991-2#1)(2008-10#1)(2010-12#1)
responsible for the selective recognition of PHI by##2##8##(1996-5#2)
responsible for the selective##3##4##(1996-5#2)(2005-7#1)
responsible for the suppression of##2##5##(1991-5#1)(2008-10#1)
responsible for the synthesis of##2##5##(1990-3#1)(1996-8#1)
responsible for the synthesis##4##4##(1990-3#1)(1996-8#1)(2008-10#1)(2008-11#1)
responsible for the toxicity##2##4##(1995-1#1)(2008-8#1)
responsible for the translocation of##2##5##(1993-11#1)(1997-2#1)
responsible for the ts phenotype##2##5##(1990-5#2)
responsible for the variability##2##4##(1992-3#1)(2008-8#1)
responsible for the variation##2##4##(1994-12#1)(2005-10#1)
responsible for the##539##3##(1990-11#1)(1990-12#5)(1990-2#4)(1990-3#4)(1990-4#5)(1990-5#7)(1990-6#2)(1990-7#1)(1990-8#6)(1990-9#2)(1991-1#1)(1991-10#5)(1991-11#1)(1991-12#2)(1991-2#6)(1991-3#2)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#3)(1991-8#3)(1991-9#3)(1992-1#2)(1992-11#7)(1992-12#4)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#4)(1992-8#2)(1992-9#1)(1993-10#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#4)(1993-7#2)(1993-8#2)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#4)(1994-12#6)(1994-2#2)(1994-3#6)(1994-5#3)(1994-6#2)(1994-8#7)(1994-9#2)(1995-1#5)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#5)(1995-8#4)(1995-9#1)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#2)(1996-4#2)(1996-5#5)(1996-6#4)(1996-7#2)(1996-8#5)(1996-9#3)(1997-1#4)(1997-2#7)(1997-3#2)(1997-4#6)(1997-5#5)(1997-6#2)(1997-7#9)(1997-8#3)(1997-9#2)(2004-4#1)(2004-7#1)(2004-9#1)(2005-10#1)(2005-11#3)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#8)(2006-12#8)(2006-2#2)(2006-5#1)(2006-6#1)(2006-8#3)(2006-9#2)(2007-10#1)(2007-11#5)(2007-12#14)(2007-3#2)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#7)(2007-9#2)(2008-1#8)(2008-10#35)(2008-11#6)(2008-12#2)(2008-2#6)(2008-3#9)(2008-4#10)(2008-5#10)(2008-6#5)(2008-7#11)(2008-8#11)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#3)(2009-3#5)(2009-4#3)(2009-5#6)(2009-6#1)(2009-7#1)(2009-8#6)(2009-9#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#8)(2011-12#1)(2011-2#15)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#7)(2012-3#5)(2013-1#7)(2013-8#7)
responsible for their##15##3##(1991-7#1)(1992-10#1)(1993-11#1)(1994-12#1)(1995-3#1)(1995-5#1)(1996-1#2)(1997-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-4#1)(2011-1#1)(2011-2#1)
responsible for them##2##3##(2008-6#1)(2013-8#1)
responsible for these activities##3##4##(1990-6#1)(1997-7#1)(2012-3#1)
responsible for these changes##2##4##(1992-4#1)(2008-2#1)
responsible for these effects##3##4##(1992-1#1)(2008-11#1)(2011-2#1)
responsible for these increases##2##4##(1993-9#1)(2009-11#1)
responsible for these results##2##4##(1994-2#1)(2006-1#1)
responsible for these##37##3##(1990-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-10#1)(1995-12#1)(1995-5#2)(1996-4#1)(1997-7#3)(2006-1#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-8#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-3#1)
responsible for this behavior##2##4##(1991-7#1)(2007-12#1)
responsible for this binding##2##4##(1990-5#1)(1991-10#1)
responsible for this effect##2##4##(1991-5#1)(2012-12#1)
responsible for this event##2##4##(1997-1#1)(2007-10#1)
responsible for this inhibition##3##4##(1991-9#1)(1995-11#1)(2008-7#1)
responsible for this phenotype##2##4##(2008-8#1)(2010-12#1)
responsible for this toxicity##2##4##(1995-10#1)(2008-10#1)
responsible for this##48##3##(1990-2#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-7#1)(1993-12#2)(1993-3#1)(1994-12#2)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-5#1)(2005-10#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-2#1)(2010-12#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
responsible for tissue damage and##2##5##(2012-12#1)(2013-8#1)
responsible for tissue damage##3##4##(2006-10#1)(2012-12#1)(2013-8#1)
responsible for tissue##4##3##(1997-2#1)(2006-10#1)(2012-12#1)(2013-8#1)
responsible for transmitting##4##3##(1996-6#1)(2006-10#1)(2006-7#1)(2010-1#1)
responsible for tumor##6##3##(1994-8#1)(1995-6#1)(2011-12#1)(2011-2#1)(2012-12#2)
responsible for variation in##2##4##(2008-9#1)(2009-2#1)
responsible for various##2##3##(1997-4#1)(2010-10#1)
responsible for vegetative incompatibility##2##4##(1995-8#2)
responsible for vision##2##3##(1995-1#1)(2008-7#1)
responsible for##1437##2##(1990-11#7)(1990-12#9)(1990-2#5)(1990-3#6)(1990-4#9)(1990-5#12)(1990-6#5)(1990-7#5)(1990-8#15)(1990-9#5)(1991-1#7)(1991-10#10)(1991-11#6)(1991-12#9)(1991-2#10)(1991-3#3)(1991-4#6)(1991-5#5)(1991-6#5)(1991-7#8)(1991-8#8)(1991-9#7)(1992-1#3)(1992-10#3)(1992-11#10)(1992-12#6)(1992-2#6)(1992-3#6)(1992-4#2)(1992-5#2)(1992-6#13)(1992-7#6)(1992-8#7)(1992-9#4)(1993-10#2)(1993-11#6)(1993-12#6)(1993-2#5)(1993-3#7)(1993-4#3)(1993-5#5)(1993-6#6)(1993-7#3)(1993-8#4)(1993-9#6)(1994-1#1)(1994-10#1)(1994-11#10)(1994-12#12)(1994-2#7)(1994-3#9)(1994-5#7)(1994-6#4)(1994-7#1)(1994-8#16)(1994-9#6)(1995-1#8)(1995-10#4)(1995-11#8)(1995-12#11)(1995-2#6)(1995-3#6)(1995-5#9)(1995-6#10)(1995-7#2)(1995-8#9)(1995-9#4)(1996-1#4)(1996-10#3)(1996-11#3)(1996-12#5)(1996-2#7)(1996-3#5)(1996-4#6)(1996-5#10)(1996-6#11)(1996-7#4)(1996-8#6)(1996-9#4)(1997-1#9)(1997-2#15)(1997-3#5)(1997-4#14)(1997-5#13)(1997-6#9)(1997-7#14)(1997-8#9)(1997-9#2)(2004-11#2)(2004-2#1)(2004-4#3)(2004-7#1)(2004-9#1)(2005-10#5)(2005-11#4)(2005-12#1)(2005-5#3)(2005-7#6)(2005-8#4)(2005-9#1)(2006-1#2)(2006-10#26)(2006-11#1)(2006-12#15)(2006-2#7)(2006-3#2)(2006-4#1)(2006-5#4)(2006-6#4)(2006-7#5)(2006-8#11)(2006-9#6)(2007-1#2)(2007-10#9)(2007-11#17)(2007-12#26)(2007-2#5)(2007-3#5)(2007-4#4)(2007-5#2)(2007-6#3)(2007-7#7)(2007-8#16)(2007-9#7)(2008-1#25)(2008-10#102)(2008-11#20)(2008-12#8)(2008-2#13)(2008-3#24)(2008-4#32)(2008-5#24)(2008-6#8)(2008-7#23)(2008-8#26)(2008-9#9)(2009-1#1)(2009-10#3)(2009-11#6)(2009-12#3)(2009-2#10)(2009-3#8)(2009-4#5)(2009-5#11)(2009-6#3)(2009-7#3)(2009-8#13)(2009-9#4)(2010-1#2)(2010-10#3)(2010-11#5)(2010-12#9)(2010-2#5)(2010-3#5)(2010-4#7)(2010-5#7)(2010-6#2)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#25)(2011-10#1)(2011-12#3)(2011-2#44)(2012-1#6)(2012-11#4)(2012-12#21)(2012-2#24)(2012-3#17)(2013-1#22)(2013-7#3)(2013-8#20)
responsible in part for the##2##5##(1991-12#1)(2007-1#1)
responsible in##4##2##(1991-12#1)(2007-1#1)(2008-10#1)(2010-12#1)
responsible mechanism for the##2##4##(1992-11#1)(2013-1#1)
responsible mechanism##3##2##(1992-11#1)(2010-6#1)(2013-1#1)
responsible of the##3##3##(1996-3#1)(2007-11#1)(2009-11#1)
responsible of##14##2##(1991-4#1)(1996-3#1)(2006-12#1)(2006-2#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-12#1)(2009-11#1)(2010-12#1)(2012-2#2)
responsible pathogens##2##2##(1992-6#1)(2012-2#1)
responsible to##3##2##(2008-10#1)(2008-11#1)(2012-12#1)
responsible use##2##2##(1992-10#1)(2009-4#1)
responsible was##2##2##(1992-4#1)(2008-8#1)
responsible##1542##1##(1990-11#7)(1990-12#9)(1990-2#5)(1990-3#7)(1990-4#9)(1990-5#12)(1990-6#6)(1990-7#6)(1990-8#15)(1990-9#5)(1991-1#7)(1991-10#10)(1991-11#6)(1991-12#10)(1991-2#10)(1991-3#3)(1991-4#7)(1991-5#5)(1991-6#5)(1991-7#8)(1991-8#8)(1991-9#7)(1992-1#3)(1992-10#5)(1992-11#12)(1992-12#6)(1992-2#6)(1992-3#7)(1992-4#3)(1992-5#3)(1992-6#16)(1992-7#6)(1992-8#7)(1992-9#4)(1993-10#2)(1993-11#8)(1993-12#6)(1993-2#7)(1993-3#7)(1993-4#3)(1993-5#6)(1993-6#7)(1993-7#3)(1993-8#4)(1993-9#6)(1994-1#1)(1994-10#1)(1994-11#10)(1994-12#12)(1994-2#7)(1994-3#9)(1994-5#7)(1994-6#4)(1994-7#1)(1994-8#16)(1994-9#7)(1995-1#8)(1995-10#4)(1995-11#9)(1995-12#11)(1995-2#6)(1995-3#7)(1995-5#10)(1995-6#11)(1995-7#2)(1995-8#9)(1995-9#4)(1996-1#4)(1996-10#3)(1996-11#3)(1996-12#6)(1996-2#8)(1996-3#6)(1996-4#6)(1996-5#10)(1996-6#12)(1996-7#5)(1996-8#6)(1996-9#4)(1997-1#10)(1997-2#17)(1997-3#6)(1997-4#14)(1997-5#13)(1997-6#9)(1997-7#15)(1997-8#10)(1997-9#2)(2004-11#2)(2004-12#1)(2004-2#1)(2004-4#3)(2004-7#1)(2004-9#1)(2005-10#7)(2005-11#4)(2005-12#1)(2005-5#3)(2005-7#6)(2005-8#4)(2005-9#1)(2006-1#2)(2006-10#29)(2006-11#1)(2006-12#19)(2006-2#9)(2006-3#2)(2006-4#1)(2006-5#4)(2006-6#4)(2006-7#7)(2006-8#11)(2006-9#6)(2007-1#3)(2007-10#10)(2007-11#19)(2007-12#27)(2007-2#5)(2007-3#5)(2007-4#5)(2007-5#2)(2007-6#3)(2007-7#7)(2007-8#17)(2007-9#7)(2008-1#26)(2008-10#109)(2008-11#24)(2008-12#10)(2008-2#13)(2008-3#24)(2008-4#33)(2008-5#25)(2008-6#8)(2008-7#25)(2008-8#28)(2008-9#11)(2009-1#1)(2009-10#3)(2009-11#7)(2009-12#3)(2009-2#11)(2009-3#8)(2009-4#6)(2009-5#11)(2009-6#3)(2009-7#3)(2009-8#13)(2009-9#5)(2010-1#2)(2010-10#3)(2010-11#5)(2010-12#13)(2010-2#7)(2010-3#5)(2010-4#8)(2010-5#7)(2010-6#4)(2010-7#5)(2010-8#3)(2010-9#1)(2011-1#26)(2011-10#1)(2011-12#3)(2011-2#47)(2012-1#6)(2012-11#4)(2012-12#22)(2012-2#28)(2012-3#17)(2013-1#23)(2013-7#3)(2013-8#20)
responsibly##4##1##(1994-2#1)(1995-9#1)(2011-1#1)(2013-1#1)
responsive breast and endometrial##2##4##(1997-4#1)(2011-2#1)
responsive breast##3##2##(1990-5#1)(1997-4#1)(2011-2#1)
responsive cells##8##2##(1990-11#1)(1991-12#1)(1994-8#1)(1996-3#1)(1996-5#1)(2008-10#1)(2008-4#1)(2008-9#1)
responsive cis-acting##4##2##(1994-11#3)(2011-2#1)
responsive controlled-release system##4##3##(2012-11#4)
responsive element (ARE)##3##3##(1993-6#1)(1996-11#1)(2009-8#1)
responsive element and##2##3##(1992-5#1)(1993-8#1)
responsive element in the##2##4##(1992-6#1)(1994-6#1)
responsive element of##3##3##(1993-8#2)(2006-12#1)
responsive element##32##2##(1990-11#1)(1990-3#1)(1991-9#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#2)(1993-6#1)(1993-8#5)(1994-11#1)(1994-6#2)(1994-8#2)(1995-3#1)(1995-6#1)(1996-11#1)(1996-2#1)(1997-2#1)(2006-12#1)(2008-10#1)(2008-3#1)(2009-8#1)(2011-2#2)
responsive elements##5##2##(1993-3#1)(1995-2#1)(1996-11#1)(1996-8#1)(2006-12#1)
responsive gene##4##2##(1991-4#1)(1997-7#1)(2006-12#1)(2008-9#1)
responsive genes in##7##3##(1991-7#1)(2008-9#3)(2009-3#2)(2009-8#1)
responsive genes##11##2##(1991-7#1)(1994-8#1)(1995-2#1)(1995-3#1)(2008-9#3)(2009-3#2)(2009-4#1)(2009-8#1)
responsive or##4##2##(1993-11#1)(1997-2#1)(2008-2#1)(2011-2#1)
responsive patients##3##2##(2006-6#1)(2007-8#1)(2011-1#1)
responsive state##2##2##(2008-11#2)
responsive to LPS##2##3##(2008-11#1)(2008-2#1)
responsive to a##2##3##(2011-2#1)(2013-1#1)
responsive to both##2##3##(2005-12#1)(2006-4#1)
responsive to cellular##2##3##(1996-2#1)(2005-8#1)
responsive to changes in##3##4##(1994-11#1)(2006-4#1)(2007-10#1)
responsive to changes##4##3##(1994-11#1)(2006-4#1)(2007-10#1)(2007-3#1)
responsive to insulin##2##3##(1994-11#1)(2008-1#1)
responsive to the needs##2##4##(2008-7#1)(2013-8#1)
responsive to the##20##3##(1993-12#1)(1993-2#1)(1994-12#1)(1995-1#1)(1995-3#2)(1995-8#2)(1996-12#1)(1996-3#1)(1997-2#2)(1997-7#1)(2005-9#1)(2006-3#1)(2006-4#1)(2008-10#1)(2008-7#1)(2008-9#1)(2013-8#1)
responsive to treatment##2##3##(2007-8#1)(2008-1#1)
responsive to##131##2##(1990-11#1)(1990-12#2)(1990-4#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-2#2)(1992-5#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-9#3)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#3)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-6#2)(1997-7#2)(2004-3#1)(2005-12#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#6)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-8#1)(2008-1#4)(2008-10#10)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#3)(2011-9#1)(2012-12#3)(2012-2#4)(2013-1#5)(2013-8#1)
responsive##296##1##(1990-11#3)(1990-12#2)(1990-3#1)(1990-4#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-2#2)(1992-5#4)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#4)(1993-12#3)(1993-2#1)(1993-3#3)(1993-6#2)(1993-8#5)(1993-9#4)(1994-1#1)(1994-11#6)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#6)(1995-1#1)(1995-10#1)(1995-11#4)(1995-12#1)(1995-2#5)(1995-3#4)(1995-5#1)(1995-6#2)(1995-8#5)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#2)(1996-8#2)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#3)(1997-6#2)(1997-7#3)(1997-8#1)(2004-1#2)(2004-3#1)(2005-11#1)(2005-12#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#3)(2006-12#6)(2006-2#2)(2006-3#1)(2006-4#6)(2006-6#2)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#13)(2008-11#8)(2008-2#5)(2008-3#3)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#13)(2009-11#1)(2009-12#2)(2009-3#3)(2009-4#1)(2009-7#2)(2009-8#4)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#10)(2011-9#1)(2012-11#4)(2012-12#5)(2012-2#5)(2013-1#7)(2013-7#1)(2013-8#2)
responsiveness after##2##2##(2005-10#1)(2010-3#1)
responsiveness and##9##2##(1992-1#1)(1992-10#1)(1995-3#1)(2005-10#1)(2006-8#2)(2007-6#1)(2008-10#1)(2009-5#1)
responsiveness are##2##2##(1991-8#1)(1993-12#1)
responsiveness as##3##2##(1991-12#1)(1995-2#1)(2009-6#1)
responsiveness by##5##2##(1991-3#1)(1994-11#1)(1994-9#1)(1995-3#1)(1996-8#1)
responsiveness during the##2##3##(1996-3#1)(1996-4#1)
responsiveness in the##6##3##(1990-8#1)(1991-6#1)(1993-11#1)(1994-11#1)(1994-6#1)(1997-7#1)
responsiveness in##15##2##(1990-10#1)(1990-5#1)(1990-8#1)(1991-6#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-3#1)(1996-4#1)(1997-7#1)(2005-10#1)(2006-5#1)
responsiveness is##3##2##(1996-3#1)(2007-11#1)(2008-4#1)
responsiveness of a##3##3##(1991-2#1)(1993-11#1)(1995-5#1)
responsiveness of human##2##3##(1995-12#1)(2005-10#1)
responsiveness of the HPA axis##2##5##(1995-12#1)(2008-4#1)
responsiveness of the##20##3##(1991-2#1)(1991-9#1)(1992-7#1)(1993-11#1)(1993-3#1)(1994-12#1)(1995-10#1)(1995-12#1)(1995-3#2)(1996-3#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-3#1)(2007-2#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-6#1)
responsiveness of these##3##3##(1991-3#1)(1995-11#1)(1995-3#1)
responsiveness of##61##2##(1990-5#2)(1990-7#2)(1991-2#3)(1991-3#1)(1991-9#1)(1992-10#2)(1992-12#1)(1992-7#2)(1993-11#2)(1993-3#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-10#1)(1995-11#1)(1995-12#5)(1995-3#3)(1995-5#1)(1996-10#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-3#1)(1997-4#1)(1997-7#2)(2005-10#1)(2006-2#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-9#1)(2011-12#1)
responsiveness since##2##2##(1990-11#1)(1996-10#1)
responsiveness to ACh##2##3##(2010-8#2)
responsiveness to a variety of##3##5##(1993-4#1)(1995-12#1)(2008-4#1)
responsiveness to a##8##3##(1990-11#1)(1993-4#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-5#2)(2008-4#1)
responsiveness to agonist##2##3##(1995-12#1)(2008-9#1)
responsiveness to bronchodilator##2##3##(2011-2#2)
responsiveness to the##7##3##(1993-11#1)(1994-2#1)(1994-5#1)(1995-5#1)(2006-9#1)(2008-4#1)(2008-6#1)
responsiveness to therapy##2##3##(2005-8#1)(2010-12#1)
responsiveness to these##3##3##(1990-7#1)(1995-12#1)(2008-4#1)
responsiveness to##80##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-12#2)(1992-4#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-4#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-6#3)(1995-10#1)(1995-12#5)(1995-2#1)(1995-5#3)(1996-11#1)(1996-12#1)(1996-5#2)(1997-2#1)(1997-8#1)(2004-11#1)(2005-8#2)(2006-12#1)(2006-8#1)(2006-9#4)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#5)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#3)(2011-12#2)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
responsiveness was##5##2##(1991-3#1)(1993-11#1)(1993-12#1)(1994-3#1)(1995-3#1)
responsiveness were##3##2##(2005-10#1)(2005-4#1)(2006-8#1)
responsiveness##259##1##(1990-10#1)(1990-11#3)(1990-12#1)(1990-5#4)(1990-7#3)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#5)(1991-3#4)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#4)(1992-12#4)(1992-4#1)(1992-7#2)(1992-9#1)(1993-11#7)(1993-12#3)(1993-2#3)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#5)(1994-12#1)(1994-2#6)(1994-3#1)(1994-5#3)(1994-6#4)(1994-9#3)(1995-1#1)(1995-10#3)(1995-11#1)(1995-12#10)(1995-2#3)(1995-3#7)(1995-5#5)(1995-7#1)(1995-8#1)(1996-10#5)(1996-11#2)(1996-12#2)(1996-3#5)(1996-4#7)(1996-5#3)(1996-6#1)(1996-8#4)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-7#5)(1997-8#1)(2004-11#1)(2005-10#6)(2005-4#1)(2005-7#1)(2005-8#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#4)(2006-9#5)(2007-10#2)(2007-11#3)(2007-2#2)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#7)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-8#3)(2011-1#1)(2011-12#3)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
responsivities##5##1##(2008-2#1)(2008-3#4)
responsivity and##6##2##(2007-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-10#1)
responsivity at a##2##3##(1995-12#1)(2007-12#1)
responsivity at##4##2##(1995-12#1)(2007-12#1)(2008-3#1)(2009-10#1)
responsivity in##4##2##(1996-7#2)(2008-2#1)(2008-3#1)
responsivity of the##3##3##(1996-7#1)(2008-2#2)
responsivity of various types of##2##5##(2008-2#1)(2008-3#1)
responsivity of##17##2##(1993-6#1)(1994-8#1)(1995-12#1)(1996-7#1)(2007-11#2)(2007-12#1)(2008-2#7)(2008-3#3)
responsivity to##5##2##(1993-6#1)(1995-12#1)(1995-8#1)(2007-5#1)(2008-3#1)
responsivity values##2##2##(2008-3#2)
responsivity##54##1##(1993-6#2)(1994-8#1)(1995-12#3)(1995-8#1)(1996-7#4)(1997-5#1)(2007-11#2)(2007-12#4)(2007-5#1)(2008-2#11)(2008-3#18)(2008-4#1)(2009-10#4)(2012-2#1)
ressources##4##1##(2005-5#1)(2008-11#1)(2012-2#2)
rest and during##13##3##(1990-7#1)(1991-4#3)(2005-8#1)(2007-8#1)(2008-3#3)(2008-7#2)(2010-12#1)(2013-1#1)
rest and##43##2##(1990-7#1)(1991-4#4)(1991-6#1)(1992-6#1)(1995-3#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-8#1)(2005-8#1)(2006-10#2)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-3#4)(2008-7#7)(2009-3#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
rest as##2##2##(2008-10#1)(2010-6#1)
rest at##2##2##(2006-12#1)(2006-4#1)
rest being##2##2##(2010-4#1)(2011-12#1)
rest between##2##2##(1991-2#1)(2013-8#1)
rest by##4##2##(1992-2#1)(2007-12#1)(2007-3#1)(2007-7#1)
rest disorders##2##2##(2013-8#2)
rest had##5##2##(1990-4#1)(1991-7#1)(1995-2#1)(2008-7#1)(2008-8#1)
rest in##6##2##(1991-11#1)(1992-12#1)(1997-4#1)(2008-1#1)(2012-12#1)(2013-1#1)
rest is##2##2##(2005-10#1)(2006-8#1)
rest of the patients##7##4##(1993-5#1)(1995-5#1)(2007-7#1)(2007-8#2)(2009-2#1)(2011-2#1)
rest of the##118##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-8#4)(1992-10#3)(1992-11#2)(1992-3#1)(1992-4#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-8#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-7#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#6)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2009-2#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#9)(2012-1#1)(2012-2#1)(2012-9#1)(2013-1#3)(2013-7#2)(2013-8#1)
rest of##144##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-8#4)(1992-10#4)(1992-11#2)(1992-3#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-3#3)(1994-4#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-5#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2004-2#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-7#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#7)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#2)(2009-2#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#12)(2012-1#1)(2012-2#3)(2012-9#1)(2013-1#5)(2013-7#2)(2013-8#2)
rest on the##3##3##(1995-9#1)(2006-7#1)(2012-2#1)
rest on##6##2##(1991-1#1)(1995-9#1)(1996-2#1)(2006-7#2)(2012-2#1)
rest only##2##2##(1990-10#1)(2008-1#1)
rest or##9##2##(1991-4#1)(1994-8#2)(2006-12#1)(2007-10#1)(2008-10#1)(2008-8#1)(2009-10#1)(2013-7#1)
rest pain##2##2##(1997-1#1)(2008-8#1)
rest period##5##2##(1991-2#1)(2007-6#1)(2009-1#1)(2010-3#2)
rest position##2##2##(2007-12#1)(2012-12#1)
rest to##3##2##(2008-12#1)(2008-9#1)(2013-1#1)
rest using##2##2##(1996-1#1)(2007-4#1)
rest was##2##2##(1995-3#1)(2009-1#1)
rest went##2##2##(1991-1#1)(1992-2#1)
rest were##9##2##(2005-12#1)(2006-3#1)(2006-4#2)(2007-2#1)(2007-7#1)(2008-10#1)(2008-7#1)(2012-12#1)
rest with##5##2##(1996-2#1)(2006-10#1)(2007-12#1)(2008-7#1)(2010-9#1)
rest##391##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#2)(1991-1#3)(1991-11#2)(1991-2#3)(1991-4#7)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#4)(1992-10#4)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#3)(1993-2#3)(1993-3#1)(1993-5#1)(1993-8#2)(1994-10#1)(1994-2#1)(1994-3#3)(1994-4#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#2)(1995-8#1)(1995-9#2)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#4)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#3)(1997-8#5)(2004-11#1)(2004-2#1)(2005-1#1)(2005-10#3)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#10)(2006-12#3)(2006-2#2)(2006-3#2)(2006-4#3)(2006-6#4)(2006-7#3)(2006-8#1)(2007-10#4)(2007-11#4)(2007-12#8)(2007-2#4)(2007-3#2)(2007-4#2)(2007-5#3)(2007-6#1)(2007-7#6)(2007-8#6)(2007-9#2)(2008-1#3)(2008-10#20)(2008-11#3)(2008-12#2)(2008-2#7)(2008-3#10)(2008-4#4)(2008-5#7)(2008-6#3)(2008-7#24)(2008-8#7)(2008-9#3)(2009-1#2)(2009-10#2)(2009-2#1)(2009-3#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#4)(2010-4#5)(2010-6#1)(2010-8#4)(2010-9#2)(2011-1#5)(2011-12#2)(2011-2#15)(2012-1#4)(2012-12#5)(2012-2#5)(2012-3#3)(2012-9#1)(2013-1#18)(2013-7#3)(2013-8#13)
rest/activity##3##1##(2008-6#3)
restaging##6##1##(2006-10#1)(2010-11#1)(2010-12#1)(2012-12#1)(2012-2#2)
restaining of##2##2##(1995-7#1)(2008-9#1)
restart##7##1##(2008-7#2)(2011-2#3)(2013-1#2)
restarted##5##1##(1997-7#1)(2005-7#1)(2008-10#1)(2009-6#1)(2012-2#1)
restarting##2##1##(2007-9#1)(2008-7#1)
restate##2##1##(2010-5#1)(2013-1#1)
restaurant employment##2##2##(2007-11#2)
restaurant industry##2##2##(2007-11#2)
restaurant##14##1##(1990-6#1)(1993-8#1)(1994-3#1)(1996-11#1)(1996-3#1)(1996-6#1)(2007-11#6)(2010-2#1)(2013-1#1)
restaurants in##2##2##(1994-3#1)(2012-1#1)
restaurants##5##1##(1994-3#1)(2006-12#1)(2012-1#3)
reste##2##1##(2011-2#1)(2012-2#1)
rested in##2##2##(1993-10#1)(2008-5#1)
rested##5##1##(1993-10#1)(2006-10#1)(2007-10#1)(2008-5#1)(2008-9#1)
restenoses##2##1##(1994-11#1)(2008-10#1)
restenosis (p = 0##3##4##(2005-10#3)
restenosis after angioplasty##5##3##(1994-8#1)(2007-11#1)(2007-3#1)(2008-4#2)
restenosis after coronary angioplasty##2##4##(1992-9#1)(2012-2#1)
restenosis after percutaneous##3##3##(1995-8#1)(1996-12#1)(2010-4#1)
restenosis after##17##2##(1991-5#1)(1992-9#1)(1994-8#1)(1995-8#1)(1996-12#1)(1996-8#1)(2005-10#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-4#2)(2008-7#1)(2009-11#1)(2010-11#1)(2010-4#1)(2012-2#1)
restenosis and thrombosis##2##3##(2006-6#1)(2010-5#1)
restenosis and##11##2##(2005-7#1)(2006-6#1)(2007-11#2)(2008-12#2)(2008-5#2)(2009-1#1)(2010-5#1)(2011-2#1)
restenosis are##2##2##(2006-7#1)(2008-7#1)
restenosis following##5##2##(2005-7#1)(2007-11#1)(2008-1#1)(2008-12#1)(2013-1#1)
restenosis in patients##3##3##(2008-11#1)(2009-6#2)
restenosis in the##2##3##(1992-9#1)(1994-9#1)
restenosis in##7##2##(1992-9#1)(1994-9#1)(2007-8#2)(2008-11#1)(2009-6#2)
restenosis is##3##2##(1994-9#2)(2008-6#1)
restenosis rate after##2##3##(1991-3#1)(2008-5#1)
restenosis rate##9##2##(1991-3#3)(1992-9#1)(2008-12#2)(2008-5#3)
restenosis rates for Dacron and vein patched CEA were##3##9##(2005-10#3)
restenosis rates##6##2##(1996-8#1)(2005-10#3)(2007-11#1)(2008-11#1)
restenosis was##3##2##(2005-10#1)(2008-11#2)
restenosis which##2##2##(1994-10#1)(2008-7#1)
restenosis##136##1##(1991-3#4)(1991-5#1)(1992-4#2)(1992-9#10)(1994-10#2)(1994-11#4)(1994-8#1)(1994-9#3)(1995-8#1)(1996-12#1)(1996-6#1)(1996-8#7)(1997-2#1)(2005-10#12)(2005-7#2)(2005-9#1)(2006-10#1)(2006-11#1)(2006-6#2)(2006-7#2)(2006-8#1)(2007-11#8)(2007-3#1)(2007-8#5)(2008-1#1)(2008-11#10)(2008-12#6)(2008-4#7)(2008-5#11)(2008-6#6)(2008-7#3)(2008-8#1)(2009-1#1)(2009-11#1)(2009-5#1)(2009-6#5)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
resternotomy for##2##2##(1990-2#1)(2007-8#1)
resternotomy##10##1##(1990-2#1)(2007-8#9)
restimulated##2##1##(1991-2#1)(1992-8#1)
restimulation##3##1##(1991-2#1)(1997-7#1)(2007-12#1)
resting B cells##4##3##(1993-11#3)(2008-4#1)
resting ECG##4##2##(2007-12#1)(2010-1#1)(2011-2#2)
resting EEG##2##2##(1993-5#1)(2009-8#1)
resting GABA efflux##2##3##(1993-12#2)
resting HR##2##2##(2012-2#2)
resting PBMC##2##2##(1993-8#1)(2008-4#1)
resting T cells##6##3##(1992-6#2)(1994-12#1)(1994-9#3)
resting T##7##2##(1992-6#2)(1993-12#1)(1994-12#1)(1994-9#3)
resting [Ca2+]i##2##2##(1996-11#2)
resting and activated cells##2##4##(1995-2#1)(2008-9#1)
resting and activated##6##3##(1993-4#1)(1994-9#2)(1995-2#1)(2008-9#1)(2010-1#1)
resting and in##2##3##(1994-12#1)(2008-9#1)
resting and vigilance-controlled conditions##2##4##(1996-7#2)
resting and##35##2##(1991-7#2)(1992-2#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-4#1)(1993-9#2)(1994-12#1)(1994-3#1)(1994-9#3)(1995-2#1)(1995-7#1)(1995-8#1)(1996-7#2)(1997-6#1)(2005-10#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-7#3)(2008-9#2)(2009-12#1)(2009-5#1)(2010-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
resting blood pressure##7##3##(1990-8#1)(1992-4#1)(1994-3#3)(2008-3#1)(2013-8#1)
resting blood##9##2##(1990-3#1)(1990-8#1)(1992-4#1)(1994-3#3)(2008-3#1)(2012-11#1)(2013-8#1)
resting cells of##3##3##(1990-2#1)(1995-3#1)(1996-1#1)
resting cells##12##2##(1990-11#1)(1990-2#1)(1991-5#1)(1992-3#1)(1994-3#1)(1995-3#1)(1996-1#1)(1997-6#1)(2006-10#1)(2006-3#1)(2008-7#1)(2008-8#1)
resting conditions##9##2##(1992-8#1)(1994-2#1)(1995-5#1)(1996-1#1)(1997-7#1)(2007-10#1)(2007-9#1)(2008-4#1)(2008-8#1)
resting electrocardiogram##2##2##(2010-1#1)(2012-2#1)
resting energy expenditure##4##3##(2007-11#1)(2008-5#2)(2009-5#1)
resting enzyme##3##2##(1990-10#1)(1991-7#2)
resting heart rate##3##3##(2005-8#1)(2008-3#1)(2010-2#1)
resting heart##4##2##(1991-8#1)(2005-8#1)(2008-3#1)(2010-2#1)
resting hormonal concentrations##2##3##(2008-5#2)
resting human T cells##2##4##(1990-4#2)
resting human##4##2##(1990-4#2)(1992-6#1)(2004-11#1)
resting level##3##2##(1990-2#1)(1993-12#1)(2008-4#1)
resting limb during##2##3##(2013-8#2)
resting limb##3##2##(2013-8#3)
resting lymphocytes##2##2##(1994-3#1)(2007-11#1)
resting membrane potential and##2##4##(1990-2#1)(1993-2#1)
resting membrane potential##8##3##(1990-2#1)(1993-2#1)(1994-2#1)(1995-11#1)(1995-6#1)(1997-8#2)(2008-4#1)
resting membrane##11##2##(1990-2#1)(1993-12#1)(1993-2#2)(1994-2#1)(1995-11#2)(1995-6#1)(1997-8#2)(2008-4#1)
resting metabolic rate##5##3##(1994-12#1)(2005-1#2)(2008-4#2)
resting metabolic##6##2##(1994-12#1)(2005-1#3)(2008-4#2)
resting microglia##2##2##(1993-4#2)
resting motor threshold##3##3##(2011-2#3)
resting neutrophils##4##2##(1991-2#1)(1992-7#1)(1994-3#1)(1996-2#1)
resting on##4##2##(2007-6#1)(2008-10#1)(2008-5#1)(2012-2#1)
resting or activated##2##3##(1991-5#1)(2008-4#1)
resting or##4##2##(1990-12#1)(1991-5#1)(2008-4#1)(2013-8#1)
resting oxygen##2##2##(1994-12#1)(2008-5#1)
resting pain##2##2##(2006-7#1)(2007-11#1)
resting period##2##2##(1991-12#1)(2012-2#1)
resting peripheral blood mononuclear cells##2##5##(1992-6#1)(1994-9#1)
resting phase##3##2##(1992-8#1)(1994-3#1)(2008-5#1)
resting platelets was##2##3##(1992-6#1)(1996-2#1)
resting platelets##15##2##(1991-6#1)(1992-6#6)(1993-8#1)(1996-2#2)(1997-7#2)(2006-6#3)
resting potential and##2##3##(1992-8#1)(2008-4#1)
resting potential##7##2##(1991-6#1)(1992-1#1)(1992-8#2)(1994-10#1)(2005-10#1)(2008-4#1)
resting potentials##4##2##(1994-2#1)(2007-12#2)(2008-10#1)
resting spores##5##2##(2008-10#5)
resting stage from##2##3##(2013-7#2)
resting state##14##2##(1990-10#1)(1996-10#1)(1997-4#1)(2006-4#3)(2008-11#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-8#2)
resting tension##4##2##(1990-12#1)(1996-5#1)(1996-9#1)(2008-12#1)
resting time##3##2##(1996-7#1)(2008-12#1)(2011-2#1)
resting tremor##5##2##(2008-11#2)(2008-7#1)(2013-8#2)
resting upper arm##2##3##(2013-8#2)
resting##316##1##(1990-10#4)(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#2)(1990-4#2)(1990-6#2)(1990-8#2)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#3)(1991-6#7)(1991-7#4)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-6#10)(1992-7#2)(1992-8#4)(1992-9#1)(1993-11#5)(1993-12#6)(1993-2#2)(1993-4#4)(1993-5#1)(1993-8#2)(1993-9#3)(1994-10#1)(1994-12#5)(1994-2#3)(1994-3#12)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#8)(1995-11#3)(1995-12#3)(1995-2#2)(1995-3#4)(1995-5#2)(1995-6#1)(1995-7#2)(1995-8#2)(1996-1#2)(1996-10#1)(1996-11#2)(1996-2#5)(1996-4#1)(1996-5#3)(1996-7#3)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#2)(1997-7#7)(1997-8#3)(2004-11#1)(2005-1#3)(2005-10#2)(2005-12#1)(2005-8#1)(2006-10#2)(2006-3#1)(2006-4#5)(2006-6#3)(2006-7#2)(2007-10#2)(2007-11#4)(2007-12#3)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#12)(2008-5#8)(2008-7#8)(2008-8#2)(2008-9#2)(2009-12#1)(2009-2#1)(2009-5#3)(2009-8#1)(2009-9#1)(2010-1#5)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#9)(2012-11#1)(2012-12#3)(2012-2#7)(2012-3#1)(2013-1#3)(2013-7#4)(2013-8#16)
resting&quot##2##1##(1993-11#1)(2009-10#1)
restitutio##2##1##(1996-2#1)(2006-6#1)
restitution and##2##2##(1993-7#1)(2007-12#1)
restitution of function##2##3##(1993-7#1)(1994-2#1)
restitution of##4##2##(1993-7#1)(1994-2#1)(1995-8#1)(1997-1#1)
restitution##12##1##(1990-5#1)(1992-3#1)(1993-7#2)(1994-2#1)(1995-12#1)(1995-8#1)(1996-11#1)(1997-1#1)(2006-10#1)(2007-12#1)(2008-7#1)
restless leg syndrome##2##3##(2007-2#1)(2013-1#1)
restless legs syndrome##4##3##(2008-8#1)(2012-12#1)(2012-3#1)(2013-7#1)
restless legs##5##2##(2008-8#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
restless legs]##2##2##(2008-4#2)
restless##10##1##(2007-2#1)(2007-9#1)(2008-4#2)(2008-8#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
restlessness and##2##2##(1994-3#1)(1995-8#1)
restlessness##12##1##(1991-2#1)(1994-11#1)(1994-3#1)(1995-8#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-7#2)(2009-7#1)(2010-5#1)(2011-2#1)
restoration and the##2##3##(2007-7#1)(2008-11#1)
restoration and##12##2##(1991-1#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-12#1)(2011-12#1)(2011-2#2)
restoration application##2##2##(2008-2#2)
restoration area and disturbed area##2##5##(2013-8#2)
restoration area##4##2##(2013-8#4)
restoration by##4##2##(1994-8#1)(1995-6#1)(1997-1#1)(2013-7#1)
restoration filter for##3##3##(2008-2#3)
restoration for##5##2##(2008-3#2)(2008-7#2)(2012-12#1)
restoration from##3##2##(2008-2#1)(2008-3#2)
restoration in women-client survivors of##2##5##(2007-3#2)
restoration in##13##2##(1996-5#2)(2004-4#1)(2007-3#2)(2007-8#1)(2008-2#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
restoration is##3##2##(1997-1#1)(2008-10#1)(2011-2#1)
restoration of 4Pi confocal##2##4##(2007-12#2)
restoration of a##5##3##(1991-5#1)(2007-11#1)(2008-2#1)(2010-7#1)(2013-7#1)
restoration of anterior teeth##2##4##(1990-5#1)(2013-1#1)
restoration of cell##3##3##(1992-5#1)(1994-8#1)(2010-2#1)
restoration of coronary##2##3##(1993-12#1)(2006-10#1)
restoration of elbow##2##3##(2006-3#1)(2008-9#1)
restoration of full##3##3##(1990-5#1)(2007-8#1)(2008-9#1)
restoration of function in##3##4##(1992-10#1)(2008-9#2)
restoration of function##5##3##(1992-10#1)(2007-8#1)(2008-9#3)
restoration of images##2##3##(2008-2#1)(2008-3#1)
restoration of limb##2##3##(2007-11#1)(2010-5#1)
restoration of motion blurred##2##4##(2008-2#1)(2008-6#1)
restoration of motor function##2##4##(2012-2#1)(2013-1#1)
restoration of normal##5##3##(2006-8#1)(2007-11#1)(2008-11#1)(2009-7#1)(2011-1#1)
restoration of spontaneous circulation##4##4##(1990-12#1)(1993-8#1)(2007-3#2)
restoration of the original##3##4##(2008-3#1)(2008-5#1)(2011-2#1)
restoration of the proper##2##4##(2007-8#1)(2013-1#1)
restoration of the secretory##2##4##(1994-12#1)(2010-12#1)
restoration of the two##2##4##(1995-9#1)(2008-2#1)
restoration of the##39##3##(1991-3#1)(1994-12#1)(1994-8#1)(1995-9#1)(1997-7#1)(2004-4#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-6#1)(2011-11#1)(2011-2#1)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#2)
restoration of tissue##2##3##(2006-10#1)(2012-12#1)
restoration of##177##2##(1990-12#2)(1990-5#3)(1991-12#1)(1991-3#1)(1991-5#1)(1992-10#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#4)(1995-5#1)(1995-6#1)(1995-8#4)(1995-9#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-11#1)(2006-10#4)(2006-12#1)(2006-3#1)(2006-5#3)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#4)(2007-12#3)(2007-3#2)(2007-7#2)(2007-8#6)(2008-1#3)(2008-10#4)(2008-11#7)(2008-2#6)(2008-3#6)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#5)(2008-9#6)(2009-2#1)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-11#3)(2011-12#1)(2011-2#3)(2012-1#4)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#10)(2013-7#4)
restoration performance##2##2##(2008-3#2)
restoration programs##4##2##(2008-4#1)(2013-7#3)
restoration sites##2##2##(2011-2#2)
restoration to##5##2##(1990-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
restoration using##3##2##(2008-2#1)(2008-7#1)(2012-3#1)
restoration was##4##2##(2006-8#1)(2009-8#1)(2011-11#1)(2013-7#1)
restoration with##4##2##(2007-12#2)(2007-8#1)(2011-2#1)
restoration##353##1##(1990-12#3)(1990-5#5)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#2)(1992-10#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#4)(1995-5#1)(1995-6#2)(1995-8#4)(1995-9#1)(1996-11#1)(1996-12#1)(1996-5#4)(1997-1#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-4#2)(2004-9#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-3#1)(2006-5#3)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#2)(2007-10#1)(2007-11#5)(2007-12#14)(2007-3#4)(2007-7#3)(2007-8#12)(2007-9#1)(2008-1#4)(2008-10#8)(2008-11#8)(2008-2#30)(2008-3#23)(2008-4#3)(2008-5#7)(2008-6#4)(2008-7#11)(2008-9#6)(2009-2#1)(2009-3#1)(2009-4#2)(2009-7#2)(2009-8#3)(2010-10#2)(2010-11#6)(2010-12#3)(2010-2#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-11#6)(2011-12#2)(2011-2#22)(2012-1#5)(2012-11#1)(2012-12#8)(2012-2#13)(2012-3#4)(2013-1#15)(2013-7#11)(2013-8#11)
restorations and extractions##2##3##(2011-1#1)(2011-2#1)
restorations and##5##2##(1991-5#1)(2011-1#1)(2011-2#1)(2013-1#2)
restorations in the##2##3##(2008-7#1)(2012-12#1)
restorations in##7##2##(2008-5#1)(2008-7#2)(2009-4#1)(2012-12#2)(2013-1#1)
restorations on##2##2##(2009-8#1)(2012-12#1)
restorations were provided##2##3##(2013-1#2)
restorations were##6##2##(2009-8#3)(2011-2#1)(2013-1#2)
restorations##53##1##(1990-9#1)(1991-5#1)(2006-8#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#1)(2009-2#1)(2009-4#1)(2009-8#8)(2010-12#1)(2010-2#1)(2011-1#4)(2011-2#2)(2012-11#1)(2012-12#9)(2012-2#5)(2012-3#1)(2013-1#6)
restorations'##3##1##(2012-2#3)
restorative and prosthetic##2##3##(2013-1#2)
restorative and##4##2##(2008-11#1)(2012-2#1)(2013-1#2)
restorative dental##2##2##(2008-3#1)(2013-1#1)
restorative dentistry##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
restorative material##6##2##(2008-7#1)(2009-7#3)(2010-8#1)(2012-12#1)
restorative materials##9##2##(2008-7#1)(2009-7#1)(2010-3#1)(2011-2#4)(2012-12#1)(2012-6#1)
restorative procedures##2##2##(2010-11#1)(2011-2#1)
restorative proctocolectomy with##2##3##(1991-6#1)(2006-10#1)
restorative proctocolectomy##3##2##(1991-6#1)(2006-10#1)(2011-12#1)
restorative techniques##2##2##(2005-9#1)(2012-12#1)
restorative treatment of##2##3##(2007-8#1)(2008-7#1)
restorative treatment planning##2##3##(2010-10#1)(2012-12#1)
restorative treatment##9##2##(2007-8#1)(2008-7#1)(2009-2#1)(2010-10#2)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
restorative##78##1##(1991-6#1)(1992-3#1)(1994-6#1)(1995-8#1)(2005-9#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#6)(2008-12#4)(2008-3#1)(2008-7#6)(2008-8#1)(2009-2#1)(2009-4#1)(2009-7#5)(2010-10#2)(2010-11#1)(2010-3#5)(2010-6#1)(2010-8#2)(2011-12#1)(2011-2#6)(2012-11#1)(2012-12#13)(2012-2#2)(2012-6#1)(2013-1#7)(2013-7#2)
restore a##6##2##(1993-9#1)(2005-8#1)(2007-11#1)(2008-2#1)(2008-3#1)(2012-1#1)
restore at##2##2##(2007-11#1)(2012-3#1)
restore brain##3##2##(2006-12#1)(2008-1#1)(2013-1#1)
restore function##2##2##(2011-2#1)(2013-7#1)
restore immune##2##2##(1995-12#1)(2007-3#1)
restore knee##2##2##(2009-7#1)(2011-1#1)
restore normal##3##2##(2007-11#1)(2009-7#2)
restore the correct##2##3##(1990-6#1)(1992-1#1)
restore the integrity##2##3##(2007-12#1)(2008-2#1)
restore the patient##2##3##(2004-3#1)(2007-7#1)
restore the##44##2##(1990-10#1)(1990-6#1)(1992-1#1)(1993-2#1)(1993-3#1)(1994-10#1)(1995-5#1)(1995-6#1)(1996-1#1)(2004-3#1)(2005-1#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#2)(2007-7#1)(2007-8#2)(2008-2#3)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-8#2)(2010-11#1)(2011-2#3)(2012-2#1)(2013-1#1)
restore their##2##2##(2008-3#1)(2008-7#1)
restore##158##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-6#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-10#2)(1994-9#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-3#2)(1996-7#3)(1997-2#1)(1997-3#1)(1997-8#1)(2004-3#1)(2005-1#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#3)(2007-10#1)(2007-11#10)(2007-12#3)(2007-3#1)(2007-5#3)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#1)(2008-2#5)(2008-3#6)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#6)(2008-9#9)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#3)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-2#8)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#3)(2013-7#1)
restored MIF levels##2##3##(2012-12#2)
restored a portion of the life that would have been lost due to##2##13##(2008-7#2)
restored a##6##2##(1996-11#1)(1996-8#1)(2008-10#1)(2008-7#2)(2010-7#1)
restored after##4##2##(1990-12#1)(1991-9#1)(1996-5#1)(2004-4#1)
restored and##5##2##(2006-9#1)(2007-11#1)(2007-8#1)(2008-11#1)(2011-2#1)
restored at##2##2##(1994-6#1)(2009-8#1)
restored by addition of##3##4##(1994-2#1)(1994-8#1)(2008-8#1)
restored by increasing the##2##4##(2008-7#2)
restored by the addition of calcium##2##6##(1992-3#1)(2008-10#1)
restored by the addition of##5##5##(1990-11#1)(1992-3#1)(1992-8#1)(1996-5#1)(2008-10#1)
restored by use of a##2##5##(2008-2#1)(2008-3#1)
restored by use of##4##4##(2008-2#1)(2008-3#1)(2013-8#2)
restored by##50##2##(1990-11#2)(1990-5#1)(1990-6#1)(1991-1#1)(1991-5#2)(1991-9#1)(1992-3#1)(1992-8#2)(1993-12#1)(1994-2#2)(1994-7#1)(1994-8#2)(1995-11#1)(1995-8#1)(1996-10#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(2006-3#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2011-2#1)(2011-3#1)(2013-7#1)(2013-8#2)
restored if##2##2##(1994-8#1)(2008-11#1)
restored image##3##2##(2008-2#1)(2008-3#2)
restored images##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
restored in the##4##3##(1992-1#1)(1997-3#1)(1997-5#1)(1997-7#1)
restored in##14##2##(1991-10#1)(1992-1#1)(1993-5#1)(1997-3#2)(1997-5#1)(1997-7#1)(2007-9#1)(2008-1#1)(2008-11#1)(2009-8#1)(2010-5#1)(2012-3#2)
restored normal##2##2##(1996-5#1)(1996-8#1)
restored projection image##2##3##(2008-5#2)
restored the GTH-II##2##3##(2008-5#2)
restored the reduced##2##3##(1993-11#2)
restored the##26##2##(1990-10#1)(1990-3#1)(1991-5#2)(1991-8#1)(1992-1#1)(1993-11#2)(1994-12#1)(1994-5#1)(1995-12#1)(1996-11#1)(1997-1#1)(1997-5#1)(2005-8#1)(2008-10#4)(2008-11#1)(2008-5#2)(2011-2#1)(2012-3#1)(2013-1#2)
restored to Ery+##2##3##(1990-5#2)
restored to control##2##3##(1995-5#1)(1997-8#1)
restored to normal##4##3##(1993-11#1)(1997-4#1)(2008-5#1)(2011-2#1)
restored to the level##3##4##(1993-8#1)(1997-3#1)(2008-9#1)
restored to the##5##3##(1993-8#1)(1996-9#1)(1997-3#1)(2008-2#1)(2008-9#1)
restored to##21##2##(1990-5#3)(1992-11#1)(1993-11#1)(1993-3#1)(1993-8#1)(1995-5#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-8#1)(2008-2#1)(2008-5#1)(2008-9#1)(2011-2#3)(2012-2#1)
restored upon##2##2##(1995-5#1)(2005-11#1)
restored using##4##2##(2009-8#2)(2010-6#1)(2013-7#1)
restored with a##4##3##(2013-1#4)
restored with composite resin##4##4##(2013-1#4)
restored with##22##2##(1990-2#1)(1990-6#1)(1994-2#1)(1997-8#1)(2005-9#1)(2006-8#1)(2007-11#1)(2008-2#1)(2008-5#2)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#8)
restored##286##1##(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#5)(1990-6#2)(1991-1#1)(1991-10#1)(1991-2#2)(1991-4#1)(1991-5#5)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#3)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#3)(1993-8#1)(1994-10#1)(1994-12#2)(1994-2#3)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#3)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#5)(1996-8#3)(1996-9#3)(1997-1#3)(1997-2#2)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#2)(2004-4#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-2#1)(2006-3#3)(2006-5#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-3#2)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#11)(2008-11#5)(2008-12#2)(2008-2#7)(2008-3#7)(2008-4#3)(2008-5#12)(2008-6#4)(2008-7#5)(2008-8#5)(2008-9#1)(2009-10#1)(2009-8#4)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-11#1)(2011-2#13)(2011-3#1)(2012-11#2)(2012-12#6)(2012-2#6)(2012-3#5)(2013-1#14)(2013-7#2)(2013-8#6)
restorer line##3##2##(2006-12#1)(2008-10#2)
restorer##7##1##(1996-5#2)(2006-12#2)(2008-10#2)(2008-9#1)
restores cell##2##2##(1993-6#2)
restores full##2##2##(1994-12#1)(1995-2#1)
restores the##12##2##(1990-5#1)(1993-9#1)(1994-10#1)(1994-6#1)(1995-6#1)(1996-5#1)(1996-8#1)(2008-10#2)(2009-2#1)(2010-10#1)(2010-2#1)
restores their##2##2##(1994-8#1)(2007-9#1)
restores##59##1##(1990-10#1)(1990-5#1)(1990-9#1)(1991-3#1)(1991-7#1)(1992-5#1)(1992-7#1)(1993-2#1)(1993-6#2)(1993-9#1)(1994-10#2)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#2)(1995-6#3)(1995-8#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-10#1)(2006-10#1)(2006-3#2)(2006-7#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#3)(2008-6#1)(2008-7#2)(2009-2#1)(2009-7#1)(2010-10#1)(2010-2#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
restoring a##2##2##(2010-4#1)(2012-2#1)
restoring and##3##2##(2010-2#1)(2012-12#2)
restoring both##2##2##(2006-3#1)(2011-1#1)
restoring dopamine##2##2##(2008-7#1)(2010-12#1)
restoring force##2##2##(2013-8#2)
restoring forces that##2##3##(2013-8#2)
restoring forces##4##2##(2009-4#1)(2013-8#3)
restoring function##3##2##(2007-8#1)(2008-8#1)(2012-1#1)
restoring normal##2##2##(2006-10#1)(2008-2#1)
restoring the Th1/Th2##2##3##(2008-10#1)(2012-1#1)
restoring the activity of##2##4##(1992-1#1)(2008-1#1)
restoring the##18##2##(1990-5#1)(1992-1#1)(1993-2#1)(1993-8#1)(1995-3#1)(1996-6#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
restoring##82##1##(1990-5#1)(1992-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-7#1)(1995-10#1)(1995-12#1)(1995-3#1)(1996-6#1)(2005-7#2)(2006-10#2)(2006-3#1)(2007-10#1)(2007-11#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-1#3)(2012-12#8)(2012-2#3)(2013-1#1)(2013-7#2)(2013-8#6)
restrain the##5##2##(2008-11#1)(2008-2#1)(2010-8#1)(2012-1#1)(2013-1#1)
restrain##11##1##(1990-12#1)(1995-12#1)(1995-9#1)(1996-3#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
restrained and##2##2##(1993-4#1)(2007-12#1)
restrained by##6##2##(1992-2#1)(1995-10#1)(1997-6#1)(2007-4#1)(2008-11#1)(2011-2#1)
restrained in##2##2##(2007-1#1)(2008-4#1)
restrained least-squares##2##2##(1992-4#1)(1993-8#1)
restrained molecular dynamics##10##3##(1990-10#1)(1993-11#2)(1994-11#3)(1995-10#1)(1997-7#1)(2007-10#1)(2008-8#1)
restrained molecular##11##2##(1990-10#1)(1993-11#2)(1994-11#3)(1994-8#1)(1995-10#1)(1997-7#1)(2007-10#1)(2008-8#1)
restrained occupants##4##2##(2007-4#2)(2012-12#2)
restrained##57##1##(1990-10#1)(1990-11#1)(1990-4#1)(1991-1#1)(1991-5#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-11#2)(1993-4#2)(1993-8#1)(1993-9#1)(1994-11#3)(1994-5#1)(1994-8#1)(1995-10#3)(1995-11#1)(1995-3#1)(1996-1#3)(1996-2#1)(1997-6#1)(1997-7#1)(2007-1#2)(2007-10#1)(2007-12#4)(2007-4#4)(2008-10#1)(2008-11#1)(2008-4#5)(2008-7#2)(2008-8#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#3)
restraining forces##3##2##(2012-2#3)
restraining the##4##2##(1990-12#1)(1993-9#1)(1997-6#1)(2005-9#1)
restraining##17##1##(1990-12#1)(1991-12#1)(1993-9#1)(1997-1#1)(1997-6#1)(2005-10#1)(2005-9#1)(2007-2#1)(2008-11#1)(2008-4#2)(2008-8#1)(2009-6#2)(2012-2#3)
restrains##2##1##(1996-8#1)(2008-11#1)
restraint and seclusion##2##3##(1991-5#1)(1996-2#1)
restraint and##5##2##(1991-5#1)(1996-2#1)(1997-2#1)(2007-12#1)(2007-4#1)
restraint condition##3##2##(2007-4#3)
restraint conditions##2##2##(2007-4#2)
restraint forces##3##2##(2007-4#3)
restraint of##3##2##(2007-2#1)(2008-4#2)
restraint practices##2##2##(2007-1#1)(2008-7#1)
restraint rates##2##2##(2008-7#2)
restraint stress in the##2##4##(1994-2#1)(1995-12#1)
restraint stress on##3##3##(2010-12#2)(2013-1#1)
restraint stress##23##2##(1993-2#3)(1994-2#5)(1995-12#1)(2005-11#2)(2005-8#1)(2007-11#1)(2009-2#1)(2010-12#5)(2010-5#1)(2012-1#2)(2013-1#1)
restraint system##6##2##(1995-5#1)(2006-11#1)(2007-4#4)
restraint systems##8##2##(2006-11#7)(2013-1#1)
restraint types##3##2##(2006-11#3)
restraint use##3##2##(1991-8#2)(2008-7#1)
restraint##128##1##(1990-5#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-8#2)(1993-12#2)(1993-2#5)(1993-7#1)(1994-2#6)(1994-3#1)(1995-1#1)(1995-12#5)(1995-3#2)(1995-5#1)(1996-10#4)(1996-2#1)(1997-2#4)(2004-2#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-11#21)(2006-12#3)(2006-2#1)(2007-1#4)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#18)(2007-6#1)(2008-2#1)(2008-4#7)(2008-7#5)(2008-8#2)(2009-2#1)(2009-6#2)(2010-12#5)(2010-5#1)(2011-12#1)(2011-2#2)(2012-1#2)(2013-1#2)
restraint-induced##2##1##(1990-7#1)(1993-9#1)
restraints and##4##2##(1995-6#1)(2006-2#1)(2007-1#1)(2010-10#1)
restraints for##2##2##(1993-11#1)(2008-8#1)
restraints in molecular##3##3##(1995-1#1)(1996-7#1)(2007-10#1)
restraints in##7##2##(1994-12#1)(1994-8#1)(1995-1#1)(1996-7#1)(2004-12#1)(2007-10#1)(2008-7#1)
restraints on a##2##3##(1994-2#1)(1996-3#1)
restraints on##4##2##(1994-2#1)(1996-3#1)(2008-5#1)(2008-8#1)
restraints per##2##2##(1991-4#1)(1996-3#1)
restraints were obtained##2##3##(1995-10#2)
restraints were##6##2##(1990-10#1)(1994-11#1)(1995-10#2)(2007-4#2)
restraints##54##1##(1990-10#1)(1991-11#1)(1991-12#1)(1991-4#4)(1992-12#1)(1992-2#1)(1993-11#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#3)(1995-10#2)(1995-5#2)(1995-6#1)(1996-3#3)(1996-7#1)(1997-7#1)(2004-12#1)(2006-11#1)(2006-2#1)(2007-1#1)(2007-10#2)(2007-4#2)(2007-7#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2009-3#1)(2010-10#3)(2010-7#1)(2011-2#1)(2012-12#1)
restrict funding##2##2##(1991-1#1)(1994-2#1)
restrict minors'##2##2##(1991-5#2)
restrict the##19##2##(1990-12#1)(1992-1#1)(1992-9#1)(1993-11#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2010-2#1)(2012-2#1)
restrict their##3##2##(1996-5#1)(2008-5#1)(2010-6#1)
restrict##66##1##(1990-11#1)(1990-12#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#4)(1992-1#1)(1992-11#2)(1992-12#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#1)(1994-2#1)(1994-7#1)(1995-9#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-7#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-12#2)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2009-2#1)(2009-4#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
restricta##3##1##(2007-7#1)(2008-5#2)
restricted access##2##2##(1990-5#1)(1993-12#1)
restricted among##2##2##(1991-3#1)(2008-10#1)
restricted and##8##2##(1990-11#1)(1992-1#1)(1992-8#1)(1992-9#1)(1995-5#1)(2006-1#1)(2008-10#1)(2013-1#1)
restricted areas##2##2##(1994-12#1)(2011-2#1)
restricted both##2##2##(1993-7#1)(2005-9#1)
restricted by the##11##3##(1990-4#1)(1996-10#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2011-3#1)
restricted by##25##2##(1990-11#1)(1990-4#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-2#1)(1992-4#1)(1993-5#1)(1995-1#1)(1996-10#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#1)
restricted diet##3##2##(2008-3#2)(2013-7#1)
restricted diffusion##3##2##(2006-10#1)(2007-10#1)(2009-9#1)
restricted exclusively##2##2##(1994-12#1)(2008-7#1)
restricted expression in the##2##4##(1997-6#1)(2012-2#1)
restricted expression in##4##3##(1997-6#1)(2008-9#1)(2011-1#1)(2012-2#1)
restricted expression##7##2##(1994-8#1)(1997-4#1)(1997-6#1)(2008-9#1)(2011-1#1)(2012-2#2)
restricted feeding##4##2##(1992-12#1)(1997-1#1)(2010-4#1)(2012-3#1)
restricted for##2##2##(1995-9#1)(2008-6#1)
restricted gene flow between##2##4##(2008-10#1)(2012-3#1)
restricted gene flow##5##3##(2008-10#2)(2008-9#1)(2010-8#1)(2012-3#1)
restricted in scope##2##3##(2007-6#1)(2008-10#1)
restricted in the##2##3##(1993-10#1)(2009-9#1)
restricted in##13##2##(1991-5#1)(1991-9#1)(1992-7#1)(1993-10#1)(1994-2#1)(1996-4#1)(2006-4#1)(2007-6#1)(2008-10#2)(2009-9#1)(2011-2#1)(2012-12#1)
restricted intake##2##2##(2007-2#2)
restricted mobility##2##2##(2007-10#1)(2007-2#1)
restricted motion##2##2##(1990-3#1)(2010-1#1)
restricted number of##3##3##(1990-8#1)(1993-12#1)(2008-1#1)
restricted only##2##2##(2006-10#1)(2008-11#1)
restricted or##3##2##(2007-5#1)(2008-10#1)(2008-5#1)
restricted patterns of##3##3##(1990-7#1)(1995-8#1)(2010-2#1)
restricted population of##2##3##(1993-12#1)(1994-2#1)
restricted primarily to##3##3##(2008-4#1)(2008-7#2)
restricted range of##3##3##(1994-5#1)(2007-11#1)(2013-8#1)
restricted range##4##2##(1994-5#1)(2007-11#1)(2008-9#1)(2013-8#1)
restricted rats##2##2##(1991-12#1)(1995-1#1)
restricted regions of##2##3##(1991-9#1)(1992-9#1)
restricted substances in flavor and fragrant samples##2##7##(2012-12#2)
restricted substances in flavor and fragrant##3##6##(2012-12#3)
restricted substrate specificity##2##3##(1991-4#1)(1993-7#1)
restricted substrate##3##2##(1991-4#1)(1993-7#1)(2013-1#1)
restricted than##3##2##(1991-9#1)(1995-1#1)(1995-10#1)
restricted the##6##2##(1992-6#1)(1993-3#1)(1997-6#1)(2008-10#1)(2009-12#1)(2010-2#1)
restricted to Schwann cells##2##4##(1991-9#2)
restricted to a few##5##4##(1990-4#1)(1991-5#1)(1993-10#1)(2008-5#1)(2013-1#1)
restricted to a narrow##2##4##(1997-1#1)(2008-2#1)
restricted to a particular##2##4##(2009-6#1)(2010-12#1)
restricted to a single##6##4##(1992-8#1)(1994-2#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)
restricted to a small##2##4##(2008-10#1)(2008-8#1)
restricted to a##25##3##(1990-3#1)(1990-4#1)(1991-5#1)(1992-3#1)(1992-8#1)(1993-10#1)(1994-2#1)(1995-10#1)(1995-6#1)(1997-1#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-12#1)(2013-1#1)(2013-8#1)
restricted to any##2##3##(1995-2#1)(2008-11#1)
restricted to be##2##3##(2008-10#1)(2012-2#1)
restricted to certain##3##3##(1990-2#1)(1990-5#1)(2011-2#1)
restricted to neighboring patches##2##4##(2007-9#2)
restricted to patients##3##3##(2006-9#1)(2008-11#1)(2012-12#1)
restricted to small##2##3##(2008-3#1)(2010-10#1)
restricted to some##2##3##(1994-2#1)(1995-9#1)
restricted to specific##2##3##(1991-11#1)(2010-5#1)
restricted to the cytoplasm##3##4##(1992-8#1)(1997-4#1)(2006-12#1)
restricted to the dorsal##2##4##(1990-11#1)(2008-11#1)
restricted to the epidermis and outer cortex tissues##2##8##(2008-10#2)
restricted to the epidermis and##3##5##(2008-10#3)
restricted to the liver##3##4##(1993-12#1)(1995-10#1)(2008-5#1)
restricted to the##92##3##(1990-10#1)(1990-11#3)(1990-5#3)(1990-6#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-8#1)(1993-12#1)(1993-3#2)(1994-12#2)(1994-2#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-6#1)(1995-8#3)(1996-10#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-12#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#2)(2008-10#11)(2008-11#2)(2008-2#4)(2008-3#2)(2008-5#5)(2008-7#4)(2008-8#1)(2009-4#1)(2009-5#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-7#1)
restricted to these##2##3##(1990-10#1)(2006-10#1)
restricted to##254##2##(1990-10#2)(1990-11#5)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-5#2)(1991-6#3)(1991-9#3)(1992-1#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#3)(1992-9#1)(1993-10#1)(1993-12#3)(1993-3#2)(1994-12#3)(1994-2#4)(1994-3#2)(1994-8#1)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#3)(1995-9#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#3)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#4)(1997-8#3)(2004-1#1)(2005-11#1)(2005-7#3)(2006-10#3)(2006-12#4)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#4)(2007-12#6)(2007-3#1)(2007-5#3)(2007-7#3)(2007-9#2)(2008-1#3)(2008-10#24)(2008-11#5)(2008-2#8)(2008-3#4)(2008-4#5)(2008-5#11)(2008-6#3)(2008-7#9)(2008-8#6)(2008-9#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
restricted use of##3##3##(2007-7#1)(2008-10#1)(2012-1#1)
restricted use##4##2##(1992-3#1)(2007-7#1)(2008-10#1)(2012-1#1)
restricted volumes##2##2##(2005-11#1)(2008-10#1)
restricted with##3##2##(1991-4#1)(2007-7#1)(2008-5#1)
restricted within the##2##3##(1990-3#1)(1995-11#1)
restricted##582##1##(1990-10#2)(1990-11#7)(1990-12#1)(1990-2#1)(1990-3#5)(1990-4#3)(1990-5#6)(1990-6#1)(1990-7#4)(1990-8#1)(1991-1#2)(1991-10#2)(1991-11#3)(1991-12#6)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#4)(1991-6#4)(1991-9#7)(1992-1#7)(1992-10#1)(1992-12#4)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#4)(1992-9#4)(1993-10#2)(1993-11#1)(1993-12#9)(1993-3#3)(1993-5#2)(1993-7#4)(1994-11#2)(1994-12#5)(1994-2#6)(1994-3#3)(1994-5#1)(1994-7#1)(1994-8#3)(1995-1#4)(1995-10#4)(1995-11#3)(1995-12#1)(1995-2#3)(1995-3#2)(1995-4#2)(1995-5#2)(1995-6#2)(1995-8#5)(1995-9#2)(1996-10#2)(1996-11#2)(1996-2#1)(1996-3#2)(1996-4#4)(1996-5#4)(1996-6#4)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#3)(1997-7#5)(1997-8#4)(2004-1#1)(2004-11#2)(2005-11#3)(2005-7#3)(2005-9#1)(2006-1#1)(2006-10#9)(2006-12#4)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#3)(2007-1#2)(2007-10#6)(2007-11#2)(2007-12#12)(2007-2#5)(2007-3#2)(2007-5#4)(2007-6#2)(2007-7#5)(2007-8#3)(2007-9#3)(2008-1#5)(2008-10#53)(2008-11#11)(2008-2#15)(2008-3#13)(2008-4#8)(2008-5#21)(2008-6#4)(2008-7#17)(2008-8#15)(2008-9#8)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#3)(2009-7#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#4)(2011-1#4)(2011-12#1)(2011-2#12)(2011-3#2)(2012-1#1)(2012-11#1)(2012-12#14)(2012-2#18)(2012-3#6)(2013-1#17)(2013-7#5)(2013-8#3)
restricted-access material##2##2##(2012-12#2)
restricted-access##4##1##(2008-10#1)(2012-12#3)
restricting a##2##2##(2007-12#1)(2013-1#1)
restricting the##13##2##(1995-3#1)(1996-11#1)(1996-12#1)(2005-8#1)(2006-6#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2010-2#1)(2011-10#1)(2013-8#1)
restricting their##4##2##(1993-12#1)(2009-5#1)(2010-4#1)(2010-8#1)
restricting##36##1##(1992-4#1)(1993-1#1)(1993-12#1)(1995-11#1)(1995-3#2)(1996-11#1)(1996-12#1)(2005-10#1)(2005-8#1)(2006-6#2)(2007-12#1)(2007-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-10#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
restriction (CR)##6##2##(1994-5#1)(2005-8#1)(2008-11#1)(2008-7#2)(2009-5#1)
restriction analysis and##2##3##(1992-3#1)(2008-10#1)
restriction analysis of the##3##4##(1994-2#1)(2006-8#1)(2008-10#1)
restriction analysis of##8##3##(1993-6#1)(1994-2#1)(1996-3#1)(1996-6#1)(2006-3#1)(2006-8#1)(2008-10#2)
restriction analysis to##2##3##(2006-5#2)
restriction analysis##21##2##(1990-4#1)(1990-9#1)(1992-3#1)(1992-8#1)(1993-6#2)(1994-2#1)(1996-3#1)(1996-6#1)(2006-3#2)(2006-5#4)(2006-8#2)(2008-10#4)
restriction and modification genes##2##4##(1990-4#1)(1990-9#1)
restriction and modification systems in##2##5##(2006-8#2)
restriction and modification##11##3##(1990-4#1)(1990-5#2)(1990-9#1)(1994-12#1)(1995-8#1)(1996-10#1)(2006-8#4)
restriction and the##5##3##(1990-2#1)(1990-5#1)(2007-11#1)(2008-10#1)(2008-4#1)
restriction and##38##2##(1990-2#1)(1990-4#1)(1990-5#3)(1990-9#2)(1994-12#1)(1994-3#1)(1995-6#1)(1995-8#1)(1996-10#2)(1996-11#1)(1996-12#1)(2006-11#1)(2006-2#1)(2006-8#4)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#3)(2009-10#1)(2009-5#2)(2009-8#2)(2010-7#1)(2011-1#1)(2011-12#1)(2013-1#1)
restriction and/or##2##2##(2006-8#1)(2007-8#1)
restriction by##4##2##(1995-5#1)(2007-11#1)(2008-10#1)(2008-3#1)
restriction did not##3##3##(1990-3#1)(1995-9#1)(2008-4#1)
restriction digest##2##2##(2008-10#1)(2008-4#1)
restriction digestion of##4##3##(1995-3#1)(2008-10#1)(2008-2#1)(2008-4#1)
restriction digestion##9##2##(1994-8#1)(1995-3#1)(2005-11#1)(2008-10#2)(2008-2#1)(2008-4#2)(2009-5#1)
restriction digests##2##2##(1992-3#1)(1997-3#1)
restriction element##3##2##(1990-8#1)(1991-12#1)(1994-11#1)
restriction endonuclease (ENase)##4##3##(1990-3#1)(1993-12#1)(1993-9#1)(1996-10#1)
restriction endonuclease analysis##4##3##(1997-6#2)(2007-8#2)
restriction endonuclease and##4##3##(1991-7#1)(1995-10#1)(1995-8#1)(1997-1#1)
restriction endonuclease digestion##2##3##(2008-8#1)(2012-3#1)
restriction endonuclease from##3##3##(1990-10#1)(2006-8#2)
restriction endonuclease mapping##3##3##(1991-2#1)(2008-10#1)(2008-5#1)
restriction endonuclease was##3##3##(1991-9#1)(1997-1#1)(2006-8#1)
restriction endonuclease##44##2##(1990-10#1)(1990-11#1)(1990-3#2)(1991-2#1)(1991-7#2)(1991-9#1)(1993-12#2)(1993-9#1)(1994-12#2)(1994-5#1)(1994-8#2)(1995-1#2)(1995-10#1)(1995-8#1)(1996-10#1)(1996-12#1)(1997-1#3)(1997-6#2)(2005-11#3)(2006-8#5)(2007-2#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#2)(2012-3#1)
restriction endonucleases##17##2##(1990-4#2)(1992-4#1)(1993-9#2)(1997-5#1)(2006-8#4)(2008-1#1)(2008-2#1)(2008-4#2)(2008-5#1)(2010-12#1)(2010-4#1)
restriction enzyme analysis##12##3##(1990-7#1)(1992-5#1)(1992-8#1)(1997-4#1)(2005-10#1)(2005-6#1)(2005-9#1)(2008-10#2)(2008-5#3)
restriction enzyme digestion and##4##4##(1993-12#1)(2006-12#1)(2008-10#1)(2012-3#1)
restriction enzyme digestion of##2##4##(1990-12#1)(1992-5#1)
restriction enzyme digestion##10##3##(1990-12#1)(1992-5#1)(1993-12#1)(1996-11#2)(2006-12#1)(2008-10#2)(2008-3#1)(2012-3#1)
restriction enzyme digests##2##3##(1992-11#1)(2008-10#1)
restriction enzyme recognition sites##2##4##(1997-2#1)(1997-4#1)
restriction enzyme recognition##3##3##(1991-9#1)(1997-2#1)(1997-4#1)
restriction enzyme site in##2##4##(1995-1#1)(1997-5#1)
restriction enzyme site##5##3##(1990-12#1)(1991-5#1)(1995-1#1)(1996-11#1)(1997-5#1)
restriction enzyme##63##2##(1990-12#2)(1990-3#1)(1990-7#1)(1990-9#2)(1991-12#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-11#3)(1992-5#2)(1992-8#1)(1993-12#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-10#2)(1995-12#1)(1995-8#1)(1996-11#3)(1996-12#1)(1996-4#2)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#2)(2005-10#1)(2005-6#1)(2005-9#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-2#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-5#5)(2008-7#1)(2012-3#1)
restriction enzyme-based##2##2##(2008-2#1)(2012-12#1)
restriction enzyme-mediated integration (REMI)##4##4##(2008-10#4)
restriction enzyme-mediated integration##6##3##(1994-12#1)(2008-10#5)
restriction enzymes and##2##3##(2007-10#1)(2008-2#1)
restriction enzymes##39##2##(1990-10#1)(1990-12#1)(1990-3#1)(1994-12#1)(1994-6#1)(1995-8#1)(1996-2#1)(1996-6#1)(1997-2#2)(2006-5#1)(2007-10#2)(2008-10#15)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#4)(2008-8#1)(2009-10#1)(2012-12#1)
restriction factors##2##2##(1994-2#1)(2011-2#1)
restriction for##3##2##(1992-2#1)(2010-4#2)
restriction fragment containing##3##3##(1990-10#1)(1990-9#1)(1993-12#1)
restriction fragment length polymorphism (RFLP) analyses##2##6##(2008-10#2)
restriction fragment length polymorphism (RFLP) analysis of##3##7##(2008-10#3)
restriction fragment length polymorphism (RFLP) analysis##10##6##(1990-12#1)(2008-10#6)(2008-5#2)(2012-3#1)
restriction fragment length polymorphism (RFLP) and##2##6##(1997-4#1)(2008-10#1)
restriction fragment length polymorphism (RFLP) loci##2##6##(2008-10#2)
restriction fragment length polymorphism (RFLP) markers were##2##7##(2008-10#1)(2008-9#1)
restriction fragment length polymorphism (RFLP) markers##8##6##(1995-6#1)(1996-10#1)(1996-12#1)(2008-10#4)(2008-9#1)
restriction fragment length polymorphism (RFLP)##39##5##(1990-12#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-6#1)(1997-4#2)(2008-10#24)(2008-4#1)(2008-5#3)(2008-9#2)(2012-3#1)(2013-1#1)
restriction fragment length polymorphism analyses##2##5##(2008-10#2)
restriction fragment length polymorphism analysis of a##2##7##(2008-10#2)
restriction fragment length polymorphism analysis of the##3##7##(2008-10#3)
restriction fragment length polymorphism analysis of##7##6##(2008-10#7)
restriction fragment length polymorphism analysis##14##5##(2006-3#1)(2008-10#11)(2008-4#1)(2008-5#1)
restriction fragment length polymorphism and##2##5##(2008-10#2)
restriction fragment length polymorphism banding##2##5##(2008-10#2)
restriction fragment length polymorphism linkage##2##5##(1996-10#1)(2008-10#1)
restriction fragment length polymorphism loci##3##5##(1997-4#1)(2008-10#2)
restriction fragment length polymorphism map##2##5##(2008-10#2)
restriction fragment length polymorphism marker##2##5##(2008-10#2)
restriction fragment length polymorphism markers##5##5##(1997-4#1)(2008-10#4)
restriction fragment length polymorphism of##4##5##(2008-10#3)(2010-12#1)
restriction fragment length polymorphism probes##3##5##(2008-10#3)
restriction fragment length polymorphism with##2##5##(2008-10#1)(2008-9#1)
restriction fragment length polymorphism##106##4##(1990-12#1)(1990-3#1)(1990-4#1)(1992-3#1)(1995-6#1)(1996-10#2)(1996-12#1)(1996-3#1)(1996-6#1)(1997-4#4)(2006-3#1)(2006-8#1)(2008-10#77)(2008-4#2)(2008-5#4)(2008-9#3)(2010-12#1)(2012-3#1)(2013-1#2)
restriction fragment length polymorphisms (RFLPs) and##2##6##(1994-7#1)(2008-5#1)
restriction fragment length polymorphisms (RFLPs) of##2##6##(1990-5#1)(2008-10#1)
restriction fragment length polymorphisms (RFLPs)##8##5##(1990-5#1)(1994-7#1)(2008-10#5)(2008-5#1)
restriction fragment length polymorphisms analysis##3##5##(2011-1#3)
restriction fragment length polymorphisms##25##4##(1990-5#1)(1991-8#1)(1994-11#1)(1994-7#1)(1996-12#2)(1996-5#1)(1997-4#1)(1997-5#1)(2008-10#10)(2008-12#1)(2008-5#2)(2011-1#3)
restriction fragment length##133##3##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-8#1)(1992-3#1)(1994-11#1)(1994-7#1)(1995-6#1)(1996-10#2)(1996-12#3)(1996-3#1)(1996-5#1)(1996-6#1)(1997-4#5)(1997-5#1)(2006-3#1)(2006-8#1)(2008-10#88)(2008-12#1)(2008-4#3)(2008-5#6)(2008-9#3)(2010-12#1)(2011-1#3)(2012-3#1)(2013-1#2)
restriction fragment patterns##2##3##(1993-11#1)(2008-1#1)
restriction fragment##140##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-8#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-7#1)(1995-6#1)(1996-10#2)(1996-12#3)(1996-3#1)(1996-5#1)(1996-6#1)(1997-4#5)(1997-5#1)(2006-3#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#89)(2008-12#1)(2008-4#3)(2008-5#6)(2008-9#3)(2010-12#1)(2011-1#3)(2012-3#1)(2013-1#2)
restriction fragments by##2##3##(1991-4#1)(1994-3#1)
restriction fragments containing##2##3##(1995-5#1)(2008-5#1)
restriction fragments from##6##3##(1992-6#1)(1993-2#1)(2008-2#2)(2008-4#2)
restriction fragments##22##2##(1991-4#1)(1991-7#1)(1991-8#2)(1992-3#1)(1992-4#2)(1992-6#2)(1993-2#1)(1994-3#1)(1995-5#1)(1995-6#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-4#2)(2008-5#1)
restriction in##8##2##(1992-12#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-5#1)(2006-11#1)(2006-8#1)(2008-3#1)
restriction is##6##2##(1995-1#1)(1996-11#1)(2006-9#1)(2008-4#1)(2009-5#1)(2010-2#1)
restriction landmark genomic scanning##2##4##(1994-12#1)(1995-12#1)
restriction map of the##2##4##(1991-12#1)(1992-3#1)
restriction map of##3##3##(1991-12#1)(1992-3#1)(1993-6#1)
restriction map##5##2##(1990-9#1)(1991-12#1)(1992-3#1)(1993-6#1)(1994-9#1)
restriction mapping##8##2##(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#1)(1994-12#1)(1996-10#1)(1997-2#1)(2008-4#1)
restriction maps and##2##3##(1992-1#1)(1992-11#1)
restriction maps##4##2##(1990-4#1)(1992-1#1)(1992-11#1)(2008-4#1)
restriction may##2##2##(1996-7#1)(2005-9#1)
restriction of antigen-specific responses)##2##4##(2008-4#2)
restriction of fungal##2##3##(2008-10#2)
restriction of knee##2##3##(2007-8#1)(2012-12#1)
restriction of physical activity##2##4##(2004-10#1)(2010-3#1)
restriction of the##9##3##(1990-11#1)(1991-7#1)(2005-11#1)(2006-4#1)(2007-7#1)(2008-10#2)(2008-7#1)(2008-8#1)
restriction of##51##2##(1990-11#1)(1990-8#1)(1991-7#1)(1992-1#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-11#1)(1996-4#1)(1997-1#1)(1997-6#1)(2004-10#1)(2005-11#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-7#4)(2007-8#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
restriction on the##11##3##(1990-3#1)(1991-6#1)(1991-9#1)(1993-12#2)(2006-10#1)(2008-10#1)(2008-3#3)(2013-7#1)
restriction on##25##2##(1990-3#1)(1990-9#1)(1991-6#1)(1991-9#2)(1993-12#2)(1994-10#1)(1995-1#3)(1995-12#1)(1996-5#1)(1996-7#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-7#2)(2009-2#1)(2013-7#1)
restriction or##2##2##(1990-9#1)(2007-2#1)
restriction pattern of##2##3##(1992-9#1)(2006-8#1)
restriction pattern##9##2##(1992-9#1)(1993-11#1)(1996-7#2)(1997-8#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
restriction patterns of##2##3##(2006-8#1)(2008-10#1)
restriction patterns##8##2##(1997-2#2)(1997-6#2)(2006-8#1)(2007-8#1)(2008-10#2)
restriction profile##2##2##(1997-2#1)(2008-10#1)
restriction profiles of##3##3##(2008-10#1)(2010-12#2)
restriction profiles##4##2##(1997-2#1)(2008-10#1)(2010-12#2)
restriction site analysis##2##3##(1996-4#1)(2008-5#1)
restriction site for##2##3##(1990-6#1)(1992-7#1)
restriction site in##3##3##(1990-7#3)
restriction site polymorphism was##2##4##(2008-10#1)(2008-5#1)
restriction site polymorphism##3##3##(2008-10#2)(2008-5#1)
restriction site##27##2##(1990-12#1)(1990-4#1)(1990-6#1)(1990-7#3)(1991-7#2)(1992-7#3)(1994-12#4)(1996-4#1)(1997-6#1)(2006-6#1)(2008-10#4)(2008-2#1)(2008-5#4)
restriction sites for##2##3##(1991-5#1)(1996-2#1)
restriction sites in the##2##4##(1990-7#1)(1995-2#1)
restriction sites in##4##3##(1990-5#1)(1990-7#1)(1995-2#1)(2008-11#1)
restriction sites that are##2##4##(1991-9#1)(1994-3#1)
restriction sites was##2##3##(1990-5#2)
restriction sites were##2##3##(1990-4#1)(1993-5#1)
restriction sites##33##2##(1990-3#3)(1990-4#1)(1990-5#5)(1990-7#1)(1990-9#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-3#1)(1993-11#2)(1993-5#1)(1993-8#1)(1994-12#2)(1994-3#1)(1995-2#1)(1996-2#1)(1997-1#2)(1997-4#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-9#1)
restriction to##4##2##(1990-3#1)(1991-12#1)(2006-10#1)(2008-10#1)
restriction was##2##2##(2006-4#1)(2008-7#1)
restriction with##2##2##(1995-9#1)(2008-3#1)
restriction would##2##2##(1996-7#1)(2008-4#1)
restriction##747##1##(1990-10#3)(1990-11#4)(1990-12#5)(1990-2#2)(1990-3#15)(1990-4#9)(1990-5#9)(1990-6#1)(1990-7#5)(1990-8#2)(1990-9#11)(1991-11#1)(1991-12#5)(1991-2#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#9)(1991-8#3)(1991-9#6)(1992-1#4)(1992-11#5)(1992-12#1)(1992-2#1)(1992-3#6)(1992-4#4)(1992-5#2)(1992-6#2)(1992-7#4)(1992-8#3)(1992-9#3)(1993-1#1)(1993-11#5)(1993-12#9)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#6)(1994-10#1)(1994-11#2)(1994-12#13)(1994-2#3)(1994-3#5)(1994-5#4)(1994-6#1)(1994-7#2)(1994-8#7)(1994-9#1)(1995-1#8)(1995-10#3)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#3)(1995-8#4)(1995-9#5)(1996-10#6)(1996-11#6)(1996-12#6)(1996-2#2)(1996-3#3)(1996-4#4)(1996-5#4)(1996-6#3)(1996-7#8)(1996-8#1)(1996-9#1)(1997-1#6)(1997-2#8)(1997-3#2)(1997-4#9)(1997-5#3)(1997-6#6)(1997-7#2)(1997-8#1)(2004-10#2)(2005-1#1)(2005-10#1)(2005-11#5)(2005-6#1)(2005-8#3)(2005-9#2)(2006-10#2)(2006-11#3)(2006-12#3)(2006-2#1)(2006-3#3)(2006-4#2)(2006-5#5)(2006-6#2)(2006-7#1)(2006-8#22)(2006-9#2)(2007-10#2)(2007-11#7)(2007-12#2)(2007-2#3)(2007-4#1)(2007-6#1)(2007-7#6)(2007-8#7)(2008-1#5)(2008-10#155)(2008-11#9)(2008-12#3)(2008-2#10)(2008-3#10)(2008-4#31)(2008-5#24)(2008-7#13)(2008-8#6)(2008-9#7)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#2)(2009-4#2)(2009-5#6)(2009-8#6)(2009-9#1)(2010-1#2)(2010-12#5)(2010-2#3)(2010-3#1)(2010-4#5)(2010-7#1)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#5)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#7)(2013-7#3)(2013-8#2)
restriction-enzyme analysis##2##2##(1991-9#1)(1996-7#1)
restriction-enzyme##3##1##(1991-9#1)(1992-2#1)(1996-7#1)
restriction-fragment length##2##2##(1993-2#1)(1993-9#1)
restriction-fragment##3##1##(1992-2#1)(1993-2#1)(1993-9#1)
restriction-modification (R-M) system of##2##4##(1993-9#1)(1996-10#1)
restriction-modification (R-M) system##3##3##(1991-9#1)(1993-9#1)(1996-10#1)
restriction-modification system of##2##3##(1993-9#1)(1996-10#1)
restriction-modification system##4##2##(1993-9#1)(1994-12#1)(1996-10#1)(1997-1#1)
restriction-modification##9##1##(1991-9#1)(1993-9#2)(1994-12#1)(1994-9#1)(1996-10#2)(1997-1#1)(2012-1#1)
restriction-site##3##1##(1993-11#1)(1994-12#1)(1994-3#1)
restriction/modification systems##2##2##(1990-5#2)
restrictions and##6##2##(1991-6#1)(1997-1#1)(2008-2#1)(2008-7#3)
restrictions are##3##2##(2005-11#1)(2008-2#1)(2008-3#1)
restrictions as##2##2##(1994-2#1)(2010-5#1)
restrictions during##2##2##(1992-3#1)(2010-6#1)
restrictions imposed by##2##3##(1991-11#1)(2008-3#1)
restrictions in the##3##3##(1991-3#1)(1992-1#1)(2012-2#1)
restrictions in##5##2##(1991-3#1)(1992-1#1)(2008-10#1)(2012-2#1)(2013-1#1)
restrictions lead to##2##3##(2008-12#1)(2012-2#1)
restrictions of the##2##3##(2007-12#1)(2008-12#1)
restrictions of##9##2##(1993-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-3#1)(2009-7#1)
restrictions on eating and drinking##2##5##(2007-2#2)
restrictions on insurance coverage of abortion for public employees##2##9##(1994-2#2)
restrictions on the##7##3##(1991-10#1)(1995-7#1)(1996-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-4#1)
restrictions on##29##2##(1991-10#1)(1991-5#2)(1992-6#2)(1994-2#4)(1995-7#1)(1996-11#1)(1997-8#1)(2007-12#1)(2007-2#2)(2007-6#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#2)(2009-10#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-11#1)(2012-12#1)
restrictions were##2##2##(2004-4#1)(2008-3#1)
restrictions which##2##2##(1994-2#1)(2012-2#1)
restrictions##105##1##(1990-12#2)(1990-2#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-5#2)(1991-6#1)(1992-1#3)(1992-12#1)(1992-3#2)(1992-6#2)(1993-1#1)(1993-3#1)(1994-2#9)(1995-7#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-6#1)(1997-8#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#4)(2007-2#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)
restrictive abortion laws##2##3##(1991-6#1)(2007-1#1)
restrictive and##2##2##(1996-5#1)(2008-9#1)
restrictive anorexia nervosa##3##3##(2012-3#3)
restrictive attitude##2##2##(1996-12#1)(1996-4#1)
restrictive cardiomyopathy is##2##3##(2008-7#2)
restrictive cardiomyopathy##8##2##(2007-8#1)(2008-7#3)(2009-10#1)(2010-4#1)(2010-8#1)(2012-12#1)
restrictive conditions##3##2##(1995-4#1)(2008-2#1)(2011-1#1)
restrictive impairment of##2##3##(1994-6#1)(2007-8#1)
restrictive in##2##2##(1995-3#1)(2010-8#1)
restrictive lung disease##4##3##(2005-11#1)(2006-10#2)(2008-8#1)
restrictive lung function and##2##4##(1991-12#1)(2012-1#1)
restrictive lung function##6##3##(1991-12#3)(2012-1#2)(2012-2#1)
restrictive lung##11##2##(1991-12#3)(1997-4#1)(2005-11#1)(2006-10#2)(2008-8#1)(2012-1#2)(2012-2#1)
restrictive pattern##5##2##(1997-3#1)(2006-10#2)(2007-8#1)(2010-2#1)
restrictive temperature##4##2##(1995-9#1)(1997-4#2)(1997-6#1)
restrictive thoracic dystrophy##2##3##(2007-8#2)
restrictive thoracic##3##2##(1997-4#1)(2007-8#2)
restrictive ventilatory##2##2##(2005-8#1)(2008-1#1)
restrictive##103##1##(1990-12#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-12#3)(1991-6#2)(1992-2#1)(1993-1#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-3#2)(1995-4#1)(1995-5#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#5)(1997-5#2)(1997-6#1)(2004-3#1)(2005-11#1)(2005-8#2)(2006-10#6)(2006-12#1)(2006-3#2)(2006-5#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-8#5)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-6#2)(2010-11#1)(2010-12#1)(2010-2#4)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#1)(2013-8#1)
restricts its##3##2##(1994-12#1)(1994-8#1)(2008-9#1)
restricts the##8##2##(1993-9#1)(2006-6#1)(2008-10#2)(2008-3#3)(2008-5#1)
restricts##22##1##(1991-11#1)(1991-7#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-8#1)(1996-5#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-5#1)(2013-1#2)(2013-8#1)
restrictus##3##1##(1993-2#1)(2007-7#1)(2008-11#1)
restrooms##2##1##(2008-4#1)(2011-2#1)
restrospective##2##1##(2006-7#1)(2006-8#1)
restructure the##3##2##(1994-1#1)(1995-1#1)(2007-9#1)
restructure##9##1##(1994-1#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-3#1)(2007-9#1)(2008-9#1)(2012-11#1)
restructured beef gels##2##3##(2010-4#2)
restructured environment##3##2##(1994-3#1)(1995-2#1)(1996-3#1)
restructured hospital is##2##3##(1994-12#1)(1994-3#1)
restructured##26##1##(1993-3#1)(1994-1#1)(1994-12#2)(1994-3#3)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-3#3)(2006-10#1)(2010-4#7)(2010-8#1)(2012-2#1)
restructuring and##3##2##(1995-12#1)(1996-1#1)(2008-5#1)
restructuring at the BTB##2##4##(2009-10#1)(2012-2#1)
restructuring at##3##2##(1994-3#1)(2009-10#1)(2012-2#1)
restructuring education##2##2##(1995-2#2)
restructuring efforts##2##2##(1994-3#1)(1996-12#1)
restructuring initiative##5##2##(1994-12#1)(1994-3#1)(1996-1#3)
restructuring initiatives##3##2##(1995-2#1)(1996-1#1)(2012-3#1)
restructuring is##2##2##(1995-12#1)(2012-3#1)
restructuring of the##4##3##(1992-1#1)(1996-1#1)(2006-1#1)(2011-1#1)
restructuring of##11##2##(1991-3#1)(1992-1#1)(1994-12#1)(1996-1#1)(1997-2#1)(2006-1#1)(2006-8#1)(2009-2#1)(2010-9#1)(2011-1#2)
restructuring on##2##2##(1993-1#1)(2007-12#1)
restructuring process##2##2##(1996-1#1)(1996-12#1)
restructuring program##5##2##(1993-3#1)(1994-2#1)(1995-1#1)(1995-2#1)(2005-8#1)
restructuring that##3##2##(1995-12#1)(1996-3#1)(2009-10#1)
restructuring the health care##2##4##(1993-12#1)(1996-12#1)
restructuring the##7##2##(1991-3#1)(1993-12#1)(1995-2#1)(1996-12#1)(2008-3#1)(2008-6#1)(2010-4#1)
restructuring##111##1##(1991-1#1)(1991-3#2)(1992-1#2)(1992-12#1)(1993-1#3)(1993-12#7)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#4)(1994-2#3)(1994-3#6)(1995-1#4)(1995-10#1)(1995-12#5)(1995-2#6)(1995-3#3)(1996-1#12)(1996-12#5)(1996-3#3)(1997-2#2)(1997-3#1)(2004-10#1)(2005-8#1)(2006-1#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-10#6)(2009-11#1)(2009-2#1)(2010-4#1)(2010-9#1)(2011-1#3)(2012-2#5)(2012-3#5)(2013-1#1)
restructuring?##3##1##(1994-2#1)(1994-3#2)
rests on a##3##3##(1994-8#1)(2011-1#1)(2012-2#1)
rests on the##8##3##(1990-1#1)(1994-12#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
rests on##18##2##(1990-1#1)(1992-11#1)(1993-5#1)(1994-12#2)(1994-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-2#1)(2011-1#1)(2012-2#1)
rests upon##2##2##(2007-9#1)(2009-3#1)
rests with the##2##3##(1997-7#1)(2013-8#1)
rests with##5##2##(1992-1#1)(1996-11#1)(1997-7#1)(2007-12#1)(2013-8#1)
rests##31##1##(1990-1#1)(1992-1#1)(1992-11#1)(1993-5#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-3#1)(1996-11#1)(1996-5#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
result a##3##2##(2007-11#1)(2008-3#1)(2008-5#1)
result achieved##2##2##(1994-5#1)(2008-10#1)
result after##5##2##(2007-11#1)(2008-7#1)(2012-3#1)(2013-1#2)
result also##4##2##(1996-3#1)(2005-6#1)(2007-11#1)(2008-5#1)
result analysis##2##2##(2007-7#1)(2012-3#1)
result and the##4##3##(1995-9#1)(2007-8#1)(2008-9#1)(2011-2#1)
result and##18##2##(1990-11#1)(1991-3#1)(1991-6#1)(1992-2#1)(1995-9#2)(1996-12#1)(1996-3#1)(1996-5#1)(2005-10#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-2#1)(2011-2#1)
result are##2##2##(2006-3#1)(2008-9#1)
result as##7##2##(1996-12#1)(2006-10#1)(2007-9#1)(2008-2#1)(2008-3#2)(2008-4#1)
result at the##2##3##(1996-9#1)(2008-10#1)
result at##3##2##(1996-9#1)(2008-10#1)(2012-3#1)
result being##3##2##(1991-9#1)(1992-9#1)(2007-7#1)
result by##5##2##(1990-11#1)(2007-12#1)(2008-3#1)(2008-8#1)(2012-1#1)
result can be achieved##2##4##(2007-12#1)(2008-10#1)
result can be##6##3##(1993-6#1)(2007-1#1)(2007-12#2)(2008-10#1)(2010-10#1)
result confirmed the##2##3##(1992-1#1)(2008-6#1)
result confirmed##5##2##(1992-1#1)(1995-5#1)(1996-4#1)(2006-5#1)(2008-6#1)
result confirms##4##2##(2008-10#1)(2008-8#3)
result corresponds to##2##3##(2007-11#1)(2008-10#1)
result could be##5##3##(1994-10#1)(2008-3#2)(2008-7#1)(2011-2#1)
result could##8##2##(1994-10#1)(2007-9#1)(2008-3#2)(2008-5#1)(2008-7#2)(2011-2#1)
result demonstrates that the##4##4##(1992-6#1)(2007-11#1)(2008-2#1)(2008-9#1)
result demonstrates that##8##3##(1992-6#1)(1994-10#1)(1995-8#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-9#1)
result demonstrates##9##2##(1992-6#1)(1994-10#1)(1995-8#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-9#1)(2012-2#1)
result does not##7##3##(1990-4#1)(1992-6#1)(1996-11#1)(1996-5#1)(2007-12#1)(2008-1#1)(2011-1#1)
result either from##2##3##(1997-2#1)(2009-10#1)
result for a##2##3##(2008-3#1)(2013-1#1)
result for the##9##3##(1990-4#1)(2006-12#1)(2007-12#1)(2008-2#2)(2008-3#3)(2011-2#1)
result for##27##2##(1990-4#1)(1992-10#1)(1997-2#1)(2006-12#1)(2006-4#1)(2007-1#2)(2007-12#1)(2007-6#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#4)(2008-9#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
result from a combination of##3##5##(2005-11#1)(2008-2#1)(2011-12#1)
result from a direct##2##4##(1992-6#1)(1995-11#1)
result from a large##2##4##(1997-1#1)(2008-8#1)
result from a perturbation of##2##5##(1994-8#1)(1997-7#1)
result from a single##2##4##(2008-2#1)(2008-4#1)
result from a##41##3##(1990-3#1)(1992-1#1)(1992-6#1)(1994-3#1)(1994-4#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-7#1)(2005-10#2)(2005-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-12#1)(2013-8#1)
result from alteration##2##3##(1991-4#1)(2008-7#1)
result from an action of##2##5##(1991-8#1)(1994-8#1)
result from an action##3##4##(1991-8#1)(1994-8#1)(2010-8#1)
result from an##10##3##(1990-3#1)(1990-5#1)(1991-8#1)(1992-4#1)(1994-8#1)(1995-5#1)(2006-10#1)(2007-9#1)(2008-3#1)(2010-8#1)
result from applying##2##3##(2008-10#1)(2008-5#1)
result from both##2##3##(2006-10#1)(2008-2#1)
result from changes in the##2##5##(1994-9#1)(1996-4#1)
result from changes in##4##4##(1990-8#1)(1994-9#1)(1996-4#1)(2009-8#1)
result from decreased##3##3##(1991-11#1)(1997-5#1)(2008-7#1)
result from differential##2##3##(2008-6#2)
result from enhanced##2##3##(1994-11#1)(1994-8#1)
result from increased##5##3##(1992-7#1)(1997-3#1)(2006-10#1)(2006-9#1)(2008-9#1)
result from interactions between##2##4##(1997-7#1)(2012-2#1)
result from interactions##3##3##(1997-7#1)(2012-2#1)(2012-3#1)
result from its##3##3##(1993-4#1)(2008-11#1)(2011-1#1)
result from local##2##3##(2008-1#1)(2013-8#1)
result from progressive##3##3##(2007-11#1)(2012-2#1)(2013-7#1)
result from reduced##2##3##(1992-7#1)(2008-11#1)
result from selective##2##3##(2008-7#1)(2011-2#1)
result from several##4##3##(1994-3#1)(2004-4#1)(2008-8#1)(2011-2#1)
result from strong##2##3##(2008-8#1)(2008-9#1)
result from structural##3##3##(1995-5#1)(2010-8#1)(2012-3#1)
result from the absence of##3##5##(1990-5#1)(1990-8#1)(2009-10#1)
result from the formation of##2##5##(1996-11#1)(2009-3#1)
result from the interaction of##4##5##(1994-3#1)(2005-8#1)(2008-9#1)(2013-1#1)
result from the use of##2##5##(1994-9#1)(2007-7#1)
result from the##72##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#3)(1991-12#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-12#1)(2005-4#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-12#4)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#2)(2009-6#1)(2009-8#1)(2010-12#3)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#2)
result from their##2##3##(1990-11#1)(1995-6#1)
result from thermally induced##2##4##(2008-3#2)
result from this##3##3##(1991-3#1)(2006-4#1)(2008-3#1)
result from##330##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#4)(1990-7#2)(1990-8#5)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-2#3)(1992-3#3)(1992-4#1)(1992-6#4)(1992-7#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#5)(1994-4#1)(1994-5#1)(1994-8#4)(1994-9#5)(1995-1#1)(1995-11#4)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#2)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#4)(1996-5#3)(1996-6#3)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#3)(1997-5#1)(1997-7#3)(1997-8#5)(2004-4#1)(2005-10#3)(2005-11#3)(2005-12#2)(2005-4#1)(2005-8#1)(2005-9#2)(2006-10#12)(2006-11#2)(2006-4#4)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#9)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#6)(2008-10#8)(2008-11#7)(2008-12#1)(2008-2#8)(2008-3#14)(2008-4#2)(2008-5#5)(2008-6#5)(2008-7#8)(2008-8#12)(2008-9#6)(2009-10#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#5)(2012-2#8)(2012-3#5)(2013-1#7)(2013-7#2)(2013-8#4)
result has been##5##3##(1994-3#1)(1997-1#1)(2007-11#1)(2008-10#1)(2012-3#1)
result has##8##2##(1994-3#1)(1997-1#1)(2005-4#1)(2007-11#1)(2008-10#1)(2008-9#1)(2009-2#1)(2012-3#1)
result if##3##2##(1996-12#1)(2006-8#1)(2008-6#1)
result implies that##8##3##(1990-5#1)(1996-6#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)
result implies the existence of##2##5##(1990-7#1)(1990-8#1)
result implies##10##2##(1990-5#1)(1990-7#1)(1990-8#1)(1996-6#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)
result in 20##2##3##(2007-11#1)(2007-8#1)
result in a better understanding of the##2##7##(1991-6#1)(2007-10#1)
result in a better##4##4##(1991-6#1)(2007-10#1)(2008-11#1)(2008-5#1)
result in a broad##2##4##(1994-12#2)
result in a decline##2##4##(1991-7#1)(1995-5#1)
result in a decreased##4##4##(2004-9#1)(2007-11#1)(2008-1#1)(2008-11#1)
result in a functional##2##4##(1993-7#1)(2009-2#1)
result in a greater##2##4##(1997-1#1)(2007-11#1)
result in a high##3##4##(1991-12#1)(2008-11#1)(2010-12#1)
result in a higher incidence of##2##6##(2007-11#1)(2009-6#1)
result in a higher##7##4##(1994-11#1)(1994-12#1)(1996-2#1)(2007-11#1)(2008-10#1)(2009-6#1)(2012-1#1)
result in a large##2##4##(1994-9#1)(2008-4#1)
result in a loss of##2##5##(1990-8#2)
result in a marked##2##4##(2006-10#1)(2008-4#1)
result in a measurable##2##4##(2009-6#1)(2012-1#1)
result in a more##3##4##(1991-12#1)(2006-11#1)(2006-12#1)
result in a potentially##2##4##(2006-4#1)(2012-1#1)
result in a reduced##2##4##(2006-10#1)(2011-2#1)
result in a reduction in##2##5##(2005-10#1)(2013-1#1)
result in a reduction##4##4##(1995-6#1)(2005-10#1)(2011-1#1)(2013-1#1)
result in a significant increase in the##2##7##(2008-10#2)
result in a significant increase in##4##6##(2007-11#1)(2008-10#2)(2008-11#1)
result in a significant##11##4##(1992-3#1)(1994-9#1)(1996-12#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#1)(2011-1#1)
result in a truncated protein##2##5##(1993-9#1)(1997-5#1)
result in a variety of##2##5##(2010-4#1)(2013-8#1)
result in a##136##3##(1990-8#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#2)(1992-3#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#5)(1994-3#2)(1994-9#2)(1995-10#1)(1995-2#1)(1995-4#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-3#2)(1997-5#2)(1997-7#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#6)(2007-12#2)(2007-2#2)(2008-1#1)(2008-10#8)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#2)(2009-6#2)(2009-7#2)(2009-9#3)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#3)(2012-2#2)(2013-1#6)(2013-8#3)
result in abnormal##2##3##(2006-11#1)(2012-2#1)
result in adverse##2##3##(1992-7#1)(2006-10#1)
result in amino acid changes##2##5##(1994-11#1)(1994-8#1)
result in an increase in the number##4##7##(1991-6#1)(1995-3#1)(1997-6#1)(2008-10#1)
result in an increase in##5##5##(1991-6#1)(1994-5#1)(1995-3#1)(1997-6#1)(2008-10#1)
result in an increase of##5##5##(1994-9#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-7#1)
result in an increase##10##4##(1991-6#1)(1994-5#1)(1994-9#1)(1995-3#1)(1997-6#1)(2008-10#2)(2008-5#1)(2008-8#1)(2013-7#1)
result in an increased##2##4##(1996-5#1)(2006-10#1)
result in an##39##3##(1991-2#1)(1991-6#1)(1992-9#1)(1994-5#1)(1994-9#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#5)(2008-3#2)(2008-5#2)(2008-8#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-5#1)(2012-3#1)(2013-1#1)(2013-7#1)
result in bacterial##2##3##(2011-2#1)(2013-8#1)
result in behavioral##2##3##(2008-4#1)(2010-9#1)
result in better##3##3##(2007-11#1)(2011-2#1)(2013-7#1)
result in biased estimates##2##4##(1997-6#1)(2008-2#1)
result in both##3##3##(2008-3#1)(2008-5#1)(2008-7#1)
result in cell##2##3##(1991-4#1)(1995-12#1)
result in changes in the##2##5##(1990-8#1)(2007-11#1)
result in changes in##3##4##(1990-8#1)(2007-11#1)(2008-3#1)
result in changes of the##2##5##(1997-2#1)(2009-2#1)
result in changes of##4##4##(1992-5#1)(1993-12#1)(1997-2#1)(2009-2#1)
result in changes to##2##4##(2012-2#1)(2012-3#1)
result in changes##9##3##(1990-8#1)(1992-5#1)(1993-12#1)(1997-2#1)(2007-11#1)(2008-3#1)(2009-2#1)(2012-2#1)(2012-3#1)
result in chronic##3##3##(2006-10#1)(2007-2#1)(2008-8#1)
result in clinical##2##3##(2010-5#1)(2011-2#1)
result in complete##4##3##(1992-6#1)(2006-12#1)(2008-11#1)(2008-5#1)
result in complex##3##3##(2007-11#1)(2009-8#1)(2011-2#1)
result in death##6##3##(1995-8#1)(2006-5#1)(2007-12#1)(2007-7#1)(2008-9#1)(2013-1#1)
result in decreased##6##3##(1990-3#1)(2007-1#1)(2007-7#1)(2008-7#1)(2008-8#1)(2009-2#1)
result in differences in##2##4##(1996-12#1)(2006-10#1)
result in different##3##3##(2008-9#1)(2011-2#1)(2013-7#1)
result in disease##2##3##(2008-9#1)(2010-5#1)
result in disruption of normal##2##5##(2008-9#1)(2009-9#1)
result in distinctly##2##3##(1994-3#1)(2009-5#1)
result in early##2##3##(2007-8#1)(2011-12#1)
result in either##3##3##(2008-5#1)(2008-9#1)(2009-9#1)
result in enhanced levels of##2##5##(1995-3#1)(2008-5#1)
result in enhanced##8##3##(1994-10#1)(1995-3#1)(2005-11#1)(2006-12#1)(2008-11#1)(2008-5#1)(2008-9#1)(2013-1#1)
result in excess##2##3##(2006-10#1)(2006-9#1)
result in exposure##2##3##(1992-1#1)(1997-4#1)
result in failure of##2##4##(2007-12#1)(2012-2#1)
result in false##2##3##(2006-5#2)
result in fewer complications##3##4##(2007-8#1)(2010-2#1)(2013-1#1)
result in formation of##3##4##(1991-9#1)(2008-10#1)(2010-5#1)
result in great##2##3##(2006-10#1)(2008-7#1)
result in greater##6##3##(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)
result in health##2##3##(2007-11#1)(2011-2#1)
result in high levels of##2##5##(2008-10#1)(2009-9#1)
result in high##7##3##(2008-10#2)(2008-3#1)(2008-4#1)(2009-9#1)(2010-12#1)(2012-3#1)
result in higher##7##3##(1990-12#2)(2004-9#1)(2008-10#1)(2008-2#1)(2009-8#1)(2012-2#1)
result in highly##3##3##(2006-4#1)(2008-2#1)(2008-3#1)
result in immunotoxicity##2##3##(2008-10#2)
result in improved quality of##2##5##(1992-3#1)(2010-12#1)
result in improved##12##3##(1992-3#1)(1997-1#1)(2005-7#1)(2006-4#1)(2008-3#2)(2009-2#1)(2009-3#1)(2009-6#1)(2010-12#1)(2011-1#2)
result in improvement of##3##4##(2006-12#1)(2008-5#1)(2010-7#1)
result in inappropriate##2##3##(2012-12#1)(2013-7#1)
result in increased##22##3##(1993-2#1)(1993-7#1)(1995-2#2)(1996-6#1)(1997-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-8#1)(2009-10#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
result in internal##2##3##(1996-4#1)(2010-10#1)
result in its##2##3##(1992-9#1)(1993-3#1)
result in large##2##3##(1997-5#1)(2009-5#1)
result in less##3##3##(2007-4#1)(2011-2#1)(2012-2#1)
result in long-term##5##3##(2005-11#1)(2008-6#1)(2009-10#1)(2012-1#1)(2013-8#1)
result in loss of##2##4##(1993-6#1)(2006-10#1)
result in low##2##3##(2010-7#1)(2011-2#1)
result in lower##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
result in lung##2##3##(1990-5#1)(2011-2#1)
result in major##2##3##(2005-11#1)(2008-6#1)
result in many##2##3##(1994-3#1)(2013-7#1)
result in misleading##2##3##(1994-12#1)(2008-11#1)
result in more##9##3##(1992-8#1)(1994-3#1)(1996-3#1)(2004-9#1)(2005-10#1)(2008-3#1)(2008-4#1)(2009-3#1)(2012-12#1)
result in neurological##2##3##(2006-5#1)(2011-2#1)
result in new##3##3##(2005-7#1)(2005-8#1)(2011-2#1)
result in noticeable##2##3##(2008-2#2)
result in novel##3##3##(1996-2#1)(2010-12#1)(2012-1#1)
result in osteoarthritis##2##3##(1993-11#1)(2010-2#1)
result in pathology##2##3##(2008-10#1)(2010-3#1)
result in poor##2##3##(1996-8#1)(2012-3#1)
result in positive##2##3##(2005-11#1)(2008-11#1)
result in premature##3##3##(2006-12#1)(2008-10#1)(2008-6#1)
result in progressive##2##3##(2007-5#1)(2012-12#1)
result in protein##2##3##(1997-5#1)(2008-12#1)
result in reduced##8##3##(2006-10#1)(2006-9#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-1#1)(2010-12#1)
result in reduction of##3##4##(2007-11#1)(2012-3#2)
result in reduction##4##3##(2007-11#1)(2008-5#1)(2012-3#2)
result in remission of##2##4##(2006-10#1)(2007-11#1)
result in selection##2##3##(1995-8#1)(2008-9#1)
result in serious##5##3##(1992-8#1)(2007-11#1)(2009-3#1)(2010-8#1)(2012-2#1)
result in severe##9##3##(1995-11#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-3#1)(2008-8#1)(2011-2#2)
result in significant morbidity and##2##5##(1997-3#1)(2008-7#1)
result in significant morbidity##3##4##(1997-3#1)(2006-10#1)(2008-7#1)
result in significant##19##3##(1991-8#1)(1993-6#1)(1996-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2005-2#1)(2006-10#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-3#1)
result in significantly##3##3##(2007-7#1)(2008-10#1)(2010-12#1)
result in similar##3##3##(1994-12#1)(1996-9#1)(2008-12#1)
result in some##2##3##(1996-12#1)(2005-8#1)
result in stronger##2##3##(1996-6#1)(2013-8#1)
result in structural##3##3##(2006-6#1)(2008-3#1)(2012-1#1)
result in substantial##3##3##(1996-12#1)(2009-8#1)(2013-1#1)
result in systemic##2##3##(1991-4#1)(2008-10#1)
result in the accumulation of##2##5##(1995-6#1)(2008-7#1)
result in the best##2##4##(2006-11#1)(2011-2#1)
result in the decrease of##2##5##(2009-10#1)(2009-2#1)
result in the development of##3##5##(1993-12#1)(2006-4#1)(2007-7#1)
result in the formation of a##2##6##(1995-5#1)(2005-11#1)
result in the formation of##6##5##(1990-4#1)(1993-6#1)(1994-3#1)(1995-5#1)(2005-11#1)(2009-2#1)
result in the generation of##2##5##(2008-10#1)(2010-9#1)
result in the localization of##2##5##(2007-12#1)(2009-5#1)
result in the loss of##2##5##(2008-8#1)(2008-9#1)
result in the production of a##2##6##(1990-7#1)(1997-7#1)
result in the production of##4##5##(1990-7#1)(1997-7#1)(2007-8#1)(2008-4#1)
result in the same##2##4##(1996-7#1)(2009-3#1)
result in the truncation of##2##5##(1993-11#1)(1997-4#1)
result in the##98##3##(1990-4#1)(1990-7#1)(1991-12#1)(1991-3#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#2)(1993-11#1)(1993-12#1)(1993-6#2)(1993-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-4#1)(1996-5#2)(1996-7#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2005-11#3)(2006-10#1)(2006-11#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#6)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#2)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#2)
result in three##2##3##(1997-2#1)(2006-8#1)
result in tumor##2##3##(2010-3#1)(2013-8#1)
result in unacceptable##3##3##(2007-8#1)(2008-6#1)(2012-2#1)
result in various##2##3##(2007-3#1)(2007-8#1)
result in very##2##3##(2008-10#1)(2008-2#1)
result in##903##2##(1990-1#1)(1990-12#3)(1990-3#3)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#3)(1991-12#4)(1991-2#4)(1991-3#3)(1991-4#3)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#3)(1991-9#5)(1992-1#3)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#5)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#6)(1993-11#5)(1993-12#6)(1993-2#2)(1993-3#4)(1993-6#6)(1993-7#2)(1993-8#2)(1993-9#5)(1994-1#1)(1994-10#1)(1994-11#4)(1994-12#7)(1994-2#2)(1994-3#7)(1994-5#2)(1994-8#4)(1994-9#4)(1995-1#4)(1995-10#2)(1995-11#2)(1995-12#4)(1995-2#7)(1995-3#3)(1995-4#1)(1995-5#5)(1995-6#5)(1995-8#5)(1995-9#1)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#7)(1996-2#4)(1996-3#3)(1996-4#7)(1996-5#4)(1996-6#3)(1996-7#2)(1996-8#4)(1996-9#5)(1997-1#7)(1997-2#5)(1997-3#3)(1997-4#4)(1997-5#6)(1997-6#3)(1997-7#6)(1997-8#3)(2004-11#2)(2004-12#1)(2004-4#1)(2004-9#4)(2005-10#3)(2005-11#9)(2005-2#1)(2005-7#4)(2005-8#5)(2005-9#1)(2006-1#1)(2006-10#27)(2006-11#6)(2006-12#11)(2006-2#2)(2006-4#4)(2006-5#6)(2006-6#6)(2006-7#2)(2006-8#4)(2006-9#6)(2007-1#1)(2007-10#3)(2007-11#24)(2007-12#12)(2007-2#6)(2007-3#2)(2007-4#2)(2007-5#2)(2007-7#10)(2007-8#14)(2007-9#3)(2008-1#8)(2008-10#53)(2008-11#24)(2008-12#3)(2008-2#23)(2008-3#29)(2008-4#21)(2008-5#18)(2008-6#9)(2008-7#15)(2008-8#16)(2008-9#16)(2009-1#2)(2009-10#6)(2009-11#1)(2009-2#8)(2009-3#6)(2009-4#3)(2009-5#5)(2009-6#8)(2009-7#6)(2009-8#4)(2009-9#10)(2010-1#2)(2010-10#3)(2010-11#3)(2010-12#15)(2010-2#4)(2010-3#3)(2010-4#1)(2010-5#8)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#5)(2011-1#8)(2011-12#3)(2011-2#35)(2012-1#7)(2012-10#1)(2012-11#1)(2012-12#7)(2012-2#17)(2012-3#11)(2013-1#20)(2013-7#6)(2013-8#9)
result indicated that the##6##4##(2005-11#1)(2008-1#1)(2008-8#3)(2012-2#1)
result indicated that##15##3##(1997-1#1)(2005-11#2)(2008-1#1)(2008-5#1)(2008-8#6)(2008-9#1)(2010-2#1)(2012-2#1)(2012-3#1)
result indicates that the##9##4##(1990-4#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-7#1)(1995-11#1)(2008-10#2)(2008-5#1)
result indicates that##27##3##(1990-12#1)(1990-2#1)(1990-4#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-5#1)(1992-7#1)(1994-11#1)(1995-11#1)(1996-11#1)(1996-9#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-5#1)(2009-6#1)(2009-9#1)(2010-3#1)(2012-12#1)(2012-2#1)
result indicates the##2##3##(1991-1#1)(2008-9#1)
result indicates##29##2##(1990-12#1)(1990-2#1)(1990-4#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-5#1)(1992-7#1)(1994-11#1)(1995-11#1)(1996-11#1)(1996-9#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-3#1)(2012-12#1)(2012-2#1)
result is a better##2##4##(2008-3#1)(2008-9#1)
result is a new##2##4##(1991-1#1)(2008-2#1)
result is a##20##3##(1991-1#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-9#1)(2009-3#1)(2010-3#1)(2010-7#1)(2013-1#1)
result is an##4##3##(1992-3#1)(2007-12#1)(2008-10#1)(2013-1#1)
result is compared with##3##4##(2006-10#2)(2008-2#1)
result is consistent with##3##4##(2008-3#1)(2009-5#1)(2012-2#1)
result is discussed##4##3##(1993-3#1)(1996-5#1)(1996-6#1)(2008-1#1)
result is excellent##2##3##(2007-8#1)(2008-9#1)
result is in good agreement with##2##6##(2007-11#1)(2007-12#1)
result is in##10##3##(1992-12#1)(1993-2#1)(1995-4#1)(1996-11#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)
result is not##6##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-5#1)(2012-3#1)
result is obtained##3##3##(1992-11#1)(2007-12#2)
result is of practical##2##4##(2007-12#1)(2008-10#1)
result is of##4##3##(1996-12#1)(2007-12#1)(2008-10#1)(2008-2#1)
result is particularly##2##3##(1992-9#1)(1997-7#1)
result is quite different##2##4##(1994-12#1)(2010-7#1)
result is that the##3##4##(2008-8#1)(2010-1#1)(2013-8#1)
result is that##18##3##(1991-12#1)(1996-10#1)(1997-1#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2010-1#1)(2010-12#1)(2013-8#1)
result is the##4##3##(1992-1#1)(1996-12#1)(2005-11#1)(2008-3#1)
result is##125##2##(1990-12#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-12#2)(1994-7#1)(1995-4#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-7#2)(2005-10#3)(2005-11#2)(2005-4#1)(2006-10#3)(2006-12#1)(2006-5#2)(2006-7#1)(2007-11#6)(2007-12#12)(2007-5#1)(2007-8#3)(2008-1#2)(2008-10#5)(2008-2#7)(2008-3#10)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#4)(2009-2#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
result may be##5##3##(1990-2#1)(1994-5#1)(2008-12#1)(2011-2#1)(2012-2#1)
result may have##2##3##(1993-3#1)(2008-3#1)
result may indicate##2##3##(2007-9#1)(2008-10#1)
result may##12##2##(1990-2#1)(1993-3#1)(1994-5#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#1)
result means that the##2##4##(1993-8#1)(2008-11#1)
result means##3##2##(1993-8#1)(2008-11#1)(2009-4#1)
result not only in##2##4##(2007-12#1)(2009-3#1)
result not only##4##3##(2006-10#1)(2007-12#1)(2008-3#1)(2009-3#1)
result obtained##9##2##(1992-2#1)(1994-9#1)(1996-8#1)(2005-11#1)(2005-4#1)(2007-8#2)(2008-10#1)(2008-2#1)
result of DNA##2##3##(2008-10#1)(2008-11#1)
result of a complex##5##4##(2007-11#1)(2008-1#1)(2009-10#1)(2010-12#1)(2011-1#1)
result of a number of##2##5##(2008-8#1)(2009-11#1)
result of a rational##2##4##(1990-12#1)(2008-5#1)
result of a##100##3##(1990-11#2)(1990-12#2)(1990-7#1)(1990-9#1)(1991-11#1)(1991-2#1)(1993-7#1)(1994-1#2)(1994-10#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#2)(1995-6#4)(1995-8#1)(1996-3#2)(1996-5#1)(1996-7#1)(1997-1#1)(1997-6#1)(2004-3#1)(2005-11#1)(2006-1#1)(2006-11#1)(2006-3#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
result of activation of##2##4##(1990-12#1)(1992-6#1)
result of all##2##3##(2007-12#1)(2008-5#1)
result of alternative##3##3##(1993-4#1)(1994-12#1)(1995-2#1)
result of an increase in##3##5##(1997-1#2)(2006-9#1)
result of an increase##4##4##(1997-1#2)(2006-9#1)(2007-12#1)
result of an##38##3##(1990-5#1)(1991-4#2)(1993-12#1)(1993-2#1)(1993-4#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-8#1)(1996-11#2)(1996-5#1)(1996-6#1)(1997-1#2)(1997-5#1)(1997-6#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-3#1)(2010-8#1)(2012-1#1)(2013-1#4)
result of analysis##3##3##(1993-2#1)(2005-4#1)(2008-5#1)
result of binding##2##3##(1990-11#1)(1993-11#1)
result of both##11##3##(1991-5#1)(1992-9#1)(2004-12#1)(2006-11#1)(2006-3#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
result of cardiac##2##3##(1990-9#1)(1996-2#1)
result of cell##5##3##(1990-12#1)(1990-7#1)(1995-11#1)(2008-4#1)(2011-3#1)
result of cellular##2##3##(1990-5#1)(2008-7#1)
result of changes in##6##4##(1992-8#1)(1994-5#1)(1996-4#1)(1996-9#1)(2008-11#1)(2008-3#1)
result of changes##7##3##(1992-8#1)(1994-5#1)(1996-4#1)(1996-9#1)(2008-11#1)(2008-3#1)(2008-5#1)
result of coevolution##2##3##(2008-10#1)(2013-1#1)
result of concomitant##2##3##(1997-4#1)(2007-11#1)
result of contamination##2##3##(2006-5#1)(2008-5#1)
result of decreased##5##3##(1993-3#1)(2007-2#1)(2008-1#1)(2008-8#1)(2013-7#1)
result of developmental##2##3##(1996-8#1)(2010-8#1)
result of differences in##3##4##(2007-12#1)(2008-10#1)(2012-3#1)
result of different##5##3##(1990-8#1)(1991-6#1)(1994-9#1)(1996-3#1)(2007-11#1)
result of drug##2##3##(2007-11#1)(2013-8#1)
result of early##2##3##(1993-11#1)(2009-3#1)
result of either##4##3##(1995-3#1)(2005-8#1)(2008-8#1)(2012-2#1)
result of enhanced##2##3##(1991-12#1)(2008-3#1)
result of evolution##2##3##(2007-8#1)(2008-4#1)
result of excessive##2##3##(1995-12#1)(2008-5#1)
result of excitation##2##3##(1993-9#1)(2007-11#1)
result of exercise##2##3##(2005-7#1)(2013-7#1)
result of exposure to##7##4##(1991-3#1)(1997-6#1)(2006-10#1)(2007-9#1)(2010-2#1)(2010-6#1)(2013-8#1)
result of expression##2##3##(1993-3#1)(2010-2#1)
result of gene##2##3##(2008-8#1)(2012-1#1)
result of genetic##3##3##(2007-2#1)(2007-5#1)(2008-4#1)
result of greater##2##3##(2004-12#1)(2012-2#1)
result of high##2##3##(2007-8#1)(2008-10#1)
result of increased##9##3##(1991-3#1)(1994-6#1)(1997-7#1)(2004-11#1)(2006-10#1)(2008-12#1)(2008-9#1)(2010-4#1)(2011-2#1)
result of infection##2##3##(2006-5#1)(2008-10#1)
result of intracellular##2##3##(1991-1#1)(1991-2#1)
result of investigation of##2##4##(2005-10#1)(2008-11#1)
result of its treatment##2##4##(2005-1#2)
result of its##11##3##(1991-4#1)(1995-2#1)(1995-6#1)(1996-12#1)(2005-1#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)
result of liver##2##3##(2006-10#1)(2007-2#1)
result of long standing##2##4##(1997-1#1)(2008-4#1)
result of long##3##3##(1997-1#1)(2008-12#1)(2008-4#1)
result of low##4##3##(2007-11#1)(2007-12#1)(2011-1#1)(2013-1#1)
result of many##3##3##(2007-11#1)(2008-10#1)(2010-12#1)
result of multiple##3##3##(2007-12#1)(2007-8#1)(2008-8#1)
result of negligent medical##2##4##(2004-1#1)(2007-4#1)
result of operative treatment##2##4##(2007-11#2)
result of our study##2##4##(2011-1#1)(2012-2#1)
result of our##5##3##(2007-12#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
result of patient##2##3##(2007-12#1)(2008-9#1)
result of psychological treatments##2##4##(2011-2#2)
result of radiological##2##3##(1991-11#1)(2007-3#1)
result of recent##3##3##(2005-7#1)(2008-3#1)(2008-5#1)
result of reduced##5##3##(1994-3#1)(1995-2#1)(1996-1#1)(2007-11#1)(2013-8#1)
result of repeated##3##3##(2008-5#1)(2008-7#1)(2011-1#1)
result of signal##2##3##(2008-11#1)(2008-2#1)
result of specific##4##3##(1992-5#1)(2004-11#1)(2008-3#1)(2008-7#1)
result of spontaneous##2##3##(1993-3#1)(2009-9#1)
result of stimulation of##2##4##(1990-8#1)(2007-11#1)
result of such##3##3##(1997-8#1)(2006-6#1)(2008-10#1)
result of surgical##2##3##(2008-7#1)(2013-8#1)
result of synovitis or chondropathy##2##5##(2006-11#1)(2006-12#1)
result of the continuous##4##4##(1996-12#1)(2008-10#2)(2008-11#1)
result of the depletion of##2##5##(1991-9#1)(1994-10#1)
result of the excitation##2##4##(2007-12#1)(2008-2#1)
result of the formation of##2##5##(1993-11#1)(1994-11#1)
result of the impact##2##4##(1997-5#1)(2007-4#1)
result of the inhibition##2##4##(1990-5#1)(1992-11#1)
result of the interaction of the##2##6##(2006-6#1)(2008-3#1)
result of the interaction##5##4##(1992-3#1)(2006-6#1)(2008-10#1)(2008-3#2)
result of the introduction of##4##5##(2006-10#1)(2008-11#1)(2012-12#2)
result of the optimization##2##4##(1997-1#1)(2007-12#1)
result of the overall##2##4##(1990-10#1)(2011-2#1)
result of the present study##3##5##(1995-8#1)(2009-12#1)(2012-3#1)
result of the previous##2##4##(1990-2#1)(2010-11#1)
result of the rapid##4##4##(1993-8#1)(1994-9#1)(2007-11#1)(2008-5#1)
result of the reaction between##2##5##(1997-3#1)(2006-12#1)
result of the reaction##3##4##(1997-3#1)(2005-11#1)(2006-12#1)
result of the relative##2##4##(2007-11#1)(2008-3#1)
result of the team's##2##4##(1993-12#1)(2007-8#1)
result of the##245##3##(1990-10#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-8#2)(1991-1#1)(1991-12#2)(1991-3#2)(1991-5#1)(1991-9#1)(1992-11#3)(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#3)(1993-12#1)(1993-8#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-4#1)(1995-8#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-8#1)(2005-1#1)(2005-10#2)(2005-11#4)(2005-2#1)(2005-4#1)(2005-7#1)(2005-9#1)(2006-10#10)(2006-11#2)(2006-12#4)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#8)(2007-12#9)(2007-2#1)(2007-3#2)(2007-4#3)(2007-5#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-10#26)(2008-11#7)(2008-2#8)(2008-3#11)(2008-4#5)(2008-5#6)(2008-6#4)(2008-7#5)(2008-8#4)(2008-9#3)(2009-10#1)(2009-12#1)(2009-4#3)(2009-6#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#10)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#3)
result of their##21##3##(1991-8#1)(1992-9#1)(1995-1#1)(1995-3#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
result of thermal##2##3##(1995-3#1)(2008-10#1)
result of these two##2##4##(1996-12#1)(2005-11#1)
result of these##17##3##(1992-1#1)(1992-3#1)(1996-12#1)(1996-9#1)(1997-2#1)(2005-11#1)(2006-7#1)(2006-9#1)(2007-7#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
result of this research##2##4##(2010-8#1)(2013-1#1)
result of this study##9##4##(1993-3#1)(1995-6#1)(2007-3#1)(2008-3#1)(2008-4#1)(2008-7#1)(2013-1#3)
result of this##41##3##(1990-10#1)(1990-11#1)(1991-12#1)(1993-11#1)(1993-3#1)(1994-11#1)(1995-1#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-4#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-7#2)(2010-3#1)(2010-5#2)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#3)
result of treatment##6##3##(1992-5#1)(2007-11#1)(2007-7#1)(2007-8#2)(2012-12#1)
result of two##5##3##(1991-8#1)(1996-4#2)(2006-10#1)(2008-6#1)
result of using##5##3##(2006-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-3#1)
result of various##2##3##(1991-10#1)(2013-8#1)
result of which##2##3##(1990-6#1)(1991-9#1)
result of##1222##2##(1990-10#2)(1990-11#8)(1990-12#5)(1990-2#4)(1990-3#3)(1990-4#3)(1990-5#6)(1990-6#3)(1990-7#2)(1990-8#5)(1990-9#2)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#6)(1991-2#5)(1991-3#6)(1991-4#4)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#4)(1991-9#4)(1992-1#3)(1992-11#5)(1992-12#2)(1992-2#2)(1992-3#2)(1992-5#2)(1992-6#3)(1992-8#5)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#7)(1993-12#6)(1993-2#2)(1993-3#5)(1993-4#2)(1993-6#2)(1993-7#2)(1993-8#3)(1993-9#4)(1994-1#4)(1994-10#3)(1994-11#6)(1994-12#3)(1994-2#4)(1994-3#6)(1994-4#1)(1994-5#4)(1994-6#2)(1994-8#4)(1994-9#2)(1995-1#4)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#4)(1995-3#3)(1995-4#2)(1995-5#1)(1995-6#7)(1995-8#7)(1995-9#2)(1996-1#3)(1996-10#1)(1996-11#5)(1996-12#4)(1996-2#3)(1996-3#8)(1996-4#5)(1996-5#5)(1996-6#2)(1996-7#1)(1996-8#5)(1996-9#8)(1997-1#6)(1997-2#5)(1997-3#5)(1997-4#4)(1997-5#4)(1997-6#5)(1997-7#3)(1997-8#6)(2004-1#1)(2004-11#2)(2004-12#2)(2004-3#2)(2004-4#1)(2005-1#3)(2005-10#7)(2005-11#10)(2005-2#1)(2005-4#2)(2005-7#4)(2005-8#5)(2005-9#1)(2006-1#2)(2006-10#29)(2006-11#7)(2006-12#10)(2006-2#10)(2006-3#2)(2006-4#4)(2006-5#5)(2006-6#3)(2006-7#3)(2006-8#11)(2006-9#3)(2007-1#2)(2007-10#7)(2007-11#49)(2007-12#50)(2007-2#6)(2007-3#7)(2007-4#8)(2007-5#2)(2007-6#3)(2007-7#12)(2007-8#27)(2007-9#5)(2008-1#15)(2008-10#74)(2008-11#29)(2008-12#16)(2008-2#23)(2008-3#40)(2008-4#17)(2008-5#28)(2008-6#11)(2008-7#33)(2008-8#22)(2008-9#18)(2009-1#2)(2009-10#5)(2009-11#4)(2009-12#7)(2009-2#8)(2009-3#3)(2009-4#6)(2009-5#4)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#3)(2010-10#3)(2010-11#4)(2010-12#9)(2010-2#5)(2010-3#3)(2010-4#7)(2010-5#7)(2010-6#4)(2010-7#5)(2010-8#7)(2010-9#1)(2011-1#18)(2011-12#2)(2011-2#32)(2011-3#1)(2012-1#8)(2012-11#1)(2012-12#15)(2012-2#13)(2012-3#15)(2012-5#1)(2013-1#31)(2013-7#14)(2013-8#25)
result on the##2##3##(1990-4#1)(2008-8#1)
result on##6##2##(1990-4#1)(1994-11#1)(2007-1#1)(2008-4#1)(2008-6#1)(2008-8#1)
result proves##2##2##(2007-12#1)(2008-3#1)
result represents##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
result revealed##3##2##(2012-12#2)(2012-2#1)
result reveals##4##2##(2007-10#1)(2008-10#1)(2010-11#1)(2010-8#1)
result should be##2##3##(2007-8#1)(2013-1#1)
result should##4##2##(2007-8#1)(2008-2#1)(2008-5#1)(2013-1#1)
result showed that##21##3##(1994-8#1)(1997-2#1)(2005-11#3)(2005-4#1)(2006-4#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-6#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-8#1)
result showed##22##2##(1994-8#1)(1997-2#1)(2005-11#3)(2005-4#1)(2006-4#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-6#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-8#1)
result shows that the##4##4##(2005-11#1)(2008-10#1)(2008-11#1)(2008-2#1)
result shows that##19##3##(1990-4#1)(1992-3#1)(1992-4#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-7#1)(2012-2#1)(2013-8#1)
result shows the##3##3##(2005-6#1)(2008-10#2)
result shows##27##2##(1990-4#1)(1992-3#1)(1992-4#1)(1997-8#1)(2005-11#1)(2005-6#1)(2006-10#1)(2006-4#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-4#1)(2010-5#1)(2010-7#1)(2012-2#1)(2013-8#1)
result solely from##2##3##(2007-4#1)(2013-1#1)
result strongly suggests that the##2##5##(1990-12#1)(1995-8#1)
result suggest that##2##3##(1991-5#1)(1993-6#1)
result suggest##3##2##(1991-5#1)(1993-6#1)(1994-11#1)
result suggested that the##5##4##(1990-5#1)(1992-9#1)(2008-10#1)(2008-11#1)(2009-3#1)
result suggested that##12##3##(1990-5#1)(1992-9#1)(1997-8#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-9#2)(2009-10#1)(2009-3#1)(2013-1#1)(2013-8#1)
result suggests a##5##3##(1990-10#1)(1991-1#1)(2006-12#1)(2008-3#1)(2008-5#1)
result suggests that a##2##4##(1994-8#1)(2008-7#1)
result suggests that both##2##4##(1990-5#1)(1995-10#1)
result suggests that the##15##4##(1990-4#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-3#1)(1994-12#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-3#1)(2004-11#1)(2006-5#1)(2008-10#2)(2010-6#1)
result suggests that##46##3##(1990-4#2)(1990-5#1)(1991-1#1)(1991-11#1)(1991-2#3)(1991-5#1)(1992-11#1)(1992-3#2)(1992-5#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-3#1)(2004-11#1)(2005-11#1)(2006-4#1)(2006-5#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-10#1)(2010-6#1)(2010-7#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
result suggests the##6##3##(1991-2#1)(1997-8#1)(2007-12#1)(2008-5#1)(2012-2#1)(2013-1#1)
result suggests##58##2##(1990-10#1)(1990-4#2)(1990-5#1)(1991-1#2)(1991-11#1)(1991-2#4)(1991-5#1)(1992-11#1)(1992-3#2)(1992-5#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-8#1)(2004-11#1)(2005-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#2)(2008-9#1)(2009-2#1)(2010-10#1)(2010-6#1)(2010-7#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
result supports the##6##3##(1993-9#1)(1994-6#1)(1996-1#1)(1997-1#1)(2008-8#1)(2011-2#1)
result supports##7##2##(1993-9#1)(1994-6#1)(1996-1#1)(1997-1#1)(2008-8#2)(2011-2#1)
result that both##2##3##(1992-3#1)(1995-8#1)
result that has##2##3##(2006-4#1)(2008-2#1)
result that##26##2##(1990-7#1)(1990-9#1)(1991-12#1)(1991-5#1)(1992-2#1)(1992-3#1)(1995-1#1)(1995-8#1)(1997-7#1)(1997-8#1)(2006-1#1)(2006-4#1)(2007-12#2)(2008-10#4)(2008-2#1)(2009-10#1)(2010-2#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
result the##13##2##(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-8#1)(2011-2#1)(2012-1#1)
result to be##3##3##(1996-12#1)(2007-7#1)(2009-3#1)
result to##7##2##(1996-12#1)(2005-9#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2009-3#1)
result was a##5##3##(1996-12#1)(2007-9#1)(2008-12#1)(2009-4#1)(2013-8#1)
result was achieved##4##3##(2008-8#1)(2008-9#1)(2009-4#1)(2012-3#1)
result was also obtained with##2##5##(1994-11#1)(1994-9#1)
result was also##3##3##(1994-11#1)(1994-9#1)(2010-4#1)
result was evaluated##2##3##(2009-2#1)(2013-8#1)
result was found in##2##4##(1996-3#1)(2007-11#1)
result was in##4##3##(2008-10#2)(2008-5#1)(2008-9#1)
result was not##4##3##(1996-1#1)(2008-10#1)(2008-9#1)(2013-1#1)
result was obtained by using##2##5##(1997-4#1)(1997-8#1)
result was obtained for##2##4##(2008-11#1)(2008-3#1)
result was obtained in##2##4##(1991-6#1)(1991-8#1)
result was obtained with##5##4##(2007-10#1)(2007-8#1)(2008-10#2)(2008-6#1)
result was obtained##14##3##(1991-6#1)(1991-8#1)(1997-4#1)(1997-8#1)(2005-4#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2011-2#1)
result was satisfactory##3##3##(2008-10#2)(2008-8#1)
result was that##4##3##(1991-12#1)(2008-2#1)(2008-5#1)(2011-2#1)
result was very good##2##4##(2006-8#1)(2007-8#1)
result was##75##2##(1990-6#1)(1991-12#1)(1991-6#1)(1991-8#1)(1993-4#1)(1993-7#1)(1994-11#1)(1994-2#1)(1994-7#1)(1994-9#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-9#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-4#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#2)(2008-8#2)(2008-9#3)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-7#1)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#2)
result we##11##2##(1993-9#1)(1996-9#1)(1997-7#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
result were##4##2##(2006-1#1)(2009-2#2)(2013-1#1)
result when##6##2##(1991-12#1)(1994-3#1)(1994-7#1)(2008-3#1)(2008-8#1)(2013-8#1)
result will be##3##3##(1997-3#1)(2006-10#1)(2010-8#1)
result will##4##2##(1997-3#1)(2006-10#1)(2008-9#1)(2010-8#1)
result with the##4##3##(1990-3#1)(1991-5#1)(2010-5#1)(2010-8#1)
result with##8##2##(1990-3#1)(1990-9#1)(1991-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2010-5#1)(2010-8#1)
result without##3##2##(1997-5#1)(2008-2#1)(2008-3#1)
result would##2##2##(1990-7#1)(2012-3#1)
result##3717##1##(1990-1#1)(1990-10#3)(1990-11#14)(1990-12#16)(1990-2#11)(1990-3#9)(1990-4#14)(1990-5#17)(1990-6#6)(1990-7#10)(1990-8#17)(1990-9#5)(1991-1#6)(1991-10#2)(1991-11#5)(1991-12#18)(1991-2#21)(1991-3#17)(1991-4#9)(1991-5#10)(1991-6#7)(1991-7#6)(1991-8#10)(1991-9#14)(1992-1#11)(1992-10#2)(1992-11#9)(1992-12#4)(1992-2#12)(1992-3#16)(1992-4#4)(1992-5#5)(1992-6#10)(1992-7#4)(1992-8#10)(1992-9#13)(1993-1#3)(1993-10#2)(1993-11#16)(1993-12#17)(1993-2#6)(1993-3#15)(1993-4#4)(1993-5#3)(1993-6#10)(1993-7#5)(1993-8#9)(1993-9#12)(1994-1#7)(1994-10#6)(1994-11#16)(1994-12#15)(1994-2#8)(1994-3#22)(1994-4#2)(1994-5#10)(1994-6#4)(1994-7#4)(1994-8#15)(1994-9#14)(1995-1#11)(1995-10#5)(1995-11#13)(1995-12#8)(1995-2#15)(1995-3#13)(1995-4#6)(1995-5#12)(1995-6#21)(1995-8#20)(1995-9#7)(1996-1#8)(1996-10#5)(1996-11#12)(1996-12#23)(1996-2#12)(1996-3#19)(1996-4#18)(1996-5#17)(1996-6#13)(1996-7#3)(1996-8#11)(1996-9#26)(1997-1#19)(1997-2#19)(1997-3#17)(1997-4#15)(1997-5#16)(1997-6#11)(1997-7#19)(1997-8#23)(2004-1#1)(2004-11#5)(2004-12#3)(2004-3#2)(2004-4#3)(2004-9#5)(2005-1#3)(2005-10#18)(2005-11#40)(2005-12#2)(2005-2#2)(2005-4#9)(2005-6#2)(2005-7#8)(2005-8#16)(2005-9#5)(2006-1#6)(2006-10#89)(2006-11#16)(2006-12#28)(2006-2#13)(2006-3#6)(2006-4#20)(2006-5#17)(2006-6#10)(2006-7#10)(2006-8#20)(2006-9#11)(2007-1#10)(2007-10#16)(2007-11#111)(2007-12#127)(2007-2#13)(2007-3#9)(2007-4#15)(2007-5#9)(2007-6#5)(2007-7#38)(2007-8#58)(2007-9#17)(2008-1#41)(2008-10#234)(2008-11#87)(2008-12#32)(2008-2#100)(2008-3#149)(2008-4#54)(2008-5#79)(2008-6#35)(2008-7#74)(2008-8#89)(2008-9#76)(2009-1#4)(2009-10#15)(2009-11#5)(2009-12#10)(2009-2#26)(2009-3#27)(2009-4#15)(2009-5#16)(2009-6#15)(2009-7#11)(2009-8#13)(2009-9#17)(2010-1#4)(2010-10#10)(2010-11#9)(2010-12#35)(2010-2#14)(2010-3#10)(2010-4#14)(2010-5#20)(2010-6#10)(2010-7#18)(2010-8#17)(2010-9#6)(2011-1#38)(2011-12#8)(2011-2#101)(2011-3#4)(2012-1#22)(2012-10#1)(2012-11#4)(2012-12#39)(2012-2#67)(2012-3#49)(2012-5#1)(2013-1#96)(2013-7#26)(2013-8#62)
resultant acidic##2##2##(2008-5#2)
resultant cell##3##2##(2006-11#1)(2009-4#1)(2012-1#1)
resultant decrease in the##2##4##(1990-3#1)(2009-6#1)
resultant decrease in##3##3##(1990-3#1)(1996-5#1)(2009-6#1)
resultant fluorescence quenching##2##3##(1997-1#2)
resultant fluorescence##3##2##(1997-1#2)(2008-2#1)
resultant increase in##4##3##(1993-11#1)(2005-12#1)(2007-12#1)(2008-11#1)
resultant mRNA##2##2##(1993-4#1)(2011-2#1)
resultant phase##3##2##(2008-3#2)(2010-4#1)
resultant recombinant##2##2##(1992-4#1)(2006-10#1)
resultant system##2##2##(1992-8#1)(2008-3#1)
resultant##210##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1991-10#2)(1991-11#2)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-8#2)(1996-11#2)(1996-12#1)(1996-5#1)(1997-1#4)(1997-3#2)(1997-4#2)(1997-5#1)(2004-9#1)(2005-11#3)(2005-12#2)(2005-2#1)(2005-9#1)(2006-10#2)(2006-11#3)(2006-12#1)(2006-5#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#12)(2007-3#2)(2007-4#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#5)(2008-12#1)(2008-2#12)(2008-3#19)(2008-4#5)(2008-5#6)(2008-7#2)(2008-8#2)(2009-1#1)(2009-10#1)(2009-11#2)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-3#2)(2010-4#3)(2010-5#1)(2010-8#2)(2010-9#3)(2011-1#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#8)(2013-8#4)
resultants are##2##2##(2006-11#1)(2010-8#1)
resulted a significant##3##3##(2008-12#1)(2008-7#1)(2009-12#1)
resulted a##4##2##(2008-10#1)(2008-12#1)(2008-7#1)(2009-12#1)
resulted also in##2##3##(1994-11#1)(2010-12#1)
resulted as##2##2##(2007-8#1)(2008-10#1)
resulted from a##8##3##(1990-7#1)(1996-10#2)(2007-10#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-5#1)
resulted from an##3##3##(1991-8#1)(2005-8#1)(2008-2#1)
resulted from changes in the##2##5##(2004-11#1)(2008-10#1)
resulted from increased##2##3##(2008-10#1)(2008-9#1)
resulted from the##30##3##(1992-2#1)(1992-9#1)(1993-12#2)(1995-6#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-12#1)(2006-8#1)(2007-11#2)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2011-1#1)(2011-12#1)(2012-12#1)
resulted from their##3##3##(1995-4#1)(1997-8#1)(2010-2#1)
resulted from##107##2##(1990-3#1)(1990-7#1)(1991-2#1)(1991-8#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-7#1)(1994-12#2)(1995-4#1)(1995-6#1)(1996-10#3)(1996-11#2)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#2)(2004-11#2)(2005-12#1)(2005-7#1)(2005-8#2)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#4)(2007-8#1)(2008-10#15)(2008-11#2)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#2)
resulted in 1##3##3##(2007-11#1)(2008-6#1)(2013-8#1)
resulted in 10##2##3##(1992-2#1)(2008-1#1)
resulted in 100%##3##3##(2008-5#1)(2008-7#1)(2013-1#1)
resulted in 13##2##3##(2004-2#1)(2008-10#1)
resulted in 17##3##3##(1992-7#1)(2007-2#1)(2008-5#1)
resulted in 83%##2##3##(2006-8#1)(2008-10#1)
resulted in a 1##3##4##(1994-12#1)(1994-9#1)(2008-11#1)
resulted in a 10-fold##2##4##(1992-3#1)(1995-3#1)
resulted in a 2##3##4##(1990-4#1)(1994-2#1)(2008-5#1)
resulted in a 35% decrease in##2##6##(1995-2#1)(2008-10#1)
resulted in a 4##2##4##(1995-2#1)(2012-2#1)
resulted in a 50%##2##4##(1993-6#1)(2008-10#1)
resulted in a 90%##2##4##(1995-5#1)(2012-12#1)
resulted in a better##3##4##(1997-4#1)(2004-9#1)(2008-10#1)
resulted in a biphasic##3##4##(1990-2#1)(1997-3#1)(2009-4#1)
resulted in a change in##3##5##(1990-11#1)(2006-10#1)(2008-11#1)
resulted in a change of##3##5##(1991-2#1)(2008-10#1)(2008-8#1)
resulted in a change##7##4##(1990-11#1)(1991-2#1)(1994-12#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-8#1)
resulted in a complete loss of##4##6##(1994-3#1)(1994-8#1)(1997-3#1)(2011-12#1)
resulted in a complete##6##4##(1991-12#1)(1994-3#1)(1994-8#1)(1997-3#1)(2008-10#1)(2011-12#1)
resulted in a concentration##2##4##(1990-3#1)(1996-5#1)
resulted in a concentration-dependent increase in##2##6##(1993-9#1)(1997-4#1)
resulted in a concentration-dependent inhibition of##2##6##(1991-8#1)(2004-12#1)
resulted in a concentration-dependent##5##4##(1990-3#1)(1991-8#1)(1993-9#1)(1997-4#1)(2004-12#1)
resulted in a concomitant##2##4##(1995-10#1)(2008-11#1)
resulted in a considerable##4##4##(1993-2#1)(2008-10#2)(2008-6#1)
resulted in a cure with##2##5##(2007-12#1)(2010-12#1)
resulted in a decline in##3##5##(1991-4#1)(2007-10#1)(2007-9#1)
resulted in a decrease in the##10##6##(1990-3#1)(1991-9#1)(1993-11#1)(1994-2#1)(1996-7#1)(1997-5#1)(2008-10#1)(2008-7#2)(2012-2#1)
resulted in a decrease in##21##5##(1990-3#1)(1991-12#1)(1991-9#1)(1992-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-2#1)(1996-5#1)(1996-7#1)(1997-5#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2012-2#1)(2013-8#1)
resulted in a decrease of##5##5##(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2013-1#1)
resulted in a decrease##29##4##(1990-3#1)(1991-12#1)(1991-9#1)(1992-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1996-5#1)(1996-7#1)(1997-5#1)(2005-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
resulted in a decreased##2##4##(1997-8#1)(2007-1#1)
resulted in a deeper##2##4##(2008-9#1)(2012-1#1)
resulted in a dose- and time-dependent##2##6##(1993-2#1)(1995-10#1)
resulted in a dose-dependent increase in##3##6##(1991-12#2)(1996-6#1)
resulted in a dose-dependent reduction##2##5##(1994-9#1)(1995-11#1)
resulted in a dose-dependent##8##4##(1991-12#2)(1992-11#1)(1994-10#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-6#1)
resulted in a dose-related##3##4##(1990-3#1)(1991-8#1)(2008-9#1)
resulted in a dramatic increase in##2##6##(1992-8#1)(2008-7#1)
resulted in a dramatic##6##4##(1990-6#1)(1992-8#1)(1994-8#1)(2007-11#1)(2008-12#1)(2008-7#1)
resulted in a drastic reduction##2##5##(1997-4#1)(2008-10#1)
resulted in a drastic##5##4##(1993-12#1)(1997-4#1)(1997-5#1)(2008-10#2)
resulted in a faster##2##4##(1992-12#1)(2007-8#1)
resulted in a fatal outcome##2##5##(2010-10#1)(2013-8#1)
resulted in a good##4##4##(1990-8#1)(1992-2#1)(2007-8#1)(2008-8#1)
resulted in a gradual##2##4##(1995-11#1)(2008-2#1)
resulted in a greater reduction in##2##6##(2008-4#1)(2010-4#1)
resulted in a greater##5##4##(1994-9#1)(2008-4#1)(2010-4#1)(2010-8#1)(2013-7#1)
resulted in a growth##2##4##(2009-4#1)(2010-1#1)
resulted in a high##6##4##(2007-8#1)(2008-10#2)(2010-4#1)(2011-2#1)(2013-1#1)
resulted in a higher##6##4##(1994-8#1)(2006-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)
resulted in a large##4##4##(1994-8#1)(2008-11#1)(2008-6#2)
resulted in a linear##3##4##(2008-10#2)(2010-2#1)
resulted in a loss of##6##5##(1991-7#1)(1994-11#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-12#1)
resulted in a low##5##4##(2007-7#1)(2008-10#1)(2008-2#1)(2009-9#1)(2010-7#1)
resulted in a lower##6##4##(1996-1#1)(1996-11#1)(2007-11#1)(2009-12#1)(2012-2#1)(2013-1#1)
resulted in a marked decrease of##2##6##(1995-12#1)(2008-10#1)
resulted in a marked increase##2##5##(1996-12#1)(2010-10#1)
resulted in a marked##11##4##(1990-11#1)(1991-7#1)(1992-11#1)(1993-11#1)(1995-12#1)(1996-12#1)(2005-8#1)(2008-10#2)(2010-10#1)(2013-1#1)
resulted in a mean##3##4##(1993-11#1)(2008-10#1)(2010-7#1)
resulted in a moderate##2##4##(1992-12#1)(1993-2#1)
resulted in a more##4##4##(2006-6#1)(2008-1#1)(2011-1#1)(2012-12#1)
resulted in a new##2##4##(2008-3#1)(2009-11#1)
resulted in a novel##2##4##(1991-7#1)(2011-12#1)
resulted in a product##2##4##(2008-12#1)(2010-5#1)
resulted in a production##2##4##(2005-8#1)(2008-6#1)
resulted in a progressive##4##4##(1992-12#1)(1993-3#1)(1994-9#1)(1996-5#1)
resulted in a pronounced##2##4##(1993-12#1)(1995-12#1)
resulted in a rapid and##2##5##(1991-9#1)(1994-10#1)
resulted in a rapid decline##2##5##(2007-11#1)(2008-11#1)
resulted in a rapid decrease in##2##6##(1990-12#1)(2008-11#1)
resulted in a rapid increase in##2##6##(1992-12#2)
resulted in a rapid increase##3##5##(1992-12#2)(1992-4#1)
resulted in a rapid##24##4##(1990-12#2)(1991-1#1)(1991-3#1)(1991-9#1)(1992-12#3)(1992-3#1)(1992-4#1)(1992-5#1)(1994-10#1)(1994-12#1)(1995-10#1)(1995-3#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-11#3)(2010-4#1)(2012-12#1)
resulted in a reduced##3##4##(2007-5#1)(2008-10#1)(2008-7#1)
resulted in a reduction in the##4##6##(1990-12#1)(1992-10#1)(1995-6#1)(2012-2#1)
resulted in a reduction in##6##5##(1990-12#1)(1992-10#1)(1995-6#1)(2009-5#1)(2010-4#1)(2012-2#1)
resulted in a reduction of the##3##6##(1994-12#1)(2007-1#1)(2011-1#1)
resulted in a reduction of##7##5##(1994-12#2)(1996-4#1)(1997-5#1)(2007-1#1)(2007-7#1)(2011-1#1)
resulted in a reduction##13##4##(1990-12#1)(1992-10#1)(1994-12#2)(1995-6#1)(1996-4#1)(1997-5#1)(2007-1#1)(2007-7#1)(2009-5#1)(2010-4#1)(2011-1#1)(2012-2#1)
resulted in a rise in##2##5##(1991-7#1)(1992-1#1)
resulted in a rise##3##4##(1991-7#1)(1992-1#1)(2006-9#1)
resulted in a shift of the##2##6##(1996-7#1)(1997-4#1)
resulted in a shift##4##4##(1995-1#1)(1996-7#1)(1997-4#1)(2007-4#1)
resulted in a short##2##4##(1992-2#1)(2005-11#1)
resulted in a significant (P &lt##2##6##(1993-12#1)(2008-10#1)
resulted in a significant and##2##5##(1991-7#1)(1992-5#1)
resulted in a significant decrease in##11##6##(1990-7#1)(1991-6#1)(1992-5#1)(1995-3#1)(2007-10#1)(2007-8#1)(2008-5#1)(2010-4#1)(2012-12#2)(2012-3#1)
resulted in a significant decrease of##4##6##(1990-12#1)(1993-12#1)(2008-11#1)(2008-5#1)
resulted in a significant decrease##17##5##(1990-12#1)(1990-7#1)(1991-6#1)(1991-9#1)(1992-5#1)(1993-12#1)(1995-3#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-5#2)(2010-4#1)(2012-12#2)(2012-2#1)(2012-3#1)
resulted in a significant improvement in##2##6##(2008-3#1)(2012-2#1)
resulted in a significant improvement##4##5##(2008-3#1)(2012-2#1)(2012-7#1)(2013-1#1)
resulted in a significant increase in the##6##7##(1994-3#1)(1994-8#1)(2005-11#1)(2008-11#1)(2008-12#1)(2010-10#1)
resulted in a significant increase in##19##6##(1992-12#1)(1993-7#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-6#1)(1997-2#1)(2005-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2009-6#1)(2010-10#1)(2013-1#1)(2013-7#2)
resulted in a significant increase of##3##6##(2008-10#1)(2008-5#1)(2011-12#1)
resulted in a significant increase##22##5##(1992-12#1)(1993-7#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-6#1)(1997-2#1)(2005-11#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2009-6#1)(2010-10#1)(2011-12#1)(2013-1#1)(2013-7#2)
resulted in a significant induction of##2##6##(1990-7#1)(1994-5#1)
resulted in a significant reduction in##6##6##(1991-12#1)(1991-9#1)(1995-6#1)(2008-10#1)(2008-5#1)(2010-12#1)
resulted in a significant reduction of the##2##7##(1992-1#1)(1996-10#1)
resulted in a significant reduction of##6##6##(1992-1#1)(1993-12#1)(1996-10#1)(2008-10#1)(2008-3#1)(2011-1#1)
resulted in a significant reduction##12##5##(1991-12#1)(1991-9#1)(1992-1#1)(1993-12#1)(1995-6#1)(1996-10#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-12#1)(2011-1#1)
resulted in a significant rise in##2##6##(2006-10#1)(2008-10#1)
resulted in a significant##79##4##(1990-12#1)(1990-7#2)(1991-12#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-5#2)(1992-9#2)(1993-12#3)(1993-3#1)(1993-7#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-3#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-7#1)(1997-2#1)(2005-11#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#4)(2009-12#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-12#2)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#3)(2013-7#2)
resulted in a significantly greater##2##5##(1990-7#1)(1996-1#1)
resulted in a significantly higher##2##5##(2007-2#1)(2008-4#1)
resulted in a significantly lower##3##5##(1997-3#1)(2007-8#1)(2008-10#1)
resulted in a significantly##9##4##(1990-7#1)(1993-3#1)(1996-1#1)(1997-3#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-4#1)
resulted in a similar##3##4##(1990-10#1)(1991-4#1)(2007-2#1)
resulted in a single##3##4##(1994-11#1)(1994-8#1)(2008-3#1)
resulted in a slight decrease##2##5##(2008-10#1)(2011-2#1)
resulted in a specific##2##4##(1990-8#1)(1995-1#1)
resulted in a striking##3##4##(1990-3#1)(1992-8#1)(1994-12#1)
resulted in a strong##2##4##(1990-11#1)(2006-3#1)
resulted in a substantial increase in##2##6##(2008-10#1)(2009-11#1)
resulted in a substantial##4##4##(1993-8#1)(2007-11#1)(2008-10#1)(2009-11#1)
resulted in a sustained##2##4##(1995-3#1)(2008-1#1)
resulted in a time- and##2##5##(1991-5#1)(1991-6#1)
resulted in a time-dependent decrease##2##5##(1990-5#1)(1995-5#1)
resulted in a transient increase in##2##6##(1993-9#1)(2008-7#1)
resulted in a transient increase##3##5##(1993-9#1)(1997-2#1)(2008-7#1)
resulted in a transient##4##4##(1993-9#2)(1997-2#1)(2008-7#1)
resulted in a trend##2##4##(2007-9#1)(2008-8#1)
resulted in a very##3##4##(1995-3#1)(2007-11#1)(2010-7#1)
resulted in a viable##2##4##(1996-5#1)(2008-7#1)
resulted in a##582##3##(1990-10#2)(1990-11#3)(1990-12#5)(1990-2#2)(1990-3#5)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#3)(1990-8#3)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#7)(1991-2#3)(1991-3#2)(1991-4#2)(1991-5#3)(1991-6#4)(1991-7#5)(1991-8#2)(1991-9#7)(1992-1#4)(1992-10#1)(1992-11#2)(1992-12#9)(1992-2#3)(1992-3#4)(1992-4#1)(1992-5#3)(1992-8#2)(1992-9#2)(1993-11#4)(1993-12#10)(1993-2#3)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#4)(1993-7#1)(1993-8#6)(1993-9#5)(1994-10#2)(1994-11#3)(1994-12#11)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#9)(1994-9#4)(1995-1#2)(1995-10#4)(1995-11#3)(1995-12#5)(1995-2#7)(1995-3#6)(1995-5#4)(1995-6#5)(1995-8#1)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#6)(1996-6#2)(1996-7#5)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#7)(1997-4#5)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#7)(2005-8#3)(2005-9#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#4)(2007-11#9)(2007-12#8)(2007-2#3)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#9)(2007-9#4)(2008-1#3)(2008-10#64)(2008-11#18)(2008-12#6)(2008-2#5)(2008-3#6)(2008-4#3)(2008-5#9)(2008-6#8)(2008-7#13)(2008-8#6)(2008-9#3)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-12#2)(2010-2#1)(2010-4#8)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#7)(2011-12#3)(2011-2#4)(2012-1#6)(2012-12#6)(2012-2#9)(2012-3#2)(2012-7#1)(2013-1#13)(2013-7#4)(2013-8#4)
resulted in abnormal##2##3##(2008-8#1)(2011-2#1)
resulted in about##2##3##(2008-11#1)(2008-12#1)
resulted in accelerated##2##3##(2008-1#1)(2008-10#1)
resulted in accumulation of##5##4##(1990-3#1)(1995-1#1)(1997-7#1)(2011-12#1)(2012-3#1)
resulted in activation of##4##4##(1993-11#1)(1993-3#1)(1994-5#1)(2010-12#1)
resulted in additive##2##3##(1990-10#1)(2008-10#1)
resulted in adequate##2##3##(2007-2#1)(2012-3#1)
resulted in almost complete##3##4##(1990-2#1)(2008-12#1)(2008-7#1)
resulted in amino acid##2##4##(1990-4#1)(2008-10#1)
resulted in amplification of##2##4##(2008-2#1)(2011-2#1)
resulted in an accumulation of##2##5##(1994-11#1)(2006-12#1)
resulted in an amino acid change##2##6##(1996-2#2)
resulted in an amino acid##3##5##(1996-2#2)(2008-10#1)
resulted in an approximate##2##4##(1991-10#1)(2013-1#1)
resulted in an approximately##3##4##(1996-2#1)(1996-3#1)(2008-8#1)
resulted in an enhanced##4##4##(1990-7#1)(1995-6#1)(2007-11#1)(2008-12#1)
resulted in an excellent##2##4##(2008-12#1)(2009-9#1)
resulted in an immediate##2##4##(1996-7#1)(2008-4#1)
resulted in an improvement of##2##5##(1995-11#1)(2008-11#1)
resulted in an inactive##2##4##(1991-10#1)(1997-6#1)
resulted in an increase in the##6##6##(1990-3#1)(1994-8#2)(2005-11#1)(2008-10#1)(2010-12#1)
resulted in an increase in##24##5##(1990-11#1)(1990-3#1)(1990-5#1)(1992-11#1)(1992-6#1)(1994-3#1)(1994-8#2)(1995-12#1)(1995-8#1)(1996-6#2)(2005-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2013-8#1)
resulted in an increase of the##4##6##(1993-8#1)(1996-12#1)(1996-6#1)(2008-5#1)
resulted in an increase of##8##5##(1991-2#1)(1993-8#1)(1995-10#1)(1995-8#1)(1996-12#1)(1996-6#1)(2008-5#2)
resulted in an increase##32##4##(1990-11#1)(1990-3#1)(1990-5#1)(1991-2#1)(1992-11#1)(1992-6#1)(1993-8#1)(1994-3#1)(1994-8#2)(1995-10#1)(1995-12#1)(1995-8#2)(1996-12#1)(1996-6#3)(2005-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2013-8#1)
resulted in an increased number of##2##6##(1991-12#1)(2013-8#1)
resulted in an increased##17##4##(1991-12#2)(1992-1#1)(1992-6#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-6#1)(2005-8#1)(2006-12#1)(2008-11#1)(2008-2#1)(2009-8#1)(2011-12#2)(2013-8#1)
resulted in an increasing##2##4##(1990-5#1)(2008-7#1)
resulted in an inhibition of##2##5##(1990-10#1)(1992-11#1)
resulted in an overall##3##4##(1993-5#1)(2007-10#1)(2007-3#1)
resulted in an##121##3##(1990-10#2)(1990-11#1)(1990-3#1)(1990-5#3)(1990-7#1)(1990-8#1)(1991-10#2)(1991-12#2)(1991-2#2)(1991-3#1)(1992-1#1)(1992-11#3)(1992-6#3)(1992-7#1)(1992-9#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-5#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-6#3)(1995-8#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#1)(1996-6#6)(1996-7#1)(1997-3#1)(1997-6#1)(2004-11#1)(2004-4#1)(2005-11#1)(2005-8#1)(2006-12#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#3)(2008-10#7)(2008-11#5)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
resulted in any##2##3##(2008-10#1)(2008-2#1)
resulted in approximately##3##3##(1992-2#1)(2006-2#1)(2006-7#1)
resulted in better##6##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-2#1)(2012-2#1)
resulted in both##3##3##(1991-3#1)(2008-10#1)(2012-12#1)
resulted in bright##2##3##(2007-8#1)(2008-11#1)
resulted in catastrophic##2##3##(2008-10#1)(2008-3#1)
resulted in cell##4##3##(1996-4#1)(1997-6#1)(2008-10#1)(2011-1#1)
resulted in changes in the##2##5##(1991-3#1)(1992-6#1)
resulted in changes in##4##4##(1991-3#1)(1992-6#1)(2008-10#2)
resulted in changes##5##3##(1991-3#1)(1992-6#1)(2008-10#2)(2008-5#1)
resulted in cleavage##3##3##(1991-11#1)(1996-8#1)(1997-2#1)
resulted in clinical##3##3##(1991-2#1)(2005-7#1)(2011-12#1)
resulted in complete recovery of##2##5##(1996-10#1)(1996-9#1)
resulted in complete resolution##2##4##(1992-12#1)(2007-7#1)
resulted in complete##16##3##(1991-8#1)(1992-12#1)(1993-12#1)(1995-11#1)(1996-10#1)(1996-9#1)(2007-3#1)(2007-6#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)
resulted in considerable##5##3##(1990-7#1)(1992-11#1)(2007-11#1)(2008-10#1)(2008-4#1)
resulted in consistently##2##3##(2008-11#1)(2009-3#1)
resulted in cylindrical##2##3##(2006-2#1)(2012-2#1)
resulted in cytotoxicity##2##3##(1990-5#1)(2012-12#1)
resulted in death##2##3##(2005-8#1)(2008-10#1)
resulted in decrease##2##3##(1996-4#1)(1996-5#1)
resulted in decreased##21##3##(1990-12#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-6#1)(1994-6#1)(1995-12#1)(1995-2#2)(1996-2#1)(1996-9#1)(2006-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-2#2)(2009-4#1)(2011-1#1)(2012-3#1)(2013-1#1)
resulted in delayed##2##3##(1992-8#1)(2007-11#1)
resulted in detection limits of##2##5##(2008-10#2)
resulted in detection of##3##4##(1991-10#1)(2008-10#2)
resulted in detection##5##3##(1991-10#1)(2008-10#4)
resulted in different##4##3##(1990-7#1)(1997-4#1)(2007-8#1)(2008-10#1)
resulted in disappearance of##2##4##(1993-10#1)(1995-3#1)
resulted in disease##3##3##(2008-10#3)
resulted in distinct##3##3##(1996-6#1)(2008-10#1)(2011-2#1)
resulted in dose-dependent inhibition of##2##5##(1994-6#1)(2008-10#1)
resulted in dose-dependent##4##3##(1994-6#1)(1995-11#1)(2008-10#1)(2013-1#1)
resulted in dramatic##4##3##(1994-12#1)(1996-12#1)(2006-10#1)(2010-7#1)
resulted in drastic##3##3##(2012-12#2)(2012-3#1)
resulted in eight##3##3##(1992-9#1)(1994-8#1)(2008-10#1)
resulted in either##2##3##(1991-9#1)(2008-10#1)
resulted in elevated levels of##2##5##(1995-2#1)(2008-10#1)
resulted in elevated##5##3##(1991-5#1)(1995-2#1)(1996-8#1)(2008-10#1)(2008-5#1)
resulted in enhanced##5##3##(1992-8#1)(2009-8#1)(2010-4#1)(2012-12#2)
resulted in equal##2##3##(1996-9#1)(2008-10#1)
resulted in excellent##3##3##(2008-1#1)(2008-10#1)(2013-7#1)
resulted in expression of##3##4##(1994-2#1)(1995-8#1)(2012-3#1)
resulted in expression##4##3##(1994-2#1)(1995-8#1)(2006-12#1)(2012-3#1)
resulted in extensive##4##3##(1991-5#1)(1996-3#1)(2007-7#1)(2008-10#1)
resulted in formation of##2##4##(1994-2#1)(2008-10#1)
resulted in further##5##3##(1993-11#1)(1994-3#1)(2008-11#1)(2011-1#1)(2012-2#1)
resulted in good##3##3##(1990-6#1)(2006-10#1)(2008-10#1)
resulted in great##2##3##(2005-11#1)(2008-11#1)
resulted in greater##10##3##(1990-10#1)(2005-11#1)(2008-10#2)(2008-6#1)(2008-8#1)(2009-6#1)(2010-1#1)(2012-1#1)(2013-1#1)
resulted in greatly reduced##2##4##(2008-10#1)(2008-8#1)
resulted in greatly##3##3##(1994-12#1)(2008-10#1)(2008-8#1)
resulted in guidelines for##3##4##(2007-11#1)(2012-12#2)
resulted in healing##2##3##(2009-2#1)(2013-1#1)
resulted in high##6##3##(2006-9#1)(2007-1#1)(2008-10#2)(2008-3#1)(2008-7#1)
resulted in higher percentages of##2##5##(2006-5#2)
resulted in higher rates of##2##5##(2006-3#1)(2008-10#1)
resulted in higher##21##3##(1994-6#1)(1996-12#1)(1997-5#1)(2006-3#1)(2006-5#2)(2006-6#1)(2008-10#6)(2008-8#1)(2009-10#1)(2010-8#1)(2012-3#1)(2013-1#3)(2013-8#1)
resulted in identification of##3##4##(1990-2#1)(2008-10#1)(2013-8#1)
resulted in immediate secretion of##3##5##(2008-11#1)(2008-4#1)(2008-8#1)
resulted in immediate##5##3##(1995-2#1)(2008-11#1)(2008-4#1)(2008-8#1)(2012-2#1)
resulted in improved outcome##2##4##(2008-12#1)(2010-12#1)
resulted in improved overall##2##4##(2008-8#2)
resulted in improved##17##3##(1993-3#1)(2006-10#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)
resulted in improvement of##3##4##(1996-2#1)(2008-4#1)(2013-8#1)
resulted in increased apoptosis##2##4##(2011-1#1)(2012-2#1)
resulted in increased cell##3##4##(1993-8#1)(1994-11#1)(2010-6#1)
resulted in increased expression of##2##5##(1997-5#1)(2008-1#1)
resulted in increased production of##2##5##(1992-8#1)(2008-10#1)
resulted in increased resistance to##2##5##(2011-1#1)(2011-12#1)
resulted in increased##48##3##(1990-11#1)(1990-5#1)(1990-9#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-3#2)(1995-5#1)(1996-4#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#1)(2006-10#1)(2006-9#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-2#2)(2013-1#2)
resulted in increases of##2##4##(1990-5#1)(1993-7#1)
resulted in increases##3##3##(1990-5#1)(1993-7#1)(1994-8#1)
resulted in increasing##3##3##(1991-5#1)(1993-4#1)(2007-8#1)
resulted in induction of##2##4##(1994-3#1)(2013-1#1)
resulted in infection##3##3##(2008-10#2)(2008-5#1)
resulted in inhibition of##4##4##(1992-6#1)(1995-12#1)(2006-8#1)(2011-1#1)
resulted in inhibition##5##3##(1990-7#1)(1992-6#1)(1995-12#1)(2006-8#1)(2011-1#1)
resulted in injuries##2##3##(1991-9#1)(2007-1#1)
resulted in inoculum##2##3##(2008-10#2)
resulted in irreversible##2##3##(1990-6#1)(1994-8#1)
resulted in its##2##3##(1994-5#1)(1996-5#1)
resulted in large increases in##2##5##(1992-9#1)(2008-10#1)
resulted in large##5##3##(1992-9#1)(2005-11#1)(2008-10#1)(2008-3#1)(2008-6#1)
resulted in larger##5##3##(1997-1#1)(2005-11#1)(2006-12#1)(2008-10#2)
resulted in less##7##3##(2006-12#2)(2007-11#1)(2008-10#2)(2010-4#1)(2013-1#1)
resulted in limited##2##3##(2008-5#1)(2011-2#1)
resulted in linear##2##3##(2006-11#1)(2010-2#1)
resulted in little##2##3##(1996-6#1)(1997-4#1)
resulted in loss of##8##4##(1990-7#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-12#1)(2008-10#1)(2011-12#1)(2013-8#1)
resulted in low##3##3##(2008-5#1)(2009-4#1)(2010-7#1)
resulted in lower##13##3##(1996-10#1)(1997-3#1)(2008-10#3)(2008-7#1)(2008-8#3)(2010-2#1)(2010-4#1)(2011-2#1)(2012-1#1)
resulted in many##3##3##(2005-8#1)(2012-11#1)(2012-3#1)
resulted in marked##6##3##(1993-12#2)(1995-2#1)(1996-12#1)(1997-6#1)(2008-5#1)
resulted in measurable improvements in##2##5##(1995-12#1)(2006-10#1)
resulted in more effective##2##4##(2005-10#1)(2007-8#1)
resulted in more extensive##2##4##(1990-2#1)(1992-8#1)
resulted in more than##3##4##(1990-7#1)(2008-10#1)(2009-2#1)
resulted in more##14##3##(1990-2#1)(1990-7#1)(1992-8#2)(2005-10#1)(2007-8#1)(2008-10#2)(2008-11#2)(2009-2#1)(2010-11#1)(2011-1#1)(2013-1#1)
resulted in morphological##2##3##(1994-6#1)(2012-12#1)
resulted in much##2##3##(2006-10#1)(2009-12#1)
resulted in mutant##2##3##(1994-11#2)
resulted in nearly##4##3##(1993-7#1)(1997-6#1)(2008-10#1)(2008-5#1)
resulted in new##5##3##(1996-2#1)(2006-10#2)(2008-10#2)
resulted in no significant change in##2##6##(1991-3#1)(1995-3#1)
resulted in no significant reduction in the formation of##2##9##(1993-11#2)
resulted in no significant##6##4##(1991-3#1)(1993-11#2)(1995-3#1)(2007-3#1)(2008-5#1)
resulted in no##12##3##(1990-7#1)(1991-3#1)(1993-11#2)(1995-2#1)(1995-3#1)(2004-3#1)(2007-3#1)(2007-8#1)(2008-5#1)(2011-2#1)(2012-12#1)
resulted in normal##3##3##(1994-6#1)(1997-7#1)(2008-7#1)
resulted in only a##2##4##(1990-9#1)(1994-3#1)
resulted in only##9##3##(1990-9#1)(1991-5#1)(1992-7#1)(1994-3#1)(1995-2#1)(2007-4#1)(2008-3#1)(2010-2#1)(2010-8#1)
resulted in over##3##3##(1996-5#1)(2006-12#1)(2011-1#1)
resulted in partial##2##3##(1992-3#1)(1996-12#1)
resulted in permanent##2##3##(1991-10#1)(1995-11#1)
resulted in plants##2##3##(2008-10#1)(2009-10#1)
resulted in plasma##2##3##(2007-10#1)(2009-1#1)
resulted in poor##3##3##(2008-11#1)(2010-5#1)(2011-2#1)
resulted in population##2##3##(2008-10#1)(2010-9#1)
resulted in positive##3##3##(1997-5#1)(2007-12#1)(2009-11#1)
resulted in production of the##2##5##(2005-12#1)(2008-10#1)
resulted in production of##4##4##(1991-5#1)(2005-12#1)(2008-10#2)
resulted in progressive##2##3##(2012-2#1)(2012-3#1)
resulted in prolongation of##2##4##(2006-10#1)(2008-3#1)
resulted in pronounced##3##3##(1995-8#1)(2008-10#2)
resulted in protection from##2##4##(1995-2#1)(2007-2#1)
resulted in rapid##6##3##(1992-8#1)(1996-11#1)(2005-11#1)(2007-7#1)(2007-8#1)(2012-1#1)
resulted in recovery of##2##4##(1990-7#1)(2013-8#1)
resulted in reduced##13##3##(1991-9#1)(1993-12#1)(1993-4#1)(1994-9#1)(1995-12#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-6#1)(2010-3#1)(2011-2#1)(2012-12#1)
resulted in reduction of the activity by about##2##8##(1990-5#2)
resulted in reduction of##4##4##(1990-5#2)(1993-9#1)(2013-8#1)
resulted in reduction##5##3##(1990-5#2)(1990-9#1)(1993-9#1)(2013-8#1)
resulted in relatively##6##3##(1994-8#1)(2006-5#1)(2008-10#2)(2008-4#1)(2012-2#1)
resulted in removal of##2##4##(2008-10#1)(2013-1#1)
resulted in resistance to##2##4##(1996-7#1)(2008-10#1)
resulted in reversal of##2##4##(1996-10#1)(2007-11#1)
resulted in right##2##3##(1994-3#1)(2010-9#1)
resulted in sensitivity##2##3##(1991-8#1)(2008-10#1)
resulted in seven##2##3##(2007-4#1)(2008-10#1)
resulted in severe##5##3##(1995-4#1)(1996-10#1)(1997-4#1)(2007-7#1)(2010-5#1)
resulted in significant changes in##4##5##(1995-7#1)(1997-4#1)(2008-10#1)(2012-2#1)
resulted in significant decreases in##2##5##(1993-6#1)(2009-5#1)
resulted in significant differences##2##4##(1994-3#1)(2009-9#1)
resulted in significant improvement in##6##5##(2008-5#1)(2009-8#1)(2010-5#1)(2010-8#1)(2012-12#2)
resulted in significant increase in##2##5##(1992-8#1)(2012-1#1)
resulted in significant increases in##4##5##(1990-9#1)(1997-2#1)(2007-7#1)(2013-7#1)
resulted in significant reduction##2##4##(2008-7#2)
resulted in significant reductions in##2##5##(2008-10#2)
resulted in significant rise##2##4##(2008-5#1)(2013-1#1)
resulted in significant##45##3##(1990-10#1)(1990-11#1)(1990-9#1)(1991-6#1)(1992-6#1)(1992-8#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-7#1)(1996-3#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#2)(2009-10#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-8#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)
resulted in significantly greater##4##4##(1996-8#1)(2007-6#1)(2008-10#2)
resulted in significantly higher##8##4##(1994-6#1)(1995-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#2)
resulted in significantly lower##3##4##(1992-4#1)(2006-11#1)(2013-1#1)
resulted in significantly more##3##4##(2007-1#1)(2008-10#1)(2011-12#1)
resulted in significantly##24##3##(1992-4#1)(1994-2#1)(1994-6#1)(1995-2#1)(1996-8#1)(2004-11#1)(2006-11#1)(2007-1#1)(2007-2#1)(2007-6#1)(2008-10#6)(2008-5#1)(2008-7#1)(2008-9#1)(2011-12#1)(2011-2#2)(2013-1#2)
resulted in similar##7##3##(1995-11#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-3#1)(2010-4#1)
resulted in slightly##2##3##(1992-2#1)(2009-7#1)
resulted in small##2##3##(1992-9#1)(1993-12#1)
resulted in strong##3##3##(1992-3#1)(1992-8#1)(1995-7#1)
resulted in stronger##2##3##(2008-9#1)(2011-2#1)
resulted in suppression of##4##4##(1992-8#1)(1995-5#1)(2006-10#1)(2008-11#1)
resulted in systemic##2##3##(2008-10#2)
resulted in the accumulation of##6##5##(1994-11#1)(1994-5#1)(1997-4#1)(2006-12#1)(2008-10#1)(2008-7#1)
resulted in the appearance of a single##2##7##(1993-11#1)(1997-4#1)
resulted in the appearance of a##3##6##(1993-11#1)(1994-8#1)(1997-4#1)
resulted in the appearance of##7##5##(1990-5#1)(1992-8#1)(1993-11#1)(1994-8#1)(1995-11#1)(1997-4#1)(2011-12#1)
resulted in the complete##4##4##(1994-3#1)(1996-4#1)(2008-10#1)(2011-1#1)
resulted in the conversion of##2##5##(1993-3#1)(2008-5#1)
resulted in the creation of a##2##6##(1997-3#1)(2010-1#1)
resulted in the creation of the##2##6##(2008-11#1)(2009-7#1)
resulted in the creation of##4##5##(1997-3#1)(2008-11#1)(2009-7#1)(2010-1#1)
resulted in the determination of##2##5##(1994-11#1)(2008-10#1)
resulted in the development of the##2##6##(2005-8#1)(2007-12#1)
resulted in the development of##11##5##(2004-12#1)(2005-8#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-3#1)(2011-2#1)
resulted in the disappearance of the##3##6##(1995-4#1)(1996-11#1)(2009-2#1)
resulted in the disappearance of##4##5##(1995-4#1)(1996-11#1)(1997-5#1)(2009-2#1)
resulted in the discovery of##3##5##(1996-4#1)(2006-12#1)(2008-3#1)
resulted in the early##2##4##(1992-6#1)(2012-12#1)
resulted in the elimination of##2##5##(1990-11#1)(1997-3#1)
resulted in the emergence of##2##5##(2008-11#2)
resulted in the establishment of##2##5##(1994-9#1)(1996-12#1)
resulted in the expression of##5##5##(1992-3#2)(1994-9#2)(2008-10#1)
resulted in the final##2##4##(2008-8#1)(2011-1#1)
resulted in the formation of a##3##6##(1990-3#1)(1991-2#1)(2005-12#1)
resulted in the formation of the##2##6##(1996-5#1)(2010-5#1)
resulted in the formation of two##3##6##(1997-7#1)(2006-12#1)(2008-10#1)
resulted in the formation of##28##5##(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#1)(1991-2#1)(1992-11#1)(1993-11#1)(1994-6#1)(1995-10#1)(1996-5#1)(1996-7#1)(1997-7#2)(2005-12#1)(2006-12#3)(2008-10#2)(2008-5#2)(2008-8#1)(2009-11#2)(2009-2#1)(2010-4#1)(2010-5#2)
resulted in the functional##2##4##(1994-9#1)(1997-6#1)
resulted in the generation of a##2##6##(1995-7#1)(2009-9#1)
resulted in the generation of##5##5##(1990-9#1)(1994-9#1)(1995-7#1)(2009-9#2)
resulted in the greatest##4##4##(2008-10#2)(2008-8#1)(2012-5#1)
resulted in the highest##3##4##(2009-2#1)(2009-6#1)(2013-1#1)
resulted in the identification of##12##5##(1991-7#1)(1994-11#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#4)(2008-7#1)(2010-3#1)
resulted in the increase of the##2##6##(1997-6#1)(2010-5#1)
resulted in the induction of##4##5##(1992-8#1)(1993-11#1)(1995-5#1)(2008-10#1)
resulted in the induction##5##4##(1992-8#1)(1993-11#2)(1995-5#1)(2008-10#1)
resulted in the inhibition of##2##5##(1990-8#1)(2012-2#1)
resulted in the intracellular accumulation of##2##6##(1992-1#1)(1995-6#1)
resulted in the isolation of a##2##6##(1994-11#1)(2007-1#1)
resulted in the isolation of##11##5##(1991-5#1)(1991-7#1)(1994-11#1)(1995-5#1)(1997-2#1)(1997-3#1)(2006-12#1)(2007-1#2)(2008-11#1)(2013-1#1)
resulted in the largest##2##4##(1992-12#1)(1992-8#1)
resulted in the loss of the##2##6##(1997-5#1)(2008-10#1)
resulted in the loss of##5##5##(1992-5#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#1)
resulted in the loss##6##4##(1992-5#1)(1996-1#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#1)
resulted in the most##2##4##(1994-9#1)(2008-5#1)
resulted in the optimal##2##4##(2006-12#1)(2008-9#1)
resulted in the production of biologically active##2##7##(1993-6#1)(2007-11#1)
resulted in the production of##7##5##(1993-6#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-11#1)(1997-4#1)(2007-11#1)
resulted in the production##8##4##(1991-9#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-11#1)(1997-4#1)(2007-11#1)
resulted in the recovery of##2##5##(1997-4#1)(2010-4#1)
resulted in the reduction of##3##5##(1996-12#1)(2008-3#1)(2011-1#1)
resulted in the release of a##2##6##(1992-7#1)(2008-11#1)
resulted in the release of##7##5##(1990-2#1)(1991-1#1)(1992-7#1)(1993-5#1)(2008-10#1)(2008-11#1)(2008-4#1)
resulted in the retention of##2##5##(2007-11#1)(2012-1#1)
resulted in the significant##2##4##(2012-3#1)(2013-8#1)
resulted in the specific##2##4##(1992-12#1)(1992-5#1)
resulted in the successful##3##4##(2008-10#1)(2008-7#1)(2009-4#1)
resulted in the suppression of##2##5##(1990-12#1)(2010-1#1)
resulted in the##282##3##(1990-10#1)(1990-11#3)(1990-12#4)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#2)(1991-2#1)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#3)(1992-6#1)(1992-7#1)(1992-8#3)(1993-10#1)(1993-11#5)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#1)(1993-8#2)(1994-11#5)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#7)(1995-10#1)(1995-11#2)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-4#2)(1996-5#4)(1996-7#1)(1996-9#2)(1997-2#1)(1997-3#3)(1997-4#5)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#2)(2004-12#1)(2005-10#1)(2005-11#2)(2005-12#2)(2005-8#1)(2005-9#1)(2006-10#4)(2006-11#3)(2006-12#8)(2006-5#1)(2006-8#1)(2007-1#2)(2007-11#7)(2007-12#1)(2007-4#1)(2007-8#3)(2008-1#4)(2008-10#23)(2008-11#12)(2008-12#2)(2008-3#4)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#7)(2009-11#3)(2009-2#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#2)(2010-1#3)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#4)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#8)(2013-7#2)(2013-8#1)
resulted in their##4##3##(1994-8#1)(2006-12#1)(2007-8#1)(2009-4#1)
resulted in transient##3##3##(1994-6#1)(2011-2#2)
resulted in tumor##3##3##(1996-4#1)(2007-12#1)(2008-6#1)
resulted in two##5##3##(1990-7#1)(1996-11#1)(1996-5#1)(2008-11#1)(2008-6#1)
resulted in up to##2##4##(2008-10#1)(2011-1#1)
resulted in very low##2##4##(2006-7#1)(2008-10#1)
resulted in very##4##3##(1992-9#1)(2006-7#1)(2008-10#2)
resulted in weak##2##3##(1991-7#1)(2005-11#1)
resulted in yields##2##3##(2008-10#1)(2008-11#1)
resulted in##2017##2##(1990-10#9)(1990-11#10)(1990-12#12)(1990-2#7)(1990-3#9)(1990-4#5)(1990-5#14)(1990-6#4)(1990-7#15)(1990-8#7)(1990-9#7)(1991-1#4)(1991-10#5)(1991-11#5)(1991-12#11)(1991-2#9)(1991-3#7)(1991-4#3)(1991-5#10)(1991-6#6)(1991-7#9)(1991-8#8)(1991-9#15)(1992-1#7)(1992-10#1)(1992-11#7)(1992-12#15)(1992-2#9)(1992-3#10)(1992-4#4)(1992-5#7)(1992-6#12)(1992-7#4)(1992-8#16)(1992-9#9)(1993-10#2)(1993-11#13)(1993-12#17)(1993-2#4)(1993-3#10)(1993-4#5)(1993-5#5)(1993-6#9)(1993-7#3)(1993-8#14)(1993-9#8)(1994-10#2)(1994-11#14)(1994-12#20)(1994-2#6)(1994-3#16)(1994-5#7)(1994-6#14)(1994-7#1)(1994-8#20)(1994-9#18)(1995-1#4)(1995-10#7)(1995-11#10)(1995-12#17)(1995-2#27)(1995-3#15)(1995-4#3)(1995-5#9)(1995-6#13)(1995-7#4)(1995-8#5)(1995-9#2)(1996-1#7)(1996-10#8)(1996-11#5)(1996-12#12)(1996-2#8)(1996-3#6)(1996-4#7)(1996-5#18)(1996-6#11)(1996-7#9)(1996-8#6)(1996-9#6)(1997-1#4)(1997-2#10)(1997-3#16)(1997-4#16)(1997-5#9)(1997-6#11)(1997-7#9)(1997-8#4)(2004-11#4)(2004-12#3)(2004-2#1)(2004-3#2)(2004-4#2)(2004-9#1)(2005-10#3)(2005-11#19)(2005-12#5)(2005-3#1)(2005-6#1)(2005-7#1)(2005-8#8)(2005-9#2)(2006-1#1)(2006-10#24)(2006-11#16)(2006-12#20)(2006-2#3)(2006-3#2)(2006-4#2)(2006-5#6)(2006-6#3)(2006-7#2)(2006-8#6)(2006-9#3)(2007-1#9)(2007-10#8)(2007-11#31)(2007-12#17)(2007-2#10)(2007-3#4)(2007-4#7)(2007-5#1)(2007-6#2)(2007-7#16)(2007-8#32)(2007-9#7)(2008-1#15)(2008-10#245)(2008-11#60)(2008-12#22)(2008-2#11)(2008-3#23)(2008-4#15)(2008-5#50)(2008-6#25)(2008-7#36)(2008-8#29)(2008-9#17)(2009-1#1)(2009-10#6)(2009-11#10)(2009-12#4)(2009-2#11)(2009-3#3)(2009-4#10)(2009-5#3)(2009-6#7)(2009-7#4)(2009-8#6)(2009-9#8)(2010-1#5)(2010-10#4)(2010-11#2)(2010-12#8)(2010-2#9)(2010-3#4)(2010-4#17)(2010-5#11)(2010-6#3)(2010-7#5)(2010-8#8)(2010-9#4)(2011-1#28)(2011-12#12)(2011-2#32)(2012-1#13)(2012-11#3)(2012-12#26)(2012-2#26)(2012-3#15)(2012-5#1)(2012-7#1)(2013-1#49)(2013-7#10)(2013-8#17)
resulted not##2##2##(2007-2#1)(2008-5#1)
resulted only in##2##3##(2006-12#1)(2008-10#1)
resulted only##3##2##(2006-12#1)(2008-10#2)
resulted to be##5##3##(1993-4#1)(2007-8#1)(2008-2#1)(2008-4#1)(2013-1#1)
resulted##2200##1##(1990-10#9)(1990-11#10)(1990-12#15)(1990-2#7)(1990-3#11)(1990-4#5)(1990-5#14)(1990-6#4)(1990-7#17)(1990-8#7)(1990-9#7)(1991-1#4)(1991-10#5)(1991-11#5)(1991-12#11)(1991-2#10)(1991-3#8)(1991-4#3)(1991-5#10)(1991-6#8)(1991-7#9)(1991-8#9)(1991-9#15)(1992-1#7)(1992-10#1)(1992-11#7)(1992-12#15)(1992-2#11)(1992-3#10)(1992-4#4)(1992-5#7)(1992-6#12)(1992-7#4)(1992-8#16)(1992-9#10)(1993-10#3)(1993-11#14)(1993-12#20)(1993-2#5)(1993-3#11)(1993-4#6)(1993-5#5)(1993-6#9)(1993-7#4)(1993-8#14)(1993-9#8)(1994-10#2)(1994-11#15)(1994-12#22)(1994-2#6)(1994-3#16)(1994-5#7)(1994-6#16)(1994-7#1)(1994-8#21)(1994-9#18)(1995-1#4)(1995-10#7)(1995-11#10)(1995-12#18)(1995-2#27)(1995-3#15)(1995-4#4)(1995-5#9)(1995-6#14)(1995-7#4)(1995-8#5)(1995-9#2)(1996-1#7)(1996-10#11)(1996-11#7)(1996-12#12)(1996-2#8)(1996-3#6)(1996-4#7)(1996-5#18)(1996-6#12)(1996-7#9)(1996-8#6)(1996-9#6)(1997-1#4)(1997-2#10)(1997-3#18)(1997-4#16)(1997-5#9)(1997-6#13)(1997-7#11)(1997-8#6)(2004-11#6)(2004-12#3)(2004-2#1)(2004-3#2)(2004-4#2)(2004-9#1)(2005-10#3)(2005-11#19)(2005-12#6)(2005-3#1)(2005-6#1)(2005-7#2)(2005-8#10)(2005-9#2)(2006-1#1)(2006-10#25)(2006-11#16)(2006-12#21)(2006-2#3)(2006-3#2)(2006-4#2)(2006-5#7)(2006-6#5)(2006-7#3)(2006-8#7)(2006-9#3)(2007-1#11)(2007-10#9)(2007-11#36)(2007-12#19)(2007-2#16)(2007-3#4)(2007-4#8)(2007-5#1)(2007-6#2)(2007-7#16)(2007-8#35)(2007-9#7)(2008-1#15)(2008-10#274)(2008-11#62)(2008-12#24)(2008-2#19)(2008-3#27)(2008-4#18)(2008-5#53)(2008-6#28)(2008-7#42)(2008-8#32)(2008-9#19)(2009-1#1)(2009-10#7)(2009-11#10)(2009-12#6)(2009-2#11)(2009-3#3)(2009-4#10)(2009-5#3)(2009-6#7)(2009-7#4)(2009-8#7)(2009-9#9)(2010-1#5)(2010-10#4)(2010-11#2)(2010-12#11)(2010-2#11)(2010-3#5)(2010-4#20)(2010-5#13)(2010-6#3)(2010-7#5)(2010-8#8)(2010-9#4)(2011-1#29)(2011-12#13)(2011-2#37)(2012-1#14)(2012-11#3)(2012-12#27)(2012-2#26)(2012-3#15)(2012-5#1)(2012-7#1)(2013-1#58)(2013-7#12)(2013-8#19)
resulting 2D##3##2##(2008-10#1)(2010-5#1)(2010-6#1)
resulting action##2##2##(1994-2#1)(2013-8#1)
resulting analysis##3##2##(2008-1#1)(2010-7#1)(2012-3#1)
resulting both from##2##3##(1997-3#1)(2009-10#1)
resulting cDNA was##2##3##(1993-2#1)(1997-2#1)
resulting cDNA##3##2##(1991-9#1)(1993-2#1)(1997-2#1)
resulting cells were##2##3##(1994-11#1)(2007-11#1)
resulting chimeric##4##2##(1996-2#1)(1996-7#1)(2008-6#2)
resulting clone##2##2##(2008-11#1)(2008-9#1)
resulting clones were##3##3##(1993-3#1)(1994-12#1)(2008-10#1)
resulting cognitive##2##2##(1993-11#1)(2013-8#1)
resulting competitive##2##2##(2007-12#1)(2011-12#1)
resulting complex##6##2##(1994-3#1)(2007-11#2)(2008-10#2)(2010-5#1)
resulting complexes##5##2##(1991-10#1)(1994-6#1)(1997-7#1)(2008-10#1)(2008-5#1)
resulting complications##2##2##(2008-1#2)
resulting construct##2##2##(1993-12#1)(2008-10#1)
resulting constructs##2##2##(1995-2#1)(2011-1#1)
resulting control##2##2##(2007-8#1)(2012-1#1)
resulting data were##3##3##(1990-2#1)(2004-9#1)(2008-8#1)
resulting data##12##2##(1990-2#1)(1995-2#1)(1997-2#1)(2004-9#1)(2006-11#1)(2006-12#1)(2008-10#3)(2008-3#1)(2008-8#1)(2009-12#1)
resulting derivative##3##2##(2008-10#2)(2008-9#1)
resulting diacylglycerols##2##2##(1996-5#2)
resulting effects on##3##3##(1995-1#1)(1995-3#1)(2008-8#1)
resulting electron density##2##3##(1994-8#1)(2007-12#1)
resulting estimates##2##2##(2008-3#1)(2012-2#1)
resulting fluorescent##3##2##(1994-11#1)(1995-1#1)(2008-10#1)
resulting fragments##4##2##(1990-7#1)(1992-3#1)(1993-6#1)(2006-10#1)
resulting from a variety of##2##5##(2007-1#1)(2012-1#1)
resulting from a##34##3##(1990-3#1)(1993-2#1)(1994-2#1)(1994-3#1)(1995-4#1)(1996-1#1)(2005-12#1)(2005-8#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-7#3)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-1#1)(2012-3#1)
resulting from activation of##4##4##(1995-3#1)(1996-5#2)(2006-10#1)
resulting from an##9##3##(1991-1#1)(1992-12#1)(1992-3#1)(1993-6#1)(2006-9#1)(2008-10#2)(2010-2#1)(2011-1#1)
resulting from both##2##3##(2008-1#1)(2008-11#1)
resulting from changes in##3##4##(2008-11#1)(2008-4#1)(2008-7#1)
resulting from chronic##4##3##(1993-3#1)(2008-6#1)(2008-7#1)(2010-8#1)
resulting from continued##3##3##(2006-8#2)(2008-5#1)
resulting from contrast##2##3##(2008-3#1)(2009-9#1)
resulting from differences in##3##4##(2008-5#1)(2012-3#1)(2013-1#1)
resulting from different##2##3##(1993-6#1)(2006-10#1)
resulting from exposure to##3##4##(1991-12#1)(2008-7#1)(2009-3#1)
resulting from exposure##4##3##(1991-12#1)(2006-1#1)(2008-7#1)(2009-3#1)
resulting from free##2##3##(1997-8#1)(2008-9#1)
resulting from human##2##3##(2007-12#1)(2011-2#1)
resulting from increased##2##3##(1997-6#1)(2008-1#1)
resulting from ischemia##2##3##(1996-9#1)(2007-10#1)
resulting from its##2##3##(2010-1#1)(2011-1#1)
resulting from low##2##3##(1996-12#1)(2006-4#1)
resulting from more##2##3##(2011-2#1)(2013-1#1)
resulting from mutation of##2##4##(1990-5#1)(1993-11#1)
resulting from over-expression of the##2##5##(1993-2#1)(1995-8#1)
resulting from phase and amplitude errors in arrayed-waveguide grating##2##9##(2007-12#2)
resulting from presence of##2##4##(2008-10#1)(2013-8#1)
resulting from primary##2##3##(2008-10#1)(2012-2#1)
resulting from proteolytic##2##3##(1996-8#1)(2007-12#1)
resulting from radiation##2##3##(2008-6#1)(2010-5#1)
resulting from recycled tires##2##4##(2008-10#2)
resulting from sexual##2##3##(1994-6#1)(2008-8#1)
resulting from small##2##3##(2008-10#1)(2013-8#1)
resulting from specific##2##3##(2006-10#1)(2008-7#1)
resulting from stroke##2##3##(2012-11#1)(2013-1#1)
resulting from the implementation of##3##5##(1991-3#1)(2013-1#2)
resulting from the interaction between##2##5##(1993-3#1)(2007-12#1)
resulting from the interaction of##2##5##(2007-12#1)(2008-10#1)
resulting from the interaction##4##4##(1993-3#1)(2007-12#2)(2008-10#1)
resulting from the lack of##2##5##(2008-7#1)(2012-3#1)
resulting from the long-term##2##4##(2005-9#1)(2010-5#1)
resulting from the loss of##3##5##(1994-3#1)(2007-11#1)(2008-11#1)
resulting from the presence of##2##5##(2008-3#2)
resulting from the program##2##4##(2008-11#1)(2010-3#1)
resulting from the reaction of##2##5##(2005-4#1)(2008-10#1)
resulting from the use of##5##5##(2008-10#1)(2008-7#1)(2010-5#1)(2011-3#1)(2012-3#1)
resulting from the##121##3##(1990-12#1)(1990-6#1)(1991-3#2)(1991-4#1)(1992-4#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-6#2)(1996-8#1)(1997-4#2)(2005-11#5)(2005-4#1)(2005-9#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-11#3)(2007-12#9)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#7)(2008-7#4)(2008-8#2)(2009-12#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-8#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-11#4)(2012-12#3)(2012-3#4)(2013-1#4)(2013-8#2)
resulting from thermally induced##2##4##(2007-12#2)
resulting from these##6##3##(1990-12#1)(1990-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-12#1)
resulting from this##3##3##(1995-3#1)(2006-6#1)(2008-9#1)
resulting from various##2##3##(1991-2#1)(1996-3#1)
resulting from##499##2##(1990-11#1)(1990-12#2)(1990-3#4)(1990-4#4)(1990-5#1)(1990-6#3)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#5)(1991-4#2)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#3)(1993-2#3)(1993-3#2)(1993-6#3)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#3)(1994-8#1)(1994-9#1)(1995-12#4)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-10#1)(2005-10#2)(2005-11#7)(2005-12#1)(2005-4#1)(2005-5#1)(2005-7#1)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#10)(2006-11#2)(2006-12#4)(2006-4#3)(2006-5#3)(2006-6#3)(2006-7#3)(2006-8#6)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#14)(2007-12#21)(2007-2#2)(2007-3#2)(2007-4#4)(2007-7#8)(2007-8#5)(2007-9#4)(2008-1#5)(2008-10#39)(2008-11#15)(2008-12#2)(2008-2#17)(2008-3#15)(2008-4#4)(2008-5#9)(2008-6#3)(2008-7#17)(2008-8#10)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#5)(2009-4#3)(2009-5#1)(2009-8#1)(2009-9#3)(2010-1#2)(2010-11#1)(2010-12#7)(2010-2#4)(2010-3#2)(2010-4#3)(2010-5#8)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#9)(2011-3#1)(2012-1#2)(2012-11#6)(2012-12#3)(2012-2#5)(2012-3#10)(2013-1#10)(2013-8#5)
resulting fusion protein was##3##4##(1994-8#1)(2008-10#2)
resulting fusion protein##6##3##(1994-8#1)(1995-1#1)(2008-10#2)(2008-4#2)
resulting high##3##2##(1995-12#1)(2008-11#1)(2008-3#1)
resulting hybrid##5##2##(1990-11#1)(1990-3#1)(2007-11#1)(2008-2#1)(2012-3#1)
resulting image##3##2##(1995-6#1)(2008-2#1)(2012-1#1)
resulting images##5##2##(1991-2#1)(2008-2#1)(2009-12#1)(2009-4#1)(2010-9#1)
resulting impact##2##2##(1995-1#1)(2007-7#1)
resulting in 0##3##3##(1993-8#1)(2006-9#1)(2007-11#1)
resulting in a &quot##3##4##(1992-12#1)(2007-5#1)(2011-2#1)
resulting in a better##4##4##(1990-10#1)(2007-10#1)(2008-2#2)
resulting in a cell##2##4##(2008-11#1)(2008-4#1)
resulting in a decrease in the##3##6##(1994-11#1)(2006-6#1)(2008-6#1)
resulting in a decrease in##6##5##(1994-11#1)(2006-10#1)(2006-6#1)(2008-1#1)(2008-4#1)(2008-6#1)
resulting in a decrease##7##4##(1994-11#1)(2006-10#1)(2006-6#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-6#1)
resulting in a decreased##4##4##(1992-11#1)(2006-8#1)(2008-10#1)(2008-11#1)
resulting in a diagnosis of##2##5##(2012-1#1)(2013-8#1)
resulting in a distorted grating pattern##2##6##(2008-3#2)
resulting in a greater##2##4##(2005-10#1)(2009-4#1)
resulting in a high##3##4##(2007-12#1)(2008-11#1)(2010-5#1)
resulting in a large##2##4##(2008-10#1)(2008-7#1)
resulting in a loss of##2##5##(1995-5#1)(2006-11#1)
resulting in a lower##2##4##(2004-9#1)(2007-6#1)
resulting in a major##2##4##(1991-2#1)(2005-8#1)
resulting in a marked##2##4##(2010-10#1)(2011-2#1)
resulting in a maximum##2##4##(2008-7#1)(2011-1#1)
resulting in a more##3##4##(2008-12#1)(2008-7#1)(2008-8#1)
resulting in a peak##2##4##(2007-10#1)(2007-11#1)
resulting in a poor prognosis##2##5##(2012-2#1)(2013-1#1)
resulting in a reduced##4##4##(1994-12#1)(2007-11#1)(2008-10#1)(2008-7#1)
resulting in a reduction##2##4##(1990-2#1)(1990-8#1)
resulting in a sensitive assay##2##5##(1995-11#1)(2008-11#1)
resulting in a significant economic##2##5##(2008-11#1)(2013-1#1)
resulting in a significant##8##4##(1994-5#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2013-1#1)
resulting in a slightly higher##2##5##(1996-10#1)(2008-10#1)
resulting in a stable##2##4##(1993-3#1)(2008-10#1)
resulting in a total##2##4##(1990-3#1)(2008-10#1)
resulting in a truncated##2##4##(1991-12#1)(1996-11#1)
resulting in a##212##3##(1990-10#1)(1990-2#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-8#1)(1993-12#2)(1993-3#2)(1993-6#4)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-5#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#2)(1995-8#2)(1996-1#1)(1996-10#2)(1996-11#1)(1996-2#1)(1996-5#1)(1996-8#2)(1997-3#1)(1997-5#1)(1997-7#4)(1997-8#1)(2004-9#2)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#3)(2007-11#4)(2007-12#11)(2007-5#1)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#24)(2008-11#10)(2008-12#3)(2008-2#5)(2008-3#10)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#3)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#2)
resulting in abnormal##3##3##(1995-8#1)(2012-2#1)(2013-7#1)
resulting in activation of##3##4##(2009-3#1)(2010-11#2)
resulting in activation##4##3##(2009-3#1)(2010-11#2)(2012-3#1)
resulting in acute##3##3##(2008-10#1)(2008-9#1)(2010-4#1)
resulting in alterations in##2##4##(2008-1#1)(2010-2#1)
resulting in altered##3##3##(1991-5#1)(1997-3#1)(2012-3#1)
resulting in amino acid changes##2##5##(1992-3#1)(1997-4#1)
resulting in amino acid substitution##2##5##(2012-12#2)
resulting in amino acid##4##4##(1992-3#1)(1997-4#1)(2012-12#2)
resulting in an 11-amino acid##2##5##(1995-10#2)
resulting in an accumulation of acetylcholine and continued stimulation of acetylcholine receptors##2##12##(2013-1#2)
resulting in an almost##2##4##(1996-6#1)(2006-12#1)
resulting in an amino acid change from##2##7##(1991-2#1)(1992-2#1)
resulting in an amino acid substitution of##2##7##(1993-3#1)(1994-11#1)
resulting in an amino acid substitution##3##6##(1993-3#1)(1994-11#1)(2008-10#1)
resulting in an amino acid##5##5##(1991-2#1)(1992-2#1)(1993-3#1)(1994-11#1)(2008-10#1)
resulting in an average##2##4##(2009-8#1)(2012-3#1)
resulting in an enhanced##2##4##(1990-5#1)(2010-12#1)
resulting in an enrichment##2##4##(1993-3#1)(2008-10#1)
resulting in an improvement##2##4##(2008-10#1)(2012-1#1)
resulting in an increase in##2##5##(2006-1#1)(2008-10#1)
resulting in an increase of##2##5##(2008-3#1)(2008-7#1)
resulting in an increase##4##4##(2006-1#1)(2008-10#1)(2008-3#1)(2008-7#1)
resulting in an increased##6##4##(1990-5#1)(1993-6#1)(1997-8#1)(2008-3#1)(2008-5#1)(2013-1#1)
resulting in an intense##2##4##(2008-10#2)
resulting in an overall##3##4##(1992-9#1)(2008-3#1)(2008-7#1)
resulting in an##66##3##(1990-4#1)(1990-5#3)(1990-8#1)(1991-2#1)(1992-2#1)(1992-7#1)(1992-9#2)(1993-3#2)(1993-6#1)(1994-11#1)(1995-10#2)(1996-6#1)(1997-8#2)(2004-12#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-3#1)(2009-8#3)(2009-9#1)(2010-12#1)(2010-2#2)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
resulting in better##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2012-3#1)
resulting in bone##2##3##(2013-1#2)
resulting in cell##3##3##(1992-8#1)(1993-12#1)(1995-2#1)
resulting in chromosome##2##3##(2008-8#1)(2009-12#1)
resulting in chronic##3##3##(2006-8#1)(2008-7#1)(2013-7#1)
resulting in considerable##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
resulting in death##4##3##(1992-10#1)(1996-2#1)(2007-2#1)(2013-7#1)
resulting in decreased##6##3##(1997-6#1)(2008-10#1)(2008-5#1)(2010-11#1)(2011-12#1)(2013-8#1)
resulting in devastating##2##3##(2008-10#2)
resulting in deviations from##3##4##(2005-11#1)(2013-1#2)
resulting in disruption of##2##4##(1995-2#1)(2010-12#1)
resulting in effective inhibition##2##4##(1991-12#1)(2011-1#1)
resulting in effective##3##3##(1991-12#1)(2008-10#1)(2011-1#1)
resulting in efficient energy##2##4##(2007-12#2)
resulting in efficient##3##3##(2007-12#2)(2012-2#1)
resulting in either##3##3##(1990-7#1)(2009-5#1)(2010-3#1)
resulting in endothelial##2##3##(2008-1#1)(2008-12#1)
resulting in enhanced##3##3##(1992-6#1)(1992-7#1)(2012-3#1)
resulting in erratic dosing##2##4##(1996-3#2)
resulting in excessive##3##3##(2005-10#1)(2005-11#1)(2010-2#1)
resulting in formation of##2##4##(1995-1#1)(2008-9#1)
resulting in good##3##3##(2006-10#1)(2007-7#1)(2012-3#1)
resulting in greater##5##3##(1991-1#1)(1991-4#1)(1993-12#1)(2009-8#1)(2010-5#1)
resulting in high morbidity and mortality##2##6##(2007-12#1)(2011-12#1)
resulting in high sensitivity##2##4##(2009-5#1)(2012-2#1)
resulting in high##9##3##(1991-9#1)(2005-11#1)(2007-12#1)(2008-11#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-12#1)(2012-2#1)
resulting in higher##9##3##(1992-11#1)(1992-8#1)(1993-12#1)(2008-1#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-2#1)
resulting in immune##2##3##(2007-11#1)(2011-2#1)
resulting in impaired##2##3##(1990-10#1)(2008-11#1)
resulting in improved##9##3##(2005-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2010-8#1)(2011-2#1)(2012-12#1)
resulting in increased##15##3##(1991-11#1)(1993-12#1)(1994-9#1)(1996-8#1)(2004-4#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-11#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-3#1)
resulting in inhibition of##2##4##(2008-5#1)(2012-2#1)
resulting in innovative deviations while minimizing errors made##2##8##(2013-1#2)
resulting in its##5##3##(1994-5#1)(1995-10#1)(2006-12#1)(2007-11#1)(2013-8#1)
resulting in large##2##3##(2007-12#1)(2008-3#1)
resulting in less##3##3##(1994-11#1)(2008-10#1)(2009-2#1)
resulting in long##3##3##(1996-12#1)(2007-9#1)(2008-11#1)
resulting in long-term##3##3##(2008-11#1)(2008-6#1)(2012-2#1)
resulting in low##2##3##(2008-8#1)(2011-1#1)
resulting in lower##6##3##(1992-12#1)(2008-3#1)(2008-8#1)(2009-10#1)(2012-2#1)(2013-1#1)
resulting in marked##5##3##(2005-11#1)(2008-11#1)(2009-6#1)(2010-4#1)(2011-1#1)
resulting in mechanical##2##3##(1997-3#1)(2007-11#1)
resulting in modulation of the##2##5##(2008-3#1)(2009-10#1)
resulting in more accurate##2##4##(2008-5#1)(2008-6#1)
resulting in more##4##3##(2008-10#1)(2008-5#1)(2008-6#1)(2010-2#1)
resulting in no##2##3##(2008-10#1)(2013-1#1)
resulting in permanent##2##3##(2007-7#1)(2013-1#1)
resulting in poor##3##3##(1991-11#1)(2010-3#1)(2010-4#1)
resulting in preparations##2##3##(1992-9#1)(2008-4#1)
resulting in reduced##3##3##(1994-11#1)(2006-5#1)(2008-10#1)
resulting in severe##8##3##(1990-2#1)(1990-8#1)(1996-10#1)(2006-8#1)(2008-4#1)(2008-5#1)(2009-3#1)(2010-7#1)
resulting in shorter##2##3##(2007-6#1)(2010-8#1)
resulting in significant##7##3##(2007-12#1)(2007-8#1)(2008-10#1)(2010-3#1)(2010-9#1)(2011-2#1)(2013-1#1)
resulting in significantly##3##3##(2004-1#1)(2008-10#1)(2013-8#1)
resulting in strong##2##3##(2007-11#1)(2008-10#1)
resulting in substitution of##2##4##(1994-12#1)(2008-10#1)
resulting in sustained##2##3##(1995-3#1)(2012-12#1)
resulting in the ability##2##4##(2008-10#1)(2011-1#1)
resulting in the accumulation of##5##5##(1991-7#1)(1992-6#1)(1997-7#1)(2006-10#1)(2008-10#1)
resulting in the activation of##2##5##(2007-5#1)(2008-10#1)
resulting in the amplification of##2##5##(1997-2#1)(2010-4#1)
resulting in the appearance of two##2##6##(1991-7#1)(1993-8#1)
resulting in the appearance of##4##5##(1991-7#1)(1993-8#1)(1994-3#1)(2005-8#1)
resulting in the death of##3##5##(1991-8#1)(2007-3#1)(2007-6#1)
resulting in the development of##2##5##(2005-11#1)(2006-7#1)
resulting in the fluorescence##2##4##(1991-9#1)(2008-10#1)
resulting in the formation of the##3##6##(2008-10#1)(2008-3#1)(2008-4#1)
resulting in the formation of##11##5##(1993-9#1)(1997-4#1)(2005-10#1)(2006-5#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-6#1)(2009-8#1)
resulting in the generation of##5##5##(1991-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)
resulting in the generation##6##4##(1991-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-12#1)
resulting in the inhibition of##2##5##(1990-2#1)(2006-10#1)
resulting in the loss of##2##5##(1993-6#1)(2011-2#1)
resulting in the lowest##2##4##(1995-7#1)(2008-10#1)
resulting in the production of a##2##6##(2007-11#1)(2011-3#1)
resulting in the production of##9##5##(1990-3#1)(1993-12#1)(2007-11#1)(2007-8#1)(2008-6#1)(2009-10#2)(2011-3#1)(2012-11#1)
resulting in the specific##2##4##(1995-1#1)(2008-7#1)
resulting in the substitution of##2##5##(1993-3#1)(2006-8#1)
resulting in the synthesis of##2##5##(1994-3#1)(1994-5#1)
resulting in the##125##3##(1990-2#1)(1990-3#2)(1991-7#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#2)(1995-1#1)(1995-10#1)(1995-7#1)(1996-12#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#3)(2006-11#2)(2006-4#2)(2006-5#2)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#4)(2007-3#1)(2007-5#1)(2007-6#2)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#2)
resulting in their##2##3##(2012-2#1)(2013-1#1)
resulting in total##2##3##(1997-6#1)(2010-3#1)
resulting in trismus##2##3##(2013-1#2)
resulting in two##8##3##(1991-5#1)(1996-10#1)(1996-2#1)(2005-7#1)(2008-10#4)
resulting in up to##5##4##(2007-12#1)(2007-8#1)(2008-3#1)(2008-8#1)(2009-10#1)
resulting in weight##2##3##(1996-12#1)(2008-3#1)
resulting in yield##2##3##(2008-10#1)(2011-10#1)
resulting in##975##2##(1990-10#2)(1990-2#3)(1990-3#3)(1990-4#2)(1990-5#6)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#2)(1991-11#3)(1991-12#3)(1991-2#4)(1991-3#1)(1991-4#2)(1991-5#3)(1991-7#3)(1991-8#1)(1991-9#6)(1992-1#1)(1992-10#1)(1992-11#4)(1992-12#5)(1992-2#2)(1992-3#3)(1992-5#2)(1992-6#3)(1992-7#3)(1992-8#4)(1992-9#7)(1993-11#1)(1993-12#10)(1993-3#5)(1993-5#1)(1993-6#8)(1993-8#4)(1993-9#2)(1994-10#2)(1994-11#7)(1994-12#3)(1994-2#1)(1994-3#6)(1994-5#5)(1994-9#3)(1995-1#4)(1995-10#4)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#3)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#5)(1995-9#1)(1996-1#1)(1996-10#5)(1996-11#1)(1996-12#6)(1996-2#4)(1996-3#3)(1996-5#3)(1996-6#2)(1996-8#4)(1997-1#3)(1997-2#1)(1997-3#4)(1997-4#8)(1997-5#1)(1997-6#2)(1997-7#6)(1997-8#4)(2004-1#1)(2004-11#1)(2004-12#1)(2004-4#1)(2004-9#3)(2005-1#1)(2005-10#5)(2005-11#14)(2005-3#1)(2005-5#1)(2005-7#2)(2005-8#4)(2006-1#4)(2006-10#12)(2006-11#6)(2006-12#10)(2006-2#1)(2006-4#4)(2006-5#5)(2006-6#3)(2006-7#1)(2006-8#6)(2006-9#2)(2007-10#8)(2007-11#22)(2007-12#30)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#4)(2007-6#6)(2007-7#6)(2007-8#12)(2007-9#1)(2008-1#13)(2008-10#101)(2008-11#33)(2008-12#5)(2008-2#9)(2008-3#34)(2008-4#14)(2008-5#22)(2008-6#9)(2008-7#18)(2008-8#22)(2008-9#10)(2009-1#1)(2009-10#7)(2009-11#3)(2009-12#2)(2009-2#3)(2009-3#7)(2009-4#5)(2009-5#7)(2009-6#6)(2009-7#3)(2009-8#8)(2009-9#2)(2010-10#4)(2010-11#7)(2010-12#9)(2010-2#8)(2010-3#7)(2010-4#6)(2010-5#5)(2010-7#4)(2010-8#5)(2010-9#5)(2011-1#14)(2011-10#1)(2011-12#8)(2011-2#20)(2011-3#1)(2011-7#1)(2012-1#5)(2012-11#2)(2012-12#16)(2012-2#25)(2012-3#15)(2012-7#1)(2013-1#32)(2013-7#5)(2013-8#11)
resulting increase in##7##3##(1991-5#1)(1992-8#1)(1993-3#1)(1997-1#1)(2008-1#1)(2009-9#1)(2013-8#1)
resulting layers##2##2##(1996-2#1)(2010-4#1)
resulting library##3##2##(1994-3#1)(1997-3#1)(2007-12#1)
resulting mainly from##2##3##(2007-11#1)(2007-7#1)
resulting material is##2##3##(2007-8#1)(2008-11#1)
resulting material##4##2##(2007-8#2)(2008-10#1)(2008-11#1)
resulting method##3##2##(1996-2#1)(2008-10#2)
resulting model##6##2##(1991-1#1)(1995-5#1)(2007-12#1)(2008-2#1)(2008-7#1)(2010-12#1)
resulting modified##3##2##(2008-10#3)
resulting mutant##5##2##(1990-2#1)(1990-7#1)(1991-9#1)(1994-5#1)(2013-8#1)
resulting number of##4##3##(2008-2#1)(2012-12#2)(2012-2#1)
resulting optical##4##2##(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#1)
resulting peptides are##2##3##(1993-8#1)(2008-9#1)
resulting peptides##4##2##(1993-8#1)(1995-1#1)(2008-4#1)(2008-9#1)
resulting phenotype##3##2##(1996-2#1)(2008-2#1)(2009-5#1)
resulting phenotypes##4##2##(1996-8#2)(2008-10#1)(2008-4#1)
resulting plasmid##2##2##(2008-8#2)
resulting polymer##2##2##(2007-8#1)(2008-10#1)
resulting product##3##2##(1993-12#1)(2008-10#1)(2013-7#1)
resulting protein##3##2##(1990-12#1)(1991-11#1)(1992-8#1)
resulting public health##2##3##(2007-12#1)(2008-10#1)
resulting recombinant##3##2##(1992-9#1)(2008-6#1)(2008-8#1)
resulting recombinants##2##2##(1991-6#1)(1992-6#1)
resulting resin##3##2##(2008-10#3)
resulting sensor exhibited##2##3##(2008-10#1)(2013-1#1)
resulting sensor##3##2##(2008-10#2)(2013-1#1)
resulting sequences##4##2##(2008-5#1)(2011-12#1)(2011-2#1)(2013-8#1)
resulting set of##4##3##(1995-2#1)(2005-11#1)(2006-10#1)(2008-2#1)
resulting signal##3##2##(2008-2#3)
resulting social##2##2##(1991-4#1)(2007-2#1)
resulting solution##7##2##(2008-10#7)
resulting spatial##2##2##(2007-11#1)(2008-2#1)
resulting stable##2##2##(2008-2#1)(2010-7#1)
resulting uncertainty##2##2##(1992-6#1)(2013-1#1)
resulting##2230##1##(1990-10#2)(1990-11#2)(1990-12#5)(1990-2#5)(1990-3#9)(1990-4#6)(1990-5#9)(1990-6#3)(1990-7#5)(1990-8#4)(1990-9#2)(1991-1#4)(1991-10#3)(1991-11#4)(1991-12#4)(1991-2#9)(1991-3#6)(1991-4#7)(1991-5#5)(1991-6#7)(1991-7#8)(1991-8#4)(1991-9#11)(1992-1#3)(1992-10#1)(1992-11#5)(1992-12#8)(1992-2#4)(1992-3#7)(1992-4#2)(1992-5#2)(1992-6#15)(1992-7#5)(1992-8#9)(1992-9#10)(1993-1#2)(1993-10#1)(1993-11#7)(1993-12#17)(1993-2#6)(1993-3#9)(1993-5#2)(1993-6#13)(1993-8#12)(1993-9#3)(1994-10#2)(1994-11#16)(1994-12#9)(1994-2#5)(1994-3#14)(1994-5#11)(1994-6#5)(1994-8#6)(1994-9#7)(1995-1#12)(1995-10#5)(1995-11#2)(1995-12#8)(1995-2#12)(1995-3#9)(1995-4#1)(1995-5#8)(1995-6#9)(1995-7#2)(1995-8#10)(1995-9#1)(1996-1#5)(1996-10#6)(1996-11#3)(1996-12#9)(1996-2#12)(1996-3#7)(1996-4#2)(1996-5#9)(1996-6#5)(1996-7#3)(1996-8#9)(1996-9#2)(1997-1#4)(1997-2#4)(1997-3#9)(1997-4#14)(1997-5#2)(1997-6#4)(1997-7#11)(1997-8#8)(2004-1#1)(2004-10#1)(2004-11#1)(2004-12#1)(2004-4#1)(2004-9#7)(2005-1#1)(2005-10#9)(2005-11#27)(2005-12#1)(2005-3#1)(2005-4#1)(2005-5#2)(2005-7#3)(2005-8#5)(2005-9#2)(2006-1#5)(2006-10#26)(2006-11#13)(2006-12#20)(2006-2#2)(2006-3#2)(2006-4#10)(2006-5#9)(2006-6#6)(2006-7#5)(2006-8#12)(2006-9#5)(2007-1#5)(2007-10#14)(2007-11#52)(2007-12#67)(2007-2#7)(2007-3#3)(2007-4#5)(2007-5#5)(2007-6#6)(2007-7#16)(2007-8#30)(2007-9#9)(2008-1#29)(2008-10#252)(2008-11#64)(2008-12#11)(2008-2#76)(2008-3#91)(2008-4#49)(2008-5#47)(2008-6#17)(2008-7#48)(2008-8#46)(2008-9#28)(2009-1#2)(2009-10#13)(2009-11#6)(2009-12#6)(2009-2#8)(2009-3#15)(2009-4#9)(2009-5#9)(2009-6#7)(2009-7#3)(2009-8#9)(2009-9#11)(2010-1#2)(2010-10#6)(2010-11#12)(2010-12#24)(2010-2#16)(2010-3#11)(2010-4#18)(2010-5#18)(2010-6#4)(2010-7#11)(2010-8#13)(2010-9#7)(2011-1#23)(2011-10#1)(2011-12#12)(2011-2#38)(2011-3#2)(2011-7#1)(2012-1#13)(2012-11#10)(2012-12#27)(2012-2#42)(2012-3#31)(2012-7#1)(2013-1#53)(2013-7#7)(2013-8#24)
results (&gt##2##2##(2008-10#1)(2012-2#1)
results (3##2##2##(1991-4#1)(2008-1#1)
results (R##4##2##(2008-10#4)
results (mean##2##2##(1996-9#1)(2007-11#1)
results a##4##2##(2007-11#1)(2008-10#1)(2008-3#2)
results about the##2##3##(2007-8#1)(2008-11#1)
results about##5##2##(1994-3#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)
results above##5##2##(2004-9#1)(2005-4#1)(2006-6#1)(2008-8#2)
results according to the##2##4##(1990-6#1)(2008-8#1)
results according to##3##3##(1990-6#1)(1996-9#1)(2008-8#1)
results achieved by##2##3##(2007-11#1)(2008-1#1)
results achieved in the##2##4##(1990-10#1)(1990-6#1)
results achieved in##5##3##(1990-10#1)(1990-6#1)(1991-2#1)(1992-6#1)(2005-12#1)
results achieved using##2##3##(2006-10#1)(2007-7#1)
results achieved with##4##3##(1991-9#1)(2007-7#1)(2008-1#1)(2009-10#1)
results achieved##21##2##(1990-10#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-6#1)(1993-8#1)(1995-2#1)(1997-6#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-7#2)(2008-1#2)(2008-10#2)(2008-3#1)(2009-10#1)(2010-2#1)
results acquired##2##2##(2008-10#1)(2008-2#1)
results across##8##2##(1991-9#1)(2008-11#1)(2008-7#2)(2011-1#1)(2012-3#1)(2013-1#2)
results add to the growing##2##5##(1993-6#1)(2009-10#1)
results add to the##6##4##(1993-6#1)(1994-11#1)(2008-4#1)(2009-10#1)(2010-10#1)(2010-9#1)
results add to##9##3##(1993-6#1)(1994-11#1)(1995-5#1)(1997-7#1)(2006-7#1)(2008-4#1)(2009-10#1)(2010-10#1)(2010-9#1)
results add##12##2##(1993-6#1)(1994-10#1)(1994-11#1)(1995-5#1)(1997-7#1)(2006-7#2)(2008-4#1)(2009-10#1)(2010-10#1)(2010-9#1)(2013-1#1)
results affect##2##2##(2007-4#1)(2008-11#1)
results after liver##2##3##(1994-6#1)(2006-10#1)
results after surgical repair##2##4##(2006-3#2)
results after surgical##3##3##(2006-3#2)(2013-1#1)
results after##29##2##(1990-11#2)(1994-6#1)(1995-11#1)(2006-10#1)(2006-3#2)(2006-6#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-11#1)(2011-2#2)(2011-3#1)(2013-1#3)
results against a reference procedure##2##5##(2008-10#2)
results against##8##2##(1992-12#1)(2008-10#2)(2008-3#1)(2013-1#4)
results agree to within##2##4##(2008-3#2)
results agree well with the theoretical##2##6##(2008-2#1)(2008-5#1)
results agree well with the##3##5##(2008-2#2)(2008-5#1)
results agree well with##7##4##(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2009-2#1)
results agree well##8##3##(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2009-2#1)
results agree with the##4##4##(1993-7#1)(2008-10#2)(2008-3#1)
results agree with##11##3##(1991-7#1)(1993-7#1)(1994-9#1)(2007-12#2)(2008-10#4)(2008-3#2)
results agree##23##2##(1991-7#1)(1993-7#1)(1994-9#1)(2007-12#3)(2008-10#8)(2008-2#2)(2008-3#5)(2008-5#1)(2009-2#1)
results agreed well with the##2##5##(2008-10#2)
results agreed with##6##3##(2008-10#5)(2011-2#1)
results agreed##9##2##(1992-8#1)(2008-10#7)(2011-2#1)
results allow the##3##3##(1993-4#1)(2007-11#1)(2013-8#1)
results allow to##3##3##(1990-11#1)(2007-11#1)(2008-10#1)
results allow us to##3##4##(1994-6#1)(2008-3#1)(2010-12#1)
results allow##13##2##(1990-11#1)(1993-4#1)(1994-6#1)(1995-10#1)(1996-4#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)(2010-4#1)(2013-8#1)
results allowed the##3##3##(2008-6#1)(2011-2#1)(2013-7#1)
results allowed us to##2##4##(2006-8#1)(2008-8#1)
results allowed##10##2##(2005-11#1)(2006-8#1)(2007-3#1)(2008-10#2)(2008-6#2)(2008-8#1)(2011-2#1)(2013-7#1)
results already obtained##2##3##(2007-6#1)(2008-3#1)
results already##4##2##(2007-11#1)(2007-6#1)(2008-3#1)(2013-1#1)
results also allow##2##3##(1992-11#1)(2010-4#1)
results also clarify##2##3##(1994-9#1)(2008-2#1)
results also demonstrate that the##2##5##(2006-12#1)(2013-1#1)
results also demonstrate the##2##4##(1992-4#1)(1993-5#1)
results also demonstrate##6##3##(1992-4#1)(1993-5#1)(1995-2#1)(1997-7#1)(2006-12#1)(2013-1#1)
results also have##2##3##(2008-8#1)(2011-2#1)
results also highlight##2##3##(2008-4#1)(2009-9#1)
results also imply that##2##4##(2008-8#1)(2010-2#1)
results also in##2##3##(1990-2#1)(2008-10#1)
results also indicate a##2##4##(1996-2#1)(2013-1#1)
results also indicate that the##8##5##(1990-11#1)(1990-2#1)(1990-8#1)(1995-3#1)(1995-6#1)(1996-6#1)(2006-1#1)(2007-11#1)
results also indicate that##22##4##(1990-11#1)(1990-2#1)(1990-8#1)(1992-6#1)(1992-7#1)(1992-8#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-6#1)(2005-4#1)(2005-8#1)(2006-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-3#1)(2013-1#1)
results also indicate##28##3##(1990-11#1)(1990-2#1)(1990-8#1)(1992-6#1)(1992-7#1)(1992-8#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-6#1)(2005-4#1)(2005-8#1)(2006-1#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-3#1)(2011-2#1)(2013-1#3)
results also indicated that##3##4##(2007-8#1)(2008-8#1)(2008-9#1)
results also indicated##4##3##(2007-10#1)(2007-8#1)(2008-8#1)(2008-9#1)
results also provide##6##3##(1992-3#1)(1996-11#1)(2006-10#1)(2008-8#2)(2009-8#1)
results also show that the##2##5##(1990-12#1)(1992-8#1)
results also show that##13##4##(1990-12#1)(1991-12#1)(1992-8#1)(2004-4#1)(2006-10#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#2)
results also show##17##3##(1990-12#1)(1991-12#1)(1992-8#1)(2004-4#1)(2006-10#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#2)(2010-6#1)(2011-2#1)
results also showed that the##5##5##(2008-10#1)(2008-2#1)(2008-7#1)(2009-4#1)(2010-6#1)
results also showed that##9##4##(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-6#1)(2012-1#1)
results also showed##10##3##(2005-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-6#1)(2012-1#1)
results also suggest that a##3##5##(1995-12#1)(2008-10#1)(2009-10#1)
results also suggest that the##9##5##(1992-6#1)(1992-9#1)(1993-8#1)(1996-1#1)(2005-4#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-8#1)
results also suggest that##32##4##(1991-3#1)(1992-6#1)(1992-9#1)(1993-3#4)(1993-8#1)(1993-9#1)(1995-10#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-2#1)(2005-4#1)(2006-10#1)(2006-4#1)(2007-7#1)(2008-10#7)(2008-6#1)(2008-8#2)(2009-10#1)(2011-12#1)(2012-3#1)(2013-7#1)
results also suggest the##2##4##(2008-7#1)(2010-8#1)
results also suggest##35##3##(1991-3#1)(1992-6#1)(1992-9#1)(1993-3#4)(1993-8#1)(1993-9#1)(1995-10#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-2#1)(2005-4#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-7#1)(2008-10#7)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-8#1)(2011-12#1)(2012-3#1)(2013-7#1)
results also suggested that##2##4##(2008-10#1)(2008-12#1)
results also support the##2##4##(2012-1#1)(2013-8#1)
results also support##4##3##(1992-3#1)(2010-8#1)(2012-1#1)(2013-8#1)
results also##145##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-3#1)(1992-11#1)(1992-3#3)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-3#4)(1993-5#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-7#1)(2004-4#1)(2005-11#1)(2005-4#3)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-12#2)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#8)(2008-9#5)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
results among the##2##3##(2007-3#1)(2009-10#1)
results among##6##2##(2007-3#2)(2008-10#1)(2008-8#1)(2009-10#1)(2013-1#1)
results analyzed##4##2##(1995-9#1)(2008-5#1)(2013-1#1)(2013-8#1)
results and a##9##3##(2006-8#1)(2007-12#1)(2008-10#1)(2008-3#4)(2009-5#1)(2012-1#1)
results and also##4##3##(1992-9#1)(2008-10#1)(2008-3#1)(2012-2#1)
results and can be##2##4##(2007-8#1)(2012-3#1)
results and can##3##3##(2006-3#1)(2007-8#1)(2012-3#1)
results and complications of##2##4##(2006-6#1)(2007-7#1)
results and complications##5##3##(1994-4#1)(2006-10#1)(2006-6#1)(2007-7#1)(2011-2#1)
results and conclusions##2##3##(2007-8#1)(2009-10#1)
results and demonstrate##3##3##(2008-2#1)(2008-7#1)(2010-5#1)
results and discuss the##2##4##(2007-12#1)(2009-3#1)
results and discuss##4##3##(2007-11#1)(2007-12#1)(2008-9#1)(2009-3#1)
results and discusses how##2##4##(1994-3#1)(2007-8#1)
results and discusses##3##3##(1993-12#1)(1994-3#1)(2007-8#1)
results and empirical##2##3##(1992-9#1)(1995-4#1)
results and further##3##3##(2008-2#2)(2009-8#1)
results and future directions##2##4##(2007-12#1)(2007-7#1)
results and future##5##3##(1992-4#1)(2007-12#2)(2007-7#1)(2013-1#1)
results and greater##2##3##(2010-6#1)(2012-2#1)
results and have##3##3##(1992-8#1)(2008-11#1)(2012-2#1)
results and implications##2##3##(1992-11#1)(2010-4#1)
results and in##2##3##(1992-2#1)(1997-4#1)
results and is##7##3##(1990-7#1)(1996-5#1)(2008-10#2)(2008-3#1)(2009-3#1)(2010-9#1)
results and may##2##3##(2008-12#1)(2011-2#1)
results and more##2##3##(1996-1#1)(2013-1#1)
results and numerical simulations##2##4##(1995-11#1)(2010-12#1)
results and numerical##4##3##(1995-11#1)(2007-12#2)(2010-12#1)
results and our##3##3##(2005-11#1)(2008-3#1)(2008-6#1)
results and outcome##2##3##(2007-2#1)(2008-1#1)
results and patient##3##3##(2007-12#1)(2007-8#1)(2008-7#1)
results and previous##2##3##(2011-1#1)(2013-1#1)
results and provide##4##3##(1993-11#1)(2006-10#1)(2007-4#1)(2012-1#1)
results and publication##2##3##(1993-12#2)
results and study weaknesses of these papers are tabulated##4##9##(2007-8#4)
results and study weaknesses were tabulated##6##6##(2007-8#6)
results and study weaknesses##10##4##(2007-8#10)
results and study##11##3##(2007-8#11)
results and the TSS concentration##2##5##(2013-8#2)
results and the ability to##2##5##(1997-5#1)(2007-7#1)
results and the available data##2##5##(1994-11#1)(2008-8#1)
results and the fact that##2##5##(1994-12#1)(2008-2#1)
results and the##37##3##(1990-10#1)(1990-2#1)(1990-9#1)(1991-6#1)(1991-8#1)(1992-6#1)(1994-11#1)(1994-12#1)(1997-5#1)(2005-11#1)(2006-10#1)(2007-11#3)(2007-5#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-2#5)(2008-8#3)(2009-9#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-8#2)
results and their##2##3##(2005-7#1)(2007-12#1)
results and theoretical predictions##2##4##(2007-12#1)(2010-2#1)
results and those of##2##4##(2008-10#1)(2008-5#1)
results and those##7##3##(1990-2#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-5#1)
results and to##4##3##(2006-10#1)(2010-12#1)(2010-8#1)(2013-7#1)
results and##300##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-3#2)(1991-5#3)(1991-6#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#2)(1992-9#2)(1993-11#3)(1993-12#4)(1993-3#2)(1993-8#3)(1994-11#1)(1994-12#1)(1994-3#4)(1994-4#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#3)(1995-4#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#1)(2005-11#3)(2005-7#2)(2006-10#5)(2006-11#1)(2006-12#2)(2006-3#2)(2006-4#2)(2006-6#1)(2006-7#1)(2006-8#3)(2007-11#7)(2007-12#13)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#3)(2007-7#5)(2007-8#19)(2007-9#1)(2008-1#1)(2008-10#26)(2008-11#3)(2008-12#4)(2008-2#19)(2008-3#14)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#1)(2009-10#2)(2009-3#2)(2009-4#1)(2009-5#5)(2009-7#1)(2009-8#2)(2009-9#2)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#8)(2011-3#1)(2012-1#4)(2012-12#1)(2012-2#6)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#6)
results and/or##2##2##(2005-11#1)(2008-7#1)
results appear to##3##3##(1991-12#1)(2008-11#1)(2008-2#1)
results appear##4##2##(1991-12#1)(2006-8#1)(2008-11#1)(2008-2#1)
results apply##2##2##(2007-12#1)(2008-2#1)
results are a##4##3##(1993-8#1)(2006-10#1)(2007-2#1)(2008-9#1)
results are achieved by##2##4##(2006-12#1)(2007-12#1)
results are achieved##5##3##(1994-11#1)(2005-5#1)(2006-12#1)(2006-5#1)(2007-12#1)
results are also presented##3##4##(1992-2#1)(2008-3#2)
results are also##14##3##(1992-2#1)(1993-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-1#1)
results are analyzed##4##3##(1990-3#1)(1990-8#1)(2008-3#1)(2012-3#1)
results are applicable to##4##4##(2008-2#1)(2008-3#2)(2008-8#1)
results are applied##2##3##(2008-1#1)(2008-2#1)
results are as follows##3##4##(1992-10#1)(1994-5#1)(2007-7#1)
results are as##4##3##(1992-10#1)(1994-5#1)(2007-7#1)(2008-2#1)
results are available from##2##4##(2005-7#1)(2006-10#1)
results are available##6##3##(2005-7#1)(2006-10#1)(2008-2#2)(2009-5#1)(2009-6#1)
results are based on##3##4##(2008-12#1)(2008-3#1)(2011-1#1)
results are better than##2##4##(2007-8#1)(2008-7#1)
results are better##4##3##(1992-12#1)(2007-8#1)(2008-2#1)(2008-7#1)
results are comparable to those##3##5##(2007-7#1)(2007-8#1)(2008-10#1)
results are comparable to##4##4##(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#1)
results are comparable with those achieved##2##6##(1991-2#1)(1991-3#1)
results are comparable with those##3##5##(1991-2#1)(1991-3#1)(2012-1#1)
results are comparable##9##3##(1991-2#1)(1991-3#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2009-10#1)(2011-1#1)(2012-1#1)
results are compared and##2##4##(2005-11#1)(2008-10#1)
results are compared to those obtained##2##6##(2006-9#1)(2008-10#1)
results are compared to those##3##5##(2006-9#1)(2008-10#2)
results are compared to##14##4##(1991-8#1)(1992-5#1)(1993-5#1)(1996-11#1)(2006-9#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-8#2)(2010-8#1)
results are compared with a##4##5##(2007-12#1)(2008-3#3)
results are compared with experimental data##2##6##(2008-2#2)
results are compared with experimental##4##5##(2008-2#2)(2008-3#1)(2009-4#1)
results are compared with predictions of##3##6##(2008-2#1)(2008-3#2)
results are compared with results from##2##6##(1991-2#1)(2008-2#1)
results are compared with the corresponding##2##6##(2008-10#1)(2008-2#1)
results are compared with the data obtained##2##7##(2008-10#1)(2008-2#1)
results are compared with the data##4##6##(2005-11#1)(2008-10#1)(2008-2#2)
results are compared with the results##3##6##(2008-10#1)(2008-2#2)
results are compared with the##18##5##(2005-11#2)(2007-11#1)(2007-12#2)(2008-10#5)(2008-2#6)(2008-3#2)
results are compared with theoretical predictions##2##6##(2008-2#1)(2008-3#1)
results are compared with theoretical##3##5##(2008-2#2)(2008-3#1)
results are compared with those obtained by##2##7##(2008-3#2)
results are compared with those obtained in##2##7##(1997-8#1)(2008-3#1)
results are compared with those obtained with##3##7##(2007-11#1)(2008-10#1)(2008-3#1)
results are compared with those obtained##11##6##(1997-8#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#5)
results are compared with those##19##5##(1996-7#1)(1997-8#1)(2007-11#2)(2008-1#1)(2008-10#5)(2008-2#3)(2008-3#6)
results are compared with##68##4##(1991-2#1)(1992-2#1)(1996-7#1)(1997-8#1)(2005-11#2)(2006-1#1)(2006-6#1)(2007-11#5)(2007-12#5)(2008-1#1)(2008-10#10)(2008-2#17)(2008-3#17)(2008-5#1)(2009-11#1)(2009-4#2)(2012-1#1)
results are compared##87##3##(1991-2#1)(1991-8#1)(1992-2#1)(1992-5#1)(1993-5#1)(1996-11#1)(1996-7#1)(1997-8#1)(2005-11#3)(2006-1#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#5)(2007-12#5)(2008-1#1)(2008-10#16)(2008-2#19)(2008-3#18)(2008-5#1)(2008-8#2)(2009-11#1)(2009-4#2)(2010-8#1)(2012-1#1)
results are compatible with a##2##5##(1995-6#1)(2006-2#1)
results are compatible with the##2##5##(1991-2#1)(1996-7#1)
results are compatible with##5##4##(1991-2#1)(1995-6#1)(1996-12#1)(1996-7#1)(2006-2#1)
results are confirmed with##2##4##(1993-11#1)(2008-3#1)
results are consistent with a hypothesis that##2##7##(2008-11#1)(2009-5#1)
results are consistent with a model in which##4##8##(1990-2#1)(1991-4#1)(1992-12#1)(2008-10#1)
results are consistent with a model##6##6##(1990-2#1)(1991-4#1)(1992-12#1)(1992-6#1)(2007-1#1)(2008-10#1)
results are consistent with a##26##5##(1990-2#2)(1991-4#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-5#1)(1992-6#1)(1994-11#1)(1994-5#3)(1995-2#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-6#1)(2005-11#1)(2007-1#1)(2008-10#3)(2008-11#1)(2009-12#1)(2009-5#1)
results are consistent with our##2##5##(1991-12#1)(1996-2#1)
results are consistent with previous observations that##2##7##(2008-10#1)(2010-8#1)
results are consistent with previous work##2##6##(1992-9#1)(2011-1#1)
results are consistent with previous##7##5##(1992-9#1)(2008-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
results are consistent with the hypothesis that the##5##8##(1993-4#1)(1994-2#1)(1997-3#1)(2007-12#1)(2012-1#1)
results are consistent with the hypothesis that##18##7##(1990-2#1)(1991-9#1)(1992-12#1)(1993-12#2)(1993-4#1)(1993-8#1)(1994-2#1)(1995-2#2)(1996-1#1)(1996-7#1)(1997-3#1)(2007-12#1)(2008-10#1)(2009-1#1)(2009-4#1)(2012-1#1)
results are consistent with the idea that##3##7##(1990-11#1)(1995-11#1)(1995-3#1)
results are consistent with the interpretation that the##2##8##(1995-2#1)(2008-4#1)
results are consistent with the notion that##4##7##(1990-7#1)(1990-8#1)(1995-3#1)(2012-1#1)
results are consistent with the view that##3##7##(1992-1#1)(1994-2#1)(2008-1#1)
results are consistent with the##59##5##(1990-11#2)(1990-2#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#2)(1993-4#1)(1993-8#2)(1994-2#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#4)(1995-3#2)(1996-1#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(2006-3#1)(2007-1#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-4#1)(2009-9#1)(2010-2#1)(2012-1#2)(2012-2#1)
results are consistent with##125##4##(1990-11#2)(1990-2#4)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#3)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#2)(1993-12#2)(1993-4#1)(1993-8#2)(1994-11#1)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#6)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-9#1)(2005-11#2)(2006-3#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#1)(2013-8#1)
results are consistent##126##3##(1990-11#2)(1990-2#4)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#3)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#2)(1993-12#2)(1993-4#1)(1993-8#2)(1994-11#1)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#6)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-9#1)(2005-11#2)(2006-3#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#1)(2013-8#1)
results are contradictory##2##3##(1997-1#1)(2008-5#1)
results are contrasted with##2##4##(1996-8#1)(2009-7#1)
results are demonstrated##5##3##(1996-12#1)(2007-11#1)(2008-2#1)(2008-3#2)
results are described##11##3##(1994-6#1)(1995-5#1)(1996-9#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)
results are difficult to##2##4##(1993-2#1)(1996-8#1)
results are discussed and compared with##2##6##(1993-11#1)(2011-2#1)
results are discussed and compared##3##5##(1993-11#1)(2010-3#1)(2011-2#1)
results are discussed and##4##4##(1993-11#1)(1994-3#1)(2010-3#1)(2011-2#1)
results are discussed in light of the##4##7##(1991-4#1)(1997-8#1)(2006-10#1)(2007-12#1)
results are discussed in light of##8##6##(1991-4#2)(1997-8#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-8#1)
results are discussed in relation to the##12##7##(1990-12#1)(1990-2#1)(1991-12#1)(1991-5#1)(1992-12#1)(1993-2#1)(1993-6#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
results are discussed in relation to##20##6##(1990-12#1)(1990-2#1)(1990-3#1)(1991-12#1)(1991-5#1)(1992-12#1)(1993-2#1)(1993-6#2)(1993-8#1)(1993-9#1)(2005-11#2)(2006-1#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
results are discussed in terms of the##13##7##(1990-11#1)(1990-7#2)(1992-6#1)(1992-7#1)(1993-12#1)(1993-6#1)(1995-11#1)(1995-12#2)(1996-2#1)(2008-10#1)(2012-1#1)
results are discussed in terms of their##2##7##(1991-4#1)(1992-11#1)
results are discussed in terms of##37##6##(1990-10#1)(1990-11#1)(1990-2#1)(1990-7#2)(1991-2#1)(1991-3#1)(1991-4#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#3)(1993-4#1)(1993-6#2)(1993-9#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#2)(1996-2#1)(1997-4#1)(2006-10#1)(2008-10#2)(2008-4#1)(2008-5#2)(2009-4#1)(2010-12#1)(2012-1#1)
results are discussed in the context of##7##7##(1990-11#1)(1996-1#1)(1996-5#1)(1996-8#1)(2007-2#1)(2008-2#1)(2008-9#1)
results are discussed in the context##8##6##(1990-11#1)(1993-9#1)(1996-1#1)(1996-5#1)(1996-8#1)(2007-2#1)(2008-2#1)(2008-9#1)
results are discussed in the light of##3##7##(1992-9#1)(1994-9#1)(2008-10#1)
results are discussed in the##11##5##(1990-11#1)(1992-9#1)(1993-9#1)(1994-9#1)(1996-1#1)(1996-5#1)(1996-8#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-9#1)
results are discussed in this##2##5##(2008-5#1)(2009-8#1)
results are discussed in##84##4##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-7#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#3)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-4#1)(1993-6#4)(1993-8#1)(1993-9#3)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#2)(1996-1#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-8#1)(2005-11#3)(2005-8#1)(2006-1#1)(2006-10#2)(2006-4#1)(2007-12#4)(2007-2#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-12#1)(2012-1#1)(2013-1#1)(2013-7#1)
results are discussed on the basis of##2##7##(1990-10#1)(2007-12#1)
results are discussed using##2##4##(1992-9#1)(1997-7#1)
results are discussed with reference to##3##6##(1990-5#1)(1991-9#1)(2011-1#1)
results are discussed with regard to##2##6##(1991-3#1)(1993-3#1)
results are discussed with##9##4##(1990-5#1)(1991-3#1)(1991-9#1)(1993-3#1)(1995-11#1)(1995-12#1)(1995-8#1)(2009-4#1)(2011-1#1)
results are discussed##130##3##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-4#3)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#4)(1993-8#1)(1993-9#3)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#4)(1995-11#2)(1995-12#3)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-2#1)(2005-11#3)(2005-8#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-4#1)(2006-7#1)(2007-12#5)(2007-2#1)(2008-10#7)(2008-11#2)(2008-2#3)(2008-4#1)(2008-5#6)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#3)(2009-5#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
results are due##2##3##(1990-12#1)(2008-10#1)
results are encouraging and##2##4##(2005-5#1)(2008-5#1)
results are encouraging##6##3##(1994-2#1)(2005-5#1)(2006-10#1)(2006-6#1)(2008-5#1)(2013-1#1)
results are evaluated in##2##4##(2006-6#1)(2008-10#1)
results are evaluated##5##3##(2006-6#1)(2008-1#1)(2008-10#1)(2010-8#2)
results are excellent##2##3##(2008-10#1)(2009-5#1)
results are expected to be##2##5##(2006-10#1)(2007-8#1)
results are expected##3##3##(2006-10#1)(2007-8#1)(2008-5#1)
results are found for##2##4##(2008-2#2)
results are found to be##3##5##(2007-12#2)(2008-3#1)
results are found when##2##4##(1995-1#1)(2005-11#1)
results are found##10##3##(1995-1#1)(2005-11#1)(2007-12#2)(2008-2#3)(2008-3#1)(2008-8#1)(2010-4#1)
results are given for a##2##5##(2008-2#2)
results are given for##3##4##(1994-5#1)(2008-2#2)
results are given in##2##4##(2008-3#2)
results are given to verify the##2##6##(2007-12#1)(2008-2#1)
results are given to##4##4##(2007-12#1)(2008-2#2)(2010-2#1)
results are given##20##3##(1994-5#1)(1995-3#1)(2005-4#1)(2007-12#1)(2008-2#9)(2008-3#5)(2010-2#1)(2013-7#1)
results are highly##2##3##(2008-10#1)(2008-2#1)
results are important for##3##4##(2007-12#1)(2008-10#1)(2008-12#1)
results are important##5##3##(2005-9#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
results are in accord with the##3##6##(1991-4#1)(1995-10#1)(2008-3#1)
results are in accord with##5##5##(1991-4#1)(1995-10#1)(2007-12#1)(2008-10#1)(2008-3#1)
results are in accordance with the##4##6##(1994-8#1)(1997-6#1)(2006-8#1)(2008-4#1)
results are in accordance with##6##5##(1994-8#1)(1997-6#1)(2006-8#1)(2008-4#1)(2009-2#1)(2011-1#1)
results are in agreement with##11##5##(1991-11#1)(1991-7#1)(1991-9#1)(1994-5#1)(1996-9#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
results are in excellent agreement with##4##6##(2007-12#3)(2008-3#1)
results are in excellent agreement##5##5##(2007-12#3)(2008-3#2)
results are in good agreement with the theoretical##2##8##(2008-3#2)
results are in good agreement with the##4##7##(1994-11#1)(2008-2#1)(2008-3#2)
results are in good agreement with those obtained by##2##9##(2008-10#2)
results are in good agreement with those obtained##3##8##(2008-10#2)(2008-3#1)
results are in good agreement with those##4##7##(2008-10#2)(2008-2#1)(2008-3#1)
results are in good agreement with##14##6##(1994-11#1)(2005-4#1)(2007-12#3)(2008-10#3)(2008-2#2)(2008-3#4)
results are in good agreement##16##5##(1994-11#1)(2005-4#1)(2007-12#5)(2008-10#3)(2008-2#2)(2008-3#4)
results are in good##17##4##(1994-11#1)(2005-4#1)(2007-12#5)(2008-10#3)(2008-2#3)(2008-3#4)
results are in reasonable agreement with##2##6##(2008-3#1)(2012-11#1)
results are in the##2##4##(2008-10#1)(2008-3#1)
results are in##63##3##(1991-11#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-9#1)(1994-11#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-10#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-6#1)(2005-11#1)(2005-4#1)(2006-10#2)(2006-8#1)(2007-12#12)(2008-1#1)(2008-10#8)(2008-2#4)(2008-3#11)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-4#1)(2011-1#1)(2012-11#1)
results are included##2##3##(2008-2#1)(2008-3#1)
results are interpreted in terms of a##2##7##(1994-11#1)(2009-10#1)
results are interpreted in terms of##5##6##(1994-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-10#1)
results are interpreted on the##2##5##(1992-6#1)(1997-1#1)
results are interpreted with##3##4##(2007-12#2)(2011-2#1)
results are interpreted##16##3##(1991-11#1)(1991-5#1)(1992-6#1)(1994-11#1)(1994-6#1)(1997-1#1)(2007-12#3)(2008-2#1)(2008-3#1)(2009-10#2)(2010-2#1)(2011-2#1)(2012-1#1)
results are largely##3##3##(1990-9#1)(2004-2#1)(2006-12#1)
results are more##4##3##(2008-10#1)(2008-2#1)(2009-7#1)(2009-8#1)
results are most##2##3##(2006-9#1)(2013-7#1)
results are needed##2##3##(1996-6#1)(2006-8#1)
results are not compatible with##2##5##(2008-4#1)(2008-5#1)
results are not##13##3##(1990-12#1)(1992-6#1)(1993-10#1)(2007-3#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-2#2)
results are observed##5##3##(1992-3#1)(1994-12#1)(1996-7#1)(2008-10#1)(2010-11#1)
results are obtained by##2##4##(1990-6#1)(2008-10#1)
results are obtained for##3##4##(2005-11#1)(2007-11#1)(2008-2#1)
results are obtained in##5##4##(1990-12#1)(1996-6#1)(2008-10#1)(2008-3#1)(2008-7#1)
results are obtained with a##2##5##(2008-2#2)
results are obtained with the##3##5##(2008-10#1)(2008-3#2)
results are obtained with##8##4##(1992-12#1)(1994-4#1)(2008-10#1)(2008-2#2)(2008-3#2)(2010-5#1)
results are obtained##26##3##(1990-12#1)(1990-6#1)(1992-12#1)(1994-4#1)(1996-6#1)(2005-11#1)(2007-11#1)(2007-4#1)(2008-10#7)(2008-2#4)(2008-3#3)(2008-7#1)(2010-5#1)(2010-9#1)(2012-2#1)
results are of considerable##2##4##(2007-11#1)(2008-2#1)
results are of##5##3##(1990-7#1)(1995-6#1)(2006-10#1)(2007-11#1)(2008-2#1)
results are only##2##3##(2012-1#1)(2012-2#1)
results are presented and compared with##3##6##(2007-11#1)(2008-2#1)(2008-3#1)
results are presented and discussed##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
results are presented and##6##4##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
results are presented as##3##4##(2008-2#1)(2013-1#2)
results are presented for a##3##5##(1994-6#1)(2007-11#1)(2008-3#1)
results are presented for both##2##5##(2008-2#2)
results are presented for the##3##5##(2008-10#1)(2008-3#2)
results are presented for##18##4##(1992-12#1)(1994-6#1)(2007-11#1)(2008-10#2)(2008-2#5)(2008-3#8)
results are presented here##2##4##(2008-2#1)(2010-7#1)
results are presented in this##2##5##(2008-2#1)(2009-5#1)
results are presented in##11##4##(1994-3#1)(1995-8#1)(2006-6#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-4#1)(2009-5#1)
results are presented on the##2##5##(2007-11#1)(2007-9#1)
results are presented on##3##4##(2007-11#2)(2007-9#1)
results are presented showing the##3##5##(2008-2#1)(2008-3#1)(2008-6#1)
results are presented that demonstrate the validity of the##3##9##(2008-3#3)
results are presented that demonstrate the##5##6##(2007-12#1)(2008-3#4)
results are presented that show##2##5##(2007-11#1)(2008-2#1)
results are presented that##8##4##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#4)
results are presented to demonstrate the##2##6##(2007-9#1)(2008-3#1)
results are presented to illustrate the##2##6##(2008-2#1)(2008-3#1)
results are presented to support##2##5##(2008-2#1)(2008-3#1)
results are presented to##10##4##(2007-12#1)(2007-9#1)(2008-2#3)(2008-3#4)(2008-7#1)
results are presented with##2##4##(2008-2#1)(2013-1#1)
results are presented##109##3##(1992-12#1)(1994-3#1)(1994-6#1)(1995-8#1)(2005-8#2)(2006-12#1)(2006-6#1)(2007-1#1)(2007-11#7)(2007-12#10)(2007-9#2)(2008-10#4)(2008-2#24)(2008-3#41)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#3)
results are promising and##2##4##(2004-9#1)(2008-9#1)
results are promising##6##3##(1995-11#1)(2004-9#1)(2005-7#1)(2006-6#1)(2006-7#1)(2008-9#1)
results are provided to##3##4##(2008-2#2)(2008-3#1)
results are provided##10##3##(2006-6#1)(2008-2#3)(2008-3#5)(2013-7#1)
results are qualitatively##2##3##(1995-8#1)(2008-2#1)
results are quantified##2##3##(2008-2#1)(2008-7#1)
results are reported for##2##4##(1994-11#1)(2006-4#1)
results are reported##14##3##(1994-11#1)(2006-12#2)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-3#1)(2008-5#2)(2009-10#1)(2010-8#1)
results are satisfactory##3##3##(1991-4#1)(2005-4#1)(2008-2#1)
results are sensitive to##2##4##(2006-12#1)(2013-1#1)
results are shown for##2##4##(1992-9#1)(2008-3#1)
results are shown to be##3##5##(2006-2#1)(2007-11#1)(2008-3#1)
results are shown to##4##4##(2006-2#1)(2007-11#1)(2008-2#1)(2008-3#1)
results are shown with##2##4##(2007-12#1)(2008-3#1)
results are shown##16##3##(1992-9#1)(1996-6#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#5)
results are similar to those of the##2##7##(1995-5#1)(2008-3#1)
results are similar to those##5##5##(1992-12#1)(1995-5#1)(2007-11#1)(2008-3#1)(2011-2#1)
results are similar to##7##4##(1992-12#1)(1994-12#1)(1995-5#1)(2006-8#1)(2007-11#1)(2008-3#1)(2011-2#1)
results are similar##8##3##(1992-12#1)(1994-12#1)(1995-5#1)(2006-8#1)(2007-11#1)(2008-2#1)(2008-3#1)(2011-2#1)
results are strongly##3##3##(1991-4#1)(1997-7#1)(2008-3#1)
results are summarized##4##3##(1995-11#1)(2007-1#1)(2007-8#1)(2008-10#1)
results are systematically##2##3##(2008-10#1)(2009-8#1)
results are taken to##2##4##(1993-12#1)(1994-8#1)
results are tested by##2##4##(2008-2#1)(2008-3#1)
results are the first demonstration of##2##6##(1991-5#1)(2007-12#1)
results are the first demonstration##4##5##(1991-5#1)(1997-2#1)(2007-12#1)(2012-1#1)
results are the first to demonstrate##2##6##(2008-3#1)(2010-11#1)
results are the first to##3##5##(1993-7#1)(2008-3#1)(2010-11#1)
results are the first##9##4##(1991-5#1)(1992-5#1)(1993-7#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-3#1)(2010-11#1)(2012-1#1)
results are the##12##3##(1990-6#1)(1991-5#1)(1992-5#1)(1992-9#1)(1993-7#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-3#1)(2010-11#1)(2011-2#1)(2012-1#1)
results are then##3##3##(2008-3#1)(2009-9#1)(2012-12#1)
results are thus##2##3##(1995-8#1)(2013-1#1)
results are used to##9##4##(1991-11#1)(1992-12#1)(1992-9#1)(2007-12#1)(2008-2#2)(2008-3#3)
results are used##10##3##(1991-11#1)(1992-12#1)(1992-9#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)
results are useful for##4##4##(1993-5#1)(2007-11#1)(2008-2#1)(2008-3#1)
results are useful##6##3##(1993-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
results are valid for##2##4##(1994-5#1)(2009-5#1)
results are verified by##3##4##(2007-12#2)(2010-12#1)
results are verified##4##3##(2007-11#1)(2007-12#2)(2010-12#1)
results are very##5##3##(1993-11#1)(1993-9#1)(2005-4#1)(2012-12#1)(2012-2#1)
results are##1004##2##(1990-10#2)(1990-11#4)(1990-12#5)(1990-2#7)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#4)(1990-8#2)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#4)(1991-12#6)(1991-2#6)(1991-3#3)(1991-4#7)(1991-5#4)(1991-6#2)(1991-7#2)(1991-8#3)(1991-9#3)(1992-1#2)(1992-10#2)(1992-11#1)(1992-12#9)(1992-2#4)(1992-3#6)(1992-5#3)(1992-6#6)(1992-7#1)(1992-8#1)(1992-9#8)(1993-10#2)(1993-11#3)(1993-12#8)(1993-2#2)(1993-3#1)(1993-4#2)(1993-5#2)(1993-6#4)(1993-7#1)(1993-8#4)(1993-9#4)(1994-11#5)(1994-12#3)(1994-2#4)(1994-3#4)(1994-4#1)(1994-5#7)(1994-6#4)(1994-7#1)(1994-8#4)(1994-9#6)(1995-1#3)(1995-10#2)(1995-11#5)(1995-12#4)(1995-2#6)(1995-3#3)(1995-5#3)(1995-6#5)(1995-7#1)(1995-8#4)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#2)(1996-5#3)(1996-6#3)(1996-7#5)(1996-8#4)(1996-9#3)(1997-1#5)(1997-2#2)(1997-3#4)(1997-4#3)(1997-6#4)(1997-7#3)(1997-8#2)(1997-9#1)(2004-2#2)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#12)(2005-4#4)(2005-5#3)(2005-7#2)(2005-8#4)(2005-9#2)(2006-1#2)(2006-10#17)(2006-12#11)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#4)(2006-6#6)(2006-7#3)(2006-8#5)(2006-9#2)(2007-1#5)(2007-10#1)(2007-11#26)(2007-12#54)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#5)(2007-9#2)(2008-1#5)(2008-10#79)(2008-11#6)(2008-12#4)(2008-2#107)(2008-3#126)(2008-4#8)(2008-5#20)(2008-6#3)(2008-7#9)(2008-8#12)(2008-9#10)(2009-1#1)(2009-10#5)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#7)(2009-5#7)(2009-6#1)(2009-7#3)(2009-8#4)(2009-9#3)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#3)(2010-3#2)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#7)(2010-9#3)(2011-1#6)(2011-12#4)(2011-2#12)(2012-1#11)(2012-11#1)(2012-12#4)(2012-2#7)(2012-3#4)(2013-1#17)(2013-7#4)(2013-8#6)
results argue against the##2##4##(1992-1#1)(2008-8#1)
results argue for##3##3##(1993-6#1)(1997-7#2)
results argue that##3##3##(1992-10#1)(1992-5#1)(1993-11#1)
results argue##10##2##(1992-1#1)(1992-10#1)(1992-5#1)(1993-11#1)(1993-6#1)(1997-2#1)(1997-7#3)(2008-8#1)
results as a##4##3##(2005-10#1)(2006-6#1)(2008-10#1)(2010-3#1)
results as compared to##3##4##(2005-11#1)(2006-1#1)(2008-10#1)
results as regards##2##3##(1990-9#1)(2008-2#1)
results as well as##6##4##(1990-2#1)(1991-10#1)(2005-11#1)(2007-12#1)(2008-3#1)(2009-10#1)
results as well##8##3##(1990-2#1)(1991-10#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-10#1)(2011-2#1)
results as##38##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-10#1)(1991-3#1)(1997-2#2)(2005-10#1)(2005-11#2)(2006-1#1)(2006-12#1)(2006-6#1)(2007-12#2)(2008-10#7)(2008-11#2)(2008-2#3)(2008-3#1)(2008-9#1)(2009-10#1)(2010-3#1)(2010-4#2)(2011-2#2)(2013-1#2)(2013-7#1)
results associated with the##2##4##(1996-1#1)(2008-3#1)
results at a##2##3##(2013-1#1)(2013-8#1)
results at different stages##2##4##(2008-8#2)
results at the##6##3##(1997-3#1)(2008-10#1)(2008-2#1)(2009-9#1)(2012-3#1)(2013-1#1)
results at##26##2##(1992-10#1)(1993-1#1)(1997-3#1)(2006-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-8#2)(2009-9#2)(2011-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
results attest to##2##3##(2010-12#1)(2012-1#1)
results attest##3##2##(2010-12#1)(2012-1#1)(2013-8#1)
results available##3##2##(2008-4#1)(2013-1#2)
results based on##15##3##(1993-9#1)(1997-8#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#2)(2009-9#1)(2011-2#1)
results be##3##2##(1994-11#1)(2007-6#1)(2008-8#1)
results bear##2##2##(2008-3#1)(2013-1#1)
results became##3##2##(1995-12#1)(1996-11#1)(2011-2#1)
results because of the##2##4##(1993-3#1)(2008-1#1)
results because##4##2##(1993-3#1)(2008-1#1)(2008-2#1)(2008-7#1)
results before##2##2##(2005-11#1)(2013-8#1)
results being##5##2##(1994-3#1)(1995-2#1)(2007-9#1)(2008-10#1)(2008-11#1)
results better than##3##3##(2008-10#3)
results between laboratories##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
results between the##2##3##(2007-10#1)(2008-10#1)
results between##19##2##(1990-12#1)(2006-10#1)(2006-12#1)(2007-10#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-6#1)(2011-2#1)(2013-1#3)
results both##4##2##(1990-12#1)(1994-3#1)(2008-3#1)(2008-8#1)
results brought##2##2##(1994-6#1)(2008-10#1)
results but##7##2##(1990-12#1)(1992-1#1)(1994-12#1)(2005-11#1)(2006-10#1)(2008-9#1)(2010-12#1)
results by other##3##3##(2006-12#1)(2008-2#1)(2012-1#1)
results by showing##3##3##(2007-11#1)(2007-5#1)(2010-2#1)
results by the##5##3##(2007-2#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#1)
results by use of##3##4##(2007-12#1)(2008-2#2)
results by using##2##3##(2006-9#1)(2008-10#1)
results by##44##2##(1993-12#1)(1994-9#1)(1996-5#1)(1997-2#2)(2006-10#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#3)(2008-5#1)(2008-8#3)(2009-4#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
results calculated##2##2##(2005-11#1)(2011-2#1)
results call for##2##3##(2011-2#1)(2013-1#1)
results can be achieved##4##4##(1993-1#1)(1995-2#1)(2006-6#2)
results can be affected by##2##5##(1996-3#1)(2008-3#1)
results can be explained in##2##5##(1993-8#1)(2008-7#1)
results can be explained##3##4##(1993-8#1)(1994-5#1)(2008-7#1)
results can be interpreted##3##4##(1996-5#1)(2005-11#1)(2007-12#1)
results can be obtained by##3##5##(1993-3#1)(2005-4#1)(2007-8#1)
results can be obtained##10##4##(1993-3#1)(2005-11#1)(2005-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-6#1)
results can be summarized as follows##2##6##(1995-7#1)(2008-10#1)
results can be used to##9##5##(2007-4#1)(2008-10#3)(2008-2#1)(2010-5#1)(2010-7#1)(2013-1#2)
results can be used##12##4##(2007-1#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-2#1)(2010-5#1)(2010-7#1)(2013-1#3)
results can be##52##3##(1990-12#1)(1990-5#1)(1993-1#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-7#1)(1996-3#1)(1996-5#1)(2005-11#3)(2005-12#1)(2005-4#1)(2005-7#1)(2006-12#1)(2006-6#2)(2007-1#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-2#1)(2010-5#1)(2010-7#1)(2013-1#5)
results can help##3##3##(1997-2#1)(2012-11#2)
results can provide##2##3##(2008-2#1)(2013-1#1)
results can##61##2##(1990-12#1)(1990-5#1)(1993-1#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-7#1)(1996-3#1)(1996-5#1)(1997-2#1)(2005-11#3)(2005-12#1)(2005-4#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-6#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-2#1)(2010-5#1)(2010-7#1)(2012-11#2)(2013-1#7)
results cannot be##6##3##(1991-6#1)(1996-2#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-8#1)
results cannot##7##2##(1991-6#1)(1996-2#1)(2007-9#1)(2008-11#2)(2008-3#1)(2008-8#1)
results caused by the##3##4##(2008-10#1)(2008-11#2)
results caused by##4##3##(1997-4#1)(2008-10#1)(2008-11#2)
results challenge##3##2##(2008-10#1)(2008-8#1)(2009-4#1)
results clearly demonstrate that##12##4##(1990-11#1)(1990-2#1)(1990-7#1)(1994-6#1)(1995-1#1)(1996-3#1)(1997-7#1)(2007-11#1)(2008-5#2)(2009-6#1)(2009-8#1)
results clearly demonstrate the##2##4##(1995-12#1)(2008-10#1)
results clearly demonstrate##15##3##(1990-11#1)(1990-2#1)(1990-7#1)(1994-6#1)(1995-1#1)(1995-12#1)(1996-3#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-5#2)(2009-6#1)(2009-7#1)(2009-8#1)
results clearly demonstrated##2##3##(2006-10#1)(2010-2#1)
results clearly indicate that the##2##5##(1996-7#2)
results clearly indicate that##8##4##(1991-10#1)(1994-5#1)(1994-8#1)(1996-7#2)(1997-1#1)(2008-4#1)(2013-1#1)
results clearly show a##2##4##(1990-2#1)(2008-5#1)
results clearly show that the##3##5##(1990-5#1)(1995-3#1)(2007-11#1)
results clearly show that##10##4##(1990-5#1)(1990-7#1)(1991-9#1)(1994-5#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)
results clearly show##12##3##(1990-2#1)(1990-5#1)(1990-7#1)(1991-9#1)(1994-5#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#1)
results clearly showed that##5##4##(1993-11#1)(1995-12#1)(1996-11#1)(1996-4#1)(2008-5#1)
results clearly showed##7##3##(1993-11#1)(1995-12#1)(1996-11#1)(1996-4#1)(2008-10#1)(2008-3#1)(2008-5#1)
results clearly suggest that##2##4##(1993-1#1)(2005-8#1)
results clearly##52##2##(1990-11#1)(1990-2#2)(1990-5#1)(1990-7#2)(1991-10#1)(1991-9#1)(1993-1#1)(1993-11#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-7#1)(2005-8#1)(2006-10#1)(2007-11#2)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-5#1)(2012-2#1)(2013-1#1)
results closely##3##2##(1991-6#1)(2008-3#1)(2009-4#1)
results coincide with the##2##4##(2006-10#1)(2008-5#1)
results coincide with##3##3##(2006-10#1)(2008-3#1)(2008-5#1)
results coincide##4##2##(2006-10#1)(2008-3#2)(2008-5#1)
results collected##3##2##(1991-12#1)(2008-12#1)(2013-1#1)
results collectively##2##2##(2006-5#1)(2008-10#1)
results combined with##2##3##(2008-10#1)(2009-4#1)
results combined##3##2##(2008-10#1)(2009-11#1)(2009-4#1)
results comparable to the##3##4##(2008-2#1)(2013-1#2)
results comparable to those obtained using##2##6##(2008-10#2)
results comparable to those##4##4##(1991-2#1)(2008-10#3)
results comparable to##12##3##(1991-2#1)(1996-7#1)(2008-10#4)(2008-2#1)(2008-9#1)(2012-1#1)(2013-1#2)(2013-8#1)
results comparable with##2##3##(2008-10#2)
results comparable##14##2##(1991-2#1)(1996-7#1)(2008-10#6)(2008-2#1)(2008-9#1)(2012-1#1)(2013-1#2)(2013-8#1)
results compare favorably with##2##4##(2007-11#1)(2013-1#1)
results compare favorably##3##3##(2007-11#1)(2008-2#1)(2013-1#1)
results compare favourably with##2##4##(2008-10#1)(2008-11#1)
results compare favourably##3##3##(2008-10#2)(2008-11#1)
results compare##8##2##(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2013-1#1)
results compared favorably##2##3##(2008-1#1)(2008-10#1)
results compared to##6##3##(1992-7#1)(2005-11#1)(2005-7#1)(2008-5#1)(2010-1#1)(2010-8#1)
results compared with the##3##4##(1996-12#1)(2006-8#1)(2009-11#1)
results compared with##12##3##(1993-5#1)(1996-12#1)(2004-4#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-5#1)(2009-11#1)
results compared##23##2##(1990-6#1)(1992-7#1)(1993-5#1)(1996-12#1)(2004-4#1)(2005-11#1)(2005-7#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-5#2)(2008-6#1)(2009-11#1)(2010-1#1)(2010-8#1)
results complement those##2##3##(1994-5#1)(2008-10#1)
results concerning a##2##3##(2006-2#1)(2008-2#1)
results concerning the##7##3##(1993-12#1)(1994-6#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
results concerning##21##2##(1993-12#1)(1994-6#1)(1995-9#1)(1997-2#1)(2006-2#2)(2006-6#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#3)(2008-9#1)(2011-2#2)
results conclusively show##2##3##(1994-9#1)(2013-8#1)
results confirm our##3##3##(1994-3#1)(1997-6#1)(2012-3#1)
results confirm previous findings##2##4##(1997-5#1)(1997-6#1)
results confirm previous reports that##2##5##(1992-9#1)(1994-8#1)
results confirm previous reports##3##4##(1992-9#1)(1994-8#1)(1994-9#1)
results confirm previous##8##3##(1991-2#1)(1991-6#1)(1992-9#1)(1994-8#1)(1994-9#1)(1996-11#1)(1997-5#1)(1997-6#1)
results confirm that both##2##4##(2008-9#1)(2012-1#1)
results confirm that the##9##4##(1990-8#1)(1992-8#1)(1996-8#1)(2005-12#1)(2006-12#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-8#1)
results confirm that##34##3##(1990-12#1)(1990-2#1)(1990-8#1)(1991-5#1)(1992-8#1)(1993-4#1)(1994-10#1)(1994-12#1)(1994-6#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-6#1)(2005-12#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#1)(2010-5#1)(2010-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
results confirm the effectiveness of the proposed##2##7##(2007-11#1)(2008-2#1)
results confirm the efficacy##2##4##(2007-7#1)(2008-11#1)
results confirm the hypothesis that##3##5##(1992-6#1)(1997-1#1)(2007-6#1)
results confirm the hypothesis##4##4##(1992-6#1)(1997-1#1)(2007-6#1)(2010-12#1)
results confirm the importance of##2##5##(2008-10#1)(2010-3#1)
results confirm the observation that##2##5##(1991-10#1)(1992-4#1)
results confirm the##38##3##(1990-8#1)(1991-10#1)(1991-4#1)(1991-9#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-4#1)(1993-5#1)(1994-2#1)(1996-8#1)(1997-1#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#2)
results confirm##93##2##(1990-12#1)(1990-2#1)(1990-8#2)(1991-10#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-4#2)(1993-5#1)(1994-10#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-5#1)(1997-6#4)(1997-7#1)(2005-12#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-10#4)(2008-11#3)(2008-2#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-7#2)(2011-1#2)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
results confirmed a significant##2##4##(2004-11#1)(2008-5#1)
results confirmed a##3##3##(1994-3#1)(2004-11#1)(2008-5#1)
results confirmed our##2##3##(1994-8#1)(2013-8#1)
results confirmed that in##2##4##(2006-6#1)(2008-12#1)
results confirmed that the use of##2##6##(2008-10#1)(2010-6#1)
results confirmed that the##8##4##(1993-11#1)(1995-3#1)(1997-2#1)(2005-11#1)(2007-6#1)(2008-10#2)(2010-6#1)
results confirmed that##16##3##(1993-11#1)(1995-3#1)(1997-2#1)(2005-11#1)(2006-6#1)(2007-6#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-6#1)(2012-2#1)
results confirmed the##8##3##(2007-10#1)(2007-11#1)(2008-8#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#1)(2013-8#1)
results confirmed##30##2##(1993-11#1)(1994-3#1)(1994-8#1)(1995-3#1)(1997-1#1)(1997-2#1)(2004-11#1)(2005-11#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-6#2)(2010-8#1)(2011-1#1)(2012-2#1)(2013-8#2)
results confirms that##2##3##(2005-10#1)(2008-2#1)
results considering the##2##3##(2008-10#2)
results consistent with the##4##4##(1992-12#1)(2008-3#1)(2011-2#1)(2013-8#1)
results consistent with##6##3##(1992-12#1)(1997-3#1)(2008-3#1)(2009-4#1)(2011-2#1)(2013-8#1)
results consistent##7##2##(1992-12#1)(1997-3#1)(2008-10#1)(2008-3#1)(2009-4#1)(2011-2#1)(2013-8#1)
results consistently show##2##3##(2008-3#1)(2008-5#1)
results consistently##3##2##(2006-8#1)(2008-3#1)(2008-5#1)
results constitute a##2##3##(2007-11#1)(2007-7#1)
results constitute##3##2##(2007-11#1)(2007-7#1)(2009-5#1)
results contribute to a better understanding of##4##7##(2008-10#3)(2011-1#1)
results contribute to##5##3##(2007-6#1)(2008-10#3)(2011-1#1)
results correlate##2##2##(1990-2#1)(2008-3#1)
results correlated well with the##3##5##(1995-2#1)(1995-7#1)(2008-10#1)
results correlated well with##5##4##(1995-2#1)(1995-7#1)(1997-1#1)(2007-8#1)(2008-10#1)
results correlated with##2##3##(2008-10#1)(2012-11#1)
results correlated##8##2##(1995-2#1)(1995-7#1)(1997-1#1)(2007-8#1)(2008-10#3)(2012-11#1)
results correspond to##2##3##(1990-10#1)(2007-12#1)
results correspond##3##2##(1990-10#1)(1995-11#1)(2007-12#1)
results corroborate the##2##3##(2007-12#1)(2010-12#1)
results corroborate##4##2##(2007-12#1)(2008-10#1)(2010-12#2)
results could be obtained with##2##5##(2008-3#1)(2012-7#1)
results could be obtained##3##4##(2008-10#1)(2008-3#1)(2012-7#1)
results could be used##2##4##(2008-5#1)(2012-12#1)
results could be##11##3##(1990-7#1)(1996-8#1)(2006-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2012-12#2)(2012-7#1)
results could not##2##3##(1997-7#1)(2008-7#1)
results could##20##2##(1990-5#1)(1990-7#1)(1991-3#1)(1996-8#1)(1997-7#1)(2006-11#1)(2006-2#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#2)(2012-3#1)(2012-7#1)
results define the##2##3##(1993-11#1)(1993-12#1)
results define##7##2##(1993-11#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-1#1)(2006-7#1)(2012-12#1)
results demonstrate a direct##2##4##(1994-6#1)(1996-5#1)
results demonstrate a##24##3##(1990-11#1)(1991-5#1)(1992-7#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-7#1)(1996-12#1)(1996-5#1)(1997-4#2)(2004-4#1)(2006-12#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-10#1)(2012-12#2)(2012-2#1)
results demonstrate an##6##3##(1990-10#1)(1997-6#1)(2007-10#1)(2008-2#1)(2008-5#1)(2008-8#1)
results demonstrate how##3##3##(2008-7#1)(2008-9#1)(2010-2#1)
results demonstrate significant##2##3##(2008-7#1)(2012-1#1)
results demonstrate that a##7##4##(1990-5#1)(1990-8#1)(1991-11#1)(1994-9#1)(2006-10#2)(2007-11#1)
results demonstrate that alterations in the##2##6##(2006-12#1)(2013-8#1)
results demonstrate that alterations in##3##5##(1997-4#1)(2006-12#1)(2013-8#1)
results demonstrate that an##2##4##(1996-8#1)(2008-3#1)
results demonstrate that both##8##4##(1990-2#1)(1994-11#1)(1995-2#1)(1996-7#1)(2004-9#1)(2008-10#1)(2008-12#1)(2008-7#1)
results demonstrate that different##2##4##(1990-3#1)(1995-11#1)
results demonstrate that exposure to##3##5##(2008-10#2)(2013-1#1)
results demonstrate that exposure##4##4##(1992-8#1)(2008-10#2)(2013-1#1)
results demonstrate that in the##2##5##(1991-2#1)(1993-11#1)
results demonstrate that in##5##4##(1991-2#1)(1993-11#1)(1994-3#1)(1995-1#1)(1997-7#1)
results demonstrate that our##5##4##(2008-2#2)(2008-3#1)(2010-2#1)(2012-3#1)
results demonstrate that partial##2##4##(1991-12#1)(2011-2#1)
results demonstrate that pregnenolone sulfate##2##5##(1996-2#1)(1997-1#1)
results demonstrate that the cellular##2##5##(2008-5#1)(2013-1#1)
results demonstrate that the proposed##5##5##(2008-3#1)(2010-9#1)(2012-3#1)(2013-1#2)
results demonstrate that the##73##4##(1990-7#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-3#3)(1994-6#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-6#1)(1997-7#2)(2005-10#1)(2005-4#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#4)(2008-2#4)(2008-3#2)(2008-5#3)(2008-7#3)(2008-9#1)(2009-11#1)(2009-4#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#4)
results demonstrate that there is a##2##6##(2010-4#1)(2010-8#1)
results demonstrate that there is##3##5##(1993-7#1)(2010-4#1)(2010-8#1)
results demonstrate that these##4##4##(1994-6#1)(2008-10#3)
results demonstrate that this##5##4##(1995-3#1)(1997-7#2)(2011-2#1)(2013-1#1)
results demonstrate that##329##3##(1990-10#1)(1990-12#5)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#3)(1990-7#3)(1990-8#3)(1991-11#5)(1991-12#2)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#3)(1991-7#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-7#1)(1994-10#1)(1994-11#7)(1994-2#5)(1994-3#5)(1994-5#3)(1994-6#2)(1994-8#3)(1994-9#5)(1995-1#4)(1995-11#4)(1995-12#4)(1995-2#5)(1995-3#2)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#4)(1996-2#2)(1996-4#1)(1996-5#6)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#6)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#9)(1997-8#2)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-4#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-8#1)(2007-11#5)(2007-12#6)(2007-2#1)(2007-5#1)(2007-8#3)(2007-9#1)(2008-10#31)(2008-11#13)(2008-12#1)(2008-2#10)(2008-3#7)(2008-5#8)(2008-7#6)(2008-8#5)(2008-9#3)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-7#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#3)(2012-12#4)(2012-2#1)(2012-3#5)(2013-1#17)(2013-8#1)
results demonstrate the ability to##2##5##(2008-7#1)(2012-2#1)
results demonstrate the ability##3##4##(2006-4#1)(2008-7#1)(2012-2#1)
results demonstrate the capabilities of the##2##6##(2007-12#1)(2008-2#1)
results demonstrate the efficacy of##2##5##(1993-9#1)(2008-3#1)
results demonstrate the feasibility of the##3##6##(2007-12#1)(2008-10#1)(2008-2#1)
results demonstrate the feasibility of##6##5##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2010-2#1)
results demonstrate the importance of##3##5##(1995-12#1)(1995-9#1)(2008-10#1)
results demonstrate the need##2##4##(2007-1#1)(2008-11#1)
results demonstrate the potential of##10##5##(1995-11#1)(1996-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-4#1)(2009-5#1)(2013-1#2)
results demonstrate the potential##11##4##(1995-11#1)(1996-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-4#1)(2009-5#1)(2013-1#2)
results demonstrate the presence of##3##5##(1993-9#1)(1995-5#1)(1996-2#1)
results demonstrate the presence##4##4##(1993-6#1)(1993-9#1)(1995-5#1)(1996-2#1)
results demonstrate the significant##2##4##(2008-3#1)(2013-8#1)
results demonstrate the utility of##4##5##(1990-4#1)(1990-5#1)(2007-11#1)(2012-2#1)
results demonstrate the validity of##2##5##(2007-11#1)(2008-3#1)
results demonstrate the validity##3##4##(2007-11#1)(2008-3#1)(2013-8#1)
results demonstrate the##78##3##(1990-4#1)(1990-5#1)(1990-9#1)(1992-4#1)(1993-6#1)(1993-9#3)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-2#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-11#3)(2007-12#9)(2008-10#5)(2008-11#2)(2008-2#6)(2008-3#9)(2008-5#2)(2008-6#1)(2008-7#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#4)(2013-8#2)
results demonstrate##472##2##(1990-10#2)(1990-11#2)(1990-12#5)(1990-2#1)(1990-3#3)(1990-4#2)(1990-5#4)(1990-7#3)(1990-8#3)(1990-9#2)(1991-11#5)(1991-12#2)(1991-2#3)(1991-3#2)(1991-4#2)(1991-5#4)(1991-6#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#3)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#3)(1993-7#1)(1993-9#3)(1994-10#1)(1994-11#7)(1994-12#1)(1994-2#6)(1994-3#6)(1994-5#4)(1994-6#3)(1994-8#3)(1994-9#6)(1995-1#5)(1995-11#6)(1995-12#7)(1995-2#8)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#3)(1995-9#1)(1996-1#2)(1996-10#2)(1996-11#3)(1996-12#6)(1996-2#3)(1996-4#1)(1996-5#7)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#7)(1997-2#3)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#4)(1997-7#9)(1997-8#2)(2004-12#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-4#1)(2005-8#1)(2006-10#2)(2006-12#3)(2006-4#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#16)(2007-2#1)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#38)(2008-11#17)(2008-12#1)(2008-2#17)(2008-3#17)(2008-4#1)(2008-5#12)(2008-6#1)(2008-7#9)(2008-8#6)(2008-9#5)(2009-10#2)(2009-11#2)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#6)(2010-3#1)(2010-4#4)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#6)(2012-12#7)(2012-2#6)(2012-3#5)(2013-1#21)(2013-8#3)
results demonstrated a##7##3##(1994-2#1)(1995-4#1)(2007-9#1)(2008-7#1)(2008-8#1)(2009-9#1)(2012-2#1)
results demonstrated that a##3##4##(1992-9#1)(1995-4#1)(1996-2#1)
results demonstrated that both##2##4##(1995-6#1)(2010-4#1)
results demonstrated that the##18##4##(1992-6#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-3#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-8#1)
results demonstrated that this##2##4##(2007-8#1)(2009-5#1)
results demonstrated that##75##3##(1990-6#1)(1991-4#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-6#1)(1995-10#1)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-8#2)(2008-10#9)(2008-11#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-4#3)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
results demonstrated the feasibility of##2##5##(2008-8#1)(2012-1#1)
results demonstrated the##15##3##(1991-2#1)(1994-9#1)(1995-2#1)(2006-5#1)(2007-8#1)(2008-10#3)(2008-8#2)(2008-9#1)(2009-6#1)(2010-12#1)(2010-8#1)(2012-1#1)
results demonstrated##114##2##(1990-6#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-4#2)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#1)(1997-7#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-8#3)(2007-9#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#8)(2008-9#3)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-4#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#2)(2012-11#1)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#2)
results demonstrating that##3##3##(1995-6#1)(1997-7#1)(2007-3#1)
results demonstrating##5##2##(1995-6#1)(1997-7#1)(2007-3#1)(2008-2#1)(2008-3#1)
results depend on##4##3##(2007-2#1)(2008-10#2)(2012-3#1)
results depending on the##2##4##(2008-2#1)(2010-11#1)
results derived by##3##3##(2007-10#1)(2008-2#1)(2008-3#1)
results derived from##3##3##(2008-1#1)(2008-2#1)(2009-12#1)
results derived##8##2##(1990-12#1)(2005-11#1)(2007-10#1)(2008-1#1)(2008-2#2)(2008-3#1)(2009-12#1)
results describe##4##2##(1993-11#1)(1993-12#1)(2008-4#1)(2012-3#1)
results described##3##2##(1996-11#1)(2006-12#1)(2010-3#1)
results determined by##5##3##(1996-1#1)(2008-10#4)
results determined##6##2##(1996-1#1)(2008-10#4)(2013-1#1)
results did not attain statistical significance##2##6##(2007-7#1)(2007-8#1)
results did not differ##2##4##(2012-2#1)(2013-1#1)
results did not##10##3##(2006-8#1)(2007-7#2)(2007-8#1)(2008-10#1)(2009-11#1)(2012-2#1)(2013-1#3)
results differ from those of##2##5##(1991-6#1)(2008-8#1)
results differ from those##4##4##(1990-9#1)(1991-6#1)(1996-4#1)(2008-8#1)
results differ from##6##3##(1990-9#1)(1991-6#1)(1996-2#1)(1996-4#1)(1996-7#1)(2008-8#1)
results differ##9##2##(1990-8#1)(1990-9#1)(1991-6#1)(1995-9#1)(1996-2#1)(1996-4#1)(1996-7#1)(2008-2#1)(2008-8#1)
results directly##4##2##(1990-7#1)(2005-7#1)(2007-4#1)(2013-1#1)
results do not confirm##2##4##(1991-8#1)(2008-7#1)
results do not suggest##2##4##(1990-12#1)(2007-10#1)
results do not support a##2##5##(1994-10#1)(2007-12#1)
results do not support the hypothesis of a##2##8##(1991-12#1)(1996-3#1)
results do not support the hypothesis##3##6##(1991-12#1)(1996-3#1)(2004-11#1)
results do not support the notion that##3##7##(1990-2#1)(1993-11#1)(1997-7#1)
results do not support the##10##5##(1990-2#1)(1991-12#1)(1991-6#1)(1991-8#1)(1993-11#1)(1995-6#1)(1996-3#1)(1997-7#1)(2004-11#1)(2008-8#1)
results do not support##16##4##(1990-2#1)(1991-12#1)(1991-6#1)(1991-8#1)(1993-11#1)(1993-4#1)(1994-10#1)(1995-11#1)(1995-6#1)(1996-3#1)(1997-7#1)(2004-11#1)(2007-12#1)(2008-11#1)(2008-8#1)(2013-1#1)
results do not##28##3##(1990-12#1)(1990-2#1)(1991-12#1)(1991-6#1)(1991-8#2)(1993-11#1)(1993-4#1)(1994-10#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-11#1)(2004-12#1)(2005-12#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
results do##30##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-6#1)(1991-8#2)(1993-11#1)(1993-4#1)(1994-10#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-11#1)(2004-12#1)(2005-12#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2011-2#1)(2013-1#1)
results document that##2##3##(2008-10#1)(2011-12#1)
results document##3##2##(1995-3#1)(2008-10#1)(2011-12#1)
results draw attention to the##2##5##(1993-1#1)(2008-10#1)
results due to the##3##4##(1993-3#1)(2008-10#1)(2012-2#1)
results due to##8##3##(1993-3#1)(1994-3#1)(2007-12#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-2#1)
results during##4##2##(2007-8#1)(2008-10#1)(2009-8#1)(2012-11#1)
results elucidate the##2##3##(1996-5#1)(2009-2#1)
results elucidate##3##2##(1996-5#1)(2009-2#1)(2012-3#1)
results emerge from##2##3##(2010-6#1)(2010-8#1)
results emphasize that##5##3##(1993-11#1)(1993-6#1)(1996-9#1)(2008-12#1)(2008-8#1)
results emphasize the importance of##8##5##(1991-12#1)(1991-4#1)(1993-2#1)(1993-3#2)(1994-3#1)(1997-2#1)(2008-10#1)
results emphasize the##15##3##(1990-2#1)(1990-5#1)(1991-12#1)(1991-4#1)(1993-2#1)(1993-3#2)(1994-3#1)(1995-9#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)
results emphasize##20##2##(1990-2#1)(1990-5#1)(1991-12#1)(1991-4#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-3#1)(1995-9#1)(1996-9#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)
results enable##3##2##(1991-7#1)(2008-2#1)(2011-2#1)
results encourage us to##3##4##(2008-2#1)(2013-1#2)
results encourage##4##2##(1996-9#1)(2008-2#1)(2013-1#2)
results equivalent to those##2##4##(2009-5#1)(2010-9#1)
results equivalent to##4##3##(2008-8#1)(2009-5#1)(2010-9#1)(2011-2#1)
results essentially##2##2##(1996-12#1)(2009-2#1)
results establish that the##4##4##(1993-11#1)(1994-11#1)(1996-2#1)(1996-7#1)
results establish that##12##3##(1990-11#1)(1991-10#1)(1993-11#1)(1994-11#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-7#1)(2008-10#1)(2010-2#1)(2012-3#1)
results establish the##3##3##(1992-11#1)(2006-10#1)(2013-1#1)
results establish##18##2##(1990-11#1)(1991-10#1)(1992-11#1)(1992-4#1)(1993-11#1)(1994-11#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-7#1)(2006-10#1)(2008-10#1)(2009-6#1)(2010-2#1)(2012-3#1)(2013-1#1)
results established##2##2##(1995-12#1)(2004-9#1)
results even in##2##3##(1991-5#1)(2007-8#1)
results even##3##2##(1991-5#1)(2007-8#1)(2010-2#1)
results evidence##3##2##(1991-4#1)(2005-11#1)(2008-10#1)
results explain##3##2##(1991-1#1)(1992-12#1)(2007-12#1)
results extend previous##2##3##(1994-12#1)(1994-8#1)
results extend the##2##3##(1992-9#1)(2007-12#1)
results extend##8##2##(1990-11#1)(1992-9#1)(1994-12#1)(1994-8#1)(2007-12#1)(2008-9#2)(2012-3#1)
results fail to support a##2##5##(1991-10#1)(1991-5#1)
results fail to support##3##4##(1991-10#1)(1991-5#1)(1993-12#1)
results failed to##2##3##(1995-7#1)(2012-5#1)
results falling##2##2##(1996-12#1)(2008-10#1)
results favor the##2##3##(2007-8#1)(2011-2#1)
results favor##3##2##(2007-8#1)(2008-3#1)(2011-2#1)
results fit##2##2##(2008-10#1)(2008-2#1)
results focused on the##2##4##(2009-10#1)(2009-9#1)
results focused on##3##3##(1996-6#1)(2009-10#1)(2009-9#1)
results following##2##2##(1996-7#1)(2008-9#1)
results for a test##2##4##(2008-2#1)(2008-3#1)
results for a##24##3##(2007-11#4)(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#9)(2008-9#1)(2009-9#1)(2012-3#1)(2013-1#1)
results for all##3##3##(1996-11#2)(2008-12#1)
results for an##7##3##(2008-10#1)(2008-2#3)(2008-3#2)(2008-8#1)
results for both methods##2##4##(2008-10#1)(2008-2#1)
results for both##7##3##(1997-1#1)(2005-11#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
results for each##5##3##(1995-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2012-1#1)
results for homogeneous##2##3##(2008-2#1)(2008-3#1)
results for model##2##3##(2008-2#1)(2008-9#1)
results for most##2##3##(2006-6#1)(2008-8#1)
results for optical##2##3##(2007-12#1)(2008-3#1)
results for other##2##3##(2008-10#1)(2008-5#1)
results for patients##3##3##(1996-6#1)(2013-1#2)
results for several##4##3##(1996-7#1)(2007-12#1)(2008-10#1)(2009-2#1)
results for some##3##3##(2008-10#1)(2012-1#1)(2012-3#1)
results for specific##2##3##(2007-9#1)(2010-8#1)
results for the determination of##3##5##(2008-10#3)
results for the development of##2##5##(1994-1#1)(2008-2#1)
results for the three##2##4##(2008-10#1)(2010-2#1)
results for the use##2##4##(2006-10#1)(2012-1#1)
results for the##78##3##(1991-9#2)(1992-6#1)(1992-9#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-10#1)(1996-2#3)(1997-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-11#2)(2007-12#3)(2007-6#1)(2007-8#2)(2008-10#14)(2008-11#1)(2008-2#9)(2008-3#10)(2008-5#4)(2008-7#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-2#1)(2013-1#2)
results for these two##2##4##(1995-10#1)(2008-3#1)
results for these##3##3##(1995-10#1)(2007-11#1)(2008-3#1)
results for this##5##3##(2008-10#1)(2008-2#1)(2008-5#1)(2013-1#2)
results for three##2##3##(2007-11#1)(2012-2#1)
results for understanding the##2##4##(1996-8#1)(2006-10#1)
results for##326##2##(1990-10#1)(1990-5#1)(1990-6#1)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#2)(1992-2#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#2)(1994-1#1)(1994-2#2)(1994-3#1)(1994-4#1)(1995-1#2)(1995-10#3)(1995-4#1)(1995-8#1)(1995-9#1)(1996-11#2)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-5#1)(2004-4#1)(2005-10#1)(2005-11#3)(2005-12#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#2)(2006-6#1)(2007-11#19)(2007-12#17)(2007-5#2)(2007-6#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#54)(2008-11#2)(2008-12#2)(2008-2#30)(2008-3#39)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#6)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#3)(2011-1#4)(2011-2#7)(2012-1#7)(2012-12#1)(2012-2#6)(2012-3#4)(2013-1#17)(2013-8#1)
results form the basis for##2##5##(1994-9#1)(2012-3#1)
results form the##3##3##(1994-9#1)(2008-9#1)(2012-3#1)
results found by##4##3##(1994-8#1)(2008-10#3)
results found in the literature##2##5##(2007-2#1)(2008-3#1)
results found in##3##3##(1996-11#1)(2007-2#1)(2008-3#1)
results found##11##2##(1994-8#1)(1996-11#1)(2004-11#1)(2007-2#1)(2008-10#5)(2008-3#1)(2009-7#1)
results from [19]##2##3##(2008-9#2)
results from a demonstration##2##4##(2008-3#1)(2009-2#1)
results from a national##3##4##(2005-9#1)(2012-2#1)(2012-3#1)
results from a number of##3##5##(2004-12#1)(2007-8#1)(2008-10#1)
results from a randomised##2##4##(2012-3#1)(2013-1#1)
results from a randomized##2##4##(1994-8#1)(1996-6#1)
results from a recent##3##4##(1995-1#1)(2008-5#1)(2008-7#1)
results from a series of##5##5##(1995-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)
results from a series##6##4##(1995-8#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)
results from a single##2##4##(2010-4#1)(2011-2#1)
results from a study of##2##5##(1994-3#1)(2008-10#1)
results from a study##4##4##(1994-3#1)(2004-10#1)(2008-10#1)(2010-11#1)
results from a##101##3##(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-5#1)(1992-12#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-10#1)(2004-12#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-1#2)(2007-11#3)(2007-12#6)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#3)(2008-2#7)(2008-3#8)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#3)(2013-8#1)
results from all##2##3##(1997-7#1)(2006-8#1)
results from an imbalance between##3##5##(2008-1#1)(2008-10#1)(2009-8#1)
results from an##20##3##(1991-2#1)(1991-5#1)(1991-7#2)(1994-11#1)(1994-2#1)(1995-6#1)(1997-1#1)(2005-7#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-4#1)(2009-8#2)(2010-12#1)(2012-12#1)
results from both methods##2##4##(2007-8#1)(2012-3#1)
results from both##4##3##(1991-9#1)(1993-11#1)(2007-8#1)(2012-3#1)
results from chemical##2##3##(1997-2#2)
results from clinical trials##2##4##(2008-11#1)(2012-12#1)
results from clinical##3##3##(2008-11#1)(2010-5#1)(2012-12#1)
results from complex##2##3##(2006-10#1)(2008-4#1)
results from different studies##4##4##(2008-10#3)(2011-12#1)
results from different##9##3##(1996-3#1)(2008-10#3)(2008-2#2)(2008-4#1)(2011-12#1)(2011-2#1)
results from experiments##2##3##(1995-3#1)(2007-5#1)
results from full##2##3##(2006-11#1)(2009-12#1)
results from impaired##2##3##(1991-7#1)(2008-10#1)
results from in situ##2##4##(1990-11#1)(1992-12#1)
results from in vitro##2##4##(1992-11#1)(2012-2#1)
results from in##4##3##(1990-11#1)(1992-11#1)(1992-12#1)(2012-2#1)
results from infection##2##3##(1992-12#1)(2011-2#1)
results from its##2##3##(1994-11#1)(1997-2#1)
results from laboratory##5##3##(2008-1#1)(2008-10#2)(2008-8#1)(2010-2#1)
results from large##2##3##(2004-11#1)(2012-3#1)
results from multiple##4##3##(2007-8#1)(2008-4#1)(2008-7#1)(2013-1#1)
results from mutations in the##2##5##(2006-8#1)(2007-8#1)
results from mutations in##4##4##(1991-12#1)(2006-8#2)(2007-8#1)
results from non-RCT##2##3##(2011-2#2)
results from one##2##3##(1993-6#1)(2008-10#1)
results from other studies##3##4##(2005-11#1)(2006-10#1)(2010-4#1)
results from other##5##3##(2005-11#1)(2006-10#1)(2008-10#1)(2009-8#1)(2010-4#1)
results from our##9##3##(1995-12#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-6#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
results from preliminary##2##3##(1997-7#1)(2008-3#1)
results from previous studies##2##4##(2006-6#1)(2007-4#1)
results from random##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
results from randomized##2##3##(2006-10#1)(2008-12#1)
results from recent clinical trials##3##5##(1991-7#1)(2005-10#1)(2010-12#1)
results from recent##7##3##(1991-7#1)(1992-6#1)(2005-10#1)(2007-7#1)(2010-12#1)(2010-2#1)(2011-2#1)
results from reduced##2##3##(2008-5#1)(2008-9#1)
results from repetitive##2##3##(2008-8#1)(2011-2#1)
results from several##5##3##(2006-10#1)(2008-10#2)(2008-12#1)(2008-7#1)
results from simulation##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2009-12#1)
results from simulations##2##3##(1995-5#1)(2008-3#1)
results from studies conducted by##2##5##(2011-2#1)(2012-3#1)
results from studies in##2##4##(2004-11#1)(2008-1#1)
results from studies##6##3##(1996-3#1)(2004-11#1)(2007-2#1)(2008-1#1)(2011-2#1)(2012-3#1)
results from subsequent##2##3##(2004-10#1)(2008-8#1)
results from tests##2##3##(2008-2#1)(2012-3#1)
results from the Demographic and Health Survey##2##7##(2006-4#2)
results from the Global Orthopaedic Registry (GLORY)##2##7##(2011-2#2)
results from the activity of##2##5##(1995-2#1)(2008-10#1)
results from the demographic and health survey##2##7##(2012-11#2)
results from the different##2##4##(1990-10#1)(2008-7#1)
results from the first##4##4##(1991-10#1)(2012-3#1)(2013-1#2)
results from the interaction##3##4##(2006-10#1)(2006-12#1)(2009-10#1)
results from the interference##2##4##(2008-2#2)
results from the literature##2##4##(2008-2#1)(2009-3#1)
results from the measurement##2##4##(2008-10#2)
results from the model##2##4##(2008-3#2)
results from the other##2##4##(2007-2#1)(2009-11#1)
results from the presence of##2##5##(1995-11#1)(1995-4#1)
results from the present study suggest##2##6##(1992-8#1)(2010-11#1)
results from the present study##3##5##(1992-8#1)(2008-10#1)(2010-11#1)
results from the randomised##2##4##(2007-8#1)(2010-5#1)
results from the scattering of light by deformed liquid droplets and droplets with inclusions##2##14##(2008-3#2)
results from the system##3##4##(2008-2#1)(2008-3#2)
results from the three##3##4##(2008-10#1)(2008-2#1)(2008-7#1)
results from the two##2##4##(1993-8#1)(1996-3#1)
results from the##166##3##(1990-10#3)(1990-11#2)(1990-8#1)(1991-10#2)(1991-12#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-5#1)(1992-6#2)(1992-8#2)(1993-1#1)(1993-11#1)(1993-8#1)(1994-11#2)(1994-2#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-5#2)(1996-12#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-4#4)(2006-8#1)(2007-11#6)(2007-12#4)(2007-2#1)(2007-7#3)(2007-8#4)(2008-1#2)(2008-10#17)(2008-11#4)(2008-12#1)(2008-2#12)(2008-3#10)(2008-5#5)(2008-6#2)(2008-7#4)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-5#2)(2009-6#2)(2009-8#1)(2009-9#1)(2010-11#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-11#2)(2012-2#1)(2012-3#2)(2013-1#7)(2013-8#4)
results from these experiments##2##4##(1992-10#1)(1994-10#1)
results from these##13##3##(1992-10#1)(1994-10#1)(1995-9#1)(2005-11#1)(2006-1#1)(2006-5#1)(2008-10#4)(2008-4#1)(2008-7#1)(2010-12#1)
results from this study are##2##5##(1990-10#1)(2008-9#1)
results from this study have##2##5##(1996-9#1)(2011-2#1)
results from this study##15##4##(1990-10#1)(1993-9#1)(1996-9#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2009-9#1)(2010-7#1)(2010-8#2)(2011-2#1)
results from this##27##3##(1990-10#1)(1993-9#1)(1996-9#1)(1997-4#1)(2005-8#1)(2007-4#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-1#2)(2012-3#2)
results from those##2##3##(2007-3#1)(2008-10#1)
results from two##8##3##(1993-9#1)(1995-8#1)(2005-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)
results from use of##3##4##(2007-12#1)(2008-3#2)
results from##704##2##(1990-10#4)(1990-11#4)(1990-12#1)(1990-3#1)(1990-5#2)(1990-7#2)(1990-8#2)(1990-9#3)(1991-1#3)(1991-10#3)(1991-12#3)(1991-2#1)(1991-5#4)(1991-6#3)(1991-7#4)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#4)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#4)(1994-10#1)(1994-11#5)(1994-12#1)(1994-2#2)(1994-3#3)(1994-8#1)(1994-9#3)(1995-1#2)(1995-10#2)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#4)(1995-4#1)(1995-5#3)(1995-6#3)(1995-8#4)(1995-9#3)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#5)(1996-4#1)(1996-5#4)(1996-6#2)(1996-7#3)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#4)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#5)(1997-8#2)(2004-10#3)(2004-11#2)(2004-12#2)(2005-10#1)(2005-11#4)(2005-12#1)(2005-7#3)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#22)(2006-11#3)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#4)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#4)(2006-9#4)(2007-1#3)(2007-10#1)(2007-11#14)(2007-12#21)(2007-2#4)(2007-3#1)(2007-4#5)(2007-5#2)(2007-7#11)(2007-8#11)(2007-9#4)(2008-1#12)(2008-10#56)(2008-11#13)(2008-12#5)(2008-2#28)(2008-3#38)(2008-4#7)(2008-5#14)(2008-6#4)(2008-7#17)(2008-8#13)(2008-9#9)(2009-10#2)(2009-11#5)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#3)(2009-7#2)(2009-8#6)(2009-9#3)(2010-10#1)(2010-11#4)(2010-12#5)(2010-2#5)(2010-3#2)(2010-4#7)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#9)(2011-12#2)(2011-2#23)(2012-1#8)(2012-11#2)(2012-12#12)(2012-2#6)(2012-3#16)(2013-1#18)(2013-7#1)(2013-8#7)
results further demonstrate that##3##4##(2008-2#1)(2008-3#1)(2008-7#1)
results further demonstrate##4##3##(1991-1#1)(2008-2#1)(2008-3#1)(2008-7#1)
results further indicate that##2##4##(2008-3#1)(2009-7#1)
results further suggest that##7##4##(1990-2#1)(1991-11#1)(1992-12#1)(1994-8#1)(2008-10#1)(2008-7#1)(2010-7#1)
results further support the##5##4##(1991-5#1)(1993-12#1)(1996-8#1)(2008-1#1)(2008-7#1)
results further##22##2##(1990-2#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-5#1)(1992-12#1)(1993-12#1)(1994-8#1)(1996-10#1)(1996-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#3)(2009-7#1)(2010-7#1)(2013-8#1)
results gave##2##2##(1994-12#1)(2006-2#1)
results generally support the view that##2##6##(1993-3#1)(2008-8#1)
results generally##3##2##(1993-3#1)(2008-1#1)(2008-8#1)
results generated##4##2##(1994-3#1)(2006-1#1)(2008-10#1)(2008-5#1)
results give a##3##3##(1995-4#1)(2008-2#1)(2008-8#1)
results give new##2##3##(1997-3#1)(2008-11#1)
results give us##2##3##(2008-11#1)(2008-9#1)
results give##14##2##(1991-9#1)(1994-2#1)(1995-4#1)(1997-3#1)(2007-12#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#1)(2013-1#2)
results given here##2##3##(2008-3#2)
results given##4##2##(2008-10#1)(2008-3#2)(2008-5#1)
results had##4##2##(1990-12#1)(2008-2#1)(2008-9#1)(2013-8#1)
results has been##6##3##(1990-3#1)(1995-2#1)(1996-5#1)(2008-10#1)(2011-1#1)(2012-3#1)
results has##8##2##(1990-3#1)(1995-2#1)(1996-5#1)(2006-10#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-3#1)
results have a##5##3##(1992-9#1)(2007-11#1)(2008-2#1)(2013-1#2)
results have also been##2##4##(1991-5#1)(1994-11#1)
results have also##3##3##(1991-5#1)(1994-11#1)(2008-3#1)
results have been achieved##4##4##(1994-12#1)(2007-11#1)(2007-9#1)(2010-12#1)
results have been compared with those##2##6##(2005-11#1)(2006-10#1)
results have been compared with##6##5##(1996-7#1)(2005-11#2)(2006-10#1)(2008-10#1)(2008-3#1)
results have been compared##7##4##(1996-7#1)(2005-11#2)(2006-10#1)(2008-10#2)(2008-3#1)
results have been found##3##4##(1996-4#1)(2006-10#1)(2008-2#1)
results have been obtained by##2##5##(1992-6#1)(2008-10#1)
results have been obtained in##3##5##(1994-4#1)(2006-9#1)(2007-11#1)
results have been obtained with##4##5##(1993-11#1)(2007-11#1)(2008-2#1)(2013-1#1)
results have been obtained##13##4##(1992-6#1)(1993-11#1)(1994-4#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-11#2)(2008-10#2)(2008-2#1)(2012-12#1)(2013-1#1)
results have been published##3##4##(1990-11#1)(1997-1#1)(2010-12#1)
results have been reported about##2##5##(1990-12#1)(2008-6#1)
results have been reported##10##4##(1990-12#1)(2006-7#1)(2007-3#1)(2007-8#1)(2008-6#1)(2008-7#1)(2009-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
results have been used to##2##5##(2006-5#1)(2007-12#1)
results have been##65##3##(1990-11#1)(1990-12#1)(1991-3#1)(1992-6#1)(1993-10#1)(1993-11#1)(1994-12#1)(1994-4#1)(1994-6#1)(1994-9#1)(1996-4#1)(1996-7#1)(1997-1#1)(2005-11#2)(2005-2#1)(2006-10#3)(2006-12#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#6)(2008-2#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-2#1)(2010-1#1)(2010-12#2)(2010-8#2)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
results have clearly##2##3##(2010-4#1)(2010-8#1)
results have demonstrated that the##2##5##(2006-11#1)(2008-10#1)
results have demonstrated that##3##4##(2006-11#1)(2008-10#1)(2008-12#1)
results have demonstrated##6##3##(2006-11#1)(2007-11#2)(2008-10#1)(2008-12#1)(2012-12#1)
results have implications for##7##4##(1994-6#1)(1994-8#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-1#1)(2012-12#1)
results have implications regarding the##2##5##(1992-7#1)(2013-1#1)
results have implications##10##3##(1992-7#1)(1994-6#1)(1994-8#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
results have important implications for##3##5##(2008-7#1)(2009-5#1)(2013-7#1)
results have important implications##4##4##(2007-7#1)(2008-7#1)(2009-5#1)(2013-7#1)
results have important##5##3##(1993-12#1)(2007-7#1)(2008-7#1)(2009-5#1)(2013-7#1)
results have indicated##2##3##(2008-10#1)(2008-5#1)
results have not been##3##4##(1995-1#1)(2006-7#1)(2008-5#1)
results have not##4##3##(1995-1#1)(2006-7#1)(2008-5#1)(2011-2#1)
results have only been##2##4##(1995-10#1)(2007-11#1)
results have provided##4##3##(2007-10#1)(2008-11#1)(2008-9#1)(2009-8#1)
results have shown that the##2##5##(1993-4#1)(2008-10#1)
results have shown that##9##4##(1993-4#1)(2004-12#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-6#1)(2013-1#1)
results have shown the##4##4##(2008-2#1)(2008-3#1)(2008-7#1)(2013-8#1)
results have shown##14##3##(1993-4#1)(2004-12#1)(2006-5#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2013-1#1)(2013-8#1)
results have##153##2##(1990-10#1)(1990-11#1)(1990-12#1)(1991-3#1)(1991-5#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-4#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1996-4#1)(1996-7#1)(1997-1#2)(2004-12#1)(2004-2#1)(2005-11#2)(2005-2#1)(2005-7#1)(2006-10#4)(2006-11#2)(2006-12#3)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#2)(2006-7#2)(2006-9#1)(2007-10#1)(2007-11#8)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#7)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-2#1)(2009-5#2)(2009-8#2)(2010-1#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#4)
results here##6##2##(1992-8#1)(1993-2#1)(1995-3#1)(2008-10#1)(2008-3#1)(2008-8#1)
results highlight the ability##2##4##(2010-8#1)(2012-3#1)
results highlight the importance of##6##5##(1995-5#1)(2008-5#1)(2009-8#1)(2011-2#2)(2012-12#1)
results highlight the need to##2##5##(2008-10#1)(2012-12#1)
results highlight the need##3##4##(2008-10#1)(2012-12#1)(2013-1#1)
results highlight the value of##2##5##(2007-3#1)(2012-3#1)
results highlight the##25##3##(1990-8#1)(1992-10#1)(1995-5#1)(2007-3#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
results highlight##28##2##(1990-8#1)(1992-10#1)(1993-11#1)(1995-5#1)(2007-3#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
results highlighted that##2##3##(2008-10#1)(2008-8#1)
results highlighted##3##2##(2007-3#1)(2008-10#1)(2008-8#1)
results hold##3##2##(2007-9#1)(2008-10#1)(2008-3#1)
results however##2##2##(2008-9#1)(2010-8#1)
results i##2##2##(2007-11#2)
results identified a##2##3##(1994-6#1)(2008-11#1)
results identified##4##2##(1994-6#1)(2006-10#1)(2007-8#1)(2008-11#1)
results identify a##2##3##(1990-11#1)(1995-1#1)
results identify##10##2##(1990-11#1)(1992-3#1)(1993-12#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-8#1)(1997-4#1)(2011-2#1)(2012-12#1)
results if the##4##3##(1994-2#1)(2008-2#1)(2008-3#1)(2011-2#1)
results if##8##2##(1993-8#1)(1994-2#1)(2006-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2011-2#1)
results illustrate how##2##3##(2008-10#1)(2008-8#1)
results illustrate that the##3##4##(2008-10#1)(2008-6#1)(2010-8#1)
results illustrate that##6##3##(2007-11#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-8#1)
results illustrate the importance of##3##5##(2008-8#1)(2010-1#1)(2011-2#1)
results illustrate the potential##2##4##(2008-3#2)
results illustrate the##13##3##(1994-2#1)(1994-9#1)(1996-3#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-1#1)(2011-2#1)
results illustrate##22##2##(1994-2#1)(1994-9#1)(1996-3#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#3)(2010-1#1)(2010-8#1)(2011-2#1)
results illustrated that##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
results implicate the##2##3##(1991-8#1)(2008-10#1)
results implicate##11##2##(1991-8#1)(1992-3#1)(1993-11#2)(1993-12#1)(1994-2#1)(1994-8#1)(1995-6#1)(2008-10#1)(2008-11#1)(2009-4#1)
results implied that##3##3##(1992-4#1)(1997-3#1)(2008-9#1)
results implied##4##2##(1992-4#1)(1997-3#1)(2008-8#1)(2008-9#1)
results imply a##2##3##(1992-1#1)(1992-2#1)
results imply that a##5##4##(1993-11#1)(1995-2#1)(2008-3#1)(2008-8#1)(2009-8#1)
results imply that it is##2##5##(1992-8#1)(2010-9#1)
results imply that it##3##4##(1992-8#1)(2008-7#1)(2010-9#1)
results imply that the protein##2##5##(1990-10#1)(1997-4#1)
results imply that the##17##4##(1990-10#1)(1990-7#1)(1991-1#1)(1994-11#1)(1995-12#1)(1996-1#1)(1996-10#1)(1996-11#1)(1997-4#1)(2006-12#1)(2006-7#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-8#1)(2013-1#1)
results imply that##51##3##(1990-10#1)(1990-2#1)(1990-7#1)(1991-1#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-2#1)(1997-4#1)(1997-6#1)(2006-12#1)(2006-7#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-7#1)(2009-8#2)(2010-2#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
results imply##54##2##(1990-10#1)(1990-2#1)(1990-7#1)(1991-1#1)(1992-1#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-11#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-2#1)(1997-4#1)(1997-6#1)(2006-12#1)(2006-7#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-7#1)(2009-8#2)(2010-2#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
results in 2##2##3##(1997-7#1)(2007-7#1)
results in 4##3##3##(2007-11#1)(2007-7#2)
results in a 50% decrease##2##5##(1990-11#1)(1991-11#1)
results in a better##3##4##(2005-11#3)
results in a change##2##4##(1992-6#1)(2012-3#1)
results in a conformational change##2##5##(1991-10#1)(1991-5#1)
results in a considerable##2##4##(1997-6#1)(2008-10#1)
results in a decrease in the##2##6##(1995-1#1)(1996-5#1)
results in a decrease in##8##5##(1994-8#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-5#1)(2007-7#1)(2008-4#1)(2013-1#1)
results in a decrease of the##2##6##(1996-7#1)(2008-10#1)
results in a decrease of##3##5##(1996-7#1)(2008-10#1)(2008-2#1)
results in a decrease##11##4##(1994-8#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-5#1)(1996-7#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-4#1)(2013-1#1)
results in a decreased##2##4##(1997-6#1)(2006-12#1)
results in a diminished##2##4##(2008-10#1)(2009-10#1)
results in a dramatic##3##4##(1991-5#1)(1993-3#1)(1994-9#1)
results in a fast##3##4##(1990-5#1)(1994-5#1)(1997-5#1)
results in a high level of##2##6##(1992-11#1)(2012-12#1)
results in a high##5##4##(1990-4#1)(1992-11#1)(2008-3#1)(2008-5#1)(2012-12#1)
results in a higher##2##4##(2007-8#1)(2008-10#1)
results in a lack of##2##5##(1997-6#1)(2012-12#1)
results in a large##3##4##(2007-12#1)(2009-6#1)(2013-1#1)
results in a loss of##2##5##(2008-9#1)(2010-10#1)
results in a low##2##4##(1992-3#1)(2007-8#1)
results in a lower##4##4##(1992-3#1)(2007-11#1)(2007-12#1)(2008-10#1)
results in a marked decrease in the##2##7##(1992-8#1)(1995-3#1)
results in a marked decrease in##4##6##(1992-8#1)(1995-3#1)(1996-3#1)(2007-3#1)
results in a marked reduction in##2##6##(1993-8#1)(1996-12#1)
results in a marked##10##4##(1992-8#1)(1993-6#1)(1993-8#1)(1994-3#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-6#1)(2007-3#1)(2010-2#1)
results in a more##2##4##(1992-1#1)(2006-4#1)
results in a much##2##4##(1990-5#1)(2008-3#1)
results in a mutant enzyme##2##5##(1990-2#1)(1993-6#1)
results in a mutant##3##4##(1990-2#1)(1993-6#1)(1997-6#1)
results in a net##2##4##(2006-8#2)
results in a new##2##4##(2008-10#1)(2010-2#1)
results in a predictable##2##4##(2006-5#1)(2007-12#1)
results in a progressive##3##4##(1992-8#1)(2008-4#1)(2012-12#1)
results in a range of##2##5##(2006-10#1)(2008-9#1)
results in a rapid increase in##2##6##(1990-5#1)(1997-5#1)
results in a rapid##4##4##(1990-5#1)(1991-5#1)(1996-4#1)(1997-5#1)
results in a reduced##2##4##(2005-11#1)(2008-7#1)
results in a reduction in the##3##6##(1994-11#1)(2006-9#1)(2009-11#1)
results in a reduction in##7##5##(1994-11#1)(1994-8#1)(2006-9#1)(2007-12#1)(2009-11#1)(2012-2#2)
results in a reduction of##3##5##(2006-10#1)(2008-1#2)
results in a reduction##10##4##(1994-11#1)(1994-8#1)(2006-10#1)(2006-9#1)(2007-12#1)(2008-1#2)(2009-11#1)(2012-2#2)
results in a robust##2##4##(2012-12#1)(2012-2#1)
results in a series of##2##5##(1994-2#1)(2007-8#1)
results in a shift in##2##5##(1995-3#1)(2008-2#1)
results in a significant##6##4##(2006-6#1)(2008-2#1)(2008-5#1)(2008-6#1)(2012-12#1)(2012-2#1)
results in a simple##2##4##(2008-2#1)(2008-3#1)
results in a smaller##2##4##(1995-3#1)(2013-1#1)
results in a strong##2##4##(1993-3#1)(2008-9#1)
results in a surface##2##4##(2005-11#2)
results in a time dependent##2##5##(1991-4#1)(1991-9#1)
results in a total##2##4##(1993-4#1)(2011-1#1)
results in a unique##2##4##(1996-5#1)(2008-4#1)
results in a very##3##4##(1990-12#1)(2007-4#1)(2008-10#1)
results in a##289##3##(1990-11#3)(1990-12#1)(1990-2#2)(1990-4#4)(1990-5#5)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#6)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#3)(1992-9#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-6#3)(1993-8#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#4)(1994-6#1)(1994-8#4)(1994-9#3)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#3)(1996-3#1)(1996-4#3)(1996-5#3)(1996-6#1)(1996-7#2)(1997-1#2)(1997-4#1)(1997-5#2)(1997-6#5)(1997-7#2)(2004-9#2)(2005-11#10)(2006-10#3)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#4)(2006-8#2)(2006-9#3)(2007-11#6)(2007-12#13)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#18)(2008-3#10)(2008-4#7)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#5)(2009-10#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#3)(2010-3#2)(2010-7#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#11)(2012-2#4)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#1)
results in aberrant##2##3##(1991-9#1)(1996-2#1)
results in abnormal##2##3##(1997-5#1)(2012-3#1)
results in about##2##3##(1990-12#1)(1992-9#1)
results in accumulation##2##3##(2008-12#1)(2008-5#1)
results in accurate##2##3##(2009-2#1)(2012-1#1)
results in activation of##2##4##(1994-9#1)(2013-1#1)
results in adult##3##3##(1996-4#1)(2007-8#1)(2008-1#1)
results in agreement with##3##4##(1996-7#1)(2008-10#1)(2008-3#1)
results in an additional##3##4##(1992-8#1)(1994-9#1)(2007-12#1)
results in an enzyme##2##4##(1992-9#2)
results in an immediate##2##4##(1997-5#1)(2005-7#1)
results in an improved##3##4##(1996-9#1)(2006-2#1)(2008-3#1)
results in an increase in the##3##6##(1990-8#1)(1991-2#1)(2008-10#1)
results in an increase in##10##5##(1990-8#1)(1991-2#1)(1992-6#1)(1992-8#1)(1996-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)
results in an increase of the##2##6##(1994-12#1)(2008-2#1)
results in an increase of##4##5##(1991-5#1)(1994-12#1)(2005-10#1)(2008-2#1)
results in an increase##14##4##(1990-8#1)(1991-2#1)(1991-5#1)(1992-6#1)(1992-8#1)(1994-12#1)(1996-12#1)(2005-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)
results in an increased##8##4##(1990-2#1)(2006-2#1)(2008-3#1)(2008-7#1)(2009-3#1)(2011-1#1)(2013-1#1)(2013-7#1)
results in an##71##3##(1990-12#1)(1990-2#1)(1990-4#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-7#2)(1992-6#1)(1992-8#2)(1992-9#2)(1994-12#1)(1994-2#1)(1994-9#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-11#3)(2005-7#1)(2006-2#2)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#4)(2008-3#5)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-6#1)(2010-12#2)(2011-1#2)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
results in approximately##3##3##(1990-2#1)(1994-9#1)(2009-8#1)
results in better##2##3##(1995-2#1)(2008-10#1)
results in both##10##3##(1992-2#1)(2005-8#1)(2007-11#2)(2008-10#3)(2008-2#1)(2008-4#1)(2012-12#1)
results in cellular##3##3##(1992-2#1)(2008-10#1)(2008-9#1)
results in change in##2##4##(2008-10#1)(2008-8#1)
results in changes in##5##4##(1994-12#1)(1996-4#1)(1996-5#1)(2007-4#1)(2013-8#1)
results in children with##4##4##(2006-10#1)(2011-2#3)
results in clinical trials##2##4##(2008-1#1)(2011-2#1)
results in clinical##3##3##(2008-1#1)(2008-12#1)(2011-2#1)
results in comparison with##4##4##(1992-10#1)(1997-8#1)(2008-10#1)(2008-7#1)
results in comparison##5##3##(1992-10#1)(1997-8#1)(2008-10#1)(2008-7#1)(2010-4#1)
results in complete recovery##2##4##(1992-12#1)(2009-6#1)
results in complete##6##3##(1992-12#1)(1995-6#1)(1996-7#1)(2008-3#1)(2009-2#1)(2009-6#1)
results in considerable##6##3##(2006-10#1)(2007-3#1)(2007-7#2)(2008-11#1)(2008-3#1)
results in context of##2##4##(2006-1#1)(2012-2#1)
results in controlled##2##3##(1997-4#1)(2009-2#1)
results in death in##2##4##(1992-9#1)(2010-2#1)
results in death##4##3##(1992-9#1)(2008-11#1)(2008-3#1)(2010-2#1)
results in decreased##4##3##(1990-11#1)(2006-10#1)(2011-1#1)(2013-1#1)
results in decreasing##2##3##(1993-9#1)(2007-8#1)
results in defective##3##3##(1995-1#1)(2012-12#1)(2013-7#1)
results in degeneration of##2##4##(1996-10#1)(2010-3#1)
results in diagnosis##2##3##(2007-7#1)(2008-7#1)
results in diverse##2##3##(2008-7#1)(2009-12#1)
results in earlier##3##3##(1993-3#1)(1997-8#1)(2008-8#1)
results in early##2##3##(2006-12#1)(2007-11#1)
results in edema formation##2##4##(1994-8#1)(1996-9#1)
results in efficient##4##3##(1994-9#1)(1997-4#1)(2007-12#1)(2009-6#1)
results in embryonic lethality##2##4##(1995-2#1)(2007-8#1)
results in embryonic##3##3##(1995-2#1)(2007-8#1)(2008-8#1)
results in enhanced##12##3##(1990-3#1)(1993-11#1)(1994-11#1)(1994-9#1)(1995-1#1)(2007-12#1)(2008-10#2)(2008-3#2)(2009-3#1)(2013-8#1)
results in experimental##3##3##(1996-12#1)(2007-11#1)(2007-5#1)
results in expression of##2##4##(1992-12#1)(1995-5#1)
results in failure of##2##4##(2006-10#1)(2008-7#1)
results in faster##2##3##(2007-10#1)(2007-8#1)
results in formation of##3##4##(1996-10#1)(2006-6#1)(2008-5#1)
results in good agreement with##2##5##(2008-10#1)(2008-3#1)
results in greater##6##3##(1997-7#1)(2007-11#1)(2008-2#1)(2010-2#1)(2011-1#2)
results in growth##2##3##(1993-9#1)(1996-10#1)
results in high##11##3##(1990-11#1)(1991-7#1)(1995-4#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#2)
results in higher##5##3##(2006-10#1)(2008-11#2)(2008-4#1)(2010-6#1)
results in highly##2##3##(2008-11#1)(2009-9#1)
results in hypersensitivity##2##3##(1995-8#1)(2008-3#1)
results in images##2##3##(2007-12#1)(2008-3#1)
results in impaired##4##3##(1994-10#1)(1995-2#1)(2008-10#1)(2010-5#1)
results in improved##10##3##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-8#1)(2011-2#2)(2012-2#1)
results in improvement of##2##4##(2006-2#1)(2006-6#1)
results in inactivation of the##2##5##(1992-11#1)(1994-8#1)
results in increased##23##3##(1993-4#2)(1993-7#1)(1994-3#1)(1996-5#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
results in induction of##2##4##(1992-8#1)(1994-11#1)
results in inhibition of##3##4##(1992-8#1)(2006-9#1)(2010-12#1)
results in initial##2##3##(1990-2#1)(2006-10#1)
results in its##5##3##(1995-8#1)(1996-8#1)(2005-7#1)(2006-6#1)(2008-10#1)
results in kidney##2##3##(2007-7#1)(2013-1#1)
results in large##2##3##(1997-6#1)(2010-1#1)
results in less##3##3##(1996-7#1)(2007-10#1)(2008-5#1)
results in liver##2##3##(1990-4#1)(2010-8#1)
results in loss of##5##4##(1995-3#1)(2005-7#1)(2008-7#2)(2013-1#1)
results in low##3##3##(1997-5#1)(2008-2#1)(2012-2#1)
results in lower##2##3##(2007-6#1)(2009-5#1)
results in malignant transformation##2##4##(2005-11#1)(2007-12#1)
results in many##2##3##(2007-6#1)(2013-8#1)
results in more accurate##3##4##(1990-3#1)(1996-8#1)(2010-6#1)
results in more##5##3##(1990-3#1)(1993-2#1)(1996-8#1)(2007-8#1)(2010-6#1)
results in much##2##3##(2008-11#1)(2009-6#1)
results in multiple##2##3##(1993-11#1)(2010-3#1)
results in neonatal##2##3##(1992-2#1)(1997-2#1)
results in net##2##3##(2006-10#1)(2008-10#1)
results in no##2##3##(1996-10#1)(2013-1#1)
results in one##2##3##(1997-7#1)(2008-5#1)
results in only a small##2##5##(1994-8#1)(2008-3#1)
results in only##3##3##(1994-8#1)(2008-3#1)(2013-8#1)
results in other populations##3##4##(2010-2#1)(2012-2#1)(2013-1#1)
results in other##6##3##(2006-10#1)(2008-12#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
results in our##3##3##(2006-10#1)(2007-11#1)(2008-1#1)
results in overexpression of##2##4##(2009-3#1)(2010-11#1)
results in part from##2##4##(2007-5#1)(2011-2#1)
results in partial##2##3##(1995-1#1)(2008-9#1)
results in patient##2##3##(2006-7#1)(2010-6#1)
results in patients with##10##4##(2006-3#1)(2006-8#1)(2007-11#1)(2007-8#3)(2008-10#2)(2010-10#1)(2013-8#1)
results in patients##14##3##(2006-3#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-8#4)(2008-10#2)(2009-12#1)(2010-10#1)(2011-1#1)(2013-8#1)
results in production of##3##4##(1994-3#1)(1995-2#1)(2008-4#1)
results in progressive##2##3##(1993-12#1)(2010-10#1)
results in prolonged##3##3##(2007-8#1)(2008-10#1)(2008-11#1)
results in pulmonary##2##3##(2010-3#1)(2012-12#1)
results in rapid##4##3##(1992-8#1)(1996-4#1)(1996-8#1)(2008-10#1)
results in real time##3##4##(2008-1#1)(2008-10#1)(2010-8#1)
results in reduced##13##3##(1996-5#1)(2005-11#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-6#1)(2012-2#1)(2013-1#2)
results in reduction of the##2##5##(2008-10#1)(2008-9#1)
results in reduction of##3##4##(2008-10#1)(2008-9#1)(2012-2#1)
results in reduction##4##3##(2008-10#1)(2008-6#1)(2008-9#1)(2012-2#1)
results in relation to the##2##5##(2007-11#1)(2008-10#1)
results in relation to##4##4##(1993-10#1)(1994-7#1)(2007-11#1)(2008-10#1)
results in repeated##2##3##(2008-11#1)(2008-5#1)
results in residual##2##3##(2006-8#1)(2007-12#1)
results in samples##2##3##(1993-1#1)(2008-12#1)
results in selected##3##3##(1994-2#1)(1996-11#1)(2007-8#1)
results in several##3##3##(1992-3#1)(1993-3#1)(2008-10#1)
results in severe and##2##4##(2007-11#1)(2011-2#1)
results in severe##7##3##(1992-7#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-4#1)(2008-9#1)(2011-2#1)
results in significant morbidity and##2##5##(2006-10#2)
results in significant##14##3##(1992-7#1)(1993-2#1)(1993-6#1)(2006-10#2)(2007-11#1)(2008-10#3)(2008-7#1)(2010-12#1)(2011-1#1)(2012-2#2)
results in significantly##3##3##(1996-11#1)(1996-12#1)(2008-2#1)
results in similar##4##3##(1993-3#1)(1994-8#1)(2006-11#1)(2006-5#1)
results in simple##2##3##(1990-6#1)(2008-10#1)
results in small##2##3##(2006-10#1)(2011-2#1)
results in some##3##3##(2008-1#1)(2008-4#2)
results in specific##3##3##(1990-10#1)(1992-9#1)(2007-8#1)
results in strong##2##3##(2008-10#1)(2011-12#1)
results in substantial##2##3##(2008-8#1)(2011-3#1)
results in terms of the##3##5##(1994-2#1)(2006-4#1)(2007-12#1)
results in terms of##20##4##(1990-6#1)(1992-10#1)(1994-2#1)(1996-2#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
results in the 1##2##4##(1992-6#1)(2007-9#1)
results in the accumulation of##2##5##(2008-3#1)(2009-12#1)
results in the acquisition of##2##5##(1991-8#1)(1997-7#1)
results in the activation of##2##5##(2007-12#1)(2009-8#1)
results in the analysis##2##4##(2008-10#1)(2008-3#1)
results in the appearance of##2##5##(1995-10#1)(2008-3#1)
results in the case of##3##5##(2008-10#2)(2008-2#1)
results in the clinical##2##4##(2008-1#1)(2009-5#1)
results in the complete loss of##2##6##(1992-12#1)(2012-2#1)
results in the context of the##2##6##(2007-12#1)(2008-1#1)
results in the context of##7##5##(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#2)
results in the decrease of##2##5##(2008-10#1)(2013-1#1)
results in the determination of##3##5##(2008-10#3)
results in the development of##7##5##(1994-3#1)(1996-5#1)(2004-12#1)(2007-9#1)(2008-1#1)(2008-6#1)(2011-1#1)
results in the differentiation##2##4##(2012-11#1)(2012-2#1)
results in the expression of##2##5##(1992-11#1)(2008-11#1)
results in the formation of a##4##6##(2007-12#2)(2008-10#1)(2009-7#1)
results in the formation of isomeric##2##6##(1996-2#1)(1996-5#1)
results in the formation of the##3##6##(1994-9#1)(2006-4#1)(2009-10#1)
results in the formation of two##2##6##(2006-12#1)(2008-10#1)
results in the formation of##24##5##(1994-9#2)(1996-2#1)(1996-5#3)(2006-10#1)(2006-12#2)(2006-4#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-3#1)(2008-4#2)(2008-5#1)(2009-10#1)(2009-7#1)(2012-2#1)
results in the fusion of##2##5##(1991-11#1)(2007-11#1)
results in the generation of a##3##6##(1992-6#1)(1992-9#1)(1995-3#1)
results in the generation of##5##5##(1992-6#1)(1992-9#1)(1995-3#1)(2006-2#1)(2010-4#1)
results in the increase of##2##5##(1990-5#1)(2013-7#1)
results in the increased##2##4##(1994-9#1)(2008-8#1)
results in the induction of##2##5##(1994-3#1)(1994-9#1)
results in the inhibition of##3##5##(1990-8#1)(1991-10#1)(1995-2#1)
results in the literature##3##4##(2008-12#1)(2009-5#1)(2011-2#1)
results in the local##2##4##(1991-5#1)(1992-12#1)
results in the loss of##4##5##(1991-2#1)(1991-9#1)(1994-3#1)(2008-12#1)
results in the management of##2##5##(1993-4#1)(2006-8#1)
results in the production of##6##5##(1994-12#1)(1996-5#2)(2006-12#1)(2008-3#1)(2012-1#1)
results in the rapid##4##4##(1991-2#1)(1991-7#1)(1992-12#1)(1994-8#1)
results in the release of##2##5##(2009-8#1)(2013-8#1)
results in the same##2##4##(1991-2#1)(1994-12#1)
results in the studies##2##4##(2008-10#1)(2008-3#1)
results in the treatment of##5##5##(1990-6#1)(1995-5#1)(2007-8#1)(2010-9#1)(2011-3#1)
results in the##229##3##(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-5#3)(1991-7#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-4#2)(1993-5#1)(1993-7#2)(1994-11#1)(1994-12#4)(1994-3#3)(1994-8#1)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-9#1)(1996-2#5)(1996-5#8)(1997-2#1)(1997-4#1)(1997-7#1)(2004-10#1)(2004-12#1)(2005-11#3)(2005-6#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#4)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#4)(2007-12#6)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#3)(2008-1#3)(2008-10#23)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#9)(2008-4#7)(2008-5#3)(2008-6#3)(2008-7#6)(2008-8#5)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#3)(2009-7#2)(2009-8#3)(2010-12#4)(2010-4#2)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
results in their##4##3##(1992-5#1)(2007-5#1)(2008-4#1)(2010-8#1)
results in these##2##3##(2008-5#1)(2011-2#1)
results in this area##2##4##(2005-7#1)(2008-9#1)
results in this paper##2##4##(1997-2#1)(2012-2#1)
results in this report##2##4##(2007-7#1)(2013-7#1)
results in this##11##3##(1995-11#1)(1997-2#1)(2005-7#2)(2007-2#1)(2007-7#2)(2008-9#1)(2012-12#1)(2012-2#1)(2013-7#1)
results in those##2##3##(2006-8#1)(2010-5#1)
results in tissue##3##3##(2007-2#1)(2008-9#1)(2009-3#1)
results in transformation##2##3##(2006-10#1)(2008-4#1)
results in two##5##3##(1991-9#1)(1994-12#1)(2005-8#1)(2007-12#1)(2009-12#1)
results in tyrosine phosphorylation of Shc##2##6##(1997-7#2)
results in various##3##3##(2008-1#1)(2009-12#1)(2012-2#1)
results in very##3##3##(2007-8#1)(2008-2#1)(2008-3#1)
results in view of the##2##5##(1991-7#1)(2008-10#1)
results in vitro##3##3##(1995-11#1)(2007-11#1)(2011-2#1)
results in##1484##2##(1990-10#2)(1990-11#8)(1990-12#6)(1990-2#6)(1990-3#4)(1990-4#10)(1990-5#9)(1990-6#3)(1990-7#2)(1990-8#3)(1991-1#1)(1991-10#2)(1991-11#4)(1991-12#5)(1991-2#4)(1991-3#3)(1991-4#1)(1991-5#12)(1991-7#10)(1991-8#4)(1991-9#9)(1992-1#2)(1992-10#2)(1992-11#5)(1992-12#6)(1992-2#7)(1992-3#7)(1992-4#1)(1992-5#3)(1992-6#7)(1992-7#4)(1992-8#9)(1992-9#9)(1993-1#2)(1993-10#1)(1993-11#6)(1993-12#4)(1993-2#4)(1993-3#8)(1993-4#6)(1993-5#1)(1993-6#7)(1993-7#4)(1993-8#3)(1993-9#5)(1994-10#3)(1994-11#6)(1994-12#13)(1994-2#5)(1994-3#11)(1994-5#6)(1994-6#2)(1994-7#1)(1994-8#12)(1994-9#14)(1995-1#6)(1995-10#1)(1995-11#6)(1995-12#6)(1995-2#8)(1995-3#10)(1995-4#1)(1995-5#3)(1995-6#3)(1995-7#2)(1995-8#5)(1995-9#2)(1996-1#1)(1996-10#9)(1996-11#5)(1996-12#9)(1996-2#9)(1996-3#4)(1996-4#7)(1996-5#19)(1996-6#2)(1996-7#8)(1996-8#5)(1996-9#3)(1997-1#6)(1997-2#6)(1997-3#4)(1997-4#8)(1997-5#7)(1997-6#8)(1997-7#9)(1997-8#4)(2004-1#1)(2004-10#1)(2004-12#1)(2004-9#3)(2005-10#6)(2005-11#20)(2005-6#1)(2005-7#7)(2005-8#5)(2005-9#2)(2006-1#1)(2006-10#30)(2006-11#4)(2006-12#7)(2006-2#6)(2006-3#2)(2006-4#4)(2006-5#8)(2006-6#10)(2006-7#3)(2006-8#8)(2006-9#5)(2007-1#2)(2007-10#3)(2007-11#38)(2007-12#49)(2007-2#5)(2007-3#3)(2007-4#3)(2007-5#3)(2007-6#4)(2007-7#19)(2007-8#29)(2007-9#9)(2008-1#20)(2008-10#91)(2008-11#27)(2008-12#8)(2008-2#46)(2008-3#45)(2008-4#29)(2008-5#30)(2008-6#17)(2008-7#37)(2008-8#24)(2008-9#20)(2009-10#3)(2009-11#2)(2009-12#7)(2009-2#4)(2009-3#7)(2009-4#2)(2009-5#6)(2009-6#8)(2009-7#5)(2009-8#13)(2009-9#4)(2010-1#1)(2010-10#4)(2010-11#3)(2010-12#13)(2010-2#11)(2010-3#6)(2010-4#4)(2010-5#6)(2010-6#3)(2010-7#4)(2010-8#4)(2010-9#3)(2011-1#20)(2011-12#3)(2011-2#31)(2011-3#3)(2012-1#9)(2012-11#2)(2012-12#27)(2012-2#25)(2012-3#12)(2013-1#33)(2013-7#7)(2013-8#13)
results include the following##2##4##(1993-8#1)(2008-11#1)
results include the##3##3##(1993-8#1)(2008-11#1)(2008-3#1)
results include##5##2##(1993-8#1)(2008-10#1)(2008-11#1)(2008-3#2)
results including##2##2##(2006-3#1)(2008-10#1)
results indicate a high##2##4##(1990-2#1)(2012-12#1)
results indicate a positive impact##2##5##(2011-2#2)
results indicate a previously##2##4##(1995-5#2)
results indicate a##35##3##(1990-2#1)(1990-6#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-8#1)(1993-3#1)(1993-7#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#1)(1997-1#1)(1997-7#1)(2006-12#2)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)
results indicate an important##2##4##(2008-10#1)(2008-2#1)
results indicate an##7##3##(1991-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-3#2)
results indicate for the first time##2##6##(1993-6#1)(2013-1#1)
results indicate that (1) the##2##5##(1993-1#1)(2006-11#1)
results indicate that (1)##3##4##(1993-1#1)(2006-11#1)(2007-12#1)
results indicate that (a)##3##4##(1993-3#1)(1997-6#1)(2007-5#1)
results indicate that 1##2##4##(1994-11#1)(2009-6#1)
results indicate that 1)##2##4##(1996-5#1)(2006-5#1)
results indicate that GABA##3##4##(1997-6#1)(2008-8#2)
results indicate that PAF##2##4##(1991-4#1)(1993-4#1)
results indicate that PKC##3##4##(1994-8#1)(1995-2#1)(1996-8#1)
results indicate that RA##2##4##(1993-6#1)(2006-10#1)
results indicate that X##2##4##(1997-2#1)(2008-10#1)
results indicate that a combination of##2##6##(1996-4#1)(2006-5#1)
results indicate that a significant##2##5##(1991-6#1)(1995-1#1)
results indicate that a##30##4##(1991-1#1)(1991-11#2)(1991-12#1)(1991-6#1)(1992-11#1)(1994-11#1)(1994-9#1)(1995-1#1)(1996-4#1)(1996-9#1)(1997-2#1)(2004-12#1)(2006-5#1)(2006-8#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
results indicate that adenosine##4##4##(1994-11#1)(1994-6#2)(2009-6#1)
results indicate that administration of##2##5##(1992-2#1)(2013-1#1)
results indicate that after##2##4##(1993-3#1)(2013-8#1)
results indicate that an##5##4##(1990-11#1)(1990-8#1)(1992-8#1)(1992-9#1)(1995-2#1)
results indicate that at least##4##5##(1991-4#1)(1992-5#1)(1994-11#1)(1994-2#1)
results indicate that at##7##4##(1991-2#1)(1991-4#1)(1992-5#1)(1994-11#1)(1994-2#1)(2005-11#1)(2008-7#1)
results indicate that basal##2##4##(1995-11#1)(2013-1#1)
results indicate that binding of##2##5##(1992-12#1)(1995-10#1)
results indicate that both##12##4##(1990-6#1)(1991-10#1)(1991-12#1)(1992-1#1)(1992-4#1)(1996-12#1)(1997-4#1)(2007-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2012-3#1)
results indicate that by##2##4##(1990-3#1)(2008-10#1)
results indicate that central##2##4##(1991-11#1)(1994-2#1)
results indicate that changes##2##4##(1990-7#1)(2013-7#1)
results indicate that chronic##3##4##(1990-3#1)(1990-7#1)(1996-12#1)
results indicate that dietary##2##4##(1992-4#1)(2006-8#1)
results indicate that differences##2##4##(1992-7#1)(1995-11#1)
results indicate that different##6##4##(1992-12#1)(1992-9#1)(1995-12#1)(2004-11#1)(2007-11#1)(2013-1#1)
results indicate that endogenous##3##4##(1991-11#1)(1993-11#1)(2008-5#1)
results indicate that for##4##4##(1992-1#1)(1992-7#1)(2008-10#1)(2010-2#1)
results indicate that high##3##4##(1991-4#1)(1996-4#1)(2010-2#1)
results indicate that human##3##4##(1990-9#1)(1992-7#1)(1997-5#1)
results indicate that hypertension##2##4##(1990-2#1)(2008-1#1)
results indicate that in human##2##5##(1990-10#1)(1994-3#1)
results indicate that in the##6##5##(1994-3#1)(1997-1#1)(2006-8#1)(2008-2#2)(2008-5#1)
results indicate that in##21##4##(1990-10#1)(1992-5#1)(1994-3#3)(1995-6#1)(1996-5#2)(1997-1#2)(2005-8#1)(2006-6#1)(2006-8#1)(2008-10#1)(2008-2#2)(2008-5#2)(2008-8#1)(2009-4#1)(2012-12#1)
results indicate that intracellular##2##4##(1994-6#1)(2008-8#1)
results indicate that it is##2##5##(1992-12#1)(2009-6#1)
results indicate that it##5##4##(1992-12#1)(2008-3#2)(2008-4#1)(2009-6#1)
results indicate that most##5##4##(1990-8#1)(1996-2#1)(2007-12#1)(2010-12#1)(2010-3#1)
results indicate that not only##3##5##(1993-2#1)(1994-8#1)(2008-11#1)
results indicate that one of the##3##6##(2008-5#1)(2009-9#1)(2012-1#1)
results indicate that one##4##4##(1991-8#1)(2008-5#1)(2009-9#1)(2012-1#1)
results indicate that only##4##4##(1990-5#1)(1992-3#1)(1993-4#1)(2005-9#1)
results indicate that oxidative stress##2##5##(1992-12#1)(1996-3#1)
results indicate that protein##2##4##(1991-7#1)(1997-5#1)
results indicate that selective##2##4##(1996-10#1)(2012-1#1)
results indicate that some complexes have##2##6##(2008-5#2)
results indicate that some##9##4##(1990-7#1)(1992-8#1)(1995-1#1)(1995-12#1)(1996-5#1)(2005-11#1)(2007-12#1)(2008-5#2)
results indicate that statistical##2##4##(1992-4#1)(2008-9#1)
results indicate that staurosporine##2##4##(1990-12#1)(1995-12#1)
results indicate that the NH2-terminal##2##5##(1992-11#1)(1996-8#1)
results indicate that the association##3##5##(1995-8#1)(2008-10#1)(2008-12#1)
results indicate that the beneficial##2##5##(1994-6#1)(2006-8#1)
results indicate that the best##2##5##(1992-2#1)(2007-11#1)
results indicate that the conditions##2##5##(1995-8#1)(2008-8#1)
results indicate that the dynamics of##2##6##(2007-12#1)(2008-8#1)
results indicate that the effect of##2##6##(1996-2#1)(2012-2#1)
results indicate that the effects of##4##6##(1993-2#1)(1994-9#1)(2008-12#1)(2011-2#1)
results indicate that the effects##5##5##(1993-2#1)(1994-9#1)(2008-11#1)(2008-12#1)(2011-2#1)
results indicate that the electrode##2##5##(2008-10#2)
results indicate that the enhanced##2##5##(1993-11#1)(2008-10#1)
results indicate that the increased##2##5##(1993-9#1)(2008-10#1)
results indicate that the inhibition##2##5##(1994-11#1)(1994-5#1)
results indicate that the initial##2##5##(1990-11#1)(2007-9#1)
results indicate that the major##5##5##(1990-7#2)(1991-8#1)(1995-5#1)(2008-9#1)
results indicate that the method##3##5##(1991-8#1)(2005-12#1)(2008-10#1)
results indicate that the peak##2##5##(1997-3#1)(2007-1#1)
results indicate that the population##2##5##(1993-5#1)(2008-5#1)
results indicate that the procedure##2##5##(2008-10#1)(2011-2#1)
results indicate that the proposed##2##5##(2007-12#1)(2012-3#1)
results indicate that the shape of the##2##7##(1994-8#1)(2007-12#1)
results indicate that the suppression of##2##6##(1993-12#1)(2007-11#1)
results indicate that the transmission##2##5##(2008-3#1)(2013-8#1)
results indicate that the type##2##5##(1997-4#1)(2013-1#1)
results indicate that the##294##4##(1990-10#1)(1990-11#4)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#6)(1990-8#2)(1991-1#2)(1991-11#1)(1991-12#4)(1991-2#1)(1991-4#3)(1991-5#1)(1991-6#1)(1991-8#6)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#5)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#4)(1994-6#3)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#2)(1995-12#3)(1995-3#1)(1995-5#4)(1995-6#5)(1995-7#1)(1995-8#5)(1996-10#1)(1996-11#1)(1996-2#5)(1996-3#1)(1996-5#3)(1996-8#4)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-10#2)(2005-11#1)(2005-12#2)(2005-4#1)(2005-9#1)(2006-10#1)(2006-12#3)(2006-3#3)(2006-5#1)(2006-7#1)(2006-8#4)(2007-1#1)(2007-11#5)(2007-12#6)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#25)(2008-11#5)(2008-12#3)(2008-2#4)(2008-3#10)(2008-4#2)(2008-5#8)(2008-6#4)(2008-7#5)(2008-8#9)(2008-9#3)(2009-5#1)(2009-7#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#5)
results indicate that there is a##5##6##(1990-2#1)(1997-4#1)(2007-1#1)(2007-6#1)(2008-5#1)
results indicate that there is no##4##6##(1992-12#1)(1997-1#1)(2004-9#1)(2006-10#1)
results indicate that there is##9##5##(1990-2#1)(1992-12#1)(1997-1#1)(1997-4#1)(2004-9#1)(2006-10#1)(2007-1#1)(2007-6#1)(2008-5#1)
results indicate that there was no##2##6##(2007-2#1)(2013-1#1)
results indicate that there was##4##5##(2007-2#1)(2008-1#1)(2008-5#1)(2013-1#1)
results indicate that there##15##4##(1990-2#1)(1992-12#1)(1995-3#1)(1997-1#1)(1997-4#1)(2004-9#1)(2006-10#1)(2007-1#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-5#3)(2013-1#1)
results indicate that these##10##4##(1990-10#1)(1991-6#1)(1993-9#1)(1994-5#1)(1995-12#2)(1995-8#1)(1997-5#1)(2008-10#1)(2010-8#1)
results indicate that this##9##4##(1991-5#1)(1992-8#1)(1993-6#1)(1996-4#1)(2005-10#1)(2007-10#1)(2008-10#1)(2008-11#1)(2010-5#1)
results indicate that under certain conditions##2##6##(1992-3#1)(2007-11#1)
results indicate that we##2##4##(1994-12#1)(2008-3#1)
results indicate that women##2##4##(2006-5#1)(2008-1#1)
results indicate that##1127##3##(1990-10#6)(1990-11#8)(1990-12#7)(1990-2#6)(1990-3#3)(1990-4#5)(1990-5#5)(1990-6#1)(1990-7#19)(1990-8#6)(1990-9#7)(1991-1#5)(1991-10#6)(1991-11#6)(1991-12#11)(1991-2#4)(1991-3#3)(1991-4#9)(1991-5#4)(1991-6#5)(1991-7#5)(1991-8#11)(1991-9#5)(1992-1#4)(1992-11#4)(1992-12#10)(1992-2#5)(1992-3#8)(1992-4#6)(1992-5#4)(1992-6#5)(1992-7#8)(1992-8#11)(1992-9#8)(1993-1#1)(1993-11#16)(1993-12#8)(1993-2#5)(1993-3#4)(1993-4#3)(1993-5#3)(1993-6#8)(1993-7#6)(1993-8#6)(1993-9#9)(1994-10#2)(1994-11#15)(1994-12#8)(1994-2#9)(1994-3#12)(1994-4#2)(1994-5#11)(1994-6#13)(1994-7#1)(1994-8#9)(1994-9#9)(1995-1#6)(1995-10#4)(1995-11#6)(1995-12#18)(1995-2#8)(1995-3#9)(1995-5#9)(1995-6#9)(1995-7#5)(1995-8#9)(1995-9#1)(1996-1#4)(1996-10#4)(1996-11#4)(1996-12#7)(1996-2#13)(1996-3#5)(1996-4#3)(1996-5#13)(1996-8#6)(1996-9#7)(1997-1#11)(1997-2#13)(1997-3#7)(1997-4#8)(1997-5#8)(1997-6#9)(1997-7#4)(1997-8#6)(2004-1#1)(2004-11#3)(2004-12#2)(2004-9#1)(2005-10#4)(2005-11#9)(2005-12#2)(2005-4#2)(2005-8#2)(2005-9#2)(2006-10#5)(2006-11#3)(2006-12#6)(2006-2#1)(2006-3#4)(2006-5#10)(2006-6#1)(2006-7#2)(2006-8#12)(2007-1#2)(2007-10#4)(2007-11#9)(2007-12#15)(2007-2#2)(2007-3#2)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#4)(2007-9#7)(2008-1#6)(2008-10#83)(2008-11#18)(2008-12#12)(2008-2#13)(2008-3#24)(2008-4#9)(2008-5#29)(2008-6#10)(2008-7#13)(2008-8#25)(2008-9#10)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#5)(2009-7#4)(2009-8#4)(2009-9#1)(2010-1#4)(2010-10#3)(2010-11#3)(2010-12#5)(2010-2#8)(2010-3#3)(2010-4#3)(2010-5#4)(2010-6#2)(2010-7#4)(2010-8#6)(2011-1#3)(2011-10#1)(2011-2#12)(2012-1#5)(2012-12#13)(2012-2#9)(2012-3#5)(2012-6#1)(2013-1#26)(2013-7#4)(2013-8#12)
results indicate the effectiveness of##2##5##(2008-7#1)(2010-6#1)
results indicate the existence of##5##5##(1992-3#1)(1993-9#1)(1994-8#1)(1996-4#1)(2008-10#1)
results indicate the following##3##4##(1992-6#1)(1996-4#1)(2008-6#1)
results indicate the importance of##4##5##(1990-10#1)(1990-6#1)(2010-6#1)(2013-8#1)
results indicate the need for##2##5##(1994-3#1)(2012-1#1)
results indicate the need##3##4##(1994-3#1)(2006-4#1)(2012-1#1)
results indicate the possibility of##4##5##(2008-3#1)(2010-12#1)(2012-1#1)(2013-8#1)
results indicate the presence of a##6##6##(1990-4#1)(1991-5#1)(1992-2#1)(1997-1#1)(2007-12#1)(2012-11#1)
results indicate the presence of##12##5##(1990-4#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-2#1)(1996-2#1)(1997-1#1)(2005-11#1)(2006-1#1)(2007-12#1)(2008-12#1)(2012-11#1)
results indicate the##47##3##(1990-10#1)(1990-4#1)(1990-6#1)(1991-4#2)(1991-5#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#2)(1993-9#2)(1994-3#1)(1994-8#1)(1996-2#1)(1996-4#3)(1997-1#1)(2005-11#1)(2006-1#1)(2006-4#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2010-12#1)(2010-6#2)(2011-1#1)(2012-1#2)(2012-11#1)(2012-12#1)(2013-8#2)
results indicate##1262##2##(1990-10#7)(1990-11#9)(1990-12#7)(1990-2#7)(1990-3#3)(1990-4#6)(1990-5#5)(1990-6#4)(1990-7#19)(1990-8#6)(1990-9#7)(1991-1#5)(1991-10#6)(1991-11#6)(1991-12#12)(1991-2#4)(1991-3#6)(1991-4#12)(1991-5#5)(1991-6#6)(1991-7#5)(1991-8#11)(1991-9#5)(1992-1#4)(1992-11#5)(1992-12#10)(1992-2#6)(1992-3#9)(1992-4#7)(1992-5#4)(1992-6#7)(1992-7#9)(1992-8#12)(1992-9#8)(1993-1#1)(1993-11#16)(1993-12#9)(1993-2#6)(1993-3#6)(1993-4#3)(1993-5#3)(1993-6#9)(1993-7#7)(1993-8#6)(1993-9#11)(1994-10#2)(1994-11#16)(1994-12#8)(1994-2#10)(1994-3#14)(1994-4#2)(1994-5#11)(1994-6#13)(1994-7#1)(1994-8#10)(1994-9#10)(1995-1#6)(1995-10#4)(1995-11#8)(1995-12#21)(1995-2#9)(1995-3#10)(1995-5#11)(1995-6#10)(1995-7#5)(1995-8#9)(1995-9#1)(1996-1#4)(1996-10#4)(1996-11#4)(1996-12#7)(1996-2#14)(1996-3#5)(1996-4#6)(1996-5#13)(1996-8#6)(1996-9#7)(1997-1#14)(1997-2#13)(1997-3#7)(1997-4#8)(1997-5#8)(1997-6#9)(1997-7#6)(1997-8#6)(2004-1#1)(2004-11#3)(2004-12#2)(2004-4#1)(2004-9#1)(2005-10#4)(2005-11#11)(2005-12#2)(2005-4#2)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#5)(2006-11#3)(2006-12#8)(2006-2#1)(2006-3#4)(2006-4#2)(2006-5#10)(2006-6#1)(2006-7#2)(2006-8#12)(2007-1#2)(2007-10#4)(2007-11#10)(2007-12#18)(2007-2#4)(2007-3#2)(2007-5#1)(2007-6#3)(2007-7#1)(2007-8#8)(2007-9#8)(2008-1#7)(2008-10#91)(2008-11#21)(2008-12#13)(2008-2#16)(2008-3#28)(2008-4#10)(2008-5#34)(2008-6#11)(2008-7#15)(2008-8#26)(2008-9#11)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#5)(2009-7#4)(2009-8#4)(2009-9#1)(2010-1#4)(2010-10#3)(2010-11#3)(2010-12#7)(2010-2#8)(2010-3#5)(2010-4#3)(2010-5#4)(2010-6#4)(2010-7#5)(2010-8#7)(2011-1#4)(2011-10#1)(2011-2#16)(2012-1#7)(2012-11#1)(2012-12#15)(2012-2#11)(2012-3#7)(2012-6#1)(2013-1#28)(2013-7#4)(2013-8#15)
results indicated a##20##3##(1992-2#1)(1993-12#1)(1993-9#1)(1994-11#1)(1995-6#1)(1996-5#1)(2005-8#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2009-8#1)(2012-11#1)(2012-12#1)
results indicated an##3##3##(1993-9#1)(1994-6#1)(2008-9#1)
results indicated clearly that##2##4##(2007-11#1)(2008-9#1)
results indicated that a##5##4##(1993-3#1)(1996-2#1)(2007-8#1)(2008-5#1)(2008-8#1)
results indicated that although##3##4##(1995-5#1)(2007-9#1)(2008-11#1)
results indicated that children##2##4##(2006-3#1)(2013-1#1)
results indicated that for##2##4##(2005-4#1)(2006-11#1)
results indicated that in##2##4##(2008-10#1)(2008-12#1)
results indicated that most##2##4##(2010-12#1)(2012-2#1)
results indicated that some##2##4##(2007-11#1)(2008-12#1)
results indicated that the tested compounds##2##6##(2009-6#1)(2012-11#1)
results indicated that the##91##4##(1990-2#1)(1991-8#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-4#1)(1994-3#2)(1995-10#1)(1995-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-4#1)(2004-10#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-4#2)(2005-7#2)(2006-12#1)(2007-10#2)(2007-11#2)(2007-6#1)(2007-8#1)(2008-10#17)(2008-11#4)(2008-12#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#3)(2009-1#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#1)(2011-3#4)(2012-1#2)(2012-11#1)(2013-1#2)(2013-7#1)(2013-8#3)
results indicated that there was a significant##2##7##(2008-10#2)
results indicated that there was a##3##6##(2008-10#3)
results indicated that there was##5##5##(1996-5#1)(2007-2#1)(2008-10#3)
results indicated that there##6##4##(1996-5#1)(2005-11#1)(2007-2#1)(2008-10#3)
results indicated that this##3##4##(1997-4#1)(2007-12#1)(2008-8#1)
results indicated that##241##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1991-10#1)(1991-12#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#2)(1992-8#3)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#3)(1993-7#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#2)(1995-5#2)(1995-6#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#2)(1996-8#1)(1997-2#1)(1997-4#4)(1997-8#2)(2004-10#1)(2004-12#2)(2005-10#1)(2005-11#4)(2005-12#1)(2005-4#4)(2005-7#2)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2007-10#3)(2007-11#3)(2007-12#3)(2007-2#3)(2007-6#1)(2007-8#3)(2007-9#1)(2008-10#39)(2008-11#6)(2008-12#6)(2008-3#1)(2008-4#2)(2008-5#10)(2008-6#2)(2008-7#1)(2008-8#8)(2008-9#12)(2009-1#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#3)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#6)(2011-3#5)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#4)(2013-1#3)(2013-7#5)(2013-8#7)
results indicated##289##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#3)(1992-9#1)(1993-1#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-4#3)(1993-7#1)(1993-9#3)(1994-11#2)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#2)(1995-5#2)(1995-6#2)(1995-7#1)(1996-12#1)(1996-2#1)(1996-5#3)(1996-6#2)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#4)(1997-7#1)(1997-8#2)(2004-10#1)(2004-12#2)(2005-10#1)(2005-11#4)(2005-12#1)(2005-4#5)(2005-7#2)(2005-8#1)(2006-11#1)(2006-12#2)(2006-3#2)(2006-4#1)(2006-8#1)(2007-10#3)(2007-11#4)(2007-12#5)(2007-2#4)(2007-6#1)(2007-8#3)(2007-9#1)(2008-10#42)(2008-11#7)(2008-12#8)(2008-3#2)(2008-4#2)(2008-5#11)(2008-6#3)(2008-7#1)(2008-8#8)(2008-9#16)(2009-1#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#3)(2011-2#7)(2011-3#5)(2012-1#3)(2012-11#3)(2012-12#3)(2012-2#4)(2013-1#3)(2013-7#6)(2013-8#8)
results indicates that the##2##4##(2008-3#1)(2011-1#1)
results indicates that##5##3##(1990-9#1)(1991-12#1)(2008-3#1)(2008-7#1)(2011-1#1)
results indicating that the##3##4##(2007-12#1)(2008-10#1)(2008-11#1)
results indicating that##6##3##(1994-11#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#2)
results indicating##9##2##(1991-7#1)(1994-11#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)
results influenced##2##2##(1992-1#1)(2009-9#1)
results into clinical##2##3##(1993-10#1)(2008-3#1)
results into the##2##3##(1996-6#1)(1997-2#1)
results into##8##2##(1993-10#1)(1996-6#1)(1997-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2012-2#1)
results introduce##2##2##(2008-11#1)(2011-2#1)
results involving##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
results is also##3##3##(2007-10#1)(2007-2#1)(2008-3#1)
results is demonstrated##3##3##(1995-2#1)(2007-12#1)(2008-3#1)
results is discussed##5##3##(1993-8#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-4#1)
results is given##2##3##(2008-2#1)(2008-5#1)
results is important##2##3##(2007-7#1)(2011-2#1)
results is limited by##2##4##(2006-10#1)(2011-2#1)
results is that##7##3##(1991-12#1)(1994-5#1)(1995-7#1)(2005-11#1)(2006-9#1)(2007-6#1)(2008-10#1)
results is the##2##3##(1994-2#1)(2008-9#1)
results is##53##2##(1991-12#2)(1992-9#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-7#1)(1997-3#1)(1997-5#1)(2004-4#1)(2005-11#2)(2006-10#1)(2006-2#1)(2006-4#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-2#7)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-3#2)(2011-2#2)(2011-7#1)(2013-7#1)
results it can be##4##4##(1990-12#1)(1991-2#1)(2007-12#1)(2008-2#1)
results it is suggested that##2##5##(2008-11#1)(2010-12#1)
results it is##6##3##(1991-3#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-12#1)
results it was##5##3##(1990-10#1)(1994-2#1)(2006-2#1)(2008-3#2)
results it##18##2##(1990-10#1)(1990-12#1)(1990-8#1)(1991-2#1)(1991-3#1)(1993-8#1)(1994-2#1)(1994-8#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2010-12#1)
results justify the creation of a new pathovar##2##8##(2008-10#2)
results justify the##5##3##(2004-2#1)(2007-11#1)(2008-10#2)(2010-5#1)
results largely##2##2##(1995-2#1)(2004-4#1)
results lead to##2##3##(1995-11#1)(2008-5#1)
results lead us to##4##4##(1994-2#1)(2008-10#2)(2008-4#1)
results lead##6##2##(1994-2#1)(1995-11#1)(2008-10#2)(2008-4#1)(2008-5#1)
results leading to##2##3##(2007-11#1)(2013-7#1)
results led to a diagnosis of##2##6##(2009-3#1)(2012-2#1)
results led to a##3##4##(2008-2#1)(2009-3#1)(2012-2#1)
results led to##4##3##(1995-9#1)(2008-2#1)(2009-3#1)(2012-2#1)
results led##6##2##(1994-8#1)(1995-9#1)(2008-2#1)(2008-6#1)(2009-3#1)(2012-2#1)
results lend support to##3##4##(2007-2#1)(2008-7#1)(2009-7#1)
results lend##5##2##(2007-2#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-2#1)
results look##2##2##(1991-3#1)(2008-1#1)
results mainly##2##2##(1997-8#1)(2010-7#1)
results make it##3##3##(1990-9#1)(1994-2#1)(2007-11#1)
results make##4##2##(1990-9#1)(1994-2#1)(2007-11#1)(2013-8#1)
results match##2##2##(2007-12#1)(2010-2#1)
results matched##3##2##(2007-7#1)(2007-9#1)(2008-5#1)
results may be an##2##4##(2007-8#1)(2008-10#1)
results may be useful for##2##5##(2008-5#2)
results may be useful##3##4##(1990-4#1)(2008-5#2)
results may be##19##3##(1990-4#1)(1995-1#1)(1995-10#1)(1997-5#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-9#1)(2010-3#1)(2010-8#1)(2012-2#1)
results may explain##2##3##(1994-8#1)(2008-10#1)
results may have##4##3##(1991-8#1)(1995-12#1)(2007-9#1)(2008-3#1)
results may help##7##3##(2005-11#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2011-2#1)
results may indicate that##2##4##(1991-5#1)(2008-10#1)
results may indicate##4##3##(1991-5#1)(1993-12#1)(2006-6#1)(2008-10#1)
results may lead to##2##4##(1993-12#1)(2012-12#1)
results may not be##2##4##(2006-7#1)(2010-1#1)
results may not##3##3##(2006-7#1)(2007-3#1)(2010-1#1)
results may prove##2##3##(2005-8#1)(2006-10#1)
results may provide##5##3##(1995-12#1)(2005-11#1)(2007-2#1)(2008-5#1)(2010-12#1)
results may reflect the##3##4##(1995-5#1)(2007-10#1)(2009-10#1)
results may reflect##5##3##(1995-5#1)(2006-9#1)(2007-10#1)(2008-7#1)(2009-10#1)
results may suggest that##2##4##(1997-8#1)(2007-10#1)
results may##70##2##(1990-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1993-12#2)(1993-3#1)(1994-1#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#2)(1995-5#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-11#3)(2005-8#1)(2006-10#3)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-3#1)(2008-5#4)(2008-7#4)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#4)(2013-8#1)
results mean##2##2##(2005-10#1)(2008-5#1)
results measured by##2##3##(2008-10#1)(2011-1#1)
results might be##2##3##(1990-6#1)(2011-1#1)
results might##6##2##(1990-6#1)(1992-8#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#1)
results monitoring##2##2##(2008-10#1)(2011-2#1)
results must be confirmed##2##4##(2007-11#1)(2008-10#1)
results must be##5##3##(1993-11#1)(2006-2#1)(2007-11#1)(2008-10#1)(2009-4#1)
results need to be##6##4##(2006-11#1)(2007-9#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-8#1)
results need##8##2##(2006-11#1)(2007-9#1)(2008-1#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-1#1)
results not only provide##2##4##(1994-11#1)(2008-9#1)
results not only##5##3##(1993-11#1)(1994-11#1)(1996-4#1)(2008-11#1)(2008-9#1)
results not##6##2##(1993-11#1)(1994-11#1)(1996-4#1)(2008-11#1)(2008-9#1)(2011-1#1)
results observed in the##2##4##(1992-12#1)(2011-2#1)
results observed in##5##3##(1992-12#1)(1993-7#1)(1997-3#1)(2007-7#1)(2011-2#1)
results observed##8##2##(1992-12#1)(1993-7#1)(1997-3#1)(1997-4#1)(2007-7#1)(2008-5#1)(2011-2#2)
results obtained after##4##3##(2008-10#3)(2008-8#1)
results obtained agree##5##3##(2007-12#1)(2008-10#4)
results obtained and##3##3##(1992-6#1)(2008-3#1)(2012-12#1)
results obtained are discussed##4##4##(1995-8#1)(2008-10#1)(2009-9#1)(2010-2#1)
results obtained are in excellent agreement##2##6##(2008-10#1)(2008-2#1)
results obtained are in good agreement with the##2##8##(2008-10#1)(2008-2#1)
results obtained are in good agreement with##3##7##(2008-10#2)(2008-2#1)
results obtained are in##5##4##(2008-10#3)(2008-2#2)
results obtained are##26##3##(1990-11#1)(1995-8#1)(1996-9#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-10#1)(2008-10#9)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#1)(2009-9#1)(2010-2#1)(2012-12#1)
results obtained at the##2##4##(1993-3#1)(2008-3#1)
results obtained at##3##3##(1993-3#1)(2008-3#2)
results obtained by ICP-AES##3##4##(2008-10#2)(2013-7#1)
results obtained by a##2##4##(2008-2#1)(2008-3#1)
results obtained by both##3##4##(2008-10#3)
results obtained by other##2##4##(1991-9#1)(2008-3#1)
results obtained by the present##2##5##(2008-10#2)
results obtained by the proposed method and those##2##8##(2008-10#2)
results obtained by the proposed method and##4##7##(2008-10#4)
results obtained by the proposed method were##3##7##(2008-10#3)
results obtained by the proposed method##8##6##(2008-10#8)
results obtained by the proposed##11##5##(2008-10#11)
results obtained by the two methods##6##6##(1996-5#1)(2006-1#1)(2007-7#1)(2008-10#2)(2009-6#1)
results obtained by the two##9##5##(1992-4#1)(1996-5#1)(2006-1#1)(2007-7#1)(2008-10#3)(2008-5#1)(2009-6#1)
results obtained by the##40##4##(1991-12#1)(1992-4#1)(1996-5#1)(2005-11#1)(2006-1#1)(2006-4#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#26)(2008-2#1)(2008-5#1)(2008-6#1)(2009-6#1)
results obtained by these##2##4##(1992-2#1)(1992-8#1)
results obtained by this method were compared with the##2##9##(2008-10#2)
results obtained by this method##4##5##(2008-10#4)
results obtained by this##8##4##(2008-10#7)(2008-3#1)
results obtained by use of##3##5##(2008-3#3)
results obtained by using a##2##5##(2008-10#1)(2009-4#1)
results obtained by using the##2##5##(2007-8#1)(2012-1#1)
results obtained by using this electrode##2##6##(2008-10#2)
results obtained by using##8##4##(2007-8#1)(2008-10#5)(2009-4#1)(2012-1#1)
results obtained by##103##3##(1990-5#1)(1991-12#1)(1991-9#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-3#1)(1996-11#1)(1996-5#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#62)(2008-11#1)(2008-2#3)(2008-3#6)(2008-5#2)(2008-6#1)(2009-4#2)(2009-6#1)(2012-1#1)(2013-7#1)(2013-8#1)
results obtained compared##2##3##(2008-10#2)
results obtained could be explained by##2##6##(2006-8#1)(2008-10#1)
results obtained do not##2##4##(2008-4#1)(2008-5#1)
results obtained during the##2##4##(2007-11#1)(2008-8#1)
results obtained during##4##3##(2004-9#1)(2007-11#1)(2008-8#1)(2011-2#1)
results obtained for a##3##4##(2008-12#1)(2008-2#1)(2008-3#1)
results obtained for the assay of##2##6##(2008-10#2)
results obtained for the##16##4##(1996-11#1)(2005-11#1)(2006-10#1)(2007-8#1)(2008-10#10)(2008-3#1)(2009-4#1)
results obtained for##56##3##(1990-2#1)(1990-9#1)(1996-11#1)(1996-2#1)(2005-11#2)(2006-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#36)(2008-12#1)(2008-2#2)(2008-3#3)(2009-4#1)(2010-8#1)
results obtained from a##2##4##(2008-2#2)
results obtained from experiments##2##4##(1991-8#1)(2008-2#1)
results obtained from in##3##4##(2008-10#2)(2008-11#1)
results obtained from laboratory##2##4##(2008-1#1)(2008-10#1)
results obtained from the##13##4##(2005-11#1)(2006-10#1)(2006-4#1)(2007-8#2)(2008-10#2)(2008-3#1)(2008-5#2)(2010-12#1)(2010-2#1)(2011-1#1)
results obtained from##58##3##(1990-10#1)(1991-8#1)(1992-12#1)(1992-2#1)(1995-11#1)(2005-11#2)(2005-12#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-8#6)(2008-1#1)(2008-10#16)(2008-11#1)(2008-2#6)(2008-3#3)(2008-5#3)(2009-4#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-3#1)
results obtained have been##2##4##(1996-11#1)(2008-2#1)
results obtained have##4##3##(1993-8#1)(1996-11#1)(2008-10#1)(2008-2#1)
results obtained here##7##3##(1996-1#1)(2007-7#1)(2008-10#2)(2008-7#1)(2012-2#2)
results obtained in a##2##4##(1990-10#1)(1992-5#1)
results obtained in an##2##4##(2007-12#1)(2008-10#1)
results obtained in patients##2##4##(2008-5#1)(2011-2#1)
results obtained in the analysis of##3##6##(2008-10#3)
results obtained in the present study##2##6##(2008-10#1)(2008-5#1)
results obtained in the##19##4##(1992-9#1)(1994-2#2)(1996-5#1)(2006-11#1)(2007-11#1)(2008-1#1)(2008-10#8)(2008-5#2)(2009-12#1)(2010-5#1)
results obtained in these##2##4##(2008-5#1)(2009-5#1)
results obtained in this study##5##5##(1993-3#1)(2005-10#1)(2006-8#1)(2008-10#1)(2012-12#1)
results obtained in this work##3##5##(2008-10#1)(2010-11#1)(2011-1#1)
results obtained in this##18##4##(1992-2#1)(1993-3#1)(1993-8#1)(2005-10#1)(2005-4#1)(2006-11#1)(2006-8#1)(2007-10#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
results obtained in##69##3##(1990-10#1)(1990-6#1)(1990-7#1)(1992-2#1)(1992-5#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-8#1)(1994-2#2)(1996-4#1)(1996-5#1)(1996-8#1)(1997-3#1)(2005-10#1)(2005-11#1)(2005-4#1)(2006-11#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#2)(2009-5#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
results obtained indicated that##4##4##(1991-5#1)(1997-4#1)(2008-10#1)(2009-2#1)
results obtained indicated##6##3##(1991-5#1)(1997-4#1)(2008-10#3)(2009-2#1)
results obtained it##3##3##(1991-3#1)(2010-2#1)(2011-2#1)
results obtained on a##2##4##(2008-2#1)(2008-5#1)
results obtained on##4##3##(1997-7#1)(2008-2#1)(2008-5#1)(2011-3#1)
results obtained previously##2##3##(2008-3#2)
results obtained revealed##3##3##(2008-10#1)(2008-12#1)(2012-12#1)
results obtained show that##15##4##(1990-8#1)(1991-12#1)(1992-3#1)(2006-12#1)(2006-2#1)(2006-5#1)(2008-1#1)(2008-10#5)(2008-2#1)(2010-2#1)(2012-1#1)
results obtained show##23##3##(1990-8#1)(1991-12#1)(1991-5#1)(1992-3#1)(1997-7#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-5#3)(2010-2#1)(2010-5#1)(2012-1#1)
results obtained showed##13##3##(1990-2#1)(1990-5#1)(1991-10#1)(1993-3#1)(2008-10#5)(2008-8#1)(2010-5#1)(2010-8#1)(2013-7#1)
results obtained suggest the##2##4##(1994-5#1)(2009-2#1)
results obtained suggest##12##3##(1990-5#1)(1992-6#1)(1993-10#1)(1993-2#1)(1994-5#1)(1995-1#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-2#1)(2013-7#1)
results obtained support the##2##4##(1990-5#1)(2008-3#1)
results obtained through##2##3##(2007-11#1)(2012-3#1)
results obtained to date##2##4##(1993-8#1)(2008-7#1)
results obtained using a##4##4##(1996-5#2)(2008-10#1)(2008-2#1)
results obtained using liquid chromatography##2##5##(2008-10#2)
results obtained using the present method##2##6##(2008-10#1)(2012-2#1)
results obtained using the##13##4##(1990-8#1)(1997-4#1)(2008-10#7)(2008-5#1)(2008-6#1)(2010-8#1)(2012-2#1)
results obtained using these##3##4##(1995-2#1)(2008-10#1)(2008-5#1)
results obtained using##34##3##(1990-8#1)(1995-2#1)(1996-5#2)(1997-4#2)(1997-6#1)(2007-4#1)(2008-10#18)(2008-2#1)(2008-5#2)(2008-6#2)(2009-8#1)(2010-8#1)(2012-2#1)
results obtained were in##4##4##(2005-4#2)(2008-10#2)
results obtained were validated by comparison with##2##7##(1992-2#1)(2008-10#1)
results obtained were validated by##3##5##(1992-2#1)(2008-10#2)
results obtained were validated##4##4##(1992-2#1)(1996-3#1)(2008-10#2)
results obtained were##28##3##(1992-2#1)(1993-3#1)(1996-3#1)(2005-4#2)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#14)(2008-4#1)(2008-5#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-3#1)
results obtained with a demonstration model##2##6##(2008-2#2)
results obtained with a##15##4##(1996-12#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#1)(2008-5#1)(2008-7#1)(2010-2#1)(2011-12#1)
results obtained with an##3##4##(2007-12#1)(2008-11#1)(2008-2#1)
results obtained with both##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
results obtained with the proposed method##3##6##(2008-10#3)
results obtained with the proposed##4##5##(2008-10#4)
results obtained with the two##2##5##(2008-10#1)(2008-5#1)
results obtained with the##35##4##(1994-9#1)(1995-2#1)(2005-9#1)(2006-6#1)(2007-3#1)(2007-8#1)(2008-10#15)(2008-11#2)(2008-2#3)(2008-3#3)(2008-5#1)(2008-9#1)(2011-2#2)(2012-1#1)(2013-1#1)
results obtained with these##3##4##(2007-8#1)(2008-3#1)(2008-5#1)
results obtained with this technique##3##5##(2007-8#1)(2008-10#1)(2008-2#1)
results obtained with this##7##4##(1990-3#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)
results obtained with##104##3##(1990-12#1)(1990-3#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-9#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-5#2)(2004-9#1)(2005-9#1)(2006-6#3)(2007-11#3)(2007-12#3)(2007-3#1)(2007-8#4)(2008-1#2)(2008-10#29)(2008-11#3)(2008-2#12)(2008-3#8)(2008-4#1)(2008-5#4)(2008-7#1)(2008-9#2)(2010-2#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
results obtained##694##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#4)(1990-6#2)(1990-7#2)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#3)(1991-6#2)(1991-8#1)(1991-9#4)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#5)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#4)(1992-8#3)(1992-9#3)(1993-10#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#4)(1993-8#4)(1993-9#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-1#1)(1996-11#4)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#7)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#1)(2004-9#2)(2005-10#2)(2005-11#8)(2005-12#1)(2005-4#3)(2005-9#1)(2006-1#1)(2006-10#5)(2006-11#3)(2006-12#2)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#4)(2006-8#3)(2007-1#2)(2007-10#2)(2007-11#16)(2007-12#15)(2007-3#2)(2007-4#2)(2007-6#1)(2007-7#4)(2007-8#14)(2008-1#6)(2008-10#264)(2008-11#9)(2008-12#3)(2008-2#34)(2008-3#29)(2008-4#3)(2008-5#32)(2008-6#6)(2008-7#6)(2008-8#5)(2008-9#4)(2009-12#2)(2009-2#2)(2009-4#5)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#6)(2010-3#2)(2010-4#1)(2010-5#5)(2010-8#4)(2011-1#2)(2011-12#2)(2011-2#12)(2011-3#1)(2012-1#3)(2012-12#5)(2012-2#3)(2012-3#4)(2013-1#4)(2013-7#3)(2013-8#3)
results of 100##3##3##(1992-5#1)(2005-12#1)(2011-2#1)
results of 2##3##3##(2007-11#1)(2009-10#1)(2011-2#1)
results of 24 patients##2##4##(2006-12#1)(2008-6#1)
results of 30##2##3##(2010-2#1)(2011-1#1)
results of 4##3##3##(1990-6#1)(2007-11#1)(2007-4#1)
results of ELISA##3##3##(2005-10#1)(2008-10#1)(2013-1#1)
results of MR##2##3##(1990-11#1)(2007-6#1)
results of MTT##2##3##(2008-8#1)(2011-3#1)
results of RT-PCR##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
results of Western##4##3##(1995-6#1)(2008-8#1)(2008-9#2)
results of X-ray##2##3##(2006-5#1)(2008-10#1)
results of a clinical##6##4##(1990-5#2)(1991-9#1)(1996-2#1)(1997-6#1)(2008-7#1)
results of a comprehensive##3##4##(1997-2#1)(2008-3#1)(2010-9#1)
results of a direct##2##4##(2007-12#1)(2008-9#1)
results of a double-blind##2##4##(1991-3#1)(2007-9#1)
results of a follow-up##3##4##(1990-3#1)(1991-6#1)(2007-9#1)
results of a meta-analysis of##4##5##(1997-7#1)(2007-9#1)(2008-9#1)(2011-12#1)
results of a modular neck##2##5##(2011-2#2)
results of a modular##3##4##(2009-10#1)(2011-2#2)
results of a multi-centre##2##4##(1992-12#1)(2008-7#1)
results of a multidisciplinary##3##4##(1994-1#1)(2007-9#1)(2013-8#1)
results of a national survey##5##5##(1992-8#1)(1997-3#1)(2007-3#1)(2007-9#1)(2012-1#1)
results of a national##7##4##(1992-8#1)(1997-3#1)(2006-8#2)(2007-3#1)(2007-9#1)(2012-1#1)
results of a new##6##4##(2005-10#1)(2005-7#1)(2006-3#1)(2008-4#1)(2008-5#1)(2012-2#1)
results of a novel##2##4##(2007-12#1)(2011-2#1)
results of a numerical study of##2##6##(2008-3#1)(2008-5#1)
results of a numerical##4##4##(2007-12#1)(2008-3#2)(2008-5#1)
results of a personal##2##4##(1995-2#1)(2006-6#1)
results of a phase##2##4##(1995-8#1)(2005-10#1)
results of a pilot study of##2##6##(2010-9#1)(2013-1#1)
results of a pilot study##6##5##(1994-10#1)(2008-5#1)(2010-8#1)(2010-9#1)(2012-1#1)(2013-1#1)
results of a pilot##8##4##(1993-1#1)(1994-10#1)(2008-5#1)(2010-12#1)(2010-8#1)(2010-9#1)(2012-1#1)(2013-1#1)
results of a preliminary study##2##5##(1996-7#1)(1997-2#1)
results of a previous study##3##5##(2007-1#1)(2007-7#1)(2008-9#1)
results of a previous##4##4##(1991-7#1)(2007-1#1)(2007-7#1)(2008-9#1)
results of a prospective randomized##2##5##(1993-9#1)(2007-8#1)
results of a prospective study##3##5##(2008-4#1)(2008-8#1)(2009-5#1)
results of a prospective##7##4##(1993-9#1)(2007-8#1)(2008-4#2)(2008-6#1)(2008-8#1)(2009-5#1)
results of a questionnaire##2##4##(1994-12#1)(1996-8#1)
results of a randomized controlled trial##3##6##(2007-7#1)(2009-12#1)(2010-2#1)
results of a randomized controlled##4##5##(2006-12#1)(2007-7#1)(2009-12#1)(2010-2#1)
results of a randomized##8##4##(1994-8#1)(1995-4#1)(2005-8#1)(2006-12#1)(2007-7#1)(2008-6#1)(2009-12#1)(2010-2#1)
results of a research##2##4##(2008-9#1)(2013-1#1)
results of a retrospective study##2##5##(1993-1#1)(2009-5#1)
results of a retrospective##3##4##(1993-1#1)(1996-4#1)(2009-5#1)
results of a series of##5##5##(1996-7#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)
results of a similar##2##4##(1990-6#1)(1996-11#1)
results of a simulation study##2##5##(1996-3#1)(1997-3#1)
results of a simulation##3##4##(1996-3#1)(1997-3#1)(2008-3#1)
results of a single case##2##5##(1991-4#1)(2009-5#1)
results of a single##3##4##(1991-4#1)(1994-6#1)(2009-5#1)
results of a study of the##4##6##(1992-5#1)(2008-5#1)(2009-8#1)(2011-2#1)
results of a study of##10##5##(1992-1#1)(1992-5#1)(1993-9#1)(1996-12#1)(2006-7#1)(2007-12#1)(2008-5#1)(2009-8#1)(2010-10#1)(2011-2#1)
results of a study on##4##5##(1991-9#1)(1994-6#1)(2008-2#1)(2009-4#1)
results of a study##26##4##(1991-9#1)(1992-1#1)(1992-5#1)(1993-3#1)(1993-9#1)(1994-6#1)(1996-1#1)(1996-12#2)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#4)(2008-5#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-1#1)
results of a survey conducted among the##2##7##(1996-1#1)(1997-3#1)
results of a survey conducted among##3##6##(1996-1#1)(1996-12#1)(1997-3#1)
results of a survey conducted##4##5##(1996-1#1)(1996-12#1)(1997-3#1)(2008-11#1)
results of a survey of##7##5##(1993-2#1)(1994-12#1)(1994-3#1)(2006-4#1)(2008-1#1)(2009-4#1)(2009-6#1)
results of a survey##15##4##(1992-3#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-6#1)(1996-1#1)(1996-12#2)(1997-3#1)(2006-4#1)(2008-1#1)(2008-11#1)(2009-4#1)(2009-6#1)
results of a systematic study##3##5##(1994-10#1)(1997-2#1)(2008-12#1)
results of a systematic##4##4##(1994-10#1)(1997-2#1)(2008-12#1)(2013-1#1)
results of a trial##3##4##(1993-4#1)(2005-8#1)(2006-10#1)
results of a##272##3##(1990-10#1)(1990-2#2)(1990-3#2)(1990-5#2)(1990-6#1)(1990-8#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#2)(1991-9#2)(1992-1#3)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-5#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-9#2)(1994-1#1)(1994-10#2)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#1)(1995-1#2)(1995-10#1)(1995-2#3)(1995-4#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#6)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-4#1)(1996-7#2)(1996-8#2)(1997-1#1)(1997-2#3)(1997-3#4)(1997-6#1)(1997-7#1)(2004-10#2)(2004-4#1)(2004-9#1)(2005-10#3)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#5)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#2)(2006-6#2)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#9)(2007-3#2)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#3)(2007-9#7)(2008-1#2)(2008-10#7)(2008-11#4)(2008-12#2)(2008-2#10)(2008-3#10)(2008-4#6)(2008-5#7)(2008-6#6)(2008-7#6)(2008-8#4)(2008-9#5)(2009-10#3)(2009-11#2)(2009-12#1)(2009-4#2)(2009-5#3)(2009-6#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-8#2)(2010-9#3)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#5)(2012-2#1)(2013-1#3)(2013-8#1)
results of all##4##3##(1992-6#1)(1993-2#1)(2008-10#1)(2012-3#1)
results of an evaluation##2##4##(2007-2#1)(2011-12#1)
results of an experiment##5##4##(2007-11#1)(2008-2#1)(2008-3#3)
results of an experimental##3##4##(2007-11#2)(2008-8#1)
results of an investigation##4##4##(1993-5#1)(2008-10#1)(2008-3#1)(2008-6#1)
results of an ongoing study##2##5##(2007-11#1)(2008-2#1)
results of an ongoing##4##4##(1992-7#1)(2007-11#1)(2008-11#1)(2008-2#1)
results of an open##3##4##(1990-12#1)(1990-5#1)(1991-8#1)
results of an##54##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1991-11#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-7#1)(1993-2#1)(1993-5#1)(1997-2#2)(1997-4#1)(1997-5#1)(2006-7#1)(2007-10#1)(2007-11#6)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#8)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-8#2)
results of analyses of##2##4##(2008-10#2)
results of analyses##3##3##(2008-10#2)(2011-1#1)
results of analysis of##2##4##(2008-3#1)(2013-1#1)
results of analysis##8##3##(2005-4#1)(2008-3#1)(2008-7#2)(2010-12#1)(2010-5#1)(2012-1#1)(2013-1#1)
results of animal##2##3##(1996-1#1)(2007-11#1)
results of ankle arthrodesis with screws##2##6##(2011-2#2)
results of any##4##3##(1991-1#1)(2007-12#1)(2008-7#2)
results of basic##2##3##(1997-3#1)(2008-2#1)
results of biofidelity##2##3##(2006-11#2)
results of biological##2##3##(1994-6#1)(2013-7#1)
results of biomechanical testing##2##4##(2006-11#1)(2007-4#1)
results of blood##2##3##(2010-6#1)(2011-2#1)
results of both methods##3##4##(2007-8#1)(2008-2#1)(2008-3#1)
results of both##8##3##(1992-12#1)(1996-6#1)(2007-8#1)(2008-2#2)(2008-3#1)(2008-7#2)
results of breast##2##3##(1990-9#1)(2004-1#1)
results of chemical##2##3##(1991-4#1)(1996-4#1)
results of children##2##3##(2011-2#2)
results of clinical studies##4##4##(1996-12#1)(2012-12#1)(2013-1#2)
results of clinical trials of##2##5##(2008-1#1)(2008-8#1)
results of clinical trials##12##4##(1993-12#1)(1994-11#1)(1994-8#1)(1995-1#1)(1996-8#1)(2005-7#1)(2007-10#1)(2008-1#1)(2008-7#1)(2008-8#1)(2013-1#2)
results of clinical##25##3##(1993-12#1)(1994-11#1)(1994-8#1)(1995-1#1)(1996-12#1)(1996-8#1)(2005-1#1)(2005-7#1)(2007-10#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-2#1)(2010-4#1)(2012-12#2)(2013-1#4)
results of combined##2##3##(2007-11#1)(2008-9#1)
results of complete##2##3##(2007-8#2)
results of complex##2##3##(2008-11#1)(2009-2#1)
results of conservative treatment##3##4##(1993-8#1)(2007-11#1)(2007-7#1)
results of conservative##4##3##(1993-8#1)(1995-9#1)(2007-11#1)(2007-7#1)
results of controlled##4##3##(2005-10#1)(2006-12#1)(2008-1#1)(2008-10#1)
results of conventional##4##3##(2005-12#1)(2008-5#1)(2010-11#1)(2010-9#1)
results of determination of##4##4##(2008-10#2)(2008-12#1)(2009-8#1)
results of determination##8##3##(2005-4#1)(2008-10#5)(2008-12#1)(2009-8#1)
results of different studies##2##4##(2006-10#1)(2008-9#1)
results of different##13##3##(1990-6#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-9#1)(2013-1#1)
results of differential##2##3##(1996-2#1)(2008-10#1)
results of direct##4##3##(1993-3#1)(2007-11#1)(2007-9#1)(2008-3#1)
results of dissociation experiments##2##4##(2006-2#2)
results of early clinical##2##4##(2008-7#1)(2010-12#1)
results of early##5##3##(2006-11#1)(2007-8#1)(2008-7#1)(2008-8#1)(2010-12#1)
results of economic##2##3##(1996-1#1)(2006-2#1)
results of endoscopic##5##3##(1996-12#1)(2006-10#1)(2007-5#1)(2010-12#1)(2012-1#1)
results of endovascular##2##3##(2007-8#1)(2008-10#1)
results of epidemiologic##2##3##(1992-3#1)(2011-1#1)
results of epidemiological studies##4##4##(2005-3#1)(2007-8#1)(2008-10#1)(2010-12#1)
results of existing##2##3##(2009-12#1)(2012-2#1)
results of experimental and clinical##2##5##(1994-2#1)(1994-7#1)
results of experimental studies##2##4##(2007-11#1)(2007-8#1)
results of experimental##6##3##(1994-2#1)(1994-7#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#1)
results of experiments on the##2##5##(2008-4#1)(2008-8#1)
results of experiments with##4##4##(1992-6#1)(1992-7#1)(1994-2#1)(2008-11#1)
results of experiments##10##3##(1990-12#1)(1992-6#1)(1992-7#1)(1994-2#1)(1996-6#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-1#1)
results of extremity##2##3##(2008-6#2)
results of fitting##2##3##(1997-2#1)(2005-11#1)
results of fluorescence##3##3##(2008-2#1)(2008-5#1)(2008-9#1)
results of four##3##3##(2008-2#1)(2011-2#1)(2012-3#1)
results of genomic##2##3##(1992-7#1)(1997-2#1)
results of group##2##3##(2007-9#1)(2012-1#1)
results of growth##2##3##(1993-2#1)(2008-10#1)
results of human##3##3##(1994-2#1)(2007-11#1)(2008-10#1)
results of hysteroscopic##3##3##(1996-2#2)(2007-8#1)
results of immunohistochemical##3##3##(1997-5#1)(1997-8#1)(2008-5#1)
results of immunological##2##3##(1993-12#1)(2010-12#1)
results of in vitro studies##2##5##(1991-3#1)(2008-11#1)
results of in vitro##5##4##(1991-3#1)(2007-8#1)(2008-11#1)(2008-5#2)
results of in vivo##3##4##(1993-9#1)(1995-12#1)(2012-1#1)
results of in##9##3##(1991-3#1)(1993-9#1)(1995-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#2)(2012-1#1)
results of intensive##2##3##(2007-11#1)(2011-2#1)
results of internal##2##3##(2008-4#1)(2012-3#1)
results of interviews conducted##3##4##(1991-12#1)(1996-12#1)(2008-2#1)
results of investigation##3##3##(2007-11#1)(2008-10#1)(2009-2#1)
results of investigations##3##3##(2007-1#1)(2008-4#1)(2008-8#1)
results of its##3##3##(1995-5#1)(2008-2#1)(2011-1#1)
results of kinetic##5##3##(1992-2#1)(1992-4#1)(1992-6#1)(1994-3#1)(2008-8#1)
results of laboratory##5##3##(1994-11#1)(2005-11#1)(2007-11#1)(2008-3#1)(2008-9#1)
results of large##4##3##(1994-11#1)(2006-10#1)(2006-11#1)(2007-11#1)
results of light scattering##2##4##(2008-2#1)(2008-3#1)
results of light##4##3##(1992-2#1)(2007-12#1)(2008-2#1)(2008-3#1)
results of liver##2##3##(1993-3#1)(2008-3#1)
results of major##2##3##(2008-7#1)(2010-5#1)
results of many##2##3##(2010-10#1)(2013-7#1)
results of measurement of the##2##5##(2007-11#1)(2007-12#1)
results of measurement of##3##4##(2007-11#1)(2007-12#1)(2013-1#1)
results of measurements of the##2##5##(2007-12#1)(2008-3#1)
results of measurements of##5##4##(2007-12#2)(2008-2#1)(2008-3#2)
results of measurements on##2##4##(2007-11#1)(2008-2#1)
results of measurements##14##3##(2006-2#1)(2007-11#1)(2007-12#3)(2008-2#5)(2008-3#2)(2011-2#2)
results of medical##2##3##(1997-5#1)(2007-8#1)
results of modeling##2##3##(2007-12#1)(2008-3#1)
results of molecular##6##3##(1990-8#1)(1995-3#1)(1997-8#1)(2007-12#1)(2008-9#1)(2011-2#1)
results of monitoring##2##3##(2011-2#1)(2013-1#1)
results of more##3##3##(1990-2#1)(2006-11#1)(2007-2#1)
results of morphological##2##3##(1992-11#1)(2008-7#1)
results of multiple regression##2##4##(1995-10#1)(2008-5#1)
results of multiple##5##3##(1995-10#1)(2006-8#1)(2007-12#1)(2008-5#1)(2008-7#1)
results of neurobiology and##2##4##(2012-2#2)
results of new##2##3##(1997-8#1)(2007-11#1)
results of newer##2##3##(2008-1#1)(2013-1#1)
results of numerical##6##3##(2005-11#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
results of one##3##3##(1996-1#1)(2007-10#1)(2008-3#1)
results of ongoing randomized##2##4##(2008-8#1)(2009-10#1)
results of ongoing trials##2##4##(2005-10#1)(2008-3#1)
results of ongoing##9##3##(2005-10#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-1#1)
results of only##2##3##(2008-2#1)(2010-12#1)
results of open##3##3##(2008-4#1)(2009-3#1)(2011-2#1)
results of operative treatment##4##4##(2007-11#3)(2008-3#1)
results of optical##2##3##(2005-11#1)(2008-3#1)
results of our analysis##3##4##(1997-5#1)(2007-7#1)(2007-8#1)
results of our clinical##2##4##(2008-5#1)(2013-1#1)
results of our own##4##4##(1991-2#1)(2007-9#1)(2013-1#1)(2013-8#1)
results of our recent##2##4##(1994-11#1)(2006-6#1)
results of our research##3##4##(2007-7#1)(2011-1#1)(2011-2#1)
results of our study suggest higher##2##6##(2007-2#1)(2011-1#1)
results of our study suggest##3##5##(1992-12#1)(2007-2#1)(2011-1#1)
results of our study##18##4##(1992-12#1)(2006-11#1)(2007-2#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
results of our theoretical##2##4##(2007-9#1)(2008-3#1)
results of our##69##3##(1990-9#1)(1991-2#1)(1991-6#1)(1992-12#1)(1994-11#1)(1995-1#1)(1995-5#1)(1997-5#1)(2005-10#1)(2006-11#1)(2006-6#1)(2007-12#3)(2007-2#1)(2007-7#4)(2007-8#4)(2007-9#4)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-4#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#3)
results of patients who##2##4##(2007-7#1)(2008-7#1)
results of patients##4##3##(2007-11#1)(2007-7#1)(2008-7#1)(2011-2#1)
results of percutaneous##2##3##(2006-6#1)(2007-8#1)
results of phylogenetic##3##3##(1991-6#1)(2005-11#1)(2008-10#1)
results of preclinical##2##3##(2010-3#1)(2012-3#1)
results of preliminary##5##3##(1992-3#1)(1997-2#1)(2006-8#1)(2007-11#2)
results of previous studies##5##4##(1991-10#1)(2006-10#1)(2008-10#1)(2008-11#1)(2010-12#1)
results of previous##12##3##(1991-10#1)(1994-2#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2010-12#1)(2011-1#1)
results of primary##3##3##(2007-1#1)(2008-6#1)(2010-12#1)
results of prospective studies##2##4##(1997-6#1)(2005-10#1)
results of prospective##3##3##(1997-6#1)(2005-10#1)(2012-3#1)
results of protein##2##3##(2006-10#1)(2012-12#1)
results of quality##2##3##(1996-6#1)(2011-1#1)
results of radical##2##3##(2006-10#1)(2006-6#1)
results of randomized clinical trials##2##5##(2009-7#1)(2010-6#1)
results of randomized##5##3##(2007-8#1)(2008-8#1)(2009-7#1)(2010-12#1)(2010-6#1)
results of real sample analysis##2##5##(2008-10#2)
results of real sample##3##4##(2008-10#3)
results of real##4##3##(2005-4#1)(2008-10#3)
results of recent clinical##3##4##(1996-11#1)(2008-8#1)(2009-3#1)
results of recent studies##4##4##(2006-10#1)(2008-10#1)(2009-2#1)(2010-12#1)
results of recent##20##3##(1991-3#1)(1996-11#2)(2005-1#1)(2006-10#2)(2006-9#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-2#1)(2009-3#1)(2010-12#3)(2011-1#1)(2013-1#2)
results of reconstruction##3##3##(2006-3#1)(2007-11#1)(2008-8#1)
results of renal transplantation##3##4##(2006-10#1)(2008-1#2)
results of representative##2##3##(1992-1#1)(2008-2#1)
results of reproductive system##2##4##(2011-2#2)
results of research##8##3##(2005-9#1)(2007-11#2)(2008-2#2)(2008-3#1)(2009-2#1)(2009-4#1)
results of retrospective##3##3##(2005-10#1)(2006-10#1)(2008-11#1)
results of routine##2##3##(2006-2#1)(2013-8#1)
results of sequence##4##3##(1993-2#1)(2011-1#1)(2013-8#2)
results of serum##3##3##(2005-11#1)(2007-3#1)(2011-2#1)
results of several studies##2##4##(2006-10#1)(2009-5#1)
results of several##13##3##(2006-10#2)(2006-7#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-4#1)(2009-5#1)(2010-7#1)(2012-1#1)(2012-3#1)
results of simulation##3##3##(2008-2#2)(2008-3#1)
results of single##2##3##(1991-12#1)(1991-9#1)
results of six##3##3##(1991-3#1)(1993-3#1)(2008-10#1)
results of some##5##3##(1993-7#1)(1994-6#1)(2008-4#1)(2010-12#1)(2013-8#1)
results of spinal##2##3##(1997-6#1)(2013-7#1)
results of standard##2##3##(1993-8#1)(2005-1#1)
results of studies of##3##4##(1997-4#1)(1997-8#1)(2008-3#1)
results of studies on the##3##5##(2008-10#1)(2008-12#1)(2011-2#1)
results of studies on##5##4##(2004-9#1)(2008-10#2)(2008-12#1)(2011-2#1)
results of studies##20##3##(1993-9#1)(1994-5#1)(1997-4#1)(1997-8#1)(2004-9#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-2#1)(2011-2#2)(2012-3#1)
results of study##3##3##(2007-9#1)(2013-1#2)
results of studying##3##3##(2007-11#1)(2008-7#1)(2013-1#1)
results of such##8##3##(1991-2#1)(1993-7#1)(1994-12#1)(1996-12#1)(1997-4#1)(2009-2#1)(2013-1#1)(2013-7#1)
results of surgery##3##3##(2006-8#1)(2013-1#2)
results of surgical treatment for##3##5##(2006-7#1)(2007-7#1)(2008-8#1)
results of surgical treatment of##6##5##(2007-11#1)(2007-7#1)(2008-8#1)(2009-2#2)(2013-1#1)
results of surgical treatment##13##4##(1994-5#1)(2006-7#1)(2007-11#2)(2007-7#2)(2007-8#1)(2008-7#1)(2008-8#2)(2009-2#2)(2013-1#1)
results of surgical##17##3##(1992-4#1)(1994-5#1)(2006-7#1)(2007-11#2)(2007-7#2)(2007-8#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#2)(2013-1#1)
results of tests##4##3##(2006-10#1)(2006-2#1)(2008-10#1)(2008-3#1)
results of the National##2##4##(1991-12#1)(2012-1#1)
results of the analyses##3##4##(1995-5#1)(2008-10#1)(2008-11#1)
results of the analysis of synthetic##2##6##(2008-10#2)
results of the analysis of##3##5##(2008-10#3)
results of the analysis##8##4##(1995-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)(2010-5#1)
results of the application of the##2##6##(1990-9#1)(1993-10#1)
results of the atmospheric##2##4##(2008-3#2)
results of the clinical##3##4##(1992-10#1)(2008-5#2)
results of the current study##4##5##(2007-1#1)(2007-11#1)(2008-10#1)(2011-2#1)
results of the experiments##4##4##(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
results of the extraction##2##4##(1993-1#1)(2005-4#1)
results of the first two##2##5##(2008-10#1)(2011-2#1)
results of the first##15##4##(1990-12#1)(1990-2#1)(1992-9#1)(1995-3#1)(1996-6#1)(2007-3#1)(2008-10#1)(2008-5#1)(2009-10#1)(2011-12#1)(2011-2#2)(2012-12#2)(2013-8#1)
results of the fluorescence##2##4##(2005-4#1)(2008-4#1)
results of the hysterosalpingography##2##4##(2011-1#2)
results of the in vitro##3##5##(2007-6#1)(2008-11#2)
results of the initial##3##4##(1991-3#1)(1996-2#1)(1997-5#1)
results of the investigation##4##4##(2008-10#2)(2008-3#1)(2012-2#1)
results of the large##2##4##(2007-11#1)(2008-8#1)
results of the meta-analysis##3##4##(1996-6#1)(2007-7#1)(2008-2#1)
results of the most##4##4##(1995-6#1)(2006-6#1)(2008-1#1)(2013-1#1)
results of the new##4##4##(1995-4#1)(1997-8#1)(2005-11#1)(2007-5#1)
results of the present study suggest that##8##7##(1991-4#1)(1995-10#1)(1996-7#1)(2006-8#2)(2007-12#1)(2008-2#1)(2012-5#1)
results of the present study suggest##9##6##(1991-4#1)(1995-10#1)(1996-1#1)(1996-7#1)(2006-8#2)(2007-12#1)(2008-2#1)(2012-5#1)
results of the present study##33##5##(1990-5#1)(1991-4#1)(1994-10#1)(1994-3#2)(1995-10#1)(1996-1#1)(1996-7#2)(1997-3#1)(2006-5#1)(2006-8#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-5#3)(2008-6#1)(2008-8#1)(2009-5#1)(2010-2#1)(2011-12#1)(2011-7#1)(2012-12#2)(2012-5#1)
results of the present##40##4##(1990-11#1)(1990-5#1)(1991-4#1)(1992-11#1)(1994-10#2)(1994-3#2)(1995-10#1)(1995-3#1)(1996-1#1)(1996-7#2)(1997-3#1)(2006-5#1)(2006-8#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-12#3)(2008-2#1)(2008-5#3)(2008-6#1)(2008-8#1)(2009-5#1)(2010-2#1)(2010-9#1)(2011-12#1)(2011-7#1)(2012-12#2)(2012-5#1)(2013-8#1)
results of the proposed##6##4##(1997-8#1)(2008-10#3)(2009-8#1)(2012-1#1)
results of the reflectivity measurements based on##2##7##(2008-3#2)
results of the review##2##4##(1992-1#1)(2012-12#1)
results of the second##2##4##(2006-8#1)(2008-6#1)
results of the simulation##2##4##(2008-3#2)
results of the simulations show that the##2##7##(2008-2#1)(2008-3#1)
results of the simulations show##3##5##(2008-2#1)(2008-3#2)
results of the studies##3##4##(1997-1#1)(2008-7#1)(2013-7#1)
results of the study showed that##4##6##(2007-10#1)(2007-7#1)(2008-5#1)(2008-6#1)
results of the study showed##7##5##(2007-10#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-6#1)(2012-2#1)
results of the study suggest that the##2##7##(1992-10#1)(2009-2#1)
results of the study suggest that##3##6##(1992-10#1)(1996-12#1)(2009-2#1)
results of the study##32##4##(1990-10#1)(1991-3#1)(1991-5#1)(1992-10#2)(1992-3#1)(1993-1#1)(1995-10#1)(1996-1#2)(1996-12#1)(1996-5#1)(2005-10#1)(2007-10#2)(2007-3#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-2#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
results of the surgical##2##4##(2006-12#1)(2007-11#1)
results of the survey##9##4##(1990-10#1)(1991-5#1)(1991-6#1)(1994-4#1)(2007-1#1)(2008-10#2)(2008-12#1)(2012-2#1)
results of the treatment of##5##5##(1991-9#1)(1995-8#1)(2008-7#1)(2011-1#1)(2011-2#1)
results of the treatment##9##4##(1991-9#1)(1993-9#1)(1995-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-7#1)(2011-1#1)(2011-2#1)
results of the trial##2##4##(2006-10#1)(2007-5#1)
results of the two methods##2##5##(2007-8#1)(2008-10#1)
results of the two models##2##5##(2008-10#1)(2008-2#1)
results of the two##8##4##(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2013-8#1)
results of the various##2##4##(1994-2#1)(2007-3#1)
results of the##459##3##(1990-10#3)(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-9#3)(1991-10#1)(1991-12#3)(1991-3#3)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-9#2)(1992-1#1)(1992-10#3)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#3)(1993-10#1)(1993-2#2)(1993-9#2)(1994-1#1)(1994-10#2)(1994-11#3)(1994-2#4)(1994-3#3)(1994-4#1)(1995-1#1)(1995-10#3)(1995-11#1)(1995-12#3)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#3)(1996-12#2)(1996-2#2)(1996-4#1)(1996-5#2)(1996-6#3)(1996-7#2)(1997-1#1)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#2)(2004-10#1)(2005-1#1)(2005-10#1)(2005-11#7)(2005-12#2)(2005-4#3)(2005-8#1)(2006-10#7)(2006-11#2)(2006-12#3)(2006-2#2)(2006-4#2)(2006-5#1)(2006-6#3)(2006-8#5)(2007-1#3)(2007-10#2)(2007-11#11)(2007-12#8)(2007-2#1)(2007-3#4)(2007-4#3)(2007-5#2)(2007-6#2)(2007-7#5)(2007-8#6)(2007-9#1)(2008-1#4)(2008-10#46)(2008-11#9)(2008-12#7)(2008-2#22)(2008-3#34)(2008-4#3)(2008-5#14)(2008-6#6)(2008-7#8)(2008-8#9)(2008-9#3)(2009-10#1)(2009-2#2)(2009-3#2)(2009-4#5)(2009-5#3)(2009-8#3)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#1)(2010-9#3)(2011-1#5)(2011-12#2)(2011-2#9)(2011-7#2)(2012-1#2)(2012-12#13)(2012-2#6)(2012-3#3)(2012-5#1)(2013-1#9)(2013-7#4)(2013-8#5)
results of their##10##3##(1990-5#1)(1990-9#1)(1991-1#1)(1992-9#1)(1996-1#1)(2005-1#1)(2006-11#1)(2008-10#1)(2009-2#1)(2010-8#1)
results of theoretical##4##3##(2008-2#1)(2008-3#1)(2011-1#1)(2013-7#1)
results of these analyses##5##4##(1994-1#1)(1995-5#1)(1996-1#1)(2008-10#1)(2008-2#1)
results of these experiments##12##4##(1990-8#1)(1994-3#1)(2006-12#1)(2006-5#1)(2007-3#1)(2008-10#4)(2008-5#1)(2008-6#1)(2013-1#1)
results of these studies are##5##5##(1991-9#1)(2006-9#1)(2007-8#1)(2008-7#1)(2012-1#1)
results of these studies##24##4##(1990-12#1)(1991-9#2)(1992-11#2)(1992-7#1)(1994-3#1)(1996-2#1)(1997-4#1)(2006-9#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2011-2#1)(2012-1#2)
results of these tests##7##4##(1993-1#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-2#1)(2008-4#1)(2008-5#1)
results of these trials will##2##5##(1991-12#1)(2007-4#1)
results of these trials##4##4##(1991-12#1)(1996-11#1)(2007-4#1)(2008-11#1)
results of these##76##3##(1990-12#1)(1990-8#1)(1991-12#1)(1991-9#2)(1992-11#2)(1992-7#1)(1993-1#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-3#2)(1994-8#2)(1995-11#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-11#2)(1996-2#1)(1996-4#1)(1997-2#1)(1997-4#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-10#8)(2008-11#2)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#2)(2010-2#1)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#2)
results of this analysis##11##4##(1991-9#1)(1994-11#1)(1997-5#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-2#1)(2011-2#1)
results of this data##2##4##(2011-1#1)(2013-1#1)
results of this investigation##5##4##(2008-10#3)(2008-5#1)(2011-1#1)
results of this method##3##4##(2007-7#1)(2008-2#1)(2008-4#1)
results of this pilot study##3##5##(2006-10#1)(2006-11#1)(2008-12#1)
results of this series##4##4##(1992-10#1)(2006-5#1)(2006-9#1)(2012-12#1)
results of this study also show##2##6##(1991-12#1)(1997-2#1)
results of this study also##3##5##(1991-12#1)(1996-5#1)(1997-2#1)
results of this study and the##2##6##(1990-6#1)(2008-5#1)
results of this study are##8##5##(1994-3#1)(1996-12#1)(1996-2#1)(2006-8#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-7#1)
results of this study clearly##2##5##(2008-10#1)(2008-11#1)
results of this study demonstrated that##6##6##(1992-9#1)(2007-10#1)(2008-10#1)(2008-7#1)(2008-9#1)(2013-8#1)
results of this study have##2##5##(2004-9#1)(2008-10#1)
results of this study indicate that##26##6##(1990-4#1)(1990-5#1)(1991-11#1)(1992-8#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-8#1)(2005-8#1)(2006-8#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-6#2)(2009-2#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-8#2)
results of this study indicate the##2##6##(2007-8#1)(2008-12#1)
results of this study indicate##30##5##(1990-4#1)(1990-5#1)(1991-11#1)(1992-8#1)(1993-4#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-8#1)(2005-8#1)(2006-1#1)(2006-8#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-6#2)(2009-2#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-8#2)
results of this study may##2##5##(2008-10#1)(2008-12#1)
results of this study show that the##3##7##(2006-8#1)(2007-10#1)(2008-10#1)
results of this study show that##9##6##(1990-12#1)(2006-12#1)(2006-8#2)(2007-10#1)(2008-10#1)(2008-7#1)(2010-2#1)(2011-2#1)
results of this study show##10##5##(1990-12#1)(2006-12#1)(2006-8#2)(2007-10#1)(2008-10#1)(2008-7#1)(2010-2#1)(2010-3#1)(2011-2#1)
results of this study suggest that##18##6##(1990-2#1)(1991-3#1)(1992-12#1)(1993-9#1)(1994-12#1)(1995-3#2)(2006-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-7#2)(2010-12#1)(2013-1#1)
results of this study suggest##21##5##(1990-2#1)(1991-3#2)(1992-12#1)(1993-9#1)(1994-12#1)(1995-3#2)(1996-11#1)(2006-12#1)(2007-10#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-7#2)(2010-12#1)(2013-1#1)
results of this study suggested that##2##6##(1992-2#1)(2011-3#1)
results of this study support the##4##6##(2006-12#1)(2008-10#2)(2012-1#1)
results of this study support##7##5##(1991-9#1)(2004-9#1)(2006-12#1)(2008-10#2)(2011-1#1)(2012-1#1)
results of this study were as follows##2##7##(1991-2#1)(1997-2#1)
results of this study were##5##5##(1990-8#1)(1991-2#1)(1997-2#1)(2007-10#1)(2008-11#1)
results of this study with##2##5##(2008-11#1)(2009-5#1)
results of this study##177##4##(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-9#1)(1994-12#1)(1994-3#2)(1995-1#3)(1995-3#2)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-8#1)(2004-9#2)(2005-10#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-11#2)(2006-12#4)(2006-8#5)(2007-1#2)(2007-10#5)(2007-12#5)(2007-2#5)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#20)(2008-11#5)(2008-12#8)(2008-3#2)(2008-4#2)(2008-5#9)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-7#3)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#1)(2013-1#5)(2013-8#4)
results of this treatment##4##4##(1990-4#1)(2006-10#1)(2006-3#1)(2006-9#1)
results of this##276##3##(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-7#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-1#3)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-12#1)(2004-9#2)(2005-10#2)(2005-11#2)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#4)(2006-11#3)(2006-12#5)(2006-3#1)(2006-5#2)(2006-6#1)(2006-8#7)(2006-9#2)(2007-1#3)(2007-10#6)(2007-12#6)(2007-2#6)(2007-4#1)(2007-5#3)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#26)(2008-11#5)(2008-12#16)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#11)(2008-6#4)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#2)(2009-4#2)(2009-5#2)(2009-7#3)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#5)(2011-12#1)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#8)(2013-8#4)
results of those##2##3##(1997-1#1)(2006-5#1)
results of three##7##3##(1994-4#1)(2006-10#1)(2006-4#1)(2008-2#2)(2009-12#1)(2009-4#1)
results of total hip arthroplasties using##2##6##(2007-11#2)
results of total hip##3##4##(2007-11#2)(2008-3#1)
results of total##8##3##(1991-12#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#2)
results of treating the##2##4##(1992-5#1)(2013-1#1)
results of treating##4##3##(1992-5#1)(1996-11#1)(2006-8#1)(2013-1#1)
results of treatment in##2##4##(2007-11#1)(2008-7#1)
results of treatment of oncological patients##2##6##(2006-6#2)
results of treatment of##15##4##(1995-5#1)(2006-6#4)(2007-8#3)(2009-2#4)(2010-3#1)(2011-1#1)(2011-12#1)
results of treatment with the##2##5##(2007-8#1)(2008-6#1)
results of treatment with##8##4##(1992-2#1)(1994-7#1)(2004-10#1)(2006-6#1)(2007-8#1)(2008-12#1)(2008-6#1)(2013-1#1)
results of treatment##39##3##(1990-4#1)(1992-2#1)(1992-5#1)(1993-1#1)(1994-7#1)(1995-5#1)(1995-9#1)(2004-10#1)(2006-6#5)(2007-11#3)(2007-7#1)(2007-8#4)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-2#5)(2009-4#1)(2010-3#1)(2011-1#2)(2011-12#1)(2011-2#1)(2013-1#1)
results of two##16##3##(1991-2#1)(1994-3#1)(1995-4#1)(1996-9#1)(1997-4#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-2#1)
results of upper thoracic sympathectomy##2##5##(2011-2#2)
results of using this##2##4##(2007-12#1)(2008-2#1)
results of using##7##3##(2006-7#1)(2007-11#1)(2007-12#2)(2008-2#1)(2009-2#1)(2012-1#1)
results of various##3##3##(1994-3#1)(2007-11#1)(2007-4#1)
results of##2452##2##(1990-10#7)(1990-11#3)(1990-12#8)(1990-2#6)(1990-3#5)(1990-4#5)(1990-5#8)(1990-6#9)(1990-7#1)(1990-8#6)(1990-9#11)(1991-1#4)(1991-10#3)(1991-11#3)(1991-12#15)(1991-2#7)(1991-3#10)(1991-4#4)(1991-5#6)(1991-6#9)(1991-7#7)(1991-8#4)(1991-9#11)(1992-1#5)(1992-10#5)(1992-11#8)(1992-12#8)(1992-2#9)(1992-3#7)(1992-4#3)(1992-5#6)(1992-6#7)(1992-7#7)(1992-8#2)(1992-9#6)(1993-1#8)(1993-10#2)(1993-11#4)(1993-12#8)(1993-2#12)(1993-3#5)(1993-4#3)(1993-5#2)(1993-6#1)(1993-7#2)(1993-8#7)(1993-9#8)(1994-1#5)(1994-10#4)(1994-11#11)(1994-12#4)(1994-2#10)(1994-3#13)(1994-4#2)(1994-5#4)(1994-6#5)(1994-7#3)(1994-8#6)(1995-1#8)(1995-10#5)(1995-11#6)(1995-12#5)(1995-2#9)(1995-3#8)(1995-4#7)(1995-5#11)(1995-6#6)(1995-8#6)(1995-9#5)(1996-1#16)(1996-11#8)(1996-12#17)(1996-2#10)(1996-3#3)(1996-4#5)(1996-5#4)(1996-6#12)(1996-7#6)(1996-8#3)(1996-9#5)(1997-1#4)(1997-2#12)(1997-3#12)(1997-4#10)(1997-5#9)(1997-6#7)(1997-7#1)(1997-8#13)(2004-1#2)(2004-10#4)(2004-12#1)(2004-2#1)(2004-4#1)(2004-9#4)(2005-1#5)(2005-10#15)(2005-11#19)(2005-12#8)(2005-3#1)(2005-4#8)(2005-7#6)(2005-8#6)(2005-9#4)(2006-1#1)(2006-10#45)(2006-11#20)(2006-12#16)(2006-2#17)(2006-3#4)(2006-4#7)(2006-5#8)(2006-6#18)(2006-7#9)(2006-8#23)(2006-9#7)(2007-1#12)(2007-10#18)(2007-11#79)(2007-12#59)(2007-2#14)(2007-3#15)(2007-4#13)(2007-5#10)(2007-6#8)(2007-7#32)(2007-8#59)(2007-9#21)(2008-1#21)(2008-10#178)(2008-11#38)(2008-12#38)(2008-2#92)(2008-3#110)(2008-4#26)(2008-5#71)(2008-6#33)(2008-7#56)(2008-8#43)(2008-9#32)(2009-10#8)(2009-11#2)(2009-12#5)(2009-2#23)(2009-3#8)(2009-4#21)(2009-5#13)(2009-6#3)(2009-7#4)(2009-8#10)(2009-9#2)(2010-10#3)(2010-11#4)(2010-12#26)(2010-2#11)(2010-3#8)(2010-4#8)(2010-5#9)(2010-6#6)(2010-7#2)(2010-8#11)(2010-9#12)(2011-1#32)(2011-12#9)(2011-2#63)(2011-3#4)(2011-7#2)(2012-1#26)(2012-12#26)(2012-2#34)(2012-3#26)(2012-5#1)(2013-1#67)(2013-7#12)(2013-8#26)
results offer a##5##3##(1991-10#1)(2007-11#1)(2008-3#1)(2008-5#1)(2011-1#1)
results offer##11##2##(1991-10#1)(1991-3#1)(1994-8#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-2#1)
results on a##2##3##(2004-12#1)(2008-3#1)
results on simulated##2##3##(1993-9#1)(2008-3#1)
results on synthetic##2##3##(2008-10#1)(2012-12#1)
results on the basis of##2##5##(1993-12#1)(2008-4#1)
results on the development of##2##5##(2007-11#1)(2011-2#1)
results on the stability##2##4##(2008-5#1)(2011-2#1)
results on the##47##3##(1991-10#1)(1991-2#1)(1991-4#1)(1992-11#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-8#1)(1996-2#1)(1996-9#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-12#2)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-8#1)(2009-5#2)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
results on##104##2##(1990-10#1)(1990-12#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-5#3)(1997-7#1)(1997-8#1)(2003-11#1)(2004-12#1)(2005-11#1)(2006-10#2)(2006-12#2)(2006-5#1)(2006-6#1)(2007-1#3)(2007-10#1)(2007-11#2)(2007-12#3)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#8)(2008-3#8)(2008-4#2)(2008-5#4)(2008-6#1)(2008-8#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
results only##6##2##(1992-6#1)(1994-3#1)(1996-5#1)(2008-2#2)(2010-2#1)
results open the##2##3##(1992-1#1)(2009-3#1)
results open##6##2##(1992-1#1)(1995-3#1)(2008-10#1)(2008-2#1)(2009-3#1)(2010-7#1)
results or##5##2##(1991-12#1)(1994-12#1)(2006-8#1)(2009-6#1)(2010-12#1)
results over##3##2##(1992-12#1)(2008-10#1)(2008-6#1)
results particularly##2##2##(1993-12#1)(1995-2#1)
results permit##2##2##(1992-8#1)(1993-11#1)
results point out the##3##4##(1991-8#1)(2007-2#1)(2012-8#1)
results point out##6##3##(1991-8#1)(2005-11#1)(2007-2#1)(2008-10#1)(2012-2#1)(2012-8#1)
results point to a##4##4##(1992-5#1)(1993-7#1)(2008-10#1)(2011-2#1)
results point to the need of##2##6##(1996-5#1)(2012-3#1)
results point to the need##3##5##(1996-5#1)(2008-2#1)(2012-3#1)
results point to the##11##4##(1990-6#1)(1993-12#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-4#1)(2007-1#1)(2007-9#1)(2008-2#1)(2010-8#1)(2012-3#1)
results point to##23##3##(1990-11#1)(1990-3#1)(1990-6#1)(1991-10#1)(1992-5#1)(1993-12#1)(1993-7#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-4#1)(2007-1#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-3#1)
results point##29##2##(1990-11#1)(1990-3#1)(1990-6#1)(1991-10#1)(1991-8#1)(1992-5#1)(1993-12#1)(1993-7#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-4#1)(2005-11#1)(2007-1#1)(2007-2#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2012-8#1)
results predict that##2##3##(2008-2#1)(2009-11#1)
results present##2##2##(1996-1#1)(2008-2#1)
results presented a##2##3##(2008-10#2)
results presented here are based##2##5##(1993-6#1)(2008-5#1)
results presented here are##5##4##(1993-6#1)(2008-3#2)(2008-5#1)(2008-9#1)
results presented here illustrate the##2##5##(1994-2#1)(2008-7#1)
results presented here provide##2##4##(2009-10#1)(2012-1#1)
results presented here show that##2##5##(2008-10#1)(2008-3#1)
results presented here##29##3##(1990-3#1)(1991-7#1)(1991-9#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-3#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2010-8#1)(2012-1#1)
results presented herein##3##3##(2006-12#1)(2012-12#1)(2012-2#1)
results presented in this paper##4##5##(1991-6#1)(1991-9#1)(1993-6#1)(2008-10#1)
results presented in this##9##4##(1991-6#1)(1991-9#1)(1992-6#1)(1993-6#1)(1995-1#1)(2008-10#2)(2008-7#1)(2009-5#1)
results presented in##10##3##(1991-6#1)(1991-9#1)(1992-6#1)(1993-6#1)(1995-1#1)(2008-10#3)(2008-7#1)(2009-5#1)
results presented##57##2##(1990-12#1)(1990-3#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-6#1)(1993-6#2)(1994-2#1)(1994-5#1)(1995-1#1)(1995-3#2)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#6)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)
results primarily from##3##3##(1990-5#1)(1995-2#1)(1995-4#1)
results primarily##5##2##(1990-5#1)(1995-2#1)(1995-4#1)(1996-5#1)(2008-8#1)
results produced by the##2##4##(2008-2#1)(2008-6#1)
results produced by##5##3##(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2013-1#1)
results propose##3##2##(1997-6#1)(2009-10#1)(2013-1#1)
results prove that the proposed##2##5##(2007-11#1)(2008-3#1)
results prove that##7##3##(1992-9#1)(1994-5#1)(2004-9#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
results prove the##2##3##(1997-3#1)(2011-1#1)
results prove##11##2##(1992-8#1)(1992-9#1)(1994-5#1)(1997-3#1)(2004-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2011-1#1)
results proved that the##2##4##(2006-2#1)(2007-6#1)
results proved that##5##3##(1990-8#1)(2006-2#1)(2007-11#1)(2007-6#1)(2008-3#1)
results proved to be##2##4##(2008-3#1)(2013-1#1)
results proved##12##2##(1990-8#1)(2005-12#1)(2006-2#1)(2007-11#1)(2007-6#1)(2008-10#2)(2008-3#2)(2008-5#1)(2011-2#1)(2013-1#1)
results provide a basis for##2##5##(1995-5#1)(2010-12#1)
results provide a better understanding of the##2##7##(1997-2#1)(2006-6#1)
results provide a better##3##4##(1997-2#1)(2006-6#1)(2008-7#1)
results provide a new##2##4##(1993-6#1)(2011-1#1)
results provide a theoretical##2##4##(2008-8#1)(2013-8#1)
results provide a##24##3##(1991-3#1)(1992-11#1)(1993-6#1)(1994-9#1)(1995-10#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1997-2#1)(2006-10#2)(2006-6#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-12#1)(2011-1#1)(2013-8#1)
results provide additional evidence##2##4##(1991-5#1)(1992-3#1)
results provide additional##4##3##(1991-10#1)(1991-5#1)(1992-3#1)(1993-2#1)
results provide an##6##3##(1991-6#1)(1996-11#1)(2008-10#1)(2008-9#1)(2010-8#1)(2011-1#1)
results provide direct evidence for the##3##6##(1990-7#1)(1994-12#1)(1997-6#1)
results provide direct evidence for##4##5##(1990-7#1)(1994-12#1)(1995-8#1)(1997-6#1)
results provide direct evidence that the##3##6##(1993-12#1)(1994-3#1)(1995-7#1)
results provide direct evidence that##6##5##(1993-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-7#1)(2008-10#1)
results provide direct evidence##11##4##(1990-7#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-7#1)(1995-8#1)(1996-10#1)(1997-6#1)(2008-10#1)
results provide direct##14##3##(1990-2#1)(1990-7#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-7#1)(1995-8#1)(1996-10#1)(1997-6#1)(2008-10#2)
results provide evidence for a##4##5##(1991-4#1)(1996-4#1)(1997-2#1)(2013-1#1)
results provide evidence for the involvement of##2##7##(1994-2#1)(1996-2#1)
results provide evidence for the##4##5##(1994-2#1)(1995-8#1)(1996-2#1)(2009-4#1)
results provide evidence for##12##4##(1991-4#1)(1991-5#1)(1994-2#1)(1994-8#1)(1995-8#2)(1996-2#1)(1996-4#1)(1997-2#1)(2006-10#1)(2009-4#1)(2013-1#1)
results provide evidence of##5##4##(1996-1#1)(1996-3#1)(1997-7#1)(2009-7#1)(2012-1#1)
results provide evidence that a##3##5##(1992-3#1)(1993-6#1)(1995-3#1)
results provide evidence that the##4##5##(1991-11#1)(1991-7#1)(1993-12#1)(2008-8#1)
results provide evidence that##22##4##(1990-11#1)(1990-12#1)(1990-7#1)(1991-11#1)(1991-7#1)(1992-3#1)(1993-12#2)(1993-6#1)(1993-9#1)(1995-3#1)(1997-4#1)(2004-2#1)(2004-9#1)(2008-10#3)(2008-8#3)(2013-1#2)
results provide evidence##42##3##(1990-11#1)(1990-12#1)(1990-7#1)(1991-11#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-3#1)(1993-12#2)(1993-6#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-3#1)(1995-7#1)(1995-8#3)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-2#1)(2004-9#1)(2006-10#1)(2008-10#3)(2008-8#3)(2009-4#1)(2009-7#1)(2011-1#1)(2012-1#1)(2013-1#3)
results provide further evidence that##4##5##(1991-5#1)(1994-5#1)(1995-7#1)(2008-3#1)
results provide further evidence##6##4##(1991-5#1)(1994-5#1)(1995-7#1)(1997-7#1)(2008-3#1)(2009-9#1)
results provide further##9##3##(1991-5#1)(1992-2#1)(1994-5#1)(1995-5#1)(1995-7#1)(1997-7#1)(2008-3#1)(2008-4#1)(2009-9#1)
results provide guidance in##2##4##(2008-2#2)
results provide important clues for##2##5##(1996-7#1)(2011-1#1)
results provide important##4##3##(1992-7#1)(1996-7#1)(2010-8#1)(2011-1#1)
results provide information about the##2##5##(1994-8#1)(2013-8#1)
results provide information##4##3##(1994-8#1)(2007-9#1)(2008-11#1)(2013-8#1)
results provide new##3##3##(1991-7#1)(2008-10#1)(2009-8#1)
results provide opportunities to##2##4##(2006-7#1)(2009-9#1)
results provide some##3##3##(2006-4#1)(2007-1#1)(2013-1#1)
results provide strong evidence for##2##5##(1990-11#1)(1990-5#1)
results provide strong evidence that the##2##6##(1990-8#1)(1996-8#1)
results provide strong evidence that##3##5##(1990-7#1)(1990-8#1)(1996-8#1)
results provide strong evidence##7##4##(1990-11#1)(1990-5#1)(1990-7#1)(1990-8#1)(1995-11#1)(1996-8#1)(2006-12#1)
results provide strong support##2##4##(1990-3#1)(1992-2#1)
results provide strong##9##3##(1990-11#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1992-2#1)(1995-11#1)(1996-8#1)(2006-12#1)
results provide support for the hypothesis that##2##7##(1994-8#1)(2013-8#1)
results provide support for the##3##5##(1994-8#1)(1995-1#1)(2013-8#1)
results provide support for##8##4##(1994-8#1)(1994-9#1)(1995-1#1)(2008-9#1)(2009-3#1)(2009-7#1)(2011-2#1)(2013-8#1)
results provide the first demonstration##3##5##(1991-8#1)(1992-8#1)(2008-8#1)
results provide the first evidence that##3##6##(1990-7#1)(2013-1#1)(2013-7#1)
results provide the first evidence##4##5##(1990-7#1)(1994-3#1)(2013-1#1)(2013-7#1)
results provide the first##10##4##(1990-7#1)(1991-8#1)(1992-8#1)(1994-3#1)(2008-10#1)(2008-8#1)(2009-2#1)(2009-4#1)(2013-1#1)(2013-7#1)
results provide the##14##3##(1990-7#1)(1991-8#1)(1992-8#1)(1993-12#1)(1994-3#1)(1995-2#1)(2008-10#1)(2008-8#1)(2009-2#1)(2009-4#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-7#1)
results provide useful information for##2##5##(2008-2#1)(2010-5#1)
results provide useful information##3##4##(2008-2#1)(2010-5#1)(2011-1#1)
results provide##189##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#4)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#3)(1991-8#1)(1992-11#1)(1992-2#4)(1992-3#3)(1992-7#1)(1992-8#1)(1993-12#4)(1993-2#1)(1993-6#3)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#4)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-7#3)(1995-8#5)(1996-1#2)(1996-10#1)(1996-11#3)(1996-2#1)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#4)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-2#1)(2004-9#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-6#2)(2006-7#1)(2007-1#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-9#2)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-7#2)(2009-8#1)(2009-9#2)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#3)
results provided a##3##3##(2008-10#1)(2008-8#1)(2012-12#1)
results provided by the proposed method##2##6##(2008-10#2)
results provided by the##3##4##(2008-10#2)(2008-2#1)
results provided evidence that##2##4##(1992-7#1)(2008-12#1)
results provided##17##2##(1992-7#1)(1994-7#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-8#2)(2008-9#3)(2010-12#1)(2010-4#1)(2012-12#2)
results published##6##2##(1990-9#1)(1995-11#1)(1996-7#1)(2007-11#1)(2008-2#1)(2013-1#1)
results quickly##2##2##(2008-11#1)(2010-5#1)
results raise the possibility that##5##5##(1990-11#1)(1992-7#1)(1993-8#1)(1994-3#1)(1996-5#1)
results raise##6##2##(1990-11#1)(1992-7#1)(1993-8#1)(1994-3#1)(1996-5#1)(1996-8#1)
results reflect the##5##3##(1990-11#1)(2005-9#1)(2008-10#1)(2008-2#1)(2012-3#1)
results regarding the##6##3##(1993-10#1)(2008-1#1)(2008-4#1)(2010-4#1)(2011-12#1)(2011-2#1)
results regarding##10##2##(1993-10#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-2#1)
results reinforce the importance of##2##5##(1996-7#1)(2004-1#1)
results relating to the##3##4##(1992-1#1)(2010-2#1)(2011-2#1)
results relating to##5##3##(1992-1#1)(2008-2#1)(2010-2#1)(2011-2#1)(2013-8#1)
results relating##6##2##(1992-1#1)(2008-2#2)(2010-2#1)(2011-2#1)(2013-8#1)
results relative to the##2##4##(2008-10#2)
results remain##4##2##(1996-5#1)(2007-4#1)(2008-2#1)(2008-8#1)
results remained##2##2##(1995-11#1)(1996-1#1)
results reported by the labs using the##2##7##(2008-10#2)
results reported by##6##3##(1992-12#1)(1992-7#1)(2005-9#1)(2008-10#2)(2008-6#1)
results reported for##2##3##(1990-6#1)(2008-10#1)
results reported from##3##3##(1990-11#1)(1994-3#1)(2009-8#1)
results reported here are##2##4##(1997-6#1)(2008-2#1)
results reported here##8##3##(1993-4#1)(1994-3#1)(1995-1#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-5#1)
results reported in the literature##7##5##(1991-1#1)(1994-6#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2013-1#1)
results reported in the##9##4##(1990-3#1)(1991-1#1)(1994-6#1)(1996-9#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2013-1#1)
results reported in##11##3##(1990-3#1)(1991-1#1)(1991-2#1)(1994-6#1)(1996-9#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2013-1#1)
results reported##35##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-2#1)(1992-12#1)(1992-7#1)(1993-4#1)(1994-3#2)(1994-6#1)(1995-1#1)(1996-9#1)(1997-6#1)(2005-8#1)(2005-9#1)(2006-8#1)(2007-11#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2009-5#1)(2009-8#1)(2012-1#1)(2013-1#1)
results represent a##3##3##(2007-12#1)(2008-5#1)(2008-6#1)
results represent the first##5##4##(1991-7#1)(1992-3#1)(2007-12#1)(2008-8#1)(2011-1#1)
results represent the##6##3##(1991-7#1)(1992-3#1)(2006-12#1)(2007-12#1)(2008-8#1)(2011-1#1)
results represent##12##2##(1991-7#1)(1992-3#1)(1993-5#1)(2006-12#1)(2007-12#2)(2008-2#2)(2008-5#1)(2008-6#1)(2008-8#1)(2011-1#1)
results require##3##2##(1991-2#1)(2008-2#1)(2013-1#1)
results requires##2##2##(1994-1#1)(2007-12#1)
results reveal a##7##3##(1991-8#1)(1992-5#1)(2005-9#1)(2007-11#1)(2008-11#1)(2008-7#1)(2009-3#1)
results reveal that the##9##4##(1994-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#1)(2011-2#1)(2012-11#2)(2012-2#1)
results reveal that##34##3##(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-1#1)(1994-9#1)(2005-11#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-6#2)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#2)(2009-12#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#1)
results reveal the presence of a##2##6##(1990-3#1)(1992-6#1)
results reveal the presence of##3##5##(1990-3#1)(1992-6#1)(2010-8#1)
results reveal the##5##3##(1990-3#1)(1992-6#1)(1993-12#1)(2010-8#1)(2011-2#1)
results reveal##54##2##(1990-3#1)(1991-8#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-4#1)(1994-1#1)(1994-9#1)(1995-8#1)(2005-11#1)(2005-9#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-3#1)(2007-6#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#3)(2009-12#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#1)
results revealed a##9##3##(2006-11#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-4#1)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#1)
results revealed an##3##3##(1991-12#1)(2009-2#1)(2011-1#1)
results revealed significant##3##3##(2008-10#1)(2008-12#1)(2009-7#1)
results revealed that a##2##4##(2007-10#1)(2008-12#1)
results revealed that in##2##4##(1994-11#1)(2006-6#1)
results revealed that the##15##4##(2007-10#1)(2007-4#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-6#1)(2012-2#1)(2013-7#2)(2013-8#1)
results revealed that there is##2##5##(2007-10#1)(2008-12#1)
results revealed that there##3##4##(2007-10#2)(2008-12#1)
results revealed that this##2##4##(2008-10#1)(2012-2#1)
results revealed that##63##3##(1991-6#1)(1992-2#1)(1994-11#1)(1994-12#1)(1994-2#1)(1997-8#1)(2003-11#1)(2004-10#1)(2006-6#1)(2007-10#5)(2007-11#1)(2007-3#1)(2007-4#2)(2008-10#9)(2008-11#3)(2008-12#5)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#2)(2013-8#2)
results revealed the presence of##2##5##(1997-3#1)(2007-2#1)
results revealed the##8##3##(1991-2#1)(1997-3#1)(2007-2#1)(2008-10#3)(2008-5#1)(2011-12#1)
results revealed##100##2##(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1994-11#1)(1994-12#1)(1994-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2003-11#1)(2004-10#1)(2005-11#1)(2006-11#1)(2006-3#1)(2006-6#1)(2007-10#5)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#1)(2008-10#14)(2008-11#3)(2008-12#7)(2008-3#1)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#3)(2009-8#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#4)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#2)(2013-8#2)
results seem to indicate that##3##5##(1997-8#1)(2007-8#2)
results seem to indicate##4##4##(1997-8#1)(2007-8#2)(2008-7#1)
results seem to suggest that the##2##6##(1993-3#1)(2009-7#1)
results seem to suggest that##4##5##(1993-3#1)(1995-12#1)(1997-3#1)(2009-7#1)
results seem to##11##3##(1992-6#1)(1993-3#1)(1995-12#1)(1997-3#1)(1997-8#1)(2007-8#2)(2008-10#1)(2008-7#1)(2009-7#1)(2013-1#1)
results seem##13##2##(1990-5#1)(1992-6#1)(1993-3#1)(1995-12#1)(1996-7#1)(1997-3#1)(1997-8#1)(2007-8#2)(2008-10#1)(2008-7#1)(2009-7#1)(2013-1#1)
results seen with##2##3##(2006-12#1)(2010-12#1)
results seen##5##2##(1990-4#1)(2006-12#1)(2007-12#1)(2008-10#1)(2010-12#1)
results shed light on##3##4##(1994-1#1)(2012-2#1)(2012-3#1)
results shed##5##2##(1994-1#1)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
results should be useful in##2##5##(2008-3#1)(2010-4#1)
results should be##9##3##(1990-3#1)(1991-12#1)(1996-12#1)(1997-5#1)(2008-3#1)(2008-5#1)(2010-4#1)(2010-6#1)(2011-1#1)
results should##19##2##(1990-3#1)(1991-12#1)(1992-6#1)(1994-3#1)(1996-12#1)(1996-6#1)(1997-5#1)(2007-2#1)(2008-10#1)(2008-3#2)(2008-5#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#1)
results show a clear##4##4##(1990-5#1)(1992-7#1)(2008-5#1)(2008-6#1)
results show a considerable##2##4##(2008-2#1)(2012-12#1)
results show a good##2##4##(1995-12#1)(2008-2#1)
results show a low##2##4##(2008-9#1)(2011-2#1)
results show a significant##3##4##(2007-11#1)(2008-6#1)(2013-1#1)
results show a##44##3##(1990-5#2)(1991-9#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-10#1)(1995-12#1)(1995-5#1)(2004-9#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#4)(2008-5#2)(2008-6#3)(2008-7#1)(2008-9#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
results show an interesting##2##4##(2008-2#1)(2009-10#1)
results show an##9##3##(1992-4#1)(1994-6#1)(2007-11#2)(2008-10#1)(2008-2#1)(2009-10#1)(2010-12#1)(2010-5#1)
results show clearly the##2##4##(2007-9#1)(2008-2#1)
results show clearly##3##3##(1991-5#1)(2007-9#1)(2008-2#1)
results show different##3##3##(2008-9#1)(2009-11#1)(2012-1#1)
results show good agreement with the##4##6##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
results show good agreement with##5##5##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
results show good agreement##7##4##(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#1)
results show good##11##3##(2007-12#2)(2008-10#2)(2008-2#4)(2008-3#2)(2011-1#1)
results show high##3##3##(2009-10#1)(2013-1#2)
results show how##5##3##(2008-3#1)(2009-11#1)(2012-2#1)(2013-1#2)
results show no##3##3##(1996-6#1)(2008-5#1)(2009-8#1)
results show significant##4##3##(1990-6#1)(1996-1#1)(2007-4#1)(2008-4#1)
results show successful##2##3##(2007-11#1)(2012-12#1)
results show that (1)##2##4##(2008-3#1)(2009-9#1)
results show that G##2##4##(2008-3#1)(2010-8#1)
results show that T##2##4##(1996-2#1)(2008-10#1)
results show that a##20##4##(1990-11#2)(1990-12#1)(1991-3#1)(1994-2#1)(1996-6#1)(2006-12#2)(2006-6#1)(2007-12#3)(2008-3#3)(2008-7#1)(2008-8#1)(2010-2#1)(2010-4#1)(2013-8#1)
results show that all of the##2##6##(1995-7#1)(1995-9#1)
results show that all##6##4##(1990-12#1)(1992-3#1)(1993-4#1)(1995-7#1)(1995-9#1)(2007-10#1)
results show that although the##2##5##(1995-11#1)(2013-7#1)
results show that although##5##4##(1995-1#1)(1995-11#1)(2008-3#1)(2008-5#1)(2013-7#1)
results show that an##3##4##(1994-2#1)(2007-12#1)(2007-8#1)
results show that both##11##4##(1992-1#1)(1993-3#1)(1997-2#1)(1997-3#1)(2006-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-10#1)
results show that by##2##4##(2008-10#1)(2008-11#1)
results show that changes in##2##5##(1994-2#1)(2008-3#1)
results show that changes##3##4##(1994-2#1)(2008-11#1)(2008-3#1)
results show that chronic##3##4##(1992-5#1)(1996-12#1)(2009-5#1)
results show that collapsing##2##4##(2012-3#2)
results show that different##2##4##(2008-1#1)(2012-3#1)
results show that during##3##4##(1990-3#1)(1992-3#1)(1996-9#1)
results show that each##2##4##(2007-7#1)(2008-3#1)
results show that exposure to##2##5##(1991-12#1)(1997-3#1)
results show that for##2##4##(2008-3#2)
results show that in the##4##5##(1993-3#1)(1994-8#1)(2005-4#1)(2008-3#1)
results show that in##14##4##(1992-6#1)(1993-3#1)(1993-9#1)(1994-4#1)(1994-8#1)(1995-2#1)(1996-2#1)(1997-7#1)(2005-4#1)(2008-10#2)(2008-3#1)(2008-9#1)(2011-2#1)
results show that it is possible##2##6##(1994-6#1)(2008-10#1)
results show that it is##3##5##(1994-6#1)(2008-10#1)(2013-8#1)
results show that it##4##4##(1994-6#1)(2008-10#2)(2013-8#1)
results show that low##3##4##(1996-8#1)(2006-12#1)(2008-7#1)
results show that more##2##4##(2008-10#1)(2010-12#1)
results show that no##3##4##(1993-8#1)(2008-9#1)(2010-3#1)
results show that only##4##4##(1991-9#1)(2007-12#1)(2008-10#1)(2008-3#1)
results show that our##4##4##(2008-5#1)(2009-3#1)(2011-1#1)(2011-2#1)
results show that serum##2##4##(1996-8#1)(2008-7#1)
results show that social##2##4##(2007-12#1)(2013-1#1)
results show that the average##3##5##(2005-11#1)(2008-2#1)(2011-2#1)
results show that the constructed##2##5##(2008-3#1)(2012-1#1)
results show that the different##3##5##(1990-8#1)(2008-10#1)(2010-4#1)
results show that the dominant##2##5##(1996-12#1)(2008-3#1)
results show that the extent of##3##6##(2007-9#1)(2008-10#1)(2008-6#1)
results show that the fraction of##2##6##(2007-12#1)(2008-8#1)
results show that the fully##2##5##(2008-3#2)
results show that the interference##2##5##(2008-3#1)(2013-8#1)
results show that the method##2##5##(2005-4#1)(2008-10#1)
results show that the most##2##5##(2010-8#1)(2011-2#1)
results show that the polarization##2##5##(1990-9#1)(2007-12#1)
results show that the presence of##2##6##(2008-3#1)(2008-5#1)
results show that the proposed approach##2##6##(2013-7#1)(2013-8#1)
results show that the proposed##11##5##(2008-2#6)(2008-3#1)(2010-8#1)(2012-1#1)(2013-7#1)(2013-8#1)
results show that the same##2##5##(1994-8#1)(1996-1#1)
results show that the sensitivity of##2##6##(2005-4#1)(2007-11#1)
results show that the three##2##5##(1994-9#1)(2012-1#1)
results show that the use of##3##6##(1991-9#1)(2008-3#1)(2011-2#1)
results show that the##299##4##(1990-1#1)(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-11#2)(1996-12#2)(1996-2#2)(1996-5#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#2)(1997-6#1)(1997-7#3)(2005-11#13)(2005-4#10)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-11#4)(2007-12#7)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#39)(2008-11#5)(2008-2#31)(2008-3#21)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#1)(2008-8#13)(2008-9#3)(2009-11#2)(2009-3#1)(2009-5#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#4)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#12)
results show that there are two##2##6##(2008-3#1)(2008-8#1)
results show that there are##3##5##(1994-9#1)(2008-3#1)(2008-8#1)
results show that there is no##2##6##(2008-10#1)(2009-6#1)
results show that there is##6##5##(1991-9#1)(1992-8#1)(2008-10#2)(2008-2#1)(2009-6#1)
results show that there##10##4##(1991-9#1)(1992-8#1)(1994-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#1)(2009-6#1)
results show that these##3##4##(2007-5#1)(2008-10#1)(2008-3#1)
results show that this##14##4##(2006-10#1)(2006-4#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2009-8#1)(2013-7#2)
results show that those##2##4##(2007-12#1)(2010-1#1)
results show that using##2##4##(2008-2#1)(2012-3#1)
results show that while##3##4##(1991-12#1)(1996-5#1)(2012-3#1)
results show that with##2##4##(2007-12#1)(2008-10#1)
results show that##804##3##(1990-1#1)(1990-10#1)(1990-11#6)(1990-12#2)(1990-2#2)(1990-3#3)(1990-5#2)(1990-6#1)(1990-7#3)(1990-8#3)(1990-9#2)(1991-10#1)(1991-12#5)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#3)(1991-7#2)(1991-9#5)(1992-1#4)(1992-10#2)(1992-11#2)(1992-12#2)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#5)(1992-8#7)(1992-9#3)(1993-11#1)(1993-12#5)(1993-2#4)(1993-3#3)(1993-4#3)(1993-6#6)(1993-8#3)(1993-9#5)(1994-1#1)(1994-10#2)(1994-11#4)(1994-12#2)(1994-2#8)(1994-3#5)(1994-4#2)(1994-5#1)(1994-6#1)(1994-8#9)(1994-9#5)(1995-1#4)(1995-10#1)(1995-11#4)(1995-12#5)(1995-2#4)(1995-3#5)(1995-5#5)(1995-6#5)(1995-7#3)(1995-8#2)(1995-9#2)(1996-1#3)(1996-10#1)(1996-11#3)(1996-12#3)(1996-2#5)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#3)(1996-7#3)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#8)(1997-5#2)(1997-6#6)(1997-7#7)(1997-8#1)(2004-12#1)(2004-4#1)(2004-9#2)(2005-11#22)(2005-4#13)(2005-8#2)(2006-10#5)(2006-11#2)(2006-12#4)(2006-4#2)(2006-5#2)(2006-6#4)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#9)(2007-12#18)(2007-2#2)(2007-3#4)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#3)(2008-1#5)(2008-10#82)(2008-11#12)(2008-12#3)(2008-2#49)(2008-3#44)(2008-4#11)(2008-5#20)(2008-6#4)(2008-7#9)(2008-8#20)(2008-9#8)(2009-10#4)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#4)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#2)(2010-2#10)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#4)(2010-7#2)(2010-8#7)(2010-9#1)(2011-1#9)(2011-12#2)(2011-2#14)(2012-1#6)(2012-11#2)(2012-12#5)(2012-2#11)(2012-3#11)(2012-6#1)(2013-1#13)(2013-7#5)(2013-8#29)
results show the feasibility##2##4##(2008-3#1)(2012-3#1)
results show the importance of##2##5##(2008-10#1)(2011-2#1)
results show the potential##3##4##(2006-10#1)(2008-10#2)
results show the usefulness##2##4##(1992-5#1)(2008-10#1)
results show the##41##3##(1990-12#1)(1990-8#1)(1991-11#1)(1992-5#1)(1995-11#1)(1995-12#1)(1996-12#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#7)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#1)(2009-10#1)(2009-11#1)(2010-10#1)(2010-4#2)(2011-2#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-8#1)
results show##975##2##(1990-1#1)(1990-10#1)(1990-11#6)(1990-12#3)(1990-2#2)(1990-3#3)(1990-5#5)(1990-6#2)(1990-7#3)(1990-8#4)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#4)(1991-7#2)(1991-9#6)(1992-1#4)(1992-10#2)(1992-11#3)(1992-12#2)(1992-3#4)(1992-4#2)(1992-5#2)(1992-6#2)(1992-7#6)(1992-8#8)(1992-9#3)(1993-11#2)(1993-12#5)(1993-2#4)(1993-3#3)(1993-4#3)(1993-6#6)(1993-8#5)(1993-9#5)(1994-1#1)(1994-10#3)(1994-11#4)(1994-12#2)(1994-2#9)(1994-3#5)(1994-4#2)(1994-5#1)(1994-6#2)(1994-8#9)(1994-9#5)(1995-1#4)(1995-10#1)(1995-11#5)(1995-12#7)(1995-2#5)(1995-3#5)(1995-5#7)(1995-6#5)(1995-7#3)(1995-8#4)(1995-9#2)(1996-1#4)(1996-10#1)(1996-11#3)(1996-12#4)(1996-2#5)(1996-3#2)(1996-4#1)(1996-5#5)(1996-6#4)(1996-7#3)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#8)(1997-5#2)(1997-6#6)(1997-7#7)(1997-8#1)(2004-12#1)(2004-4#1)(2004-9#3)(2005-11#23)(2005-4#13)(2005-8#2)(2006-10#7)(2006-11#3)(2006-12#4)(2006-4#2)(2006-5#3)(2006-6#5)(2006-8#2)(2007-1#2)(2007-10#2)(2007-11#16)(2007-12#25)(2007-2#2)(2007-3#4)(2007-4#1)(2007-5#3)(2007-6#3)(2007-7#3)(2007-8#8)(2007-9#4)(2008-1#9)(2008-10#99)(2008-11#12)(2008-12#3)(2008-2#62)(2008-3#57)(2008-4#12)(2008-5#27)(2008-6#7)(2008-7#11)(2008-8#21)(2008-9#10)(2009-10#7)(2009-11#5)(2009-12#1)(2009-2#3)(2009-3#3)(2009-4#2)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#4)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#3)(2010-2#10)(2010-3#2)(2010-4#4)(2010-5#3)(2010-6#4)(2010-7#2)(2010-8#7)(2010-9#1)(2011-1#13)(2011-12#2)(2011-2#18)(2012-1#9)(2012-11#3)(2012-12#7)(2012-2#16)(2012-3#12)(2012-6#1)(2012-9#1)(2013-1#19)(2013-7#6)(2013-8#33)
results showed a greater##2##4##(2008-4#1)(2013-8#1)
results showed a high##3##4##(2008-10#1)(2012-1#1)(2013-7#1)
results showed a significant decrease in##2##6##(1995-3#1)(2008-12#1)
results showed a significant decrease of##2##6##(2008-1#1)(2009-6#1)
results showed a significant decrease##4##5##(1995-3#1)(2008-1#1)(2008-12#1)(2009-6#1)
results showed a significant increase##3##5##(2008-10#1)(2009-5#1)(2011-12#1)
results showed a significant##11##4##(1995-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-5#1)(2009-6#1)(2011-1#2)(2011-12#1)(2011-2#1)
results showed a strong##2##4##(2007-2#1)(2009-4#1)
results showed a##39##3##(1990-12#1)(1991-9#1)(1995-12#1)(1995-3#1)(2005-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-12#3)(2008-4#2)(2008-5#2)(2008-8#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
results showed an increase in##3##5##(2007-2#1)(2010-5#1)(2011-2#1)
results showed an##10##3##(1991-2#1)(1991-8#1)(1992-4#1)(2006-10#1)(2007-2#1)(2008-10#1)(2010-5#1)(2011-2#2)(2012-1#1)
results showed for##2##3##(2008-10#1)(2008-5#1)
results showed good agreement##4##4##(2008-10#3)(2011-1#1)
results showed good correlation##2##4##(2008-2#1)(2008-5#1)
results showed good##6##3##(2008-10#3)(2008-2#1)(2008-5#1)(2011-1#1)
results showed no significant##4##4##(1994-5#1)(1994-6#1)(2004-11#1)(2008-9#1)
results showed no##9##3##(1991-4#1)(1994-5#1)(1994-6#1)(2004-11#1)(2006-5#1)(2007-5#1)(2008-4#1)(2008-9#1)(2012-12#1)
results showed significant##8##3##(1995-11#1)(2006-8#1)(2007-1#2)(2007-2#1)(2008-12#1)(2010-3#1)(2010-8#1)
results showed that (1)##2##4##(1996-7#1)(2008-10#1)
results showed that (i)##4##4##(2008-10#1)(2008-8#1)(2008-9#2)
results showed that all##7##4##(1990-12#1)(1991-5#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-3#1)(2013-1#1)
results showed that both the##2##5##(2008-9#1)(2010-8#1)
results showed that both##9##4##(1997-8#1)(2006-3#1)(2008-10#2)(2008-9#1)(2009-8#1)(2010-10#1)(2010-8#1)(2013-1#1)
results showed that compared##2##4##(1992-11#1)(2010-10#1)
results showed that in the##2##5##(2008-10#1)(2009-6#1)
results showed that in##15##4##(1995-12#1)(1996-3#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
results showed that it is possible to##2##7##(2006-6#1)(2010-4#1)
results showed that it##3##4##(2006-6#1)(2008-10#1)(2010-4#1)
results showed that only##2##4##(1997-8#1)(2013-1#1)
results showed that patient##2##4##(2008-9#1)(2011-10#1)
results showed that the effect of##2##6##(1991-2#1)(2007-12#1)
results showed that the majority of##3##6##(1997-3#1)(2007-3#1)(2008-8#1)
results showed that the mean##3##5##(2006-9#1)(2007-2#1)(2012-3#1)
results showed that the method is##2##6##(2005-12#1)(2008-3#1)
results showed that the method##4##5##(2005-12#1)(2008-10#2)(2008-3#1)
results showed that the most##2##5##(2007-12#1)(2007-2#1)
results showed that the optimum##2##5##(2008-10#1)(2012-12#1)
results showed that the same##3##5##(2008-10#1)(2008-8#1)(2012-1#1)
results showed that the three##2##5##(2008-9#1)(2013-1#1)
results showed that the total##3##5##(2006-4#2)(2013-8#1)
results showed that the##168##4##(1991-12#1)(1991-2#1)(1992-10#1)(1992-11#1)(1993-12#1)(1995-10#1)(1995-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-3#1)(2005-11#5)(2005-12#3)(2005-4#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#4)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#2)(2007-3#2)(2007-8#1)(2008-10#25)(2008-11#3)(2008-12#2)(2008-3#5)(2008-4#4)(2008-5#12)(2008-6#2)(2008-7#2)(2008-8#9)(2008-9#6)(2009-11#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#6)(2011-12#1)(2011-2#3)(2011-3#3)(2012-1#4)(2012-12#7)(2012-2#2)(2012-3#3)(2013-1#8)(2013-7#2)(2013-8#8)
results showed that there was a##2##6##(1997-3#1)(2005-11#1)
results showed that there was##4##5##(1997-3#1)(2005-11#1)(2006-8#1)(2008-9#1)
results showed that there##13##4##(1991-5#1)(1997-3#1)(2005-11#2)(2006-8#2)(2007-7#1)(2008-12#2)(2008-8#1)(2008-9#1)(2011-12#1)(2011-2#1)
results showed that these##5##4##(1995-12#1)(1996-1#1)(2008-10#2)(2008-9#1)
results showed that this##6##4##(2005-4#1)(2008-10#1)(2012-11#1)(2012-12#2)(2013-7#1)
results showed that water##2##4##(2007-1#1)(2013-7#1)
results showed that with##4##4##(2006-8#1)(2008-2#1)(2011-2#1)(2013-1#1)
results showed that##491##3##(1990-10#1)(1990-12#3)(1990-6#1)(1990-8#3)(1991-12#1)(1991-2#1)(1991-5#3)(1991-9#1)(1992-10#2)(1992-11#2)(1992-12#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#5)(1995-3#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-8#2)(2004-4#1)(2004-9#3)(2005-1#1)(2005-10#1)(2005-11#13)(2005-12#4)(2005-4#3)(2005-6#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#3)(2006-4#2)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#8)(2006-9#1)(2007-1#7)(2007-10#5)(2007-11#4)(2007-12#9)(2007-2#5)(2007-3#4)(2007-5#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#66)(2008-11#16)(2008-12#12)(2008-2#2)(2008-3#8)(2008-4#8)(2008-5#17)(2008-6#4)(2008-7#5)(2008-8#26)(2008-9#26)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#4)(2010-10#3)(2010-12#6)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#13)(2011-10#1)(2011-12#3)(2011-2#8)(2011-3#4)(2012-1#6)(2012-11#1)(2012-12#12)(2012-2#7)(2012-3#8)(2013-1#22)(2013-7#7)(2013-8#22)
results showed the##27##3##(1990-7#1)(1993-1#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-5#3)(2008-6#1)(2009-10#1)(2009-4#2)(2010-12#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
results showed##648##2##(1990-10#1)(1990-12#4)(1990-6#1)(1990-7#1)(1990-8#3)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#3)(1991-8#1)(1991-9#2)(1992-10#2)(1992-11#2)(1992-12#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#6)(1995-3#3)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#3)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#2)(2004-11#1)(2004-4#1)(2004-9#3)(2005-1#1)(2005-10#1)(2005-11#16)(2005-12#4)(2005-4#3)(2005-6#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#3)(2006-4#2)(2006-5#4)(2006-6#1)(2006-7#1)(2006-8#12)(2006-9#1)(2007-1#10)(2007-10#5)(2007-11#5)(2007-12#11)(2007-2#9)(2007-3#4)(2007-5#2)(2007-7#3)(2007-8#6)(2007-9#1)(2008-1#5)(2008-10#90)(2008-11#19)(2008-12#18)(2008-2#5)(2008-3#8)(2008-4#12)(2008-5#25)(2008-6#5)(2008-7#5)(2008-8#29)(2008-9#29)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#4)(2009-4#4)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#4)(2010-10#3)(2010-12#9)(2010-3#3)(2010-4#3)(2010-5#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#23)(2011-10#1)(2011-12#4)(2011-2#15)(2011-3#4)(2012-1#9)(2012-11#1)(2012-12#15)(2012-2#8)(2012-3#11)(2013-1#27)(2013-7#8)(2013-8#26)
results showing a##2##3##(2007-12#1)(2013-7#1)
results showing that the##2##4##(1990-2#1)(2008-2#1)
results showing that##6##3##(1990-2#1)(1994-12#1)(1996-9#1)(2008-2#1)(2008-7#1)(2010-4#1)
results showing the##2##3##(1991-11#1)(2009-3#1)
results showing##17##2##(1990-2#1)(1991-11#1)(1994-12#1)(1996-9#1)(1997-7#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)(2008-7#1)(2009-3#1)(2010-4#1)(2013-7#1)(2013-8#1)
results shown a##2##3##(2006-10#1)(2008-10#1)
results shown that##2##3##(2007-10#1)(2008-11#1)
results shown##6##2##(2006-10#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-7#1)
results shows that the##2##4##(1991-2#1)(2010-8#1)
results shows that##5##3##(1991-2#1)(2006-10#1)(2008-10#1)(2010-8#1)(2013-8#1)
results shows##7##2##(1990-4#1)(1991-2#1)(2006-10#1)(2008-10#1)(2008-5#1)(2010-8#1)(2013-8#1)
results similar to the##2##4##(1997-1#1)(2010-6#1)
results similar to those##5##4##(1990-3#1)(1994-3#1)(2008-10#2)(2010-4#1)
results similar to##8##3##(1990-3#1)(1994-3#1)(1997-1#1)(2008-10#2)(2008-3#1)(2010-4#1)(2010-6#1)
results so far##2##3##(2006-12#1)(2006-8#1)
results so##3##2##(2006-12#1)(2006-8#1)(2008-10#1)
results strengthen the##2##3##(1992-8#1)(1994-12#1)
results stress the importance of##3##5##(1991-10#1)(2009-2#1)(2010-12#1)
results stress the##5##3##(1991-10#1)(1992-2#1)(1992-7#1)(2009-2#1)(2010-12#1)
results strongly implicate##2##3##(1990-5#1)(1995-5#1)
results strongly indicate that##7##4##(1990-3#2)(1991-12#1)(1993-12#1)(1993-8#1)(1997-7#2)
results strongly suggest that the##12##5##(1991-1#1)(1991-12#1)(1991-5#1)(1993-6#1)(1994-6#1)(1995-2#1)(1995-6#1)(1997-4#1)(1997-6#1)(2007-1#1)(2008-6#1)(2008-8#1)
results strongly suggest that##39##4##(1990-3#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-12#4)(1991-5#1)(1992-8#1)(1993-6#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-4#1)(1997-6#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#1)(2009-2#1)(2009-3#1)(2010-3#1)(2012-12#2)(2013-1#1)
results strongly suggest the##4##4##(1994-5#1)(1995-3#1)(2008-4#1)(2010-11#1)
results strongly suggest##45##3##(1990-3#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-12#4)(1991-2#1)(1991-5#1)(1992-8#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-4#1)(1997-6#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2009-2#1)(2009-3#1)(2010-11#1)(2010-3#1)(2012-12#2)(2013-1#1)
results strongly suggested that##6##4##(1992-11#1)(1992-7#1)(1993-4#1)(1994-9#1)(2008-10#1)(2008-4#1)
results strongly support a##2##4##(1993-6#1)(1997-4#1)
results strongly support the##6##4##(1992-3#1)(1995-3#1)(2006-12#1)(2008-3#1)(2011-12#1)(2013-1#1)
results strongly support##11##3##(1991-8#1)(1992-3#1)(1993-6#1)(1995-3#1)(1997-4#1)(2006-12#1)(2008-10#1)(2008-3#1)(2011-12#1)(2013-1#2)
results strongly##75##2##(1990-3#3)(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#5)(1991-2#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-12#2)(1993-4#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#1)(1997-4#2)(1997-6#1)(1997-7#2)(2006-10#1)(2006-12#1)(2007-1#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-3#1)(2010-11#1)(2010-3#1)(2011-12#1)(2012-12#2)(2013-1#3)
results substantiate the##3##3##(1991-3#1)(1992-12#1)(2008-7#1)
results suggest a possible role of##2##6##(1990-11#1)(1995-8#1)
results suggest a possible role##6##5##(1990-11#1)(1991-1#1)(1992-3#1)(1995-8#1)(1997-5#1)(1997-6#1)
results suggest a possible##15##4##(1990-11#1)(1990-8#1)(1991-1#1)(1991-5#1)(1992-10#1)(1992-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-8#1)(1996-5#1)(1997-5#1)(1997-6#1)(2008-4#1)(2011-2#1)
results suggest a potential role##2##5##(1996-5#1)(2008-10#1)
results suggest a potential##4##4##(1994-9#1)(1996-5#1)(2008-10#1)(2013-1#1)
results suggest a role for##3##5##(1992-11#1)(1992-12#1)(2012-3#1)
results suggest a##68##3##(1990-11#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-5#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-9#2)(1995-7#1)(1995-8#3)(1996-10#1)(1996-2#1)(1996-5#3)(1996-8#1)(1997-5#1)(1997-6#4)(2004-9#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-4#1)(2009-6#2)(2010-4#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
results suggest an important role##2##5##(1994-3#1)(1995-1#1)
results suggest an inhibitory##2##4##(1993-12#1)(2008-5#1)
results suggest an interaction of##2##5##(1990-6#1)(1994-2#1)
results suggest an##24##3##(1990-6#1)(1991-10#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-8#2)(1995-1#1)(1995-3#1)(1996-11#1)(1996-9#1)(1997-2#1)(1997-6#1)(2005-10#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2010-12#1)
results suggest direct##3##3##(2011-2#1)(2012-12#2)
results suggest some##2##3##(1992-12#1)(1997-5#1)
results suggest strongly that##2##4##(1991-8#1)(1992-3#1)
results suggest that (a)##2##4##(1994-2#1)(2008-4#1)
results suggest that (i)##4##4##(1991-2#1)(1993-9#1)(1995-5#1)(2008-10#1)
results suggest that ACh##3##4##(1992-7#1)(1995-12#1)(1997-5#1)
results suggest that CR##2##4##(1995-11#1)(2008-10#1)
results suggest that Ca2+##4##4##(1990-7#1)(1992-1#1)(1993-11#1)(1997-7#1)
results suggest that DNA##3##4##(1990-6#1)(1990-9#1)(2010-5#1)
results suggest that EGF##2##4##(1993-9#1)(1995-11#1)
results suggest that FGF##2##4##(1995-10#1)(2008-5#1)
results suggest that IL-1##2##4##(1994-12#1)(1996-3#1)
results suggest that IL-6##2##4##(1990-5#1)(1996-2#1)
results suggest that InsP6##2##4##(1990-7#1)(1997-4#1)
results suggest that NO is##2##5##(1995-5#1)(2012-2#1)
results suggest that NO##5##4##(1994-5#1)(1995-11#1)(1995-5#1)(1997-6#1)(2012-2#1)
results suggest that PKA##2##4##(1990-7#1)(2008-8#1)
results suggest that PKC##3##4##(1993-3#1)(1995-2#1)(1996-8#1)
results suggest that a combinatorial##2##5##(2008-2#1)(2009-10#1)
results suggest that a high##3##5##(1992-9#1)(1994-2#1)(2008-8#1)
results suggest that a minimum##2##5##(2008-2#1)(2010-4#1)
results suggest that a reduction in##2##6##(2011-2#1)(2013-1#1)
results suggest that a##45##4##(1990-4#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-3#2)(1992-4#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-8#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-8#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
results suggest that acoustic##2##4##(2008-3#1)(2013-7#1)
results suggest that alternative##2##4##(2006-10#1)(2008-6#1)
results suggest that although##10##4##(1991-4#1)(1993-5#1)(1994-12#1)(1994-8#1)(1997-3#1)(1997-4#1)(2007-12#1)(2013-1#3)
results suggest that an increased##2##5##(2006-12#1)(2008-5#1)
results suggest that an##12##4##(1990-2#1)(1991-3#1)(1993-6#1)(1993-9#1)(1995-3#1)(1997-2#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2013-8#1)
results suggest that at##5##4##(1990-2#1)(1991-6#1)(1995-12#1)(1996-7#1)(2008-10#1)
results suggest that both the##3##5##(1991-12#1)(1991-4#1)(1994-9#1)
results suggest that both##13##4##(1990-11#1)(1990-2#1)(1991-1#1)(1991-12#1)(1991-4#1)(1993-3#1)(1993-7#1)(1994-5#1)(1994-9#2)(2008-10#1)(2008-9#1)(2012-12#1)
results suggest that cell##2##4##(1991-1#1)(1992-11#1)
results suggest that certain##2##4##(2006-10#1)(2006-9#1)
results suggest that cholesterol##2##4##(1990-2#1)(2010-4#1)
results suggest that chronic##4##4##(1993-2#1)(1996-10#1)(1997-4#1)(2013-1#1)
results suggest that despite##2##4##(2007-8#1)(2008-5#1)
results suggest that dietary##5##4##(1991-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-2#1)
results suggest that different##9##4##(1990-7#1)(1996-5#1)(1997-7#1)(2006-8#1)(2007-10#1)(2008-10#1)(2008-9#1)(2013-1#1)(2013-8#1)
results suggest that either##4##4##(2006-8#1)(2009-12#1)(2010-12#1)(2010-2#1)
results suggest that electrical##2##4##(1990-5#1)(1993-11#1)
results suggest that endogenously##2##4##(1990-4#1)(1993-9#1)
results suggest that endoscopic##2##4##(1990-6#1)(1993-5#1)
results suggest that enhanced##3##4##(1991-9#1)(1996-9#1)(2008-10#1)
results suggest that exogenous##2##4##(1992-5#1)(2012-3#1)
results suggest that extracellular##4##4##(1990-8#1)(1997-1#1)(1997-6#1)(2006-5#1)
results suggest that family##2##4##(2011-1#1)(2012-11#1)
results suggest that for##4##4##(1990-3#1)(1992-11#1)(2008-7#1)(2009-7#1)
results suggest that further studies##2##5##(1990-12#1)(1994-10#1)
results suggest that high##2##4##(1992-11#1)(2010-5#1)
results suggest that hormonal##2##4##(1991-5#1)(1994-2#1)
results suggest that human##4##4##(1990-12#1)(1994-2#1)(2008-8#1)(2012-11#1)
results suggest that in addition to##4##6##(1992-7#1)(1992-9#1)(1993-3#1)(1993-9#1)
results suggest that in the##3##5##(1990-2#1)(1990-3#1)(2008-10#1)
results suggest that in##24##4##(1990-2#1)(1990-3#1)(1992-7#1)(1992-9#1)(1993-3#2)(1993-8#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-5#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-7#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-5#1)(2009-10#1)
results suggest that increased##5##4##(1992-3#1)(1993-11#1)(1994-3#1)(1996-9#1)(1997-7#1)
results suggest that individuals##2##4##(2007-2#1)(2010-11#1)
results suggest that information##2##4##(2008-12#1)(2010-2#1)
results suggest that intracellular##3##4##(1995-8#1)(1996-2#1)(2008-10#1)
results suggest that it may be##3##6##(1997-4#1)(2004-1#1)(2008-10#1)
results suggest that it##6##4##(1990-4#1)(1997-4#2)(2004-1#1)(2008-10#2)
results suggest that large##2##4##(2008-11#1)(2008-8#1)
results suggest that local##2##4##(2008-9#1)(2009-10#1)
results suggest that long-term##3##4##(1991-2#1)(1994-5#1)(1994-6#1)
results suggest that many##4##4##(1992-4#1)(1992-8#1)(1994-2#1)(1996-6#1)
results suggest that memory##2##4##(1995-11#1)(2008-9#1)
results suggest that multiple##3##4##(1991-6#1)(1997-3#1)(2012-3#1)
results suggest that not only##2##5##(1991-9#1)(1992-9#1)
results suggest that occupational##2##4##(2009-5#1)(2013-7#1)
results suggest that organic##2##4##(1992-6#1)(2008-10#1)
results suggest that other##2##4##(1993-6#1)(2013-1#1)
results suggest that overexpression of##2##5##(1992-12#1)(2008-10#1)
results suggest that parental##2##4##(2009-10#1)(2010-1#1)
results suggest that patients with##3##5##(1996-8#1)(2007-6#1)(2012-2#1)
results suggest that patients##5##4##(1996-8#1)(2004-10#1)(2007-6#1)(2008-10#1)(2012-2#1)
results suggest that phage##2##4##(2008-8#1)(2013-1#1)
results suggest that protein##8##4##(1990-5#1)(1991-11#1)(1991-6#1)(1992-12#1)(1993-8#1)(1994-9#1)(1995-12#1)(1997-6#1)
results suggest that repeated##3##4##(1993-2#1)(1995-2#1)(1996-12#1)
results suggest that serotonin##2##4##(2008-5#1)(2010-12#1)
results suggest that some##10##4##(1990-2#1)(1993-11#1)(1993-4#1)(1995-1#1)(1996-6#1)(1996-8#1)(2008-10#1)(2008-7#1)(2008-9#2)
results suggest that special##2##4##(2012-1#1)(2012-2#1)
results suggest that specific##3##4##(1990-11#1)(1992-12#1)(2008-9#1)
results suggest that stimulation of##3##5##(1996-12#1)(1997-7#2)
results suggest that structural##2##4##(1993-12#1)(1994-9#1)
results suggest that such##2##4##(1993-3#1)(2008-11#1)
results suggest that systemic##2##4##(1992-3#1)(2008-10#1)
results suggest that the R##2##5##(1991-12#1)(2008-10#1)
results suggest that the altered##2##5##(1992-10#1)(1997-1#1)
results suggest that the amygdala##2##5##(1993-6#2)
results suggest that the combination of##2##6##(1997-1#1)(2008-9#1)
results suggest that the difference##2##5##(1990-4#1)(2012-1#1)
results suggest that the effect of##4##6##(1993-3#1)(1994-3#1)(1996-12#1)(2008-8#1)
results suggest that the effect##5##5##(1993-3#1)(1994-2#1)(1994-3#1)(1996-12#1)(2008-8#1)
results suggest that the effects of##3##6##(1992-9#1)(2006-6#1)(2009-11#1)
results suggest that the enhanced##3##5##(1995-8#1)(2008-10#1)(2008-5#1)
results suggest that the expression of##2##6##(1993-8#1)(1997-7#1)
results suggest that the formation##4##5##(1991-7#1)(1997-2#1)(2007-3#1)(2008-5#1)
results suggest that the inability of##3##6##(1990-8#1)(1995-2#1)(2010-2#1)
results suggest that the increase in##3##6##(1991-9#1)(1996-11#1)(2013-8#1)
results suggest that the increase##4##5##(1990-4#1)(1991-9#1)(1996-11#1)(2013-8#1)
results suggest that the inhibition of##3##6##(1993-12#1)(1997-4#1)(2008-11#1)
results suggest that the inhibitory##6##5##(1990-5#1)(1991-12#1)(1995-11#1)(1996-12#1)(2006-4#1)(2008-4#1)
results suggest that the lysine##2##5##(1995-5#1)(1997-6#1)
results suggest that the mechanism of##3##6##(1991-10#1)(1997-2#1)(2008-5#1)
results suggest that the observed##2##5##(1994-12#1)(1995-12#1)
results suggest that the phosphorylation of the##2##7##(1991-11#1)(1996-2#1)
results suggest that the presence of##3##6##(1990-5#1)(1995-6#1)(2008-10#1)
results suggest that the product##2##5##(1990-2#1)(2011-2#1)
results suggest that the protein##2##5##(1990-12#1)(1995-10#1)
results suggest that the reduced##2##5##(2008-10#1)(2011-12#1)
results suggest that the relationship between##2##6##(2008-11#1)(2012-12#1)
results suggest that the role of##3##6##(1995-8#1)(1996-12#1)(2010-1#1)
results suggest that the stimulation of##2##6##(1995-12#1)(2013-1#1)
results suggest that the structural##2##5##(1993-6#1)(1995-5#1)
results suggest that the two##4##5##(1990-4#1)(1996-4#1)(2008-11#1)(2010-8#1)
results suggest that the use of##5##6##(2007-8#1)(2008-7#1)(2010-4#1)(2012-3#1)(2013-8#1)
results suggest that the##423##4##(1990-10#1)(1990-11#3)(1990-12#4)(1990-2#5)(1990-3#5)(1990-4#6)(1990-5#6)(1990-8#3)(1991-1#3)(1991-10#3)(1991-11#2)(1991-12#5)(1991-2#3)(1991-4#2)(1991-5#2)(1991-6#3)(1991-7#7)(1991-8#1)(1991-9#6)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#2)(1992-5#2)(1992-6#1)(1992-7#3)(1992-8#7)(1992-9#5)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#6)(1993-4#1)(1993-6#8)(1993-7#2)(1993-8#2)(1994-10#2)(1994-11#4)(1994-12#9)(1994-2#5)(1994-3#4)(1994-5#2)(1994-6#3)(1994-8#5)(1994-9#4)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#8)(1995-2#2)(1995-3#3)(1995-5#3)(1995-6#2)(1995-8#3)(1995-9#1)(1996-1#1)(1996-10#4)(1996-11#3)(1996-12#4)(1996-2#3)(1996-4#4)(1996-5#3)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#4)(1997-2#8)(1997-4#2)(1997-5#1)(1997-6#5)(1997-7#6)(1997-8#4)(2004-2#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-4#1)(2006-6#1)(2007-10#4)(2007-11#2)(2007-12#4)(2007-2#1)(2007-3#3)(2007-4#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-10#29)(2008-11#10)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#11)(2008-6#3)(2008-7#4)(2008-8#10)(2008-9#7)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#3)(2010-8#2)(2010-9#2)(2011-1#1)(2011-12#3)(2011-2#9)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#8)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#3)
results suggest that there is a##8##6##(1991-12#1)(1991-6#1)(1991-7#1)(2008-3#1)(2009-8#1)(2010-12#1)(2010-7#1)(2010-9#1)
results suggest that there is##14##5##(1991-12#1)(1991-6#1)(1991-7#1)(1992-9#1)(1994-3#1)(2008-10#4)(2008-3#1)(2009-8#1)(2010-12#1)(2010-7#1)(2010-9#1)
results suggest that there may be##3##6##(2006-3#1)(2008-12#1)(2011-2#1)
results suggest that there##25##4##(1990-4#1)(1991-12#1)(1991-6#1)(1991-7#1)(1992-5#1)(1992-9#1)(1994-11#1)(1994-3#1)(1995-7#1)(1995-9#1)(1996-10#1)(2006-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#1)
results suggest that these##7##4##(1992-8#1)(1993-11#1)(1994-12#1)(2006-5#1)(2008-10#1)(2008-5#1)(2012-1#1)
results suggest that this compound##2##5##(1991-5#1)(1993-9#1)
results suggest that this new##2##5##(2008-3#1)(2012-3#1)
results suggest that this##14##4##(1990-5#1)(1991-5#1)(1992-4#1)(1993-9#1)(1994-12#2)(1996-1#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2012-3#1)
results suggest that thyroid##2##4##(1993-3#1)(1995-7#1)
results suggest that treatment with##2##5##(1996-7#1)(2008-11#1)
results suggest that treatment##3##4##(1996-7#1)(2008-11#1)(2012-2#1)
results suggest that two##2##4##(1994-6#1)(2008-6#1)
results suggest that type##3##4##(1991-4#1)(1991-7#1)(1995-7#1)
results suggest that under##2##4##(1990-12#1)(1991-12#1)
results suggest that vitamin##2##4##(2008-11#1)(2010-12#1)
results suggest that when##4##4##(1992-10#1)(2008-8#1)(2009-9#1)(2012-2#1)
results suggest that##1728##3##(1990-1#1)(1990-10#4)(1990-11#12)(1990-12#10)(1990-2#22)(1990-3#9)(1990-4#12)(1990-5#19)(1990-6#4)(1990-7#15)(1990-8#8)(1990-9#4)(1991-1#11)(1991-10#7)(1991-11#7)(1991-12#21)(1991-2#8)(1991-3#3)(1991-4#13)(1991-5#10)(1991-6#9)(1991-7#13)(1991-8#4)(1991-9#15)(1992-1#7)(1992-10#3)(1992-11#13)(1992-12#12)(1992-2#1)(1992-3#17)(1992-4#13)(1992-5#8)(1992-6#9)(1992-7#10)(1992-8#17)(1992-9#13)(1993-1#1)(1993-11#16)(1993-12#14)(1993-2#7)(1993-3#24)(1993-4#7)(1993-5#2)(1993-6#19)(1993-7#4)(1993-8#11)(1993-9#11)(1994-10#5)(1994-11#13)(1994-12#28)(1994-2#23)(1994-3#22)(1994-5#10)(1994-6#10)(1994-7#3)(1994-8#15)(1994-9#24)(1995-1#6)(1995-10#7)(1995-11#17)(1995-12#26)(1995-2#9)(1995-3#12)(1995-4#3)(1995-5#14)(1995-6#9)(1995-7#6)(1995-8#9)(1995-9#4)(1996-1#9)(1996-10#11)(1996-11#8)(1996-12#16)(1996-2#20)(1996-3#5)(1996-4#7)(1996-5#16)(1996-6#3)(1996-7#3)(1996-8#10)(1996-9#8)(1997-1#13)(1997-2#15)(1997-3#8)(1997-4#13)(1997-5#12)(1997-6#16)(1997-7#20)(1997-8#15)(2003-11#1)(2004-1#1)(2004-10#1)(2004-11#4)(2004-12#1)(2004-2#3)(2004-4#2)(2005-10#1)(2005-11#3)(2005-9#1)(2006-10#7)(2006-11#3)(2006-12#7)(2006-3#1)(2006-4#1)(2006-5#5)(2006-6#5)(2006-7#2)(2006-8#4)(2006-9#2)(2007-1#2)(2007-10#6)(2007-11#6)(2007-12#16)(2007-2#3)(2007-3#9)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#13)(2007-9#6)(2008-1#3)(2008-10#121)(2008-11#51)(2008-12#6)(2008-2#13)(2008-3#14)(2008-4#12)(2008-5#33)(2008-6#12)(2008-7#21)(2008-8#34)(2008-9#25)(2009-10#12)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#4)(2009-4#3)(2009-5#4)(2009-6#1)(2009-7#5)(2009-8#10)(2009-9#6)(2010-1#3)(2010-10#3)(2010-11#2)(2010-12#14)(2010-2#9)(2010-3#4)(2010-4#8)(2010-5#6)(2010-6#1)(2010-7#3)(2010-8#6)(2010-9#5)(2011-1#7)(2011-12#5)(2011-2#27)(2012-1#10)(2012-11#6)(2012-12#11)(2012-2#31)(2012-3#17)(2012-7#1)(2013-1#26)(2013-7#8)(2013-8#11)
results suggest the involvement of##4##5##(1996-12#1)(1996-5#1)(1997-1#1)(2007-3#1)
results suggest the need for further##2##6##(2006-7#1)(2012-2#1)
results suggest the need for##6##5##(1995-1#1)(2006-7#1)(2008-3#1)(2008-9#1)(2009-10#1)(2012-2#1)
results suggest the possibility of a##2##6##(1993-12#1)(1994-8#1)
results suggest the possibility of using##2##6##(1995-7#1)(2008-2#1)
results suggest the possibility of##6##5##(1993-12#1)(1993-3#1)(1994-8#1)(1995-7#1)(2008-2#1)(2009-11#1)
results suggest the possibility that##5##5##(1990-12#1)(1990-3#1)(1994-11#1)(1995-8#1)(1996-12#1)
results suggest the possibility##12##4##(1990-12#1)(1990-3#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-7#1)(1995-8#1)(1996-12#1)(2006-12#1)(2008-2#1)(2009-11#1)
results suggest the potential##5##4##(1993-11#1)(1995-10#1)(2008-10#2)(2008-11#1)
results suggest the presence of a##6##6##(1991-2#1)(1993-11#1)(1995-12#1)(2008-10#1)(2008-6#1)(2008-9#1)
results suggest the presence of##10##5##(1990-2#1)(1991-2#1)(1991-3#1)(1993-11#1)(1995-12#1)(2008-10#1)(2008-6#1)(2008-9#1)(2010-2#1)(2013-8#1)
results suggest the##66##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-10#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#2)(1995-6#1)(1995-7#1)(1995-8#2)(1996-12#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-5#1)(2004-12#1)(2005-8#1)(2006-12#1)(2006-7#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-9#2)(2009-10#1)(2009-11#1)(2010-2#1)(2011-12#1)(2012-2#1)(2013-8#1)
results suggest two##4##3##(1991-8#1)(1995-1#1)(1995-2#1)(2012-3#1)
results suggest##1961##2##(1990-1#1)(1990-10#4)(1990-11#13)(1990-12#11)(1990-2#23)(1990-3#10)(1990-4#12)(1990-5#20)(1990-6#5)(1990-7#16)(1990-8#9)(1990-9#4)(1991-1#12)(1991-10#8)(1991-11#9)(1991-12#23)(1991-2#10)(1991-3#4)(1991-4#13)(1991-5#13)(1991-6#9)(1991-7#13)(1991-8#7)(1991-9#18)(1992-1#7)(1992-10#5)(1992-11#15)(1992-12#15)(1992-2#2)(1992-3#20)(1992-4#14)(1992-5#8)(1992-6#10)(1992-7#12)(1992-8#18)(1992-9#15)(1993-1#1)(1993-11#19)(1993-12#16)(1993-2#8)(1993-3#27)(1993-4#7)(1993-5#2)(1993-6#22)(1993-7#4)(1993-8#12)(1993-9#12)(1994-10#6)(1994-11#15)(1994-12#31)(1994-2#27)(1994-3#28)(1994-4#1)(1994-5#12)(1994-6#12)(1994-7#3)(1994-8#19)(1994-9#29)(1995-1#10)(1995-10#8)(1995-11#17)(1995-12#28)(1995-2#10)(1995-3#13)(1995-4#3)(1995-5#14)(1995-6#10)(1995-7#8)(1995-8#14)(1995-9#4)(1996-1#9)(1996-10#12)(1996-11#9)(1996-12#18)(1996-2#21)(1996-3#6)(1996-4#7)(1996-5#21)(1996-6#3)(1996-7#3)(1996-8#11)(1996-9#10)(1997-1#14)(1997-2#16)(1997-3#8)(1997-4#13)(1997-5#15)(1997-6#21)(1997-7#20)(1997-8#16)(2003-11#1)(2004-1#1)(2004-10#1)(2004-11#4)(2004-12#2)(2004-2#3)(2004-4#2)(2004-9#1)(2005-10#2)(2005-11#4)(2005-8#1)(2005-9#1)(2006-10#7)(2006-11#3)(2006-12#9)(2006-3#2)(2006-4#1)(2006-5#6)(2006-6#5)(2006-7#5)(2006-8#5)(2006-9#2)(2007-1#2)(2007-10#7)(2007-11#6)(2007-12#22)(2007-2#5)(2007-3#10)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#13)(2007-9#6)(2008-1#4)(2008-10#133)(2008-11#58)(2008-12#7)(2008-2#15)(2008-3#17)(2008-4#13)(2008-5#39)(2008-6#13)(2008-7#23)(2008-8#36)(2008-9#28)(2009-10#13)(2009-11#2)(2009-12#4)(2009-2#2)(2009-3#4)(2009-4#4)(2009-5#5)(2009-6#3)(2009-7#5)(2009-8#11)(2009-9#6)(2010-1#3)(2010-10#4)(2010-11#2)(2010-12#16)(2010-2#11)(2010-3#4)(2010-4#10)(2010-5#6)(2010-6#2)(2010-7#4)(2010-8#7)(2010-9#5)(2011-1#7)(2011-12#6)(2011-2#32)(2012-1#11)(2012-11#6)(2012-12#13)(2012-2#35)(2012-3#20)(2012-7#1)(2013-1#27)(2013-7#8)(2013-8#15)
results suggested a##6##3##(1990-5#1)(1992-11#1)(1997-2#1)(1997-8#1)(2008-6#1)(2008-8#1)
results suggested specific##2##3##(1996-12#1)(2009-1#1)
results suggested that oral##2##4##(2008-4#1)(2011-1#1)
results suggested that the##33##4##(1990-5#1)(1991-2#1)(1991-4#1)(1991-9#1)(1994-12#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-9#1)(1997-4#1)(1997-7#1)(1997-8#2)(2005-11#1)(2007-2#2)(2008-10#2)(2008-11#4)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#1)(2010-4#1)(2011-3#1)(2012-1#1)(2013-1#1)(2013-8#1)
results suggested that##107##3##(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-7#1)(1997-8#2)(2004-11#1)(2004-12#1)(2005-11#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-7#2)(2007-9#1)(2008-10#6)(2008-11#7)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#8)(2008-9#3)(2009-3#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#1)(2013-1#5)(2013-8#2)
results suggested the##3##3##(1991-8#1)(2008-5#1)(2008-9#1)
results suggested##125##2##(1990-12#1)(1990-3#1)(1990-5#2)(1990-7#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-7#1)(1997-8#3)(2004-11#1)(2004-12#1)(2004-9#1)(2005-11#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-7#2)(2007-9#1)(2008-10#6)(2008-11#7)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#9)(2008-9#4)(2009-1#1)(2009-11#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-1#3)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#1)(2013-1#7)(2013-8#2)
results suggesting that##3##3##(1990-9#1)(1993-2#1)(2008-3#1)
results suggesting##4##2##(1990-9#1)(1992-12#1)(1993-2#1)(2008-3#1)
results suggests that##7##3##(1996-5#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)
results suggests##8##2##(1996-5#1)(1996-9#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)
results support a model in which##2##6##(1994-9#1)(1995-8#1)
results support a model of##3##5##(1994-9#1)(2010-2#1)(2013-8#1)
results support a model##5##4##(1994-9#2)(1995-8#1)(2010-2#1)(2013-8#1)
results support a role for##6##5##(1990-5#1)(1992-5#1)(1994-8#1)(1995-1#1)(1995-5#1)(1995-6#1)
results support a role##7##4##(1990-5#1)(1992-11#1)(1992-5#1)(1994-8#1)(1995-1#1)(1995-5#1)(1995-6#1)
results support a##23##3##(1990-5#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-5#1)(1993-11#1)(1993-7#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-2#1)(2012-12#1)(2013-8#1)
results support an##2##3##(1995-2#1)(2013-8#1)
results support earlier##2##3##(1996-12#1)(2009-2#1)
results support our hypothesis that##2##5##(1994-10#1)(1996-12#1)
results support our##7##3##(1994-10#1)(1995-5#1)(1996-12#1)(2007-12#2)(2008-6#1)(2010-8#1)
results support previous findings##2##4##(1996-5#1)(2006-7#1)
results support previous##9##3##(1990-10#1)(1993-7#1)(1996-5#1)(1997-6#1)(1997-7#1)(2006-7#1)(2008-11#1)(2008-7#1)(2011-2#1)
results support that##3##3##(2008-5#1)(2010-1#1)(2012-1#1)
results support the application of##3##5##(1996-3#1)(2007-7#1)(2010-5#1)
results support the concept that##2##5##(1996-5#1)(1997-8#1)
results support the concept##3##4##(1991-9#1)(1996-5#1)(1997-8#1)
results support the conclusion that##3##5##(1991-9#1)(1992-2#1)(2013-8#1)
results support the hypotheses that##3##5##(2008-10#1)(2008-7#1)(2010-6#1)
results support the hypothesis for##2##5##(2008-10#2)
results support the hypothesis that a##4##6##(1990-3#1)(1992-2#1)(1995-7#1)(2009-5#1)
results support the hypothesis that the##5##6##(1992-7#1)(1994-8#1)(1994-9#1)(2008-10#2)
results support the hypothesis that##40##5##(1990-3#1)(1990-7#1)(1992-1#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-7#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-8#1)(2007-1#1)(2007-3#1)(2008-10#6)(2008-4#1)(2008-5#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-8#1)(2012-12#2)
results support the hypothesis##45##4##(1990-3#1)(1990-7#1)(1992-1#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-7#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-8#1)(2007-1#1)(2007-3#1)(2008-10#8)(2008-4#1)(2008-5#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-8#1)(2012-12#2)
results support the idea that the##2##6##(2007-6#1)(2008-5#1)
results support the idea that##8##5##(1990-8#1)(1991-8#1)(1996-6#1)(2007-6#1)(2008-10#1)(2008-5#1)(2009-3#1)(2010-10#1)
results support the idea##9##4##(1990-8#1)(1991-8#1)(1996-6#1)(1997-2#1)(2007-6#1)(2008-10#1)(2008-5#1)(2009-3#1)(2010-10#1)
results support the involvement of##2##5##(1993-4#1)(1995-12#1)
results support the notion that the##5##6##(1991-10#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-4#1)
results support the notion that##10##5##(1990-11#1)(1990-5#1)(1991-10#1)(1991-9#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-4#1)(1997-8#1)(2010-10#1)
results support the proposal that##2##5##(1990-10#1)(1996-5#1)
results support the suggestion that##3##5##(1990-11#1)(1995-8#1)(2007-12#1)
results support the suggestion##4##4##(1990-11#1)(1995-8#1)(1996-5#1)(2007-12#1)
results support the use of the##2##6##(2008-8#1)(2012-12#1)
results support the use of##4##5##(1995-3#1)(2008-8#1)(2009-12#1)(2012-12#1)
results support the view that##12##5##(1990-2#1)(1993-2#1)(1993-5#1)(1994-2#1)(1996-10#1)(1996-3#1)(2004-3#1)(2007-1#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-11#1)
results support the##135##3##(1990-1#1)(1990-10#1)(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-6#2)(1992-7#3)(1992-8#1)(1993-2#1)(1993-4#1)(1993-5#2)(1993-7#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-3#2)(1996-4#2)(1996-5#3)(1996-6#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#3)(2004-11#1)(2004-3#1)(2006-10#1)(2006-8#1)(2007-1#2)(2007-12#4)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#4)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#2)(2012-12#3)(2013-1#4)(2013-8#2)
results support##200##2##(1990-1#1)(1990-10#2)(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-5#2)(1992-6#3)(1992-7#3)(1992-8#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-5#2)(1993-7#4)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-8#3)(1994-9#4)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#4)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#3)(2004-11#1)(2004-3#1)(2004-4#1)(2006-10#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-12#7)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#6)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-2#2)(2012-1#1)(2012-12#4)(2013-1#5)(2013-8#4)
results supported our##2##3##(2008-10#1)(2009-8#1)
results supported##4##2##(2007-12#1)(2008-10#2)(2009-8#1)
results taken together suggest that##2##5##(1990-12#1)(2008-5#1)
results taken together##5##3##(1990-12#1)(1996-12#1)(1997-1#1)(2008-11#1)(2008-5#1)
results taken##6##2##(1990-12#1)(1996-12#1)(1997-1#1)(2007-6#1)(2008-11#1)(2008-5#1)
results takes##2##2##(1995-2#1)(2008-3#1)
results tentatively##3##2##(1991-7#1)(1991-9#1)(2009-10#1)
results testify##2##2##(2008-8#1)(2013-1#1)
results than other##2##3##(2006-6#1)(2008-10#1)
results than the other##3##4##(2008-2#2)(2013-1#1)
results than the##10##3##(1991-4#1)(1991-9#1)(1994-6#1)(2007-11#1)(2008-2#2)(2008-6#1)(2011-2#2)(2013-1#1)
results than those##3##3##(2006-6#1)(2008-2#1)(2010-8#1)
results than##40##2##(1990-12#1)(1991-4#1)(1991-6#1)(1991-9#1)(1993-11#1)(1994-6#1)(1996-3#1)(1997-7#3)(2006-11#1)(2006-6#2)(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#2)(2008-2#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-8#2)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)
results that agree##2##3##(1991-8#1)(2013-8#1)
results that are comparable##2##4##(1993-4#1)(2008-10#1)
results that are in good agreement##2##6##(1994-5#1)(2007-12#1)
results that are in##3##4##(1994-5#1)(2007-12#1)(2008-10#1)
results that are similar to##2##5##(2006-10#1)(2009-10#1)
results that are##18##3##(1992-11#1)(1993-4#1)(1994-5#1)(1997-2#1)(2005-5#1)(2006-10#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#2)(2009-10#1)(2010-2#1)(2012-12#3)
results that can be##2##4##(2009-10#1)(2009-8#1)
results that compare##4##3##(1993-9#1)(2008-10#2)(2008-2#1)
results that confirm##2##3##(2007-11#2)
results that demonstrate a##2##4##(2007-12#1)(2008-2#1)
results that demonstrate the##4##4##(2008-2#2)(2008-3#2)
results that demonstrate##9##3##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#3)(2010-8#1)
results that have been##3##4##(1990-5#1)(2004-1#1)(2007-8#1)
results that have##4##3##(1990-5#1)(2004-1#1)(2007-8#1)(2008-3#1)
results that illustrate the##2##4##(2007-12#1)(2008-2#1)
results that may##2##3##(2008-5#1)(2011-2#1)
results that provide##2##3##(1997-4#1)(2008-3#1)
results that revealed##2##3##(2006-10#1)(2009-4#1)
results that show that the##2##5##(2007-12#2)
results that show##3##3##(2007-12#2)(2008-3#1)
results that support##2##3##(1994-9#1)(2008-1#1)
results that the##6##3##(1992-8#1)(1996-5#1)(2007-12#1)(2008-10#1)(2010-8#1)(2013-1#1)
results that were in good agreement##2##6##(2007-2#1)(2008-10#1)
results that were##9##3##(1991-7#1)(1993-11#1)(1994-3#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-3#2)(2012-2#1)
results that##105##2##(1990-5#1)(1990-9#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-12#2)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(2004-1#1)(2004-10#1)(2005-11#2)(2005-5#1)(2006-10#3)(2006-11#1)(2007-11#5)(2007-12#9)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#10)(2008-2#8)(2008-3#14)(2008-5#2)(2009-10#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-8#3)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#1)
results the authors##2##3##(1991-9#1)(2008-11#1)
results the##15##2##(1991-8#1)(1991-9#1)(1993-10#1)(1996-3#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2011-12#1)(2011-2#1)(2013-8#1)
results therefore suggest##2##3##(1990-12#1)(2008-5#1)
results therefore##11##2##(1990-11#1)(1990-12#1)(1991-7#1)(1997-4#1)(1997-5#2)(2008-11#1)(2008-5#1)(2009-4#1)(2010-4#1)(2011-1#1)
results through##3##2##(2009-6#1)(2012-3#1)(2013-7#1)
results thus indicate a##3##4##(1994-6#1)(1995-2#1)(1996-5#1)
results thus indicate that##3##4##(1990-3#1)(1994-2#1)(1995-6#1)
results thus indicate##6##3##(1990-3#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-5#1)
results thus suggest that##3##4##(1996-10#1)(1997-8#1)(2012-11#1)
results thus##18##2##(1990-3#2)(1994-2#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-3#1)(1996-5#1)(1997-6#1)(1997-8#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#2)(2012-11#1)(2013-1#1)
results to a##6##3##(1990-12#1)(1990-5#1)(2008-12#1)(2008-9#1)(2009-7#1)(2012-3#1)
results to be##5##3##(2008-3#1)(2008-6#1)(2008-7#2)(2011-1#1)
results to date##8##3##(1990-11#1)(1994-12#1)(1997-3#1)(2006-6#1)(2008-1#1)(2008-4#1)(2011-2#1)(2012-1#1)
results to demonstrate the##2##4##(2007-12#1)(2008-2#1)
results to our##2##3##(2008-10#1)(2008-3#1)
results to the analysis of##2##5##(2008-10#2)
results to the##21##3##(1991-12#1)(1996-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#4)(2008-8#1)(2010-10#1)(2011-2#1)(2012-3#1)
results to those obtained##4##4##(1994-2#1)(1995-10#1)(2008-10#1)(2012-12#1)
results to those of##2##4##(1995-12#1)(2008-10#1)
results to those##8##3##(1991-3#1)(1994-2#1)(1995-10#1)(1995-12#1)(2008-10#2)(2012-12#2)
results to##111##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-3#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-12#1)(1995-3#2)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-12#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-4#2)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#11)(2008-4#2)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-3#5)(2013-1#2)(2013-7#1)
results together with##2##3##(2008-3#1)(2012-2#1)
results together##4##2##(2008-3#2)(2011-1#1)(2012-2#1)
results unambiguously##2##2##(1994-12#1)(1995-4#1)
results under##4##2##(1993-12#1)(2007-8#1)(2008-2#1)(2013-8#1)
results underline the importance of##3##5##(1993-3#1)(1995-12#1)(2008-7#1)
results underline the##4##3##(1992-8#1)(1993-3#1)(1995-12#1)(2008-7#1)
results underline##5##2##(1992-8#1)(1993-3#1)(1994-11#1)(1995-12#1)(2008-7#1)
results underscore the importance of##5##5##(1990-6#1)(1993-2#1)(1996-1#1)(2007-4#1)(2008-9#1)
results underscore the##7##3##(1990-6#1)(1993-2#1)(1996-1#1)(1997-1#1)(2005-10#1)(2007-4#1)(2008-9#1)
results underscore##8##2##(1990-6#1)(1993-2#1)(1996-1#1)(1997-1#1)(2005-10#1)(2007-4#1)(2008-9#1)(2013-1#1)
results upon##2##2##(2008-11#1)(2008-7#1)
results using a##7##3##(1994-12#1)(1997-6#1)(2008-3#2)(2008-6#1)(2012-1#2)
results using the##7##3##(1996-12#1)(2005-10#1)(2007-8#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-12#1)
results using this##2##3##(2008-10#2)
results using##41##2##(1990-1#1)(1990-12#2)(1993-1#1)(1994-12#1)(1994-8#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-6#1)(2005-10#2)(2005-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2013-8#1)
results validate the##4##3##(2008-3#3)(2009-12#1)
results varied##4##2##(2007-5#1)(2008-10#1)(2008-7#1)(2009-12#1)
results verified##2##2##(1991-8#1)(2008-2#1)
results verify that##2##3##(2008-3#1)(2011-1#1)
results verify the##5##3##(2008-11#1)(2008-3#2)(2008-8#1)(2013-8#1)
results verify##8##2##(1996-8#1)(2008-11#1)(2008-3#3)(2008-8#1)(2011-1#1)(2013-8#1)
results via##2##2##(2008-10#1)(2010-12#1)
results warrant further##3##3##(2008-10#1)(2010-12#1)(2012-2#1)
results warrant##4##2##(2008-10#1)(2010-12#1)(2011-2#1)(2012-2#1)
results was achieved##2##3##(2007-12#1)(2007-5#1)
results was checked by##2##4##(2008-10#2)
results was checked##3##3##(2008-10#3)
results was##39##2##(1990-12#2)(1990-8#1)(1992-12#1)(1994-6#1)(1997-8#1)(2005-11#1)(2005-12#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#9)(2008-12#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-9#2)(2009-8#1)(2010-1#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
results we conclude that the##3##5##(1990-5#1)(1995-4#1)(2008-10#1)
results we conclude that##7##4##(1990-5#1)(1990-9#1)(1991-9#1)(1995-4#1)(1995-6#1)(1996-7#1)(2008-10#1)
results we obtained##6##3##(1995-5#1)(2005-10#1)(2007-11#1)(2007-8#2)(2008-2#1)
results we##31##2##(1990-5#1)(1990-9#1)(1991-10#1)(1991-9#1)(1992-6#1)(1994-2#1)(1995-4#2)(1995-5#1)(1995-6#1)(1996-7#1)(2005-10#1)(2007-10#1)(2007-11#1)(2007-8#5)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2013-1#1)(2013-7#1)
results well##3##2##(2008-10#3)
results were a##2##3##(1994-6#1)(2006-10#1)
results were accurate and##2##4##(2008-10#1)(2012-1#1)
results were achieved by##2##4##(1990-5#1)(2008-6#1)
results were achieved in those##2##5##(2006-2#1)(2007-7#1)
results were achieved in##5##4##(2006-2#1)(2007-7#2)(2008-1#1)(2009-3#1)
results were achieved without##3##4##(2008-10#1)(2008-2#1)(2011-1#1)
results were achieved##17##3##(1990-5#2)(1994-1#1)(2006-2#1)(2007-12#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-3#1)(2011-1#2)
results were also compared##2##4##(2006-10#1)(2008-10#1)
results were also seen##2##4##(1992-9#1)(2004-11#1)
results were also##17##3##(1992-3#1)(1992-9#1)(1995-6#1)(1996-12#1)(2004-11#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-1#1)
results were analysed##5##3##(1991-9#1)(2007-7#1)(2009-2#1)(2011-2#1)(2012-2#1)
results were analyzed and compared##2##5##(2007-8#1)(2008-3#1)
results were analyzed and##3##4##(2007-8#1)(2008-10#1)(2008-3#1)
results were analyzed by##3##4##(2007-10#1)(2008-10#1)(2012-2#1)
results were analyzed to##2##4##(2008-3#1)(2008-6#1)
results were analyzed##14##3##(1994-3#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-6#1)(2009-7#1)(2012-2#1)(2013-7#1)(2013-8#1)
results were announced##2##3##(2008-5#2)
results were applied to##2##4##(2008-10#2)
results were as follows##6##4##(1990-12#1)(1990-2#1)(1992-10#1)(1993-8#1)(1995-2#1)(2007-11#1)
results were assessed using##2##4##(2007-7#1)(2011-1#1)
results were assessed##5##3##(1995-2#1)(2007-11#1)(2007-7#1)(2010-2#1)(2011-1#1)
results were associated with##2##4##(1993-12#1)(2012-12#1)
results were comparable to the##2##5##(2006-10#1)(2008-10#1)
results were comparable to##3##4##(2006-10#1)(2008-10#1)(2008-5#1)
results were comparable with##3##4##(1997-4#1)(2007-3#1)(2008-8#1)
results were comparable##7##3##(1997-4#1)(2006-10#1)(2007-3#1)(2008-10#2)(2008-5#1)(2008-8#1)
results were compared between##5##4##(2006-10#1)(2007-10#1)(2007-9#1)(2008-7#1)(2009-2#1)
results were compared to the##4##5##(2007-8#2)(2008-10#1)(2008-7#1)
results were compared to those obtained by##2##7##(2008-10#2)
results were compared to those##5##5##(2008-10#4)(2008-8#1)
results were compared to##15##4##(2006-8#1)(2007-4#1)(2007-8#2)(2008-10#6)(2008-2#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)
results were compared with a##3##5##(2008-10#1)(2010-8#1)(2013-8#1)
results were compared with other##3##5##(2007-2#1)(2008-10#2)
results were compared with standard##2##5##(2008-10#1)(2008-5#1)
results were compared with the results obtained##2##7##(2008-10#2)
results were compared with the##20##5##(1993-9#1)(1996-3#1)(2005-11#1)(2007-10#1)(2007-11#1)(2008-1#2)(2008-10#7)(2008-2#1)(2008-6#1)(2010-2#1)(2010-4#1)(2012-3#1)(2013-8#1)
results were compared with those obtained by a##2##8##(2008-10#1)(2008-2#1)
results were compared with those obtained by##8##7##(2008-10#6)(2008-2#1)(2008-3#1)
results were compared with those obtained using##5##7##(1995-2#1)(2008-10#4)
results were compared with those obtained with the##2##8##(2008-10#2)
results were compared with those obtained with##4##7##(2008-10#3)(2008-6#1)
results were compared with those obtained##21##6##(1994-4#1)(1995-2#1)(1996-5#1)(2007-8#1)(2008-10#13)(2008-2#1)(2008-3#1)(2008-6#1)(2012-12#1)
results were compared with those of the##2##7##(2008-10#2)
results were compared with those of##5##6##(1995-1#1)(2008-10#3)(2008-7#1)
results were compared with those##30##5##(1994-4#1)(1995-1#1)(1995-2#1)(1996-5#1)(2007-8#2)(2008-10#17)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-1#1)(2012-12#1)
results were compared with##96##4##(1990-7#1)(1991-8#1)(1993-3#1)(1993-9#2)(1994-3#1)(1994-4#1)(1995-1#1)(1995-2#1)(1996-3#1)(1996-5#2)(1996-8#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-4#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-8#4)(2008-1#2)(2008-10#35)(2008-12#1)(2008-2#6)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2009-2#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2012-1#2)(2012-12#1)(2012-3#2)(2013-8#2)
results were compared##133##3##(1990-7#1)(1991-8#1)(1993-3#1)(1993-9#2)(1994-3#2)(1994-4#1)(1995-1#1)(1995-2#1)(1996-3#1)(1996-5#2)(1996-8#1)(2004-12#2)(2005-10#1)(2005-11#1)(2005-4#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#49)(2008-12#1)(2008-2#7)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#1)(2009-2#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#3)
results were compatible with##2##4##(2006-2#1)(2007-12#1)
results were confirmed by##8##4##(1994-11#1)(1997-4#1)(2006-12#1)(2008-10#2)(2010-5#1)(2011-2#1)(2012-2#1)
results were confirmed in an##2##5##(2007-10#1)(2012-1#1)
results were confirmed in the##2##5##(2008-10#1)(2011-2#1)
results were confirmed in##5##4##(1994-12#1)(2007-10#1)(2008-10#1)(2011-2#1)(2012-1#1)
results were confirmed using##3##4##(1995-1#1)(2007-12#1)(2008-5#1)
results were confirmed##19##3##(1994-11#1)(1994-12#1)(1995-1#1)(1996-1#1)(1997-4#1)(2006-12#1)(2007-10#1)(2007-12#1)(2008-10#5)(2008-5#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-2#1)
results were consistent and##2##4##(1991-5#1)(2013-1#1)
results were consistent with the##4##5##(1990-5#1)(2008-2#1)(2008-8#1)(2013-1#1)
results were consistent with those obtained##2##6##(1996-9#1)(1997-2#1)
results were consistent with those##4##5##(1996-9#1)(1997-2#1)(2008-10#2)
results were consistent with##12##4##(1990-5#1)(1995-11#1)(1996-9#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-8#1)(2011-12#1)(2013-1#1)
results were consistent##16##3##(1990-5#1)(1991-5#1)(1993-9#1)(1995-11#1)(1996-9#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-8#1)(2011-12#1)(2013-1#2)
results were correlated with the##3##5##(2008-2#1)(2008-7#1)(2013-8#1)
results were correlated with##6##4##(1991-2#1)(1997-7#1)(2008-2#1)(2008-5#1)(2008-7#1)(2013-8#1)
results were correlated##7##3##(1991-2#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2013-8#1)
results were detected in##2##4##(1991-2#1)(2012-3#1)
results were different##2##3##(2007-7#1)(2013-1#1)
results were discussed in##4##4##(1994-2#1)(2005-11#1)(2008-10#1)(2008-12#1)
results were discussed##6##3##(1993-11#1)(1994-2#1)(2005-11#2)(2008-10#1)(2008-12#1)
results were downloaded##2##3##(2013-1#2)
results were due to##2##4##(2008-8#1)(2008-9#1)
results were due##3##3##(2004-9#1)(2008-8#1)(2008-9#1)
results were evaluated by means of##2##6##(1990-3#1)(1997-6#1)
results were evaluated by##3##4##(1990-3#1)(1997-6#1)(2009-4#1)
results were evaluated using##2##4##(1991-7#1)(2007-8#1)
results were evaluated##8##3##(1990-3#1)(1991-7#1)(1992-4#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-7#1)(2009-4#1)
results were examined##3##3##(1991-9#1)(1995-2#2)
results were excellent in##3##4##(1996-9#1)(2005-10#1)(2008-8#1)
results were excellent##5##3##(1992-6#1)(1992-9#1)(1996-9#1)(2005-10#1)(2008-8#1)
results were expressed##3##3##(1990-12#1)(1992-8#1)(2008-7#1)
results were found for##6##4##(1997-1#1)(2008-10#2)(2008-9#1)(2010-7#1)(2010-9#1)
results were found in##6##4##(2007-11#2)(2007-7#1)(2008-8#2)(2011-1#1)
results were found to be comparable##2##6##(2008-10#2)
results were found to be in good agreement with##3##9##(2008-10#3)
results were found to be in##4##6##(2008-10#4)
results were found to be##12##5##(1997-2#1)(2007-7#1)(2008-10#9)(2011-1#1)
results were found##30##3##(1996-10#1)(1996-2#1)(1997-1#1)(1997-2#1)(2006-10#1)(2007-11#4)(2007-7#2)(2008-10#11)(2008-8#2)(2008-9#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#1)
results were further##6##3##(1993-3#1)(1994-11#1)(1997-1#1)(2009-6#1)(2010-6#1)(2011-2#1)
results were in agreement with the certified##2##7##(2008-10#2)
results were in agreement with those obtained by##3##8##(2008-10#3)
results were in agreement with those##5##6##(2005-4#1)(2008-10#4)
results were in agreement with##9##5##(1993-2#1)(2005-4#1)(2008-10#6)(2008-11#1)
results were in agreement##11##4##(1993-2#1)(1994-6#1)(2005-4#1)(2008-10#6)(2008-11#1)(2008-5#1)
results were in good agreement with the##3##7##(1992-9#1)(2008-10#2)
results were in good agreement with those obtained by##2##9##(2008-10#2)
results were in good agreement with those obtained##3##8##(2008-10#3)
results were in good agreement with those##7##7##(2008-10#7)
results were in good agreement with##16##6##(1992-9#1)(2007-12#1)(2008-10#13)(2008-3#1)
results were in good##17##4##(1992-9#1)(2007-1#1)(2007-12#1)(2008-10#13)(2008-3#1)
results were in the##3##4##(1991-12#1)(2008-10#1)(2008-9#1)
results were in##34##3##(1991-12#1)(1992-9#1)(1993-2#1)(1994-6#1)(2005-4#1)(2007-1#1)(2007-12#1)(2008-10#21)(2008-11#1)(2008-3#2)(2008-5#1)(2008-9#1)(2012-12#1)
results were interpreted##9##3##(1990-11#1)(1993-8#1)(1994-5#1)(2005-10#1)(2008-10#2)(2008-5#2)(2012-12#1)
results were lower##3##3##(2006-10#1)(2008-10#1)(2009-9#1)
results were more##2##3##(1996-5#1)(2008-12#1)
results were negative##3##3##(2006-2#1)(2007-5#1)(2011-2#1)
results were not consistent##2##4##(2008-11#1)(2013-8#1)
results were not statistically significant##2##5##(1992-2#1)(2010-8#1)
results were not##9##3##(1991-2#1)(1992-2#1)(1994-9#1)(1996-1#1)(2004-2#1)(2008-11#1)(2008-4#1)(2010-8#1)(2013-8#1)
results were noted in##2##4##(1990-12#1)(2007-11#1)
results were noted##3##3##(1990-12#1)(2007-11#2)
results were observed in##5##4##(2005-6#1)(2006-8#1)(2008-8#1)(2009-10#1)(2011-2#1)
results were observed with##4##4##(1997-4#1)(2005-11#1)(2008-10#1)(2008-5#1)
results were observed##19##3##(1991-4#1)(1993-6#1)(1994-9#1)(1997-4#1)(2004-11#1)(2005-11#2)(2005-6#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
results were obtained after##5##4##(1990-2#1)(1997-8#1)(2007-8#1)(2012-1#1)(2012-3#1)
results were obtained at##3##4##(2007-2#1)(2008-10#2)
results were obtained by the##2##5##(2007-8#1)(2008-10#1)
results were obtained by##16##4##(1990-10#1)(1990-2#1)(1991-12#1)(1993-12#1)(1994-9#2)(2007-8#1)(2008-10#7)(2008-3#1)(2008-5#1)
results were obtained for all##2##5##(2008-10#2)
results were obtained for the##8##5##(1991-12#1)(1994-11#1)(1996-8#1)(2004-9#1)(2005-11#1)(2008-10#3)
results were obtained for##20##4##(1991-12#1)(1993-6#1)(1994-11#1)(1996-8#2)(1997-8#1)(2004-9#1)(2005-11#1)(2007-8#1)(2008-10#11)
results were obtained from##5##4##(1993-3#1)(2006-2#1)(2007-5#1)(2008-10#1)(2008-3#1)
results were obtained in the determination of##3##7##(2008-10#3)
results were obtained in the##8##5##(1993-2#1)(2007-10#1)(2008-10#5)(2008-11#1)
results were obtained in##23##4##(1990-2#1)(1992-3#1)(1993-2#1)(1994-8#1)(1996-4#1)(1996-5#1)(1997-7#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
results were obtained using the##4##5##(2006-7#1)(2008-10#1)(2008-3#1)(2013-1#1)
results were obtained using##15##4##(1992-5#1)(1994-8#1)(2004-8#1)(2006-7#1)(2007-5#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#2)(2013-1#1)
results were obtained when##10##4##(1990-5#1)(1994-3#1)(1994-9#1)(1995-5#1)(2008-10#4)(2011-12#1)(2012-2#1)
results were obtained with 0##2##5##(2003-11#1)(2008-10#1)
results were obtained with a##4##5##(1995-5#1)(2008-10#2)(2008-5#1)
results were obtained with an##2##5##(2007-11#1)(2007-8#1)
results were obtained with different##2##5##(1992-12#1)(1995-12#1)
results were obtained with the##13##5##(1992-12#1)(1992-5#1)(1994-2#1)(1995-8#1)(1997-3#1)(2006-12#1)(2007-11#1)(2008-10#4)(2008-11#1)(2011-2#1)
results were obtained with##39##4##(1990-2#1)(1990-5#1)(1990-8#1)(1991-10#1)(1992-11#1)(1992-12#2)(1992-5#1)(1992-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-5#1)(1995-8#1)(1997-3#1)(2003-11#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-5#2)(2011-2#1)
results were obtained##171##3##(1990-10#1)(1990-2#4)(1990-5#2)(1990-8#1)(1991-10#1)(1991-12#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-4#1)(1994-8#2)(1994-9#3)(1995-12#1)(1995-5#2)(1995-8#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-3#1)(1997-7#1)(1997-8#2)(2003-11#1)(2004-12#1)(2004-8#1)(2004-9#1)(2005-11#1)(2005-4#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-3#1)(2007-5#3)(2007-8#6)(2008-10#62)(2008-11#4)(2008-3#4)(2008-4#1)(2008-5#7)(2008-7#3)(2008-8#1)(2008-9#2)(2009-6#1)(2010-5#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
results were only##2##3##(1995-11#1)(2009-5#1)
results were presented at the##2##5##(2008-5#2)
results were presented##3##3##(2008-5#3)
results were quite##2##3##(1997-4#1)(2008-10#1)
results were related to the##2##5##(1991-5#1)(2013-1#1)
results were reported##3##3##(1990-12#1)(1991-12#1)(2012-1#1)
results were robust##2##3##(2008-9#1)(2009-12#1)
results were satisfactory##9##3##(1990-9#1)(1991-4#1)(1992-12#1)(2008-10#5)(2010-11#1)
results were seen in##2##4##(2007-8#1)(2013-8#1)
results were seen##4##3##(1991-6#1)(2006-10#1)(2007-8#1)(2013-8#1)
results were significantly##2##3##(2007-8#1)(2011-2#1)
results were similar in##2##4##(1994-12#1)(2007-8#1)
results were similar to those##5##5##(1993-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2011-12#1)
results were similar to##6##4##(1993-12#1)(2008-10#2)(2008-6#1)(2008-8#1)(2011-12#1)
results were similar##11##3##(1993-12#1)(1994-12#1)(1994-3#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-12#1)
results were statistically compared with##3##5##(2008-10#3)
results were statistically compared##4##4##(2008-10#4)
results were statistically##8##3##(2008-10#5)(2010-5#1)(2012-12#2)
results were still##2##3##(2008-10#1)(2011-2#1)
results were studied##2##3##(2008-10#1)(2008-7#1)
results were tabulated and##2##4##(2010-8#1)(2013-8#1)
results were that##5##3##(1994-3#1)(1997-6#1)(2007-12#1)(2008-4#1)(2010-12#1)
results were the##4##3##(2008-10#1)(2008-5#1)(2012-12#1)(2013-1#1)
results were then compared with##4##5##(2008-3#1)(2008-5#1)(2012-2#2)
results were then##5##3##(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#2)
results were used for##2##4##(2008-10#2)
results were used to calculate the##3##6##(2007-8#1)(2008-2#1)(2011-12#1)
results were used to##6##4##(1997-1#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-12#1)
results were used##13##3##(1993-10#1)(1997-1#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-3#1)(2011-1#1)(2011-12#1)
results were verified##2##3##(2008-2#1)(2010-6#1)
results were well consistent with the##2##6##(2008-10#1)(2013-1#1)
results were##766##2##(1990-10#2)(1990-11#1)(1990-12#4)(1990-2#5)(1990-3#2)(1990-5#5)(1990-7#3)(1990-8#2)(1990-9#2)(1991-1#1)(1991-10#1)(1991-12#4)(1991-2#3)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#3)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#3)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#3)(1993-6#2)(1993-8#3)(1993-9#3)(1994-1#1)(1994-11#5)(1994-12#2)(1994-2#2)(1994-3#7)(1994-4#3)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#5)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#5)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#5)(1996-6#3)(1996-8#3)(1996-9#4)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#4)(1997-6#2)(1997-7#4)(1997-8#2)(2003-11#1)(2004-11#2)(2004-12#4)(2004-2#1)(2004-8#1)(2004-9#2)(2005-10#4)(2005-11#6)(2005-12#2)(2005-4#4)(2005-6#1)(2006-1#1)(2006-10#12)(2006-11#2)(2006-12#3)(2006-2#5)(2006-6#2)(2006-7#2)(2006-8#2)(2007-1#3)(2007-10#7)(2007-11#17)(2007-12#11)(2007-2#4)(2007-3#2)(2007-4#1)(2007-5#4)(2007-7#12)(2007-8#23)(2007-9#1)(2008-1#4)(2008-10#205)(2008-11#8)(2008-12#5)(2008-2#13)(2008-3#15)(2008-4#4)(2008-5#28)(2008-6#6)(2008-7#10)(2008-8#12)(2008-9#6)(2009-10#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#5)(2010-6#3)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#8)(2011-12#5)(2011-2#18)(2012-1#6)(2012-12#11)(2012-2#9)(2012-3#8)(2013-1#16)(2013-7#3)(2013-8#9)
results when applied to##2##4##(1990-7#1)(2008-2#1)
results when applied##3##3##(1990-7#1)(2008-2#1)(2011-2#1)
results when compared to the##2##5##(2006-5#1)(2008-12#1)
results when compared with a##3##5##(2008-10#1)(2013-1#2)
results when compared##5##3##(2006-5#1)(2008-10#1)(2008-12#1)(2013-1#2)
results when the##5##3##(1994-6#1)(2008-10#2)(2008-2#1)(2009-9#1)
results when used##2##3##(2008-10#1)(2008-5#1)
results when using##2##3##(2009-10#1)(2012-12#1)
results when##32##2##(1990-5#1)(1990-7#1)(1994-3#1)(1994-6#1)(1996-3#1)(2006-5#2)(2007-11#2)(2007-6#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#2)
results where##2##2##(1995-5#1)(2012-1#1)
results which show that##2##4##(2006-10#1)(2011-1#1)
results which##12##2##(1991-2#1)(1992-12#1)(1995-2#1)(1996-5#1)(1997-2#1)(2006-10#1)(2008-10#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-1#2)
results will assist##2##3##(1995-1#1)(2008-11#1)
results will be described in##2##5##(1995-9#1)(2008-3#1)
results will be helpful##2##4##(2006-10#1)(2008-8#1)
results will be useful to##2##5##(2008-8#1)(2013-7#1)
results will be useful##3##4##(2007-12#1)(2008-8#1)(2013-7#1)
results will be##17##3##(1990-3#1)(1995-3#1)(1995-9#1)(1997-1#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#2)(2009-2#1)(2013-7#1)
results will facilitate##3##3##(2008-8#1)(2008-9#2)
results will help to##2##4##(2008-9#1)(2011-2#1)
results will help##3##3##(2008-9#1)(2010-6#1)(2011-2#1)
results will##33##2##(1990-3#1)(1995-1#1)(1995-3#1)(1995-9#1)(1997-1#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-6#1)(2008-8#4)(2008-9#3)(2009-2#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-7#1)
results with 30##2##3##(1993-11#1)(1996-8#1)
results with a##24##3##(1992-9#1)(1993-2#1)(1993-8#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-2#3)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2012-12#1)(2012-3#1)
results with an##4##3##(2007-11#1)(2008-10#2)(2008-3#1)
results with both##2##3##(2005-9#1)(2008-2#1)
results with data##2##3##(1994-1#1)(2008-7#1)
results with different##2##3##(1994-10#1)(2008-3#1)
results with early##2##3##(1994-6#1)(2009-5#1)
results with low##2##3##(2007-8#2)
results with minimal##2##3##(2009-9#1)(2011-2#1)
results with minimum##2##3##(2008-1#1)(2008-10#1)
results with other##2##3##(1996-5#1)(2008-9#1)
results with real samples##2##4##(2008-10#1)(2008-3#1)
results with recent##2##3##(2007-12#1)(2008-8#1)
results with reference to##2##4##(1997-7#1)(2008-9#1)
results with reference##3##3##(1997-7#1)(2008-9#1)(2010-9#1)
results with regard to##2##4##(2008-6#1)(2011-2#1)
results with respect to the##2##5##(2008-2#1)(2009-7#1)
results with respect to##5##4##(1993-12#1)(2006-2#1)(2008-2#1)(2009-7#1)(2010-10#1)
results with standard##3##3##(2007-8#1)(2008-10#1)(2008-5#1)
results with the use of##2##5##(1992-2#1)(2011-2#1)
results with the##39##3##(1990-2#1)(1990-3#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-3#1)(1997-8#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-10#6)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#1)(2011-2#2)(2012-3#1)(2013-1#3)
results with their##2##3##(2011-1#1)(2013-1#1)
results with theoretical##2##3##(2008-6#1)(2008-7#1)
results with this##2##3##(2008-3#1)(2009-4#1)
results with those from the##2##5##(2006-8#1)(2012-3#1)
results with those from##4##4##(2006-7#1)(2006-8#1)(2007-11#1)(2012-3#1)
results with those obtained by##7##5##(2005-4#1)(2008-10#5)(2008-2#1)
results with those obtained from##3##5##(2007-11#1)(2008-10#1)(2008-7#1)
results with those obtained with##3##5##(2007-10#1)(2008-2#2)
results with those obtained##14##4##(2005-4#1)(2007-10#1)(2007-11#1)(2008-10#6)(2008-2#3)(2008-7#1)(2009-3#1)
results with those of the##2##5##(2008-7#1)(2010-11#1)
results with those of##8##4##(2006-12#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2010-11#1)
results with those##33##3##(1992-7#1)(1995-2#1)(2005-4#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#10)(2008-2#4)(2008-5#2)(2008-7#2)(2009-3#1)(2010-11#1)(2012-3#1)
results with##240##2##(1990-10#1)(1990-2#2)(1990-3#3)(1990-7#1)(1990-9#2)(1991-1#1)(1991-4#1)(1991-5#1)(1992-2#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#5)(1993-12#2)(1993-2#2)(1993-6#1)(1993-8#2)(1994-1#1)(1994-10#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-8#2)(1997-2#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-4#2)(2005-9#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-7#2)(2006-8#2)(2007-10#3)(2007-11#9)(2007-12#9)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#8)(2008-1#1)(2008-10#36)(2008-11#2)(2008-12#1)(2008-2#20)(2008-3#20)(2008-4#3)(2008-5#5)(2008-6#4)(2008-7#10)(2008-8#3)(2008-9#3)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#3)(2011-2#6)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#10)
results within the##3##3##(1994-1#1)(2006-11#1)(2008-3#1)
results within##13##2##(1994-1#1)(1994-3#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-6#1)(2010-8#1)(2011-3#1)(2012-2#1)
results without##5##2##(1992-10#1)(2007-11#1)(2007-7#1)(2008-3#1)(2008-6#1)
results would indicate##2##3##(2008-7#1)(2013-1#1)
results would##10##2##(1990-2#1)(1992-3#1)(1992-7#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2013-1#1)
results yield##2##2##(2007-12#1)(2008-10#1)
results yielded##2##2##(2007-11#1)(2008-3#1)
results##19344##1##(1990-1#4)(1990-10#53)(1990-11#75)(1990-12#90)(1990-2#85)(1990-3#61)(1990-4#45)(1990-5#84)(1990-6#50)(1990-7#77)(1990-8#57)(1990-9#55)(1991-1#38)(1991-10#42)(1991-11#41)(1991-12#105)(1991-2#68)(1991-3#52)(1991-4#65)(1991-5#81)(1991-6#56)(1991-7#65)(1991-8#59)(1991-9#88)(1992-1#40)(1992-10#29)(1992-11#57)(1992-12#85)(1992-2#56)(1992-3#81)(1992-4#47)(1992-5#41)(1992-6#79)(1992-7#59)(1992-8#90)(1992-9#80)(1993-1#25)(1993-10#13)(1993-11#101)(1993-12#105)(1993-2#57)(1993-3#90)(1993-4#42)(1993-5#17)(1993-6#75)(1993-7#30)(1993-8#63)(1993-9#75)(1994-1#15)(1994-10#29)(1994-11#96)(1994-12#94)(1994-2#104)(1994-3#122)(1994-4#16)(1994-5#63)(1994-6#66)(1994-7#12)(1994-8#99)(1994-9#111)(1995-1#71)(1995-10#37)(1995-11#77)(1995-12#113)(1995-2#97)(1995-3#94)(1995-4#22)(1995-5#75)(1995-6#63)(1995-7#32)(1995-8#65)(1995-9#32)(1996-1#66)(1996-10#40)(1996-11#55)(1996-12#101)(1996-2#96)(1996-3#54)(1996-4#42)(1996-5#119)(1996-6#43)(1996-7#51)(1996-8#60)(1996-9#58)(1997-1#82)(1997-2#101)(1997-3#66)(1997-4#95)(1997-5#68)(1997-6#94)(1997-7#98)(1997-8#79)(1997-9#1)(2003-11#5)(2004-1#9)(2004-10#14)(2004-11#17)(2004-12#24)(2004-2#11)(2004-3#2)(2004-4#14)(2004-8#2)(2004-9#27)(2005-1#9)(2005-10#54)(2005-11#185)(2005-12#30)(2005-2#1)(2005-3#1)(2005-4#59)(2005-5#7)(2005-6#3)(2005-7#33)(2005-8#36)(2005-9#17)(2006-1#16)(2006-10#258)(2006-11#56)(2006-12#115)(2006-2#56)(2006-3#39)(2006-4#40)(2006-5#58)(2006-6#87)(2006-7#41)(2006-8#114)(2006-9#28)(2007-1#55)(2007-10#88)(2007-11#393)(2007-12#465)(2007-2#81)(2007-3#64)(2007-4#49)(2007-5#41)(2007-6#41)(2007-7#142)(2007-8#343)(2007-9#92)(2008-1#141)(2008-10#2126)(2008-11#348)(2008-12#157)(2008-2#704)(2008-3#824)(2008-4#203)(2008-5#499)(2008-6#168)(2008-7#327)(2008-8#367)(2008-9#274)(2009-1#4)(2009-10#66)(2009-11#34)(2009-12#41)(2009-2#63)(2009-3#60)(2009-4#78)(2009-5#75)(2009-6#49)(2009-7#47)(2009-8#96)(2009-9#51)(2010-1#21)(2010-10#41)(2010-11#39)(2010-12#144)(2010-2#111)(2010-3#55)(2010-4#87)(2010-5#67)(2010-6#48)(2010-7#40)(2010-8#111)(2010-9#43)(2011-1#210)(2011-10#3)(2011-12#58)(2011-2#421)(2011-3#27)(2011-7#3)(2012-1#155)(2012-11#36)(2012-12#217)(2012-2#254)(2012-3#194)(2012-5#2)(2012-6#2)(2012-7#2)(2012-8#1)(2012-9#2)(2013-1#490)(2013-7#86)(2013-8#243)
results'##2##1##(2008-1#1)(2013-8#1)
results)##7##1##(1990-2#1)(1993-11#1)(1994-10#1)(1996-2#1)(2008-3#1)(2010-4#1)(2011-2#1)
results--a##2##1##(2007-12#1)(2008-7#1)
results?##2##1##(2007-8#1)(2010-12#1)
results]##28##1##(1990-10#1)(1990-3#2)(1990-6#2)(1990-9#1)(1991-8#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-6#1)(1995-11#1)(1995-5#1)(1996-11#1)(1996-3#1)(2005-1#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#2)(2011-2#3)(2013-1#1)
resume the##4##2##(2006-10#1)(2008-9#1)(2013-1#2)
resume##22##1##(1990-2#1)(1994-8#1)(1995-9#1)(1996-8#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-12#4)(2008-11#1)(2008-5#3)(2008-9#1)(2010-1#1)(2011-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
resumed and##2##2##(1995-9#1)(2010-2#1)
resumed full##2##2##(1995-9#1)(2009-3#1)
resumed growth##2##2##(1995-8#1)(1997-7#1)
resumed their##2##2##(1992-1#1)(2010-7#1)
resumed##30##1##(1990-12#1)(1990-3#1)(1990-9#2)(1991-10#1)(1992-1#1)(1992-3#1)(1993-2#1)(1993-6#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-8#1)(1995-9#2)(1997-7#2)(2006-5#1)(2006-9#2)(2007-6#1)(2007-8#1)(2008-10#1)(2009-3#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
resumes##2##1##(1994-8#1)(1995-6#1)
resuming##5##1##(1991-4#1)(1996-3#1)(1996-8#1)(2007-6#1)(2011-2#1)
resumption of normal##3##3##(1996-12#1)(2006-10#1)(2008-10#1)
resumption of the##2##3##(2005-9#1)(2008-4#1)
resumption of##14##2##(1992-5#1)(1993-2#1)(1996-12#1)(1997-2#1)(2005-9#1)(2006-10#1)(2006-5#2)(2006-9#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2013-8#1)
resumption##19##1##(1992-11#1)(1992-5#1)(1993-2#1)(1996-12#1)(1996-3#1)(1997-2#1)(2005-9#1)(2006-10#1)(2006-5#3)(2006-9#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2013-8#1)
resurface##2##1##(1997-7#1)(2011-2#1)
resurfacing techniques##2##2##(2006-12#1)(2007-12#1)
resurfacing##24##1##(2006-12#4)(2007-12#8)(2009-4#1)(2010-11#1)(2011-2#5)(2012-1#1)(2012-2#3)(2013-1#1)
resurgence in the##4##3##(2006-4#1)(2008-11#1)(2008-8#1)(2009-12#1)
resurgence in##6##2##(2006-10#1)(2006-4#1)(2008-11#1)(2008-8#1)(2009-10#1)(2009-12#1)
resurgence of interest in##5##4##(1997-7#1)(2007-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
resurgence of interest##7##3##(1997-7#1)(2006-12#1)(2007-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
resurgence of serious Streptococcus pyogenes##2##5##(1992-2#2)
resurgence of the##2##3##(1994-9#1)(2012-2#1)
resurgence of##15##2##(1992-2#2)(1993-2#1)(1994-9#1)(1997-7#1)(2006-12#1)(2006-2#1)(2007-11#2)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
resurgence##23##1##(1992-2#2)(1993-2#1)(1994-9#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-11#2)(2007-9#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
resurgent##2##1##(1994-5#1)(2008-4#1)
resurrect##2##1##(1995-12#1)(2008-8#1)
resurrection of##2##2##(2008-10#1)(2008-12#1)
resurrection##5##1##(1993-9#1)(2008-10#1)(2008-12#1)(2009-7#1)(2010-5#1)
resuscitate##6##1##(1994-1#1)(2006-10#3)(2008-10#1)(2010-7#1)
resuscitated after##3##2##(1990-12#1)(1993-8#1)(2006-10#1)
resuscitated and##3##2##(1995-3#1)(2010-7#1)(2012-3#1)
resuscitated by##2##2##(1991-9#1)(2005-8#1)
resuscitated from##2##2##(1996-6#1)(2005-12#1)
resuscitated##15##1##(1990-12#1)(1991-9#1)(1993-8#1)(1995-3#1)(1996-6#2)(2005-12#1)(2005-8#1)(2006-10#3)(2006-4#1)(2008-3#1)(2010-7#1)(2012-3#1)
resuscitation -##2##2##(2006-4#1)(2010-3#1)
resuscitation and##15##2##(1992-4#1)(1993-8#1)(1995-5#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-4#1)(2007-11#1)(2007-7#1)(2008-4#1)(2011-2#3)
resuscitation during##2##2##(1990-9#1)(2007-9#1)
resuscitation for##5##2##(2006-10#2)(2006-4#1)(2012-2#1)(2012-3#1)
resuscitation from##5##2##(1990-12#1)(2006-10#3)(2006-4#1)
resuscitation guidelines##4##2##(2006-10#1)(2007-11#1)(2008-11#2)
resuscitation has##3##2##(2006-10#2)(2009-4#1)
resuscitation he##2##2##(2006-4#2)
resuscitation in the##2##3##(1993-6#1)(2006-10#1)
resuscitation in##9##2##(1990-10#1)(1990-9#1)(1993-6#1)(1997-3#1)(2006-10#2)(2006-4#1)(2010-12#1)(2012-2#1)
resuscitation including##3##2##(1994-6#2)(2007-8#1)
resuscitation is##2##2##(2006-10#1)(2008-3#1)
resuscitation maneuvers##2##2##(1996-9#1)(2011-3#1)
resuscitation of infants##2##3##(2006-10#1)(2012-2#1)
resuscitation of##6##2##(1994-6#2)(1996-9#1)(2006-10#2)(2012-2#1)
resuscitation or##2##2##(1990-6#2)
resuscitation package##2##2##(2011-2#2)
resuscitation should##2##2##(2006-10#2)
resuscitation therapy##2##2##(2006-10#1)(2008-3#1)
resuscitation time##2##2##(2007-3#2)
resuscitation using##2##2##(2006-10#1)(2006-4#1)
resuscitation was##8##2##(1992-5#2)(1993-8#1)(1994-3#1)(2007-3#1)(2007-8#1)(2009-4#1)(2011-12#1)
resuscitation##211##1##(1990-10#1)(1990-12#3)(1990-3#1)(1990-6#3)(1990-9#4)(1992-4#1)(1992-5#4)(1993-3#1)(1993-6#2)(1993-7#8)(1993-8#4)(1994-3#1)(1994-6#9)(1994-9#2)(1995-11#1)(1995-5#1)(1995-7#3)(1995-9#1)(1996-3#1)(1996-6#1)(1996-9#5)(1997-3#2)(2005-11#1)(2005-2#1)(2005-4#1)(2005-8#1)(2006-10#60)(2006-2#1)(2006-4#11)(2006-8#1)(2007-11#2)(2007-2#1)(2007-3#7)(2007-5#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#4)(2008-3#8)(2008-4#2)(2008-5#1)(2008-8#2)(2009-4#6)(2009-8#1)(2010-10#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-8#1)(2011-12#2)(2011-2#9)(2011-3#1)(2012-2#6)(2012-3#1)(2013-1#6)
resuscitation?##2##1##(2006-4#1)(2008-3#1)
resuscitations##2##1##(1996-6#1)(2006-10#1)
resuscitative##3##1##(2005-8#1)(2006-10#2)
resuspended in medium##2##3##(1994-9#1)(1996-1#1)
resuspended in##7##2##(1991-9#1)(1994-8#1)(1994-9#1)(1996-1#1)(2008-11#1)(2008-8#1)(2012-12#1)
resuspended soil particles##2##3##(1992-6#2)
resuspended##17##1##(1991-9#1)(1992-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1996-1#2)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#3)(2012-12#1)
resuspension##4##1##(1992-6#2)(2007-5#1)(2008-9#1)
resveratrol acts as##2##3##(2010-12#2)
resveratrol acts##3##2##(2009-12#1)(2010-12#2)
resveratrol and##3##2##(2007-6#1)(2008-11#1)(2010-3#1)
resveratrol can be##2##3##(2008-5#1)(2010-12#1)
resveratrol had a##3##3##(2010-3#1)(2011-2#2)
resveratrol has##2##2##(2009-12#1)(2010-12#1)
resveratrol in##6##2##(2008-3#1)(2008-7#2)(2009-12#1)(2010-12#1)(2011-2#1)
resveratrol increased##2##2##(2012-4#1)(2013-1#1)
resveratrol is##4##2##(2008-5#1)(2008-8#1)(2009-12#1)(2013-1#1)
resveratrol on##3##2##(2009-12#1)(2012-4#1)(2013-1#1)
resveratrol produced neurotrophic effects##2##4##(2013-1#2)
resveratrol to##2##2##(2008-8#1)(2011-2#1)
resveratrol##69##1##(2006-9#1)(2007-1#3)(2007-6#1)(2008-10#11)(2008-11#2)(2008-3#2)(2008-5#3)(2008-7#3)(2008-8#3)(2009-12#6)(2009-3#1)(2010-12#8)(2010-3#3)(2011-2#12)(2012-4#3)(2013-1#7)
resveratrol-mediated neurotrophic##2##2##(2013-1#2)
reswelling##2##1##(2005-11#2)
resynchronisation therapy##3##2##(2008-10#1)(2008-3#1)(2012-2#1)
resynchronisation##4##1##(2008-10#2)(2008-3#1)(2012-2#1)
resynchronization therapy (CRT)##4##3##(2006-9#1)(2010-6#1)(2012-12#1)(2012-2#1)
resynchronization therapy##15##2##(2006-10#1)(2006-9#2)(2008-11#1)(2008-12#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#1)(2012-12#2)(2012-2#3)
resynchronization##18##1##(2005-8#1)(2006-10#1)(2006-9#2)(2008-11#1)(2008-12#1)(2008-5#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#2)(2012-12#2)(2012-2#3)
resynthesis##4##1##(1994-11#1)(1994-8#1)(1997-4#1)(2008-2#1)
resynthesized##4##1##(1996-11#1)(2008-10#3)
ret proto-oncogene##7##2##(1990-4#3)(1991-9#1)(1994-12#2)(2008-1#1)
ret##12##1##(1990-4#5)(1991-9#1)(1993-8#3)(1994-12#2)(2008-1#1)
retTPC##6##1##(1990-4#2)(1991-9#4)
retail and household level##2##4##(2007-2#2)
retail and household##3##3##(2007-2#3)
retail display##3##2##(1996-3#1)(2010-4#2)
retail life##2##2##(2010-4#2)
retail outlets##2##2##(1997-1#2)
retail pharmacies##2##2##(1992-3#1)(2011-1#1)
retail prescription##2##2##(1997-1#1)(2008-11#1)
retail##36##1##(1991-12#1)(1992-3#1)(1993-3#2)(1994-1#1)(1994-3#1)(1996-3#3)(1997-1#5)(2007-12#1)(2007-2#5)(2008-10#1)(2008-11#1)(2009-12#2)(2010-2#2)(2010-4#4)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#1)
retailers##5##1##(1996-11#1)(1997-1#1)(2007-2#1)(2008-1#2)
retailing##5##1##(1994-12#3)(2009-2#1)(2010-12#1)
retain a##8##2##(1993-2#1)(1994-3#1)(1995-2#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-11#2)
retain an##4##2##(1991-11#1)(1991-12#1)(2006-10#1)(2008-5#1)
retain and##4##2##(1992-12#1)(2008-10#1)(2008-8#1)(2013-7#1)
retain information##2##2##(1996-11#1)(2009-8#1)
retain its##6##2##(1990-12#1)(1994-3#1)(1996-10#1)(2007-12#1)(2007-4#1)(2010-4#1)
retain nurses##2##2##(2004-10#1)(2007-10#1)
retain over##2##2##(2007-8#1)(2008-10#1)
retain phenotypic plasticity##2##3##(2008-1#1)(2008-9#1)
retain the ability to interact##2##5##(1991-8#1)(2011-1#1)
retain the ability to##5##4##(1990-6#1)(1991-8#1)(1995-11#1)(1997-1#1)(2011-1#1)
retain the most##2##3##(2008-11#1)(2008-2#1)
retain the##36##2##(1990-2#2)(1990-6#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-4#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-11#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-10#2)(2006-12#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-7#1)(2010-8#1)(2011-1#2)
retain their##14##2##(1990-2#1)(1991-5#1)(1995-12#1)(1995-8#2)(1996-1#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-9#1)(2010-10#1)(2012-2#1)
retain this##3##2##(1995-5#1)(2008-4#1)(2008-9#1)
retain##152##1##(1990-12#1)(1990-2#3)(1990-6#2)(1991-11#2)(1991-12#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-11#2)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-5#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#3)(1996-8#1)(1997-1#1)(1997-2#1)(1997-6#2)(1997-7#1)(2004-10#1)(2004-12#1)(2006-1#1)(2006-10#4)(2006-12#2)(2006-3#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-4#2)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#5)(2008-2#1)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#4)(2008-9#4)(2009-10#3)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
retained Cr(VI)##3##2##(2008-10#3)
retained a good activity##2##4##(2008-10#2)
retained a##8##2##(1990-11#1)(1992-5#1)(1994-9#1)(2005-11#1)(2008-10#2)(2009-4#1)(2010-11#1)
retained about 50%##2##3##(1994-8#1)(1997-2#1)
retained activity##3##2##(2008-10#1)(2012-11#2)
retained after##3##2##(1993-6#1)(1997-8#1)(2012-1#1)
retained all of the##2##4##(1995-2#1)(2008-8#1)
retained all##4##2##(1995-2#1)(2008-5#2)(2008-8#1)
retained an##2##2##(1995-6#1)(2008-10#1)
retained analytes##2##2##(2008-10#2)
retained and promoted children##2##4##(2008-12#2)
retained and##12##2##(1990-5#1)(1995-2#3)(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2012-1#1)
retained as##4##2##(2008-10#3)(2008-11#1)
retained at a##2##3##(1992-6#1)(2008-10#1)
retained at pH 6##2##4##(1990-12#1)(2008-10#1)
retained at pH##3##3##(1990-12#1)(2008-10#2)
retained at the##2##3##(1995-1#1)(2008-9#1)
retained at##11##2##(1990-12#1)(1992-6#1)(1995-1#1)(2004-11#1)(2007-8#1)(2008-10#5)(2008-9#1)
retained bile##2##2##(1991-3#1)(2005-10#1)
retained both##4##2##(1992-6#1)(1994-2#1)(2008-7#1)(2013-7#1)
retained by the##11##3##(1992-6#2)(1994-3#1)(1996-2#2)(1996-5#1)(1996-8#1)(1997-4#1)(2004-8#1)(2008-10#2)
retained by##28##2##(1990-8#1)(1992-2#1)(1992-3#1)(1992-6#3)(1993-1#1)(1993-6#1)(1994-3#1)(1995-2#1)(1996-2#3)(1996-5#1)(1996-8#1)(1997-4#1)(2004-8#1)(2008-10#7)(2008-3#1)(2009-5#1)(2013-1#2)
retained enough##2##2##(1990-2#1)(2008-11#1)
retained for this##2##3##(2005-11#1)(2007-2#1)
retained for##3##2##(1997-2#1)(2005-11#1)(2007-2#1)
retained full##2##2##(1995-11#1)(2006-11#1)
retained high##4##2##(1994-12#1)(1994-9#1)(2007-8#1)(2013-1#1)
retained in solution##2##3##(1996-2#2)
retained in the circulation##2##4##(1990-3#1)(1996-5#1)
retained in the model##2##4##(2007-8#1)(2008-10#1)
retained in the##37##3##(1990-3#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-12#1)(1994-10#1)(1994-11#2)(1994-9#2)(1995-10#1)(1995-2#1)(1996-5#2)(1997-4#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-9#2)(2010-5#1)(2011-2#2)(2012-12#1)
retained in##53##2##(1990-3#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-12#1)(1993-6#1)(1994-10#1)(1994-11#3)(1994-9#2)(1995-10#1)(1995-12#1)(1995-2#1)(1996-2#2)(1996-5#3)(1997-4#2)(2005-11#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#12)(2008-4#1)(2008-7#2)(2008-9#3)(2010-3#1)(2010-5#1)(2011-2#2)(2012-12#1)
retained its ability to induce##2##5##(1995-3#1)(2013-8#1)
retained its ability to##4##4##(1995-3#1)(2008-10#2)(2013-8#1)
retained its binding##2##3##(1995-11#1)(2009-9#1)
retained its specificity##2##3##(1991-12#1)(1994-12#1)
retained its##17##2##(1990-7#1)(1990-9#1)(1991-12#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-3#1)(1997-1#1)(2008-10#5)(2008-5#1)(2009-9#1)(2012-2#1)(2013-8#1)
retained longer##2##2##(1992-1#1)(2008-10#1)
retained normal##2##2##(1992-12#1)(2009-2#1)
retained on C(18)##3##3##(2008-10#3)
retained on a##7##3##(1993-8#1)(2008-10#6)
retained on the column##5##4##(1990-11#1)(2008-10#4)
retained on the filter##2##4##(2008-10#2)
retained on the sorbent##2##4##(2008-10#2)
retained on the surface##2##4##(2008-10#1)(2012-2#1)
retained on the##22##3##(1990-11#1)(1990-12#1)(1997-3#1)(2008-10#18)(2012-2#1)
retained on##45##2##(1990-11#1)(1990-12#2)(1992-9#1)(1993-8#1)(1997-3#1)(1997-6#1)(2008-10#36)(2012-2#1)(2013-7#1)
retained only##2##2##(1990-7#1)(1997-5#1)
retained onto##2##2##(2007-8#1)(2008-10#1)
retained placenta and its effects##2##5##(1996-11#2)
retained placenta##6##2##(1992-1#1)(1996-11#4)(2006-5#1)
retained second twin##2##3##(2004-10#2)
retained second twins##2##3##(2004-10#2)
retained second##4##2##(2004-10#4)
retained surgical##2##2##(2007-2#1)(2012-2#1)
retained the ability to##7##4##(1993-12#1)(1994-9#2)(1995-5#1)(2006-12#1)(2008-10#2)
retained the activity##2##3##(1995-1#1)(1996-9#1)
retained the bacteria##2##3##(2008-10#2)
retained the same##3##3##(1992-7#1)(1994-2#1)(2011-2#1)
retained the##30##2##(1990-9#1)(1992-7#1)(1993-12#1)(1994-2#1)(1994-5#1)(1994-9#3)(1995-1#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-4#1)(2004-9#1)(2006-12#1)(2006-5#1)(2007-11#1)(2008-10#4)(2008-11#2)(2011-2#2)(2012-1#2)(2013-1#1)
retained their##13##2##(1991-5#1)(1992-8#1)(1994-6#1)(1995-1#1)(1996-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-7#1)
retained this##2##2##(2009-12#1)(2013-1#1)
retained to##2##2##(1996-7#1)(2008-5#1)
retained under##2##2##(1993-6#1)(2008-12#1)
retained with##2##2##(1992-12#1)(2011-12#1)
retained within the cells##2##4##(1990-3#1)(1993-9#1)
retained within the##6##3##(1990-3#1)(1993-9#1)(1994-9#1)(1997-4#1)(2008-8#2)
retained wooden foreign bodies##3##4##(2010-5#3)
retained##458##1##(1990-10#1)(1990-11#3)(1990-12#4)(1990-2#1)(1990-3#4)(1990-4#1)(1990-5#3)(1990-7#2)(1990-8#2)(1990-9#2)(1991-10#1)(1991-11#2)(1991-12#2)(1991-3#4)(1991-4#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#3)(1992-12#3)(1992-2#2)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#5)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#2)(1993-6#4)(1993-8#1)(1993-9#4)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#3)(1994-8#3)(1994-9#8)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#7)(1995-3#6)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#6)(1996-12#2)(1996-2#6)(1996-3#1)(1996-4#1)(1996-5#6)(1996-7#1)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#5)(1997-3#3)(1997-4#5)(1997-5#1)(1997-6#4)(1997-8#2)(2004-10#5)(2004-11#1)(2004-8#1)(2004-9#3)(2005-10#2)(2005-11#4)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-5#2)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#5)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#9)(2008-1#2)(2008-10#115)(2008-11#7)(2008-12#6)(2008-2#3)(2008-3#3)(2008-4#5)(2008-5#11)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#6)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#2)(2010-4#1)(2010-5#4)(2011-1#2)(2011-12#5)(2011-2#7)(2012-1#8)(2012-11#2)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#7)(2013-7#3)(2013-8#2)
retainer##2##1##(2010-3#1)(2012-2#1)
retaining a##4##2##(1993-3#1)(1994-8#1)(1996-3#1)(2005-11#1)
retaining an##2##2##(1991-10#1)(2008-10#1)
retaining and##3##2##(1994-1#2)(2007-7#1)
retaining both##2##2##(1997-6#1)(2008-2#1)
retaining its##3##2##(2008-2#1)(2008-6#1)(2010-5#1)
retaining only##2##2##(1992-6#1)(1997-7#1)
retaining the##15##2##(1991-1#1)(1991-5#1)(1992-3#1)(1992-6#1)(1994-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-12#1)(2010-4#1)(2011-2#1)
retaining their##3##2##(1993-2#1)(2008-11#1)(2012-2#1)
retaining##89##1##(1991-1#1)(1991-10#1)(1991-5#1)(1991-9#1)(1992-3#3)(1992-6#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#3)(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#2)(2005-8#1)(2006-12#1)(2006-3#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#3)(2008-6#3)(2008-9#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
retainment##3##1##(2008-10#1)(2012-1#2)
retains 0##2##2##(1996-7#2)
retains 11 beta-hydroxylase activity##2##4##(1994-2#2)
retains a##3##2##(1993-6#1)(1994-5#1)(1995-1#1)
retains its 3(10)-helical conformation##2##4##(1995-2#2)
retains its##15##2##(1990-7#1)(1991-4#1)(1992-1#1)(1993-11#1)(1995-2#2)(1995-5#1)(1996-5#1)(2005-10#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2009-3#1)(2010-11#1)
retains most of the##2##4##(1994-11#1)(2008-2#1)
retains some of the##2##4##(1991-2#1)(2007-3#1)
retains the ability##2##3##(1990-5#1)(1996-3#1)
retains the capacity to##2##4##(1990-5#1)(1994-8#1)
retains the simplicity of the##2##5##(2007-12#1)(2008-3#1)
retains the##25##2##(1990-11#1)(1990-5#2)(1991-9#1)(1992-11#1)(1993-1#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-5#1)(1996-3#1)(1997-2#1)(2005-8#1)(2006-2#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2013-1#1)
retains##75##1##(1990-11#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-2#3)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#4)(1995-5#2)(1996-3#1)(1996-5#2)(1996-7#2)(1996-8#1)(1997-2#2)(1997-7#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#4)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
retaliation##2##1##(1996-6#1)(2007-10#1)
retard or reverse the##2##4##(1992-9#1)(2004-11#1)
retard or##3##2##(1992-9#1)(2004-11#1)(2008-2#1)
retard preparation##2##2##(1990-11#2)
retard the##8##2##(1996-4#1)(1997-5#1)(2005-11#1)(2008-11#1)(2008-5#1)(2009-2#1)(2010-12#1)(2010-5#1)
retard##26##1##(1990-10#1)(1990-11#2)(1992-9#1)(1993-10#1)(1993-12#1)(1994-6#2)(1995-12#1)(1995-3#2)(1996-4#1)(1997-4#1)(1997-5#1)(2004-11#1)(2005-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2009-2#1)(2010-12#1)(2010-5#2)(2013-1#1)
retardance and##2##2##(2007-12#1)(2008-2#1)
retardance measurement##2##2##(2008-2#2)
retardance measurements##2##2##(2008-2#1)(2008-3#1)
retardance of##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
retardance##36##1##(2007-12#8)(2008-2#17)(2008-3#11)
retardant##2##1##(2007-8#1)(2011-2#1)
retardation and lethality##2##3##(2006-4#2)
retardation and thickness##2##3##(2009-4#2)
retardation and##34##2##(1990-11#1)(1991-5#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-2#2)(1997-5#1)(1997-7#1)(2004-10#1)(2006-10#1)(2006-11#1)(2006-4#3)(2006-9#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-3#1)(2009-4#4)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
retardation assay##4##2##(1991-1#1)(1992-11#1)(1997-1#1)(2008-8#1)
retardation assays##10##2##(1990-4#1)(1990-5#1)(1992-11#1)(1993-6#1)(1994-10#1)(1994-8#1)(1995-5#1)(1995-6#2)(1996-7#1)
retardation associated with##2##3##(2006-10#1)(2008-1#1)
retardation at##3##2##(1996-3#1)(2005-11#1)(2008-1#1)
retardation during##2##2##(2006-10#1)(2011-1#1)
retardation effects##2##2##(1995-10#1)(2007-12#1)
retardation in growth##2##3##(1995-1#1)(2008-6#1)
retardation in the##4##3##(1995-6#1)(2006-4#1)(2008-11#1)(2012-12#1)
retardation in##17##2##(1992-2#2)(1993-3#1)(1993-5#1)(1995-1#1)(1995-6#1)(1996-6#1)(2006-4#3)(2008-11#1)(2008-3#2)(2008-6#1)(2009-8#1)(2011-1#1)(2012-12#1)
retardation is##5##2##(1991-10#1)(2007-5#1)(2008-10#1)(2009-5#1)(2012-2#1)
retardation of DNA##2##3##(1991-5#1)(1995-5#1)
retardation of body##2##3##(1995-3#1)(1996-5#1)
retardation of the##8##3##(2007-12#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)
retardation of##27##2##(1991-5#1)(1991-8#1)(1992-1#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-5#2)(2004-4#1)(2006-1#1)(2007-12#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2011-1#1)
retardation on##2##2##(2008-2#1)(2008-3#1)
retardation or##3##2##(1993-3#1)(1997-3#1)(2008-10#1)
retardation syndrome##3##2##(1996-12#1)(2010-12#1)(2012-2#1)
retardation was##3##2##(1990-10#1)(1993-2#1)(2006-4#1)
retardation with##4##2##(1990-9#1)(1991-10#1)(1996-12#1)(2011-12#1)
retardation##263##1##(1990-10#1)(1990-11#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#2)(1990-9#2)(1991-1#1)(1991-10#3)(1991-12#2)(1991-3#2)(1991-4#1)(1991-5#2)(1991-8#1)(1992-1#3)(1992-11#2)(1992-12#1)(1992-2#7)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#2)(1993-2#1)(1993-3#6)(1993-5#1)(1993-6#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#5)(1995-10#2)(1995-11#2)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#3)(1995-8#5)(1995-9#1)(1996-1#1)(1996-12#6)(1996-3#7)(1996-5#2)(1996-6#4)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-10#2)(2004-11#1)(2004-4#1)(2005-11#2)(2006-1#2)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#2)(2006-4#8)(2006-9#2)(2007-11#3)(2007-12#5)(2007-3#2)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#10)(2008-11#2)(2008-2#4)(2008-3#14)(2008-4#1)(2008-5#4)(2008-6#3)(2008-8#5)(2008-9#1)(2009-11#2)(2009-4#4)(2009-5#4)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#8)(2011-12#1)(2011-2#2)(2012-1#3)(2012-12#5)(2012-2#6)(2012-3#1)(2013-1#4)(2013-8#1)
retarded and##3##2##(1993-1#1)(1993-4#1)(2008-11#1)
retarded band##2##2##(1990-10#1)(1994-8#1)
retarded by##7##2##(1992-5#1)(1994-12#1)(1994-3#1)(1995-1#1)(1996-3#1)(2008-10#1)(2008-3#1)
retarded clients##3##2##(2007-3#3)
retarded fetuses##2##2##(1991-12#1)(2004-10#1)
retarded growth of##2##3##(1994-3#1)(1995-9#1)
retarded growth##8##2##(1991-6#1)(1994-3#2)(1995-11#1)(1995-9#1)(2006-9#1)(2012-2#1)(2013-8#1)
retarded in the##2##3##(1994-11#1)(1995-12#1)
retarded in##8##2##(1991-10#1)(1992-5#1)(1994-11#1)(1994-2#1)(1995-12#1)(1996-1#1)(1997-8#1)(2008-10#1)
retarded mobility##2##2##(1991-3#1)(1994-8#1)
retarded replication##2##2##(1995-12#1)(1996-7#1)
retarded the development of##3##4##(1993-7#1)(2008-10#1)(2009-2#1)
retarded the##8##2##(1990-7#1)(1993-7#1)(1994-3#1)(1996-5#1)(2007-11#1)(2007-8#1)(2008-10#1)(2009-2#1)
retarded##98##1##(1990-10#1)(1990-11#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-1#2)(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#3)(1991-8#1)(1992-1#1)(1992-5#3)(1993-1#2)(1993-12#1)(1993-4#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-8#3)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-7#1)(1995-9#1)(1996-1#4)(1996-10#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#3)(1997-8#5)(2004-10#1)(2004-11#2)(2005-12#1)(2006-4#2)(2006-9#1)(2007-11#2)(2007-3#4)(2007-6#1)(2007-8#4)(2008-10#6)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-2#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
retarder is##2##2##(2007-11#1)(2008-2#1)
retarder orientation angles##3##3##(2007-12#3)
retarder##26##1##(2007-11#3)(2007-12#5)(2008-2#10)(2008-3#6)(2010-4#2)
retarders##9##1##(2006-4#2)(2007-12#2)(2008-2#5)
retarding the##3##2##(1991-6#1)(2009-2#1)(2012-2#1)
retarding##12##1##(1991-6#1)(1995-11#1)(1996-11#1)(1996-5#1)(1996-6#1)(2006-9#1)(2008-1#1)(2008-8#1)(2009-2#1)(2010-1#1)(2012-2#1)(2013-1#1)
retards the folding of barnase##2##5##(1996-4#2)
retards the progression of##2##4##(1991-7#1)(2008-3#1)
retards the##9##2##(1991-7#1)(1992-12#1)(1996-3#1)(1996-4#2)(2005-11#2)(2008-3#1)(2008-7#1)
retards##16##1##(1991-7#1)(1992-12#1)(1995-12#1)(1995-6#1)(1996-3#1)(1996-4#2)(1996-9#1)(1997-7#1)(2005-11#2)(2007-8#1)(2008-3#1)(2008-7#2)(2009-8#1)
retching##5##1##(1991-11#1)(1993-11#1)(1995-6#3)
rete mirabile##3##2##(2013-8#3)
rete ridges##2##2##(2008-5#1)(2011-2#1)
rete testis fluid##2##3##(1992-3#1)(1996-2#1)
rete##13##1##(1992-11#1)(1992-3#1)(1996-2#1)(2007-2#1)(2008-5#1)(2009-4#2)(2011-2#1)(2013-8#5)
retentate and filtrate##2##3##(2008-10#1)(2008-7#1)
retentate and##3##2##(2008-10#2)(2008-7#1)
retentate##7##1##(2005-11#1)(2008-10#3)(2008-12#1)(2008-7#2)
retentates##3##1##(2008-10#1)(2008-12#2)
retention 24 h##2##3##(1994-2#1)(1994-5#1)
retention after##2##2##(1994-2#1)(2008-10#1)
retention among##3##2##(2010-6#1)(2013-8#2)
retention and complexation mechanisms##3##4##(2008-10#3)
retention and elution conditions##3##4##(2008-10#3)
retention and elution##6##3##(2008-10#6)
retention and enantioselectivity of##2##4##(2008-10#2)
retention and enantioselectivity were##2##4##(2008-10#2)
retention and enantioselectivity##5##3##(1995-6#1)(2008-10#4)
retention and recruitment##2##3##(1992-1#1)(2012-3#1)
retention and selectivity of##3##4##(1990-8#1)(2008-10#2)
retention and selectivity##6##3##(1990-8#1)(2007-8#1)(2008-10#4)
retention and separation##3##3##(2005-12#1)(2008-10#2)
retention and the##3##3##(2004-10#1)(2008-7#1)(2009-2#1)
retention and##64##2##(1990-8#1)(1992-1#1)(1992-6#1)(1993-1#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-8#1)(2004-10#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#24)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-10#2)(2010-6#3)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
retention at##4##2##(2008-10#1)(2008-8#1)(2008-9#1)(2013-8#1)
retention behavior of##6##3##(1996-5#1)(2005-12#1)(2008-10#4)
retention behavior##12##2##(1996-5#1)(2005-12#1)(2008-10#10)
retention behaviors of polyaromatic hydrocarbons##2##5##(2008-10#2)
retention behaviour of##4##3##(1992-1#1)(1995-3#1)(2007-8#1)(2008-10#1)
retention behaviour##8##2##(1992-1#2)(1995-3#1)(1996-5#1)(2007-8#1)(2008-10#3)
retention between the##2##3##(1996-6#1)(2007-8#1)
retention between##3##2##(1996-6#1)(2007-6#1)(2007-8#1)
retention by##3##2##(1994-5#1)(2008-9#1)(2011-1#1)
retention can##2##2##(2008-6#1)(2011-1#1)
retention capacity##3##2##(2010-4#2)(2012-2#1)
retention characteristics of drugs were correlated with their physicochemical##2##9##(1996-5#2)
retention characteristics of##3##3##(1996-5#2)(2008-10#1)
retention characteristics##5##2##(1996-5#3)(2008-10#2)
retention data##3##2##(1996-11#2)(2005-12#1)
retention decreases##2##2##(2008-10#1)(2008-5#1)
retention delays##2##2##(1992-11#1)(1993-5#1)
retention during##2##2##(2008-10#1)(2013-8#1)
retention efficiencies were##2##3##(2008-10#1)(2012-3#1)
retention efficiencies##3##2##(2008-10#2)(2012-3#1)
retention efficiency##6##2##(2007-8#1)(2008-10#4)(2012-3#1)
retention factor##5##2##(2008-10#4)(2013-8#1)
retention factors of##2##3##(2008-10#2)
retention factors##3##2##(2007-11#1)(2008-10#2)
retention for##3##2##(1994-3#1)(1995-12#1)(2008-10#1)
retention from##2##2##(2008-10#1)(2008-9#1)
retention in a##3##3##(2008-5#1)(2011-2#1)(2012-3#1)
retention in the endoplasmic reticulum##2##5##(1996-3#1)(2006-11#1)
retention in the##11##3##(1995-12#1)(1996-3#1)(1996-8#1)(1997-3#1)(2006-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2009-12#1)(2013-1#1)(2013-8#1)
retention in##32##2##(1993-12#1)(1994-5#2)(1994-9#1)(1995-12#1)(1996-11#2)(1996-3#1)(1996-8#1)(1997-3#1)(1997-7#2)(2006-10#1)(2006-11#1)(2007-2#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-8#1)(2009-12#2)(2009-9#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
retention increased##2##2##(2008-10#1)(2008-11#1)
retention index##5##2##(2005-12#2)(2008-10#2)(2011-2#1)
retention indicated that##2##3##(1990-2#1)(2008-10#1)
retention indices for##2##3##(2008-10#2)
retention indices of##6##3##(2008-10#6)
retention indices##12##2##(2007-3#1)(2008-10#11)
retention intervals##3##2##(2009-11#3)
retention is the##2##3##(1997-7#1)(2008-10#1)
retention is##13##2##(1993-12#1)(1993-4#1)(1995-11#1)(1997-7#2)(2007-12#1)(2008-10#4)(2008-8#1)(2013-1#1)(2013-8#1)
retention mechanism of the##2##4##(2008-10#1)(2013-8#1)
retention mechanism of##5##3##(2008-10#2)(2013-8#3)
retention mechanism##12##2##(2005-12#1)(2008-10#6)(2013-8#5)
retention mechanisms of the##2##4##(2008-10#2)
retention mechanisms##5##2##(2008-10#5)
retention models of##2##3##(2008-10#1)(2013-8#1)
retention models##3##2##(2008-10#1)(2013-8#2)
retention of a##3##3##(1993-5#1)(2007-5#1)(2008-10#1)
retention of aluminium##2##3##(1992-7#1)(1996-12#1)
retention of analytes##2##3##(1993-2#1)(1996-8#1)
retention of arsenic##2##3##(1995-11#2)
retention of configuration at##2##4##(1996-5#1)(2008-4#1)
retention of configuration##4##3##(1991-2#1)(1996-5#1)(2008-4#1)(2009-12#1)
retention of fetal membranes##2##4##(2006-5#2)
retention of the modified##2##4##(1996-10#1)(2012-1#1)
retention of the temporal component##2##5##(1993-5#2)
retention of the##31##3##(1991-8#1)(1992-11#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-5#3)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-9#1)(1997-3#2)(1997-8#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-8#2)
retention of these##2##3##(1994-3#1)(1994-8#1)
retention of this##2##3##(1992-8#1)(1995-12#1)
retention of two##2##3##(2012-1#1)(2012-12#1)
retention of viability##3##3##(1995-8#1)(2007-6#1)(2008-11#1)
retention of viable cells in##2##5##(2008-11#2)
retention of##190##2##(1990-11#2)(1990-4#1)(1990-8#3)(1991-11#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#4)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#2)(1993-5#6)(1993-7#1)(1994-1#1)(1994-12#1)(1994-3#4)(1994-8#5)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#4)(1996-3#2)(1996-5#8)(1996-8#1)(1996-9#1)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#2)(2005-12#3)(2005-7#1)(2005-9#1)(2006-10#1)(2006-3#1)(2006-5#2)(2007-11#2)(2007-12#1)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#23)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#1)(2008-9#2)(2009-12#1)(2009-4#2)(2009-5#2)(2009-6#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#6)(2012-1#3)(2012-12#8)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#3)
retention on the##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
retention on##6##2##(1992-1#1)(2007-7#1)(2008-10#1)(2008-12#2)(2008-5#1)
retention or##6##2##(1993-7#1)(1994-8#1)(2005-10#1)(2008-3#1)(2009-12#1)(2013-8#1)
retention over##2##2##(1990-3#1)(1992-12#1)
retention performance in##2##3##(1994-6#1)(2008-10#1)
retention performance##6##2##(1990-10#1)(1994-6#1)(1994-8#1)(2008-10#1)(2008-11#2)
retention policy and##2##3##(2007-10#2)
retention process##3##2##(2008-10#3)
retention programs in##2##3##(2007-10#2)
retention relative to##2##3##(1990-7#1)(2008-10#1)
retention signal##4##2##(1990-6#1)(1994-9#1)(2008-3#1)(2008-8#1)
retention system##4##2##(1990-6#3)(2008-11#1)
retention test in##2##3##(1990-7#1)(1994-3#1)
retention test##8##2##(1990-7#2)(1991-2#1)(1992-8#1)(1994-3#1)(1994-8#1)(1996-1#1)(2010-3#1)
retention testing##4##2##(1991-2#2)(1994-8#1)(2010-3#1)
retention than##2##2##(1994-2#1)(2013-8#1)
retention that##3##2##(1992-2#1)(1996-5#1)(2007-6#1)
retention throughout the##2##3##(2008-8#1)(2012-3#1)
retention time and##5##3##(1990-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-1#1)
retention time in##2##3##(1991-1#1)(2008-7#1)
retention time of the##6##4##(1990-8#1)(1991-3#1)(2005-12#1)(2008-10#2)(2008-11#1)
retention time of##15##3##(1990-12#1)(1990-8#2)(1991-3#1)(1992-2#1)(2005-12#1)(2008-10#3)(2008-11#2)(2010-2#1)(2011-3#1)(2012-12#1)(2013-1#1)
retention time on##3##3##(1990-7#1)(1992-7#1)(1996-9#1)
retention time was##3##3##(2006-5#1)(2008-10#1)(2009-4#1)
retention time with##2##3##(1990-10#1)(2009-4#1)
retention time##58##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-3#2)(1992-2#1)(1992-7#1)(1996-9#1)(2005-12#2)(2006-5#1)(2006-8#1)(2007-8#2)(2008-10#12)(2008-11#4)(2008-5#1)(2008-7#1)(2008-9#2)(2009-4#2)(2010-12#1)(2010-2#2)(2010-6#1)(2011-1#4)(2011-3#2)(2012-12#2)(2013-1#4)
retention time)##2##2##(2008-6#1)(2008-7#1)
retention times and##7##3##(1990-12#1)(1997-2#1)(2005-12#1)(2007-8#1)(2008-10#1)(2010-11#1)(2010-12#1)
retention times are##2##3##(2008-10#2)
retention times for##2##3##(1990-6#1)(1997-8#1)
retention times of the##8##4##(1991-5#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-11#2)(2012-12#2)
retention times of##22##3##(1990-8#1)(1991-2#1)(1991-5#1)(1992-6#1)(1992-7#1)(1996-8#2)(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#4)(2008-11#2)(2009-8#1)(2010-2#2)(2012-12#2)(2013-1#1)
retention times with those of##3##5##(1995-8#1)(1996-6#1)(2008-10#1)
retention times with##5##3##(1990-12#1)(1995-8#2)(1996-6#1)(2008-10#1)
retention times##63##2##(1990-12#3)(1990-3#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-6#4)(1992-7#1)(1995-8#2)(1996-6#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-8#3)(2005-11#1)(2005-12#3)(2007-1#1)(2007-8#2)(2008-10#18)(2008-11#2)(2008-5#1)(2008-6#1)(2009-8#1)(2010-11#2)(2010-12#3)(2010-2#2)(2012-12#2)(2013-1#1)
retention to##2##2##(2008-5#1)(2010-11#1)
retention value##3##2##(1990-8#1)(2009-2#1)(2013-8#1)
retention was also##2##3##(1995-6#1)(2008-12#1)
retention was observed##2##3##(1990-7#1)(2008-3#1)
retention was##15##2##(1990-7#1)(1995-6#1)(1997-1#1)(2004-8#1)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#1)(2008-8#1)(2012-2#1)(2013-8#2)
retention were##5##2##(2004-10#1)(2005-9#1)(2008-12#1)(2013-1#2)
retention when##2##2##(2008-5#1)(2012-3#1)
retention##829##1##(1990-10#3)(1990-11#2)(1990-12#5)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#7)(1990-7#5)(1990-8#8)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#10)(1991-3#2)(1991-5#3)(1991-7#1)(1991-8#2)(1992-1#5)(1992-10#4)(1992-11#7)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#7)(1992-7#5)(1992-8#3)(1993-1#3)(1993-11#2)(1993-12#5)(1993-2#4)(1993-3#3)(1993-4#2)(1993-5#7)(1993-7#2)(1993-8#1)(1993-9#1)(1994-1#2)(1994-10#1)(1994-12#1)(1994-2#6)(1994-3#7)(1994-5#5)(1994-6#2)(1994-8#12)(1994-9#4)(1995-1#2)(1995-11#3)(1995-12#9)(1995-2#2)(1995-3#4)(1995-5#2)(1995-6#6)(1995-8#3)(1996-1#2)(1996-10#1)(1996-11#4)(1996-12#4)(1996-3#3)(1996-5#20)(1996-6#2)(1996-8#5)(1996-9#3)(1997-1#4)(1997-2#1)(1997-3#6)(1997-4#3)(1997-6#1)(1997-7#7)(1997-8#6)(2004-10#2)(2004-11#1)(2004-8#1)(2005-10#1)(2005-11#1)(2005-12#16)(2005-7#1)(2005-9#3)(2006-10#7)(2006-11#1)(2006-3#1)(2006-5#4)(2006-8#1)(2007-1#1)(2007-10#8)(2007-11#7)(2007-12#2)(2007-2#2)(2007-3#2)(2007-4#5)(2007-5#2)(2007-6#4)(2007-7#3)(2007-8#15)(2008-1#4)(2008-10#172)(2008-11#30)(2008-12#11)(2008-2#5)(2008-3#7)(2008-4#6)(2008-5#13)(2008-6#8)(2008-7#6)(2008-8#13)(2008-9#9)(2009-11#5)(2009-12#5)(2009-2#3)(2009-4#6)(2009-5#4)(2009-6#1)(2009-8#3)(2009-9#2)(2010-10#3)(2010-11#4)(2010-12#4)(2010-2#7)(2010-3#6)(2010-4#4)(2010-5#1)(2010-6#6)(2010-7#1)(2010-8#2)(2011-1#9)(2011-12#1)(2011-2#16)(2011-3#5)(2012-1#5)(2012-11#2)(2012-12#13)(2012-2#8)(2012-3#13)(2013-1#14)(2013-7#2)(2013-8#28)
retention)##4##1##(1996-1#1)(2008-8#1)(2013-1#2)
retention]##2##1##(1991-2#1)(2008-10#1)
retentions##3##1##(1991-8#1)(2007-8#1)(2008-10#1)
reteplase 10 + 10U##3##4##(2007-11#3)
reteplase regimen##2##2##(2007-11#2)
reteplase##17##1##(2006-4#3)(2007-11#11)(2007-9#2)(2008-7#1)
retest reliability##3##2##(1994-1#1)(2006-1#2)
retest##8##1##(1992-6#1)(1994-1#1)(2006-1#2)(2006-10#1)(2007-12#1)(2008-10#1)(2013-1#1)
retested with a##2##3##(2007-12#1)(2012-2#1)
retested with##3##2##(2007-1#1)(2007-12#1)(2012-2#1)
retested##15##1##(1992-7#2)(1994-3#2)(1996-6#1)(1997-8#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-8#1)(2010-8#1)(2012-2#1)(2013-1#2)
retesting##7##1##(1996-12#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-12#1)
rethink the##5##2##(1991-12#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-8#1)
rethink##15##1##(1991-12#1)(1995-2#1)(2006-6#1)(2007-9#2)(2009-8#2)(2010-3#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
rethinking the &quot##2##3##(2004-10#2)
rethinking the##3##2##(2004-10#2)(2008-7#1)
rethinking##12##1##(1992-4#1)(1995-12#1)(1996-1#1)(1996-2#1)(2004-10#2)(2007-8#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-7#1)
rethrombosis##5##1##(1990-11#5)
rethymectomy in##2##2##(2007-8#2)
rethymectomy##4##1##(2007-8#4)
reticence##2##1##(2009-9#2)
reticula##4##1##(2007-12#1)(2007-2#2)(2008-7#1)
reticular abnormality##2##2##(2005-8#2)
reticular and erosive##2##3##(2013-1#2)
reticular and##5##2##(1997-2#1)(1997-5#1)(2013-1#3)
reticular area##2##2##(1992-8#1)(1997-7#1)
reticular dermis##2##2##(2005-11#1)(2008-9#1)
reticular formation in##2##3##(1990-9#1)(1995-7#1)
reticular formation of the##3##4##(1996-1#1)(1996-9#1)(1997-2#1)
reticular formation of##5##3##(1990-7#2)(1996-1#1)(1996-9#1)(1997-2#1)
reticular formation##34##2##(1990-7#6)(1990-9#4)(1991-3#3)(1991-5#1)(1992-7#1)(1993-12#1)(1994-3#1)(1994-6#2)(1995-7#2)(1996-1#1)(1996-11#1)(1996-9#4)(1997-2#2)(1997-3#2)(1997-6#2)(2007-1#1)
reticular lamina##5##2##(1995-5#5)
reticular nucleus##11##2##(1991-5#1)(1993-12#3)(1993-9#1)(1995-8#1)(1996-9#2)(1997-6#2)(1997-8#1)
reticular type##2##2##(1992-9#1)(2013-1#1)
reticular##88##1##(1990-6#1)(1990-7#6)(1990-9#4)(1991-12#1)(1991-3#3)(1991-5#3)(1991-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#4)(1993-7#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#4)(1995-5#6)(1995-7#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-8#1)(1996-9#8)(1997-2#4)(1997-3#2)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#2)(2007-1#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#6)
reticularis gigantocellularis##3##2##(1991-5#2)(1997-2#1)
reticularis tegmenti pontis##2##3##(1991-3#2)
reticularis##11##1##(1990-5#1)(1991-3#2)(1991-5#2)(1995-12#1)(1997-2#1)(2007-5#1)(2008-6#1)(2010-9#1)(2012-3#1)
reticulata were##2##2##(1995-2#1)(2007-3#1)
reticulata##20##1##(1992-10#1)(1992-9#3)(1993-12#2)(1995-12#1)(1995-2#1)(2007-11#1)(2007-3#6)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-10#1)
reticulata) and##2##2##(2008-10#2)
reticulata)##6##1##(2008-10#3)(2008-8#3)
reticulate evolution##5##2##(2008-8#2)(2010-6#2)(2013-1#1)
reticulate##11##1##(1997-6#2)(2008-8#3)(2008-9#1)(2010-3#1)(2010-6#2)(2013-1#1)(2013-7#1)
reticulated platelets##7##2##(2006-6#5)(2008-9#2)
reticulated vitreous carbon##4##3##(2008-10#4)
reticulated##15##1##(1997-8#1)(2006-6#5)(2007-12#2)(2008-10#4)(2008-9#2)(2009-8#1)
reticulation##3##1##(2008-10#1)(2008-8#1)(2009-6#1)
reticulatum##6##1##(2008-5#6)
reticulin and##2##2##(1991-11#1)(2005-12#1)
reticulin##3##1##(1991-11#2)(2005-12#1)
reticulin-antibody-positive##2##1##(1991-11#2)
reticuline##3##1##(2007-1#3)
reticulocyte analysis##2##2##(2006-6#1)(2008-10#1)
reticulocyte count##6##2##(1991-10#1)(1992-4#1)(1994-12#1)(1994-6#1)(2006-6#1)(2013-1#1)
reticulocyte counts##3##2##(1992-8#1)(2008-10#1)(2009-10#1)
reticulocyte lysate translation system##2##4##(1990-2#1)(1991-10#1)
reticulocyte lysate##19##2##(1990-11#2)(1990-2#1)(1991-10#1)(1991-12#1)(1991-7#1)(1993-12#1)(1994-3#1)(1994-5#4)(1994-9#1)(1995-5#1)(1995-6#1)(1996-5#3)(2008-4#1)
reticulocyte lysates##11##2##(1990-2#2)(1990-6#2)(1992-11#2)(1993-2#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)
reticulocyte maturation##5##2##(1992-4#4)(2007-12#1)
reticulocyte##63##1##(1990-10#1)(1990-11#3)(1990-2#3)(1990-6#2)(1991-10#2)(1991-12#1)(1991-7#1)(1992-11#2)(1992-4#6)(1992-6#1)(1992-8#2)(1993-12#1)(1993-2#3)(1993-3#1)(1993-4#1)(1994-12#2)(1994-3#2)(1994-5#5)(1994-6#2)(1994-8#1)(1994-9#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-5#3)(1997-2#1)(2006-6#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-9#1)(2009-10#1)(2011-1#1)(2013-1#1)
reticulocytes and erythrocytes##2##3##(1996-6#2)
reticulocytes and##3##2##(1996-6#2)(2012-2#1)
reticulocytes by##2##2##(1993-2#1)(1996-2#1)
reticulocytes in##4##2##(1996-2#1)(2008-9#3)
reticulocytes is##2##2##(1993-2#2)
reticulocytes was##2##2##(1996-12#1)(1996-2#1)
reticulocytes##28##1##(1990-12#1)(1990-5#1)(1991-2#1)(1992-4#1)(1993-2#3)(1994-6#1)(1995-11#1)(1996-12#1)(1996-2#5)(1996-6#2)(2008-9#9)(2010-8#1)(2012-2#1)
reticuloendothelial cells##5##2##(1992-10#2)(1992-6#1)(1997-7#1)(2008-8#1)
reticuloendothelial system (RES)##2##3##(2008-5#1)(2010-2#1)
reticuloendothelial system##12##2##(1991-12#1)(1991-9#1)(1992-6#1)(1995-6#1)(2006-10#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-5#1)(2012-11#1)
reticuloendothelial##18##1##(1991-12#1)(1991-9#1)(1992-10#2)(1992-6#2)(1993-4#1)(1995-6#1)(1997-7#1)(2006-10#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-5#1)(2012-11#1)
reticuloendotheliosis virus##5##2##(2008-5#3)(2013-8#2)
reticuloendotheliosis viruses in##2##3##(2008-5#1)(2013-8#1)
reticuloendotheliosis##8##1##(2008-5#4)(2013-8#4)
reticulospinal##2##1##(1992-3#1)(1997-4#1)
reticulum Ca2+ ATPase##2##3##(1992-11#1)(2007-7#1)
reticulum Ca2+##6##2##(1992-11#1)(1994-2#1)(1995-2#1)(1996-12#1)(1997-2#1)(2007-7#1)
reticulum aminopeptidase##2##2##(2012-2#2)
reticulum and the##6##3##(1990-4#1)(1990-7#1)(1990-8#1)(1997-5#1)(2008-11#1)(2009-8#1)
reticulum and##36##2##(1990-4#1)(1990-7#1)(1990-8#1)(1991-7#1)(1992-11#1)(1992-6#1)(1994-11#2)(1994-2#1)(1994-9#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-5#1)(1996-9#1)(1997-5#1)(2006-10#1)(2007-12#4)(2007-5#1)(2008-11#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#2)(2010-2#1)(2011-2#1)(2013-1#2)
reticulum by##3##2##(1991-5#1)(1994-3#1)(1996-8#1)
reticulum during##3##2##(1992-3#1)(2007-10#1)(2012-3#1)
reticulum for##3##2##(1994-2#1)(1995-3#1)(2012-2#1)
reticulum in the##2##3##(1993-1#1)(2010-12#1)
reticulum in##4##2##(1990-3#1)(1993-1#1)(1994-2#1)(2010-12#1)
reticulum is##4##2##(1990-2#1)(1990-3#1)(1996-12#1)(1997-4#1)
reticulum membranes##4##2##(1991-1#1)(1991-7#1)(1992-11#1)(1992-6#1)
reticulum transport enzyme##2##3##(1991-2#2)
reticulum type##2##2##(1990-12#1)(1992-11#1)
reticulum vesicles##7##2##(1990-2#1)(1990-7#3)(1991-5#1)(1996-2#1)(2007-12#1)
reticulum via##2##2##(1996-8#1)(2007-9#1)
reticulum was##5##2##(1992-6#1)(1994-10#1)(1996-8#1)(2008-11#1)(2009-7#1)
reticulum were##2##2##(1991-9#1)(2008-11#1)
reticulum which##2##2##(1994-2#1)(1994-8#1)
reticulum##333##1##(1990-10#1)(1990-11#7)(1990-12#2)(1990-2#7)(1990-3#5)(1990-4#3)(1990-5#1)(1990-7#4)(1990-8#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#7)(1991-5#2)(1991-7#4)(1991-8#2)(1991-9#5)(1992-1#1)(1992-11#8)(1992-12#2)(1992-2#2)(1992-3#4)(1992-6#7)(1992-7#2)(1992-8#1)(1993-1#5)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#3)(1993-7#1)(1993-8#3)(1993-9#3)(1994-10#4)(1994-11#6)(1994-12#8)(1994-2#7)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#5)(1994-9#10)(1995-1#2)(1995-2#4)(1995-3#5)(1995-5#1)(1995-6#6)(1995-7#3)(1995-8#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#4)(1996-5#4)(1996-6#1)(1996-8#6)(1996-9#5)(1997-1#2)(1997-2#2)(1997-4#4)(1997-5#2)(1997-7#3)(2005-8#2)(2006-10#5)(2006-11#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-12#10)(2007-5#1)(2007-7#1)(2007-9#5)(2008-1#4)(2008-10#3)(2008-11#8)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#6)(2008-7#11)(2008-8#7)(2008-9#1)(2009-10#3)(2009-2#3)(2009-4#1)(2009-7#3)(2009-8#6)(2010-12#4)(2010-2#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#8)(2012-3#3)(2013-1#5)(2013-8#1)
retiming##2##1##(2007-12#2)
retina and hypothalamus##3##3##(2010-9#3)
retina and the##6##3##(1994-5#1)(2008-3#1)(2008-8#1)(2009-2#1)(2011-2#1)(2013-1#1)
retina and##39##2##(1990-12#1)(1992-8#1)(1994-5#1)(1995-11#1)(1996-5#1)(1997-3#2)(1997-5#1)(1997-6#1)(2006-1#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-1#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-7#1)(2008-8#1)(2009-2#1)(2010-1#1)(2010-9#3)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#2)(2013-8#2)
retina are##9##2##(1990-5#1)(1992-7#1)(1995-1#1)(2007-12#1)(2008-1#1)(2009-2#2)(2012-12#2)
retina as##2##2##(1997-8#1)(2008-5#1)
retina at##2##2##(1990-7#1)(2012-12#1)
retina by##2##2##(1991-10#1)(2008-4#1)
retina degenerated##2##2##(1994-2#1)(1997-3#1)
retina explants##3##2##(2010-1#3)
retina has been##5##3##(1992-7#1)(2011-2#1)(2012-12#2)(2013-8#1)
retina have been##2##3##(2008-1#1)(2008-8#1)
retina in the##4##3##(2007-3#1)(2008-3#1)(2011-1#1)(2012-12#1)
retina in vivo##6##3##(2007-11#1)(2008-4#2)(2010-1#2)(2012-12#1)
retina in##17##2##(1992-2#1)(1994-2#1)(2007-11#1)(2007-3#1)(2008-2#1)(2008-3#1)(2008-4#2)(2009-2#1)(2010-1#2)(2011-1#1)(2011-2#1)(2012-12#4)
retina is##8##2##(1992-7#2)(1996-1#1)(1996-2#1)(1997-3#1)(1997-8#1)(2008-12#1)(2011-2#1)
retina of a##3##3##(1994-2#1)(1996-5#1)(2008-2#1)
retina of the##5##3##(1991-10#1)(1992-3#1)(2008-5#1)(2009-2#1)(2010-1#1)
retina of##14##2##(1991-10#2)(1992-3#2)(1994-2#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-6#1)(2008-2#1)(2008-5#1)(2009-2#1)(2010-1#2)
retina that##4##2##(1995-1#1)(1997-6#1)(2008-11#1)(2008-2#1)
retina the##2##2##(1990-12#1)(1997-8#1)
retina was##2##2##(2008-2#1)(2008-8#1)
retina with##3##2##(1997-3#2)(2012-1#1)
retina##283##1##(1990-11#4)(1990-12#5)(1990-5#6)(1990-7#3)(1991-10#7)(1991-2#1)(1991-6#1)(1991-7#2)(1992-2#3)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#12)(1992-8#2)(1993-3#1)(1993-9#3)(1994-11#2)(1994-12#1)(1994-2#4)(1994-3#2)(1994-5#2)(1995-1#4)(1995-11#6)(1995-12#1)(1995-5#1)(1995-6#1)(1995-9#2)(1996-1#1)(1996-10#2)(1996-12#2)(1996-2#5)(1996-5#7)(1996-6#1)(1997-2#2)(1997-3#9)(1997-4#1)(1997-5#3)(1997-6#2)(1997-8#4)(2006-1#2)(2006-10#2)(2006-6#1)(2006-8#2)(2007-11#9)(2007-12#5)(2007-3#2)(2007-6#1)(2007-9#1)(2008-1#5)(2008-10#1)(2008-11#6)(2008-12#1)(2008-2#8)(2008-3#3)(2008-4#11)(2008-5#9)(2008-7#3)(2008-8#6)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#10)(2009-4#3)(2010-1#11)(2010-12#1)(2010-6#1)(2010-8#1)(2010-9#5)(2011-1#5)(2011-2#7)(2011-7#2)(2012-1#2)(2012-12#18)(2012-2#1)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#4)
retina-specific##6##1##(1990-7#1)(1992-8#2)(1994-9#3)
retina?##2##1##(1994-2#1)(2011-2#1)
retinacula##4##1##(2011-2#4)
retinaculum##3##1##(2006-10#1)(2011-2#1)(2012-2#1)
retinae of##2##2##(1990-5#1)(1992-3#1)
retinae##8##1##(1990-5#1)(1992-3#1)(2006-7#2)(2006-8#3)(2012-12#1)
retinal and choroidal##2##3##(2010-1#1)(2011-7#1)
retinal and##4##2##(1994-5#1)(2007-10#1)(2010-1#1)(2011-7#1)
retinal architecture##2##2##(2011-7#1)(2012-12#1)
retinal arteries##5##2##(1990-7#1)(2008-2#1)(2008-3#1)(2009-2#1)(2009-8#1)
retinal artery occlusion and##2##4##(2009-2#1)(2010-10#1)
retinal artery occlusion##7##3##(2007-10#2)(2009-2#2)(2009-8#1)(2010-10#1)(2013-7#1)
retinal artery##10##2##(2007-10#2)(2009-2#2)(2009-8#1)(2010-10#2)(2010-3#1)(2012-3#1)(2013-7#1)
retinal as well as##2##4##(1995-1#1)(2006-8#1)
retinal binding site##2##3##(1995-1#2)
retinal bipolar cells##2##3##(1991-3#2)
retinal blood##3##2##(2007-2#1)(2012-12#2)
retinal capillaries##2##2##(2008-1#1)(2011-2#1)
retinal cell##3##2##(1992-3#1)(2007-12#1)(2013-1#1)
retinal cells##4##2##(1993-12#1)(1996-1#1)(1996-11#1)(2008-4#1)
retinal changes##2##2##(1995-1#1)(2009-12#1)
retinal chromophore##7##2##(1990-3#1)(1995-1#2)(1997-3#1)(2006-6#1)(2007-12#1)(2008-7#1)
retinal degeneration B gene##2##4##(1997-7#2)
retinal degeneration##11##2##(1990-11#1)(1995-1#1)(1997-7#3)(2008-7#1)(2011-1#1)(2012-3#2)(2013-8#2)
retinal degenerative diseases##2##3##(1995-10#1)(2010-10#1)
retinal degenerative##5##2##(1995-10#1)(2010-10#1)(2012-12#3)
retinal detachment and##3##3##(2007-3#1)(2008-4#1)(2009-4#1)
retinal detachment in##2##3##(2008-1#1)(2013-8#1)
retinal detachment##14##2##(2007-3#1)(2008-1#2)(2008-4#1)(2009-4#3)(2011-1#1)(2013-1#1)(2013-7#2)(2013-8#3)
retinal development##3##2##(1992-7#1)(2012-12#2)
retinal disease##2##2##(1997-3#1)(2009-2#1)
retinal diseases such as##2##4##(2009-12#1)(2013-8#1)
retinal diseases##8##2##(1995-1#1)(1995-10#1)(2008-10#1)(2009-12#1)(2010-10#2)(2011-1#1)(2013-8#1)
retinal disorders##3##2##(2009-4#1)(2012-12#1)(2013-1#1)
retinal dysplasia##2##2##(1996-6#1)(1997-3#1)
retinal dystrophies##4##2##(1995-1#1)(2008-5#1)(2012-12#2)
retinal explants##4##2##(1996-5#4)
retinal function##3##2##(1990-3#1)(1994-2#1)(1997-3#1)
retinal ganglion cell death##2##4##(1992-3#1)(2010-2#1)
retinal ganglion cell##7##3##(1992-3#1)(1996-1#1)(1996-3#1)(2008-7#1)(2010-2#1)(2012-12#2)
retinal ganglion cells (RGCs)##4##4##(1991-3#1)(1996-1#1)(2009-12#1)(2013-8#1)
retinal ganglion cells and##2##4##(2008-3#1)(2011-2#1)
retinal ganglion cells##16##3##(1991-10#1)(1991-3#1)(1993-12#2)(1994-5#1)(1996-1#2)(1996-2#1)(2007-6#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#2)(2011-2#1)(2013-8#1)
retinal ganglion##23##2##(1991-10#1)(1991-3#1)(1992-3#1)(1993-12#2)(1994-5#1)(1996-1#3)(1996-2#1)(1996-3#1)(2007-6#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-12#2)(2010-2#1)(2011-2#1)(2012-12#2)(2013-8#1)
retinal glial##2##2##(2008-4#1)(2008-5#1)
retinal hemangioblastomas##2##2##(2011-2#2)
retinal hemorrhages##3##2##(1994-9#1)(1996-10#1)(2006-8#1)
retinal image##5##2##(1990-10#1)(2007-12#1)(2010-5#1)(2010-9#2)
retinal images of##2##3##(1990-3#1)(2011-1#1)
retinal images##7##2##(1990-3#1)(2007-11#1)(2007-12#4)(2011-1#1)
retinal imaging##4##2##(2007-11#2)(2011-7#2)
retinal input##2##2##(1992-10#1)(2008-7#1)
retinal ischemia##2##2##(2007-9#1)(2011-1#1)
retinal ischemia-induced##2##2##(1995-1#1)(2011-1#1)
retinal laser##4##2##(2009-4#3)(2011-1#1)
retinal layers##2##2##(1995-11#1)(1997-3#1)
retinal melatonin##2##2##(1995-12#2)
retinal membranes##2##2##(1991-7#1)(1993-8#1)
retinal microcirculation##2##2##(2007-12#1)(2009-2#1)
retinal necrosis##3##2##(2009-2#2)(2013-7#1)
retinal neovascularization in##2##3##(1997-7#1)(2011-1#1)
retinal neovascularization##5##2##(1995-1#2)(1997-7#1)(2008-1#1)(2011-1#1)
retinal nerve fiber layer (RNFL)##3##5##(2007-11#1)(2007-3#1)(2009-4#1)
retinal nerve fiber layer##20##4##(2007-11#2)(2007-3#3)(2007-6#10)(2008-3#1)(2009-4#1)(2010-12#1)(2012-12#1)(2013-1#1)
retinal nerve##21##2##(2007-11#2)(2007-3#3)(2007-6#10)(2008-3#1)(2009-4#1)(2010-12#1)(2012-12#1)(2013-1#2)
retinal neurons in##2##3##(2008-8#1)(2012-12#1)
retinal neurons##8##2##(1994-2#1)(1997-4#2)(2008-8#4)(2012-12#1)
retinal on-bipolar cell##3##3##(1993-8#3)
retinal pericyte##2##2##(1993-3#1)(2012-4#1)
retinal photocoagulation##2##2##(2011-1#2)
retinal photoreceptors and##2##3##(1994-5#1)(2011-2#1)
retinal photoreceptors##3##2##(1994-5#1)(1996-9#1)(2011-2#1)
retinal physiology##2##2##(1995-5#1)(2008-4#1)
retinal pigment epithelial cells##6##4##(1992-11#1)(1993-3#3)(2008-12#1)(2012-3#1)
retinal pigment epithelial##10##3##(1992-11#2)(1993-3#3)(1996-5#2)(2008-12#1)(2010-10#1)(2012-3#1)
retinal pigment epithelium (RPE)##9##4##(1990-6#1)(1992-2#1)(1995-9#1)(2008-3#1)(2008-4#1)(2012-12#3)(2013-1#1)
retinal pigment epithelium and##3##4##(1990-3#1)(2008-7#1)(2009-4#1)
retinal pigment epithelium##19##3##(1990-3#1)(1990-6#1)(1992-2#1)(1995-9#2)(1997-6#1)(2006-4#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#1)(2011-7#2)(2012-12#4)(2012-3#1)(2013-1#1)
retinal pigment##31##2##(1990-3#1)(1990-6#1)(1992-11#2)(1992-2#1)(1993-3#3)(1995-9#2)(1996-1#1)(1996-5#2)(1997-6#1)(2006-4#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-10#1)(2011-2#1)(2011-7#2)(2012-12#4)(2012-3#2)(2013-1#1)
retinal pigmented epithelial cells##4##4##(1992-7#3)(2008-11#1)
retinal pigmented epithelium##3##3##(1996-9#1)(2008-4#2)
retinal pigmented##7##2##(1992-7#3)(1996-9#1)(2008-11#1)(2008-4#2)
retinal progenitor cells##3##3##(1996-5#3)
retinal projections##2##2##(1992-7#1)(2008-7#1)
retinal prosthesis##4##2##(2009-12#3)(2013-7#1)
retinal rod outer segments (ROS)##2##5##(1990-2#1)(1995-5#1)
retinal rod outer segments##7##4##(1990-2#1)(1990-7#1)(1992-6#2)(1993-4#1)(1995-5#1)(1997-1#1)
retinal rod outer##8##3##(1990-11#1)(1990-2#1)(1990-7#1)(1992-6#2)(1993-4#1)(1995-5#1)(1997-1#1)
retinal rod##11##2##(1990-11#1)(1990-2#2)(1990-7#1)(1992-6#3)(1993-4#1)(1995-5#2)(1997-1#1)
retinal rods##3##2##(1994-9#1)(1995-6#1)(1997-1#1)
retinal stem##4##2##(2012-12#4)
retinal surface##6##2##(2008-2#1)(2008-5#3)(2011-2#1)(2012-12#1)
retinal surgery##2##2##(2011-1#1)(2013-8#1)
retinal temperature##2##2##(2009-4#2)
retinal thickening and##2##3##(2012-12#1)(2013-1#1)
retinal thickness##3##2##(1992-7#1)(2011-2#1)(2011-7#1)
retinal tissue in##2##3##(1996-12#2)
retinal tissue##4##2##(1996-12#2)(2011-1#1)(2011-2#1)
retinal toxicity secondary to hydroxychloroquine##4##5##(2013-1#4)
retinal toxicity##12##2##(2013-1#12)
retinal vascular occlusions is##2##4##(2009-4#2)
retinal vascular##8##2##(2009-10#2)(2009-4#3)(2012-12#2)(2013-1#1)
retinal vasculature##4##2##(2006-8#1)(2007-12#1)(2009-10#1)(2012-2#1)
retinal vasculitis in##2##3##(2007-1#1)(2011-1#1)
retinal vasculitis##3##2##(2007-1#1)(2011-1#2)
retinal vein occlusion##21##3##(1992-10#1)(2007-2#1)(2009-2#1)(2009-4#10)(2009-8#2)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#1)
retinal veins##2##2##(1990-7#1)(2011-1#1)
retinal vessel oximetry##2##3##(2008-2#1)(2008-3#1)
retinal vessel##6##2##(2007-11#1)(2008-2#2)(2008-3#3)
retinal##498##1##(1990-10#1)(1990-11#3)(1990-2#2)(1990-3#5)(1990-5#1)(1990-6#1)(1990-7#4)(1991-10#2)(1991-12#2)(1991-2#1)(1991-3#3)(1991-5#1)(1991-7#7)(1992-10#2)(1992-11#3)(1992-2#1)(1992-3#3)(1992-6#3)(1992-7#8)(1992-8#1)(1993-12#5)(1993-3#4)(1993-4#1)(1993-8#4)(1993-9#2)(1994-11#6)(1994-2#3)(1994-5#3)(1994-6#1)(1994-9#2)(1995-1#18)(1995-10#3)(1995-11#2)(1995-12#2)(1995-5#4)(1995-6#2)(1995-9#3)(1996-1#9)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#11)(1996-6#1)(1996-9#3)(1997-1#2)(1997-3#6)(1997-4#3)(1997-6#1)(1997-7#6)(2006-10#1)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#4)(2006-9#4)(2007-1#1)(2007-10#3)(2007-11#7)(2007-12#11)(2007-2#2)(2007-3#7)(2007-5#2)(2007-6#11)(2007-9#1)(2008-1#8)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#9)(2008-3#11)(2008-4#10)(2008-5#6)(2008-7#9)(2008-8#7)(2008-9#1)(2009-10#5)(2009-12#9)(2009-2#10)(2009-4#25)(2009-6#2)(2009-8#9)(2010-1#2)(2010-10#6)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-9#2)(2011-1#21)(2011-2#16)(2011-7#13)(2011-9#2)(2012-12#29)(2012-2#1)(2012-3#5)(2012-4#3)(2013-1#29)(2013-7#5)(2013-8#9)
retinaldehyde to##2##2##(1993-12#1)(1994-12#1)
retinally-generated##2##1##(2006-7#2)
retinas and##2##2##(1990-11#1)(2007-5#1)
retinas but##2##2##(1994-9#1)(2007-5#1)
retinas of##5##2##(1990-11#2)(1994-8#1)(1995-12#1)(2007-5#1)
retinas were##2##2##(1994-5#1)(2008-4#1)
retinas##29##1##(1990-11#4)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-5#1)(1996-6#1)(1997-3#2)(1997-4#3)(2007-5#4)(2008-1#1)(2008-11#1)(2008-3#3)(2008-4#4)(2010-1#1)
retinex coding##4##2##(2008-3#4)
retinitis due to##2##3##(2009-2#2)
retinitis pigmentosa and##5##3##(1995-10#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)
retinitis pigmentosa##13##2##(1991-6#1)(1995-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2011-1#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
retinitis with##2##2##(1991-8#1)(2007-12#1)
retinitis##20##1##(1991-6#1)(1991-8#1)(1995-10#1)(1996-8#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#3)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
retinoblastoma cell##3##2##(1991-7#1)(1992-5#1)(1994-10#1)
retinoblastoma cells##6##2##(1991-7#1)(1994-8#2)(1995-2#1)(1995-5#2)
retinoblastoma gene (RB1)##2##3##(1996-4#1)(2008-6#1)
retinoblastoma gene product (Rb)##2##4##(1995-2#1)(1996-5#1)
retinoblastoma gene product##7##3##(1992-8#1)(1994-5#1)(1995-2#2)(1996-5#1)(1997-7#2)
retinoblastoma gene##13##2##(1992-8#1)(1993-6#1)(1994-5#1)(1995-2#2)(1996-4#1)(1996-5#1)(1997-7#3)(2003-11#1)(2008-6#1)(2010-3#1)
retinoblastoma in##2##2##(2011-1#2)
retinoblastoma protein##7##2##(1993-6#2)(1993-9#1)(1996-4#1)(1997-1#1)(2003-11#1)(2008-11#1)
retinoblastoma##55##1##(1991-7#2)(1991-8#1)(1992-5#1)(1992-8#1)(1993-3#1)(1993-6#3)(1993-9#1)(1994-10#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-2#3)(1995-5#2)(1996-11#1)(1996-2#2)(1996-4#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-7#3)(2003-11#2)(2004-1#1)(2007-5#1)(2008-11#1)(2008-6#4)(2008-7#1)(2010-2#2)(2010-3#3)(2011-1#5)(2011-2#4)
retinoblastoma]##2##1##(2011-2#1)(2013-1#1)
retinofugal##2##1##(1996-1#2)
retinoic X receptor alpha##2##4##(1997-7#2)
retinoic X receptor##3##3##(1996-4#1)(1997-7#2)
retinoic acid (RA) and synthetic##2##5##(1991-9#1)(1994-6#1)
retinoic acid (RA) and##3##4##(1991-9#1)(1994-6#1)(1994-8#1)
retinoic acid (RA) in##2##4##(1994-11#1)(1995-9#1)
retinoic acid (RA) on##2##4##(1993-9#1)(1996-5#1)
retinoic acid (RA)##29##3##(1990-11#1)(1990-6#1)(1991-9#1)(1992-1#2)(1992-5#1)(1992-9#1)(1993-9#2)(1994-11#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-10#2)(1995-9#1)(1996-5#2)(1997-7#1)(2006-12#1)(2006-6#1)(2008-11#1)(2008-5#3)(2012-1#1)
retinoic acid and##12##3##(1990-12#1)(1992-8#1)(1992-9#2)(1994-12#2)(1994-8#2)(1995-10#1)(1995-11#2)(2011-1#1)
retinoic acid binding##4##3##(1995-1#1)(1995-11#3)
retinoic acid but not by##2##5##(1990-10#1)(1994-9#1)
retinoic acid could##2##3##(1990-10#1)(1991-1#1)
retinoic acid for##2##3##(1991-2#1)(1993-3#1)
retinoic acid in##7##3##(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#1)(1994-11#1)(2007-11#1)(2011-2#1)
retinoic acid induced differentiation##2##4##(1992-5#1)(2011-1#1)
retinoic acid induced##4##3##(1991-1#1)(1992-5#1)(2008-9#1)(2011-1#1)
retinoic acid is##4##3##(1990-10#1)(1993-3#1)(1997-6#1)(2006-12#1)
retinoic acid on##5##3##(1993-3#1)(1994-11#1)(1994-9#1)(2008-11#1)(2011-1#1)
retinoic acid or PDGF or bFGF##2##6##(1991-12#2)
retinoic acid or##4##3##(1991-12#3)(2008-5#1)
retinoic acid receptor (RAR)##3##4##(1990-11#1)(1996-8#1)(2005-11#1)
retinoic acid receptor alpha (RARA)##3##5##(1991-11#1)(2007-12#1)(2012-2#1)
retinoic acid receptor alpha##6##4##(1990-9#1)(1991-11#1)(1991-9#1)(1995-3#1)(2007-12#1)(2012-2#1)
retinoic acid receptor and##2##4##(1992-8#1)(2010-12#1)
retinoic acid receptor##19##3##(1990-11#2)(1990-9#1)(1991-11#1)(1991-9#3)(1992-12#1)(1992-8#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-8#1)(2005-11#1)(2007-12#1)(2010-12#1)(2012-1#1)(2012-2#1)
retinoic acid receptors as##2##4##(1995-8#2)
retinoic acid receptors##12##3##(1991-9#2)(1994-11#1)(1994-12#1)(1995-8#5)(2007-11#1)(2008-5#1)(2010-3#1)
retinoic acid response element##4##4##(1992-9#1)(1995-3#1)(1995-8#2)
retinoic acid response elements##3##4##(1994-8#2)(1995-8#1)
retinoic acid response##7##3##(1992-9#1)(1994-8#2)(1995-3#1)(1995-8#3)
retinoic acid responsive##4##3##(1990-11#1)(1991-4#1)(1991-9#1)(1993-3#1)
retinoic acid to##2##3##(1992-12#1)(2009-6#1)
retinoic acid treatment##3##3##(1993-12#1)(2005-10#1)(2009-4#1)
retinoic acid was detected##2##4##(1994-12#2)
retinoic acid was##3##3##(1994-12#2)(1997-6#1)
retinoic acid with##2##3##(1995-10#1)(1995-11#1)
retinoic acid##210##2##(1990-10#4)(1990-11#4)(1990-12#2)(1990-6#2)(1990-8#1)(1990-9#1)(1991-1#4)(1991-11#1)(1991-12#4)(1991-2#7)(1991-3#1)(1991-4#1)(1991-9#9)(1992-1#3)(1992-12#2)(1992-2#2)(1992-5#3)(1992-8#5)(1992-9#4)(1993-12#8)(1993-3#9)(1993-4#2)(1993-8#1)(1993-9#3)(1994-10#2)(1994-11#10)(1994-12#15)(1994-6#1)(1994-8#8)(1994-9#5)(1995-1#1)(1995-10#6)(1995-11#8)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#8)(1995-9#2)(1996-11#1)(1996-5#4)(1996-8#2)(1997-3#1)(1997-6#2)(1997-7#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-12#3)(2006-6#1)(2007-1#2)(2007-11#2)(2007-12#1)(2007-4#1)(2008-11#3)(2008-4#1)(2008-5#7)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#2)(2010-12#1)(2010-3#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#2)
retinoic acid-binding protein##4##3##(1992-12#2)(1994-12#1)(1995-1#1)
retinoic acid-binding proteins##2##3##(1995-1#2)
retinoic acid-binding##6##2##(1992-12#2)(1994-12#1)(1995-1#3)
retinoic acid-induced differentiated cells##2##4##(1996-5#1)(1997-2#1)
retinoic acid-induced##6##2##(1991-2#1)(1992-12#1)(1996-5#1)(1997-2#1)(1997-7#1)(2008-4#1)
retinoic acids##2##2##(1992-8#1)(1995-1#1)
retinoic##240##1##(1990-10#5)(1990-11#4)(1990-12#2)(1990-6#2)(1990-8#1)(1990-9#1)(1991-1#4)(1991-11#1)(1991-12#4)(1991-2#8)(1991-3#1)(1991-4#1)(1991-9#9)(1992-1#3)(1992-12#5)(1992-2#2)(1992-5#3)(1992-8#6)(1992-9#4)(1993-12#9)(1993-3#10)(1993-4#2)(1993-8#1)(1993-9#3)(1994-10#2)(1994-11#10)(1994-12#18)(1994-6#1)(1994-8#8)(1994-9#5)(1995-1#6)(1995-10#6)(1995-11#8)(1995-2#1)(1995-3#3)(1995-5#1)(1995-8#8)(1995-9#2)(1996-11#1)(1996-4#1)(1996-5#7)(1996-8#2)(1997-2#2)(1997-3#1)(1997-6#2)(1997-7#5)(2005-10#1)(2005-11#1)(2006-10#3)(2006-12#3)(2006-6#1)(2007-1#2)(2007-11#2)(2007-12#1)(2007-4#1)(2008-11#3)(2008-4#2)(2008-5#7)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#2)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#2)
retinoid X receptor (RXR)##6##4##(1995-10#1)(1995-3#1)(1995-8#2)(1996-8#1)(2012-12#1)
retinoid X receptor alpha##3##4##(1994-8#1)(1995-3#1)(2012-12#1)
retinoid X receptor##14##3##(1994-8#1)(1994-9#1)(1995-10#2)(1995-3#2)(1995-8#3)(1996-8#2)(2005-11#1)(2012-12#2)
retinoid X receptors##8##3##(1993-3#2)(1993-6#1)(1994-12#1)(1994-8#1)(1995-8#1)(2008-10#1)(2010-3#1)
retinoid X##25##2##(1993-3#2)(1993-6#1)(1994-12#1)(1994-8#2)(1994-9#2)(1995-10#2)(1995-3#2)(1995-8#5)(1996-8#2)(2005-11#1)(2006-10#1)(2008-10#1)(2010-3#1)(2012-12#2)
retinoid and##2##2##(1993-3#1)(2008-5#1)
retinoid receptor##3##2##(1995-3#1)(1995-6#1)(2012-12#1)
retinoid receptors##5##2##(1994-12#2)(1994-6#1)(1996-5#1)(1996-8#1)
retinoid##69##1##(1991-12#1)(1992-2#1)(1992-9#4)(1993-3#5)(1993-6#1)(1993-9#1)(1994-12#4)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#3)(1995-10#3)(1995-3#6)(1995-6#1)(1995-8#5)(1995-9#1)(1996-5#1)(1996-8#4)(2004-1#1)(2005-11#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-5#2)(2009-6#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#4)(2012-2#2)(2013-1#3)
retinoid-binding protein##5##2##(1991-3#2)(1994-12#1)(1994-9#2)
retinoid-binding proteins and##2##3##(1991-3#1)(1995-1#1)
retinoid-binding proteins##7##2##(1991-3#1)(1993-12#1)(1994-12#1)(1995-1#4)
retinoid-binding##12##1##(1991-3#3)(1993-12#1)(1994-12#2)(1994-9#2)(1995-1#4)
retinoids (ie##2##2##(2007-10#2)
retinoids and##7##2##(1992-2#2)(1992-6#1)(1994-8#1)(2005-11#1)(2007-10#1)(2010-3#1)
retinoids are##2##2##(1995-9#1)(2008-4#1)
retinoids have been##2##3##(1995-1#1)(2007-11#1)
retinoids in the##2##3##(1991-3#2)
retinoids in##6##2##(1990-11#1)(1991-3#2)(1993-12#1)(1997-3#1)(2008-4#1)
retinoids may be##4##3##(1994-6#1)(2007-11#2)(2008-4#1)
retinoids may##7##2##(1993-12#1)(1994-6#2)(2006-10#1)(2007-11#2)(2008-4#1)
retinoids were##2##2##(1996-5#1)(2011-2#1)
retinoids##71##1##(1990-11#2)(1991-3#2)(1991-9#3)(1992-2#3)(1992-6#1)(1992-9#1)(1993-12#3)(1993-3#1)(1994-6#3)(1994-8#1)(1995-1#3)(1995-10#1)(1995-3#1)(1995-9#3)(1996-4#1)(1996-5#1)(1996-8#1)(1997-3#1)(2005-11#2)(2006-10#1)(2006-12#3)(2007-10#4)(2007-11#9)(2007-8#1)(2008-1#1)(2008-4#4)(2008-5#5)(2008-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
retinol acyltransferase##2##2##(1993-3#2)
retinol also##2##2##(1993-2#1)(1994-12#1)
retinol and##8##2##(1991-5#1)(1993-12#1)(1994-12#1)(2006-12#1)(2009-6#3)(2011-1#1)
retinol content##2##2##(1995-3#1)(2006-10#1)
retinol deficient groups##2##3##(1994-8#2)
retinol deficient##7##2##(1994-8#7)
retinol in the skin of##3##5##(2008-8#3)
retinol in the##4##3##(2008-5#1)(2008-8#3)
retinol in##7##2##(1992-2#1)(2008-5#3)(2008-8#3)
retinol per se##3##3##(2008-5#3)
retinol to##2##2##(1994-12#2)
retinol uptake##2##2##(1994-12#1)(2006-10#1)
retinol was##2##2##(1994-12#1)(2008-5#1)
retinol##93##1##(1990-6#1)(1991-2#2)(1991-3#1)(1991-5#2)(1992-2#2)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#2)(1994-10#1)(1994-12#16)(1994-8#9)(1995-3#1)(1995-5#2)(1995-9#1)(1996-5#2)(2006-10#6)(2006-12#1)(2007-8#2)(2008-5#24)(2008-8#5)(2009-6#6)(2010-6#1)(2011-1#1)(2013-1#1)
retinol'##2##1##(2008-5#2)
retinol-binding protein (RBP) and##3##4##(1990-4#1)(1991-2#1)(1992-4#1)
retinol-binding protein (RBP)##7##3##(1990-11#1)(1990-4#1)(1991-2#1)(1991-9#1)(1992-4#1)(1994-11#1)(1994-6#1)
retinol-binding protein and asialo-orosomucoid##2##4##(1995-6#2)
retinol-binding protein and##3##3##(1995-6#2)(2012-2#1)
retinol-binding protein is##2##3##(1995-6#2)
retinol-binding protein##23##2##(1990-11#2)(1990-12#1)(1990-4#1)(1991-2#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-4#1)(1994-11#2)(1994-6#1)(1995-5#1)(1995-6#5)(2006-10#1)(2009-6#1)(2010-1#1)(2012-2#1)
retinol-deficient##2##1##(1994-8#2)
retinol-induced##3##1##(1994-12#3)
retinopathy (DR)##5##2##(2008-1#3)(2010-8#1)(2011-2#1)
retinopathy and coronary artery disease in type 1 diabetes##2##9##(2013-1#2)
retinopathy and coronary##3##3##(2013-1#3)
retinopathy and##9##2##(2004-10#1)(2005-10#1)(2007-8#2)(2009-11#1)(2013-1#4)
retinopathy are##3##2##(1997-2#1)(2009-2#1)(2010-10#1)
retinopathy in##14##2##(1991-8#1)(1997-6#1)(2005-10#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#2)(2013-1#3)
retinopathy is##7##2##(2006-1#1)(2008-1#1)(2008-8#1)(2009-2#1)(2010-10#1)(2011-2#1)(2012-2#1)
retinopathy of prematurity##8##3##(1992-7#1)(2007-2#1)(2011-1#5)(2012-12#1)
retinopathy of##9##2##(1991-8#1)(1992-7#1)(2007-2#1)(2011-1#5)(2012-12#1)
retinopathy##137##1##(1990-5#1)(1990-8#1)(1991-12#2)(1991-8#4)(1991-9#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-9#1)(1995-1#1)(1995-6#1)(1995-9#5)(1996-11#1)(1996-6#2)(1996-8#1)(1997-2#1)(1997-6#2)(1997-7#3)(2004-10#1)(2005-10#4)(2006-1#6)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#20)(2008-10#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-11#2)(2009-2#5)(2009-4#1)(2010-10#7)(2010-12#1)(2010-8#2)(2011-1#7)(2011-2#8)(2012-1#3)(2012-12#2)(2012-2#4)(2013-1#12)(2013-8#1)
retinotopic##4##1##(1990-5#1)(2008-3#1)(2010-6#1)(2012-2#1)
retinoyl-beta-glucuronides##3##1##(1996-8#3)
retinula cells##2##2##(2007-12#2)
retinula##3##1##(2007-12#3)
retinular##2##1##(2007-12#2)
retinyl acetate and tocopherols##2##4##(2008-10#2)
retinyl acetate##4##2##(2008-10#3)(2008-8#1)
retinyl esters##3##2##(1991-2#1)(1994-12#1)(2008-8#1)
retinyl palmitate and retinol##3##4##(2008-8#3)
retinyl palmitate and##8##3##(1993-10#1)(2008-8#7)
retinyl palmitate##18##2##(1993-10#1)(2008-8#17)
retinyl##25##1##(1991-2#1)(1993-10#1)(1994-12#1)(2008-10#3)(2008-8#19)
retinylidene##2##1##(1994-2#1)(1995-11#1)
retire##2##1##(2007-6#1)(2009-12#1)
retired and##2##2##(2008-1#1)(2008-8#1)
retired workers who##2##3##(1993-1#2)
retired workers##3##2##(1993-1#3)
retired##19##1##(1991-12#1)(1992-1#1)(1993-1#3)(1993-8#1)(1997-1#1)(2006-10#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-8#1)(2012-3#1)
retiree##2##1##(1992-2#1)(1995-1#1)
retirees##6##1##(1991-12#2)(1992-2#1)(1996-12#1)(2009-12#1)(2013-8#1)
retirement benefits##4##2##(2007-4#3)(2008-9#1)
retirement plan##3##2##(1992-3#2)(1994-1#1)
retirement plans are##2##3##(2007-4#2)
retirement plans##5##2##(1993-3#1)(2007-4#4)
retirement##37##1##(1991-2#2)(1992-3#2)(1993-2#1)(1993-3#1)(1994-1#2)(1994-2#2)(1996-12#1)(2005-9#1)(2007-3#1)(2007-4#8)(2007-9#1)(2008-1#4)(2008-10#1)(2008-5#1)(2008-9#1)(2009-12#3)(2010-3#1)(2010-9#2)(2011-2#2)
retiring##3##1##(2007-5#1)(2007-6#1)(2008-5#1)
retooling##2##1##(1997-3#1)(2012-12#1)
retraces the##2##2##(2010-1#1)(2011-2#1)
retracing##2##1##(2007-12#1)(2008-3#1)
retract##5##1##(2008-2#1)(2008-5#2)(2010-9#1)(2013-1#1)
retractable##3##1##(1990-7#1)(2007-2#1)(2008-11#1)
retracted##13##1##(1990-7#1)(1992-1#1)(1994-2#1)(1996-11#1)(2006-11#1)(2006-3#1)(2008-10#6)(2008-2#1)
retracting this article##3##3##(2008-10#3)
retracting##6##1##(1992-1#1)(2006-8#1)(2008-10#3)(2008-8#1)
retraction and##6##2##(1997-6#2)(2005-7#1)(2007-10#1)(2008-4#1)(2013-1#1)
retraction for##3##2##(1990-3#1)(2005-9#1)(2006-12#1)
retraction is##2##2##(2005-11#1)(2008-7#1)
retraction mechanism##2##2##(2005-11#2)
retraction mode##2##2##(2007-1#2)
retraction of the##10##3##(1990-3#1)(1994-9#2)(2006-10#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2013-7#1)
retraction of##17##2##(1990-3#1)(1992-11#1)(1994-9#2)(1995-12#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-10#1)(2011-2#1)(2013-7#1)
retraction suture##2##2##(2013-7#2)
retraction syndrome with##2##3##(2011-1#2)
retraction was##2##2##(2007-8#1)(2008-11#1)
retraction##61##1##(1990-3#2)(1991-3#1)(1991-8#1)(1991-9#1)(1992-11#1)(1994-11#2)(1994-9#2)(1995-12#1)(1996-1#1)(1997-4#1)(1997-6#2)(2005-11#4)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#3)(2006-4#2)(2006-5#1)(2006-6#1)(2007-1#2)(2007-10#1)(2007-12#2)(2007-8#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#2)(2008-7#3)(2008-8#1)(2009-2#1)(2009-8#1)(2010-10#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#3)
retractions##2##1##(1996-1#2)
retractor muscle of##2##3##(1990-2#1)(1991-7#1)
retractor##11##1##(1990-2#1)(1991-3#1)(1991-7#1)(1992-1#4)(2007-1#1)(2007-4#2)(2007-8#1)
retracts##2##1##(2007-12#1)(2008-7#1)
retrained as##3##2##(1993-7#1)(2008-5#2)
retrained##5##1##(1991-1#1)(1992-3#1)(1993-7#1)(2008-5#2)
retraining of##2##2##(1995-5#1)(2011-2#1)
retraining##10##1##(1995-1#1)(1995-5#1)(2007-6#1)(2007-8#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-1#3)
retransfusion of##2##2##(1990-2#1)(2005-11#1)
retransfusion##6##1##(1990-2#3)(2005-11#1)(2006-7#1)(2009-3#1)
retransplantation of##2##2##(1995-2#1)(2007-2#1)
retransplantation##11##1##(1995-2#4)(2006-10#2)(2007-2#1)(2007-8#1)(2008-4#1)(2008-8#1)(2011-2#1)
retransplanted##4##1##(1995-2#3)(2007-8#1)
retreat##8##1##(1991-3#4)(1993-3#1)(1994-1#1)(2006-2#1)(2008-6#1)
retreatment of##4##2##(2011-2#1)(2012-12#1)(2013-1#2)
retreatment##10##1##(1997-4#1)(2007-11#2)(2011-2#3)(2012-12#1)(2013-1#2)(2013-7#1)
retreats##2##1##(1991-3#1)(2006-10#1)
retrenchment plan##2##2##(1996-1#2)
retrenchment##7##1##(1995-3#2)(1996-1#4)(2013-1#1)
retrenchment)##2##1##(1995-3#2)
retrievability##2##1##(1994-3#1)(2008-3#1)
retrievable##4##1##(2007-10#1)(2008-10#2)(2011-2#1)
retrieval accuracy##2##2##(2008-2#1)(2008-3#1)
retrieval algorithm##7##2##(2007-12#1)(2008-2#4)(2008-3#2)
retrieval algorithms for##2##3##(2008-2#2)
retrieval algorithms##7##2##(2008-2#4)(2008-3#3)
retrieval and relearning##4##3##(1995-12#4)
retrieval and##17##2##(1995-12#4)(2007-2#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-3#1)(2011-3#1)(2012-12#1)(2013-1#2)
retrieval becomes##2##2##(2008-2#1)(2008-3#1)
retrieval by##5##2##(2007-11#1)(2007-12#1)(2008-2#2)(2013-7#1)
retrieval condition##2##2##(2009-1#2)
retrieval cues##2##2##(2009-2#2)
retrieval error##4##2##(2008-3#4)
retrieval errors##2##2##(2008-2#1)(2008-3#1)
retrieval for##8##2##(1997-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-2#1)(2008-3#2)(2012-11#1)
retrieval from##8##2##(1994-12#1)(2007-12#2)(2008-2#2)(2008-3#1)(2011-2#1)(2012-3#1)
retrieval in the##6##3##(1994-8#1)(2007-2#1)(2008-2#1)(2008-9#1)(2013-1#2)
retrieval in##10##2##(1994-8#1)(2007-2#1)(2008-2#2)(2008-3#2)(2008-9#1)(2011-2#1)(2013-1#2)
retrieval interference##2##2##(2007-12#1)(2008-1#1)
retrieval is accomplished##2##3##(2007-12#1)(2008-3#1)
retrieval is##9##2##(1995-8#1)(2007-12#1)(2008-2#1)(2008-3#5)(2013-8#1)
retrieval method##5##2##(1997-7#1)(2008-2#1)(2013-7#1)(2013-8#2)
retrieval mode##2##2##(1995-12#2)
retrieval of a more##2##4##(2010-8#2)
retrieval of a##4##3##(2008-7#1)(2010-8#2)(2012-3#1)
retrieval of aerosol##3##3##(2008-2#1)(2008-3#2)
retrieval of an##2##3##(2007-8#1)(2009-2#1)
retrieval of dilysine-tagged proteins##2##4##(1994-12#2)
retrieval of information from##3##4##(2006-3#1)(2008-4#2)
retrieval of information on the##2##5##(2007-12#1)(2008-3#1)
retrieval of information##6##3##(2006-3#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#2)
retrieval of profiles##2##3##(2008-2#1)(2008-3#1)
retrieval of such##4##3##(2008-11#1)(2008-3#1)(2013-1#2)
retrieval of temperature and##2##4##(2008-3#2)
retrieval of the absorption##2##4##(2008-3#2)
retrieval of the optical##2##4##(2007-12#1)(2008-3#1)
retrieval of the##19##3##(1993-12#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-2#4)(2008-3#8)(2008-7#1)(2009-7#1)
retrieval of these##2##3##(2008-2#1)(2008-3#1)
retrieval of urban##2##3##(2008-3#2)
retrieval of##106##2##(1990-6#1)(1991-8#2)(1992-11#1)(1993-12#3)(1993-6#1)(1994-12#2)(1995-3#1)(1996-8#1)(2005-8#1)(2006-3#1)(2007-1#1)(2007-11#3)(2007-12#9)(2007-5#1)(2007-7#2)(2007-8#2)(2008-11#2)(2008-2#22)(2008-3#28)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-8#2)(2011-1#2)(2012-3#1)(2013-1#4)(2013-8#1)
retrieval on the##2##3##(2008-2#1)(2008-3#1)
retrieval or##3##2##(1993-12#2)(2008-3#1)
retrieval performance##2##2##(2008-3#1)(2009-10#1)
retrieval process##3##2##(1991-8#1)(2008-3#1)(2010-8#1)
retrieval processes##3##2##(1995-12#1)(2009-10#1)(2010-8#1)
retrieval scheme##5##2##(2008-2#3)(2008-3#2)
retrieval software##2##2##(2008-3#2)
retrieval system for##2##3##(2007-11#1)(2008-5#1)
retrieval system##5##2##(1992-2#1)(1996-3#1)(2007-11#1)(2008-5#1)(2009-7#1)
retrieval systems##5##2##(1997-3#2)(2008-7#1)(2008-9#1)(2009-8#1)
retrieval technique##2##2##(2008-2#2)
retrieval techniques##3##2##(2008-11#1)(2008-2#1)(2008-9#1)
retrieval to##2##2##(1994-12#1)(2007-12#1)
retrieval using##2##2##(2007-11#1)(2007-7#1)
retrieval was achieved##2##3##(2008-3#1)(2012-12#1)
retrieval was##6##2##(1994-12#2)(2008-3#2)(2011-2#1)(2012-12#1)
retrieval when##2##2##(1993-3#1)(2007-12#1)
retrieval with##2##2##(2008-8#2)
retrieval##370##1##(1990-12#1)(1990-6#1)(1991-8#6)(1992-1#3)(1992-11#3)(1992-12#1)(1992-2#1)(1993-12#6)(1993-3#1)(1993-6#2)(1994-12#7)(1994-3#1)(1994-8#3)(1995-12#8)(1995-3#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-3#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#3)(1997-7#1)(2004-9#2)(2005-8#1)(2006-3#1)(2007-1#1)(2007-10#1)(2007-11#10)(2007-12#21)(2007-2#4)(2007-5#2)(2007-7#6)(2007-8#6)(2007-9#1)(2008-1#3)(2008-11#11)(2008-2#70)(2008-3#80)(2008-4#7)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#6)(2009-1#5)(2009-10#3)(2009-2#4)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#2)(2010-12#1)(2010-7#1)(2010-8#4)(2011-1#2)(2011-2#3)(2011-3#1)(2012-11#1)(2012-12#6)(2012-3#3)(2013-1#12)(2013-7#3)(2013-8#8)
retrievals and##2##2##(2008-2#1)(2008-3#1)
retrievals are##2##2##(2008-2#1)(2008-3#1)
retrievals by##3##2##(2008-2#2)(2008-3#1)
retrievals from##3##2##(2008-2#1)(2008-3#2)
retrievals of the##5##3##(2008-2#3)(2008-3#2)
retrievals of##13##2##(2008-2#6)(2008-3#7)
retrievals over##2##2##(2008-3#2)
retrievals with an accuracy of better than##2##7##(2008-2#2)
retrievals with##3##2##(2008-2#3)
retrievals##43##1##(1992-12#1)(2008-2#22)(2008-3#20)
retrieve a set of##2##4##(2008-8#2)
retrieve a##5##2##(1995-6#1)(2008-2#2)(2008-8#2)
retrieve all##3##2##(1990-12#1)(2008-7#1)(2010-6#1)
retrieve the aerosol##2##3##(2008-2#2)
retrieve the##29##2##(1993-12#1)(1997-3#1)(2008-2#8)(2008-3#10)(2008-4#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
retrieve##81##1##(1990-12#2)(1991-1#1)(1993-12#2)(1993-7#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-1#1)(1997-3#1)(2005-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#17)(2008-3#24)(2008-4#1)(2008-7#5)(2008-8#3)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#7)
retrieved aerosol parameters##2##3##(2008-3#2)
retrieved aerosol##5##2##(2008-2#2)(2008-3#3)
retrieved and rated##2##3##(2010-8#2)
retrieved and##8##2##(1991-9#1)(2006-8#1)(2008-11#1)(2010-8#2)(2011-3#1)(2012-12#1)(2013-1#1)
retrieved at##4##2##(1993-11#1)(2008-10#1)(2008-3#1)(2011-2#1)
retrieved by the##4##3##(2008-2#2)(2008-3#2)
retrieved by##13##2##(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-7#1)
retrieved cloud optical thicknesses from##2##5##(2008-2#2)
retrieved data##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
retrieved for##3##2##(2010-12#1)(2011-11#1)(2013-1#1)
retrieved from our##3##3##(2011-2#1)(2013-1#2)
retrieved from the##18##3##(2004-2#1)(2006-10#2)(2006-8#1)(2007-12#3)(2008-11#1)(2008-2#3)(2008-3#5)(2011-12#1)(2012-1#1)
retrieved from##35##2##(1991-4#1)(1995-3#1)(2004-2#1)(2006-10#3)(2006-8#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#9)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
retrieved geophysical parameters##2##3##(2008-3#2)
retrieved images##2##2##(2007-12#1)(2008-3#1)
retrieved in##4##2##(2008-10#1)(2008-11#1)(2009-6#1)(2013-8#1)
retrieved ocean##2##2##(2008-3#2)
retrieved profiles##3##2##(2008-3#3)
retrieved through##4##2##(2008-3#1)(2008-4#2)(2012-2#1)
retrieved under##2##2##(2008-2#1)(2008-3#1)
retrieved with a##2##3##(2007-11#1)(2008-3#1)
retrieved with the##2##3##(2008-3#2)
retrieved with##11##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#6)
retrieved without##2##2##(2008-3#1)(2008-4#1)
retrieved##188##1##(1990-12#1)(1991-4#1)(1991-9#1)(1993-11#1)(1994-3#3)(1995-3#1)(2004-10#1)(2004-2#1)(2004-9#1)(2005-11#1)(2006-10#4)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#14)(2007-7#1)(2008-1#3)(2008-10#5)(2008-11#4)(2008-2#32)(2008-3#54)(2008-4#5)(2008-7#2)(2008-8#2)(2008-9#2)(2009-2#1)(2009-5#1)(2009-6#1)(2010-12#5)(2010-8#2)(2010-9#1)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#12)(2013-8#5)
retriever##5##1##(2013-8#5)
retrieves the##2##2##(2008-3#2)
retrieves##4##1##(1990-6#1)(2008-3#3)
retrieving the##12##2##(2007-12#2)(2008-2#3)(2008-3#5)(2008-4#2)
retrieving##39##1##(1992-12#1)(1993-2#2)(1993-6#1)(1994-3#2)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-2#10)(2008-3#9)(2008-4#2)(2008-6#1)(2008-8#1)(2009-12#1)(2013-1#4)
retro##2##1##(2008-6#1)(2008-7#1)
retro-orbital pain##3##2##(1994-9#1)(2008-4#1)(2013-8#1)
retro-orbital##5##1##(1994-9#1)(2008-11#2)(2008-4#1)(2013-8#1)
retro-portal##2##1##(2012-2#2)
retroactive##2##1##(1992-8#1)(1995-9#1)
retroauricular##7##1##(2008-7#3)(2008-9#2)(2013-8#2)
retrobulbar space##2##2##(2008-10#1)(2009-2#1)
retrobulbar##3##1##(2006-1#1)(2008-10#1)(2009-2#1)
retrocalcaneal##3##1##(2008-8#2)(2009-10#1)
retroelement##3##1##(1995-12#1)(2008-10#1)(2012-2#1)
retroelements##4##1##(1991-12#1)(1995-12#1)(2008-10#1)(2008-5#1)
retroesophageal##2##1##(2008-11#1)(2011-3#1)
retrofitting##4##1##(1996-4#1)(2012-12#3)
retrograde amnesia##8##2##(1992-10#2)(2008-7#1)(2008-9#5)
retrograde and anterograde##3##3##(1990-11#1)(1990-7#1)(2012-12#1)
retrograde and##4##2##(1990-11#1)(1990-7#1)(2007-9#1)(2012-12#1)
retrograde axonal tracing##2##3##(1996-11#1)(1996-9#1)
retrograde axonal transport of horseradish peroxidase##2##6##(2009-2#2)
retrograde axonal transport of##4##4##(1996-2#1)(1996-3#1)(2009-2#2)
retrograde axonal transport##5##3##(1996-2#1)(1996-3#1)(2008-7#1)(2009-2#2)
retrograde axonal##8##2##(1996-11#1)(1996-2#1)(1996-3#1)(1996-9#1)(2007-12#1)(2008-7#1)(2009-2#2)
retrograde balloon dilatation##2##3##(2013-1#2)
retrograde blood microcardioplegia##2##3##(2013-1#2)
retrograde cardioplegia##3##2##(2007-8#1)(2007-9#1)(2013-1#1)
retrograde cell##2##2##(1991-5#1)(1993-7#1)
retrograde cerebral perfusion (RCP)##2##4##(2007-8#2)
retrograde cerebral perfusion##10##3##(2007-8#9)(2008-8#1)
retrograde cerebral##11##2##(2007-8#10)(2008-8#1)
retrograde cholangiography##4##2##(2005-12#1)(2006-10#2)(2010-5#1)
retrograde cholangiopancreatography (ERCP)##6##3##(2007-2#1)(2007-3#1)(2007-5#3)(2013-1#1)
retrograde cholangiopancreatography in##2##3##(1991-4#1)(2006-10#1)
retrograde cholangiopancreatography##19##2##(1991-4#1)(1992-5#1)(2006-10#4)(2006-6#2)(2007-10#1)(2007-2#1)(2007-3#2)(2007-5#4)(2008-3#1)(2013-1#1)(2013-8#1)
retrograde degeneration##2##2##(1991-10#1)(1995-6#1)
retrograde ejaculation##5##2##(2006-4#1)(2006-8#1)(2011-2#3)
retrograde flow##4##2##(2007-8#3)(2008-9#1)
retrograde fluorescent##3##2##(1991-9#1)(1992-8#1)(1993-5#1)
retrograde labeling##3##2##(1990-5#1)(1991-12#1)(1995-5#1)
retrograde labelling##5##2##(1992-8#1)(1996-1#1)(1996-3#2)(1996-5#1)
retrograde messengers##2##2##(1995-5#1)(2008-7#1)
retrograde neuronal##2##2##(1994-12#1)(1996-11#1)
retrograde pyelography##5##2##(1991-10#1)(2007-7#1)(2008-7#3)
retrograde survival signals from the##2##5##(1996-1#2)
retrograde tracer##9##2##(1990-11#1)(1992-12#1)(1993-12#1)(1994-2#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-9#1)(2010-10#1)
retrograde tracers##2##2##(1990-5#1)(1996-5#1)
retrograde tracing and##2##3##(1990-5#1)(1994-12#1)
retrograde tracing techniques##2##3##(1996-9#1)(2010-10#1)
retrograde tracing##7##2##(1990-5#1)(1991-9#1)(1994-12#1)(1995-10#1)(1995-7#1)(1996-9#1)(2010-10#1)
retrograde traffic##2##2##(2009-2#2)
retrograde transport of##5##3##(1990-7#1)(1991-8#1)(1997-2#1)(1997-6#1)(2008-7#1)
retrograde transport##14##2##(1990-7#1)(1991-12#2)(1991-8#1)(1995-8#2)(1996-12#1)(1997-2#1)(1997-6#1)(2008-1#3)(2008-4#1)(2008-7#1)
retrograde transvenous##4##2##(2006-12#1)(2009-9#1)(2013-1#2)
retrograde urethrography##2##2##(1990-4#1)(1994-7#1)
retrograde##203##1##(1990-11#2)(1990-4#2)(1990-5#3)(1990-7#2)(1991-10#2)(1991-11#1)(1991-12#4)(1991-3#1)(1991-4#2)(1991-5#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#2)(1992-12#1)(1992-5#1)(1992-8#2)(1993-12#3)(1993-5#1)(1993-7#3)(1994-12#3)(1994-2#1)(1994-4#1)(1994-7#1)(1995-10#1)(1995-11#1)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#2)(1996-1#5)(1996-11#3)(1996-12#2)(1996-2#3)(1996-3#4)(1996-5#2)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-12#1)(2006-10#8)(2006-12#2)(2006-4#1)(2006-6#5)(2006-8#1)(2007-10#3)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#3)(2007-5#4)(2007-7#4)(2007-8#22)(2007-9#4)(2008-1#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#5)(2008-7#8)(2008-8#1)(2008-9#6)(2009-2#7)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#11)(2013-8#1)
retrogradely labeled neurons##2##3##(1995-10#1)(1995-6#1)
retrogradely labeled preganglionic##3##3##(1992-1#3)
retrogradely labeled##16##2##(1990-7#1)(1991-12#1)(1992-1#8)(1994-12#1)(1994-2#1)(1995-10#2)(1995-6#1)(1996-11#1)
retrogradely labelled##6##2##(1991-9#1)(1992-8#1)(1994-12#1)(1997-2#1)(1997-6#2)
retrogradely transported##10##2##(1990-5#1)(1991-12#2)(1993-12#1)(1995-12#1)(1995-8#1)(1996-12#2)(1996-3#2)
retrogradely with##2##2##(1997-1#1)(1997-3#1)
retrogradely##43##1##(1990-5#1)(1990-7#1)(1991-12#4)(1991-6#1)(1991-9#1)(1992-1#8)(1992-8#1)(1993-12#1)(1994-12#3)(1994-2#2)(1994-5#1)(1995-10#2)(1995-12#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#5)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#2)(2007-8#1)
retrolabyrinthine approach##3##2##(2006-11#1)(2006-5#2)
retrolabyrinthine##4##1##(2006-11#2)(2006-5#2)
retromer##4##1##(2012-12#4)
retron EC83##2##2##(1997-6#2)
retron##4##1##(1997-6#2)(2010-12#2)
retropatellar crepitus##2##2##(2011-2#2)
retropatellar##5##1##(2007-4#1)(2008-9#2)(2011-2#2)
retroperitoneal ESS##2##2##(2009-5#2)
retroperitoneal approach was##3##3##(1992-8#2)(2007-7#1)
retroperitoneal approach##12##2##(1992-8#5)(2006-10#1)(2006-8#2)(2007-7#1)(2008-10#1)(2012-12#2)
retroperitoneal benign##2##2##(2012-3#1)(2013-1#1)
retroperitoneal dissection##3##2##(1994-3#2)(2006-6#1)
retroperitoneal fibrosis associated with generalized atherosclerosis##2##6##(2008-1#2)
retroperitoneal fibrosis##6##2##(2008-1#3)(2009-8#2)(2013-1#1)
retroperitoneal hemangiopericytoma##2##2##(1993-6#2)
retroperitoneal hematoma##2##2##(2007-2#1)(2013-1#1)
retroperitoneal laparoscopic pyelolithotomy##2##3##(2006-6#2)
retroperitoneal laparoscopic##6##2##(2006-6#5)(2013-1#1)
retroperitoneal liposarcoma##4##2##(1990-9#2)(2008-1#1)(2009-9#1)
retroperitoneal lymph nodes##3##3##(2008-4#1)(2008-6#1)(2008-7#1)
retroperitoneal lymph##4##2##(1995-5#1)(2008-4#1)(2008-6#1)(2008-7#1)
retroperitoneal malignant schwannoma##2##3##(1994-6#2)
retroperitoneal malignant##3##2##(1994-6#3)
retroperitoneal mass##4##2##(2009-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
retroperitoneal sarcoma##7##2##(2007-8#1)(2008-6#6)
retroperitoneal sarcomas##4##2##(2006-6#2)(2008-6#2)
retroperitoneal soft tissue sarcomas is##2##5##(1992-12#1)(2006-6#1)
retroperitoneal soft tissue sarcomas##5##4##(1992-12#3)(2006-6#2)
retroperitoneal soft tissue##6##3##(1992-12#3)(1994-7#1)(2006-6#2)
retroperitoneal space##5##2##(2006-6#1)(2008-10#1)(2008-8#1)(2012-3#1)(2013-1#1)
retroperitoneal tumor##5##2##(1990-6#1)(2008-5#2)(2008-6#2)
retroperitoneal tumors of the pelvic##2##5##(1990-5#2)
retroperitoneal tumors##5##2##(1990-5#2)(2008-5#1)(2008-6#1)(2013-1#1)
retroperitoneal undifferentiated##3##2##(2008-5#1)(2009-5#2)
retroperitoneal##126##1##(1990-5#2)(1990-6#2)(1990-9#3)(1992-12#3)(1992-8#6)(1993-6#2)(1994-3#3)(1994-6#4)(1994-7#1)(1995-5#1)(1996-6#1)(2006-10#1)(2006-6#13)(2006-8#3)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#4)(2008-1#4)(2008-10#6)(2008-4#2)(2008-5#4)(2008-6#17)(2008-7#1)(2008-8#4)(2009-4#1)(2009-5#4)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#1)(2011-2#6)(2012-12#4)(2012-2#3)(2012-3#5)(2013-1#7)
retroperitoneoscopic approach##2##2##(2008-10#2)
retroperitoneoscopic nephrectomy##2##2##(2006-6#1)(2008-10#1)
retroperitoneoscopic##10##1##(2006-6#1)(2008-10#4)(2012-12#5)
retroperitoneum in##2##2##(2009-1#1)(2009-7#1)
retroperitoneum is##2##2##(1992-12#1)(2008-6#1)
retroperitoneum were##2##2##(2006-8#1)(2009-2#1)
retroperitoneum##25##1##(1992-12#3)(1993-6#1)(2006-8#1)(2007-2#1)(2008-6#5)(2009-1#1)(2009-2#1)(2009-7#2)(2009-9#1)(2010-12#3)(2012-3#5)(2013-1#1)
retropharyngeal##3##1##(2006-6#2)(2008-12#1)
retropubic periosteum##2##2##(1990-12#1)(1996-12#1)
retropubic prostatectomy##5##2##(2006-10#1)(2006-9#1)(2007-11#1)(2008-1#1)(2013-1#1)
retropubic radical prostatectomy##2##3##(2007-3#1)(2012-2#1)
retropubic##12##1##(1990-12#1)(1996-12#3)(1996-9#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-3#1)(2008-1#1)(2012-2#1)(2013-1#1)
retrorectal##4##1##(2009-3#3)(2010-5#1)
retroreflected beams##2##2##(2008-2#2)
retroreflected##5##1##(2007-12#1)(2008-2#3)(2008-3#1)
retroreflecting##2##1##(2008-2#1)(2008-3#1)
retroreflection##2##1##(2008-3#2)
retroreflective##7##1##(2008-2#2)(2008-3#3)(2011-2#1)(2013-1#1)
retroreflector##9##1##(2008-2#1)(2008-3#8)
retroreflectors are##2##2##(2008-3#2)
retroreflectors##7##1##(2008-3#7)
retrosigmoid##7##1##(2006-11#2)(2006-12#1)(2006-5#2)(2011-2#2)
retrospect##5##1##(1990-6#1)(2006-4#1)(2006-5#1)(2007-8#1)(2008-7#1)
retrospective 6-year##2##2##(2008-7#1)(2012-2#1)
retrospective accounts of##2##3##(2008-12#1)(2009-6#1)
retrospective analyses##4##2##(2006-11#1)(2006-5#1)(2007-4#1)(2011-2#1)
retrospective analysis of 24 consecutive patients##2##6##(2006-11#1)(2008-9#1)
retrospective analysis of 24##3##4##(2006-11#1)(2007-3#1)(2008-9#1)
retrospective analysis of a##2##4##(2007-8#1)(2009-8#1)
retrospective analysis of all##3##4##(1993-11#1)(2007-2#1)(2011-2#1)
retrospective analysis of clinical##2##4##(2008-3#1)(2010-2#1)
retrospective analysis of our experience##2##5##(1993-10#1)(2008-1#1)
retrospective analysis of our##3##4##(1991-12#1)(1993-10#1)(2008-1#1)
retrospective analysis of the clinical##3##5##(1993-11#1)(2007-3#2)
retrospective analysis of the effectiveness##2##5##(2011-12#1)(2013-1#1)
retrospective analysis of the##13##4##(1992-5#1)(1993-11#1)(1996-9#1)(2005-12#1)(2007-3#2)(2007-7#3)(2008-1#1)(2011-12#1)(2013-1#2)
retrospective analysis of##95##3##(1990-6#1)(1990-9#1)(1991-12#1)(1992-4#1)(1992-5#1)(1993-10#1)(1993-11#2)(1993-9#1)(1994-12#1)(1994-4#1)(1996-11#1)(1996-9#1)(1997-3#1)(1997-8#1)(2004-10#1)(2005-10#1)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#2)(2006-12#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-12#2)(2007-2#1)(2007-3#3)(2007-7#5)(2007-8#7)(2007-9#2)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-8#1)(2010-2#1)(2010-3#2)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#4)(2013-1#6)(2013-7#1)(2013-8#4)
retrospective analysis showed that the##2##5##(1992-11#1)(2008-5#1)
retrospective analysis was performed##4##4##(2006-12#1)(2006-6#1)(2006-7#1)(2008-6#1)
retrospective analysis was##13##3##(1995-11#1)(2005-8#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-6#1)(2008-6#2)(2008-9#1)(2011-2#2)(2012-12#1)
retrospective analysis##140##2##(1990-6#1)(1990-9#1)(1991-12#1)(1992-11#1)(1992-4#1)(1992-5#1)(1993-10#1)(1993-11#2)(1993-2#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-4#1)(1994-6#1)(1995-11#1)(1996-11#2)(1996-9#1)(1997-3#1)(1997-8#1)(2004-10#1)(2005-10#1)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#2)(2006-10#3)(2006-11#3)(2006-12#3)(2006-2#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#3)(2007-6#1)(2007-7#5)(2007-8#9)(2007-9#2)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#4)(2008-8#2)(2008-9#3)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#3)(2010-7#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#4)
retrospective and multicentre study##2##4##(2011-2#2)
retrospective and prospective study was##2##5##(2012-12#1)(2013-8#1)
retrospective and prospective study##6##4##(1992-12#1)(1995-2#1)(2008-4#1)(2009-2#1)(2012-12#1)(2013-8#1)
retrospective and prospective##8##3##(1992-12#1)(1993-10#1)(1995-2#1)(2008-4#1)(2008-8#1)(2009-2#1)(2012-12#1)(2013-8#1)
retrospective and##15##2##(1992-12#1)(1993-10#1)(1995-2#1)(2006-2#1)(2007-11#1)(2008-4#2)(2008-8#1)(2009-2#2)(2011-2#3)(2012-12#1)(2013-8#1)
retrospective approach##3##2##(2006-10#1)(2008-11#2)
retrospective assessment of##2##3##(2008-7#2)
retrospective assessment##3##2##(1991-2#1)(2008-7#2)
retrospective case series##9##3##(2006-12#1)(2006-2#1)(2007-10#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
retrospective case##13##2##(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
retrospective chart review of##10##4##(1991-12#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2013-1#1)
retrospective chart review was##3##4##(2008-7#1)(2010-8#1)(2011-2#1)
retrospective chart review##27##3##(1991-12#1)(1995-2#1)(2006-10#1)(2006-2#1)(2006-8#2)(2006-9#1)(2007-10#3)(2007-2#2)(2007-3#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-7#3)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
retrospective chart##28##2##(1991-12#1)(1994-3#1)(1995-2#1)(2006-10#1)(2006-2#1)(2006-8#2)(2006-9#1)(2007-10#3)(2007-2#2)(2007-3#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-7#3)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
retrospective clinical analysis##2##3##(2005-9#1)(2007-11#1)
retrospective clinical study of##2##4##(2010-5#1)(2012-3#1)
retrospective clinical study##3##3##(2008-5#1)(2010-5#1)(2012-3#1)
retrospective clinical##6##2##(2005-9#1)(2007-11#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-3#1)
retrospective cohort analysis##3##3##(1996-11#1)(2012-2#1)(2013-8#1)
retrospective cohort study in##2##4##(2012-1#1)(2013-1#1)
retrospective cohort study##23##3##(1996-2#1)(2006-8#1)(2007-10#3)(2008-5#1)(2008-8#3)(2009-2#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#3)(2013-7#1)
retrospective cohort##28##2##(1996-11#1)(1996-2#1)(2006-8#1)(2007-10#3)(2008-5#1)(2008-8#3)(2008-9#1)(2009-2#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
retrospective comparison of##4##3##(1992-9#1)(2007-8#1)(2008-9#1)(2013-8#1)
retrospective cross sectional study##2##4##(2007-12#1)(2011-2#1)
retrospective data analysis##4##3##(2006-5#1)(2007-7#1)(2008-6#1)(2011-2#1)
retrospective data##17##2##(1994-6#1)(2006-10#1)(2006-5#5)(2007-7#1)(2007-8#1)(2008-5#1)(2008-6#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
retrospective database##2##2##(2009-10#1)(2013-1#1)
retrospective descriptive study of##3##4##(2007-7#1)(2012-12#1)(2012-2#1)
retrospective descriptive study##5##3##(2007-7#1)(2008-1#1)(2012-12#1)(2012-2#2)
retrospective descriptive##6##2##(2006-8#1)(2007-7#1)(2008-1#1)(2012-12#1)(2012-2#2)
retrospective design##2##2##(1993-2#1)(2006-2#1)
retrospective evaluation from a##2##4##(2007-8#1)(2012-12#1)
retrospective evaluation of##5##3##(1993-6#1)(2007-11#1)(2010-9#1)(2011-1#1)(2011-2#1)
retrospective evaluation##9##2##(1992-3#1)(1993-6#1)(2006-8#1)(2007-11#1)(2007-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
retrospective evaluations##3##2##(2006-8#3)
retrospective hospital##2##2##(1991-3#1)(2011-1#1)
retrospective investigation##2##2##(1991-9#1)(2008-7#1)
retrospective medical record##3##3##(2007-10#1)(2008-11#1)(2013-1#1)
retrospective medical##5##2##(2007-10#1)(2008-11#1)(2010-4#1)(2012-3#1)(2013-1#1)
retrospective multicenter study##3##3##(2008-4#1)(2010-6#1)(2012-2#1)
retrospective nature of##2##3##(1996-6#1)(2009-8#1)
retrospective nature##3##2##(1993-8#1)(1996-6#1)(2009-8#1)
retrospective observational study##3##3##(2007-9#1)(2008-3#1)(2009-2#1)
retrospective observational##4##2##(2007-9#1)(2008-3#1)(2009-2#1)(2013-1#1)
retrospective on##3##2##(2007-4#1)(2009-12#1)(2009-9#1)
retrospective qualitative study##2##3##(2006-2#1)(2008-11#1)
retrospective record review##3##3##(2006-10#1)(2009-7#1)(2012-2#1)
retrospective research##2##2##(2009-2#1)(2011-1#1)
retrospective review of a##2##4##(2010-8#1)(2013-1#1)
retrospective review of cases##3##4##(2008-1#2)(2011-11#1)
retrospective review of the medical records##2##6##(2008-6#1)(2008-9#1)
retrospective review of the##7##4##(2004-10#1)(2005-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-12#1)(2012-2#1)
retrospective review of##41##3##(1994-2#1)(1994-8#1)(1995-12#1)(1997-8#1)(2004-10#1)(2005-10#2)(2006-10#2)(2006-12#1)(2007-3#2)(2007-7#1)(2007-8#1)(2008-1#5)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-11#1)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#2)(2013-8#1)
retrospective review was made of##3##5##(1996-1#1)(2005-10#1)(2006-2#1)
retrospective review was performed of##2##5##(2008-6#1)(2008-9#1)
retrospective review was performed##3##4##(2008-6#1)(2008-9#1)(2009-10#1)
retrospective review was##7##3##(1996-1#1)(2005-10#1)(2006-2#1)(2008-6#1)(2008-9#1)(2009-10#1)(2012-3#1)
retrospective review##65##2##(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-9#1)(1996-1#1)(1997-8#1)(2004-10#1)(2005-10#3)(2005-12#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-6#1)(2007-3#2)(2007-7#2)(2007-8#2)(2008-1#5)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-11#1)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#2)
retrospective series of##4##3##(1990-12#1)(1993-11#1)(2004-2#1)(2009-5#1)
retrospective series##6##2##(1990-12#1)(1993-11#1)(1994-6#1)(2004-2#1)(2009-5#1)(2013-1#1)
retrospective studies and##4##3##(2005-10#1)(2009-10#1)(2010-12#1)(2012-3#1)
retrospective studies of##6##3##(1991-11#1)(1992-4#1)(1994-11#1)(1996-6#1)(2005-10#1)(2005-12#1)
retrospective studies with a##2##4##(2006-10#1)(2011-2#1)
retrospective studies##18##2##(1991-11#2)(1992-4#1)(1994-11#1)(1996-6#1)(2005-10#2)(2005-12#1)(2006-10#1)(2006-2#1)(2006-8#1)(2008-7#1)(2009-10#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-3#1)
retrospective study in##3##3##(1992-5#1)(2007-8#1)(2009-10#1)
retrospective study included##4##3##(2006-5#1)(2007-11#1)(2007-8#2)
retrospective study involving##2##3##(2011-11#1)(2011-2#1)
retrospective study is to##2##4##(2008-11#1)(2011-1#1)
retrospective study is##3##3##(1997-5#1)(2008-11#1)(2011-1#1)
retrospective study of all##2##4##(1995-1#1)(2011-1#1)
retrospective study of patients##3##4##(1993-11#1)(2006-11#1)(2008-9#1)
retrospective study of the##8##4##(1990-8#1)(1991-4#1)(1993-10#1)(2007-7#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-3#1)
retrospective study of##60##3##(1990-3#2)(1990-8#1)(1990-9#1)(1991-2#1)(1991-4#1)(1993-1#1)(1993-10#2)(1993-11#1)(1993-5#1)(1993-8#1)(1995-1#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-3#1)(2004-10#1)(2004-3#2)(2004-7#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-2#2)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#2)(2010-10#1)(2010-11#1)(2010-12#2)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
retrospective study on##3##3##(1992-4#1)(2009-10#1)(2009-9#1)
retrospective study showed##2##3##(1992-4#1)(2008-7#1)
retrospective study shows##2##3##(2007-7#1)(2008-6#1)
retrospective study that##4##3##(2011-2#2)(2012-3#1)(2013-1#1)
retrospective study the results of##2##5##(1993-8#1)(2006-7#1)
retrospective study the##4##3##(1993-8#1)(1996-11#1)(1996-6#1)(2006-7#1)
retrospective study to determine##3##4##(2008-11#1)(2010-8#1)(2011-2#1)
retrospective study to##6##3##(2004-10#2)(2007-7#1)(2008-11#1)(2010-8#1)(2011-2#1)
retrospective study was carried out##6##5##(1991-8#2)(2007-9#1)(2011-2#2)(2012-2#1)
retrospective study was conducted in##2##5##(2006-5#1)(2011-1#1)
retrospective study was conducted on##5##5##(1995-10#1)(2007-2#2)(2007-3#1)(2011-2#1)
retrospective study was conducted##9##4##(1995-10#1)(2006-5#1)(2007-2#2)(2007-3#1)(2007-6#1)(2011-1#1)(2011-2#1)(2012-12#1)
retrospective study was done##2##4##(1997-8#1)(2006-2#1)
retrospective study was performed on##2##5##(1990-6#1)(2010-3#1)
retrospective study was performed##3##4##(1990-6#1)(2007-8#1)(2010-3#1)
retrospective study was undertaken##4##4##(1990-10#1)(1990-12#1)(1996-1#1)(2008-9#1)
retrospective study was##38##3##(1990-10#1)(1990-12#1)(1990-6#1)(1991-8#2)(1992-12#1)(1993-2#1)(1995-10#1)(1996-1#1)(1997-8#1)(2006-2#1)(2006-5#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-3#1)(2008-9#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)
retrospective study we##4##3##(1990-7#1)(1996-11#1)(1997-2#1)(2013-7#1)
retrospective study were to##2##4##(2012-3#1)(2013-1#1)
retrospective study##234##2##(1990-10#2)(1990-12#1)(1990-3#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-4#2)(1991-8#2)(1992-12#1)(1992-4#2)(1992-5#1)(1993-1#1)(1993-10#2)(1993-11#1)(1993-2#1)(1993-4#1)(1993-5#3)(1993-6#1)(1993-8#3)(1994-8#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#3)(1996-3#1)(1996-6#1)(1997-2#1)(1997-5#2)(1997-8#1)(2004-1#1)(2004-10#3)(2004-3#2)(2004-7#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-2#2)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-2#5)(2007-3#7)(2007-5#1)(2007-6#5)(2007-7#11)(2007-8#20)(2007-9#2)(2008-1#3)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#5)(2009-1#1)(2009-10#5)(2009-3#3)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#6)(2011-11#1)(2011-12#2)(2011-2#22)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#7)(2013-1#9)(2013-7#2)(2013-8#2)
retrospective study]##3##2##(1991-9#1)(1994-8#1)(1996-4#1)
retrospective survey of##5##3##(1990-12#1)(1992-8#1)(1996-4#1)(2006-10#1)(2007-7#1)
retrospective survey##9##2##(1990-12#1)(1990-8#1)(1991-8#1)(1992-8#1)(1996-4#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-9#1)
retrospective##744##1##(1990-10#2)(1990-12#4)(1990-3#2)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#2)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#2)(1991-8#3)(1991-9#2)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#4)(1992-5#3)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#4)(1993-11#5)(1993-2#3)(1993-4#1)(1993-5#3)(1993-6#2)(1993-7#1)(1993-8#4)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-4#1)(1994-6#3)(1994-8#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#2)(1995-9#2)(1996-1#2)(1996-11#7)(1996-2#1)(1996-3#1)(1996-4#2)(1996-6#3)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#3)(1997-7#1)(1997-8#3)(2004-1#1)(2004-10#7)(2004-2#1)(2004-3#2)(2004-7#1)(2005-10#6)(2005-12#3)(2005-5#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#25)(2006-11#5)(2006-12#7)(2006-2#11)(2006-4#2)(2006-5#11)(2006-6#3)(2006-7#2)(2006-8#14)(2006-9#2)(2007-1#2)(2007-10#11)(2007-11#9)(2007-12#3)(2007-2#12)(2007-3#13)(2007-4#4)(2007-5#1)(2007-6#6)(2007-7#24)(2007-8#37)(2007-9#7)(2008-1#13)(2008-10#5)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#7)(2008-4#7)(2008-5#9)(2008-6#12)(2008-7#19)(2008-8#10)(2008-9#18)(2009-1#1)(2009-10#8)(2009-12#1)(2009-2#7)(2009-3#3)(2009-4#2)(2009-5#4)(2009-6#2)(2009-7#2)(2009-8#5)(2009-9#6)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#6)(2010-2#3)(2010-3#6)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#5)(2010-9#3)(2011-1#16)(2011-11#2)(2011-12#3)(2011-2#48)(2012-1#3)(2012-12#20)(2012-2#24)(2012-3#19)(2013-1#37)(2013-7#5)(2013-8#15)
retrospectively analysed the records of##2##5##(2010-9#1)(2012-2#1)
retrospectively analysed the##6##3##(1991-3#1)(1997-4#1)(2007-8#1)(2010-9#1)(2012-2#1)(2013-1#1)
retrospectively analysed##13##2##(1991-3#1)(1995-5#1)(1996-5#1)(1997-4#1)(2006-8#1)(2007-8#1)(2008-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
retrospectively analyzed the##4##3##(1993-2#1)(2007-7#1)(2007-8#1)(2012-12#1)
retrospectively analyzed##27##2##(1993-2#1)(1993-5#1)(2004-1#1)(2004-3#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-2#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#1)
retrospectively and the##2##3##(1997-8#1)(2013-1#1)
retrospectively and##7##2##(1990-9#1)(1995-2#1)(1997-8#2)(2010-8#1)(2011-1#1)(2013-1#1)
retrospectively assessed##4##2##(2006-7#1)(2006-8#1)(2007-8#1)(2008-6#1)
retrospectively compared##4##2##(1993-3#1)(2004-1#1)(2013-1#2)
retrospectively diagnosed##2##2##(1990-6#1)(2013-8#1)
retrospectively enrolled##2##2##(2012-3#1)(2013-1#1)
retrospectively evaluate the##2##3##(2011-1#1)(2011-2#1)
retrospectively evaluate##3##2##(2011-1#1)(2011-2#1)(2012-1#1)
retrospectively evaluated on##2##3##(1992-10#1)(1997-1#1)
retrospectively evaluated the##3##3##(2006-10#1)(2006-11#1)(2011-2#1)
retrospectively evaluated##11##2##(1992-10#1)(1995-2#1)(1996-9#1)(1997-1#1)(2006-10#1)(2006-11#1)(2007-8#1)(2008-4#1)(2011-2#2)(2012-12#1)
retrospectively examined##4##2##(1997-8#1)(2005-8#1)(2006-6#1)(2011-2#1)
retrospectively for##5##2##(1990-11#1)(1997-2#1)(1997-8#1)(2008-6#1)(2012-3#1)
retrospectively from##3##2##(2006-8#1)(2007-9#1)(2008-12#1)
retrospectively identified##2##2##(2009-8#1)(2012-2#1)
retrospectively in##7##2##(1994-12#1)(1994-7#1)(1997-3#1)(2008-7#1)(2011-11#1)(2012-2#1)(2013-1#1)
retrospectively investigated the##3##3##(2006-12#2)(2013-8#1)
retrospectively investigated##5##2##(1990-12#1)(2006-12#2)(2008-7#1)(2013-8#1)
retrospectively review##2##2##(2007-7#1)(2008-6#1)
retrospectively reviewed the clinical records##2##5##(2006-12#1)(2007-7#1)
retrospectively reviewed the clinical##4##4##(2006-12#2)(2007-3#1)(2007-7#1)
retrospectively reviewed the records of##3##5##(2007-3#1)(2007-8#1)(2008-1#1)
retrospectively reviewed the records##4##4##(2005-10#1)(2007-3#1)(2007-8#1)(2008-1#1)
retrospectively reviewed the##13##3##(2005-10#1)(2006-12#2)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-5#1)(2008-6#1)
retrospectively reviewed to##6##3##(1992-9#1)(2006-1#1)(2007-7#1)(2008-6#1)(2012-2#1)(2012-3#1)
retrospectively reviewed##46##2##(1992-9#1)(1997-8#1)(2004-3#1)(2005-10#1)(2005-12#1)(2006-1#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-8#1)(2007-2#2)(2007-3#2)(2007-7#2)(2007-8#8)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#2)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
retrospectively studied##12##2##(1991-12#1)(1993-11#1)(1995-10#1)(2006-4#1)(2006-7#1)(2007-7#2)(2008-1#1)(2008-4#1)(2009-8#1)(2010-8#1)(2011-2#1)
retrospectively the##5##2##(1990-6#1)(2005-1#1)(2006-6#1)(2007-7#1)(2011-1#1)
retrospectively to##3##2##(1990-6#1)(1990-8#1)(2008-11#1)
retrospectively##243##1##(1990-1#1)(1990-11#1)(1990-12#1)(1990-6#4)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#3)(1993-8#1)(1994-12#1)(1994-7#1)(1995-10#2)(1995-2#3)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#6)(2004-1#2)(2004-10#1)(2004-3#2)(2005-1#1)(2005-10#2)(2005-12#1)(2005-5#1)(2005-8#2)(2006-1#1)(2006-10#7)(2006-11#1)(2006-12#6)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#6)(2007-10#1)(2007-2#4)(2007-3#4)(2007-7#11)(2007-8#19)(2007-9#2)(2008-1#4)(2008-11#1)(2008-12#3)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#6)(2008-7#6)(2009-10#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-8#5)(2010-9#1)(2011-1#7)(2011-11#1)(2011-2#12)(2012-1#3)(2012-12#4)(2012-2#7)(2012-3#11)(2013-1#15)(2013-8#4)
retrosplenial and##2##2##(1992-3#1)(1994-2#1)
retrosplenial cortex and##2##3##(1997-2#1)(2009-4#1)
retrosplenial cortex##6##2##(1991-11#1)(1995-7#3)(1997-2#1)(2009-4#1)
retrosplenial##10##1##(1991-11#1)(1992-3#1)(1994-2#1)(1995-7#3)(1996-9#1)(1997-2#1)(2008-9#1)(2009-4#1)
retrosternal defect of the diaphragm##2##5##(2012-1#2)
retrosternal pain and##2##3##(1996-9#1)(2007-9#1)
retrosternal pain##4##2##(1996-9#1)(2007-9#1)(2008-5#1)(2010-9#1)
retrosternal##9##1##(1996-9#1)(2005-12#1)(2007-9#1)(2008-5#1)(2010-9#1)(2011-1#2)(2012-1#2)
retrosternally##2##1##(1997-6#1)(2007-8#1)
retrotransposable elements include##2##3##(2008-8#2)
retrotransposable elements##4##2##(2008-8#4)
retrotransposed##3##1##(1996-11#3)
retrotransposition##6##1##(1991-12#1)(1993-5#2)(1996-11#2)(2009-10#1)
retrotransposon family##2##2##(1995-1#1)(1995-8#1)
retrotransposon##18##1##(1994-8#3)(1995-1#2)(1995-5#2)(1995-8#2)(2005-10#3)(2006-12#2)(2008-10#1)(2009-10#1)(2012-3#2)
retrotransposons in##2##2##(2006-12#2)
retrotransposons##10##1##(1995-1#1)(1995-8#2)(2006-12#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-2#1)
retrovaginal##2##1##(1990-6#1)(2012-2#1)
retrovascular##2##1##(2013-1#2)
retrovectors##2##1##(2005-6#2)
retroversion##2##1##(2011-2#1)(2012-2#1)
retroviral expression##5##2##(1991-12#1)(1994-12#1)(1994-8#1)(2007-6#1)(2010-3#1)
retroviral gene##2##2##(1990-8#1)(2008-11#1)
retroviral infection##3##2##(1995-5#1)(1996-4#1)(2007-7#1)
retroviral latency##2##2##(1995-2#1)(2012-12#1)
retroviral particles##3##2##(2007-6#2)(2008-11#1)
retroviral protease##2##2##(1993-9#1)(1994-6#1)
retroviral proteases##3##2##(1990-2#1)(1990-3#1)(1992-6#1)
retroviral proteins##2##2##(2007-6#2)
retroviral replication##6##2##(1990-11#1)(1995-2#3)(2007-3#1)(2011-3#1)
retroviral reverse##2##2##(1994-9#1)(2008-5#1)
retroviral vector in##4##3##(1994-3#1)(2008-11#3)
retroviral vector that##2##3##(1997-8#1)(2008-11#1)
retroviral vector##22##2##(1994-3#2)(1994-5#1)(1995-5#3)(1996-10#1)(1997-8#2)(2008-11#9)(2008-4#1)(2008-8#1)(2008-9#2)
retroviral vectors are##2##3##(1995-2#1)(2008-11#1)
retroviral vectors for##2##3##(1994-5#1)(2008-11#1)
retroviral vectors##13##2##(1992-8#1)(1994-5#1)(1995-1#1)(1995-2#1)(1996-1#1)(1997-8#2)(2008-11#5)(2012-12#1)
retroviral##106##1##(1990-11#3)(1990-2#2)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-5#1)(1992-6#1)(1992-8#1)(1993-2#2)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-2#6)(1995-3#1)(1995-5#4)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-4#1)(1997-3#2)(1997-8#4)(2005-10#1)(2006-12#2)(2006-7#1)(2007-3#1)(2007-6#8)(2007-7#1)(2008-10#1)(2008-11#20)(2008-4#7)(2008-5#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-7#1)(2010-3#1)(2011-3#1)(2012-12#2)(2012-3#1)
retroviral-mediated gene transfer##2##3##(1994-3#1)(1997-7#1)
retroviral-mediated##6##1##(1994-3#1)(1995-2#1)(1995-8#2)(1996-10#1)(1997-7#1)
retrovirally##3##1##(1991-5#1)(2012-12#2)
retrovirus by##2##2##(2008-11#2)
retrovirus carrying the##2##3##(2008-11#2)
retrovirus carrying##3##2##(1994-5#1)(2008-11#2)
retrovirus particles##6##2##(2008-11#6)
retrovirus vector##5##2##(1994-5#1)(1997-8#2)(2008-11#1)(2008-8#1)
retrovirus##52##1##(1990-5#1)(1990-9#1)(1991-12#2)(1991-7#2)(1992-9#2)(1994-11#1)(1994-5#3)(1995-1#1)(1995-2#1)(1995-5#2)(1996-4#1)(1997-8#2)(2005-10#1)(2007-6#1)(2008-11#19)(2008-4#1)(2008-5#2)(2008-8#2)(2009-10#3)(2009-6#1)(2010-10#1)(2012-12#2)
retrovirus-like element Ty3##2##3##(1997-7#2)
retrovirus-like##4##1##(1996-12#2)(1997-7#2)
retrovirus-mediated gene transfer##3##3##(1995-5#1)(2008-2#1)(2010-12#1)
retrovirus-mediated gene##4##2##(1994-5#1)(1995-5#1)(2008-2#1)(2010-12#1)
retrovirus-mediated##5##1##(1994-5#1)(1995-5#1)(2008-2#1)(2010-12#1)(2012-2#1)
retroviruses and##4##2##(2007-6#1)(2008-7#1)(2009-12#1)(2013-1#1)
retroviruses are##2##2##(1994-4#1)(2008-4#1)
retroviruses in cell cultures##2##4##(2008-11#2)
retroviruses in##3##2##(1990-5#1)(2008-11#2)
retroviruses such as##3##3##(1992-12#1)(2007-6#2)
retroviruses to##2##2##(2006-11#1)(2007-11#1)
retroviruses were##2##2##(1995-5#1)(2007-6#1)
retroviruses##46##1##(1990-10#1)(1990-11#1)(1990-5#5)(1991-12#1)(1992-12#1)(1992-8#1)(1994-4#1)(1994-6#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-3#1)(2005-10#1)(2006-11#1)(2007-11#2)(2007-6#7)(2008-11#7)(2008-4#5)(2008-7#2)(2009-12#1)(2009-7#1)(2011-2#1)(2013-1#1)
retrusion##3##1##(2009-7#2)(2013-1#1)
return ED##2##2##(2005-10#1)(2010-8#1)
return and##3##2##(1996-3#1)(2010-12#1)(2013-7#1)
return for a##4##3##(1990-4#1)(1993-2#1)(2008-4#1)(2013-1#1)
return for an##2##3##(2008-5#1)(2008-9#1)
return for follow-up##2##3##(1996-12#1)(2006-8#1)
return for the##2##3##(2006-2#1)(2008-10#1)
return for##19##2##(1990-4#1)(1992-12#1)(1992-2#1)(1993-2#1)(1993-6#1)(1995-12#2)(1996-12#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-9#1)(2013-1#1)
return from##3##2##(2006-12#1)(2006-4#1)(2012-2#1)
return home##4##2##(1995-5#1)(2007-9#1)(2008-1#1)(2008-9#1)
return hospital visits##2##3##(2006-10#2)
return hospital##3##2##(2006-10#3)
return in##2##2##(2008-11#1)(2008-6#1)
return into##2##2##(2009-5#1)(2011-2#1)
return is##4##2##(2007-9#1)(2008-2#1)(2008-9#1)(2011-2#1)
return loss at##2##3##(2008-3#2)
return loss##5##2##(2007-12#3)(2008-3#2)
return migration##2##2##(2011-2#1)(2013-8#1)
return of angina in the##2##5##(2007-8#2)
return of bowel function after##2##5##(2010-6#1)(2012-12#1)
return of bowel function##3##4##(2010-6#1)(2012-12#2)
return of the##11##3##(1990-5#1)(1992-2#1)(1995-10#1)(1996-6#1)(1997-3#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-8#1)(2013-1#2)
return of##43##2##(1990-5#1)(1991-10#2)(1991-12#1)(1992-2#1)(1993-6#1)(1994-6#1)(1995-1#2)(1995-10#1)(1996-1#1)(1996-6#1)(1997-3#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-9#1)(2010-6#4)(2011-2#1)(2012-12#4)(2013-1#2)
return on investment##5##3##(2007-9#2)(2008-7#2)(2013-1#1)
return on##11##2##(1995-12#1)(1997-4#1)(2007-1#1)(2007-4#1)(2007-9#2)(2008-11#1)(2008-7#2)(2008-8#1)(2013-1#1)
return power##4##2##(2008-2#1)(2008-3#3)
return rate##5##2##(1991-2#1)(1995-2#1)(2005-10#1)(2007-12#1)(2008-12#1)
return rates##2##2##(1995-2#2)
return signal##6##2##(2008-2#3)(2008-3#3)
return signals for a##2##4##(2008-2#1)(2008-3#1)
return signals for##4##3##(2008-2#2)(2008-3#2)
return signals from##2##3##(2008-3#2)
return signals##15##2##(1996-8#1)(2007-12#1)(2008-2#6)(2008-3#7)
return to a##4##3##(1991-3#1)(1991-9#1)(1994-3#1)(1997-3#1)
return to activity##2##3##(2006-8#1)(2013-1#1)
return to an##2##3##(2007-8#1)(2013-7#1)
return to baseline##2##3##(1991-12#1)(2007-8#1)
return to control values##2##4##(1995-10#1)(2006-1#1)
return to control##4##3##(1995-10#1)(1995-12#1)(2006-1#1)(2008-7#1)
return to full##2##3##(2008-7#2)
return to function##6##3##(2004-2#1)(2007-2#1)(2009-3#1)(2009-9#1)(2013-1#2)
return to investors##2##3##(1992-1#1)(1997-4#1)
return to more##2##3##(2007-2#1)(2009-4#1)
return to normal activities##2##4##(1993-2#1)(2006-6#1)
return to normal activity##3##4##(1994-3#1)(2007-1#1)(2011-2#1)
return to normal health##2##4##(2007-7#2)
return to normal##23##3##(1991-6#2)(1992-11#1)(1992-4#1)(1992-5#1)(1993-11#2)(1993-2#1)(1994-3#1)(2004-1#1)(2006-1#1)(2006-6#2)(2007-1#1)(2007-7#2)(2008-2#1)(2008-4#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
return to pitching##2##3##(2006-8#2)
return to play##2##3##(2006-8#1)(2009-5#1)
return to previous##2##3##(2008-12#1)(2008-4#1)
return to school##2##3##(2006-5#1)(2010-5#1)
return to sinus rhythm##2##4##(1990-9#1)(2007-9#1)
return to sport##2##3##(1993-3#1)(2011-1#1)
return to the operating room##2##5##(2009-3#1)(2012-3#1)
return to the##23##3##(1991-12#2)(1991-3#1)(1994-11#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
return to their##7##3##(1990-8#1)(1992-5#1)(2005-7#1)(2008-7#1)(2010-3#1)(2011-2#1)(2013-1#1)
return to within##2##3##(2006-7#1)(2011-2#1)
return to work after##2##4##(2007-10#1)(2012-12#1)
return to work and##2##4##(2010-2#1)(2012-12#1)
return to work rates##2##4##(2007-11#2)
return to work##19##3##(1992-5#1)(1993-12#1)(1997-5#1)(2006-12#1)(2006-8#2)(2007-10#2)(2007-11#2)(2007-8#1)(2008-1#1)(2009-3#1)(2010-2#1)(2010-5#1)(2012-12#3)(2012-3#1)
return to##168##2##(1990-4#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-3#2)(1991-6#3)(1991-9#1)(1992-1#2)(1992-11#1)(1992-4#1)(1992-5#3)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#2)(1994-3#2)(1995-10#1)(1995-12#1)(1995-7#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-1#1)(2004-2#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-1#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#7)(2007-1#1)(2007-10#2)(2007-11#4)(2007-2#5)(2007-7#2)(2007-8#6)(2007-9#2)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#1)(2009-10#1)(2009-3#5)(2009-4#1)(2009-5#3)(2009-6#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#1)
return visits##3##2##(1995-1#1)(2013-1#2)
return was##2##2##(2008-4#1)(2012-12#1)
return were##2##2##(1993-1#1)(2008-12#1)
return with a##2##3##(2007-8#1)(2008-3#1)
return with##3##2##(2007-8#1)(2008-10#1)(2008-3#1)
return within 72 hours##4##4##(2013-1#4)
return##404##1##(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#4)(1991-11#1)(1991-12#6)(1991-2#1)(1991-3#2)(1991-6#3)(1991-9#1)(1992-1#3)(1992-11#1)(1992-12#2)(1992-2#2)(1992-4#1)(1992-5#3)(1992-9#1)(1993-1#6)(1993-11#2)(1993-12#2)(1993-2#3)(1993-3#1)(1993-6#2)(1993-7#1)(1994-11#1)(1994-12#2)(1994-3#3)(1994-6#1)(1994-8#1)(1995-1#3)(1995-10#2)(1995-12#4)(1995-2#3)(1995-3#2)(1995-5#2)(1995-7#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#1)(1997-8#1)(2004-1#1)(2004-2#1)(2004-3#1)(2005-10#3)(2005-11#1)(2005-7#1)(2006-1#3)(2006-10#7)(2006-11#1)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#3)(2006-7#3)(2006-8#8)(2007-1#3)(2007-10#2)(2007-11#7)(2007-12#8)(2007-2#7)(2007-4#3)(2007-5#1)(2007-7#2)(2007-8#12)(2007-9#7)(2008-1#4)(2008-10#10)(2008-11#5)(2008-12#5)(2008-2#21)(2008-3#30)(2008-4#5)(2008-5#7)(2008-6#5)(2008-7#10)(2008-8#5)(2008-9#7)(2009-10#3)(2009-3#5)(2009-4#2)(2009-5#4)(2009-6#2)(2009-9#2)(2010-1#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-5#7)(2010-6#4)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#13)(2012-1#3)(2012-12#10)(2012-2#4)(2012-3#3)(2013-1#18)(2013-7#3)(2013-8#2)
return-based##2##1##(2008-8#2)
return-to-sport##2##1##(2011-1#2)
return-to-zero pulse##2##2##(2007-12#2)
return-to-zero signals by optical time gating of a##2##8##(2007-12#2)
return-to-zero transmission##2##2##(2007-11#1)(2007-12#1)
return-to-zero##13##1##(2007-11#1)(2007-12#11)(2008-1#1)
returned a##2##2##(1994-6#1)(1996-6#1)
returned and##4##2##(2005-8#1)(2005-9#1)(2008-4#1)(2011-2#1)
returned completed##2##2##(1996-3#1)(2007-11#1)
returned for a##4##3##(1993-2#1)(1997-2#1)(2008-4#1)(2008-9#1)
returned for##8##2##(1993-2#1)(1997-2#1)(2006-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2011-2#2)
returned from##11##2##(1994-7#1)(2006-8#1)(2007-2#6)(2009-4#1)(2009-7#1)(2011-1#1)
returned migrants##3##2##(2012-3#3)
returned questionnaires##3##2##(2012-2#1)(2013-1#1)(2013-8#1)
returned survey cards for##2##4##(1994-11#2)
returned the questionnaire##3##3##(1992-3#1)(1993-3#1)(1997-2#1)
returned the questionnaires##2##3##(1997-3#1)(2008-11#1)
returned the##7##2##(1992-3#1)(1993-3#1)(1994-4#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-11#1)
returned to basal levels##2##4##(1993-2#1)(1996-11#1)
returned to basal values##2##4##(1990-10#1)(1991-6#1)
returned to basal##5##3##(1990-10#1)(1990-4#1)(1991-6#1)(1993-2#1)(1996-11#1)
returned to baseline levels##3##4##(1990-10#1)(1991-6#1)(2012-2#1)
returned to baseline##13##3##(1990-10#1)(1991-6#1)(1992-12#1)(1992-7#1)(1993-1#1)(1993-12#1)(1995-2#1)(2005-10#1)(2006-10#1)(2012-2#1)(2013-1#1)(2013-8#2)
returned to control level##2##4##(1992-6#1)(1993-12#1)
returned to control levels after##2##5##(1994-3#1)(2007-11#1)
returned to control levels##13##4##(1990-10#1)(1991-5#1)(1993-7#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-12#3)(2004-11#1)(2007-11#1)(2008-5#1)(2010-5#1)
returned to control values##2##4##(1990-7#1)(1994-5#1)
returned to control##17##3##(1990-10#1)(1990-7#1)(1991-5#1)(1992-6#1)(1993-12#1)(1993-7#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-3#1)(1996-12#3)(2004-11#1)(2007-11#1)(2008-5#1)(2010-5#1)
returned to dialysis##4##3##(1995-2#1)(2008-1#3)
returned to independent living##2##4##(2008-12#1)(2009-10#1)
returned to independent##3##3##(2008-12#1)(2009-10#1)(2009-3#1)
returned to its##2##3##(1990-3#1)(2006-3#1)
returned to near##3##3##(1993-11#1)(1995-3#1)(2013-1#1)
returned to normal after##3##4##(2005-12#1)(2006-10#1)(2013-1#1)
returned to normal from##2##4##(1992-8#1)(2007-1#1)
returned to normal in##6##4##(1990-11#1)(1991-3#1)(1991-5#1)(1993-3#1)(2006-4#1)(2008-4#1)
returned to normal levels##4##4##(1992-3#1)(1994-6#1)(1995-12#1)(2010-2#1)
returned to normal over##2##4##(1997-6#1)(2006-10#1)
returned to normal values##2##4##(2005-12#1)(2008-12#1)
returned to normal within##5##4##(1991-7#1)(1991-8#1)(1993-11#1)(1993-12#1)(1996-6#1)
returned to normal##39##3##(1990-11#1)(1990-12#1)(1990-7#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-6#1)(1995-12#1)(1996-4#1)(1996-6#1)(1997-6#1)(2004-9#1)(2005-12#2)(2006-10#2)(2006-4#1)(2007-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#2)(2010-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
returned to that##2##3##(1995-5#2)
returned to the control##3##4##(1996-2#1)(2008-6#2)
returned to the hospital##3##4##(1996-5#1)(2011-2#1)(2012-12#1)
returned to the normal level##4##5##(1991-2#1)(1997-2#1)(2008-6#1)(2010-12#1)
returned to the normal##5##4##(1991-2#1)(1997-2#1)(2008-6#1)(2010-12#1)(2012-12#1)
returned to the original level##2##5##(1992-9#1)(1994-5#1)
returned to the prebypass value in##2##6##(2007-8#2)
returned to the##35##3##(1990-7#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-8#1)(1992-9#1)(1994-5#2)(1995-10#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-7#2)(2007-12#1)(2007-8#3)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-8#3)(2008-9#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)
returned to their##7##3##(1996-4#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-9#1)(2010-8#1)(2013-1#1)
returned to within the normal##2##5##(1993-9#1)(2011-1#1)
returned to within##3##3##(1993-9#1)(2011-1#1)(2013-1#1)
returned to work##10##3##(1991-5#1)(1992-3#1)(1995-12#1)(2006-11#1)(2006-4#1)(2006-7#1)(2006-8#2)(2008-7#1)(2012-12#1)
returned to##179##2##(1990-10#3)(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#2)(1990-7#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#3)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#1)(1995-10#1)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#2)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-4#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-6#2)(1997-7#2)(2004-11#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-12#2)(2006-10#3)(2006-11#1)(2006-3#1)(2006-4#2)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#6)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#4)(2009-10#1)(2009-3#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#4)(2013-1#6)(2013-8#2)
returned towards##2##2##(1996-1#1)(2007-5#1)
returned traveller##3##2##(1994-7#1)(2005-8#1)(2007-2#1)
returned with##3##2##(1991-8#1)(1992-10#1)(2010-7#1)
returned##281##1##(1990-10#3)(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#2)(1990-7#3)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#3)(1991-7#1)(1991-8#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-4#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#4)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#3)(1994-6#2)(1994-7#2)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#3)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#3)(1996-4#2)(1996-5#1)(1996-6#2)(1997-2#3)(1997-3#2)(1997-5#1)(1997-6#2)(1997-7#2)(2004-11#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#3)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#4)(2006-11#1)(2006-3#1)(2006-4#2)(2006-6#1)(2006-7#1)(2006-8#4)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#14)(2007-5#2)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#4)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#5)(2008-6#3)(2008-7#4)(2008-8#5)(2008-9#5)(2009-10#1)(2009-2#1)(2009-3#4)(2009-4#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#6)(2012-3#3)(2013-1#8)(2013-8#4)
returning from Operation Desert##2##4##(1991-3#1)(1992-2#1)
returning from endemic##2##3##(2007-2#1)(2011-2#1)
returning from foreign countries##2##4##(2012-3#2)
returning from the##3##3##(1992-7#1)(2006-10#1)(2008-2#1)
returning from##16##2##(1991-3#1)(1992-2#1)(1992-5#1)(1992-7#1)(1996-9#1)(2006-10#1)(2006-6#1)(2007-2#2)(2008-10#1)(2008-2#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-3#2)
returning to basal##3##3##(1990-7#1)(1992-6#1)(1996-12#1)
returning to baseline##2##3##(1994-3#1)(2013-1#1)
returning to normal values##2##4##(1994-3#1)(2013-1#1)
returning to normal##5##3##(1994-10#1)(1994-3#1)(1996-5#1)(2009-11#1)(2013-1#1)
returning to sport##2##3##(2008-12#1)(2008-2#1)
returning to the##7##3##(1991-1#1)(1993-1#1)(1994-12#1)(2007-2#1)(2007-8#1)(2008-11#1)(2012-12#1)
returning to##35##2##(1990-7#1)(1991-1#1)(1991-12#1)(1992-6#1)(1993-1#1)(1994-10#1)(1994-12#2)(1994-3#2)(1994-6#1)(1994-9#1)(1996-12#1)(1996-5#1)(1997-1#1)(2006-4#1)(2006-6#1)(2007-2#2)(2007-3#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#3)
returning travelers##4##2##(2010-12#1)(2011-2#3)
returning travellers##10##2##(2007-2#7)(2009-5#3)
returning##87##1##(1990-7#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-10#1)(1994-10#1)(1994-12#2)(1994-3#2)(1994-6#1)(1994-9#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-1#1)(2004-10#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-4#1)(2006-6#2)(2007-11#1)(2007-2#14)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-11#1)(2009-5#4)(2009-6#1)(2010-12#3)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#6)
returns a##2##2##(2007-12#1)(2008-4#1)
returns and##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
returns from a##2##3##(2008-2#1)(2008-3#1)
returns from##10##2##(1993-1#1)(1994-2#1)(2008-2#3)(2008-3#2)(2008-8#2)(2011-2#1)
returns is##3##2##(1991-11#1)(2008-2#1)(2008-3#1)
returns on##4##2##(1995-1#1)(1995-3#1)(2010-12#1)(2013-1#1)
returns the##5##2##(2006-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-1#1)
returns to its##2##3##(1995-1#1)(1995-8#1)
returns to normal##2##3##(1990-2#1)(2008-6#1)
returns to the##5##3##(2006-11#1)(2008-10#2)(2010-12#1)(2011-2#1)
returns to##17##2##(1990-2#1)(1991-2#1)(1991-5#1)(1993-2#1)(1995-1#1)(1995-8#1)(2006-11#1)(2006-3#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#1)
returns##74##1##(1990-2#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-5#1)(1993-1#1)(1993-2#1)(1994-2#2)(1995-1#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#2)(1996-9#1)(1997-2#2)(1997-3#1)(2004-3#1)(2006-10#1)(2006-11#1)(2006-3#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#8)(2008-3#11)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#5)(2010-12#2)(2010-8#1)(2011-2#2)(2012-1#1)(2013-1#3)
reuniens##2##1##(1993-12#1)(1997-5#1)
reunification##4##1##(1992-1#1)(1995-1#1)(2008-11#1)(2009-11#1)
reunion##2##1##(1990-12#1)(2006-3#1)
reuptake complex##2##2##(1991-1#2)
reuptake did not##2##3##(1991-8#1)(1992-7#1)
reuptake inhibition##3##2##(1990-11#1)(1995-7#1)(2011-1#1)
reuptake inhibitor (SSRI)##4##3##(2008-3#2)(2008-6#1)(2009-6#1)
reuptake inhibitor venlafaxine##2##3##(2007-4#1)(2011-1#1)
reuptake inhibitor##27##2##(1990-11#2)(1991-1#1)(1996-3#1)(1996-8#1)(1997-3#1)(2006-10#2)(2007-4#1)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-2#1)(2011-1#2)(2012-3#1)(2013-1#1)
reuptake inhibitor)##2##2##(2011-1#2)
reuptake inhibitors (SNRIs)##2##3##(2008-6#1)(2012-3#1)
reuptake inhibitors and##7##3##(1996-12#2)(1997-8#3)(2004-3#1)(2008-8#1)
reuptake inhibitors in the##2##4##(1996-12#1)(2011-2#1)
reuptake inhibitors in##4##3##(1996-12#1)(2008-8#2)(2011-2#1)
reuptake inhibitors##50##2##(1996-1#1)(1996-12#3)(1996-7#2)(1997-2#1)(1997-8#3)(2004-3#2)(2005-6#1)(2005-7#3)(2005-9#1)(2006-12#1)(2006-4#2)(2006-9#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#6)(2008-8#4)(2008-9#1)(2010-2#1)(2011-2#1)(2012-3#5)(2013-1#1)(2013-8#3)
reuptake of##4##2##(1990-3#1)(1994-3#1)(2008-3#1)(2012-3#1)
reuptake sites in##3##3##(1996-4#3)
reuptake sites##6##2##(1995-12#1)(1996-4#5)
reuptake transporter##3##2##(2006-10#1)(2007-11#1)(2008-6#1)
reuptake##115##1##(1990-11#3)(1990-2#1)(1990-3#1)(1991-1#3)(1991-5#1)(1991-8#5)(1992-7#1)(1994-3#1)(1995-12#3)(1995-7#1)(1996-1#1)(1996-12#3)(1996-3#1)(1996-4#5)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#3)(2004-3#2)(2005-6#1)(2005-7#3)(2005-9#1)(2006-10#3)(2006-12#1)(2006-4#2)(2006-9#1)(2007-11#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#5)(2008-4#4)(2008-5#2)(2008-6#10)(2008-7#1)(2008-8#6)(2008-9#2)(2009-6#1)(2010-2#2)(2011-1#6)(2011-2#1)(2012-3#7)(2013-1#2)(2013-8#3)
reusability of the##3##3##(2008-10#2)(2010-4#1)
reusability##10##1##(2007-9#1)(2008-1#1)(2008-10#3)(2008-6#1)(2009-12#1)(2010-4#1)(2013-1#1)(2013-8#1)
reusable catalyst##4##2##(2007-10#1)(2010-4#1)(2010-6#2)
reusable method##2##2##(2008-10#1)(2008-2#1)
reusable##23##1##(1992-12#1)(1995-2#1)(2006-6#1)(2007-10#1)(2007-4#1)(2008-10#6)(2008-2#1)(2008-7#1)(2009-2#1)(2010-4#1)(2010-5#1)(2010-6#2)(2011-2#3)(2012-3#2)
reuse has increased##2##3##(2008-1#2)
reuse of##11##2##(1994-11#1)(1996-11#1)(2006-10#1)(2007-7#1)(2008-1#3)(2010-5#1)(2012-2#2)(2012-3#1)
reuse system in a developing##2##5##(2007-6#2)
reuse##46##1##(1990-2#1)(1992-3#1)(1994-11#1)(1996-11#1)(2006-10#2)(2007-6#6)(2007-7#1)(2008-1#16)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2010-4#1)(2010-5#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)
reused for##5##2##(2008-10#4)(2010-1#1)
reused##24##1##(1996-11#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#14)(2008-2#1)(2010-1#1)(2010-4#1)(2013-1#2)
reuteri##4##1##(2010-4#2)(2012-2#1)(2013-1#1)
reutilization##3##1##(1996-1#1)(2012-1#2)
rev##4##1##(1990-11#1)(1996-4#1)(2007-8#2)
revaccination##11##1##(1996-8#1)(2005-7#1)(2007-4#1)(2013-1#1)(2013-8#7)
revalidation of the##2##3##(2011-2#1)(2013-7#1)
revalidation of##3##2##(2006-10#1)(2011-2#1)(2013-7#1)
revalidation##5##1##(2006-1#1)(2006-10#2)(2011-2#1)(2013-7#1)
revamp##3##1##(1994-10#1)(1995-5#2)
revascularisation for##2##2##(2007-8#2)
revascularisation is##2##2##(2005-12#1)(2007-8#1)
revascularisation of##3##2##(2006-9#1)(2007-8#2)
revascularisation procedures##2##2##(1997-1#1)(1997-6#1)
revascularisation using##2##2##(2005-12#1)(2007-9#1)
revascularisation with##2##2##(2005-12#1)(2008-6#1)
revascularisation##36##1##(1993-5#1)(1996-9#1)(1997-1#1)(1997-6#1)(2005-12#8)(2005-7#2)(2006-9#1)(2007-11#2)(2007-5#3)(2007-7#2)(2007-8#10)(2007-9#3)(2008-6#1)
revascularization and in##4##3##(1992-4#1)(2005-1#2)(2009-7#1)
revascularization and##8##2##(1992-4#1)(2005-1#2)(2007-8#1)(2007-9#1)(2008-9#1)(2009-7#1)(2013-8#1)
revascularization are##2##2##(1997-6#1)(2006-10#1)
revascularization for##5##2##(1997-1#2)(2005-1#1)(2007-8#1)(2009-12#1)
revascularization in patients with##4##4##(2007-8#3)(2012-3#1)
revascularization in patients##5##3##(2007-8#4)(2012-3#1)
revascularization in##14##2##(1990-10#1)(1990-4#1)(1991-6#1)(1997-3#1)(1997-8#1)(2006-11#1)(2007-11#1)(2007-8#6)(2012-3#1)
revascularization is##3##2##(2007-8#2)(2009-7#1)
revascularization of ischemic##2##3##(2006-10#1)(2010-8#1)
revascularization of the heart muscle##3##5##(2005-1#3)
revascularization of the ischemic##2##4##(1990-4#1)(2006-4#1)
revascularization of the##14##3##(1990-4#2)(1990-5#2)(2005-1#4)(2006-10#1)(2006-4#1)(2007-8#2)(2010-8#1)(2012-3#1)
revascularization of##20##2##(1990-4#2)(1990-5#2)(1992-9#1)(2005-1#4)(2006-10#2)(2006-4#1)(2007-8#2)(2008-10#1)(2010-8#2)(2011-3#1)(2012-12#1)(2012-3#1)
revascularization procedures##7##2##(1995-10#1)(2007-8#1)(2008-11#1)(2008-5#1)(2009-10#2)(2012-3#1)
revascularization strategies##2##2##(2005-9#1)(2009-12#1)
revascularization strategy##2##2##(2006-10#1)(2009-12#1)
revascularization that##2##2##(1997-3#1)(2008-1#1)
revascularization was achieved##2##3##(1990-4#1)(1992-4#1)
revascularization was##7##2##(1990-4#1)(1992-4#1)(1997-1#1)(2005-1#1)(2006-10#1)(2007-8#2)
revascularization with##8##2##(2006-6#1)(2007-8#5)(2008-3#1)(2008-9#1)
revascularization##168##1##(1990-10#2)(1990-4#4)(1990-5#2)(1990-9#2)(1991-6#1)(1992-4#3)(1992-9#1)(1993-12#1)(1995-10#1)(1995-12#1)(1996-3#1)(1996-9#3)(1997-1#4)(1997-3#2)(1997-6#1)(1997-8#1)(2005-1#13)(2005-9#2)(2006-10#9)(2006-11#3)(2006-4#2)(2006-6#2)(2007-10#1)(2007-11#1)(2007-8#37)(2007-9#2)(2008-1#3)(2008-10#4)(2008-11#4)(2008-12#5)(2008-3#4)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#6)(2009-10#2)(2009-12#5)(2009-4#2)(2009-7#8)(2010-8#2)(2011-12#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#5)
revascularization?##2##1##(2009-10#1)(2012-2#1)
revascularized##3##1##(2007-8#1)(2008-9#1)(2012-12#1)
reveal a clear##2##3##(1997-5#1)(2008-3#1)
reveal a considerable##2##3##(2007-8#1)(2008-7#1)
reveal a difference##2##3##(1991-8#1)(1994-12#1)
reveal a general##2##3##(1990-2#1)(2009-8#1)
reveal a gradual##2##3##(1995-5#1)(2008-7#1)
reveal a link between##2##4##(1995-12#1)(2012-12#1)
reveal a new##3##3##(1996-9#1)(2007-10#1)(2008-3#1)
reveal a novel##6##3##(1991-4#1)(2007-12#1)(2012-12#4)
reveal a remarkable##2##3##(1995-9#1)(2012-11#1)
reveal a significant##2##3##(2007-11#1)(2011-2#1)
reveal a single##4##3##(1992-12#1)(1992-6#1)(1996-10#2)
reveal a strong##2##3##(2006-7#1)(2007-11#1)
reveal a##82##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-10#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-10#2)(1996-12#2)(1996-2#2)(1996-7#1)(1996-9#2)(1997-2#1)(1997-5#1)(2005-9#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-5#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#4)(2008-8#2)(2009-10#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-8#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#5)(2012-3#1)(2013-1#1)
reveal about##2##2##(1991-5#1)(2009-5#1)
reveal an important role##3##4##(1995-2#1)(1995-8#1)(2011-1#1)
reveal an increase in##2##4##(1992-10#1)(1996-8#1)
reveal an unexpected##2##3##(1992-9#1)(1993-7#1)
reveal an##24##2##(1991-11#1)(1992-10#1)(1992-9#1)(1993-7#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-8#2)(1997-8#1)(2006-10#2)(2006-3#1)(2006-8#2)(2007-10#1)(2007-11#2)(2008-10#1)(2009-5#1)(2010-8#1)(2011-1#1)
reveal and##2##2##(2008-3#2)
reveal any apparent##2##3##(1995-3#1)(1997-8#1)
reveal any clear##2##3##(2010-10#1)(2012-12#1)
reveal any evidence of##3##4##(1993-5#1)(2008-10#1)(2011-2#1)
reveal any study##2##3##(2009-6#1)(2010-7#1)
reveal any##44##2##(1991-2#1)(1991-7#1)(1992-1#1)(1993-5#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#2)(2008-7#2)(2009-10#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#2)
reveal common##2##2##(1993-5#1)(2007-12#1)
reveal differences##2##2##(1990-8#1)(2010-11#1)
reveal different##3##2##(2008-10#2)(2009-10#1)
reveal distinct differences in the##2##5##(1991-4#1)(2008-4#1)
reveal dynamic##3##2##(1992-4#1)(1994-3#1)(2011-1#1)
reveal evidence of##3##3##(2009-7#1)(2010-11#1)(2012-3#1)
reveal fine##2##2##(1995-12#1)(2007-11#1)
reveal how##4##2##(2007-8#1)(2008-6#1)(2009-12#1)(2009-5#1)
reveal important##4##2##(1992-12#1)(1996-2#1)(2009-2#1)(2009-3#1)
reveal information##2##2##(2006-10#1)(2006-2#1)
reveal interesting##3##2##(2008-10#1)(2008-8#1)(2011-1#1)
reveal low##3##2##(1993-3#1)(2010-7#1)(2011-1#1)
reveal many##3##2##(1996-11#1)(1997-7#1)(2009-10#1)
reveal more##3##2##(2008-10#1)(2008-5#1)(2010-12#1)
reveal much about##2##3##(2007-9#1)(2008-10#1)
reveal new##4##2##(1997-9#1)(2007-10#1)(2009-4#1)(2013-1#1)
reveal no evidence for##2##4##(1992-8#1)(1993-11#1)
reveal no evidence##3##3##(1992-8#1)(1993-11#1)(1996-4#1)
reveal no##7##2##(1992-8#1)(1992-9#1)(1993-11#2)(1995-10#1)(1996-4#1)(2008-2#1)
reveal not only##2##3##(2010-2#1)(2012-1#1)
reveal novel##5##2##(2008-1#1)(2008-4#2)(2011-2#1)(2012-2#1)
reveal other##2##2##(1992-5#1)(1994-3#1)
reveal patterns##2##2##(2006-7#1)(2009-9#1)
reveal precise##2##2##(2007-8#1)(2008-4#1)
reveal selective##2##2##(1995-11#1)(2008-4#1)
reveal sequence##2##2##(1993-9#1)(1997-9#1)
reveal significant differences in##3##4##(1990-5#1)(2007-11#1)(2008-12#1)
reveal significant##6##2##(1990-5#1)(2007-11#1)(2007-12#1)(2008-12#1)(2010-10#1)(2013-8#1)
reveal some##4##2##(1990-8#1)(1993-5#1)(2009-3#1)(2009-4#1)
reveal structural##3##2##(1990-4#1)(2007-12#2)
reveal subtle##3##2##(1994-9#1)(1996-5#1)(2008-10#1)
reveal that a##5##3##(1993-3#1)(1995-1#1)(2007-12#1)(2007-2#1)(2011-2#1)
reveal that all##4##3##(1993-11#1)(1996-5#1)(2007-11#1)(2008-6#1)
reveal that an important##2##4##(2005-11#1)(2011-2#1)
reveal that each##2##3##(2007-8#1)(2008-8#1)
reveal that in##2##3##(2007-11#1)(2007-9#1)
reveal that less##2##3##(1993-12#1)(2007-11#1)
reveal that the majority of the##2##6##(1991-11#1)(2011-2#1)
reveal that the primary##2##4##(1993-3#1)(1995-11#1)
reveal that the risk factors of##8##6##(2013-8#8)
reveal that the##76##3##(1990-12#1)(1991-10#1)(1991-11#1)(1991-12#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-11#2)(1993-3#1)(1994-1#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-6#2)(1996-1#1)(1996-5#1)(1997-1#1)(2005-11#3)(2006-10#1)(2007-10#2)(2007-12#4)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-7#2)(2010-2#2)(2010-4#1)(2010-8#2)(2011-2#2)(2012-11#2)(2012-2#1)(2012-3#1)(2013-8#10)
reveal that there##2##3##(1994-9#1)(2006-6#1)
reveal that these##2##3##(2006-6#1)(2012-3#1)
reveal that they are##3##4##(1997-7#1)(2007-12#1)(2010-11#1)
reveal that this##3##3##(2007-11#1)(2008-10#1)(2008-7#1)
reveal that##214##2##(1990-11#1)(1990-12#1)(1990-6#2)(1990-7#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#4)(1993-12#1)(1993-3#4)(1994-1#2)(1994-12#1)(1994-3#1)(1994-5#3)(1994-6#2)(1994-8#2)(1994-9#3)(1995-1#3)(1995-11#2)(1995-2#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-3#1)(1996-5#3)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#2)(2005-11#4)(2006-10#2)(2006-12#2)(2006-2#2)(2006-6#2)(2006-8#1)(2007-10#2)(2007-11#5)(2007-12#11)(2007-2#3)(2007-3#2)(2007-6#2)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#3)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#5)(2010-4#6)(2010-8#2)(2011-1#1)(2011-2#8)(2012-11#2)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#12)
reveal the changes in##2##4##(2008-3#2)
reveal the development of##2##4##(2008-8#1)(2012-2#1)
reveal the existence of##5##4##(1993-12#1)(1993-5#1)(2006-12#1)(2008-10#1)(2008-3#1)
reveal the expected##2##3##(1994-9#1)(1996-7#1)
reveal the function of##2##4##(2008-4#1)(2013-1#1)
reveal the high##2##3##(2007-11#1)(2008-5#1)
reveal the importance of##3##4##(2007-2#1)(2008-3#1)(2011-1#1)
reveal the mechanisms##2##3##(2008-9#1)(2009-6#1)
reveal the molecular##2##3##(2009-2#1)(2009-8#1)
reveal the possibility of##3##4##(2007-11#1)(2011-1#2)
reveal the possible##2##3##(1990-2#1)(2010-7#1)
reveal the presence of a##4##5##(1990-3#1)(1992-6#1)(1995-3#1)(1996-8#1)
reveal the presence of##8##4##(1990-3#1)(1992-6#1)(1995-3#1)(1996-8#1)(2005-11#1)(2006-12#1)(2007-11#1)(2010-8#1)
reveal the presence##9##3##(1990-3#1)(1992-6#1)(1995-3#1)(1996-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2010-8#1)
reveal the prevalence of##2##4##(1994-6#1)(2012-2#1)
reveal the specific##2##3##(2007-5#1)(2008-10#1)
reveal the structural##2##3##(1991-11#1)(2010-2#1)
reveal the underlying##2##3##(2007-11#1)(2007-12#1)
reveal the##123##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-11#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-6#1)(1993-12#1)(1993-5#1)(1994-4#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-5#1)(1996-7#2)(1996-8#1)(1997-3#1)(1997-5#1)(2005-11#1)(2006-10#2)(2006-12#3)(2006-2#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#4)(2007-2#2)(2007-5#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#10)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-2#1)(2009-5#2)(2009-6#1)(2009-8#3)(2009-9#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#7)(2011-2#6)(2012-11#1)(2012-2#6)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
reveal two##5##2##(1995-11#1)(1995-2#1)(2008-10#1)(2009-4#1)(2012-2#1)
reveal why##2##2##(2009-5#1)(2010-2#1)
reveal##764##1##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#5)(1991-10#1)(1991-11#3)(1991-12#4)(1991-2#1)(1991-4#3)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#4)(1991-9#1)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#3)(1992-4#2)(1992-5#2)(1992-6#4)(1992-7#1)(1992-8#3)(1992-9#3)(1993-10#1)(1993-11#6)(1993-12#2)(1993-3#6)(1993-4#1)(1993-5#5)(1993-6#1)(1993-7#2)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#4)(1994-4#1)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#6)(1994-9#6)(1995-1#6)(1995-10#1)(1995-11#6)(1995-12#3)(1995-2#6)(1995-3#4)(1995-5#2)(1995-6#4)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#4)(1996-11#1)(1996-12#3)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#5)(1996-7#4)(1996-8#4)(1996-9#3)(1997-1#1)(1997-2#5)(1997-3#3)(1997-4#1)(1997-5#6)(1997-6#1)(1997-7#8)(1997-8#3)(1997-9#2)(2005-11#5)(2005-9#1)(2006-10#8)(2006-12#6)(2006-2#4)(2006-3#2)(2006-6#4)(2006-7#2)(2006-8#6)(2007-1#1)(2007-10#11)(2007-11#23)(2007-12#24)(2007-2#7)(2007-3#2)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#4)(2007-8#10)(2007-9#4)(2008-1#7)(2008-10#48)(2008-11#11)(2008-12#7)(2008-2#11)(2008-3#27)(2008-4#8)(2008-5#11)(2008-6#8)(2008-7#24)(2008-8#7)(2008-9#7)(2009-10#8)(2009-12#4)(2009-2#5)(2009-3#6)(2009-4#5)(2009-5#7)(2009-6#3)(2009-7#3)(2009-8#8)(2009-9#4)(2010-10#4)(2010-11#4)(2010-12#9)(2010-2#9)(2010-4#7)(2010-5#1)(2010-6#1)(2010-7#6)(2010-8#5)(2010-9#1)(2011-1#21)(2011-12#1)(2011-2#26)(2012-1#2)(2012-11#5)(2012-12#16)(2012-2#16)(2012-3#11)(2013-1#15)(2013-7#3)(2013-8#20)
revealed 1 to##2##3##(1994-7#1)(2006-12#1)
revealed 1##5##2##(1994-7#1)(2006-12#1)(2007-7#1)(2008-11#1)(2008-6#1)
revealed 11##2##2##(2007-11#1)(2008-10#1)
revealed 13 open reading frames (ORFs)##2##6##(1995-4#1)(1996-3#1)
revealed 13##3##2##(1995-4#1)(1996-3#1)(2011-1#1)
revealed 14##2##2##(1997-3#1)(2005-11#1)
revealed 15##2##2##(2006-9#1)(2007-3#1)
revealed 16##2##2##(2007-6#1)(2011-1#1)
revealed 2##3##2##(1991-11#1)(2009-2#1)(2011-1#1)
revealed 21##3##2##(2008-10#1)(2008-3#1)(2011-1#1)
revealed 23##2##2##(1993-8#1)(2008-10#1)
revealed 3##3##2##(2007-10#1)(2009-1#1)(2012-3#1)
revealed 40##2##2##(2007-2#1)(2008-10#1)
revealed 5##4##2##(1990-11#1)(1991-8#1)(2010-2#1)(2010-3#1)
revealed 6##2##2##(2006-9#1)(2008-6#1)
revealed a 1##3##3##(1994-6#1)(1997-4#1)(2006-5#1)
revealed a 2##2##3##(1994-9#1)(2012-12#1)
revealed a 4 cm##2##4##(2008-12#1)(2010-3#1)
revealed a 4##3##3##(1994-2#1)(2008-12#1)(2010-3#1)
revealed a band##2##3##(1993-3#1)(2008-10#1)
revealed a characteristic##2##3##(2008-5#1)(2012-12#1)
revealed a clear##4##3##(1992-6#1)(2006-11#1)(2008-5#1)(2012-2#1)
revealed a close relationship##2##4##(2008-10#2)
revealed a close##3##3##(2008-10#2)(2010-3#1)
revealed a complete##2##3##(1991-9#1)(1993-12#1)
revealed a complex##4##3##(1991-8#2)(2007-11#1)(2012-3#1)
revealed a consensus sequence##2##4##(1994-9#1)(2008-10#1)
revealed a consistent##2##3##(2008-10#1)(2011-1#1)
revealed a correlation between##2##4##(1996-11#1)(2012-2#1)
revealed a cyst##2##3##(2010-12#1)(2012-2#1)
revealed a decrease in the##2##5##(1994-3#1)(2010-12#1)
revealed a decrease in##6##4##(1994-3#1)(1995-7#1)(2008-6#1)(2010-12#1)(2012-12#2)
revealed a decreased##2##3##(2007-11#1)(2007-7#1)
revealed a difference between##2##4##(1990-6#1)(2012-1#1)
revealed a diffuse##2##3##(2006-6#1)(2008-7#1)
revealed a dinuclear complex with##2##5##(1996-2#1)(1997-7#1)
revealed a distinct##2##3##(1995-12#1)(1997-2#1)
revealed a distinctive##2##3##(2008-10#1)(2008-9#1)
revealed a dramatic##3##3##(1993-4#1)(2010-5#1)(2012-3#1)
revealed a dynamic##2##3##(2008-1#1)(2010-5#1)
revealed a fibrous##2##3##(2008-3#1)(2008-5#1)
revealed a gallbladder##3##3##(2008-3#1)(2013-1#2)
revealed a general##2##3##(2007-10#1)(2008-10#1)
revealed a glucose##2##3##(1996-2#1)(2011-1#1)
revealed a good##4##3##(1991-8#1)(1995-2#1)(2008-10#1)(2013-1#1)
revealed a great##3##3##(2008-10#1)(2009-6#1)(2009-7#1)
revealed a heterogeneous##2##3##(2008-11#1)(2008-6#1)
revealed a heterogenous##2##3##(1991-11#1)(2008-4#1)
revealed a high degree of similarity##2##6##(1990-11#1)(1993-2#1)
revealed a high degree of##4##5##(1990-11#1)(1993-11#1)(1993-2#1)(2008-10#1)
revealed a high prevalence of##2##5##(1995-2#1)(2007-7#1)
revealed a high proportion of##2##5##(1991-9#1)(2011-2#1)
revealed a high##17##3##(1990-11#1)(1991-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#2)(1995-2#1)(1995-5#1)(2006-1#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-7#1)(2011-2#2)(2012-2#1)
revealed a higher degree of##3##5##(2006-11#1)(2006-12#1)(2008-10#1)
revealed a higher##6##3##(2006-11#1)(2006-12#1)(2008-1#1)(2008-10#2)(2012-12#1)
revealed a highly significant##2##4##(1993-10#1)(1993-2#1)
revealed a highly##4##3##(1993-10#1)(1993-2#1)(1994-11#1)(2006-7#1)
revealed a huge##2##3##(2007-12#1)(2011-2#1)
revealed a large mass in the##2##6##(2008-6#2)
revealed a large mass##4##4##(2008-11#2)(2008-6#2)
revealed a large number of##4##5##(2008-7#1)(2009-7#1)(2011-1#1)(2013-1#1)
revealed a large##29##3##(1993-12#1)(1993-9#1)(1997-3#1)(2005-5#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-6#1)(2008-11#2)(2008-12#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-3#1)(2009-4#1)(2009-7#1)(2011-1#2)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
revealed a left##3##3##(1997-8#1)(2007-12#1)(2008-7#1)
revealed a lesion##3##3##(2006-8#1)(2008-5#1)(2010-12#1)
revealed a linear##3##3##(2008-10#1)(2008-5#2)
revealed a lobulated##2##3##(2009-9#1)(2012-12#1)
revealed a low level of##2##5##(2008-10#2)
revealed a low##4##3##(2008-10#3)(2008-5#1)
revealed a lower##3##3##(1990-8#1)(1992-12#1)(2006-10#1)
revealed a major##5##3##(1990-10#1)(1990-3#1)(1991-11#1)(1993-6#1)(2012-11#1)
revealed a marked reduction in##2##5##(1995-7#1)(1996-10#1)
revealed a marked##5##3##(1993-7#1)(1995-7#1)(1996-10#1)(2009-12#1)(2010-6#1)
revealed a mass in the##4##5##(2007-8#1)(2008-5#1)(2010-11#1)(2013-8#1)
revealed a mass##6##3##(2007-7#1)(2007-8#1)(2008-5#1)(2010-11#1)(2011-2#1)(2013-8#1)
revealed a mean##3##3##(1990-11#1)(1996-9#1)(2008-4#1)
revealed a mild##2##3##(2006-10#1)(2007-11#1)
revealed a moderate##2##3##(1997-4#1)(2008-10#1)
revealed a necrotic##2##3##(2008-7#1)(2012-12#1)
revealed a negative##3##3##(2008-7#1)(2009-9#1)(2012-1#1)
revealed a new##3##3##(1992-6#1)(1994-8#1)(2008-8#1)
revealed a novel##9##3##(1992-1#1)(1993-6#1)(2008-5#1)(2009-2#1)(2009-3#1)(2009-8#2)(2011-1#1)(2011-2#1)
revealed a number of##12##4##(1990-2#1)(1991-11#1)(2005-7#1)(2005-8#1)(2006-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-10#1)(2011-2#1)(2013-7#1)(2013-8#1)
revealed a pancreatic##2##3##(1991-9#1)(2013-1#1)
revealed a partial##2##3##(2006-4#1)(2007-7#1)
revealed a patent foramen ovale##2##5##(2007-10#1)(2011-2#1)
revealed a polypoid##2##3##(1992-6#1)(1993-9#1)
revealed a poor##2##3##(1991-9#1)(1995-3#1)
revealed a positive##4##3##(2006-4#1)(2008-9#1)(2009-4#1)(2012-3#1)
revealed a previously unidentified##3##4##(1994-8#1)(1997-7#1)(2011-2#1)
revealed a protein##2##3##(1990-5#1)(1992-12#1)
revealed a pulmonary##3##3##(2008-1#1)(2008-6#1)(2011-1#1)
revealed a reduction in##2##4##(1996-6#1)(2006-5#1)
revealed a reduction##3##3##(1996-6#1)(2006-5#1)(2008-1#1)
revealed a remarkable##2##3##(1996-11#1)(2008-5#1)
revealed a right##4##3##(2006-4#1)(2006-5#1)(2008-5#1)(2008-8#1)
revealed a selective##2##3##(1996-5#1)(2005-8#1)
revealed a separation##2##3##(2010-5#2)
revealed a severe##5##3##(2005-7#1)(2006-5#1)(2007-3#1)(2008-9#1)(2012-3#1)
revealed a sharp##2##3##(2007-7#1)(2012-12#1)
revealed a significant correlation##2##4##(1997-7#1)(2008-12#1)
revealed a significant difference##3##4##(2009-7#1)(2010-8#1)(2013-8#1)
revealed a significant effect##2##4##(2007-12#1)(2009-12#1)
revealed a significant increase in##2##5##(2007-2#1)(2010-12#1)
revealed a significant reduction in##3##5##(1993-5#1)(2008-10#2)
revealed a significant##32##3##(1990-5#1)(1991-7#1)(1992-10#1)(1993-12#1)(1993-5#1)(1995-8#1)(1997-5#1)(1997-7#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2009-12#2)(2009-4#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-8#1)
revealed a significantly##3##3##(1992-11#1)(2008-10#1)(2009-12#1)
revealed a similar pattern of##2##5##(1995-7#1)(1997-2#1)
revealed a similar pattern##3##4##(1995-7#1)(1997-2#1)(2008-10#1)
revealed a similar##6##3##(1991-12#1)(1995-7#1)(1997-2#1)(2007-7#1)(2008-10#1)(2012-3#1)
revealed a single approximately##2##4##(1991-9#1)(1995-2#1)
revealed a single class of##2##5##(1994-2#1)(1995-10#1)
revealed a single protein##2##4##(1994-8#1)(2009-9#1)
revealed a single##24##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-5#1)(1991-6#1)(1991-9#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-2#1)(1996-12#1)(1997-5#1)(1997-7#1)(2006-10#1)(2008-10#1)(2009-9#1)
revealed a slight##3##3##(1991-6#1)(1994-12#1)(2013-8#1)
revealed a slightly##2##3##(1993-8#1)(2010-12#1)
revealed a small##7##3##(1992-3#1)(2006-4#1)(2007-12#1)(2012-12#1)(2012-2#1)(2013-1#2)
revealed a solid##2##3##(2008-10#1)(2009-8#1)
revealed a specific interaction of##2##5##(1994-11#2)
revealed a specific##4##3##(1994-11#2)(1994-5#1)(1995-3#1)
revealed a statistically significant decrease in##2##6##(2008-5#1)(2012-12#1)
revealed a statistically significant##3##4##(2008-5#2)(2012-12#1)
revealed a strong##8##3##(1992-7#1)(1996-1#1)(1996-4#1)(1996-9#1)(2005-10#1)(2006-10#1)(2006-12#1)(2008-2#1)
revealed a tendency##2##3##(1991-12#1)(2013-8#1)
revealed a total of##8##4##(2006-11#1)(2006-12#1)(2007-10#1)(2007-12#1)(2008-12#1)(2008-5#1)(2009-5#1)(2012-2#1)
revealed a total##10##3##(2006-11#1)(2006-12#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-5#1)(2012-1#1)(2012-2#1)
revealed a typical##2##3##(1993-8#1)(2010-6#1)
revealed a unique##2##3##(1996-11#1)(2008-10#1)
revealed a very high##2##4##(1994-2#1)(2008-10#1)
revealed a very##5##3##(1994-2#1)(2007-7#1)(2008-10#2)(2013-7#1)
revealed a well-defined##2##3##(1993-11#1)(2008-5#1)
revealed a wide##6##3##(2008-10#2)(2008-5#1)(2010-10#1)(2010-3#1)(2011-2#1)
revealed a##639##2##(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#3)(1990-3#7)(1990-4#3)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#3)(1991-11#4)(1991-12#4)(1991-3#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#4)(1991-9#6)(1992-1#2)(1992-10#2)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#6)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#5)(1993-2#3)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#7)(1993-7#2)(1993-8#4)(1993-9#4)(1994-10#2)(1994-11#7)(1994-12#6)(1994-2#4)(1994-3#5)(1994-5#1)(1994-6#2)(1994-8#5)(1994-9#5)(1995-1#2)(1995-10#1)(1995-12#2)(1995-2#3)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#4)(1995-7#3)(1995-8#4)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#3)(1996-2#2)(1996-4#2)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#3)(1997-6#1)(1997-7#8)(1997-8#1)(2005-10#2)(2005-11#2)(2005-5#1)(2005-7#4)(2005-8#2)(2006-1#1)(2006-10#12)(2006-11#4)(2006-12#4)(2006-2#1)(2006-4#5)(2006-5#4)(2006-6#2)(2006-7#1)(2006-8#5)(2006-9#1)(2007-10#6)(2007-11#4)(2007-12#8)(2007-2#2)(2007-3#3)(2007-5#1)(2007-6#1)(2007-7#9)(2007-8#16)(2007-9#2)(2008-1#5)(2008-10#38)(2008-11#11)(2008-12#11)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#28)(2008-6#11)(2008-7#16)(2008-8#7)(2008-9#6)(2009-12#4)(2009-2#4)(2009-3#4)(2009-4#4)(2009-5#3)(2009-6#2)(2009-7#6)(2009-8#8)(2009-9#4)(2010-10#5)(2010-11#2)(2010-12#10)(2010-2#2)(2010-3#6)(2010-4#1)(2010-5#6)(2010-6#4)(2010-7#1)(2010-8#1)(2011-1#11)(2011-12#1)(2011-2#22)(2012-1#6)(2012-11#1)(2012-12#16)(2012-2#15)(2012-3#6)(2013-1#12)(2013-7#3)(2013-8#14)
revealed about##3##2##(2005-11#1)(2006-4#1)(2010-12#1)
revealed activation of##2##3##(2009-12#1)(2009-8#1)
revealed activation##3##2##(1995-12#1)(2009-12#1)(2009-8#1)
revealed acute##3##2##(1990-9#1)(2007-10#1)(2008-12#1)
revealed additional##6##2##(1993-11#1)(2008-10#1)(2009-2#1)(2009-5#1)(2012-2#1)(2013-8#1)
revealed adenocarcinoma##2##2##(2008-5#1)(2010-9#1)
revealed after##2##2##(1995-5#1)(2007-11#1)
revealed an 8##2##3##(1993-9#1)(2012-12#1)
revealed an ORF##2##3##(1995-8#1)(1997-4#1)
revealed an accessory##2##3##(2012-2#1)(2013-1#1)
revealed an apparent##2##3##(1990-2#1)(1994-3#1)
revealed an apparently##2##3##(1994-12#1)(2008-7#1)
revealed an approximately##2##3##(1990-12#1)(2007-8#1)
revealed an association between the##3##5##(1993-7#1)(2008-8#1)(2013-8#1)
revealed an association##5##3##(1993-7#1)(2008-7#1)(2008-8#1)(2010-8#1)(2013-8#1)
revealed an average##2##3##(2008-12#1)(2008-9#1)
revealed an extensive##2##3##(1996-8#1)(2007-7#1)
revealed an increase in the##4##5##(1991-12#1)(1991-8#1)(1994-2#1)(2008-1#1)
revealed an increase in##11##4##(1991-12#1)(1991-8#1)(1994-2#1)(1995-5#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-5#1)(2010-6#1)(2012-2#1)
revealed an increase of##2##4##(1995-6#1)(2010-2#1)
revealed an increase##13##3##(1991-12#1)(1991-8#1)(1994-2#1)(1995-5#1)(1995-6#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-5#1)(2010-2#1)(2010-6#1)(2012-2#1)
revealed an increased##6##3##(1994-3#1)(1995-2#1)(1996-3#1)(2008-1#1)(2009-8#1)(2012-12#1)
revealed an initial##3##3##(1991-8#1)(2005-11#2)
revealed an interaction##2##3##(2008-10#1)(2012-12#1)
revealed an obstructive##2##3##(2006-5#1)(2008-11#1)
revealed an open reading frame (ORF) of##2##7##(1991-9#1)(1995-8#1)
revealed an open reading frame (ORF)##4##6##(1991-9#1)(1994-12#1)(1995-2#1)(1995-8#1)
revealed an open reading frame encoding a##5##7##(1994-8#1)(1995-6#1)(1996-11#1)(1996-7#1)(2008-8#1)
revealed an open reading frame encoding##6##6##(1991-1#1)(1994-8#1)(1995-6#1)(1996-11#1)(1996-7#1)(2008-8#1)
revealed an open reading frame of##4##6##(1991-2#1)(1992-3#1)(1996-10#1)(1997-2#1)
revealed an open reading frame##17##5##(1991-1#1)(1991-10#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-4#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-7#2)(1997-2#1)(2008-8#1)
revealed an overall##3##3##(2008-11#1)(2008-7#1)(2008-8#1)
revealed an unexpected##5##3##(2008-1#1)(2010-3#1)(2010-6#1)(2012-12#2)
revealed an##143##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-7#2)(1993-9#1)(1994-10#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-8#1)(1995-2#2)(1995-5#1)(1995-6#3)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(2005-10#1)(2005-11#2)(2006-10#2)(2006-5#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#6)(2008-12#3)(2008-2#2)(2008-5#2)(2008-7#3)(2008-8#5)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-1#2)(2012-12#6)(2012-2#5)(2013-1#6)(2013-7#3)(2013-8#2)
revealed anterior##2##2##(1997-1#1)(2012-12#1)
revealed as a##2##3##(2007-12#1)(2011-2#1)
revealed as an##3##3##(2006-6#1)(2008-5#1)(2010-11#1)
revealed as##10##2##(1990-8#1)(1991-9#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-5#1)(2010-11#1)(2010-6#2)(2011-2#1)
revealed at least##5##3##(1994-3#1)(1995-5#1)(2006-10#1)(2008-10#2)
revealed at##11##2##(1991-10#1)(1994-3#1)(1995-11#1)(1995-5#1)(2004-12#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2012-12#1)
revealed atypical##2##2##(1996-6#1)(2007-8#1)
revealed azoospermia##2##2##(2006-10#1)(2011-2#1)
revealed beneficial##2##2##(2006-10#1)(2008-10#1)
revealed benign##2##2##(2007-3#1)(2007-8#1)
revealed between##3##2##(1990-5#1)(2011-1#1)(2013-8#1)
revealed bilateral##12##2##(1997-6#1)(2008-11#1)(2008-8#1)(2010-2#1)(2011-12#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
revealed bone##3##2##(1995-9#1)(2007-1#1)(2008-12#1)
revealed both##11##2##(1990-7#1)(1991-9#1)(1994-2#1)(2006-8#1)(2007-10#1)(2008-10#3)(2009-2#1)(2009-3#1)(2013-8#1)
revealed by Fourier##2##3##(2007-2#1)(2008-7#1)
revealed by a##9##3##(1990-5#1)(1992-4#1)(1994-5#1)(1995-9#1)(2007-12#1)(2007-2#2)(2010-12#1)(2013-1#1)
revealed by amino acid##3##4##(1991-1#1)(1992-12#1)(1995-6#1)
revealed by annexin##2##3##(2006-11#1)(2012-12#1)
revealed by both##2##3##(1995-5#1)(2008-8#1)
revealed by chromosome##2##3##(2008-11#1)(2010-3#1)
revealed by comparative##2##3##(2010-12#1)(2012-3#1)
revealed by different##2##3##(2007-12#1)(2013-8#1)
revealed by event-related##2##3##(1997-7#1)(2008-11#1)
revealed by functional##2##3##(1995-8#1)(2008-11#1)
revealed by immunocytochemistry##2##3##(1994-2#1)(1995-5#1)
revealed by intracellular##2##3##(1995-8#1)(1996-1#1)
revealed by molecular dynamics##2##4##(1997-1#1)(2006-10#1)
revealed by molecular##4##3##(1993-6#1)(1997-1#1)(2006-10#1)(2008-9#1)
revealed by monoclonal antibodies##2##4##(1990-4#1)(1991-9#1)
revealed by studies##2##3##(1997-7#1)(2011-12#1)
revealed by the##24##3##(1992-12#1)(1992-3#1)(1992-9#2)(1994-6#1)(1995-10#2)(1997-2#1)(1997-8#1)(2004-12#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#1)
revealed by this##2##3##(2006-7#1)(2010-12#1)
revealed by##200##2##(1990-11#1)(1990-12#3)(1990-4#1)(1990-5#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#2)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#3)(1993-10#2)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-2#1)(1994-5#4)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-10#4)(1995-5#3)(1995-6#3)(1995-8#3)(1995-9#3)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#3)(2004-12#1)(2005-10#1)(2005-11#3)(2006-10#4)(2006-11#1)(2006-12#1)(2006-6#1)(2006-7#2)(2007-11#1)(2007-12#6)(2007-2#4)(2007-3#1)(2007-6#2)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#6)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#6)(2008-9#4)(2009-10#1)(2009-5#4)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
revealed characteristic##3##2##(2006-4#1)(2009-10#1)(2009-6#1)
revealed close##4##2##(2005-8#1)(2008-10#1)(2008-8#1)(2013-8#1)
revealed comparable##5##2##(1993-3#1)(1994-12#1)(2006-7#1)(2008-4#1)(2013-1#1)
revealed comparatively##2##2##(1994-3#1)(2008-10#1)
revealed complete##4##2##(1995-12#1)(2006-10#1)(2007-12#1)(2010-12#1)
revealed complex##5##2##(1997-2#1)(1997-6#1)(2007-5#1)(2010-8#1)(2011-1#1)
revealed concerning##2##2##(2008-2#1)(2008-8#1)
revealed considerable##3##2##(1990-11#1)(1992-6#1)(2008-7#1)
revealed consistent##2##2##(1991-5#1)(2010-12#1)
revealed correlation##2##2##(2007-7#1)(2008-7#1)
revealed decreased expression of the mesodermal marker brachyury and subsequent defects in neural crest induction##2##15##(2012-12#2)
revealed decreased expression of##3##4##(2009-12#1)(2012-12#2)
revealed decreased##6##2##(1996-5#1)(1996-6#1)(2009-12#1)(2010-5#1)(2012-12#2)
revealed differences between the##3##4##(1997-5#1)(2006-11#1)(2008-10#1)
revealed differences between##5##3##(1997-5#1)(2006-11#1)(2008-10#1)(2010-10#1)(2013-1#1)
revealed differences in the##5##4##(1991-2#1)(1993-12#1)(2008-1#1)(2008-10#1)(2012-1#1)
revealed differences in##6##3##(1990-12#1)(1991-2#1)(1993-12#1)(2008-1#1)(2008-10#1)(2012-1#1)
revealed differences##14##2##(1990-12#1)(1991-2#1)(1993-12#1)(1997-2#2)(1997-5#1)(2006-11#1)(2008-1#1)(2008-10#2)(2008-5#1)(2010-10#1)(2012-1#1)(2013-1#1)
revealed different##4##2##(1995-12#1)(2008-10#2)(2008-3#1)
revealed differential expression##2##3##(2008-10#1)(2010-12#1)
revealed differential##6##2##(2008-10#1)(2010-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
revealed diffuse##8##2##(1992-5#1)(2010-10#1)(2010-5#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
revealed direct##2##2##(2008-10#2)
revealed disseminated##2##2##(2007-2#1)(2008-12#1)
revealed distinct clustering of point mutations##2##6##(1991-4#1)(1991-5#1)
revealed distinct##8##2##(1991-4#2)(1991-5#1)(1994-3#1)(2006-12#1)(2008-10#1)(2012-2#1)(2013-1#1)
revealed during##3##2##(2007-11#1)(2010-12#1)(2012-2#1)
revealed ectopic##2##2##(1990-2#1)(2012-2#1)
revealed eight##3##2##(1994-11#1)(1994-9#1)(1995-8#1)
revealed elevated serum##2##3##(2006-4#1)(2010-1#1)
revealed elevated##4##2##(1996-11#1)(2006-4#1)(2006-5#1)(2010-1#1)
revealed enhanced##5##2##(1996-7#1)(2008-10#2)(2008-5#1)(2012-2#1)
revealed evidence of##2##3##(2009-7#1)(2010-7#1)
revealed evidence##3##2##(2009-7#1)(2010-7#1)(2011-2#1)
revealed expression of##7##3##(1990-5#1)(1991-9#1)(1993-7#1)(1995-10#2)(1995-2#1)(2007-12#1)
revealed extensive##9##2##(1991-2#1)(2005-7#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-3#1)(2012-2#1)
revealed factors affecting##2##3##(1994-3#1)(2009-5#1)
revealed factors##3##2##(1990-7#1)(1994-3#1)(2009-5#1)
revealed features of##3##3##(2007-7#1)(2010-4#1)(2011-1#1)
revealed features##6##2##(2007-7#1)(2008-10#1)(2008-5#1)(2010-4#1)(2011-1#1)(2012-3#1)
revealed few##2##2##(1992-12#1)(2008-10#1)
revealed findings##2##2##(1993-5#1)(2006-5#1)
revealed five categories##2##3##(2007-11#1)(2009-6#1)
revealed five##4##2##(2006-7#1)(2007-11#1)(2008-10#1)(2009-6#1)
revealed for the first time##2##5##(2006-12#1)(2010-4#1)
revealed for the##3##3##(2006-12#1)(2008-10#1)(2010-4#1)
revealed for##7##2##(1992-6#1)(1995-11#1)(2006-12#1)(2007-12#1)(2008-10#1)(2010-4#1)(2012-2#1)
revealed four distinct##2##3##(2007-8#1)(2012-11#1)
revealed four main themes##3##4##(2009-5#1)(2013-1#2)
revealed four open reading frames##2##5##(1995-3#1)(1997-2#1)
revealed four##20##2##(1990-11#1)(1990-5#1)(1995-3#1)(1997-2#1)(1997-7#1)(2007-8#1)(2008-10#4)(2009-5#1)(2010-10#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#2)(2013-7#1)
revealed free##2##2##(2007-5#1)(2011-2#1)
revealed frequent##2##2##(1995-12#1)(2008-11#1)
revealed from##3##2##(1996-9#1)(2008-10#1)(2008-3#1)
revealed fungal elements##2##3##(2007-7#2)
revealed further##2##2##(2008-11#1)(2008-7#1)
revealed genetic##2##2##(2006-8#1)(2008-7#1)
revealed good selectivity##4##3##(2008-10#4)
revealed good##9##2##(2008-10#8)(2008-6#1)
revealed greater than##3##3##(2006-11#1)(2008-10#2)
revealed greater##4##2##(2006-11#1)(2008-10#2)(2008-8#1)
revealed groups##3##2##(2008-10#1)(2013-1#2)
revealed heterogeneity##2##2##(1992-8#1)(2008-10#1)
revealed high levels of##3##4##(1995-8#1)(2008-10#1)(2009-11#1)
revealed high##8##2##(1995-3#1)(1995-5#1)(1995-8#1)(2008-10#1)(2008-11#1)(2009-11#1)(2011-1#1)(2013-1#1)
revealed higher levels of##3##4##(1994-6#1)(1995-2#1)(2008-10#1)
revealed higher##11##2##(1993-4#1)(1994-6#1)(1995-2#1)(2007-8#1)(2008-10#2)(2008-5#1)(2010-5#1)(2012-1#1)(2012-12#1)(2013-8#1)
revealed how##2##2##(2007-12#1)(2013-1#1)
revealed immunoreactive##2##2##(1990-2#1)(1990-4#1)
revealed impaired##2##2##(2008-9#1)(2012-2#1)
revealed important##3##2##(1995-5#1)(2008-11#1)(2012-3#1)
revealed improvement in##2##3##(1993-5#1)(2006-3#1)
revealed in adults##2##3##(1991-11#1)(1991-5#1)
revealed in all##2##3##(1991-1#1)(2012-3#1)
revealed in the##11##3##(1994-9#1)(1996-9#1)(2005-1#1)(2007-1#1)(2007-5#1)(2008-12#2)(2008-3#1)(2013-1#3)
revealed in this study##2##4##(1993-9#1)(2008-6#1)
revealed in##44##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1996-3#1)(1996-9#1)(2005-1#1)(2006-10#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-12#1)(2010-2#2)(2011-2#1)(2012-3#1)(2013-1#3)
revealed increased expression of##2##4##(1992-7#1)(1995-8#1)
revealed increased##11##2##(1990-11#1)(1992-7#1)(1993-5#1)(1995-8#1)(2007-7#1)(2008-3#1)(2009-3#1)(2011-1#2)(2011-2#1)(2012-12#1)
revealed inflammation##2##2##(2008-10#1)(2011-2#1)
revealed inhibition of##2##3##(2008-11#1)(2008-7#1)
revealed inhibition##3##2##(2008-11#1)(2008-7#1)(2013-1#1)
revealed interactions between##2##3##(1996-11#1)(2008-10#1)
revealed it##2##2##(2012-12#1)(2012-2#1)
revealed its##7##2##(1995-11#1)(2008-9#1)(2009-1#1)(2010-12#1)(2011-1#1)(2011-2#2)
revealed itself##2##2##(2006-6#1)(2011-1#1)
revealed key##2##2##(2009-4#1)(2012-2#1)
revealed large##5##2##(2005-7#1)(2007-7#1)(2008-11#1)(2008-5#1)(2012-12#1)
revealed left##3##2##(2007-10#1)(2007-7#1)(2010-8#1)
revealed lesions##2##2##(2007-2#1)(2008-12#1)
revealed less##3##2##(1995-2#1)(2008-10#1)(2012-2#1)
revealed leukopenia##2##2##(1992-11#1)(2007-2#1)
revealed linkage##2##2##(1992-5#1)(1993-8#1)
revealed little evidence of##3##4##(1993-11#1)(2008-8#2)
revealed little##8##2##(1993-11#1)(1995-7#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-8#2)
revealed low##8##2##(1992-6#1)(1995-5#1)(2004-9#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
revealed lower##2##2##(2004-2#1)(2006-12#1)
revealed lymphocytic##2##2##(1993-7#1)(2008-7#1)
revealed major##3##2##(2007-8#1)(2008-10#1)(2008-7#1)
revealed malignant##3##2##(2006-4#1)(2007-10#1)(2008-1#1)
revealed many##7##2##(1993-8#1)(1995-5#1)(1997-8#1)(2006-8#1)(2007-8#1)(2011-1#1)(2012-3#1)
revealed marked##5##2##(1995-5#1)(2006-4#1)(2008-5#1)(2008-6#1)(2013-8#1)
revealed mass##2##2##(2007-8#1)(2008-12#1)
revealed massive##2##2##(2005-12#1)(2006-4#1)
revealed mixed##4##2##(2008-4#1)(2012-12#1)(2013-1#2)
revealed moderate##2##2##(2009-3#1)(2009-9#1)
revealed more##5##2##(2007-11#1)(2007-8#1)(2008-2#1)(2008-6#1)(2011-12#1)
revealed much##3##2##(1991-4#1)(1996-10#1)(2012-2#1)
revealed multiple bilateral##2##3##(2008-10#1)(2013-1#1)
revealed multiple##17##2##(1993-8#1)(1994-10#1)(1994-2#1)(1995-1#1)(1997-2#1)(2006-10#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2009-3#1)(2010-7#1)(2011-2#1)(2012-3#2)(2013-1#1)
revealed new##4##2##(1992-12#1)(2008-1#1)(2008-10#1)(2013-1#1)
revealed nine##4##2##(2008-10#2)(2008-12#1)(2010-8#1)
revealed no apparent##3##3##(1992-8#1)(1992-9#1)(2008-10#1)
revealed no change in the##2##5##(1993-2#1)(1997-2#1)
revealed no changes in the##2##5##(2007-8#1)(2009-11#1)
revealed no clear##3##3##(1991-7#1)(2005-8#1)(2012-5#1)
revealed no difference in the##2##5##(1993-5#1)(2008-10#1)
revealed no difference in##3##4##(1993-5#1)(1996-9#1)(2008-10#1)
revealed no differences between##3##4##(1991-2#1)(1993-3#1)(1996-2#1)
revealed no differences##4##3##(1991-2#1)(1993-3#2)(1996-2#1)
revealed no evidence of##5##4##(1991-4#1)(2008-10#1)(2009-3#2)(2013-8#1)
revealed no evidence##6##3##(1991-4#1)(2008-10#1)(2009-3#2)(2009-9#1)(2013-8#1)
revealed no impairment##2##3##(1994-8#1)(2007-11#1)
revealed no mutation##2##3##(1993-6#1)(2012-2#1)
revealed no residual##2##3##(2005-10#1)(2007-8#1)
revealed no significant changes in##2##5##(1997-3#1)(1997-7#1)
revealed no significant correlation##2##4##(2007-2#1)(2008-12#1)
revealed no significant differences among##2##5##(2008-5#1)(2008-9#1)
revealed no significant differences between the two##2##7##(2006-7#1)(2007-2#1)
revealed no significant differences between##3##5##(1996-1#1)(2006-7#1)(2007-2#1)
revealed no significant differences##8##4##(1993-11#1)(1996-1#1)(2006-7#1)(2007-2#1)(2008-5#2)(2008-9#1)(2011-2#1)
revealed no significant##18##3##(1993-11#1)(1993-7#1)(1996-1#1)(1997-3#1)(1997-7#1)(2006-7#1)(2007-11#1)(2007-2#3)(2008-10#1)(2008-12#1)(2008-5#2)(2008-9#1)(2009-6#1)(2011-2#1)(2013-8#1)
revealed no signs of##2##4##(1990-5#1)(2008-4#1)
revealed no statistically significant differences in##2##6##(2007-8#1)(2009-7#1)
revealed no statistically significant##4##4##(2004-1#1)(2007-8#1)(2008-10#1)(2009-7#1)
revealed no##98##2##(1990-10#2)(1990-5#1)(1990-6#1)(1991-2#1)(1991-4#3)(1991-7#2)(1991-9#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#1)(1993-7#1)(1994-6#1)(1994-8#2)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-1#1)(2005-10#1)(2005-8#1)(2006-12#1)(2006-7#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#4)(2007-8#7)(2008-1#1)(2008-10#7)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#3)(2009-11#1)(2009-3#3)(2009-6#1)(2009-7#1)(2009-9#1)(2010-3#2)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2012-5#1)(2013-8#2)
revealed normal coronary arteries##2##4##(1991-3#1)(2007-8#1)
revealed normal##12##2##(1991-10#1)(1991-3#1)(1995-5#1)(2006-10#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-5#1)(2011-1#1)
revealed nothing##2##2##(2013-1#1)(2013-8#1)
revealed novel##3##2##(2007-12#1)(2008-8#1)(2012-2#1)
revealed numerous##6##2##(1996-3#1)(2006-2#1)(2006-5#1)(2007-7#1)(2008-5#1)(2008-7#1)
revealed occlusion of the##2##4##(2008-7#1)(2010-10#1)
revealed one##7##2##(1991-4#1)(1992-6#1)(1994-3#1)(1996-11#1)(1996-2#1)(2008-10#1)(2009-11#1)
revealed only a##3##3##(1991-7#1)(2008-12#1)(2010-5#1)
revealed only five##2##3##(1995-1#1)(2007-2#1)
revealed only inflammatory##2##3##(1990-8#1)(2011-2#1)
revealed only one##3##3##(1990-3#1)(2008-10#1)(2008-12#1)
revealed only##20##2##(1990-3#1)(1990-5#1)(1990-8#1)(1991-4#1)(1991-7#2)(1993-2#1)(1995-1#1)(1996-9#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-12#3)(2009-3#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)
revealed over##2##2##(2008-10#2)
revealed pancreatic##2##2##(2008-5#1)(2013-8#1)
revealed polymorphism in##2##3##(1993-6#1)(2008-10#1)
revealed polymorphism##3##2##(1993-6#1)(1994-8#1)(2008-10#1)
revealed positive##5##2##(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#2)
revealed potential##2##2##(2007-12#1)(2011-2#1)
revealed predominant##2##2##(1993-5#1)(2007-12#1)
revealed primary##2##2##(2005-12#1)(2008-10#1)
revealed progressive##2##2##(2010-8#1)(2013-1#1)
revealed protein##3##2##(1995-10#1)(1996-7#1)(2008-4#1)
revealed reactive##2##2##(2009-9#1)(2010-12#1)
revealed recently##2##2##(2008-2#1)(2009-7#1)
revealed reduced##5##2##(1992-12#1)(1996-6#1)(2008-10#1)(2008-12#1)(2008-7#1)
revealed relative##2##2##(1992-12#1)(2008-10#1)
revealed relatively##2##2##(2008-10#2)
revealed remarkable##4##2##(2007-12#1)(2010-9#1)(2013-1#2)
revealed resolution of the##2##4##(2008-10#1)(2013-1#1)
revealed resolution of##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
revealed reversible##3##2##(1990-5#1)(1993-6#1)(2008-10#1)
revealed right##3##2##(2008-7#1)(2009-6#1)(2011-1#1)
revealed robust##2##2##(2008-10#1)(2010-2#1)
revealed selective##2##2##(1997-2#1)(2006-9#1)
revealed several##20##2##(1993-12#2)(1993-3#1)(1994-9#2)(1995-11#1)(1995-12#1)(1997-7#1)(2006-10#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
revealed severe left##2##3##(2010-12#1)(2013-1#1)
revealed severe##12##2##(1990-4#1)(1990-8#1)(1991-5#1)(1992-5#1)(1993-12#1)(2004-4#1)(2007-8#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
revealed significant (P&lt##2##3##(2005-10#1)(2012-11#1)
revealed significant correlations##2##3##(2005-9#1)(2008-8#1)
revealed significant differences among##2##4##(1995-12#1)(2008-10#1)
revealed significant differences between##4##4##(1994-12#1)(2006-8#1)(2007-8#1)(2012-12#1)
revealed significant differences in##5##4##(1996-7#1)(2008-10#1)(2008-12#1)(2009-6#1)(2012-2#1)
revealed significant differences##14##3##(1992-8#1)(1994-12#1)(1995-12#1)(1996-7#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-12#1)(2009-6#1)(2012-12#1)(2012-2#1)
revealed significant homology to##2##4##(1995-12#1)(1997-2#1)
revealed significant homology##3##3##(1995-12#1)(1995-5#1)(1997-2#1)
revealed significant positive correlations between##2##5##(2007-6#1)(2007-8#1)
revealed significant positive##5##3##(1993-12#1)(2007-6#1)(2007-8#1)(2008-9#1)(2013-8#1)
revealed significant##57##2##(1992-1#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-12#2)(1995-12#2)(1995-2#1)(1995-5#1)(1996-1#1)(1996-3#1)(1996-7#2)(1997-2#1)(2005-10#1)(2005-9#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-6#1)(2007-8#3)(2008-10#6)(2008-11#2)(2008-12#4)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-12#1)(2011-12#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#1)
revealed significantly higher##2##3##(1996-9#1)(2007-5#1)
revealed significantly more##3##3##(1993-4#1)(2006-7#1)(2006-8#1)
revealed significantly##9##2##(1993-4#1)(1995-12#1)(1996-9#1)(2006-7#1)(2006-8#1)(2007-5#1)(2007-7#1)(2009-1#1)(2009-11#1)
revealed signs##2##2##(2008-12#1)(2009-6#1)
revealed similar##12##2##(1990-4#1)(1990-5#1)(1991-5#1)(1991-7#1)(2008-10#2)(2008-5#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
revealed similarities##4##2##(2008-10#1)(2009-12#1)(2010-1#1)(2011-12#1)
revealed slight##2##2##(1997-3#1)(2008-7#1)
revealed slightly##2##2##(1992-5#1)(2013-1#1)
revealed small##2##2##(1992-2#1)(2010-2#1)
revealed solid##3##2##(2008-5#1)(2008-8#1)(2012-3#1)
revealed some##13##2##(1994-6#1)(1995-11#1)(1995-8#1)(1996-9#1)(2006-10#2)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-8#1)
revealed specific##4##2##(1991-2#2)(2008-11#1)(2010-4#1)
revealed statistically significant differences##2##4##(2008-12#2)
revealed statistically significant##3##3##(2007-10#1)(2008-12#2)
revealed striking differences in the extent of##2##7##(2008-10#2)
revealed striking##4##2##(1992-9#1)(2007-12#1)(2008-10#2)
revealed strong##8##2##(1992-8#1)(1997-8#1)(2004-11#1)(2008-10#3)(2008-11#1)(2008-7#1)
revealed substantial##4##2##(1992-6#1)(1994-11#1)(2007-11#1)(2008-7#1)
revealed subtle##3##2##(1994-8#1)(2008-11#1)(2009-12#1)
revealed ten##2##2##(2006-3#1)(2008-4#1)
revealed that (i)##3##3##(1990-11#1)(2008-8#1)(2012-2#1)
revealed that 10##2##3##(1990-6#1)(2008-12#1)
revealed that 33##2##3##(1996-12#1)(2011-2#1)
revealed that C##2##3##(2007-1#1)(2008-6#1)
revealed that F##2##3##(2008-10#1)(2008-5#1)
revealed that M##2##3##(2008-10#1)(2010-2#1)
revealed that SA##4##3##(2009-6#1)(2009-8#2)(2011-2#1)
revealed that SHW1##2##3##(2009-8#2)
revealed that UV##2##3##(2006-5#1)(2008-10#1)
revealed that Vti1p##2##3##(1997-6#2)
revealed that a high##2##4##(1997-5#1)(2010-4#1)
revealed that a higher##2##4##(2008-3#1)(2012-12#1)
revealed that a single##4##4##(1994-12#1)(2008-10#2)(2008-5#1)
revealed that a##30##3##(1991-12#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-6#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-5#1)(2005-11#2)(2007-10#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#1)(2012-12#1)
revealed that about##2##3##(1991-5#1)(2006-11#1)
revealed that activation of##2##4##(1995-3#1)(2007-4#1)
revealed that addition of##2##4##(2009-4#1)(2010-3#1)
revealed that after##3##3##(1996-10#1)(2008-11#2)
revealed that all the##2##4##(1995-5#1)(2008-5#1)
revealed that all three##4##4##(1994-3#1)(1996-5#1)(2008-10#1)(2012-3#1)
revealed that all##22##3##(1990-12#1)(1991-9#1)(1992-4#1)(1993-7#1)(1994-3#1)(1995-5#1)(1996-5#1)(1997-2#1)(2005-11#1)(2007-10#1)(2007-6#1)(2008-10#6)(2008-12#2)(2008-5#1)(2012-3#1)(2013-7#1)
revealed that almost all##2##4##(1992-7#1)(2012-2#1)
revealed that although##2##3##(1993-5#1)(2005-11#1)
revealed that among##2##3##(2010-12#1)(2011-2#1)
revealed that an##4##3##(1990-4#1)(1995-1#1)(2007-8#1)(2012-12#1)
revealed that at least##6##4##(1994-12#1)(1996-12#1)(1997-4#2)(2008-10#1)(2008-11#1)
revealed that at##7##3##(1994-12#1)(1996-12#1)(1997-4#2)(2008-10#1)(2008-11#1)(2009-2#1)
revealed that both of these##2##5##(1997-3#1)(2012-3#1)
revealed that both of##3##4##(1993-3#1)(1997-3#1)(2012-3#1)
revealed that both the##4##4##(1991-4#2)(1996-9#1)(2008-10#1)
revealed that both##33##3##(1990-5#1)(1991-2#2)(1991-4#2)(1991-8#1)(1993-3#1)(1994-11#1)(1994-12#2)(1995-6#2)(1995-8#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(2005-11#2)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-11#3)(2009-3#1)(2012-3#3)
revealed that bromination##2##3##(2008-10#2)
revealed that by##2##3##(2007-10#1)(2008-9#1)
revealed that cardiovascular diseases##2##4##(2009-4#1)(2010-7#1)
revealed that cathepsin D##2##4##(1990-10#1)(1991-8#1)
revealed that cell##3##3##(1997-1#1)(2008-5#1)(2010-11#1)
revealed that cells##2##3##(1993-6#1)(2008-11#1)
revealed that compounds##3##3##(1990-7#1)(1994-9#1)(2006-12#1)
revealed that each##5##3##(1990-6#1)(1991-10#1)(1993-11#1)(1995-8#1)(2008-10#1)
revealed that even##2##3##(1996-6#1)(2007-9#1)
revealed that five##2##3##(1991-9#1)(2008-1#1)
revealed that for##2##3##(2007-7#1)(2010-3#1)
revealed that four##2##3##(1990-7#1)(1991-9#1)
revealed that high##4##3##(1990-12#1)(2007-12#1)(2008-10#2)
revealed that higher##2##3##(2008-10#1)(2010-2#1)
revealed that his##2##3##(2006-6#1)(2010-10#1)
revealed that human##3##3##(2007-11#1)(2008-11#1)(2012-12#1)
revealed that in all##2##4##(1990-3#1)(1995-1#1)
revealed that in the##8##4##(1991-12#1)(1992-8#1)(1994-8#1)(1995-12#1)(1996-6#1)(2006-6#1)(2007-12#1)(2008-12#1)
revealed that in##25##3##(1990-3#1)(1991-12#1)(1991-7#1)(1992-11#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-8#2)(1995-1#1)(1995-12#1)(1996-6#1)(1997-6#1)(1997-8#1)(2004-7#1)(2006-10#1)(2006-6#2)(2007-12#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-3#1)(2011-1#1)
revealed that isolates of##2##4##(2008-10#2)
revealed that isolates##4##3##(2008-10#4)
revealed that it is##6##4##(1991-11#1)(1992-12#1)(1994-12#2)(1996-2#1)(1997-2#1)
revealed that it was##6##4##(1990-3#1)(1996-11#1)(1997-1#1)(2006-2#1)(2008-9#1)(2012-12#1)
revealed that it##23##3##(1990-10#1)(1990-3#1)(1991-11#1)(1992-12#1)(1992-3#1)(1992-9#1)(1994-12#2)(1994-5#1)(1996-11#1)(1996-2#1)(1997-1#2)(1997-2#1)(1997-4#1)(2005-10#1)(2006-2#1)(2006-8#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-12#1)(2012-12#1)
revealed that its##2##3##(1992-11#1)(2008-10#1)
revealed that low##3##3##(1990-10#1)(1991-2#1)(2006-12#1)
revealed that many were##2##4##(1995-6#1)(2008-11#1)
revealed that many##4##3##(1994-3#1)(1995-6#1)(2008-10#1)(2008-11#1)
revealed that men##2##3##(2008-1#1)(2009-5#1)
revealed that mice##2##3##(2005-11#1)(2008-5#1)
revealed that molecular biology majors rarely use molecular level ideas in their discourse##2##13##(2012-12#2)
revealed that molecular##3##3##(1990-11#1)(2012-12#2)
revealed that most of the##5##5##(1997-1#1)(1997-6#1)(2008-9#1)(2011-2#1)(2013-8#1)
revealed that most of##7##4##(1997-1#1)(1997-2#1)(1997-6#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-8#1)
revealed that most##18##3##(1995-12#1)(1995-2#1)(1995-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-8#1)(2011-2#1)(2013-8#2)
revealed that neither##7##3##(1992-2#1)(1993-9#1)(1996-5#1)(1996-6#1)(2006-7#1)(2008-10#1)(2008-8#1)
revealed that nine##3##3##(1996-8#1)(1997-2#1)(2013-8#1)
revealed that no##3##3##(1992-11#1)(2007-1#1)(2008-2#1)
revealed that one of the##3##5##(1994-2#1)(2007-12#1)(2008-8#1)
revealed that one of##5##4##(1992-4#1)(1994-2#1)(2007-12#1)(2008-10#1)(2008-8#1)
revealed that one##9##3##(1990-2#1)(1992-4#1)(1994-12#1)(1994-2#1)(2006-4#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-8#1)
revealed that only the##2##4##(1994-9#1)(1996-2#1)
revealed that only##14##3##(1990-4#1)(1991-2#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-3#1)(1996-2#1)(2006-8#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-6#1)(2009-7#1)(2010-12#1)
revealed that out of##3##4##(2007-7#1)(2008-8#1)(2010-5#1)
revealed that participants'##2##3##(2007-10#1)(2007-12#1)
revealed that participation in##2##4##(2006-6#1)(2007-12#1)
revealed that patients with##4##4##(1993-11#1)(1995-10#1)(2007-7#1)(2013-1#1)
revealed that patients##6##3##(1993-11#1)(1995-10#1)(2007-10#1)(2007-11#1)(2007-7#1)(2013-1#1)
revealed that peak##2##3##(1997-3#1)(2007-7#1)
revealed that performance##2##3##(1993-12#1)(1996-7#1)
revealed that positive##2##3##(2009-12#1)(2013-1#1)
revealed that sequences##2##3##(1996-8#1)(1997-2#1)
revealed that several##5##3##(1996-8#1)(2006-12#1)(2008-10#2)(2011-12#1)
revealed that she had##2##4##(2011-12#1)(2012-2#1)
revealed that significantly##2##3##(2008-10#1)(2012-12#1)
revealed that small##2##3##(2007-1#1)(2011-1#1)
revealed that some of the##2##5##(2008-10#1)(2008-12#1)
revealed that some##6##3##(2008-10#2)(2008-11#1)(2008-12#1)(2012-2#1)(2013-8#1)
revealed that staff##2##3##(2004-8#1)(2007-11#1)
revealed that students##2##3##(1996-1#1)(2008-12#1)
revealed that such##2##3##(2007-12#1)(2008-6#1)
revealed that the 1##2##4##(1991-9#1)(1997-1#1)
revealed that the 8-bp sequence##2##5##(1995-6#2)
revealed that the C-terminal##3##4##(1997-2#2)(2008-8#1)
revealed that the ability of##2##5##(2008-10#2)
revealed that the addition of##2##5##(1993-6#1)(1993-9#1)
revealed that the amount of##2##5##(1991-9#1)(2012-2#1)
revealed that the antibodies##2##4##(1993-2#1)(1994-5#1)
revealed that the average##2##4##(2012-2#1)(2013-1#1)
revealed that the cause of##3##5##(2013-1#3)
revealed that the core##2##4##(1990-12#1)(1992-8#1)
revealed that the deduced##2##4##(1994-12#1)(1997-1#1)
revealed that the different##2##4##(1993-8#1)(2008-10#1)
revealed that the distal##3##4##(1996-11#1)(1996-5#1)(2007-12#1)
revealed that the drug##3##4##(1992-9#1)(2006-4#1)(2010-5#1)
revealed that the effect of##2##5##(1994-3#1)(1995-12#1)
revealed that the enzyme##4##4##(1991-3#1)(1995-8#1)(2009-12#1)(2011-1#1)
revealed that the expression level of##2##6##(2008-10#1)(2009-8#1)
revealed that the expression of##6##5##(1994-8#1)(1995-7#1)(1997-4#1)(2010-12#1)(2013-1#2)
revealed that the expression##8##4##(1994-8#1)(1995-7#1)(1997-4#1)(2008-10#1)(2009-8#1)(2010-12#1)(2013-1#2)
revealed that the gene##8##4##(1994-10#1)(1995-6#1)(1996-10#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-8#1)(2013-1#1)
revealed that the heme##2##4##(1997-4#1)(2009-3#1)
revealed that the increase in##2##5##(1990-2#1)(2012-2#1)
revealed that the level of##2##5##(2007-6#1)(2009-6#1)
revealed that the main##2##4##(1991-2#1)(2007-10#1)
revealed that the major##3##4##(1990-5#1)(1992-1#1)(1993-11#1)
revealed that the majority of##3##5##(1995-10#1)(1995-3#1)(1997-8#1)
revealed that the majority##4##4##(1995-10#1)(1995-3#1)(1997-8#1)(2011-2#1)
revealed that the mature##2##4##(1991-3#1)(1997-2#1)
revealed that the mean##2##4##(2009-11#1)(2012-3#1)
revealed that the method##2##4##(2008-10#2)
revealed that the minimum##2##4##(1996-5#1)(2008-5#1)
revealed that the mutant##3##4##(1994-6#1)(1995-3#1)(2008-10#1)
revealed that the mutations##2##4##(1992-12#1)(2008-10#1)
revealed that the native##2##4##(1990-7#1)(1994-9#1)
revealed that the new##4##4##(2007-8#1)(2008-10#1)(2008-4#1)(2013-8#1)
revealed that the number of##2##5##(1994-12#1)(2010-11#1)
revealed that the patient##3##4##(1995-4#1)(2006-10#1)(2006-9#1)
revealed that the peptide##3##4##(1993-11#1)(1995-6#1)(1997-4#1)
revealed that the performance of##2##5##(2008-10#1)(2008-12#1)
revealed that the presence of##4##5##(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)
revealed that the prevalence of##2##5##(2010-12#1)(2013-1#1)
revealed that the proposed procedure##2##5##(2008-10#2)
revealed that the proposed##3##4##(2007-8#1)(2008-10#2)
revealed that the protein is##3##5##(1991-2#1)(1992-11#1)(2012-12#1)
revealed that the protein##5##4##(1991-2#1)(1992-11#2)(2008-11#1)(2012-12#1)
revealed that the rate of##2##5##(1992-1#1)(1994-3#1)
revealed that the sensitivity of##2##5##(1995-7#1)(2012-2#1)
revealed that the stereochemistry of##2##5##(1990-10#1)(1996-5#1)
revealed that the surface##4##4##(2007-12#1)(2008-10#1)(2008-8#1)(2013-1#1)
revealed that the three##3##4##(1996-7#1)(2008-5#1)(2009-9#1)
revealed that the tissue##2##4##(1992-9#1)(2008-6#1)
revealed that the transcriptional##2##4##(1991-1#1)(1997-4#1)
revealed that the tumor was##3##5##(1994-7#1)(2007-12#1)(2013-1#1)
revealed that the tumor##4##4##(1994-7#1)(2007-12#2)(2013-1#1)
revealed that the two##3##4##(1991-2#1)(1991-8#1)(1993-12#1)
revealed that the##484##3##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#6)(1990-4#1)(1990-5#4)(1990-7#4)(1990-8#3)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#9)(1991-3#2)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#4)(1992-1#3)(1992-11#5)(1992-12#3)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#4)(1992-9#6)(1993-11#5)(1993-12#4)(1993-2#4)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#4)(1993-9#2)(1994-10#3)(1994-11#1)(1994-12#6)(1994-2#2)(1994-3#6)(1994-5#3)(1994-6#5)(1994-7#1)(1994-8#5)(1994-9#2)(1995-1#2)(1995-10#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#4)(1995-4#1)(1995-6#4)(1995-7#2)(1995-8#2)(1995-9#2)(1996-10#5)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#7)(1996-6#1)(1996-7#5)(1996-8#3)(1996-9#2)(1997-1#5)(1997-2#8)(1997-4#8)(1997-5#2)(1997-6#4)(1997-7#4)(1997-8#6)(2004-11#1)(2004-9#1)(2005-11#9)(2006-10#2)(2006-12#2)(2006-4#2)(2006-8#1)(2006-9#1)(2007-10#3)(2007-12#14)(2007-2#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#3)(2008-10#58)(2008-11#14)(2008-12#10)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#12)(2008-6#5)(2008-8#6)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#3)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-11#3)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#4)(2010-7#1)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#9)(2012-1#4)(2012-11#1)(2012-12#7)(2012-2#10)(2012-3#3)(2013-1#14)(2013-7#2)(2013-8#5)
revealed that their##5##3##(1990-12#1)(2008-11#1)(2008-9#1)(2009-8#1)(2012-12#1)
revealed that there are##2##4##(1996-12#1)(1996-4#1)
revealed that there is a##2##5##(1994-11#1)(2006-9#1)
revealed that there is##5##4##(1994-11#1)(2006-9#1)(2007-10#1)(2008-12#1)(2010-11#1)
revealed that there was no significant difference##2##7##(2007-7#1)(2008-10#1)
revealed that there was no##3##5##(2007-7#1)(2008-10#2)
revealed that there was##7##4##(2007-10#1)(2007-7#1)(2008-10#2)(2008-9#1)(2010-8#1)(2013-8#1)
revealed that there were##7##4##(1992-8#1)(1996-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-9#1)(2013-8#1)
revealed that there##22##3##(1992-8#1)(1994-11#1)(1996-12#2)(1996-4#1)(2006-9#1)(2007-10#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-9#3)(2010-11#1)(2010-8#1)(2013-8#2)
revealed that these two##3##4##(1990-12#1)(1992-2#1)(2010-2#1)
revealed that these##17##3##(1990-12#1)(1990-2#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1997-4#1)(1997-8#2)(2008-1#1)(2008-10#2)(2009-3#1)(2010-2#1)(2012-11#1)(2012-2#2)
revealed that they all##2##4##(1991-2#1)(1992-11#1)
revealed that they are##6##4##(1994-12#1)(1994-6#1)(1995-3#1)(1996-10#1)(2008-10#1)(2011-1#1)
revealed that they contain##2##4##(1992-7#1)(2010-8#1)
revealed that they had##3##4##(1992-5#1)(1993-3#1)(2008-4#1)
revealed that they were not##2##5##(2007-11#1)(2007-3#1)
revealed that they were##8##4##(1993-8#1)(1996-4#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-2#1)
revealed that they##23##3##(1991-2#1)(1992-11#1)(1992-5#1)(1992-7#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-3#1)(1996-10#1)(1996-4#1)(1997-3#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-4#2)(2008-5#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)
revealed that this gene is##3##5##(1991-12#1)(1991-6#1)(1994-12#1)
revealed that this protein##2##4##(1991-5#1)(1994-11#1)
revealed that this##21##3##(1990-8#1)(1991-12#1)(1991-5#1)(1991-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-3#1)(1996-12#1)(1996-5#1)(1997-7#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-11#1)(2012-2#1)
revealed that three of##2##4##(1994-9#1)(2007-3#1)
revealed that three##5##3##(1994-9#1)(2007-12#1)(2007-3#1)(2008-10#1)(2009-7#1)
revealed that two of##2##4##(1994-11#1)(2008-9#1)
revealed that two##7##3##(1991-7#1)(1994-11#1)(1996-7#1)(2008-10#2)(2008-9#1)(2011-1#1)
revealed that tyrosine##2##3##(1992-8#1)(1997-7#1)
revealed that under##3##3##(1992-9#1)(1996-5#1)(1997-6#1)
revealed that when##4##3##(1995-5#1)(2007-6#1)(2008-11#1)(2010-3#1)
revealed that while##3##3##(1992-12#1)(2009-4#1)(2010-9#1)
revealed that with the##2##4##(1995-1#1)(1995-12#1)
revealed that##1554##2##(1990-10#7)(1990-11#4)(1990-12#12)(1990-2#13)(1990-3#4)(1990-4#4)(1990-5#8)(1990-6#5)(1990-7#7)(1990-8#4)(1990-9#2)(1991-1#2)(1991-10#2)(1991-11#3)(1991-12#7)(1991-2#17)(1991-3#7)(1991-4#4)(1991-5#5)(1991-6#5)(1991-7#4)(1991-8#7)(1991-9#9)(1992-1#4)(1992-10#1)(1992-11#10)(1992-12#8)(1992-2#5)(1992-3#4)(1992-4#2)(1992-5#7)(1992-6#4)(1992-7#7)(1992-8#14)(1992-9#12)(1993-11#10)(1993-12#13)(1993-2#5)(1993-3#7)(1993-4#1)(1993-5#1)(1993-6#8)(1993-7#4)(1993-8#7)(1993-9#4)(1994-10#4)(1994-11#11)(1994-12#22)(1994-2#10)(1994-3#12)(1994-5#6)(1994-6#8)(1994-7#1)(1994-8#10)(1994-9#7)(1995-1#10)(1995-10#3)(1995-11#4)(1995-12#8)(1995-2#6)(1995-3#14)(1995-4#2)(1995-5#4)(1995-6#15)(1995-7#3)(1995-8#7)(1995-9#3)(1996-1#1)(1996-10#8)(1996-11#2)(1996-12#9)(1996-2#7)(1996-3#3)(1996-4#3)(1996-5#13)(1996-6#6)(1996-7#9)(1996-8#7)(1996-9#5)(1997-1#13)(1997-2#16)(1997-3#6)(1997-4#15)(1997-5#6)(1997-6#16)(1997-7#10)(1997-8#14)(2003-11#1)(2004-10#1)(2004-11#2)(2004-12#2)(2004-7#1)(2004-8#1)(2004-9#2)(2005-10#3)(2005-11#19)(2005-3#2)(2005-9#1)(2006-10#5)(2006-11#3)(2006-12#9)(2006-2#2)(2006-4#3)(2006-5#1)(2006-6#6)(2006-7#2)(2006-8#6)(2006-9#6)(2007-1#5)(2007-10#14)(2007-11#8)(2007-12#29)(2007-2#6)(2007-3#5)(2007-4#4)(2007-5#2)(2007-6#6)(2007-7#12)(2007-8#9)(2007-9#3)(2008-1#9)(2008-10#176)(2008-11#43)(2008-12#24)(2008-2#4)(2008-3#9)(2008-4#14)(2008-5#38)(2008-6#11)(2008-7#9)(2008-8#31)(2008-9#19)(2009-1#2)(2009-10#5)(2009-11#1)(2009-12#6)(2009-2#4)(2009-3#8)(2009-4#9)(2009-5#6)(2009-6#6)(2009-7#9)(2009-8#13)(2009-9#4)(2010-1#5)(2010-10#5)(2010-11#6)(2010-12#12)(2010-2#14)(2010-3#11)(2010-4#7)(2010-5#6)(2010-6#1)(2010-7#8)(2010-8#6)(2010-9#4)(2011-1#19)(2011-12#9)(2011-2#28)(2012-1#10)(2012-11#6)(2012-12#24)(2012-2#40)(2012-3#16)(2013-1#32)(2013-7#6)(2013-8#19)
revealed the ability of##3##4##(1992-2#1)(1995-6#1)(2008-10#1)
revealed the absence of##3##4##(2006-12#1)(2008-10#1)(2012-2#1)
revealed the accumulation##2##3##(2008-10#1)(2008-11#1)
revealed the characteristic##2##3##(2006-2#1)(2012-12#1)
revealed the concomitant##2##3##(1995-3#1)(2008-10#1)
revealed the diagnosis##2##3##(1991-3#1)(2006-4#1)
revealed the different##2##3##(2008-10#1)(2008-7#1)
revealed the existence of a##11##5##(1991-1#1)(1992-11#1)(1992-3#1)(1994-12#2)(1995-8#2)(2008-10#1)(2008-3#1)(2008-6#1)(2012-12#1)
revealed the existence of correlated motions among residues connected by hydrogen bonds##2##12##(2006-10#2)
revealed the existence of two##4##5##(1991-1#1)(1993-11#1)(2008-10#1)(2008-11#1)
revealed the existence of##31##4##(1991-1#2)(1991-5#1)(1992-11#1)(1992-3#1)(1993-11#1)(1994-11#2)(1994-12#2)(1994-9#1)(1995-3#1)(1995-8#2)(1996-2#1)(1997-3#1)(2006-10#2)(2006-11#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2010-6#1)(2010-7#1)(2012-12#1)
revealed the expression of##3##4##(1992-3#1)(1994-3#1)(2006-12#1)
revealed the expression##4##3##(1992-3#1)(1994-2#1)(1994-3#1)(2006-12#1)
revealed the following concentrations##2##4##(2007-12#1)(2013-1#1)
revealed the following##10##3##(1997-2#1)(2004-11#1)(2006-6#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
revealed the formation of##7##4##(1991-8#1)(1997-7#1)(2008-10#2)(2010-5#1)(2012-1#1)(2013-1#1)
revealed the formation##8##3##(1991-8#1)(1997-7#1)(2008-10#2)(2010-5#1)(2012-1#1)(2012-2#1)(2013-1#1)
revealed the genetic##2##3##(2008-10#1)(2010-4#1)
revealed the genomic##2##3##(1995-8#1)(2008-10#1)
revealed the great##2##3##(2008-5#1)(2008-8#1)
revealed the high##2##3##(1995-12#1)(2008-5#1)
revealed the importance of##3##4##(2008-7#1)(2009-3#2)
revealed the incidence##2##3##(1997-2#1)(2007-7#1)
revealed the integration of the##2##5##(2008-8#1)(2013-8#1)
revealed the location of the##2##5##(1990-8#1)(2006-10#1)
revealed the most##2##3##(1997-2#1)(1997-4#1)
revealed the potential of##2##4##(2008-7#1)(2012-12#1)
revealed the presence of 10##2##5##(1997-3#1)(2012-2#1)
revealed the presence of HSA in the##2##7##(1997-8#2)
revealed the presence of a consensus##2##6##(1993-2#1)(2008-10#1)
revealed the presence of a major##3##6##(1994-9#1)(1997-6#1)(2008-8#1)
revealed the presence of a single##2##6##(1993-12#1)(1997-5#1)
revealed the presence of a##27##5##(1990-5#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-8#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-1#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
revealed the presence of an open reading frame##2##8##(1990-4#1)(1995-3#1)
revealed the presence of an##7##5##(1990-4#1)(1994-10#1)(1994-9#1)(1995-3#1)(1997-5#1)(2006-10#1)(2008-10#1)
revealed the presence of five##4##5##(1990-1#1)(1994-12#1)(2008-10#2)
revealed the presence of one##3##5##(1991-9#1)(2008-10#1)(2012-12#1)
revealed the presence of only##2##5##(1993-12#1)(1994-5#1)
revealed the presence of the##8##5##(1993-11#1)(1993-3#1)(1994-10#1)(1994-6#1)(1996-6#1)(2008-10#1)(2008-8#1)(2012-12#1)
revealed the presence of two##6##5##(1990-5#1)(1991-9#1)(1992-5#1)(1995-4#1)(1995-5#1)(2008-10#1)
revealed the presence of##141##4##(1990-1#1)(1990-3#1)(1990-4#2)(1990-5#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-8#1)(1991-9#4)(1992-1#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#2)(1994-10#2)(1994-12#2)(1994-5#3)(1994-6#1)(1994-7#2)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#4)(2004-2#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#19)(2008-11#2)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#5)(2013-1#2)
revealed the prevalence##2##3##(2006-8#1)(2013-8#1)
revealed the production of##2##4##(1997-7#1)(2007-12#1)
revealed the recovery of##2##4##(2008-10#1)(2010-4#1)
revealed the same##3##3##(1992-5#1)(2007-9#1)(2008-10#1)
revealed the##377##2##(1990-1#1)(1990-10#1)(1990-12#3)(1990-3#1)(1990-4#2)(1990-5#3)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#4)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#2)(1991-9#4)(1992-1#2)(1992-11#2)(1992-2#2)(1992-3#4)(1992-5#3)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#3)(1993-5#1)(1993-6#2)(1994-10#3)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#2)(1994-7#2)(1994-8#2)(1994-9#4)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#4)(1995-4#2)(1995-5#2)(1995-6#2)(1995-8#4)(1996-12#1)(1996-2#3)(1996-3#2)(1996-5#4)(1996-6#1)(1996-7#1)(1996-9#2)(1997-2#3)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#5)(1997-8#4)(2004-11#1)(2004-2#1)(2005-11#1)(2006-1#2)(2006-10#5)(2006-11#3)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#2)(2006-8#3)(2007-1#2)(2007-10#1)(2007-11#7)(2007-12#7)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#10)(2007-9#2)(2008-1#2)(2008-10#45)(2008-11#10)(2008-12#3)(2008-3#4)(2008-4#2)(2008-5#7)(2008-6#4)(2008-7#9)(2008-8#8)(2008-9#2)(2009-1#2)(2009-10#1)(2009-12#1)(2009-3#3)(2009-4#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#4)(2010-3#1)(2010-4#5)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#4)(2011-2#4)(2012-1#2)(2012-12#8)(2012-2#10)(2012-3#3)(2013-1#6)(2013-8#4)
revealed their##10##2##(1990-10#1)(1996-5#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-12#1)
revealed there was##2##3##(1992-4#1)(2005-11#1)
revealed there##4##2##(1992-4#1)(2005-11#1)(2007-9#1)(2011-2#1)
revealed these differences##2##3##(1995-2#1)(2007-11#1)
revealed these proteins##2##3##(1992-12#1)(1995-8#1)
revealed these##4##2##(1992-12#1)(1995-2#1)(1995-8#1)(2007-11#1)
revealed thickened##2##2##(2006-10#1)(2009-3#1)
revealed thickening of the##2##4##(1996-3#1)(2006-4#1)
revealed thickening##3##2##(1996-3#1)(2006-4#1)(2008-10#1)
revealed this##2##2##(1990-7#1)(2008-10#1)
revealed three clades##2##3##(2008-10#2)
revealed three different##2##3##(2006-7#1)(2011-1#1)
revealed three distinct##6##3##(1995-8#1)(2008-10#2)(2010-6#1)(2012-3#1)(2013-7#1)
revealed three major##2##3##(1996-8#1)(2008-12#1)
revealed three themes##2##3##(2008-11#1)(2009-5#1)
revealed three##25##2##(1993-12#1)(1993-5#1)(1994-12#2)(1994-9#1)(1995-8#1)(1996-8#1)(2006-7#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
revealed through##5##2##(2008-3#1)(2008-5#1)(2009-9#1)(2012-12#2)
revealed to be a##2##4##(1992-11#1)(2009-2#1)
revealed to be##9##3##(1992-11#1)(1997-3#1)(1997-6#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-2#1)(2012-12#1)(2013-7#1)
revealed to have a##2##4##(2008-5#1)(2011-2#1)
revealed to have##5##3##(1997-4#1)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)
revealed to##19##2##(1990-5#1)(1991-2#1)(1992-11#1)(1992-7#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2009-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-7#1)
revealed two bands##2##3##(1994-6#1)(1997-6#1)
revealed two distinct##6##3##(1990-7#1)(1992-3#1)(1992-6#1)(2008-10#1)(2009-9#1)(2010-10#1)
revealed two independent##2##3##(1991-3#1)(2008-10#1)
revealed two main##3##3##(2008-10#3)
revealed two major##3##3##(1991-9#1)(1992-12#1)(2012-12#1)
revealed two peaks##2##3##(1990-2#1)(1991-10#1)
revealed two types of##2##4##(1994-8#1)(2008-7#1)
revealed two well##2##3##(2009-9#1)(2013-1#1)
revealed two##57##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#2)(1991-10#1)(1991-2#1)(1991-3#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-6#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#2)(1996-10#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#3)(1997-7#1)(2006-7#1)(2008-10#10)(2008-12#1)(2008-7#1)(2009-6#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2012-12#1)(2012-2#2)(2013-1#1)
revealed typical##2##2##(2006-10#1)(2011-12#1)
revealed under##2##2##(1991-9#1)(1992-3#1)
revealed unexpected##3##2##(1996-4#1)(2006-9#1)(2009-8#1)
revealed unilateral##3##2##(2007-12#1)(2011-1#1)(2011-2#1)
revealed unique##4##2##(1996-11#1)(2007-12#1)(2008-11#1)(2008-7#1)
revealed up to##2##3##(2006-8#1)(2012-3#1)
revealed upon##2##2##(2008-1#1)(2012-2#1)
revealed using##2##2##(1995-8#1)(2012-11#1)
revealed various##3##2##(2006-11#1)(2007-1#1)(2008-2#1)
revealed varying##3##2##(1993-11#1)(2009-5#1)(2012-2#1)
revealed very high##2##3##(1993-9#1)(2008-10#1)
revealed very##5##2##(1993-9#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
revealed when##2##2##(2009-3#1)(2009-8#1)
revealed widespread systemic##2##3##(2006-12#1)(2009-4#1)
revealed widespread##6##2##(1997-8#1)(2006-12#1)(2008-7#2)(2009-4#1)(2010-2#1)
revealed with##4##2##(1990-5#1)(1994-12#1)(2008-10#1)(2013-1#1)
revealed##4611##1##(1990-1#1)(1990-10#16)(1990-11#14)(1990-12#26)(1990-2#21)(1990-3#15)(1990-4#13)(1990-5#28)(1990-6#11)(1990-7#17)(1990-8#11)(1990-9#10)(1991-1#12)(1991-10#14)(1991-11#12)(1991-12#16)(1991-2#31)(1991-3#17)(1991-4#16)(1991-5#15)(1991-6#11)(1991-7#12)(1991-8#20)(1991-9#35)(1992-1#10)(1992-10#4)(1992-11#20)(1992-12#20)(1992-2#11)(1992-3#19)(1992-4#7)(1992-5#16)(1992-6#22)(1992-7#11)(1992-8#33)(1992-9#22)(1993-1#4)(1993-10#4)(1993-11#23)(1993-12#34)(1993-2#14)(1993-3#24)(1993-4#4)(1993-5#12)(1993-6#23)(1993-7#13)(1993-8#20)(1993-9#15)(1994-10#12)(1994-11#26)(1994-12#43)(1994-2#23)(1994-3#28)(1994-5#15)(1994-6#18)(1994-7#6)(1994-8#25)(1994-9#26)(1995-1#15)(1995-10#11)(1995-11#16)(1995-12#22)(1995-2#19)(1995-3#28)(1995-4#6)(1995-5#23)(1995-6#28)(1995-7#9)(1995-8#27)(1995-9#8)(1996-1#8)(1996-10#16)(1996-11#13)(1996-12#21)(1996-2#16)(1996-3#15)(1996-4#8)(1996-5#25)(1996-6#14)(1996-7#18)(1996-8#13)(1996-9#21)(1997-1#19)(1997-2#37)(1997-3#18)(1997-4#28)(1997-5#16)(1997-6#28)(1997-7#33)(1997-8#28)(2003-11#1)(2004-1#1)(2004-10#1)(2004-11#4)(2004-12#4)(2004-2#2)(2004-4#1)(2004-7#1)(2004-8#1)(2004-9#4)(2005-1#1)(2005-10#14)(2005-11#34)(2005-12#3)(2005-3#2)(2005-4#1)(2005-5#1)(2005-7#6)(2005-8#5)(2005-9#3)(2006-1#4)(2006-10#52)(2006-11#15)(2006-12#26)(2006-2#7)(2006-3#4)(2006-4#22)(2006-5#14)(2006-6#15)(2006-7#16)(2006-8#27)(2006-9#15)(2007-1#12)(2007-10#36)(2007-11#44)(2007-12#84)(2007-2#31)(2007-3#17)(2007-4#7)(2007-5#11)(2007-6#12)(2007-7#53)(2007-8#75)(2007-9#14)(2008-1#35)(2008-10#442)(2008-11#105)(2008-12#71)(2008-2#14)(2008-3#29)(2008-4#35)(2008-5#124)(2008-6#39)(2008-7#82)(2008-8#80)(2008-9#52)(2009-1#7)(2009-10#14)(2009-11#6)(2009-12#16)(2009-2#19)(2009-3#28)(2009-4#22)(2009-5#21)(2009-6#17)(2009-7#20)(2009-8#31)(2009-9#16)(2010-1#11)(2010-10#16)(2010-11#14)(2010-12#52)(2010-2#28)(2010-3#24)(2010-4#25)(2010-5#29)(2010-6#17)(2010-7#15)(2010-8#17)(2010-9#9)(2011-1#76)(2011-12#24)(2011-2#110)(2012-1#27)(2012-11#12)(2012-12#95)(2012-2#124)(2012-3#48)(2012-5#1)(2013-1#119)(2013-7#22)(2013-8#60)
revealing a##20##2##(1992-10#1)(1997-3#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-3#1)(2010-11#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
revealing an##5##2##(2007-8#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-2#1)
revealing both##2##2##(1997-8#1)(2008-1#1)
revealing hidden##2##2##(2008-1#1)(2012-1#1)
revealing its##3##2##(2007-11#1)(2008-5#1)(2013-1#1)
revealing new##3##2##(2007-10#1)(2007-9#1)(2012-12#1)
revealing no##2##2##(2007-8#1)(2008-5#1)
revealing novel older-specific rules that link mass presence to invasive##2##10##(2013-1#2)
revealing novel##4##2##(2011-2#2)(2013-1#2)
revealing of##2##2##(2008-3#1)(2008-4#1)
revealing that the##7##3##(1994-9#1)(1995-6#1)(1996-12#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-5#1)
revealing that these##2##3##(2006-3#1)(2010-8#1)
revealing that##15##2##(1994-9#2)(1995-6#2)(1996-12#1)(2006-3#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-3#1)(2010-5#1)(2010-8#1)
revealing the first##2##3##(1993-1#1)(2007-12#1)
revealing the presence of##3##4##(1991-2#1)(2008-9#1)(2012-1#1)
revealing the##25##2##(1991-2#1)(1992-9#1)(1993-1#1)(1994-9#1)(1997-8#1)(2006-6#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#1)(2009-9#1)(2011-1#1)(2012-1#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
revealing their##2##2##(1994-3#1)(2007-11#1)
revealing two##5##2##(1995-3#1)(2007-4#1)(2008-10#1)(2008-2#1)(2013-1#1)
revealing##158##1##(1990-4#1)(1990-6#1)(1991-11#2)(1991-2#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-9#2)(1993-1#1)(1993-5#1)(1993-9#1)(1994-3#1)(1994-9#3)(1995-3#1)(1995-6#2)(1995-9#1)(1996-12#1)(1997-3#2)(1997-6#1)(1997-8#2)(2005-11#1)(2006-1#1)(2006-10#3)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#11)(2008-11#2)(2008-12#3)(2008-2#4)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#4)(2009-5#4)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#6)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#2)(2012-4#1)(2013-1#6)(2013-8#2)
reveals &quot##2##2##(1995-6#1)(2013-8#1)
reveals 100%##2##2##(1990-2#1)(1996-7#1)
reveals a broad##2##3##(1992-12#1)(2008-9#1)
reveals a common##2##3##(1993-3#1)(1994-9#1)
reveals a high degree of homology##3##6##(1991-7#1)(1993-2#1)(1997-2#1)
reveals a high degree of##5##5##(1991-2#1)(1991-7#1)(1993-2#1)(1996-6#1)(1997-2#1)
reveals a high##8##3##(1991-2#1)(1991-7#1)(1992-7#1)(1993-2#1)(1996-6#1)(1997-2#1)(2006-10#1)(2007-7#1)
reveals a highly conserved##2##4##(1990-6#1)(1994-12#1)
reveals a highly##3##3##(1990-6#1)(1994-12#1)(2008-3#1)
reveals a more##2##3##(1992-10#1)(1994-12#1)
reveals a new fold##2##4##(2010-10#2)
reveals a novel##4##3##(1992-7#1)(1994-11#1)(2010-10#1)(2011-1#1)
reveals a number of##3##4##(1991-9#1)(1992-3#1)(2010-10#1)
reveals a previously##2##3##(1993-4#1)(2013-8#1)
reveals a significant##2##3##(1996-9#1)(2008-5#1)
reveals a single##2##3##(1993-7#1)(2008-2#1)
reveals a very##3##3##(1995-1#1)(2007-12#1)(2010-11#1)
reveals a##104##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-2#2)(1991-5#1)(1991-7#2)(1991-8#2)(1991-9#1)(1992-10#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-2#2)(1993-3#2)(1993-4#1)(1993-7#2)(1994-11#1)(1994-12#2)(1994-5#2)(1994-6#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-4#2)(2005-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#3)(2007-12#5)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#3)(2008-9#1)(2009-10#3)(2009-5#2)(2010-10#5)(2010-11#1)(2010-4#2)(2010-6#2)(2010-7#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-2#4)(2013-8#1)
reveals all##2##2##(1996-9#1)(2010-12#1)
reveals alternative##2##2##(1994-3#1)(1994-9#1)
reveals an important##4##3##(1996-5#1)(2007-5#2)(2008-8#1)
reveals an##26##2##(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-4#1)(1995-8#1)(1995-9#1)(1996-5#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-5#2)(2008-4#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-10#1)(2010-5#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
reveals both##2##2##(1995-4#1)(2007-12#1)
reveals changes##2##2##(2006-10#1)(2010-9#1)
reveals common##3##2##(1990-2#1)(2006-12#1)(2012-12#1)
reveals differences##4##2##(2006-9#1)(2008-10#1)(2008-8#1)(2011-2#1)
reveals different##2##2##(2006-7#1)(2007-12#1)
reveals distinct##3##2##(1990-4#1)(2008-11#1)(2009-9#1)
reveals five##2##2##(1995-9#1)(2005-4#1)
reveals four##3##2##(1994-8#1)(2009-7#1)(2010-2#1)
reveals good##3##2##(2008-10#2)(2008-3#1)
reveals her##2##2##(2008-9#1)(2011-2#1)
reveals high##5##2##(1996-10#1)(1996-12#1)(1997-2#1)(2011-2#1)(2013-7#1)
reveals how##5##2##(1994-9#1)(2007-8#1)(2008-11#1)(2008-8#1)(2009-12#1)
reveals its##2##2##(2011-1#2)
reveals itself in##2##3##(1993-3#1)(2011-1#1)
reveals large##3##2##(1995-6#1)(2008-3#1)(2008-7#1)
reveals little##2##2##(1995-2#1)(2008-9#1)
reveals marked##2##2##(1994-7#1)(2005-8#1)
reveals no##6##2##(1991-7#1)(1992-3#1)(1995-5#1)(2006-10#1)(2007-3#1)(2012-2#1)
reveals only##3##2##(1990-2#1)(1992-4#1)(2010-6#1)
reveals previously##2##2##(1991-11#1)(2012-2#1)
reveals significant##6##2##(1990-7#1)(1991-5#1)(1996-2#1)(1996-9#1)(2008-2#1)(2010-12#1)
reveals some##7##2##(1990-5#1)(1995-1#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-12#1)
reveals structural##2##2##(1993-3#1)(1993-8#1)
reveals that Avicenna has made a significant contribution to the evolution of following knowledge##2##14##(2013-1#2)
reveals that a##4##3##(1992-8#1)(1994-12#1)(2008-10#1)(2011-2#1)
reveals that all##2##3##(1991-7#1)(1995-2#1)
reveals that an##2##3##(1994-5#1)(2008-10#1)
reveals that average##2##3##(2008-5#1)(2012-12#1)
reveals that it is a##2##5##(1995-8#1)(2011-1#1)
reveals that it is##6##4##(1992-6#1)(1994-12#1)(1995-8#1)(2007-12#1)(2011-1#1)(2012-3#1)
reveals that it##8##3##(1992-6#1)(1994-12#1)(1994-9#1)(1995-8#1)(2007-11#1)(2007-12#1)(2011-1#1)(2012-3#1)
reveals that some##2##3##(1993-3#1)(1997-9#1)
reveals that the regulatory##2##4##(1990-5#1)(1996-11#1)
reveals that the two##2##4##(2008-11#1)(2008-8#1)
reveals that the##66##3##(1990-11#1)(1990-12#1)(1990-5#2)(1990-8#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-1#3)(1995-2#2)(1995-3#1)(1996-1#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#6)(2008-8#2)(2009-5#1)(2010-10#3)(2010-12#1)(2010-5#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#1)
reveals that there is a##3##5##(2008-10#1)(2013-1#2)
reveals that there is##4##4##(2008-10#1)(2008-11#1)(2013-1#2)
reveals that there##5##3##(2008-10#2)(2008-11#1)(2013-1#2)
reveals that these##3##3##(1990-8#1)(2007-12#2)
reveals that they##3##3##(1993-12#1)(1994-3#1)(1995-4#1)
reveals that this##3##3##(1992-12#1)(1994-3#1)(2009-4#1)
reveals that within the##2##4##(1994-3#1)(2012-3#1)
reveals that##193##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#3)(1991-12#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#2)(1994-11#1)(1994-12#3)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#4)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(1997-9#1)(2005-11#2)(2006-10#2)(2006-11#1)(2006-3#1)(2006-8#1)(2007-10#2)(2007-11#4)(2007-12#7)(2007-2#2)(2008-1#3)(2008-10#9)(2008-11#6)(2008-12#2)(2008-2#5)(2008-3#6)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-10#4)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-12#4)(2012-2#7)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#1)
reveals the existence of##2##4##(1994-8#1)(2011-12#1)
reveals the following##3##3##(1992-12#1)(1995-12#1)(1996-3#1)
reveals the need##2##3##(1993-2#1)(2009-2#1)
reveals the potential of##3##4##(2006-10#2)(2008-2#1)
reveals the potential##5##3##(2006-10#3)(2008-2#1)(2012-12#1)
reveals the presence of a##5##5##(1990-12#1)(1991-2#1)(1995-12#1)(2007-12#1)(2011-1#1)
reveals the presence of two##5##5##(1990-5#1)(1991-12#1)(1992-9#1)(1997-3#1)(2007-3#1)
reveals the presence of##21##4##(1990-11#1)(1990-12#1)(1990-5#2)(1991-12#1)(1991-2#2)(1992-6#1)(1992-9#1)(1995-12#1)(1997-3#3)(2007-12#1)(2007-3#2)(2008-11#2)(2008-7#1)(2009-7#1)(2011-1#1)
reveals the presence##23##3##(1990-11#1)(1990-12#1)(1990-5#2)(1991-12#1)(1991-2#2)(1992-6#1)(1992-9#1)(1993-3#1)(1993-4#1)(1995-12#1)(1997-3#3)(2007-12#1)(2007-3#2)(2008-11#2)(2008-7#1)(2009-7#1)(2011-1#1)
reveals the##74##2##(1990-11#1)(1990-12#2)(1990-5#2)(1991-12#1)(1991-2#2)(1992-11#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-12#2)(1995-8#1)(1996-2#1)(1996-3#1)(1997-3#3)(1997-4#1)(1997-5#1)(2006-10#4)(2006-5#1)(2006-9#1)(2007-10#1)(2007-12#3)(2007-3#2)(2007-5#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#5)(2011-12#1)(2012-12#1)(2012-2#2)(2013-1#2)
reveals their##2##2##(2010-12#1)(2010-2#1)
reveals three##2##2##(1994-9#1)(1995-6#1)
reveals two##4##2##(1994-11#1)(1995-11#1)(1995-2#1)(1995-4#1)
reveals##628##1##(1990-10#2)(1990-11#4)(1990-12#3)(1990-2#6)(1990-3#2)(1990-4#1)(1990-5#7)(1990-6#4)(1990-7#2)(1990-8#5)(1990-9#1)(1991-11#2)(1991-12#2)(1991-2#6)(1991-3#2)(1991-4#3)(1991-5#4)(1991-6#2)(1991-7#5)(1991-8#4)(1991-9#3)(1992-10#2)(1992-11#1)(1992-12#5)(1992-2#1)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#4)(1992-7#3)(1992-8#2)(1992-9#3)(1993-11#3)(1993-12#4)(1993-2#4)(1993-3#7)(1993-4#3)(1993-6#1)(1993-7#2)(1993-8#1)(1994-11#5)(1994-12#6)(1994-3#6)(1994-4#1)(1994-5#5)(1994-6#3)(1994-7#1)(1994-8#7)(1994-9#9)(1995-1#7)(1995-10#3)(1995-11#2)(1995-12#4)(1995-2#7)(1995-3#4)(1995-4#3)(1995-5#3)(1995-6#5)(1995-8#6)(1995-9#3)(1996-1#3)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#5)(1996-4#1)(1996-5#2)(1996-6#4)(1996-7#2)(1996-8#3)(1996-9#5)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#5)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#4)(1997-9#1)(2005-11#2)(2005-4#1)(2005-8#2)(2006-10#13)(2006-11#2)(2006-12#3)(2006-3#1)(2006-4#1)(2006-5#3)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#9)(2007-12#22)(2007-2#3)(2007-3#4)(2007-5#4)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#24)(2008-11#14)(2008-12#4)(2008-2#12)(2008-3#13)(2008-4#6)(2008-5#9)(2008-6#1)(2008-7#12)(2008-8#11)(2008-9#8)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#4)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#1)(2010-10#10)(2010-11#2)(2010-12#7)(2010-2#3)(2010-4#3)(2010-5#4)(2010-6#6)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#15)(2011-12#3)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#8)(2012-2#20)(2012-3#7)(2013-1#16)(2013-7#2)(2013-8#5)
revelation of##3##2##(1993-1#1)(2008-5#1)(2012-2#1)
revelations##2##1##(2007-7#1)(2013-8#1)
reveled##4##1##(2008-10#1)(2010-11#1)(2011-2#1)(2012-12#1)
revenge##4##1##(1997-5#1)(2008-12#1)(2008-4#1)(2011-1#1)
revenue and##6##2##(1991-3#1)(1992-12#1)(1995-3#1)(2007-4#1)(2008-11#2)
revenue cycle##3##2##(2007-1#1)(2007-9#2)
revenue generation activities##2##3##(1991-12#2)
revenue generation##5##2##(1991-12#5)
revenue in##2##2##(2005-7#1)(2007-4#1)
revenue levels##2##2##(2008-7#2)
revenue opportunities##2##2##(2007-1#2)
revenue was##3##2##(1992-1#1)(1994-9#1)(2008-11#1)
revenue##57##1##(1990-5#1)(1991-1#1)(1991-12#5)(1991-3#4)(1992-1#1)(1992-12#5)(1992-2#1)(1992-3#1)(1993-12#1)(1994-1#1)(1994-2#2)(1994-9#1)(1995-3#1)(1995-8#1)(1996-2#2)(1996-3#2)(1997-3#2)(2005-7#1)(2007-1#4)(2007-2#1)(2007-4#4)(2007-5#1)(2007-9#4)(2008-11#5)(2008-7#2)(2008-8#1)(2009-8#1)(2010-8#1)
revenues and expenses##3##3##(2007-4#1)(2010-8#2)
revenues and profits##3##3##(1991-3#1)(2007-4#1)(2008-11#1)
revenues and##9##2##(1991-3#1)(1992-12#1)(2007-4#2)(2008-11#1)(2010-8#2)(2013-1#2)
revenues generated##2##2##(2004-9#2)
revenues grew more##2##3##(1993-3#2)
revenues of##2##2##(1992-1#1)(2008-5#1)
revenues that##2##2##(1992-3#1)(2010-12#1)
revenues##37##1##(1990-12#1)(1991-3#1)(1992-1#1)(1992-12#3)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#2)(1994-1#2)(1994-3#1)(1995-2#2)(1996-12#1)(2004-9#2)(2005-9#1)(2007-4#7)(2007-9#1)(2008-11#3)(2008-5#1)(2010-12#1)(2010-8#2)(2013-1#2)
reverberation activity##2##2##(2008-11#2)
reverberation##5##1##(2008-11#3)(2008-2#1)(2008-9#1)
reversal VEP##2##2##(1991-4#2)
reversal agents##4##2##(2006-10#1)(2007-2#3)
reversal and##4##2##(1993-3#1)(1995-11#2)(2012-2#1)
reversal by##4##2##(1990-2#1)(1990-7#1)(1995-3#1)(2008-7#1)
reversal effect##2##2##(1997-5#1)(2008-5#1)
reversal from##3##2##(1997-5#1)(2008-5#1)(2008-6#1)
reversal in the##6##3##(1992-6#1)(1995-11#1)(2006-10#1)(2008-10#1)(2009-6#1)(2009-7#1)
reversal in##12##2##(1990-11#1)(1990-8#1)(1992-6#1)(1993-2#1)(1995-11#2)(2006-10#1)(2008-10#1)(2008-3#1)(2009-6#1)(2009-7#1)(2011-2#1)
reversal is##4##2##(1995-11#1)(2006-8#1)(2007-11#1)(2008-10#1)
reversal learning##2##2##(1993-3#1)(1994-2#1)
reversal of EMT##2##3##(2012-12#2)
reversal of an##2##3##(2006-12#1)(2008-7#1)
reversal of drug resistance##2##4##(1990-2#1)(1995-8#1)
reversal of stereoselectivity##2##3##(1991-12#2)
reversal of the inhibition##2##4##(1996-2#1)(1997-7#1)
reversal of the inhibitory effect of##2##6##(1993-12#1)(1997-5#1)
reversal of the##30##3##(1990-8#1)(1992-10#1)(1992-12#1)(1993-12#1)(1994-5#1)(1994-9#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1997-5#3)(1997-7#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#1)(2008-7#1)(2010-8#1)
reversal of this##2##3##(1992-8#1)(1996-7#1)
reversal of tolerance##4##3##(1996-10#1)(1996-2#3)
reversal of ultrafast waveforms by wave mixing##2##7##(2007-12#2)
reversal of ultrafast##3##3##(2007-12#3)
reversal of##109##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-7#1)(1990-8#1)(1991-12#3)(1991-3#1)(1991-4#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-6#1)(1995-7#2)(1995-8#1)(1996-1#1)(1996-10#4)(1996-11#1)(1996-2#4)(1996-7#2)(1996-8#1)(1997-2#1)(1997-5#3)(1997-7#1)(2004-4#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#2)(2006-5#2)(2006-7#1)(2006-8#1)(2007-11#5)(2007-12#6)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#5)(2012-3#1)(2013-1#1)
reversal potential and##3##3##(1991-9#1)(1993-12#1)(1994-2#1)
reversal potential for##3##3##(1991-3#1)(1992-9#1)(1993-2#1)
reversal potential of the current##2##5##(1993-12#1)(1995-12#1)
reversal potential of the##5##4##(1991-9#1)(1993-12#1)(1994-2#1)(1995-12#1)(1995-6#1)
reversal potential of##8##3##(1990-7#1)(1991-9#1)(1993-12#1)(1994-2#1)(1995-12#1)(1995-6#2)(1997-1#1)
reversal potential was##2##3##(1992-11#1)(1994-2#1)
reversal potential##22##2##(1990-7#1)(1991-3#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-7#1)(1992-9#1)(1993-12#2)(1993-2#1)(1994-2#3)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-9#1)(1997-1#1)
reversal provides##2##2##(1990-11#1)(2008-10#1)
reversal times##2##2##(2008-10#2)
reversal to##2##2##(2008-10#1)(2011-2#1)
reversal with##2##2##(2010-4#1)(2013-8#1)
reversal##225##1##(1990-11#4)(1990-12#1)(1990-2#3)(1990-7#3)(1990-8#2)(1991-11#1)(1991-12#3)(1991-3#2)(1991-4#3)(1991-8#1)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#2)(1993-3#3)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#4)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#11)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#3)(1995-7#2)(1995-8#2)(1996-1#2)(1996-10#4)(1996-11#1)(1996-2#4)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#5)(1997-7#1)(2004-11#1)(2004-4#1)(2005-11#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-4#2)(2006-5#2)(2006-7#1)(2006-8#2)(2007-11#6)(2007-12#7)(2007-2#3)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#14)(2008-11#3)(2008-2#6)(2008-3#10)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-6#3)(2009-7#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
reversal)##2##1##(1995-11#1)(2010-10#1)
reversals are##2##2##(2008-2#1)(2013-1#1)
reversals in##2##2##(2008-8#2)
reversals of the##3##3##(1991-1#1)(1995-12#1)(2008-10#1)
reversals of##6##2##(1991-1#1)(1995-12#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)
reversals##25##1##(1990-7#1)(1991-1#1)(1992-6#1)(1993-5#1)(1995-12#1)(1995-6#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#4)(2008-4#1)(2008-8#2)(2008-9#1)(2013-1#3)
reverse Na-Ca exchange##2##3##(2013-1#2)
reverse PCR##2##2##(1992-11#2)
reverse Trendelenburg position##2##3##(2013-7#2)
reverse a##2##2##(1996-11#1)(2009-4#1)
reverse activation barrier##2##3##(2006-1#1)(2006-4#1)
reverse and forward##2##3##(2007-12#1)(2008-10#1)
reverse and##3##2##(2007-12#1)(2008-10#1)(2011-1#1)
reverse bias##2##2##(2005-11#1)(2007-11#1)
reverse causation##2##2##(2012-12#2)
reverse correlation##2##2##(2008-7#1)(2013-8#1)
reverse direction and##2##3##(1996-5#1)(2008-10#1)
reverse direction##4##2##(1992-3#1)(1996-5#1)(2008-10#1)(2008-5#1)
reverse dot blot hybridization##4##4##(1997-2#3)(2008-10#1)
reverse dot blot system##2##4##(2008-10#2)
reverse dot blot##7##3##(1996-7#1)(1997-2#3)(2008-10#3)
reverse electron transfer from NADH to ubiquinone##2##7##(1990-8#2)
reverse electron transfer##3##3##(1990-8#3)
reverse engineering of##2##3##(2010-10#1)(2010-9#1)
reverse fibrosis##2##2##(2009-8#1)(2012-12#1)
reverse flow injection analysis##2##4##(2008-10#2)
reverse flow injection method##2##4##(2008-10#2)
reverse flow injection##5##3##(2008-10#5)
reverse flow##11##2##(1992-5#1)(2006-4#1)(2008-10#7)(2008-12#2)
reverse flow-injection##2##2##(2008-10#2)
reverse genetic##5##2##(2009-2#1)(2012-11#3)(2013-8#1)
reverse genetics in##2##3##(2006-12#1)(2008-2#1)
reverse genetics##15##2##(2006-12#1)(2007-12#4)(2008-2#1)(2008-7#3)(2008-8#1)(2009-5#1)(2011-1#1)(2012-11#2)(2012-3#1)
reverse hemolytic plaque assay##2##4##(1995-10#1)(2008-4#1)
reverse hybridization##3##2##(2007-12#1)(2008-4#2)
reverse iontophoresis##3##2##(2006-5#3)
reverse its##2##2##(1991-7#1)(2007-10#1)
reverse latissimus dorsi##2##3##(2008-7#2)
reverse light##2##2##(1997-6#2)
reverse micellar system##2##3##(2005-11#2)
reverse micellar##6##2##(1992-8#1)(1995-3#1)(2005-11#2)(2006-12#1)(2008-10#1)
reverse micelles##12##2##(1992-8#3)(1995-2#3)(1995-3#1)(1995-4#1)(2005-11#2)(2006-12#1)(2010-1#1)
reverse mutation##3##2##(1990-6#1)(2007-7#1)(2011-2#1)
reverse oblique fractures##3##3##(2013-1#3)
reverse oblique##5##2##(2013-1#5)
reverse of the &quot##2##4##(1991-12#1)(2010-7#1)
reverse of the##6##3##(1990-2#1)(1991-12#1)(1992-6#1)(1995-9#1)(2007-11#1)(2010-7#1)
reverse of##8##2##(1990-2#1)(1991-12#1)(1992-6#1)(1995-9#1)(2007-11#2)(2010-7#1)(2011-2#1)
reverse order##5##2##(1991-11#1)(1993-2#1)(2007-12#1)(2008-10#2)
reverse orientation##4##2##(1995-4#1)(1996-12#1)(1997-4#1)(2005-11#1)
reverse passive haemagglutination##2##3##(1995-2#2)
reverse peptide##2##2##(1991-4#1)(1994-11#1)
reverse phase HPLC##7##3##(1990-12#1)(1991-1#1)(1991-8#1)(1995-5#1)(2007-8#1)(2008-10#1)(2008-8#1)
reverse phase and##2##3##(1991-8#1)(1994-11#1)
reverse phase chromatography##2##3##(1997-4#1)(2008-10#1)
reverse phase high performance liquid chromatography (HPLC)##2##7##(1992-9#1)(1997-3#1)
reverse phase high performance liquid chromatography##9##6##(1990-7#1)(1992-12#1)(1992-4#1)(1992-9#1)(1994-6#1)(1997-3#1)(2007-8#1)(2008-10#1)(2010-12#1)
reverse phase liquid chromatographic method has been developed##2##8##(2010-2#1)(2010-3#1)
reverse phase liquid chromatography##3##4##(2008-10#2)(2010-2#1)
reverse phase liquid##5##3##(2008-10#2)(2010-2#2)(2010-3#1)
reverse phase##38##2##(1990-12#1)(1990-7#1)(1991-1#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-4#1)(1992-9#2)(1994-11#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-5#1)(1997-3#1)(1997-4#1)(2007-8#3)(2008-10#8)(2008-5#1)(2008-8#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2011-2#1)
reverse polarity##2##2##(2008-4#1)(2008-9#1)
reverse primers##2##2##(1990-2#1)(1994-8#1)
reverse radial forearm##2##3##(2008-9#2)
reverse rate constants##3##3##(1990-12#1)(1992-4#1)(1997-2#1)
reverse rate##4##2##(1990-12#1)(1992-4#1)(1997-2#1)(2009-2#1)
reverse reaction##10##2##(1991-5#1)(1991-9#2)(1993-3#1)(1994-8#2)(1995-6#1)(2006-10#1)(2008-3#2)
reverse remodeling##4##2##(2007-8#2)(2010-11#1)(2012-1#1)
reverse sample genome##2##3##(2005-12#2)
reverse saturable absorber materials##2##4##(2008-3#2)
reverse saturable absorber##3##3##(2007-12#1)(2008-3#2)
reverse saturable absorption##2##3##(2007-12#1)(2008-3#1)
reverse saturable##5##2##(2007-12#2)(2008-3#3)
reverse simulated annealing##2##3##(2008-3#2)
reverse some of the##2##4##(1996-7#1)(2008-1#1)
reverse some of##4##3##(1996-7#1)(2005-8#1)(2006-9#1)(2008-1#1)
reverse some##5##2##(1996-7#1)(2005-8#1)(2006-9#1)(2008-1#2)
reverse the effects of##5##4##(1993-11#1)(1995-2#1)(2007-10#1)(2008-5#1)(2011-1#1)
reverse the inhibitory effect of##3##5##(1990-7#1)(1992-6#1)(1996-8#1)
reverse the inhibitory##4##3##(1990-7#1)(1992-6#1)(1996-8#1)(2013-1#1)
reverse the process of fibrosis##2##5##(2012-12#2)
reverse the process of##3##4##(1992-9#1)(2012-12#2)
reverse the process##4##3##(1992-9#1)(1995-3#1)(2012-12#2)
reverse the transformed##3##3##(1996-4#2)(1997-1#1)
reverse the trend##3##3##(1991-3#1)(1992-8#1)(2009-12#1)
reverse the##62##2##(1990-7#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-4#2)(1996-5#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-8#1)(2004-11#2)(2005-10#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-2#1)(2007-10#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)
reverse these##4##2##(2006-9#1)(2008-1#1)(2012-2#2)
reverse this##6##2##(1990-8#1)(1991-3#1)(1991-6#1)(1996-10#1)(1997-5#1)(2008-8#1)
reverse to the##3##3##(2007-1#1)(2007-7#1)(2008-5#1)
reverse tolerance in##2##3##(1996-10#1)(1996-2#1)
reverse tolerance##3##2##(1996-10#2)(1996-2#1)
reverse transcribed and##3##3##(1990-12#1)(1991-11#1)(2008-2#1)
reverse transcribed##6##2##(1990-12#1)(1991-11#1)(1993-3#1)(1995-10#1)(2008-2#1)(2008-4#1)
reverse transcriptase (RT) and##3##4##(1997-2#1)(1997-6#1)(2007-3#1)
reverse transcriptase (RT)##13##3##(1991-9#1)(1994-6#2)(1995-1#1)(1995-8#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-6#1)(2006-3#1)(2007-3#1)(2013-1#1)
reverse transcriptase activity##6##3##(1991-12#2)(1993-9#1)(1994-6#2)(2008-11#1)
reverse transcriptase and##6##3##(1991-2#2)(1993-9#1)(1997-6#1)(2008-1#1)(2011-3#1)
reverse transcriptase at the##2##4##(1990-2#1)(1991-10#1)
reverse transcriptase enzyme##2##3##(1993-9#1)(2008-5#1)
reverse transcriptase inhibitor##8##3##(1996-4#1)(2005-7#1)(2007-11#1)(2008-5#1)(2009-11#1)(2009-12#1)(2011-2#2)
reverse transcriptase inhibitor-based##3##3##(2007-12#1)(2009-4#1)(2012-2#1)
reverse transcriptase inhibitors and protease inhibitors##2##6##(2006-11#1)(2008-1#1)
reverse transcriptase inhibitors and##4##4##(2006-11#1)(2007-11#1)(2008-1#1)(2009-4#1)
reverse transcriptase inhibitors##28##3##(1993-9#2)(1995-8#1)(2005-7#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-3#1)(2009-12#1)(2009-4#4)(2010-3#1)(2011-2#4)(2011-3#3)(2012-11#2)(2012-12#3)
reverse transcriptase or##2##3##(1990-3#1)(2011-3#1)
reverse transcriptase polymerase chain reaction (RT-PCR)##7##6##(1994-11#1)(1996-12#1)(1997-4#1)(2008-1#1)(2008-5#1)(2008-7#1)(2013-1#1)
reverse transcriptase polymerase chain reaction and##5##6##(1995-2#1)(1997-3#1)(2007-12#1)(2011-2#1)(2012-12#1)
reverse transcriptase polymerase chain reaction##19##5##(1993-9#2)(1994-11#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
reverse transcriptase using##4##3##(1991-2#3)(1992-9#1)
reverse transcriptase were##2##3##(1994-12#1)(1994-6#1)
reverse transcriptase##154##2##(1990-10#1)(1990-2#3)(1990-3#1)(1990-9#2)(1991-10#2)(1991-12#3)(1991-2#5)(1991-9#1)(1992-11#2)(1992-3#2)(1992-6#1)(1992-9#2)(1993-3#3)(1993-6#1)(1993-9#12)(1994-11#1)(1994-12#2)(1994-6#6)(1994-8#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-8#3)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#2)(1996-7#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#3)(1997-7#1)(2005-7#2)(2006-11#2)(2006-3#1)(2007-11#2)(2007-12#4)(2007-3#1)(2008-1#5)(2008-10#1)(2008-11#7)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#1)(2009-11#2)(2009-12#2)(2009-4#5)(2009-7#2)(2009-8#1)(2010-3#1)(2011-2#8)(2011-3#8)(2012-11#2)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
reverse transcriptase-PCR##3##2##(1995-1#1)(1997-4#1)(2009-7#1)
reverse transcriptase-activity##2##2##(2008-11#2)
reverse transcriptase-polymerase chain reaction (RT-PCR)##11##5##(1994-2#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-2#2)(1997-6#1)(2005-10#1)(2007-8#1)(2008-5#1)(2008-8#1)
reverse transcriptase-polymerase chain reaction and##2##5##(1995-3#1)(2008-5#1)
reverse transcriptase-polymerase chain reaction##25##4##(1993-6#1)(1994-11#1)(1994-2#1)(1994-9#2)(1995-12#1)(1995-3#1)(1996-12#3)(1996-2#2)(1997-6#1)(1997-7#1)(1997-9#1)(2005-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-8#1)(2012-3#1)
reverse transcriptase-polymerase chain##26##3##(1993-6#1)(1994-11#1)(1994-2#1)(1994-9#2)(1995-12#1)(1995-3#1)(1996-12#3)(1996-2#3)(1997-6#1)(1997-7#1)(1997-9#1)(2005-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-8#1)(2012-3#1)
reverse transcriptases##4##2##(1991-12#1)(1992-8#1)(1994-9#1)(2006-11#1)
reverse transcription (RT) and##2##4##(1994-9#1)(1996-4#1)
reverse transcription (RT)##4##3##(1992-9#1)(1994-9#1)(1996-4#1)(2008-4#1)
reverse transcription PCR in##2##4##(1993-8#1)(2011-2#1)
reverse transcription PCR##8##3##(1992-8#1)(1993-8#1)(2008-2#2)(2008-6#1)(2008-8#1)(2010-5#1)(2011-2#1)
reverse transcription and PCR##2##4##(1992-12#1)(2008-4#1)
reverse transcription and polymerase chain reaction (RT-PCR)##2##7##(1993-7#1)(1995-12#1)
reverse transcription and polymerase chain reaction##7##6##(1992-9#2)(1993-7#1)(1995-12#2)(1996-11#1)(2011-2#1)
reverse transcription and##12##3##(1991-7#1)(1992-12#1)(1992-9#2)(1993-7#1)(1993-8#1)(1995-12#2)(1996-11#1)(2008-4#1)(2010-5#1)(2011-2#1)
reverse transcription coupled to polymerase chain reaction##2##7##(1994-2#1)(1994-6#1)
reverse transcription is##2##3##(1996-11#2)
reverse transcription loop-mediated isothermal amplification##2##5##(2012-2#2)
reverse transcription of##3##3##(1994-3#1)(1995-8#1)(2008-4#1)
reverse transcription polymerase chain reaction (RT-PCR)##11##6##(1992-12#1)(1995-11#1)(1996-12#1)(2005-11#1)(2007-10#1)(2007-6#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)
reverse transcription polymerase chain reaction and##2##6##(2008-10#1)(2008-8#1)
reverse transcription polymerase chain reaction##19##5##(1992-12#1)(1995-11#1)(1996-12#1)(1997-7#1)(2005-11#1)(2007-10#2)(2007-12#1)(2007-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
reverse transcription polymerase chain##20##4##(1992-12#1)(1995-11#1)(1996-12#1)(1997-7#1)(2005-11#1)(2007-10#2)(2007-12#1)(2007-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
reverse transcription##71##2##(1990-11#1)(1991-10#1)(1991-7#1)(1992-12#3)(1992-6#1)(1992-8#1)(1992-9#3)(1993-12#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#2)(1994-9#2)(1995-11#1)(1995-12#2)(1995-8#1)(1996-11#3)(1996-12#1)(1996-4#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-11#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-6#1)(2008-10#2)(2008-2#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
reverse transcription-PCR##15##2##(1993-12#1)(1993-5#1)(1995-8#1)(1996-12#1)(1996-4#2)(1997-4#2)(2007-3#1)(2008-9#3)(2010-11#1)(2011-2#1)(2013-8#1)
reverse transcription-polymerase chain reaction (RT-PCR) analysis##2##6##(1992-8#1)(2008-10#1)
reverse transcription-polymerase chain reaction (RT-PCR) and Northern##2##7##(1994-11#1)(1995-5#1)
reverse transcription-polymerase chain reaction (RT-PCR) and##5##6##(1994-11#1)(1995-10#1)(1995-5#1)(2008-10#1)(2010-12#1)
reverse transcription-polymerase chain reaction (RT-PCR) in##2##6##(2008-10#2)
reverse transcription-polymerase chain reaction (RT-PCR) method##5##6##(1992-11#1)(1994-12#1)(1996-11#1)(1996-6#1)(2008-10#1)
reverse transcription-polymerase chain reaction (RT-PCR) was used##2##7##(2008-10#2)
reverse transcription-polymerase chain reaction (RT-PCR) was##4##6##(1994-3#1)(2004-11#1)(2008-10#2)
reverse transcription-polymerase chain reaction (RT-PCR)##39##5##(1992-11#1)(1992-8#1)(1993-12#1)(1993-4#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-7#1)(2004-11#1)(2006-4#1)(2008-10#12)(2008-11#1)(2008-5#1)(2008-9#1)(2010-1#1)(2010-12#1)
reverse transcription-polymerase chain reaction analysis##2##5##(2008-10#1)(2011-2#1)
reverse transcription-polymerase chain reaction and##4##5##(1995-12#1)(2008-10#2)(2009-9#1)
reverse transcription-polymerase chain reaction assay##2##5##(2004-11#1)(2008-10#1)
reverse transcription-polymerase chain reaction followed by Southern##2##7##(1993-3#1)(1997-5#1)
reverse transcription-polymerase chain reaction procedure##2##5##(2008-10#2)
reverse transcription-polymerase chain reaction with##2##5##(2008-10#2)
reverse transcription-polymerase chain reaction##85##4##(1991-10#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-12#4)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-5#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#2)(2004-11#2)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#1)(2008-10#30)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-9#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#2)
reverse transcription-polymerase chain reactions##2##4##(1995-3#1)(2008-10#1)
reverse transcription-polymerase chain##88##3##(1991-10#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-12#4)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#2)(2004-11#2)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#1)(2008-10#31)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-9#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#2)
reverse transfection array##2##3##(2008-7#2)
reverse transfection##4##2##(2008-7#4)
reverse trend was observed##2##4##(2008-10#1)(2009-4#1)
reverse trend was##3##3##(2008-10#1)(2009-4#2)
reverse trend##4##2##(2005-11#1)(2008-10#1)(2009-4#2)
reverse turn##3##2##(1992-4#2)(1992-5#1)
reverse vascular##2##2##(2008-3#1)(2012-12#1)
reverse was##3##2##(1996-6#1)(2008-10#1)(2009-7#1)
reverse##862##1##(1990-10#1)(1990-11#4)(1990-12#3)(1990-2#6)(1990-3#2)(1990-6#3)(1990-7#2)(1990-8#5)(1990-9#5)(1991-1#1)(1991-10#4)(1991-11#2)(1991-12#6)(1991-2#7)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#5)(1991-8#3)(1991-9#6)(1992-1#1)(1992-11#7)(1992-12#6)(1992-3#7)(1992-4#6)(1992-5#4)(1992-6#5)(1992-8#9)(1992-9#9)(1993-11#2)(1993-12#7)(1993-2#3)(1993-3#6)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#15)(1994-11#8)(1994-12#8)(1994-2#5)(1994-3#2)(1994-5#1)(1994-6#11)(1994-8#8)(1994-9#9)(1995-1#4)(1995-10#3)(1995-11#4)(1995-12#6)(1995-2#9)(1995-3#8)(1995-4#3)(1995-5#8)(1995-6#3)(1995-8#8)(1995-9#1)(1996-1#1)(1996-10#4)(1996-11#7)(1996-12#8)(1996-2#7)(1996-3#1)(1996-4#8)(1996-5#5)(1996-6#2)(1996-7#5)(1996-8#2)(1996-9#2)(1997-1#6)(1997-2#9)(1997-3#3)(1997-4#7)(1997-5#3)(1997-6#10)(1997-7#5)(1997-8#3)(1997-9#2)(2004-11#4)(2005-10#4)(2005-11#9)(2005-12#2)(2005-7#3)(2005-8#3)(2005-9#2)(2006-1#3)(2006-10#2)(2006-11#3)(2006-12#5)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#6)(2006-8#2)(2006-9#3)(2007-1#2)(2007-10#5)(2007-11#11)(2007-12#22)(2007-3#3)(2007-6#1)(2007-7#2)(2007-8#6)(2007-9#2)(2008-1#11)(2008-10#81)(2008-11#16)(2008-12#2)(2008-2#6)(2008-3#13)(2008-4#15)(2008-5#14)(2008-6#4)(2008-7#17)(2008-8#12)(2008-9#16)(2009-10#2)(2009-11#3)(2009-12#4)(2009-2#2)(2009-4#8)(2009-5#2)(2009-7#4)(2009-8#3)(2009-9#4)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#4)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#8)(2011-2#20)(2011-3#8)(2012-1#4)(2012-11#7)(2012-12#18)(2012-2#14)(2012-3#6)(2013-1#22)(2013-7#2)(2013-8#8)
reverse-correlation##7##1##(2008-11#1)(2008-7#1)(2013-8#5)
reverse-flow injection analysis##2##3##(2008-10#2)
reverse-flow injection##3##2##(2008-10#3)
reverse-phase HPLC##22##2##(1990-10#3)(1990-5#1)(1990-7#1)(1991-1#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-7#2)(1994-5#1)(1995-5#1)(1995-8#1)(1996-9#1)(1997-2#1)(2006-12#2)(2007-12#1)(2008-10#2)(2008-7#1)
reverse-phase chromatography##7##2##(1992-12#1)(1992-5#1)(1994-11#1)(1996-4#1)(2008-10#2)(2008-6#1)
reverse-phase column##3##2##(1990-2#1)(1995-6#1)(2013-1#1)
reverse-phase high performance liquid chromatography (HPLC) and##2##7##(1991-8#1)(1992-8#1)
reverse-phase high performance liquid chromatography (RP-HPLC)##2##6##(1990-2#1)(2008-10#1)
reverse-phase high performance liquid chromatography##7##5##(1990-2#1)(1991-7#1)(1991-8#1)(1992-7#1)(1992-8#1)(2008-10#2)
reverse-phase high##8##2##(1990-2#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-7#1)(1992-8#1)(2008-10#2)
reverse-phase high-performance liquid chromatography##6##4##(1990-7#1)(1990-8#1)(1993-11#1)(1993-9#1)(1995-1#1)(1995-2#1)
reverse-phase high-performance liquid##7##3##(1990-7#1)(1990-8#1)(1993-11#1)(1993-9#1)(1995-1#1)(1995-2#1)(2010-2#1)
reverse-phase high-pressure liquid chromatography##2##4##(1991-3#1)(1996-4#1)
reverse-phase liquid chromatography##2##3##(2008-10#1)(2008-5#1)
reverse-phase##54##1##(1990-10#3)(1990-2#2)(1990-5#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-4#2)(1996-9#1)(1997-2#1)(1997-6#1)(2006-12#2)(2007-12#1)(2008-10#7)(2008-5#1)(2008-6#1)(2008-7#1)(2010-2#1)(2012-2#1)(2013-1#1)
reverse-transcribed##2##1##(1995-6#1)(2008-4#1)
reverse-transcriptase polymerase chain reaction##2##4##(2008-10#2)
reverse-transcriptase##4##1##(2008-10#3)(2008-9#1)
reverse-transcription polymerase chain reaction (RT-PCR)##7##5##(1993-3#1)(1994-12#1)(2008-10#4)(2008-4#1)
reverse-transcription polymerase chain reaction##19##4##(1993-3#1)(1994-12#1)(1994-8#1)(2005-9#1)(2007-11#1)(2008-10#11)(2008-4#1)(2008-5#1)(2011-1#1)
reverse-transcription##20##1##(1993-3#1)(1994-12#1)(1994-8#1)(2005-9#1)(2007-11#1)(2008-10#11)(2008-4#2)(2008-5#1)(2011-1#1)
reversed a##4##2##(1993-7#1)(1996-5#1)(1997-5#1)(2012-12#1)
reversed after##4##2##(1991-3#1)(1992-12#1)(1993-12#1)(2007-8#1)
reversed as##2##2##(2006-4#1)(2007-12#1)
reversed at##6##2##(1991-9#1)(1992-1#1)(1994-2#1)(1995-12#1)(1997-1#1)(2006-10#1)
reversed by L-arginine##3##3##(1990-11#1)(1993-11#1)(1995-12#1)
reversed by NAC##2##3##(2009-9#2)
reversed by a##5##3##(1990-6#1)(1997-4#1)(1997-5#1)(2007-1#1)(2007-11#1)
reversed by addition of##3##4##(1990-5#1)(1990-7#1)(1994-8#1)
reversed by cyclosporin A##2##4##(1991-12#1)(1997-4#1)
reversed by hydroxylamine##2##3##(1991-4#1)(1995-3#1)
reversed by increasing the##2##4##(1991-2#1)(1993-12#1)
reversed by increasing##3##3##(1991-2#1)(1993-12#1)(2008-4#1)
reversed by pretreatment with##2##4##(1990-11#1)(1993-3#1)
reversed by sodium##2##3##(1994-9#1)(2008-5#1)
reversed by the addition of##7##5##(1990-10#1)(1991-8#1)(1994-12#1)(1995-3#1)(1997-1#1)(2008-7#1)(2008-8#1)
reversed by the opioid##2##4##(1991-1#1)(1995-6#1)
reversed by the##19##3##(1990-10#1)(1990-7#1)(1991-1#1)(1991-8#2)(1991-9#1)(1992-7#1)(1994-12#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-1#1)(2007-10#1)(2008-10#1)(2008-7#1)(2008-8#1)
reversed by treatment##2##3##(1992-8#1)(1997-7#1)
reversed by two##2##3##(1993-2#1)(2009-10#1)
reversed by##106##2##(1990-10#2)(1990-11#3)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#3)(1991-1#3)(1991-12#1)(1991-2#2)(1991-4#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#2)(1993-5#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#4)(1994-9#2)(1995-12#5)(1995-2#1)(1995-3#3)(1995-5#3)(1995-6#2)(1996-1#1)(1996-12#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-5#2)(1997-7#1)(1997-8#1)(2004-11#1)(2005-8#1)(2006-3#1)(2007-1#1)(2007-10#2)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-9#2)(2010-4#1)(2012-12#4)(2013-1#1)(2013-7#1)(2013-8#1)
reversed causation##2##2##(2012-1#2)
reversed flow##4##2##(1991-3#2)(1993-3#1)(2008-10#1)
reversed from##2##2##(1991-3#1)(2008-10#1)
reversed hexagonal##2##2##(1990-12#2)
reversed if##2##2##(1996-5#1)(2013-1#1)
reversed in the##3##3##(1991-3#1)(1996-1#1)(2012-3#1)
reversed in##9##2##(1990-3#1)(1991-3#1)(1993-2#1)(1996-1#1)(1996-10#1)(1996-5#1)(2008-12#1)(2012-3#2)
reversed inhibition of##2##3##(1995-12#1)(2005-8#1)
reversed its##2##2##(1995-7#1)(2008-10#1)
reversed micellar##3##2##(1990-5#2)(2008-10#1)
reversed micelles as##3##3##(2008-10#3)
reversed micelles of##4##3##(1992-7#1)(1995-12#1)(1995-3#1)(2008-10#1)
reversed micelles upon addition of##2##5##(2005-11#2)
reversed micelles##19##2##(1990-5#1)(1992-7#2)(1995-12#1)(1995-3#3)(2005-11#6)(2008-10#5)(2008-6#1)
reversed on##4##2##(1991-3#1)(1991-7#1)(1994-11#1)(2008-3#1)
reversed phase HPLC##6##3##(1990-10#1)(1991-5#1)(1992-1#1)(1995-5#1)(2007-1#1)(2008-10#1)
reversed phase and##4##3##(2008-10#3)(2011-2#1)
reversed phase chromatography##7##3##(1993-9#1)(1994-11#1)(1996-7#1)(2008-10#4)
reversed phase column##3##3##(1992-8#1)(2008-10#1)(2008-6#1)
reversed phase columns##2##3##(2008-10#1)(2008-5#1)
reversed phase high performance liquid chromatographic##2##6##(2008-10#1)(2010-2#1)
reversed phase high performance liquid chromatography##7##6##(1990-8#1)(1993-12#1)(2008-10#3)(2008-5#1)(2011-2#1)
reversed phase high performance liquid##9##5##(1990-8#1)(1993-12#1)(2008-10#4)(2008-5#1)(2010-2#1)(2011-2#1)
reversed phase high-performance liquid chromatography and##2##6##(1995-2#1)(2007-2#1)
reversed phase liquid chromatography (RPLC)##4##5##(2008-10#4)
reversed phase liquid chromatography with##2##5##(2008-10#1)(2010-11#1)
reversed phase liquid chromatography##12##4##(1990-2#1)(2008-10#10)(2010-11#1)
reversed phase##57##2##(1990-10#1)(1990-2#1)(1990-8#1)(1991-5#1)(1992-1#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-2#1)(1995-5#1)(1996-7#1)(1996-9#2)(2004-11#1)(2007-1#1)(2007-2#1)(2008-10#30)(2008-5#3)(2008-6#1)(2010-11#2)(2010-2#1)(2011-2#2)
reversed polarity at##2##3##(1992-1#1)(1995-7#1)
reversed polarity##4##2##(1992-1#1)(1995-7#1)(2007-12#2)
reversed risperidone antinociceptive effect##2##4##(1997-5#2)
reversed saphenous vein##2##3##(2007-8#2)
reversed the CO-induced decrease in##2##5##(1994-5#2)
reversed the changes in##2##4##(1994-3#1)(1995-11#1)
reversed the effect of##2##4##(1991-4#1)(1996-10#1)
reversed the effects of##5##4##(1993-11#2)(1995-11#1)(1995-12#1)(1997-2#1)
reversed the inhibitory##3##3##(1990-11#1)(1994-2#1)(1995-7#1)
reversed the resistance##2##3##(1997-7#1)(2012-1#1)
reversed the suppression##2##3##(1997-5#1)(2008-10#1)
reversed the transformed##2##3##(1996-4#1)(2008-8#1)
reversed the##56##2##(1990-11#1)(1990-5#1)(1991-4#1)(1991-5#1)(1991-9#2)(1992-6#1)(1993-11#3)(1993-8#1)(1994-11#1)(1994-2#3)(1994-3#2)(1994-5#4)(1994-9#1)(1995-11#2)(1995-12#6)(1995-5#2)(1995-6#1)(1995-7#1)(1996-10#2)(1996-2#1)(1996-4#1)(1996-6#2)(1997-2#1)(1997-5#3)(1997-7#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
reversed this effect##3##3##(1992-1#1)(1992-11#1)(1992-3#1)
reversed this##9##2##(1991-2#2)(1992-1#1)(1992-11#1)(1992-3#1)(1993-2#1)(1993-7#1)(1996-5#1)(2008-11#1)
reversed to##3##2##(1992-3#1)(2004-4#1)(2008-10#1)
reversed upon##4##2##(1991-12#1)(1992-4#1)(1994-11#1)(1997-7#1)
reversed when##8##2##(1990-6#1)(1994-8#1)(1995-1#1)(1996-8#1)(2007-6#1)(2008-10#1)(2008-3#1)(2013-8#1)
reversed with##4##2##(2006-10#1)(2007-6#1)(2008-1#1)(2011-2#1)
reversed##452##1##(1990-10#3)(1990-11#7)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#7)(1990-6#3)(1990-7#7)(1990-8#1)(1991-1#4)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#5)(1991-3#7)(1991-4#2)(1991-5#3)(1991-7#2)(1991-8#2)(1991-9#5)(1992-1#5)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#3)(1992-8#3)(1992-9#5)(1993-11#7)(1993-12#4)(1993-2#5)(1993-3#4)(1993-4#1)(1993-5#1)(1993-7#3)(1993-8#3)(1993-9#3)(1994-11#5)(1994-12#1)(1994-2#8)(1994-3#3)(1994-5#5)(1994-6#2)(1994-8#6)(1994-9#3)(1995-1#1)(1995-11#4)(1995-12#15)(1995-2#2)(1995-3#6)(1995-5#6)(1995-6#5)(1995-7#3)(1995-8#1)(1996-1#2)(1996-10#4)(1996-12#2)(1996-2#2)(1996-4#2)(1996-5#5)(1996-6#4)(1996-7#1)(1996-8#2)(1996-9#6)(1997-1#3)(1997-2#1)(1997-4#2)(1997-5#8)(1997-7#5)(1997-8#1)(2004-10#1)(2004-11#2)(2004-4#1)(2005-10#2)(2005-11#7)(2005-8#2)(2006-10#4)(2006-12#1)(2006-3#1)(2006-4#2)(2007-1#3)(2007-10#2)(2007-11#6)(2007-12#4)(2007-2#1)(2007-6#2)(2007-8#5)(2008-1#1)(2008-10#59)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#5)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#7)(2008-9#5)(2009-10#3)(2009-11#2)(2009-2#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#3)(2010-10#1)(2010-11#2)(2010-2#2)(2010-4#1)(2011-1#1)(2011-12#2)(2011-2#5)(2012-1#3)(2012-12#5)(2012-3#3)(2012-4#1)(2013-1#4)(2013-7#2)(2013-8#2)
reversed-phase (RP) columns##2##3##(1991-3#2)
reversed-phase (RP)##4##2##(1991-3#2)(2008-10#1)(2013-8#1)
reversed-phase C18 column with a##3##5##(1990-11#1)(1992-2#1)(1997-8#1)
reversed-phase C18 column with##5##4##(1990-11#1)(1992-2#1)(1997-8#1)(2008-10#2)
reversed-phase C18 column##8##3##(1990-11#1)(1992-2#2)(1997-8#1)(2008-10#3)(2013-7#1)
reversed-phase C18##10##2##(1990-11#1)(1992-2#2)(1997-8#1)(2008-10#4)(2012-12#1)(2013-7#1)
reversed-phase HPLC column##2##3##(1996-8#1)(1997-2#1)
reversed-phase HPLC from##2##3##(1993-11#1)(2008-10#1)
reversed-phase HPLC method for##2##4##(2007-8#1)(2008-10#1)
reversed-phase HPLC method##4##3##(2007-8#1)(2008-10#3)
reversed-phase HPLC with##3##3##(1990-5#1)(1990-9#1)(1997-3#1)
reversed-phase HPLC##51##2##(1990-2#1)(1990-5#2)(1990-9#1)(1991-3#1)(1992-8#1)(1993-11#2)(1993-8#1)(1994-12#1)(1994-6#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-8#5)(1997-2#3)(1997-3#2)(1997-8#3)(2006-12#1)(2007-8#1)(2008-10#15)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
reversed-phase amino-type##2##2##(2005-12#2)
reversed-phase chromatographic separation##2##3##(2008-10#2)
reversed-phase chromatographic##7##2##(1996-6#1)(1997-3#1)(2008-10#3)(2012-12#1)(2013-8#1)
reversed-phase chromatography##11##2##(1990-12#2)(1990-7#1)(1991-1#1)(1992-2#1)(1995-3#1)(1997-2#1)(1997-6#1)(2008-10#1)(2012-12#2)
reversed-phase column and##4##3##(1990-12#1)(1990-8#1)(1993-11#1)(2013-1#1)
reversed-phase column with a##2##4##(1996-8#1)(1997-1#1)
reversed-phase column with##4##3##(1996-8#1)(1997-1#1)(1997-2#1)(2007-1#1)
reversed-phase column##22##2##(1990-12#2)(1990-8#3)(1991-5#1)(1992-2#2)(1993-11#1)(1993-2#1)(1994-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#2)(2007-1#1)(2008-10#1)(2013-1#1)
reversed-phase columns##11##2##(1990-12#1)(1991-3#2)(1992-11#1)(1992-2#1)(1996-5#1)(1996-6#1)(2005-12#1)(2008-10#3)
reversed-phase high performance liquid chromatographic method##3##6##(2005-12#1)(2007-1#1)(2010-12#1)
reversed-phase high performance liquid chromatographic##5##5##(2005-12#2)(2007-1#1)(2008-10#1)(2010-12#1)
reversed-phase high performance liquid chromatography (RP-HPLC)##3##6##(1996-7#1)(2005-3#1)(2011-1#1)
reversed-phase high performance liquid chromatography##12##5##(1990-7#1)(1996-5#2)(1996-7#1)(2005-12#1)(2005-3#1)(2008-10#4)(2008-11#1)(2011-1#1)
reversed-phase high performance liquid chromatography]##4##5##(2005-12#2)(2005-3#1)(2011-1#1)
reversed-phase high performance liquid##21##4##(1990-7#1)(1996-5#2)(1996-7#1)(2005-12#5)(2005-3#2)(2007-1#1)(2008-10#5)(2008-11#1)(2010-12#1)(2011-1#2)
reversed-phase high##22##2##(1990-7#1)(1993-9#1)(1996-5#2)(1996-7#1)(2005-12#5)(2005-3#2)(2007-1#1)(2008-10#5)(2008-11#1)(2010-12#1)(2011-1#2)
reversed-phase high-performance liquid chromatographic (HPLC) method has been developed##2##9##(1990-6#1)(1991-8#1)
reversed-phase high-performance liquid chromatographic (HPLC) method##3##6##(1990-6#1)(1991-8#1)(1997-8#1)
reversed-phase high-performance liquid chromatographic (HPLC)##4##5##(1990-6#1)(1991-8#1)(1993-2#1)(1997-8#1)
reversed-phase high-performance liquid chromatographic (RP-HPLC) method##3##6##(1995-6#1)(2008-10#1)(2012-12#1)
reversed-phase high-performance liquid chromatographic assay for##2##6##(1991-5#1)(1996-6#1)
reversed-phase high-performance liquid chromatographic assay##3##5##(1991-5#1)(1996-6#1)(1997-3#1)
reversed-phase high-performance liquid chromatographic method for the##3##7##(1991-5#1)(1992-2#1)(1993-2#1)
reversed-phase high-performance liquid chromatographic method for##4##6##(1991-5#1)(1992-2#2)(1993-2#1)
reversed-phase high-performance liquid chromatographic method with##2##6##(1990-8#1)(1996-3#1)
reversed-phase high-performance liquid chromatographic method##10##5##(1990-6#2)(1990-8#1)(1991-5#1)(1992-2#3)(1993-2#1)(1996-3#1)(2008-10#1)
reversed-phase high-performance liquid chromatographic##25##4##(1990-6#3)(1990-8#1)(1991-5#3)(1991-8#1)(1992-2#4)(1992-7#1)(1993-2#2)(1995-6#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-8#1)(2008-10#2)(2012-12#1)
reversed-phase high-performance liquid chromatography (HPLC)##5##5##(1990-8#1)(1992-6#1)(1997-8#1)(2008-10#2)
reversed-phase high-performance liquid chromatography (RP-HPLC)##10##5##(1990-8#1)(1992-2#1)(1993-9#1)(1996-8#3)(2008-10#3)(2013-7#1)
reversed-phase high-performance liquid chromatography after##2##5##(1991-12#1)(1996-6#1)
reversed-phase high-performance liquid chromatography and##6##5##(1992-6#1)(1993-9#1)(1996-5#1)(1996-6#1)(1996-8#1)(2008-10#1)
reversed-phase high-performance liquid chromatography method##2##5##(1997-2#1)(2010-4#1)
reversed-phase high-performance liquid chromatography using##8##5##(1990-11#2)(1990-6#1)(1991-5#1)(1991-8#1)(1996-6#1)(1997-8#1)(2008-10#1)
reversed-phase high-performance liquid chromatography with mass spectrometry##2##7##(1993-11#1)(2007-8#1)
reversed-phase high-performance liquid chromatography with photodiode-array detection##2##7##(1990-11#1)(1990-3#1)
reversed-phase high-performance liquid chromatography with##15##5##(1990-11#1)(1990-3#1)(1990-8#1)(1991-5#2)(1992-2#1)(1993-11#1)(1996-5#1)(1996-8#1)(1997-8#1)(2007-8#1)(2008-10#3)(2010-4#1)
reversed-phase high-performance liquid chromatography##71##4##(1990-11#4)(1990-12#1)(1990-3#1)(1990-6#2)(1990-8#6)(1990-9#1)(1991-12#1)(1991-5#7)(1991-8#2)(1992-2#2)(1992-6#3)(1993-11#1)(1993-9#3)(1995-11#1)(1995-6#2)(1996-5#3)(1996-6#3)(1996-8#5)(1997-2#2)(1997-8#3)(2007-8#1)(2008-10#14)(2010-4#2)(2013-7#1)
reversed-phase high-performance liquid##98##3##(1990-11#4)(1990-12#1)(1990-3#1)(1990-6#5)(1990-8#7)(1990-9#1)(1991-12#1)(1991-5#10)(1991-8#3)(1992-2#6)(1992-6#3)(1992-7#1)(1993-11#1)(1993-2#2)(1993-9#3)(1995-11#1)(1995-6#3)(1996-3#1)(1996-5#4)(1996-6#4)(1996-8#7)(1997-2#2)(1997-3#1)(1997-8#4)(2007-11#1)(2007-8#1)(2008-10#16)(2010-4#2)(2012-12#1)(2013-7#1)
reversed-phase high-performance or medium-pressure liquid chromatography##2##6##(1992-7#2)
reversed-phase high-performance##101##2##(1990-11#4)(1990-12#1)(1990-3#1)(1990-6#5)(1990-8#7)(1990-9#1)(1991-12#1)(1991-5#10)(1991-8#3)(1992-2#6)(1992-6#3)(1992-7#3)(1993-11#1)(1993-2#2)(1993-9#3)(1995-11#1)(1995-6#3)(1996-3#1)(1996-5#4)(1996-6#4)(1996-8#7)(1997-2#2)(1997-3#1)(1997-8#4)(2007-11#1)(2007-8#1)(2008-10#17)(2010-4#2)(2012-12#1)(2013-7#1)
reversed-phase high-pressure liquid chromatography (HPLC)##2##5##(1990-2#1)(2008-6#1)
reversed-phase high-pressure liquid chromatography##3##4##(1990-2#1)(1991-2#1)(2008-6#1)
reversed-phase ion-pair HPLC##2##3##(2008-10#2)
reversed-phase ion-pair chromatography##2##3##(1990-12#1)(2009-10#1)
reversed-phase ion-pair high-performance liquid chromatography with##2##6##(1992-1#1)(2008-10#1)
reversed-phase ion-pair high-performance liquid chromatography##4##5##(1992-1#2)(1997-8#1)(2008-10#1)
reversed-phase ion-pair high-performance liquid##5##4##(1992-1#2)(1997-8#1)(2007-8#1)(2008-10#1)
reversed-phase ion-pair##11##2##(1990-12#1)(1992-1#2)(1997-8#1)(2007-8#2)(2008-10#4)(2009-10#1)
reversed-phase liquid chromatographic method##5##4##(1990-6#1)(1997-3#1)(2007-8#1)(2010-12#1)(2013-7#1)
reversed-phase liquid chromatographic separation of##2##5##(2008-10#2)
reversed-phase liquid chromatographic##7##3##(1990-6#1)(1997-3#1)(2007-8#1)(2008-10#2)(2010-12#1)(2013-7#1)
reversed-phase liquid chromatography (HPLC)##2##4##(2008-10#1)(2008-5#1)
reversed-phase liquid chromatography and##2##4##(1990-12#1)(1991-1#1)
reversed-phase liquid chromatography##16##3##(1990-12#2)(1990-6#2)(1991-1#1)(1996-5#1)(1997-8#1)(2008-10#6)(2008-5#2)(2013-8#1)
reversed-phase liquid##25##2##(1990-12#2)(1990-6#3)(1991-1#1)(1996-5#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#8)(2008-5#2)(2010-12#1)(2013-7#1)(2013-8#3)
reversed-phase mode##2##2##(1996-5#1)(2008-10#1)
reversed-phase packing##3##2##(1991-5#1)(2008-10#2)
reversed-phase separation##2##2##(1992-1#1)(2013-8#1)
reversed-phase silica##3##2##(1990-11#1)(1990-8#1)(1996-5#1)
reversed-phase stationary##2##2##(2007-8#1)(2012-12#1)
reversed-phase supports##2##2##(2008-10#1)(2012-12#1)
reversed-phase thin-layer chromatography##2##3##(1996-5#1)(2008-6#1)
reversed-phase##331##1##(1990-11#6)(1990-12#11)(1990-2#3)(1990-3#1)(1990-5#2)(1990-6#9)(1990-7#2)(1990-8#15)(1990-9#2)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#6)(1991-5#12)(1991-8#3)(1992-1#3)(1992-11#2)(1992-2#12)(1992-6#3)(1992-7#3)(1992-8#1)(1993-11#4)(1993-2#3)(1993-8#1)(1993-9#4)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-3#2)(1995-6#3)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#15)(1996-6#8)(1996-7#1)(1996-8#14)(1997-1#1)(1997-2#8)(1997-3#6)(1997-4#1)(1997-6#1)(1997-8#13)(2005-12#8)(2005-3#2)(2006-12#1)(2007-1#2)(2007-11#1)(2007-8#7)(2008-10#79)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#2)(2010-4#2)(2011-1#2)(2011-2#1)(2012-12#10)(2013-1#1)(2013-7#3)(2013-8#6)
reversed-phased##2##1##(2007-8#1)(2008-10#1)
reverses the##13##2##(1990-11#1)(1991-10#1)(1991-2#1)(1992-5#1)(1992-6#1)(1994-2#1)(1995-12#1)(1995-6#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-11#1)(2012-1#1)
reverses##38##1##(1990-11#2)(1990-2#1)(1991-10#1)(1991-2#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-7#1)(1994-11#1)(1994-2#1)(1994-5#2)(1995-12#2)(1995-6#1)(1996-10#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#2)(2007-1#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-7#1)
reversibility and##6##2##(2006-5#1)(2007-9#1)(2008-10#3)(2011-2#1)
reversibility in##5##2##(1995-3#1)(2007-2#4)
reversibility is##2##2##(1994-11#1)(2008-1#1)
reversibility of the##9##3##(1992-8#1)(2006-12#1)(2008-10#7)
reversibility of##25##2##(1990-5#1)(1992-10#1)(1992-12#1)(1992-8#1)(1993-6#1)(2005-10#1)(2005-11#1)(2006-12#1)(2007-2#2)(2008-10#10)(2008-4#1)(2008-8#1)(2009-4#1)(2011-2#1)(2013-8#1)
reversibility##58##1##(1990-5#1)(1992-10#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-6#2)(1994-11#1)(1995-1#1)(1995-3#1)(1996-11#1)(1997-2#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-12#1)(2006-5#1)(2007-2#6)(2007-9#1)(2008-1#2)(2008-10#19)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-4#1)(2011-1#1)(2011-2#4)(2013-8#1)
reversible PAI-1 binding##2##3##(1992-12#2)
reversible addition fragmentation chain transfer (RAFT)##2##6##(2008-12#1)(2009-10#1)
reversible addition##3##2##(2008-12#1)(2009-10#1)(2013-8#1)
reversible after a##2##3##(1991-3#1)(1995-7#1)
reversible after cessation of##2##4##(1994-6#1)(2008-5#1)
reversible after##8##2##(1991-11#1)(1991-3#1)(1993-12#1)(1994-6#1)(1995-7#1)(2006-10#1)(2007-2#1)(2008-5#1)
reversible airflow##2##2##(1992-3#1)(2010-10#1)
reversible airway obstruction##2##3##(1992-3#1)(2008-10#1)
reversible and irreversible##2##3##(1995-3#1)(2012-12#1)
reversible and is##2##3##(2008-8#1)(2011-2#1)
reversible and progressive brain injury##2##5##(2009-10#2)
reversible and reproducible##2##3##(1990-7#1)(2008-10#1)
reversible and saturable##2##3##(1990-8#1)(1994-2#1)
reversible and the##3##3##(1990-4#1)(2008-10#2)
reversible and was##2##3##(1990-2#1)(1992-3#1)
reversible and##33##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#1)(1990-8#1)(1992-12#1)(1992-3#1)(1993-4#1)(1994-2#2)(1994-6#1)(1994-9#1)(1995-3#1)(1996-1#1)(1996-5#1)(1996-9#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-7#1)(2008-8#1)(2009-10#2)(2011-2#2)(2012-12#1)
reversible as well as##2##4##(2008-8#1)(2012-2#1)
reversible as##3##2##(2006-8#1)(2008-8#1)(2012-2#1)
reversible binary##2##2##(1992-2#1)(1992-6#1)
reversible binding of##2##3##(1990-8#1)(1994-6#1)
reversible binding with##2##3##(1995-12#1)(2007-3#1)
reversible binding##8##2##(1990-8#1)(1994-6#1)(1995-12#2)(1996-12#1)(2007-3#1)(2008-4#1)(2009-7#1)
reversible biotinylation##2##2##(2008-4#2)
reversible bonding of the device to##2##6##(2008-11#2)
reversible by##5##2##(1991-2#1)(1996-8#1)(1997-6#1)(2008-1#1)(2009-3#1)
reversible cause of##3##3##(1991-1#1)(2006-10#1)(2008-1#1)
reversible cause##4##2##(1991-1#1)(2006-10#1)(2008-1#1)(2012-12#1)
reversible changes in the##3##4##(1990-3#1)(2008-3#2)
reversible changes in##4##3##(1990-3#1)(1996-6#1)(2008-3#2)
reversible changes##5##2##(1990-3#1)(1993-6#1)(1996-6#1)(2008-3#2)
reversible chemical##3##2##(1993-6#1)(2008-10#1)(2011-2#1)
reversible condition##3##2##(1994-6#1)(2007-10#1)(2009-10#1)
reversible contraception##2##2##(2013-1#2)
reversible decrease##2##2##(2008-11#1)(2008-8#1)
reversible denaturation##2##2##(1990-7#1)(1992-6#1)
reversible electroporation##3##2##(2009-11#3)
reversible encephalopathy syndrome (PRES)##2##4##(2012-12#1)(2013-1#1)
reversible encephalopathy syndrome##8##3##(2010-12#2)(2012-12#4)(2012-2#1)(2013-1#1)
reversible encephalopathy##9##2##(2010-12#2)(2012-12#4)(2012-2#2)(2013-1#1)
reversible fashion##3##2##(1994-2#1)(2007-12#1)(2008-12#1)
reversible following##2##2##(1996-6#1)(1997-1#1)
reversible forebrain ischemia##2##3##(1991-5#2)
reversible formation of##3##3##(2009-10#1)(2010-12#1)(2010-6#1)
reversible in all##2##3##(1991-8#1)(2008-6#1)
reversible in the##2##3##(1992-5#1)(2008-10#1)
reversible in##8##2##(1991-8#1)(1992-5#1)(1996-5#1)(2005-8#1)(2008-1#1)(2008-10#2)(2008-6#1)
reversible inactivation##2##2##(1991-2#1)(1997-4#1)
reversible increase in##5##3##(1992-3#1)(1992-8#1)(1994-5#1)(1996-3#1)(2008-3#1)
reversible increase##6##2##(1992-3#2)(1992-8#1)(1994-5#1)(1996-3#1)(2008-3#1)
reversible inhibition of the sarcoplasmic-reticulum calcium-transport enzyme##2##7##(1990-3#2)
reversible inhibition of the##3##4##(1990-3#2)(2008-10#1)
reversible inhibition of##9##3##(1990-3#2)(1991-10#1)(1992-11#1)(1993-6#1)(1995-7#1)(1996-5#1)(2007-11#1)(2008-10#1)
reversible inhibitor of##5##3##(1991-5#1)(1994-8#1)(1995-7#2)(2007-11#1)
reversible inhibitor##6##2##(1990-11#1)(1991-5#1)(1994-8#1)(1995-7#2)(2007-11#1)
reversible inhibitors of##2##3##(1993-11#1)(1995-7#1)
reversible inhibitors##6##2##(1990-5#2)(1993-11#1)(1995-7#2)(2010-9#1)
reversible interconversion between the high##2##5##(2008-10#2)
reversible ischaemia##2##2##(1990-9#1)(2005-1#1)
reversible manner##6##2##(1993-11#1)(1994-2#1)(1995-10#1)(1995-12#1)(1995-5#1)(2007-11#1)
reversible modification##2##2##(1992-6#1)(2008-4#1)
reversible monoamine##3##2##(1995-6#2)(2005-9#1)
reversible myocardial ischaemia##2##3##(1990-9#1)(2005-1#1)
reversible nature##2##2##(1990-2#1)(2008-10#1)
reversible on##5##2##(1990-5#1)(1991-12#1)(1994-12#1)(2006-10#1)(2008-1#1)
reversible or irreversible##2##3##(2005-8#1)(2011-2#1)
reversible or##3##2##(2005-8#1)(2011-2#1)(2012-3#1)
reversible phosphorylation and##2##3##(1994-3#2)
reversible phosphorylation of##3##3##(1995-6#1)(2009-5#2)
reversible phosphorylation##5##2##(1994-3#2)(1995-6#1)(2009-5#2)
reversible protein##3##2##(2005-11#1)(2008-2#1)(2008-4#1)
reversible reactions##2##2##(1997-2#1)(2006-2#1)
reversible redox##4##2##(2008-10#4)
reversible reduction potentials##2##3##(1991-10#2)
reversible reduction##4##2##(1990-5#1)(1991-10#2)(2008-10#1)
reversible sensing##2##2##(2008-10#2)
reversible since##2##2##(1990-10#1)(1992-3#1)
reversible upon removal of##3##4##(1990-10#1)(1991-5#1)(1992-11#1)
reversible upon the removal of##2##5##(1990-2#2)
reversible upon##11##2##(1990-10#2)(1990-2#2)(1991-10#1)(1991-5#1)(1992-11#1)(1995-8#1)(1996-10#1)(2005-7#1)(2006-2#1)
reversible waves##3##2##(2009-9#3)
reversible with##11##2##(1990-12#1)(1993-11#1)(1994-8#1)(1996-5#1)(1996-9#1)(1997-8#1)(2006-10#2)(2009-5#1)(2010-5#1)(2013-7#1)
reversible within the##2##3##(1995-2#1)(2008-10#1)
reversible within##4##2##(1991-3#1)(1995-2#1)(1996-11#1)(2008-10#1)
reversible work##2##2##(2006-10#2)
reversible##517##1##(1990-10#5)(1990-11#3)(1990-12#3)(1990-2#6)(1990-3#6)(1990-4#1)(1990-5#10)(1990-7#5)(1990-8#2)(1990-9#3)(1991-1#3)(1991-10#4)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#2)(1991-5#4)(1991-7#2)(1991-8#3)(1991-9#1)(1992-11#4)(1992-12#4)(1992-2#1)(1992-3#11)(1992-4#1)(1992-5#1)(1992-6#6)(1992-7#1)(1992-8#4)(1992-9#1)(1993-1#1)(1993-11#5)(1993-12#2)(1993-3#1)(1993-4#3)(1993-6#7)(1993-8#1)(1993-9#2)(1994-11#6)(1994-12#1)(1994-2#5)(1994-3#3)(1994-5#2)(1994-6#5)(1994-8#4)(1994-9#2)(1995-1#3)(1995-10#6)(1995-11#3)(1995-12#5)(1995-2#5)(1995-3#5)(1995-5#4)(1995-6#5)(1995-7#7)(1995-8#2)(1996-1#2)(1996-10#2)(1996-11#3)(1996-12#4)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#7)(1996-6#3)(1996-8#4)(1996-9#2)(1997-1#2)(1997-2#5)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#1)(2004-10#1)(2004-3#1)(2004-9#1)(2005-1#3)(2005-10#3)(2005-11#6)(2005-7#3)(2005-8#4)(2005-9#1)(2006-10#9)(2006-12#2)(2006-2#4)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#12)(2007-12#4)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#5)(2008-10#52)(2008-11#7)(2008-12#2)(2008-2#3)(2008-3#10)(2008-4#11)(2008-5#2)(2008-6#2)(2008-7#12)(2008-8#5)(2008-9#2)(2009-10#5)(2009-11#4)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#4)(2010-10#1)(2010-12#5)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-11#2)(2012-12#11)(2012-2#6)(2012-3#3)(2013-1#13)(2013-7#2)(2013-8#1)
reversibly and##2##2##(1995-8#1)(2006-3#1)
reversibly between##2##2##(2008-10#1)(2012-2#1)
reversibly blocked the##3##3##(1994-2#2)(2008-4#1)
reversibly blocked##7##2##(1990-7#1)(1993-7#1)(1994-2#2)(1995-3#1)(2008-2#1)(2008-4#1)
reversibly bound MG##2##3##(2006-5#1)(2008-11#1)
reversibly bound##3##2##(2006-5#1)(2008-11#2)
reversibly cross-linking gel##2##3##(2010-4#2)
reversibly cross-linking##3##2##(2010-4#3)
reversibly in##2##2##(1994-6#1)(2008-10#1)
reversibly inactivated by##2##3##(1990-5#1)(1997-4#1)
reversibly inhibited by##5##3##(1990-11#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-11#1)
reversibly inhibited##7##2##(1990-11#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-11#1)(1994-3#1)(1995-5#1)
reversibly inhibits the##2##3##(1997-1#1)(2009-10#1)
reversibly inhibits##3##2##(1997-1#1)(1997-5#1)(2009-10#1)
reversibly oxidized##2##2##(1990-8#1)(1997-8#1)
reversibly reduced at##2##3##(1996-2#1)(2008-5#1)
reversibly reduced##4##2##(1992-7#1)(1992-8#1)(1996-2#1)(2008-5#1)
reversibly suppressed##2##2##(1993-12#1)(1997-5#1)
reversibly to##3##2##(1990-7#1)(1994-11#1)(1996-5#1)
reversibly with##3##2##(1995-3#1)(1996-5#1)(2006-4#1)
reversibly##92##1##(1990-11#1)(1990-4#1)(1990-5#1)(1990-7#3)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#2)(1992-1#1)(1992-11#1)(1992-3#2)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-7#1)(1994-11#2)(1994-2#3)(1994-3#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-3#2)(1995-5#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#3)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#3)(1997-6#2)(1997-8#2)(2006-3#1)(2006-4#1)(2006-5#2)(2007-7#2)(2008-10#9)(2008-11#4)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-4#3)(2011-1#1)(2011-2#1)(2012-2#3)
reversing of##2##2##(2005-10#1)(2007-9#1)
reversing the##20##2##(1992-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-6#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2012-2#2)(2012-3#1)(2013-1#2)
reversing weight##2##2##(1992-8#1)(2008-3#1)
reversing##42##1##(1992-12#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-5#2)(1995-6#2)(1997-5#1)(2005-10#1)(2007-10#1)(2007-11#2)(2007-9#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2010-12#2)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
reversion events##3##2##(1997-4#3)
reversion of the##4##3##(1994-9#1)(1997-4#1)(1997-7#1)(2007-3#1)
reversion of##9##2##(1990-7#1)(1994-9#1)(1997-4#1)(1997-7#1)(2006-12#1)(2007-11#1)(2007-3#1)(2008-8#1)(2009-10#1)
reversion to##3##2##(1997-1#2)(2008-10#1)
reversion##29##1##(1990-7#1)(1991-1#1)(1992-3#1)(1994-8#2)(1994-9#1)(1997-1#3)(1997-4#4)(1997-7#1)(1997-8#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-3#1)(2008-10#3)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#1)
reversions##2##1##(1994-8#1)(2010-6#1)
revert to the##2##3##(2008-10#1)(2009-3#1)
revert to##3##2##(2008-10#2)(2009-3#1)
revert##11##1##(1994-8#2)(2006-10#2)(2006-4#1)(2008-10#3)(2008-9#1)(2009-3#1)(2012-2#1)
revertant cell lines##3##3##(1992-9#3)
revertant cells##2##2##(1991-1#1)(1995-11#1)
revertant clone R1-5##2##3##(1995-11#2)
revertant clone##3##2##(1995-11#3)
revertant virus##4##2##(1995-5#3)(2013-8#1)
revertant##21##1##(1991-1#1)(1992-9#3)(1993-9#1)(1994-10#2)(1995-11#6)(1995-5#5)(2006-11#1)(2008-8#1)(2013-8#1)
revertants of the##2##3##(1993-11#1)(1997-4#1)
revertants of##3##2##(1993-11#1)(1994-12#1)(1997-4#1)
revertants was##2##2##(1995-11#1)(1995-5#1)
revertants##22##1##(1991-1#2)(1992-2#1)(1992-3#1)(1993-11#1)(1994-12#3)(1995-11#2)(1995-5#2)(1995-6#5)(1997-4#1)(2006-11#1)(2008-10#2)(2008-9#1)
reverted back to##2##3##(2010-4#1)(2012-1#1)
reverted by the##3##3##(1993-9#1)(1996-11#1)(2009-9#1)
reverted by##5##2##(1993-9#1)(1996-11#1)(1997-1#1)(2009-9#1)(2012-3#1)
reverted to a##2##3##(1995-11#1)(2007-8#1)
reverted to normal##2##3##(1990-7#1)(1994-12#1)
reverted to the##2##3##(1997-1#1)(2012-1#1)
reverted to##13##2##(1990-7#1)(1991-7#1)(1994-12#1)(1995-11#1)(1997-1#2)(1997-7#1)(2005-8#1)(2006-4#1)(2007-8#1)(2008-10#1)(2012-1#1)(2013-8#1)
reverted with an##2##3##(2006-4#1)(2013-8#1)
reverted with##3##2##(2006-4#2)(2013-8#1)
reverted##30##1##(1990-7#1)(1991-7#1)(1992-12#1)(1992-4#1)(1993-9#1)(1994-12#1)(1995-11#1)(1996-11#1)(1997-1#3)(1997-7#2)(2005-8#1)(2006-4#3)(2007-8#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-2#2)(2012-1#2)(2012-3#1)(2013-8#2)
reverts##5##1##(1991-1#1)(1994-12#1)(1994-9#1)(1996-5#1)(2005-11#1)
review a series of##3##4##(2006-8#1)(2008-11#2)
review a##13##2##(1996-12#1)(1996-2#1)(1997-3#1)(2006-8#1)(2007-4#1)(2008-11#3)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-8#1)
review about the##2##3##(1990-10#1)(2008-12#1)
review about##5##2##(1990-10#1)(2007-3#1)(2008-12#2)(2012-3#1)
review addresses recent##3##3##(2005-8#1)(2006-10#1)(2008-1#1)
review addresses the##11##3##(2005-11#1)(2005-7#1)(2008-1#2)(2008-6#1)(2010-11#1)(2011-1#1)(2011-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
review addresses##24##2##(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#6)(2007-11#1)(2008-1#3)(2008-11#1)(2008-6#2)(2008-8#1)(2009-11#1)(2010-11#1)(2011-1#1)(2011-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
review aims at providing an##2##5##(2012-12#2)
review aims at providing##3##4##(2008-4#1)(2012-12#2)
review aims at##5##3##(2008-4#1)(2011-2#1)(2012-12#2)(2013-8#1)
review aims to summarise##2##4##(2008-9#1)(2011-1#1)
review aims to summarize the##2##5##(2011-12#1)(2013-1#1)
review aims to summarize##5##4##(2006-10#1)(2008-11#1)(2011-12#1)(2013-1#2)
review aims to##24##3##(2005-7#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-12#3)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
review aims##30##2##(2005-7#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-9#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-12#3)(2011-2#2)(2012-11#1)(2012-12#4)(2012-2#1)(2013-1#2)(2013-8#2)
review all##6##2##(2008-2#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
review also discusses##3##3##(2006-10#1)(2010-10#1)(2013-8#1)
review also##13##2##(1993-12#2)(2006-10#1)(2007-7#1)(2008-1#1)(2008-8#1)(2009-10#1)(2010-10#1)(2011-1#1)(2012-1#1)(2013-1#2)(2013-8#1)
review analyses the##2##3##(2007-11#1)(2008-6#1)
review analyzes the##2##3##(2011-1#1)(2013-1#1)
review and a new##2##4##(1993-12#1)(2008-4#1)
review and a##7##3##(1992-1#1)(1993-12#1)(1996-3#1)(1997-5#1)(2006-11#1)(2007-3#1)(2008-4#1)
review and analysis##4##3##(1992-2#1)(2007-12#1)(2010-2#1)(2013-8#1)
review and case report##2##4##(2008-11#1)(2011-12#1)
review and case report]##2##4##(2008-8#1)(2008-9#1)
review and case##7##3##(1992-12#1)(2007-1#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-12#1)
review and comment on##2##4##(2007-7#1)(2008-1#1)
review and current##2##3##(2006-8#1)(2012-2#1)
review and discuss current##3##4##(2008-1#1)(2012-12#2)
review and discuss the##4##4##(1994-2#1)(1996-2#1)(2005-8#1)(2008-8#1)
review and discuss##7##3##(1994-2#1)(1996-2#1)(2005-8#1)(2008-1#1)(2008-8#1)(2012-12#2)
review and evaluate##2##3##(2012-12#1)(2013-8#1)
review and hypothesis##2##3##(2008-1#1)(2009-12#1)
review and meta-analysis of##6##4##(2008-3#1)(2010-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
review and meta-analysis##14##3##(2008-3#2)(2009-11#1)(2009-2#1)(2010-10#1)(2010-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#2)
review and proposed##2##3##(2006-7#1)(2008-9#1)
review and recent##2##3##(2006-10#1)(2008-5#1)
review and the##3##3##(1990-12#1)(2006-10#1)(2011-2#1)
review and update of##2##4##(2005-8#1)(2008-8#1)
review and update##4##3##(2005-8#1)(2008-8#1)(2012-3#1)(2013-1#1)
review and##144##2##(1990-12#2)(1991-1#1)(1991-4#1)(1992-1#2)(1992-12#3)(1992-2#1)(1993-12#1)(1993-4#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-8#1)(1995-1#1)(1996-11#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-5#1)(2005-12#1)(2005-3#1)(2005-8#3)(2006-10#3)(2006-11#1)(2006-2#1)(2006-6#2)(2006-7#1)(2006-8#2)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2008-1#4)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#5)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#3)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#4)(2012-2#7)(2012-3#7)(2013-1#6)(2013-7#4)(2013-8#7)
review are to##6##3##(1990-11#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-8#1)(2012-2#1)
review are##21##2##(1990-11#1)(2005-10#1)(2006-10#4)(2006-12#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2009-5#1)(2012-2#2)(2013-1#2)
review article focuses on the##4##5##(2010-12#1)(2010-7#1)(2011-1#1)(2012-12#1)
review article focuses on##5##4##(2010-12#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-3#1)
review article highlights the##2##4##(2010-12#1)(2013-1#1)
review article is to##9##4##(2006-9#2)(2007-4#1)(2008-3#1)(2009-4#1)(2009-8#1)(2010-6#1)(2012-2#1)(2013-7#1)
review article is##12##3##(2006-9#2)(2007-4#1)(2007-9#1)(2008-3#1)(2009-4#1)(2009-8#1)(2010-6#1)(2012-2#3)(2013-7#1)
review article on##2##3##(2006-10#1)(2010-1#1)
review article summarizes the##3##4##(1993-12#1)(2007-10#1)(2011-2#1)
review article summarizes##7##3##(1993-12#1)(2006-12#1)(2007-10#1)(2008-10#3)(2011-2#1)
review article that##2##3##(2005-10#1)(2010-9#1)
review article##77##2##(1993-10#1)(1993-12#1)(2005-10#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-3#1)(2006-9#4)(2007-10#2)(2007-11#4)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#4)(2012-2#6)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
review articles on the##2##4##(2005-7#1)(2008-7#1)
review articles##12##2##(1996-7#1)(2005-7#1)(2006-11#4)(2006-8#1)(2008-7#1)(2009-10#1)(2009-5#1)(2012-12#1)(2013-1#1)
review as well as##3##4##(1991-1#1)(2006-10#1)(2006-8#1)
review as##5##2##(1991-1#1)(2006-10#1)(2006-8#1)(2007-4#1)(2007-8#1)
review aspects##2##2##(2006-2#1)(2011-2#1)
review assesses the##5##3##(1995-9#1)(2006-10#1)(2006-12#1)(2009-10#1)(2010-5#1)
review assesses##8##2##(1995-9#1)(2006-10#2)(2006-12#1)(2008-10#1)(2008-4#1)(2009-10#1)(2010-5#1)
review at##4##2##(1992-12#1)(2006-8#1)(2007-2#1)(2013-1#1)
review available##2##2##(2005-8#1)(2008-10#1)
review based on the##2##4##(2006-8#1)(2009-10#1)
review based on##5##3##(1993-8#1)(1995-12#1)(2006-8#1)(2008-10#1)(2009-10#1)
review basic##3##2##(1993-12#1)(2012-3#1)(2013-1#1)
review begins with a##2##4##(2008-6#1)(2009-4#1)
review board##9##2##(1991-6#1)(1993-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2010-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
review boards##6##2##(1995-1#1)(1996-1#1)(2006-10#1)(2006-12#1)(2007-11#1)(2013-8#1)
review both the##2##3##(2008-4#1)(2009-9#1)
review both##5##2##(1993-3#1)(2008-4#1)(2008-8#1)(2009-5#1)(2009-9#1)
review briefly##10##2##(2004-9#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-1#1)(2009-11#1)(2009-5#1)(2011-1#1)
review by the##6##3##(1993-6#1)(1995-6#1)(2007-4#1)(2010-3#1)(2012-12#1)(2013-1#1)
review by##13##2##(1990-12#1)(1993-6#1)(1995-6#2)(1996-3#1)(1997-3#1)(2005-11#1)(2007-4#1)(2007-8#1)(2010-3#1)(2012-1#1)(2012-12#1)(2013-1#1)
review can be##2##3##(2004-2#1)(2008-11#1)
review can##3##2##(1990-11#1)(2004-2#1)(2008-11#1)
review clinical##4##2##(1991-2#1)(2005-11#1)(2009-8#1)(2013-8#1)
review comparing##5##2##(2008-7#1)(2012-12#3)(2013-1#1)
review concentrates on##7##3##(2006-10#2)(2006-11#1)(2007-11#1)(2007-9#1)(2008-10#1)(2010-9#1)
review concerning the##3##3##(1993-10#1)(2007-4#1)(2009-5#1)
review concerning##4##2##(1993-10#1)(2007-11#1)(2007-4#1)(2009-5#1)
review concludes that##3##3##(2005-7#1)(2008-11#1)(2010-8#1)
review concludes##9##2##(2005-7#1)(2008-11#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#2)(2012-2#1)
review confirms the##2##3##(2008-8#1)(2012-1#1)
review confirms##4##2##(2006-10#1)(2007-11#1)(2008-8#1)(2012-1#1)
review covers the##14##3##(2005-7#1)(2006-10#2)(2006-12#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-5#3)(2008-8#1)(2011-2#1)(2012-11#1)(2012-12#1)
review covers##37##2##(2005-7#2)(2005-8#1)(2006-10#9)(2006-12#2)(2007-10#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#5)(2008-8#1)(2009-10#1)(2009-9#1)(2010-11#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)
review current and##2##3##(2005-8#1)(2009-3#1)
review current knowledge about##3##4##(2008-11#1)(2008-7#1)(2010-3#1)
review current knowledge##8##3##(2003-11#1)(2005-8#1)(2007-12#1)(2008-11#1)(2008-7#2)(2008-8#1)(2010-3#1)
review current methods##2##3##(2008-11#1)(2013-1#1)
review current##22##2##(2003-11#1)(2005-10#1)(2005-8#2)(2006-11#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-1#2)(2013-1#2)
review data on##2##3##(2007-5#1)(2008-10#1)
review data suggesting that##2##4##(2008-5#1)(2011-2#1)
review data##11##2##(1991-2#1)(2005-9#1)(2006-11#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-3#1)(2011-2#1)(2012-11#1)
review deals with the##8##4##(1994-11#1)(1994-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)
review deals with##14##3##(1994-11#1)(1994-2#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-7#1)(2010-12#1)
review deals##15##2##(1994-11#1)(1994-2#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-7#1)(2010-12#1)
review demonstrates that##2##3##(2007-6#1)(2010-11#1)
review demonstrates the##2##3##(1997-6#1)(2008-8#1)
review demonstrates##4##2##(1997-6#1)(2007-6#1)(2008-8#1)(2010-11#1)
review describes the##39##3##(2005-7#1)(2006-1#1)(2006-10#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2009-2#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-4#1)(2010-5#1)(2011-2#1)(2012-11#2)(2013-1#1)(2013-7#3)(2013-8#1)
review describes these##2##3##(2009-5#1)(2010-1#1)
review describes##79##2##(1991-5#1)(1993-12#1)(2005-7#1)(2006-1#1)(2006-10#4)(2006-7#2)(2006-8#11)(2006-9#1)(2007-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#5)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-11#2)(2013-1#1)(2013-7#3)(2013-8#2)
review did not##2##3##(1996-2#1)(2011-2#1)
review different##4##2##(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
review discusses current##2##3##(2008-1#1)(2013-7#1)
review discusses different##2##3##(2006-10#1)(2010-6#1)
review discusses some of the##3##5##(2008-8#1)(2009-5#1)(2011-2#1)
review discusses some##4##3##(2006-11#1)(2008-8#1)(2009-5#1)(2011-2#1)
review discusses the potential##2##4##(1997-2#1)(2008-8#1)
review discusses the##45##3##(1996-9#1)(1997-2#1)(2005-7#2)(2006-10#3)(2006-11#2)(2006-12#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#1)(2009-4#1)(2010-12#1)(2010-6#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#2)(2013-8#2)
review discusses these issues##2##4##(2010-12#1)(2011-2#1)
review discusses these##3##3##(2007-8#1)(2010-12#1)(2011-2#1)
review discusses##91##2##(1993-3#1)(1996-9#1)(1997-2#1)(2005-10#1)(2005-12#1)(2005-7#2)(2006-10#5)(2006-11#3)(2006-12#1)(2006-6#2)(2006-8#4)(2006-9#1)(2007-11#1)(2007-12#2)(2007-8#8)(2008-1#3)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#2)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#4)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#6)(2011-3#1)(2012-1#2)(2012-2#4)(2013-1#4)(2013-7#1)(2013-8#2)
review documented##2##2##(1997-3#1)(2008-7#1)
review does not##2##3##(2008-8#1)(2010-1#1)
review draws on##2##3##(2009-2#1)(2012-12#1)
review emphasizes##4##2##(1995-6#1)(2006-10#1)(2007-11#1)(2008-8#1)
review evidence on the##2##4##(2008-3#1)(2010-2#1)
review evidence on##3##3##(2007-8#1)(2008-3#1)(2010-2#1)
review evidence showing that##2##4##(2008-9#1)(2009-11#1)
review evidence that##2##3##(1991-12#1)(2007-12#1)
review evidence##13##2##(1991-12#1)(2007-12#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-11#2)(2010-2#1)(2013-8#1)
review examined the##5##3##(1994-2#1)(2007-12#1)(2007-2#1)(2012-1#1)(2013-1#1)
review examines the recent##5##4##(2006-10#3)(2008-3#1)(2010-4#1)
review examines the role of##2##5##(2008-1#1)(2012-12#1)
review examines the##29##3##(1990-12#1)(2006-10#8)(2006-7#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
review examines##44##2##(1990-12#1)(2005-7#1)(2006-10#12)(2006-7#1)(2007-1#1)(2007-11#1)(2007-6#1)(2007-8#2)(2008-1#3)(2008-10#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
review existing data##2##3##(2005-6#1)(2013-1#1)
review existing##5##2##(2005-6#1)(2008-10#1)(2008-2#1)(2008-7#1)(2013-1#1)
review experimental##2##2##(2008-2#1)(2009-12#1)
review explains the##2##3##(2007-7#1)(2008-6#1)
review explains##4##2##(2007-7#1)(2007-8#1)(2008-6#1)(2011-1#1)
review explores the##8##3##(2006-9#1)(2008-10#1)(2008-11#2)(2009-4#1)(2011-2#1)(2012-12#1)(2012-3#1)
review explores##15##2##(2005-11#1)(2006-10#2)(2006-9#1)(2008-10#1)(2008-11#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
review findings from##2##3##(2009-8#1)(2010-8#1)
review first##2##2##(2005-7#1)(2011-1#1)
review focuses mainly on##3##4##(2009-12#1)(2010-5#2)
review focuses on key##3##4##(2006-10#1)(2008-1#1)(2011-1#1)
review focuses on recent##9##4##(1990-6#1)(2006-10#4)(2008-10#1)(2008-7#1)(2009-3#1)(2010-12#1)
review focuses on some##2##4##(2006-10#2)
review focuses on the application of##2##6##(2007-5#1)(2011-2#1)
review focuses on the current##2##5##(2008-11#1)(2012-3#1)
review focuses on the effects of##3##6##(2006-10#1)(2008-5#1)(2012-2#1)
review focuses on the effects##4##5##(2006-10#1)(2008-1#1)(2008-5#1)(2012-2#1)
review focuses on the major##2##5##(2012-2#1)(2013-1#1)
review focuses on the most recent##3##6##(2006-10#2)(2008-5#1)
review focuses on the most##4##5##(2006-10#2)(2008-1#1)(2008-5#1)
review focuses on the recent advances##2##6##(2012-2#1)(2012-3#1)
review focuses on the recent##6##5##(2006-10#1)(2007-11#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
review focuses on the role of##2##6##(2008-8#1)(2012-2#1)
review focuses on the role##3##5##(2008-8#1)(2012-12#1)(2012-2#1)
review focuses on the use of##3##6##(2006-10#1)(2010-4#1)(2013-1#1)
review focuses on the##72##4##(1991-7#1)(1992-6#1)(1994-1#1)(2005-10#1)(2005-7#1)(2006-10#10)(2006-6#1)(2007-11#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-12#3)(2012-2#5)(2012-3#5)(2013-1#2)
review focuses on##119##3##(1990-6#1)(1991-7#1)(1992-6#1)(1994-1#1)(2005-10#1)(2005-6#1)(2005-7#2)(2005-8#1)(2006-10#28)(2006-6#2)(2007-11#4)(2007-12#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#4)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#3)(2008-5#4)(2008-7#5)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#7)(2013-1#2)
review focuses upon##2##3##(1997-2#1)(2008-7#1)
review focuses##129##2##(1990-6#1)(1991-7#1)(1992-6#1)(1994-1#1)(1997-2#1)(2005-10#1)(2005-6#1)(2005-7#2)(2005-8#1)(2006-10#28)(2006-6#2)(2007-11#4)(2007-12#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#4)(2008-10#3)(2008-11#2)(2008-3#3)(2008-4#3)(2008-5#4)(2008-7#7)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#2)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#5)(2012-1#1)(2012-12#5)(2012-2#7)(2012-3#7)(2013-1#2)(2013-8#1)
review for##9##2##(1992-1#1)(2006-3#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-9#1)(2010-10#1)(2010-12#1)
review found##3##2##(2008-8#1)(2013-1#2)
review from a##3##3##(2005-10#1)(2006-2#1)(2007-7#1)
review from the##4##3##(2008-1#2)(2009-5#1)(2011-2#1)
review from##12##2##(2005-10#1)(2005-12#1)(2006-11#1)(2006-2#1)(2007-7#1)(2008-1#3)(2008-10#1)(2009-5#1)(2011-2#1)(2012-3#1)
review gives a##6##3##(2006-10#1)(2008-10#1)(2010-12#1)(2011-1#2)(2012-1#1)
review gives##12##2##(2006-10#1)(2007-7#1)(2008-10#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-4#1)(2011-1#2)(2012-1#1)(2012-2#1)
review has been##4##3##(2006-10#1)(2008-2#1)(2008-4#1)(2008-8#1)
review has##6##2##(2006-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-1#1)
review have##2##2##(2006-10#1)(2010-12#1)
review here the##9##3##(1997-1#1)(2006-2#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-12#1)(2010-12#1)(2012-12#1)
review here##14##2##(1994-8#1)(1997-1#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-12#1)(2012-12#1)(2013-8#1)
review herein##2##2##(2009-3#1)(2013-1#1)
review highlights recent advances##2##4##(2008-4#1)(2012-12#1)
review highlights recent##8##3##(2005-7#1)(2006-10#5)(2008-4#1)(2012-12#1)
review highlights the potential##2##4##(2010-1#1)(2011-1#1)
review highlights the##20##3##(1995-8#1)(2006-10#3)(2008-1#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
review highlights##43##2##(1995-8#1)(2005-7#1)(2006-10#11)(2007-12#1)(2008-1#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#2)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)
review how the##2##3##(2008-8#1)(2009-3#1)
review how##16##2##(1996-9#1)(2004-11#1)(2004-7#2)(2007-12#1)(2007-6#1)(2008-8#2)(2009-3#1)(2010-12#2)(2010-4#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-8#1)
review human studies##2##3##(2011-1#1)(2012-2#1)
review identified##2##2##(2006-10#1)(2011-1#1)
review identifies##3##2##(2006-10#1)(2006-7#1)(2006-9#1)
review important##2##2##(1994-6#1)(2008-3#1)
review in a##2##3##(2007-11#1)(2007-3#1)
review in the##5##3##(2006-10#1)(2007-8#1)(2008-1#1)(2011-1#1)(2013-8#1)
review in this##2##3##(1996-9#1)(2009-10#1)
review in##21##2##(1992-1#1)(1996-9#1)(1997-3#1)(2005-9#1)(2006-10#2)(2007-1#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-5#1)(2009-10#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-8#2)
review include##8##2##(2006-10#2)(2007-11#1)(2007-12#1)(2008-10#1)(2012-1#1)(2012-12#2)
review included##3##2##(2006-8#1)(2009-9#1)(2011-2#1)
review includes##8##2##(1993-3#1)(1997-1#1)(1997-4#1)(2006-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2011-12#1)
review indicate that##2##3##(2012-12#1)(2012-2#1)
review indicates that##5##3##(2007-3#1)(2007-7#1)(2009-3#1)(2010-4#1)(2012-1#1)
review indicates##6##2##(2007-3#1)(2007-7#1)(2009-3#1)(2010-4#1)(2011-12#1)(2012-1#1)
review information on##2##3##(2009-10#1)(2013-1#1)
review information##3##2##(2007-6#1)(2009-10#1)(2013-1#1)
review intends to##4##3##(1994-6#1)(2008-1#2)(2013-1#1)
review investigates the##2##3##(2006-9#1)(2008-12#1)
review is a##5##3##(1992-1#1)(1994-3#1)(2006-10#1)(2009-4#1)(2012-2#1)
review is aimed at##5##4##(2008-1#1)(2009-3#1)(2010-12#1)(2012-2#1)(2012-3#1)
review is an##3##3##(2005-7#1)(2008-10#1)(2012-3#1)
review is available##3##3##(2013-1#1)(2013-7#2)
review is based on##5##4##(1997-5#1)(2005-8#1)(2006-10#1)(2007-2#1)(2008-7#1)
review is divided into##3##4##(2006-10#1)(2007-3#1)(2008-10#1)
review is focused on the##4##5##(1992-6#1)(2008-1#1)(2012-11#2)
review is focused on##12##4##(1992-6#1)(2007-7#1)(2008-1#1)(2008-11#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-2#1)
review is given of##4##4##(1992-6#1)(2006-2#1)(2006-4#1)(2008-5#1)
review is given on##2##4##(1990-10#1)(2008-5#1)
review is given##6##3##(1990-10#1)(1992-6#1)(2006-2#1)(2006-4#1)(2008-5#2)
review is intended to##5##4##(2006-8#1)(2007-11#1)(2008-4#1)(2009-3#1)(2010-11#1)
review is intended##6##3##(2006-8#1)(2007-11#2)(2008-4#1)(2009-3#1)(2010-11#1)
review is not to##2##4##(2008-7#1)(2010-7#1)
review is not##5##3##(1993-1#1)(2007-10#1)(2007-11#1)(2008-7#1)(2010-7#1)
review is presented##2##3##(2006-10#1)(2012-2#1)
review is the##2##3##(2009-2#1)(2011-1#1)
review is to assess the##2##5##(1996-9#1)(2013-8#1)
review is to describe the##2##5##(2008-1#1)(2012-2#1)
review is to describe##6##4##(2006-1#1)(2006-10#1)(2008-1#1)(2008-8#1)(2010-11#1)(2012-2#1)
review is to determine the##2##5##(2006-8#1)(2012-12#1)
review is to discuss the##6##5##(2007-4#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#1)
review is to discuss##7##4##(2004-4#1)(2007-4#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#1)
review is to evaluate the##5##5##(2008-10#1)(2008-3#1)(2009-7#1)(2010-6#1)(2012-2#1)
review is to evaluate##6##4##(2007-8#1)(2008-10#1)(2008-3#1)(2009-7#1)(2010-6#1)(2012-2#1)
review is to examine the##5##5##(2007-7#1)(2008-5#1)(2009-12#1)(2009-4#1)(2012-1#1)
review is to examine##9##4##(2006-10#2)(2007-1#1)(2007-7#1)(2008-5#1)(2009-12#1)(2009-4#1)(2012-1#1)(2012-12#1)
review is to give an##2##5##(2008-5#1)(2012-2#1)
review is to give##4##4##(2008-1#1)(2008-5#1)(2011-3#1)(2012-2#1)
review is to highlight##2##4##(2010-12#1)(2010-9#1)
review is to identify##2##4##(2010-12#1)(2013-1#1)
review is to present##9##4##(1997-6#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-3#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
review is to provide a##3##5##(2008-4#1)(2012-12#2)
review is to provide##10##4##(2006-10#1)(2007-11#1)(2008-11#1)(2008-4#1)(2009-6#1)(2012-12#2)(2012-2#2)(2013-8#1)
review is to summarize the##6##5##(2008-1#1)(2009-3#1)(2010-1#1)(2010-2#1)(2012-11#1)(2012-12#1)
review is to summarize##9##4##(2006-10#1)(2006-12#1)(2008-1#1)(2008-10#1)(2009-3#1)(2010-1#1)(2010-2#1)(2012-11#1)(2012-12#1)
review is to##112##3##(1993-12#1)(1996-9#1)(1997-6#1)(2004-4#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#3)(2008-11#3)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#6)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#1)(2011-3#2)(2012-1#1)(2012-11#2)(2012-12#5)(2012-2#10)(2012-3#1)(2013-1#8)(2013-8#3)
review is##200##2##(1990-10#1)(1990-9#1)(1992-1#2)(1992-6#2)(1993-1#1)(1993-12#1)(1994-3#1)(1996-9#1)(1997-5#1)(1997-6#1)(2004-4#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#10)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#8)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#7)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#9)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#3)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#4)(2011-3#2)(2012-1#3)(2012-11#4)(2012-12#5)(2012-2#14)(2012-3#4)(2013-1#9)(2013-7#2)(2013-8#3)
review it is##2##3##(1993-11#1)(1993-12#1)
review it##5##2##(1991-4#1)(1993-11#1)(1993-12#1)(2008-10#1)(2013-1#1)
review its##7##2##(1990-12#1)(1992-12#1)(2006-10#2)(2008-11#1)(2011-2#1)(2012-2#1)
review literature##5##2##(1997-2#1)(2008-1#1)(2009-10#1)(2009-4#1)(2009-9#1)
review looks at the##2##4##(2007-6#1)(2011-2#1)
review looks##4##2##(2007-6#1)(2008-10#1)(2011-2#1)(2013-8#1)
review makes##2##2##(2008-10#1)(2010-7#1)
review may##2##2##(1992-8#1)(2013-1#1)
review new findings##2##3##(2008-8#1)(2010-8#1)
review of 1##2##3##(1997-8#1)(2012-2#1)
review of 16 patients##2##4##(1994-2#1)(2012-1#1)
review of 2##2##3##(2006-8#1)(2007-6#1)
review of 30##3##3##(1991-12#1)(2007-2#1)(2010-9#1)
review of 42 patients##2##4##(2008-6#1)(2010-5#1)
review of 42##3##3##(2008-6#1)(2008-7#1)(2010-5#1)
review of 47##2##3##(2007-7#1)(2008-1#1)
review of 53##2##3##(1991-8#1)(2007-7#1)
review of Canadian##2##3##(2008-11#1)(2008-7#1)
review of English##2##3##(1993-10#1)(2009-5#1)
review of a rare##2##4##(2010-5#1)(2013-8#1)
review of a##14##3##(1990-12#1)(1992-12#1)(1994-6#1)(2006-11#1)(2006-8#1)(2007-3#1)(2008-11#1)(2010-5#1)(2010-8#1)(2012-3#1)(2013-1#3)(2013-8#1)
review of all##10##3##(1997-8#1)(2006-10#1)(2007-10#2)(2008-3#1)(2008-9#1)(2009-7#1)(2011-1#1)(2012-2#2)
review of an##2##3##(1990-5#1)(2007-8#1)
review of available##3##3##(1990-1#1)(2008-12#1)(2009-5#1)
review of both##2##3##(2010-8#1)(2011-7#1)
review of care##3##3##(1991-10#1)(2010-8#1)(2013-1#1)
review of case##2##3##(2006-12#1)(2009-10#1)
review of cases##4##3##(2008-1#2)(2009-4#1)(2011-11#1)
review of cell##2##3##(2008-10#2)
review of clinical data##2##4##(1997-2#1)(2006-7#1)
review of clinical studies##3##4##(2005-9#1)(2011-2#1)(2013-7#1)
review of clinical##16##3##(1994-3#1)(1995-9#1)(1997-2#1)(2005-9#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-7#1)
review of contemporary##2##3##(1991-3#1)(2009-2#1)
review of controlled##2##3##(2011-2#1)(2012-1#1)
review of current concepts##2##4##(1995-12#1)(2013-1#1)
review of current literature##3##4##(1994-1#1)(2006-10#1)(2007-1#1)
review of current##21##3##(1994-1#1)(1995-12#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-12#1)(2010-8#1)(2011-2#2)(2012-11#1)(2013-1#2)(2013-8#1)
review of currently available##2##4##(2005-8#1)(2012-2#1)
review of data##5##3##(2006-2#1)(2007-10#1)(2008-1#1)(2008-5#1)(2013-1#1)
review of eight##2##3##(2006-10#1)(2013-7#1)
review of epidemiology##2##3##(1995-4#1)(2009-9#1)
review of esophageal##2##3##(2012-2#1)(2013-1#1)
review of evidence##4##3##(1997-8#1)(2004-12#1)(2008-8#1)(2011-2#1)
review of five cases##2##4##(2007-2#1)(2012-12#1)
review of five##3##3##(2007-2#2)(2012-12#1)
review of health##3##3##(2010-10#1)(2010-7#1)(2012-12#1)
review of imaging##2##3##(2006-7#1)(2012-2#1)
review of interventions##2##3##(2010-8#1)(2012-12#1)
review of its therapeutic##2##4##(2007-11#1)(2008-5#1)
review of its##15##3##(1992-12#1)(2006-4#1)(2007-11#10)(2008-5#1)(2009-8#1)(2012-12#1)
review of literature and##4##4##(2007-2#1)(2008-11#1)(2008-7#1)(2010-7#1)
review of literature is presented##2##5##(2010-11#1)(2010-8#1)
review of literature##76##3##(1990-10#1)(1990-3#1)(1992-5#1)(1993-6#1)(1993-9#1)(1994-6#1)(1996-5#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-5#1)(2007-11#3)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#2)(2008-3#3)(2008-4#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#2)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#5)(2013-7#2)
review of literature]##7##3##(1996-8#1)(2009-5#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-3#2)
review of management##2##3##(2006-4#1)(2013-1#1)
review of medical records##3##4##(1997-3#1)(2008-1#1)(2013-8#1)
review of medical##5##3##(1996-3#1)(1997-3#1)(2008-1#1)(2009-5#1)(2013-8#1)
review of methods##3##3##(2007-11#1)(2007-8#1)(2013-1#1)
review of one##3##3##(1991-2#1)(2007-3#1)(2009-11#1)
review of other##3##3##(1990-9#1)(2005-11#1)(2006-6#1)
review of our##5##3##(1993-5#1)(1993-8#1)(1994-6#1)(2006-2#1)(2012-2#1)
review of outcome measures##2##4##(2007-11#2)
review of patent literature##3##4##(2005-8#1)(2008-1#2)
review of pathological##2##3##(2008-11#1)(2010-7#1)
review of patient##3##3##(2008-12#1)(2010-2#1)(2013-1#1)
review of patients##3##3##(2007-9#1)(2008-3#1)(2009-10#1)
review of patients'##2##3##(2006-10#1)(2010-8#1)
review of pediatric##2##3##(2006-12#1)(2011-12#1)
review of pertinent literature##2##4##(2006-10#1)(2008-2#1)
review of physician##2##3##(1994-3#1)(2007-4#1)
review of previous##4##3##(2006-9#1)(2007-4#1)(2008-1#1)(2012-1#1)
review of problems##2##3##(2008-10#1)(2012-12#1)
review of prospective cohort studies##2##5##(2005-10#1)(2008-8#1)
review of prospective##3##3##(2005-10#1)(2008-8#1)(2010-12#1)
review of published data##2##4##(2008-10#1)(2009-10#1)
review of published literature##2##4##(2008-9#1)(2012-3#1)
review of published reports##2##4##(1995-9#1)(2012-12#1)
review of published##12##3##(1995-9#2)(2005-10#1)(2006-9#1)(2008-10#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
review of qualitative##2##3##(2010-9#1)(2012-12#1)
review of randomized clinical trials##2##5##(2007-10#1)(2008-10#1)
review of randomized##3##3##(2007-10#2)(2008-10#1)
review of recent literature##4##4##(1996-1#1)(2007-7#1)(2013-8#2)
review of recent publications##2##4##(1993-3#1)(2006-7#1)
review of recent studies##2##4##(2006-9#1)(2010-7#1)
review of recent##18##3##(1993-3#1)(1993-8#1)(1996-1#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-5#1)(2009-3#1)(2009-4#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#2)
review of records of##2##4##(2007-6#1)(2011-1#1)
review of relevant##5##3##(2007-7#1)(2008-11#1)(2009-2#1)(2012-2#1)(2012-3#1)
review of research##6##3##(1992-3#1)(2006-8#1)(2007-8#1)(2008-10#1)(2009-4#1)(2010-8#1)
review of scientific##2##3##(2012-3#1)(2013-1#1)
review of several##4##3##(2006-2#1)(2006-7#1)(2008-1#1)(2008-8#1)
review of similar##2##3##(2008-12#1)(2010-4#1)
review of state##2##3##(2007-10#1)(2008-11#1)
review of statistical##2##3##(1995-1#1)(1997-6#1)
review of studies##8##3##(1992-3#1)(2005-7#1)(2008-3#1)(2008-5#1)(2011-1#1)(2011-12#1)(2012-1#1)(2013-1#1)
review of such##3##3##(1996-11#1)(1997-3#1)(2005-7#1)
review of terminology##2##3##(2005-9#1)(2006-8#1)
review of the English##2##4##(2009-5#1)(2011-2#1)
review of the English-language literature was undertaken##2##7##(2012-12#2)
review of the English-language literature##3##5##(2007-10#1)(2012-12#2)
review of the application of##2##5##(2007-5#1)(2010-1#1)
review of the association##3##4##(1993-6#1)(2006-10#1)(2010-1#1)
review of the available##6##4##(1996-1#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-8#2)
review of the clinical##6##4##(1992-9#1)(2007-10#1)(2007-11#2)(2008-1#1)(2012-3#1)
review of the current literature on##2##6##(2011-2#2)
review of the current literature##13##5##(2005-11#1)(2007-4#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-11#1)(2012-12#1)
review of the current status##3##5##(1996-8#1)(2009-11#1)(2010-11#1)
review of the current##27##4##(1996-8#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-4#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-12#1)(2011-2#2)(2011-7#1)(2012-11#1)(2012-12#1)(2012-2#1)
review of the development of##3##5##(2008-10#1)(2009-11#1)(2010-12#1)
review of the diagnostic criteria##2##5##(2008-7#1)(2011-2#1)
review of the diagnostic##3##4##(2007-5#1)(2008-7#1)(2011-2#1)
review of the effect of##2##5##(2005-8#1)(2013-1#1)
review of the effectiveness of##2##5##(2013-1#2)
review of the effects of##2##5##(2007-10#1)(2008-11#1)
review of the effects##3##4##(2007-10#1)(2008-11#1)(2011-2#1)
review of the empirical##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
review of the epidemiological##2##4##(2005-10#1)(2013-1#1)
review of the evidence and##2##5##(2008-8#1)(2009-4#1)
review of the evidence for the##2##6##(2006-8#1)(2011-12#1)
review of the evidence##18##4##(1996-12#1)(2005-10#2)(2006-8#3)(2007-11#1)(2008-12#1)(2008-6#1)(2008-8#2)(2009-11#1)(2009-4#1)(2011-12#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
review of the experimental##3##4##(2008-1#1)(2008-10#1)(2011-1#1)
review of the history of##2##5##(1990-5#1)(2007-12#1)
review of the history##3##4##(1990-5#1)(2007-12#1)(2007-7#1)
review of the last##2##4##(2008-4#1)(2010-12#1)
review of the literature and a##2##6##(2006-5#1)(2007-8#1)
review of the literature and presentation of two cases##2##9##(2006-2#1)(2008-4#1)
review of the literature and presentation of##3##7##(1991-4#1)(2006-2#1)(2008-4#1)
review of the literature and##23##5##(1990-3#1)(1991-1#1)(1991-3#1)(1991-4#1)(1995-3#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-4#2)(2008-9#1)(2012-2#2)(2012-3#1)(2013-1#2)
review of the literature as well as##2##7##(1996-12#1)(2008-1#1)
review of the literature concerning the##2##6##(2010-9#1)(2011-2#1)
review of the literature concerning##4##5##(1996-3#1)(2008-8#1)(2010-9#1)(2011-2#1)
review of the literature found##4##5##(2007-3#1)(2008-10#2)(2008-11#1)
review of the literature from##2##5##(2008-10#1)(2008-9#1)
review of the literature has##2##5##(1994-6#1)(2008-2#1)
review of the literature in##3##5##(2006-10#1)(2008-10#1)(2008-11#1)
review of the literature is given##2##6##(1991-3#1)(1996-9#1)
review of the literature is presented##3##6##(1990-3#1)(2010-12#1)(2011-1#1)
review of the literature is reported##3##6##(2006-10#1)(2007-12#1)(2007-8#1)
review of the literature is##15##5##(1990-3#1)(1991-3#1)(1996-9#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#1)
review of the literature of##6##5##(1996-8#1)(2006-12#1)(2008-6#1)(2008-9#1)(2012-3#2)
review of the literature on the##10##6##(1991-9#1)(1996-12#1)(2007-6#1)(2008-11#1)(2008-9#1)(2009-6#1)(2010-2#1)(2013-1#2)(2013-8#1)
review of the literature on this rare##3##7##(2007-7#1)(2008-12#1)(2010-8#1)
review of the literature on this##8##6##(1992-10#1)(1993-6#1)(2006-2#1)(2007-7#1)(2008-12#1)(2008-5#1)(2010-8#1)(2013-1#1)
review of the literature on##34##5##(1991-9#1)(1992-10#1)(1993-6#1)(1996-12#1)(1996-3#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
review of the literature pertaining to##3##6##(1993-1#1)(2007-6#2)
review of the literature pertaining##4##5##(1993-1#1)(2007-6#2)(2008-8#1)
review of the literature presents##2##5##(2008-7#1)(2010-12#1)
review of the literature published##4##5##(2009-4#1)(2009-8#2)(2010-8#1)
review of the literature regarding##6##5##(2009-3#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
review of the literature relating to##2##6##(2005-7#1)(2007-8#1)
review of the literature revealed only##2##6##(1995-1#1)(2008-12#1)
review of the literature revealed##6##5##(1995-1#1)(2004-12#1)(2006-10#1)(2006-11#1)(2008-12#1)(2008-3#1)
review of the literature showed that##3##6##(1992-11#1)(1992-5#1)(2011-2#1)
review of the literature showed##4##5##(1992-11#1)(1992-5#1)(2011-2#2)
review of the literature shows that##5##6##(2005-10#1)(2008-10#1)(2011-2#1)(2011-3#1)(2012-3#1)
review of the literature shows##6##5##(2005-10#1)(2006-10#1)(2008-10#1)(2011-2#1)(2011-3#1)(2012-3#1)
review of the literature suggests that##4##6##(2006-9#1)(2008-11#2)(2009-3#1)
review of the literature was undertaken to##2##7##(2008-7#1)(2012-2#1)
review of the literature was undertaken##3##6##(2008-7#1)(2012-12#1)(2012-2#1)
review of the literature was##6##5##(2007-6#1)(2008-7#1)(2009-5#1)(2012-12#2)(2012-2#1)
review of the literature with##2##5##(2008-10#1)(2009-3#1)
review of the literature##419##4##(1990-10#1)(1990-12#2)(1990-3#2)(1990-6#1)(1991-1#1)(1991-12#1)(1991-3#2)(1991-4#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-12#3)(1996-3#3)(1996-8#1)(1996-9#1)(1997-5#1)(2004-12#1)(2005-10#3)(2005-11#2)(2005-12#2)(2005-2#1)(2005-7#1)(2005-8#1)(2005-9#3)(2006-1#1)(2006-10#15)(2006-11#1)(2006-12#15)(2006-2#4)(2006-5#2)(2006-6#1)(2006-7#3)(2006-8#4)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#7)(2007-12#7)(2007-2#13)(2007-3#9)(2007-4#6)(2007-5#4)(2007-6#10)(2007-7#7)(2007-8#6)(2007-9#1)(2008-1#6)(2008-10#17)(2008-11#12)(2008-12#10)(2008-2#4)(2008-3#3)(2008-4#6)(2008-5#5)(2008-6#8)(2008-7#7)(2008-8#4)(2008-9#10)(2009-10#1)(2009-3#6)(2009-4#4)(2009-5#2)(2009-6#5)(2009-8#3)(2009-9#1)(2010-10#2)(2010-12#6)(2010-2#2)(2010-3#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#5)(2010-9#2)(2011-1#5)(2011-2#20)(2011-3#1)(2012-1#3)(2012-12#11)(2012-2#15)(2012-3#7)(2013-1#30)(2013-7#1)(2013-8#5)
review of the literature]##31##4##(1990-10#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-9#1)(1992-5#1)(1992-9#1)(1993-10#1)(1993-5#1)(1993-6#1)(1993-9#1)(1997-2#1)(1997-3#1)(2008-10#5)(2008-12#1)(2008-8#1)(2008-9#4)(2009-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
review of the literatures##2##4##(2009-5#1)(2009-8#1)
review of the litterature##2##4##(2006-8#1)(2007-8#1)
review of the main##2##4##(2008-10#2)
review of the medical literature##5##5##(1992-12#1)(2007-5#1)(2008-12#1)(2009-10#1)(2012-3#1)
review of the medical##9##4##(1992-12#1)(2007-2#1)(2007-5#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-8#1)(2012-3#1)
review of the methods##2##4##(2007-11#1)(2011-1#1)
review of the most recent literature##2##6##(1991-2#1)(1991-4#1)
review of the most recent##5##5##(1991-2#1)(1991-4#1)(2006-10#1)(2008-11#1)(2011-2#1)
review of the most##8##4##(1991-2#1)(1991-4#1)(2006-10#2)(2006-8#1)(2008-11#1)(2008-6#1)(2011-2#1)
review of the past##2##4##(2008-7#1)(2010-3#1)
review of the patent literature##2##5##(2005-6#1)(2008-1#1)
review of the protocols by##2##5##(2008-10#2)
review of the published literature##2##5##(2008-6#1)(2009-9#1)
review of the recent literature reveals the potential##2##8##(2006-10#2)
review of the recent literature reveals##3##6##(2006-10#3)
review of the recent literature##10##5##(1990-6#1)(2006-10#4)(2007-4#1)(2007-7#1)(2008-12#1)(2009-9#1)(2011-2#1)
review of the recent patent literature##6##6##(2005-7#2)(2005-8#2)(2008-1#2)
review of the recent##19##4##(1990-6#1)(1994-3#1)(2005-7#2)(2005-8#2)(2006-10#4)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-12#1)(2008-4#1)(2009-9#1)(2011-2#1)
review of the related##2##4##(2008-12#1)(2008-9#1)
review of the relevant##9##4##(2007-12#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
review of the results##2##4##(1993-1#1)(2008-4#1)
review of the role of##6##5##(1993-6#1)(2005-7#1)(2006-12#1)(2008-5#1)(2010-12#1)(2012-2#1)
review of the scientific literature##2##5##(1993-6#1)(2007-11#1)
review of the surgical##3##4##(2008-10#1)(2008-8#1)(2011-2#1)
review of the use of##6##5##(2008-10#2)(2008-5#1)(2010-12#1)(2010-2#1)(2010-8#1)
review of the various##2##4##(2009-7#1)(2012-12#1)
review of the##769##3##(1990-10#2)(1990-12#4)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#3)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#2)(1991-6#2)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-5#3)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#3)(1993-10#2)(1993-12#1)(1993-3#4)(1993-5#2)(1993-6#6)(1993-8#1)(1993-9#1)(1994-10#1)(1994-3#5)(1994-6#3)(1994-7#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#4)(1996-2#1)(1996-3#3)(1996-5#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#1)(2004-10#1)(2004-12#1)(2005-10#7)(2005-11#3)(2005-12#3)(2005-2#1)(2005-5#1)(2005-6#3)(2005-7#4)(2005-8#4)(2005-9#3)(2006-1#1)(2006-10#24)(2006-11#1)(2006-12#17)(2006-2#5)(2006-4#1)(2006-5#5)(2006-6#1)(2006-7#5)(2006-8#9)(2006-9#4)(2007-1#2)(2007-10#5)(2007-11#20)(2007-12#16)(2007-2#18)(2007-3#10)(2007-4#10)(2007-5#7)(2007-6#10)(2007-7#10)(2007-8#7)(2007-9#3)(2008-1#13)(2008-10#38)(2008-11#20)(2008-12#17)(2008-2#6)(2008-3#8)(2008-4#12)(2008-5#11)(2008-6#16)(2008-7#17)(2008-8#18)(2008-9#17)(2009-10#2)(2009-11#5)(2009-3#7)(2009-4#8)(2009-5#8)(2009-6#5)(2009-7#1)(2009-8#5)(2009-9#3)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#12)(2010-2#5)(2010-3#7)(2010-4#1)(2010-5#2)(2010-6#5)(2010-7#3)(2010-8#8)(2010-9#3)(2011-1#10)(2011-12#2)(2011-2#33)(2011-3#1)(2011-7#1)(2012-1#3)(2012-11#1)(2012-12#21)(2012-2#20)(2012-3#10)(2013-1#44)(2013-7#3)(2013-8#7)
review of their##5##3##(1993-2#1)(1995-5#1)(2008-11#1)(2008-5#1)(2009-4#1)
review of theoretical##2##3##(1994-3#1)(2006-2#1)
review of these##7##3##(1995-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2010-5#1)(2012-1#1)(2012-12#1)
review of this literature##2##4##(2008-10#1)(2008-4#1)
review of this##5##3##(2008-10#2)(2008-4#1)(2011-1#1)(2011-2#1)
review of topics##2##3##(2005-8#1)(2006-2#1)
review of treatment##3##3##(2008-10#1)(2008-6#1)(2009-3#1)
review of two patients##2##4##(2008-10#1)(2012-12#1)
review of two##5##3##(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-12#1)
review of##1472##2##(1990-1#1)(1990-10#3)(1990-12#7)(1990-3#4)(1990-4#1)(1990-5#3)(1990-6#3)(1990-7#1)(1990-9#2)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#4)(1991-4#3)(1991-6#3)(1991-8#1)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#6)(1992-2#2)(1992-3#4)(1992-5#4)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#3)(1993-10#3)(1993-12#4)(1993-2#2)(1993-3#5)(1993-5#3)(1993-6#7)(1993-8#3)(1993-9#2)(1994-1#1)(1994-10#1)(1994-2#3)(1994-3#8)(1994-5#1)(1994-6#6)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#4)(1995-6#1)(1995-9#3)(1996-1#3)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#4)(1996-5#2)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#3)(2004-10#2)(2004-12#2)(2004-2#1)(2005-10#12)(2005-11#8)(2005-12#4)(2005-2#1)(2005-5#1)(2005-6#3)(2005-7#8)(2005-8#9)(2005-9#6)(2006-1#2)(2006-10#37)(2006-11#3)(2006-12#26)(2006-2#14)(2006-3#3)(2006-4#8)(2006-5#6)(2006-6#2)(2006-7#9)(2006-8#18)(2006-9#10)(2007-1#5)(2007-10#14)(2007-11#52)(2007-12#24)(2007-2#29)(2007-3#13)(2007-4#14)(2007-5#8)(2007-6#14)(2007-7#17)(2007-8#16)(2007-9#6)(2008-1#32)(2008-10#63)(2008-11#37)(2008-12#24)(2008-2#10)(2008-3#20)(2008-4#25)(2008-5#22)(2008-6#21)(2008-7#33)(2008-8#36)(2008-9#24)(2009-10#8)(2009-11#7)(2009-12#1)(2009-2#3)(2009-3#11)(2009-4#18)(2009-5#15)(2009-6#10)(2009-7#5)(2009-8#10)(2009-9#9)(2010-1#2)(2010-10#5)(2010-11#7)(2010-12#16)(2010-2#9)(2010-3#7)(2010-4#6)(2010-5#8)(2010-6#8)(2010-7#8)(2010-8#19)(2010-9#9)(2011-1#26)(2011-11#1)(2011-12#5)(2011-2#54)(2011-3#1)(2011-7#2)(2012-1#19)(2012-11#2)(2012-12#45)(2012-2#40)(2012-3#24)(2013-1#85)(2013-7#11)(2013-8#16)
review offers##2##2##(2010-11#1)(2010-8#1)
review on the##16##3##(1996-7#1)(1997-7#1)(2005-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
review on##48##2##(1991-3#1)(1994-6#1)(1995-6#1)(1996-1#1)(1996-7#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#3)(2008-5#2)(2008-7#2)(2008-8#1)(2009-12#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
review or##4##2##(1993-7#1)(2006-8#1)(2008-7#1)(2011-1#1)
review organizations##6##2##(1991-3#2)(1991-4#1)(1993-2#1)(1995-1#1)(1995-12#1)
review our current understanding of the##3##6##(2008-8#1)(2009-2#1)(2012-2#1)
review our current##4##3##(1996-7#1)(2008-8#1)(2009-2#1)(2012-2#1)
review our recent##3##3##(1993-6#1)(2009-3#1)(2011-2#1)
review our##17##2##(1993-6#1)(1996-7#1)(1997-4#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
review outlines##17##2##(1997-2#1)(2004-1#1)(2005-8#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#2)(2010-4#1)(2012-1#1)(2012-3#1)(2013-1#2)
review over##2##2##(1995-5#1)(2010-2#1)
review panel##5##2##(1990-5#2)(2005-8#1)(2005-9#1)(2009-6#1)
review panels##3##2##(1990-5#1)(2008-12#1)(2008-9#1)
review paper##4##2##(1996-5#1)(2007-8#1)(2012-12#1)(2013-1#1)
review papers##2##2##(2006-10#1)(2010-12#1)
review pays particular attention to the##2##6##(2006-5#1)(2008-4#1)
review period##5##2##(2006-10#5)
review pertinent##2##2##(2006-10#1)(2010-8#1)
review practices##2##2##(1992-12#2)
review presented##2##2##(1991-10#1)(2008-12#1)
review presents a##11##3##(2005-7#1)(2006-10#3)(2007-11#1)(2007-12#1)(2010-12#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-11#1)
review presents an##5##3##(2007-8#1)(2008-11#1)(2009-4#1)(2009-6#1)(2011-2#1)
review presents the##13##3##(1995-11#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-9#2)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-7#1)(2012-12#2)
review presents##38##2##(1992-6#1)(1994-6#1)(1995-11#1)(2005-7#1)(2006-10#7)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-4#1)(2009-6#1)(2010-12#2)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#3)(2011-3#1)(2011-7#1)(2012-11#1)(2012-12#2)
review process can##2##3##(2006-1#1)(2007-8#1)
review process for##3##3##(1993-1#1)(2013-1#2)
review process to##3##3##(1993-1#1)(1995-12#1)(2008-8#1)
review process##26##2##(1991-1#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-1#4)(1993-2#1)(1995-12#1)(2005-7#1)(2006-1#4)(2006-5#1)(2006-6#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-8#1)(2009-6#1)(2010-5#1)(2012-3#1)(2013-1#2)
review provides a comprehensive##3##4##(2007-12#1)(2009-8#1)(2011-3#1)
review provides a##11##3##(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-3#1)(2012-12#1)
review provides examples##2##3##(2008-11#1)(2008-7#1)
review provides##41##2##(1996-9#1)(2005-8#2)(2006-10#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)
review recent advances in our understanding of##2##7##(2008-8#1)(2011-1#1)
review recent advances in the##2##5##(2010-11#1)(2013-7#1)
review recent advances in##5##4##(2008-1#1)(2008-8#1)(2010-11#1)(2011-1#1)(2013-7#1)
review recent advances##7##3##(2006-10#2)(2008-1#1)(2008-8#1)(2010-11#1)(2011-1#1)(2013-7#1)
review recent developments in##3##4##(1996-9#1)(2008-1#1)(2008-7#1)
review recent findings##2##3##(2008-7#1)(2009-4#1)
review recent literature##3##3##(2005-10#1)(2008-10#1)(2011-1#1)
review recent neuroimaging##2##3##(2006-9#1)(2008-11#1)
review recent progress in the##2##5##(2008-11#1)(2011-2#1)
review recent progress in##4##4##(2008-1#1)(2008-11#1)(2010-12#1)(2011-2#1)
review recent studies##3##3##(2009-10#1)(2012-2#1)(2013-1#1)
review recent##40##2##(1990-8#1)(1996-9#1)(2005-10#1)(2006-10#6)(2006-5#1)(2006-9#2)(2008-1#3)(2008-10#1)(2008-11#3)(2008-2#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
review reports some##2##3##(2010-12#2)
review reports##9##2##(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#1)(2009-3#1)(2010-12#2)(2012-1#1)(2013-1#1)
review represents##2##2##(2005-6#1)(2006-9#1)
review research in##2##3##(2008-4#1)(2008-6#1)
review research on the##3##4##(2005-7#1)(2008-11#1)(2012-1#1)
review research##6##2##(2005-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2012-1#1)
review revealed##7##2##(2007-10#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-6#1)
review reveals that##4##3##(2008-1#1)(2008-8#1)(2013-1#2)
review serves as a##2##4##(2011-2#1)(2012-1#1)
review serves##4##2##(1997-4#1)(2010-6#1)(2011-2#1)(2012-1#1)
review several##9##2##(1996-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-3#1)(2010-10#1)(2011-2#2)
review showed that##3##3##(2007-11#1)(2008-10#1)(2009-7#1)
review showed##5##2##(2007-11#1)(2008-10#1)(2009-7#1)(2013-1#2)
review shows that##4##3##(2008-1#1)(2010-4#1)(2010-7#1)(2013-8#1)
review shows##7##2##(2006-9#1)(2007-9#1)(2008-1#1)(2008-10#1)(2010-4#1)(2010-7#1)(2013-8#1)
review some of the##14##4##(1991-4#1)(1993-12#1)(1995-7#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-5#1)(2011-1#1)
review some of these##3##4##(2006-10#2)(2007-6#1)
review some of##17##3##(1991-4#1)(1993-12#1)(1995-7#1)(2006-10#3)(2006-8#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-5#1)(2011-1#1)
review some##29##2##(1990-12#1)(1991-4#1)(1993-12#1)(1994-8#2)(1995-7#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#3)(2006-8#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-2#2)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#1)(2011-1#1)(2012-11#1)
review specifically##2##2##(2010-11#1)(2013-1#1)
review strategies to##3##3##(2007-11#1)(2009-10#1)(2012-2#1)
review studies##3##2##(2008-7#1)(2012-2#1)(2013-7#1)
review suggest a##2##3##(2009-4#1)(2011-2#1)
review suggest##3##2##(2009-4#1)(2011-2#2)
review suggests that the use of##2##6##(2006-10#1)(2009-10#1)
review suggests that##6##3##(1995-1#1)(2006-10#1)(2009-10#2)(2010-6#1)(2013-8#1)
review summarises our current##2##4##(2007-11#1)(2011-2#1)
review summarises##13##2##(2005-7#1)(2007-11#4)(2007-2#1)(2008-10#1)(2008-11#1)(2009-2#1)(2011-10#1)(2011-2#2)(2012-2#1)
review summarizes available data##2##4##(2008-4#1)(2013-8#1)
review summarizes available##3##3##(2005-10#1)(2008-4#1)(2013-8#1)
review summarizes our current knowledge##2##5##(2008-1#1)(2010-8#1)
review summarizes our current##3##4##(2008-1#1)(2008-11#1)(2010-8#1)
review summarizes our##4##3##(2008-1#1)(2008-11#1)(2008-8#1)(2010-8#1)
review summarizes recent advances in##4##5##(2005-8#1)(2007-7#1)(2008-1#1)(2010-2#1)
review summarizes recent##14##3##(2005-8#1)(2006-10#5)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-6#1)(2010-2#1)
review summarizes some of the##2##5##(2008-5#1)(2010-5#1)
review summarizes the current understanding of the##2##7##(2008-1#1)(2008-7#1)
review summarizes the current##14##4##(2005-10#2)(2005-6#1)(2005-8#1)(2006-2#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2012-3#1)
review summarizes the recent##3##4##(2007-11#1)(2010-11#1)(2012-12#1)
review summarizes the##59##3##(1991-12#1)(1996-8#1)(2005-10#3)(2005-6#1)(2005-8#2)(2006-10#6)(2006-2#1)(2007-11#2)(2007-4#2)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2009-10#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-9#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#3)
review summarizes##107##2##(1991-12#1)(1996-3#1)(1996-8#1)(2005-10#5)(2005-6#1)(2005-8#3)(2006-10#12)(2006-2#2)(2007-11#4)(2007-12#2)(2007-4#2)(2007-7#1)(2007-8#2)(2008-1#7)(2008-10#6)(2008-11#4)(2008-2#1)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#5)(2008-8#4)(2009-10#1)(2009-5#1)(2009-8#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-9#1)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#4)
review surveys the##4##3##(1996-5#3)(2013-7#1)
review surveys##5##2##(1996-5#4)(2013-7#1)
review system##3##2##(1993-2#1)(2008-4#1)(2009-2#1)
review that##8##2##(2006-10#1)(2007-11#1)(2008-10#1)(2008-6#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-3#1)
review the application of##4##4##(2006-9#1)(2010-8#1)(2011-2#1)(2012-11#1)
review the assessment##2##3##(2005-6#1)(2010-11#1)
review the authors##6##3##(1991-11#1)(2006-10#2)(2006-7#2)(2007-12#1)
review the available data##2##4##(2010-10#1)(2012-2#1)
review the available evidence on##2##5##(2006-9#1)(2011-2#1)
review the available evidence##3##4##(2006-9#1)(2008-7#1)(2011-2#1)
review the available literature on##2##5##(2007-11#1)(2011-1#1)
review the available##8##3##(2006-9#1)(2007-11#1)(2008-7#2)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
review the basic##3##3##(1997-1#1)(2005-10#1)(2011-1#1)
review the biology of##3##4##(2008-8#1)(2009-5#1)(2010-4#1)
review the case##4##3##(2009-4#1)(2010-6#1)(2010-7#1)(2012-12#1)
review the cases##2##3##(1993-2#1)(2006-5#1)
review the clinical and##2##4##(2005-9#1)(2011-2#1)
review the clinical manifestations##2##4##(1996-12#1)(2007-12#1)
review the clinical##8##3##(1996-12#1)(2005-10#1)(2005-9#1)(2007-12#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-2#1)
review the complications##4##3##(2007-7#1)(2008-8#1)(2008-9#1)(2009-5#1)
review the contribution of##2##4##(2007-9#1)(2009-9#1)
review the current knowledge about##2##5##(2006-7#1)(2008-11#1)
review the current knowledge of##4##5##(2006-12#1)(2008-1#1)(2012-2#1)(2013-1#1)
review the current knowledge on##2##5##(2007-12#1)(2008-1#1)
review the current knowledge##8##4##(2006-12#1)(2006-7#1)(2007-12#1)(2008-1#2)(2008-11#1)(2012-2#1)(2013-1#1)
review the current state of knowledge##3##6##(2007-11#1)(2008-11#1)(2010-3#1)
review the current state of##6##5##(2007-11#1)(2008-11#1)(2010-3#1)(2010-9#1)(2012-12#1)(2012-3#1)
review the current status of##7##5##(2008-10#1)(2010-12#1)(2010-4#1)(2012-11#1)(2012-2#2)(2013-1#1)
review the current understanding of##2##5##(1996-11#1)(2010-5#1)
review the current##41##3##(1996-11#1)(1996-12#1)(2004-3#1)(2006-11#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-1#3)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-9#2)(2011-1#1)(2011-12#2)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
review the currently available##2##4##(2006-7#1)(2008-10#1)
review the currently##3##3##(2006-7#1)(2008-10#1)(2011-2#1)
review the data from##2##4##(1992-6#1)(2006-11#1)
review the development of the##2##5##(1996-6#1)(2005-11#1)
review the development of##6##4##(1996-6#1)(2005-11#1)(2008-11#1)(2008-7#1)(2009-11#1)(2012-1#1)
review the development##7##3##(1996-6#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-11#1)(2012-1#1)
review the different##4##3##(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)
review the epidemiology##6##3##(2005-6#1)(2007-2#1)(2008-6#1)(2010-8#1)(2011-2#1)(2012-2#1)
review the evidence for##5##4##(2006-12#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-7#1)
review the evidence that##5##4##(1994-11#1)(2006-2#1)(2008-7#1)(2009-10#1)(2009-11#1)
review the evidence##20##3##(1994-11#1)(2004-10#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-11#1)(2010-2#1)(2010-5#1)(2011-12#1)
review the evolution of##2##4##(1996-2#1)(2010-3#1)
review the evolution##3##3##(1996-2#1)(2010-3#1)(2011-2#1)
review the existing literature##2##4##(2010-8#1)(2012-1#1)
review the existing##3##3##(2010-8#1)(2011-2#1)(2012-1#1)
review the historical##3##3##(2006-7#1)(2007-2#1)(2008-3#1)
review the history of the##2##5##(2007-4#1)(2010-8#1)
review the history of##3##4##(2007-4#1)(2008-1#1)(2010-8#1)
review the history##5##3##(1997-1#1)(2007-4#1)(2008-1#1)(2010-8#1)(2012-2#1)
review the impact##2##3##(2008-10#1)(2008-7#1)
review the importance of##2##4##(2006-3#1)(2008-11#1)
review the incidence##4##3##(1993-5#1)(1995-9#1)(2006-10#1)(2007-5#1)
review the key##2##3##(1994-3#1)(2010-7#1)
review the known##2##3##(1990-8#1)(2008-7#1)
review the latest##5##3##(2006-10#2)(2008-1#1)(2008-10#1)(2009-12#1)
review the literature and discuss the##2##6##(2004-7#1)(2005-10#1)
review the literature and discuss##5##5##(2004-7#1)(2005-10#2)(2007-10#1)(2007-6#1)
review the literature and present##2##5##(2005-11#1)(2013-1#1)
review the literature and##9##4##(1993-5#1)(2004-7#1)(2005-10#2)(2005-11#1)(2007-10#1)(2007-6#1)(2008-6#1)(2013-1#1)
review the literature in##2##4##(2007-6#1)(2013-1#1)
review the literature of this##2##5##(2006-10#1)(2008-7#1)
review the literature of##6##4##(2006-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2009-8#1)
review the literature on the subject##2##6##(1993-10#1)(2009-1#1)
review the literature on the##6##5##(1993-10#1)(2009-1#1)(2010-3#1)(2011-2#2)(2012-2#1)
review the literature on##21##4##(1990-2#1)(1993-10#1)(2006-11#1)(2006-2#1)(2007-6#3)(2007-8#1)(2009-1#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#4)(2012-2#1)(2013-1#1)
review the literature regarding##3##4##(2007-10#1)(2008-3#1)(2009-5#1)
review the literature related to the##2##6##(2006-10#1)(2010-2#1)
review the literature##58##3##(1990-2#1)(1993-10#1)(1993-5#1)(1993-8#1)(1996-9#1)(1997-3#1)(2004-7#1)(2005-10#2)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2007-10#3)(2007-11#2)(2007-6#5)(2007-8#2)(2008-11#2)(2008-3#1)(2008-6#4)(2008-7#1)(2009-1#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#4)
review the main##10##3##(1992-10#1)(2006-1#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#2)(2011-2#1)
review the major##4##3##(2006-8#1)(2007-11#1)(2008-1#1)(2008-11#1)
review the management of##3##4##(2006-5#1)(2008-10#1)(2011-2#1)
review the management##4##3##(2006-5#1)(2006-9#1)(2008-10#1)(2011-2#1)
review the medical##3##3##(1991-12#1)(2007-2#1)(2008-6#1)
review the molecular mechanisms##2##4##(2008-11#1)(2012-12#1)
review the molecular##3##3##(2008-11#1)(2012-12#1)(2013-1#1)
review the most common##2##4##(2009-12#1)(2010-7#1)
review the most important##3##4##(2006-10#1)(2008-10#1)(2008-6#1)
review the most##9##3##(2006-10#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-12#1)(2010-7#1)(2012-3#1)
review the pathogenesis of##4##4##(1993-2#1)(1993-9#1)(2007-10#1)(2009-1#1)
review the pathogenesis##5##3##(1993-2#1)(1993-9#1)(2007-10#1)(2007-7#1)(2009-1#1)
review the pathophysiology of##3##4##(2008-11#1)(2008-4#1)(2012-3#1)
review the pathophysiology##4##3##(2006-5#1)(2008-11#1)(2008-4#1)(2012-3#1)
review the pertinent##2##3##(2006-10#1)(2010-12#1)
review the possible##3##3##(2008-7#2)(2008-8#1)
review the practice of##2##4##(2010-12#1)(2011-1#1)
review the present state of##2##5##(2006-6#1)(2011-1#1)
review the present##5##3##(2006-10#1)(2006-6#1)(2007-8#1)(2011-1#1)(2012-11#1)
review the prevalence##2##3##(2006-9#1)(2008-12#1)
review the principles of##2##4##(2006-2#1)(2012-2#1)
review the progress made in the##2##6##(2008-5#1)(2010-5#1)
review the progress that has been##2##6##(2008-1#1)(2008-7#1)
review the progress##6##3##(2008-1#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-5#1)
review the published literature##2##4##(2006-3#1)(2008-3#1)
review the published##7##3##(1995-2#1)(2006-3#1)(2006-8#1)(2008-12#1)(2008-3#1)(2009-2#1)(2009-7#1)
review the rationale##4##3##(2005-10#1)(2005-8#1)(2006-7#1)(2008-5#1)
review the recent advances##2##4##(2005-2#1)(2008-1#1)
review the recent literature concerning##2##5##(2006-10#1)(2008-8#1)
review the recent literature##3##4##(2006-10#1)(2008-8#1)(2013-1#1)
review the recent progress##3##4##(2008-3#1)(2011-1#2)
review the recent##17##3##(2005-2#1)(2006-10#2)(2006-6#1)(2007-7#1)(2008-1#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-1#1)(2009-12#1)(2010-12#1)(2011-1#3)(2013-1#1)
review the relevant literature##6##4##(1994-12#1)(2006-5#1)(2008-2#1)(2008-5#1)(2010-6#1)(2013-1#1)
review the relevant##9##3##(1994-12#1)(2006-5#1)(2008-2#1)(2008-5#1)(2009-7#1)(2010-12#1)(2010-6#2)(2013-1#1)
review the reported##2##3##(2008-6#1)(2012-12#1)
review the results of##8##4##(1990-2#1)(2006-10#1)(2007-6#1)(2008-11#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-1#1)
review the results##9##3##(1990-2#1)(2006-10#1)(2007-6#1)(2008-11#1)(2008-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-1#1)
review the risk##2##3##(2007-12#1)(2012-2#1)
review the role of##15##4##(1996-5#1)(2006-2#1)(2007-2#1)(2007-4#2)(2008-1#2)(2009-8#2)(2010-11#1)(2010-2#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-1#1)
review the role##16##3##(1996-5#1)(2006-2#1)(2007-2#1)(2007-4#2)(2008-1#2)(2009-8#2)(2010-11#1)(2010-2#2)(2011-1#1)(2011-12#1)(2012-2#1)(2013-1#1)
review the scientific##3##3##(2006-7#1)(2008-9#1)(2010-12#1)
review the standard##2##3##(1995-10#1)(2008-7#1)
review the state of the art of##2##7##(2008-5#1)(2012-3#1)
review the state of the art##4##6##(1993-3#1)(2006-6#1)(2008-5#1)(2012-3#1)
review the state-of-the-art##2##3##(2008-10#1)(2008-8#1)
review the technical##2##3##(1990-12#1)(2006-8#1)
review the technique##2##3##(2007-7#1)(2011-7#1)
review the theory and##3##4##(2005-6#1)(2007-4#1)(2008-2#1)
review the treatment##3##3##(2006-8#1)(2013-1#2)
review the unique##2##3##(2008-7#1)(2011-2#1)
review the use of##2##4##(2008-10#1)(2008-7#1)
review the use##3##3##(2008-10#1)(2008-7#1)(2013-8#1)
review the various##2##3##(2006-2#1)(2011-1#1)
review the##550##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-10#2)(1993-2#3)(1993-3#1)(1993-5#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-4#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#3)(1997-3#1)(1997-6#1)(1997-7#1)(2004-1#1)(2004-10#1)(2004-3#1)(2004-7#1)(2005-10#5)(2005-11#2)(2005-2#1)(2005-6#3)(2005-7#1)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#21)(2006-11#5)(2006-12#3)(2006-2#8)(2006-3#2)(2006-5#6)(2006-6#3)(2006-7#8)(2006-8#5)(2006-9#4)(2007-1#1)(2007-10#7)(2007-11#15)(2007-12#10)(2007-2#9)(2007-4#5)(2007-5#2)(2007-6#7)(2007-7#7)(2007-8#6)(2007-9#3)(2008-1#14)(2008-10#16)(2008-11#17)(2008-12#4)(2008-2#7)(2008-3#9)(2008-4#5)(2008-5#9)(2008-6#12)(2008-7#19)(2008-8#10)(2008-9#6)(2009-1#3)(2009-10#2)(2009-11#2)(2009-12#7)(2009-2#1)(2009-4#3)(2009-5#5)(2009-7#3)(2009-8#6)(2009-9#5)(2010-10#2)(2010-11#3)(2010-12#12)(2010-2#6)(2010-3#4)(2010-4#6)(2010-5#4)(2010-6#4)(2010-7#3)(2010-8#6)(2010-9#4)(2011-1#18)(2011-11#1)(2011-12#6)(2011-2#18)(2011-7#1)(2012-1#6)(2012-11#5)(2012-12#12)(2012-2#20)(2012-3#7)(2013-1#19)(2013-2#1)(2013-7#1)(2013-8#4)
review their##9##2##(1994-3#1)(2005-11#1)(2006-12#1)(2006-5#2)(2007-11#1)(2008-3#1)(2009-7#1)(2012-12#1)
review there##2##2##(2006-10#1)(2011-2#1)
review therefore##2##2##(2005-8#1)(2008-11#1)
review these issues and##2##4##(2008-11#1)(2008-7#1)
review these##20##2##(1993-4#1)(1995-1#1)(1996-3#1)(2005-10#1)(2006-10#1)(2006-4#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-12#1)
review this literature##2##3##(1996-8#1)(2008-10#1)
review this##8##2##(1994-3#1)(1996-8#1)(2005-11#1)(2008-10#1)(2008-7#1)(2009-5#1)(2013-1#2)
review three##2##2##(2005-6#1)(2011-1#1)
review to better##2##3##(2007-10#1)(2007-4#1)
review to##16##2##(1992-2#1)(2005-10#1)(2005-7#1)(2006-12#1)(2007-10#1)(2007-4#1)(2007-7#2)(2008-10#1)(2008-4#1)(2009-4#1)(2010-5#1)(2012-12#1)(2013-1#3)
review tries to##2##3##(2008-11#1)(2008-8#1)
review two##2##2##(2007-11#1)(2009-11#1)
review updates##5##2##(2006-10#1)(2008-4#1)(2011-1#1)(2011-2#1)(2013-7#1)
review using##4##2##(1993-1#1)(2009-6#1)(2010-12#1)(2013-8#1)
review various aspects of##2##4##(1996-11#1)(2008-7#1)
review various##4##2##(1996-11#1)(2006-4#1)(2008-7#1)(2012-2#1)
review was carried out##4##4##(2007-1#1)(2011-2#1)(2013-1#2)
review was conducted##5##3##(2007-11#1)(2008-7#1)(2009-11#1)(2011-2#1)(2013-1#1)
review was done##2##3##(2008-5#1)(2010-8#1)
review was made of the##3##5##(2006-2#1)(2011-1#1)(2013-7#1)
review was made of##7##4##(1996-1#1)(2005-10#1)(2006-2#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
review was made##10##3##(1996-1#1)(2005-10#1)(2006-2#1)(2007-11#1)(2009-7#1)(2011-1#1)(2012-12#2)(2013-1#1)(2013-7#1)
review was performed of all##2##5##(2006-10#1)(2008-9#1)
review was performed of##6##4##(2006-10#1)(2008-3#1)(2008-6#1)(2008-9#2)(2011-2#1)
review was performed on##4##4##(2007-2#1)(2009-10#1)(2013-1#2)
review was performed to##3##4##(2008-10#1)(2011-2#1)(2012-3#1)
review was performed##16##3##(2006-10#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#2)(2009-10#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#4)
review was to determine whether##2##5##(1996-6#1)(2012-3#1)
review was to evaluate the##2##5##(2006-6#1)(2008-5#1)
review was to##22##3##(1996-6#1)(2005-8#1)(2006-6#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2009-11#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
review was undertaken##6##3##(2005-8#1)(2006-8#1)(2011-2#1)(2012-12#3)
review was##77##2##(1994-6#1)(1995-6#1)(1996-1#1)(1996-6#1)(2005-10#1)(2005-8#2)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-7#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-12#5)(2012-2#1)(2012-3#4)(2013-1#13)(2013-7#1)(2013-8#2)
review we aim to##3##4##(2008-7#2)(2013-1#1)
review we attempt to##2##4##(2008-1#1)(2012-3#1)
review we discuss evidence##2##4##(1992-2#1)(2008-4#1)
review we discuss the##13##4##(2006-10#1)(2007-1#1)(2007-5#1)(2007-9#1)(2008-1#1)(2009-3#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
review we discuss##21##3##(1992-2#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-1#2)(2008-4#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
review we examine the##3##4##(2006-10#1)(2008-10#1)(2008-8#1)
review we have##3##3##(2005-7#1)(2008-1#1)(2010-8#1)
review we provide an##3##4##(2008-7#1)(2012-12#1)(2012-2#1)
review we provide##4##3##(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
review we##107##2##(1992-2#1)(1992-5#1)(1996-8#1)(2005-10#1)(2005-7#2)(2006-10#4)(2006-11#1)(2006-2#2)(2007-1#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#10)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#11)(2008-8#1)(2008-9#1)(2009-3#3)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#2)(2010-10#2)(2010-11#3)(2010-12#4)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-1#4)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#5)(2013-8#5)
review were##5##2##(1991-2#1)(2008-1#1)(2009-1#1)(2011-2#1)(2013-1#1)
review what is known about the##2##6##(2005-7#1)(2008-3#1)
review what is known##3##4##(2005-7#1)(2007-12#1)(2008-3#1)
review what is##4##3##(2005-7#1)(2007-12#1)(2008-3#1)(2008-7#1)
review will address the##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
review will address##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
review will also##5##3##(2008-1#1)(2008-10#1)(2008-7#1)(2010-8#1)(2012-3#1)
review will briefly##3##3##(2008-1#1)(2008-7#2)
review will describe##4##3##(2008-1#1)(2010-11#1)(2013-7#1)(2013-8#1)
review will discuss the##22##4##(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-8#1)(2007-1#1)(2007-10#1)(2008-1#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
review will discuss##33##3##(2005-10#2)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-8#2)(2007-1#1)(2007-10#1)(2008-1#4)(2008-11#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
review will examine##7##3##(2005-7#1)(2008-10#1)(2008-5#1)(2009-4#1)(2009-6#1)(2012-12#1)(2012-2#1)
review will focus on the##18##5##(1994-3#1)(2007-9#1)(2008-1#3)(2008-3#1)(2008-5#2)(2008-7#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-2#1)(2010-8#1)(2012-2#1)
review will focus on##32##4##(1994-3#1)(2006-10#2)(2007-9#1)(2008-1#7)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-2#1)(2010-8#2)(2012-12#1)(2012-2#1)
review will focus##34##3##(1994-3#1)(2006-10#2)(2007-9#1)(2008-1#7)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-2#1)(2010-7#1)(2010-8#2)(2012-12#1)(2012-2#1)
review will highlight the##2##4##(2010-1#1)(2010-5#1)
review will highlight##6##3##(2006-10#1)(2008-11#1)(2009-3#1)(2010-1#1)(2010-2#1)(2010-5#1)
review will identify the##2##4##(2008-2#1)(2009-5#1)
review will provide a##5##4##(2008-11#1)(2009-12#1)(2009-5#1)(2010-6#1)(2012-2#1)
review will provide##8##3##(2007-11#1)(2008-1#1)(2008-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-6#1)(2012-2#1)
review will summarize recent##3##4##(2008-1#1)(2008-11#1)(2011-2#1)
review will summarize##12##3##(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-11#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
review will##147##2##(1994-3#1)(2005-10#2)(2005-7#2)(2005-8#1)(2006-10#6)(2006-11#1)(2006-2#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-7#1)(2007-9#1)(2008-1#22)(2008-10#7)(2008-11#7)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#12)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#5)(2009-4#4)(2009-5#4)(2009-6#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#4)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
review with a##2##3##(2008-7#1)(2010-8#1)
review with##9##2##(1993-5#1)(1995-12#1)(2007-10#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-8#1)(2013-8#1)
review work##3##2##(1994-11#1)(2006-4#1)(2009-10#1)
review##5732##1##(1990-1#1)(1990-10#5)(1990-11#2)(1990-12#20)(1990-2#2)(1990-3#5)(1990-4#2)(1990-5#11)(1990-6#5)(1990-7#1)(1990-8#5)(1990-9#4)(1991-1#12)(1991-10#5)(1991-11#3)(1991-12#9)(1991-2#13)(1991-3#8)(1991-4#9)(1991-5#1)(1991-6#8)(1991-7#1)(1991-8#1)(1991-9#5)(1992-1#14)(1992-10#3)(1992-11#1)(1992-12#17)(1992-2#9)(1992-3#6)(1992-5#7)(1992-6#9)(1992-8#3)(1992-9#4)(1993-1#11)(1993-10#7)(1993-11#2)(1993-12#18)(1993-2#14)(1993-3#12)(1993-4#2)(1993-5#7)(1993-6#14)(1993-7#3)(1993-8#5)(1993-9#4)(1994-1#4)(1994-10#2)(1994-11#4)(1994-12#3)(1994-2#9)(1994-3#19)(1994-4#2)(1994-5#2)(1994-6#17)(1994-7#1)(1994-8#7)(1994-9#1)(1995-1#9)(1995-10#1)(1995-11#5)(1995-12#8)(1995-2#7)(1995-3#3)(1995-4#2)(1995-5#8)(1995-6#9)(1995-7#1)(1995-8#5)(1995-9#5)(1996-1#7)(1996-10#2)(1996-11#7)(1996-12#10)(1996-2#12)(1996-3#10)(1996-5#8)(1996-6#3)(1996-7#6)(1996-8#7)(1996-9#11)(1997-1#8)(1997-2#14)(1997-3#14)(1997-4#7)(1997-5#3)(1997-6#5)(1997-7#3)(1997-8#7)(2003-11#1)(2004-1#2)(2004-10#4)(2004-11#2)(2004-12#3)(2004-2#6)(2004-3#1)(2004-4#3)(2004-7#3)(2004-9#1)(2005-10#43)(2005-11#24)(2005-12#7)(2005-2#2)(2005-3#2)(2005-4#2)(2005-5#2)(2005-6#13)(2005-7#53)(2005-8#41)(2005-9#14)(2006-1#14)(2006-10#288)(2006-11#30)(2006-12#55)(2006-2#43)(2006-3#11)(2006-4#17)(2006-5#22)(2006-6#19)(2006-7#24)(2006-8#65)(2006-9#36)(2007-1#18)(2007-10#46)(2007-11#148)(2007-12#73)(2007-2#69)(2007-3#39)(2007-4#38)(2007-5#27)(2007-6#33)(2007-7#57)(2007-8#67)(2007-9#24)(2008-1#172)(2008-10#220)(2008-11#160)(2008-12#66)(2008-2#42)(2008-3#88)(2008-4#88)(2008-5#110)(2008-6#72)(2008-7#187)(2008-8#122)(2008-9#61)(2009-1#10)(2009-10#40)(2009-11#25)(2009-12#23)(2009-2#18)(2009-3#39)(2009-4#58)(2009-5#61)(2009-6#26)(2009-7#21)(2009-8#37)(2009-9#27)(2010-1#15)(2010-10#25)(2010-11#49)(2010-12#113)(2010-2#36)(2010-3#23)(2010-4#34)(2010-5#39)(2010-6#31)(2010-7#48)(2010-8#46)(2010-9#31)(2011-1#155)(2011-10#1)(2011-11#2)(2011-12#33)(2011-2#208)(2011-3#9)(2011-7#7)(2011-9#1)(2012-1#80)(2012-11#28)(2012-12#184)(2012-2#187)(2012-3#96)(2013-1#248)(2013-2#1)(2013-7#40)(2013-8#109)
review&quot##4##1##(2007-11#1)(2007-5#2)(2011-2#1)
review)##4##1##(1994-12#1)(1995-11#1)(2009-10#1)(2012-12#1)
review)]##2##1##(2012-3#1)(2013-8#1)
review]##44##1##(1990-12#1)(1990-2#1)(1991-3#1)(1991-4#1)(1991-9#2)(1992-11#1)(1993-3#1)(1993-5#1)(1993-8#2)(1996-12#1)(1996-9#1)(2006-8#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#6)(2013-1#3)(2013-8#4)
reviewed 3##2##2##(2006-10#1)(2006-6#1)
reviewed 55##3##2##(2006-2#1)(2007-6#2)
reviewed a##9##2##(1992-1#1)(1992-12#1)(2006-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-12#1)(2010-12#1)(2011-2#1)
reviewed after##4##2##(1994-2#1)(2006-10#1)(2009-3#1)(2013-8#1)
reviewed all##6##2##(1994-2#1)(1996-11#1)(2006-10#1)(2007-2#1)(2007-8#1)(2011-2#1)
reviewed along with the##2##4##(2010-3#1)(2013-1#1)
reviewed along with##3##3##(2009-5#1)(2010-3#1)(2013-1#1)
reviewed and a##3##3##(2007-11#1)(2007-12#1)(2007-3#1)
reviewed and analyzed##2##3##(1996-12#1)(2011-1#1)
reviewed and assessed##2##3##(2009-8#1)(2011-2#1)
reviewed and categorized##2##3##(2007-7#2)
reviewed and compared##2##3##(1996-12#1)(1996-3#1)
reviewed and discussed in##3##4##(1994-11#1)(2008-7#2)
reviewed and discussed##9##3##(1994-11#1)(2006-11#1)(2007-6#1)(2007-8#1)(2008-7#2)(2008-8#1)(2010-12#1)(2011-1#1)
reviewed and evaluated##2##3##(2008-11#1)(2009-4#1)
reviewed and summarized##2##3##(1996-3#1)(2008-6#1)
reviewed and the##12##3##(1991-6#1)(1992-10#1)(1993-3#1)(1993-8#1)(1996-3#1)(2005-7#1)(2006-8#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-8#1)
reviewed and##77##2##(1991-3#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-3#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-10#1)(1996-12#2)(1996-3#3)(1996-8#1)(1997-7#1)(2005-11#1)(2005-5#1)(2005-7#2)(2006-10#3)(2006-11#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
reviewed are##3##2##(2006-10#2)(2007-8#1)
reviewed articles##2##2##(2005-7#1)(2012-12#1)
reviewed as##8##2##(1995-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#2)(2010-9#1)
reviewed available##2##2##(2007-10#1)(2012-12#1)
reviewed before##3##2##(1996-8#1)(2008-6#1)(2010-12#1)
reviewed briefly##7##2##(1990-5#1)(2006-4#1)(2006-5#1)(2007-12#1)(2007-2#1)(2008-1#1)(2009-7#1)
reviewed by a##2##3##(2008-5#1)(2010-2#1)
reviewed by the##2##3##(2007-4#1)(2013-8#1)
reviewed by two##3##3##(1992-6#1)(1992-8#1)(2011-2#1)
reviewed by##14##2##(1991-2#1)(1992-6#1)(1992-8#1)(1996-1#1)(2007-12#1)(2007-4#1)(2008-5#1)(2008-7#1)(2010-2#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
reviewed cases##2##2##(2008-1#1)(2008-10#1)
reviewed clinical##3##2##(2009-8#1)(2012-3#1)(2013-8#1)
reviewed concerning##2##2##(2006-8#1)(2008-8#1)
reviewed data##6##2##(2006-9#1)(2007-3#1)(2007-7#1)(2008-5#1)(2008-6#1)(2010-4#1)
reviewed existing##2##2##(2008-1#1)(2008-12#1)
reviewed extensively##3##2##(1994-10#1)(2009-3#1)(2010-7#1)
reviewed for a##2##3##(2008-8#1)(2008-9#1)
reviewed for the##4##3##(1996-11#1)(2007-2#1)(2011-2#1)(2012-3#1)
reviewed for##26##2##(1995-12#1)(1996-11#1)(1996-3#1)(2005-8#1)(2006-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#1)(2009-5#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#2)
reviewed from the literature##2##4##(1991-12#1)(2008-7#1)
reviewed from the##5##3##(1991-12#1)(1991-8#1)(2006-10#1)(2007-10#1)(2008-7#1)
reviewed from##13##2##(1991-12#1)(1991-8#1)(1995-6#1)(2005-11#1)(2006-10#2)(2007-10#1)(2008-11#1)(2008-7#1)(2011-1#2)(2013-1#2)
reviewed here##26##2##(1990-8#1)(1994-12#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#2)(2008-8#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#1)(2013-1#1)
reviewed herein##8##2##(2005-8#1)(2007-1#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-4#1)(2009-5#1)(2013-8#1)
reviewed in light of##2##4##(2006-10#1)(2008-8#1)
reviewed in relation to the##2##5##(1992-2#1)(2008-4#1)
reviewed in relation to##3##4##(1992-2#1)(2008-1#1)(2008-4#1)
reviewed in terms of the##2##5##(1991-2#1)(2006-12#1)
reviewed in terms of##4##4##(1991-2#1)(2006-12#1)(2008-10#2)
reviewed in the light of##2##5##(1991-4#1)(2007-11#1)
reviewed in the literature##2##4##(1990-12#1)(2007-8#1)
reviewed in the present paper##2##5##(2005-8#1)(2008-8#1)
reviewed in the##11##3##(1990-12#1)(1991-4#1)(1997-6#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-8#1)(2011-1#1)(2012-12#1)
reviewed in this article##21##4##(1993-6#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-5#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-6#2)(2009-9#1)(2010-12#2)(2011-12#1)(2012-12#1)(2012-2#1)
reviewed in this paper##6##4##(1993-12#1)(1996-6#1)(1997-2#1)(2006-2#1)(2008-1#1)(2012-1#1)
reviewed in this##33##3##(1993-12#1)(1993-6#1)(1996-6#1)(1997-2#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-2#1)(2006-4#1)(2007-11#1)(2007-5#1)(2008-1#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-6#2)(2009-9#1)(2010-12#2)(2010-9#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)
reviewed in##73##2##(1990-12#1)(1990-4#2)(1991-2#1)(1991-4#1)(1992-1#1)(1992-2#1)(1993-12#1)(1993-6#1)(1994-2#1)(1996-6#2)(1997-2#1)(1997-6#1)(2005-4#1)(2005-5#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#5)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#3)(2008-7#4)(2008-8#3)(2009-12#1)(2009-6#2)(2009-9#1)(2010-12#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)
reviewed include##2##2##(2006-10#1)(2007-12#1)
reviewed literature##5##2##(2005-7#1)(2007-7#1)(2008-1#1)(2008-7#1)(2010-11#1)
reviewed medical##2##2##(1993-6#1)(2006-2#1)
reviewed on##3##2##(2007-10#1)(2008-11#1)(2008-8#1)
reviewed other##2##2##(2008-6#1)(2010-3#1)
reviewed our data##2##3##(1994-12#1)(2007-7#1)
reviewed our experience##2##3##(2007-8#1)(2008-6#1)
reviewed our##10##2##(1993-5#1)(1994-12#1)(2007-7#3)(2007-8#3)(2008-6#1)(2012-3#1)
reviewed papers##3##2##(2005-7#2)(2007-3#1)
reviewed publications##2##2##(2006-10#1)(2008-10#1)
reviewed retrospectively##12##2##(1991-2#1)(1993-5#2)(1993-8#1)(2006-10#2)(2007-8#3)(2009-9#1)(2011-1#1)(2011-2#1)
reviewed some of##2##3##(1997-5#1)(2008-4#1)
reviewed some##3##2##(1997-5#1)(2008-4#1)(2011-3#1)
reviewed studies that##2##3##(2012-1#1)(2012-2#1)
reviewed studies##4##2##(2009-7#1)(2012-1#1)(2012-2#1)(2012-3#1)
reviewed that##6##2##(1996-12#1)(1996-7#1)(2008-10#1)(2009-4#1)(2010-10#1)(2012-1#1)
reviewed the clinical##6##3##(1996-6#1)(1997-6#1)(2006-12#2)(2007-3#1)(2007-7#1)
reviewed the current literature on##2##5##(1995-12#1)(2011-2#1)
reviewed the current##5##3##(1995-12#1)(2006-2#1)(2010-2#1)(2011-2#1)(2012-2#1)
reviewed the data##2##3##(2007-8#1)(2008-10#1)
reviewed the evidence##2##3##(2006-5#1)(2011-2#1)
reviewed the literature on the##2##5##(1991-10#1)(2013-1#1)
reviewed the literature on##3##4##(1991-10#1)(2007-11#1)(2013-1#1)
reviewed the literature##18##3##(1991-10#1)(1994-2#1)(1996-6#1)(2004-4#1)(2007-11#1)(2007-9#1)(2008-5#1)(2008-8#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)
reviewed the medical records of##6##5##(1990-2#1)(2007-8#1)(2008-8#1)(2009-10#1)(2012-12#1)(2012-2#1)
reviewed the medical records##8##4##(1990-2#1)(2007-8#1)(2008-1#1)(2008-8#1)(2009-10#1)(2010-4#1)(2012-12#1)(2012-2#1)
reviewed the medical##11##3##(1990-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-8#1)
reviewed the most##3##3##(1992-5#1)(2009-1#1)(2010-9#1)
reviewed the progress##2##3##(2005-8#1)(2008-5#1)
reviewed the records and##2##4##(2007-7#1)(2008-1#1)
reviewed the records of the active renal transplant patients at two large transplant centers in Riyadh and Jeddah in Saudi Arabia##2##21##(2008-1#2)
reviewed the records of the##3##5##(2008-1#3)
reviewed the records of##7##4##(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#3)(2011-2#1)
reviewed the records##10##3##(2005-10#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#4)(2011-2#1)
reviewed the relevant##2##3##(2007-7#1)(2011-2#1)
reviewed the surgical##2##3##(2007-8#1)(2009-5#1)
reviewed the various##2##3##(1990-9#1)(2009-12#1)
reviewed the##125##2##(1990-2#2)(1990-4#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-9#1)(1992-3#1)(1992-5#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-6#3)(1997-3#1)(1997-6#1)(1997-7#1)(2004-4#1)(2005-10#1)(2005-8#3)(2006-11#1)(2006-12#2)(2006-2#2)(2006-5#2)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-3#2)(2007-5#1)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#6)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-1#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#9)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#5)
reviewed their experience with this disease##2##6##(1993-3#1)(2006-11#1)
reviewed their management##2##3##(1991-2#1)(2006-9#1)
reviewed their##5##2##(1991-2#1)(1993-3#1)(2006-11#1)(2006-9#1)(2011-1#1)
reviewed this##2##2##(1992-12#1)(2006-10#1)
reviewed through##3##2##(2007-12#1)(2007-5#1)(2008-3#1)
reviewed to determine##3##3##(2005-9#1)(2008-6#1)(2010-6#1)
reviewed to##16##2##(1991-3#1)(1992-9#1)(1993-1#1)(2005-9#1)(2006-1#1)(2006-3#1)(2007-11#1)(2007-7#1)(2008-6#2)(2010-6#2)(2011-2#1)(2012-2#2)(2012-3#1)
reviewed together with the##3##4##(1996-1#1)(2007-2#1)(2009-5#1)
reviewed under##3##2##(1994-11#1)(2005-11#1)(2007-7#1)
reviewed using##4##2##(2007-10#1)(2012-12#2)(2013-1#1)
reviewed were##3##2##(1997-2#1)(2007-12#1)(2013-1#1)
reviewed which##4##2##(1993-12#1)(1996-3#1)(2008-8#2)
reviewed with emphasis on the##3##5##(1993-6#1)(2008-10#2)
reviewed with emphasis on##4##4##(1993-6#1)(2008-10#2)(2008-2#1)
reviewed with particular##6##3##(1991-12#1)(1993-6#1)(2005-11#1)(2008-11#1)(2010-12#1)(2011-2#1)
reviewed with respect to##2##4##(2006-8#1)(2007-2#1)
reviewed with special emphasis on##6##5##(1991-3#1)(1996-12#1)(2006-12#1)(2006-7#1)(2008-7#1)(2012-11#1)
reviewed with##30##2##(1990-3#1)(1991-12#1)(1991-3#1)(1993-6#2)(1996-12#1)(1996-6#1)(2005-11#1)(2005-9#1)(2006-11#2)(2006-12#2)(2006-7#1)(2006-8#1)(2007-2#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-11#1)
reviewed##1297##1##(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#4)(1990-4#4)(1990-5#1)(1990-6#4)(1990-8#2)(1990-9#4)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#8)(1991-2#6)(1991-3#3)(1991-4#2)(1991-5#3)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#4)(1992-10#3)(1992-11#1)(1992-12#4)(1992-2#6)(1992-3#5)(1992-4#2)(1992-5#1)(1992-6#4)(1992-8#5)(1992-9#1)(1993-1#3)(1993-11#3)(1993-12#5)(1993-2#3)(1993-3#2)(1993-5#5)(1993-6#5)(1993-8#5)(1994-10#1)(1994-11#4)(1994-12#3)(1994-2#7)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#3)(1994-8#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-4#3)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#3)(1996-12#8)(1996-2#1)(1996-3#6)(1996-4#1)(1996-5#3)(1996-6#7)(1996-7#3)(1996-8#3)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#2)(1997-5#2)(1997-6#4)(1997-7#3)(1997-8#3)(2004-1#1)(2004-10#3)(2004-11#2)(2004-12#1)(2004-2#1)(2004-3#1)(2004-4#1)(2005-10#4)(2005-11#6)(2005-12#1)(2005-4#2)(2005-5#2)(2005-7#20)(2005-8#10)(2005-9#4)(2006-1#1)(2006-10#67)(2006-11#12)(2006-12#14)(2006-2#15)(2006-3#3)(2006-4#6)(2006-5#8)(2006-6#8)(2006-7#6)(2006-8#13)(2006-9#8)(2007-1#6)(2007-10#14)(2007-11#23)(2007-12#18)(2007-2#21)(2007-3#11)(2007-4#7)(2007-5#6)(2007-6#5)(2007-7#19)(2007-8#47)(2007-9#8)(2008-1#36)(2008-10#44)(2008-11#23)(2008-12#12)(2008-2#17)(2008-3#20)(2008-4#26)(2008-5#21)(2008-6#21)(2008-7#42)(2008-8#36)(2008-9#8)(2009-1#2)(2009-10#9)(2009-11#2)(2009-12#7)(2009-2#2)(2009-3#8)(2009-4#9)(2009-5#10)(2009-6#4)(2009-7#8)(2009-8#3)(2009-9#5)(2010-1#2)(2010-10#3)(2010-11#9)(2010-12#13)(2010-2#2)(2010-3#9)(2010-4#5)(2010-5#2)(2010-6#4)(2010-7#2)(2010-8#8)(2010-9#11)(2011-1#28)(2011-12#7)(2011-2#41)(2011-3#2)(2012-1#10)(2012-11#1)(2012-12#23)(2012-2#28)(2012-3#21)(2013-1#34)(2013-7#3)(2013-8#21)
reviewer##9##1##(1993-12#1)(1995-12#1)(2006-8#1)(2007-6#1)(2008-11#1)(2008-8#2)(2012-3#1)(2013-7#1)
reviewers assessed##4##2##(2008-10#1)(2012-12#3)
reviewers should##3##2##(1996-9#1)(2013-1#2)
reviewers who##2##2##(2005-7#1)(2010-11#1)
reviewers##39##1##(1993-12#2)(1996-9#1)(1997-2#1)(1997-8#1)(2005-7#1)(2006-1#1)(2006-6#1)(2007-11#1)(2008-10#10)(2008-12#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-9#2)(2011-2#1)(2012-12#6)(2013-1#4)(2013-8#1)
reviewing and##4##2##(2007-3#1)(2010-4#1)(2012-3#1)(2013-8#1)
reviewing current##2##2##(2008-10#1)(2010-8#1)
reviewing recent##2##2##(2009-10#1)(2010-9#1)
reviewing research##3##2##(1993-12#1)(2009-4#1)(2009-8#1)
reviewing the current##2##3##(2006-10#1)(2007-2#1)
reviewing the literature##5##3##(2006-10#1)(2006-9#1)(2007-2#1)(2008-6#1)(2010-7#1)
reviewing the results of##2##4##(1996-12#1)(2008-6#1)
reviewing the results##3##3##(1995-3#1)(1996-12#1)(2008-6#1)
reviewing the##44##2##(1991-6#1)(1992-6#1)(1993-6#1)(1995-12#1)(1995-3#2)(1996-12#2)(1996-3#1)(1997-3#1)(2006-10#2)(2006-4#2)(2006-9#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-6#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-5#1)(2010-7#3)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)
reviewing these##3##2##(2005-8#1)(2008-12#1)(2011-12#1)
reviewing this##2##2##(2008-12#1)(2009-4#1)
reviewing##99##1##(1990-8#1)(1991-6#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-6#1)(1995-12#2)(1995-3#2)(1996-1#1)(1996-12#2)(1996-3#1)(1997-3#1)(1997-5#2)(2005-8#1)(2006-10#3)(2006-12#1)(2006-4#2)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-3#2)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2009-10#1)(2009-12#1)(2009-2#2)(2009-4#5)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-7#3)(2010-8#1)(2010-9#3)(2011-1#1)(2011-12#1)(2011-2#6)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
reviews -##4##2##(2011-2#4)
reviews a number of##2##4##(2004-12#1)(2009-10#1)
reviews a##9##2##(1993-12#2)(2004-11#1)(2004-12#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-4#1)(2009-10#1)
reviews about##2##2##(2011-2#2)
reviews and meta-analyses##2##3##(2012-1#1)(2013-8#1)
reviews and studies##2##3##(1993-6#1)(2006-10#1)
reviews and##35##2##(1991-12#1)(1992-2#1)(1992-6#1)(1993-6#2)(1997-3#2)(2005-11#1)(2006-10#2)(2006-3#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-2#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#3)
reviews are##4##2##(1993-12#1)(1994-10#1)(2004-3#1)(2010-12#1)
reviews available##3##2##(2008-4#1)(2010-12#1)(2011-10#1)
reviews by##4##2##(2006-11#1)(2008-4#2)(2012-3#1)
reviews clinical##2##2##(2005-6#1)(2006-11#1)
reviews current##14##2##(2005-12#1)(2006-6#1)(2006-9#1)(2007-4#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-9#1)(2013-8#1)
reviews eight##2##2##(2007-2#1)(2010-9#1)
reviews evidence on##2##3##(1991-3#1)(2005-10#1)
reviews evidence suggesting that##2##4##(1996-3#1)(2007-8#1)
reviews evidence##5##2##(1991-3#1)(1996-3#1)(2005-10#1)(2007-8#1)(2008-4#1)
reviews existing##4##2##(1996-2#1)(1997-8#1)(2008-11#2)
reviews four##3##2##(1996-2#1)(2007-2#1)(2010-9#1)
reviews from the##2##3##(2008-7#2)
reviews have##4##2##(2006-10#1)(2008-10#2)(2008-9#1)
reviews how to##3##3##(2008-4#2)(2008-9#1)
reviews how##6##2##(2006-1#1)(2008-4#2)(2008-9#1)(2009-9#1)(2012-2#1)
reviews in urology##2##3##(2006-9#2)
reviews in##8##2##(1996-11#1)(2006-10#1)(2006-9#2)(2007-5#2)(2008-3#1)(2008-4#1)
reviews its##3##2##(1991-2#1)(2006-7#1)(2011-12#1)
reviews of the##9##3##(1993-12#2)(2005-3#1)(2005-8#1)(2008-8#1)(2010-4#1)(2012-2#2)(2013-1#1)
reviews of##36##2##(1990-12#1)(1993-12#4)(1994-6#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(2005-10#2)(2005-3#1)(2005-8#1)(2006-10#2)(2006-9#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)
reviews on##5##2##(2006-12#1)(2008-11#1)(2009-9#1)(2011-2#1)(2013-7#1)
reviews one##2##2##(1995-2#1)(2007-9#1)
reviews our current understanding of the##2##6##(2006-10#1)(2007-12#1)
reviews our current##4##3##(1997-7#1)(2006-10#1)(2007-12#1)(2008-7#1)
reviews previous##2##2##(2008-10#1)(2008-11#1)
reviews published studies##2##3##(1990-6#1)(2012-3#1)
reviews recent advances##2##3##(2009-4#1)(2009-7#1)
reviews recent developments in the##3##5##(1994-9#1)(2008-10#1)(2010-4#1)
reviews recent developments##4##3##(1994-9#1)(2006-10#1)(2008-10#1)(2010-4#1)
reviews recent studies of##2##4##(2006-10#1)(2008-4#1)
reviews recent studies##5##3##(2006-10#1)(2007-2#1)(2008-4#1)(2010-4#1)(2012-1#1)
reviews recent##24##2##(1994-9#1)(2006-10#3)(2006-2#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-7#1)(2010-4#2)(2012-1#1)(2012-12#1)(2013-8#1)
reviews relevant##3##2##(2005-10#1)(2009-10#1)(2009-5#1)
reviews research on the##2##4##(1995-2#1)(2010-1#1)
reviews research on##3##3##(1995-2#1)(2010-1#1)(2012-3#1)
reviews research##7##2##(1995-2#1)(2004-12#1)(2006-9#1)(2008-3#1)(2008-7#1)(2010-1#1)(2012-3#1)
reviews several##2##2##(2008-4#1)(2010-12#1)
reviews some of the current##2##5##(2008-5#1)(2013-7#1)
reviews some of the##16##4##(1992-4#1)(1993-1#1)(1993-12#1)(2004-11#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#2)(2013-7#1)
reviews some of##18##3##(1992-4#1)(1993-1#1)(1993-12#1)(1996-3#1)(2004-11#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#2)(2013-7#1)
reviews some recent##2##3##(1996-6#1)(2008-10#1)
reviews some##23##2##(1992-4#1)(1993-1#1)(1993-12#1)(1996-3#1)(1996-6#1)(2004-11#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-2#1)(2012-12#1)(2013-7#1)
reviews that##3##2##(2006-1#1)(2009-8#1)(2011-1#1)
reviews the anatomical##2##3##(2009-5#1)(2009-7#1)
reviews the available data##3##4##(2010-11#1)(2013-1#2)
reviews the available literature on the##2##6##(2008-4#1)(2012-2#1)
reviews the available literature on##5##5##(2004-3#1)(2006-10#1)(2008-4#1)(2012-12#1)(2012-2#1)
reviews the available##15##3##(2004-3#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-4#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
reviews the classification##2##3##(2008-4#1)(2011-2#1)
reviews the clinical studies##2##4##(2006-6#1)(2007-11#1)
reviews the clinical##10##3##(2005-8#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-8#2)(2008-2#2)(2008-3#1)(2013-1#1)
reviews the current evidence##3##4##(2009-8#1)(2013-1#2)
reviews the current international##2##4##(2006-8#1)(2011-2#1)
reviews the current knowledge on##2##5##(2006-2#1)(2010-12#1)
reviews the current literature##4##4##(2008-6#1)(2009-7#1)(2010-11#1)(2012-2#1)
reviews the current state of##4##5##(1997-4#1)(2007-12#1)(2008-6#1)(2011-2#1)
reviews the current status of##3##5##(2009-3#1)(2010-12#1)(2012-2#1)
reviews the current##33##3##(1997-4#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-6#2)(2008-8#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#3)(2010-3#1)(2010-9#2)(2011-1#2)(2011-2#2)(2011-7#1)(2012-2#3)(2013-1#2)
reviews the development##4##3##(1993-3#1)(2008-10#1)(2008-12#1)(2009-8#1)
reviews the epidemiology##5##3##(1994-4#1)(2007-10#1)(2008-1#1)(2009-12#1)(2010-12#1)
reviews the evidence for and##2##5##(2006-10#1)(2007-8#1)
reviews the evidence for##6##4##(2005-8#1)(2006-10#2)(2007-8#1)(2008-1#1)(2008-10#1)
reviews the evidence##13##3##(2005-8#1)(2006-10#2)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-12#1)(2011-2#2)
reviews the evolution of##2##4##(2008-11#1)(2013-7#1)
reviews the existing##2##3##(2012-12#1)(2013-1#1)
reviews the factors##3##3##(2006-11#1)(2008-1#1)(2008-4#1)
reviews the features##2##3##(2007-2#1)(2008-4#1)
reviews the historical##2##3##(1994-6#1)(2011-1#1)
reviews the literature and##4##4##(1997-2#1)(2008-1#1)(2008-4#1)(2013-1#1)
reviews the literature concerning##2##4##(2007-11#1)(2011-2#1)
reviews the literature on the effects##2##6##(1996-3#1)(2008-7#1)
reviews the literature on the##6##5##(1996-3#1)(1997-2#1)(2007-11#1)(2007-4#1)(2008-12#1)(2008-7#1)
reviews the literature on##13##4##(1994-9#1)(1996-3#1)(1997-2#1)(2006-3#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-12#1)(2008-4#1)(2008-7#1)(2012-1#1)(2012-2#1)
reviews the literature##25##3##(1994-9#1)(1996-3#1)(1997-2#2)(1997-7#1)(2005-9#1)(2006-3#1)(2006-4#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-4#2)(2008-7#2)(2010-11#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
reviews the main##6##3##(1993-9#1)(2006-10#1)(2010-12#1)(2011-2#2)(2012-2#1)
reviews the major##4##3##(1994-3#1)(2006-10#1)(2008-7#1)(2012-2#1)
reviews the management of##2##4##(2012-2#1)(2013-8#1)
reviews the mechanisms##2##3##(2005-11#1)(2008-11#1)
reviews the method##2##3##(1994-6#1)(2009-8#1)
reviews the most##5##3##(1996-9#1)(2006-10#1)(2008-1#2)(2008-11#1)
reviews the new##2##3##(2008-4#1)(2008-7#1)
reviews the pathogenesis##2##3##(2005-8#1)(2010-2#1)
reviews the pharmacology##2##3##(2006-12#1)(2007-12#1)
reviews the potential##2##3##(2008-3#1)(2010-2#1)
reviews the preclinical##2##3##(2008-6#1)(2009-9#1)
reviews the present##3##3##(2008-1#1)(2008-7#1)(2009-12#1)
reviews the principles of##3##4##(2007-12#1)(2011-2#1)(2012-2#1)
reviews the principles##4##3##(2005-7#1)(2007-12#1)(2011-2#1)(2012-2#1)
reviews the process of##2##4##(2006-2#1)(2007-8#1)
reviews the processes##2##3##(1995-2#1)(2012-2#1)
reviews the progress##4##3##(1996-5#1)(2005-9#1)(2008-5#1)(2008-7#1)
reviews the recent advances in##2##5##(2006-10#1)(2008-1#1)
reviews the recent literature##2##4##(1993-10#1)(1994-6#1)
reviews the recent##7##3##(1993-10#1)(1994-6#1)(2006-10#3)(2008-1#1)(2010-2#1)
reviews the results of##3##4##(2004-2#1)(2006-7#1)(2008-5#1)
reviews the role of##4##4##(2006-10#1)(2006-2#1)(2008-5#1)(2013-1#1)
reviews the role##5##3##(2006-10#1)(2006-2#1)(2007-7#1)(2008-5#1)(2013-1#1)
reviews the steps##2##3##(2007-7#1)(2007-9#1)
reviews the structure and##2##4##(2006-10#1)(2007-12#1)
reviews the theory##2##3##(2008-4#1)(2013-1#1)
reviews the use of##4##4##(2006-4#1)(2008-10#2)(2012-12#1)
reviews the various##8##3##(2005-11#1)(2005-8#1)(2007-12#1)(2008-11#1)(2008-6#1)(2009-9#1)(2010-10#1)(2011-1#1)
reviews the##375##2##(1990-12#3)(1990-2#1)(1990-8#1)(1991-1#1)(1991-2#1)(1992-10#1)(1992-2#2)(1992-3#1)(1993-10#2)(1993-12#2)(1993-3#2)(1993-5#1)(1993-9#1)(1994-2#3)(1994-3#1)(1994-4#1)(1994-6#3)(1994-9#1)(1995-1#1)(1995-2#4)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#1)(2004-11#3)(2004-2#1)(2004-3#1)(2004-7#1)(2005-10#2)(2005-11#4)(2005-7#1)(2005-8#5)(2005-9#2)(2006-10#18)(2006-11#2)(2006-12#7)(2006-2#4)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#3)(2007-11#7)(2007-12#15)(2007-2#5)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#6)(2007-9#3)(2008-1#11)(2008-10#6)(2008-11#14)(2008-12#3)(2008-2#8)(2008-3#5)(2008-4#14)(2008-5#3)(2008-6#6)(2008-7#11)(2008-8#10)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#5)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#7)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#5)(2010-6#3)(2010-7#1)(2010-9#2)(2011-1#5)(2011-11#1)(2011-12#2)(2011-2#14)(2011-3#1)(2011-7#1)(2012-1#3)(2012-11#2)(2012-12#3)(2012-2#15)(2013-1#14)(2013-7#1)(2013-8#5)
reviews these##11##2##(1995-6#1)(2006-10#3)(2007-6#1)(2008-11#2)(2008-5#1)(2008-6#2)(2012-3#1)
reviews three##3##2##(2006-2#1)(2007-12#1)(2007-2#1)
reviews to##3##2##(2008-4#2)(2010-12#1)
reviews various##4##2##(1991-12#1)(2006-5#1)(2006-7#1)(2013-1#1)
reviews were##2##2##(1990-12#1)(1997-2#1)
reviews what is known about##3##5##(2008-11#1)(2008-9#1)(2009-5#1)
reviews what is##5##3##(1995-6#1)(2008-11#1)(2008-9#1)(2009-5#1)(2012-11#1)
reviews##812##1##(1990-12#5)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#4)(1991-3#2)(1991-6#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#3)(1992-3#1)(1992-4#1)(1992-6#1)(1993-1#1)(1993-10#2)(1993-12#12)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#2)(1994-1#1)(1994-10#1)(1994-2#4)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#5)(1994-9#3)(1995-1#1)(1995-2#6)(1995-6#4)(1995-9#1)(1996-1#5)(1996-11#3)(1996-12#2)(1996-2#7)(1996-3#5)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#4)(1997-2#6)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-11#6)(2004-12#2)(2004-2#1)(2004-3#2)(2004-7#1)(2005-10#7)(2005-11#5)(2005-12#1)(2005-3#1)(2005-6#1)(2005-7#2)(2005-8#9)(2005-9#2)(2006-1#3)(2006-10#38)(2006-11#4)(2006-12#9)(2006-2#7)(2006-3#3)(2006-4#2)(2006-5#6)(2006-6#5)(2006-7#5)(2006-8#6)(2006-9#7)(2007-1#1)(2007-10#6)(2007-11#11)(2007-12#24)(2007-2#15)(2007-3#2)(2007-4#9)(2007-5#9)(2007-6#5)(2007-7#6)(2007-8#10)(2007-9#5)(2008-1#17)(2008-10#20)(2008-11#30)(2008-12#7)(2008-2#10)(2008-3#10)(2008-4#30)(2008-5#11)(2008-6#13)(2008-7#22)(2008-8#15)(2008-9#11)(2009-1#1)(2009-10#5)(2009-12#6)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#6)(2009-6#3)(2009-7#4)(2009-8#5)(2009-9#5)(2010-1#3)(2010-10#4)(2010-11#5)(2010-12#14)(2010-2#8)(2010-3#1)(2010-4#6)(2010-5#8)(2010-6#3)(2010-7#2)(2010-8#4)(2010-9#6)(2011-1#9)(2011-10#1)(2011-11#1)(2011-12#4)(2011-2#32)(2011-3#1)(2011-7#2)(2012-1#7)(2012-11#3)(2012-12#11)(2012-2#22)(2012-3#9)(2013-1#22)(2013-7#5)(2013-8#14)
revise the##4##2##(2006-8#1)(2008-10#1)(2009-2#1)(2011-2#1)
revise##13##1##(1993-2#1)(1996-2#1)(1996-6#1)(1997-2#1)(2005-12#1)(2006-8#1)(2007-9#3)(2008-10#1)(2009-2#1)(2011-2#1)(2012-3#1)
revised International Health Regulations##2##4##(2008-1#1)(2010-5#1)
revised Jones criteria##2##3##(1997-1#1)(2011-2#1)
revised Medicare##2##2##(1992-2#1)(2008-4#1)
revised accordingly##2##2##(2006-7#1)(2009-8#1)
revised and updated##3##3##(1994-12#1)(2008-6#1)(2013-1#1)
revised and##13##2##(1994-12#1)(1994-2#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-8#1)(2011-12#2)(2012-2#1)(2013-1#1)
revised by##4##2##(2006-2#1)(2007-12#1)(2010-5#1)(2012-1#1)
revised criteria##4##2##(2006-7#1)(2007-3#2)(2011-2#1)
revised diagnosis##2##2##(2006-8#1)(2012-2#1)
revised for##2##2##(2005-3#1)(2011-2#1)
revised guidelines##2##2##(2011-12#1)(2012-2#1)
revised in##4##2##(1991-2#1)(2006-12#1)(2010-12#1)(2012-2#1)
revised its##3##2##(1996-6#1)(1997-1#1)(2005-11#1)
revised model of##2##3##(1991-9#2)
revised model##6##2##(1990-3#1)(1991-9#2)(2008-10#1)(2008-3#1)(2010-6#1)
revised resuscitation policy##2##3##(1994-6#2)
revised severity##2##2##(2008-9#2)
revised system##2##2##(1992-2#1)(2008-1#1)
revised the##4##2##(1991-8#1)(1992-3#1)(2008-5#1)(2013-1#1)
revised their writing##2##3##(2013-7#2)
revised their##4##2##(2005-6#1)(2011-2#1)(2013-7#2)
revised to##10##2##(1992-1#1)(1993-2#1)(1995-11#1)(1996-5#1)(2005-7#1)(2006-12#1)(2007-1#1)(2008-1#1)(2008-11#1)(2008-7#1)
revised version of the##3##4##(2007-10#1)(2008-7#1)(2009-7#1)
revised version of##5##3##(2004-10#1)(2007-10#1)(2008-7#1)(2009-4#1)(2009-7#1)
revised##318##1##(1990-12#2)(1990-3#1)(1991-2#1)(1991-8#1)(1991-9#2)(1992-1#3)(1992-10#1)(1992-2#2)(1992-3#1)(1993-2#2)(1993-5#1)(1993-6#3)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#2)(1997-4#1)(2004-10#2)(2005-11#2)(2005-3#1)(2005-6#1)(2005-7#1)(2006-10#3)(2006-12#4)(2006-2#2)(2006-7#4)(2006-8#1)(2007-1#4)(2007-10#3)(2007-12#5)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#2)(2008-11#7)(2008-3#5)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#6)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#9)(2010-5#4)(2010-6#1)(2010-8#1)(2011-1#55)(2011-12#7)(2011-2#20)(2012-1#73)(2012-11#1)(2012-12#1)(2012-2#9)(2013-1#2)(2013-7#2)(2013-8#2)
revises the##3##2##(1991-3#1)(1995-6#1)(2009-8#1)
revises##5##1##(1991-3#1)(1992-12#1)(1994-1#1)(1995-6#1)(2009-8#1)
revising medical staff bylaws##2##4##(1991-2#2)
revising the classical##2##3##(1990-3#1)(2012-1#1)
revising the##3##2##(1990-3#1)(2010-7#1)(2012-1#1)
revising##9##1##(1990-3#1)(1991-2#2)(2007-6#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-1#2)
revision THA##5##2##(2009-3#2)(2013-1#3)
revision TKA##2##2##(2013-1#2)
revision amputation##2##2##(2006-3#2)
revision and##7##2##(2006-10#1)(2006-8#1)(2008-5#1)(2010-6#1)(2011-1#1)(2012-12#1)(2013-1#1)
revision arthroplasty##8##2##(2007-11#2)(2008-11#1)(2009-3#1)(2013-1#4)
revision as##2##2##(2006-10#1)(2007-9#1)
revision femoral##2##2##(2009-3#1)(2011-2#1)
revision for##5##2##(2007-8#1)(2008-1#1)(2008-8#1)(2013-1#2)
revision hip arthroplasty##5##3##(2007-11#1)(2007-7#2)(2011-2#1)(2013-1#1)
revision hip##7##2##(2007-11#1)(2007-7#3)(2011-2#2)(2013-1#1)
revision is to##3##3##(1993-1#1)(2006-10#1)(2008-10#1)
revision is##6##2##(1993-1#2)(1994-2#1)(1997-2#1)(2006-10#1)(2008-10#1)
revision nailing##2##2##(2008-4#1)(2008-8#1)
revision of an##2##3##(2008-12#1)(2013-7#1)
revision of the##31##3##(1992-7#1)(1992-9#1)(1993-6#1)(1994-3#1)(2006-12#1)(2006-4#1)(2006-7#2)(2007-12#1)(2007-7#2)(2008-10#4)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-2#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#4)(2013-8#2)
revision of this##2##3##(1990-12#1)(2013-1#1)
revision of##49##2##(1990-12#1)(1992-7#1)(1992-9#1)(1993-6#1)(1994-3#1)(1995-3#1)(1995-6#1)(2006-12#1)(2006-4#1)(2006-7#2)(2007-1#1)(2007-12#1)(2007-7#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#4)(2009-3#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#6)(2013-7#2)(2013-8#2)
revision rate##2##2##(2011-2#1)(2013-1#1)
revision rates##2##2##(2011-2#1)(2013-1#1)
revision stem##2##2##(2013-1#2)
revision surgeries##2##2##(2006-6#1)(2013-1#1)
revision surgery and##2##3##(2011-2#1)(2012-3#1)
revision surgery for##5##3##(2006-12#1)(2007-7#1)(2008-9#1)(2009-7#1)(2012-3#1)
revision surgery in##3##3##(2007-7#1)(2008-9#1)(2012-3#1)
revision surgery##25##2##(2006-12#1)(2007-12#1)(2007-7#5)(2008-8#1)(2008-9#3)(2009-3#1)(2009-7#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#2)
revision to##5##2##(2006-5#1)(2008-3#1)(2008-6#1)(2009-3#1)(2013-7#1)
revision total hip arthroplasty##2##4##(2008-11#1)(2009-3#1)
revision total hip##3##3##(2008-11#1)(2009-3#2)
revision total##4##2##(2008-11#1)(2008-8#1)(2009-3#2)
revision was performed##2##3##(2008-3#1)(2011-2#1)
revision was##7##2##(1993-6#1)(2008-3#1)(2008-8#2)(2010-5#1)(2011-2#1)(2013-1#1)
revision with##2##2##(2011-2#1)(2013-1#1)
revision##211##1##(1990-12#1)(1990-2#1)(1990-6#1)(1992-11#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-1#3)(1993-5#1)(1993-6#2)(1993-9#1)(1994-2#1)(1994-3#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-2#1)(1997-2#1)(2005-12#1)(2006-10#3)(2006-12#3)(2006-3#2)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#2)(2007-11#4)(2007-12#2)(2007-5#1)(2007-6#1)(2007-7#11)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#4)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#5)(2008-8#16)(2008-9#3)(2009-10#2)(2009-12#1)(2009-3#10)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#15)(2011-3#2)(2012-11#1)(2012-12#6)(2012-2#2)(2012-3#5)(2013-1#33)(2013-7#5)(2013-8#3)
revisions of##3##2##(1995-1#1)(2008-10#1)(2008-2#1)
revisions to##3##2##(1992-3#1)(2008-10#1)(2009-10#1)
revisions##23##1##(1992-3#3)(1995-1#1)(1995-3#1)(2005-12#1)(2006-3#1)(2007-11#3)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2009-10#1)(2011-1#2)(2011-2#2)(2012-2#1)
revisit the##8##2##(2006-10#1)(2008-2#1)(2008-3#2)(2009-12#1)(2010-10#1)(2012-12#1)(2013-8#1)
revisit##21##1##(1991-1#1)(1997-8#1)(2006-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-10#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
revisited in##5##2##(2004-4#1)(2007-11#1)(2012-3#1)(2013-1#2)
revisited the##3##2##(2010-5#1)(2012-3#1)(2012-7#1)
revisited##81##1##(1990-11#1)(1990-8#1)(1991-1#1)(1991-12#3)(1991-3#1)(1991-8#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-8#1)(1996-6#2)(1996-8#2)(2004-4#1)(2005-10#1)(2006-10#5)(2006-4#1)(2006-5#1)(2006-7#2)(2007-11#2)(2007-12#1)(2007-2#2)(2007-4#1)(2007-9#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#2)(2010-11#1)(2010-5#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#2)
revisited?##3##1##(1995-1#1)(2006-4#1)(2008-3#1)
revisiting the##3##2##(2006-12#1)(2007-6#1)(2007-8#1)
revisiting##5##1##(2006-12#1)(2007-12#1)(2007-6#1)(2007-8#1)(2009-1#1)
revisits the##2##2##(1996-12#1)(2010-12#1)
revisits##3##1##(1996-12#1)(2010-12#1)(2013-1#1)
revitalization of##3##2##(1992-3#1)(1995-12#1)(2008-10#1)
revitalization##6##1##(1992-3#1)(1994-2#1)(1995-12#1)(1997-3#1)(2008-10#1)(2009-10#1)
revitalize the##2##2##(2009-10#1)(2013-1#1)
revitalize##3##1##(1996-3#1)(2009-10#1)(2013-1#1)
revitalizing the##2##2##(1991-3#1)(2010-5#1)
revitalizing##3##1##(1991-3#1)(1997-3#1)(2010-5#1)
revival in##3##2##(1991-8#1)(2006-10#1)(2011-1#1)
revival of##5##2##(1990-12#1)(1991-4#1)(1997-4#1)(2011-1#1)(2012-2#1)
revival##11##1##(1990-12#1)(1991-4#1)(1991-8#1)(1997-4#2)(2006-10#1)(2010-3#1)(2011-1#3)(2012-2#1)
revivals##3##1##(2007-12#3)
revived after##2##2##(1990-5#1)(2012-3#1)
revived interest in##3##3##(2008-1#1)(2008-3#1)(2008-4#1)
revived##8##1##(1990-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-12#1)(2012-3#2)
revolution and##2##2##(2006-12#1)(2008-2#1)
revolution in our understanding of##3##5##(1996-11#1)(2007-6#1)(2010-12#1)
revolution in the##2##3##(2010-12#1)(2012-2#1)
revolution in##24##2##(1990-8#1)(1992-4#1)(1996-11#1)(1996-9#1)(1997-8#1)(2006-4#1)(2007-10#1)(2007-6#1)(2007-8#6)(2008-12#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-5#1)(2010-12#2)(2010-6#1)(2011-2#1)(2012-2#1)
revolution of##5##2##(1995-4#1)(2006-6#1)(2008-10#1)(2008-8#1)(2011-1#1)
revolution that##3##2##(1993-2#1)(2008-2#1)(2008-3#1)
revolution will##2##2##(1995-4#1)(2007-10#1)
revolution##81##1##(1990-12#2)(1990-8#1)(1991-1#1)(1991-7#1)(1992-11#1)(1992-4#1)(1992-5#1)(1993-12#1)(1993-2#2)(1993-3#1)(1995-1#1)(1995-12#1)(1995-4#2)(1995-6#1)(1996-11#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-8#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-12#2)(2006-4#2)(2006-6#2)(2007-10#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-5#1)(2010-12#4)(2010-6#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-2#2)(2013-1#2)
revolutionary advances in##2##3##(2009-5#1)(2010-7#1)
revolutionary change##2##2##(2006-10#1)(2006-5#1)
revolutionary changes##2##2##(1994-3#1)(1996-2#1)
revolutionary##27##1##(1994-3#1)(1996-1#1)(1996-2#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-9#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-7#2)(2010-8#3)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
revolutionised the##4##2##(2007-11#2)(2008-3#1)(2012-10#1)
revolutionised##5##1##(2007-11#2)(2008-1#1)(2008-3#1)(2012-10#1)
revolutionising##2##1##(2008-2#1)(2012-2#1)
revolutionize the##10##2##(1990-9#1)(2006-10#1)(2007-4#1)(2008-4#2)(2008-7#1)(2009-5#1)(2010-3#1)(2011-11#1)(2013-1#1)
revolutionize##21##1##(1990-9#1)(1993-5#1)(1995-1#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2009-5#2)(2010-3#1)(2011-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
revolutionized our##2##2##(2010-3#1)(2010-7#1)
revolutionized the field of##2##4##(2006-10#1)(2008-6#1)
revolutionized the treatment of##4##4##(2006-10#1)(2006-5#1)(2007-4#1)(2007-7#1)
revolutionized the##19##2##(2006-10#2)(2006-5#1)(2006-7#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-2#2)(2012-8#1)
revolutionized##35##1##(1991-9#1)(1994-9#1)(2004-2#1)(2006-10#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-2#2)(2012-8#1)
revolutionizing##6##1##(1992-8#1)(1995-1#1)(2006-10#1)(2008-4#1)(2008-8#1)(2009-5#1)
revolutions##3##1##(2008-3#2)(2012-2#1)
revolve around##3##2##(2004-3#1)(2007-12#2)
revolves around a##4##3##(1996-3#1)(1996-9#1)(2006-4#1)(2007-11#1)
revolves around##7##2##(1994-3#1)(1996-3#1)(1996-9#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-4#1)
revolves##8##1##(1994-3#1)(1996-3#1)(1996-9#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-4#1)(2011-12#1)
reward (&quot##2##2##(2012-1#1)(2013-8#1)
reward and punishment##2##3##(2009-2#1)(2010-2#1)
reward and recognition##2##3##(1991-3#2)
reward and##14##2##(1991-3#2)(1993-6#3)(1994-2#1)(1994-8#2)(2007-8#1)(2008-4#1)(2008-7#1)(2009-2#1)(2010-2#1)(2013-8#1)
reward anticipation##2##2##(2012-1#2)
reward circuit##3##2##(2007-8#1)(2009-8#1)(2012-2#1)
reward circuitry##2##2##(2012-12#1)(2013-8#1)
reward correlates)##2##2##(1994-2#2)
reward delivery##2##2##(2011-1#1)(2012-1#1)
reward in the##2##3##(1990-2#1)(1993-6#1)
reward in##3##2##(1990-2#1)(1993-6#1)(2013-8#1)
reward is##2##2##(1991-12#1)(2008-11#1)
reward magnitude##4##2##(1992-12#1)(1993-12#3)
reward processing in##2##3##(2009-2#1)(2011-1#1)
reward processing##4##2##(2009-2#1)(2011-1#2)(2013-8#1)
reward reduction##2##2##(1993-12#2)
reward structure##4##2##(2009-5#4)
reward system##7##2##(1992-1#1)(2007-8#1)(2008-1#1)(2009-6#1)(2011-2#1)(2013-8#2)
reward systems##4##2##(1994-1#1)(1995-12#1)(1996-3#2)
reward to##2##2##(1992-12#1)(1992-9#1)
reward was##5##2##(1990-2#1)(1992-11#1)(1992-12#1)(1995-11#1)(1997-6#1)
reward when##2##2##(2009-6#1)(2012-2#1)
reward##147##1##(1990-10#1)(1990-2#3)(1991-1#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#2)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#5)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#8)(1993-2#3)(1993-6#7)(1993-7#1)(1994-1#1)(1994-2#5)(1994-3#2)(1994-8#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-10#3)(1996-3#2)(1996-5#2)(1997-6#3)(1997-7#1)(2006-7#1)(2007-2#1)(2007-4#4)(2007-8#5)(2007-9#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#3)(2008-4#7)(2008-7#2)(2008-9#1)(2009-12#1)(2009-2#2)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#5)(2009-9#1)(2010-10#1)(2010-2#4)(2010-9#1)(2011-1#4)(2011-2#2)(2012-1#6)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#8)
reward-related##8##1##(1993-6#3)(1994-2#1)(2007-8#1)(2009-2#1)(2013-8#2)
reward-relevant axons##2##2##(1992-12#2)
rewarded by##3##2##(2005-8#1)(2006-11#1)(2007-3#1)
rewarded for##4##2##(1997-1#1)(2007-8#1)(2012-3#1)(2013-8#1)
rewarded##15##1##(1993-5#2)(1993-6#1)(1993-9#2)(1997-1#1)(2005-8#1)(2006-11#1)(2007-3#1)(2007-8#1)(2008-6#1)(2010-2#1)(2011-1#1)(2012-3#1)(2013-8#1)
rewarding and##2##2##(1992-9#1)(1995-11#1)
rewarding effects of##3##3##(1991-1#1)(1992-9#1)(1993-6#1)
rewarding experience##2##2##(2006-2#1)(2012-12#1)
rewarding in the##2##3##(1996-2#1)(2008-5#1)
rewarding locus coeruleus stimulation##2##4##(1992-9#2)
rewarding properties of##4##3##(1992-9#1)(1993-6#1)(1996-5#1)(2008-4#1)
rewarding properties##5##2##(1992-9#1)(1993-6#1)(1996-5#1)(2008-4#2)
rewarding teaching##2##2##(1991-2#1)(2007-4#1)
rewarding to##2##2##(1991-2#1)(2012-2#1)
rewarding##50##1##(1990-9#1)(1991-1#1)(1991-2#2)(1992-9#5)(1993-3#1)(1993-6#3)(1994-2#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-8#1)(2006-2#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-1#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-8#2)
rewards and##2##2##(2009-2#1)(2012-1#1)
rewards of##6##2##(1995-12#1)(1997-2#1)(2007-4#1)(2010-9#2)(2013-1#1)
rewards##30##1##(1990-2#1)(1992-12#1)(1994-12#1)(1995-12#1)(1996-1#2)(1996-3#1)(1997-1#1)(1997-2#1)(2007-3#1)(2007-4#2)(2009-2#1)(2009-7#1)(2010-4#1)(2010-5#1)(2010-9#2)(2012-1#8)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
rewarmed##4##1##(1990-9#1)(1992-1#1)(1993-8#2)
rewarming is indicated for##2##4##(2011-2#2)
rewarming is##4##2##(2005-8#1)(2011-2#3)
rewarming techniques##2##2##(2005-8#2)
rewarming to##2##2##(1993-11#1)(2007-10#1)
rewarming##21##1##(1990-9#1)(1993-11#1)(1993-8#2)(2005-8#7)(2006-6#1)(2007-10#3)(2007-4#1)(2011-2#5)
reweighted least-squares##3##2##(2008-10#3)
rewiring##4##1##(2008-11#1)(2010-10#1)(2011-1#2)
rework##3##1##(1996-1#1)(1996-3#2)
reworking##2##1##(1991-12#1)(1997-5#1)
rewritable optical##2##2##(2008-3#2)
rewritable phase-change optical##2##3##(2008-3#2)
rewritable##4##1##(2008-3#4)
rewriting the##2##2##(1994-11#1)(2008-3#1)
rewriting##5##1##(1994-11#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-12#1)
rex##3##1##(1991-2#3)
rf power##2##2##(2007-11#1)(2007-12#1)
rf signal##3##2##(2007-12#2)(2008-3#1)
rf sputtering##3##2##(2007-12#2)(2008-2#1)
rf##30##1##(2007-11#5)(2007-12#11)(2008-1#2)(2008-2#5)(2008-3#5)(2013-8#2)
rf2##3##1##(1996-5#3)
rfaD locus##2##2##(1997-1#2)
rfaD##3##1##(1997-1#3)
rfaD(O139)##2##1##(1997-1#2)
rh TNF##4##2##(1992-9#4)
rh##6##1##(1992-9#4)(2005-10#1)(2012-3#1)
rhAPC##2##1##(2007-12#2)
rhAT III##4##2##(2008-7#4)
rhBMP use##2##2##(2013-1#2)
rhBMP##5##1##(2012-12#2)(2013-1#3)
rhBMP-2 and##2##2##(2012-12#1)(2013-7#1)
rhBMP-2 as##2##2##(2009-8#1)(2013-7#1)
rhBMP-2 induced periosteal cells##3##4##(2008-5#3)
rhBMP-2 state##2##2##(2013-7#2)
rhBMP-2##18##1##(2008-5#4)(2009-8#2)(2011-2#2)(2012-12#4)(2013-7#6)
rhBMP-7##3##1##(2012-12#3)
rhEGF##2##1##(2011-2#2)
rhEPO in##2##2##(2008-8#2)
rhEPO##3##1##(2008-8#3)
rhFKBP12##5##1##(2008-9#5)
rhG-CSF##7##1##(1991-9#5)(2012-3#2)
rhGGF2##2##1##(1996-5#2)
rhGH has##2##2##(2007-11#2)
rhGH##7##1##(2005-8#1)(2007-11#5)(2013-1#1)
rhIGF-I##2##1##(1991-1#2)
rhIL-1 alpha##3##2##(1990-12#1)(1990-2#2)
rhIL-1 beta and rhTNF alpha##2##5##(1990-2#2)
rhIL-1 beta##3##2##(1990-12#1)(1990-2#2)
rhIL-1##6##1##(1990-12#2)(1990-2#4)
rhIL-11 has direct effects on##2##5##(2007-11#2)
rhIL-11 has##4##2##(2007-11#4)
rhIL-11 is currently in clinical trials for##2##7##(2007-11#2)
rhIL-11 is##4##2##(2007-11#4)
rhIL-11 treatment reduced##2##3##(2007-11#2)
rhIL-11 treatment##3##2##(2007-11#3)
rhIL-11##18##1##(2007-11#18)
rhIL-2##3##1##(1992-8#1)(2008-11#2)
rhIL-4##7##1##(2006-11#7)
rhKGF##4##1##(1994-11#4)
rhLIF##3##1##(1994-2#3)
rhPC##4##1##(2008-12#4)
rhTNF##7##1##(1990-12#2)(1990-2#2)(1990-7#2)(2008-8#1)
rhTNF-beta was##2##2##(1997-1#2)
rhTNF-beta##5##1##(1997-1#5)
rhTSH patients (n = 18) were oftener ≥45 years old and higher stage (P = 0##2##16##(2013-1#2)
rhTSH patients were significantly oftener successfully ablated compared to THW patients (83% versus 67%##2##14##(2013-1#2)
rhTSH patients##6##2##(2013-1#6)
rhTSH stimulation is associated with at least as good outcomes as is THW in ablation of high-risk DTC patients##2##19##(2013-1#2)
rhTSH##8##1##(2013-1#8)
rhabditid##4##1##(2007-12#4)
rhabditids##4##1##(2007-12#4)
rhabdoid##3##1##(2005-5#1)(2009-5#1)(2011-2#1)
rhabdom membrane and##2##3##(2009-10#2)
rhabdom membranes##2##2##(2009-10#2)
rhabdom##8##1##(2007-12#4)(2009-10#4)
rhabdomeres##2##1##(2007-12#2)
rhabdomeric##3##1##(2007-12#3)
rhabdoms##8##1##(2007-12#7)(2009-10#1)
rhabdomyolysis and acute renal##2##4##(2011-2#1)(2013-8#1)
rhabdomyolysis and##5##2##(2006-4#1)(2008-1#1)(2011-2#2)(2013-8#1)
rhabdomyolysis due to##2##3##(2011-2#2)
rhabdomyolysis in a##3##3##(2007-12#1)(2008-12#1)(2013-8#1)
rhabdomyolysis in##5##2##(1997-5#1)(2007-12#1)(2008-12#1)(2009-11#1)(2013-8#1)
rhabdomyolysis was##3##2##(2008-12#1)(2013-1#2)
rhabdomyolysis##49##1##(1991-7#1)(1992-2#1)(1993-10#1)(1994-4#3)(1997-5#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-5#3)(2007-12#1)(2007-3#1)(2008-1#3)(2008-10#3)(2008-12#3)(2008-4#1)(2009-11#1)(2011-2#8)(2013-1#10)(2013-8#4)
rhabdomyoma presenting as left ventricular outflow tract obstruction##2##8##(2007-8#2)
rhabdomyomatous differentiation##2##2##(2009-7#2)
rhabdomyomatous##3##1##(2009-7#3)
rhabdomyosarcoma (RMS)##3##2##(2008-6#2)(2011-1#1)
rhabdomyosarcoma cell line RD##2##4##(1993-9#2)
rhabdomyosarcoma cell line##3##3##(1991-2#1)(1993-9#2)
rhabdomyosarcoma cell##4##2##(1991-2#1)(1993-9#2)(2008-6#1)
rhabdomyosarcoma cells##2##2##(1991-2#1)(1991-3#1)
rhabdomyosarcoma in##2##2##(2007-8#1)(2008-10#1)
rhabdomyosarcoma of the bladder in an adult##2##7##(2007-10#2)
rhabdomyosarcoma of the bladder##3##4##(2006-10#1)(2007-10#2)
rhabdomyosarcoma of the##6##3##(2006-10#1)(2007-10#2)(2007-8#1)(2013-1#2)
rhabdomyosarcoma of##7##2##(2006-10#1)(2007-10#2)(2007-8#1)(2010-11#1)(2013-1#2)
rhabdomyosarcoma with##6##2##(2007-7#2)(2010-11#2)(2011-1#1)(2012-12#1)
rhabdomyosarcoma##43##1##(1991-2#2)(1991-3#2)(1991-4#1)(1991-9#1)(1993-9#2)(2006-10#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-7#4)(2007-8#2)(2008-10#2)(2008-6#9)(2009-8#1)(2010-11#4)(2010-3#1)(2011-1#2)(2012-12#3)(2013-1#2)
rhabdomyosarcoma)##3##1##(1995-12#1)(2008-6#2)
rhabdovirus##4##1##(2008-10#1)(2008-8#3)
rhabdoviruses##5##1##(2008-8#2)(2012-3#2)(2013-1#1)
rhamnogalacturonan II##2##2##(1991-9#2)
rhamnogalacturonan##4##1##(1991-7#2)(1991-9#2)
rhamnogalacturonase##2##1##(1990-9#2)
rhamnoides##5##1##(2008-10#3)(2012-8#1)(2013-8#1)
rhamnolipid##2##1##(2008-5#1)(2009-6#1)
rhamnolipids##7##1##(2009-6#3)(2012-2#4)
rhamnopyranosyl-(1--&gt##2##1##(1992-12#2)
rhamnose residues##2##2##(1991-12#1)(2008-10#1)
rhamnose##18##1##(1991-12#2)(1992-7#2)(1993-11#2)(1993-7#1)(1995-1#2)(1996-12#1)(1996-5#1)(2007-1#1)(2008-10#2)(2008-11#1)(2008-5#3)
rhamnoside##4##1##(2008-5#4)
rhamnosus##4##1##(2006-2#1)(2008-7#1)(2009-12#2)
rhea (Rhea americana)##3##3##(2007-2#2)(2013-1#1)
rhea (Rhea##4##2##(2007-2#2)(2013-1#2)
rhea##5##1##(2007-2#2)(2013-1#3)
rheas (Rhea##2##2##(2013-1#2)
rheas##8##1##(2013-1#8)
rhein##7##1##(2008-10#3)(2010-3#4)
rhenium##5##1##(1993-7#1)(1996-2#2)(2008-10#1)(2008-5#1)
rhenium(I)##2##1##(1997-7#2)
rhenium(II)##2##1##(1997-7#2)
rheologic##3##1##(2005-4#1)(2005-9#1)(2008-5#1)
rheological and##2##2##(2008-10#1)(2010-4#1)
rheological behavior of##3##3##(2006-5#1)(2008-5#1)(2008-8#1)
rheological behavior##7##2##(2006-5#1)(2008-10#1)(2008-5#3)(2008-8#1)(2011-3#1)
rheological behaviour##3##2##(2008-5#3)
rheological measurements##3##2##(2008-5#2)(2009-11#1)
rheological parameters were##2##3##(1994-8#1)(2008-5#1)
rheological parameters##5##2##(1991-12#1)(1994-8#2)(2008-5#1)(2012-12#1)
rheological properties of the##2##4##(2006-11#1)(2006-5#1)
rheological properties of##11##3##(1994-9#1)(2005-11#1)(2006-11#1)(2006-5#1)(2008-5#4)(2008-7#1)(2011-2#1)(2012-11#1)
rheological properties##19##2##(1994-9#1)(2004-9#1)(2005-11#1)(2006-11#1)(2006-5#1)(2008-5#8)(2008-7#2)(2011-2#2)(2012-11#1)(2012-3#1)
rheological variables##3##2##(2005-10#3)
rheological##60##1##(1991-12#1)(1994-3#1)(1994-8#2)(1994-9#1)(2004-9#1)(2005-10#3)(2005-11#4)(2006-11#1)(2006-5#2)(2008-10#2)(2008-5#23)(2008-7#2)(2008-8#1)(2009-11#1)(2009-4#2)(2010-4#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-11#3)(2012-12#2)(2012-3#1)
rheology and dielectric spectroscopy##3##4##(2008-5#3)
rheology and##7##2##(1995-6#1)(2008-5#5)(2010-12#1)
rheology is##2##2##(2005-11#1)(2009-4#1)
rheology of creams##2##3##(2008-5#2)
rheology of the##2##3##(2008-5#1)(2011-1#1)
rheology of##7##2##(2008-5#6)(2011-1#1)
rheology##33##1##(1993-12#1)(1995-6#1)(1997-1#1)(2005-11#4)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#15)(2009-4#2)(2009-6#1)(2010-12#1)(2011-1#2)(2012-12#1)(2012-3#1)
rheometer##2##1##(2005-11#1)(2007-1#1)
rheometry##2##1##(2006-10#1)(2008-10#1)
rhesus and##2##2##(1992-12#1)(2007-11#1)
rhesus glycoproteins##2##2##(2013-8#2)
rhesus macaques (Macaca mulatta)##2##4##(2007-2#2)
rhesus macaques with##3##3##(2006-8#3)
rhesus macaques##17##2##(1990-11#1)(1993-9#1)(1997-5#1)(2006-8#5)(2007-11#1)(2007-2#5)(2007-3#1)(2008-4#1)(2012-3#1)
rhesus monkey and squirrel monkey##2##5##(1991-12#2)
rhesus monkey and##4##3##(1991-1#1)(1991-12#2)(1995-11#1)
rhesus monkey##17##2##(1991-1#2)(1991-12#2)(1993-5#1)(1994-4#1)(1994-9#1)(1995-11#2)(1995-12#1)(1996-10#1)(1996-5#1)(1997-8#2)(2007-11#1)(2008-9#1)(2010-2#1)
rhesus monkeys (Macaca mulatta)##2##4##(1996-4#1)(2010-2#1)
rhesus monkeys to##2##3##(1995-2#1)(2010-2#1)
rhesus monkeys##32##2##(1990-11#2)(1991-1#3)(1991-11#1)(1991-2#1)(1991-9#1)(1992-5#1)(1995-12#2)(1995-2#3)(1996-1#2)(1996-2#4)(1996-4#4)(1996-5#1)(1996-8#1)(1997-2#1)(2008-4#2)(2008-5#1)(2010-2#2)
rhesus rotavirus vaccine##2##3##(2006-10#1)(2007-11#1)
rhesus rotavirus##3##2##(2006-10#1)(2007-11#2)
rhesus##81##1##(1990-11#3)(1991-1#5)(1991-11#1)(1991-12#2)(1991-2#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-5#1)(1993-9#1)(1994-4#1)(1994-9#1)(1995-11#3)(1995-12#3)(1995-2#3)(1996-1#2)(1996-10#1)(1996-2#4)(1996-4#5)(1996-5#2)(1996-8#1)(1997-2#2)(1997-5#1)(1997-8#2)(2006-10#2)(2006-8#5)(2007-11#5)(2007-2#5)(2007-3#1)(2008-4#5)(2008-5#1)(2008-9#1)(2010-12#2)(2010-2#3)(2012-3#1)(2013-8#2)
rhetoric and##3##2##(1994-1#1)(2008-11#1)(2008-7#1)
rhetoric of##2##2##(1992-10#1)(2013-1#1)
rhetoric##15##1##(1992-10#1)(1994-1#2)(1995-12#1)(1996-12#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-5#1)(2010-7#1)(2012-1#1)(2013-1#1)
rhetorical practice##2##2##(2013-7#2)
rhetorical##4##1##(2006-12#1)(2013-7#3)
rheumaorthopaedics##2##1##(2007-8#2)
rheumatic arthritis##2##2##(2007-7#1)(2010-2#1)
rheumatic carditis##6##2##(1997-1#3)(2011-2#3)
rheumatic disease by##2##3##(1994-8#1)(2006-10#1)
rheumatic disease##26##2##(1990-6#2)(1993-3#1)(1994-8#1)(2005-11#1)(2006-10#12)(2007-11#1)(2008-7#2)(2008-8#2)(2009-7#1)(2011-2#2)(2012-12#1)
rheumatic diseases such as##3##4##(1993-11#1)(2010-12#1)(2012-2#1)
rheumatic diseases##36##2##(1990-6#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1993-11#1)(1993-3#1)(2006-10#7)(2007-11#3)(2007-8#1)(2007-9#3)(2008-7#2)(2008-8#3)(2010-12#1)(2010-9#3)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
rheumatic diseases]##4##2##(1990-7#2)(1991-2#1)(2007-12#1)
rheumatic disorders##7##2##(2006-10#3)(2007-11#3)(2011-2#1)
rheumatic fever and##3##3##(2005-12#1)(2008-1#1)(2008-7#1)
rheumatic fever##21##2##(1990-7#1)(1990-8#1)(1992-2#1)(1996-11#1)(1996-12#4)(1997-1#1)(2005-12#1)(2006-2#2)(2008-1#3)(2008-7#2)(2009-10#1)(2011-2#3)
rheumatic heart disease and##2##4##(1996-12#1)(2008-8#1)
rheumatic heart disease in##3##4##(2007-8#1)(2008-1#2)
rheumatic heart disease##15##3##(1996-12#1)(2005-12#1)(2007-7#2)(2007-8#2)(2008-1#6)(2008-8#1)(2010-12#2)
rheumatic heart##17##2##(1996-12#1)(2005-10#1)(2005-12#1)(2007-7#2)(2007-8#2)(2008-1#7)(2008-8#1)(2010-12#2)
rheumatic manifestations##2##2##(1993-3#1)(1994-5#1)
rheumatic mitral stenosis##4##3##(1995-6#1)(2008-11#1)(2010-7#2)
rheumatic mitral valve disease##3##4##(1994-3#1)(2007-8#2)
rheumatic mitral valve##4##3##(1994-3#1)(2007-8#2)(2007-9#1)
rheumatic mitral##8##2##(1994-3#1)(1995-6#1)(2007-8#2)(2007-9#1)(2008-11#1)(2010-7#2)
rheumatic##149##1##(1990-12#1)(1990-6#4)(1990-7#3)(1990-8#1)(1991-2#2)(1991-3#1)(1991-5#3)(1991-8#1)(1992-2#1)(1993-11#1)(1993-3#4)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-11#1)(1996-12#5)(1997-1#4)(2005-10#1)(2005-11#1)(2005-12#2)(2006-10#26)(2006-2#2)(2007-11#7)(2007-12#2)(2007-7#4)(2007-8#5)(2007-9#4)(2008-1#10)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#6)(2008-8#6)(2009-10#1)(2009-7#1)(2010-12#3)(2010-2#1)(2010-7#2)(2010-9#3)(2011-2#13)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#4)
rheumatica (PMR)##2##2##(2006-10#2)
rheumatica and temporal arteritis##11##4##(1994-9#3)(1997-8#5)(2006-10#3)
rheumatica in##2##2##(1995-4#2)
rheumatica##24##1##(1994-11#2)(1994-9#5)(1995-4#2)(1997-8#5)(2006-10#8)(2008-7#2)
rheumatism and##3##2##(1991-9#1)(2006-5#1)(2011-1#1)
rheumatism##11##1##(1990-10#2)(1990-2#1)(1991-9#1)(1993-3#1)(2006-10#1)(2006-5#1)(2008-3#1)(2008-7#1)(2010-4#1)(2011-1#1)
rheumatism]##3##1##(1990-10#1)(1991-6#1)(1992-5#1)
rheumatoid arthritis (RA##2##3##(1993-2#1)(1994-3#1)
rheumatoid arthritis (RA) and other##2##5##(2005-8#1)(2008-4#1)
rheumatoid arthritis (RA) and##5##4##(2005-8#1)(2006-10#1)(2008-4#1)(2008-7#1)(2012-2#1)
rheumatoid arthritis (RA) are##3##4##(2006-10#3)
rheumatoid arthritis (RA) has##2##4##(2006-10#2)
rheumatoid arthritis (RA) in##3##4##(2008-4#1)(2012-3#2)
rheumatoid arthritis (RA) patients##5##4##(1994-6#1)(2006-10#1)(2008-10#1)(2011-1#1)(2011-2#1)
rheumatoid arthritis (RA)##44##3##(1993-3#1)(1994-6#1)(2005-10#1)(2005-8#1)(2006-10#12)(2007-11#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2010-12#2)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
rheumatoid arthritis a##2##3##(1993-11#1)(2013-1#1)
rheumatoid arthritis and ankylosing spondylitis##3##5##(2006-10#1)(2007-11#1)(2012-12#1)
rheumatoid arthritis and degenerative arthritis##2##5##(2013-1#2)
rheumatoid arthritis and osteoarthritis##2##4##(1992-3#1)(2007-11#1)
rheumatoid arthritis and other autoimmune##2##5##(2005-8#1)(2006-11#1)
rheumatoid arthritis and other##4##4##(2005-8#1)(2006-11#1)(2007-11#1)(2012-3#1)
rheumatoid arthritis and polymyositis##2##4##(1997-8#1)(2009-7#1)
rheumatoid arthritis and##41##3##(1991-5#2)(1992-3#1)(1992-5#1)(1993-3#1)(1997-5#1)(1997-8#1)(2005-8#3)(2006-10#6)(2006-11#1)(2006-7#1)(2007-1#1)(2007-11#4)(2007-12#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-9#1)(2009-1#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#3)
rheumatoid arthritis are##3##3##(1993-3#1)(2007-11#1)(2008-7#1)
rheumatoid arthritis at##3##3##(2007-11#2)(2008-5#1)
rheumatoid arthritis by supplementing the kidney and invigorating##2##8##(2006-4#2)
rheumatoid arthritis during##2##3##(1992-5#1)(2012-1#1)
rheumatoid arthritis for##2##3##(1997-5#1)(2008-10#1)
rheumatoid arthritis has##2##3##(1990-6#1)(2007-11#1)
rheumatoid arthritis in a##2##4##(1993-3#1)(2012-3#1)
rheumatoid arthritis in the##3##4##(2008-8#1)(2011-1#1)(2012-12#1)
rheumatoid arthritis in##10##3##(1991-8#1)(1993-3#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
rheumatoid arthritis is##8##3##(1990-6#1)(2007-11#4)(2007-12#1)(2007-7#1)(2008-3#1)
rheumatoid arthritis on##2##3##(2010-4#2)
rheumatoid arthritis or##4##3##(1994-12#1)(1996-1#1)(2006-10#1)(2008-3#1)
rheumatoid arthritis patient##3##3##(1990-4#1)(2008-8#1)(2012-2#1)
rheumatoid arthritis patients and##2##4##(1991-5#1)(2008-4#1)
rheumatoid arthritis patients of Shen deficiency##2##6##(2013-8#2)
rheumatoid arthritis patients treated with##2##5##(2008-8#1)(2012-2#1)
rheumatoid arthritis patients who##3##4##(2006-10#3)
rheumatoid arthritis patients##20##3##(1990-4#1)(1991-1#1)(1991-5#2)(2006-10#3)(2007-11#4)(2008-4#2)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
rheumatoid arthritis presented##2##3##(2006-1#1)(2006-10#1)
rheumatoid arthritis treated with##6##4##(1995-6#1)(2006-10#3)(2011-2#1)(2012-2#1)
rheumatoid arthritis was##2##3##(2006-10#2)
rheumatoid arthritis were##5##3##(1990-6#1)(1992-11#2)(2006-10#1)(2013-8#1)
rheumatoid arthritis who had##2##4##(2006-10#1)(2006-9#1)
rheumatoid arthritis who have##2##4##(2006-10#1)(2008-3#1)
rheumatoid arthritis who##9##3##(2006-10#4)(2006-9#1)(2008-3#1)(2008-9#1)(2010-8#1)(2012-2#1)
rheumatoid arthritis with##7##3##(1992-10#1)(2006-10#3)(2006-3#1)(2006-7#1)(2011-2#1)
rheumatoid arthritis##433##2##(1990-2#1)(1990-4#3)(1990-6#5)(1991-1#1)(1991-10#1)(1991-12#4)(1991-5#4)(1991-8#3)(1992-10#2)(1992-11#7)(1992-12#1)(1992-3#1)(1992-5#3)(1993-1#1)(1993-11#4)(1993-2#3)(1993-3#5)(1993-6#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-4#2)(1996-9#1)(1997-1#2)(1997-4#1)(1997-5#3)(1997-6#1)(1997-8#1)(2005-10#2)(2005-11#1)(2005-8#5)(2005-9#1)(2006-1#1)(2006-10#90)(2006-11#1)(2006-3#1)(2006-4#2)(2006-7#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#67)(2007-12#3)(2007-3#4)(2007-5#2)(2007-6#2)(2007-7#17)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-3#10)(2008-4#6)(2008-5#12)(2008-6#1)(2008-7#5)(2008-8#12)(2008-9#3)(2009-1#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#5)(2010-4#9)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#8)(2012-1#1)(2012-12#4)(2012-2#14)(2012-3#13)(2013-1#13)(2013-7#2)(2013-8#7)
rheumatoid arthritis)##2##2##(2007-7#1)(2008-1#1)
rheumatoid arthritis?##4##2##(2006-10#1)(2007-11#3)
rheumatoid arthritis]##14##2##(1991-11#2)(1991-3#1)(1992-10#1)(1992-11#1)(1993-11#2)(1993-3#1)(1993-5#1)(1994-3#1)(1994-6#1)(2005-3#1)(2006-4#1)(2012-2#1)
rheumatoid disease##2##2##(2006-7#1)(2007-6#1)
rheumatoid factor (RF)##3##3##(2008-3#1)(2011-2#1)(2012-2#1)
rheumatoid factor##12##2##(1994-3#1)(2006-10#3)(2006-4#2)(2007-11#1)(2008-3#1)(2008-4#1)(2011-2#2)(2012-2#1)
rheumatoid factors##4##2##(1992-3#1)(2006-10#1)(2006-2#1)(2008-10#1)
rheumatoid foot##2##2##(2007-11#1)(2010-3#1)
rheumatoid nodules##7##2##(2006-10#4)(2007-7#3)
rheumatoid patients##2##2##(1993-2#1)(2007-11#1)
rheumatoid process##4##2##(2007-11#2)(2007-7#2)
rheumatoid synovial fibroblasts##4##3##(1990-12#2)(1992-4#2)
rheumatoid synovial##6##2##(1990-12#3)(1992-4#2)(2010-9#1)
rheumatoid vasculitis and##2##3##(2006-10#2)
rheumatoid##512##1##(1990-12#3)(1990-2#1)(1990-4#3)(1990-6#5)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#4)(1991-3#1)(1991-5#4)(1991-8#3)(1992-10#3)(1992-11#8)(1992-12#1)(1992-3#2)(1992-4#2)(1992-5#3)(1993-1#1)(1993-11#6)(1993-2#4)(1993-3#6)(1993-5#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-3#3)(1994-6#2)(1994-8#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-4#2)(1996-9#1)(1997-1#2)(1997-4#1)(1997-5#3)(1997-6#1)(1997-8#1)(2005-10#2)(2005-11#1)(2005-3#1)(2005-8#5)(2005-9#1)(2006-1#1)(2006-10#105)(2006-11#1)(2006-2#1)(2006-3#2)(2006-4#7)(2006-7#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#79)(2007-12#3)(2007-3#4)(2007-5#2)(2007-6#3)(2007-7#23)(2007-8#7)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-3#11)(2008-4#7)(2008-5#12)(2008-6#1)(2008-7#5)(2008-8#12)(2008-9#3)(2009-1#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#5)(2010-3#1)(2010-4#9)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#10)(2012-1#1)(2012-12#4)(2012-2#17)(2012-3#13)(2013-1#13)(2013-7#2)(2013-8#7)
rheumatologic and##3##2##(1997-8#1)(2006-10#1)(2009-2#1)
rheumatologic diseases##4##2##(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#1)
rheumatologic disorders##3##2##(2006-10#1)(2009-10#1)(2009-3#1)
rheumatologic manifestations##2##2##(2006-10#1)(2011-2#1)
rheumatologic##20##1##(1992-11#1)(1993-12#1)(1993-8#1)(1995-4#1)(1997-8#1)(2006-10#5)(2009-10#1)(2009-2#1)(2009-3#1)(2010-11#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-3#1)
rheumatological conditions##3##2##(1993-3#1)(2013-1#2)
rheumatological diseases##3##2##(2010-4#1)(2011-1#2)
rheumatological emergency situations##2##3##(1990-6#2)
rheumatological emergency##3##2##(1990-6#3)
rheumatological manifestations##2##2##(2007-7#1)(2011-2#1)
rheumatological##22##1##(1990-6#4)(1993-3#1)(1995-4#1)(1997-5#1)(2007-11#2)(2007-7#1)(2008-12#1)(2010-4#1)(2011-1#2)(2011-2#1)(2013-1#7)
rheumatologist##12##1##(1993-3#1)(1997-4#4)(1997-6#1)(2006-10#5)(2007-11#1)
rheumatologists and##3##2##(1993-3#1)(2006-10#1)(2009-2#1)
rheumatologists to##3##2##(2006-10#1)(2007-11#1)(2010-4#1)
rheumatologists##15##1##(1993-3#1)(2006-10#7)(2007-11#3)(2009-2#2)(2010-4#1)(2010-8#1)
rheumatology and##2##2##(2005-11#1)(2007-8#1)
rheumatology clinic in##2##3##(2011-2#1)(2013-7#1)
rheumatology clinic##3##2##(2006-10#1)(2011-2#1)(2013-7#1)
rheumatology in##4##2##(2006-10#3)(2010-4#1)
rheumatology##37##1##(1991-11#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-10#15)(2007-12#2)(2007-2#1)(2007-8#1)(2008-8#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-4#4)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#2)
rhg1-s and Rhg4##2##3##(2012-11#2)
rhg1-s and##3##2##(2012-11#3)
rhinal##5##1##(1990-10#1)(1994-8#1)(1997-7#1)(2007-9#2)
rhinitis (AR)##6##2##(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#2)(2013-8#1)
rhinitis and allergic conjunctivitis##2##4##(1991-2#1)(2006-12#1)
rhinitis and asthma##3##3##(1994-6#1)(2007-2#1)(2007-9#1)
rhinitis and##18##2##(1990-7#1)(1991-2#1)(1994-6#1)(2006-12#1)(2007-11#3)(2007-2#2)(2007-9#2)(2008-7#1)(2010-6#3)(2012-12#1)(2013-1#1)(2013-8#1)
rhinitis as##2##2##(2008-4#1)(2011-1#1)
rhinitis can##3##2##(1996-3#1)(2007-11#1)(2010-6#1)
rhinitis in the Kingdom##2##4##(2007-2#1)(2007-3#1)
rhinitis in the##3##3##(2007-2#2)(2007-3#1)
rhinitis in##17##2##(1991-8#1)(2007-11#2)(2007-2#5)(2007-3#1)(2008-5#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
rhinitis is an##2##3##(2007-2#2)
rhinitis is##9##2##(2007-11#1)(2007-2#3)(2011-1#2)(2012-1#1)(2012-12#2)
rhinitis or##2##2##(2005-7#1)(2006-12#1)
rhinitis were##3##2##(1990-3#1)(2007-2#1)(2008-4#1)
rhinitis with##2##2##(2007-11#1)(2011-1#1)
rhinitis##155##1##(1990-3#1)(1990-7#2)(1991-2#1)(1991-8#1)(1992-8#1)(1994-6#1)(1996-3#3)(1997-4#1)(1997-6#1)(2005-7#3)(2006-12#2)(2006-8#1)(2007-11#17)(2007-2#17)(2007-3#1)(2007-9#5)(2008-10#2)(2008-11#1)(2008-3#8)(2008-4#6)(2008-5#4)(2008-7#3)(2008-8#2)(2010-5#1)(2010-6#5)(2011-1#24)(2011-2#6)(2012-1#1)(2012-12#11)(2012-2#5)(2012-3#9)(2013-1#5)(2013-8#4)
rhinobronchitis##3##1##(2008-7#2)(2008-8#1)
rhinocerebral mucormycosis##2##2##(2011-2#2)
rhinoceros beetles##2##2##(2008-8#2)
rhinoceros iguanas##7##2##(2007-2#7)
rhinoceros##14##1##(1992-9#5)(2007-2#7)(2008-8#2)
rhinoconjunctivitis##7##1##(1991-2#1)(1992-8#2)(2006-10#2)(2006-12#1)(2012-3#1)
rhinogenic##4##1##(2008-4#3)(2012-12#1)
rhinolarynx endoscope portion##2##3##(2008-5#2)
rhinolarynx##3##1##(2008-5#3)
rhinologic procedures##2##2##(2012-1#2)
rhinologists##2##1##(2012-1#2)
rhinology fellowship experience##2##3##(2012-1#2)
rhinology fellowship##4##2##(2012-1#4)
rhinology##6##1##(2012-1#6)
rhinopathy##6##1##(1990-7#1)(2011-1#3)(2013-1#2)
rhinophyma##3##1##(2006-12#1)(2008-2#2)
rhinoplastic##2##1##(2009-6#2)
rhinoplasty for the Asian nose##2##5##(2010-8#2)
rhinoplasty in this##2##3##(2010-8#2)
rhinoplasty in##6##2##(2008-2#1)(2009-6#1)(2010-8#3)(2012-1#1)
rhinoplasty is##3##2##(2010-8#3)
rhinoplasty##26##1##(2008-2#2)(2009-6#4)(2010-8#19)(2012-1#1)
rhinorrhea and##3##2##(2008-12#1)(2011-1#1)(2012-3#1)
rhinorrhea##15##1##(2005-9#3)(2006-12#3)(2008-12#2)(2009-10#1)(2011-1#3)(2012-12#1)(2012-3#2)
rhinorrhoea##2##1##(1991-3#1)(2005-11#1)
rhinosinusitis (CRS)##3##2##(2008-3#1)(2011-2#1)(2013-8#1)
rhinosinusitis and##4##2##(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
rhinosinusitis caused by##4##3##(2009-2#2)(2012-1#1)(2013-1#1)
rhinosinusitis in##2##2##(2012-3#1)(2013-8#1)
rhinosinusitis##33##1##(1996-2#1)(2008-3#2)(2009-2#3)(2010-2#2)(2010-6#3)(2011-1#1)(2011-2#3)(2012-1#9)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
rhinosporidiosis and##2##2##(2007-7#2)
rhinosporidiosis##10##1##(2007-7#4)(2007-8#3)(2012-2#3)
rhinotracheitis (TRT) virus##2##3##(1997-3#1)(2008-5#1)
rhinotracheitis virus##9##2##(1997-6#2)(2008-11#1)(2008-5#6)
rhinotracheitis##11##1##(1997-3#1)(1997-6#2)(2008-11#1)(2008-5#7)
rhinovirus##5##1##(2005-8#2)(2008-10#1)(2013-8#2)
rhizinflata##3##1##(2006-8#3)
rhizo-sphere##2##1##(2008-10#2)
rhizobacteria##21##1##(2005-11#1)(2006-3#2)(2007-12#2)(2008-10#15)(2012-2#1)
rhizobacterial##4##1##(2006-3#1)(2008-10#3)
rhizobia and##2##2##(2008-7#1)(2009-10#1)
rhizobia##8##1##(2004-4#1)(2008-7#2)(2009-10#1)(2011-1#2)(2011-2#2)
rhizobial##6##1##(1996-7#1)(2008-10#1)(2009-8#2)(2011-1#1)(2011-2#1)
rhizoctonia##4##1##(2008-10#4)
rhizoid##3##1##(2009-8#2)(2013-1#1)
rhizolysis##2##1##(2011-2#2)
rhizoma and##4##2##(2008-10#1)(2011-1#3)
rhizoma##12##1##(2008-10#4)(2011-1#6)(2012-3#2)
rhizomania##10##1##(2008-10#10)
rhizome of##3##2##(1996-9#1)(2005-12#2)
rhizome##11##1##(1996-9#1)(2005-12#4)(2008-5#4)(2012-11#1)(2012-3#1)
rhizomelic##5##1##(1993-8#1)(1996-12#2)(2009-9#2)
rhizomes of Paris polyphylla var##2##5##(2013-1#2)
rhizomes of##10##2##(2007-1#5)(2008-11#1)(2008-12#1)(2012-11#1)(2013-1#2)
rhizomes##16##1##(2007-1#8)(2008-11#1)(2008-12#1)(2008-6#1)(2012-11#3)(2013-1#2)
rhizophorae##3##1##(2007-5#1)(2008-5#2)
rhizoplane##3##1##(2008-10#3)
rhizosphere abundance of##3##3##(2008-10#3)
rhizosphere and non-rhizosphere soils of##2##5##(2013-8#2)
rhizosphere and non-rhizosphere soils##3##4##(2013-8#3)
rhizosphere and##9##2##(2008-10#5)(2013-8#4)
rhizosphere bacterium##2##2##(2008-10#2)
rhizosphere colonization by##2##3##(2008-10#2)
rhizosphere colonization was##2##3##(2008-10#2)
rhizosphere colonization##5##2##(2008-10#5)
rhizosphere competence##3##2##(2008-10#3)
rhizosphere densities of##2##3##(2008-10#2)
rhizosphere microorganisms for their ability to induce systemic resistance##2##9##(2008-10#2)
rhizosphere of Festuca arundinacea##2##4##(2008-2#2)
rhizosphere of##17##2##(2008-10#15)(2008-2#2)
rhizosphere population densities of##3##4##(2008-10#3)
rhizosphere population##5##2##(2008-10#5)
rhizosphere populations of Phytophthora parasitica##3##5##(2008-10#3)
rhizosphere populations of##6##3##(2008-10#6)
rhizosphere priming may##3##3##(2013-8#3)
rhizosphere priming##5##2##(2013-8#5)
rhizosphere soil of##4##3##(2010-3#1)(2013-8#3)
rhizosphere soil##16##2##(2006-3#2)(2008-10#3)(2010-3#1)(2013-8#10)
rhizosphere were##3##2##(2008-10#3)
rhizosphere##103##1##(2004-4#1)(2006-3#2)(2007-3#4)(2008-10#69)(2008-12#2)(2008-2#3)(2009-8#1)(2010-3#1)(2013-8#20)
rhizospheric microbes##3##2##(2013-8#3)
rhizospheric microbial metabolic functional##2##4##(2013-8#2)
rhizospheric microbial##3##2##(2013-8#3)
rhizospheric##7##1##(2013-8#7)
rhizotomy and##2##2##(1993-4#1)(1995-7#1)
rhizotomy on##3##2##(1995-7#2)(2005-10#1)
rhizotomy##20##1##(1991-9#1)(1993-4#2)(1995-12#1)(1995-7#12)(1996-5#1)(2005-10#1)(2006-10#2)
rhizoxin##9##1##(1991-7#8)(1995-5#1)
rho 1 receptor function##2##4##(1995-11#2)
rho 1 subunit##3##3##(1995-7#3)
rho 1##13##2##(1992-9#1)(1995-11#4)(1995-4#1)(1995-5#4)(1995-7#3)
rho 1P309S##3##2##(1995-7#3)
rho 2##2##2##(1995-4#1)(1995-7#1)
rho =##2##2##(1996-12#1)(2005-8#1)
rho A##6##2##(1992-12#2)(1994-11#4)
rho A-rho GDI complex purified from##2##6##(1994-11#2)
rho A-rho GDI complex##3##4##(1994-11#3)
rho E1E2##2##2##(1995-4#2)
rho GDI and##2##3##(1991-2#1)(1992-5#1)
rho GDI was##2##3##(1991-2#2)
rho GDI##14##2##(1991-2#4)(1992-1#3)(1992-5#6)(1994-11#1)
rho GDS and rho GDI##2##5##(1992-5#2)
rho GDS##6##2##(1992-5#6)
rho H##2##2##(1991-4#2)
rho and##3##2##(1992-12#2)(1996-5#1)
rho as a function of##2##5##(2008-10#1)(2008-3#1)
rho p21 activation##2##3##(1992-5#2)
rho p21##11##2##(1992-1#3)(1992-5#8)
rho protein##3##2##(1992-12#1)(1993-4#2)
rho proteins##6##2##(1991-2#4)(1992-12#1)(1992-3#1)
rho subunits##2##2##(1995-7#2)
rho t1t2##2##2##(1995-4#2)
rho##113##1##(1991-2#8)(1991-4#2)(1992-1#6)(1992-11#1)(1992-12#8)(1992-3#1)(1992-5#20)(1992-9#1)(1993-4#2)(1993-6#1)(1994-11#8)(1995-11#4)(1995-2#1)(1995-4#6)(1995-5#4)(1995-7#9)(1995-8#1)(1996-12#1)(1996-5#1)(2005-8#1)(2006-10#1)(2006-9#1)(2008-1#1)(2008-10#10)(2008-2#1)(2008-3#7)(2008-4#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-8#1)
rho(CH2)##3##1##(2007-11#3)
rho(p)##2##1##(2008-3#2)
rho(s)##2##1##(2008-3#2)
rho(t##4##1##(2008-10#4)
rho(theta)##3##1##(2008-3#3)
rho(w)##3##1##(2008-2#3)
rho)##2##1##(1995-5#1)(2008-10#1)
rho- mitochondria##2##2##(1997-2#2)
rho-##3##1##(1995-6#1)(1997-2#2)
rho0 mutants##3##2##(1997-6#1)(2005-8#2)
rho0##6##1##(1997-6#1)(2005-8#5)
rho1##5##1##(1995-11#1)(1995-4#1)(2008-4#3)
rho2 mRNA##3##2##(2008-4#3)
rho2 subunit##2##2##(2008-4#2)
rho2##9##1##(1995-4#1)(2008-4#8)
rhoA gene product##2##3##(1990-7#2)
rhoA##5##1##(1990-7#3)(1995-8#1)(1996-5#1)
rhoB##2##1##(1996-5#2)
rhod##2##1##(2008-11#1)(2008-5#1)
rhodamine 123 uptake##3##3##(1994-3#3)
rhodamine 123##14##2##(1994-2#1)(1994-3#3)(1996-5#4)(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#1)
rhodamine 6G (RhG) and rhodamine S (RhS)##2##7##(2008-10#2)
rhodamine 6G as##2##3##(2008-10#2)
rhodamine 6G##16##2##(2005-4#2)(2007-8#1)(2008-10#12)(2013-7#1)
rhodamine B (RhB)##2##3##(2008-10#2)
rhodamine B and##3##3##(2005-4#1)(2008-10#2)
rhodamine B hydrazide##4##3##(2008-10#4)
rhodamine B isothiocyanate##3##3##(2007-8#1)(2008-10#2)
rhodamine B##28##2##(2005-4#3)(2007-8#3)(2008-10#20)(2008-12#1)(2013-8#1)
rhodamine S##6##2##(2008-10#6)
rhodamine dyes##4##2##(2008-10#3)(2008-2#1)
rhodamine##91##1##(1990-12#1)(1991-12#1)(1991-3#1)(1992-9#1)(1993-3#1)(1993-9#4)(1994-12#1)(1994-2#1)(1994-3#3)(1995-5#1)(1996-5#5)(1997-7#1)(2005-11#1)(2005-4#5)(2006-10#1)(2007-8#4)(2008-10#50)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2013-7#1)(2013-8#1)
rhodamine-labeled##2##1##(1990-5#1)(2007-12#1)
rhodanate##3##1##(2005-4#3)
rhodanese (thiosulfate##2##2##(1991-10#1)(1992-12#1)
rhodanese##10##1##(1991-10#4)(1991-7#1)(1992-12#4)(1995-3#1)
rhodium II##2##2##(2008-5#2)
rhodium and##2##2##(2008-10#1)(2010-5#1)
rhodium has##3##2##(2008-10#3)
rhodium on##2##2##(2008-10#2)
rhodium permanent##2##2##(2008-10#2)
rhodium##41##1##(2005-4#1)(2008-10#34)(2008-5#3)(2009-5#1)(2010-5#1)(2010-7#1)
rhodium(II)##3##1##(1996-2#1)(2008-5#2)
rhodium-catalyzed allylic substitution##2##3##(2006-9#2)
rhodium-catalyzed##3##1##(2006-9#2)(2010-7#1)
rhodium-doped barium titanate##3##3##(2007-12#1)(2008-2#2)
rhodizonic acid##2##2##(2010-2#2)
rhodochrous J1##4##2##(1996-4#4)
rhodochrous##6##1##(1995-2#2)(1996-4#4)
rhododendron##5##1##(2008-10#4)(2013-7#1)
rhodopsin and bathorhodopsin##2##3##(1995-1#2)
rhodopsin and isorhodopsin##4##3##(1991-7#2)(1995-10#2)
rhodopsin and##11##2##(1990-10#1)(1990-7#1)(1991-7#2)(1995-1#4)(1995-10#3)
rhodopsin in##5##2##(1990-6#2)(1991-4#1)(1994-9#1)(1995-1#1)
rhodopsin is##3##2##(1994-9#1)(1995-1#1)(1995-10#1)
rhodopsin kinase##2##2##(1990-10#2)
rhodopsin or##2##2##(1995-10#1)(2009-10#1)
rhodopsin phosphorylation in##2##3##(1995-6#2)
rhodopsin phosphorylation##8##2##(1994-8#4)(1995-1#1)(1995-6#3)
rhodopsin to##2##2##(1994-11#1)(1995-1#1)
rhodopsin##80##1##(1990-10#6)(1990-12#2)(1990-2#2)(1990-5#1)(1990-6#3)(1990-7#3)(1991-4#3)(1991-6#1)(1991-7#3)(1992-3#1)(1992-5#1)(1994-11#4)(1994-8#4)(1994-9#5)(1995-1#18)(1995-10#7)(1995-6#3)(1996-12#1)(1997-7#3)(2006-3#3)(2008-4#1)(2009-10#1)(2009-8#1)(2012-12#2)(2012-3#1)
rhodopsins##2##1##(2009-6#1)(2009-8#1)
rhodostomin##3##1##(1994-12#3)
rhodozyma (Xanthophyllomyces dendrorhous)##2##3##(2008-5#2)
rhodozyma was##3##2##(2006-3#1)(2008-5#2)
rhodozyma##9##1##(2006-3#3)(2008-5#6)
rhombic EPR##2##2##(1992-8#1)(1997-7#1)
rhombic##10##1##(1990-3#1)(1992-8#1)(1994-3#1)(1997-7#4)(2007-11#1)(2008-9#1)(2009-7#1)
rhombohedral##3##1##(1995-11#1)(2005-11#2)
rhomboid##2##1##(1994-10#1)(2008-3#1)
rhombomeres##3##1##(1991-3#1)(1993-12#1)(2012-12#1)
rhombs##3##1##(2008-2#3)
rhopalia##3##1##(1991-6#3)
rhu GM-CSF##4##2##(1993-1#4)
rhubarbs##2##1##(2008-10#2)
rhumatoid factor##2##2##(2007-8#2)
rhumatoid##3##1##(2007-8#3)
rhusiopathiae endocarditis and##2##3##(2007-12#2)
rhusiopathiae##7##1##(1996-9#1)(2007-12#6)
rhyme monitoring##2##2##(2012-12#2)
rhyme##4##1##(2012-12#4)
rhynchus&quot##2##1##(2008-5#2)
rhythm after##2##2##(2007-9#1)(2011-2#1)
rhythm and a##2##3##(1990-5#1)(2006-9#1)
rhythm and contraction##2##3##(2007-8#1)(2009-10#1)
rhythm and the##5##3##(1991-10#1)(1997-1#1)(1997-6#1)(2006-2#1)(2008-5#1)
rhythm and##16##2##(1990-3#1)(1990-5#1)(1991-10#1)(1995-12#1)(1997-1#1)(1997-6#1)(2006-10#2)(2006-2#1)(2006-9#1)(2007-8#1)(2008-5#2)(2009-10#2)(2011-2#1)
rhythm are##2##2##(1992-12#1)(1994-10#1)
rhythm at##2##2##(1992-11#1)(1997-1#1)
rhythm devices##4##2##(2006-9#1)(2011-2#3)
rhythm disturbance##3##2##(1993-10#1)(2007-8#1)(2008-3#1)
rhythm disturbances and##3##3##(2007-9#1)(2008-10#1)(2008-5#1)
rhythm disturbances##7##2##(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-10#1)(2010-12#2)
rhythm generator##3##2##(1992-8#2)(2008-11#1)
rhythm in patients with##3##4##(2005-7#1)(2010-6#1)(2011-2#1)
rhythm in the human##2##4##(1997-1#2)
rhythm in the##9##3##(1992-3#2)(1993-1#1)(1993-9#2)(1996-3#1)(1997-1#2)(1997-8#1)
rhythm in##30##2##(1992-3#2)(1993-1#1)(1993-9#3)(1994-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-8#2)(2005-7#1)(2008-11#2)(2008-5#5)(2008-7#1)(2008-8#1)(2009-2#1)(2010-6#1)(2011-1#1)(2011-2#1)
rhythm is an##2##3##(1997-3#1)(2008-5#1)
rhythm is##7##2##(1996-9#1)(1997-3#1)(1997-6#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-12#1)
rhythm management##2##2##(2006-10#1)(2010-12#1)
rhythm of blood pressure##2##4##(1992-12#1)(1993-1#1)
rhythm of the##5##3##(1992-2#1)(1994-2#1)(1994-5#1)(1997-4#1)(2008-10#1)
rhythm of##36##2##(1990-7#2)(1991-12#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#4)(1993-1#2)(1993-11#1)(1994-10#1)(1994-2#2)(1994-5#1)(1995-6#1)(1995-9#2)(1996-3#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-4#1)(2006-4#1)(2007-3#1)(2008-10#1)(2008-12#1)(2010-8#1)(2011-1#1)(2012-2#2)
rhythm parameters##2##2##(2008-6#2)
rhythm reversal##3##2##(2008-6#3)
rhythm to##3##2##(1994-2#1)(2008-5#1)(2013-7#1)
rhythm was##7##2##(1992-12#1)(1997-1#1)(2007-8#1)(2008-11#1)(2010-8#1)(2011-2#1)(2012-3#1)
rhythm were##2##2##(1994-2#1)(2008-5#1)
rhythm when##2##2##(2008-1#1)(2012-1#1)
rhythm with a##3##3##(1991-2#1)(1996-3#1)(1997-1#1)
rhythm with##7##2##(1991-2#1)(1994-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(2005-1#1)(2007-8#1)
rhythm##248##1##(1990-3#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-10#2)(1991-12#1)(1991-2#2)(1992-11#2)(1992-12#6)(1992-2#1)(1992-3#6)(1992-8#2)(1993-1#3)(1993-10#1)(1993-11#2)(1993-12#2)(1993-6#1)(1993-9#4)(1994-10#2)(1994-2#7)(1994-3#1)(1994-5#1)(1995-11#2)(1995-12#4)(1995-4#1)(1995-6#1)(1995-9#2)(1996-2#2)(1996-3#4)(1996-4#1)(1996-6#4)(1996-9#4)(1997-1#13)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#4)(1997-8#3)(2004-11#1)(2005-1#1)(2005-7#1)(2006-10#6)(2006-2#2)(2006-4#1)(2006-6#1)(2006-9#3)(2007-11#2)(2007-3#3)(2007-6#1)(2007-7#1)(2007-8#14)(2007-9#6)(2008-1#2)(2008-10#4)(2008-11#12)(2008-12#2)(2008-3#1)(2008-5#15)(2008-6#10)(2008-7#2)(2008-8#2)(2009-10#4)(2009-2#1)(2010-12#6)(2010-2#1)(2010-3#1)(2010-6#2)(2010-8#3)(2011-1#6)(2011-2#12)(2012-1#3)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#4)(2013-7#3)
rhythm)##3##1##(1997-1#1)(2008-11#1)(2008-6#1)
rhythmic EEG##2##2##(1991-12#1)(1996-3#1)
rhythmic activity##3##2##(1992-10#1)(1995-11#1)(2007-10#1)
rhythmic bladder contractions were##2##4##(1992-3#2)
rhythmic bladder contractions##3##3##(1992-3#3)
rhythmic changes##2##2##(1990-8#1)(1996-3#1)
rhythmic gymnastics##2##2##(2012-12#2)
rhythmic movements##3##2##(2008-2#2)(2009-12#1)
rhythmic patterns##2##2##(1993-9#1)(2008-2#1)
rhythmic##47##1##(1990-2#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-10#2)(1992-3#4)(1992-9#1)(1993-9#2)(1994-3#2)(1994-5#1)(1995-11#1)(1995-12#1)(1996-3#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-4#3)(1997-7#1)(2004-11#1)(2007-10#1)(2007-9#2)(2008-11#1)(2008-2#3)(2008-8#1)(2009-12#1)(2010-2#1)(2012-12#3)(2012-2#4)(2013-8#1)
rhythmical digastric##2##2##(1990-9#1)(1995-7#1)
rhythmical jaw movements##2##3##(1990-9#2)
rhythmical jaw##3##2##(1990-9#3)
rhythmical##12##1##(1990-9#4)(1991-12#1)(1991-2#1)(1992-12#1)(1995-7#1)(2007-8#1)(2008-11#1)(2008-8#1)(2012-2#1)
rhythmically##5##1##(1993-2#1)(1994-11#1)(1994-5#1)(1995-12#1)(2008-3#1)
rhythmicity in##3##2##(1994-5#1)(2006-1#1)(2008-8#1)
rhythmicity of##2##2##(1994-5#1)(2008-5#1)
rhythmicity##13##1##(1991-10#2)(1992-3#1)(1994-5#2)(2004-11#1)(2006-1#1)(2008-5#1)(2008-6#1)(2008-8#2)(2010-8#1)(2013-8#1)
rhythms and##8##2##(1990-5#1)(1993-2#1)(1996-11#1)(1996-2#1)(1997-1#1)(2008-12#1)(2008-6#1)(2013-1#1)
rhythms are##7##2##(1990-8#1)(1993-12#1)(1997-1#1)(2006-1#1)(2008-8#1)(2008-9#1)(2009-8#1)
rhythms as##2##2##(2008-6#1)(2008-8#1)
rhythms in the##4##3##(1992-9#1)(1997-1#1)(2013-7#1)(2013-8#1)
rhythms in##14##2##(1990-3#1)(1991-12#1)(1992-8#1)(1992-9#1)(1994-6#1)(1995-12#1)(1997-1#2)(2006-1#2)(2008-5#1)(2010-8#1)(2013-7#1)(2013-8#1)
rhythms is##2##2##(1994-6#1)(1997-1#1)
rhythms of##9##2##(1991-12#1)(1992-8#1)(1993-12#1)(1995-12#2)(1997-5#1)(2008-5#1)(2010-8#1)(2012-12#1)
rhythms were##2##2##(1992-8#1)(1995-12#1)
rhythms##94##1##(1990-3#1)(1990-5#4)(1990-8#1)(1991-12#2)(1991-5#1)(1992-10#2)(1992-8#5)(1992-9#3)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#3)(1993-5#1)(1994-10#1)(1994-6#6)(1995-12#7)(1995-7#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#5)(1997-5#1)(2006-1#4)(2006-10#1)(2006-12#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#9)(2008-8#4)(2008-9#2)(2009-8#2)(2010-8#3)(2012-12#1)(2013-1#1)(2013-7#2)(2013-8#2)
rhythms' at##2##2##(1992-10#2)
rhytidectomy##3##1##(2010-11#3)
riNOS##4##1##(1994-11#4)
rib and##2##2##(1993-9#1)(2007-2#1)
rib cage defect was##2##4##(1996-2#2)
rib cage##9##2##(1996-2#3)(2007-11#2)(2007-4#2)(2007-8#1)(2012-2#1)
rib deflection and ASA of##2##5##(2006-11#2)
rib extensions##2##2##(2006-11#2)
rib eye area##2##3##(2010-2#2)
rib fracture##3##2##(2007-4#2)(2007-8#1)
rib fractures##9##2##(2006-11#7)(2006-8#1)(2013-1#1)
rib graft##3##2##(2009-1#2)(2009-10#1)
rib hump##6##2##(2007-11#3)(2007-7#2)(2009-3#1)
rib resection##2##2##(2005-12#1)(2007-8#1)
rib spreading##3##2##(2007-8#1)(2012-12#2)
rib thickness##3##2##(2010-2#3)
rib waveguide##2##2##(2007-12#1)(2008-2#1)
rib##79##1##(1993-9#1)(1996-2#4)(1996-3#1)(1997-3#1)(2005-12#1)(2006-11#11)(2006-8#1)(2007-11#6)(2007-12#3)(2007-2#1)(2007-4#4)(2007-7#2)(2007-8#7)(2008-2#1)(2008-3#2)(2008-6#1)(2009-1#2)(2009-10#1)(2009-3#2)(2009-4#2)(2009-9#1)(2010-2#7)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#10)
rib-gap defects##2##2##(1996-3#2)
ribBP##4##1##(1994-9#4)
ribavirin (RBV) and##2##3##(2009-7#1)(2013-1#1)
ribavirin and##4##2##(1991-7#1)(2006-2#1)(2007-11#1)(2008-5#1)
ribavirin for chronic hepatitis C##3##5##(2009-5#1)(2010-2#2)
ribavirin for##4##2##(2009-5#1)(2010-2#2)(2012-12#1)
ribavirin in patients with chronic hepatitis C##3##7##(2007-11#1)(2012-12#1)(2013-1#1)
ribavirin in patients with chronic hepatitis##4##6##(2005-11#1)(2007-11#1)(2012-12#1)(2013-1#1)
ribavirin in##9##2##(1994-6#1)(2005-11#1)(2007-11#1)(2007-3#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#2)
ribavirin therapy##5##2##(2005-6#1)(2008-6#1)(2010-11#1)(2010-2#1)(2013-7#1)
ribavirin with##2##2##(2008-10#1)(2009-8#1)
ribavirin##53##1##(1990-10#3)(1991-7#2)(1994-6#2)(1994-8#1)(2005-11#1)(2005-6#2)(2005-7#1)(2006-10#3)(2006-2#1)(2007-11#3)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#3)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#3)(2010-4#1)(2011-2#2)(2012-12#2)(2013-1#4)(2013-7#1)
ribavirin)##2##1##(2008-10#1)(2012-2#1)
ribbon and##2##2##(2008-3#1)(2013-7#1)
ribbon##4##1##(2007-1#1)(2008-3#2)(2013-7#1)
ribbon-like inclusions maps to##2##4##(2008-10#2)
ribbon-like inclusions##4##2##(2008-10#4)
ribbon-like structures##5##2##(1992-6#5)
ribbon-like##14##1##(1992-1#1)(1992-6#8)(1997-7#1)(2008-10#4)
ribbon-shaped##2##1##(2009-7#1)(2009-8#1)
ribbons##3##1##(2006-12#1)(2008-3#2)
ribcage##3##1##(2006-11#2)(2007-4#1)
ribeye steaks##2##2##(2010-4#2)
ribicola was##2##2##(2008-10#2)
ribicola##18##1##(2008-10#18)
riboflavin or##3##2##(1993-9#1)(2005-10#1)(2008-10#1)
riboflavin synthase##3##2##(1996-7#3)
riboflavin was##2##2##(1992-3#1)(2008-10#1)
riboflavin##40##1##(1992-3#1)(1992-6#2)(1992-9#1)(1993-9#1)(1994-9#2)(1996-7#3)(2005-10#2)(2006-4#1)(2008-10#12)(2008-9#8)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)
riboflavine and 0##2##3##(2008-10#2)
riboflavine and##3##2##(2008-10#3)
ribofuranans were##2##2##(1996-2#2)
ribofuranans##8##1##(1996-2#8)
ribokinase##2##1##(1990-10#1)(2011-1#1)
ribonuclear protein##2##2##(2008-11#1)(2011-2#1)
ribonuclear##3##1##(2008-11#1)(2011-2#1)(2013-1#1)
ribonuclease (BS-RNase)##2##2##(1994-2#1)(2006-12#1)
ribonuclease (RNase)##4##2##(1991-2#1)(1994-2#1)(1995-11#1)(1995-2#1)
ribonuclease A and##2##3##(1994-5#1)(2009-12#1)
ribonuclease A##15##2##(1990-8#2)(1994-5#1)(1994-8#4)(1997-2#3)(1997-3#1)(1997-6#1)(2008-10#1)(2009-12#1)(2011-2#1)
ribonuclease B##3##2##(2008-7#1)(2009-12#2)
ribonuclease H (RNase H)##2##4##(1992-9#1)(1995-3#1)
ribonuclease H##6##2##(1990-2#2)(1992-9#2)(1995-3#1)(2008-10#1)
ribonuclease L##2##2##(1991-4#1)(2007-1#1)
ribonuclease T1 (RNase T1)##2##4##(1992-10#1)(1992-4#1)
ribonuclease T1##5##2##(1992-10#2)(1992-4#1)(1994-2#1)(1997-7#1)
ribonuclease activity##3##2##(1992-8#1)(1993-4#1)(1994-5#1)
ribonuclease and##2##2##(1993-12#1)(2005-8#1)
ribonuclease from human##2##3##(1990-7#2)
ribonuclease from the extreme##2##4##(1995-2#2)
ribonuclease from the##3##3##(1995-2#3)
ribonuclease from##5##2##(1990-7#2)(1995-2#3)
ribonuclease gene##3##2##(1992-12#3)
ribonuclease or##2##2##(1994-2#1)(2008-7#1)
ribonuclease protection assay##6##3##(1993-3#1)(1994-12#1)(1995-6#1)(2008-10#2)(2008-4#1)
ribonuclease protection##11##2##(1992-6#1)(1993-3#1)(1994-12#1)(1995-3#1)(1995-6#1)(1996-4#1)(1997-5#1)(2008-10#3)(2008-4#1)
ribonuclease treatment##2##2##(1990-12#1)(2008-2#1)
ribonuclease with##2##2##(1991-2#1)(1994-8#1)
ribonuclease##82##1##(1990-10#1)(1990-12#1)(1990-2#2)(1990-7#3)(1990-8#3)(1991-2#4)(1991-4#1)(1992-10#2)(1992-11#1)(1992-12#3)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-2#5)(1994-5#2)(1994-8#5)(1995-11#2)(1995-2#5)(1995-3#2)(1995-6#1)(1996-4#1)(1996-5#1)(1997-2#3)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-8#1)(2006-12#2)(2007-1#1)(2008-10#5)(2008-2#2)(2008-4#1)(2008-7#2)(2009-12#3)(2009-5#1)(2011-2#1)(2012-3#1)
ribonucleases##6##1##(1990-8#1)(1992-8#1)(1995-2#1)(1995-4#2)(2012-3#1)
ribonucleic acid##8##2##(1991-4#1)(1992-9#1)(1995-12#1)(1995-3#1)(2006-12#1)(2006-7#1)(2006-9#1)(2009-11#1)
ribonucleic acids##5##2##(1990-8#2)(2008-10#1)(2008-4#1)(2013-8#1)
ribonucleic guanidine##2##2##(1996-4#2)
ribonucleic##15##1##(1990-8#2)(1991-4#1)(1992-9#1)(1995-12#1)(1995-3#1)(1996-4#2)(2006-12#1)(2006-7#1)(2006-9#1)(2008-10#1)(2008-4#1)(2009-11#1)(2013-8#1)
ribonucleolytic activity##2##2##(1996-4#1)(1997-7#1)
ribonucleolytic##5##1##(1990-2#1)(1996-4#1)(1997-4#1)(1997-7#1)(2008-10#1)
ribonucleoprotein A1##3##2##(1995-6#2)(2008-9#1)
ribonucleoprotein complex##3##2##(1994-3#2)(1995-1#1)
ribonucleoprotein complexes##4##2##(2011-2#1)(2012-12#2)(2013-1#1)
ribonucleoprotein components##2##2##(1995-2#2)
ribonucleoprotein particle##9##2##(1992-11#2)(1992-7#1)(1993-8#1)(1994-8#1)(1995-11#1)(2006-12#2)(2007-12#1)
ribonucleoprotein particles##9##2##(1994-11#2)(1995-2#1)(1995-3#2)(1995-6#1)(2005-10#1)(2006-11#1)(2006-12#1)
ribonucleoprotein##39##1##(1991-6#1)(1992-11#2)(1992-12#1)(1992-7#2)(1993-8#1)(1994-11#2)(1994-3#4)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#3)(1995-3#2)(1995-6#3)(1997-4#1)(2004-1#1)(2005-10#1)(2006-11#1)(2006-12#3)(2007-12#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-12#2)(2013-1#1)
ribonucleoproteins##5##1##(1992-12#2)(1995-6#1)(2007-12#1)(2013-1#1)
ribonucleoside diphosphate##2##2##(1990-2#1)(2008-4#1)
ribonucleoside triphosphate##2##2##(1995-3#1)(2008-4#1)
ribonucleoside##17##1##(1990-2#3)(1991-5#1)(1991-9#1)(1994-5#1)(1995-3#1)(1997-2#3)(2008-4#4)(2010-11#3)
ribonucleosides and ribonucleotides##3##3##(1994-11#1)(1997-1#2)
ribonucleosides and##4##2##(1994-11#1)(1997-1#2)(2006-3#1)
ribonucleosides for##2##2##(2008-4#2)
ribonucleosides##27##1##(1994-11#2)(1996-8#2)(1997-1#2)(1997-2#6)(2006-3#1)(2008-4#13)(2010-11#1)
ribonucleotide reductase activity##3##3##(1990-2#1)(1991-2#1)(1994-8#1)
ribonucleotide reductase by##2##3##(1993-11#1)(1994-8#1)
ribonucleotide reductase from Escherichia coli##3##5##(1991-5#1)(1995-10#2)
ribonucleotide reductase from##5##3##(1991-5#1)(1992-4#2)(1995-10#2)
ribonucleotide reductase while the##2##4##(1992-8#1)(1993-9#1)
ribonucleotide reductase##47##2##(1990-12#1)(1990-2#4)(1990-4#1)(1991-12#1)(1991-2#3)(1991-5#3)(1991-7#3)(1992-10#2)(1992-4#2)(1992-8#3)(1992-9#3)(1993-11#3)(1993-9#2)(1994-8#5)(1994-9#1)(1995-10#2)(1995-8#1)(1996-7#1)(1997-7#1)(2006-8#1)(2008-5#1)(2009-5#1)(2013-8#2)
ribonucleotide reductases##3##2##(1992-4#2)(1997-7#1)
ribonucleotide reduction##2##2##(1993-11#1)(1994-9#1)
ribonucleotide synthetase##3##2##(1993-12#3)
ribonucleotide transformylase##2##2##(2011-2#2)
ribonucleotide##61##1##(1990-12#1)(1990-2#4)(1990-4#1)(1991-12#1)(1991-2#3)(1991-5#3)(1991-7#3)(1992-10#2)(1992-4#4)(1992-8#3)(1992-9#3)(1993-11#4)(1993-12#4)(1993-9#2)(1994-8#5)(1994-9#2)(1995-10#2)(1995-8#1)(1996-7#1)(1997-7#2)(2006-8#1)(2007-11#2)(2008-5#1)(2009-5#1)(2011-1#1)(2011-2#2)(2013-8#2)
ribonucleotides by##2##2##(1997-1#1)(2006-12#1)
ribonucleotides##8##1##(1994-11#2)(1997-1#2)(2006-12#1)(2009-3#1)(2010-11#1)(2012-2#1)
riboprobe##2##1##(1996-5#1)(1997-8#1)
riboprobes and##3##2##(1996-12#2)(2008-2#1)
riboprobes##12##1##(1993-2#1)(1996-12#3)(1996-2#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#1)
ribose 5-phosphate##3##2##(1992-12#1)(1995-8#2)
ribose of##2##2##(1992-6#1)(1995-8#1)
ribose or##2##2##(1995-8#2)
ribose was administered##2##3##(1991-2#2)
ribose##52##1##(1990-5#1)(1991-2#4)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-9#3)(1995-1#3)(1995-11#1)(1995-3#1)(1995-8#12)(1996-5#3)(1996-7#1)(1997-7#1)(2006-10#2)(2006-3#1)(2008-10#1)(2008-4#2)(2008-7#2)(2010-11#2)(2011-1#2)(2012-1#1)
ribose)##3##1##(1990-5#1)(1991-12#1)(2009-3#1)
ribose-1-phosphate##2##1##(1993-12#1)(1994-6#1)
ribose-binding##5##1##(1993-9#2)(1996-11#3)
ribose-phosphate##2##1##(1991-11#1)(1995-8#1)
riboside##10##1##(1994-11#1)(1994-8#2)(2007-11#1)(2007-8#1)(2008-4#5)
ribosomal (r) protein##3##3##(1991-5#1)(1991-6#1)(1991-8#1)
ribosomal (r)DNA##2##2##(2008-10#2)
ribosomal DNA (rDNA) and##2##4##(1996-5#1)(2008-10#1)
ribosomal DNA (rDNA) from##2##4##(1991-12#1)(2008-5#1)
ribosomal DNA (rDNA)##11##3##(1991-12#1)(1991-8#1)(1996-5#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-9#1)
ribosomal DNA from##2##3##(1992-12#1)(2006-5#1)
ribosomal DNA internal transcribed spacer region##2##6##(2008-10#2)
ribosomal DNA internal transcribed spacer##5##5##(2008-10#5)
ribosomal DNA with##2##3##(2007-3#1)(2009-2#1)
ribosomal DNA##54##2##(1991-11#1)(1991-12#2)(1991-8#2)(1992-12#1)(1993-11#1)(1996-5#1)(2005-9#1)(2006-10#1)(2006-3#1)(2006-5#2)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#27)(2008-12#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-2#1)(2010-3#2)(2012-2#2)(2013-1#1)
ribosomal P proteins##2##3##(1995-2#2)
ribosomal RNA (rRNA) genes##2##4##(2006-10#1)(2011-2#1)
ribosomal RNA (rRNA)##6##3##(1993-11#1)(2006-10#1)(2008-10#2)(2011-2#1)(2013-1#1)
ribosomal RNA and##2##3##(2006-8#1)(2013-1#1)
ribosomal RNA coding##2##3##(1997-7#1)(2008-5#1)
ribosomal RNA gene (rDNA)##2##4##(2008-10#1)(2008-8#1)
ribosomal RNA gene cluster##2##4##(1993-9#1)(2008-10#1)
ribosomal RNA gene##10##3##(1993-4#1)(1993-9#1)(2008-10#3)(2008-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
ribosomal RNA genes in##3##4##(1992-3#1)(1997-2#1)(2008-5#1)
ribosomal RNA genes##11##3##(1992-3#1)(1997-2#2)(2008-10#3)(2008-5#3)(2009-5#1)(2010-6#1)
ribosomal RNA in Drosophila melanogaster##2##5##(1997-7#2)
ribosomal RNA is##3##3##(1991-2#1)(1995-2#1)(1997-7#1)
ribosomal RNA##59##2##(1991-2#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-4#1)(1993-9#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-8#1)(1997-1#3)(1997-2#2)(1997-7#4)(2005-10#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-12#2)(2008-10#9)(2008-5#5)(2008-7#1)(2008-8#1)(2009-5#2)(2010-4#1)(2010-6#2)(2011-1#2)(2011-2#4)(2012-3#1)(2013-1#3)
ribosomal RNAs##5##2##(1990-8#1)(1992-3#1)(2005-10#1)(2007-11#1)(2008-7#1)
ribosomal S6 kinase##2##3##(1996-5#1)(2011-2#1)
ribosomal S6##6##2##(1995-6#4)(1996-5#1)(2011-2#1)
ribosomal cistron##2##2##(1993-12#2)
ribosomal crystallography##2##2##(2009-11#2)
ribosomal frameshifting##6##2##(1995-9#5)(2006-12#1)
ribosomal gene##6##2##(1991-11#2)(1993-3#1)(1997-6#1)(2008-10#2)
ribosomal genes##6##2##(1996-5#2)(2008-10#3)(2011-12#1)
ribosomal intergenic spacer analysis##2##4##(2008-10#2)
ribosomal intergenic spacer##3##3##(2008-10#3)
ribosomal intergenic##4##2##(2008-10#4)
ribosomal internal transcribed spacer (ITS)##2##5##(2008-10#1)(2008-9#1)
ribosomal internal transcribed spacer region##3##5##(2008-10#3)
ribosomal internal transcribed spacer##5##4##(2008-10#4)(2008-9#1)
ribosomal large subunit##2##3##(1990-10#1)(2009-8#1)
ribosomal protein L11##2##3##(1992-5#1)(1995-6#1)
ribosomal protein L15##2##3##(1992-2#1)(1994-5#1)
ribosomal protein L3##3##3##(1992-8#1)(1995-8#1)(2006-12#1)
ribosomal protein L7/L12##2##3##(1996-11#2)
ribosomal protein S1##3##3##(1997-1#2)(1997-2#1)
ribosomal protein S14##4##3##(1996-6#3)(2012-12#1)
ribosomal protein S15##4##3##(1996-8#3)(2006-12#1)
ribosomal protein S2##2##3##(1992-4#1)(1994-2#1)
ribosomal protein S3a##3##3##(1997-2#1)(2008-11#2)
ribosomal protein S6##4##3##(1993-2#1)(1993-5#1)(1996-2#2)
ribosomal protein gene##4##3##(1997-2#1)(2005-11#1)(2008-10#1)(2008-8#1)
ribosomal protein genes##3##3##(1996-3#1)(2008-11#1)(2009-8#1)
ribosomal protein in##2##3##(1994-12#1)(2009-11#1)
ribosomal protein operons##2##3##(2008-8#2)
ribosomal protein##77##2##(1990-10#1)(1990-3#1)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-4#6)(1993-5#1)(1994-12#3)(1994-2#2)(1994-5#2)(1995-6#4)(1995-8#3)(1996-11#2)(1996-2#2)(1996-3#1)(1996-6#3)(1996-8#4)(1997-1#2)(1997-2#3)(2005-11#1)(2006-10#1)(2006-12#2)(2007-12#1)(2008-10#2)(2008-11#4)(2008-5#1)(2008-8#6)(2009-11#1)(2009-6#1)(2009-8#2)(2012-12#1)(2013-8#1)
ribosomal proteins and##3##3##(1993-11#1)(2005-10#1)(2006-12#1)
ribosomal proteins in##2##3##(1997-4#1)(2008-8#1)
ribosomal proteins##25##2##(1990-3#2)(1990-5#1)(1992-5#1)(1992-8#1)(1993-11#1)(1994-12#1)(1994-5#2)(1995-2#1)(1997-4#5)(2005-10#2)(2006-10#1)(2006-12#1)(2008-7#2)(2008-8#2)(2009-8#1)(2013-8#1)
ribosomal stress##2##2##(2012-12#2)
ribosomal subunit and##3##3##(1994-2#1)(2006-12#1)(2008-11#1)
ribosomal subunit##23##2##(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-4#3)(1994-12#4)(1994-2#2)(1994-5#2)(1996-10#1)(1997-4#1)(2006-12#1)(2008-11#1)(2009-11#1)(2009-9#2)
ribosomal subunits##4##2##(1992-2#1)(1995-6#1)(2011-2#1)(2012-2#1)
ribosomal##333##1##(1990-10#2)(1990-3#3)(1990-5#3)(1990-8#1)(1991-11#3)(1991-12#2)(1991-2#1)(1991-5#3)(1991-6#5)(1991-7#3)(1991-8#4)(1991-9#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#1)(1992-8#4)(1993-11#5)(1993-12#3)(1993-2#1)(1993-3#1)(1993-4#11)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#9)(1994-2#4)(1994-5#6)(1994-9#1)(1995-2#4)(1995-6#10)(1995-8#6)(1995-9#5)(1996-10#1)(1996-11#2)(1996-2#2)(1996-3#1)(1996-5#4)(1996-6#3)(1996-8#5)(1996-9#1)(1997-1#5)(1997-2#5)(1997-4#7)(1997-6#1)(1997-7#4)(2005-10#4)(2005-11#1)(2005-9#1)(2006-10#4)(2006-12#9)(2006-3#1)(2006-5#2)(2006-8#2)(2007-11#3)(2007-12#4)(2007-2#1)(2007-3#1)(2008-10#57)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#8)(2008-7#4)(2008-8#10)(2008-9#4)(2009-11#4)(2009-2#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-8#4)(2009-9#3)(2010-11#1)(2010-3#3)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#2)
ribosome and##3##2##(1994-11#1)(1994-2#1)(1995-3#1)
ribosome as##4##2##(1990-2#1)(2006-10#1)(2006-12#2)
ribosome assembly##4##2##(1993-11#1)(1994-2#1)(2006-12#1)(2012-3#1)
ribosome binding sequence##2##3##(2008-10#1)(2010-6#1)
ribosome binding site##6##3##(1991-11#1)(1992-12#1)(1992-4#1)(1995-3#1)(1997-1#1)(2010-6#1)
ribosome binding##8##2##(1991-11#1)(1992-12#1)(1992-4#1)(1995-3#1)(1997-1#1)(2008-10#1)(2010-6#2)
ribosome biogenesis and##2##3##(2011-1#1)(2011-2#1)
ribosome biogenesis##7##2##(1997-1#1)(2011-1#2)(2011-2#4)
ribosome engineering technology##2##3##(2013-1#2)
ribosome engineering##3##2##(2013-1#3)
ribosome function##2##2##(1991-6#1)(2006-12#1)
ribosome is##4##2##(1991-9#1)(2006-12#1)(2008-11#1)(2008-7#1)
ribosome pause##2##2##(1995-3#2)
ribosome solutions##2##2##(1995-1#2)
ribosome structure and##2##3##(2005-10#1)(2006-12#1)
ribosome synthesis##4##2##(2006-12#3)(2011-12#1)
ribosome##104##1##(1990-2#3)(1990-5#1)(1991-11#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#3)(1992-8#1)(1993-11#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-9#1)(1995-1#2)(1995-3#6)(1995-4#1)(1996-4#1)(1997-1#2)(1997-2#1)(1997-7#1)(1997-8#2)(2005-10#3)(2005-7#3)(2006-10#1)(2006-11#3)(2006-12#15)(2007-12#3)(2007-9#3)(2008-10#2)(2008-11#4)(2008-7#2)(2008-9#2)(2009-8#4)(2009-9#1)(2010-12#1)(2010-6#2)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-3#1)(2013-1#4)(2013-8#1)
ribosome-activated ATPase activity of EF-3##3##5##(1996-2#3)
ribosome-activated ATPase activity##4##3##(1996-2#4)
ribosome-binding site##10##2##(1990-3#1)(1990-9#1)(1991-9#2)(1993-6#1)(1993-9#2)(1994-12#2)(1995-3#1)
ribosome-binding sites##4##2##(1990-5#1)(1990-7#1)(1990-9#1)(1993-12#1)
ribosome-binding##15##1##(1990-3#1)(1990-5#1)(1990-7#1)(1990-9#2)(1991-9#2)(1993-12#1)(1993-6#1)(1993-9#2)(1994-12#2)(1995-3#1)(1995-5#1)
ribosome-inactivating protein##8##2##(1991-2#2)(1993-2#2)(1994-2#2)(2008-10#2)
ribosome-inactivating proteins (RIPs)##2##3##(1990-12#1)(1994-5#1)
ribosome-inactivating proteins##7##2##(1990-11#1)(1990-12#2)(1991-2#1)(1994-2#1)(1994-5#2)
ribosome-inactivating##16##1##(1990-11#1)(1990-12#2)(1991-2#4)(1993-2#2)(1994-2#3)(1994-5#2)(2008-10#2)
ribosomes and##4##2##(1990-11#1)(1993-3#1)(2007-12#2)
ribosomes are##2##2##(1990-2#1)(2005-10#1)
ribosomes at##2##2##(1995-6#2)
ribosomes by##2##2##(1992-1#1)(1992-3#1)
ribosomes from##3##2##(1993-11#1)(1997-4#1)(2008-7#1)
ribosomes in##2##2##(1991-12#1)(1997-2#1)
ribosomes on##2##2##(1990-10#1)(1993-3#1)
ribosomes that##2##2##(1995-1#1)(1995-6#1)
ribosomes to##2##2##(1995-9#1)(1997-6#1)
ribosomes was##2##2##(1995-5#1)(1997-4#1)
ribosomes were##2##2##(2007-9#1)(2008-7#1)
ribosomes##58##1##(1990-10#1)(1990-11#1)(1990-2#3)(1990-4#1)(1991-12#1)(1992-1#3)(1992-2#1)(1992-3#3)(1992-5#1)(1992-8#1)(1993-11#1)(1993-3#2)(1993-4#1)(1994-12#1)(1995-1#1)(1995-4#4)(1995-5#1)(1995-6#4)(1995-8#1)(1995-9#2)(1996-4#2)(1997-1#1)(1997-2#2)(1997-4#2)(1997-6#2)(2005-10#1)(2006-11#1)(2006-12#2)(2007-12#2)(2007-9#1)(2008-10#1)(2008-7#4)(2008-9#1)(2009-10#1)(2009-11#1)
ribostamycin##2##1##(1992-6#1)(2009-4#1)
ribosylation factor##3##2##(1997-4#2)(2009-8#1)
ribosylation##4##1##(1990-7#1)(1997-4#2)(2009-8#1)
ribotide##3##1##(1994-11#3)
ribotoxin##3##1##(1997-4#1)(2007-7#2)
ribotype##2##1##(1997-3#1)(2011-1#1)
ribotypes##2##1##(1997-3#1)(2006-8#1)
ribotyping##8##1##(1997-3#1)(1997-4#1)(2006-3#1)(2006-8#2)(2008-10#1)(2008-5#1)(2012-2#1)
ribozyme and a##2##3##(2006-11#2)
ribozyme cassette##2##2##(2006-12#2)
ribozyme in vitro and in vivo##2##6##(2008-9#2)
ribozyme in vitro##3##3##(1994-9#1)(2008-9#2)
ribozyme in##7##2##(1993-9#2)(1994-9#1)(2006-10#1)(2008-9#3)
ribozyme is##2##2##(1991-11#1)(1995-6#1)
ribozyme specific for the##2##4##(1994-9#1)(2004-1#1)
ribozyme targeted##2##2##(1992-7#2)
ribozyme targeting##2##2##(1997-6#1)(2008-9#1)
ribozyme that##7##2##(1991-3#1)(1992-7#1)(1995-3#1)(1996-9#1)(1997-7#1)(2006-11#1)(2006-12#1)
ribozyme to##2##2##(1992-7#1)(1996-9#1)
ribozyme##82##1##(1991-11#4)(1991-3#1)(1992-7#8)(1993-9#7)(1994-11#6)(1994-9#7)(1995-1#4)(1995-3#1)(1995-6#6)(1996-7#3)(1996-9#4)(1997-6#3)(1997-7#1)(2004-1#4)(2006-10#1)(2006-11#4)(2006-12#3)(2008-11#1)(2008-3#2)(2008-9#12)
ribozymes and##2##2##(2008-11#1)(2008-7#1)
ribozymes for##3##2##(1996-9#1)(2004-1#1)(2007-3#1)
ribozymes have been##2##3##(1997-6#1)(2004-1#1)
ribozymes were##3##2##(1991-3#1)(1994-9#1)(1996-7#1)
ribozymes with a##2##3##(1996-8#1)(1997-7#1)
ribozymes with##5##2##(1991-11#1)(1996-7#2)(1996-8#1)(1997-7#1)
ribozymes##32##1##(1991-11#1)(1991-3#1)(1992-7#1)(1994-9#1)(1996-7#9)(1996-8#2)(1996-9#1)(1997-6#1)(1997-7#1)(2004-1#2)(2006-10#1)(2006-12#4)(2007-11#2)(2007-3#1)(2008-11#1)(2008-7#1)(2008-9#2)
ribs and the##2##3##(2007-11#1)(2007-12#1)
ribs and##7##2##(1997-3#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2009-3#1)(2013-1#1)
ribs are##2##2##(2007-7#1)(2010-12#1)
ribs in##2##2##(1997-3#1)(2007-3#1)
ribs to##2##2##(2006-11#1)(2006-7#1)
ribs##26##1##(1991-11#1)(1993-12#2)(1994-12#1)(1996-3#1)(1997-3#2)(2006-11#2)(2006-12#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#4)(2009-3#1)(2010-12#1)(2012-2#1)(2013-1#3)
ribulose 1##8##2##(1991-9#1)(1992-4#1)(1997-1#3)(1997-6#3)
ribulose bisphosphate carboxylase-oxygenase##2##3##(1994-12#1)(2009-10#1)
ribulose bisphosphate##3##2##(1994-12#1)(2009-10#2)
ribulose##13##1##(1991-9#1)(1992-12#1)(1992-4#1)(1994-12#1)(1997-1#3)(1997-6#3)(2009-10#2)(2013-8#1)
ribulosebisphosphate carboxylase/oxygenase activase##2##3##(1992-12#2)
rice (Oryza sativa L##17##4##(1992-8#1)(1994-11#1)(1997-4#2)(2006-9#1)(2007-12#2)(2008-10#2)(2008-4#1)(2008-9#5)(2009-3#1)(2009-8#1)
rice (Oryza sativa##21##3##(1992-8#1)(1994-11#1)(1997-4#2)(2006-12#1)(2006-9#1)(2007-12#2)(2008-10#2)(2008-4#1)(2008-9#6)(2009-10#2)(2009-3#1)(2009-8#1)
rice (Oryza sativa)##6##3##(2008-10#3)(2008-7#2)(2009-10#1)
rice (Oryza##30##2##(1992-8#1)(1994-11#1)(1996-12#1)(1997-4#2)(2006-12#1)(2006-9#1)(2007-12#2)(2008-10#5)(2008-4#1)(2008-7#3)(2008-9#6)(2009-10#4)(2009-3#1)(2009-8#1)
rice 5460S##2##2##(2008-8#2)
rice EST##2##2##(2006-12#1)(2008-10#1)
rice GTs##2##2##(2009-10#2)
rice MADS box gene##2##4##(1997-2#1)(2008-8#1)
rice MADS box##3##3##(1997-2#1)(1997-8#1)(2008-8#1)
rice Pi21##2##2##(2012-2#2)
rice PyrDC##2##2##(1990-12#2)
rice SVP-group MADS-box proteins##2##4##(2009-8#2)
rice U-box##2##2##(2009-10#2)
rice allergenic protein##2##3##(2008-11#2)
rice and Arabidopsis U-box proteins##3##5##(2009-10#3)
rice and Arabidopsis##4##3##(2009-10#4)
rice and St##3##3##(2008-10#3)
rice and barley gene expression databases##2##6##(2009-10#2)
rice and barley##3##3##(2009-10#3)
rice and designated as##2##4##(2006-9#1)(2009-8#1)
rice and maize##2##3##(2008-8#1)(2009-10#1)
rice and wheat##4##3##(2006-4#1)(2008-10#1)(2008-11#1)(2008-12#1)
rice and##34##2##(2005-6#1)(2006-4#2)(2006-9#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#11)(2009-8#1)(2011-3#1)(2013-8#1)
rice as a##2##3##(2008-7#1)(2009-8#1)
rice as##4##2##(1997-4#1)(2008-7#1)(2009-8#1)(2011-1#1)
rice bacterial artificial chromosome (BAC) library##2##6##(2008-8#2)
rice bacterial artificial##3##3##(2008-10#1)(2008-8#2)
rice bacterial blight##3##3##(2008-10#3)
rice bacterial##6##2##(2008-10#4)(2008-8#2)
rice black-streaked dwarf virus##3##4##(2005-11#3)
rice blast caused by##2##4##(2008-10#2)
rice blast fungus##5##3##(2008-10#5)
rice blast in the##2##4##(2008-10#2)
rice blast in##3##3##(2008-10#2)(2012-2#1)
rice blast resistance##2##3##(2008-10#2)
rice blast##24##2##(2008-10#23)(2012-2#1)
rice bran wax##4##3##(2010-2#4)
rice bran##8##2##(1990-12#1)(2010-2#6)(2012-1#1)
rice brans##2##2##(2012-1#2)
rice breeding##3##2##(2008-10#1)(2008-8#1)(2011-1#1)
rice by##4##2##(2006-12#1)(2008-10#2)(2008-9#1)
rice cDNA##4##2##(1996-8#1)(2008-10#1)(2008-9#2)
rice cells##2##2##(1990-7#1)(1994-11#1)
rice chromosome 1##3##3##(1996-10#2)(2008-10#1)
rice chromosome 4##2##3##(2009-10#2)
rice chromosome 5##2##3##(1996-10#2)
rice chromosome##13##2##(1995-6#1)(1996-10#4)(1997-4#3)(2008-10#1)(2008-8#1)(2008-9#1)(2009-10#2)
rice chromosomes 3 and 11##2##5##(1997-4#2)
rice chromosomes##10##2##(1996-12#3)(1997-2#2)(1997-4#3)(2008-8#1)(2008-9#1)
rice cultivar##7##2##(2008-10#6)(2008-9#1)
rice cultivars was##2##3##(2008-10#2)
rice cultivars were##2##3##(2008-10#2)
rice cultivars##16##2##(2006-12#2)(2008-10#12)(2008-12#1)(2009-10#1)
rice cv##5##2##(2008-10#3)(2008-9#2)
rice epsps cDNA##2##3##(2008-9#2)
rice epsps##4##2##(2008-9#4)
rice field##2##2##(2005-8#1)(2008-10#1)
rice flour##7##2##(2008-10#7)
rice for##2##2##(1995-6#1)(2006-12#1)
rice from##2##2##(2008-10#2)
rice gene##3##2##(2006-12#2)(2008-7#1)
rice genetic##2##2##(1994-8#1)(2009-10#1)
rice genome and##2##3##(2008-9#1)(2009-10#1)
rice genome by##2##3##(2008-8#1)(2009-10#1)
rice genome##22##2##(1996-8#2)(1997-2#1)(2006-11#1)(2006-12#1)(2008-10#1)(2008-8#4)(2008-9#8)(2009-10#3)(2012-2#1)
rice genomic DNA##2##3##(1996-12#1)(2008-8#1)
rice genomic library##4##3##(2008-8#1)(2008-9#3)
rice genomic##6##2##(1996-12#1)(2008-8#2)(2008-9#3)
rice genotypes##3##2##(2006-11#2)(2008-12#1)
rice grain##5##2##(2006-12#1)(2008-10#1)(2013-1#3)
rice grains##5##2##(1995-3#1)(2008-10#2)(2008-12#2)
rice growth stages##4##3##(2007-8#2)(2008-10#2)
rice growth##8##2##(2007-8#5)(2008-10#2)(2008-9#1)
rice haploid genome equivalents##2##4##(1996-10#1)(2008-8#1)
rice has##3##2##(1994-8#1)(2006-11#2)
rice hull##3##2##(2008-12#3)
rice hulls##4##2##(2008-12#1)(2008-5#3)
rice hybrid##2##2##(2008-9#2)
rice hybrids##2##2##(2008-10#1)(2009-10#1)
rice in the United States##2##5##(2008-10#1)(2013-8#1)
rice in##7##2##(2008-10#3)(2008-12#1)(2013-1#1)(2013-8#2)
rice is##3##2##(1996-12#1)(2006-11#1)(2006-12#1)
rice isolate##2##2##(2008-10#2)
rice leaves##6##2##(2008-10#5)(2009-8#1)
rice line##4##2##(2006-12#1)(2008-10#2)(2008-9#1)
rice lines##5##2##(1994-8#1)(2008-10#2)(2008-12#1)(2008-9#1)
rice or##2##2##(2010-12#1)(2013-1#1)
rice paddy##4##2##(2008-12#2)(2008-3#2)
rice pest management##2##3##(2008-10#2)
rice plant##5##2##(2008-10#2)(2009-8#3)
rice plants were##3##3##(2006-11#1)(2008-10#2)
rice plants##24##2##(1996-6#1)(1997-2#1)(2006-11#2)(2006-12#3)(2007-8#2)(2008-10#9)(2008-8#1)(2008-9#2)(2009-8#2)(2013-8#1)
rice plus canola oil##3##4##(2008-10#3)
rice production in##3##3##(2008-10#2)(2008-4#1)
rice production##5##2##(1994-8#1)(2008-10#3)(2008-4#1)
rice resistance to blast##2##4##(2008-10#1)(2012-2#1)
rice root##7##2##(2008-9#7)
rice samples##3##2##(2008-10#3)
rice seed##4##2##(2006-12#2)(2008-10#2)
rice seedlings##4##2##(1990-7#1)(2008-10#3)
rice seeds##5##2##(1992-8#1)(2006-12#1)(2008-9#3)
rice species##4##2##(2007-3#2)(2008-8#1)(2009-10#1)
rice starch 4##2##3##(2008-5#2)
rice starch##3##2##(2008-5#3)
rice syrup##2##2##(2012-12#2)
rice to##4##2##(1997-3#1)(2008-10#3)
rice tungro spherical virus##2##4##(2008-10#2)
rice tungro##3##2##(2008-10#3)
rice using##5##2##(2008-7#1)(2009-10#1)(2011-1#3)
rice varieties in##2##3##(2008-12#1)(2011-1#1)
rice varieties##12##2##(1996-8#3)(2006-12#1)(2008-10#1)(2008-12#2)(2008-8#2)(2008-9#1)(2011-1#2)
rice variety##3##2##(2008-9#3)
rice was##4##2##(1993-11#1)(2006-4#1)(2008-4#1)(2008-9#1)
rice yellow mottle virus##2##4##(2008-10#2)
rice yellow stunt rhabdovirus##2##4##(2008-8#2)
rice yellow##5##2##(2008-10#3)(2008-8#2)
rice yield was##2##3##(2008-12#2)
rice yield##3##2##(2008-12#2)(2013-8#1)
rice##679##1##(1990-12#3)(1990-7#5)(1991-5#1)(1992-8#2)(1993-11#3)(1993-9#1)(1994-11#2)(1994-8#5)(1994-9#1)(1995-3#1)(1995-6#2)(1996-10#8)(1996-12#6)(1996-6#1)(1996-8#7)(1997-2#9)(1997-3#1)(1997-4#9)(1997-8#2)(2005-11#4)(2005-6#1)(2005-8#1)(2006-11#18)(2006-12#35)(2006-4#5)(2006-9#2)(2007-11#1)(2007-12#4)(2007-3#3)(2007-6#2)(2007-7#1)(2007-8#10)(2008-10#192)(2008-11#7)(2008-12#24)(2008-3#2)(2008-4#5)(2008-5#9)(2008-6#3)(2008-7#12)(2008-8#60)(2008-9#84)(2009-10#57)(2009-3#2)(2009-4#1)(2009-8#15)(2010-12#1)(2010-2#6)(2011-1#9)(2011-3#3)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#7)(2013-1#9)(2013-8#7)
rice)##2##1##(2008-10#2)
rice-M##2##1##(2009-10#1)(2012-2#1)
rice-diverged##2##1##(2009-10#2)
rices##2##1##(2006-4#1)(2008-10#1)
rich and poor##4##3##(1992-5#1)(1996-7#1)(2008-11#1)(2008-5#1)
rich and##19##2##(1991-6#1)(1992-5#2)(1993-12#1)(1994-2#1)(1994-9#1)(1996-7#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#2)(2011-1#1)(2012-3#1)(2013-8#1)
rich blood supply##3##3##(2008-4#1)(2008-5#1)(2009-1#1)
rich countries##3##2##(2006-11#1)(2008-11#1)(2011-1#1)
rich data##3##2##(2008-11#1)(2010-7#1)(2011-2#1)
rich environment##2##2##(2008-7#1)(2009-4#1)
rich flames##2##2##(2008-3#2)
rich foods##2##2##(2007-11#1)(2012-2#1)
rich history##2##2##(2006-7#1)(2012-12#1)
rich in a##2##3##(2008-5#1)(2010-9#1)
rich in acidic residues##2##4##(1992-7#1)(1995-6#1)
rich in basic and##2##4##(1991-1#1)(1991-10#1)
rich in basic##4##3##(1991-1#1)(1991-10#1)(1992-2#1)(1994-3#1)
rich in cysteine##3##3##(1990-9#2)(2007-6#1)
rich in fat and##2##4##(1995-2#1)(2008-1#1)
rich in fat##3##3##(1995-2#1)(1997-8#1)(2008-1#1)
rich in fibre##2##3##(2010-4#1)(2010-6#1)
rich in glutamine##2##3##(1990-4#1)(1995-2#1)
rich in glycine##2##3##(1992-4#1)(1992-7#1)
rich in iron##2##3##(2012-12#1)(2013-8#1)
rich in proline and##2##4##(1991-8#1)(1997-5#1)
rich in the##5##3##(1990-10#1)(1995-6#1)(2007-1#1)(2008-10#1)(2010-4#1)
rich in these##2##3##(1994-3#1)(2008-4#1)
rich in##115##2##(1990-10#2)(1990-11#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#2)(1991-8#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-7#2)(1993-12#1)(1993-3#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#4)(1996-1#1)(1997-3#1)(1997-5#3)(1997-7#1)(1997-8#5)(2005-11#2)(2005-6#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-1#4)(2007-11#2)(2007-12#2)(2007-3#1)(2007-6#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-3#3)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#2)(2009-1#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-3#2)(2010-4#5)(2010-6#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#3)(2013-1#2)(2013-8#1)
rich information about##3##3##(2009-11#1)(2013-1#2)
rich information##5##2##(2008-10#1)(2009-11#1)(2012-3#1)(2013-1#2)
rich material##2##2##(2007-12#1)(2010-8#1)
rich medium with##2##3##(1994-8#1)(2004-8#1)
rich medium##12##2##(1991-10#1)(1994-8#1)(1994-9#1)(1996-10#1)(1997-1#1)(1997-4#1)(2004-8#4)(2007-12#1)(2008-11#1)
rich phase##2##2##(2008-10#1)(2012-1#1)
rich region##8##2##(1993-3#2)(1997-2#2)(1997-7#2)(2008-8#2)
rich regions##2##2##(1997-7#1)(2009-1#1)
rich repeat##4##2##(2008-9#2)(2010-10#1)(2010-7#1)
rich soil##3##2##(2006-9#1)(2008-10#1)(2008-5#1)
rich source of##11##3##(1992-12#1)(1994-3#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-11#1)(2012-12#1)(2013-8#1)
rich sources of##4##3##(1992-3#1)(2006-12#1)(2007-10#1)(2008-5#1)
rich variety of##4##3##(2007-12#1)(2007-9#1)(2008-11#1)(2011-1#1)
rich with##3##2##(2007-10#1)(2008-12#1)(2009-4#1)
rich##330##1##(1990-10#2)(1990-11#1)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#1)(1990-9#2)(1991-1#1)(1991-10#3)(1991-12#4)(1991-2#2)(1991-4#2)(1991-5#2)(1991-6#1)(1991-8#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#2)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-9#1)(1994-2#1)(1994-3#3)(1994-6#1)(1994-8#2)(1994-9#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#2)(1995-6#4)(1996-1#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-7#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#3)(1997-7#7)(1997-8#5)(2004-8#4)(2005-11#2)(2005-6#1)(2006-10#2)(2006-11#2)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-9#2)(2007-1#5)(2007-10#3)(2007-11#4)(2007-12#10)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#14)(2008-11#12)(2008-12#5)(2008-2#2)(2008-3#8)(2008-4#4)(2008-5#16)(2008-6#4)(2008-7#9)(2008-8#4)(2008-9#10)(2009-1#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-2#2)(2010-3#5)(2010-4#6)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#8)(2011-2#6)(2012-1#4)(2012-11#1)(2012-12#8)(2012-2#2)(2012-3#5)(2013-1#13)(2013-7#1)(2013-8#5)
richer in##2##2##(2005-11#1)(2013-1#1)
richer than##4##2##(2005-12#1)(2008-11#1)(2013-1#2)
richer understanding of##3##3##(1997-5#1)(2011-1#1)(2012-12#1)
richer##15##1##(1997-1#1)(1997-5#1)(2005-11#1)(2005-12#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#1)
richest##8##1##(1990-12#1)(1991-5#1)(2007-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-5#1)(2011-3#1)
richly vascularized##2##2##(1995-12#1)(2011-2#1)
richly##7##1##(1995-12#1)(1995-3#1)(1997-4#1)(2007-10#1)(2009-2#1)(2011-2#1)(2013-1#1)
richness (S)##3##2##(2008-5#1)(2008-8#1)(2013-7#1)
richness and abundance of##3##4##(2007-5#1)(2008-5#1)(2008-6#1)
richness and abundance##11##3##(2007-3#1)(2007-5#1)(2008-5#2)(2008-6#4)(2013-7#3)
richness and altitude##2##3##(2008-8#2)
richness and complexity##4##3##(2006-1#1)(2008-10#2)(2008-12#1)
richness and composition##3##3##(2008-8#1)(2013-7#2)
richness and diversity##6##3##(2008-10#1)(2008-5#5)
richness and##47##2##(2006-1#1)(2007-3#1)(2007-5#3)(2008-10#4)(2008-12#1)(2008-5#9)(2008-6#4)(2008-8#9)(2008-9#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#7)(2013-8#1)
richness at##3##2##(2007-5#1)(2008-8#1)(2013-7#1)
richness in##3##2##(2007-5#1)(2008-10#1)(2008-5#1)
richness increased##2##2##(2008-8#2)
richness is##10##2##(2007-5#1)(2008-10#1)(2008-8#7)(2008-9#1)
richness of the##2##3##(2007-12#1)(2011-2#1)
richness of##22##2##(1994-3#1)(2006-1#1)(2007-12#1)(2007-3#1)(2007-5#3)(2008-11#1)(2008-5#3)(2008-8#1)(2008-9#2)(2009-10#1)(2010-10#1)(2011-2#6)
richness or##2##2##(2008-10#1)(2012-3#1)
richness was##10##2##(2007-5#1)(2008-5#5)(2008-9#1)(2011-12#1)(2012-2#1)(2013-7#1)
richness were##3##2##(2008-8#1)(2008-9#1)(2013-7#1)
richness##164##1##(1994-3#4)(2006-1#2)(2007-12#1)(2007-3#3)(2007-5#13)(2008-10#8)(2008-11#1)(2008-12#1)(2008-5#25)(2008-6#6)(2008-8#45)(2008-9#15)(2009-10#1)(2010-10#1)(2011-12#1)(2011-2#10)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#20)(2013-8#1)
ricin A chain toxin##2##4##(1993-7#1)(1994-2#1)
ricin A chain##7##3##(1990-12#1)(1991-2#3)(1992-3#1)(1993-7#1)(1994-2#1)
ricin A##8##2##(1990-12#1)(1991-2#3)(1992-3#1)(1993-7#1)(1994-2#1)(2008-5#1)
ricin A-chain##4##2##(1991-9#3)(1994-5#1)
ricin and abrin##3##3##(1994-5#3)
ricin and##6##2##(1990-11#1)(1994-5#3)(2006-7#2)
ricin toxin##4##2##(2012-11#4)
ricin##44##1##(1990-11#1)(1990-12#1)(1991-2#3)(1991-3#6)(1991-9#4)(1992-3#3)(1993-11#2)(1993-12#1)(1993-7#3)(1994-2#1)(1994-5#7)(2006-7#4)(2008-5#2)(2010-4#2)(2012-11#4)
ricini##4##1##(2007-12#1)(2008-6#1)(2008-8#2)
ricinus as a vector of zoonotic##2##6##(2011-1#2)
ricinus##12##1##(2004-11#3)(2007-12#2)(2008-12#1)(2008-4#2)(2011-1#3)(2013-8#1)
rickets and##3##2##(2008-1#2)(2008-7#1)
rickets in##2##2##(2008-1#2)
rickets is##2##2##(2008-1#2)
rickets##29##1##(1994-11#3)(1997-3#1)(2006-12#1)(2006-4#1)(2006-7#1)(2007-8#1)(2008-1#11)(2008-7#1)(2011-1#5)(2012-12#2)(2012-2#1)(2013-1#1)
rickettsia##2##1##(1995-12#1)(2006-10#1)
rickettsiae##5##1##(1995-12#1)(2006-2#3)(2009-2#1)
rickettsial diseases##4##2##(1994-7#1)(2007-2#1)(2008-4#1)(2010-9#1)
rickettsial infection##5##2##(2006-2#3)(2008-4#1)(2010-9#1)
rickettsial##16##1##(1994-12#1)(1994-7#1)(1995-12#1)(1996-1#1)(2006-2#5)(2007-2#1)(2007-7#1)(2008-4#3)(2010-9#2)
rickettsii##5##1##(1991-8#2)(1995-12#1)(2006-2#1)(2008-7#1)
rickettsiosis##4##1##(2006-2#2)(2007-2#1)(2012-12#1)
ricochetal brachiation and continuous contact brachiation##2##6##(2012-12#2)
ricochetal brachiation##4##2##(2012-12#4)
rid##7##1##(1996-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-4#1)(2009-11#1)
ridden##2##1##(2012-12#2)
riddle of##4##2##(1992-11#1)(1993-12#1)(2007-8#1)(2008-5#1)
riddle##6##1##(1991-2#1)(1992-11#1)(1993-12#1)(2007-8#2)(2008-5#1)
riddled with##3##2##(2008-2#1)(2009-11#1)(2010-12#1)
ride##5##1##(1994-2#1)(1997-4#1)(2008-7#1)(2012-2#1)(2012-3#1)
rider assistance systems##5##3##(2012-12#5)
rider##9##1##(2006-3#1)(2012-12#8)
riders##10##1##(1995-1#1)(2006-5#1)(2007-1#2)(2008-5#1)(2012-12#2)(2013-7#3)
rides##3##1##(2006-5#1)(2012-2#2)
ridge and a##2##3##(1997-5#1)(2007-11#1)
ridge and##6##2##(1997-5#1)(2006-3#1)(2007-11#1)(2007-12#1)(2008-7#1)(2012-2#1)
ridge at##2##2##(1995-11#1)(2008-7#1)
ridge count##2##2##(2012-12#2)
ridge density##3##2##(2012-12#3)
ridge development##2##2##(1995-11#1)(2007-12#1)
ridge extraction##3##2##(2008-3#3)
ridge gourd##2##2##(2013-8#2)
ridge in##2##2##(2010-3#1)(2012-2#1)
ridge of the##2##3##(2008-3#1)(2011-12#1)
ridge of##4##2##(1995-11#1)(2008-3#1)(2008-5#1)(2011-12#1)
ridge regression and##2##3##(1994-9#2)
ridge regression##5##2##(1994-9#2)(2005-4#1)(2010-1#1)(2012-3#1)
ridge splitting techniques##2##3##(2007-12#2)
ridge tillage##6##2##(2008-10#6)
ridge waveguide##2##2##(2007-12#2)
ridge waveguides##3##2##(2007-11#1)(2008-2#2)
ridge##84##1##(1993-11#1)(1994-11#1)(1994-9#2)(1995-11#4)(1996-12#1)(1996-5#1)(1996-8#1)(1997-5#1)(2005-4#1)(2006-11#1)(2006-12#1)(2006-3#1)(2007-11#4)(2007-12#18)(2007-3#1)(2007-7#1)(2007-9#3)(2008-1#1)(2008-10#6)(2008-2#4)(2008-3#4)(2008-5#2)(2008-7#5)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2011-12#1)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
ridge-nosed rattlesnake (Crotalus willardi)##2##4##(2007-2#2)
ridge-type channel##2##2##(2008-1#1)(2008-2#1)
ridge-type##4##1##(2008-1#2)(2008-2#1)(2008-3#1)
ridgelet transform##3##2##(2008-2#3)
ridgelet##4##1##(2008-2#4)
ridges and##4##2##(2007-8#1)(2008-2#1)(2008-5#1)(2013-7#1)
ridges are##3##2##(1991-8#1)(1992-7#1)(2008-2#1)
ridges in##2##2##(2008-2#2)
ridges of the##2##3##(2008-2#1)(2008-5#1)
ridges of##4##2##(1994-11#1)(2008-2#2)(2008-5#1)
ridges that are##2##3##(2007-11#1)(2013-1#1)
ridges with##3##2##(2011-12#1)(2011-2#1)(2013-1#1)
ridges##46##1##(1991-8#2)(1992-7#8)(1994-11#2)(1994-7#1)(1995-11#1)(1995-8#1)(2006-5#1)(2007-11#3)(2007-12#3)(2007-8#1)(2007-9#2)(2008-10#1)(2008-2#7)(2008-5#4)(2011-12#1)(2011-2#1)(2013-1#5)(2013-7#1)(2013-8#1)
riding##12##1##(2007-1#1)(2007-3#1)(2007-8#1)(2008-10#1)(2009-1#1)(2012-12#6)(2012-2#1)
rifabutin##3##1##(1995-4#1)(2008-4#1)(2010-10#1)
rifalazil##3##1##(2008-5#3)
rifampicin and##7##2##(1991-11#1)(2006-11#1)(2008-10#4)(2008-2#1)
rifampicin in##2##2##(1992-2#1)(2007-7#1)
rifampicin resistance##5##2##(2007-7#5)
rifampicin##40##1##(1990-7#4)(1991-11#1)(1992-2#3)(1993-5#2)(1993-9#1)(1997-2#1)(2005-9#1)(2006-10#1)(2006-11#1)(2007-7#7)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-8#2)(2009-2#2)(2010-10#1)(2010-4#1)(2011-2#1)(2013-1#1)
rifampicin-resistant##5##1##(1994-7#1)(1997-2#1)(2007-6#2)(2008-10#1)
rifampin and##2##2##(2005-12#1)(2008-4#1)
rifampin therapy##2##2##(2007-12#1)(2008-5#1)
rifampin##19##1##(2005-12#1)(2005-8#1)(2007-11#1)(2007-12#4)(2008-4#5)(2008-5#4)(2009-4#1)(2011-2#2)
rifamycin B production##2##3##(1994-8#2)
rifamycin B##3##2##(1994-8#3)
rifamycin##5##1##(1993-2#1)(1994-8#3)(2008-5#1)
rifamycins##2##1##(2009-4#2)
rifaximin##2##1##(2006-2#1)(2011-2#1)
rife##3##1##(1996-2#1)(2007-2#1)(2012-2#1)
rift##2##1##(2007-7#1)(2013-8#1)
rig##7##1##(2005-11#2)(2007-8#1)(2008-3#2)(2011-2#1)(2013-1#1)
rigaudi##4##1##(2012-2#4)
right AV##2##2##(2008-5#2)
right B2##2##2##(2008-5#2)
right FG##2##2##(2008-9#2)
right IFG##3##2##(2009-1#2)(2013-1#1)
right MCA##5##2##(1997-6#1)(2007-10#1)(2008-12#3)
right SGB##3##2##(2006-12#3)
right above##3##2##(2013-8#3)
right accessory##2##2##(2008-11#1)(2008-7#1)
right adrenal gland##6##3##(1997-3#1)(2008-5#3)(2012-12#2)
right adrenal##10##2##(1991-10#1)(1997-3#1)(2007-10#1)(2008-1#1)(2008-5#3)(2008-8#1)(2012-12#2)
right after##2##2##(1990-9#1)(2009-3#1)
right amygdala volumes##2##3##(2004-11#2)
right amygdala##3##2##(2004-11#2)(2009-2#1)
right and left atria##3##4##(1990-10#2)(2013-1#1)
right and left coronary##2##4##(2010-12#1)(2012-2#1)
right and left eyes##3##4##(1997-2#1)(2006-9#1)(2007-3#1)
right and left hands##2##4##(2012-12#2)
right and left hemisphere##4##4##(1992-9#1)(1993-9#1)(2007-9#1)(2009-4#1)
right and left hemispheres##4##4##(1997-6#1)(2012-1#3)
right and left lobes of the thyroid gland##2##8##(2013-1#2)
right and left lobes##3##4##(2013-1#3)
right and left side##4##4##(2005-10#4)
right and left ventricle##2##4##(2008-5#2)
right and left ventricles##5##4##(1995-6#1)(2006-5#1)(2007-8#1)(2012-1#2)
right and left ventricular##5##4##(1997-1#1)(2007-8#2)(2008-5#1)(2012-1#1)
right and left##60##3##(1990-10#2)(1991-5#1)(1992-9#1)(1993-12#1)(1993-9#1)(1995-11#1)(1995-4#2)(1995-6#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(2005-10#4)(2006-5#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-8#3)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#4)(2008-8#1)(2009-4#3)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#7)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)
right and##73##2##(1990-10#2)(1990-11#1)(1991-5#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-9#1)(1995-11#1)(1995-12#1)(1995-4#2)(1995-6#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(2005-10#4)(2005-12#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-8#3)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#1)(2009-4#4)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#7)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#5)
right angle##4##2##(1996-9#1)(2008-5#1)(2009-8#1)(2010-12#1)
right ankle##3##2##(2007-11#2)(2008-12#1)
right anterior##9##2##(1995-8#1)(2006-10#1)(2008-11#3)(2008-8#1)(2009-4#2)(2012-12#1)
right aortic sinus##3##3##(2007-8#3)
right aortic##4##2##(2007-8#4)
right arm and leg##2##4##(2010-9#2)
right arm and##4##3##(2007-10#1)(2008-5#1)(2010-9#2)
right arm##34##2##(1990-12#1)(1993-11#1)(1993-5#1)(1995-4#2)(1995-6#6)(1995-9#1)(1996-11#1)(1996-3#2)(1996-6#4)(1996-9#1)(1997-3#5)(2006-10#1)(2007-10#1)(2007-7#1)(2008-5#1)(2009-3#1)(2010-9#2)(2011-2#1)(2012-12#1)
right atria##2##2##(1990-10#2)
right atrial aneurysm##3##3##(2010-7#3)
right atrial appendage##5##3##(1997-1#2)(2007-8#2)(2012-2#1)
right atrial injections of##2##4##(1993-7#2)
right atrial mass##2##3##(2007-8#2)
right atrial myxoma##3##3##(2007-8#2)(2012-12#1)
right atrial pressure##4##3##(1995-5#1)(1997-5#1)(2007-9#1)(2008-11#1)
right atrial tunnel##2##3##(2008-4#2)
right atrial##39##2##(1990-12#2)(1990-5#1)(1993-7#2)(1994-3#1)(1995-5#1)(1997-1#2)(1997-2#1)(1997-5#1)(2006-9#1)(2007-8#13)(2007-9#1)(2008-11#1)(2008-4#3)(2010-7#4)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)
right atrium and##11##3##(1991-2#1)(2007-8#5)(2008-11#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-1#1)
right atrium in##2##3##(2007-8#1)(2010-12#1)
right atrium via##2##3##(1993-2#1)(2012-2#1)
right atrium##46##2##(1990-7#2)(1991-2#1)(1992-8#1)(1993-2#1)(1997-6#1)(2006-10#1)(2006-9#1)(2007-7#2)(2007-8#21)(2008-11#1)(2008-4#2)(2008-8#1)(2010-12#1)(2010-8#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-2#2)
right axilla##2##2##(2011-12#1)(2012-3#1)
right basal##2##2##(1996-9#1)(2007-10#1)
right brain##3##2##(1995-8#1)(1996-2#1)(2009-2#1)
right breast##10##2##(1994-12#1)(1994-7#1)(1995-4#2)(1996-3#2)(1996-6#1)(2008-10#2)(2008-2#1)
right bundle branch block and##2##5##(2007-8#1)(2008-12#1)
right bundle branch block##8##4##(2006-4#1)(2006-9#2)(2007-8#1)(2008-12#2)(2008-7#1)(2012-12#1)
right bundle branch##9##3##(1990-11#1)(2006-4#1)(2006-9#2)(2007-8#1)(2008-12#2)(2008-7#1)(2012-12#1)
right bundle##11##2##(1990-11#1)(2006-4#1)(2006-9#2)(2007-8#1)(2008-12#2)(2008-4#2)(2008-7#1)(2012-12#1)
right calf##3##2##(1991-6#1)(2007-12#1)(2009-3#1)
right cardiac##3##2##(1993-2#1)(2007-7#1)(2010-6#1)
right carotid artery##5##3##(2006-2#1)(2006-4#2)(2009-7#1)(2011-1#1)
right carotid##10##2##(1993-12#2)(1994-5#1)(2006-2#1)(2006-4#2)(2007-8#1)(2008-7#1)(2009-7#1)(2011-1#1)
right caudate##2##2##(2007-12#1)(2008-7#1)
right censored##3##2##(1992-9#1)(2010-7#2)
right central##2##2##(2008-12#1)(2010-10#1)
right cerebral##6##2##(1990-3#1)(1997-1#1)(2011-1#2)(2013-8#2)
right chest pain##2##3##(2012-2#2)
right chest##3##2##(2012-1#1)(2012-2#2)
right choice in##2##3##(1993-1#1)(2010-5#1)
right choice##7##2##(1993-1#1)(2007-11#1)(2007-8#1)(2007-9#1)(2009-5#1)(2010-5#1)(2013-1#1)
right colectomy##2##2##(2008-12#1)(2010-1#1)
right colon##8##2##(1990-4#2)(1991-6#1)(1991-7#1)(2006-7#1)(2006-8#2)(2012-2#1)
right colonic##2##2##(2006-2#2)
right common carotid##3##3##(1997-7#1)(2010-12#1)(2012-2#1)
right common iliac artery##3##4##(2005-10#1)(2006-6#1)(2007-7#1)
right common##7##2##(1991-11#1)(1997-7#1)(2005-10#1)(2006-6#1)(2007-7#1)(2010-12#1)(2012-2#1)
right coronary artery (RCA)##3##4##(2007-8#1)(2008-7#1)(2013-2#1)
right coronary artery and##3##4##(1990-3#1)(2008-4#1)(2013-8#1)
right coronary artery aneurysm##2##4##(1997-1#1)(2013-8#1)
right coronary artery from the##2##5##(2007-8#1)(2008-12#1)
right coronary artery from##3##4##(2007-8#1)(2008-12#1)(2009-8#1)
right coronary artery to##5##4##(2007-8#3)(2008-12#1)(2010-7#1)
right coronary artery##36##3##(1990-3#2)(1990-4#1)(1991-3#1)(1994-11#1)(1996-9#1)(1997-1#1)(2007-3#1)(2007-8#14)(2008-12#2)(2008-4#1)(2008-7#1)(2009-8#1)(2010-12#3)(2010-5#1)(2010-7#1)(2011-2#1)(2013-2#1)(2013-8#2)
right coronary##46##2##(1990-3#2)(1990-4#1)(1991-3#2)(1994-11#1)(1996-9#1)(1997-1#1)(2005-12#1)(2007-3#1)(2007-8#19)(2008-12#2)(2008-4#1)(2008-7#1)(2009-8#1)(2010-12#4)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-2#1)(2013-8#2)
right diaphragmatic##4##2##(1993-10#1)(2009-2#1)(2011-2#1)(2012-1#1)
right distal##2##2##(2007-12#1)(2007-9#1)
right ear##4##2##(1996-6#1)(2008-7#1)(2010-6#1)(2011-2#1)
right elbow##4##2##(2006-10#1)(2007-7#1)(2008-5#1)(2008-9#1)
right eye after##2##3##(2009-8#1)(2011-1#1)
right eye and##5##3##(2007-3#2)(2011-2#1)(2013-1#1)(2013-7#1)
right eye for the##2##4##(2011-1#1)(2013-7#1)
right eye with##2##3##(2008-7#1)(2011-2#1)
right eye##38##2##(1994-2#5)(1994-8#1)(1996-2#1)(1997-2#1)(2007-3#3)(2007-7#1)(2008-11#1)(2008-7#2)(2009-8#2)(2010-10#3)(2011-1#7)(2011-2#4)(2012-2#1)(2013-1#2)(2013-7#3)(2013-8#1)
right fallopian tube##2##3##(2011-1#1)(2013-8#1)
right femoral##7##2##(1993-12#1)(2006-10#1)(2007-7#1)(2008-12#1)(2009-4#1)(2012-1#1)(2013-8#1)
right femur##3##2##(2008-12#1)(2008-6#1)(2011-2#1)
right first##2##2##(1992-3#1)(2007-7#1)
right flank pain##2##3##(1994-10#1)(2006-9#1)
right flank##5##2##(1994-10#1)(2006-10#1)(2006-9#1)(2008-11#1)(2009-3#1)
right foot##10##2##(2005-11#1)(2006-8#1)(2007-11#1)(2008-12#1)(2008-5#1)(2009-10#1)(2010-3#1)(2012-3#1)(2013-1#2)
right for##7##2##(1992-2#1)(1993-1#1)(2007-4#1)(2007-9#2)(2013-1#1)(2013-7#1)
right forearm##3##2##(2007-7#1)(2010-6#1)(2012-3#1)
right forelimb lameness##2##3##(2012-3#1)(2013-8#1)
right forelimb##3##2##(2012-3#1)(2013-8#2)
right from the##2##3##(1997-6#1)(2009-6#1)
right frontal##9##2##(1996-2#1)(1996-5#1)(2006-3#1)(2007-10#3)(2007-12#1)(2007-4#1)(2008-7#1)
right fusiform##4##2##(2009-4#4)
right gastro-epiploic artery##2##3##(2007-8#2)
right groin##2##2##(2007-7#1)(2009-7#1)
right half of##3##3##(2007-8#1)(2009-2#1)(2012-2#1)
right half##4##2##(2007-8#1)(2008-4#1)(2009-2#1)(2012-2#1)
right hand##17##2##(1990-11#1)(1994-3#1)(1995-12#1)(1997-1#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-4#1)(2010-9#1)(2012-1#1)(2012-12#2)(2013-7#1)
right hand)##2##2##(1992-11#1)(1997-2#1)
right heart catheterization and##2##4##(2006-10#1)(2011-2#1)
right heart catheterization##5##3##(2006-10#1)(2007-12#1)(2011-2#1)(2013-1#2)
right heart dilatation##2##3##(1993-8#1)(1996-3#1)
right heart failure##10##3##(1993-8#1)(1995-6#1)(1997-4#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-3#1)(2010-10#1)(2010-5#1)(2012-12#1)
right heart##25##2##(1993-5#1)(1993-8#2)(1995-6#1)(1996-3#2)(1997-1#1)(1997-4#1)(2006-10#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-3#1)(2010-10#3)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-1#2)
right hemianopia##2##2##(1996-2#1)(2008-4#1)
right hemicolectomy was performed##3##4##(1993-9#1)(2006-7#1)(2007-9#1)
right hemicolectomy##5##2##(1990-4#1)(1993-9#1)(2006-7#1)(2007-9#1)(2013-1#1)
right hemidiaphragm##6##2##(2006-10#1)(2009-2#3)(2012-1#1)(2012-12#1)
right hemiparesis##6##2##(2007-12#1)(2007-8#1)(2008-7#2)(2010-9#1)(2013-8#1)
right hemiplegia##3##2##(1997-8#1)(2008-1#1)(2013-8#1)
right hemispace##3##2##(1997-1#2)(2009-10#1)
right hemisphere brain damage##2##4##(2012-3#2)
right hemisphere is##2##3##(2008-11#2)
right hemisphere stroke##2##3##(2008-2#2)
right hemisphere##45##2##(1990-3#5)(1991-11#1)(1991-6#1)(1993-12#2)(1993-9#5)(1995-11#2)(1996-2#4)(1996-5#3)(1997-7#1)(1997-8#3)(2005-10#1)(2007-10#2)(2007-7#2)(2007-9#1)(2008-1#2)(2008-11#2)(2008-2#2)(2009-2#2)(2010-7#1)(2012-2#1)(2012-3#2)
right hemispheric##6##2##(2007-10#4)(2007-9#1)(2008-1#1)
right hemithorax##3##2##(2007-12#1)(2009-2#1)(2010-12#1)
right hepatectomies##2##2##(1995-9#2)
right hepatic artery##5##3##(1990-3#1)(2011-12#1)(2012-2#1)(2013-1#2)
right hepatic vein##2##3##(1991-6#1)(2008-3#1)
right hepatic##11##2##(1990-3#1)(1991-6#1)(1996-9#1)(2008-3#1)(2008-5#1)(2009-2#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#2)
right hip##7##2##(2006-10#3)(2007-8#2)(2009-2#1)(2013-7#1)
right iliac fossa pain##3##4##(2008-7#1)(2010-2#2)
right iliac fossa##4##3##(2008-7#2)(2010-2#2)
right in the##6##3##(1990-11#1)(1997-5#1)(2004-12#1)(2008-4#1)(2009-5#1)(2012-12#1)
right in##12##2##(1990-11#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-11#1)(1997-5#1)(2004-12#1)(2005-12#1)(2008-4#1)(2009-5#1)(2012-12#1)
right inferior frontal##3##3##(2008-9#1)(2013-1#2)
right inferior##11##2##(1992-4#2)(1995-12#2)(2008-11#1)(2008-12#1)(2008-9#1)(2009-10#1)(2010-2#1)(2013-1#2)
right inguinal##2##2##(1997-6#1)(2011-2#1)
right internal jugular vein##3##4##(2012-12#2)(2012-3#1)
right internal jugular##5##3##(2007-7#1)(2012-12#2)(2012-3#1)(2013-8#1)
right internal mammary artery##2##4##(2006-6#1)(2007-8#1)
right internal mammary##3##3##(2006-6#1)(2007-7#1)(2007-8#1)
right internal thoracic artery (RITA) to##2##6##(2007-8#2)
right internal thoracic artery (RITA)##3##5##(2007-8#3)
right internal thoracic artery##6##4##(2007-8#6)
right internal##21##2##(1996-9#1)(2006-2#1)(2006-4#2)(2006-6#1)(2007-7#3)(2007-8#7)(2009-2#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-8#1)
right jugular vein##2##3##(1993-2#1)(2007-7#1)
right kidney and##4##3##(2008-9#1)(2011-2#1)(2012-1#2)
right kidney weights of##3##4##(2008-9#3)
right kidney weights##4##3##(2008-9#4)
right kidney##24##2##(1990-9#1)(1994-5#1)(2006-6#1)(2007-10#1)(2007-2#1)(2007-7#2)(2008-10#1)(2008-9#6)(2011-1#3)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#2)
right knee##8##2##(2006-1#1)(2006-10#2)(2006-4#1)(2007-11#1)(2008-6#1)(2012-12#1)(2013-1#1)
right lateral##4##2##(2006-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
right leg##6##2##(2006-6#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-6#1)(2012-3#1)
right liver##5##2##(1990-6#1)(2012-12#2)(2012-3#1)(2013-1#1)
right lobe and##4##3##(1990-4#1)(2008-5#1)(2009-9#1)(2011-12#1)
right lobe##18##2##(1990-4#1)(1993-6#1)(2005-12#1)(2006-2#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#1)(2011-12#1)(2012-2#2)(2013-8#1)
right lobes##2##2##(2006-10#1)(2008-11#1)
right location##2##2##(2008-5#1)(2012-2#1)
right lower leg##3##3##(2008-6#2)(2010-6#1)
right lower limb##4##3##(1992-11#1)(2007-1#1)(2010-3#1)(2011-12#1)
right lower lobe of the##2##5##(1992-2#1)(2009-5#1)
right lower lobe##8##3##(1992-2#1)(2007-12#1)(2007-8#2)(2008-4#1)(2008-5#1)(2009-5#1)(2012-2#1)
right lower lobectomy was performed##2##5##(2006-8#1)(2008-1#1)
right lower quadrant##5##3##(1991-10#1)(2005-8#1)(2006-1#1)(2010-6#1)(2013-1#1)
right lower##32##2##(1991-10#1)(1991-12#1)(1992-11#1)(1992-2#1)(2005-8#1)(2006-1#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-8#3)(2008-1#3)(2008-4#1)(2008-5#1)(2008-6#3)(2009-5#1)(2010-12#1)(2010-3#1)(2010-6#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
right lung##15##2##(1993-10#1)(2006-2#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#1)(2008-8#1)(2010-7#1)(2010-9#1)(2011-1#1)(2013-1#1)
right lungs##2##2##(1996-3#1)(2008-10#1)
right main bronchus##4##3##(1990-12#1)(2007-8#2)(2012-2#1)
right main##5##2##(1990-12#1)(2007-8#2)(2012-12#1)(2012-2#1)
right maxillary##5##2##(2011-1#2)(2012-2#2)(2013-1#1)
right median##2##2##(1997-8#1)(2010-8#1)
right method##2##2##(1996-3#1)(2007-8#1)
right middle cerebral artery##11##4##(1992-7#1)(1996-3#1)(2006-4#1)(2007-10#2)(2008-12#1)(2008-4#1)(2008-7#3)(2013-8#1)
right middle cerebral##12##3##(1992-7#1)(1996-3#1)(2006-4#1)(2007-10#2)(2008-12#1)(2008-4#1)(2008-7#4)(2013-8#1)
right middle finger##2##3##(1996-2#1)(2007-7#1)
right middle lobe##4##3##(2008-1#2)(2013-8#2)
right middle##24##2##(1992-7#1)(1996-2#1)(1996-3#2)(2006-4#1)(2007-10#2)(2007-7#1)(2008-1#3)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#4)(2013-1#2)(2013-8#3)
right nasal##5##2##(2007-7#1)(2009-9#1)(2011-1#1)(2012-2#2)
right nephrectomy for##2##3##(2008-1#1)(2008-10#1)
right nephrectomy##4##2##(2007-7#1)(2008-1#1)(2008-10#1)(2012-2#1)
right nostril##3##2##(2011-1#1)(2013-1#2)
right occipital##3##2##(2006-11#1)(2009-10#1)(2012-2#1)
right of choice&quot##2##3##(2013-7#2)
right of fixation##3##3##(2008-1#1)(2009-2#1)(2009-5#1)
right of the##5##3##(1990-12#1)(1993-10#2)(2008-4#1)(2009-2#1)
right of##15##2##(1990-12#1)(1993-10#2)(1994-12#1)(1995-12#1)(1995-9#1)(2006-3#1)(2008-1#1)(2008-4#1)(2009-2#2)(2009-5#1)(2012-2#1)(2013-7#2)
right on##2##2##(1994-12#1)(2008-1#1)
right or left##8##3##(1995-11#2)(1996-6#1)(2006-12#1)(2008-4#1)(2008-5#1)(2009-8#1)(2013-8#1)
right or##15##2##(1991-12#1)(1991-3#1)(1991-5#1)(1994-1#2)(1995-11#2)(1996-6#1)(2006-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2013-8#2)
right orbit##3##2##(2008-4#1)(2008-7#1)(2011-1#1)
right orbital##3##2##(1995-12#1)(2013-1#2)
right ovarian##3##2##(2010-9#1)(2013-8#2)
right ovary##5##2##(1991-9#1)(2008-3#2)(2011-1#1)(2013-8#1)
right panel##2##2##(1990-10#2)
right parietal cortex##2##3##(1993-7#2)
right parietal lobe##2##3##(2009-1#1)(2009-4#1)
right parietal##10##2##(1991-11#1)(1993-7#2)(2006-5#1)(2007-10#1)(2008-11#1)(2009-1#1)(2009-4#1)(2013-7#1)(2013-8#1)
right partial##2##2##(2009-6#1)(2011-2#1)
right patient##4##2##(1993-12#1)(1993-8#1)(2010-5#1)(2012-2#1)
right pelvic##3##2##(2005-10#1)(2006-10#1)(2008-6#1)
right place##4##2##(1994-2#1)(1996-3#1)(2008-11#1)(2008-2#1)
right pleural##4##2##(2008-1#1)(2011-2#1)(2012-2#2)
right pneumonectomy##2##2##(2007-8#1)(2008-1#1)
right pneumothorax##3##2##(2007-8#1)(2012-1#1)(2013-1#1)
right posterior regions##2##3##(1996-3#1)(2008-11#1)
right posterior##8##2##(1995-8#1)(1996-3#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-5#1)
right prefrontal##2##2##(1995-12#1)(2008-11#1)
right pulmonary artery##5##3##(1997-5#1)(2007-8#2)(2008-11#1)(2010-10#1)
right pulmonary##6##2##(1997-5#1)(2007-8#3)(2008-11#1)(2010-10#1)
right renal artery stenosis##2##4##(1990-2#1)(1991-10#1)
right renal artery##5##3##(1990-2#1)(1991-10#1)(1991-6#1)(2007-7#2)
right renal##7##2##(1990-2#1)(1991-10#1)(1991-6#1)(2007-7#2)(2008-1#1)(2008-10#1)
right ring finger##2##3##(2007-7#1)(2010-9#1)
right second molar##2##3##(2010-2#2)
right shift##2##2##(1997-8#2)
right shoulder##5##2##(2006-10#1)(2007-1#1)(2009-4#1)(2013-1#2)
right side of##16##3##(1996-3#1)(2005-10#1)(2007-10#1)(2007-8#1)(2008-4#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-12#2)(2013-7#1)
right side##50##2##(1991-6#1)(1992-10#1)(1995-12#1)(1996-3#1)(2005-10#1)(2006-7#1)(2007-10#2)(2007-7#2)(2007-8#5)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-2#1)(2009-6#2)(2009-9#1)(2010-4#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#3)(2013-7#2)(2013-8#2)
right sided pleural effusion##3##4##(2008-1#1)(2012-2#2)
right sided##12##2##(2007-8#3)(2008-1#1)(2010-11#1)(2011-1#1)(2012-2#5)(2013-8#1)
right sinus##2##2##(2007-8#2)
right solution##2##2##(1996-12#1)(2006-6#1)
right subclavian artery##8##3##(1991-11#2)(2006-2#1)(2007-8#2)(2008-11#2)(2010-5#1)
right subclavian##12##2##(1991-11#2)(2006-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-11#3)(2010-5#1)(2011-2#1)
right submandibular##2##2##(2009-7#1)(2013-8#1)
right superior parietal##2##3##(2008-11#1)(2013-8#1)
right superior temporal##2##3##(1996-7#1)(1997-8#1)
right superior vena cava##2##4##(2007-8#1)(2010-11#1)
right superior##13##2##(1996-7#1)(1996-9#1)(1997-8#1)(2006-7#1)(2007-8#4)(2008-11#1)(2009-1#1)(2010-11#1)(2011-2#1)(2013-8#1)
right suprarenal mass##2##3##(2011-1#2)
right suprarenal##3##2##(2011-1#3)
right system##2##2##(2007-8#1)(2011-2#1)
right temporal bone##2##3##(2008-8#1)(2009-10#1)
right temporal##12##2##(1992-12#1)(2006-10#1)(2007-12#2)(2007-3#1)(2007-9#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-7#1)(2013-8#1)
right testis##4##2##(1997-3#1)(2008-10#2)(2008-9#1)
right that##2##2##(1992-10#1)(2008-7#1)
right the##2##2##(1995-12#1)(1997-1#1)
right thigh##10##2##(1994-10#1)(2006-1#1)(2006-7#3)(2007-6#1)(2007-7#2)(2012-3#2)
right thoracic##2##2##(2007-8#1)(2010-4#1)
right thoracotomy##2##2##(2013-1#1)(2013-7#1)
right through##2##2##(2008-1#1)(2008-9#1)
right thumb##3##2##(2007-7#3)
right tibia##2##2##(2008-6#2)
right time##8##2##(1993-12#1)(1996-3#2)(2006-6#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
right to abortion##2##3##(1992-6#1)(1993-3#1)
right to be free from##2##5##(1991-6#1)(1992-1#1)
right to be##3##3##(1990-5#1)(1991-6#1)(1992-1#1)
right to choose##3##3##(1995-9#1)(1997-1#1)(2008-7#1)
right to compensation##2##3##(1991-7#1)(1996-2#1)
right to confidentiality##3##3##(1991-12#1)(1992-3#1)(2005-7#1)
right to die##10##3##(1990-12#1)(1991-11#1)(1994-2#1)(1996-11#1)(1996-3#1)(1997-6#1)(2006-4#2)(2006-9#1)(2009-4#1)
right to health##5##3##(1994-2#1)(1995-2#1)(2006-2#1)(2012-12#1)(2013-8#1)
right to healthcare##4##3##(2008-9#4)
right to know##2##3##(2007-6#1)(2013-1#1)
right to left shunt##4##4##(2007-8#2)(2009-3#1)(2013-1#1)
right to left##10##3##(2007-12#1)(2007-6#1)(2007-8#3)(2009-10#2)(2009-3#1)(2012-12#1)(2013-1#1)
right to life##7##3##(1995-12#1)(2011-2#4)(2012-11#1)(2013-1#1)
right to make##3##3##(1995-12#2)(1995-9#1)
right to privacy##5##3##(1993-9#1)(1996-12#1)(1996-9#1)(1997-5#1)(2008-12#1)
right to receive an##2##4##(2008-9#1)(2013-8#1)
right to refuse treatment##4##4##(1995-12#2)(1995-2#1)(2006-5#1)
right to refuse##7##3##(1990-11#1)(1992-12#1)(1995-12#2)(1995-2#1)(2004-12#1)(2006-5#1)
right to seek##2##3##(1990-12#1)(1997-7#1)
right to self-determination##4##3##(1991-2#2)(1997-8#2)
right to share in the##2##5##(2008-9#2)
right to##130##2##(1990-11#1)(1990-12#4)(1990-3#1)(1990-5#2)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-6#1)(1991-7#2)(1992-1#1)(1992-10#3)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-6#2)(1993-12#2)(1993-3#2)(1993-9#1)(1994-2#2)(1994-8#1)(1995-1#1)(1995-12#8)(1995-2#2)(1995-5#1)(1995-6#1)(1995-9#3)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-12#1)(2005-12#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-12#2)(2006-2#2)(2006-3#2)(2006-4#3)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#7)(2009-10#2)(2009-3#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#1)(2011-2#4)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#2)
right transradial approach##4##3##(2008-11#3)(2011-2#1)
right transverse##2##2##(1997-6#1)(2010-2#1)
right unilateral##3##2##(2010-7#1)(2012-12#1)(2012-2#1)
right up##2##2##(1990-11#1)(2008-5#1)
right upper abdominal and##2##4##(1992-2#1)(2012-2#1)
right upper extremity##3##3##(2005-1#1)(2008-12#1)(2010-9#1)
right upper lobe##10##3##(1991-11#1)(2007-11#1)(2007-12#1)(2007-8#3)(2011-2#1)(2012-1#1)(2013-1#2)
right upper lobectomy##6##3##(2007-8#5)(2012-1#1)
right upper lung##3##3##(2012-2#2)(2013-1#1)
right upper quadrant##4##3##(2005-12#1)(2010-12#1)(2013-1#2)
right upper##37##2##(1990-9#1)(1991-11#1)(1992-2#1)(1996-3#1)(2005-1#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#8)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-9#1)(2011-2#3)(2012-1#2)(2012-2#3)(2013-1#5)
right uterine adnexa region##2##4##(2007-12#2)
right uterine##3##2##(2007-12#2)(2008-3#1)
right ventricle and left ventricular subepicardium##2##6##(2008-8#2)
right ventricle and left##3##4##(2008-7#1)(2008-8#2)
right ventricle and##5##3##(2007-8#1)(2008-7#1)(2008-8#2)(2012-2#1)
right ventricle with##2##3##(2010-10#1)(2012-2#1)
right ventricle##46##2##(1994-3#2)(1995-12#1)(1997-1#2)(2005-1#2)(2007-8#13)(2008-10#5)(2008-11#1)(2008-7#4)(2008-8#2)(2009-10#1)(2009-12#1)(2009-5#1)(2010-10#1)(2011-2#3)(2012-1#1)(2012-2#4)(2012-3#1)(2013-7#1)
right ventricular cardiomyopathy##5##3##(1993-8#1)(2008-6#1)(2009-10#1)(2009-2#1)(2012-12#1)
right ventricular cavity##2##3##(1991-10#1)(2008-5#1)
right ventricular dysfunction##5##3##(1994-3#2)(1997-1#1)(2008-5#1)(2011-2#1)
right ventricular dysplasia##10##3##(1993-8#4)(1996-3#3)(2008-12#1)(2012-2#1)(2012-3#1)
right ventricular endomyocardial##2##3##(2007-8#2)
right ventricular failure##5##3##(2007-8#1)(2008-5#2)(2010-10#1)(2010-6#1)
right ventricular function in##2##4##(2007-8#1)(2011-2#1)
right ventricular function##5##3##(1994-3#1)(2007-8#2)(2009-10#1)(2011-2#1)
right ventricular infarction##2##3##(1997-3#1)(2008-4#1)
right ventricular myocardium##3##3##(1993-8#1)(2012-1#2)
right ventricular outflow tract obstruction##2##5##(2007-9#1)(2012-2#1)
right ventricular outflow tract##10##4##(1997-1#1)(2006-9#2)(2007-8#2)(2007-9#1)(2008-4#1)(2012-1#1)(2012-2#1)(2013-2#1)
right ventricular pressure##2##3##(1993-3#1)(2007-8#1)
right ventricular systolic##3##3##(2007-8#1)(2007-9#2)
right ventricular weight ratio##2##4##(1993-3#1)(2005-9#1)
right ventricular##95##2##(1990-11#1)(1991-10#1)(1992-5#1)(1993-12#1)(1993-3#4)(1993-8#7)(1994-3#4)(1996-11#1)(1996-3#3)(1997-1#2)(1997-3#2)(2005-9#3)(2006-9#9)(2007-8#12)(2007-9#4)(2008-12#1)(2008-3#2)(2008-4#5)(2008-5#5)(2008-6#1)(2009-10#4)(2009-2#2)(2010-10#2)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-1#5)(2012-12#2)(2012-2#2)(2012-3#1)(2013-2#1)
right vertebral artery dissection##2##4##(1991-8#1)(2013-8#1)
right vertebral artery##5##3##(1991-8#1)(2012-1#2)(2013-8#2)
right vertebral##6##2##(1991-8#1)(2012-1#2)(2013-8#3)
right visual field##4##3##(1996-2#2)(2008-4#2)
right visual##5##2##(1996-2#2)(1996-3#1)(2008-4#2)
right vocal cord##2##3##(2009-10#1)(2012-2#1)
right wing##2##2##(2010-3#1)(2013-8#1)
right with##4##2##(1990-5#1)(1994-11#1)(2006-5#1)(2008-11#1)
right wrist##4##2##(2006-10#1)(2008-6#1)(2011-2#1)(2013-8#1)
right##1983##1##(1990-10#7)(1990-11#10)(1990-12#9)(1990-2#3)(1990-3#11)(1990-4#6)(1990-5#7)(1990-6#4)(1990-7#2)(1990-8#2)(1990-9#6)(1991-1#4)(1991-10#5)(1991-11#10)(1991-12#3)(1991-2#6)(1991-3#3)(1991-5#4)(1991-6#8)(1991-7#3)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#5)(1992-11#4)(1992-12#2)(1992-2#9)(1992-3#4)(1992-4#4)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#3)(1993-1#4)(1993-10#7)(1993-11#3)(1993-12#17)(1993-2#4)(1993-3#9)(1993-4#1)(1993-5#3)(1993-6#1)(1993-7#4)(1993-8#11)(1993-9#10)(1994-1#3)(1994-10#2)(1994-11#2)(1994-12#8)(1994-2#13)(1994-3#8)(1994-5#3)(1994-7#1)(1994-8#5)(1995-1#5)(1995-11#7)(1995-12#26)(1995-2#3)(1995-3#2)(1995-4#8)(1995-5#2)(1995-6#13)(1995-7#1)(1995-8#5)(1995-9#7)(1996-1#1)(1996-10#2)(1996-11#5)(1996-12#4)(1996-2#18)(1996-3#25)(1996-5#8)(1996-6#8)(1996-7#1)(1996-8#1)(1996-9#15)(1997-1#17)(1997-2#6)(1997-3#12)(1997-4#1)(1997-5#8)(1997-6#8)(1997-7#4)(1997-8#12)(2004-11#2)(2004-12#2)(2005-1#3)(2005-10#10)(2005-11#3)(2005-12#6)(2005-7#2)(2005-8#1)(2005-9#7)(2006-1#5)(2006-10#32)(2006-11#2)(2006-12#8)(2006-2#13)(2006-3#5)(2006-4#13)(2006-5#5)(2006-6#10)(2006-7#8)(2006-8#9)(2006-9#19)(2007-1#5)(2007-10#28)(2007-11#7)(2007-12#29)(2007-2#6)(2007-3#7)(2007-4#10)(2007-5#1)(2007-6#4)(2007-7#45)(2007-8#174)(2007-9#19)(2008-1#27)(2008-10#28)(2008-11#50)(2008-12#28)(2008-2#7)(2008-3#15)(2008-4#38)(2008-5#44)(2008-6#15)(2008-7#44)(2008-8#14)(2008-9#27)(2009-1#6)(2009-10#15)(2009-11#1)(2009-12#2)(2009-2#26)(2009-3#8)(2009-4#16)(2009-5#8)(2009-6#8)(2009-7#6)(2009-8#8)(2009-9#6)(2010-1#2)(2010-10#13)(2010-11#4)(2010-12#21)(2010-2#15)(2010-3#6)(2010-4#5)(2010-5#7)(2010-6#11)(2010-7#18)(2010-8#5)(2010-9#12)(2011-1#35)(2011-12#6)(2011-2#69)(2012-1#31)(2012-11#1)(2012-12#45)(2012-2#66)(2012-3#26)(2012-7#1)(2013-1#60)(2013-2#4)(2013-7#21)(2013-8#44)
right&quot##13##1##(1993-2#1)(1993-3#2)(1994-2#4)(1995-1#1)(1995-2#1)(1995-3#1)(1996-12#1)(2006-2#1)(2007-2#1)
right'##2##1##(1990-2#1)(2012-12#1)
right)##2##1##(2006-2#1)(2008-10#1)
right- and left-handed##3##3##(1991-5#1)(1995-6#1)(2007-11#1)
right- and##5##2##(1991-5#2)(1995-6#1)(2007-11#1)(2008-3#1)
right- or##2##2##(1995-11#1)(2008-7#1)
right-##9##1##(1991-5#2)(1995-11#1)(1995-6#1)(2007-11#1)(2008-3#1)(2008-4#2)(2008-7#1)
right-angle prism##2##2##(2008-2#2)
right-angle scattering##2##2##(2006-4#1)(2008-3#1)
right-angle##7##1##(2006-4#1)(2008-2#3)(2008-3#2)(2008-9#1)
right-brain-damaged patients##2##2##(2009-10#2)
right-circular##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
right-hand##5##1##(1991-10#1)(1992-2#1)(2007-12#1)(2008-10#1)(2008-3#1)
right-handed conformation##2##2##(2006-10#2)
right-handed form##5##2##(2006-10#5)
right-handed healthy##2##2##(1995-12#1)(2011-2#1)
right-handed helical##3##2##(2008-7#2)(2011-12#1)
right-handed##44##1##(1990-2#1)(1991-5#3)(1992-12#3)(1992-2#1)(1993-3#1)(1993-6#1)(1993-9#3)(1994-3#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-7#1)(1996-2#2)(1996-8#1)(1997-2#1)(2006-10#9)(2006-12#1)(2006-4#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
right-handedness##3##1##(1995-11#1)(2007-12#2)
right-heart##2##1##(2007-8#2)
right-hemisphere initiation mechanisms##2##3##(2007-7#2)
right-hemisphere##4##1##(2007-7#2)(2008-11#2)
right-left##4##1##(1996-9#1)(2007-1#2)(2008-3#1)
right-pawed##2##1##(1997-2#2)
right-side##10##1##(1992-2#1)(2006-11#1)(2007-8#3)(2008-4#3)(2013-7#2)
right-side-out##2##1##(1990-11#1)(2008-5#1)
right-sided abdominal##2##2##(1993-9#1)(2008-6#1)
right-sided chest##2##2##(1997-8#1)(2009-6#1)
right-sided endocarditis##2##2##(1997-2#1)(2008-5#1)
right-sided facial pain##2##3##(2011-2#1)(2012-12#1)
right-sided facial##4##2##(2008-7#1)(2011-2#2)(2012-12#1)
right-sided hearing loss##2##3##(2005-5#1)(2010-2#1)
right-sided hemiparesis##2##2##(2006-12#1)(2013-8#1)
right-sided weakness##3##2##(1995-6#1)(2006-12#1)(2012-2#1)
right-sided##52##1##(1990-11#1)(1990-3#1)(1990-5#1)(1991-11#1)(1991-3#1)(1993-9#1)(1995-6#1)(1996-1#1)(1996-9#1)(1997-2#1)(1997-8#1)(2005-5#1)(2006-1#1)(2006-10#1)(2006-12#2)(2006-5#1)(2006-8#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-6#1)(2010-2#1)(2010-7#2)(2011-1#1)(2011-2#10)(2012-1#1)(2012-12#1)(2012-2#1)(2012-8#1)(2013-1#2)(2013-8#1)
right-to-left shunt##2##2##(2010-5#1)(2011-2#1)
right-to-left##4##1##(1990-11#1)(1994-7#1)(2010-5#1)(2011-2#1)
right-ventricular function and pulmonary perfusion##2##5##(1993-2#2)
right-ventricular##6##1##(1993-2#6)
right-wing##2##1##(2008-11#1)(2008-7#1)
right?##5##1##(1991-8#1)(1997-3#1)(2008-11#1)(2011-2#1)(2012-3#1)
rightful##3##1##(1996-1#1)(2007-5#1)(2010-9#1)
righting modes##2##2##(2007-12#2)
righting reflexes##3##2##(1994-10#1)(2008-4#1)(2009-4#1)
righting response##2##2##(1995-12#2)
righting##21##1##(1991-4#2)(1992-11#2)(1992-12#2)(1993-12#1)(1993-9#1)(1994-10#1)(1995-10#1)(1995-12#2)(2007-12#6)(2007-2#1)(2008-4#1)(2009-4#1)
rightly##7##1##(1997-1#1)(2008-1#1)(2008-7#2)(2009-9#1)(2010-12#1)(2013-1#1)
rights activists##3##2##(2012-3#3)
rights and a##2##3##(2011-2#1)(2012-3#1)
rights and benefits##2##3##(2005-11#2)
rights and duties##4##3##(1996-8#1)(2005-7#3)
rights and obligations##2##3##(2005-5#2)
rights and responsibilities##4##3##(1994-3#1)(2009-10#1)(2010-5#1)(2012-3#1)
rights and the##3##3##(2008-12#1)(2012-11#1)(2012-3#1)
rights and##44##2##(1990-12#1)(1990-6#2)(1994-3#1)(1995-9#2)(1996-7#1)(1996-8#1)(2005-11#2)(2005-12#1)(2005-5#2)(2005-7#3)(2007-10#2)(2007-11#1)(2007-12#1)(2007-5#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#2)(2009-10#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-11#1)(2012-3#9)(2013-8#1)
rights approach to##3##3##(2006-3#1)(2013-1#2)
rights are##5##2##(2007-10#1)(2008-2#2)(2012-3#2)
rights as##3##2##(2005-7#1)(2007-4#1)(2012-3#1)
rights by##2##2##(1991-10#1)(1997-7#1)
rights claiming##2##2##(2012-3#2)
rights for##7##2##(1992-12#1)(2005-8#1)(2007-9#1)(2008-12#1)(2008-5#1)(2012-3#2)
rights groups##2##2##(2007-9#1)(2012-2#1)
rights has##2##2##(1991-3#1)(2012-3#1)
rights in African##3##3##(2012-3#3)
rights in Brazil##2##3##(2010-7#2)
rights in the##6##3##(1997-8#1)(2005-11#1)(2006-2#2)(2009-4#1)(2012-3#1)
rights in##28##2##(1990-5#1)(1992-2#1)(1994-3#1)(1997-8#2)(2004-12#1)(2005-11#1)(2006-2#2)(2006-3#1)(2007-4#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-7#2)(2012-1#1)(2012-3#9)(2013-8#1)
rights is##2##2##(1990-5#1)(1995-11#1)
rights issues##5##2##(1995-9#1)(2006-4#1)(2012-3#2)(2013-8#1)
rights law##2##2##(1995-12#1)(2012-3#1)
rights of mother and fetus##2##5##(1990-12#2)
rights of the##3##3##(2005-8#2)(2009-4#1)
rights of women##2##3##(1995-9#1)(2008-11#1)
rights of##26##2##(1990-12#2)(1991-10#2)(1995-6#1)(1995-9#1)(1996-5#1)(1996-6#1)(1997-5#1)(2005-7#1)(2005-8#2)(2006-3#1)(2008-11#1)(2008-2#2)(2008-7#3)(2009-11#1)(2009-4#1)(2010-3#1)(2010-9#2)(2012-3#2)
rights over##2##2##(1997-8#1)(2012-3#1)
rights than##2##2##(1992-12#1)(2006-7#1)
rights to the##2##3##(2007-11#1)(2008-5#1)
rights to##27##2##(1990-12#1)(1990-5#1)(1991-6#1)(1994-8#1)(1997-8#2)(2005-6#1)(2005-7#2)(2005-8#5)(2005-9#1)(2007-11#1)(2008-11#1)(2008-5#4)(2008-7#1)(2008-9#3)(2009-7#1)(2012-3#1)
rights under the##2##3##(1991-10#1)(1991-6#1)
rights were##3##2##(2005-8#1)(2013-8#2)
rights##299##1##(1990-11#1)(1990-12#5)(1990-2#1)(1990-5#3)(1990-6#3)(1990-7#1)(1990-8#2)(1991-10#4)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-6#2)(1991-8#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-6#3)(1995-9#9)(1996-1#2)(1996-11#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-5#1)(1997-7#1)(1997-8#5)(2004-12#1)(2005-11#4)(2005-12#1)(2005-5#2)(2005-6#1)(2005-7#13)(2005-8#11)(2005-9#1)(2006-10#1)(2006-2#4)(2006-3#3)(2006-4#1)(2006-5#2)(2006-7#2)(2006-8#2)(2007-10#3)(2007-11#4)(2007-12#1)(2007-4#2)(2007-5#5)(2007-7#1)(2007-9#3)(2008-1#1)(2008-10#3)(2008-11#8)(2008-12#3)(2008-2#8)(2008-5#6)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#9)(2009-10#1)(2009-11#1)(2009-4#4)(2009-7#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#3)(2010-8#1)(2010-9#4)(2011-1#1)(2011-2#6)(2012-1#1)(2012-11#2)(2012-2#3)(2012-3#66)(2013-1#3)(2013-8#9)
rights&quot##2##1##(2008-2#1)(2012-3#1)
rights-based##3##1##(2006-10#1)(2008-11#1)(2012-3#1)
rights]##2##1##(1992-8#1)(1995-9#1)
rightsizing##4##1##(1993-1#2)(2010-8#2)
rightward bisection error##2##3##(2009-10#2)
rightward shift of the##5##4##(1990-10#1)(1990-7#1)(1996-12#2)(2006-2#1)
rightward shift##7##2##(1990-10#1)(1990-7#1)(1995-12#1)(1996-12#3)(2006-2#1)
rightward##18##1##(1990-10#1)(1990-5#1)(1990-7#1)(1994-8#1)(1995-12#3)(1996-12#3)(2006-2#1)(2007-8#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#2)
rightward)##2##1##(1993-12#1)(2009-2#1)
rigid and nonrigid##2##3##(1991-8#1)(2008-2#1)
rigid and padded##2##3##(2006-11#1)(2007-4#1)
rigid and stable##2##3##(2008-10#2)
rigid and##14##2##(1991-8#1)(1992-1#1)(1992-6#1)(2006-11#1)(2007-1#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2012-12#2)
rigid bodies##3##2##(1992-9#1)(2007-12#1)(2007-4#1)
rigid body##5##2##(1993-3#1)(1995-3#1)(2008-3#1)(2009-10#2)
rigid bronchoscope##3##2##(2007-8#2)(2007-9#1)
rigid bronchoscopy for##2##3##(2007-9#2)
rigid bronchoscopy##7##2##(2007-8#3)(2007-9#2)(2012-3#1)(2013-1#1)
rigid disk drives##2##3##(2008-2#2)
rigid endoscope##4##2##(2007-1#1)(2008-3#1)(2008-5#2)
rigid endoscopes##6##2##(2006-11#1)(2006-6#3)(2011-1#2)
rigid fixation of##2##3##(2006-3#1)(2007-8#1)
rigid fixation##5##2##(2006-3#3)(2007-8#1)(2012-12#1)
rigid flat##2##2##(2005-11#1)(2008-7#1)
rigid laparoscopic cameras and a single incision laparoscopic surgery trocar##2##10##(2012-12#2)
rigid part##3##2##(1994-8#2)(2012-2#1)
rigid phase##2##2##(1990-3#1)(2009-10#1)
rigid portion##2##2##(2008-5#2)
rigid probe##5##2##(2005-11#1)(2007-10#4)
rigid protein##2##2##(1992-4#1)(2008-4#1)
rigid rectangular##2##2##(2007-1#1)(2009-9#1)
rigid registration##2##2##(2007-5#1)(2009-12#1)
rigid sagittal deformity##2##3##(2008-8#2)
rigid structure of##2##3##(1994-3#1)(2008-12#1)
rigid structure##4##2##(1990-7#1)(1993-4#1)(1994-3#1)(2008-12#1)
rigid than##3##2##(1990-4#1)(2005-11#1)(2009-10#1)
rigid thoracoscopy##2##2##(2012-12#2)
rigid to##3##2##(2007-12#1)(2007-8#1)(2009-7#1)
rigid##204##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-2#2)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#3)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-6#1)(2005-11#10)(2005-5#1)(2005-8#1)(2006-10#5)(2006-11#10)(2006-12#1)(2006-2#1)(2006-3#3)(2006-6#3)(2006-7#2)(2006-8#2)(2007-1#3)(2007-10#5)(2007-11#2)(2007-12#5)(2007-4#12)(2007-5#2)(2007-7#1)(2007-8#12)(2007-9#4)(2008-1#4)(2008-10#8)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#4)(2008-8#3)(2009-10#6)(2009-12#2)(2009-4#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#2)(2011-1#3)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#10)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
rigid&quot##2##1##(2009-12#2)
rigid-bar##5##1##(2007-4#5)
rigid-body##2##1##(2008-2#1)(2012-1#1)
rigidity across relationships##2##3##(2009-7#2)
rigidity and bradykinesia##2##3##(2008-11#1)(2008-7#1)
rigidity and##16##2##(1991-11#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#2)(2009-11#2)(2009-12#1)(2011-2#1)(2012-3#1)(2013-8#3)
rigidity in##6##2##(1991-3#3)(1994-9#1)(2005-8#1)(2008-12#1)
rigidity of the##14##3##(1991-7#1)(1994-9#1)(1995-1#3)(1995-8#1)(2005-11#2)(2006-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2009-4#1)
rigidity of##22##2##(1991-3#1)(1991-7#1)(1994-9#1)(1995-1#3)(1995-2#1)(1995-8#1)(2005-11#2)(2006-12#1)(2006-6#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#3)(2009-4#1)(2013-1#1)
rigidity with##2##2##(1994-9#1)(2011-2#1)
rigidity##95##1##(1991-11#1)(1991-3#10)(1991-7#1)(1993-11#1)(1994-9#4)(1995-1#3)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#2)(1995-9#1)(1996-8#1)(2005-11#3)(2005-8#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-10#6)(2008-11#5)(2008-12#9)(2008-3#1)(2008-5#1)(2008-7#7)(2009-10#1)(2009-11#4)(2009-12#2)(2009-4#4)(2009-7#4)(2009-9#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#4)
rigidly##7##1##(1997-7#1)(2004-9#1)(2005-11#1)(2006-11#1)(2007-5#1)(2008-5#1)(2009-5#1)
rigidus##4##1##(2010-3#2)(2012-2#1)(2012-3#1)
rigor and AMPPNP##2##3##(1996-11#2)
rigor and##4##2##(1996-11#3)(2009-8#1)
rigor crossbridges##2##2##(1996-11#2)
rigor fibers##2##2##(1994-11#1)(1996-11#1)
rigor mortis by##2##3##(1996-5#2)
rigor mortis##5##2##(1996-5#4)(2011-2#1)
rigor to##2##2##(1996-11#1)(2008-8#1)
rigor##45##1##(1992-12#1)(1994-11#3)(1994-5#1)(1995-6#5)(1996-11#21)(1996-2#2)(1996-5#4)(1997-4#1)(2008-5#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-12#1)
rigor-like and##2##2##(1995-6#1)(1996-11#1)
rigor-like##3##1##(1995-6#2)(1996-11#1)
rigorous analysis of##2##3##(2006-10#1)(2007-2#1)
rigorous analysis##3##2##(2006-10#1)(2007-2#1)(2010-4#1)
rigorous and##6##2##(1992-1#1)(1992-2#1)(2008-8#2)(2012-12#1)(2012-2#1)
rigorous approach to##2##3##(2007-6#1)(2012-3#1)
rigorous approach##4##2##(2007-6#1)(2008-3#2)(2012-3#1)
rigorous boundary-element method and##2##4##(2008-2#2)
rigorous calculations##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
rigorous coupled-wave analysis##7##3##(2007-12#1)(2008-2#5)(2008-3#1)
rigorous criteria##2##2##(1992-9#1)(2007-9#1)
rigorous design to##2##3##(2010-5#1)(2011-2#1)
rigorous determination of the##2##4##(1990-3#1)(1990-7#1)
rigorous diffraction##2##2##(2007-12#1)(2008-3#1)
rigorous electromagnetic##8##2##(2007-12#2)(2008-2#2)(2008-3#4)
rigorous evaluation of##4##3##(1991-11#1)(1995-2#1)(2005-11#1)(2008-3#1)
rigorous evaluation##5##2##(1991-11#1)(1995-2#1)(2005-11#1)(2007-9#1)(2008-3#1)
rigorous investigation##2##2##(2010-2#1)(2011-2#1)
rigorous method##2##2##(2008-3#1)(2009-5#1)
rigorous methodology are##2##3##(2008-10#2)
rigorous methods##3##2##(2008-10#1)(2008-6#1)(2011-2#1)
rigorous numerical calculations##2##3##(2007-11#1)(2007-12#1)
rigorous numerical simulations##2##3##(2007-12#1)(2008-3#1)
rigorous numerical##5##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
rigorous quantitative##2##2##(2009-9#1)(2010-5#1)
rigorous radiative transfer##2##3##(2008-3#2)
rigorous research##4##2##(2007-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
rigorous screening##2##2##(2007-11#1)(2011-2#1)
rigorous selection##3##2##(1993-10#1)(1993-12#1)(2012-2#1)
rigorous solution for transient propagation of electromagnetic waves through a medium##2##11##(2007-12#2)
rigorous solution##3##2##(2007-12#2)(2008-2#1)
rigorous statistical##4##2##(2008-2#2)(2008-3#1)(2012-2#1)
rigorous studies##2##2##(2006-5#1)(2008-3#1)
rigorous study of##2##3##(2007-11#1)(2008-10#1)
rigorous study##4##2##(2007-11#1)(2008-10#1)(2012-3#2)
rigorous theoretical analysis##2##3##(1993-6#1)(2010-2#1)
rigorous theoretical##4##2##(1993-6#1)(2007-3#1)(2008-3#1)(2010-2#1)
rigorous theory##2##2##(2008-3#1)(2008-8#1)
rigorous trials##2##2##(1997-1#1)(2013-8#1)
rigorous use of##2##3##(1993-3#1)(2009-4#1)
rigorous##177##1##(1990-3#1)(1990-7#1)(1990-9#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#1)(1995-10#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(2005-11#1)(2006-10#4)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#2)(2007-11#7)(2007-12#11)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#22)(2008-3#28)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#4)(2010-2#2)(2010-4#1)(2010-5#4)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#6)(2012-3#4)(2013-1#4)(2013-8#1)
rigorously and##2##2##(1994-4#1)(2006-10#1)
rigorously characterized##2##2##(1997-1#1)(2009-7#1)
rigorously controlled##2##2##(2008-10#1)(2013-1#1)
rigorously examined##2##2##(2006-10#1)(2010-7#1)
rigorously tested##2##2##(1995-8#1)(2008-1#1)
rigorously##38##1##(1991-8#1)(1992-4#1)(1994-4#1)(1995-8#1)(1996-3#2)(1997-1#1)(1997-3#1)(2005-11#1)(2006-10#2)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#4)(2008-7#2)(2008-8#2)(2009-7#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#3)
rigorousness##2##1##(2007-12#1)(2007-2#1)
rigors and##3##2##(1995-12#1)(1997-2#1)(2007-12#1)
rigors##8##1##(1990-10#1)(1995-12#1)(1997-2#1)(2005-9#1)(2007-12#2)(2007-7#1)(2008-1#1)
rigour of##2##2##(2005-7#1)(2008-11#1)
rigour##6##1##(2005-7#1)(2008-11#2)(2008-7#1)(2011-1#1)(2012-3#1)
riluzole##11##1##(1996-1#6)(2008-7#1)(2011-12#4)
rim and##3##2##(2005-11#1)(2007-10#1)(2013-7#1)
rim fracture##2##2##(2006-12#1)(2010-7#1)
rim is##2##2##(1993-10#1)(2013-7#1)
rim of the##7##3##(1990-3#1)(1994-11#1)(1996-5#1)(1996-9#1)(1997-1#1)(2006-11#1)(2008-8#1)
rim of##9##2##(1990-3#1)(1991-9#1)(1994-11#1)(1996-5#1)(1996-9#1)(1997-1#1)(2006-11#1)(2008-6#1)(2008-8#1)
rim##46##1##(1990-3#1)(1991-9#1)(1993-10#1)(1994-11#1)(1996-5#3)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#2)(2005-11#1)(2006-11#2)(2006-12#5)(2007-10#3)(2007-12#3)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-8#2)(2009-3#1)(2010-12#2)(2010-7#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-7#4)
rimalkalim##8##1##(1997-7#8)
rimantadine##2##1##(2005-7#1)(2011-1#1)
rimmed vacuoles##3##2##(2008-7#1)(2010-12#2)
rimmed##5##1##(2008-7#1)(2009-7#1)(2010-12#3)
rimosus##2##1##(1993-9#1)(2008-4#1)
rims##7##1##(1991-2#1)(1995-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)
rind##4##1##(2008-10#2)(2008-11#1)(2009-5#1)
rinderpest##7##1##(1990-3#4)(1992-8#1)(2011-2#2)
ring A##3##2##(1994-5#1)(2007-11#2)
ring N-atoms##2##2##(2006-12#2)
ring Nd##2##2##(2008-2#2)
ring adopts a##2##3##(1995-1#1)(2004-7#1)
ring analogues and derivatives of##2##5##(1993-1#2)
ring and a##4##3##(1997-4#1)(2007-11#1)(2007-12#1)(2010-12#1)
ring and the##5##3##(1991-9#1)(1995-8#1)(1996-8#1)(2010-2#1)(2013-8#1)
ring and##28##2##(1990-7#1)(1991-4#1)(1991-9#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-6#1)(1995-8#1)(1996-8#1)(1997-4#3)(2005-11#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#3)(2009-3#1)(2010-12#1)(2010-2#1)(2011-1#1)(2013-1#2)(2013-8#1)
ring annulation with hydrazine##3##4##(1997-2#3)
ring annuloplasty##2##2##(2008-10#2)
ring arcs##3##2##(1991-8#3)
ring are reported##2##3##(1996-2#1)(2007-11#1)
ring are##5##2##(1990-8#1)(1991-2#1)(1996-2#1)(2007-11#2)
ring around##2##2##(2007-11#1)(2007-12#1)
ring as a##3##3##(1994-9#1)(2006-5#1)(2008-1#1)
ring as##6##2##(1994-9#1)(2006-5#1)(2008-1#1)(2008-10#2)(2012-2#1)
ring at the##2##3##(1992-6#1)(2007-8#1)
ring at##3##2##(1992-6#1)(1996-7#1)(2007-8#1)
ring by##2##2##(1994-9#1)(2007-11#1)
ring can be##2##3##(2008-3#1)(2010-12#1)
ring can##3##2##(2008-3#2)(2010-12#1)
ring cavity##24##2##(2007-11#4)(2007-12#12)(2008-1#1)(2008-2#2)(2008-3#5)
ring cell##5##2##(1993-12#3)(2008-10#2)
ring cells##3##2##(2012-2#3)
ring closing metathesis reaction##2##4##(2007-11#1)(2009-10#1)
ring closure of##2##3##(2007-11#2)
ring closure reaction##2##3##(1997-3#1)(2007-11#1)
ring closure##12##2##(1995-3#4)(1997-3#1)(2007-11#6)(2011-1#1)
ring configuration##3##2##(1997-3#1)(2008-2#1)(2008-3#1)
ring conformations of##2##3##(1991-5#1)(1991-8#1)
ring conformations##3##2##(1991-5#1)(1991-8#1)(2008-5#1)
ring considerably##2##2##(2008-10#1)(2008-3#1)
ring contraction##5##2##(2007-10#3)(2007-11#2)
ring could##2##2##(2007-11#1)(2010-3#1)
ring doping##2##2##(2007-12#2)
ring electrode##2##2##(2008-3#1)(2008-5#1)
ring electrodes##5##2##(2005-11#1)(2007-12#2)(2008-10#2)
ring enhancement##3##2##(1993-5#1)(2011-2#1)(2012-2#1)
ring enhancing lesions##2##3##(1991-6#1)(2011-1#1)
ring expansion##2##2##(2008-5#1)(2009-5#1)
ring finger##5##2##(2006-8#1)(2007-7#1)(2008-9#1)(2010-9#2)
ring for##2##2##(2006-5#1)(2007-8#1)
ring formation##6##2##(1992-3#1)(1992-9#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)
ring from##4##2##(1992-4#1)(2008-8#1)(2009-10#1)(2010-7#1)
ring has##2##2##(2005-4#1)(2008-9#1)
ring have a##2##3##(1996-2#1)(2010-11#1)
ring have been##2##3##(1996-8#1)(1997-4#1)
ring have##4##2##(1996-2#1)(1996-8#1)(1997-4#1)(2010-11#1)
ring in the##5##3##(1990-3#1)(1991-3#1)(1995-11#1)(1997-2#1)(2008-8#1)
ring in##15##2##(1990-3#1)(1991-11#1)(1991-3#1)(1991-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-5#1)(1997-2#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-8#1)(2013-7#1)
ring is a##2##3##(2006-10#1)(2013-1#1)
ring is also##2##3##(2009-9#1)(2010-12#1)
ring is similar##2##3##(1991-2#1)(1994-5#1)
ring is##22##2##(1991-2#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-2#1)(1996-8#1)(2006-10#1)(2006-12#1)(2006-5#2)(2007-12#1)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-6#1)(2012-2#1)(2013-1#1)
ring junction##2##2##(2006-12#2)
ring laser as##2##3##(2007-12#1)(2008-1#1)
ring laser gyroscope##3##3##(2008-2#2)(2008-3#1)
ring laser gyroscopes##2##3##(2008-3#2)
ring laser is##3##3##(2007-11#2)(2008-2#1)
ring laser that##2##3##(2007-12#2)
ring laser to##2##3##(2007-12#1)(2008-2#1)
ring laser was##2##3##(2007-12#1)(2008-3#1)
ring laser with a superluminescent diode##2##6##(2008-2#2)
ring laser with a##3##4##(2007-12#1)(2008-2#2)
ring laser##40##2##(2007-11#9)(2007-12#15)(2008-1#1)(2008-2#8)(2008-3#7)
ring lasers##6##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)
ring macrolides##4##2##(2005-7#3)(2006-11#1)
ring moiety##2##2##(1994-12#1)(1997-3#1)
ring nematodes##2##2##(2008-10#2)
ring network##2##2##(2007-11#1)(2008-3#1)
ring nitrogen##3##2##(1993-1#1)(1995-3#1)(2008-5#1)
ring of ATP##2##3##(1996-5#1)(2008-10#1)
ring of the cofactor##2##4##(1990-4#1)(1990-7#1)
ring of the##20##3##(1990-4#2)(1990-7#1)(1991-12#1)(1991-4#1)(1992-1#1)(1993-11#1)(1993-6#1)(1994-5#1)(1995-6#1)(1996-7#1)(1997-8#1)(2006-5#1)(2008-10#3)(2008-6#1)(2010-2#1)(2012-12#2)
ring of##57##2##(1990-4#2)(1990-7#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-1#1)(1992-12#2)(1992-3#1)(1993-11#1)(1993-3#1)(1993-6#2)(1994-2#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-2#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-5#1)(1997-8#1)(2005-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#1)(2010-2#1)(2010-9#1)(2012-12#3)
ring on the##2##3##(2008-10#1)(2008-9#1)
ring on##3##2##(1991-5#1)(2008-10#1)(2008-9#1)
ring opening to##2##3##(2007-12#1)(2012-12#1)
ring opening##8##2##(1994-5#1)(1995-2#1)(2007-11#2)(2007-12#1)(2008-8#2)(2012-12#1)
ring optical parametric oscillator##3##4##(2007-11#3)
ring optical##5##2##(2007-11#4)(2008-2#1)
ring or the##2##3##(1991-2#1)(1995-3#1)
ring or##5##2##(1991-2#1)(1992-11#1)(1992-6#1)(1995-3#1)(2007-12#1)
ring oscillator for sub-10-fs pulse generation&quot##2##6##(2008-1#2)
ring oscillator##4##2##(2007-12#2)(2008-1#2)
ring patterns##4##2##(2007-12#1)(2008-2#3)
ring region##2##2##(1991-8#1)(2006-10#1)
ring resonance##2##2##(2009-5#1)(2011-1#1)
ring resonator filter##2##3##(2008-3#2)
ring resonator for##2##3##(2007-12#1)(2011-1#1)
ring resonator with##3##3##(2008-3#2)(2011-1#1)
ring resonator##18##2##(2007-11#4)(2007-12#4)(2008-3#7)(2011-1#3)
ring resonators##4##2##(2007-12#2)(2008-3#2)
ring self-pumped phase-conjugate mirror##2##4##(2007-12#2)
ring shaped##2##2##(2011-1#1)(2011-12#1)
ring sinus##4##2##(2011-2#4)
ring size##6##2##(1995-1#1)(1996-8#3)(2007-11#2)
ring sizes##2##2##(1995-8#1)(2008-5#1)
ring spots##2##2##(2008-10#2)
ring stages##2##2##(2010-12#2)
ring structure of##2##3##(2009-10#2)
ring structure##12##2##(1990-7#1)(1991-6#1)(1994-5#1)(1997-3#1)(2007-8#1)(2008-10#3)(2008-3#1)(2009-10#2)(2013-8#1)
ring structures##5##2##(1995-3#1)(2007-12#2)(2008-11#1)(2008-7#1)
ring study##2##2##(2008-10#2)
ring substitution##3##2##(1995-4#1)(2007-1#1)(2013-7#1)
ring system and the##2##4##(1993-12#2)
ring system and##3##3##(1993-12#3)
ring system of##3##3##(1994-8#1)(1995-2#1)(2008-7#1)
ring system##26##2##(1991-3#1)(1993-12#5)(1994-8#1)(1995-1#1)(1995-2#1)(1996-8#2)(1997-2#1)(2006-12#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#1)(2009-9#3)(2010-2#2)(2012-11#2)(2013-8#1)
ring systems##4##2##(1991-10#1)(2006-9#1)(2007-11#1)(2009-5#1)
ring that##3##2##(1994-9#1)(2008-3#2)
ring to a##3##3##(1991-2#1)(1995-3#1)(2012-2#1)
ring to be##2##3##(2007-11#1)(2008-11#1)
ring to the##2##3##(1991-3#1)(1995-1#1)
ring to##14##2##(1990-12#1)(1991-2#1)(1991-3#1)(1994-11#1)(1995-1#2)(1995-2#1)(1995-3#1)(2007-11#2)(2007-9#1)(2008-11#1)(2008-6#1)(2012-2#1)
ring transformations##2##2##(2007-11#2)
ring was observed##2##3##(1996-6#1)(2007-12#1)
ring was##9##2##(1992-8#1)(1996-10#1)(1996-6#1)(1997-8#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-6#1)(2009-8#1)
ring were##4##2##(1992-10#1)(2007-10#1)(2008-11#1)(2009-9#1)
ring which##2##2##(2010-5#1)(2011-1#1)
ring with##6##2##(1992-1#1)(1994-9#1)(1995-10#1)(2006-4#1)(2008-10#1)(2008-3#1)
ring##790##1##(1990-10#1)(1990-12#2)(1990-3#3)(1990-4#3)(1990-5#1)(1990-7#4)(1990-8#1)(1990-9#4)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#8)(1991-3#3)(1991-4#6)(1991-5#4)(1991-6#2)(1991-8#7)(1991-9#2)(1992-1#6)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#6)(1992-4#1)(1992-5#1)(1992-6#4)(1992-8#1)(1992-9#4)(1993-1#4)(1993-11#1)(1993-12#8)(1993-3#1)(1993-4#3)(1993-5#1)(1993-6#7)(1993-8#4)(1993-9#1)(1994-11#3)(1994-12#6)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#5)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#12)(1995-1#6)(1995-10#7)(1995-11#2)(1995-2#5)(1995-3#9)(1995-4#2)(1995-5#7)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#9)(1996-5#4)(1996-6#3)(1996-7#5)(1996-8#11)(1996-9#1)(1997-2#8)(1997-3#4)(1997-4#4)(1997-5#2)(1997-6#1)(1997-8#4)(2004-2#1)(2004-7#4)(2005-11#5)(2005-4#3)(2005-5#1)(2005-7#3)(2005-8#1)(2006-10#6)(2006-11#4)(2006-12#14)(2006-2#1)(2006-3#3)(2006-4#4)(2006-5#14)(2006-6#1)(2006-8#2)(2006-9#6)(2007-1#3)(2007-10#4)(2007-11#69)(2007-12#68)(2007-3#1)(2007-7#4)(2007-8#10)(2007-9#1)(2008-1#7)(2008-10#54)(2008-11#8)(2008-12#3)(2008-2#34)(2008-3#49)(2008-4#3)(2008-5#10)(2008-6#5)(2008-7#3)(2008-8#6)(2008-9#8)(2009-10#4)(2009-11#2)(2009-12#1)(2009-3#5)(2009-5#3)(2009-7#2)(2009-8#1)(2009-9#5)(2010-11#1)(2010-12#6)(2010-2#8)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#4)(2010-9#3)(2011-1#12)(2011-12#2)(2011-2#12)(2012-1#2)(2012-11#3)(2012-12#4)(2012-2#17)(2012-3#1)(2012-5#1)(2013-1#7)(2013-7#3)(2013-8#3)
ring)##2##1##(1990-5#1)(1996-2#1)
ring-cavity##3##1##(2007-12#2)(2008-1#1)
ring-closing metathesis##4##2##(2005-8#1)(2008-11#1)(2009-10#1)(2010-12#1)
ring-closing##7##1##(1990-9#1)(2005-8#1)(2006-12#1)(2008-11#1)(2009-10#1)(2010-12#1)(2010-2#1)
ring-contracted products##2##2##(1992-3#2)
ring-contracted##3##1##(1992-3#3)
ring-disc electrode##4##2##(2008-10#4)
ring-disk dual##2##2##(2008-10#2)
ring-disk working electrode##2##3##(2008-10#2)
ring-disk##6##1##(2008-10#5)(2008-5#1)
ring-down##4##1##(2007-11#2)(2010-7#2)
ring-enhancing##2##1##(2006-10#1)(2012-2#1)
ring-laser design##2##2##(2008-2#1)(2008-3#1)
ring-like##3##1##(1994-9#1)(1995-6#1)(2007-12#1)
ring-opened##3##1##(1991-6#1)(1994-8#1)(1994-9#1)
ring-opening and##2##2##(1990-9#1)(2010-6#1)
ring-opening metathesis polymerization (ROMP)##2##4##(2009-11#1)(2011-1#1)
ring-opening of##3##2##(1993-11#1)(1996-5#1)(2010-4#1)
ring-opening polymerization of##3##3##(1996-2#2)(2005-11#1)
ring-opening polymerization##6##2##(1996-2#2)(2005-11#1)(2010-12#1)(2012-12#2)
ring-opening##20##1##(1990-9#2)(1993-11#1)(1996-2#2)(1996-5#1)(2005-11#1)(2008-12#1)(2009-11#1)(2010-12#1)(2010-4#1)(2010-6#2)(2011-1#1)(2012-12#6)
ring-saturated##2##1##(1994-7#2)
ring-shaped##10##1##(1997-6#3)(2007-11#1)(2007-12#1)(2008-2#2)(2009-2#1)(2012-2#1)(2013-8#1)
ring-substituted##6##1##(1995-3#2)(1996-10#1)(2007-10#1)(2007-8#2)
ring-toric lenses##2##2##(2008-2#2)
ring-toric##3##1##(2008-2#3)
ring-wedge detector##4##2##(2008-2#2)(2008-3#2)
ringdown cavity##2##2##(2008-2#1)(2008-3#1)
ringdown spectral photography##2##3##(2008-3#2)
ringdown spectroscopy with##2##3##(2008-2#1)(2008-3#1)
ringdown spectroscopy##17##2##(2007-12#2)(2008-2#2)(2008-3#13)
ringdown time##3##2##(2008-3#3)
ringdown##45##1##(2007-12#7)(2008-2#5)(2008-3#33)
ringed seals##2##2##(2008-10#2)
ringed##7##1##(2006-12#1)(2007-6#1)(2007-9#1)(2008-10#4)
ringing##9##1##(2008-2#3)(2008-3#1)(2010-8#1)(2011-1#3)(2012-11#1)
ringlike##3##1##(2007-12#2)(2011-2#1)
rings and the##2##3##(2008-5#1)(2009-4#1)
rings and their##2##3##(1997-7#1)(2007-11#1)
rings and was##2##3##(1992-1#1)(1992-9#1)
rings and##14##2##(1990-12#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-11#1)(1994-2#1)(1994-3#1)(1997-7#1)(2007-11#1)(2008-5#1)(2009-4#1)(2010-11#1)(2010-2#1)
rings are planar##2##3##(1996-2#1)(2007-11#1)
rings are##8##2##(1994-5#1)(1995-10#1)(1995-4#1)(1996-2#1)(1997-7#1)(2007-11#1)(2010-7#1)(2011-1#1)
rings as##2##2##(1995-8#1)(1996-5#1)
rings for##2##2##(2007-12#1)(2007-2#1)
rings from##4##2##(1997-5#1)(2008-4#3)
rings have been synthesized##2##4##(2005-4#1)(2008-10#1)
rings have been##5##3##(1996-2#1)(2005-4#1)(2007-10#1)(2008-10#2)
rings have##7##2##(1996-2#1)(1996-5#1)(2005-4#1)(2007-10#1)(2008-10#2)(2011-12#1)
rings in the##8##3##(1990-3#1)(1994-9#1)(1996-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-7#2)
rings in##17##2##(1990-11#1)(1990-3#1)(1993-8#1)(1994-5#1)(1994-9#3)(1995-11#1)(1996-7#1)(2005-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-4#1)(2010-7#2)
rings is##2##2##(1993-3#1)(2007-8#1)
rings obtained from##2##3##(1993-11#1)(2008-4#1)
rings of the##6##3##(1994-5#2)(1995-1#1)(2007-11#2)(2010-5#1)
rings of##26##2##(1990-12#1)(1990-4#1)(1992-5#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-4#1)(1997-5#1)(1997-7#1)(2005-7#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-10#1)(2008-3#2)(2008-5#2)(2010-5#2)(2011-2#1)
rings precontracted with##2##3##(1990-11#1)(1992-1#1)
rings to##5##2##(1993-6#1)(1994-2#1)(2005-8#1)(2010-8#1)(2012-2#1)
rings was##6##2##(1990-11#1)(1990-12#1)(1993-8#1)(1995-3#1)(2005-4#1)(2008-10#1)
rings were##12##2##(1990-5#1)(1993-6#1)(1993-8#1)(1995-10#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#2)(2009-5#1)(2011-2#2)
rings with and without##2##4##(1994-2#1)(2009-5#1)
rings with intact endothelium##2##4##(1997-5#1)(2009-5#1)
rings with##15##2##(1990-11#1)(1992-1#1)(1992-11#1)(1993-11#1)(1994-2#2)(1997-5#1)(2006-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-5#2)(2010-2#1)
rings##235##1##(1990-11#4)(1990-12#6)(1990-3#2)(1990-4#1)(1990-5#3)(1990-8#1)(1991-5#1)(1991-8#1)(1992-1#3)(1992-11#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#3)(1993-3#2)(1993-6#4)(1993-8#4)(1994-10#2)(1994-12#1)(1994-2#5)(1994-3#1)(1994-5#7)(1994-6#1)(1994-9#6)(1995-1#2)(1995-10#4)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#2)(1995-8#2)(1996-2#4)(1996-5#2)(1996-7#1)(1997-2#1)(1997-5#3)(1997-7#8)(2005-11#1)(2005-4#3)(2005-7#2)(2005-8#1)(2006-10#1)(2006-12#5)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#17)(2007-12#8)(2007-2#2)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#11)(2008-11#4)(2008-2#2)(2008-3#5)(2008-4#5)(2008-5#7)(2008-7#2)(2008-8#4)(2008-9#1)(2009-4#1)(2009-5#4)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-4#2)(2010-5#7)(2010-7#8)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#1)
rings)##2##1##(2008-10#1)(2013-8#1)
ringspot virus in##2##3##(2008-10#2)
ringspot virus##21##2##(2008-10#21)
ringspot##27##1##(2008-10#27)
ringworm##2##1##(2008-5#2)
ringwulst##2##1##(2011-2#2)
rinse and##2##2##(2007-8#1)(2008-10#1)
rinse##13##1##(1997-6#2)(2005-11#1)(2007-8#2)(2008-10#2)(2010-3#1)(2012-12#1)(2012-2#2)(2013-1#2)
rinsed with##4##2##(2008-10#2)(2008-8#1)(2013-1#1)
rinsed##8##1##(1997-6#1)(2007-12#1)(2008-10#2)(2008-12#2)(2008-8#1)(2013-1#1)
rinses##3##1##(1995-10#1)(2006-2#1)(2008-5#1)
rinsing and drying##2##3##(2008-12#2)
rinsing and##4##2##(2008-12#2)(2010-5#1)(2012-12#1)
rinsing of the##2##3##(2008-10#2)
rinsing procedures##2##2##(2006-12#1)(2011-1#1)
rinsing the##2##2##(1991-6#1)(2007-3#1)
rinsing with water##2##3##(2006-12#1)(2008-12#1)
rinsing with##6##2##(2006-12#2)(2006-2#1)(2008-10#1)(2008-12#1)(2008-5#1)
rinsing##30##1##(1991-6#1)(2005-11#3)(2006-12#3)(2006-2#2)(2007-3#1)(2007-8#1)(2008-10#7)(2008-12#3)(2008-3#1)(2008-5#1)(2010-5#1)(2011-1#2)(2012-12#4)
riobrave##2##1##(2009-3#2)
riots##2##1##(2008-8#2)
riparian##6##1##(1993-6#1)(2006-12#1)(2008-2#3)(2008-5#1)
ripe fleshy fruits##2##3##(2008-9#2)
ripe for a##3##3##(1991-12#1)(2007-5#1)(2008-7#1)
ripe for##6##2##(1991-12#1)(1993-7#1)(2007-4#1)(2007-5#1)(2008-7#1)(2010-9#1)
ripe fruit##2##2##(2006-12#1)(2008-5#1)
ripe honey##3##2##(2006-12#3)
ripe##22##1##(1991-12#1)(1993-7#1)(2006-12#4)(2007-1#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-9#1)(2011-2#3)(2012-11#1)(2013-1#1)
ripened honey##2##2##(2008-10#2)
ripened##4##1##(2008-10#2)(2012-2#2)
ripeness##2##1##(2008-10#2)
ripening and##4##2##(2005-11#1)(2011-2#2)(2013-8#1)
ripening at##2##2##(2005-11#1)(2011-2#1)
ripening fruits##2##2##(2008-10#2)
ripening in##4##2##(1992-1#1)(1994-3#1)(2006-12#1)(2008-12#1)
ripening of##4##2##(2005-11#2)(2008-12#2)
ripening process##3##2##(1990-4#1)(2005-11#1)(2010-4#1)
ripening processes##2##2##(2008-7#2)
ripening stages##2##2##(2008-12#2)
ripening state##2##2##(2008-10#2)
ripening##58##1##(1990-4#4)(1992-1#3)(1994-3#1)(1995-10#1)(2005-11#13)(2005-9#1)(2006-12#3)(2007-11#1)(2008-10#8)(2008-12#6)(2008-7#2)(2009-11#1)(2010-4#3)(2011-2#5)(2012-12#1)(2012-2#3)(2013-8#2)
ripping##2##1##(1993-2#1)(2011-12#1)
ripple of##2##2##(2008-2#1)(2008-3#1)
ripple structure##2##2##(2008-3#2)
ripple##14##1##(1997-2#1)(2007-12#3)(2008-2#3)(2008-3#6)(2010-9#1)
ripples##7##1##(2007-11#4)(2007-12#1)(2008-3#2)
rips##2##1##(1991-9#1)(1993-8#1)
rise above##3##2##(1990-4#1)(2005-4#1)(2006-5#1)
rise after##2##2##(1990-11#1)(2008-7#1)
rise and decay times##2##4##(2008-2#1)(2008-3#1)
rise and decay##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
rise and fall of##4##4##(2006-8#1)(2008-10#1)(2008-8#1)(2010-7#1)
rise and fall##5##3##(2006-8#1)(2008-10#1)(2008-8#1)(2010-7#1)(2013-1#1)
rise and##15##2##(2006-1#1)(2006-8#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-3#1)(2010-7#1)(2013-1#3)
rise as high as##2##4##(1990-11#1)(2008-2#1)
rise as##5##2##(1990-11#1)(1994-5#1)(2008-10#1)(2008-2#1)(2008-3#1)
rise at the##2##3##(1996-3#1)(2007-12#1)
rise at##6##2##(1996-3#2)(2007-12#1)(2008-5#1)(2010-12#1)(2012-3#1)
rise by##5##2##(1992-1#1)(1995-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
rise during the##2##3##(1990-12#1)(2006-10#1)
rise during##3##2##(1990-12#1)(2006-10#1)(2008-1#1)
rise following##2##2##(2006-9#1)(2009-4#1)
rise further##2##2##(1990-9#1)(2008-7#1)
rise in ACA##2##3##(1991-2#2)
rise in [Ca2+]##3##3##(1991-10#1)(1991-6#2)
rise in [Ca2+]i at##2##4##(1994-2#1)(1995-12#1)
rise in [Ca2+]i in##3##4##(1992-6#1)(1994-2#1)(1995-12#1)
rise in [Ca2+]i was##3##4##(1992-8#1)(1994-2#1)(1995-3#1)
rise in [Ca2+]i##18##3##(1990-12#1)(1991-2#2)(1992-6#1)(1992-8#1)(1994-2#5)(1994-3#1)(1995-12#5)(1995-3#2)
rise in [Ca]i##2##3##(1992-7#2)
rise in arterial##2##3##(1992-1#1)(2009-2#1)
rise in baseline [Ca(2+)](i)##2##4##(2007-10#2)
rise in beta cell##2##4##(1992-4#2)
rise in blood pressure##2##4##(1993-4#1)(2007-9#1)
rise in blood##4##3##(1993-4#1)(1996-2#1)(2007-9#1)(2008-4#1)
rise in cAMP##3##3##(1990-3#2)(1993-6#1)
rise in current##2##3##(1990-5#2)
rise in cytosolic Ca2+##2##4##(1991-10#1)(1995-12#1)
rise in cytosolic calcium##4##4##(1990-9#1)(1992-4#1)(1995-12#1)(1995-3#1)
rise in cytosolic free##2##4##(1991-5#1)(1995-5#1)
rise in cytosolic##10##3##(1990-9#1)(1991-1#2)(1991-10#1)(1991-5#1)(1992-4#1)(1995-12#2)(1995-3#1)(1995-5#1)
rise in incidence of##2##4##(2008-10#1)(2008-8#1)
rise in incidence##5##3##(1991-12#1)(1995-2#2)(2008-10#1)(2008-8#1)
rise in intracellular Ca++##2##4##(1990-3#2)
rise in intracellular calcium##4##4##(1990-7#1)(1990-9#1)(1994-12#1)(2007-9#1)
rise in intracellular##12##3##(1990-3#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-7#1)(1994-12#1)(1994-2#3)(1994-6#1)(2007-9#1)
rise in lipid peroxidation##2##4##(1990-3#1)(2013-1#1)
rise in methanol concentration##2##4##(1996-5#2)
rise in plasma##7##3##(1991-2#1)(1993-3#4)(2008-1#1)(2011-2#1)
rise in serum##3##3##(1991-11#1)(1995-12#1)(1996-10#1)
rise in temperature in the##2##5##(2008-2#2)
rise in temperature##3##3##(2008-2#2)(2008-3#1)
rise in the Tco##2##4##(1997-8#2)
rise in the level of##2##5##(2006-6#1)(2007-8#1)
rise in the number of##5##5##(1990-3#1)(1992-12#1)(1994-5#1)(2006-10#1)(2012-1#1)
rise in the past##2##4##(2010-9#1)(2013-1#1)
rise in the prevalence##3##4##(2008-3#1)(2009-10#1)(2011-2#1)
rise in the serum##2##4##(1995-3#1)(2006-9#1)
rise in the##50##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-2#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-3#1)(1997-2#1)(1997-6#1)(1997-8#2)(2006-10#2)(2006-6#1)(2006-9#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
rise in their##3##3##(1992-3#1)(1995-2#1)(2013-1#1)
rise in##252##2##(1990-10#2)(1990-11#4)(1990-12#2)(1990-2#1)(1990-3#6)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#4)(1990-9#3)(1991-1#3)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#7)(1991-5#2)(1991-6#3)(1991-7#1)(1991-9#1)(1992-1#4)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#3)(1992-4#5)(1992-5#1)(1992-6#1)(1992-7#4)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#5)(1993-4#2)(1993-5#1)(1993-6#1)(1994-10#1)(1994-12#4)(1994-2#10)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-10#1)(1995-12#10)(1995-2#4)(1995-3#5)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-6#2)(1997-8#2)(2004-10#1)(2005-9#1)(2006-1#3)(2006-10#4)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#4)(2007-11#1)(2007-2#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#7)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#2)(2009-7#1)(2010-12#2)(2010-3#1)(2010-4#3)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#4)(2012-12#2)(2012-2#3)(2013-1#4)(2013-8#4)
rise induced by the##2##4##(1995-11#1)(2013-1#1)
rise induced by##4##3##(1994-5#1)(1995-11#1)(2008-4#1)(2013-1#1)
rise is##4##2##(1996-7#2)(2005-11#1)(2010-12#1)
rise of body temperature in acutely reserpinized mice##2##8##(1990-5#2)
rise of body temperature induced by the##2##7##(1990-5#2)
rise of body temperature##7##4##(1990-5#7)
rise of free intracellular calcium##2##5##(1990-2#1)(1995-5#1)
rise of serum##3##3##(1990-6#1)(1995-12#1)(2008-5#1)
rise of the##12##3##(1990-8#1)(1991-12#1)(1994-3#1)(1994-6#2)(1997-4#1)(2005-11#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#1)
rise of these##3##3##(1994-1#1)(2007-12#1)(2008-7#1)
rise of##71##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#7)(1990-6#1)(1990-7#1)(1990-8#2)(1991-11#1)(1991-12#1)(1992-1#2)(1992-11#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#3)(1994-3#1)(1994-6#2)(1995-10#1)(1995-12#3)(1995-5#1)(1997-4#1)(1997-8#1)(2005-11#2)(2006-1#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-6#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-1#4)(2012-2#1)(2013-1#2)
rise on##3##2##(1993-5#1)(2005-12#1)(2007-11#1)
rise or##4##2##(1997-6#1)(2008-10#1)(2008-3#1)(2010-9#1)
rise the##2##2##(1992-11#1)(2008-10#1)
rise time of##2##3##(2008-10#1)(2008-2#1)
rise time##8##2##(1991-6#1)(1992-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-3#2)
rise to a better##2##4##(1996-2#1)(2008-5#1)
rise to a form of##2##5##(1993-11#1)(2006-2#1)
rise to a new##5##4##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-3#1)
rise to a peak##2##4##(1994-2#1)(2007-11#1)
rise to a##61##3##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-3#2)(1991-7#1)(1991-9#3)(1992-3#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-11#3)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-7#1)(2012-2#1)(2013-8#2)
rise to an analogous##2##4##(1992-5#1)(2008-7#1)
rise to an increase in##2##5##(1992-1#1)(2006-2#1)
rise to an increase of the##2##6##(2008-10#1)(2008-2#1)
rise to an increase##4##4##(1992-1#1)(2006-2#1)(2008-10#1)(2008-2#1)
rise to an##19##3##(1990-11#1)(1992-1#1)(1992-5#1)(1992-9#1)(1994-8#2)(1995-8#1)(1997-2#1)(2006-2#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-2#2)(2008-7#1)(2010-11#1)(2010-12#1)
rise to chromosome##2##3##(2008-11#1)(2012-3#1)
rise to different##2##3##(2008-10#2)
rise to hair##2##3##(2012-2#2)
rise to many##4##3##(1992-3#1)(2008-5#1)(2009-1#1)(2011-1#1)
rise to metastases##2##3##(1991-6#1)(2009-5#1)
rise to more##2##3##(1992-2#1)(2006-10#1)
rise to much##2##3##(2006-4#1)(2008-11#1)
rise to multiple##2##3##(1997-4#1)(2008-7#1)
rise to neurons##3##3##(1991-11#1)(2008-11#2)
rise to new##6##3##(1990-3#1)(1992-6#1)(2008-1#1)(2009-12#1)(2009-8#1)(2012-2#1)
rise to significant##2##3##(2008-2#1)(2008-7#1)
rise to smaller##2##3##(1991-9#1)(2008-3#1)
rise to stable##3##3##(1990-5#1)(1997-3#1)(2007-12#1)
rise to the large##2##4##(1994-12#1)(2007-12#1)
rise to the most##2##4##(2010-7#1)(2013-1#1)
rise to the possibility##2##4##(2007-11#1)(2010-2#1)
rise to the##52##3##(1990-3#3)(1990-8#1)(1991-8#1)(1992-8#1)(1993-6#1)(1994-12#2)(1995-11#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-5#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-8#2)(2010-2#1)(2010-7#2)(2011-2#1)(2012-1#1)(2012-12#5)(2012-2#2)(2013-1#2)
rise to tumors##2##3##(2011-2#1)(2012-12#1)
rise to two##4##3##(1990-2#1)(1992-1#1)(1994-3#1)(2007-12#1)
rise to##370##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#5)(1990-4#1)(1990-5#4)(1990-8#4)(1990-9#1)(1991-11#2)(1991-3#3)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#8)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-2#3)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#4)(1994-5#3)(1994-6#2)(1994-8#3)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#4)(1995-8#4)(1995-9#1)(1996-11#3)(1996-12#4)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#1)(1996-7#2)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(1997-9#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-5#1)(2005-7#1)(2006-10#2)(2006-12#2)(2006-2#2)(2006-4#3)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#8)(2007-12#14)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#3)(2008-1#6)(2008-10#24)(2008-11#12)(2008-12#1)(2008-2#13)(2008-3#9)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#11)(2008-8#6)(2008-9#4)(2009-1#1)(2009-10#2)(2009-12#2)(2009-2#5)(2009-3#3)(2009-4#1)(2009-5#5)(2009-7#2)(2009-8#7)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-4#4)(2010-6#2)(2010-7#4)(2010-9#1)(2011-1#5)(2011-2#5)(2012-1#4)(2012-12#10)(2012-2#8)(2012-3#4)(2013-1#4)(2013-8#7)
rise transiently##2##2##(1991-12#1)(2008-4#1)
rise up##2##2##(1996-5#1)(2007-11#1)
rise was not statistically significant##2##5##(1993-2#1)(1997-8#1)
rise was not##3##3##(1993-2#1)(1997-8#1)(2013-1#1)
rise was##7##2##(1991-12#1)(1992-4#1)(1993-2#1)(1997-8#1)(2008-5#2)(2013-1#1)
rise with##7##2##(1992-8#1)(1993-3#1)(1993-9#1)(2008-3#1)(2008-9#1)(2011-1#1)(2013-1#1)
rise within the##2##3##(1996-3#1)(2005-11#1)
rise##864##1##(1990-10#2)(1990-11#9)(1990-12#7)(1990-2#5)(1990-3#11)(1990-4#4)(1990-5#14)(1990-6#3)(1990-7#6)(1990-8#6)(1990-9#5)(1991-1#3)(1991-10#2)(1991-11#4)(1991-12#8)(1991-2#7)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#5)(1991-7#3)(1991-8#2)(1991-9#10)(1992-1#9)(1992-11#3)(1992-12#4)(1992-2#6)(1992-3#5)(1992-4#7)(1992-5#4)(1992-6#4)(1992-7#4)(1992-8#4)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#5)(1993-3#9)(1993-4#3)(1993-5#6)(1993-6#3)(1993-8#1)(1993-9#3)(1994-1#2)(1994-10#1)(1994-11#3)(1994-12#11)(1994-2#15)(1994-3#7)(1994-5#6)(1994-6#7)(1994-8#4)(1994-9#1)(1995-1#2)(1995-10#4)(1995-11#5)(1995-12#15)(1995-2#5)(1995-3#6)(1995-5#3)(1995-6#5)(1995-8#5)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#4)(1996-12#5)(1996-2#4)(1996-3#9)(1996-4#2)(1996-5#5)(1996-7#4)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#5)(1997-9#1)(2004-10#2)(2004-4#1)(2004-8#1)(2004-9#1)(2005-10#1)(2005-11#6)(2005-12#3)(2005-4#1)(2005-5#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#5)(2006-10#10)(2006-12#2)(2006-2#2)(2006-4#3)(2006-5#3)(2006-6#2)(2006-7#3)(2006-8#5)(2006-9#5)(2007-1#1)(2007-10#7)(2007-11#13)(2007-12#16)(2007-2#3)(2007-4#1)(2007-6#1)(2007-7#4)(2007-8#6)(2007-9#9)(2008-1#8)(2008-10#42)(2008-11#20)(2008-12#3)(2008-2#22)(2008-3#23)(2008-4#10)(2008-5#20)(2008-6#5)(2008-7#16)(2008-8#12)(2008-9#7)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#6)(2009-3#5)(2009-4#5)(2009-5#5)(2009-6#1)(2009-7#3)(2009-8#8)(2009-9#1)(2010-11#3)(2010-12#7)(2010-2#3)(2010-3#2)(2010-4#7)(2010-6#2)(2010-7#7)(2010-8#3)(2010-9#5)(2011-1#14)(2011-12#1)(2011-2#11)(2012-1#8)(2012-12#14)(2012-2#14)(2012-3#6)(2013-1#19)(2013-7#1)(2013-8#11)
rised##2##1##(2006-6#1)(2008-5#1)
risedronate##9##1##(2005-3#2)(2008-3#2)(2008-4#1)(2008-8#3)(2013-8#1)
risen from##2##2##(1997-7#1)(2007-12#1)
risen in##3##2##(1995-3#1)(2007-2#1)(2010-7#1)
risen significantly##2##2##(1991-1#1)(2006-10#1)
risen##23##1##(1991-1#1)(1992-5#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-4#1)(1995-1#1)(1995-10#1)(1995-3#2)(1997-7#1)(2005-9#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-2#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-7#1)
rises from##3##2##(1990-7#1)(1993-10#1)(1995-7#1)
rises in [Ca2+]i caused by##2##5##(1994-2#2)
rises in [Ca2+]i##4##3##(1991-9#1)(1994-2#2)(1995-3#1)
rises in both cytosolic free##2##5##(1990-7#1)(1991-9#1)
rises in cAMP##2##3##(1990-3#1)(1995-9#1)
rises in##18##2##(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-3#1)(1991-9#2)(1992-3#1)(1994-2#2)(1994-6#1)(1994-8#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-8#1)(2007-10#1)(2008-5#1)
rises with age##3##3##(2010-12#2)(2013-8#1)
rises##59##1##(1990-2#1)(1990-3#1)(1990-4#2)(1990-7#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-10#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-7#1)(1995-9#1)(1996-10#1)(1996-8#1)(2006-7#2)(2007-10#3)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-12#2)(2010-4#3)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
rising CO2##2##2##(1995-8#2)
rising PSA levels indicate##2##4##(2006-9#2)
rising PSA levels##3##3##(2006-9#2)(2007-11#1)
rising PSA##5##2##(2006-9#4)(2007-11#1)
rising again##2##2##(1993-7#1)(1997-7#1)
rising and falling##2##3##(2008-3#2)
rising and##5##2##(1992-2#1)(2005-1#1)(2008-3#2)(2013-7#1)
rising blood##2##2##(1995-10#1)(2005-7#1)
rising costs##7##2##(1991-12#2)(1992-12#1)(2007-12#1)(2007-2#1)(2011-7#1)(2012-3#1)
rising demand for##2##3##(2007-11#1)(2007-4#1)
rising demand##3##2##(2007-11#1)(2007-4#2)
rising from##5##2##(1993-10#1)(2007-8#2)(2008-6#1)(2013-7#1)
rising health care costs and##2##5##(1992-3#1)(1997-1#1)
rising health care costs##5##4##(1990-12#1)(1992-3#1)(1997-1#1)(2007-4#1)(2012-2#1)
rising health care##6##3##(1990-12#2)(1992-3#1)(1997-1#1)(2007-4#1)(2012-2#1)
rising health##7##2##(1990-12#3)(1992-3#1)(1997-1#1)(2007-4#1)(2012-2#1)
rising in##4##2##(1991-6#1)(2008-4#1)(2011-2#1)(2012-3#1)
rising incarceration rates##2##3##(1991-3#2)
rising incidence##7##2##(1990-6#1)(1992-2#1)(2006-10#2)(2006-2#1)(2009-3#1)(2012-12#1)
rising interest##2##2##(2010-11#1)(2010-9#1)
rising numbers of##5##3##(1995-1#1)(1995-9#1)(1996-3#1)(2010-7#1)(2012-2#1)
rising of##5##2##(1991-3#1)(2005-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
rising patterns##2##2##(2006-10#2)
rising prevalence of##3##3##(2005-11#1)(2011-1#1)(2012-1#1)
rising rapidly##2##2##(2008-5#1)(2009-3#1)
rising task##2##2##(2006-10#2)
rising to UK pounds sterling##2##5##(2005-8#2)
rising to a##2##3##(2008-10#1)(2008-8#1)
rising to##18##2##(1992-3#1)(1993-11#1)(2005-8#11)(2005-9#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-8#1)
rising worldwide##2##2##(2010-10#1)(2013-1#1)
rising##188##1##(1990-12#4)(1990-6#1)(1990-9#1)(1991-12#3)(1991-2#1)(1991-3#4)(1991-5#2)(1991-6#3)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-4#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-5#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-5#1)(1997-7#1)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#3)(2005-7#2)(2005-8#13)(2005-9#1)(2006-1#1)(2006-10#10)(2006-11#1)(2006-2#1)(2006-5#1)(2006-9#4)(2007-11#4)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#6)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-5#3)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#5)(2011-12#2)(2011-2#6)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#7)(2012-6#1)(2013-1#1)(2013-7#2)(2013-8#5)
risk (HR##2##2##(1995-8#1)(2012-6#1)
risk (OR##2##2##(2006-1#1)(2011-2#1)
risk (RR) 0##2##3##(1993-9#1)(2011-1#1)
risk (RR)##12##2##(1991-7#1)(1992-11#1)(1992-9#1)(1993-8#1)(1993-9#2)(1995-5#1)(1996-12#1)(2011-1#2)(2011-2#1)(2013-1#1)
risk (p=0##2##2##(2011-11#1)(2011-2#1)
risk 0##4##2##(1991-11#1)(1993-7#1)(2008-10#1)(2011-2#1)
risk =##4##2##(1991-2#1)(1997-8#1)(2008-1#1)(2008-7#1)
risk accounts##2##2##(1991-12#1)(2009-4#1)
risk across##2##2##(2010-3#1)(2013-1#1)
risk adjusted capitation##2##3##(1997-1#2)
risk adjustment for##2##3##(1997-1#2)
risk adjustment of##2##3##(1995-2#1)(2010-12#1)
risk adjustment##16##2##(1994-5#1)(1995-2#3)(1995-3#3)(1997-1#3)(2005-9#1)(2008-11#1)(2008-7#1)(2010-12#1)(2013-1#2)
risk after##5##2##(1991-11#1)(1995-1#1)(1996-7#1)(2007-8#2)
risk among adolescents##2##3##(1994-2#1)(2013-1#1)
risk among male##2##3##(2008-7#1)(2009-6#1)
risk among the##2##3##(1995-3#1)(2009-6#1)
risk among women with##2##4##(2007-1#1)(2011-1#1)
risk among##25##2##(1992-5#1)(1994-2#1)(1994-6#1)(1995-3#1)(1996-3#1)(2006-7#1)(2007-1#1)(2007-12#1)(2008-11#1)(2008-12#2)(2008-7#2)(2009-6#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#2)(2013-1#2)(2013-8#1)
risk analyses##3##2##(2004-4#1)(2005-5#1)(2012-2#1)
risk analysis approach##2##3##(2008-10#1)(2012-2#1)
risk analysis in trade##2##4##(2005-5#2)
risk analysis in##5##3##(1997-4#1)(2005-5#2)(2006-10#1)(2008-10#1)
risk analysis of##3##3##(2008-11#1)(2012-2#2)
risk analysis unit##3##3##(2005-5#3)
risk analysis##38##2##(1990-11#1)(1997-4#1)(2005-5#8)(2006-10#2)(2006-8#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2009-10#3)(2009-7#1)(2010-2#1)(2012-12#1)(2012-2#10)
risk and associated##3##3##(1996-2#1)(2013-1#2)
risk and benefit##4##3##(2008-7#2)(2013-1#1)(2013-7#1)
risk and delay##2##3##(2006-7#1)(2012-12#1)
risk and health##4##3##(2005-10#1)(2010-2#1)(2010-9#2)
risk and in##2##3##(2010-12#1)(2010-9#1)
risk and long-term##2##3##(1990-8#1)(2013-8#1)
risk and possibly##2##3##(2006-10#1)(2008-10#1)
risk and protective factors##5##4##(2008-2#1)(2008-5#1)(2009-7#3)
risk and protective##7##3##(2006-10#1)(2008-2#1)(2008-5#1)(2009-7#4)
risk and provide##2##3##(2007-1#1)(2010-3#1)
risk and safety##2##3##(2008-2#1)(2013-1#1)
risk and the##8##3##(1991-12#1)(1995-4#1)(1996-1#1)(2006-10#1)(2008-12#1)(2008-2#1)(2012-11#2)
risk and to##2##3##(1997-7#1)(2008-12#1)
risk and uncertainty##3##3##(2007-4#1)(2012-12#2)
risk and##141##2##(1990-8#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-12#1)(1993-1#1)(1993-7#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-9#2)(1997-3#1)(1997-5#2)(1997-7#1)(2004-2#1)(2005-10#4)(2006-10#7)(2006-12#1)(2006-2#3)(2006-5#2)(2006-7#2)(2007-1#1)(2007-12#2)(2007-2#2)(2007-4#2)(2007-5#2)(2007-8#3)(2008-10#6)(2008-11#4)(2008-12#3)(2008-2#3)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#4)(2008-9#1)(2009-10#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#4)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#3)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#11)(2013-7#1)(2013-8#2)
risk and/or##4##2##(1995-6#1)(2005-10#1)(2008-1#1)(2008-12#1)
risk appraisal##5##2##(1995-8#3)(2010-7#2)
risk are related##3##3##(2008-10#2)(2009-12#1)
risk are still##2##3##(1990-6#1)(2008-1#1)
risk are##15##2##(1990-12#1)(1990-6#1)(1994-2#1)(1997-5#1)(2006-10#1)(2008-1#2)(2008-10#2)(2008-7#1)(2008-8#1)(2009-12#2)(2010-10#1)(2012-1#1)
risk area for##2##3##(2007-2#1)(2011-2#1)
risk area##3##2##(2004-11#1)(2007-2#1)(2011-2#1)
risk areas for##2##3##(2008-8#2)
risk areas##7##2##(2008-8#3)(2011-2#2)(2012-12#1)(2012-3#1)
risk as a function of##2##5##(1996-11#1)(1997-8#1)
risk as a##5##3##(1994-11#1)(1996-11#1)(1997-8#1)(2008-8#1)(2013-7#1)
risk as##11##2##(1991-7#1)(1994-11#1)(1996-11#1)(1996-8#1)(1997-8#1)(2007-4#1)(2008-8#1)(2009-4#1)(2010-2#1)(2010-8#1)(2013-7#1)
risk assessment and management##3##4##(2006-10#1)(2008-11#1)(2010-8#1)
risk assessment and##16##3##(2006-10#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)
risk assessment are##3##3##(1997-3#1)(2008-10#1)(2011-1#1)
risk assessment at##2##3##(2008-10#1)(2011-2#1)
risk assessment by##3##3##(2005-3#1)(2010-10#1)(2010-4#1)
risk assessment for##5##3##(2006-10#1)(2008-10#2)(2008-7#1)(2011-2#1)
risk assessment in the cosmetic industry have led to the development of##2##12##(2008-5#2)
risk assessment in the##7##4##(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-9#1)
risk assessment in##14##3##(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#1)
risk assessment is##3##3##(2008-5#1)(2010-2#1)(2013-7#1)
risk assessment methodologies##2##3##(1995-2#1)(2006-9#1)
risk assessment model##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
risk assessment models##2##3##(2008-10#2)
risk assessment of pharmaceutical residues##2##5##(2008-10#2)
risk assessment of plant protection products##2##6##(2008-11#2)
risk assessment of##15##3##(1995-9#1)(1996-3#1)(1997-4#1)(2008-10#3)(2008-11#5)(2008-5#1)(2008-9#1)(2012-1#1)(2012-3#1)
risk assessment on##2##3##(2012-2#1)(2013-1#1)
risk assessment process##2##3##(2008-10#1)(2008-5#1)
risk assessment to##2##3##(2008-9#1)(2012-3#1)
risk assessment tool##2##3##(2007-12#2)
risk assessment with##2##3##(2010-9#1)(2012-2#1)
risk assessment##183##2##(1991-12#3)(1991-3#1)(1993-1#1)(1994-12#1)(1995-11#2)(1995-2#1)(1995-9#1)(1996-12#3)(1996-3#1)(1997-3#2)(1997-4#1)(2004-4#1)(2005-3#1)(2006-10#4)(2006-9#2)(2007-12#6)(2007-2#1)(2007-7#3)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#29)(2008-11#11)(2008-12#1)(2008-3#5)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#13)(2008-8#2)(2008-9#7)(2009-3#1)(2009-4#3)(2009-7#1)(2010-10#1)(2010-11#3)(2010-12#4)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#12)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#10)(2013-7#4)(2013-8#2)
risk assessments and##3##3##(2008-10#2)(2010-4#1)
risk assessments at##2##3##(2006-10#1)(2008-10#1)
risk assessments for##2##3##(2011-12#1)(2011-2#1)
risk assessments of##2##3##(2008-10#2)
risk assessments##23##2##(1997-8#1)(2006-10#2)(2008-10#7)(2008-5#1)(2010-2#2)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#5)(2013-7#2)
risk associated with the##3##4##(2007-12#1)(2008-1#1)(2012-2#1)
risk associated with##23##3##(1991-12#1)(1996-3#1)(1996-9#1)(2005-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-4#1)(2009-6#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-6#1)
risk associated##24##2##(1991-12#1)(1996-3#1)(1996-9#1)(2005-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-4#1)(2009-10#1)(2009-6#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-6#1)
risk at the individual##2##4##(2008-3#2)
risk at##8##2##(1996-12#1)(2008-1#1)(2008-3#3)(2008-7#1)(2011-2#1)(2012-2#1)
risk attributable to##2##3##(1991-12#1)(2007-12#1)
risk averse##2##2##(2011-2#2)
risk based on##3##3##(1990-8#1)(1997-3#1)(2009-12#1)
risk because of##2##3##(1991-12#1)(2008-7#1)
risk because##4##2##(1991-12#1)(2008-10#1)(2008-7#1)(2012-1#1)
risk before the##2##3##(2010-4#1)(2011-12#1)
risk before##3##2##(2008-10#1)(2010-4#1)(2011-12#1)
risk behavior among##2##3##(2008-12#1)(2011-2#1)
risk behavior in##3##3##(2008-4#1)(2010-5#1)(2013-1#1)
risk behavior of##2##3##(2008-4#1)(2011-2#1)
risk behavior##23##2##(2005-10#1)(2007-6#1)(2008-12#4)(2008-4#2)(2009-5#1)(2009-8#2)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
risk behaviors among##3##3##(2010-9#1)(2013-1#1)(2013-8#1)
risk behaviors and the##2##4##(2012-12#1)(2013-8#1)
risk behaviors and##7##3##(1991-1#1)(2007-12#1)(2008-12#1)(2008-4#1)(2012-11#1)(2012-12#1)(2013-8#1)
risk behaviors in##6##3##(2008-4#1)(2008-8#1)(2012-11#1)(2013-1#3)
risk behaviors than the##2##4##(2011-1#1)(2012-3#1)
risk behaviors##43##2##(1991-1#1)(1995-12#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-12#2)(2007-6#1)(2008-12#1)(2008-4#5)(2008-8#1)(2009-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-1#3)(2012-11#5)(2012-12#1)(2012-3#1)(2013-1#7)(2013-8#7)
risk behaviour and##2##3##(2008-4#1)(2012-12#1)
risk behaviour##10##2##(1996-1#2)(2007-7#3)(2008-10#1)(2008-4#1)(2009-9#1)(2010-12#1)(2012-12#1)
risk behaviours among##3##3##(2010-12#1)(2011-12#1)(2012-3#1)
risk behaviours were##3##3##(2010-12#2)(2012-3#1)
risk behaviours##14##2##(2008-1#1)(2010-12#8)(2011-12#1)(2012-3#4)
risk being##3##2##(1991-4#1)(2007-12#1)(2009-10#1)
risk benefit##4##2##(2005-7#1)(2008-4#1)(2009-12#1)(2013-1#1)
risk between##6##2##(1994-4#1)(1995-6#1)(1997-7#1)(2008-3#1)(2008-7#1)(2009-5#1)
risk biomarkers##2##2##(2008-10#1)(2010-12#1)
risk but##7##2##(1997-8#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-12#1)(2010-12#1)(2010-2#1)
risk by the##2##3##(2008-3#1)(2008-4#1)
risk by##15##2##(1991-5#1)(1992-2#1)(1993-11#1)(1996-12#1)(1996-7#1)(1997-1#1)(2007-4#1)(2008-3#1)(2008-4#1)(2009-6#1)(2010-9#2)(2012-2#1)(2012-3#1)(2013-7#1)
risk calculations were##4##3##(2008-7#2)(2013-1#2)
risk calculations##6##2##(2008-7#3)(2010-12#1)(2013-1#2)
risk calculators##2##2##(2010-4#2)
risk can be##5##3##(1994-4#1)(2007-11#1)(2007-4#1)(2008-10#1)(2012-11#1)
risk categories##6##2##(1996-12#1)(1996-8#4)(2010-11#1)
risk category##5##2##(2007-2#1)(2008-1#1)(2008-7#1)(2010-11#1)(2011-11#1)
risk caused by##2##3##(2007-1#1)(2009-10#1)
risk classification##8##2##(1993-12#2)(1994-12#1)(1995-1#1)(2011-2#3)(2013-8#1)
risk communication##6##2##(2008-9#1)(2010-11#1)(2013-1#1)(2013-7#3)
risk compared with##2##3##(2012-12#1)(2013-8#1)
risk compared##3##2##(2008-3#1)(2012-12#1)(2013-8#1)
risk compensation##2##2##(2008-7#2)
risk condition##2##2##(2008-3#1)(2008-7#1)
risk conditions##10##2##(1994-1#1)(2005-1#1)(2006-10#1)(2009-10#4)(2011-1#3)
risk conferred by##2##3##(2009-4#1)(2013-1#1)
risk conferring##2##2##(2011-2#2)
risk contracting##3##2##(1990-12#1)(1991-3#1)(1994-12#1)
risk contracts with Medicare##3##4##(1990-12#2)(1995-12#1)
risk contracts with##4##3##(1990-12#2)(1995-12#2)
risk contracts##7##2##(1990-12#2)(1995-12#3)(1996-3#1)(1997-2#1)
risk control in##2##3##(2008-9#1)(2009-10#1)
risk control##7##2##(2008-9#3)(2009-10#1)(2011-2#1)(2013-1#2)
risk correlation##2##2##(2007-1#1)(2008-3#1)
risk could be##2##3##(1990-5#1)(2007-12#1)
risk criteria##2##2##(2008-7#1)(2011-2#1)
risk curves for##3##3##(2007-1#1)(2007-4#2)
risk curves##5##2##(2006-11#1)(2007-1#1)(2007-4#3)
risk declines##2##2##(1991-4#1)(2005-10#1)
risk difference##4##2##(1994-9#1)(1996-7#1)(2006-5#1)(2008-11#1)
risk differences for##2##3##(2008-1#1)(2012-2#1)
risk differences##7##2##(1996-7#3)(2005-10#1)(2006-5#1)(2008-1#1)(2012-2#1)
risk distribution##3##2##(1992-12#3)
risk due to the##5##4##(2004-4#1)(2007-7#1)(2008-11#1)(2008-4#1)(2010-12#1)
risk due to##19##3##(1991-12#1)(1991-5#1)(1992-3#1)(1996-4#1)(2004-4#1)(2006-11#1)(2007-1#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-6#1)
risk during the##3##3##(1990-2#1)(2011-1#1)(2012-3#1)
risk during##12##2##(1990-2#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-8#2)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#3)
risk emphasis##2##2##(2012-2#2)
risk environment##3##2##(2006-4#1)(2013-1#2)
risk estimate##2##2##(1996-12#1)(2012-12#1)
risk estimates for##2##3##(2006-10#1)(2008-7#1)
risk estimates##12##2##(1990-6#1)(1991-5#1)(1993-12#1)(1993-6#1)(1995-8#1)(1996-3#2)(2006-10#2)(2008-7#1)(2011-2#1)(2012-2#1)
risk estimation##10##2##(1990-3#1)(1992-6#1)(1996-12#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-5#1)(2010-4#1)(2013-8#1)
risk evaluation and mitigation strategy##2##5##(2010-12#1)(2012-3#1)
risk evaluation and##4##3##(1992-9#1)(2006-6#1)(2010-12#1)(2012-3#1)
risk evaluation##7##2##(1992-9#1)(2006-6#1)(2007-1#1)(2007-8#1)(2009-5#1)(2010-12#1)(2012-3#1)
risk exists##4##2##(1990-12#1)(1995-8#1)(2012-2#2)
risk exposure##3##2##(2004-11#1)(2005-8#1)(2010-7#1)
risk exposures##2##2##(2011-1#1)(2011-2#1)
risk factor among##2##3##(1994-2#1)(2009-12#1)
risk factor and##8##3##(2005-8#1)(2006-2#1)(2007-10#1)(2007-8#1)(2008-5#1)(2008-8#1)(2011-1#1)(2013-1#1)
risk factor assessment##3##3##(2005-10#1)(2008-4#1)(2010-4#1)
risk factor associated with##5##4##(1994-2#1)(2006-2#1)(2008-3#1)(2009-11#1)(2009-6#1)
risk factor control after##2##4##(2007-10#1)(2007-11#1)
risk factor control##6##3##(2007-10#1)(2007-11#2)(2010-8#1)(2011-2#2)
risk factor evaluation##3##3##(2006-10#1)(2010-9#1)(2012-2#1)
risk factor for CVD##3##4##(1990-6#1)(2005-10#1)(2011-2#1)
risk factor for HIV##2##4##(1994-7#1)(2007-11#1)
risk factor for acute##2##4##(1993-11#1)(2010-7#1)
risk factor for atherosclerosis##5##4##(1990-2#1)(1993-1#1)(1996-5#1)(2007-10#1)(2011-12#1)
risk factor for cardiovascular disease in##2##6##(2007-8#1)(2012-12#1)
risk factor for cardiovascular disease##8##5##(2007-8#1)(2008-1#1)(2008-3#2)(2009-11#1)(2010-12#1)(2012-12#1)(2012-2#1)
risk factor for cardiovascular diseases##4##5##(1992-4#1)(1997-1#1)(2010-5#1)(2012-3#1)
risk factor for cardiovascular morbidity and mortality##3##7##(1992-8#1)(1995-10#1)(2006-2#1)
risk factor for cardiovascular##18##4##(1992-4#1)(1992-8#1)(1995-10#1)(1997-1#1)(2005-12#1)(2006-2#1)(2007-8#1)(2008-1#1)(2008-3#2)(2009-11#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
risk factor for coronary artery disease##3##6##(1995-6#1)(1997-8#1)(2008-7#1)
risk factor for coronary heart disease (CHD)##2##7##(2005-10#1)(2008-6#1)
risk factor for coronary heart disease and##2##7##(1991-10#1)(2006-2#1)
risk factor for coronary heart disease##5##6##(1990-7#1)(1991-10#1)(2005-10#1)(2006-2#1)(2008-6#1)
risk factor for coronary##8##4##(1990-7#1)(1991-10#1)(1995-6#1)(1997-8#1)(2005-10#1)(2006-2#1)(2008-6#1)(2008-7#1)
risk factor for developing##7##4##(1992-9#1)(2007-1#1)(2008-6#1)(2012-2#2)(2012-5#1)(2013-8#1)
risk factor for development of venous##2##6##(1997-3#2)
risk factor for development of##7##5##(1996-12#1)(1997-3#2)(2007-10#1)(2007-11#2)(2011-2#1)
risk factor for early revision##2##5##(2013-1#2)
risk factor for falls##2##4##(2008-7#1)(2011-2#1)
risk factor for faster##2##4##(2011-2#1)(2013-1#1)
risk factor for hepatocellular carcinoma##3##5##(2006-8#1)(2009-2#1)(2010-12#1)
risk factor for infantile##2##4##(2006-8#1)(2010-7#1)
risk factor for ischemic stroke##3##5##(2007-10#1)(2008-1#1)(2008-9#1)
risk factor for metabolic syndrome##2##5##(2008-3#1)(2009-2#1)
risk factor for mortality##3##4##(1991-2#1)(2008-2#1)(2010-2#1)
risk factor for neural tube defects##2##6##(1996-6#1)(2009-10#1)
risk factor for osteoporosis##2##4##(2009-3#1)(2012-2#1)
risk factor for pancreatic cancer##2##5##(1995-5#1)(2013-1#1)
risk factor for premature##3##4##(2008-1#1)(2008-10#1)(2012-3#1)
risk factor for sporadic##2##4##(1994-5#2)
risk factor for stroke##8##4##(2007-10#3)(2007-9#3)(2008-8#1)(2012-1#1)
risk factor for the development of hepatocellular carcinoma##2##8##(2008-5#1)(2010-12#1)
risk factor for the development of##17##6##(1994-4#1)(1997-2#1)(2006-10#2)(2008-1#3)(2008-3#1)(2008-5#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-12#2)(2012-12#1)(2013-1#1)
risk factor for the##24##4##(1994-4#1)(1997-2#1)(2005-8#1)(2006-10#3)(2007-7#1)(2008-1#4)(2008-3#1)(2008-5#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
risk factor for thyroid##2##4##(1995-5#1)(2007-4#1)
risk factor for tuberculosis##2##4##(2005-11#2)
risk factor for vascular##2##4##(2007-7#1)(2007-8#1)
risk factor for##238##3##(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#1)(1992-12#1)(1992-4#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-2#1)(1993-9#1)(1994-4#2)(1994-5#2)(1994-7#2)(1995-10#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-5#1)(1996-6#3)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#11)(2006-12#2)(2006-2#5)(2006-5#1)(2006-7#1)(2006-8#6)(2006-9#1)(2007-1#2)(2007-10#8)(2007-11#6)(2007-2#5)(2007-4#1)(2007-7#2)(2007-8#3)(2007-9#6)(2008-1#9)(2008-10#3)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#6)(2010-2#2)(2010-4#2)(2010-5#1)(2010-7#4)(2010-9#1)(2011-1#4)(2011-12#4)(2011-2#14)(2012-1#4)(2012-11#2)(2012-12#4)(2012-2#11)(2012-3#6)(2012-5#1)(2013-1#9)(2013-7#2)(2013-8#3)
risk factor in the##3##4##(2006-2#1)(2008-10#1)(2008-4#1)
risk factor in##23##3##(1991-4#1)(1992-3#1)(1995-9#1)(1996-1#1)(1997-2#1)(2006-10#3)(2006-2#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-4#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-2#1)
risk factor intervention##2##3##(1992-9#1)(2008-7#1)
risk factor is a##2##4##(1993-5#1)(1994-2#1)
risk factor is##5##3##(1993-5#1)(1994-2#1)(1997-3#1)(2008-5#1)(2010-7#1)
risk factor levels in##2##4##(1991-6#1)(2008-7#1)
risk factor levels##4##3##(1990-4#1)(1991-6#2)(2008-7#1)
risk factor management##2##3##(2011-1#2)
risk factor of IHD##2##4##(2008-3#2)
risk factor of the##3##4##(1990-9#1)(2008-3#1)(2010-8#1)
risk factor of##20##3##(1990-9#1)(1994-12#1)(1994-4#1)(1996-1#1)(1996-6#1)(1996-8#1)(2006-6#1)(2007-11#1)(2008-1#2)(2008-3#3)(2008-4#1)(2008-8#1)(2009-10#1)(2010-8#1)(2011-1#2)(2011-2#1)
risk factor profile and##2##4##(2007-10#1)(2008-7#1)
risk factor profile##6##3##(2007-10#3)(2007-8#1)(2008-7#2)
risk factor profiles##2##3##(2007-9#1)(2008-3#1)
risk factor reduction##2##3##(2007-10#1)(2011-1#1)
risk factor screening##3##3##(1991-6#1)(1994-11#1)(1997-6#1)
risk factor such as##2##4##(1997-1#1)(2011-1#1)
risk factor to the development of##4##6##(2011-2#4)
risk factor to##6##3##(2009-8#1)(2011-1#1)(2011-2#4)
risk factor treatment##2##3##(2007-10#1)(2008-7#1)
risk factor was##3##3##(1990-6#1)(2011-1#1)(2013-8#1)
risk factor##431##2##(1990-12#3)(1990-2#1)(1990-4#1)(1990-6#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#3)(1992-11#1)(1992-12#3)(1992-3#1)(1992-4#2)(1992-8#1)(1992-9#4)(1993-1#1)(1993-11#2)(1993-2#1)(1993-5#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#5)(1994-4#3)(1994-5#2)(1994-7#2)(1995-10#1)(1995-2#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-5#1)(1996-6#4)(1996-8#3)(1997-1#3)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2005-10#4)(2005-11#2)(2005-12#1)(2005-7#2)(2005-8#2)(2006-10#20)(2006-12#2)(2006-2#12)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#6)(2006-9#1)(2007-1#3)(2007-10#18)(2007-11#12)(2007-2#5)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#6)(2007-9#9)(2008-1#12)(2008-10#4)(2008-11#5)(2008-12#6)(2008-2#1)(2008-3#16)(2008-4#6)(2008-5#7)(2008-6#2)(2008-7#7)(2008-8#7)(2008-9#2)(2009-10#4)(2009-11#2)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#3)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#7)(2010-2#3)(2010-4#4)(2010-5#1)(2010-7#5)(2010-8#4)(2010-9#3)(2011-1#15)(2011-11#1)(2011-12#4)(2011-2#33)(2012-1#5)(2012-11#2)(2012-12#4)(2012-2#14)(2012-3#6)(2012-5#1)(2013-1#10)(2013-7#4)(2013-8#5)
risk factor-adjusted##6##2##(1990-5#1)(2007-10#5)
risk factor-gene interaction##2##3##(2007-10#2)
risk factor?##3##2##(2008-6#1)(2012-12#1)(2013-1#1)
risk factors (age##2##3##(1993-2#1)(2013-1#1)
risk factors (e##4##3##(2005-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
risk factors affecting the##2##4##(2007-2#1)(2012-3#1)
risk factors among##11##3##(1991-9#1)(1996-7#1)(2006-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-7#1)(2013-8#3)
risk factors analysis##2##3##(2011-1#2)
risk factors and blood pressure in a##2##7##(1996-4#1)(2008-7#1)
risk factors and clinical signs and symptoms##2##7##(2006-11#1)(2007-9#1)
risk factors and clinical##6##4##(1992-12#1)(2006-11#1)(2007-10#2)(2007-11#1)(2007-9#1)
risk factors and complications##3##4##(2007-8#1)(2008-1#1)(2011-1#1)
risk factors and diseases##2##4##(2008-7#1)(2009-9#1)
risk factors and mortality##4##4##(2007-3#1)(2012-12#3)
risk factors and no##2##4##(2005-10#1)(2013-1#1)
risk factors and physical##2##4##(2006-8#1)(2008-5#1)
risk factors and preventive strategies##2##5##(1996-12#1)(2010-7#1)
risk factors and preventive##3##4##(1994-5#1)(1996-12#1)(2010-7#1)
risk factors and protective##2##4##(2010-2#1)(2011-1#1)
risk factors and the##5##4##(2007-12#1)(2008-5#1)(2010-6#1)(2011-1#1)(2013-1#1)
risk factors and their##4##4##(2006-10#1)(2008-10#1)(2011-2#2)
risk factors and to##3##4##(1995-8#1)(2008-7#1)(2011-2#1)
risk factors and underlying determinants##2##5##(2012-3#2)
risk factors and##121##3##(1991-12#1)(1992-12#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-12#1)(1996-4#1)(2005-10#1)(2006-10#6)(2006-11#1)(2006-2#2)(2006-6#1)(2006-8#1)(2007-10#6)(2007-11#2)(2007-12#6)(2007-2#2)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#1)(2008-11#2)(2008-2#2)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#1)(2009-5#1)(2009-7#3)(2009-9#1)(2010-2#1)(2010-4#1)(2010-6#2)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#7)(2012-1#1)(2012-11#2)(2012-12#5)(2012-2#5)(2012-3#5)(2013-1#3)(2013-7#1)(2013-8#1)
risk factors are associated with##2##5##(2008-11#1)(2010-6#1)
risk factors are discussed##2##4##(2006-8#1)(2010-9#1)
risk factors are more##2##4##(2008-1#1)(2008-9#1)
risk factors are not##4##4##(1992-4#1)(2005-10#1)(2011-1#2)
risk factors are presented##2##4##(2009-5#1)(2011-2#1)
risk factors are##36##3##(1991-7#1)(1992-12#1)(1992-4#3)(1994-11#1)(1995-8#1)(1996-11#1)(2005-10#1)(2006-12#1)(2006-8#2)(2007-10#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#2)(2010-9#1)(2011-1#3)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
risk factors as##5##3##(2007-8#1)(2007-9#1)(2008-1#1)(2008-3#2)
risk factors associated with diabetes##2##5##(2008-1#1)(2008-5#1)
risk factors associated with metabolic syndrome##3##6##(2008-1#2)(2008-3#1)
risk factors associated with the##4##5##(2008-3#1)(2009-5#1)(2011-2#1)(2012-12#1)
risk factors associated with this##4##5##(1990-12#1)(2008-1#1)(2012-2#1)(2013-8#1)
risk factors associated with##42##4##(1990-12#1)(1993-11#1)(1993-12#1)(1994-8#1)(1995-5#1)(1996-2#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#2)(2009-11#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
risk factors associated##43##3##(1990-12#1)(1993-11#1)(1993-12#1)(1994-8#1)(1995-5#1)(1996-2#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-7#1)(2007-8#3)(2008-1#4)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#2)(2009-11#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
risk factors at delivery##2##4##(1994-6#2)
risk factors at the##2##4##(1991-12#1)(2009-4#1)
risk factors at##6##3##(1991-12#1)(1994-6#2)(2007-1#1)(2009-4#1)(2012-2#1)
risk factors before##2##3##(2007-10#1)(2009-7#1)
risk factors being##2##3##(2007-12#1)(2009-8#1)
risk factors can##2##3##(2007-9#1)(2012-2#1)
risk factors compared to##2##4##(2009-8#1)(2013-1#1)
risk factors could##2##3##(2011-2#1)(2012-2#1)
risk factors do not##3##4##(1992-9#1)(2008-4#1)(2010-9#1)
risk factors during##2##3##(1992-12#1)(2004-11#1)
risk factors for ARF##2##4##(2007-12#1)(2007-8#1)
risk factors for AVN##2##4##(2007-8#2)
risk factors for CAD##3##4##(1996-2#1)(2010-9#1)(2011-1#1)
risk factors for CHD##2##4##(2005-10#1)(2013-8#1)
risk factors for CVD##3##4##(2008-1#1)(2008-7#1)(2012-2#1)
risk factors for HCC##3##4##(2006-10#1)(2009-8#1)(2013-8#1)
risk factors for HIV infection##2##5##(2007-12#1)(2008-5#1)
risk factors for PAD##2##4##(2010-4#2)
risk factors for SIDS##4##4##(1991-2#1)(1992-11#2)(2008-1#1)
risk factors for adult##3##4##(1997-8#1)(2013-1#2)
risk factors for and##2##4##(2007-5#1)(2008-1#1)
risk factors for atherosclerosis and##2##5##(2005-10#1)(2008-10#1)
risk factors for atherosclerosis##4##4##(2005-10#1)(2007-10#2)(2008-10#1)
risk factors for atherosclerotic##2##4##(2007-10#1)(2010-9#1)
risk factors for cardiovascular disease##10##5##(1990-11#1)(1991-12#1)(1992-12#1)(2006-10#1)(2006-12#1)(2008-3#2)(2011-1#1)(2012-2#1)(2013-7#1)
risk factors for cardiovascular diseases##7##5##(1990-12#1)(1990-8#1)(1994-11#1)(2004-11#2)(2008-3#1)(2012-12#1)
risk factors for cardiovascular##19##4##(1990-11#1)(1990-12#1)(1990-8#1)(1991-12#1)(1992-12#1)(1994-11#1)(2004-11#2)(2006-10#1)(2006-12#1)(2006-2#1)(2008-3#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
risk factors for cerebral##3##4##(1997-5#1)(2006-10#1)(2007-10#1)
risk factors for cholera##2##4##(2008-1#2)
risk factors for chronic disease##4##5##(1993-3#2)(2005-10#2)
risk factors for chronic##5##4##(1993-3#2)(2005-10#2)(2011-1#1)
risk factors for coronary artery disease##3##6##(1993-2#1)(2006-9#1)(2007-8#1)
risk factors for coronary heart disease and##2##7##(1990-3#1)(2008-12#1)
risk factors for coronary heart disease##4##6##(1990-3#1)(2006-10#1)(2008-12#2)
risk factors for coronary##9##4##(1990-3#1)(1993-12#1)(1993-2#1)(2006-10#1)(2006-9#1)(2007-8#1)(2008-12#2)(2012-2#1)
risk factors for dental##3##4##(2011-2#2)(2012-2#1)
risk factors for developing##4##4##(2006-10#1)(2008-8#1)(2010-7#1)(2013-8#1)
risk factors for development of##2##5##(2008-12#1)(2008-4#1)
risk factors for drunk driving##2##5##(2013-7#2)
risk factors for eating disorders##2##5##(2006-12#2)
risk factors for falls##3##4##(2007-8#1)(2008-3#1)(2008-7#1)
risk factors for future##2##4##(2006-2#1)(2008-3#1)
risk factors for gastrointestinal##2##4##(2006-10#1)(2011-1#1)
risk factors for heart failure##2##5##(2008-3#1)(2010-8#1)
risk factors for heart##3##4##(2008-3#1)(2010-8#1)(2011-2#1)
risk factors for hepatitis##2##4##(2007-6#1)(2013-8#1)
risk factors for hypertension##3##4##(2008-3#1)(2008-4#1)(2011-1#1)
risk factors for incident##2##4##(1994-2#1)(2010-12#1)
risk factors for increased##2##4##(2007-11#1)(2007-8#1)
risk factors for infection##5##4##(1991-7#1)(2006-8#1)(2007-2#1)(2008-12#1)(2008-7#1)
risk factors for misbehaviour##2##4##(2012-12#2)
risk factors for mortality##2##4##(2007-8#1)(2011-3#1)
risk factors for oral cancer##3##5##(2011-2#3)
risk factors for postoperative##4##4##(2006-10#2)(2010-7#1)(2012-2#1)
risk factors for progression##3##4##(1992-8#1)(2008-1#1)(2008-9#1)
risk factors for pulmonary##2##4##(2010-10#1)(2011-2#1)
risk factors for sepsis-related mortality in##2##6##(2010-2#2)
risk factors for some forms of diabetes mellitus and neurodegenerative diseases##2##11##(1995-7#1)(1996-6#1)
risk factors for spontaneous##2##4##(2007-10#1)(2013-7#1)
risk factors for stroke##9##4##(2007-10#5)(2007-9#2)(2008-8#1)(2012-2#1)
risk factors for sudden death##3##5##(1997-1#2)(2010-11#1)
risk factors for sudden##4##4##(1997-1#2)(2010-11#1)(2011-1#1)
risk factors for suicidal##2##4##(2012-1#1)(2013-7#1)
risk factors for suicide##3##4##(2008-11#1)(2009-7#1)(2013-8#1)
risk factors for the development of##9##6##(1991-3#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-7#1)
risk factors for the##20##4##(1991-3#1)(1993-9#1)(1995-4#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
risk factors for these##3##4##(1996-2#1)(2009-10#1)(2012-1#1)
risk factors for this##4##4##(2008-10#1)(2008-7#1)(2013-1#2)
risk factors for thromboembolism##4##4##(1991-8#1)(1995-9#1)(2006-8#1)(2008-7#1)
risk factors for vascular##3##4##(2008-1#3)
risk factors for violence##2##4##(2011-1#1)(2013-8#1)
risk factors for##341##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#2)(1991-8#1)(1992-11#2)(1992-12#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-9#3)(1994-11#1)(1994-2#2)(1994-3#1)(1995-4#1)(1995-6#5)(1995-7#1)(1995-9#1)(1996-2#2)(1996-6#1)(1997-1#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#1)(2004-10#1)(2004-11#2)(2005-10#4)(2005-11#1)(2005-3#1)(2005-7#1)(2005-8#3)(2006-10#16)(2006-12#3)(2006-2#3)(2006-6#1)(2006-7#3)(2006-8#4)(2006-9#1)(2007-1#2)(2007-10#15)(2007-11#6)(2007-12#3)(2007-2#4)(2007-3#2)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#11)(2007-9#2)(2008-1#10)(2008-10#4)(2008-11#3)(2008-12#5)(2008-3#9)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#12)(2008-8#6)(2008-9#1)(2009-10#1)(2009-2#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-10#4)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#4)(2010-7#3)(2010-8#2)(2010-9#5)(2011-1#13)(2011-2#28)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#7)(2012-2#13)(2012-3#4)(2013-1#22)(2013-7#8)(2013-8#10)
risk factors from##3##3##(2013-1#3)
risk factors has##2##3##(2007-10#1)(2008-3#1)
risk factors have been##4##4##(2007-10#1)(2007-12#1)(2007-7#1)(2010-12#1)
risk factors have##6##3##(2007-10#1)(2007-12#1)(2007-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
risk factors identified were##2##4##(2009-10#2)
risk factors identified##4##3##(2006-6#1)(2008-10#1)(2009-10#2)
risk factors in Saudi##2##4##(2006-2#2)
risk factors in a##9##4##(1993-10#1)(2008-3#1)(2009-6#2)(2010-4#2)(2012-2#1)(2013-8#2)
risk factors in an##5##4##(1993-12#1)(2007-9#1)(2008-5#1)(2012-11#2)
risk factors in hypertension##2##4##(1992-8#1)(2009-1#1)
risk factors in medical##2##4##(2012-2#2)
risk factors in patients with##4##5##(2007-10#1)(2007-9#1)(2011-2#1)(2012-1#1)
risk factors in patients##5##4##(2007-10#1)(2007-9#2)(2011-2#1)(2012-1#1)
risk factors in relation to##2##5##(2007-12#1)(2012-2#1)
risk factors in the occurrence of##2##6##(2011-2#1)(2013-1#1)
risk factors in the##27##4##(1992-2#1)(1995-8#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#12)
risk factors in these##2##4##(1996-2#1)(2007-2#1)
risk factors in young adults##2##5##(2012-12#2)
risk factors in##98##3##(1991-12#1)(1992-2#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-8#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-2#2)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-7#1)(2007-9#5)(2008-1#2)(2008-10#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2009-1#1)(2009-4#1)(2009-6#4)(2009-7#1)(2010-1#1)(2010-3#1)(2010-4#3)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#7)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#5)(2013-1#3)(2013-8#17)
risk factors include##5##3##(2005-10#1)(2007-7#1)(2008-2#1)(2008-7#1)(2013-1#1)
risk factors included##3##3##(2006-10#1)(2007-8#1)(2011-2#1)
risk factors involved##2##3##(1990-6#1)(2008-3#1)
risk factors is##8##3##(1990-9#1)(1995-8#1)(2005-10#1)(2008-1#1)(2009-2#1)(2010-8#1)(2010-9#1)(2012-2#1)
risk factors like##2##3##(2007-10#1)(2009-4#1)
risk factors likely to##2##4##(1997-4#1)(2006-8#1)
risk factors may be##2##4##(2010-4#1)(2013-1#1)
risk factors may##8##3##(2010-4#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#4)
risk factors measured at##3##4##(2008-7#3)
risk factors of atherosclerosis##2##4##(2008-3#1)(2008-7#1)
risk factors of cardiovascular diseases##2##5##(2008-11#1)(2009-10#1)
risk factors of cardiovascular##3##4##(2008-11#1)(2008-4#1)(2009-10#1)
risk factors of cerebrovascular##2##4##(2007-10#1)(2011-2#1)
risk factors of hypertension##2##4##(2008-1#1)(2008-11#1)
risk factors of interest##2##4##(1994-2#1)(2008-7#1)
risk factors of metabolic syndrome##2##5##(2012-2#1)(2013-1#1)
risk factors of the disease was##2##6##(1990-9#2)
risk factors of the disease##3##5##(1990-9#2)(2010-8#1)
risk factors of the##6##4##(1990-9#2)(2005-10#1)(2007-11#1)(2010-8#1)(2013-1#1)
risk factors of venous##2##4##(1993-5#1)(1996-9#1)
risk factors of##81##3##(1990-9#2)(1993-5#1)(1994-12#2)(1994-2#2)(1995-7#1)(1996-6#1)(1996-9#1)(1997-4#1)(2005-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-7#1)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-11#1)(2011-12#1)(2011-2#8)(2012-12#5)(2012-2#3)(2013-1#4)(2013-7#2)(2013-8#8)
risk factors on the abundance##2##5##(2009-5#2)
risk factors on the##4##4##(2004-10#1)(2005-10#1)(2009-5#2)
risk factors on##10##3##(1990-6#1)(1992-9#1)(2004-10#1)(2005-10#1)(2006-12#1)(2009-5#2)(2011-1#1)(2013-1#2)
risk factors or##5##3##(1991-8#1)(2007-10#2)(2008-12#1)(2013-1#1)
risk factors other than the##2##5##(2013-8#2)
risk factors related to the##3##5##(2005-12#1)(2008-1#1)(2011-1#1)
risk factors related to##9##4##(1992-7#1)(2005-12#1)(2008-1#1)(2008-2#1)(2008-7#1)(2010-2#1)(2011-1#2)(2011-2#1)
risk factors remains##2##3##(2011-2#1)(2012-3#1)
risk factors should be##2##4##(2004-3#1)(2005-8#1)
risk factors showed##2##3##(1996-12#1)(2012-12#1)
risk factors such as age##2##5##(1991-10#1)(1995-8#1)
risk factors such as diabetes and##2##6##(1996-9#1)(2011-2#1)
risk factors such as hypertension##3##5##(2007-10#1)(2008-11#1)(2008-7#1)
risk factors such as smoking and##2##6##(2008-3#1)(2010-7#1)
risk factors such as smoking##3##5##(2007-2#1)(2008-3#1)(2010-7#1)
risk factors such as the##2##5##(2005-7#1)(2013-8#1)
risk factors such as##28##4##(1990-12#1)(1991-10#1)(1991-9#1)(1995-7#1)(1995-8#1)(1996-9#1)(2005-7#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-11#2)(2008-3#2)(2008-7#2)(2009-4#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
risk factors than##2##3##(2007-11#1)(2009-5#1)
risk factors that are unique##2##5##(2011-2#1)(2012-12#1)
risk factors that are##3##4##(2008-7#1)(2011-2#1)(2012-12#1)
risk factors that have been##2##5##(2005-11#1)(2013-1#1)
risk factors that##18##3##(1992-1#1)(2005-11#1)(2006-10#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-6#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#3)(2013-8#1)
risk factors to be##2##4##(2007-10#1)(2012-12#1)
risk factors to predict##2##4##(1994-2#1)(2013-8#1)
risk factors to the##3##4##(1997-6#1)(2011-2#1)(2013-1#1)
risk factors to##15##3##(1990-3#1)(1992-4#1)(1993-3#1)(1994-2#1)(1997-6#1)(2006-2#1)(2007-10#2)(2007-8#1)(2008-4#1)(2009-12#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
risk factors varied##2##3##(2009-7#1)(2011-2#1)
risk factors viz##2##3##(2011-2#2)
risk factors was##10##3##(1991-6#1)(1992-4#1)(1996-8#1)(2007-10#1)(2007-9#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
risk factors were considered##2##4##(2006-8#1)(2010-2#1)
risk factors were identified##2##4##(1993-12#1)(2009-3#1)
risk factors were measured at##2##5##(2008-3#1)(2010-7#1)
risk factors were similar##2##4##(2007-10#1)(2011-2#1)
risk factors were##30##3##(1991-6#1)(1992-4#1)(1992-6#1)(1993-12#1)(2004-10#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-3#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
risk factors which##3##3##(1991-2#1)(1993-9#1)(2008-11#1)
risk factors with##4##3##(2005-10#1)(2006-6#1)(2011-2#2)
risk factors within##3##3##(2005-10#1)(2013-1#2)
risk factors##1413##2##(1990-11#1)(1990-12#6)(1990-3#2)(1990-5#1)(1990-6#3)(1990-8#2)(1990-9#3)(1991-10#1)(1991-12#7)(1991-2#4)(1991-3#2)(1991-4#2)(1991-6#3)(1991-7#6)(1991-8#2)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#5)(1992-12#6)(1992-2#1)(1992-4#6)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#9)(1993-2#5)(1993-3#7)(1993-5#1)(1993-9#10)(1994-11#2)(1994-12#2)(1994-2#10)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#3)(1994-8#2)(1995-10#2)(1995-12#2)(1995-4#2)(1995-5#1)(1995-6#5)(1995-7#3)(1995-8#5)(1995-9#2)(1996-1#1)(1996-11#3)(1996-12#2)(1996-2#4)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#3)(1996-7#1)(1996-8#4)(1996-9#6)(1997-1#3)(1997-2#1)(1997-3#4)(1997-4#4)(1997-5#2)(1997-6#3)(1997-8#6)(2004-10#4)(2004-11#3)(2004-12#1)(2004-3#1)(2005-10#23)(2005-11#4)(2005-12#2)(2005-3#1)(2005-6#2)(2005-7#4)(2005-8#6)(2006-10#36)(2006-11#2)(2006-12#6)(2006-2#17)(2006-3#1)(2006-4#1)(2006-6#9)(2006-7#3)(2006-8#17)(2006-9#3)(2007-1#6)(2007-10#60)(2007-11#20)(2007-12#25)(2007-2#17)(2007-3#4)(2007-5#4)(2007-6#8)(2007-7#19)(2007-8#29)(2007-9#24)(2008-1#38)(2008-10#14)(2008-11#21)(2008-12#7)(2008-2#7)(2008-3#46)(2008-4#16)(2008-5#12)(2008-6#10)(2008-7#46)(2008-8#19)(2008-9#6)(2009-1#1)(2009-10#8)(2009-11#1)(2009-12#3)(2009-2#3)(2009-3#1)(2009-4#7)(2009-5#17)(2009-6#8)(2009-7#14)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#6)(2010-11#6)(2010-12#12)(2010-2#9)(2010-3#4)(2010-4#16)(2010-5#2)(2010-6#6)(2010-7#18)(2010-8#11)(2010-9#18)(2011-1#56)(2011-11#1)(2011-12#1)(2011-2#95)(2011-3#1)(2012-1#11)(2012-11#5)(2012-12#38)(2012-2#42)(2012-3#17)(2013-1#78)(2013-3#2)(2013-4#2)(2013-7#12)(2013-8#61)
risk factors)##5##2##(1990-6#1)(1995-9#1)(2006-10#1)(2007-10#2)
risk factors]##7##2##(1990-12#1)(1990-9#1)(1995-4#1)(1996-12#1)(2008-10#2)(2012-2#1)
risk for AD##2##3##(1996-1#1)(1996-6#1)
risk for Alzheimer's##2##3##(2009-10#1)(2011-2#1)
risk for CHD##2##3##(1990-7#1)(2005-10#1)
risk for CMM formation##2##4##(2007-10#2)
risk for CP##2##3##(2006-10#1)(2011-2#1)
risk for CVD is##3##4##(2005-10#1)(2011-1#1)(2013-8#1)
risk for CVD##4##3##(2005-10#1)(2008-1#1)(2011-1#1)(2013-8#1)
risk for HCC##3##3##(2010-12#3)
risk for HIV and##2##4##(1997-5#1)(2012-3#1)
risk for HIV infection##4##4##(1992-2#2)(1996-5#1)(2012-11#1)
risk for HIV##9##3##(1992-2#3)(1996-5#1)(1997-5#1)(2009-12#1)(2012-11#1)(2012-3#1)(2013-1#1)
risk for MS##3##3##(2011-2#2)(2013-1#1)
risk for VAPP##4##3##(1997-1#2)(2004-12#2)
risk for a##10##3##(1997-8#1)(2006-10#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-4#2)(2012-12#1)(2012-3#1)(2013-1#1)
risk for acute##3##3##(2007-8#1)(2008-10#1)(2012-12#1)
risk for adjustment problems##3##4##(2009-8#3)
risk for adult##2##3##(2004-11#1)(2010-4#1)
risk for adverse##2##3##(2005-8#1)(2009-10#1)
risk for alcoholism##3##3##(1991-1#1)(1994-2#2)
risk for all##3##3##(2006-11#1)(2007-4#1)(2013-1#1)
risk for an##2##3##(2008-5#1)(2008-7#1)
risk for and##2##3##(2007-8#1)(2009-12#1)
risk for another##2##3##(2006-10#1)(2013-7#1)
risk for atherosclerosis##2##3##(2007-10#1)(2008-1#1)
risk for becoming infected##2##4##(1996-8#1)(2005-7#1)
risk for bladder cancer##5##4##(2006-9#1)(2008-4#3)(2010-2#1)
risk for body image dissatisfaction##2##5##(2007-12#1)(2012-2#1)
risk for body image##3##4##(2006-7#1)(2007-12#1)(2012-2#1)
risk for both##6##3##(1993-12#2)(2006-8#1)(2008-1#1)(2008-7#1)(2010-10#1)
risk for breast cancer##3##4##(1995-9#1)(2010-7#1)(2011-2#1)
risk for breast##4##3##(1995-9#1)(2007-8#1)(2010-7#1)(2011-2#1)
risk for cancer##3##3##(2006-10#1)(2007-4#1)(2008-7#1)
risk for cancers##3##3##(1995-9#1)(2009-7#1)(2012-2#1)
risk for cardiovascular disease##7##4##(2007-10#1)(2007-8#1)(2008-1#1)(2008-3#2)(2009-1#1)(2009-6#1)
risk for cardiovascular events and##3##5##(2008-3#1)(2012-2#1)(2013-8#1)
risk for cardiovascular events##10##4##(2008-3#1)(2010-4#1)(2011-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
risk for cardiovascular##21##3##(2007-1#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-3#3)(2009-1#1)(2009-6#1)(2010-4#1)(2010-6#2)(2011-12#1)(2012-2#2)(2013-1#5)(2013-8#1)
risk for cerebrovascular disease##2##4##(1996-2#1)(2007-9#1)
risk for chronic##3##3##(2006-12#1)(2008-1#1)(2008-4#1)
risk for colorectal##2##3##(1997-5#1)(2007-4#1)
risk for complications from##2##4##(2007-3#1)(2012-2#1)
risk for complications##4##3##(1990-11#1)(2007-3#1)(2011-2#1)(2012-2#1)
risk for congenital malformations##2##4##(1990-5#2)
risk for coronary artery disease##2##5##(1993-12#1)(1993-9#1)
risk for coronary##4##3##(1990-3#1)(1993-12#1)(1993-9#1)(1996-11#1)
risk for developing breast cancer##2##5##(1993-1#1)(2007-11#1)
risk for developing cancer##2##4##(1991-5#1)(2006-10#1)
risk for developing##29##3##(1990-12#1)(1991-10#1)(1991-5#1)(1993-1#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-9#2)(2008-1#1)(2008-12#3)(2008-2#1)(2008-7#2)(2009-3#2)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
risk for development of##10##4##(1993-9#1)(2005-11#1)(2006-10#2)(2006-6#2)(2008-3#1)(2008-7#1)(2009-11#1)(2011-2#1)
risk for disease##2##3##(2006-2#1)(2007-2#1)
risk for disordered##2##3##(2009-2#2)
risk for dyslexia##3##3##(2007-9#2)(2008-11#1)
risk for each##2##3##(2005-10#1)(2012-2#1)
risk for eating##3##3##(2006-7#2)(2007-12#1)
risk for esophageal##2##3##(1992-9#1)(2006-10#1)
risk for future##2##3##(1991-2#1)(2009-7#1)
risk for graft failure##4##4##(2007-8#4)
risk for having##2##3##(1994-12#1)(2008-1#1)
risk for health##2##3##(2004-4#1)(2009-5#1)
risk for hepatocellular carcinoma##2##4##(2008-1#1)(2011-2#1)
risk for heterosexual HIV transmission##2##5##(2006-10#1)(2013-1#1)
risk for human##2##3##(1990-8#1)(2012-12#1)
risk for hypertension##2##3##(1996-9#1)(2009-9#1)
risk for individuals##2##3##(1996-6#1)(2011-1#1)
risk for infection with##2##4##(2007-12#1)(2012-12#1)
risk for infection##7##3##(2007-12#1)(2008-10#1)(2009-9#1)(2010-2#1)(2011-2#2)(2012-12#1)
risk for injury##2##3##(2006-8#1)(2010-5#1)
risk for insulin resistance##2##4##(2010-5#1)(2011-1#1)
risk for late##2##3##(1997-1#1)(1997-6#1)
risk for local##3##3##(2008-6#3)
risk for low birth weight##2##5##(1993-3#1)(2007-3#1)
risk for low##3##3##(1993-3#1)(2007-3#1)(2011-12#1)
risk for malignant##3##3##(2007-12#2)(2007-6#1)
risk for more##3##3##(1991-2#1)(2007-11#1)(2010-12#1)
risk for mortality##3##3##(2007-10#1)(2007-8#1)(2012-2#1)
risk for myocardial##2##3##(2006-10#1)(2007-9#1)
risk for osteoporosis##3##3##(2006-10#1)(2008-3#1)(2008-7#1)
risk for other##3##3##(1996-9#1)(1997-5#1)(2012-2#1)
risk for patients##7##3##(1991-12#1)(2006-8#1)(2007-7#1)(2008-12#1)(2008-5#1)(2009-11#1)(2012-3#1)
risk for perioperative##3##3##(2007-12#1)(2008-3#1)(2010-9#1)
risk for physical##2##3##(1995-1#1)(2008-12#1)
risk for poor##4##3##(1996-12#1)(2008-12#1)(2010-5#1)(2013-1#1)
risk for postoperative##2##3##(2006-10#1)(2007-8#1)
risk for potential##2##3##(1994-6#1)(2013-1#1)
risk for progression##3##3##(2006-9#1)(2008-7#1)(2013-1#1)
risk for pulmonary##3##3##(2006-10#2)(2013-8#1)
risk for recurrence##4##3##(1991-8#1)(2006-10#1)(2007-8#1)(2008-4#1)
risk for relapse##7##3##(2007-11#1)(2007-12#1)(2007-5#2)(2007-6#1)(2008-1#1)(2010-12#1)
risk for schizophrenia##2##3##(2006-9#1)(2011-1#1)
risk for school##2##3##(1994-1#1)(2005-10#1)
risk for serious##2##3##(2007-12#1)(2009-12#1)
risk for smoking initiation##2##4##(2008-8#2)
risk for some##2##3##(1997-2#1)(2008-11#1)
risk for subsequent##4##3##(2007-10#1)(2008-11#1)(2008-7#2)
risk for substance##2##3##(1997-5#1)(2009-12#1)
risk for such##3##3##(2006-2#1)(2006-6#1)(2009-3#1)
risk for sudden##2##3##(2006-9#1)(2008-10#1)
risk for surgical##2##3##(2006-12#2)
risk for the development of##10##5##(1992-8#1)(1996-4#1)(1997-7#1)(2005-10#1)(2005-8#1)(2006-10#1)(2008-12#1)(2008-8#1)(2009-1#1)(2009-9#1)
risk for the development##11##4##(1992-8#1)(1996-4#1)(1997-7#1)(2004-3#1)(2005-10#1)(2005-8#1)(2006-10#1)(2008-12#1)(2008-8#1)(2009-1#1)(2009-9#1)
risk for the disorder##2##4##(2006-10#2)
risk for the patient##2##4##(1995-9#1)(2006-10#1)
risk for the##38##3##(1990-12#1)(1991-12#1)(1991-5#1)(1992-8#1)(1995-6#1)(1995-9#1)(1996-4#1)(1997-7#1)(2004-3#2)(2005-10#1)(2005-8#1)(2006-10#5)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-1#1)(2009-10#1)(2009-9#1)(2010-4#2)(2012-3#1)
risk for these##4##3##(1993-1#1)(1993-4#1)(1993-5#1)(2006-2#1)
risk for this complication##2##4##(2005-12#1)(2011-2#1)
risk for this##6##3##(1996-6#1)(2005-12#1)(2011-2#2)(2012-12#1)(2013-7#1)
risk for those##2##3##(1993-12#1)(2011-2#1)
risk for tuberculosis##2##3##(1997-7#1)(2006-6#1)
risk for tumor##3##3##(2007-10#1)(2008-7#2)
risk for venous thrombosis##2##4##(2006-10#1)(2006-2#1)
risk for venous##5##3##(2006-10#1)(2006-2#1)(2010-2#1)(2013-1#2)
risk for violence##4##3##(2005-6#1)(2009-7#1)(2013-1#1)(2013-8#1)
risk for##630##2##(1990-11#1)(1990-12#2)(1990-3#3)(1990-5#4)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#3)(1991-8#3)(1992-2#6)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#3)(1994-1#1)(1994-12#1)(1994-2#2)(1994-6#2)(1995-1#1)(1995-10#1)(1995-2#1)(1995-6#1)(1995-7#1)(1995-9#3)(1996-1#1)(1996-11#1)(1996-12#5)(1996-2#4)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#4)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#1)(1997-3#1)(1997-5#5)(1997-6#1)(1997-7#2)(1997-8#2)(2004-11#2)(2004-12#3)(2004-2#1)(2004-3#2)(2004-4#1)(2005-10#7)(2005-11#1)(2005-12#1)(2005-6#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#35)(2006-11#1)(2006-12#5)(2006-2#6)(2006-5#1)(2006-6#5)(2006-7#5)(2006-8#6)(2006-9#4)(2007-1#4)(2007-10#13)(2007-11#9)(2007-12#17)(2007-2#5)(2007-3#6)(2007-4#9)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#22)(2007-9#6)(2008-1#15)(2008-10#14)(2008-11#18)(2008-12#14)(2008-2#1)(2008-3#9)(2008-4#8)(2008-5#6)(2008-6#5)(2008-7#17)(2008-8#7)(2008-9#1)(2009-1#2)(2009-10#3)(2009-11#2)(2009-12#5)(2009-2#4)(2009-3#7)(2009-5#2)(2009-6#1)(2009-7#6)(2009-8#4)(2009-9#5)(2010-10#4)(2010-12#9)(2010-2#3)(2010-4#11)(2010-5#3)(2010-6#3)(2010-7#6)(2010-8#2)(2010-9#3)(2011-1#12)(2011-11#1)(2011-12#2)(2011-2#28)(2012-1#1)(2012-11#1)(2012-12#18)(2012-2#17)(2012-3#7)(2013-1#37)(2013-7#5)(2013-8#8)
risk from coronary##2##3##(2005-10#1)(2008-10#1)
risk from low##2##3##(2008-7#1)(2013-1#1)
risk from radiation##2##3##(2008-7#1)(2013-1#1)
risk from##21##2##(1996-8#1)(2005-10#1)(2006-10#1)(2007-4#2)(2008-10#1)(2008-3#1)(2008-7#5)(2010-12#1)(2011-2#2)(2012-12#3)(2013-1#3)
risk function that##2##3##(2006-11#1)(2007-1#1)
risk function##5##2##(1995-8#2)(2006-11#1)(2007-1#1)(2009-5#1)
risk functions for##3##3##(2007-1#1)(2007-4#2)
risk functions##6##2##(1995-8#1)(2007-1#3)(2007-4#2)
risk group and##4##3##(1993-5#1)(2011-2#2)(2012-12#1)
risk group for##8##3##(1992-9#1)(2006-2#1)(2006-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#2)
risk group in##3##3##(2007-11#1)(2008-7#1)(2011-1#1)
risk group of##2##3##(2008-5#1)(2012-3#1)
risk group##40##2##(1992-9#2)(1993-5#1)(1994-11#1)(1995-4#1)(1997-6#1)(2006-2#1)(2006-8#1)(2007-11#3)(2007-2#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-2#1)(2009-8#2)(2011-1#1)(2011-2#9)(2012-12#3)(2012-3#3)(2013-1#1)
risk groups by##2##3##(2010-7#1)(2011-2#1)
risk groups for##3##3##(2007-8#2)(2008-8#1)
risk groups in##2##3##(2006-12#1)(2011-2#1)
risk groups is##3##3##(2005-11#1)(2010-9#1)(2013-8#1)
risk groups of##2##3##(1995-5#1)(2012-2#1)
risk groups##44##2##(1990-12#1)(1990-3#1)(1990-9#1)(1993-11#1)(1995-1#1)(1995-5#1)(2005-11#1)(2006-12#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#5)(2012-2#1)(2013-1#5)(2013-8#3)
risk has been##3##3##(2007-10#1)(2008-5#1)(2013-8#1)
risk has not been##2##4##(2008-12#1)(2013-8#1)
risk has##6##2##(2007-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2013-8#2)
risk have been##2##3##(1993-5#1)(2010-5#1)
risk have##5##2##(1993-5#1)(2007-9#1)(2008-12#1)(2008-7#1)(2010-5#1)
risk held##2##2##(2007-2#1)(2009-8#1)
risk if##3##2##(1990-5#1)(2006-10#1)(2013-7#1)
risk in a population##2##4##(2008-7#1)(2008-9#1)
risk in a##7##3##(1994-12#1)(1995-11#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#2)
risk in an##2##3##(2010-5#1)(2012-1#1)
risk in both##2##3##(2005-12#1)(2008-7#1)
risk in case-control studies##3##4##(1995-9#1)(1996-7#2)
risk in children##2##3##(2006-10#1)(2013-1#1)
risk in dental##2##3##(1991-6#1)(2007-1#1)
risk in only##2##3##(2007-4#1)(2011-12#1)
risk in order to##2##4##(2005-10#1)(2008-7#1)
risk in patients undergoing##2##4##(2006-10#1)(2009-12#1)
risk in patients with##6##4##(2007-9#1)(2008-8#1)(2009-11#1)(2010-12#1)(2012-2#1)(2013-8#1)
risk in patients##8##3##(2006-10#1)(2007-9#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-12#1)(2012-2#1)(2013-8#1)
risk in relation to##4##4##(2007-4#1)(2008-8#1)(2011-1#1)(2012-2#1)
risk in the elderly##4##4##(2007-9#3)(2008-11#1)
risk in the general population##2##5##(2005-10#1)(2011-1#1)
risk in the##28##3##(1991-3#1)(1991-8#1)(1992-2#1)(1992-6#1)(1994-3#1)(1997-5#1)(2005-10#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-9#3)(2008-10#1)(2008-11#2)(2008-8#2)(2009-11#1)(2009-12#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#2)(2012-2#1)
risk in these patients##3##4##(2006-6#1)(2008-1#1)(2008-3#1)
risk in these##4##3##(2005-10#1)(2006-6#1)(2008-1#1)(2008-3#1)
risk in type##3##3##(2008-3#1)(2008-7#1)(2013-1#1)
risk in which##2##3##(2006-5#1)(2008-8#1)
risk in women##4##3##(1990-6#1)(2007-8#1)(2010-12#2)
risk in##165##2##(1990-6#3)(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-12#2)(1994-2#2)(1994-3#1)(1995-11#1)(1995-12#1)(1995-9#3)(1996-3#1)(1996-4#1)(1996-7#2)(1997-1#1)(1997-5#2)(1997-8#1)(2005-10#4)(2005-12#1)(2005-8#1)(2006-10#5)(2006-11#2)(2006-2#3)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#2)(2007-2#1)(2007-4#4)(2007-5#1)(2007-8#2)(2007-9#6)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#3)(2008-5#2)(2008-7#10)(2008-8#10)(2008-9#2)(2009-11#5)(2009-12#2)(2009-3#2)(2010-11#1)(2010-12#7)(2010-2#1)(2010-4#2)(2010-5#2)(2011-1#2)(2011-11#1)(2011-12#2)(2011-2#4)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#9)(2012-6#1)(2013-1#4)(2013-7#1)(2013-8#2)
risk include##3##2##(1997-3#1)(2009-12#1)(2010-7#1)
risk increase##3##2##(2009-10#2)(2012-2#1)
risk increased##2##2##(1992-9#1)(2013-4#1)
risk index##3##2##(2006-2#1)(2008-10#1)(2010-4#1)
risk indexes##2##2##(1991-11#1)(2009-10#1)
risk indicator of##3##3##(1990-9#1)(2005-10#1)(2008-7#1)
risk indicator##5##2##(1990-9#1)(2005-10#1)(2008-7#1)(2010-8#1)(2012-3#1)
risk indicators##3##2##(2008-7#1)(2010-4#1)(2010-9#1)
risk indices##2##2##(2012-1#1)(2012-3#1)
risk infants##4##2##(1993-12#1)(2007-11#1)(2008-11#1)(2009-5#1)
risk information##8##2##(1995-9#1)(2010-2#1)(2013-1#6)
risk involved##3##2##(1992-12#1)(2008-11#1)(2011-2#1)
risk is a##2##3##(1992-3#1)(2010-9#1)
risk is achieved##2##3##(2010-2#2)
risk is compounded##2##3##(1994-2#1)(2010-7#1)
risk is considered##2##3##(2008-1#1)(2012-2#1)
risk is high##3##3##(1993-9#1)(2013-1#2)
risk is higher##2##3##(2007-8#1)(2012-2#1)
risk is in##2##3##(2004-3#1)(2008-8#1)
risk is the##4##3##(2007-4#1)(2008-1#1)(2008-5#1)(2013-8#1)
risk is very##3##3##(2005-8#1)(2008-7#1)(2011-1#1)
risk is##63##2##(1990-11#1)(1990-2#1)(1990-6#1)(1991-3#1)(1992-3#1)(1993-9#1)(1994-2#3)(1995-10#1)(1996-11#1)(1996-3#1)(1996-7#1)(2004-3#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#2)(2007-8#2)(2008-1#2)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-5#1)(2010-12#1)(2010-2#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#2)(2013-1#2)(2013-8#2)
risk issues##2##2##(2008-11#1)(2009-4#1)
risk lesions)##2##2##(1994-6#1)(2011-2#1)
risk level of##3##3##(2008-10#1)(2008-3#1)(2012-12#1)
risk level##10##2##(1991-6#2)(1997-8#2)(2006-8#1)(2007-8#1)(2008-10#1)(2008-3#1)(2012-12#1)(2012-3#1)
risk levels of latent infection##2##5##(2008-10#2)
risk levels of##3##3##(1997-8#1)(2008-10#2)
risk levels##7##2##(1995-9#1)(1997-8#1)(2008-10#2)(2009-8#1)(2011-2#1)(2012-12#1)
risk management and##5##3##(1990-12#1)(1991-12#1)(1994-2#1)(2008-8#1)(2013-1#1)
risk management consulting##2##3##(2009-9#2)
risk management issues##3##3##(1993-1#1)(1993-2#1)(2008-11#1)
risk management policies##2##3##(2012-3#1)(2013-1#1)
risk management program##4##3##(1991-12#1)(1993-2#1)(2008-8#1)(2013-1#1)
risk management programs##2##3##(1991-12#1)(1996-1#1)
risk management services##2##3##(1991-12#1)(1994-2#1)
risk management strategies##3##3##(1990-11#1)(1994-1#1)(2013-1#1)
risk management##88##2##(1990-11#1)(1990-12#1)(1991-12#6)(1992-12#2)(1992-3#2)(1993-1#3)(1993-12#1)(1993-2#7)(1994-1#2)(1994-12#2)(1994-2#5)(1994-3#2)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#1)(2005-5#2)(2006-10#1)(2007-1#3)(2007-11#2)(2007-3#2)(2007-4#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#2)(2009-6#1)(2009-9#5)(2010-2#1)(2011-1#1)(2011-2#4)(2011-7#1)(2012-11#4)(2012-12#1)(2012-3#1)(2013-1#5)
risk management's##2##2##(1994-12#1)(1995-2#1)
risk manager##10##2##(1992-1#1)(1992-2#3)(1993-2#2)(1993-3#1)(1994-1#3)
risk manager's role##4##3##(1992-12#1)(1994-2#1)(1995-1#1)(1996-1#1)
risk manager's##9##2##(1990-12#2)(1992-12#1)(1994-2#2)(1995-1#1)(1996-1#1)(1997-1#1)(2007-3#1)
risk managers need to know##2##5##(1992-3#1)(1996-2#1)
risk managers need to##3##4##(1992-3#1)(1996-2#1)(2007-3#1)
risk managers to##4##3##(1991-12#1)(1992-2#1)(1994-1#1)(2007-3#1)
risk managers##14##2##(1991-12#1)(1991-3#1)(1992-2#3)(1992-3#1)(1994-1#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-3#1)(2007-3#2)(2008-5#1)
risk map##3##2##(1994-6#2)(2008-8#1)
risk maps##4##2##(2008-10#1)(2008-8#3)
risk marker for##3##3##(2008-11#1)(2010-5#1)(2012-12#1)
risk marker##6##2##(2008-11#1)(2008-3#1)(2010-5#1)(2011-12#1)(2012-12#1)(2012-3#1)
risk markers##4##2##(2006-10#1)(2008-3#2)(2008-7#1)
risk marketing##2##2##(1997-3#2)
risk may be##6##3##(1993-12#1)(1994-11#1)(2007-2#1)(2010-12#1)(2011-2#1)(2012-2#1)
risk may##10##2##(1993-11#1)(1993-12#1)(1994-11#1)(2007-2#1)(2008-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
risk medical##2##2##(1993-5#1)(2013-7#1)
risk might##2##2##(1996-8#1)(2007-10#1)
risk model for##3##3##(2007-8#1)(2008-12#1)(2013-1#1)
risk model has been##2##4##(2007-8#1)(2011-2#1)
risk model in##2##3##(2007-8#1)(2013-1#1)
risk model##19##2##(2005-12#1)(2007-8#4)(2008-12#1)(2008-7#3)(2009-11#2)(2009-9#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#4)
risk modelling##2##2##(2007-8#1)(2008-8#1)
risk models##7##2##(1992-12#1)(1995-8#1)(2008-10#1)(2008-7#4)
risk more##2##2##(2007-2#1)(2009-5#1)
risk must be evaluated##2##4##(2008-3#2)
risk must be##3##3##(2008-3#3)
risk must##4##2##(1997-8#1)(2008-3#3)
risk needs to be##2##4##(2008-7#2)
risk of 2##2##3##(1993-9#1)(2013-1#1)
risk of AD##2##3##(2008-8#1)(2009-12#1)
risk of CHD##5##3##(2005-10#2)(2005-12#1)(2007-1#1)(2011-12#1)
risk of CRC##4##3##(2008-10#1)(2010-12#1)(2013-1#2)
risk of CVD##4##3##(2005-10#1)(2008-3#1)(2008-6#1)(2011-2#1)
risk of DS##2##3##(2012-12#2)
risk of E##2##3##(2007-12#1)(2008-12#1)
risk of ED##3##3##(2013-8#3)
risk of HCC in patients taking the drugs##2##8##(2008-11#2)
risk of HCC in patients##3##5##(2006-10#1)(2008-11#2)
risk of HCC in##5##4##(2006-10#1)(2008-11#3)(2011-2#1)
risk of HCC##6##3##(2006-10#1)(2008-11#3)(2010-12#1)(2011-2#1)
risk of HCV##3##3##(1992-5#1)(2007-11#1)(2012-2#1)
risk of HIV among##2##4##(1991-1#1)(2010-8#1)
risk of HIV infection relative to their##2##7##(2012-12#2)
risk of HIV infection##13##4##(1991-2#1)(1993-6#1)(1995-6#1)(1996-5#1)(2004-9#1)(2007-7#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#1)
risk of HIV transmission##8##4##(1995-6#2)(2007-11#1)(2009-5#1)(2009-7#1)(2012-12#3)
risk of HIV##26##3##(1991-1#1)(1991-2#1)(1993-6#1)(1995-6#3)(1996-5#1)(2004-9#1)(2007-11#1)(2007-7#1)(2009-5#1)(2009-7#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#7)(2012-2#1)(2012-3#1)
risk of IHD##4##3##(1994-2#2)(2008-3#2)
risk of M##2##3##(2013-1#2)
risk of NSAID-related gastrointestinal bleeding is##2##6##(2006-10#2)
risk of NSAID-related gastrointestinal bleeding##3##5##(2006-10#3)
risk of NSAID-related##4##3##(2006-10#4)
risk of PC##4##3##(1990-6#4)
risk of PD##3##3##(2008-12#1)(2010-10#2)
risk of Parkinson's disease in##2##5##(2008-7#2)
risk of Parkinson's disease##6##4##(2008-11#1)(2008-7#3)(2008-8#1)(2010-10#1)
risk of Parkinson's##7##3##(2008-11#1)(2008-7#4)(2008-8#1)(2010-10#1)
risk of Pneumocystis carinii pneumonia##2##5##(1990-5#1)(1996-12#1)
risk of Pneumocystis##3##3##(1990-5#1)(1996-12#1)(2011-2#1)
risk of SCD##3##3##(2006-9#1)(2008-10#2)
risk of SIDS##2##3##(1992-11#1)(2008-1#1)
risk of TB infection##2##4##(2007-2#2)
risk of TB##3##3##(2007-2#2)(2007-4#1)
risk of TEEs##2##3##(2008-7#2)
risk of a cardiovascular event##2##5##(2008-4#1)(2009-11#1)
risk of a patient##2##4##(1990-6#1)(2008-3#1)
risk of a##32##3##(1990-6#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-9#1)(1996-12#1)(1996-9#1)(1997-4#1)(2004-4#1)(2005-10#1)(2008-10#1)(2008-3#2)(2008-4#2)(2008-5#1)(2009-11#1)(2009-4#2)(2010-2#2)(2010-5#1)(2010-9#1)(2012-1#1)(2012-11#2)(2012-2#2)(2013-1#1)
risk of abdominal##2##3##(2007-1#1)(2013-1#1)
risk of accidents##2##3##(1995-8#1)(2010-5#1)
risk of acquiring HIV##8##4##(2012-3#8)
risk of acquiring##19##3##(2005-8#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-5#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#9)(2013-1#1)
risk of activation##2##3##(1991-3#1)(2008-4#1)
risk of acute complications##2##4##(1993-5#1)(2013-7#1)
risk of acute##9##3##(1993-5#1)(1996-8#1)(2007-8#1)(2009-1#1)(2009-12#1)(2011-2#1)(2013-1#2)(2013-7#1)
risk of addiction##2##3##(2007-2#1)(2013-1#1)
risk of adult##2##3##(2004-11#1)(2008-3#1)
risk of adverse effects##6##4##(1991-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2009-6#2)
risk of adverse pregnancy outcome##2##5##(2008-3#1)(2011-2#1)
risk of adverse pregnancy##3##4##(2008-3#1)(2011-2#2)
risk of adverse##20##3##(1991-11#2)(1991-9#1)(1996-3#1)(1997-5#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-6#2)(2010-6#1)(2011-2#2)
risk of alloimmunization##2##3##(1994-6#1)(1996-1#1)
risk of an##10##3##(1990-5#1)(1992-6#1)(1994-3#1)(2006-10#1)(2008-11#1)(2008-4#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
risk of arterial##3##3##(2007-12#2)(2008-5#1)
risk of aspiration##3##3##(1993-10#1)(2010-12#1)(2010-3#1)
risk of associated##3##3##(2006-10#1)(2010-5#1)(2012-2#1)
risk of asthma##2##3##(2005-8#1)(2008-12#1)
risk of atherosclerosis##7##3##(2008-1#1)(2008-3#1)(2008-6#3)(2008-7#1)(2012-2#1)
risk of atherosclerotic##2##3##(1996-2#1)(2008-3#1)
risk of autoimmune##2##3##(2009-6#1)(2013-7#1)
risk of axillary##2##3##(2004-1#1)(2008-10#1)
risk of bacteremia##2##3##(2007-7#1)(2010-5#1)
risk of becoming##3##3##(1997-6#1)(2008-12#1)(2011-2#1)
risk of being carriers##2##4##(1994-7#2)
risk of being##11##3##(1991-3#1)(1993-8#1)(1994-7#2)(1997-4#1)(2006-10#1)(2008-2#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
risk of bias##6##3##(2008-5#1)(2012-2#1)(2013-1#2)(2013-8#2)
risk of bleeding complications##2##4##(2006-10#1)(2007-11#1)
risk of bleeding in the##2##5##(2008-7#1)(2010-5#1)
risk of bleeding in##3##4##(2008-7#1)(2009-2#1)(2010-5#1)
risk of bleeding##19##3##(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2013-1#2)
risk of blood##3##3##(1992-12#2)(2012-2#1)
risk of both##5##3##(2008-1#1)(2008-11#1)(2009-9#1)(2010-9#1)(2013-1#1)
risk of bowel##3##3##(1994-2#1)(1996-6#1)(2006-10#1)
risk of brain##5##3##(1997-7#2)(2007-8#1)(2010-12#1)(2010-9#1)
risk of breast cancer and##2##5##(1993-11#1)(2009-4#1)
risk of breast cancer associated with##2##6##(1991-7#1)(1994-2#1)
risk of breast cancer in##3##5##(1991-4#1)(2007-2#1)(2008-3#1)
risk of breast cancer was##2##5##(1991-7#1)(2012-3#1)
risk of breast cancer##27##4##(1990-8#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-7#7)(1992-8#1)(1993-11#1)(1994-2#4)(1994-9#1)(1997-3#1)(2007-2#1)(2008-10#1)(2008-3#1)(2009-12#1)(2009-4#2)(2012-3#1)
risk of breast##32##3##(1990-8#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-7#7)(1992-8#1)(1993-11#1)(1994-2#4)(1994-9#1)(1997-3#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-12#1)(2009-2#1)(2009-4#2)(2012-3#1)(2013-1#2)(2013-7#1)
risk of cancer and##2##4##(2008-7#1)(2012-1#1)
risk of cancer in##3##4##(1994-2#1)(2006-10#1)(2012-6#1)
risk of cancer was##2##4##(2012-12#2)
risk of cancer##31##3##(1990-8#1)(1991-5#3)(1993-10#2)(1994-2#3)(1994-8#1)(1994-9#1)(1996-11#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-11#2)(2008-7#3)(2012-1#2)(2012-12#3)(2012-2#1)(2012-6#1)(2013-1#4)
risk of cancers##2##3##(2009-6#1)(2012-12#1)
risk of cardiac##3##3##(1992-2#1)(2008-1#1)(2009-5#1)
risk of cardiovascular disease (CVD)##2##5##(2005-10#1)(2012-2#1)
risk of cardiovascular disease in##2##5##(2005-12#1)(2012-2#1)
risk of cardiovascular disease was##2##5##(1990-5#1)(1991-12#1)
risk of cardiovascular disease##32##4##(1990-5#1)(1991-12#1)(1992-8#1)(1993-11#1)(1993-6#1)(1996-6#3)(1996-9#1)(1997-8#1)(2005-10#5)(2005-12#1)(2006-12#1)(2006-6#1)(2007-1#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-1#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
risk of cardiovascular disease]##2##4##(1993-9#1)(2013-8#1)
risk of cardiovascular diseases##4##4##(1993-11#1)(2005-10#1)(2008-3#1)(2010-12#1)
risk of cardiovascular events##7##4##(2006-10#2)(2008-3#1)(2009-11#1)(2010-12#1)(2011-11#1)(2012-3#1)
risk of cardiovascular##49##3##(1990-5#1)(1991-12#1)(1992-8#1)(1993-11#2)(1993-6#1)(1993-9#1)(1996-6#3)(1996-9#1)(1997-8#1)(2005-10#6)(2005-12#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-1#1)(2008-1#1)(2008-3#3)(2008-4#1)(2008-7#2)(2009-1#1)(2009-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-11#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
risk of carrying##2##3##(2006-10#1)(2008-2#1)
risk of cerebral embolism##2##4##(2013-1#2)
risk of cerebral##6##3##(1991-11#1)(2007-10#1)(2007-8#1)(2008-7#1)(2013-1#2)
risk of cervical cancer##2##4##(1991-9#1)(2006-10#1)
risk of cervical##6##3##(1991-9#1)(1994-2#2)(2006-10#2)(2013-1#1)
risk of childhood cancer##3##4##(2012-1#3)
risk of chronic disease##4##4##(2006-10#1)(2008-5#1)(2009-5#1)(2010-1#1)
risk of chronic rejection##2##4##(2007-11#2)
risk of chronic##14##3##(1991-4#1)(2004-4#2)(2006-10#1)(2007-11#2)(2008-5#1)(2009-11#1)(2009-5#1)(2010-1#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)
risk of chronicity##2##3##(1992-8#1)(2009-11#1)
risk of colon cancer##4##4##(1991-9#1)(2006-10#2)(2006-2#1)
risk of colon##5##3##(1991-9#1)(2006-10#2)(2006-2#1)(2009-12#1)
risk of colorectal cancer in##2##5##(1993-9#2)
risk of colorectal cancer##8##4##(1993-9#3)(2006-10#1)(2008-10#1)(2009-8#1)(2010-6#1)(2013-1#1)
risk of colorectal##10##3##(1990-2#1)(1993-9#3)(1995-9#1)(2006-10#1)(2008-10#1)(2009-8#1)(2010-6#1)(2013-1#1)
risk of complications and##3##4##(1996-12#1)(2007-8#1)(2011-2#1)
risk of complications during##2##4##(1996-6#1)(2007-7#1)
risk of complications is##2##4##(1994-9#1)(2013-1#1)
risk of complications than##2##4##(1991-6#1)(1996-12#1)
risk of complications##32##3##(1990-11#1)(1990-3#2)(1991-6#1)(1994-9#1)(1996-11#1)(1996-12#2)(1996-6#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-7#1)
risk of congenital malformations##2##4##(2013-1#2)
risk of congenital##4##3##(2008-4#1)(2013-1#3)
risk of contamination from##2##4##(2008-3#1)(2009-9#1)
risk of contamination##10##3##(2008-10#7)(2008-11#1)(2008-3#1)(2009-9#1)
risk of continuous##2##3##(2006-10#1)(2013-8#1)
risk of contracting HIV##2##4##(2012-1#1)(2012-12#1)
risk of contracting##10##3##(1995-9#2)(2007-2#2)(2007-7#1)(2008-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
risk of coronary artery##4##4##(1991-8#1)(1996-3#1)(2012-12#1)(2013-8#1)
risk of coronary heart disease (CHD)##3##6##(1995-3#1)(2005-10#2)
risk of coronary heart disease and##2##6##(2005-10#1)(2006-10#1)
risk of coronary heart disease events##2##6##(2008-12#2)
risk of coronary heart disease##17##5##(1991-8#1)(1993-5#1)(1995-3#1)(1995-9#1)(1996-3#1)(2005-10#4)(2006-10#2)(2006-2#1)(2008-10#1)(2008-12#3)(2011-1#1)
risk of coronary heart##18##4##(1991-8#1)(1993-5#1)(1995-3#1)(1995-9#1)(1996-3#1)(2005-10#4)(2006-10#2)(2006-2#1)(2008-10#1)(2008-12#3)(2011-1#1)(2013-1#1)
risk of coronary##24##3##(1991-8#2)(1993-5#1)(1995-3#1)(1995-9#1)(1996-3#2)(1996-8#1)(2005-10#4)(2005-7#1)(2006-10#2)(2006-2#1)(2008-10#1)(2008-12#3)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
risk of death associated with##2##5##(2012-3#1)(2013-1#1)
risk of death from cardiovascular disease##3##6##(2005-10#1)(2008-11#1)(2011-1#1)
risk of death from##8##4##(1993-9#1)(2005-10#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-7#1)(2011-1#1)
risk of death of##2##4##(1990-5#1)(2011-3#1)
risk of death was##2##4##(2008-6#1)(2011-1#1)
risk of death##29##3##(1990-5#1)(1993-9#1)(1995-2#1)(1997-3#1)(2005-10#1)(2006-6#1)(2007-10#2)(2007-12#1)(2007-8#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-1#2)(2011-2#3)(2011-3#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
risk of dehydration##2##3##(2006-10#1)(2012-1#1)
risk of depression and##2##4##(2008-2#1)(2010-7#1)
risk of depression##3##3##(2008-2#1)(2008-6#1)(2010-7#1)
risk of developing PCOS##2##4##(2008-4#2)
risk of developing TLS is##2##5##(2008-7#2)
risk of developing a new##2##5##(1990-12#1)(2006-10#1)
risk of developing a##5##4##(1990-12#1)(1993-9#1)(2006-10#1)(2012-1#1)(2012-2#1)
risk of developing an##2##4##(1993-9#1)(2010-7#1)
risk of developing breast cancer before menopause##2##7##(1994-4#2)
risk of developing breast cancer##10##5##(1991-2#1)(1994-4#4)(1995-9#1)(2003-11#1)(2008-12#2)(2008-4#1)
risk of developing cardiovascular disease and##2##6##(2005-10#1)(2008-10#1)
risk of developing cardiovascular disease##5##5##(1995-8#1)(2005-10#1)(2007-1#1)(2008-1#1)(2008-10#1)
risk of developing cardiovascular##6##4##(1993-11#1)(1995-8#1)(2005-10#1)(2007-1#1)(2008-1#1)(2008-10#1)
risk of developing cervical##2##4##(1993-9#1)(2009-3#1)
risk of developing chronic##2##4##(2005-7#1)(2006-2#1)
risk of developing colorectal cancer##2##5##(1991-7#1)(1991-9#1)
risk of developing colorectal##3##4##(1991-7#1)(1991-9#1)(1992-9#1)
risk of developing complications##2##4##(2006-10#1)(2012-2#1)
risk of developing coronary##2##4##(2007-2#1)(2011-2#1)
risk of developing diabetes##3##4##(1993-11#1)(2008-1#1)(2012-2#1)
risk of developing respiratory##2##4##(1994-6#1)(2008-12#1)
risk of developing severe##3##4##(1996-2#1)(2006-10#1)(2007-11#1)
risk of developing skin##2##4##(1991-6#1)(2012-3#1)
risk of developing the##4##4##(1990-11#1)(1996-6#1)(2008-11#1)(2008-4#1)
risk of developing this##3##4##(2006-2#1)(2012-12#2)
risk of developing##131##3##(1990-11#2)(1990-12#1)(1990-9#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#3)(1992-1#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-9#4)(1994-4#4)(1994-6#1)(1994-9#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-6#1)(2003-11#1)(2005-10#2)(2005-11#1)(2005-7#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#2)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#4)(2008-12#3)(2008-3#3)(2008-4#6)(2008-6#2)(2008-7#2)(2008-8#3)(2009-10#1)(2009-12#2)(2009-3#3)(2009-6#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#6)(2012-1#2)(2012-12#6)(2012-2#6)(2012-3#5)(2013-1#4)(2013-7#1)
risk of development of##15##4##(1990-1#2)(1997-3#1)(2005-1#2)(2006-10#1)(2006-6#2)(2007-10#1)(2007-4#1)(2008-4#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
risk of development##17##3##(1990-1#2)(1997-3#1)(2005-1#2)(2006-10#1)(2006-6#2)(2007-10#1)(2007-4#1)(2007-8#1)(2008-4#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
risk of diabetes and##4##4##(2008-1#2)(2008-3#1)(2013-8#1)
risk of diabetes mellitus##2##4##(2007-9#1)(2008-10#1)
risk of diabetes##10##3##(2007-9#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
risk of diabetic##2##3##(1996-12#1)(2008-1#1)
risk of digestive and cardiovascular complications##2##6##(2008-3#2)
risk of digestive and cardiovascular##3##5##(2008-3#3)
risk of digestive##4##3##(2008-3#4)
risk of disease in##3##4##(1995-6#1)(2007-1#1)(2008-10#1)
risk of disease recurrence and##2##5##(2009-5#1)(2013-1#1)
risk of disease transmission to##2##5##(1992-12#1)(2011-2#1)
risk of disease##17##3##(1992-12#1)(1993-11#1)(1995-6#1)(1997-8#1)(2005-10#1)(2007-1#1)(2007-2#1)(2008-10#2)(2008-12#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-1#2)(2013-1#1)(2013-8#1)
risk of diseases##2##3##(2012-2#2)
risk of dying of other diseases##2##6##(1997-7#2)
risk of dying of##3##4##(1997-7#3)
risk of dying##8##3##(1997-7#3)(2009-10#3)(2011-2#1)(2013-1#1)
risk of each##2##3##(2011-2#1)(2013-1#1)
risk of early##14##3##(1990-8#1)(1992-2#1)(1997-2#1)(2007-2#1)(2008-10#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
risk of either##2##3##(1990-12#1)(2011-2#1)
risk of elbow##2##3##(2006-11#2)
risk of emergence##2##3##(2005-8#1)(2010-4#1)
risk of endometrial cancer##2##4##(1993-10#1)(2008-10#1)
risk of epidemics##3##3##(2006-2#2)(2006-4#1)
risk of esophageal cancer##2##4##(2011-2#1)(2013-7#1)
risk of esophageal##3##3##(2011-2#1)(2012-2#1)(2013-7#1)
risk of exposure to##8##4##(1990-8#1)(1991-11#1)(1991-12#1)(2005-11#1)(2007-1#1)(2008-7#1)(2009-12#1)(2012-12#1)
risk of exposure##13##3##(1990-2#1)(1990-8#1)(1991-11#1)(1991-12#1)(2005-11#1)(2007-1#1)(2008-7#1)(2009-12#1)(2010-12#1)(2012-11#2)(2012-12#1)(2012-2#1)
risk of extinction##4##3##(2008-9#1)(2010-8#2)(2012-12#1)
risk of failing##2##3##(2007-7#1)(2012-2#1)
risk of failure is##2##4##(1996-3#1)(2007-4#1)
risk of failure##6##3##(1991-11#1)(1996-3#1)(2007-4#2)(2009-7#1)(2012-12#1)
risk of falling##6##3##(2008-4#1)(2011-1#5)
risk of falls in hospitalized psychiatric patients##2##7##(2013-8#2)
risk of falls##7##3##(2005-12#1)(2008-7#1)(2013-8#5)
risk of fatal CVD (RR =##2##6##(1995-12#2)
risk of fatal##6##3##(1992-10#1)(1994-2#1)(1995-12#3)(2012-12#1)
risk of febrile neutropenia##2##4##(2005-10#1)(2007-3#1)
risk of fetal##4##3##(2009-11#1)(2011-1#1)(2011-2#2)
risk of fluorosis##2##3##(2006-2#1)(2011-2#1)
risk of fracture in##2##4##(2007-8#1)(2012-12#1)
risk of fracture##12##3##(2004-9#1)(2006-10#1)(2006-11#2)(2007-8#2)(2008-11#2)(2011-2#1)(2012-12#2)(2013-1#1)
risk of fractures##7##3##(2007-11#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-10#1)(2011-1#1)
risk of fungal##5##3##(2006-10#1)(2008-7#1)(2011-2#1)(2012-11#2)
risk of gastric cancer in patients with##3##7##(2008-12#3)
risk of gastric cancer in##5##5##(2008-12#3)(2008-5#1)(2010-5#1)
risk of gastric cancer##12##4##(1997-1#1)(2006-2#1)(2008-12#5)(2008-5#1)(2010-5#1)(2011-2#3)
risk of gastric##13##3##(1997-1#1)(2006-2#1)(2008-1#1)(2008-12#5)(2008-5#1)(2010-5#1)(2011-2#3)
risk of gastrointestinal##2##3##(2006-2#1)(2008-11#1)
risk of getting##3##3##(1990-5#1)(2008-7#1)(2009-10#1)
risk of glioma in##2##4##(1997-7#1)(2011-2#1)
risk of glioma##3##3##(1997-7#2)(2011-2#1)
risk of graft failure##2##4##(1995-2#1)(2011-2#1)
risk of graft loss##2##4##(2007-11#1)(2008-8#1)
risk of graft##4##3##(1995-2#1)(2007-11#1)(2008-8#1)(2011-2#1)
risk of growth rate suppression##2##5##(2007-11#2)
risk of growth##4##3##(1994-7#1)(2007-11#3)
risk of haemorrhage##3##3##(1992-6#1)(1996-6#1)(1996-9#1)
risk of having a##4##4##(1997-5#1)(2008-11#1)(2008-4#1)(2008-8#1)
risk of having##11##3##(1997-5#1)(1997-8#1)(2006-4#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-8#1)(2012-1#1)(2013-8#1)
risk of head and neck##2##5##(2007-1#1)(2013-1#1)
risk of heart disease##2##4##(2010-9#1)(2013-1#1)
risk of heart##4##3##(2010-5#1)(2010-8#1)(2010-9#1)(2013-1#1)
risk of hemorrhagic stroke##2##4##(2006-10#1)(2010-10#1)
risk of hepatitis B##2##4##(1990-10#1)(1996-3#1)
risk of hepatitis C virus (HCV)##2##6##(2010-12#1)(2012-2#1)
risk of hepatitis C virus##3##5##(2010-12#1)(2012-2#2)
risk of hepatitis##7##3##(1990-10#1)(1996-3#1)(2009-9#2)(2010-12#1)(2012-2#2)
risk of hepatocellular carcinoma in patients with##2##7##(2006-10#1)(2010-12#1)
risk of hepatocellular carcinoma in##3##5##(1992-9#1)(2006-10#1)(2010-12#1)
risk of hepatocellular carcinoma##7##4##(1992-9#1)(2006-10#3)(2008-11#1)(2010-12#2)
risk of hip##3##3##(2006-11#2)(2008-7#1)
risk of homicidal behavior##3##4##(1996-5#3)
risk of hospital##3##3##(2010-4#2)(2013-1#1)
risk of hospitalization##4##3##(1995-2#2)(2006-10#1)(2007-4#1)
risk of human##4##3##(2008-8#2)(2010-11#1)(2011-2#1)
risk of hypertension in##2##4##(2008-11#1)(2013-8#1)
risk of hypertension was##2##4##(2013-1#2)
risk of hypertension##7##3##(2008-11#2)(2008-5#1)(2013-1#3)(2013-8#1)
risk of hypoglycaemia##2##3##(2006-1#1)(2011-1#1)
risk of hypoglycemia##3##3##(1996-11#1)(2006-6#1)(2007-5#1)
risk of immediate##2##3##(1990-5#1)(2007-8#1)
risk of immunization##2##3##(1992-10#2)
risk of increased##2##3##(2008-8#1)(2013-8#1)
risk of inducing##3##3##(1994-9#1)(2007-8#1)(2009-10#1)
risk of infarction##2##3##(1993-11#1)(2007-9#1)
risk of infection and##4##4##(2008-1#1)(2008-10#1)(2010-12#1)(2011-2#1)
risk of infection by##3##4##(2007-2#1)(2009-2#1)(2013-1#1)
risk of infection in##10##4##(1990-4#1)(1992-6#2)(1994-6#1)(2007-12#3)(2008-10#1)(2008-4#1)(2013-1#1)
risk of infection or##3##4##(2006-12#1)(2013-1#2)
risk of infection with hepatitis##2##5##(1992-8#1)(2007-2#1)
risk of infection with##6##4##(1992-8#1)(1996-6#1)(2007-2#1)(2009-12#1)(2011-2#2)
risk of infection##48##3##(1990-3#1)(1990-4#1)(1992-6#2)(1992-8#1)(1994-6#2)(1996-6#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-12#1)(2007-11#1)(2007-12#3)(2007-2#5)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#1)(2009-1#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-12#1)(2011-2#5)(2012-2#1)(2013-1#4)
risk of infections and##2##4##(1995-3#1)(1996-8#1)
risk of infections##8##3##(1992-2#1)(1995-3#1)(1996-8#1)(2006-10#1)(2007-11#2)(2008-11#1)(2011-2#1)
risk of infectious##3##3##(2006-10#1)(2007-12#1)(2010-2#1)
risk of infertility##2##3##(2006-7#1)(2012-2#1)
risk of initial##2##3##(2008-1#1)(2008-7#1)
risk of injury##9##3##(1992-6#3)(1996-6#1)(1997-7#1)(2007-1#1)(2008-6#1)(2008-8#1)(2013-1#1)
risk of intracerebral haemorrhage##2##4##(2008-8#1)(2010-12#1)
risk of intracranial##4##3##(1992-6#1)(2007-11#1)(2011-2#1)(2012-2#1)
risk of intraoperative awareness##2##4##(2006-10#2)
risk of intraoperative##4##3##(1992-6#1)(2006-10#2)(2012-2#1)
risk of intrauterine##2##3##(1990-9#1)(2013-1#1)
risk of invasion##2##3##(2006-10#2)
risk of invasive bladder cancer##2##5##(1993-9#2)
risk of invasive##8##3##(1993-9#2)(2007-12#1)(2007-2#1)(2008-11#1)(2008-4#1)(2010-12#1)(2013-1#1)
risk of ipsilateral##3##3##(1992-8#1)(2008-5#1)(2013-1#1)
risk of ischaemic##3##3##(1993-7#1)(1994-2#1)(2012-2#1)
risk of ischemic complications##2##4##(2006-10#1)(2010-12#1)
risk of ischemic heart disease##3##5##(1994-2#1)(2008-3#2)
risk of ischemic stroke among##4##5##(2011-1#4)
risk of ischemic stroke##9##4##(2009-12#1)(2010-4#1)(2011-1#7)
risk of ischemic##16##3##(1994-10#1)(1994-2#1)(2005-10#1)(2006-10#1)(2008-3#2)(2009-12#1)(2010-12#1)(2010-4#1)(2011-1#7)
risk of kidney##2##3##(2011-2#1)(2013-8#1)
risk of large bowel cancer##3##5##(1990-7#3)
risk of large##4##3##(1990-7#3)(2011-2#1)
risk of late##6##3##(1992-10#1)(2009-1#1)(2010-12#1)(2010-7#1)(2011-2#2)
risk of lethal##2##3##(1995-4#1)(2007-2#1)
risk of liability##4##3##(1992-2#1)(1993-1#1)(1996-3#1)(1997-1#1)
risk of life-threatening##2##3##(2008-7#1)(2009-6#1)
risk of local recurrence##3##4##(2008-6#3)
risk of local##4##3##(2008-6#3)(2008-8#1)
risk of long-term##2##3##(2008-7#1)(2010-7#1)
risk of losing##5##3##(1991-8#1)(1992-5#1)(1996-11#1)(2008-10#1)(2008-8#1)
risk of low##2##3##(2007-9#1)(2013-1#1)
risk of lung cancer##3##4##(2008-7#1)(2011-1#1)(2011-2#1)
risk of lymph node metastasis##2##5##(2009-12#1)(2011-2#1)
risk of major bleeding##3##4##(2007-10#1)(2008-3#1)(2008-8#1)
risk of major complications##2##4##(2010-3#1)(2013-1#1)
risk of major##10##3##(2007-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-1#1)(2010-3#1)(2010-9#1)(2013-1#1)(2013-7#1)
risk of malaria infection (adjusted OR =##2##7##(2008-4#2)
risk of malignancies##3##3##(2007-11#1)(2007-3#1)(2008-4#1)
risk of malignancy##5##3##(1992-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2010-7#1)
risk of malignant transformation##8##4##(2007-8#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-8#2)(2012-12#1)(2013-1#1)
risk of malignant##11##3##(1993-10#1)(2007-3#1)(2007-8#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-8#2)(2012-12#1)(2012-2#1)(2013-1#1)
risk of malnutrition##3##3##(2007-7#1)(2010-9#1)(2012-12#1)
risk of maternal##2##3##(1994-3#1)(1996-12#1)
risk of metabolic##3##3##(1993-11#1)(2008-3#1)(2013-1#1)
risk of metastasis##3##3##(1993-8#1)(2007-10#1)(2007-6#1)
risk of metastatic##2##3##(1991-7#1)(1996-4#1)
risk of microbial contamination##2##4##(1997-4#1)(2008-5#1)
risk of microbial##3##3##(1997-4#1)(2008-5#1)(2011-2#1)
risk of minor##2##3##(2007-8#1)(2010-12#1)
risk of morbidity and mortality##6##5##(1990-8#1)(1995-12#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-10#1)
risk of morbidity##8##3##(1990-8#1)(1995-12#1)(2006-10#2)(2007-2#1)(2007-8#1)(2008-10#1)(2012-2#1)
risk of mortality and morbidity##2##5##(2010-12#1)(2012-1#1)
risk of mortality and##5##4##(2008-5#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
risk of mortality associated with##2##5##(2006-10#1)(2008-7#1)
risk of mortality##20##3##(1994-11#1)(2005-8#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)
risk of myocardial infarction##5##4##(1994-2#1)(2005-8#1)(2007-11#1)(2007-9#1)(2008-10#1)
risk of myocardial##6##3##(1994-2#1)(1997-3#1)(2005-8#1)(2007-11#1)(2007-9#1)(2008-10#1)
risk of nasal cancer##2##4##(1992-10#2)
risk of negative##2##3##(2007-11#1)(2010-10#1)
risk of neonatal##2##3##(1994-6#1)(2008-11#1)
risk of neoplasia##2##3##(1992-9#1)(2008-8#1)
risk of neurological##6##3##(1996-3#1)(2006-5#1)(2007-11#1)(2010-8#1)(2011-1#1)(2012-12#1)
risk of new vertebral fractures##2##5##(2007-11#1)(2008-11#1)
risk of new##3##3##(2007-11#1)(2007-2#1)(2008-11#1)
risk of nicotine dependence##4##4##(2010-9#2)(2011-2#2)
risk of nicotine##5##3##(2010-9#3)(2011-2#2)
risk of non-Hodgkins##2##3##(1993-9#2)
risk of nosocomial##4##3##(1992-10#1)(2006-10#1)(2007-12#1)(2010-4#1)
risk of nursing home placement##2##5##(1990-5#2)
risk of nursing home##3##4##(1990-5#2)(2010-12#1)
risk of obesity and##3##4##(2008-3#1)(2010-3#1)(2010-7#1)
risk of obesity##7##3##(1991-3#1)(2007-12#1)(2008-3#1)(2010-1#1)(2010-3#1)(2010-7#1)(2013-1#1)
risk of obtaining##3##3##(2007-1#1)(2008-10#1)(2012-12#1)
risk of occupational##3##3##(1990-8#1)(1993-6#1)(2007-7#1)
risk of occurrence##3##3##(2007-7#1)(2008-12#1)(2011-2#1)
risk of opportunistic infections##2##4##(2007-12#1)(2011-2#1)
risk of osteoporosis in##2##4##(1995-9#1)(2006-10#1)
risk of osteoporosis##8##3##(1993-11#1)(1994-9#1)(1995-9#1)(1997-8#1)(2006-10#1)(2006-8#1)(2008-4#1)(2010-6#1)
risk of other##3##3##(2006-12#1)(2009-12#1)(2010-1#1)
risk of ovarian cancer##6##4##(1990-5#2)(1993-9#2)(1994-9#1)(2012-2#1)
risk of ovarian##8##3##(1990-5#3)(1993-9#2)(1994-9#1)(2012-12#1)(2012-2#1)
risk of overweight and##2##4##(2008-3#2)
risk of overweight##9##3##(2007-12#2)(2008-3#3)(2009-9#2)(2011-2#2)
risk of pancreatic cancer##4##4##(1990-6#2)(1994-3#1)(2008-3#1)
risk of pancreatic##5##3##(1990-6#2)(1994-3#1)(2005-11#1)(2008-3#1)
risk of pathogen##2##3##(2008-10#1)(2008-3#1)
risk of patients##2##3##(1994-12#1)(2011-1#1)
risk of perinatal##2##3##(1994-6#1)(1996-2#1)
risk of perioperative##8##3##(2005-10#1)(2006-10#2)(2007-8#1)(2009-5#2)(2010-9#1)(2012-2#1)
risk of post##2##3##(2008-1#1)(2008-4#1)
risk of postoperative respiratory complications##2##5##(2006-10#1)(2009-5#1)
risk of postoperative##11##3##(1992-5#1)(1996-9#1)(2006-10#2)(2006-12#1)(2007-8#2)(2008-7#1)(2008-8#1)(2009-5#1)(2012-2#1)
risk of postpartum depression##2##4##(2010-1#1)(2013-1#1)
risk of predation##2##3##(2008-9#1)(2010-8#1)
risk of pregnancy complications##2##4##(2007-3#1)(2008-11#1)
risk of pregnancy##4##3##(1990-6#1)(2007-3#1)(2007-7#1)(2008-11#1)
risk of premature cardiovascular disease##3##5##(2006-12#1)(2009-11#2)
risk of premature##4##3##(1997-2#1)(2006-12#1)(2009-11#2)
risk of preterm delivery##3##4##(1996-11#1)(1996-9#1)(2011-1#1)
risk of preterm##4##3##(1996-11#1)(1996-9#1)(2011-1#1)(2011-2#1)
risk of primary##4##3##(1991-11#1)(1992-9#1)(1994-6#1)(2008-6#1)
risk of problematic##2##3##(2007-1#1)(2009-12#1)
risk of progression to##4##4##(2007-2#1)(2008-9#1)(2010-5#1)(2012-12#1)
risk of progression##10##3##(1994-7#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-4#1)(2010-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
risk of prostate cancer in smokers##2##6##(2009-5#2)
risk of prostate cancer##5##4##(2006-9#1)(2009-5#3)(2012-12#1)
risk of puncture or rupture##2##5##(2012-2#2)
risk of radiation exposure##2##4##(2006-8#1)(2008-7#1)
risk of radiation##3##3##(2006-8#1)(2008-7#1)(2013-1#1)
risk of raised ICP##3##4##(2010-5#3)
risk of recurrence and death##2##5##(2007-3#1)(2013-1#1)
risk of recurrence and##3##4##(2007-3#1)(2010-12#1)(2013-1#1)
risk of recurrence in##2##4##(2007-11#1)(2011-2#1)
risk of recurrence##21##3##(1992-1#1)(1993-9#2)(1996-11#1)(2007-11#1)(2007-3#1)(2008-4#1)(2008-5#3)(2008-8#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-7#3)(2013-8#1)
risk of recurrent cardiovascular events##2##5##(2008-3#2)
risk of recurrent stroke (Hazards ratio##2##6##(2007-9#2)
risk of recurrent stroke##7##4##(2007-10#1)(2007-9#3)(2008-8#2)(2010-12#1)
risk of recurrent##13##3##(2007-10#1)(2007-9#3)(2008-3#2)(2008-8#4)(2009-12#1)(2010-12#1)(2011-12#1)
risk of redisplacement##2##3##(2011-2#2)
risk of rejection##3##3##(1996-8#1)(1997-5#1)(2006-10#1)
risk of relapse and##4##4##(1993-1#1)(1995-9#1)(2007-3#1)(2009-11#1)
risk of relapse##13##3##(1990-11#1)(1990-12#1)(1993-1#1)(1995-9#1)(1996-4#1)(2007-3#1)(2008-6#1)(2009-11#2)(2009-5#1)(2011-2#3)
risk of renal##3##3##(1995-9#1)(2012-2#2)
risk of reoperation##3##3##(2007-8#2)(2012-12#1)
risk of requiring##2##3##(2009-2#1)(2013-1#1)
risk of respiratory##3##3##(2006-10#1)(2007-11#1)(2012-2#1)
risk of rupture##8##3##(1994-1#1)(2006-10#1)(2007-7#2)(2008-6#1)(2011-2#1)(2012-1#1)(2013-8#1)
risk of schizophrenia in the##2##5##(1997-2#1)(1997-8#1)
risk of schizophrenia##3##3##(1997-2#1)(1997-8#1)(2005-6#1)
risk of secondary##3##3##(2005-11#1)(2007-12#1)(2008-4#1)
risk of serious bacterial##2##4##(1994-9#1)(2008-11#1)
risk of serious complications##4##4##(2006-10#1)(2007-12#1)(2008-11#1)(2008-7#1)
risk of serious##13##3##(1994-9#2)(2006-10#2)(2007-12#1)(2008-11#3)(2008-7#1)(2009-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
risk of severe##11##3##(1995-5#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)
risk of side effects##3##4##(1991-7#1)(1997-3#1)(2007-11#1)
risk of significant##2##3##(2007-2#1)(2007-7#1)
risk of six malignancies##2##4##(2007-3#2)
risk of skeletal##3##3##(2007-11#2)(2008-8#1)
risk of spinal cord compression##3##5##(2007-11#3)
risk of spinal cord##4##4##(2007-11#4)
risk of spontaneous##2##3##(1996-2#1)(2011-2#1)
risk of sternal wound##2##4##(2007-8#2)
risk of stroke and##4##4##(2006-10#1)(2007-10#1)(2007-4#1)(2008-8#1)
risk of stroke by##2##4##(2007-10#1)(2008-8#1)
risk of stroke in##5##4##(2007-8#1)(2007-9#1)(2008-5#1)(2008-8#1)(2011-1#1)
risk of stroke is##2##4##(2007-8#1)(2008-9#1)
risk of stroke recurrence##2##4##(2007-9#1)(2012-3#1)
risk of stroke##37##3##(1991-11#1)(1996-11#1)(2005-10#1)(2006-10#2)(2007-10#6)(2007-4#1)(2007-8#2)(2007-9#4)(2008-1#1)(2008-5#1)(2008-8#9)(2008-9#2)(2010-11#2)(2011-1#2)(2011-2#1)(2012-3#1)
risk of subsequent##10##3##(1993-3#1)(1994-12#1)(1994-2#1)(1995-9#2)(1997-1#1)(2006-10#1)(2007-10#1)(2007-11#1)(2010-12#1)
risk of such##5##3##(1993-9#2)(1995-9#1)(2009-4#1)(2011-3#1)
risk of sudden death##9##4##(2005-8#1)(2006-9#4)(2010-11#1)(2012-2#2)(2013-8#1)
risk of sudden##12##3##(1992-4#1)(2005-8#1)(2006-9#5)(2010-11#1)(2012-2#2)(2013-7#1)(2013-8#1)
risk of suicide##8##3##(1993-7#3)(2008-8#2)(2009-7#1)(2010-12#1)(2012-2#1)
risk of surgical complications##2##4##(2008-9#1)(2011-1#1)
risk of surgical##4##3##(2006-6#1)(2008-9#1)(2011-1#1)(2011-2#1)
risk of systemic##3##3##(2005-10#1)(2008-8#1)(2012-3#1)
risk of testicular cancer##2##4##(2012-2#2)
risk of the development of##3##5##(1995-6#1)(2009-2#2)
risk of the disease##5##4##(1992-10#1)(1993-9#1)(1994-9#1)(2008-1#1)(2012-12#1)
risk of the patient##3##4##(1996-2#1)(2007-12#1)(2008-10#1)
risk of the##35##3##(1990-5#1)(1990-9#1)(1991-4#1)(1992-10#1)(1993-9#1)(1994-9#1)(1995-6#1)(1996-2#1)(2006-10#2)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-4#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-2#2)(2009-5#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
risk of thermal##2##3##(1990-2#1)(1995-1#1)
risk of these##3##3##(2007-4#1)(2007-8#1)(2009-9#1)
risk of this complication##2##4##(2007-11#2)
risk of this##4##3##(1996-12#1)(2007-11#2)(2008-5#1)
risk of thromboembolic complications##2##4##(1997-5#1)(2007-8#1)
risk of thromboembolic##6##3##(1997-5#1)(2005-12#1)(2007-12#1)(2007-8#1)(2008-7#1)(2013-1#1)
risk of thromboembolism##3##3##(2006-8#1)(2008-5#1)(2010-6#1)
risk of thrombosis##6##3##(1990-11#2)(1997-3#1)(2005-10#1)(2007-7#1)(2008-7#1)
risk of thrombotic##3##3##(1996-2#1)(2007-12#2)
risk of thyroid##2##3##(1990-8#1)(1991-5#1)
risk of transfer##2##3##(2004-4#1)(2011-2#1)
risk of transmission of##3##4##(2010-5#1)(2012-1#1)(2013-1#1)
risk of transmission##12##3##(1992-6#2)(1994-12#1)(1994-4#1)(2006-10#2)(2006-8#1)(2008-10#1)(2010-5#1)(2012-1#1)(2012-3#1)(2013-1#1)
risk of transmitting##2##3##(2006-10#1)(2012-11#1)
risk of treatment##3##3##(1993-9#1)(2008-7#1)(2011-2#1)
risk of tuberculosis##2##3##(1993-7#1)(2007-12#1)
risk of tumour##3##3##(2013-1#3)
risk of type 2 diabetes##6##5##(2006-10#1)(2008-1#2)(2008-3#1)(2012-2#1)(2013-8#1)
risk of type##8##3##(2006-10#1)(2007-2#1)(2007-5#1)(2008-1#2)(2008-3#1)(2012-2#1)(2013-8#1)
risk of unwanted##2##3##(1995-7#1)(2008-11#1)
risk of using a##2##4##(2008-11#1)(2011-2#1)
risk of vascular disease##4##4##(1990-3#1)(2005-10#1)(2005-12#1)(2010-12#1)
risk of vascular##6##3##(1990-3#1)(2005-10#1)(2005-12#1)(2007-10#1)(2010-12#1)(2011-2#1)
risk of venous thromboembolism associated with##2##6##(1996-11#1)(2010-12#1)
risk of venous thromboembolism##6##4##(1996-11#1)(2006-2#2)(2010-11#1)(2010-12#2)
risk of venous thrombosis##4##4##(2006-10#1)(2007-9#1)(2010-2#1)(2013-7#1)
risk of venous##14##3##(1996-11#1)(1996-3#1)(2006-10#1)(2006-2#2)(2007-8#1)(2007-9#1)(2010-11#1)(2010-12#4)(2010-2#1)(2013-7#1)
risk of vitamin A deficiency##2##5##(1991-8#2)
risk of wound##2##3##(2008-7#1)(2012-2#1)
risk of##2315##2##(1990-1#2)(1990-10#1)(1990-11#6)(1990-12#4)(1990-2#6)(1990-3#7)(1990-4#1)(1990-5#13)(1990-6#10)(1990-7#4)(1990-8#9)(1990-9#3)(1991-1#2)(1991-11#9)(1991-12#5)(1991-2#6)(1991-3#3)(1991-4#4)(1991-5#6)(1991-6#6)(1991-7#12)(1991-8#8)(1991-9#11)(1992-1#2)(1992-10#9)(1992-11#1)(1992-12#5)(1992-2#9)(1992-3#3)(1992-4#2)(1992-5#5)(1992-6#13)(1992-8#8)(1992-9#9)(1993-1#3)(1993-10#6)(1993-11#10)(1993-12#1)(1993-2#2)(1993-3#4)(1993-5#4)(1993-6#6)(1993-7#7)(1993-8#5)(1993-9#25)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#19)(1994-3#6)(1994-4#6)(1994-6#9)(1994-7#6)(1994-8#1)(1994-9#14)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#5)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#9)(1995-7#1)(1995-8#5)(1995-9#11)(1996-1#2)(1996-11#10)(1996-12#9)(1996-2#10)(1996-3#13)(1996-4#3)(1996-5#6)(1996-6#13)(1996-8#9)(1996-9#8)(1997-1#3)(1997-2#5)(1997-3#7)(1997-4#3)(1997-5#5)(1997-6#1)(1997-7#11)(1997-8#6)(2003-11#1)(2004-1#1)(2004-11#1)(2004-2#2)(2004-4#5)(2004-9#2)(2005-1#3)(2005-10#33)(2005-11#9)(2005-12#5)(2005-6#1)(2005-7#4)(2005-8#10)(2005-9#1)(2006-1#1)(2006-10#92)(2006-11#10)(2006-12#9)(2006-2#14)(2006-3#1)(2006-4#3)(2006-5#6)(2006-6#10)(2006-7#4)(2006-8#14)(2006-9#13)(2007-1#18)(2007-10#27)(2007-11#48)(2007-12#45)(2007-2#30)(2007-3#15)(2007-4#15)(2007-5#9)(2007-6#4)(2007-7#26)(2007-8#53)(2007-9#14)(2008-1#33)(2008-10#54)(2008-11#45)(2008-12#24)(2008-2#7)(2008-3#51)(2008-4#33)(2008-5#24)(2008-6#24)(2008-7#48)(2008-8#56)(2008-9#13)(2009-1#6)(2009-10#9)(2009-11#13)(2009-12#20)(2009-2#9)(2009-3#4)(2009-4#10)(2009-5#13)(2009-6#13)(2009-7#6)(2009-8#7)(2009-9#11)(2010-1#6)(2010-10#8)(2010-11#7)(2010-12#47)(2010-2#8)(2010-3#7)(2010-4#10)(2010-5#16)(2010-6#7)(2010-7#9)(2010-8#15)(2010-9#17)(2011-1#41)(2011-11#1)(2011-12#10)(2011-2#118)(2011-3#5)(2012-1#23)(2012-11#9)(2012-12#60)(2012-2#75)(2012-3#32)(2012-6#1)(2013-1#117)(2013-7#22)(2013-8#41)
risk on the##2##3##(1994-3#1)(1995-5#1)
risk on##5##2##(1994-3#2)(1995-5#1)(2010-8#1)(2011-1#1)
risk or harm reduction##2##4##(2009-7#2)
risk or##13##2##(1993-6#1)(1994-12#1)(1995-8#1)(1995-9#1)(1997-3#1)(2006-8#1)(2008-3#1)(2008-7#2)(2009-7#2)(2013-1#1)(2013-8#1)
risk patients with##2##3##(2007-7#1)(2008-1#1)
risk patients##43##2##(1992-6#1)(1993-5#1)(1994-8#1)(1996-11#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-5#1)(2007-7#2)(2007-8#6)(2008-1#2)(2008-10#4)(2008-3#1)(2008-4#2)(2008-7#2)(2009-10#1)(2009-4#1)(2009-7#1)(2010-10#2)(2010-3#3)(2011-12#1)(2011-2#3)(2012-12#2)(2013-1#1)
risk pattern during the period##2##5##(1991-6#2)
risk pattern##4##2##(1991-6#2)(1992-2#1)(2011-1#1)
risk patterns##2##2##(1991-5#1)(2012-2#1)
risk per##2##2##(1992-6#1)(2010-12#1)
risk perception and##2##3##(1990-9#1)(2012-3#1)
risk perception in##2##3##(2008-11#2)
risk perception of##2##3##(2012-2#1)(2012-3#1)
risk perception##11##2##(1990-9#1)(2008-11#4)(2009-4#1)(2012-2#1)(2012-3#4)
risk perceptions among young adults##2##5##(2010-2#1)(2012-1#1)
risk perceptions##5##2##(2008-12#1)(2010-2#2)(2012-1#1)(2013-7#1)
risk period was##2##3##(2011-1#2)
risk plans##2##2##(1996-3#2)
risk pool##3##2##(1993-12#2)(1995-12#1)
risk population for##2##3##(2007-7#1)(2007-8#1)
risk population##8##2##(1995-1#1)(2007-7#1)(2007-8#1)(2011-2#3)(2012-3#2)
risk populations##7##2##(1994-3#1)(2009-1#1)(2009-3#1)(2011-2#1)(2012-3#2)(2013-1#1)
risk practices##4##2##(2006-7#1)(2008-12#1)(2008-5#2)
risk prediction and##3##3##(2007-8#1)(2008-7#1)(2012-11#1)
risk prediction in##2##3##(2010-10#1)(2012-3#1)
risk prediction research##3##3##(2012-3#3)
risk prediction##21##2##(2005-10#1)(2006-10#1)(2007-8#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-10#1)(2012-11#1)(2012-12#1)(2012-3#11)
risk predictions##2##2##(2007-8#1)(2008-7#1)
risk predictor##3##2##(2008-8#1)(2010-2#1)(2013-1#1)
risk preference in##2##3##(2009-12#2)
risk preference##9##2##(2009-12#9)
risk pregnancy##2##2##(2005-10#1)(2013-1#1)
risk probability##2##2##(1996-6#1)(2008-10#1)
risk profile##14##2##(1993-11#1)(1993-2#1)(2006-6#1)(2008-1#1)(2008-2#1)(2008-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#2)(2013-1#2)
risk profiles of##2##3##(2008-10#1)(2008-11#1)
risk profiles##6##2##(1990-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-9#1)(2011-1#1)
risk program##3##2##(1994-12#1)(1994-3#2)
risk ratio and##3##3##(1993-9#1)(2007-11#1)(2012-3#1)
risk ratio for##2##3##(1995-2#1)(2012-2#1)
risk ratio of##2##3##(2008-11#1)(2012-2#1)
risk ratio##14##2##(1993-9#3)(1994-9#1)(1995-2#1)(1997-8#1)(2006-8#3)(2007-11#1)(2008-11#1)(2012-2#2)(2012-3#1)
risk ratios of##2##3##(1990-5#1)(2008-7#1)
risk ratios##5##2##(1990-5#1)(2008-7#1)(2013-1#2)(2013-8#1)
risk reduction and##2##3##(2007-7#1)(2008-12#1)
risk reduction counselling intervention##4##4##(2007-7#4)
risk reduction counselling##5##3##(2007-7#5)
risk reduction in##2##3##(2008-3#1)(2010-8#1)
risk reduction intervention##3##3##(2008-4#2)(2011-12#1)
risk reduction of##5##3##(1994-2#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
risk reduction provided by##2##4##(1994-2#2)
risk reduction through##2##3##(2007-3#1)(2013-8#1)
risk reduction##38##2##(1993-7#1)(1994-2#4)(2005-10#3)(2006-10#2)(2006-7#1)(2007-3#1)(2007-7#7)(2008-12#1)(2008-3#1)(2008-4#2)(2009-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
risk reductions##9##2##(1990-12#1)(2007-10#1)(2008-10#1)(2008-8#1)(2011-11#5)
risk regulation##2##2##(2008-9#1)(2009-4#1)
risk related to##3##3##(1994-4#1)(1995-11#1)(1996-11#1)
risk remain##2##2##(2007-10#1)(2008-4#1)
risk remains controversial##2##3##(2008-4#1)(2011-2#1)
risk remains##9##2##(2005-10#1)(2006-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2010-12#1)(2010-8#1)(2011-2#1)
risk requires##2##2##(1993-11#1)(1996-12#1)
risk research##2##2##(2010-12#2)
risk score for the##2##4##(1991-6#1)(2007-8#1)
risk score for##6##3##(1991-6#2)(2007-8#1)(2008-9#1)(2012-3#2)
risk score in the##2##4##(1994-11#1)(2011-1#1)
risk score in##3##3##(1994-11#1)(2008-9#1)(2011-1#1)
risk score##23##2##(1991-6#3)(1994-11#4)(2007-8#2)(2008-9#2)(2010-10#1)(2010-11#1)(2010-5#1)(2011-1#2)(2012-2#4)(2012-3#2)(2013-1#1)
risk scores##4##2##(1994-11#1)(2012-2#2)(2013-8#1)
risk screening##2##2##(1997-3#1)(2010-8#1)
risk selection##3##2##(1994-3#1)(1995-1#1)(1997-1#1)
risk should be##4##3##(1992-5#1)(2007-12#1)(2008-3#1)(2012-1#1)
risk situations##3##2##(1995-5#1)(2013-1#2)
risk spreading##2##2##(2008-8#2)
risk status of##2##3##(2011-2#1)(2012-3#1)
risk status##9##2##(1995-9#2)(1996-1#1)(1997-5#1)(2006-10#1)(2011-11#1)(2011-2#1)(2012-3#2)
risk stratification in patients##2##4##(2008-8#1)(2010-5#1)
risk stratification in##6##3##(2008-10#1)(2008-8#1)(2010-5#1)(2010-6#1)(2010-9#1)(2013-7#1)
risk stratification is##2##3##(2006-5#1)(2011-1#1)
risk stratification of patients with##2##5##(2006-10#1)(2010-11#1)
risk stratification of patients##3##4##(2006-10#2)(2010-11#1)
risk stratification of##11##3##(1996-4#1)(2006-10#2)(2008-3#2)(2010-11#1)(2011-2#2)(2012-2#1)(2012-3#2)
risk stratification systems##3##3##(2007-8#3)
risk stratification##50##2##(1996-4#2)(2006-10#3)(2006-5#1)(2006-9#1)(2007-7#1)(2007-8#7)(2008-10#1)(2008-3#6)(2008-8#2)(2009-1#1)(2009-7#1)(2010-11#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-9#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#2)
risk such as##2##3##(2009-7#1)(2011-1#1)
risk taking##8##2##(1995-2#1)(2008-11#3)(2009-3#1)(2010-8#2)(2013-1#1)
risk than men##3##3##(2008-4#1)(2010-6#1)(2013-8#1)
risk than others##2##3##(2006-8#1)(2008-10#1)
risk than##14##2##(1991-5#1)(1994-3#1)(1994-6#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-6#1)(2011-2#1)(2013-8#1)
risk that is##2##3##(2011-2#2)
risk that it##2##3##(1990-12#1)(2011-2#1)
risk that##13##2##(1990-12#1)(1992-9#1)(2008-10#2)(2008-6#1)(2008-8#1)(2009-10#1)(2010-6#1)(2011-2#3)(2012-11#1)(2013-8#1)
risk threshold##3##2##(2008-10#3)
risk through##9##2##(1992-12#1)(1992-3#1)(1995-3#2)(2005-10#1)(2008-10#1)(2008-6#1)(2009-2#1)(2012-12#1)
risk to an individual##2##4##(2006-10#1)(2008-7#1)
risk to an##3##3##(2006-10#1)(2008-7#2)
risk to be##2##3##(2008-2#1)(2012-1#1)
risk to develop##6##3##(2006-6#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-9#1)(2012-12#1)
risk to human##3##3##(2006-8#1)(2008-12#1)(2008-7#1)
risk to public health##4##4##(2007-12#1)(2008-12#1)(2012-12#2)
risk to the patient##7##4##(1992-4#1)(1995-11#1)(1995-12#1)(2007-11#1)(2007-7#1)(2010-11#1)(2012-3#1)
risk to the##21##3##(1992-4#1)(1995-11#1)(1995-12#1)(1995-2#1)(2006-10#1)(2007-1#2)(2007-11#1)(2007-4#1)(2007-7#4)(2007-8#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
risk to themselves##2##3##(1990-12#1)(1991-12#1)
risk to travellers##2##3##(2007-2#2)
risk to##81##2##(1990-12#1)(1990-9#1)(1991-12#2)(1992-12#1)(1992-2#2)(1992-4#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-6#1)(1996-8#1)(2006-10#2)(2006-11#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#4)(2007-11#1)(2007-12#1)(2007-2#5)(2007-4#2)(2007-7#6)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-7#1)(2010-9#1)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
risk tolerance##4##2##(2011-2#4)
risk under##3##2##(1994-5#1)(2006-10#1)(2006-11#1)
risk using the##2##3##(1995-9#1)(2008-7#1)
risk using##3##2##(1995-9#1)(2008-7#1)(2010-6#1)
risk variables##4##2##(2008-4#1)(2009-10#1)(2011-1#1)(2012-12#1)
risk variants##2##2##(2012-3#2)
risk was 1##4##3##(1991-7#1)(2006-10#1)(2009-4#1)(2013-1#1)
risk was also##2##3##(1991-6#1)(1992-10#1)
risk was found##3##3##(1991-2#1)(2006-8#1)(2011-2#1)
risk was high##2##3##(2007-10#2)
risk was observed in##2##4##(1991-7#1)(2011-1#1)
risk was observed##4##3##(1991-2#1)(1991-7#1)(1993-8#1)(2011-1#1)
risk was present in##2##4##(1991-3#1)(2007-10#1)
risk was seen##2##3##(2007-1#1)(2008-3#1)
risk was##38##2##(1990-6#1)(1991-2#2)(1991-3#1)(1991-5#3)(1991-6#1)(1991-7#2)(1992-10#1)(1993-8#1)(1993-9#2)(1994-2#1)(1994-6#1)(1996-5#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-1#2)(2007-10#6)(2008-3#1)(2009-10#2)(2009-4#2)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
risk were##10##2##(1991-5#1)(1992-5#1)(1993-9#1)(1995-5#1)(2007-8#1)(2009-4#1)(2009-7#1)(2010-9#1)(2011-1#1)(2013-1#1)
risk when##3##2##(2007-4#1)(2009-10#1)(2011-12#1)
risk while##4##2##(1991-3#1)(2007-10#1)(2008-8#1)(2013-1#1)
risk will also be##2##4##(1992-2#1)(1996-12#1)
risk will be##4##3##(1992-3#1)(1995-6#1)(1997-3#1)(2006-2#1)
risk will##6##2##(1992-2#1)(1992-3#1)(1995-6#1)(1996-12#1)(1997-3#1)(2006-2#1)
risk with a##3##3##(1990-6#1)(1991-9#1)(2007-4#1)
risk with rofecoxib##3##3##(2007-12#3)
risk with##21##2##(1990-6#1)(1991-9#1)(1992-9#2)(1997-5#1)(1997-8#2)(2007-12#3)(2007-4#2)(2008-7#3)(2009-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
risk within##2##2##(2005-8#1)(2012-12#1)
risk women##5##2##(2006-7#1)(2007-7#1)(2008-1#1)(2008-9#1)(2011-2#1)
risk youth##2##2##(2007-4#1)(2012-12#1)
risk##7908##1##(1990-1#2)(1990-10#1)(1990-11#13)(1990-12#29)(1990-2#13)(1990-3#17)(1990-4#3)(1990-5#26)(1990-6#28)(1990-7#8)(1990-8#16)(1990-9#13)(1991-1#5)(1991-10#4)(1991-11#16)(1991-12#33)(1991-2#19)(1991-3#16)(1991-4#9)(1991-5#26)(1991-6#25)(1991-7#27)(1991-8#18)(1991-9#16)(1992-1#7)(1992-10#14)(1992-11#8)(1992-12#37)(1992-2#30)(1992-3#14)(1992-4#12)(1992-5#11)(1992-6#18)(1992-7#2)(1992-8#14)(1992-9#27)(1993-1#14)(1993-10#7)(1993-11#29)(1993-12#28)(1993-2#25)(1993-3#16)(1993-4#2)(1993-5#17)(1993-6#11)(1993-7#12)(1993-8#9)(1993-9#64)(1994-1#10)(1994-10#1)(1994-11#13)(1994-12#20)(1994-2#65)(1994-3#24)(1994-4#14)(1994-5#8)(1994-6#25)(1994-7#9)(1994-8#4)(1994-9#16)(1995-1#10)(1995-10#6)(1995-11#7)(1995-12#14)(1995-2#19)(1995-3#13)(1995-4#7)(1995-5#11)(1995-6#23)(1995-7#5)(1995-8#28)(1995-9#36)(1996-1#14)(1996-11#20)(1996-12#36)(1996-2#23)(1996-3#32)(1996-4#11)(1996-5#10)(1996-6#31)(1996-7#13)(1996-8#28)(1996-9#23)(1997-1#26)(1997-2#13)(1997-3#36)(1997-4#14)(1997-5#30)(1997-6#14)(1997-7#19)(1997-8#37)(2003-11#1)(2004-1#2)(2004-10#6)(2004-11#10)(2004-12#4)(2004-2#4)(2004-3#4)(2004-4#9)(2004-9#3)(2005-1#4)(2005-10#107)(2005-11#20)(2005-12#13)(2005-3#3)(2005-5#13)(2005-6#5)(2005-7#13)(2005-8#27)(2005-9#3)(2006-1#4)(2006-10#249)(2006-11#26)(2006-12#27)(2006-2#65)(2006-3#3)(2006-4#8)(2006-5#18)(2006-6#35)(2006-7#22)(2006-8#58)(2006-9#29)(2007-1#67)(2007-10#156)(2007-11#119)(2007-12#132)(2007-2#78)(2007-3#35)(2007-4#53)(2007-5#23)(2007-6#21)(2007-7#85)(2007-8#182)(2007-9#66)(2008-1#130)(2008-10#205)(2008-11#145)(2008-12#85)(2008-2#28)(2008-3#204)(2008-4#98)(2008-5#77)(2008-6#59)(2008-7#240)(2008-8#146)(2008-9#54)(2009-1#11)(2009-10#54)(2009-11#33)(2009-12#60)(2009-2#21)(2009-3#23)(2009-4#42)(2009-5#51)(2009-6#36)(2009-7#51)(2009-8#26)(2009-9#33)(2010-1#10)(2010-10#32)(2010-11#30)(2010-12#135)(2010-2#56)(2010-3#17)(2010-4#64)(2010-5#34)(2010-6#31)(2010-7#55)(2010-8#53)(2010-9#65)(2011-1#179)(2011-11#16)(2011-12#31)(2011-2#444)(2011-3#7)(2011-7#1)(2012-1#61)(2012-11#35)(2012-12#187)(2012-2#235)(2012-3#145)(2012-5#1)(2012-6#8)(2013-1#379)(2013-3#3)(2013-4#3)(2013-7#72)(2013-8#166)
risk&quot##12##1##(1990-2#2)(1992-6#1)(1993-9#1)(1994-6#1)(1997-3#1)(2007-1#1)(2007-8#1)(2008-1#1)(2010-2#1)(2012-11#1)(2012-3#1)
risk'##3##1##(1996-7#1)(2008-3#1)(2009-5#1)
risk)##11##1##(1990-12#1)(1996-2#1)(2007-11#1)(2008-3#3)(2008-7#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
risk-adapted programs##2##2##(2009-2#2)
risk-adapted##3##1##(2008-8#1)(2009-2#2)
risk-adjusted model##2##2##(2007-8#2)
risk-adjusted outcome models##2##3##(2007-8#2)
risk-adjusted outcome##3##2##(2007-8#2)(2008-11#1)
risk-adjusted##15##1##(1995-2#1)(1996-12#1)(1996-2#1)(1997-1#1)(2005-12#1)(2006-10#1)(2007-5#1)(2007-8#5)(2008-11#1)(2013-1#2)
risk-adjustment##3##1##(1996-2#1)(1997-1#1)(2008-7#1)
risk-assessment##5##1##(2004-4#1)(2008-12#1)(2008-7#2)(2013-1#1)
risk-averse##2##1##(2009-12#1)(2010-8#1)
risk-based##7##1##(1991-3#1)(2008-7#3)(2010-12#1)(2012-2#2)
risk-benefit analysis##4##2##(2012-11#3)(2013-1#1)
risk-benefit and##2##2##(2007-12#1)(2008-7#1)
risk-benefit assessment##4##2##(2005-11#1)(2007-2#1)(2009-6#1)(2012-2#1)
risk-benefit balance of##2##3##(2009-6#2)
risk-benefit balance##3##2##(2009-6#3)
risk-benefit ratio of using##2##4##(2006-10#1)(2008-3#1)
risk-benefit ratio of##3##3##(2006-10#1)(2006-8#1)(2008-3#1)
risk-benefit ratio##8##2##(1993-12#1)(1996-3#1)(2006-10#1)(2006-8#2)(2007-12#1)(2008-3#1)(2010-6#1)
risk-benefit##26##1##(1993-12#1)(1993-2#1)(1996-3#1)(2005-11#1)(2006-10#2)(2006-8#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-6#4)(2010-6#1)(2012-11#3)(2012-2#1)(2013-1#2)(2013-7#1)
risk-factor epidemiology##2##2##(2006-6#2)
risk-factor##4##1##(1990-4#1)(2006-6#2)(2008-7#1)
risk-level cut scores##2##3##(2008-12#2)
risk-level##3##1##(2008-12#3)
risk-lovers##2##1##(2007-7#2)
risk-management##4##1##(2007-9#2)(2008-11#1)(2012-2#1)
risk-neutral##2##1##(2007-7#1)(2010-5#1)
risk-reducing recommendations##2##2##(1993-12#2)
risk-reducing##5##1##(1993-12#5)
risk-reduction##5##1##(1996-2#2)(2010-7#1)(2011-1#1)(2013-1#1)
risk-selection in BI##2##3##(2008-7#2)
risk-selection in##4##2##(2008-7#4)
risk-selection##7##1##(2008-7#7)
risk-sharing##2##1##(1990-5#1)(1996-2#1)
risk-stratify patients##3##2##(2009-10#2)(2009-9#1)
risk-taking among##2##2##(2006-7#1)(2011-2#1)
risk-taking and##2##2##(2006-9#1)(2012-12#1)
risk-taking behavior##2##2##(2013-1#1)(2013-8#1)
risk-taking behaviour##2##2##(2010-8#2)
risk-taking##18##1##(2006-10#1)(2006-7#1)(2006-9#1)(2008-11#1)(2009-3#2)(2010-2#1)(2010-8#4)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
risk-to-benefit ratio##2##2##(1992-11#1)(1996-9#1)
risk-tolerant individuals##2##2##(2009-12#2)
risk-tolerant##3##1##(2009-12#3)
risk/benefit of##3##2##(1990-12#1)(2011-1#1)(2012-1#1)
risk/benefit ratio of##3##3##(2007-9#2)(2008-3#1)
risk/benefit ratio##8##2##(1991-8#1)(1992-11#1)(2006-8#1)(2007-11#1)(2007-8#1)(2007-9#2)(2008-3#1)
risk/benefit ratios##2##2##(1991-3#1)(2005-7#1)
risk/benefit##17##1##(1990-12#1)(1991-3#1)(1991-8#1)(1992-11#1)(1993-11#1)(2005-7#1)(2006-8#1)(2007-11#2)(2007-8#1)(2007-9#2)(2008-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
risk?##20##1##(1991-12#1)(1992-2#1)(1994-12#1)(1994-8#1)(1996-2#1)(1997-1#1)(1997-5#1)(2006-10#3)(2006-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-9#1)(2012-12#1)(2012-2#1)
risk?]##2##1##(2007-12#1)(2011-2#1)
risk]##6##1##(1993-3#1)(1994-2#1)(1994-6#1)(1995-4#1)(2008-10#1)(2008-11#1)
risked##2##1##(2005-10#1)(2006-7#1)
riskier##4##1##(2007-7#1)(2008-11#1)(2011-2#2)
risking##8##1##(1990-8#1)(2008-10#2)(2008-11#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
risks after##2##2##(2011-2#1)(2013-1#1)
risks against##2##2##(2006-10#1)(2012-11#1)
risks and a##2##3##(1994-6#1)(2007-11#1)
risks and benefits of the##4##5##(1990-3#1)(2006-10#1)(2007-8#1)(2013-1#1)
risks and benefits of##28##4##(1990-3#1)(1990-9#1)(1993-9#1)(1996-12#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#2)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#2)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
risks and benefits##42##3##(1990-3#1)(1990-9#1)(1993-9#1)(1996-12#1)(2005-10#1)(2005-6#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#3)(2009-12#2)(2009-4#1)(2010-11#2)(2010-12#2)(2010-8#2)(2010-9#1)(2011-2#3)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
risks and hazards##2##3##(1991-12#1)(2013-1#1)
risks and the##5##3##(2006-10#1)(2007-2#1)(2009-6#1)(2011-1#1)(2011-2#1)
risks and##83##2##(1990-11#1)(1990-3#1)(1990-9#1)(1991-12#1)(1991-3#1)(1992-12#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-12#1)(1997-5#1)(1997-8#2)(2005-10#2)(2005-5#1)(2005-6#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-11#3)(2007-2#5)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#3)(2009-12#2)(2009-4#1)(2009-6#1)(2009-9#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#6)(2012-11#2)(2012-12#1)(2012-2#3)(2013-1#3)(2013-7#1)
risks are identified##2##3##(1991-12#1)(2012-12#1)
risks are##9##2##(1991-12#1)(2006-8#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-8#1)(2012-12#1)(2013-7#1)
risks as##4##2##(2005-10#1)(2009-3#1)(2009-6#1)(2012-12#1)
risks associated with an##2##4##(2008-7#1)(2011-2#1)
risks associated with exposure to##3##5##(2007-12#1)(2008-6#1)(2011-1#1)
risks associated with the##6##4##(2006-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
risks associated with their use##2##5##(2011-3#1)(2013-1#1)
risks associated with their##3##4##(2009-7#1)(2011-3#1)(2013-1#1)
risks associated with this##3##4##(2007-4#1)(2008-5#1)(2010-8#1)
risks associated with##54##3##(1991-3#1)(1992-2#1)(1994-6#1)(1995-1#1)(1996-1#1)(1997-3#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-7#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#1)(2013-1#3)(2013-8#4)
risks associated##55##2##(1991-3#1)(1992-2#1)(1994-6#1)(1995-1#1)(1996-1#1)(1997-3#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-7#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#1)(2013-1#4)(2013-8#4)
risks before##2##2##(1993-2#1)(1996-12#1)
risks by##3##2##(2005-5#1)(2008-3#1)(2008-9#1)
risks can be minimized and maximum safety maintained##2##8##(2012-2#2)
risks can be minimized##3##4##(2006-12#1)(2012-2#2)
risks can be##5##3##(2006-12#1)(2011-2#1)(2012-11#1)(2012-2#2)
risks can##6##2##(2006-12#1)(2008-11#1)(2011-2#1)(2012-11#1)(2012-2#2)
risks could be##2##3##(2008-7#1)(2013-1#1)
risks during##3##2##(1996-6#1)(2007-2#1)(2008-9#1)
risks factors for CAD##2##4##(2011-1#2)
risks factors for##4##3##(2011-1#2)(2012-12#1)(2013-1#1)
risks factors##5##2##(1991-4#1)(2011-1#2)(2012-12#1)(2013-1#1)
risks for mothers and##2##4##(2010-9#1)(2011-1#1)
risks for obesity##2##3##(2004-12#1)(2013-1#1)
risks for the##6##3##(1991-3#1)(2007-1#1)(2007-11#1)(2009-9#1)(2010-12#1)(2013-8#1)
risks for##40##2##(1991-3#1)(1992-1#1)(1992-2#1)(1994-3#1)(1994-6#1)(1996-8#1)(1997-8#1)(2004-12#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-11#2)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#1)(2009-4#1)(2009-9#1)(2010-12#2)(2010-9#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
risks from##10##2##(1991-3#1)(1996-11#1)(2006-10#2)(2008-11#1)(2008-7#2)(2008-9#1)(2009-4#1)(2011-1#1)
risks have##2##2##(2009-3#1)(2013-1#1)
risks in pregnancy##2##3##(2012-3#1)(2013-8#1)
risks in the##6##3##(1993-12#1)(1993-9#1)(1996-3#1)(2008-9#1)(2011-1#1)(2012-1#1)
risks in##25##2##(1990-6#1)(1991-11#1)(1993-12#1)(1993-9#1)(1994-6#1)(1996-3#1)(1997-7#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#2)(2010-4#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
risks include infection##2##3##(2009-5#1)(2012-12#1)
risks include##6##2##(1993-9#1)(2006-10#1)(2006-8#1)(2007-11#1)(2009-5#1)(2012-12#1)
risks including##2##2##(2008-6#1)(2012-3#1)
risks inherent in##2##3##(1994-3#1)(2010-12#1)
risks involved in##4##3##(1993-1#1)(1996-2#1)(2005-12#1)(2007-12#1)
risks involved##11##2##(1992-12#1)(1992-3#1)(1993-1#1)(1994-1#1)(1996-2#1)(2005-12#1)(2006-6#1)(2007-12#1)(2009-6#1)(2010-5#1)(2012-2#1)
risks is##5##2##(1994-6#1)(2009-4#1)(2010-9#1)(2013-1#2)
risks may be##4##3##(1992-2#1)(2008-11#1)(2008-7#1)(2010-2#1)
risks may##5##2##(1992-2#1)(2008-11#1)(2008-7#2)(2010-2#1)
risks of adverse events##2##4##(2007-11#1)(2013-1#1)
risks of asbestos##2##3##(1991-12#1)(2008-6#1)
risks of both types were##2##5##(1991-5#2)
risks of both##3##3##(1991-5#3)
risks of cancer##3##3##(1990-5#1)(2008-11#1)(2008-7#1)
risks of cardiac##3##3##(2005-9#1)(2006-10#1)(2010-4#1)
risks of cardiovascular##2##3##(2008-7#1)(2012-12#1)
risks of delayed##2##3##(2008-10#1)(2008-9#1)
risks of each##2##3##(1991-5#1)(2011-2#1)
risks of epidural##2##3##(2006-10#1)(2008-9#1)
risks of exposure to##2##4##(1991-11#1)(2007-2#1)
risks of infection##3##3##(2006-8#1)(2007-2#1)(2008-7#1)
risks of perforation and##2##4##(2010-8#2)
risks of secondary##2##3##(1991-11#1)(2013-7#1)
risks of stroke and##2##4##(1990-3#1)(2005-10#1)
risks of such##2##3##(2010-6#1)(2011-2#1)
risks of surgery##2##3##(2006-10#1)(2006-9#1)
risks of the procedure##2##4##(1994-6#1)(2006-8#1)
risks of the##5##3##(1993-3#1)(1994-6#1)(2006-8#1)(2008-4#1)(2012-2#1)
risks of these##5##3##(1996-9#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
risks of this therapy##2##4##(2006-10#1)(2006-9#1)
risks of this##4##3##(1994-6#1)(2006-10#1)(2006-9#1)(2007-10#1)
risks of treatment##2##3##(2008-4#1)(2012-1#1)
risks of##191##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-5#6)(1991-8#2)(1992-10#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-2#1)(1993-3#3)(1993-9#1)(1994-3#1)(1994-6#4)(1994-9#1)(1995-3#1)(1995-4#2)(1996-12#1)(1996-2#1)(1996-6#1)(1996-9#2)(1997-4#1)(1997-5#2)(2005-10#5)(2005-11#1)(2005-12#2)(2005-7#1)(2005-9#1)(2006-10#8)(2006-11#2)(2006-12#1)(2006-2#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#2)(2007-2#7)(2007-4#2)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#11)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#7)(2008-8#4)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#10)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#5)(2013-1#13)(2013-7#2)(2013-8#1)
risks on##2##2##(2011-1#1)(2011-2#1)
risks or##2##2##(1996-3#1)(2011-12#1)
risks outweigh##2##2##(2007-2#1)(2008-11#1)
risks posed by##3##3##(2005-8#1)(2008-4#1)(2010-10#1)
risks posed##4##2##(2005-8#1)(2008-11#1)(2008-4#1)(2010-10#1)
risks related to##4##3##(2010-9#2)(2011-2#2)
risks should be##2##3##(2008-11#1)(2011-2#1)
risks so##2##2##(1992-10#1)(2011-2#1)
risks such as##4##3##(2008-9#1)(2009-3#1)(2009-5#1)(2012-12#1)
risks than##3##2##(2007-11#1)(2010-6#1)(2010-8#1)
risks that##4##2##(2007-11#1)(2008-11#1)(2008-7#1)(2010-12#1)
risks the##2##2##(1993-4#1)(2012-2#1)
risks to develop##2##3##(1991-4#1)(2012-2#1)
risks to health##2##3##(1997-8#1)(2008-8#1)
risks to patients##2##3##(2008-8#1)(2010-9#1)
risks to the patients##2##4##(1993-2#1)(2008-7#1)
risks to the##7##3##(1993-2#1)(2007-7#1)(2008-7#2)(2008-9#1)(2013-8#2)
risks to##26##2##(1991-4#1)(1993-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-1#1)(1997-8#1)(2005-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#3)(2008-8#2)(2008-9#1)(2010-12#1)(2010-9#1)(2012-2#1)(2013-1#2)(2013-8#2)
risks using##2##2##(2005-9#1)(2007-4#1)
risks versus benefits##3##3##(1990-12#1)(2007-12#1)(2008-8#1)
risks were observed for##2##4##(1992-10#1)(1994-2#1)
risks were##12##2##(1991-3#2)(1992-10#2)(1992-9#1)(1994-2#2)(1996-11#1)(1996-5#1)(1997-7#1)(2010-8#1)(2011-3#1)
risks will##3##2##(1993-2#1)(2007-9#1)(2010-3#1)
risks with the##2##3##(2008-11#1)(2010-5#1)
risks with##4##2##(1996-7#1)(2007-4#1)(2008-11#1)(2010-5#1)
risks##774##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#5)(1991-12#3)(1991-2#4)(1991-3#6)(1991-4#2)(1991-5#7)(1991-6#4)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#4)(1992-12#2)(1992-2#3)(1992-3#4)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#3)(1993-1#3)(1993-11#2)(1993-12#1)(1993-2#8)(1993-3#5)(1993-4#2)(1993-6#1)(1993-9#5)(1994-1#2)(1994-2#2)(1994-3#7)(1994-5#1)(1994-6#12)(1994-7#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-3#1)(1995-4#2)(1995-6#2)(1995-9#2)(1996-1#4)(1996-11#2)(1996-12#3)(1996-2#5)(1996-3#4)(1996-5#1)(1996-6#2)(1996-7#7)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#2)(1997-4#4)(1997-5#3)(1997-7#2)(1997-8#7)(2004-12#1)(2004-4#1)(2005-10#13)(2005-11#2)(2005-12#3)(2005-5#3)(2005-6#1)(2005-7#2)(2005-8#1)(2005-9#4)(2006-10#28)(2006-11#6)(2006-12#6)(2006-2#3)(2006-4#1)(2006-5#1)(2006-6#3)(2006-8#4)(2006-9#4)(2007-1#8)(2007-10#5)(2007-11#13)(2007-12#7)(2007-2#24)(2007-3#1)(2007-4#9)(2007-7#3)(2007-8#10)(2007-9#5)(2008-1#8)(2008-10#23)(2008-11#24)(2008-12#4)(2008-2#3)(2008-3#10)(2008-4#9)(2008-5#5)(2008-6#9)(2008-7#24)(2008-8#17)(2008-9#14)(2009-10#4)(2009-11#1)(2009-12#6)(2009-3#4)(2009-4#5)(2009-5#2)(2009-6#4)(2009-7#3)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#4)(2010-12#13)(2010-2#4)(2010-3#5)(2010-4#6)(2010-5#4)(2010-6#5)(2010-7#2)(2010-8#10)(2010-9#9)(2011-1#17)(2011-12#3)(2011-2#40)(2011-3#2)(2011-9#1)(2012-1#6)(2012-11#10)(2012-12#12)(2012-2#18)(2012-3#5)(2013-1#40)(2013-7#7)(2013-8#14)
risks&quot##4##1##(1990-8#1)(2007-1#1)(2007-6#1)(2013-1#1)
risks?##5##1##(1992-2#1)(2007-8#1)(2009-4#1)(2010-2#1)(2010-3#1)
risks]##6##1##(1990-11#1)(1994-6#1)(1995-12#1)(1996-2#1)(1997-1#1)(2011-3#1)
risky alcohol##2##2##(2009-8#1)(2013-1#1)
risky behavior##7##2##(1996-2#1)(2009-7#3)(2009-8#1)(2009-9#1)(2011-2#1)
risky behaviors##4##2##(2007-12#1)(2010-5#1)(2010-9#1)(2013-8#1)
risky behaviours##3##2##(2011-1#2)(2011-2#1)
risky decision making##2##3##(2008-11#1)(2009-3#1)
risky decision-making in##2##3##(2009-3#1)(2010-2#1)
risky decision-making##7##2##(2009-3#3)(2010-2#1)(2013-7#1)(2013-8#2)
risky drug use behavior##2##4##(2011-12#2)
risky injection##2##2##(2013-8#2)
risky sexual behavior##8##3##(2009-5#1)(2011-12#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
risky sexual behaviors in places of##2##6##(2012-3#2)
risky sexual behaviors##9##3##(2007-12#3)(2009-5#1)(2012-3#4)(2013-8#1)
risky sexual##20##2##(2007-12#3)(2007-7#1)(2009-5#2)(2011-12#2)(2011-2#2)(2012-12#1)(2012-3#6)(2013-1#1)(2013-8#2)
risky situations##2##2##(2009-10#1)(2013-1#1)
risky to##2##2##(1990-2#1)(2006-8#1)
risky##90##1##(1990-2#1)(1992-1#2)(1992-8#1)(1996-2#1)(1997-8#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#5)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#4)(2009-4#1)(2009-5#2)(2009-7#4)(2009-8#2)(2009-9#1)(2010-2#4)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#4)(2011-2#6)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#6)(2013-7#2)(2013-8#8)
risperidone antinociceptive effect##3##3##(1997-5#3)
risperidone did not##2##3##(1996-12#1)(2004-3#1)
risperidone in##3##2##(1997-5#1)(2004-3#2)
risperidone##30##1##(1996-12#1)(1996-2#2)(1997-5#8)(2004-12#1)(2004-3#9)(2005-8#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2011-12#1)(2012-2#1)(2012-3#1)
risque##6##1##(2008-11#3)(2013-1#3)
ristocetin cofactor##3##2##(1990-11#2)(2007-10#1)
ristocetin##5##1##(1990-11#2)(1997-6#1)(2007-10#1)(2008-8#1)
ritanserin alone##2##2##(1990-11#2)
ritanserin pretreatment##2##2##(1996-5#2)
ritanserin##12##1##(1990-11#5)(1995-12#1)(1996-5#5)(1997-5#1)
rites##2##1##(2008-1#1)(2009-10#1)
ritodrine##6##1##(2008-10#4)(2010-6#2)
ritonavir and##2##2##(1995-9#1)(2011-3#1)
ritonavir treatment##2##2##(2008-11#2)
ritonavir##16##1##(1995-9#2)(2007-11#3)(2008-11#4)(2008-5#2)(2011-3#5)
ritonavir-induced##2##1##(2008-11#2)
ritual circumcision##3##2##(1991-8#2)(2008-1#1)
ritual##15##1##(1991-8#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#5)(2013-1#1)(2013-8#1)
rituals and family identity##2##4##(2012-2#2)
rituals and##4##2##(2011-2#1)(2012-2#3)
rituals##15##1##(1993-3#2)(2006-12#1)(2008-11#1)(2009-10#2)(2010-12#1)(2011-2#1)(2012-2#6)(2013-8#1)
rituximab (Rituxan)##2##2##(2008-10#1)(2012-2#1)
rituximab and##5##2##(2005-10#1)(2005-11#1)(2010-11#1)(2010-12#1)(2011-2#1)
rituximab for##4##2##(2006-10#1)(2008-7#1)(2010-1#1)(2013-1#1)
rituximab has##3##2##(2005-10#1)(2010-12#1)(2012-2#1)
rituximab have##2##2##(2008-3#1)(2012-3#1)
rituximab in the treatment of##3##5##(2012-3#1)(2013-1#2)
rituximab in##10##2##(2010-12#2)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#5)
rituximab plus##2##2##(2005-10#1)(2007-10#1)
rituximab therapy##3##2##(2006-10#1)(2009-8#1)(2012-2#1)
rituximab##61##1##(2005-10#4)(2005-11#1)(2006-10#7)(2007-10#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-7#1)(2009-8#3)(2010-1#1)(2010-11#1)(2010-12#8)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#9)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#1)
rituximab-bendamustine regimen##2##2##(2013-8#2)
rival the##2##2##(1992-2#1)(2012-2#1)
rival those of##2##3##(2010-7#1)(2011-1#1)
rival##17##1##(1992-2#1)(1992-9#1)(1997-4#1)(2006-9#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-6#2)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-2#1)
rivaled##2##1##(1991-12#1)(2008-8#1)
rivaling##2##1##(2008-3#1)(2008-4#1)
rivalries##2##1##(2008-12#1)(2008-7#1)
rivalry##6##1##(1992-3#1)(1997-4#1)(2007-9#1)(2008-11#1)(2009-2#1)(2013-8#1)
rivals that of##2##3##(2006-10#2)
rivals##8##1##(1991-11#1)(1995-10#1)(2006-10#2)(2007-9#1)(2008-11#1)(2009-6#1)(2012-2#1)
rivanol##5##1##(2008-10#5)
rivaroxaban and apixaban##2##3##(2012-12#2)
rivastigmine has##2##2##(2008-11#1)(2011-2#1)
rivastigmine treatment groups##2##3##(2004-3#1)(2011-2#1)
rivastigmine##23##1##(2004-12#1)(2004-3#4)(2005-8#1)(2008-11#1)(2011-12#6)(2011-2#10)
river and sea##2##3##(2008-10#2)
river and seawater samples##2##4##(2008-10#2)
river and seawater##5##3##(2008-10#5)
river and tap water and##2##5##(2008-10#2)
river and tap water samples##4##5##(2008-10#4)
river and tap water##6##4##(2008-10#6)
river and the##2##3##(1997-4#1)(2008-10#1)
river and##27##2##(1997-4#1)(2007-10#1)(2008-10#25)
river at##2##2##(2008-10#2)
river basin##7##2##(2007-3#1)(2008-10#3)(2008-12#1)(2008-5#2)
river basins##2##2##(2008-5#1)(2009-6#1)
river flooding##2##2##(1991-2#1)(2007-5#1)
river humic substances (HS)##2##4##(2008-10#2)
river humic substances##4##3##(2008-10#4)
river in##3##2##(1993-9#1)(2007-8#1)(2013-7#1)
river kilometre##2##2##(2010-8#2)
river mouths##2##2##(2007-5#2)
river samples##2##2##(2008-10#2)
river sediment##7##2##(2008-10#4)(2008-6#2)(2013-8#1)
river sediments##5##2##(2008-10#4)(2013-8#1)
river system##2##2##(2010-8#1)(2013-1#1)
river water and##7##3##(2008-10#7)
river water as##2##3##(2007-10#1)(2008-10#1)
river water samples is demonstrated##2##5##(2008-10#2)
river water samples spiked with##2##5##(2008-10#1)(2011-1#1)
river water samples##27##3##(2007-8#1)(2008-10#24)(2011-1#2)
river water spiked with##2##4##(2008-10#2)
river water using##2##3##(2008-10#2)
river water was##2##3##(2008-10#2)
river water were##2##3##(1992-6#1)(2008-10#1)
river water##96##2##(1992-6#1)(2005-4#1)(2006-10#2)(2007-10#1)(2007-8#2)(2008-10#85)(2011-1#2)(2012-12#2)
river waters by##2##3##(2008-10#2)
river waters##17##2##(1996-11#1)(2008-10#15)(2011-12#1)
river##259##1##(1991-2#1)(1992-6#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1996-11#1)(1996-6#1)(1997-4#1)(2005-4#1)(2005-8#1)(2006-10#3)(2007-10#2)(2007-3#8)(2007-5#3)(2007-7#1)(2007-8#4)(2008-10#166)(2008-12#3)(2008-4#1)(2008-5#16)(2008-6#2)(2008-8#4)(2009-2#1)(2009-6#5)(2009-7#2)(2010-5#1)(2010-8#7)(2011-1#2)(2011-12#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#2)(2013-7#4)(2013-8#4)
riverine communities of the##2##4##(2013-7#2)
riverine communities##3##2##(2013-7#3)
riverine water reference by a graphite furnace atomic absorption spectroscopy##2##10##(2008-10#2)
riverine water##3##2##(2008-10#3)
riverine##12##1##(2004-4#2)(2008-10#4)(2008-2#1)(2013-7#5)
rivers and##8##2##(2004-4#1)(2006-5#1)(2007-5#1)(2008-5#2)(2008-9#1)(2013-8#2)
rivers in the State of Selangor##2##6##(2008-10#2)
rivers in the##4##3##(2008-10#2)(2010-8#1)(2013-8#1)
rivers in##6##2##(1993-9#1)(2008-10#2)(2010-8#1)(2011-12#1)(2013-8#1)
rivers of##3##2##(2012-3#1)(2013-1#2)
rivers##42##1##(1990-6#2)(1993-9#3)(2004-4#1)(2006-5#1)(2007-5#6)(2008-10#9)(2008-2#1)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#1)(2010-8#2)(2011-12#1)(2012-3#1)(2013-1#3)(2013-8#3)
rivularis##3##1##(2008-10#3)
rizatriptan 10 mg##2##3##(2005-7#2)
rizatriptan##8##1##(2005-7#6)(2008-6#1)(2009-2#1)
rkm##2##1##(2010-8#2)
rmIL-12##5##1##(1996-10#5)
rms and##3##2##(2008-2#1)(2008-3#2)
rms at##3##2##(2007-12#2)(2008-3#1)
rms can##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
rms deviation of##2##3##(2007-12#1)(2008-8#1)
rms deviation##5##2##(1991-4#1)(1992-4#1)(1995-1#1)(2007-12#1)(2008-8#1)
rms deviations of##2##3##(1994-5#1)(2008-3#1)
rms deviations##3##2##(1994-5#1)(2008-3#1)(2008-8#1)
rms error in##3##3##(2007-11#1)(2008-3#2)
rms error is##2##3##(2007-11#1)(2008-2#1)
rms error##11##2##(2007-11#2)(2007-12#1)(2008-2#4)(2008-3#4)
rms errors of##2##3##(2008-3#2)
rms errors##3##2##(2008-3#3)
rms frequency##2##2##(2007-12#2)
rms in the##2##3##(2007-11#1)(2008-3#1)
rms of the##4##3##(2008-2#1)(2008-3#3)
rms percent##2##2##(2008-10#1)(2008-2#1)
rms power##2##2##(2008-3#1)(2012-1#1)
rms surface##2##2##(2008-2#1)(2008-3#1)
rms timing jitter##2##3##(2007-11#1)(2007-12#1)
rms timing##3##2##(2007-11#1)(2007-12#2)
rms to##2##2##(2008-2#2)
rms##115##1##(1991-4#1)(1992-4#1)(1994-5#1)(1995-1#1)(1995-10#4)(2006-10#1)(2007-11#8)(2007-12#15)(2008-10#1)(2008-2#35)(2008-3#44)(2008-8#2)(2012-1#1)
rms)##4##1##(2007-12#1)(2008-2#3)
rnpA gene##2##2##(1997-4#2)
rnpA##3##1##(1996-12#1)(1997-4#2)
rnpA49 mutation##4##2##(1997-4#4)
rnpA49##5##1##(1997-4#5)
rnpB##4##1##(1995-10#1)(1997-2#3)
roNa##2##1##(1991-8#2)
roa307##3##1##(1995-8#3)
roach Rutilus rutilus##2##3##(2010-8#2)
roach and burbot##2##3##(2008-7#2)
roach and##3##2##(2008-7#3)
roach##13##1##(1997-3#1)(2008-11#1)(2008-7#8)(2010-8#3)
road accidents##6##2##(2007-2#1)(2009-10#2)(2012-12#1)(2013-8#2)
road ahead##4##2##(1994-6#2)(2008-4#1)(2010-12#1)
road and air##2##3##(2009-4#2)
road and##8##2##(2007-1#1)(2009-10#1)(2009-4#2)(2013-1#4)
road conditions##2##2##(2009-10#1)(2012-12#1)
road crashes##4##2##(1991-2#2)(2011-2#2)
road dust and garden soil##2##5##(1993-9#2)
road dust##6##2##(1993-9#3)(2007-8#2)(2008-3#1)
road from##2##2##(2006-12#1)(2013-8#1)
road incidents##2##2##(2007-2#2)
road map for##3##3##(1992-1#1)(1992-2#1)(2008-3#1)
road map##8##2##(1992-1#1)(1992-2#2)(1997-5#1)(2007-9#1)(2008-3#1)(2010-12#1)(2011-1#1)
road maps for##2##3##(2010-8#2)
road maps##4##2##(2010-8#4)
road safety##9##2##(1991-2#1)(2008-10#1)(2011-2#2)(2012-12#3)(2013-1#2)
road to the title of doctor of medicine##2##8##(2010-12#2)
road to##14##2##(1992-5#1)(1993-3#1)(1995-1#1)(1995-3#1)(2005-8#1)(2007-9#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-12#2)(2011-2#1)(2012-12#1)(2013-8#1)
road towards##2##2##(2011-2#1)(2012-2#1)
road traffic accident##4##3##(2007-8#1)(2008-8#1)(2012-2#1)(2013-1#1)
road traffic accidents##7##3##(1992-6#1)(1996-11#1)(1996-2#1)(2007-3#1)(2007-4#1)(2008-4#1)(2013-7#1)
road traffic and##2##3##(2010-11#2)
road traffic injuries in##3##4##(2008-10#1)(2008-4#1)(2011-2#1)
road traffic injuries##5##3##(1992-6#1)(2008-10#2)(2008-4#1)(2011-2#1)
road traffic##35##2##(1992-6#2)(1993-5#4)(1993-9#1)(1996-11#1)(1996-2#1)(2006-2#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#3)(2008-8#1)(2010-11#8)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
road transport##3##2##(2005-7#1)(2009-10#1)(2012-2#1)
road##159##1##(1990-6#5)(1991-2#3)(1992-1#1)(1992-2#2)(1992-5#1)(1992-6#2)(1993-3#1)(1993-5#5)(1993-9#4)(1994-6#3)(1995-1#1)(1995-3#1)(1996-11#2)(1996-2#1)(1996-3#3)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#1)(2005-7#1)(2005-8#1)(2006-11#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#6)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#3)(2007-9#3)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#5)(2008-7#2)(2008-8#2)(2009-10#8)(2009-12#1)(2009-4#4)(2009-6#1)(2009-7#2)(2010-11#9)(2010-12#4)(2010-8#4)(2011-1#2)(2011-2#8)(2012-12#9)(2012-2#4)(2013-1#10)(2013-7#2)(2013-8#4)
roadblocks to##2##2##(1993-2#1)(2010-6#1)
roadblocks##6##1##(1992-1#1)(1993-2#1)(2006-10#1)(2008-6#1)(2008-7#1)(2010-6#1)
roadmap for##6##2##(2008-4#1)(2008-7#2)(2009-9#1)(2010-11#1)(2010-8#1)
roadmap of##2##2##(2008-2#1)(2010-11#1)
roadmap##13##1##(2006-6#1)(2007-4#2)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-11#2)(2010-8#2)
roadmap&quot##2##1##(2013-1#2)
roads and##2##2##(2007-10#1)(2013-1#1)
roads##10##1##(1997-4#1)(2007-10#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#4)
roadside soil##2##2##(2008-10#1)(2008-11#1)
roadside soils##3##2##(2008-10#3)
roadside testing##2##2##(2013-7#2)
roadside##13##1##(2007-2#1)(2008-10#4)(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#3)
roadway##3##1##(2010-2#1)(2013-1#2)
roaming##2##1##(2006-12#1)(2011-1#1)
roasted coffee beans##2##3##(2008-10#2)
roasted coffee##4##2##(1997-3#1)(2008-10#3)
roasted##10##1##(1997-3#1)(2006-12#2)(2008-10#5)(2008-11#1)(2010-4#1)
roasting process##2##2##(2013-1#2)
roasting##8##1##(2006-12#1)(2008-10#1)(2008-4#2)(2013-1#4)
rob##3##1##(1993-3#1)(1994-4#2)
robbery rates of##2##3##(2009-12#2)
robbery rates##4##2##(2009-12#4)
robbery victim##2##2##(1996-12#2)
robbery##11##1##(1996-12#2)(1996-5#1)(1997-5#1)(2008-9#2)(2009-12#5)
robert C##2##2##(2008-3#2)
robert##3##1##(2008-3#2)(2011-1#1)
robin and##2##2##(2008-9#2)
robin##4##1##(2008-10#2)(2008-9#2)
robo1##2##1##(2008-2#2)
robot and##3##2##(2012-1#3)
robot assistance##2##2##(2008-10#1)(2012-1#1)
robot can##3##2##(2009-12#1)(2012-1#2)
robot characteristics##2##2##(2012-1#2)
robot for##5##2##(2007-5#2)(2012-1#3)
robot hardware##2##2##(2007-12#2)
robot has##2##2##(2007-7#1)(2012-1#1)
robot in a##3##3##(2008-2#1)(2012-1#2)
robot in##7##2##(2007-8#1)(2008-2#1)(2012-1#5)
robot is##8##2##(2007-12#1)(2012-1#6)(2012-2#1)
robot kinematics##2##2##(2007-5#1)(2008-1#1)
robot may##2##2##(2011-2#1)(2012-1#1)
robot system##4##2##(2006-6#2)(2007-5#2)
robot technology##2##2##(2012-1#2)
robot to##2##2##(2008-10#1)(2012-1#1)
robot was##4##2##(2009-5#1)(2011-1#1)(2012-1#2)
robot with##3##2##(2012-1#3)
robot##141##1##(2006-6#4)(2006-7#2)(2007-12#8)(2007-5#14)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#2)(2008-2#7)(2008-4#1)(2008-6#3)(2009-12#2)(2009-5#4)(2010-2#2)(2011-1#3)(2011-2#1)(2012-1#79)(2012-2#2)(2013-1#1)
robot's##5##1##(2006-6#1)(2011-1#2)(2012-1#2)
robot-aided##2##1##(2012-1#2)
robot-assisted locomotor##2##2##(2012-1#2)
robot-assisted rehabilitation system##3##3##(2012-1#3)
robot-assisted rehabilitation##6##2##(2012-1#6)
robot-assisted##18##1##(2006-6#2)(2011-3#1)(2012-1#14)(2013-7#1)
robotic applications##2##2##(2007-5#2)
robotic arm##2##2##(2012-1#2)
robotic arms##3##2##(2006-6#1)(2007-8#1)(2011-2#1)
robotic assistance in surgical treatment of degenerative##2##7##(2011-1#2)
robotic assistance in##3##3##(2007-8#1)(2011-1#2)
robotic assistance##7##2##(2006-6#1)(2007-7#1)(2007-8#1)(2011-1#4)
robotic assisted##3##2##(2007-5#2)(2012-1#1)
robotic device for##3##3##(2012-1#3)
robotic device that##2##3##(2012-1#2)
robotic device##10##2##(1994-6#1)(2012-1#9)
robotic devices are##2##3##(2012-1#1)(2013-1#1)
robotic devices for##3##3##(2012-1#1)(2013-1#2)
robotic devices##9##2##(2012-1#5)(2013-1#4)
robotic exoskeleton##4##2##(2012-1#4)
robotic instrumentation and##3##3##(2007-8#2)(2008-11#1)
robotic instruments##3##2##(2006-6#1)(2007-8#2)
robotic manipulators##4##2##(2006-6#4)
robotic orthosis for##2##3##(2012-1#2)
robotic radical##2##2##(2010-9#1)(2011-2#1)
robotic surgery##10##2##(2006-6#4)(2007-5#3)(2007-8#2)(2012-1#1)
robotic surgical system##3##3##(2007-8#3)
robotic surgical##4##2##(2007-8#3)(2013-8#1)
robotic system is##3##3##(2006-6#1)(2007-5#2)
robotic system that##2##3##(2006-6#1)(2008-10#1)
robotic system##15##2##(2006-6#6)(2007-5#3)(2007-8#1)(2008-10#1)(2010-7#1)(2012-1#3)
robotic systems have##2##3##(2006-6#1)(2007-5#1)
robotic systems in##2##3##(2007-5#1)(2008-10#1)
robotic systems##7##2##(2006-6#1)(2007-5#2)(2008-10#2)(2012-1#2)
robotic therapy##7##2##(2012-1#7)
robotic training##2##2##(2012-1#2)
robotic videoendoscopic##2##2##(2007-8#2)
robotic##154##1##(1994-6#3)(2006-6#20)(2007-12#2)(2007-5#25)(2007-7#3)(2007-8#17)(2008-1#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#3)(2010-12#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-1#55)(2013-1#4)(2013-8#2)
robotic-assisted laparoscopic radical prostatectomy##2##4##(2007-7#1)(2008-6#1)
robotic-assisted laparoscopic##5##2##(2006-6#1)(2007-7#3)(2008-6#1)
robotic-assisted##9##1##(2006-6#2)(2007-7#3)(2008-6#1)(2012-1#2)(2013-7#1)
robotic-enhanced##2##1##(2007-8#2)
robotically assisted##2##2##(2008-10#1)(2012-3#1)
robotically##6##1##(1994-3#1)(2006-6#1)(2008-10#1)(2008-7#1)(2012-1#1)(2012-3#1)
robotics and##3##2##(2006-5#1)(2006-6#1)(2008-10#1)
robotics are##2##2##(2006-6#1)(2012-1#1)
robotics to##2##2##(2006-6#1)(2008-11#1)
robotics were##2##2##(2007-5#1)(2007-8#1)
robotics##43##1##(1990-12#1)(2006-5#1)(2006-6#5)(2006-9#1)(2007-12#3)(2007-5#5)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#3)(2009-12#1)(2009-5#2)(2010-7#1)(2012-1#7)(2013-1#1)
robots and##4##2##(2012-1#4)
robots are##4##2##(2006-6#1)(2012-1#2)(2012-2#1)
robots as##2##2##(2012-1#2)
robots can##2##2##(2012-1#1)(2013-1#1)
robots for##2##2##(2012-1#2)
robots have been developed##3##4##(2012-1#2)(2012-2#1)
robots have been##4##3##(2007-5#1)(2012-1#2)(2012-2#1)
robots have##6##2##(2006-9#1)(2007-5#1)(2012-1#3)(2012-2#1)
robots in##3##2##(2012-1#2)(2013-1#1)
robots is##2##2##(2011-1#1)(2012-1#1)
robots that##3##2##(2007-12#1)(2007-9#1)(2012-2#1)
robots to##4##2##(2007-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
robots##65##1##(1990-12#1)(2006-5#1)(2006-6#2)(2006-9#2)(2007-12#8)(2007-5#6)(2007-9#2)(2008-11#2)(2009-5#1)(2011-1#1)(2011-2#4)(2012-1#29)(2012-2#3)(2013-1#3)
robur L##2##2##(2009-3#1)(2013-8#1)
robur##9##1##(2008-10#1)(2009-3#1)(2009-6#1)(2011-12#1)(2012-5#1)(2012-6#1)(2012-7#1)(2012-9#1)(2013-8#1)
roburin##2##1##(2006-12#2)
robust Bayesian##3##2##(1994-4#1)(1995-6#2)
robust adaptive##2##2##(2008-2#1)(2013-1#1)
robust against the##2##3##(2008-2#1)(2008-3#1)
robust against##6##2##(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)
robust algorithm for##2##3##(2008-10#1)(2008-3#1)
robust analytical##2##2##(1990-11#1)(2008-10#1)
robust and accurate##2##3##(2008-3#1)(2012-3#1)
robust and can be##4##4##(2010-12#2)(2010-2#1)(2010-3#1)
robust and can##5##3##(2008-3#1)(2010-12#2)(2010-2#1)(2010-3#1)
robust and flexible##2##3##(2008-3#1)(2012-2#1)
robust and reliable##5##3##(1996-12#1)(2007-5#1)(2008-10#1)(2013-1#1)(2013-8#1)
robust and resistant to##2##4##(2007-12#1)(2008-11#1)
robust and sensitive##3##3##(2008-10#2)(2008-4#1)
robust and simple##2##3##(2007-2#1)(2007-8#1)
robust and##56##2##(1996-12#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-12#5)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#5)(2008-4#2)(2008-7#4)(2008-9#3)(2009-2#1)(2009-3#1)(2009-9#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
robust association##2##2##(2009-11#1)(2011-12#1)
robust brain##2##2##(2008-4#2)
robust clinical##7##2##(2008-12#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-2#1)(2010-6#2)
robust data##2##2##(2010-10#1)(2010-9#1)
robust design##2##2##(1993-3#2)
robust detection of##2##3##(2007-12#1)(2008-2#1)
robust detection##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
robust effect##2##2##(1992-6#1)(2010-1#1)
robust enough for##2##3##(2007-11#1)(2011-1#1)
robust enough to##4##3##(2007-9#1)(2008-10#2)(2008-2#1)
robust enough##7##2##(2007-11#1)(2007-9#1)(2008-10#2)(2008-2#1)(2009-10#1)(2011-1#1)
robust estimation of##2##3##(2008-10#1)(2008-2#1)
robust estimation##5##2##(1996-12#1)(2008-10#1)(2008-2#2)(2010-2#1)
robust estimators##3##2##(1996-12#1)(2008-10#2)
robust even##2##2##(1996-5#1)(2008-5#1)
robust evidence##6##2##(2008-10#2)(2010-8#1)(2011-2#2)(2013-1#1)
robust expression of##2##3##(2009-8#1)(2013-1#1)
robust expression##3##2##(1995-5#1)(2009-8#1)(2013-1#1)
robust flow injection##2##3##(2008-10#2)
robust for##4##2##(1995-4#1)(1996-5#1)(2008-2#2)
robust framework for##3##3##(2008-11#1)(2008-5#1)(2013-1#1)
robust image representation algorithm##2##4##(2008-2#2)
robust image##3##2##(2008-2#3)
robust imaging modality##2##3##(2008-7#2)
robust immune##2##2##(2008-5#1)(2012-12#1)
robust in the presence of##3##5##(2007-12#1)(2008-1#1)(2008-2#1)
robust in the##4##3##(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#1)
robust in##8##2##(1991-1#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-2#1)(2010-7#1)(2012-3#1)
robust information##2##2##(2008-2#1)(2011-2#1)
robust integrated##2##2##(1997-7#1)(2008-3#1)
robust method for the##2##4##(2008-1#1)(2008-10#1)
robust method for##5##3##(2008-1#1)(2008-10#2)(2008-11#1)(2008-9#1)
robust method##10##2##(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#1)(2008-9#1)
robust methods##6##2##(2008-10#3)(2008-7#1)(2009-2#1)(2010-2#1)
robust nature of the##2##4##(2008-2#1)(2008-6#1)
robust nature of##3##3##(2008-2#1)(2008-4#1)(2008-6#1)
robust nature##4##2##(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)
robust of##3##2##(2008-3#1)(2009-3#1)(2012-3#1)
robust operation##2##2##(2008-10#1)(2008-3#1)
robust performance of the##2##4##(2008-1#1)(2009-7#1)
robust performance with respect to##2##5##(2008-2#2)
robust performance##5##2##(2008-1#1)(2008-10#1)(2008-2#2)(2009-7#1)
robust predictors##2##2##(2009-9#1)(2010-4#1)
robust procedure for##3##3##(1993-9#1)(2008-2#1)(2010-2#1)
robust procedure##4##2##(1993-9#1)(2008-2#1)(2008-3#1)(2010-2#1)
robust process##2##2##(2012-2#1)(2013-1#1)
robust psychometric properties##2##3##(2008-1#1)(2011-1#1)
robust regeneration##3##2##(2008-1#1)(2009-3#1)(2010-7#1)
robust regression method##2##3##(2008-10#2)
robust regression##4##2##(2008-10#4)
robust relationship between##2##3##(2008-12#1)(2008-3#1)
robust rhythms##2##2##(2008-6#2)
robust solid##3##2##(2008-10#2)(2010-12#1)
robust system##2##2##(1996-11#1)(2008-2#1)
robust to noise##2##3##(2007-12#1)(2008-6#1)
robust to the##2##3##(1996-8#1)(2012-3#1)
robust to these##2##3##(1994-5#1)(2008-2#1)
robust to##29##2##(1994-2#1)(1994-5#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-12#1)(2010-4#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)
robust##523##1##(1990-11#1)(1990-4#1)(1991-1#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-3#3)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-4#1)(1995-5#1)(1995-6#2)(1996-11#2)(1996-12#4)(1996-5#2)(1996-7#1)(1996-8#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(2005-7#1)(2005-8#2)(2006-10#2)(2006-11#2)(2006-7#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#11)(2007-12#23)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#5)(2007-8#5)(2007-9#3)(2008-1#13)(2008-10#79)(2008-11#16)(2008-12#3)(2008-2#39)(2008-3#28)(2008-4#16)(2008-5#9)(2008-6#14)(2008-7#17)(2008-8#7)(2008-9#11)(2009-10#4)(2009-11#2)(2009-12#2)(2009-2#6)(2009-3#4)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#5)(2010-1#3)(2010-10#5)(2010-12#8)(2010-2#11)(2010-3#4)(2010-4#5)(2010-6#4)(2010-7#3)(2010-8#4)(2010-9#3)(2011-1#7)(2011-12#3)(2011-2#8)(2012-1#1)(2012-12#6)(2012-2#12)(2012-3#10)(2013-1#27)(2013-7#7)(2013-8#5)
robusta##7##1##(2008-10#5)(2012-2#1)(2013-8#1)
robusticity##2##1##(2006-9#1)(2011-2#1)
robustly associated with##3##3##(2012-12#2)(2013-1#1)
robustly augmented##2##2##(1996-12#1)(2008-2#1)
robustly##16##1##(1996-12#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-12#3)(2012-2#2)(2013-1#1)(2013-7#1)
robustness and recovery##2##3##(2007-8#1)(2008-10#1)
robustness and reliability##2##3##(1995-11#1)(2013-8#1)
robustness and##13##2##(1995-11#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2010-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
robustness are##3##2##(2005-11#1)(2008-10#1)(2013-8#1)
robustness in##2##2##(2008-2#1)(2013-7#1)
robustness is##2##2##(2008-2#1)(2010-5#1)
robustness of our##2##3##(2010-8#1)(2013-1#1)
robustness of the method##4##4##(2008-10#3)(2011-1#1)
robustness of the proposed method##2##5##(2008-10#2)
robustness of the proposed system was##2##6##(2008-10#1)(2008-2#1)
robustness of the proposed##6##4##(2008-10#3)(2008-2#1)(2012-2#2)
robustness of the##38##3##(1993-3#1)(1995-6#1)(1997-3#2)(1997-5#1)(2006-11#1)(2007-1#1)(2007-12#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#3)(2008-3#3)(2008-5#1)(2008-6#3)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
robustness of these##3##3##(1994-9#1)(2006-12#1)(2008-9#1)
robustness of this procedure##2##4##(2008-10#1)(2008-11#1)
robustness of this##11##3##(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2010-10#1)(2011-2#1)
robustness of##84##2##(1993-3#1)(1994-9#1)(1995-6#1)(1997-3#3)(1997-5#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-12#2)(2007-1#2)(2007-11#1)(2007-12#7)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#8)(2008-2#6)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
robustness than##2##2##(2008-2#2)
robustness to geometrical##2##3##(2008-2#2)
robustness to kernel estimation##2##4##(2008-3#2)
robustness to the##3##3##(1997-5#1)(2008-2#2)
robustness to##17##2##(1994-6#1)(1994-9#1)(1997-5#1)(1997-7#1)(2007-11#1)(2008-2#5)(2008-3#4)(2010-2#1)(2010-4#1)(2013-8#1)
robustness was##2##2##(2008-10#2)
robustness with##2##2##(2008-10#2)
robustness##178##1##(1993-3#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-6#1)(1996-5#1)(1997-3#3)(1997-5#2)(1997-7#1)(2005-11#1)(2005-7#1)(2006-10#6)(2006-11#1)(2006-12#2)(2007-1#2)(2007-11#2)(2007-12#8)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#34)(2008-11#10)(2008-12#2)(2008-2#24)(2008-3#11)(2008-4#3)(2008-5#4)(2008-6#4)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#2)(2009-3#2)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#4)(2013-8#3)
rock and##5##2##(1993-1#4)(2013-8#1)
rock dust##2##2##(2006-6#1)(2013-1#1)
rock has##2##2##(2008-10#1)(2013-8#1)
rock sample##6##2##(2008-10#3)(2013-8#3)
rock samples##8##2##(2005-11#1)(2008-10#6)(2013-8#1)
rock##49##1##(1993-1#4)(1996-4#1)(2005-11#3)(2006-3#1)(2006-6#1)(2007-2#1)(2007-5#2)(2007-7#1)(2008-10#16)(2008-5#1)(2010-6#1)(2011-2#2)(2013-1#1)(2013-8#14)
rock)##2##1##(2008-10#1)(2010-5#1)
rocked##2##1##(1997-8#1)(2007-9#1)
rocker##4##1##(2007-2#1)(2010-3#1)(2013-8#2)
rocket engine##2##2##(2008-2#1)(2008-3#1)
rocket exhausts##2##2##(2008-3#2)
rocket propellant fuel##2##3##(2008-10#2)
rocket propellant##3##2##(2007-8#1)(2008-10#2)
rocket##19##1##(1992-3#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#10)
rocket-borne##2##1##(2008-3#2)
rockets##4##1##(2008-3#2)(2012-12#2)
rocking##7##1##(2006-4#1)(2006-5#1)(2007-11#1)(2008-11#1)(2008-5#3)
rocking-chair##2##1##(2010-4#2)
rocks and pure apatite##2##4##(2008-10#2)
rocks and the##2##3##(1993-7#1)(2008-10#1)
rocks and##9##2##(1993-7#2)(2008-10#5)(2010-12#1)(2010-5#1)
rocks in##3##2##(1996-4#1)(2007-5#1)(2013-1#1)
rocks that##2##2##(2007-9#1)(2010-7#1)
rocks##33##1##(1992-7#1)(1993-7#4)(1996-4#2)(2007-5#3)(2007-9#2)(2008-10#11)(2008-3#2)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2013-1#2)(2013-7#2)
rockwool slabs##2##2##(2008-10#2)
rockwool to##2##2##(2008-10#2)
rockwool##25##1##(2008-10#25)
rocky shores##3##2##(2007-5#1)(2010-8#2)
rocky##20##1##(2006-7#1)(2007-3#2)(2007-5#11)(2007-9#1)(2008-5#2)(2010-8#2)(2012-2#1)
rocky-shore##2##1##(2007-5#2)
rocuronium in an infant##2##4##(2012-12#2)
rocuronium in##4##2##(2009-4#1)(2011-2#1)(2012-12#2)
rocuronium##19##1##(2006-10#1)(2007-12#1)(2008-10#1)(2009-4#2)(2010-4#2)(2011-2#7)(2012-12#3)(2013-7#2)
rod and cone outer segments##2##5##(1997-4#2)
rod and cone##5##3##(1990-7#1)(1992-7#2)(1997-4#2)
rod and##13##2##(1990-7#3)(1992-7#2)(1997-4#2)(2007-11#1)(2008-2#2)(2008-7#1)(2012-2#1)(2013-1#1)
rod cells##2##2##(1990-10#1)(1995-1#1)
rod densities##2##2##(1997-3#1)(2007-5#1)
rod derived indices##2##3##(2008-7#2)
rod domain##4##2##(1996-4#1)(1997-4#2)(2008-8#1)
rod domains##2##2##(1995-3#2)
rod for##2##2##(2006-7#1)(2008-12#1)
rod inner segments##3##3##(1992-7#1)(1997-4#2)
rod is##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
rod laser##7##2##(2007-12#5)(2008-2#1)(2008-3#1)
rod lenses in the##2##4##(2008-3#2)
rod lenses in##3##3##(2008-3#3)
rod lenses##9##2##(2008-3#9)
rod of##2##2##(2008-2#1)(2008-6#1)
rod or##3##2##(1990-7#1)(2005-11#1)(2007-7#1)
rod outer segment membranes##4##4##(1990-11#1)(1990-7#1)(1994-8#1)(1997-1#1)
rod outer segment##7##3##(1990-11#1)(1990-7#1)(1993-4#1)(1994-8#1)(1996-5#1)(1997-1#1)(1997-4#1)
rod outer segments##17##3##(1990-11#1)(1990-2#2)(1990-7#1)(1991-10#2)(1992-6#2)(1992-7#2)(1993-4#1)(1993-8#1)(1995-1#1)(1995-10#1)(1995-5#1)(1997-1#1)(2008-4#1)
rod outer##24##2##(1990-11#2)(1990-2#2)(1990-7#2)(1991-10#2)(1992-6#2)(1992-7#2)(1993-4#2)(1993-8#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-5#1)(1996-5#1)(1997-1#2)(1997-4#1)(2008-4#1)
rod photoreceptor##4##2##(1990-11#1)(1994-12#1)(1995-10#1)(2008-5#1)
rod photoreceptors##4##2##(1994-12#1)(1997-4#1)(1997-7#1)(2010-1#1)
rod system##2##2##(2008-12#1)(2012-2#1)
rod was##6##2##(2007-7#1)(2008-10#2)(2008-3#1)(2008-8#1)(2012-2#1)
rod with a##2##3##(2007-12#1)(2008-2#1)
rod with an##2##3##(2008-2#2)
rod with##8##2##(2005-12#1)(2007-12#1)(2008-2#6)
rod##189##1##(1990-10#2)(1990-11#3)(1990-2#3)(1990-5#1)(1990-6#1)(1990-7#8)(1991-10#2)(1992-6#3)(1992-7#5)(1992-8#1)(1992-9#1)(1993-4#2)(1993-8#1)(1994-12#2)(1994-8#1)(1994-9#2)(1995-1#6)(1995-10#2)(1995-3#3)(1995-5#3)(1996-4#1)(1996-5#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#8)(1997-7#1)(2005-11#1)(2005-12#2)(2006-7#2)(2006-8#3)(2007-11#4)(2007-12#15)(2007-5#1)(2007-7#6)(2007-9#2)(2008-1#2)(2008-10#5)(2008-12#2)(2008-2#28)(2008-3#17)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2010-1#1)(2010-10#5)(2011-2#2)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
rod's rotation##2##2##(2008-2#1)(2009-3#1)
rod's##5##1##(2008-2#3)(2008-3#1)(2009-3#1)
rod-like structures##3##2##(2007-8#1)(2008-5#1)(2008-8#1)
rod-like##7##1##(1990-7#1)(1992-7#1)(2007-8#1)(2008-5#1)(2008-8#1)(2012-11#2)
rod-packing##3##1##(2008-5#3)
rod-ring retina##2##2##(1992-7#2)
rod-shaped bacterium##2##2##(2005-11#1)(2006-5#1)
rod-shaped cells##2##2##(2005-11#1)(2007-2#1)
rod-shaped##20##1##(1992-11#1)(1996-5#1)(1997-6#1)(2005-11#4)(2006-12#1)(2006-5#1)(2007-2#1)(2007-8#2)(2008-10#3)(2008-7#2)(2011-2#1)(2012-2#2)
rod-to-cone##2##1##(1997-3#2)
rodent SCF is##2##3##(2008-4#2)
rodent SCF##3##2##(2008-4#3)
rodent and human mammary explant##2##5##(1995-9#2)
rodent and human##13##3##(1992-7#1)(1994-12#1)(1995-12#1)(1995-7#2)(1995-9#2)(1997-3#1)(1997-7#1)(2006-10#1)(2008-11#1)(2008-4#2)
rodent and##22##2##(1992-12#1)(1992-7#1)(1993-3#1)(1993-7#1)(1994-12#1)(1995-12#1)(1995-7#2)(1995-9#2)(1997-1#1)(1997-3#1)(1997-7#1)(2006-10#1)(2008-11#1)(2008-4#4)(2010-11#2)(2010-6#1)
rodent blood##2##2##(2008-4#1)(2008-9#1)
rodent brain##8##2##(1991-12#1)(1991-2#1)(1994-2#1)(1996-12#1)(1997-7#1)(2007-1#1)(2008-7#1)(2010-2#1)
rodent brains are##2##3##(2008-11#1)(2010-11#1)
rodent brains##3##2##(1996-2#1)(2008-11#1)(2010-11#1)
rodent carcasses##2##2##(2004-11#2)
rodent carcinogens##4##2##(1990-8#1)(1990-9#3)
rodent cell lines that##2##4##(1994-9#1)(1996-2#1)
rodent cell lines##7##3##(1993-12#1)(1994-9#1)(1996-2#1)(2008-11#3)(2008-4#1)
rodent cell##9##2##(1993-12#1)(1994-9#1)(1995-9#1)(1996-2#1)(2008-11#3)(2008-4#1)(2008-7#1)
rodent cells##7##2##(1991-1#1)(1992-5#1)(1992-9#1)(1994-8#1)(2008-4#1)(2008-7#2)
rodent cerebral##2##2##(1997-2#1)(2011-1#1)
rodent fibroblasts##2##2##(1990-8#1)(1996-5#1)
rodent guilds##2##2##(2008-8#2)
rodent liver##3##2##(1992-8#1)(1993-12#1)(1994-6#1)
rodent mammary##2##2##(1993-2#1)(1995-9#1)
rodent mast cells##3##3##(2008-4#3)
rodent micronucleus##5##2##(1997-2#4)(2008-9#1)
rodent model for##3##3##(1997-1#1)(2009-4#1)(2011-1#1)
rodent model##14##2##(1995-7#1)(1997-1#2)(2005-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-4#1)(2009-4#1)(2010-4#1)(2011-1#1)(2012-12#2)
rodent models for##2##3##(2008-4#1)(2012-3#1)
rodent models of##10##3##(1992-7#1)(1996-3#1)(2005-7#1)(2006-10#2)(2007-5#1)(2008-4#3)(2013-8#1)
rodent models##20##2##(1992-7#1)(1993-11#1)(1996-3#1)(2005-7#1)(2006-10#2)(2007-5#1)(2008-10#2)(2008-4#7)(2009-10#1)(2010-5#1)(2012-3#1)(2013-8#1)
rodent monoclonal antibodies##2##3##(2007-11#2)
rodent or##2##2##(1993-4#1)(1995-9#1)
rodent pest population controlled with short-acting##2##6##(2013-8#2)
rodent pest population##4##3##(2013-8#4)
rodent pests##2##2##(2012-2#1)(2013-8#1)
rodent species and##2##3##(2011-1#2)
rodent species##15##2##(1990-5#2)(1990-9#1)(1994-12#1)(1995-10#1)(1996-6#1)(1997-2#1)(2006-4#1)(2007-2#1)(2007-3#1)(2010-6#1)(2011-1#3)(2012-3#1)
rodent studies##3##2##(1992-7#1)(2008-11#1)(2008-9#1)
rodent ventricular##2##2##(2008-11#2)
rodent##230##1##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#4)(1990-7#1)(1990-8#2)(1990-9#4)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#2)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#5)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#3)(1993-2#4)(1993-3#1)(1993-4#1)(1993-7#3)(1994-12#6)(1994-2#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#2)(1995-5#2)(1995-6#1)(1995-7#3)(1995-9#5)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#3)(1997-2#7)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#2)(2004-11#3)(2005-10#1)(2005-7#1)(2006-10#3)(2006-4#1)(2007-1#1)(2007-11#4)(2007-12#2)(2007-2#2)(2007-3#3)(2007-5#2)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#11)(2008-4#28)(2008-5#3)(2008-7#5)(2008-8#4)(2008-9#6)(2009-10#1)(2009-4#1)(2010-11#4)(2010-2#5)(2010-4#1)(2010-5#1)(2010-6#2)(2011-1#8)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#6)
rodenticide##2##1##(2011-2#1)(2013-8#1)
rodenticides##4##1##(1996-8#1)(2008-10#2)(2011-2#1)
rodentium##5##1##(2011-1#5)
rodents and humans##2##3##(2007-8#1)(2008-4#1)
rodents and primates##4##3##(2008-1#1)(2008-10#1)(2012-12#1)(2013-8#1)
rodents and the##2##3##(1992-7#1)(2008-10#1)
rodents and##18##2##(1992-7#1)(1993-3#1)(1995-10#1)(1995-9#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
rodents are##2##2##(1991-3#1)(2012-12#1)
rodents by##2##2##(2008-4#1)(2010-2#1)
rodents from##2##2##(2012-2#1)(2013-1#1)
rodents has##3##2##(2006-12#1)(2008-5#1)(2008-7#1)
rodents have##3##2##(1993-11#1)(1995-8#1)(2008-10#1)
rodents in##5##2##(1992-6#1)(1993-7#1)(2004-11#1)(2008-4#1)(2008-8#1)
rodents is##5##2##(1992-9#1)(2007-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
rodents of##3##2##(2008-5#2)(2010-6#1)
rodents that##3##2##(2008-4#2)(2011-2#1)
rodents to##4##2##(1990-7#1)(1992-2#1)(1997-6#1)(2006-10#1)
rodents using##3##2##(1990-5#1)(2008-10#1)(2009-4#1)
rodents were##4##2##(2011-1#4)
rodents##176##1##(1990-11#1)(1990-3#2)(1990-5#1)(1990-7#2)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-2#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-4#1)(1993-7#3)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#3)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(2004-11#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#2)(2008-4#22)(2008-5#8)(2008-7#7)(2008-8#3)(2008-9#3)(2009-4#1)(2009-5#3)(2009-7#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#5)(2011-2#6)(2012-12#5)(2012-2#9)(2013-1#3)(2013-8#1)
rodlet layer##3##2##(2010-12#3)
rodlike molecules##2##2##(2007-12#1)(2007-8#1)
rodlike##10##1##(1994-11#1)(2005-11#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2010-4#1)
rods and##5##2##(1992-7#1)(2006-8#1)(2008-7#1)(2009-2#1)(2009-8#1)
rods are##3##2##(1990-2#1)(2008-7#1)(2012-2#1)
rods as##3##2##(1995-12#1)(2006-5#1)(2013-8#1)
rods by##3##2##(1995-6#1)(2006-12#1)(2007-8#1)
rods have been##2##3##(2007-11#1)(2008-12#1)
rods in##5##2##(2007-7#1)(2007-8#1)(2008-2#1)(2012-12#2)
rods of##5##2##(1992-3#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-8#1)
rods that##2##2##(2008-2#1)(2011-2#1)
rods was##2##2##(1997-1#1)(2006-8#1)
rods were##6##2##(1996-1#1)(2007-5#1)(2008-2#1)(2009-2#1)(2011-2#1)(2013-8#1)
rods with##6##2##(2008-2#2)(2009-3#1)(2009-5#1)(2011-2#1)(2012-12#1)
rods##90##1##(1990-2#1)(1990-5#1)(1991-7#1)(1992-3#1)(1992-7#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-1#1)(1997-1#1)(1997-3#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-5#4)(2006-7#1)(2006-8#4)(2007-11#2)(2007-12#6)(2007-5#1)(2007-7#2)(2007-8#5)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#9)(2008-3#2)(2008-5#1)(2008-7#5)(2008-8#1)(2009-11#3)(2009-2#2)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#2)(2011-2#4)(2012-12#4)(2012-2#1)(2013-8#2)
rods)##2##1##(1991-3#1)(2008-8#1)
roe deer##3##2##(1996-3#3)
roe##4##1##(1996-3#3)(2007-5#1)
roentgen##4##1##(1990-5#1)(1993-10#1)(1993-2#1)(1993-8#1)
roentgenogram showed##2##2##(1991-12#1)(1993-6#1)
roentgenogram##6##1##(1991-12#1)(1993-6#1)(1994-6#1)(2007-8#3)
roentgenograms##8##1##(1992-11#1)(1992-4#1)(1993-6#2)(1995-2#1)(2007-11#1)(2008-1#1)(2008-7#1)
roentgenographic##5##1##(1993-11#1)(1993-2#1)(2007-8#1)(2008-5#2)
roentgenographs##2##1##(1996-3#2)
roentgenography##2##1##(1997-8#1)(2008-7#1)
roentgenologic##3##1##(1993-6#1)(2006-6#1)(2013-1#1)
rofecoxib 25 mg##2##3##(2006-10#2)
rofecoxib and celecoxib##3##3##(2006-10#1)(2007-12#1)(2011-2#1)
rofecoxib and##5##2##(2006-10#1)(2007-12#2)(2008-8#1)(2011-2#1)
rofecoxib were##2##2##(2006-10#1)(2007-7#1)
rofecoxib##38##1##(2006-10#14)(2007-12#12)(2007-7#2)(2007-8#2)(2008-4#1)(2008-8#2)(2011-2#5)
rofecoxib-treated patients##2##2##(2006-10#2)
roflumilast##3##1##(2010-12#3)
rogue##2##1##(2007-8#1)(2008-9#1)
roguing##3##1##(2008-10#3)
rol##2##1##(1990-2#1)(2008-8#1)
rolC##6##1##(1991-7#2)(2008-9#4)
rolandic spikes##2##2##(1996-6#2)
rolandic##5##1##(1995-12#2)(1996-6#2)(2012-12#1)
role after##2##2##(2007-2#1)(2011-1#1)
role against##5##2##(1995-1#1)(2006-8#1)(2010-4#1)(2010-9#1)(2011-2#1)
role among##2##2##(2008-4#1)(2010-11#1)
role and WHR not reaching significance##2##6##(2007-12#2)
role and are##2##3##(2005-11#1)(2006-10#1)
role and contribution##2##3##(1997-8#1)(2011-2#1)
role and future##2##3##(2010-8#1)(2012-3#1)
role and importance##2##3##(2008-10#1)(2012-2#1)
role and its##2##3##(1995-12#1)(2010-3#1)
role and may##2##3##(1994-12#1)(2010-2#1)
role and mechanism of##4##4##(2008-8#1)(2009-6#1)(2010-11#1)(2011-2#1)
role and potential of##2##4##(2005-10#1)(2011-1#1)
role and responsibilities##3##3##(1995-3#1)(1997-2#1)(2011-2#1)
role and responsibility##4##3##(2008-11#1)(2008-3#1)(2011-2#2)
role and scope of##2##4##(2007-3#1)(2011-2#1)
role and the##4##3##(1992-2#1)(1996-2#1)(2010-2#1)(2012-2#1)
role and value of##2##4##(1995-1#1)(2008-9#1)
role and##91##2##(1990-12#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-9#2)(1993-1#2)(1993-10#1)(1993-3#2)(1993-9#1)(1994-12#1)(1995-1#1)(1995-10#1)(1995-12#2)(1995-3#1)(1996-2#3)(1996-3#1)(1996-7#1)(1997-2#1)(1997-8#2)(2004-1#1)(2004-10#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#4)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-6#2)(2009-9#1)(2010-11#1)(2010-2#3)(2010-3#2)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#10)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)
role are##5##2##(1990-12#1)(1994-2#1)(2006-10#1)(2006-8#1)(2008-3#1)
role as a &quot##2##4##(2012-11#1)(2013-1#1)
role as a mediator of##3##5##(1992-9#1)(2003-11#1)(2010-8#1)
role as a##49##3##(1990-11#1)(1990-5#1)(1991-1#1)(1991-9#1)(1992-6#1)(1992-9#1)(1994-2#2)(1995-3#1)(1995-6#1)(1997-5#2)(2003-11#1)(2004-12#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-2#2)(2007-7#1)(2008-10#5)(2008-11#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-11#1)(2013-1#3)
role as an##10##3##(1990-8#1)(1991-5#1)(1994-12#1)(1997-4#1)(2006-10#1)(2008-7#1)(2009-3#1)(2011-1#1)(2012-3#1)(2013-1#1)
role as both##2##3##(1995-7#1)(2007-8#1)
role as part of the##2##5##(2005-11#1)(2011-2#1)
role as part of##3##4##(2005-11#1)(2008-3#1)(2011-2#1)
role as structural##2##3##(2008-10#1)(2008-12#1)
role as the##6##3##(1990-4#1)(1991-10#1)(1995-3#2)(2006-10#1)(2012-1#1)
role as well##2##3##(1992-9#1)(2008-11#1)
role as##111##2##(1990-11#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-6#2)(1992-9#2)(1993-11#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-5#1)(1995-1#2)(1995-3#3)(1995-6#2)(1995-7#1)(1996-11#1)(1996-2#1)(1996-7#1)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#1)(2003-11#1)(2004-12#1)(2005-11#2)(2005-8#2)(2006-10#3)(2006-2#1)(2007-10#1)(2007-11#2)(2007-2#4)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#2)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#2)(2010-10#2)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-1#1)(2012-11#1)(2012-3#2)(2013-1#4)
role at the##5##3##(1994-9#1)(2007-6#1)(2010-2#2)(2011-1#1)
role at##10##2##(1990-8#1)(1994-9#1)(1995-10#1)(1997-1#1)(2007-6#1)(2009-8#1)(2010-12#1)(2010-2#2)(2011-1#1)
role attributes##2##2##(2006-1#2)
role behaviors##2##2##(1990-8#2)
role both in##2##3##(2006-4#1)(2007-5#1)
role both##4##2##(1994-10#1)(2006-4#1)(2007-5#1)(2010-8#1)
role but##2##2##(1996-12#1)(2006-3#1)
role by##7##2##(1993-11#1)(1994-2#1)(1995-2#1)(2005-7#1)(2008-5#1)(2011-2#1)(2012-3#1)
role can be##2##3##(1995-3#1)(2011-1#1)
role can##4##2##(1993-3#1)(1995-3#1)(2006-8#1)(2011-1#1)
role conflict and professional attitude of##2##6##(1990-2#2)
role conflict and professional attitude##3##5##(1990-2#3)
role conflict and##4##3##(1990-2#4)
role conflict##5##2##(1990-2#5)
role definition##2##2##(2007-10#1)(2011-1#1)
role depends on the##2##4##(1990-10#1)(2013-8#1)
role depends##3##2##(1990-10#1)(2011-1#1)(2013-8#1)
role development##2##2##(2008-11#2)
role does##4##2##(1990-2#1)(1995-1#1)(2009-10#1)(2012-12#1)
role during the##7##3##(1990-10#1)(1990-11#1)(1992-6#2)(1996-4#1)(2008-8#1)(2010-9#1)
role during##30##2##(1990-10#1)(1990-11#1)(1991-7#1)(1991-9#1)(1992-6#2)(1993-4#1)(1995-12#1)(1996-4#1)(2006-10#2)(2007-1#1)(2007-10#2)(2007-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-8#2)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#3)
role early in##2##3##(1992-10#1)(1997-8#1)
role even##2##2##(2008-3#1)(2011-2#1)
role for CGRP##2##3##(1992-6#1)(1992-9#1)
role for CRH in the##2##5##(1995-12#1)(2008-4#1)
role for CRH##3##3##(1995-12#2)(2008-4#1)
role for DHA##2##3##(2012-1#2)
role for DNA methylation in the##2##6##(1992-11#1)(2008-1#1)
role for DNA methylation in##3##5##(1992-11#1)(2008-1#2)
role for DNA##4##3##(1992-11#1)(1993-3#1)(2008-1#2)
role for HDAC##2##3##(2007-10#1)(2010-3#1)
role for NO in##2##4##(1994-2#1)(2011-2#1)
role for NO##3##3##(1994-2#1)(2005-7#1)(2011-2#1)
role for VE-cadherin in modulation of##2##6##(2011-1#2)
role for a specific##2##4##(1994-6#1)(2012-1#1)
role for a##17##3##(1992-4#2)(1992-6#1)(1992-7#1)(1993-12#1)(1993-7#1)(1994-3#1)(1994-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
role for an##3##3##(1992-9#1)(1993-3#1)(2008-9#1)
role for both##2##3##(1993-4#1)(1995-5#1)
role for corticosterone##2##3##(1995-7#1)(2007-11#1)
role for fatty##2##3##(1991-5#1)(1997-6#1)
role for insulin in##2##4##(1991-2#1)(2010-11#1)
role for insulin##6##3##(1991-2#2)(1994-5#1)(2008-1#1)(2010-11#2)
role for lipid##2##3##(1992-6#1)(2009-12#1)
role for microglia in##2##4##(2008-5#2)
role for microtubules##2##3##(2007-10#1)(2009-10#1)
role for neurotrophins in##3##4##(1995-8#1)(1996-12#1)(1996-3#1)
role for nitric oxide in##3##5##(1991-5#1)(1995-5#1)(1996-12#1)
role for nitric##4##3##(1991-3#1)(1991-5#1)(1995-5#1)(1996-12#1)
role for physicians in##2##4##(1996-2#1)(2006-12#1)
role for physicians##3##3##(1996-2#1)(2006-12#1)(2012-11#1)
role for receptor##2##3##(1996-5#1)(2007-10#1)
role for some##2##3##(1993-2#1)(2009-1#1)
role for such##2##3##(1992-10#1)(1994-9#1)
role for the amygdala##2##4##(1991-1#1)(1997-5#1)
role for the protein##2##4##(1996-8#1)(2012-2#1)
role for the##85##3##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-1#2)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#3)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-10#2)(1996-12#1)(1996-2#3)(1996-4#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#2)(2005-11#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-4#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#4)
role for these enzymes in the##2##6##(1991-2#1)(2006-6#1)
role for these proteins in##2##5##(1994-12#1)(2012-3#1)
role for these##17##3##(1990-3#1)(1990-8#1)(1991-2#1)(1994-11#1)(1994-12#1)(1995-11#1)(1996-11#1)(1996-5#1)(1997-5#1)(1997-8#1)(2006-11#1)(2006-6#1)(2006-8#1)(2007-9#1)(2008-1#1)(2011-2#1)(2012-3#1)
role for this cytokine in##2##5##(1995-2#2)
role for this enzyme in##3##5##(1993-11#1)(1994-8#1)(2008-5#1)
role for this protein in##2##5##(1995-1#1)(2008-10#1)
role for this residue##2##4##(1995-2#2)
role for this##36##3##(1990-10#1)(1990-2#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-3#1)(1993-11#1)(1994-8#1)(1995-1#3)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-4#2)(2006-8#2)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-11#1)
role for veterinary##2##3##(2005-7#1)(2007-12#1)
role for##565##2##(1990-1#1)(1990-10#2)(1990-11#4)(1990-12#1)(1990-2#4)(1990-3#1)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#5)(1991-10#3)(1991-12#3)(1991-2#6)(1991-3#4)(1991-4#1)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#4)(1992-1#2)(1992-10#2)(1992-11#4)(1992-12#3)(1992-2#1)(1992-3#6)(1992-4#3)(1992-5#2)(1992-6#4)(1992-7#3)(1992-9#3)(1993-10#1)(1993-11#3)(1993-12#6)(1993-2#2)(1993-3#5)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#8)(1994-12#8)(1994-2#4)(1994-3#6)(1994-5#2)(1994-6#3)(1994-8#6)(1994-9#6)(1995-1#5)(1995-11#3)(1995-12#10)(1995-2#9)(1995-3#2)(1995-5#7)(1995-6#5)(1995-7#2)(1995-8#5)(1995-9#1)(1996-1#1)(1996-10#5)(1996-11#5)(1996-12#6)(1996-2#10)(1996-3#1)(1996-4#3)(1996-5#8)(1996-6#1)(1996-7#1)(1996-8#6)(1996-9#2)(1997-1#4)(1997-2#4)(1997-3#1)(1997-4#7)(1997-5#3)(1997-6#8)(1997-7#5)(1997-8#3)(1997-9#1)(2004-11#1)(2004-2#1)(2005-10#2)(2005-11#3)(2005-5#1)(2005-7#3)(2005-8#1)(2006-10#16)(2006-11#1)(2006-12#6)(2006-2#1)(2006-3#1)(2006-4#4)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#4)(2007-1#1)(2007-10#3)(2007-11#15)(2007-12#8)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#6)(2008-10#17)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#9)(2008-5#10)(2008-6#3)(2008-7#8)(2008-8#8)(2008-9#2)(2009-1#1)(2009-10#5)(2009-11#1)(2009-12#4)(2009-3#1)(2009-4#4)(2009-6#4)(2009-8#4)(2009-9#2)(2010-10#2)(2010-11#4)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#7)(2011-12#2)(2011-2#9)(2012-1#5)(2012-11#3)(2012-12#10)(2012-2#11)(2012-3#6)(2013-1#4)(2013-7#4)(2013-8#1)
role from##2##2##(2008-7#1)(2012-1#1)
role has been##4##3##(1995-8#1)(2006-10#1)(2008-9#1)(2010-12#1)
role has not yet been##2##5##(1990-11#1)(2006-2#1)
role has##10##2##(1990-11#1)(1995-8#1)(2006-1#1)(2006-10#2)(2006-2#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#1)
role in &quot##2##3##(2008-1#1)(2009-11#1)
role in (1)##2##3##(1997-7#1)(2012-12#1)
role in AD##3##3##(1991-3#1)(2004-12#1)(2012-12#1)
role in DNA synthesis and##2##5##(1990-2#1)(1994-8#1)
role in DNA##6##3##(1990-2#1)(1991-2#1)(1994-2#1)(1994-8#1)(2008-11#1)(2009-7#1)
role in HIV-associated##2##3##(2007-11#1)(2013-1#1)
role in RNA##3##3##(1992-9#1)(1993-12#1)(2012-3#1)
role in a health##2##4##(1990-12#1)(1997-1#1)
role in a variety of##2##5##(2007-8#1)(2008-4#1)
role in a wide##2##4##(1990-2#1)(1994-10#1)
role in a##16##3##(1990-12#1)(1990-2#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-6#1)(1995-11#1)(1997-1#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-3#1)
role in achieving##3##3##(2005-5#1)(2008-7#1)(2012-2#1)
role in activating##4##3##(1995-12#1)(2008-1#1)(2008-11#1)(2009-8#1)
role in activation and##2##4##(1997-8#1)(2011-1#1)
role in activation of##2##4##(1994-2#1)(2012-12#1)
role in activation##5##3##(1991-2#1)(1994-2#1)(1997-8#1)(2011-1#1)(2012-12#1)
role in acute##4##3##(1993-6#1)(2007-12#1)(2008-1#1)(2013-1#1)
role in adaptation##2##3##(2010-10#1)(2013-1#1)
role in adding##2##3##(2008-7#1)(2009-10#1)
role in adhesion##2##3##(2004-9#1)(2008-1#1)
role in advancing##2##3##(2009-9#1)(2011-1#1)
role in affecting##4##3##(1992-6#1)(2008-10#1)(2012-2#1)(2013-8#1)
role in age-related##2##3##(2012-2#1)(2012-3#1)
role in aggressive##2##3##(2010-8#1)(2012-12#1)
role in aging##3##3##(1992-5#1)(1994-11#1)(2009-5#1)
role in all##2##3##(1993-1#1)(2012-2#1)
role in allowing##2##3##(1995-6#1)(2006-6#1)
role in altering the##3##4##(1992-11#1)(2013-1#2)
role in amino acid##2##4##(1994-11#1)(2009-8#1)
role in an##3##3##(1992-1#1)(1997-7#1)(2008-3#1)
role in apoptosis##4##3##(1994-10#1)(1995-8#1)(2007-1#1)(2011-1#1)
role in apoptotic cell death##2##5##(2008-7#1)(2012-2#1)
role in apoptotic cell##3##4##(2008-7#1)(2011-1#1)(2012-2#1)
role in apoptotic##4##3##(2008-7#2)(2011-1#1)(2012-2#1)
role in atherogenesis##3##3##(1990-2#1)(1995-8#1)(1997-8#1)
role in atherosclerosis and##2##4##(2008-3#1)(2013-1#1)
role in atherosclerosis##6##3##(1990-7#1)(1995-12#1)(1997-2#1)(2008-3#1)(2012-2#1)(2013-1#1)
role in athletic##2##3##(2009-5#1)(2012-3#1)
role in bacterial##2##3##(1990-8#1)(2013-1#1)
role in binding##2##3##(1994-9#1)(1997-2#1)
role in biological##4##3##(1991-6#1)(2008-3#1)(2008-5#1)(2008-8#1)
role in biology##2##3##(2008-2#1)(2011-1#1)
role in blood##2##3##(2008-10#1)(2011-2#1)
role in bone##6##3##(1990-11#1)(1991-11#1)(1992-12#1)(1992-7#1)(2007-8#1)(2013-1#1)
role in both the##3##4##(2008-8#1)(2010-10#1)(2011-2#1)
role in both##11##3##(1991-2#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-10#1)(2011-1#1)(2011-2#2)(2013-1#1)
role in brain development##2##4##(1996-1#1)(2011-2#1)
role in brain##4##3##(1992-5#1)(1996-1#1)(2008-3#1)(2011-2#1)
role in breast cancer##4##4##(2008-12#1)(2008-4#2)(2009-4#1)
role in breast##6##3##(2008-12#1)(2008-4#3)(2009-2#1)(2009-4#1)
role in cancer progression##2##4##(2007-9#1)(2011-1#1)
role in cancer##10##3##(1991-12#1)(1994-12#1)(2007-11#2)(2007-9#1)(2008-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
role in carbohydrate##2##3##(1997-4#1)(2008-10#1)
role in carcinogenesis##5##3##(1992-4#1)(1992-8#1)(1997-3#1)(2004-1#1)(2013-1#1)
role in cardiovascular disease##2##4##(2008-3#1)(2009-1#1)
role in cardiovascular##4##3##(1993-2#1)(2005-10#1)(2008-3#1)(2009-1#1)
role in causing##4##3##(2008-10#1)(2011-2#2)(2011-3#1)
role in cell adhesion##2##4##(1994-8#1)(1994-9#1)
role in cell growth##4##4##(1992-12#1)(1994-12#1)(2011-2#2)
role in cell proliferation##3##4##(2008-9#1)(2009-5#1)(2013-1#1)
role in cell##18##3##(1992-11#1)(1992-12#1)(1994-10#1)(1994-12#1)(1994-8#1)(1994-9#1)(1996-4#2)(1996-5#1)(2003-11#1)(2008-1#1)(2008-9#1)(2009-5#1)(2009-8#1)(2011-12#1)(2011-2#2)(2013-1#1)
role in cellular physiology##3##4##(1994-11#1)(2008-10#1)(2008-8#1)
role in cellular proliferation##3##4##(1995-6#1)(2008-11#1)(2010-4#1)
role in cellular redox homeostasis##2##5##(2009-6#1)(2009-9#1)
role in cellular##12##3##(1991-5#1)(1994-11#1)(1995-6#1)(1997-7#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-9#1)(2010-4#1)
role in cervical##2##3##(2007-11#1)(2010-2#1)
role in changing##2##3##(1995-6#1)(2008-10#1)
role in cholesterol##2##3##(1995-6#1)(2008-11#1)
role in chronic##9##3##(2005-7#1)(2006-10#1)(2006-7#1)(2008-1#1)(2008-7#1)(2009-4#1)(2011-1#1)(2011-2#2)
role in clearance of##2##4##(1996-3#1)(2007-9#1)
role in clinical##4##3##(2008-12#1)(2008-7#1)(2010-2#2)
role in collagen biosynthesis##2##4##(1997-7#1)(2012-2#1)
role in combating##3##3##(2006-7#1)(2012-1#1)(2012-2#1)
role in combination##3##3##(1991-7#1)(2006-10#1)(2007-11#1)
role in community##2##3##(2008-9#2)
role in complementary##2##3##(2008-10#1)(2009-10#1)
role in complex##2##3##(2007-7#1)(2013-1#1)
role in conferring##2##3##(2008-10#1)(2011-1#1)
role in contributing to##2##4##(1995-3#1)(2011-2#1)
role in contributing##3##3##(1995-3#1)(2011-2#2)
role in control of##4##4##(1996-8#1)(1997-7#2)(2009-6#1)
role in controlling the##6##4##(1995-6#1)(1996-4#1)(1997-7#1)(2008-10#1)(2008-9#1)(2009-11#1)
role in controlling##17##3##(1995-6#1)(1996-4#1)(1997-1#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-9#2)(2009-11#1)(2009-8#1)(2010-8#1)(2011-1#2)(2012-12#1)
role in coordinating the##2##4##(1991-3#1)(1993-6#1)
role in counseling##2##3##(2007-3#1)(2007-6#1)
role in defending the##2##4##(1994-3#1)(2008-8#1)
role in detecting##3##3##(2008-7#1)(2010-12#2)
role in determining the level of##2##6##(2007-7#1)(2008-11#1)
role in determining the structure and##2##6##(1995-10#1)(2005-11#1)
role in determining the##22##4##(1995-10#1)(1995-5#1)(2005-10#1)(2005-11#1)(2006-7#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-1#1)(2013-1#2)
role in determining whether##2##4##(1993-1#1)(2006-6#1)
role in determining##37##3##(1993-1#1)(1993-5#1)(1995-10#1)(1995-5#1)(1997-2#1)(1997-4#1)(2004-12#1)(2005-10#1)(2005-11#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-12#1)(2013-1#4)
role in detoxification of##2##4##(1996-3#1)(2008-11#1)
role in detoxification##3##3##(1996-3#1)(2008-11#1)(2008-7#1)
role in developing##2##3##(1995-3#1)(2008-11#1)
role in development of##2##4##(1994-6#1)(2008-8#1)
role in development##5##3##(1993-8#1)(1994-6#1)(1996-3#1)(2003-11#1)(2008-8#1)
role in developmental##2##3##(2008-8#1)(2009-5#1)
role in diabetes##2##3##(2009-8#1)(2010-11#1)
role in diabetic##3##3##(1997-6#1)(2008-1#1)(2008-3#1)
role in diagnosing##3##3##(1994-6#1)(2009-4#1)(2013-7#1)
role in diagnosis##3##3##(2006-10#1)(2007-8#1)(2010-11#1)
role in different##6##3##(2006-2#1)(2007-11#1)(2008-4#1)(2010-2#1)(2010-5#1)(2012-2#1)
role in directing the##4##4##(1996-8#1)(2007-8#1)(2008-7#1)(2010-5#1)
role in directing##5##3##(1996-8#1)(1997-7#1)(2007-8#1)(2008-7#1)(2010-5#1)
role in disaster preparedness##2##4##(2009-4#2)
role in disease pathogenesis##2##4##(1994-8#1)(1995-3#1)
role in disease resistance##2##4##(2008-10#1)(2009-8#1)
role in disease suppression##2##4##(2008-10#2)
role in disease##15##3##(1991-12#1)(1994-8#1)(1995-3#1)(2005-12#1)(2006-2#1)(2008-10#4)(2008-5#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#1)
role in drug metabolism##2##4##(2006-2#1)(2012-2#1)
role in drug##7##3##(1993-2#1)(1994-11#1)(1997-8#1)(2006-11#1)(2006-2#1)(2012-2#2)
role in early development of##2##5##(1993-3#1)(2008-4#1)
role in early diagnosis##2##4##(2011-2#2)
role in early##11##3##(1992-4#1)(1993-3#1)(1994-2#1)(2006-11#1)(2006-9#1)(2008-4#1)(2008-9#1)(2009-8#1)(2011-2#2)(2013-8#1)
role in eliciting##2##3##(2008-8#1)(2011-2#1)
role in embryogenesis##2##3##(2008-8#1)(2011-1#1)
role in energy metabolism##2##4##(1993-11#1)(1996-5#1)
role in enhancing##7##3##(1996-1#1)(2005-11#1)(2006-6#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
role in environmental adaptation##3##4##(2013-8#3)
role in environmental##4##3##(2008-11#1)(2013-8#3)
role in enzymatic##2##3##(1997-4#1)(2011-2#1)
role in epithelial cell##2##4##(1991-9#1)(2008-4#1)
role in establishing##5##3##(1991-10#1)(1995-12#1)(1997-1#1)(2006-7#1)(2011-1#1)
role in eukaryotic##3##3##(1993-8#1)(2008-4#1)(2008-8#1)
role in excitation-contraction coupling##2##4##(2007-9#1)(2008-1#1)
role in explaining##3##3##(2007-11#1)(2008-9#1)(2012-1#1)
role in facilitating the##3##4##(1995-8#1)(1996-8#1)(2009-2#1)
role in facilitating##6##3##(1995-8#1)(1996-8#1)(2005-11#1)(2006-10#1)(2007-8#1)(2009-2#1)
role in female##2##3##(2009-10#1)(2010-8#1)
role in fetal##3##3##(1990-11#1)(1995-12#1)(2008-8#1)
role in future##2##3##(1995-7#1)(2007-11#1)
role in gene##2##3##(2010-11#1)(2012-2#1)
role in generating##5##3##(1990-11#1)(1991-5#1)(1994-5#1)(1997-3#1)(2007-12#1)
role in genome##2##3##(1997-4#1)(2012-2#1)
role in glucose homeostasis in##2##5##(1995-1#1)(2012-2#1)
role in glucose homeostasis##4##4##(1995-1#2)(2008-1#1)(2012-2#1)
role in glucose##6##3##(1992-7#1)(1995-1#2)(2008-1#1)(2011-12#1)(2012-2#1)
role in growth control##2##4##(1997-7#1)(2009-8#1)
role in growth##3##3##(1997-7#1)(2009-8#1)(2013-1#1)
role in gut homeostasis##2##4##(2006-10#1)(2009-9#1)
role in health and disease##5##5##(2006-7#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-2#1)
role in health and##6##4##(2006-7#1)(2009-4#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#1)
role in health care reform##2##5##(1994-12#1)(1994-3#1)
role in health care##3##4##(1994-12#1)(1994-3#1)(1996-3#1)
role in health##11##3##(1994-12#1)(1994-3#1)(1996-3#1)(2006-7#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#1)
role in helping##4##3##(1992-6#1)(2006-4#1)(2007-2#1)(2010-11#1)
role in hemostasis##2##3##(1994-12#1)(1995-2#1)
role in hepatic##2##3##(2008-10#1)(2012-2#1)
role in high##2##3##(1990-12#1)(2010-7#1)
role in hormone-dependent##2##3##(1991-7#1)(1992-2#1)
role in host defense##3##4##(2008-10#1)(2008-4#1)(2009-10#1)
role in host##5##3##(1994-12#1)(1994-3#1)(2008-10#1)(2008-4#1)(2009-10#1)
role in how##5##3##(1996-3#1)(2008-11#1)(2009-5#1)(2010-1#2)
role in human##13##3##(1991-9#1)(1992-8#1)(1995-1#1)(1996-1#1)(1996-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-1#2)(2011-2#2)(2012-12#1)
role in identifying##4##3##(2007-10#1)(2008-11#1)(2008-12#1)(2008-3#1)
role in immune##4##3##(1991-10#1)(2007-11#1)(2008-4#1)(2008-9#1)
role in immunity##3##3##(2009-6#1)(2010-3#1)(2011-1#1)
role in immunological##2##3##(2010-12#1)(2012-12#1)
role in immunoregulation and##2##4##(1991-9#1)(2011-2#1)
role in implementing##2##3##(1994-1#1)(2010-4#1)
role in improving the quality of##2##6##(1993-3#1)(2012-3#1)
role in improving the##3##4##(1993-3#1)(2012-3#1)(2013-1#1)
role in improving##5##3##(1993-3#1)(2007-12#1)(2010-12#1)(2012-3#1)(2013-1#1)
role in in vivo##2##4##(2008-11#2)
role in in##3##3##(2008-11#2)(2013-1#1)
role in increasing the##2##4##(2008-11#1)(2013-1#1)
role in increasing##4##3##(2008-11#1)(2012-11#1)(2012-12#1)(2013-1#1)
role in inducing##6##3##(1990-4#1)(2006-8#1)(2008-11#1)(2008-8#1)(2010-6#1)(2012-2#1)
role in induction##2##3##(1992-3#1)(2007-9#1)
role in infection##4##3##(2007-3#1)(2008-10#2)(2009-8#1)
role in inflammation by##2##4##(2004-3#1)(2011-2#1)
role in inflammation##7##3##(1990-2#1)(1990-9#1)(2004-3#1)(2011-2#1)(2013-1#1)(2013-8#2)
role in inflammatory##3##3##(1995-12#1)(2007-12#1)(2008-5#1)
role in influencing the##2##4##(2004-11#1)(2005-11#1)
role in influencing##5##3##(1994-9#1)(1996-3#1)(2004-11#1)(2005-11#1)(2010-7#1)
role in information##3##3##(1992-1#1)(2009-3#1)(2010-10#1)
role in inhibiting##4##3##(1995-6#1)(1996-5#1)(2006-8#1)(2007-11#1)
role in inhibition of##2##4##(2008-10#1)(2010-10#1)
role in initial##2##3##(1995-3#1)(2010-3#1)
role in initiating and##2##4##(1994-8#1)(1995-2#1)
role in initiating##3##3##(1994-8#1)(1995-2#1)(2006-10#1)
role in initiation of##2##4##(1991-9#1)(2008-10#1)
role in initiation##3##3##(1991-9#1)(1996-5#1)(2008-10#1)
role in insulin##4##3##(1991-10#1)(2005-7#1)(2008-1#1)(2010-11#1)
role in interactions##2##3##(1994-6#1)(1995-2#1)
role in intestinal##3##3##(1991-12#1)(2006-10#1)(2010-2#1)
role in invasion##2##3##(1991-12#1)(2008-10#1)
role in iron metabolism##2##4##(1996-4#1)(1996-7#1)
role in iron##3##3##(1996-4#1)(1996-7#1)(2008-10#1)
role in ischemic preconditioning##2##4##(2006-10#1)(2007-8#1)
role in ischemic##3##3##(2006-10#1)(2007-8#1)(2010-1#1)
role in its##14##3##(1994-8#1)(1996-10#1)(2006-10#1)(2007-2#1)(2007-5#1)(2008-10#2)(2008-8#2)(2009-9#1)(2010-8#2)(2011-2#1)(2012-12#1)
role in joint##3##3##(2007-11#1)(2007-7#1)(2010-10#1)
role in learning and memory##2##5##(1997-7#1)(2012-2#1)
role in learning##4##3##(1997-7#1)(2008-8#1)(2012-12#1)(2012-2#1)
role in ligand##2##3##(1994-8#1)(1996-7#1)
role in limiting the##2##4##(2009-4#1)(2010-5#1)
role in limiting##4##3##(1995-7#1)(1997-6#1)(2009-4#1)(2010-5#1)
role in lipid##2##3##(1991-2#1)(2007-12#1)
role in liver cell injury##2##5##(1995-2#1)(2006-10#1)
role in local##3##3##(1992-6#1)(1993-9#1)(1994-6#1)
role in long-term memory##2##4##(1996-9#1)(1997-4#1)
role in long-term##3##3##(1996-9#1)(1997-4#1)(2007-8#1)
role in lung##3##3##(2011-2#1)(2012-1#1)(2013-7#1)
role in maintaining the##5##4##(2005-12#1)(2009-10#2)(2009-8#1)(2012-2#1)
role in maintaining##20##3##(1991-4#1)(1994-11#1)(1994-8#1)(1995-2#1)(2005-12#1)(2007-5#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#3)(2009-8#1)(2010-11#2)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#1)
role in making##3##3##(2007-12#1)(2010-12#1)(2012-12#1)
role in managing##5##3##(2007-2#1)(2008-12#1)(2008-2#1)(2010-10#1)(2013-8#1)
role in many aspects of##2##5##(1996-6#1)(2008-11#1)
role in many biological##2##4##(1996-8#1)(2008-8#1)
role in many cellular processes##2##5##(1994-6#1)(2008-7#1)
role in many of##2##4##(2008-12#1)(2008-6#1)
role in many##15##3##(1991-9#1)(1994-6#1)(1996-6#1)(1996-8#1)(1997-3#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)
role in mediating cell##2##4##(2008-9#1)(2010-12#1)
role in mediating the##6##4##(1993-6#1)(1994-8#1)(1996-5#1)(1997-2#1)(2008-5#1)(2013-1#1)
role in mediating##27##3##(1990-12#1)(1990-4#1)(1990-9#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-12#2)(1996-10#1)(1996-2#1)(1996-5#1)(1997-2#1)(2005-7#1)(2006-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
role in medical##2##3##(2005-7#1)(2007-11#1)
role in meeting##2##3##(2008-7#1)(2011-2#1)
role in meiotic##2##3##(1993-7#1)(2013-8#1)
role in modern##3##3##(1994-3#1)(2006-10#1)(2011-2#1)
role in modulating the biological##2##5##(1994-11#1)(2008-11#1)
role in modulating the##6##4##(1990-2#1)(1993-4#1)(1994-11#1)(1997-4#1)(2008-11#1)(2013-7#1)
role in modulating##18##3##(1990-2#1)(1990-5#2)(1993-12#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-10#1)(1997-4#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-10#2)(2010-12#1)(2013-7#1)
role in modulation of the##2##5##(1996-12#1)(2007-6#1)
role in modulation of##3##4##(1993-2#1)(1996-12#1)(2007-6#1)
role in monitoring##2##3##(1990-9#1)(2008-1#1)
role in motivating##2##3##(2006-10#1)(2008-4#1)
role in motor control##2##4##(1992-8#1)(2008-11#1)
role in nectar##2##3##(2009-6#1)(2009-8#1)
role in neural##2##3##(2006-3#1)(2008-9#1)
role in neuronal cell death##2##5##(2008-7#1)(2013-8#1)
role in neuronal morphogenesis##2##4##(1996-1#1)(1997-6#1)
role in neuronal##8##3##(1990-8#1)(1994-10#1)(1996-1#1)(1996-6#1)(1997-6#1)(2008-7#2)(2013-8#1)
role in normal##7##3##(1992-3#1)(1992-8#1)(2006-8#1)(2008-5#3)(2009-10#1)
role in obtaining##2##3##(1996-9#1)(2007-1#1)
role in our##4##3##(1992-12#1)(2008-11#1)(2008-9#2)
role in ovarian##2##3##(2009-4#1)(2012-12#1)
role in overcoming##2##3##(1990-10#1)(2005-7#1)
role in pain##6##3##(1996-12#1)(2006-10#1)(2007-12#1)(2008-4#1)(2008-8#1)(2009-3#1)
role in pancreatic##2##3##(2006-10#2)
role in pathogenesis of##4##4##(1993-12#1)(2007-9#1)(2008-7#1)(2008-8#1)
role in pathogenesis##5##3##(1993-12#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-8#1)
role in pathophysiology of##3##4##(2006-1#1)(2006-6#1)(2007-2#1)
role in patient safety##2##4##(2006-1#1)(2007-9#1)
role in patient##4##3##(1994-2#1)(2006-1#1)(2007-9#1)(2012-2#1)
role in patients with##3##4##(2006-10#1)(2011-2#1)(2013-7#1)
role in patients##4##3##(2006-10#1)(2011-2#1)(2012-2#1)(2013-7#1)
role in pattern formation##2##4##(1997-4#1)(2008-6#1)
role in pattern##3##3##(1995-11#1)(1997-4#1)(2008-6#1)
role in peptide antigenicity##2##4##(1997-6#2)
role in peripheral##2##3##(1990-7#1)(2008-5#1)
role in phenotypic evolution##2##4##(2009-2#1)(2010-12#1)
role in plant growth##3##4##(2006-9#1)(2008-10#1)(2008-9#1)
role in plant##7##3##(2006-9#1)(2008-10#2)(2008-9#1)(2009-6#2)(2012-2#1)
role in population##2##3##(1993-2#1)(1994-8#1)
role in predicting##4##3##(2008-9#1)(2009-7#1)(2009-9#1)(2010-2#1)
role in preparing for##2##4##(2007-4#1)(2012-3#1)
role in preparing##3##3##(2007-4#1)(2009-6#1)(2012-3#1)
role in preserving##3##3##(2008-10#1)(2010-11#1)(2012-11#1)
role in preventing##6##3##(2006-10#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-6#1)(2012-1#1)
role in prevention of##2##4##(2008-1#1)(2012-12#1)
role in production of##2##4##(1992-11#1)(2009-8#1)
role in proliferation##2##3##(1992-8#1)(2008-4#1)
role in promoting##7##3##(1996-10#1)(2007-11#1)(2008-4#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
role in protecting the##3##4##(1990-3#1)(2007-9#1)(2013-8#1)
role in protecting##6##3##(1990-3#1)(2007-8#1)(2007-9#1)(2009-12#1)(2010-11#1)(2013-8#1)
role in protection against##6##4##(2009-6#1)(2009-8#1)(2013-1#2)(2013-7#1)(2013-8#1)
role in protection##7##3##(2007-10#1)(2009-6#1)(2009-8#1)(2013-1#2)(2013-7#1)(2013-8#1)
role in protective##3##3##(2005-10#1)(2008-5#1)(2012-2#1)
role in protein##4##3##(2008-8#1)(2009-10#1)(2009-3#1)(2013-8#1)
role in providing care to##2##5##(2009-2#1)(2009-5#1)
role in providing##5##3##(1994-2#1)(2008-5#1)(2009-2#1)(2009-5#1)(2010-2#1)
role in public health##2##4##(1996-2#1)(2008-5#1)
role in public##3##3##(1996-2#1)(2008-11#1)(2008-5#1)
role in radiation##2##3##(1995-6#1)(2013-8#1)
role in recognition of##2##4##(1995-2#2)
role in recognition##3##3##(1995-2#2)(2011-1#1)
role in reducing the##3##4##(2008-8#1)(2011-12#1)(2011-2#1)
role in reducing##11##3##(2008-7#1)(2008-8#1)(2009-3#1)(2010-10#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
role in reduction of##2##4##(2005-10#1)(2008-10#1)
role in regulating cell##2##4##(1991-12#1)(2012-12#1)
role in regulating membrane excitability##2##5##(2008-8#2)
role in regulating the##19##4##(1991-3#2)(1991-5#1)(1991-7#1)(1992-12#1)(1994-11#1)(1995-2#1)(1995-8#1)(1996-8#1)(1997-5#1)(1997-8#1)(2006-1#1)(2007-5#1)(2008-11#2)(2008-4#1)(2010-11#1)(2012-12#1)(2012-3#1)
role in regulating##56##3##(1991-12#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-7#1)(1992-12#1)(1992-5#1)(1993-5#1)(1994-11#2)(1994-9#1)(1995-12#2)(1995-2#2)(1995-8#2)(1996-11#1)(1996-4#1)(1996-5#3)(1996-8#1)(1997-4#1)(1997-5#1)(1997-8#1)(1997-9#1)(2006-1#1)(2006-2#1)(2007-11#1)(2007-5#1)(2008-11#2)(2008-4#2)(2008-8#2)(2009-10#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-5#1)(2011-10#1)(2012-12#4)(2012-3#2)(2013-1#1)
role in regulation of##9##4##(1990-12#1)(1992-11#1)(1994-12#1)(1995-3#1)(1996-1#1)(2008-1#1)(2008-9#1)(2010-11#1)(2013-1#1)
role in relation to##2##4##(1993-6#1)(2009-7#1)
role in renal##4##3##(1992-9#1)(2011-2#2)(2013-8#1)
role in replication##2##3##(2008-10#1)(2008-5#1)
role in resistance to##2##4##(2008-10#2)
role in resistance##6##3##(1992-7#1)(2008-10#5)
role in respiratory##2##3##(2011-2#2)
role in restricting##2##3##(2005-10#1)(2005-8#1)
role in risk management##2##4##(1993-2#2)
role in risk##5##3##(1993-2#2)(2008-11#1)(2012-3#1)(2013-7#1)
role in selecting the##2##4##(1995-8#1)(2012-12#1)
role in selecting##4##3##(1995-12#1)(1995-8#1)(2009-3#1)(2012-12#1)
role in serum##2##3##(1996-8#1)(2008-7#1)
role in several##8##3##(1994-11#1)(1994-2#1)(2006-8#1)(2007-11#1)(2008-1#1)(2012-12#2)(2012-2#1)
role in sex##2##3##(2010-3#1)(2011-2#1)
role in shaping##4##3##(2006-5#1)(2007-11#1)(2008-8#1)(2012-2#1)
role in signal transduction##6##4##(1992-11#1)(1994-12#1)(1994-3#1)(1995-8#1)(1997-8#1)(2012-12#1)
role in signaling##2##3##(1995-6#1)(2009-10#1)
role in skin##3##3##(2008-5#1)(2008-9#1)(2012-12#1)
role in society##2##3##(2010-3#1)(2013-7#1)
role in some##9##3##(1990-3#1)(1991-12#1)(1994-12#2)(1995-12#2)(2006-12#1)(2008-5#1)(2010-7#1)
role in spinal##2##3##(2007-1#1)(2010-12#1)
role in spore formation##2##4##(2008-8#1)(2010-2#1)
role in stabilizing the##2##4##(1994-12#1)(2013-8#1)
role in stabilizing##3##3##(1994-12#1)(1994-9#1)(2013-8#1)
role in substrate binding##2##4##(1991-4#1)(1991-7#1)
role in substrate##3##3##(1991-4#1)(1991-7#1)(2011-1#1)
role in such##2##3##(2008-5#1)(2010-7#1)
role in supporting##3##3##(2005-5#1)(2008-12#1)(2013-7#1)
role in suppressing##3##3##(1997-2#1)(2008-10#1)(2008-9#1)
role in synaptic plasticity##2##4##(1996-2#1)(1996-5#1)
role in synaptic##3##3##(1994-12#1)(1996-2#1)(1996-5#1)
role in targeting##2##3##(2007-8#1)(2011-1#1)
role in the ability of##2##5##(2008-10#1)(2011-1#1)
role in the activation of the##2##6##(1992-1#1)(2008-1#1)
role in the activation of##4##5##(1990-5#1)(1992-1#1)(2008-1#1)(2008-4#1)
role in the activation##5##4##(1990-5#1)(1992-1#1)(1996-7#1)(2008-1#1)(2008-4#1)
role in the adaptive immune##2##5##(2008-1#1)(2009-6#1)
role in the adult##2##4##(1993-12#1)(1995-8#1)
role in the aetiology of##4##5##(1992-4#1)(2007-11#1)(2008-5#1)(2013-8#1)
role in the assembly of##4##5##(1995-2#1)(2006-11#2)(2006-12#1)
role in the assembly##5##4##(1995-2#1)(1995-8#1)(2006-11#2)(2006-12#1)
role in the assessment of##7##5##(1993-11#1)(2005-11#1)(2007-1#1)(2008-11#1)(2008-7#1)(2009-11#1)(2012-2#1)
role in the binding of the##2##6##(2006-12#1)(2008-10#1)
role in the binding of##5##5##(1991-3#1)(1991-8#1)(1994-8#1)(2006-12#1)(2008-10#1)
role in the binding##9##4##(1991-3#1)(1991-8#1)(1994-12#1)(1994-8#1)(2006-12#2)(2008-10#2)(2010-7#1)
role in the biogeochemical##2##4##(2008-5#2)
role in the biological##2##4##(2008-6#1)(2008-8#1)
role in the brain##2##4##(1990-2#1)(2013-1#1)
role in the capture##2##4##(1994-11#1)(2006-12#1)
role in the cell##3##4##(1990-10#1)(2008-2#1)(2011-2#1)
role in the cellular##3##4##(1995-8#1)(2003-11#1)(2011-2#1)
role in the central##3##4##(1992-7#1)(1996-11#1)(1996-2#1)
role in the characterization of##2##5##(1997-1#1)(2011-12#1)
role in the clearance of##3##5##(1994-3#1)(1997-6#1)(2007-11#1)
role in the communication between the##2##6##(2008-3#1)(2008-4#1)
role in the context of##2##5##(2005-10#1)(2008-3#1)
role in the control of cell proliferation##2##7##(1993-3#1)(2009-5#1)
role in the control of cell##3##6##(1993-3#1)(1994-12#1)(2009-5#1)
role in the control of growth##2##6##(1993-9#1)(1994-10#1)
role in the control of the##2##6##(1994-12#1)(2008-7#1)
role in the control of##14##5##(1990-11#1)(1993-3#1)(1993-9#1)(1994-10#2)(1994-12#3)(1994-2#1)(1996-3#1)(2008-7#1)(2009-5#1)(2013-1#1)(2013-8#1)
role in the conversion of##2##5##(1990-8#1)(1992-12#1)
role in the course of##2##5##(2006-8#1)(2011-2#1)
role in the decision-making process##2##5##(2009-6#1)(2011-2#1)
role in the decrease of##2##5##(1993-11#1)(2007-2#1)
role in the detection and##2##5##(2005-8#1)(2010-12#1)
role in the detection of##3##5##(2008-2#1)(2011-1#1)(2011-2#1)
role in the detection##5##4##(2005-8#1)(2008-2#1)(2010-12#1)(2011-1#1)(2011-2#1)
role in the development and maintenance of##2##7##(2007-12#1)(2008-6#1)
role in the development and progression of breast cancer##2##9##(2009-5#1)(2012-3#1)
role in the development and progression of##4##7##(2009-5#1)(2010-3#1)(2012-3#1)(2013-1#1)
role in the development and##12##5##(1991-12#1)(1996-2#1)(2006-2#1)(2007-12#1)(2008-11#1)(2008-6#1)(2009-5#1)(2010-12#1)(2010-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
role in the development of atherosclerosis##2##6##(1997-2#1)(2008-5#1)
role in the development of atherosclerotic##2##6##(2010-4#1)(2010-8#1)
role in the development of breast cancer##2##7##(1994-12#1)(2008-12#1)
role in the development of breast##3##6##(1994-12#1)(1997-4#1)(2008-12#1)
role in the development of chronic##2##6##(2010-10#1)(2011-2#1)
role in the development of renal##2##6##(1992-4#1)(2009-11#1)
role in the development of retinal##2##6##(1995-1#1)(2013-8#1)
role in the development of the##6##6##(1993-3#1)(2006-10#1)(2008-3#1)(2012-1#1)(2013-1#2)
role in the development of these##2##6##(2008-11#1)(2011-2#1)
role in the development of##68##5##(1990-4#1)(1991-1#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-4#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-1#1)(1995-12#1)(1996-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-10#3)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-2#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
role in the development##81##4##(1990-4#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-4#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-10#3)(2006-2#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#3)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#4)(2012-1#2)(2012-12#2)(2012-3#2)(2013-1#3)(2013-8#2)
role in the diagnosis and##7##5##(2006-10#2)(2007-4#1)(2008-5#1)(2009-4#1)(2010-12#1)(2012-2#1)
role in the diagnosis of##4##5##(1993-10#1)(2008-11#1)(2009-11#1)(2012-2#1)
role in the diagnosis##12##4##(1991-12#1)(1993-10#1)(2006-10#2)(2007-4#1)(2008-11#1)(2008-5#1)(2009-11#1)(2009-4#1)(2010-12#1)(2012-2#2)
role in the differentiation of##2##5##(1994-12#1)(1996-4#1)
role in the differentiation##4##4##(1994-12#1)(1994-4#1)(1995-6#1)(1996-4#1)
role in the disease##2##4##(2012-12#1)(2013-1#1)
role in the dynamics##2##4##(1990-10#1)(2008-8#1)
role in the early##11##4##(1992-12#1)(1992-5#1)(1994-11#1)(1994-3#1)(1996-1#1)(1997-3#1)(2006-2#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#1)
role in the epidemiology of##2##5##(2008-10#2)
role in the etiology of##11##5##(1990-8#1)(1992-1#1)(1996-12#1)(2006-10#1)(2006-4#1)(2007-8#1)(2008-12#1)(2008-5#1)(2009-11#1)(2012-12#2)
role in the etiology##12##4##(1990-11#1)(1990-8#1)(1992-1#1)(1996-12#1)(2006-10#1)(2006-4#1)(2007-8#1)(2008-12#1)(2008-5#1)(2009-11#1)(2012-12#2)
role in the evaluation of the##2##6##(2008-7#2)
role in the evaluation of##8##5##(1993-11#1)(2007-4#1)(2008-12#1)(2008-2#2)(2008-7#2)(2011-2#1)
role in the evolution of the##3##6##(2008-12#1)(2012-12#2)
role in the evolution of##13##5##(1995-8#1)(2005-8#1)(2006-9#1)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-3#1)(2012-12#2)(2012-3#1)(2013-1#1)
role in the execution##2##4##(2006-12#1)(2009-4#1)
role in the expression of##4##5##(1991-8#1)(1992-8#1)(1993-3#1)(2008-11#1)
role in the formation of protein##2##6##(1990-12#1)(2010-10#1)
role in the formation of the##3##6##(1992-6#1)(1993-11#2)
role in the formation of##12##5##(1990-12#1)(1991-10#1)(1992-3#1)(1992-6#1)(1993-11#2)(1996-6#1)(1997-6#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-10#1)
role in the functioning of##3##5##(2012-11#1)(2012-12#1)(2013-8#1)
role in the future##5##4##(1996-2#1)(1996-3#1)(2004-7#1)(2006-6#1)(2010-11#1)
role in the generation of##3##5##(1990-3#1)(2008-3#1)(2012-3#1)
role in the generation##4##4##(1990-3#1)(2008-3#1)(2008-5#1)(2012-3#1)
role in the genesis of##6##5##(1995-6#1)(1995-8#1)(1996-11#1)(2006-9#1)(2011-2#1)(2012-2#1)
role in the health##2##4##(1993-11#1)(1993-12#1)
role in the homeostasis of##2##5##(1994-12#1)(1995-3#1)
role in the host defense##2##5##(2008-4#1)(2012-2#1)
role in the host##3##4##(2008-4#1)(2008-8#1)(2012-2#1)
role in the immune system##2##5##(2006-11#1)(2010-12#1)
role in the immune##5##4##(1995-2#1)(2006-11#1)(2006-6#1)(2010-12#1)(2011-12#1)
role in the improvement of##5##5##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-7#1)
role in the increased##2##4##(1991-1#1)(2008-7#1)
role in the induction of##5##5##(1991-12#1)(1993-4#1)(1997-6#1)(2008-1#1)(2012-3#1)
role in the induction##6##4##(1991-12#1)(1993-4#1)(1993-9#1)(1997-6#1)(2008-1#1)(2012-3#1)
role in the inflammatory##2##4##(1995-12#1)(2006-10#1)
role in the inhibition of##2##5##(1993-9#1)(2010-12#1)
role in the initiation and##5##5##(1994-8#1)(2006-7#1)(2008-5#1)(2010-2#2)
role in the initiation of##7##5##(1990-6#1)(1994-11#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-5#1)(2008-8#1)
role in the initiation##14##4##(1990-6#1)(1994-11#1)(1994-8#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-5#2)(2008-8#1)(2010-2#2)(2013-1#1)
role in the interaction between##4##5##(1995-12#1)(1996-12#1)(2008-10#2)
role in the interaction##6##4##(1993-3#1)(1995-12#1)(1995-6#1)(1996-12#1)(2008-10#2)
role in the intracellular##3##4##(1991-4#1)(1992-5#1)(2008-11#1)
role in the intricate##2##4##(2009-8#1)(2012-12#1)
role in the investigation of##2##5##(1997-8#1)(2006-10#1)
role in the life##2##4##(2008-10#1)(2013-7#1)
role in the ligand##2##4##(2009-3#2)
role in the local##2##4##(1990-6#1)(2008-12#1)
role in the maintenance of##13##5##(1995-1#1)(1996-5#1)(1997-1#1)(2004-12#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-3#1)
role in the maintenance##15##4##(1995-1#1)(1996-5#1)(1997-1#1)(2004-12#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-4#1)(2008-5#2)(2008-7#2)(2011-2#1)(2012-3#1)
role in the mammalian##2##4##(1992-7#1)(2012-2#1)
role in the management of breast##2##6##(2010-12#1)(2013-8#1)
role in the management of chronic##2##6##(1996-7#1)(2006-8#1)
role in the management of patients with##3##7##(1996-9#1)(2007-1#2)
role in the management of##14##5##(1996-7#1)(1996-9#1)(2006-10#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#2)(2008-1#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-8#1)
role in the management##15##4##(1996-7#1)(1996-9#1)(2006-10#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#2)(2008-1#1)(2008-7#1)(2009-4#1)(2010-12#1)(2011-2#1)(2013-8#1)
role in the mechanism of##6##5##(1993-6#1)(1995-12#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-7#1)
role in the mechanisms##2##4##(1994-2#1)(2009-7#1)
role in the metabolic activation of##2##6##(1994-6#1)(2008-8#1)
role in the metabolic##3##4##(1994-6#1)(2008-8#1)(2012-3#1)
role in the metabolism of##4##5##(1996-5#1)(2008-10#1)(2008-11#1)(2011-2#1)
role in the metastatic process##2##5##(1993-9#1)(2008-4#1)
role in the mode of##2##5##(2008-5#1)(2013-1#1)
role in the modulation of##7##5##(1993-12#2)(1994-9#1)(1995-3#1)(2008-1#1)(2012-2#1)(2013-8#1)
role in the modulation##8##4##(1993-12#2)(1994-9#1)(1995-3#1)(2006-10#1)(2008-1#1)(2012-2#1)(2013-8#1)
role in the molecular events##2##5##(1996-11#1)(2008-8#1)
role in the molecular pathogenesis of##5##6##(2006-11#1)(2007-8#2)(2008-3#1)(2010-2#1)
role in the molecular##8##4##(1996-11#1)(2005-11#1)(2006-11#1)(2007-8#2)(2008-3#1)(2008-8#1)(2010-2#1)
role in the natural##3##4##(2007-11#1)(2008-10#2)
role in the neural##3##4##(1990-11#1)(1992-8#1)(1997-4#1)
role in the neurodegenerative process##2##5##(1995-1#1)(1997-4#1)
role in the normal development and##2##6##(1991-11#1)(2009-4#1)
role in the normal development##3##5##(1991-11#1)(2006-4#1)(2009-4#1)
role in the normal##5##4##(1991-11#1)(1993-12#1)(1993-7#1)(2006-4#1)(2009-4#1)
role in the occurrence of##5##5##(1990-8#1)(1997-3#1)(2010-4#1)(2012-12#1)(2012-2#1)
role in the organization of##2##5##(1990-10#1)(1990-9#1)
role in the organization##3##4##(1990-10#1)(1990-9#1)(2008-9#1)
role in the overall##4##4##(1995-1#1)(2008-8#1)(2012-3#1)(2013-1#1)
role in the oxidative##3##4##(1995-6#1)(2006-12#2)
role in the pathogenesis and##2##5##(1993-9#1)(2008-4#1)
role in the pathogenesis of Alzheimer's disease (AD)##3##8##(1995-10#1)(1997-2#1)(2013-7#1)
role in the pathogenesis of asthma##2##6##(2007-11#1)(2010-5#1)
role in the pathogenesis of cancer##2##6##(1990-11#1)(2011-1#1)
role in the pathogenesis of chronic inflammatory##2##7##(2010-12#2)
role in the pathogenesis of chronic##4##6##(2006-9#1)(2009-8#1)(2010-12#2)
role in the pathogenesis of human##2##6##(2004-12#1)(2012-12#1)
role in the pathogenesis of infectious##2##6##(2006-10#1)(2006-8#1)
role in the pathogenesis of the disease##3##7##(1992-6#1)(1996-3#1)(2006-11#1)
role in the pathogenesis of the##6##6##(1990-11#1)(1991-5#1)(1992-6#1)(1996-3#1)(2006-11#1)(2008-1#1)
role in the pathogenesis of this disease##2##7##(2012-1#1)(2013-7#1)
role in the pathogenesis of this##4##6##(1992-2#1)(1996-10#1)(2012-1#1)(2013-7#1)
role in the pathogenesis of##81##5##(1990-11#2)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-12#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-10#1)(1995-2#1)(1996-10#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-8#1)(2004-12#1)(2005-7#1)(2006-10#4)(2006-11#1)(2006-5#1)(2006-8#3)(2006-9#2)(2007-1#2)(2007-11#3)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#3)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#1)(2009-1#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-12#3)(2010-5#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#2)(2013-3#1)(2013-7#2)(2013-8#1)
role in the pathogenesis##83##4##(1990-11#2)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-10#1)(1995-2#1)(1996-10#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-8#1)(2004-12#1)(2005-7#1)(2006-10#4)(2006-11#1)(2006-5#1)(2006-8#3)(2006-9#2)(2007-1#2)(2007-11#3)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#3)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#1)(2008-7#1)(2009-1#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-12#3)(2010-5#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#2)(2013-3#1)(2013-7#2)(2013-8#1)
role in the pathology of##2##5##(2009-4#1)(2010-8#1)
role in the pathophysiology of this##2##6##(2009-8#1)(2010-12#1)
role in the pathophysiology of##18##5##(1995-12#1)(1995-3#1)(1995-6#1)(2006-9#1)(2007-10#1)(2008-1#3)(2008-3#2)(2008-4#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-1#1)(2013-1#2)
role in the physiology of the##2##6##(1996-2#1)(1997-7#1)
role in the physiology of##3##5##(1996-2#1)(1997-7#1)(2006-2#1)
role in the presence of surface charges and a##2##9##(2005-11#2)
role in the prevention of##7##5##(1993-2#1)(1996-11#1)(2007-10#1)(2007-11#2)(2007-7#1)(2012-11#1)
role in the prevention##8##4##(1993-2#1)(1996-11#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-7#1)(2012-11#1)
role in the process of##10##5##(1992-4#1)(1993-11#1)(1994-3#1)(1995-6#1)(1996-5#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-11#1)(2008-1#1)
role in the process##12##4##(1992-12#1)(1992-4#1)(1993-11#1)(1994-3#1)(1995-6#1)(1996-5#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-11#1)(2008-1#1)(2009-6#1)
role in the processes of##3##5##(1996-4#1)(2007-11#1)(2012-12#1)
role in the production of##3##5##(1995-10#1)(2006-2#1)(2008-1#1)
role in the progression of##6##5##(1996-12#1)(1997-7#1)(2005-7#1)(2008-4#1)(2012-12#2)
role in the promotion of##3##5##(1993-6#1)(1996-11#1)(2007-3#1)
role in the promotion##5##4##(1993-6#1)(1993-7#2)(1996-11#1)(2007-3#1)
role in the provision of##2##5##(2008-8#1)(2011-1#1)
role in the rate of##2##5##(1991-4#1)(1997-4#1)
role in the recognition of##5##5##(1991-5#1)(1991-7#2)(1995-2#1)(2009-3#1)
role in the recovery##4##4##(1992-7#1)(2008-10#1)(2008-11#1)(2008-6#1)
role in the regulation of blood pressure and##2##8##(1993-12#1)(2007-1#1)
role in the regulation of blood pressure##3##7##(1993-12#1)(2007-1#1)(2008-1#1)
role in the regulation of blood##4##6##(1992-12#1)(1993-12#1)(2007-1#1)(2008-1#1)
role in the regulation of cell##2##6##(1994-12#1)(2008-4#1)
role in the regulation of coronary##2##6##(1990-10#1)(2008-4#1)
role in the regulation of gene expression##3##7##(1991-6#1)(1996-4#1)(1997-4#1)
role in the regulation of genes##2##6##(2008-1#2)
role in the regulation of proliferation##2##6##(1992-8#1)(2013-1#1)
role in the regulation of the##10##6##(1992-11#1)(1993-11#1)(1994-12#1)(1995-12#1)(1995-8#1)(2007-12#1)(2008-4#1)(2008-8#1)(2009-9#1)(2013-7#1)
role in the regulation of##79##5##(1990-10#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#2)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#3)(1995-8#2)(1996-11#1)(1996-3#1)(1996-4#1)(1996-5#2)(1997-2#1)(1997-4#3)(1997-5#1)(1997-8#1)(2006-1#1)(2006-10#3)(2007-1#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#4)(2008-4#5)(2008-8#3)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)
role in the response of##3##5##(2006-10#1)(2007-1#1)(2012-7#1)
role in the response to##2##5##(1990-5#1)(2009-8#1)
role in the response##5##4##(1990-5#1)(2006-10#1)(2007-1#1)(2009-8#1)(2012-7#1)
role in the rise of health care costs##2##8##(1994-2#2)
role in the secretion of##2##5##(1993-9#1)(2008-5#1)
role in the signal transduction##2##5##(1990-12#1)(2008-8#1)
role in the sorption##2##4##(2008-10#2)
role in the stability of##2##5##(2008-10#1)(2009-9#1)
role in the staging of##2##5##(2012-12#1)(2012-2#1)
role in the stimulation of##2##5##(1992-12#1)(1994-6#1)
role in the structure and function of##3##7##(2006-10#1)(2008-4#1)(2008-8#1)
role in the suppression of##5##5##(1990-2#1)(2008-10#4)
role in the survival and##3##5##(1993-11#1)(2008-10#1)(2008-7#1)
role in the survival of##2##5##(1997-6#1)(2008-10#1)
role in the survival##5##4##(1993-11#1)(1997-6#1)(2008-10#2)(2008-7#1)
role in the synthesis##2##4##(1990-11#1)(2013-1#1)
role in the therapeutic##4##4##(1991-6#1)(2007-5#1)(2008-8#1)(2011-2#1)
role in the therapy of##3##5##(1991-4#1)(2005-7#1)(2005-9#1)
role in the transcriptional regulation of##2##6##(1996-12#1)(2011-2#1)
role in the transduction of##2##5##(1991-5#1)(1995-7#1)
role in the transduction##3##4##(1990-9#1)(1991-5#1)(1995-7#1)
role in the transfer##2##4##(1994-12#1)(2007-12#1)
role in the transmission of##7##5##(2006-10#1)(2006-11#1)(2008-10#2)(2010-1#2)(2013-1#1)
role in the treatment and prevention of##2##7##(2008-5#1)(2008-7#1)
role in the treatment of many##2##6##(2006-8#1)(2011-3#1)
role in the treatment of patients with##2##7##(2007-11#2)
role in the treatment of##30##5##(1991-9#1)(1993-11#1)(1994-4#1)(1995-11#1)(1996-7#1)(2006-10#1)(2006-8#1)(2007-11#5)(2007-4#1)(2007-6#2)(2007-8#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#2)(2013-1#2)(2013-8#1)
role in the treatment##33##4##(1991-9#1)(1993-11#1)(1994-4#1)(1995-11#1)(1996-7#1)(2006-10#1)(2006-8#1)(2007-11#5)(2007-4#1)(2007-6#2)(2007-8#1)(2008-1#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-8#2)(2009-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#2)(2013-1#2)(2013-8#1)
role in the up-regulation of##2##5##(2009-3#1)(2012-12#1)
role in the uroporphyrin##3##4##(1991-10#3)
role in the work-up of##2##5##(2008-6#1)(2011-1#1)
role in the##1138##3##(1990-10#7)(1990-11#6)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#7)(1990-6#2)(1990-7#3)(1990-8#5)(1990-9#4)(1991-1#4)(1991-10#6)(1991-11#4)(1991-12#7)(1991-2#2)(1991-3#1)(1991-4#5)(1991-5#7)(1991-6#2)(1991-7#3)(1991-8#3)(1991-9#4)(1992-1#3)(1992-10#2)(1992-11#4)(1992-12#7)(1992-2#2)(1992-3#5)(1992-4#3)(1992-5#3)(1992-6#3)(1992-7#6)(1992-8#5)(1992-9#2)(1993-10#2)(1993-11#12)(1993-12#9)(1993-2#3)(1993-3#9)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#4)(1993-8#3)(1993-9#9)(1994-1#1)(1994-10#3)(1994-11#6)(1994-12#14)(1994-2#7)(1994-3#6)(1994-4#2)(1994-5#1)(1994-6#7)(1994-8#8)(1994-9#5)(1995-1#4)(1995-10#2)(1995-11#6)(1995-12#14)(1995-2#7)(1995-3#14)(1995-5#1)(1995-6#11)(1995-7#2)(1995-8#11)(1996-1#3)(1996-10#6)(1996-11#6)(1996-12#8)(1996-2#4)(1996-3#5)(1996-4#5)(1996-5#10)(1996-6#3)(1996-7#4)(1996-8#1)(1996-9#3)(1997-1#5)(1997-2#6)(1997-3#4)(1997-4#10)(1997-5#1)(1997-6#9)(1997-7#8)(1997-8#4)(2003-11#1)(2004-12#3)(2004-7#1)(2005-10#5)(2005-11#8)(2005-7#4)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#27)(2006-11#8)(2006-12#8)(2006-2#9)(2006-3#1)(2006-4#4)(2006-5#3)(2006-6#4)(2006-7#2)(2006-8#9)(2006-9#7)(2007-1#9)(2007-10#7)(2007-11#20)(2007-12#11)(2007-2#2)(2007-3#3)(2007-4#4)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#11)(2007-9#3)(2008-1#26)(2008-10#49)(2008-11#20)(2008-12#7)(2008-2#7)(2008-3#16)(2008-4#24)(2008-5#23)(2008-6#9)(2008-7#31)(2008-8#22)(2008-9#11)(2009-1#3)(2009-10#3)(2009-11#4)(2009-12#1)(2009-2#3)(2009-3#5)(2009-4#7)(2009-5#3)(2009-6#3)(2009-7#4)(2009-8#8)(2009-9#7)(2010-1#3)(2010-10#4)(2010-11#4)(2010-12#15)(2010-2#7)(2010-3#6)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#4)(2011-1#18)(2011-10#1)(2011-12#7)(2011-2#33)(2011-3#2)(2011-7#2)(2012-1#5)(2012-11#4)(2012-12#23)(2012-2#22)(2012-3#12)(2012-7#1)(2013-1#27)(2013-3#1)(2013-7#7)(2013-8#12)
role in their##10##3##(1992-6#1)(1995-11#1)(1995-12#1)(1996-12#1)(2006-1#1)(2007-11#1)(2007-12#1)(2008-8#1)(2010-9#1)(2011-1#1)
role in these##10##3##(1991-5#1)(1992-11#1)(1992-9#1)(2006-10#1)(2007-12#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-3#1)(2013-8#1)
role in this area##2##4##(1996-1#1)(2008-7#1)
role in this association##2##4##(2007-7#1)(2008-1#1)
role in this pathway##3##4##(1994-11#1)(1995-6#1)(2010-2#1)
role in this process##7##4##(1991-9#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-4#1)(2009-7#1)(2011-2#1)
role in this transition##2##4##(1994-2#1)(2010-8#1)
role in this##47##3##(1990-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-7#1)(2004-9#1)(2006-10#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-12#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)
role in thyroid homeostasis##4##4##(2013-1#4)
role in thyroid##5##3##(2013-1#5)
role in tissue##4##3##(1995-6#1)(1997-2#1)(2007-2#1)(2010-1#1)
role in today's##2##3##(1997-1#1)(2007-5#1)
role in transcription##2##3##(1992-5#1)(2010-7#1)
role in transcriptional##3##3##(1991-5#1)(2008-7#1)(2009-9#1)
role in transduction of##2##4##(1991-1#1)(1994-5#1)
role in transmembrane##2##3##(2008-9#1)(2012-2#1)
role in transmission##2##3##(1996-12#1)(2008-10#1)
role in treating##6##3##(1991-2#1)(2008-3#1)(2008-4#1)(2009-6#1)(2010-11#1)(2011-2#1)
role in treatment of##2##4##(2007-11#1)(2010-4#1)
role in treatment##6##3##(2006-8#1)(2007-11#1)(2008-7#1)(2009-4#1)(2010-4#1)(2011-1#1)
role in triggering##3##3##(2010-11#2)(2010-2#1)
role in tumor growth##2##4##(2005-11#1)(2008-9#1)
role in tumor progression##2##4##(1993-9#1)(2009-3#1)
role in tumor##9##3##(1993-7#1)(1993-9#1)(1994-5#1)(1997-7#1)(2005-11#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-3#1)
role in tumorigenesis##4##3##(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
role in tyrosine##2##3##(1994-12#1)(1994-9#1)
role in understanding the##3##4##(2007-4#1)(2010-1#1)(2012-2#1)
role in understanding##5##3##(2007-4#1)(2008-4#1)(2008-8#1)(2010-1#1)(2012-2#1)
role in upregulating##2##3##(2009-11#1)(2011-2#1)
role in various##7##3##(1992-6#1)(1995-3#1)(2007-2#1)(2008-1#1)(2009-12#1)(2009-3#1)(2010-1#1)
role in vascular##3##3##(2008-3#1)(2008-4#1)(2009-11#1)
role in vesicle##2##3##(2008-11#1)(2009-8#1)
role in viral##2##3##(2011-1#1)(2012-2#1)
role in vivo##3##3##(1994-10#1)(1997-4#1)(2008-10#1)
role in which##2##3##(1994-2#1)(2008-12#1)
role in wound healing##2##4##(2007-1#1)(2008-12#1)
role in wound##3##3##(2006-9#1)(2007-1#1)(2008-12#1)
role in##3059##2##(1990-10#8)(1990-11#14)(1990-12#11)(1990-2#7)(1990-3#5)(1990-4#3)(1990-5#12)(1990-6#3)(1990-7#7)(1990-8#8)(1990-9#10)(1991-1#5)(1991-10#10)(1991-11#5)(1991-12#17)(1991-2#8)(1991-3#8)(1991-4#10)(1991-5#17)(1991-6#4)(1991-7#10)(1991-8#6)(1991-9#13)(1992-1#7)(1992-10#4)(1992-11#11)(1992-12#16)(1992-2#5)(1992-3#9)(1992-4#7)(1992-5#9)(1992-6#10)(1992-7#13)(1992-8#16)(1992-9#10)(1993-1#3)(1993-10#3)(1993-11#16)(1993-12#17)(1993-2#10)(1993-3#17)(1993-4#5)(1993-5#3)(1993-6#9)(1993-7#11)(1993-8#5)(1993-9#15)(1994-1#3)(1994-10#8)(1994-11#24)(1994-12#30)(1994-2#20)(1994-3#16)(1994-4#3)(1994-5#8)(1994-6#16)(1994-8#20)(1994-9#16)(1995-1#13)(1995-10#6)(1995-11#11)(1995-12#32)(1995-2#25)(1995-3#26)(1995-5#6)(1995-6#26)(1995-7#5)(1995-8#23)(1996-1#11)(1996-10#13)(1996-11#8)(1996-12#17)(1996-2#11)(1996-3#14)(1996-4#12)(1996-5#28)(1996-6#7)(1996-7#8)(1996-8#12)(1996-9#5)(1997-1#12)(1997-2#16)(1997-3#11)(1997-4#24)(1997-5#5)(1997-6#25)(1997-7#25)(1997-8#10)(1997-9#2)(2003-11#4)(2004-1#2)(2004-11#1)(2004-12#5)(2004-3#1)(2004-4#1)(2004-7#1)(2004-9#2)(2005-10#12)(2005-11#14)(2005-12#2)(2005-5#2)(2005-7#12)(2005-8#8)(2005-9#3)(2006-1#5)(2006-10#69)(2006-11#12)(2006-12#13)(2006-2#20)(2006-3#2)(2006-4#9)(2006-5#6)(2006-6#10)(2006-7#7)(2006-8#18)(2006-9#11)(2007-1#18)(2007-10#14)(2007-11#46)(2007-12#36)(2007-2#11)(2007-3#6)(2007-4#12)(2007-5#6)(2007-6#5)(2007-7#14)(2007-8#30)(2007-9#15)(2008-1#51)(2008-10#131)(2008-11#58)(2008-12#19)(2008-2#14)(2008-3#33)(2008-4#63)(2008-5#70)(2008-6#18)(2008-7#76)(2008-8#63)(2008-9#40)(2009-1#4)(2009-10#23)(2009-11#10)(2009-12#4)(2009-2#10)(2009-3#17)(2009-4#23)(2009-5#10)(2009-6#21)(2009-7#14)(2009-8#39)(2009-9#16)(2010-1#9)(2010-10#19)(2010-11#25)(2010-12#41)(2010-2#22)(2010-3#17)(2010-4#15)(2010-5#12)(2010-6#6)(2010-7#8)(2010-8#20)(2010-9#3)(2011-1#58)(2011-10#3)(2011-12#13)(2011-2#95)(2011-3#5)(2011-7#2)(2012-1#15)(2012-11#7)(2012-12#73)(2012-2#76)(2012-3#27)(2012-7#2)(2013-1#90)(2013-3#1)(2013-7#18)(2013-8#40)
role is also played by##2##5##(1995-5#1)(2007-8#1)
role is not##3##3##(1994-3#1)(1997-7#1)(2008-1#1)
role is one that##2##4##(2008-1#1)(2008-11#1)
role is the##2##3##(2006-10#1)(2009-1#1)
role is to##4##3##(1991-2#1)(1994-2#1)(1996-2#1)(1997-2#1)
role is##40##2##(1990-4#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-2#1)(1992-9#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-7#1)(2004-3#1)(2005-1#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#1)(2009-1#1)(2009-10#1)(2010-12#1)(2010-3#1)(2010-9#1)(2012-1#1)(2012-2#2)
role it has##2##3##(1993-6#1)(2008-5#1)
role it plays in the##5##5##(2005-12#1)(2012-12#1)(2013-1#2)(2013-7#1)
role it##8##2##(1992-6#1)(1993-6#1)(2005-12#1)(2008-5#1)(2012-12#1)(2013-1#2)(2013-7#1)
role limitations due to emotional##3##5##(2007-11#2)(2012-12#1)
role limitations due to physical problems##2##6##(2007-11#2)
role limitations due to##5##4##(2007-11#4)(2012-12#1)
role may be##3##3##(1991-10#1)(1997-6#1)(2008-10#1)
role model for##2##3##(1995-11#1)(2007-7#1)
role model##6##2##(1995-11#1)(2007-7#1)(2008-12#1)(2008-8#1)(2011-2#1)(2012-2#1)
role modeling##3##2##(1994-3#1)(1995-12#1)(2012-12#1)
role modelling##6##2##(1990-5#1)(2008-12#5)
role models had##2##3##(2008-11#1)(2009-7#1)
role models in##2##3##(2009-8#1)(2012-12#1)
role models to##3##3##(1991-2#1)(2008-12#1)(2009-5#1)
role models##17##2##(1991-2#1)(1996-3#1)(1997-2#1)(2007-3#1)(2008-11#1)(2008-12#2)(2008-7#1)(2009-5#2)(2009-7#4)(2009-8#1)(2012-12#1)(2012-3#1)
role not only in the##5##5##(2008-11#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-1#1)
role not only in##6##4##(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-3#1)(2011-1#1)
role of 5-HT in##3##4##(2006-10#1)(2012-12#2)
role of 5-HT##4##3##(2006-10#1)(2008-8#1)(2012-12#2)
role of ATP receptors##2##4##(2008-4#2)
role of ATP##3##3##(1993-3#1)(2008-4#2)
role of B cells in##3##5##(2006-10#1)(2008-3#1)(2009-8#1)
role of B##5##3##(2006-10#1)(2008-3#1)(2009-8#2)(2012-2#1)
role of BRCA1 in##2##4##(2011-1#2)
role of COX##2##3##(2007-4#1)(2010-2#1)
role of COX-2 in##2##4##(2008-11#1)(2013-8#1)
role of CRF##2##3##(1995-12#2)
role of CT##4##3##(1992-9#1)(2007-6#1)(2008-1#1)(2009-9#1)
role of Ca2+ was studied in##2##6##(1990-7#1)(1994-2#1)
role of Ca2+##4##3##(1990-7#1)(1991-4#1)(1994-2#1)(1995-11#1)
role of Cys-138##2##3##(1993-8#2)
role of DA##2##3##(1991-1#1)(2013-1#1)
role of DCs in##3##4##(2005-11#1)(2010-5#2)
role of DNA##5##3##(1994-7#1)(1995-6#1)(1997-4#1)(2007-8#1)(2008-5#1)
role of E##2##3##(1993-9#1)(1995-10#1)
role of EBV in##2##4##(1990-5#1)(1997-7#1)
role of EBV##4##3##(1990-5#1)(1991-9#1)(1993-8#1)(1997-7#1)
role of ECM in##2##4##(2009-10#2)
role of ER##2##3##(1997-4#1)(2013-1#1)
role of EUS in##3##4##(1993-5#1)(2007-5#2)
role of G-proteins##2##3##(1990-11#1)(1991-1#1)
role of GH in##2##4##(1997-8#1)(2006-1#1)
role of GH##4##3##(1997-8#1)(2006-1#1)(2006-9#1)(2012-1#1)
role of H##9##3##(2006-10#5)(2006-2#2)(2008-1#1)(2008-10#1)
role of H2O2 in##2##4##(1990-1#1)(1996-5#1)
role of HDAC##2##3##(2007-11#1)(2008-7#1)
role of HIV##3##3##(1994-11#1)(1996-8#1)(2008-8#1)
role of HLA##2##3##(2007-5#1)(2007-8#1)
role of HPV##4##3##(1997-7#2)(2012-12#1)(2013-1#1)
role of HSP in##2##4##(1994-11#2)
role of Helicobacter##7##3##(1992-5#2)(2006-10#5)
role of IL-12 in the pathogenesis of##2##7##(1996-10#2)
role of IL-12 in the##3##5##(1996-10#3)
role of IL-12 in##6##4##(1996-10#6)
role of IRF-8 in the cross talk between melanoma##2##9##(2013-1#2)
role of LMP2 as##2##4##(2012-2#2)
role of MBL in human##2##5##(2005-11#1)(2012-3#1)
role of MC1R in human##2##5##(2006-12#2)
role of MEL in##2##4##(2007-8#1)(2010-8#1)
role of MEL##3##3##(2007-8#1)(2010-8#2)
role of MT in##2##4##(1997-2#1)(2008-10#1)
role of MTs in the##2##5##(2013-7#2)
role of MTs in##3##4##(2008-11#1)(2013-7#2)
role of Mg2+ in##3##4##(1993-6#1)(1995-1#2)
role of NF-κB in##2##4##(2010-10#1)(2011-2#1)
role of NGF in##2##4##(2010-8#2)
role of NMDA receptors##3##4##(1993-7#1)(1997-2#1)(1997-7#1)
role of NO in##4##4##(1997-6#1)(2007-2#1)(2008-6#1)(2013-1#1)
role of NO##5##3##(1997-6#1)(2007-2#1)(2008-10#1)(2008-6#1)(2013-1#1)
role of P2 receptors##5##4##(2008-3#1)(2008-4#4)
role of P2##6##3##(2008-3#1)(2008-4#4)(2008-5#1)
role of PAF in##2##4##(2007-11#1)(2007-9#1)
role of PAF##3##3##(2007-11#2)(2007-9#1)
role of PAR-2##2##3##(2011-2#2)
role of PGRN##2##3##(2011-1#2)
role of PKC in##2##4##(1994-2#1)(2008-4#1)
role of PKC##6##3##(1994-11#1)(1994-2#2)(1996-7#1)(1996-8#1)(2008-4#1)
role of Quaker##2##3##(2008-9#1)(2012-2#1)
role of RNA##3##3##(1994-8#1)(2010-5#1)(2012-2#1)
role of ROS##3##3##(2006-2#1)(2009-5#1)(2010-4#1)
role of Ras in##2##4##(1994-8#2)
role of S##2##3##(2008-5#1)(2010-8#1)
role of Src in##2##4##(2012-12#2)
role of T cells##2##4##(1995-1#1)(2006-10#1)
role of T##5##3##(1992-2#1)(1995-1#1)(2006-10#1)(2006-5#1)(2008-8#1)
role of TGF##2##3##(1990-3#1)(1996-4#1)
role of TGF-beta in##2##4##(1995-2#1)(2009-4#1)
role of TLR4##3##3##(2008-3#1)(2013-8#2)
role of TNF-alpha in the pathogenesis##2##6##(2008-3#1)(2009-8#1)
role of TSPO##3##3##(2012-2#3)
role of XBP1 in##3##4##(2011-2#3)
role of Zn in##2##4##(2012-2#2)
role of a##33##3##(1990-12#1)(1990-5#1)(1991-7#1)(1991-9#1)(1992-2#1)(1993-11#1)(1993-2#1)(1994-5#2)(1995-12#1)(1995-8#2)(1996-9#1)(1997-4#1)(2005-5#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-6#2)(2009-3#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-8#2)
role of abnormal##2##3##(1996-12#1)(2013-8#1)
role of activated##3##3##(1991-2#1)(2008-10#1)(2012-12#1)
role of activin##2##3##(1990-11#1)(1994-9#1)
role of additional##2##3##(1997-6#1)(2007-11#1)
role of adenosine##3##3##(2005-10#1)(2008-7#1)(2010-5#1)
role of adjuvant therapy##2##4##(1992-8#1)(2012-3#1)
role of adjuvant##7##3##(1992-8#1)(2006-2#1)(2007-11#2)(2007-12#1)(2008-6#1)(2012-3#1)
role of advanced##3##3##(2007-12#1)(2011-2#1)(2013-1#1)
role of affective##3##3##(2008-1#2)(2008-2#1)
role of age##2##3##(2008-4#1)(2012-11#1)
role of age-related##2##3##(2008-7#1)(2012-1#1)
role of aging in##2##4##(2008-7#1)(2013-7#1)
role of air##2##3##(2010-10#1)(2011-2#1)
role of all##2##3##(1996-7#1)(2009-4#1)
role of alpha##3##3##(1994-12#1)(1994-8#1)(1995-11#1)
role of amino acids##2##4##(1993-3#2)
role of amyloid##2##3##(1993-11#1)(2012-2#1)
role of an intermediate##2##4##(2008-10#1)(2008-4#1)
role of an##11##3##(1990-9#1)(1992-3#1)(1994-11#1)(1994-6#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-7#1)(2010-4#1)(2011-2#1)
role of angiogenesis in##2##4##(2007-11#1)(2007-2#1)
role of angiotensin II in##2##5##(2005-6#1)(2013-1#1)
role of angiotensin##4##3##(1993-6#1)(2005-6#1)(2005-8#1)(2013-1#1)
role of anions on##2##4##(2008-5#2)
role of anions##3##3##(2008-5#3)
role of antibiotics##3##3##(2006-10#1)(2008-10#1)(2010-3#1)
role of apical##2##3##(2007-8#1)(2008-10#1)
role of apoptosis in##2##4##(1991-11#1)(2011-2#1)
role of apoptosis##4##3##(1991-11#1)(2006-10#1)(2008-8#1)(2011-2#1)
role of aquaporins##2##3##(2007-12#1)(2009-8#1)
role of aromatase##2##3##(2008-5#1)(2012-2#1)
role of attitudes##2##3##(2009-1#1)(2010-2#1)
role of atypical##3##3##(2008-8#3)
role of behavioral##2##3##(2006-10#1)(2008-12#1)
role of beta-amyloid protein##2##4##(2008-7#2)
role of beta-carotene##3##3##(1990-5#1)(1992-9#1)(1993-12#1)
role of bevacizumab##3##3##(2009-8#1)(2010-12#1)(2010-7#1)
role of biomarkers##2##3##(2008-3#1)(2013-1#1)
role of biopsy##3##3##(2008-5#1)(2013-7#2)
role of bisphosphonates##3##3##(1993-11#1)(2008-7#1)(2010-4#1)
role of bone##3##3##(1997-6#1)(2008-4#1)(2012-11#1)
role of both##7##3##(1991-5#1)(1996-10#1)(1996-4#1)(1997-6#1)(2008-10#1)(2008-12#1)(2011-1#1)
role of brain##3##3##(1995-11#1)(2008-5#1)(2013-1#1)
role of cAMP##3##3##(1992-6#1)(1996-5#1)(2008-7#1)
role of calcitonin##2##3##(1991-8#1)(1991-9#1)
role of calcium as##2##4##(1991-11#1)(1992-9#1)
role of calcium in the##2##5##(1991-11#1)(2009-5#1)
role of calcium in##4##4##(1991-11#1)(1992-1#1)(1993-6#1)(2009-5#1)
role of calcium##13##3##(1991-11#2)(1992-1#1)(1992-9#1)(1993-6#1)(1994-10#1)(1994-2#1)(1995-11#1)(1995-8#1)(2007-7#1)(2008-5#1)(2009-5#1)(2010-5#1)
role of calmodulin##2##3##(1992-7#1)(1994-5#1)
role of cardiac##3##3##(1997-6#1)(2005-10#1)(2013-2#1)
role of catecholamines##2##3##(1996-9#1)(1997-2#1)
role of cell cycle##2##4##(2006-10#1)(2008-11#1)
role of cell##8##3##(2005-10#1)(2006-10#1)(2007-8#2)(2008-11#2)(2008-8#1)(2011-2#1)
role of cellular glutathione peroxidase##2##5##(2007-10#2)
role of cellular##4##3##(1993-6#1)(2006-10#1)(2007-10#2)
role of certain##5##3##(1993-2#1)(1993-4#1)(1996-5#1)(2007-9#1)(2012-1#1)
role of chemokines in##2##4##(2008-5#1)(2008-8#1)
role of chemokines##3##3##(2008-2#1)(2008-5#1)(2008-8#1)
role of chemotherapy in##3##4##(1997-5#1)(2008-6#1)(2010-11#1)
role of chemotherapy##7##3##(1991-4#1)(1997-5#1)(2007-2#1)(2008-6#2)(2010-11#1)(2012-12#1)
role of child##2##3##(2011-12#1)(2012-1#1)
role of childbirth educator##2##4##(2007-2#1)(2008-9#1)
role of cholinergic##2##3##(2008-5#1)(2013-8#1)
role of citrate complexes in preventing urolithiasis##2##7##(1992-9#2)
role of classroom##2##3##(2008-12#2)
role of clinical##4##3##(1996-2#1)(2008-4#1)(2011-2#1)(2013-7#1)
role of collagens##2##3##(1992-9#2)
role of combined##3##3##(2004-11#1)(2008-6#2)
role of common##2##3##(2008-12#1)(2010-12#1)
role of complement in##2##4##(2012-12#2)
role of complement##3##3##(1995-8#1)(2012-12#2)
role of conserved##2##3##(2006-8#1)(2007-12#1)
role of contrast enhanced three-dimensional MR angiography##2##7##(2007-8#2)
role of contrast enhanced##3##4##(2007-8#2)(2010-12#1)
role of corticosteroids##2##3##(2007-7#1)(2009-8#1)
role of cultural norms##2##4##(2007-12#2)
role of cultural##3##3##(2007-12#2)(2009-7#1)
role of cyclic AMP##3##4##(1994-6#2)(1995-10#1)
role of cyclic##6##3##(1991-10#1)(1994-11#1)(1994-6#2)(1995-10#1)(2010-12#1)
role of cysteine##4##3##(1993-6#1)(1994-9#1)(1995-2#1)(2013-1#1)
role of cytokines and##3##4##(2006-10#2)(2007-11#1)
role of cytokines##4##3##(2006-10#2)(2006-11#1)(2007-11#1)
role of daptomycin##2##3##(2008-5#2)
role of depression##3##3##(2005-6#1)(2009-11#1)(2010-4#1)
role of diet##3##3##(1990-8#2)(2008-4#1)
role of dietary protein intake##2##5##(2008-5#2)
role of dietary protein##3##4##(1994-3#1)(2008-5#2)
role of dietary##6##3##(1993-9#1)(1994-3#1)(1996-1#1)(2008-5#2)(2011-2#1)
role of different##11##3##(1997-2#1)(1997-4#1)(1997-8#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-8#2)(2011-2#1)(2012-3#1)
role of dopamine##5##3##(1990-2#2)(1993-5#1)(1997-7#1)(2010-2#1)
role of dopaminergic##2##3##(1996-11#1)(1996-2#1)
role of dynamic##2##3##(2011-2#1)(2012-1#1)
role of each of these##5##5##(1990-11#1)(1990-5#1)(2006-10#1)(2013-1#2)
role of each##9##3##(1990-11#1)(1990-5#1)(1992-4#1)(1995-11#1)(1996-9#1)(2006-10#1)(2010-12#1)(2013-1#2)
role of economic##2##3##(1997-2#1)(2010-4#1)
role of education##2##3##(1990-12#1)(2008-11#1)
role of electrical##3##3##(1990-9#1)(2007-10#1)(2013-1#1)
role of electron##2##3##(1990-8#1)(2007-9#1)
role of elevated##4##3##(1991-12#1)(1992-4#1)(1995-2#1)(2008-1#1)
role of endogenous cytokines in host resistance against an intragastric infection with##2##12##(1996-12#2)
role of endogenous cytokines##3##4##(1996-12#3)
role of endogenous##9##3##(1990-2#1)(1991-11#1)(1995-12#1)(1995-2#1)(1996-12#3)(1996-2#1)(2007-11#1)
role of endoscopic retrograde cholangiopancreatography (ERCP)##2##6##(2007-3#1)(2007-5#1)
role of endoscopic ultrasound in the evaluation of rectal polypoid lesions in 25 dogs##2##14##(2013-1#2)
role of endoscopic ultrasound##4##4##(2007-5#1)(2008-2#1)(2013-1#2)
role of endoscopic##10##3##(2006-10#3)(2007-3#1)(2007-5#2)(2008-2#1)(2009-5#1)(2013-1#2)
role of endoscopy##2##3##(1997-8#1)(2006-10#1)
role of environmental factors##2##4##(2008-12#1)(2009-12#1)
role of environmental##7##3##(1996-6#1)(2005-8#1)(2007-8#1)(2008-1#1)(2008-12#1)(2009-12#1)(2009-8#1)
role of erlotinib##2##3##(2010-12#2)
role of estradiol##2##3##(1996-11#1)(2008-5#1)
role of estrogen in##3##4##(1995-9#1)(2007-10#1)(2010-6#1)
role of estrogen##6##3##(1995-9#1)(1997-8#1)(2007-10#1)(2008-3#2)(2010-6#1)
role of evidence##2##3##(1993-12#1)(2008-11#1)
role of exercise as an##3##5##(1993-11#1)(2008-1#1)(2011-1#1)
role of exercise##8##3##(1993-11#1)(2005-10#1)(2008-1#1)(2011-1#1)(2013-1#4)
role of experience##3##3##(1993-6#1)(2008-1#1)(2009-9#1)
role of external##2##3##(1996-6#1)(2009-9#1)
role of extracellular Ca2+##2##4##(1996-1#2)
role of extracellular nucleotides in##3##5##(2008-3#1)(2008-4#1)(2013-8#1)
role of extracellular##6##3##(1996-1#2)(1997-6#1)(2008-3#1)(2008-4#1)(2013-8#1)
role of families in##2##4##(1991-3#1)(2008-2#1)
role of family##6##3##(1991-6#1)(1993-11#1)(2006-4#2)(2008-1#1)(2010-2#1)
role of fine needle aspiration cytology##3##6##(1990-6#1)(1992-4#1)(2013-8#1)
role of fine needle aspiration##4##5##(1990-6#1)(1992-4#1)(2012-2#1)(2013-8#1)
role of food##3##3##(1994-3#1)(1997-6#1)(2008-5#1)
role of free radicals in##4##5##(1992-12#1)(1993-12#1)(2008-10#1)(2012-1#1)
role of free radicals##5##4##(1992-12#1)(1993-12#1)(2004-11#1)(2008-10#1)(2012-1#1)
role of free##7##3##(1992-12#1)(1993-12#1)(2004-11#1)(2008-10#1)(2008-12#1)(2010-8#1)(2012-1#1)
role of functional##2##3##(2008-1#1)(2009-9#1)
role of gamma delta T cells##2##6##(1990-11#1)(1991-12#1)
role of general##5##3##(1990-12#1)(1993-1#1)(1997-6#1)(2010-1#2)
role of genes##5##3##(2008-1#1)(2008-2#1)(2009-5#1)(2012-3#1)(2013-1#1)
role of genetic and##2##4##(1992-3#1)(2012-2#1)
role of genetic factors in##3##5##(2008-4#1)(2009-4#1)(2013-8#1)
role of genetic factors##5##4##(1997-8#1)(2007-2#1)(2008-4#1)(2009-4#1)(2013-8#1)
role of genetic variation##2##4##(2005-10#1)(2009-12#1)
role of genetic##16##3##(1992-3#1)(1997-8#2)(2005-10#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-12#1)(2009-4#1)(2012-2#1)(2013-8#1)
role of genetics in##3##4##(2005-11#1)(2006-10#1)(2008-7#1)
role of genetics##4##3##(2005-11#1)(2006-10#2)(2008-7#1)
role of glia##2##3##(1994-5#1)(2008-5#1)
role of glucocorticoids##2##3##(1994-11#1)(2008-3#1)
role of glutamate in the##2##5##(1991-3#1)(1996-10#1)
role of glutamate in##4##4##(1991-3#1)(1996-10#1)(2009-4#1)(2012-12#1)
role of glutamate##6##3##(1991-3#2)(1996-10#1)(2008-7#1)(2009-4#1)(2012-12#1)
role of glutathione##3##3##(1992-8#1)(1994-5#1)(2008-5#1)
role of glycosylation in##2##4##(1990-3#1)(1992-12#1)
role of government in##2##4##(1996-12#1)(2012-2#1)
role of government##4##3##(1994-2#1)(1996-12#1)(2007-12#1)(2012-2#1)
role of gravity in##2##4##(1994-2#1)(2008-11#1)
role of health care##4##4##(1992-8#1)(1997-2#1)(2005-7#1)(2010-4#1)
role of health##9##3##(1992-12#1)(1992-8#1)(1993-12#1)(1997-2#1)(2005-7#1)(2008-11#1)(2010-4#1)(2010-7#1)(2012-2#1)
role of heat shock proteins in the##2##7##(1994-11#2)
role of heat shock proteins##3##5##(1993-11#1)(1994-11#2)
role of heat shock##4##4##(1993-11#1)(1994-11#2)(2012-1#1)
role of high##6##3##(1997-5#1)(2007-4#1)(2008-5#1)(2009-3#1)(2009-4#1)(2011-2#1)
role of host##3##3##(2008-10#3)
role of human##5##3##(2009-5#1)(2010-3#1)(2012-1#1)(2012-12#1)(2013-1#1)
role of hydrogen##4##3##(1990-3#1)(1991-1#1)(1992-5#1)(2011-1#1)
role of hyperglycemia##2##3##(1993-2#1)(2006-10#1)
role of imaging in##3##4##(2007-5#1)(2009-4#2)
role of imaging##6##3##(1997-6#1)(2007-5#2)(2008-11#1)(2009-4#2)
role of immune##3##3##(2008-1#1)(2012-3#1)(2013-7#1)
role of in##2##3##(2004-12#1)(2008-8#1)
role of individual##6##3##(1991-1#1)(1991-12#1)(1991-6#1)(1994-6#1)(1997-4#1)(2012-1#1)
role of infections##2##3##(1996-11#1)(2010-5#1)
role of inflammation in##2##4##(2005-10#1)(2007-10#1)
role of information and##2##4##(1993-4#1)(2012-12#1)
role of information##5##3##(1993-4#1)(1997-3#1)(2007-5#1)(2011-1#1)(2012-12#1)
role of inhaled corticosteroids##2##4##(2006-10#1)(2009-1#1)
role of inhibition##3##3##(1993-12#1)(2008-7#1)(2010-7#1)
role of insulin##5##3##(2005-10#1)(2008-3#1)(2010-11#1)(2011-1#1)(2011-12#1)
role of insulin-like##2##3##(2006-11#1)(2008-6#1)
role of interleukin##4##3##(1997-7#1)(2006-10#1)(2007-9#1)(2008-11#1)
role of internal##2##3##(1990-10#1)(2007-8#1)
role of international agencies in##2##5##(2006-10#2)
role of international agencies##4##4##(2006-10#4)
role of intracellular MIF in##2##5##(2009-6#2)
role of intracellular##8##3##(1994-11#1)(1995-8#2)(2008-10#1)(2009-5#1)(2009-6#2)(2012-12#1)
role of intraoperative transesophageal##2##4##(2008-10#2)
role of intraoperative##3##3##(2008-10#2)(2011-1#1)
role of intravenous##2##3##(1993-3#1)(2009-12#1)
role of ionic##4##3##(1990-7#1)(1994-9#1)(2006-5#1)(2010-7#1)
role of iron in##3##4##(1991-10#1)(2012-12#1)(2012-2#1)
role of iron##5##3##(1991-10#1)(1993-11#1)(1996-5#1)(2012-12#1)(2012-2#1)
role of irradiation##2##3##(2008-3#1)(2008-6#1)
role of laparoscopic surgery in the##2##6##(2008-3#1)(2012-1#1)
role of laparoscopic surgery##3##4##(2006-10#1)(2008-3#1)(2012-1#1)
role of laparoscopic##4##3##(2004-2#1)(2006-10#1)(2008-3#1)(2012-1#1)
role of leptin##3##3##(2006-1#1)(2006-10#1)(2006-2#1)
role of linear##2##3##(2012-3#2)
role of lipid rafts in cardiac##2##6##(2010-5#2)
role of lipid rafts in##3##5##(2005-7#1)(2010-5#2)
role of lipid##4##3##(1994-8#1)(2005-7#1)(2010-5#2)
role of lipids in##2##4##(1991-4#1)(1993-1#1)
role of lipids##5##3##(1991-3#1)(1991-4#1)(1993-1#1)(1995-8#1)(2008-3#1)
role of low##3##3##(2008-7#3)
role of lymphocytes in the##2##5##(1991-9#1)(2006-10#1)
role of magnesium##2##3##(1991-2#1)(2006-10#1)
role of magnetic resonance imaging and##2##6##(2012-2#1)(2013-1#1)
role of magnetic resonance imaging##5##5##(2006-7#1)(2008-4#1)(2008-8#1)(2012-2#1)(2013-1#1)
role of magnetic resonance##7##4##(1994-8#1)(2006-7#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
role of male##2##3##(2007-3#1)(2009-6#1)
role of managed care##2##4##(1995-12#1)(2008-6#1)
role of maternal##4##3##(2008-4#1)(2008-9#1)(2010-7#1)(2011-2#1)
role of mechanical stress on the formation##2##7##(2011-1#2)
role of mechanical##7##3##(2007-10#1)(2008-11#1)(2009-8#1)(2011-1#2)(2012-2#1)(2012-3#1)
role of mediastinoscopy in##2##4##(2007-6#2)
role of medical##6##3##(1993-10#1)(2006-6#1)(2008-12#1)(2008-7#1)(2008-8#1)(2013-8#1)
role of membrane##2##3##(1995-2#1)(2008-8#1)
role of menin in##4##4##(2010-2#4)
role of menin##5##3##(2010-2#5)
role of metabolic and##2##4##(2009-10#1)(2011-2#1)
role of metabolic##3##3##(2009-10#1)(2011-2#1)(2012-2#1)
role of metabotropic glutamate##2##4##(1995-11#1)(1995-12#1)
role of microRNAs##2##3##(2007-10#1)(2011-2#1)
role of mitochondria in##3##4##(1994-12#1)(2008-1#1)(2010-12#1)
role of mitochondria##5##3##(1994-12#1)(2008-1#2)(2010-12#1)(2013-8#1)
role of mitochondrial##2##3##(2005-8#1)(2011-12#1)
role of modeling in##2##4##(2006-5#1)(2008-2#1)
role of modeling##3##3##(2006-5#1)(2008-2#1)(2010-9#1)
role of molecular##5##3##(2008-1#1)(2008-4#1)(2008-7#1)(2010-1#1)(2011-2#1)
role of mtDNA##2##3##(1991-10#1)(2009-11#1)
role of murine##2##3##(1993-6#1)(2010-6#1)
role of muscarinic##3##3##(1993-2#1)(1994-2#1)(1995-12#1)
role of muscle##2##3##(1996-3#1)(2012-3#1)
role of natural##5##3##(2008-11#2)(2009-1#1)(2010-4#1)(2010-5#1)
role of negative##2##3##(2006-2#1)(2007-4#1)
role of neuroimaging in translational##2##5##(2010-9#2)
role of neuropeptides##2##3##(1994-10#1)(2010-5#1)
role of neurotrophins in the##2##5##(1994-8#1)(1996-3#1)
role of neurotrophins in##4##4##(1994-8#1)(1996-3#2)(2008-7#1)
role of neutrophils in##2##4##(2012-3#2)
role of neutrophils##3##3##(2010-9#1)(2012-3#2)
role of new##5##3##(2006-10#1)(2008-6#1)(2009-5#1)(2011-3#1)(2013-1#1)
role of nicotinic mechanisms in REM sleep generation##2##8##(1990-7#2)
role of nicotinic##3##3##(1990-7#2)(1995-5#1)
role of nitric oxide (NO) in##4##6##(1992-8#1)(2005-7#1)(2008-10#1)(2008-8#1)
role of nitric oxide##8##4##(1991-3#1)(1992-8#1)(1995-5#1)(2004-12#1)(2005-7#1)(2008-10#1)(2008-8#1)(2013-1#1)
role of norepinephrine##2##3##(1990-5#1)(2005-10#1)
role of nucleotides in##2##4##(2008-4#2)
role of nurses##4##3##(1992-12#1)(2007-3#1)(2013-1#2)
role of nursing##3##3##(2008-1#2)(2012-3#1)
role of nutrition in##2##4##(2005-10#1)(2008-12#1)
role of nutrition##3##3##(2005-10#2)(2008-12#1)
role of nutritional##2##3##(2004-11#1)(2006-10#1)
role of omega-3 polyunsaturated fatty acids in clinical medicine##2##9##(2006-7#2)
role of omega-3 polyunsaturated fatty acids in##3##7##(2006-7#3)
role of omega-3##4##3##(2006-7#3)(2007-11#1)
role of oncogenes in drug resistance##3##6##(2008-11#3)
role of oospores in##2##4##(2008-10#2)
role of other##9##3##(1995-12#1)(1996-8#1)(2004-12#1)(2006-9#1)(2008-1#1)(2008-3#1)(2008-6#1)(2009-3#1)(2013-7#1)
role of oxidative stress in the##2##6##(1990-4#1)(2010-12#1)
role of oxidative stress in##9##5##(1990-4#1)(1996-3#1)(1996-5#1)(2008-1#1)(2008-11#1)(2009-6#1)(2010-12#2)(2010-4#1)
role of oxidative stress##10##4##(1990-4#1)(1996-3#1)(1996-5#1)(2008-1#1)(2008-11#1)(2009-5#1)(2009-6#1)(2010-12#2)(2010-4#1)
role of oxidative##11##3##(1990-4#1)(1996-3#1)(1996-5#1)(2008-1#1)(2008-11#1)(2009-5#1)(2009-6#1)(2010-12#2)(2010-3#1)(2010-4#1)
role of oxidized##2##3##(1992-9#1)(1995-6#1)
role of oxygen therapy in##2##5##(2008-8#2)
role of oxygen##8##3##(1991-9#1)(1992-12#1)(1994-10#1)(1994-2#1)(1994-3#1)(2008-10#1)(2008-8#2)
role of p53 in##3##4##(1995-8#1)(2008-9#1)(2011-2#1)
role of p53##6##3##(1991-10#1)(1995-8#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)
role of pancreatic##3##3##(2005-10#1)(2010-10#1)(2013-7#1)
role of parenteral##2##3##(1993-5#1)(2005-10#1)
role of patient##3##3##(2006-1#1)(2008-2#1)(2010-8#1)
role of peer##2##3##(1990-8#1)(2006-6#1)
role of peptide##2##3##(1990-6#1)(1997-6#1)
role of phenolics##2##3##(2008-10#2)
role of phospholipase##2##3##(1994-12#1)(1996-5#1)
role of phosphorylation##6##3##(1990-4#1)(1990-6#1)(1994-11#1)(1995-10#1)(1996-4#1)(1997-2#1)
role of physical therapy##2##4##(2008-7#1)(2010-3#1)
role of platelet##3##3##(2007-10#1)(2007-11#1)(2009-1#1)
role of platelets in##3##4##(2006-6#1)(2007-11#1)(2008-1#1)
role of play##3##3##(2005-7#1)(2008-12#1)(2008-9#1)
role of positive##2##3##(2010-10#1)(2011-2#1)
role of potassium channels##2##4##(1997-4#1)(2007-10#1)
role of preoperative##5##3##(2006-10#2)(2007-2#1)(2008-3#1)(2008-7#1)
role of primary care##2##4##(2006-8#1)(2007-5#1)
role of primary##6##3##(1993-6#1)(1997-4#1)(2005-9#1)(2006-8#1)(2007-3#1)(2007-5#1)
role of professionals##2##3##(1993-2#1)(2008-2#1)
role of proinflammatory cytokines in##2##5##(2010-4#1)(2013-7#1)
role of prostaglandin E2##2##4##(1996-2#1)(1997-2#1)
role of prostaglandin##3##3##(1991-4#1)(1996-2#1)(1997-2#1)
role of prostaglandins##2##3##(1991-1#1)(2006-10#1)
role of protein kinase C (PKC)##2##6##(1991-9#1)(2013-8#1)
role of protein kinase C and##2##6##(1994-5#1)(1994-9#1)
role of protein kinase C in##3##6##(1990-4#1)(1992-8#1)(1996-9#1)
role of protein kinase C##7##5##(1990-4#1)(1991-9#1)(1992-8#1)(1994-5#1)(1994-9#1)(1996-9#1)(2013-8#1)
role of protein##15##3##(1990-4#1)(1991-7#1)(1991-9#1)(1992-8#1)(1994-5#1)(1994-9#1)(1995-10#1)(1996-9#1)(1997-5#1)(2008-11#1)(2008-6#1)(2010-12#1)(2013-8#3)
role of proteinases##2##3##(2012-12#1)(2013-1#1)
role of public health##3##4##(1996-2#1)(1997-3#2)
role of public relations for image creating in health services##2##10##(2008-12#2)
role of public relations##3##4##(2008-12#3)
role of public##6##3##(1996-2#1)(1997-3#2)(2008-12#3)
role of purinergic signaling##2##4##(2013-8#2)
role of quinolones in##2##4##(2006-10#2)
role of radiation therapy##3##4##(1992-4#1)(1994-6#1)(1997-5#1)
role of radiation##4##3##(1992-4#1)(1994-6#1)(1997-5#1)(2010-5#1)
role of radical surgery##2##4##(2008-6#1)(2013-7#1)
role of radiofrequency ablation##3##4##(2006-9#2)(2011-2#1)
role of radiotherapy for##2##4##(2007-11#1)(2012-2#1)
role of radiotherapy in the treatment of##2##7##(1994-8#1)(2012-2#1)
role of radiotherapy in the##4##5##(1994-8#1)(1995-9#1)(2007-10#1)(2012-2#1)
role of radiotherapy in##6##4##(1994-8#1)(1995-9#1)(2006-6#1)(2007-10#1)(2010-3#1)(2012-2#1)
role of radiotherapy##13##3##(1993-9#1)(1994-4#1)(1994-8#1)(1995-9#1)(2006-6#1)(2007-10#1)(2007-11#1)(2009-1#1)(2010-3#1)(2012-2#3)(2013-1#1)
role of reactive oxygen species in the##2##7##(1994-3#1)(2008-5#1)
role of reactive oxygen species in##4##6##(1992-6#2)(1994-3#1)(2008-5#1)
role of reactive oxygen species##5##5##(1992-6#2)(1994-3#1)(2008-5#1)(2008-8#1)
role of reactive oxygen##6##4##(1992-6#2)(1993-7#1)(1994-3#1)(2008-5#1)(2008-8#1)
role of reactive##7##3##(1992-6#2)(1992-7#1)(1993-7#1)(1994-3#1)(2008-5#1)(2008-8#1)
role of recombinant##2##3##(2005-10#1)(2008-11#1)
role of redox##2##3##(2009-10#1)(2012-12#1)
role of reduced##2##3##(1990-12#1)(1993-9#1)
role of regulatory T cells in##3##6##(2006-10#1)(2008-4#1)(2011-2#1)
role of regulatory T##4##4##(2006-10#1)(2007-5#1)(2008-4#1)(2011-2#1)
role of rehabilitation##2##3##(2009-12#1)(2011-2#1)
role of renal##2##3##(2005-10#1)(2008-10#1)
role of risk management##2##4##(1993-2#1)(1994-2#1)
role of risk##3##3##(1993-2#1)(1994-2#1)(1995-3#1)
role of science##2##3##(1991-6#1)(2008-5#1)
role of scientific##2##3##(1992-12#1)(2013-7#1)
role of second##2##3##(1996-5#1)(2008-10#1)
role of selenium##2##3##(1996-11#1)(2008-7#1)
role of senior##2##3##(1993-12#1)(1994-2#1)
role of serine##4##3##(1993-3#1)(1994-11#1)(1994-5#1)(1995-8#1)
role of serotonin (5-HT) in##2##5##(1993-3#1)(2008-6#1)
role of serotonin##5##3##(1993-3#1)(1994-11#1)(2008-6#1)(2008-8#1)(2010-5#1)
role of serum##3##3##(2011-2#1)(2012-12#1)(2012-2#1)
role of social workers##2##4##(2010-2#2)
role of social##10##3##(1991-1#1)(1994-3#1)(2006-3#1)(2007-7#1)(2008-2#1)(2010-2#2)(2011-2#1)(2012-12#2)
role of soluble##2##3##(1996-11#1)(2011-12#1)
role of solvent##2##3##(2008-10#1)(2009-9#1)
role of some##8##3##(1994-12#1)(1994-9#1)(2006-10#1)(2007-1#1)(2008-10#1)(2009-10#1)(2009-11#1)(2009-8#1)
role of spatial##2##3##(2008-11#1)(2010-12#1)
role of specific##11##3##(1993-11#1)(1994-9#1)(1996-5#1)(2006-10#2)(2007-12#1)(2008-7#1)(2009-12#1)(2009-2#1)(2011-2#1)(2012-1#1)
role of spirituality in##2##4##(2008-12#2)
role of spirituality##3##3##(2008-12#2)(2012-12#1)
role of standby emergency medication for falciparum malaria##2##8##(2007-2#2)
role of standby emergency##3##4##(2007-2#3)
role of state##2##3##(1997-8#1)(2012-2#1)
role of stem##4##3##(2008-5#1)(2010-12#1)(2012-2#1)(2013-7#1)
role of stochastic##2##3##(1991-6#1)(2008-8#1)
role of stress proteins in##2##5##(1992-5#1)(2008-7#1)
role of stress##3##3##(1992-5#1)(2008-7#1)(2013-8#1)
role of structural protein Gag and related gene (protein) in late stages of the HIV-1 replication cycle and##2##18##(2011-3#2)
role of structural##5##3##(1992-9#1)(2005-8#1)(2008-7#1)(2011-3#2)
role of such##3##3##(1992-8#1)(1997-6#1)(2007-11#1)
role of sulfhydryl groups in##2##5##(1991-5#1)(1993-6#1)
role of supplemental oxygen##2##4##(2010-2#2)
role of surface##2##3##(1992-6#1)(2008-2#1)
role of surgery in the treatment of##2##7##(2005-12#2)
role of surgery in the##3##5##(2005-12#2)(2007-8#1)
role of surgery in##5##4##(2005-12#2)(2007-8#2)(2008-6#1)
role of surgery##6##3##(2005-12#2)(2007-11#1)(2007-8#2)(2008-6#1)
role of targeted therapy in##2##5##(2009-8#1)(2011-3#1)
role of targeted##3##3##(2009-8#1)(2011-3#1)(2012-2#1)
role of telomeres##3##3##(2008-8#1)(2010-2#1)(2011-2#1)
role of the &quot##2##4##(2007-4#1)(2009-4#1)
role of the BBB##2##4##(2007-11#1)(2008-8#1)
role of the DNA##2##4##(1992-7#1)(2012-3#1)
role of the N-methyl-D-aspartate##2##4##(1991-6#1)(1995-12#1)
role of the adventitia in##2##5##(1997-8#2)
role of the amygdala in##2##5##(1993-12#1)(2008-11#1)
role of the amygdala##3##4##(1993-12#1)(1994-8#1)(2008-11#1)
role of the autonomic nervous system in##2##7##(1996-12#2)
role of the brain##4##4##(1991-5#1)(1996-10#1)(2004-11#1)(2007-9#1)
role of the cell##2##4##(2008-11#1)(2008-2#1)
role of the cellular##4##4##(1990-4#1)(1994-8#1)(1995-11#1)(2008-11#1)
role of the central nervous system in##2##7##(2005-10#1)(2006-10#1)
role of the central##3##4##(1993-3#1)(2005-10#1)(2006-10#1)
role of the community##3##4##(1996-2#1)(2009-5#1)(2013-1#1)
role of the disulfide##2##4##(1991-1#1)(1995-6#1)
role of the emergency##2##4##(2007-5#1)(2009-7#1)
role of the endogenous##2##4##(1995-12#1)(2013-8#1)
role of the environment##2##4##(2008-11#1)(2012-2#1)
role of the enzyme##2##4##(1991-2#1)(2010-12#1)
role of the epidemiologist##2##4##(1994-3#2)
role of the extracellular##2##4##(1991-3#1)(2008-10#1)
role of the family##3##4##(1991-2#2)(2008-9#1)
role of the fungi##2##4##(2007-3#1)(2008-10#1)
role of the gamma##2##4##(1992-11#1)(2008-1#1)
role of the gene##3##4##(1997-1#1)(1997-4#1)(1997-7#1)
role of the hippocampus##3##4##(1994-2#1)(2009-2#2)
role of the immune system in##3##6##(2010-12#1)(2011-2#1)(2012-3#1)
role of the intestine in the##2##6##(2008-3#2)
role of the lateral##2##4##(1993-6#1)(1994-2#1)
role of the lecturer practitioner##2##5##(2008-12#2)
role of the lecturer##3##4##(2008-11#1)(2008-12#2)
role of the left##2##4##(1993-9#1)(2008-1#1)
role of the low##3##4##(1992-12#1)(2007-8#1)(2008-2#1)
role of the medical##7##4##(1990-12#1)(1994-2#2)(1995-11#1)(2007-2#1)(2013-1#2)
role of the mitochondria in##3##5##(2006-9#1)(2008-10#1)(2009-11#1)
role of the mitochondria##4##4##(2006-9#1)(2008-10#1)(2009-11#2)
role of the noradrenergic##2##4##(1995-12#1)(2011-1#1)
role of the nurse in##4##5##(1991-11#1)(2005-11#1)(2011-1#1)(2011-2#1)
role of the nurse##8##4##(1991-11#1)(2005-11#1)(2008-11#2)(2008-6#1)(2011-1#2)(2011-2#1)
role of the oxidative stress##2##5##(2009-4#2)
role of the p53##2##4##(2007-11#1)(2008-5#1)
role of the patient##2##4##(2009-2#1)(2009-6#1)
role of the peptide in the##2##6##(1992-6#2)
role of the peptide##3##4##(1992-6#2)(1997-7#1)
role of the periaqueductal grey##2##5##(1994-6#2)
role of the physician in##2##5##(1995-2#1)(1996-1#1)
role of the physician##4##4##(1995-2#1)(1996-1#1)(1996-2#1)(2012-12#1)
role of the pineal##2##4##(1994-5#1)(1995-1#1)
role of the posterior##2##4##(1992-9#1)(2007-7#1)
role of the small##2##4##(1994-11#1)(1994-8#1)
role of the substrate##3##4##(2008-10#1)(2008-2#1)(2008-7#1)
role of the therapist is##2##5##(2009-6#2)
role of the two##2##4##(1992-6#1)(1994-9#1)
role of the vgf gene and##2##6##(2008-10#2)
role of the virus##2##4##(2006-2#1)(2008-1#1)
role of the visual input in the##2##7##(1991-2#2)
role of the zinc hydroxide (water)-Thr199-Glu106 hydrogen bond network##2##9##(1990-8#2)
role of the##548##3##(1990-12#5)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#5)(1991-1#2)(1991-10#1)(1991-11#4)(1991-2#7)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#3)(1991-8#2)(1991-9#2)(1992-1#2)(1992-11#2)(1992-12#2)(1992-2#5)(1992-3#5)(1992-6#6)(1992-7#3)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#5)(1993-2#3)(1993-3#4)(1993-6#5)(1993-8#2)(1993-9#1)(1994-10#2)(1994-11#4)(1994-12#2)(1994-2#9)(1994-3#9)(1994-5#4)(1994-6#6)(1994-7#1)(1994-8#11)(1994-9#4)(1995-1#5)(1995-11#3)(1995-12#11)(1995-2#6)(1995-3#4)(1995-5#1)(1995-6#4)(1995-7#1)(1995-8#2)(1996-1#3)(1996-10#1)(1996-12#5)(1996-2#4)(1996-3#1)(1996-5#3)(1996-8#3)(1997-1#3)(1997-2#2)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#3)(2004-11#1)(2004-2#1)(2005-1#2)(2005-10#2)(2005-11#4)(2005-12#1)(2005-7#2)(2005-8#3)(2006-1#3)(2006-10#8)(2006-11#1)(2006-12#1)(2006-2#3)(2006-3#2)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#8)(2007-12#16)(2007-2#2)(2007-3#1)(2007-4#5)(2007-5#1)(2007-7#4)(2007-8#5)(2007-9#7)(2008-1#8)(2008-10#24)(2008-11#18)(2008-12#4)(2008-2#6)(2008-3#5)(2008-4#7)(2008-5#8)(2008-6#5)(2008-7#10)(2008-8#11)(2008-9#4)(2009-10#4)(2009-11#2)(2009-2#4)(2009-3#1)(2009-4#7)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#7)(2010-3#1)(2010-4#2)(2010-5#3)(2010-7#2)(2010-9#1)(2011-1#15)(2011-2#16)(2011-3#2)(2012-1#3)(2012-12#8)(2012-2#12)(2012-3#6)(2012-6#1)(2013-1#5)(2013-7#5)(2013-8#5)
role of these antibodies##2##4##(1990-6#1)(2008-1#1)
role of these cells in the##3##6##(1995-2#1)(2009-5#1)(2012-12#1)
role of these cells##4##4##(1991-8#1)(1995-2#1)(2009-5#1)(2012-12#1)
role of these compounds in##2##5##(2008-10#1)(2011-2#1)
role of these cytokines in##2##5##(1994-6#1)(2008-3#1)
role of these drugs##2##4##(1990-5#1)(2007-11#1)
role of these enzymes in##3##5##(1995-3#1)(2008-8#1)(2010-2#1)
role of these enzymes##4##4##(1995-3#1)(2008-11#1)(2008-8#1)(2010-2#1)
role of these factors##3##4##(2006-8#1)(2008-2#1)(2013-8#1)
role of these genes##2##4##(2006-10#1)(2013-8#1)
role of these molecules##3##4##(1991-2#1)(2007-10#1)(2008-4#1)
role of these proteins in##5##5##(1993-6#1)(1995-2#2)(2007-7#1)(2013-1#1)
role of these proteins##7##4##(1993-6#1)(1995-2#2)(2007-7#1)(2009-5#1)(2009-8#1)(2013-1#1)
role of these techniques in the##2##6##(2005-8#1)(2012-2#1)
role of these two##2##4##(1996-5#1)(2011-2#1)
role of these##83##3##(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#4)(1995-3#1)(1995-6#1)(1996-5#1)(2004-11#1)(2005-8#1)(2006-10#2)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-7#2)(2008-1#3)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#2)(2010-11#1)(2010-2#2)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
role of thiamine##2##3##(2008-1#1)(2012-4#1)
role of thiol-containing agents##2##4##(1991-9#2)
role of this conserved residue##2##5##(1994-9#1)(1995-2#1)
role of this enzyme in##2##5##(1994-8#1)(2009-8#1)
role of this factor##3##4##(1990-2#1)(1992-12#1)(2009-3#1)
role of this group##2##4##(1990-3#1)(1994-10#1)
role of this phenomenon##2##4##(2008-12#1)(2013-1#1)
role of this protein##3##4##(1992-7#1)(1997-2#1)(2013-1#1)
role of this##57##3##(1990-11#2)(1990-2#2)(1990-3#1)(1991-12#1)(1991-6#3)(1992-11#1)(1992-12#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-2#3)(1996-2#1)(1997-2#1)(1997-7#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-1#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-2#2)(2013-1#3)
role of thyroid##2##3##(1993-12#1)(2007-1#1)
role of topoisomerase II in##2##5##(1994-12#1)(1996-7#1)
role of topoisomerase##3##3##(1994-12#1)(1996-7#1)(2008-11#1)
role of traditional##2##3##(2009-6#1)(2013-1#1)
role of transcription##2##3##(1996-2#1)(2008-4#1)
role of translational##2##3##(1990-3#1)(2009-3#1)
role of tumor necrosis factor##2##5##(1994-9#1)(2006-10#1)
role of tumor suppressor##2##4##(1990-12#1)(1995-6#1)
role of tumor##7##3##(1990-10#2)(1990-12#1)(1994-9#1)(1995-6#1)(2006-10#1)(2009-12#1)
role of two of##2##4##(2008-10#1)(2008-3#1)
role of two##5##3##(1996-5#1)(1997-2#1)(2008-10#1)(2008-3#1)(2011-2#1)
role of type##2##3##(1993-6#1)(1994-11#1)
role of tyrosine phosphorylation in##4##5##(1990-3#1)(1994-6#1)(1995-5#1)(2008-4#1)
role of ubiquitin##2##3##(1994-9#1)(2012-11#1)
role of ultrasonography##4##3##(1991-6#1)(2007-3#2)(2010-12#1)
role of ultrasound in##2##4##(2008-1#1)(2008-10#1)
role of ultrasound##4##3##(2008-1#1)(2008-10#1)(2012-2#1)(2013-1#1)
role of various##8##3##(1996-3#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-5#1)(2008-10#2)(2011-1#1)
role of vascular##5##3##(1990-12#1)(1995-1#1)(2008-7#1)(2010-12#1)(2012-12#1)
role of vertebroplasty in metastatic spinal disease##2##7##(2006-2#2)
role of violent media##3##4##(2009-7#3)
role of viral##4##3##(1994-1#1)(2005-8#1)(2008-11#1)(2008-12#1)
role of vitamin B12##2##4##(2010-1#1)(2010-12#1)
role of vitamin D in##3##5##(2010-7#1)(2012-12#2)
role of vitamin D##8##4##(2010-12#1)(2010-7#2)(2012-12#2)(2012-2#2)(2013-1#1)
role of vitamin##13##3##(1992-9#1)(2008-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-7#2)(2012-12#2)(2012-2#2)(2013-1#1)
role of vitamins##2##3##(2008-11#1)(2008-6#1)
role of water##4##3##(1992-12#1)(1993-4#1)(2006-8#1)(2011-1#1)
role of wild##3##3##(1995-9#1)(2007-6#1)(2013-1#1)
role of women in##2##4##(1992-12#1)(1996-9#1)
role of women##4##3##(1991-6#1)(1992-12#1)(1993-6#1)(1996-9#1)
role of working##3##3##(1996-8#1)(2007-9#1)(2012-1#1)
role of x-rays in the treatment of gas gangrene##2##9##(2013-1#2)
role of##3634##2##(1990-1#3)(1990-10#6)(1990-11#11)(1990-12#17)(1990-2#12)(1990-3#9)(1990-4#9)(1990-5#10)(1990-6#7)(1990-7#7)(1990-8#15)(1990-9#5)(1991-1#14)(1991-10#7)(1991-11#10)(1991-12#10)(1991-2#15)(1991-3#13)(1991-4#8)(1991-5#9)(1991-6#14)(1991-7#9)(1991-8#8)(1991-9#16)(1992-1#10)(1992-11#7)(1992-12#17)(1992-2#14)(1992-3#19)(1992-4#8)(1992-5#9)(1992-6#14)(1992-7#12)(1992-8#13)(1992-9#19)(1993-1#4)(1993-10#4)(1993-11#32)(1993-12#20)(1993-2#14)(1993-3#22)(1993-4#7)(1993-5#8)(1993-6#25)(1993-7#3)(1993-8#6)(1993-9#8)(1994-1#1)(1994-10#9)(1994-11#26)(1994-12#17)(1994-2#25)(1994-3#19)(1994-4#2)(1994-5#20)(1994-6#24)(1994-7#3)(1994-8#29)(1994-9#26)(1995-1#17)(1995-10#5)(1995-11#14)(1995-12#38)(1995-2#30)(1995-3#13)(1995-4#2)(1995-5#8)(1995-6#14)(1995-7#1)(1995-8#19)(1995-9#6)(1996-1#9)(1996-10#17)(1996-11#10)(1996-12#15)(1996-2#16)(1996-3#12)(1996-4#10)(1996-5#25)(1996-6#6)(1996-7#8)(1996-8#13)(1996-9#12)(1997-1#6)(1997-2#20)(1997-3#7)(1997-4#17)(1997-5#6)(1997-6#17)(1997-7#16)(1997-8#19)(2003-11#1)(2004-1#1)(2004-10#1)(2004-11#9)(2004-12#5)(2004-2#2)(2004-3#1)(2004-9#1)(2005-1#2)(2005-10#26)(2005-11#15)(2005-12#4)(2005-3#1)(2005-5#4)(2005-6#2)(2005-7#11)(2005-8#15)(2005-9#4)(2006-1#9)(2006-10#118)(2006-11#9)(2006-12#13)(2006-2#22)(2006-3#6)(2006-4#4)(2006-5#9)(2006-6#13)(2006-7#16)(2006-8#16)(2006-9#10)(2007-1#11)(2007-10#22)(2007-11#65)(2007-12#56)(2007-2#20)(2007-3#13)(2007-4#23)(2007-5#17)(2007-6#6)(2007-7#27)(2007-8#37)(2007-9#22)(2008-1#81)(2008-10#130)(2008-11#90)(2008-12#39)(2008-2#33)(2008-3#48)(2008-4#59)(2008-5#58)(2008-6#32)(2008-7#73)(2008-8#66)(2008-9#22)(2009-1#8)(2009-10#22)(2009-11#11)(2009-12#13)(2009-2#13)(2009-3#16)(2009-4#30)(2009-5#25)(2009-6#19)(2009-7#18)(2009-8#38)(2009-9#16)(2010-1#8)(2010-10#10)(2010-11#14)(2010-12#47)(2010-2#22)(2010-3#15)(2010-4#18)(2010-5#19)(2010-6#4)(2010-7#18)(2010-8#19)(2010-9#12)(2011-1#65)(2011-10#1)(2011-12#14)(2011-2#109)(2011-3#8)(2011-7#1)(2011-9#2)(2012-1#30)(2012-11#7)(2012-12#69)(2012-2#89)(2012-3#43)(2012-4#1)(2012-6#2)(2013-1#105)(2013-2#1)(2013-7#24)(2013-8#60)
role on the outcome of the oncolytic efficacy of conditionally replicative adenoviruses##2##12##(2009-4#2)
role on the##9##3##(1997-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-3#1)(2009-4#2)(2013-1#1)
role on##19##2##(1992-3#1)(1993-12#1)(1995-2#1)(1996-12#1)(1997-8#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-4#2)(2009-6#1)(2013-1#2)
role or##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
role over time##2##3##(1996-12#1)(2008-1#1)
role over##3##2##(1996-12#1)(2008-1#1)(2008-7#1)
role played by Social##2##4##(2008-6#1)(2008-9#1)
role played by serine proteases in the development and worsening of vascular complications in##2##14##(2008-1#2)
role played by the##15##4##(1996-4#1)(1997-1#1)(2005-11#1)(2006-10#2)(2006-2#1)(2007-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2012-2#1)
role played by##57##3##(1990-11#1)(1990-9#1)(1992-12#1)(1992-2#1)(1993-12#2)(1994-12#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-5#1)(2005-11#2)(2006-10#8)(2006-2#1)(2007-1#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-7#1)(2010-10#2)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
role played##61##2##(1990-11#1)(1990-9#1)(1992-12#1)(1992-2#1)(1993-12#2)(1994-12#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-5#1)(2005-11#2)(2005-9#1)(2006-10#8)(2006-2#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-7#1)(2010-10#2)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
role plays##9##2##(1990-1#1)(2009-11#7)(2009-12#1)
role preferences##4##2##(2008-7#4)
role remains to be##2##4##(1991-1#1)(2012-2#1)
role remains##4##2##(1991-1#1)(1997-4#1)(2009-10#1)(2012-2#1)
role should##2##2##(2007-3#1)(2008-1#1)
role statement##2##2##(1992-2#2)
role statements and##2##3##(1992-12#1)(1992-2#1)
role statements##3##2##(1992-12#1)(1992-2#2)
role than the##3##3##(1991-11#1)(2008-10#1)(2011-1#1)
role than##9##2##(1991-11#1)(1992-3#1)(1995-6#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-1#1)
role that a##2##3##(2009-2#1)(2013-7#1)
role that family physicians##2##4##(2007-6#1)(2008-2#1)
role that the##5##3##(1996-9#1)(2004-9#1)(2006-10#1)(2007-11#1)(2008-12#1)
role that##52##2##(1993-1#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-12#2)(1995-8#1)(1996-3#1)(1996-9#1)(1997-2#1)(2004-9#1)(2005-11#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-7#2)(2009-2#2)(2009-4#1)(2010-12#2)(2010-3#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
role the type of vascular access plays in the transmission of##2##11##(2007-7#2)
role the##4##2##(1992-7#1)(2007-7#2)(2009-8#1)
role these cells##2##3##(1990-5#1)(1997-8#1)
role these##3##2##(1990-5#1)(1997-8#1)(2007-11#1)
role they play in##4##4##(1990-12#1)(1995-2#1)(2005-11#1)(2012-12#1)
role they play##5##3##(1990-12#1)(1995-2#1)(2005-11#1)(2006-10#1)(2012-12#1)
role they##7##2##(1990-12#1)(1995-2#1)(2005-11#1)(2006-10#1)(2008-12#1)(2010-1#1)(2012-12#1)
role this##3##2##(1992-6#1)(2008-11#1)(2008-9#1)
role through##3##2##(1994-8#1)(2008-9#1)(2010-11#1)
role to include##2##3##(1990-12#1)(1997-1#1)
role to play in helping##2##5##(2008-2#1)(2010-10#1)
role to play in the##8##5##(1992-3#1)(2007-6#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-12#1)(2013-7#1)
role to play in##17##4##(1992-3#1)(1997-2#1)(2006-5#1)(2007-6#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-10#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
role to play##22##3##(1992-3#1)(1993-12#1)(1997-2#1)(2006-5#1)(2007-6#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
role to##52##2##(1990-12#1)(1990-5#1)(1992-3#1)(1993-12#1)(1994-8#1)(1995-12#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-10#1)(2006-5#1)(2006-6#2)(2007-10#1)(2007-6#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)
role transition##3##2##(1995-1#1)(2008-11#2)
role was##7##2##(1991-2#1)(2008-1#1)(2008-11#3)(2008-7#1)(2010-11#1)
role we##2##2##(2010-11#1)(2011-12#1)
role when##4##2##(1991-1#1)(2008-2#1)(2008-3#1)(2008-8#1)
role which##4##2##(1991-1#1)(1991-5#1)(1992-6#1)(2007-11#1)
role while the##2##3##(1993-12#1)(2007-3#1)
role while##3##2##(1993-12#1)(2007-3#1)(2008-11#1)
role will##2##2##(1991-3#1)(2005-8#1)
role within health##2##3##(1995-12#1)(1996-12#1)
role within the##5##3##(1996-11#1)(1997-7#1)(2008-11#1)(2010-6#1)(2011-2#1)
role within##9##2##(1995-12#1)(1996-11#1)(1996-12#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2010-6#1)(2011-2#1)
role##8391##1##(1990-1#5)(1990-10#18)(1990-11#34)(1990-12#35)(1990-2#29)(1990-3#15)(1990-4#14)(1990-5#31)(1990-6#11)(1990-7#16)(1990-8#36)(1990-9#17)(1991-1#31)(1991-10#22)(1991-11#16)(1991-12#31)(1991-2#35)(1991-3#27)(1991-4#20)(1991-5#34)(1991-6#21)(1991-7#23)(1991-8#17)(1991-9#36)(1992-1#21)(1992-10#8)(1992-11#22)(1992-12#41)(1992-2#29)(1992-3#41)(1992-4#18)(1992-5#23)(1992-6#39)(1992-7#30)(1992-8#30)(1992-9#38)(1993-1#12)(1993-10#10)(1993-11#53)(1993-12#55)(1993-2#30)(1993-3#50)(1993-4#15)(1993-5#14)(1993-6#42)(1993-7#16)(1993-8#13)(1993-9#27)(1994-1#5)(1994-10#20)(1994-11#60)(1994-12#62)(1994-2#54)(1994-3#43)(1994-4#6)(1994-5#31)(1994-6#44)(1994-7#3)(1994-8#59)(1994-9#51)(1995-1#43)(1995-10#13)(1995-11#30)(1995-12#92)(1995-2#70)(1995-3#51)(1995-4#4)(1995-5#23)(1995-6#50)(1995-7#9)(1995-8#50)(1995-9#9)(1996-1#23)(1996-10#36)(1996-11#27)(1996-12#42)(1996-2#47)(1996-3#30)(1996-4#28)(1996-5#62)(1996-6#17)(1996-7#20)(1996-8#33)(1996-9#22)(1997-1#28)(1997-2#46)(1997-3#21)(1997-4#50)(1997-5#19)(1997-6#54)(1997-7#50)(1997-8#39)(1997-9#3)(2003-11#6)(2004-1#4)(2004-10#2)(2004-11#11)(2004-12#11)(2004-2#3)(2004-3#3)(2004-4#1)(2004-7#1)(2004-8#1)(2004-9#4)(2005-1#3)(2005-10#47)(2005-11#41)(2005-12#8)(2005-3#1)(2005-5#7)(2005-6#2)(2005-7#29)(2005-8#28)(2005-9#8)(2006-1#22)(2006-10#240)(2006-11#23)(2006-12#34)(2006-2#48)(2006-3#10)(2006-4#19)(2006-5#24)(2006-6#26)(2006-7#27)(2006-8#43)(2006-9#22)(2007-1#33)(2007-10#53)(2007-11#143)(2007-12#111)(2007-2#40)(2007-3#23)(2007-4#39)(2007-5#26)(2007-6#17)(2007-7#50)(2007-8#75)(2007-9#45)(2008-1#163)(2008-10#312)(2008-11#208)(2008-12#92)(2008-2#53)(2008-3#98)(2008-4#145)(2008-5#165)(2008-6#64)(2008-7#184)(2008-8#149)(2008-9#79)(2009-1#15)(2009-10#57)(2009-11#33)(2009-12#25)(2009-2#26)(2009-3#38)(2009-4#68)(2009-5#37)(2009-6#51)(2009-7#41)(2009-8#95)(2009-9#37)(2010-1#20)(2010-10#38)(2010-11#51)(2010-12#106)(2010-2#59)(2010-3#41)(2010-4#37)(2010-5#34)(2010-6#13)(2010-7#33)(2010-8#50)(2010-9#18)(2011-1#159)(2011-10#4)(2011-12#32)(2011-2#260)(2011-3#13)(2011-7#3)(2011-9#2)(2012-1#59)(2012-11#21)(2012-12#172)(2012-2#196)(2012-3#92)(2012-4#1)(2012-6#2)(2012-7#2)(2013-1#228)(2013-2#1)(2013-3#1)(2013-7#52)(2013-8#112)
role(s) for##4##2##(1991-5#1)(1992-12#1)(1995-3#1)(1995-6#1)
role(s) in the##2##3##(1992-11#1)(1997-7#1)
role(s) in##5##2##(1992-11#1)(1995-11#2)(1997-7#1)(2008-11#1)
role(s) of the##2##3##(1996-9#1)(2008-11#1)
role(s) of##7##2##(1993-8#1)(1996-9#1)(1997-4#1)(2007-11#1)(2008-11#1)(2008-4#1)(2012-12#1)
role(s)##16##1##(1991-5#1)(1992-11#1)(1992-12#1)(1993-8#1)(1995-11#2)(1995-3#1)(1995-6#1)(1996-9#1)(1997-4#1)(1997-7#1)(2007-11#1)(2008-11#2)(2008-4#1)(2012-12#1)
role-based access control) are embedded in enterprise-level systems##2##8##(2013-1#2)
role-based training##2##2##(2013-1#2)
role-based##4##1##(2013-1#4)
role-physical##3##1##(2008-8#2)(2010-5#1)
role-play as a##2##3##(2008-11#2)
role-play as an##2##3##(2008-11#2)
role-play as##4##2##(2008-11#4)
role-play##8##1##(2006-9#2)(2008-11#6)
role-specific self-representations##2##2##(2008-9#2)
role?##8##1##(1995-2#1)(1996-4#1)(2004-2#1)(2006-10#2)(2007-7#1)(2010-3#1)(2011-1#1)
role?]##2##1##(1991-11#1)(2010-9#1)
role]##3##1##(1992-2#1)(1992-6#1)(2008-8#1)
roles across##2##2##(2006-5#1)(2008-5#1)
roles and activities regarding psychiatric medication##2##6##(2007-9#2)
roles and activities##3##3##(2007-9#2)(2013-1#1)
roles and functions##2##3##(2007-10#2)
roles and responsibilities of the##3##5##(2007-4#3)
roles and responsibilities of##9##4##(1994-1#2)(1995-2#1)(1996-1#1)(2007-2#1)(2007-4#3)(2008-3#1)
roles and responsibilities##18##3##(1994-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(2007-12#1)(2007-2#1)(2007-4#3)(2008-3#1)(2010-2#1)(2010-5#1)(2011-1#1)(2013-1#3)
roles and the##2##3##(2005-8#1)(2008-5#1)
roles and##50##2##(1991-1#1)(1993-12#1)(1994-1#2)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-3#2)(2004-3#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-10#3)(2007-12#1)(2007-2#1)(2007-4#3)(2007-8#1)(2007-9#2)(2008-11#1)(2008-3#1)(2008-5#1)(2009-12#1)(2009-7#1)(2010-2#2)(2010-3#1)(2010-5#2)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)
roles are##11##2##(1991-2#1)(1992-12#1)(2005-7#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-12#1)(2009-4#1)(2012-12#1)(2012-3#1)(2013-1#1)
roles as a##2##3##(1991-2#1)(2008-10#1)
roles as well##2##3##(2007-3#1)(2008-10#1)
roles as##17##2##(1991-2#1)(1995-6#1)(1996-3#1)(1996-5#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-10#3)(2008-5#1)(2008-8#1)(2010-7#1)(2011-12#1)(2012-2#1)(2013-8#1)
roles at##2##2##(2006-5#1)(2008-7#1)
roles both as a##2##4##(1990-4#1)(2008-10#1)
roles carried out by##2##4##(2007-9#1)(2009-5#1)
roles during the##4##3##(1990-12#1)(1992-6#1)(1996-3#1)(2004-11#1)
roles during##12##2##(1990-12#1)(1992-6#1)(1996-3#1)(1997-2#1)(2004-11#1)(2006-8#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-8#1)
roles for B lymphocytes in##2##5##(2010-5#2)
roles for GCC##2##3##(2009-9#2)
roles for both ionotropic and metabotropic##2##6##(2008-7#2)
roles for both##5##3##(1992-3#1)(2005-10#1)(2008-7#2)(2008-8#1)
roles for the C-system in##2##5##(1996-6#2)
roles for the##13##3##(1992-12#1)(1993-3#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-7#1)(1996-3#1)(1996-6#2)(2008-8#1)(2009-10#1)(2012-12#1)(2012-2#1)
roles for these##3##3##(1993-9#1)(1994-11#1)(2008-11#1)
roles for##92##2##(1990-5#1)(1990-6#1)(1991-12#1)(1991-4#1)(1992-12#2)(1992-3#2)(1992-4#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-9#2)(1994-11#1)(1994-9#1)(1995-10#1)(1995-12#3)(1995-2#2)(1995-6#1)(1995-7#1)(1995-8#4)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#2)(1996-7#1)(2005-10#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-12#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#3)(2009-10#3)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#2)(2010-12#2)(2010-2#3)(2010-5#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#4)(2012-2#4)(2013-8#1)
roles has##3##2##(2005-11#1)(2008-11#1)(2008-5#1)
roles have been##4##3##(1997-7#1)(2007-4#1)(2011-1#1)(2011-2#1)
roles have not been##2##4##(2008-8#1)(2011-1#1)
roles have##9##2##(1997-7#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-12#1)(2011-1#2)(2011-2#1)
roles in DNA##3##3##(1992-8#1)(1994-3#1)(2008-9#1)
roles in a number of##2##5##(2005-7#1)(2008-11#1)
roles in a##5##3##(1994-1#1)(2005-7#1)(2008-11#1)(2009-5#1)(2010-7#1)
roles in autoimmune##2##3##(2009-9#1)(2010-5#1)
roles in biological systems##2##4##(2008-10#1)(2008-9#1)
roles in biological##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
roles in both##10##3##(1997-2#1)(1997-8#1)(2008-4#1)(2008-7#2)(2009-10#2)(2009-6#1)(2011-1#1)(2012-2#1)
roles in cardiovascular##2##3##(1995-6#1)(1997-6#1)
roles in cell fate##2##4##(2006-11#1)(2008-1#1)
roles in cell growth##2##4##(1994-10#1)(2007-11#1)
roles in cell##11##3##(1991-5#1)(1994-10#1)(1994-2#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-1#1)(2009-8#1)(2011-12#1)(2011-2#2)
roles in determining##5##3##(1993-6#1)(1995-2#1)(1996-5#1)(2006-10#1)(2009-4#1)
roles in development and##3##4##(1992-11#1)(2007-12#1)(2009-10#1)
roles in development##4##3##(1992-11#1)(2007-12#1)(2008-1#1)(2009-10#1)
roles in drug abuse##2##4##(1991-1#1)(2009-7#1)
roles in drug##3##3##(1991-1#1)(1994-11#1)(2009-7#1)
roles in formation##2##3##(2009-11#1)(2013-7#1)
roles in fundamental##3##3##(2011-1#1)(2012-12#2)
roles in health and disease##2##5##(2008-10#1)(2008-4#1)
roles in health care##2##4##(1992-1#1)(2008-12#1)
roles in health##4##3##(1992-1#1)(2008-10#1)(2008-12#1)(2008-4#1)
roles in inflammatory diseases##2##4##(2010-1#2)
roles in inflammatory##4##3##(2008-1#1)(2008-12#1)(2010-1#2)
roles in insulin##2##3##(1992-10#1)(2008-1#1)
roles in maintaining##3##3##(2008-7#1)(2008-8#1)(2012-12#1)
roles in many biological processes##5##5##(2008-2#1)(2009-11#1)(2010-12#1)(2010-5#1)(2013-8#1)
roles in many biological##6##4##(2007-11#1)(2008-2#1)(2009-11#1)(2010-12#1)(2010-5#1)(2013-8#1)
roles in many##10##3##(1994-11#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-11#1)(2010-12#1)(2010-5#1)(2012-2#1)(2013-8#1)
roles in metabolism##2##3##(2010-11#1)(2010-4#1)
roles in modulating##2##3##(1994-6#1)(2009-8#1)
roles in neural development##2##4##(1996-12#1)(2009-9#1)
roles in neuronal##3##3##(2008-7#1)(2009-8#1)(2013-8#1)
roles in normal##3##3##(1996-9#1)(2009-8#1)(2012-12#1)
roles in physiological##2##3##(2008-11#1)(2011-12#1)
roles in plant##4##3##(2008-9#2)(2009-8#1)(2012-3#1)
roles in proliferation##2##3##(1993-8#1)(2009-6#1)
roles in regulating the##5##4##(1995-3#1)(2007-12#1)(2009-8#1)(2011-2#1)(2012-3#1)
roles in regulating##12##3##(1995-11#1)(1995-2#1)(1995-3#1)(2004-2#1)(2007-12#1)(2008-11#1)(2009-8#2)(2010-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
roles in regulation of##8##4##(1996-10#1)(2008-1#1)(2008-10#1)(2009-4#1)(2010-4#1)(2012-12#2)(2012-3#1)
roles in signaling pathways##2##4##(2009-8#1)(2012-12#1)
roles in survival and##2##4##(2011-1#1)(2011-2#1)
roles in the assembly of the##2##6##(1994-12#1)(2013-1#1)
roles in the development and##3##5##(2007-12#1)(2007-7#1)(2008-8#1)
roles in the development of##3##5##(1991-1#1)(2007-10#1)(2010-12#1)
roles in the development##6##4##(1991-1#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-8#1)(2010-12#1)
roles in the etiology##3##4##(2007-2#2)(2009-10#1)
roles in the growth and##2##5##(2008-4#1)(2008-8#1)
roles in the growth##3##4##(2008-4#1)(2008-8#1)(2010-5#1)
roles in the management of##2##5##(2008-8#2)
roles in the pathogenesis of##8##5##(2006-10#2)(2006-8#1)(2007-8#2)(2008-1#1)(2008-8#1)(2009-9#1)
roles in the regulation of cell##2##6##(2008-1#1)(2008-4#1)
roles in the regulation of##9##5##(1991-4#1)(1993-12#1)(2008-1#1)(2008-4#1)(2008-5#1)(2009-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
roles in the##92##3##(1990-8#1)(1991-1#1)(1991-11#1)(1991-4#1)(1992-12#1)(1992-9#1)(1993-12#1)(1994-12#2)(1994-6#1)(1994-8#2)(1995-10#1)(1995-11#2)(1995-4#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#2)(1997-1#2)(1997-2#1)(1997-7#1)(1997-8#2)(2006-10#3)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#3)(2008-11#5)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#4)(2008-8#5)(2008-9#1)(2009-10#2)(2009-6#1)(2009-8#1)(2009-9#2)(2010-12#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#1)
roles in these##3##3##(1992-12#1)(2009-4#1)(2010-11#1)
roles in this##2##3##(1995-10#1)(2011-1#1)
roles in tissue##3##3##(2010-9#1)(2011-1#1)(2012-2#1)
roles in tumor progression##2##4##(1997-7#1)(2006-10#1)
roles in various##5##3##(1994-8#1)(2008-8#1)(2009-8#1)(2012-11#1)(2012-2#1)
roles in##396##2##(1990-12#2)(1990-8#2)(1991-1#2)(1991-11#1)(1991-4#1)(1991-5#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#4)(1994-6#2)(1994-8#5)(1994-9#1)(1995-10#2)(1995-11#5)(1995-12#1)(1995-2#4)(1995-3#2)(1995-4#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#3)(1996-12#2)(1996-2#1)(1996-3#3)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#2)(1997-4#1)(1997-6#3)(1997-7#5)(1997-8#3)(2004-2#1)(2005-10#1)(2005-7#2)(2005-8#3)(2006-10#6)(2006-11#1)(2006-4#1)(2006-6#3)(2006-8#2)(2007-10#3)(2007-11#5)(2007-12#9)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#11)(2008-10#8)(2008-11#13)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#14)(2008-5#5)(2008-6#1)(2008-7#14)(2008-8#11)(2008-9#9)(2009-10#11)(2009-11#3)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#4)(2009-7#1)(2009-8#13)(2009-9#7)(2010-1#3)(2010-10#1)(2010-11#3)(2010-12#6)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#5)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#14)(2011-12#2)(2011-2#8)(2012-1#2)(2012-11#3)(2012-12#13)(2012-2#15)(2012-3#6)(2013-1#11)(2013-7#1)(2013-8#10)
roles involved in##2##3##(2010-1#1)(2011-1#1)
roles is##4##2##(1995-1#1)(2006-10#1)(2009-7#1)(2011-2#1)
roles of CNG channels in##2##5##(2009-10#2)
roles of a##6##3##(1990-8#1)(1992-2#1)(1993-12#1)(2006-2#1)(2008-10#1)(2008-11#1)
roles of active site residues##2##5##(1992-11#1)(2013-8#1)
roles of conserved##2##3##(1995-8#1)(2008-8#1)
roles of dietary##2##3##(2008-4#1)(2012-2#1)
roles of glia##3##3##(2008-7#3)
roles of histamine and##3##4##(1992-7#2)(2005-7#1)
roles of kappa-opioid and NMDA##2##5##(1997-2#2)
roles of management##2##3##(1994-1#1)(1996-3#1)
roles of nitric oxide in##2##5##(2004-12#1)(2006-11#1)
roles of nitric oxide##3##4##(1997-5#1)(2004-12#1)(2006-11#1)
roles of oestrogen in the male##2##6##(2008-4#2)
roles of other##2##3##(2007-12#1)(2010-12#1)
roles of sex##2##3##(1995-12#1)(2007-7#1)
roles of somatostatin in the##2##5##(1997-2#2)
roles of specific##5##3##(1992-6#1)(1997-7#1)(2007-12#2)(2012-12#1)
roles of such##2##3##(1993-12#1)(2010-3#1)
roles of the arterial baroreflex during the##2##7##(2010-11#2)
roles of the##43##3##(1991-8#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-8#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-6#1)(2005-11#1)(2005-6#1)(2006-11#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-12#1)(2009-3#1)(2009-8#3)(2009-9#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#2)(2012-12#1)(2012-2#2)(2013-8#1)
roles of these proteins##2##4##(2012-12#1)(2013-1#1)
roles of these##15##3##(1990-5#1)(1991-11#1)(1991-9#1)(1993-11#1)(1994-5#1)(1995-3#1)(1995-8#1)(2007-12#1)(2008-7#1)(2009-10#1)(2010-12#1)(2012-12#1)(2012-2#2)(2013-1#1)
roles of this type of##2##5##(1994-8#1)(2010-8#1)
roles of this##6##3##(1993-9#1)(1994-8#1)(1995-6#1)(2010-8#1)(2011-12#1)(2012-2#1)
roles of three##2##3##(1991-8#1)(1996-2#1)
roles of two##2##3##(1994-8#1)(2009-8#1)
roles of various##2##3##(2008-4#1)(2012-3#1)
roles of##348##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-4#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#3)(1992-6#3)(1992-7#2)(1993-11#1)(1993-12#4)(1993-3#1)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#8)(1994-9#2)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#4)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#6)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#2)(2005-10#3)(2005-11#1)(2005-6#1)(2005-7#1)(2006-10#3)(2006-11#2)(2006-2#3)(2006-3#1)(2006-5#2)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#5)(2007-12#9)(2007-4#2)(2007-7#3)(2007-8#3)(2008-1#5)(2008-10#11)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#9)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#13)(2008-9#4)(2009-10#4)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#6)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#14)(2009-9#5)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#7)(2010-2#3)(2010-3#3)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#4)(2011-1#8)(2011-12#1)(2011-2#10)(2012-1#3)(2012-11#1)(2012-12#10)(2012-2#9)(2012-3#6)(2013-1#8)(2013-8#6)
roles on##3##2##(1990-2#1)(2008-8#1)(2011-12#1)
roles performed##2##2##(2007-9#1)(2012-12#1)
roles played by the##2##4##(1991-2#1)(2008-12#1)
roles played by these##2##4##(1990-10#1)(2009-8#1)
roles played by##15##3##(1990-10#2)(1991-2#1)(1994-12#1)(1997-7#1)(2007-12#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2013-1#1)
roles played##16##2##(1990-10#2)(1991-2#1)(1994-12#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2013-1#1)
roles such as##2##3##(2008-10#1)(2008-5#1)
roles that the##3##3##(2008-5#1)(2008-7#1)(2012-12#1)
roles that##14##2##(1994-3#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#3)
roles they play##3##3##(2006-10#1)(2008-12#1)(2009-8#1)
roles through##3##2##(1992-7#1)(2006-7#1)(2008-7#1)
roles to play in##2##4##(2008-2#1)(2008-7#1)
roles to##3##2##(1994-12#1)(2008-2#1)(2008-7#1)
roles were##3##2##(1990-12#1)(2007-1#1)(2010-8#1)
roles which##2##2##(2005-7#1)(2008-4#1)
roles will##2##2##(1995-2#1)(2008-1#1)
roles within the cell##2##4##(1996-8#1)(2008-4#1)
roles within the##4##3##(1996-8#1)(2008-11#1)(2008-4#1)(2013-1#1)
roles within##9##2##(1991-12#1)(1996-12#1)(1996-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-1#1)(2013-1#1)
roles##1199##1##(1990-10#2)(1990-11#2)(1990-12#7)(1990-2#3)(1990-3#1)(1990-4#3)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#5)(1990-9#1)(1991-1#3)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#3)(1991-4#4)(1991-5#3)(1991-8#2)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#10)(1992-2#4)(1992-3#6)(1992-4#2)(1992-6#5)(1992-7#3)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#9)(1993-2#3)(1993-3#2)(1993-6#5)(1993-7#1)(1993-8#3)(1993-9#4)(1994-1#7)(1994-10#1)(1994-11#4)(1994-12#6)(1994-2#5)(1994-3#6)(1994-4#1)(1994-5#2)(1994-6#2)(1994-8#14)(1994-9#4)(1995-1#2)(1995-10#3)(1995-11#7)(1995-12#9)(1995-2#9)(1995-3#5)(1995-4#1)(1995-5#4)(1995-6#5)(1995-7#1)(1995-8#9)(1995-9#2)(1996-1#7)(1996-10#4)(1996-11#1)(1996-12#10)(1996-2#4)(1996-3#13)(1996-4#1)(1996-5#2)(1996-6#4)(1996-7#3)(1996-8#4)(1996-9#2)(1997-1#5)(1997-2#10)(1997-3#4)(1997-4#4)(1997-5#2)(1997-6#5)(1997-7#11)(1997-8#5)(2004-11#1)(2004-12#2)(2004-2#1)(2004-3#2)(2005-10#8)(2005-11#3)(2005-6#1)(2005-7#5)(2005-8#5)(2006-1#3)(2006-10#17)(2006-11#3)(2006-12#3)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#4)(2006-6#3)(2006-7#7)(2006-8#3)(2006-9#1)(2007-1#6)(2007-10#12)(2007-11#14)(2007-12#25)(2007-2#4)(2007-3#4)(2007-4#11)(2007-5#1)(2007-7#4)(2007-8#7)(2007-9#5)(2008-1#24)(2008-10#25)(2008-11#37)(2008-12#16)(2008-2#8)(2008-3#5)(2008-4#30)(2008-5#17)(2008-6#6)(2008-7#37)(2008-8#38)(2008-9#23)(2009-1#1)(2009-10#21)(2009-11#3)(2009-12#2)(2009-2#2)(2009-3#4)(2009-4#14)(2009-5#11)(2009-6#9)(2009-7#6)(2009-8#34)(2009-9#14)(2010-1#6)(2010-10#7)(2010-11#6)(2010-12#17)(2010-2#13)(2010-3#7)(2010-4#3)(2010-5#12)(2010-6#1)(2010-7#5)(2010-8#11)(2010-9#2)(2011-1#31)(2011-12#6)(2011-2#26)(2012-1#6)(2012-11#6)(2012-12#40)(2012-2#36)(2012-3#17)(2013-1#32)(2013-7#1)(2013-8#21)
rolfsii and##3##2##(2008-10#3)
rolfsii sclerotia##2##2##(2008-10#2)
rolfsii was##2##2##(2005-12#1)(2008-6#1)
rolfsii were##2##2##(2008-10#2)
rolfsii##38##1##(2005-12#4)(2007-7#1)(2008-10#27)(2008-6#3)(2008-8#2)(2009-8#1)
rolipram##11##1##(1993-7#1)(1996-6#1)(2004-12#1)(2007-11#2)(2007-8#1)(2008-3#5)
roll axis##2##2##(1990-10#1)(2008-2#1)
roll on##2##2##(1991-5#2)
roll rotation##2##2##(2012-2#2)
roll tilt##4##2##(2012-2#4)
roll##27##1##(1990-10#1)(1991-5#2)(1995-12#1)(1995-8#2)(1997-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2010-8#1)(2012-11#2)(2012-2#7)(2012-3#1)
roll-off##5##1##(2007-11#1)(2008-3#1)(2008-7#2)(2010-4#1)
roll-out of##2##2##(2012-12#1)(2012-3#1)
roll-out##10##1##(1995-12#1)(2011-1#2)(2011-2#1)(2012-12#5)(2012-3#1)
roll-over##2##1##(2013-1#2)
rolled out##2##2##(1996-7#1)(2007-9#1)
rolled##8##1##(1996-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-5#1)(2013-8#2)
roller bottle##2##2##(2008-11#1)(2008-6#1)
roller bottles##6##2##(2008-11#5)(2013-8#1)
roller coaster##2##2##(1994-2#1)(1996-3#1)
roller pump##2##2##(2007-8#2)
roller##15##1##(1994-2#1)(1996-3#1)(2007-10#1)(2007-8#2)(2008-11#8)(2008-6#1)(2013-8#1)
rolling circle##3##2##(1996-5#1)(1997-6#2)
rolling of the##2##3##(1993-11#1)(2008-5#1)
rolling of##4##2##(1993-11#1)(2008-11#1)(2008-3#1)(2008-5#1)
rolling on##2##2##(1991-5#2)
rolling with different reduction##2##4##(2013-8#2)
rolling with##3##2##(2013-8#3)
rolling##26##1##(1991-5#2)(1993-11#1)(1993-8#1)(1994-11#1)(1996-5#1)(1997-6#2)(2005-8#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#3)(2008-8#1)(2009-4#2)(2010-2#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#3)
rolling-circle##3##1##(1996-7#1)(1997-6#2)
rollover crashes##4##2##(2012-12#4)
rollover occupant protection##2##3##(2012-12#2)
rollover##12##1##(1997-4#1)(2007-12#1)(2012-12#10)
rollovers##2##1##(2012-12#2)
rolls of tape##2##3##(2012-2#2)
rolls of##3##2##(2012-2#3)
rolls##8##1##(1991-7#1)(1995-8#1)(2007-12#1)(2007-6#2)(2012-2#3)
rom-1##5##1##(1995-10#5)
romance##3##1##(2012-2#3)
romantic experiences##2##2##(2009-5#2)
romantic partner##4##2##(2007-12#2)(2009-7#2)
romantic partners##6##2##(2008-8#1)(2009-7#3)(2009-9#1)(2013-1#1)
romantic relationship distress##3##3##(2008-12#3)
romantic relationship##7##2##(2006-7#1)(2008-12#4)(2009-9#1)(2013-1#1)
romantic relationships##11##2##(2004-12#1)(2006-7#1)(2007-12#1)(2008-12#1)(2008-9#1)(2009-9#4)(2010-8#1)(2013-1#1)
romantic##38##1##(2004-12#1)(2006-7#3)(2007-12#3)(2008-12#5)(2008-8#1)(2008-9#2)(2009-5#4)(2009-7#5)(2009-9#10)(2010-8#1)(2013-1#3)
romifidine##6##1##(2012-3#5)(2013-1#1)
ronchigram##3##1##(2008-3#3)
rood pattern search##2##3##(2008-2#2)
rood pattern##4##2##(2008-2#4)
roof and##3##2##(2007-7#1)(2008-10#1)(2009-2#1)
roof installed parallel plate##2##4##(2013-1#2)
roof of a##2##3##(2007-4#1)(2008-5#1)
roof of the##11##3##(1994-5#3)(1995-11#1)(1997-5#1)(2006-12#1)(2006-5#1)(2007-8#1)(2007-9#1)(2009-3#1)(2010-5#1)
roof of##13##2##(1994-5#3)(1995-11#1)(1997-5#1)(2006-12#1)(2006-5#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-5#1)(2009-3#1)(2010-5#1)
roof slabs##4##2##(2013-8#4)
roof##40##1##(1993-5#1)(1994-5#3)(1995-11#1)(1997-5#1)(2005-11#1)(2006-12#3)(2006-5#1)(2007-4#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-10#1)(2008-2#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-2#1)(2009-3#1)(2010-5#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#5)
roofs and##2##2##(1993-9#1)(2006-12#1)
roofs##6##1##(1992-11#1)(1993-9#2)(2006-12#1)(2007-10#1)(2008-10#1)
rooftop##3##1##(1997-3#1)(2008-2#2)
rookeries##2##1##(2005-7#2)
room -##3##2##(2006-6#2)(2012-2#1)
room air##14##2##(1993-1#1)(1996-3#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-3#1)(2010-7#2)(2013-8#1)
room and##11##2##(2006-10#2)(2006-8#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-12#3)(2010-2#1)(2010-8#1)
room at 15##2##3##(2007-12#1)(2010-7#1)
room at##6##2##(2006-8#1)(2007-12#1)(2007-7#1)(2008-3#1)(2010-7#1)(2011-2#1)
room climate##2##2##(2006-6#2)
room conditions##3##2##(2006-6#1)(2008-10#2)
room for a##2##3##(2007-9#1)(2013-1#1)
room for improvement in the quality of##2##7##(1996-2#1)(1996-8#1)
room for improvement in the##4##5##(1996-2#1)(1996-8#1)(2007-12#1)(2008-3#1)
room for improvement in##6##4##(1996-2#1)(1996-8#1)(2007-12#1)(2008-3#1)(2012-12#1)(2012-3#1)
room for improvement##10##3##(1996-2#1)(1996-8#1)(2006-10#1)(2007-12#1)(2008-3#1)(2008-6#1)(2012-12#1)(2012-2#1)(2012-3#2)
room for the##2##3##(1991-8#1)(2010-3#1)
room for##37##2##(1990-8#2)(1991-8#1)(1992-11#1)(1994-10#1)(1995-11#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-8#1)(2004-10#1)(2005-8#1)(2006-10#3)(2006-3#1)(2007-12#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
room humidity##2##2##(1990-8#1)(2008-5#1)
room in##4##2##(2006-10#1)(2008-2#2)(2011-2#1)
room is##3##2##(1990-2#1)(2006-10#1)(2012-3#1)
room light##2##2##(1994-8#1)(2008-10#1)
room of the##2##3##(2006-2#1)(2008-10#1)
room of##6##2##(1995-11#1)(2006-2#1)(2007-3#2)(2008-10#2)
room or##5##2##(1991-3#1)(1994-8#1)(2006-6#1)(2007-9#1)(2008-11#1)
room temperature and at 40 degrees##2##6##(2008-5#2)
room temperature and at##3##4##(2008-10#1)(2008-5#2)
room temperature and pressure##2##4##(2007-12#2)
room temperature and##34##3##(1990-6#1)(1994-9#1)(1995-1#1)(1997-2#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2009-11#1)(2009-12#1)(2009-3#1)(2012-11#2)(2012-12#1)(2012-2#1)
room temperature as##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
room temperature fluorimetry for##2##4##(2008-10#2)
room temperature fluorimetry##3##3##(2008-10#3)
room temperature for##14##3##(1991-3#1)(1991-8#1)(1995-2#3)(1997-7#1)(2006-5#1)(2007-12#1)(2008-10#4)(2008-5#1)(2012-12#1)
room temperature have been##2##4##(2007-12#1)(2008-2#1)
room temperature ionic liquids##2##4##(2008-10#2)
room temperature ionic##4##3##(2008-10#4)
room temperature is##5##3##(1990-3#1)(1995-2#1)(2007-11#1)(2008-10#2)
room temperature or##4##3##(2008-10#2)(2008-5#2)
room temperature phosphorescence (RTP)##7##4##(2007-8#1)(2008-10#6)
room temperature phosphorescence of##2##4##(2008-10#2)
room temperature phosphorescence##21##3##(1991-8#1)(2007-8#1)(2008-10#19)
room temperature the##3##3##(1994-8#1)(2007-12#2)
room temperature to##12##3##(1997-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-9#1)(2009-6#1)(2010-9#1)
room temperature was##6##3##(1996-10#1)(1996-2#1)(2005-11#1)(2007-12#1)(2008-3#2)
room temperature with##4##3##(1996-11#1)(2008-10#1)(2008-3#1)(2010-12#1)
room temperature##358##2##(1990-10#1)(1990-11#5)(1990-3#3)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-7#2)(1991-8#3)(1992-12#1)(1992-2#2)(1992-4#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#2)(1995-11#3)(1995-2#6)(1995-5#1)(1995-6#1)(1996-1#1)(1996-10#3)(1996-11#2)(1996-12#3)(1996-2#5)(1996-5#2)(1996-7#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#3)(1997-8#2)(2005-11#10)(2005-4#1)(2006-10#3)(2006-12#6)(2006-5#1)(2007-10#2)(2007-11#15)(2007-12#38)(2007-3#1)(2007-5#1)(2007-8#4)(2008-1#3)(2008-10#86)(2008-11#2)(2008-12#1)(2008-2#14)(2008-3#18)(2008-4#2)(2008-5#11)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-11#2)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#6)(2010-5#2)(2010-6#1)(2010-7#2)(2010-9#2)(2011-1#2)(2011-2#2)(2012-11#2)(2012-12#7)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#4)(2013-8#3)
room to improve##2##3##(2008-6#1)(2010-9#1)
room to##8##2##(1993-7#1)(2006-6#1)(2008-10#1)(2008-6#2)(2010-9#1)(2011-12#1)(2013-7#1)
room utilization##2##2##(2006-10#1)(2011-2#1)
room visits##2##2##(2007-5#1)(2008-10#1)
room with the##2##3##(2006-10#1)(2010-5#1)
room with##11##2##(2006-10#1)(2007-9#1)(2008-3#1)(2009-3#2)(2010-12#1)(2010-5#2)(2013-1#1)(2013-8#2)
room##655##1##(1990-10#1)(1990-11#5)(1990-2#1)(1990-3#5)(1990-6#1)(1990-8#6)(1991-1#3)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#3)(1991-7#2)(1991-8#4)(1992-1#3)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-7#1)(1993-8#2)(1994-10#1)(1994-12#2)(1994-2#3)(1994-7#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-10#2)(1995-11#5)(1995-12#1)(1995-2#6)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#4)(1996-10#3)(1996-11#2)(1996-12#3)(1996-2#6)(1996-3#4)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-4#2)(1997-7#3)(1997-8#2)(2004-10#1)(2005-10#2)(2005-11#10)(2005-12#1)(2005-4#1)(2005-8#1)(2006-10#27)(2006-12#6)(2006-2#2)(2006-3#2)(2006-5#1)(2006-6#14)(2006-8#5)(2006-9#2)(2007-1#2)(2007-10#4)(2007-11#17)(2007-12#47)(2007-2#4)(2007-3#6)(2007-4#1)(2007-5#4)(2007-7#3)(2007-8#11)(2007-9#3)(2008-1#3)(2008-10#99)(2008-11#5)(2008-12#2)(2008-2#19)(2008-3#23)(2008-4#4)(2008-5#15)(2008-6#8)(2008-7#5)(2008-8#11)(2008-9#5)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#4)(2009-5#1)(2009-6#5)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#12)(2010-2#5)(2010-3#2)(2010-4#7)(2010-5#5)(2010-6#1)(2010-7#7)(2010-8#2)(2010-9#4)(2011-1#5)(2011-12#2)(2011-2#13)(2012-11#2)(2012-12#16)(2012-2#13)(2012-3#7)(2013-1#14)(2013-7#5)(2013-8#10)
room)##2##1##(2006-12#1)(2009-4#1)
room-temperature continuous-wave##2##2##(2008-1#1)(2008-2#1)
room-temperature diode##3##2##(2008-2#3)
room-temperature fluorescence##2##2##(1995-5#1)(2008-2#1)
room-temperature ionic##3##2##(2007-8#1)(2008-10#1)(2010-5#1)
room-temperature laser##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
room-temperature mid-infrared##2##2##(2007-12#1)(2008-2#1)
room-temperature operation and##2##3##(2007-11#1)(2007-12#1)
room-temperature operation##3##2##(2007-11#1)(2007-12#2)
room-temperature phosphorescence (RTP)##2##3##(2008-10#2)
room-temperature phosphorescence of##3##3##(2007-8#1)(2008-10#2)
room-temperature phosphorescence##8##2##(2005-4#1)(2007-8#3)(2008-10#4)
room-temperature phosphorimetric##2##2##(2008-10#2)
room-temperature phosphorimetry##2##2##(2008-10#2)
room-temperature##67##1##(1990-4#1)(1995-5#1)(2005-4#1)(2006-12#1)(2007-11#6)(2007-12#17)(2007-8#4)(2008-1#1)(2008-10#11)(2008-2#14)(2008-3#7)(2010-5#1)(2012-2#2)
room?##2##1##(1993-2#1)(2012-2#1)
room]##2##1##(1996-8#1)(2008-4#1)
rooming-in##4##1##(2007-2#1)(2008-6#2)(2010-12#1)
rooms and##2##2##(2008-10#1)(2008-5#1)
rooms as##2##2##(1993-8#1)(2008-10#1)
rooms for##2##2##(1992-5#1)(2007-9#1)
rooms in the##2##3##(2005-8#1)(2008-9#1)
rooms of##3##2##(2008-10#1)(2008-5#1)(2012-12#1)
rooms was##2##2##(1993-8#1)(1997-2#1)
rooms with##3##2##(1990-2#2)(1996-12#1)
rooms##51##1##(1990-2#3)(1991-6#1)(1991-7#2)(1992-5#1)(1993-8#2)(1995-6#1)(1996-12#2)(1996-2#1)(1997-2#1)(2005-10#1)(2005-8#1)(2006-5#1)(2006-6#7)(2006-8#1)(2007-3#1)(2007-9#1)(2008-10#6)(2008-11#2)(2008-5#3)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#2)
roost in##2##2##(2004-11#1)(2008-3#1)
roost##4##1##(2004-11#1)(2008-3#1)(2013-8#2)
roosts in##3##2##(2009-9#3)
roosts##6##1##(2008-5#1)(2009-9#5)
root abscess##2##2##(2007-2#1)(2007-9#1)
root and apical meristem##2##4##(2008-12#2)
root and crown rot##2##4##(2008-10#2)
root and crown##3##3##(2008-10#3)
root and foliar##2##3##(2008-10#1)(2009-6#1)
root and leaf pathogens##2##4##(2008-10#2)
root and shoot dry weights##2##5##(2008-10#2)
root and shoot elongation##2##4##(2011-12#2)
root and shoot were##2##4##(2008-12#2)
root and shoot##8##3##(2008-10#3)(2008-12#2)(2011-12#3)
root and stem rot##3##4##(2008-10#3)
root and stem##5##3##(2008-10#5)
root and the##5##3##(2007-8#2)(2008-10#2)(2011-12#1)
root and##56##2##(1996-3#1)(1996-8#1)(2005-12#3)(2006-8#1)(2007-8#4)(2008-10#24)(2008-12#4)(2008-3#1)(2008-5#1)(2008-9#2)(2009-6#2)(2009-8#1)(2010-2#1)(2011-12#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
root angulation##3##2##(2010-3#2)(2011-2#1)
root apex##5##2##(2009-6#2)(2012-2#2)(2013-8#1)
root apical meristem##4##3##(2008-10#1)(2009-8#3)
root apices##4##2##(2009-6#2)(2012-12#1)(2012-2#1)
root are##2##2##(2005-12#1)(2008-10#1)
root as##4##2##(1991-3#1)(1993-12#2)(2008-5#1)
root associated with##3##3##(2006-11#1)(2008-5#1)(2013-8#1)
root at##2##2##(2008-10#1)(2010-10#1)
root avulsion##2##2##(2008-9#1)(2011-2#1)
root bark of Aralia elata##2##5##(1994-3#2)
root bark of Calotropis gigantea##2##5##(2008-12#2)
root bark of Oroxylum indicum##2##5##(2008-10#2)
root bark of##11##3##(1994-3#2)(2007-1#2)(2008-10#3)(2008-11#1)(2008-12#2)(2011-1#1)
root bark##14##2##(1994-3#2)(2007-1#5)(2008-10#3)(2008-11#1)(2008-12#2)(2011-1#1)
root between##2##2##(1995-3#1)(2008-9#1)
root biomass##3##2##(2004-4#1)(2008-10#1)(2008-5#1)
root canal filling##7##3##(1991-3#1)(2007-11#1)(2013-1#5)
root canal irrigation##2##3##(2013-1#2)
root canal morphology##3##3##(2012-12#1)(2013-1#2)
root canal system and##2##4##(1990-4#1)(2013-1#1)
root canal system##8##3##(1990-4#1)(2008-7#1)(2012-12#1)(2013-1#5)
root canal treatment##5##3##(2013-1#5)
root canal walls##4##3##(2008-11#2)(2013-1#1)(2013-7#1)
root canal##48##2##(1990-4#1)(1991-3#1)(2005-10#2)(2006-8#1)(2007-11#1)(2007-2#2)(2008-11#3)(2008-7#4)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#27)(2013-7#1)(2013-8#1)
root canals and##2##3##(2013-1#1)(2013-8#1)
root canals of##2##3##(2008-5#1)(2013-1#1)
root canals using##2##3##(2008-11#1)(2013-8#1)
root canals were##2##3##(2008-11#1)(2013-8#1)
root canals##19##2##(2004-3#1)(2006-8#1)(2008-11#2)(2008-5#1)(2012-12#3)(2012-3#2)(2013-1#4)(2013-8#5)
root cap cells##2##3##(2008-10#2)
root cap was divested##2##4##(2008-9#2)
root cap was##3##3##(2008-9#3)
root cap##11##2##(2008-10#3)(2008-9#5)(2009-8#3)
root carbohydrate concentrations decreased##2##4##(2008-10#2)
root caries##3##2##(2008-1#2)(2008-5#1)
root cause analysis##3##3##(2007-5#2)(2011-1#1)
root cause##6##2##(1990-5#1)(2007-5#2)(2008-6#1)(2009-9#1)(2011-1#1)
root causes##5##2##(1995-12#1)(1996-3#1)(2009-10#1)(2010-8#1)(2013-8#1)
root cells##7##2##(2008-10#3)(2008-7#1)(2009-8#2)(2011-1#1)
root clones (n =##2##4##(2007-1#2)
root clones##5##2##(2007-1#5)
root colonization by##5##3##(2008-10#5)
root colonization was##2##3##(2008-10#1)(2010-10#1)
root colonization##15##2##(2008-10#12)(2010-10#3)
root compression##5##2##(2005-10#1)(2006-10#1)(2006-8#1)(2011-2#1)(2012-3#1)
root coverage and##2##3##(2013-1#1)(2013-7#1)
root coverage procedure##3##3##(2013-7#3)
root coverage##16##2##(2013-1#6)(2013-7#10)
root culture##4##2##(1994-11#2)(2008-10#2)
root cultures of##6##3##(1992-12#2)(1994-11#2)(1994-3#1)(2007-1#1)
root cultures##15##2##(1992-12#2)(1994-11#5)(1994-3#2)(2007-1#4)(2008-11#2)
root damage##3##2##(2008-10#1)(2009-6#1)(2012-3#1)
root dentin thickness##2##3##(2008-11#2)
root dentin##3##2##(2008-11#2)(2013-1#1)
root development##8##2##(1997-5#1)(2008-12#2)(2011-1#2)(2012-12#2)(2012-2#1)
root dimensions##2##2##(2007-8#2)
root dip##2##2##(2008-10#2)
root disease severity##3##3##(2008-10#3)
root disease##12##2##(2008-10#10)(2010-10#1)(2010-2#1)
root diseases##2##2##(2008-10#2)
root during##2##2##(2007-8#1)(2008-10#1)
root elongation and##2##3##(2006-12#1)(2009-8#1)
root elongation##6##2##(2006-12#2)(2008-7#1)(2009-8#2)(2011-12#1)
root entry##4##2##(1992-9#2)(2011-1#2)
root epidermal##2##2##(2008-9#1)(2009-6#1)
root epidermis and##5##3##(1993-6#1)(2008-10#3)(2009-6#1)
root epidermis##6##2##(1993-6#1)(2008-10#3)(2009-6#1)(2009-8#1)
root extract of##4##3##(2007-1#1)(2012-2#3)
root extract##6##2##(2007-1#1)(2008-5#1)(2012-2#3)(2013-8#1)
root extracts##2##2##(2008-10#1)(2013-1#1)
root exudates from##3##3##(2008-10#2)(2013-8#1)
root exudates##15##2##(2008-10#6)(2009-8#1)(2013-8#8)
root formation##2##2##(2008-12#1)(2009-8#1)
root from##2##2##(2007-1#1)(2008-10#1)
root galling of cucumber seedlings##2##5##(2008-10#2)
root galling##4##2##(2008-10#4)
root ganglia##41##2##(1990-11#1)(1990-4#2)(1990-7#2)(1991-10#1)(1991-2#1)(1992-12#1)(1992-3#2)(1993-5#1)(1994-10#1)(1994-2#3)(1995-5#1)(1996-11#1)(1996-3#5)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#1)(2006-12#1)(2008-1#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#3)(2012-12#1)
root ganglion neurons##6##3##(1992-8#1)(1992-9#1)(1996-3#2)(2008-5#1)(2013-8#1)
root ganglion##48##2##(1990-4#1)(1990-7#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-4#2)(1993-5#1)(1994-10#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-12#3)(1996-12#1)(1996-3#4)(1996-7#1)(1997-2#2)(1997-5#1)(2006-11#1)(2006-12#5)(2006-8#2)(2008-4#2)(2008-5#1)(2008-8#3)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
root gravitropism and##2##3##(2009-10#1)(2009-8#1)
root growth for##2##3##(2008-10#1)(2009-8#1)
root growth to inoculum##3##4##(2008-10#3)
root growth to##4##3##(2008-10#4)
root growth##20##2##(2008-10#12)(2008-12#1)(2008-8#1)(2009-8#4)(2011-12#2)
root hair area##2##3##(2008-10#2)
root hair cells of##3##4##(2006-12#1)(2009-8#2)
root hair cells##4##3##(2006-12#1)(2009-8#3)
root hair development in Arabidopsis##2##5##(2009-6#2)
root hair##14##2##(2006-12#2)(2008-10#3)(2009-6#4)(2009-8#5)
root hairs##7##2##(2008-10#2)(2009-8#5)
root in the##4##3##(1996-12#1)(2011-2#1)(2013-1#2)
root in##8##2##(1994-3#1)(1996-12#1)(2008-10#2)(2011-2#1)(2012-2#1)(2013-1#2)
root infection by##7##3##(2008-10#7)
root infection##11##2##(2008-10#11)
root injury##3##2##(2006-2#1)(2006-8#1)(2008-7#1)
root is##5##2##(2006-11#1)(2008-10#2)(2008-3#1)(2010-3#1)
root length##14##2##(2008-10#8)(2008-12#4)(2008-5#1)(2013-8#1)
root lesions##2##2##(2008-10#2)
root material##2##2##(2007-1#1)(2008-10#1)
root mean square (RMS)##2##4##(2010-9#1)(2012-12#1)
root mean square (rms)##3##4##(1992-4#1)(2008-2#1)(2008-3#1)
root mean square deviation##5##4##(1994-11#1)(1994-5#1)(1995-1#1)(2006-10#1)(2008-9#1)
root mean square deviations##3##4##(1997-4#1)(2006-10#2)
root mean square difference##2##4##(1993-3#1)(2008-10#1)
root mean square displacement of oil##2##6##(2005-11#2)
root mean square error (RMSE)##2##5##(2010-2#1)(2011-2#1)
root mean square error of calibration##3##6##(2008-1#1)(2008-10#1)(2012-12#1)
root mean square error of prediction (RMSEP)##3##7##(2008-10#3)
root mean square error of prediction##5##6##(2008-10#5)
root mean square error of##12##5##(2008-1#1)(2008-10#8)(2008-6#1)(2010-5#1)(2012-12#1)
root mean square error##15##4##(2008-1#1)(2008-10#8)(2008-6#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)
root mean square##36##3##(1992-4#1)(1993-3#1)(1994-11#1)(1994-5#2)(1995-1#1)(1997-4#1)(2005-11#2)(2006-10#3)(2008-1#1)(2008-10#9)(2008-2#1)(2008-3#3)(2008-6#1)(2008-9#1)(2009-4#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#2)
root mean squared error##2##4##(2008-10#2)
root mean squared##3##3##(2008-10#2)(2008-7#1)
root mean##41##2##(1992-4#1)(1993-3#1)(1994-11#1)(1994-5#2)(1995-1#1)(1997-4#1)(2005-11#2)(2006-10#3)(2008-1#1)(2008-10#12)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#2)
root meristems##3##2##(2009-8#3)
root mineralisation##4##2##(2010-5#4)
root necrosis##9##2##(2008-10#9)
root nodule##2##2##(2012-11#2)
root nodules in##2##3##(1995-3#1)(2012-11#1)
root nodules##4##2##(1995-3#1)(2008-11#1)(2011-2#1)(2012-11#1)
root of median nerve##3##4##(2011-12#3)
root of the##24##3##(1990-6#1)(1993-10#1)(1993-12#2)(1994-9#1)(2007-12#3)(2007-2#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-3#1)(2011-2#1)(2013-7#1)
root of##61##2##(1990-11#1)(1990-6#1)(1993-10#1)(1993-12#3)(1993-8#1)(1993-9#1)(1994-12#1)(1994-9#1)(1996-5#1)(2005-11#1)(2006-1#1)(2006-4#1)(2006-6#1)(2007-12#5)(2007-2#2)(2008-1#1)(2008-10#7)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#4)(2010-3#1)(2011-12#4)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
root oils##2##2##(2006-12#2)
root or##4##2##(2006-8#1)(2007-8#1)(2008-1#1)(2013-8#1)
root pathogen##2##2##(2008-10#2)
root pathogens##3##2##(2008-10#3)
root perforation##2##2##(2013-1#2)
root planing##11##2##(2006-10#8)(2012-2#1)(2012-3#1)(2013-7#1)
root populations##2##2##(2008-10#2)
root powder##3##2##(2008-10#3)
root production for##2##3##(2008-10#2)
root production##10##2##(2006-4#1)(2008-10#9)
root protection and grub control##2##5##(2011-2#2)
root re-replacement##2##2##(2007-8#2)
root regulates##2##2##(2008-10#1)(2009-6#1)
root remodeling and concomitant aortic annuloplasty##2##6##(2007-8#2)
root remodeling##3##2##(2007-8#3)
root replacement for##2##3##(2007-8#2)
root replacement with the Carboseal##2##5##(2007-8#2)
root replacement##9##2##(2007-8#5)(2007-9#2)(2008-4#1)(2013-7#1)
root representing##2##2##(2011-2#2)
root resorption##14##2##(2008-5#2)(2010-2#1)(2013-1#11)
root rot and##5##3##(2008-10#5)
root rot caused by##3##4##(2008-10#3)
root rot complex##2##3##(2008-10#2)
root rot disease##3##3##(2008-10#3)
root rot in##5##3##(2008-10#5)
root rot of apple##3##4##(2008-10#3)
root rot of sugarcane##2##4##(2008-10#2)
root rot of##18##3##(2008-10#18)
root rot pathogen##3##3##(2008-10#1)(2010-3#1)(2012-2#1)
root rot severity##7##3##(2008-10#7)
root rot symptoms##3##3##(2008-10#3)
root rot##75##2##(2006-5#1)(2008-10#69)(2010-3#2)(2012-11#1)(2012-2#2)
root samples from##2##3##(2008-10#2)
root samples##7##2##(2007-1#1)(2008-10#5)(2012-6#1)
root segments of##2##3##(1997-8#1)(2008-10#1)
root segments##3##2##(1997-8#1)(2008-10#2)
root sheath##4##2##(1990-6#1)(2008-5#1)(2012-12#1)(2013-8#1)
root surface##11##2##(2008-10#4)(2012-12#1)(2013-1#4)(2013-8#2)
root surfaces##2##2##(2008-10#1)(2013-7#1)
root symbiosis##2##2##(2010-10#1)(2012-8#1)
root symptoms##3##2##(2007-8#1)(2008-10#2)
root system##9##2##(2008-10#7)(2009-8#1)(2011-1#1)
root systems of##3##3##(2004-4#1)(2008-10#2)
root systems##9##2##(2004-4#1)(2008-10#7)(2009-3#1)
root than##2##2##(1991-6#1)(1996-10#1)
root the##2##2##(1992-12#1)(2010-11#1)
root tip cells##2##3##(2008-5#1)(2009-10#1)
root tip exudates##3##3##(2008-10#3)
root tip##10##2##(2008-10#5)(2008-5#3)(2009-10#1)(2009-6#1)
root tips and##2##3##(1994-3#1)(2011-12#1)
root tips were##2##3##(2008-10#1)(2008-9#1)
root tips##12##2##(1994-3#1)(2008-10#3)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2011-12#1)
root tissue##16##2##(2008-10#15)(2008-8#1)
root tissues in##2##3##(2008-10#2)
root tissues of##2##3##(2008-10#2)
root tissues##14##2##(2008-10#12)(2009-10#1)(2009-8#1)
root to##7##2##(2008-10#1)(2008-5#3)(2008-9#2)(2012-2#1)
root was##15##2##(1992-11#2)(2008-11#1)(2008-12#5)(2008-5#2)(2008-7#1)(2008-9#2)(2011-1#1)(2013-1#1)
root weight##2##2##(2008-10#2)
root were##2##2##(2008-9#2)
root with a##3##3##(1991-6#1)(2013-1#2)
root with##4##2##(1991-6#1)(2009-4#1)(2013-1#2)
root zone##4##2##(2008-7#1)(2009-6#1)(2011-1#1)(2011-2#1)
root##1206##1##(1990-11#2)(1990-2#1)(1990-4#5)(1990-5#2)(1990-6#2)(1990-7#3)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#6)(1991-7#1)(1991-9#2)(1992-11#4)(1992-12#4)(1992-3#2)(1992-4#1)(1992-8#3)(1992-9#5)(1993-10#1)(1993-12#9)(1993-2#1)(1993-3#1)(1993-4#2)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#8)(1994-12#2)(1994-2#6)(1994-3#6)(1994-5#4)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#6)(1995-3#3)(1995-5#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-3#11)(1996-5#3)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#6)(1997-5#5)(1997-6#2)(1997-8#2)(2004-3#1)(2004-4#4)(2004-9#1)(2005-10#4)(2005-11#5)(2005-12#4)(2005-9#1)(2006-1#2)(2006-10#15)(2006-11#4)(2006-12#15)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#20)(2006-9#1)(2007-1#27)(2007-11#3)(2007-12#8)(2007-2#5)(2007-5#3)(2007-8#36)(2007-9#7)(2008-1#7)(2008-10#375)(2008-11#13)(2008-12#22)(2008-2#5)(2008-3#8)(2008-4#5)(2008-5#40)(2008-6#4)(2008-7#19)(2008-8#10)(2008-9#33)(2009-10#6)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#21)(2009-7#1)(2009-8#52)(2009-9#1)(2010-10#7)(2010-11#3)(2010-12#4)(2010-2#5)(2010-3#11)(2010-5#7)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#14)(2011-12#14)(2011-2#17)(2011-3#1)(2012-1#3)(2012-11#5)(2012-12#15)(2012-2#18)(2012-3#8)(2012-6#1)(2012-8#3)(2013-1#70)(2013-7#15)(2013-8#28)
root)##6##1##(2006-7#1)(2007-8#1)(2008-10#3)(2008-5#1)
root-cause analysis##3##2##(2006-6#1)(2007-4#1)(2007-7#1)
root-colonizing##3##1##(2008-10#3)
root-end##2##1##(2010-8#1)(2012-12#1)
root-feeding insects##2##2##(2009-6#2)
root-feeding##3##1##(2008-10#1)(2009-6#2)
root-filled maxillary central incisor associated with pain and sinus tract##2##10##(2013-1#2)
root-galling##2##1##(2008-10#2)
root-infecting##2##1##(2008-10#1)(2010-10#1)
root-knot and cyst nematodes##2##4##(2008-10#2)
root-knot and cyst##3##3##(2008-10#3)
root-knot nematode Meloidogyne incognita##2##4##(2008-10#2)
root-knot nematode Meloidogyne##7##3##(2008-10#7)
root-knot nematode species and was##2##5##(2008-10#1)(2009-3#1)
root-knot nematode species##5##3##(2008-10#3)(2009-3#2)
root-knot nematode##20##2##(2008-10#17)(2009-3#3)
root-knot nematodes and##2##3##(2008-10#1)(2009-3#1)
root-knot nematodes##11##2##(2008-10#9)(2009-3#2)
root-knot##37##1##(2008-10#31)(2009-3#5)(2009-8#1)
root-lesion nematodes##2##2##(2008-10#2)
root-lesion##5##1##(2008-10#5)
root-mean-square deviation##5##2##(1995-3#1)(1996-6#1)(1997-2#1)(1997-5#1)(2008-8#1)
root-mean-square deviations from##2##3##(1994-9#1)(1995-6#1)
root-mean-square deviations##6##2##(1994-9#1)(1995-6#1)(1995-8#1)(1997-5#1)(2006-12#1)(2010-12#1)
root-mean-square error of an##2##4##(2008-2#1)(2008-3#1)
root-mean-square error of##3##3##(2008-2#2)(2008-3#1)
root-mean-square error##4##2##(2005-12#1)(2008-2#2)(2008-3#1)
root-mean-square errors of##2##3##(2007-11#1)(2008-10#1)
root-mean-square##30##1##(1993-2#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-6#2)(1997-2#1)(1997-5#2)(2005-12#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-8#3)(2010-12#1)(2010-4#1)(2012-2#1)
root-related pain##2##2##(2006-12#2)
root-related##3##1##(2006-12#3)
root-resistant##2##1##(2008-10#2)
root-tip cells##2##2##(2008-11#1)(2008-9#1)
root-to-root spread##4##2##(2008-10#4)
root/shoot ratio##2##2##(2008-12#1)(2008-5#1)
rooted in the##6##3##(1993-11#1)(1997-1#1)(2005-7#1)(2008-10#1)(2008-11#1)(2009-6#1)
rooted in##15##2##(1991-12#1)(1993-11#1)(1997-1#1)(2005-7#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-6#1)(2010-8#1)(2012-1#1)(2012-2#3)
rooted##31##1##(1991-12#1)(1993-11#1)(1995-5#1)(1997-1#1)(2005-7#1)(2006-12#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#2)(2009-11#1)(2009-6#1)(2010-2#2)(2010-8#1)(2012-1#1)(2012-2#3)
rooting was obtained##2##3##(2007-3#2)
rooting##8##1##(1992-12#2)(1996-3#1)(2007-3#2)(2008-2#1)(2008-4#2)
rootlets##3##1##(1996-12#1)(2008-10#2)
roots against##2##2##(2008-10#1)(2011-2#1)
roots and a##2##3##(2008-11#1)(2010-5#1)
roots and canals##4##3##(2013-1#4)
roots and hypocotyls##2##3##(2008-10#2)
roots and leaves##12##3##(1992-3#1)(1996-5#1)(2008-12#3)(2012-7#1)(2013-8#6)
roots and shoots##5##3##(2008-10#1)(2008-12#3)(2008-5#1)
roots and stems##4##3##(2007-1#1)(2008-10#3)
roots and the##5##3##(2007-1#1)(2008-10#2)(2008-11#1)(2013-8#1)
roots and their##2##3##(2008-9#1)(2009-10#1)
roots and##68##2##(1992-3#1)(1994-3#1)(1994-8#1)(1995-7#1)(1996-5#1)(2004-4#1)(2006-1#1)(2006-12#1)(2006-5#1)(2007-1#5)(2007-3#1)(2008-10#22)(2008-11#2)(2008-12#7)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-5#2)(2010-7#1)(2012-3#1)(2012-7#1)(2013-1#4)(2013-8#7)
roots are##5##2##(2008-10#1)(2008-7#1)(2008-9#2)(2011-2#1)
roots as##5##2##(1995-3#1)(2008-10#1)(2008-9#1)(2009-3#1)(2012-12#1)
roots at the##2##3##(2008-10#2)
roots at##4##2##(2008-10#4)
roots but##2##2##(2008-10#2)
roots by##13##2##(2008-10#13)
roots collected##3##2##(1997-4#1)(2008-10#2)
roots developed##2##2##(2007-1#1)(2008-10#1)
roots did not##2##3##(2008-10#2)
roots during##5##2##(1994-8#1)(2009-8#1)(2013-1#3)
roots exposed to##2##3##(2008-10#1)(2008-4#1)
roots following##2##2##(2012-1#2)
roots for the treatment##2##4##(2008-9#2)
roots for##4##2##(2007-3#1)(2008-9#2)(2012-2#1)
roots from plants##2##3##(2008-10#2)
roots from##11##2##(2008-10#9)(2008-7#1)(2009-8#1)
roots grown##3##2##(2007-11#1)(2008-10#1)(2010-10#1)
roots have##2##2##(2008-12#1)(2008-4#1)
roots in a##3##3##(2008-10#2)(2008-5#1)
roots in the##6##3##(1993-2#1)(1997-2#1)(2008-10#1)(2008-9#1)(2010-9#1)(2012-2#1)
roots in which##2##3##(2008-10#2)
roots in##22##2##(1993-2#1)(1997-2#1)(2006-7#1)(2008-10#10)(2008-5#2)(2008-9#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-9#1)(2012-2#2)
roots increased##2##2##(2008-10#2)
roots inoculated with##2##3##(2008-10#2)
roots is##4##2##(2006-4#1)(2007-8#1)(2008-10#1)(2009-8#1)
roots may be##2##3##(1992-12#1)(2008-10#1)
roots occurred##2##2##(2008-10#2)
roots of Angelica##2##3##(1996-11#1)(2011-1#1)
roots of Brugmansia candida##2##4##(2008-6#2)
roots of Cynanchum chekiangense##2##4##(2007-8#2)
roots of Panax notoginseng##2##4##(2006-12#2)
roots of Panax##3##3##(1994-12#1)(2006-12#2)
roots of Scutellaria planipes##2##4##(2007-1#2)
roots of apple seedlings grown in##2##6##(2008-10#2)
roots of apple seedlings##3##4##(2008-10#3)
roots of the##16##3##(1991-12#1)(1992-8#1)(1993-12#1)(1996-12#2)(2005-11#2)(2007-1#1)(2007-12#1)(2007-9#1)(2008-3#1)(2008-7#1)(2011-1#2)(2011-2#1)(2012-6#1)
roots of tomato##2##3##(2008-10#2)
roots of wheat##5##3##(2008-10#5)
roots of##146##2##(1990-11#2)(1990-2#1)(1991-1#1)(1991-12#1)(1991-7#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-11#1)(1996-12#2)(2005-11#2)(2006-12#6)(2006-7#1)(2006-9#1)(2007-1#27)(2007-11#3)(2007-12#1)(2007-3#1)(2007-8#4)(2007-9#1)(2008-10#39)(2008-11#1)(2008-12#5)(2008-3#1)(2008-6#2)(2008-7#1)(2008-9#3)(2009-3#3)(2009-8#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2011-1#8)(2011-2#6)(2012-12#3)(2012-6#1)(2013-1#1)(2013-8#1)
roots on##2##2##(2008-10#1)(2008-5#1)
roots or##7##2##(2006-12#1)(2008-10#4)(2012-1#1)(2013-1#1)
roots over time##4##3##(2008-10#4)
roots prior to##2##3##(2008-10#2)
roots produced on##2##3##(2008-10#2)
roots produced##3##2##(2008-10#3)
roots resulted in##2##3##(1995-9#1)(2008-10#1)
roots revealed that##2##3##(2008-10#1)(2009-8#1)
roots revealed##3##2##(2008-10#2)(2009-8#1)
roots showed##4##2##(2008-10#3)(2010-5#1)
roots than##2##2##(2008-10#2)
roots that were##2##3##(2008-10#2)
roots that##6##2##(2007-8#1)(2008-10#5)
roots to the##2##3##(2008-10#1)(2008-11#1)
roots to##14##2##(2006-8#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-9#1)(2009-10#2)(2009-3#1)(2010-5#1)(2012-2#1)
roots under copper stress##4##4##(2013-8#4)
roots under copper##5##3##(2013-8#5)
roots via##2##2##(2008-10#1)(2013-8#1)
roots was investigated##2##3##(1990-2#1)(2008-10#1)
roots was significantly##2##3##(2008-10#1)(2008-5#1)
roots was##20##2##(1990-2#1)(2007-1#1)(2008-10#14)(2008-12#1)(2008-5#1)(2008-9#1)(2009-10#1)
roots were affected##2##3##(2008-10#2)
roots were infected for Genghis and Savannah##2##7##(2008-10#2)
roots were infected##4##3##(2008-10#4)
roots were##38##2##(1993-12#1)(2004-4#1)(2007-1#3)(2007-8#1)(2008-10#24)(2008-12#1)(2008-5#1)(2009-6#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)
roots with increasing##2##3##(2008-10#1)(2008-12#1)
roots with##9##2##(2008-10#7)(2008-12#1)(2009-5#1)
roots##678##1##(1990-10#1)(1990-11#3)(1990-2#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-12#4)(1993-2#1)(1993-8#1)(1994-12#1)(1994-3#3)(1994-8#2)(1995-3#4)(1995-6#1)(1995-7#1)(1995-9#1)(1996-11#1)(1996-12#4)(1996-5#1)(1997-2#2)(1997-4#1)(2004-12#1)(2004-4#7)(2005-11#2)(2006-1#3)(2006-10#1)(2006-12#12)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#5)(2006-9#1)(2007-1#45)(2007-11#8)(2007-12#3)(2007-3#3)(2007-5#2)(2007-8#10)(2007-9#1)(2008-1#1)(2008-10#291)(2008-11#7)(2008-12#22)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#16)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#18)(2009-10#8)(2009-11#1)(2009-3#8)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#20)(2010-1#1)(2010-10#3)(2010-12#1)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#8)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#10)(2011-10#4)(2011-12#1)(2011-2#15)(2012-1#6)(2012-11#1)(2012-12#7)(2012-2#4)(2012-3#1)(2012-5#1)(2012-6#1)(2012-7#2)(2013-1#14)(2013-8#18)
roots)##4##1##(2007-1#1)(2008-10#3)
rootstock was inoculated##2##3##(2008-10#1)(2010-10#1)
rootstock##7##1##(2008-10#5)(2010-10#2)
rootstocks##12##1##(2008-10#9)(2009-8#1)(2010-10#2)
rootworm##12##1##(2008-10#1)(2010-12#1)(2011-12#2)(2011-2#8)
rop##2##1##(1992-2#1)(1992-9#1)
rope sign&quot##2##2##(2005-11#2)
rope##3##1##(2005-11#2)(2006-7#1)
ropinirole on blood pressure and noradrenaline##2##6##(2008-7#2)
ropinirole##13##1##(1990-9#1)(2005-7#1)(2008-7#9)(2010-2#2)
ropivacain (5##2##2##(2012-3#2)
ropivacain 5##2##2##(2012-3#2)
ropivacain##6##1##(2012-3#6)
ropivacaine 0##4##2##(2012-2#1)(2013-7#3)
ropivacaine and levobupivacaine##3##3##(2006-10#2)(2013-7#1)
ropivacaine in##3##2##(2006-10#2)(2010-12#1)
ropivacaine##13##1##(2006-10#6)(2010-12#1)(2012-2#1)(2012-3#1)(2013-7#4)
roreri##7##1##(2008-10#7)
roretzi hemocytes##2##2##(2008-6#2)
roretzi plasma##2##2##(2008-6#2)
roretzi##9##1##(1993-6#1)(2008-5#2)(2008-6#6)
rosa and C##2##3##(2007-6#2)
rosa and##3##2##(1990-5#1)(2007-6#2)
rosa##11##1##(1990-5#5)(1993-6#2)(2007-6#4)
rosacea and##2##2##(2006-12#1)(2010-4#1)
rosacea##12##1##(2006-12#3)(2007-1#1)(2007-7#1)(2008-2#1)(2008-3#1)(2009-4#1)(2010-4#1)(2010-8#2)(2013-1#1)
rose (Rosa##2##2##(2008-10#1)(2011-2#1)
rose again##2##2##(2007-12#1)(2008-5#1)
rose bengal##4##2##(1994-3#2)(2006-5#1)(2008-10#1)
rose by##6##2##(1995-2#1)(2007-3#2)(2007-7#1)(2010-11#1)(2010-7#1)
rose from 1##2##3##(1990-12#1)(1990-5#1)
rose from 4##2##3##(1995-3#1)(1995-4#1)
rose from##13##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-5#1)(1994-2#1)(1995-1#1)(1995-3#2)(1995-4#1)(1996-12#1)(2007-8#1)(2012-12#1)
rose isolates##2##2##(2008-10#2)
rose more##3##2##(1990-11#1)(1993-7#1)(2009-4#1)
rose progressively##2##2##(1995-2#1)(2006-9#1)
rose rapidly##2##2##(1993-7#1)(2008-11#1)
rose sharply##2##2##(1993-3#1)(2006-10#1)
rose significantly in##2##3##(2007-7#1)(2008-4#1)
rose significantly##13##2##(1990-12#1)(1992-1#1)(1992-11#1)(1992-2#1)(1993-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-7#1)(2010-8#1)(2011-1#1)
rose steadily##2##2##(1997-7#1)(2008-10#1)
rose to a##3##3##(1992-8#1)(1993-2#1)(2008-10#1)
rose to the##4##3##(1993-2#1)(2008-7#1)(2008-9#1)(2010-8#1)
rose to##23##2##(1990-4#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-2#3)(1993-5#1)(1994-6#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)
rose wines##3##2##(2008-10#3)
rose with increasing##2##3##(1994-2#1)(2008-11#1)
rose with##4##2##(1994-2#1)(1994-6#1)(1997-4#1)(2008-11#1)
rose##133##1##(1990-11#2)(1990-12#2)(1990-3#2)(1990-4#2)(1990-5#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-6#1)(1992-8#2)(1993-2#5)(1993-3#1)(1993-5#1)(1993-7#4)(1993-9#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#5)(1995-4#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-5#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-12#2)(2007-3#2)(2007-5#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#23)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-4#1)(2009-6#1)(2010-11#2)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#1)(2013-7#1)
rosea IK726##4##2##(2008-10#4)
rosea##13##1##(2007-1#1)(2008-10#10)(2008-5#2)
rosea)##2##1##(2008-10#1)(2010-3#1)
roseicollis)##2##1##(1997-3#2)
rosemary##3##1##(2008-10#1)(2008-6#1)(2010-12#1)
roses##7##1##(2007-7#1)(2008-10#6)
rosette assistor virus (GRAV)##2##4##(2008-10#2)
rosette assistor virus##3##3##(2008-10#3)
rosette formation##2##2##(1996-5#1)(2008-4#1)
rosette infections##2##2##(2008-10#2)
rosette leaves of Tsu-0 plants##2##5##(2008-10#2)
rosette leaves##3##2##(2008-10#2)(2008-8#1)
rosette species##2##2##(2009-8#2)
rosette virus (GRV)##2##3##(2008-10#2)
rosette##29##1##(1995-12#1)(1996-5#1)(1997-2#1)(2007-12#2)(2008-10#15)(2008-2#1)(2008-4#2)(2008-8#2)(2009-8#3)(2012-2#1)
rosettes and##3##2##(1995-6#1)(1996-10#1)(2007-12#1)
rosettes##12##1##(1991-8#1)(1993-4#1)(1995-6#1)(1996-10#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-8#1)(2011-2#1)(2012-12#1)
rosetting##4##1##(1993-4#1)(2008-4#2)(2012-12#1)
roseum MF2##3##2##(2005-11#3)
roseum and##2##2##(2007-7#2)
roseum##15##1##(2005-11#3)(2007-7#4)(2008-10#5)(2008-5#3)
roseus##5##1##(1997-8#1)(2007-1#1)(2009-8#3)
roseus)##3##1##(2008-10#3)
rosiglitazone and##3##2##(2007-1#1)(2010-10#2)
rosiglitazone in##2##2##(2008-11#1)(2010-4#1)
rosiglitazone use##2##2##(2010-4#2)
rosiglitazone##17##1##(2007-1#1)(2008-1#3)(2008-11#1)(2008-3#3)(2008-5#1)(2010-10#2)(2010-4#5)(2010-7#1)
rosmarinic acid and##2##3##(2007-1#1)(2013-1#1)
rosmarinic acid production##2##3##(2013-1#2)
rosmarinic acid##12##2##(2007-1#4)(2008-10#1)(2013-1#7)
rostellar hooks##2##2##(2011-2#2)
roster of##2##2##(2005-9#1)(2007-9#1)
roster##4##1##(1990-2#1)(1995-2#1)(2005-9#1)(2007-9#1)
rostochiensis and G##4##3##(2008-10#4)
rostral and caudal##4##3##(1993-9#1)(1995-5#1)(1996-3#1)(2008-7#1)
rostral and##5##2##(1993-9#1)(1995-5#1)(1996-3#1)(1997-5#1)(2008-7#1)
rostral migratory stream##3##3##(1996-4#2)(2008-1#1)
rostral part of area 23c##2##5##(1996-5#2)
rostral part of area##4##4##(1996-5#4)
rostral part of##9##3##(1991-9#1)(1993-12#4)(1996-5#4)
rostral to the otic capsules##2##5##(1996-4#2)
rostral to the##5##3##(1993-3#1)(1996-4#3)(2007-2#1)
rostral to##6##2##(1993-3#1)(1994-10#1)(1996-4#3)(2007-2#1)
rostral ventrolateral medulla##10##3##(1991-5#1)(1993-12#1)(1997-2#2)(1997-6#2)(1997-8#2)(2007-10#2)
rostral##73##1##(1990-9#1)(1991-11#1)(1991-5#2)(1991-9#1)(1992-8#1)(1993-12#9)(1993-2#2)(1993-3#1)(1993-5#1)(1993-7#3)(1993-9#2)(1994-10#1)(1994-12#2)(1995-5#1)(1995-6#1)(1995-7#2)(1996-12#1)(1996-3#2)(1996-4#6)(1996-5#4)(1997-2#2)(1997-5#4)(1997-6#2)(1997-7#2)(1997-8#3)(2006-7#1)(2007-10#2)(2007-2#2)(2008-1#1)(2008-11#3)(2008-7#3)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)
rostrally adjacent##2##2##(1991-11#1)(1992-8#1)
rostrally##4##1##(1991-11#1)(1992-8#1)(1996-7#1)(2010-2#1)
rostratum##13##1##(2007-7#3)(2008-10#10)
rostro-caudal gradient##2##2##(1991-5#1)(1992-12#1)
rostro-caudal##5##1##(1991-5#1)(1992-12#1)(1995-5#1)(2009-2#1)(2013-8#1)
rostrocaudal##5##1##(1990-4#1)(1991-5#2)(1995-5#1)(1996-9#1)
rostroventrolateral medulla##2##2##(1995-3#2)
rostrum##2##1##(2008-5#1)(2009-2#1)
rosuvastatin in##2##2##(2010-12#1)(2011-1#1)
rosuvastatin##14##1##(2010-12#2)(2010-4#1)(2010-9#2)(2011-1#9)
rosy##3##1##(1992-3#1)(2008-5#2)
rot and##22##2##(2008-10#22)
rot are caused by##2##4##(2008-10#2)
rot caused by##7##3##(2008-10#7)
rot development on##2##3##(2008-10#2)
rot development##3##2##(2008-10#3)
rot disease of##3##3##(2008-10#2)(2008-8#1)
rot disease##4##2##(2008-10#3)(2008-8#1)
rot fungal##2##2##(2008-10#1)(2009-9#1)
rot fungi##3##2##(2008-10#2)(2009-9#1)
rot fungus##5##2##(1991-2#1)(2005-12#1)(2008-10#1)(2008-6#1)(2009-9#1)
rot in different##2##3##(2008-10#2)
rot in the##2##3##(2008-10#2)
rot in##25##2##(2008-10#24)(2010-10#1)
rot incidence##4##2##(2008-10#4)
rot is a##2##3##(2008-10#2)
rot is likely##2##3##(2008-10#2)
rot is##6##2##(2008-10#5)(2010-3#1)
rot isolates##2##2##(2008-10#2)
rot of citrus##2##3##(2008-10#2)
rot of corn##3##3##(2008-10#3)
rot of sugarcane##3##3##(2008-10#3)
rot of##44##2##(2008-10#44)
rot on##7##2##(2008-10#6)(2012-2#1)
rot pathogen##4##2##(2008-10#2)(2010-3#1)(2012-2#1)
rot pathogens##3##2##(2006-5#1)(2008-10#2)
rot severity by##3##3##(2008-10#3)
rot severity were##2##3##(2008-10#2)
rot severity##11##2##(2008-10#11)
rot symptoms in##2##3##(2008-10#2)
rot symptoms##7##2##(2008-10#7)
rot was##8##2##(2008-10#8)
rot were##3##2##(2008-10#3)
rot when##2##2##(2008-10#2)
rot##285##1##(1991-2#1)(1996-12#1)(2005-12#1)(2006-5#1)(2008-10#269)(2008-6#1)(2008-8#1)(2009-9#3)(2010-10#1)(2010-3#2)(2012-11#1)(2012-2#2)(2012-3#1)
rot)##2##1##(2008-10#2)
rotamer libraries##4##2##(2012-3#4)
rotamer library##4##2##(2012-3#4)
rotamer##12##1##(1990-5#2)(1995-8#1)(2012-3#9)
rotameric##2##1##(1995-10#1)(1995-8#1)
rotamers##6##1##(1992-6#3)(1996-6#1)(2006-12#1)(2012-3#1)
rotarod test##3##2##(1997-2#3)
rotarod##6##1##(1997-2#4)(2008-7#1)(2009-4#1)
rotary biofilm contactor##2##3##(2008-5#2)
rotary cultivator##5##2##(2008-10#5)
rotary cutting instruments##2##3##(2012-12#2)
rotary displacement##2##2##(2008-2#2)
rotary shadowed##2##2##(1991-3#1)(2008-4#1)
rotary##41##1##(1991-3#1)(2006-11#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-12#1)(2008-10#9)(2008-11#3)(2008-2#5)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-7#2)(2011-2#1)(2012-1#1)(2012-12#3)(2013-1#1)
rotatable##7##1##(2006-6#1)(2007-12#1)(2007-9#1)(2008-7#1)(2010-12#1)(2012-2#2)
rotate the##4##2##(1995-8#1)(2008-10#1)(2008-2#2)
rotate##20##1##(1991-11#1)(1991-2#2)(1993-11#1)(1995-5#1)(1995-8#2)(1996-1#1)(1997-7#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-7#1)(2010-12#1)
rotated about##3##2##(2008-2#3)
rotated and##2##2##(1997-5#1)(2008-3#1)
rotated by##2##2##(2007-11#1)(2007-12#1)
rotated horizontally##2##2##(2009-3#1)(2013-7#1)
rotated in the##2##3##(2007-1#1)(2008-11#1)
rotated in##6##2##(2007-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)
rotated through##2##2##(2004-3#1)(2008-7#1)
rotated to##2##2##(2008-10#1)(2008-3#1)
rotated##57##1##(1991-12#1)(1993-6#1)(1995-8#1)(1997-5#1)(2004-3#1)(2007-1#1)(2007-11#3)(2007-12#6)(2008-1#1)(2008-10#3)(2008-11#4)(2008-2#6)(2008-3#15)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#3)(2009-3#2)(2011-2#1)(2012-12#1)(2013-7#1)
rotates the polarization##2##3##(2007-12#1)(2008-2#1)
rotates the##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
rotates to##3##2##(1991-7#1)(1996-2#1)(2008-2#1)
rotates##18##1##(1991-2#1)(1991-7#1)(1992-3#1)(1996-2#1)(2007-12#3)(2007-5#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)
rotating Ronchi##2##2##(2008-2#2)
rotating X-ray shutter##2##3##(2006-5#2)
rotating analyzer##2##2##(2008-3#2)
rotating bioreactor##3##2##(2008-10#3)
rotating bioreactors##2##2##(2007-11#2)
rotating biosensor##4##2##(2008-10#4)
rotating clusters##2##2##(2008-10#1)(2009-7#1)
rotating disc electrode##2##3##(2008-10#2)
rotating disc##3##2##(2008-10#2)(2008-7#1)
rotating disk electrode measurements##2##4##(2008-10#2)
rotating disk electrode##3##3##(2008-10#3)
rotating disk##12##2##(2007-8#1)(2008-10#8)(2008-3#2)(2008-7#1)
rotating glassy carbon##2##3##(2008-10#2)
rotating magnetic field##2##3##(2008-10#2)
rotating magnetic fields##3##3##(2005-11#2)(2008-10#1)
rotating magnetic##5##2##(2005-11#2)(2008-10#3)
rotating spiral##2##2##(1990-3#1)(1992-3#1)
rotating the grating##3##3##(2008-2#1)(2008-3#2)
rotating the##9##2##(2006-3#1)(2007-12#1)(2008-2#1)(2008-3#6)
rotating##121##1##(1990-12#2)(1990-3#1)(1991-2#1)(1992-3#2)(1992-9#2)(1993-4#2)(1994-2#1)(1996-2#1)(2005-11#4)(2006-2#1)(2006-3#1)(2006-5#2)(2007-1#1)(2007-11#5)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#26)(2008-11#2)(2008-12#1)(2008-2#20)(2008-3#19)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-3#1)(2009-7#2)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#1)
rotating-anode##2##1##(2006-5#2)
rotating-compensator##2##1##(2008-2#2)
rotating-disc##2##1##(2008-10#2)
rotating-polarizer##4##1##(2008-2#1)(2008-3#3)
rotating-wall vessel##2##2##(2008-11#2)
rotating-wall##3##1##(2008-11#3)
rotation about##2##2##(1994-8#1)(2008-3#1)
rotation and translation##2##3##(2008-2#1)(2008-8#1)
rotation and##34##2##(1992-10#1)(1993-3#1)(1994-11#1)(1996-5#3)(2006-10#1)(2006-11#1)(2007-1#1)(2007-2#2)(2007-7#2)(2007-8#1)(2008-10#2)(2008-12#3)(2008-2#3)(2008-3#3)(2008-6#1)(2008-8#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-9#1)(2011-1#2)(2012-2#1)
rotation angle of##3##3##(1995-8#1)(2008-2#2)
rotation angle##16##2##(1995-8#1)(2006-11#1)(2007-1#1)(2007-7#1)(2007-8#2)(2008-2#6)(2008-3#4)
rotation angles of##3##3##(1995-8#1)(2008-2#1)(2008-3#1)
rotation angles with##2##3##(2008-2#1)(2008-3#1)
rotation angles##9##2##(1995-8#1)(2007-11#1)(2008-2#3)(2008-3#4)
rotation are##5##2##(2007-5#1)(2008-2#1)(2008-3#3)
rotation as the##2##3##(2007-11#1)(2012-1#1)
rotation as well as##3##4##(2007-11#2)(2007-4#1)
rotation as##7##2##(2007-11#3)(2007-4#1)(2008-2#1)(2008-7#1)(2012-1#1)
rotation at##2##2##(1996-5#1)(2007-10#1)
rotation between the two helices##2##5##(1993-1#2)
rotation between the two##3##4##(1993-1#2)(2008-8#1)
rotation between##5##2##(1993-1#3)(2008-8#1)(2008-9#1)
rotation by##3##2##(2008-3#1)(2008-7#1)(2010-12#1)
rotation can##3##2##(2006-6#1)(2007-11#1)(2008-2#1)
rotation during##2##2##(2007-6#1)(2009-9#1)
rotation for a##3##3##(2007-12#1)(2008-3#2)
rotation for##6##2##(2007-12#1)(2008-11#2)(2008-3#2)(2008-4#1)
rotation has##2##2##(2008-12#1)(2008-2#1)
rotation in a##3##3##(2007-11#1)(2008-1#1)(2008-3#1)
rotation in its own plane##2##5##(2007-11#1)(2008-3#1)
rotation in the##11##3##(1994-8#1)(1997-1#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-3#1)(2008-8#1)(2009-3#1)(2013-7#1)
rotation in##32##2##(1991-5#1)(1994-8#1)(1995-8#1)(1996-1#1)(1997-1#1)(1997-3#1)(2006-5#1)(2007-11#3)(2007-12#1)(2007-7#3)(2007-8#4)(2008-1#2)(2008-12#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2013-7#1)
rotation induced by##2##3##(2007-11#1)(2008-7#1)
rotation invariance##3##2##(2008-3#3)
rotation is a##4##3##(2008-10#2)(2009-3#1)(2011-2#1)
rotation is##15##2##(1990-2#1)(1991-1#2)(1993-8#1)(1996-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-3#1)(2011-2#1)
rotation mechanism##4##2##(1997-4#3)(2006-6#1)
rotation of a##4##3##(1993-3#1)(1994-2#1)(2008-2#1)(2008-3#1)
rotation of gamma over##2##4##(1997-4#2)
rotation of gamma##3##3##(1997-4#3)
rotation of magnetic beads##2##4##(2007-12#2)
rotation of the lower leg##4##5##(2007-8#4)
rotation of the principal axis##2##5##(2007-12#1)(2008-3#1)
rotation of the principal##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
rotation of the##63##3##(1990-2#1)(1991-11#1)(1991-5#1)(1992-12#1)(1994-11#1)(1994-9#1)(1996-2#1)(1997-1#1)(1997-7#1)(1997-8#1)(2005-11#2)(2006-11#1)(2006-4#1)(2007-11#4)(2007-12#8)(2007-7#1)(2007-8#5)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#12)(2008-6#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
rotation of##91##2##(1990-2#1)(1990-8#1)(1991-11#1)(1991-5#1)(1991-7#2)(1992-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-9#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-4#3)(1997-7#1)(1997-8#1)(2005-11#2)(2006-11#1)(2006-4#1)(2007-11#5)(2007-12#11)(2007-4#1)(2007-7#1)(2007-8#5)(2008-10#2)(2008-11#2)(2008-2#6)(2008-3#14)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-3#2)(2009-4#1)(2009-8#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
rotation on the##2##3##(2008-2#1)(2008-3#1)
rotation on##6##2##(1995-12#1)(2008-2#1)(2008-3#1)(2009-3#1)(2012-2#1)(2013-8#1)
rotation or translation##2##3##(2008-3#1)(2012-1#1)
rotation or##3##2##(2008-3#1)(2011-2#1)(2012-1#1)
rotation rate of##3##3##(1997-4#1)(2008-11#1)(2008-8#1)
rotation rate with##3##3##(1996-5#1)(2008-3#2)
rotation rate##11##2##(1992-7#2)(1996-5#1)(1997-2#1)(1997-4#1)(2008-11#2)(2008-3#2)(2008-6#1)(2008-8#1)
rotation rates##3##2##(1992-7#1)(1997-7#2)
rotation seems##2##2##(1991-2#1)(2012-2#1)
rotation significantly increased##2##3##(2008-12#2)
rotation speeds##2##2##(1997-2#1)(2008-7#1)
rotation the##2##2##(2009-3#1)(2012-2#1)
rotation to within##2##3##(2008-8#2)
rotation to##3##2##(2007-12#1)(2008-8#2)
rotation was used to##2##4##(2006-12#1)(2008-6#1)
rotation was##11##2##(1995-6#1)(1996-1#1)(1996-7#1)(2006-12#1)(2007-1#2)(2007-11#2)(2008-10#1)(2008-6#2)
rotation with##6##2##(1990-3#1)(1993-9#1)(2006-12#1)(2008-12#1)(2008-8#2)
rotation##484##1##(1990-2#3)(1990-3#2)(1990-8#1)(1991-1#8)(1991-11#1)(1991-2#2)(1991-4#2)(1991-5#3)(1991-7#2)(1992-1#1)(1992-10#3)(1992-12#1)(1992-7#6)(1992-9#1)(1993-1#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#4)(1996-1#3)(1996-2#5)(1996-5#10)(1996-7#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#9)(1997-7#4)(1997-8#1)(2005-11#2)(2006-10#1)(2006-11#4)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-8#1)(2007-1#5)(2007-10#2)(2007-11#25)(2007-12#24)(2007-2#2)(2007-4#2)(2007-5#1)(2007-6#3)(2007-7#9)(2007-8#22)(2007-9#1)(2008-1#4)(2008-10#22)(2008-11#17)(2008-12#13)(2008-2#36)(2008-3#63)(2008-4#3)(2008-5#2)(2008-6#8)(2008-7#7)(2008-8#17)(2008-9#4)(2009-2#1)(2009-3#11)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#3)(2010-12#4)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#8)(2012-1#6)(2012-2#10)(2012-3#3)(2013-1#4)(2013-7#4)(2013-8#2)
rotation)##3##1##(2007-6#1)(2007-7#1)(2008-10#1)
rotation-invariant pattern recognition##2##3##(2008-3#2)
rotation-invariant##7##1##(2008-2#2)(2008-3#3)(2008-6#2)
rotation-vibration energies of twenty##2##4##(2005-4#2)
rotational (lacking##2##2##(2008-10#2)
rotational CARS##6##2##(2007-12#1)(2008-2#5)
rotational Raman lines##2##3##(2007-12#1)(2008-3#1)
rotational Raman scattering##4##3##(2007-12#2)(2008-3#2)
rotational Raman sidebands##3##3##(2007-11#3)
rotational Raman##19##2##(2007-11#5)(2007-12#3)(2008-10#1)(2008-3#10)
rotational acceleration##3##2##(2006-11#1)(2007-4#2)
rotational and##4##2##(2006-10#1)(2007-11#1)(2009-8#1)(2013-1#1)
rotational angiography##2##2##(2009-12#1)(2010-5#1)
rotational atherectomy##2##2##(2011-2#2)
rotational behaviour##2##2##(2010-2#2)
rotational coherent anti-Stokes Raman spectroscopy##2##5##(2007-12#1)(2008-2#1)
rotational coherent anti-Stokes Raman##5##4##(2007-12#1)(2008-2#3)(2008-3#1)
rotational coherent anti-stokes Raman scattering##2##5##(2008-2#1)(2008-3#1)
rotational coherent##7##2##(2007-12#1)(2008-2#4)(2008-3#2)
rotational correlation time (tau##2##4##(1992-9#1)(1996-7#1)
rotational correlation time##12##3##(1992-3#1)(1992-9#1)(1994-9#2)(1995-5#3)(1996-5#1)(1996-7#2)(2008-10#1)(2010-9#1)
rotational degrees of freedom##2##4##(1990-12#1)(1994-9#1)
rotational depolarization##2##2##(1991-7#2)
rotational diffusion coefficient##3##3##(1990-7#3)
rotational diffusion coefficients##2##3##(1997-7#1)(2010-9#1)
rotational diffusion##13##2##(1990-3#1)(1990-5#2)(1990-7#3)(1990-8#1)(1996-11#1)(1997-6#1)(1997-7#1)(2008-10#1)(2010-9#1)(2011-1#1)
rotational energy transfer##4##3##(2008-2#3)(2008-3#1)
rotational fine structure##2##3##(2008-10#2)
rotational instability of the##2##4##(2007-8#1)(2012-3#1)
rotational instability##3##2##(2007-8#1)(2008-8#1)(2012-3#1)
rotational invariant##3##2##(2008-2#3)
rotational isomer or##2##3##(1990-2#1)(2009-3#1)
rotational isomer##4##2##(1990-2#1)(2009-3#3)
rotational isomers##2##2##(1997-2#1)(2007-12#1)
rotational lines##2##2##(2007-12#1)(2008-10#1)
rotational model##3##2##(1993-12#2)(2010-2#1)
rotational motion##8##2##(1990-2#1)(1990-3#1)(1991-7#1)(1994-3#1)(2006-12#1)(2008-11#1)(2008-6#1)(2009-8#1)
rotational or##2##2##(2007-11#1)(2008-2#1)
rotational positions##2##2##(2007-12#1)(2008-3#1)
rotational relaxation times##2##3##(1991-4#1)(1992-7#1)
rotational relaxation##4##2##(1991-4#1)(1992-7#1)(1997-1#2)
rotational resonance##2##2##(1991-11#1)(1997-6#1)
rotational response##3##2##(1993-12#1)(1994-10#2)
rotational shear##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
rotational shearing##2##2##(2008-3#2)
rotational state##3##2##(1995-5#1)(2008-2#2)
rotational strengths##2##2##(1990-8#1)(2009-12#1)
rotational symmetry##9##2##(1990-12#1)(1990-8#1)(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#2)
rotational thrombectomy##2##2##(2011-2#2)
rotational transitions##3##2##(1990-8#1)(2008-2#1)(2008-3#1)
rotational##223##1##(1990-12#3)(1990-2#3)(1990-3#3)(1990-4#1)(1990-5#2)(1990-7#3)(1990-8#4)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#2)(1991-7#3)(1992-3#1)(1992-7#2)(1992-9#1)(1993-12#4)(1994-10#2)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#3)(1995-5#7)(1995-9#1)(1996-11#2)(1996-5#2)(1996-7#2)(1997-1#2)(1997-2#2)(1997-4#1)(1997-6#2)(1997-7#1)(2005-4#2)(2005-9#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-2#1)(2007-11#13)(2007-12#20)(2007-4#4)(2007-8#2)(2008-10#12)(2008-11#2)(2008-2#29)(2008-3#30)(2008-4#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-12#2)(2009-3#3)(2009-7#1)(2009-8#2)(2010-10#1)(2010-2#3)(2010-5#2)(2010-9#2)(2011-1#3)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
rotationally symmetric beam##2##3##(2007-12#2)
rotationally symmetric two-dimensional beam##2##4##(2007-12#2)
rotationally symmetric##17##2##(1995-4#1)(2007-12#6)(2008-2#4)(2008-3#6)
rotationally##21##1##(1995-4#1)(2007-12#6)(2008-2#5)(2008-3#9)
rotations about the##2##3##(2006-5#1)(2008-8#1)
rotations and translations##2##3##(2008-2#1)(2012-2#1)
rotations and##3##2##(2008-2#1)(2008-3#1)(2012-2#1)
rotations in a##2##3##(2008-11#1)(2008-3#1)
rotations in the##2##3##(1995-5#1)(2011-2#1)
rotations in##5##2##(1995-5#2)(2008-11#1)(2008-3#1)(2011-2#1)
rotations induced by##2##3##(1995-12#2)
rotations of the##4##3##(1996-5#1)(1997-8#1)(2008-11#1)(2008-3#1)
rotations of##7##2##(1992-6#1)(1994-11#1)(1996-5#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#1)
rotations with##3##2##(2008-10#3)
rotations##48##1##(1991-5#1)(1992-6#2)(1994-11#1)(1994-3#1)(1995-11#1)(1995-12#4)(1995-5#6)(1996-2#1)(1996-5#1)(1997-3#1)(1997-8#2)(2006-5#1)(2007-1#1)(2007-11#1)(2007-6#1)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#5)(2008-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
rotator cuff disease##2##3##(2007-11#1)(2008-12#1)
rotator cuff lesion##2##3##(2007-11#2)
rotator cuff lesions and##2##4##(2007-11#2)
rotator cuff lesions##3##3##(2007-11#3)
rotator cuff repair##7##3##(2007-12#1)(2010-7#3)(2013-1#2)(2013-7#1)
rotator cuff tear##5##3##(2007-11#1)(2008-7#1)(2012-11#2)(2013-7#1)
rotator cuff tears##4##3##(2006-12#1)(2011-12#1)(2012-11#1)(2013-7#1)
rotator cuff tendinopathy##2##3##(2006-10#2)
rotator cuff tendons##2##3##(2008-7#1)(2012-12#1)
rotator cuff with##2##3##(1994-2#1)(2007-11#1)
rotator cuff##47##2##(1994-2#3)(1995-5#1)(2006-10#2)(2006-12#1)(2007-11#12)(2007-12#2)(2007-7#1)(2008-12#1)(2008-6#1)(2008-7#4)(2009-4#1)(2009-9#2)(2010-7#3)(2011-12#1)(2012-11#3)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#3)
rotator muscles##2##2##(2007-7#1)(2012-1#1)
rotator to##2##2##(2008-2#2)
rotator##65##1##(1990-3#1)(1994-2#3)(1995-5#1)(2006-10#2)(2006-12#1)(2007-11#13)(2007-12#5)(2007-7#2)(2008-12#1)(2008-2#6)(2008-3#3)(2008-6#1)(2008-7#4)(2009-4#1)(2009-9#4)(2010-7#3)(2011-12#1)(2012-1#1)(2012-11#3)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#3)
rotators##17##1##(2007-11#2)(2007-12#1)(2007-7#7)(2008-2#1)(2008-8#1)(2009-9#2)(2010-9#2)(2013-1#1)
rotatory##10##1##(1992-8#1)(1995-8#1)(1997-4#1)(2006-3#2)(2007-8#1)(2008-10#2)(2008-4#1)(2013-1#1)
rotaviral##2##1##(2007-11#1)(2008-5#1)
rotavirus VP6##2##2##(2006-12#2)
rotavirus binding and infectivity of host cells##2##7##(2012-1#2)
rotavirus binding and##3##3##(2012-1#3)
rotavirus binding to##2##3##(2012-1#2)
rotavirus binding##5##2##(2012-1#5)
rotavirus disease##2##2##(2012-1#2)
rotavirus gastroenteritis##6##2##(2007-11#5)(2007-12#1)
rotavirus infection##6##2##(2006-10#2)(2007-6#1)(2011-2#2)(2012-1#1)
rotavirus infections##3##2##(2009-5#3)
rotavirus strains##2##2##(2007-11#2)
rotavirus vaccine##7##2##(1994-9#1)(2006-10#1)(2007-11#4)(2013-8#1)
rotavirus##57##1##(1994-9#1)(2006-10#6)(2006-12#3)(2007-11#14)(2007-12#2)(2007-6#2)(2007-7#1)(2008-12#1)(2008-5#1)(2008-7#2)(2009-5#3)(2010-12#1)(2011-2#3)(2012-1#12)(2012-3#1)(2013-7#1)(2013-8#3)
rotaviruses##9##1##(2005-9#1)(2006-10#2)(2007-6#3)(2008-12#1)(2008-7#1)(2012-1#1)
rotenoid##3##1##(2007-1#1)(2008-11#2)
rotenoids##3##1##(2011-1#3)
rotenone analogues##2##2##(1996-9#2)
rotenone and##5##2##(1990-11#1)(1994-11#1)(1994-8#1)(2006-8#1)(2011-1#1)
rotenone or##3##2##(1990-5#1)(1992-11#1)(2008-7#1)
rotenone##37##1##(1990-11#1)(1990-5#4)(1990-8#1)(1992-11#2)(1992-7#1)(1994-11#1)(1994-12#1)(1994-8#3)(1995-11#3)(1995-3#1)(1996-9#9)(1997-6#2)(2005-7#1)(2005-8#1)(2006-8#1)(2008-11#1)(2008-7#1)(2011-1#2)(2013-8#1)
rotenone-insensitive##3##1##(1990-11#1)(1990-8#1)(1997-8#1)
rotenone-sensitive NADH cytochrome c reductase activity##2##6##(1990-11#2)
rotenone-sensitive NADH##3##2##(1990-11#2)(1996-5#1)
rotenone-sensitive##6##1##(1990-11#3)(1990-8#2)(1996-5#1)
rotifer populations##2##2##(2010-12#2)
rotifer species##2##2##(2012-2#2)
rotifer##10##1##(2010-12#3)(2012-2#7)
rotifers##12##1##(2007-3#4)(2008-5#1)(2010-12#1)(2010-8#3)(2012-2#3)
rotor is##2##2##(2007-11#1)(2008-8#1)
rotor##10##1##(2005-10#2)(2005-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-8#1)
rotors##5##1##(2007-11#1)(2008-2#2)(2008-7#2)
rots and fumonisin##2##3##(2008-10#2)
rots and##4##2##(2008-10#4)
rots##9##1##(2008-10#8)(2008-8#1)
rotted##2##1##(2008-10#2)
rotting of##2##2##(1991-6#1)(2008-10#1)
rotting##7##1##(1991-11#1)(1991-6#1)(2007-4#1)(2008-10#4)
rottlerin##3##1##(1994-2#3)
rotundata and D##2##3##(2008-5#2)
rotundata and##3##2##(2008-5#3)
rotundata##6##1##(2008-5#6)
rotundifolia##3##1##(2008-10#3)
rotundus##7##1##(1992-8#2)(2008-12#1)(2008-5#2)(2011-2#2)
rough ER##2##2##(1993-6#1)(2007-9#1)
rough and##5##2##(1991-12#1)(1991-2#1)(2008-2#1)(2008-3#1)(2013-1#1)
rough boundary##4##2##(2008-3#4)
rough colony##3##2##(2006-8#3)
rough dielectric##2##2##(2007-11#1)(2007-12#1)
rough endoplasmic reticulum and##6##4##(1992-6#1)(1996-5#1)(2007-12#1)(2007-5#1)(2008-5#1)(2013-1#1)
rough endoplasmic reticulum##22##3##(1992-12#1)(1992-3#1)(1992-6#4)(1996-5#1)(1996-8#2)(2007-12#1)(2007-5#1)(2007-9#2)(2008-5#2)(2008-7#5)(2009-2#1)(2013-1#1)
rough endoplasmic reticulum)##2##3##(1997-8#1)(2009-2#1)
rough endoplasmic##27##2##(1992-12#1)(1992-3#1)(1992-6#4)(1996-5#1)(1996-8#3)(1997-8#1)(2007-12#2)(2007-5#1)(2007-9#2)(2008-5#2)(2008-7#5)(2009-2#2)(2012-1#1)(2013-1#1)
rough estimate##4##2##(1994-9#1)(2005-11#1)(2008-11#1)(2008-3#1)
rough estimation##2##2##(1994-9#1)(1996-12#1)
rough gold films##2##3##(2008-3#2)
rough gold##3##2##(2007-12#1)(2008-3#2)
rough lemon##7##2##(2008-10#7)
rough mapping##2##2##(2008-11#2)
rough metallic##2##2##(2007-11#1)(2008-2#1)
rough morphology##2##2##(2005-11#1)(2010-4#1)
rough plane surface of##2##4##(2008-3#2)
rough rice##3##2##(2013-1#3)
rough surface is##2##3##(2008-3#2)
rough surface##21##2##(2005-11#1)(2006-4#1)(2007-11#1)(2007-12#6)(2008-1#1)(2008-2#2)(2008-3#9)
rough surfaces by##2##3##(2005-11#1)(2008-3#1)
rough surfaces in a conical configuration##2##6##(2007-11#2)
rough surfaces in##4##3##(2007-11#2)(2008-3#2)
rough surfaces is##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
rough surfaces##26##2##(1990-7#1)(2005-11#3)(2007-11#3)(2007-12#2)(2008-2#4)(2008-3#13)
rough targets##2##2##(2008-2#2)
rough##176##1##(1990-7#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#6)(1993-6#1)(1994-3#1)(1994-5#1)(1994-9#2)(1996-12#1)(1996-5#2)(1996-8#3)(1997-1#1)(1997-8#1)(2004-9#1)(2005-11#12)(2006-1#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#4)(2007-11#6)(2007-12#21)(2007-5#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#9)(2008-11#3)(2008-2#14)(2008-3#41)(2008-5#4)(2008-7#5)(2008-8#1)(2008-9#1)(2009-2#2)(2009-5#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#8)
rough-surface zirconia implants##2##3##(2009-8#2)
rough-surface##4##1##(2007-12#1)(2008-2#1)(2009-8#2)
roughened aluminum##2##2##(2008-2#2)
roughened by##2##2##(2007-8#2)
roughened##14##1##(2007-12#3)(2007-7#1)(2007-8#3)(2008-2#2)(2008-5#2)(2008-7#1)(2010-12#1)(2012-12#1)
roughening transition##2##2##(1991-9#1)(1992-9#1)
roughening##6##1##(1991-9#1)(1992-9#1)(1993-6#1)(1995-11#1)(2006-4#1)(2007-12#1)
rougher##3##1##(2004-9#1)(2008-2#1)(2010-1#1)
roughly 1##4##2##(1997-4#1)(2008-10#2)(2008-7#1)
roughly 3##4##2##(1991-2#1)(1993-3#1)(2007-9#1)(2008-2#1)
roughly additive##2##2##(1997-7#1)(2009-2#1)
roughly constant##2##2##(2008-6#1)(2011-2#1)
roughly divided into##2##3##(2008-10#1)(2011-12#1)
roughly doubles##2##2##(1993-2#1)(1995-9#1)
roughly equal to the##3##4##(1995-2#1)(2007-11#1)(2008-8#1)
roughly equal to##4##3##(1995-2#1)(2007-11#1)(2008-3#1)(2008-8#1)
roughly equal##5##2##(1995-2#1)(2006-9#1)(2007-11#1)(2008-3#1)(2008-8#1)
roughly equivalent##3##2##(1990-11#1)(1992-10#1)(1994-11#1)
roughly estimated##3##2##(1992-11#1)(1997-4#1)(2008-10#1)
roughly halved##2##2##(1992-9#1)(1994-12#1)
roughly in##2##2##(1990-3#1)(1994-3#1)
roughly monitored by counting the numbers of##2##7##(1997-6#1)(1997-8#1)
roughly one##2##2##(1990-8#1)(1997-2#1)
roughly parallel##2##2##(2007-9#1)(2012-11#1)
roughly proportional to the##3##4##(1990-3#1)(2008-11#1)(2008-3#1)
roughly proportional to##4##3##(1990-3#1)(1992-12#1)(2008-11#1)(2008-3#1)
roughly the same##3##3##(2005-11#1)(2005-8#1)(2008-3#1)
roughly the##4##2##(2005-11#1)(2005-8#1)(2007-8#1)(2008-3#1)
roughly to##2##2##(1990-11#1)(1994-9#1)
roughly with##2##2##(2008-10#1)(2010-2#1)
roughly##120##1##(1990-11#2)(1990-3#2)(1990-8#1)(1991-2#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#3)(1997-4#4)(1997-6#1)(1997-7#1)(1997-8#2)(2005-11#2)(2005-8#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#2)(2007-11#2)(2007-12#6)(2007-8#1)(2007-9#4)(2008-10#9)(2008-11#2)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#4)(2008-9#2)(2009-2#1)(2009-4#1)(2009-9#1)(2010-12#2)(2010-2#4)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-7#1)
roughness and hydrophilicity##2##3##(2013-1#2)
roughness and the##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
roughness and##27##2##(2004-9#1)(2006-12#1)(2006-5#1)(2008-10#1)(2008-2#7)(2008-3#7)(2008-5#2)(2009-7#1)(2010-8#1)(2011-2#1)(2012-7#1)(2013-1#3)
roughness are##2##2##(2008-3#2)
roughness between##2##2##(2008-3#1)(2012-2#1)
roughness equations##3##2##(2008-3#3)
roughness features##2##2##(2008-2#2)
roughness for##4##2##(2008-3#2)(2011-2#1)(2012-2#1)
roughness from##3##2##(2007-12#1)(2008-3#2)
roughness had##2##2##(2008-5#1)(2013-1#1)
roughness in##4##2##(2007-12#2)(2008-3#1)(2008-7#1)
roughness is##5##2##(2008-3#5)
roughness measurements##3##2##(2008-3#3)
roughness of 0##2##3##(2012-2#2)
roughness of the interfaces##2##4##(2008-3#2)
roughness of the silver film##2##5##(2008-3#2)
roughness of the##16##3##(2005-11#2)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#8)(2011-2#1)
roughness of##40##2##(2005-11#3)(2006-12#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#8)(2008-3#16)(2009-11#1)(2010-4#1)(2011-2#4)(2012-2#2)
roughness on##8##2##(2006-12#1)(2007-12#1)(2007-2#1)(2008-2#2)(2008-3#3)
roughness parameters##4##2##(2008-3#2)(2009-7#2)
roughness to the##3##3##(2008-2#2)(2008-3#1)
roughness to##4##2##(2006-5#1)(2008-2#2)(2008-3#1)
roughness values##5##2##(2006-5#1)(2008-2#1)(2008-3#3)
roughness was measured by##2##4##(2008-2#1)(2008-5#1)
roughness was measured##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
roughness was modeled##2##3##(2008-2#1)(2008-3#1)
roughness was##8##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)(2008-5#1)
roughness##195##1##(2004-9#1)(2005-11#8)(2006-12#4)(2006-5#3)(2007-11#3)(2007-12#14)(2007-2#5)(2008-10#4)(2008-2#39)(2008-3#73)(2008-5#7)(2008-7#2)(2009-11#1)(2009-7#4)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-2#6)(2012-7#1)(2013-1#7)(2013-8#2)
roughnesses were##2##2##(2006-5#1)(2007-2#1)
roughnesses##8##1##(2006-5#2)(2007-2#1)(2008-2#2)(2008-3#3)
round 1##3##2##(1995-9#2)(2007-11#1)
round 5##2##2##(1995-9#2)
round and slippery##2##3##(2008-5#2)
round and##10##2##(1991-9#1)(1997-4#2)(2008-5#3)(2008-6#1)(2009-5#1)(2010-12#1)(2011-2#1)
round cells##12##2##(1992-4#1)(1993-4#3)(1995-1#2)(1996-5#4)(2006-10#1)(2012-3#1)
round cuticular##2##2##(2007-12#2)
round face##2##2##(1996-12#1)(2010-6#1)
round had##3##2##(1991-6#1)(1997-4#2)
round harmony##4##2##(2012-12#4)
round in##2##2##(1996-11#1)(2010-3#1)
round mucous##2##2##(2008-6#2)
round nuclei and##2##3##(1991-8#1)(2008-5#1)
round nuclei##3##2##(1991-8#1)(2008-5#1)(2010-12#1)
round of audit##2##3##(2007-11#2)
round of selection##2##3##(2008-2#1)(2008-9#1)
round of##29##2##(1990-11#1)(1990-5#1)(1994-12#1)(1995-12#1)(1996-3#1)(1996-5#1)(1997-4#2)(1997-7#1)(2006-10#1)(2007-11#3)(2007-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#1)(2011-1#2)(2012-3#1)(2013-1#1)
round or oval##2##3##(1997-3#1)(2012-2#1)
round or##7##2##(1995-12#1)(1997-3#1)(2008-6#1)(2009-5#1)(2010-6#1)(2012-1#1)(2012-2#1)
round robin test##2##3##(2008-10#2)
round shape##2##2##(1993-4#1)(1996-2#1)
round spermatid nuclei##3##3##(2012-12#2)(2012-2#1)
round spermatids##5##2##(1990-11#1)(2008-9#1)(2012-12#2)(2012-2#1)
round synaptic vesicles and##3##4##(1995-12#2)(1997-2#1)
round table discussion##2##3##(1994-6#2)
round table##3##2##(1994-6#2)(2010-11#1)
round the##2##2##(2008-10#1)(2008-5#1)
round to polygonal##2##3##(2008-6#1)(2012-1#1)
round to##3##2##(2008-6#1)(2012-1#2)
round trip##2##2##(2007-11#1)(2008-2#1)
round trips##2##2##(2007-12#2)
round window##3##2##(2008-9#3)
round##191##1##(1990-11#2)(1990-3#1)(1990-5#1)(1991-3#1)(1991-6#3)(1991-8#2)(1991-9#2)(1992-4#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-4#4)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#2)(1995-1#3)(1995-12#5)(1995-9#4)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#5)(1997-2#1)(1997-3#1)(1997-4#16)(1997-5#1)(1997-7#1)(2004-8#1)(2005-10#1)(2005-8#1)(2006-10#5)(2006-12#1)(2007-10#2)(2007-11#9)(2007-12#6)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-12#3)(2008-2#4)(2008-3#2)(2008-5#9)(2008-6#6)(2008-7#1)(2008-8#3)(2008-9#5)(2009-2#1)(2009-4#1)(2009-5#4)(2010-11#1)(2010-12#3)(2010-3#1)(2010-6#3)(2011-1#2)(2011-2#2)(2012-1#4)(2012-12#12)(2012-2#5)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
round-bottom 96-well polystyrene plate coated with##2##6##(2008-11#2)
round-robin experiment##3##2##(2008-3#3)
round-robin##5##1##(2007-9#1)(2008-3#3)(2009-9#1)
round-shaped##3##1##(1996-3#1)(2007-12#1)(2011-1#1)
round-trip optical parametric process##2##4##(2007-12#2)
round-trip##8##1##(2007-11#1)(2007-12#6)(2008-3#1)
roundabouts##9##1##(2007-2#1)(2012-12#8)
rounded up##4##2##(1990-9#1)(1997-1#1)(2007-7#2)
rounded##28##1##(1990-9#1)(1996-12#1)(1997-1#1)(2006-11#1)(2006-5#1)(2007-12#2)(2007-7#4)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-3#2)(2009-7#1)(2010-7#2)(2010-9#1)(2013-7#1)
rounding and##5##2##(1990-9#1)(1995-5#1)(1997-6#1)(2006-10#1)(2008-5#1)
rounding up of cells##2##4##(1993-12#1)(2007-6#1)
rounding up of##3##3##(1992-12#1)(1993-12#1)(2007-6#1)
rounding##16##1##(1990-9#2)(1992-12#1)(1993-12#1)(1995-5#1)(1997-6#3)(2005-7#1)(2006-10#1)(2007-6#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)
roundness##2##1##(2008-11#1)(2012-5#1)
rounds and##2##2##(2008-10#1)(2008-7#1)
rounds are##2##2##(2007-9#1)(2008-10#1)
rounds of PCR##2##3##(2008-10#1)(2008-4#1)
rounds of selection against##2##4##(2008-10#2)
rounds of selection##6##3##(1991-7#1)(1995-7#1)(2008-10#2)(2008-4#1)(2011-1#1)
rounds of##50##2##(1991-3#1)(1991-7#1)(1992-2#1)(1992-6#1)(1995-12#1)(1995-2#1)(1995-7#1)(1995-8#2)(1997-2#1)(1997-3#1)(1997-4#4)(1997-7#1)(2004-1#1)(2005-11#2)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#2)(2011-1#3)(2011-12#1)(2012-3#4)(2013-1#1)
rounds to##2##2##(1995-3#1)(2007-4#1)
rounds##83##1##(1991-3#1)(1991-6#1)(1991-7#1)(1992-2#1)(1992-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#2)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#14)(1997-7#2)(2004-1#1)(2004-8#1)(2005-11#2)(2007-4#1)(2007-8#1)(2007-9#2)(2008-10#13)(2008-11#4)(2008-12#2)(2008-4#5)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-6#2)(2011-1#3)(2011-12#1)(2012-3#5)(2013-1#2)(2013-8#1)
roundtable discussion##4##2##(2008-3#1)(2008-6#1)(2008-8#1)(2009-4#1)
roundtable##10##1##(1993-3#1)(2005-6#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-4#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
roundup##2##1##(1997-3#1)(2011-2#1)
route and##15##2##(1994-10#1)(1997-7#1)(2007-10#1)(2007-11#3)(2007-2#1)(2008-10#3)(2008-5#1)(2010-12#1)(2010-4#1)(2011-12#1)(2013-1#1)
route at##3##2##(1997-8#2)(2008-5#1)
route but##3##2##(1992-2#1)(2008-10#1)(2008-5#1)
route by which##6##3##(1991-7#1)(2006-10#1)(2008-10#2)(2009-5#1)(2010-7#1)
route by##7##2##(1991-7#1)(2006-10#1)(2008-10#2)(2008-5#1)(2009-5#1)(2010-7#1)
route for the synthesis of##2##5##(1996-5#1)(2007-11#1)
route for the##5##3##(1992-2#1)(1996-5#1)(2007-11#2)(2012-2#1)
route for##25##2##(1991-3#1)(1991-9#1)(1992-12#1)(1992-2#2)(1993-6#1)(1996-5#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-11#3)(2008-10#3)(2008-4#1)(2009-10#1)(2009-3#1)(2010-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
route from the##3##3##(1995-7#2)(2010-4#1)
route from##4##2##(1995-7#2)(2008-10#1)(2010-4#1)
route had##2##2##(1996-2#1)(2008-5#1)
route has##3##2##(2009-11#1)(2011-1#1)(2011-2#1)
route in the##3##3##(1994-9#1)(2009-2#1)(2013-1#1)
route in##9##2##(1992-8#1)(1994-9#1)(1997-1#1)(2007-8#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
route include##2##2##(2008-3#1)(2010-1#1)
route is the##2##3##(1990-3#1)(1997-1#1)
route is##10##2##(1990-3#1)(1997-1#1)(1997-3#1)(2006-10#1)(2006-11#1)(2007-11#1)(2008-1#1)(2010-6#1)(2012-12#1)(2012-2#1)
route leading to##2##3##(2005-11#1)(2010-2#1)
route may be##3##3##(1991-7#1)(2008-10#1)(2008-5#1)
route may##5##2##(1991-7#1)(1993-11#1)(2008-10#1)(2008-5#2)
route of administration and##3##4##(2007-11#2)(2008-4#1)
route of administration##24##3##(1990-11#1)(1992-11#3)(1993-11#1)(1994-6#1)(1996-8#1)(1997-1#2)(2005-10#1)(2006-10#1)(2006-12#1)(2007-11#5)(2007-2#1)(2008-3#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-11#1)(2012-3#1)
route of delivery did not##2##5##(2006-10#2)
route of delivery##5##3##(1993-6#1)(2006-10#3)(2008-8#1)
route of elimination of##2##4##(1996-1#1)(2009-8#1)
route of elimination##3##3##(1996-1#1)(2009-8#1)(2011-2#1)
route of entry##2##3##(1990-4#1)(1994-6#1)
route of exposure##3##3##(1997-2#1)(2006-12#1)(2008-10#1)
route of hysterectomy##3##3##(1994-2#1)(1996-2#2)
route of infection##6##3##(2005-9#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-6#1)
route of inoculation##2##3##(2008-5#2)
route of the##2##3##(2007-1#1)(2010-12#1)
route of transmission##7##3##(1996-11#1)(2007-12#1)(2007-7#1)(2008-5#1)(2011-1#1)(2012-11#2)
route of##90##2##(1990-11#1)(1990-3#1)(1990-4#2)(1992-11#3)(1992-8#1)(1993-11#2)(1993-12#1)(1993-6#2)(1993-7#1)(1994-2#1)(1994-6#2)(1994-8#1)(1995-11#1)(1996-1#1)(1996-11#1)(1996-2#3)(1996-8#1)(1997-1#2)(1997-2#1)(1997-8#1)(2005-10#2)(2005-9#1)(2006-10#6)(2006-12#2)(2006-2#1)(2007-1#1)(2007-11#6)(2007-12#1)(2007-2#2)(2007-7#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-8#2)(2008-9#3)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#3)(2012-3#2)(2013-1#1)(2013-8#1)
route or##4##2##(2007-11#1)(2008-11#1)(2008-9#1)(2013-8#1)
route predominates##2##2##(1991-7#1)(2010-8#1)
route that##2##2##(2007-11#1)(2008-11#1)
route the optical signals##2##4##(2008-3#2)
route the optical##3##3##(2008-2#1)(2008-3#2)
route the##4##2##(2006-10#1)(2008-2#1)(2008-3#2)
route to 2##2##3##(2007-11#2)
route to a##4##3##(2007-9#1)(2008-4#1)(2009-9#1)(2010-5#1)
route to chaos##2##3##(2007-12#2)
route to methyl##2##3##(2007-10#1)(2007-11#1)
route to the##13##3##(1991-1#1)(1991-2#1)(1994-9#1)(1995-5#1)(1996-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-11#1)(2009-5#1)(2011-12#1)
route to##70##2##(1991-1#1)(1991-11#2)(1991-2#1)(1994-6#1)(1994-9#1)(1995-5#1)(1996-5#1)(2006-12#2)(2006-4#1)(2007-10#2)(2007-11#10)(2007-12#3)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
route toward##2##2##(2009-7#1)(2010-7#1)
route was the##2##3##(2007-7#2)
route was used##2##3##(1993-10#1)(1995-12#1)
route was##6##2##(1993-10#1)(1994-2#1)(1995-12#1)(2007-7#2)(2008-7#1)
route with##2##2##(2006-12#1)(2008-5#1)
route##429##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#3)(1990-4#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#2)(1991-7#3)(1991-9#1)(1992-10#1)(1992-11#5)(1992-12#2)(1992-2#5)(1992-3#1)(1992-8#3)(1992-9#1)(1993-10#1)(1993-11#4)(1993-12#1)(1993-5#1)(1993-6#3)(1993-7#1)(1994-10#2)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#6)(1995-1#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#2)(1995-7#2)(1996-1#4)(1996-11#1)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#3)(2004-12#1)(2004-9#3)(2005-1#2)(2005-10#2)(2005-11#2)(2005-9#1)(2006-10#13)(2006-11#1)(2006-12#9)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#3)(2007-10#5)(2007-11#35)(2007-12#4)(2007-2#5)(2007-3#1)(2007-5#1)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#23)(2008-11#6)(2008-12#2)(2008-2#5)(2008-3#7)(2008-4#11)(2008-5#23)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#7)(2009-10#2)(2009-11#5)(2009-2#5)(2009-3#1)(2009-4#1)(2009-5#5)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#4)(2010-10#1)(2010-12#5)(2010-2#2)(2010-4#3)(2010-5#5)(2010-6#2)(2010-7#6)(2010-8#2)(2011-1#6)(2011-12#3)(2011-2#10)(2012-1#1)(2012-11#3)(2012-12#9)(2012-2#6)(2012-3#4)(2013-1#9)(2013-7#3)(2013-8#2)
route) and##2##2##(1991-11#1)(1995-12#1)
route)##4##1##(1991-11#1)(1995-12#1)(2005-1#1)(2008-4#1)
route-tracking synchronization is##2##3##(2007-12#2)
route-tracking synchronization##3##2##(2007-12#3)
routed to lysosomes via##2##4##(1990-9#2)
routed to##3##2##(1990-9#2)(1995-2#1)
routed##6##1##(1990-9#2)(1995-2#1)(2007-7#1)(2008-3#2)
router with##4##2##(2007-11#3)(2008-3#1)
router##10##1##(2007-11#5)(2008-3#4)(2013-7#1)
routes and##11##2##(2007-1#1)(2007-11#1)(2008-5#1)(2009-4#1)(2009-8#1)(2011-1#1)(2011-2#4)(2012-1#1)
routes are##2##2##(2009-9#1)(2010-8#1)
routes as##2##2##(1997-6#1)(2008-10#1)
routes for the##5##3##(1994-3#1)(2006-10#1)(2007-3#1)(2008-10#1)(2010-4#1)
routes for##13##2##(1992-12#1)(1994-3#1)(1996-2#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-5#1)(2010-4#1)(2013-1#1)(2013-7#1)
routes from##4##2##(2008-6#1)(2008-9#1)(2010-8#1)(2012-2#1)
routes in southern Somalia##2##4##(2011-2#2)
routes in the##2##3##(1992-3#1)(1993-3#1)
routes in##6##2##(1992-3#1)(1993-3#1)(2007-11#1)(2008-2#1)(2011-2#2)
routes of administration are##2##4##(1993-11#1)(2010-10#1)
routes of administration of##3##4##(2008-5#1)(2008-7#1)(2013-1#1)
routes of administration##15##3##(1991-1#1)(1993-11#1)(1995-5#1)(1996-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-12#2)(2013-1#1)
routes of exposure##2##3##(1995-11#1)(1996-8#1)
routes of transmission##3##3##(2006-10#1)(2007-7#1)(2009-5#1)
routes of##49##2##(1991-1#1)(1991-4#1)(1993-11#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-6#1)(1996-8#2)(1997-3#1)(1997-6#1)(2006-10#4)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#3)(2008-7#2)(2009-5#1)(2010-10#1)(2010-12#3)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#2)
routes to a##2##3##(2008-2#1)(2010-8#1)
routes to doctoral degrees##2##4##(2007-8#2)
routes to the##3##3##(1991-8#1)(2005-8#1)(2008-7#1)
routes to##22##2##(1991-8#1)(1995-3#1)(1996-1#1)(1997-7#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-8#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-7#1)(2010-12#1)(2010-7#1)(2010-8#1)(2012-12#1)
routes with##2##2##(1996-12#1)(1997-6#1)
routes##190##1##(1991-1#1)(1991-12#1)(1991-4#1)(1991-8#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-5#1)(1993-11#1)(1993-3#1)(1994-3#1)(1994-5#2)(1994-6#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-8#2)(1997-3#4)(1997-4#1)(1997-6#3)(1997-7#2)(2004-9#1)(2005-10#1)(2005-7#2)(2005-8#1)(2006-10#5)(2006-12#5)(2006-3#3)(2006-4#3)(2006-5#1)(2006-6#7)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#10)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#2)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#5)(2008-5#12)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#4)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#3)(2011-12#1)(2011-2#13)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#3)(2013-7#3)(2013-8#2)
routes]##2##1##(1990-3#1)(2013-7#1)
routine &quot##2##2##(2007-1#1)(2012-2#1)
routine ECG##2##2##(1993-10#1)(2010-11#1)
routine EEG##4##2##(2008-7#4)
routine EEGs##2##2##(2008-7#2)
routine HIV##3##2##(2007-2#1)(2010-12#2)
routine X-ray##2##2##(1996-3#1)(2007-8#1)
routine administration of##5##3##(2007-9#1)(2011-2#1)(2012-12#3)
routine anaesthesia##2##2##(2006-10#2)
routine analyses of pharmaceuticals##2##4##(2008-10#2)
routine analyses of##6##3##(2008-10#5)(2008-5#1)
routine analyses##11##2##(1995-2#1)(2007-8#1)(2008-10#6)(2008-5#2)(2010-5#1)
routine analysis a##2##3##(1993-11#1)(2008-10#1)
routine analysis of##21##3##(1996-6#1)(2005-4#1)(2008-10#13)(2008-11#1)(2008-3#1)(2010-2#1)(2010-4#1)(2012-2#1)(2013-7#1)
routine analysis##42##2##(1993-11#1)(1996-6#1)(2005-12#1)(2005-4#2)(2007-8#1)(2008-10#29)(2008-11#1)(2008-3#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-7#1)
routine analytical##2##2##(2008-10#2)
routine and##13##2##(1997-3#1)(1997-7#1)(2006-11#1)(2007-10#2)(2007-7#2)(2007-8#1)(2008-11#1)(2008-12#1)(2009-5#1)(2012-12#1)(2012-2#1)
routine application of##3##3##(2008-10#1)(2008-6#1)(2009-4#1)
routine application##6##2##(1994-6#1)(2005-5#1)(2008-10#2)(2008-6#1)(2009-4#1)
routine applications##2##2##(2007-5#1)(2008-4#1)
routine assay##3##2##(2008-10#2)(2012-2#1)
routine assessment of##3##3##(1993-9#1)(2008-6#1)(2009-1#1)
routine auditory stimulation##3##3##(1991-12#3)
routine basis##9##2##(2006-10#1)(2007-12#1)(2008-3#3)(2008-4#1)(2008-7#2)(2009-7#1)
routine biochemical##2##2##(2006-2#1)(2013-1#1)
routine biochemistry##2##2##(2006-10#1)(2012-1#1)
routine blood level##2##3##(1991-11#2)
routine blood##6##2##(1991-11#2)(1992-12#1)(1997-3#1)(2007-9#1)(2012-2#1)
routine calibration##2##2##(2007-11#1)(2008-10#1)
routine care without##2##3##(1994-7#1)(2010-4#1)
routine care##4##2##(1994-7#1)(2007-11#1)(2010-12#1)(2010-4#1)
routine chest##7##2##(1990-6#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-7#1)(2008-8#1)
routine childhood##4##2##(2004-12#2)(2006-10#1)(2007-11#1)
routine cholecystectomy##2##2##(1993-3#1)(2012-2#1)
routine clinical and##4##3##(1994-6#1)(2006-5#1)(2008-7#1)(2011-2#1)
routine clinical applications##2##3##(2007-11#1)(2008-10#1)
routine clinical care##5##3##(2009-12#3)(2013-1#2)
routine clinical monitoring of##2##4##(1995-2#1)(2013-1#1)
routine clinical practice##18##3##(1992-10#1)(1996-8#1)(2005-8#1)(2005-9#1)(2007-10#2)(2007-11#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-10#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)
routine clinical##53##2##(1992-10#1)(1994-6#1)(1995-2#1)(1995-9#1)(1996-8#1)(1997-7#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#2)(2006-5#1)(2006-6#1)(2007-10#2)(2007-11#3)(2007-4#1)(2007-7#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#3)(2008-7#2)(2009-12#3)(2010-10#1)(2010-4#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)
routine control##4##2##(2008-10#3)(2008-5#1)
routine dental##5##2##(1996-2#3)(2013-1#2)
routine detection of##4##3##(1994-3#1)(2006-12#1)(2008-10#2)
routine detection##6##2##(1994-3#1)(2005-8#1)(2006-12#1)(2008-10#3)
routine determination of##9##3##(1992-2#1)(1993-12#1)(2008-10#5)(2010-12#1)(2010-4#1)
routine diagnosis of##2##3##(2008-10#1)(2008-7#1)
routine diagnosis##4##2##(2006-6#1)(2008-10#1)(2008-4#1)(2008-7#1)
routine diagnostic##7##2##(1992-2#1)(1993-5#1)(2006-8#1)(2008-12#1)(2008-7#1)(2010-1#1)(2010-10#1)
routine evaluations##2##2##(2008-7#1)(2012-2#1)
routine examination of##4##3##(1994-7#1)(2008-12#1)(2008-9#1)(2012-2#1)
routine examination##10##2##(1990-2#1)(1990-8#1)(1994-7#1)(2007-7#2)(2008-12#1)(2008-7#1)(2008-9#1)(2012-2#2)
routine examinations##3##2##(1992-11#1)(2006-10#1)(2008-3#1)
routine for all##2##3##(1991-4#1)(1993-11#1)
routine for##4##2##(1991-4#1)(1993-11#1)(2006-10#1)(2013-1#1)
routine forensic##2##2##(2008-12#2)
routine health##7##2##(1990-8#1)(1994-6#1)(2007-12#1)(2009-6#1)(2010-9#2)(2012-12#1)
routine histological examination of##2##4##(2011-1#2)
routine histological examination##3##3##(1990-6#1)(2011-1#2)
routine histological##7##2##(1990-6#1)(2007-5#1)(2010-2#1)(2011-1#2)(2011-2#1)(2013-1#1)
routine hospital##3##2##(1993-1#1)(2007-2#1)(2009-7#1)
routine housework##3##2##(2008-5#2)(2009-3#1)
routine identification##4##2##(2008-1#1)(2008-10#3)
routine imaging##2##2##(2007-7#1)(2008-7#1)
routine in the##2##3##(1992-11#1)(2008-9#1)
routine in##13##2##(1990-4#1)(1991-6#1)(1992-11#1)(1995-6#1)(1996-3#1)(2005-11#1)(2006-10#1)(2008-11#1)(2008-9#2)(2010-5#1)(2012-3#1)(2013-8#1)
routine interventions##9##2##(2006-9#1)(2007-2#4)(2008-6#1)(2008-9#2)(2011-2#1)
routine investigation##2##2##(2008-7#1)(2009-4#1)
routine is##2##2##(2006-12#1)(2007-12#1)
routine labor epidural analgesia##2##4##(1993-7#2)
routine laboratories##5##2##(1994-1#1)(2008-10#3)(2009-8#1)
routine laboratory investigations##2##3##(2005-11#1)(2009-8#1)
routine laboratory procedure##2##3##(2008-10#1)(2009-5#1)
routine laboratory tests##5##3##(2008-10#1)(2010-12#1)(2011-2#2)(2012-3#1)
routine laboratory##21##2##(1990-2#1)(1992-9#1)(1994-1#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-9#2)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-3#1)
routine maintenance##2##2##(2009-6#1)(2011-2#1)
routine management of##2##3##(2004-1#1)(2007-10#1)
routine measurement of##3##3##(1993-1#1)(1995-1#1)(2008-7#1)
routine measurement##4##2##(1993-1#1)(1995-1#1)(2008-10#1)(2008-7#1)
routine medical##3##2##(1997-1#1)(1997-5#1)(2007-2#1)
routine method##6##2##(1996-4#1)(1996-7#1)(1996-9#1)(2007-7#1)(2008-10#2)
routine methods##3##2##(1990-6#1)(1994-3#1)(2008-10#1)
routine monitoring and##2##3##(1993-5#1)(2011-1#1)
routine monitoring of patients##2##4##(2008-10#1)(2013-1#1)
routine monitoring of##7##3##(2007-8#1)(2008-10#2)(2012-1#1)(2013-1#2)(2013-8#1)
routine monitoring##13##2##(1993-5#1)(2007-2#1)(2007-8#1)(2008-10#3)(2011-1#1)(2012-1#1)(2013-1#2)(2013-8#3)
routine of##8##2##(2007-12#1)(2008-3#3)(2011-2#1)(2013-1#3)
routine operation##4##2##(1991-6#1)(2006-5#1)(2008-3#1)(2008-9#1)
routine oral##3##2##(1990-2#1)(2005-11#1)(2006-8#1)
routine paternity##2##2##(2008-12#1)(2010-9#1)
routine pathology##2##2##(1990-6#1)(2008-10#1)
routine pelvic examination a few days after##2##7##(1992-8#2)
routine pelvic examination##4##3##(1992-8#4)
routine physical examination##2##3##(1993-2#1)(2006-9#1)
routine physical##3##2##(1993-2#1)(2006-10#1)(2006-9#1)
routine practice##13##2##(1996-12#1)(1997-6#1)(2005-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
routine practices##2##2##(2009-5#1)(2012-11#1)
routine procedures##3##2##(1996-2#1)(2007-2#1)(2013-1#1)
routine program monitoring##2##3##(2012-3#2)
routine prophylactic##2##2##(1990-6#1)(1992-12#1)
routine recall##2##2##(2004-2#1)(2007-2#1)
routine resistance monitoring##2##3##(2010-2#1)(2011-2#1)
routine scan##2##2##(1990-2#2)
routine screening for##2##3##(2007-3#1)(2012-2#1)
routine screening of##4##3##(1991-10#1)(1997-8#1)(2007-10#1)(2008-10#1)
routine screening##16##2##(1991-10#1)(1991-7#1)(1994-4#1)(1997-8#2)(2006-10#1)(2006-9#1)(2007-10#2)(2007-3#1)(2008-10#2)(2008-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
routine serological##2##2##(1992-5#1)(2013-8#1)
routine staining of##3##3##(2010-8#1)(2012-12#2)
routine stains##2##2##(2008-4#1)(2010-8#1)
routine study##2##2##(2007-5#1)(2008-7#1)
routine surgical##4##2##(1991-4#1)(1993-2#1)(2006-6#1)(2007-8#1)
routine tasks##2##2##(1996-1#1)(2008-11#1)
routine testing##5##2##(2007-1#1)(2009-5#1)(2012-2#3)
routine therapy##3##2##(1997-1#1)(2006-7#1)(2007-5#1)
routine thyroid##2##2##(2013-1#1)(2013-8#1)
routine to##3##2##(2008-2#1)(2010-12#1)(2010-2#1)
routine toxicity##2##2##(1997-2#1)(2008-10#1)
routine transabdominal sonography and##2##4##(2008-7#2)
routine transabdominal##3##2##(2008-7#3)
routine treatment for##2##3##(2008-11#1)(2011-2#1)
routine treatment##8##2##(2007-11#1)(2007-8#1)(2008-11#1)(2010-12#4)(2011-2#1)
routine ultrasound##4##2##(1994-6#1)(2007-10#1)(2007-9#1)(2011-2#1)
routine urine##2##2##(2010-8#1)(2013-8#1)
routine use in##3##3##(2006-10#1)(2008-10#1)(2011-2#1)
routine use is##2##3##(2007-12#1)(2007-5#1)
routine use of the##2##4##(2005-12#1)(2008-10#1)
routine use of##31##3##(1990-6#1)(1993-5#1)(1995-2#1)(2005-12#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-7#1)(2006-9#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-6#2)(2008-7#1)(2010-11#1)(2010-8#2)(2011-2#4)(2012-12#1)(2012-3#1)
routine use within##2##3##(1993-5#1)(1997-2#1)
routine use##52##2##(1990-6#1)(1991-11#1)(1991-6#1)(1993-10#1)(1993-11#1)(1993-5#2)(1995-2#1)(1995-5#1)(1996-12#1)(1997-2#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-10#3)(2008-11#1)(2008-3#3)(2008-6#2)(2008-7#1)(2008-9#2)(2010-11#1)(2010-8#2)(2011-2#6)(2012-12#1)(2012-3#1)
routine vaccination##3##2##(1994-3#1)(1997-1#1)(2013-8#1)
routine work##5##2##(1990-12#1)(1995-7#1)(2006-6#1)(2007-9#1)(2008-4#1)
routine##880##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#6)(1990-3#1)(1990-4#2)(1990-6#8)(1990-8#3)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#5)(1991-2#1)(1991-4#2)(1991-6#3)(1991-7#3)(1992-10#2)(1992-11#3)(1992-12#2)(1992-2#4)(1992-3#1)(1992-5#1)(1992-6#3)(1992-8#4)(1992-9#1)(1993-1#3)(1993-10#2)(1993-11#4)(1993-12#3)(1993-2#4)(1993-3#2)(1993-5#4)(1993-7#2)(1993-8#1)(1993-9#2)(1994-1#2)(1994-12#1)(1994-3#10)(1994-4#1)(1994-6#6)(1994-7#2)(1994-9#4)(1995-1#2)(1995-11#1)(1995-2#7)(1995-3#2)(1995-5#1)(1995-6#3)(1995-7#1)(1995-9#2)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#7)(1996-3#3)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#5)(1997-2#3)(1997-3#7)(1997-5#3)(1997-6#1)(1997-7#3)(1997-8#5)(2004-1#1)(2004-10#2)(2004-12#2)(2004-2#1)(2005-10#2)(2005-11#5)(2005-12#3)(2005-4#3)(2005-5#1)(2005-7#3)(2005-8#5)(2005-9#1)(2006-1#2)(2006-10#24)(2006-11#1)(2006-12#5)(2006-2#7)(2006-5#2)(2006-6#7)(2006-7#4)(2006-8#4)(2006-9#7)(2007-1#2)(2007-10#12)(2007-11#10)(2007-12#6)(2007-2#16)(2007-3#4)(2007-4#2)(2007-5#7)(2007-7#20)(2007-8#16)(2007-9#7)(2008-1#12)(2008-10#111)(2008-11#13)(2008-12#9)(2008-2#4)(2008-3#23)(2008-4#12)(2008-5#8)(2008-6#7)(2008-7#28)(2008-8#3)(2008-9#29)(2009-1#1)(2009-11#2)(2009-12#3)(2009-2#4)(2009-3#3)(2009-4#3)(2009-5#5)(2009-6#3)(2009-7#3)(2009-8#2)(2010-1#3)(2010-10#4)(2010-11#3)(2010-12#16)(2010-2#9)(2010-4#6)(2010-5#3)(2010-6#4)(2010-7#1)(2010-8#6)(2010-9#7)(2011-1#12)(2011-12#4)(2011-2#36)(2012-1#3)(2012-11#1)(2012-12#17)(2012-2#25)(2012-3#13)(2013-1#23)(2013-7#4)(2013-8#12)
routine]##4##1##(1995-3#1)(2005-6#1)(2007-9#2)
routinely and##5##2##(1994-2#1)(1996-3#1)(2008-10#1)(2008-9#1)(2012-2#1)
routinely applied##4##2##(1994-8#1)(2006-8#1)(2007-8#1)(2010-3#1)
routinely as##2##2##(2007-2#1)(2007-3#1)
routinely available##3##2##(1993-11#1)(2009-4#1)(2010-5#1)
routinely be##4##2##(1992-6#1)(1996-2#1)(2008-10#1)(2008-8#1)
routinely by##3##2##(1996-9#1)(2006-8#1)(2012-12#1)
routinely collected##5##2##(1990-9#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
routinely employed##2##2##(1992-6#1)(2008-10#1)
routinely for##2##2##(2008-10#1)(2010-9#1)
routinely in all##3##3##(1990-8#1)(2007-11#1)(2007-8#1)
routinely in##13##2##(1990-8#1)(1992-1#1)(1995-3#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-12#1)(2012-11#1)(2012-12#1)
routinely monitored by##2##3##(1993-2#1)(2008-3#1)
routinely monitored##5##2##(1993-2#1)(1997-3#1)(2008-10#1)(2008-3#1)(2011-1#1)
routinely monitoring##2##2##(1996-9#1)(2013-8#1)
routinely obtained##9##2##(2006-12#1)(2007-12#1)(2007-6#1)(2008-10#4)(2008-5#1)(2009-12#1)
routinely offered to##2##3##(1994-2#1)(2007-2#1)
routinely on##3##2##(1991-6#1)(2011-1#1)(2012-2#1)
routinely performed in##2##3##(2007-8#1)(2008-7#1)
routinely performed##4##2##(2006-6#1)(2007-8#1)(2008-7#1)(2012-2#1)
routinely produce##2##2##(1994-6#1)(2011-1#1)
routinely produced##3##2##(2008-11#1)(2008-3#1)(2008-5#1)
routinely recommended##2##2##(1997-2#1)(2008-10#1)
routinely required##2##2##(2009-4#1)(2009-9#1)
routinely stained##3##2##(2007-5#1)(2012-1#2)
routinely tested##2##2##(1990-3#1)(1993-1#1)
routinely to##6##2##(1994-7#1)(2007-12#1)(2007-2#1)(2008-7#1)(2013-1#1)(2013-8#1)
routinely used as a##2##4##(1993-8#1)(2009-5#1)
routinely used as##5##3##(1993-8#1)(2006-10#1)(2009-5#1)(2012-12#2)
routinely used for##4##3##(2006-6#1)(2008-11#1)(2008-5#1)(2009-12#1)
routinely used in##7##3##(2006-6#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-2#2)(2012-3#1)
routinely used to assess##2##4##(2008-4#1)(2008-9#1)
routinely used to##9##3##(1994-5#1)(2006-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#2)(2011-2#1)(2012-12#1)
routinely used##40##2##(1993-7#1)(1993-8#1)(1994-5#1)(1997-4#1)(2006-10#2)(2006-6#2)(2007-8#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#4)(2009-12#1)(2009-5#1)(2010-9#1)(2011-2#3)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)
routinely##239##1##(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-5#3)(1992-6#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-2#3)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-3#2)(1995-5#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-8#2)(2006-10#5)(2006-12#2)(2006-6#3)(2006-7#1)(2006-8#3)(2007-11#3)(2007-12#2)(2007-2#6)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#7)(2007-9#1)(2008-1#2)(2008-10#17)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#8)(2008-6#3)(2008-7#5)(2008-8#6)(2008-9#12)(2009-11#1)(2009-12#2)(2009-4#3)(2009-5#2)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#3)(2012-1#2)(2012-11#4)(2012-12#13)(2012-2#8)(2012-3#4)(2013-1#10)(2013-8#5)
routines and the##4##3##(1990-9#1)(1992-11#1)(2007-2#1)(2008-3#1)
routines and##12##2##(1990-9#1)(1992-11#1)(1993-5#1)(1997-8#1)(2006-10#2)(2006-8#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-6#1)
routines are##4##2##(1991-2#1)(1993-9#1)(1996-12#1)(2005-11#1)
routines for##9##2##(1990-4#1)(1990-6#1)(1993-5#3)(1994-6#1)(2007-6#2)(2008-9#1)
routines in##5##2##(1991-12#1)(1993-5#1)(1993-6#1)(1993-8#1)(2011-2#1)
routines that##2##2##(1996-12#1)(2008-11#1)
routines were##2##2##(1993-5#1)(2008-10#1)
routines##74##1##(1990-4#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-5#8)(1993-6#1)(1993-8#1)(1993-9#1)(1994-6#1)(1994-8#2)(1994-9#1)(1996-12#5)(1997-8#2)(2005-11#3)(2006-10#4)(2006-11#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-6#5)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-9#2)(2009-2#2)(2010-6#1)(2010-9#4)(2011-2#1)(2013-1#6)
routing and switching##2##3##(2012-2#2)
routing engine##2##2##(2008-2#2)
routing of##2##2##(1994-3#1)(2008-2#1)
routing##26##1##(1993-5#1)(1994-3#1)(2006-4#1)(2007-11#2)(2007-12#8)(2008-2#8)(2008-3#1)(2012-2#2)(2013-7#1)(2013-8#1)
rouxii##3##1##(1997-3#1)(2008-3#2)
rove beetle##4##2##(2007-12#2)(2008-7#2)
rover##2##1##(2007-9#1)(2013-8#1)
rovibrational line##2##2##(2008-2#2)
rovibrational lines##2##2##(2008-1#1)(2008-2#1)
rovibrational resonance of nitrous oxide##2##5##(2007-11#1)(2007-12#1)
rovibrational transition of##2##3##(2007-12#1)(2008-3#1)
rovibrational##12##1##(2007-11#2)(2007-12#4)(2008-1#1)(2008-2#3)(2008-3#2)
row CT##5##2##(2008-7#3)(2010-8#1)(2011-2#1)
row and##3##2##(2008-10#2)(2011-2#1)
row by row type&quot##2##4##(2007-12#2)
row by row##3##3##(2007-12#2)(2008-3#1)
row centering##2##2##(2008-10#2)
row computed tomography##2##3##(2008-7#1)(2009-10#1)
row distance##2##2##(2008-12#2)
row of three##2##3##(2007-12#2)
row of##10##2##(1994-2#2)(2007-12#3)(2007-3#1)(2008-10#1)(2008-2#1)(2009-5#1)(2011-2#1)
row or##2##2##(2008-10#1)(2011-2#1)
row over##2##2##(1991-10#1)(2010-8#1)
row spacing##3##2##(2008-12#3)
row##67##1##(1991-10#1)(1994-2#2)(1995-9#1)(2005-11#1)(2006-11#1)(2006-4#1)(2007-11#1)(2007-12#9)(2007-3#2)(2007-8#1)(2008-10#11)(2008-12#8)(2008-2#1)(2008-3#2)(2008-7#6)(2009-10#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-7#5)(2010-8#2)(2011-2#5)(2013-1#3)
rows and columns##2##3##(1994-11#1)(2010-6#1)
rows and##7##2##(1994-11#1)(2008-10#1)(2008-12#2)(2008-7#1)(2010-6#1)(2011-2#1)
rows in the##2##3##(2008-5#1)(2010-12#1)
rows in##5##2##(2008-5#2)(2010-12#1)(2011-2#1)(2012-1#1)
rows of##19##2##(2006-10#1)(2007-12#4)(2007-3#1)(2007-6#2)(2007-9#1)(2008-10#3)(2008-5#2)(2011-2#3)(2012-2#1)(2013-8#1)
rows with##2##2##(2007-3#1)(2008-10#1)
rows##60##1##(1994-11#2)(1995-8#1)(2006-10#1)(2007-12#5)(2007-3#2)(2007-6#2)(2007-9#4)(2008-10#19)(2008-12#5)(2008-3#1)(2008-5#4)(2008-7#1)(2010-12#1)(2010-6#1)(2011-12#2)(2011-2#6)(2012-1#1)(2012-2#1)(2013-8#1)
roxarsone##5##1##(2008-10#1)(2010-11#4)
roxithromycin##3##1##(2007-8#1)(2011-1#2)
royal family##2##2##(2011-1#1)(2013-8#1)
royal jelly##6##2##(2008-10#5)(2011-2#1)
royal##17##1##(2007-5#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
royalisin was##2##2##(2011-2#2)
royalisin##5##1##(2011-2#5)
royalties##2##1##(1994-6#1)(2005-8#1)
rp subgroup##2##2##(2008-10#2)
rp##3##1##(2008-10#3)
rpGH##3##1##(2008-9#3)
rpL3##2##1##(1995-8#2)
rpS1##3##1##(1993-9#3)
rpm and##3##2##(2008-11#1)(2008-5#2)
rpm for##6##2##(1994-11#1)(2005-11#1)(2008-11#2)(2008-5#1)(2008-6#1)
rpm in##3##2##(1994-11#1)(2008-5#2)
rpm##41##1##(1994-11#3)(2005-11#2)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#12)(2008-5#11)(2008-6#3)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
rpm) in##2##2##(2008-11#1)(2008-5#1)
rpm)##11##1##(2007-8#1)(2008-11#5)(2008-5#3)(2011-2#1)(2012-11#1)
rpoB and##2##2##(1990-4#1)(2008-2#1)
rpoB gene##2##2##(1994-7#1)(2009-6#1)
rpoB##11##1##(1990-4#1)(1994-7#1)(1997-2#5)(2007-1#1)(2008-2#1)(2009-6#2)
rpoD gene##4##2##(1995-8#1)(2005-11#3)
rpoD##7##1##(1994-12#2)(1995-8#1)(2005-11#4)
rpoH host##2##2##(1990-3#2)
rpoH mutant##2##2##(1990-3#2)
rpoH##6##1##(1990-3#5)(1991-5#1)
rpoS##3##1##(1997-4#1)(1997-5#1)(2006-8#1)
rpr-1##3##1##(1997-6#3)
rps1##4##1##(2008-10#4)
rps14##3##1##(1996-6#3)
rpsA##3##1##(1997-2#3)
rpsL and##2##2##(1991-7#1)(1994-7#1)
rpsL##4##1##(1991-7#3)(1994-7#1)
rpsU##2##1##(1994-12#2)
rrn##4##1##(1997-1#1)(2006-12#2)(2008-7#1)
rrnB T1##2##2##(1997-5#2)
rrnB operon##2##2##(1994-12#1)(1997-1#1)
rrnB##7##1##(1993-12#1)(1994-12#1)(1997-1#2)(1997-5#3)
rrs##4##1##(1993-12#3)(1994-7#1)
rs##4##1##(1993-3#1)(2007-12#2)(2008-11#1)
rs10490924 ARMS2##3##2##(2013-1#3)
rs1054##2##1##(1995-8#2)
rs12979860##3##1##(2012-12#1)(2012-2#1)(2013-1#1)
rs1410996 CFH polymorphism##2##3##(2013-1#2)
rs1410996 CFH##4##2##(2013-1#4)
rs1426654##2##1##(2009-5#2)
rs1805794##3##1##(2011-1#3)
rs1860746##2##1##(2010-12#2)
rs2292813##2##1##(2009-4#2)
rs2735383##2##1##(2011-1#2)
rs301979##2##1##(2009-4#2)
rs344781##2##1##(2009-4#2)
rs8099917##3##1##(2012-12#2)(2012-2#1)
rsd##3##1##(2008-10#3)
rsp1##2##1##(2008-10#2)
rsp2##2##1##(2008-10#2)
rt##3##1##(1996-5#1)(2007-10#1)(2010-6#1)
rt-PA or study enrollment##2##4##(2007-9#2)
rt-PA or##4##2##(2007-10#1)(2007-9#3)
rt-PA patients##3##2##(1993-2#3)
rt-PA use in##4##3##(2007-10#3)(2008-8#1)
rt-PA use##9##2##(2007-10#7)(2008-8#2)
rt-PA##42##1##(1990-11#1)(1993-2#4)(1997-8#1)(2005-8#1)(2007-10#20)(2007-9#9)(2008-10#1)(2008-7#1)(2008-8#4)
rt-PA)##2##1##(1993-2#1)(2007-9#1)
rt-TSP1##4##1##(1993-4#4)
rtA181T##3##1##(2013-1#3)
rtA181V and rtA181T##2##3##(2013-1#2)
rtN236T mutant virus showed similar##2##5##(2013-1#2)
rtN236T mutant viruses##2##3##(2013-1#2)
rtN236T mutant##4##2##(2013-1#4)
rtN236T##16##1##(2013-1#16)
rtPA##3##1##(2007-11#3)
rtfMRI##2##1##(2009-6#2)
rtp##4##1##(1993-9#4)
rub##8##1##(2007-12#1)(2008-10#2)(2008-5#2)(2008-8#1)(2011-12#1)(2012-2#1)
rubbed##5##1##(2005-11#1)(2007-12#2)(2008-4#1)(2010-3#1)
rubber bleb##2##2##(1997-6#2)
rubber gloves##2##2##(1995-6#2)
rubber##34##1##(1994-11#1)(1995-6#2)(1997-6#2)(2004-9#2)(2005-4#3)(2006-11#1)(2006-4#1)(2006-8#1)(2007-11#2)(2007-5#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-8#1)
rubber-like##2##1##(2007-12#1)(2012-12#1)
rubbery moduli##2##2##(2009-7#2)
rubbery##4##1##(2009-7#3)(2009-9#1)
rubbing##6##1##(2004-2#1)(2005-11#3)(2008-10#1)(2011-2#1)
rubble##4##1##(2007-5#3)(2007-9#1)
rubella antigen##3##2##(2007-8#3)
rubella syndrome -##2##3##(2013-1#2)
rubella syndrome##6##2##(2008-11#1)(2010-10#1)(2013-1#4)
rubella vaccination##2##2##(1992-5#1)(2007-2#1)
rubella vaccine##10##2##(1995-3#1)(2007-11#2)(2007-2#1)(2010-10#6)
rubella virus##2##2##(2011-1#1)(2012-2#1)
rubella##51##1##(1992-5#1)(1992-7#1)(1993-12#1)(1993-3#1)(1994-3#2)(1995-3#1)(1996-5#1)(1997-6#1)(2006-8#1)(2007-11#5)(2007-12#1)(2007-2#3)(2007-8#4)(2008-11#1)(2008-4#2)(2009-5#1)(2010-10#7)(2010-9#1)(2011-1#3)(2011-2#5)(2012-2#1)(2013-1#7)
ruber##9##1##(1992-10#1)(2007-3#1)(2009-8#1)(2011-2#6)
rubescens##2##1##(2007-6#1)(2011-2#1)
rubida##3##1##(2006-10#3)
rubidate##7##1##(2008-10#7)
rubidium atoms##4##2##(2007-11#1)(2007-12#3)
rubidium vapor##2##2##(2008-1#1)(2008-3#1)
rubidium##28##1##(1993-2#1)(1997-6#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#10)(2008-2#3)(2008-3#7)
rubisco activase in the presence of##2##6##(1991-9#2)
rubisco activase##9##2##(1991-9#7)(1992-12#2)
rubisco##12##1##(1991-9#9)(1992-12#2)(1997-1#1)
rubra##6##1##(2007-1#2)(2007-2#1)(2007-7#1)(2008-8#1)(2013-7#1)
rubra]##2##1##(2012-12#1)(2012-3#1)
rubredoxin##5##1##(1991-11#4)(1997-2#1)
rubredoxin-like##3##1##(1991-11#3)
rubrene##2##1##(2007-11#2)
rubrerythrin from Desulfovibrio vulgaris (Hildenborough)##2##5##(1991-11#1)(1991-12#1)
rubrerythrin from Desulfovibrio vulgaris##3##4##(1991-11#1)(1991-12#2)
rubrerythrin from##4##2##(1991-11#2)(1991-12#2)
rubrerythrin##14##1##(1990-8#2)(1991-11#7)(1991-12#5)
rubric##7##1##(2008-11#1)(2008-5#1)(2008-6#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
rubripes##5##1##(1995-2#3)(2008-11#1)(2008-7#1)
rubrum by##2##2##(1990-2#1)(2012-3#1)
rubrum is##2##2##(2008-5#1)(2011-2#1)
rubrum was the##2##3##(2007-7#1)(2008-5#1)
rubrum was##3##2##(2007-7#1)(2008-5#2)
rubrum##26##1##(1990-2#2)(1991-12#4)(1994-5#1)(2007-7#1)(2008-11#2)(2008-5#8)(2009-2#3)(2011-2#3)(2012-11#1)(2012-3#1)
ruby laser is##2##3##(2008-3#2)
ruby laser##6##2##(2008-2#1)(2008-3#5)
ruby##11##1##(2007-11#3)(2008-2#3)(2008-3#5)
ruddy bunting (Emberiza rutila)##2##4##(2008-9#2)
ruddy##3##1##(2007-2#1)(2008-9#2)
rudimentary horn pregnancy##3##3##(2011-1#2)(2013-1#1)
rudimentary horn with##2##3##(2011-1#2)
rudimentary horn##7##2##(2011-1#4)(2013-1#3)
rudimentary##34##1##(1991-2#1)(1991-5#1)(1992-7#1)(1996-6#1)(1997-1#1)(1997-2#2)(2006-10#2)(2007-12#2)(2007-8#2)(2008-10#1)(2008-7#1)(2008-9#5)(2010-12#1)(2010-7#1)(2011-1#5)(2011-12#2)(2011-2#1)(2012-1#1)(2013-1#3)
rue##2##1##(1991-8#1)(2013-8#1)
ruelene and trichlorfon##2##3##(2008-10#2)
ruelene##3##1##(2008-10#3)
ruffled##3##1##(1994-3#1)(2008-4#1)(2008-5#1)
ruffling and actin polymerization##2##4##(1991-8#2)
ruffling##6##1##(1991-8#3)(1997-6#1)(2008-5#1)(2008-7#1)
ruffs##2##1##(2008-8#2)
rufipogon and O##3##3##(2007-3#3)
rufipogon##6##1##(2007-3#6)
rugged and##5##2##(2007-11#1)(2008-10#2)(2008-3#2)
rugged terrain##2##2##(2008-2#1)(2008-3#1)
rugged##16##1##(1995-1#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#6)(2013-7#1)
ruggedness and##2##2##(2008-10#2)
ruggedness of##2##2##(2008-10#1)(2009-10#1)
ruggedness##11##1##(2008-10#7)(2009-10#1)(2010-7#1)(2011-2#1)(2013-7#1)
rugosa and##2##2##(1992-7#1)(2007-12#1)
rugosa##10##1##(1992-7#1)(1994-11#2)(1995-2#2)(2007-12#1)(2008-5#1)(2008-7#3)
rugose##2##1##(2008-10#2)
rugulosa##6##1##(2007-3#4)(2008-4#2)
ruin##4##1##(1995-6#1)(2007-9#1)(2008-7#1)(2011-1#1)
rule and##11##2##(1992-2#1)(1993-8#1)(1996-11#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-9#1)(2012-2#1)
rule as##2##2##(1991-10#1)(1996-7#1)
rule based##2##2##(2010-8#1)(2012-12#1)
rule by##2##2##(2006-6#1)(2007-7#1)
rule for the##6##3##(1996-2#1)(2007-12#1)(2007-7#1)(2008-2#2)(2008-3#1)
rule for##13##2##(1993-8#1)(1996-12#1)(1996-2#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-2#2)(2008-3#1)(2008-8#1)
rule in the##2##3##(2008-2#1)(2008-9#1)
rule in which##2##3##(1997-7#1)(2010-2#1)
rule in##16##2##(1991-11#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-6#1)(2007-9#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#2)(2010-2#2)(2012-2#1)
rule is the##2##3##(2007-11#1)(2008-3#1)
rule is##12##2##(1994-11#1)(1995-2#1)(1996-5#1)(1997-1#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)(2013-1#2)
rule mining##8##2##(2013-1#8)
rule models##2##2##(2008-10#2)
rule must##2##2##(1996-12#1)(2006-8#1)
rule of##14##2##(2004-4#1)(2005-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2009-2#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
rule on##6##2##(1993-6#1)(1996-5#1)(2006-7#1)(2006-8#1)(2007-9#1)(2012-2#1)
rule out a diagnosis of##2##5##(1993-11#1)(2008-4#1)
rule out a##8##3##(1990-3#1)(1993-11#1)(1995-11#1)(2007-2#1)(2008-1#1)(2008-4#1)(2012-11#1)(2012-3#1)
rule out coronary artery##2##4##(2008-3#2)
rule out the possibility of##3##5##(1994-9#1)(2008-1#1)(2011-2#1)
rule out the possibility##4##4##(1994-9#1)(1997-8#1)(2008-1#1)(2011-2#1)
rule out the presence of##3##5##(1990-10#1)(1996-1#1)(2011-2#1)
rule out the##16##3##(1990-10#1)(1992-5#1)(1994-9#1)(1996-1#1)(1996-12#1)(1996-7#1)(1997-8#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-2#1)(2010-5#1)(2011-2#3)(2012-12#1)
rule out this##2##3##(2012-12#1)(2013-1#1)
rule out##58##2##(1990-10#1)(1990-3#1)(1991-12#1)(1991-7#1)(1992-5#1)(1993-11#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-7#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-10#2)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-8#1)(2009-6#1)(2010-12#2)(2010-5#1)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
rule table are##2##3##(2008-2#2)
rule that##2##2##(1997-8#1)(2006-8#1)
rule the##3##2##(1990-3#1)(2007-11#1)(2008-7#1)
rule to##3##2##(1996-1#1)(2006-8#2)
rule was##4##2##(2006-8#2)(2008-9#2)
rule will##2##2##(2004-9#1)(2006-7#1)
rule##332##1##(1990-10#1)(1990-11#1)(1990-3#2)(1990-4#1)(1990-7#1)(1991-10#4)(1991-11#5)(1991-12#1)(1991-2#1)(1991-4#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-3#3)(1993-6#2)(1993-8#3)(1994-11#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-2#2)(1995-5#2)(1995-9#1)(1996-1#2)(1996-11#3)(1996-12#7)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2004-11#1)(2004-4#2)(2004-9#2)(2005-1#1)(2005-11#1)(2005-4#1)(2005-8#2)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#3)(2006-7#10)(2006-8#23)(2007-1#1)(2007-10#2)(2007-11#8)(2007-12#9)(2007-2#1)(2007-6#2)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#17)(2008-11#10)(2008-12#1)(2008-2#15)(2008-3#12)(2008-4#3)(2008-5#6)(2008-6#4)(2008-7#4)(2008-8#6)(2008-9#11)(2009-10#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#3)(2010-2#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#5)(2011-3#1)(2012-11#1)(2012-12#4)(2012-2#14)(2012-3#3)(2013-1#19)(2013-8#4)
rule&quot##6##1##(1992-8#1)(2007-11#1)(2008-8#3)(2013-8#1)
rule)##2##1##(1992-11#1)(2007-12#1)
rule-based decision##3##2##(2007-4#2)(2008-10#1)
rule-based##14##1##(2007-4#3)(2008-10#1)(2008-11#1)(2009-5#2)(2013-1#7)
rule-breaking behavior##2##2##(2008-11#2)
rule-breaking##3##1##(2008-11#2)(2011-12#1)
rule-building expert system (FuRES)##2##4##(2008-10#1)(2011-1#1)
rule-building expert##3##2##(2008-10#1)(2011-1#2)
rule?##2##1##(2006-9#1)(2008-8#1)
ruled grating##2##2##(2008-3#2)
ruled out a##3##3##(1990-2#1)(1994-12#1)(2010-6#1)
ruled out and##2##3##(2005-10#1)(2010-12#1)
ruled out as a##5##4##(1990-8#1)(1995-6#1)(2006-10#1)(2007-12#1)(2008-3#1)
ruled out as##9##3##(1990-8#1)(1992-12#1)(1995-6#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-12#1)(2012-2#1)
ruled out by##6##3##(1990-3#1)(1991-10#1)(1993-6#1)(1996-6#1)(1997-6#1)(2012-1#1)
ruled out##69##2##(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-10#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-1#1)(2005-10#1)(2005-11#3)(2006-10#2)(2006-2#2)(2006-3#1)(2006-4#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#2)(2008-1#3)(2008-10#2)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#1)
ruled that a##3##3##(1995-12#1)(1996-12#1)(1997-5#1)
ruled that the##9##3##(1990-5#1)(1995-12#2)(1995-6#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-5#2)
ruled that##32##2##(1990-5#1)(1994-2#1)(1995-12#6)(1995-6#2)(1996-11#4)(1996-12#6)(1996-5#1)(1996-6#3)(1997-5#8)
ruled varied-line-spacing##2##2##(2008-2#2)
ruled##115##1##(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-12#7)(1995-2#1)(1995-6#4)(1995-8#1)(1996-11#4)(1996-12#6)(1996-5#1)(1996-6#4)(1997-4#1)(1997-5#9)(1997-6#1)(2005-1#1)(2005-10#1)(2005-11#3)(2006-10#2)(2006-2#2)(2006-3#1)(2006-4#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#2)(2008-1#3)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#9)(2008-5#1)(2008-7#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#5)(2013-1#1)
rulemaking##3##1##(1995-3#1)(1996-12#1)(2007-1#1)
ruler for##2##2##(2008-3#1)(2008-7#1)
ruler##7##1##(2007-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#2)
rules and an##2##3##(2005-11#1)(2012-2#1)
rules and guidelines##2##3##(1996-3#1)(2006-1#1)
rules and regulations##6##3##(1996-8#1)(2006-8#2)(2007-2#1)(2008-1#1)(2008-7#1)
rules and the##4##3##(1991-2#1)(1993-3#1)(1997-3#1)(2011-3#1)
rules and##35##2##(1991-2#1)(1991-8#1)(1992-12#1)(1993-12#1)(1993-3#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-3#1)(2005-11#1)(2006-1#1)(2006-8#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#1)(2009-9#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
rules are##13##2##(1991-11#1)(1995-6#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-6#1)(2008-9#1)(2010-2#1)(2012-12#1)
rules as##3##2##(1991-2#1)(2006-10#1)(2008-2#1)
rules based on the##2##4##(2012-2#1)(2013-1#1)
rules can be##2##3##(2007-12#1)(2008-8#1)
rules can##5##2##(1995-5#1)(2007-12#2)(2008-10#1)(2008-8#1)
rules for allocating##2##3##(2008-9#1)(2010-2#1)
rules for the##7##3##(1995-10#1)(2007-11#1)(2007-7#1)(2008-2#1)(2008-3#1)(2009-5#1)(2012-12#1)
rules for##40##2##(1990-10#1)(1990-11#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-6#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-2#1)(1996-4#1)(1997-2#1)(1997-3#2)(1997-8#1)(2007-11#2)(2007-3#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)
rules governing the##2##3##(1995-3#1)(2010-11#1)
rules governing##10##2##(1995-3#1)(1995-5#1)(2005-5#1)(2006-7#1)(2007-11#1)(2008-8#3)(2008-9#1)(2010-11#1)
rules have been##2##3##(2008-8#1)(2012-2#1)
rules have##3##2##(1995-6#1)(2008-8#1)(2012-2#1)
rules in a##2##3##(1995-6#1)(2008-2#1)
rules in##8##2##(1993-6#1)(1995-6#2)(1996-9#1)(2005-7#1)(2008-2#1)(2013-1#2)
rules is##4##2##(2007-1#1)(2008-10#2)(2008-3#1)
rules may##3##2##(1992-9#1)(1995-6#1)(2008-10#1)
rules of India##2##3##(2007-7#2)
rules of early##2##3##(2008-7#1)(2011-2#1)
rules of inheritance of female##2##5##(2008-11#2)
rules of the##6##3##(1990-3#1)(1993-12#1)(2005-4#1)(2007-11#2)(2008-3#1)
rules of thumb##3##3##(2008-8#2)(2009-10#1)
rules of##31##2##(1990-3#1)(1992-4#1)(1993-12#1)(1995-6#1)(1997-2#1)(2004-3#1)(2004-5#1)(2005-4#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-7#2)(2007-8#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-2#1)(2011-12#1)(2011-2#2)(2012-2#1)
rules on##10##2##(1991-10#6)(1996-6#1)(1997-4#1)(2008-10#1)(2008-7#1)
rules out the##3##3##(1991-5#1)(1993-12#1)(2010-4#1)
rules out##9##2##(1991-5#1)(1993-12#1)(1994-9#1)(1997-1#1)(2006-12#1)(2007-11#1)(2008-6#1)(2010-4#1)(2012-1#1)
rules regarding##2##2##(2012-12#2)
rules that will##2##3##(2008-4#1)(2009-2#1)
rules that##18##2##(1991-8#1)(1993-3#1)(1996-4#1)(2005-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-8#1)(2011-2#1)(2013-1#3)(2013-8#1)
rules to the##3##3##(2007-10#1)(2013-1#2)
rules to##12##2##(1990-5#1)(1993-2#1)(2006-2#1)(2007-10#1)(2007-4#1)(2007-9#1)(2008-2#1)(2008-3#1)(2011-2#1)(2013-1#3)
rules used to##2##3##(2006-10#1)(2008-9#1)
rules used##3##2##(1991-8#1)(2006-10#1)(2008-9#1)
rules were##5##2##(1996-4#1)(2007-8#1)(2008-4#1)(2010-8#1)(2013-8#1)
rules will##2##2##(1990-5#1)(1995-8#1)
rules with##3##2##(2005-4#1)(2010-2#1)(2012-12#1)
rules##365##1##(1990-10#1)(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#6)(1991-11#1)(1991-12#1)(1991-2#4)(1991-5#1)(1991-6#1)(1991-8#3)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#2)(1993-12#4)(1993-2#1)(1993-3#4)(1993-5#1)(1993-6#1)(1993-8#3)(1994-2#4)(1994-3#1)(1994-6#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#8)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-4#3)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#7)(1997-4#1)(1997-7#1)(1997-8#2)(2004-1#1)(2004-3#1)(2004-5#1)(2005-10#1)(2005-11#1)(2005-4#2)(2005-5#1)(2005-7#1)(2006-1#2)(2006-10#4)(2006-12#2)(2006-2#1)(2006-6#1)(2006-7#3)(2006-8#5)(2007-1#1)(2007-10#3)(2007-11#9)(2007-12#3)(2007-2#1)(2007-3#3)(2007-4#2)(2007-6#2)(2007-7#8)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#11)(2008-11#7)(2008-12#1)(2008-2#20)(2008-3#8)(2008-4#7)(2008-5#2)(2008-6#5)(2008-7#8)(2008-8#11)(2008-9#10)(2009-10#2)(2009-2#3)(2009-3#2)(2009-5#3)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#4)(2010-4#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#3)(2012-12#8)(2012-2#12)(2013-1#44)(2013-7#1)(2013-8#4)
rules]##2##1##(1993-1#1)(1993-9#1)
ruling against##3##2##(1996-2#1)(1997-5#2)
ruling has##2##2##(1990-12#1)(1997-5#1)
ruling in##3##2##(1996-6#2)(1997-5#1)
ruling out##14##2##(1993-12#2)(1996-12#1)(2005-1#1)(2006-5#1)(2007-5#1)(2008-4#2)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
ruling that##5##2##(1996-11#1)(1996-12#1)(1997-5#2)(2007-8#1)
ruling##60##1##(1990-12#1)(1991-1#1)(1991-11#1)(1992-6#2)(1993-12#2)(1993-2#1)(1994-2#1)(1994-5#1)(1995-12#3)(1995-6#2)(1996-11#3)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#5)(1997-1#2)(1997-5#8)(1997-6#1)(2005-1#1)(2005-11#1)(2005-6#1)(2006-4#1)(2006-5#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-2#2)(2008-3#2)(2008-4#2)(2009-4#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
rulings##8##1##(1990-6#1)(1992-11#1)(1994-1#1)(1996-11#3)(1996-6#1)(2004-9#1)
rumen anaerobe##2##2##(2006-8#2)
rumen bacteria##9##2##(2006-5#1)(2006-8#6)(2009-4#2)
rumen bacterial concentrations##3##3##(2009-4#3)
rumen contents and##2##3##(1991-12#1)(2009-4#1)
rumen contents##4##2##(1991-12#1)(2006-8#2)(2009-4#1)
rumen fluid##3##2##(2006-8#2)(2009-4#1)
rumen impaction##5##2##(2012-12#5)
rumen##41##1##(1991-12#3)(2006-5#1)(2006-8#15)(2008-12#1)(2008-4#1)(2009-4#10)(2011-2#4)(2012-12#5)(2013-1#1)
ruminal bacteria##3##2##(2006-8#3)
ruminal contents##2##2##(1991-12#1)(2006-8#1)
ruminal##12##1##(1991-12#1)(2006-8#8)(2008-5#1)(2010-3#1)(2013-1#1)
ruminant animals##3##2##(2006-8#1)(2007-11#1)(2008-12#1)
ruminant hemoglobins##2##2##(1990-8#1)(1991-6#1)
ruminant##14##1##(1990-8#1)(1991-6#1)(1991-8#3)(1997-8#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-12#1)(2008-5#1)(2011-2#2)(2012-3#1)
ruminantium##9##1##(1996-12#4)(2006-8#2)(2008-5#2)(2010-1#1)
ruminants and##3##2##(2006-10#1)(2010-2#1)(2011-1#1)
ruminants by##2##2##(1993-2#1)(2006-10#1)
ruminants in##5##2##(1997-7#1)(2007-8#1)(2008-12#1)(2011-2#1)(2012-2#1)
ruminants##35##1##(1991-8#1)(1993-2#2)(1993-8#2)(1996-10#2)(1996-9#2)(1997-7#3)(2006-10#3)(2006-8#1)(2007-2#5)(2007-8#1)(2008-12#2)(2009-4#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#3)
rumination and##6##2##(2009-11#1)(2009-4#1)(2010-10#1)(2010-8#2)(2012-1#1)
rumination frequency##2##2##(2008-8#2)
rumination is##4##2##(2008-8#1)(2009-11#1)(2009-3#1)(2012-1#1)
rumination##34##1##(2008-8#7)(2009-11#7)(2009-3#1)(2009-4#1)(2010-10#5)(2010-6#1)(2010-8#7)(2012-1#5)
ruminative response##2##2##(2012-1#2)
ruminative thinking##4##2##(2008-8#1)(2012-1#3)
ruminative##7##1##(2008-8#1)(2012-1#5)(2012-12#1)
ruminicola##3##1##(2006-8#3)
rumor##2##1##(1996-11#1)(2008-5#1)
rump##4##1##(1990-3#1)(2010-4#1)(2012-1#2)
run (n = 10)##2##4##(1991-8#2)
run a##6##2##(1990-3#1)(1991-9#1)(1993-12#1)(2006-10#1)(2011-2#1)(2012-2#1)
run along##3##2##(2008-7#2)(2013-1#1)
run an##2##2##(1994-9#1)(2005-9#1)
run and##4##2##(1991-9#1)(1997-1#1)(2008-3#1)(2008-7#1)
run as##3##2##(2006-8#1)(2008-10#1)(2012-2#1)
run at a flow-rate of 1##2##6##(1996-5#1)(1997-8#1)
run at a##5##3##(1996-5#1)(1997-8#1)(2008-4#1)(2010-2#2)
run at the Municipal##2##4##(2008-9#2)
run at the##3##3##(2008-9#2)(2013-1#1)
run at##12##2##(1996-5#1)(1997-8#1)(2006-2#1)(2008-4#1)(2008-9#2)(2010-2#2)(2012-1#2)(2013-1#2)
run away##2##2##(1994-2#1)(2009-10#1)
run buffer##9##2##(1996-5#2)(2008-10#7)
run by Western##3##3##(2007-10#1)(2007-12#1)(2008-5#1)
run by the##5##3##(1993-7#1)(1996-5#1)(2007-2#1)(2007-9#1)(2011-2#1)
run by##18##2##(1990-5#1)(1991-2#1)(1993-7#4)(1994-12#1)(1996-5#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-2#1)(2008-5#1)(2008-9#1)(2011-2#3)
run counter to##3##3##(2008-11#1)(2008-5#1)(2012-11#1)
run down##2##2##(2007-6#1)(2011-7#1)
run for##2##2##(1991-12#1)(2008-10#1)
run in parallel##2##3##(1995-1#1)(2008-5#1)
run in the##3##3##(1990-12#1)(1993-12#2)
run in##12##2##(1990-12#1)(1990-3#1)(1991-7#1)(1993-12#2)(1995-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)(2012-2#1)
run increased risk of developing##2##5##(1990-9#1)(1994-9#1)
run increased risk of##3##4##(1990-9#1)(1994-9#2)
run is a run##2##4##(1993-2#2)
run is##3##2##(1993-2#2)(2013-8#1)
run its course##2##3##(2008-8#1)(2010-7#1)
run length##2##2##(2010-4#1)(2010-8#1)
run locally on##3##3##(2008-4#2)(2008-9#1)
run of##5##2##(1996-5#1)(1997-7#1)(2006-9#1)(2008-6#1)(2010-10#1)
run off##2##2##(1990-11#1)(2008-5#1)
run on a##5##3##(1990-3#1)(2007-8#2)(2008-2#1)(2008-4#1)
run on any##2##3##(1993-9#1)(2008-4#1)
run on the##2##3##(2008-2#1)(2011-2#1)
run on##15##2##(1990-3#1)(1993-4#1)(1993-9#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#3)(2011-2#1)(2013-1#1)
run out of##5##3##(1992-5#2)(1994-3#2)(2008-2#1)
run out##6##2##(1992-5#2)(1994-3#2)(2008-2#1)(2008-4#1)
run over##4##2##(2006-10#1)(2008-4#1)(2012-12#2)
run the risk of##3##4##(1992-12#1)(2006-9#1)(2008-8#1)
run the##7##2##(1992-12#1)(2005-5#1)(2006-9#1)(2008-4#1)(2008-8#1)(2012-2#1)(2013-7#1)
run through##3##2##(2007-12#1)(2008-9#1)(2012-2#1)
run time and##2##3##(1996-8#1)(2008-3#1)
run time of 3##2##4##(2011-2#1)(2012-12#1)
run time of less than##2##5##(1996-12#1)(2008-3#1)
run time of##7##3##(1996-12#1)(1996-5#1)(2008-10#1)(2008-3#1)(2010-2#1)(2011-2#1)(2012-12#1)
run time##15##2##(1992-2#1)(1996-12#1)(1996-5#1)(1996-8#1)(2008-10#2)(2008-3#2)(2010-12#2)(2010-2#1)(2011-2#1)(2012-12#2)(2012-2#1)
run times##3##2##(1996-8#1)(2008-10#1)(2008-3#1)
run to##6##2##(2007-8#1)(2007-9#1)(2008-10#2)(2008-7#1)(2013-7#1)
run under##2##2##(2005-11#1)(2005-12#1)
run using##2##2##(1992-2#1)(2012-2#1)
run was##6##2##(1991-8#1)(1992-11#1)(1995-3#1)(1996-8#1)(2008-10#2)
run with##8##2##(1990-11#1)(1990-8#1)(2006-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-3#1)
run##288##1##(1990-11#3)(1990-12#1)(1990-3#3)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#4)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-5#2)(1992-8#1)(1993-12#3)(1993-2#3)(1993-4#1)(1993-7#4)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-4#3)(1994-5#1)(1994-6#1)(1994-9#3)(1995-1#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#7)(1996-8#3)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2005-10#2)(2005-11#1)(2005-12#1)(2005-5#1)(2005-9#1)(2006-10#4)(2006-2#1)(2006-8#2)(2006-9#2)(2007-10#1)(2007-12#4)(2007-2#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-8#10)(2007-9#4)(2008-10#40)(2008-11#9)(2008-12#1)(2008-2#9)(2008-3#8)(2008-4#12)(2008-5#7)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#2)(2010-10#1)(2010-12#4)(2010-2#4)(2010-4#4)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#7)(2011-7#1)(2012-1#2)(2012-11#1)(2012-12#9)(2012-2#9)(2012-3#3)(2013-1#7)(2013-7#3)(2013-8#1)
run)##3##1##(1990-2#1)(1990-6#1)(2012-2#1)
run-in is##3##2##(1993-1#3)
run-in on##2##2##(1993-1#2)
run-in period##2##2##(2012-3#1)(2013-1#1)
run-in phase##3##2##(1995-12#1)(2008-5#1)(2008-7#1)
run-in strategy##2##2##(1993-1#2)
run-in##20##1##(1993-1#13)(1994-11#1)(1995-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#1)
run-off experiments##2##2##(1991-7#1)(1992-8#1)
run-off transcription##3##2##(1991-4#1)(1994-3#1)(2008-4#1)
run-off water##2##2##(2008-10#2)
run-off##13##1##(1990-10#1)(1990-11#1)(1990-6#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-8#1)(1994-11#1)(1994-3#1)(2008-10#2)(2008-4#1)(2012-2#1)
run-off&quot##2##1##(1991-12#2)
run-on analysis##2##2##(1995-3#1)(1995-6#1)
run-on assays##5##2##(1991-7#1)(1992-12#1)(1995-3#1)(1997-1#1)(1997-2#1)
run-on##17##1##(1991-2#1)(1991-7#1)(1992-12#2)(1992-2#1)(1994-12#1)(1994-3#1)(1995-3#2)(1995-6#2)(1997-1#1)(1997-2#1)(1997-4#1)(2008-8#1)(2012-3#2)
run-to-run##4##1##(1997-5#1)(2007-8#1)(2008-10#1)(2008-3#1)
runaway youth and their families##2##5##(2008-7#2)
runaway youth##3##2##(2008-7#3)
runaway youths##2##2##(2008-9#2)
runaway##15##1##(1995-2#1)(2006-8#2)(2008-7#3)(2008-9#5)(2010-9#1)(2011-2#1)(2013-1#2)
runaways or throwaways to##2##4##(2006-8#2)
runaways##5##1##(2006-8#4)(2008-6#1)
runaways/throwaways##2##1##(2006-8#2)
rundown##2##1##(2008-8#1)(2011-2#1)
rungs##2##1##(2007-12#1)(2011-1#1)
runner hyphae##2##2##(2008-11#2)
runner##11##1##(2007-6#2)(2008-10#3)(2008-11#2)(2011-2#3)(2013-8#1)
runners during the##2##3##(2013-8#2)
runners##13##1##(1990-5#1)(1994-4#2)(1995-9#2)(2008-10#1)(2008-6#1)(2011-12#1)(2013-8#5)
running a##6##2##(1995-12#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-9#1)
running along the##2##3##(1996-12#1)(2013-8#1)
running and##5##2##(1992-11#1)(2007-1#1)(2007-6#1)(2008-4#2)
running at a##4##3##(2007-12#1)(2007-8#1)(2008-6#1)(2008-9#1)
running at##7##2##(1991-1#1)(2007-12#1)(2007-8#1)(2008-6#1)(2008-9#1)(2013-1#1)(2013-7#1)
running away from home##6##4##(2006-8#1)(2008-9#1)(2010-2#4)
running away from##7##3##(1995-5#1)(2006-8#1)(2008-9#1)(2010-2#4)
running away##9##2##(1995-5#1)(2006-8#1)(2007-7#1)(2008-9#1)(2010-2#5)
running buffer (pH##2##3##(2008-10#2)
running buffer##22##2##(1992-2#1)(1996-5#1)(1997-8#3)(2005-12#2)(2007-8#1)(2008-10#12)(2008-11#1)(2010-7#1)
running cost##2##2##(2008-10#2)
running electrolyte##2##2##(2007-8#1)(2008-10#1)
running exercise##3##2##(2007-2#2)(2012-12#1)
running from the##2##3##(1993-8#1)(2011-12#1)
running in##7##2##(2005-8#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-1#1)
running increases##2##2##(1997-7#1)(2013-1#1)
running into##2##2##(2005-7#1)(2007-8#1)
running of the##2##3##(2007-10#1)(2008-9#1)
running on##6##2##(2006-5#1)(2008-1#1)(2008-12#2)(2011-1#1)(2012-1#1)
running out##2##2##(1991-3#1)(1992-5#1)
running parallel##2##2##(2008-11#1)(2008-5#1)
running sutures##3##2##(2006-6#1)(2012-3#2)
running the##8##2##(1994-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-4#1)(2011-2#1)(2013-8#1)
running through##3##2##(2006-4#1)(2008-10#1)(2013-8#1)
running time##5##2##(1996-5#1)(2008-3#1)(2008-5#1)(2009-6#1)(2012-3#1)
running water ecosystems##2##3##(2006-5#2)
running water##5##2##(1993-7#1)(2006-5#2)(2008-10#1)(2013-8#1)
running with##2##2##(2007-1#1)(2007-6#1)
running##175##1##(1990-2#1)(1991-1#1)(1991-3#1)(1992-11#2)(1992-2#3)(1992-5#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-4#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#3)(1997-5#1)(1997-7#3)(1997-8#4)(2004-9#1)(2005-12#2)(2005-7#1)(2005-8#1)(2006-10#2)(2006-4#2)(2006-5#4)(2006-6#3)(2006-8#1)(2007-1#2)(2007-10#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-6#3)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#30)(2008-11#8)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#8)(2008-5#3)(2008-6#2)(2008-7#3)(2008-9#4)(2009-1#1)(2009-10#2)(2009-2#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2010-2#5)(2010-7#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#4)(2012-12#1)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#4)
runoff by cotton wicks##2##4##(2008-10#2)
runoff##24##1##(1994-3#1)(1994-9#1)(1995-3#1)(2004-4#1)(2006-4#2)(2007-5#1)(2007-9#3)(2008-1#2)(2008-10#8)(2008-5#1)(2010-2#1)(2011-2#2)
runs a##2##2##(1995-7#1)(2006-10#1)
runs across the##2##3##(1994-11#1)(2006-3#1)
runs analysis##9##2##(2008-10#9)
runs at##3##2##(1990-11#1)(2008-6#2)
runs in a##2##3##(2008-2#1)(2008-7#1)
runs in##3##2##(2008-2#1)(2008-7#1)(2012-12#1)
runs of the##3##3##(1995-6#1)(2008-10#1)(2011-2#1)
runs of##6##2##(1995-10#1)(1995-6#1)(2007-8#1)(2008-10#2)(2011-2#1)
runs on##3##2##(2008-10#1)(2008-4#1)(2012-2#1)
runs parallel to the##2##4##(1997-7#1)(2008-7#1)
runs performed##2##2##(2007-9#1)(2011-2#1)
runs posteriorly##2##2##(2008-5#2)
runs the risk of##3##4##(1993-8#1)(2007-10#1)(2012-2#1)
runs the##5##2##(1992-6#1)(1993-8#1)(2007-10#1)(2007-12#1)(2012-2#1)
runs under the##2##3##(2006-5#1)(2008-10#1)
runs under##3##2##(1991-8#1)(2006-5#1)(2008-10#1)
runs with##5##2##(2007-9#3)(2011-2#1)(2013-1#1)
runs##105##1##(1990-11#1)(1990-3#1)(1991-11#2)(1991-3#3)(1991-8#1)(1992-1#2)(1992-6#1)(1993-10#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-6#1)(1995-7#1)(1997-7#1)(2004-3#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2007-9#4)(2008-10#21)(2008-11#4)(2008-2#3)(2008-4#2)(2008-5#5)(2008-6#4)(2008-7#3)(2009-6#2)(2010-12#1)(2010-2#1)(2011-2#3)(2012-12#15)(2012-2#3)(2013-1#3)
runt-related transcription factor##2##3##(2011-1#1)(2013-8#1)
runtime analysis of##2##3##(2010-2#2)
runtime##13##1##(2008-2#3)(2008-6#1)(2009-3#1)(2010-12#1)(2010-2#6)(2012-3#1)
rupestris stem-pitting disease##2##3##(2008-10#2)
rupestris##7##1##(1992-1#1)(2007-1#1)(2008-10#5)
rupintrivir##5##1##(2008-10#5)
rupture after coronary artery bypass##2##5##(2008-4#1)(2012-2#1)
rupture after minimal trauma##2##4##(1991-4#1)(1996-12#1)
rupture after##10##2##(1990-8#1)(1991-4#2)(1996-12#1)(2005-10#1)(2008-12#1)(2008-4#1)(2012-1#1)(2012-2#2)
rupture and a##2##3##(2008-3#1)(2012-11#1)
rupture and the##2##3##(2006-10#1)(2012-3#1)
rupture and thrombosis##2##3##(1992-12#1)(2008-3#1)
rupture and##33##2##(1990-8#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-5#2)(1992-8#1)(1995-3#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-9#1)(2004-10#1)(2006-10#1)(2006-11#1)(2007-2#1)(2007-8#4)(2008-3#2)(2008-7#1)(2010-2#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#2)
rupture are##3##2##(1990-6#1)(1993-10#1)(2012-3#1)
rupture as##2##2##(1996-4#1)(2007-8#1)
rupture causing##2##2##(2007-8#1)(2011-2#1)
rupture de rate##2##3##(2012-2#2)
rupture due to##3##3##(2007-4#1)(2008-11#1)(2012-3#1)
rupture during##4##2##(2006-10#1)(2006-11#1)(2007-7#1)(2012-2#1)
rupture event##2##2##(2009-10#1)(2009-9#1)
rupture following acute myocardial##2##4##(2007-8#1)(2013-7#1)
rupture following##6##2##(2007-4#1)(2007-8#1)(2009-4#1)(2010-3#2)(2013-7#1)
rupture had##2##2##(1997-3#1)(2011-3#1)
rupture has##3##2##(1991-4#1)(2006-11#1)(2007-4#1)
rupture in a patient##2##4##(1992-2#1)(2010-3#1)
rupture in a##7##3##(1992-2#1)(1993-12#1)(2005-10#1)(2006-4#1)(2007-8#1)(2009-10#1)(2010-3#1)
rupture in patients##2##3##(1996-12#1)(2007-8#1)
rupture in the##5##3##(1996-4#2)(2007-7#1)(2008-4#1)(2011-2#1)
rupture in##27##2##(1990-8#1)(1991-9#1)(1992-2#2)(1992-5#1)(1993-12#1)(1993-9#1)(1995-12#1)(1996-12#2)(1996-4#2)(2005-10#1)(2006-4#2)(2007-7#2)(2007-8#3)(2008-4#1)(2009-10#1)(2010-3#1)(2011-2#3)(2013-1#1)
rupture is a very rare##2##5##(1992-5#1)(1997-8#1)
rupture is a##7##3##(1992-5#1)(1997-8#1)(2007-4#1)(2007-8#1)(2008-1#1)(2009-10#1)(2012-2#1)
rupture is rare##2##3##(2011-2#2)
rupture is##16##2##(1992-5#1)(1997-8#1)(2007-10#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-3#1)(2009-10#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)
rupture occurs##3##2##(1994-3#1)(2010-4#1)(2013-7#1)
rupture of a##17##3##(1990-4#1)(1992-8#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-6#1)(2009-2#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#1)
rupture of an anterior communicating artery aneurysm##2##7##(1996-3#2)
rupture of an infected urachal cyst##2##6##(2008-10#2)
rupture of an##8##3##(1991-5#1)(1991-6#1)(1995-5#1)(1996-3#2)(2008-10#2)(2008-7#1)
rupture of hydatid cyst##2##4##(2008-12#2)
rupture of intracranial##3##3##(1995-5#1)(2010-9#1)(2011-2#1)
rupture of membranes at term##2##5##(1996-12#1)(2010-3#1)
rupture of membranes##9##3##(1993-1#1)(1993-4#1)(1996-12#1)(2004-10#1)(2006-7#1)(2008-6#1)(2010-3#1)(2012-3#1)(2013-1#1)
rupture of spleen##2##3##(1992-2#1)(2012-2#1)
rupture of the amniotic##2##4##(1992-2#1)(2008-10#1)
rupture of the aneurysm##2##4##(2008-7#1)(2011-2#1)
rupture of the anterior##2##4##(2007-4#1)(2013-7#1)
rupture of the cyst and##2##5##(1991-8#1)(2012-1#1)
rupture of the cyst##4##4##(1990-6#1)(1991-8#1)(2006-5#1)(2012-1#1)
rupture of the descending thoracic aorta##2##6##(2010-8#2)
rupture of the kidney##3##4##(1990-6#3)
rupture of the membranes##7##4##(1992-2#2)(1992-5#1)(1993-5#1)(2004-10#1)(2005-11#1)(2007-2#1)
rupture of the pericardium with cardiac herniation##2##7##(2007-4#2)
rupture of the pericardium##3##4##(2007-4#2)(2008-11#1)
rupture of the posterior##2##4##(2007-1#1)(2009-5#1)
rupture of the right##5##4##(1997-6#1)(2009-2#3)(2012-3#1)
rupture of the spleen##6##4##(1990-4#1)(1992-5#1)(1993-9#1)(2008-11#1)(2011-12#2)
rupture of the##92##3##(1990-11#1)(1990-2#4)(1990-4#1)(1990-6#4)(1991-8#2)(1992-2#4)(1992-5#2)(1993-10#2)(1993-3#1)(1993-5#1)(1993-9#1)(1994-3#1)(1994-7#1)(1996-1#1)(1996-12#1)(1997-6#2)(2004-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-11#1)(2006-3#2)(2006-5#1)(2006-9#1)(2007-1#1)(2007-2#2)(2007-4#5)(2007-7#2)(2007-8#6)(2008-10#3)(2008-11#3)(2008-7#2)(2008-8#1)(2009-2#3)(2009-4#2)(2009-5#3)(2009-9#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#6)(2012-1#2)(2012-11#1)(2012-2#2)(2012-3#1)(2013-7#2)
rupture of##168##2##(1990-11#1)(1990-2#4)(1990-3#1)(1990-4#2)(1990-6#4)(1991-5#2)(1991-6#2)(1991-8#2)(1992-2#6)(1992-5#4)(1992-8#1)(1993-1#1)(1993-10#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-3#1)(1994-7#1)(1995-5#2)(1995-9#1)(1996-1#1)(1996-12#2)(1996-3#2)(1997-6#2)(2004-10#2)(2005-11#1)(2005-7#1)(2005-8#1)(2006-11#1)(2006-3#2)(2006-5#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-2#2)(2007-3#2)(2007-4#5)(2007-6#2)(2007-7#5)(2007-8#12)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#2)(2008-6#2)(2008-7#5)(2008-8#1)(2009-2#5)(2009-3#1)(2009-4#5)(2009-5#3)(2009-9#1)(2010-3#2)(2010-8#2)(2010-9#2)(2011-1#2)(2011-12#3)(2011-2#12)(2012-1#3)(2012-11#2)(2012-2#4)(2012-3#3)(2013-1#2)(2013-7#3)(2013-8#2)
rupture or##3##2##(2007-8#1)(2010-2#1)(2011-2#1)
rupture risk##3##2##(2007-8#1)(2008-7#1)(2011-2#1)
rupture than##2##2##(1996-3#1)(2007-4#1)
rupture was##11##2##(1990-6#1)(1996-3#1)(2006-11#1)(2006-5#1)(2007-8#4)(2009-4#1)(2011-1#1)(2011-3#1)
rupture with cardiac##2##3##(1991-6#1)(2007-4#1)
rupture with##9##2##(1991-6#1)(1991-9#1)(1997-8#1)(2007-4#1)(2007-8#1)(2008-10#1)(2010-12#1)(2011-1#1)(2012-12#1)
rupture without##2##2##(1992-2#1)(2012-2#1)
rupture##484##1##(1990-11#1)(1990-2#4)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#6)(1990-8#3)(1991-4#4)(1991-5#2)(1991-6#3)(1991-8#3)(1991-9#4)(1992-12#1)(1992-2#11)(1992-5#9)(1992-8#3)(1993-1#2)(1993-10#4)(1993-12#3)(1993-3#1)(1993-4#1)(1993-5#1)(1993-9#2)(1994-1#1)(1994-3#2)(1994-7#1)(1994-8#1)(1995-12#2)(1995-3#1)(1995-5#3)(1995-9#1)(1996-1#1)(1996-12#6)(1996-3#6)(1996-4#13)(1996-5#1)(1996-6#2)(1996-9#1)(1997-3#1)(1997-6#2)(1997-8#3)(2003-11#1)(2004-10#3)(2005-10#3)(2005-11#8)(2005-7#5)(2005-8#2)(2006-10#6)(2006-11#11)(2006-3#6)(2006-4#3)(2006-5#2)(2006-7#1)(2006-9#2)(2007-1#3)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#3)(2007-3#3)(2007-4#18)(2007-5#1)(2007-6#3)(2007-7#15)(2007-8#42)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#6)(2008-12#5)(2008-3#5)(2008-4#5)(2008-5#1)(2008-6#6)(2008-7#14)(2008-8#1)(2008-9#1)(2009-10#3)(2009-2#7)(2009-3#2)(2009-4#11)(2009-5#5)(2009-8#1)(2009-9#7)(2010-12#1)(2010-2#2)(2010-3#5)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#4)(2011-1#6)(2011-12#6)(2011-2#29)(2011-3#2)(2012-1#10)(2012-11#4)(2012-12#5)(2012-2#23)(2012-3#8)(2013-1#3)(2013-7#6)(2013-8#6)
rupture) in##2##2##(2007-8#2)
rupture)##4##1##(2005-1#1)(2006-11#1)(2007-8#2)
rupture]##2##1##(1990-6#1)(1996-11#1)
ruptured Achilles tendon##2##3##(2009-5#2)
ruptured abdominal aortic aneurysm##2##4##(1990-5#1)(2008-2#1)
ruptured abdominal aortic##3##3##(1990-5#2)(2008-2#1)
ruptured and##2##2##(2006-2#1)(2008-10#1)
ruptured aneurysm in##2##3##(1997-8#1)(2013-8#1)
ruptured aneurysm##12##2##(1992-8#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-10#4)(2008-7#1)(2012-12#1)(2013-8#2)
ruptured aneurysms##6##2##(1990-10#1)(1990-5#1)(1990-8#2)(2006-4#2)
ruptured aortic##2##2##(2006-1#1)(2007-8#1)
ruptured basilar tip aneurysm associated with##2##6##(2008-7#1)(2012-12#1)
ruptured basilar tip aneurysm##5##4##(2008-7#1)(2012-12#4)
ruptured basilar tip##6##3##(2008-7#2)(2012-12#4)
ruptured diaphragm##3##2##(2007-3#3)
ruptured ectopic pregnancy##2##3##(2007-4#2)
ruptured fetal membranes##5##3##(1993-1#2)(1994-9#1)(1996-9#2)
ruptured into the inferior vena##2##5##(1993-5#1)(2012-2#1)
ruptured into the##6##3##(1991-11#1)(1991-6#1)(1993-5#1)(2008-12#1)(2011-2#1)(2012-2#1)
ruptured into##7##2##(1991-11#1)(1991-6#1)(1993-5#1)(2008-12#1)(2010-7#1)(2011-2#1)(2012-2#1)
ruptured intracranial aneurysm##2##3##(2007-10#1)(2008-7#1)
ruptured intracranial aneurysms##7##3##(2006-4#1)(2006-7#1)(2007-10#3)(2008-7#1)(2012-12#1)
ruptured intracranial##10##2##(2006-4#1)(2006-7#1)(2007-10#4)(2008-7#2)(2010-9#1)(2012-12#1)
ruptured sinus of Valsalva##2##4##(2009-10#2)
ruptured tubal ectopic pregnancy on the##2##6##(2012-2#2)
ruptured##106##1##(1990-10#1)(1990-5#3)(1990-8#2)(1991-11#1)(1991-5#1)(1991-6#1)(1992-8#1)(1993-1#2)(1993-5#1)(1994-11#1)(1994-9#1)(1995-12#1)(1996-9#2)(1997-3#3)(1997-8#1)(2005-10#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-4#4)(2006-5#2)(2006-7#4)(2007-10#9)(2007-11#1)(2007-12#1)(2007-3#3)(2007-4#2)(2007-5#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#10)(2008-8#1)(2009-10#2)(2009-5#2)(2010-5#2)(2010-7#2)(2010-9#1)(2011-2#3)(2012-12#6)(2012-2#4)(2013-1#1)(2013-7#1)(2013-8#3)
ruptures and##4##2##(1991-9#1)(2007-1#1)(2008-9#1)(2013-7#1)
ruptures are##5##2##(1996-12#2)(1996-4#1)(2007-4#1)(2007-8#1)
ruptures in the##2##3##(2007-4#1)(2009-4#1)
ruptures in##4##2##(2007-4#1)(2009-4#2)(2011-2#1)
ruptures is##2##2##(1993-3#1)(1996-12#1)
ruptures of the##9##3##(1993-3#1)(1995-8#2)(1996-11#1)(2006-3#1)(2008-7#1)(2009-4#1)(2013-1#2)
ruptures of##10##2##(1993-3#1)(1995-8#2)(1996-11#1)(1996-4#1)(2006-3#1)(2008-7#1)(2009-4#1)(2013-1#2)
ruptures were##2##2##(2007-7#1)(2009-9#1)
ruptures##56##1##(1991-11#1)(1991-4#2)(1991-9#1)(1993-10#1)(1993-3#2)(1993-5#1)(1995-8#2)(1996-11#1)(1996-12#3)(1996-4#4)(2005-9#1)(2006-3#3)(2006-4#1)(2007-1#2)(2007-4#4)(2007-7#4)(2007-8#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-4#4)(2009-6#1)(2009-9#1)(2010-11#1)(2011-2#2)(2012-2#2)(2013-1#3)(2013-7#1)
rupturing the##4##2##(2006-3#1)(2009-11#1)(2009-3#1)(2013-8#1)
rupturing##5##1##(2006-3#1)(2008-6#1)(2009-11#1)(2009-3#1)(2013-8#1)
rural AFDC##2##2##(1996-3#2)
rural African American##2##3##(2009-7#2)
rural Alaska hospitals##2##3##(1996-12#2)
rural Australia##2##2##(2008-3#1)(2013-8#1)
rural China##3##2##(2007-7#2)(2010-12#1)
rural Chinese women##2##3##(2006-10#1)(2006-4#1)
rural Chinese##5##2##(2006-10#1)(2006-4#3)(2011-2#1)
rural Ethiopia##2##2##(2006-4#1)(2006-8#1)
rural Nepal##3##2##(2006-4#1)(2007-3#1)(2010-11#1)
rural South Africa##2##3##(2011-1#2)
rural Uganda##4##2##(2006-9#1)(2012-2#1)(2013-1#2)
rural adults##2##2##(2010-10#1)(2010-4#1)
rural and remote areas##2##4##(2007-2#1)(2012-12#1)
rural and remote##3##3##(2007-2#1)(2009-4#1)(2012-12#1)
rural and urban and##2##4##(2008-6#1)(2010-4#1)
rural and urban areas##6##4##(1992-9#1)(1994-2#1)(2008-6#1)(2009-7#1)(2011-2#1)(2013-8#1)
rural and urban beneficiaries##3##4##(1994-2#2)(1996-3#1)
rural and urban pharmacies in##3##5##(2013-1#3)
rural and urban populations##2##4##(2011-11#2)
rural and urban school going children##3##6##(2012-2#3)
rural and urban##31##3##(1990-12#1)(1992-9#1)(1994-2#4)(1996-3#1)(2007-7#1)(2007-9#1)(2008-6#4)(2009-10#1)(2009-7#1)(2010-3#1)(2010-4#1)(2011-11#3)(2011-2#1)(2012-1#2)(2012-2#4)(2013-1#3)(2013-8#1)
rural and##48##2##(1990-12#1)(1992-5#1)(1992-9#1)(1994-2#4)(1996-3#1)(1997-4#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-6#6)(2009-10#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#2)(2011-11#3)(2011-2#1)(2012-1#6)(2012-12#2)(2012-2#4)(2013-1#6)(2013-8#1)
rural area in##3##3##(2006-4#1)(2007-8#1)(2013-1#1)
rural area of##5##3##(1995-3#1)(2008-6#1)(2010-12#1)(2010-6#1)(2012-12#1)
rural area##25##2##(1991-3#1)(1992-1#1)(1995-3#2)(1996-3#1)(1997-4#1)(2004-8#1)(2005-12#1)(2006-4#2)(2006-8#1)(2007-2#2)(2007-8#1)(2008-2#1)(2008-6#1)(2009-6#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-11#1)(2012-12#1)(2013-1#3)
rural areas and the##3##4##(2007-7#3)
rural areas and##6##3##(1993-6#1)(2007-7#3)(2011-2#1)(2013-1#1)
rural areas are##3##3##(1994-2#1)(2008-3#1)(2013-1#1)
rural areas from 6 western provinces##2##6##(2012-2#2)
rural areas from##3##3##(2012-2#3)
rural areas in##7##3##(1991-6#1)(1994-3#1)(2007-2#1)(2007-8#1)(2010-1#1)(2011-1#1)(2013-1#1)
rural areas of tropical##2##4##(2006-4#1)(2013-1#1)
rural areas of##19##3##(2006-10#1)(2006-4#1)(2008-5#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
rural areas than##2##3##(2007-7#1)(2012-1#1)
rural areas to##2##3##(1994-9#1)(2006-2#1)
rural areas where##3##3##(1996-12#1)(1996-5#1)(2009-6#1)
rural areas##111##2##(1991-1#1)(1991-3#2)(1991-6#2)(1992-6#2)(1993-12#1)(1993-6#1)(1994-1#2)(1994-2#2)(1994-3#3)(1994-9#1)(1995-3#1)(1996-12#2)(1996-3#5)(1996-5#1)(1997-2#2)(2006-10#1)(2006-2#3)(2006-4#1)(2006-8#2)(2007-12#1)(2007-2#4)(2007-7#7)(2007-8#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#5)(2009-5#1)(2009-6#1)(2010-1#2)(2010-10#3)(2010-12#1)(2010-7#2)(2011-1#8)(2011-2#6)(2012-1#4)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#9)(2013-8#1)
rural based##2##2##(2008-7#1)(2010-3#1)
rural beneficiaries##4##2##(1992-12#3)(1996-3#1)
rural children aged##2##3##(2013-1#2)
rural children##3##2##(1990-12#1)(2013-1#2)
rural communities and##2##3##(2008-7#1)(2013-1#1)
rural communities have##2##3##(2010-7#1)(2013-1#1)
rural communities in Saudi Arabia##2##5##(1997-1#2)
rural communities in the##3##4##(2008-10#1)(2008-9#1)(2010-7#1)
rural communities in##10##3##(1994-9#1)(1997-1#2)(2007-3#1)(2008-10#1)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
rural communities of##4##3##(1997-1#1)(2005-11#1)(2007-7#1)(2011-2#1)
rural communities to##2##3##(2008-1#1)(2013-1#1)
rural communities##47##2##(1992-12#1)(1994-9#1)(1996-11#1)(1996-2#1)(1997-1#6)(1997-4#1)(2005-11#2)(2006-8#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#4)(2008-9#1)(2009-11#1)(2009-7#2)(2010-4#1)(2010-7#3)(2011-1#1)(2011-2#4)(2013-1#10)
rural community and##2##3##(2011-11#1)(2013-1#1)
rural community of Bangladesh##3##4##(2008-5#3)
rural community##26##2##(1994-1#1)(1997-2#1)(2005-8#1)(2007-3#3)(2008-11#1)(2008-12#2)(2008-5#4)(2009-10#1)(2010-3#1)(2010-6#2)(2010-9#2)(2011-1#1)(2011-11#1)(2011-2#1)(2012-2#1)(2013-1#3)
rural counties are##2##3##(1996-3#2)
rural counties##9##2##(1993-6#1)(1996-3#7)(2008-10#1)
rural development##2##2##(1997-7#1)(2010-5#1)
rural district of##3##3##(2007-12#1)(2007-4#1)(2010-4#1)
rural district##5##2##(1994-6#1)(2007-12#1)(2007-4#1)(2010-4#1)(2012-2#1)
rural districts##2##2##(2012-3#1)(2013-1#1)
rural dogs in##2##3##(2008-12#1)(2012-2#1)
rural dogs##4##2##(2008-12#3)(2012-2#1)
rural dwellers##3##2##(1994-3#1)(2010-10#1)(2013-1#1)
rural elderly##2##2##(1994-2#1)(2011-1#1)
rural emergency##2##2##(2007-7#1)(2011-1#1)
rural general##2##2##(2008-4#1)(2008-6#1)
rural girls##2##2##(2011-1#2)
rural health care##5##3##(1992-12#1)(1994-1#1)(1995-2#1)(1996-2#1)(1996-3#1)
rural health##16##2##(1991-1#1)(1992-12#1)(1993-3#1)(1994-1#1)(1995-2#1)(1996-2#1)(1996-3#3)(1997-3#1)(2005-7#1)(2008-12#1)(2008-3#1)(2008-9#1)(2012-12#1)(2012-3#1)
rural hospital##13##2##(1991-1#3)(1993-5#1)(1996-3#4)(2007-3#1)(2007-7#1)(2008-5#1)(2009-4#1)(2012-2#1)
rural hospitals are##4##3##(1991-1#1)(1993-12#1)(1993-2#1)(1996-3#1)
rural hospitals in##3##3##(1992-2#2)(1996-3#1)
rural hospitals##32##2##(1990-12#1)(1991-1#2)(1992-12#3)(1992-2#2)(1992-8#1)(1993-12#5)(1993-2#3)(1993-5#1)(1995-1#1)(1996-12#1)(1996-3#5)(2007-12#2)(2007-2#1)(2007-7#1)(2008-11#2)(2012-1#1)
rural hospitals?##2##2##(1992-12#1)(1996-3#1)
rural household##2##2##(2009-2#1)(2011-2#1)
rural households##2##2##(2006-4#1)(2010-6#1)
rural individuals##2##2##(2013-1#2)
rural localities##2##2##(2005-8#1)(2011-1#1)
rural locations##5##2##(2008-10#1)(2008-3#2)(2008-7#1)(2012-2#1)
rural markets##2##2##(1995-5#1)(1996-3#1)
rural medical##3##2##(1991-3#1)(2008-12#1)(2011-2#1)
rural men##2##2##(2006-10#1)(2009-5#1)
rural mothers##3##2##(2013-1#3)
rural municipalities##2##2##(1994-11#1)(1995-5#1)
rural or##3##2##(1991-1#1)(2008-8#1)(2012-1#1)
rural participants were##2##3##(2007-12#1)(2008-11#1)
rural participants##4##2##(2007-12#2)(2008-11#2)
rural patients##5##2##(1992-12#1)(1997-3#1)(2007-7#1)(2013-1#2)
rural physician##3##2##(2007-7#2)(2008-12#1)
rural placement##2##2##(2013-1#2)
rural population##9##2##(1994-6#1)(1997-1#1)(2007-9#1)(2008-6#1)(2008-8#1)(2011-1#1)(2012-12#2)(2013-1#1)
rural population]##2##2##(1995-5#1)(2011-1#1)
rural populations##11##2##(1996-11#2)(1996-7#2)(2006-4#1)(2008-10#1)(2008-7#1)(2011-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
rural practice##7##2##(1991-3#1)(2007-7#1)(2008-10#1)(2008-12#4)
rural primary care training##2##4##(1996-1#2)
rural primary care##3##3##(1993-12#1)(1996-1#2)
rural primary##4##2##(1993-12#1)(1996-1#2)(2012-2#1)
rural residence##4##2##(2005-10#1)(2010-9#1)(2011-1#1)(2013-1#1)
rural residents##6##2##(1995-12#1)(1997-2#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
rural road and general driving##2##5##(2013-1#2)
rural road and general##3##4##(2013-1#3)
rural road##6##2##(2013-1#6)
rural setting##9##2##(2005-9#1)(2006-8#1)(2007-12#1)(2007-7#1)(2009-6#1)(2010-5#1)(2010-7#1)(2012-12#2)
rural settings##11##2##(1996-1#2)(2007-12#2)(2007-3#1)(2008-11#1)(2008-8#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
rural sites##5##2##(1992-6#1)(1996-1#1)(1996-2#1)(2008-10#1)(2010-6#1)
rural smokers##4##2##(2013-1#4)
rural state##3##2##(2006-5#1)(2010-5#2)
rural states##4##2##(1994-1#4)
rural subjects##4##2##(1997-1#4)
rural veterans##4##2##(2012-1#4)
rural women had decreased odds of##2##6##(2013-1#2)
rural women had##3##3##(2013-1#3)
rural women##4##2##(1994-4#1)(2013-1#3)
rural youth##3##2##(2010-4#1)(2010-7#1)(2011-1#1)
rural##733##1##(1990-12#6)(1991-1#9)(1991-3#5)(1991-6#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#12)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#10)(1993-2#6)(1993-3#1)(1993-5#4)(1993-6#4)(1994-1#11)(1994-11#1)(1994-2#9)(1994-3#7)(1994-4#1)(1994-6#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-5#3)(1995-9#1)(1996-1#7)(1996-11#3)(1996-12#6)(1996-2#3)(1996-3#35)(1996-5#1)(1996-7#2)(1997-1#13)(1997-2#5)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#2)(2004-8#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#7)(2006-12#1)(2006-2#3)(2006-4#14)(2006-5#1)(2006-8#6)(2006-9#1)(2007-1#2)(2007-10#4)(2007-12#11)(2007-2#9)(2007-3#7)(2007-4#2)(2007-6#1)(2007-7#22)(2007-8#5)(2007-9#3)(2008-1#2)(2008-10#13)(2008-11#8)(2008-12#17)(2008-2#5)(2008-3#7)(2008-4#6)(2008-5#12)(2008-6#13)(2008-7#14)(2008-8#4)(2008-9#3)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#10)(2009-5#3)(2009-6#5)(2009-7#8)(2009-8#2)(2009-9#4)(2010-1#2)(2010-10#7)(2010-11#1)(2010-12#9)(2010-3#4)(2010-4#7)(2010-5#4)(2010-6#6)(2010-7#8)(2010-8#1)(2010-9#5)(2011-1#26)(2011-11#8)(2011-2#28)(2012-1#19)(2012-12#14)(2012-2#24)(2012-3#8)(2013-1#88)(2013-7#1)(2013-8#9)
rurality##5##1##(2011-2#4)(2013-1#1)
rush to embrace##2##3##(1994-12#1)(2006-5#1)
rush to##5##2##(1994-12#1)(1995-7#1)(2006-5#1)(2006-7#1)(2007-4#1)
rush##12##1##(1991-8#1)(1993-1#1)(1994-12#1)(1995-7#1)(2006-5#1)(2006-7#1)(2007-4#1)(2008-2#1)(2008-3#2)(2008-6#1)(2013-1#1)
rushed to##4##2##(1990-3#1)(1993-1#1)(2007-9#1)(2008-7#1)
rushed##6##1##(1990-3#1)(1993-1#1)(1996-2#1)(2007-8#1)(2007-9#1)(2008-7#1)
russelli##6##1##(1992-12#5)(2013-7#1)
rust (Puccinia##8##2##(2008-10#6)(2012-2#2)
rust (Uromyces##2##2##(2008-10#2)
rust (caused by##2##3##(2008-10#2)
rust and anthracnose on the##2##5##(2008-10#2)
rust and stripe rust##6##4##(2008-10#6)
rust and##19##2##(2008-10#19)
rust by##2##2##(2008-10#2)
rust caused by Puccinia##2##4##(2008-10#2)
rust caused by##5##3##(2008-10#5)
rust epidemics##9##2##(2008-10#9)
rust fungi##5##2##(2008-10#5)
rust fungus Puccinia##3##3##(2008-10#3)
rust fungus##13##2##(2008-10#13)
rust have##2##2##(2008-10#2)
rust in the##2##3##(2008-10#2)
rust in##16##2##(2008-10#16)
rust infection##5##2##(2008-10#5)
rust is##3##2##(2008-10#3)
rust isolates##5##2##(2008-10#5)
rust lesions##3##2##(2008-10#3)
rust occurs in##2##3##(2008-10#2)
rust of wheat##3##3##(2008-10#3)
rust of##13##2##(2008-10#13)
rust on##6##2##(2008-10#6)
rust pathogen##7##2##(2008-10#7)
rust pathogens##4##2##(2008-10#4)
rust pathosystem##5##2##(2008-10#5)
rust pathotypes##2##2##(2008-10#2)
rust population in##2##3##(2008-10#2)
rust populations##5##2##(2008-10#5)
rust race##2##2##(2008-10#2)
rust races##5##2##(2008-10#5)
rust ratings##2##2##(2008-10#2)
rust resistance and##4##3##(2008-10#4)
rust resistance from##2##3##(2008-10#2)
rust resistance gene Lr34##3##4##(2008-10#3)
rust resistance gene in##2##4##(2008-10#2)
rust resistance gene##16##3##(2008-10#16)
rust resistance genes in##2##4##(2008-10#2)
rust resistance genes##15##3##(2008-10#15)
rust resistance in the##4##4##(2008-10#4)
rust resistance in##14##3##(2008-10#14)
rust resistance was##2##3##(2008-10#2)
rust resistance##71##2##(2008-10#71)
rust severity and##5##3##(2008-10#5)
rust severity##17##2##(2008-10#17)
rust species##6##2##(2008-10#6)
rust susceptible##2##2##(2008-10#2)
rust uredospore production and##2##4##(2008-10#2)
rust uredospore production##3##3##(2008-10#3)
rust was detected##2##3##(2008-10#2)
rust was##9##2##(2008-10#9)
rust were##3##2##(2008-10#3)
rust##388##1##(2008-10#385)(2012-2#3)
rust)##4##1##(2008-10#4)
rustic##2##1##(2008-12#1)(2010-4#1)
rustica##3##1##(2006-12#1)(2008-10#1)(2008-9#1)
rusticyanin##5##1##(1994-9#5)
rusts in##2##2##(2008-10#2)
rusts##11##1##(2008-10#11)
rusty##3##1##(2008-10#1)(2008-9#1)(2010-9#1)
rut element##2##2##(1996-8#2)
rut##7##1##(1996-8#5)(2004-11#2)
rutaecarpa (Juss##2##2##(2007-1#2)
rutaecarpa##5##1##(1996-12#1)(2007-1#4)
rutaecarpine (40-200 microM) inhibited##2##4##(1996-12#2)
rutaecarpine (40-200 microM)##3##3##(1996-12#3)
rutaecarpine##8##1##(1996-12#7)(2007-1#1)
ruthenium (III)##2##2##(2008-10#2)
ruthenium and##5##2##(2008-10#4)(2010-7#1)
ruthenium as##2##2##(2008-10#2)
ruthenium catalyst##2##2##(2010-5#1)(2010-7#1)
ruthenium complex##9##2##(2005-11#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#1)(2010-12#1)
ruthenium complexes##4##2##(2008-10#3)(2009-2#1)
ruthenium concentration##2##2##(2008-10#2)
ruthenium in##4##2##(2008-10#4)
ruthenium nanoparticles immobilized on poly(4-vinylpyridine)##2##5##(2008-12#2)
ruthenium nitrido##2##2##(2010-5#2)
ruthenium oxide materials##3##3##(2010-4#3)
ruthenium oxide##5##2##(2006-12#1)(2010-4#4)
ruthenium red##12##2##(1990-11#1)(1990-5#3)(1991-3#2)(1992-6#1)(1994-12#1)(1994-3#1)(1995-3#1)(2006-8#1)(2008-8#1)
ruthenium with##3##2##(2008-10#3)
ruthenium##93##1##(1990-11#1)(1990-5#3)(1991-3#2)(1992-6#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-2#1)(1996-5#1)(2005-11#2)(2005-7#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-8#2)(2008-10#39)(2008-12#4)(2008-3#4)(2008-5#3)(2008-8#1)(2009-2#2)(2009-8#1)(2010-12#1)(2010-4#4)(2010-5#11)(2010-7#3)
ruthenium(II) complex##4##2##(2008-10#2)(2008-3#1)(2012-1#1)
ruthenium(II) complexes containing##2##3##(2008-10#2)
ruthenium(II) complexes##6##2##(1996-2#1)(2008-10#4)(2008-3#1)
ruthenium(II)##18##1##(1996-2#1)(2008-10#14)(2008-3#2)(2012-1#1)
ruthenium(III) complexes##5##2##(2008-5#5)
ruthenium(III)##7##1##(2008-5#7)
rutile particles in water##2##4##(2008-3#2)
rutile particles##3##2##(2008-3#3)
rutile##14##1##(1996-5#2)(2005-11#2)(2007-12#2)(2008-1#3)(2008-3#5)
rutile-type titanium oxide coated LTI-carbon##2##5##(2008-8#2)
rutile-type titanium oxide##3##3##(2008-8#3)
rutile-type##4##1##(2008-8#4)
rutilus (L##2##2##(2008-7#1)(2010-8#1)
rutilus##7##1##(2004-11#2)(2008-7#1)(2010-8#4)
rutin and quercetin##2##3##(2008-9#2)
rutin and##8##2##(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#2)(2009-6#1)(2010-12#1)
rutin concentration##2##2##(2008-10#1)(2012-1#1)
rutin in##6##2##(1997-8#2)(2008-10#4)
rutin or##2##2##(2008-9#1)(2010-12#1)
rutin##40##1##(1997-8#5)(2006-12#1)(2008-10#18)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#3)(2009-6#1)(2010-12#5)(2012-1#1)(2012-11#1)
rvWF/106 cells x day##3##4##(2008-11#3)
rvs161 and rvs167##2##3##(1997-6#2)
rvs161##3##1##(1997-6#3)
rvs167 mutant##2##2##(1997-6#2)
rvs167##4##1##(1997-6#4)
ryanae##2##1##(2013-1#2)
ryanodine and##3##2##(1991-7#1)(1992-3#1)(1996-5#1)
ryanodine binding##4##2##(1990-2#4)
ryanodine receptor (RyR)##2##3##(1991-3#1)(2006-10#1)
ryanodine receptor##14##2##(1991-3#2)(1991-7#1)(1993-9#1)(1994-12#2)(1994-8#1)(1994-9#3)(1995-2#1)(1997-3#1)(2006-10#2)
ryanodine receptors in##2##3##(1993-12#1)(2008-9#1)
ryanodine receptors##7##2##(1993-12#1)(1995-3#2)(2008-10#1)(2008-8#1)(2008-9#1)(2010-11#1)
ryanodine sensitive ion channel##3##4##(1994-8#3)
ryanodine##43##1##(1990-2#6)(1991-3#3)(1991-7#2)(1992-1#1)(1992-3#3)(1993-12#2)(1993-2#1)(1993-9#1)(1994-12#3)(1994-8#5)(1994-9#3)(1995-2#1)(1995-3#2)(1996-5#1)(1997-3#1)(2006-10#2)(2008-10#1)(2008-8#1)(2008-9#2)(2010-11#1)(2013-8#1)
ryanodine-sensitive##4##1##(1990-2#1)(1993-12#1)(2007-9#2)
ryckmani##5##1##(2007-3#5)
rye (Secale cereale)##2##3##(2008-10#1)(2008-5#1)
rye B medium##2##3##(2008-10#2)
rye and barley##2##3##(1991-12#2)
rye and##4##2##(1991-12#2)(2008-5#1)(2008-8#1)
rye flour##2##2##(1990-3#1)(1993-3#1)
rye grass##3##2##(2008-10#3)
rye telomeric##2##2##(2008-5#2)
rye##42##1##(1990-3#1)(1991-12#2)(1992-6#2)(1993-3#1)(1995-8#1)(1997-3#2)(1997-5#1)(2008-10#16)(2008-12#1)(2008-5#11)(2008-8#3)(2011-2#1)
rye-vetch green manure##3##3##(2008-10#3)
ryegrass (Lolium multiflorum##2##3##(2008-5#1)(2012-2#1)
ryegrass (Lolium perenne)##3##3##(2008-10#3)
ryegrass (Lolium##6##2##(2008-10#4)(2008-5#1)(2012-2#1)
ryegrass and##4##2##(2008-10#4)
ryegrass##42##1##(2008-10#37)(2008-5#2)(2012-2#3)
r = 0##6##1##(2012-5#6)
réalisation##2##1##(2011-2#1)(2012-2#1)
réalisé##4##1##(2012-2#3)(2013-1#1)
résection du dôme saillant##2##4##(2011-2#2)
résection##4##1##(2011-2#3)(2012-2#1)
révélé##2##1##(2011-2#1)(2012-2#1)
rô1e##2##1##(2007-9#2)
r = 0##2##1##(2012-1#2)
s (n =##2##3##(2006-7#2)
s -polarized##2##2##(2007-12#1)(2008-2#1)
s = 0##2##3##(2007-11#2)
s = 3##3##3##(2005-11#1)(2007-11#2)
s =##11##2##(2005-11#2)(2007-11#7)(2008-5#1)(2009-7#1)
s accumulation time##2##3##(2008-10#2)
s accumulation##3##2##(2008-10#3)
s after addition of##3##4##(1990-5#1)(1991-12#1)(1994-12#1)
s after the reactants##2##4##(2008-10#2)
s after the start of##3##5##(1995-12#1)(2006-8#1)(2008-10#1)
s after the##8##3##(1991-2#1)(1992-11#1)(1995-12#1)(1996-5#1)(2006-8#1)(2008-10#3)
s after##20##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-8#1)(1993-11#2)(1994-12#1)(1994-9#1)(1995-12#1)(1996-11#1)(1996-5#1)(1997-5#1)(2006-8#1)(2008-10#4)
s and a scan rate of##2##6##(2007-8#1)(2008-10#1)
s and a##5##3##(2007-8#1)(2008-10#3)(2008-11#1)
s and can be used for at least 3 months without any##2##12##(2008-10#2)
s and can be used for at least##6##8##(2008-10#6)
s and can be used for##8##6##(2008-10#8)
s and p polarization of##2##5##(2007-11#1)(2008-3#1)
s and p polarization##5##4##(2007-11#2)(2007-12#1)(2008-3#2)
s and p##8##3##(2007-11#3)(2007-12#1)(2008-3#4)
s and the detection limit##2##5##(2008-10#2)
s and the membrane##2##4##(2008-10#2)
s and the##8##3##(2008-10#5)(2008-4#1)(2008-5#1)(2012-12#1)
s and was##2##3##(1991-5#1)(2008-10#1)
s and##55##2##(1991-5#1)(1992-10#1)(1992-11#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-7#1)(1994-12#1)(1996-5#1)(2004-9#2)(2006-5#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#23)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#1)(2010-8#2)(2012-12#1)
s are##4##2##(1994-8#1)(2008-10#1)(2008-2#1)(2009-4#1)
s at P0(2) ranging from##2##5##(1996-3#2)
s at a##2##3##(2008-10#1)(2008-9#1)
s at pCO(2) ranging from##2##5##(1996-3#2)
s at##13##2##(1996-3#5)(1996-5#1)(2004-9#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#1)
s between##2##2##(1993-6#1)(2008-10#1)
s caused##2##2##(1990-10#1)(1995-12#1)
s circulation period)##2##3##(1997-2#2)
s disease##9##2##(2006-10#3)(2006-8#4)(2009-3#1)(2010-12#1)
s exposure and##2##3##(1992-1#1)(1994-2#1)
s exposure##3##2##(1992-1#2)(1994-2#1)
s for a##2##3##(2007-12#1)(2010-12#1)
s for copolymers##2##3##(2010-4#2)
s for the##2##3##(2008-10#2)
s for##11##2##(2005-11#1)(2007-12#1)(2008-10#6)(2010-12#1)(2010-4#2)
s from the##2##3##(2008-10#1)(2009-2#1)
s from##4##2##(1990-2#1)(2008-10#1)(2008-11#1)(2009-2#1)
s have##2##2##(2008-3#1)(2010-12#1)
s in a##3##3##(2008-10#3)
s in clinical##2##3##(2008-12#2)
s in the##3##3##(1993-8#1)(1996-10#1)(1996-12#1)
s in##22##2##(1990-7#1)(1991-10#1)(1991-9#2)(1992-8#1)(1993-8#1)(1996-10#1)(1996-12#1)(1996-5#1)(2005-4#1)(2006-10#1)(2008-10#3)(2008-12#3)(2008-7#1)(2009-8#2)(2013-8#2)
s is the##2##3##(1990-5#1)(2005-11#1)
s is##4##2##(1990-5#1)(2005-11#2)(2008-3#1)
s lymphoma##2##2##(2006-10#1)(2006-8#1)
s mRNAs##2##2##(1994-12#2)
s of the##4##3##(1997-8#1)(2005-11#1)(2008-10#1)(2008-3#1)
s of##19##2##(1991-2#1)(1992-2#1)(1994-5#1)(1997-8#1)(2005-11#1)(2008-10#7)(2008-3#1)(2008-9#1)(2010-3#1)(2012-12#1)(2012-3#3)
s on##2##2##(2008-12#1)(2008-2#1)
s or##7##2##(1993-9#1)(1994-3#2)(1994-8#1)(2007-5#1)(2008-10#1)(2013-1#1)
s per##3##2##(2008-10#1)(2008-2#1)(2010-5#1)
s polarization##2##2##(2008-3#2)
s polarized##2##2##(2007-12#1)(2008-3#1)
s preconcentration time the sample frequency was##2##7##(2007-8#1)(2008-10#1)
s preconcentration time##9##3##(2007-8#1)(2008-10#8)
s preconcentration##12##2##(2007-8#1)(2008-10#11)
s showed a##2##3##(2005-11#2)
s species##2##2##(1992-11#1)(2011-2#1)
s to 13##2##3##(2008-10#1)(2008-2#1)
s to##6##2##(1990-8#1)(2007-1#1)(2008-10#2)(2008-2#1)(2013-8#1)
s under##2##2##(2008-10#2)
s using##3##2##(1993-11#1)(2007-8#1)(2008-10#1)
s vs##2##2##(1997-8#1)(2013-1#1)
s was##3##2##(1990-11#1)(2008-3#1)(2008-5#1)
s were##5##2##(1997-8#1)(2006-7#1)(2006-8#1)(2008-10#2)
s with a##2##3##(2008-7#2)
s with##9##2##(1991-4#1)(1993-2#1)(1994-5#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-7#2)
s without##2##2##(2008-10#1)(2008-3#1)
s##863##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#5)(1990-5#14)(1990-6#2)(1990-7#4)(1990-8#2)(1991-1#2)(1991-10#1)(1991-11#4)(1991-12#2)(1991-2#9)(1991-3#1)(1991-4#5)(1991-5#4)(1991-6#3)(1991-7#2)(1991-8#2)(1991-9#6)(1992-1#3)(1992-10#4)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#5)(1992-4#4)(1992-5#1)(1992-6#14)(1992-7#1)(1992-8#5)(1992-9#3)(1993-11#6)(1993-12#7)(1993-2#4)(1993-3#3)(1993-5#1)(1993-6#4)(1993-7#5)(1993-8#1)(1993-9#7)(1994-10#1)(1994-12#11)(1994-2#2)(1994-3#5)(1994-5#8)(1994-6#2)(1994-8#2)(1994-9#4)(1995-1#1)(1995-11#4)(1995-12#21)(1995-3#6)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#2)(1996-1#1)(1996-10#18)(1996-11#1)(1996-12#5)(1996-2#7)(1996-3#6)(1996-4#1)(1996-5#7)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#10)(1997-4#6)(1997-5#7)(1997-6#4)(1997-7#6)(1997-8#9)(2004-2#1)(2004-4#1)(2004-9#3)(2005-10#1)(2005-11#12)(2005-4#1)(2005-7#1)(2006-1#1)(2006-10#14)(2006-12#1)(2006-2#1)(2006-5#3)(2006-6#7)(2006-7#5)(2006-8#11)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#16)(2007-12#31)(2007-2#2)(2007-3#2)(2007-4#3)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#11)(2007-9#2)(2008-1#3)(2008-10#170)(2008-11#18)(2008-12#7)(2008-2#13)(2008-3#34)(2008-4#5)(2008-5#14)(2008-6#6)(2008-7#10)(2008-8#12)(2008-9#6)(2009-10#7)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#2)(2009-8#3)(2010-1#2)(2010-12#4)(2010-3#5)(2010-4#5)(2010-5#1)(2010-6#1)(2010-8#7)(2010-9#2)(2011-1#1)(2011-2#5)(2012-1#1)(2012-11#2)(2012-12#5)(2012-2#3)(2012-3#3)(2012-6#1)(2013-1#12)(2013-7#3)(2013-8#18)
s&gt##2##1##(2005-11#1)(2007-12#1)
s(-1) and 3##2##3##(2008-3#2)
s(-1) and##13##2##(1997-2#1)(2008-10#5)(2008-3#2)(2008-7#1)(2008-9#1)(2009-7#1)(2010-5#1)(2012-11#1)
s(-1) at 22 degrees C##2##5##(1996-9#1)(2010-5#1)
s(-1) at##5##2##(1996-9#1)(2008-10#2)(2008-5#1)(2010-5#1)
s(-1) for the##3##3##(1996-2#2)(2009-8#1)
s(-1) for##13##2##(1996-2#2)(1997-7#1)(2005-11#2)(2005-8#2)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-8#1)
s(-1) in##3##2##(2006-12#1)(2008-10#1)(2009-4#1)
s(-1) on##2##2##(2006-5#1)(2010-5#1)
s(-1) was##2##2##(2005-11#1)(2008-5#1)
s(-1)##108##1##(1996-2#2)(1996-7#3)(1996-9#1)(1997-2#2)(1997-7#2)(2004-11#1)(2005-11#4)(2005-8#2)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#2)(2007-8#2)(2008-10#36)(2008-11#3)(2008-2#2)(2008-3#6)(2008-5#3)(2008-7#3)(2008-8#4)(2008-9#2)(2009-11#1)(2009-4#5)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-4#2)(2010-5#4)(2010-7#1)(2010-8#4)(2010-9#1)(2012-11#2)
s(-1)) and the##2##3##(2008-10#1)(2010-5#1)
s(-1)) and##4##2##(1997-4#1)(2008-10#1)(2010-5#2)
s(-1)) were##2##2##(2006-4#1)(2009-8#1)
s(-1))##34##1##(1996-9#1)(1997-4#5)(2005-11#1)(2006-11#1)(2006-4#3)(2006-5#1)(2007-5#1)(2008-10#11)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-5#2)(2010-7#1)(2012-12#1)
s(-2)##2##1##(2008-3#1)(2010-8#1)
s(0)##2##1##(2008-3#2)
s(b)##2##1##(2008-10#2)
s(r##6##1##(2008-10#6)
s(r)##2##1##(2008-10#2)
s(r)&lt##2##1##(2008-10#2)
s(x) of##2##2##(2008-2#1)(2008-3#1)
s(x)##7##1##(2008-2#3)(2008-3#4)
s(z)##3##1##(2008-3#3)
s) and a##2##3##(2008-10#2)
s) and high##2##3##(2008-10#2)
s) and##16##2##(1992-10#1)(1992-4#1)(1995-8#1)(2006-12#1)(2007-10#1)(2008-10#6)(2008-12#1)(2008-3#2)(2013-1#1)(2013-8#1)
s) at##2##2##(1992-3#1)(1994-5#1)
s) for##2##2##(2008-10#1)(2008-3#1)
s) in the##2##3##(1990-2#1)(2008-10#1)
s) in##3##2##(1990-2#1)(2008-10#1)(2011-1#1)
s) of##3##2##(2008-10#3)
s) the##2##2##(1993-11#1)(1993-6#1)
s) was##4##2##(1992-10#1)(1994-12#2)(2008-10#1)
s) were##4##2##(1995-1#1)(1996-3#1)(1997-8#1)(2008-10#1)
s) with##2##2##(1995-11#1)(2008-3#1)
s)##76##1##(1990-2#1)(1990-3#1)(1990-5#1)(1992-10#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-12#3)(1994-5#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-8#2)(1996-10#1)(1996-3#2)(1996-7#1)(1996-9#1)(1997-6#1)(1997-8#1)(2006-12#2)(2006-7#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-8#1)(2008-10#22)(2008-12#1)(2008-3#7)(2009-8#1)(2010-2#1)(2010-3#3)(2011-1#1)(2013-1#1)(2013-8#1)
s)-1##3##1##(1990-2#3)
s- and p-polarized light##3##4##(2008-3#3)
s- and p-polarized##7##3##(2007-11#1)(2007-8#1)(2008-2#2)(2008-3#3)
s- and##10##2##(2007-11#1)(2007-8#1)(2008-2#2)(2008-3#6)
s-##12##1##(2007-11#1)(2007-8#2)(2008-2#2)(2008-3#6)(2011-12#1)
s-1 and 0##2##3##(1991-9#1)(1996-9#1)
s-1 and 1##2##3##(1994-11#1)(1995-2#1)
s-1 and 2##3##3##(1992-6#1)(1995-5#1)(1997-2#1)
s-1 and a Kd value of##2##6##(1994-8#2)
s-1 and##20##2##(1990-5#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-6#1)(1992-7#1)(1993-8#1)(1994-11#1)(1994-8#3)(1995-2#1)(1995-5#1)(1995-6#1)(1996-7#1)(1996-9#1)(1997-2#1)(2004-8#1)(2008-10#1)
s-1 at pH##7##3##(1993-8#1)(1995-1#1)(1996-7#5)
s-1 at##10##2##(1993-3#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-1#1)(1996-7#5)
s-1 for the##2##3##(1994-5#2)
s-1 for##11##2##(1990-2#2)(1992-6#2)(1994-5#2)(1995-11#1)(1995-3#2)(1995-8#2)
s-1 in grassland and##2##4##(2011-12#2)
s-1 in##5##2##(1992-6#1)(1994-9#1)(2011-12#3)
s-1 of##3##2##(1993-8#2)(2013-8#1)
s-1 to##2##2##(1993-9#1)(1997-7#1)
s-1 with##3##2##(1990-5#1)(1992-3#1)(1994-5#1)
s-1##152##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#4)(1990-5#11)(1990-7#2)(1991-2#5)(1991-4#1)(1991-5#9)(1991-7#8)(1991-9#3)(1992-3#4)(1992-6#6)(1992-7#2)(1992-9#1)(1993-3#2)(1993-8#5)(1993-9#3)(1994-11#6)(1994-12#1)(1994-5#9)(1994-8#6)(1994-9#2)(1995-1#4)(1995-10#1)(1995-11#7)(1995-2#6)(1995-3#2)(1995-5#4)(1995-6#2)(1995-8#6)(1996-1#1)(1996-5#1)(1996-7#7)(1996-9#3)(1997-2#1)(1997-4#2)(1997-7#3)(2004-8#1)(2008-10#3)(2011-12#3)(2013-8#1)
s-1) and##4##2##(1990-2#1)(1990-5#1)(1992-3#1)(1995-6#1)
s-1) approximately beta-erythro-2-pentulofuranose (0##2##4##(1990-9#2)
s-1) approximately##4##2##(1990-9#4)
s-1) greater than alpha-erythrofuranose##2##4##(1990-9#2)
s-1) greater than alpha-threo-2-pentulofuranose (0##2##5##(1990-9#2)
s-1) greater than alpha-threofuranose##2##4##(1990-9#2)
s-1) greater than##10##3##(1990-9#10)
s-1) were##2##2##(1990-2#1)(1991-5#1)
s-1)##44##1##(1990-2#2)(1990-5#1)(1990-9#16)(1991-2#1)(1991-5#1)(1991-7#2)(1992-11#2)(1992-3#2)(1993-6#1)(1994-9#1)(1995-1#4)(1995-11#1)(1995-2#4)(1995-6#3)(1997-2#1)(2006-11#1)(2008-10#1)
s-1M-1)##2##1##(1992-12#2)
s-1]##2##1##(1991-2#1)(1995-11#1)
s-AHP was##3##2##(1993-2#3)
s-Le &amp##2##2##(1996-3#2)
s-NSP##2##1##(1996-4#2)
s-cis##2##1##(2009-7#2)
s-polarized##9##1##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#3)
s-triazine##2##1##(1997-2#1)(2010-2#1)
s-triazines##2##1##(2008-10#2)
s-wave polarized##3##2##(2008-2#3)
s/cm(5))##2##1##(2007-8#2)
s/mm2##2##1##(2009-11#2)
s20##4##1##(1990-7#1)(1991-4#2)(1995-6#1)
sA beta##7##2##(1993-12#2)(1993-4#1)(1995-3#4)
sAPP695##2##1##(1994-11#2)
sAPP770##2##1##(1994-11#2)
sCD23##3##1##(1995-2#3)
sCD8##3##1##(1997-8#3)
sCT##3##1##(1990-10#2)(1992-8#1)
sCysC in SLE##3##3##(2013-1#3)
sCysC##7##1##(2013-1#7)
sE-selectin##2##1##(2009-7#1)(2012-3#1)
sEMG##3##1##(2013-8#3)
sFTX##2##1##(1993-7#2)
sFasL##3##1##(2008-8#1)(2010-12#2)
sFv##3##1##(1995-8#3)
sFv'##5##1##(1995-8#5)
sGAG-storage##2##1##(1993-12#2)
sGC activity in##2##3##(2007-9#2)
sGC subunit mRNA levels##5##4##(1997-2#5)
sGC subunit mRNA stability##2##4##(1997-2#2)
sGC subunit mRNA##7##3##(1997-2#7)
sGC subunit##8##2##(1997-2#8)
sGC##20##1##(1997-2#11)(2007-9#4)(2008-4#2)(2008-8#2)(2010-6#1)
sGFP418##3##1##(2009-10#3)
sGP74##2##1##(1994-3#2)
sGnRH##5##1##(1994-8#5)
sI/R##2##1##(2013-7#2)
sICAM-1 in##3##2##(1993-8#2)(2012-11#1)
sICAM-1 levels were##4##3##(2008-9#4)
sICAM-1 levels##6##2##(2008-9#6)
sICAM-1##15##1##(1993-8#4)(2008-9#9)(2009-7#1)(2012-11#1)
sIL-1R I##3##2##(2008-10#3)
sIL-1R##10##1##(1995-2#7)(2008-10#3)
sIL-2R and##2##2##(1995-7#1)(1997-8#1)
sIL-2R##4##1##(1995-7#3)(1997-8#1)
sIL-6R and##4##2##(1995-7#1)(1996-11#2)(1997-7#1)
sIL-6R is##2##2##(1996-11#1)(1997-7#1)
sIL-6R##18##1##(1994-2#5)(1995-7#2)(1996-11#7)(1997-7#4)
sIgA##5##1##(2008-5#1)(2011-1#4)
sIgM##4##1##(1992-9#4)
sLe(x)##2##1##(1995-1#2)
sLe(x)[Glc]##3##1##(1995-1#3)
sMDH##3##1##(1993-11#3)
sMNs##3##1##(2012-12#3)
sNCT##2##1##(2006-12#2)
sOB-R##2##1##(2006-9#2)
sPLA2##6##1##(1992-4#2)(2008-8#1)(2011-2#3)
sPLA2I and PGHS2##3##3##(1996-8#3)
sPLA2I and##4##2##(1996-8#4)
sPLA₂ from##2##2##(2013-1#2)
sPLA₂##3##1##(2013-1#3)
sPLA₂s##3##1##(2013-1#3)
sRANKL levels##2##2##(2010-10#2)
sRANKL was##2##2##(2010-10#2)
sRANKL##8##1##(2010-10#6)(2013-8#2)
sRBC##4##1##(1995-2#3)(2008-10#1)
sRNA##3##1##(2008-9#3)
sRNAs##2##1##(2008-9#2)
sTF##5##1##(1993-3#5)
sTM and sICAM-1 levels were##2##5##(2008-9#2)
sTM and sICAM-1 levels##3##4##(2008-9#3)
sTM and sICAM-1##5##3##(2008-9#5)
sTM concentrations##2##2##(2007-10#2)
sTM##13##1##(2007-10#5)(2008-9#8)
sTNF-R2 was##2##2##(1993-3#2)
sTNF-R2##8##1##(1993-3#8)
sTNF-Rs##3##1##(2008-4#3)
sTRAIL##5##1##(2009-3#4)(2013-8#1)
sTT level was##2##3##(2012-12#2)
sTT##4##1##(2012-12#4)
sTT/PSA ratio in##2##3##(2012-12#2)
sTT/PSA ratio##4##2##(2012-12#4)
sTfR and##2##2##(2013-1#2)
sa##4##1##(2008-8#1)(2012-2#2)(2013-1#1)
saCBMFX##6##1##(2008-11#6)
saGH##3##1##(2008-3#3)
saGHF-1/Pit-1##2##1##(1997-1#2)
saGHFIM##2##1##(2008-3#2)
sabanensis##3##1##(2007-3#3)
sabinene##3##1##(2007-1#2)(2007-11#1)
sac and the##4##3##(1995-1#1)(2007-12#1)(2007-8#1)(2011-1#1)
sac and##18##2##(1993-8#1)(1995-1#5)(2006-8#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-6#1)(2009-12#2)(2009-7#1)(2011-1#1)(2012-12#2)(2012-3#1)
sac during##4##2##(2007-4#1)(2008-11#2)(2011-3#1)
sac in##3##2##(2007-8#1)(2008-9#1)(2009-8#1)
sac is a##3##3##(2006-9#1)(2007-12#1)(2009-6#1)
sac is##6##2##(2006-9#1)(2007-12#2)(2009-6#1)(2012-12#2)
sac of##5##2##(2007-12#1)(2008-5#1)(2008-9#1)(2009-12#1)(2013-8#1)
sac tumour arising in##2##4##(2012-2#2)
sac tumour is##3##3##(2012-2#3)
sac tumour##6##2##(2012-2#6)
sac was##5##2##(2007-8#2)(2008-11#1)(2008-12#1)(2009-6#1)
sac##127##1##(1991-9#1)(1992-2#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-1#8)(1995-11#2)(1995-4#1)(1997-3#2)(1997-4#1)(2005-7#1)(2005-9#1)(2006-11#1)(2006-12#4)(2006-8#2)(2006-9#1)(2007-12#11)(2007-4#1)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#9)(2008-11#6)(2008-12#10)(2008-4#3)(2008-5#3)(2008-6#1)(2008-9#4)(2009-12#3)(2009-6#4)(2009-7#1)(2009-8#3)(2010-1#1)(2010-8#4)(2011-1#3)(2011-3#3)(2012-1#4)(2012-12#5)(2012-2#6)(2012-3#3)(2013-1#1)(2013-8#1)
sac-like##2##1##(2007-12#2)
sacB[BamP]##2##1##(1990-11#2)
sacS##2##1##(1990-5#2)
sacX##2##1##(1990-5#2)
sacY##2##1##(1990-5#2)
saca cena##3##2##(2006-7#3)
saccade amplitude##3##2##(2008-4#1)(2008-7#2)
saccade error##2##2##(2008-7#2)
saccade latency##2##2##(2008-4#2)
saccade toward the##2##3##(2006-4#1)(2009-2#1)
saccade##18##1##(1996-1#1)(2006-4#1)(2008-4#5)(2008-7#5)(2009-2#4)(2011-1#2)
saccades to##2##2##(1995-8#1)(1996-1#1)
saccades were##3##2##(1995-1#1)(1996-1#1)(2008-7#1)
saccades##21##1##(1991-5#1)(1995-1#3)(1995-8#1)(1996-1#8)(2008-7#2)(2009-2#1)(2010-10#1)(2010-5#2)(2013-1#2)
saccadic eye movements##5##3##(1995-8#1)(2006-7#1)(2008-7#1)(2011-12#2)
saccadic eye##7##2##(1991-10#1)(1992-9#1)(1995-8#1)(2006-7#1)(2008-7#1)(2011-12#2)
saccadic head movements##2##3##(1993-12#2)
saccadic response##2##2##(1996-1#2)
saccadic suppression##6##2##(1997-8#1)(2006-7#5)
saccadic##26##1##(1991-10#1)(1991-5#1)(1992-10#1)(1992-9#1)(1993-12#3)(1995-8#1)(1996-1#5)(1997-8#1)(2006-7#6)(2008-11#1)(2008-7#2)(2011-12#2)(2012-1#1)
sacchari##2##1##(2008-10#2)
saccharide composition##2##2##(1991-7#2)
saccharide units##3##2##(1995-4#2)(1997-1#1)
saccharide##15##1##(1991-7#2)(1995-2#1)(1995-4#2)(1996-1#1)(1997-1#1)(2006-12#1)(2008-10#3)(2008-4#1)(2009-2#1)(2012-12#1)(2012-3#1)
saccharides and##2##2##(1991-7#1)(1996-5#1)
saccharides on##2##2##(2008-5#1)(2009-2#1)
saccharides were##2##2##(1991-7#1)(1994-9#1)
saccharides##17##1##(1990-12#1)(1991-12#2)(1991-7#5)(1994-9#1)(1995-5#2)(1996-5#1)(2008-11#1)(2008-4#1)(2008-5#2)(2009-2#1)
saccharification and fermentation##10##3##(2008-5#1)(2008-6#7)(2013-1#2)
saccharification and##14##2##(2008-5#4)(2008-6#8)(2013-1#2)
saccharification of the##2##3##(2004-8#1)(2008-6#1)
saccharification of##9##2##(2004-8#4)(2008-5#1)(2008-6#3)(2010-6#1)
saccharification##26##1##(2004-8#5)(2008-5#6)(2008-6#12)(2010-6#1)(2013-1#2)
saccharin and##2##2##(1992-11#1)(2008-5#1)
saccharin aversion##3##2##(2008-5#3)
saccharin preference##2##2##(2008-2#1)(2008-5#1)
saccharin##18##1##(1992-11#2)(1993-12#1)(1995-11#1)(1995-12#1)(2008-2#1)(2008-5#10)(2011-1#2)
saccharina##4##1##(2007-6#1)(2008-10#3)
saccharolytic##2##1##(2006-5#1)(2012-12#1)
saccharophilia##3##1##(2006-8#3)
saccharopine##2##1##(1994-3#1)(2008-10#1)
saccharose##4##1##(2006-2#1)(2008-10#2)(2008-2#1)
saccular IA##2##2##(2007-10#2)
saccular aneurysm arising from the##2##5##(2007-8#2)
saccular aneurysm arising from##3##4##(2007-8#2)(2013-8#1)
saccular aneurysm of the##2##4##(1992-8#1)(2008-7#1)
saccular aneurysm of##3##3##(1992-8#1)(2007-8#1)(2008-7#1)
saccular aneurysm##11##2##(1992-8#1)(2007-8#3)(2008-3#1)(2008-7#3)(2010-12#2)(2013-8#1)
saccular aneurysms##5##2##(1992-8#1)(1995-11#1)(2010-12#1)(2010-9#2)
saccular cyst##3##2##(2008-5#3)
saccular intracranial##2##2##(2007-10#1)(2008-6#1)
saccular macula##3##2##(1991-9#3)
saccular##34##1##(1991-9#4)(1992-8#2)(1995-11#1)(2007-10#3)(2007-8#3)(2008-3#1)(2008-5#6)(2008-6#1)(2008-7#3)(2010-12#3)(2010-5#1)(2010-9#2)(2013-8#4)
sacculus##3##1##(1997-8#1)(2007-12#2)
sachalinensis##2##1##(2008-11#2)
sachet##3##1##(2004-12#3)
sachets##3##1##(2004-12#1)(2006-10#1)(2008-5#1)
sack lunches##3##2##(2012-12#3)
sack##6##1##(1990-5#1)(2006-12#1)(2012-12#3)(2012-3#1)
sacoglossan##2##1##(2007-11#2)
sacral ala##2##2##(2006-1#1)(2008-12#1)
sacral and pelvic##2##3##(2006-10#1)(2006-12#1)
sacral and##3##2##(1992-2#1)(2006-10#1)(2006-12#1)
sacral bone##4##2##(2007-11#2)(2009-3#1)(2013-8#1)
sacral fractures##2##2##(2008-12#2)
sacral meningocele may##2##3##(2009-3#2)
sacral meningocele##4##2##(2009-3#4)
sacral nerve stimulation##2##3##(2006-9#1)(2008-1#1)
sacral neuromodulation##2##2##(1997-3#1)(2008-6#1)
sacral pressure sores##3##3##(2007-9#3)
sacral segments##2##2##(1993-12#1)(2012-1#1)
sacral##58##1##(1990-7#1)(1991-5#1)(1991-8#1)(1992-2#1)(1993-12#7)(1997-3#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-8#4)(2006-9#1)(2007-11#2)(2007-5#1)(2007-7#2)(2007-9#4)(2008-1#1)(2008-10#1)(2008-12#4)(2008-3#1)(2008-6#2)(2008-7#5)(2008-8#1)(2009-2#1)(2009-3#5)(2010-2#1)(2010-6#1)(2010-9#1)(2012-1#1)(2013-7#1)(2013-8#3)
sacred##8##1##(2007-2#1)(2008-1#5)(2009-8#1)(2011-2#1)
sacredness of##2##2##(2008-1#2)
sacredness##5##1##(2008-1#5)
sacrifice at##2##2##(1990-5#1)(1996-1#1)
sacrifice of##4##2##(2006-3#1)(2008-2#2)(2012-3#1)
sacrifice the##4##2##(1995-5#1)(2008-12#1)(2008-2#1)(2008-4#1)
sacrifice##31##1##(1990-5#1)(1991-11#1)(1992-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-7#1)(1996-1#1)(1996-2#1)(1997-4#1)(2004-9#1)(2005-10#1)(2006-3#2)(2007-2#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#5)(2008-4#1)(2010-10#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-7#1)
sacrificed 1##2##2##(1994-12#1)(2008-10#1)
sacrificed 14 days after##2##4##(1995-2#1)(2007-6#1)
sacrificed 24 h##3##3##(1994-2#1)(1996-12#1)(2010-7#1)
sacrificed and##10##2##(1996-5#1)(1996-7#1)(1997-7#1)(2006-8#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-7#3)
sacrificed at day##2##3##(1997-6#1)(2008-10#1)
sacrificed at the##6##3##(1994-2#1)(1997-4#3)(2007-1#1)(2010-4#1)
sacrificed at##23##2##(1992-7#1)(1994-2#2)(1994-6#1)(1995-11#1)(1997-4#3)(1997-6#2)(2006-10#1)(2006-8#2)(2007-1#1)(2008-10#1)(2008-7#1)(2010-1#1)(2010-4#1)(2012-3#1)(2013-1#3)(2013-8#1)
sacrificed during##2##2##(2008-1#1)(2008-9#1)
sacrificed with##2##2##(2012-1#1)(2012-2#1)
sacrificed##80##1##(1992-12#1)(1992-2#1)(1992-7#1)(1993-4#1)(1993-7#1)(1993-9#2)(1994-10#1)(1994-12#1)(1994-2#3)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#2)(1996-4#1)(1996-5#1)(1996-7#1)(1997-4#6)(1997-6#2)(1997-7#1)(2006-10#2)(2006-6#1)(2006-7#1)(2006-8#3)(2007-1#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#6)(2010-1#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#3)
sacrificial##8##1##(2006-6#3)(2007-8#1)(2009-10#1)(2009-11#1)(2009-9#1)(2010-5#1)
sacrificing the##4##2##(1991-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
sacrificing##23##1##(1991-11#1)(1992-12#2)(2006-3#2)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-5#1)(2009-9#2)(2010-11#1)(2013-1#2)(2013-7#1)
sacrococcygeal teratoma##5##2##(2005-11#2)(2009-4#1)(2011-1#2)
sacrococcygeal##10##1##(1995-6#1)(2005-11#2)(2007-5#2)(2008-9#1)(2009-4#1)(2011-1#2)(2011-12#1)
sacrocolpopexy with Burch colposuspension to reduce urinary stress incontinence##2##9##(2007-12#1)(2008-1#1)
sacrocolpopexy##4##1##(2007-12#1)(2008-1#1)(2013-1#2)
sacroiliac (SI) joint##2##3##(2006-10#1)(2012-2#1)
sacroiliac joint (SIJ)##2##3##(2006-12#2)
sacroiliac joint injection##3##3##(2006-8#3)
sacroiliac joint injections##4##3##(2006-12#1)(2006-8#3)
sacroiliac joint pain##2##3##(2006-8#2)
sacroiliac joint syndrome##2##3##(2006-8#1)(2011-12#1)
sacroiliac joint##35##2##(2005-10#1)(2006-1#1)(2006-12#5)(2006-8#19)(2007-11#3)(2008-7#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-2#2)
sacroiliac joints in patients with##2##5##(2011-2#2)
sacroiliac joints in##3##3##(2011-2#3)
sacroiliac joints##7##2##(1990-6#2)(2006-10#1)(2006-12#1)(2011-2#3)
sacroiliac##47##1##(1990-6#3)(2005-10#1)(2006-1#1)(2006-10#2)(2006-12#6)(2006-8#19)(2007-11#4)(2007-7#1)(2008-7#1)(2010-4#1)(2011-12#1)(2011-2#4)(2012-2#3)
sacroiliitis and osteitis pubis have##2##5##(2006-10#2)
sacroiliitis and osteitis pubis##4##4##(2006-10#4)
sacroiliitis as##2##2##(2006-10#1)(2011-2#1)
sacroiliitis##16##1##(2006-10#11)(2006-12#2)(2010-12#1)(2011-2#1)(2012-12#1)
sacrorum##2##1##(2013-8#2)
sacrum##15##1##(1991-11#1)(1991-8#1)(1995-9#1)(2006-10#2)(2007-11#1)(2007-4#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#2)(2013-8#1)
sacs of the##2##3##(2007-12#1)(2008-5#1)
sacs of##5##2##(2007-12#1)(2008-11#2)(2008-5#1)(2008-9#1)
sacs##16##1##(2007-12#5)(2008-10#1)(2008-11#4)(2008-5#3)(2008-9#2)(2011-1#1)
sad##8##1##(2008-1#1)(2008-10#1)(2008-11#2)(2008-6#1)(2009-10#1)(2010-3#1)(2013-8#1)
saddle anesthesia##2##2##(2008-12#1)(2009-3#1)
saddle nose deformity##2##3##(2006-10#1)(2013-8#1)
saddle nose##3##2##(1996-12#1)(2006-10#1)(2013-8#1)
saddle##13##1##(1996-12#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-12#1)(2009-2#2)(2009-3#1)(2013-8#2)
saddle-node##2##1##(1993-9#1)(2009-8#1)
sadness##7##1##(1996-3#1)(2007-7#1)(2008-11#2)(2009-9#1)(2010-12#1)(2012-12#1)
sadomasochism associated bleeding##2##3##(2011-1#2)
sadomasochism associated with bleeding##2##4##(2011-1#2)
sadomasochism associated##4##2##(2011-1#4)
sadomasochism##6##1##(2011-1#6)
safe abortion##4##2##(2011-1#3)(2011-2#1)
safe adjunct in the management of##2##6##(1992-10#1)(2013-8#1)
safe after##2##2##(2007-7#1)(2013-8#1)
safe agent##3##2##(1991-9#2)(2006-9#1)
safe alternative to the##2##4##(1990-8#1)(1997-4#1)
safe alternative to##8##3##(1990-8#1)(1997-4#1)(2008-10#1)(2008-8#1)(2010-4#1)(2010-7#2)(2011-2#1)
safe alternative##11##2##(1990-8#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-4#1)(2010-7#2)(2011-2#2)
safe and accurate##2##3##(1991-12#1)(2007-3#1)
safe and adequate##2##3##(2007-8#1)(2013-8#1)
safe and appropriate##2##3##(1993-3#1)(2006-2#1)
safe and clinically##3##3##(1993-11#1)(2008-11#1)(2008-7#1)
safe and compatible##2##3##(1992-3#1)(2008-5#1)
safe and cost effective##2##4##(1996-11#1)(2006-8#1)
safe and cost##3##3##(1996-11#1)(2006-8#1)(2008-5#1)
safe and cost-effective##6##3##(1990-8#1)(1994-11#1)(1997-8#1)(2006-10#1)(2007-9#1)(2012-2#1)
safe and easy to##2##4##(2006-10#1)(2009-2#1)
safe and easy##4##3##(2006-10#1)(2007-8#1)(2008-3#1)(2009-2#1)
safe and effective agents for##2##5##(2005-8#1)(2006-12#1)
safe and effective agents##3##4##(2005-8#1)(2006-12#1)(2008-5#1)
safe and effective approach##2##4##(2007-8#1)(2011-2#1)
safe and effective for treating##4##5##(2006-6#1)(2008-7#1)(2010-8#1)(2012-2#1)
safe and effective for##7##4##(2006-6#1)(2007-1#1)(2007-2#1)(2008-11#1)(2008-7#1)(2010-8#1)(2012-2#1)
safe and effective in the##3##5##(2006-8#1)(2008-7#1)(2009-3#1)
safe and effective in##14##4##(1991-3#1)(2006-8#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
safe and effective means of##2##5##(1990-8#1)(2011-2#1)
safe and effective medicines##2##4##(2008-10#1)(2008-8#1)
safe and effective method for the##2##6##(2005-4#1)(2008-5#1)
safe and effective method for##3##5##(2005-4#1)(2008-5#1)(2012-2#1)
safe and effective method##6##4##(2005-4#1)(2007-8#1)(2008-11#1)(2008-5#1)(2010-12#1)(2012-2#1)
safe and effective therapy for##2##5##(2006-9#1)(2008-7#1)
safe and effective treatment for##6##5##(1990-12#1)(1993-3#1)(2008-2#1)(2008-5#1)(2008-9#1)(2013-1#1)
safe and effective treatment in##2##5##(2006-10#1)(2012-12#1)
safe and effective treatment modality##2##5##(2006-1#1)(2011-2#1)
safe and effective treatment of##3##5##(2006-12#1)(2008-9#1)(2009-8#1)
safe and effective treatment##18##4##(1990-12#1)(1993-3#1)(2005-6#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-9#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
safe and effective use of##2##5##(2008-7#1)(2008-8#1)
safe and effective vaccine##2##4##(1995-2#1)(2012-2#1)
safe and effective when used##2##5##(1996-12#1)(2008-11#1)
safe and effective when##3##4##(1996-12#1)(2008-11#1)(2010-12#1)
safe and effective##148##3##(1990-12#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-10#1)(1992-2#1)(1993-12#1)(1993-3#1)(1995-2#1)(1995-4#2)(1995-8#1)(1996-12#1)(2005-2#1)(2005-4#1)(2005-5#1)(2005-6#1)(2005-8#3)(2006-1#2)(2006-10#4)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#4)(2006-7#1)(2006-8#5)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-7#3)(2007-8#8)(2007-9#2)(2008-1#4)(2008-10#1)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#6)(2008-7#5)(2008-8#4)(2008-9#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-12#3)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#9)(2012-12#6)(2012-2#7)(2013-1#12)
safe and efficacious##13##3##(1993-1#1)(1996-1#1)(1996-9#1)(2005-7#1)(2005-8#1)(2006-8#1)(2006-9#1)(2008-10#1)(2008-4#1)(2009-5#1)(2010-2#1)(2010-4#1)(2013-8#1)
safe and efficient therapeutic##2##4##(2007-3#1)(2012-12#1)
safe and efficient##8##3##(1991-12#1)(1991-6#1)(1992-6#1)(1994-5#1)(2006-2#1)(2007-3#1)(2008-5#1)(2012-12#1)
safe and feasible##4##3##(2006-2#1)(2006-6#2)(2012-1#1)
safe and has##3##3##(2005-10#1)(2007-6#1)(2012-2#1)
safe and highly immunogenic##4##4##(1995-5#1)(2005-7#1)(2007-8#1)(2008-4#1)
safe and highly##5##3##(1995-5#1)(2005-7#1)(2007-8#1)(2008-4#1)(2009-11#1)
safe and immunogenic##3##3##(2005-7#1)(2006-10#1)(2013-1#1)
safe and inexpensive##2##3##(2007-7#1)(2008-10#1)
safe and legal##3##3##(2008-11#2)(2008-5#1)
safe and may##4##3##(2007-8#1)(2007-9#2)(2008-1#1)
safe and novel##2##3##(2010-5#1)(2011-2#1)
safe and predictable##2##3##(2007-12#2)
safe and reliable diagnostic##2##4##(2006-7#1)(2012-3#1)
safe and reliable##8##3##(2006-7#1)(2007-3#1)(2007-8#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-1#2)
safe and reproducible##3##3##(2007-8#1)(2008-8#1)(2013-8#1)
safe and secure environment for##2##5##(1992-2#1)(1992-3#1)
safe and secure##6##3##(1992-2#1)(1992-3#1)(1995-2#2)(1996-12#1)(2010-10#1)
safe and simple technique##3##4##(2007-7#2)(2013-7#1)
safe and simple##6##3##(1992-3#1)(2007-7#3)(2013-1#1)(2013-7#1)
safe and successful##3##3##(2011-2#1)(2013-1#2)
safe and that##2##3##(1994-3#1)(2008-9#1)
safe and unsafe##2##3##(2008-5#1)(2010-8#1)
safe and well tolerated in##2##5##(1996-1#1)(2012-12#1)
safe and well tolerated##16##4##(1992-8#1)(1996-1#1)(2005-7#1)(2005-8#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-10#1)(2010-5#1)(2012-12#1)(2013-1#1)
safe and well-tolerated procedure##2##4##(1990-8#1)(2012-2#1)
safe and well-tolerated##5##3##(1990-8#1)(1995-5#1)(2006-10#1)(2010-5#1)(2012-2#1)
safe and##359##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#3)(1991-11#1)(1991-12#3)(1991-3#1)(1991-4#1)(1991-6#1)(1992-10#1)(1992-2#2)(1992-3#3)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#3)(1995-4#2)(1995-5#2)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#1)(1996-9#1)(1997-8#1)(2005-10#3)(2005-2#1)(2005-4#1)(2005-5#3)(2005-6#1)(2005-7#5)(2005-8#5)(2006-1#2)(2006-10#12)(2006-11#1)(2006-12#3)(2006-2#4)(2006-4#2)(2006-5#3)(2006-6#7)(2006-7#2)(2006-8#9)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-2#3)(2007-3#3)(2007-4#1)(2007-6#1)(2007-7#9)(2007-8#21)(2007-9#6)(2008-1#5)(2008-10#6)(2008-11#10)(2008-12#3)(2008-2#3)(2008-3#10)(2008-4#4)(2008-5#13)(2008-7#12)(2008-8#6)(2008-9#5)(2009-1#2)(2009-11#1)(2009-2#4)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#2)(2010-1#1)(2010-10#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#5)(2011-2#18)(2012-1#4)(2012-11#1)(2012-12#11)(2012-2#13)(2012-3#3)(2013-1#21)(2013-7#1)(2013-8#3)
safe application##4##2##(2006-10#1)(2006-11#1)(2012-11#2)
safe approach##3##2##(2006-10#1)(2008-12#1)(2008-8#1)
safe as##7##2##(1990-12#1)(1993-5#1)(1994-3#1)(2005-12#1)(2006-2#1)(2006-6#1)(2008-7#1)
safe at##2##2##(1993-3#1)(1997-6#1)
safe because it##2##3##(2007-11#1)(2013-8#1)
safe blood##2##2##(2008-12#1)(2013-8#1)
safe but##2##2##(2007-2#1)(2009-12#1)
safe care-providing robot##2##3##(2012-1#2)
safe chemical##2##2##(2008-1#1)(2008-10#1)
safe delivery of##3##3##(2009-10#1)(2010-5#1)(2013-1#1)
safe dental##2##2##(2011-12#2)
safe drinking water and##2##4##(2008-10#1)(2013-1#1)
safe driving behaviors##3##3##(2013-1#3)
safe drug##6##2##(2007-2#1)(2008-3#2)(2008-8#1)(2010-4#1)(2011-2#1)
safe drugs##3##2##(2008-7#1)(2008-8#2)
safe environment##4##2##(2007-10#1)(2007-2#1)(2008-1#1)(2009-4#1)
safe evacuation of patients and employees##2##6##(1996-2#2)
safe even##2##2##(2010-6#1)(2013-1#1)
safe for the##3##3##(1992-11#1)(2006-2#1)(2008-3#1)
safe for those performing the procedure##2##6##(2008-4#2)
safe for##27##2##(1991-12#1)(1991-6#1)(1991-9#1)(1992-11#1)(1994-9#1)(2006-2#1)(2006-6#1)(2007-11#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-3#2)(2008-4#2)(2009-6#1)(2010-1#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#1)(2013-1#1)(2013-7#1)
safe handling##2##2##(2008-8#1)(2009-4#1)
safe harbor##3##2##(1992-12#1)(1993-1#2)
safe harbors##9##2##(1991-1#1)(1992-12#2)(1992-3#2)(1993-1#3)(2007-9#1)
safe health care##3##3##(2006-10#1)(2008-1#1)(2009-6#1)
safe health##4##2##(2006-10#1)(2008-1#1)(2009-6#1)(2011-1#1)
safe in children##2##3##(2008-10#1)(2009-5#1)
safe in patients with##3##4##(2007-9#1)(2008-10#1)(2012-3#1)
safe in patients##4##3##(2006-8#1)(2007-9#1)(2008-10#1)(2012-3#1)
safe in the##10##3##(1993-11#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-11#1)(2008-6#1)(2010-12#2)
safe in##33##2##(1993-11#1)(1995-5#1)(1997-2#1)(2006-10#3)(2006-2#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#2)(2008-7#1)(2009-5#1)(2010-12#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
safe intraoperative##2##2##(2007-7#1)(2010-7#1)
safe is##2##2##(1996-12#1)(2005-6#1)
safe level##2##2##(2008-11#1)(2012-2#1)
safe management of##3##3##(1996-6#1)(2008-11#1)(2008-3#1)
safe method for##3##3##(1990-11#1)(1993-1#1)(2010-1#1)
safe method##10##2##(1990-11#1)(1992-3#1)(1993-1#1)(2006-8#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#1)(2010-1#1)(2012-12#1)
safe motherhood##4##2##(1994-3#1)(2004-8#2)(2007-3#1)
safe opioid##2##2##(2007-12#1)(2013-1#1)
safe option for##3##3##(1997-2#1)(2008-4#1)(2009-10#1)
safe option##6##2##(1997-2#1)(2006-10#1)(2008-1#1)(2008-4#1)(2009-10#1)(2011-1#1)
safe patient care##3##3##(2012-2#1)(2013-1#2)
safe patient##5##2##(2007-7#1)(2010-2#1)(2012-2#1)(2013-1#2)
safe place##2##2##(1993-12#1)(2008-11#1)
safe practices##2##2##(2007-8#1)(2008-12#1)
safe procedure for the##2##4##(2007-8#1)(2008-10#1)
safe procedure for##3##3##(2007-8#2)(2008-10#1)
safe procedure in##3##3##(2011-12#1)(2011-2#1)(2012-12#1)
safe procedure##22##2##(1990-4#1)(1990-6#1)(1992-4#1)(1993-8#1)(1994-9#1)(1995-1#1)(2006-5#2)(2006-8#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2013-8#1)
safe removal of##2##3##(1994-3#1)(2011-2#1)
safe resection of##2##3##(1993-8#1)(2006-12#1)
safe sex and##2##3##(1991-6#1)(2007-3#1)
safe sex behaviors##2##3##(2012-3#2)
safe sex practices##4##3##(1997-6#2)(2009-5#1)(2012-3#1)
safe sex##12##2##(1991-6#1)(1997-6#5)(2007-3#1)(2009-5#1)(2012-3#4)
safe sexual practices##2##3##(2012-3#2)
safe sexual##4##2##(2005-10#1)(2008-2#1)(2012-3#2)
safe surgical##2##2##(2008-9#1)(2010-3#1)
safe technique for##3##3##(1996-9#1)(2007-7#1)(2007-8#1)
safe technique in##2##3##(2006-10#1)(2012-3#1)
safe technique##7##2##(1996-3#1)(1996-9#1)(2006-10#1)(2007-7#1)(2007-8#2)(2012-3#1)
safe than##4##2##(1996-12#1)(2008-11#1)(2008-7#1)(2009-4#1)
safe to administer##2##3##(1996-3#1)(2004-1#1)
safe to the##2##3##(2007-11#1)(2013-1#1)
safe to use in##3##4##(2007-2#1)(2010-11#1)(2012-3#1)
safe to use##5##3##(2007-2#1)(2008-11#1)(2008-12#1)(2010-11#1)(2012-3#1)
safe to##20##2##(1993-9#1)(1996-3#1)(1997-4#1)(2004-1#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-11#2)(2008-12#1)(2009-11#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
safe treatment for##2##3##(1992-2#1)(2007-8#1)
safe treatment##6##2##(1992-2#1)(1997-3#1)(2004-10#1)(2007-8#2)(2008-3#1)
safe use of##14##3##(1993-4#1)(1994-12#1)(2006-10#1)(2007-11#1)(2008-2#2)(2008-8#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#3)
safe use##17##2##(1993-4#1)(1994-12#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-2#2)(2008-8#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#1)(2013-1#4)
safe water##3##2##(1996-6#1)(2007-2#1)(2008-1#1)
safe with##3##2##(2007-1#1)(2011-1#1)(2013-1#1)
safe working##2##2##(1991-12#1)(2008-4#1)
safe zone##2##2##(2010-8#1)(2013-1#1)
safe##966##1##(1990-10#1)(1990-11#2)(1990-12#3)(1990-3#1)(1990-4#2)(1990-6#3)(1990-8#5)(1991-1#1)(1991-11#2)(1991-12#6)(1991-2#1)(1991-3#4)(1991-4#2)(1991-6#4)(1991-8#1)(1991-9#3)(1992-10#3)(1992-11#1)(1992-12#5)(1992-2#7)(1992-3#6)(1992-4#1)(1992-5#3)(1992-6#1)(1992-8#2)(1993-1#7)(1993-11#2)(1993-12#3)(1993-3#3)(1993-4#1)(1993-5#1)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#5)(1994-5#1)(1994-6#2)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-4#2)(1995-5#3)(1995-8#1)(1996-1#3)(1996-10#2)(1996-11#2)(1996-12#4)(1996-2#4)(1996-3#3)(1996-6#2)(1996-8#2)(1996-9#4)(1997-2#2)(1997-3#1)(1997-4#4)(1997-6#8)(1997-7#1)(1997-8#2)(2004-1#1)(2004-10#1)(2004-5#1)(2004-8#2)(2004-9#1)(2005-1#1)(2005-10#4)(2005-12#1)(2005-2#1)(2005-4#1)(2005-5#4)(2005-6#2)(2005-7#6)(2005-8#6)(2006-1#3)(2006-10#32)(2006-11#3)(2006-12#9)(2006-2#8)(2006-3#1)(2006-4#3)(2006-5#6)(2006-6#13)(2006-7#4)(2006-8#15)(2006-9#6)(2007-1#5)(2007-10#5)(2007-11#16)(2007-12#7)(2007-2#15)(2007-3#8)(2007-4#5)(2007-5#2)(2007-6#3)(2007-7#17)(2007-8#51)(2007-9#11)(2008-1#16)(2008-10#31)(2008-11#23)(2008-12#14)(2008-2#7)(2008-3#22)(2008-4#12)(2008-5#19)(2008-6#4)(2008-7#22)(2008-8#17)(2008-9#11)(2009-1#3)(2009-10#3)(2009-11#2)(2009-12#3)(2009-2#5)(2009-3#2)(2009-4#9)(2009-5#6)(2009-6#3)(2009-7#1)(2009-8#3)(2010-1#3)(2010-10#2)(2010-11#2)(2010-12#17)(2010-2#3)(2010-3#3)(2010-4#9)(2010-5#10)(2010-6#3)(2010-7#10)(2010-8#4)(2010-9#5)(2011-1#19)(2011-12#5)(2011-2#46)(2012-1#8)(2012-11#3)(2012-12#23)(2012-2#23)(2012-3#17)(2013-1#48)(2013-7#7)(2013-8#13)
safe&quot##3##1##(2008-3#3)
safe-haven##3##1##(2007-2#3)
safe-sex##4##1##(1995-1#1)(2004-9#1)(2010-7#2)
safe?##8##1##(1997-8#1)(2008-11#1)(2009-4#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
safeguard against##4##2##(1993-3#1)(1997-7#1)(2008-10#1)(2008-11#1)
safeguard the##4##2##(1994-4#1)(2007-1#1)(2011-2#1)(2012-2#1)
safeguard##19##1##(1993-3#1)(1994-2#1)(1994-4#1)(1994-9#1)(1997-7#1)(2005-11#1)(2006-11#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
safeguarding the##3##2##(1990-9#1)(2007-11#1)(2008-7#1)
safeguarding##11##1##(1990-9#1)(1991-12#1)(2006-10#1)(2007-11#2)(2008-7#1)(2009-10#1)(2011-2#1)(2012-12#1)(2013-1#2)
safeguards##12##1##(1993-3#1)(1993-7#1)(1993-9#1)(1996-3#1)(1997-4#2)(2006-10#1)(2006-11#1)(2008-4#1)(2010-8#1)(2011-2#1)(2012-11#1)
safely administered to##2##3##(2008-1#1)(2008-5#1)
safely administered##4##2##(1991-12#1)(2005-10#1)(2008-1#1)(2008-5#1)
safely and economically##2##3##(2007-2#1)(2008-1#1)
safely and effectively be##3##4##(1991-1#1)(2005-2#1)(2012-1#1)
safely and effectively in##4##4##(1991-1#1)(1995-8#1)(2006-8#1)(2007-8#1)
safely and effectively with##2##4##(1992-2#1)(2007-9#1)
safely and effectively##17##3##(1991-1#2)(1992-2#1)(1995-8#1)(2005-2#1)(2006-10#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
safely and efficiently##4##3##(2006-6#1)(2008-4#1)(2011-2#1)(2012-12#1)
safely and##36##2##(1991-1#2)(1991-3#1)(1992-2#1)(1995-8#1)(1996-11#1)(2005-2#1)(2005-6#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
safely be inserted##2##3##(1994-8#1)(2012-2#1)
safely be##11##2##(1991-4#1)(1994-8#1)(2005-10#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-9#1)(2012-2#1)
safely for##3##2##(1995-7#1)(2006-10#1)(2007-11#1)
safely in the##2##3##(2006-10#1)(2008-9#1)
safely in##8##2##(2006-10#1)(2006-8#1)(2007-8#1)(2008-9#1)(2010-12#1)(2010-5#1)(2010-8#1)(2012-12#1)
safely performed##9##2##(1993-7#1)(2006-10#2)(2006-11#1)(2007-8#2)(2008-8#1)(2011-2#1)(2012-12#1)
safely reduce bleeding without increasing thrombotic complications in patients undergoing cardiac##2##11##(2007-8#2)
safely reduce##4##2##(2007-8#3)(2010-5#1)
safely removed##2##2##(2008-7#1)(2012-2#1)
safely to##2##2##(1995-8#1)(2005-6#1)
safely treated with##2##3##(2007-10#1)(2011-2#1)
safely treated##4##2##(1997-8#1)(2007-10#1)(2011-2#2)
safely with##4##2##(2005-8#1)(2006-10#1)(2008-4#1)(2008-7#1)
safely##173##1##(1990-6#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-3#2)(1991-4#2)(1991-5#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-7#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-7#1)(1995-8#2)(1996-11#1)(1996-7#1)(1996-9#1)(1997-6#1)(1997-8#1)(2005-10#5)(2005-2#1)(2005-6#2)(2005-8#1)(2006-1#1)(2006-10#18)(2006-11#2)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#4)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#2)(2007-7#3)(2007-8#16)(2007-9#2)(2008-1#4)(2008-10#4)(2008-11#1)(2008-12#5)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-3#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#8)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#2)
safely?##2##1##(1995-2#1)(2006-10#1)
safer alternative to##2##3##(2006-10#1)(2008-7#1)
safer alternative##4##2##(2006-10#2)(2007-8#1)(2008-7#1)
safer and more##5##3##(1995-9#1)(1997-4#1)(2006-6#1)(2010-4#1)(2010-8#1)
safer and##9##2##(1995-9#1)(1997-4#1)(1997-6#1)(2006-10#2)(2006-6#1)(2007-7#1)(2010-4#1)(2010-8#1)
safer blood##2##2##(1993-1#1)(2013-1#1)
safer crack-smoking##2##2##(2008-5#2)
safer for##4##2##(2007-7#1)(2010-12#1)(2011-12#1)(2013-1#1)
safer medication##2##2##(2008-9#1)(2011-12#1)
safer methods of##2##3##(2006-5#1)(2008-5#1)
safer sex##8##2##(1996-12#1)(1996-6#1)(2006-7#1)(2007-7#1)(2008-12#2)(2009-5#2)
safer sexual##3##2##(2007-7#1)(2009-5#1)(2011-2#1)
safer technique##2##2##(1991-6#1)(2010-12#1)
safer than general anesthesia##2##4##(2006-10#1)(2013-8#1)
safer than general##3##3##(2006-10#2)(2013-8#1)
safer than##7##2##(1990-4#1)(2006-10#3)(2006-11#1)(2006-2#1)(2013-8#1)
safer to use##4##3##(2006-10#1)(2008-7#1)(2012-3#2)
safer to##7##2##(2006-10#1)(2007-11#1)(2007-7#1)(2008-7#1)(2008-9#1)(2012-3#2)
safer##112##1##(1990-4#2)(1991-6#1)(1993-1#1)(1993-12#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-6#1)(2004-8#1)(2005-7#1)(2006-10#13)(2006-11#2)(2006-2#1)(2006-5#2)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#6)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#5)(2009-1#1)(2009-12#1)(2009-2#1)(2009-5#3)(2009-7#1)(2010-11#1)(2010-12#4)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#3)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
safer&quot##3##1##(2006-9#1)(2008-3#2)
safest and most##4##3##(1990-12#1)(2007-11#1)(2008-5#1)(2008-7#1)
safest and##5##2##(1990-12#1)(2007-11#1)(2008-5#1)(2008-7#1)(2010-9#1)
safest##16##1##(1990-12#1)(1991-3#1)(1994-12#1)(2006-12#1)(2007-11#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-9#1)
safety -##2##2##(2007-12#1)(2008-8#1)
safety advantages##2##2##(2006-10#1)(2010-2#1)
safety and clinical utility##2##4##(2007-11#1)(2009-10#1)
safety and clinical##5##3##(2007-11#1)(2008-1#1)(2008-7#2)(2009-10#1)
safety and convenience##2##3##(1991-3#1)(2008-3#1)
safety and cost containment##2##4##(1993-2#1)(2008-9#1)
safety and cost##3##3##(1993-2#1)(2008-10#1)(2008-9#1)
safety and effectiveness of##9##4##(2006-10#1)(2008-10#1)(2008-8#1)(2010-6#1)(2010-8#1)(2011-12#2)(2011-2#1)(2012-2#1)
safety and effectiveness##14##3##(2006-10#1)(2008-10#1)(2008-8#2)(2010-6#1)(2010-8#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)
safety and efficacy for##3##4##(1994-12#1)(2013-1#1)(2013-8#1)
safety and efficacy have##3##4##(1992-5#1)(2006-5#1)(2008-7#1)
safety and efficacy in##3##4##(2005-7#1)(2007-10#1)(2011-2#1)
safety and efficacy of acamprosate##2##5##(2008-2#2)
safety and efficacy of the##6##5##(2006-10#1)(2006-8#1)(2007-8#1)(2008-11#2)(2012-12#1)
safety and efficacy of this##3##5##(2007-10#1)(2008-8#1)(2010-12#1)
safety and efficacy of##71##4##(1991-11#1)(1992-8#1)(1994-5#2)(1996-3#1)(1997-3#1)(2004-1#1)(2005-7#1)(2006-10#5)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-10#3)(2007-11#1)(2007-2#1)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#6)(2008-2#2)(2008-3#1)(2008-5#4)(2008-7#2)(2008-8#4)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
safety and efficacy##104##3##(1991-11#1)(1992-3#1)(1992-5#1)(1992-8#1)(1994-12#1)(1994-5#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(2004-1#1)(2005-7#3)(2006-1#1)(2006-10#7)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#3)(2006-8#2)(2006-9#1)(2007-10#4)(2007-11#1)(2007-2#1)(2007-7#4)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#6)(2008-2#2)(2008-3#2)(2008-5#6)(2008-7#4)(2008-8#7)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
safety and efficiency of##2##4##(2005-10#1)(2008-9#1)
safety and efficiency##3##3##(2005-10#1)(2008-9#1)(2010-3#1)
safety and feasibility##3##3##(2006-6#1)(2007-10#1)(2013-1#1)
safety and flexibility##2##3##(1991-10#1)(1995-7#1)
safety and functional##2##3##(2007-10#1)(2010-4#1)
safety and health##9##3##(1993-12#1)(1993-2#1)(1993-3#1)(2007-1#2)(2008-12#1)(2008-7#1)(2008-9#1)(2013-1#1)
safety and immunogenicity##4##3##(2008-4#2)(2010-1#1)(2012-12#1)
safety and low cost##2##4##(2006-8#1)(2008-10#1)
safety and low##3##3##(2006-8#1)(2008-10#1)(2012-1#1)
safety and quality##5##3##(2006-10#3)(2007-11#1)(2008-10#1)
safety and reliability##4##3##(2007-3#1)(2007-8#1)(2008-5#1)(2008-7#1)
safety and security directors##2##4##(1992-2#2)
safety and security##5##3##(1992-2#3)(1996-12#2)
safety and the efficacy of##2##5##(1997-4#1)(2007-8#1)
safety and the##7##3##(1997-4#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-8#1)(2013-1#1)
safety and their##3##3##(1993-8#1)(2008-4#1)(2011-2#1)
safety and therapeutic##2##3##(2008-5#1)(2013-1#1)
safety and tolerability of##2##4##(1996-9#1)(2007-7#1)
safety and tolerability##12##3##(1996-9#1)(2004-3#1)(2005-7#1)(2005-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-3#3)(2011-1#1)
safety and tolerance##2##3##(2006-2#1)(2011-1#1)
safety and toxicity of##2##4##(2007-8#1)(2012-12#1)
safety and toxicity##3##3##(2007-8#1)(2008-8#1)(2012-12#1)
safety and viability##2##3##(2007-7#1)(2011-2#1)
safety and##270##2##(1990-12#1)(1990-5#1)(1991-10#1)(1991-11#1)(1991-3#1)(1992-2#3)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-8#1)(1994-12#1)(1994-5#2)(1995-11#1)(1995-2#1)(1995-7#1)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-1#1)(2004-10#1)(2004-3#1)(2005-10#1)(2005-5#2)(2005-7#4)(2005-8#1)(2006-1#1)(2006-10#11)(2006-11#1)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#3)(2006-6#2)(2006-8#4)(2006-9#1)(2007-1#3)(2007-10#6)(2007-11#4)(2007-12#3)(2007-2#3)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#8)(2007-8#7)(2008-1#3)(2008-10#6)(2008-11#11)(2008-12#4)(2008-2#3)(2008-3#6)(2008-4#3)(2008-5#10)(2008-6#1)(2008-7#9)(2008-8#13)(2008-9#4)(2009-10#2)(2009-12#1)(2009-2#1)(2009-4#3)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#6)(2010-3#1)(2010-4#5)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#3)(2011-2#17)(2012-1#2)(2012-12#8)(2012-2#5)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#4)
safety approach for##2##3##(2009-10#1)(2012-1#1)
safety approach##3##2##(2009-10#2)(2012-1#1)
safety are##5##2##(1996-2#1)(2007-12#1)(2008-3#1)(2008-8#1)(2012-1#1)
safety as##5##2##(2008-10#1)(2008-6#1)(2008-8#1)(2010-5#1)(2012-11#1)
safety aspects##5##2##(1994-6#2)(2005-11#1)(2008-3#1)(2011-12#1)
safety assessment of##4##3##(2006-12#1)(2010-11#1)(2010-6#1)(2013-7#1)
safety assessment##11##2##(2005-8#1)(2006-12#1)(2008-10#1)(2008-7#1)(2010-11#3)(2010-6#1)(2013-1#2)(2013-7#1)
safety assessments##6##2##(1991-10#1)(2008-8#1)(2009-10#1)(2010-11#2)(2011-12#1)
safety at home##2##3##(2007-12#1)(2012-2#1)
safety at work##4##3##(1992-10#1)(2006-8#1)(2008-11#1)(2010-9#1)
safety at##9##2##(1991-3#1)(1992-10#1)(2006-8#1)(2007-12#1)(2008-11#2)(2010-9#1)(2012-2#1)(2013-1#1)
safety benefit for##2##3##(2012-12#2)
safety benefit of##2##3##(2012-12#2)
safety benefit##4##2##(2012-12#4)
safety benefits##2##2##(2008-11#1)(2008-8#1)
safety between##3##2##(2008-11#1)(2011-1#1)(2012-2#1)
safety by##7##2##(2007-10#1)(2007-4#2)(2008-12#1)(2012-12#1)(2013-1#2)
safety climate strength##4##3##(2010-6#4)
safety climate##5##2##(2010-6#5)
safety concerns associated with##2##4##(1996-7#1)(2008-8#1)
safety concerns##18##2##(1996-7#1)(2005-9#1)(2006-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#5)
safety considerations##9##2##(1992-3#1)(1994-5#1)(2006-5#1)(2008-10#1)(2008-2#1)(2010-12#1)(2012-12#3)
safety control##2##2##(2005-5#1)(2012-3#1)
safety criteria are##2##3##(2008-12#1)(2011-2#1)
safety critical events##3##3##(2012-12#3)
safety critical##5##2##(2007-2#1)(2012-12#4)
safety culture##3##2##(2008-8#2)(2011-2#1)
safety data from##2##3##(2008-5#1)(2008-8#1)
safety data##18##2##(2006-10#2)(2008-11#2)(2008-5#2)(2008-8#6)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-3#1)(2013-7#1)
safety day camps##2##3##(2013-1#2)
safety day##3##2##(2013-1#3)
safety devices##2##2##(2007-1#1)(2008-6#1)
safety due##2##2##(2012-12#1)(2013-1#1)
safety during pregnancy##2##3##(2010-12#2)
safety during the##3##3##(2006-7#1)(2011-2#1)(2012-3#1)
safety during##7##2##(2006-10#1)(2006-7#1)(2010-12#3)(2011-2#1)(2012-3#1)
safety effects of##2##3##(2012-12#2)
safety effects##3##2##(2012-12#3)
safety evaluation##7##2##(2007-1#1)(2007-11#1)(2007-8#1)(2008-11#2)(2010-7#1)(2012-12#1)
safety factor##5##2##(1990-7#1)(1992-6#1)(1994-6#1)(2013-1#2)
safety feature##2##2##(2007-5#2)
safety features##3##2##(2010-9#1)(2011-2#1)(2013-1#1)
safety for both##2##3##(2007-2#1)(2007-4#1)
safety for##12##2##(2007-10#1)(2007-2#1)(2007-4#1)(2010-2#2)(2010-8#3)(2011-2#1)(2012-12#1)(2013-1#2)
safety from##2##2##(2010-11#1)(2010-12#1)
safety glasses##2##2##(1991-6#2)
safety has##3##2##(2005-5#1)(2007-4#1)(2008-3#1)
safety have##3##2##(2006-10#2)(2007-2#1)
safety in the construction industry in##2##6##(2013-1#2)
safety in the##16##3##(1994-4#1)(1996-10#1)(1996-3#1)(2006-1#1)(2007-12#2)(2007-3#1)(2007-9#2)(2008-4#1)(2008-8#3)(2009-9#1)(2013-1#2)
safety in##49##2##(1994-4#1)(1995-3#3)(1996-10#1)(1996-3#1)(2005-7#2)(2005-9#1)(2006-1#1)(2006-10#1)(2006-6#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-9#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#4)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-9#1)(2011-12#1)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#5)
safety incidents##3##2##(2009-2#2)(2011-1#1)
safety information##4##2##(2008-1#1)(2008-12#1)(2008-4#1)(2008-8#1)
safety initiatives##3##2##(2007-3#1)(2011-2#1)(2013-8#1)
safety interventions##2##2##(2008-10#1)(2008-6#1)
safety into##2##2##(1991-3#1)(2008-3#1)
safety is a##3##3##(1994-3#1)(2008-10#1)(2008-11#1)
safety is also##2##3##(2008-1#1)(2011-2#1)
safety is##17##2##(1991-12#1)(1994-3#2)(1996-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#1)
safety issues and##3##3##(2008-7#1)(2013-1#2)
safety issues associated with##2##4##(2011-12#1)(2012-12#1)
safety issues for##2##3##(2007-12#1)(2007-2#1)
safety issues related to the##2##5##(2005-6#1)(2008-8#1)
safety issues related to##3##4##(2005-6#1)(2007-4#1)(2008-8#1)
safety issues relating to##2##4##(1993-3#1)(2008-8#1)
safety issues that##2##3##(2008-11#1)(2008-4#1)
safety issues##36##2##(1991-12#1)(1993-2#1)(1993-3#2)(2005-10#1)(2005-6#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2010-8#1)(2010-9#1)(2011-12#1)(2012-12#1)(2013-1#2)
safety limits for##2##3##(2007-11#1)(2013-1#1)
safety limits##3##2##(2006-8#1)(2007-11#1)(2013-1#1)
safety management##3##2##(1991-12#1)(2010-8#2)
safety margin##4##2##(2006-10#1)(2006-12#1)(2007-8#1)(2009-7#1)
safety margins##5##2##(1995-2#1)(2005-11#2)(2006-6#1)(2009-10#1)
safety measures for##2##3##(1996-3#1)(2006-11#1)
safety measures##7##2##(1991-6#1)(1996-3#1)(2006-11#1)(2007-11#1)(2009-10#1)(2010-7#1)(2010-8#1)
safety net for##3##3##(2007-2#1)(2007-7#1)(2011-2#1)
safety net##10##2##(1996-12#1)(1997-5#1)(2004-9#1)(2007-2#1)(2007-4#1)(2007-7#2)(2008-4#1)(2008-9#1)(2011-2#1)
safety of a##13##3##(1990-11#1)(1992-10#1)(1993-2#1)(2006-10#1)(2007-2#1)(2007-6#1)(2008-10#2)(2008-4#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
safety of antidepressants in##2##4##(2008-11#1)(2008-8#1)
safety of both##2##3##(1991-1#1)(2012-3#1)
safety of enoxaparin##2##3##(2007-10#1)(2007-8#1)
safety of infant##2##3##(2006-8#1)(2008-10#1)
safety of intravenous##2##3##(2007-11#1)(2007-9#1)
safety of medical##2##3##(1993-12#1)(2012-2#1)
safety of medications##2##3##(2008-8#1)(2010-11#1)
safety of oral calcium formate##2##5##(2005-7#2)
safety of oral##5##3##(1993-7#1)(2005-7#2)(2011-2#1)(2013-8#1)
safety of patients with##2##4##(1996-11#1)(2010-9#1)
safety of patients##3##3##(1993-12#1)(1996-11#1)(2010-9#1)
safety of percutaneous##2##3##(2008-9#2)
safety of the drug##3##4##(2006-11#1)(2007-11#1)(2008-7#1)
safety of the method##2##4##(2006-10#1)(2011-1#1)
safety of the personnel##2##4##(2009-2#2)
safety of the procedure##3##4##(2008-11#1)(2010-12#1)(2011-2#1)
safety of the use of##2##5##(1991-2#1)(2008-8#1)
safety of the##55##3##(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#1)(1996-4#1)(1996-9#1)(1997-3#1)(2004-1#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-4#1)(2006-6#3)(2007-1#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#2)(2009-4#2)(2009-7#1)(2010-12#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
safety of their use##2##4##(1992-3#1)(2013-7#1)
safety of these##5##3##(2006-10#1)(2008-10#1)(2008-7#1)(2009-11#2)
safety of this drug##3##4##(2008-11#2)(2010-12#1)
safety of this##13##3##(1992-10#1)(1992-2#1)(1997-3#2)(2006-8#2)(2007-8#2)(2008-11#2)(2008-5#1)(2010-12#1)(2010-5#1)
safety of topical##3##3##(2007-11#1)(2010-3#1)(2010-8#1)
safety of treatment##2##3##(2007-11#1)(2013-1#1)
safety of vaginal##2##3##(2009-7#1)(2011-12#1)
safety of various##2##3##(2006-10#1)(2008-11#1)
safety of##324##2##(1990-11#1)(1990-6#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1992-10#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-7#1)(1994-2#1)(1994-7#1)(1995-4#1)(1995-5#1)(1996-11#1)(1996-3#3)(1996-4#1)(1996-7#1)(1996-9#3)(1997-1#2)(1997-3#3)(2004-1#1)(2004-3#1)(2005-10#1)(2005-11#2)(2005-5#3)(2005-7#4)(2006-1#2)(2006-10#17)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#5)(2006-8#6)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#7)(2007-2#3)(2007-4#1)(2007-6#1)(2007-7#6)(2007-8#6)(2007-9#3)(2008-1#2)(2008-10#10)(2008-11#10)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#8)(2008-5#6)(2008-6#3)(2008-7#12)(2008-8#11)(2008-9#5)(2009-1#2)(2009-10#4)(2009-11#2)(2009-2#2)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#8)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-12#3)(2011-2#17)(2011-3#1)(2012-1#4)(2012-12#8)(2012-2#9)(2012-3#7)(2013-1#22)(2013-7#2)(2013-8#10)
safety officers##2##2##(1993-3#1)(2007-4#1)
safety on the road##2##4##(1996-11#1)(2006-11#1)
safety or##2##2##(2006-10#1)(2008-10#1)
safety practices and##3##3##(2008-4#1)(2008-9#1)(2009-6#1)
safety practices in##2##3##(1996-5#1)(2010-9#1)
safety practices##8##2##(1996-5#1)(2005-11#2)(2008-4#1)(2008-9#1)(2009-6#1)(2010-9#1)(2013-1#1)
safety precautions##4##2##(1993-2#1)(1996-3#1)(2007-2#1)(2007-7#1)
safety problem##2##2##(2008-11#1)(2012-12#1)
safety procedures##4##2##(2007-1#1)(2008-4#1)(2008-7#1)(2012-2#1)
safety profile and##10##3##(2006-10#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2011-2#1)(2013-1#2)
safety profile in##4##3##(2005-7#1)(2008-11#1)(2008-5#1)(2012-2#1)
safety profile is##2##3##(2009-8#1)(2012-3#1)
safety profile may##2##3##(2005-7#1)(2008-8#1)
safety profile of##13##3##(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#4)(2010-12#2)(2010-5#1)
safety profile than##2##3##(2008-3#1)(2012-12#1)
safety profile was##2##3##(2006-10#1)(2008-3#1)
safety profile##68##2##(1991-12#1)(1996-1#1)(1996-9#1)(2004-12#1)(2005-7#3)(2005-9#1)(2006-10#5)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#9)(2009-11#1)(2009-8#2)(2009-9#1)(2010-12#4)(2010-5#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)
safety profiles and##2##3##(2007-9#1)(2009-8#1)
safety profiles of##2##3##(2005-7#1)(2008-8#1)
safety profiles##11##2##(2005-7#1)(2006-10#3)(2007-9#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-12#1)
safety program##6##2##(1991-12#1)(1994-12#1)(1995-2#1)(2007-4#1)(2008-12#1)(2010-11#1)
safety programs##3##2##(1993-3#1)(1994-12#1)(1995-1#1)
safety protection##4##2##(2008-9#2)(2012-1#1)(2013-1#1)
safety record##3##2##(2008-11#1)(2008-3#1)(2008-7#1)
safety regulations##2##2##(1991-3#1)(2006-11#1)
safety requirements##5##2##(1993-3#1)(2012-1#4)
safety review##2##2##(2008-12#1)(2008-8#1)
safety risk##3##2##(2008-8#1)(2008-9#1)(2011-2#1)
safety seat##4##2##(1991-11#2)(1991-8#1)(2008-6#1)
safety should be##2##3##(1995-5#1)(2012-11#1)
safety should not be##2##4##(2006-10#1)(2012-12#1)
safety should##4##2##(1995-5#1)(2006-10#1)(2012-11#1)(2012-12#1)
safety signals##2##2##(2008-8#1)(2013-1#1)
safety solutions##2##2##(2007-10#1)(2012-2#1)
safety standards##6##2##(1993-3#3)(1994-5#1)(2007-12#1)(2008-10#1)
safety studies##3##2##(2007-2#1)(2012-2#2)
safety study of##3##3##(1993-10#1)(2010-12#1)(2013-1#1)
safety surveillance##3##2##(2007-4#1)(2008-11#2)
safety system##4##2##(2007-8#1)(2008-3#1)(2011-1#1)(2013-1#1)
safety test##2##2##(2007-8#1)(2008-11#1)
safety testing##6##2##(1992-3#2)(2008-4#1)(2008-5#2)(2010-11#1)
safety through##2##2##(2006-10#1)(2007-12#1)
safety to the##4##3##(1995-8#1)(2008-9#1)(2013-1#2)
safety to##10##2##(1995-8#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-11#2)(2013-1#2)
safety training##2##2##(1996-2#1)(2013-1#1)
safety update##2##2##(2007-3#1)(2009-5#1)
safety using##2##2##(2006-11#1)(2013-1#1)
safety was##3##2##(1992-11#1)(2012-12#2)
safety were##2##2##(2007-4#1)(2012-3#1)
safety when##3##2##(2007-11#1)(2012-12#2)
safety while##2##2##(2006-10#1)(2007-5#1)
safety will##2##2##(2007-11#1)(2008-11#1)
safety with##7##2##(2005-10#1)(2007-11#1)(2010-9#1)(2011-2#1)(2013-1#3)
safety zone##5##2##(2012-12#5)
safety##1586##1##(1990-11#3)(1990-12#2)(1990-3#3)(1990-5#1)(1990-6#2)(1990-7#1)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#4)(1991-12#8)(1991-2#4)(1991-3#5)(1991-5#2)(1991-6#3)(1991-8#1)(1992-10#4)(1992-11#2)(1992-2#4)(1992-3#7)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#1)(1993-1#1)(1993-10#2)(1993-11#3)(1993-12#5)(1993-2#8)(1993-3#12)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#5)(1994-2#1)(1994-3#5)(1994-4#1)(1994-5#5)(1994-6#3)(1994-7#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#5)(1995-4#1)(1995-5#7)(1995-7#1)(1995-8#1)(1996-1#4)(1996-10#1)(1996-11#4)(1996-12#6)(1996-2#7)(1996-3#11)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#8)(1997-1#3)(1997-3#4)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-1#2)(2004-10#1)(2004-12#2)(2004-3#2)(2004-7#1)(2004-9#1)(2005-10#4)(2005-11#7)(2005-5#10)(2005-6#2)(2005-7#17)(2005-8#4)(2005-9#4)(2006-1#5)(2006-10#68)(2006-11#8)(2006-12#7)(2006-2#3)(2006-4#2)(2006-5#6)(2006-6#14)(2006-7#3)(2006-8#19)(2006-9#3)(2007-1#11)(2007-10#12)(2007-11#25)(2007-12#16)(2007-2#18)(2007-3#10)(2007-4#32)(2007-5#7)(2007-6#7)(2007-7#23)(2007-8#23)(2007-9#10)(2008-1#19)(2008-10#39)(2008-11#53)(2008-12#19)(2008-2#10)(2008-3#28)(2008-4#28)(2008-5#41)(2008-6#15)(2008-7#34)(2008-8#79)(2008-9#26)(2009-1#3)(2009-10#20)(2009-11#5)(2009-12#2)(2009-2#7)(2009-3#2)(2009-4#6)(2009-5#3)(2009-6#2)(2009-7#4)(2009-8#8)(2009-9#4)(2010-1#2)(2010-10#2)(2010-11#15)(2010-12#34)(2010-2#6)(2010-3#3)(2010-4#14)(2010-5#11)(2010-6#11)(2010-7#5)(2010-8#14)(2010-9#17)(2011-1#26)(2011-12#10)(2011-2#75)(2011-3#2)(2012-1#20)(2012-11#6)(2012-12#76)(2012-2#32)(2012-3#26)(2013-1#98)(2013-7#7)(2013-8#23)
safety?##2##1##(2008-3#1)(2012-12#1)
safety]##3##1##(1992-2#1)(1993-5#1)(2013-8#1)
safflower oil##2##2##(1992-5#1)(2013-1#1)
safflower seedlings##2##2##(2008-10#2)
safflower##9##1##(1992-5#1)(2008-10#4)(2008-12#2)(2008-5#1)(2013-1#1)
saffron samples##2##2##(2007-8#2)
saffron##11##1##(2007-8#5)(2008-10#4)(2008-12#2)
safranal##13##1##(2007-8#9)(2008-10#4)
safranin O##2##2##(2010-2#1)(2012-3#1)
safranin##4##1##(2008-4#1)(2008-9#1)(2010-2#1)(2012-3#1)
safranine##2##1##(2008-10#2)
safrole##4##1##(1992-11#1)(1996-2#1)(2005-12#2)
sag score##2##2##(2008-5#2)
sag treatment lotion##3##3##(2008-5#3)
sag##15##1##(2008-5#10)(2009-6#1)(2012-2#4)
saga of##2##2##(1991-2#1)(2011-2#1)
saga##4##1##(1990-6#1)(1991-2#1)(1991-6#1)(2011-2#1)
sagging in the cheeks##2##4##(2008-5#2)
sagging in the##3##3##(2008-5#3)
sagging##12##1##(2008-5#11)(2010-8#1)
sagitta##4##1##(2008-3#1)(2013-7#3)
sagittal T2-weighted##2##2##(2006-3#1)(2006-5#1)
sagittal alignment##3##2##(2006-8#1)(2013-1#1)(2013-8#1)
sagittal and coronal##2##3##(1995-5#1)(2006-3#1)
sagittal and##9##2##(1995-5#1)(1997-6#1)(2006-3#1)(2008-3#1)(2008-9#2)(2009-4#1)(2010-3#1)(2012-2#1)
sagittal balance and physical ability##3##5##(2011-12#3)
sagittal balance and##4##3##(2011-12#4)
sagittal balance in the##2##4##(2008-8#1)(2013-8#1)
sagittal balance##10##2##(2006-10#1)(2008-8#1)(2011-12#7)(2013-8#1)
sagittal focusing##2##2##(2006-5#2)
sagittal plane##22##2##(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#2)(2010-9#1)(2011-2#1)(2012-1#3)(2012-12#1)(2013-1#1)
sagittal sinus pressure##2##3##(1993-1#2)
sagittal sinus thrombosis##8##3##(1997-3#1)(2007-10#1)(2007-9#6)
sagittal sinus##19##2##(1992-3#1)(1993-1#2)(1997-3#3)(2006-5#1)(2007-10#2)(2007-9#7)(2008-7#1)(2013-8#2)
sagittal slice##5##2##(2005-10#4)(2008-2#1)
sagittal suture##2##2##(2005-10#1)(2006-7#1)
sagittal synostosis##6##2##(1996-3#4)(2006-7#2)
sagittal tomogram##2##2##(2008-2#2)
sagittal##119##1##(1992-3#1)(1992-8#1)(1993-1#2)(1993-3#1)(1995-11#2)(1995-12#2)(1995-5#1)(1996-3#4)(1997-3#3)(1997-6#1)(1997-8#1)(2004-3#1)(2005-10#5)(2006-10#1)(2006-11#1)(2006-12#2)(2006-3#4)(2006-4#1)(2006-5#6)(2006-7#3)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-4#1)(2007-7#4)(2007-8#2)(2007-9#8)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#5)(2008-8#4)(2008-9#3)(2009-4#1)(2009-6#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-12#7)(2011-2#1)(2012-1#4)(2012-12#2)(2012-2#3)(2013-1#4)(2013-8#5)
sagittally##2##1##(2007-4#1)(2012-12#1)
said and##2##2##(2007-8#1)(2012-3#1)
said he##3##2##(1995-12#1)(1996-5#1)(2008-10#1)
said it##3##2##(1993-3#1)(1995-6#1)(2006-10#1)
said parameters were##2##3##(2008-1#1)(2009-6#1)
said she##3##2##(1996-11#2)(1996-5#1)
said than done##2##3##(1995-1#1)(2007-4#1)
said that a##2##3##(2006-12#1)(2009-4#1)
said that the##4##3##(1990-2#1)(1995-10#1)(2006-8#1)(2009-3#1)
said that their##2##3##(2006-8#2)
said that they were##2##4##(2007-7#1)(2013-8#1)
said that they##5##3##(1991-3#2)(1996-1#1)(2007-7#1)(2013-8#1)
said that##37##2##(1990-2#1)(1990-6#1)(1991-3#2)(1992-4#1)(1993-3#1)(1995-10#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-5#1)(2005-9#1)(2006-12#1)(2006-8#5)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
said the##7##2##(1992-3#1)(1992-8#1)(1995-6#1)(1997-5#1)(2008-2#1)(2009-6#1)(2010-12#1)
said they had##6##3##(1994-3#1)(2006-10#1)(2009-6#3)(2013-8#1)
said they were##3##3##(2007-2#1)(2007-3#1)(2011-1#1)
said they would##3##3##(1993-5#1)(1993-8#1)(2007-7#1)
said they##19##2##(1993-5#1)(1993-8#1)(1994-3#1)(2006-10#2)(2006-2#2)(2007-2#2)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-9#1)(2009-6#3)(2011-1#1)(2013-8#1)
said to be a##2##4##(1996-12#1)(2008-7#1)
said to be rare in##2##5##(2009-4#1)(2012-12#1)
said to be##20##3##(1992-5#1)(1993-5#1)(1993-9#1)(1996-12#1)(1996-4#1)(1996-6#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-9#1)(2008-4#3)(2008-7#1)(2009-4#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
said to have##2##3##(1995-6#1)(2013-8#1)
said to##28##2##(1992-5#1)(1993-5#1)(1993-9#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-8#1)(2005-11#2)(2006-10#1)(2006-4#1)(2006-9#1)(2007-7#1)(2008-1#1)(2008-4#3)(2008-7#2)(2009-4#2)(2010-7#1)(2011-1#1)(2012-12#1)(2013-8#2)
said##155##1##(1990-2#1)(1990-6#1)(1990-8#1)(1991-3#2)(1991-5#1)(1991-8#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-3#2)(1993-4#1)(1993-5#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-6#6)(1996-1#1)(1996-11#3)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#1)(1997-5#3)(1997-8#1)(2005-11#3)(2005-9#1)(2006-10#4)(2006-12#1)(2006-2#2)(2006-4#1)(2006-8#5)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-11#1)(2009-3#2)(2009-4#4)(2009-6#6)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#2)(2011-1#5)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#4)(2013-8#4)
saikogenin E##3##2##(2008-11#3)
saikosaponin c was##3##3##(2008-11#3)
saikosaponin c##5##2##(2008-11#5)
sailors##3##1##(2008-8#2)(2011-2#1)
sails##2##1##(1991-8#1)(1995-6#1)
saimiri##7##1##(1991-6#4)(1995-5#1)(2008-4#2)
saitoana to##2##2##(2008-10#2)
saitoana##15##1##(2008-10#15)
sakazakii in##2##2##(2007-12#2)
sakazakii isolates##2##2##(2007-12#2)
sakazakii##10##1##(2007-12#9)(2008-5#1)
sake at 2 x 10(6) CFU ml(-1)##2##7##(2008-10#2)
sake at 2 x 10(6)##3##5##(2008-10#3)
sake at 2 x##4##4##(2008-10#4)
sake of comparison##2##3##(2007-5#1)(2008-10#1)
sake of##11##2##(1994-12#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-9#1)(2009-6#1)(2013-8#1)
sake##28##1##(1994-12#1)(2007-5#1)(2008-1#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-9#1)(2009-6#1)(2010-7#1)(2011-1#1)(2013-8#1)
salIM##2##1##(1994-12#2)
salIR##2##1##(1994-12#2)
salad##4##1##(1991-5#1)(1997-4#2)(2008-6#1)
salamander and##2##2##(2008-5#2)
salamander##9##1##(1991-9#1)(1996-6#1)(2008-5#2)(2008-7#1)(2012-12#4)
salamanders##3##1##(2008-5#1)(2012-12#2)
salami and##2##2##(1991-5#1)(1997-4#1)
salar L##6##2##(2008-7#1)(2009-4#2)(2009-6#1)(2012-2#1)(2013-1#1)
salar##7##1##(2008-7#1)(2009-4#2)(2009-6#1)(2012-2#1)(2013-1#2)
salaried##3##1##(1991-12#1)(2010-9#1)(2011-2#1)
salaries##19##1##(1991-1#2)(1991-2#2)(1991-3#2)(1992-1#1)(1992-3#2)(1993-3#1)(1994-1#1)(1995-1#1)(1995-3#1)(2007-4#2)(2007-8#1)(2007-9#2)(2008-1#1)
salaris##3##1##(2013-1#3)
salary and satisfaction##2##3##(1991-3#1)(1993-3#1)
salary and##5##2##(1991-12#1)(1991-3#1)(1993-3#1)(2007-4#1)(2012-12#1)
salary increase##2##2##(1995-3#2)
salary is##3##2##(1995-3#3)
salary level##2##2##(1991-12#1)(2013-1#1)
salary or##2##2##(1993-3#1)(1997-2#1)
salary survey##5##2##(1991-12#2)(1991-3#1)(1995-1#1)(1995-3#1)
salary##43##1##(1990-9#1)(1991-1#1)(1991-12#7)(1991-3#4)(1992-6#1)(1993-3#2)(1994-1#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#10)(1997-2#2)(2007-4#2)(2008-12#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-12#3)(2013-1#1)
salbutamol and##7##2##(1990-9#1)(1993-2#1)(1995-1#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)
salbutamol in##7##2##(1994-6#2)(2008-10#4)(2008-11#1)
salbutamol sulfate##2##2##(2008-10#2)
salbutamol sulphate and##4##3##(2010-2#4)
salbutamol was##2##2##(2008-10#1)(2013-1#1)
salbutamol##65##1##(1990-9#1)(1992-1#2)(1992-10#1)(1993-2#1)(1994-12#1)(1994-6#3)(1995-1#2)(1996-1#5)(1996-12#1)(1996-2#2)(2004-12#3)(2007-11#7)(2007-2#2)(2007-8#2)(2008-10#22)(2008-11#2)(2010-2#4)(2011-1#1)(2013-1#3)
salcatonin##3##1##(2007-11#3)
sale of##19##2##(1990-4#1)(1990-5#1)(1991-10#1)(1992-11#1)(1992-8#1)(1993-10#1)(1996-11#3)(1996-12#1)(2005-7#1)(2008-1#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2013-1#1)(2013-8#1)
sale to##2##2##(1991-7#1)(1993-8#1)
sale##28##1##(1990-4#2)(1990-5#1)(1991-10#1)(1991-7#1)(1992-11#1)(1992-8#1)(1993-10#1)(1993-8#1)(1994-6#1)(1995-11#1)(1996-11#3)(1996-12#1)(2005-7#1)(2006-2#1)(2007-5#1)(2008-1#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
sales and##2##2##(1991-5#1)(1994-2#1)
sales are predicted to be##2##5##(2005-8#2)
sales force development##2##3##(1990-12#2)
sales force##4##2##(1990-12#4)
sales have##2##2##(2008-5#1)(2012-2#1)
sales in##2##2##(2008-1#1)(2008-5#1)
sales of UK pounds sterling##2##5##(2005-8#2)
sales of US##3##3##(2005-8#3)
sales of##22##2##(1996-11#1)(2005-8#14)(2005-9#4)(2007-11#2)(2012-1#1)
sales representatives##3##2##(1995-3#1)(2006-2#2)
sales would##2##2##(2005-8#2)
sales##60##1##(1990-12#5)(1990-5#1)(1991-5#1)(1992-2#1)(1993-5#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-11#2)(1996-3#1)(1997-3#1)(2005-7#1)(2005-8#19)(2005-9#4)(2006-2#2)(2007-11#2)(2008-1#1)(2008-11#3)(2008-5#3)(2009-4#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)
salesman##4##1##(1991-3#1)(1992-12#1)(1992-6#1)(2007-7#1)
salexigens flavodoxin and##2##3##(1994-5#2)
salexigens##4##1##(1990-4#2)(1994-5#2)
salicaria##2##1##(2010-12#2)
salicyl fluorones##2##2##(2008-10#2)
salicylaldehyde thiosemicarbazone##5##2##(2008-10#5)
salicylaldehyde##11##1##(2008-10#8)(2008-3#1)(2008-5#1)(2010-5#1)
salicylaldehyde)##2##1##(2004-2#1)(2008-10#1)
salicylamide##3##1##(2008-10#3)
salicylate (SA)##2##2##(2008-10#2)
salicylate and iodide##2##3##(2008-10#2)
salicylate and##6##2##(2008-10#4)(2008-2#1)(2009-6#1)
salicylate hydroxylase from P##2##4##(1990-6#2)
salicylate hydroxylase from##3##3##(1990-6#3)
salicylate hydroxylase##11##2##(1990-6#5)(1996-7#3)(2008-10#3)
salicylate hydroxylation assay##2##3##(1997-8#2)
salicylate in##5##2##(2008-10#4)(2012-2#1)
salicylate ions##2##2##(2008-10#2)
salicylate##65##1##(1990-3#2)(1990-6#5)(1991-3#1)(1993-12#3)(1996-7#3)(1997-2#1)(1997-3#2)(1997-8#3)(2007-8#1)(2008-10#30)(2008-2#2)(2008-5#8)(2009-6#2)(2009-8#1)(2012-2#1)
salicylate) (CAS RN##2##3##(2008-5#2)
salicylate)##3##1##(2007-11#1)(2008-5#2)
salicylates##5##1##(1991-8#1)(1993-11#1)(1996-3#1)(2008-10#1)(2009-1#1)
salicylatoxidans##3##1##(2007-1#3)
salicylglycine##2##1##(2008-3#2)
salicylhydroxamic acid##2##2##(1991-5#1)(2008-3#1)
salicylic Acid##2##2##(2008-10#2)
salicylic acid (SA) accumulation##2##4##(2008-10#1)(2009-8#1)
salicylic acid (SA) and jasmonic acid (JA)##2##7##(2009-6#1)(2009-8#1)
salicylic acid (SA) and##4##4##(2008-10#1)(2009-6#2)(2009-8#1)
salicylic acid (SA) in##2##4##(2008-10#1)(2009-8#1)
salicylic acid (SA)##16##3##(2004-2#1)(2007-8#1)(2008-10#8)(2009-6#2)(2009-8#4)
salicylic acid (SA)-mediated##2##3##(2009-6#1)(2011-10#1)
salicylic acid and acetylsalicylic acid##2##5##(2008-10#2)
salicylic acid and##15##3##(1993-11#3)(2006-10#1)(2007-8#1)(2008-10#7)(2008-5#1)(2011-2#1)(2013-7#1)
salicylic acid as an##2##4##(2007-8#1)(2008-10#1)
salicylic acid by##3##3##(2006-10#1)(2007-8#1)(2008-10#1)
salicylic acid in##6##3##(1994-3#1)(2007-8#1)(2008-10#3)(2008-5#1)
salicylic acid to##2##3##(1996-6#1)(2008-10#1)
salicylic acid was##3##3##(2008-10#2)(2013-8#1)
salicylic acid with##2##3##(2008-5#2)
salicylic acid without##2##3##(2007-8#1)(2008-10#1)
salicylic acid##101##2##(1993-11#5)(1994-3#2)(1994-6#1)(1995-5#1)(1996-6#1)(2004-2#1)(2005-11#1)(2006-10#3)(2007-12#3)(2007-8#13)(2008-10#41)(2008-5#12)(2008-8#1)(2009-10#1)(2009-5#1)(2009-6#3)(2009-8#5)(2011-10#1)(2011-2#1)(2013-7#2)(2013-8#2)
salicylic acid-dependent##3##2##(2008-10#1)(2009-6#2)
salicylic and##2##2##(2008-10#1)(2008-5#1)
salicylic##114##1##(1990-8#1)(1993-11#5)(1994-3#2)(1994-6#1)(1995-5#1)(1996-6#1)(2004-2#1)(2005-11#1)(2006-10#3)(2007-12#3)(2007-8#13)(2008-10#47)(2008-5#15)(2008-8#1)(2009-10#1)(2009-5#1)(2009-6#5)(2009-8#5)(2011-10#1)(2011-2#2)(2013-7#2)(2013-8#2)
salience changes##2##2##(2010-2#2)
salience of exercise##2##3##(2007-6#2)
salience of##8##2##(1997-3#1)(2007-6#2)(2008-12#1)(2008-3#1)(2009-9#1)(2011-1#1)(2012-2#1)
salience##14##1##(1997-3#2)(2007-11#1)(2007-6#2)(2008-12#1)(2008-3#1)(2009-9#1)(2010-2#4)(2011-1#1)(2012-2#1)
saliency##2##1##(2008-11#2)
salient and##4##2##(2007-8#1)(2008-6#2)(2010-6#1)
salient feature of the##3##4##(1993-2#1)(2008-2#1)(2012-12#1)
salient feature of##5##3##(1993-2#1)(2008-2#2)(2010-5#1)(2012-12#1)
salient feature##6##2##(1991-5#1)(1993-2#1)(2008-2#2)(2010-5#1)(2012-12#1)
salient features are##2##3##(2008-11#1)(2008-7#1)
salient features of the##4##4##(1993-8#1)(2008-4#1)(2009-11#2)
salient features of##8##3##(1993-8#1)(1994-5#1)(2007-12#1)(2007-4#1)(2008-2#1)(2008-4#1)(2009-11#2)
salient features##16##2##(1990-11#1)(1992-9#1)(1993-8#1)(1994-5#1)(1994-8#1)(1997-8#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-11#2)(2010-5#1)
salient in##2##2##(2010-4#1)(2012-12#1)
salient points##2##2##(2008-10#1)(2008-2#1)
salient results##3##2##(1994-1#1)(2008-7#1)(2010-6#1)
salient themes##2##2##(1993-3#1)(2013-1#1)
salient##71##1##(1990-11#1)(1991-5#1)(1992-4#1)(1992-9#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-10#1)(1994-5#1)(1994-8#1)(1995-3#1)(1997-3#1)(1997-8#1)(2005-8#2)(2006-3#1)(2006-5#1)(2007-12#4)(2007-4#1)(2007-8#3)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#3)(2008-2#4)(2008-4#1)(2008-6#2)(2008-7#3)(2009-11#3)(2009-4#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#3)(2010-6#3)(2010-8#1)(2012-12#3)(2012-2#3)(2013-1#2)(2013-8#1)
salina 1650##3##2##(2008-6#3)
salina##15##1##(1991-5#1)(1992-1#3)(2007-1#1)(2007-12#4)(2007-6#3)(2008-6#3)
saline (0##8##2##(1990-4#1)(1994-10#1)(1997-4#1)(2006-10#2)(2010-2#1)(2011-2#1)(2012-3#1)
saline (1 ml/kg)##2##3##(1993-12#1)(1996-10#1)
saline (1##3##2##(1993-12#1)(1996-10#1)(2007-1#1)
saline (10 ml##4##3##(2006-5#3)(2008-10#1)
saline (10##5##2##(1994-11#1)(2006-5#3)(2008-10#1)
saline (40##2##2##(2008-4#1)(2010-12#1)
saline (PBS)##7##2##(1992-11#1)(1994-8#1)(2005-10#1)(2006-5#1)(2008-10#2)(2010-12#1)
saline (SAL)##2##2##(1995-12#1)(1996-12#1)
saline (control)##2##2##(1996-10#1)(2011-2#1)
saline (n =##3##3##(1996-5#1)(2010-6#1)(2012-3#1)
saline alone##2##2##(1991-11#1)(1994-2#1)
saline and sodic tolerances##2##4##(2012-11#2)
saline and sodic##4##3##(2012-11#4)
saline and the##2##3##(2007-10#1)(2008-11#1)
saline and##31##2##(1990-2#1)(1992-10#1)(1993-12#1)(1993-3#1)(1994-10#1)(1996-6#1)(1997-2#1)(1997-7#2)(2006-4#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-7#1)(2010-8#1)(2012-11#4)
saline are##3##2##(2007-7#1)(2010-12#1)(2012-3#1)
saline at a##2##3##(1993-3#1)(2008-5#1)
saline at##6##2##(1993-3#1)(1994-8#1)(1995-12#1)(2007-1#1)(2008-5#1)(2010-7#1)
saline buffer##2##2##(1991-2#1)(2008-5#1)
saline concentrates for hemodialysis##2##4##(2008-10#2)
saline conditions##2##2##(2008-10#1)(2013-1#1)
saline containing 0##2##3##(2008-10#1)(2009-9#1)
saline control group##2##3##(1995-12#1)(2009-6#1)
saline control##4##2##(1995-12#1)(2008-7#2)(2009-6#1)
saline controls in##2##3##(1992-5#1)(2012-3#1)
saline controls##10##2##(1992-5#2)(1993-2#1)(1995-12#2)(2007-11#1)(2008-10#1)(2008-4#1)(2010-5#1)(2012-3#1)
saline crops##2##2##(2008-5#2)
saline did not##2##3##(2007-1#2)
saline dressing##2##2##(2013-8#2)
saline flush##2##2##(2006-10#1)(2008-7#1)
saline for##8##2##(1992-11#1)(1996-10#2)(1997-5#1)(2006-10#1)(2006-4#1)(2011-2#2)
saline group##2##2##(1993-7#1)(2007-10#1)
saline had##2##2##(1991-4#1)(2007-8#1)
saline in a##2##3##(2007-7#1)(2010-12#1)
saline in##10##2##(1992-7#2)(1993-10#1)(2006-4#1)(2007-7#1)(2008-5#1)(2008-9#1)(2010-12#1)(2012-12#1)(2013-1#1)
saline infusion##3##2##(1990-10#1)(1991-2#1)(1991-6#1)
saline injection##5##2##(1995-12#1)(2004-10#1)(2006-10#1)(2007-5#1)(2012-2#1)
saline injections##4##2##(1994-8#1)(1996-10#1)(1996-4#1)(2008-4#1)
saline instead of##2##3##(1997-2#1)(2012-2#1)
saline into the##4##3##(1993-10#3)(2008-7#1)
saline irrigation and##3##3##(2010-7#3)
saline is##4##2##(1997-1#1)(1997-2#1)(2006-8#1)(2010-1#1)
saline matrices##6##2##(2008-10#6)
saline matrix##4##2##(2008-10#4)
saline media##4##2##(2008-10#3)(2008-3#1)
saline on##5##2##(1992-10#1)(1993-11#1)(1993-12#1)(2012-12#1)(2012-3#1)
saline only##2##2##(2007-10#1)(2011-1#1)
saline or 5% glucose and##2##5##(2012-12#2)
saline or NPY##2##3##(1991-6#1)(1995-11#1)
saline or amphetamine##2##3##(1994-2#1)(1997-7#1)
saline or##27##2##(1990-11#1)(1991-11#1)(1991-6#1)(1991-8#1)(1993-1#1)(1993-12#1)(1994-2#2)(1995-11#2)(1995-12#1)(1996-4#1)(1997-6#1)(1997-7#1)(2006-9#1)(2008-10#3)(2008-5#2)(2008-7#1)(2008-9#1)(2012-12#2)(2013-1#1)(2013-8#2)
saline produced##2##2##(1994-10#1)(2008-10#1)
saline samples##2##2##(2008-10#2)
saline soil##2##2##(2009-8#1)(2011-2#1)
saline solution was##2##3##(2004-12#1)(2008-7#1)
saline solution##26##2##(1992-9#1)(1994-9#1)(1995-3#1)(2004-12#1)(2006-9#7)(2007-10#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#1)
saline solution- and S##2##4##(2006-9#2)
saline solution- and##3##3##(2006-9#3)
saline solution-##4##2##(2006-9#4)
saline solution-treated incisions##2##3##(2006-9#2)
saline solutions##8##2##(1990-10#1)(1993-3#1)(2006-10#1)(2008-10#4)(2012-2#1)
saline suspensions##2##2##(2008-10#1)(2008-5#1)
saline to##3##2##(1993-3#1)(2005-10#1)(2006-12#1)
saline tolerance##2##2##(2012-11#2)
saline using a##2##3##(1991-12#1)(1995-3#1)
saline using##3##2##(1991-12#1)(1993-12#1)(1995-3#1)
saline vehicle##4##2##(1990-7#1)(1994-8#1)(2011-2#1)(2013-1#1)
saline was infused##2##3##(1991-2#1)(1993-2#1)
saline was injected##3##3##(1994-2#1)(1995-3#1)(1997-2#1)
saline was##7##2##(1991-2#1)(1993-2#1)(1994-2#1)(1995-3#1)(1997-2#1)(2007-9#1)(2013-1#1)
saline water##15##2##(1990-10#1)(2007-12#1)(2008-10#10)(2008-12#1)(2012-5#2)
saline waters##2##2##(2008-10#2)
saline were##3##2##(1996-1#1)(2006-5#1)(2008-5#1)
saline with##4##2##(1993-3#1)(1993-4#1)(2010-7#2)
saline##469##1##(1990-10#3)(1990-11#4)(1990-2#1)(1990-4#1)(1990-5#2)(1990-7#3)(1990-8#3)(1991-11#4)(1991-12#2)(1991-2#4)(1991-3#3)(1991-4#2)(1991-6#4)(1991-8#4)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#1)(1992-3#1)(1992-5#2)(1992-7#3)(1992-8#2)(1992-9#2)(1993-1#2)(1993-10#4)(1993-11#1)(1993-12#8)(1993-2#4)(1993-3#10)(1993-4#1)(1993-7#2)(1994-10#5)(1994-11#4)(1994-12#1)(1994-2#5)(1994-5#1)(1994-8#7)(1994-9#2)(1995-11#3)(1995-12#8)(1995-2#1)(1995-3#4)(1995-5#1)(1995-8#1)(1996-1#1)(1996-10#6)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#7)(1997-4#5)(1997-5#3)(1997-6#1)(1997-7#3)(1997-8#1)(2004-10#2)(2004-11#1)(2004-12#1)(2004-9#1)(2005-10#2)(2005-11#1)(2005-8#1)(2006-10#8)(2006-12#4)(2006-4#4)(2006-5#5)(2006-7#1)(2006-8#5)(2006-9#16)(2007-1#8)(2007-10#7)(2007-11#4)(2007-12#6)(2007-2#1)(2007-5#3)(2007-7#4)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#57)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#8)(2008-5#14)(2008-7#7)(2008-8#2)(2008-9#5)(2009-10#3)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#6)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#2)(2010-12#5)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#9)(2010-8#4)(2011-1#2)(2011-12#3)(2011-2#10)(2012-1#1)(2012-11#7)(2012-12#8)(2012-2#3)(2012-3#7)(2012-5#2)(2013-1#10)(2013-8#7)
saline) into##2##2##(2004-10#1)(2007-10#1)
saline)##13##1##(1990-5#1)(1995-5#1)(2004-10#1)(2005-8#1)(2007-10#1)(2008-12#1)(2008-4#2)(2008-9#1)(2009-5#2)(2011-12#1)(2012-12#1)
saline- and##5##2##(1992-10#2)(1996-10#1)(1996-4#1)(2008-10#1)
saline-##7##1##(1992-10#2)(1996-10#1)(1996-4#1)(2008-10#1)(2012-2#2)
saline-injected##3##1##(1990-5#1)(1993-11#1)(1996-3#1)
saline-instilled##2##1##(2008-10#2)
saline-pretreated##2##1##(1991-3#1)(1996-12#1)
saline-stressed plants##2##2##(2013-1#2)
saline-treated animals##5##2##(1992-8#1)(1994-10#1)(1995-12#1)(1996-10#2)
saline-treated control##5##2##(1992-3#1)(1993-3#2)(1994-6#1)(1996-10#1)
saline-treated controls##6##2##(1993-12#1)(1995-9#1)(1996-10#2)(1996-12#1)(1997-4#1)
saline-treated rats##4##2##(1994-10#2)(1995-12#1)(1996-10#1)
saline-treated##25##1##(1991-3#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#2)(1994-10#3)(1994-6#1)(1995-12#4)(1995-9#1)(1996-10#6)(1996-12#1)(1997-4#1)(2006-9#1)(2009-10#1)
salines##3##1##(1997-4#2)(2008-4#1)
salinities##11##1##(2007-5#4)(2008-10#1)(2008-5#4)(2008-7#1)(2012-2#1)
salinity 37##2##2##(2007-5#1)(2008-5#1)
salinity and alkalinity##2##3##(2013-8#2)
salinity and dissolved##2##3##(2008-5#1)(2013-7#1)
salinity and drought##2##3##(2008-5#1)(2009-8#1)
salinity and temperature##3##3##(2008-2#1)(2008-5#1)(2011-2#1)
salinity and temperatures##2##3##(2013-7#2)
salinity and##21##2##(2007-3#1)(2008-10#1)(2008-2#1)(2008-5#8)(2009-8#3)(2011-2#1)(2013-1#1)(2013-7#3)(2013-8#2)
salinity induced##2##2##(1997-6#2)
salinity level##2##2##(2008-12#1)(2013-1#1)
salinity levels##2##2##(2008-12#1)(2008-5#1)
salinity of##4##2##(2007-5#1)(2007-8#1)(2008-3#2)
salinity on the##2##3##(2008-10#1)(2008-5#1)
salinity on##5##2##(2004-2#2)(2008-10#1)(2008-5#1)(2009-8#1)
salinity stress##2##2##(2008-11#1)(2008-8#1)
salinity substrate##2##2##(2013-1#2)
salinity tolerance##9##2##(1992-8#1)(1997-6#1)(2008-12#2)(2011-1#1)(2011-12#3)(2012-5#1)
salinity##95##1##(1992-8#1)(1997-6#5)(2004-2#3)(2004-4#1)(2007-10#1)(2007-3#4)(2007-5#6)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#7)(2008-2#3)(2008-3#2)(2008-5#17)(2008-8#1)(2009-8#10)(2011-1#1)(2011-12#5)(2011-2#2)(2012-2#1)(2012-5#2)(2013-1#6)(2013-7#5)(2013-8#3)
salinization##3##1##(1993-4#1)(2011-12#1)(2012-5#1)
salinized##3##1##(2008-11#1)(2008-12#2)
salinomycin and narasin##2##3##(2007-6#2)
salinomycin and##3##2##(2007-11#1)(2007-6#2)
salinomycin##7##1##(2007-11#1)(2007-6#6)
saliva and hemolymph of##2##4##(1991-8#1)(2008-10#1)
saliva and serum##2##3##(2007-2#1)(2013-8#1)
saliva and urine samples##3##4##(1992-2#1)(2008-10#2)
saliva and urine##4##3##(1992-2#1)(2008-10#2)(2009-9#1)
saliva and##19##2##(1991-8#1)(1992-2#1)(1992-4#1)(1993-2#1)(1993-5#2)(2007-2#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-5#1)(2009-9#1)(2013-7#1)(2013-8#2)
saliva as##2##2##(1990-10#1)(2012-3#1)
saliva by capillary isotachophoresis##2##4##(2008-10#2)
saliva by##4##2##(2007-10#1)(2008-10#3)
saliva cathepsin L levels##2##4##(2011-12#2)
saliva cathepsin L##3##3##(2011-12#3)
saliva during##2##2##(2008-10#1)(2009-4#1)
saliva flow rate##5##3##(2013-1#1)(2013-8#4)
saliva for##3##2##(2008-10#2)(2013-1#1)
saliva from##6##2##(1990-10#1)(1993-3#1)(1996-1#1)(2006-4#1)(2008-10#1)(2010-2#1)
saliva in##2##2##(2008-10#1)(2009-6#1)
saliva is##2##2##(2006-4#1)(2012-12#1)
saliva levels##4##2##(1991-1#1)(2011-12#3)
saliva of##13##2##(1991-8#1)(1995-1#1)(2008-10#1)(2008-12#1)(2009-3#1)(2010-12#1)(2011-12#7)
saliva on HIV-1##2##3##(2006-4#2)
saliva on##4##2##(1991-1#1)(2004-11#1)(2006-4#2)
saliva osmolality##2##2##(2013-8#2)
saliva production##3##2##(2007-11#3)
saliva resulted in##2##3##(2006-4#1)(2008-5#1)
saliva samples from##2##3##(2007-10#1)(2012-3#1)
saliva samples were collected##3##4##(2007-2#1)(2009-4#1)(2013-1#1)
saliva samples were##5##3##(2006-3#1)(2007-2#2)(2009-4#1)(2013-1#1)
saliva samples##20##2##(1992-2#2)(1993-5#1)(2006-3#1)(2007-10#3)(2007-2#3)(2008-10#4)(2008-5#1)(2009-4#1)(2012-3#3)(2013-1#1)
saliva seems to##2##3##(1993-5#1)(2006-4#1)
saliva substitutes##2##2##(2008-7#2)
saliva to##2##2##(2006-10#1)(2008-10#1)
saliva was collected##2##3##(2011-12#1)(2013-8#1)
saliva was found##2##3##(1993-5#1)(2012-12#1)
saliva was##12##2##(1991-8#1)(1993-5#2)(1996-6#2)(2004-11#1)(2008-12#1)(2008-5#1)(2010-5#1)(2011-12#1)(2012-12#1)(2013-8#1)
saliva were##2##2##(2010-12#1)(2012-3#1)
saliva with Na levels##2##4##(2006-4#2)
saliva with##4##2##(1991-8#1)(2006-4#2)(2007-10#1)
saliva##233##1##(1990-10#3)(1990-5#1)(1991-1#2)(1991-12#1)(1991-8#8)(1992-2#3)(1992-4#1)(1993-2#1)(1993-3#1)(1993-5#6)(1995-1#2)(1995-11#1)(1996-1#1)(1996-11#1)(1996-12#5)(1996-5#1)(1996-6#4)(1997-5#1)(1997-6#5)(2004-11#6)(2004-9#1)(2006-10#1)(2006-2#5)(2006-3#1)(2006-4#13)(2006-8#7)(2007-10#5)(2007-11#3)(2007-2#8)(2007-3#1)(2007-8#1)(2007-9#3)(2008-10#36)(2008-11#2)(2008-12#6)(2008-3#2)(2008-4#1)(2008-5#6)(2008-7#4)(2008-8#1)(2009-3#1)(2009-4#4)(2009-6#3)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-5#4)(2011-1#2)(2011-12#20)(2012-12#6)(2012-3#6)(2013-1#4)(2013-7#1)(2013-8#14)
saliva-saliva##2##1##(2008-12#2)
salivarius MTC 1026##4##3##(2012-2#4)
salivarius##11##1##(2006-5#1)(2008-5#2)(2011-1#2)(2012-2#6)
salivary IgA##2##2##(2013-8#2)
salivary Streptococcus mutans##5##3##(2012-12#5)
salivary acinar cells##2##3##(1997-6#2)
salivary adenocarcinoma##3##2##(1990-6#1)(1991-5#1)(2009-5#1)
salivary and##7##2##(1995-1#1)(2011-1#1)(2013-8#5)
salivary bacteria##2##2##(2010-5#2)
salivary biomarkers##2##2##(2010-12#2)
salivary concentrations of##2##3##(2006-8#1)(2010-12#1)
salivary cortisol levels##2##3##(2007-11#1)(2013-8#1)
salivary cortisol##6##2##(2007-11#1)(2010-2#4)(2013-8#1)
salivary duct##5##2##(1992-5#3)(2007-12#1)(2008-10#1)
salivary flow rate##3##3##(2006-10#2)(2007-9#1)
salivary flow##7##2##(2006-10#4)(2006-8#1)(2007-9#1)(2008-7#1)
salivary gland and##4##3##(1990-5#1)(1993-9#1)(2007-6#1)(2010-4#1)
salivary gland cells##5##3##(2008-10#2)(2008-11#1)(2011-2#2)
salivary gland hypofunction##2##3##(2008-7#2)
salivary gland is##3##3##(1994-7#1)(2009-3#1)(2012-2#1)
salivary gland neoplasm##3##3##(2008-8#1)(2009-5#1)(2013-1#1)
salivary gland of Chironomus##3##4##(2008-11#3)
salivary gland of the##7##4##(2008-4#3)(2013-1#4)
salivary gland of##10##3##(2008-11#3)(2008-4#3)(2013-1#4)
salivary gland tissue##3##3##(1991-11#1)(2007-11#1)(2008-7#1)
salivary gland tissues##2##3##(2010-12#2)
salivary gland tumors##2##3##(1993-9#1)(2010-7#1)
salivary gland tumours##5##3##(2010-12#1)(2012-2#4)
salivary gland##87##2##(1990-5#3)(1991-11#1)(1992-4#1)(1992-5#3)(1993-9#5)(1994-7#2)(1995-1#1)(1995-11#3)(1995-8#1)(1997-5#1)(2004-11#3)(2006-10#3)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-6#1)(2008-10#5)(2008-11#4)(2008-4#3)(2008-7#5)(2008-8#2)(2009-1#1)(2009-3#2)(2009-5#2)(2009-7#1)(2010-12#4)(2010-4#1)(2010-7#2)(2011-2#4)(2012-2#7)(2012-3#1)(2013-1#6)(2013-8#1)
salivary glands and##7##3##(1994-7#1)(1995-1#1)(2004-11#2)(2008-10#2)(2011-2#1)
salivary glands are##2##3##(2008-11#1)(2012-3#1)
salivary glands in##4##3##(1995-9#1)(2008-4#2)(2013-1#1)
salivary glands of the##2##4##(1991-11#1)(2013-1#1)
salivary glands of##15##3##(1990-11#2)(1991-11#1)(2007-12#2)(2008-10#4)(2008-4#3)(2008-8#1)(2011-2#1)(2013-1#1)
salivary glands##80##2##(1990-11#3)(1990-12#1)(1990-6#2)(1991-11#1)(1991-9#2)(1992-4#1)(1994-5#1)(1994-7#5)(1995-1#1)(1995-9#1)(1997-4#1)(2004-11#2)(2006-10#1)(2006-11#1)(2007-12#3)(2007-5#1)(2008-10#23)(2008-11#3)(2008-4#9)(2008-7#2)(2008-8#2)(2010-12#2)(2011-1#2)(2011-2#6)(2012-12#1)(2012-3#1)(2013-1#2)
salivary immunoglobulin A##2##3##(2013-1#1)(2013-8#1)
salivary markers##3##2##(1996-6#1)(2013-1#2)
salivary mesenchyme##3##2##(1991-2#3)
salivary pH##3##2##(2012-12#1)(2013-1#1)(2013-8#1)
salivary proteins from five aphid##2##5##(2011-12#2)
salivary proteins##5##2##(2010-12#1)(2010-2#1)(2011-12#3)
salivary secretion##2##2##(1993-3#2)
salivary stones##2##2##(1992-5#2)
salivary tumors##2##2##(2007-6#2)
salivary α-amylase##2##2##(2013-8#2)
salivary##298##1##(1990-11#3)(1990-12#4)(1990-5#3)(1990-6#3)(1991-1#1)(1991-11#2)(1991-2#3)(1991-5#2)(1991-8#1)(1991-9#2)(1992-4#2)(1992-5#8)(1993-12#4)(1993-3#2)(1993-5#1)(1993-9#5)(1994-12#3)(1994-5#1)(1994-7#7)(1995-1#4)(1995-11#3)(1995-2#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-6#2)(2004-11#5)(2006-10#8)(2006-11#2)(2006-2#1)(2006-4#1)(2006-8#5)(2007-10#1)(2007-11#3)(2007-12#7)(2007-5#2)(2007-6#3)(2007-9#4)(2008-10#34)(2008-11#7)(2008-4#15)(2008-5#1)(2008-7#9)(2008-8#4)(2009-1#1)(2009-3#2)(2009-5#4)(2009-6#1)(2009-7#1)(2010-12#12)(2010-2#6)(2010-4#1)(2010-5#3)(2010-7#2)(2011-1#4)(2011-12#6)(2011-2#12)(2012-12#13)(2012-2#7)(2012-3#2)(2013-1#15)(2013-8#19)
salivary-gland##2##1##(2007-7#1)(2007-8#1)
salivas have##2##2##(2008-10#2)
salivas##6##1##(1991-8#1)(2008-10#3)(2008-5#2)
salivation##13##1##(1993-11#2)(1996-12#3)(1997-5#1)(2008-10#3)(2008-7#1)(2010-12#1)(2012-12#1)(2012-2#1)
salivatory nucleus##2##2##(1992-8#2)
salix sp##2##2##(2007-7#2)
salmeterol and fluticasone propionate (FP)##2##5##(1996-2#2)
salmeterol and##4##2##(1996-1#2)(1996-2#2)
salmeterol##10##1##(1993-2#1)(1996-1#4)(1996-2#4)(2008-10#1)
salmon (O##2##2##(2008-11#1)(2008-5#1)
salmon (Oncorhynchus nerka)##2##3##(1995-11#1)(2008-5#1)
salmon (Oncorhynchus##3##2##(1993-3#1)(1995-11#1)(2008-5#1)
salmon (Salmo salar)##6##3##(1990-6#1)(1991-5#1)(1992-9#1)(1994-7#1)(1995-11#1)(2008-7#1)
salmon (Salmo##12##2##(1990-6#1)(1991-5#1)(1992-9#1)(1994-7#1)(1995-11#1)(2008-7#3)(2009-4#2)(2012-2#1)(2013-1#1)
salmon GnRH##2##2##(1994-8#1)(1995-11#1)
salmon Oncorhynchus nerka##3##3##(2010-8#2)(2012-3#1)
salmon Oncorhynchus##5##2##(2010-8#4)(2012-3#1)
salmon Salmo##2##2##(2008-7#1)(2013-1#1)
salmon and##2##2##(1991-7#1)(2012-3#1)
salmon calcitonin 100IU (1 mL) + NaCl 0##2##8##(2006-12#2)
salmon calcitonin and##2##3##(1993-11#1)(2006-12#1)
salmon calcitonin in##2##3##(1990-3#1)(2006-12#1)
salmon calcitonin##18##2##(1990-12#1)(1990-3#2)(1991-7#1)(1992-8#3)(1993-11#4)(1997-4#1)(2006-12#5)(2007-11#1)
salmon egg cell cytoplasm was diluted five-fold with 0##2##9##(2008-10#2)
salmon egg cell cytoplasm was##3##5##(2008-10#3)
salmon egg cell cytoplasm##5##4##(2008-10#5)
salmon genome##2##2##(1993-3#2)
salmon muscle tissue##6##3##(1990-9#3)(1991-8#3)
salmon population##2##2##(2008-8#1)(2013-1#1)
salmon##103##1##(1990-12#4)(1990-3#2)(1990-6#1)(1990-9#5)(1991-5#2)(1991-7#3)(1991-8#4)(1992-1#3)(1992-6#3)(1992-8#3)(1992-9#1)(1993-11#4)(1993-3#4)(1994-2#1)(1994-7#2)(1994-8#1)(1995-11#5)(1997-3#1)(1997-4#1)(2006-12#5)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-5#5)(2008-7#8)(2008-8#4)(2009-3#1)(2009-4#2)(2009-6#4)(2010-8#4)(2011-12#1)(2012-2#2)(2012-3#3)(2013-1#3)
salmonella and##2##2##(1996-3#1)(1997-3#1)
salmonella aortitis in a##2##4##(2007-7#2)
salmonella aortitis##3##2##(2007-7#3)
salmonella bacteremia##3##2##(2007-2#2)(2007-7#1)
salmonella in##2##2##(1996-3#1)(2007-2#1)
salmonella was##3##2##(1997-3#2)(2007-7#1)
salmonella##22##1##(1993-8#1)(1995-9#1)(1996-3#4)(1997-3#4)(2006-10#1)(2007-12#1)(2007-2#5)(2007-7#5)
salmonellas in##2##2##(1996-3#1)(1997-3#1)
salmonellas##3##1##(1996-3#2)(1997-3#1)
salmonellosis in##3##2##(2011-2#1)(2012-2#2)
salmonellosis##13##1##(1991-3#1)(1993-8#1)(1997-3#2)(2006-10#1)(2007-2#4)(2008-1#1)(2011-2#1)(2012-2#2)
salmonid##5##1##(1995-11#1)(2008-11#1)(2008-5#1)(2008-8#1)(2013-1#1)
salmonids##9##1##(1993-3#1)(2008-10#3)(2008-5#1)(2008-7#2)(2009-6#2)
salmoninarum##6##1##(2009-6#6)
salon##2##1##(1996-12#1)(2008-8#1)
salons##2##1##(2008-5#1)(2008-8#1)
salpingectomy##3##1##(1991-3#1)(1993-12#1)(2010-12#1)
salpingitis in a##2##3##(2013-8#2)
salpingitis##10##1##(1992-2#1)(1994-2#3)(1994-9#1)(1997-6#2)(2013-8#3)
salpingo-oophorectomy##4##1##(2010-12#1)(2012-3#1)(2013-8#2)
salpingostomies##2##1##(1993-1#1)(2011-1#1)
salpingostomy##2##1##(1993-12#1)(1993-3#1)
salsalate in##4##2##(2008-10#4)
salsalate##8##1##(2008-10#7)(2009-4#1)
salt + L-NAME##2##3##(2008-4#2)
salt 4-N##2##2##(2007-12#2)
salt added##2##2##(2013-1#2)
salt and a##2##3##(1995-4#1)(2008-10#1)
salt and iodine##3##3##(2013-1#3)
salt and sodium##4##3##(1994-5#1)(2008-10#1)(2008-4#1)(2013-1#1)
salt and##44##2##(1990-9#3)(1991-1#1)(1994-5#1)(1994-8#1)(1995-4#1)(1995-6#1)(1997-8#1)(2005-11#2)(2006-4#1)(2007-7#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#2)(2009-10#1)(2009-8#1)(2012-2#1)(2013-1#4)(2013-8#1)
salt appetite##2##2##(1994-10#1)(1997-8#1)
salt are##2##2##(2005-4#1)(2013-1#1)
salt as##2##2##(2008-10#1)(2010-3#1)
salt at##4##2##(2007-2#2)(2008-10#1)(2011-1#1)
salt bridge and##3##3##(1990-12#2)(1993-3#1)
salt bridge between##2##3##(2006-12#1)(2008-3#1)
salt bridge formation between##3##4##(1993-9#3)
salt bridge in##3##3##(1990-8#1)(1993-3#1)(2006-3#1)
salt bridge may##2##3##(1993-3#1)(2008-8#1)
salt bridge with##3##3##(1990-12#1)(1991-7#1)(1996-8#1)
salt bridge##30##2##(1990-10#1)(1990-12#4)(1990-8#1)(1991-5#1)(1991-7#1)(1993-3#5)(1993-9#3)(1995-1#2)(1996-6#1)(1996-8#1)(1997-5#1)(2006-12#1)(2006-3#2)(2008-10#3)(2008-3#1)(2008-4#1)(2008-8#1)
salt bridges##5##2##(1991-6#1)(1995-1#1)(1996-8#1)(2006-2#1)(2006-4#1)
salt buffer##3##2##(1995-6#3)
salt by ion chromatography with##2##5##(1990-9#1)(2008-10#1)
salt by##6##2##(1990-9#1)(2005-4#2)(2006-10#1)(2008-10#2)
salt can##2##2##(1990-6#1)(2008-10#1)
salt concentration and pH##2##4##(2009-12#1)(2012-12#1)
salt concentration and##6##3##(1990-5#1)(1991-1#1)(2005-11#1)(2009-12#1)(2012-12#2)
salt concentration of##2##3##(2008-5#1)(2013-8#1)
salt concentration##30##2##(1990-12#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-5#1)(1991-8#1)(1994-11#1)(1994-8#1)(1996-7#1)(1997-2#1)(1997-5#1)(1997-6#1)(2005-11#3)(2006-12#2)(2008-10#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-12#1)(2012-12#2)(2012-2#1)(2013-8#2)
salt concentrations##20##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-3#1)(1991-7#1)(1993-11#1)(1994-11#2)(1995-5#1)(1997-3#1)(2005-12#1)(2008-10#2)(2008-12#2)(2008-5#2)(2008-6#1)(2010-4#1)(2011-2#1)
salt conditions##2##2##(2009-8#1)(2013-1#1)
salt consumption in##2##3##(2013-1#2)
salt consumption##5##2##(2011-2#1)(2012-2#1)(2013-1#3)
salt content##7##2##(1996-5#1)(2005-12#1)(2008-10#4)(2010-4#1)
salt diffusion##3##2##(2005-11#3)
salt does not##2##3##(1994-11#1)(2013-1#1)
salt during##2##2##(1995-3#1)(2013-1#1)
salt effect##4##2##(1990-5#1)(1997-1#2)(2007-8#1)
salt effects on##2##3##(2009-10#1)(2012-2#1)
salt environment##2##2##(1994-12#1)(2008-11#1)
salt environments##2##2##(2009-6#2)
salt gradient##3##2##(1992-11#2)(2008-7#1)
salt in the diet##2##4##(2008-4#1)(2013-1#1)
salt in the##4##3##(2008-4#1)(2012-11#1)(2013-1#2)
salt in##10##2##(2007-2#1)(2008-10#1)(2008-4#1)(2012-11#1)(2012-2#2)(2013-1#4)
salt increased##2##2##(2008-5#1)(2013-1#1)
salt intake in##2##3##(2012-2#1)(2013-1#1)
salt intake is##2##3##(2013-1#2)
salt intake of##2##3##(2012-12#1)(2013-1#1)
salt intake##22##2##(1995-5#1)(1997-8#1)(2008-1#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#13)
salt iodization##4##2##(2007-11#2)(2013-1#2)
salt is##9##2##(1990-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2009-6#1)(2013-1#1)
salt linkages##2##2##(1990-8#1)(1997-2#1)
salt loading##3##2##(1992-8#1)(1996-8#1)(2008-10#1)
salt loss##3##2##(1995-4#1)(2006-4#1)(2006-9#1)
salt marsh##2##2##(2006-6#2)
salt of a##3##3##(1997-2#1)(2007-10#2)
salt of the##2##3##(2008-10#2)
salt of##26##2##(1991-11#1)(1992-9#1)(1993-4#1)(1995-3#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-10#2)(2007-11#1)(2007-8#1)(2008-10#11)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)
salt on the##4##3##(2005-11#1)(2008-5#1)(2010-4#2)
salt or##3##2##(1997-1#1)(2008-2#1)(2008-5#1)
salt programs##2##2##(2007-11#2)
salt reduction##3##2##(2013-1#3)
salt restriction##7##2##(1991-9#1)(1995-9#4)(2009-4#1)(2009-8#1)
salt samples were collected from##2##5##(2007-2#2)
salt samples were##4##3##(2007-2#3)(2013-1#1)
salt samples##12##2##(2006-4#2)(2007-2#4)(2008-10#5)(2013-1#1)
salt sensitivity of blood pressure##2##5##(2008-7#2)
salt signal##2##2##(2009-6#2)
salt signaling##4##2##(2009-8#4)
salt sodium##2##2##(2005-11#1)(2011-1#1)
salt solution##15##2##(1991-5#1)(1993-9#1)(1996-10#1)(1997-2#1)(2004-9#1)(2008-5#2)(2008-6#1)(2009-5#3)(2010-3#1)(2010-4#1)(2010-8#1)(2013-1#1)
salt solutions##14##2##(1991-5#2)(1996-5#1)(1997-8#2)(2008-10#5)(2009-10#1)(2009-12#1)(2010-4#1)(2012-3#1)
salt split technique##4##3##(2007-7#4)
salt split##6##2##(2007-7#6)
salt stress and nonstress##2##4##(2008-9#2)
salt stress in bryophytes##3##4##(2009-6#3)
salt stress in##6##3##(2008-11#1)(2009-10#1)(2009-6#3)(2009-8#1)
salt stress responses in Arabidopsis##2##5##(1997-8#2)
salt stress##33##2##(1997-7#1)(1997-8#3)(2008-11#2)(2008-12#2)(2008-8#1)(2008-9#5)(2009-10#2)(2009-6#8)(2009-8#8)(2012-11#1)
salt stress-inducible ESTs##2##3##(1997-8#2)
salt taste sensitivity##2##3##(2011-2#2)
salt taste##4##2##(2006-12#1)(2007-9#1)(2011-2#2)
salt technique##2##2##(2013-1#2)
salt to##4##2##(1996-6#1)(2008-4#1)(2009-9#1)(2012-12#1)
salt tolerance in##3##3##(2008-9#2)(2009-8#1)
salt tolerance##10##2##(1996-5#2)(2008-12#1)(2008-9#4)(2009-8#1)(2011-2#1)(2012-11#1)
salt tolerant##9##2##(2008-12#7)(2011-12#1)(2013-1#1)
salt was found##2##3##(2008-5#2)
salt was##9##2##(2005-4#1)(2008-10#3)(2008-5#4)(2008-9#1)
salt wasting syndrome##3##3##(2006-4#3)
salt wasting##4##2##(2006-4#3)(2007-7#1)
salt water##2##2##(2006-10#1)(2007-12#1)
salt were##2##2##(2005-4#1)(2008-10#1)
salt with##3##2##(1997-2#1)(2008-5#1)(2013-1#1)
salt##676##1##(1990-10#1)(1990-12#8)(1990-2#6)(1990-5#6)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#4)(1991-1#2)(1991-11#1)(1991-12#1)(1991-3#2)(1991-4#1)(1991-5#6)(1991-6#2)(1991-7#3)(1991-8#1)(1991-9#1)(1992-11#3)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#3)(1993-11#1)(1993-2#3)(1993-3#5)(1993-4#1)(1993-6#3)(1993-8#3)(1993-9#5)(1994-10#1)(1994-11#5)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#4)(1995-11#3)(1995-3#4)(1995-4#2)(1995-5#3)(1995-6#7)(1995-9#5)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#5)(1996-6#4)(1996-7#1)(1996-8#3)(1997-1#3)(1997-2#14)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#12)(2004-9#1)(2005-11#15)(2005-12#2)(2005-4#6)(2006-10#10)(2006-12#4)(2006-2#2)(2006-3#2)(2006-4#11)(2006-5#1)(2006-6#3)(2006-9#3)(2007-10#2)(2007-11#14)(2007-12#8)(2007-2#11)(2007-4#1)(2007-5#1)(2007-7#8)(2007-8#8)(2007-9#3)(2008-1#1)(2008-10#105)(2008-11#9)(2008-12#12)(2008-2#3)(2008-3#4)(2008-4#14)(2008-5#32)(2008-6#3)(2008-7#9)(2008-8#8)(2008-9#14)(2009-10#5)(2009-12#2)(2009-4#1)(2009-5#3)(2009-6#16)(2009-8#17)(2009-9#1)(2010-1#1)(2010-2#1)(2010-3#3)(2010-4#10)(2010-5#4)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#9)(2012-1#2)(2012-11#4)(2012-12#5)(2012-2#15)(2012-3#2)(2013-1#57)(2013-8#4)
salt) and##2##2##(2008-10#2)
salt)##10##1##(1994-12#1)(1995-10#1)(2008-10#7)(2008-5#1)
salt-bridge or##2##2##(1992-8#1)(2006-4#1)
salt-bridge structure##7##2##(1996-7#1)(2006-2#6)
salt-bridge structures in##2##3##(1996-7#1)(2006-2#1)
salt-bridge structures##3##2##(1996-7#1)(2006-2#1)(2006-4#1)
salt-bridge##19##1##(1992-8#1)(1996-7#2)(2006-2#9)(2006-3#3)(2006-4#4)
salt-bridges##3##1##(1991-5#2)(1995-6#1)
salt-free shampoo##2##2##(2008-5#2)
salt-free##7##1##(2006-10#1)(2008-5#4)(2009-11#1)(2010-5#1)
salt-induced change in##2##3##(2008-7#2)
salt-induced root##2##2##(2009-6#1)(2009-8#1)
salt-induced##9##1##(1990-5#1)(1992-8#1)(1995-5#1)(2004-4#2)(2008-7#2)(2009-6#1)(2009-8#1)
salt-relief##2##1##(2008-5#2)
salt-sensitive phenotype##3##2##(1996-5#1)(2009-8#2)
salt-sensitive##5##1##(1990-8#1)(1991-12#1)(1996-5#1)(2009-8#2)
salt-soluble##2##1##(1995-12#1)(2010-4#1)
salt-stress##2##1##(2008-9#1)(2009-8#1)
salt-stressed barley##2##2##(2008-9#2)
salt-tolerant##3##1##(2008-8#1)(2009-8#2)
salt/sodium##4##1##(2013-1#4)
salt]##2##1##(2005-4#1)(2011-2#1)
saltation##2##1##(2012-3#2)
saltatory##3##1##(2008-12#1)(2009-3#1)(2010-8#1)
saltcedar##4##1##(2011-12#4)
salted food##2##2##(2011-2#2)
salted meat##4##2##(2011-2#4)
salted out##2##2##(1990-5#2)
salted##11##1##(1990-5#2)(1992-10#1)(2008-10#1)(2011-2#7)
saltern ponds##2##2##(2007-3#1)(2012-2#1)
saltiness##3##1##(1990-9#1)(2010-4#1)(2011-2#1)
salting in&quot##4##2##(2005-11#4)
salting out##2##2##(2008-10#1)(2013-1#1)
salting out&quot##3##2##(2005-11#3)
salting##11##1##(2005-11#7)(2008-10#2)(2011-2#1)(2013-1#1)
salting-out##7##1##(1990-5#3)(2008-10#4)
salts and their##2##3##(2007-11#2)
salts and##15##2##(1993-2#1)(1995-7#1)(1995-8#1)(2007-11#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2011-2#1)
salts are used##2##3##(1994-6#1)(2009-8#1)
salts are##6##2##(1994-6#1)(1996-2#1)(2008-10#2)(2008-11#1)(2009-8#1)
salts as##5##2##(1990-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-6#1)
salts at different##2##3##(1992-5#1)(2008-10#1)
salts at##4##2##(1992-5#1)(2008-10#2)(2011-2#1)
salts do not##2##3##(2005-11#1)(2008-10#1)
salts do##3##2##(2005-11#1)(2008-10#1)(2009-10#1)
salts for##2##2##(2007-11#1)(2008-11#1)
salts has##2##2##(2005-11#1)(2008-10#1)
salts have##3##2##(1995-3#1)(1996-5#1)(2008-10#1)
salts in solution##2##3##(2008-10#2)
salts in##14##2##(1990-11#1)(1992-11#1)(2005-11#1)(2007-11#1)(2008-10#6)(2008-5#4)
salts is##3##2##(2008-10#1)(2008-3#2)
salts medium##4##2##(2008-10#1)(2008-6#3)
salts of the##4##3##(1995-3#1)(1995-5#1)(1997-2#1)(2008-5#1)
salts of##17##2##(1992-9#1)(1993-11#1)(1995-3#1)(1995-5#1)(1997-2#1)(2005-11#1)(2007-10#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-5#1)
salts on the##5##3##(1990-2#1)(1991-5#1)(1994-5#1)(2005-11#1)(2008-10#1)
salts on##8##2##(1990-2#1)(1991-5#1)(1994-5#1)(2005-11#3)(2008-10#1)(2009-10#1)
salts or##3##2##(1994-11#1)(1996-8#1)(2006-10#1)
salts such as##4##3##(2006-4#1)(2007-11#1)(2008-10#2)
salts to##4##2##(1992-8#1)(1993-2#1)(2008-11#1)(2008-5#1)
salts upon##2##2##(2008-10#2)
salts was##4##2##(1997-2#1)(2005-11#1)(2007-11#1)(2008-10#1)
salts were##11##2##(1995-3#1)(1996-2#1)(2007-11#3)(2008-5#3)(2009-8#1)(2010-4#2)
salts which##2##2##(2005-11#1)(2007-11#1)
salts with##6##2##(1996-2#1)(2007-11#1)(2007-3#1)(2008-10#1)(2009-8#1)(2012-2#1)
salts##266##1##(1990-11#1)(1990-2#4)(1990-3#1)(1990-5#2)(1990-8#3)(1990-9#1)(1991-4#2)(1991-5#3)(1991-7#3)(1991-9#1)(1992-11#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#3)(1993-3#1)(1994-11#1)(1994-5#4)(1994-6#1)(1994-9#3)(1995-3#6)(1995-5#3)(1995-7#1)(1995-8#2)(1996-11#1)(1996-2#5)(1996-5#3)(1996-8#1)(1997-2#4)(1997-8#4)(2005-10#1)(2005-11#17)(2006-10#2)(2006-12#2)(2006-4#1)(2007-10#3)(2007-11#20)(2007-3#1)(2007-8#4)(2008-10#73)(2008-11#9)(2008-12#1)(2008-3#4)(2008-4#3)(2008-5#18)(2008-6#4)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#2)(2009-2#2)(2009-6#1)(2009-8#3)(2010-12#1)(2010-3#1)(2010-4#2)(2010-6#1)(2011-1#1)(2011-2#5)(2012-11#1)(2012-2#2)(2012-3#3)(2012-7#1)(2013-1#1)
salts)##5##1##(1997-5#1)(2005-11#1)(2008-11#1)(2008-3#1)(2011-1#1)
saltwater##4##1##(2007-12#1)(2010-3#2)(2012-3#1)
saltworks##2##1##(2008-5#2)
salty##4##1##(1993-2#1)(1996-1#1)(2006-12#2)
salutary effect##2##2##(1994-3#1)(2007-7#1)
salutary effects##2##2##(2007-8#1)(2013-1#1)
salutary##9##1##(1994-3#1)(1997-7#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2010-4#1)(2013-1#1)(2013-8#1)
salutogenic##2##1##(2005-10#1)(2006-6#1)
salvage and##2##2##(1991-2#1)(2006-7#1)
salvage by##4##2##(2007-7#1)(2008-4#1)(2008-6#1)(2011-3#1)
salvage chemotherapy in heavily pretreated##2##5##(1992-2#2)
salvage chemotherapy in##3##3##(1992-2#3)
salvage chemotherapy##8##2##(1992-10#1)(1992-2#3)(2007-10#1)(2008-1#2)(2008-6#1)
salvage in##3##2##(2008-1#1)(2011-2#1)(2012-3#1)
salvage is##3##2##(2008-4#1)(2010-3#1)(2011-1#1)
salvage ischemic##2##2##(2007-8#1)(2007-9#1)
salvage mastectomy##3##2##(1996-6#1)(2013-1#2)
salvage of the##2##3##(2007-7#1)(2008-10#1)
salvage of##9##2##(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-2#1)
salvage or##2##2##(2008-9#1)(2009-9#1)
salvage pathway##5##2##(1991-1#1)(1995-8#1)(1996-10#2)(1997-8#1)
salvage patients##4##2##(2007-8#1)(2008-6#1)(2010-3#2)
salvage procedure##2##2##(2006-10#1)(2012-12#1)
salvage procedures##2##2##(1993-8#1)(2006-3#1)
salvage radiation therapy##3##3##(2006-9#3)
salvage radiation##4##2##(2006-9#4)
salvage resection##2##2##(2012-3#2)
salvage surgery##6##2##(1990-12#1)(1990-6#1)(2006-10#1)(2008-8#1)(2010-3#1)(2012-2#1)
salvage the##3##2##(2007-8#2)(2011-1#1)
salvage therapy##6##2##(2007-10#1)(2008-1#1)(2008-5#1)(2010-4#1)(2011-2#1)(2013-1#1)
salvage treatment for##2##3##(1991-12#1)(2008-3#1)
salvage treatment##6##2##(1991-12#2)(1991-6#1)(2008-3#1)(2010-3#1)(2011-2#1)
salvage was##3##2##(1991-8#1)(2010-3#1)(2011-2#1)
salvage with a##2##3##(2007-8#1)(2008-8#1)
salvage##123##1##(1990-12#1)(1990-6#3)(1991-1#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-2#3)(1992-8#1)(1993-8#1)(1994-4#1)(1995-10#1)(1995-8#1)(1996-10#2)(1996-6#1)(1997-8#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-9#5)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#7)(2007-9#1)(2008-1#4)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#8)(2008-8#2)(2008-9#3)(2009-1#2)(2009-10#1)(2009-5#1)(2009-9#5)(2010-10#1)(2010-11#1)(2010-3#7)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#5)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#5)
salvageable tissue##4##2##(2007-9#4)
salvageable##8##1##(2006-10#1)(2007-9#6)(2008-7#1)
salvaged with##3##2##(2008-6#1)(2009-3#1)(2011-2#1)
salvaged##9##1##(1991-1#1)(1997-5#1)(2007-8#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#1)
salvaging##3##1##(2008-2#1)(2010-12#1)(2012-2#1)
salvation of##2##2##(2006-12#1)(2007-8#1)
salvation to##2##2##(2008-5#2)
salvation##6##1##(2006-12#1)(2007-8#1)(2008-4#1)(2008-5#2)(2009-11#1)
salvational process##2##2##(2009-11#2)
salvia miltiorrhiza pretreatment##3##3##(2010-12#3)
salvia miltiorrhiza##4##2##(2010-12#4)
salvianolic acid##2##2##(2008-10#2)
salvianolic acids from##2##3##(2008-10#2)
salvianolic acids##4##2##(2008-10#4)
salvianolic##6##1##(2008-10#6)
salvinorin##10##1##(2008-7#1)(2009-2#4)(2009-3#5)
samarium hydroxide##3##2##(2008-10#3)
samarium iodide##3##2##(2008-10#3)
samarium##16##1##(2005-4#1)(2007-11#1)(2008-10#13)(2012-2#1)
samarium(III)##2##1##(2008-10#2)
samarium-cobalt magnet##3##2##(2008-10#3)
sambucinum##3##1##(2008-10#3)
same &quot##3##2##(1994-3#1)(2008-1#1)(2008-7#1)
same VCG##3##2##(2008-10#3)
same active##4##2##(1994-2#1)(2008-10#1)(2008-4#1)(2008-5#1)
same advantages##2##2##(1994-2#1)(2012-1#1)
same affinity##7##2##(1990-11#1)(1990-2#1)(1991-7#1)(1994-9#1)(1996-5#2)(2008-10#1)
same age and sex##3##4##(1990-11#1)(1991-11#1)(2008-7#1)
same age and##6##3##(1990-11#1)(1991-11#1)(2006-4#1)(2008-7#1)(2012-2#1)(2013-1#1)
same age control plants at 14##2##6##(2008-10#2)
same age control##3##3##(2008-10#3)
same age group##10##3##(1990-2#1)(1990-6#1)(1992-4#1)(2004-2#1)(2008-1#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
same age##42##2##(1990-11#2)(1990-2#1)(1990-6#1)(1991-11#2)(1991-12#2)(1991-9#2)(1992-10#1)(1992-4#1)(1994-12#1)(1995-9#1)(1996-6#1)(1997-5#1)(2004-11#1)(2004-2#1)(2006-10#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-12#1)(2008-1#3)(2008-10#3)(2008-12#1)(2008-7#2)(2009-4#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
same amino acid##11##3##(1990-10#1)(1990-12#1)(1991-6#1)(1992-5#1)(1992-7#1)(1993-11#1)(1994-12#1)(1995-3#1)(2013-8#3)
same amino##13##2##(1990-10#1)(1990-12#1)(1991-6#1)(1992-5#1)(1992-7#1)(1993-11#1)(1994-12#2)(1995-3#1)(2008-8#1)(2013-8#3)
same amount of##14##3##(1990-2#1)(1993-7#1)(1996-1#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
same amount##21##2##(1990-2#1)(1992-1#1)(1992-9#1)(1993-7#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-2#1)(2006-7#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
same analysis##4##2##(1990-5#1)(1997-2#1)(2008-10#1)(2008-7#1)
same and different##3##3##(1995-12#1)(1996-6#1)(2008-3#1)
same and##8##2##(1990-4#1)(1993-8#1)(1995-12#1)(1996-6#1)(2007-3#1)(2007-7#1)(2008-3#1)(2012-1#1)
same animals were##5##3##(1991-5#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-6#1)
same animals##12##2##(1990-4#1)(1991-5#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-6#1)(1996-3#1)(1996-4#1)(2004-9#1)
same antibodies##2##2##(1991-9#1)(1994-3#1)
same antibody##6##2##(1993-11#1)(1996-7#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-7#1)
same applies to##3##3##(1990-9#1)(1994-9#1)(2006-8#1)
same approach has##2##3##(2010-12#1)(2011-2#1)
same approach##11##2##(1992-5#1)(1996-11#1)(2008-10#1)(2008-4#3)(2008-6#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)
same as that of##30##4##(1990-10#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-7#1)(1991-9#1)(1992-3#1)(1993-9#1)(1994-8#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(2005-11#1)(2007-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#2)(2008-8#2)(2011-1#1)(2011-12#1)(2013-8#1)
same as that##51##3##(1990-10#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-7#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-6#1)(2004-12#1)(2004-8#1)(2005-11#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#4)(2008-8#3)(2008-9#1)(2010-1#1)(2011-1#1)(2011-12#1)(2013-8#1)
same as##172##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#3)(1990-5#3)(1990-6#1)(1990-7#3)(1990-8#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-2#2)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#3)(1995-10#1)(1995-12#1)(1995-2#4)(1995-3#4)(1995-5#2)(1995-6#2)(1995-8#5)(1996-11#3)(1996-12#1)(1996-3#2)(1996-6#2)(1996-8#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-12#1)(2004-8#1)(2005-11#3)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#15)(2008-11#1)(2008-2#7)(2008-3#5)(2008-4#3)(2008-5#4)(2008-7#2)(2008-8#5)(2008-9#3)(2009-1#1)(2009-12#1)(2009-5#1)(2009-6#3)(2009-8#1)(2010-1#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
same bacteria##2##2##(2006-8#1)(2008-10#1)
same bacterial##3##2##(2008-10#1)(2011-2#1)(2012-12#1)
same behavior##5##2##(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-1#1)
same can be##2##3##(1991-6#1)(2006-6#1)
same can##4##2##(1991-6#1)(2006-6#1)(2007-11#1)(2007-6#1)
same capillary##2##2##(1996-5#1)(2008-10#1)
same cases##2##2##(1990-5#1)(2008-5#1)
same cell lines##2##3##(1991-9#1)(1993-6#1)
same cell##26##2##(1990-12#1)(1990-5#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-6#1)(1993-9#1)(1995-3#2)(1995-8#2)(1996-10#1)(1997-1#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-4#3)(2008-8#2)(2008-9#2)(2009-12#1)(2013-1#1)(2013-8#1)
same cells were##2##3##(1992-12#1)(1996-5#1)
same cells##14##2##(1990-11#1)(1990-7#1)(1990-8#1)(1991-8#1)(1992-12#1)(1992-6#1)(1994-12#2)(1994-3#1)(1996-5#2)(2008-11#1)(2008-4#1)(2013-1#1)
same characteristics##5##2##(1994-9#1)(2005-11#1)(2008-4#1)(2008-5#1)(2013-1#1)
same chromosomal##4##2##(1993-12#1)(1994-7#1)(2008-10#2)
same clinical##4##2##(1993-11#1)(1996-9#1)(2009-8#1)(2011-2#1)
same cognitive##3##2##(2006-3#1)(2007-5#1)(2008-4#1)
same compounds##9##2##(1991-5#1)(1992-5#1)(1993-3#1)(1996-4#1)(2007-8#1)(2008-10#2)(2008-4#2)
same concentrations of##7##3##(1990-2#1)(1990-8#1)(1992-7#1)(1995-1#1)(2008-10#1)(2008-7#1)(2013-8#1)
same concentrations##15##2##(1990-2#1)(1990-8#1)(1991-9#1)(1992-7#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-6#1)(2006-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2013-8#1)
same concerns##2##2##(2008-3#1)(2009-4#1)
same condition##8##2##(1991-5#1)(1994-9#1)(1996-11#1)(2005-10#1)(2006-10#2)(2010-2#1)(2013-1#1)
same conditions##66##2##(1990-2#2)(1990-4#1)(1990-5#1)(1991-3#2)(1991-4#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-3#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-7#1)(1996-9#2)(1997-8#1)(2004-9#1)(2005-4#1)(2006-5#1)(2006-8#1)(2007-12#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-4#1)(2011-2#2)(2013-8#2)
same consensus##3##2##(1993-2#1)(1993-6#1)(1994-9#1)
same constant##3##2##(1995-5#1)(2008-10#1)(2008-3#1)
same cortical##2##2##(2006-8#1)(2011-2#1)
same data##13##2##(1990-12#2)(1996-12#1)(1997-2#1)(2004-9#1)(2007-11#2)(2008-10#1)(2008-7#1)(2010-4#1)(2012-2#1)(2013-1#2)
same day##18##2##(1994-10#1)(1995-5#1)(1995-7#1)(1997-3#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
same developmental##6##2##(1994-12#1)(1994-3#1)(1995-2#1)(2007-12#2)(2008-9#1)
same device##2##2##(2008-3#1)(2008-5#1)
same dimensions##4##2##(1992-2#1)(2004-9#1)(2007-11#1)(2013-1#1)
same distance##2##2##(1995-2#1)(2013-8#1)
same domain##3##2##(1993-8#1)(1997-2#1)(2009-10#1)
same dose of##10##3##(1994-8#1)(1995-3#1)(1996-1#1)(1996-10#2)(1997-4#1)(2007-1#1)(2008-5#1)(2009-6#1)(2012-3#1)
same dose##19##2##(1992-5#1)(1992-6#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-3#1)(1996-1#1)(1996-10#3)(1996-6#1)(1997-4#1)(1997-7#1)(2007-1#1)(2008-5#1)(2008-6#1)(2009-6#1)(2010-11#1)(2012-3#1)
same doses of##5##3##(1991-2#1)(1995-12#1)(1996-6#1)(2008-10#1)(2009-6#1)
same doses##11##2##(1991-2#1)(1993-4#1)(1995-12#1)(1996-6#1)(2005-3#1)(2008-10#1)(2008-8#1)(2008-9#3)(2009-6#1)
same dosing##2##2##(1992-7#1)(1996-5#1)
same drugs##4##2##(1992-6#1)(1995-8#1)(2007-7#1)(2008-4#1)
same duration of##2##3##(2008-7#1)(2012-3#1)
same duration##6##2##(2006-4#1)(2008-7#2)(2012-2#1)(2012-3#2)
same effect on##7##3##(1991-8#1)(1995-1#1)(1995-12#1)(2006-6#1)(2007-2#1)(2008-10#1)(2009-3#1)
same effect##20##2##(1990-10#1)(1990-2#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-6#1)(1994-5#1)(1995-1#1)(1995-12#2)(1997-4#1)(2005-11#1)(2006-6#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-3#1)
same effects##4##2##(1990-1#1)(1990-2#1)(2008-10#1)(2008-2#1)
same environmental##5##2##(1993-7#1)(1994-6#1)(2008-1#1)(2008-10#1)(2011-1#1)
same enzyme##7##2##(1990-11#1)(1990-12#1)(1992-1#1)(1993-1#1)(1994-8#1)(1995-6#1)(2008-11#1)
same experimental conditions##17##3##(1990-10#1)(1990-8#2)(1995-12#2)(1997-2#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-5#1)(2010-12#1)
same experimental##27##2##(1990-10#1)(1990-8#2)(1993-4#1)(1995-12#2)(1996-10#1)(1997-2#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-2#1)(2012-1#1)(2013-8#1)
same experiments##4##2##(1996-2#1)(2007-8#1)(2008-10#1)(2008-3#1)
same faces##2##2##(2008-5#1)(2009-4#1)
same factors##5##2##(2007-12#1)(2008-11#1)(2008-3#1)(2009-11#1)(2011-12#1)
same forces##2##2##(2007-5#1)(2008-11#1)
same fortified##2##2##(2006-10#1)(2008-10#1)
same four##8##2##(1990-4#1)(1992-11#1)(1997-5#1)(2007-12#1)(2007-9#1)(2008-10#2)(2011-2#1)
same fragments##2##2##(1992-11#1)(2008-9#1)
same functional##4##2##(1991-2#1)(1992-6#1)(1995-11#1)(2008-2#1)
same gender sexual partners##3##4##(2011-1#3)
same gender##4##2##(2008-9#1)(2011-1#3)
same gene or##2##3##(2008-10#1)(2012-3#1)
same gene##32##2##(1990-2#1)(1991-11#1)(1991-4#1)(1992-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-9#2)(1995-3#2)(1995-8#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#6)(2010-7#1)(2011-1#1)(2012-3#3)
same general mechanism##2##3##(2006-9#1)(2009-12#1)
same general##6##2##(1997-5#1)(2006-9#1)(2007-9#1)(2008-10#1)(2009-12#1)(2010-12#1)
same genes##3##2##(1995-1#1)(2008-8#1)(2010-12#1)
same genetic##12##2##(1993-2#1)(1994-12#1)(2006-2#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
same group of##6##3##(1993-8#1)(1995-7#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
same group##19##2##(1993-8#1)(1995-4#1)(1995-7#2)(1997-6#2)(2007-11#1)(2007-6#1)(2008-10#3)(2008-6#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
same grouping##2##2##(2008-10#1)(2008-5#1)
same groups of##4##3##(1991-11#1)(1991-2#1)(2008-10#2)
same groups##7##2##(1991-11#1)(1991-2#1)(2006-5#1)(2008-10#2)(2010-2#1)(2012-2#1)
same growth##2##2##(1991-5#1)(2007-1#1)
same guidelines##3##2##(1995-9#1)(2009-6#1)(2012-1#1)
same high##7##2##(1994-3#1)(1995-1#1)(1995-10#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-6#1)
same hospital##11##2##(1991-2#1)(1991-3#1)(1996-1#2)(1997-8#1)(2004-10#1)(2007-12#4)(2011-12#1)
same host##11##2##(1996-5#1)(1997-3#1)(2006-10#1)(2008-10#5)(2008-6#1)(2008-9#1)(2010-12#1)
same in both the##2##4##(2008-1#1)(2012-12#1)
same in both##11##3##(1991-2#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-1#1)(1996-7#1)(2004-11#1)(2008-1#1)(2008-11#1)(2012-12#1)
same in the##13##3##(1992-11#1)(1993-11#1)(1996-11#1)(1996-9#1)(1997-1#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-5#2)(2009-9#1)
same in##56##2##(1990-2#1)(1990-5#1)(1991-11#1)(1991-2#4)(1991-4#1)(1991-7#1)(1992-11#1)(1992-4#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-6#1)(1995-1#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-11#2)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#1)(2004-11#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-4#3)(2008-5#2)(2008-9#1)(2009-10#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
same individual##14##2##(1990-4#1)(1996-3#1)(2006-10#2)(2006-7#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-6#1)(2012-3#2)(2013-7#1)
same induction##2##2##(1991-9#1)(2008-10#1)
same input##2##2##(2008-10#1)(2008-11#1)
same institution##5##2##(1990-6#1)(2007-1#1)(2008-2#1)(2008-9#1)(2011-2#1)
same is not true for##3##5##(2008-10#1)(2013-1#2)
same is probably true##2##4##(1990-12#1)(2006-2#1)
same is##9##2##(1990-12#1)(2006-2#1)(2008-10#3)(2008-3#1)(2012-2#1)(2013-1#2)
same kind of##7##3##(1991-12#1)(1997-3#1)(2007-8#2)(2008-10#2)(2013-1#1)
same lesions##4##2##(1991-1#1)(2006-6#1)(2007-10#1)(2008-10#1)
same location##19##2##(1996-11#1)(1996-3#1)(1997-7#1)(2007-12#2)(2008-10#4)(2008-2#3)(2008-3#4)(2010-11#1)(2011-1#1)(2013-1#1)
same locus##9##2##(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-7#1)(2012-11#1)
same manner##23##2##(1991-5#1)(1991-8#2)(1992-8#1)(1994-2#1)(1997-6#1)(2005-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-5#2)(2009-3#1)(2009-6#1)(2010-2#1)(2010-5#2)(2012-2#1)
same mapping population##2##3##(2008-10#1)(2008-5#1)
same marker##2##2##(2008-10#1)(2012-1#1)
same mechanisms##6##2##(2006-10#1)(2007-12#1)(2010-10#1)(2010-5#1)(2012-11#1)(2012-12#1)
same medium##9##2##(1991-3#1)(1992-6#1)(1994-5#1)(2005-11#1)(2007-1#1)(2008-10#2)(2008-11#1)(2011-1#1)
same method##7##2##(1995-2#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2013-8#1)
same methodology##5##2##(1993-6#1)(1995-2#1)(2006-8#1)(2007-12#1)(2013-1#1)
same mode##3##2##(1992-5#1)(2008-9#1)(2013-1#1)
same moisturizer##3##2##(2008-5#3)
same molecular weight##7##3##(1992-3#1)(1994-11#1)(1994-2#1)(1994-9#1)(2007-11#1)(2008-3#2)
same molecular##16##2##(1990-11#1)(1990-5#1)(1990-8#1)(1992-3#1)(1992-8#1)(1994-11#1)(1994-2#1)(1994-9#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-3#2)(2009-8#1)(2010-4#1)
same month##3##2##(2008-5#1)(2008-6#1)(2012-2#1)
same mouse##2##2##(1995-2#1)(2008-10#1)
same mutants also##2##3##(1996-8#1)(2011-1#1)
same mutants##3##2##(1994-8#1)(1996-8#1)(2011-1#1)
same mutation##7##2##(1990-12#1)(1993-6#1)(1994-11#1)(1994-3#1)(2007-10#1)(2008-10#1)(2010-10#1)
same mutations##3##2##(1993-11#1)(1994-12#1)(1994-8#1)
same nerve##4##2##(1992-3#1)(2008-5#1)(2008-6#1)(2008-7#1)
same neurons##2##2##(1995-12#1)(1996-9#1)
same number of##11##3##(1990-11#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-5#1)
same old##4##2##(1994-1#1)(1995-3#1)(1996-12#1)(2010-12#1)
same or different##6##3##(1996-10#1)(2005-12#1)(2008-12#1)(2008-3#1)(2008-6#1)(2012-12#1)
same or##31##2##(1991-2#1)(1993-1#1)(1993-11#1)(1994-3#1)(1996-10#1)(1996-2#2)(1996-6#2)(1996-9#1)(2005-11#1)(2005-12#1)(2006-6#1)(2007-6#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-8#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
same order##32##2##(1990-3#1)(1991-11#2)(1991-2#1)(1991-5#2)(1992-11#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-11#2)(1994-6#1)(1995-10#1)(1995-6#1)(1997-2#1)(2004-11#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-4#1)(2007-11#2)(2007-12#2)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
same organism##10##2##(1990-2#1)(1990-3#1)(1990-9#1)(1993-6#1)(1995-2#1)(1997-6#1)(2007-8#1)(2008-10#1)(2009-3#1)(2013-1#1)
same pH##5##2##(1990-6#1)(1991-7#1)(1994-8#1)(2008-10#2)
same parameters##7##2##(1990-5#1)(2004-11#1)(2007-7#2)(2008-2#1)(2008-5#1)(2010-8#1)
same parts##2##2##(1997-8#1)(2011-2#1)
same pathology##2##2##(2006-9#1)(2013-1#1)
same patients were##3##3##(1991-4#1)(2007-9#1)(2008-1#1)
same patients##15##2##(1990-5#1)(1990-6#1)(1991-4#1)(1993-4#1)(1996-8#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
same pattern of response##2##4##(1990-6#1)(2008-10#1)
same pattern of##8##3##(1990-6#1)(1991-2#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#1)(2008-10#1)(2008-11#1)
same pattern##27##2##(1990-12#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-12#2)(1997-6#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2009-4#1)(2009-5#1)(2010-8#1)
same patterns##3##2##(1996-12#1)(2008-11#1)(2008-7#1)
same period##71##2##(1990-11#1)(1990-6#1)(1990-7#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-2#2)(1992-6#3)(1992-8#2)(1993-1#1)(1993-8#1)(1994-6#1)(1995-1#2)(1995-11#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-3#1)(2004-10#1)(2004-2#1)(2006-10#2)(2006-11#1)(2006-4#1)(2006-7#1)(2007-12#3)(2007-3#2)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#4)(2008-5#2)(2008-6#2)(2008-7#4)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#2)(2013-1#1)(2013-8#1)
same phenomenon##4##2##(2004-11#1)(2008-11#1)(2008-7#1)(2012-2#1)
same phenotype##10##2##(1992-3#1)(1994-3#1)(1996-6#1)(1997-6#1)(2007-11#1)(2008-10#3)(2009-10#1)(2012-12#1)
same plane##6##2##(2008-10#1)(2008-3#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#1)
same plants##2##2##(1994-6#1)(2006-3#1)
same population##19##2##(1990-12#1)(1990-7#1)(1991-2#1)(1992-2#1)(1994-5#1)(1995-12#1)(1997-3#1)(1997-4#2)(2008-10#6)(2008-8#1)(2011-2#1)(2012-12#2)
same populations##3##2##(1991-9#1)(2008-9#1)(2011-2#1)
same position##20##2##(1990-2#1)(1990-5#1)(1990-7#2)(1993-2#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-6#1)(1997-1#1)(2006-11#1)(2007-5#3)(2008-11#1)(2008-8#1)(2010-3#1)
same primer##2##2##(1992-2#1)(2008-10#1)
same primers##4##2##(1997-6#1)(1997-7#1)(2008-10#2)
same procedure was##3##3##(1993-12#1)(2008-10#1)(2012-12#1)
same procedure##11##2##(1992-8#1)(1993-12#1)(1995-2#1)(1995-6#1)(1996-3#1)(2006-8#1)(2008-10#2)(2008-8#1)(2009-6#1)(2012-12#1)
same procedures##6##2##(1996-12#1)(2004-11#1)(2006-4#1)(2007-1#1)(2008-5#1)(2008-9#1)
same process##4##2##(1996-2#1)(1997-3#1)(2007-6#1)(2008-5#1)
same proportion of##3##3##(1990-10#1)(1991-7#1)(1994-1#1)
same proportion##4##2##(1990-10#1)(1991-2#1)(1991-7#1)(1994-1#1)
same protein family##2##3##(2010-7#1)(2011-1#1)
same protein##16##2##(1990-11#2)(1991-10#1)(1991-11#1)(1991-2#1)(1992-7#1)(1993-6#1)(1995-6#1)(1996-7#1)(1997-4#1)(1997-6#1)(2006-10#1)(2008-2#1)(2010-7#1)(2011-1#1)(2012-2#1)
same quantity##2##2##(2005-11#1)(2006-8#1)
same rats##4##2##(1993-12#1)(1993-3#1)(1993-6#2)
same reagents##2##2##(1990-10#1)(2007-8#1)
same regimen##2##2##(1993-11#1)(2007-11#1)
same region of the##3##4##(1990-12#1)(1994-12#1)(1994-8#1)
same region of##5##3##(1990-12#1)(1992-11#1)(1994-12#1)(1994-8#1)(2008-1#1)
same region##20##2##(1990-10#1)(1990-12#1)(1991-3#1)(1992-11#1)(1993-10#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-8#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#2)(2011-1#2)
same relationship##2##2##(2007-8#1)(2008-10#1)
same result##9##2##(1990-11#1)(1994-11#2)(1994-6#1)(1996-2#1)(1997-4#1)(1997-6#1)(2005-10#1)(2008-3#1)
same results##15##2##(1990-12#1)(1997-2#1)(2005-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)(2010-12#1)(2010-6#1)(2012-1#1)(2012-2#2)(2013-7#1)(2013-8#1)
same risk##3##2##(2008-1#2)(2012-2#1)
same rules##3##2##(1997-2#1)(1997-3#1)(2006-10#1)
same sample##20##2##(1990-12#1)(1995-5#1)(2006-10#1)(2008-1#1)(2008-10#11)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#1)
same samples##15##2##(1991-12#1)(1993-6#1)(1996-8#1)(2008-10#9)(2008-3#1)(2010-4#1)(2013-8#1)
same search##2##2##(2005-7#1)(2008-1#1)
same sequence##14##2##(1991-10#1)(1992-2#1)(1993-6#1)(1996-5#1)(1996-8#1)(1997-4#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2013-1#1)
same set of##19##3##(1990-11#1)(1991-7#1)(1992-12#1)(1992-5#1)(1994-2#1)(1996-5#1)(1996-7#1)(2004-2#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)(2009-10#1)(2009-11#1)
same sex##7##2##(1994-5#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-9#2)(2011-1#1)
same side##12##2##(1990-5#1)(1991-1#1)(1991-9#1)(1995-11#1)(1996-8#1)(2006-9#1)(2007-12#1)(2008-10#1)(2011-2#2)(2012-3#1)(2013-1#1)
same site##29##2##(1990-5#3)(1990-9#1)(1992-5#1)(1993-11#1)(1995-12#1)(1995-5#3)(1996-5#1)(2003-11#1)(2007-6#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#2)
same sites in the##2##4##(1995-3#1)(2004-4#1)
same sites##6##2##(1995-12#1)(1995-3#1)(2004-4#1)(2006-5#1)(2008-10#1)(2008-11#1)
same size and##2##3##(2008-2#1)(2013-8#1)
same size##19##2##(1992-9#1)(1994-11#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-10#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-1#1)(2013-8#1)
same solvent##3##2##(1991-4#1)(2008-10#1)(2008-5#1)
same species##27##2##(1995-11#1)(1995-2#1)(1996-12#2)(2007-3#2)(2007-6#1)(2008-10#4)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2011-12#1)(2012-12#1)(2012-2#2)(2013-7#2)
same specificity##5##2##(1990-5#1)(1991-2#1)(1994-12#1)(2004-1#1)(2008-10#1)
same specimen##4##2##(2008-5#1)(2010-2#2)(2012-1#1)
same step##3##2##(1997-1#1)(2008-10#2)
same stimulation##3##2##(1991-7#1)(1994-2#1)(1996-1#1)
same strains##5##2##(1990-7#1)(1994-2#1)(1996-12#1)(2008-10#2)
same substitution##2##2##(1991-7#1)(1993-3#1)
same system is##2##3##(1996-1#1)(2008-10#1)
same system##10##2##(1991-2#1)(1994-2#1)(1996-1#1)(2007-12#1)(2008-10#3)(2008-2#1)(2010-5#1)(2012-2#1)
same techniques##2##2##(1995-2#1)(2005-11#1)
same technology##2##2##(2008-10#1)(2008-7#1)
same tendencies##2##2##(1996-2#1)(2007-3#1)
same tendency was##2##3##(1996-7#1)(2011-1#1)
same tendency##5##2##(1996-7#1)(2006-11#1)(2008-4#1)(2008-5#1)(2011-1#1)
same test##5##2##(1994-6#1)(2006-3#1)(2008-9#1)(2013-1#2)
same thickness and##2##3##(2007-11#2)
same thickness##4##2##(2006-6#1)(2007-11#2)(2007-12#1)
same three##6##2##(1994-2#1)(1994-9#1)(2008-10#3)(2009-12#1)
same time period##9##3##(1991-2#1)(1993-4#1)(2004-3#1)(2005-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2012-11#1)(2013-1#1)
same time##356##2##(1990-10#3)(1990-11#3)(1990-12#4)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#2)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-10#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-6#3)(1994-7#1)(1994-8#1)(1995-1#4)(1995-11#4)(1995-12#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#4)(1997-6#3)(1997-8#2)(2004-11#1)(2004-12#1)(2004-2#1)(2004-3#1)(2005-1#2)(2005-10#2)(2005-11#2)(2005-12#1)(2005-3#1)(2005-5#1)(2006-1#2)(2006-10#1)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#3)(2007-10#4)(2007-11#9)(2007-12#10)(2007-2#1)(2007-3#1)(2007-4#4)(2007-5#2)(2007-7#4)(2007-8#3)(2007-9#4)(2008-1#7)(2008-10#25)(2008-11#6)(2008-12#3)(2008-2#10)(2008-3#8)(2008-4#2)(2008-5#12)(2008-6#4)(2008-7#5)(2008-8#14)(2008-9#3)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#3)(2009-8#2)(2009-9#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#3)(2010-7#5)(2010-8#2)(2010-9#1)(2011-1#9)(2011-2#3)(2011-3#1)(2011-7#1)(2012-11#1)(2012-12#5)(2012-2#9)(2012-3#6)(2013-1#9)(2013-8#4)
same tissue##9##2##(1990-2#1)(1992-1#1)(1992-3#1)(1994-10#2)(1995-11#1)(1995-7#1)(2008-7#1)(2009-4#1)
same tissues##9##2##(1994-11#1)(1994-9#1)(1995-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)
same transcript##2##2##(1990-9#1)(1991-7#1)
same treatment for##3##3##(2007-7#2)(2008-6#1)
same treatment##20##2##(1990-11#1)(1990-6#1)(1990-7#1)(1991-2#1)(1993-6#1)(1994-6#1)(1994-8#1)(1996-7#1)(1997-7#1)(2007-7#2)(2008-10#1)(2008-11#2)(2008-5#2)(2008-6#1)(2008-8#1)(2012-3#1)(2013-8#1)
same trend in##2##3##(2007-1#1)(2008-11#1)
same trend##7##2##(1990-11#1)(1996-1#1)(1996-8#1)(2005-11#1)(2007-1#1)(2008-11#1)(2010-4#1)
same type of##16##3##(1990-9#1)(1992-6#1)(1992-9#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#2)(2009-5#1)
same type##23##2##(1990-9#1)(1992-6#2)(1992-9#1)(1995-12#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-4#2)(1997-6#2)(1997-7#1)(2004-2#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-9#1)(2009-5#1)(2012-2#1)
same types of##6##3##(1991-12#1)(1991-3#1)(1994-10#1)(1997-3#1)(2008-10#1)(2010-2#1)
same value##5##2##(1990-3#1)(1994-3#1)(2006-4#1)(2008-2#1)(2008-3#1)
same virus##7##2##(1991-3#1)(2005-9#1)(2008-10#2)(2008-8#2)(2010-4#1)
same volume of##3##3##(1990-7#1)(2012-3#2)
same volume##7##2##(1990-7#1)(1996-11#1)(2007-12#1)(2008-3#1)(2011-1#1)(2012-3#2)
same was found##2##3##(2008-10#1)(2011-2#1)
same was##7##2##(1992-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-2#1)
same wave-front##2##2##(2008-3#2)
same way##48##2##(1990-8#1)(1990-9#1)(1991-9#2)(1992-7#1)(1992-9#1)(1993-3#2)(1993-6#1)(1994-1#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-7#2)(2005-4#1)(2006-2#1)(2006-8#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#2)(2008-5#2)(2009-10#1)(2009-4#1)(2010-4#1)(2011-12#1)(2013-7#1)
same wheat##3##2##(2008-10#2)(2008-9#1)
same year the##2##3##(1990-4#1)(2008-8#1)
same year##10##2##(1990-10#1)(1990-4#1)(1991-2#1)(2004-11#1)(2008-1#1)(2008-10#2)(2008-8#1)(2012-1#1)(2013-1#1)
same##4923##1##(1990-1#2)(1990-10#23)(1990-11#24)(1990-12#33)(1990-2#36)(1990-3#11)(1990-4#15)(1990-5#37)(1990-6#13)(1990-7#21)(1990-8#18)(1990-9#13)(1991-1#6)(1991-10#9)(1991-11#16)(1991-12#23)(1991-2#33)(1991-3#23)(1991-4#13)(1991-5#24)(1991-6#11)(1991-7#16)(1991-8#18)(1991-9#26)(1992-1#11)(1992-10#11)(1992-11#17)(1992-12#20)(1992-2#17)(1992-3#18)(1992-4#15)(1992-5#14)(1992-6#33)(1992-7#14)(1992-8#17)(1992-9#12)(1993-1#5)(1993-10#3)(1993-11#20)(1993-12#20)(1993-2#16)(1993-3#21)(1993-4#10)(1993-5#6)(1993-6#32)(1993-7#8)(1993-8#23)(1993-9#28)(1994-1#6)(1994-10#12)(1994-11#21)(1994-12#41)(1994-2#25)(1994-3#30)(1994-5#24)(1994-6#24)(1994-7#3)(1994-8#33)(1994-9#35)(1995-1#33)(1995-10#7)(1995-11#26)(1995-12#28)(1995-2#37)(1995-3#31)(1995-4#7)(1995-5#35)(1995-6#26)(1995-7#7)(1995-8#26)(1995-9#6)(1996-1#21)(1996-10#13)(1996-11#23)(1996-12#25)(1996-2#24)(1996-3#22)(1996-4#8)(1996-5#22)(1996-6#17)(1996-7#19)(1996-8#20)(1996-9#15)(1997-1#17)(1997-2#32)(1997-3#16)(1997-4#27)(1997-5#13)(1997-6#36)(1997-7#21)(1997-8#29)(2003-11#1)(2004-1#2)(2004-10#2)(2004-11#13)(2004-12#2)(2004-2#8)(2004-3#2)(2004-4#2)(2004-7#1)(2004-8#3)(2004-9#12)(2005-1#2)(2005-10#14)(2005-11#38)(2005-12#10)(2005-3#4)(2005-4#6)(2005-5#1)(2005-7#6)(2005-8#6)(2005-9#3)(2006-1#5)(2006-10#49)(2006-11#8)(2006-12#21)(2006-2#13)(2006-3#12)(2006-4#20)(2006-5#14)(2006-6#18)(2006-7#7)(2006-8#30)(2006-9#9)(2007-1#19)(2007-10#19)(2007-11#79)(2007-12#113)(2007-2#13)(2007-3#19)(2007-4#11)(2007-5#16)(2007-6#14)(2007-7#39)(2007-8#47)(2007-9#31)(2008-1#52)(2008-10#583)(2008-11#109)(2008-12#29)(2008-2#128)(2008-3#150)(2008-4#58)(2008-5#131)(2008-6#38)(2008-7#92)(2008-8#92)(2008-9#68)(2009-1#5)(2009-10#23)(2009-11#10)(2009-12#14)(2009-2#3)(2009-3#10)(2009-4#24)(2009-5#14)(2009-6#20)(2009-7#7)(2009-8#15)(2009-9#12)(2010-1#6)(2010-10#9)(2010-11#9)(2010-12#31)(2010-2#18)(2010-3#12)(2010-4#23)(2010-5#16)(2010-6#6)(2010-7#15)(2010-8#20)(2010-9#3)(2011-1#54)(2011-11#1)(2011-12#13)(2011-2#69)(2011-3#2)(2011-7#1)(2012-1#34)(2012-11#7)(2012-12#55)(2012-2#68)(2012-3#49)(2012-4#2)(2013-1#73)(2013-7#14)(2013-8#64)
same-##3##1##(2009-4#2)(2010-5#1)
same-day##3##1##(2008-7#1)(2012-1#1)(2013-8#1)
same-ethnic peers##2##2##(2009-7#1)(2010-4#1)
same-ethnic##4##1##(2009-7#3)(2010-4#1)
same-race##2##1##(2009-4#1)(2009-7#1)
same-sex desire##3##2##(2009-7#3)
same-sex helpers##2##2##(2008-9#2)
same-sex##13##1##(1997-5#1)(2006-7#1)(2008-10#1)(2008-12#2)(2008-8#1)(2008-9#2)(2009-7#3)(2010-7#1)(2011-1#1)
samfR gene##2##2##(2008-8#2)
samfR##4##1##(2008-8#4)
sample (100##2##2##(2008-10#2)
sample (N =##5##3##(2007-2#1)(2008-1#1)(2009-8#1)(2012-11#1)(2012-2#1)
sample (i##3##2##(2008-11#1)(2008-4#1)(2009-10#1)
sample (n =##7##3##(1997-8#1)(2007-12#1)(2008-8#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-1#1)
sample (or##2##2##(2008-10#2)
sample Mueller matrix##2##3##(2008-2#2)
sample acidification##2##2##(2008-10#2)
sample acidity##3##2##(2008-10#3)
sample addition##4##2##(2008-10#4)
sample after the##3##3##(1996-10#1)(2008-10#2)
sample after##4##2##(1996-10#1)(2008-10#3)
sample aliquot was##3##3##(2008-10#1)(2008-3#2)
sample aliquot##6##2##(2008-10#4)(2008-3#2)
sample aliquots##2##2##(2008-10#2)
sample amount##3##2##(2008-10#3)
sample amounts##2##2##(2008-10#2)
sample analyses##2##2##(1996-6#1)(2008-10#1)
sample analysis and##2##3##(2008-10#2)
sample analysis were##2##3##(2008-10#2)
sample analysis##21##2##(1996-12#1)(2005-4#1)(2007-8#1)(2008-10#13)(2008-5#1)(2008-9#1)(2009-3#1)(2011-1#1)(2013-8#1)
sample analyzed##2##2##(2008-10#1)(2008-4#1)
sample and a##6##3##(2007-11#1)(2008-10#3)(2008-12#1)(2009-4#1)
sample and an##3##3##(1996-7#1)(2007-12#1)(2008-10#1)
sample and by##3##3##(2007-12#1)(2008-1#1)(2008-10#1)
sample and eluent##5##3##(2008-10#5)
sample and in##2##3##(2006-5#1)(2008-10#1)
sample and its##2##3##(2007-11#1)(2008-7#1)
sample and organic##2##3##(2008-10#2)
sample and reagent consumption##3##4##(2008-10#2)(2011-1#1)
sample and reagent volumes##2##4##(2008-10#2)
sample and reagent zones##2##4##(2008-10#2)
sample and reagent##16##3##(2007-10#1)(2008-10#14)(2011-1#1)
sample and reagents are##2##4##(2008-10#2)
sample and reagents##9##3##(2007-8#1)(2008-10#7)(2010-7#1)
sample and results##2##3##(2008-1#1)(2008-10#1)
sample and standard##2##3##(2008-10#1)(2008-4#1)
sample and the sample##3##4##(2008-10#3)
sample and the##23##3##(2006-6#1)(2007-12#1)(2008-10#15)(2008-2#3)(2008-3#1)(2008-5#2)
sample and then##3##3##(2008-10#2)(2008-5#1)
sample and to##2##3##(2008-10#1)(2012-2#1)
sample and##162##2##(1992-2#1)(1992-6#1)(1993-11#1)(1995-12#1)(1996-6#1)(1996-7#1)(1997-2#1)(2005-4#2)(2005-8#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#7)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#97)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#3)(2008-4#3)(2008-5#4)(2008-7#3)(2009-4#3)(2009-8#1)(2010-12#1)(2010-7#1)(2010-9#2)(2011-1#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
sample and/or reagent##2##3##(2008-10#2)
sample and/or##6##2##(2008-10#5)(2008-12#1)
sample application##3##2##(1991-11#1)(1992-2#1)(2008-8#1)
sample applications##2##2##(2008-10#1)(2008-2#1)
sample are separated##2##3##(1990-8#1)(2008-10#1)
sample are##16##2##(1990-8#1)(1996-5#1)(2005-9#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-4#1)(2011-1#1)
sample area##3##2##(2008-10#1)(2010-2#1)(2011-2#1)
sample as a##2##3##(2007-9#1)(2008-6#1)
sample as##6##2##(1994-6#1)(2005-11#1)(2007-9#1)(2008-10#2)(2008-6#1)
sample aspiration##3##2##(2008-10#2)(2008-11#1)
sample at different##2##3##(2005-11#1)(2008-3#1)
sample at the##4##3##(2007-1#1)(2007-12#1)(2008-10#2)
sample at##18##2##(1991-3#1)(2005-11#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#3)(2008-5#1)
sample beam##2##2##(2007-12#2)
sample before##4##2##(1991-5#1)(2007-12#1)(2008-10#1)(2008-3#1)
sample between two##2##3##(2007-12#1)(2008-10#1)
sample blank##2##2##(2008-10#2)
sample breakthrough volume##2##3##(2008-10#2)
sample buffer##4##2##(2006-8#1)(2007-8#1)(2008-10#1)(2008-4#1)
sample by a##2##3##(2008-10#1)(2008-6#1)
sample by means of##2##4##(2008-10#1)(2011-2#1)
sample by the##3##3##(2008-10#2)(2008-12#1)
sample by##21##2##(2004-9#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#12)(2008-12#1)(2008-2#1)(2008-6#1)(2011-2#1)(2012-12#1)
sample can be##11##3##(1997-8#1)(2005-12#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-4#1)
sample can##12##2##(1997-8#1)(2005-12#1)(2007-5#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-4#1)
sample carryover##3##2##(2008-10#3)
sample cell##8##2##(2006-10#1)(2008-2#2)(2008-3#4)(2008-4#1)
sample chamber##6##2##(2007-11#1)(2008-10#1)(2008-11#3)(2008-9#1)
sample characteristics##4##2##(2007-8#1)(2009-7#1)(2013-1#2)
sample classification##2##2##(2011-1#2)
sample clean-up##9##2##(1996-5#1)(1996-8#1)(1997-2#1)(2007-8#1)(2008-10#3)(2008-12#1)(2013-7#1)
sample cleanup and##2##3##(2008-10#2)
sample cleanup##8##2##(2008-10#7)(2010-1#1)
sample clustering##2##2##(2010-12#1)(2011-1#1)
sample collected from##2##3##(2007-7#1)(2008-10#1)
sample collected##3##2##(2007-1#1)(2007-7#1)(2008-10#1)
sample collection and preparation##2##4##(2012-12#2)
sample collection and storage##2##4##(1990-11#1)(2008-10#1)
sample collection and##6##3##(1990-11#1)(1992-7#1)(2008-10#1)(2008-5#1)(2012-12#2)
sample collection in##2##3##(2008-10#1)(2013-8#1)
sample collection##28##2##(1990-11#1)(1992-7#1)(2005-11#1)(2007-11#1)(2008-10#14)(2008-5#3)(2009-10#1)(2010-11#1)(2010-4#1)(2012-12#2)(2013-1#1)(2013-8#1)
sample collections##2##2##(2008-10#1)(2010-8#1)
sample combustion##2##2##(2008-10#2)
sample communities and##2##3##(2012-3#2)
sample compartment of a##2##4##(2008-10#2)
sample compartment of##3##3##(2008-10#2)(2008-3#1)
sample completed##3##2##(2007-4#2)(2008-8#1)
sample components##2##2##(1992-1#1)(2009-3#1)
sample comprised of##3##3##(2007-7#1)(2011-1#1)(2012-12#1)
sample comprised##9##2##(1994-4#1)(2007-7#1)(2008-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
sample comprises##2##2##(1995-1#1)(2013-1#1)
sample concentration and##4##3##(2008-10#4)
sample concentration technique##2##3##(1997-3#1)(2008-10#1)
sample concentration##14##2##(1996-5#1)(1997-3#1)(2008-1#1)(2008-10#9)(2008-4#1)(2011-2#1)
sample concentrations##2##2##(2008-10#2)
sample conformations##2##2##(1996-7#1)(2006-10#1)
sample consisted of 55##2##4##(1996-5#1)(2007-7#1)
sample consisted of##35##3##(1991-4#1)(1994-1#1)(1994-6#1)(1995-1#1)(1996-5#1)(2006-9#1)(2007-12#3)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
sample consisting of##2##3##(2006-2#1)(2007-12#1)
sample consisting##3##2##(2006-2#1)(2007-12#1)(2009-11#1)
sample consists of##5##3##(2007-12#1)(2008-6#1)(2009-4#1)(2009-7#1)(2013-8#1)
sample consists##6##2##(2007-12#2)(2008-6#1)(2009-4#1)(2009-7#1)(2013-8#1)
sample consumed##3##2##(2008-10#3)
sample consumption##6##2##(2007-10#1)(2007-8#1)(2008-10#4)
sample contained##5##2##(1990-9#1)(2006-8#1)(2008-10#1)(2008-8#1)(2011-12#1)
sample containing the##2##3##(2007-12#1)(2008-10#1)
sample containing##29##2##(1993-11#1)(2004-9#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#21)(2008-4#1)(2011-1#1)
sample contains##3##2##(2008-10#1)(2009-7#1)(2011-2#1)
sample contamination##2##2##(2008-10#2)
sample could be detected##2##4##(2007-8#1)(2008-1#1)
sample could be##5##3##(1993-1#1)(1993-7#1)(2007-8#1)(2008-1#1)(2008-10#1)
sample data##4##2##(1992-8#1)(2008-3#1)(2008-9#1)(2011-12#1)
sample demonstrated##2##2##(2006-5#1)(2007-12#1)
sample depth##3##2##(2008-2#2)(2008-3#1)
sample detected by the method is in good agreement with the certified value##2##13##(2008-10#2)
sample determined##2##2##(2008-10#2)
sample digestion and##3##3##(2008-10#3)
sample digestion##14##2##(1996-3#1)(2008-10#13)
sample dilution and##2##3##(1995-1#1)(2008-10#1)
sample dilution##7##2##(1995-1#3)(1996-1#1)(2007-8#1)(2008-10#2)
sample disks were##2##3##(2008-3#2)
sample dissolution##7##2##(2008-10#5)(2008-5#1)(2012-2#1)
sample drawn##3##2##(1992-6#1)(2008-1#1)(2012-3#1)
sample due to the##2##4##(2008-10#2)
sample during##5##2##(1990-5#1)(1993-12#1)(2007-12#1)(2008-10#2)
sample enrichment##2##2##(2008-10#2)
sample exceeded the MRL regulated by##2##6##(2013-8#2)
sample extraction##13##2##(1990-12#1)(1992-2#2)(1997-3#1)(2008-10#9)
sample extracts##4##2##(1997-8#1)(2008-10#3)
sample filtration##3##2##(2007-8#2)(2008-10#1)
sample flow rate and##5##4##(2008-10#5)
sample flow rate of 6##2##5##(2008-10#1)(2008-3#1)
sample flow rate of##6##4##(2008-10#5)(2008-3#1)
sample flow rate##27##3##(2007-8#1)(2008-10#24)(2008-3#2)
sample flow rates##2##3##(2007-8#1)(2008-10#1)
sample flow##32##2##(2007-8#2)(2008-10#27)(2008-3#2)(2008-9#1)
sample followed by##2##3##(2008-10#2)
sample for all##2##3##(2008-10#1)(2008-4#1)
sample for the##2##3##(2008-10#1)(2011-1#1)
sample for this##2##3##(1995-6#1)(2006-10#1)
sample for##23##2##(1995-6#1)(1997-5#2)(2005-4#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-9#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-4#1)(2011-1#2)(2012-2#1)
sample frame##4##2##(1995-1#3)(1996-1#1)
sample frames##2##2##(1995-1#1)(2012-3#1)
sample free from sulphur dioxide##2##5##(2008-10#2)
sample free##3##2##(1996-12#1)(2008-10#2)
sample frequency of 27 samples per##2##6##(2008-10#2)
sample frequency of##11##3##(2008-10#11)
sample frequency##15##2##(2007-8#1)(2008-10#14)
sample from a##9##3##(1993-3#1)(2008-10#4)(2008-12#1)(2010-11#1)(2010-2#1)(2013-1#1)
sample from the##12##3##(1990-10#1)(1997-2#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2009-4#1)(2011-2#1)(2013-1#1)
sample from##41##2##(1990-10#1)(1991-6#2)(1992-6#1)(1993-3#1)(1994-2#1)(1995-6#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-12#5)(2008-2#2)(2008-4#1)(2008-7#2)(2009-4#1)(2009-8#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#2)
sample group of##5##3##(1991-4#1)(1992-9#1)(1993-11#1)(1993-2#1)(2008-10#1)
sample group##8##2##(1991-4#1)(1992-9#1)(1993-11#1)(1993-2#1)(2008-1#1)(2008-10#2)(2009-11#1)
sample groups##3##2##(2008-10#2)(2009-11#1)
sample h(-1)##3##2##(2008-10#3)
sample had a##2##3##(2008-10#1)(2010-3#1)
sample had been##2##3##(1992-4#1)(1994-6#1)
sample had##9##2##(1992-4#1)(1994-6#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2010-3#1)
sample handling and##5##3##(2008-1#1)(2008-10#3)(2008-3#1)
sample handling##25##2##(1997-6#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#2)(2011-2#1)
sample has been##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2011-12#1)
sample has##11##2##(1992-2#1)(2006-10#1)(2006-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-5#1)(2011-12#1)(2013-1#1)(2013-8#1)
sample health##3##2##(2007-6#1)(2013-1#2)
sample heterogeneity##3##2##(2008-9#1)(2011-2#1)(2013-7#1)
sample history##2##2##(2006-10#1)(2008-1#1)
sample in a##3##3##(1996-12#1)(2008-10#1)(2008-5#1)
sample in an##2##3##(2007-12#1)(2008-10#1)
sample in order to##2##4##(1991-8#1)(2008-10#1)
sample in the##10##3##(2005-4#1)(2006-5#1)(2008-10#6)(2008-2#1)(2012-12#1)
sample in##44##2##(1990-11#1)(1991-2#2)(1991-8#1)(1996-12#1)(2005-4#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-10#19)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-8#1)
sample included##13##2##(1991-2#1)(1991-6#1)(1993-2#1)(1994-3#1)(2004-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-7#1)(2010-7#1)(2011-2#1)(2013-1#1)
sample includes##4##2##(2007-2#1)(2008-2#1)(2009-3#1)(2010-1#1)
sample including##4##2##(1994-8#1)(2008-10#1)(2008-7#1)(2009-7#1)
sample incubation##2##2##(2007-8#1)(2008-10#1)
sample indicated##2##2##(1993-7#1)(2007-8#1)
sample injection and##6##3##(1990-12#1)(1992-11#1)(1995-3#1)(2008-10#3)
sample injection by##2##3##(1994-9#1)(2008-10#1)
sample injection is##3##3##(2007-8#1)(2008-10#2)
sample injection of##2##3##(2008-10#2)
sample injection volume##5##3##(2008-10#4)(2012-3#1)
sample injection##34##2##(1990-12#1)(1990-8#2)(1992-11#1)(1992-2#1)(1994-9#1)(1995-3#1)(2007-8#3)(2008-10#23)(2012-3#1)
sample injections##4##2##(2008-10#4)
sample insertion##2##2##(2008-10#2)
sample into a##3##3##(2008-10#3)
sample into the##5##3##(1990-12#1)(1992-1#1)(2008-10#3)
sample into##11##2##(1990-12#1)(1992-1#1)(2008-10#8)(2008-9#1)
sample introduction in##2##3##(2008-10#2)
sample introduction system##6##3##(2008-10#6)
sample introduction techniques##2##3##(2008-10#2)
sample introduction was##2##3##(2007-8#1)(2008-10#1)
sample introduction##34##2##(2007-8#1)(2008-10#32)(2010-7#1)
sample irradiated at##2##3##(1994-11#2)
sample is a##2##3##(2007-11#1)(2007-12#1)
sample is about##3##3##(1991-8#1)(2006-5#1)(2008-10#1)
sample is assumed to##2##4##(1994-11#1)(2008-3#1)
sample is described##2##3##(1992-1#1)(2008-10#1)
sample is determined##2##3##(2008-2#1)(2008-4#1)
sample is directly##3##3##(2008-10#2)(2008-2#1)
sample is fused with##2##4##(2008-10#2)
sample is in##2##3##(2005-4#1)(2008-3#1)
sample is injected##2##3##(2008-10#2)
sample is introduced##2##3##(2008-10#2)
sample is measured##2##3##(2008-3#2)
sample is not required##2##4##(2008-10#1)(2010-4#1)
sample is placed##2##3##(2007-11#1)(2007-8#1)
sample is presented##2##3##(2007-12#1)(2008-3#1)
sample is required##2##3##(2008-1#1)(2008-10#1)
sample is subjected to##2##4##(1997-2#1)(2008-5#1)
sample is taken##2##3##(2008-2#1)(2010-8#1)
sample is the##2##3##(2008-10#2)
sample is then##2##3##(2008-10#1)(2008-4#1)
sample is treated with##2##4##(2008-10#2)
sample is##108##2##(1991-1#1)(1991-8#1)(1992-1#1)(1993-1#1)(1994-11#1)(1995-12#1)(1997-2#2)(2005-11#1)(2005-4#2)(2006-5#1)(2007-11#2)(2007-12#6)(2007-8#1)(2008-1#1)(2008-10#50)(2008-12#2)(2008-2#5)(2008-3#11)(2008-4#4)(2008-5#3)(2008-9#2)(2009-12#1)(2009-7#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-2#3)(2013-1#1)
sample load time##2##3##(2008-10#2)
sample load##3##2##(2008-10#2)(2008-5#1)
sample loading and##2##3##(2008-10#2)
sample loading flow rate##5##4##(2008-10#5)
sample loading time of##2##4##(2008-10#2)
sample loading time##3##3##(2008-10#3)
sample loading volume##2##3##(2008-10#2)
sample loading##16##2##(1990-9#1)(2008-10#14)(2013-8#1)
sample locations##2##2##(2006-4#1)(2007-5#1)
sample loop of##3##3##(2008-10#3)
sample loop##10##2##(2008-10#10)
sample loss##3##2##(2008-10#1)(2008-11#1)(2010-1#1)
sample manipulation is##2##3##(2007-8#1)(2008-10#1)
sample manipulation##6##2##(2007-8#1)(2008-10#5)
sample mass##9##2##(2007-8#1)(2008-10#8)
sample material##3##2##(1996-2#1)(2008-1#1)(2008-5#1)
sample materials##2##2##(2008-10#2)
sample matrices##6##2##(2008-10#4)(2008-3#1)(2010-11#1)
sample matrix and##2##3##(2008-10#2)
sample matrix was##5##3##(2008-10#5)
sample matrix##34##2##(1992-1#1)(2007-8#1)(2008-10#31)(2008-5#1)
sample may be stored##2##4##(2008-10#2)
sample may be##4##3##(2008-10#2)(2011-2#1)(2013-1#1)
sample may##10##2##(1995-1#1)(2006-6#1)(2008-10#2)(2008-4#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#2)
sample mean##3##2##(1994-3#1)(2008-7#1)(2010-4#1)
sample measurement frequency##4##3##(2008-10#4)
sample measurement##6##2##(2008-10#6)
sample measurements##2##2##(2008-10#2)
sample model##2##2##(1997-3#1)(2008-3#1)
sample morphology##2##2##(2008-7#1)(2011-1#1)
sample must be##2##3##(2008-10#1)(2011-1#1)
sample number##2##2##(2008-10#2)
sample obtained from the##2##4##(2007-8#1)(2008-10#1)
sample obtained from##3##3##(1991-8#1)(2007-8#1)(2008-10#1)
sample obtained##6##2##(1991-8#1)(2006-6#1)(2006-7#1)(2007-8#1)(2008-10#1)(2013-8#1)
sample of 0##2##3##(2008-10#2)
sample of 1##18##3##(1990-9#1)(1992-8#1)(1993-2#1)(1993-8#1)(1995-8#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-12#2)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
sample of 10##3##3##(1993-3#1)(2007-10#1)(2008-11#1)
sample of 100##3##3##(1992-12#1)(2007-12#1)(2009-2#1)
sample of 103##2##3##(1997-7#1)(2011-1#1)
sample of 105##2##3##(1996-7#1)(2013-1#1)
sample of 127##2##3##(1995-3#1)(2013-1#1)
sample of 133##2##3##(2007-12#1)(2008-7#1)
sample of 15##5##3##(1991-2#1)(2006-2#1)(2008-5#2)(2010-11#1)
sample of 150##2##3##(2006-10#1)(2008-10#1)
sample of 16##3##3##(2007-12#1)(2007-2#1)(2011-1#1)
sample of 168##2##3##(1991-8#1)(2008-10#1)
sample of 19##2##3##(2007-1#1)(2007-2#1)
sample of 197##3##3##(2008-9#1)(2009-12#1)(2011-2#1)
sample of 2##6##3##(1992-12#1)(1992-3#1)(1993-12#1)(2008-4#1)(2012-2#1)(2013-1#1)
sample of 20##5##3##(2007-7#1)(2008-11#1)(2008-12#1)(2013-1#1)(2013-7#1)
sample of 200##3##3##(2008-8#1)(2009-4#1)(2010-2#1)
sample of 201##2##3##(2012-1#1)(2013-1#1)
sample of 24##3##3##(2008-12#1)(2010-8#1)(2013-1#1)
sample of 250##2##3##(1992-5#1)(2009-7#1)
sample of 3##3##3##(1994-1#1)(2013-8#2)
sample of 30##3##3##(1992-1#1)(2008-10#1)(2012-3#1)
sample of 34##2##3##(1997-5#1)(2011-1#1)
sample of 37##3##3##(2008-12#1)(2010-6#1)(2013-8#1)
sample of 4##2##3##(1997-4#1)(2012-12#1)
sample of 40##3##3##(1993-2#1)(2007-11#1)(2009-12#1)
sample of 400##4##3##(1994-12#1)(2006-10#1)(2007-7#1)(2013-1#1)
sample of 43##2##3##(1993-12#1)(2009-11#1)
sample of 500##3##3##(1991-3#1)(1993-12#1)(2006-8#1)
sample of 52##2##3##(2007-11#1)(2007-12#1)
sample of 60##2##3##(2010-3#1)(2013-7#1)
sample of 7##2##3##(1991-2#1)(2009-7#1)
sample of 964##2##3##(2007-2#1)(2010-8#1)
sample of Australian##2##3##(2011-1#1)(2012-12#1)
sample of L##2##3##(2007-8#1)(2008-10#1)
sample of MSM##2##3##(2009-5#2)
sample of North##2##3##(2008-11#1)(2009-2#1)
sample of Norwegian general practitioners##2##5##(1993-2#1)(1995-5#1)
sample of Norwegian##4##3##(1993-2#1)(1995-5#1)(2005-10#1)(2007-12#1)
sample of Saudi##2##3##(2007-2#1)(2012-1#1)
sample of US##2##3##(2006-10#1)(2008-10#1)
sample of a##7##3##(1992-8#1)(2007-8#1)(2008-10#2)(2008-5#1)(2011-1#1)(2011-2#1)
sample of adolescents##5##3##(2006-7#1)(2009-2#1)(2009-7#1)(2010-2#1)(2010-3#1)
sample of adults##2##3##(2013-1#1)(2013-8#1)
sample of all##2##3##(1991-2#1)(1991-8#1)
sample of an##2##3##(1994-8#1)(2009-8#1)
sample of approximately##2##3##(2008-12#1)(2013-1#1)
sample of caregivers##2##3##(2007-11#1)(2013-1#1)
sample of children##4##3##(2005-8#1)(2006-11#1)(2011-1#1)(2013-1#1)
sample of college##2##3##(2007-12#1)(2008-8#1)
sample of family##5##3##(1991-3#1)(1991-8#2)(2007-6#1)(2012-2#1)
sample of five##5##3##(1995-11#1)(2007-11#1)(2008-11#1)(2012-3#1)(2013-8#1)
sample of healthy individuals##2##4##(2008-7#1)(2009-10#1)
sample of healthy##6##3##(2007-2#1)(2008-7#1)(2009-10#1)(2010-2#2)(2012-12#1)
sample of hospitalized##2##3##(1990-6#1)(2007-8#1)
sample of households##2##3##(2010-8#1)(2012-3#1)
sample of human plasma##2##4##(1996-3#1)(2008-10#1)
sample of individuals##3##3##(1994-6#1)(2009-8#1)(2012-2#1)
sample of interest##3##3##(1991-8#1)(2008-3#1)(2008-7#1)
sample of known##2##3##(2007-11#1)(2008-3#1)
sample of male and female##2##5##(2006-1#1)(2012-2#1)
sample of men##3##3##(2006-1#2)(2009-5#1)
sample of nurses##4##3##(2007-2#1)(2008-11#1)(2009-9#1)(2010-11#1)
sample of nursing##2##3##(2006-3#1)(2008-11#1)
sample of older##2##3##(2008-3#1)(2010-2#1)
sample of over##4##3##(2008-10#1)(2008-2#1)(2012-1#1)(2012-12#1)
sample of parents##4##3##(2008-9#1)(2009-9#1)(2012-12#2)
sample of patients##6##3##(1992-2#1)(2007-2#1)(2007-9#1)(2009-12#1)(2010-3#1)(2011-2#1)
sample of pure##2##3##(2007-12#1)(2008-3#1)
sample of six##3##3##(2007-10#1)(2008-11#1)(2009-4#1)
sample of students##3##3##(2007-3#1)(2008-11#1)(2013-1#1)
sample of subjects##3##3##(1994-9#1)(1997-2#1)(2008-7#1)
sample of the Italian population##2##5##(2008-7#1)(2010-11#1)
sample of the population##5##4##(1994-3#1)(1996-8#1)(1997-6#1)(2007-2#1)(2012-12#1)
sample of the##34##3##(1992-2#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-4#1)(1996-8#1)(1997-6#1)(2005-11#2)(2006-10#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-2#2)(2008-10#1)(2008-5#2)(2008-7#3)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#2)
sample of water##2##3##(1991-8#1)(2008-10#1)
sample of women aged##2##4##(1990-8#1)(1992-1#1)
sample of women##9##3##(1990-8#1)(1992-1#1)(2007-12#1)(2007-2#1)(2008-3#1)(2011-2#3)(2013-1#1)
sample of young adolescents##2##4##(2012-1#1)(2012-2#1)
sample of young##7##3##(2007-4#1)(2009-5#1)(2009-7#1)(2012-1#1)(2012-11#1)(2012-2#2)
sample of##656##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#5)(1991-3#2)(1991-6#1)(1991-7#1)(1991-8#7)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#3)(1994-3#5)(1994-5#1)(1994-6#5)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#3)(1995-8#1)(1996-1#2)(1996-2#3)(1996-3#2)(1996-4#1)(1996-6#2)(1996-7#4)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#3)(1997-5#4)(1997-6#2)(1997-7#2)(1997-8#3)(2004-12#1)(2004-4#1)(2005-10#3)(2005-11#4)(2005-4#1)(2005-8#1)(2006-1#3)(2006-10#9)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#4)(2006-4#1)(2006-7#2)(2006-8#4)(2006-9#2)(2007-1#3)(2007-10#5)(2007-11#9)(2007-12#27)(2007-2#19)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#9)(2007-9#5)(2008-1#5)(2008-10#44)(2008-11#20)(2008-12#23)(2008-2#3)(2008-3#8)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#11)(2008-8#6)(2008-9#5)(2009-10#4)(2009-11#3)(2009-12#6)(2009-2#4)(2009-3#1)(2009-4#4)(2009-5#9)(2009-6#1)(2009-7#15)(2009-8#6)(2009-9#6)(2010-1#3)(2010-10#2)(2010-11#5)(2010-12#2)(2010-2#12)(2010-3#9)(2010-4#3)(2010-5#4)(2010-6#5)(2010-7#5)(2010-8#5)(2010-9#5)(2011-1#19)(2011-2#20)(2012-1#12)(2012-11#1)(2012-12#18)(2012-2#12)(2012-3#15)(2013-1#30)(2013-7#9)(2013-8#11)
sample on the##2##3##(2008-10#1)(2008-4#1)
sample only##2##2##(1995-2#1)(2006-10#1)
sample onto the##2##3##(2008-10#1)(2013-1#1)
sample or a##3##3##(1990-8#1)(2009-10#1)(2010-11#1)
sample or the##2##3##(2008-3#2)
sample or##14##2##(1990-8#1)(1994-5#1)(2006-8#1)(2008-10#5)(2008-3#2)(2009-10#1)(2010-11#1)(2010-2#1)(2013-7#1)
sample origin##2##2##(2008-7#2)
sample pH and##4##3##(2008-10#4)
sample pH##14##2##(2008-10#12)(2008-3#1)(2008-9#1)
sample pair had##2##3##(2008-12#2)
sample pairs##4##2##(2008-12#2)(2009-6#1)(2012-2#1)
sample parameters##3##2##(2008-3#2)(2011-2#1)
sample passes##2##2##(2008-10#2)
sample per##2##2##(2008-10#2)
sample performance##4##2##(1995-5#1)(2009-10#1)(2010-3#1)(2012-1#1)
sample period##4##2##(2007-12#1)(2008-10#2)(2012-3#1)
sample periods##3##2##(2008-10#3)
sample plan##3##2##(1993-3#1)(2008-10#2)
sample plate##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
sample plug##7##2##(2007-8#2)(2008-10#5)
sample points##4##2##(2007-11#1)(2008-3#2)(2009-5#1)
sample population from the##2##4##(2007-7#1)(2012-12#1)
sample population##16##2##(1990-5#1)(1993-8#1)(1995-12#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#2)(2009-5#2)(2012-12#1)(2012-3#1)
sample position##2##2##(2006-5#1)(2008-6#1)
sample positioning##2##2##(2008-10#2)
sample pre-concentration##3##2##(2008-10#2)(2010-5#1)
sample pre-treatment and##3##3##(2008-10#3)
sample pre-treatment procedure##2##3##(2008-10#1)(2013-1#1)
sample pre-treatment##23##2##(2007-8#3)(2008-10#17)(2010-5#1)(2011-1#1)(2013-1#1)
sample pre-treatments##2##2##(2008-10#2)
sample preconcentration##4##2##(2008-10#3)(2010-7#1)
sample preparation and determination##2##4##(2008-10#2)
sample preparation and##18##3##(1991-5#1)(1993-2#1)(1996-5#1)(2008-10#6)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)(2010-4#1)(2010-7#1)(2013-1#1)
sample preparation as##2##3##(2008-10#1)(2010-4#1)
sample preparation for direct##2##4##(2008-4#1)(2013-1#1)
sample preparation for##8##3##(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-9#1)(2013-1#1)
sample preparation from##2##3##(1991-5#1)(2008-4#1)
sample preparation in##3##3##(2008-10#2)(2013-1#1)
sample preparation instead of intensive treatments inherent with the##3##9##(2008-10#3)
sample preparation is##7##3##(1991-8#1)(2008-10#4)(2008-2#1)(2008-4#1)
sample preparation method based on##3##5##(2008-10#3)
sample preparation method##10##3##(2007-8#1)(2008-10#7)(2008-9#1)(2012-12#1)
sample preparation methods##7##3##(2007-8#2)(2008-10#3)(2010-7#1)(2012-12#1)
sample preparation prior to analysis##2##5##(2008-10#1)(2010-5#1)
sample preparation procedure based on##2##5##(2008-10#2)
sample preparation procedure for##3##4##(2007-8#1)(2008-10#2)
sample preparation procedure##8##3##(2007-8#2)(2008-10#6)
sample preparation procedures##3##3##(2008-10#3)
sample preparation process##2##3##(2008-10#2)
sample preparation techniques##3##3##(2005-11#1)(2012-12#2)
sample preparation to##2##3##(2007-5#1)(2008-10#1)
sample preparation was##4##3##(1997-8#1)(2008-10#3)
sample preparation##147##2##(1990-1#1)(1991-5#2)(1991-8#1)(1992-2#1)(1993-2#1)(1994-12#1)(1994-9#3)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-8#3)(2005-11#2)(2006-12#1)(2007-5#1)(2007-8#9)(2008-1#2)(2008-10#76)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#8)(2008-5#2)(2008-7#2)(2008-9#4)(2009-4#1)(2010-11#2)(2010-4#2)(2010-5#1)(2010-7#2)(2012-12#5)(2013-1#3)
sample preparations##3##2##(2008-10#2)(2010-11#1)
sample preparator##3##2##(1992-2#1)(1997-3#1)(1997-8#1)
sample preservation##2##2##(2005-7#1)(2008-10#1)
sample pretreatment and##4##3##(1996-5#1)(2008-10#2)(2008-4#1)
sample pretreatment for the##3##4##(2005-4#1)(2008-10#2)
sample pretreatment for##4##3##(2005-4#1)(2008-10#3)
sample pretreatment in##2##3##(2007-8#1)(2008-10#1)
sample pretreatment steps##2##3##(2008-10#1)(2010-11#1)
sample pretreatment using##3##3##(2008-10#2)(2009-6#1)
sample pretreatment##36##2##(1992-2#2)(1993-2#1)(1996-5#2)(2005-12#1)(2005-4#1)(2007-8#2)(2008-10#22)(2008-4#1)(2009-6#1)(2010-11#1)(2013-1#1)(2013-8#1)
sample prior to##3##3##(2008-10#2)(2008-11#1)
sample processing and##2##3##(2008-10#2)
sample processing##14##2##(1990-12#1)(2007-11#1)(2008-10#8)(2008-11#2)(2008-9#2)
sample properties of the##2##4##(1993-9#1)(2010-2#1)
sample properties##3##2##(1993-9#1)(2010-2#1)(2010-8#1)
sample proteins##2##2##(1993-2#1)(1997-2#1)
sample provided##2##2##(2007-8#1)(2008-12#1)
sample purification on##2##3##(1992-2#2)
sample purification##3##2##(1992-2#2)(2008-10#1)
sample quality##2##2##(2008-10#1)(2013-1#1)
sample rate##2##2##(2008-10#2)
sample refractive index##2##3##(2007-11#1)(2008-2#1)
sample regression##2##2##(1995-4#1)(2008-10#1)
sample representing##2##2##(2006-10#1)(2008-7#1)
sample requirement##2##2##(2005-11#1)(2008-9#1)
sample results are##2##3##(2007-12#1)(2008-2#1)
sample results in##2##3##(2008-10#1)(2011-1#1)
sample results##5##2##(2007-12#1)(2008-10#2)(2008-2#1)(2011-1#1)
sample revealed##2##2##(1997-7#1)(2008-10#1)
sample search##2##2##(1992-12#1)(2010-8#1)
sample selected##2##2##(2006-7#1)(2008-2#1)
sample selection##2##2##(1997-1#1)(2011-1#1)
sample set of##2##3##(2007-11#1)(2013-8#1)
sample set with##2##3##(2008-2#1)(2013-8#1)
sample set##13##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#4)(2013-8#5)
sample sets##4##2##(2008-10#1)(2008-2#2)(2010-11#1)
sample should be##3##3##(2007-12#1)(2008-10#1)(2010-11#1)
sample should##5##2##(1995-3#1)(2007-12#1)(2008-10#2)(2010-11#1)
sample show##2##2##(1997-7#1)(2007-11#1)
sample showed a##2##3##(2008-11#1)(2011-2#1)
sample showed##6##2##(1994-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
sample showing##2##2##(2007-8#2)
sample shows##2##2##(2008-2#1)(2008-3#1)
sample site##2##2##(2006-3#1)(2007-3#1)
sample sites##4##2##(2008-10#1)(2008-5#1)(2010-2#2)
sample size and the##4##4##(1993-1#1)(2005-11#1)(2006-1#1)(2008-11#1)
sample size and##19##3##(1992-2#1)(1993-1#1)(1994-2#1)(1995-6#1)(1996-12#1)(2005-11#1)(2006-1#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)
sample size are##2##3##(2007-10#1)(2008-10#1)
sample size based on##2##4##(1995-9#1)(2012-2#1)
sample size calculation##5##3##(1992-6#1)(1993-8#2)(2007-7#1)(2013-1#1)
sample size calculations for##2##4##(2007-8#1)(2012-3#1)
sample size calculations##7##3##(1992-6#1)(2007-8#1)(2010-1#1)(2012-3#4)
sample size can##2##3##(2007-7#1)(2008-10#1)
sample size determination for##2##4##(1992-2#1)(1994-6#1)
sample size determination##3##3##(1992-2#2)(1994-6#1)
sample size due to##3##4##(2008-10#1)(2013-1#2)
sample size estimate##2##3##(1994-9#1)(2010-4#1)
sample size for a##3##4##(1995-9#1)(1996-12#1)(2006-10#1)
sample size for estimating##2##4##(1994-6#1)(2012-12#1)
sample size for##12##3##(1994-6#1)(1994-9#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-12#1)(2006-10#1)(2007-7#2)(2008-10#2)(2012-12#1)
sample size formula##2##3##(1992-9#1)(1996-3#1)
sample size formulae##4##3##(1995-8#2)(2012-3#2)
sample size has##2##3##(2005-11#1)(2012-12#1)
sample size in##3##3##(1994-11#1)(1996-7#1)(2012-2#1)
sample size is the##2##4##(1995-8#1)(2008-10#1)
sample size is##12##3##(1995-8#1)(2007-7#3)(2008-10#1)(2008-7#1)(2009-11#1)(2012-1#1)(2012-2#2)(2012-3#2)
sample size necessary to##2##4##(1996-12#1)(2009-12#1)
sample size of the##2##4##(2008-8#1)(2012-3#1)
sample size of##7##3##(1996-12#1)(2008-8#2)(2012-2#1)(2012-3#1)(2013-1#2)
sample size re-estimation##2##3##(2012-2#2)
sample size reassessment##2##3##(2012-2#2)
sample size required to##3##4##(1992-9#1)(1994-6#1)(1995-9#1)
sample size required##6##3##(1992-2#1)(1992-9#1)(1993-1#1)(1994-6#2)(1995-9#1)
sample size requirements##2##3##(1993-1#2)
sample size that would##3##4##(2010-2#3)
sample size that##6##3##(1997-2#1)(2008-10#1)(2010-2#4)
sample size to##2##3##(1995-6#1)(2008-10#1)
sample size was##9##3##(2008-10#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
sample size##208##2##(1992-2#4)(1992-3#1)(1992-6#5)(1992-9#3)(1993-1#5)(1993-8#2)(1994-11#1)(1994-2#1)(1994-4#1)(1994-6#6)(1994-9#4)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#4)(1995-8#4)(1995-9#3)(1996-12#6)(1996-3#1)(1996-7#2)(1997-2#2)(2004-11#1)(2005-10#2)(2005-11#2)(2006-1#1)(2006-10#3)(2006-12#1)(2006-4#1)(2007-10#2)(2007-11#2)(2007-7#9)(2007-8#3)(2007-9#1)(2008-10#27)(2008-11#1)(2008-12#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#3)(2009-4#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-2#8)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#3)(2012-1#4)(2012-12#4)(2012-2#14)(2012-3#16)(2013-1#16)(2013-8#1)
sample sizes and##8##3##(1992-2#1)(1993-1#2)(1996-1#1)(2007-5#1)(2009-12#1)(2011-2#2)
sample sizes are##3##3##(1993-4#1)(2010-12#1)(2012-3#1)
sample sizes can be##2##4##(1995-5#1)(2008-2#1)
sample sizes differ##2##3##(2008-10#2)
sample sizes for##8##3##(1994-6#2)(2006-8#1)(2010-8#1)(2011-12#1)(2012-12#1)(2013-1#2)
sample sizes in##4##3##(1992-9#1)(2008-10#2)(2012-3#1)
sample sizes of##2##3##(2008-10#1)(2013-8#1)
sample sizes required##2##3##(2012-2#1)(2012-3#1)
sample sizes that##3##3##(1996-8#2)(2008-10#1)
sample sizes##77##2##(1991-12#1)(1992-2#2)(1992-9#1)(1993-1#4)(1993-4#1)(1994-6#2)(1994-9#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-3#1)(1996-7#1)(1996-8#3)(1997-6#1)(2006-8#1)(2007-5#1)(2007-6#2)(2007-8#2)(2007-9#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-2#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#8)(2013-1#3)(2013-8#1)
sample solution and eluent##4##4##(2008-10#4)
sample solution and##9##3##(2008-10#9)
sample solution by##2##3##(2008-10#2)
sample solution can be determined##2##5##(2008-10#2)
sample solution can be##3##4##(2007-8#1)(2008-10#2)
sample solution containing##8##3##(2005-4#1)(2008-10#7)
sample solution for##2##3##(2008-10#2)
sample solution from##2##3##(2008-10#2)
sample solution in##3##3##(2008-10#3)
sample solution is injected into the##2##6##(2008-10#2)
sample solution is##9##3##(2008-10#8)(2008-2#1)
sample solution was injected##6##4##(2008-10#6)
sample solution was introduced into the##2##6##(2008-10#2)
sample solution was##15##3##(2008-10#14)(2008-6#1)
sample solution were##6##3##(2008-10#5)(2010-5#1)
sample solution with##2##3##(2007-12#1)(2007-8#1)
sample solution##138##2##(1994-9#1)(2005-4#1)(2006-5#1)(2007-12#1)(2007-8#8)(2008-1#1)(2008-10#120)(2008-2#1)(2008-3#1)(2008-6#1)(2010-5#1)(2013-8#1)
sample solutions by##3##3##(2008-10#3)
sample solutions containing##2##3##(2008-10#2)
sample solutions using##2##3##(2008-10#2)
sample solutions were##5##3##(2008-10#3)(2013-8#2)
sample solutions##21##2##(2006-2#1)(2007-8#1)(2008-10#17)(2013-8#2)
sample spiked with##2##3##(2008-10#1)(2010-5#1)
sample stabilization##4##2##(2008-10#3)(2012-3#1)
sample stacking for the##2##4##(2008-10#1)(2012-12#1)
sample stacking for##3##3##(2008-10#2)(2012-12#1)
sample stacking##13##2##(1994-12#1)(1996-5#2)(2007-8#1)(2008-10#7)(2012-12#2)
sample stage##2##2##(2007-12#1)(2008-10#1)
sample stimuli##2##2##(2006-7#1)(2011-2#1)
sample storage protocols##2##3##(2008-10#2)
sample storage##6##2##(2006-2#2)(2008-10#4)
sample stream##5##2##(2007-8#1)(2008-10#4)
sample structure##3##2##(2008-3#3)
sample studied##3##2##(1991-9#1)(2005-11#1)(2008-10#1)
sample such as##2##3##(1991-5#1)(2011-1#1)
sample surface to the##2##4##(2008-10#1)(2008-3#1)
sample surface to##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
sample surface##23##2##(1994-9#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#6)(2008-7#1)(2009-7#2)(2012-2#1)(2013-8#1)
sample surfaces##2##2##(1994-9#1)(2007-12#1)
sample survey of##2##3##(2012-11#2)
sample survey##5##2##(1994-2#1)(1994-3#1)(2011-12#1)(2012-11#2)
sample surveys##4##2##(2009-12#1)(2010-11#1)(2011-2#1)(2012-2#1)
sample t test##2##3##(2011-2#2)
sample t-test##2##2##(2011-2#2)
sample taken##4##2##(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#1)
sample temperature##8##2##(2006-5#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-9#2)
sample temperatures##2##2##(2007-12#1)(2008-10#1)
sample test##4##2##(1996-12#1)(2006-11#1)(2007-8#1)(2008-10#1)
sample textures##2##2##(2008-6#2)
sample than##2##2##(2007-7#1)(2009-10#1)
sample that can##2##3##(2006-5#1)(2010-5#1)
sample that is##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
sample that was##5##3##(1992-6#1)(2007-12#1)(2008-7#1)(2010-8#1)(2012-3#1)
sample that##19##2##(1992-6#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-7#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-3#1)
sample the##16##2##(1992-9#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-4#1)(2012-2#1)
sample then##2##2##(2008-10#2)
sample theory##4##2##(1995-9#1)(1996-3#1)(2008-12#1)(2008-7#1)
sample thickness in##2##3##(2008-2#2)
sample thickness##8##2##(2005-11#1)(2008-2#5)(2008-3#2)
sample through the##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
sample through##6##2##(2008-10#4)(2008-2#1)(2008-3#1)
sample throughout##2##2##(2008-10#2)
sample throughput and##5##3##(2008-10#3)(2008-9#2)
sample throughput by##2##3##(2007-8#1)(2008-10#1)
sample throughput is##3##3##(2008-10#3)
sample throughput of##27##3##(2007-10#1)(2008-10#26)
sample throughput was##11##3##(2008-10#11)
sample throughput##77##2##(1990-1#1)(1992-11#1)(2007-10#1)(2007-8#3)(2008-10#67)(2008-9#2)(2010-11#1)(2011-1#1)
sample to another##2##3##(1994-2#1)(2008-10#1)
sample to be##8##3##(2004-9#1)(2007-8#1)(2008-10#2)(2008-3#1)(2011-2#1)(2012-12#2)
sample to sample##4##3##(1994-2#1)(2008-10#2)(2010-4#1)
sample to the##3##3##(2008-10#2)(2008-3#1)
sample to##43##2##(1992-2#1)(1994-11#1)(1994-2#2)(1997-8#1)(2004-9#1)(2006-2#1)(2007-12#3)(2007-8#1)(2008-10#16)(2008-12#1)(2008-3#4)(2008-9#1)(2009-3#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#4)(2012-2#1)
sample transport##2##2##(2007-10#1)(2007-12#1)
sample treated##4##2##(2008-10#2)(2008-9#1)(2013-1#1)
sample treatment and##6##3##(2008-10#6)
sample treatment for the##2##4##(2008-10#2)
sample treatment for##3##3##(2008-10#3)
sample treatment is##2##3##(2008-10#2)
sample treatment procedures##2##3##(2008-10#1)(2010-11#1)
sample treatment to##2##3##(1994-3#1)(2008-10#1)
sample treatment##35##2##(1990-8#1)(1993-9#1)(1994-3#1)(1996-5#1)(2008-10#29)(2009-3#1)(2010-11#1)
sample treatments##2##2##(2008-10#2)
sample tube length##2##3##(2008-10#2)
sample tube##5##2##(2008-10#5)
sample type##5##2##(2008-10#3)(2012-12#2)
sample types##10##2##(2006-12#1)(2008-10#6)(2008-3#1)(2013-8#2)
sample under##7##2##(2006-12#1)(2008-10#1)(2008-3#3)(2008-5#1)(2010-12#1)
sample unit##2##2##(2004-11#2)
sample units##6##2##(2004-11#6)
sample up to##3##3##(2004-9#1)(2007-12#1)(2010-12#1)
sample used##2##2##(2006-4#1)(2008-8#1)
sample using a##5##3##(1996-3#1)(2008-10#4)
sample using the##2##3##(2008-10#1)(2009-10#1)
sample using##15##2##(1996-3#1)(2008-10#11)(2009-10#1)(2011-1#2)
sample volume and##7##3##(1996-8#1)(2008-10#5)(2010-11#1)
sample volume are##2##3##(2008-10#2)
sample volume injected##2##3##(2008-10#2)
sample volume of 100 ml##3##5##(2008-10#3)
sample volume of 100##4##4##(2008-10#4)
sample volume of##21##3##(2007-8#1)(2008-10#20)
sample volume up to##2##4##(2008-10#2)
sample volume was##3##3##(2008-10#2)(2012-1#1)
sample volume were##2##3##(2008-10#2)
sample volume with##2##3##(2008-10#1)(2008-2#1)
sample volume##93##2##(1990-12#1)(1996-8#2)(2007-12#1)(2007-8#3)(2007-9#2)(2008-10#74)(2008-12#1)(2008-2#3)(2008-3#2)(2010-11#2)(2010-12#1)(2012-1#1)
sample volumes and##3##3##(1990-6#1)(2008-10#2)
sample volumes in##2##3##(2008-10#1)(2013-1#1)
sample volumes of##2##3##(2008-10#1)(2012-3#1)
sample volumes##20##2##(1990-6#1)(1994-9#1)(2008-10#12)(2008-2#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
sample was &lt##2##3##(2008-10#2)
sample was 10##2##3##(1996-7#1)(2012-12#1)
sample was added##2##3##(1997-2#1)(2008-10#1)
sample was also##3##3##(2008-10#3)
sample was analyzed by##2##4##(2008-5#1)(2012-12#1)
sample was analyzed##3##3##(2008-10#1)(2008-5#1)(2012-12#1)
sample was calculated##3##3##(2006-8#1)(2007-11#1)(2008-10#1)
sample was collected##4##3##(1993-8#1)(2007-2#1)(2009-5#1)(2011-1#1)
sample was composed of##2##4##(2004-10#1)(2011-2#1)
sample was concentrated##2##3##(2008-10#1)(2012-3#1)
sample was continuously pumped##2##4##(2007-8#1)(2008-10#1)
sample was determined with##2##4##(2008-10#2)
sample was determined##3##3##(2005-4#1)(2008-10#2)
sample was developed##2##3##(2008-10#1)(2009-6#1)
sample was diluted##2##3##(2005-4#1)(2013-1#1)
sample was divided into##3##4##(2008-12#1)(2013-1#2)
sample was divided##5##3##(2008-12#1)(2008-6#1)(2011-2#1)(2013-1#2)
sample was drawn##3##3##(2007-11#1)(2008-11#1)(2013-1#1)
sample was injected into the##2##5##(1990-8#1)(2008-10#1)
sample was injected into##4##4##(1990-8#1)(2008-10#3)
sample was injected##6##3##(1990-8#2)(2008-10#4)
sample was loaded##2##3##(1997-8#1)(2008-10#1)
sample was measured##2##3##(2008-10#2)
sample was not##2##3##(2006-12#1)(2007-8#1)
sample was obtained by##2##4##(2008-5#1)(2013-1#1)
sample was obtained from##3##4##(2008-2#1)(2013-8#2)
sample was obtained##9##3##(2006-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2013-1#2)(2013-8#2)
sample was of##2##3##(1996-4#1)(2008-10#1)
sample was performed##2##3##(1990-8#1)(2011-2#1)
sample was positive for##2##4##(2005-8#1)(2011-2#1)
sample was separated##2##3##(2005-4#1)(2008-10#1)
sample was taken from##3##4##(2006-8#1)(2012-12#1)(2012-2#1)
sample was taken##9##3##(1994-12#1)(2006-12#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-12#1)(2012-2#1)
sample was tested##2##3##(2007-12#1)(2013-8#1)
sample was used##4##3##(2008-10#3)(2013-7#1)
sample was##162##2##(1990-6#1)(1990-8#5)(1991-8#1)(1993-8#1)(1994-12#3)(1994-2#1)(1994-6#1)(1995-1#1)(1996-12#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2004-10#1)(2004-9#1)(2005-4#4)(2005-8#1)(2006-10#4)(2006-12#3)(2006-7#1)(2006-8#4)(2006-9#1)(2007-11#3)(2007-12#2)(2007-2#3)(2007-8#6)(2008-1#1)(2008-10#51)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#4)(2008-6#1)(2008-9#2)(2009-5#2)(2009-6#1)(2009-7#2)(2010-1#1)(2010-8#1)(2011-1#5)(2011-2#5)(2012-12#6)(2012-2#2)(2012-3#3)(2013-1#6)(2013-7#2)(2013-8#3)
sample weight##2##2##(2008-10#2)
sample were also##4##3##(2007-8#1)(2008-10#3)
sample were collected from##2##4##(2008-10#1)(2011-1#1)
sample were determined##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
sample were used##2##3##(2006-5#1)(2008-10#1)
sample were##40##2##(1990-12#1)(1992-5#1)(1995-5#1)(1996-3#1)(2005-4#1)(2006-5#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-3#1)(2009-2#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
sample when##2##2##(2006-12#1)(2008-10#1)
sample where##2##2##(2008-10#1)(2008-3#1)
sample which##3##2##(1990-4#1)(2006-9#1)(2008-12#1)
sample while preserving##2##3##(1992-7#1)(2008-3#1)
sample while##4##2##(1992-7#1)(2008-10#2)(2008-3#1)
sample will be##2##3##(2008-10#1)(2008-3#1)
sample will##4##2##(1996-5#1)(1997-4#1)(2008-10#1)(2008-3#1)
sample with a##12##3##(2007-12#2)(2008-10#6)(2008-3#3)(2008-6#1)
sample with satisfactory results##3##4##(2005-4#1)(2008-10#2)
sample with the##6##3##(2008-10#4)(2008-5#1)(2009-4#1)
sample with##57##2##(1990-10#1)(1990-11#1)(1990-3#1)(1991-12#1)(1992-2#1)(1996-12#1)(1996-5#1)(2005-4#2)(2007-11#2)(2007-12#5)(2007-9#1)(2008-1#1)(2008-10#25)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2012-3#1)(2013-7#1)
sample without##6##2##(2004-9#1)(2007-12#1)(2008-10#2)(2008-4#2)
sample would##4##2##(1991-8#1)(1992-12#1)(2009-4#1)(2012-3#1)
sample zone was##2##3##(2008-10#2)
sample zone##14##2##(2008-10#14)
sample##4641##1##(1990-1#2)(1990-10#4)(1990-11#4)(1990-12#9)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#3)(1990-6#3)(1990-8#13)(1990-9#3)(1991-1#2)(1991-11#5)(1991-12#3)(1991-2#10)(1991-3#4)(1991-4#2)(1991-5#7)(1991-6#7)(1991-7#1)(1991-8#20)(1991-9#2)(1992-1#8)(1992-11#5)(1992-12#9)(1992-2#28)(1992-3#2)(1992-4#3)(1992-5#2)(1992-6#11)(1992-7#3)(1992-8#9)(1992-9#7)(1993-1#15)(1993-11#9)(1993-12#12)(1993-2#8)(1993-3#4)(1993-4#1)(1993-7#2)(1993-8#7)(1993-9#7)(1994-1#4)(1994-11#6)(1994-12#8)(1994-2#11)(1994-3#13)(1994-4#2)(1994-5#3)(1994-6#21)(1994-8#3)(1994-9#19)(1995-1#14)(1995-11#4)(1995-12#9)(1995-2#6)(1995-3#6)(1995-4#4)(1995-5#10)(1995-6#8)(1995-7#2)(1995-8#6)(1995-9#6)(1996-1#8)(1996-10#1)(1996-12#16)(1996-2#6)(1996-3#8)(1996-4#2)(1996-5#15)(1996-6#7)(1996-7#15)(1996-8#12)(1996-9#1)(1997-1#5)(1997-2#18)(1997-3#13)(1997-4#7)(1997-5#8)(1997-6#6)(1997-7#6)(1997-8#17)(2004-10#2)(2004-11#11)(2004-12#2)(2004-4#1)(2004-9#8)(2005-10#6)(2005-11#29)(2005-12#6)(2005-4#28)(2005-7#1)(2005-8#3)(2005-9#1)(2006-1#4)(2006-10#34)(2006-11#4)(2006-12#16)(2006-2#11)(2006-3#5)(2006-4#10)(2006-5#14)(2006-6#7)(2006-7#8)(2006-8#15)(2006-9#6)(2007-1#11)(2007-10#19)(2007-11#54)(2007-12#141)(2007-2#32)(2007-3#6)(2007-4#4)(2007-5#8)(2007-6#6)(2007-7#27)(2007-8#115)(2007-9#16)(2008-1#35)(2008-10#1794)(2008-11#62)(2008-12#62)(2008-2#96)(2008-3#147)(2008-4#76)(2008-5#46)(2008-6#23)(2008-7#41)(2008-8#19)(2008-9#49)(2009-1#1)(2009-10#18)(2009-11#10)(2009-12#17)(2009-2#6)(2009-3#9)(2009-4#21)(2009-5#22)(2009-6#7)(2009-7#27)(2009-8#12)(2009-9#16)(2010-1#9)(2010-10#5)(2010-11#26)(2010-12#10)(2010-2#34)(2010-3#16)(2010-4#17)(2010-5#15)(2010-6#7)(2010-7#14)(2010-8#16)(2010-9#11)(2011-1#67)(2011-11#1)(2011-12#11)(2011-2#80)(2012-1#28)(2012-11#6)(2012-12#65)(2012-2#53)(2012-3#75)(2013-1#111)(2013-3#1)(2013-7#19)(2013-8#60)
sample's composition##2##2##(2010-7#1)(2012-11#1)
sample's##10##1##(2007-11#2)(2008-2#1)(2008-3#3)(2010-7#1)(2012-11#2)(2012-3#1)
sample) and##6##2##(1992-9#1)(2008-10#4)(2010-5#1)
sample) for##3##2##(2006-11#1)(2008-10#2)
sample)##41##1##(1990-12#1)(1991-12#1)(1991-4#1)(1992-9#1)(1997-2#1)(1997-3#1)(2006-11#1)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#19)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-5#1)(2012-3#1)
sample-and-hold switch##2##2##(2008-3#2)
sample-based##4##1##(2008-6#2)(2011-12#2)
sample-handling##3##1##(1995-7#1)(2008-10#2)
sample-preparation and##2##2##(2008-10#1)(2008-3#1)
sample-preparation techniques##2##2##(2010-11#1)(2010-7#1)
sample-preparation##6##1##(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-11#1)(2010-7#1)
sample-size##2##1##(2010-12#1)(2012-1#1)
sample-specific##2##1##(2009-3#1)(2011-1#1)
sample-to-sample##5##1##(2007-12#1)(2008-10#2)(2008-5#1)(2012-2#1)
sample/reagent##4##1##(2007-10#1)(2008-10#3)
sample/standard##3##1##(2008-10#3)
sample]##4##1##(2008-9#1)(2009-9#1)(2013-1#2)
sampled (p&lt##2##2##(2008-4#2)
sampled and analysed##3##3##(1991-5#1)(2004-4#1)(2008-5#1)
sampled and analyzed##3##3##(2008-10#2)(2013-1#1)
sampled and##21##2##(1991-5#1)(1994-3#1)(1995-1#1)(2004-4#1)(2006-8#1)(2007-5#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-9#1)(2013-1#1)
sampled at the##4##3##(2008-10#1)(2008-3#1)(2009-3#1)(2012-3#1)
sampled at##19##2##(1993-2#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-2#2)(2008-3#3)(2008-5#1)(2008-9#1)(2009-3#1)(2010-5#1)(2011-2#1)(2012-3#1)
sampled between##3##2##(1996-9#1)(2004-11#1)(2013-7#1)
sampled by a##2##3##(2008-2#1)(2011-2#1)
sampled by the##2##3##(2004-4#1)(2007-12#1)
sampled by##15##2##(1994-6#1)(2004-4#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
sampled during the##4##3##(1996-8#1)(2006-4#1)(2008-10#1)(2008-5#1)
sampled during##6##2##(1996-8#1)(2006-4#1)(2008-10#3)(2008-5#1)
sampled either##2##2##(2008-2#1)(2008-5#1)
sampled fiber Bragg grating##2##4##(2007-11#1)(2007-12#1)
sampled for##8##2##(1995-6#1)(2007-2#2)(2008-10#2)(2008-4#2)(2009-12#1)
sampled from 10##3##3##(2007-9#1)(2008-10#1)(2011-12#1)
sampled from RL##3##3##(2008-10#3)
sampled from a##5##3##(1994-6#2)(2008-10#1)(2008-11#1)(2009-7#1)
sampled from different##4##3##(2008-10#4)
sampled from nine##3##3##(2005-10#1)(2008-10#2)
sampled from one##2##3##(2008-10#1)(2009-7#1)
sampled from the same##2##4##(2007-12#1)(2008-10#1)
sampled from the##9##3##(1990-5#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2012-2#1)
sampled from two##2##3##(2008-10#2)
sampled from wheat##2##3##(2008-10#2)
sampled from##77##2##(1990-5#1)(1991-11#1)(1994-6#2)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#2)(2005-10#2)(2006-5#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#44)(2008-11#2)(2008-3#1)(2008-5#2)(2008-8#1)(2009-2#1)(2009-7#3)(2010-8#3)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
sampled imaging systems##2##3##(2008-2#2)
sampled in a##5##3##(2008-10#5)
sampled in the##9##3##(2007-3#1)(2008-10#6)(2008-5#1)(2011-2#1)
sampled in##34##2##(1990-3#1)(1996-3#1)(2007-3#2)(2007-5#1)(2008-10#21)(2008-5#3)(2009-4#1)(2009-9#1)(2011-2#2)(2013-7#1)
sampled locations##2##2##(2008-10#1)(2008-8#1)
sampled on a##2##3##(2008-10#2)
sampled on the##2##3##(2008-10#2)
sampled on##6##2##(2007-6#1)(2008-10#5)
sampled or##2##2##(2007-12#1)(2008-10#1)
sampled over time##2##3##(2008-10#2)
sampled over##5##2##(2008-10#4)(2008-4#1)
sampled plants##2##2##(2008-10#1)(2008-5#1)
sampled plots##3##2##(2006-12#3)
sampled points##2##2##(2008-10#2)
sampled populations##3##2##(2008-10#2)(2008-5#1)
sampled seedlings##2##2##(2008-10#2)
sampled sites##2##2##(2008-10#1)(2008-5#1)
sampled speckle##2##2##(2007-12#1)(2008-2#1)
sampled the##2##2##(2008-5#1)(2008-7#1)
sampled to##4##2##(2007-9#1)(2008-10#2)(2008-3#1)
sampled twice##3##2##(2007-5#1)(2010-8#1)(2013-1#1)
sampled using##2##2##(2008-10#1)(2009-6#1)
sampled values##2##2##(2008-2#2)
sampled volume##2##2##(2008-10#1)(2011-1#1)
sampled were##4##2##(2007-2#1)(2008-10#3)
sampled with##6##2##(2004-4#1)(2007-10#1)(2008-5#3)(2008-6#1)
sampled##385##1##(1990-12#1)(1990-3#1)(1990-5#1)(1991-11#1)(1991-3#1)(1991-5#1)(1992-1#1)(1993-2#1)(1993-7#1)(1994-3#1)(1994-6#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-4#1)(1995-6#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(2004-11#1)(2004-4#3)(2005-10#2)(2005-12#1)(2006-10#2)(2006-12#3)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#10)(2007-2#3)(2007-3#3)(2007-5#5)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#151)(2008-11#5)(2008-12#1)(2008-2#15)(2008-3#14)(2008-4#8)(2008-5#26)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#3)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#3)(2009-9#1)(2010-10#2)(2010-5#2)(2010-6#1)(2010-8#5)(2011-1#2)(2011-12#3)(2011-2#6)(2012-12#2)(2012-2#4)(2012-3#7)(2012-7#1)(2013-1#8)(2013-7#7)(2013-8#6)
sampler and##2##2##(2007-8#1)(2008-10#1)
sampler for##6##2##(2008-10#4)(2010-5#2)
sampler height##2##2##(2008-10#2)
sampler is used to##2##4##(1993-6#1)(2008-10#1)
sampler is##3##2##(1993-6#1)(2008-10#2)
sampler method##2##2##(2008-10#1)(2010-5#1)
sampler technique##3##2##(2008-10#3)
sampler to##5##2##(1993-6#1)(1994-9#1)(2008-4#1)(2012-1#1)(2012-3#1)
sampler with##2##2##(2005-4#1)(2011-1#1)
sampler##56##1##(1993-6#2)(1994-9#1)(1997-7#1)(2004-10#1)(2005-4#1)(2007-12#1)(2007-8#1)(2008-10#29)(2008-11#3)(2008-4#1)(2008-5#1)(2010-5#7)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#2)(2012-7#1)
samplers##25##1##(1991-6#1)(1994-6#1)(2007-10#1)(2008-10#10)(2008-11#2)(2008-5#4)(2010-2#1)(2010-4#1)(2010-5#2)(2011-1#2)
samples (0##7##2##(2008-10#6)(2013-1#1)
samples (1##3##2##(2007-3#1)(2008-10#1)(2013-8#1)
samples (10##2##2##(2010-4#1)(2013-8#1)
samples (30##3##2##(2008-10#2)(2012-2#1)
samples (40%)##2##2##(2008-12#1)(2013-7#1)
samples (5##2##2##(1993-8#1)(2008-10#1)
samples (52##2##2##(2007-7#1)(2008-12#1)
samples (60##2##2##(2008-12#1)(2010-4#1)
samples (P##2##2##(1996-8#1)(2007-7#1)
samples (e##3##2##(1992-2#1)(2008-10#2)
samples (from##2##2##(1993-11#1)(2008-10#1)
samples (i##2##2##(2008-10#1)(2012-12#1)
samples (n =##6##3##(1996-6#1)(2006-5#1)(2011-2#1)(2012-3#3)
samples (p &lt##2##3##(2008-12#1)(2008-8#1)
samples a##2##2##(2007-12#1)(2010-1#1)
samples according to the level of##2##6##(1996-7#1)(2008-10#1)
samples according to their##2##4##(2008-10#2)
samples according to##5##3##(1996-7#1)(2008-10#3)(2009-5#1)
samples acquired##2##2##(2012-1#1)(2012-2#1)
samples after a simple##2##4##(2008-10#2)
samples after a##4##3##(1993-2#1)(2008-10#3)
samples after adsorption of its##3##5##(2008-10#3)
samples after preconcentration of##3##4##(2008-10#3)
samples after preconcentration##6##3##(2006-12#1)(2008-10#5)
samples after##26##2##(1993-2#1)(2006-12#1)(2007-8#1)(2008-10#21)(2010-4#2)
samples against##2##2##(1990-12#1)(2008-10#1)
samples agree##2##2##(2007-8#1)(2008-10#1)
samples all##2##2##(2005-11#1)(2008-10#1)
samples also##3##2##(1997-8#1)(2008-10#1)(2010-8#1)
samples analysed##10##2##(1997-3#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#3)(2012-12#1)
samples analysis##6##2##(2008-10#4)(2008-12#1)(2011-1#1)
samples analyzed were##2##3##(2008-10#2)
samples analyzed with##2##3##(2008-10#2)
samples analyzed##20##2##(1993-6#1)(1996-3#1)(2007-11#1)(2008-10#13)(2008-11#1)(2008-5#1)(2010-4#1)(2013-7#1)
samples and 2##2##3##(2007-8#1)(2008-10#1)
samples and a##9##3##(2006-5#1)(2008-10#7)(2008-2#1)
samples and after##2##3##(1994-5#1)(2013-1#1)
samples and also##4##3##(2008-10#2)(2010-11#1)(2011-2#1)
samples and between##2##3##(2008-10#1)(2009-2#1)
samples and by##2##3##(1991-2#1)(2008-6#1)
samples and calibration##2##3##(2008-10#2)
samples and can be##2##4##(2008-1#1)(2008-10#1)
samples and chromium##2##3##(2008-10#2)
samples and clinical##2##3##(1993-2#1)(2011-2#1)
samples and compared##2##3##(2008-10#1)(2013-8#1)
samples and detection##2##3##(2008-10#1)(2008-3#1)
samples and following##2##3##(2004-11#1)(2008-10#1)
samples and for##5##3##(1997-6#1)(2008-10#2)(2008-3#2)
samples and from##2##3##(2008-10#1)(2008-11#1)
samples and good##2##3##(2008-10#2)
samples and in the##3##4##(1990-5#1)(2008-10#1)(2008-5#1)
samples and in##15##3##(1990-5#1)(1992-12#1)(1995-12#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-10#7)(2008-2#1)(2008-5#1)
samples and it##2##3##(2008-10#2)
samples and its##5##3##(2008-10#3)(2008-6#1)(2010-5#1)
samples and on##2##3##(2008-10#2)
samples and one##4##3##(2006-8#1)(2007-8#1)(2008-10#1)(2008-3#1)
samples and other##3##3##(1990-11#1)(2008-10#2)
samples and reagents##4##3##(1991-3#1)(1996-8#1)(2008-10#2)
samples and several##2##3##(2008-10#2)
samples and solvents##2##3##(2005-4#1)(2008-10#1)
samples and spiked##2##3##(2008-10#2)
samples and standard##3##3##(2008-10#3)
samples and standards##2##3##(1997-8#1)(2008-10#1)
samples and the results obtained##2##5##(2008-10#2)
samples and the results were##2##5##(2008-10#2)
samples and the results##6##4##(2008-10#5)(2008-3#1)
samples and the##28##3##(1991-8#1)(1992-2#1)(1995-10#1)(2006-5#1)(2008-10#20)(2008-3#1)(2008-5#1)(2008-7#1)(2013-8#1)
samples and their##5##3##(2004-4#1)(2005-11#1)(2007-1#1)(2010-4#1)(2011-1#1)
samples and those of##2##4##(1991-3#2)
samples and three##4##3##(2008-10#3)(2008-3#1)
samples and to##3##3##(2008-1#1)(2008-10#1)(2008-5#1)
samples and was##2##3##(2008-10#2)
samples and waters##2##3##(2008-10#2)
samples and were##2##3##(1994-5#1)(2012-3#1)
samples and##305##2##(1990-11#1)(1990-5#1)(1990-8#3)(1991-2#2)(1991-3#3)(1991-8#2)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-4#1)(1994-11#1)(1994-4#1)(1994-5#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-6#1)(1997-8#1)(2004-11#1)(2004-4#1)(2005-11#2)(2005-4#3)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#3)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#4)(2007-7#2)(2007-8#5)(2008-1#2)(2008-10#149)(2008-11#3)(2008-12#4)(2008-2#4)(2008-3#9)(2008-4#1)(2008-5#10)(2008-6#2)(2008-7#5)(2008-8#3)(2009-2#1)(2010-11#1)(2010-2#1)(2010-4#5)(2010-5#3)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#6)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#4)
samples are also reported##2##4##(2006-4#1)(2008-10#1)
samples are also##3##3##(2006-4#1)(2008-10#1)(2008-3#1)
samples are analysed##3##3##(1995-1#1)(2008-10#2)
samples are collected##4##3##(1994-6#1)(2005-10#1)(2008-10#2)
samples are considered##2##3##(2008-10#1)(2008-3#1)
samples are described##6##3##(1990-9#1)(1996-6#1)(2007-7#1)(2008-10#3)
samples are discussed in##2##4##(1996-8#1)(2008-10#1)
samples are discussed##3##3##(1996-8#1)(2007-5#1)(2008-10#1)
samples are examined##3##3##(2004-9#1)(2008-2#1)(2012-2#1)
samples are identified##2##3##(1993-1#1)(2008-10#1)
samples are investigated##2##3##(2007-8#1)(2008-10#1)
samples are obtained##3##3##(2008-10#2)(2010-6#1)
samples are prepared##2##3##(2008-10#1)(2008-6#1)
samples are presented and##2##4##(2007-12#1)(2008-10#1)
samples are presented##6##3##(2007-12#1)(2008-10#3)(2008-3#2)
samples are reported##2##3##(2006-5#1)(2008-10#1)
samples are reviewed##3##3##(2008-10#3)
samples are selected##2##3##(2008-10#1)(2012-3#1)
samples are then##2##3##(2008-4#2)
samples are used##3##3##(2008-10#1)(2008-3#1)(2011-1#1)
samples are usually##2##3##(2008-10#1)(2010-11#1)
samples are##126##2##(1990-9#1)(1991-12#1)(1993-1#2)(1994-6#1)(1995-1#1)(1995-6#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-4#2)(2006-4#1)(2006-5#2)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#62)(2008-2#2)(2008-3#8)(2008-4#7)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#3)(2009-4#1)(2010-11#2)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
samples as well as in##3##5##(2008-10#2)(2008-11#1)
samples as well as##10##4##(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-9#1)(2011-2#1)(2012-3#1)
samples as##23##2##(2005-4#1)(2006-9#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
samples aspirated##2##2##(1995-10#1)(2008-10#1)
samples assayed##2##2##(1993-9#1)(2008-10#1)
samples at a##2##3##(2008-10#1)(2011-2#1)
samples at concentration levels between##2##5##(2008-10#2)
samples at different##2##3##(2008-10#1)(2013-7#1)
samples at the##6##3##(1990-12#1)(2004-4#1)(2008-10#3)(2008-12#1)
samples at trace##2##3##(2008-10#2)
samples at##37##2##(1990-1#1)(1990-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1993-11#1)(1997-4#1)(1997-6#1)(2004-4#1)(2005-11#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#17)(2008-12#1)(2008-2#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-7#1)
samples available##3##2##(1993-6#1)(2005-7#1)(2008-10#1)
samples based on the use of##2##6##(2008-10#2)
samples based on the##4##4##(2008-10#3)(2008-5#1)
samples based on##11##3##(2006-10#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-5#1)(2012-2#1)(2013-7#1)
samples because##2##2##(2008-10#1)(2008-4#1)
samples before and after##2##4##(2008-2#1)(2011-1#1)
samples before##8##2##(1996-8#1)(2008-10#4)(2008-2#1)(2008-5#1)(2011-1#1)
samples being##4##2##(1996-8#1)(2008-10#1)(2012-12#1)(2012-2#1)
samples belonged to##3##3##(2008-10#2)(2011-2#1)
samples belonging to##3##3##(2007-7#1)(2008-10#1)(2010-4#1)
samples both##4##2##(1992-2#1)(2008-10#1)(2008-2#1)(2008-3#1)
samples bought from Osu and Nima##2##6##(2007-2#2)
samples bought##3##2##(2007-2#3)
samples but not##2##3##(2008-10#2)
samples but##5##2##(1995-1#1)(2008-10#3)(2011-2#1)
samples by FAAS##2##3##(2008-10#2)
samples by Fourier transform infrared##2##5##(2006-12#1)(2007-8#1)
samples by HPLC##3##3##(1991-2#1)(2008-10#2)
samples by a##2##3##(2008-10#2)
samples by capillary##4##3##(1996-5#1)(2008-10#3)
samples by electrothermal atomic absorption spectrometry using##3##7##(2008-10#3)
samples by electrothermal atomic absorption spectrometry##7##6##(2008-10#7)
samples by electrothermal atomic absorption##8##5##(2008-10#8)
samples by electrothermal##10##3##(2008-10#10)
samples by extraction##2##3##(2008-10#2)
samples by flame AAS##3##4##(2008-10#3)
samples by flame atomic absorption spectrometry##5##6##(2007-8#1)(2008-10#4)
samples by flame atomic absorption##6##5##(2007-8#1)(2008-10#5)
samples by flame##9##3##(2007-8#1)(2008-10#8)
samples by flow injection##2##4##(2008-10#1)(2008-3#1)
samples by flow##3##3##(2008-10#2)(2008-3#1)
samples by flow-injection##3##3##(2008-10#3)
samples by gas chromatography with##2##5##(2008-10#2)
samples by gas chromatography##4##4##(2008-10#4)
samples by gas##5##3##(2008-10#5)
samples by graphite furnace atomic absorption spectrometry (GFAAS)##2##8##(2008-10#2)
samples by graphite furnace atomic absorption spectrometry after##3##8##(2008-10#3)
samples by graphite furnace atomic absorption spectrometry##7##7##(2008-10#7)
samples by graphite furnace atomic absorption##8##6##(2005-4#1)(2008-10#7)
samples by graphite furnace atomic##9##5##(2005-4#1)(2008-10#8)
samples by high-performance liquid chromatography with##3##6##(1992-2#1)(1993-2#2)
samples by high-performance liquid chromatography##4##5##(1992-2#1)(1993-2#2)(1993-9#1)
samples by high-performance liquid##5##4##(1992-2#1)(1993-2#2)(1993-9#1)(1996-6#1)
samples by high-performance##6##3##(1992-2#1)(1993-2#2)(1993-9#1)(1996-6#1)(2008-10#1)
samples by hydride generation-four-channel##2##4##(2008-10#2)
samples by hydride##6##3##(2008-10#6)
samples by inductively coupled plasma atomic emission spectrometry##3##8##(1992-3#1)(2008-10#2)
samples by inductively coupled plasma atomic emission##4##7##(1992-3#1)(2008-10#3)
samples by inductively coupled plasma##7##5##(1992-3#1)(1996-3#1)(2008-10#5)
samples by inductively coupled##8##4##(1992-3#1)(1996-3#1)(2008-10#6)
samples by liquid##2##3##(2008-10#2)
samples by solid phase micro-extraction##2##5##(1996-12#1)(2008-10#1)
samples by solid phase##3##4##(1996-12#1)(2008-10#2)
samples by solid-phase##3##3##(2008-10#3)
samples by the proposed##2##4##(2008-10#2)
samples by the standard addition method##2##6##(2008-10#2)
samples by the##15##3##(1991-9#1)(2005-11#1)(2007-12#1)(2008-10#11)(2009-5#1)
samples by this method were##2##5##(2008-10#2)
samples by this method##4##4##(2005-4#1)(2008-10#3)
samples by this##5##3##(2005-4#1)(2008-10#4)
samples by use of##2##4##(2007-12#1)(2008-3#1)
samples by using a##3##4##(2008-10#3)
samples by using the##2##4##(2008-10#2)
samples by using##9##3##(2008-10#8)(2012-3#1)
samples by##206##2##(1991-2#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-2#2)(1993-9#1)(1994-3#3)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#1)(2005-11#1)(2005-12#2)(2005-4#3)(2005-8#1)(2006-12#2)(2006-8#1)(2007-12#2)(2007-8#3)(2008-10#148)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-11#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-8#1)
samples came from##4##3##(1991-6#1)(1992-12#1)(1995-6#1)(2007-8#1)
samples can be analyzed per hour with a relative standard deviation of less than##2##14##(2008-10#2)
samples can be analyzed per hour with a relative##3##9##(2008-10#3)
samples can be analyzed per hour##4##6##(2008-10#4)
samples can be analyzed##6##4##(2008-10#6)
samples can be processed in##2##5##(1990-12#1)(1993-2#1)
samples can be processed##3##4##(1990-12#1)(1993-2#1)(2008-10#1)
samples can be separated##2##4##(2008-10#1)(2008-3#1)
samples can be used##2##4##(2005-12#1)(2008-7#1)
samples can be##29##3##(1990-12#1)(1991-5#1)(1993-2#1)(2005-12#1)(2007-8#1)(2008-10#17)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-8#1)
samples cannot be##3##3##(2007-8#1)(2008-10#2)
samples collected after##2##3##(1992-2#1)(2013-8#1)
samples collected and##2##3##(2007-2#1)(2007-6#1)
samples collected at the##2##4##(2006-11#1)(2007-7#1)
samples collected at##8##3##(1995-12#1)(2006-11#1)(2007-7#1)(2008-10#3)(2008-5#1)(2012-11#1)
samples collected by##3##3##(2008-10#3)
samples collected during the##2##4##(1994-6#1)(2008-7#1)
samples collected during##4##3##(1993-2#2)(1994-6#1)(2008-7#1)
samples collected from 6##2##4##(2008-9#1)(2013-8#1)
samples collected from an##3##4##(2008-10#3)
samples collected from different##2##4##(2007-8#1)(2009-6#1)
samples collected from patients with##2##5##(1996-1#1)(2007-8#1)
samples collected from the##18##4##(1993-9#1)(2007-5#1)(2007-8#1)(2008-10#6)(2009-12#1)(2009-2#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-12#1)(2011-2#1)(2012-2#1)
samples collected from##67##3##(1993-9#3)(1996-1#1)(1996-12#2)(2005-11#2)(2006-4#1)(2006-8#1)(2007-5#5)(2007-8#4)(2008-10#22)(2008-11#1)(2008-12#1)(2008-5#4)(2008-9#1)(2009-12#1)(2009-2#2)(2009-6#1)(2010-5#1)(2010-8#1)(2010-9#3)(2011-1#1)(2011-12#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#2)
samples collected in the##8##4##(2006-12#1)(2008-10#4)(2008-5#2)(2012-2#1)
samples collected in##19##3##(2006-12#1)(2007-3#1)(2008-10#10)(2008-3#1)(2008-5#2)(2011-2#2)(2012-2#1)(2012-3#1)
samples collected on##3##3##(2010-2#1)(2010-9#1)(2012-3#1)
samples collected over##2##3##(2008-8#1)(2010-8#1)
samples collected##125##2##(1991-6#1)(1992-2#1)(1992-3#2)(1993-2#2)(1993-9#3)(1994-6#1)(1995-12#1)(1996-1#1)(1996-12#2)(1996-4#1)(2005-11#2)(2005-8#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-2#1)(2007-3#3)(2007-5#5)(2007-6#1)(2007-7#1)(2007-8#4)(2008-10#41)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#9)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#2)(2009-6#1)(2010-2#1)(2010-5#1)(2010-8#2)(2010-9#4)(2011-1#1)(2011-12#2)(2011-2#4)(2012-11#1)(2012-2#3)(2012-3#4)(2013-7#1)(2013-8#3)
samples coming from the##2##4##(2008-10#2)
samples coming from##3##3##(2008-10#3)
samples compared to##2##3##(1996-9#1)(2008-10#1)
samples compared well with those found by##2##7##(2008-10#2)
samples compared well with those##3##5##(2008-10#3)
samples compared well with##4##4##(1992-2#1)(2008-10#3)
samples compared with##2##3##(1991-5#1)(2009-4#1)
samples compared##9##2##(1991-5#1)(1992-2#1)(1992-7#1)(1996-9#1)(2008-10#4)(2009-4#1)
samples confirmed##2##2##(2006-8#1)(2008-10#1)
samples contain##5##2##(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#1)
samples contained##14##2##(1990-11#1)(1991-5#1)(1993-2#1)(1994-2#1)(2006-4#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-10#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#2)
samples containing 0##3##3##(1992-3#1)(2007-12#1)(2008-10#1)
samples containing a##4##3##(2007-9#1)(2008-10#2)(2008-12#1)
samples containing both##2##3##(2008-10#2)
samples containing different concentrations of##2##5##(2008-10#2)
samples containing high##5##3##(2008-10#3)(2009-8#1)(2012-12#1)
samples containing low concentrations of##3##5##(2008-10#2)(2012-12#1)
samples containing the##2##3##(1990-11#1)(2008-2#1)
samples containing##65##2##(1990-11#1)(1991-12#1)(1992-11#1)(1992-3#1)(1993-2#1)(1996-12#1)(1997-2#1)(1997-7#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#33)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-8#1)(2009-10#1)(2009-8#1)(2010-4#3)(2010-5#1)(2012-11#2)(2012-12#2)(2013-8#1)
samples corresponding to##5##3##(1996-3#2)(2008-10#3)
samples could be##19##3##(1990-6#1)(1990-8#1)(1992-10#1)(1993-2#1)(1994-2#1)(1995-1#1)(2005-4#1)(2007-8#1)(2008-10#10)(2011-2#1)
samples could##22##2##(1990-6#1)(1990-8#1)(1991-1#1)(1992-10#1)(1993-2#1)(1994-2#1)(1995-1#1)(2005-4#1)(2007-8#1)(2008-10#12)(2011-2#1)
samples covering a##2##3##(2008-10#1)(2008-3#1)
samples cured with LED LCU##2##5##(2007-9#2)
samples demonstrated that the##2##4##(2008-10#2)
samples demonstrated that##3##3##(2008-10#2)(2012-3#1)
samples demonstrated##7##2##(1991-10#1)(1997-8#1)(2008-10#4)(2012-3#1)
samples depleted of##2##3##(1995-12#1)(1995-8#1)
samples derived from##2##3##(1990-11#1)(1996-4#1)
samples despite##2##2##(2008-10#1)(2013-8#1)
samples determined##4##2##(2008-10#1)(2008-12#1)(2008-5#1)(2012-3#1)
samples did not differ##2##4##(1995-6#1)(2009-8#1)
samples did not##4##3##(1995-6#1)(2008-10#1)(2008-11#1)(2009-8#1)
samples directly into##2##3##(1990-8#1)(2008-10#1)
samples directly##4##2##(1990-8#1)(2008-10#1)(2008-5#1)(2011-1#1)
samples displaying##2##2##(1990-2#1)(2008-10#1)
samples does not##3##3##(2005-11#1)(2008-10#1)(2008-3#1)
samples during the##2##3##(2008-5#1)(2012-12#1)
samples during##7##2##(1997-6#1)(2007-8#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-7#2)
samples each##4##2##(1996-8#1)(2008-10#1)(2013-1#2)
samples elaborated##2##2##(2008-10#2)
samples examined for##2##3##(2007-2#1)(2009-10#1)
samples examined##13##2##(1992-2#1)(1994-6#1)(1996-2#1)(2007-2#2)(2008-12#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
samples exhibit##2##2##(2004-9#1)(2009-11#1)
samples exhibited##4##2##(2004-9#1)(2008-1#1)(2008-10#1)(2008-2#1)
samples exhibiting##2##2##(2008-10#1)(2011-2#1)
samples exposed to##2##3##(2006-3#1)(2008-11#1)
samples extracted from##5##3##(2005-11#1)(2008-10#1)(2009-4#1)(2012-3#1)(2013-1#1)
samples extracted##7##2##(2005-11#1)(2008-10#2)(2009-4#1)(2010-12#1)(2012-3#1)(2013-1#1)
samples fixed in##2##3##(2008-10#1)(2010-12#1)
samples followed by##3##3##(1994-9#1)(2008-10#1)(2012-1#1)
samples followed##4##2##(1994-9#1)(2008-10#1)(2012-1#1)(2012-12#1)
samples following##5##2##(1990-4#1)(1994-12#1)(2007-12#1)(2008-10#1)(2010-12#1)
samples for subsequent##2##3##(2008-10#2)
samples for the determination of##4##5##(1994-3#1)(2008-10#3)
samples for the measurement##2##4##(2006-6#1)(2008-10#1)
samples for the presence of##3##5##(1990-5#1)(1994-11#1)(2008-9#1)
samples for the##12##3##(1990-5#1)(1993-1#1)(1994-11#1)(1994-3#1)(2006-6#1)(2008-1#1)(2008-10#4)(2008-7#1)(2008-9#1)
samples for which the##2##4##(2008-10#1)(2008-3#1)
samples for##78##2##(1990-5#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-12#1)(1993-1#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-6#1)(2005-11#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#25)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#3)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#6)(2013-7#2)
samples fortified##3##2##(2008-10#3)
samples found to be##2##4##(2008-10#1)(2008-5#1)
samples found##5##2##(1992-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-5#1)
samples from 11##2##3##(2007-8#1)(2008-10#1)
samples from 19##2##3##(2007-8#1)(2008-5#1)
samples from 20##2##3##(1993-8#1)(1996-9#1)
samples from 24##2##3##(2008-10#1)(2012-12#1)
samples from 28##2##3##(1990-5#1)(1997-1#1)
samples from 3##2##3##(2008-3#1)(2011-12#1)
samples from 5##2##3##(2012-3#1)(2013-1#1)
samples from 78##2##3##(1991-4#1)(1992-6#1)
samples from HIV infected patients##2##5##(1990-2#1)(2007-7#1)
samples from HIV##3##3##(1990-2#1)(2007-11#1)(2007-7#1)
samples from a separate##2##4##(1993-1#1)(1993-7#1)
samples from a##17##3##(1990-9#1)(1991-5#1)(1992-2#1)(1993-1#1)(1993-7#1)(1993-9#1)(1994-12#1)(1996-9#1)(2008-10#6)(2009-3#1)(2010-11#1)(2011-1#1)
samples from all##3##3##(2006-5#1)(2008-10#1)(2008-5#1)
samples from an##7##3##(2008-10#5)(2008-12#1)(2011-2#1)
samples from approximately##2##3##(1996-5#1)(2013-8#1)
samples from both##4##3##(1994-2#1)(1995-12#1)(2007-12#1)(2008-12#1)
samples from cancer patients##3##4##(1995-1#1)(1996-11#1)(2008-10#1)
samples from children##2##3##(2007-1#1)(2007-2#1)
samples from deceased##2##3##(1997-3#1)(2007-2#1)
samples from diabetic patients##2##4##(2005-12#1)(2008-10#1)
samples from different sources##2##4##(2007-8#1)(2008-10#1)
samples from different##16##3##(2005-10#1)(2007-1#1)(2007-8#1)(2008-10#10)(2008-2#1)(2011-1#1)(2013-1#1)
samples from each##3##3##(2008-12#1)(2010-4#1)(2011-2#1)
samples from five##2##3##(2008-10#1)(2013-8#1)
samples from four##4##3##(1996-3#1)(2007-5#1)(2008-10#1)(2008-6#1)
samples from groups of##2##4##(1991-3#1)(1996-12#1)
samples from healthy adults##2##4##(2008-10#1)(2009-8#1)
samples from healthy##9##3##(2005-10#1)(2008-10#2)(2008-4#1)(2008-9#1)(2009-8#1)(2010-4#1)(2011-2#2)
samples from individuals##3##3##(1993-12#1)(1993-3#1)(2008-10#1)
samples from infected##2##3##(2008-12#1)(2010-12#1)
samples from items of the cultural heritage of Valencia (Spain)##2##10##(2008-10#2)
samples from local markets##2##4##(2008-10#2)
samples from major##2##3##(2007-8#1)(2010-4#1)
samples from male##2##3##(1996-7#1)(2008-9#1)
samples from nine##2##3##(1996-4#1)(2007-2#1)
samples from normal##2##3##(1991-2#1)(2009-4#1)
samples from patients with##12##4##(1990-6#1)(1992-8#1)(1993-9#1)(1996-1#1)(1997-3#1)(1997-7#1)(2007-8#1)(2009-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
samples from patients##21##3##(1990-11#1)(1990-6#1)(1991-11#1)(1992-10#1)(1992-2#1)(1992-8#1)(1993-8#1)(1993-9#1)(1996-1#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-7#1)(2006-8#1)(2007-8#1)(2008-10#1)(2009-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
samples from rural domestic##2##4##(2013-1#2)
samples from seven##2##3##(1992-6#1)(1996-7#1)
samples from several##6##3##(2008-10#5)(2010-5#1)
samples from suspected##2##3##(1990-7#1)(2012-12#1)
samples from the same##3##4##(2007-1#1)(2007-3#1)(2008-9#1)
samples from the three lowland stretches##2##6##(1993-9#2)
samples from the three##3##4##(1993-9#2)(2008-10#1)
samples from the##41##3##(1992-4#2)(1993-7#2)(1993-9#3)(1995-11#1)(1996-12#1)(1997-1#1)(1997-8#1)(2006-3#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-5#1)(2008-10#9)(2008-11#1)(2008-5#2)(2008-9#2)(2010-12#1)(2010-4#2)(2010-6#2)(2011-12#1)(2012-12#1)(2013-1#2)(2013-8#1)
samples from their##2##3##(2008-10#1)(2008-4#1)
samples from these##4##3##(1991-8#1)(1996-6#1)(2007-3#1)(2007-8#1)
samples from three##6##3##(1990-1#1)(1992-7#1)(1997-4#1)(2006-8#1)(2008-10#2)
samples from two##6##3##(1990-12#1)(1992-1#1)(1994-7#1)(1995-5#1)(1996-12#1)(2011-1#1)
samples from various##2##3##(2006-3#1)(2013-8#1)
samples from which##3##3##(2008-10#2)(2008-7#1)
samples from women with##3##4##(1993-1#1)(1994-3#1)(1995-12#1)
samples from##425##2##(1990-1#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-2#2)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#1)(1993-1#4)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#5)(1993-8#2)(1993-9#6)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#5)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#3)(1996-1#3)(1996-11#2)(1996-12#5)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#3)(1996-8#1)(1996-9#2)(1997-1#2)(1997-3#4)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#1)(2004-9#1)(2005-10#2)(2005-11#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#5)(2007-1#3)(2007-10#2)(2007-11#1)(2007-12#5)(2007-2#9)(2007-3#3)(2007-5#3)(2007-7#5)(2007-8#10)(2008-1#1)(2008-10#109)(2008-11#4)(2008-12#11)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#13)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#8)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-4#8)(2010-5#1)(2010-6#3)(2010-8#2)(2011-1#7)(2011-10#1)(2011-12#2)(2011-2#11)(2012-12#5)(2012-2#4)(2012-3#4)(2013-1#16)(2013-8#10)
samples gave positive results in##3##5##(1997-4#1)(1997-7#2)
samples gave results that##2##4##(1991-8#1)(2008-10#1)
samples gave results##3##3##(1991-8#1)(2005-12#1)(2008-10#1)
samples gave##12##2##(1991-8#1)(1995-10#1)(1997-1#1)(1997-4#1)(1997-7#2)(2005-12#1)(2008-10#4)(2009-1#1)
samples generated##3##2##(1992-2#1)(2008-10#1)(2010-2#1)
samples h(-1) were##2##3##(2008-10#2)
samples h(-1)##33##2##(2008-10#33)
samples h(-1))##4##2##(2008-10#4)
samples had a##3##3##(1993-9#1)(2010-4#1)(2013-8#1)
samples had no##3##3##(2006-12#1)(2008-10#1)(2008-11#1)
samples had##18##2##(1993-9#2)(1994-3#1)(1995-5#1)(1996-7#1)(2006-12#2)(2006-5#2)(2007-2#1)(2007-5#2)(2007-8#1)(2008-10#2)(2008-11#1)(2010-4#1)(2013-8#1)
samples harvested##2##2##(2008-11#1)(2010-5#1)
samples has been carried out##2##5##(2008-10#2)
samples has been determined##2##4##(2008-10#2)
samples has been developed##4##4##(2007-8#1)(2008-10#3)
samples has been##21##3##(1997-2#1)(2007-8#2)(2008-10#18)
samples has##27##2##(1997-2#1)(2007-12#1)(2007-8#2)(2008-10#22)(2011-2#1)
samples have been carried##2##4##(2005-11#1)(2012-1#1)
samples have been collected##2##4##(2008-11#1)(2008-12#1)
samples have been performed##2##4##(2008-1#1)(2008-3#1)
samples have been studied##2##4##(2008-7#1)(2010-8#1)
samples have been used##2##4##(1995-10#1)(2008-10#1)
samples have been##19##3##(1995-10#1)(2005-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-8#1)(2012-1#1)
samples have##25##2##(1995-10#1)(1997-4#1)(2005-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-4#2)(2010-8#1)(2011-2#1)(2012-1#1)
samples having##5##2##(2007-12#1)(2007-5#1)(2008-10#2)(2012-2#1)
samples heated at 1100 degrees C##2##6##(2010-4#2)
samples imply##2##2##(2008-10#1)(2008-5#1)
samples in China##2##3##(2005-11#1)(2008-10#1)
samples in a short##2##4##(1996-6#1)(2010-11#1)
samples in a wide range of##2##6##(2008-10#1)(2008-3#1)
samples in a##16##3##(1993-2#2)(1994-11#1)(1996-6#1)(2004-9#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-6#1)(2010-11#1)
samples in an##2##3##(2006-2#1)(2008-3#1)
samples in aqueous##2##3##(2008-10#2)
samples in different##2##3##(2008-10#1)(2013-1#1)
samples in order to##6##4##(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2011-1#1)
samples in six##2##3##(2008-5#2)
samples in the range##4##4##(1995-2#1)(2008-10#3)
samples in the##23##3##(1992-9#1)(1993-12#1)(1995-2#1)(2007-4#1)(2007-5#1)(2008-10#11)(2008-3#2)(2009-5#1)(2010-4#1)(2010-9#1)(2011-2#2)
samples in this study##2##4##(2008-10#1)(2010-4#1)
samples in this##3##3##(1995-1#1)(2008-10#1)(2010-4#1)
samples in which##3##3##(2008-10#1)(2010-4#1)(2013-1#1)
samples in##129##2##(1990-11#1)(1990-12#1)(1990-8#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#3)(1994-11#1)(1995-1#1)(1995-2#1)(1996-6#2)(2004-9#2)(2005-11#2)(2006-2#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#48)(2008-11#2)(2008-2#3)(2008-3#9)(2008-4#3)(2008-5#6)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-4#4)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#7)(2012-11#1)(2012-2#4)(2013-1#2)
samples included##2##2##(2009-4#1)(2012-1#1)
samples including##5##2##(2007-1#1)(2008-10#3)(2008-4#1)
samples indicated that##3##3##(2005-11#1)(2008-10#1)(2008-12#1)
samples indicated##4##2##(2005-11#1)(2008-10#1)(2008-12#1)(2009-6#1)
samples indicates that the##2##4##(1997-5#1)(2008-3#1)
samples indicates that##4##3##(1997-5#1)(2008-10#1)(2008-3#1)(2011-2#1)
samples indicating the##2##3##(2004-4#1)(2005-11#1)
samples indicating##3##2##(2004-4#1)(2005-11#1)(2011-2#1)
samples infected##2##2##(2008-10#1)(2008-12#1)
samples into a##3##3##(1990-8#1)(2008-10#1)(2008-9#1)
samples into the##2##3##(2008-10#1)(2008-2#1)
samples into##9##2##(1990-8#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#1)
samples investigated##4##2##(1994-2#2)(2007-11#1)(2008-3#1)
samples is also##2##3##(2008-10#1)(2008-3#1)
samples is demonstrated##6##3##(2008-10#5)(2011-1#1)
samples is described##16##3##(2005-4#1)(2007-8#1)(2008-10#14)
samples is discussed##2##3##(2008-10#2)
samples is illustrated##2##3##(2008-10#2)
samples is necessary##2##3##(2007-2#1)(2008-10#1)
samples is not##2##3##(2008-10#2)
samples is of##2##3##(1990-4#1)(2008-10#1)
samples is presented##11##3##(1993-9#1)(1995-1#1)(1996-6#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-3#1)
samples is proposed##5##3##(2008-10#5)
samples is successful##3##3##(2008-10#3)
samples is##87##2##(1990-4#1)(1990-8#1)(1992-2#1)(1993-9#1)(1995-1#1)(1995-2#1)(1996-6#1)(1997-7#1)(2005-4#1)(2007-12#1)(2007-2#1)(2007-8#4)(2008-10#59)(2008-2#3)(2008-3#3)(2008-4#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
samples larger##2##2##(1995-4#1)(2008-3#1)
samples like##3##2##(1996-5#1)(2008-10#2)
samples may be##4##3##(2008-10#1)(2008-11#2)(2010-11#1)
samples may contain##2##3##(1995-1#1)(2008-10#1)
samples may have##3##3##(1990-11#1)(2010-8#1)(2012-11#1)
samples may##11##2##(1990-11#1)(1995-1#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2010-11#1)(2010-8#1)(2012-11#1)
samples measured##2##2##(2006-12#1)(2007-11#1)
samples more than##2##3##(2008-10#1)(2013-1#1)
samples more##3##2##(2006-10#1)(2008-10#1)(2013-1#1)
samples must be##3##3##(2008-10#2)(2012-12#1)
samples must##4##2##(2008-10#3)(2012-12#1)
samples need to be##2##4##(2008-12#1)(2008-5#1)
samples need##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
samples needed##2##2##(2008-10#2)
samples not##2##2##(2008-10#2)
samples obtained at##3##3##(1990-6#1)(1991-8#1)(1996-9#1)
samples obtained by FNAB##2##4##(1996-6#2)
samples obtained by##13##3##(1990-8#1)(1992-5#1)(1994-1#1)(1996-6#2)(2005-4#1)(2007-2#1)(2008-1#1)(2008-10#4)(2009-10#1)
samples obtained during##3##3##(1990-1#1)(1994-3#1)(2013-1#1)
samples obtained from hospitalized##2##4##(1992-3#1)(2008-10#1)
samples obtained from patients##3##4##(1993-9#1)(1995-12#1)(1996-8#1)
samples obtained from the##5##4##(1990-5#1)(1993-1#1)(1993-6#1)(2007-7#1)(2010-4#1)
samples obtained from##35##3##(1990-5#1)(1991-12#1)(1992-3#2)(1992-7#1)(1993-1#2)(1993-6#1)(1993-8#1)(1993-9#1)(1995-12#2)(1996-12#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-11#1)(2007-12#1)(2007-7#2)(2008-10#9)(2008-6#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
samples obtained with##3##3##(2008-10#1)(2011-1#1)(2011-12#1)
samples obtained##67##2##(1990-1#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-3#2)(1992-5#1)(1992-7#1)(1993-1#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-3#1)(1995-12#2)(1996-12#1)(1996-6#2)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-8#1)(2004-11#1)(2005-4#1)(2006-5#2)(2006-8#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#14)(2008-2#1)(2008-6#1)(2009-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
samples of &quot##2##3##(2008-10#2)
samples of 0##2##3##(2008-10#2)
samples of 10##2##3##(1996-3#1)(2007-8#1)
samples of 11##2##3##(2008-7#1)(2009-1#1)
samples of 18##2##3##(1991-5#1)(2008-5#1)
samples of 2##2##3##(2013-1#2)
samples of 20##2##3##(1994-6#1)(2008-5#1)
samples of 5##2##3##(2008-10#1)(2009-4#1)
samples of Cordyceps sinensis##3##4##(2007-1#3)
samples of Monsel's solution##2##4##(2006-10#2)
samples of Monsel's##4##3##(2006-10#4)
samples of N##2##3##(2008-10#2)
samples of a##7##3##(1990-10#1)(1990-8#1)(1994-12#1)(2008-10#3)(2008-11#1)
samples of adolescents##2##3##(2009-7#1)(2012-12#1)
samples of adult##2##3##(1993-9#1)(2009-5#1)
samples of all##4##3##(1990-11#1)(2004-11#1)(2004-9#1)(2013-1#1)
samples of amniotic fluid##2##4##(1993-12#1)(1995-8#1)
samples of an##4##3##(2005-11#1)(2007-12#1)(2008-10#2)
samples of animal##2##3##(2008-10#1)(2013-8#1)
samples of beef liver and muscle##2##6##(1997-8#2)
samples of blood or serum##2##5##(1996-8#1)(2007-2#1)
samples of blood##5##3##(1996-8#1)(2007-2#2)(2008-7#1)(2010-12#1)
samples of children##3##3##(2009-12#1)(2011-2#1)(2013-1#1)
samples of college##3##3##(2007-12#3)
samples of commercial##2##3##(2008-10#2)
samples of different origin##2##4##(2007-11#1)(2008-10#1)
samples of different types of##2##5##(2008-10#2)
samples of different types##3##4##(2008-10#3)
samples of different##14##3##(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#8)(2008-3#1)(2009-3#1)(2011-1#1)
samples of distilled##3##3##(2008-10#2)(2008-5#1)
samples of each patient##2##4##(2007-10#1)(2008-5#1)
samples of each##6##3##(1997-4#1)(2007-10#1)(2008-10#1)(2008-5#2)(2008-7#1)
samples of feces and##2##4##(2008-10#1)(2013-1#1)
samples of fish##2##3##(2008-10#2)
samples of gastric##2##3##(2008-10#1)(2008-4#1)
samples of healthy##4##3##(1996-7#1)(2008-10#1)(2008-12#1)(2013-1#1)
samples of human##8##3##(1990-12#1)(1991-9#1)(1994-11#1)(1994-3#1)(2008-10#1)(2008-4#1)(2012-12#2)
samples of interest##5##3##(1995-2#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-2#1)
samples of men##2##3##(2007-12#1)(2010-10#1)
samples of natural water##3##4##(2008-10#3)
samples of natural##6##3##(2008-10#6)
samples of normal##3##3##(1992-3#1)(1994-8#1)(2008-5#1)
samples of older##2##3##(2009-3#1)(2011-1#1)
samples of patients with##5##4##(1992-12#1)(1992-4#1)(1996-7#1)(2006-2#1)(2011-2#1)
samples of patients##9##3##(1992-12#1)(1992-4#1)(1996-7#1)(1997-8#1)(2006-2#1)(2007-8#1)(2008-10#1)(2011-1#1)(2011-2#1)
samples of plant##2##3##(2008-10#1)(2013-7#1)
samples of plants##2##3##(2008-10#1)(2011-12#1)
samples of plasma##2##3##(1997-3#1)(2008-10#1)
samples of primary##2##3##(1994-9#1)(2008-9#1)
samples of pure##2##3##(2007-5#1)(2008-11#1)
samples of rat##3##3##(1990-12#1)(2008-2#1)(2013-8#1)
samples of red##2##3##(2007-8#1)(2008-10#1)
samples of river##2##3##(2008-10#2)
samples of small##2##3##(1996-6#1)(2008-10#1)
samples of soil##2##3##(2007-10#1)(2008-10#1)
samples of standard##2##3##(2007-8#1)(2008-10#1)
samples of stratum corneum##2##4##(2008-5#2)
samples of suspected##2##3##(2012-3#1)(2013-8#1)
samples of the##26##3##(1991-1#1)(1996-2#1)(1996-3#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-3#1)
samples of these##3##3##(2007-10#1)(2007-8#1)(2008-10#1)
samples of treated##2##3##(1990-10#1)(2008-8#1)
samples of two##4##3##(1996-7#1)(2007-1#1)(2008-10#1)(2008-5#1)
samples of various##2##3##(2008-3#1)(2009-4#1)
samples of water##4##3##(2007-10#1)(2008-10#2)(2010-5#1)
samples of women##2##3##(2008-2#1)(2009-4#1)
samples of workers##2##3##(2007-3#1)(2013-1#1)
samples of##480##2##(1990-10#2)(1990-11#3)(1990-12#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#2)(1993-1#2)(1993-12#2)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-12#4)(1996-2#1)(1996-3#4)(1996-6#1)(1996-7#3)(1996-8#3)(1997-3#2)(1997-4#2)(1997-7#2)(1997-8#3)(2004-1#1)(2004-11#2)(2004-4#2)(2004-9#1)(2005-11#6)(2005-8#1)(2005-9#1)(2006-10#6)(2006-2#1)(2006-3#1)(2006-8#2)(2006-9#1)(2007-1#9)(2007-10#7)(2007-11#3)(2007-12#9)(2007-2#12)(2007-3#3)(2007-5#3)(2007-7#4)(2007-8#12)(2008-1#1)(2008-10#142)(2008-11#7)(2008-12#5)(2008-2#7)(2008-3#8)(2008-4#4)(2008-5#21)(2008-6#3)(2008-7#9)(2008-8#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#4)(2009-5#3)(2009-7#4)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-4#4)(2010-5#6)(2010-6#1)(2011-1#6)(2011-12#2)(2011-2#10)(2012-1#1)(2012-11#2)(2012-12#11)(2012-2#1)(2012-3#6)(2013-1#13)(2013-7#5)(2013-8#6)
samples on a##3##3##(2008-10#2)(2008-2#1)
samples on the##7##3##(2008-10#5)(2011-1#1)(2012-3#1)
samples on##19##2##(1992-8#1)(1996-3#2)(2006-8#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-8#1)(2011-1#1)(2012-3#1)
samples only##6##2##(1992-10#1)(1993-4#1)(2004-11#1)(2006-8#1)(2008-10#1)(2013-8#1)
samples or data##2##3##(2008-7#1)(2010-2#1)
samples or##18##2##(1993-11#1)(1993-5#1)(2005-11#1)(2005-4#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-2#1)(2011-2#1)
samples originated from##2##3##(1993-7#1)(2008-10#1)
samples originated##3##2##(1993-7#1)(2008-10#1)(2011-2#1)
samples originating from##2##3##(2008-10#2)
samples out of##4##3##(1992-12#1)(2007-2#1)(2008-10#1)(2008-6#1)
samples over a##3##3##(1996-9#1)(1997-8#1)(2008-10#1)
samples over##7##2##(1996-3#1)(1996-9#1)(1997-8#1)(2007-8#1)(2008-10#2)(2008-6#1)
samples passed##2##2##(2007-7#1)(2008-10#1)
samples per h and the##2##5##(2008-10#2)
samples per h and##3##4##(2008-10#3)
samples per h with a##3##5##(2008-10#3)
samples per h##13##3##(2008-10#13)
samples per hour analyzed by##2##5##(2008-10#2)
samples per hour and##6##4##(2008-10#6)
samples per hour could be##2##5##(2008-10#2)
samples per hour was achieved##2##5##(2008-10#2)
samples per hour was obtained##2##5##(2008-10#2)
samples per hour was##4##4##(2008-10#4)
samples per hour were##2##4##(2008-10#2)
samples per hour with a relative standard deviation##3##8##(2008-10#3)
samples per hour with a##4##5##(2008-10#4)
samples per hour##52##3##(2008-10#52)
samples per##78##2##(1995-2#1)(2008-10#69)(2008-5#2)(2009-8#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-7#1)
samples placed##2##2##(2006-3#1)(2008-10#1)
samples preparation##2##2##(2008-10#2)
samples prepared from##3##3##(1990-7#1)(2008-10#2)
samples prepared in##5##3##(2008-10#5)
samples prepared using the##2##4##(2008-5#2)
samples prepared using##5##3##(2005-11#2)(2008-5#3)
samples prepared with##6##3##(2008-10#3)(2008-5#1)(2009-3#1)(2011-1#1)
samples prepared##21##2##(1990-7#1)(2005-11#2)(2008-10#11)(2008-5#5)(2009-3#1)(2011-1#1)
samples presenting##2##2##(2008-9#2)
samples prior to the##2##4##(2008-10#2)
samples prior to##8##3##(2008-10#5)(2008-4#1)(2009-3#1)(2013-8#1)
samples processed##4##2##(2004-9#1)(2007-8#1)(2012-1#1)(2012-2#1)
samples produced##5##2##(1991-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)
samples provided by##2##3##(2008-12#1)(2012-1#1)
samples provided##8##2##(2007-2#1)(2008-10#3)(2008-12#2)(2008-8#1)(2012-1#1)
samples randomly##2##2##(2012-12#1)(2013-8#1)
samples range from##2##3##(2008-10#2)
samples ranged between##3##3##(2008-10#1)(2011-1#1)(2012-2#1)
samples ranged from 0##2##4##(2007-8#1)(2013-1#1)
samples ranged from 95##2##4##(2008-10#2)
samples ranged from 97##3##4##(2008-10#3)
samples ranged from 99##3##4##(2008-10#3)
samples ranged from##15##3##(1993-1#1)(2007-8#1)(2008-10#12)(2013-1#1)
samples ranged##18##2##(1993-1#1)(2007-8#1)(2008-10#13)(2011-1#1)(2012-2#1)(2013-1#1)
samples ranging from##2##3##(2008-10#1)(2008-11#1)
samples remained##3##2##(1992-6#1)(1996-12#1)(2008-5#1)
samples reported##2##2##(2008-10#1)(2011-2#1)
samples representing##2##2##(1992-3#1)(2008-4#1)
samples respectively##3##2##(1994-4#1)(2013-1#1)(2013-7#1)
samples resulted in##5##3##(2007-11#1)(2008-10#2)(2008-12#1)(2009-4#1)
samples resulted##6##2##(2007-11#1)(2008-10#2)(2008-12#1)(2009-4#1)(2013-1#1)
samples retained##2##2##(1995-1#1)(2008-12#1)
samples revealed that the##2##4##(2008-10#2)
samples revealed that##4##3##(2005-11#1)(2008-10#2)(2013-8#1)
samples revealed the##2##3##(2008-10#1)(2010-4#1)
samples revealed##10##2##(2005-11#1)(2008-10#5)(2009-3#1)(2010-4#1)(2013-8#2)
samples screened##3##2##(2008-10#2)(2008-7#1)
samples seized##2##2##(2010-5#1)(2013-7#1)
samples should be##3##3##(2007-7#1)(2008-10#1)(2010-4#1)
samples show##7##2##(1994-9#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)
samples showed a##4##3##(2007-2#1)(2007-8#1)(2008-10#1)(2008-6#1)
samples showed good##2##3##(2007-8#1)(2008-10#1)
samples showed that the##2##4##(2008-12#1)(2011-1#1)
samples showed that##6##3##(1990-2#1)(1990-5#1)(2007-8#1)(2008-10#1)(2008-12#1)(2011-1#1)
samples showed the presence of##2##5##(2008-10#1)(2012-12#1)
samples showed##27##2##(1990-12#1)(1990-2#1)(1990-5#1)(1994-3#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#3)(2008-10#6)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#2)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
samples showing##4##2##(1997-7#1)(2007-2#1)(2007-8#1)(2010-4#1)
samples significantly##4##2##(2007-3#2)(2008-10#1)(2010-12#1)
samples simultaneously##7##2##(1996-1#1)(1997-2#1)(1997-6#1)(2007-7#1)(2008-1#1)(2008-10#2)
samples since the##2##3##(2008-10#2)
samples solubilized with##2##3##(1992-6#1)(2008-10#1)
samples solubilized##3##2##(1992-6#1)(2008-10#2)
samples spiked at##2##3##(2008-10#1)(2011-2#1)
samples spiked with different##2##4##(2007-8#1)(2008-10#1)
samples spiked with known amounts of##2##6##(2008-10#2)
samples spiked with known##3##4##(2008-10#2)(2012-3#1)
samples spiked with the target##2##5##(2008-10#2)
samples spiked with##31##3##(1993-9#1)(2007-8#1)(2008-10#27)(2011-1#1)(2012-3#1)
samples spiked##33##2##(1993-9#1)(2007-8#1)(2008-10#28)(2011-1#1)(2011-2#1)(2012-3#1)
samples stored##2##2##(1993-10#1)(1995-1#1)
samples studied##12##2##(1991-12#1)(1991-5#1)(1992-6#1)(1996-12#1)(1997-3#1)(2007-7#1)(2008-10#5)(2011-2#1)
samples subjected to##5##3##(2004-9#1)(2005-11#1)(2009-11#1)(2009-7#1)(2013-1#1)
samples subjected##6##2##(2004-9#1)(2005-11#1)(2008-10#1)(2009-11#1)(2009-7#1)(2013-1#1)
samples submitted to##2##3##(2007-3#1)(2008-12#1)
samples submitted##3##2##(2007-3#1)(2008-12#1)(2013-8#1)
samples successfully##3##2##(2008-10#3)
samples such as urine##2##4##(2008-10#2)
samples such as water##2##4##(2008-10#2)
samples such as##21##3##(1996-12#1)(2007-11#1)(2008-1#1)(2008-10#16)(2008-7#1)(2012-12#1)
samples taken after 95 days of quarantine were##2##8##(2008-5#2)
samples taken after##3##3##(1996-2#1)(2008-5#2)
samples taken at##3##3##(1991-9#1)(1995-9#1)(2008-10#1)
samples taken from an##3##4##(2008-10#3)
samples taken from the##6##4##(1997-3#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-5#1)(2013-1#1)
samples taken from##20##3##(1990-12#1)(1990-8#1)(1990-9#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-10#8)(2008-12#1)(2008-5#1)(2009-10#1)(2010-4#1)(2013-1#1)
samples taken##37##2##(1990-12#1)(1990-8#1)(1990-9#2)(1991-9#1)(1992-3#1)(1992-4#1)(1994-12#1)(1994-6#1)(1995-4#1)(1995-7#1)(1995-9#1)(1996-2#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-10#9)(2008-12#2)(2008-5#4)(2009-10#1)(2009-6#1)(2010-4#1)(2011-2#1)(2013-1#1)
samples tested by##2##3##(2007-2#1)(2007-8#1)
samples tested positive##3##3##(1991-6#1)(2006-10#1)(2008-7#1)
samples tested##14##2##(1991-6#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-4#1)(2010-5#1)(2013-8#1)
samples than##3##2##(1990-8#1)(1994-2#1)(2008-10#1)
samples that are##9##3##(2008-10#4)(2008-2#3)(2008-3#1)(2008-7#1)
samples that contain##2##3##(2008-10#2)
samples that have been##2##4##(2008-10#1)(2008-4#1)
samples that have##3##3##(2008-10#2)(2008-4#1)
samples that were collected##3##4##(2007-8#1)(2008-10#1)(2012-3#1)
samples that were##12##3##(1992-6#1)(1996-8#1)(1997-3#1)(2007-2#2)(2007-8#1)(2008-10#3)(2008-3#1)(2009-4#1)(2012-3#1)
samples that##46##2##(1992-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(2004-11#1)(2005-8#1)(2007-2#2)(2007-3#1)(2007-5#1)(2007-8#2)(2008-10#20)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-6#2)(2008-7#1)(2009-4#1)(2012-3#1)(2013-8#1)
samples the wave front##2##4##(2007-12#1)(2008-3#1)
samples the##15##2##(1990-8#1)(1992-4#1)(1994-12#1)(2005-11#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-3#1)(2010-12#1)(2010-5#1)
samples through##4##2##(2008-10#4)
samples to be analyzed##2##4##(2008-10#1)(2008-4#1)
samples to be##11##3##(1994-3#1)(2007-3#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2011-2#2)
samples to determine##4##3##(2008-10#3)(2008-5#1)
samples to the##4##3##(2006-8#1)(2008-10#1)(2008-2#1)(2010-6#1)
samples to##49##2##(1991-9#1)(1993-2#1)(1994-3#1)(1996-9#1)(1997-7#1)(2006-5#2)(2006-8#1)(2007-3#2)(2007-8#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#1)(2009-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)
samples treated with##7##3##(2005-11#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-5#2)
samples treated##9##2##(2005-11#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-5#2)
samples under study##6##3##(2005-11#2)(2008-10#2)(2009-3#1)(2009-8#1)
samples under ultrasonic effect has been described##2##7##(2008-10#2)
samples under##17##2##(2004-9#1)(2005-11#3)(2006-5#1)(2007-8#1)(2008-10#6)(2008-4#1)(2009-3#1)(2009-8#1)(2010-9#1)(2013-1#1)
samples underwent##3##2##(1994-9#1)(2008-12#1)(2011-2#1)
samples used for##2##3##(1996-7#1)(2008-10#1)
samples used in##3##3##(2005-11#2)(2008-10#1)
samples used##6##2##(1996-7#1)(2005-11#2)(2008-10#2)(2011-2#1)
samples using a flow injection##2##5##(2008-10#2)
samples using a##13##3##(1990-8#1)(1990-9#1)(1996-5#1)(2007-8#1)(2008-10#8)(2008-3#1)
samples using an##2##3##(2007-8#1)(2008-10#1)
samples using electrothermal atomic absorption spectrometry with##2##7##(2008-10#2)
samples using electrothermal##3##3##(2008-10#3)
samples using flame atomic absorption spectrometry##2##6##(2007-8#1)(2008-10#1)
samples using flow injection##3##4##(2008-10#3)
samples using inductively coupled plasma##2##5##(2008-10#2)
samples using octadecyl##2##3##(2008-10#2)
samples using on-line##2##3##(2008-10#2)
samples using standard##2##3##(2008-10#2)
samples using the proposed##3##4##(2008-10#3)
samples using the##15##3##(1994-6#1)(2007-8#1)(2008-10#11)(2010-6#1)(2013-8#1)
samples using this##2##3##(2008-10#2)
samples using##100##2##(1990-8#1)(1990-9#1)(1991-8#1)(1993-2#1)(1994-6#1)(1996-5#1)(1997-2#1)(2005-4#1)(2007-8#5)(2008-10#72)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2009-12#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-6#1)(2010-7#1)(2013-1#1)(2013-8#1)
samples varied##3##2##(2008-10#3)
samples was 0##4##3##(2007-3#1)(2008-10#3)
samples was 1##2##3##(1996-6#1)(2008-10#1)
samples was 98##3##3##(1990-2#1)(1996-6#1)(2005-4#1)
samples was achieved##2##3##(1990-12#1)(2007-8#1)
samples was also##9##3##(2008-10#8)(2009-8#1)
samples was analyzed##2##3##(2007-10#1)(2008-10#1)
samples was assessed##2##3##(2008-10#1)(2008-5#1)
samples was carried out by##2##5##(2008-10#2)
samples was carried out using##2##5##(2007-8#1)(2008-10#1)
samples was carried out##10##4##(2007-1#1)(2007-10#1)(2007-8#1)(2008-10#6)(2009-6#1)
samples was checked by##2##4##(2008-10#1)(2013-1#1)
samples was demonstrated##2##3##(2008-10#2)
samples was detected##2##3##(1996-9#1)(2008-10#1)
samples was determined by Zeeman graphite AAS##2##7##(2005-4#2)
samples was determined by##5##4##(2005-4#2)(2008-10#3)
samples was determined##9##3##(1995-12#1)(2005-4#2)(2008-10#6)
samples was developed by##2##4##(2008-10#2)
samples was developed##11##3##(1990-12#1)(2007-8#1)(2008-10#9)
samples was evaluated##2##3##(2008-10#2)
samples was found to be##2##5##(2008-10#1)(2009-5#1)
samples was found to##3##4##(2008-10#2)(2009-5#1)
samples was found##5##3##(2008-10#3)(2008-5#1)(2009-5#1)
samples was investigated##5##3##(2008-10#4)(2011-1#1)
samples was less than##3##4##(2007-10#1)(2008-10#2)
samples was lower##2##3##(1995-2#1)(2008-12#1)
samples was made##3##3##(2008-10#2)(2008-3#1)
samples was measured using##2##4##(2008-6#1)(2011-12#1)
samples was measured##6##3##(1992-2#1)(2007-5#1)(2008-10#2)(2008-6#1)(2011-12#1)
samples was not##2##3##(2008-10#1)(2008-9#1)
samples was performed in##2##4##(2008-1#1)(2008-10#1)
samples was performed##7##3##(2007-8#1)(2008-1#1)(2008-10#4)(2009-4#1)
samples was positive by PCR##2##5##(1991-9#1)(2008-5#1)
samples was positive##3##3##(1991-9#1)(2007-2#1)(2008-5#1)
samples was significantly higher (P &lt##2##6##(1996-12#1)(2007-6#1)
samples was significantly higher in##2##5##(1991-7#1)(2010-4#1)
samples was significantly higher##4##4##(1991-7#1)(1996-12#1)(2007-6#1)(2010-4#1)
samples was significantly##5##3##(1991-7#1)(1996-12#1)(2007-5#1)(2007-6#1)(2010-4#1)
samples was similar to##2##4##(1996-3#1)(2008-10#1)
samples was similar##3##3##(1996-3#1)(2008-10#1)(2012-12#1)
samples was studied##3##3##(2008-10#2)(2011-1#1)
samples was then##2##3##(2007-8#1)(2008-10#1)
samples was used to##2##4##(2008-10#1)(2009-4#1)
samples was used##4##3##(2008-10#3)(2009-4#1)
samples was##176##2##(1990-1#1)(1990-12#2)(1990-2#1)(1990-8#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-8#2)(1993-11#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-7#1)(2005-4#3)(2006-5#1)(2007-1#1)(2007-10#3)(2007-2#3)(2007-3#2)(2007-5#2)(2007-6#1)(2007-8#8)(2008-1#1)(2008-10#97)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-4#1)(2011-1#3)(2011-12#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
samples we##2##2##(1990-7#1)(2007-12#1)
samples were 0##6##3##(1996-6#1)(2005-12#1)(2008-10#3)(2008-5#1)
samples were 1##2##3##(2008-10#2)
samples were 4##2##3##(2008-10#2)
samples were 5##2##3##(2008-10#1)(2008-5#1)
samples were achieved##2##3##(2008-10#1)(2008-2#1)
samples were almost##2##3##(2008-10#2)
samples were also analysed##2##4##(2008-10#1)(2010-4#1)
samples were also collected##2##4##(1994-6#1)(1997-4#1)
samples were also obtained##2##4##(1994-12#1)(2013-8#1)
samples were also tested##4##4##(1994-3#1)(2008-10#2)(2008-3#1)
samples were also##22##3##(1994-12#1)(1994-3#1)(1994-6#1)(1996-1#1)(1997-4#1)(2006-7#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#9)(2008-3#1)(2010-4#1)(2012-12#1)(2013-8#1)
samples were analysed by##3##4##(2004-4#1)(2008-10#2)
samples were analysed for##2##4##(1993-9#1)(2012-6#1)
samples were analysed using##2##4##(1996-6#1)(2008-10#1)
samples were analysed with##3##4##(2008-10#2)(2008-11#1)
samples were analysed##14##3##(1993-9#1)(1996-6#1)(1997-3#1)(2004-4#1)(2008-10#7)(2008-11#1)(2012-6#1)(2013-7#1)
samples were analyzed by this##2##5##(2005-4#1)(2008-10#1)
samples were analyzed by##12##4##(1993-3#1)(1996-11#1)(2005-11#1)(2005-4#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-4#1)(2009-6#1)(2011-2#2)
samples were analyzed for the##2##5##(1997-2#1)(2008-10#1)
samples were analyzed for total##2##5##(2008-10#1)(2008-5#1)
samples were analyzed for##9##4##(1997-2#1)(2006-5#1)(2008-10#4)(2008-5#1)(2011-1#2)
samples were analyzed from##2##4##(2007-10#1)(2007-2#1)
samples were analyzed in##2##4##(2008-10#1)(2010-4#1)
samples were analyzed using##5##4##(2007-5#1)(2007-8#1)(2008-10#1)(2008-12#1)(2012-2#1)
samples were analyzed##41##3##(1990-11#1)(1993-3#1)(1996-11#1)(1997-2#1)(2005-11#1)(2005-4#1)(2006-10#2)(2006-5#1)(2007-10#1)(2007-2#1)(2007-5#1)(2007-8#3)(2008-10#13)(2008-12#2)(2008-4#1)(2008-5#1)(2009-6#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-2#1)
samples were assayed for##2##4##(2007-8#1)(2012-2#1)
samples were assayed##5##3##(1994-11#1)(2007-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
samples were available##3##3##(1990-1#1)(2007-12#1)(2008-10#1)
samples were below the##2##4##(2007-2#1)(2007-4#1)
samples were below##4##3##(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#1)
samples were between##6##3##(2008-10#5)(2008-5#1)
samples were characterized by##3##4##(2005-11#1)(2007-12#1)(2009-11#1)
samples were characterized##4##3##(2005-11#2)(2007-12#1)(2009-11#1)
samples were classified into##2##4##(2008-10#1)(2010-4#1)
samples were classified##3##3##(2008-10#2)(2010-4#1)
samples were collected after##2##4##(1996-11#1)(2006-5#1)
samples were collected and analyzed for##2##6##(2008-5#1)(2008-7#1)
samples were collected and used##2##5##(2008-12#1)(2013-1#1)
samples were collected and##9##4##(1997-2#1)(2007-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-4#1)(2011-1#1)(2013-1#1)
samples were collected at 0##2##5##(2007-1#1)(2007-2#1)
samples were collected at different##2##5##(2007-10#1)(2012-1#1)
samples were collected at the##2##5##(1995-6#1)(2007-2#1)
samples were collected at##14##4##(1991-6#1)(1993-4#1)(1995-6#1)(2007-1#1)(2007-10#1)(2007-2#2)(2007-5#2)(2008-10#1)(2008-3#1)(2008-5#1)(2012-1#1)(2013-8#1)
samples were collected before and after##2##6##(2006-5#1)(2013-1#1)
samples were collected before and at##2##6##(1995-4#1)(2011-2#1)
samples were collected before and##7##5##(1991-12#1)(1995-4#1)(2006-5#1)(2007-9#2)(2011-2#1)(2013-1#1)
samples were collected before##11##4##(1991-12#1)(1993-3#1)(1993-7#1)(1995-4#1)(2006-5#1)(2007-8#1)(2007-9#2)(2011-2#1)(2012-12#1)(2013-1#1)
samples were collected during the##2##5##(2006-8#1)(2011-2#1)
samples were collected during three##2##5##(2008-5#1)(2008-7#1)
samples were collected during##7##4##(1991-6#1)(2006-8#1)(2007-2#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-8#1)
samples were collected for the##2##5##(2008-12#1)(2011-2#1)
samples were collected for##10##4##(1991-2#1)(1993-4#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2010-4#1)(2011-2#1)(2013-8#1)
samples were collected from 12##2##5##(2009-6#1)(2012-3#1)
samples were collected from cattle##2##5##(2011-2#1)(2012-2#1)
samples were collected from five##2##5##(2008-10#2)
samples were collected from patients##2##5##(2008-2#1)(2012-3#1)
samples were collected from six##2##5##(2008-10#1)(2010-6#1)
samples were collected from the##7##5##(2007-2#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-8#1)
samples were collected from##53##4##(1992-10#1)(1997-6#1)(2004-4#1)(2006-10#1)(2006-5#2)(2007-10#1)(2007-2#4)(2007-5#3)(2007-7#2)(2008-10#6)(2008-12#2)(2008-2#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-4#3)(2009-6#2)(2010-2#2)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
samples were collected in##5##4##(1996-12#1)(2008-10#1)(2011-1#1)(2011-12#1)(2011-2#1)
samples were collected on##3##4##(2006-8#1)(2007-12#1)(2008-5#1)
samples were collected to measure##2##5##(2008-10#1)(2008-7#1)
samples were collected to##3##4##(2008-10#1)(2008-7#1)(2009-4#1)
samples were collected twice##3##4##(2006-5#1)(2008-10#1)(2012-2#1)
samples were collected until##2##4##(2008-10#2)
samples were collected##149##3##(1990-12#1)(1991-12#1)(1991-2#1)(1991-6#2)(1992-10#1)(1992-4#1)(1993-11#1)(1993-3#1)(1993-4#2)(1993-7#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-2#2)(1997-6#2)(1997-7#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-5#5)(2006-8#2)(2007-1#2)(2007-10#3)(2007-12#1)(2007-2#11)(2007-5#5)(2007-7#3)(2007-8#2)(2007-9#2)(2008-10#16)(2008-12#4)(2008-2#1)(2008-3#2)(2008-5#8)(2008-7#5)(2008-9#1)(2009-11#1)(2009-4#4)(2009-5#1)(2009-6#3)(2010-2#2)(2010-4#2)(2010-6#1)(2010-8#2)(2011-1#6)(2011-12#1)(2011-2#8)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#7)
samples were comparable##2##3##(2008-10#2)
samples were concentrated##3##3##(2006-12#1)(2008-10#1)(2011-1#1)
samples were cultured on##2##4##(2011-1#1)(2011-2#1)
samples were cultured##4##3##(2008-2#1)(2008-5#1)(2011-1#1)(2011-2#1)
samples were detected by##2##4##(2007-1#1)(2013-8#1)
samples were determined by##7##4##(2007-1#1)(2008-10#4)(2008-3#1)(2011-1#1)
samples were determined with satisfactory results##2##6##(2008-10#2)
samples were determined with the##2##5##(2008-10#2)
samples were determined with##5##4##(2008-10#5)
samples were determined##17##3##(1992-8#1)(2007-1#1)(2007-10#1)(2008-10#12)(2008-3#1)(2011-1#1)
samples were developed##2##3##(1990-8#1)(2008-10#1)
samples were digested by##2##4##(2008-10#2)
samples were digested##5##3##(2008-10#5)
samples were diluted and##2##4##(1993-11#1)(2006-8#1)
samples were diluted with##3##4##(2006-12#1)(2008-10#2)
samples were diluted##6##3##(1993-11#1)(2006-12#1)(2006-8#1)(2008-10#3)
samples were drawn at baseline##2##5##(2012-3#1)(2013-8#1)
samples were drawn at##4##4##(1991-12#1)(1994-9#1)(2012-3#1)(2013-8#1)
samples were drawn before##2##4##(1990-11#1)(1991-6#1)
samples were drawn from##3##4##(2008-1#1)(2008-10#1)(2013-1#1)
samples were drawn##13##3##(1990-11#1)(1991-12#1)(1991-6#1)(1994-9#1)(1997-1#1)(2005-12#1)(2007-10#1)(2008-1#1)(2008-10#1)(2010-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
samples were due##2##3##(1997-4#1)(2010-4#1)
samples were estimated##2##3##(2008-10#2)
samples were evaluated for##3##4##(1990-12#1)(2008-5#1)(2009-4#1)
samples were evaluated##6##3##(1990-12#1)(2005-11#1)(2008-5#1)(2009-4#1)(2011-2#1)(2013-8#1)
samples were examined by##2##4##(2011-2#1)(2013-1#1)
samples were examined for the##2##5##(1996-8#1)(2007-7#1)
samples were examined##6##3##(1996-8#1)(2007-7#1)(2008-10#2)(2011-2#1)(2013-1#1)
samples were extracted and##2##4##(2008-5#1)(2011-3#1)
samples were extracted by##3##4##(1990-6#1)(2007-8#1)(2008-10#1)
samples were extracted from##2##4##(2008-10#1)(2011-2#1)
samples were extracted with##10##4##(1992-2#1)(1996-5#1)(2005-12#1)(2008-10#4)(2010-4#1)(2011-1#1)(2012-12#1)
samples were extracted##19##3##(1990-6#1)(1992-2#1)(1996-5#1)(1996-6#1)(2005-12#1)(2007-8#1)(2008-10#7)(2008-5#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)
samples were fabricated##2##3##(2008-2#1)(2008-3#1)
samples were finally##2##3##(2007-7#1)(2007-8#1)
samples were first##2##3##(1994-3#1)(2008-10#1)
samples were fixed in##2##4##(2012-2#1)(2012-3#1)
samples were fixed##3##3##(2010-2#1)(2012-2#1)(2012-3#1)
samples were found to be##2##5##(2007-1#1)(2008-10#1)
samples were found to contain##4##5##(2007-8#1)(2008-10#2)(2008-12#1)
samples were found to##7##4##(2007-1#1)(2007-8#1)(2008-10#4)(2008-12#1)
samples were found##11##3##(2007-1#1)(2007-8#1)(2008-10#7)(2008-12#1)(2010-12#1)
samples were from##2##3##(2007-7#1)(2008-10#1)
samples were gathered##2##3##(2008-10#1)(2011-2#1)
samples were higher than the##3##5##(2008-12#1)(2010-5#2)
samples were higher than##4##4##(2008-10#1)(2008-12#1)(2010-5#2)
samples were identified##4##3##(2007-8#1)(2008-10#1)(2008-5#1)(2012-2#1)
samples were in agreement with those##3##6##(2008-10#3)
samples were in agreement with##4##5##(2008-10#4)
samples were in the range##2##5##(2008-10#2)
samples were in##8##3##(2005-4#1)(2008-10#7)
samples were included in##2##4##(1990-1#1)(2008-6#1)
samples were injected##2##3##(1990-6#1)(2008-10#1)
samples were inoculated##2##3##(2008-5#1)(2012-2#1)
samples were investigated by##2##4##(2005-4#1)(2012-11#1)
samples were investigated##6##3##(2005-4#1)(2008-10#1)(2008-3#1)(2009-7#1)(2011-1#1)(2012-11#1)
samples were irradiated##2##3##(2008-10#1)(2008-5#1)
samples were isolated##3##3##(2006-12#1)(2011-2#1)(2013-8#1)
samples were lower than##3##4##(2008-10#1)(2008-12#1)(2013-1#1)
samples were made##2##3##(2007-12#1)(2013-7#1)
samples were measured##4##3##(1990-4#1)(2008-10#1)(2010-5#1)(2011-2#1)
samples were more##2##3##(2008-10#1)(2013-8#1)
samples were mounted##2##3##(2007-7#1)(2008-5#1)
samples were obtained at##2##4##(2008-5#1)(2010-8#1)
samples were obtained before and after##3##6##(1991-10#1)(2006-3#1)(2007-8#1)
samples were obtained before##4##4##(1991-10#1)(1995-2#1)(2006-3#1)(2007-8#1)
samples were obtained by##6##4##(1996-4#1)(2007-3#1)(2008-10#1)(2008-5#1)(2012-1#1)(2012-2#1)
samples were obtained for##2##4##(2008-5#1)(2011-2#1)
samples were obtained from 32##2##5##(2008-10#1)(2013-1#1)
samples were obtained from the##2##5##(2007-8#1)(2013-8#1)
samples were obtained from##18##4##(1994-9#1)(1995-4#1)(2004-4#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#2)
samples were obtained##49##3##(1991-10#1)(1993-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-4#1)(1996-3#1)(1996-4#1)(2004-4#1)(2006-3#1)(2006-5#1)(2007-2#1)(2007-3#2)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#6)(2008-12#1)(2008-5#5)(2008-6#1)(2008-7#1)(2010-4#1)(2010-8#2)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#2)
samples were performed##4##3##(1992-2#2)(2008-10#2)
samples were placed in##4##4##(2008-10#2)(2008-5#1)(2008-6#1)
samples were placed##5##3##(2008-10#2)(2008-5#1)(2008-6#1)(2012-1#1)
samples were plated in##2##4##(2008-12#1)(2013-1#1)
samples were plated##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
samples were positive by##3##4##(2006-3#2)(2007-2#1)
samples were positive for##8##4##(2005-8#1)(2007-7#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
samples were positive##17##3##(1991-9#2)(2005-8#1)(2006-3#2)(2007-1#1)(2007-2#1)(2007-7#2)(2008-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
samples were pre-concentrated##2##3##(2007-8#1)(2008-10#1)
samples were pre-treated with##2##4##(2008-10#2)
samples were prepared and##2##4##(2008-10#1)(2011-1#1)
samples were prepared by##5##4##(2004-9#1)(2005-11#1)(2008-1#1)(2008-2#1)(2008-5#1)
samples were prepared using##3##4##(1990-2#1)(2008-10#1)(2010-9#1)
samples were prepared##13##3##(1990-2#1)(1996-7#1)(1996-8#1)(2004-9#1)(2005-11#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)(2010-9#1)(2011-1#1)
samples were pretreated with##2##4##(1996-3#1)(2005-4#1)
samples were processed according to##2##5##(2012-12#1)(2012-2#1)
samples were processed##4##3##(2007-2#1)(2008-5#1)(2012-12#1)(2012-2#1)
samples were produced from##2##4##(2008-10#1)(2011-1#1)
samples were quantitative##3##3##(2008-10#3)
samples were reactive##2##3##(2006-10#1)(2007-12#1)
samples were recorded##2##3##(2006-5#1)(2010-10#1)
samples were reviewed##2##3##(1992-12#1)(2006-8#1)
samples were screened for##3##4##(2007-7#2)(2008-1#1)
samples were screened##6##3##(2007-2#1)(2007-7#2)(2008-1#1)(2011-1#1)(2013-8#1)
samples were sent to##2##4##(1990-11#1)(2008-3#1)
samples were separated on##2##4##(1996-2#1)(2011-2#1)
samples were separated##3##3##(1992-2#1)(1996-2#1)(2011-2#1)
samples were sequenced##2##3##(2013-8#2)
samples were similar to##2##4##(2008-10#1)(2008-2#1)
samples were spiked with known##3##5##(2008-10#3)
samples were spiked with##5##4##(2007-8#1)(2008-10#4)
samples were stained##4##3##(2004-1#1)(2007-3#1)(2010-2#2)
samples were stored at##2##4##(1993-2#1)(2008-10#1)
samples were stored under##2##4##(2005-11#1)(2010-4#1)
samples were stored##5##3##(1993-2#1)(2005-11#1)(2008-10#1)(2010-4#1)(2013-8#1)
samples were studied##2##3##(2008-10#1)(2008-3#1)
samples were subjected to##11##4##(1995-3#1)(2004-9#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-7#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)
samples were subjected##12##3##(1995-3#1)(2004-9#2)(2007-10#1)(2007-7#1)(2007-8#1)(2008-7#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)
samples were submitted to##3##4##(1991-3#1)(2011-2#1)(2013-1#1)
samples were successfully##2##3##(2008-10#1)(2011-1#1)
samples were suspended in##2##4##(2008-10#2)
samples were suspended##3##3##(2008-10#3)
samples were taken at##5##4##(1994-3#1)(2006-7#1)(2007-5#1)(2008-10#1)(2013-1#1)
samples were taken before and after##2##6##(1990-12#1)(2013-8#1)
samples were taken before and##4##5##(1990-12#1)(1995-1#1)(2007-8#1)(2013-8#1)
samples were taken before##9##4##(1990-12#1)(1990-3#1)(1992-1#1)(1995-1#1)(2007-8#1)(2009-7#1)(2010-8#1)(2013-1#1)(2013-8#1)
samples were taken every##2##4##(1991-3#1)(2007-3#1)
samples were taken for##6##4##(2006-6#1)(2008-10#1)(2010-1#1)(2010-12#1)(2012-1#1)(2012-3#1)
samples were taken from each##2##5##(2006-12#1)(2008-5#1)
samples were taken from the##4##5##(1997-5#1)(2006-5#1)(2008-12#1)(2013-8#1)
samples were taken from##17##4##(1995-6#1)(1995-7#1)(1997-3#1)(1997-4#1)(1997-5#1)(2004-11#1)(2004-4#1)(2006-12#1)(2006-5#1)(2008-10#2)(2008-12#1)(2008-5#2)(2010-4#1)(2011-2#1)(2013-8#1)
samples were taken monthly##2##4##(2008-5#1)(2010-8#1)
samples were taken##58##3##(1990-12#1)(1990-3#1)(1991-3#1)(1992-1#1)(1993-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-6#1)(1995-7#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(2004-11#1)(2004-4#1)(2005-8#1)(2006-12#2)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-3#1)(2007-5#2)(2007-6#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-5#4)(2008-8#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#3)
samples were tested by both##2##5##(2008-8#1)(2013-1#1)
samples were tested by##4##4##(2007-7#1)(2008-12#1)(2008-8#1)(2013-1#1)
samples were tested for##7##4##(1991-3#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-12#1)(2013-1#1)
samples were tested##15##3##(1991-3#1)(2004-9#1)(2006-8#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-12#1)(2013-1#2)
samples were treated with##4##4##(1992-8#1)(1997-8#1)(2008-10#2)
samples were treated##7##3##(1992-8#1)(1997-8#1)(2008-10#4)(2011-1#1)
samples were used as a##2##5##(2008-10#1)(2008-11#1)
samples were used as##4##4##(2008-10#3)(2008-11#1)
samples were used to##6##4##(1995-10#1)(2008-10#3)(2011-2#1)(2012-2#1)
samples were used##13##3##(1995-10#1)(1996-12#1)(2008-10#6)(2008-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
samples were##834##2##(1990-1#2)(1990-11#3)(1990-12#6)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#2)(1990-8#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-6#3)(1991-9#3)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#5)(1992-4#1)(1992-8#3)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#2)(1993-4#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-6#2)(1994-9#3)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-4#2)(1995-6#3)(1995-7#1)(1996-1#2)(1996-11#2)(1996-12#5)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#4)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-1#1)(2004-11#1)(2004-4#4)(2004-9#4)(2005-11#11)(2005-12#4)(2005-4#5)(2005-8#2)(2006-10#5)(2006-12#5)(2006-3#4)(2006-5#10)(2006-6#1)(2006-7#2)(2006-8#7)(2007-1#7)(2007-10#10)(2007-11#2)(2007-12#7)(2007-2#18)(2007-3#7)(2007-4#1)(2007-5#10)(2007-6#1)(2007-7#17)(2007-8#18)(2007-9#2)(2008-1#6)(2008-10#237)(2008-11#5)(2008-12#19)(2008-2#6)(2008-3#11)(2008-4#1)(2008-5#34)(2008-6#4)(2008-7#8)(2008-8#3)(2008-9#1)(2009-11#2)(2009-4#6)(2009-5#1)(2009-6#6)(2009-7#3)(2010-1#1)(2010-10#2)(2010-12#4)(2010-2#5)(2010-3#1)(2010-4#15)(2010-5#4)(2010-6#3)(2010-8#7)(2010-9#1)(2011-1#24)(2011-12#1)(2011-2#30)(2011-3#2)(2012-1#4)(2012-11#2)(2012-12#13)(2012-2#15)(2012-3#9)(2012-6#1)(2013-1#20)(2013-7#6)(2013-8#27)
samples when##7##2##(1996-12#1)(2005-12#1)(2008-10#2)(2008-3#3)
samples where##2##2##(2008-12#1)(2008-4#1)
samples whereas##2##2##(2008-10#1)(2010-5#1)
samples which are##2##3##(2008-10#1)(2013-1#1)
samples which contain##2##3##(1991-9#1)(1992-7#1)
samples which were collected from##2##5##(2008-11#1)(2013-8#1)
samples which were##6##3##(1993-2#1)(2008-11#1)(2013-1#1)(2013-8#3)
samples which##16##2##(1991-9#1)(1992-7#1)(1993-2#1)(2006-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-5#1)(2013-1#2)(2013-8#3)
samples while##5##2##(2008-10#2)(2010-6#1)(2011-1#1)(2012-12#1)
samples with a high degree of##2##6##(1997-2#1)(2008-11#1)
samples with a high##3##4##(1997-2#1)(2007-8#1)(2008-11#1)
samples with a recovery of##2##5##(2008-10#1)(2010-4#1)
samples with a recovery range of##2##6##(2008-10#2)
samples with a recovery##4##4##(2008-10#3)(2010-4#1)
samples with a##27##3##(1994-3#1)(1997-2#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#17)(2008-11#1)(2008-5#1)(2010-4#1)(2012-2#1)
samples with added##2##3##(1994-8#1)(2008-10#1)
samples with an##4##3##(1990-12#1)(2008-10#3)
samples with and without##2##4##(2008-10#1)(2008-5#1)
samples with different##10##3##(2005-11#1)(2007-8#1)(2008-10#7)(2009-4#1)
samples with good##2##3##(2008-10#2)
samples with high##7##3##(1995-10#1)(2007-3#1)(2007-8#1)(2008-10#2)(2011-1#1)(2013-7#1)
samples with low##2##3##(1997-1#1)(2008-10#1)
samples with minimal##2##3##(1991-9#1)(2008-10#1)
samples with one##2##3##(2008-4#1)(2008-7#1)
samples with respect to##3##4##(2007-11#1)(2008-10#1)(2010-12#1)
samples with satisfactory results##26##4##(2007-8#1)(2008-10#24)(2012-12#1)
samples with satisfactory##28##3##(2007-8#1)(2008-10#26)(2012-12#1)
samples with satisfied results##2##4##(2008-10#2)
samples with similar##2##3##(2008-10#1)(2008-2#1)
samples with the use of##2##5##(2008-10#1)(2010-9#1)
samples with the##11##3##(1990-12#1)(1990-5#1)(1996-12#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2010-9#1)(2011-2#1)
samples with this##2##3##(2008-10#2)
samples with those##2##3##(2008-10#1)(2008-2#1)
samples with unknown##2##3##(2008-10#1)(2008-11#1)
samples with very##3##3##(1994-11#1)(1995-1#1)(2008-10#1)
samples with##217##2##(1990-12#2)(1990-2#1)(1990-5#1)(1991-9#1)(1994-11#1)(1994-3#3)(1994-8#1)(1995-1#2)(1995-10#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-4#1)(2005-10#1)(2005-11#1)(2005-4#3)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#7)(2007-3#1)(2007-7#1)(2007-8#5)(2008-10#114)(2008-11#4)(2008-2#5)(2008-3#3)(2008-4#3)(2008-5#7)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#2)(2009-7#1)(2010-12#1)(2010-4#3)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#3)
samples within the##2##3##(2008-10#1)(2008-6#1)
samples within##4##2##(1991-9#1)(2008-10#2)(2008-6#1)
samples without any sample##2##4##(1993-2#1)(2008-10#1)
samples without any##5##3##(1993-2#1)(2008-10#3)(2009-4#1)
samples without previous##2##3##(2008-10#2)
samples without##17##2##(1993-2#1)(1996-7#1)(2007-8#1)(2008-10#10)(2008-9#1)(2009-4#1)(2010-4#1)(2011-1#1)
samples yielded##2##2##(2008-10#1)(2009-10#1)
samples##6969##1##(1990-1#8)(1990-10#3)(1990-11#17)(1990-12#31)(1990-2#8)(1990-3#3)(1990-4#3)(1990-5#6)(1990-6#8)(1990-7#4)(1990-8#27)(1990-9#6)(1991-1#3)(1991-10#4)(1991-11#3)(1991-12#16)(1991-2#8)(1991-3#12)(1991-4#3)(1991-5#9)(1991-6#8)(1991-7#7)(1991-8#10)(1991-9#22)(1992-1#5)(1992-10#9)(1992-11#4)(1992-12#11)(1992-2#25)(1992-3#13)(1992-4#11)(1992-5#3)(1992-6#13)(1992-7#12)(1992-8#19)(1992-9#2)(1993-1#14)(1993-10#1)(1993-11#11)(1993-12#7)(1993-2#30)(1993-3#4)(1993-4#9)(1993-5#2)(1993-6#6)(1993-7#8)(1993-8#6)(1993-9#21)(1994-1#1)(1994-10#1)(1994-11#10)(1994-12#8)(1994-2#14)(1994-3#17)(1994-4#3)(1994-5#4)(1994-6#19)(1994-7#1)(1994-8#8)(1994-9#10)(1995-1#18)(1995-10#8)(1995-11#6)(1995-12#18)(1995-2#15)(1995-3#4)(1995-4#4)(1995-5#2)(1995-6#13)(1995-7#5)(1995-8#8)(1995-9#1)(1996-1#9)(1996-11#8)(1996-12#43)(1996-2#9)(1996-3#18)(1996-4#4)(1996-5#11)(1996-6#23)(1996-7#18)(1996-8#18)(1996-9#13)(1997-1#9)(1997-2#26)(1997-3#23)(1997-4#20)(1997-5#8)(1997-6#14)(1997-7#18)(1997-8#19)(2004-1#2)(2004-10#2)(2004-11#9)(2004-12#1)(2004-2#1)(2004-4#11)(2004-9#20)(2005-10#6)(2005-11#68)(2005-12#15)(2005-4#30)(2005-7#1)(2005-8#9)(2005-9#1)(2006-10#27)(2006-11#2)(2006-12#23)(2006-2#10)(2006-3#10)(2006-4#6)(2006-5#39)(2006-6#2)(2006-7#5)(2006-8#37)(2006-9#4)(2007-1#31)(2007-10#39)(2007-11#32)(2007-12#77)(2007-2#74)(2007-3#44)(2007-4#7)(2007-5#41)(2007-6#4)(2007-7#59)(2007-8#175)(2007-9#8)(2008-1#33)(2008-10#3039)(2008-11#69)(2008-12#93)(2008-2#85)(2008-3#131)(2008-4#82)(2008-5#196)(2008-6#40)(2008-7#53)(2008-8#25)(2008-9#44)(2009-1#3)(2009-10#6)(2009-11#13)(2009-12#13)(2009-2#7)(2009-3#19)(2009-4#43)(2009-5#15)(2009-6#18)(2009-7#11)(2009-8#7)(2009-9#5)(2010-1#4)(2010-10#3)(2010-11#17)(2010-12#27)(2010-2#15)(2010-3#6)(2010-4#81)(2010-5#32)(2010-6#13)(2010-7#4)(2010-8#21)(2010-9#13)(2011-1#93)(2011-10#1)(2011-12#14)(2011-2#130)(2011-3#5)(2012-1#26)(2012-11#10)(2012-12#82)(2012-2#78)(2012-3#62)(2012-6#1)(2013-1#120)(2013-7#35)(2013-8#110)
samples'##5##1##(2008-10#1)(2009-4#1)(2013-7#2)(2013-8#1)
samples) and##5##2##(1994-6#1)(2005-10#1)(2008-10#1)(2008-4#1)(2011-2#1)
samples) was##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
samples) were##2##2##(2008-10#1)(2012-12#1)
samples)##35##1##(1990-8#1)(1994-6#2)(1994-9#1)(1996-7#2)(2004-10#1)(2005-10#1)(2007-5#1)(2008-10#15)(2008-3#1)(2008-4#1)(2010-12#3)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)
samples/h##8##1##(1993-8#2)(2008-10#6)
samples/hour##2##1##(2008-10#1)(2010-5#1)
samples]##3##1##(2007-11#1)(2013-8#2)
samplesh(-1)##6##1##(2008-10#6)
sampling ETAAS method##2##3##(2008-10#2)
sampling ETAAS##6##2##(2008-10#6)
sampling MTF##3##2##(2008-2#3)
sampling a##3##2##(2008-10#3)
sampling and analysis##3##3##(2008-10#2)(2008-12#1)
sampling and for##2##3##(1990-8#1)(2008-10#1)
sampling and the##5##3##(1996-3#1)(1997-8#1)(2008-10#3)
sampling and washing##5##3##(2008-10#5)
sampling and##67##2##(1990-8#1)(1992-12#1)(1992-2#1)(1992-4#1)(1994-9#1)(1995-2#1)(1995-7#1)(1996-3#2)(1997-8#1)(2004-11#1)(2005-4#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#31)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2009-10#1)(2009-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#4)(2013-7#1)(2013-8#1)
sampling approach##5##2##(2008-10#2)(2008-2#1)(2011-2#1)(2012-3#1)
sampling are##5##2##(2008-10#3)(2008-11#1)(2008-2#1)
sampling area##2##2##(2006-12#1)(2008-10#1)
sampling arm assembly##4##3##(2007-10#1)(2008-10#3)
sampling arm##6##2##(2007-10#1)(2008-10#5)
sampling artifacts##2##2##(2009-10#2)
sampling as##2##2##(1992-3#1)(1993-9#1)
sampling at##6##2##(1991-3#1)(2007-3#1)(2008-10#1)(2009-1#1)(2010-8#1)(2013-1#1)
sampling based on##2##3##(2007-11#1)(2010-4#1)
sampling bias##4##2##(1993-9#1)(2007-9#1)(2008-10#1)(2012-11#1)
sampling bout##5##2##(2008-10#2)(2008-8#3)
sampling bouts##3##2##(2008-8#3)
sampling by##7##2##(2007-7#1)(2008-10#3)(2008-3#1)(2012-2#2)
sampling campaigns##3##2##(2008-10#1)(2008-7#2)
sampling can be##6##3##(1993-2#1)(2004-4#1)(2005-11#1)(2008-2#1)(2009-9#1)(2011-2#1)
sampling conditions##2##2##(2007-8#1)(2008-10#1)
sampling data##2##2##(1996-3#1)(2010-2#1)
sampling date##8##2##(1996-12#1)(2008-10#5)(2008-7#1)(2012-8#1)
sampling dates in##3##3##(2008-12#1)(2010-8#1)(2013-8#1)
sampling dates##13##2##(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#3)(2010-8#1)(2013-8#1)
sampling days##2##2##(2007-5#1)(2013-1#1)
sampling density and spatial resolution##2##5##(2008-9#2)
sampling density and##3##3##(2008-3#1)(2008-9#2)
sampling density##4##2##(2008-3#1)(2008-6#1)(2008-9#2)
sampling design in##2##3##(1996-3#1)(2008-10#1)
sampling design is##2##3##(1994-5#1)(2008-10#1)
sampling design that##5##3##(2010-2#2)(2010-9#1)(2013-7#2)
sampling design##22##2##(1994-5#2)(1996-3#1)(2008-10#2)(2010-2#5)(2010-6#2)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-7#4)
sampling designs##3##2##(1997-2#1)(2008-10#1)(2010-11#1)
sampling device##3##2##(2008-10#2)(2012-2#1)
sampling distribution##3##2##(2008-10#3)
sampling duration##3##2##(2008-11#1)(2013-7#2)
sampling during the##2##3##(1992-6#1)(2013-1#1)
sampling during##4##2##(1992-6#1)(2008-10#1)(2012-12#1)(2013-1#1)
sampling efficiency for##2##3##(2004-11#1)(2008-5#1)
sampling efficiency##3##2##(2004-11#2)(2008-5#1)
sampling effort##4##2##(2007-6#2)(2010-6#1)(2013-7#1)
sampling electrothermal atomic absorption spectrometry##5##5##(2008-10#5)
sampling electrothermal atomic absorption##6##4##(2008-10#6)
sampling electrothermal##9##2##(2008-10#9)
sampling error and##2##3##(2004-3#1)(2009-3#1)
sampling error##6##2##(2004-3#1)(2008-10#2)(2008-2#1)(2008-8#1)(2009-3#1)
sampling errors##4##2##(2007-8#1)(2008-11#1)(2008-2#2)
sampling field sensor##2##3##(2008-3#2)
sampling field##3##2##(2008-10#1)(2008-3#2)
sampling followed by##2##3##(2008-10#2)
sampling for##13##2##(1996-12#1)(1996-7#1)(2004-11#1)(2007-2#1)(2008-10#8)(2009-9#1)
sampling frequency is##7##3##(1995-3#1)(2008-10#4)(2012-2#1)(2012-3#1)
sampling frequency of 30 h(-1)##2##5##(2008-10#2)
sampling frequency of 40h(-1)##2##4##(2008-10#2)
sampling frequency of 50##2##4##(2008-10#2)
sampling frequency of 60 h(-1)##2##5##(2008-10#2)
sampling frequency of the system was##2##6##(2008-10#2)
sampling frequency of##35##3##(2007-8#1)(2008-10#32)(2010-9#1)(2013-1#1)
sampling frequency was##9##3##(2008-10#9)
sampling frequency##62##2##(1995-3#1)(2007-8#2)(2008-10#54)(2008-2#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
sampling from an##2##3##(2006-12#1)(2012-3#1)
sampling from the##2##3##(2007-10#1)(2008-10#1)
sampling from##12##2##(1994-2#1)(1995-2#1)(2006-12#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-2#1)(2011-2#1)(2012-3#1)(2013-8#1)
sampling graphite furnace atomic absorption spectrometry##3##6##(2008-10#3)
sampling grating##2##2##(2008-2#2)
sampling grid##4##2##(2008-10#4)
sampling has been##3##3##(2008-10#1)(2008-8#2)
sampling has##4##2##(1990-9#1)(2008-10#1)(2008-8#2)
sampling in a##3##3##(2007-11#1)(2007-12#1)(2013-8#1)
sampling in##22##2##(1990-9#2)(1993-10#1)(1996-3#1)(2004-11#1)(2004-12#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-2#1)(2011-3#1)(2013-1#1)(2013-8#1)
sampling intensity##2##2##(2006-3#1)(2008-10#1)
sampling interval##6##2##(2008-2#1)(2008-3#4)(2011-2#1)
sampling is a##3##3##(1996-3#1)(2004-11#1)(2010-9#1)
sampling is an##3##3##(1995-7#1)(1996-3#1)(2008-10#1)
sampling is carried out in##2##5##(2007-6#2)
sampling is required to##2##4##(2010-4#1)(2013-1#1)
sampling is##23##2##(1990-2#1)(1992-2#1)(1994-6#1)(1995-7#1)(1996-3#2)(2004-11#1)(2007-12#1)(2007-6#2)(2007-8#1)(2008-10#4)(2008-8#1)(2010-11#2)(2010-4#1)(2010-5#1)(2010-9#1)(2013-1#2)
sampling locations##3##2##(2008-10#1)(2010-8#1)(2011-12#1)
sampling loop##2##2##(2008-10#2)
sampling method and##3##3##(2007-1#1)(2007-12#1)(2008-10#1)
sampling method used##2##3##(2008-1#1)(2008-10#1)
sampling method was used##3##4##(2007-10#1)(2010-3#1)(2013-1#1)
sampling method was##7##3##(1993-12#1)(2007-10#1)(2008-1#1)(2010-3#1)(2010-5#1)(2011-1#1)(2013-1#1)
sampling method##21##2##(1993-12#1)(1997-7#1)(2005-4#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-2#1)(2009-11#2)(2010-3#1)(2010-5#2)(2011-1#2)(2011-2#1)(2013-1#1)
sampling methodologies##2##2##(2008-10#1)(2008-3#1)
sampling methodology##2##2##(2008-10#1)(2010-9#1)
sampling methods for##7##3##(2008-10#4)(2009-4#1)(2009-9#1)(2010-11#1)
sampling methods##23##2##(1992-12#1)(2008-10#12)(2008-5#1)(2009-4#1)(2009-9#2)(2010-11#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
sampling models##2##2##(2008-10#2)
sampling occasion##4##2##(2004-11#2)(2007-6#1)(2013-1#1)
sampling occasions##2##2##(2004-11#2)
sampling of a##6##3##(2006-10#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-8#1)
sampling of different##2##3##(1997-3#1)(2008-10#1)
sampling of the##12##3##(1996-12#2)(2006-12#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#2)(2009-2#1)(2011-1#1)
sampling of##62##2##(1995-8#1)(1996-12#2)(1997-3#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-12#4)(2007-6#2)(2007-8#1)(2008-1#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-5#1)(2010-3#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-3#2)
sampling on the##2##3##(2007-5#1)(2008-10#1)
sampling on##4##2##(2007-5#1)(2008-10#1)(2010-4#1)(2013-1#1)
sampling over##2##2##(2009-3#1)(2010-8#1)
sampling patterns##2##2##(2008-10#1)(2008-6#1)
sampling period was##2##3##(2008-10#1)(2013-7#1)
sampling period##18##2##(2006-5#1)(2007-5#4)(2007-9#1)(2008-10#3)(2008-2#1)(2008-5#5)(2009-6#1)(2012-2#1)(2013-7#1)
sampling periods and##3##3##(2007-5#1)(2008-12#1)(2008-7#1)
sampling periods##9##2##(2007-12#1)(2007-5#2)(2008-10#3)(2008-12#1)(2008-7#1)(2013-1#1)
sampling plan##2##2##(2008-10#2)
sampling plans##2##2##(2008-10#1)(2011-12#1)
sampling point##3##2##(2008-2#1)(2008-3#2)
sampling points##15##2##(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#8)
sampling problems##2##2##(2010-2#1)(2010-6#1)
sampling procedure to##2##3##(2006-5#1)(2008-10#1)
sampling procedure was##2##3##(2007-3#1)(2008-10#1)
sampling procedure##13##2##(2006-5#2)(2007-3#2)(2008-1#1)(2008-10#5)(2010-5#1)(2010-8#1)(2013-1#1)
sampling procedures##7##2##(1992-2#1)(1994-12#1)(2007-12#1)(2008-10#3)(2012-3#1)
sampling process##4##2##(1993-8#1)(2008-10#1)(2008-2#1)(2011-2#1)
sampling programs##2##2##(2008-10#2)
sampling properties of##2##3##(1994-9#1)(2009-5#1)
sampling protocol was##2##3##(2008-10#2)
sampling protocols##2##2##(2013-7#2)
sampling pulse##2##2##(2008-2#2)
sampling rate for the##2##4##(2008-10#1)(2011-2#1)
sampling rate for##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
sampling rate is##4##3##(2007-12#1)(2008-10#3)
sampling rate of 120##3##4##(2008-10#3)
sampling rate of 30##3##4##(2008-10#3)
sampling rate of 40##2##4##(2008-10#2)
sampling rate of 60##4##4##(2008-10#4)
sampling rate of about##5##4##(2008-10#5)
sampling rate of##38##3##(2007-12#2)(2007-3#1)(2007-4#1)(2008-10#31)(2008-3#3)
sampling rate was about##2##4##(2008-10#2)
sampling rate was##13##3##(2008-10#11)(2008-3#1)(2010-5#1)
sampling rate##70##2##(2007-12#5)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#52)(2008-3#6)(2010-5#1)(2011-2#1)(2012-2#1)(2013-7#1)
sampling rates of##3##3##(2008-10#3)
sampling rates##10##2##(1997-6#1)(2008-10#8)(2008-3#1)
sampling record##2##2##(2008-5#2)
sampling routines##3##2##(2007-6#3)
sampling scheme##6##2##(1997-5#1)(2008-10#2)(2008-2#1)(2010-3#1)(2011-11#1)
sampling schemes and##3##3##(1991-8#1)(2008-10#1)(2009-5#1)
sampling schemes##7##2##(1991-8#1)(1997-5#1)(2008-10#4)(2009-5#1)
sampling seasons##3##2##(2008-10#3)
sampling site##6##2##(2008-10#3)(2008-11#1)(2008-2#1)(2012-2#1)
sampling sites in##2##3##(2007-8#1)(2011-2#1)
sampling sites of##3##3##(2008-10#1)(2008-7#1)(2013-7#1)
sampling sites##23##2##(2007-2#1)(2007-3#1)(2007-5#2)(2007-8#1)(2008-10#6)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#2)(2012-12#2)(2013-7#4)(2013-8#1)
sampling spinning rates##2##3##(2008-10#2)
sampling station##4##2##(2007-5#1)(2008-5#2)(2011-2#1)
sampling stations were##3##3##(1997-4#1)(2007-5#1)(2008-5#1)
sampling stations##5##2##(1997-4#1)(2007-5#1)(2008-5#3)
sampling strategies##5##2##(2007-8#1)(2008-10#2)(2008-6#1)(2008-8#1)
sampling strategy##7##2##(1996-5#1)(2008-10#1)(2011-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
sampling study##3##2##(1992-2#1)(1996-3#1)(2012-1#1)
sampling survey##3##2##(1991-9#1)(1997-2#1)(2013-7#1)
sampling system##7##2##(2008-10#5)(2008-12#1)(2008-8#1)
sampling systems##3##2##(2008-10#1)(2008-11#2)
sampling technique was used to##2##5##(2007-10#1)(2012-12#1)
sampling technique##17##2##(2004-11#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
sampling techniques##10##2##(1992-2#1)(1992-4#1)(2007-2#1)(2008-1#1)(2008-10#4)(2012-12#1)(2012-2#1)
sampling the##12##2##(1991-5#1)(2004-11#2)(2005-11#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)
sampling theorem##2##2##(2007-11#1)(2008-3#1)
sampling theory##2##2##(1994-6#1)(2008-3#1)
sampling throughput of##3##3##(2007-8#1)(2008-10#2)
sampling throughput##5##2##(2007-8#2)(2008-10#3)
sampling time and##2##3##(2008-10#2)
sampling time of##3##3##(2008-10#1)(2008-3#2)
sampling time##15##2##(2008-10#9)(2008-3#2)(2008-5#1)(2008-6#1)(2010-5#1)(2012-3#1)
sampling times##13##2##(1994-6#1)(1997-4#1)(2008-10#7)(2008-3#1)(2008-4#1)(2010-1#1)(2013-8#1)
sampling to##9##2##(1990-9#1)(1995-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-2#2)
sampling tubes##2##2##(2004-12#1)(2008-10#1)
sampling unit is##2##3##(2008-10#1)(2011-2#1)
sampling unit##9##2##(2004-11#1)(2008-10#6)(2011-2#2)
sampling units observed in each##2##5##(2008-10#2)
sampling units were##2##3##(2008-10#1)(2011-2#1)
sampling units##22##2##(2008-10#19)(2008-5#1)(2011-2#2)
sampling using##4##2##(1992-12#1)(1996-12#1)(2008-10#1)(2008-11#1)
sampling variability and package effects associated with particles##2##8##(2008-3#2)
sampling variability##3##2##(2008-3#3)
sampling variance##5##2##(2008-10#4)(2008-8#1)
sampling volume of##4##3##(1997-8#1)(2008-10#3)
sampling volume##12##2##(1997-8#1)(2008-10#4)(2008-2#1)(2008-3#6)
sampling was applied and##2##4##(2011-2#2)
sampling was applied##3##3##(2011-2#2)(2012-12#1)
sampling was carried out##2##4##(1993-10#1)(2004-11#1)
sampling was carried##3##3##(1993-10#1)(2004-11#1)(2011-1#1)
sampling was conducted##2##3##(2008-10#1)(2008-12#1)
sampling was done##3##3##(2007-3#1)(2011-2#1)(2012-12#1)
sampling was performed for##2##4##(1993-10#1)(2008-5#1)
sampling was performed##6##3##(1993-10#1)(1994-7#1)(2007-2#1)(2008-5#3)
sampling was used to select##2##5##(2012-12#1)(2013-8#1)
sampling was used to##3##4##(2008-10#1)(2012-12#1)(2013-8#1)
sampling was used##4##3##(2008-10#1)(2012-1#1)(2012-12#1)(2013-8#1)
sampling was##27##2##(1993-10#2)(1994-7#1)(1996-12#1)(2004-11#1)(2006-8#1)(2007-2#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-5#3)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#1)(2013-1#1)(2013-8#1)
sampling were##3##2##(1997-1#1)(2008-10#1)(2008-2#1)
sampling with a##2##3##(2008-10#1)(2012-7#1)
sampling with the##2##3##(2005-4#1)(2008-10#1)
sampling with##11##2##(1991-10#1)(1996-12#1)(1997-2#1)(2005-4#2)(2008-10#2)(2010-5#1)(2011-2#1)(2012-7#1)(2013-7#1)
sampling year##2##2##(2008-10#2)
sampling zone##2##2##(2008-11#2)
sampling##1279##1##(1990-2#1)(1990-8#1)(1990-9#8)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-8#1)(1991-9#1)(1992-12#3)(1992-2#8)(1992-3#2)(1992-4#2)(1992-6#1)(1993-10#4)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-5#2)(1994-6#5)(1994-7#1)(1994-9#2)(1995-2#2)(1995-3#1)(1995-6#1)(1995-7#2)(1995-8#1)(1995-9#3)(1996-12#12)(1996-3#13)(1996-5#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#2)(2004-11#18)(2004-12#2)(2004-3#1)(2004-4#1)(2005-11#3)(2005-4#5)(2006-10#5)(2006-12#5)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#4)(2006-7#2)(2006-8#5)(2007-1#1)(2007-10#5)(2007-11#9)(2007-12#30)(2007-2#5)(2007-3#10)(2007-4#1)(2007-5#16)(2007-6#12)(2007-7#2)(2007-8#17)(2007-9#3)(2008-1#6)(2008-10#508)(2008-11#16)(2008-12#10)(2008-2#49)(2008-3#59)(2008-4#6)(2008-5#30)(2008-6#7)(2008-7#19)(2008-8#19)(2008-9#4)(2009-1#1)(2009-10#5)(2009-11#3)(2009-2#1)(2009-3#2)(2009-4#5)(2009-5#4)(2009-6#1)(2009-9#5)(2010-1#1)(2010-11#4)(2010-12#5)(2010-2#9)(2010-3#4)(2010-4#5)(2010-5#13)(2010-6#7)(2010-7#1)(2010-8#6)(2010-9#5)(2011-1#13)(2011-11#1)(2011-12#6)(2011-2#38)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#12)(2012-2#20)(2012-3#22)(2012-7#1)(2012-8#2)(2013-1#23)(2013-7#22)(2013-8#10)
sampling)##2##1##(2007-5#1)(2008-10#1)
sampling-electrothermal##2##1##(2008-10#2)
sampling-graphite furnace atomic absorption spectrometry for the direct determination of silver##2##11##(2007-8#2)
sampling-graphite furnace atomic absorption spectrometry##4##5##(2007-8#2)(2008-10#2)
sampling-unit##4##1##(2008-10#4)
samplings were carried out##4##4##(2008-5#1)(2008-6#1)(2013-1#1)(2013-7#1)
samplings were##7##2##(2008-5#3)(2008-6#1)(2013-1#1)(2013-7#2)
samplings##27##1##(2007-11#1)(2007-3#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-5#7)(2008-6#5)(2012-12#1)(2013-1#1)(2013-7#3)
sampsonii GS 1322##2##3##(2005-11#2)
samuelsii##2##1##(2013-7#2)
san francisco##2##2##(1990-11#1)(2006-9#1)
san##6##1##(1990-11#1)(1995-11#1)(2006-9#2)(2012-3#2)
sanA is##3##2##(2008-9#3)
sanA##6##1##(2008-9#6)
sanation##2##1##(2006-6#1)(2011-2#1)
sanatorium##3##1##(2009-7#1)(2013-8#2)
sanatoriums##5##1##(2009-7#5)
sanction##2##1##(2007-3#2)
sanctioned by##3##2##(2008-12#1)(2008-7#1)(2012-1#1)
sanctions and##2##2##(2007-12#1)(2009-7#1)
sanctions that##2##2##(1991-2#2)
sanctions##12##1##(1991-1#1)(1991-2#3)(1992-1#2)(1993-10#2)(2007-12#2)(2008-11#1)(2009-7#1)
sanctity of life##4##3##(2006-4#1)(2006-7#2)(2007-2#1)
sanctity of##5##2##(2006-4#1)(2006-7#2)(2007-2#1)(2009-4#1)
sanctity##6##1##(2006-4#1)(2006-7#2)(2007-2#1)(2009-4#1)(2009-7#1)
sanctuary site##2##2##(2008-4#1)(2008-6#1)
sanctuary##6##1##(2008-4#1)(2008-6#1)(2009-3#1)(2013-7#3)
sand + silt + leaf mold##2##6##(2008-12#2)
sand + silt##3##3##(2008-12#3)
sand +##4##2##(2008-12#4)
sand and##11##2##(2007-3#4)(2007-5#1)(2008-10#3)(2008-2#1)(2009-3#1)(2011-12#1)
sand beaches##2##2##(2007-5#2)
sand dollars##2##2##(2007-5#2)
sand flies (Diptera##3##3##(2007-12#2)(2012-12#1)
sand flies and##2##3##(2008-12#1)(2013-1#1)
sand flies in##2##3##(2012-12#1)(2013-1#1)
sand flies is##2##3##(2004-11#1)(2012-12#1)
sand flies##22##2##(2004-11#4)(2007-12#2)(2008-12#8)(2011-1#1)(2012-12#3)(2013-1#4)
sand fly##9##2##(2004-11#1)(2007-12#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-1#1)(2012-12#2)(2012-2#1)
sand grains##2##2##(2005-11#1)(2010-2#1)
sand sample##2##2##(2008-10#1)(2008-3#1)
sand soil##2##2##(2008-10#2)
sand treated with 1- and 2-methoxynaphthalene##2##6##(2011-2#2)
sand were##3##2##(2007-5#1)(2008-8#1)(2011-2#1)
sand with##2##2##(2007-5#1)(2008-2#1)
sand##119##1##(1991-12#1)(2004-11#5)(2004-4#2)(2005-11#2)(2006-12#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-3#4)(2007-5#9)(2008-1#2)(2008-10#18)(2008-12#14)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#9)(2008-8#2)(2009-3#4)(2010-1#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#6)(2012-12#5)(2012-2#1)(2013-1#4)
sand-injured and punctured fruits##2##4##(1997-6#2)
sand-injured##4##1##(1997-6#4)
sandbar opening and##4##3##(2013-7#4)
sandbar opening##7##2##(2013-7#7)
sandbar##8##1##(2013-7#8)
sandblasting with##2##2##(2009-8#2)
sandblasting##4##1##(2009-7#1)(2009-8#2)(2013-8#1)
sandflies (Diptera##2##2##(2007-12#1)(2007-6#1)
sandflies were##3##2##(2007-6#2)(2008-8#1)
sandflies##7##1##(2007-12#1)(2007-6#5)(2008-8#1)
sandfly##8##1##(2005-8#4)(2007-12#1)(2007-6#2)(2011-1#1)
sandgobies##2##1##(2008-8#2)
sandpaper##2##1##(2006-12#1)(2010-5#1)
sands in##2##2##(2008-5#1)(2009-11#1)
sands##5##1##(2005-11#1)(2008-5#1)(2009-11#2)(2013-1#1)
sandstone##3##1##(2006-8#2)(2013-1#1)
sandwich ELISA based on##2##4##(1995-4#2)
sandwich ELISA for##5##3##(1992-4#2)(2008-10#1)(2008-5#1)(2010-12#1)
sandwich ELISA system##3##3##(1994-2#1)(2008-10#1)(2008-11#1)
sandwich ELISA##19##2##(1992-12#1)(1992-4#2)(1994-2#1)(1994-3#1)(1995-4#2)(1995-8#1)(2005-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2010-12#2)(2013-1#1)
sandwich and##3##2##(2007-8#1)(2008-10#1)(2008-7#1)
sandwich arrays##2##2##(2010-11#2)
sandwich assay##3##2##(2008-10#2)(2010-11#1)
sandwich enzyme immunoassay for human##4##5##(1991-2#1)(1993-11#1)(1996-1#2)
sandwich enzyme immunoassay for##7##4##(1991-2#1)(1993-11#1)(1995-3#1)(1996-1#2)(1996-6#2)
sandwich enzyme immunoassay##13##3##(1991-10#1)(1991-2#1)(1993-11#2)(1995-1#1)(1995-3#1)(1995-6#1)(1996-1#4)(1996-6#2)
sandwich enzyme immunoassays for##2##4##(1995-1#1)(1996-6#1)
sandwich enzyme linked##2##3##(1991-10#1)(1995-8#1)
sandwich enzyme##17##2##(1991-10#2)(1991-2#1)(1993-11#2)(1995-1#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#4)(1996-6#3)
sandwich enzyme-linked immunosorbent assay (ELISA) was##2##6##(1995-11#1)(2008-10#1)
sandwich enzyme-linked immunosorbent assay (ELISA)##5##5##(1992-7#1)(1995-11#1)(1996-12#1)(2008-10#2)
sandwich enzyme-linked immunosorbent assay##11##4##(1992-7#1)(1995-11#2)(1996-12#1)(2008-10#7)
sandwich enzyme-linked##12##2##(1992-7#1)(1995-11#2)(1995-3#1)(1996-12#1)(2008-10#7)
sandwich hybridization assay##4##3##(2008-10#2)(2010-5#2)
sandwich immunoassay format##2##3##(2007-8#1)(2008-10#1)
sandwich immunoassay##9##2##(1991-9#1)(2007-8#5)(2008-10#2)(2008-9#1)
sandwich immunoassays##3##2##(2007-8#2)(2008-4#1)
sandwich method##3##2##(1991-10#1)(2008-10#2)
sandwich type##3##2##(1991-10#1)(2008-10#2)
sandwich##120##1##(1990-12#1)(1991-10#5)(1991-2#2)(1991-9#1)(1992-12#1)(1992-4#2)(1992-7#1)(1993-11#2)(1993-2#1)(1993-8#1)(1994-11#3)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-3#2)(1995-4#2)(1995-6#1)(1995-8#2)(1996-1#4)(1996-12#1)(1996-3#1)(1996-6#3)(1997-4#2)(2005-12#1)(2007-8#11)(2007-9#1)(2008-1#1)(2008-10#38)(2008-11#1)(2008-2#5)(2008-4#3)(2008-5#2)(2008-7#3)(2008-9#1)(2010-11#3)(2010-12#2)(2010-5#2)(2013-1#1)
sandwich&quot##3##1##(1997-2#1)(2008-10#1)(2010-11#1)
sandwich-ELISA for the determination of##2##5##(1990-12#1)(1995-3#1)
sandwich-ELISA for the##3##3##(1990-12#1)(1992-7#1)(1995-3#1)
sandwich-ELISA##6##1##(1990-12#2)(1992-7#1)(1995-3#1)(2005-6#1)(2008-10#1)
sandwich-enzyme-linked immunosorbent assay##2##3##(2008-10#2)
sandwich-type ELISA##2##2##(1997-7#1)(2008-10#1)
sandwich-type enzyme immunoassay##3##3##(1990-3#1)(1991-9#1)(2008-6#1)
sandwich-type enzyme##4##2##(1990-3#1)(1991-10#1)(1991-9#1)(2008-6#1)
sandwich-type##12##1##(1990-3#1)(1990-9#1)(1991-10#1)(1991-9#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-6#1)
sandwiched between a##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
sandwiched between gold##2##3##(2009-2#1)(2010-7#1)
sandwiched between the##2##3##(2006-10#1)(2008-4#1)
sandwiched between two##6##3##(1995-8#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)
sandwiched between##18##2##(1993-3#1)(1995-8#1)(1996-2#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-2#1)(2010-7#1)
sandwiched by##2##2##(1994-5#1)(2008-10#1)
sandwiched##24##1##(1993-3#1)(1994-5#1)(1995-8#1)(1996-2#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#4)(2008-3#1)(2008-4#1)(2008-7#2)(2009-2#1)(2010-7#1)
sandwiching##2##1##(2008-10#1)(2008-2#1)
sandy beach##2##2##(2013-7#2)
sandy loam field soil were larger##2##6##(2008-10#2)
sandy loam##8##2##(2004-4#1)(2008-10#6)(2011-1#1)
sandy patches##2##2##(1996-12#2)
sandy soil##6##2##(2008-10#4)(2008-12#1)(2011-1#1)
sandy soils##8##2##(2008-10#3)(2009-3#2)(2010-12#2)(2013-7#1)
sandy##38##1##(1996-12#2)(2004-4#1)(2006-10#1)(2007-5#1)(2008-1#1)(2008-10#14)(2008-12#1)(2008-3#1)(2008-5#2)(2009-3#2)(2010-12#2)(2011-1#2)(2011-12#2)(2011-2#1)(2013-1#2)(2013-7#3)
sandyi##2##1##(2008-10#2)
sangivamycin##2##1##(1996-8#2)
sanguinalis and##2##2##(2008-10#2)
sanguinarine alkanolamine form##2##3##(1994-11#2)
sanguinarine and ethidium##4##3##(2006-10#4)
sanguinarine binds##2##2##(2006-10#2)
sanguinarine##21##1##(1994-11#5)(2006-10#9)(2008-10#3)(2011-2#4)
sanguinea##3##1##(2008-10#2)(2012-2#1)
sanguineous##3##1##(1996-9#2)(2007-7#1)
sanguinis##3##1##(2012-2#3)
sanguis##6##1##(1991-9#2)(2006-6#2)(2008-5#2)
sanitary and##2##2##(2005-5#1)(2012-12#1)
sanitary conditions##4##2##(1991-12#1)(2006-10#1)(2007-1#1)(2011-1#1)
sanitary control of##2##3##(2007-1#1)(2008-10#1)
sanitary control##4##2##(2007-1#1)(2008-10#2)(2012-12#1)
sanitary regulations##2##2##(2009-10#1)(2013-8#1)
sanitary state of night soil##2##5##(2011-12#2)
sanitary workers##2##2##(2009-12#2)
sanitary##44##1##(1991-12#1)(1992-2#1)(1994-3#1)(2005-5#2)(2006-10#1)(2006-12#1)(2006-8#1)(2007-1#2)(2007-6#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-8#2)(2009-10#1)(2009-12#3)(2009-7#4)(2010-12#2)(2011-1#2)(2011-12#4)(2011-2#3)(2012-12#4)(2013-8#3)
sanitation and##6##2##(2008-1#1)(2008-10#2)(2008-9#1)(2010-8#1)(2013-8#1)
sanitation in##2##2##(1994-9#1)(2012-1#1)
sanitation of##3##2##(2009-12#1)(2010-1#1)(2011-1#1)
sanitation practices##2##2##(2008-10#2)
sanitation##38##1##(1993-3#1)(1994-9#1)(1997-3#1)(2006-10#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#10)(2008-7#1)(2008-9#1)(2009-12#1)(2010-1#1)(2010-4#1)(2010-8#2)(2011-1#2)(2012-1#1)(2012-2#7)(2013-1#1)(2013-8#1)
sanitations##3##1##(2009-2#3)
sanitizers and##3##2##(1996-9#3)
sanitizers##5##1##(1996-9#4)(2013-1#1)
sanitizing agents##2##2##(2012-1#2)
sanity##2##1##(2010-9#2)
sank##2##1##(1995-3#1)(2007-9#1)
sanofi pasteur##2##2##(2010-10#1)(2013-1#1)
sanofi##3##1##(2010-10#1)(2013-1#2)
sans##6##1##(1997-6#3)(2012-2#2)(2013-1#1)
santé et##2##2##(2008-11#1)(2008-2#1)
santé##9##1##(2008-11#1)(2008-2#2)(2012-2#6)
sap and##3##2##(1991-9#2)(2012-8#1)
sap flow rates##2##3##(2008-5#2)
sap flow##5##2##(2008-5#5)
sap flux and##2##3##(2008-10#2)
sap inoculation from infected##2##4##(2008-10#2)
sap##23##1##(1991-9#4)(2007-12#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-5#5)(2008-9#1)(2009-8#1)(2012-8#1)(2013-8#1)
sap-sucking##4##1##(2006-12#2)(2013-7#1)(2013-8#1)
saphena##3##1##(1991-10#1)(1992-5#1)(1993-7#1)
saphenofemoral##4##1##(2013-1#4)
saphenous (L2) spinal##2##3##(1995-11#1)(1996-5#1)
saphenous electrical stimulation##2##3##(1995-11#1)(1996-5#1)
saphenous nerve##4##2##(1992-3#1)(1994-2#1)(1997-3#2)
saphenous neurones##2##2##(1994-2#1)(1996-5#1)
saphenous stimulation of##2##3##(1995-11#1)(1996-5#1)
saphenous vein (SV)##2##3##(2007-7#1)(2011-2#1)
saphenous vein and##2##3##(2008-11#1)(2008-4#1)
saphenous vein bypass##4##3##(1996-2#1)(2005-12#2)(2007-8#1)
saphenous vein graft aneurysms##2##4##(2007-8#2)
saphenous vein graft to##2##4##(2007-8#1)(2008-12#1)
saphenous vein graft##15##3##(2006-6#1)(2007-8#10)(2008-12#1)(2009-5#2)(2012-2#1)
saphenous vein grafts##6##3##(2005-12#1)(2007-8#4)(2008-7#1)
saphenous vein harvesting##3##3##(2007-7#2)(2007-8#1)
saphenous vein patch##2##3##(2005-10#2)
saphenous vein was##2##3##(2006-9#1)(2007-8#1)
saphenous vein##62##2##(1990-9#1)(1991-10#1)(1991-2#1)(1991-6#1)(1994-11#1)(1994-6#2)(1996-2#3)(1997-5#3)(2005-10#5)(2005-12#3)(2006-6#3)(2006-9#1)(2007-7#3)(2007-8#22)(2008-11#3)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#1)(2009-5#2)(2011-2#1)(2012-2#1)
saphenous veins##3##2##(1991-6#1)(2006-6#1)(2007-8#1)
saphenous venous##2##2##(2007-8#1)(2011-2#1)
saphenous##88##1##(1990-9#1)(1991-10#1)(1991-2#1)(1991-6#2)(1992-3#1)(1994-11#1)(1994-2#2)(1994-6#2)(1995-11#5)(1996-12#2)(1996-2#3)(1996-5#5)(1997-3#2)(1997-5#3)(2005-10#6)(2005-12#3)(2006-6#5)(2006-9#1)(2007-7#3)(2007-8#25)(2008-11#4)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#1)(2009-5#2)(2011-2#2)(2012-2#1)
saphenus##3##1##(1993-7#1)(1996-6#2)
sapidus##11##1##(1994-11#2)(2007-12#4)(2007-5#1)(2008-5#4)
sapiens and##2##2##(1991-5#1)(2013-8#1)
sapiens##20##1##(1991-11#1)(1991-5#2)(1992-10#1)(1994-3#1)(1997-2#1)(2006-10#1)(2006-3#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-11#2)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
sapinea DNA##2##2##(2008-10#2)
sapinea infections in##2##3##(2008-10#2)
sapinea##11##1##(2008-10#11)
sapling crown##2##2##(2008-9#2)
sapling##4##1##(2008-9#4)
saplings of##2##2##(2008-5#1)(2012-5#1)
saplings##11##1##(2008-5#6)(2008-9#1)(2012-5#3)(2012-9#1)
saponification by lead salts##2##4##(2008-10#2)
saponification##10##1##(1991-9#1)(1992-3#1)(1996-7#1)(1997-1#1)(2007-8#1)(2008-10#4)(2008-5#1)
saponified##5##1##(1996-5#1)(1997-1#2)(2008-10#2)
saponin and##2##2##(1993-4#1)(2007-1#1)
saponin fraction##3##2##(1997-4#3)
saponin fractions##2##2##(1997-4#1)(2007-1#1)
saponin from Panax##2##3##(1995-8#1)(2012-12#1)
saponin from##3##2##(1995-8#1)(2007-1#1)(2012-12#1)
saponin mixture##2##2##(2007-1#2)
saponin on##2##2##(1997-2#1)(2008-11#1)
saponin##40##1##(1992-5#1)(1992-8#1)(1993-4#1)(1995-8#3)(1997-2#8)(1997-4#5)(2005-10#1)(2006-12#1)(2006-6#1)(2007-1#9)(2008-10#1)(2008-11#2)(2008-12#1)(2012-11#4)(2012-12#1)
saponin-permeabilized rat parotid acinar cells##2##5##(1991-8#1)(1992-3#1)
saponin-permeabilized##3##1##(1991-8#1)(1992-3#1)(1994-8#1)
saponin-skinned human##3##2##(1994-12#3)
saponins and##4##2##(1997-2#1)(2007-1#1)(2007-11#1)(2010-12#1)
saponins are##2##2##(2012-2#1)(2013-1#1)
saponins from the##2##3##(2006-12#1)(2013-7#1)
saponins from##6##2##(1994-3#1)(2006-12#1)(2007-1#1)(2013-1#1)(2013-7#2)
saponins of##3##2##(1994-3#1)(2011-3#2)
saponins##53##1##(1994-3#3)(1997-2#2)(1997-4#2)(2006-12#2)(2007-1#6)(2007-11#2)(2008-10#3)(2008-11#4)(2008-12#2)(2008-4#1)(2008-5#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-3#2)(2012-11#3)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#5)(2013-8#2)
saposin C##3##2##(1997-4#3)
saposins were not##2##3##(1991-4#2)
saposins##7##1##(1991-4#5)(1997-4#2)
sapphire (Ti##2##2##(2007-12#2)
sapphire amplifier laser system that##2##5##(2007-12#2)
sapphire amplifier##6##2##(2007-12#4)(2008-1#2)
sapphire and Cr##4##3##(2007-11#2)(2007-12#2)
sapphire and##8##2##(2007-11#2)(2007-12#4)(2008-2#1)(2008-3#1)
sapphire as##2##2##(2008-2#1)(2008-3#1)
sapphire fiber##2##2##(2008-2#2)
sapphire fibers##6##2##(2008-2#3)(2008-3#3)
sapphire is##2##2##(2007-12#1)(2008-10#1)
sapphire laser amplifiers##2##3##(2007-11#1)(2007-12#1)
sapphire laser and the##2##4##(2007-12#2)
sapphire laser and##6##3##(2007-12#3)(2008-1#2)(2008-3#1)
sapphire laser at##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
sapphire laser has been developed##2##5##(2007-12#2)
sapphire laser in the##2##4##(2008-2#1)(2008-3#1)
sapphire laser in##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
sapphire laser is focused##2##4##(2007-12#2)
sapphire laser is##6##3##(2007-11#3)(2007-12#3)
sapphire laser operating at##2##4##(2007-12#1)(2008-2#1)
sapphire laser operating##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
sapphire laser producing##4##3##(2007-11#2)(2007-12#2)
sapphire laser pulses##3##3##(2007-12#1)(2008-1#1)(2008-2#1)
sapphire laser pumping##2##3##(2007-11#1)(2008-1#1)
sapphire laser system##5##3##(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#1)
sapphire laser to##2##3##(2007-12#2)
sapphire laser was used##2##4##(2007-11#1)(2008-3#1)
sapphire laser was##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
sapphire laser with a##4##4##(2007-11#1)(2007-12#2)(2008-3#1)
sapphire laser with##7##3##(2007-11#1)(2007-12#5)(2008-3#1)
sapphire laser##111##2##(2007-11#21)(2007-12#60)(2008-1#6)(2008-2#12)(2008-3#12)
sapphire lasers with##3##3##(2008-3#3)
sapphire lasers##11##2##(2007-11#4)(2007-12#2)(2008-3#5)
sapphire microlenses##3##2##(2008-3#3)
sapphire oscillator##5##2##(2007-12#3)(2008-3#2)
sapphire planar waveguide##2##3##(2007-11#1)(2008-1#1)
sapphire regenerative amplifier##7##3##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#1)
sapphire regenerative##9##2##(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#2)
sapphire ring laser##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
sapphire slab##2##2##(2008-3#2)
sapphire substrate##3##2##(2008-1#1)(2008-3#2)
sapphire substrates##2##2##(2008-2#1)(2008-3#1)
sapphire system##2##2##(2007-11#1)(2008-2#1)
sapphire waveguide##2##2##(2007-12#1)(2008-10#1)
sapphire with a##2##3##(2007-12#1)(2008-2#1)
sapphire##229##1##(1991-1#1)(1993-1#2)(1993-4#1)(2007-11#34)(2007-12#101)(2008-1#14)(2008-10#2)(2008-2#29)(2008-3#44)(2008-7#1)
sapphire-Nd##3##1##(2007-12#3)
sapphire-fiber##4##1##(2008-10#3)(2008-2#1)
sapphire-pumped##2##1##(2007-11#1)(2007-12#1)
sapphyrin##2##1##(2008-10#2)
saprophyte##8##1##(1993-9#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-9#1)(2012-2#1)
saprophytes and nonpathogens##2##3##(2008-10#2)
saprophytes and##3##2##(2008-10#3)
saprophytes##6##1##(2008-10#6)
saprophytic ability##2##2##(2008-10#2)
saprophytic and pathogenic##2##3##(2008-9#1)(2013-1#1)
saprophytic and##3##2##(2008-9#1)(2013-1#2)
saprophytic bacteria##2##2##(2008-10#2)
saprophytic fungal##2##2##(2008-10#2)
saprophytic phase##2##2##(2008-10#2)
saprophytic##31##1##(2005-7#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-10#19)(2008-2#1)(2008-9#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
saprophytically##2##1##(2008-10#2)
saprophyticus##7##1##(1992-4#4)(2006-10#2)(2010-4#1)
saprotrophs##3##1##(2007-7#2)(2010-6#1)
saprotrophy##2##1##(2010-6#2)
sapstain fungi##2##2##(2008-10#2)
sapstain fungus##2##2##(2008-10#2)
sapstain##12##1##(2008-10#12)
sapstaining##2##1##(2008-10#2)
sapwood of##2##2##(2008-10#2)
sapwood##13##1##(2007-6#1)(2008-10#12)
saquinavir##14##1##(1995-9#7)(1996-6#2)(2004-12#1)(2007-1#3)(2008-5#1)
sarafotoxin S6c##4##2##(1991-11#1)(1992-12#2)(1994-11#1)
sarafotoxin##6##1##(1991-11#1)(1992-12#4)(1994-11#1)
sarafotoxins##2##1##(1990-9#1)(1992-12#1)
sarah##5##1##(2008-9#1)(2012-11#4)
saralasin##8##1##(1990-12#1)(1991-5#3)(1994-8#1)(1994-9#1)(1997-2#1)(2008-1#1)
sarco/endoplasmic reticulum-type Ca2(+)-ATPase##3##3##(1990-12#3)
sarco/endoplasmic reticulum-type##4##2##(1990-12#4)
sarco/endoplasmic##5##1##(1990-12#5)
sarcoid##8##1##(1994-3#1)(1994-6#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-7#1)
sarcoidlike##2##1##(2007-10#2)
sarcoidosis (n =##2##3##(1994-3#1)(2010-6#1)
sarcoidosis after##2##2##(2007-7#1)(2012-12#1)
sarcoidosis and healthy##2##3##(2010-6#2)
sarcoidosis and tuberculosis##2##3##(2007-11#1)(2007-4#1)
sarcoidosis and##8##2##(1994-6#1)(2007-11#1)(2007-4#1)(2008-12#1)(2010-6#2)(2012-2#1)(2013-7#1)
sarcoidosis are##2##2##(2007-6#1)(2008-7#1)
sarcoidosis associated##2##2##(2010-6#1)(2012-12#1)
sarcoidosis diagnosed##3##2##(2006-10#1)(2011-12#1)(2012-2#1)
sarcoidosis in##5##2##(1994-6#1)(2005-8#1)(2007-11#1)(2007-4#1)(2012-12#1)
sarcoidosis is rare and##2##4##(2008-4#1)(2011-12#1)
sarcoidosis is##11##2##(2005-8#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-4#1)(2011-12#2)(2012-2#1)
sarcoidosis patients with##3##3##(2006-10#2)(2007-10#1)
sarcoidosis patients##11##2##(2006-10#5)(2007-10#3)(2007-11#1)(2010-6#2)
sarcoidosis with##4##2##(2006-8#1)(2007-7#1)(2008-1#1)(2011-2#1)
sarcoidosis##161##1##(1993-2#1)(1993-9#1)(1994-3#2)(1994-6#3)(1997-5#1)(2004-11#1)(2005-11#2)(2005-8#9)(2006-10#16)(2006-8#4)(2007-10#21)(2007-11#11)(2007-4#4)(2007-6#1)(2007-7#8)(2007-8#2)(2008-1#1)(2008-12#1)(2008-4#4)(2008-7#5)(2009-2#1)(2009-4#1)(2009-5#2)(2010-10#3)(2010-6#26)(2011-12#3)(2011-2#3)(2012-11#3)(2012-12#6)(2012-2#8)(2012-3#2)(2013-1#2)(2013-7#3)
sarcoidosis]##6##1##(1990-6#1)(1992-10#1)(1994-3#1)(2008-7#2)(2011-12#1)
sarcoids in##2##2##(2007-2#2)
sarcoiliac joint##2##2##(2010-1#2)
sarcolemma and##5##2##(1991-11#1)(1994-8#1)(2009-7#1)(2013-1#1)(2013-8#1)
sarcolemma membranes with##2##3##(1993-4#1)(2007-9#1)
sarcolemma##31##1##(1990-3#1)(1990-7#2)(1990-8#1)(1991-1#2)(1991-11#2)(1991-2#1)(1991-9#2)(1993-2#1)(1993-4#2)(1994-5#1)(1994-8#1)(1996-9#3)(2007-9#6)(2008-1#1)(2008-8#1)(2009-7#1)(2013-1#2)(2013-8#1)
sarcolemmal Ca2+ influx##2##3##(1996-12#2)
sarcolemmal membrane and##2##3##(1991-11#1)(2008-10#1)
sarcolemmal membrane##4##2##(1990-3#1)(1991-11#1)(1996-9#1)(2008-10#1)
sarcolemmal membranes##2##2##(1991-1#1)(1996-9#1)
sarcolemmal vesicles##2##2##(1991-5#2)
sarcolemmal##25##1##(1990-3#1)(1991-1#3)(1991-11#1)(1991-5#3)(1992-12#1)(1993-2#1)(1996-12#3)(1996-9#5)(2004-11#1)(2008-1#2)(2008-10#1)(2008-8#3)
sarcoma (KS) is a##2##4##(2007-4#1)(2010-6#1)
sarcoma (KS)##9##2##(1990-9#1)(1991-12#1)(1991-8#1)(1996-8#1)(2007-4#1)(2008-6#1)(2009-11#1)(2010-6#1)(2012-3#1)
sarcoma after##4##2##(2009-5#2)(2010-6#1)(2011-2#1)
sarcoma and carcinoids##2##3##(1993-9#2)
sarcoma and some##2##3##(2008-6#1)(2011-3#1)
sarcoma and the##2##3##(2011-2#1)(2013-7#1)
sarcoma and##23##2##(1990-8#1)(1992-12#1)(1993-9#2)(1994-7#1)(1996-3#1)(2005-11#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-6#5)(2009-3#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-7#1)
sarcoma antigens##2##2##(1997-7#2)
sarcoma are##2##2##(1992-12#1)(2006-10#1)
sarcoma arising from the##3##4##(2008-6#2)(2013-1#1)
sarcoma arising in##3##3##(2008-6#2)(2013-7#1)
sarcoma arising##6##2##(2008-6#4)(2013-1#1)(2013-7#1)
sarcoma associated with the acquired immunodeficiency syndrome##2##7##(1990-9#1)(1992-2#1)
sarcoma at the##3##3##(2008-6#3)
sarcoma at##4##2##(2008-6#4)
sarcoma cell line##3##3##(1994-2#1)(1997-7#1)(2008-6#1)
sarcoma cell##7##2##(1994-2#1)(1997-7#1)(2008-6#5)
sarcoma cells##12##2##(1990-11#1)(1991-10#1)(1992-2#1)(1992-3#1)(1993-12#2)(1997-7#2)(2008-6#4)
sarcoma clones expressing different##2##4##(1991-9#2)
sarcoma database##3##2##(2008-6#3)
sarcoma in the left##2##4##(2008-6#2)
sarcoma in the##6##3##(1994-7#1)(2007-2#1)(2008-6#3)(2011-2#1)
sarcoma in##18##2##(1991-9#1)(1994-6#1)(1994-7#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-6#8)(2008-7#1)(2009-7#1)(2011-2#1)(2013-1#1)
sarcoma is a##2##3##(2007-7#1)(2008-6#1)
sarcoma is the##2##3##(2008-6#1)(2012-12#1)
sarcoma is##11##2##(1990-8#1)(1991-9#1)(1992-1#2)(2007-3#1)(2007-7#1)(2008-6#3)(2009-3#1)(2012-12#1)
sarcoma of the breast##4##4##(1992-2#3)(1994-7#1)
sarcoma of the extremities##4##4##(2008-6#4)
sarcoma of the left##2##4##(2008-6#2)
sarcoma of the limbs##2##4##(1996-6#1)(2007-11#1)
sarcoma of the thyroid gland##2##5##(2012-1#2)
sarcoma of the thyroid##4##4##(2012-1#4)
sarcoma of the##49##3##(1990-2#1)(1991-11#1)(1992-12#1)(1992-2#3)(1993-8#1)(1994-7#1)(1995-9#1)(1996-6#1)(2006-12#1)(2007-11#2)(2007-12#2)(2008-6#21)(2008-7#1)(2009-3#1)(2009-5#1)(2011-2#2)(2012-1#5)(2013-1#2)(2013-7#1)
sarcoma of##59##2##(1990-2#1)(1991-11#1)(1992-12#1)(1992-2#3)(1993-8#1)(1994-7#1)(1995-9#1)(1996-6#1)(2006-12#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-6#24)(2008-7#1)(2009-3#1)(2009-5#2)(2011-2#2)(2012-1#5)(2012-12#1)(2013-1#4)(2013-7#2)
sarcoma or##2##2##(1990-3#1)(2008-9#1)
sarcoma patients##5##2##(2008-6#3)(2008-7#1)(2010-3#1)
sarcoma presenting as##3##3##(1990-2#1)(2006-10#1)(2007-12#1)
sarcoma presenting##4##2##(1990-2#1)(2006-10#1)(2007-12#2)
sarcoma remains##2##2##(2008-6#2)
sarcoma resistant to##2##3##(2008-6#2)
sarcoma specimens##3##2##(2008-6#3)
sarcoma treatment##2##2##(2008-6#1)(2010-3#1)
sarcoma virus##13##2##(1990-12#1)(1992-11#2)(1993-12#1)(1994-8#1)(1995-6#2)(1997-6#1)(1997-8#1)(2008-11#2)(2008-9#1)(2009-12#1)
sarcoma virus-transformed##2##2##(1990-7#1)(1992-11#1)
sarcoma viruses##2##2##(1991-1#1)(1994-12#1)
sarcoma was##7##2##(2008-4#1)(2008-6#4)(2008-7#1)(2009-5#1)
sarcoma were##6##2##(2007-8#1)(2008-6#4)(2008-9#1)
sarcoma who##3##2##(1991-8#1)(2008-6#2)
sarcoma with myxoid##2##3##(1993-2#2)
sarcoma with##14##2##(1990-6#1)(1992-1#1)(1993-2#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-6#4)(2009-7#1)(2011-1#1)
sarcoma##437##1##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-6#2)(1990-7#1)(1990-8#4)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-8#3)(1991-9#9)(1992-1#3)(1992-11#3)(1992-12#6)(1992-2#8)(1992-3#2)(1993-12#4)(1993-2#3)(1993-8#1)(1993-9#2)(1994-12#2)(1994-2#1)(1994-4#2)(1994-6#1)(1994-7#5)(1994-8#1)(1995-4#1)(1995-6#2)(1995-9#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-6#1)(1997-7#6)(1997-8#1)(2005-11#1)(2005-8#2)(2006-10#4)(2006-12#4)(2006-6#6)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#10)(2007-2#5)(2007-3#3)(2007-4#2)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#171)(2008-7#9)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#4)(2009-4#1)(2009-5#8)(2009-7#2)(2010-12#1)(2010-3#8)(2010-6#2)(2010-9#1)(2011-1#5)(2011-2#7)(2011-3#1)(2012-1#8)(2012-12#11)(2012-2#2)(2012-3#2)(2013-1#8)(2013-7#7)
sarcoma)##2##1##(1993-10#1)(2008-6#1)
sarcoma-associated herpesvirus (KSHV)##2##3##(2009-11#1)(2012-12#1)
sarcoma-associated##3##1##(2009-11#1)(2012-12#2)
sarcoma-like##3##1##(1993-2#1)(2012-12#1)(2012-3#1)
sarcoma-reactive##2##1##(1997-7#2)
sarcoma/tumor##3##1##(2009-7#3)
sarcoma]##2##1##(2012-3#1)(2013-8#1)
sarcomas and##10##2##(2008-6#7)(2012-12#1)(2013-7#2)
sarcomas are rare##3##3##(2007-12#1)(2008-6#2)
sarcomas are##11##2##(1991-11#1)(2007-12#1)(2008-6#7)(2009-3#1)(2012-12#1)
sarcomas has##2##2##(2006-6#1)(2008-6#1)
sarcomas in##8##2##(1992-12#1)(2008-6#2)(2008-7#1)(2008-8#3)(2012-12#1)
sarcomas is##4##2##(1992-12#1)(2006-6#1)(2008-6#1)(2009-3#1)
sarcomas may##2##2##(2008-6#2)
sarcomas of the extremity and superficial trunk##2##7##(1993-9#1)(2008-6#1)
sarcomas of the##11##3##(1993-9#1)(2006-6#1)(2007-4#1)(2008-6#6)(2008-7#1)(2013-7#1)
sarcomas the##2##2##(2008-6#2)
sarcomas to##3##2##(2008-6#2)(2013-8#1)
sarcomas were##5##2##(2008-6#3)(2009-3#1)(2010-3#1)
sarcomas##168##1##(1990-12#1)(1991-11#1)(1992-12#3)(1992-3#1)(1992-9#1)(1993-10#3)(1993-9#1)(1994-6#1)(2005-9#1)(2006-6#8)(2007-12#2)(2007-2#1)(2007-4#1)(2008-4#1)(2008-6#104)(2008-7#5)(2008-8#3)(2008-9#1)(2009-3#4)(2010-12#1)(2010-3#2)(2010-5#1)(2011-1#3)(2011-2#3)(2012-12#8)(2013-1#1)(2013-7#3)(2013-8#3)
sarcomatoid carcinoma of the breast##2##5##(1992-8#1)(2012-3#1)
sarcomatoid carcinoma of the##3##4##(1992-8#1)(2009-5#1)(2012-3#1)
sarcomatoid carcinoma##7##2##(1992-8#1)(2009-5#1)(2010-8#1)(2012-12#3)(2012-3#1)
sarcomatoid variant of##2##3##(2007-2#1)(2010-12#1)
sarcomatoid variant##3##2##(2007-2#1)(2010-12#1)(2012-3#1)
sarcomatoid##15##1##(1990-8#1)(1992-8#1)(2007-2#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#3)
sarcomatous component after##2##3##(2007-12#2)
sarcomatous component##5##2##(2007-12#3)(2011-2#1)(2012-3#1)
sarcomatous components were##2##3##(2012-1#2)
sarcomatous components##4##2##(1991-4#1)(2009-5#1)(2012-1#2)
sarcomatous##21##1##(1990-12#2)(1991-4#1)(1993-6#1)(1994-5#1)(1994-6#1)(2006-9#2)(2007-12#3)(2008-5#3)(2008-6#1)(2009-5#1)(2011-2#2)(2012-1#2)(2012-3#1)
sarcomere length##11##2##(1997-2#8)(2010-4#1)(2010-5#1)(2013-1#1)
sarcomere##18##1##(1996-11#2)(1997-2#8)(2007-9#1)(2008-6#1)(2010-4#1)(2010-5#3)(2011-2#1)(2013-1#1)
sarcomeric##4##1##(1993-4#1)(1997-4#1)(2008-7#1)(2008-9#1)
sarcoplasmatic proteins##2##2##(2010-4#1)(2012-2#1)
sarcoplasmatic##3##1##(1991-2#1)(2010-4#1)(2012-2#1)
sarcoplasmic reticulum (SR)##17##3##(1990-11#2)(1990-3#1)(1991-2#1)(1991-7#1)(1991-8#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-6#1)(2006-10#1)(2008-11#1)(2008-8#2)
sarcoplasmic reticulum Ca(2+)-ATPase##6##3##(1992-6#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-8#1)(2010-12#1)
sarcoplasmic reticulum and##6##3##(1990-8#1)(1992-11#1)(1994-2#1)(2008-5#1)(2008-8#1)(2010-2#1)
sarcoplasmic reticulum by##2##3##(1991-5#1)(1994-3#1)
sarcoplasmic reticulum calcium##2##3##(1995-3#1)(2013-8#1)
sarcoplasmic reticulum during##2##3##(1992-3#1)(2012-3#1)
sarcoplasmic reticulum from##2##3##(1992-7#1)(1996-1#1)
sarcoplasmic reticulum in##3##3##(1990-3#1)(1994-2#1)(2010-12#1)
sarcoplasmic reticulum membranes##3##3##(1991-1#1)(1991-7#1)(1992-11#1)
sarcoplasmic reticulum vesicles##4##3##(1990-7#3)(1991-5#1)
sarcoplasmic reticulum was##3##3##(1992-6#1)(1994-10#1)(2009-7#1)
sarcoplasmic reticulum##107##2##(1990-11#6)(1990-2#4)(1990-3#5)(1990-4#1)(1990-5#1)(1990-7#3)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#4)(1991-5#2)(1991-7#2)(1991-8#2)(1991-9#5)(1992-11#6)(1992-3#2)(1992-6#2)(1992-7#2)(1993-12#1)(1993-3#2)(1994-10#3)(1994-11#2)(1994-12#5)(1994-2#6)(1994-3#3)(1994-5#1)(1994-8#3)(1994-9#4)(1995-3#1)(1995-6#2)(1996-1#1)(1996-12#2)(1996-9#2)(1997-7#1)(2006-10#1)(2007-9#2)(2008-11#1)(2008-5#1)(2008-8#4)(2009-7#2)(2010-12#3)(2010-2#1)(2012-3#1)(2013-8#1)
sarcoplasmic##111##1##(1990-11#6)(1990-2#4)(1990-3#5)(1990-4#1)(1990-5#1)(1990-7#3)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#4)(1991-5#2)(1991-7#2)(1991-8#2)(1991-9#5)(1992-11#7)(1992-3#2)(1992-6#2)(1992-7#2)(1993-12#1)(1993-3#2)(1994-10#3)(1994-11#2)(1994-12#5)(1994-2#6)(1994-3#3)(1994-5#1)(1994-8#3)(1994-9#4)(1995-3#1)(1995-6#2)(1996-1#1)(1996-12#2)(1996-9#3)(1997-7#1)(2006-10#1)(2007-9#2)(2008-11#1)(2008-5#1)(2008-8#4)(2009-7#2)(2010-12#3)(2010-2#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-8#1)
sarcoptic##2##1##(1990-3#2)
sarcosinate##2##1##(1996-5#1)(2012-12#1)
sarcosine##4##1##(2006-8#1)(2007-10#1)(2008-10#1)(2011-1#1)
sardine##5##1##(1992-2#1)(2008-10#1)(2008-5#2)(2008-7#1)
sardous plots##2##2##(2008-10#2)
sardous##5##1##(2008-10#5)
sargramostim##2##1##(2009-7#1)(2009-8#1)
sarin##8##1##(2008-11#3)(2008-2#3)(2010-2#2)
sarkosyl treatment##2##2##(1990-7#2)
sarkosyl##4##1##(1990-7#3)(1997-6#1)
sarson##3##1##(2011-1#2)(2011-12#1)
sartans##2##1##(2010-9#2)
sartorius muscle##2##2##(2008-6#2)
sartorius was##2##2##(2008-6#2)
sartorius##13##1##(1993-12#1)(2008-6#11)(2013-1#1)
saruplase##3##1##(2007-11#3)
sat down##2##2##(2008-6#1)(2010-8#1)
sat in front of a mirror##2##6##(2006-6#2)
sat##7##1##(2006-6#2)(2006-8#1)(2008-10#1)(2008-6#1)(2010-8#1)(2013-1#1)
satDNA##2##1##(2008-10#2)
satRNA variants##2##2##(2008-10#2)
satRNA##9##1##(2008-10#9)
satRNA-free##2##1##(2008-10#2)
satRNAs from##2##2##(2008-10#2)
satRNAs##13##1##(2008-10#13)
sated##5##1##(1992-2#1)(1993-6#4)
satellite DNA in##3##3##(1996-9#2)(2010-8#1)
satellite DNA is##2##3##(1996-9#1)(2010-8#1)
satellite DNA sequences##2##3##(1996-9#1)(2008-8#1)
satellite DNA##16##2##(1991-5#2)(1996-9#5)(1997-6#2)(2008-10#1)(2008-8#2)(2010-8#4)
satellite DNAs##5##2##(1991-5#1)(2008-10#2)(2008-5#1)(2010-8#1)
satellite RNA of cucumber mosaic virus##2##6##(1990-7#2)
satellite RNA of##3##3##(1990-7#2)(2008-10#1)
satellite RNA##10##2##(1990-7#3)(1997-6#1)(2008-10#6)
satellite RNAs##3##2##(2008-10#3)
satellite altitude##2##2##(2008-2#2)
satellite and##3##2##(2008-2#1)(2008-3#1)(2008-8#1)
satellite cell##4##2##(1993-3#1)(2008-7#1)(2009-3#2)
satellite cells##18##2##(1993-3#2)(1993-4#1)(1995-12#2)(2007-8#2)(2008-11#2)(2008-4#1)(2008-7#1)(2009-3#6)(2011-12#1)
satellite clinic##4##2##(1994-1#2)(2011-1#2)
satellite communication##3##2##(2008-3#3)
satellite data##3##2##(1992-5#1)(2008-2#1)(2013-8#1)
satellite imagery##6##2##(2007-5#2)(2008-2#2)(2008-3#1)(2012-2#1)
satellite images##7##2##(2008-12#1)(2008-2#4)(2008-3#1)(2013-8#1)
satellite instrument##2##2##(2008-2#1)(2008-3#1)
satellite is##2##2##(1996-9#1)(2008-3#1)
satellite laser##2##2##(2008-2#1)(2008-3#1)
satellite lesions##2##2##(2008-1#1)(2012-3#1)
satellite measurements##2##2##(1990-3#1)(2008-8#1)
satellite model organism##2##3##(2007-12#2)
satellite ocean color imagery##4##4##(2008-3#4)
satellite ocean color##6##3##(2008-3#6)
satellite of the##2##3##(2007-9#1)(2008-5#1)
satellite of##3##2##(1993-12#1)(2007-9#1)(2008-5#1)
satellite peaks and dips in##2##5##(2007-12#2)
satellite peaks##4##2##(2007-12#2)(2008-3#2)
satellite regions##2##2##(1996-4#1)(2007-12#1)
satellite retrieval##2##2##(2008-2#2)
satellite sensor##3##2##(2008-2#1)(2008-3#1)(2008-8#1)
satellite sensors##3##2##(2008-2#2)(2008-3#1)
satellite solar occultation##2##3##(2008-2#2)
satellite stem cells##2##3##(2009-3#2)
satellite symposium##3##2##(2005-8#1)(2008-5#1)(2012-1#1)
satellite that##2##2##(2008-3#2)
satellite to##2##2##(2008-2#1)(2008-5#1)
satellite tobacco mosaic virus##4##4##(2008-10#2)(2008-9#2)
satellite was##2##2##(2008-3#2)
satellite were##2##2##(2008-3#2)
satellite##210##1##(1990-3#1)(1990-7#5)(1991-5#3)(1991-8#2)(1992-5#1)(1993-12#2)(1993-3#3)(1993-4#1)(1994-1#2)(1994-7#1)(1995-11#1)(1995-12#2)(1996-4#1)(1996-9#6)(1997-3#1)(1997-6#4)(2005-11#1)(2005-8#2)(2005-9#1)(2007-11#1)(2007-12#8)(2007-5#2)(2007-7#2)(2007-8#4)(2007-9#4)(2008-1#1)(2008-10#16)(2008-11#2)(2008-12#2)(2008-2#33)(2008-3#45)(2008-4#3)(2008-5#4)(2008-7#3)(2008-8#7)(2008-9#2)(2009-3#11)(2010-8#6)(2010-9#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#7)
satellite&quot##2##1##(2007-6#1)(2008-8#1)
satellite-based##8##1##(2008-2#2)(2008-3#4)(2011-1#1)(2013-8#1)
satelliteborne##2##1##(2008-3#2)
satellites and##5##2##(2008-2#1)(2008-8#4)
satellites in##3##2##(2007-9#1)(2008-2#1)(2012-2#1)
satellites to##2##2##(2007-9#1)(2008-3#1)
satellites whose##2##2##(2006-5#1)(2007-8#1)
satellites##39##1##(1990-3#2)(1991-8#1)(1997-7#1)(2006-5#2)(2006-6#1)(2007-8#1)(2007-9#4)(2008-10#1)(2008-2#9)(2008-3#5)(2008-7#1)(2008-8#10)(2012-2#1)
satiated##5##1##(1993-2#1)(1993-7#1)(2009-9#1)(2012-1#2)
satiating##2##1##(2012-2#2)
satiation##7##1##(1994-6#2)(2006-7#1)(2008-6#2)(2008-8#1)(2011-2#1)
satiety##18##1##(1991-11#1)(1991-8#1)(1997-8#1)(2004-12#1)(2006-10#1)(2006-2#1)(2007-5#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#5)(2010-12#1)(2012-1#2)
satin##2##1##(2008-8#2)
satisfaction after##4##2##(2007-10#1)(2007-12#1)(2012-1#1)(2013-8#1)
satisfaction along with##2##3##(1994-3#1)(1997-3#1)
satisfaction among the##4##3##(1995-9#1)(2006-4#1)(2008-10#1)(2010-8#1)
satisfaction among##15##2##(1992-1#1)(1993-2#1)(1994-1#1)(1995-9#1)(2006-1#1)(2006-4#1)(2006-7#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-8#1)
satisfaction and efficacy##3##3##(1995-2#3)
satisfaction and high##2##3##(2007-11#1)(2012-3#1)
satisfaction and in##2##3##(1994-1#1)(2011-2#1)
satisfaction and loyalty to##2##4##(2008-8#2)
satisfaction and loyalty were##3##4##(2008-8#3)
satisfaction and loyalty##7##3##(2008-8#7)
satisfaction and more##2##3##(1996-9#1)(2008-6#1)
satisfaction and performance##2##3##(2007-10#2)
satisfaction and psychological##2##3##(2008-11#1)(2011-2#1)
satisfaction and service quality are##2##5##(1995-1#1)(2010-8#1)
satisfaction and service quality##5##4##(1995-1#3)(2008-8#1)(2010-8#1)
satisfaction and the##3##3##(1991-2#1)(2008-11#1)(2011-1#1)
satisfaction and willingness to recommend the provider##3##7##(1993-12#3)
satisfaction and willingness to##4##4##(1993-12#3)(2007-1#1)
satisfaction and work-life##2##3##(2009-11#2)
satisfaction and##93##2##(1990-6#1)(1991-2#2)(1992-12#1)(1993-12#5)(1993-2#1)(1994-1#1)(1994-2#2)(1995-1#3)(1995-12#2)(1995-2#3)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-9#1)(1997-1#1)(1997-2#1)(2004-4#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-7#2)(2007-1#1)(2007-10#4)(2007-11#1)(2007-12#4)(2007-4#3)(2007-5#2)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#8)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#5)(2012-3#2)(2013-1#4)
satisfaction are##4##2##(1996-2#1)(2007-12#2)(2008-8#1)
satisfaction at##4##2##(1997-3#1)(2006-7#1)(2007-10#2)
satisfaction between##2##2##(1992-2#1)(2007-2#1)
satisfaction by##2##2##(1995-12#1)(2007-8#1)
satisfaction data##4##2##(1996-1#1)(1997-2#1)(1997-3#1)(2008-10#1)
satisfaction did not##3##3##(1997-1#1)(2013-1#2)
satisfaction during##3##2##(2010-2#2)(2012-2#1)
satisfaction following##3##2##(1996-3#1)(2007-7#1)(2009-6#1)
satisfaction for##6##2##(1990-12#1)(1993-12#1)(2008-2#1)(2008-9#1)(2011-1#1)(2011-2#1)
satisfaction have##2##2##(2007-4#1)(2007-9#1)
satisfaction improvement##2##2##(2008-8#1)(2013-1#1)
satisfaction in a##2##3##(1997-6#1)(2011-2#1)
satisfaction in the##6##3##(1993-12#2)(1994-1#1)(2006-1#2)(2006-10#1)
satisfaction in##19##2##(1993-11#1)(1993-12#2)(1994-1#1)(1997-1#1)(1997-6#1)(2006-1#3)(2006-10#1)(2007-11#1)(2007-7#2)(2008-12#1)(2008-9#1)(2010-10#1)(2011-2#2)(2012-2#1)
satisfaction information as competitive intelligence##2##5##(1996-3#2)
satisfaction information##5##2##(1995-3#1)(1996-2#1)(1996-3#3)
satisfaction is a##2##3##(1994-12#1)(2006-1#1)
satisfaction is high##3##3##(2007-8#1)(2010-9#1)(2011-2#1)
satisfaction is##13##2##(1994-12#2)(1994-3#1)(2006-1#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#2)(2010-9#1)(2011-2#1)(2013-1#1)
satisfaction levels##5##2##(1994-2#1)(1994-3#1)(2006-6#1)(2007-4#1)(2010-10#1)
satisfaction may##5##2##(1995-1#1)(2006-1#1)(2007-9#1)(2012-2#2)
satisfaction measures##3##2##(1994-3#1)(1997-2#1)(2010-2#1)
satisfaction of the##9##3##(1991-1#1)(1992-1#1)(1994-5#1)(2008-2#1)(2008-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2013-1#1)
satisfaction of##35##2##(1991-1#1)(1991-2#1)(1992-1#1)(1992-3#1)(1992-5#1)(1994-5#1)(1995-3#1)(2006-1#2)(2006-12#1)(2007-10#4)(2007-4#1)(2007-8#2)(2007-9#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#1)(2013-1#3)(2013-7#1)(2013-8#2)
satisfaction on##2##2##(1996-3#1)(2008-8#1)
satisfaction one##3##2##(2007-10#2)(2009-7#1)
satisfaction or##4##2##(1992-3#1)(1996-1#1)(2008-9#1)(2009-12#1)
satisfaction outcomes##3##2##(2006-10#3)
satisfaction rates##2##2##(2009-3#1)(2013-8#1)
satisfaction ratings##4##2##(1995-12#1)(1997-3#2)(2007-5#1)
satisfaction score##3##2##(2007-8#1)(2008-8#1)(2012-12#1)
satisfaction scores##2##2##(2007-2#1)(2009-9#1)
satisfaction scoring##2##2##(2010-2#1)(2013-1#1)
satisfaction survey to##2##3##(1996-2#1)(2008-12#1)
satisfaction survey##12##2##(1993-1#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-3#2)(2007-11#1)(2008-12#5)
satisfaction surveys##9##2##(1994-12#1)(1994-3#1)(1996-2#1)(1996-3#6)
satisfaction than##5##2##(1997-1#1)(2007-12#1)(2007-4#1)(2010-11#1)(2013-1#1)
satisfaction to##4##2##(1992-12#1)(1996-2#1)(2007-11#1)(2007-12#1)
satisfaction was high##3##3##(1995-3#1)(2007-8#1)(2013-1#1)
satisfaction was measured##2##3##(2006-4#1)(2008-4#1)
satisfaction was##21##2##(1992-10#1)(1992-2#1)(1994-2#1)(1995-3#1)(1996-3#2)(2006-4#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-8#2)(2009-5#1)(2009-7#1)(2010-8#1)(2012-2#2)(2013-1#1)
satisfaction were found##2##3##(2008-11#1)(2010-10#1)
satisfaction were not##2##3##(2007-12#1)(2009-7#1)
satisfaction were often##2##3##(2006-7#1)(2009-5#1)
satisfaction were##18##2##(1992-1#1)(1992-3#1)(1994-1#1)(1996-2#1)(1996-3#1)(2006-1#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-8#1)(2009-3#2)(2009-5#1)(2009-7#1)(2010-10#1)(2013-1#1)
satisfaction when##2##2##(2008-9#1)(2010-4#1)
satisfaction with a##3##3##(1997-5#1)(2009-9#1)(2012-12#1)
satisfaction with anaesthesia##2##3##(2012-2#2)
satisfaction with and##2##3##(2007-8#1)(2008-8#1)
satisfaction with care##5##3##(1995-2#1)(1995-3#1)(1996-3#1)(1997-1#1)(1997-3#1)
satisfaction with cessation##2##3##(2010-2#2)
satisfaction with clinical experience in##2##5##(2007-8#1)(2008-11#1)
satisfaction with clinical experience##3##4##(2007-8#2)(2008-11#1)
satisfaction with clinical##4##3##(2007-8#2)(2008-11#2)
satisfaction with dental##3##3##(1993-12#2)(2013-1#1)
satisfaction with food-related life##4##4##(2012-2#4)
satisfaction with hospital##2##3##(1993-6#1)(2006-1#1)
satisfaction with life in general##2##5##(1991-4#1)(1993-6#1)
satisfaction with life##6##3##(1991-4#1)(1993-6#1)(1997-2#1)(1997-4#1)(2007-12#1)(2012-2#1)
satisfaction with medical care##3##4##(1996-2#1)(1996-3#1)(2008-8#1)
satisfaction with music##3##3##(2007-6#2)(2008-9#1)
satisfaction with pain treatment##2##4##(2009-12#2)
satisfaction with primary health care services##2##6##(1991-4#2)
satisfaction with primary heath care##2##5##(2008-8#2)
satisfaction with primary##5##3##(1991-4#2)(1992-2#1)(2008-8#2)
satisfaction with radiology##2##3##(1993-1#1)(2012-2#1)
satisfaction with service##2##3##(1993-12#1)(2011-1#1)
satisfaction with services##3##3##(2008-12#1)(2012-3#2)
satisfaction with the TEMPO+##2##4##(2008-9#2)
satisfaction with the##31##3##(1990-10#1)(1993-12#1)(1994-8#1)(1995-2#1)(1996-3#1)(1997-3#1)(2007-6#3)(2007-7#2)(2008-11#1)(2008-12#1)(2008-8#2)(2008-9#3)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
satisfaction with their bodies##3##4##(2008-9#3)
satisfaction with their##7##3##(1997-1#1)(2006-4#1)(2006-9#1)(2008-9#4)
satisfaction with therapy##2##3##(1997-3#1)(2007-8#1)
satisfaction with treatment##3##3##(1995-12#1)(2006-12#1)(2009-12#1)
satisfaction with undergraduate education##3##4##(1993-3#3)
satisfaction with##151##2##(1990-10#1)(1991-4#3)(1992-2#1)(1993-1#1)(1993-12#6)(1993-2#2)(1993-3#3)(1993-4#2)(1993-6#2)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-2#1)(1996-3#7)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-9#2)(2007-1#1)(2007-12#6)(2007-6#5)(2007-7#2)(2007-8#5)(2007-9#1)(2008-11#4)(2008-12#3)(2008-3#1)(2008-7#1)(2008-8#7)(2008-9#10)(2009-12#3)(2009-5#1)(2009-6#1)(2009-7#3)(2009-9#2)(2010-10#1)(2010-2#4)(2010-8#3)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#11)(2012-3#9)(2013-1#8)(2013-8#2)
satisfaction##782##1##(1990-10#1)(1990-12#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#7)(1991-3#3)(1991-4#4)(1992-1#8)(1992-10#2)(1992-12#3)(1992-2#4)(1992-3#4)(1992-5#1)(1993-1#2)(1993-11#1)(1993-12#20)(1993-2#5)(1993-3#7)(1993-4#5)(1993-6#3)(1994-1#5)(1994-11#1)(1994-12#4)(1994-2#8)(1994-3#8)(1994-5#1)(1994-8#1)(1995-1#6)(1995-12#13)(1995-2#8)(1995-3#8)(1995-9#1)(1996-1#9)(1996-12#1)(1996-2#17)(1996-3#36)(1996-9#2)(1997-1#7)(1997-2#6)(1997-3#17)(1997-4#1)(1997-5#1)(1997-6#1)(2004-4#2)(2005-11#3)(2006-1#15)(2006-10#8)(2006-11#1)(2006-12#3)(2006-2#2)(2006-3#3)(2006-4#7)(2006-6#2)(2006-7#9)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#22)(2007-11#7)(2007-12#44)(2007-2#4)(2007-4#12)(2007-5#6)(2007-6#6)(2007-7#10)(2007-8#21)(2007-9#11)(2008-10#7)(2008-11#17)(2008-12#17)(2008-2#4)(2008-3#7)(2008-4#4)(2008-6#2)(2008-7#6)(2008-8#33)(2008-9#19)(2009-10#2)(2009-11#3)(2009-12#7)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#6)(2009-6#4)(2009-7#7)(2009-9#6)(2010-10#9)(2010-11#6)(2010-2#12)(2010-4#2)(2010-5#3)(2010-7#1)(2010-8#11)(2010-9#4)(2011-1#7)(2011-12#3)(2011-2#17)(2012-1#6)(2012-12#5)(2012-2#25)(2012-3#14)(2013-1#38)(2013-7#2)(2013-8#10)
satisfaction) and##2##2##(2007-12#2)
satisfaction)##6##1##(2007-12#2)(2008-7#1)(2009-3#1)(2012-12#1)(2013-1#1)
satisfaction/dissatisfaction##2##1##(1992-1#1)(2008-12#1)
satisfaction]##3##1##(1994-6#1)(1996-11#1)(2007-12#1)
satisfactorily applied for the##4##4##(2008-10#4)
satisfactorily applied to the determination of##13##6##(2008-10#13)
satisfactorily applied to the##19##4##(1993-2#1)(1994-11#1)(2008-10#17)
satisfactorily applied to##23##3##(1993-2#1)(1994-11#1)(2008-10#21)
satisfactorily applied##28##2##(1993-2#1)(1994-11#1)(2008-10#26)
satisfactorily by a##2##3##(2005-11#1)(2008-3#1)
satisfactorily for the determination of##2##5##(2008-10#2)
satisfactorily for the##3##3##(2005-11#1)(2008-10#2)
satisfactorily for##6##2##(1996-2#1)(2005-11#1)(2008-10#4)
satisfactorily identified##2##2##(2008-10#1)(2008-3#1)
satisfactorily in the##5##3##(2008-10#4)(2011-2#1)
satisfactorily in##7##2##(1995-6#1)(2008-10#5)(2011-2#1)
satisfactorily predicted##2##2##(2008-10#1)(2008-7#1)
satisfactorily prioritizing patient privacy##2##4##(2013-1#2)
satisfactorily resolve##2##2##(2008-10#1)(2012-3#1)
satisfactorily the##2##2##(2008-10#2)
satisfactorily to##19##2##(1997-1#1)(2007-8#1)(2008-1#1)(2008-10#16)
satisfactorily used##3##2##(2008-10#3)
satisfactorily with the##3##3##(2007-8#1)(2008-10#1)(2008-2#1)
satisfactorily with those##2##3##(2008-10#2)
satisfactorily with##7##2##(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#1)
satisfactorily##129##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1991-1#1)(1993-2#1)(1993-3#1)(1994-11#1)(1995-1#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-3#2)(2005-11#2)(2005-7#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#80)(2008-11#1)(2008-2#4)(2008-3#6)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#3)
satisfactory accuracy and precision in the presence of excess##2##9##(2008-10#2)
satisfactory accuracy and precision in the presence of##3##8##(2008-10#3)
satisfactory accuracy and precision##5##4##(2008-10#5)
satisfactory accuracy##6##2##(2008-10#5)(2008-3#1)
satisfactory agreement with the##3##4##(2007-12#1)(2008-2#2)
satisfactory agreement with##7##3##(2007-12#3)(2008-10#2)(2008-2#2)
satisfactory agreement##13##2##(1995-2#1)(2007-12#3)(2008-10#4)(2008-2#3)(2008-3#2)
satisfactory analytical##2##2##(2005-12#1)(2008-10#1)
satisfactory and a##2##3##(2008-12#1)(2008-3#1)
satisfactory and##13##2##(1996-1#1)(2006-6#1)(2007-8#2)(2008-10#3)(2008-12#1)(2008-3#1)(2012-2#2)(2013-1#1)(2013-8#1)
satisfactory classification results##2##3##(2006-12#1)(2008-10#1)
satisfactory clinical##5##2##(1995-11#1)(2007-7#2)(2011-2#1)(2013-1#1)
satisfactory control of##2##3##(1991-4#1)(2008-10#1)
satisfactory control##3##2##(1991-4#1)(2008-10#1)(2011-2#1)
satisfactory despite##2##2##(2008-7#1)(2011-1#1)
satisfactory evolution##2##2##(1991-11#1)(2013-8#1)
satisfactory fits##2##2##(1996-1#1)(2008-3#1)
satisfactory for practical##2##3##(2006-5#1)(2008-10#1)
satisfactory for the##3##3##(1992-3#1)(2008-10#2)
satisfactory for##19##2##(1990-4#1)(1992-3#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#8)(2008-3#1)(2008-7#2)(2008-9#1)
satisfactory in 85%##2##3##(1996-11#1)(2006-10#1)
satisfactory in all##2##3##(2007-8#1)(2012-12#1)
satisfactory in cases of##2##4##(2006-3#1)(2009-3#1)
satisfactory in two (10%)##3##4##(1996-9#3)
satisfactory in##21##2##(1991-2#1)(1993-8#1)(1996-11#1)(1996-9#3)(1997-8#1)(2006-10#1)(2006-3#1)(2007-8#4)(2008-10#2)(2008-7#2)(2009-3#1)(2011-2#2)(2012-12#1)
satisfactory manner##3##2##(1990-11#1)(1996-12#1)(2006-10#1)
satisfactory or##2##2##(2008-7#1)(2011-2#1)
satisfactory outcome##5##2##(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)
satisfactory outcomes##2##2##(2006-9#1)(2007-7#1)
satisfactory performance##7##2##(2005-12#1)(2005-4#1)(2008-10#3)(2008-3#1)(2012-12#1)
satisfactory precision##5##2##(2007-8#1)(2008-10#4)
satisfactory prediction##2##2##(2006-11#1)(2008-10#1)
satisfactory recovery##6##2##(2006-10#1)(2008-10#4)(2012-2#1)
satisfactory relief##2##2##(1991-2#1)(1995-2#1)
satisfactory reproducibility##4##2##(1997-2#1)(2007-8#1)(2008-10#2)
satisfactory resolution##3##2##(1991-2#1)(2006-12#1)(2008-10#1)
satisfactory response##4##2##(2011-2#2)(2012-3#2)
satisfactory result##4##2##(2008-10#3)(2008-2#1)
satisfactory results and##5##3##(1996-12#1)(2007-8#1)(2008-10#3)
satisfactory results for##2##3##(2010-11#1)(2013-1#1)
satisfactory results in the##2##4##(2007-8#1)(2008-10#1)
satisfactory results in##9##3##(1994-3#1)(1997-4#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2010-12#1)
satisfactory results obtained##2##3##(1992-6#1)(2008-5#1)
satisfactory results on##2##3##(2008-10#2)
satisfactory results that##2##3##(2005-11#1)(2007-12#1)
satisfactory results to##3##3##(2008-10#2)(2012-1#1)
satisfactory results were obtained##2##4##(2008-10#2)
satisfactory results were##4##3##(1994-9#1)(2008-10#2)(2011-2#1)
satisfactory results with##2##3##(1992-9#1)(2008-10#1)
satisfactory results without##2##3##(1992-10#1)(2007-7#1)
satisfactory results##152##2##(1990-12#1)(1990-5#1)(1992-10#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-3#1)(1994-9#1)(1996-12#1)(1997-4#1)(2005-11#1)(2005-4#5)(2006-10#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-7#3)(2007-8#8)(2008-1#1)(2008-10#98)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-8#1)(2009-10#1)(2010-10#1)(2010-11#1)(2010-12#2)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#3)
satisfactory separation of##2##3##(2008-10#2)
satisfactory surgical##2##2##(2006-12#1)(2008-7#1)
satisfactory therapeutic##2##2##(2007-8#1)(2008-11#1)
satisfactory to##3##2##(2008-10#3)
satisfactory treatment##2##2##(2011-1#1)(2011-2#1)
satisfactory when the##2##3##(1995-2#1)(2006-8#1)
satisfactory when##3##2##(1995-2#1)(2006-8#1)(2008-2#1)
satisfactory with##5##2##(1990-5#1)(1991-11#1)(2006-9#1)(2008-10#2)
satisfactory##562##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#2)(1990-5#3)(1990-9#1)(1991-11#3)(1991-2#3)(1991-3#1)(1991-4#3)(1991-5#1)(1991-6#1)(1991-8#2)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-8#2)(1994-12#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#3)(1995-5#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#5)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#2)(2004-1#1)(2004-10#1)(2005-11#2)(2005-12#3)(2005-4#13)(2005-5#1)(2006-10#8)(2006-11#3)(2006-12#6)(2006-2#1)(2006-3#3)(2006-4#1)(2006-5#2)(2006-6#2)(2006-8#5)(2006-9#3)(2007-1#1)(2007-11#8)(2007-12#6)(2007-2#1)(2007-3#2)(2007-7#15)(2007-8#35)(2008-1#5)(2008-10#205)(2008-11#5)(2008-12#3)(2008-2#12)(2008-3#11)(2008-4#6)(2008-5#6)(2008-6#1)(2008-7#11)(2008-8#2)(2008-9#5)(2009-10#1)(2009-3#2)(2009-4#3)(2009-6#1)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#6)(2011-2#17)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#7)(2012-3#4)(2013-1#12)(2013-7#1)(2013-8#5)
satisfactory&quot##2##1##(1993-2#2)
satisfiability##2##1##(2010-2#2)
satisfied and##2##2##(2006-6#1)(2012-2#1)
satisfied both##2##2##(2006-10#1)(2006-6#1)
satisfied by the##3##3##(1992-12#1)(1992-3#1)(2008-11#1)
satisfied by##8##2##(1990-6#1)(1992-12#1)(1992-3#1)(1997-3#1)(2005-7#1)(2006-5#1)(2008-11#2)
satisfied customers##2##2##(1992-1#1)(1993-1#1)
satisfied for##4##2##(2008-10#1)(2008-2#2)(2008-8#1)
satisfied in##5##2##(1991-4#1)(1993-6#1)(1997-2#1)(1997-3#1)(2012-3#1)
satisfied or##3##2##(1992-5#1)(1996-3#1)(2008-10#1)
satisfied than the##2##3##(1996-2#1)(2009-11#1)
satisfied than##6##2##(1996-2#2)(2007-12#1)(2009-11#1)(2012-2#2)
satisfied that##2##2##(1996-3#1)(2013-1#1)
satisfied the##4##2##(1990-7#1)(1991-2#1)(2008-3#1)(2009-6#1)
satisfied with life##2##3##(2007-10#1)(2009-11#1)
satisfied with the organisation's##2##4##(2008-7#2)
satisfied with the overall quality of##2##6##(1995-12#1)(2008-8#1)
satisfied with the results of treatment##2##6##(1990-4#1)(1992-5#1)
satisfied with the service##3##4##(1994-8#1)(1995-9#1)(2012-3#1)
satisfied with the services##2##4##(1994-1#1)(2012-3#1)
satisfied with the treatment##2##4##(2008-9#1)(2013-1#1)
satisfied with the##37##3##(1990-4#1)(1991-1#1)(1991-2#1)(1992-5#1)(1994-1#1)(1994-8#1)(1995-12#1)(1995-9#1)(1996-2#1)(1996-3#1)(1997-2#1)(2004-2#1)(2006-10#1)(2007-10#1)(2007-7#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-7#3)(2008-8#2)(2008-9#3)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#1)
satisfied with their bodies##4##4##(2007-12#1)(2009-5#2)(2010-10#1)
satisfied with their experience##2##4##(2007-2#1)(2009-9#1)
satisfied with their present##2##4##(1993-3#1)(2006-2#1)
satisfied with their##25##3##(1990-12#1)(1993-3#2)(1996-2#2)(1996-9#1)(2006-2#1)(2007-1#3)(2007-10#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#2)(2009-9#1)(2010-10#1)(2010-3#1)(2010-8#1)(2012-2#1)
satisfied with this##2##3##(1990-2#1)(1991-1#1)
satisfied with##89##2##(1990-12#1)(1990-2#1)(1990-4#1)(1991-1#2)(1991-2#1)(1991-4#1)(1992-2#1)(1992-5#2)(1993-3#4)(1994-1#1)(1994-8#1)(1995-12#1)(1995-9#1)(1996-2#3)(1996-3#1)(1996-9#1)(1997-2#1)(2004-2#1)(2006-10#2)(2006-2#1)(2007-1#3)(2007-10#4)(2007-12#2)(2007-2#2)(2007-7#5)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#4)(2008-8#2)(2008-9#4)(2009-11#1)(2009-5#2)(2009-9#1)(2010-10#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#9)
satisfied##170##1##(1990-12#1)(1990-2#2)(1990-4#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#2)(1991-2#2)(1991-4#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#3)(1993-1#1)(1993-3#5)(1993-6#1)(1994-1#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-9#1)(1996-2#5)(1996-3#5)(1996-9#1)(1997-2#2)(1997-3#2)(2004-11#1)(2004-2#1)(2005-11#2)(2005-7#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#2)(2006-7#4)(2006-8#1)(2007-1#3)(2007-10#4)(2007-11#1)(2007-12#5)(2007-2#2)(2007-7#6)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#4)(2008-7#4)(2008-8#3)(2008-9#7)(2009-11#2)(2009-5#2)(2009-6#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#7)(2012-3#9)(2013-1#11)(2013-8#1)
satisfied)##2##1##(2008-4#2)
satisfies all of##2##3##(1997-8#1)(2009-1#1)
satisfies all##3##2##(1997-8#1)(2008-7#1)(2009-1#1)
satisfies its##2##2##(2007-10#1)(2010-2#1)
satisfies the##11##2##(2008-10#2)(2008-2#4)(2008-3#4)(2013-1#1)
satisfies this requirement##2##3##(2008-3#1)(2008-4#1)
satisfies##28##1##(1997-8#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-2#5)(2008-3#5)(2008-4#3)(2008-7#2)(2008-9#1)(2009-1#1)(2009-12#1)(2010-2#1)(2013-1#3)(2013-8#1)
satisfy all##2##2##(1996-12#1)(2008-3#1)
satisfy both##2##2##(2007-12#1)(2008-5#1)
satisfy patients'##2##2##(1994-1#1)(1997-3#1)
satisfy the condition##2##3##(2007-11#1)(2008-2#1)
satisfy the criteria of##2##4##(2008-3#1)(2012-2#1)
satisfy the criteria##3##3##(2004-11#1)(2008-3#1)(2012-2#1)
satisfy the need for##2##4##(1992-3#1)(2008-12#1)
satisfy the need##3##3##(1992-3#1)(2008-12#1)(2011-1#1)
satisfy the needs of##4##4##(1994-12#1)(1995-1#1)(2008-2#1)(2013-7#1)
satisfy the wave equation##2##4##(2007-12#2)
satisfy the##48##2##(1991-4#1)(1992-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-1#2)(1995-9#1)(1996-1#1)(1996-4#1)(1997-3#1)(1997-4#1)(1997-6#1)(2004-11#1)(2005-9#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#4)(2008-3#5)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#2)
satisfy their##2##2##(2007-10#1)(2007-9#1)
satisfy these requirements##2##3##(2006-11#1)(2007-6#1)
satisfy these##3##2##(2006-11#1)(2007-6#1)(2008-2#1)
satisfy##79##1##(1991-4#1)(1992-3#1)(1993-1#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#2)(1995-10#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(2004-11#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-6#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#7)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#2)
satisfying both##2##2##(1995-3#1)(2008-3#1)
satisfying the basic requirements of a virus with pandemic potential##2##10##(2012-12#2)
satisfying the##10##2##(1993-12#1)(1997-3#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-3#1)(2011-1#1)(2012-12#2)(2013-7#1)
satisfying##40##1##(1991-12#1)(1993-12#2)(1994-1#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-1#1)(1997-3#1)(2005-4#2)(2005-5#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
sativa (L##2##2##(2008-12#1)(2008-5#1)
sativa L##47##2##(1990-12#1)(1992-8#1)(1994-11#1)(1996-10#1)(1997-2#1)(1997-4#2)(2006-12#2)(2006-3#1)(2006-9#1)(2007-12#2)(2008-10#4)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#13)(2009-3#3)(2009-8#1)(2011-2#2)(2012-1#1)(2012-3#1)
sativa and##3##2##(2008-10#1)(2008-5#1)(2012-3#1)
sativa seeds##4##2##(1991-10#1)(1992-3#2)(2009-7#1)
sativa ssp##5##2##(2006-12#1)(2008-9#1)(2009-10#3)
sativa##105##1##(1990-12#1)(1991-10#2)(1992-3#2)(1992-8#1)(1994-11#1)(1994-6#1)(1994-9#1)(1996-10#1)(1997-2#1)(1997-4#2)(1997-8#1)(2006-12#3)(2006-3#1)(2006-9#1)(2007-12#2)(2007-3#5)(2008-10#13)(2008-11#2)(2008-12#5)(2008-4#1)(2008-5#6)(2008-7#1)(2008-8#3)(2008-9#20)(2009-10#7)(2009-12#1)(2009-3#3)(2009-4#3)(2009-7#3)(2009-8#2)(2010-10#1)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#3)
sativa) and##2##2##(2004-4#1)(2008-10#1)
sativa) in##2##2##(2008-10#1)(2008-12#1)
sativa) were##2##2##(2004-4#1)(2008-10#1)
sativa)##24##1##(2004-4#2)(2008-10#15)(2008-12#2)(2008-7#2)(2009-10#1)(2012-2#2)
sativum L##7##2##(1995-1#1)(2006-9#2)(2007-1#1)(2008-2#2)(2013-1#1)
sativum and##3##2##(1992-12#1)(2008-10#1)(2008-2#1)
sativum##16##1##(1992-12#2)(1995-1#1)(2006-9#2)(2007-1#1)(2007-5#1)(2008-10#3)(2008-2#3)(2008-4#1)(2011-2#1)(2013-1#1)
sativum) and##3##2##(1992-9#1)(2008-1#1)(2008-10#1)
sativum)##8##1##(1992-12#1)(1992-9#1)(1993-6#1)(2008-1#1)(2008-10#3)(2011-12#1)
sativus L##8##2##(1990-3#1)(1997-1#2)(2008-10#2)(2008-12#1)(2008-5#1)(2009-12#1)
sativus and##6##2##(2008-10#6)
sativus isolates##2##2##(2008-10#2)
sativus##36##1##(1990-3#1)(1997-1#2)(2007-1#1)(2008-10#26)(2008-12#1)(2008-5#4)(2009-12#1)
sativus)##12##1##(2008-10#11)(2011-2#1)
saturability##3##1##(1990-2#1)(1996-12#1)(2007-11#1)
saturable (Bmax =##2##3##(1992-9#1)(1994-12#1)
saturable (Bmax##3##2##(1992-9#1)(1994-12#1)(1996-10#1)
saturable Bragg reflector as the##2##5##(2007-11#1)(2008-3#1)
saturable Bragg reflector##8##3##(2007-11#6)(2007-12#1)(2008-3#1)
saturable absorber is studied##2##4##(2007-12#1)(2008-3#1)
saturable absorber is##7##3##(2007-11#1)(2007-12#2)(2008-3#4)
saturable absorber mirror##4##3##(2007-11#2)(2007-12#1)(2008-2#1)
saturable absorber##46##2##(2007-11#6)(2007-12#13)(2008-1#3)(2008-2#5)(2008-3#19)
saturable absorbers##10##2##(2007-11#1)(2007-12#5)(2008-2#2)(2008-3#2)
saturable absorption in##2##3##(2008-1#1)(2008-3#1)
saturable absorption##7##2##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#4)
saturable amplifier##3##2##(2007-12#3)
saturable and reversible binding##2##4##(1990-8#1)(2008-4#1)
saturable and reversible##4##3##(1990-11#1)(1990-2#1)(1990-8#1)(2008-4#1)
saturable and specific##2##3##(1991-1#1)(1994-3#1)
saturable and##16##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1992-12#3)(1994-3#1)(1994-6#1)(1994-8#2)(1995-2#1)(1995-7#1)(2008-4#1)
saturable association##2##2##(1990-2#1)(1996-1#1)
saturable at##2##2##(1990-11#1)(1996-2#1)
saturable binding to##2##3##(1991-6#1)(1992-6#1)
saturable binding##4##2##(1991-2#1)(1991-6#1)(1992-6#1)(1993-6#1)
saturable gain##5##2##(2007-12#4)(2008-3#1)
saturable in##3##2##(1995-3#1)(1996-6#1)(1997-8#1)
saturable mechanism##4##2##(1990-12#4)
saturable nonlinear media##2##3##(2007-12#2)
saturable nonlinear##3##2##(2007-12#3)
saturable##167##1##(1990-11#3)(1990-12#4)(1990-2#5)(1990-5#1)(1990-7#2)(1990-8#2)(1991-1#2)(1991-12#3)(1991-2#1)(1991-4#1)(1991-6#1)(1992-12#3)(1992-3#4)(1992-6#2)(1992-9#2)(1993-1#2)(1993-12#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#4)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-7#1)(1996-1#3)(1996-10#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-8#1)(2007-11#14)(2007-12#33)(2008-1#5)(2008-2#9)(2008-3#28)(2008-4#3)(2009-8#1)
saturable-absorber mirror##16##2##(2007-11#2)(2007-12#12)(2008-3#2)
saturable-absorber mode locking##2##3##(2007-12#2)
saturable-absorber response##2##2##(2007-12#2)
saturable-absorber##26##1##(2007-11#3)(2007-12#21)(2008-3#2)
saturable-gain or-absorber gratings##2##3##(2007-12#2)
saturably to##3##2##(1993-6#1)(1993-9#1)(1996-5#1)
saturably##4##1##(1990-7#1)(1993-6#1)(1993-9#1)(1996-5#1)
saturate the##5##2##(1990-7#1)(1991-2#1)(1991-5#1)(2008-3#1)(2009-11#1)
saturate##13##1##(1990-7#1)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(2006-3#1)(2007-8#1)(2008-10#1)(2008-3#3)(2009-11#1)
saturated (SFA)##2##2##(2004-11#1)(2011-2#1)
saturated FA##2##2##(1994-9#1)(2012-1#1)
saturated FFA##2##2##(1995-7#2)
saturated absorption##4##2##(2007-8#1)(2008-1#1)(2008-3#2)
saturated alpha-isoprene unit##3##3##(1994-8#3)
saturated and unsaturated fatty acids##2##5##(1990-8#1)(2008-10#1)
saturated and unsaturated##3##3##(1990-8#1)(1992-6#1)(2008-10#1)
saturated and##7##2##(1990-5#1)(1990-8#1)(1992-6#1)(2005-12#1)(2006-12#1)(2008-10#1)(2011-2#1)
saturated aqueous##2##2##(1991-12#1)(2011-1#1)
saturated as##2##2##(1994-9#1)(2008-7#1)
saturated branched fatty acyl chains substituted in the 2-positions of the main chains##2##13##(1996-5#1)(1997-2#1)
saturated branched##3##2##(1996-5#2)(1997-2#1)
saturated calomel electrode##3##3##(1997-1#1)(2008-10#2)
saturated calomel reference electrode##3##4##(2008-10#3)
saturated calomel##6##2##(1997-1#1)(2008-10#5)
saturated degenerate four-wave mixing##2##4##(2008-3#2)
saturated esters on##2##3##(2008-10#2)
saturated fat diet##4##3##(1991-7#1)(1994-2#3)
saturated fat group##2##3##(1994-2#2)
saturated fat##23##2##(1990-11#1)(1991-7#1)(1993-9#2)(1994-2#6)(1995-4#1)(1996-11#1)(2005-10#2)(2008-1#1)(2008-10#1)(2008-3#1)(2010-4#2)(2012-2#1)(2013-8#3)
saturated fats##5##2##(2006-2#1)(2008-3#1)(2008-7#1)(2010-4#2)
saturated fatty acid (SFA)##3##4##(2010-2#1)(2010-4#2)
saturated fatty acid in##3##4##(2012-11#1)(2013-1#2)
saturated fatty acid##15##3##(1990-8#1)(1995-11#1)(2006-12#1)(2008-12#1)(2010-2#1)(2010-4#2)(2012-11#1)(2013-1#7)
saturated fatty acids and cholesterol##4##5##(1992-8#2)(2004-11#1)(2006-2#1)
saturated fatty acids in the##2##5##(1991-12#1)(1996-2#1)
saturated fatty acids in##5##4##(1991-12#1)(1996-2#1)(2005-12#1)(2006-12#2)
saturated fatty acids was##3##4##(2005-12#1)(2008-11#2)
saturated fatty acids were##3##4##(1994-8#1)(2009-8#1)(2012-2#1)
saturated fatty acids##30##3##(1990-10#1)(1990-2#2)(1991-12#1)(1992-6#1)(1992-8#2)(1994-8#1)(1994-9#1)(1995-3#1)(1996-2#1)(1997-7#1)(2004-11#1)(2005-12#2)(2006-12#4)(2006-2#1)(2006-6#1)(2008-11#2)(2008-12#1)(2009-8#1)(2010-4#3)(2012-12#1)(2012-2#1)
saturated fatty##47##2##(1990-10#1)(1990-2#2)(1990-8#1)(1991-12#1)(1992-6#1)(1992-8#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-2#1)(1997-7#1)(2004-11#1)(2005-12#2)(2006-12#5)(2006-2#1)(2006-6#1)(2008-10#1)(2008-11#2)(2008-12#2)(2009-8#1)(2010-2#1)(2010-4#5)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#7)
saturated hydrocarbons##2##2##(1996-5#1)(2010-5#1)
saturated lipid##3##2##(1990-2#1)(1991-2#1)(1992-6#1)
saturated mixed-chain##2##2##(1990-7#2)
saturated or unsaturated fatty acids##2##5##(1990-2#1)(1994-8#1)
saturated or unsaturated##4##3##(1990-2#1)(1994-8#1)(1995-5#1)(2007-9#1)
saturated or##5##2##(1990-2#1)(1993-9#1)(1994-8#1)(1995-5#1)(2007-9#1)
saturated palmitic fatty acid##2##4##(2013-1#2)
saturated phosphatidylcholine##2##2##(1991-2#2)
saturated side chain##2##3##(1992-3#1)(2007-11#1)
saturated solution of##3##3##(2007-7#1)(2008-10#2)
saturated the##2##2##(1990-6#1)(2007-11#1)
saturated to##2##2##(2005-12#1)(2008-10#1)
saturated transmission and##2##3##(2008-3#2)
saturated transmission##3##2##(2008-3#3)
saturated vapor pressure##2##3##(2005-11#1)(2008-5#1)
saturated with the##2##3##(1993-9#1)(2005-11#1)
saturated with##18##2##(1990-2#2)(1990-4#1)(1991-2#1)(1993-9#1)(1995-1#1)(1996-3#1)(2005-11#3)(2006-10#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2010-2#1)(2011-2#1)
saturated##245##1##(1990-10#1)(1990-11#2)(1990-2#8)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#3)(1990-8#2)(1991-12#4)(1991-2#6)(1991-4#3)(1991-7#1)(1992-3#1)(1992-6#3)(1992-8#2)(1992-9#1)(1993-11#1)(1993-9#4)(1994-11#1)(1994-2#6)(1994-8#5)(1994-9#4)(1995-1#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-7#2)(1996-11#2)(1996-2#1)(1996-3#1)(1996-5#4)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-11#3)(2004-4#1)(2005-10#2)(2005-11#7)(2005-12#4)(2006-10#1)(2006-12#7)(2006-2#2)(2006-6#1)(2007-11#3)(2007-12#6)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#30)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#18)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-8#1)(2010-10#1)(2010-2#2)(2010-4#11)(2010-5#3)(2011-1#3)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#8)(2013-1#9)(2013-8#3)
saturated-absorption spectra recorded by use of##2##6##(2007-11#1)(2007-12#1)
saturated-absorption##5##1##(2007-11#2)(2007-12#3)
saturates at##3##2##(1993-9#1)(2007-12#1)(2008-10#1)
saturates##10##1##(1993-9#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2013-8#1)
saturating Ca2+ and##2##3##(1993-3#1)(2008-8#1)
saturating Ca2+##3##2##(1993-3#2)(2008-8#1)
saturating amounts of the##3##4##(1994-12#2)(1995-11#1)
saturating concentration of##7##3##(1990-10#1)(1990-2#1)(1990-4#1)(1991-7#1)(1992-3#1)(1993-6#1)(1996-2#1)
saturating concentration##9##2##(1990-10#1)(1990-2#1)(1990-4#1)(1991-7#1)(1992-3#1)(1993-6#1)(1994-10#1)(1994-2#1)(1996-2#1)
saturating concentrations of##3##3##(1990-10#1)(1991-7#1)(1997-2#1)
saturating concentrations##4##2##(1990-10#1)(1991-7#1)(1992-3#1)(1997-2#1)
saturating levels of##2##3##(1992-6#1)(1995-8#1)
saturating light##2##2##(1990-5#1)(1995-1#1)
saturating substrate concentration##2##3##(1994-11#1)(1994-8#1)
saturating substrate##3##2##(1991-2#1)(1994-11#1)(1994-8#1)
saturating##45##1##(1990-10#2)(1990-2#2)(1990-4#1)(1990-5#3)(1991-2#1)(1991-5#1)(1991-7#2)(1992-12#1)(1992-3#2)(1992-6#1)(1993-3#2)(1993-4#1)(1993-6#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-3#2)(2008-8#3)
saturation (SpO2)##4##2##(1993-1#2)(2007-2#2)
saturation absorption##2##2##(2008-3#2)
saturation analysis##2##2##(1990-2#1)(1994-11#1)
saturation and excited-state absorption##2##4##(2008-3#2)
saturation and near##2##3##(2006-10#1)(2013-1#1)
saturation and predominant in the##2##5##(1990-5#2)
saturation and the##2##3##(2007-12#1)(2007-8#1)
saturation and##32##2##(1990-10#1)(1990-5#2)(1992-12#1)(1993-5#2)(1995-12#1)(1997-6#2)(2006-10#2)(2006-3#1)(2007-1#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-8#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2009-4#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
saturation as##2##2##(2008-3#1)(2008-8#1)
saturation behavior##2##2##(2007-12#1)(2008-3#1)
saturation binding studies##2##3##(1991-7#2)
saturation binding##5##2##(1991-7#2)(1995-1#1)(1996-11#1)(2006-6#1)
saturation capacity##2##2##(2008-10#2)
saturation conditions##2##2##(1991-3#1)(2008-2#1)
saturation coverage##2##2##(2005-11#1)(2008-10#1)
saturation data##2##2##(1995-11#1)(2007-11#1)
saturation during##3##2##(1993-1#1)(1997-8#1)(2007-12#1)
saturation effects##3##2##(2008-3#1)(2008-7#1)(2012-2#1)
saturation experiments with##2##3##(1993-2#1)(1995-3#1)
saturation experiments##4##2##(1993-2#1)(1993-6#1)(1995-3#1)(1996-2#1)
saturation fluence##3##2##(2008-3#3)
saturation for##3##2##(1994-3#1)(1994-5#1)(2008-2#1)
saturation function##2##2##(1990-8#1)(2010-7#1)
saturation in the##3##3##(1994-12#1)(1997-6#1)(2007-12#1)
saturation in##14##2##(1993-5#1)(1994-12#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)(2008-7#1)(2010-10#1)(2010-3#1)(2011-12#1)
saturation increased##2##2##(2008-1#1)(2013-1#1)
saturation intensity and##2##3##(2008-2#1)(2008-3#1)
saturation intensity##10##2##(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#3)
saturation irradiance##10##2##(2008-2#4)(2008-3#6)
saturation is##8##2##(1992-7#1)(1994-5#1)(1996-2#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-3#1)(2011-12#1)
saturation kinetics with##3##3##(1991-5#1)(1991-8#1)(1992-5#1)
saturation kinetics##9##2##(1990-11#1)(1990-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-4#1)(1992-5#1)(2010-5#1)
saturation level##4##2##(1996-7#1)(2008-9#1)(2011-1#1)(2013-8#1)
saturation levels of the receptor##2##5##(1995-10#2)
saturation levels##6##2##(1993-7#1)(1995-10#2)(2008-3#1)(2011-1#2)
saturation magnetization##3##2##(2008-5#1)(2012-11#1)(2013-1#1)
saturation measurements##2##2##(2008-2#1)(2008-3#1)
saturation mutagenesis##4##2##(1990-3#1)(1994-3#1)(2011-1#2)
saturation of the##18##3##(1991-2#1)(1991-5#1)(1992-4#1)(1994-2#1)(1997-1#1)(2005-10#1)(2007-10#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#2)(2010-5#1)(2011-2#1)(2012-11#1)(2013-1#1)
saturation of two-photon##2##3##(2007-11#2)
saturation of##44##2##(1991-2#1)(1991-5#1)(1991-8#1)(1992-4#1)(1992-6#1)(1993-4#1)(1994-2#1)(1994-5#1)(1994-8#1)(1996-1#1)(1997-1#1)(1997-6#1)(2005-10#1)(2006-3#1)(2007-10#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#4)(2008-2#3)(2008-3#4)(2008-7#2)(2009-5#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-11#1)(2013-1#1)
saturation on the##5##3##(2008-2#1)(2008-3#4)
saturation parameter of##2##3##(2008-2#2)
saturation point##2##2##(2005-11#1)(2013-8#1)
saturation profile##2##2##(1991-6#1)(1991-7#1)
saturation properties of terahertz emission from##2##6##(2007-12#2)
saturation properties of##4##3##(2007-12#3)(2008-2#1)
saturation solubility##3##2##(2008-5#1)(2010-12#2)
saturation spectroscopy##2##2##(2007-12#2)
saturation to##2##2##(2004-11#1)(2008-2#1)
saturation transfer EPR##5##3##(1990-8#2)(1991-9#2)(1992-3#1)
saturation transfer##11##2##(1990-8#2)(1991-9#2)(1992-3#1)(1992-4#2)(1992-9#2)(1995-10#1)(2011-1#1)
saturation using##2##2##(1992-9#1)(2008-10#1)
saturation values##3##2##(2007-12#2)(2007-2#1)
saturation was higher##2##3##(1990-3#1)(1991-9#1)
saturation was##7##2##(1990-3#1)(1991-5#1)(1991-9#1)(2007-12#1)(2007-8#2)(2008-11#1)
saturation with##4##2##(1990-8#1)(1991-7#1)(1994-11#1)(2007-12#1)
saturation within##3##2##(1991-9#1)(2008-10#1)(2008-3#1)
saturation##368##1##(1990-10#1)(1990-11#2)(1990-2#2)(1990-3#2)(1990-5#2)(1990-8#5)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#1)(1991-7#5)(1991-8#2)(1991-9#6)(1992-1#1)(1992-12#1)(1992-3#4)(1992-4#4)(1992-5#2)(1992-6#6)(1992-7#1)(1992-9#3)(1993-1#3)(1993-2#2)(1993-4#1)(1993-5#3)(1993-6#1)(1993-7#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#4)(1994-8#1)(1995-1#1)(1995-10#4)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-11#1)(1996-2#4)(1996-3#2)(1996-5#1)(1996-7#1)(1997-1#2)(1997-3#1)(1997-6#7)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#4)(2006-10#3)(2006-2#1)(2006-3#3)(2006-4#1)(2006-6#1)(2006-7#1)(2006-9#3)(2007-1#4)(2007-10#3)(2007-11#15)(2007-12#32)(2007-2#6)(2007-3#3)(2007-7#2)(2007-8#4)(2008-1#5)(2008-10#18)(2008-11#2)(2008-2#24)(2008-3#47)(2008-4#1)(2008-5#5)(2008-7#6)(2008-8#5)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-10#6)(2010-12#2)(2010-3#2)(2010-5#4)(2010-7#3)(2010-8#2)(2011-1#10)(2011-12#4)(2011-2#2)(2012-11#2)(2012-2#2)(2013-1#8)(2013-7#1)(2013-8#5)
saturation)##4##1##(1994-3#1)(2007-12#2)(2010-2#1)
saturation-transfer EPR##2##2##(1991-9#1)(1994-11#1)
saturation-transfer##4##1##(1990-5#1)(1990-9#1)(1991-9#1)(1994-11#1)
saturation-type##3##1##(1991-9#1)(2008-10#2)
saturations##9##1##(1990-8#1)(1993-5#1)(1997-1#2)(1997-8#1)(2007-8#2)(2008-2#1)(2008-4#1)
saturatus##2##1##(2010-3#2)
satureiodes decoction##2##2##(2008-2#2)
satureioides##7##1##(2007-1#4)(2008-2#3)
saturnus##2##1##(1993-12#2)
sauce##14##1##(1996-2#5)(1997-3#1)(2008-10#2)(2010-4#3)(2011-1#2)(2012-11#1)
saudi arabia##16##2##(2007-7#1)(2008-1#12)(2008-4#2)(2012-2#1)
saudi male##2##2##(2007-7#1)(2008-1#1)
saudi##23##1##(2007-1#1)(2007-7#2)(2008-1#16)(2008-4#3)(2012-2#1)
sauna bathing##6##2##(2007-10#2)(2008-7#4)
sauna##9##1##(1990-10#1)(1991-12#1)(2007-10#3)(2008-7#4)
sauropsids has##2##2##(2010-3#2)
sauropsids##4##1##(2010-3#4)
sausage during storage at##2##4##(2007-3#1)(2013-1#1)
sausage##7##1##(2007-3#3)(2010-4#2)(2013-1#2)
sausages##23##1##(1991-5#1)(2008-10#1)(2010-4#19)(2013-1#2)
sauvagine##3##1##(1995-1#2)(1997-5#1)
savanna##5##1##(2006-4#1)(2007-6#1)(2008-7#3)
savannah##4##1##(1991-11#2)(2008-8#2)
savannas##4##1##(1990-6#1)(2008-5#3)
savant abilities##2##2##(2008-3#1)(2008-9#1)
savant syndrome##5##2##(2008-3#5)
savant##8##1##(2008-3#6)(2008-9#2)
savastanoi and##2##2##(2008-10#2)
savastanoi pv##5##2##(2008-10#5)
savastanoi##18##1##(2008-10#18)
save a##4##2##(1997-6#1)(2007-12#1)(2008-3#1)(2012-3#1)
save lives and##4##3##(1993-9#1)(2009-3#1)(2010-8#1)(2013-1#1)
save lives##10##2##(1991-3#1)(1993-9#1)(2005-8#1)(2006-10#1)(2008-12#1)(2009-3#1)(2010-11#1)(2010-8#1)(2013-1#2)
save money for##3##3##(1994-3#1)(1997-8#1)(2008-6#1)
save money##6##2##(1990-4#1)(1993-9#1)(1994-3#1)(1995-1#1)(1997-8#1)(2008-6#1)
save the eye##2##3##(2008-7#1)(2011-2#1)
save the life of a##2##5##(1997-7#1)(2008-1#1)
save the life of##4##4##(1997-7#1)(2008-1#2)(2008-6#1)
save the lives of##2##4##(2007-2#1)(2008-11#1)
save the patient's life##2##4##(1990-5#1)(2010-5#1)
save the##19##2##(1990-10#1)(1990-5#1)(1994-7#1)(1997-7#1)(2005-9#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-5#1)(2010-8#2)(2011-2#1)
save time and money##2##4##(2008-4#1)(2008-5#1)
save time and##5##3##(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-12#1)
save time##10##2##(1993-10#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-6#1)(2012-12#1)
save women's##2##2##(1997-5#1)(2008-11#1)
save your life##2##3##(1996-2#1)(2005-9#1)
save your##3##2##(1996-2#1)(2005-9#1)(2012-2#1)
save##97##1##(1990-10#1)(1990-2#1)(1990-4#2)(1990-5#1)(1991-3#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-3#1)(1993-10#2)(1993-9#2)(1994-2#2)(1994-3#1)(1994-7#1)(1995-1#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#1)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-8#1)(2005-9#2)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#3)(2009-3#1)(2009-6#1)(2010-11#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)
saved and##2##2##(2008-7#1)(2013-1#1)
saved by##6##2##(1991-8#1)(1992-2#1)(2007-8#1)(2008-6#1)(2008-8#1)(2009-5#1)
saved for##2##2##(2006-6#1)(2008-8#1)
saved in##5##2##(1993-9#1)(2007-9#1)(2008-10#1)(2012-1#1)(2013-7#1)
saved lives##2##2##(1991-8#1)(2013-8#1)
saved##36##1##(1991-8#2)(1992-2#2)(1993-8#1)(1993-9#1)(1997-3#2)(2006-12#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-2#1)(2009-5#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
saver##3##1##(1996-8#1)(2010-8#1)(2013-8#1)
saves a##2##2##(2008-10#1)(2008-8#1)
saves lives##2##2##(1996-9#1)(2008-5#1)
saves the##2##2##(1994-12#1)(2012-1#1)
saves##15##1##(1992-10#1)(1994-12#1)(1996-9#1)(1997-3#1)(2004-12#1)(2006-3#1)(2006-4#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-8#1)(2012-1#1)(2012-2#1)
saving and##2##2##(2007-8#2)
saving both##2##2##(2008-8#1)(2012-2#1)
saving compared with##2##3##(2006-12#1)(2008-10#1)
saving in##3##2##(2013-1#3)
saving of##8##2##(1992-3#1)(1994-5#2)(1997-5#1)(2007-3#1)(2008-10#2)(2008-9#1)
saving the##6##2##(1990-3#1)(1993-8#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-7#1)
saving time##3##2##(2007-7#1)(2008-10#1)(2012-2#1)
saving##65##1##(1990-11#1)(1990-3#1)(1992-2#1)(1992-3#1)(1993-8#1)(1994-5#3)(1996-8#1)(1997-4#1)(1997-5#2)(2006-12#3)(2006-2#1)(2007-10#2)(2007-11#2)(2007-3#2)(2007-7#5)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-5#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#3)
savings accounts##4##2##(1995-2#1)(2007-10#1)(2008-1#1)(2008-4#1)
savings and##4##2##(1992-2#1)(1994-12#1)(1994-2#1)(1994-3#1)
savings are##3##2##(1992-2#1)(1995-1#1)(1995-2#1)
savings associated with##4##3##(1990-12#1)(1993-12#1)(2007-4#1)(2009-3#1)
savings for##7##2##(1991-1#1)(1995-2#1)(1997-2#1)(2007-11#1)(2007-12#1)(2009-3#1)(2013-8#1)
savings from##9##2##(1990-12#1)(1992-2#1)(1993-12#1)(1994-12#1)(2005-9#1)(2006-8#1)(2008-10#1)(2008-11#2)
savings in Medicaid costs during the first 60 days##2##9##(1993-3#2)
savings in the##2##3##(2010-2#1)(2013-8#1)
savings in##18##2##(1991-1#1)(1993-3#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1997-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#3)(2010-2#1)(2013-1#1)(2013-8#1)
savings may be##2##3##(1992-2#1)(2009-5#1)
savings may##3##2##(1992-2#1)(2006-10#1)(2009-5#1)
savings of the##2##3##(2008-10#1)(2010-2#1)
savings of##17##2##(1992-2#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-2#1)(2006-10#2)(2008-1#2)(2008-10#3)(2008-2#1)(2008-7#1)(2010-2#1)(2011-2#1)
savings on##2##2##(1992-1#1)(1992-2#1)
savings over##3##2##(1991-12#1)(2006-10#1)(2013-8#1)
savings potential of##2##3##(1992-2#1)(1997-3#1)
savings potential##3##2##(1992-2#1)(1995-2#1)(1997-3#1)
savings targets##2##2##(1995-1#2)
savings through##3##2##(1995-1#1)(1995-2#1)(2007-7#1)
savings to the##2##3##(1993-12#1)(1993-3#1)
savings to##4##2##(1993-12#1)(1993-3#1)(1994-6#1)(1997-3#1)
savings was##2##2##(1993-9#1)(1996-1#1)
savings##141##1##(1990-12#2)(1990-4#2)(1990-5#2)(1991-1#2)(1991-12#1)(1992-1#2)(1992-12#1)(1992-2#9)(1992-8#1)(1993-12#3)(1993-3#3)(1993-9#1)(1994-12#5)(1994-2#3)(1994-3#5)(1994-6#1)(1994-9#2)(1995-1#4)(1995-12#1)(1995-2#9)(1995-3#1)(1996-1#3)(1996-12#2)(1996-3#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-8#3)(2005-9#1)(2006-10#5)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#4)(2007-7#2)(2007-9#3)(2008-1#4)(2008-10#7)(2008-11#4)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#2)(2009-5#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-2#2)(2013-1#3)(2013-8#3)
savvy##2##1##(1991-1#1)(1991-5#1)
saw a##10##2##(1996-7#2)(2005-7#1)(2007-11#1)(2007-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-11#1)(2012-2#1)
saw an##3##2##(2007-2#1)(2008-10#1)(2009-9#1)
saw changes##2##2##(1996-4#1)(2008-8#1)
saw its##2##2##(1992-3#1)(2008-10#1)
saw the##10##2##(1992-1#1)(1993-2#1)(1997-2#1)(2004-2#2)(2007-7#1)(2008-4#1)(2008-7#1)(2009-2#1)(2012-12#1)
saw##62##1##(1990-11#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-3#1)(1993-2#1)(1993-8#1)(1994-3#2)(1994-6#1)(1996-4#1)(1996-7#2)(1997-2#1)(1997-8#1)(2004-2#2)(2005-7#1)(2006-12#1)(2006-3#2)(2006-7#1)(2006-9#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#2)(2009-2#1)(2009-9#1)(2010-11#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#4)
sawB##6##1##(2008-8#6)
sawE##5##1##(2005-11#5)
sawbones##5##1##(2007-5#1)(2008-9#4)
sawdust particles##3##2##(2008-12#3)
sawdust to##2##2##(2008-12#2)
sawdust was##2##2##(2005-11#1)(2008-12#1)
sawdust##20##1##(2005-11#2)(2007-7#1)(2008-12#13)(2008-5#1)(2008-9#1)(2013-1#2)
sawing from the xiphisternum##2##4##(2007-8#2)
sawing##4##1##(1995-6#1)(2007-8#2)(2008-4#1)
sawmill in Sapele##2##3##(2008-12#2)
sawmill##3##1##(2008-10#1)(2008-12#2)
sawmills##2##1##(2008-10#1)(2008-12#1)
sawtooth##7##1##(1990-7#1)(1992-12#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2009-4#1)
saxiphilin##6##1##(1994-3#6)
saxitoxin##4##1##(1993-11#1)(1994-3#2)(1995-9#1)
say a##2##2##(1992-11#2)
say about##3##2##(1992-8#1)(1996-4#1)(2012-2#1)
say but##2##2##(1993-8#1)(2008-10#1)
say goodbye##2##2##(1990-4#1)(2008-6#1)
say how##2##2##(1991-6#1)(1997-6#1)
say it is##2##3##(2006-6#1)(2007-9#1)
say it##3##2##(2006-6#1)(2007-9#2)
say that the##4##3##(2004-9#1)(2007-8#1)(2008-7#1)(2009-6#1)
say that##18##2##(1990-6#1)(1991-3#1)(1996-11#1)(1996-2#1)(1997-6#1)(2004-9#1)(2006-1#1)(2007-3#1)(2007-6#1)(2007-8#2)(2007-9#3)(2008-7#1)(2009-6#1)(2012-3#1)(2013-7#1)
say the authors##2##3##(1991-12#1)(1995-2#1)
say the##13##2##(1991-12#1)(1991-4#1)(1993-5#1)(1993-9#1)(1995-2#1)(1996-5#1)(2004-9#1)(2007-8#1)(2007-9#3)(2008-10#1)(2011-2#1)
say they have##2##3##(2007-9#2)
say they would##3##3##(2005-4#1)(2010-2#2)
say they##6##2##(1997-2#1)(2005-4#1)(2007-9#2)(2010-2#2)
say to##6##2##(2009-4#2)(2010-11#1)(2011-2#1)(2013-1#2)
say##108##1##(1990-4#1)(1990-5#2)(1990-6#1)(1991-12#1)(1991-3#1)(1991-4#3)(1991-6#1)(1992-11#2)(1992-4#1)(1992-8#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-7#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-6#3)(1997-8#1)(2004-10#2)(2004-9#2)(2005-4#1)(2006-1#2)(2006-10#4)(2006-4#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#9)(2007-9#15)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#2)(2009-12#1)(2009-4#2)(2009-6#2)(2009-8#1)(2010-11#1)(2010-2#3)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)
say?##2##1##(2008-4#1)(2008-9#1)
saying &quot##2##2##(1992-2#1)(2006-9#1)
saying that##6##2##(1992-5#1)(1995-6#1)(2005-5#1)(2007-9#2)(2008-8#1)
saying the##2##2##(1996-5#1)(2013-8#1)
saying##16##1##(1992-2#1)(1992-5#1)(1993-2#1)(1994-1#1)(1995-6#2)(1996-5#1)(2005-5#1)(2006-9#2)(2007-9#2)(2008-8#1)(2009-4#1)(2012-2#1)(2013-8#1)
says that##5##2##(2007-9#3)(2009-10#2)
says the author##9##3##(1991-3#1)(1993-2#2)(1994-12#2)(1994-2#1)(1995-2#1)(1996-2#2)
says##61##1##(1990-4#1)(1990-5#2)(1990-7#1)(1991-3#1)(1991-4#2)(1993-12#1)(1993-2#5)(1993-3#1)(1994-1#1)(1994-10#1)(1994-12#3)(1994-2#2)(1994-3#1)(1995-10#1)(1995-12#2)(1995-2#2)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-5#4)(2006-5#1)(2007-8#2)(2007-9#7)(2008-1#1)(2008-11#1)(2008-9#1)(2009-10#2)(2010-12#2)(2010-8#1)(2013-8#2)
sb=0##2##1##(2013-1#2)
sc##11##1##(1990-12#1)(1990-8#2)(1994-6#2)(1995-12#1)(2005-8#2)(2008-10#2)(2011-1#1)
scFv M97 transfection##2##3##(2008-8#2)
scFv M97##3##2##(2008-8#3)
scFv antibodies##3##2##(2008-10#1)(2010-12#2)
scFv fusion proteins were##3##4##(2008-10#3)
scFv fusion proteins##4##3##(2008-10#4)
scFv in##2##2##(2008-10#2)
scFv is##2##2##(2008-10#1)(2009-9#1)
scFv was##2##2##(1994-12#1)(1997-2#1)
scFv were##5##2##(1994-12#2)(2008-10#3)
scFv##38##1##(1993-8#1)(1994-12#6)(1997-2#3)(2006-12#1)(2008-10#16)(2008-4#2)(2008-8#3)(2009-2#2)(2009-9#1)(2010-12#2)(2013-7#1)
scFvC(L) fusion proteins##3##3##(2008-10#3)
scFvC(L)##4##1##(2008-10#4)
scFvs##3##1##(2008-10#3)
scRNA##5##1##(1994-3#1)(1996-5#4)
scTcr##3##1##(1994-6#3)
scab (Venturia inaequalis)##3##3##(2008-10#3)
scab and##4##2##(2008-10#4)
scab development##3##2##(2008-10#3)
scab disease##2##2##(2008-10#1)(2008-8#1)
scab in the##2##3##(2008-10#2)
scab in##4##2##(2008-10#4)
scab incidence and severity##2##4##(2008-10#2)
scab incidence##5##2##(2008-10#5)
scab is a##2##3##(2008-10#2)
scab is##4##2##(2008-10#4)
scab lesions##4##2##(1991-11#1)(2008-10#3)
scab management##2##2##(2008-10#2)
scab on##5##2##(2008-10#5)
scab pathogen##2##2##(2008-10#1)(2010-10#1)
scab pathogen)##2##2##(2008-10#2)
scab resistance genes##3##3##(2008-10#3)
scab resistance##12##2##(2008-10#12)
scab severity##5##2##(2008-10#5)
scab symptoms##2##2##(2008-10#2)
scab were##2##2##(2008-10#2)
scab##89##1##(1991-11#1)(2008-10#83)(2008-11#1)(2008-8#1)(2010-10#1)(2011-1#2)
scab)##2##1##(2008-10#2)
scab-causing streptomycetes##2##2##(2008-10#2)
scab-susceptible##2##1##(2008-10#2)
scabbed##3##1##(2008-10#3)
scaber##6##1##(2007-12#4)(2008-11#2)
scabiei##7##1##(1990-3#4)(2008-12#3)
scabies ATCC##2##2##(2008-10#2)
scabies in##5##2##(1997-5#1)(2007-3#1)(2008-12#1)(2010-6#2)
scabies##34##1##(1991-2#1)(1996-12#4)(1997-5#1)(2005-11#2)(2006-10#3)(2006-12#1)(2007-3#1)(2007-7#1)(2008-10#12)(2008-12#3)(2010-2#1)(2010-6#4)
scabra 'Fitzroy'##2##2##(2008-10#2)
scabra##5##1##(2008-10#4)(2010-2#1)
scaffold and##7##2##(1992-12#1)(1995-8#1)(2006-9#1)(2007-10#1)(2008-5#2)(2012-12#1)
scaffold architecture##2##2##(2009-7#1)(2012-11#1)
scaffold at##2##2##(1995-8#1)(2012-1#1)
scaffold fabrication##5##2##(2010-8#1)(2010-9#4)
scaffold for bone tissue engineering##2##5##(2008-5#1)(2009-7#1)
scaffold for the##8##3##(2006-10#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-8#1)(2010-7#1)(2012-2#1)
scaffold for##21##2##(1996-5#1)(1997-3#2)(2006-10#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-7#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-2#3)
scaffold in##2##2##(2009-4#1)(2012-2#1)
scaffold of##6##2##(2007-12#2)(2008-7#2)(2009-7#1)(2011-12#1)
scaffold proteins##7##2##(1992-4#3)(2007-10#1)(2008-7#1)(2009-4#1)(2012-12#1)
scaffold that##2##2##(2009-8#1)(2012-2#1)
scaffold to enhance##3##3##(2008-9#1)(2009-12#1)(2012-11#1)
scaffold to##8##2##(1997-3#1)(2007-8#1)(2008-9#1)(2009-12#2)(2012-11#2)(2012-8#1)
scaffold was##5##2##(2008-5#4)(2012-2#1)
scaffold which##2##2##(2007-12#1)(2010-1#1)
scaffold with##2##2##(2009-11#1)(2011-1#1)
scaffold##137##1##(1992-12#1)(1992-4#3)(1993-11#3)(1994-8#1)(1995-1#1)(1995-4#1)(1995-8#2)(1996-5#1)(1997-3#3)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-10#4)(2007-11#1)(2007-12#9)(2007-8#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#18)(2008-7#4)(2008-8#3)(2008-9#2)(2009-11#2)(2009-12#3)(2009-4#5)(2009-7#8)(2009-8#3)(2009-9#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#11)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#4)(2012-11#4)(2012-12#2)(2012-2#9)(2012-3#1)(2012-8#1)(2013-1#2)(2013-7#1)(2013-8#2)
scaffold-associated region (SAR)##2##3##(2008-8#2)
scaffold-free##3##1##(2011-2#3)
scaffolding for##4##2##(1997-2#1)(2007-7#1)(2010-9#1)(2012-2#1)
scaffolding material##3##2##(2009-12#1)(2009-7#1)(2011-1#1)
scaffolding of##2##2##(1993-2#1)(2009-4#1)
scaffolding proteins##5##2##(1994-9#1)(2008-4#2)(2009-3#1)(2012-3#1)
scaffolding##28##1##(1993-2#1)(1994-9#1)(1996-8#1)(1997-2#1)(1997-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#3)(2010-10#1)(2010-9#2)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
scaffolds (+)##3##2##(2008-5#3)
scaffolds (-)##2##2##(2008-5#2)
scaffolds and membranes##2##3##(2008-5#2)
scaffolds and##12##2##(2008-5#4)(2008-9#1)(2010-9#2)(2012-1#1)(2012-4#1)(2012-5#1)(2013-1#1)(2013-8#1)
scaffolds are##11##2##(2008-5#4)(2009-7#1)(2010-12#2)(2012-11#4)
scaffolds as##3##2##(2008-1#1)(2010-10#1)(2010-9#1)
scaffolds by##4##2##(2008-5#2)(2010-12#1)(2010-8#1)
scaffolds coated with Bioglass##2##4##(2008-5#2)
scaffolds for bone tissue engineering##2##5##(2010-1#1)(2012-11#1)
scaffolds for bone##4##3##(2009-7#1)(2010-1#1)(2012-11#2)
scaffolds for cell##3##3##(2010-9#1)(2012-11#2)
scaffolds for the##4##3##(1997-2#1)(2007-11#1)(2010-4#1)(2012-8#1)
scaffolds for tissue engineering applications##2##5##(2010-8#2)
scaffolds for tissue engineering##7##4##(2009-11#1)(2009-7#1)(2010-4#1)(2010-8#2)(2012-11#2)
scaffolds for tissue##8##3##(2009-11#1)(2009-7#1)(2010-10#1)(2010-4#1)(2010-8#2)(2012-11#2)
scaffolds for##24##2##(1997-2#1)(2007-11#1)(2007-8#1)(2008-5#3)(2008-7#1)(2009-11#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-4#2)(2010-8#2)(2010-9#1)(2012-11#6)(2012-8#1)
scaffolds from##2##2##(2009-7#1)(2010-10#1)
scaffolds had##2##2##(2012-1#1)(2012-12#1)
scaffolds has##3##2##(2008-5#1)(2009-7#1)(2009-8#1)
scaffolds have been##2##3##(2008-5#2)
scaffolds have##5##2##(2008-5#3)(2009-7#2)
scaffolds in vitro##2##3##(2008-5#2)
scaffolds in##9##2##(2006-2#1)(2007-11#1)(2008-5#5)(2009-7#1)(2011-2#1)
scaffolds is##3##2##(2010-7#1)(2010-9#1)(2011-2#1)
scaffolds seeded using the##2##4##(2011-2#2)
scaffolds showed##4##2##(2008-5#1)(2009-3#1)(2010-12#1)(2010-9#1)
scaffolds that provide structural##2##4##(2010-10#1)(2012-1#1)
scaffolds that##5##2##(2008-11#1)(2009-4#1)(2009-7#1)(2010-10#1)(2012-1#1)
scaffolds to##3##2##(1997-2#1)(2008-5#1)(2012-1#1)
scaffolds using##3##2##(2009-3#1)(2010-9#1)(2011-2#1)
scaffolds was##6##2##(2008-5#1)(2009-7#1)(2010-12#1)(2010-4#1)(2012-11#2)
scaffolds were##20##2##(2008-5#4)(2009-3#1)(2009-7#1)(2010-12#3)(2011-2#1)(2012-1#1)(2012-11#4)(2012-2#5)
scaffolds will be##2##3##(2010-6#1)(2010-8#1)
scaffolds with a##2##3##(2008-5#2)
scaffolds with##12##2##(2008-5#5)(2009-4#1)(2010-12#1)(2010-8#1)(2010-9#2)(2012-12#2)
scaffolds##242##1##(1992-2#1)(1995-8#1)(1997-2#2)(2004-12#1)(2005-8#2)(2006-12#1)(2006-2#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-8#3)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#60)(2008-7#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-3#5)(2009-4#7)(2009-7#17)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#6)(2010-12#13)(2010-4#5)(2010-6#2)(2010-7#1)(2010-8#6)(2010-9#15)(2011-1#2)(2011-2#9)(2011-3#1)(2012-1#9)(2012-11#30)(2012-12#4)(2012-2#11)(2012-3#2)(2012-4#1)(2012-5#1)(2012-8#2)(2013-1#1)(2013-7#1)(2013-8#1)
scala vestibuli##2##2##(2008-9#1)(2012-2#1)
scalability and##6##2##(2008-2#1)(2010-8#1)(2013-1#4)
scalability of##5##2##(2008-2#1)(2008-3#1)(2010-8#1)(2013-1#2)
scalability to higher##2##3##(2007-12#2)
scalability##28##1##(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#5)(2008-3#1)(2008-4#1)(2009-3#1)(2010-2#3)(2010-8#6)(2012-3#1)(2013-1#6)
scalable and dynamic tool##2##4##(2013-1#2)
scalable and##5##2##(2008-2#1)(2013-1#4)
scalable approach to##2##3##(2008-7#1)(2013-7#1)
scalable approach##3##2##(2008-7#2)(2013-7#1)
scalable for##3##2##(2008-4#1)(2013-1#2)
scalable layers##2##2##(2008-2#2)
scalable multiprocessor##2##2##(2008-3#2)
scalable to##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
scalable video compression##4##3##(2008-2#4)
scalable video##6##2##(2008-2#6)
scalable##63##1##(1990-12#1)(1992-1#1)(2006-11#1)(2007-11#1)(2007-12#4)(2008-11#2)(2008-2#17)(2008-3#7)(2008-4#2)(2008-7#5)(2009-3#1)(2010-10#1)(2010-2#1)(2010-8#1)(2012-11#2)(2012-2#1)(2013-1#14)(2013-7#1)
scalar and##3##2##(2007-12#1)(2008-2#2)
scalar approach##2##2##(2007-11#1)(2008-2#1)
scalar coupling##2##2##(2008-3#1)(2008-5#1)
scalar diffraction theory is##3##4##(2008-2#1)(2008-3#2)
scalar diffraction theory##11##3##(2007-12#1)(2008-2#5)(2008-3#5)
scalar diffraction##18##2##(2007-12#3)(2008-2#7)(2008-3#8)
scalar field##2##2##(1994-5#1)(2007-12#1)
scalar fields##2##2##(2007-11#1)(2008-10#1)
scalar imaging##2##2##(2008-3#2)
scalar irradiance##2##2##(2008-3#2)
scalar theory##3##2##(2008-3#3)
scalar treatment##2##2##(2007-12#1)(2008-2#1)
scalar wave fields##2##3##(2007-11#1)(2007-12#1)
scalar wave##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
scalar waves##4##2##(2007-12#3)(2008-3#1)
scalar##76##1##(1994-5#1)(1996-4#1)(1997-6#1)(2006-4#1)(2007-11#5)(2007-12#11)(2008-10#1)(2008-2#25)(2008-3#24)(2008-5#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-8#2)
scalars##2##1##(1990-7#1)(1992-9#1)
scald##9##1##(2008-10#8)(2008-7#1)
scalding##4##1##(1991-12#2)(1995-3#2)
scalds##4##1##(1993-5#4)
scale (1##2##2##(2008-11#1)(2011-1#1)
scale (VAS)##13##2##(2006-12#1)(2006-8#1)(2007-2#1)(2007-7#3)(2008-6#1)(2008-7#1)(2009-3#1)(2010-5#1)(2012-1#1)(2012-2#1)(2013-1#1)
scale (e##3##2##(2008-10#2)(2013-1#1)
scale (p&lt##2##2##(2008-1#2)
scale (proportion of sampling units with one or more diseased##2##10##(2008-10#2)
scale according to the##3##4##(1993-6#1)(2011-2#1)(2012-3#1)
scale according to##4##3##(1993-6#1)(2008-10#1)(2011-2#1)(2012-3#1)
scale analysis##3##2##(2008-10#1)(2008-6#1)(2012-3#1)
scale and a##2##3##(2005-9#1)(2008-2#1)
scale and in##2##3##(2008-5#2)
scale and resolution##2##3##(2006-7#1)(2012-2#1)
scale and that the##2##4##(2008-8#1)(2012-2#1)
scale and the##19##3##(1992-4#1)(1993-7#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
scale and##80##2##(1990-3#1)(1991-11#1)(1992-4#1)(1993-11#1)(1993-7#1)(1994-5#1)(1994-9#1)(1995-1#1)(1996-1#1)(1996-2#1)(2005-9#1)(2006-10#1)(2006-7#2)(2007-11#2)(2007-12#3)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-2#2)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#4)(2013-1#6)(2013-8#1)
scale are##4##2##(2008-1#1)(2008-10#2)(2009-8#1)
scale as the##2##3##(1996-2#1)(2009-9#1)
scale as##7##2##(1995-8#1)(1996-2#1)(1996-7#1)(1997-7#1)(2009-7#1)(2009-9#1)(2012-11#1)
scale associated with the##2##4##(2008-2#1)(2008-3#1)
scale at the##2##3##(2007-9#1)(2008-11#1)
scale at which##3##3##(2008-10#1)(2009-10#1)(2012-12#1)
scale at##5##2##(2007-9#1)(2008-10#1)(2008-11#1)(2009-10#1)(2012-12#1)
scale based on##2##3##(1990-7#1)(2010-12#1)
scale bases##2##2##(2013-1#2)
scale before##3##2##(2008-10#1)(2012-2#1)(2012-3#1)
scale between##2##2##(2008-3#1)(2012-2#1)
scale but##2##2##(2008-10#1)(2012-2#1)
scale by##5##2##(1994-3#1)(2007-12#2)(2009-12#1)(2013-1#1)
scale can be##3##3##(1993-12#1)(2008-10#1)(2012-11#1)
scale can##4##2##(1993-12#1)(2008-10#1)(2010-8#1)(2012-11#1)
scale cell##3##2##(2008-11#3)
scale clinical##5##2##(1992-4#1)(2005-7#1)(2007-11#1)(2010-8#1)(2011-1#1)
scale counts##2##2##(2008-8#2)
scale cultivation##3##2##(1994-5#1)(2008-11#1)(2012-3#1)
scale cultures##2##2##(2008-11#2)
scale derived##2##2##(1990-10#1)(1995-4#1)
scale developed##2##2##(2007-11#1)(2008-5#1)
scale did not##2##3##(2008-10#1)(2012-2#1)
scale down##4##2##(1992-1#1)(2006-12#1)(2008-7#1)(2012-3#1)
scale experiments##4##2##(1997-2#1)(2008-11#3)
scale factor##4##2##(2008-2#1)(2008-3#2)(2009-3#1)
scale factors##4##2##(2006-11#3)(2007-4#1)
scale following##2##2##(1990-8#1)(2007-11#1)
scale for adolescents and##2##4##(2010-4#2)
scale for assessing##2##3##(2011-8#1)(2013-1#1)
scale for evaluating##2##3##(2007-11#1)(2011-2#1)
scale for mental##2##3##(2007-10#1)(2011-2#1)
scale for the##6##3##(1996-2#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-12#1)
scale for young##2##3##(2010-4#2)
scale for##31##2##(1991-1#1)(1993-12#1)(1996-2#1)(1997-5#2)(2004-3#1)(2005-10#2)(2006-10#1)(2006-12#1)(2007-10#2)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-8#1)(2010-12#1)(2010-4#4)(2011-2#2)(2011-8#1)(2012-12#1)(2012-2#1)(2013-1#2)
scale from##7##2##(1992-3#1)(1995-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-9#1)
scale has##6##2##(1991-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)
scale height##2##2##(2008-5#2)
scale heights##2##2##(2008-5#2)
scale hollow##2##2##(2008-11#2)
scale in the##5##3##(2007-11#2)(2008-11#1)(2008-2#1)(2008-8#1)
scale in which##2##3##(2007-12#1)(2010-9#1)
scale in##26##2##(1993-10#1)(1993-6#1)(1994-3#1)(1997-2#1)(2006-12#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2010-5#2)(2010-9#1)(2012-11#1)(2012-2#1)(2012-3#1)
scale increased##2##2##(2007-11#1)(2012-11#1)
scale independent##2##2##(2008-7#1)(2010-2#1)
scale insects (Hemiptera##3##3##(2007-12#3)
scale insects##5##2##(2007-12#5)
scale insects)##2##2##(2007-12#2)
scale into##2##2##(2007-11#1)(2010-6#1)
scale invariance##4##2##(2008-3#2)(2012-2#2)
scale is presented##2##3##(2008-3#1)(2010-2#1)
scale is##26##2##(1991-12#1)(1994-4#1)(1996-4#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-10#3)(2008-2#3)(2008-3#4)(2008-7#2)(2009-1#1)(2009-2#1)(2010-2#1)(2010-8#1)(2012-2#1)(2013-1#1)
scale isometrically with##2##3##(2007-12#1)(2008-8#1)
scale items##2##2##(2004-3#1)(2011-2#1)
scale manufacturing##3##2##(1990-11#1)(2006-1#1)(2007-9#1)
scale measurements##2##2##(2007-6#1)(2008-2#1)
scale method for##3##3##(2008-2#1)(2013-1#2)
scale model##3##2##(2010-8#1)(2012-2#2)
scale models##2##2##(2008-1#1)(2008-8#1)
scale of 1##3##3##(1994-12#1)(2006-10#1)(2012-3#1)
scale of 1-5##3##3##(1990-2#2)(2007-11#1)
scale of 10##2##3##(2008-2#2)
scale of a few##2##4##(2008-2#1)(2008-3#1)
scale of a##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-1#1)
scale of an##2##3##(2008-8#1)(2012-2#1)
scale of less than##2##4##(1992-9#1)(2008-1#1)
scale of measurement##2##3##(1996-12#1)(2008-10#1)
scale of operation##3##3##(2008-11#3)
scale of perceived##2##3##(2010-7#1)(2013-8#1)
scale of the noise##2##4##(2008-3#1)(2008-8#1)
scale of the##29##3##(1993-2#1)(2006-7#1)(2007-12#1)(2007-7#1)(2008-10#7)(2008-2#2)(2008-3#5)(2008-7#2)(2008-8#4)(2008-9#1)(2009-12#1)(2010-9#2)(2011-1#1)
scale of turbulence##3##3##(2007-12#1)(2008-3#2)
scale of##125##2##(1990-10#1)(1990-2#2)(1990-3#1)(1990-7#1)(1991-2#1)(1992-1#1)(1992-7#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-8#1)(1996-12#1)(1996-6#1)(1997-2#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#4)(2007-2#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#15)(2008-11#5)(2008-2#7)(2008-3#10)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#8)(2008-9#2)(2009-12#1)(2009-4#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#1)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#2)
scale on the##7##3##(1991-2#1)(2007-6#1)(2008-11#1)(2008-2#3)(2013-8#1)
scale on##9##2##(1991-2#1)(2006-2#1)(2007-6#1)(2008-11#1)(2008-2#3)(2013-7#1)(2013-8#1)
scale or##5##2##(1990-8#1)(1996-4#1)(2007-8#1)(2008-12#1)(2009-2#1)
scale parameters and##2##3##(1995-9#1)(2008-2#1)
scale parameters##4##2##(1995-4#2)(1995-9#1)(2008-2#1)
scale production##9##2##(1991-2#1)(1992-7#1)(1996-11#1)(2007-11#1)(2008-11#3)(2011-2#1)(2012-2#1)
scale ranging from##3##3##(1992-9#1)(2008-9#1)(2010-10#1)
scale rupture##2##2##(1996-4#2)
scale score##3##2##(2007-10#1)(2007-2#1)(2013-1#1)
scale scores from##2##3##(2007-2#1)(2009-11#1)
scale scores##6##2##(2006-10#1)(2007-2#1)(2008-8#1)(2009-11#1)(2009-4#1)(2011-2#1)
scale showed a##3##3##(1990-8#1)(1997-3#1)(2011-1#1)
scale shows##2##2##(2007-7#1)(2013-1#1)
scale studies##2##2##(1994-3#1)(2007-11#1)
scale study##2##2##(2009-9#1)(2013-8#1)
scale than##3##2##(1991-11#1)(2004-11#1)(2009-12#1)
scale that##2##2##(2007-12#1)(2008-10#1)
scale the##5##2##(2007-12#1)(2007-3#1)(2008-3#1)(2009-7#1)(2010-4#1)
scale to assess the##2##4##(1997-3#1)(2008-5#1)
scale to assess##4##3##(1997-3#1)(2007-11#1)(2008-5#1)(2012-2#1)
scale to measure the##2##4##(2007-2#1)(2008-12#1)
scale to measure##6##3##(1995-11#1)(1996-8#2)(2006-4#1)(2007-2#1)(2008-12#1)
scale to the##3##3##(2005-11#1)(2008-10#1)(2012-2#1)
scale to##25##2##(1995-11#1)(1996-8#2)(1997-3#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-4#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-9#1)(2010-10#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#1)
scale total##2##2##(1992-1#1)(2012-11#1)
scale under##2##2##(2009-12#1)(2013-1#1)
scale up and##2##3##(2008-3#1)(2008-7#1)
scale up of antibody production from##2##6##(2008-11#2)
scale up of##5##3##(2008-11#2)(2008-5#1)(2008-7#1)(2009-7#1)
scale up to##2##3##(1996-7#1)(2009-8#1)
scale up##25##2##(1996-7#1)(2008-11#9)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#5)(2009-3#3)(2009-7#1)(2009-8#1)(2010-4#1)(2012-3#1)
scale using a##2##3##(2009-2#1)(2010-5#1)
scale using##3##2##(2008-11#1)(2009-2#1)(2010-5#1)
scale variations##2##2##(2007-12#1)(2008-2#1)
scale was 0##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
scale was applied to##2##4##(2006-4#1)(2007-11#1)
scale was applied##3##3##(2006-4#1)(2007-10#1)(2007-11#1)
scale was developed##3##3##(2006-12#1)(2006-4#1)(2008-10#1)
scale was found to be more strongly associated with##2##9##(2004-3#2)
scale was found##3##3##(2004-3#2)(2008-8#1)
scale was not##2##3##(2008-10#2)
scale was used for##2##4##(2007-7#1)(2013-1#1)
scale was used to assess##2##5##(2008-7#1)(2012-12#1)
scale was used to measure##2##5##(2010-3#1)(2011-2#1)
scale was used to##6##4##(2007-11#1)(2008-7#2)(2010-3#1)(2011-2#1)(2012-12#1)
scale was used##11##3##(1997-8#2)(2007-11#1)(2007-7#1)(2008-7#2)(2008-8#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
scale was##42##2##(1991-12#1)(1997-8#2)(2004-3#2)(2006-12#1)(2006-4#2)(2007-10#2)(2007-11#4)(2007-7#2)(2008-1#2)(2008-10#4)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-4#1)(2010-3#1)(2011-1#2)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
scale were less likely to##2##5##(2006-7#1)(2008-7#1)
scale were used##3##3##(1991-6#1)(2007-2#1)(2008-5#1)
scale were##12##2##(1991-6#1)(2004-3#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#2)(2008-10#2)(2008-5#1)(2008-7#1)(2013-8#1)
scale when##2##2##(2008-8#1)(2009-12#1)
scale whereas##2##2##(2008-12#1)(2010-4#1)
scale with a##4##3##(1992-1#1)(1994-3#1)(2007-12#1)(2012-2#1)
scale with##12##2##(1992-1#1)(1994-3#1)(1995-11#1)(2006-4#1)(2007-12#2)(2009-2#1)(2010-2#1)(2011-2#2)(2012-2#1)(2012-3#1)
scale##1321##1##(1990-10#2)(1990-11#3)(1990-12#3)(1990-2#5)(1990-3#4)(1990-5#2)(1990-7#2)(1990-8#7)(1991-1#2)(1991-10#1)(1991-11#6)(1991-12#2)(1991-2#8)(1991-3#1)(1991-6#1)(1991-7#1)(1992-1#6)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#4)(1992-5#2)(1992-6#3)(1992-7#2)(1992-8#1)(1992-9#4)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#5)(1993-3#1)(1993-4#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#5)(1994-4#1)(1994-5#6)(1994-6#5)(1994-8#3)(1994-9#2)(1995-1#5)(1995-10#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#4)(1995-4#5)(1995-7#3)(1995-8#5)(1995-9#2)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#5)(1996-3#5)(1996-4#10)(1996-6#1)(1996-7#7)(1996-8#2)(1997-1#2)(1997-2#4)(1997-3#4)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#4)(2004-11#3)(2004-3#7)(2004-4#2)(2005-1#1)(2005-10#3)(2005-11#6)(2005-4#1)(2005-7#1)(2005-8#1)(2005-9#2)(2006-1#2)(2006-10#18)(2006-11#4)(2006-12#10)(2006-2#2)(2006-3#3)(2006-4#6)(2006-5#1)(2006-6#7)(2006-7#7)(2006-8#3)(2006-9#2)(2007-10#14)(2007-11#43)(2007-12#48)(2007-2#8)(2007-3#2)(2007-4#3)(2007-5#2)(2007-6#7)(2007-7#23)(2007-8#9)(2007-9#14)(2008-1#14)(2008-10#122)(2008-11#70)(2008-12#13)(2008-2#64)(2008-3#50)(2008-4#11)(2008-5#27)(2008-6#12)(2008-7#46)(2008-8#29)(2008-9#27)(2009-1#3)(2009-10#1)(2009-11#7)(2009-12#7)(2009-2#4)(2009-3#8)(2009-4#6)(2009-5#3)(2009-6#3)(2009-7#9)(2009-8#2)(2009-9#9)(2010-1#2)(2010-10#4)(2010-11#2)(2010-12#6)(2010-2#10)(2010-3#3)(2010-4#12)(2010-5#6)(2010-6#4)(2010-7#7)(2010-8#14)(2010-9#6)(2011-1#26)(2011-2#37)(2011-3#1)(2011-8#1)(2012-1#6)(2012-11#9)(2012-12#9)(2012-2#47)(2012-3#22)(2013-1#42)(2013-7#8)(2013-8#13)
scale&quot##2##1##(2008-3#1)(2010-11#1)
scale's##3##1##(2007-12#1)(2009-11#1)(2012-11#1)
scale) and##3##2##(2007-11#1)(2007-5#1)(2012-12#1)
scale) were##3##2##(2007-11#2)(2010-12#1)
scale)##33##1##(1990-8#1)(1992-10#1)(1997-8#1)(2007-11#6)(2007-5#2)(2007-7#1)(2007-9#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-12#1)(2012-12#3)(2013-1#1)(2013-7#3)(2013-8#3)
scale- and##4##2##(2007-12#1)(2007-9#2)(2009-6#1)
scale-##6##1##(2007-12#3)(2007-9#2)(2009-6#1)
scale-dependent##2##1##(2008-2#1)(2009-6#1)
scale-free##3##1##(2008-1#2)(2012-2#1)
scale-invariant##7##1##(2008-3#6)(2012-2#1)
scale-space##5##1##(2008-2#4)(2008-3#1)
scale-tunable##2##1##(2008-3#2)
scale-up in##3##2##(2009-3#1)(2009-5#1)(2010-5#1)
scale-up of##9##2##(2007-6#1)(2008-11#3)(2008-7#1)(2010-11#1)(2011-12#1)(2011-2#1)(2012-3#1)
scale-up##34##1##(1992-12#1)(1997-3#1)(2006-12#1)(2007-6#2)(2008-11#12)(2008-6#2)(2008-7#2)(2009-2#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
scaleable process##2##2##(2008-5#1)(2008-8#1)
scaleable##7##1##(2005-8#1)(2006-11#1)(2008-11#3)(2008-5#1)(2008-8#1)
scaled by##2##2##(1996-4#1)(2008-8#1)
scaled for##2##2##(2006-4#1)(2008-2#1)
scaled from##4##2##(2005-10#1)(2007-12#1)(2007-4#1)(2008-3#1)
scaled in order to account for the differences between the##2##10##(2006-11#1)(2007-1#1)
scaled scores##3##2##(2006-10#3)
scaled to a##2##3##(2006-11#1)(2008-3#1)
scaled to the##3##3##(2006-11#2)(2008-10#1)
scaled to##12##2##(1991-12#1)(2006-11#5)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)
scaled up and##3##3##(2008-2#1)(2012-3#2)
scaled up##10##2##(1994-12#1)(2005-8#1)(2008-11#2)(2008-2#1)(2008-7#1)(2009-3#1)(2012-3#3)
scaled##61##1##(1991-12#1)(1994-12#1)(1995-5#1)(1996-4#1)(2005-10#1)(2005-11#3)(2005-8#1)(2006-10#3)(2006-11#7)(2006-4#1)(2007-1#1)(2007-12#3)(2007-4#1)(2008-10#2)(2008-11#3)(2008-2#8)(2008-3#4)(2008-7#4)(2008-8#4)(2009-11#1)(2009-12#1)(2009-3#1)(2010-10#1)(2010-11#1)(2012-2#1)(2012-3#4)(2013-1#1)
scaled-down##3##1##(2006-10#1)(2006-6#1)(2007-9#1)
scaled-up##6##1##(1994-12#1)(1996-8#1)(2008-11#2)(2008-5#1)(2010-4#1)
scalenohedral##2##1##(2005-11#2)
scales (VAS)##2##2##(1996-3#1)(2011-1#1)
scales (e##3##2##(2007-9#3)
scales and feathers##2##3##(2007-9#2)
scales and over##2##3##(2008-10#1)(2008-3#1)
scales and the number of##2##5##(2010-1#1)(2013-7#1)
scales and the##5##3##(2008-5#1)(2010-1#1)(2013-7#2)(2013-8#1)
scales and to##2##3##(1993-2#1)(2013-7#1)
scales and##39##2##(1991-8#1)(1993-2#1)(1995-11#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-8#1)(2007-9#4)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-8#1)(2010-1#1)(2010-6#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-7#4)(2013-8#1)
scales are the most##2##4##(2008-5#1)(2009-12#1)
scales are##15##2##(1990-5#1)(2005-11#1)(2007-12#2)(2007-3#1)(2007-8#1)(2007-9#1)(2008-2#2)(2008-5#1)(2008-6#2)(2008-8#1)(2009-12#1)(2013-1#1)
scales as##5##2##(2007-11#1)(2007-12#1)(2008-7#1)(2009-12#1)(2012-2#1)
scales at##2##2##(2008-2#1)(2012-11#1)
scales between##5##2##(1995-5#1)(2008-5#1)(2013-7#3)
scales could be##2##3##(2008-10#1)(2012-3#1)
scales could##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
scales for each##2##3##(2008-3#1)(2008-5#1)
scales for the##6##3##(2006-10#1)(2007-10#1)(2007-6#1)(2007-9#2)(2013-7#1)
scales for##21##2##(1996-7#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-6#1)(2007-9#2)(2008-10#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2012-2#1)(2013-7#1)
scales from Cyprinus carpio##2##4##(2012-2#2)
scales from the##3##3##(2011-1#1)(2012-2#2)
scales from##8##2##(1990-3#1)(1995-1#1)(2008-3#1)(2011-1#1)(2012-2#4)
scales have been##4##3##(2006-10#1)(2008-8#1)(2009-5#1)(2011-2#1)
scales have##6##2##(2006-10#1)(2007-3#1)(2007-9#1)(2008-8#1)(2009-5#1)(2011-2#1)
scales in both##2##3##(2006-10#1)(2007-9#1)
scales in stroke survivors##2##4##(2007-10#2)
scales in the##4##3##(2008-6#1)(2010-8#1)(2013-1#1)(2013-8#1)
scales in##17##2##(1990-3#1)(1993-6#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-8#1)(2013-1#1)(2013-8#3)
scales involving##2##2##(2009-7#1)(2012-3#1)
scales is##2##2##(2008-3#2)
scales linearly with the##4##4##(1991-3#1)(2007-11#1)(2008-2#1)(2010-4#1)
scales may##2##2##(1993-2#1)(2008-8#1)
scales measuring##3##2##(1995-11#1)(2007-7#1)(2012-2#1)
scales of biological organization##2##4##(2008-1#1)(2010-5#1)
scales of biological##3##3##(2008-1#1)(2010-5#1)(2010-9#1)
scales of spatial##2##3##(2008-10#1)(2008-8#1)
scales of the##18##3##(2006-7#1)(2007-3#1)(2007-9#2)(2008-10#2)(2008-2#4)(2008-3#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-1#3)(2011-2#1)
scales of##51##2##(1990-2#1)(1991-6#1)(1996-4#2)(2006-7#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#5)(2008-3#4)(2008-7#2)(2008-8#4)(2008-9#2)(2009-2#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#1)(2012-11#1)(2012-2#1)(2013-8#1)
scales or##3##2##(2006-8#1)(2008-11#1)(2008-7#1)
scales ranging from##2##3##(2008-10#1)(2008-4#1)
scales revealed##2##2##(1990-12#1)(2008-1#1)
scales tested##2##2##(2008-10#2)
scales than##3##2##(2007-9#1)(2008-10#1)(2008-7#1)
scales that can##2##3##(2007-9#2)
scales that##7##2##(2007-9#2)(2008-10#1)(2008-6#1)(2008-7#1)(2009-11#1)(2011-1#1)
scales the##2##2##(1991-3#1)(2012-2#1)
scales to assess the##2##4##(2008-10#1)(2009-5#1)
scales to be##2##3##(2007-9#1)(2008-5#1)
scales to evaluate##3##3##(2007-12#1)(2008-9#1)(2013-8#1)
scales to##12##2##(1990-5#1)(1991-3#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-12#1)(2009-5#1)(2013-8#1)
scales up##2##2##(1996-11#1)(2010-2#1)
scales using##2##2##(2008-10#1)(2012-11#1)
scales was##3##2##(2006-1#1)(2006-7#1)(2009-7#1)
scales were evaluated##2##3##(2013-1#1)(2013-7#1)
scales were##15##2##(2005-11#2)(2006-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-12#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#2)(2013-7#2)
scales will##2##2##(1991-2#1)(2008-7#1)
scales with##2##2##(1992-4#1)(2007-12#1)
scales##504##1##(1990-12#3)(1990-2#1)(1990-3#3)(1990-5#3)(1990-6#1)(1990-8#1)(1991-2#2)(1991-3#3)(1991-6#1)(1991-8#2)(1992-4#1)(1993-2#6)(1993-3#1)(1993-4#1)(1993-6#1)(1994-4#2)(1994-9#1)(1995-1#2)(1995-11#3)(1995-2#3)(1995-5#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#2)(1996-7#3)(1997-1#1)(1997-6#1)(1997-8#1)(2004-4#1)(2005-11#8)(2006-1#1)(2006-10#7)(2006-11#1)(2006-12#3)(2006-4#1)(2006-7#5)(2006-8#1)(2007-10#6)(2007-11#7)(2007-12#21)(2007-2#3)(2007-3#6)(2007-6#2)(2007-7#2)(2007-8#6)(2007-9#29)(2008-1#6)(2008-10#50)(2008-11#7)(2008-2#23)(2008-3#19)(2008-4#2)(2008-5#13)(2008-6#10)(2008-7#26)(2008-8#25)(2008-9#9)(2009-11#1)(2009-12#7)(2009-2#5)(2009-4#1)(2009-5#5)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-3#3)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#9)(2010-9#2)(2011-1#13)(2011-2#5)(2011-8#1)(2012-1#7)(2012-11#3)(2012-12#2)(2012-2#23)(2012-3#4)(2012-5#1)(2013-1#17)(2013-7#15)(2013-8#10)
scales'##2##1##(1994-8#1)(2012-1#1)
scales)##4##1##(1991-8#1)(1996-7#1)(2007-12#1)(2008-3#1)
scaliness##4##1##(2008-5#4)
scaling analysis##3##2##(1996-12#1)(2005-11#1)(2008-8#1)
scaling and alignment of##2##4##(2013-8#2)
scaling and frequency stabilization of##2##5##(2008-3#2)
scaling and root planing procedure##2##5##(2006-10#2)
scaling and root planing procedures##3##5##(2006-10#3)
scaling and root planing##8##4##(2006-10#7)(2013-7#1)
scaling and##20##2##(1996-7#1)(2004-11#1)(2006-10#7)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#2)
scaling arguments##2##2##(2007-10#1)(2011-1#1)
scaling bases for##2##3##(2006-11#2)
scaling behavior##2##2##(1992-4#1)(1995-2#1)
scaling between these##2##3##(2008-5#1)(2009-8#1)
scaling between##3##2##(1993-6#1)(2008-5#1)(2009-8#1)
scaling effects##2##2##(2007-12#2)
scaling exponent##5##2##(1993-2#3)(2006-4#2)
scaling exponents and##2##3##(1993-5#1)(1996-12#1)
scaling exponents##3##2##(1993-5#1)(1996-12#1)(2008-8#1)
scaling factor##6##2##(2005-11#2)(2007-12#1)(2008-2#1)(2008-3#2)
scaling factors for##2##3##(2008-2#1)(2008-3#1)
scaling factors##4##2##(2008-2#1)(2008-3#2)(2011-2#1)
scaling for##2##2##(1995-5#1)(2005-11#1)
scaling form##2##2##(2008-2#2)
scaling grating##3##2##(2008-2#3)
scaling in the##2##3##(1993-5#1)(1995-5#1)
scaling in##9##2##(1993-12#1)(1993-5#1)(1994-10#1)(1994-5#1)(1995-5#2)(2007-8#1)(2009-9#1)(2012-2#1)
scaling is##3##2##(2008-2#1)(2008-4#1)(2009-9#1)
scaling law is##2##3##(2005-11#1)(2008-3#1)
scaling law##8##2##(2005-11#2)(2007-12#2)(2008-3#2)(2009-3#1)(2012-11#1)
scaling laws for the##3##4##(2008-3#1)(2010-9#2)
scaling laws##8##2##(2006-2#1)(2008-2#2)(2008-3#1)(2010-7#1)(2010-9#2)(2012-2#1)
scaling of the##8##3##(1993-5#1)(1995-9#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-12#1)
scaling of##22##2##(1991-1#1)(1993-5#1)(1995-9#1)(1996-4#1)(2005-11#2)(2006-11#1)(2007-10#2)(2007-11#1)(2007-12#3)(2008-10#1)(2008-3#3)(2008-8#1)(2009-6#1)(2011-1#1)(2011-12#1)(2011-2#1)
scaling parameter##2##2##(1996-4#1)(2012-2#1)
scaling parameters##2##2##(2008-5#2)
scaling properties of##3##3##(2007-11#2)(2008-12#1)
scaling ratios##2##2##(2006-11#2)
scaling relationships among##2##3##(2008-8#1)(2013-8#1)
scaling relationships##8##2##(1997-5#1)(2006-11#1)(2007-4#2)(2008-2#1)(2008-8#2)(2013-8#1)
scaling symptoms##2##2##(2008-10#2)
scaling the##3##2##(2006-10#1)(2006-11#1)(2012-3#1)
scaling to higher##2##3##(2007-12#1)(2008-1#1)
scaling to the##2##3##(1992-1#1)(2008-3#1)
scaling to##5##2##(1992-1#1)(2007-12#1)(2008-1#1)(2008-3#1)(2012-2#1)
scaling up ART##2##3##(2008-4#1)(2010-8#1)
scaling up the##2##3##(2006-12#1)(2008-11#1)
scaling up##6##2##(2006-12#1)(2008-11#1)(2008-4#3)(2010-8#1)
scaling was##2##2##(2007-11#1)(2012-2#1)
scaling with##2##2##(1995-5#1)(2008-3#1)
scaling##227##1##(1991-1#1)(1992-1#2)(1992-12#2)(1992-4#1)(1993-12#3)(1993-2#4)(1993-5#3)(1993-6#1)(1994-10#1)(1994-5#1)(1995-2#1)(1995-5#6)(1995-9#2)(1996-12#3)(1996-4#2)(1996-7#1)(1997-5#1)(2004-11#1)(2005-11#12)(2005-8#1)(2006-10#8)(2006-11#8)(2006-12#1)(2006-2#3)(2006-4#2)(2007-10#5)(2007-11#4)(2007-12#14)(2007-4#5)(2007-7#4)(2007-8#2)(2008-1#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#18)(2008-3#21)(2008-4#5)(2008-5#13)(2008-6#2)(2008-8#8)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#10)(2012-3#1)(2013-7#4)(2013-8#4)
scaling-up##3##1##(2006-6#1)(2008-11#1)(2009-7#1)
scallop##5##1##(1994-11#1)(2013-8#4)
scalp EEG##3##2##(1994-2#2)(2010-5#1)
scalp and skin##2##3##(2007-8#1)(2013-1#1)
scalp and##13##2##(1996-4#1)(2005-11#1)(2005-8#1)(2007-12#1)(2007-8#3)(2008-5#2)(2008-6#1)(2008-7#1)(2013-1#1)(2013-8#1)
scalp at##2##2##(2012-12#1)(2012-3#1)
scalp biopsy##2##2##(2012-11#1)(2013-8#1)
scalp condition##2##2##(2008-5#2)
scalp distribution##2##2##(2008-8#2)
scalp electrodes##2##2##(2008-11#1)(2008-4#1)
scalp hair samples##2##3##(2008-10#2)
scalp hair##8##2##(1996-7#1)(2006-12#1)(2008-10#3)(2010-3#1)(2013-1#2)
scalp in a##2##3##(2007-7#1)(2011-12#1)
scalp in##4##2##(2007-7#1)(2008-9#1)(2011-12#1)(2012-11#1)
scalp is##4##2##(2007-11#1)(2010-5#1)(2010-6#1)(2011-12#1)
scalp lidocaine##3##2##(2006-12#3)
scalp or##3##2##(1995-6#1)(2007-7#1)(2011-1#1)
scalp sites##2##2##(1992-8#1)(1995-12#1)
scalp under##2##2##(2008-8#2)
scalp##139##1##(1990-2#1)(1990-7#1)(1990-9#1)(1992-4#1)(1992-8#2)(1994-2#5)(1994-5#1)(1995-12#2)(1995-6#2)(1996-4#1)(1996-7#2)(1997-3#1)(1997-6#1)(1997-8#1)(2005-11#4)(2005-8#1)(2006-10#1)(2006-12#8)(2007-11#3)(2007-12#1)(2007-7#10)(2007-8#9)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#13)(2008-6#6)(2008-7#2)(2008-8#4)(2008-9#2)(2009-4#1)(2010-3#1)(2010-5#6)(2010-6#5)(2010-7#1)(2011-1#2)(2011-12#6)(2011-2#2)(2012-11#6)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
scalp-recorded##2##1##(1994-2#1)(1997-1#1)
scalpel and##4##2##(1992-3#1)(2007-12#1)(2007-8#1)(2011-1#1)
scalpel blade remover##2##3##(2012-3#2)
scalpel blade##5##2##(2007-7#1)(2012-3#4)
scalpel technique##2##2##(2012-3#2)
scalpel##30##1##(1992-3#3)(2006-12#2)(2007-12#1)(2007-7#1)(2007-8#9)(2008-3#1)(2010-8#3)(2011-1#1)(2012-3#9)
scalpels##2##1##(2007-5#1)(2010-8#1)
scaly skin##6##2##(1994-4#1)(2007-7#3)(2007-8#1)(2008-5#1)
scaly##13##1##(1994-4#1)(2005-11#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-5#2)(2010-6#1)(2012-2#1)(2012-3#2)
scan (p = 0##2##2##(2011-2#1)(2012-2#1)
scan after##3##2##(1990-6#1)(2012-3#1)(2013-1#1)
scan an##2##2##(2007-12#1)(2008-3#1)
scan and by##2##3##(2007-8#1)(2008-3#1)
scan and magnetic resonance imaging##2##5##(1990-12#1)(2007-10#1)
scan and the##2##3##(2008-10#1)(2008-3#1)
scan and##31##2##(1990-12#1)(1992-10#1)(1992-12#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-4#1)(2007-10#1)(2007-8#3)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-7#1)(2010-6#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#3)
scan as##3##2##(2004-10#1)(2008-3#1)(2010-1#1)
scan at##4##2##(2007-11#1)(2008-7#1)(2009-6#1)(2013-1#1)
scan can##4##2##(1991-1#2)(2010-6#1)(2011-2#1)
scan confirmed##4##2##(2006-10#1)(2010-3#1)(2013-1#2)
scan demonstrated a##4##3##(2008-7#1)(2010-12#1)(2013-1#2)
scan did not reveal##2##4##(2007-8#1)(2013-8#1)
scan file acquisition rate##2##4##(1992-1#2)
scan file acquisition##3##3##(1992-1#3)
scan file##4##2##(1992-1#4)
scan finding##2##2##(2008-7#1)(2013-1#1)
scan findings and##2##3##(2005-10#1)(2008-7#1)
scan findings were##3##3##(1991-8#1)(1993-5#1)(2005-10#1)
scan findings##8##2##(1991-8#1)(1993-5#1)(2005-10#3)(2007-9#1)(2008-7#1)(2009-9#1)
scan for the##2##3##(2007-10#1)(2012-12#1)
scan for##11##2##(2006-10#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-7#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-3#1)
scan in a patient of##2##5##(2010-12#1)(2012-2#1)
scan in a patient##4##4##(2007-10#1)(2010-12#1)(2012-2#1)(2012-3#1)
scan in a##5##3##(2007-10#1)(2008-2#1)(2010-12#1)(2012-2#1)(2012-3#1)
scan in the##4##3##(2007-10#1)(2008-10#1)(2008-3#1)(2010-12#1)
scan in##16##2##(1990-12#1)(2007-10#3)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
scan increment of##2##3##(2008-10#2)
scan increment##3##2##(2008-10#3)
scan is##10##2##(1990-8#1)(1995-11#1)(2005-8#1)(2007-11#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-3#1)
scan lines##2##2##(2008-2#2)
scan may be##2##3##(1992-3#1)(2011-2#1)
scan may##4##2##(1992-3#1)(1995-11#1)(2011-2#1)(2012-12#1)
scan mode##3##2##(2007-8#1)(2008-10#2)
scan of a##5##3##(2007-12#1)(2008-10#1)(2008-3#1)(2012-1#1)(2012-2#1)
scan of chest##2##3##(2011-12#1)(2012-12#1)
scan of the NIMH genetics initiative bipolar pedigrees##3##8##(1997-5#3)
scan of the abdomen##2##4##(2008-6#1)(2010-9#1)
scan of the brain##3##4##(1995-11#1)(2006-10#1)(2007-11#1)
scan of the chest##3##4##(2007-8#1)(2010-2#1)(2012-12#1)
scan of the neck##2##4##(2007-3#2)
scan of the thorax##2##4##(2007-12#1)(2007-8#1)
scan of the##30##3##(1995-11#1)(1997-5#3)(2006-10#1)(2007-11#1)(2007-12#1)(2007-3#3)(2007-8#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-9#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
scan of##46##2##(1995-10#1)(1995-11#1)(1997-5#5)(2006-10#1)(2007-11#2)(2007-12#2)(2007-3#3)(2007-8#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#3)(2010-12#1)(2010-2#2)(2010-3#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#2)
scan offers##2##2##(2007-11#1)(2008-10#1)
scan on##3##2##(2007-10#1)(2007-9#1)(2010-12#1)
scan or##3##2##(2007-9#1)(2010-12#1)(2010-4#1)
scan paths##2##2##(2009-10#2)
scan performed##4##2##(2006-4#1)(2007-10#1)(2012-1#1)(2013-1#1)
scan position##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
scan range##4##2##(2007-11#1)(2008-10#1)(2008-3#2)
scan rate and##5##3##(2007-12#1)(2008-10#4)
scan rate in##2##3##(2008-10#2)
scan rate of 0##2##4##(2008-3#1)(2008-5#1)
scan rate of 100 mV s(-1)##3##6##(2008-10#3)
scan rate of##14##3##(1991-8#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-3#1)(2008-5#1)
scan rate was##2##3##(1991-8#1)(2008-10#1)
scan rate were optimized##2##4##(2008-10#2)
scan rate##47##2##(1991-8#2)(1992-1#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#35)(2008-2#1)(2008-3#3)(2008-5#1)
scan rates##2##2##(2008-10#1)(2008-5#1)
scan revealed a##7##3##(2007-12#1)(2007-7#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)
scan revealed##18##2##(1992-11#1)(1992-5#1)(1996-9#1)(2006-4#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
scan should##2##2##(1992-3#1)(2007-8#1)
scan showed a##10##3##(1990-6#1)(1993-12#1)(1997-3#1)(2006-6#1)(2007-9#1)(2008-1#1)(2009-8#1)(2010-1#1)(2012-2#1)(2013-8#1)
scan showed an##3##3##(1996-5#1)(2013-1#2)
scan showed the##2##3##(2008-7#1)(2009-4#1)
scan showed##33##2##(1990-6#1)(1993-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(2006-10#1)(2006-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-7#4)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#2)
scan statistic##5##2##(2007-11#1)(2009-2#1)(2010-2#3)
scan suggested##2##2##(2008-10#1)(2009-6#1)
scan taken##3##2##(2007-9#1)(2013-1#2)
scan that##2##2##(2008-7#1)(2013-8#1)
scan the##6##2##(1993-9#1)(2007-12#1)(2008-3#2)(2008-7#1)(2010-4#1)
scan through the##2##3##(2007-12#1)(2008-7#1)
scan through##3##2##(2007-11#1)(2007-12#1)(2008-7#1)
scan time##5##2##(2006-6#1)(2007-8#2)(2008-7#1)(2009-3#1)
scan times##5##2##(1997-5#2)(2007-4#1)(2009-3#1)(2010-4#1)
scan to##7##2##(2008-1#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#3)
scan using##2##2##(2008-10#1)(2008-5#1)
scan was performed##3##3##(1997-5#1)(2007-10#1)(2010-12#1)
scan was##18##2##(1990-3#1)(1991-9#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
scan were##3##2##(2007-8#1)(2008-7#1)(2011-2#1)
scan which##2##2##(1995-9#1)(2008-7#1)
scan with a##3##3##(2007-11#1)(2008-3#2)
scan with the##2##3##(1996-5#2)
scan with##11##2##(1996-5#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-3#3)(2011-12#1)(2012-2#1)(2013-7#1)
scan within##3##2##(2008-7#1)(2009-5#1)(2012-12#1)
scan##592##1##(1990-12#2)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#2)(1990-8#2)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#4)(1991-9#1)(1992-1#6)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#4)(1992-5#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-5#4)(1993-9#1)(1994-6#1)(1994-9#2)(1995-10#1)(1995-11#5)(1995-9#1)(1996-11#1)(1996-3#1)(1996-5#5)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#9)(2004-10#2)(2004-2#1)(2005-10#4)(2005-11#3)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#10)(2006-12#3)(2006-2#1)(2006-4#8)(2006-5#2)(2006-6#4)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#8)(2007-11#23)(2007-12#15)(2007-3#5)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#22)(2007-9#6)(2008-1#5)(2008-10#80)(2008-11#3)(2008-12#3)(2008-2#16)(2008-3#31)(2008-4#1)(2008-5#8)(2008-6#6)(2008-7#38)(2008-9#3)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#3)(2009-8#3)(2009-9#5)(2010-1#2)(2010-10#1)(2010-12#15)(2010-2#7)(2010-3#3)(2010-4#3)(2010-6#3)(2010-8#2)(2010-9#2)(2011-1#12)(2011-12#4)(2011-2#18)(2012-1#5)(2012-11#3)(2012-12#12)(2012-2#20)(2012-3#8)(2013-1#32)(2013-7#3)(2013-8#11)
scandal of manhood##2##3##(2006-7#2)
scandal of##3##2##(2006-7#2)(2012-12#1)
scandal##10##1##(1991-10#1)(1996-12#1)(1996-2#1)(2006-7#2)(2007-9#1)(2008-1#1)(2008-10#1)(2012-12#1)(2013-8#1)
scandals##2##1##(1990-5#1)(2008-8#1)
scandium##7##1##(2004-4#1)(2008-10#5)(2010-5#1)
scandium(III) and yttrium(III) from##2##4##(2008-10#2)
scandium(III) and yttrium(III)##4##3##(2008-10#4)
scandium(III)##5##1##(2007-11#1)(2008-10#4)
scanned across##2##2##(2007-12#1)(2008-3#1)
scanned against##2##2##(2008-2#1)(2008-7#1)
scanned and##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
scanned at##3##2##(2008-10#1)(2010-4#1)(2012-2#1)
scanned by a##2##3##(2007-4#1)(2011-2#1)
scanned by both##2##3##(1996-1#2)
scanned by##7##2##(1996-1#2)(2007-4#1)(2008-10#1)(2008-8#1)(2011-1#1)(2011-2#1)
scanned for##3##2##(2008-3#1)(2010-5#1)(2013-8#1)
scanned from##2##2##(2008-10#1)(2012-12#1)
scanned in a##3##3##(2008-1#1)(2008-10#1)(2008-2#1)
scanned in two dimensions##2##4##(2008-2#2)
scanned in##10##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#1)(2010-2#1)(2011-12#1)
scanned into##2##2##(2008-3#2)
scanned on##3##2##(2008-10#1)(2010-10#1)(2011-1#1)
scanned over##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
scanned pinhole camera##2##3##(2007-12#2)
scanned the##2##2##(1995-8#1)(2010-12#1)
scanned through##3##2##(2007-12#1)(2008-3#1)(2012-2#1)
scanned with a##4##3##(2008-3#1)(2010-5#1)(2011-2#1)(2012-1#1)
scanned with##8##2##(2007-10#1)(2008-3#2)(2008-8#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#1)
scanned##87##1##(1995-8#1)(1996-1#2)(2006-5#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#11)(2007-4#2)(2007-5#1)(2008-1#1)(2008-10#9)(2008-2#7)(2008-3#15)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#2)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#3)(2013-8#1)
scanner and##3##2##(1997-7#1)(2008-3#1)(2011-2#1)
scanner can be used##2##4##(2011-1#1)(2012-12#1)
scanner can be##3##3##(2008-3#1)(2011-1#1)(2012-12#1)
scanner can##4##2##(2008-3#1)(2009-5#1)(2011-1#1)(2012-12#1)
scanner for##4##2##(1991-9#1)(1992-11#2)(2011-1#1)
scanner in the##2##3##(2006-6#1)(2011-1#1)
scanner in##3##2##(2006-6#1)(2010-2#1)(2011-1#1)
scanner is##3##2##(2008-2#1)(2008-3#2)
scanner on##2##2##(2008-3#2)
scanner that##2##2##(2008-3#2)
scanner to##3##2##(2007-11#1)(2007-12#1)(2008-7#1)
scanner was##6##2##(1993-9#1)(2006-6#1)(2006-7#1)(2008-2#1)(2008-7#1)(2011-1#1)
scanner with a##3##3##(2006-5#1)(2007-12#1)(2008-12#1)
scanner##101##1##(1991-9#1)(1992-11#4)(1993-9#1)(1997-7#1)(2005-12#3)(2006-5#2)(2006-6#4)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#27)(2008-4#1)(2008-5#1)(2008-7#5)(2009-10#3)(2009-5#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#6)(2011-2#2)(2011-7#2)(2012-1#1)(2012-12#3)(2012-2#4)
scanner)##3##1##(2007-12#1)(2008-3#1)(2011-2#1)
scanners and the##2##3##(2008-3#1)(2010-9#1)
scanners and##4##2##(2007-7#1)(2008-3#1)(2009-9#1)(2010-9#1)
scanners is##2##2##(2008-10#1)(2012-1#1)
scanners with##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
scanners##40##1##(1997-8#2)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#7)(2008-3#5)(2008-6#1)(2008-7#7)(2008-9#1)(2009-10#1)(2009-5#1)(2009-9#2)(2010-8#2)(2010-9#2)(2012-1#1)(2012-12#1)(2013-1#2)
scanning a##4##2##(1992-2#1)(1996-6#1)(2008-2#1)(2008-3#1)
scanning acoustic##2##2##(2007-12#1)(2011-1#1)
scanning and transmission electron microscopy##15##5##(2007-12#9)(2007-6#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-7#1)
scanning and transmission electron##17##4##(2007-12#10)(2007-6#1)(2007-9#2)(2008-10#2)(2008-11#1)(2008-7#1)
scanning and transmission##19##3##(2007-12#10)(2007-6#1)(2007-9#2)(2008-10#3)(2008-11#1)(2008-7#1)(2009-7#1)
scanning and##41##2##(1992-2#1)(1992-8#1)(1993-8#1)(2005-10#2)(2005-12#1)(2006-10#1)(2006-7#1)(2007-12#12)(2007-6#1)(2007-9#3)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#4)(2009-7#1)(2010-8#1)(2012-2#1)
scanning approach for##2##3##(2008-4#2)
scanning are##2##2##(2008-10#1)(2012-12#1)
scanning at##2##2##(2007-11#1)(2012-1#1)
scanning by##3##2##(2007-4#1)(2008-4#1)(2009-4#1)
scanning calorimetric (DSC)##3##3##(1990-7#2)(1990-8#1)
scanning calorimetric##9##2##(1990-7#3)(1990-8#2)(1995-8#1)(1996-11#1)(2008-5#1)(2010-12#1)
scanning calorimetry (DSC) and##7##4##(2004-9#2)(2006-10#1)(2007-11#1)(2008-5#1)(2010-12#1)(2010-4#1)
scanning calorimetry (DSC)##25##3##(1990-3#1)(1991-8#1)(1992-10#1)(1993-8#1)(1996-1#2)(2004-9#3)(2005-11#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#2)(2009-3#1)(2010-12#1)(2010-4#1)(2011-1#1)(2013-7#1)
scanning calorimetry and##12##3##(1990-2#1)(1992-3#1)(1995-11#1)(1997-1#1)(1997-7#3)(2005-11#1)(2006-10#1)(2008-10#1)(2008-5#1)(2011-1#1)
scanning calorimetry data##2##3##(1993-11#1)(2006-10#1)
scanning calorimetry studies##2##3##(1992-3#1)(2008-10#1)
scanning calorimetry study on the##2##5##(1991-2#1)(1994-3#1)
scanning calorimetry study##3##3##(1990-7#1)(1991-2#1)(1994-3#1)
scanning calorimetry transitions for the##2##5##(1991-2#2)
scanning calorimetry was used##2##4##(1994-5#1)(2008-5#1)
scanning calorimetry##84##2##(1990-2#2)(1990-3#1)(1990-7#1)(1991-2#5)(1991-5#1)(1991-8#2)(1992-10#1)(1992-3#3)(1992-8#1)(1993-11#1)(1993-3#1)(1993-8#3)(1993-9#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-5#1)(1996-1#2)(1996-5#1)(1997-1#1)(1997-2#3)(1997-5#1)(1997-7#4)(2004-9#5)(2005-11#4)(2006-10#5)(2007-11#3)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-8#2)(2009-2#1)(2009-3#1)(2010-12#1)(2010-4#2)(2011-1#3)(2011-2#1)(2013-7#1)
scanning confocal microscope##3##3##(2007-12#1)(2008-1#1)(2008-9#1)
scanning confocal microscopy to##2##4##(2007-12#1)(2008-11#1)
scanning confocal microscopy##9##3##(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2011-12#2)
scanning confocal##15##2##(2006-12#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2011-12#2)
scanning densitometry##2##2##(2006-10#1)(2008-10#1)
scanning device##4##2##(2008-3#1)(2008-6#1)(2011-2#1)(2013-1#1)
scanning electron micrographs revealed that##2##5##(2005-11#1)(2009-2#1)
scanning electron micrographs##5##3##(2005-11#1)(2008-10#3)(2009-2#1)
scanning electron microscope (SEM)##9##4##(2004-9#1)(2005-11#2)(2007-7#1)(2008-10#1)(2008-5#2)(2009-11#1)(2009-3#1)
scanning electron microscope##32##3##(1991-2#2)(1992-12#1)(2004-9#1)(2005-11#3)(2005-4#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-3#1)(2008-5#7)(2008-6#1)(2009-11#1)(2009-3#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#2)
scanning electron microscopic (SEM)##2##4##(2007-12#1)(2008-10#1)
scanning electron microscopic##5##3##(1992-12#1)(1995-8#1)(2007-12#1)(2008-10#1)(2012-2#1)
scanning electron microscopy (FESEM)##2##4##(2010-4#1)(2011-2#1)
scanning electron microscopy (SEM) and X-ray##2##6##(2008-10#1)(2009-7#1)
scanning electron microscopy (SEM) and atomic force microscopy (AFM)##3##9##(2005-11#1)(2008-5#1)(2009-7#1)
scanning electron microscopy (SEM) and##11##5##(2005-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-7#3)(2010-4#1)(2010-8#1)(2012-2#1)
scanning electron microscopy (SEM) images##3##5##(2008-3#1)(2009-11#1)(2012-1#1)
scanning electron microscopy (SEM) observation##2##5##(2004-9#1)(2008-5#1)
scanning electron microscopy (SEM) of##2##5##(1996-3#1)(2008-8#1)
scanning electron microscopy (SEM)##61##4##(1992-2#1)(1996-3#1)(2004-9#5)(2005-11#3)(2006-10#1)(2006-12#1)(2007-12#2)(2007-9#1)(2008-10#13)(2008-11#1)(2008-3#1)(2008-5#6)(2008-7#2)(2008-8#2)(2009-11#2)(2009-12#1)(2009-7#5)(2009-9#1)(2010-11#1)(2010-4#1)(2010-8#3)(2012-1#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
scanning electron microscopy and electrochemical method##2##6##(2008-10#2)
scanning electron microscopy and transmission electron microscopy##2##7##(2006-12#1)(2007-12#1)
scanning electron microscopy and##15##4##(1995-6#2)(2005-11#2)(2006-12#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#5)(2008-2#1)(2009-7#1)
scanning electron microscopy coupled with##2##5##(2008-10#1)(2013-7#1)
scanning electron microscopy coupled##3##4##(2008-10#1)(2008-5#1)(2013-7#1)
scanning electron microscopy in conjunction with##2##6##(1993-9#1)(2008-10#1)
scanning electron microscopy of##4##4##(2006-11#1)(2008-10#1)(2010-4#1)(2011-2#1)
scanning electron microscopy to##4##4##(2007-12#2)(2008-12#1)(2009-7#1)
scanning electron microscopy was##2##4##(1997-1#1)(2010-6#1)
scanning electron microscopy##172##3##(1990-3#2)(1991-5#1)(1992-2#2)(1993-9#1)(1995-6#2)(1996-3#1)(1997-1#2)(1997-4#1)(2004-9#5)(2005-11#7)(2006-10#1)(2006-11#1)(2006-12#3)(2006-5#1)(2007-12#11)(2007-2#1)(2007-3#1)(2007-5#3)(2007-9#1)(2008-10#37)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#21)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-5#1)(2009-7#8)(2009-9#1)(2010-11#1)(2010-4#7)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#4)(2011-2#3)(2012-1#1)(2012-2#5)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#1)
scanning electron##221##2##(1990-3#2)(1991-2#2)(1991-5#1)(1992-12#2)(1992-2#2)(1993-9#1)(1995-6#2)(1995-8#1)(1996-3#1)(1997-1#2)(1997-4#1)(2004-9#6)(2005-11#11)(2005-4#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-5#2)(2006-8#1)(2007-12#13)(2007-2#1)(2007-3#1)(2007-5#3)(2007-7#1)(2007-9#1)(2008-10#48)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#28)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#3)(2009-3#1)(2009-5#1)(2009-7#8)(2009-9#1)(2010-11#1)(2010-4#7)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#4)(2011-2#4)(2012-1#1)(2012-2#7)(2012-3#3)(2013-1#6)(2013-7#3)(2013-8#4)
scanning electronic microscopy##2##3##(2008-7#1)(2010-8#1)
scanning electronic##3##2##(2008-10#1)(2008-7#1)(2010-8#1)
scanning far-field##2##2##(2007-12#2)
scanning fluorescence microscopy##2##3##(2007-12#1)(2008-9#1)
scanning fluorescence##3##2##(2007-12#1)(2008-3#1)(2008-9#1)
scanning force##2##2##(2006-10#1)(2008-10#1)
scanning gives##2##2##(2005-11#1)(2007-9#1)
scanning has##2##2##(1996-9#1)(2007-9#1)
scanning holography##6##2##(2007-12#2)(2008-1#1)(2008-3#3)
scanning imaging##2##2##(2007-12#1)(2008-1#1)
scanning in children##2##3##(2005-11#1)(2009-12#1)
scanning in the##3##3##(1995-11#1)(2007-8#1)(2012-2#1)
scanning in##16##2##(1991-3#1)(1993-8#3)(1995-11#1)(2005-10#2)(2005-11#1)(2005-8#1)(2007-8#2)(2008-2#1)(2008-3#1)(2009-12#1)(2012-11#1)(2012-2#1)
scanning interferometry is##2##3##(2008-3#2)
scanning interferometry##9##2##(2007-11#2)(2008-2#2)(2008-3#5)
scanning is##12##2##(1991-3#2)(2006-10#1)(2007-11#2)(2007-12#1)(2008-3#3)(2008-4#1)(2010-3#1)(2011-2#1)
scanning laser ophthalmoscope##7##3##(2007-11#1)(2008-3#1)(2010-5#1)(2011-1#3)(2013-1#1)
scanning laser ophthalmoscopy##4##3##(2007-11#1)(2007-6#1)(2011-1#1)(2011-7#1)
scanning laser polarimetry##3##3##(2007-6#1)(2009-4#2)
scanning laser##24##2##(2007-11#3)(2007-6#2)(2008-1#1)(2008-3#4)(2008-5#3)(2008-7#1)(2008-9#1)(2009-4#2)(2010-5#1)(2011-1#4)(2011-7#1)(2013-1#1)
scanning measurement##2##2##(2008-3#2)
scanning mechanism##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
scanning method##6##2##(2007-12#1)(2008-2#2)(2008-3#1)(2008-9#1)(2010-9#1)
scanning microcalorimetry##3##2##(1990-5#1)(1997-6#1)(1997-7#1)
scanning micrographs of##2##3##(2004-11#2)
scanning microscope to##2##3##(2007-11#1)(2008-5#1)
scanning microscope with a self-pumped phase-conjugate mirror##2##7##(2008-2#2)
scanning microscope with##3##3##(1994-2#1)(2008-2#2)
scanning microscope##24##2##(1991-9#1)(1992-7#1)(1993-11#1)(1994-2#1)(1996-9#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-4#1)(2011-1#2)(2012-3#1)
scanning microscopes##2##2##(2008-2#1)(2008-3#1)
scanning microscopy and##8##3##(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-11#4)
scanning microscopy to##2##3##(2008-3#1)(2008-5#1)
scanning microscopy##34##2##(1992-9#1)(1995-8#1)(1996-1#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#4)(2010-8#1)(2011-1#1)(2012-11#4)
scanning mirror##2##2##(2007-11#1)(2007-12#1)
scanning modes##2##2##(2007-12#2)
scanning moiré fringes##2##3##(2008-1#2)
scanning moiré pattern##2##3##(2008-1#2)
scanning moiré##5##2##(2008-1#4)(2008-3#1)
scanning mutagenesis##6##2##(1990-12#2)(1993-11#1)(1994-11#1)(1996-5#1)(2008-10#1)
scanning near-field optical microscope with##2##5##(2008-1#2)
scanning near-field optical microscope##9##4##(2007-11#2)(2007-12#1)(2008-1#2)(2008-2#2)(2008-3#2)
scanning near-field optical microscopy (SNOM)##2##5##(2008-3#2)
scanning near-field optical microscopy##9##4##(2007-12#2)(2008-2#3)(2008-3#4)
scanning near-field optical##19##3##(2007-11#2)(2007-12#3)(2008-1#2)(2008-2#5)(2008-3#7)
scanning near-field##20##2##(2007-11#2)(2007-12#4)(2008-1#2)(2008-2#5)(2008-3#7)
scanning of a##2##3##(2007-12#1)(2008-2#1)
scanning of multiple beams##2##4##(2008-2#2)
scanning of the##18##3##(1990-5#1)(1992-2#1)(2005-10#1)(2006-6#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-2#1)(2008-10#1)(2008-3#4)(2011-1#1)(2013-7#1)
scanning of##31##2##(1990-5#1)(1992-2#1)(1994-3#1)(1996-12#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-6#1)(2007-1#1)(2007-11#3)(2007-12#4)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#6)(2011-1#1)(2011-2#1)(2013-7#1)
scanning optical delay line##3##4##(2008-3#3)
scanning optical delay##4##3##(2008-3#4)
scanning optical microscope##9##3##(2007-12#5)(2008-1#1)(2008-2#2)(2008-3#1)
scanning optical microscopy of single molecules##2##6##(2007-12#2)
scanning optical microscopy##7##3##(1997-5#1)(2007-12#4)(2008-3#2)
scanning optical##22##2##(1997-5#1)(2007-11#1)(2007-12#10)(2008-1#1)(2008-2#2)(2008-3#7)
scanning optics##3##2##(2008-2#2)(2011-1#1)
scanning or##3##2##(2006-8#1)(2008-2#1)(2008-3#1)
scanning over##2##2##(2006-6#1)(2007-11#1)
scanning permittivity measurements##2##3##(2008-11#2)
scanning potentiometry##4##2##(2008-10#4)
scanning probe microscope##5##3##(2008-2#2)(2008-3#2)(2012-1#1)
scanning probe microscopy##4##3##(2005-11#1)(2006-12#1)(2007-9#1)(2009-12#1)
scanning probe microscopy-based##2##3##(2008-7#2)
scanning probe technique##2##3##(2008-1#1)(2008-7#1)
scanning probe##16##2##(2005-11#1)(2006-12#1)(2007-9#1)(2008-1#1)(2008-2#2)(2008-3#2)(2008-7#4)(2009-12#1)(2010-4#1)(2010-7#1)(2012-1#1)
scanning procedure##4##2##(1994-9#1)(2011-1#3)
scanning range##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2013-8#1)
scanning rate of##2##3##(2008-1#1)(2008-10#1)
scanning rate##5##2##(1991-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
scanning should be##3##3##(1993-7#1)(1993-8#1)(1996-1#1)
scanning showed evidence of##2##4##(2008-4#1)(2010-12#1)
scanning showed##3##2##(2005-12#1)(2008-4#1)(2010-12#1)
scanning system and##2##3##(2008-2#1)(2011-2#1)
scanning system##10##2##(2007-12#3)(2008-2#1)(2008-3#4)(2011-2#2)
scanning systems##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
scanning techniques##3##2##(1993-12#1)(2007-11#1)(2008-3#1)
scanning technology##4##2##(2008-11#1)(2008-6#3)
scanning the potential in##2##4##(2008-10#2)
scanning the potential##6##3##(2007-8#1)(2008-10#5)
scanning the##20##2##(2006-4#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#1)(2010-12#1)(2011-2#1)
scanning to##2##2##(2005-10#1)(2012-2#1)
scanning transmission##3##2##(1995-8#1)(2008-10#2)
scanning tunneling microscope (STM)##3##4##(1990-4#1)(1992-2#1)(2010-7#1)
scanning tunneling microscope##14##3##(1990-11#1)(1990-4#1)(1991-11#2)(1992-1#2)(1992-2#1)(1996-5#1)(2007-11#1)(2007-12#4)(2010-7#1)
scanning tunneling microscopy##11##3##(1990-12#1)(1990-4#1)(1991-11#1)(1991-3#1)(1992-5#1)(1993-8#1)(1995-2#1)(2006-12#1)(2007-12#1)(2007-9#2)
scanning tunneling optical##3##3##(2007-12#2)(2008-2#1)
scanning tunneling##30##2##(1990-11#1)(1990-12#1)(1990-4#2)(1991-11#3)(1991-3#1)(1992-1#2)(1992-2#1)(1992-5#1)(1993-8#1)(1995-2#1)(1996-5#1)(2006-12#1)(2007-11#1)(2007-12#7)(2007-9#2)(2008-10#1)(2008-2#1)(2010-7#2)
scanning tunnelling##2##2##(2005-4#1)(2008-7#1)
scanning was##6##2##(1991-3#1)(1996-7#1)(2007-10#1)(2007-8#1)(2008-4#1)(2008-7#1)
scanning while##2##2##(2008-11#1)(2013-8#1)
scanning white-light##3##2##(2007-11#1)(2008-3#2)
scanning with a high##2##4##(2008-1#1)(2008-4#1)
scanning with a##5##3##(1995-12#1)(2008-1#2)(2008-3#1)(2008-4#1)
scanning with##10##2##(1993-9#1)(1995-12#1)(2008-1#2)(2008-3#2)(2008-4#1)(2010-12#1)(2012-11#1)(2012-3#1)
scanning##1020##1##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#3)(1990-4#2)(1990-5#2)(1990-7#4)(1990-8#2)(1991-10#1)(1991-11#3)(1991-12#1)(1991-2#8)(1991-3#6)(1991-5#2)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#6)(1992-3#4)(1992-5#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-7#1)(1993-8#10)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-7#2)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-5#3)(1995-6#2)(1995-8#4)(1996-1#5)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#3)(1997-2#3)(1997-4#1)(1997-5#3)(1997-6#3)(1997-7#5)(1997-8#1)(2004-10#1)(2004-11#5)(2004-12#1)(2004-9#11)(2005-10#7)(2005-11#20)(2005-12#3)(2005-4#3)(2005-8#3)(2006-10#14)(2006-11#1)(2006-12#7)(2006-4#1)(2006-5#6)(2006-6#3)(2006-7#4)(2006-8#4)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#34)(2007-12#101)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#3)(2007-7#2)(2007-8#14)(2007-9#11)(2008-1#19)(2008-10#96)(2008-11#17)(2008-12#1)(2008-2#67)(2008-3#112)(2008-4#19)(2008-5#45)(2008-6#11)(2008-7#28)(2008-8#10)(2008-9#17)(2009-10#1)(2009-11#3)(2009-12#3)(2009-2#4)(2009-3#4)(2009-4#4)(2009-5#1)(2009-7#9)(2009-9#1)(2010-11#1)(2010-12#6)(2010-2#2)(2010-3#1)(2010-4#10)(2010-5#2)(2010-6#1)(2010-7#5)(2010-8#7)(2010-9#2)(2011-1#19)(2011-12#2)(2011-2#11)(2011-3#1)(2011-7#2)(2012-1#3)(2012-11#6)(2012-12#5)(2012-2#13)(2012-3#6)(2013-1#9)(2013-7#5)(2013-8#7)
scanning)##3##1##(1993-12#1)(2008-10#1)(2011-2#1)
scanning- and transmission electron microscopy##2##5##(2007-12#2)
scanning-beam technique##2##2##(2008-3#2)
scanning-beam##4##1##(2008-3#4)
scanning-electron microscopy##3##2##(2008-2#1)(2008-3#2)
scanning-electron##5##1##(2005-12#1)(2007-11#1)(2008-2#1)(2008-3#2)
scanning-laser##2##1##(2008-2#1)(2008-3#1)
scanning-tunneling microscope##2##2##(2008-2#1)(2008-3#1)
scanning-tunneling##3##1##(2008-2#2)(2008-3#1)
scanningelectron microscope##2##2##(2008-11#1)(2008-2#1)
scans across##3##2##(2008-2#1)(2008-3#2)
scans after##4##2##(1992-12#1)(1994-7#1)(2008-7#1)(2010-10#1)
scans and EEG recording##2##4##(1992-7#2)
scans and a##2##3##(1992-3#1)(2008-2#1)
scans and##19##2##(1992-3#1)(1992-7#2)(2006-10#1)(2006-5#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-11#1)(2010-12#1)(2010-2#1)(2012-12#1)(2013-7#1)
scans are more##2##3##(2005-8#2)
scans are useful for##2##4##(2008-10#1)(2008-9#1)
scans are##10##2##(2005-8#2)(2006-10#1)(2006-7#1)(2007-9#2)(2008-10#2)(2008-9#1)(2013-1#1)
scans at a##4##3##(1992-3#2)(2008-10#1)(2008-3#1)
scans at##9##2##(1990-6#1)(1992-3#2)(2008-10#1)(2008-3#2)(2009-9#1)(2012-12#2)
scans because##2##2##(2007-9#1)(2008-3#1)
scans before##2##2##(1994-7#1)(2013-8#1)
scans demonstrated##2##2##(2008-1#1)(2012-12#1)
scans for##6##2##(1996-7#1)(2004-1#1)(2007-11#1)(2007-4#1)(2008-10#1)(2013-1#1)
scans have been##2##3##(1993-6#1)(2005-11#1)
scans have##6##2##(1993-6#1)(2005-11#1)(2008-1#1)(2008-9#1)(2011-2#2)
scans in##8##2##(1996-3#1)(1996-5#1)(2006-12#1)(2008-10#2)(2010-1#1)(2012-11#1)(2013-7#1)
scans is##2##2##(2008-3#1)(2010-3#1)
scans of all##2##3##(1990-8#1)(2009-5#1)
scans of the##12##3##(1990-8#1)(2004-11#1)(2006-11#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#2)(2010-10#1)(2013-8#1)
scans of##25##2##(1990-8#2)(1992-2#1)(1996-11#1)(1997-8#1)(2004-11#1)(2006-11#1)(2007-1#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-2#1)(2008-5#2)(2008-7#2)(2009-5#1)(2010-10#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-8#1)
scans on the##2##3##(1990-5#1)(2007-10#1)
scans or##2##2##(2008-7#1)(2013-7#1)
scans per spectrum##2##3##(2007-8#1)(2008-10#1)
scans per##3##2##(2007-8#1)(2008-10#2)
scans performed##3##2##(2009-7#1)(2011-2#2)
scans revealed a##3##3##(2008-1#1)(2008-5#1)(2008-7#1)
scans revealed an##2##3##(2008-11#1)(2012-2#1)
scans revealed##9##2##(2008-1#1)(2008-11#1)(2008-5#2)(2008-7#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-8#1)
scans showed a##2##3##(2008-1#1)(2011-1#1)
scans showed##9##2##(1996-5#1)(2006-1#1)(2007-11#1)(2008-1#2)(2008-7#1)(2011-1#2)(2011-2#1)
scans taken at the##2##4##(2007-7#1)(2011-2#1)
scans that##3##2##(2005-10#1)(2008-9#1)(2012-2#1)
scans the##4##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)
scans to##3##2##(2004-10#1)(2007-10#1)(2008-9#1)
scans was##4##2##(2007-11#1)(2007-5#1)(2009-8#1)(2011-2#1)
scans were obtained##4##3##(1993-2#1)(1995-12#1)(2008-7#1)(2011-2#1)
scans were performed in##4##4##(1997-8#1)(2007-10#1)(2008-7#1)(2009-11#1)
scans were performed on##4##4##(2007-7#1)(2008-7#2)(2013-1#1)
scans were performed##9##3##(1997-8#1)(2007-10#2)(2007-7#1)(2008-7#3)(2009-11#1)(2013-1#1)
scans were positive##2##3##(1992-3#1)(2012-2#1)
scans were taken##2##3##(2007-4#1)(2008-11#1)
scans were##26##2##(1992-3#1)(1993-2#1)(1995-12#1)(1996-7#2)(1997-8#1)(2004-1#2)(2005-10#1)(2006-10#1)(2007-10#2)(2007-4#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-7#4)(2009-11#1)(2011-2#2)(2012-2#1)(2013-1#1)
scans with a##3##3##(1993-9#1)(2006-5#1)(2008-3#1)
scans with##12##2##(1993-9#1)(1996-5#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-5#1)(2008-3#3)(2010-9#1)(2012-11#1)(2012-12#1)
scans##285##1##(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#2)(1992-12#1)(1992-2#1)(1992-3#4)(1992-7#4)(1992-8#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-7#5)(1995-12#1)(1995-5#2)(1996-11#1)(1996-3#1)(1996-5#6)(1996-7#3)(1997-1#1)(1997-8#3)(2004-1#3)(2004-10#2)(2004-11#1)(2004-9#1)(2005-10#3)(2005-11#1)(2005-8#4)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#4)(2006-4#1)(2006-5#5)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#7)(2007-11#9)(2007-12#8)(2007-4#5)(2007-5#3)(2007-7#5)(2007-8#4)(2007-9#9)(2008-1#9)(2008-10#18)(2008-11#4)(2008-2#6)(2008-3#15)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#22)(2008-8#1)(2008-9#4)(2009-1#1)(2009-11#2)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#3)(2010-12#2)(2010-2#2)(2010-3#3)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#15)(2012-11#2)(2012-12#6)(2012-2#6)(2012-3#2)(2013-1#6)(2013-7#3)(2013-8#3)
scans)##2##1##(2005-11#1)(2008-7#1)
scant attention to##2##3##(2008-7#1)(2010-5#1)
scant attention##3##2##(2008-7#1)(2009-5#1)(2010-5#1)
scant literature##3##2##(2006-10#1)(2008-11#1)(2012-11#1)
scant##23##1##(1990-12#1)(1993-7#1)(1994-9#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-11#2)(2007-5#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-5#1)(2011-2#2)(2012-11#1)(2012-12#1)(2013-1#1)
scanty and##2##2##(1995-9#1)(2008-5#1)
scanty##19##1##(1991-4#1)(1992-10#1)(1995-10#1)(1995-9#1)(2004-4#1)(2005-12#1)(2007-3#2)(2007-9#1)(2008-1#1)(2008-12#1)(2008-5#2)(2009-5#1)(2011-1#2)(2011-2#1)(2013-1#2)
scaphocephaly##2##1##(1996-3#1)(2005-10#1)
scaphoid and##4##2##(2006-3#1)(2007-11#1)(2008-9#1)(2012-1#1)
scaphoid bone##4##2##(2009-2#3)(2012-2#1)
scaphoid can##2##2##(2006-3#2)
scaphoid fracture was##3##3##(2006-3#2)(2008-9#1)
scaphoid fracture##9##2##(2006-3#6)(2008-9#3)
scaphoid fractures##7##2##(2006-4#1)(2008-9#6)
scaphoid in##2##2##(2008-9#1)(2012-2#1)
scaphoid nonunion##6##2##(2006-3#5)(2006-4#1)
scaphoid waist fractures##3##3##(2008-9#3)
scaphoid waist##4##2##(2008-9#4)
scaphoid with##3##2##(2006-3#1)(2007-11#1)(2013-1#1)
scaphoid##55##1##(2006-3#22)(2006-4#4)(2007-11#3)(2008-9#17)(2009-2#3)(2012-1#1)(2012-2#4)(2013-1#1)
scapholunate dissociation##2##2##(2006-4#2)
scapholunate##10##1##(2006-3#3)(2006-4#3)(2012-1#2)(2013-1#2)
scapula to##2##2##(1993-12#1)(2006-11#1)
scapula##11##1##(1993-12#1)(2005-10#1)(2006-10#1)(2006-11#2)(2007-2#1)(2007-4#1)(2009-3#2)(2012-12#1)(2013-7#1)
scapulae##3##1##(2007-4#1)(2010-9#2)
scapular aneurysmal bone cyst in a child##2##7##(2012-12#2)
scapular bone##2##2##(2011-2#1)(2013-7#1)
scapular upward rotators during##2##4##(2010-9#2)
scapular##13##1##(2006-12#1)(2007-10#1)(2008-12#1)(2010-12#1)(2010-9#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)
scapularis were collected##2##3##(2004-11#2)
scapularis##22##1##(2004-11#13)(2008-11#6)(2012-12#3)
scapulohumeral##3##1##(1992-11#1)(2007-2#2)
scar and the##2##3##(1992-8#1)(2013-8#1)
scar and##11##2##(1990-8#1)(1992-8#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2012-1#1)(2013-8#1)
scar by##2##2##(1996-4#1)(2008-9#1)
scar count##2##2##(2004-2#2)
scar fibroblasts treated with##2##4##(2008-9#2)
scar formation and##2##3##(2006-12#1)(2006-7#1)
scar formation that##2##3##(2008-9#1)(2012-12#1)
scar formation##12##2##(2006-12#1)(2006-7#2)(2006-9#1)(2008-9#4)(2010-8#1)(2010-9#1)(2012-12#2)
scar in a##2##3##(2009-10#1)(2009-6#1)
scar in the##2##3##(2012-1#2)
scar in##10##2##(2007-10#1)(2008-9#1)(2009-10#2)(2009-6#1)(2009-9#1)(2012-1#2)(2012-12#1)(2013-8#1)
scar is##2##2##(2007-11#2)
scar on the##4##3##(2007-2#1)(2007-8#1)(2009-4#1)(2011-2#1)
scar on##5##2##(2007-2#1)(2007-8#1)(2009-4#1)(2011-2#1)(2013-1#1)
scar or##3##2##(2006-12#2)(2008-5#1)
scar reduction##2##2##(2008-9#2)
scar sarcoidosis##2##2##(2010-6#1)(2011-2#1)
scar severity and body-esteem##3##4##(2007-12#3)
scar severity##4##2##(2007-12#4)
scar size##2##2##(2004-2#1)(2012-12#1)
scar tissue and##3##3##(1997-3#2)(2008-6#1)
scar tissue##20##2##(1990-2#1)(1992-12#1)(1996-4#1)(1997-3#4)(2004-2#1)(2006-11#2)(2006-6#2)(2006-8#1)(2008-3#1)(2008-6#1)(2008-9#3)(2009-4#1)(2013-7#1)
scar tissues##2##2##(1996-4#1)(2011-1#1)
scar was defined##2##3##(2004-2#1)(2007-8#1)
scar was present##2##3##(1991-10#1)(2012-3#1)
scar was##6##2##(1991-10#1)(1996-6#1)(2004-2#1)(2007-2#1)(2007-8#1)(2012-3#1)
scar were##2##2##(1996-4#1)(2007-6#1)
scar with##2##2##(2007-8#1)(2008-9#1)
scar##163##1##(1990-12#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-10#1)(1992-12#1)(1992-8#3)(1994-8#1)(1995-3#1)(1996-4#6)(1996-6#1)(1997-3#4)(2004-10#1)(2004-2#5)(2006-11#3)(2006-12#5)(2006-6#2)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#10)(2007-12#4)(2007-2#3)(2007-3#1)(2007-6#3)(2007-8#4)(2008-10#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#22)(2009-10#3)(2009-4#3)(2009-5#1)(2009-6#5)(2009-8#1)(2009-9#4)(2010-6#1)(2010-8#3)(2010-9#3)(2011-1#1)(2011-2#6)(2012-1#3)(2012-11#1)(2012-12#8)(2012-2#2)(2012-3#8)(2013-1#4)(2013-7#1)(2013-8#4)
scar&quot##2##1##(2007-12#1)(2010-4#1)
scarce and##9##2##(1997-1#1)(2006-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
scarce in##3##2##(2008-9#1)(2009-2#1)(2013-8#1)
scarce information##3##2##(2007-5#1)(2010-12#1)(2013-7#1)
scarce or##3##2##(2007-12#1)(2008-10#1)(2012-12#1)
scarce resources##10##2##(1992-3#1)(1993-2#1)(1996-12#1)(1996-2#1)(2006-4#1)(2007-9#1)(2008-7#1)(2012-2#1)(2013-1#2)
scarce##100##1##(1990-5#1)(1991-11#2)(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-2#2)(1995-11#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-2#1)(2003-11#1)(2005-10#1)(2006-1#1)(2006-10#2)(2006-4#1)(2006-6#1)(2007-1#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#4)(2008-9#4)(2009-2#1)(2009-3#1)(2009-7#2)(2010-10#1)(2010-12#6)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#7)(2012-2#4)(2012-3#3)(2013-1#5)(2013-7#3)(2013-8#4)
scarcely been##3##2##(2007-7#1)(2012-12#1)(2013-1#1)
scarcely##21##1##(1990-2#1)(1990-4#1)(1991-12#1)(1993-12#1)(1994-12#1)(1995-11#1)(1996-3#1)(1996-4#1)(2005-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#2)(2008-9#1)(2009-6#1)(2009-9#1)(2012-12#1)(2013-1#1)
scarcity and##3##2##(2008-4#1)(2008-7#1)(2009-4#1)
scarcity of cadaveric##2##3##(2011-2#2)
scarcity of studies##2##3##(2007-12#1)(2011-2#1)
scarcity of##27##2##(1991-11#1)(1993-7#1)(1994-12#1)(1994-3#1)(1995-8#1)(1996-3#1)(2005-7#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#4)(2011-3#2)(2012-12#1)(2013-8#1)
scarcity on##2##2##(2007-12#1)(2009-8#1)
scarcity##42##1##(1991-11#2)(1993-3#1)(1993-7#1)(1994-12#1)(1994-3#1)(1995-8#1)(1996-3#1)(2005-7#1)(2007-12#2)(2008-1#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#4)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-5#1)(2013-8#2)
scare##4##1##(1994-7#1)(2008-11#1)(2008-9#1)(2011-1#1)
scarf osteotomy for##2##3##(2009-5#1)(2012-2#1)
scarification##5##1##(2007-12#1)(2010-12#1)(2013-1#1)(2013-7#2)
scarification&quot##2##1##(2008-5#2)
scarification)##2##1##(2009-2#1)(2013-7#1)
scaring##2##1##(2008-11#1)(2012-12#1)
scarlet gilia##2##2##(2008-9#2)
scarlet##4##1##(1992-2#1)(2008-10#1)(2008-9#2)
scarred abdomen##2##2##(1991-12#1)(2005-10#1)
scarred##7##1##(1991-12#1)(1997-6#1)(2005-10#1)(2007-10#1)(2007-9#1)(2008-2#1)(2009-5#1)
scarring alopecia##3##2##(2007-11#1)(2013-1#2)
scarring and the##2##3##(2004-2#1)(2008-12#1)
scarring and##9##2##(1997-8#1)(2004-2#1)(2007-7#1)(2008-12#2)(2008-4#1)(2011-1#1)(2012-11#1)(2013-8#1)
scarring in the group##2##4##(1991-2#1)(1997-3#1)
scarring in the##3##3##(1991-2#1)(1997-3#1)(2006-5#1)
scarring in##6##2##(1991-2#2)(1997-3#1)(2006-5#1)(2008-10#1)(2008-4#1)
scarring is##7##2##(1996-4#1)(2004-2#1)(2006-12#1)(2008-5#1)(2008-9#1)(2010-10#1)(2012-12#1)
scarring of the##4##3##(1990-12#1)(1991-12#1)(2008-11#1)(2008-7#1)
scarring of##6##2##(1990-12#1)(1991-12#1)(2007-7#1)(2008-11#1)(2008-7#1)(2008-9#1)
scarring or##2##2##(2008-5#1)(2010-6#1)
scarring were##2##2##(1991-12#2)
scarring##80##1##(1990-12#1)(1990-3#1)(1991-12#4)(1991-2#2)(1996-1#1)(1996-10#1)(1996-4#1)(1997-3#2)(1997-8#1)(2004-2#6)(2006-10#1)(2006-11#1)(2006-12#3)(2006-3#1)(2006-5#1)(2007-11#2)(2007-7#3)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-2#1)(2008-4#8)(2008-5#2)(2008-7#1)(2008-9#6)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-6#2)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#6)(2013-1#4)(2013-8#1)
scarring?##2##1##(2008-10#1)(2008-9#1)
scars and##8##2##(2005-11#1)(2007-11#2)(2008-10#1)(2008-7#1)(2008-9#2)(2009-2#1)
scars in the##2##3##(2008-9#1)(2009-6#1)
scars in##3##2##(2008-8#1)(2008-9#1)(2009-6#1)
scars on the##3##3##(2007-7#1)(2009-1#1)(2010-12#1)
scars were##2##2##(2004-2#1)(2009-6#1)
scars##58##1##(1991-10#1)(1991-11#1)(1991-2#1)(1992-2#1)(1995-2#1)(2004-10#1)(2004-2#2)(2005-11#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-6#2)(2007-7#2)(2007-8#1)(2008-10#4)(2008-7#1)(2008-8#1)(2008-9#8)(2009-1#1)(2009-2#1)(2009-4#2)(2009-6#3)(2010-12#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-12#4)(2013-1#2)(2013-8#1)
scary##3##1##(2007-7#1)(2009-10#1)(2011-1#1)
scat##2##1##(2008-5#2)
scats of opossums##2##3##(2008-5#2)
scats of##4##2##(2008-5#4)
scats##9##1##(2005-7#1)(2008-5#7)(2013-7#1)
scatter and##4##2##(2005-4#1)(2007-12#1)(2008-2#1)(2008-9#1)
scatter are##2##2##(2008-3#2)
scatter coefficient##2##2##(2008-2#2)
scatter corrected##2##2##(2008-5#1)(2012-1#1)
scatter correction##3##2##(2007-11#1)(2008-10#1)(2012-1#1)
scatter distribution##3##2##(2008-5#3)
scatter effects##2##2##(2008-3#2)
scatter estimation##2##2##(2008-5#2)
scatter factor##5##2##(1991-10#4)(2007-8#1)
scatter for##2##2##(1992-7#1)(1996-12#1)
scatter imaging##2##2##(2007-12#2)
scatter in the##5##3##(1991-9#1)(1996-12#1)(2008-2#1)(2008-3#1)(2010-12#1)
scatter in##8##2##(1991-3#1)(1991-9#1)(1996-12#1)(2008-2#3)(2008-3#1)(2010-12#1)
scatter is##8##2##(2008-2#2)(2008-3#2)(2008-6#2)(2008-9#2)
scatter of contact angle values##3##5##(2005-11#3)
scatter of##7##2##(2005-11#3)(2005-4#1)(2008-2#3)
scatter radiation##4##2##(2006-8#2)(2008-2#1)(2008-3#1)
scatter that##2##2##(2008-2#1)(2009-4#1)
scatter to##2##2##(2012-1#2)
scatter was the greatest contributor to the peripheral dose##2##9##(2009-10#2)
scatter was##3##2##(2009-10#2)(2012-1#1)
scatter##119##1##(1990-8#2)(1991-10#4)(1991-3#1)(1991-5#1)(1991-9#1)(1992-6#1)(1992-7#1)(1995-8#1)(1995-9#1)(1996-12#2)(2005-11#3)(2005-4#2)(2006-12#1)(2006-6#1)(2006-8#3)(2007-11#1)(2007-12#6)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#24)(2008-3#14)(2008-5#9)(2008-6#3)(2008-9#9)(2009-10#3)(2009-4#1)(2009-5#1)(2010-12#2)(2011-1#7)(2012-1#8)(2013-8#1)
scattered across##4##2##(2008-1#1)(2008-5#1)(2012-1#1)(2012-3#1)
scattered and##4##2##(1990-8#1)(2007-12#1)(2008-2#1)(2008-3#1)
scattered at##2##2##(2007-12#1)(2008-2#1)
scattered by a##8##3##(2007-1#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#2)
scattered by an##2##3##(2008-2#1)(2008-3#1)
scattered by the##7##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)
scattered by##27##2##(2007-1#1)(2007-11#3)(2007-12#5)(2008-1#1)(2008-2#8)(2008-3#9)
scattered field is##2##3##(2008-2#1)(2008-3#1)
scattered field##15##2##(2007-11#2)(2007-12#3)(2008-2#5)(2008-3#4)(2009-10#1)
scattered fields##3##2##(2008-2#2)(2008-3#1)
scattered from a##9##3##(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#5)
scattered from cylindrical rough surfaces##2##5##(2008-3#2)
scattered from cylindrical##3##3##(2008-2#1)(2008-3#2)
scattered from##28##2##(1993-5#1)(2006-2#1)(2007-12#7)(2008-1#1)(2008-2#7)(2008-3#11)
scattered in the##8##3##(1991-9#1)(1996-7#1)(1996-9#1)(2008-1#2)(2008-3#1)(2008-5#1)(2008-7#1)
scattered in##11##2##(1991-9#1)(1992-12#1)(1996-7#1)(1996-9#1)(2008-1#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)
scattered intensity fluctuations##2##3##(2007-12#1)(2008-2#1)
scattered intensity is##2##3##(2007-12#1)(2008-3#1)
scattered intensity##8##2##(1992-7#1)(2007-12#3)(2008-2#1)(2008-3#3)
scattered into##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
scattered laser light##3##3##(2007-1#1)(2008-2#1)(2008-3#1)
scattered laser##5##2##(2007-1#1)(2007-12#1)(2008-2#1)(2008-3#2)
scattered light and fluorescence##2##4##(2008-10#2)
scattered light and the##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
scattered light and##9##3##(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)
scattered light from##3##3##(2008-3#3)
scattered light in the##2##4##(2008-2#1)(2008-3#1)
scattered light in##6##3##(2008-2#3)(2008-3#2)(2008-9#1)
scattered light intensity##3##3##(2005-11#1)(2007-12#1)(2011-2#1)
scattered light is imaged##2##4##(2007-12#1)(2008-2#1)
scattered light is##8##3##(2007-12#2)(2008-2#2)(2008-3#4)
scattered light to the##2##4##(2006-2#1)(2008-2#1)
scattered light to##4##3##(2006-2#1)(2007-11#1)(2008-2#2)
scattered light was##4##3##(2007-12#3)(2008-10#1)
scattered light with##2##3##(2008-3#2)
scattered light##84##2##(2005-11#1)(2006-12#1)(2006-2#1)(2007-11#2)(2007-12#14)(2008-10#5)(2008-2#25)(2008-3#29)(2008-4#1)(2008-9#1)(2011-2#4)
scattered lymphocytes##2##2##(2006-10#1)(2008-7#1)
scattered photons by##2##3##(2007-12#1)(2008-2#1)
scattered photons##6##2##(2007-12#1)(2008-2#4)(2008-3#1)
scattered pundate##2##2##(2007-7#2)
scattered radiance##2##2##(2008-3#2)
scattered radiation##8##2##(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2011-1#1)
scattered solar##3##2##(2008-2#1)(2008-3#2)
scattered throughout the entire##3##4##(1993-3#1)(1995-11#1)(1996-12#1)
scattered throughout the##7##3##(1990-2#1)(1990-5#1)(1993-3#1)(1995-11#1)(1996-12#1)(2008-7#1)(2011-2#1)
scattered throughout##11##2##(1990-2#1)(1990-5#1)(1992-8#1)(1993-3#1)(1995-10#1)(1995-11#1)(1996-12#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
scattered to##3##2##(2008-11#1)(2008-2#2)
scattered waves##2##2##(2008-2#1)(2008-3#1)
scattered##320##1##(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#2)(1991-11#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-5#1)(1994-11#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-4#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-2#2)(2006-4#2)(2007-1#2)(2007-11#10)(2007-12#44)(2007-7#4)(2008-1#7)(2008-10#8)(2008-11#3)(2008-2#78)(2008-3#89)(2008-4#2)(2008-5#4)(2008-7#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-6#2)(2010-9#1)(2011-1#2)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
scattered-light##8##1##(2007-12#1)(2008-2#7)
scatterer concentration##3##2##(2007-12#3)
scatterer size and concentration in##2##5##(2007-11#1)(2008-3#1)
scatterer size and##3##3##(2007-11#1)(2008-3#2)
scatterer size is##2##3##(2007-11#1)(2008-3#1)
scatterer size##9##2##(2007-1#1)(2007-11#2)(2008-3#6)
scatterer##28##1##(1995-6#1)(1995-9#1)(2007-1#1)(2007-11#4)(2007-12#4)(2008-2#4)(2008-3#13)
scatterers are##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
scatterers at##3##2##(2008-2#2)(2008-3#1)
scatterers has been##2##3##(2008-3#2)
scatterers in##3##2##(1995-6#1)(2007-12#1)(2008-2#1)
scatterers on##3##2##(2008-3#3)
scatterers with##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
scatterers##50##1##(1995-6#1)(1995-8#1)(1997-6#1)(2006-4#1)(2007-11#3)(2007-12#9)(2008-1#1)(2008-2#14)(2008-3#19)
scattering (DW-RLS)##2##2##(2008-10#2)
scattering (RS)##3##2##(2007-12#1)(2008-10#2)
scattering (SAXS) curves##2##3##(1995-8#1)(2009-6#1)
scattering (SAXS)##7##2##(1995-8#1)(2005-11#1)(2006-10#1)(2008-10#3)(2009-6#1)
scattering activity##2##2##(1996-5#1)(2008-10#1)
scattering after##2##2##(1995-11#1)(2007-11#1)
scattering amplitude##2##2##(2006-4#1)(2008-2#1)
scattering amplitudes##3##2##(2007-11#1)(2008-3#1)(2010-7#1)
scattering analysis##3##2##(2008-2#1)(2008-4#1)(2009-2#1)
scattering and Rayleigh scattering##2##4##(2007-11#1)(2008-3#1)
scattering and absorbing##6##3##(2007-12#1)(2008-3#5)
scattering and absorption by##2##4##(2008-2#1)(2008-3#1)
scattering and absorption coefficients are##2##5##(2007-12#1)(2011-1#1)
scattering and absorption coefficients of##6##5##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
scattering and absorption coefficients per unit length##2##7##(2008-2#1)(2008-3#1)
scattering and absorption coefficients##14##4##(2007-11#1)(2007-12#2)(2008-2#5)(2008-3#5)(2011-1#1)
scattering and absorption cross sections##2##5##(2008-3#2)
scattering and absorption in##2##4##(1997-6#1)(2007-12#1)
scattering and absorption properties##3##4##(2008-2#1)(2008-3#2)
scattering and absorption##34##3##(1997-6#2)(2007-11#2)(2007-12#3)(2008-2#8)(2008-3#18)(2011-1#1)
scattering and backscattering##2##3##(2008-2#2)
scattering and depolarizing##3##3##(2008-2#3)
scattering and fluorescence in##2##4##(2008-10#1)(2008-3#1)
scattering and fluorescence##4##3##(1992-3#1)(2008-10#1)(2008-3#1)(2008-9#1)
scattering and the absorption coefficients##3##5##(2008-2#2)(2008-3#1)
scattering and the absorption properties##2##5##(2008-2#1)(2008-3#1)
scattering and the absorption##6##4##(2007-11#1)(2008-2#3)(2008-3#2)
scattering and the##10##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#3)
scattering and##109##2##(1992-3#1)(1995-11#3)(1995-7#1)(1997-6#2)(2005-11#1)(2007-11#6)(2007-12#8)(2008-1#1)(2008-10#4)(2008-2#29)(2008-3#45)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
scattering angle for##2##3##(2008-3#2)
scattering angle of##6##3##(2007-12#1)(2008-2#3)(2008-3#2)
scattering angle##21##2##(2007-12#2)(2008-2#11)(2008-3#8)
scattering angles from##2##3##(2008-3#2)
scattering angles##11##2##(2007-12#2)(2008-2#2)(2008-3#6)(2009-6#1)
scattering anisotropy##4##2##(2008-3#4)
scattering approximation##3##2##(2008-2#1)(2008-3#2)
scattering are##14##2##(1994-3#1)(2005-11#1)(2007-11#1)(2007-12#3)(2008-2#4)(2008-3#4)
scattering as a function of##2##5##(2008-10#1)(2008-3#1)
scattering as a##7##3##(1992-8#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#2)
scattering at a##2##3##(2007-12#1)(2008-3#1)
scattering at an##2##3##(2008-3#2)
scattering at the##3##3##(2008-2#1)(2008-3#1)(2010-7#1)
scattering at##16##2##(1995-2#1)(1995-7#1)(2006-12#2)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#5)(2009-11#1)(2010-7#1)
scattering based on##2##3##(2008-2#1)(2008-3#1)
scattering behavior of the##2##4##(2008-2#1)(2008-3#1)
scattering by a##8##3##(2008-2#2)(2008-3#6)
scattering by aerosols##2##3##(2008-2#1)(2008-3#1)
scattering by air##2##3##(2008-2#2)
scattering by an##6##3##(2008-2#4)(2008-3#2)
scattering by dielectric particles##4##4##(2007-11#1)(2008-3#3)
scattering by dielectric##5##3##(2007-11#2)(2008-3#3)
scattering by particles##2##3##(2007-12#1)(2008-2#1)
scattering by red blood cells##2##5##(2008-2#2)
scattering by small##2##3##(2008-2#2)
scattering by the##2##3##(2007-12#1)(2013-1#1)
scattering by water##2##3##(2008-2#1)(2008-3#1)
scattering by##69##2##(1992-3#1)(1993-5#1)(2007-11#6)(2007-12#5)(2008-2#31)(2008-3#24)(2013-1#1)
scattering calculations##3##2##(2007-11#1)(2008-2#1)(2009-12#1)
scattering can be##5##3##(2007-12#1)(2008-2#1)(2008-3#2)(2009-4#1)
scattering can##6##2##(2007-12#1)(2008-2#1)(2008-3#3)(2009-4#1)
scattering centers in##3##3##(2008-2#2)(2008-3#1)
scattering centers##8##2##(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#1)
scattering changes##2##2##(2007-12#2)
scattering characteristics of##2##3##(2008-3#2)
scattering characteristics##5##2##(2008-2#2)(2008-3#2)(2010-2#1)
scattering coefficient and the##3##4##(2007-11#1)(2008-3#2)
scattering coefficient and##6##3##(2007-11#1)(2008-2#1)(2008-3#2)(2011-1#2)
scattering coefficient are##2##3##(1997-6#1)(2008-2#1)
scattering coefficient b##2##3##(2008-3#2)
scattering coefficient can be##2##4##(2008-2#1)(2008-3#1)
scattering coefficient is##2##3##(2008-2#2)
scattering coefficient of##5##3##(2008-2#2)(2008-3#3)
scattering coefficient##45##2##(1997-6#2)(2007-11#1)(2007-12#4)(2008-2#16)(2008-3#18)(2011-1#3)(2013-1#1)
scattering coefficients and##3##3##(2008-2#1)(2008-3#1)(2011-1#1)
scattering coefficients at##2##3##(2008-3#1)(2011-1#1)
scattering coefficients from##3##3##(2008-2#1)(2008-3#2)
scattering coefficients in##2##3##(2008-2#1)(2008-3#1)
scattering coefficients of the##2##4##(2008-2#2)
scattering coefficients of##9##3##(2007-11#2)(2008-2#4)(2008-3#3)
scattering coefficients##37##2##(2007-11#4)(2007-12#2)(2008-2#11)(2008-3#17)(2011-1#3)
scattering component##3##2##(2008-2#1)(2008-3#2)
scattering components##2##2##(2008-2#1)(2009-12#1)
scattering contribution##3##2##(1997-6#1)(2008-2#1)(2010-5#1)
scattering cross section and the##2##5##(2007-12#1)(2008-2#1)
scattering cross section##9##3##(2007-12#4)(2008-2#2)(2008-3#3)
scattering cross sections##6##3##(1993-8#1)(2007-12#2)(2008-2#1)(2008-3#2)
scattering cross##15##2##(1993-8#1)(2007-12#6)(2008-2#3)(2008-3#5)
scattering data##4##2##(2008-2#2)(2008-3#1)(2010-2#1)
scattering delay##4##2##(2008-2#4)
scattering detection##8##2##(2007-8#3)(2008-10#4)(2012-2#1)
scattering dichroism##2##2##(2005-11#2)
scattering direction##4##2##(2008-2#2)(2008-3#2)
scattering distribution##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
scattering does not##2##3##(2008-2#2)
scattering effect##7##2##(1995-7#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)
scattering effects##6##2##(2006-5#1)(2007-11#2)(2008-2#2)(2008-7#1)
scattering efficiency##3##2##(2008-3#3)
scattering errors##2##2##(2008-3#2)
scattering events##4##2##(2007-12#1)(2008-10#1)(2008-3#2)
scattering experiments##15##2##(1991-7#1)(1992-5#1)(1995-3#1)(1996-11#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
scattering for##9##2##(2006-4#2)(2007-12#1)(2008-10#1)(2008-3#5)
scattering force##2##2##(2007-12#2)
scattering from a##4##3##(2007-12#1)(2008-1#1)(2008-3#2)
scattering from an optically active sphere##2##6##(2008-2#2)
scattering from an optically##3##4##(2008-2#3)
scattering from cells##2##3##(2008-3#2)
scattering from dielectric bispheres in the specular direction##2##8##(2007-11#2)
scattering from homogeneous##2##3##(2008-2#1)(2008-3#1)
scattering from particulate##2##3##(2008-2#1)(2008-3#1)
scattering from rough surfaces##2##4##(2008-3#2)
scattering from surface##2##3##(2008-1#1)(2008-2#1)
scattering from the##10##3##(2006-10#1)(2007-12#3)(2008-2#2)(2008-3#4)
scattering from##71##2##(1992-3#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-11#4)(2007-12#9)(2008-1#3)(2008-2#20)(2008-3#27)(2008-6#2)(2011-1#2)
scattering function##5##2##(2008-2#2)(2008-3#3)
scattering gain media##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
scattering has been##3##3##(2006-4#1)(2007-12#1)(2008-3#1)
scattering have been##2##3##(2006-5#1)(2008-3#1)
scattering image##2##2##(2008-2#1)(2008-3#1)
scattering images##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
scattering in a##11##3##(2007-11#1)(2007-12#5)(2008-2#2)(2008-3#3)
scattering in an##4##3##(2007-11#2)(2007-12#2)
scattering in impulsively excited##2##4##(2007-11#2)
scattering in optical fibers##2##4##(2008-1#2)
scattering in optical##7##3##(2007-11#2)(2007-12#1)(2008-1#3)(2008-3#1)
scattering in the##13##3##(1994-3#1)(1994-5#1)(1995-11#1)(2007-12#1)(2008-10#1)(2008-2#6)(2008-3#1)(2013-8#1)
scattering in##73##2##(1990-12#1)(1993-6#1)(1994-3#2)(1994-5#1)(1995-11#1)(1995-3#1)(2006-5#1)(2007-11#10)(2007-12#17)(2008-1#5)(2008-10#1)(2008-2#15)(2008-3#14)(2010-5#1)(2011-1#1)(2013-8#1)
scattering inhomogeneities##2##2##(2008-2#1)(2008-3#1)
scattering intensities##2##2##(2008-10#1)(2008-2#1)
scattering intensity at##2##3##(2008-10#2)
scattering intensity##14##2##(2006-4#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#3)(2008-3#1)(2009-12#1)(2011-1#1)
scattering into##2##2##(2008-2#2)
scattering is a##4##3##(2007-11#1)(2008-1#1)(2008-3#2)
scattering is an##2##3##(2008-3#1)(2009-9#1)
scattering is described##2##3##(2006-4#1)(2008-2#1)
scattering is not an##2##4##(2005-4#1)(2008-3#1)
scattering is presented##3##3##(2006-4#1)(2008-2#2)
scattering is shown##2##3##(2006-5#1)(2007-12#1)
scattering is##38##2##(1994-9#1)(2005-11#1)(2005-4#1)(2006-4#2)(2006-5#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-2#10)(2008-3#12)(2008-4#1)(2008-9#1)(2009-9#1)
scattering layer##6##2##(2008-2#5)(2008-3#1)
scattering layers##6##2##(2007-11#1)(2008-3#5)
scattering length##2##2##(2008-3#2)
scattering lengths##2##2##(2008-2#1)(2008-3#1)
scattering lidar##2##2##(2008-3#2)
scattering lidars##3##2##(2008-3#3)
scattering light##4##2##(2007-12#1)(2008-10#1)(2008-6#1)(2012-3#1)
scattering loss in##2##3##(2008-2#2)
scattering loss##8##2##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#2)
scattering losses##5##2##(2007-12#3)(2008-3#2)
scattering materials##2##2##(2008-2#2)
scattering matrices##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
scattering matrix elements of##2##4##(2008-3#2)
scattering matrix elements##4##3##(2008-2#2)(2008-3#2)
scattering matrix##10##2##(1991-8#2)(1993-6#1)(2008-2#2)(2008-3#5)
scattering mean free paths##5##4##(2007-12#2)(2008-2#1)(2008-3#2)
scattering mean free##7##3##(2005-11#1)(2007-12#3)(2008-2#1)(2008-3#2)
scattering measurements for##2##3##(2008-2#1)(2008-3#1)
scattering measurements of polarized light##3##5##(2008-2#3)
scattering measurements of##5##3##(1992-12#1)(2008-2#3)(2012-2#1)
scattering measurements on##2##3##(2008-2#1)(2008-3#1)
scattering measurements##23##2##(1992-12#1)(2005-11#2)(2006-2#1)(2006-5#1)(2007-1#1)(2008-2#10)(2008-3#5)(2011-1#1)(2012-2#1)
scattering media and##4##3##(2008-2#2)(2008-3#2)
scattering media based on##2##4##(2007-12#2)
scattering media by use of a##2##6##(2007-12#1)(2008-3#1)
scattering media by use of##4##5##(2007-12#2)(2008-3#2)
scattering media by##8##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#4)
scattering media in##2##3##(2008-2#2)
scattering media is##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
scattering media was##2##3##(2007-12#1)(2008-2#1)
scattering media with##5##3##(2007-12#2)(2008-2#2)(2008-3#1)
scattering media##90##2##(1992-8#1)(2007-11#2)(2007-12#26)(2008-1#1)(2008-2#24)(2008-3#35)(2010-4#1)
scattering medium and##2##3##(2007-12#1)(2008-3#1)
scattering medium by use of##2##5##(2007-12#1)(2008-3#1)
scattering medium by##4##3##(2007-12#3)(2008-3#1)
scattering medium##55##2##(2007-11#2)(2007-12#14)(2008-2#17)(2008-3#22)
scattering method for the##2##4##(2008-10#2)
scattering method##5##2##(1994-3#1)(2008-10#4)
scattering methods##2##2##(2008-2#1)(2008-4#1)
scattering object##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
scattering objects##4##2##(2007-11#2)(2007-12#2)
scattering of He-Ne laser light##2##5##(2008-3#2)
scattering of a##9##3##(2006-5#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#2)(2009-10#1)
scattering of an##3##3##(2008-2#1)(2008-3#1)(2009-10#1)
scattering of diffuse##3##3##(2007-12#1)(2008-2#2)
scattering of light at oblique incidence by##2##7##(2008-2#2)
scattering of light by##9##4##(2008-2#2)(2008-3#7)
scattering of light from##6##4##(2007-12#3)(2008-10#1)(2008-2#1)(2008-9#1)
scattering of light in##3##4##(2007-12#1)(2008-2#2)
scattering of light##25##3##(2007-11#1)(2007-12#6)(2008-10#1)(2008-2#8)(2008-3#8)(2008-9#1)
scattering of optical##2##3##(2008-3#2)
scattering of the##12##3##(1990-12#1)(1994-4#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-2#2)(2008-3#3)(2011-2#1)
scattering of##99##2##(1990-12#1)(1991-10#1)(1991-12#1)(1991-8#1)(1992-3#1)(1992-7#1)(1993-8#1)(1994-10#1)(1994-4#1)(1995-11#2)(2005-4#2)(2006-4#1)(2006-5#2)(2007-11#3)(2007-12#14)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-2#27)(2008-3#22)(2008-9#1)(2009-10#2)(2009-4#1)(2011-2#1)(2013-8#2)
scattering on a##3##3##(2006-5#1)(2007-12#1)(2008-2#1)
scattering on large particles##2##4##(2008-2#2)
scattering on particles##2##3##(2008-2#2)
scattering on the measured##2##4##(2008-3#2)
scattering on the measurement##2##4##(2008-2#2)
scattering on the##8##3##(2008-2#3)(2008-3#5)
scattering on##25##2##(1996-4#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-2#12)(2008-3#9)
scattering or absorbing##2##3##(2008-2#1)(2008-3#1)
scattering or##6##2##(2007-12#2)(2008-2#2)(2008-3#2)
scattering outside##2##2##(2008-2#1)(2008-3#1)
scattering over a##2##3##(2008-2#2)
scattering over##5##2##(2008-2#4)(2008-3#1)
scattering parameters##5##2##(1992-8#1)(2008-2#1)(2008-3#3)
scattering particles##6##2##(2007-12#1)(2008-2#1)(2008-3#4)
scattering path##2##2##(2008-2#1)(2008-3#1)
scattering pattern##7##2##(2007-12#1)(2008-2#1)(2008-3#5)
scattering patterns from##2##3##(2008-2#2)
scattering patterns of##2##3##(2008-2#2)
scattering patterns##10##2##(2006-2#1)(2007-11#1)(2007-12#2)(2008-2#5)(2008-5#1)
scattering phase function is##3##4##(2008-2#1)(2008-3#2)
scattering phase function of##2##4##(2008-2#2)
scattering phase function##16##3##(2008-2#7)(2008-3#7)(2008-6#2)
scattering phase matrix##3##3##(2008-2#2)(2008-3#1)
scattering phase##21##2##(2008-2#10)(2008-3#9)(2008-6#2)
scattering photons##2##2##(2007-12#2)
scattering potential##2##2##(2007-12#1)(2008-2#1)
scattering power##4##2##(2005-4#1)(2006-4#1)(2011-1#2)
scattering problem for##4##3##(2008-2#4)
scattering problem##9##2##(2008-2#7)(2008-3#2)
scattering process##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
scattering processes##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
scattering properties and##2##3##(2007-11#1)(2011-1#1)
scattering properties are##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
scattering properties of a##2##4##(2008-3#1)(2013-1#1)
scattering properties of an##2##4##(2008-2#1)(2008-3#1)
scattering properties of the##5##4##(2008-2#2)(2008-3#3)
scattering properties of##19##3##(2007-11#2)(2008-2#5)(2008-3#11)(2013-1#1)
scattering properties##31##2##(2007-1#1)(2007-11#5)(2008-2#7)(2008-3#16)(2011-1#1)(2013-1#1)
scattering provide##2##2##(1995-8#1)(2006-7#1)
scattering quantities##4##2##(2008-3#4)
scattering rate##3##2##(2007-12#1)(2012-2#2)
scattering regime##2##2##(2008-2#1)(2008-3#1)
scattering regimes##2##2##(2008-3#2)
scattering results##5##2##(1996-11#1)(2005-11#1)(2008-3#2)(2008-7#1)
scattering samples##5##2##(2007-12#2)(2008-3#3)
scattering shows##2##2##(2007-12#1)(2008-3#1)
scattering signal##4##2##(2007-12#1)(2008-10#1)(2011-1#2)
scattering signals##5##2##(2008-10#4)(2010-2#1)
scattering simulations##2##2##(2007-12#1)(2008-2#1)
scattering slab is presented##2##4##(2008-3#2)
scattering slab is##4##3##(2008-3#4)
scattering slab##7##2##(2008-3#7)
scattering spectra and##2##3##(2008-10#1)(2008-7#1)
scattering spectra of##2##3##(2008-2#1)(2008-3#1)
scattering spectra##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
scattering spectroscopy##4##2##(1990-4#1)(1996-2#1)(2008-10#1)(2009-5#1)
scattering strength of the medium##2##5##(2008-2#1)(2008-3#1)
scattering strength##4##2##(2008-2#1)(2008-3#3)
scattering studies##5##2##(1990-12#1)(1993-7#1)(1995-3#2)(2008-11#1)
scattering study of the##2##4##(1991-12#1)(2008-10#1)
scattering study of##3##3##(1991-12#1)(1993-8#1)(2008-10#1)
scattering study on##2##3##(2007-8#1)(2008-10#1)
scattering study##7##2##(1991-12#1)(1992-7#1)(1993-8#1)(1996-11#1)(2007-8#1)(2008-10#2)
scattering systems##2##2##(2007-12#1)(2008-3#1)
scattering technique##14##2##(1991-2#1)(2007-10#1)(2008-10#9)(2008-2#1)(2008-3#1)(2011-2#1)
scattering techniques##5##2##(1992-3#1)(2008-10#1)(2009-5#1)(2011-2#1)(2012-1#1)
scattering that is due to##2##5##(2007-11#1)(2008-2#1)
scattering that is##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
scattering that##5##2##(2007-11#1)(2008-2#3)(2008-3#1)
scattering theory##7##2##(2007-11#1)(2008-2#1)(2008-3#5)
scattering to the##6##3##(2008-2#1)(2008-3#5)
scattering to##13##2##(2005-11#1)(2007-11#2)(2007-8#1)(2008-2#1)(2008-3#7)(2009-9#1)
scattering using##5##2##(1992-9#1)(1993-7#1)(1995-2#1)(2006-4#1)(2008-2#1)
scattering vector and##2##3##(2006-4#1)(2008-3#1)
scattering vector##3##2##(2006-4#1)(2008-10#1)(2008-3#1)
scattering volume##2##2##(2008-2#1)(2008-3#1)
scattering was##12##2##(2005-11#3)(2008-10#1)(2008-2#3)(2008-3#4)(2010-2#1)
scattering wave vectors##2##3##(2008-2#2)
scattering were##7##2##(2008-10#1)(2008-2#3)(2008-3#2)(2008-8#1)
scattering will##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
scattering with a##2##3##(2007-12#1)(2008-2#1)
scattering with##10##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#1)(2011-7#1)
scattering##1803##1##(1990-12#5)(1990-2#2)(1990-4#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-7#1)(1991-8#5)(1992-12#1)(1992-3#5)(1992-5#1)(1992-7#2)(1992-8#4)(1992-9#2)(1993-5#1)(1993-6#3)(1993-7#3)(1993-8#3)(1994-10#1)(1994-2#1)(1994-3#4)(1994-4#1)(1994-5#4)(1994-9#2)(1995-11#7)(1995-2#2)(1995-3#5)(1995-5#1)(1995-6#2)(1995-7#4)(1995-8#2)(1996-11#3)(1996-2#1)(1996-4#2)(1996-5#1)(1997-1#1)(1997-6#8)(1997-8#1)(2004-9#1)(2005-11#27)(2005-4#6)(2006-10#7)(2006-12#7)(2006-2#2)(2006-4#14)(2006-5#13)(2006-7#1)(2007-1#5)(2007-10#1)(2007-11#95)(2007-12#226)(2007-5#1)(2007-8#12)(2008-1#16)(2008-10#109)(2008-11#3)(2008-2#465)(2008-3#574)(2008-4#8)(2008-5#3)(2008-6#5)(2008-7#4)(2008-8#3)(2008-9#4)(2009-10#5)(2009-11#1)(2009-12#3)(2009-2#1)(2009-4#3)(2009-5#4)(2009-6#2)(2009-9#2)(2010-2#5)(2010-4#2)(2010-5#4)(2010-7#7)(2010-9#1)(2011-1#22)(2011-2#8)(2011-7#1)(2012-1#2)(2012-2#6)(2012-3#1)(2013-1#4)(2013-7#3)(2013-8#8)
scattering)##6##1##(2006-5#1)(2006-7#1)(2007-12#1)(2008-2#1)(2008-3#2)
scattering-extinction##3##1##(2008-2#1)(2008-3#2)
scattering-induced##2##1##(2007-12#2)
scattering-loss##2##1##(2008-3#2)
scattering-matrix##2##1##(2007-12#1)(2008-2#1)
scatterings##5##1##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
scatterometer##4##1##(2008-2#3)(2008-3#1)
scatterometry is##2##2##(2008-2#1)(2008-3#1)
scatterometry technique##2##2##(2008-2#2)
scatterometry##9##1##(2008-2#6)(2008-3#3)
scatterplots##2##1##(2008-3#1)(2009-12#1)
scatters from##2##2##(2007-12#1)(2008-3#1)
scatters##7##1##(1995-8#1)(2007-12#1)(2008-2#3)(2008-3#1)(2008-7#1)
scavenge free radicals##4##3##(1992-9#1)(2007-11#1)(2008-7#1)(2012-12#1)
scavenge##21##1##(1992-5#1)(1992-9#1)(1993-4#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-8#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-11#3)(2008-7#2)(2009-8#1)(2012-11#1)(2012-12#1)
scavenged by##2##2##(2008-10#1)(2011-2#1)
scavenged##9##1##(1990-10#2)(1992-5#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-4#1)(2011-2#1)(2013-1#1)
scavenger activity##4##2##(2008-5#3)(2011-2#1)
scavenger and an antioxidant##2##4##(2004-12#1)(2007-8#1)
scavenger and##4##2##(1993-9#1)(2004-12#1)(2007-8#1)(2010-2#1)
scavenger in##2##2##(1992-9#1)(2008-5#1)
scavenger of superoxide anion##2##4##(1991-12#1)(2008-5#1)
scavenger of##6##2##(1990-4#1)(1991-12#1)(1995-2#1)(2008-11#2)(2008-5#1)
scavenger properties##3##2##(1994-6#1)(2008-5#1)(2009-8#1)
scavenger receptor##8##2##(1990-2#1)(1992-12#1)(1993-8#1)(2006-10#1)(2011-1#2)(2013-1#1)(2013-7#1)
scavenger receptors##3##2##(1992-12#1)(1993-8#1)(2013-1#1)
scavenger##77##1##(1990-2#1)(1990-4#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-9#1)(1992-12#3)(1992-5#1)(1992-7#1)(1992-9#1)(1993-4#1)(1993-6#2)(1993-8#4)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#3)(1995-11#1)(1995-12#2)(1995-2#2)(1995-7#1)(1995-8#3)(1996-2#1)(1997-7#1)(1997-8#2)(2004-12#1)(2005-7#1)(2006-10#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#3)(2008-5#9)(2009-8#1)(2010-2#2)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#2)(2013-7#1)
scavenger)##2##1##(1995-12#1)(1995-7#1)
scavengers and antioxidants##3##3##(2008-11#1)(2008-5#1)(2009-6#1)
scavengers and##7##2##(1996-2#1)(2006-12#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-6#1)
scavengers in the##4##3##(2005-7#1)(2006-8#1)(2009-12#1)(2012-2#1)
scavengers in##5##2##(1993-4#1)(2005-7#1)(2006-8#1)(2009-12#1)(2012-2#1)
scavengers of the##2##3##(1991-11#1)(1991-9#1)
scavengers of##10##2##(1990-11#1)(1991-11#1)(1991-9#1)(1992-9#1)(1995-1#3)(1996-2#1)(1997-7#1)(2013-8#1)
scavengers such as##2##3##(2008-7#1)(2011-2#1)
scavengers were##2##2##(1993-8#1)(2008-6#1)
scavengers##66##1##(1990-11#1)(1990-3#1)(1991-11#1)(1991-9#4)(1992-9#1)(1993-2#1)(1993-4#1)(1993-8#2)(1993-9#1)(1994-2#1)(1994-6#1)(1995-1#3)(1995-10#1)(1995-11#1)(1995-2#2)(1995-6#2)(1995-8#1)(1996-2#6)(1997-7#1)(2005-7#3)(2006-12#4)(2006-8#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-5#6)(2008-6#2)(2008-7#4)(2008-9#1)(2009-12#1)(2009-3#1)(2009-6#1)(2010-11#1)(2011-2#2)(2012-2#1)(2013-8#1)
scavenges the##2##2##(1995-8#1)(2008-10#1)
scavenges##7##1##(1993-9#1)(1994-6#1)(1994-8#1)(1995-8#1)(1997-7#1)(2008-10#1)(2008-11#1)
scavenging abilities of##2##3##(2008-10#1)(2008-5#1)
scavenging action##5##2##(1991-2#1)(1995-12#1)(2008-4#1)(2008-6#1)(2010-8#1)
scavenging activities in##2##3##(2013-1#1)(2013-8#1)
scavenging activities##7##2##(2008-12#1)(2008-5#1)(2008-9#1)(2009-3#2)(2013-1#1)(2013-8#1)
scavenging activity of##3##3##(1997-7#1)(2006-12#1)(2008-10#1)
scavenging activity with##2##3##(2008-11#1)(2011-2#1)
scavenging activity##21##2##(1993-4#1)(1997-7#1)(2006-12#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-5#3)(2009-6#1)(2010-4#2)(2011-1#1)(2011-2#2)(2012-11#1)
scavenging and##6##2##(1991-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-6#1)
scavenging by##3##2##(1995-3#1)(1997-7#1)(2008-9#1)
scavenging effect of##2##3##(1993-6#1)(2008-11#1)
scavenging effect on##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
scavenging effect##6##2##(1993-6#1)(1997-7#1)(2008-10#1)(2008-11#2)(2012-2#1)
scavenging is##2##2##(1991-11#1)(1997-7#1)
scavenging of##13##2##(1993-12#1)(1993-9#2)(1994-6#1)(1995-3#1)(2008-11#1)(2008-4#1)(2010-5#3)(2011-1#1)(2011-2#1)(2012-2#1)
scavenging properties##5##2##(1991-2#1)(2007-1#1)(2008-11#1)(2011-1#1)(2012-1#1)
scavenging reactive oxygen species##2##4##(1994-2#1)(2008-10#1)
scavenging superoxide anion##2##3##(2008-10#1)(2013-8#1)
scavenging the##2##2##(1991-12#1)(2009-10#1)
scavenging were##2##2##(2007-8#1)(2010-12#1)
scavenging##124##1##(1991-11#3)(1991-12#1)(1991-2#2)(1991-9#1)(1992-2#1)(1992-8#1)(1993-1#2)(1993-12#1)(1993-4#2)(1993-6#1)(1993-9#2)(1994-2#2)(1994-6#1)(1995-1#1)(1995-12#1)(1995-3#3)(1995-6#1)(1996-2#1)(1997-7#4)(2006-10#1)(2006-12#1)(2007-1#2)(2007-11#1)(2007-6#1)(2007-8#3)(2008-10#12)(2008-11#12)(2008-12#2)(2008-3#2)(2008-4#3)(2008-5#8)(2008-6#2)(2008-7#3)(2008-9#3)(2009-10#1)(2009-3#2)(2009-6#4)(2010-12#1)(2010-4#2)(2010-5#4)(2010-8#3)(2011-1#3)(2011-2#6)(2012-1#1)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
sceletal##5##1##(2006-10#1)(2007-11#4)
scenario analysis##3##2##(1991-2#1)(1992-9#1)(1997-3#1)
scenario and the##2##3##(2008-11#1)(2011-2#1)
scenario and##6##2##(2006-10#2)(2006-6#1)(2007-11#1)(2008-11#1)(2011-2#1)
scenario are##2##2##(1993-12#1)(2012-2#1)
scenario for health##2##3##(1992-3#1)(1996-2#1)
scenario for the##3##3##(2008-11#1)(2010-7#1)(2012-12#1)
scenario for##8##2##(1992-3#1)(1996-2#1)(2007-1#1)(2007-8#1)(2008-11#1)(2010-7#1)(2012-1#1)(2012-12#1)
scenario in which the##2##4##(2008-8#1)(2009-2#1)
scenario in which##4##3##(2007-7#1)(2008-8#1)(2009-2#1)(2013-1#1)
scenario in##7##2##(2006-4#1)(2007-7#1)(2008-11#1)(2008-8#1)(2009-2#1)(2010-2#1)(2013-1#1)
scenario is##7##2##(1995-1#1)(2006-10#1)(2008-7#2)(2008-9#1)(2012-11#1)(2012-2#1)
scenario of##16##2##(2005-4#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#4)(2009-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
scenario that##4##2##(2007-1#1)(2008-12#1)(2011-1#1)(2012-1#1)
scenario was##2##2##(2008-11#1)(2012-1#1)
scenario where##3##2##(2006-6#1)(2008-9#1)(2013-1#1)
scenario within the##2##3##(2008-11#1)(2011-1#1)
scenario without##3##2##(2007-7#2)(2012-12#1)
scenario##145##1##(1991-2#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-9#2)(1995-1#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-6#1)(1996-7#1)(1997-3#1)(2005-12#1)(2005-4#1)(2005-8#2)(2006-10#4)(2006-4#1)(2006-6#4)(2006-9#1)(2007-1#4)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#6)(2007-8#4)(2007-9#4)(2008-1#1)(2008-10#7)(2008-11#8)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#5)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#2)(2009-8#1)(2010-11#3)(2010-12#2)(2010-2#4)(2010-3#1)(2010-7#2)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#8)(2012-2#8)(2012-3#1)(2012-5#1)(2013-1#3)(2013-7#1)(2013-8#2)
scenario-based design##3##2##(2010-8#3)
scenario-based##5##1##(2008-11#2)(2010-8#3)
scenarios and##6##2##(1996-3#1)(2009-12#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
scenarios are discussed##2##3##(2008-3#1)(2009-2#1)
scenarios are##5##2##(2008-3#1)(2009-10#1)(2009-2#1)(2012-12#2)
scenarios based on##3##3##(2010-12#1)(2010-3#1)(2013-1#1)
scenarios for##8##2##(1996-1#1)(2006-12#1)(2007-9#1)(2008-11#1)(2008-4#1)(2010-8#1)(2012-3#1)(2013-1#1)
scenarios generated##3##2##(2009-10#2)(2012-3#1)
scenarios has been##2##3##(2006-11#1)(2009-10#1)
scenarios in the##2##3##(2009-10#1)(2012-12#1)
scenarios in which##2##3##(2008-1#1)(2008-6#1)
scenarios in##6##2##(2008-1#1)(2008-11#1)(2008-6#1)(2009-10#1)(2012-12#1)(2012-3#1)
scenarios involving##2##2##(2008-7#1)(2009-10#1)
scenarios of##13##2##(1997-6#1)(2007-4#1)(2008-8#1)(2008-9#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)
scenarios that##3##2##(2007-4#1)(2011-2#1)(2012-2#1)
scenarios to##4##2##(2007-10#2)(2008-5#1)(2012-2#1)
scenarios triggered by fire##2##4##(2009-10#2)
scenarios were##7##2##(2007-5#1)(2008-11#1)(2009-10#1)(2010-8#1)(2012-12#2)(2013-1#1)
scenarios where the##3##3##(2008-11#1)(2008-6#1)(2010-8#1)
scenarios where##4##2##(2008-10#1)(2008-11#1)(2008-6#1)(2010-8#1)
scenarios with##2##2##(2007-7#1)(2013-1#1)
scenarios##158##1##(1996-1#1)(1996-12#2)(1996-3#2)(1997-6#2)(2005-10#1)(2005-4#2)(2006-10#3)(2006-11#3)(2006-12#2)(2006-4#1)(2007-1#2)(2007-10#3)(2007-11#1)(2007-4#3)(2007-5#1)(2007-7#4)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#8)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#8)(2008-8#8)(2008-9#2)(2009-10#13)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-11#2)(2010-12#3)(2010-3#2)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#5)(2011-1#1)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#8)(2012-2#9)(2012-3#5)(2013-1#10)(2013-8#3)
scene analysis##2##2##(2008-2#2)
scene and##3##2##(2008-3#2)(2011-2#1)
scene elements##3##2##(2009-4#1)(2010-2#2)
scene for##3##2##(2007-12#1)(2010-2#1)(2012-2#1)
scene image##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
scene is##3##2##(2008-3#3)
scene of a##2##3##(1995-11#1)(2005-8#1)
scene of##9##2##(1991-8#1)(1995-11#1)(1996-8#1)(2005-10#1)(2005-8#1)(2008-10#1)(2011-2#2)(2012-12#1)
scene recognition in##2##3##(2008-4#2)
scene segmentation##3##2##(2008-2#3)
scene with an##2##3##(2007-12#1)(2008-3#1)
scene with##3##2##(2007-12#1)(2008-3#1)(2009-12#1)
scene##127##1##(1990-12#2)(1991-2#1)(1991-8#1)(1993-12#1)(1994-12#1)(1995-11#2)(1995-3#1)(1995-6#1)(1996-2#3)(1996-8#1)(2004-7#1)(2005-10#1)(2005-12#2)(2005-8#1)(2006-10#2)(2006-6#2)(2007-11#2)(2007-12#4)(2007-5#2)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#5)(2008-2#28)(2008-3#25)(2008-4#5)(2008-6#3)(2008-7#2)(2008-9#2)(2009-12#2)(2009-4#2)(2009-7#1)(2010-2#3)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-7#2)
scene-based nonuniformity correction##2##3##(2008-2#1)(2008-3#1)
scene-based##3##1##(2008-2#1)(2008-3#2)
scene-related##2##1##(2009-4#2)
scene-unrelated##4##1##(2009-4#4)
scenes and##2##2##(2008-10#1)(2008-3#1)
scenes are##2##2##(2008-10#1)(2008-3#1)
scenes of##2##2##(2008-8#1)(2012-12#1)
scenes that##2##2##(2007-12#1)(2008-3#1)
scenes with##2##2##(2008-3#1)(2010-2#1)
scenes##43##1##(1991-2#1)(2007-12#2)(2008-10#5)(2008-11#2)(2008-2#8)(2008-3#10)(2008-4#6)(2008-6#1)(2008-8#1)(2009-4#3)(2010-2#1)(2010-8#1)(2012-12#1)(2012-2#1)
scent marks of##2##3##(2009-6#2)
scent##16##1##(1995-5#1)(2004-2#1)(2006-12#1)(2007-12#1)(2008-4#1)(2008-5#3)(2009-6#6)(2012-2#2)
sceptical##6##1##(1990-4#1)(1996-6#1)(1997-6#2)(2007-5#1)(2007-9#1)
scepticism##2##1##(1993-9#1)(1994-9#1)
schachtii J2##2##2##(2008-10#2)
schachtii and##4##2##(2008-10#2)(2008-12#1)(2009-3#1)
schachtii cysts##4##2##(2008-10#4)
schachtii eggs##2##2##(2008-10#2)
schachtii in##2##2##(2008-10#2)
schachtii multiplied##2##2##(2008-10#2)
schachtii population densities##2##3##(2008-10#2)
schachtii population##4##2##(2008-10#4)
schachtii populations##3##2##(2008-10#3)
schachtii was##2##2##(2008-10#2)
schachtii##45##1##(2008-10#38)(2008-12#3)(2009-3#4)
schachtii)##2##1##(2008-10#1)(2009-3#1)
schedule (p##2##2##(1992-2#1)(2010-2#1)
schedule and##11##2##(1992-3#1)(1992-8#1)(1994-1#1)(1995-5#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2013-8#1)
schedule based##2##2##(1992-12#1)(2011-2#1)
schedule for a##2##3##(2007-11#1)(2008-12#1)
schedule for the##2##3##(1995-8#2)
schedule for##17##2##(1990-6#1)(1991-11#1)(1992-2#1)(1993-11#1)(1993-2#1)(1994-3#1)(1994-7#1)(1995-8#2)(2004-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-12#1)(2010-7#1)(2013-8#1)
schedule in the##2##3##(1990-8#1)(2006-10#1)
schedule in##3##2##(1990-8#1)(2006-10#1)(2007-4#1)
schedule is##6##2##(1991-12#1)(2008-3#1)(2008-6#3)(2009-4#1)
schedule of 3##2##3##(1992-2#1)(2007-11#1)
schedule of administration##2##3##(2007-11#1)(2008-7#1)
schedule of ifosfamide##2##3##(2008-6#2)
schedule of male##3##3##(2008-6#3)
schedule of reinforcement##3##3##(1990-2#1)(1993-6#2)
schedule of reproductive effort##2##4##(2008-8#2)
schedule of the##2##3##(1990-4#1)(2013-8#1)
schedule of##34##2##(1990-2#4)(1990-4#1)(1991-12#1)(1991-6#1)(1992-2#2)(1993-2#1)(1993-6#2)(1997-1#1)(1997-7#1)(2004-12#1)(2005-11#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-5#1)(2008-6#6)(2008-7#2)(2008-8#2)(2009-3#1)(2010-9#1)(2013-8#1)
schedule on##2##2##(1991-2#1)(2007-4#1)
schedule or##4##2##(1991-8#1)(1993-11#1)(2007-12#1)(2009-4#1)
schedule was##8##2##(1991-8#1)(1993-6#1)(1997-1#1)(1997-6#1)(2004-1#1)(2008-7#1)(2010-8#1)(2012-2#1)
schedule were##2##2##(1992-3#1)(1992-9#1)
schedule with##6##2##(1994-8#1)(1995-5#1)(2004-12#1)(2007-12#1)(2007-3#1)(2008-7#1)
schedule##210##1##(1990-10#1)(1990-12#1)(1990-2#7)(1990-4#1)(1990-6#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-6#3)(1991-8#3)(1992-1#4)(1992-12#1)(1992-2#9)(1992-3#2)(1992-8#2)(1992-9#1)(1993-11#3)(1993-2#2)(1993-3#2)(1993-6#4)(1994-1#9)(1994-12#1)(1994-3#1)(1994-6#1)(1994-7#2)(1994-8#1)(1995-11#1)(1995-5#5)(1995-6#1)(1995-8#5)(1996-1#3)(1996-12#1)(1996-3#5)(1996-9#1)(1997-1#3)(1997-2#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-1#1)(2004-12#4)(2005-11#1)(2005-8#1)(2006-10#1)(2006-6#3)(2006-7#1)(2007-11#8)(2007-12#9)(2007-2#1)(2007-3#2)(2007-4#3)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#14)(2008-7#6)(2008-8#2)(2009-12#2)(2009-3#1)(2009-4#2)(2009-7#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-12#2)(2011-2#6)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
schedule)##2##1##(1992-4#1)(1996-1#1)
schedule-induced polydipsia (SIP)##2##3##(1993-6#1)(1994-2#1)
schedule-induced polydipsia##3##2##(1993-6#2)(1994-2#1)
schedule-induced##4##1##(1993-6#2)(1994-2#2)
scheduled basis##2##2##(2005-8#1)(2010-12#1)
scheduled for a##5##3##(1990-12#1)(2006-10#2)(2008-2#1)(2010-5#1)
scheduled for coronary artery bypass graft##2##6##(2007-9#1)(2012-2#1)
scheduled for elective surgery##4##4##(1995-1#1)(1996-9#1)(2006-12#1)(2010-7#1)
scheduled for elective##12##3##(1993-10#1)(1995-1#1)(1996-3#1)(1996-9#1)(2006-12#1)(2007-8#1)(2007-9#1)(2010-7#1)(2011-2#2)(2013-7#1)(2013-8#1)
scheduled for laparoscopic##3##3##(2006-6#1)(2010-7#1)(2013-7#1)
scheduled for mitral valve repair##2##5##(2011-2#2)
scheduled for mitral valve##3##4##(2008-4#1)(2011-2#2)
scheduled for surgery##2##3##(1993-10#1)(2008-9#1)
scheduled for the##2##3##(2008-5#1)(2010-4#1)
scheduled for##55##2##(1990-12#1)(1991-2#1)(1991-4#1)(1993-1#2)(1993-10#2)(1994-2#1)(1995-1#1)(1995-11#1)(1996-2#1)(1996-3#1)(1996-9#1)(2005-12#1)(2006-10#3)(2006-12#2)(2006-6#1)(2007-11#1)(2007-8#4)(2007-9#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-2#6)(2012-12#1)(2012-2#2)(2013-7#2)(2013-8#1)
scheduled in the##2##3##(2005-8#1)(2008-11#1)
scheduled to attend##2##3##(1993-3#1)(2007-10#1)
scheduled to be##4##3##(1992-1#1)(2007-4#1)(2008-6#1)(2011-4#1)
scheduled to begin##3##3##(2005-7#1)(2008-5#2)
scheduled to undergo##3##3##(2006-6#1)(2008-11#1)(2011-2#1)
scheduled to##15##2##(1992-1#1)(1993-3#1)(2005-7#1)(2006-6#1)(2007-10#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-5#2)(2008-6#1)(2011-2#1)(2011-4#1)(2012-12#1)
scheduled##111##1##(1990-12#1)(1991-2#1)(1991-4#1)(1992-1#1)(1992-3#1)(1993-1#2)(1993-10#2)(1993-3#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-5#1)(2005-12#1)(2005-7#1)(2005-8#5)(2006-10#6)(2006-12#2)(2006-5#1)(2006-6#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#7)(2007-9#5)(2008-11#3)(2008-2#1)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#2)(2009-5#1)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#1)(2011-2#8)(2011-4#1)(2012-12#3)(2012-2#3)(2013-1#7)(2013-7#2)(2013-8#1)
scheduler##4##1##(2008-3#4)
schedules and##10##2##(1993-12#1)(2007-2#1)(2007-7#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-11#1)(2013-1#1)
schedules can##2##2##(2007-2#1)(2010-5#1)
schedules for##4##2##(1993-3#1)(2007-11#2)(2008-7#1)
schedules have been##2##3##(2005-11#1)(2008-10#1)
schedules have##4##2##(1992-10#2)(2005-11#1)(2008-10#1)
schedules in the##2##3##(1996-3#1)(2005-9#1)
schedules in##6##2##(1992-10#1)(1993-3#1)(1994-9#1)(1996-3#1)(2005-9#1)(2007-6#1)
schedules may##2##2##(1995-5#1)(2007-8#1)
schedules of##10##2##(1992-12#1)(1995-5#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-3#1)(2011-2#1)
schedules on##2##2##(2006-6#1)(2007-4#1)
schedules that##3##2##(2008-2#1)(2013-1#2)
schedules used##2##2##(1993-3#1)(2007-11#1)
schedules were##3##2##(1992-10#1)(2008-1#1)(2008-7#1)
schedules##104##1##(1990-12#1)(1991-12#2)(1992-10#5)(1992-12#1)(1992-2#1)(1992-3#3)(1992-8#1)(1993-12#1)(1993-3#3)(1993-9#1)(1994-9#1)(1995-5#5)(1996-3#2)(1997-8#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-6#3)(2006-7#2)(2007-11#10)(2007-12#2)(2007-2#3)(2007-4#5)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-3#2)(2009-4#1)(2009-8#1)(2010-5#1)(2010-7#1)(2011-2#6)(2012-11#1)(2012-12#1)(2013-1#5)(2013-8#1)
scheduling and##4##2##(1994-3#1)(2008-7#1)(2010-2#1)(2010-8#1)
scheduling can be a##2##4##(1994-2#1)(1996-2#1)
scheduling can##4##2##(1994-2#2)(1996-2#2)
scheduling for##2##2##(1994-2#1)(2012-1#1)
scheduling has##2##2##(2012-3#1)(2013-1#1)
scheduling in a##2##3##(1994-2#1)(1996-3#1)
scheduling in##8##2##(1994-2#1)(1996-3#1)(2007-11#1)(2008-2#2)(2008-5#1)(2013-1#2)
scheduling of##3##2##(1991-4#1)(2008-2#1)(2009-3#1)
scheduling patients##2##2##(1996-1#1)(2013-1#1)
scheduling process##6##2##(1991-2#1)(1996-1#2)(2010-8#3)
scheduling system##2##2##(1994-2#2)
scheduling##70##1##(1991-2#4)(1991-4#1)(1994-2#11)(1994-3#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-1#5)(1996-12#1)(1996-2#4)(1996-3#2)(1997-3#1)(2007-11#1)(2007-2#1)(2007-4#2)(2008-2#8)(2008-5#1)(2008-7#1)(2009-3#1)(2010-10#1)(2010-2#1)(2010-8#6)(2012-1#1)(2012-3#2)(2013-1#11)
schema and##2##2##(2010-12#1)(2013-1#1)
schema of the##2##3##(2007-11#1)(2007-12#1)
schema that##3##2##(2004-3#1)(2008-7#1)(2010-3#1)
schema##20##1##(1994-2#1)(1995-2#2)(1997-8#1)(2004-3#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-4#1)(2008-7#4)(2008-8#1)(2010-12#1)(2010-3#1)(2013-1#3)
schemas are##3##2##(2006-9#1)(2013-1#2)
schemas##11##1##(2006-9#4)(2008-7#1)(2009-12#2)(2010-7#1)(2010-8#1)(2013-1#2)
schematic##8##1##(2008-2#1)(2008-3#1)(2008-4#1)(2009-4#4)(2013-8#1)
schematically##3##1##(1997-3#1)(2008-4#1)(2008-5#1)
schematized##2##1##(1994-6#1)(2007-12#1)
scheme I##2##2##(2007-6#2)
scheme II##2##2##(2007-6#2)
scheme allows to##2##3##(2008-10#1)(2008-2#1)
scheme allows##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
scheme also provides a##2##4##(2008-2#1)(2008-3#1)
scheme also provides##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
scheme also##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
scheme and a##2##3##(2008-2#2)
scheme and the##5##3##(2008-2#2)(2008-3#1)(2013-1#2)
scheme and##20##2##(1997-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#4)(2008-3#4)(2009-12#1)(2012-3#1)(2013-1#2)
scheme are##13##2##(1991-12#1)(1995-2#1)(1995-4#1)(1996-8#1)(2006-8#1)(2007-12#3)(2008-2#4)(2008-7#1)
scheme at##3##2##(2008-7#1)(2009-10#1)(2009-8#1)
scheme based on a##2##4##(2008-10#1)(2009-3#1)
scheme based on the##4##4##(1993-9#1)(1994-10#1)(2007-9#1)(2009-11#1)
scheme based on##17##3##(1993-9#1)(1994-10#1)(1997-8#1)(2007-12#4)(2007-6#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#3)(2009-11#1)(2009-3#1)(2011-11#1)
scheme based##18##2##(1993-9#1)(1994-10#1)(1997-8#1)(2007-12#4)(2007-6#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#3)(2009-11#2)(2009-3#1)(2011-11#1)
scheme by a##2##3##(2007-12#1)(2008-3#1)
scheme by##8##2##(1994-2#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2011-2#1)
scheme can be extended##2##4##(2007-11#1)(2007-8#1)
scheme can be##6##3##(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)
scheme can provide##2##3##(2007-12#2)
scheme can##11##2##(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-5#1)
scheme developed for##2##3##(2007-12#1)(2008-3#1)
scheme first##2##2##(2006-4#1)(2010-6#1)
scheme for a##6##3##(2007-12#4)(2008-2#2)
scheme for an interferometric##2##4##(2007-12#2)
scheme for an##3##3##(2007-12#2)(2008-1#1)
scheme for calculating##2##3##(2008-3#1)(2010-3#1)
scheme for enhancing the##2##4##(2007-12#1)(2008-2#1)
scheme for generating##2##3##(2007-12#2)
scheme for measuring##2##3##(2007-12#1)(2008-3#1)
scheme for optical##2##3##(2008-1#1)(2008-2#1)
scheme for phase##2##3##(2008-2#1)(2008-3#1)
scheme for polarization-insensitive and frequency-conversion##2##5##(2007-12#2)
scheme for the interpretation of primary and secondary##2##8##(1995-2#2)
scheme for the reaction##2##4##(1994-2#1)(2005-11#1)
scheme for the##15##3##(1990-8#1)(1991-5#1)(1994-2#1)(1995-2#2)(1995-3#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2013-8#1)
scheme for##119##2##(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-9#2)(1993-4#1)(1994-2#1)(1994-7#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-8#1)(2005-11#2)(2005-8#1)(2006-11#2)(2006-8#1)(2007-1#1)(2007-11#9)(2007-12#26)(2008-1#4)(2008-10#9)(2008-11#1)(2008-2#16)(2008-3#20)(2008-5#1)(2008-6#2)(2010-3#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-8#1)
scheme has been demonstrated##2##4##(2007-12#1)(2008-10#1)
scheme has been developed for##4##5##(2007-12#1)(2008-10#1)(2008-3#2)
scheme has been developed##5##4##(2007-12#1)(2008-10#2)(2008-3#2)
scheme has been##13##3##(1996-6#1)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#4)(2012-12#1)
scheme has##16##2##(1996-6#1)(2007-12#2)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#4)(2012-12#1)(2012-2#1)(2012-3#1)
scheme improves##2##2##(2008-2#2)
scheme in which a##2##4##(2007-11#1)(2007-12#1)
scheme in which the##3##4##(2007-1#1)(2008-2#1)(2008-3#1)
scheme in which##8##3##(2006-12#1)(2007-1#1)(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)
scheme in##24##2##(1992-9#1)(1994-11#1)(1996-8#1)(2006-12#1)(2007-1#1)(2007-11#2)(2007-12#2)(2008-11#1)(2008-2#6)(2008-3#2)(2008-7#1)(2008-9#1)(2009-3#1)(2013-1#3)
scheme involved##2##2##(1990-12#1)(2008-10#1)
scheme involving the use of##2##5##(2007-8#1)(2008-10#1)
scheme involving the##3##3##(2007-12#1)(2007-8#1)(2008-10#1)
scheme involving##6##2##(2007-12#3)(2007-8#1)(2008-10#1)(2008-2#1)
scheme is also##3##3##(2006-8#1)(2007-12#1)(2008-2#1)
scheme is applied##2##3##(2007-11#1)(2012-2#1)
scheme is based on the##3##5##(2007-11#1)(2008-10#1)(2008-3#1)
scheme is demonstrated##2##3##(2008-10#1)(2008-2#1)
scheme is developed##2##3##(2008-3#1)(2008-6#1)
scheme is discussed##2##3##(1993-12#1)(2008-2#1)
scheme is employed##2##3##(2006-4#1)(2008-2#1)
scheme is not##2##3##(2008-3#1)(2010-8#1)
scheme is presented##4##3##(2007-7#1)(2008-2#2)(2009-4#1)
scheme is proposed for##2##4##(1990-7#1)(2008-3#1)
scheme is proposed to##2##4##(2007-11#1)(2009-10#1)
scheme is proposed##7##3##(1990-7#1)(2007-11#1)(2008-2#1)(2008-3#3)(2009-10#1)
scheme is robust to##2##4##(2008-2#1)(2008-3#1)
scheme is therefore##2##3##(2006-2#1)(2007-12#1)
scheme is used to##2##4##(2008-10#1)(2010-8#1)
scheme is used##3##3##(2008-10#1)(2008-2#1)(2010-8#1)
scheme is##77##2##(1990-7#1)(1992-10#1)(1992-9#1)(1993-12#2)(1995-2#1)(1995-6#1)(1997-8#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-11#3)(2007-12#5)(2007-7#1)(2008-1#2)(2008-10#6)(2008-2#19)(2008-3#18)(2008-6#1)(2009-1#1)(2009-10#2)(2009-4#2)(2010-8#2)(2012-2#4)
scheme may be##2##3##(1995-5#1)(2006-12#1)
scheme not only##2##3##(2008-2#1)(2013-8#1)
scheme of the##7##3##(1991-2#1)(1991-6#1)(1991-7#1)(1994-2#1)(2006-6#1)(2008-3#1)(2008-7#1)
scheme of##34##2##(1990-12#1)(1990-2#1)(1991-2#1)(1991-6#1)(1991-7#1)(1994-2#1)(1995-11#1)(1995-5#1)(1996-1#1)(1996-3#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-4#1)(2008-10#5)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-2#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
scheme offers a##2##3##(2007-11#1)(2008-10#1)
scheme or##2##2##(2007-12#1)(2007-4#1)
scheme permits##2##2##(2007-12#1)(2008-3#1)
scheme provides##3##2##(2007-12#2)(2008-2#1)
scheme seems to be##2##4##(2008-10#2)
scheme seems##3##2##(1992-6#1)(2008-10#2)
scheme that employs##2##3##(2008-3#2)
scheme that is capable of##2##5##(2008-3#1)(2012-2#1)
scheme that is##7##3##(1997-3#1)(2007-11#1)(2008-2#2)(2008-3#1)(2009-10#1)(2012-2#1)
scheme that uses a##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
scheme that uses##8##3##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#2)
scheme that we##2##3##(2007-11#1)(2010-8#1)
scheme that##39##2##(1996-12#1)(1997-3#1)(2007-11#4)(2007-12#5)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#8)(2008-3#8)(2008-4#1)(2008-6#1)(2009-10#1)(2009-3#1)(2009-7#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
scheme the##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
scheme to be##2##3##(2006-11#1)(2008-2#1)
scheme to study the##2##4##(2008-10#2)
scheme to the##2##3##(2008-10#1)(2008-2#1)
scheme to##28##2##(2006-11#1)(2006-12#2)(2007-12#7)(2008-10#3)(2008-11#1)(2008-2#6)(2008-3#6)(2009-5#1)(2012-2#1)
scheme used for##2##3##(2007-12#1)(2008-2#1)
scheme used##4##2##(1997-5#1)(2004-9#1)(2007-12#1)(2008-2#1)
scheme uses##2##2##(2007-12#1)(2008-2#1)
scheme using a##2##3##(2007-11#1)(2008-10#1)
scheme using##5##2##(2007-11#2)(2007-12#1)(2008-10#1)(2013-8#1)
scheme was developed##2##3##(2008-10#2)
scheme was##11##2##(1994-2#1)(2007-12#2)(2007-7#1)(2008-10#5)(2008-3#1)(2008-9#1)
scheme we##2##2##(2007-12#1)(2012-2#1)
scheme were##2##2##(2007-7#1)(2009-10#1)
scheme where##2##2##(1995-6#1)(2008-2#1)
scheme which##3##2##(1996-12#1)(2008-2#1)(2012-2#1)
scheme with a##7##3##(2007-11#2)(2007-12#3)(2008-2#2)
scheme with an##2##3##(2008-2#1)(2009-10#1)
scheme with##16##2##(1990-8#1)(1992-4#1)(2007-11#4)(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#2)(2009-10#1)
scheme##756##1##(1990-11#3)(1990-12#2)(1990-2#1)(1990-4#2)(1990-5#2)(1990-7#1)(1990-8#3)(1991-12#3)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#2)(1992-10#2)(1992-2#1)(1992-4#1)(1992-6#3)(1992-9#4)(1993-12#2)(1993-4#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#5)(1994-5#1)(1994-7#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#6)(1996-1#1)(1996-12#4)(1996-3#1)(1996-6#4)(1996-7#1)(1996-8#4)(1997-2#3)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#5)(2004-9#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-11#3)(2006-12#4)(2006-2#1)(2006-4#3)(2006-6#4)(2006-8#6)(2007-1#2)(2007-11#44)(2007-12#108)(2007-2#1)(2007-4#2)(2007-6#5)(2007-7#7)(2007-8#9)(2007-9#3)(2008-1#16)(2008-10#56)(2008-11#8)(2008-12#1)(2008-2#137)(2008-3#109)(2008-4#1)(2008-5#8)(2008-6#8)(2008-7#13)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#6)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#4)(2009-7#2)(2009-8#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-6#3)(2010-8#3)(2011-1#5)(2011-11#1)(2011-2#2)(2012-1#2)(2012-12#4)(2012-2#15)(2012-3#3)(2013-1#15)(2013-8#6)
schemes allow##2##2##(2006-12#1)(2009-6#1)
schemes and the##5##3##(1993-12#2)(1993-6#1)(2006-9#1)(2008-10#1)
schemes and##15##2##(1991-8#1)(1993-12#2)(1993-6#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#3)(2008-5#1)(2009-5#1)
schemes are presented##2##3##(1997-4#1)(2008-3#1)
schemes are##15##2##(1994-7#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-2#4)(2008-3#2)(2008-7#2)(2010-8#1)
schemes as##2##2##(1997-5#1)(2008-7#1)
schemes based on##5##3##(2007-12#2)(2008-7#1)(2010-5#1)(2013-7#1)
schemes by##2##2##(2007-11#1)(2010-12#1)
schemes can be##3##3##(1997-1#1)(2007-11#1)(2008-2#1)
schemes can##6##2##(1995-3#1)(1997-1#1)(2007-11#1)(2008-2#3)
schemes designed to##2##3##(2008-4#1)(2010-7#1)
schemes for##21##2##(1991-4#1)(1992-2#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#4)(2008-4#1)(2008-9#1)(2009-11#1)(2009-3#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
schemes have been##2##3##(2006-8#1)(2007-7#1)
schemes have##3##2##(1997-8#1)(2006-8#1)(2007-7#1)
schemes in##7##2##(2008-11#1)(2008-2#1)(2008-7#1)(2009-10#2)(2012-1#1)(2013-7#1)
schemes is##2##2##(1992-10#1)(2008-2#1)
schemes may be##2##3##(2008-10#1)(2008-11#1)
schemes may##4##2##(2006-5#1)(2008-10#1)(2008-11#1)(2008-2#1)
schemes of the##2##3##(1991-3#1)(1994-6#1)
schemes of##6##2##(1991-3#1)(1994-6#1)(2006-6#2)(2007-10#1)(2008-10#1)
schemes such as##2##3##(2008-2#1)(2008-7#1)
schemes that are used to##2##5##(1996-2#1)(2008-3#1)
schemes that are##3##3##(1996-2#1)(2008-3#2)
schemes that##7##2##(1991-12#1)(1996-2#1)(2006-10#1)(2008-3#4)
schemes to obtain##2##3##(2006-10#1)(2008-2#1)
schemes to##4##2##(2006-10#1)(2008-2#1)(2009-10#1)(2012-1#1)
schemes used##2##2##(1995-12#1)(2008-2#1)
schemes using##2##2##(2008-10#1)(2008-2#1)
schemes were##2##2##(2007-8#1)(2008-10#1)
schemes with##3##2##(2007-9#1)(2008-3#1)(2013-8#1)
schemes##206##1##(1990-3#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-8#1)(1992-10#2)(1992-2#1)(1992-3#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-7#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-11#2)(1996-2#1)(1996-5#1)(1996-8#3)(1997-1#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-10#4)(2007-11#4)(2007-12#13)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#25)(2008-11#2)(2008-2#35)(2008-3#17)(2008-4#6)(2008-5#2)(2008-7#9)(2008-9#2)(2009-10#3)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#5)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-1#3)(2012-12#1)(2013-1#2)(2013-7#2)(2013-8#1)
schiff##3##1##(2006-9#1)(2008-7#1)(2011-1#1)
schistosomal portal##3##2##(2011-12#1)(2013-8#2)
schistosomal##7##1##(1992-4#1)(1996-8#1)(2008-8#1)(2011-1#1)(2011-12#1)(2013-8#2)
schistosome infection##5##2##(1996-10#1)(2007-2#1)(2009-5#1)(2011-12#1)(2012-3#1)
schistosome##18##1##(1996-10#1)(1996-12#1)(2006-10#3)(2006-8#2)(2007-2#1)(2008-4#3)(2009-5#1)(2010-12#2)(2011-12#2)(2012-3#2)
schistosomes##13##1##(2006-10#5)(2008-4#1)(2009-5#3)(2010-9#1)(2013-1#2)(2013-8#1)
schistosomiasis alone##2##2##(1996-12#1)(2012-1#1)
schistosomiasis among##2##2##(2007-2#1)(2011-12#1)
schistosomiasis and##7##2##(2006-10#1)(2007-7#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-3#1)(2013-8#1)
schistosomiasis are##2##2##(2007-2#1)(2008-4#1)
schistosomiasis as##2##2##(1994-3#1)(1996-12#1)
schistosomiasis at the##2##3##(2007-2#1)(2008-8#1)
schistosomiasis at##3##2##(1996-12#1)(2007-2#1)(2008-8#1)
schistosomiasis by##2##2##(1996-12#1)(2007-7#1)
schistosomiasis control in##3##3##(2008-8#1)(2011-12#2)
schistosomiasis control strategy with emphasis on controlling sources of infection in lake and marshland endemic##2##15##(2012-3#2)
schistosomiasis control strategy with emphasis on##3##6##(2012-3#3)
schistosomiasis control##12##2##(1993-3#2)(2006-10#1)(2007-2#1)(2008-8#1)(2011-12#3)(2012-3#4)
schistosomiasis endemic##4##2##(2012-3#4)
schistosomiasis haematobium##2##2##(1996-12#2)
schistosomiasis has##2##2##(2006-10#1)(2012-3#1)
schistosomiasis in Shitai County##2##4##(2011-12#2)
schistosomiasis in##26##2##(1991-9#1)(1994-3#1)(1996-8#1)(2006-10#1)(2007-2#1)(2007-6#1)(2008-8#1)(2011-12#11)(2012-3#8)
schistosomiasis interventions##3##2##(2007-7#3)
schistosomiasis is##5##2##(1992-4#2)(1996-12#1)(2011-1#1)(2011-12#1)
schistosomiasis japonica in##2##3##(2012-3#2)
schistosomiasis japonica##6##2##(2008-8#2)(2012-3#4)
schistosomiasis morbidity##2##2##(2007-6#1)(2012-3#1)
schistosomiasis of##3##2##(1993-2#1)(1996-12#1)(2012-3#1)
schistosomiasis patients combined with acute hepatitis##2##6##(2012-3#2)
schistosomiasis patients##4##2##(2011-12#2)(2012-3#2)
schistosomiasis surveillance##6##2##(2012-3#6)
schistosomiasis transmission##8##2##(2006-10#2)(2008-8#2)(2011-12#1)(2012-3#3)
schistosomiasis vaccine##4##2##(2006-10#4)
schistosomiasis was##2##2##(1996-12#1)(2006-10#1)
schistosomiasis were##3##2##(1996-12#1)(2008-8#1)(2011-12#1)
schistosomiasis with##2##2##(2006-10#1)(2011-1#1)
schistosomiasis##178##1##(1990-10#1)(1990-6#2)(1991-9#1)(1992-4#2)(1993-2#1)(1993-3#2)(1993-8#1)(1994-3#4)(1996-10#1)(1996-12#23)(1996-8#2)(2006-10#24)(2007-2#7)(2007-6#4)(2007-7#5)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#10)(2009-5#2)(2010-12#1)(2011-1#5)(2011-12#31)(2011-2#1)(2012-1#4)(2012-3#39)(2013-8#2)
schistosomiasis]##5##1##(1990-10#1)(1994-3#1)(2011-12#1)(2012-3#2)
schistosomula in the##2##3##(2006-8#2)
schistosomula##3##1##(2006-8#3)
schistosomules##2##1##(2008-4#2)
schizo-affective disorder and##2##3##(2008-6#1)(2012-2#1)
schizo-obsessive subtype##4##2##(2008-3#4)
schizoaffective disorder (n =##2##4##(1996-3#1)(1997-8#1)
schizoaffective disorder and schizophrenia##2##4##(1997-8#1)(2008-8#1)
schizoaffective disorder##12##2##(1995-1#1)(1996-3#1)(1997-5#1)(1997-8#3)(2004-3#1)(2008-3#1)(2008-8#3)(2009-9#1)
schizoaffective disorder)##2##2##(1996-7#1)(1996-8#1)
schizoaffective disorders##2##2##(2004-3#1)(2008-8#1)
schizoaffective subjects##2##2##(1997-8#2)
schizoaffective##25##1##(1991-9#1)(1995-1#1)(1996-3#2)(1996-7#1)(1996-8#1)(1997-5#4)(1997-8#6)(2004-3#2)(2008-3#1)(2008-8#4)(2009-9#1)(2011-2#1)
schizoid personality disorder##2##3##(2012-12#2)
schizoid##4##1##(2007-7#1)(2012-12#3)
schizont##2##1##(1990-2#1)(2007-2#1)
schizophrenia (SZ)##4##2##(1997-5#3)(2006-9#1)
schizophrenia (n =##4##3##(1996-2#1)(1996-7#1)(1997-8#2)
schizophrenia among##2##2##(1997-8#1)(2012-12#1)
schizophrenia and AD##2##3##(2011-1#2)
schizophrenia and Alzheimer's disease##3##4##(1992-10#1)(1995-6#1)(2011-1#1)
schizophrenia and bipolar disorder##7##4##(1997-2#1)(1997-8#1)(2006-8#1)(2008-3#1)(2009-6#2)(2011-2#1)
schizophrenia and bipolar##8##3##(1997-2#1)(1997-5#1)(1997-8#1)(2006-8#1)(2008-3#1)(2009-6#2)(2011-2#1)
schizophrenia and depression##3##3##(2005-7#1)(2005-8#1)(2012-1#1)
schizophrenia and in##2##3##(2007-7#1)(2011-2#1)
schizophrenia and other##4##3##(1997-2#1)(2008-5#1)(2013-8#2)
schizophrenia and schizoaffective disorder##2##4##(2004-3#1)(2008-8#1)
schizophrenia and schizoaffective##3##3##(2004-3#1)(2008-8#2)
schizophrenia and the##2##3##(1995-12#1)(1997-2#1)
schizophrenia and##78##2##(1991-4#1)(1992-10#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-7#3)(1996-8#1)(1997-2#6)(1997-5#3)(1997-8#2)(2004-3#1)(2005-6#1)(2005-7#3)(2005-8#2)(2006-3#1)(2006-8#1)(2007-7#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-8#2)(2009-10#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#6)(2011-2#5)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#2)
schizophrenia are##4##2##(1996-8#1)(1997-8#1)(2006-3#1)(2012-11#1)
schizophrenia because##3##2##(1993-9#1)(1997-8#1)(2009-9#1)
schizophrenia brain##2##2##(1993-9#2)
schizophrenia but##3##2##(1997-8#1)(2008-7#1)(2009-12#1)
schizophrenia could##2##2##(1997-8#1)(2012-3#1)
schizophrenia delusions##2##2##(2009-4#2)
schizophrenia genetics##3##2##(2010-1#1)(2012-11#2)
schizophrenia group had##3##3##(1997-8#2)(2013-1#1)
schizophrenia group##7##2##(1997-8#3)(2004-11#2)(2013-1#2)
schizophrenia has been##3##3##(2005-6#1)(2007-7#1)(2008-3#1)
schizophrenia has##8##2##(1996-11#2)(2005-6#1)(2007-7#2)(2007-8#1)(2008-3#1)(2012-12#1)
schizophrenia have been##2##3##(1995-12#1)(2010-1#1)
schizophrenia have##5##2##(1995-1#1)(1995-12#1)(2005-6#1)(2009-6#1)(2010-1#1)
schizophrenia in a##2##3##(1995-11#1)(2006-2#1)
schizophrenia in late life##2##4##(1996-3#2)
schizophrenia in the UK##2##4##(2006-12#2)
schizophrenia in the elderly##2##4##(2008-8#2)
schizophrenia in the##11##3##(1995-11#1)(1997-2#2)(1997-5#1)(1997-8#1)(2006-12#2)(2008-8#2)(2011-1#2)
schizophrenia in##25##2##(1994-12#1)(1995-11#2)(1996-2#1)(1996-3#2)(1996-5#1)(1997-2#2)(1997-5#2)(1997-8#3)(2006-12#2)(2006-2#1)(2006-9#1)(2008-8#2)(2009-6#1)(2010-12#1)(2011-1#2)(2012-2#1)
schizophrenia is associated with##2##4##(1995-12#1)(1997-8#1)
schizophrenia is the##2##3##(2006-2#1)(2008-2#1)
schizophrenia is##19##2##(1990-11#1)(1993-9#2)(1995-12#1)(1995-8#1)(1996-3#2)(1997-8#3)(2006-2#1)(2006-3#2)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-9#1)(2011-2#1)
schizophrenia may##2##2##(1997-8#1)(2008-4#1)
schizophrenia of##2##2##(1996-5#1)(2012-11#1)
schizophrenia on##4##2##(1997-8#1)(2008-11#1)(2011-1#1)(2013-1#1)
schizophrenia or affective disorder##2##4##(1995-11#2)
schizophrenia or affective##3##3##(1995-11#2)(2008-9#1)
schizophrenia or other##5##3##(1992-8#1)(2011-2#4)
schizophrenia or schizoaffective disorder##3##4##(1995-1#1)(2008-3#1)(2009-9#1)
schizophrenia or schizoaffective##5##3##(1995-1#1)(1996-7#1)(2004-3#1)(2008-3#1)(2009-9#1)
schizophrenia or##16##2##(1992-8#1)(1995-1#1)(1995-11#2)(1996-7#1)(1997-8#1)(2004-3#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-9#1)(2011-2#4)
schizophrenia patients and##4##3##(2006-4#2)(2012-12#1)(2012-2#1)
schizophrenia patients with##2##3##(1997-8#1)(2011-1#1)
schizophrenia patients##23##2##(1995-12#1)(1997-5#1)(1997-8#2)(2004-11#1)(2005-8#1)(2006-4#4)(2006-9#2)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#6)(2012-3#1)
schizophrenia per##2##2##(1996-5#1)(2007-8#1)
schizophrenia remain##2##2##(1996-7#1)(2008-6#1)
schizophrenia research##3##2##(1995-1#1)(2006-3#1)(2011-1#1)
schizophrenia showing##2##2##(2009-10#1)(2012-2#1)
schizophrenia spectrum disorders##5##3##(2008-6#1)(2011-2#4)
schizophrenia spectrum##7##2##(1995-11#1)(2004-3#1)(2008-6#1)(2011-2#4)
schizophrenia subjects##2##2##(1997-2#2)
schizophrenia that are##2##3##(2008-4#1)(2009-7#1)
schizophrenia that##4##2##(2008-4#1)(2009-7#1)(2011-2#1)(2012-2#1)
schizophrenia to##4##2##(1997-2#1)(1997-5#2)(2008-1#1)
schizophrenia treated with##3##3##(2007-7#1)(2008-7#2)
schizophrenia treated##4##2##(2007-7#1)(2008-7#2)(2012-3#1)
schizophrenia using##2##2##(1996-3#1)(2010-1#1)
schizophrenia was##5##2##(1993-9#1)(1995-11#1)(2007-3#1)(2008-3#1)(2011-2#1)
schizophrenia were compared##2##3##(1997-8#2)
schizophrenia were##10##2##(1996-1#1)(1996-5#1)(1997-8#4)(2008-11#1)(2008-6#1)(2009-7#1)(2013-1#1)
schizophrenia who##4##2##(1996-8#1)(2005-10#1)(2007-7#1)(2009-9#1)
schizophrenia##708##1##(1990-11#1)(1990-12#1)(1990-2#1)(1991-2#1)(1991-4#1)(1991-9#3)(1992-10#1)(1992-8#1)(1993-3#1)(1993-5#1)(1993-6#3)(1993-9#11)(1994-12#1)(1995-1#10)(1995-11#23)(1995-12#17)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#5)(1996-1#9)(1996-11#3)(1996-2#4)(1996-3#18)(1996-5#17)(1996-6#6)(1996-7#19)(1996-8#13)(1997-2#26)(1997-5#24)(1997-8#62)(2004-11#7)(2004-12#2)(2004-3#5)(2005-10#5)(2005-6#6)(2005-7#12)(2005-8#6)(2006-12#3)(2006-2#2)(2006-3#26)(2006-4#6)(2006-8#4)(2006-9#27)(2007-1#1)(2007-10#1)(2007-3#3)(2007-7#10)(2007-8#9)(2007-9#1)(2008-1#10)(2008-11#3)(2008-2#7)(2008-3#7)(2008-4#10)(2008-5#2)(2008-6#13)(2008-7#4)(2008-8#4)(2008-9#4)(2009-10#3)(2009-11#1)(2009-12#4)(2009-4#6)(2009-6#5)(2009-7#9)(2009-9#12)(2010-1#8)(2010-11#1)(2010-12#4)(2010-2#2)(2010-6#7)(2010-7#1)(2010-9#1)(2011-1#34)(2011-12#1)(2011-2#36)(2011-3#1)(2012-1#11)(2012-11#7)(2012-12#11)(2012-2#30)(2012-3#5)(2013-1#12)(2013-7#2)(2013-8#6)
schizophrenia?##4##1##(1997-8#1)(2006-3#1)(2007-8#1)(2008-11#1)
schizophrenia]##7##1##(2008-9#1)(2009-10#1)(2009-4#1)(2012-1#1)(2012-12#2)(2013-7#1)
schizophrenic and bipolar I disorder##2##5##(1997-5#2)
schizophrenic and control subjects##3##4##(1995-11#3)
schizophrenic and##10##2##(1993-5#1)(1995-11#3)(1995-5#1)(1996-3#1)(1997-2#1)(1997-5#2)(1997-8#1)
schizophrenic disorders##2##2##(1997-2#1)(1997-8#1)
schizophrenic group##6##2##(1995-11#1)(1996-3#2)(1996-7#2)(2013-1#1)
schizophrenic groups##3##2##(1996-3#1)(1996-8#2)
schizophrenic individuals##2##2##(1995-4#2)
schizophrenic men##3##2##(1996-3#2)(1997-8#1)
schizophrenic patient##3##2##(1993-2#1)(2006-3#1)(2008-7#1)
schizophrenic patients (n =##2##4##(1996-7#1)(1996-8#1)
schizophrenic patients and##6##3##(1995-5#2)(1996-3#2)(2008-6#1)(2013-1#1)
schizophrenic patients from##2##3##(1995-11#1)(1996-3#1)
schizophrenic patients had##2##3##(1990-1#1)(1997-5#1)
schizophrenic patients have##2##3##(1995-11#1)(1997-8#1)
schizophrenic patients may##2##3##(1996-7#1)(2008-6#1)
schizophrenic patients on##2##3##(1996-3#1)(2008-6#1)
schizophrenic patients sharing the rare allele##2##6##(1997-2#2)
schizophrenic patients sharing##3##3##(1997-2#3)
schizophrenic patients than in##3##4##(1996-1#1)(1996-5#1)(1996-7#1)
schizophrenic patients treated with##2##4##(2007-7#1)(2012-1#1)
schizophrenic patients was##3##3##(1995-11#1)(1996-8#1)(2006-3#1)
schizophrenic patients were##5##3##(1995-11#1)(1996-3#1)(1996-8#2)(2008-12#1)
schizophrenic patients who##2##3##(1996-8#1)(1997-2#1)
schizophrenic patients with##3##3##(1997-2#1)(1997-8#1)(2008-6#1)
schizophrenic patients##94##2##(1990-1#1)(1994-11#1)(1995-1#2)(1995-11#4)(1995-12#1)(1995-5#4)(1996-1#5)(1996-2#1)(1996-3#9)(1996-5#2)(1996-7#7)(1996-8#7)(1997-2#10)(1997-5#1)(1997-6#1)(1997-8#7)(2004-11#1)(2006-3#6)(2007-7#1)(2008-12#5)(2008-6#6)(2008-9#1)(2009-9#2)(2010-2#1)(2011-2#1)(2012-1#3)(2013-1#4)
schizophrenic psychosis##3##2##(1996-2#1)(1996-5#1)(2007-1#1)
schizophrenic spectrum##3##2##(2012-12#3)
schizophrenic subjects performed##2##3##(1996-3#2)
schizophrenic subjects##10##2##(1995-11#1)(1996-3#3)(1996-5#1)(1996-7#1)(1997-2#1)(1997-8#3)
schizophrenic symptoms##3##2##(1996-5#1)(1997-8#1)(2007-8#1)
schizophrenic##174##1##(1990-1#1)(1990-11#2)(1992-12#1)(1993-2#1)(1993-5#1)(1994-11#1)(1995-1#2)(1995-11#12)(1995-12#1)(1995-4#3)(1995-5#5)(1995-7#1)(1996-1#6)(1996-10#3)(1996-11#1)(1996-2#2)(1996-3#18)(1996-5#6)(1996-7#11)(1996-8#11)(1997-2#15)(1997-5#4)(1997-6#1)(1997-8#17)(2004-11#1)(2006-3#7)(2006-9#1)(2007-1#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#5)(2008-6#6)(2008-7#1)(2008-9#2)(2009-9#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-12#3)(2012-2#3)(2013-1#5)
schizophrenics and controls##2##3##(1997-2#1)(1997-5#1)
schizophrenics and normal controls##2##4##(1997-2#1)(2006-3#1)
schizophrenics and the##2##3##(1997-2#1)(2010-2#1)
schizophrenics and##7##2##(1997-2#4)(1997-5#1)(2006-3#1)(2010-2#1)
schizophrenics in##2##2##(1997-2#1)(1997-5#1)
schizophrenics with##2##2##(1997-5#2)
schizophrenics##29##1##(1993-3#2)(1995-1#1)(1995-4#1)(1996-11#2)(1996-5#1)(1997-2#7)(1997-5#4)(1997-8#2)(2004-11#1)(2006-3#4)(2007-8#1)(2008-10#1)(2010-2#1)(2012-12#1)
schizophreniform disorder##6##2##(1995-11#4)(1996-8#1)(2012-2#1)
schizophreniform##11##1##(1991-9#1)(1995-11#5)(1995-5#1)(1996-8#2)(2004-12#1)(2012-2#1)
schizophyllan and##4##2##(1991-12#2)(2006-12#2)
schizophyllan forms a complex with##2##5##(2006-12#2)
schizophyllan##11##1##(1991-12#4)(2006-12#7)
schizotypal personality disorder (SPD)##2##4##(1995-11#1)(2008-1#1)
schizotypal personality disorder##4##3##(1995-11#2)(2006-9#1)(2008-1#1)
schizotypal personality##11##2##(1995-1#3)(1995-11#2)(1997-8#4)(2006-9#1)(2008-1#1)
schizotypal traits##3##2##(2008-1#3)
schizotypal##15##1##(1995-1#3)(1995-11#2)(1997-8#4)(2006-8#1)(2006-9#1)(2008-1#4)
schizotypy and##3##2##(1997-8#1)(2006-3#2)
schizotypy##8##1##(1995-1#1)(1997-8#4)(2006-3#2)(2008-1#1)
schlieren##3##1##(2008-2#1)(2008-3#2)
schneideri##2##1##(2010-3#2)
scholar##8##1##(1995-6#1)(2006-12#1)(2009-10#1)(2011-1#2)(2012-3#1)(2013-1#2)
scholarly journals##2##2##(2008-8#1)(2012-12#1)
scholarly paper##2##2##(2005-12#2)
scholarly recognition##2##2##(2012-3#2)
scholarly work##2##2##(2008-7#1)(2009-2#1)
scholarly##26##1##(1995-12#1)(1996-12#1)(2005-12#3)(2006-1#1)(2006-7#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-7#2)(2011-1#2)(2012-12#1)(2012-3#4)
scholars have##2##2##(2006-10#1)(2006-12#1)
scholars of##2##2##(2008-1#1)(2009-5#1)
scholars##24##1##(1996-2#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-4#3)(2007-9#1)(2008-1#3)(2008-10#1)(2008-12#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
scholarship is##3##2##(2007-4#1)(2009-10#1)(2011-1#1)
scholarship on##2##2##(2009-12#1)(2013-8#1)
scholarship##17##1##(1991-7#1)(1996-12#1)(2005-12#2)(2007-10#1)(2007-2#1)(2007-4#4)(2007-6#1)(2008-3#1)(2009-10#1)(2009-12#2)(2011-1#1)(2013-8#1)
scholarships##3##1##(1997-2#1)(2010-3#2)
scholastic##4##1##(1996-1#1)(2007-1#1)(2012-2#1)(2013-1#1)
schomburgkii##2##1##(2013-7#2)
school absences##2##2##(2011-12#1)(2013-1#1)
school adolescents##2##2##(2011-1#2)
school age children##5##3##(2006-3#1)(2008-3#1)(2012-1#1)(2012-2#2)
school age##9##2##(1992-7#1)(2006-10#1)(2006-3#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-2#2)
school and a##2##3##(2008-1#1)(2011-2#1)
school and university##3##3##(2008-1#1)(2010-2#1)(2012-12#1)
school and work##2##3##(2007-2#1)(2010-2#1)
school and##33##2##(1991-8#1)(1993-8#1)(1994-12#1)(1994-4#1)(1996-12#1)(2006-10#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2008-1#3)(2008-11#2)(2009-2#1)(2009-7#1)(2009-9#1)(2010-2#3)(2011-2#2)(2012-11#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
school as##2##2##(2008-2#1)(2009-7#1)
school at##2##2##(1992-1#1)(2008-8#1)
school attendance##2##2##(2007-3#1)(2008-9#1)
school authorities##2##2##(2010-12#1)(2013-1#1)
school based##3##2##(2006-7#1)(2012-2#2)
school behavior were##2##3##(2011-1#2)
school burnout and depressive symptoms##4##5##(2009-9#4)
school burnout and##5##3##(2009-9#5)
school burnout##8##2##(2009-9#8)
school but##2##2##(1991-6#1)(2006-1#1)
school catering##2##2##(2007-1#2)
school children aged##2##3##(2006-1#1)(2012-2#1)
school children and##4##3##(1996-7#1)(2006-8#2)(2007-2#1)
school children from##4##3##(1993-6#1)(2007-12#2)(2010-9#1)
school children in a##3##4##(1994-12#1)(2007-2#1)(2012-2#1)
school children in##21##3##(1992-8#1)(1994-12#1)(2006-12#1)(2007-1#2)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#3)(2008-7#2)(2009-2#1)(2010-8#1)(2011-2#2)(2012-2#2)(2013-8#1)
school children of##9##3##(2007-1#1)(2007-2#1)(2007-7#2)(2008-1#1)(2009-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
school children were##3##3##(1991-9#1)(2007-1#2)
school children##78##2##(1991-9#3)(1992-1#1)(1992-6#1)(1992-8#2)(1993-6#2)(1993-8#1)(1994-12#1)(1996-7#1)(2006-1#1)(2006-12#1)(2006-2#1)(2006-7#2)(2006-8#2)(2007-1#9)(2007-12#3)(2007-2#10)(2007-4#2)(2007-6#1)(2007-7#3)(2008-1#3)(2008-10#3)(2008-12#1)(2008-7#2)(2009-2#1)(2009-7#2)(2009-9#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#6)(2013-7#1)(2013-8#2)
school classes##7##2##(1991-5#2)(1995-5#1)(2006-7#1)(2010-1#3)
school classrooms##2##2##(2009-7#1)(2010-8#1)
school connectedness##6##2##(2009-7#6)
school curricula##3##2##(1994-1#1)(2011-2#1)(2012-3#1)
school curriculum##7##2##(1996-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-3#1)(2009-11#1)(2012-3#1)
school day##2##2##(1996-3#1)(2006-10#1)
school district##4##2##(1991-12#1)(2007-12#1)(2009-8#2)
school districts in##2##3##(2007-12#1)(2008-6#1)
school districts##4##2##(2007-12#1)(2007-9#1)(2008-11#1)(2008-6#1)
school dropout##6##2##(2005-10#3)(2012-11#1)(2012-12#1)(2013-1#1)
school dropouts##2##2##(2006-8#1)(2007-10#1)
school education##6##2##(1991-10#1)(1992-5#1)(2007-11#1)(2007-7#1)(2008-9#1)(2011-2#1)
school engagement##6##2##(2009-7#6)
school entry and##2##3##(2008-2#1)(2011-1#1)
school entry##4##2##(2008-11#1)(2008-2#1)(2009-8#1)(2011-1#1)
school environment##5##2##(2006-7#1)(2007-10#1)(2009-7#2)(2009-8#1)
school environments##3##2##(1996-3#1)(2010-1#1)(2010-5#1)
school for the##3##3##(2007-7#1)(2010-3#1)(2013-1#1)
school for##9##2##(1990-3#1)(1991-5#1)(1992-1#1)(2007-7#1)(2010-3#1)(2010-5#1)(2011-2#1)(2013-1#2)
school going children in##2##4##(2007-7#1)(2008-7#1)
school going children of##3##4##(2007-7#1)(2011-1#1)(2012-2#1)
school going children##9##3##(2007-7#2)(2008-7#1)(2011-1#1)(2012-2#4)(2012-3#1)
school going##11##2##(2006-4#2)(2007-7#2)(2008-7#1)(2011-1#1)(2012-2#4)(2012-3#1)
school graduates are##2##3##(1992-8#1)(2008-1#1)
school graduates##3##2##(1992-8#1)(2008-1#1)(2009-4#1)
school group##3##2##(1990-12#2)(1991-5#1)
school had##2##2##(1996-6#1)(2007-10#1)
school health personnel##2##3##(2008-10#2)
school health policies##2##3##(2009-8#2)
school health program##3##3##(1996-10#1)(2009-8#2)
school health##21##2##(1990-6#2)(1996-10#1)(2006-12#1)(2006-4#1)(2006-8#1)(2008-10#2)(2009-8#12)(2013-7#1)
school in Europe##2##3##(2010-12#1)(2013-8#1)
school in the##2##3##(2009-1#1)(2013-8#1)
school in##18##2##(1993-1#1)(1995-4#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-1#1)(2009-5#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#4)
school maintenance##2##2##(1991-12#2)
school nurses##4##2##(2006-7#1)(2010-5#3)
school nutrition##2##2##(2012-2#2)
school of nursing##4##3##(2006-5#1)(2008-11#1)(2008-12#1)(2010-3#1)
school of thought##3##3##(1997-2#1)(2006-9#1)(2013-8#1)
school of##20##2##(1993-5#1)(1997-2#1)(2006-10#1)(2006-4#2)(2006-5#1)(2006-9#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-2#1)(2009-2#1)(2009-9#1)(2010-3#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
school or##7##2##(2008-11#1)(2009-7#1)(2009-9#2)(2010-7#1)(2011-2#1)(2013-7#1)
school outcomes##3##2##(2008-12#1)(2009-7#1)(2012-2#1)
school performance##9##2##(2006-8#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-7#2)(2013-1#1)
school personnel##2##2##(2006-7#1)(2012-12#1)
school population##4##2##(1995-10#1)(1995-2#1)(2007-9#1)(2011-2#1)
school principals##2##2##(2007-7#1)(2012-2#1)
school professionals##3##2##(2008-12#3)
school psychology##2##2##(2008-12#1)(2008-2#1)
school pupils##4##2##(1992-8#2)(1996-6#1)(2011-2#1)
school readiness##5##2##(2008-11#1)(2008-12#3)(2010-7#1)
school reintegration intervention##2##3##(1993-1#2)
school reintegration##4##2##(1993-1#4)
school setting##8##2##(1990-5#1)(1992-3#1)(1997-2#1)(2004-10#2)(2008-10#1)(2008-11#1)(2012-12#1)
school settings##5##2##(1996-3#1)(2007-10#2)(2007-9#1)(2012-2#1)
school student##3##2##(2008-5#1)(2011-2#1)(2012-12#1)
school students (N =##2##4##(2006-7#2)
school students in Maputo##2##4##(2006-7#2)
school students in##16##3##(2006-7#2)(2007-5#1)(2008-12#2)(2008-6#1)(2012-12#2)(2013-1#4)(2013-7#4)
school students were##3##3##(2008-1#1)(2010-2#1)(2011-1#1)
school students##74##2##(1990-12#1)(1990-2#1)(1993-3#1)(2004-8#1)(2005-10#1)(2006-2#1)(2006-7#8)(2006-9#1)(2007-1#2)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#2)(2008-10#1)(2008-12#2)(2008-6#1)(2008-7#2)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-1#1)(2010-12#6)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#10)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#5)(2013-8#2)
school survey##2##2##(2010-9#1)(2012-12#1)
school teachers##13##2##(1991-12#4)(2005-9#1)(2008-12#1)(2009-5#1)(2012-2#5)(2012-3#1)
school that##3##2##(1990-3#1)(2007-5#1)(2010-4#1)
school to##5##2##(1994-6#1)(2008-7#1)(2010-2#1)(2012-2#1)(2012-3#1)
school was##2##2##(1997-3#1)(2012-3#1)
school were##2##2##(2007-7#1)(2012-2#1)
school with##2##2##(2008-7#1)(2009-7#1)
school year##9##2##(2008-12#4)(2008-7#1)(2008-9#1)(2010-1#1)(2010-3#1)(2010-8#1)
school years##9##2##(1991-10#1)(2006-7#1)(2006-8#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-2#1)(2010-4#1)
school##794##1##(1990-10#1)(1990-12#4)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#4)(1990-8#1)(1991-10#2)(1991-11#2)(1991-12#11)(1991-2#3)(1991-3#2)(1991-5#5)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#3)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#5)(1993-1#10)(1993-10#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#5)(1993-8#2)(1994-1#3)(1994-12#3)(1994-4#4)(1994-6#4)(1995-1#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-3#3)(1996-4#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#2)(2004-10#2)(2004-12#1)(2004-8#2)(2005-10#6)(2005-11#1)(2005-9#1)(2006-1#2)(2006-10#6)(2006-12#2)(2006-2#3)(2006-3#4)(2006-4#6)(2006-5#4)(2006-6#2)(2006-7#22)(2006-8#12)(2006-9#3)(2007-1#16)(2007-10#8)(2007-11#3)(2007-12#13)(2007-2#18)(2007-3#2)(2007-4#8)(2007-5#3)(2007-6#2)(2007-7#12)(2007-8#1)(2007-9#9)(2008-1#19)(2008-10#13)(2008-11#17)(2008-12#39)(2008-2#14)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#5)(2008-7#15)(2008-8#3)(2008-9#7)(2009-1#2)(2009-11#4)(2009-12#3)(2009-2#4)(2009-3#1)(2009-4#4)(2009-5#6)(2009-7#41)(2009-8#20)(2009-9#16)(2010-1#10)(2010-10#2)(2010-12#11)(2010-2#5)(2010-3#4)(2010-4#4)(2010-5#12)(2010-7#6)(2010-8#7)(2010-9#2)(2011-1#17)(2011-12#3)(2011-2#21)(2012-1#1)(2012-11#6)(2012-12#28)(2012-2#46)(2012-3#16)(2013-1#28)(2013-7#12)(2013-8#13)
school's##2##1##(1996-1#1)(2008-12#1)
school) and##2##2##(1997-4#1)(2010-1#1)
school)##3##1##(1997-4#1)(2010-1#1)(2010-4#1)
school-age child with##2##3##(2006-10#1)(2012-12#1)
school-age children 7-14 years##2##4##(2011-2#2)
school-age children anticipating##2##3##(1995-1#2)
school-age children in##3##3##(2007-2#1)(2009-9#1)(2011-2#1)
school-age children##16##2##(1991-2#2)(1994-12#1)(1994-6#1)(1995-1#2)(2006-4#1)(2007-2#2)(2009-9#1)(2011-1#1)(2011-12#1)(2011-2#4)
school-age##23##1##(1991-2#3)(1993-12#1)(1994-12#1)(1994-6#1)(1995-1#2)(1995-12#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-2#2)(2009-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#1)
school-aged children during##2##3##(1992-2#1)(1992-5#1)
school-aged children with##2##3##(2008-9#1)(2009-4#1)
school-aged children##12##2##(1992-2#2)(1992-5#1)(1993-3#1)(2006-10#1)(2007-2#1)(2008-9#1)(2009-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
school-aged##18##1##(1992-12#1)(1992-2#2)(1992-5#1)(1993-3#1)(2006-10#1)(2007-2#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-9#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
school-based childhood obesity prevention programs##2##5##(2009-6#1)(2012-2#1)
school-based health centers (SBHCs)##2##4##(2009-8#2)
school-based health centers##6##3##(2009-8#6)
school-based health##8##2##(2009-8#8)
school-based intervention##4##2##(2007-10#1)(2010-2#1)(2010-9#1)(2012-3#1)
school-based programs##2##2##(2009-6#1)(2012-1#1)
school-based##46##1##(1993-1#1)(1995-12#2)(2006-6#2)(2006-7#2)(2007-10#1)(2007-4#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-6#3)(2009-7#1)(2009-8#9)(2010-11#1)(2010-12#1)(2010-2#5)(2010-9#1)(2011-1#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#2)
school-children##3##1##(2007-2#1)(2011-1#2)
school-entry##2##1##(2008-4#2)
school-going##3##1##(2007-7#2)(2009-4#1)
school-level##2##1##(2009-7#2)
school-related##3##1##(1991-2#1)(2008-12#1)(2009-7#1)
school]##3##1##(1994-4#1)(2005-9#1)(2013-1#1)
schoolchildren aged##3##2##(1990-3#1)(2006-2#1)(2008-1#1)
schoolchildren and##3##2##(2004-12#1)(2006-10#1)(2011-1#1)
schoolchildren from##2##2##(1994-6#1)(2012-2#1)
schoolchildren in the United Arab Emirates##2##6##(2007-3#2)
schoolchildren in the##5##3##(1993-11#1)(2006-10#1)(2007-3#2)(2013-1#1)
schoolchildren in##13##2##(1990-3#1)(1993-11#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-3#2)(2009-4#1)(2010-8#2)(2012-2#1)(2013-1#1)(2013-7#1)
schoolchildren living in##2##3##(2005-8#1)(2006-4#1)
schoolchildren of##2##2##(1996-5#1)(2006-4#1)
schoolchildren were##2##2##(2010-8#2)
schoolchildren##54##1##(1990-3#3)(1991-6#1)(1992-6#1)(1993-11#1)(1994-12#1)(1994-6#1)(1996-11#2)(1996-5#1)(2004-12#1)(2005-8#2)(2006-1#2)(2006-10#5)(2006-2#3)(2006-4#4)(2007-3#3)(2007-4#1)(2008-1#2)(2009-4#1)(2010-12#1)(2010-8#6)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#4)(2013-7#2)(2013-8#1)
schoolgirls##2##1##(1995-6#1)(2007-12#1)
schooling and##2##2##(2008-9#1)(2009-4#1)
schooling##20##1##(1997-7#1)(2007-7#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-3#2)(2011-1#6)(2013-1#1)
schools about##2##2##(2007-5#1)(2008-5#1)
schools and from##2##3##(2012-12#1)(2013-1#1)
schools and health##2##3##(1997-3#1)(2008-9#1)
schools and teachers##2##3##(2008-12#2)
schools and the##2##3##(2008-2#1)(2008-7#1)
schools and##30##2##(1991-8#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-8#1)(1997-3#1)(2005-12#1)(2006-8#2)(2007-12#1)(2007-2#4)(2007-4#1)(2008-12#2)(2008-2#1)(2008-7#1)(2008-9#4)(2009-2#1)(2010-12#1)(2010-5#1)(2011-12#1)(2012-12#2)(2013-1#1)
schools are##7##2##(2008-10#1)(2008-6#1)(2009-7#1)(2009-8#2)(2012-3#2)
schools as##5##2##(2007-7#2)(2008-12#1)(2009-7#1)(2010-2#1)
schools can##2##2##(2007-4#1)(2012-12#1)
schools currently##2##2##(1994-2#1)(1997-3#1)
schools during##2##2##(2007-2#1)(2013-1#1)
schools for##2##2##(1996-6#1)(2008-7#1)
schools has##2##2##(1991-2#1)(1992-6#1)
schools have##3##2##(1994-1#1)(2008-12#1)(2013-1#1)
schools in Fiji##2##3##(2008-1#2)
schools in Nigeria##2##3##(2007-1#1)(2009-10#1)
schools in Norway##2##3##(1991-6#1)(2009-9#1)
schools in the United##2##4##(2007-12#1)(2013-1#1)
schools in the##13##3##(2007-12#1)(2007-4#1)(2007-7#2)(2008-12#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-7#2)(2011-1#1)(2012-3#1)(2013-1#1)
schools in##57##2##(1991-10#1)(1991-11#1)(1991-12#2)(1991-6#1)(1993-6#1)(1996-1#1)(1996-3#1)(2005-9#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#4)(2008-1#2)(2008-10#2)(2008-12#2)(2008-7#1)(2008-9#2)(2009-10#2)(2009-2#2)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#2)(2010-8#1)(2011-1#4)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#2)
schools is##3##2##(2007-4#1)(2012-12#1)(2012-3#1)
schools must be##2##3##(2008-10#1)(2012-3#1)
schools must##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
schools of medicine##5##3##(1991-1#1)(1991-6#1)(1994-3#1)(2007-4#1)(2008-12#1)
schools of nursing are##4##4##(2005-12#1)(2008-12#2)(2010-8#1)
schools of nursing for##2##4##(2006-12#1)(2008-12#1)
schools of nursing have##2##4##(2008-1#1)(2011-2#1)
schools of nursing##15##3##(2005-12#1)(2006-12#1)(2006-5#2)(2007-8#2)(2008-1#2)(2008-11#1)(2008-12#4)(2010-8#1)(2011-2#1)
schools of pharmacy##3##3##(2010-3#2)(2011-2#1)
schools of public health##12##4##(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#2)(1997-2#3)(1997-3#2)
schools of the##3##3##(2007-2#2)(2008-3#1)
schools of##51##2##(1991-1#1)(1991-2#1)(1991-6#1)(1991-8#1)(1994-2#1)(1994-3#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#2)(1997-2#3)(1997-3#2)(2005-12#1)(2006-12#1)(2006-5#2)(2007-2#3)(2007-4#1)(2007-8#2)(2008-1#2)(2008-11#1)(2008-12#5)(2008-3#1)(2009-4#1)(2010-3#2)(2010-8#2)(2011-1#2)(2011-2#3)(2012-12#1)(2013-1#2)(2013-7#1)
schools or##2##2##(2008-2#1)(2011-2#1)
schools reported##2##2##(2007-10#1)(2010-1#1)
schools should##3##2##(1993-10#1)(2007-7#1)(2013-8#1)
schools through##2##2##(1993-6#1)(2008-12#1)
schools to##6##2##(2007-4#1)(2008-12#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-2#1)
schools was##2##2##(1993-6#1)(2008-9#1)
schools were##7##2##(1991-10#1)(2007-1#1)(2007-10#1)(2008-9#1)(2009-10#1)(2010-2#1)(2012-12#1)
schools will##2##2##(2006-2#1)(2009-6#1)
schools with##4##2##(1991-8#1)(2009-7#1)(2010-2#2)
schools within the##2##3##(2006-8#1)(2013-1#1)
schools within##4##2##(2006-8#1)(2007-6#1)(2013-1#1)(2013-8#1)
schools##370##1##(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#5)(1991-2#4)(1991-6#3)(1991-8#3)(1992-5#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-6#7)(1993-8#2)(1994-1#1)(1994-12#3)(1994-2#3)(1994-3#1)(1994-4#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-1#4)(1996-12#1)(1996-2#1)(1996-3#4)(1996-6#1)(1997-2#5)(1997-3#4)(1997-6#1)(1997-8#1)(2004-10#1)(2005-12#2)(2005-8#1)(2005-9#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-7#4)(2006-8#3)(2007-1#3)(2007-10#6)(2007-11#1)(2007-12#5)(2007-2#12)(2007-3#3)(2007-4#10)(2007-5#2)(2007-6#3)(2007-7#10)(2007-8#2)(2007-9#4)(2008-1#9)(2008-10#9)(2008-11#1)(2008-12#23)(2008-2#4)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#17)(2009-10#5)(2009-11#1)(2009-2#8)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#12)(2009-8#5)(2009-9#1)(2010-1#3)(2010-10#1)(2010-12#3)(2010-2#6)(2010-3#3)(2010-5#2)(2010-8#3)(2010-9#1)(2011-1#11)(2011-12#1)(2011-2#12)(2012-1#2)(2012-12#13)(2012-2#8)(2012-3#12)(2013-1#20)(2013-7#3)(2013-8#3)
schools'##3##1##(2012-2#2)(2013-7#1)
schools]##3##1##(1990-10#1)(1993-6#1)(2007-9#1)
schoolwork help was##2##3##(2009-7#2)
schoolwork##3##1##(2009-7#2)(2010-9#1)
schubertii##2##1##(2007-8#2)
schwann cells##3##2##(2008-1#1)(2012-12#1)(2013-8#1)
schwannoma and##3##2##(2008-9#1)(2010-11#2)
schwannoma in a##2##3##(2012-12#1)(2012-3#1)
schwannoma in##5##2##(2009-3#1)(2012-12#3)(2012-3#1)
schwannoma is##7##2##(2006-12#1)(2008-7#2)(2009-3#1)(2012-12#2)(2013-1#1)
schwannoma of the mesentery##2##4##(1991-4#2)
schwannoma of the##18##3##(1991-4#2)(1997-8#2)(2006-12#2)(2007-8#3)(2008-6#1)(2008-8#2)(2009-3#3)(2011-2#1)(2012-12#1)(2012-3#1)
schwannoma of##19##2##(1991-4#2)(1997-8#2)(2006-12#2)(2007-8#3)(2008-6#1)(2008-8#2)(2009-3#3)(2011-2#1)(2012-12#2)(2012-3#1)
schwannoma with##6##2##(2006-12#1)(2010-11#1)(2010-3#1)(2011-2#3)
schwannoma##82##1##(1991-4#2)(1994-6#3)(1997-8#2)(2005-5#1)(2006-10#2)(2006-11#5)(2006-12#4)(2007-11#3)(2007-8#6)(2008-10#1)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#1)(2009-3#8)(2009-5#1)(2010-11#4)(2010-3#1)(2010-4#3)(2011-12#1)(2011-2#8)(2012-12#9)(2012-3#3)(2013-1#3)
schwannomas are rare##4##3##(2006-11#1)(2006-12#1)(2009-3#1)(2011-2#1)
schwannomas are##8##2##(2006-11#1)(2006-12#1)(2009-3#3)(2011-2#2)(2012-12#1)
schwannomas have##2##2##(1992-4#1)(2012-12#1)
schwannomas in##2##2##(2006-12#1)(2009-3#1)
schwannomas most commonly##2##3##(2011-2#1)(2013-1#1)
schwannomas of the##2##3##(1992-4#1)(2012-12#1)
schwannomas##37##1##(1992-4#3)(1997-8#2)(2005-5#1)(2006-10#1)(2006-11#3)(2006-12#8)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-3#5)(2011-2#4)(2012-12#3)(2013-1#2)
schwerinii##4##1##(2012-3#4)
schwetzi##6##1##(2004-11#5)(2007-6#1)
sciatic (L5-6) and##2##3##(1995-11#1)(1996-5#1)
sciatic and##2##2##(1997-3#1)(2009-5#1)
sciatic myelinated##2##2##(1997-3#2)
sciatic nerve blood flow##2##4##(1993-11#2)
sciatic nerve is##3##3##(1990-2#1)(1991-3#1)(1996-2#1)
sciatic nerve lesion##5##3##(1991-6#2)(1993-12#1)(1996-8#2)
sciatic nerve of##5##3##(1991-3#1)(1991-6#1)(1992-3#2)(1993-12#1)
sciatic nerve transection##2##3##(1990-2#1)(1991-9#1)
sciatic nerve was##3##3##(1990-7#1)(1996-2#1)(2007-10#1)
sciatic nerve##76##2##(1990-2#5)(1990-5#1)(1990-7#3)(1991-11#3)(1991-2#2)(1991-3#4)(1991-6#4)(1991-9#2)(1992-3#4)(1992-9#2)(1993-10#1)(1993-11#2)(1993-12#4)(1993-5#1)(1993-7#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-11#2)(1995-12#3)(1995-7#1)(1996-10#1)(1996-12#2)(1996-2#2)(1996-5#2)(1996-8#3)(1997-5#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-7#2)(2008-1#1)(2008-12#2)(2008-7#1)(2008-8#3)(2011-2#1)
sciatic nerves##5##2##(1992-5#1)(1993-6#1)(1995-12#1)(2011-1#1)(2011-2#1)
sciatic neuralgia##2##2##(2007-11#1)(2012-2#1)
sciatic neurectomy##4##2##(1991-6#1)(1993-12#3)
sciatic neuropathy and##2##3##(2008-8#2)
sciatic pain##2##2##(2006-2#1)(2006-8#1)
sciatic##114##1##(1990-2#5)(1990-5#1)(1990-7#3)(1991-11#3)(1991-2#3)(1991-3#4)(1991-6#5)(1991-9#2)(1992-3#4)(1992-5#1)(1992-9#2)(1993-10#1)(1993-11#2)(1993-12#7)(1993-5#2)(1993-6#1)(1993-7#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-8#1)(1995-11#4)(1995-12#4)(1995-7#1)(1996-10#1)(1996-12#3)(1996-2#2)(1996-5#5)(1996-8#3)(1997-2#1)(1997-3#5)(1997-5#2)(2006-12#1)(2006-2#2)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#6)(2009-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
sciatica without any##2##3##(1996-9#1)(2007-8#1)
sciatica##18##1##(1990-2#1)(1991-11#1)(1992-11#3)(1996-9#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-8#2)(2007-8#1)(2008-7#1)(2012-12#2)(2012-2#2)
sciatica]##2##1##(1990-2#1)(1995-9#1)
scid mice##5##2##(1994-3#3)(1994-8#1)(2010-10#1)
scid##10##1##(1994-3#4)(1994-8#1)(1995-2#2)(1995-8#1)(1996-2#1)(2010-10#1)
scidar (scintillation##2##2##(2008-2#1)(2008-3#1)
scidar##4##1##(2008-2#3)(2008-3#1)
science [Editorial]##2##2##(2006-10#1)(2006-8#1)
science and business##2##3##(2008-11#1)(2009-4#1)
science and engineering##3##3##(2011-11#2)(2011-2#1)
science and in##2##3##(1995-6#1)(1996-12#1)
science and its##2##3##(2008-5#1)(2008-7#1)
science and math##4##3##(2007-8#2)(2007-9#2)
science and medicine##3##3##(2008-6#1)(2009-2#1)(2010-9#1)
science and practice of##2##4##(1995-1#1)(2010-10#1)
science and public policy##2##4##(2007-5#1)(2007-9#1)
science and public##3##3##(2007-5#1)(2007-9#1)(2010-2#1)
science and society##3##3##(1991-6#1)(2007-10#1)(2008-9#1)
science and technology in##3##4##(1994-12#1)(2006-5#1)(2008-4#1)
science and technology##12##3##(1991-3#1)(1994-12#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-6#1)(2008-4#1)(2010-1#1)(2010-12#1)(2010-8#1)(2013-1#1)(2013-7#1)
science and the##8##3##(1992-2#1)(1993-11#1)(1995-2#1)(2006-10#2)(2008-5#1)(2009-7#1)(2010-1#1)
science and to##3##3##(1993-3#1)(2006-7#1)(2010-9#1)
science and##114##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-3#1)(1991-6#1)(1992-2#1)(1993-11#1)(1993-2#2)(1993-3#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-6#1)(2005-7#2)(2005-8#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#5)(2007-9#4)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#3)(2008-2#2)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#3)(2010-2#2)(2010-5#1)(2010-8#1)(2010-9#2)(2011-11#2)(2011-2#3)(2012-11#1)(2012-2#2)(2013-1#8)(2013-7#2)
science applications##2##2##(2006-10#1)(2006-5#1)
science are##4##2##(1991-11#1)(2006-7#1)(2009-10#1)(2013-7#1)
science as a##3##3##(2012-2#1)(2013-1#2)
science as##7##2##(2007-3#1)(2008-2#1)(2010-7#1)(2012-2#1)(2013-1#3)
science aspects##2##2##(2005-8#1)(2007-9#1)
science at##2##2##(2010-3#1)(2012-2#1)
science based##3##2##(1992-3#1)(2011-1#1)(2011-2#1)
science because##2##2##(2007-9#1)(2008-5#1)
science behind##6##2##(2008-3#1)(2008-5#1)(2010-11#1)(2011-2#1)(2013-1#2)
science community##7##2##(2007-8#1)(2007-9#2)(2008-10#1)(2008-2#1)(2008-4#1)(2013-8#1)
science continues to##2##3##(2008-10#1)(2009-3#1)
science disciplines##3##2##(1996-6#1)(2005-10#1)(2010-1#1)
science due to##2##3##(2008-10#1)(2008-7#1)
science during##2##2##(2008-11#2)
science education in##2##3##(2007-9#1)(2008-12#1)
science education##5##2##(2007-8#1)(2007-9#2)(2008-12#1)(2012-2#1)
science fiction##3##2##(2007-11#1)(2007-9#2)
science for the##2##3##(2006-10#1)(2010-1#1)
science for##7##2##(1994-3#1)(2006-10#1)(2006-9#1)(2007-12#1)(2008-3#1)(2010-1#1)(2013-1#1)
science from##4##2##(2005-7#1)(2009-12#1)(2009-2#1)(2009-6#1)
science had##2##2##(2013-1#2)
science has evolved##2##3##(2009-8#1)(2012-12#1)
science has##6##2##(1995-1#1)(2006-6#1)(2009-8#1)(2012-12#1)(2013-1#2)
science have##2##2##(2007-8#1)(2008-2#1)
science in China##2##3##(2006-7#1)(2011-1#1)
science in the##11##3##(1997-3#2)(2006-10#2)(2006-5#1)(2007-3#1)(2008-5#1)(2009-12#1)(2009-2#1)(2012-3#1)(2013-1#1)
science in this##2##3##(2007-9#1)(2010-11#1)
science in##31##2##(1991-8#1)(1996-11#2)(1997-3#3)(2004-3#1)(2005-7#1)(2006-10#3)(2006-5#1)(2006-7#1)(2006-8#1)(2007-3#2)(2007-8#1)(2007-9#1)(2008-5#1)(2009-12#1)(2009-2#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#5)(2013-7#1)
science into##7##2##(2007-9#1)(2009-4#1)(2010-12#2)(2010-3#1)(2013-1#2)
science investigations##3##2##(2005-8#1)(2006-4#1)(2010-12#1)
science is to##4##3##(2007-9#1)(2010-12#1)(2013-1#2)
science is##10##2##(2007-9#2)(2008-4#2)(2008-5#1)(2009-11#1)(2009-4#1)(2010-12#1)(2013-1#2)
science literature##2##2##(2008-5#1)(2009-7#1)
science of photomedicine##2##3##(1992-6#2)
science of the##3##3##(2006-7#1)(2008-12#1)(2009-7#1)
science of##50##2##(1990-3#1)(1991-2#1)(1992-6#2)(1993-12#1)(1993-3#1)(1994-3#1)(1995-5#1)(1996-11#2)(1996-3#1)(2004-8#1)(2006-11#1)(2006-4#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-7#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-7#1)(2012-2#6)(2013-1#4)(2013-7#1)(2013-8#1)
science on the##2##3##(2008-1#1)(2012-12#1)
science on whole grains##2##4##(2010-1#2)
science on##4##2##(2008-1#1)(2010-1#2)(2012-12#1)
science or##2##2##(2008-10#1)(2009-5#1)
science policy##3##2##(1994-7#1)(2009-4#1)(2011-1#1)
science programs##2##2##(2007-9#2)
science research has##2##3##(2008-11#1)(2008-12#1)
science research##18##2##(1995-2#1)(1997-3#1)(2005-8#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2009-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
science studies to##2##3##(2011-2#1)(2012-1#1)
science studies##6##2##(1992-6#1)(2006-5#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)
science teaching##2##2##(1990-8#1)(2005-10#1)
science that##6##2##(2007-11#1)(2007-12#1)(2008-3#1)(2012-3#1)(2013-1#2)
science to be##2##3##(2008-7#1)(2009-4#1)
science to the##2##3##(1996-9#1)(2007-12#1)
science to##18##2##(1990-4#1)(1994-5#1)(1994-6#1)(1996-9#1)(2005-8#1)(2006-5#1)(2007-10#1)(2007-12#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-4#1)(2013-1#2)
science was##5##2##(1991-6#1)(1993-11#1)(2008-5#1)(2012-2#1)(2013-1#1)
science will not##2##3##(2005-8#1)(2007-8#1)
science will##3##2##(2005-8#1)(2007-7#1)(2007-8#1)
science with##5##2##(2008-10#1)(2008-4#2)(2011-1#1)(2013-8#1)
science##719##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#4)(1990-4#1)(1990-6#1)(1990-8#4)(1990-9#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#3)(1991-8#1)(1992-2#3)(1992-3#2)(1992-5#2)(1992-6#4)(1992-7#2)(1993-11#3)(1993-12#1)(1993-2#3)(1993-3#4)(1993-4#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-7#3)(1994-9#1)(1995-1#4)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#4)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#6)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-12#1)(2004-3#1)(2004-8#2)(2005-10#5)(2005-11#1)(2005-12#1)(2005-5#1)(2005-7#8)(2005-8#6)(2005-9#1)(2006-10#18)(2006-11#1)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#8)(2006-5#9)(2006-6#2)(2006-7#9)(2006-8#7)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#8)(2007-12#7)(2007-3#6)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#15)(2007-9#40)(2008-1#10)(2008-10#21)(2008-11#18)(2008-12#17)(2008-2#12)(2008-3#5)(2008-4#8)(2008-5#18)(2008-6#3)(2008-7#11)(2008-8#13)(2008-9#6)(2009-10#7)(2009-11#2)(2009-12#6)(2009-2#11)(2009-3#3)(2009-4#18)(2009-5#5)(2009-6#3)(2009-7#6)(2009-8#4)(2009-9#2)(2010-1#6)(2010-10#5)(2010-11#3)(2010-12#14)(2010-2#8)(2010-3#2)(2010-4#1)(2010-5#5)(2010-7#4)(2010-8#3)(2010-9#7)(2011-1#13)(2011-11#2)(2011-2#13)(2012-1#9)(2012-11#4)(2012-12#7)(2012-2#22)(2012-3#8)(2013-1#66)(2013-7#10)(2013-8#9)
science&quot##15##1##(1991-11#1)(2007-12#1)(2008-5#1)(2009-6#1)(2013-1#11)
science's##3##1##(1997-8#1)(2006-7#1)(2009-4#1)
science)##3##1##(2006-10#1)(2013-1#2)
science-based##7##1##(1997-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2012-12#1)
science-oriented##2##1##(1994-12#2)
science?##7##1##(1997-3#1)(2006-10#1)(2006-4#1)(2008-10#1)(2008-12#2)(2010-12#1)
science]##3##1##(1990-5#1)(1993-5#1)(2008-11#1)
sciences and##13##2##(1994-12#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-12#1)(2009-2#1)(2011-1#1)(2011-2#2)
sciences as##4##2##(1994-12#1)(2006-2#1)(2010-4#1)(2011-2#1)
sciences at##2##2##(2006-3#1)(2007-9#1)
sciences community##2##2##(1994-3#1)(2007-9#1)
sciences from##2##2##(1996-2#1)(2008-12#1)
sciences have##4##2##(2007-1#1)(2008-2#1)(2008-7#1)(2013-1#1)
sciences in medical education##2##4##(1997-7#1)(2008-12#1)
sciences in##12##2##(1994-12#1)(1997-7#1)(2006-5#1)(2008-11#1)(2008-12#1)(2009-4#2)(2010-7#1)(2011-1#1)(2012-2#3)
sciences is##3##2##(2007-9#1)(2008-10#1)(2011-12#1)
sciences of the##2##3##(2006-8#1)(2012-2#1)
sciences of##4##2##(2006-8#1)(2007-5#1)(2012-2#1)(2013-7#1)
sciences research##2##2##(2008-11#1)(2012-11#1)
sciences students##2##2##(2011-2#1)(2012-12#1)
sciences such as##2##3##(2006-12#1)(2012-2#1)
sciences that##2##2##(1993-7#1)(2008-2#1)
sciences##197##1##(1990-12#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#2)(1992-2#3)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#9)(1994-3#2)(1994-6#1)(1995-1#1)(1995-2#2)(1996-1#1)(1996-12#4)(1996-2#5)(1996-3#1)(1996-6#2)(1997-3#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-12#2)(2006-2#3)(2006-3#2)(2006-5#1)(2006-6#1)(2006-7#4)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#4)(2007-11#3)(2007-5#2)(2007-7#2)(2007-8#2)(2007-9#4)(2008-1#4)(2008-10#9)(2008-11#9)(2008-12#7)(2008-2#6)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#8)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#6)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#3)(2010-7#6)(2011-1#3)(2011-10#1)(2011-12#2)(2011-2#11)(2012-11#1)(2012-12#1)(2012-2#13)(2012-3#1)(2013-1#2)(2013-7#1)
sciences]##2##1##(1995-11#1)(2008-3#1)
scientific abstract##2##2##(2007-7#1)(2010-4#1)
scientific abstracts##2##2##(2008-7#1)(2009-4#1)
scientific activity##2##2##(1991-6#1)(2007-7#1)
scientific advancement##2##2##(2007-11#1)(2010-2#1)
scientific advances in##3##3##(1992-2#1)(2006-10#1)(2008-1#1)
scientific advances##6##2##(1992-2#1)(1996-3#1)(2006-10#2)(2008-1#1)(2012-1#1)
scientific advice##2##2##(2008-5#2)
scientific advisers##3##2##(2008-5#3)
scientific analyses##3##2##(2006-8#1)(2008-2#1)(2008-3#1)
scientific analysis##2##2##(2009-9#1)(2010-3#1)
scientific and clinical##3##3##(2008-10#1)(2009-10#1)(2013-7#1)
scientific and cultural##2##3##(2007-3#2)
scientific and engineering##2##3##(2005-10#1)(2007-8#1)
scientific and ethical##2##3##(1991-3#1)(2008-4#1)
scientific and medical##6##3##(1990-7#1)(1996-12#1)(1997-8#2)(2007-3#1)(2008-11#1)
scientific and practical##3##3##(1996-6#1)(2008-7#1)(2008-8#1)
scientific and professional##2##3##(2006-1#1)(2006-2#1)
scientific and pseudoscientific claims##2##4##(2009-4#2)
scientific and public##2##3##(2008-10#1)(2010-9#1)
scientific and technical##4##3##(2005-5#1)(2008-7#1)(2010-10#1)(2012-12#1)
scientific and technological advances##2##4##(2008-10#1)(2013-1#1)
scientific and technological##7##3##(1991-11#1)(1995-1#1)(2006-4#1)(2006-5#1)(2008-10#1)(2010-12#1)(2013-1#1)
scientific and the##3##3##(1993-2#1)(2010-3#1)(2010-7#1)
scientific and##64##2##(1990-7#1)(1991-11#1)(1991-3#1)(1993-2#1)(1995-1#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-7#1)(1997-8#2)(2004-12#1)(2005-10#1)(2005-5#1)(2005-8#1)(2006-1#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2007-10#1)(2007-3#4)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#2)(2009-4#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-9#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
scientific articles##6##2##(1991-11#1)(2007-11#1)(2008-8#1)(2010-12#1)(2011-1#1)(2013-8#1)
scientific associations##2##2##(1990-10#1)(2006-4#1)
scientific attention##2##2##(2009-12#1)(2009-2#1)
scientific background##3##2##(2006-8#1)(2012-12#2)
scientific basis for the assessment of medical##3##7##(1996-12#3)
scientific basis for##9##3##(1994-2#1)(1996-12#3)(2006-12#1)(2008-7#2)(2010-8#1)(2013-1#1)
scientific basis of##4##3##(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
scientific basis##17##2##(1993-9#1)(1994-2#1)(1996-12#3)(1996-3#1)(2006-12#1)(2008-10#1)(2008-5#1)(2008-7#3)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
scientific challenge##4##2##(1996-4#1)(2008-5#2)(2011-1#1)
scientific communication##2##2##(2006-10#1)(2007-9#1)
scientific community and##2##3##(2006-5#1)(2008-11#1)
scientific community continues to##2##4##(1991-1#1)(2012-2#1)
scientific community has##6##3##(2006-2#1)(2007-9#2)(2008-10#1)(2010-12#1)(2012-2#1)
scientific community have##2##3##(2008-12#2)
scientific community is##2##3##(2010-11#1)(2010-6#1)
scientific community##45##2##(1991-1#1)(1994-12#1)(1997-3#1)(2004-12#1)(2004-9#1)(2005-7#1)(2006-10#3)(2006-2#1)(2006-5#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#4)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-8#1)
scientific competence##2##2##(1994-6#1)(2006-10#1)
scientific concept##3##2##(1992-12#1)(1997-6#1)(2013-1#1)
scientific conclusions##2##2##(1991-5#1)(2008-5#1)
scientific conferences##3##2##(2006-10#2)(2010-4#1)
scientific context##3##2##(1993-6#1)(2006-10#1)(2009-2#1)
scientific contributions to the field##2##5##(2012-1#1)(2012-12#1)
scientific contributions##3##2##(2011-2#1)(2012-1#1)(2012-12#1)
scientific cooperation##2##2##(2007-9#1)(2012-12#1)
scientific data and##2##3##(2006-8#1)(2008-8#1)
scientific data on##2##3##(2006-10#1)(2008-12#1)
scientific data##18##2##(1991-5#1)(2006-10#2)(2006-8#2)(2007-10#1)(2007-12#3)(2007-8#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-9#1)(2012-3#1)
scientific databases##2##2##(2011-2#1)(2013-8#1)
scientific debate##2##2##(1995-6#1)(2008-11#1)
scientific development##2##2##(1993-6#1)(2012-3#1)
scientific developments##4##2##(2005-10#1)(2007-3#1)(2009-5#1)(2010-12#1)
scientific disagreement##2##2##(2009-9#2)
scientific discipline##5##2##(1990-3#1)(1994-12#1)(1996-4#1)(2005-10#1)(2012-12#1)
scientific disciplines##6##2##(1991-12#1)(1994-5#1)(2008-4#1)(2010-12#1)(2012-2#1)(2012-3#1)
scientific discoveries##6##2##(1997-3#1)(2007-4#1)(2008-11#2)(2009-8#1)(2013-1#1)
scientific discovery and##2##3##(1991-2#1)(2011-1#1)
scientific discovery##6##2##(1991-2#1)(2011-1#1)(2012-2#3)(2013-8#1)
scientific documentation##6##2##(1992-8#1)(1993-3#1)(1994-2#1)(1996-1#1)(1997-4#1)(2013-8#1)
scientific evaluation of the hazards of##2##6##(2008-11#2)
scientific evaluation##3##2##(2008-11#2)(2013-1#1)
scientific evidence and##2##3##(2008-6#1)(2011-2#1)
scientific evidence has##2##3##(2006-10#1)(2008-12#1)
scientific evidence into##2##3##(2008-3#1)(2008-7#1)
scientific evidence is necessary##2##4##(2006-8#1)(2013-1#1)
scientific evidence is##8##3##(1993-12#1)(2006-8#1)(2008-11#1)(2008-3#1)(2013-1#4)
scientific evidence of##2##3##(2005-10#1)(2012-2#1)
scientific evidence on the##3##4##(2006-8#1)(2008-8#1)(2012-2#1)
scientific evidence on##4##3##(2006-8#1)(2008-4#1)(2008-8#1)(2012-2#1)
scientific evidence supporting##3##3##(2008-2#1)(2008-3#1)(2008-6#1)
scientific evidence that##3##3##(2007-4#1)(2008-10#1)(2008-3#1)
scientific evidence to##2##3##(2008-6#1)(2008-7#1)
scientific evidence##60##2##(1993-12#2)(1993-9#1)(1996-12#1)(1997-1#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-4#1)(2006-7#2)(2006-8#2)(2007-4#2)(2007-9#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#1)(2009-4#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#3)
scientific experience and##2##3##(2007-11#1)(2007-8#1)
scientific experience##3##2##(1992-6#1)(2007-11#1)(2007-8#1)
scientific field##3##2##(1994-12#2)(2006-10#1)
scientific fields##6##2##(2008-10#1)(2008-7#1)(2009-12#1)(2010-5#1)(2010-7#1)(2011-1#1)
scientific findings##4##2##(2009-4#1)(2010-12#1)(2011-2#1)(2013-8#1)
scientific foundation and##2##3##(2008-10#2)
scientific foundation for the##2##4##(2009-1#1)(2010-5#1)
scientific foundation##4##2##(2008-10#2)(2009-1#1)(2010-5#1)
scientific hypothesis or##2##3##(2006-4#1)(2012-3#1)
scientific impact##2##2##(2012-2#2)
scientific implications##2##2##(2007-7#1)(2008-2#1)
scientific information and##3##3##(2008-7#1)(2011-2#1)(2012-3#1)
scientific information to##3##3##(1993-12#1)(2007-4#2)
scientific information##14##2##(1990-2#1)(1993-12#1)(2005-7#1)(2006-2#1)(2007-4#2)(2008-10#2)(2008-7#1)(2010-5#2)(2011-2#2)(2012-3#1)
scientific integrity##2##2##(1996-12#1)(2013-7#1)
scientific interest in this##2##4##(2007-7#1)(2013-7#1)
scientific interest in##4##3##(2007-7#1)(2007-8#1)(2008-3#1)(2013-7#1)
scientific interest##12##2##(1992-6#1)(1996-8#1)(2006-10#1)(2006-7#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-2#1)(2013-7#2)
scientific investigation##3##2##(1992-3#1)(1996-1#1)(2005-7#1)
scientific investigations##2##2##(1997-6#1)(2008-1#1)
scientific issues##3##2##(2007-2#1)(2008-9#1)(2013-8#1)
scientific journal##4##2##(1994-12#1)(1997-3#1)(2009-2#1)(2011-1#1)
scientific journals and##3##3##(1997-3#1)(2006-5#1)(2010-1#1)
scientific journals##8##2##(1996-12#1)(1997-3#1)(2005-7#1)(2006-5#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-12#1)
scientific knowledge about##3##3##(2006-8#1)(2008-7#1)(2009-12#1)
scientific knowledge and##4##3##(2006-10#1)(2008-6#1)(2012-12#1)(2013-8#1)
scientific knowledge in##3##3##(2008-9#1)(2009-5#1)(2013-7#1)
scientific knowledge is##2##3##(1993-8#1)(2013-8#1)
scientific knowledge##33##2##(1993-8#1)(1994-6#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-8#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-5#2)(2010-1#1)(2010-2#2)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#4)
scientific literacy##2##2##(2008-2#2)
scientific literature and##2##3##(2005-7#1)(2008-4#1)
scientific literature are##2##3##(2008-8#1)(2013-8#1)
scientific literature is##2##3##(2008-11#1)(2011-2#1)
scientific literature on the##4##4##(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
scientific literature on##7##3##(2007-7#1)(2008-7#2)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
scientific literature##45##2##(1993-12#1)(1993-6#1)(1996-9#1)(1997-2#1)(2005-10#1)(2005-7#4)(2005-8#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-7#1)(2010-2#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
scientific material##2##2##(1993-1#1)(2006-10#1)
scientific medical##3##2##(1990-10#1)(2006-8#1)(2010-12#1)
scientific medicine##3##2##(1997-6#2)(2009-11#1)
scientific meeting of the##2##4##(2006-8#1)(2006-9#1)
scientific meeting##10##2##(2005-7#1)(2006-7#2)(2006-8#1)(2006-9#1)(2008-7#3)(2008-9#1)(2009-9#1)
scientific meetings##8##2##(1992-12#1)(2005-8#1)(2006-8#2)(2006-9#1)(2007-2#3)
scientific methods##5##2##(2009-12#1)(2011-1#1)(2013-1#3)
scientific misconduct##4##2##(1991-1#1)(1993-7#1)(2008-8#2)
scientific or##2##2##(2008-11#1)(2009-3#1)
scientific organization##2##2##(1991-11#1)(2012-1#1)
scientific output##3##2##(2007-3#1)(2012-2#2)
scientific papers and##2##3##(2007-8#1)(2012-3#1)
scientific papers##11##2##(1993-6#1)(2006-10#1)(2007-3#1)(2007-4#1)(2007-8#1)(2009-4#2)(2011-1#1)(2012-3#2)(2013-1#1)
scientific practice##2##2##(2008-12#1)(2012-2#1)
scientific principles and##3##3##(2006-5#1)(2008-6#1)(2009-11#1)
scientific principles##4##2##(2006-5#1)(2008-10#1)(2008-6#1)(2009-11#1)
scientific problems##4##2##(1990-11#3)(1991-10#1)
scientific process##3##2##(1996-1#1)(2007-4#1)(2012-2#1)
scientific production in##4##3##(1992-5#1)(2009-4#1)(2011-2#1)(2012-3#1)
scientific production on the##2##4##(2011-2#2)
scientific production on##3##3##(2011-2#2)(2012-3#1)
scientific production##12##2##(1992-5#1)(2009-10#1)(2009-4#2)(2010-7#1)(2011-2#4)(2012-3#2)(2013-8#1)
scientific productivity##2##2##(2007-3#1)(2012-12#1)
scientific progress##7##2##(2006-2#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
scientific proof##3##2##(1996-12#1)(2006-2#1)(2007-12#1)
scientific publications##8##2##(1992-6#1)(2005-8#1)(2007-8#1)(2008-11#1)(2010-7#1)(2011-2#1)(2012-12#2)
scientific publishing##3##2##(2006-10#1)(2007-4#1)(2012-3#1)
scientific questions##2##2##(2007-9#1)(2010-10#1)
scientific rationale for##4##3##(2006-10#1)(2008-10#1)(2013-8#2)
scientific rationale##7##2##(2006-10#1)(2008-10#1)(2008-3#1)(2010-12#2)(2013-8#2)
scientific recommendations##2##2##(2011-2#1)(2012-12#1)
scientific reports##3##2##(2005-7#1)(2007-9#1)(2008-11#1)
scientific research and##2##3##(2005-7#1)(2007-1#1)
scientific research in##4##3##(1993-3#1)(2005-8#1)(2008-5#1)(2012-2#1)
scientific research##24##2##(1990-9#1)(1991-12#1)(1993-3#1)(1994-10#1)(1994-6#1)(2005-7#1)(2005-8#1)(2007-1#2)(2007-11#1)(2007-3#1)(2007-9#1)(2008-2#2)(2008-5#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-4#1)(2012-2#1)(2013-7#1)(2013-8#1)
scientific review##2##2##(2005-10#1)(2008-12#1)
scientific revolution##2##2##(2006-10#1)(2012-2#1)
scientific rigor##3##2##(2009-6#1)(2009-8#1)(2012-12#1)
scientific session##2##2##(2005-9#2)
scientific sessions##6##2##(2007-5#1)(2007-8#1)(2008-5#2)(2009-5#1)(2009-6#1)
scientific societies##9##2##(1992-12#1)(1993-6#1)(1996-1#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-9#1)(2012-12#1)
scientific society##3##2##(2008-10#1)(2011-1#1)(2012-1#1)
scientific studies##7##2##(2006-10#1)(2007-11#1)(2008-10#1)(2009-4#1)(2010-12#1)(2010-3#1)(2011-1#1)
scientific study of##3##3##(1993-3#1)(2005-8#1)(2008-11#1)
scientific study##7##2##(1992-1#1)(1993-3#1)(2005-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2013-8#1)
scientific theory##2##2##(2008-11#1)(2008-7#1)
scientific tools##3##2##(2005-10#1)(2010-1#1)(2011-1#1)
scientific tradition##2##2##(1991-12#1)(2007-9#1)
scientific uncertainty to the##2##4##(2008-5#2)
scientific uncertainty##5##2##(2008-5#4)(2008-7#1)
scientific understanding of##3##3##(2007-2#1)(2008-7#1)(2010-4#1)
scientific understanding##4##2##(1991-12#1)(2007-2#1)(2008-7#1)(2010-4#1)
scientific work on the##2##4##(2008-10#1)(2013-1#1)
scientific work##6##2##(1992-6#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-8#1)(2013-1#1)
scientific works##2##2##(2008-8#1)(2009-10#1)
scientific##912##1##(1990-10#3)(1990-11#3)(1990-2#1)(1990-3#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#3)(1991-12#4)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-5#2)(1992-6#5)(1992-8#1)(1993-1#1)(1993-12#5)(1993-2#3)(1993-3#4)(1993-4#1)(1993-6#6)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-12#7)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#4)(1994-8#1)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#2)(1995-9#1)(1996-1#4)(1996-12#8)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#4)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#4)(2004-12#2)(2004-9#1)(2005-10#8)(2005-5#2)(2005-7#12)(2005-8#10)(2005-9#2)(2006-1#1)(2006-10#28)(2006-11#2)(2006-12#4)(2006-2#5)(2006-4#6)(2006-5#10)(2006-6#3)(2006-7#9)(2006-8#12)(2006-9#4)(2007-1#2)(2007-10#8)(2007-11#14)(2007-12#8)(2007-2#5)(2007-3#11)(2007-4#11)(2007-5#3)(2007-6#1)(2007-7#6)(2007-8#19)(2007-9#21)(2008-1#4)(2008-10#29)(2008-11#19)(2008-12#7)(2008-2#20)(2008-3#20)(2008-4#11)(2008-5#29)(2008-6#5)(2008-7#42)(2008-8#14)(2008-9#13)(2009-1#1)(2009-10#9)(2009-11#4)(2009-12#6)(2009-2#8)(2009-3#1)(2009-4#25)(2009-5#7)(2009-6#2)(2009-7#5)(2009-8#2)(2009-9#6)(2010-1#5)(2010-10#2)(2010-11#4)(2010-12#13)(2010-2#7)(2010-3#4)(2010-4#5)(2010-5#5)(2010-6#1)(2010-7#10)(2010-8#2)(2010-9#2)(2011-1#23)(2011-2#28)(2011-3#1)(2011-7#1)(2012-1#5)(2012-11#2)(2012-12#23)(2012-2#29)(2012-3#16)(2013-1#30)(2013-7#9)(2013-8#28)
scientifically and##2##2##(2009-4#1)(2010-7#1)
scientifically based##4##2##(1994-12#1)(2006-8#1)(2007-11#2)
scientifically proven##2##2##(2008-6#1)(2009-7#1)
scientifically sound##5##2##(2005-10#1)(2006-2#1)(2008-10#1)(2008-12#1)(2010-9#1)
scientifically supported##3##2##(2008-5#1)(2010-1#1)(2012-3#1)
scientifically valid and##2##3##(2006-8#1)(2007-4#1)
scientifically valid##4##2##(2006-8#1)(2007-4#1)(2011-2#1)(2013-7#1)
scientifically##46##1##(1990-10#1)(1991-12#1)(1994-12#1)(1995-11#1)(1997-3#2)(1997-6#1)(2005-10#1)(2006-12#1)(2006-2#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-3#1)(2007-4#1)(2007-9#1)(2008-10#5)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#2)(2009-10#1)(2009-4#3)(2009-7#1)(2010-1#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#2)
scientism##2##1##(1991-6#1)(2009-2#1)
scientist and##3##2##(1994-3#1)(2007-9#1)(2008-12#1)
scientist to##2##2##(2008-12#1)(2010-4#1)
scientist##41##1##(1990-12#1)(1990-3#2)(1990-8#1)(1991-2#1)(1994-12#1)(1994-3#1)(1996-3#1)(2005-11#1)(2005-8#2)(2006-12#1)(2007-9#3)(2008-12#5)(2008-4#2)(2008-5#1)(2008-9#1)(2009-2#1)(2009-4#2)(2010-1#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#5)(2013-7#1)
scientist's##3##1##(2006-7#1)(2008-7#1)(2012-2#1)
scientists and clinical##2##3##(2007-11#1)(2010-4#1)
scientists and clinicians##4##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
scientists and engineers##8##3##(1990-12#2)(2007-8#1)(2007-9#1)(2008-3#2)(2009-11#1)(2009-12#1)
scientists and other technical experts##2##5##(2006-7#2)
scientists and physicians##2##3##(2005-9#1)(2008-8#1)
scientists and the##2##3##(1990-9#1)(1997-8#1)
scientists and##43##2##(1990-12#2)(1990-9#1)(1997-8#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-7#2)(2007-11#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-5#1)(2008-8#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#2)(2010-11#1)(2010-4#1)(2010-8#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)
scientists are##11##2##(1992-2#1)(1996-9#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-2#1)
scientists around the world##2##4##(2005-10#1)(2008-5#1)
scientists around the##3##3##(2005-10#1)(2008-12#1)(2008-5#1)
scientists at the##3##3##(1996-9#1)(2006-5#1)(2007-9#1)
scientists attended this##2##3##(2005-8#1)(2008-5#1)
scientists attended##3##2##(2005-8#1)(2008-5#2)
scientists believed##2##2##(2009-2#1)(2013-1#1)
scientists can##4##2##(2007-9#1)(2008-4#1)(2012-2#1)(2013-8#1)
scientists discovered##2##2##(2008-1#1)(2010-1#1)
scientists engaged in##2##3##(1992-12#1)(2008-10#1)
scientists for##4##2##(1991-11#1)(2008-1#1)(2009-8#1)(2012-1#1)
scientists from##8##2##(1996-8#1)(2005-8#2)(2007-11#1)(2007-7#1)(2008-7#1)(2009-11#1)(2013-8#1)
scientists had##4##2##(2007-9#1)(2008-11#1)(2009-2#1)(2010-1#1)
scientists has##3##2##(2005-11#1)(2006-10#1)(2007-9#1)
scientists have been##2##3##(2006-10#1)(2008-9#1)
scientists have##9##2##(1991-9#1)(1994-12#1)(2006-10#1)(2006-7#1)(2007-9#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
scientists in the field##2##4##(1994-6#1)(2008-9#1)
scientists in the##8##3##(1992-5#1)(1994-6#1)(2007-3#2)(2008-4#1)(2008-9#1)(2009-4#1)(2013-1#1)
scientists in##15##2##(1992-5#1)(1994-6#1)(1997-2#1)(2005-8#1)(2007-3#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-4#1)(2012-12#1)(2013-1#1)
scientists into##2##2##(2007-8#1)(2009-12#1)
scientists involved##3##2##(2005-9#1)(2007-8#1)(2013-1#1)
scientists of##4##2##(2005-8#1)(2006-5#1)(2008-12#1)(2013-7#1)
scientists on the##2##3##(2007-9#1)(2009-12#1)
scientists on##3##2##(2007-9#1)(2009-12#1)(2013-1#1)
scientists or##3##2##(2007-9#1)(2009-2#1)(2012-1#1)
scientists say##2##2##(2007-8#1)(2007-9#1)
scientists studying##2##2##(2007-9#1)(2008-2#1)
scientists to learn##2##3##(2006-7#1)(2013-8#1)
scientists to##24##2##(1996-2#1)(2006-7#1)(2007-11#1)(2007-6#1)(2007-8#2)(2007-9#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-11#2)(2009-9#1)(2011-1#2)(2012-2#1)(2013-7#1)(2013-8#1)
scientists trained in##2##3##(2007-6#1)(2008-11#1)
scientists under##2##2##(2006-11#1)(2010-10#1)
scientists use##2##2##(2008-9#1)(2013-8#1)
scientists were##2##2##(2007-11#1)(2009-2#1)
scientists who##11##2##(1992-12#1)(1993-12#1)(2007-9#2)(2008-10#1)(2009-4#1)(2010-3#1)(2010-8#1)(2013-1#2)(2013-8#1)
scientists will be##2##3##(1994-12#1)(1997-3#1)
scientists with a##2##3##(2007-8#1)(2010-2#1)
scientists with##5##2##(2007-8#1)(2008-10#1)(2010-2#1)(2011-1#1)(2012-2#1)
scientists within##2##2##(1994-12#1)(1994-3#1)
scientists working##3##2##(2004-12#1)(2009-3#1)(2009-6#1)
scientists worldwide##2##2##(2008-11#1)(2011-2#1)
scientists##336##1##(1990-12#2)(1990-2#1)(1990-5#1)(1990-9#1)(1991-11#2)(1991-9#1)(1992-1#3)(1992-12#3)(1992-2#1)(1992-5#2)(1992-6#1)(1993-12#2)(1993-7#1)(1994-12#4)(1994-3#1)(1994-6#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-7#4)(2005-8#7)(2005-9#2)(2006-10#6)(2006-11#2)(2006-12#1)(2006-5#3)(2006-7#12)(2007-10#2)(2007-11#5)(2007-12#1)(2007-2#1)(2007-3#3)(2007-4#1)(2007-6#5)(2007-7#2)(2007-8#15)(2007-9#37)(2008-1#4)(2008-10#11)(2008-11#10)(2008-12#4)(2008-2#4)(2008-3#3)(2008-4#5)(2008-5#16)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#9)(2009-1#1)(2009-11#4)(2009-12#7)(2009-2#9)(2009-3#2)(2009-4#6)(2009-6#3)(2009-8#1)(2009-9#1)(2010-1#4)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#4)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-2#3)(2012-1#5)(2012-12#5)(2012-2#7)(2012-3#2)(2013-1#12)(2013-7#6)(2013-8#5)
scientists' hopes##2##2##(2007-9#2)
scientists'##7##1##(1992-12#1)(2007-9#2)(2009-2#1)(2013-1#2)(2013-7#1)
scientometric##2##1##(2013-1#2)
sciera##4##1##(1997-3#4)
scierai ectasia##2##2##(1997-3#2)
scimitar syndrome with##3##3##(2007-8#3)
scimitar syndrome##5##2##(2007-8#5)
scincus##4##1##(2010-3#4)
scintigram##4##1##(1992-7#1)(1993-7#1)(1995-6#1)(2012-2#1)
scintigrams##3##1##(1990-12#2)(2008-1#1)
scintigraphic activity##5##2##(2011-2#5)
scintigraphic and##2##2##(1997-6#1)(2008-12#1)
scintigraphic control was##2##3##(2013-1#2)
scintigraphic imaging##2##2##(2008-2#1)(2012-2#1)
scintigraphic renal lesions##2##3##(2013-1#2)
scintigraphic studies##2##2##(2008-5#1)(2012-2#1)
scintigraphic study##2##2##(2006-9#1)(2008-7#1)
scintigraphic technique##2##2##(2008-6#1)(2008-7#1)
scintigraphic##36##1##(1990-12#1)(1991-10#1)(1992-3#2)(1997-6#1)(2006-6#1)(2006-9#1)(2008-1#2)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-2#1)(2011-2#7)(2012-2#2)(2013-1#7)
scintigraphically##3##1##(1991-10#1)(1992-3#1)(1997-2#1)
scintigraphy after##3##2##(1990-3#1)(1992-5#1)(2011-2#1)
scintigraphy and coronary##2##3##(1991-9#1)(2008-7#1)
scintigraphy and radionuclide ventriculography##2##4##(1991-2#1)(1997-1#1)
scintigraphy and##13##2##(1991-2#1)(1991-9#1)(1996-12#1)(1997-1#1)(2006-1#1)(2007-11#3)(2007-7#1)(2008-1#1)(2008-7#1)(2010-10#1)(2010-12#1)
scintigraphy are##2##2##(2008-1#1)(2013-1#1)
scintigraphy at##2##2##(2010-11#1)(2013-1#1)
scintigraphy for##3##2##(1991-2#1)(2008-1#1)(2010-9#1)
scintigraphy in patients with##2##4##(1997-8#1)(2007-11#1)
scintigraphy in the evaluation of##3##5##(2006-10#1)(2008-4#1)(2008-7#1)
scintigraphy in the##6##3##(2006-10#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-2#1)
scintigraphy in##17##2##(1990-12#2)(1990-3#1)(1993-5#1)(1997-8#2)(2006-10#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-4#1)(2008-7#2)(2009-2#1)(2009-7#1)(2012-3#1)
scintigraphy is a##2##3##(1995-6#1)(2008-1#1)
scintigraphy is##4##2##(1995-6#1)(2007-7#1)(2008-1#1)(2010-10#1)
scintigraphy of##3##2##(1990-12#1)(2005-7#1)(2008-7#1)
scintigraphy performed##2##2##(1992-5#1)(2013-1#1)
scintigraphy showed##2##2##(2006-10#1)(2007-8#1)
scintigraphy to##2##2##(1997-8#1)(2009-10#1)
scintigraphy using##3##2##(2008-7#3)
scintigraphy was performed##3##3##(1993-8#1)(2008-7#2)
scintigraphy was##7##2##(1990-6#1)(1993-8#1)(2005-12#1)(2008-7#3)(2009-2#1)
scintigraphy with##7##2##(1990-4#1)(1990-6#1)(1992-5#1)(2006-2#1)(2008-1#1)(2008-4#1)(2009-4#1)
scintigraphy##112##1##(1990-10#2)(1990-12#3)(1990-3#2)(1990-4#1)(1990-6#2)(1991-11#1)(1991-2#2)(1991-9#1)(1992-10#1)(1992-5#4)(1993-5#1)(1993-8#1)(1995-6#2)(1996-12#1)(1996-3#1)(1997-1#2)(1997-8#3)(2005-11#1)(2005-12#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-2#2)(2006-8#1)(2007-11#8)(2007-5#2)(2007-7#2)(2007-8#3)(2008-1#8)(2008-11#1)(2008-4#3)(2008-7#11)(2009-10#1)(2009-2#4)(2009-3#1)(2009-4#1)(2009-7#1)(2010-10#5)(2010-11#1)(2010-12#4)(2010-6#3)(2010-9#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#4)
scintillant##2##1##(2008-4#2)
scintillated received wave fronts##2##4##(2008-3#2)
scintillated##4##1##(2008-2#1)(2008-3#3)
scintillating microplate##2##2##(2008-11#2)
scintillating##7##1##(2008-11#2)(2008-2#3)(2012-11#2)
scintillation and##2##2##(1992-2#1)(2006-5#1)
scintillation counter##2##2##(2008-4#1)(2012-2#1)
scintillation counting and##2##3##(2007-8#1)(2008-10#1)
scintillation counting##11##2##(1991-1#1)(1992-5#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#1)
scintillation effects##4##2##(2008-2#4)
scintillation in##2##2##(2008-2#1)(2008-3#1)
scintillation index##3##2##(2007-12#3)
scintillation on##2##2##(2008-2#2)
scintillation patterns##3##2##(2008-3#3)
scintillation proximity assay##2##3##(2008-11#1)(2013-1#1)
scintillation##59##1##(1990-3#1)(1991-1#1)(1992-2#1)(1992-3#1)(1992-5#1)(1994-5#1)(1994-7#1)(1996-5#1)(1997-8#1)(2006-5#1)(2006-8#1)(2007-12#4)(2007-8#1)(2008-10#2)(2008-11#3)(2008-2#10)(2008-3#18)(2008-4#2)(2008-5#1)(2008-8#1)(2012-11#2)(2012-12#1)(2012-2#2)(2013-1#1)
scintillations##5##1##(2007-12#1)(2008-3#4)
scintillator##5##1##(1996-2#1)(2008-5#1)(2009-8#1)(2013-1#2)
scintillators##2##1##(2010-4#1)(2012-12#1)
scintillometer##3##1##(2007-12#1)(2008-2#2)
scintiscan showed##2##2##(2007-5#2)
scintiscan##5##1##(1993-5#1)(2007-5#3)(2008-10#1)
scion circumference##2##2##(2008-10#2)
scion vigor##2##2##(2008-10#2)
scion##6##1##(2008-10#6)
scions##4##1##(2008-10#3)(2009-8#1)
scirrhous carcinoma##3##2##(2008-10#3)
scirrhous gastric carcinoma##2##3##(1992-11#2)
scirrhous type stomach##2##3##(1992-11#2)
scirrhous##7##1##(1992-11#4)(2008-10#3)
scirtid-O##2##1##(2008-12#2)
scirtids##5##1##(2008-12#5)
scissile bond##10##2##(1990-5#1)(1990-7#1)(1991-2#4)(1991-6#2)(1994-5#1)(1995-5#1)
scissile##12##1##(1990-5#1)(1990-7#1)(1991-2#4)(1991-6#3)(1992-3#1)(1994-5#1)(1995-5#1)
scission at the##2##3##(1990-2#1)(1990-5#1)
scission was##2##2##(1990-2#1)(1995-6#1)
scission##19##1##(1990-2#5)(1990-5#1)(1990-7#2)(1991-12#1)(1992-2#1)(1992-9#1)(1993-11#1)(1995-6#1)(1997-5#1)(2007-9#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-12#1)
scissor##4##1##(2007-11#2)(2010-12#2)
scissoring##4##1##(2008-10#4)
scissors and clips##2##3##(2007-8#2)
scissors and##4##2##(2007-8#3)(2010-8#1)
scissors##10##1##(1996-2#1)(2006-6#3)(2007-8#3)(2010-8#2)(2012-12#1)
sciuri##2##1##(2005-9#2)
sclera##7##1##(2006-11#3)(2007-7#1)(2008-2#1)(2011-1#1)(2013-1#1)
scleractinian corals##3##2##(2008-5#2)(2011-2#1)
scleractinian##5##1##(2007-5#2)(2008-5#2)(2011-2#1)
scleral##6##1##(1994-6#1)(1996-5#1)(2006-11#1)(2007-8#1)(2008-7#1)(2011-1#1)
sclerectomy##2##1##(2013-8#2)
sclerenchyma##2##1##(2008-5#2)
sclerites and##5##2##(2007-12#2)(2008-7#2)(2013-1#1)
sclerites of the##3##3##(2007-12#2)(2008-5#1)
sclerites of##5##2##(2007-12#2)(2008-5#1)(2013-1#2)
sclerites##18##1##(2007-12#8)(2008-5#1)(2008-7#4)(2013-1#5)
scleritis and recurrent erythema nodosum##2##5##(2011-1#2)
scleritis##6##1##(2009-2#1)(2011-1#3)(2012-12#1)(2012-3#1)
sclerodactyly##3##1##(2006-4#1)(2008-8#1)(2012-2#1)
scleroderma (SSc)##2##2##(2008-10#1)(2012-2#1)
scleroderma and##9##2##(1992-8#1)(2005-11#1)(2006-10#2)(2007-7#1)(2010-10#1)(2011-2#2)(2012-2#1)
scleroderma form##2##2##(1995-11#2)
scleroderma has##2##2##(2009-8#1)(2011-2#1)
scleroderma have##2##2##(2006-10#1)(2007-7#1)
scleroderma in##3##2##(2006-10#1)(2006-4#1)(2011-2#1)
scleroderma patients##3##2##(2006-10#2)(2012-2#1)
scleroderma renal crisis##7##3##(1992-12#1)(2006-10#5)(2007-7#1)
scleroderma renal##9##2##(1992-12#1)(2006-10#7)(2007-7#1)
scleroderma spectrum##2##2##(2006-10#2)
scleroderma who presented with a##2##5##(2006-10#2)
scleroderma who presented with##4##4##(2006-10#4)
scleroderma who##6##2##(2004-10#1)(2006-10#5)
scleroderma##84##1##(1990-2#1)(1991-12#1)(1992-12#2)(1992-8#5)(1993-9#1)(1995-11#3)(1997-7#1)(2004-10#1)(2005-11#1)(2005-7#1)(2006-10#33)(2006-4#2)(2007-11#4)(2007-7#3)(2008-10#3)(2008-12#2)(2009-8#4)(2010-10#1)(2010-12#1)(2011-2#7)(2012-2#6)(2013-1#1)
scleroderma-like##2##1##(2005-11#1)(2010-6#1)
sclerosant##3##1##(2009-2#1)(2011-2#2)
sclerosing agent##4##2##(1990-9#1)(1997-8#2)(2008-7#1)
sclerosing cholangitis (PSC)##6##3##(2006-10#2)(2006-2#1)(2007-11#1)(2008-12#1)(2012-2#1)
sclerosing cholangitis in children##2##4##(2006-10#1)(2009-8#1)
sclerosing cholangitis in##3##3##(2006-10#1)(2009-8#1)(2012-2#1)
sclerosing cholangitis is##6##3##(2004-11#2)(2006-10#4)
sclerosing cholangitis may##2##3##(2006-10#2)
sclerosing cholangitis##52##2##(1993-3#1)(1997-6#1)(2004-11#17)(2005-12#1)(2005-8#2)(2006-10#16)(2006-2#3)(2007-11#1)(2008-1#1)(2008-12#1)(2008-4#1)(2009-8#1)(2010-12#1)(2012-11#1)(2012-2#4)
sclerosing panencephalitis##3##2##(1991-8#1)(2012-12#2)
sclerosing peritonitis and Meig's syndrome##3##5##(2008-6#3)
sclerosing peritonitis##4##2##(1996-1#1)(2008-6#3)
sclerosing##82##1##(1990-3#1)(1990-4#1)(1990-9#1)(1991-8#1)(1992-1#1)(1992-5#1)(1993-3#1)(1994-12#1)(1994-3#1)(1996-1#1)(1996-4#1)(1997-6#1)(1997-8#2)(2004-11#18)(2005-12#1)(2005-8#2)(2006-10#16)(2006-2#4)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-6#3)(2008-7#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#4)(2013-7#1)(2013-8#1)
sclerosis (MS)##41##2##(1994-7#1)(1995-12#2)(2005-7#1)(2006-12#2)(2007-11#6)(2007-2#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#3)(2010-2#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#7)(2013-1#2)(2013-7#2)
sclerosis (SSc)##9##2##(2006-10#2)(2008-8#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#2)
sclerosis and lichen ruber planus##2##5##(2011-2#2)
sclerosis and other##2##3##(2010-12#1)(2012-3#1)
sclerosis and##31##2##(1994-10#1)(1995-12#1)(1995-4#1)(1997-8#1)(2005-11#3)(2005-8#1)(2006-10#2)(2006-2#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-7#1)(2009-8#3)(2010-12#2)(2011-2#3)(2012-2#1)(2012-3#2)
sclerosis are##4##2##(1995-9#1)(2010-10#1)(2013-1#2)
sclerosis at##2##2##(2006-2#1)(2011-2#1)
sclerosis in a patient##2##4##(2006-10#1)(2007-7#1)
sclerosis in a##4##3##(1995-11#1)(2006-10#1)(2007-7#1)(2008-8#1)
sclerosis in##13##2##(1995-11#1)(2006-10#1)(2006-12#2)(2007-2#1)(2007-7#3)(2008-1#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
sclerosis is a##4##3##(1995-1#1)(1995-12#1)(1995-6#1)(2007-7#1)
sclerosis is an##4##3##(2007-11#1)(2012-2#1)(2013-1#2)
sclerosis is##18##2##(1991-7#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#1)(2007-11#5)(2007-7#4)(2010-12#1)(2012-2#1)(2013-1#2)
sclerosis may##2##2##(2006-10#1)(2009-3#1)
sclerosis of the sacroiliac##2##4##(2006-10#1)(2011-2#1)
sclerosis of the##4##3##(2005-11#1)(2006-10#1)(2011-2#2)
sclerosis of##6##2##(2005-11#1)(2006-10#1)(2007-7#1)(2010-12#1)(2011-2#2)
sclerosis or##3##2##(2006-10#1)(2011-2#2)
sclerosis patients in##3##3##(1996-8#1)(2009-8#1)(2012-12#1)
sclerosis patients##13##2##(1996-8#2)(1997-3#1)(2007-11#1)(2009-12#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#2)
sclerosis treated with##2##3##(2007-7#1)(2007-8#1)
sclerosis was##2##2##(1996-9#1)(2011-2#1)
sclerosis who##3##2##(2006-10#1)(2007-11#1)(2011-2#1)
sclerosis with##6##2##(2007-11#1)(2008-1#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-12#1)
sclerosis##400##1##(1990-12#2)(1991-11#1)(1991-12#5)(1991-3#1)(1991-6#2)(1991-7#1)(1991-8#3)(1992-8#1)(1993-1#1)(1993-10#2)(1993-12#2)(1993-9#3)(1994-10#1)(1994-7#3)(1994-9#1)(1995-1#3)(1995-11#4)(1995-12#5)(1995-2#1)(1995-4#4)(1995-6#1)(1995-9#1)(1996-10#1)(1996-11#2)(1996-3#1)(1996-5#1)(1996-8#3)(1996-9#3)(1997-3#2)(1997-4#1)(1997-5#3)(1997-6#1)(1997-8#2)(2004-11#1)(2004-12#2)(2005-11#5)(2005-7#4)(2005-8#2)(2005-9#1)(2006-10#15)(2006-12#6)(2006-2#2)(2006-3#1)(2006-4#1)(2006-8#3)(2007-10#2)(2007-11#46)(2007-12#3)(2007-2#5)(2007-5#1)(2007-7#19)(2007-8#4)(2008-1#9)(2008-10#1)(2008-11#2)(2008-12#4)(2008-4#3)(2008-5#4)(2008-7#9)(2008-8#5)(2008-9#2)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#9)(2009-9#4)(2010-10#4)(2010-11#2)(2010-12#22)(2010-2#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#32)(2011-7#2)(2012-1#4)(2012-11#1)(2012-12#11)(2012-2#15)(2012-3#23)(2013-1#14)(2013-7#3)(2013-8#7)
sclerosis?##3##1##(2006-10#1)(2007-11#1)(2010-12#1)
sclerosis]##9##1##(1991-3#1)(1991-6#1)(1994-12#1)(1994-3#2)(1995-6#1)(1996-3#1)(2007-10#1)(2008-11#1)
sclerosus (LS)##2##2##(2010-12#1)(2012-1#1)
sclerosus and squamous cell carcinoma##2##5##(2005-11#2)
sclerosus et atrophicus##4##3##(2005-11#1)(2006-8#1)(2007-8#1)(2010-12#1)
sclerosus et##5##2##(2005-11#1)(2006-8#1)(2007-8#2)(2010-12#1)
sclerosus##18##1##(2005-11#10)(2006-8#1)(2007-8#2)(2008-3#1)(2010-12#2)(2012-1#2)
sclerotherapy and##3##2##(1995-9#1)(2013-1#2)
sclerotherapy for##3##2##(2008-8#1)(2012-1#1)(2013-1#1)
sclerotherapy was##2##2##(2008-8#2)
sclerotherapy##23##1##(1992-4#1)(1995-10#1)(1995-9#3)(1996-12#1)(1996-9#1)(2006-12#2)(2008-8#3)(2009-4#3)(2011-2#1)(2012-1#1)(2013-1#6)
sclerotherapy)##3##1##(1995-9#1)(2006-10#1)(2010-12#1)
sclerotia and the##3##3##(2008-10#3)
sclerotia and##8##2##(2008-10#8)
sclerotia buried##2##2##(2008-10#2)
sclerotia from##3##2##(2008-10#3)
sclerotia in##4##2##(2008-10#4)
sclerotia increased##2##2##(2008-10#2)
sclerotia occurred##2##2##(2008-10#2)
sclerotia of S##2##3##(2007-7#1)(2008-10#1)
sclerotia of Sclerotinia sclerotiorum##2##4##(2008-10#2)
sclerotia of##11##2##(1997-3#2)(2007-7#1)(2008-10#8)
sclerotia on##2##2##(2008-10#2)
sclerotia per square centimeter##2##4##(2008-10#2)
sclerotia produced in vitro##2##4##(2008-10#2)
sclerotia produced##4##2##(2008-10#4)
sclerotia to##2##2##(2008-10#2)
sclerotia viability and##3##3##(2008-10#3)
sclerotia was##3##2##(2008-10#3)
sclerotia were##6##2##(2007-7#1)(2008-10#5)
sclerotia within##2##2##(2008-10#2)
sclerotia##93##1##(1997-3#2)(2007-7#4)(2008-10#86)(2008-8#1)
sclerotial development in##2##3##(2008-10#2)
sclerotial development##4##2##(2008-10#4)
sclerotial size##3##2##(2008-10#3)
sclerotial##13##1##(2008-10#13)
sclerotic changes##4##2##(1990-2#1)(2006-4#1)(2010-12#2)
sclerotic lesions##2##2##(2007-11#1)(2011-2#1)
sclerotic##14##1##(1990-2#1)(1994-6#1)(2006-1#1)(2006-4#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-9#1)(2010-12#3)(2011-2#1)(2013-1#1)
sclerotinia stem rot in##2##4##(2008-10#2)
sclerotinia stem rot##5##3##(2008-10#5)
sclerotinia##8##1##(2008-10#8)
sclerotiorum Sclerotia##2##2##(2008-10#2)
sclerotiorum and the##2##3##(2007-7#2)
sclerotiorum and##4##2##(2007-7#2)(2008-10#1)(2013-8#1)
sclerotiorum from##3##2##(2008-10#3)
sclerotiorum in the##2##3##(2008-10#2)
sclerotiorum in##7##2##(2008-10#7)
sclerotiorum isolates##3##2##(2008-10#3)
sclerotiorum populations##2##2##(2008-10#2)
sclerotiorum sclerotia was##2##3##(2008-10#2)
sclerotiorum sclerotia##7##2##(2007-7#2)(2008-10#5)
sclerotiorum was##6##2##(2008-10#6)
sclerotiorum##66##1##(2007-7#4)(2008-10#61)(2013-8#1)
sclerotized##5##1##(2007-12#3)(2008-5#2)
sclerotomal##2##1##(1994-12#1)(1996-3#1)
sclerotome and##2##2##(1994-12#1)(2006-12#1)
sclerotome induction##2##2##(1994-12#2)
sclerotome##7##1##(1994-12#6)(2006-12#1)
sclerotomy##5##1##(2013-8#5)
scolaire##3##1##(2008-11#3)
scoliosis 6##2##2##(2007-8#2)
scoliosis and to##2##3##(2007-8#1)(2012-12#1)
scoliosis and##12##2##(1993-1#1)(1996-9#1)(2006-10#2)(2007-7#1)(2007-8#3)(2008-4#2)(2012-12#1)(2012-2#1)
scoliosis angle##4##2##(2007-7#2)(2007-8#2)
scoliosis before and##2##3##(2007-8#1)(2012-2#1)
scoliosis by the##2##3##(2007-11#1)(2007-7#1)
scoliosis by##5##2##(1996-9#1)(2007-11#1)(2007-7#3)
scoliosis correction##6##2##(2007-7#5)(2007-8#1)
scoliosis has##3##2##(2007-11#1)(2007-8#2)
scoliosis have##2##2##(2006-10#1)(2007-7#1)
scoliosis in relation to##2##4##(2007-7#2)
scoliosis in the##7##3##(1997-4#1)(2007-7#4)(2008-8#1)(2010-10#1)
scoliosis in##15##2##(1996-3#1)(1997-4#1)(2006-9#1)(2007-7#8)(2007-8#1)(2008-8#1)(2009-3#1)(2010-10#1)
scoliosis is still a##2##4##(2007-7#2)
scoliosis is##12##2##(2007-7#3)(2007-8#7)(2008-11#2)
scoliosis of the##3##3##(1993-3#1)(1997-4#1)(2007-7#1)
scoliosis of##5##2##(1993-3#1)(1997-4#1)(2007-7#3)
scoliosis or##2##2##(1997-4#1)(2009-3#1)
scoliosis repair surgery with intraoperative##2##5##(2011-2#2)
scoliosis repair surgery with##3##4##(2011-2#3)
scoliosis should stop the progression of##2##6##(2007-7#2)
scoliosis surgery##5##2##(2007-7#4)(2013-7#1)
scoliosis treated##3##2##(2007-7#3)
scoliosis treatment was##2##3##(2007-7#2)
scoliosis treatment##5##2##(2007-7#4)(2007-8#1)
scoliosis using##2##2##(2007-7#2)
scoliosis was##4##2##(2007-7#3)(2007-8#1)
scoliosis were##2##2##(2007-7#2)
scoliosis with a##2##3##(2007-7#1)(2007-8#1)
scoliosis with##7##2##(2007-7#4)(2007-8#2)(2009-3#1)
scoliosis##233##1##(1993-1#1)(1993-3#1)(1996-1#1)(1996-3#1)(1996-9#3)(1997-1#1)(1997-3#1)(1997-4#3)(2005-2#2)(2006-10#3)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#12)(2007-7#91)(2007-8#74)(2008-11#6)(2008-4#2)(2008-8#2)(2009-3#6)(2009-4#2)(2010-10#1)(2010-12#4)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#4)(2013-1#1)(2013-7#1)
scoliosis]##8##1##(1996-8#1)(2006-6#1)(2007-7#4)(2013-1#1)(2013-7#1)
scoliotic deformities##2##2##(2006-8#2)
scoliotic deformity##5##2##(2006-8#2)(2007-8#2)(2008-4#1)
scoliotic patients##2##2##(2007-7#2)
scoliotic##12##1##(2006-6#1)(2006-8#4)(2007-11#1)(2007-7#2)(2007-8#2)(2008-4#1)(2012-2#1)
scolopale rods##2##2##(2008-7#2)
scolopale##5##1##(2008-7#5)
scolopidia##5##1##(2007-12#1)(2008-7#4)
scoop##3##1##(2007-7#1)(2008-1#1)(2012-1#1)
scope and limitations of##4##4##(2006-12#1)(2007-11#1)(2008-4#1)(2013-1#1)
scope and limitations##7##3##(2006-12#1)(2007-11#1)(2007-8#1)(2008-4#2)(2011-2#1)(2013-1#1)
scope and the##2##3##(2007-10#1)(2008-5#1)
scope and##33##2##(1992-12#1)(1994-3#1)(1995-1#1)(1997-3#1)(2006-1#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#5)
scope by##2##2##(1997-1#1)(2007-6#1)
scope for##16##2##(1995-2#1)(1997-8#2)(2004-2#1)(2006-12#2)(2006-2#1)(2007-10#1)(2007-12#1)(2008-10#2)(2009-12#1)(2009-8#1)(2010-12#1)(2010-8#1)(2012-12#1)
scope in##5##2##(1990-12#1)(1997-1#1)(2008-9#1)(2012-2#2)
scope of action of forensic psychiatry##2##6##(2008-2#2)
scope of action##3##3##(2008-2#2)(2013-8#1)
scope of practice in##2##4##(2007-10#1)(2011-1#1)
scope of practice of##4##4##(1997-3#1)(2007-10#1)(2011-1#1)(2013-1#1)
scope of practice##24##3##(1996-12#1)(1997-3#1)(2007-10#3)(2007-3#1)(2007-4#2)(2008-12#2)(2008-7#1)(2011-1#8)(2011-2#1)(2012-12#2)(2013-1#2)
scope of responsibilities##2##3##(2008-1#1)(2012-3#1)
scope of responsibility##2##3##(1996-2#1)(1997-2#1)
scope of services##4##3##(1991-1#1)(2008-1#3)
scope of surgical##2##3##(2006-7#1)(2010-3#1)
scope of the##29##3##(1991-5#1)(1994-6#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-5#1)(2004-7#1)(2005-7#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-4#1)(2010-2#1)(2010-7#1)(2012-12#1)(2012-3#1)
scope of this review##4##4##(2006-9#1)(2008-1#1)(2008-5#1)(2012-12#1)
scope of this##18##3##(2006-9#1)(2007-10#1)(2008-1#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-4#1)(2010-10#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
scope of##154##2##(1990-5#1)(1990-8#2)(1991-1#1)(1991-12#1)(1991-5#1)(1992-10#1)(1993-1#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-3#1)(1996-12#6)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#1)(2004-7#1)(2005-7#1)(2006-10#1)(2006-12#3)(2006-2#2)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#7)(2007-11#3)(2007-12#3)(2007-2#1)(2007-3#2)(2007-4#3)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#6)(2008-10#1)(2008-11#3)(2008-12#3)(2008-2#4)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#3)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#9)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#4)(2012-3#6)(2013-1#6)(2013-7#2)(2013-8#2)
scope the##2##2##(1996-9#1)(2011-2#1)
scope to##4##2##(1994-3#1)(2007-7#1)(2008-1#1)(2008-3#1)
scope##250##1##(1990-12#1)(1990-5#3)(1990-8#2)(1991-1#2)(1991-12#2)(1991-3#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-3#3)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-12#6)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#4)(1997-2#3)(1997-3#3)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#2)(2004-2#1)(2004-7#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#6)(2006-2#3)(2006-4#2)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#10)(2007-11#4)(2007-12#6)(2007-2#1)(2007-3#3)(2007-4#3)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#3)(2008-1#10)(2008-10#9)(2008-11#3)(2008-12#4)(2008-2#6)(2008-3#3)(2008-4#6)(2008-5#5)(2008-6#1)(2008-7#11)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#2)(2009-4#4)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#10)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#2)(2012-3#8)(2013-1#11)(2013-7#2)(2013-8#2)
scopes##4##1##(2006-10#1)(2006-5#1)(2012-2#1)(2012-3#1)
scopine##2##1##(1990-6#1)(2008-10#1)
scoping##2##1##(2008-8#1)(2013-8#1)
scopolamine (0##6##2##(1991-7#3)(1992-11#1)(1994-8#1)(1996-12#1)
scopolamine (1##2##2##(1991-2#1)(1994-5#1)
scopolamine (3##2##2##(1991-2#1)(1996-12#1)
scopolamine and##3##2##(1996-9#1)(2008-10#2)
scopolamine on##3##2##(1992-11#2)(1994-8#1)
scopolamine treatment##2##2##(1994-6#2)
scopolamine was##2##2##(1990-6#1)(1996-12#1)
scopolamine##51##1##(1990-6#4)(1990-7#1)(1990-8#1)(1991-2#3)(1991-6#2)(1991-7#4)(1992-11#4)(1992-12#1)(1992-7#1)(1992-9#1)(1993-12#1)(1994-5#1)(1994-6#4)(1994-8#4)(1996-1#1)(1996-12#6)(1996-9#2)(1997-8#2)(2007-1#1)(2007-5#1)(2008-10#5)(2010-6#1)
scopolamine-induced deficit##3##2##(1993-11#3)
scopolamine-induced##5##1##(1993-11#5)
scopoletin and##2##2##(2008-10#2)
scopoletin##6##1##(2008-10#6)
scorch virus##2##2##(2008-10#2)
scorch##13##1##(2008-10#13)
scorched##3##1##(2006-10#1)(2007-9#1)(2008-10#1)
score &gt##15##2##(2004-10#1)(2006-10#1)(2007-10#1)(2007-4#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#4)(2013-4#1)(2013-8#1)
score &lt##8##2##(1994-3#1)(2007-10#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)
score (0##3##2##(2008-3#2)(2011-2#1)
score (1##2##2##(2006-10#1)(2008-3#1)
score (36##2##2##(2006-10#1)(2008-1#1)
score (4##2##2##(2008-3#1)(2013-1#1)
score (OR##2##2##(2012-2#1)(2012-3#1)
score (OR = 1##2##2##(2012-1#2)
score (P &lt##2##3##(2007-10#1)(2012-2#1)
score (P =##4##3##(2007-10#3)(2011-2#1)
score (P##6##2##(2007-10#4)(2011-2#1)(2012-2#1)
score (or score difference)##2##4##(2008-4#2)
score (p &lt##2##3##(2009-2#1)(2010-3#1)
score (p = 0##2##4##(2011-12#1)(2012-2#1)
score (p =##3##3##(1993-2#1)(2011-12#1)(2012-2#1)
score (p##6##2##(1990-8#1)(1993-2#1)(2009-2#1)(2010-3#1)(2011-12#1)(2012-2#1)
score (p=0##2##2##(2008-7#2)
score (r(s)##2##2##(2007-10#2)
score 0##2##2##(1993-4#1)(2008-3#1)
score 1##3##2##(1997-5#1)(2006-10#1)(2008-6#1)
score 13##2##2##(2006-10#1)(2008-9#1)
score 2##2##2##(2004-2#1)(2013-1#1)
score 4##3##2##(2012-1#1)(2013-1#2)
score 80##2##2##(1994-7#1)(2008-3#1)
score =##3##2##(1992-5#1)(2007-9#1)(2008-5#1)
score according##2##2##(2008-9#1)(2010-10#1)
score after##5##2##(1991-4#1)(2009-2#2)(2011-2#2)
score also##3##2##(1996-7#1)(2010-8#1)(2013-1#1)
score analysis##4##2##(1997-5#2)(2007-8#2)
score and age##2##3##(2009-3#1)(2012-12#1)
score and in##2##3##(2008-10#1)(2011-2#1)
score and the##7##3##(1992-2#1)(2006-7#1)(2007-7#1)(2009-3#1)(2011-1#2)(2013-1#1)
score and##55##2##(1991-11#1)(1991-6#1)(1992-2#1)(1993-11#1)(1993-4#1)(1996-5#2)(1996-7#1)(2004-10#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-12#2)(2007-2#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-12#1)(2008-7#2)(2009-10#1)(2009-2#1)(2009-3#2)(2009-9#1)(2010-3#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#5)(2013-7#3)(2013-8#1)
score are##3##2##(1994-9#1)(2005-10#1)(2006-12#1)
score as a predictor of##2##5##(2013-1#2)
score as a##3##3##(2008-10#1)(2013-1#2)
score as predictor of##2##4##(2013-1#2)
score as##10##2##(2008-10#2)(2008-7#1)(2008-8#3)(2013-1#4)
score at 5##2##3##(1995-6#1)(2006-10#1)
score at the end of##2##5##(1994-6#1)(2013-1#1)
score at the##5##3##(1994-6#2)(2007-9#1)(2011-1#1)(2013-1#1)
score at##15##2##(1994-12#1)(1994-6#2)(1995-6#1)(1997-8#1)(2006-10#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-6#1)(2008-8#1)(2009-2#1)(2010-5#1)(2011-1#1)(2013-1#1)
score between##5##2##(2007-10#1)(2008-8#1)(2009-7#2)(2012-2#1)
score by a##2##3##(1994-3#1)(2005-11#1)
score by##5##2##(1994-3#1)(2005-11#1)(2010-4#1)(2011-1#2)
score calculated##2##2##(2006-2#1)(2007-12#1)
score can##3##2##(2011-2#1)(2013-1#2)
score compared with##2##3##(2012-2#2)
score decreased from##2##3##(2007-9#1)(2008-7#1)
score decreased significantly in the##2##5##(2008-7#1)(2009-12#1)
score decreased significantly##3##3##(2008-7#1)(2009-12#1)(2013-1#1)
score decreased##8##2##(2007-9#1)(2008-5#1)(2008-7#4)(2009-12#1)(2013-1#1)
score did not##2##3##(2007-10#1)(2011-1#1)
score for each##7##3##(1993-12#1)(1994-9#1)(1997-3#1)(2008-10#1)(2008-6#1)(2012-3#2)
score for knowledge##2##3##(2006-9#1)(2011-2#1)
score for the##8##3##(1990-2#2)(1991-6#1)(1995-2#1)(2006-11#1)(2007-8#1)(2008-10#1)(2010-12#1)
score for##45##2##(1990-2#2)(1991-2#2)(1991-6#2)(1993-12#1)(1993-4#1)(1994-9#1)(1995-2#1)(1996-12#1)(1997-3#1)(2005-10#2)(2006-10#6)(2006-11#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-8#3)(2007-9#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#1)
score from##4##2##(1994-6#1)(2008-8#1)(2010-10#1)(2012-12#1)
score greater than##2##3##(1991-2#1)(1997-3#1)
score had##2##2##(2010-8#1)(2011-2#1)
score has been##2##3##(2007-11#1)(2011-1#1)
score has##3##2##(2007-11#1)(2008-11#1)(2011-1#1)
score improved from##3##3##(1991-3#1)(2008-7#1)(2009-3#1)
score improved##4##2##(1991-3#1)(2008-7#1)(2009-3#1)(2010-11#1)
score in the##13##3##(1991-4#1)(1994-11#1)(1994-12#1)(2006-10#1)(2007-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
score in this##2##3##(2007-8#1)(2013-1#1)
score in##29##2##(1991-4#1)(1991-9#1)(1994-11#1)(1994-12#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-8#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-2#1)(2013-1#5)(2013-8#1)
score increased significantly##2##3##(1997-1#1)(2008-3#1)
score increased to##3##3##(2008-7#1)(2011-1#1)(2013-1#1)
score increased##8##2##(1997-1#1)(2007-11#1)(2008-3#1)(2008-7#1)(2009-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
score is a##4##3##(1994-11#1)(1994-9#1)(2010-6#1)(2011-2#1)
score is##17##2##(1994-11#1)(1994-5#1)(1994-9#1)(2007-2#1)(2008-4#2)(2010-6#2)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#2)
score less than##3##3##(2009-9#1)(2011-2#2)
score less##5##2##(2009-9#1)(2011-2#2)(2012-3#2)
score means##2##2##(1990-12#1)(2007-2#1)
score of &gt##3##3##(2007-8#1)(2008-7#1)(2013-1#1)
score of 0##3##3##(2008-10#1)(2008-7#1)(2010-8#1)
score of 1##3##3##(1997-3#1)(1997-5#1)(2011-2#1)
score of 10##2##3##(2007-2#1)(2013-1#1)
score of 100%##3##3##(2007-11#1)(2011-2#2)
score of 13##2##3##(2006-10#1)(2007-11#1)
score of 2##2##3##(1997-5#1)(2008-5#1)
score of 21##2##3##(2005-10#1)(2011-1#1)
score of 3##3##3##(1997-5#2)(2006-12#1)
score of 4##2##3##(1992-5#1)(1997-5#1)
score of 8##2##3##(2007-2#1)(2007-9#1)
score of each##2##3##(2008-10#1)(2013-1#1)
score of the##9##3##(1995-4#1)(1996-7#1)(1997-8#2)(2004-3#1)(2006-7#1)(2008-1#1)(2008-4#1)(2008-8#1)
score of three##2##3##(1990-10#1)(1997-8#1)
score of##90##2##(1990-10#1)(1990-12#1)(1991-1#1)(1991-12#1)(1991-4#2)(1991-6#1)(1992-1#1)(1992-5#1)(1994-2#1)(1995-4#1)(1996-4#1)(1996-7#1)(1997-3#1)(1997-5#5)(1997-8#4)(2004-3#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-7#1)(2006-8#2)(2007-10#2)(2007-11#3)(2007-2#5)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#1)(2009-10#1)(2009-11#2)(2010-1#1)(2010-8#1)(2011-1#7)(2011-2#4)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#2)
score on the##10##3##(1995-11#1)(1997-8#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2011-2#1)(2013-1#2)
score on##18##2##(1994-2#1)(1995-11#1)(1997-5#1)(1997-8#1)(2007-9#1)(2008-10#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2011-1#1)(2011-2#1)(2013-1#4)(2013-7#1)
score or##3##2##(1991-11#1)(2010-8#1)(2011-2#1)
score outcome##2##2##(2013-1#2)
score pain##2##2##(2008-7#1)(2013-1#1)
score showed##4##2##(1990-7#1)(2007-7#1)(2012-1#1)(2013-1#1)
score system##3##2##(2006-2#1)(2007-11#1)(2009-2#1)
score test for##2##3##(1995-9#1)(2012-3#1)
score test##6##2##(1993-5#1)(1995-9#1)(1997-3#1)(2012-3#3)
score than##3##2##(2009-10#1)(2011-2#1)(2012-2#1)
score that##3##2##(2007-8#1)(2008-12#1)(2010-8#1)
score to predict##3##3##(2010-12#2)(2013-8#1)
score to##12##2##(1992-1#1)(1994-3#1)(1994-9#1)(2007-9#1)(2010-12#2)(2013-1#3)(2013-8#3)
score value##2##2##(2008-7#1)(2012-2#1)
score was 14##2##3##(1990-12#1)(2013-1#1)
score was 16##2##3##(2011-2#1)(2012-2#1)
score was 2##2##3##(2008-7#1)(2012-2#1)
score was 3##3##3##(1990-2#1)(2007-9#1)(2012-3#1)
score was 4##3##3##(2007-9#1)(2010-12#1)(2012-3#1)
score was 6##2##3##(2008-12#1)(2010-12#1)
score was 84##2##3##(1991-12#1)(2008-8#1)
score was 9##3##3##(2007-2#1)(2007-9#1)(2012-12#1)
score was a##2##3##(2012-12#1)(2013-1#1)
score was calculated##2##3##(2007-7#1)(2011-2#1)
score was evaluated##2##3##(2009-10#1)(2010-8#1)
score was lower##2##3##(1990-2#1)(2007-10#1)
score was not##2##3##(2008-5#1)(2013-8#1)
score was only##2##3##(1997-5#1)(2011-2#1)
score was significantly higher##2##4##(2008-9#1)(2013-7#1)
score was significantly##4##3##(2007-8#1)(2008-9#1)(2013-1#1)(2013-7#1)
score was the##5##3##(2007-10#2)(2007-9#1)(2008-10#1)(2010-3#1)
score was used to##2##4##(2007-8#1)(2008-3#1)
score was##91##2##(1990-12#3)(1990-2#2)(1991-12#1)(1991-6#1)(1996-6#1)(1996-7#1)(1997-5#1)(2006-5#1)(2006-7#2)(2006-9#1)(2007-10#4)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#5)(2007-9#5)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-3#3)(2009-9#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#8)(2013-7#2)(2013-8#1)
score weighting method##3##3##(2011-1#3)
score weighting##5##2##(2011-1#5)
score were recorded##2##3##(2004-2#1)(2013-8#1)
score were significantly##2##3##(2004-2#1)(2008-11#1)
score were##13##2##(1991-6#1)(1997-5#1)(2004-2#2)(2007-10#1)(2007-8#1)(2008-11#1)(2008-3#1)(2010-10#1)(2011-2#1)(2013-1#1)(2013-8#2)
score with##5##2##(1996-5#1)(2011-1#2)(2012-2#2)
score ≥ 8 and##2##4##(2010-12#2)
score ≥##4##2##(2010-12#3)(2012-12#1)
score##931##1##(1990-10#1)(1990-12#5)(1990-2#4)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#3)(1991-12#2)(1991-2#5)(1991-3#2)(1991-4#6)(1991-5#1)(1991-6#8)(1991-9#2)(1992-1#2)(1992-12#1)(1992-2#1)(1992-5#3)(1992-6#2)(1993-11#2)(1993-12#1)(1993-2#2)(1993-4#4)(1993-5#1)(1993-9#2)(1994-11#5)(1994-12#4)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#4)(1994-7#2)(1994-9#4)(1995-11#3)(1995-12#1)(1995-2#6)(1995-4#1)(1995-6#1)(1995-9#2)(1996-1#1)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#4)(1996-8#1)(1997-1#1)(1997-3#6)(1997-5#16)(1997-8#8)(2004-10#4)(2004-12#1)(2004-2#3)(2004-3#1)(2005-10#7)(2005-11#1)(2006-10#18)(2006-11#2)(2006-12#7)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#6)(2006-8#2)(2006-9#2)(2007-10#31)(2007-11#12)(2007-12#6)(2007-2#16)(2007-3#2)(2007-4#1)(2007-7#14)(2007-8#30)(2007-9#18)(2008-1#3)(2008-10#22)(2008-11#8)(2008-12#6)(2008-2#2)(2008-3#16)(2008-4#14)(2008-5#13)(2008-6#9)(2008-7#36)(2008-8#16)(2008-9#8)(2009-10#4)(2009-11#3)(2009-12#2)(2009-2#10)(2009-3#8)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#5)(2009-8#4)(2009-9#8)(2010-1#2)(2010-10#4)(2010-11#3)(2010-12#21)(2010-2#3)(2010-3#6)(2010-4#6)(2010-5#2)(2010-6#4)(2010-7#3)(2010-8#15)(2010-9#1)(2011-1#46)(2011-11#3)(2011-12#2)(2011-2#53)(2011-3#3)(2012-1#10)(2012-11#1)(2012-12#21)(2012-2#38)(2012-3#26)(2012-5#1)(2013-1#81)(2013-4#1)(2013-7#16)(2013-8#20)
score's##3##1##(1995-11#1)(2009-12#1)(2009-3#1)
score) and##2##2##(2008-4#1)(2011-2#1)
score)##16##1##(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-4#1)(2009-9#1)(2010-10#2)(2010-4#1)(2011-1#2)(2011-2#2)(2013-1#1)
score-based##2##1##(1994-6#2)
scorecard approach##2##2##(1995-12#2)
scorecard##7##1##(1995-12#3)(2008-11#2)(2009-4#1)(2011-2#1)
scorecards##5##1##(2008-11#5)
scored above##3##2##(2007-2#1)(2007-7#1)(2008-9#1)
scored according to the##2##4##(1994-3#1)(2005-9#1)
scored according to##5##3##(1994-3#1)(2005-9#1)(2006-6#1)(2008-10#1)(2008-6#1)
scored and##2##2##(2008-7#1)(2012-1#1)
scored as positive for##2##4##(1994-12#1)(2008-5#1)
scored as##7##2##(1990-11#1)(1994-12#1)(2007-8#2)(2008-10#1)(2008-5#1)(2011-1#1)
scored at##4##2##(2008-1#2)(2008-10#2)
scored below##3##2##(2007-12#1)(2008-1#1)(2009-10#1)
scored by the##3##3##(2010-12#1)(2010-5#1)(2013-1#1)
scored by two##2##3##(2007-2#1)(2008-5#1)
scored by##10##2##(1995-3#1)(2007-2#1)(2008-5#2)(2008-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-12#1)(2013-1#1)
scored for##11##2##(1991-2#1)(1996-9#1)(1997-8#1)(2006-5#1)(2008-10#3)(2008-7#1)(2011-2#3)
scored high##3##2##(2007-7#1)(2009-12#1)(2011-1#1)
scored higher on the##2##4##(1991-2#1)(2008-7#1)
scored higher on##4##3##(1991-2#1)(2006-7#1)(2008-7#1)(2012-2#1)
scored higher than##4##3##(1993-1#1)(2007-12#2)(2009-8#1)
scored higher##8##2##(1991-2#1)(1993-1#1)(2006-7#1)(2007-12#2)(2008-7#1)(2009-8#1)(2012-2#1)
scored highest##3##2##(1995-3#1)(2008-11#2)
scored in each##3##3##(2006-8#1)(2007-9#1)(2008-8#1)
scored in the##5##3##(1994-6#1)(1996-3#2)(2008-10#1)(2010-10#1)
scored in##12##2##(1990-11#1)(1994-6#1)(1994-8#1)(1996-3#2)(2006-5#2)(2006-8#1)(2007-9#1)(2008-10#1)(2008-8#1)(2010-10#1)
scored less than##2##3##(2008-1#1)(2010-12#1)
scored less##3##2##(2008-1#1)(2009-7#1)(2010-12#1)
scored lower##3##2##(1991-6#1)(2010-10#1)(2011-2#1)
scored on a##2##3##(2006-10#1)(2008-12#1)
scored on##7##2##(1993-1#1)(2006-10#1)(2007-10#1)(2008-10#2)(2008-12#1)(2009-4#1)
scored positive for##3##3##(1996-6#1)(2008-10#2)
scored positive##5##2##(1990-10#1)(1996-6#1)(1996-7#1)(2008-10#2)
scored significantly higher on##3##4##(2006-7#2)(2009-5#1)
scored significantly higher than the##3##5##(1991-5#1)(2010-8#1)(2012-2#1)
scored significantly higher than##4##4##(1991-5#1)(2010-8#2)(2012-2#1)
scored significantly higher##7##3##(1991-5#1)(2006-7#2)(2009-5#1)(2010-8#2)(2012-2#1)
scored significantly##9##2##(1991-5#1)(2005-8#1)(2006-7#2)(2008-9#1)(2009-5#1)(2010-8#2)(2012-2#1)
scored using a##3##3##(1997-3#1)(2008-10#1)(2013-1#1)
scored using the##2##3##(1997-3#1)(2007-5#1)
scored using##5##2##(1997-3#2)(2007-5#1)(2008-10#1)(2013-1#1)
scored##143##1##(1990-10#1)(1990-11#2)(1991-2#2)(1991-5#1)(1991-6#1)(1992-9#1)(1993-1#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-3#2)(1995-6#1)(1996-3#3)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#2)(1997-8#3)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-5#3)(2006-6#1)(2006-7#3)(2006-8#1)(2007-10#1)(2007-12#3)(2007-2#2)(2007-5#3)(2007-7#2)(2007-8#6)(2007-9#2)(2008-1#4)(2008-10#16)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#5)(2009-10#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-12#4)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-2#3)(2012-3#2)(2013-1#5)
scores &gt##5##2##(1994-3#1)(1995-11#1)(2008-7#2)(2009-4#1)
scores (P &lt##3##3##(1993-12#1)(2011-1#1)(2013-1#1)
scores (r = 0##2##4##(2010-9#2)
scores (r =##3##3##(2009-10#1)(2010-9#2)
scores a##2##2##(1994-9#1)(2006-12#1)
scores after##6##2##(1996-10#1)(1997-2#1)(2006-12#1)(2006-9#1)(2012-12#1)(2012-2#1)
scores among##4##2##(1995-4#1)(2008-2#1)(2009-11#1)(2013-7#1)
scores amongst##2##2##(1993-1#1)(2013-7#1)
scores and the##8##3##(1993-12#1)(1994-6#1)(2007-8#1)(2008-6#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-3#1)
scores and to##2##3##(2010-11#1)(2012-1#1)
scores and##57##2##(1991-2#1)(1991-4#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-4#2)(1994-12#1)(1994-6#1)(1995-1#1)(1995-7#1)(2004-11#1)(2005-10#1)(2006-10#2)(2006-12#2)(2006-9#1)(2007-10#2)(2007-2#1)(2007-6#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-9#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-11#2)(2010-2#2)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-1#3)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
scores are##9##2##(1992-2#1)(1993-8#1)(1997-8#1)(2007-12#1)(2007-4#1)(2008-8#1)(2010-3#1)(2011-1#1)(2012-2#1)
scores as well as##2##4##(2006-7#1)(2008-8#1)
scores as##7##2##(1996-7#1)(2006-7#1)(2007-10#1)(2008-8#1)(2012-2#3)
scores at baseline##3##3##(2006-6#1)(2012-1#1)(2013-1#1)
scores at follow-up##2##3##(2008-12#1)(2013-1#1)
scores at the##2##3##(1990-10#1)(2008-10#1)
scores at##16##2##(1990-10#1)(1991-6#1)(2006-6#1)(2006-8#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#2)
scores averaged##2##2##(2008-9#1)(2012-2#1)
scores between the##3##3##(1990-3#1)(2006-9#1)(2010-9#1)
scores between##11##2##(1990-3#1)(1996-12#1)(1996-7#1)(2004-11#1)(2006-9#1)(2008-1#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
scores but##2##2##(2006-10#1)(2006-2#1)
scores compared with patients##2##4##(2008-7#1)(2013-1#1)
scores compared with##3##3##(2006-10#1)(2008-7#1)(2013-1#1)
scores correlated##2##2##(2009-9#1)(2013-8#1)
scores decreased from##2##3##(1990-12#1)(2008-7#1)
scores decreased##3##2##(1990-12#1)(2008-7#1)(2008-9#1)
scores developed##2##2##(2009-7#1)(2013-8#1)
scores did not correlate##2##4##(2007-11#1)(2010-10#1)
scores did not##7##3##(2004-10#1)(2006-10#1)(2007-11#1)(2007-7#1)(2010-10#1)(2010-11#1)(2010-3#1)
scores during##2##2##(1995-4#1)(2009-4#1)
scores for both##2##3##(2006-11#1)(2011-2#1)
scores for children##2##3##(2012-2#2)
scores for knowledge##2##3##(2007-10#1)(2012-3#1)
scores for pain##4##3##(2008-12#1)(2011-2#1)(2012-2#2)
scores for the##14##3##(1996-7#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-10#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-12#2)(2011-1#2)(2012-2#1)(2013-7#1)
scores for##61##2##(1995-12#1)(1996-12#1)(1996-5#1)(1996-7#1)(2004-11#2)(2006-10#2)(2006-11#1)(2006-2#1)(2006-7#1)(2007-10#4)(2007-11#1)(2008-11#1)(2008-12#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#2)(2009-9#1)(2010-1#2)(2010-12#3)(2010-2#1)(2010-4#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#7)(2012-3#2)(2013-1#3)(2013-7#4)
scores from the##3##3##(1995-3#1)(2007-12#1)(2012-1#1)
scores from##13##2##(1995-3#1)(1995-6#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-2#2)(2009-11#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
scores had no##2##3##(2011-2#1)(2013-1#1)
scores had##11##2##(1992-1#1)(2007-10#1)(2008-7#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
scores have been##4##3##(2006-6#1)(2008-5#1)(2009-9#1)(2013-8#1)
scores have##5##2##(2006-6#1)(2008-5#1)(2009-9#2)(2013-8#1)
scores improved from##2##3##(2012-2#2)
scores improved##6##2##(1991-12#1)(2008-10#1)(2012-2#3)(2013-1#1)
scores in a##4##3##(1993-5#1)(2007-12#1)(2013-8#2)
scores in both##3##3##(2004-10#1)(2008-7#1)(2011-2#1)
scores in patients with##2##4##(2007-3#1)(2010-8#1)
scores in the physical##3##4##(2011-2#1)(2012-12#2)
scores in the##15##3##(1996-2#1)(1997-2#1)(2005-10#1)(2006-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#2)
scores in##41##2##(1993-3#1)(1993-5#1)(1996-2#1)(1997-2#1)(2004-10#1)(2005-10#1)(2006-10#3)(2006-12#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-11#2)(2008-5#1)(2008-6#3)(2008-7#4)(2008-9#2)(2009-4#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#1)(2013-8#3)
scores indicated##3##2##(2006-10#1)(2006-12#1)(2008-11#1)
scores is##4##2##(2008-10#3)(2008-11#1)
scores obtained by interview from##2##5##(2007-10#2)
scores obtained##7##2##(1994-3#1)(1995-12#1)(2007-10#2)(2010-3#1)(2011-1#2)
scores occurred##3##2##(2007-9#1)(2008-7#1)(2011-1#1)
scores of 2##2##3##(1997-5#1)(2006-8#1)
scores of 3##3##3##(2006-7#2)(2008-1#1)
scores of a##2##3##(2008-10#1)(2008-7#1)
scores of all##2##3##(2007-3#1)(2007-8#1)
scores of anxiety##2##3##(2006-8#1)(2009-10#1)
scores of children with##2##4##(2005-8#2)
scores of emotional stress##2##4##(2008-6#2)
scores of pain (p=0##2##4##(2008-10#2)
scores of the students##2##4##(2011-2#2)
scores of the##11##3##(1990-3#1)(1995-4#1)(2006-10#1)(2008-10#3)(2009-8#1)(2011-1#1)(2011-2#2)(2012-2#1)
scores of##77##2##(1990-3#1)(1991-12#1)(1992-1#3)(1993-3#1)(1995-4#1)(1997-5#3)(2004-11#1)(2004-3#1)(2005-11#1)(2005-8#2)(2005-9#2)(2006-10#2)(2006-12#2)(2006-4#2)(2006-7#2)(2006-8#2)(2006-9#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#8)(2008-5#2)(2008-6#3)(2008-7#4)(2008-9#1)(2009-10#3)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#6)(2011-2#3)(2012-12#1)(2012-2#5)(2013-1#2)(2013-8#1)
scores on a##3##3##(2006-2#1)(2008-12#1)(2009-9#1)
scores on all##4##3##(2007-12#1)(2008-1#1)(2013-1#2)
scores on both##2##3##(2006-7#1)(2008-2#1)
scores on measures of##2##4##(2006-7#1)(2012-1#1)
scores on the Eating##2##4##(2006-7#1)(2012-5#1)
scores on the sense of competence scale reported higher##2##9##(2009-9#2)
scores on the##23##3##(1992-2#1)(1993-3#1)(1995-11#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-5#1)(2006-10#1)(2006-7#1)(2007-12#1)(2008-12#1)(2008-7#2)(2008-8#2)(2009-8#1)(2009-9#2)(2011-12#1)(2012-2#1)(2012-5#1)(2013-7#2)
scores on##57##2##(1992-2#1)(1993-3#1)(1995-11#1)(1995-2#1)(1996-3#1)(1996-7#1)(1997-2#2)(1997-5#1)(2006-10#1)(2006-2#1)(2006-7#4)(2007-10#2)(2007-12#4)(2008-1#1)(2008-12#5)(2008-2#2)(2008-4#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-4#1)(2009-8#1)(2009-9#3)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#2)(2013-7#2)
scores or##2##2##(2011-1#1)(2012-12#1)
scores over##4##2##(1994-9#1)(2006-11#1)(2008-12#2)
scores ranged##2##2##(2008-10#1)(2008-9#1)
scores related to##3##3##(2008-10#1)(2010-10#1)(2010-8#1)
scores should##2##2##(2008-7#1)(2010-5#1)
scores showed significant improvement##2##4##(1996-3#1)(2005-9#1)
scores showed that##2##3##(2008-10#1)(2010-8#1)
scores showed##7##2##(1996-3#1)(2005-9#2)(2007-10#1)(2008-10#1)(2010-8#1)(2011-12#1)
scores significantly##3##2##(2008-10#1)(2008-8#1)(2009-10#1)
scores similar to##2##3##(2008-9#1)(2013-1#1)
scores than the##5##3##(2007-8#1)(2010-10#1)(2010-12#1)(2013-1#1)(2013-8#1)
scores than##16##2##(1992-12#1)(1995-3#1)(1997-5#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-8#2)(2009-4#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
scores that were##2##3##(2007-8#1)(2010-9#1)
scores that##5##2##(1994-6#1)(2007-8#1)(2008-5#1)(2010-9#1)(2012-2#1)
scores the##2##2##(1990-9#1)(1991-2#1)
scores to##10##2##(2004-10#2)(2006-10#1)(2008-3#1)(2008-5#1)(2009-4#1)(2009-9#1)(2012-11#3)
scores under##2##2##(2008-6#1)(2012-2#1)
scores using a##3##3##(2007-8#1)(2010-9#1)(2012-12#1)
scores using##7##2##(2007-8#1)(2008-12#1)(2008-5#1)(2010-3#1)(2010-9#1)(2012-1#1)(2012-12#1)
scores was also##2##3##(2006-8#1)(2008-8#1)
scores was not##2##3##(2011-1#1)(2012-2#1)
scores was noted##2##3##(2011-2#1)(2013-1#1)
scores was##14##2##(1994-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-12#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
scores were 4##2##3##(2007-2#1)(2011-2#1)
scores were MD/RTS = 0##2##5##(2008-7#2)
scores were also associated with##2##5##(2007-2#1)(2007-9#1)
scores were also##7##3##(1995-12#1)(2006-10#1)(2007-2#1)(2007-9#2)(2008-6#1)(2010-4#1)
scores were analyzed##2##3##(2009-9#1)(2012-12#1)
scores were assessed by##2##4##(2005-9#1)(2009-1#1)
scores were assessed##3##3##(2005-9#1)(2009-1#1)(2011-1#1)
scores were associated with##3##4##(2012-1#1)(2012-12#2)
scores were calculated##5##3##(2006-10#1)(2007-8#1)(2011-2#2)(2013-1#1)
scores were compared with##2##4##(2006-10#1)(2008-9#1)
scores were compared##3##3##(2006-10#1)(2008-9#1)(2010-5#1)
scores were elevated in##2##4##(2009-12#1)(2013-8#1)
scores were evaluated##2##3##(1995-4#1)(2010-4#1)
scores were found to be##2##5##(1996-1#1)(1996-7#1)
scores were higher in the##2##5##(1996-12#1)(2006-10#1)
scores were higher##3##3##(1996-12#1)(2006-10#1)(2013-8#1)
scores were lower##4##3##(2006-10#2)(2008-4#1)(2013-1#1)
scores were measured##3##3##(2006-10#1)(2008-9#1)(2010-2#1)
scores were observed##2##3##(1997-5#1)(2010-7#1)
scores were recorded##4##3##(2006-12#1)(2008-10#1)(2008-7#1)(2009-8#1)
scores were reduced by##2##4##(1995-3#1)(2008-3#1)
scores were significantly higher##6##4##(1995-2#1)(2006-10#2)(2008-6#1)(2008-9#1)(2011-1#1)
scores were significantly lower##3##4##(2005-8#1)(2008-9#1)(2010-12#1)
scores were significantly##13##3##(1995-2#1)(2005-8#1)(2006-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-12#1)(2011-1#2)(2011-12#1)
scores were similar##4##3##(1990-8#1)(1993-4#1)(1996-7#1)(2012-1#1)
scores were stable over a##2##5##(2007-12#2)
scores were used##2##3##(2007-8#1)(2013-1#1)
scores were##108##2##(1990-8#1)(1993-1#1)(1993-4#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-7#2)(1996-9#2)(1997-5#2)(2004-3#1)(2005-8#1)(2005-9#1)(2006-10#10)(2006-12#2)(2007-10#1)(2007-12#5)(2007-2#3)(2007-4#1)(2007-8#2)(2007-9#3)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#7)(2009-1#1)(2009-12#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-4#4)(2010-5#1)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#2)
scores when##2##2##(2008-4#1)(2013-1#1)
scores with the##3##3##(2012-3#2)(2013-8#1)
scores with##10##2##(1997-8#1)(2006-7#1)(2007-2#1)(2008-7#1)(2009-9#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-8#1)
scores##944##1##(1990-10#2)(1990-12#1)(1990-3#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#4)(1991-2#5)(1991-4#2)(1991-6#1)(1991-9#1)(1992-1#5)(1992-12#1)(1992-2#3)(1993-1#6)(1993-12#3)(1993-2#3)(1993-3#4)(1993-4#4)(1993-5#1)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#4)(1994-6#3)(1994-9#2)(1995-1#3)(1995-11#3)(1995-12#4)(1995-2#4)(1995-3#5)(1995-4#4)(1995-6#1)(1995-7#2)(1995-8#1)(1996-1#2)(1996-10#2)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#3)(1996-7#8)(1996-8#2)(1996-9#3)(1997-2#5)(1997-4#1)(1997-5#10)(1997-6#1)(1997-8#2)(2004-10#7)(2004-11#6)(2004-12#1)(2004-2#1)(2004-3#3)(2005-10#5)(2005-11#2)(2005-7#1)(2005-8#3)(2005-9#5)(2006-10#37)(2006-11#2)(2006-12#17)(2006-2#4)(2006-4#2)(2006-6#2)(2006-7#13)(2006-8#9)(2006-9#6)(2007-10#21)(2007-11#6)(2007-12#13)(2007-2#9)(2007-3#4)(2007-4#2)(2007-6#2)(2007-7#4)(2007-8#14)(2007-9#12)(2008-1#7)(2008-10#33)(2008-11#8)(2008-12#24)(2008-2#8)(2008-3#7)(2008-4#9)(2008-5#24)(2008-6#17)(2008-7#35)(2008-8#14)(2008-9#25)(2009-1#3)(2009-10#8)(2009-11#3)(2009-12#3)(2009-2#2)(2009-3#3)(2009-4#13)(2009-7#5)(2009-8#4)(2009-9#17)(2010-1#3)(2010-10#6)(2010-11#4)(2010-12#15)(2010-2#5)(2010-3#8)(2010-4#11)(2010-5#4)(2010-6#1)(2010-7#4)(2010-8#8)(2010-9#6)(2011-1#29)(2011-12#4)(2011-2#36)(2012-1#17)(2012-11#8)(2012-12#18)(2012-2#38)(2012-3#12)(2012-5#2)(2013-1#50)(2013-7#12)(2013-8#19)
scores)##2##1##(1995-1#1)(2007-12#1)
scoring a##2##2##(2008-10#1)(2009-5#1)
scoring and ranking system for##4##5##(2008-11#4)
scoring and ranking##5##3##(2008-11#5)
scoring and##11##2##(1997-1#1)(2008-11#5)(2008-5#2)(2011-2#1)(2012-2#1)(2013-1#1)
scoring centres##2##2##(2006-4#2)
scoring for##4##2##(1995-12#1)(1995-3#1)(2008-10#1)(2011-12#1)
scoring function that can##2##4##(2008-7#2)
scoring function##8##2##(2006-10#1)(2008-7#3)(2011-3#4)
scoring in##2##2##(1994-12#1)(2013-1#1)
scoring instructions##2##2##(1994-3#1)(2008-11#1)
scoring is##4##2##(1992-2#2)(1996-3#1)(2006-2#1)
scoring matrices##4##2##(2008-11#1)(2008-9#3)
scoring method##3##2##(2007-12#1)(2008-10#1)(2012-2#1)
scoring methods##8##2##(1992-9#1)(2007-12#1)(2012-12#2)(2012-2#1)(2012-3#3)
scoring of each instrument##2##4##(2005-4#1)(2007-11#1)
scoring of each##3##3##(2005-4#1)(2007-11#1)(2013-1#1)
scoring of the##5##3##(2006-7#1)(2007-10#1)(2007-12#1)(2008-11#1)(2009-4#1)
scoring of##18##2##(2005-4#1)(2006-7#2)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#2)(2009-4#1)(2011-1#1)(2012-1#1)(2013-1#1)
scoring scale##2##2##(1997-5#1)(2011-2#1)
scoring scheme##3##2##(2012-2#1)(2013-8#2)
scoring system (CFSS)##2##3##(2013-1#2)
scoring system for##4##3##(2007-12#1)(2008-5#1)(2010-3#1)(2013-1#1)
scoring system is##2##3##(2006-10#1)(2008-9#1)
scoring system of##3##3##(2007-11#1)(2009-3#1)(2012-11#1)
scoring system to assess##2##4##(2011-2#1)(2012-2#1)
scoring system to##5##3##(2007-8#2)(2011-2#1)(2012-12#1)(2012-2#1)
scoring system##49##2##(1990-4#1)(1992-2#1)(1993-8#1)(1995-4#1)(1995-7#2)(1996-4#1)(1997-8#1)(2005-1#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#4)(2008-10#2)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2010-3#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#6)
scoring systems and##8##3##(1993-7#5)(2006-10#1)(2007-10#1)(2007-8#1)
scoring systems in##2##3##(2006-10#1)(2010-11#1)
scoring systems##23##2##(1993-7#5)(1996-9#1)(2006-10#5)(2006-7#1)(2007-10#1)(2007-8#1)(2010-11#3)(2010-7#1)(2012-2#1)(2013-1#4)
scoring the##3##2##(1991-8#1)(2006-10#1)(2008-1#1)
scoring was performed using##2##4##(2008-5#1)(2011-2#1)
scoring was##5##2##(2008-10#2)(2008-5#1)(2010-8#1)(2011-2#1)
scoring##212##1##(1990-4#1)(1991-8#1)(1992-2#4)(1992-9#1)(1993-4#2)(1993-7#5)(1993-8#1)(1994-12#1)(1994-3#2)(1994-6#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-7#2)(1996-3#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-8#2)(2005-1#1)(2005-4#1)(2005-8#1)(2006-10#9)(2006-2#5)(2006-4#2)(2006-7#6)(2007-10#4)(2007-11#3)(2007-12#5)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#13)(2008-3#3)(2008-4#3)(2008-5#9)(2008-7#8)(2008-8#1)(2008-9#10)(2009-11#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#3)(2010-2#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#5)(2011-3#4)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#8)(2012-3#4)(2013-1#20)(2013-7#1)(2013-8#2)
scorodioside##2##1##(2007-1#2)
scorpioides##4##1##(2012-2#4)
scorpion beta-toxins##2##2##(2008-8#2)
scorpion##30##1##(1990-2#3)(1990-8#2)(1993-3#2)(1993-6#2)(1994-12#1)(2006-2#1)(2007-12#8)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#1)(2009-6#3)(2013-1#1)
scotopic b-wave##2##2##(2006-8#2)
scotopic##8##1##(1997-3#1)(2006-8#3)(2007-5#1)(2011-2#2)(2012-12#1)
scoured##2##1##(2010-8#2)
scourge is##2##2##(1995-2#1)(2010-12#1)
scourge##5##1##(1995-2#1)(1995-9#1)(2008-1#1)(2008-9#1)(2010-12#1)
scouting##4##1##(2008-10#1)(2011-2#3)
scrA##2##1##(1990-10#2)
scrK##2##1##(1990-10#2)
scrX##5##1##(2008-8#5)
scramblase##4##1##(2008-8#4)
scramble##4##1##(1991-11#1)(1992-7#1)(2008-9#1)(2013-1#1)
scrambled sentence##2##2##(2007-12#2)
scrambled##10##1##(1994-12#1)(1995-3#2)(1997-4#1)(2007-12#2)(2009-11#1)(2010-1#1)(2012-1#1)(2013-1#1)
scrambler mice##2##2##(2010-12#2)
scrambler##5##1##(2008-2#1)(2010-12#4)
scrambling##4##1##(2007-5#1)(2007-8#1)(2008-9#1)(2010-12#1)
scrap##7##1##(1992-9#1)(2007-9#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-5#1)(2012-2#1)
scraped##3##1##(1995-11#1)(2008-10#1)(2011-2#1)
scrapie in sheep and##2##4##(1996-3#2)
scrapie in##6##2##(1993-8#3)(1995-5#1)(1996-3#2)
scrapie##23##1##(1990-6#1)(1993-8#4)(1994-6#1)(1995-5#4)(1996-3#2)(1996-5#2)(1996-6#4)(2006-8#5)
scrapie-diseased##2##1##(1996-6#2)
scraping of##2##2##(2008-5#1)(2013-1#1)
scraping##9##1##(1991-2#1)(1991-5#1)(2008-5#1)(2009-10#1)(2010-6#1)(2013-1#4)
scrapings from##2##2##(2007-10#1)(2007-7#1)
scrapings of##4##2##(1992-9#1)(2008-10#3)
scrapings were collected##2##3##(1990-3#1)(2007-7#1)
scrapings##15##1##(1990-3#1)(1992-9#1)(1996-12#1)(1997-4#1)(2007-10#1)(2007-7#4)(2008-10#3)(2008-5#1)(2009-8#1)(2011-1#1)
scrapped##4##1##(2007-9#1)(2008-10#1)(2010-2#2)
scratch assay##3##2##(2012-12#1)(2013-8#2)
scratch lottery tickets##4##3##(2013-1#4)
scratch lottery##5##2##(2013-1#5)
scratch##14##1##(1990-3#1)(2005-11#1)(2008-4#1)(2010-4#1)(2010-8#1)(2012-12#1)(2013-1#5)(2013-8#3)
scratches##6##1##(1991-4#1)(2006-12#1)(2007-12#1)(2008-4#2)(2009-2#1)
scratching behaviour##3##2##(1996-7#3)
scratching##11##1##(1996-7#3)(2007-11#1)(2007-12#1)(2008-5#2)(2008-8#2)(2011-2#2)
screaming##4##1##(1996-1#2)(1997-1#1)(2013-1#1)
screen a##15##2##(1990-2#1)(1990-4#1)(1990-6#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-7#1)(1994-12#1)(1994-6#1)(1997-4#1)(2007-2#1)(2008-1#1)(2008-4#1)(2010-2#1)(2013-1#1)
screen along##2##2##(1992-10#1)(2008-2#1)
screen and the##3##3##(1997-4#1)(2006-10#1)(2012-12#1)
screen and##13##2##(1994-12#1)(1995-6#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-8#1)(2011-1#1)(2012-12#1)
screen are##2##2##(1990-2#1)(2008-3#1)
screen detected##2##2##(2004-2#1)(2013-1#1)
screen for HIV##2##3##(2007-7#1)(2011-2#1)
screen for all##2##3##(2008-10#1)(2008-4#1)
screen for mutations##3##3##(2005-12#1)(2006-10#1)(2008-9#1)
screen for problem outcomes##2##4##(1997-2#2)
screen for##70##2##(1990-7#1)(1991-11#1)(1991-3#1)(1992-11#1)(1994-7#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-1#4)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-7#3)(2008-9#2)(2010-11#1)(2010-12#3)(2010-5#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-2#5)(2012-3#3)(2013-1#1)(2013-8#1)
screen from##2##2##(2008-3#1)(2008-7#1)
screen in##5##2##(2009-5#1)(2011-1#1)(2011-2#2)(2012-11#1)
screen is##5##2##(2008-2#1)(2008-3#2)(2010-7#1)(2013-7#1)
screen mode using a series of##3##6##(1990-8#3)
screen mode##7##2##(1990-8#6)(2008-10#1)
screen modes were##2##3##(1990-8#2)
screen novel##2##2##(2008-4#1)(2012-12#1)
screen of a##3##3##(1994-9#1)(1997-5#1)(2008-10#1)
screen of the##2##3##(2008-3#1)(2011-2#1)
screen of##13##2##(1992-12#1)(1994-8#1)(1994-9#1)(1997-2#1)(1997-5#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-9#1)(2011-2#2)
screen positive##2##2##(1996-12#1)(2007-12#1)
screen serum##2##2##(2008-7#1)(2013-8#1)
screen that##2##2##(1992-12#1)(2008-3#1)
screen the##10##2##(1994-3#1)(1996-8#1)(1996-9#1)(1997-8#1)(2005-11#1)(2007-5#1)(2007-7#1)(2008-8#2)(2010-12#1)
screen time and##3##3##(2013-1#3)
screen time##6##2##(2008-11#1)(2010-8#2)(2013-1#3)
screen to identify##2##3##(2008-10#2)
screen to search for##2##4##(1995-6#1)(2013-8#1)
screen to##8##2##(1992-12#1)(1993-6#1)(1995-2#1)(1995-6#1)(2008-10#3)(2013-8#1)
screen using the##2##3##(2008-10#1)(2011-2#1)
screen using##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
screen was found to be##2##5##(1992-12#1)(1994-5#1)
screen was##5##2##(1992-12#2)(1992-7#1)(1994-5#1)(2008-9#1)
screen were##2##2##(2006-4#1)(2010-11#1)
screen with a##3##3##(2008-2#1)(2008-3#2)
screen with##6##2##(1996-5#1)(2008-2#1)(2008-3#4)
screen##325##1##(1990-2#2)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#8)(1991-11#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-10#2)(1992-11#2)(1992-12#6)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#3)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#4)(1994-9#3)(1995-1#1)(1995-2#2)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#3)(1997-5#4)(1997-8#1)(2004-2#1)(2005-11#3)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#6)(2006-12#3)(2006-2#1)(2006-4#1)(2006-6#1)(2007-12#5)(2007-2#2)(2007-3#1)(2007-5#3)(2007-6#2)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#9)(2008-10#27)(2008-11#6)(2008-12#2)(2008-2#18)(2008-3#20)(2008-4#11)(2008-7#7)(2008-8#7)(2008-9#13)(2009-10#2)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#5)(2010-2#1)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#3)(2011-1#4)(2011-2#6)(2012-1#4)(2012-11#2)(2012-12#5)(2012-2#8)(2012-3#3)(2013-1#12)(2013-7#2)(2013-8#5)
screen-based sedentary behavior and##3##4##(2013-1#3)
screen-based sedentary##4##2##(2013-1#4)
screen-based##6##1##(2013-1#6)
screen-detected##10##1##(1991-6#1)(1995-12#2)(1997-7#1)(2004-2#1)(2010-3#1)(2011-1#4)
screen-film mammography##4##2##(2007-4#4)
screen-printed amperometric biosensor##2##3##(2008-10#2)
screen-printed amperometric##3##2##(2008-10#3)
screen-printed biosensor##3##2##(2008-10#3)
screen-printed carbon electrode##9##3##(2007-8#2)(2008-10#7)
screen-printed carbon electrodes (SPCEs)##3##4##(2008-10#3)
screen-printed carbon electrodes##9##3##(2008-10#9)
screen-printed carbon##19##2##(2007-8#2)(2008-10#17)
screen-printed electrode (SPE)##4##3##(2008-10#4)
screen-printed electrode modified by a##2##5##(2007-8#2)
screen-printed electrode##19##2##(2007-8#4)(2008-10#15)
screen-printed electrodes are##2##3##(2008-10#2)
screen-printed electrodes for##2##3##(2008-10#2)
screen-printed electrodes##10##2##(2007-8#1)(2008-10#8)(2010-2#1)
screen-printed graphite##2##2##(2007-8#2)
screen-printed sensor##2##2##(2008-10#2)
screen-printed##66##1##(2007-8#9)(2008-10#56)(2010-2#1)
screen-printing##7##1##(2007-8#1)(2008-10#6)
screen-time##2##1##(2013-1#2)
screened 12##2##2##(1994-8#1)(1997-5#1)
screened a human##6##3##(1991-5#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-3#1)(2008-8#1)
screened a rat##2##3##(1991-9#1)(1993-8#1)
screened a##12##2##(1991-5#1)(1991-9#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-3#1)(1996-11#1)(2008-8#1)(2012-1#1)(2013-1#1)
screened against##12##2##(1992-6#1)(2008-10#2)(2008-3#1)(2008-5#5)(2008-7#1)(2010-12#1)(2012-11#1)
screened and##10##2##(1992-12#1)(1992-4#1)(1994-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2011-3#1)(2012-2#1)(2012-3#1)
screened at##2##2##(2007-7#1)(2007-8#1)
screened by PCR##3##3##(1995-8#1)(2012-2#1)(2013-8#1)
screened by a##2##3##(1993-3#1)(1996-5#1)
screened by immunoblotting##2##3##(1990-11#1)(1994-2#1)
screened by means of##2##4##(1992-2#1)(2006-12#1)
screened by##31##2##(1990-10#1)(1990-11#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-5#1)(1996-6#1)(1996-7#1)(2004-4#1)(2006-12#2)(2007-7#1)(2008-10#2)(2008-7#1)(2008-9#2)(2009-11#1)(2010-1#2)(2010-4#1)(2011-1#1)(2012-2#2)(2013-8#1)
screened for antimicrobial activity##2##4##(2010-5#1)(2012-2#1)
screened for antimicrobial##3##3##(2010-12#1)(2010-5#1)(2012-2#1)
screened for biological activity##2##4##(1995-7#1)(2008-11#1)
screened for eligibility##2##3##(2009-6#1)(2012-3#1)
screened for genes##2##3##(1994-12#1)(2008-11#1)
screened for lignin##2##3##(2008-6#2)
screened for resistance to##4##4##(2008-10#4)
screened for the presence of##8##5##(1990-6#1)(1991-5#1)(1993-9#1)(1994-11#1)(1996-12#1)(2006-12#1)(2008-10#2)
screened for the##13##3##(1990-6#1)(1991-5#1)(1991-6#1)(1993-9#1)(1994-11#1)(1996-12#1)(2006-1#1)(2006-12#1)(2008-10#4)(2011-12#1)
screened for their antibacterial activity##5##5##(2008-3#1)(2008-5#4)
screened for their in vitro##2##5##(2010-2#1)(2011-1#1)
screened for their##25##3##(1990-5#1)(1997-1#1)(1997-4#1)(2006-5#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#8)(2008-6#1)(2008-8#1)(2009-10#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
screened for##145##2##(1990-12#2)(1990-2#2)(1990-5#2)(1990-6#1)(1991-5#1)(1991-6#1)(1992-10#2)(1992-11#1)(1992-2#1)(1993-11#1)(1993-6#1)(1993-9#2)(1994-11#2)(1994-12#3)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#2)(1996-11#2)(1996-12#1)(1996-6#1)(1997-1#1)(1997-4#1)(2005-11#1)(2005-7#1)(2006-1#2)(2006-10#2)(2006-12#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-2#2)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#24)(2008-11#4)(2008-12#2)(2008-3#2)(2008-5#13)(2008-6#3)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-8#2)(2011-1#6)(2011-12#3)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
screened from a##3##3##(1995-6#1)(2008-8#1)(2012-3#1)
screened from##7##2##(1990-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-4#1)(2008-8#1)(2012-3#1)
screened in a##3##3##(1994-5#1)(2008-5#1)(2009-12#1)
screened in the##2##3##(1991-6#1)(2008-9#1)
screened in this study##2##4##(2006-12#1)(2013-8#1)
screened in vitro against##7##4##(2008-10#1)(2008-3#1)(2008-5#5)
screened in vitro##8##3##(2008-10#1)(2008-3#1)(2008-5#5)(2008-6#1)
screened in##21##2##(1990-6#1)(1991-6#1)(1994-5#1)(1997-6#1)(2006-12#1)(2008-10#2)(2008-3#2)(2008-5#6)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-5#1)(2013-8#1)
screened out and##2##3##(2008-8#1)(2012-2#1)
screened out##5##2##(2005-11#1)(2006-9#1)(2008-8#2)(2012-2#1)
screened subjects##3##2##(1993-1#1)(2011-1#2)
screened the##7##2##(2008-1#1)(2008-10#1)(2008-8#2)(2009-3#1)(2011-2#1)(2012-3#1)
screened to##13##2##(1996-11#1)(1996-7#1)(2007-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2011-3#1)(2012-2#1)
screened using a##5##3##(1991-1#1)(1992-3#1)(1994-8#1)(1996-8#1)(2009-6#1)
screened using##12##2##(1991-1#1)(1992-3#1)(1992-6#1)(1994-8#1)(1996-10#1)(1996-8#1)(2008-10#2)(2008-8#2)(2009-6#1)(2013-1#1)
screened were##4##2##(2007-9#1)(2011-2#1)(2013-8#2)
screened with a##9##3##(1990-8#1)(1991-12#1)(1991-6#1)(1991-9#1)(1993-7#1)(1994-9#1)(1997-1#1)(2008-10#1)(2011-2#1)
screened with the##5##3##(1990-12#1)(1990-7#1)(1994-6#1)(1994-8#1)(2008-10#1)
screened with##29##2##(1990-12#2)(1990-2#1)(1990-7#2)(1990-8#2)(1991-12#1)(1991-6#2)(1991-9#1)(1992-3#3)(1992-8#1)(1993-7#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1997-1#1)(2006-10#1)(2006-9#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
screened women##5##2##(1992-6#1)(2004-2#2)(2011-1#2)
screened##427##1##(1990-10#1)(1990-11#1)(1990-12#7)(1990-2#3)(1990-5#4)(1990-6#3)(1990-7#2)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-5#2)(1991-6#4)(1991-9#2)(1992-10#3)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#3)(1993-1#2)(1993-11#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#3)(1994-11#5)(1994-12#5)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-7#2)(1995-8#3)(1996-10#2)(1996-11#4)(1996-12#4)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#2)(2004-2#3)(2004-4#1)(2005-1#1)(2005-11#3)(2005-7#2)(2006-1#2)(2006-10#5)(2006-12#4)(2006-2#2)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#6)(2007-1#3)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#4)(2007-6#2)(2007-7#8)(2007-8#3)(2007-9#3)(2008-1#7)(2008-10#51)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#9)(2008-4#1)(2008-5#26)(2008-6#4)(2008-7#7)(2008-8#12)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#2)(2010-8#3)(2011-1#18)(2011-12#3)(2011-2#10)(2011-3#2)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#7)(2012-3#9)(2013-1#10)(2013-7#3)(2013-8#10)
screener##4##1##(2008-8#1)(2009-2#3)
screening (HTS)##5##2##(2005-7#1)(2008-10#2)(2008-9#1)(2010-2#1)
screening (range 2##2##3##(2011-1#2)
screening a human genomic library##4##5##(1991-6#1)(1993-12#1)(1993-7#1)(1994-11#1)
screening a human##8##3##(1991-6#1)(1991-7#1)(1993-12#1)(1993-7#1)(1994-11#1)(1994-3#1)(1996-10#1)(2008-8#1)
screening a rat##5##3##(1990-5#1)(1990-9#1)(1991-2#1)(1993-12#1)(1997-6#1)
screening a##28##2##(1990-5#2)(1990-9#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-7#1)(1993-12#2)(1993-7#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-5#1)(1996-10#1)(1997-4#1)(1997-6#1)(2005-9#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-1#1)
screening activities##2##2##(1996-4#1)(1997-1#1)
screening activity##2##2##(1991-6#1)(1992-10#1)
screening among low-income##2##3##(1997-2#1)(2013-1#1)
screening among##6##2##(1997-2#1)(2005-10#1)(2011-1#1)(2011-2#1)(2013-1#2)
screening an##2##2##(1991-7#1)(1996-5#1)
screening and analysis of##3##4##(2008-10#3)
screening and analysis##4##3##(2008-10#4)
screening and assessment##3##3##(2008-4#1)(2008-6#1)(2008-7#1)
screening and brief intervention##3##4##(2008-11#3)
screening and brief##4##3##(2008-11#4)
screening and confirmation##3##3##(2008-10#1)(2013-8#2)
screening and counselling programmes##2##4##(2010-12#2)
screening and data collection##2##4##(2009-12#2)
screening and determination##2##3##(1990-11#1)(2008-10#1)
screening and diagnosis##4##3##(2008-9#1)(2009-4#1)(2009-7#1)(2011-9#1)
screening and diagnostic##2##3##(2007-8#1)(2009-7#1)
screening and early##4##3##(1994-6#1)(2010-2#1)(2010-8#1)(2012-3#1)
screening and for##2##3##(2006-10#1)(2007-8#1)
screening and in##2##3##(2007-8#1)(2008-10#1)
screening and individual##2##3##(1994-11#1)(1994-3#1)
screening and intervention##3##3##(2005-10#1)(2008-11#1)(2011-1#1)
screening and interventions##2##3##(1997-3#1)(2008-11#1)
screening and management of##2##4##(2008-4#1)(2010-10#1)
screening and management##3##3##(2008-4#1)(2010-10#1)(2010-8#1)
screening and monitoring##2##3##(2007-11#1)(2008-10#1)
screening and prevention##5##3##(2005-10#1)(2009-9#1)(2011-2#1)(2012-2#2)
screening and preventive##2##3##(1994-3#1)(1997-3#1)
screening and quantification##2##3##(2008-10#1)(2010-9#1)
screening and surveillance##4##3##(2008-12#1)(2010-12#2)(2011-1#1)
screening and the##3##3##(2010-5#1)(2012-11#1)(2012-3#1)
screening and to##2##3##(2006-10#1)(2008-4#1)
screening and treatment##8##3##(2005-10#1)(2007-3#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-8#1)(2013-1#1)
screening and##139##2##(1990-11#2)(1990-4#1)(1991-9#1)(1992-2#1)(1992-7#1)(1993-12#2)(1993-9#1)(1994-11#1)(1994-3#2)(1994-6#1)(1995-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-3#2)(1997-8#1)(2005-10#3)(2005-11#1)(2006-10#5)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#3)(2008-10#13)(2008-11#9)(2008-12#1)(2008-3#2)(2008-4#7)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-12#2)(2009-4#2)(2009-5#3)(2009-7#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-5#2)(2010-8#5)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#4)(2011-3#1)(2011-9#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#2)
screening applications##2##2##(2008-4#1)(2011-1#1)
screening approach##5##2##(2008-10#1)(2008-8#1)(2010-10#1)(2012-3#1)(2013-1#1)
screening approaches##4##2##(1997-6#1)(2010-3#1)(2012-3#1)(2013-7#1)
screening as##2##2##(2007-2#1)(2011-2#1)
screening assay##6##2##(1991-7#1)(2004-11#1)(2008-10#1)(2008-12#1)(2010-2#1)(2011-3#1)
screening assays##6##2##(2007-7#1)(2008-11#1)(2008-9#1)(2012-12#3)
screening at##5##2##(1992-7#1)(1994-4#1)(2004-2#1)(2007-7#1)(2008-10#1)
screening based on##5##3##(1996-12#1)(1997-1#1)(2007-11#1)(2008-10#1)(2009-4#1)
screening before##2##2##(1990-9#1)(2007-7#1)
screening behaviors##2##2##(2009-5#1)(2013-1#1)
screening by##9##2##(1991-8#1)(1994-3#1)(1995-2#1)(2006-8#1)(2007-11#1)(2008-9#2)(2010-8#1)(2011-2#1)
screening can be##2##3##(1997-6#1)(2008-11#1)
screening can##6##2##(1997-6#1)(2007-11#1)(2008-11#1)(2011-2#2)(2013-1#1)
screening center##4##2##(2006-10#2)(2008-10#1)(2010-8#1)
screening checklist##3##2##(2005-8#1)(2007-11#1)(2010-9#1)
screening clinic##3##2##(2007-4#1)(2011-2#2)
screening colonoscopy##3##2##(1993-9#1)(1995-9#1)(2011-2#1)
screening combinatorial##2##2##(1997-3#1)(1997-4#1)
screening conditions##4##2##(2008-10#2)(2008-4#1)(2009-8#1)
screening could##2##2##(1996-12#1)(1997-7#1)
screening criteria##2##2##(2008-3#1)(2011-1#1)
screening data##5##2##(1993-9#1)(1994-4#1)(2008-5#1)(2010-7#2)
screening database##3##2##(1991-6#1)(2008-10#1)(2010-8#1)
screening donated blood for##2##4##(1994-2#1)(2007-8#1)
screening donated blood##3##3##(1994-2#1)(2007-8#1)(2011-2#1)
screening drugs##2##2##(2006-12#1)(2010-2#1)
screening during##2##2##(2007-9#1)(2013-1#1)
screening effects##2##2##(2009-6#2)
screening efforts##4##2##(1994-3#1)(2005-10#1)(2007-11#1)(2009-9#1)
screening examination##5##2##(1992-5#1)(2007-3#3)(2011-1#1)
screening examinations are##2##3##(1995-9#1)(2007-4#1)
screening experiments##3##2##(2008-2#1)(2009-12#1)(2013-7#1)
screening followed by##2##3##(1991-9#1)(2012-12#1)
screening for Down syndrome##2##4##(1996-12#1)(2007-4#1)
screening for Down's syndrome##7##4##(1992-12#3)(1992-9#1)(1993-12#1)(1996-12#2)
screening for a##2##3##(1997-3#1)(2006-12#1)
screening for amblyogenic##2##3##(1992-7#2)
screening for breast and##2##4##(1990-6#1)(1990-8#1)
screening for breast cancer##5##4##(1990-2#1)(1995-4#2)(2006-7#1)(2007-11#1)
screening for breast##7##3##(1990-2#1)(1990-6#1)(1990-8#1)(1995-4#2)(2006-7#1)(2007-11#1)
screening for carotid stenosis##2##4##(2008-7#1)(2011-2#1)
screening for cervical cancer##3##4##(1992-10#1)(1992-8#1)(2007-12#1)
screening for cervical##4##3##(1992-10#1)(1992-8#1)(1996-1#1)(2007-12#1)
screening for colorectal cancer##7##4##(1991-6#1)(1995-3#1)(1996-11#2)(2006-10#2)(2006-2#1)
screening for colorectal neoplasia##2##4##(2010-5#2)
screening for colorectal##10##3##(1991-6#1)(1995-3#1)(1996-11#3)(2006-10#2)(2006-2#1)(2010-5#2)
screening for drugs of abuse##2##5##(2008-10#2)
screening for familial##2##3##(1992-12#1)(2007-10#1)
screening for hepatitis B##2##4##(2012-2#1)(2013-8#1)
screening for lung cancer##2##4##(2010-5#1)(2011-2#1)
screening for lung##4##3##(2004-9#1)(2009-10#1)(2010-5#1)(2011-2#1)
screening for mutations in the##2##5##(2007-2#1)(2008-3#1)
screening for mutations in##3##4##(2007-2#1)(2008-3#1)(2008-4#1)
screening for occult##2##3##(1993-3#1)(2006-3#1)
screening for osteoporosis##5##3##(1990-9#1)(1992-8#1)(2007-7#1)(2009-3#1)(2012-2#1)
screening for possible##2##3##(1996-3#1)(2011-1#1)
screening for prostate cancer##2##4##(2006-10#1)(2009-5#1)
screening for resistance##3##3##(2008-10#3)
screening for sickle cell disease##2##5##(2006-7#1)(2008-11#1)
screening for sickle cell##3##4##(1993-9#1)(2006-7#1)(2008-11#1)
screening for syphilis##2##3##(1991-6#1)(2011-2#1)
screening for the##11##3##(1990-6#1)(1991-3#1)(1991-8#1)(2006-10#2)(2007-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2011-1#1)
screening for this##5##3##(1991-8#1)(2007-9#1)(2008-7#1)(2008-8#1)(2013-1#1)
screening for type##2##3##(2006-2#1)(2010-12#1)
screening for##203##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#5)(1990-8#1)(1990-9#2)(1991-10#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-7#2)(1991-8#3)(1991-9#1)(1992-10#1)(1992-12#5)(1992-5#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-12#2)(1993-3#1)(1993-9#2)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#4)(1995-9#1)(1996-1#1)(1996-10#2)(1996-11#3)(1996-12#4)(1996-2#1)(1996-3#1)(1996-6#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2004-9#1)(2005-12#2)(2005-7#1)(2006-10#9)(2006-12#1)(2006-2#2)(2006-3#1)(2006-7#4)(2006-8#1)(2007-10#2)(2007-11#4)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#11)(2008-11#5)(2008-2#3)(2008-3#3)(2008-4#8)(2008-5#2)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2010-12#1)(2010-5#5)(2011-1#3)(2011-12#1)(2011-2#6)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#4)(2013-8#2)
screening from##3##2##(2006-10#1)(2008-4#1)(2011-2#1)
screening guidelines##7##2##(1995-9#1)(2006-10#3)(2011-1#1)(2012-2#1)(2013-1#1)
screening had##2##2##(2008-10#1)(2013-1#1)
screening has been##2##3##(1990-12#1)(1992-2#1)
screening has##6##2##(1990-12#1)(1992-2#1)(1996-8#1)(2008-10#1)(2008-2#1)(2009-9#1)
screening healthcare information system##2##4##(2010-8#2)
screening imaging tests##3##3##(2007-4#3)
screening imaging##4##2##(2007-4#4)
screening in African American men##3##5##(2009-5#3)
screening in African American##4##4##(2008-4#1)(2009-5#3)
screening in CHCs##2##3##(2011-2#2)
screening in a##6##3##(1996-6#1)(2007-4#1)(2008-11#1)(2010-10#1)(2011-2#1)(2013-1#1)
screening in an##2##3##(1990-2#1)(2008-2#1)
screening in healthy##2##3##(2007-10#1)(2010-12#1)
screening in the elderly##2##4##(1990-3#1)(1990-9#1)
screening in the##8##3##(1990-3#1)(1990-9#1)(1996-3#2)(1996-4#1)(1996-5#1)(2011-2#2)
screening in women##3##3##(1991-6#1)(1995-9#1)(2008-1#1)
screening in##68##2##(1990-2#1)(1990-3#2)(1990-6#1)(1990-9#1)(1991-11#1)(1991-6#2)(1992-3#1)(1993-5#1)(1993-8#1)(1995-9#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#1)(1997-5#1)(1997-8#1)(2004-2#1)(2005-8#1)(2006-10#3)(2007-10#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-4#1)(2009-2#1)(2009-5#3)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#10)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#5)(2013-7#1)
screening included##2##2##(1991-6#1)(2013-1#1)
screening instrument for##2##3##(1995-4#1)(2006-1#1)
screening instrument##3##2##(1995-4#1)(2006-1#1)(2011-1#1)
screening is justified##2##3##(2006-2#1)(2008-3#1)
screening is performed##3##3##(1996-12#1)(2012-12#2)
screening is recommended##3##3##(2009-3#1)(2011-12#1)(2013-1#1)
screening is##40##2##(1991-1#1)(1991-6#1)(1992-2#1)(1992-6#1)(1994-2#1)(1994-7#1)(1995-9#1)(1996-12#2)(1997-1#1)(2004-1#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-2#1)(2007-4#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-3#1)(2013-1#2)
screening it##2##2##(1996-12#1)(2008-10#1)
screening large##4##2##(2008-10#2)(2008-9#1)(2010-12#1)
screening length of##2##3##(2007-12#1)(2008-2#1)
screening mammography##13##2##(1991-3#2)(1993-2#1)(1995-4#1)(1996-11#1)(1997-1#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-6#4)
screening may##4##2##(1995-7#1)(2006-10#1)(2008-11#1)(2008-7#1)
screening method for the##3##4##(2006-10#1)(2008-5#1)(2012-3#1)
screening method for##14##3##(1991-8#1)(1996-6#1)(2006-10#1)(2006-2#1)(2008-10#6)(2008-11#1)(2008-5#1)(2011-2#1)(2012-3#1)
screening method is##3##3##(2008-10#1)(2010-11#1)(2012-2#1)
screening method to##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
screening method was##2##3##(2005-11#1)(2010-4#1)
screening method##35##2##(1990-11#1)(1990-6#1)(1991-8#1)(1993-5#1)(1996-6#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-2#1)(2008-10#12)(2008-11#1)(2008-5#2)(2009-6#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-2#2)(2012-3#2)
screening methods are##4##3##(1994-6#1)(2006-2#1)(2013-7#2)
screening methods for##5##3##(1997-4#1)(2008-10#4)
screening methods in##2##3##(2008-10#1)(2008-12#1)
screening methods##27##2##(1990-12#1)(1994-6#1)(1995-4#1)(1996-4#1)(1997-4#1)(2006-2#2)(2007-8#2)(2008-10#8)(2008-12#1)(2008-6#1)(2008-8#1)(2009-9#1)(2010-11#1)(2012-1#1)(2013-1#2)(2013-7#2)
screening modality##2##2##(2010-11#1)(2011-2#1)
screening model##2##2##(2010-8#1)(2012-11#1)
screening models##4##2##(2008-8#1)(2008-9#1)(2011-3#2)
screening nurseries##3##2##(2008-10#3)
screening of a cDNA library derived from mRNA of##2##9##(1990-10#1)(1992-9#1)
screening of a cDNA library##4##5##(1990-10#1)(1992-9#1)(1993-3#1)(1995-2#1)
screening of a large number of##3##6##(1990-12#1)(1997-4#1)(2008-4#1)
screening of a##16##3##(1990-10#1)(1990-12#1)(1991-2#1)(1992-9#2)(1993-3#1)(1994-6#1)(1995-2#1)(1996-10#1)(1996-7#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-4#1)(2009-10#1)(2009-6#1)
screening of all##6##3##(1994-11#1)(2006-2#1)(2007-12#1)(2008-3#1)(2010-10#1)(2013-7#1)
screening of an##5##3##(1994-3#1)(1997-2#1)(2008-5#1)(2013-1#1)(2013-8#1)
screening of blood donors##4##4##(1992-10#1)(2006-12#1)(2006-7#1)(2013-1#1)
screening of blood##5##3##(1992-10#1)(2006-12#1)(2006-7#1)(2012-12#1)(2013-1#1)
screening of breeding##2##3##(2007-2#1)(2008-10#1)
screening of cancer##3##3##(1996-9#1)(1997-8#1)(2009-3#1)
screening of hip joints in newborn##2##6##(1993-5#2)
screening of in vitro##2##4##(2008-12#1)(2012-11#1)
screening of large numbers of##3##5##(2006-10#1)(2008-10#1)(2011-1#1)
screening of large##7##3##(1995-1#1)(2006-10#1)(2008-10#1)(2010-12#1)(2011-1#1)(2012-11#1)(2013-1#1)
screening of molecules##2##3##(2008-5#2)
screening of organic##2##3##(2006-2#1)(2010-5#1)
screening of organophosphorus pesticides##2##4##(2008-10#2)
screening of patients with##3##4##(1993-9#1)(1997-6#1)(2010-7#1)
screening of patients##6##3##(1990-6#1)(1993-9#1)(1997-3#1)(1997-6#1)(2007-7#1)(2010-7#1)
screening of pregnant##2##3##(1990-10#1)(1996-11#1)
screening of recombinants##2##3##(1991-9#2)
screening of the library##2##4##(1996-7#1)(2008-4#1)
screening of the##27##3##(1990-12#1)(1990-3#1)(1990-6#1)(1992-4#1)(1994-6#1)(1994-9#1)(1996-7#1)(1996-8#1)(1997-4#1)(2007-10#3)(2007-9#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-6#1)(2009-8#1)(2011-1#1)(2013-8#2)
screening of these##4##3##(2007-10#1)(2008-2#1)(2009-10#1)(2012-2#1)
screening of this##2##3##(1993-3#1)(2012-3#1)
screening of water##2##3##(2008-10#2)
screening of women##5##3##(1991-6#1)(2007-8#1)(2008-12#1)(2008-7#1)(2008-8#1)
screening of##253##2##(1990-10#2)(1990-12#2)(1990-3#1)(1990-6#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-2#2)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#2)(1992-4#2)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-5#3)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-7#1)(1996-10#1)(1996-11#3)(1996-12#1)(1996-2#1)(1996-4#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#2)(1997-4#3)(1997-6#1)(1997-8#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-12#2)(2006-2#2)(2006-7#1)(2007-1#2)(2007-10#4)(2007-11#5)(2007-12#3)(2007-2#2)(2007-4#1)(2007-7#3)(2007-8#5)(2007-9#1)(2008-10#26)(2008-11#9)(2008-12#3)(2008-2#3)(2008-3#6)(2008-4#7)(2008-5#7)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#3)(2009-3#1)(2009-4#2)(2009-6#2)(2009-8#1)(2010-10#1)(2010-12#4)(2010-3#2)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#7)(2012-1#1)(2012-11#3)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#10)(2013-7#3)(2013-8#8)
screening on##6##2##(1992-10#1)(1992-12#1)(1992-6#2)(1997-4#1)(1997-6#1)
screening or assessment##2##3##(2008-11#1)(2008-4#1)
screening or##7##2##(1996-12#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-11#1)
screening parameter##3##2##(2009-5#1)(2013-1#2)
screening patients##4##2##(1992-8#1)(1994-11#1)(2006-10#1)(2007-2#1)
screening performance##4##2##(1996-12#2)(2008-6#1)(2012-1#1)
screening platform##5##2##(2008-10#1)(2008-11#3)(2012-11#1)
screening practices##3##2##(1995-9#1)(2006-10#1)(2009-5#1)
screening prior to##2##3##(2007-7#2)
screening procedure for##2##3##(2008-10#1)(2008-2#1)
screening procedure was##2##3##(2008-10#1)(2010-4#1)
screening procedure##13##2##(1991-3#1)(1995-2#1)(1996-2#1)(1996-6#1)(2008-10#6)(2008-2#1)(2010-4#1)(2012-1#1)
screening procedures##6##2##(1991-7#1)(2008-10#1)(2008-11#1)(2010-8#2)(2012-1#1)
screening process##10##2##(1991-7#1)(1993-9#1)(2007-11#2)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2010-11#1)
screening program for cervical cancer##2##5##(1991-6#1)(1992-10#1)
screening program for##9##3##(1991-6#2)(1992-10#1)(1996-6#1)(2006-9#1)(2011-2#2)(2012-12#1)(2012-2#1)
screening program in Bogotá##2##4##(2012-12#2)
screening program in##5##3##(1992-2#1)(1993-2#1)(2007-2#1)(2012-12#2)
screening program##32##2##(1991-6#2)(1992-10#2)(1992-2#1)(1993-2#1)(1993-5#3)(1993-9#1)(1996-12#1)(1996-2#1)(1996-6#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-2#1)(2008-10#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#1)
screening programme in the##3##4##(1994-11#1)(2004-2#2)
screening programme in##5##3##(1994-11#1)(2004-2#3)(2008-1#1)
screening programme is##2##3##(1996-12#1)(2004-2#1)
screening programme##23##2##(1993-7#1)(1994-11#1)(1996-11#1)(1996-12#1)(2004-2#11)(2006-9#1)(2008-1#2)(2008-10#1)(2008-2#2)(2010-8#1)(2013-7#1)
screening programmes for##4##3##(1991-4#1)(1995-12#1)(2011-1#2)
screening programmes in##2##3##(2011-1#2)
screening programmes##18##2##(1991-4#1)(1991-8#1)(1992-10#2)(1992-7#1)(1993-3#1)(1995-12#1)(2011-1#10)(2012-12#1)
screening programs have##2##3##(2011-9#1)(2013-1#1)
screening programs in##3##3##(1990-10#1)(1990-3#1)(2008-11#1)
screening programs##27##2##(1990-10#4)(1990-3#1)(1990-6#1)(1993-9#1)(1996-12#1)(1996-6#1)(1997-1#1)(2005-9#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)(2009-12#2)(2011-2#3)(2011-9#1)(2013-1#1)
screening project##4##2##(1995-4#1)(2006-5#1)(2006-6#1)(2013-8#1)
screening protocol##3##2##(1995-12#1)(2007-10#1)(2008-11#1)
screening purposes##14##2##(1990-6#2)(1995-12#1)(1995-4#1)(1996-3#1)(1997-1#1)(2008-10#7)(2008-4#1)
screening questionnaires##2##2##(2007-3#1)(2010-11#1)
screening rates##2##2##(2009-5#1)(2013-1#1)
screening recommendations##9##2##(1990-8#1)(1993-9#1)(2006-10#3)(2008-4#1)(2009-12#1)(2010-11#1)(2011-2#1)
screening result##2##2##(1990-12#1)(2008-5#1)
screening results##9##2##(1992-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-12#1)(2011-2#1)(2011-3#1)
screening revealed that##2##3##(2008-4#1)(2010-10#1)
screening revealed##3##2##(2008-11#1)(2008-4#1)(2010-10#1)
screening services##5##2##(1996-2#2)(1997-1#1)(2008-10#1)(2012-1#1)
screening should be##5##3##(1993-9#1)(1995-11#1)(1996-2#1)(2006-10#1)(2013-8#1)
screening should##8##2##(1993-9#2)(1995-11#1)(1996-2#1)(2006-10#1)(2007-12#1)(2008-10#1)(2013-8#1)
screening sites##2##2##(2008-10#2)
screening solitons and##2##3##(2007-12#2)
screening solitons##3##2##(2007-12#3)
screening strategies for##2##3##(1994-12#1)(2012-3#1)
screening strategies##8##2##(1994-12#1)(1997-3#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-6#1)(2012-3#1)
screening strategy##4##2##(1996-4#1)(2006-2#1)(2008-4#1)(2008-5#1)
screening studies in##2##3##(2012-12#1)(2013-8#1)
screening studies##10##2##(2007-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
screening study##6##2##(1990-8#1)(1995-12#1)(1996-1#1)(2008-1#1)(2012-3#1)(2013-1#1)
screening survey##2##2##(1995-12#2)
screening system for##5##3##(2008-10#1)(2008-5#1)(2010-8#1)(2012-12#1)(2012-3#1)
screening system##14##2##(1990-7#1)(1991-12#1)(2006-11#1)(2006-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-9#1)(2010-8#2)(2012-12#1)(2012-3#1)
screening systems for antioxidants##2##4##(2008-10#2)
screening systems for##3##3##(2007-3#1)(2008-10#2)
screening systems##7##2##(1997-4#1)(2007-3#1)(2008-10#4)(2008-7#1)
screening technique for##5##3##(1990-11#1)(1993-3#1)(2008-1#1)(2008-10#1)(2008-9#1)
screening technique to##3##3##(1996-2#1)(1997-4#2)
screening technique##9##2##(1990-11#1)(1993-3#1)(1996-2#1)(1997-4#2)(2008-1#1)(2008-10#1)(2008-6#1)(2008-9#1)
screening techniques##5##2##(1996-12#1)(1996-3#1)(2008-10#2)(2011-2#1)
screening technologies and##2##3##(1997-4#1)(2005-7#1)
screening technologies##8##2##(1997-4#1)(2005-7#2)(2006-10#1)(2007-4#3)(2009-7#1)
screening technology##4##2##(2006-10#1)(2008-10#1)(2009-6#1)(2009-7#1)
screening test for the##2##4##(2006-10#1)(2008-4#1)
screening test for##14##3##(1996-11#1)(1997-8#1)(2006-10#4)(2007-9#2)(2008-1#1)(2008-3#1)(2008-4#2)(2008-5#1)(2011-12#1)
screening test is##3##3##(1997-2#1)(2008-4#1)(2012-12#1)
screening test to detect##2##4##(1993-9#1)(2011-12#1)
screening test to predict##2##4##(2008-10#1)(2011-12#1)
screening test to##6##3##(1993-9#1)(2006-10#1)(2008-10#1)(2011-12#2)(2011-2#1)
screening test##44##2##(1990-6#2)(1991-9#1)(1992-3#1)(1992-4#2)(1993-9#1)(1994-7#1)(1996-11#1)(1997-2#2)(1997-8#1)(2006-10#7)(2006-9#1)(2007-4#2)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#3)(2008-5#1)(2010-1#1)(2010-12#1)(2011-1#2)(2011-12#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
screening tests can##2##3##(1993-3#1)(2008-11#1)
screening tests for##7##3##(1990-2#1)(1991-3#1)(1992-3#1)(1993-2#1)(1994-7#1)(2006-2#1)(2007-2#1)
screening tests in##2##3##(1992-4#1)(2008-10#1)
screening tests practice##2##3##(1992-4#2)
screening tests to##2##3##(2008-11#1)(2010-1#1)
screening tests were##2##3##(2010-8#1)(2012-12#1)
screening tests##38##2##(1990-2#1)(1991-3#1)(1992-2#2)(1992-3#1)(1992-4#3)(1993-2#1)(1993-3#1)(1994-2#1)(1994-7#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-11#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-4#3)(2007-7#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#2)(2010-1#1)(2010-8#1)(2012-12#2)(2012-2#2)
screening than##2##2##(1990-12#1)(2011-2#1)
screening that##3##2##(2008-10#1)(2008-6#1)(2011-7#1)
screening the genome##2##3##(1996-5#1)(1996-6#1)
screening the##19##2##(1990-11#1)(1994-9#1)(1996-5#1)(1996-6#1)(2005-11#2)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#2)(2010-2#1)(2010-3#1)(2010-8#1)(2013-1#2)
screening to identify##5##3##(1992-6#1)(1993-11#1)(1996-11#1)(2008-8#1)(2012-3#1)
screening to##10##2##(1992-6#1)(1993-11#1)(1996-11#1)(1996-4#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-3#1)
screening tool and##2##3##(2005-11#1)(2009-9#1)
screening tool for the##4##4##(2006-10#1)(2008-10#3)
screening tool for##18##3##(1993-12#1)(2006-10#1)(2006-7#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#1)(2010-9#1)(2011-12#1)(2012-1#1)(2012-3#3)(2013-1#3)
screening tool to identify##2##4##(2009-10#1)(2013-1#1)
screening tool to##3##3##(1992-12#1)(2009-10#1)(2013-1#1)
screening tool##38##2##(1992-12#1)(1993-10#1)(1993-12#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-7#1)(2007-11#3)(2007-6#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-9#1)(2011-12#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#1)
screening tools are##2##3##(2007-11#1)(2008-6#1)
screening tools for##2##3##(2006-10#1)(2013-7#1)
screening tools to##2##3##(2008-10#1)(2012-12#1)
screening tools##12##2##(2006-10#2)(2007-11#2)(2008-10#2)(2008-11#1)(2008-6#1)(2010-10#1)(2012-12#1)(2013-7#2)
screening using a##4##3##(1993-7#1)(1997-6#1)(2008-4#1)(2011-1#1)
screening using##11##2##(1993-7#1)(1995-4#1)(1996-12#1)(1997-6#1)(2008-1#1)(2008-11#1)(2008-4#2)(2011-1#1)(2012-1#1)(2013-1#1)
screening visits##2##2##(2007-4#1)(2012-3#1)
screening was conducted in##2##4##(1990-8#1)(2007-12#1)
screening was performed##3##3##(1992-7#1)(2007-7#1)(2012-3#1)
screening was##14##2##(1990-2#1)(1990-8#1)(1992-10#1)(1992-2#1)(1992-7#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
screening were##9##2##(1990-11#1)(1990-2#1)(1992-2#1)(1993-11#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
screening will##3##2##(2006-10#1)(2008-3#1)(2012-2#1)
screening with a##2##3##(1992-5#1)(1993-2#1)
screening with the##5##3##(1993-2#1)(1997-8#1)(2006-2#1)(2008-10#1)(2011-2#1)
screening with##24##2##(1991-5#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-2#2)(1996-5#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-2#1)(2007-4#1)(2008-10#2)(2009-10#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
screening##2020##1##(1990-10#7)(1990-11#9)(1990-12#10)(1990-2#7)(1990-3#5)(1990-4#1)(1990-5#5)(1990-6#18)(1990-7#1)(1990-8#6)(1990-9#7)(1991-1#2)(1991-10#4)(1991-11#1)(1991-12#4)(1991-2#5)(1991-3#8)(1991-4#1)(1991-5#1)(1991-6#18)(1991-7#10)(1991-8#6)(1991-9#13)(1992-1#3)(1992-10#9)(1992-11#2)(1992-12#8)(1992-2#11)(1992-3#4)(1992-4#7)(1992-5#5)(1992-6#5)(1992-7#8)(1992-8#7)(1992-9#5)(1993-1#1)(1993-10#1)(1993-11#4)(1993-12#11)(1993-2#7)(1993-3#9)(1993-5#9)(1993-7#4)(1993-8#2)(1993-9#18)(1994-10#1)(1994-11#6)(1994-12#3)(1994-2#7)(1994-3#6)(1994-4#2)(1994-5#2)(1994-6#8)(1994-7#4)(1994-8#1)(1994-9#4)(1995-1#3)(1995-10#1)(1995-11#5)(1995-12#12)(1995-2#6)(1995-3#1)(1995-4#10)(1995-5#1)(1995-6#1)(1995-7#2)(1995-9#17)(1996-1#3)(1996-10#5)(1996-11#12)(1996-12#25)(1996-2#10)(1996-3#7)(1996-4#9)(1996-5#7)(1996-6#11)(1996-7#2)(1996-8#5)(1996-9#1)(1997-1#17)(1997-2#10)(1997-3#9)(1997-4#21)(1997-5#2)(1997-6#6)(1997-7#1)(1997-8#11)(2004-1#1)(2004-11#2)(2004-12#1)(2004-2#20)(2004-9#1)(2005-10#5)(2005-11#17)(2005-12#2)(2005-7#10)(2005-8#8)(2005-9#2)(2006-1#1)(2006-10#64)(2006-11#1)(2006-12#7)(2006-2#14)(2006-3#1)(2006-5#1)(2006-6#6)(2006-7#7)(2006-8#6)(2006-9#6)(2007-1#3)(2007-10#15)(2007-11#29)(2007-12#21)(2007-2#16)(2007-3#12)(2007-4#33)(2007-5#2)(2007-6#6)(2007-7#20)(2007-8#23)(2007-9#11)(2008-1#15)(2008-10#198)(2008-11#60)(2008-12#11)(2008-2#18)(2008-3#20)(2008-4#53)(2008-5#33)(2008-6#18)(2008-7#25)(2008-8#15)(2008-9#26)(2009-1#1)(2009-10#7)(2009-11#3)(2009-12#9)(2009-2#2)(2009-3#6)(2009-4#7)(2009-5#19)(2009-6#10)(2009-7#7)(2009-8#5)(2009-9#11)(2010-1#2)(2010-10#8)(2010-11#14)(2010-12#19)(2010-2#5)(2010-3#6)(2010-4#4)(2010-5#14)(2010-6#3)(2010-7#5)(2010-8#24)(2010-9#4)(2011-1#44)(2011-12#9)(2011-2#78)(2011-3#7)(2011-7#1)(2011-9#2)(2012-1#14)(2012-11#18)(2012-12#34)(2012-2#31)(2012-3#32)(2013-1#83)(2013-7#18)(2013-8#22)
screening) of##2##2##(1992-2#1)(1996-12#1)
screening)##6##1##(1992-2#1)(1992-5#1)(1996-12#1)(2012-3#1)(2013-1#2)
screening?##3##1##(1996-12#1)(2007-4#1)(2012-2#1)
screening]##8##1##(1993-10#1)(1993-6#1)(1994-3#1)(1994-4#1)(1996-12#1)(2008-4#1)(2008-8#1)(2013-7#1)
screenings for##2##2##(1991-6#1)(1995-8#1)
screenings##19##1##(1991-6#5)(1992-2#1)(1993-3#1)(1994-9#1)(1995-2#1)(1995-8#1)(2006-10#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-4#2)(2009-5#1)(2011-2#1)(2013-8#1)
screens and##4##2##(2007-11#1)(2007-12#2)(2008-7#1)
screens for##9##2##(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-12#1)(2012-3#1)(2012-4#1)
screens have been##2##3##(1993-6#1)(2007-12#1)
screens have##3##2##(1993-6#1)(2007-12#2)
screens is##2##2##(1997-4#1)(2008-2#1)
screens of##5##2##(2006-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-8#1)
screens or##3##2##(1990-3#1)(2008-7#2)
screens the##2##2##(2005-11#1)(2007-11#1)
screens to##6##2##(1993-12#1)(1997-7#1)(2008-2#1)(2008-4#1)(2008-7#1)(2012-3#1)
screens using##3##2##(2007-12#1)(2008-10#1)(2010-12#1)
screens with##2##2##(2007-12#1)(2008-3#1)
screens##79##1##(1990-3#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-2#2)(1995-11#1)(1997-4#2)(1997-7#1)(2004-2#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-7#4)(2007-11#3)(2007-12#10)(2007-4#2)(2007-6#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#5)(2008-3#3)(2008-4#4)(2008-5#1)(2008-7#6)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2012-4#1)
screw and nail withdrawal resistance of##2##6##(2009-3#2)
screw and##7##2##(2009-10#1)(2009-3#4)(2011-2#1)(2012-12#1)
screw axis##2##2##(1991-12#1)(1996-2#1)
screw breakage##2##2##(2007-8#1)(2008-9#1)
screw configuration##2##2##(2007-11#2)
screw constructs##2##2##(2009-3#2)
screw diameter##4##2##(2007-11#3)(2011-2#1)
screw drive##2##2##(2008-11#2)
screw fixation for##2##3##(2011-2#1)(2012-12#1)
screw fixation in a##2##4##(2008-6#1)(2011-2#1)
screw fixation in the##2##4##(2009-3#1)(2013-1#1)
screw fixation in##7##3##(2006-7#1)(2008-6#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
screw fixation is a##2##4##(2006-7#1)(2012-2#1)
screw fixation is##3##3##(2006-7#2)(2012-2#1)
screw fixation of##3##3##(2006-3#1)(2006-4#1)(2008-5#1)
screw fixation##37##2##(2006-3#1)(2006-4#1)(2006-7#9)(2006-8#2)(2007-5#2)(2007-8#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-1#1)(2009-3#3)(2010-9#1)(2011-12#3)(2011-2#2)(2012-12#2)(2012-2#4)(2013-1#1)
screw in##4##2##(2007-8#1)(2008-6#1)(2008-9#1)(2011-12#1)
screw insertion##3##2##(2008-4#1)(2013-1#2)
screw lateral migration##2##3##(2010-2#2)
screw phase dislocations##2##3##(2007-11#1)(2007-12#1)
screw placement##11##2##(2006-6#1)(2006-8#1)(2007-11#1)(2007-5#1)(2008-8#1)(2011-1#2)(2012-12#3)(2012-3#1)
screw projection##2##2##(2011-2#2)
screw to be##2##3##(2006-3#1)(2012-3#1)
screw trajectory##2##2##(2007-5#2)
screw was##2##2##(2006-8#1)(2010-2#1)
screw wave-front dislocations##2##3##(2007-11#1)(2007-12#1)
screw withdrawal resistance##4##3##(2009-3#4)
screw##155##1##(1991-12#1)(1991-3#1)(1996-2#1)(2006-3#8)(2006-4#2)(2006-6#1)(2006-7#9)(2006-8#5)(2007-11#16)(2007-12#2)(2007-5#5)(2007-7#1)(2007-8#4)(2008-10#1)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#1)(2008-8#6)(2008-9#6)(2009-1#1)(2009-10#3)(2009-2#1)(2009-3#17)(2010-2#4)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#4)(2011-2#12)(2012-12#8)(2012-2#5)(2012-3#2)(2013-1#7)(2013-8#1)
screw-retained implant-supported single-tooth crowns##2##4##(2013-1#2)
screw-retained implant-supported##3##2##(2013-1#3)
screw-retained##4##1##(2013-1#4)
screw-type chirality##2##2##(1996-2#2)
screw-type##3##1##(1996-2#2)(2007-11#1)
screw/rod##3##1##(2006-8#1)(2008-5#2)
screwless fixation##4##2##(2009-3#4)
screwness##2##1##(1990-2#1)(1991-5#1)
screws after anterior cruciate ligament##2##5##(2008-6#2)
screws and a##3##3##(2008-7#1)(2011-2#1)(2012-12#1)
screws and##15##2##(2007-11#2)(2008-12#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
screws are##3##2##(2006-8#1)(2007-11#1)(2008-11#1)
screws for##4##2##(2011-2#1)(2012-12#1)(2013-1#2)
screws have been##2##3##(2008-11#1)(2008-5#1)
screws in##11##2##(2006-8#2)(2007-5#4)(2008-5#2)(2008-6#1)(2011-1#1)(2011-2#1)
screws is##2##2##(2007-5#1)(2011-12#1)
screws was##2##2##(2007-11#1)(2011-2#1)
screws were 4x50mm##2##3##(2009-3#2)
screws were placed##2##3##(2006-8#1)(2008-5#1)
screws were used for##2##4##(2008-6#1)(2009-3#1)
screws were used##3##3##(2008-6#1)(2009-3#1)(2011-2#1)
screws were##12##2##(2006-8#1)(2007-11#1)(2007-7#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#5)(2011-2#1)
screws##115##1##(1991-9#2)(2004-9#1)(2006-3#2)(2006-6#1)(2006-7#1)(2006-8#6)(2007-11#12)(2007-2#1)(2007-5#7)(2007-7#2)(2007-8#6)(2008-10#1)(2008-11#2)(2008-12#5)(2008-5#5)(2008-6#8)(2008-7#3)(2008-8#2)(2008-9#2)(2009-2#2)(2009-3#13)(2011-1#2)(2011-12#1)(2011-2#11)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#8)
screws)##3##1##(2008-8#1)(2008-9#1)(2013-1#1)
screws]##2##1##(1991-9#1)(2013-1#1)
script about##2##2##(1994-3#2)
script event##4##2##(1996-2#4)
script##24##1##(1993-12#1)(1994-3#6)(1995-12#1)(1996-2#6)(2007-6#1)(2008-1#2)(2008-2#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-12#1)(2012-12#1)
scripta callirostris##2##2##(2007-3#2)
scripting##2##1##(2008-5#1)(2008-7#1)
scripts##5##1##(1994-3#1)(2008-1#1)(2012-2#1)(2013-1#2)
scrofa##3##1##(2010-4#1)(2012-2#1)(2013-8#1)
scrofa)##4##1##(2010-4#2)(2013-7#1)(2013-8#1)
scrotal pain##3##2##(2006-10#1)(2006-9#1)(2008-10#1)
scrotal pouch##3##2##(2008-10#3)
scrotal sac##3##2##(1994-8#1)(2006-9#1)(2009-7#1)
scrotal swelling##2##2##(2010-12#1)(2012-12#1)
scrotal wall##3##2##(2008-10#2)(2013-8#1)
scrotal##28##1##(1990-9#1)(1993-10#1)(1994-4#1)(1994-8#1)(2006-10#2)(2006-9#2)(2007-2#1)(2008-10#8)(2009-7#1)(2010-12#4)(2010-3#1)(2011-1#2)(2012-12#1)(2013-1#1)(2013-8#1)
scrotum following##2##2##(2008-10#1)(2010-8#1)
scrotum##21##1##(1990-9#1)(1993-10#2)(1994-1#1)(1994-2#1)(1995-11#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-7#1)(2009-2#1)(2010-8#1)(2012-3#1)(2013-1#2)
scrub typhus##12##2##(2006-2#1)(2007-2#1)(2008-4#2)(2010-12#4)(2013-1#4)
scrub##16##1##(2004-9#1)(2006-2#1)(2007-2#1)(2007-3#1)(2008-3#1)(2008-4#2)(2008-5#1)(2010-12#4)(2013-1#4)
scrubbing the##2##2##(1994-11#1)(2009-3#1)
scrubbing##3##1##(1994-11#1)(2008-5#1)(2009-3#1)
scrupulosity##3##1##(2012-2#3)
scrupulous##5##1##(1994-7#1)(2007-4#1)(2008-9#1)(2012-11#1)(2012-12#1)
scrutinised by##2##2##(1993-2#1)(2005-7#1)
scrutinised##4##1##(1993-2#1)(2005-7#1)(2008-10#1)(2010-11#1)
scrutinize the##2##2##(2008-9#1)(2012-3#1)
scrutinize##5##1##(2004-9#1)(2007-1#1)(2008-5#1)(2008-9#1)(2012-3#1)
scrutinized by##2##2##(2012-1#1)(2012-12#1)
scrutinized for##2##2##(1990-2#1)(1991-5#1)
scrutinized to##2##2##(1996-12#1)(1996-8#1)
scrutinized##17##1##(1990-2#1)(1991-12#1)(1991-5#1)(1993-12#1)(1994-8#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-8#1)(2006-10#1)(2008-10#1)(2010-12#1)(2011-1#2)(2012-1#1)(2012-12#1)(2013-7#1)
scrutinizing##4##1##(1991-6#1)(2008-12#1)(2008-7#1)(2012-11#1)
scrutiny and##3##2##(1996-7#1)(2006-6#1)(2007-2#1)
scrutiny by##3##2##(1992-12#1)(2008-11#1)(2012-12#1)
scrutiny during the##2##3##(2005-7#1)(2006-10#1)
scrutiny from##3##2##(2008-10#1)(2008-12#1)(2008-4#1)
scrutiny in##4##2##(1994-6#1)(2005-11#1)(2008-10#1)(2013-1#1)
scrutiny of the##3##3##(1990-5#1)(1993-1#1)(2011-2#1)
scrutiny of##11##2##(1990-5#1)(1991-6#1)(1993-1#1)(1997-1#1)(2005-11#1)(2007-9#1)(2008-11#2)(2009-4#1)(2010-9#1)(2011-2#1)
scrutiny##62##1##(1990-5#1)(1991-6#1)(1991-7#1)(1992-12#2)(1993-1#1)(1993-12#1)(1993-5#1)(1994-3#1)(1994-6#1)(1994-9#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-3#2)(2005-11#3)(2005-7#1)(2006-10#3)(2006-11#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#6)(2013-7#1)(2013-8#2)
scs##4##1##(1995-2#4)
scs'##2##1##(1995-2#2)
scu-PA##12##1##(1990-11#12)
scuba diving##8##2##(1990-8#1)(1991-6#1)(1994-7#2)(2007-2#1)(2008-5#1)(2010-3#2)
scuba##10##1##(1990-8#1)(1991-6#1)(1994-7#2)(1996-2#1)(2007-2#1)(2008-5#1)(2010-3#3)
scuba-diving##2##1##(1996-2#1)(2008-5#1)
sculpins##6##1##(2013-1#6)
sculpted##6##1##(1995-2#5)(2008-7#1)
sculpting for##2##2##(2007-11#2)
sculpting##6##1##(2007-11#3)(2008-7#1)(2009-12#1)(2010-4#1)
sculptured##3##1##(2007-12#1)(2008-3#2)
scurf of potato##2##3##(2008-10#2)
scurf of##4##2##(2008-10#4)
scurf##5##1##(2008-10#4)(2008-12#1)
scurred##2##1##(1997-7#2)
scurredness##2##1##(1997-7#2)
scurvy##3##1##(2005-10#3)
scutellar##2##1##(2008-10#2)
scutellaris##5##1##(2011-2#4)(2013-8#1)
scutes##2##1##(2008-7#1)(2013-1#1)
scutoxin##3##1##(1995-1#3)
scyllo-inositol and##2##2##(2008-11#1)(2012-11#1)
sd-Ab against loop f##2##4##(1992-12#2)
sd-Ab against##4##2##(1992-12#4)
sd-Ab##8##1##(1992-12#8)
sd-t(t) gene##2##2##(2008-9#2)
sd-t(t)##5##1##(2008-9#5)
sdNVP group##2##2##(2012-2#2)
sdNVP##7##1##(2011-1#2)(2012-2#5)
se##106##1##(1990-11#1)(1990-2#3)(1990-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-5#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-8#1)(2003-11#1)(2004-11#1)(2005-10#1)(2005-6#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-3#1)(2007-11#2)(2007-12#2)(2007-7#2)(2008-1#6)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#7)(2008-6#1)(2008-7#1)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#5)(2013-1#2)(2013-8#3)
sea and##12##2##(2007-2#2)(2007-9#1)(2008-10#6)(2008-3#2)(2011-1#1)
sea anemone Anthopleura elegantissima##2##4##(1991-9#1)(2012-12#1)
sea anemone##5##2##(1991-9#1)(1993-12#1)(1996-2#1)(2012-12#2)
sea anemones##8##2##(1991-9#2)(1993-12#3)(1996-11#2)(1997-7#1)
sea bass Dicentrarchus labrax##2##4##(2010-8#2)
sea bream Sparus aurata##3##4##(2008-7#1)(2009-4#2)
sea bream Sparus##5##3##(2008-7#1)(2009-4#2)(2010-8#2)
sea bream were##3##3##(2008-7#1)(2009-4#1)(2010-5#1)
sea bream##17##2##(2008-3#1)(2008-7#3)(2009-4#5)(2009-5#3)(2010-5#3)(2010-8#2)
sea cucumber##4##2##(1991-5#3)(2008-5#1)
sea fish##2##2##(1991-10#1)(1992-1#1)
sea floor##3##2##(1994-7#1)(2007-8#1)(2007-9#1)
sea hare##2##2##(2009-3#2)
sea ice##2##2##(2008-2#1)(2012-12#1)
sea level##11##2##(1990-8#1)(1991-6#1)(1997-5#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-2#2)(2008-8#2)
sea lion colonies##2##3##(2009-2#2)
sea lion##6##2##(2005-7#2)(2009-2#4)
sea lions##2##2##(2009-2#2)
sea of##6##2##(1995-12#1)(1996-11#1)(2005-12#1)(2008-11#1)(2008-4#1)(2013-1#1)
sea pansy##3##2##(2008-7#3)
sea ports##2##2##(2008-4#1)(2011-2#1)
sea raven antifreeze##2##3##(1992-5#2)
sea raven##7##2##(1991-10#1)(1992-5#4)(1994-9#2)
sea stars##4##2##(2007-5#4)
sea surface reflectance##2##3##(2008-2#1)(2008-3#1)
sea surface temperature##10##3##(2006-7#1)(2007-3#1)(2008-2#1)(2008-3#1)(2008-5#3)(2012-2#3)
sea surface temperatures##5##3##(2006-7#4)(2008-9#1)
sea surface##34##2##(2006-7#6)(2007-3#1)(2008-2#9)(2008-3#11)(2008-5#3)(2008-9#1)(2012-2#3)
sea temperature in##2##3##(2010-8#2)
sea temperature##4##2##(2010-8#4)
sea to##2##2##(2008-2#1)(2010-8#1)
sea turtle##7##2##(1995-3#4)(2007-2#1)(2007-5#1)(2011-2#1)
sea turtles##8##2##(2007-2#2)(2008-4#2)(2008-5#1)(2009-4#3)
sea urchin Diadema antillarum##2##4##(2007-5#2)
sea urchin Diadema##3##3##(2007-5#3)
sea urchin Lytechinus variegatus##4##4##(2007-5#3)(2008-8#1)
sea urchin Strongylocentrotus##2##3##(2007-5#1)(2011-2#1)
sea urchin cortical vesicles##2##4##(2009-7#1)(2012-2#1)
sea urchin density##2##3##(2007-5#1)(2011-2#1)
sea urchin egg##3##3##(1995-3#2)(1995-6#1)
sea urchin eggs##6##3##(1993-9#3)(1995-3#1)(2008-8#1)(2012-2#1)
sea urchin embryo##3##3##(1995-8#2)(1996-10#1)
sea urchin embryos##2##3##(1990-2#1)(1996-5#1)
sea urchin sperm outer arm beta dynein in##2##8##(2006-10#2)
sea urchin sperm##8##3##(1990-10#2)(1991-2#2)(1996-5#1)(2006-10#2)(2008-5#1)
sea urchin spermatozoa##3##3##(1996-5#1)(2008-4#1)(2008-5#1)
sea urchin##64##2##(1990-10#4)(1990-2#1)(1990-5#1)(1991-2#2)(1993-9#3)(1995-3#5)(1995-6#1)(1995-8#2)(1996-10#2)(1996-5#5)(1997-4#2)(2006-10#2)(2007-3#2)(2007-5#15)(2008-11#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-8#3)(2009-7#1)(2011-2#2)(2012-2#2)
sea urchins##14##2##(1990-5#1)(1994-11#1)(1997-4#1)(2007-5#5)(2008-4#1)(2008-5#2)(2009-2#2)(2010-10#1)
sea water and##8##3##(2008-10#7)(2008-5#1)
sea water samples by ETAAS##2##5##(2008-10#2)
sea water samples##13##3##(2008-10#13)
sea water using##2##3##(2008-10#2)
sea water##55##2##(1990-4#1)(1992-11#1)(1992-2#1)(1996-2#1)(2007-10#1)(2007-5#1)(2008-10#40)(2008-12#2)(2008-5#5)(2010-12#1)(2011-12#1)
sea waters##3##2##(2008-10#3)
sea with##3##2##(2007-3#1)(2008-2#2)
sea##360##1##(1990-10#4)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-8#3)(1991-10#2)(1991-11#1)(1991-2#2)(1991-5#3)(1991-6#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-2#1)(1992-5#4)(1993-12#4)(1993-9#3)(1994-11#1)(1994-7#1)(1994-9#2)(1995-12#1)(1995-3#9)(1995-6#1)(1995-7#1)(1995-8#5)(1996-10#2)(1996-11#3)(1996-2#2)(1996-5#5)(1997-4#3)(1997-5#1)(1997-7#2)(2005-12#1)(2005-7#2)(2006-10#3)(2006-6#1)(2006-7#6)(2007-10#2)(2007-12#1)(2007-2#7)(2007-3#4)(2007-4#1)(2007-5#32)(2007-7#2)(2007-8#1)(2007-9#5)(2008-1#2)(2008-10#56)(2008-11#5)(2008-12#2)(2008-2#24)(2008-3#16)(2008-4#7)(2008-5#23)(2008-6#1)(2008-7#6)(2008-8#7)(2008-9#2)(2009-2#9)(2009-3#2)(2009-4#8)(2009-5#3)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#4)(2010-5#3)(2010-8#11)(2011-1#2)(2011-12#1)(2011-2#6)(2012-12#3)(2012-2#6)(2013-1#1)(2013-7#1)
sea-going##2##1##(2008-11#2)
sea-level population##2##2##(2008-3#2)
sea-level##3##1##(1993-4#1)(2008-3#2)
sea-surface temperature##4##2##(1992-7#1)(2008-2#1)(2008-3#1)(2011-2#1)
sea-surface##6##1##(1992-7#1)(2008-2#1)(2008-3#3)(2011-2#1)
sea-urchin##2##1##(2007-3#1)(2008-5#1)
sea-urchins##4##1##(2007-3#3)(2011-2#1)
sea-viewing wide field-of-view sensor##2##4##(2008-2#1)(2008-3#1)
sea-water and waste-water##2##3##(2008-10#2)
sea-water samples##2##2##(2008-10#2)
sea-water##6##1##(2008-10#6)
seabed##3##1##(2006-6#1)(2007-5#1)(2010-8#1)
seabirds##4##1##(1994-9#2)(2007-3#1)(2008-9#1)
seabream##10##1##(1997-1#2)(2008-11#1)(2008-7#3)(2009-5#2)(2010-5#2)
seafarers and##4##2##(2007-2#1)(2011-2#3)
seafarers are##2##2##(2011-2#2)
seafarers in Croatia##2##3##(2011-2#2)
seafarers##23##1##(2007-2#2)(2011-2#21)
seafood by##3##2##(2008-10#2)(2012-1#1)
seafood products##4##2##(2008-10#2)(2011-2#2)
seafood##16##1##(2008-10#4)(2008-11#1)(2008-2#1)(2008-7#1)(2010-9#1)(2011-2#3)(2012-1#2)(2012-12#1)(2013-7#2)
seagrass and##5##2##(2007-5#3)(2011-2#2)
seagrass bed##4##2##(2007-5#1)(2008-5#1)(2011-2#2)
seagrass beds and##2##3##(2011-2#2)
seagrass beds in##2##3##(2007-5#1)(2011-2#1)
seagrass beds##9##2##(2007-5#2)(2008-5#1)(2011-2#5)(2013-7#1)
seagrass community##2##2##(2007-5#2)
seagrass##36##1##(2007-5#13)(2008-5#4)(2011-2#16)(2013-1#2)(2013-7#1)
seagrasses and mangroves##2##3##(2011-2#2)
seagrasses##8##1##(2007-5#1)(2008-5#1)(2011-2#5)(2012-2#1)
seahorse Hippocampus##3##2##(2008-5#2)(2010-8#1)
seahorse##8##1##(2008-5#2)(2010-8#2)(2012-12#4)
seahorses##5##1##(2007-5#1)(2012-12#4)
seal and##3##2##(1996-6#1)(2006-10#1)(2010-8#1)
seal blubber##3##2##(2004-4#3)
seal but##2##2##(1991-3#1)(2006-12#1)
seal of##2##2##(2006-6#1)(2006-8#1)
seal the##4##2##(2008-10#1)(2008-3#1)(2012-3#1)(2013-8#1)
seal##51##1##(1991-3#2)(1991-5#1)(1992-8#2)(1994-4#5)(1995-6#1)(1996-6#1)(1997-4#2)(2004-4#5)(2005-10#3)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-8#5)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-8#2)(2012-1#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
sealant material##2##2##(2007-8#2)
sealant materials##2##2##(2013-1#2)
sealant##18##1##(1990-12#1)(1992-3#1)(1996-12#3)(2005-10#1)(2007-2#1)(2007-8#2)(2008-5#1)(2009-6#1)(2012-3#2)(2013-1#5)
sealants in primary teeth##2##4##(2008-5#1)(2013-8#1)
sealants in##3##2##(2007-2#1)(2008-5#1)(2013-8#1)
sealants##13##1##(1994-7#1)(1995-2#1)(2006-10#1)(2007-2#1)(2008-5#1)(2008-9#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
sealed in##4##2##(2007-12#1)(2010-10#1)(2012-12#2)
sealed using##2##2##(2008-10#2)
sealed with##8##2##(1996-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2012-12#2)
sealed##46##1##(1992-6#1)(1994-3#1)(1996-1#2)(1996-12#1)(1996-5#1)(1996-8#1)(2006-2#1)(2006-3#2)(2007-1#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-10#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#6)(2013-1#3)
sealed-tube##3##1##(2006-5#1)(2008-11#1)(2008-3#1)
sealer##5##1##(2005-7#1)(2013-1#4)
sealing ability##2##2##(2010-6#1)(2010-8#1)
sealing and##2##2##(2010-8#1)(2012-11#1)
sealing of severed##2##3##(1997-4#1)(2008-11#1)
sealing of the##2##3##(2007-8#1)(2008-10#1)
sealing of##10##2##(1992-2#1)(1993-6#1)(1997-4#3)(2004-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
sealing system##2##2##(2010-8#2)
sealing the##5##2##(1996-8#1)(2008-10#1)(2008-2#1)(2013-1#1)(2013-7#1)
sealing##45##1##(1990-12#1)(1990-4#1)(1992-2#1)(1993-6#1)(1996-8#1)(1997-4#3)(2004-9#1)(2007-4#1)(2007-8#3)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-6#1)(2010-7#4)(2010-8#4)(2011-2#2)(2012-11#2)(2012-12#1)(2012-3#5)(2013-1#1)(2013-7#1)
seals and##2##2##(2008-10#1)(2008-5#1)
seals are##2##2##(1995-6#1)(2004-4#1)
seals on##2##2##(2008-10#1)(2012-2#1)
seals##17##1##(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#1)(1997-4#2)(2004-4#2)(2007-8#1)(2008-10#4)(2008-4#1)(2008-5#1)(2011-2#1)(2012-2#1)
seam##3##1##(2005-7#1)(2008-2#1)(2008-3#1)
seamen##5##1##(1991-12#5)
seamless##14##1##(1994-1#1)(1996-3#1)(2006-1#1)(2006-9#1)(2008-11#5)(2008-6#1)(2010-8#1)(2012-2#2)(2012-3#1)
seamlessly integrated##3##2##(2007-4#1)(2008-4#1)(2013-8#1)
seamlessly##8##1##(1996-3#1)(2007-4#1)(2008-4#2)(2012-2#1)(2013-1#2)(2013-8#1)
seamounts##2##1##(2007-9#1)(2012-2#1)
seams##4##1##(2008-2#4)
seaports##2##1##(2008-10#1)(2011-2#1)
search a##6##2##(1997-6#1)(2007-6#1)(2007-8#1)(2008-12#1)(2008-9#2)
search algorithm##8##2##(2007-12#1)(2008-3#2)(2008-4#1)(2010-2#1)(2012-3#1)(2013-1#2)
search algorithms for##2##3##(2008-1#1)(2011-2#1)
search algorithms##4##2##(2008-1#1)(2008-4#2)(2011-2#1)
search also##2##2##(2011-2#1)(2012-2#1)
search and a##2##3##(2008-1#1)(2008-7#1)
search and retrieval##4##3##(1996-3#1)(2008-11#3)
search and the##3##3##(1990-12#1)(2007-5#1)(2008-2#1)
search and##25##2##(1990-12#1)(1991-4#1)(1996-3#1)(2004-11#1)(2005-7#1)(2006-3#1)(2007-5#1)(2008-1#2)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#2)(2008-7#2)(2009-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)
search based on##2##3##(2008-8#1)(2012-3#1)
search by the##2##3##(2006-2#1)(2012-12#1)
search criteria##6##2##(2006-12#1)(2006-2#2)(2007-10#1)(2013-1#2)
search did not##2##3##(2008-12#1)(2010-7#1)
search engine and##3##3##(2005-7#1)(2008-12#1)(2008-4#1)
search engine is##2##3##(2010-8#2)
search engine##16##2##(2005-7#2)(2007-12#2)(2008-12#1)(2008-4#2)(2008-7#1)(2009-8#1)(2010-8#3)(2013-1#2)(2013-8#2)
search engines are##2##3##(2009-8#1)(2010-8#1)
search engines##15##2##(2004-10#1)(2007-12#2)(2007-2#2)(2008-11#2)(2008-4#1)(2009-8#1)(2010-3#1)(2010-8#4)(2012-2#1)
search failed to reveal##2##4##(2007-11#1)(2009-6#1)
search for Meckel's diverticulum##2##4##(2012-2#2)
search for a cure##2##4##(2007-12#1)(2012-12#1)
search for a##23##3##(1993-8#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-10#1)(1995-11#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-8#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-4#2)(2008-7#1)(2009-3#1)(2009-6#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
search for alternative##3##3##(2006-10#1)(2010-5#1)(2012-12#1)
search for an##12##3##(1992-5#1)(1992-8#1)(1994-5#1)(2004-12#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-2#1)(2010-8#1)(2012-1#2)
search for answers##2##3##(2008-9#1)(2012-3#1)
search for bone##2##3##(2005-3#1)(2007-11#1)
search for fast##2##3##(2008-2#2)
search for genes that##2##4##(1991-5#1)(1993-10#1)
search for information##3##3##(2009-8#1)(2011-2#2)
search for its##2##3##(1997-6#1)(2006-3#1)
search for meaning##4##3##(2008-9#4)
search for molecular##2##3##(1993-9#1)(2008-10#1)
search for mutations##2##3##(1995-1#1)(2006-10#1)
search for new and##3##4##(1991-12#1)(1996-4#1)(2008-10#1)
search for new drugs##3##4##(1994-6#1)(2010-11#1)(2013-1#1)
search for new therapeutic##2##4##(2007-11#1)(2013-1#1)
search for new##32##3##(1991-12#1)(1993-11#1)(1993-9#1)(1994-6#1)(1996-4#1)(1996-8#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-9#1)(2006-10#1)(2006-12#2)(2007-11#2)(2008-1#1)(2008-10#3)(2008-6#1)(2008-8#1)(2009-11#1)(2009-7#2)(2010-11#2)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
search for novel##5##3##(1993-4#1)(2008-1#1)(2008-11#1)(2008-5#1)(2013-8#1)
search for organising principles##2##4##(2006-10#2)
search for other##5##3##(2005-8#1)(2007-2#1)(2008-10#1)(2009-3#1)(2013-1#1)
search for possible##4##3##(1992-6#1)(2007-5#1)(2008-7#2)
search for potential##2##3##(1995-6#1)(2007-12#1)
search for relevant##3##3##(2007-4#1)(2009-5#1)(2012-2#1)
search for specific##3##3##(1996-12#1)(2005-8#1)(2011-2#1)
search for studies##2##3##(2006-10#1)(2007-10#1)
search for the best##4##4##(1995-12#1)(2008-10#2)(2009-4#1)
search for the cause of##2##5##(2008-11#1)(2010-3#1)
search for the##50##3##(1991-9#1)(1993-6#2)(1994-3#1)(1995-11#1)(1995-12#3)(1996-2#1)(1996-3#1)(1996-8#2)(1997-2#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-3#1)(2006-9#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#2)(2009-4#2)(2009-8#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
search for##315##2##(1990-12#1)(1990-2#1)(1991-1#1)(1991-12#2)(1991-3#1)(1991-5#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#4)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#2)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#3)(1995-4#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#2)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#4)(1997-1#2)(1997-2#3)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#3)(2004-12#1)(2004-7#1)(2004-9#1)(2005-11#1)(2005-3#1)(2005-8#4)(2005-9#1)(2006-10#16)(2006-12#5)(2006-2#1)(2006-3#2)(2006-5#2)(2006-6#1)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#8)(2007-12#6)(2007-2#3)(2007-4#2)(2007-5#1)(2007-8#4)(2007-9#1)(2008-1#5)(2008-10#12)(2008-11#7)(2008-12#2)(2008-2#9)(2008-4#9)(2008-5#7)(2008-6#3)(2008-7#4)(2008-8#5)(2008-9#6)(2009-11#2)(2009-12#2)(2009-3#4)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#4)(2010-1#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#8)(2011-3#1)(2012-1#5)(2012-12#9)(2012-2#8)(2012-3#7)(2013-1#10)(2013-7#1)(2013-8#3)
search found##2##2##(2007-8#1)(2013-8#1)
search from##5##2##(2006-2#1)(2007-10#1)(2008-1#1)(2008-8#1)(2012-2#1)
search further##3##2##(1997-4#1)(2008-7#1)(2010-2#1)
search in the##6##3##(1994-2#1)(1997-4#1)(2007-12#1)(2007-5#2)(2008-12#1)
search in##15##2##(1994-2#1)(1996-10#1)(1997-4#1)(2007-12#1)(2007-5#2)(2008-1#1)(2008-12#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
search included##3##2##(2006-8#1)(2008-8#1)(2012-12#1)
search is performed##2##3##(2008-2#1)(2011-2#1)
search is##12##2##(1992-10#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-1#1)
search method is##2##3##(2008-3#1)(2010-2#1)
search method##7##2##(1995-12#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-2#1)(2010-8#1)
search model##4##2##(1994-3#1)(1995-11#1)(2008-8#1)(2010-8#1)
search of MEDLINE and##2##4##(2008-12#1)(2013-1#1)
search of a##13##3##(1993-10#1)(1993-7#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-9#1)(2010-2#1)(2010-3#2)(2010-6#1)(2010-7#1)(2013-1#1)(2013-8#1)
search of all##4##3##(1990-11#1)(2008-8#1)(2012-12#1)(2013-1#1)
search of alternative##2##3##(2010-12#1)(2013-7#1)
search of an##2##3##(2006-10#1)(2013-8#1)
search of new##4##3##(1995-12#1)(2007-11#1)(2008-10#1)(2011-1#1)
search of the PubMed##2##4##(2013-8#2)
search of the literature##5##4##(1992-12#1)(1994-2#1)(1995-5#1)(2008-7#1)(2011-2#1)
search of the roots of orthopedics##2##6##(2007-11#2)
search of the##32##3##(1990-2#1)(1992-12#1)(1992-2#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-4#1)(2004-3#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#2)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#2)(2009-9#1)(2010-5#1)(2011-2#1)(2012-3#2)(2013-8#4)
search of##110##2##(1990-11#2)(1990-2#1)(1991-11#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-10#2)(1993-7#2)(1994-12#1)(1994-2#1)(1994-3#2)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-9#1)(1997-2#1)(1997-4#1)(2004-3#1)(2006-10#4)(2006-12#1)(2006-2#2)(2006-8#1)(2007-11#3)(2007-4#1)(2007-8#5)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-12#1)(2010-2#2)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#6)
search on##11##2##(1992-12#1)(1994-3#1)(2008-10#1)(2008-8#2)(2010-12#1)(2011-2#3)(2011-7#1)(2012-1#1)
search options##4##2##(2009-10#1)(2013-1#2)(2013-8#1)
search parameters##2##2##(2007-6#1)(2008-1#1)
search performance##5##2##(2008-1#2)(2008-6#1)(2010-8#2)
search procedure##2##2##(1992-9#1)(2008-3#1)
search process for##2##3##(1996-2#1)(1996-3#1)
search process##5##2##(1991-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-2#1)
search program##5##2##(1992-2#1)(2008-10#1)(2008-4#2)(2010-2#1)
search requests##2##2##(1991-8#2)
search results and##2##3##(2005-7#1)(2008-4#1)
search results##10##2##(1990-12#1)(1992-12#2)(2005-7#1)(2008-4#3)(2012-2#1)(2013-1#2)
search revealed a##2##3##(1990-2#1)(2009-5#1)
search revealed that the##2##4##(1992-3#1)(2008-10#1)
search revealed that##4##3##(1992-3#1)(1996-10#1)(2008-10#1)(2008-6#1)
search revealed##9##2##(1990-2#1)(1992-12#1)(1992-3#1)(1996-10#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-6#1)(2009-5#1)
search routine##2##2##(1994-9#1)(2007-12#1)
search software##2##2##(1993-3#1)(2008-11#1)
search space##6##2##(2010-7#2)(2012-1#1)(2013-1#3)
search stage##2##2##(2008-2#2)
search strategies##6##2##(1995-12#1)(2007-8#1)(2008-11#1)(2008-8#3)
search strategy of##2##3##(2007-8#1)(2011-2#1)
search strategy##14##2##(1993-3#1)(2006-8#1)(2007-1#1)(2007-8#1)(2008-2#1)(2008-8#1)(2010-12#1)(2010-4#1)(2011-2#3)(2012-1#1)(2013-1#2)
search system##2##2##(2008-3#1)(2008-4#1)
search task##7##2##(1997-7#1)(2009-2#1)(2010-8#4)(2012-3#1)
search tasks##4##2##(2008-1#2)(2009-10#1)(2010-8#1)
search technique##2##2##(1997-6#1)(2011-1#1)
search techniques##4##2##(1991-2#1)(2007-7#1)(2008-3#2)
search terms##9##2##(1996-9#1)(2004-3#1)(2007-12#1)(2008-7#1)(2010-9#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
search that##2##2##(1993-2#1)(2008-3#1)
search the OMIM database##2##4##(2008-4#2)
search the literature##2##3##(2007-2#1)(2013-1#1)
search the##14##2##(1991-12#2)(1993-8#1)(1997-6#1)(2007-2#1)(2008-4#4)(2008-8#2)(2009-12#1)(2011-1#1)(2013-1#1)
search to##11##2##(1991-4#1)(1996-6#1)(1997-8#1)(2006-12#1)(2006-7#1)(2008-10#1)(2008-7#2)(2010-2#1)(2011-1#1)(2012-3#1)
search tool##5##2##(2008-3#2)(2012-2#3)
search using the##2##3##(2007-11#1)(2008-10#1)
search using##3##2##(2007-11#1)(2008-10#1)(2009-10#1)
search was carried out##3##4##(2010-4#1)(2012-12#1)(2013-1#1)
search was conducted to##3##4##(2008-3#1)(2013-1#2)
search was conducted##7##3##(1996-12#1)(2004-3#1)(2008-3#1)(2012-12#1)(2013-1#3)
search was done##2##3##(2012-2#2)
search was limited to##2##4##(2011-2#1)(2013-8#1)
search was performed for##2##4##(2008-1#1)(2008-8#1)
search was performed from##2##4##(2008-1#1)(2013-1#1)
search was performed on##2##4##(2010-6#1)(2011-2#1)
search was performed using the##3##5##(2011-1#1)(2013-1#1)(2013-8#1)
search was performed using##4##4##(2010-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
search was performed##12##3##(1990-12#1)(1994-9#1)(2008-1#2)(2008-8#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
search was##34##2##(1990-12#1)(1994-9#1)(1996-12#1)(2004-3#1)(2006-2#1)(2006-8#1)(2008-1#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-4#2)(2010-6#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#2)
search were##3##2##(2006-10#1)(2006-2#1)(2008-9#1)
search with a##2##3##(2008-5#1)(2011-2#1)
search##1011##1##(1990-11#2)(1990-12#5)(1990-2#3)(1990-4#1)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#4)(1991-3#2)(1991-4#2)(1991-5#2)(1991-8#2)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#7)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#5)(1992-8#1)(1992-9#3)(1993-1#1)(1993-10#3)(1993-11#1)(1993-12#1)(1993-2#4)(1993-3#3)(1993-4#1)(1993-6#2)(1993-7#2)(1993-8#2)(1993-9#4)(1994-1#1)(1994-12#3)(1994-2#5)(1994-3#9)(1994-5#3)(1994-6#2)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#4)(1995-12#7)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#4)(1996-12#4)(1996-2#7)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#5)(1996-9#2)(1997-1#3)(1997-2#5)(1997-3#1)(1997-4#5)(1997-5#1)(1997-6#5)(1997-7#4)(1997-8#5)(2004-10#1)(2004-11#1)(2004-12#1)(2004-3#3)(2004-7#1)(2004-9#1)(2005-11#1)(2005-3#1)(2005-7#5)(2005-8#6)(2005-9#1)(2006-10#25)(2006-12#8)(2006-2#10)(2006-3#3)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#5)(2006-9#3)(2007-1#2)(2007-10#7)(2007-11#13)(2007-12#20)(2007-2#7)(2007-3#1)(2007-4#4)(2007-5#6)(2007-6#3)(2007-7#3)(2007-8#65)(2007-9#5)(2008-1#29)(2008-10#28)(2008-11#18)(2008-12#10)(2008-2#33)(2008-3#24)(2008-4#37)(2008-5#12)(2008-6#11)(2008-7#22)(2008-8#32)(2008-9#15)(2009-10#7)(2009-11#4)(2009-12#3)(2009-2#3)(2009-3#4)(2009-4#3)(2009-5#4)(2009-6#3)(2009-7#6)(2009-8#8)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#9)(2010-3#8)(2010-4#5)(2010-5#3)(2010-6#2)(2010-7#8)(2010-8#19)(2010-9#3)(2011-1#13)(2011-12#3)(2011-2#39)(2011-3#1)(2011-7#1)(2012-1#17)(2012-12#20)(2012-2#30)(2012-3#18)(2013-1#51)(2013-7#2)(2013-8#23)
search-coil##2##1##(1993-7#1)(1996-1#1)
searchable##4##1##(2005-7#1)(2007-8#1)(2008-7#1)(2008-9#1)
searched a##2##2##(1990-11#1)(2008-7#1)
searched and##2##2##(2006-12#1)(2008-10#1)
searched electronic databases##2##3##(2011-2#1)(2012-12#1)
searched for all##2##3##(2012-3#1)(2013-1#1)
searched for genes##3##3##(1994-11#1)(1997-7#1)(2008-7#1)
searched for studies##2##3##(2011-2#1)(2012-3#1)
searched for the presence of##2##5##(1990-2#1)(1992-12#1)
searched for the##6##3##(1990-2#1)(1992-12#1)(1992-5#1)(1994-9#1)(2006-10#1)(2008-11#1)
searched for##62##2##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-9#2)(1996-4#2)(1996-7#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-5#1)(2006-10#1)(2007-2#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-3#1)(2008-7#3)(2009-10#2)(2009-3#1)(2009-7#2)(2010-11#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#3)(2012-3#3)(2013-1#6)
searched in##6##2##(1990-5#1)(2004-4#1)(2008-7#1)(2010-9#1)(2011-1#1)(2013-1#1)
searched the##8##2##(1995-12#1)(1997-2#1)(2005-11#1)(2007-3#1)(2009-5#1)(2013-8#3)
searched to##6##2##(2007-11#1)(2010-12#1)(2011-2#1)(2012-12#3)
searched using the##3##3##(2011-2#2)(2012-2#1)
searched using##6##2##(2007-6#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
searched with##2##2##(2009-11#1)(2013-1#1)
searched##130##1##(1990-11#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-9#3)(1995-12#1)(1996-4#2)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(2004-4#1)(2005-11#1)(2005-5#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-6#2)(2008-1#3)(2008-10#8)(2008-11#3)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#5)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#10)(2012-1#2)(2012-12#9)(2012-2#5)(2012-3#4)(2013-1#11)(2013-8#6)
searcher##2##1##(1991-1#1)(1994-3#1)
searchers##3##1##(1991-2#1)(1992-12#1)(1995-1#1)
searches against the##2##3##(2007-8#1)(2010-4#1)
searches against##3##2##(2007-8#1)(2010-4#1)(2012-2#1)
searches and##6##2##(1996-2#1)(2004-11#1)(2008-11#1)(2008-4#1)(2012-2#1)(2013-8#1)
searches are##3##2##(1991-3#1)(2008-11#1)(2008-2#1)
searches by##3##2##(2008-10#1)(2008-4#2)
searches for the##2##3##(2007-12#1)(2012-3#1)
searches for##15##2##(1991-11#1)(1997-5#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2012-3#3)(2013-1#1)
searches have##2##2##(1994-6#1)(2011-2#1)
searches identified##2##2##(1996-5#1)(1997-1#1)
searches in##3##2##(2010-11#1)(2012-12#1)(2013-1#1)
searches of Medline##3##3##(1993-6#1)(2010-6#1)(2011-2#1)
searches of PubMed##2##3##(2009-8#1)(2009-9#1)
searches of the##3##3##(1993-12#1)(2007-10#1)(2007-12#1)
searches of##14##2##(1993-12#1)(1993-6#1)(1997-8#1)(2004-12#1)(2006-8#2)(2007-10#1)(2007-12#1)(2009-8#1)(2009-9#1)(2010-6#1)(2011-2#1)(2013-1#2)
searches on##3##2##(1995-3#1)(2008-4#1)(2010-12#1)
searches using##2##2##(2008-4#2)
searches were carried##2##3##(2006-2#1)(2008-1#1)
searches were##7##2##(1991-1#1)(1992-12#2)(2006-2#1)(2008-1#1)(2008-10#2)
searches with##2##2##(1993-2#1)(1994-9#1)
searches yielded##2##2##(2013-1#2)
searches##116##1##(1990-12#1)(1990-2#1)(1991-1#2)(1991-11#1)(1991-3#2)(1992-1#2)(1992-12#3)(1993-12#2)(1993-2#1)(1993-6#2)(1994-1#1)(1994-6#1)(1994-9#1)(1995-3#2)(1996-1#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-12#1)(2005-10#1)(2006-12#1)(2006-2#1)(2006-8#2)(2007-10#1)(2007-12#2)(2007-2#1)(2007-6#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#13)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#2)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#8)(2013-8#1)
searching MEDLINE##2##2##(1992-1#1)(1993-3#1)
searching and##9##2##(1991-3#1)(1994-6#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)
searching for a##3##3##(1997-1#1)(2006-5#1)(2008-8#1)
searching for females##2##3##(2008-5#2)
searching for genes##2##3##(2009-9#1)(2012-2#1)
searching for mates##2##3##(2008-8#1)(2013-1#1)
searching for new##3##3##(2008-5#1)(2008-7#1)(2008-8#1)
searching for the perfect##2##4##(2008-5#1)(2012-2#1)
searching for the##9##3##(1992-6#1)(1994-9#1)(2007-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-2#1)
searching for##51##2##(1990-11#1)(1992-6#1)(1993-3#1)(1994-6#1)(1994-7#1)(1994-9#1)(1997-1#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#5)(2008-7#1)(2008-8#4)(2009-9#1)(2010-11#1)(2010-12#1)(2011-2#2)(2011-3#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#1)
searching in the##2##3##(1990-12#1)(2008-8#1)
searching in##3##2##(1990-12#1)(2008-4#1)(2008-8#1)
searching is##4##2##(2008-8#2)(2008-9#1)(2010-5#1)
searching of##4##2##(1992-1#1)(2005-7#1)(2008-7#1)(2012-2#1)
searching the##6##2##(1992-12#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)
searching to identify##2##3##(2006-4#1)(2008-4#1)
searching to##3##2##(2006-4#1)(2007-6#1)(2008-4#1)
searching was##2##2##(1991-3#1)(1996-2#1)
searching with##3##2##(2008-4#2)(2008-8#1)
searching##157##1##(1990-11#1)(1990-12#3)(1991-1#1)(1991-12#1)(1991-3#8)(1992-1#3)(1992-12#1)(1992-6#1)(1993-3#4)(1994-12#2)(1994-3#3)(1994-6#2)(1994-7#1)(1994-9#1)(1995-1#3)(1995-2#1)(1995-3#3)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-3#1)(2004-12#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-4#3)(2006-5#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#17)(2008-5#5)(2008-7#5)(2008-8#11)(2008-9#8)(2009-5#1)(2009-7#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-5#2)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#11)(2013-7#1)(2013-8#2)
searchlight problem##2##2##(2008-3#2)
searchlight##4##1##(2008-2#2)(2008-3#2)
seas##9##1##(1990-11#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-7#1)(2012-2#1)
seashore##3##1##(2008-10#2)(2008-3#1)
seaside##2##1##(1993-10#1)(2011-2#1)
season (1##2##2##(2008-3#1)(2008-5#1)
season (25##2##2##(2008-5#1)(2013-7#1)
season (May-July)##2##2##(2007-3#1)(2008-5#1)
season (September##2##2##(2007-3#1)(2013-7#1)
season and in the##2##4##(1993-1#1)(2007-3#1)
season and##28##2##(1993-1#1)(2006-10#1)(2007-3#2)(2007-5#2)(2007-7#1)(2007-8#1)(2008-10#6)(2008-3#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-2#1)(2010-2#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-7#1)(2013-1#1)
season are##4##2##(1994-2#1)(2008-10#2)(2012-2#1)
season as a##2##3##(2008-10#1)(2009-2#1)
season as##3##2##(2007-10#1)(2008-10#1)(2009-2#1)
season but##3##2##(1997-7#1)(2008-5#1)(2010-2#1)
season did not##3##3##(2006-4#1)(2008-10#1)(2008-6#1)
season during##2##2##(2008-10#1)(2013-7#1)
season for##4##2##(1996-12#1)(2009-10#1)(2012-3#1)(2013-7#1)
season from##4##2##(2007-12#1)(2008-10#1)(2008-12#1)(2010-8#1)
season has##2##2##(2008-5#1)(2012-2#1)
season in the##4##3##(1991-12#1)(2008-10#2)(2008-5#1)
season in##26##2##(1991-12#1)(1993-9#1)(2007-12#1)(2007-5#2)(2007-6#1)(2008-10#9)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-6#1)(2013-8#3)
season is##3##2##(2008-10#1)(2009-2#1)(2010-12#1)
season length##2##2##(2011-12#2)
season of birth##2##3##(1996-8#2)
season of the year##3##4##(2006-5#1)(2007-3#1)(2008-3#1)
season of the##6##3##(2006-5#1)(2006-8#1)(2007-3#1)(2008-3#1)(2010-8#1)(2013-8#1)
season of##26##2##(1996-8#2)(2005-8#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-3#2)(2007-5#4)(2008-10#5)(2008-12#1)(2008-3#2)(2008-5#2)(2008-8#1)(2010-8#1)(2013-7#1)(2013-8#1)
season or##2##2##(2006-4#1)(2007-3#1)
season progressed##4##2##(2007-5#1)(2008-10#2)(2010-7#1)
season resulted in high##2##4##(2008-10#2)
season than##2##2##(2007-3#1)(2008-3#1)
season the##2##2##(1997-6#1)(2004-11#1)
season to##10##2##(1996-8#1)(2005-8#1)(2007-2#1)(2007-5#1)(2007-6#1)(2008-10#2)(2008-5#1)(2010-8#1)(2013-7#1)
season turfgrass species##2##3##(2011-12#2)
season until the##2##3##(2008-10#1)(2013-7#1)
season was##4##2##(2008-10#2)(2008-5#1)(2013-8#1)
season were##3##2##(2008-10#1)(2012-2#1)(2012-3#1)
season when##3##2##(2008-10#2)(2008-5#1)
season while##3##2##(2007-5#2)(2008-5#1)
season##484##1##(1990-6#1)(1990-8#1)(1991-12#1)(1991-8#1)(1992-1#2)(1992-2#2)(1992-6#2)(1993-1#1)(1993-5#3)(1993-9#2)(1994-2#1)(1994-9#2)(1995-11#2)(1995-6#1)(1996-1#2)(1996-12#2)(1996-6#7)(1996-8#3)(1997-1#2)(1997-2#2)(1997-6#2)(1997-7#1)(2004-11#2)(2004-4#4)(2005-7#1)(2005-8#4)(2006-10#1)(2006-2#1)(2006-3#2)(2006-4#4)(2006-5#5)(2006-8#2)(2007-1#1)(2007-10#2)(2007-12#2)(2007-2#4)(2007-3#18)(2007-4#1)(2007-5#25)(2007-6#3)(2007-7#2)(2007-8#8)(2007-9#1)(2008-1#4)(2008-10#126)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#12)(2008-4#2)(2008-5#51)(2008-6#7)(2008-7#3)(2008-8#22)(2008-9#5)(2009-10#2)(2009-2#7)(2009-4#2)(2009-6#2)(2009-8#1)(2010-10#1)(2010-12#3)(2010-2#6)(2010-4#1)(2010-7#1)(2010-8#15)(2011-1#1)(2011-12#5)(2011-2#9)(2012-12#4)(2012-2#11)(2012-3#5)(2012-5#2)(2012-6#1)(2012-7#3)(2013-1#3)(2013-7#13)(2013-8#10)
season) and##4##2##(2007-5#1)(2008-5#2)(2012-2#1)
season)##12##1##(2006-5#1)(2007-5#1)(2008-10#2)(2008-5#4)(2012-2#2)(2012-5#1)(2013-7#1)
season-dependent##3##1##(1992-3#1)(2008-7#1)(2012-7#1)
season-of-birth effect##2##2##(1996-3#2)
seasonal AR##3##2##(2007-2#1)(2012-12#1)(2013-8#1)
seasonal affective disorder (SAD)##4##4##(1995-11#1)(1996-1#1)(1997-6#1)(2010-8#1)
seasonal affective disorder##10##3##(1995-11#2)(1995-12#1)(1996-1#2)(1996-2#1)(1997-6#1)(2008-8#1)(2010-8#2)
seasonal affective##11##2##(1995-11#2)(1995-12#1)(1996-1#2)(1996-2#1)(1997-6#2)(2008-8#1)(2010-8#2)
seasonal allergens##5##2##(2011-2#5)
seasonal allergic conjunctivitis##3##3##(2007-11#3)
seasonal allergic rhinitis and##3##4##(2007-11#1)(2007-9#2)
seasonal allergic rhinitis##10##3##(2007-11#4)(2007-9#2)(2008-3#1)(2011-2#2)(2012-12#1)
seasonal allergic##14##2##(2007-11#7)(2007-9#2)(2008-3#1)(2011-2#2)(2012-12#1)(2013-1#1)
seasonal and daily variations##2##4##(2008-5#2)
seasonal and daily##3##3##(2008-10#1)(2008-5#2)
seasonal and spatial##3##3##(2007-3#1)(2010-8#1)(2013-7#1)
seasonal and##12##2##(2006-10#1)(2007-1#1)(2007-3#1)(2008-10#2)(2008-5#2)(2010-4#1)(2010-8#1)(2011-1#2)(2013-7#1)
seasonal ascospore##5##2##(2008-10#5)
seasonal breeding##3##2##(2010-8#1)(2013-8#2)
seasonal campaigns##2##2##(2008-10#1)(2008-7#1)
seasonal change in##3##3##(2008-5#1)(2011-12#1)(2013-1#1)
seasonal change##4##2##(2008-5#1)(2008-9#1)(2011-12#1)(2013-1#1)
seasonal changes in the##2##4##(2008-7#1)(2008-9#1)
seasonal changes in##5##3##(1990-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
seasonal changes##8##2##(1990-11#1)(1993-6#1)(2007-5#1)(2007-8#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
seasonal differences in##2##3##(2008-5#1)(2009-4#1)
seasonal distribution of the##2##4##(2007-10#1)(2007-7#1)
seasonal distribution of##4##3##(2007-10#2)(2007-7#1)(2008-10#1)
seasonal distribution##6##2##(2007-10#2)(2007-7#1)(2008-10#1)(2011-1#1)(2013-8#1)
seasonal effect##2##2##(2007-5#1)(2011-2#1)
seasonal environments##2##2##(2008-9#2)
seasonal fluctuations##2##2##(2008-10#1)(2008-5#1)
seasonal human##3##2##(2013-1#3)
seasonal in##2##2##(1996-3#1)(2007-3#1)
seasonal influenza##6##2##(2010-4#2)(2011-2#4)
seasonal metabolic adjustments##2##3##(2013-1#2)
seasonal migration##2##2##(2007-1#2)
seasonal mood change##2##3##(1997-5#2)
seasonal mood##4##2##(1991-8#2)(1997-5#2)
seasonal or perennial##2##3##(2007-11#1)(2013-8#1)
seasonal or##3##2##(1991-11#1)(2007-11#1)(2013-8#1)
seasonal pattern of##4##3##(1990-12#1)(1992-12#1)(2008-10#1)(2013-7#1)
seasonal pattern##12##2##(1990-12#1)(1991-8#1)(1992-12#1)(1996-3#1)(1997-3#1)(1997-6#1)(2008-10#3)(2010-8#1)(2013-7#2)
seasonal patterns of##2##3##(2010-8#1)(2012-2#1)
seasonal patterns##4##2##(1996-11#1)(1996-3#1)(2010-8#1)(2012-2#1)
seasonal time constraints##2##3##(2008-8#2)
seasonal trend##2##2##(2010-12#1)(2011-2#1)
seasonal trends##2##2##(2008-5#1)(2011-2#1)
seasonal variability##3##2##(2007-7#1)(2008-2#1)(2010-8#1)
seasonal variation in the##2##4##(2007-2#2)
seasonal variation in##7##3##(1997-3#1)(2007-10#1)(2007-2#2)(2008-10#1)(2008-5#1)(2010-8#1)
seasonal variation of##7##3##(2007-1#1)(2007-2#1)(2008-10#2)(2010-7#1)(2012-2#1)(2013-7#1)
seasonal variation was##2##3##(2007-6#1)(2013-1#1)
seasonal variation##25##2##(1995-10#1)(1995-11#1)(1997-3#1)(2007-1#1)(2007-10#2)(2007-2#3)(2007-6#1)(2008-10#3)(2008-5#2)(2010-5#1)(2010-7#1)(2010-8#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
seasonal variations in##4##3##(1991-8#1)(1992-7#1)(2008-10#1)(2010-8#1)
seasonal variations of##3##3##(1990-8#1)(2008-10#1)(2012-2#1)
seasonal variations##12##2##(1990-8#1)(1991-8#1)(1992-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-4#1)(2010-8#1)(2012-2#1)(2013-8#2)
seasonal weather##4##2##(2008-10#1)(2012-3#3)
seasonal##271##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-8#2)(1991-11#1)(1991-8#5)(1992-12#1)(1992-7#1)(1993-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#3)(1995-12#1)(1995-7#1)(1996-1#3)(1996-11#1)(1996-2#1)(1996-3#5)(1996-8#1)(1997-3#2)(1997-5#2)(1997-6#3)(2004-11#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-1#4)(2007-10#6)(2007-11#9)(2007-2#7)(2007-3#5)(2007-5#5)(2007-6#2)(2007-7#2)(2007-8#1)(2007-9#6)(2008-10#32)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#23)(2008-7#4)(2008-8#8)(2008-9#6)(2009-4#3)(2009-7#1)(2009-8#2)(2010-12#1)(2010-2#2)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#11)(2011-1#4)(2011-12#1)(2011-2#18)(2012-12#2)(2012-2#8)(2012-3#5)(2012-5#1)(2012-7#1)(2013-1#11)(2013-7#8)(2013-8#9)
seasonality and##6##2##(1997-3#1)(1997-8#1)(2008-5#2)(2011-2#1)(2013-7#1)
seasonality may##2##2##(1995-1#1)(1997-5#1)
seasonality of##3##2##(1994-12#1)(2008-3#1)(2008-5#1)
seasonality were##2##2##(2007-3#1)(2012-2#1)
seasonality##34##1##(1993-2#1)(1994-12#1)(1995-1#1)(1995-7#1)(1996-3#1)(1997-3#1)(1997-5#3)(1997-8#1)(2005-8#1)(2007-3#4)(2007-7#1)(2008-10#2)(2008-3#2)(2008-5#3)(2008-9#1)(2009-4#2)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#1)
seasonally inundated forest on the##2##5##(2008-5#2)
seasonally##13##1##(1995-5#1)(1996-1#1)(2007-5#2)(2008-5#4)(2008-8#1)(2010-3#1)(2011-12#1)(2011-3#1)(2013-7#1)
seasoned##4##1##(1991-5#1)(2006-4#1)(2007-7#1)(2008-9#1)
seasoning##2##1##(1990-8#1)(1996-2#1)
seasons and##7##2##(1996-6#1)(2004-11#1)(2007-3#1)(2008-8#3)(2010-12#1)
seasons at##2##2##(2007-3#1)(2013-1#1)
seasons by##2##2##(2008-10#2)
seasons from##3##2##(1996-12#1)(2008-10#1)(2012-12#1)
seasons in the##3##3##(2008-10#1)(2010-2#1)(2012-12#1)
seasons in##16##2##(2005-7#1)(2005-8#1)(2006-4#1)(2007-3#1)(2008-10#5)(2008-5#1)(2009-6#1)(2010-2#2)(2012-12#2)(2013-7#1)
seasons of the year##2##4##(2008-12#1)(2008-5#1)
seasons of##9##2##(1994-3#1)(2007-5#1)(2008-10#3)(2008-12#1)(2008-5#1)(2010-1#1)(2013-8#1)
seasons that##2##2##(2008-10#1)(2010-2#1)
seasons were##4##2##(2008-10#2)(2008-5#1)(2011-2#1)
seasons##152##1##(1991-10#1)(1992-6#1)(1994-3#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-6#1)(2004-11#1)(2005-7#2)(2005-8#1)(2006-4#3)(2007-1#1)(2007-11#1)(2007-2#2)(2007-3#5)(2007-4#1)(2007-5#2)(2007-6#3)(2007-8#2)(2008-10#57)(2008-11#1)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#11)(2008-7#1)(2008-8#6)(2008-9#1)(2009-12#1)(2009-4#4)(2009-6#2)(2009-7#1)(2010-1#1)(2010-12#3)(2010-2#3)(2010-8#1)(2011-2#3)(2012-12#4)(2012-2#6)(2012-8#1)(2013-1#1)(2013-7#4)(2013-8#1)
seasons)##2##1##(2006-5#1)(2007-3#1)
seat and##3##2##(1990-5#1)(2007-4#2)
seat belt##18##2##(1997-6#3)(2005-8#1)(2006-11#4)(2007-1#1)(2007-4#7)(2009-4#1)(2013-1#1)
seat belts##3##2##(1991-11#1)(1993-3#1)(2007-1#1)
seat height##4##2##(2008-6#4)
seat use##2##2##(1991-8#1)(2008-11#1)
seat with##2##2##(2006-11#2)
seat without##3##2##(2006-11#1)(2007-4#2)
seat##71##1##(1990-5#2)(1991-11#2)(1991-8#1)(1993-3#1)(1996-12#1)(1997-6#3)(2005-8#1)(2006-10#1)(2006-11#19)(2007-1#3)(2007-4#17)(2007-6#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-6#8)(2009-4#2)(2010-5#1)(2012-1#1)(2012-2#2)(2013-1#2)
seatback tests##6##2##(2007-4#6)
seatback##7##1##(2007-4#7)
seatbelt loading##3##2##(2006-11#1)(2007-4#2)
seatbelt##9##1##(2006-11#3)(2007-4#5)(2008-10#1)
seated cadavers##2##2##(2006-11#1)(2007-4#1)
seated exercise##2##2##(2010-2#1)(2010-3#1)
seated position##3##2##(1992-7#1)(2006-8#1)(2007-4#1)
seated##29##1##(1991-9#1)(1992-7#1)(1993-9#1)(1995-8#1)(2006-11#3)(2006-6#1)(2006-8#4)(2007-1#2)(2007-2#2)(2007-4#5)(2007-7#1)(2008-6#1)(2010-2#1)(2010-3#3)(2012-2#2)
seating##5##1##(1996-12#1)(2006-11#1)(2007-1#1)(2007-11#1)(2007-4#1)
seats for##2##2##(2006-11#2)
seats of##3##2##(1991-9#1)(2010-5#2)
seats were##2##2##(2006-11#1)(2007-4#1)
seats##18##1##(1991-9#1)(2006-11#7)(2007-1#1)(2007-4#3)(2009-4#2)(2010-5#4)
seaward##2##1##(1994-8#1)(2008-8#1)
seawater and##8##2##(2007-8#1)(2008-10#5)(2008-2#1)(2010-4#1)
seawater are##2##2##(2008-10#1)(2008-2#1)
seawater by##14##2##(2007-8#3)(2008-10#9)(2008-3#1)(2012-12#1)
seawater from##3##2##(2007-8#1)(2008-10#1)(2012-2#1)
seawater in the##2##3##(1990-5#1)(2008-10#1)
seawater in##4##2##(1990-5#1)(2008-10#2)(2012-12#1)
seawater is described##2##3##(2008-10#1)(2008-3#1)
seawater is##5##2##(2008-10#2)(2008-3#3)
seawater matrix##4##2##(2007-8#1)(2008-10#3)
seawater of##3##2##(2008-10#1)(2008-2#2)
seawater pH##2##2##(2008-10#2)
seawater sample##6##2##(2008-10#4)(2009-6#1)(2012-12#1)
seawater samples by##2##3##(2008-10#1)(2012-3#1)
seawater samples collected from##2##4##(2007-8#1)(2008-10#1)
seawater samples containing##2##3##(2008-10#2)
seawater samples from##2##3##(2008-10#2)
seawater samples with##2##3##(2007-8#1)(2008-10#1)
seawater samples##26##2##(2007-8#3)(2008-10#22)(2012-3#1)
seawater temperature##3##2##(2008-4#1)(2008-5#1)(2013-8#1)
seawater using flow injection##2##4##(2008-10#2)
seawater using the##2##3##(2008-10#2)
seawater using##11##2##(2008-10#10)(2012-3#1)
seawater was##3##2##(2008-10#2)(2008-2#1)
seawater were##5##2##(2008-10#4)(2012-12#1)
seawater with##6##2##(2007-8#2)(2008-10#3)(2008-2#1)
seawater##206##1##(1990-11#1)(1990-5#1)(1995-5#1)(2006-6#1)(2007-10#2)(2007-5#1)(2007-8#19)(2007-9#1)(2008-10#122)(2008-11#1)(2008-2#9)(2008-3#11)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#1)(2009-4#1)(2009-6#3)(2010-4#2)(2011-1#3)(2011-12#1)(2011-2#1)(2012-12#8)(2012-2#3)(2012-3#2)(2012-5#1)(2013-8#1)
seawaters##2##1##(2008-10#2)
seaweed Sargassum (Sargassaceae) as tropical alternative for goats'##2##8##(2008-5#2)
seaweed and##3##2##(2007-8#1)(2010-4#2)
seaweed extracts##2##2##(2011-12#2)
seaweed had##2##2##(2010-4#2)
seaweed samples##3##2##(2007-8#2)(2008-10#1)
seaweed species##3##2##(2007-8#3)
seaweed##41##1##(2006-12#1)(2007-8#7)(2008-10#7)(2008-11#3)(2008-5#4)(2010-4#14)(2011-12#3)(2013-1#2)
seaweed-type photobioreactor##2##2##(2008-6#2)
seaweed-type##4##1##(2008-6#4)
seaweeds from the##2##3##(2008-11#1)(2011-12#1)
seaweeds from##3##2##(2006-12#1)(2008-11#1)(2011-12#1)
seaweeds##15##1##(1995-8#1)(2006-12#1)(2008-10#1)(2008-11#4)(2009-2#1)(2010-4#6)(2011-12#1)
sebacate##5##1##(1994-9#2)(2008-10#3)
sebaceoma##2##1##(2008-8#1)(2010-8#1)
sebaceous and##2##2##(2010-3#1)(2013-8#1)
sebaceous cell carcinoma and BCC##2##5##(2007-11#2)
sebaceous cell carcinoma##3##3##(2007-11#2)(2009-8#1)
sebaceous cell##4##2##(2007-11#2)(2009-8#1)(2010-3#1)
sebaceous gland activity and##2##4##(2008-5#1)(2010-3#1)
sebaceous gland hyperplasia##10##3##(2007-7#1)(2008-9#8)(2010-5#1)
sebaceous gland is##2##3##(2010-3#1)(2010-5#1)
sebaceous gland##34##2##(2007-7#2)(2008-5#4)(2008-9#8)(2010-3#9)(2010-5#10)(2010-7#1)
sebaceous glands and##2##3##(2006-12#1)(2010-3#1)
sebaceous glands is##2##3##(2010-3#2)
sebaceous glands##15##2##(2006-12#3)(2008-5#2)(2008-9#1)(2009-2#1)(2010-3#6)(2010-5#1)(2010-6#1)
sebaceous lipids##3##2##(2010-3#2)(2010-5#1)
sebaceous metaplasia##2##2##(2012-3#2)
sebaceous neoplasms##2##2##(2010-8#2)
sebaceous##78##1##(1992-9#1)(2006-12#3)(2006-8#1)(2007-11#2)(2007-7#4)(2008-5#7)(2008-8#1)(2008-9#9)(2009-2#1)(2009-8#1)(2010-3#21)(2010-5#12)(2010-6#1)(2010-7#1)(2010-8#6)(2011-1#4)(2012-3#2)(2013-8#1)
sebocyte##6##1##(2010-3#4)(2010-5#1)(2010-7#1)
sebocytes are##2##2##(2010-3#2)
sebocytes##15##1##(2009-2#1)(2010-3#10)(2010-5#4)
seborrhea##3##1##(2010-3#1)(2010-5#1)(2012-12#1)
seborrheic dermatitis##9##2##(2007-7#3)(2008-5#3)(2010-8#2)(2012-11#1)
seborrheic keratosis##4##2##(2007-8#2)(2011-2#1)(2012-12#1)
seborrheic##14##1##(2007-1#1)(2007-7#3)(2007-8#2)(2008-5#3)(2010-8#2)(2011-2#1)(2012-11#1)(2012-12#1)
seborrhoeic dermatitis##3##2##(2008-5#2)(2010-9#1)
seborrhoeic eczema##2##2##(1991-2#1)(2006-12#1)
seborrhoeic##5##1##(1991-2#1)(2006-12#1)(2008-5#2)(2010-9#1)
sebum composition##2##2##(2010-5#2)
sebum content##2##2##(2008-5#2)
sebum excretion##3##2##(2006-12#1)(2008-5#1)(2010-3#1)
sebum peroxidation##2##2##(2008-5#1)(2010-5#1)
sebum production##2##2##(2008-5#1)(2010-3#1)
sebum secretion##3##2##(2008-5#1)(2010-3#2)
sebum squalene peroxidation##2##3##(2008-5#2)
sebum synthesis##2##2##(2008-5#1)(2010-5#1)
sebum using##2##2##(2008-5#1)(2010-5#1)
sebum##43##1##(2006-12#1)(2006-8#1)(2007-8#1)(2008-5#19)(2010-3#10)(2010-5#11)
sec and##12##2##(1990-3#2)(1990-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(2006-5#1)(2007-2#2)(2007-7#1)(2008-1#1)(2010-7#1)
sec in the##3##3##(2006-9#2)(2007-2#1)
sec in##5##2##(1996-6#1)(2006-9#2)(2007-2#1)(2007-9#1)
sec of##2##2##(1994-8#1)(1995-2#1)
sec##77##1##(1990-2#2)(1990-3#4)(1990-7#3)(1991-12#1)(1991-2#1)(1991-4#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-11#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#2)(1995-2#1)(1995-8#1)(1996-2#1)(1996-6#1)(1997-5#1)(2006-5#5)(2006-8#1)(2006-9#2)(2007-10#1)(2007-2#6)(2007-7#4)(2007-9#5)(2008-1#2)(2008-10#1)(2008-2#7)(2008-3#4)(2008-5#1)(2010-7#3)(2011-2#1)(2013-1#1)(2013-8#2)
sec) and##2##2##(1990-3#1)(2007-6#1)
sec)##12##1##(1990-3#1)(2007-10#4)(2007-6#1)(2008-4#1)(2008-5#4)(2012-2#1)
sec13##3##1##(1994-12#1)(1997-6#2)
sec18##2##1##(1994-12#1)(1997-1#1)
sec27-1##2##1##(1994-9#2)
sec7##3##1##(1997-1#3)
secE##2##1##(1994-3#2)
secY##4##1##(1992-2#2)(2011-2#2)
secY/flaB PCR##2##2##(2011-2#2)
secY/flaB##4##1##(2011-2#4)
secalis in##3##2##(2008-10#3)
secalis populations##2##2##(2008-10#2)
secalis were##2##2##(2008-10#2)
secalis##26##1##(2008-10#26)
sech(2) pulses##2##2##(2007-12#2)
sech(2)##7##1##(2007-11#1)(2007-12#4)(2008-2#2)
secluded##2##1##(1993-3#1)(2011-2#1)
seclusion and##2##2##(2009-6#1)(2011-2#1)
seclusion##9##1##(1991-12#2)(1991-5#2)(1996-2#1)(2007-5#1)(2009-6#2)(2011-2#1)
seco'##2##1##(1992-8#1)(1996-6#1)
secobarbital##3##1##(1991-1#1)(2007-8#1)(2008-6#1)
secoiridoid glycosides##2##2##(2007-1#2)
secoisolariciresinol##2##1##(1990-9#1)(2007-1#1)
second (FEV1)##8##2##(1990-5#1)(2007-2#2)(2008-1#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-3#1)
second Alternate Protocol##2##3##(2008-4#2)
second CR##3##2##(2007-4#1)(2008-5#1)(2012-12#1)
second European##3##2##(2008-2#1)(2010-12#2)
second F(2) population##2##3##(2008-10#2)
second Michelson interferometer##2##3##(2007-11#2)
second SH3##3##2##(1996-8#1)(1997-4#2)
second Stokes##2##2##(2007-11#1)(2007-12#1)
second after##4##2##(2008-10#1)(2013-8#3)
second aim was to##2##4##(2007-12#1)(2012-1#1)
second alkane-inducible cytochrome P450-encoding gene##2##5##(1991-9#2)
second alternate protocol##4##3##(2008-4#4)
second alternative##2##2##(1991-2#1)(2008-5#1)
second amino group##7##3##(1992-6#1)(1997-3#6)
second amino##10##2##(1992-6#1)(1997-2#2)(1997-3#6)(2008-10#1)
second analysis##3##2##(2008-10#3)
second and fifth##4##3##(1991-12#1)(1991-2#1)(1997-1#2)
second and later quanta##2##4##(1995-8#2)
second and later quantal releases##3##5##(1995-8#3)
second and later quantal##4##4##(1995-8#4)
second and later##6##3##(1995-8#6)
second and the third##7##4##(1990-3#1)(1991-12#1)(1991-8#1)(1997-3#1)(2007-7#1)(2008-5#1)(2010-2#1)
second and third groups##2##4##(2007-10#1)(2008-4#1)
second and third line##3##4##(1992-6#1)(1993-1#2)
second and third trimesters##5##4##(1993-12#2)(2009-5#1)(2011-1#2)
second and third##50##3##(1990-3#1)(1991-3#2)(1992-10#1)(1992-6#1)(1993-1#2)(1993-12#2)(1994-12#1)(1995-8#1)(1997-3#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#3)(2008-7#2)(2008-8#1)(2009-5#1)(2011-1#2)(2011-2#2)(2013-1#2)(2013-8#1)
second and##81##2##(1990-12#1)(1990-3#3)(1991-12#2)(1991-2#1)(1991-3#2)(1991-8#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-1#2)(1993-12#2)(1994-12#1)(1995-8#7)(1996-1#1)(1997-1#2)(1997-3#2)(2005-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#5)(2008-7#2)(2008-8#1)(2009-3#1)(2009-5#1)(2010-2#1)(2011-1#3)(2011-2#2)(2013-1#4)(2013-8#2)
second antenna##2##2##(2007-12#2)
second antibody##9##2##(1990-12#1)(1990-3#1)(1991-1#1)(1996-3#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)
second application##5##2##(1991-7#1)(1995-1#1)(1997-4#1)(2008-11#1)(2011-1#1)
second approach uses##3##3##(2005-10#1)(2008-2#1)(2008-3#1)
second approach##18##2##(1991-3#1)(1993-3#1)(1995-2#1)(1996-11#1)(2005-1#1)(2005-10#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2012-2#1)(2012-3#2)(2013-7#1)
second arch##4##2##(1993-12#4)
second article in##2##3##(2008-1#1)(2012-2#1)
second article##5##2##(1994-1#1)(2007-4#1)(2008-1#1)(2008-6#1)(2012-2#1)
second as##3##2##(1990-2#1)(1991-12#1)(2008-8#1)
second aspect##2##2##(1991-5#1)(2012-2#1)
second at##6##2##(1990-7#1)(1994-11#1)(1997-5#1)(2005-8#1)(2008-12#1)(2009-9#1)
second attachment site##2##3##(1995-6#2)
second author##2##2##(2007-8#1)(2008-2#1)
second basic protocol##6##3##(2008-4#6)
second basic##8##2##(1995-6#1)(2008-4#7)
second best##3##2##(2007-4#1)(2008-2#1)(2008-6#1)
second biopsy##4##2##(1990-2#1)(2006-10#1)(2007-2#1)(2010-10#1)
second birth##2##2##(2009-10#1)(2010-11#1)
second branchial##3##2##(1993-12#1)(2005-10#1)(2012-12#1)
second by##7##2##(1991-12#1)(2007-12#1)(2008-12#1)(2008-4#1)(2011-1#1)(2013-1#2)
second cDNA##4##2##(1992-5#1)(1992-8#1)(1994-12#2)
second calcitonin messenger##2##3##(1992-5#2)
second cancer was##4##3##(1990-8#1)(1993-9#3)
second cancer##5##2##(1990-8#1)(1993-9#4)
second case had##2##3##(2007-7#1)(2008-12#1)
second case is##6##3##(2005-11#2)(2007-10#1)(2007-2#2)(2008-10#1)
second case of a##2##4##(1991-4#1)(2008-6#1)
second case of##10##3##(1991-4#1)(1993-2#1)(2007-8#1)(2008-6#2)(2010-3#1)(2012-2#1)(2013-1#2)(2013-7#1)
second case##47##2##(1990-11#1)(1991-4#1)(1992-4#1)(1993-2#1)(1995-9#1)(1996-3#1)(1996-6#1)(2005-11#2)(2005-12#2)(2005-8#1)(2006-12#1)(2007-10#1)(2007-2#2)(2007-7#2)(2007-8#3)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#2)(2008-8#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#4)(2013-7#1)
second cause##3##2##(1991-11#1)(2010-12#1)(2011-3#1)
second cell##4##2##(1990-11#2)(2007-12#1)(2008-2#1)
second cervical vertebra##2##3##(2006-12#1)(2007-9#1)
second challenge of##2##3##(1997-2#1)(2006-10#1)
second challenge##5##2##(1995-8#1)(1997-2#2)(2006-10#1)(2008-10#1)
second child##3##2##(1991-8#1)(1993-2#1)(2007-8#1)
second class##5##2##(1990-3#1)(1990-5#1)(1994-11#1)(2008-11#1)(2012-11#1)
second clone##3##2##(1993-5#1)(1994-11#1)(1994-12#1)
second codon##2##2##(1993-8#1)(1997-2#1)
second cohort of##2##3##(1996-3#1)(2011-2#1)
second cohort##4##2##(1996-3#1)(2011-2#1)(2012-11#1)(2013-7#1)
second commonest##3##2##(2006-10#1)(2006-2#1)(2009-4#1)
second component##4##2##(1991-12#1)(1994-5#1)(1996-2#1)(1997-4#1)
second concerns##2##2##(2007-2#1)(2011-2#1)
second cosmic rays##2##3##(2012-2#2)
second course of##4##3##(2006-10#1)(2008-1#1)(2008-10#2)
second course##5##2##(2006-10#1)(2008-1#1)(2008-10#2)(2008-11#1)
second cousins##2##2##(1997-1#1)(2006-7#1)
second critical radius##2##3##(2006-10#2)
second crystal##3##2##(1991-7#1)(2006-5#2)
second cumulant##2##2##(2008-2#2)
second cycle of##3##3##(1991-12#1)(2008-11#1)(2013-1#1)
second cycle##5##2##(1991-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2013-1#1)
second cysteine-rich##3##2##(1990-12#2)(1992-11#1)
second data##3##2##(1994-11#1)(2008-7#1)(2009-9#1)
second day after##3##3##(1993-12#1)(1996-11#1)(2008-4#1)
second day of##10##3##(1993-12#2)(1996-4#1)(2005-8#2)(2006-5#1)(2008-4#2)(2011-1#1)(2012-3#1)
second day##27##2##(1991-9#1)(1993-1#1)(1993-12#3)(1995-5#1)(1996-11#1)(1996-4#1)(1997-3#1)(2005-8#2)(2006-5#1)(2007-12#1)(2008-12#2)(2008-4#3)(2008-6#1)(2011-1#1)(2012-12#2)(2012-3#2)(2013-1#3)
second decade of life##5##4##(2009-12#1)(2010-2#1)(2013-1#2)(2013-8#1)
second decade of##6##3##(2009-12#1)(2010-2#1)(2013-1#3)(2013-8#1)
second decade##10##2##(1992-5#1)(1993-5#1)(2007-2#1)(2008-4#1)(2009-12#1)(2010-2#1)(2013-1#3)(2013-8#1)
second degree burns##2##3##(2005-7#1)(2013-7#1)
second degree##5##2##(1992-4#1)(1994-12#1)(2005-7#1)(2007-7#1)(2013-7#1)
second derivative for##2##3##(2008-10#1)(2008-2#1)
second derivative spectra of##2##4##(1995-1#1)(2008-10#1)
second derivative spectra##5##3##(1995-1#2)(2008-10#3)
second derivative spectrophotometric method##3##4##(2008-10#3)
second derivative spectrophotometry##3##3##(2008-10#3)
second derivative##21##2##(1995-1#2)(2008-10#15)(2008-2#1)(2008-3#1)(2009-8#1)(2013-8#1)
second describes##2##2##(2008-4#2)
second design##4##2##(2008-2#2)(2013-1#2)
second diet##2##2##(1992-9#1)(2007-2#1)
second dimension##5##2##(2008-10#2)(2008-7#1)(2009-10#1)(2012-12#1)
second dissociation reactions of the##2##5##(2008-10#2)
second dissociation##6##2##(2008-10#6)
second domain##2##2##(1994-8#1)(1997-4#1)
second dose of##7##3##(1992-3#1)(1993-12#1)(1997-6#1)(2006-10#1)(2009-10#2)(2011-2#1)
second dose##13##2##(1992-3#2)(1993-12#1)(1997-6#1)(2004-12#1)(2006-10#1)(2008-5#1)(2008-7#2)(2009-10#3)(2011-2#1)
second drug##6##2##(1996-12#1)(1996-9#2)(2005-7#1)(2007-11#1)(2008-11#1)
second earthquake##2##2##(2012-2#2)
second ed##3##2##(2008-11#1)(2008-12#2)
second edition##5##2##(2008-10#2)(2010-5#1)(2013-8#2)
second enzyme##4##2##(1990-4#1)(1993-9#1)(2005-11#1)(2009-3#1)
second event##2##2##(2008-1#1)(2009-4#1)
second example##7##2##(1997-7#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-2#1)(2011-1#1)
second experiment was##4##3##(1995-8#1)(2008-1#2)(2008-10#1)
second experiment##39##2##(1990-10#1)(1991-1#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-12#1)(1994-2#1)(1994-6#1)(1995-8#1)(1996-12#2)(1997-3#1)(1997-6#1)(2006-3#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#1)(2008-1#3)(2008-10#7)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#1)(2009-3#1)(2010-8#1)(2012-3#1)(2013-8#1)
second exposure to##3##3##(1990-7#1)(2008-11#1)(2012-1#1)
second eye##2##2##(2011-1#1)(2011-2#1)
second factor##2##2##(2008-10#1)(2009-11#1)
second family##5##2##(1991-12#1)(1991-4#1)(1992-9#1)(1996-6#1)(1997-6#1)
second flavodoxin gene##2##3##(1997-7#2)
second focus##6##2##(2005-8#2)(2006-11#1)(2007-12#1)(2008-2#1)(2013-8#1)
second for##3##2##(2007-8#1)(2008-10#1)(2008-4#1)
second form of the##2##4##(1992-3#2)
second form of##3##3##(1990-5#1)(1992-3#2)
second form##4##2##(1990-5#1)(1992-3#2)(1997-2#1)
second fundamental##2##2##(1991-10#1)(2008-4#1)
second gel##2##2##(2008-4#2)
second gene for##2##3##(1996-5#1)(2008-10#1)
second gene##9##2##(1990-2#1)(1990-3#1)(1991-2#1)(1992-6#1)(1993-3#1)(1996-3#1)(1996-5#1)(2008-10#1)(2009-8#1)
second generation antihistamine##4##3##(2007-11#4)
second generation antihistamines##3##3##(2007-11#2)(2008-3#1)
second generation antipsychotics##2##3##(2009-6#1)(2012-2#1)
second generation of##11##3##(1991-5#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-9#1)(2008-10#1)(2008-3#1)(2009-3#1)(2011-2#1)(2012-12#2)
second generation##44##2##(1990-2#1)(1991-5#1)(1991-6#2)(1995-2#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-11#9)(2007-7#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-3#2)(2008-4#1)(2009-10#1)(2009-3#2)(2009-6#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
second goal##4##2##(1997-4#2)(2007-11#1)(2010-8#1)
second golden era##2##3##(2006-9#2)
second grade##5##2##(2007-9#1)(2008-12#1)(2010-3#3)
second grating##5##2##(2007-12#2)(2008-2#2)(2008-3#1)
second group comprised##2##3##(2006-5#1)(2008-7#1)
second group consisted of##2##4##(2007-8#1)(2008-10#1)
second group had##2##3##(2009-7#1)(2012-3#1)
second group included##3##3##(2005-10#1)(2008-8#1)(2011-2#1)
second group of rats##3##4##(1993-12#1)(2008-8#1)(2011-2#1)
second group of##14##3##(1990-5#1)(1991-7#1)(1992-8#1)(1993-12#1)(1994-6#2)(1997-4#1)(2006-4#1)(2008-8#1)(2011-2#2)(2012-2#1)(2012-3#2)
second group was##2##3##(1996-9#1)(2006-6#1)
second group##62##2##(1990-1#1)(1990-10#2)(1990-2#2)(1990-5#1)(1991-11#1)(1991-5#1)(1991-7#1)(1992-8#2)(1993-12#1)(1993-5#1)(1994-6#4)(1994-9#1)(1996-2#1)(1996-9#1)(1997-4#1)(2005-10#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-8#6)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-7#1)(2010-12#2)(2010-4#1)(2011-2#3)(2012-2#1)(2012-3#5)(2013-1#1)
second half of the##22##4##(1991-6#1)(2004-11#1)(2005-6#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-2#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#2)
second half of##30##3##(1991-6#1)(1994-3#1)(1995-11#1)(1996-8#1)(2004-11#1)(2005-6#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-2#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#2)
second half##33##2##(1991-6#1)(1994-3#1)(1995-11#1)(1996-8#1)(2004-11#1)(2005-6#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-2#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)
second harmonic and##2##3##(2007-11#1)(2009-7#1)
second harmonic generation (SHG)##2##4##(2008-10#1)(2013-1#1)
second harmonic generation##3##3##(2008-10#1)(2009-4#1)(2013-1#1)
second harmonic of a Nd##3##5##(2007-11#1)(2007-12#1)(2008-3#1)
second harmonic of a##6##4##(2007-11#1)(2007-12#3)(2008-1#1)(2008-3#1)
second harmonic of##11##3##(2007-11#2)(2007-12#4)(2008-1#2)(2008-2#2)(2008-3#1)
second harmonic was##3##3##(2007-12#2)(2008-2#1)
second harmonic##40##2##(2007-11#6)(2007-12#17)(2008-1#3)(2008-10#2)(2008-2#5)(2008-3#4)(2009-4#1)(2009-7#1)(2013-1#1)
second harmonics of##4##3##(2007-12#2)(2008-2#2)
second harmonics##6##2##(2007-12#4)(2008-2#2)
second heat##2##2##(1992-7#1)(2011-1#1)
second highest##4##2##(1996-4#1)(2008-10#1)(2008-7#1)(2009-7#1)
second hour post##2##3##(2012-2#2)
second hour##5##2##(2010-5#1)(2011-1#2)(2012-2#2)
second human##2##2##(2007-11#1)(2012-3#1)
second hypothesis is that##2##4##(2005-10#1)(2009-6#1)
second hypothesis##7##2##(1994-3#1)(2005-10#2)(2008-8#2)(2009-6#1)(2011-2#1)
second image##2##2##(2007-5#1)(2008-3#1)
second in a series##5##4##(1993-3#1)(1994-1#1)(1996-12#1)(2007-11#1)(2007-6#1)
second in a##10##3##(1993-3#1)(1994-1#1)(1995-1#1)(1996-12#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#1)(2011-1#1)
second in the##3##3##(1991-4#1)(2007-2#1)(2010-12#1)
second in##22##2##(1991-4#1)(1992-10#1)(1993-3#1)(1994-1#1)(1995-1#1)(1996-12#1)(1997-1#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-5#1)(2009-2#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
second independent##4##2##(1991-12#1)(1995-6#1)(2008-12#2)
second infusion##3##2##(1990-2#2)(2007-12#1)
second injection##6##2##(1990-12#1)(1996-12#2)(2006-5#1)(2008-12#1)(2013-8#1)
second instar##2##2##(2007-11#1)(2007-12#1)
second instrument##2##2##(2007-8#1)(2008-10#1)
second intention##2##2##(2008-12#1)(2008-2#1)
second intermediate##2##2##(1991-7#1)(1992-3#1)
second intervention##2##2##(1997-1#1)(2012-12#1)
second interview##2##2##(2007-1#1)(2008-11#1)
second intracellular loop##2##3##(1994-5#1)(1996-5#1)
second intron of the##3##4##(1992-8#1)(1993-8#1)(2012-3#1)
second intron##5##2##(1991-12#1)(1992-8#1)(1993-8#1)(1994-12#1)(2012-3#1)
second involves##2##2##(1992-3#1)(2008-4#1)
second is a##8##3##(1996-4#1)(2005-10#1)(2008-2#3)(2008-3#1)(2008-4#1)(2012-2#1)
second is the##8##3##(1992-9#1)(1995-8#1)(1997-2#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2012-2#1)
second is to##4##3##(1996-2#1)(2008-8#1)(2009-7#1)(2011-1#1)
second is##49##2##(1990-7#1)(1992-12#1)(1992-9#1)(1995-1#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-2#1)(2005-10#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#8)(2008-3#4)(2008-4#3)(2008-7#2)(2008-8#3)(2008-9#1)(2009-7#1)(2010-6#1)(2011-1#1)(2012-2#3)(2012-3#2)
second issue##2##2##(2006-8#1)(2008-10#1)
second key##2##2##(1995-2#1)(2005-5#1)
second kind##2##2##(2008-10#1)(2009-10#1)
second language##6##2##(1993-9#1)(2007-9#2)(2008-11#1)(2009-10#1)(2013-8#1)
second laparotomy##2##2##(1995-7#1)(1996-1#1)
second large##2##2##(1991-5#1)(2007-9#1)
second largest group##2##3##(1995-12#1)(2006-4#1)
second largest##10##2##(1992-3#1)(1992-8#1)(1995-12#1)(1996-2#1)(2006-4#1)(2007-8#1)(2008-10#1)(2010-11#1)(2010-3#1)(2010-6#1)
second laser##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
second law##2##2##(1993-12#1)(2008-10#1)
second layer##6##2##(1994-5#1)(1996-12#1)(2008-10#1)(2008-2#3)
second leading cause of death in##2##6##(2007-6#1)(2008-8#1)
second leading cause of death##5##5##(2007-6#1)(2008-8#1)(2009-3#1)(2010-11#1)(2013-1#1)
second leading cause of##12##4##(2006-8#1)(2007-6#2)(2008-1#1)(2008-8#1)(2009-3#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#2)
second leading##14##2##(2006-8#1)(2007-6#2)(2008-1#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-11#2)(2013-1#2)
second level of##3##3##(2006-10#1)(2006-7#1)(2008-7#1)
second level##7##2##(1993-3#1)(1995-2#1)(2006-10#1)(2006-7#1)(2008-11#1)(2008-7#1)(2008-8#1)
second ligand##4##2##(1990-11#1)(1991-5#1)(1995-8#1)(2010-5#1)
second line chemotherapy##4##3##(1990-2#1)(1994-2#1)(2008-6#1)(2011-1#1)
second line therapy##4##3##(1990-2#1)(1997-7#1)(2008-5#1)(2009-5#1)
second line##16##2##(1990-2#2)(1993-1#1)(1993-2#1)(1994-2#1)(1996-9#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-5#1)(2011-1#1)(2013-8#2)
second look##2##2##(1991-4#1)(2010-4#1)
second loop##2##2##(1992-5#1)(1995-2#1)
second lumbar vertebrae##2##3##(2007-2#1)(2010-12#1)
second lumbar##5##2##(2007-2#2)(2009-3#2)(2010-12#1)
second major##4##2##(1997-7#1)(2008-1#1)(2008-3#1)(2010-12#1)
second manifold##2##2##(2008-10#2)
second mating##3##2##(2008-10#1)(2008-5#2)
second measurement##5##2##(1994-6#2)(2008-3#1)(2010-6#1)(2011-1#1)
second mechanism##4##2##(1995-1#1)(1996-3#1)(2007-11#1)(2011-1#1)
second member of the##3##4##(1994-9#2)(1995-1#1)
second messenger in the##3##4##(1991-10#1)(1995-6#1)(1995-8#1)
second messenger in##4##3##(1991-10#1)(1993-6#1)(1995-6#1)(1995-8#1)
second messenger pathway##2##3##(1994-5#1)(1995-10#1)
second messenger pathways##4##3##(1994-12#1)(1995-3#1)(1996-10#1)(1996-11#1)
second messenger system##5##3##(1991-2#1)(1992-3#1)(1993-6#1)(1994-10#1)(1994-5#1)
second messenger systems##9##3##(1990-10#4)(1991-6#1)(1995-10#1)(1995-6#1)(1997-8#1)(2008-4#1)
second messenger that##3##3##(1993-6#1)(2008-11#1)(2013-1#1)
second messenger to##3##3##(1994-3#1)(2007-10#1)(2007-12#1)
second messenger##75##2##(1990-10#5)(1990-7#2)(1990-8#1)(1991-10#2)(1991-11#1)(1991-2#1)(1991-6#2)(1992-3#3)(1992-5#1)(1993-4#1)(1993-6#5)(1993-9#1)(1994-10#2)(1994-11#2)(1994-12#3)(1994-3#1)(1994-5#3)(1994-8#2)(1995-10#2)(1995-11#2)(1995-3#1)(1995-6#3)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-7#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-4#3)(2009-3#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2013-1#1)(2013-7#2)
second messengers and##3##3##(1990-3#1)(2008-7#1)(2013-1#1)
second messengers by##2##3##(1990-10#1)(1993-7#1)
second messengers in##5##3##(1991-6#1)(1994-10#1)(1995-8#1)(2008-11#1)(2009-6#1)
second messengers such as##2##4##(1996-5#1)(2008-7#1)
second messengers that##2##3##(1991-3#1)(2006-10#1)
second messengers##34##2##(1990-10#1)(1990-3#1)(1991-12#1)(1991-3#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-7#1)(1992-8#1)(1993-6#1)(1993-7#2)(1994-10#1)(1995-8#1)(1996-5#2)(2006-10#2)(2007-11#1)(2008-11#2)(2008-5#1)(2008-7#3)(2009-6#2)(2009-8#2)(2010-11#1)(2010-2#1)(2011-1#1)(2013-1#1)
second metal ion##2##3##(1995-6#1)(2010-5#1)
second metal##3##2##(1995-6#1)(2010-5#1)(2011-1#1)
second method is##7##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#1)(2012-2#1)
second method was##5##3##(2008-10#2)(2010-4#1)(2010-8#1)(2012-12#1)
second method##38##2##(1992-2#1)(1992-8#1)(1993-10#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-10#9)(2008-2#4)(2008-3#3)(2008-4#5)(2008-7#1)(2008-8#1)(2010-4#2)(2010-8#2)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#1)
second mode##2##2##(1996-8#1)(2007-11#1)
second model##9##2##(1990-8#1)(1992-6#2)(1996-4#1)(2005-11#1)(2006-3#1)(2007-12#1)(2008-8#2)
second molar##18##2##(2007-12#5)(2008-5#1)(2010-2#3)(2012-2#1)(2013-1#6)(2013-8#2)
second molars##6##2##(2007-12#3)(2013-1#3)
second molecule##2##2##(1993-4#1)(1995-3#1)
second moment of##2##3##(2007-9#1)(2009-4#1)
second moments##2##2##(2008-2#1)(2008-3#1)
second monolayer is##2##3##(2005-11#2)
second most common cancer among women worldwide##2##7##(2007-10#1)(2011-2#1)
second most common cancer among##3##5##(2007-10#1)(2007-6#1)(2011-2#1)
second most common cancer##7##4##(2007-10#1)(2007-6#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
second most common##38##3##(1996-11#1)(1997-5#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#2)(2013-7#1)
second most frequently##2##3##(1996-8#1)(2013-1#1)
second most important##4##3##(1995-9#1)(2008-12#1)(2010-10#1)(2012-12#1)
second most##56##2##(1990-8#1)(1991-6#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-8#1)(1997-5#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#3)(2012-2#3)(2013-1#4)(2013-7#1)
second mutation##2##2##(1994-3#1)(1994-8#1)
second new##3##2##(2008-11#1)(2013-1#2)
second nucleotide##6##2##(1992-6#1)(1993-12#1)(1993-3#2)(1997-2#2)
second objective was to##3##4##(2008-10#1)(2010-5#1)(2011-12#1)
second objective##5##2##(1992-11#1)(2008-10#1)(2010-5#1)(2011-1#1)(2011-12#1)
second of a##2##3##(2007-2#1)(2010-2#1)
second of two##2##3##(2006-4#1)(2012-2#1)
second of##12##2##(1993-5#1)(1995-1#1)(1995-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-4#1)(2007-2#1)(2010-2#1)(2012-2#1)(2012-3#1)
second on##4##2##(2008-11#1)(2008-6#1)(2010-4#1)(2012-11#1)
second one is##4##3##(2006-5#1)(2008-3#1)(2008-8#1)(2009-9#1)
second one was##4##3##(2007-3#1)(2008-10#1)(2008-5#1)(2008-8#1)
second one##37##2##(1990-3#1)(1991-3#1)(1992-10#1)(1993-11#1)(1994-11#1)(1995-6#1)(1997-4#1)(1997-5#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-8#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-11#2)
second one)##2##2##(1990-2#1)(1993-2#1)
second only to##10##3##(1992-3#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
second open reading frame##4##4##(1991-12#1)(1995-8#2)(1997-6#1)
second operation##9##2##(1993-5#1)(1996-6#2)(2006-12#1)(2008-6#1)(2008-7#3)(2010-12#1)
second opinion##9##2##(1996-2#1)(2005-12#1)(2007-4#1)(2008-4#1)(2008-8#1)(2010-7#1)(2011-12#3)
second opinions##8##2##(2011-12#8)
second optical feedback##2##3##(2007-12#2)
second or third line##2##4##(1992-6#1)(1993-1#1)
second or third##9##3##(1991-2#1)(1992-6#1)(1993-1#1)(2005-8#1)(2007-11#1)(2008-1#1)(2008-10#3)
second or##10##2##(1991-2#1)(1992-6#1)(1993-1#1)(2005-8#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-7#1)
second order derivative##4##3##(2005-4#1)(2008-10#3)
second order in##3##3##(2008-1#1)(2008-3#2)
second order of##3##3##(2008-3#2)(2012-3#1)
second order##35##2##(1994-10#1)(1996-7#1)(1996-9#1)(2005-4#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#5)(2008-3#4)(2008-5#1)(2008-6#1)(2009-7#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-7#1)
second oxygen##2##2##(1990-8#1)(1995-1#1)
second pair of##3##3##(1992-9#1)(2008-8#1)(2012-3#1)
second paper##3##2##(2008-3#1)(2012-3#1)(2013-1#1)
second parameter##2##2##(1996-12#1)(2008-2#1)
second part is##2##3##(2007-3#1)(2008-3#1)
second part of a two-part article##3##6##(1992-12#1)(1993-2#1)(1994-3#1)
second part of the study##4##5##(1992-5#1)(2007-4#1)(2008-1#1)(2013-8#1)
second part of the##12##4##(1990-12#1)(1990-3#2)(1992-5#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#1)(2013-8#1)
second part of this article##4##5##(1997-6#1)(2006-10#1)(2007-6#1)(2010-9#1)
second part of this paper##2##5##(1997-4#1)(2008-7#1)
second part of this##7##4##(1997-4#1)(1997-6#1)(2006-10#1)(2007-6#1)(2008-1#1)(2008-7#1)(2010-9#1)
second part of##24##3##(1990-12#1)(1990-3#2)(1992-12#1)(1992-5#1)(1993-2#1)(1994-3#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-8#1)
second part##44##2##(1990-12#1)(1990-3#2)(1992-12#1)(1992-5#1)(1993-2#1)(1994-3#1)(1994-6#2)(1995-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2009-6#2)(2010-11#2)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
second pathway##3##2##(1990-12#1)(2008-4#1)(2009-8#1)
second patient was a##3##4##(1990-4#1)(2010-12#1)(2013-1#1)
second patient was##7##3##(1990-4#1)(2009-1#1)(2010-12#2)(2011-12#1)(2012-12#1)(2013-1#1)
second patient##24##2##(1990-4#1)(1991-8#1)(1992-10#1)(1993-8#1)(1994-11#1)(2006-12#4)(2007-11#1)(2007-7#1)(2008-1#2)(2008-6#1)(2008-9#1)(2009-1#1)(2009-10#1)(2010-12#2)(2010-7#1)(2011-12#1)(2012-12#1)(2013-1#2)
second peak of##4##3##(1990-2#1)(1992-11#1)(1992-9#1)(1994-2#1)
second peak was##4##3##(1991-10#1)(1992-9#1)(2008-10#1)(2009-6#1)
second peak##16##2##(1990-2#1)(1991-10#1)(1992-11#1)(1992-9#2)(1994-2#1)(1995-12#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-6#2)(2010-3#1)
second per##2##2##(1993-2#1)(2012-12#1)
second period##10##2##(1992-6#1)(1994-5#1)(1996-3#2)(2011-2#5)(2013-1#1)
second phase III trial##2##4##(2005-8#1)(2008-5#1)
second phase of the##11##4##(1991-3#1)(1997-1#1)(1997-4#1)(2005-7#1)(2006-12#6)(2008-6#1)
second phase of##24##3##(1991-3#2)(1993-1#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#1)(2005-7#1)(2006-12#6)(2007-6#1)(2008-6#1)(2009-7#1)(2010-11#1)(2012-11#1)(2012-2#1)
second phase the##3##3##(2007-12#1)(2008-5#1)(2011-2#1)
second phase##46##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-3#2)(1991-7#1)(1992-11#1)(1993-1#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-12#6)(2007-12#2)(2007-6#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#2)(2010-11#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
second place##4##2##(1993-2#1)(2005-10#2)(2008-5#1)
second plasmid##3##2##(1991-5#1)(1995-2#1)(1997-2#1)
second point##3##2##(1991-9#1)(2008-12#1)(2013-1#1)
second population##3##2##(1995-1#1)(2008-10#1)(2009-9#1)
second position##4##2##(1991-1#1)(2008-11#3)
second posterior##3##2##(2008-12#3)
second primary cancers##3##3##(1991-6#1)(2012-12#1)(2013-1#1)
second primary carcinomata in##2##4##(2012-12#2)
second primary##12##2##(1990-8#1)(1991-6#1)(1993-5#1)(2011-2#1)(2012-1#1)(2012-12#5)(2012-2#1)(2013-1#1)
second principal##2##2##(2008-10#1)(2008-6#1)
second problem##2##2##(2008-10#1)(2008-2#1)
second procedure##4##2##(1994-9#1)(1996-9#1)(2008-4#2)
second product##2##2##(1991-1#1)(1991-3#1)
second promoter is##3##3##(1991-9#2)(1996-5#1)
second promoter##7##2##(1990-7#1)(1991-9#3)(1992-9#1)(1995-10#1)(1996-5#1)
second protocol describes##2##3##(2008-4#2)
second protocol##10##2##(1996-6#1)(2008-2#2)(2008-4#6)(2008-9#1)
second putative##2##2##(1996-9#1)(2008-10#1)
second quarter##4##2##(1993-3#1)(1995-12#1)(2008-5#1)(2009-3#1)
second question##2##2##(1994-2#1)(2012-12#1)
second ray amputation##3##3##(2006-3#3)
second reaction##2##2##(1997-8#1)(2008-6#1)
second region##7##2##(1992-12#1)(1992-7#1)(2007-12#1)(2008-10#1)(2009-5#2)(2011-1#1)
second remission##4##2##(1995-9#4)
second report of##5##3##(1995-6#1)(1996-10#1)(2006-10#1)(2008-12#1)(2012-3#1)
second report##7##2##(1995-6#1)(1996-10#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-12#1)(2012-3#1)
second round of PCR##2##4##(1997-4#1)(1997-7#1)
second round of##6##3##(1997-4#1)(1997-7#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-3#1)
second round##9##2##(1991-6#1)(1997-4#1)(1997-7#1)(2007-11#2)(2007-6#1)(2008-10#1)(2008-3#1)(2012-3#1)
second sample aliquot##2##3##(2008-10#1)(2008-3#1)
second sample##7##2##(1997-7#1)(2004-10#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#1)
second scale##2##2##(2009-6#1)(2010-4#1)
second section##12##2##(1991-1#1)(1992-6#1)(2006-10#1)(2008-10#2)(2008-4#4)(2010-11#1)(2012-2#2)
second sequence##3##2##(1995-3#2)(2011-2#1)
second series of experiments##6##4##(1992-6#1)(1995-1#1)(1997-7#2)(1997-8#1)(2009-4#1)
second series of##9##3##(1992-6#1)(1995-1#1)(1996-7#1)(1997-7#3)(1997-8#1)(2007-4#1)(2009-4#1)
second series##13##2##(1992-6#1)(1995-1#1)(1996-1#1)(1996-7#1)(1997-7#3)(1997-8#1)(2006-11#1)(2007-4#1)(2008-5#1)(2009-4#1)(2011-2#1)
second session##2##2##(2012-2#1)(2013-8#1)
second set of analyses##2##4##(2009-4#1)(2009-8#1)
second set of experiments##4##4##(1990-10#1)(1995-12#1)(1997-2#1)(2004-9#1)
second set of##17##3##(1990-10#1)(1990-12#1)(1993-12#1)(1993-6#1)(1994-11#1)(1995-12#1)(1995-2#1)(1997-2#1)(2004-9#1)(2007-6#1)(2008-10#1)(2008-4#1)(2009-4#1)(2009-8#1)(2010-10#1)(2013-1#2)
second set##19##2##(1990-10#1)(1990-12#1)(1993-12#1)(1993-6#1)(1994-11#1)(1995-12#1)(1995-2#1)(1997-2#1)(2004-9#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-4#1)(2009-8#1)(2010-10#1)(2013-1#2)
second signal##4##2##(1992-6#1)(1994-3#2)(2007-11#1)
second site##6##2##(1995-6#1)(1997-1#1)(2006-3#1)(2008-8#2)(2011-2#1)
second situation##3##2##(1992-2#1)(2008-2#1)(2008-8#1)
second specimen##2##2##(2007-12#1)(2013-1#1)
second sphere##2##2##(1991-7#2)
second stage in the##2##4##(2007-11#1)(2007-2#1)
second stage juvenile##2##3##(2008-12#2)
second stage of labour##3##4##(1993-4#2)(2013-8#1)
second stage of##7##3##(1993-4#2)(1994-2#2)(2008-8#1)(2012-3#1)(2013-8#1)
second stage was performed##2##4##(2012-2#2)
second stage was##3##3##(2008-10#1)(2012-2#2)
second stage##39##2##(1990-12#1)(1993-4#3)(1994-2#2)(1997-2#1)(2004-10#1)(2005-11#1)(2006-12#2)(2006-3#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#4)(2008-4#1)(2008-5#1)(2008-8#2)(2009-3#1)(2009-5#4)(2010-10#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
second step includes##2##3##(2007-3#1)(2008-10#1)
second step of##5##3##(1993-3#1)(2006-10#1)(2007-3#1)(2008-10#1)(2008-6#1)
second step uses##2##3##(2008-2#1)(2008-6#1)
second step was to##2##4##(2007-10#1)(2009-12#1)
second step was##3##3##(2007-10#1)(2007-6#1)(2009-12#1)
second step##40##2##(1990-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-7#1)(1997-8#1)(2004-9#1)(2006-10#1)(2006-11#1)(2007-10#3)(2007-3#2)(2007-6#1)(2007-9#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#2)(2009-12#1)(2009-5#1)(2009-8#2)(2011-1#1)(2012-2#1)
second stimulus was##2##3##(1997-5#1)(2006-5#1)
second stimulus##5##2##(1992-3#1)(1992-7#1)(1993-2#1)(1997-5#1)(2006-5#1)
second strain##2##2##(1990-12#1)(1993-11#1)
second structure##3##2##(2008-4#1)(2009-6#1)(2010-6#1)
second study##35##2##(1991-3#1)(1992-8#2)(1994-2#1)(1997-5#1)(2005-10#1)(2005-7#1)(2006-4#1)(2007-2#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#4)(2008-8#3)(2009-11#1)(2009-9#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
second substrate molecule##2##3##(1992-3#1)(2010-7#1)
second substrate##6##2##(1992-3#1)(1994-11#1)(1995-2#1)(2007-8#1)(2008-11#1)(2010-7#1)
second substrates of the enzyme##2##5##(2008-10#2)
second support protocol##3##3##(2008-4#3)
second surgery and##3##3##(2006-6#1)(2007-5#1)(2013-1#1)
second surgery##8##2##(2006-12#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-5#1)(2010-3#1)(2013-1#1)(2013-7#1)
second surgical##4##2##(1993-3#1)(2008-6#1)(2010-10#1)(2013-1#1)
second survey##2##2##(1992-12#1)(2008-10#1)
second system##7##2##(1993-6#1)(2008-10#2)(2008-3#2)(2013-1#2)
second test##8##2##(1990-6#1)(1991-10#3)(1994-6#1)(2008-3#1)(2011-1#1)(2012-3#1)
second that##2##2##(1994-10#1)(2009-4#1)
second thoracic##2##2##(1991-3#1)(2007-4#1)
second through##2##2##(2008-10#1)(2009-3#1)
second time##11##2##(1991-8#1)(1992-12#1)(1996-12#1)(1997-3#1)(2007-1#1)(2008-10#2)(2008-3#1)(2008-8#1)(2011-2#1)(2013-1#1)
second to the##3##3##(1992-6#2)(1995-3#1)
second to##11##2##(1990-8#1)(1992-6#2)(1993-12#1)(1995-3#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2011-1#1)
second toe transfer##2##3##(2009-6#2)
second toe##5##2##(1996-8#1)(2009-6#2)(2010-11#2)
second tone##3##2##(1996-5#3)
second transition##4##2##(1992-10#1)(1992-6#1)(2006-3#1)(2007-12#1)
second transplant##2##2##(2008-10#1)(2010-12#1)
second treatment##3##2##(1992-10#1)(1995-1#1)(1997-3#1)
second trial##7##2##(2004-1#1)(2008-10#1)(2008-5#1)(2009-4#2)(2013-1#2)
second trimester abortion##2##3##(1997-7#1)(2007-2#1)
second trimester##25##2##(1990-2#1)(1991-4#1)(1991-6#1)(1993-3#1)(1994-3#1)(1996-12#2)(1997-7#1)(1997-8#1)(2004-10#1)(2007-2#2)(2008-1#1)(2008-2#1)(2008-5#1)(2009-10#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
second twin##4##2##(2004-10#3)(2005-9#1)
second twins##3##2##(2004-10#3)
second type of##6##3##(1993-3#1)(1993-9#1)(1996-12#1)(1997-5#1)(2008-10#1)(2009-3#1)
second type##17##2##(1993-3#1)(1993-9#1)(1995-3#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-4#1)(2008-5#1)(2009-3#1)
second unrelated##2##2##(2012-11#1)(2012-2#1)
second valvulae##3##2##(2007-12#3)
second version of the Copenhagen Psychosocial Questionnaire##2##7##(2011-1#2)
second version##3##2##(2008-10#1)(2011-1#2)
second was a##4##3##(2006-2#1)(2006-6#1)(2008-10#1)(2008-8#1)
second was##11##2##(1993-1#1)(1994-2#1)(2004-11#1)(2006-2#2)(2006-6#1)(2008-10#1)(2008-8#1)(2009-5#1)(2009-8#1)(2011-1#1)
second wave of##2##3##(1995-3#1)(2007-3#1)
second wave##5##2##(1995-3#1)(2006-8#1)(2007-3#1)(2009-9#1)(2012-3#1)
second way##3##2##(1991-8#1)(2008-10#1)(2008-7#1)
second week##21##2##(1990-2#2)(1992-3#2)(1995-5#1)(1995-9#1)(1997-2#2)(2005-11#1)(2005-12#1)(2006-10#1)(2007-2#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2012-12#1)
second window of protection##2##4##(1994-11#1)(1996-9#1)
second with a##3##3##(2008-3#1)(2013-1#2)
second with##6##2##(2006-7#1)(2008-3#1)(2009-7#1)(2011-12#1)(2013-1#2)
second xylanase-encoding gene##2##3##(1990-1#2)
second year of life##8##4##(1993-1#1)(1996-11#1)(2007-8#2)(2008-9#1)(2009-4#2)(2012-1#1)
second year of the##4##4##(1995-5#1)(2008-10#1)(2010-3#1)(2011-2#1)
second year of##13##3##(1993-1#1)(1995-5#1)(1996-11#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-9#1)(2009-4#2)(2010-3#1)(2011-2#1)(2012-1#1)
second year##35##2##(1990-5#1)(1991-8#1)(1993-1#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-12#4)(2006-3#1)(2006-5#1)(2007-11#1)(2007-6#1)(2007-8#2)(2008-10#2)(2008-12#4)(2008-6#2)(2008-9#1)(2009-4#3)(2010-1#2)(2010-3#1)(2011-2#2)(2012-1#1)(2012-12#1)
second##3155##1##(1990-1#3)(1990-10#13)(1990-11#9)(1990-12#20)(1990-2#19)(1990-3#17)(1990-4#6)(1990-5#7)(1990-6#2)(1990-7#10)(1990-8#10)(1991-1#8)(1991-10#11)(1991-11#5)(1991-12#15)(1991-2#9)(1991-3#15)(1991-4#12)(1991-5#7)(1991-6#11)(1991-7#10)(1991-8#11)(1991-9#13)(1992-1#5)(1992-10#8)(1992-11#6)(1992-12#6)(1992-2#5)(1992-3#22)(1992-4#7)(1992-5#14)(1992-6#20)(1992-7#8)(1992-8#13)(1992-9#11)(1993-1#9)(1993-10#2)(1993-11#4)(1993-12#24)(1993-2#19)(1993-3#13)(1993-4#6)(1993-5#7)(1993-6#14)(1993-7#5)(1993-8#8)(1993-9#10)(1994-1#2)(1994-10#6)(1994-11#16)(1994-12#24)(1994-2#14)(1994-3#15)(1994-5#8)(1994-6#14)(1994-7#2)(1994-8#11)(1994-9#16)(1995-1#15)(1995-10#6)(1995-11#5)(1995-12#11)(1995-2#18)(1995-3#14)(1995-4#3)(1995-5#10)(1995-6#19)(1995-7#2)(1995-8#21)(1995-9#11)(1996-1#5)(1996-10#4)(1996-11#9)(1996-12#26)(1996-2#17)(1996-3#16)(1996-4#9)(1996-5#22)(1996-6#8)(1996-7#9)(1996-8#9)(1996-9#11)(1997-1#8)(1997-2#23)(1997-3#23)(1997-4#20)(1997-5#12)(1997-6#12)(1997-7#20)(1997-8#12)(2004-1#1)(2004-10#10)(2004-11#3)(2004-12#4)(2004-2#2)(2004-4#1)(2004-9#4)(2005-1#1)(2005-10#13)(2005-11#16)(2005-12#6)(2005-4#1)(2005-5#1)(2005-6#1)(2005-7#6)(2005-8#13)(2005-9#1)(2006-1#2)(2006-10#32)(2006-11#7)(2006-12#30)(2006-2#5)(2006-3#13)(2006-4#7)(2006-5#12)(2006-6#3)(2006-7#12)(2006-8#9)(2006-9#5)(2007-1#8)(2007-10#12)(2007-11#58)(2007-12#96)(2007-2#33)(2007-3#8)(2007-4#10)(2007-5#7)(2007-6#13)(2007-7#21)(2007-8#42)(2007-9#20)(2008-1#33)(2008-10#255)(2008-11#50)(2008-12#41)(2008-2#97)(2008-3#86)(2008-4#90)(2008-5#65)(2008-6#37)(2008-7#42)(2008-8#66)(2008-9#21)(2009-1#3)(2009-10#12)(2009-11#5)(2009-12#4)(2009-2#8)(2009-3#18)(2009-4#18)(2009-5#14)(2009-6#19)(2009-7#19)(2009-8#15)(2009-9#7)(2010-1#2)(2010-10#10)(2010-11#19)(2010-12#28)(2010-2#10)(2010-3#15)(2010-4#9)(2010-5#8)(2010-6#9)(2010-7#5)(2010-8#11)(2010-9#2)(2011-1#48)(2011-12#15)(2011-2#82)(2011-3#1)(2012-1#13)(2012-11#10)(2012-12#41)(2012-2#50)(2012-3#30)(2013-1#95)(2013-7#15)(2013-8#26)
second(n)##4##1##(2006-5#4)
second)##8##1##(1992-2#1)(1993-2#1)(1996-12#1)(1996-5#1)(2008-10#1)(2010-2#1)(2011-1#1)(2013-1#1)
second- and third-line therapy##2##4##(2008-7#2)
second- and third-order dispersion##2##4##(2007-11#1)(2008-2#1)
second- and third-order##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
second- and##9##2##(1996-12#1)(2007-11#1)(2008-2#2)(2008-3#1)(2008-7#3)(2013-1#1)
second-##13##1##(1996-12#1)(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#3)(2008-7#3)(2013-1#1)
second-and##2##1##(2006-8#1)(2008-7#1)
second-degree atrioventricular block##2##3##(2008-10#1)(2013-8#1)
second-degree##9##1##(2008-10#2)(2008-3#1)(2010-3#1)(2011-12#1)(2012-2#1)(2013-7#2)(2013-8#1)
second-derivative spectroscopy##2##2##(1993-8#2)
second-derivative##14##1##(1993-3#1)(1993-8#2)(2008-10#9)(2008-2#1)(2008-3#1)
second-dimension##3##1##(2008-2#1)(2008-4#2)
second-generation PTH assays##4##3##(2007-8#4)
second-generation TKIs##2##2##(2009-3#2)
second-generation agents##2##2##(2006-2#1)(2008-7#1)
second-generation models##2##2##(2006-7#2)
second-generation process##2##2##(2008-11#2)
second-generation tyrosine kinase inhibitors##3##4##(2009-3#2)(2012-12#1)
second-generation##40##1##(1991-12#1)(1997-7#1)(2004-12#1)(2005-8#2)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-7#2)(2007-11#1)(2007-8#5)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-11#2)(2009-3#5)(2009-8#1)(2010-12#2)(2010-6#1)(2010-7#1)(2011-2#2)(2012-12#2)(2012-2#1)
second-generation&quot##2##1##(2005-10#1)(2008-4#1)
second-hand smoke##2##2##(1992-7#1)(2008-11#1)
second-hand##3##1##(1992-7#1)(2008-10#1)(2008-11#1)
second-harmonic (2f)##2##2##(2007-12#1)(2008-2#1)
second-harmonic (SH)##4##2##(2007-12#4)
second-harmonic and sum-frequency generation of##2##5##(2007-12#2)
second-harmonic and sum-frequency generation##5##4##(2007-12#5)
second-harmonic and sum-frequency##6##3##(2007-12#5)(2008-2#1)
second-harmonic and##8##2##(2007-12#7)(2008-2#1)
second-harmonic beam##3##2##(2007-12#2)(2008-3#1)
second-harmonic beams##2##2##(2007-12#1)(2008-3#1)
second-harmonic detection##2##2##(2008-3#2)
second-harmonic field##3##2##(2008-1#1)(2008-3#2)
second-harmonic fields##3##2##(2007-12#2)(2008-1#1)
second-harmonic frequencies##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
second-harmonic generation (SHG) and##4##4##(2007-11#2)(2007-12#1)(2008-3#1)
second-harmonic generation (SHG) in##5##4##(2007-11#1)(2007-12#3)(2008-3#1)
second-harmonic generation (SHG) with##2##4##(2007-11#1)(2008-2#1)
second-harmonic generation (SHG)##19##3##(2007-11#5)(2007-12#9)(2008-1#1)(2008-2#1)(2008-3#3)
second-harmonic generation and two-photon##3##4##(2007-11#1)(2007-12#2)
second-harmonic generation and##14##3##(2007-11#2)(2007-12#8)(2008-2#2)(2008-3#2)
second-harmonic generation at 532 nm##2##5##(2008-3#2)
second-harmonic generation at##6##3##(2007-12#4)(2008-3#2)
second-harmonic generation by##3##3##(2007-12#3)
second-harmonic generation for##2##3##(2007-11#1)(2007-12#1)
second-harmonic generation frequency-resolved optical gating##4##5##(2007-11#1)(2007-12#3)
second-harmonic generation from a##3##4##(2007-12#3)
second-harmonic generation from##4##3##(2007-12#3)(2008-7#1)
second-harmonic generation in a##7##4##(2007-11#1)(2007-12#3)(2008-1#2)(2008-3#1)
second-harmonic generation in periodically poled##2##5##(2007-12#1)(2008-1#1)
second-harmonic generation in the##2##4##(2007-12#1)(2008-2#1)
second-harmonic generation in##27##3##(2007-11#7)(2007-12#13)(2008-1#5)(2008-2#1)(2008-3#1)
second-harmonic generation is presented##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
second-harmonic generation is##5##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
second-harmonic generation of a##8##4##(2007-12#4)(2008-2#3)(2008-3#1)
second-harmonic generation of##14##3##(2007-12#8)(2008-2#4)(2008-3#2)
second-harmonic generation process##3##3##(2007-12#3)
second-harmonic generation was##2##3##(2007-11#2)
second-harmonic generation with Fourier synthetic quasi-phase-matching gratings##2##7##(2007-12#2)
second-harmonic generation with a##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
second-harmonic generation with femtosecond##2##4##(2007-12#2)
second-harmonic generation with##13##3##(2007-11#3)(2007-12#8)(2008-2#1)(2008-3#1)
second-harmonic generation##175##2##(2007-11#34)(2007-12#95)(2008-1#12)(2008-2#16)(2008-3#16)(2008-7#1)(2009-4#1)
second-harmonic imaging##2##2##(2007-12#1)(2008-1#1)
second-harmonic intensity##3##2##(2007-12#3)
second-harmonic light in##2##3##(2007-12#1)(2008-2#1)
second-harmonic light##7##2##(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#2)
second-harmonic output of##2##3##(2007-12#1)(2008-2#1)
second-harmonic output##9##2##(2007-11#1)(2007-12#4)(2008-2#3)(2008-3#1)
second-harmonic power##5##2##(2007-11#3)(2007-12#2)
second-harmonic pulse##2##2##(2007-12#1)(2008-2#1)
second-harmonic pulses##4##2##(2007-12#3)(2008-1#1)
second-harmonic radiation##2##2##(2007-12#1)(2008-2#1)
second-harmonic signal is##2##3##(2007-11#1)(2007-12#1)
second-harmonic signal##8##2##(2007-11#3)(2007-12#4)(2008-3#1)
second-harmonic signals##3##2##(2007-12#3)
second-harmonic wave##5##2##(2007-12#5)
second-harmonic waves##2##2##(2007-11#2)
second-harmonic##292##1##(1995-7#1)(2007-11#51)(2007-12#164)(2008-1#19)(2008-2#25)(2008-3#28)(2008-7#1)(2009-4#1)(2011-1#2)
second-harmonic-generated holograms##2##2##(2007-12#2)
second-harmonic-generation (SHG)##2##2##(2007-11#1)(2007-12#1)
second-harmonic-generation frequency-resolved optical gating##3##4##(2007-12#3)
second-harmonic-generation##17##1##(2007-11#1)(2007-12#10)(2008-1#3)(2008-2#2)(2008-3#1)
second-instar larvae##3##2##(2008-10#3)
second-instar##4##1##(2008-10#3)(2011-2#1)
second-intention##3##1##(2007-11#2)(2012-3#1)
second-line agents##5##2##(2006-10#2)(2008-2#1)(2010-12#1)(2012-3#1)
second-line chemotherapy with##2##3##(1992-10#1)(2012-1#1)
second-line drugs##2##2##(2011-2#1)(2012-3#1)
second-line protocol##2##2##(1990-4#2)
second-line therapy for##2##3##(1993-10#1)(2010-12#1)
second-line therapy in##2##3##(1992-12#1)(2004-1#1)
second-line therapy##7##2##(1992-12#1)(1993-10#1)(1994-12#1)(2004-1#1)(2006-9#1)(2009-11#1)(2010-12#1)
second-line treatment##3##2##(1992-12#1)(2010-10#2)
second-line##37##1##(1990-10#1)(1990-4#2)(1992-10#1)(1992-12#2)(1993-10#1)(1993-11#1)(1993-5#1)(1994-12#1)(2004-1#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-9#1)(2007-2#2)(2007-6#1)(2008-2#1)(2008-6#1)(2009-11#1)(2010-10#2)(2010-12#4)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)
second-look laparoscopy##2##2##(1992-3#1)(1994-9#1)
second-look operation##2##2##(1993-3#1)(2007-3#1)
second-look procedures##2##2##(2006-10#1)(2010-2#1)
second-look##9##1##(1992-2#1)(1992-3#1)(1993-3#3)(1994-9#1)(2006-10#1)(2007-3#1)(2010-2#1)
second-messenger systems##2##2##(2006-10#2)
second-messenger##5##1##(1994-8#1)(1996-5#1)(2006-10#2)(2006-9#1)
second-order DPLL##2##2##(2008-3#2)
second-order PMD##4##2##(2007-11#2)(2007-12#2)
second-order advantage##5##2##(2008-10#4)(2010-5#1)
second-order approximation##2##2##(2007-12#1)(2007-9#1)
second-order autoregressive##2##2##(1994-8#1)(2008-3#1)
second-order calibration##3##2##(2008-10#2)(2011-1#1)
second-order cascaded##3##2##(2007-12#2)(2008-1#1)
second-order cascading##4##2##(2007-11#2)(2007-12#1)(2008-1#1)
second-order classification images##2##3##(2008-1#2)
second-order data##4##2##(2008-10#2)(2010-5#1)(2011-1#1)
second-order dispersion and##2##3##(2007-11#1)(2007-12#1)
second-order dispersion of the fiber##2##5##(2007-12#1)(2008-3#1)
second-order dispersion##6##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
second-order effects##3##2##(2007-12#1)(2008-2#2)
second-order fear conditioning##2##3##(1997-7#2)
second-order hyperpolarizability##2##2##(2007-12#2)
second-order kinetics##4##2##(1990-2#1)(1995-1#1)(1996-5#1)(2008-10#1)
second-order neurons##4##2##(1991-2#1)(1994-10#2)(1995-5#1)
second-order nonlinear optical##4##3##(2007-11#1)(2007-12#2)(2008-1#1)
second-order nonlinear susceptibility of##2##4##(2007-12#1)(2008-10#1)
second-order nonlinear##21##2##(2007-11#2)(2007-12#13)(2008-1#2)(2008-10#1)(2008-2#3)
second-order nonlinearities##2##2##(2007-12#1)(2008-1#1)
second-order nonlinearity and the##2##4##(2007-12#1)(2008-1#1)
second-order nonlinearity and##3##3##(2007-12#2)(2008-1#1)
second-order nonlinearity is##2##3##(2008-1#1)(2008-3#1)
second-order nonlinearity of poled##3##4##(2007-12#1)(2008-1#1)(2008-3#1)
second-order nonlinearity of##4##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)
second-order nonlinearity##18##2##(2007-11#2)(2007-12#10)(2008-1#3)(2008-2#1)(2008-3#2)
second-order polarization mode dispersion##2##4##(2007-11#1)(2007-12#1)
second-order polynomial##7##2##(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#1)(2011-1#1)
second-order process##4##2##(1990-2#1)(1991-4#1)(2007-12#1)(2007-5#1)
second-order processes in a##4##4##(2007-12#2)(2008-1#1)(2008-2#1)
second-order processes##7##2##(1990-2#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#2)
second-order rate constant for##2##4##(1991-2#1)(1995-2#1)
second-order rate constant of##4##4##(1991-2#1)(1996-7#1)(1997-4#1)(2008-4#1)
second-order rate constant##13##3##(1990-5#1)(1991-2#2)(1992-3#2)(1993-8#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-7#1)(1997-4#1)(2008-4#1)
second-order rate constants for reaction of##2##6##(1990-5#1)(1996-7#1)
second-order rate constants for##5##4##(1990-2#1)(1990-5#2)(1996-5#1)(1996-7#1)
second-order rate constants of##5##4##(1990-2#1)(1994-8#3)(1996-7#1)
second-order rate constants##13##3##(1990-2#2)(1990-5#2)(1994-8#3)(1995-6#1)(1996-2#1)(1996-5#1)(1996-7#2)(2008-10#1)
second-order rate##27##2##(1990-2#2)(1990-5#3)(1991-2#2)(1992-3#2)(1993-8#1)(1994-5#1)(1994-8#4)(1995-11#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-7#3)(1997-4#1)(2008-10#2)(2008-4#1)
second-order reaction##7##2##(1990-2#2)(1993-8#1)(1997-8#1)(2008-10#2)(2008-6#1)
second-order statistics##2##2##(2008-2#2)
second-order susceptibility of##2##3##(2007-12#1)(2008-3#1)
second-order susceptibility##6##2##(2007-12#3)(2008-1#1)(2008-3#2)
second-order terms result from##2##4##(2008-2#2)
second-order terms##3##2##(2008-2#3)
second-order##234##1##(1990-2#7)(1990-5#3)(1991-2#3)(1991-4#3)(1992-3#2)(1992-6#2)(1993-2#1)(1993-8#2)(1994-10#2)(1994-5#2)(1994-8#5)(1995-1#1)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-2#3)(1996-5#2)(1996-7#3)(1997-4#1)(1997-7#3)(1997-8#1)(2007-11#17)(2007-12#49)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#14)(2008-10#24)(2008-2#29)(2008-3#21)(2008-4#1)(2008-5#3)(2008-6#3)(2008-8#1)(2009-10#1)(2009-7#3)(2010-1#1)(2010-5#6)(2011-1#4)(2012-12#1)(2013-1#1)(2013-7#1)
second-order-pumped fiber Raman amplifiers##2##4##(2007-11#2)
second-phase Ca2+ response##2##3##(1990-2#2)
second-phase##3##1##(1990-2#2)(1991-5#1)
second-site binding##2##2##(1993-3#2)
second-site mutations##2##2##(1994-12#1)(1994-8#1)
second-site##7##1##(1992-3#1)(1993-3#2)(1994-12#1)(1994-8#1)(1997-2#1)(1997-4#1)
second-stage juveniles (J2)##5##3##(2008-10#5)
second-stage juveniles per##2##3##(2008-10#2)
second-stage juveniles##11##2##(2008-10#11)
second-stage##19##1##(2006-12#1)(2006-4#1)(2006-5#1)(2008-10#13)(2010-12#1)(2012-3#2)
second-trimester##4##1##(1996-12#1)(2004-11#1)(2007-4#1)(2011-1#1)
second-year harvest fields##2##3##(2008-10#2)
second-year##4##1##(2008-10#2)(2008-3#1)(2009-11#1)
secondaries##3##1##(1990-12#1)(2007-11#1)(2008-1#1)
secondarily to a##2##3##(1997-3#1)(2008-9#1)
secondarily##24##1##(1990-12#1)(1991-12#1)(1991-9#1)(1992-10#1)(1992-8#1)(1994-7#1)(1995-12#1)(1997-3#1)(1997-4#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-10#2)(2008-7#1)(2008-9#4)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#1)
secondary 2H##2##2##(1994-8#2)
secondary AA amyloidosis##2##3##(2006-10#2)
secondary APS##2##2##(2006-10#2)
secondary EL ERs in all##2##5##(1993-9#2)
secondary EL ERs in##3##4##(1993-9#3)
secondary EL ERs##6##3##(1993-9#6)
secondary GN##2##2##(2008-1#2)
secondary OH##2##2##(2005-11#1)(2006-12#1)
secondary TBI##2##2##(2012-2#2)
secondary actions##2##2##(1991-11#1)(1992-8#1)
secondary acute myeloid##2##3##(1990-9#1)(1996-2#1)
secondary acute##4##2##(1990-9#1)(1996-2#1)(2008-5#2)
secondary adenovirus-mediated gene transfer##2##4##(1997-4#2)
secondary adrenal failure##2##3##(2006-10#1)(2007-3#1)
secondary adrenocortical##2##2##(1995-12#1)(2006-8#1)
secondary alcohols and##2##3##(1992-2#1)(2010-5#1)
secondary alcohols##10##2##(1990-8#1)(1992-2#3)(2005-8#1)(2007-11#2)(2007-12#1)(2008-8#1)(2010-5#1)
secondary aliphatic##3##2##(1996-5#2)(2008-10#1)
secondary alterations##2##2##(1991-7#1)(2008-6#1)
secondary amenorrhea##2##2##(2006-10#1)(2012-3#1)
secondary amine##7##2##(1996-2#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2012-12#1)(2013-8#1)
secondary amines##6##2##(1996-5#1)(2007-11#2)(2008-10#2)(2011-1#1)
secondary amino acids##3##3##(1990-6#1)(1996-6#1)(2007-8#1)
secondary amino##5##2##(1990-6#1)(1996-6#1)(2006-12#1)(2007-8#1)(2008-10#1)
secondary amyloid##2##2##(2006-10#1)(2008-5#1)
secondary analysis of a##2##4##(2012-12#1)(2012-2#1)
secondary analysis of data from##2##5##(2007-4#1)(2013-7#1)
secondary analysis of data##4##4##(2007-4#1)(2008-12#1)(2012-12#1)(2013-7#1)
secondary analysis of##6##3##(2007-4#1)(2008-12#1)(2012-12#2)(2012-2#1)(2013-7#1)
secondary analysis##12##2##(1995-4#2)(1997-6#1)(2006-12#1)(2007-4#1)(2008-10#1)(2008-12#1)(2010-10#1)(2012-12#2)(2012-2#1)(2013-7#1)
secondary and primary##3##3##(1996-2#1)(1996-3#1)(2004-1#1)
secondary and tertiary structural##2##4##(1994-5#1)(1995-5#1)
secondary and tertiary structure of##4##5##(1991-2#1)(1991-5#1)(2008-10#1)(2008-9#1)
secondary and tertiary structure##15##4##(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#2)(1993-6#1)(1995-3#2)(1995-5#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-9#1)
secondary and tertiary structures of##2##5##(1992-1#1)(2005-11#1)
secondary and tertiary structures##3##4##(1990-7#1)(1992-1#1)(2005-11#1)
secondary and tertiary##28##3##(1990-5#1)(1990-6#1)(1990-7#2)(1991-2#1)(1991-5#2)(1992-1#1)(1993-2#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-3#2)(1995-5#2)(2005-10#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-9#1)(2011-2#1)(2013-1#1)
secondary and##35##2##(1990-5#1)(1990-6#1)(1990-7#2)(1991-2#1)(1991-5#2)(1992-1#1)(1993-2#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-3#2)(1995-5#2)(1996-2#1)(1996-3#1)(2004-1#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-1#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-4#3)(2008-9#1)(2011-2#1)(2013-1#1)
secondary anti-IgG antibody##3##3##(2008-2#1)(2008-4#2)
secondary anti-apoptotic##2##2##(2011-2#2)
secondary antibodies##10##2##(1990-12#2)(1990-8#1)(1994-2#1)(1996-12#1)(2008-10#1)(2008-11#4)
secondary antibody and##2##3##(2008-2#1)(2008-4#1)
secondary antibody responses##2##3##(2008-10#2)
secondary antibody##15##2##(1991-3#1)(1992-7#1)(1994-3#1)(2008-10#4)(2008-2#1)(2008-4#3)(2008-9#3)(2012-3#1)
secondary appraisals##2##2##(2012-1#2)
secondary arthrosis##2##2##(2007-8#2)
secondary axis##3##2##(2008-6#3)
secondary bacterial infection##3##3##(1991-4#1)(2008-7#1)(2010-5#1)
secondary bacterial infections##4##3##(2007-11#1)(2008-12#1)(2008-5#1)(2010-7#1)
secondary bacterial##9##2##(1991-4#1)(2007-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-5#1)(2010-7#2)(2013-1#1)
secondary binding##2##2##(1992-8#1)(2008-5#1)
secondary bone##2##2##(1993-8#1)(2008-8#1)
secondary brain##5##2##(2006-10#1)(2006-7#1)(2007-9#1)(2010-9#1)(2011-2#1)
secondary cancer##2##2##(1996-3#1)(2011-2#1)
secondary care##12##2##(1992-10#1)(1993-1#2)(1996-2#1)(2005-11#1)(2006-9#1)(2008-7#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
secondary caries##6##2##(2010-10#1)(2012-12#1)(2013-1#2)(2013-7#2)
secondary carnitine deficiency##2##3##(1991-2#1)(2011-2#1)
secondary cases of meningococcal disease##2##5##(1993-9#2)
secondary cases##4##2##(1993-9#3)(2007-12#1)
secondary cataracts##2##2##(1991-9#1)(2008-5#1)
secondary cause of##2##3##(2008-2#1)(2012-11#1)
secondary causes of##4##3##(2007-9#2)(2008-1#1)(2008-5#1)
secondary causes##8##2##(2007-11#1)(2007-9#2)(2008-1#3)(2008-5#1)(2012-2#1)
secondary center of diversity of##2##5##(2008-10#2)
secondary cerebral##3##2##(1992-11#1)(1996-9#1)(2006-10#1)
secondary challenge##2##2##(2008-10#1)(2008-7#1)
secondary changes in##2##3##(2007-8#1)(2008-9#1)
secondary changes##4##2##(2007-2#1)(2007-8#1)(2008-8#1)(2008-9#1)
secondary cleavage##3##2##(1990-8#3)
secondary closure##2##2##(1995-11#1)(2009-8#1)
secondary cloud##2##2##(2008-5#2)
secondary color##2##2##(2008-3#2)
secondary complication of##2##3##(2008-4#1)(2010-9#1)
secondary complication##3##2##(2006-3#1)(2008-4#1)(2010-9#1)
secondary complications##6##2##(1993-11#1)(2008-1#2)(2008-4#1)(2011-2#1)(2012-2#1)
secondary conidia and##2##3##(2008-10#2)
secondary conidia on##2##3##(2008-10#2)
secondary conidia##9##2##(2008-10#9)
secondary conidiation##2##2##(2008-10#2)
secondary contact site##2##3##(1991-4#2)
secondary contact##5##2##(1991-4#3)(2010-8#2)
secondary contamination##3##2##(1992-6#2)(2008-4#1)
secondary control##2##2##(2012-1#2)
secondary curve##4##2##(2007-7#4)
secondary damage to##2##3##(2013-8#2)
secondary damage##3##2##(2009-5#1)(2013-8#2)
secondary data from the##2##4##(2008-11#1)(2008-9#1)
secondary data from##3##3##(2008-11#1)(2008-9#1)(2013-1#1)
secondary data of##2##3##(2010-1#1)(2011-1#1)
secondary data##15##2##(2007-10#1)(2007-7#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#4)
secondary databases derived from experimental databases are also widely available##2##10##(2008-2#1)(2008-4#1)
secondary dengue##3##2##(2012-2#2)(2012-3#1)
secondary diagnosis##2##2##(1991-3#1)(1991-8#1)
secondary dispersal##2##2##(2010-4#2)
secondary droplets##2##2##(1995-3#1)(2008-5#1)
secondary education and##3##3##(2008-9#1)(2010-2#1)(2011-2#1)
secondary education##10##2##(2008-9#1)(2009-1#1)(2009-10#1)(2009-9#1)(2010-2#2)(2011-2#4)
secondary effect##4##2##(1990-8#1)(2007-12#1)(2008-9#1)(2012-2#1)
secondary effects of##3##3##(1992-8#1)(2006-6#1)(2009-12#1)
secondary effects##7##2##(1992-8#1)(1995-12#1)(1995-8#1)(2006-6#1)(2008-3#1)(2009-12#1)(2011-2#1)
secondary electron##5##2##(1995-8#1)(2006-5#1)(2007-5#1)(2008-10#1)(2008-2#1)
secondary end points##3##3##(2007-8#1)(2009-11#1)(2010-7#1)
secondary end##4##2##(2007-8#1)(2009-11#2)(2010-7#1)
secondary endpoints##4##2##(2005-8#1)(2006-6#1)(2008-5#1)(2013-1#1)
secondary events##2##2##(1996-6#1)(2008-8#1)
secondary features##2##2##(2008-1#1)(2009-11#1)
secondary female##2##2##(2008-8#2)
secondary fibrosarcoma of bone##2##4##(2008-6#2)
secondary flow##3##2##(2007-7#1)(2008-10#1)(2008-5#1)
secondary foci##3##2##(2007-11#1)(2008-10#2)
secondary form##3##2##(1990-6#1)(2011-2#2)
secondary forms of##2##3##(2008-1#1)(2013-1#1)
secondary forms##3##2##(2008-1#1)(2011-1#1)(2013-1#1)
secondary function##2##2##(1990-11#1)(1992-2#1)
secondary functionalities##2##2##(2008-3#2)
secondary functionality##2##2##(2009-12#2)
secondary generalized##2##2##(1992-8#1)(2006-8#1)
secondary germ tubes and a haustorium##2##6##(2008-10#2)
secondary germ tubes##3##3##(2008-10#3)
secondary glaucoma##3##2##(2010-2#1)(2011-2#1)(2013-7#1)
secondary glomerular disease##3##3##(2007-7#1)(2010-4#2)
secondary glomerular diseases##3##3##(2007-7#1)(2008-1#2)
secondary glomerular##6##2##(2007-7#2)(2008-1#2)(2010-4#2)
secondary gratings##2##2##(1996-12#1)(2008-3#1)
secondary growth and##2##3##(2012-5#2)
secondary growth##4##2##(2008-10#2)(2012-5#2)
secondary headspot cells##5##3##(2007-12#5)
secondary health care##2##3##(1997-8#1)(2010-3#1)
secondary health##4##2##(1992-3#1)(1997-8#1)(2010-12#1)(2010-3#1)
secondary hepatic##2##2##(1993-10#1)(1995-10#1)
secondary high##2##2##(1997-3#1)(2009-9#1)
secondary hospital in##2##3##(2013-1#1)(2013-8#1)
secondary hospital##4##2##(2007-10#1)(2013-1#2)(2013-8#1)
secondary hydatidosis##2##2##(2007-12#2)
secondary hydroxyl##3##2##(1996-2#2)(2008-11#1)
secondary hyperalgesia following heat injury##2##5##(1991-9#2)
secondary hyperalgesia##3##2##(1991-9#3)
secondary hyperparathyroidism and##2##3##(2008-1#2)
secondary hyperparathyroidism in##3##3##(1997-7#1)(2008-3#1)(2011-1#1)
secondary hyperparathyroidism with##2##3##(1991-11#1)(2009-5#1)
secondary hyperparathyroidism##23##2##(1991-11#3)(1991-5#1)(1991-8#1)(1993-11#2)(1993-3#2)(1997-7#1)(2005-10#1)(2005-9#1)(2007-7#1)(2008-1#3)(2008-3#1)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
secondary hypertension##8##2##(1990-1#1)(1997-2#1)(2006-10#1)(2008-1#2)(2008-12#1)(2011-2#2)
secondary hyphae##7##2##(2008-10#7)
secondary immune response##2##3##(1994-2#1)(1995-7#1)
secondary impairments##3##2##(2006-10#3)
secondary importance##4##2##(2006-11#1)(2007-8#1)(2008-5#1)(2012-12#1)
secondary infection from either##2##4##(2008-10#2)
secondary infection from##3##3##(2008-10#3)
secondary infection in##2##3##(2008-10#1)(2008-12#1)
secondary infection of##2##3##(1993-5#1)(2008-10#1)
secondary infection with##2##3##(1996-11#1)(2011-1#1)
secondary infection##36##2##(1991-7#1)(1993-5#1)(1996-11#1)(2005-10#1)(2005-8#1)(2006-4#1)(2007-11#1)(2008-1#1)(2008-10#22)(2008-12#1)(2008-2#1)(2008-3#1)(2010-4#1)(2011-1#1)(2012-2#1)
secondary infections##8##2##(1992-10#1)(2007-10#1)(2007-2#1)(2008-10#2)(2010-5#2)(2013-1#1)
secondary injury##3##2##(2006-10#1)(2008-10#1)(2008-7#1)
secondary inoculum##5##2##(2008-10#5)
secondary instabilities##2##2##(2007-11#2)
secondary interhospital##2##2##(2006-10#2)
secondary ion mass spectrometry (S-SIMS) for the##2##7##(2008-10#2)
secondary ion mass spectrometry (SIMS)##5##5##(1996-8#1)(2008-10#1)(2009-12#1)(2009-2#1)(2012-12#1)
secondary ion mass spectrometry##17##4##(1994-12#1)(1996-8#1)(1997-1#2)(2007-8#1)(2008-10#3)(2008-2#4)(2008-5#1)(2009-12#1)(2009-2#1)(2012-12#2)
secondary ion mass spectroscopy##2##4##(2005-11#2)
secondary ion mass##23##3##(1990-2#1)(1992-9#1)(1994-12#1)(1996-8#1)(1997-1#2)(2005-11#2)(2007-8#1)(2008-10#3)(2008-2#4)(2008-4#1)(2008-5#2)(2009-12#1)(2009-2#1)(2012-12#2)
secondary ion##24##2##(1990-2#1)(1992-9#1)(1994-12#1)(1996-8#1)(1997-1#2)(2005-11#2)(2007-8#1)(2008-10#4)(2008-2#4)(2008-4#1)(2008-5#2)(2009-12#1)(2009-2#1)(2012-12#2)
secondary ischemic##2##2##(2007-10#1)(2011-12#1)
secondary kinetic isotope##2##3##(1994-11#1)(1994-8#1)
secondary lesions##5##2##(1991-10#2)(1993-8#1)(2006-10#1)(2008-10#1)
secondary level##4##2##(2007-5#1)(2010-12#2)(2011-1#1)
secondary lymphoid organs##4##3##(1990-12#1)(2008-1#1)(2008-4#1)(2012-1#1)
secondary lymphoid##5##2##(1990-12#1)(2005-10#1)(2008-1#1)(2008-4#1)(2012-1#1)
secondary lysosomes##3##2##(1995-6#2)(2008-7#1)
secondary malignancies##3##2##(1993-8#1)(1997-6#1)(2011-2#1)
secondary malignancy##5##2##(2006-2#1)(2007-3#1)(2007-4#1)(2011-2#1)(2012-12#1)
secondary measures##2##2##(2007-11#1)(2012-12#1)
secondary messenger##2##2##(2006-10#1)(2008-4#1)
secondary metabolism##7##2##(1990-12#1)(2006-12#1)(2008-7#1)(2009-10#1)(2009-8#3)
secondary metabolite biosynthesis##2##3##(2008-10#2)
secondary metabolite production##3##3##(2006-12#1)(2008-10#2)
secondary metabolite##10##2##(1990-10#1)(2006-12#1)(2007-11#2)(2008-10#4)(2008-7#1)(2011-2#1)
secondary metabolites and##2##3##(2008-10#1)(2009-8#1)
secondary metabolites in##4##3##(2006-12#1)(2007-10#1)(2008-7#1)(2008-9#1)
secondary metabolites of Aspergillus flavus and##2##6##(1991-4#1)(2008-10#1)
secondary metabolites of##3##3##(1991-12#1)(1991-4#1)(2008-10#1)
secondary metabolites produced by##2##4##(2008-10#1)(2009-3#1)
secondary metabolites research of the##2##5##(2005-11#2)
secondary metabolites that##2##3##(2006-12#1)(2011-1#1)
secondary metabolites##31##2##(1990-12#1)(1991-12#1)(1991-4#1)(1995-8#1)(1997-1#1)(2004-2#1)(2005-11#3)(2006-12#2)(2007-10#1)(2007-7#1)(2008-10#5)(2008-4#1)(2008-7#1)(2008-9#2)(2009-3#2)(2009-8#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#2)
secondary mirror##9##2##(2008-2#8)(2008-3#1)
secondary mitral##3##2##(2006-2#1)(2007-8#1)(2011-2#1)
secondary mutation in##2##3##(1992-9#1)(2012-1#1)
secondary mutation##3##2##(1992-9#2)(2012-1#1)
secondary neuronal##3##2##(1996-1#1)(1996-9#1)(1997-5#1)
secondary neurons##2##2##(1990-4#1)(2007-12#1)
secondary objective of##2##3##(2006-2#1)(2008-12#1)
secondary objective##5##2##(2006-2#1)(2008-12#1)(2010-4#1)(2011-1#1)(2013-1#1)
secondary or tertiary##5##3##(2007-11#1)(2007-6#1)(2008-4#2)(2011-2#1)
secondary or##8##2##(2006-9#1)(2007-11#1)(2007-6#1)(2008-11#1)(2008-4#2)(2011-2#2)
secondary osteoarthritis##9##2##(2007-11#2)(2011-12#1)(2011-2#2)(2013-1#4)
secondary osteoporosis##5##2##(2008-4#2)(2012-12#1)(2013-1#2)
secondary osteosarcoma##2##2##(2008-8#1)(2010-3#1)
secondary outcome##2##2##(1991-11#1)(2008-9#1)
secondary outcomes##3##2##(2007-7#1)(2008-4#1)(2013-8#1)
secondary patency rates##4##3##(2007-7#4)
secondary patency##9##2##(2007-7#7)(2011-3#2)
secondary peaks##2##2##(2008-3#2)
secondary peritonitis##4##2##(1991-2#1)(2013-8#3)
secondary pests##2##2##(2008-5#2)
secondary phases##2##2##(1991-3#1)(2009-7#1)
secondary plant metabolites##2##3##(2007-1#1)(2012-12#1)
secondary plant products##2##3##(2012-1#2)
secondary plant##4##2##(2007-1#1)(2012-1#2)(2012-12#1)
secondary pneumatization##2##2##(2011-2#2)
secondary polarization##3##2##(2008-3#3)
secondary precursor##2##2##(2007-12#2)
secondary prevention after##2##3##(2007-10#1)(2008-5#1)
secondary prevention efforts##2##3##(2010-11#1)(2011-1#1)
secondary prevention for##2##3##(2006-5#2)
secondary prevention in##3##3##(1993-9#1)(2007-11#1)(2008-10#1)
secondary prevention of CHD##2##4##(2005-10#1)(2005-12#1)
secondary prevention of cancer##2##4##(1993-10#2)
secondary prevention of cardiovascular##2##4##(2006-5#1)(2010-1#1)
secondary prevention of coronary artery disease##5##6##(1996-1#1)(2006-10#1)(2006-5#1)(2007-8#1)(2010-2#1)
secondary prevention of coronary heart disease##3##6##(1995-11#1)(1996-3#1)(2005-10#1)
secondary prevention of coronary##8##4##(1995-11#1)(1996-1#1)(1996-3#1)(2005-10#1)(2006-10#1)(2006-5#1)(2007-8#1)(2010-2#1)
secondary prevention of ischemic heart disease##3##6##(2006-6#1)(2011-2#2)
secondary prevention of ischemic heart##4##5##(1995-11#1)(2006-6#1)(2011-2#2)
secondary prevention of ischemic##6##4##(1995-11#1)(2006-6#1)(2007-10#2)(2011-2#2)
secondary prevention of##32##3##(1990-5#1)(1993-10#2)(1994-10#1)(1995-11#2)(1996-1#1)(1996-12#1)(1996-3#1)(2005-10#2)(2005-12#1)(2006-10#1)(2006-5#2)(2006-6#1)(2007-10#4)(2007-8#2)(2008-1#2)(2008-11#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)
secondary prevention programs##2##3##(2009-9#1)(2013-1#1)
secondary prevention strategy##3##3##(1995-10#1)(2008-3#1)(2008-8#1)
secondary prevention##87##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-3#1)(1993-10#2)(1993-3#1)(1993-9#1)(1994-10#1)(1994-2#1)(1995-10#2)(1995-11#2)(1996-1#1)(1996-12#2)(1996-3#1)(1997-1#1)(2005-10#2)(2005-12#1)(2006-10#1)(2006-11#1)(2006-2#2)(2006-5#8)(2006-6#1)(2007-10#5)(2007-11#1)(2007-12#1)(2007-8#5)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#4)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-3#1)(2013-1#4)(2013-8#1)
secondary preventive##2##2##(2005-10#1)(2008-11#1)
secondary production##2##2##(2008-5#1)(2008-9#1)
secondary products##3##2##(1996-5#1)(2008-10#1)(2008-11#1)
secondary progressive##2##2##(1995-6#1)(2007-11#1)
secondary prophylaxis after##4##3##(1991-11#2)(1991-8#1)(1993-8#1)
secondary prophylaxis##8##2##(1990-9#1)(1991-11#2)(1991-8#1)(1993-8#1)(1995-9#1)(2006-10#1)(2007-11#1)
secondary pulmonary hypertension##3##3##(1994-3#1)(2009-6#1)(2010-12#1)
secondary pulmonary##5##2##(1994-3#1)(2007-11#2)(2009-6#1)(2010-12#1)
secondary purpose was to##3##4##(2007-10#1)(2007-2#1)(2010-3#1)
secondary quinone electron acceptor##2##4##(1992-6#1)(1994-8#1)
secondary reactions##2##2##(2008-10#1)(2009-8#1)
secondary recognition##2##2##(1990-8#1)(1991-6#1)
secondary responses##2##2##(2008-5#1)(2008-9#1)
secondary role in##4##3##(2008-2#1)(2008-7#2)(2011-1#1)
secondary role##6##2##(2006-8#1)(2008-2#1)(2008-7#2)(2009-9#1)(2011-1#1)
secondary root##5##2##(2008-10#1)(2008-5#4)
secondary roots##4##2##(2008-10#3)(2008-5#1)
secondary school students##6##3##(1990-2#1)(2004-8#1)(2006-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
secondary school##13##2##(1990-12#1)(1990-2#1)(1996-6#1)(2004-8#1)(2006-7#1)(2008-10#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
secondary schools in##5##3##(2007-6#1)(2008-1#1)(2008-10#1)(2009-7#1)(2010-8#1)
secondary schools of##2##3##(2011-1#1)(2013-1#1)
secondary schools##14##2##(2007-1#1)(2007-12#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#2)(2009-7#2)(2010-8#1)(2011-1#1)(2013-1#1)
secondary sexual characters in##3##4##(1995-2#2)(2007-7#1)
secondary sexual characters##5##3##(1995-2#4)(2007-7#1)
secondary sexual##12##2##(1995-2#4)(2006-10#1)(2007-12#1)(2007-7#1)(2008-9#4)(2010-9#1)
secondary sites##2##2##(2006-10#1)(2009-3#1)
secondary source of##2##3##(2007-12#1)(2008-12#1)
secondary source##3##2##(2006-2#1)(2007-12#1)(2008-12#1)
secondary sources##4##2##(2008-9#1)(2011-8#1)(2012-12#1)(2012-3#1)
secondary spectrum##9##2##(2008-2#1)(2008-3#8)
secondary spermatocytes##3##2##(2008-3#1)(2008-5#1)(2010-5#1)
secondary sporidia##4##2##(2008-10#4)
secondary spread of the##2##4##(2008-10#2)
secondary spread of##4##3##(2008-10#4)
secondary spread##12##2##(2008-10#12)
secondary standard##4##2##(1995-2#1)(2008-10#1)(2008-3#2)
secondary status##2##2##(1991-6#1)(2013-1#1)
secondary stroke prevention##5##3##(2006-7#1)(2007-10#2)(2007-9#1)(2008-8#1)
secondary stroke##6##2##(2006-7#1)(2007-10#3)(2007-9#1)(2008-8#1)
secondary structural elements are##2##4##(1994-11#1)(1994-8#1)
secondary structural elements##9##3##(1990-7#1)(1991-4#2)(1993-11#1)(1994-11#1)(1994-8#1)(1995-5#3)
secondary structural features##2##3##(1991-11#1)(2006-12#1)
secondary structural units##2##3##(1991-5#1)(1992-1#1)
secondary structural##17##2##(1990-4#1)(1990-7#1)(1991-11#1)(1991-4#2)(1991-5#1)(1992-1#1)(1992-4#1)(1993-11#1)(1994-11#1)(1994-8#2)(1995-5#3)(2005-11#1)(2006-12#1)
secondary structure analysis of human##2##5##(1993-8#1)(2009-5#1)
secondary structure analysis of##3##4##(1993-8#1)(1994-11#1)(2009-5#1)
secondary structure analysis##9##3##(1990-10#1)(1993-8#1)(1994-11#1)(2008-4#3)(2009-5#1)(2012-2#2)
secondary structure and the##2##4##(1992-2#1)(1993-11#1)
secondary structure and##11##3##(1991-3#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-11#1)(1995-12#1)(2008-4#1)(2008-7#1)(2010-7#1)(2011-2#1)
secondary structure as##2##3##(1995-6#1)(1995-8#1)
secondary structure at##2##3##(1990-10#1)(2006-10#1)
secondary structure between##2##3##(1991-5#1)(2008-8#1)
secondary structure changes##2##3##(1994-9#1)(2005-11#1)
secondary structure common to two RNA sequences##2##7##(2008-4#2)
secondary structure consists of##2##4##(1991-5#1)(1995-5#1)
secondary structure content##4##3##(1991-5#1)(1992-9#1)(1994-11#1)(2012-2#1)
secondary structure elements##2##3##(1996-8#1)(1997-2#1)
secondary structure formation##3##3##(1993-6#1)(1995-2#1)(1995-4#1)
secondary structure from circular dichroism##2##5##(1994-9#2)
secondary structure from##5##3##(1993-6#1)(1994-11#1)(1994-9#2)(1997-1#1)
secondary structure has been##4##4##(1991-7#1)(1993-6#1)(1995-1#1)(1996-2#1)
secondary structure in the##2##4##(1991-9#1)(1997-4#1)
secondary structure in##6##3##(1990-10#1)(1991-9#1)(1993-11#1)(1994-3#1)(1995-2#1)(1997-4#1)
secondary structure is##3##3##(1991-5#1)(2005-11#1)(2005-4#1)
secondary structure may be##2##4##(1990-5#1)(1994-9#1)
secondary structure model##2##3##(1995-10#1)(1996-9#1)
secondary structure of a##2##4##(1992-4#2)
secondary structure of myelin proteins##2##5##(1992-12#2)
secondary structure of subtilisin dissolved in##2##6##(2008-7#2)
secondary structure of the peptide##2##5##(1992-6#1)(1994-11#1)
secondary structure of the protein##2##5##(1994-9#1)(2008-10#1)
secondary structure of the##12##4##(1990-10#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-6#1)(1992-9#1)(1994-10#1)(1994-11#1)(1994-9#1)(2008-10#1)(2012-2#1)
secondary structure of this##2##4##(1992-8#1)(1994-3#1)
secondary structure of##44##3##(1990-10#1)(1990-2#1)(1990-7#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-8#4)(1992-9#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-3#2)(1994-8#1)(1994-9#2)(1995-5#1)(1996-11#2)(1997-2#1)(2008-10#3)(2008-4#1)(2008-7#2)(2008-9#1)(2009-7#1)(2012-2#1)(2013-8#2)
secondary structure predicted##2##3##(1995-12#1)(2008-10#1)
secondary structure prediction and##2##4##(1992-7#1)(2008-4#1)
secondary structure prediction##7##3##(1990-4#1)(1990-9#1)(1992-7#1)(1994-10#1)(2008-4#3)
secondary structure propensities##2##3##(1995-4#1)(1997-2#1)
secondary structure propensity##2##3##(1995-4#2)
secondary structure was##3##3##(1990-5#1)(1993-3#2)
secondary structure##199##2##(1990-10#6)(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#3)(1990-5#6)(1990-7#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-4#2)(1991-5#5)(1991-6#3)(1991-7#2)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#4)(1992-2#2)(1992-4#4)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#4)(1992-9#3)(1993-11#2)(1993-3#3)(1993-6#5)(1993-8#2)(1994-10#2)(1994-11#6)(1994-12#4)(1994-2#3)(1994-3#3)(1994-8#2)(1994-9#11)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-4#7)(1995-5#4)(1995-6#1)(1995-8#1)(1996-11#3)(1996-2#1)(1996-5#1)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#3)(1997-4#1)(1997-6#1)(2005-11#2)(2005-4#1)(2006-10#2)(2006-12#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-4#15)(2008-7#4)(2008-8#1)(2008-9#1)(2009-5#2)(2009-7#1)(2010-7#3)(2011-2#1)(2011-3#1)(2012-2#6)(2013-1#1)(2013-8#2)
secondary structures and##5##3##(1996-8#1)(2008-10#1)(2008-6#1)(2009-9#1)(2012-12#1)
secondary structures have been##2##4##(1995-9#1)(2009-11#1)
secondary structures in##3##3##(1991-2#1)(1995-11#1)(2008-7#1)
secondary structures observed for##2##4##(1992-8#2)
secondary structures of the##3##4##(1993-9#1)(1994-12#1)(2012-2#1)
secondary structures of these##2##4##(1995-10#1)(2008-5#1)
secondary structures of##14##3##(1990-8#1)(1991-1#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-12#2)(1995-10#1)(2007-9#1)(2008-5#2)(2012-2#1)(2013-1#1)(2013-8#1)
secondary structures were##2##3##(2008-8#1)(2009-12#1)
secondary structures##65##2##(1990-5#2)(1990-8#1)(1991-1#1)(1991-2#2)(1991-5#1)(1992-2#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-3#2)(1993-9#1)(1994-12#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-8#1)(1997-5#1)(1997-6#2)(2006-10#1)(2006-12#2)(2007-9#3)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#5)(2009-12#1)(2009-7#1)(2009-9#2)(2010-7#1)(2011-2#1)(2011-3#3)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
secondary symbiogenesis##3##2##(2007-12#3)
secondary syphilis##11##2##(1993-3#5)(1994-3#1)(2005-11#1)(2007-2#1)(2012-3#1)(2013-1#2)
secondary therapy##2##2##(2011-2#1)(2012-11#1)
secondary to a foreign body##2##5##(1990-3#1)(2007-8#1)
secondary to a number of##2##5##(2007-3#1)(2008-3#1)
secondary to a##41##3##(1990-10#1)(1990-3#1)(1993-4#1)(1994-6#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#3)(2006-9#1)(2007-3#4)(2007-7#2)(2007-8#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#6)(2009-3#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
secondary to acute##6##3##(1991-3#1)(2005-12#1)(2007-1#1)(2007-2#1)(2007-9#1)(2011-1#1)
secondary to all##2##3##(2007-8#1)(2008-7#1)
secondary to an##11##3##(1995-5#1)(2006-10#1)(2008-7#2)(2008-8#2)(2009-5#1)(2010-10#1)(2010-6#1)(2011-1#1)(2013-1#1)
secondary to another##2##3##(2005-12#1)(2007-7#1)
secondary to aortic##2##3##(2009-6#1)(2010-7#1)
secondary to arterial##2##3##(2008-10#1)(2008-2#1)
secondary to bilateral##3##3##(1993-10#1)(2008-10#1)(2011-2#1)
secondary to blunt##3##3##(2006-4#1)(2011-2#1)(2012-2#1)
secondary to both##2##3##(2010-8#2)
secondary to breast cancer##3##4##(1997-3#1)(2007-10#1)(2011-2#1)
secondary to bronchogenic##2##3##(2005-11#1)(2007-7#1)
secondary to cardiac##2##3##(1994-3#1)(2007-8#1)
secondary to changes##3##3##(1995-7#1)(1997-7#1)(2008-6#1)
secondary to chronic##8##3##(1996-1#1)(2007-11#4)(2007-2#1)(2008-7#1)(2008-9#1)
secondary to decreased##2##3##(1995-1#1)(1995-11#1)
secondary to epidural##2##3##(2006-8#1)(2007-8#1)
secondary to gallbladder carcinoma##3##4##(2009-7#3)
secondary to hypertension##3##3##(2008-12#1)(2013-1#2)
secondary to infection with##3##4##(1991-4#1)(2011-1#1)(2011-2#1)
secondary to infection##4##3##(1991-4#1)(2006-10#1)(2011-1#1)(2011-2#1)
secondary to involvement##2##3##(2007-2#1)(2007-7#1)
secondary to left##2##3##(2007-8#1)(2009-9#1)
secondary to lumbar##3##3##(2006-8#2)(2007-7#1)
secondary to lung##2##3##(1996-9#1)(2012-2#1)
secondary to lupus##3##3##(2006-10#1)(2013-1#2)
secondary to massive##2##3##(2006-7#1)(2011-2#1)
secondary to metastatic##2##3##(2007-10#1)(2007-6#1)
secondary to obstruction##2##3##(2006-5#1)(2010-12#1)
secondary to percutaneous##2##3##(2008-3#1)(2010-7#1)
secondary to primary##3##3##(2010-4#1)(2012-1#1)(2012-2#1)
secondary to renal##2##3##(2005-12#1)(2006-8#1)
secondary to right##2##3##(2007-9#1)(2012-2#1)
secondary to spinal##2##3##(2007-8#1)(2008-7#1)
secondary to stroke##2##3##(2007-7#1)(2013-1#1)
secondary to systemic##4##3##(1991-1#1)(2007-11#1)(2008-1#1)(2012-2#1)
secondary to tardive dyskinesia##2##4##(2007-6#1)(2010-12#1)
secondary to the increased##2##4##(2006-10#1)(2007-10#1)
secondary to the inflammatory##2##4##(2008-9#1)(2010-2#1)
secondary to the##31##3##(1991-3#1)(1991-5#1)(1992-1#1)(1995-3#2)(1995-5#1)(1995-8#1)(2006-10#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-7#2)(2008-1#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-2#1)(2013-1#4)(2013-8#1)
secondary to trauma or##3##4##(2008-7#2)(2009-3#1)
secondary to trauma##6##3##(2006-10#1)(2006-8#1)(2008-7#2)(2009-3#1)(2011-2#1)
secondary to trigeminal##2##3##(2006-8#1)(2007-3#1)
secondary to tuberculosis##2##3##(2007-8#1)(2009-7#1)
secondary to vasodilatation and activation of neurohumoral systems##3##8##(2006-10#3)
secondary to##416##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#2)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#2)(1993-12#1)(1993-4#3)(1993-9#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#3)(1995-7#3)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#2)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2004-11#1)(2004-3#2)(2005-10#2)(2005-11#3)(2005-12#3)(2005-6#1)(2006-10#20)(2006-12#3)(2006-2#2)(2006-3#2)(2006-4#4)(2006-5#2)(2006-6#1)(2006-7#4)(2006-8#18)(2006-9#3)(2007-1#2)(2007-10#4)(2007-11#7)(2007-12#7)(2007-2#7)(2007-3#5)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#11)(2007-8#11)(2007-9#3)(2008-1#8)(2008-10#6)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#6)(2008-7#27)(2008-8#3)(2008-9#5)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#7)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#5)(2009-8#2)(2009-9#7)(2010-10#4)(2010-11#1)(2010-12#6)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#6)(2011-12#2)(2011-2#15)(2012-1#2)(2012-12#6)(2012-2#14)(2012-3#4)(2012-8#1)(2013-1#16)(2013-7#3)(2013-8#9)
secondary tumor##2##2##(1992-6#1)(1995-10#1)
secondary tumors were##3##3##(1995-10#3)
secondary tumors##7##2##(1993-8#1)(1995-10#4)(1997-3#1)(2008-10#1)
secondary vasculitis##2##2##(1996-3#1)(2010-4#1)
secondary vegetation##2##2##(2008-5#2)
secondary xylem##2##2##(2008-10#2)
secondary##2141##1##(1990-1#1)(1990-10#9)(1990-11#5)(1990-12#14)(1990-2#4)(1990-3#2)(1990-4#10)(1990-5#15)(1990-6#3)(1990-7#7)(1990-8#9)(1990-9#4)(1991-1#2)(1991-10#3)(1991-11#13)(1991-12#5)(1991-2#7)(1991-3#11)(1991-4#11)(1991-5#13)(1991-6#7)(1991-7#7)(1991-8#4)(1991-9#15)(1992-1#4)(1992-10#3)(1992-11#4)(1992-12#10)(1992-2#9)(1992-3#2)(1992-4#6)(1992-5#3)(1992-6#7)(1992-7#3)(1992-8#12)(1992-9#9)(1993-1#4)(1993-10#5)(1993-11#7)(1993-12#4)(1993-2#3)(1993-3#13)(1993-4#3)(1993-5#3)(1993-6#9)(1993-8#9)(1993-9#19)(1994-10#3)(1994-11#8)(1994-12#7)(1994-2#11)(1994-3#10)(1994-5#6)(1994-6#1)(1994-7#2)(1994-8#11)(1994-9#12)(1995-1#7)(1995-10#10)(1995-11#8)(1995-12#9)(1995-2#9)(1995-3#7)(1995-4#9)(1995-5#13)(1995-6#5)(1995-7#5)(1995-8#7)(1995-9#2)(1996-1#3)(1996-11#9)(1996-12#5)(1996-2#9)(1996-3#8)(1996-5#6)(1996-6#5)(1996-7#2)(1996-8#7)(1996-9#9)(1997-1#9)(1997-2#8)(1997-3#4)(1997-4#10)(1997-5#2)(1997-6#9)(1997-7#4)(1997-8#3)(2004-1#1)(2004-11#1)(2004-12#2)(2004-2#2)(2004-3#2)(2004-8#1)(2005-10#10)(2005-11#23)(2005-12#4)(2005-4#1)(2005-6#2)(2005-7#1)(2005-8#6)(2005-9#1)(2006-1#1)(2006-10#60)(2006-11#3)(2006-12#21)(2006-2#9)(2006-3#4)(2006-4#8)(2006-5#12)(2006-6#6)(2006-7#11)(2006-8#23)(2006-9#7)(2007-1#6)(2007-10#19)(2007-11#39)(2007-12#39)(2007-2#14)(2007-3#10)(2007-4#4)(2007-5#5)(2007-6#6)(2007-7#38)(2007-8#39)(2007-9#15)(2008-1#36)(2008-10#162)(2008-11#22)(2008-12#12)(2008-2#33)(2008-3#43)(2008-4#55)(2008-5#47)(2008-6#18)(2008-7#53)(2008-8#17)(2008-9#35)(2009-1#2)(2009-10#5)(2009-11#8)(2009-12#7)(2009-2#4)(2009-3#16)(2009-4#5)(2009-5#7)(2009-6#2)(2009-7#14)(2009-8#14)(2009-9#17)(2010-1#2)(2010-10#6)(2010-11#8)(2010-12#17)(2010-2#16)(2010-3#7)(2010-4#14)(2010-5#7)(2010-6#4)(2010-7#17)(2010-8#10)(2010-9#6)(2011-1#28)(2011-11#1)(2011-12#5)(2011-2#76)(2011-3#7)(2011-8#1)(2012-1#12)(2012-10#1)(2012-11#2)(2012-12#31)(2012-2#49)(2012-3#17)(2012-5#2)(2012-8#1)(2013-1#61)(2013-7#8)(2013-8#29)
secondary)##3##1##(2007-11#1)(2007-8#1)(2008-7#1)
secondary-structure##2##1##(1993-11#1)(1995-3#1)
seconded to##2##2##(2007-8#1)(2008-12#1)
secondhand##2##1##(2008-11#1)(2012-12#1)
secondly the##4##2##(2008-11#2)(2008-12#1)(2013-1#1)
secondly##39##1##(1990-2#1)(1990-5#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-5#1)(1996-7#1)(1997-6#1)(1997-8#1)(2005-12#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-5#2)(2009-2#1)(2010-8#1)(2011-2#2)(2012-12#5)(2013-1#2)(2013-7#1)
secondment to##2##2##(2008-11#1)(2010-1#1)
seconds after stimulation##2##3##(1997-6#1)(2013-1#1)
seconds and##2##2##(2006-8#1)(2009-8#1)
seconds of##12##2##(1991-9#1)(1992-6#1)(1994-12#1)(1994-3#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#3)(2009-9#2)
seconds per##3##2##(1992-1#1)(2006-8#2)
seconds to complete##2##3##(2008-10#1)(2010-12#1)
seconds to##7##2##(1991-6#1)(1993-6#1)(1997-7#1)(2008-10#1)(2008-6#1)(2010-12#1)(2011-1#1)
seconds was##2##2##(1991-5#1)(1992-4#1)
seconds##103##1##(1990-11#1)(1990-2#2)(1991-5#3)(1991-6#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-2#1)(1992-4#2)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-5#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-6#1)(2006-8#5)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#2)(2007-9#4)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#3)(2009-9#2)(2010-12#3)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#4)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#5)(2013-8#2)
seconds) and##3##2##(1994-4#1)(2007-12#1)(2010-5#1)
seconds)##10##1##(1990-11#1)(1994-4#2)(1994-9#1)(1995-3#1)(2007-12#2)(2008-12#1)(2008-3#1)(2010-5#1)
secrecy##5##1##(1993-1#1)(1994-4#1)(2008-2#1)(2009-4#1)(2010-12#1)
secret of##2##2##(1990-9#1)(2012-12#1)
secret##18##1##(1990-9#1)(1993-3#1)(1994-1#1)(1995-12#1)(1995-4#1)(1996-2#1)(1997-2#1)(2007-9#2)(2008-10#2)(2008-11#1)(2009-4#1)(2009-5#1)(2010-8#1)(2012-12#3)
secretagogue in##3##2##(1990-5#1)(1991-5#1)(2008-4#1)
secretagogue receptor and##2##3##(2007-7#1)(2011-2#1)
secretagogue receptor##4##2##(2006-1#1)(2007-7#1)(2008-3#1)(2011-2#1)
secretagogue##13##1##(1990-5#1)(1991-5#2)(1992-4#1)(1994-11#1)(2006-1#1)(2006-10#1)(2007-1#1)(2007-7#1)(2008-3#1)(2008-4#1)(2010-5#1)(2011-2#1)
secretagogues##13##1##(1990-12#2)(1990-7#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-12#1)(1997-1#1)(1997-7#1)(2005-8#2)(2006-10#1)(2008-1#1)
secretariat##3##1##(1993-12#2)(2006-9#1)
secretaries and##2##2##(2007-7#1)(2011-2#1)
secretaries of##2##2##(2011-2#1)(2013-8#1)
secretaries##5##1##(2007-7#1)(2010-8#1)(2011-2#2)(2013-8#1)
secretary##4##1##(1991-8#1)(2006-5#1)(2008-9#1)(2012-12#1)
secretase&quot##2##1##(1991-9#2)
secretases and##2##2##(2008-8#1)(2012-12#1)
secretases##3##1##(2008-8#1)(2011-1#1)(2012-12#1)
secrete a##13##2##(1990-9#1)(1991-11#1)(1991-2#1)(1993-12#1)(1994-8#1)(1996-8#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-12#1)
secrete an##2##2##(1993-12#1)(2012-12#1)
secrete at least##2##3##(1990-12#2)
secrete cytokines##5##2##(1995-8#1)(1996-11#1)(1997-4#1)(2006-10#1)(2008-4#1)
secrete growth##2##2##(1994-2#1)(2006-11#1)
secrete insulin in response to##2##5##(1990-8#1)(2010-11#1)
secrete insulin##5##2##(1990-8#1)(2008-1#1)(2010-10#1)(2010-11#2)
secrete into##2##2##(2008-7#1)(2013-1#1)
secrete monoclonal antibodies##2##3##(2008-8#2)
secrete only##3##2##(1991-12#2)(1993-12#1)
secrete pancreatic##2##2##(2008-1#1)(2009-7#1)
secrete the##10##2##(1991-12#1)(1991-7#1)(1992-6#1)(1993-12#1)(1995-1#1)(2007-12#2)(2008-10#2)(2013-7#1)
secrete two##2##2##(1991-12#1)(1991-8#1)
secrete##136##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-4#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-5#2)(1991-7#2)(1991-8#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#4)(1993-3#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-5#3)(1995-8#1)(1996-10#2)(1996-11#3)(1996-2#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-4#5)(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-1#7)(2008-10#5)(2008-11#5)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-2#1)(2009-7#1)(2009-8#3)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#5)(2013-7#1)(2013-8#1)
secreted EPO##2##2##(2008-11#2)
secreted IgG##2##2##(2008-7#2)
secreted a##5##2##(1990-1#1)(1994-8#1)(1997-7#1)(2008-5#1)(2008-7#1)
secreted alkaline phosphatase (SEAP)##2##4##(2008-7#1)(2011-2#1)
secreted alkaline phosphatase##3##3##(1993-6#1)(2008-7#1)(2011-2#1)
secreted alpha-amylase##2##2##(1997-3#1)(2008-8#1)
secreted an##2##2##(2008-10#1)(2010-6#1)
secreted and the##2##3##(1991-6#1)(1995-8#1)
secreted and##12##2##(1990-11#1)(1991-11#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-4#1)(1995-8#1)(1996-8#1)(1997-6#1)(2007-1#1)(2007-11#1)(2008-4#1)
secreted antibodies##3##2##(1991-9#1)(2008-4#2)
secreted as a latent##2##4##(1993-11#2)
secreted as a##5##3##(1992-12#1)(1993-11#2)(2008-12#1)(2010-12#1)
secreted as##11##2##(1990-2#1)(1991-8#2)(1992-12#1)(1993-11#2)(1997-1#2)(2008-12#1)(2010-12#1)(2013-8#1)
secreted aspartyl##2##2##(2007-7#2)
secreted at##5##2##(1990-5#1)(1991-9#1)(1993-3#1)(1995-8#1)(1996-4#1)
secreted by E##2##3##(2010-12#1)(2010-6#1)
secreted by T##2##3##(1990-6#1)(1997-4#1)
secreted by a##4##3##(1990-10#1)(1991-5#1)(2007-1#1)(2008-4#1)
secreted by activated##4##3##(1994-5#1)(1996-11#1)(2008-4#2)
secreted by adipocytes##3##3##(1990-4#1)(2008-1#1)(2008-4#1)
secreted by adipose##2##3##(2010-7#1)(2013-8#1)
secreted by both##2##3##(1991-5#1)(1992-12#1)
secreted by cells##2##3##(1994-8#1)(2009-6#1)
secreted by glioma C6 cells##3##5##(1993-2#3)
secreted by human##3##3##(1990-2#1)(1993-8#1)(1994-3#1)
secreted by mouse##2##3##(1992-5#1)(1995-3#1)
secreted by the fungus##2##4##(1990-3#1)(1992-3#1)
secreted by the pituitary##2##4##(1991-1#1)(1994-11#1)
secreted by the##29##3##(1990-3#1)(1991-1#1)(1991-6#1)(1992-10#1)(1992-3#1)(1993-3#2)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-4#2)(1997-6#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2011-1#1)
secreted by these##3##3##(1992-4#1)(1992-9#1)(1994-9#1)
secreted by tumor cells##2##4##(1991-8#2)
secreted by##132##2##(1990-10#2)(1990-11#3)(1990-2#1)(1990-3#1)(1990-4#3)(1990-6#1)(1990-7#1)(1991-1#1)(1991-5#2)(1991-6#1)(1991-8#3)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#2)(1992-5#1)(1992-8#1)(1992-9#2)(1993-12#2)(1993-2#4)(1993-3#4)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#3)(1994-9#2)(1995-10#1)(1995-2#1)(1995-3#2)(1995-5#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#3)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#3)(1997-6#2)(1997-7#2)(1997-8#1)(2005-3#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-1#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#6)(2008-11#2)(2008-12#1)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#2)(2009-3#1)(2009-4#2)(2009-6#2)(2009-8#2)(2010-10#4)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
secreted cytokines##2##2##(2008-10#2)
secreted during##3##2##(1993-11#1)(1995-8#1)(2007-8#1)
secreted efficiently##3##2##(1990-7#3)
secreted enzymes##2##2##(1992-8#1)(2009-6#1)
secreted extracellular##2##2##(1997-8#1)(2010-7#1)
secreted form of##7##3##(1991-1#1)(1991-2#1)(1992-12#1)(1994-12#1)(1994-3#1)(2008-11#2)
secreted form##11##2##(1991-1#2)(1991-2#1)(1992-12#1)(1994-12#1)(1994-3#1)(1996-11#1)(1997-1#2)(2008-11#2)
secreted forms##2##2##(1990-12#1)(1992-9#1)
secreted from both normal and##2##5##(1991-10#1)(1991-8#1)
secreted from the cells##2##4##(2008-11#1)(2008-8#1)
secreted from the##7##3##(1991-12#1)(2008-11#1)(2008-4#1)(2008-8#2)(2010-2#1)(2010-4#1)
secreted from##26##2##(1990-3#1)(1990-9#1)(1991-10#2)(1991-12#1)(1991-8#1)(1992-4#1)(1993-12#1)(1993-3#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-3#1)(1997-4#1)(2008-11#4)(2008-4#1)(2008-8#2)(2010-2#1)(2010-4#1)(2012-3#1)
secreted growth##2##2##(1993-12#1)(1994-3#1)
secreted higher levels of##2##4##(1992-9#1)(2008-10#1)
secreted human proteins##2##3##(1997-4#2)
secreted human##7##2##(1997-2#1)(1997-4#4)(2008-11#2)
secreted immunoglobulin##3##2##(1994-12#1)(1994-2#1)(1995-1#1)
secreted in a##4##3##(1996-8#1)(1997-2#1)(2008-7#1)(2012-2#1)
secreted in parallel with##2##4##(1995-8#2)
secreted in the##7##3##(1990-10#1)(1991-8#1)(1992-12#1)(1993-11#1)(1995-1#1)(1997-4#1)(2007-12#1)
secreted in##25##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-1#1)(1991-4#1)(1991-8#2)(1992-12#1)(1992-8#1)(1993-11#1)(1995-1#1)(1995-6#1)(1995-8#2)(1996-8#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-2#2)
secreted into the blood##2##4##(1990-5#1)(1994-12#1)
secreted into the culture medium##9##5##(1993-3#1)(1993-9#3)(1996-11#1)(1996-3#1)(1997-4#2)(2006-11#1)
secreted into the culture##10##4##(1993-11#1)(1993-3#1)(1993-9#3)(1996-11#1)(1996-3#1)(1997-4#2)(2006-11#1)
secreted into the medium##10##4##(1990-3#3)(1991-9#2)(1992-3#1)(1992-8#1)(1993-3#1)(1993-9#1)(1996-9#1)
secreted into the##32##3##(1990-3#3)(1990-5#1)(1990-6#1)(1991-9#2)(1992-3#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-3#2)(1993-6#1)(1993-9#5)(1994-11#1)(1994-12#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-4#2)(2006-10#1)(2006-11#1)(2008-4#1)(2008-5#2)
secreted into urine##2##3##(1990-12#1)(1997-2#1)
secreted into##38##2##(1990-11#1)(1990-12#1)(1990-3#3)(1990-5#1)(1990-6#1)(1991-9#2)(1992-3#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-3#2)(1993-6#1)(1993-9#5)(1994-11#1)(1994-12#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-2#3)(1997-4#2)(2006-10#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)
secreted ligands##3##2##(1994-6#3)
secreted lipase##2##2##(2008-5#1)(2011-1#1)
secreted molecules##3##2##(1997-4#1)(2008-4#1)(2008-7#1)
secreted or##2##2##(1995-1#1)(2009-12#1)
secreted per##2##2##(1990-4#1)(2008-4#1)
secreted phospholipase##2##2##(1993-6#1)(2013-1#1)
secreted prorenin##2##2##(1990-8#2)
secreted protein was##2##3##(1997-4#1)(2009-3#1)
secreted protein##22##2##(1991-2#1)(1992-5#1)(1992-8#1)(1994-3#1)(1995-12#1)(1996-7#1)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-8#1)(2012-12#2)(2012-2#1)
secreted proteins and##3##3##(1990-7#1)(1993-12#1)(2009-8#1)
secreted proteins in##2##3##(1997-3#1)(2008-4#1)
secreted proteins##20##2##(1990-1#1)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#1)(1993-11#1)(1993-12#2)(1994-3#1)(1994-9#1)(1995-8#1)(1996-3#1)(1997-3#1)(2008-2#1)(2008-4#3)(2008-9#1)(2009-8#1)
secreted recombinant human##2##3##(2006-11#1)(2008-11#1)
secreted superoxide dismutase##2##3##(1997-4#2)
secreted the##4##2##(1991-12#1)(1992-9#1)(1997-6#1)(2008-4#1)
secreted through the##3##3##(1991-5#1)(1994-11#1)(2011-1#1)
secreted to the culture medium##2##5##(1997-2#1)(2009-3#1)
secreted to the##4##3##(1997-2#1)(1997-4#1)(2008-8#1)(2009-3#1)
secreted under##2##2##(2006-10#1)(2008-6#1)
secreted##529##1##(1990-1#2)(1990-10#3)(1990-11#9)(1990-12#4)(1990-2#3)(1990-3#8)(1990-4#6)(1990-5#4)(1990-6#3)(1990-7#5)(1990-8#4)(1990-9#3)(1991-1#4)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#4)(1991-4#1)(1991-5#4)(1991-6#2)(1991-8#8)(1991-9#11)(1992-10#2)(1992-11#1)(1992-12#7)(1992-3#3)(1992-4#5)(1992-5#3)(1992-6#1)(1992-7#3)(1992-8#6)(1992-9#7)(1993-11#6)(1993-12#7)(1993-2#4)(1993-3#12)(1993-4#1)(1993-6#3)(1993-8#4)(1993-9#5)(1994-11#5)(1994-12#5)(1994-2#1)(1994-3#11)(1994-5#4)(1994-6#5)(1994-8#6)(1994-9#8)(1995-1#7)(1995-10#1)(1995-12#1)(1995-2#4)(1995-3#5)(1995-5#2)(1995-6#1)(1995-8#6)(1996-10#1)(1996-11#4)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#3)(1996-5#5)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#8)(1997-2#8)(1997-3#4)(1997-4#23)(1997-6#7)(1997-7#4)(1997-8#2)(2004-11#2)(2005-3#1)(2006-10#6)(2006-11#3)(2006-12#1)(2006-2#1)(2006-9#1)(2007-1#4)(2007-11#4)(2007-12#4)(2007-7#3)(2007-8#3)(2008-1#6)(2008-10#20)(2008-11#26)(2008-12#2)(2008-2#2)(2008-4#18)(2008-5#10)(2008-6#3)(2008-7#9)(2008-8#6)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#2)(2009-6#3)(2009-8#6)(2009-9#1)(2010-10#4)(2010-11#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-6#2)(2010-7#2)(2011-1#7)(2011-2#2)(2012-1#2)(2012-12#11)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#4)
secretes a##5##2##(1990-11#1)(1994-9#1)(2007-12#1)(2008-1#1)(2008-7#1)
secretes an##2##2##(1990-5#1)(1995-1#1)
secretes large##2##2##(1994-9#1)(1997-1#1)
secretes##21##1##(1990-11#2)(1990-12#1)(1990-5#1)(1991-7#1)(1991-9#1)(1993-12#1)(1994-8#1)(1994-9#2)(1995-1#1)(1997-1#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-7#2)(2010-4#1)(2010-9#1)(2011-1#1)
secretin and##2##2##(1994-2#1)(2006-10#1)
secretin has##2##2##(1995-5#1)(2006-10#1)
secretin in##2##2##(1994-3#2)
secretin release##2##2##(2006-10#2)
secretin test##2##2##(2006-10#2)
secretin##21##1##(1992-6#1)(1993-11#2)(1994-2#1)(1994-3#2)(1995-5#1)(2004-12#2)(2006-10#8)(2007-5#1)(2009-7#1)(2011-2#1)(2013-8#1)
secreting a##2##2##(1992-4#1)(2010-12#1)
secreting an##2##2##(2008-10#1)(2013-7#1)
secreting antibodies##4##2##(1992-8#1)(1994-9#1)(2008-11#2)
secreting cells in##2##3##(1996-11#1)(2010-11#1)
secreting cells##7##2##(1994-11#1)(1996-11#2)(2008-11#1)(2008-3#1)(2008-4#1)(2010-11#1)
secreting cytokines and chemokines##2##4##(2008-3#1)(2008-4#1)
secreting hybridomas was##2##3##(1992-8#2)
secreting hybridomas##4##2##(1992-8#3)(2007-10#1)
secreting monoclonal antibodies##3##3##(1991-2#1)(2008-10#1)(2008-11#1)
secreting monoclonal antibody##2##3##(2008-11#2)
secreting monoclonal##5##2##(1991-2#1)(2008-10#1)(2008-11#3)
secreting penicillinase##2##2##(2008-4#2)
secreting recombinant##2##2##(2008-11#2)
secreting specific antibody##2##3##(1992-8#1)(2008-11#1)
secreting the##3##2##(1990-5#1)(1994-3#1)(1997-2#1)
secreting##78##1##(1990-4#1)(1990-5#1)(1991-2#1)(1991-7#1)(1991-9#2)(1992-4#1)(1992-7#1)(1992-8#5)(1993-3#1)(1994-11#1)(1994-3#2)(1994-9#1)(1996-11#2)(1996-12#1)(1996-7#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-11#2)(2006-9#2)(2007-10#1)(2007-7#2)(2008-10#2)(2008-11#15)(2008-12#2)(2008-3#2)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
secretion (SIADH)##3##2##(1991-5#1)(2006-11#1)(2011-2#1)
secretion activity##2##2##(2008-10#1)(2008-11#1)
secretion after##2##2##(1990-2#1)(1994-12#1)
secretion also##2##2##(1990-2#2)
secretion and [Ca2+]i##2##3##(1990-7#1)(1994-3#1)
secretion and a##4##3##(1992-6#1)(1995-12#1)(2009-9#1)(2010-1#1)
secretion and action##2##3##(1997-3#1)(2013-1#1)
secretion and also##2##3##(2008-11#1)(2010-11#1)
secretion and are themselves regulated##2##5##(2006-10#2)
secretion and are##3##3##(2006-10#2)(2007-12#1)
secretion and binding##2##3##(1991-12#1)(1991-8#1)
secretion and decreased##2##3##(1995-3#1)(2008-6#1)
secretion and gastric##3##3##(2007-5#1)(2009-5#1)(2010-4#1)
secretion and gene expression##2##4##(1996-2#1)(2005-10#1)
secretion and increased##3##3##(2008-10#1)(2008-6#1)(2010-12#1)
secretion and is##3##3##(1993-3#1)(2007-5#1)(2008-4#1)
secretion and its##5##3##(1993-5#1)(1994-9#1)(2007-1#1)(2008-12#1)(2011-1#1)
secretion and mucosal##3##3##(1997-1#1)(2010-12#1)(2012-2#1)
secretion and proliferation##2##3##(1991-5#1)(2007-11#1)
secretion and reducing##2##3##(2008-1#1)(2009-2#1)
secretion and synthesis##2##3##(1991-4#1)(1994-3#1)
secretion and the##9##3##(1991-10#1)(1991-5#1)(1994-9#1)(1995-3#1)(2004-11#1)(2006-10#1)(2007-12#1)(2008-3#1)(2008-4#1)
secretion and##137##2##(1990-12#2)(1990-3#1)(1990-7#2)(1991-10#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#3)(1991-7#1)(1991-8#4)(1992-11#1)(1992-4#1)(1992-6#2)(1992-7#1)(1993-11#1)(1993-3#2)(1993-5#2)(1993-6#1)(1994-12#1)(1994-3#4)(1994-5#3)(1994-8#5)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#4)(1996-10#1)(1996-2#2)(1996-4#1)(1997-1#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-11#2)(2005-10#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#6)(2007-1#2)(2007-11#1)(2007-12#2)(2007-5#4)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#2)(2009-12#1)(2009-2#1)(2009-5#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#3)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
secretion appears to be##2##4##(1996-10#1)(2007-11#1)
secretion are##8##2##(1991-1#1)(2006-10#4)(2007-11#1)(2008-1#1)(2008-11#1)
secretion as compared to##2##4##(1990-4#1)(2007-2#1)
secretion as compared with##2##4##(1996-5#1)(2010-11#1)
secretion as compared##4##3##(1990-4#1)(1996-5#1)(2007-2#1)(2010-11#1)
secretion as well as##4##4##(1994-3#1)(1995-10#1)(1995-3#1)(2006-6#1)
secretion as##11##2##(1990-4#1)(1991-10#1)(1994-3#1)(1995-10#1)(1995-3#1)(1996-12#1)(1996-5#1)(2006-6#1)(2007-12#1)(2007-2#1)(2010-11#1)
secretion assay##4##2##(2008-11#3)(2008-4#1)
secretion associated with##2##3##(1990-12#1)(2008-12#1)
secretion at a##2##3##(1994-6#1)(1995-12#1)
secretion at synapses in##2##4##(1991-6#2)
secretion at synapses##3##3##(1991-6#3)
secretion at the##3##3##(1992-11#1)(1994-12#1)(2006-10#1)
secretion at##19##2##(1990-11#1)(1990-3#1)(1991-10#1)(1991-6#7)(1992-11#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-8#1)(1997-2#1)(1997-4#1)(2006-10#1)
secretion but not##2##3##(1991-9#1)(2009-6#1)
secretion by cultured##3##3##(1991-5#1)(1992-9#1)(1994-12#1)
secretion by human##3##3##(1990-4#1)(1994-9#1)(2006-6#1)
secretion by the##9##3##(1990-10#1)(1992-12#1)(1994-10#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-1#1)(2009-3#1)(2010-9#1)
secretion by##72##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-3#2)(1993-9#4)(1994-10#1)(1994-12#4)(1994-3#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#1)(1995-8#2)(1995-9#1)(1996-10#1)(1997-4#3)(1997-5#2)(2006-10#3)(2006-6#1)(2007-12#1)(2008-1#1)(2008-11#3)(2008-12#3)(2008-4#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-9#1)(2012-12#1)
secretion can##3##2##(1992-5#1)(2005-11#1)(2007-12#1)
secretion did not##3##3##(1992-8#1)(2004-11#1)(2013-1#1)
secretion during aging##2##3##(1991-12#1)(1995-9#1)
secretion during the##2##3##(1994-6#1)(1994-9#1)
secretion during##10##2##(1990-5#1)(1991-12#1)(1993-11#1)(1994-6#1)(1994-9#2)(1995-10#1)(1995-9#1)(1997-2#1)(2013-1#1)
secretion dynamics##2##2##(2008-11#2)
secretion efficiency##3##2##(1991-6#2)(1993-3#1)
secretion following##2##2##(1994-8#1)(1995-12#1)
secretion for##5##2##(1992-4#1)(1992-9#1)(2008-11#3)
secretion from Bacillus subtilis of a 34-amino acid##2##8##(1991-6#2)
secretion from bovine##3##3##(1990-2#1)(1994-3#2)
secretion from cultured##2##3##(1994-8#1)(1995-11#1)
secretion from digitonin-permeabilized chromaffin cells##2##5##(1992-8#2)
secretion from digitonin-permeabilized##3##3##(1992-7#1)(1992-8#2)
secretion from isolated##4##3##(1991-10#1)(1994-8#2)(2006-10#1)
secretion from naive##2##3##(2008-11#2)
secretion from pancreatic##4##3##(1991-1#1)(2006-10#1)(2010-11#2)
secretion from rat##2##3##(1990-10#1)(1990-12#1)
secretion from the##16##3##(1990-10#1)(1990-11#1)(1991-10#1)(1991-8#1)(1997-5#1)(2006-1#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
secretion from##74##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#2)(1990-5#1)(1990-8#1)(1991-1#2)(1991-10#2)(1991-4#1)(1991-6#2)(1991-8#1)(1992-11#1)(1992-6#1)(1992-7#2)(1992-8#2)(1994-3#4)(1994-8#4)(1995-10#1)(1995-11#1)(1995-2#1)(1995-8#5)(1996-12#1)(1997-5#1)(1997-8#1)(2006-1#1)(2006-10#3)(2006-11#1)(2007-1#3)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#7)(2008-6#1)(2008-7#1)(2009-2#1)(2010-11#3)(2010-2#1)(2011-1#2)(2012-2#1)(2013-7#1)(2013-8#1)
secretion generally##2##2##(1997-1#1)(2006-1#1)
secretion has been##2##3##(1995-10#1)(2012-2#1)
secretion has##5##2##(1995-10#1)(1996-5#1)(2006-10#1)(2009-8#1)(2012-2#1)
secretion have been##2##3##(2006-10#2)
secretion imbalances##2##2##(2008-5#2)
secretion in GH3 cells##3##4##(1992-8#1)(1994-3#1)(1995-10#1)
secretion in GH4C1##2##3##(1990-7#1)(1991-2#1)
secretion in a dose-dependent manner##2##5##(1990-8#1)(1993-11#1)
secretion in a##7##3##(1990-8#1)(1993-11#1)(1994-3#1)(1996-4#1)(1997-4#1)(2006-2#1)(2007-1#1)
secretion in anaesthetized##2##3##(1994-3#1)(2004-12#1)
secretion in both##2##3##(1991-6#1)(1997-5#1)
secretion in bovine##2##3##(1995-11#2)
secretion in conscious##2##3##(1990-3#1)(1993-11#1)
secretion in human##5##3##(1990-4#1)(1994-12#2)(1994-3#1)(1996-6#1)
secretion in humans##3##3##(1995-5#2)(2006-10#1)
secretion in isolated##2##3##(1991-6#1)(1995-12#1)
secretion in man##3##3##(1991-12#1)(1991-2#1)(1993-5#1)
secretion in mice##2##3##(1995-11#1)(2008-4#1)
secretion in pancreatic##4##3##(1996-2#1)(1997-5#1)(2010-11#1)(2013-1#1)
secretion in patients with##3##4##(1994-2#1)(1995-11#1)(2006-6#1)
secretion in rat##2##3##(1991-8#1)(1993-11#1)
secretion in rats##9##3##(1990-2#1)(1990-5#1)(1992-6#1)(1994-11#2)(1996-4#1)(2006-12#1)(2007-1#1)(2012-12#1)
secretion in response to##6##4##(1990-11#1)(1992-8#1)(1994-12#1)(1995-8#1)(2010-11#1)(2012-12#1)
secretion in response##7##3##(1990-11#1)(1990-8#1)(1992-8#1)(1994-12#1)(1995-8#1)(2010-11#1)(2012-12#1)
secretion in the common##2##4##(2007-1#2)
secretion in the presence of##3##5##(1994-11#1)(1995-11#1)(2008-11#1)
secretion in the rat##3##4##(1991-9#1)(1994-3#1)(2007-1#1)
secretion in the##24##3##(1991-9#1)(1993-11#1)(1993-12#2)(1994-11#2)(1994-3#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-8#1)(1997-5#2)(2006-10#1)(2007-1#5)(2008-10#2)(2008-11#1)(2008-7#1)(2010-2#1)
secretion in vivo##6##3##(1992-6#1)(1993-12#1)(2006-1#1)(2010-11#3)
secretion in##133##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#3)(1991-12#1)(1991-2#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-6#2)(1992-8#2)(1993-11#4)(1993-12#4)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#4)(1994-2#1)(1994-3#5)(1995-10#3)(1995-11#6)(1995-12#5)(1995-3#1)(1995-5#2)(1995-8#7)(1996-2#1)(1996-4#2)(1996-6#1)(1997-1#4)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#4)(2004-12#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#7)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2010-11#6)(2010-2#2)(2012-12#2)(2012-2#2)(2013-1#1)
secretion increases##2##2##(1997-1#1)(2007-12#1)
secretion induced by##11##3##(1990-7#2)(1991-10#1)(1992-1#1)(1994-8#1)(1995-8#2)(1996-9#1)(1997-5#1)(2004-12#1)(2006-10#1)
secretion into the##5##3##(1990-12#1)(1994-11#1)(1994-3#1)(1996-2#1)(1997-3#1)
secretion into##9##2##(1990-12#1)(1994-11#1)(1994-3#1)(1996-1#1)(1996-2#1)(1997-3#1)(2006-6#1)(2008-11#1)(2009-9#1)
secretion is a##2##3##(2006-10#1)(2008-3#1)
secretion is associated with##2##4##(1993-9#1)(1997-1#1)
secretion is mediated##2##3##(1995-11#1)(2006-10#1)
secretion is not dependent on##3##5##(1990-12#1)(1994-8#1)(1995-11#1)
secretion is not##4##3##(1990-12#1)(1994-8#1)(1995-11#1)(1996-11#1)
secretion is regulated##2##3##(1997-4#1)(2010-10#1)
secretion is stimulated by##2##4##(1990-10#1)(1997-1#1)
secretion is stimulated##3##3##(1990-10#1)(1991-6#1)(1997-1#1)
secretion is##37##2##(1990-10#1)(1990-12#1)(1991-5#1)(1991-6#1)(1993-9#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-5#1)(1995-9#1)(1996-11#1)(1997-1#3)(1997-4#1)(2006-10#6)(2006-9#2)(2007-12#1)(2008-3#1)(2008-4#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#1)(2011-2#2)(2012-2#1)
secretion level##2##2##(1994-8#1)(1995-6#1)
secretion levels##5##2##(2008-11#1)(2008-4#1)(2009-2#1)(2010-11#1)(2012-1#1)
secretion machinery##3##2##(1994-3#1)(1997-3#1)(2012-2#1)
secretion may occur##2##3##(2007-12#1)(2009-8#1)
secretion may##6##2##(1995-2#1)(2006-9#1)(2007-12#1)(2007-5#1)(2009-8#1)(2012-12#1)
secretion observed in##2##3##(1992-8#1)(1996-2#1)
secretion observed##4##2##(1992-8#2)(1996-2#1)(2008-11#1)
secretion obtained##2##2##(1994-12#1)(2008-10#1)
secretion occurs##3##2##(1993-11#1)(1994-12#1)(2005-11#1)
secretion of ANP and BNP##2##5##(1991-5#2)
secretion of ANP and##4##4##(1991-4#1)(1991-5#2)(2006-11#1)
secretion of ANP##5##3##(1991-4#2)(1991-5#2)(2006-11#1)
secretion of CRP##2##3##(1994-9#2)
secretion of IFN-gamma##2##3##(1994-9#1)(2008-11#1)
secretion of IL-12 p70##2##4##(2008-8#2)
secretion of IL-12##5##3##(1996-10#1)(2008-8#4)
secretion of NGF##2##3##(1996-2#1)(1996-9#1)
secretion of PC1 and PC2##2##5##(1992-8#2)
secretion of T##2##3##(2007-11#1)(2011-12#1)
secretion of TGF-beta from IECs##2##5##(2008-11#2)
secretion of TNF-alpha by##2##4##(1994-5#1)(2008-10#1)
secretion of a novel##2##4##(1995-3#1)(2007-8#1)
secretion of a##8##3##(1995-2#1)(1995-3#1)(1995-8#2)(2007-11#1)(2007-8#2)(2010-2#1)
secretion of active##2##3##(1995-6#1)(1997-1#1)
secretion of an##4##3##(1993-11#1)(1995-6#1)(1997-8#1)(2008-11#1)
secretion of apolipoprotein##2##3##(1990-4#1)(1993-9#1)
secretion of beta-endorphin in##2##4##(1990-12#2)
secretion of beta-endorphin##3##3##(1990-12#2)(1994-9#1)
secretion of both##3##3##(1994-11#1)(1994-9#1)(2007-11#1)
secretion of catecholamines##2##3##(1991-8#1)(1995-12#1)
secretion of fungal##2##3##(1996-7#1)(2008-10#1)
secretion of heterologous proteins##3##4##(1992-2#1)(1997-4#1)(2008-7#1)
secretion of high##2##3##(1991-5#1)(1995-8#1)
secretion of inflammatory##2##3##(2006-9#1)(2009-11#1)
secretion of insulin##6##3##(1990-11#1)(1992-3#2)(1997-4#1)(2010-11#2)
secretion of interferon-gamma##2##3##(1997-7#1)(2008-11#1)
secretion of interleukin##3##3##(1994-3#1)(2008-11#2)
secretion of intracellular##2##3##(1990-5#1)(2008-11#1)
secretion of pancreastatin and somatostatin from QGP-1N cells##3##8##(1992-6#3)
secretion of pancreastatin and somatostatin##5##5##(1992-6#5)
secretion of proinflammatory cytokines such as##2##6##(2008-11#2)
secretion of proinflammatory cytokines##4##4##(2008-11#4)
secretion of proteins##3##3##(1990-6#1)(2011-2#1)(2012-2#1)
secretion of quanta##3##3##(1991-6#2)(1995-8#1)
secretion of recombinant##4##3##(1993-11#1)(1995-1#1)(2006-11#1)(2012-2#1)
secretion of soluble##4##3##(1995-2#2)(1997-7#1)(2005-10#1)
secretion of the amyloid precursor protein##2##6##(1993-11#2)
secretion of the##18##3##(1990-9#1)(1991-8#1)(1991-9#1)(1993-11#2)(1994-9#1)(1995-10#1)(1996-11#1)(1996-4#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2010-3#1)(2011-1#1)
secretion of total##2##3##(2004-11#1)(2008-11#1)
secretion of toxins##2##3##(2008-10#1)(2008-11#1)
secretion of transforming growth factor beta##3##6##(1996-4#1)(2008-11#2)
secretion of two##3##3##(2008-11#1)(2008-4#1)(2008-8#1)
secretion of type##3##3##(1993-9#1)(1994-2#1)(2011-1#1)
secretion of vasopressin##2##3##(1994-9#1)(2013-1#1)
secretion of##323##2##(1990-10#2)(1990-11#3)(1990-12#3)(1990-2#2)(1990-4#2)(1990-5#3)(1990-6#1)(1990-8#1)(1990-9#3)(1991-10#1)(1991-2#2)(1991-4#2)(1991-5#3)(1991-6#5)(1991-8#5)(1991-9#4)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#8)(1992-6#5)(1992-8#2)(1992-9#1)(1993-10#1)(1993-11#4)(1993-12#3)(1993-3#5)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#7)(1994-11#4)(1994-12#4)(1994-2#1)(1994-3#5)(1994-5#4)(1994-6#1)(1994-8#4)(1994-9#8)(1995-1#5)(1995-10#2)(1995-12#2)(1995-2#6)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#3)(1995-8#6)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#3)(1996-5#1)(1996-6#2)(1996-7#1)(1996-9#2)(1997-1#2)(1997-2#1)(1997-4#4)(1997-7#3)(1997-8#2)(2004-11#5)(2005-10#2)(2005-11#1)(2006-10#3)(2006-11#3)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#2)(2007-11#4)(2007-12#9)(2007-3#1)(2007-4#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#28)(2008-4#6)(2008-5#6)(2008-6#4)(2008-7#7)(2008-8#7)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-7#1)(2010-11#3)(2010-2#2)(2010-3#1)(2010-8#1)(2010-9#2)(2011-1#5)(2011-12#3)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#2)
secretion on the##3##3##(2006-6#1)(2008-11#1)(2009-8#1)
secretion on##6##2##(2006-6#1)(2007-12#1)(2007-8#1)(2008-11#1)(2009-8#1)(2011-1#1)
secretion or##10##2##(1991-10#1)(1995-2#1)(2005-8#1)(2006-6#1)(2007-11#1)(2008-4#1)(2008-7#1)(2010-12#1)(2012-1#1)(2013-8#1)
secretion pathway##2##2##(1992-2#1)(2008-1#1)
secretion patterns##4##2##(1997-8#1)(2006-5#1)(2008-10#1)(2008-7#1)
secretion profile##2##2##(2008-11#2)
secretion profiles##2##2##(2008-11#1)(2011-2#1)
secretion rate of##4##3##(1994-6#1)(1995-1#1)(2008-11#2)
secretion rate##10##2##(1993-9#1)(1994-6#1)(1995-1#1)(1997-2#1)(2008-11#3)(2010-3#2)(2013-7#1)
secretion rates were##2##3##(2013-8#2)
secretion rates##5##2##(1990-5#1)(2013-7#1)(2013-8#3)
secretion sampling##2##2##(2006-8#2)
secretion signal##2##2##(1993-2#1)(1997-4#1)
secretion stimulated by##4##3##(1990-2#1)(1995-8#1)(2006-10#1)(2007-1#1)
secretion system of Bacillus subtilis##2##5##(1997-4#2)
secretion system of##5##3##(1996-8#1)(1997-4#2)(2008-11#1)(2011-1#1)
secretion system##14##2##(1996-8#2)(1997-2#1)(1997-4#2)(2006-10#1)(2007-12#1)(2008-11#2)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
secretion systems##2##2##(2011-2#1)(2013-1#1)
secretion than##2##2##(1994-11#1)(2004-11#1)
secretion that##4##2##(1990-5#1)(1991-12#1)(1995-8#1)(2007-12#1)
secretion the##2##2##(1995-1#1)(2008-8#1)
secretion through##5##2##(1991-10#1)(1994-3#1)(2008-5#1)(2008-8#1)(2009-5#1)
secretion to the##3##3##(2008-10#2)(2012-11#1)
secretion to##11##2##(1993-2#1)(1994-6#1)(1995-12#1)(2006-4#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-11#1)
secretion type##2##2##(1991-1#2)
secretion under##3##2##(1990-2#1)(1990-5#1)(1995-8#1)
secretion vector##3##2##(1997-6#1)(2008-4#1)(2008-8#1)
secretion via##4##2##(1994-8#1)(1995-10#1)(1997-1#2)
secretion was also##2##3##(1990-2#1)(1990-9#1)
secretion was assessed in##2##4##(1995-1#1)(2012-5#1)
secretion was assessed##3##3##(1990-6#1)(1995-1#1)(2012-5#1)
secretion was inhibited##3##3##(1990-10#1)(1994-8#1)(1994-9#1)
secretion was investigated in##2##4##(1995-8#1)(1996-6#1)
secretion was not##3##3##(1995-11#1)(1997-5#1)(2008-11#1)
secretion was smaller##2##3##(1991-10#1)(1995-11#1)
secretion was stimulated by##2##4##(1990-10#2)
secretion was studied##2##3##(1992-7#1)(1992-8#1)
secretion was##35##2##(1990-10#3)(1990-2#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-10#2)(1992-3#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-8#1)(1996-6#1)(1996-9#1)(1997-5#1)(2004-11#1)(2007-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-3#1)(2012-5#1)
secretion were also##3##3##(1997-5#1)(2006-6#1)(2011-2#1)
secretion were increased##2##3##(2008-11#1)(2010-11#1)
secretion were##11##2##(1990-10#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1997-5#1)(2006-6#1)(2008-11#1)(2008-5#1)(2010-11#1)(2011-2#1)
secretion when##4##2##(1996-4#1)(2008-11#2)(2012-12#1)
secretion with a##2##3##(1997-2#1)(2013-1#1)
secretion with an##2##3##(1995-5#1)(1996-2#1)
secretion with##8##2##(1994-11#1)(1995-5#1)(1996-2#1)(1996-8#1)(1997-2#1)(2009-8#1)(2011-2#1)(2013-1#1)
secretion without##3##2##(1994-9#1)(2004-12#1)(2008-7#1)
secretion##1553##1##(1990-10#11)(1990-11#17)(1990-12#19)(1990-2#17)(1990-3#11)(1990-4#9)(1990-5#12)(1990-6#6)(1990-7#6)(1990-8#6)(1990-9#7)(1991-1#7)(1991-10#15)(1991-11#2)(1991-12#7)(1991-2#9)(1991-3#1)(1991-4#5)(1991-5#9)(1991-6#22)(1991-7#4)(1991-8#17)(1991-9#12)(1992-1#1)(1992-10#1)(1992-11#9)(1992-12#3)(1992-2#3)(1992-3#9)(1992-4#4)(1992-5#1)(1992-6#15)(1992-7#5)(1992-8#14)(1992-9#6)(1993-10#1)(1993-11#19)(1993-12#9)(1993-2#3)(1993-3#14)(1993-5#4)(1993-6#2)(1993-7#2)(1993-8#4)(1993-9#17)(1994-10#3)(1994-11#16)(1994-12#25)(1994-2#4)(1994-3#36)(1994-5#8)(1994-6#12)(1994-8#23)(1994-9#21)(1995-1#13)(1995-10#13)(1995-11#20)(1995-12#21)(1995-2#11)(1995-3#14)(1995-4#1)(1995-5#11)(1995-6#6)(1995-7#1)(1995-8#32)(1995-9#4)(1996-1#1)(1996-10#8)(1996-11#4)(1996-12#4)(1996-2#10)(1996-3#1)(1996-4#12)(1996-5#7)(1996-6#5)(1996-7#2)(1996-8#3)(1996-9#5)(1997-1#28)(1997-2#14)(1997-3#6)(1997-4#20)(1997-5#20)(1997-6#6)(1997-7#6)(1997-8#7)(2004-11#12)(2004-12#5)(2005-10#3)(2005-11#5)(2005-7#4)(2005-8#2)(2006-1#6)(2006-10#61)(2006-11#5)(2006-12#3)(2006-2#3)(2006-4#2)(2006-5#1)(2006-6#15)(2006-7#1)(2006-8#4)(2006-9#9)(2007-1#20)(2007-11#12)(2007-12#40)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#6)(2007-7#4)(2007-8#7)(2007-9#4)(2008-1#23)(2008-10#22)(2008-11#87)(2008-12#8)(2008-2#1)(2008-3#6)(2008-4#38)(2008-5#15)(2008-6#8)(2008-7#24)(2008-8#17)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#5)(2009-3#1)(2009-5#6)(2009-6#1)(2009-7#1)(2009-8#10)(2009-9#4)(2010-1#2)(2010-10#4)(2010-11#34)(2010-12#5)(2010-2#5)(2010-3#5)(2010-4#3)(2010-6#1)(2010-8#2)(2010-9#3)(2011-1#23)(2011-12#3)(2011-2#17)(2012-1#7)(2012-11#1)(2012-12#13)(2012-2#19)(2012-3#10)(2012-5#1)(2013-1#18)(2013-7#5)(2013-8#8)
secretion)##6##1##(1997-5#1)(2006-10#1)(2007-7#1)(2008-4#2)(2009-12#1)
secretion-affinity fusion system##2##3##(2008-7#2)
secretions and##10##2##(1993-3#1)(1994-8#1)(1997-1#1)(2004-2#1)(2006-12#2)(2007-11#1)(2008-5#1)(2011-1#1)(2011-12#1)
secretions as##2##2##(1993-1#1)(1994-12#1)
secretions from the##3##3##(1990-11#1)(2007-12#1)(2008-5#1)
secretions from##7##2##(1990-11#1)(1991-11#1)(1995-8#1)(1997-1#1)(2006-12#1)(2007-12#1)(2008-5#1)
secretions in##7##2##(1991-11#1)(1994-9#1)(2008-1#1)(2008-11#1)(2011-2#2)(2012-2#1)
secretions of the##2##3##(1991-5#1)(2008-12#1)
secretions of##8##2##(1991-5#1)(2004-2#1)(2006-12#2)(2007-11#1)(2008-12#1)(2008-5#1)(2010-8#1)
secretions were##6##2##(1990-9#1)(1992-9#1)(1993-5#1)(1996-4#1)(1997-6#1)(2013-1#1)
secretions##103##1##(1990-11#2)(1990-12#2)(1990-9#1)(1991-11#7)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-2#3)(1992-6#1)(1992-9#1)(1993-1#2)(1993-3#1)(1993-5#2)(1994-12#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-2#1)(1995-8#5)(1996-12#1)(1996-2#1)(1996-4#3)(1996-6#1)(1997-1#3)(1997-6#2)(2004-2#2)(2006-10#3)(2006-12#6)(2007-1#1)(2007-11#4)(2007-12#4)(2008-1#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#12)(2008-9#3)(2010-8#2)(2011-1#2)(2011-12#2)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#2)
secretive##4##1##(2007-9#1)(2008-1#1)(2008-5#1)(2012-2#1)
secretogranin II##8##2##(1991-2#2)(1992-12#6)
secretogranin##9##1##(1991-2#2)(1992-12#6)(1996-4#1)
secretome##2##1##(2010-8#1)(2013-8#1)
secretor##4##1##(1996-2#1)(2007-9#1)(2012-2#1)(2013-1#1)
secretors##3##1##(1990-9#1)(1992-8#1)(2010-5#1)
secretory IgA##13##2##(1990-12#2)(1991-3#2)(2005-11#1)(2006-10#1)(2006-2#1)(2008-10#1)(2010-12#3)(2013-1#2)
secretory PLA2##3##2##(1992-4#1)(1996-8#2)
secretory activity in rat isolated parietal cells##2##7##(1993-9#2)
secretory activity in rat##3##4##(1993-9#3)
secretory activity of the##3##4##(1993-5#1)(2006-9#1)(2012-1#1)
secretory activity of##5##3##(1993-5#2)(1994-6#1)(2006-9#1)(2012-1#1)
secretory activity##15##2##(1991-2#1)(1993-5#2)(1993-9#3)(1994-6#1)(1997-1#1)(2006-9#2)(2007-12#1)(2008-5#1)(2008-7#2)(2012-1#1)
secretory and transport##2##3##(2007-12#1)(2010-9#1)
secretory and##7##2##(1991-6#1)(1992-5#1)(1997-4#1)(2006-10#1)(2007-12#1)(2010-9#1)(2012-12#1)
secretory behavior##2##2##(1992-4#2)
secretory capacity##3##2##(1991-7#1)(2007-5#1)(2008-7#1)
secretory cavities##2##2##(1997-6#1)(2007-12#1)
secretory cavity##3##2##(1997-6#3)
secretory cell##2##2##(2007-12#1)(2008-6#1)
secretory cells and##2##3##(1992-4#1)(2007-12#1)
secretory cells with a##2##4##(1991-1#2)
secretory cells with##3##3##(1991-1#3)
secretory cells##18##2##(1991-1#3)(1992-4#1)(1993-11#1)(1997-7#1)(2007-12#8)(2008-6#1)(2008-7#1)(2008-8#2)
secretory component was found in##2##5##(1991-3#2)
secretory component##12##2##(1991-3#9)(1997-6#2)(2006-2#1)
secretory cycle##3##2##(2008-7#3)
secretory epithelial cells##2##3##(1997-6#1)(2006-11#1)
secretory fluids##2##2##(1991-4#1)(1993-2#1)
secretory form##2##2##(1991-11#1)(2009-10#1)
secretory function and##3##3##(2007-11#1)(2010-10#1)(2011-2#1)
secretory function in##2##3##(2008-7#1)(2010-10#1)
secretory function##12##2##(1992-12#1)(1992-6#1)(1994-12#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-7#1)(2010-10#4)(2011-2#1)
secretory functions##2##2##(1991-5#1)(2006-10#1)
secretory granule and##2##3##(1992-6#1)(1996-5#1)
secretory granule##10##2##(1992-6#1)(1993-5#1)(1996-5#3)(1997-7#1)(2010-11#4)
secretory granules in##3##3##(1992-12#1)(1995-8#1)(1997-7#1)
secretory granules of##6##3##(1995-3#2)(1996-4#1)(1996-5#2)(1997-4#1)
secretory granules to the##2##4##(1997-4#1)(2010-11#1)
secretory granules with##2##3##(1992-12#1)(2008-7#1)
secretory granules##36##2##(1992-12#5)(1992-2#3)(1993-5#1)(1995-3#2)(1995-8#4)(1996-4#4)(1996-5#3)(1997-4#2)(1997-7#3)(2007-12#1)(2008-1#1)(2008-4#2)(2008-7#3)(2010-11#2)
secretory immune response##2##3##(1993-5#1)(2013-1#1)
secretory immune##3##2##(1993-5#1)(2007-2#1)(2013-1#1)
secretory leukocyte##2##2##(2006-10#1)(2006-4#1)
secretory machinery of##2##3##(1991-5#1)(2012-2#1)
secretory machinery##4##2##(1991-5#2)(1997-3#1)(2012-2#1)
secretory material##4##2##(1994-5#1)(2007-12#1)(2008-4#1)(2013-8#1)
secretory pathway and##5##3##(1990-5#1)(1990-6#1)(2009-8#1)(2012-2#2)
secretory pathway of Saccharomyces cerevisiae##2##5##(1997-6#2)
secretory pathway of##4##3##(1996-4#1)(1997-6#2)(2008-4#1)
secretory pathway##31##2##(1990-3#1)(1990-5#2)(1990-6#3)(1992-11#1)(1992-9#1)(1993-3#1)(1994-11#2)(1994-12#1)(1995-12#1)(1996-4#1)(1997-1#3)(1997-6#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#3)(2009-8#1)(2012-2#2)
secretory pathways in##2##3##(1993-5#1)(1995-6#1)
secretory pathways##7##2##(1992-12#2)(1993-5#1)(1994-11#2)(1995-3#1)(1995-6#1)
secretory patterns##2##2##(1995-8#1)(1997-1#1)
secretory portions##4##2##(2007-12#4)
secretory process##2##2##(2007-9#1)(2012-2#1)
secretory processes##2##2##(1991-1#1)(1997-7#1)
secretory product##6##2##(1990-3#1)(1994-9#2)(2007-12#2)(2010-4#1)
secretory products of##2##3##(1990-12#1)(1994-5#1)
secretory products##6##2##(1990-12#1)(1990-3#2)(1992-9#1)(1994-5#1)(2007-12#1)
secretory profiles##4##2##(2007-11#1)(2012-11#1)(2013-1#2)
secretory protein##9##2##(1991-12#1)(1995-2#1)(1996-5#1)(1997-2#1)(1997-8#1)(2004-11#1)(2006-12#2)(2013-1#1)
secretory proteins and##2##3##(1990-3#1)(1994-8#1)
secretory proteins are##2##3##(1990-3#1)(2009-10#1)
secretory proteins##12##2##(1990-3#2)(1990-5#1)(1991-5#1)(1992-6#1)(1994-2#1)(1994-8#1)(1996-5#1)(2008-4#1)(2009-10#3)
secretory rate##2##2##(2004-12#1)(2012-12#1)
secretory response in##2##3##(1993-11#1)(1993-3#1)
secretory response to##6##3##(1990-12#2)(1990-5#1)(1995-10#1)(1996-5#1)(1997-4#1)
secretory response was##2##3##(1990-9#1)(2012-12#1)
secretory response##22##2##(1990-12#2)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#1)(1993-11#1)(1993-3#3)(1994-12#3)(1995-10#1)(1995-8#1)(1996-5#1)(1997-4#1)(2004-12#1)(2012-12#1)(2012-3#1)
secretory responses##3##2##(1993-3#1)(1997-5#1)(2008-4#1)
secretory small GTPase Rab27B##2##4##(2011-2#2)
secretory spines##2##2##(2007-12#2)
secretory stimulation##2##2##(1992-6#2)
secretory system##3##2##(1996-1#2)(2006-11#1)
secretory tissues##3##2##(2012-2#3)
secretory traffic##2##2##(2009-10#2)
secretory units##2##2##(2007-12#1)(2008-7#1)
secretory vesicles from##2##3##(1992-12#1)(2008-11#1)
secretory vesicles##16##2##(1991-1#3)(1992-12#2)(1992-6#1)(1994-10#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-7#1)(2012-2#1)
secretory##406##1##(1990-12#7)(1990-3#9)(1990-5#6)(1990-6#4)(1990-7#3)(1990-8#2)(1990-9#3)(1991-1#8)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#11)(1991-4#1)(1991-5#5)(1991-6#1)(1991-7#1)(1992-11#2)(1992-12#10)(1992-2#3)(1992-3#1)(1992-4#4)(1992-5#1)(1992-6#6)(1992-9#2)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#6)(1993-5#6)(1993-9#3)(1994-10#1)(1994-11#7)(1994-12#5)(1994-2#1)(1994-5#5)(1994-6#2)(1994-8#1)(1994-9#6)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-6#2)(1995-8#6)(1996-1#2)(1996-11#1)(1996-12#1)(1996-4#6)(1996-5#10)(1996-6#2)(1996-7#1)(1996-8#2)(1997-1#6)(1997-2#1)(1997-3#2)(1997-4#6)(1997-5#1)(1997-6#10)(1997-7#8)(1997-8#1)(2004-11#2)(2004-12#2)(2005-11#1)(2006-1#1)(2006-10#6)(2006-11#2)(2006-12#3)(2006-2#3)(2006-4#2)(2006-6#2)(2006-9#2)(2007-11#3)(2007-12#30)(2007-2#4)(2007-5#3)(2007-9#2)(2008-1#6)(2008-10#5)(2008-11#10)(2008-3#1)(2008-4#7)(2008-5#3)(2008-6#3)(2008-7#19)(2008-8#5)(2008-9#2)(2009-10#7)(2009-7#1)(2009-8#2)(2010-10#4)(2010-11#8)(2010-12#4)(2010-4#2)(2010-9#1)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#8)(2012-3#1)(2013-1#6)(2013-8#2)
secrets of##3##2##(1991-11#1)(1993-1#1)(2008-8#1)
secrets##9##1##(1991-11#1)(1993-1#1)(1995-9#1)(1996-3#1)(2007-9#2)(2008-8#1)(2011-1#1)(2011-2#1)
secs##2##1##(2007-9#2)
sect##4##1##(2013-1#4)
section (CS)##3##2##(2011-1#1)(2011-12#1)(2011-2#1)
section 1115 demonstration waivers##3##4##(1996-1#3)
section 1115 demonstration##4##3##(1996-1#4)
section 1115##6##2##(1996-1#6)
section EM##2##2##(1997-6#1)(2008-8#1)
section Flavi##2##2##(2008-10#2)
section addresses the##2##3##(2008-10#1)(2008-2#1)
section after##3##2##(1993-4#2)(2006-10#1)
section and the##8##3##(2007-12#2)(2008-2#2)(2008-3#1)(2011-2#2)(2012-3#1)
section and##25##2##(1993-10#1)(1993-4#1)(1994-7#1)(1995-5#1)(2004-10#3)(2006-12#1)(2006-2#1)(2007-12#3)(2008-2#3)(2008-3#3)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#3)(2012-3#1)
section are##3##2##(1995-2#1)(2007-8#1)(2008-5#1)
section as##4##2##(1993-7#1)(1995-9#1)(2007-12#1)(2008-5#1)
section at the##3##3##(1993-7#1)(2007-2#1)(2007-5#1)
section at##8##2##(1990-4#1)(1993-7#2)(2007-2#1)(2007-5#1)(2007-7#1)(2013-1#2)
section concludes with##2##3##(2007-7#1)(2008-6#1)
section considers the##2##3##(2008-10#1)(2010-2#1)
section considers##3##2##(2008-10#1)(2010-2#2)
section deals with##4##3##(2008-10#1)(2008-4#3)
section delivery##3##2##(1994-12#1)(1997-1#1)(2006-5#1)
section describes how to##2##4##(2008-4#1)(2010-10#1)
section describes the##2##3##(2006-10#1)(2008-4#1)
section describes##4##2##(2006-10#1)(2008-4#2)(2010-10#1)
section discusses##7##2##(1994-3#1)(2005-11#1)(2007-12#1)(2008-4#2)(2008-9#1)(2011-2#1)
section due to cephalopelvic disproportion##2##5##(1993-7#1)(2007-8#1)
section focuses on##2##3##(2005-7#1)(2007-11#1)
section followed by##3##3##(2008-7#1)(2013-1#2)
section for##12##2##(1990-9#1)(1995-12#1)(1996-9#1)(2005-10#1)(2007-11#2)(2008-2#3)(2008-3#2)(2010-4#1)
section from##3##2##(1993-3#1)(1995-2#1)(2011-2#1)
section had##3##2##(2007-2#1)(2011-12#1)(2013-1#1)
section have##2##2##(2006-10#2)
section in a##4##3##(1993-7#1)(2006-2#1)(2007-12#1)(2008-3#1)
section in an##3##3##(1994-11#1)(2007-11#2)
section in the##3##3##(2007-2#2)(2012-3#1)
section in which##2##3##(1996-11#1)(2008-10#1)
section in##28##2##(1991-12#1)(1991-6#1)(1993-4#2)(1993-7#1)(1994-11#1)(1995-4#1)(1996-11#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-2#4)(2008-10#2)(2008-3#2)(2009-10#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-3#2)
section is organized##2##3##(2007-12#1)(2011-2#1)
section is the##2##3##(2008-3#1)(2011-1#1)
section is##24##2##(1992-8#1)(1993-10#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-12#3)(2007-2#3)(2008-10#1)(2008-2#3)(2008-3#2)(2008-7#1)(2011-1#2)(2011-2#1)
section of a laser##2##4##(2007-12#1)(2008-3#1)
section of a##9##3##(1992-12#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)
section of an##3##3##(2008-2#1)(2013-1#2)
section of the paper##4##4##(2005-6#1)(2006-10#1)(2008-12#1)(2009-4#1)
section of the##44##3##(1992-10#1)(1992-5#1)(1993-12#1)(1993-5#1)(1995-9#1)(1996-4#1)(1996-5#1)(1997-2#2)(1997-3#1)(1997-4#1)(2005-11#2)(2005-6#1)(2005-9#1)(2006-10#2)(2007-1#1)(2007-12#2)(2007-5#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-7#1)(2009-4#1)(2009-5#1)(2010-2#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-2#1)(2013-7#1)
section of##100##2##(1990-2#1)(1991-3#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-5#1)(1994-10#1)(1994-9#1)(1995-9#1)(1996-4#1)(1996-5#1)(1997-2#2)(1997-3#2)(1997-4#1)(2005-11#3)(2005-6#1)(2005-9#1)(2006-10#2)(2007-1#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-3#1)(2007-5#3)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#9)(2008-4#1)(2008-7#6)(2008-8#3)(2009-4#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
section on##19##2##(1990-12#1)(1991-2#1)(1991-9#1)(1992-2#1)(1995-2#1)(1995-9#1)(1997-2#1)(2006-10#2)(2006-9#2)(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-12#1)(2011-2#1)(2012-2#2)
section presents##5##2##(1993-7#1)(1996-5#1)(2008-4#1)(2009-4#1)(2010-5#1)
section rate##8##2##(2004-10#1)(2006-2#1)(2007-2#1)(2008-7#1)(2009-10#2)(2011-12#2)
section reviews the##2##3##(2006-10#1)(2011-2#1)
section scar##2##2##(1992-8#1)(2004-10#1)
section should be##2##3##(1994-2#1)(2006-10#1)
section sign 337##4##3##(2010-7#4)
section summarizes##2##2##(2004-11#1)(2012-2#1)
section that##6##2##(1994-9#1)(2008-1#1)(2008-2#1)(2009-4#1)(2013-1#2)
section thickness##2##2##(2008-3#1)(2008-6#1)
section to##4##2##(2007-11#1)(2008-3#1)(2009-10#1)(2011-2#1)
section using##5##2##(2004-1#1)(2008-10#1)(2008-11#2)(2009-3#1)
section was also##2##3##(1991-12#1)(2006-5#1)
section was performed##4##3##(1992-5#1)(2006-5#1)(2011-1#1)(2012-8#1)
section was##18##2##(1991-12#1)(1992-1#1)(1992-5#1)(1995-4#1)(2006-5#2)(2007-2#1)(2007-5#1)(2007-8#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-8#1)(2013-1#2)
section we##2##2##(1992-6#1)(2007-5#1)
section will be##3##3##(2006-10#3)
section will##4##2##(2006-10#4)
section with##4##2##(2005-11#1)(2008-3#1)(2012-12#1)(2013-1#1)
section within the##2##3##(2010-4#1)(2013-8#1)
section within##3##2##(2009-2#1)(2010-4#1)(2013-8#1)
section##647##1##(1990-12#5)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#3)(1991-2#4)(1991-3#1)(1991-5#1)(1991-6#6)(1991-8#2)(1991-9#7)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-5#2)(1992-6#3)(1992-8#4)(1993-10#4)(1993-12#1)(1993-3#1)(1993-4#13)(1993-5#2)(1993-6#1)(1993-7#8)(1993-9#1)(1994-10#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-6#2)(1994-7#2)(1994-9#3)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-4#7)(1995-5#3)(1995-6#1)(1995-9#5)(1996-1#6)(1996-11#4)(1996-12#3)(1996-4#2)(1996-5#3)(1996-6#2)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#1)(1997-6#1)(1997-8#1)(2004-1#1)(2004-10#9)(2004-11#1)(2005-10#1)(2005-11#5)(2005-6#1)(2005-7#3)(2005-8#3)(2005-9#1)(2006-10#31)(2006-12#3)(2006-2#5)(2006-3#1)(2006-5#5)(2006-8#2)(2006-9#3)(2007-1#2)(2007-11#21)(2007-12#29)(2007-2#18)(2007-3#2)(2007-4#1)(2007-5#8)(2007-7#4)(2007-8#7)(2007-9#2)(2008-1#6)(2008-10#26)(2008-11#8)(2008-12#1)(2008-2#31)(2008-3#35)(2008-4#18)(2008-5#5)(2008-6#2)(2008-7#16)(2008-8#6)(2008-9#6)(2009-1#1)(2009-10#9)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#2)(2009-6#1)(2009-7#3)(2010-10#1)(2010-11#4)(2010-12#1)(2010-2#3)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#5)(2011-1#12)(2011-12#19)(2011-2#28)(2012-1#2)(2012-12#7)(2012-2#12)(2012-3#6)(2012-8#1)(2013-1#24)(2013-7#3)(2013-8#2)
section)##4##1##(1992-3#1)(1994-3#1)(1995-12#1)(1995-3#1)
section]##2##1##(2007-11#1)(2007-9#1)
sectional area##3##2##(2006-8#1)(2007-1#1)(2010-12#1)
sectional study of##4##3##(1997-3#1)(1997-5#1)(2007-7#1)(2008-8#1)
sectional study was conducted on##3##5##(2011-1#1)(2012-1#1)(2013-8#1)
sectional study was conducted##8##4##(2006-8#2)(2007-2#1)(2007-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-8#1)
sectional study was done##2##4##(2006-4#1)(2007-12#1)
sectional study was##12##3##(2006-4#1)(2006-8#2)(2007-12#1)(2007-2#1)(2007-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#2)
sectional study##34##2##(1990-6#1)(1997-3#1)(1997-5#1)(2006-4#3)(2006-8#2)(2007-12#1)(2007-2#1)(2007-7#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-12#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#3)
sectional##58##1##(1990-6#1)(1992-4#1)(1996-4#1)(1997-1#1)(1997-3#2)(1997-5#1)(2006-4#3)(2006-8#3)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-7#3)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#4)
sectioned and##2##2##(2007-3#1)(2011-2#1)
sectioned at##3##2##(1992-12#1)(2009-4#1)(2011-2#1)
sectioned fluorescence lifetime##2##3##(2007-12#2)
sectioned in the##2##3##(2006-12#1)(2009-12#1)
sectioned in##5##2##(2006-11#1)(2006-12#1)(2008-12#1)(2008-9#1)(2009-12#1)
sectioned##30##1##(1990-2#1)(1992-12#1)(1993-12#1)(1997-2#1)(2006-11#2)(2006-12#1)(2006-8#1)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-4#1)(2011-2#3)(2013-1#1)(2013-8#1)
sectioning and##4##2##(1996-12#1)(2006-3#1)(2009-4#1)(2011-2#1)
sectioning in a##3##3##(2007-12#1)(2008-1#1)(2008-4#1)
sectioning in##4##2##(1995-10#1)(2007-12#1)(2008-1#1)(2008-4#1)
sectioning of the##3##3##(2005-10#1)(2006-5#1)(2007-8#1)
sectioning of##10##2##(1990-6#1)(2005-10#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)
sectioning the##2##2##(2006-8#1)(2011-2#1)
sectioning with a##2##3##(2008-4#2)
sectioning##49##1##(1990-6#2)(1990-8#1)(1995-10#1)(1996-12#1)(1997-8#2)(2005-10#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-1#3)(2008-11#3)(2008-3#4)(2008-4#7)(2008-7#1)(2008-9#2)(2009-4#1)(2010-7#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
sections and a##2##3##(2007-12#1)(2012-1#1)
sections and stained with##2##4##(2007-8#1)(2013-8#1)
sections and##27##2##(1990-10#1)(1990-12#1)(1991-11#1)(1991-2#1)(1995-3#1)(1996-12#1)(1997-1#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-8#1)
sections are##8##2##(1995-4#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2010-12#1)
sections at##8##2##(1992-11#1)(1992-9#2)(1994-3#1)(1997-2#1)(2008-3#1)(2008-4#1)(2009-10#1)
sections by##3##2##(1996-12#1)(2008-11#1)(2008-4#1)
sections can be##2##3##(2008-11#1)(2011-2#1)
sections can##3##2##(2008-11#1)(2008-7#1)(2011-2#1)
sections confirmed the##2##3##(2008-4#1)(2012-1#1)
sections confirmed##3##2##(2008-10#1)(2008-4#1)(2012-1#1)
sections distributed##2##2##(1997-3#1)(2010-8#1)
sections for analysis##3##3##(2008-3#1)(2012-11#2)
sections for##14##2##(1992-12#1)(1994-5#1)(2007-5#1)(2008-1#1)(2008-2#5)(2008-3#1)(2008-4#1)(2012-11#2)(2012-3#1)
sections from 28##2##3##(1990-12#1)(1993-9#1)
sections from the##2##3##(1993-11#1)(2008-6#1)
sections from##20##2##(1990-12#3)(1991-9#1)(1992-6#1)(1993-11#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-7#1)(1997-8#1)(2006-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2013-8#2)
sections have##3##2##(1995-7#1)(2008-2#1)(2008-3#1)
sections in the##3##3##(1992-3#1)(1995-11#1)(2010-3#1)
sections in##11##2##(1990-10#1)(1992-10#1)(1992-3#1)(1993-12#1)(1995-11#1)(1996-11#1)(2008-2#1)(2010-3#1)(2010-8#1)(2011-12#1)(2012-1#1)
sections is##3##2##(2008-1#1)(2008-4#1)(2013-8#1)
sections obtained from##2##3##(1997-6#1)(2008-7#1)
sections of a##7##3##(2005-11#1)(2007-8#1)(2008-2#2)(2008-3#1)(2012-3#1)(2013-8#1)
sections of brain##2##3##(1994-11#1)(2010-11#1)
sections of formalin-fixed##5##3##(1994-9#1)(1997-3#1)(1997-7#1)(2012-12#2)
sections of human##2##3##(1993-9#1)(2008-10#1)
sections of mouse##2##3##(1992-11#1)(1996-2#1)
sections of normal human skin##2##5##(2008-4#1)(2010-3#1)
sections of rat##3##3##(1991-5#1)(1992-8#1)(1996-5#1)
sections of the fibers##2##4##(2005-11#1)(2008-3#1)
sections of the tissue##2##4##(2008-2#2)
sections of the tumor##2##4##(1992-9#1)(2010-12#1)
sections of the##39##3##(1990-11#1)(1992-9#1)(1993-12#1)(1993-7#2)(1994-7#1)(1995-12#1)(1996-2#1)(1996-4#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#1)(2009-2#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#1)
sections of tissue##3##3##(2008-11#2)(2008-4#1)
sections of##136##2##(1990-11#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-7#2)(1993-9#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-9#2)(1995-10#1)(1995-12#2)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-7#2)(1997-8#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#10)(2008-3#7)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-7#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#5)(2012-2#4)(2012-3#1)(2013-8#2)
sections on the##2##3##(1996-1#1)(2012-3#1)
sections on##6##2##(1996-1#1)(2005-9#1)(2006-9#1)(2008-1#1)(2008-3#1)(2012-3#1)
sections or##2##2##(2008-2#1)(2008-7#1)
sections performed##2##2##(1993-4#1)(2006-10#1)
sections prepared from##2##3##(2008-1#1)(2008-10#1)
sections remain##2##2##(1992-9#1)(2007-8#1)
sections revealed that##3##3##(1990-3#1)(1996-2#1)(2008-10#1)
sections revealed##7##2##(1990-3#1)(1996-2#1)(1997-2#1)(2006-8#1)(2008-10#1)(2008-5#1)(2011-12#1)
sections show##2##2##(1990-5#1)(2007-12#1)
sections showed that##2##3##(1994-10#1)(2008-5#1)
sections showed##6##2##(1994-10#1)(1997-5#1)(1997-6#1)(2008-5#2)(2010-11#1)
sections stained with##3##3##(1997-8#1)(2009-2#1)(2013-1#1)
sections stained##5##2##(1992-12#1)(1997-8#1)(2008-5#1)(2009-2#1)(2013-1#1)
sections than##2##2##(2008-2#1)(2008-5#1)
sections that##5##2##(1995-6#1)(2007-11#1)(2008-3#2)(2010-12#1)
sections the##3##2##(1996-10#1)(2008-3#1)(2008-9#1)
sections through the##2##3##(1994-4#1)(1997-2#1)
sections through##4##2##(1990-11#1)(1994-4#1)(1997-2#1)(2005-11#1)
sections to##9##2##(1992-12#1)(1993-11#1)(1994-9#1)(1996-2#1)(1997-2#1)(2008-2#1)(2008-4#2)(2009-2#1)
sections up to##2##3##(2008-3#1)(2008-5#1)
sections using an##3##3##(1991-6#1)(1996-1#1)(1996-5#1)
sections using the##2##3##(1991-5#1)(2008-11#1)
sections using##8##2##(1991-5#1)(1991-6#1)(1996-1#1)(1996-5#2)(2008-11#1)(2008-6#1)(2009-12#1)
sections was##6##2##(1994-9#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)
sections were analyzed##3##3##(2006-9#1)(2008-10#1)(2009-2#1)
sections were cut##2##3##(1997-2#1)(2012-3#1)
sections were examined##3##3##(1997-2#1)(2008-5#2)
sections were obtained##5##3##(2007-4#1)(2008-2#1)(2012-3#2)(2013-8#1)
sections were stained with##4##4##(1994-2#1)(2007-8#1)(2007-9#1)(2009-2#1)
sections were stained##6##3##(1994-2#1)(2007-2#1)(2007-8#1)(2007-9#2)(2009-2#1)
sections were##39##2##(1991-5#1)(1993-12#2)(1993-7#1)(1994-2#1)(1994-9#1)(1995-2#1)(1996-12#2)(1997-2#3)(2004-9#1)(2006-12#1)(2006-9#1)(2007-2#2)(2007-4#1)(2007-8#1)(2007-9#2)(2008-10#2)(2008-2#2)(2008-5#3)(2008-8#1)(2009-2#2)(2011-2#2)(2012-3#4)(2013-8#2)
sections with the##4##3##(1990-7#1)(1994-3#1)(2008-3#2)
sections with##9##2##(1990-7#2)(1994-3#2)(2007-7#1)(2008-3#2)(2009-2#1)(2010-8#1)
sections##549##1##(1990-10#4)(1990-11#2)(1990-12#5)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#3)(1991-11#1)(1991-2#4)(1991-3#1)(1991-5#3)(1991-6#1)(1991-9#3)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#3)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#4)(1993-11#2)(1993-12#5)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#5)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#1)(1994-2#5)(1994-3#4)(1994-4#1)(1994-5#1)(1994-7#2)(1994-9#6)(1995-10#2)(1995-11#3)(1995-12#3)(1995-2#2)(1995-3#2)(1995-4#4)(1995-6#5)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#3)(1996-12#11)(1996-2#5)(1996-3#5)(1996-4#1)(1996-5#3)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#7)(1997-3#2)(1997-5#1)(1997-6#4)(1997-7#4)(1997-8#5)(2004-11#1)(2004-9#2)(2005-10#1)(2005-11#5)(2005-12#1)(2005-7#1)(2005-8#2)(2005-9#2)(2006-10#7)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#11)(2007-12#11)(2007-2#3)(2007-3#3)(2007-4#1)(2007-5#4)(2007-7#3)(2007-8#8)(2007-9#5)(2008-1#7)(2008-10#26)(2008-11#14)(2008-12#3)(2008-2#35)(2008-3#31)(2008-4#24)(2008-5#22)(2008-6#3)(2008-7#11)(2008-8#3)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#8)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#4)(2010-12#8)(2010-2#1)(2010-3#3)(2010-4#4)(2010-6#1)(2010-7#1)(2010-8#7)(2011-1#6)(2011-12#3)(2011-2#14)(2012-1#5)(2012-11#3)(2012-12#6)(2012-2#6)(2012-3#11)(2013-1#2)(2013-8#8)
sections)##2##1##(2005-12#1)(2013-8#1)
sector &quot##2##2##(1995-1#1)(2013-7#1)
sector (which has##3##3##(2006-10#3)
sector and the##3##3##(1992-2#1)(1997-3#1)(2007-11#1)
sector and##18##2##(1990-2#1)(1992-2#1)(1995-2#1)(1995-3#1)(1997-3#2)(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-3#1)(2012-1#1)(2013-1#2)
sector angles of Anada##2##4##(2007-7#2)
sector angles##3##2##(2007-7#3)
sector are##4##2##(1991-12#1)(1994-9#1)(1996-3#1)(2008-11#1)
sector employment##4##2##(1994-12#1)(1996-1#1)(1996-2#2)
sector has##4##2##(1994-3#1)(1995-3#1)(1997-3#1)(2013-8#1)
sector in the##6##3##(2006-4#1)(2007-5#1)(2008-8#2)(2010-10#1)(2013-7#1)
sector in##17##2##(1990-10#1)(1993-3#1)(1994-5#1)(2006-4#1)(2007-5#1)(2007-7#1)(2008-12#2)(2008-2#1)(2008-8#2)(2010-1#1)(2010-10#1)(2012-12#1)(2012-3#2)(2013-7#1)
sector is##7##2##(1994-2#1)(1997-2#1)(2007-2#1)(2011-2#4)
sector management##2##2##(1995-3#1)(2011-1#1)
sector must##2##2##(1993-6#1)(2008-2#1)
sector of the##4##3##(1994-9#1)(1995-8#1)(1996-3#2)
sector of##11##2##(1994-9#2)(1995-11#1)(1995-2#1)(1995-8#1)(1996-3#2)(2008-1#1)(2008-5#2)(2010-9#1)
sector reform and##2##3##(1997-1#1)(2008-4#1)
sector reform in##5##3##(2008-4#4)(2008-8#1)
sector reform##7##2##(1997-1#1)(2008-4#5)(2008-8#1)
sector resection##2##2##(1996-3#2)
sector should##4##2##(2008-11#1)(2008-2#1)(2010-11#1)(2011-2#1)
sector that##2##2##(1995-3#1)(2007-4#1)
sector to##3##2##(2008-12#1)(2008-7#1)(2010-8#1)
sector will##2##2##(1997-3#1)(2006-2#1)
sector##305##1##(1990-10#1)(1990-12#3)(1990-2#6)(1990-8#1)(1991-1#2)(1991-12#2)(1991-2#1)(1991-6#1)(1992-1#2)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#1)(1992-9#1)(1993-1#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-7#1)(1993-9#2)(1994-1#2)(1994-12#2)(1994-2#6)(1994-3#3)(1994-5#1)(1994-6#1)(1994-9#5)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#9)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#6)(1996-2#7)(1996-3#5)(1997-1#6)(1997-2#7)(1997-3#5)(1997-4#1)(1997-5#5)(2005-11#1)(2005-4#1)(2005-5#4)(2005-7#1)(2005-9#2)(2006-10#9)(2006-12#1)(2006-2#2)(2006-4#2)(2006-5#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#7)(2007-8#1)(2008-1#7)(2008-10#10)(2008-11#7)(2008-12#7)(2008-2#5)(2008-4#6)(2008-5#4)(2008-6#4)(2008-7#7)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#3)(2009-4#2)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#9)(2011-7#1)(2012-1#2)(2012-12#3)(2012-2#7)(2012-3#9)(2013-1#9)(2013-7#4)(2013-8#3)
sector's##3##1##(1991-12#1)(1991-6#1)(1993-6#1)
sector-field##2##1##(2008-10#2)
sectors and##5##2##(1991-2#1)(2008-12#1)(2008-5#2)(2010-8#1)
sectors in##6##2##(1993-2#1)(1994-1#1)(2005-5#1)(2008-1#1)(2008-2#1)(2010-12#1)
sectors is##3##2##(1995-2#1)(2007-9#1)(2008-11#1)
sectors of the##8##3##(1992-4#1)(1996-5#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-2#1)(2009-4#1)
sectors of##19##2##(1990-12#1)(1991-3#1)(1992-4#1)(1993-2#2)(1993-9#1)(1994-9#1)(1996-5#1)(2007-12#1)(2007-6#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-2#1)(2009-4#2)(2010-4#1)(2012-2#2)
sectors that##3##2##(2005-5#1)(2005-7#1)(2008-12#1)
sectors to##7##2##(1996-2#2)(1997-3#1)(2006-10#1)(2008-11#1)(2008-7#1)(2012-12#1)
sectors was##3##2##(2005-9#1)(2008-10#1)(2009-7#1)
sectors within health care##2##4##(2008-11#2)
sectors##104##1##(1990-12#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#2)(1992-12#1)(1992-3#2)(1992-4#1)(1993-2#4)(1993-9#2)(1994-1#2)(1994-9#2)(1995-12#1)(1995-2#1)(1996-2#4)(1996-5#1)(1997-3#1)(2004-4#1)(2005-5#3)(2005-7#1)(2005-9#1)(2006-10#2)(2006-2#1)(2007-10#2)(2007-12#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#4)
secular changes in##2##3##(2005-11#1)(2013-1#1)
secular changes##3##2##(2005-11#1)(2008-11#1)(2013-1#1)
secular giving##2##2##(2009-10#2)
secular trend##6##2##(2006-10#4)(2011-2#1)(2012-12#1)
secular trends in##2##3##(2008-11#1)(2013-1#1)
secular trends##3##2##(2007-10#1)(2008-11#1)(2013-1#1)
secular##26##1##(1993-2#1)(2005-11#1)(2006-10#5)(2006-12#1)(2006-4#1)(2007-10#1)(2008-11#2)(2008-12#1)(2008-8#2)(2009-10#2)(2009-7#1)(2011-2#2)(2012-1#2)(2012-12#1)(2013-1#3)
secularization##4##1##(2007-10#1)(2007-12#1)(2008-9#1)(2009-10#1)
secundum atrial septal defect##6##4##(2007-8#3)(2008-11#1)(2008-4#1)(2009-3#1)
secundum atrial septal defects##2##4##(2008-4#1)(2009-10#1)
secundum atrial septal##8##3##(2007-8#3)(2008-11#1)(2008-4#2)(2009-10#1)(2009-3#1)
secundum##10##1##(1996-6#1)(2007-8#4)(2008-11#1)(2008-4#2)(2009-10#1)(2009-3#1)
secure against##2##2##(2007-11#1)(2007-12#1)
secure and efficient##2##3##(2010-5#1)(2010-8#1)
secure and##5##2##(2007-7#1)(2008-7#1)(2010-5#2)(2010-8#1)
secure as##2##2##(2008-2#1)(2013-1#1)
secure attachment##2##2##(2008-12#1)(2012-1#1)
secure communication scheme##2##3##(2007-12#2)
secure data##3##2##(1995-12#1)(2007-12#1)(2008-3#1)
secure manner##2##2##(2007-12#1)(2008-7#1)
secure the##8##2##(1996-12#1)(2008-10#1)(2009-3#1)(2009-8#1)(2012-12#1)(2012-3#1)(2013-1#2)
secure##96##1##(1990-8#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-3#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-9#1)(1997-2#1)(1997-5#1)(2005-11#1)(2006-12#2)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#6)(2007-12#11)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#4)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-5#3)(2010-8#3)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)
secured a##3##2##(1994-2#1)(2007-11#1)(2008-11#1)
secured by##4##2##(1995-5#1)(2004-11#1)(2005-8#1)(2009-9#1)
secured in##3##2##(2005-5#1)(2006-6#1)(2010-4#1)
secured interrupted stitch##2##3##(1991-2#2)
secured stitch##2##2##(1991-2#2)
secured to the##2##3##(2008-9#1)(2013-1#1)
secured with##2##2##(2008-9#1)(2011-1#1)
secured##31##1##(1990-4#1)(1991-2#4)(1993-8#1)(1994-2#1)(1995-5#1)(1997-4#1)(1997-7#1)(2004-11#1)(2005-5#1)(2005-8#1)(2006-6#5)(2007-11#1)(2007-7#1)(2008-11#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-9#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
securely##4##1##(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)
secures##2##1##(2006-6#1)(2008-2#1)
securing a##4##2##(1991-3#1)(2007-8#1)(2007-9#1)(2008-7#1)
securing an##2##2##(1991-5#1)(2006-6#1)
securing the##7##2##(1997-4#1)(2008-4#1)(2008-7#1)(2009-3#1)(2010-7#1)(2010-8#1)(2011-2#1)
securing##31##1##(1991-3#1)(1991-5#1)(1993-9#1)(1995-3#1)(1997-4#1)(1997-8#1)(2006-6#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
securities##2##1##(2011-2#2)
security OR 0##2##3##(2012-3#2)
security and privacy##3##3##(2010-8#1)(2013-1#2)
security and reliability##2##3##(2008-7#2)
security and safety##2##3##(1991-3#1)(1993-2#1)
security and##29##2##(1991-3#1)(1992-2#2)(1993-12#1)(1993-2#1)(1995-2#1)(1996-2#1)(2006-4#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-4#1)(2010-12#1)(2010-8#3)(2010-9#2)(2011-1#2)(2012-3#1)(2013-1#2)
security as##2##2##(1992-12#1)(1995-2#1)
security at##2##2##(1993-12#1)(2007-8#1)
security awareness##2##2##(1992-12#1)(1995-2#1)
security but##2##2##(2008-10#1)(2010-7#1)
security checkpoints##2##2##(2008-10#2)
security concerns##4##2##(1991-9#1)(1996-12#1)(2007-12#1)(2007-8#1)
security department##10##2##(1993-12#2)(1993-2#2)(1994-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-2#2)
security director##2##2##(1996-2#1)(1997-2#1)
security directors##6##2##(1991-3#1)(1992-12#2)(1992-2#2)(1997-2#1)
security guards##3##2##(1995-6#2)(1996-12#1)
security in the##5##3##(1995-2#1)(1996-2#1)(2007-11#1)(2008-10#1)(2011-2#1)
security in##14##2##(1991-12#1)(1994-2#1)(1995-2#1)(1996-2#1)(2006-4#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-2#3)(2010-8#2)(2011-2#1)
security initiative##2##2##(1995-2#1)(2008-10#1)
security issues##2##2##(2006-6#1)(2006-8#1)
security management##4##2##(1992-12#1)(1993-2#2)(1994-2#1)
security manager##2##2##(1996-12#1)(1997-2#1)
security measure##2##2##(2007-4#1)(2007-8#1)
security measures##3##2##(1997-3#1)(2007-11#1)(2010-8#1)
security must be##2##3##(1991-1#1)(1992-12#1)
security needs##2##2##(1992-12#1)(1992-2#1)
security of Electronic Health##2##4##(2010-8#2)
security of the##7##3##(1991-6#1)(1992-2#1)(1993-3#1)(1994-3#1)(1997-2#1)(2008-2#1)(2011-2#1)
security of##22##2##(1991-6#1)(1992-2#1)(1993-3#1)(1994-12#1)(1994-3#2)(1995-12#1)(1996-12#1)(1997-2#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-2#2)(2010-3#1)(2010-7#1)(2010-8#3)(2011-2#1)(2012-3#1)
security officer##6##2##(1992-2#1)(1993-2#2)(1996-2#1)(2006-8#2)
security officers##11##2##(1991-1#1)(1992-12#1)(1992-2#2)(1993-2#2)(1995-5#1)(1996-12#2)(1996-2#1)(1997-2#1)
security or##2##2##(1993-12#1)(2008-4#1)
security personnel##3##2##(1991-12#1)(1991-3#1)(2007-10#1)
security plan##3##2##(1995-12#1)(1997-2#1)(2008-9#1)
security practices##4##2##(1991-12#1)(1992-2#1)(2013-1#2)
security problems##4##2##(1993-12#1)(1996-2#2)(2007-12#1)
security professionals##2##2##(1996-2#1)(1997-2#1)
security program##8##2##(1991-1#4)(1992-12#1)(1994-12#1)(1994-2#1)(1995-2#1)
security requirements are##2##3##(1994-6#1)(2010-8#1)
security requirements of##2##3##(2007-12#1)(2010-8#1)
security requirements##6##2##(1994-6#1)(2007-12#1)(2010-8#4)
security rule##7##2##(2006-7#1)(2006-8#3)(2007-12#1)(2008-4#1)(2008-9#1)
security setting##2##2##(1992-12#1)(1993-2#1)
security status##2##2##(2007-11#1)(2008-1#1)
security survey##3##2##(1991-3#1)(1995-2#1)(1996-2#1)
security system##4##2##(1993-12#1)(1993-8#1)(2008-3#2)
security systems##2##2##(2006-9#1)(2008-3#1)
security training program##2##3##(1991-12#2)
security training##3##2##(1991-12#2)(1992-12#1)
security##356##1##(1990-9#1)(1991-1#10)(1991-12#5)(1991-3#7)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#18)(1992-2#17)(1993-12#10)(1993-2#18)(1993-3#2)(1993-8#1)(1994-1#1)(1994-12#8)(1994-2#6)(1994-3#3)(1994-6#2)(1995-12#4)(1995-2#13)(1995-5#5)(1995-6#2)(1996-12#12)(1996-2#15)(1996-9#1)(1997-2#20)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(2005-8#2)(2006-2#1)(2006-4#2)(2006-6#4)(2006-7#1)(2006-8#6)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#10)(2007-2#1)(2007-4#7)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#6)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#11)(2008-3#6)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#8)(2009-10#1)(2009-11#1)(2009-2#2)(2009-4#2)(2009-6#2)(2009-9#1)(2010-12#1)(2010-3#1)(2010-7#3)(2010-8#20)(2010-9#2)(2011-1#6)(2011-2#4)(2012-12#5)(2012-3#5)(2013-1#6)(2013-8#1)
security'##2##1##(2010-10#1)(2010-9#1)
security-related incidents##2##2##(1995-12#1)(1996-2#1)
security]##2##1##(2008-9#1)(2010-6#1)
sedated and##2##2##(2007-8#1)(2012-2#1)
sedated##11##1##(1992-8#1)(2006-2#1)(2007-11#2)(2007-2#1)(2007-8#1)(2008-4#1)(2008-5#1)(2010-7#1)(2012-2#2)
sedating##4##1##(1992-12#1)(2007-11#1)(2012-2#2)
sedation and analgesia##9##3##(2006-10#2)(2008-8#4)(2009-6#2)(2011-2#1)
sedation and anesthesia##2##3##(2006-10#2)
sedation and motor impairment##3##4##(1992-3#1)(1992-8#2)
sedation and##30##2##(1992-3#1)(1992-8#2)(2006-10#8)(2006-3#1)(2006-4#2)(2007-2#1)(2007-7#1)(2008-7#1)(2008-8#4)(2009-6#3)(2010-4#1)(2011-12#1)(2011-2#2)(2012-2#2)
sedation are##2##2##(2007-9#1)(2009-4#1)
sedation during##2##2##(2013-1#1)(2013-8#1)
sedation for##7##2##(1995-1#1)(1996-3#1)(2006-10#1)(2007-2#1)(2008-5#1)(2009-6#1)(2011-12#1)
sedation in a##2##3##(1993-1#1)(2008-7#1)
sedation in adults##2##3##(1992-8#1)(2006-10#1)
sedation in the##5##3##(2006-10#2)(2006-4#1)(2008-8#1)(2010-12#1)
sedation in##18##2##(1990-3#1)(1990-4#1)(1990-6#1)(1992-8#1)(1993-1#1)(1996-12#1)(2006-10#3)(2006-4#1)(2007-2#1)(2007-9#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-12#2)(2011-12#1)
sedation is##4##2##(2006-10#1)(2006-6#1)(2007-9#1)(2011-2#1)
sedation management##2##2##(2007-11#2)
sedation of##2##2##(1992-8#1)(1993-10#1)
sedation on##2##2##(2006-8#1)(2008-8#1)
sedation or anesthesia##2##3##(2006-10#2)
sedation or general anaesthesia##2##4##(2006-10#1)(2013-1#1)
sedation or general anesthesia##2##4##(1993-1#1)(2007-5#1)
sedation or general##4##3##(1993-1#1)(2006-10#1)(2007-5#1)(2013-1#1)
sedation or##10##2##(1993-1#1)(1995-3#1)(2006-10#3)(2007-5#1)(2008-5#1)(2008-6#1)(2013-1#1)(2013-7#1)
sedation protocol##4##2##(2007-11#4)
sedation score##8##2##(2008-8#1)(2012-12#1)(2012-2#5)(2013-7#1)
sedation to##2##2##(2006-10#1)(2006-4#1)
sedation until death##2##3##(2012-11#2)
sedation using##3##2##(2006-10#1)(2008-4#1)(2011-12#1)
sedation was provided for##2##4##(1993-1#1)(2007-2#1)
sedation was##3##2##(1993-1#1)(2007-2#1)(2008-8#1)
sedation were##2##2##(2010-7#1)(2013-8#1)
sedation when##3##2##(1996-8#1)(2011-1#1)(2013-8#1)
sedation with##5##2##(1993-1#1)(1995-11#1)(2006-4#1)(2011-12#2)
sedation##180##1##(1990-3#1)(1990-4#1)(1990-6#1)(1992-3#1)(1992-8#4)(1993-1#7)(1993-10#1)(1993-11#1)(1993-2#1)(1995-1#3)(1995-11#1)(1995-3#3)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-7#1)(2005-8#2)(2006-10#31)(2006-3#1)(2006-4#7)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#8)(2007-12#2)(2007-2#6)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-9#4)(2008-12#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#12)(2009-4#1)(2009-6#6)(2010-12#3)(2010-3#2)(2010-4#1)(2010-7#6)(2011-1#1)(2011-12#8)(2011-2#4)(2012-11#2)(2012-12#1)(2012-2#9)(2013-1#2)(2013-7#3)(2013-8#7)
sedation/analgesia##2##1##(2008-4#2)
sedative agents##2##2##(2010-3#1)(2010-4#1)
sedative and analgesic##2##3##(2008-8#1)(2010-7#1)
sedative and hypnotic##2##3##(2008-6#1)(2011-2#1)
sedative and##5##2##(2006-8#1)(2008-6#1)(2008-8#1)(2010-7#1)(2011-2#1)
sedative doses##2##2##(2006-10#1)(2013-8#1)
sedative properties##3##2##(2007-9#1)(2008-6#1)(2013-7#1)
sedative##40##1##(1991-1#1)(1991-4#1)(1993-8#1)(1996-1#1)(1996-10#1)(1996-3#1)(2005-9#1)(2006-10#8)(2006-4#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-6#3)(2008-8#2)(2008-9#1)(2010-3#1)(2010-4#1)(2010-7#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
sedative-analgesic##3##1##(2012-2#3)
sedatives and##2##2##(1993-8#1)(2006-10#1)
sedatives##14##1##(1992-5#1)(1993-8#1)(1994-3#2)(1996-12#1)(2006-10#4)(2009-6#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-2#1)
sedentariness##2##1##(2008-3#1)(2012-2#1)
sedentary and##2##2##(2008-9#1)(2012-12#1)
sedentary behavior and health indicators##2##5##(2013-1#2)
sedentary behavior and##5##3##(2013-1#5)
sedentary behavior##13##2##(2012-2#1)(2013-1#12)
sedentary behaviors##2##2##(2012-12#1)(2013-1#1)
sedentary behaviour##3##2##(2008-3#3)
sedentary habits##2##2##(2008-3#2)
sedentary life style##2##3##(2006-1#1)(2008-7#1)
sedentary life##3##2##(2006-1#1)(2008-7#1)(2010-4#1)
sedentary lifestyle and##2##3##(2009-3#1)(2011-1#1)
sedentary lifestyle##9##2##(2008-1#1)(2008-3#1)(2009-3#1)(2010-12#1)(2011-1#4)(2013-1#1)
sedentary lifestyles##3##2##(2007-7#1)(2008-1#1)(2008-3#1)
sedentary men##2##2##(1990-12#2)
sedentary older##2##2##(2012-12#1)(2013-8#1)
sedentary species##3##2##(2008-3#2)(2008-9#1)
sedentary subjects##2##2##(2006-9#1)(2008-5#1)
sedentary time##2##2##(2013-1#2)
sedentary women##2##2##(2010-2#2)
sedentary##91##1##(1990-12#2)(1991-8#1)(1992-3#2)(1993-11#2)(1996-2#1)(2004-12#1)(2006-1#2)(2006-10#1)(2006-9#2)(2007-7#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#12)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#2)(2009-11#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#1)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#23)(2013-8#4)
sediment BCR-CRM##2##2##(2008-10#2)
sediment and##8##2##(2008-10#5)(2008-11#1)(2008-5#1)(2013-8#1)
sediment are##2##2##(2008-10#1)(2008-5#1)
sediment certified reference material##2##4##(2008-10#2)
sediment certified reference##4##3##(2008-10#4)
sediment certified##5##2##(2008-10#5)
sediment core##2##2##(2008-10#1)(2013-7#1)
sediment cores##3##2##(1992-3#1)(2013-8#2)
sediment extracts##4##2##(2008-10#4)
sediment from##2##2##(2008-10#1)(2009-11#1)
sediment in the##4##3##(1997-4#1)(2008-10#2)(2010-7#1)
sediment in##6##2##(1997-4#1)(2008-1#1)(2008-10#2)(2010-7#1)(2013-8#1)
sediment material##2##2##(2008-10#2)
sediment movement##2##2##(2007-8#2)
sediment organic carbon##2##3##(1996-3#2)
sediment plume##2##2##(2007-5#2)
sediment pore waters##3##3##(2008-10#3)
sediment pore##4##2##(2008-10#4)
sediment quality guidelines##3##3##(2007-5#1)(2012-1#2)
sediment quality##4##2##(2007-5#1)(2012-1#3)
sediment reference##4##2##(2008-10#4)
sediment samples collected from##4##4##(2007-5#2)(2008-10#2)
sediment samples from##4##3##(2007-5#2)(2008-10#2)
sediment samples has been##2##4##(2008-10#2)
sediment samples of##2##3##(2007-10#1)(2008-5#1)
sediment samples using##2##3##(2008-10#2)
sediment samples were collected##2##4##(2007-5#1)(2008-10#1)
sediment samples were##4##3##(2007-5#1)(2008-10#3)
sediment samples with##2##3##(2008-10#2)
sediment samples##40##2##(2006-3#1)(2007-10#3)(2007-5#6)(2008-10#26)(2008-5#3)(2013-8#1)
sediment slurries##3##2##(2008-10#2)(2008-11#1)
sediment slurry samples by##2##4##(2008-10#2)
sediment using##4##2##(1997-7#1)(2004-4#1)(2008-10#2)
sediment was##3##2##(1991-3#1)(2008-5#1)(2008-6#1)
sediment were##2##2##(1996-12#1)(2008-11#1)
sediment with##2##2##(2008-10#2)
sediment##199##1##(1991-3#1)(1992-3#3)(1992-6#1)(1993-4#1)(1996-12#1)(1996-3#2)(1997-4#1)(1997-7#2)(2004-4#4)(2006-3#1)(2006-6#7)(2007-10#3)(2007-3#2)(2007-5#17)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#100)(2008-11#3)(2008-3#2)(2008-5#15)(2008-6#2)(2008-9#2)(2009-11#2)(2009-6#1)(2009-8#1)(2010-7#2)(2011-2#2)(2012-1#5)(2013-1#3)(2013-7#2)(2013-8#5)
sediment)##2##1##(2004-4#1)(2008-5#1)
sedimentability##2##1##(1990-7#2)
sedimentary##11##1##(1991-3#1)(1992-3#1)(1997-5#1)(2005-11#1)(2007-5#1)(2007-7#2)(2008-10#2)(2010-7#1)(2013-7#1)
sedimentation analysis##2##2##(1990-12#1)(1992-11#1)
sedimentation and diffusion coefficients##3##4##(2006-10#3)
sedimentation and##14##2##(1990-12#1)(1990-8#1)(1990-9#1)(1993-8#1)(1994-6#1)(1995-8#1)(2006-10#3)(2008-1#1)(2008-5#3)(2011-2#1)
sedimentation behavior of the##2##4##(1990-11#2)
sedimentation behavior##3##2##(1990-11#2)(1990-8#1)
sedimentation coefficient of##2##3##(1990-11#1)(1992-12#1)
sedimentation coefficient##6##2##(1990-11#1)(1990-7#1)(1990-8#1)(1992-12#1)(1993-11#1)(1995-8#1)
sedimentation coefficients##3##2##(1992-11#1)(2009-2#2)
sedimentation equilibrium##8##2##(1991-4#1)(1993-3#2)(1995-11#2)(1995-6#1)(1996-7#1)(2008-10#1)
sedimentation gradient##3##2##(1993-8#1)(1994-8#1)(2007-3#1)
sedimentation in##2##2##(1997-6#1)(2008-1#1)
sedimentation levels##4##2##(2008-7#3)(2011-2#1)
sedimentation methods##3##2##(1996-12#1)(2007-2#2)
sedimentation of the##2##3##(1990-12#1)(1990-7#1)
sedimentation of##6##2##(1990-12#2)(1990-7#1)(2008-1#2)(2009-8#1)
sedimentation rate and##9##3##(1990-9#1)(1993-11#2)(2006-10#3)(2007-1#1)(2008-10#1)(2013-1#1)
sedimentation rate was##2##3##(1990-11#1)(2012-12#1)
sedimentation rate##47##2##(1990-11#1)(1990-12#1)(1990-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#4)(1993-2#1)(1993-7#1)(1993-8#1)(1995-7#1)(1997-6#1)(1997-8#2)(2005-10#1)(2006-10#6)(2006-6#1)(2006-7#2)(2007-1#2)(2007-7#2)(2007-9#2)(2008-1#1)(2008-10#3)(2008-5#2)(2010-5#1)(2011-1#2)(2012-12#1)(2013-1#3)
sedimentation rates##4##2##(1990-9#1)(2007-3#1)(2007-5#2)
sedimentation technique##2##2##(2011-1#1)(2011-2#1)
sedimentation velocity at pH 7##2##5##(1990-8#1)(1997-2#1)
sedimentation velocity experiments##4##3##(2006-10#2)(2008-4#2)
sedimentation velocity##10##2##(1990-8#1)(1992-11#1)(1997-2#2)(2006-10#3)(2008-4#3)
sedimentation##158##1##(1990-11#4)(1990-12#7)(1990-7#3)(1990-8#4)(1990-9#3)(1991-4#2)(1992-11#5)(1992-12#2)(1992-3#1)(1992-6#1)(1993-11#5)(1993-2#1)(1993-3#2)(1993-7#1)(1993-8#3)(1994-5#1)(1994-6#1)(1994-8#2)(1995-10#2)(1995-11#2)(1995-3#1)(1995-4#1)(1995-6#2)(1995-7#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-7#1)(1997-2#2)(1997-6#2)(1997-8#2)(2005-10#1)(2006-10#12)(2006-6#1)(2006-7#2)(2007-1#2)(2007-12#1)(2007-2#2)(2007-3#3)(2007-5#4)(2007-7#2)(2007-9#3)(2008-1#5)(2008-10#8)(2008-4#6)(2008-5#6)(2008-7#6)(2009-2#5)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-5#1)(2011-1#3)(2011-2#7)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
sedimented at##2##2##(1990-5#1)(1990-7#1)
sedimented by##2##2##(1990-12#1)(1990-7#1)
sedimented on##2##2##(1992-12#1)(2008-11#1)
sedimented##11##1##(1990-12#1)(1990-5#1)(1990-7#3)(1991-8#1)(1992-12#1)(2008-10#2)(2008-11#1)(2008-4#1)
sedimenting##3##1##(1996-1#1)(2008-4#1)(2008-9#1)
sediments after##2##2##(2008-10#2)
sediments and fish##2##3##(2008-10#2)
sediments and organisms##2##3##(2008-10#1)(2008-5#1)
sediments and sludges using electrothermal atomic absorption spectrometry##2##8##(2008-10#2)
sediments and soil##2##3##(2008-10#1)(2008-5#1)
sediments and soils##2##3##(2008-10#1)(2008-5#1)
sediments and the##2##3##(2007-5#1)(2007-9#1)
sediments and##18##2##(2007-5#2)(2007-9#1)(2008-10#9)(2008-5#5)(2009-8#1)
sediments are##8##2##(2004-4#1)(2007-7#1)(2007-8#1)(2008-10#4)(2013-8#1)
sediments as##2##2##(1995-3#1)(2008-5#1)
sediments at##2##2##(2007-5#1)(2008-10#1)
sediments by##5##2##(2008-10#5)
sediments collected in##2##3##(2008-10#2)
sediments during##2##2##(2008-10#2)
sediments from more##2##3##(2007-5#2)
sediments from the Gulf of Paria##2##6##(2007-5#2)
sediments from the Gulf of##3##5##(2007-5#3)
sediments from the##4##3##(2007-5#3)(2007-7#1)
sediments from##13##2##(1996-3#2)(2007-5#8)(2007-7#1)(2008-10#2)
sediments has been##2##3##(2008-10#2)
sediments in the Gulf of Paria##3##6##(2007-5#3)
sediments in the##4##3##(2007-5#4)
sediments in##7##2##(2006-8#1)(2007-5#4)(2008-10#1)(2008-5#1)
sediments is##5##2##(2008-10#4)(2009-8#1)
sediments of the##5##3##(2006-8#1)(2007-5#1)(2008-5#1)(2011-2#1)(2012-3#1)
sediments of##9##2##(2006-6#1)(2006-8#1)(2007-10#1)(2007-5#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-3#1)
sediments sampled##2##2##(2007-8#1)(2008-10#1)
sediments using##5##2##(2008-10#5)
sediments were collected##2##3##(2007-8#1)(2010-5#1)
sediments were##4##2##(2007-5#1)(2007-8#2)(2010-5#1)
sediments with a##2##3##(2008-10#2)
sediments with##3##2##(1995-3#1)(2008-10#2)
sediments##183##1##(1991-8#1)(1992-3#4)(1992-8#1)(1995-3#2)(1996-3#2)(2004-4#3)(2005-11#2)(2006-3#1)(2006-6#7)(2006-8#2)(2007-10#1)(2007-5#24)(2007-7#5)(2007-8#7)(2007-9#4)(2008-10#81)(2008-3#1)(2008-5#16)(2008-9#1)(2009-8#4)(2010-5#2)(2011-2#5)(2012-2#2)(2012-3#1)(2013-8#4)
sediments)##2##1##(1992-3#1)(2011-2#1)
sedis)##2##1##(2010-8#1)(2013-7#1)
sedoheptulose 7-phosphate##3##2##(1990-3#2)(2008-7#1)
seduction##2##1##(2008-11#1)(2009-5#1)
see a##13##2##(1990-6#1)(1994-2#1)(1996-12#1)(1996-6#1)(2006-2#3)(2008-5#1)(2009-12#1)(2010-12#1)(2010-8#1)(2011-12#1)(2011-2#1)
see all##2##2##(1994-4#1)(2012-2#1)
see and treat&quot##2##3##(2006-10#2)
see and##4##2##(2006-10#2)(2007-4#1)(2008-1#1)
see as##3##2##(1996-3#1)(2008-6#1)(2009-10#1)
see how far##2##3##(2006-10#2)
see how##11##2##(1992-4#1)(2005-7#1)(2006-10#2)(2006-3#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-8#1)(2011-2#1)
see http##149##2##(2008-7#1)(2010-12#8)(2011-1#53)(2011-12#4)(2011-2#11)(2012-1#72)
see if this##2##3##(1991-9#1)(2007-8#1)
see if##25##2##(1991-9#2)(1992-3#1)(1993-3#1)(1994-11#1)(1994-9#2)(1995-12#2)(1995-9#1)(1996-2#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#2)(2010-12#1)(2012-1#1)(2012-12#1)
see in##5##2##(1991-12#1)(1996-8#1)(2006-7#1)(2008-12#1)(2008-3#1)
see it##3##2##(1997-7#1)(2006-2#1)(2007-7#1)
see its##3##2##(1995-4#1)(2007-12#1)(2008-11#1)
see more##3##2##(1996-2#1)(2008-1#1)(2009-4#1)
see patients in##3##3##(2009-4#1)(2011-1#2)
see patients##4##2##(2009-4#1)(2011-1#2)(2011-2#1)
see text)##5##2##(1990-3#1)(1990-7#1)(1991-2#2)(1995-4#1)
see text] ) and##2##4##(2004-4#1)(2008-10#1)
see text] )##3##3##(2004-4#1)(2008-10#2)
see text] A##4##3##(2005-8#4)
see text] O(2)max##3##3##(2008-3#3)
see text] O(2)max)##3##3##(2008-3#3)
see text] SE##2##3##(2008-8#2)
see text] The polysaccharide##2##4##(1991-7#1)(1995-11#1)
see text] The##8##3##(1991-7#1)(1991-9#1)(1992-12#1)(1995-11#1)(1995-6#1)(2005-8#3)
see text] and##6##3##(1991-11#1)(2008-10#5)
see text] but##2##3##(1991-11#2)
see text] for##3##3##(2008-11#1)(2013-1#2)
see text] is the##2##4##(2008-2#2)
see text] is##5##3##(1991-11#1)(2008-2#3)(2013-1#1)
see text] of##2##3##(2013-1#2)
see text] where##5##3##(1990-11#1)(1991-2#1)(1994-12#1)(1996-10#1)(2008-10#1)
see text] which##2##3##(1992-4#1)(1996-7#1)
see text]##121##2##(1990-11#1)(1991-11#9)(1991-12#2)(1991-2#1)(1991-7#1)(1991-9#2)(1992-12#4)(1992-4#2)(1992-8#4)(1992-9#1)(1994-12#1)(1995-11#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#2)(1996-10#1)(1996-7#2)(1997-8#1)(2004-4#3)(2005-8#15)(2008-10#19)(2008-11#4)(2008-2#10)(2008-3#8)(2008-8#11)(2012-2#3)(2012-7#1)(2013-1#7)
see text]HCl##2##2##(2008-11#2)
see that the##2##3##(1994-12#1)(2008-2#1)
see that##13##2##(1991-4#1)(1994-12#1)(1994-9#1)(2005-7#1)(2007-10#1)(2007-8#1)(2008-11#2)(2008-2#2)(2009-4#2)(2012-1#1)
see the same##2##3##(2008-8#1)(2012-12#1)
see the world##3##3##(2008-1#1)(2011-2#1)(2012-2#1)
see the##34##2##(1991-12#1)(1992-3#1)(1994-2#1)(1997-8#1)(2004-3#1)(2006-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-4#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
see their##4##2##(1993-8#1)(2004-10#1)(2008-10#1)(2011-1#1)
see this as a##2##4##(2007-9#1)(2012-3#1)
see this##4##2##(1992-3#1)(2007-9#1)(2009-10#1)(2012-3#1)
see to##2##2##(2008-2#1)(2010-4#1)
see what##2##2##(2008-10#1)(2008-12#1)
see whether the##4##3##(1991-3#1)(2007-8#1)(2010-10#1)(2012-12#1)
see whether##20##2##(1991-11#1)(1991-3#1)(1993-7#1)(1995-11#1)(1995-12#1)(1995-5#1)(1997-1#1)(1997-8#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2010-10#1)(2011-1#1)(2012-12#1)
see##517##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-11#10)(1991-12#5)(1991-2#4)(1991-3#1)(1991-4#3)(1991-6#1)(1991-7#1)(1991-9#4)(1992-1#2)(1992-11#2)(1992-12#4)(1992-3#4)(1992-4#3)(1992-8#4)(1992-9#1)(1993-10#1)(1993-2#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-4#1)(1994-9#3)(1995-1#2)(1995-11#4)(1995-12#4)(1995-3#2)(1995-4#2)(1995-5#2)(1995-6#1)(1995-7#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#3)(1996-3#3)(1996-6#2)(1996-7#3)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#3)(2004-10#1)(2004-3#1)(2004-4#3)(2005-10#1)(2005-7#2)(2005-8#15)(2006-10#7)(2006-12#1)(2006-2#4)(2006-3#1)(2006-4#4)(2006-7#2)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#4)(2008-1#3)(2008-10#27)(2008-11#16)(2008-12#6)(2008-2#16)(2008-3#12)(2008-4#3)(2008-5#5)(2008-6#4)(2008-7#6)(2008-8#16)(2008-9#2)(2009-10#3)(2009-12#2)(2009-4#5)(2009-5#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#2)(2010-12#11)(2010-4#2)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#59)(2011-12#6)(2011-2#18)(2012-1#75)(2012-12#3)(2012-2#6)(2012-3#6)(2012-7#1)(2013-1#12)(2013-8#3)
see&quot##2##1##(1993-2#2)
see-through##2##1##(2008-3#1)(2008-9#1)
seeberi##5##1##(2007-7#4)(2012-2#1)
seed (testperiod##2##2##(1993-9#2)
seed BACs##2##2##(2008-7#2)
seed albumins and##2##3##(2008-12#2)
seed albumins##4##2##(1994-3#1)(2008-12#3)
seed and root##2##3##(2006-12#1)(2008-10#1)
seed and seedling##2##3##(2006-5#1)(2008-8#1)
seed and soil treatments with##2##5##(2008-10#2)
seed and soil##3##3##(2008-10#3)
seed and soil&quot##3##3##(2007-4#3)
seed and##22##2##(2006-12#1)(2006-5#1)(2007-4#3)(2008-1#1)(2008-10#13)(2008-12#1)(2008-5#1)(2008-8#1)
seed aqueous extract##2##3##(2008-12#2)
seed at the##2##3##(2007-12#1)(2008-12#1)
seed at##4##2##(2007-1#1)(2007-12#1)(2008-12#1)(2009-3#1)
seed bank##5##2##(2008-5#1)(2008-8#4)
seed beam##3##2##(2007-12#1)(2008-2#2)
seed by##2##2##(2008-10#2)
seed coat pigmentation##5##3##(2012-11#5)
seed coat##26##2##(2008-10#10)(2011-2#1)(2012-11#8)(2013-8#7)
seed coats##2##2##(2008-10#1)(2012-11#1)
seed contains##3##2##(1996-4#1)(2006-4#1)(2008-5#1)
seed crops was##2##3##(2008-10#1)(2013-1#1)
seed crops##5##2##(2008-10#3)(2013-1#1)(2013-8#1)
seed defenses##2##2##(2013-1#2)
seed densities##2##2##(2008-7#2)
seed development and##2##3##(1995-6#1)(2009-8#1)
seed development##10##2##(1994-3#3)(1995-6#1)(2006-12#1)(2008-10#1)(2008-12#2)(2009-8#2)
seed diffusate##4##2##(2008-5#4)
seed diffusates##2##2##(2008-5#2)
seed dispersal##14##2##(2006-5#4)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#6)
seed dry weight##2##3##(2006-12#2)
seed embryos were##2##3##(2008-10#2)
seed embryos##3##2##(2008-10#3)
seed extract on##3##3##(2007-1#2)(2008-10#1)
seed extract##8##2##(2007-1#2)(2008-10#3)(2012-2#3)
seed extracts##4##2##(2008-10#1)(2009-5#2)(2013-1#1)
seed flour##2##2##(1996-4#1)(2006-12#1)
seed for##3##2##(2007-1#1)(2007-11#1)(2008-6#1)
seed formation##3##2##(2008-10#1)(2009-10#1)(2009-8#1)
seed from the##2##3##(1995-7#1)(2011-2#1)
seed from##5##2##(1995-7#1)(2008-10#3)(2011-2#1)
seed germination and seedling growth##2##5##(2008-12#1)(2008-5#1)
seed germination and##6##3##(2006-9#1)(2008-12#1)(2008-5#2)(2008-7#1)(2011-1#1)
seed germination in##3##3##(2004-2#1)(2006-11#1)(2008-5#1)
seed germination of##2##3##(2006-11#1)(2012-2#1)
seed germination##37##2##(2004-2#1)(2006-11#2)(2006-9#2)(2008-10#4)(2008-12#4)(2008-5#4)(2008-7#3)(2008-8#3)(2008-9#2)(2009-8#6)(2011-1#1)(2011-12#2)(2012-2#2)(2012-3#1)
seed globulins##2##2##(2008-12#2)
seed had##2##2##(2008-10#2)
seed health testing##2##3##(2008-10#2)
seed health##3##2##(2008-10#3)
seed in farms##2##3##(2008-12#2)
seed in the##3##3##(2008-10#2)(2008-12#1)
seed in##6##2##(2008-10#3)(2008-12#3)
seed infection by##2##3##(2008-10#2)
seed infection##7##2##(2008-10#7)
seed infestation by A##2##4##(2008-10#2)
seed infestation by##3##3##(2008-10#3)
seed locules##2##2##(2008-10#2)
seed lot##9##2##(2006-11#1)(2008-10#8)
seed lots were##2##3##(2008-10#2)
seed lots##10##2##(2008-10#10)
seed mass##4##2##(2008-8#4)
seed material##2##2##(2010-2#2)
seed maturation##3##2##(2006-12#1)(2008-10#1)(2008-12#1)
seed meal amendment##5##3##(2008-10#5)
seed meal amendments##4##3##(2008-10#4)
seed meal at a rate of##2##6##(2008-10#2)
seed meal type##2##3##(2008-10#2)
seed meal##21##2##(2008-10#21)
seed meals##2##2##(2008-10#2)
seed of##12##2##(2007-5#1)(2008-1#1)(2008-10#8)(2008-12#1)(2013-8#1)
seed oil was##2##3##(2008-5#1)(2009-3#1)
seed oil##15##2##(1991-2#4)(2006-12#3)(2008-11#1)(2008-5#1)(2009-10#1)(2009-3#1)(2011-2#1)(2012-11#2)(2013-1#1)
seed oils##4##2##(2008-11#4)
seed on##2##2##(2007-1#1)(2008-12#1)
seed or##6##2##(2008-10#4)(2009-8#1)(2010-2#1)
seed orchards##2##2##(2008-10#1)(2009-12#1)
seed parents##3##2##(2008-10#3)
seed particles##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
seed photon generator##2##3##(2007-12#2)
seed plant species##3##3##(2008-8#3)
seed plant##5##2##(2008-8#4)(2010-5#1)
seed poles##4##2##(2009-6#4)
seed power##2##2##(2007-12#1)(2008-2#1)
seed predation##2##2##(2008-5#1)(2013-1#1)
seed predators##7##2##(2008-5#2)(2008-8#1)(2008-9#1)(2013-1#3)
seed procyanidins##2##2##(2008-10#2)
seed production fields##3##3##(2008-10#3)
seed production in##2##3##(2008-8#1)(2009-12#1)
seed production##16##2##(2005-10#1)(2008-10#5)(2008-5#1)(2008-8#4)(2008-9#3)(2009-12#2)
seed productivity##2##2##(2009-10#1)(2012-11#1)
seed protein##3##2##(1992-7#1)(1994-10#1)(2008-12#1)
seed proteins##3##2##(1994-3#1)(2006-12#2)
seed pulses##3##2##(2008-1#1)(2008-2#2)
seed quality##6##2##(2008-10#1)(2008-12#1)(2011-12#1)(2012-11#2)(2012-3#1)
seed region##3##2##(2009-2#1)(2012-3#1)(2013-8#1)
seed set were##2##3##(2009-12#1)(2013-1#1)
seed set##5##2##(2008-9#1)(2009-12#2)(2013-1#2)
seed shattering##2##2##(2009-10#2)
seed size##10##2##(2007-3#1)(2008-9#9)
seed size)##2##2##(2008-9#2)
seed source for##2##3##(2008-3#1)(2012-9#1)
seed source##5##2##(2007-11#1)(2008-10#2)(2008-3#1)(2012-9#1)
seed stage of reed##2##4##(2008-5#2)
seed stocks##5##2##(2008-10#4)(2008-4#1)
seed storage protein genes##2##4##(2006-12#1)(2008-9#1)
seed storage proteins##2##3##(2006-12#2)
seed storage##4##2##(2006-12#3)(2008-9#1)
seed that##3##2##(2008-10#2)(2009-2#1)
seed the##3##2##(2008-11#1)(2008-8#2)
seed tissue##4##2##(2006-12#4)
seed to##2##2##(2006-9#1)(2011-12#1)
seed train##2##2##(2008-11#2)
seed transmission of##3##3##(2008-10#3)
seed transmission##7##2##(2008-10#7)
seed treated with##2##3##(2008-10#2)
seed treatment and##3##3##(2008-10#3)
seed treatment with##3##3##(2008-10#3)
seed treatment##16##2##(2008-10#16)
seed treatments in##2##3##(2008-10#2)
seed treatments##5##2##(2008-10#5)
seed tubers##7##2##(2008-10#7)
seed using##2##2##(1996-4#1)(2006-12#1)
seed was##5##2##(2008-10#4)(2008-8#1)
seed weight##5##2##(2008-10#1)(2008-12#1)(2012-2#1)(2013-8#2)
seed were##4##2##(2006-12#1)(2008-10#3)
seed with##3##2##(2008-10#2)(2008-12#1)
seed yield and quality in relation to fruit position##2##9##(2008-12#2)
seed yield and##3##3##(2008-10#1)(2008-12#2)
seed yield of##2##3##(2011-12#1)(2012-11#1)
seed yield was##2##3##(2008-10#2)
seed yield##17##2##(2008-10#9)(2008-12#6)(2011-12#1)(2012-11#1)
seed yields##2##2##(2008-10#2)
seed##673##1##(1991-2#4)(1991-7#1)(1991-8#1)(1992-7#1)(1993-4#1)(1993-9#2)(1994-10#1)(1994-11#3)(1994-3#5)(1995-3#1)(1995-6#2)(1995-7#1)(1996-10#1)(1996-2#1)(1996-4#4)(1997-5#1)(2004-2#2)(2004-4#1)(2005-10#2)(2005-11#1)(2005-8#1)(2006-11#4)(2006-12#36)(2006-4#1)(2006-5#7)(2006-8#1)(2006-9#4)(2007-1#6)(2007-11#4)(2007-12#7)(2007-3#1)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#1)(2008-1#5)(2008-10#258)(2008-11#11)(2008-12#40)(2008-2#9)(2008-3#4)(2008-4#1)(2008-5#29)(2008-6#1)(2008-7#7)(2008-8#31)(2008-9#40)(2009-10#8)(2009-12#6)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#5)(2009-8#11)(2010-2#3)(2010-4#1)(2010-5#1)(2011-1#3)(2011-12#6)(2011-2#6)(2012-11#20)(2012-2#6)(2012-3#3)(2012-9#1)(2013-1#14)(2013-7#1)(2013-8#17)
seed&quot##2##1##(1994-12#1)(2008-5#1)
seed)##5##1##(2006-12#1)(2008-10#4)
seed-borne##4##1##(1994-3#1)(2008-10#3)
seed-coat##2##1##(2008-10#2)
seed-eating##2##1##(2008-8#2)
seed-producing##2##1##(2008-5#2)
seed-size selection##2##2##(2008-8#2)
seed-size##4##1##(2008-8#2)(2008-9#2)
seed-specific##3##1##(1994-3#1)(2006-12#2)
seed-train##2##1##(2008-11#2)
seed-transmitted endophytes##4##2##(2008-8#4)
seed-transmitted##9##1##(2008-10#5)(2008-8#4)
seedborne in##2##2##(2008-10#2)
seedborne inoculum##2##2##(2008-10#2)
seedborne isolates##2##2##(2008-10#2)
seedborne##19##1##(2008-10#19)
seeded at##7##2##(1994-2#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-5#1)(2013-1#1)
seeded by an##2##3##(2007-11#1)(2008-1#1)
seeded by##4##2##(2007-11#1)(2008-1#1)(2008-2#2)
seeded cell number##2##3##(2006-12#2)
seeded from##2##2##(1995-2#1)(2008-11#1)
seeded in##4##2##(2008-2#1)(2008-5#2)(2012-3#1)
seeded inside the scaffolds##2##4##(2009-4#2)
seeded inside##4##2##(2009-4#4)
seeded on the##3##3##(2008-10#1)(2008-11#1)(2010-8#1)
seeded on##8##2##(1990-8#1)(1993-9#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-3#1)(2010-8#1)
seeded onto##11##2##(1991-1#1)(1992-12#1)(1993-4#1)(1995-2#1)(2008-11#1)(2008-5#3)(2010-11#1)(2012-4#1)(2012-8#1)
seeded scaffolds##2##2##(2011-2#2)
seeded with linearly polarized##2##4##(2007-11#1)(2007-12#1)
seeded with sugar beet##2##4##(2008-10#2)
seeded with the##3##3##(2007-12#2)(2011-12#1)
seeded with##14##2##(2007-11#1)(2007-12#3)(2008-10#3)(2008-2#2)(2009-3#1)(2010-4#1)(2011-12#1)(2012-2#2)
seeded##91##1##(1990-8#1)(1991-1#1)(1992-12#1)(1993-4#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-2#2)(2005-11#2)(2006-12#2)(2007-11#6)(2007-12#10)(2007-4#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-11#5)(2008-2#7)(2008-3#4)(2008-5#8)(2008-7#1)(2008-8#1)(2009-3#2)(2009-4#5)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-12#2)(2011-2#4)(2012-2#3)(2012-3#1)(2012-4#1)(2012-8#1)(2013-1#1)
seeder##4##1##(2007-11#2)(2008-2#1)(2008-5#1)
seeding and##5##2##(2007-12#1)(2008-10#1)(2008-12#1)(2009-12#1)(2011-2#1)
seeding are##2##2##(2008-10#1)(2008-4#1)
seeding blood##2##2##(1992-10#1)(2008-5#1)
seeding densities##2##2##(2008-10#1)(2008-11#1)
seeding density of##2##3##(1994-2#1)(2013-1#1)
seeding density##9##2##(1994-2#1)(2008-10#1)(2008-11#3)(2008-4#1)(2013-1#3)
seeding efficiencies##2##2##(2007-12#1)(2011-2#1)
seeding efficiency##3##2##(2007-12#1)(2011-2#2)
seeding in##3##2##(2008-8#1)(2011-2#1)(2012-12#1)
seeding method##2##2##(2011-2#2)
seeding methods##2##2##(2011-2#2)
seeding novel insights in diabetes research##2##6##(2012-12#2)
seeding of the##4##3##(2007-12#1)(2008-10#1)(2008-6#1)(2012-12#1)
seeding of##16##2##(1991-10#1)(2006-6#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-6#2)(2008-9#1)(2010-4#1)(2011-2#1)(2012-12#4)
seeding technique##2##2##(2005-11#1)(2008-3#1)
seeding to macroporous alginate##2##4##(2012-1#2)
seeding with##2##2##(2007-12#2)
seeding##126##1##(1990-6#1)(1991-10#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#2)(1994-11#1)(1994-2#1)(1994-9#1)(2004-9#1)(2005-11#1)(2006-6#2)(2007-10#1)(2007-11#3)(2007-12#13)(2007-3#1)(2008-1#3)(2008-10#14)(2008-11#12)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#5)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#14)(2012-1#3)(2012-12#8)(2013-1#3)
seedless laser##2##2##(2007-11#2)
seedling and adult stages##2##4##(2008-10#2)
seedling and adult##3##3##(2008-10#3)
seedling and##10##2##(2008-10#8)(2008-12#2)
seedling blight##5##2##(2008-10#5)
seedling damping-off##2##2##(2008-10#2)
seedling death##2##2##(2008-10#2)
seedling development##2##2##(2008-5#1)(2009-8#1)
seedling disease##5##2##(2008-10#5)
seedling dry weight##3##3##(2008-12#3)
seedling emergence##5##2##(2008-10#5)
seedling establishment##3##2##(2006-5#1)(2008-10#1)(2009-8#1)
seedling explants##2##2##(2008-12#2)
seedling genes##4##2##(2008-10#4)
seedling growth and##3##3##(2008-5#1)(2008-8#2)
seedling growth of##12##3##(2008-12#10)(2008-5#2)
seedling growth were##2##3##(2008-12#1)(2008-5#1)
seedling growth##25##2##(2008-10#1)(2008-12#15)(2008-5#6)(2008-8#3)
seedling leaves of##2##3##(2008-10#2)
seedling mortality##3##2##(2006-5#1)(2008-10#1)(2008-9#1)
seedling of##2##2##(2007-3#1)(2008-12#1)
seedling resistance when##2##3##(2008-10#2)
seedling resistance##5##2##(2008-10#5)
seedling root##2##2##(2008-10#2)
seedling roots##3##2##(2008-10#2)(2013-8#1)
seedling stage##10##2##(2006-12#1)(2008-10#8)(2008-12#1)
seedling stand##4##2##(2008-10#3)(2008-12#1)
seedling survival##2##2##(2008-10#1)(2008-5#1)
seedling##141##1##(2004-4#1)(2006-12#1)(2006-5#2)(2007-3#1)(2008-10#77)(2008-12#27)(2008-5#14)(2008-7#1)(2008-8#5)(2008-9#3)(2009-10#1)(2009-8#4)(2011-12#2)(2012-2#1)(2013-8#1)
seedlings (r2 = 0##2##4##(2008-5#2)
seedlings after##2##2##(1997-2#1)(2008-10#1)
seedlings and adult plants##2##4##(2008-10#2)
seedlings and saplings##2##3##(2008-5#2)
seedlings and the##3##3##(2008-10#2)(2008-8#1)
seedlings and##22##2##(1992-7#1)(1997-8#1)(2006-12#1)(2007-1#1)(2008-10#13)(2008-5#3)(2008-8#1)(2011-10#1)
seedlings are##3##2##(1994-8#1)(2008-10#1)(2009-10#1)
seedlings at##4##2##(2008-10#2)(2008-5#1)(2011-12#1)
seedlings by strain 4/4##2##4##(2008-10#2)
seedlings by##5##2##(2008-10#5)
seedlings caused by##2##3##(2008-10#2)
seedlings derived from##2##3##(2008-10#2)
seedlings did develop##2##3##(2008-10#2)
seedlings did not##2##3##(2008-10#1)(2008-5#1)
seedlings did##4##2##(2008-10#3)(2008-5#1)
seedlings do not##2##3##(1990-11#1)(2009-8#1)
seedlings expressing##3##2##(2006-12#1)(2008-10#1)(2009-6#1)
seedlings followed##2##2##(2008-10#2)
seedlings for##3##2##(2008-10#2)(2009-8#1)
seedlings grown in these##2##4##(2008-10#2)
seedlings grown in##10##3##(2004-4#1)(2008-10#9)
seedlings grown under##2##3##(2004-4#1)(2009-8#1)
seedlings grown##13##2##(2004-4#3)(2008-10#9)(2009-8#1)
seedlings growth##2##2##(2013-8#2)
seedlings had significantly less##2##4##(2008-10#2)
seedlings had the##2##3##(2008-5#1)(2011-2#1)
seedlings had##6##2##(1990-11#1)(2008-10#2)(2008-5#1)(2008-9#1)(2011-2#1)
seedlings in a##4##3##(2008-10#2)(2008-5#2)
seedlings in the greenhouse##3##4##(2008-10#3)
seedlings in the##6##3##(2004-4#1)(2008-10#5)
seedlings in##16##2##(2004-4#1)(2008-10#12)(2008-5#3)
seedlings infected with##2##3##(2008-10#2)
seedlings inoculated with the##3##4##(2008-10#3)
seedlings inoculated with##6##3##(2008-10#5)(2008-11#1)
seedlings inoculated##7##2##(2008-10#6)(2008-11#1)
seedlings of the##3##3##(2008-10#3)
seedlings of##28##2##(2004-4#3)(2007-3#1)(2008-10#16)(2008-11#1)(2008-5#1)(2008-8#3)(2009-8#1)(2011-12#1)(2012-8#1)
seedlings over##2##2##(2008-10#2)
seedlings produced##2##2##(2007-1#1)(2008-10#1)
seedlings represented##2##2##(2008-5#2)
seedlings rhizosphere soil##2##3##(2013-8#2)
seedlings that were inoculated##2##4##(2008-10#2)
seedlings that were##7##3##(2008-10#6)(2008-9#1)
seedlings that##10##2##(2008-10#9)(2008-9#1)
seedlings to##2##2##(1990-2#1)(2008-10#1)
seedlings treated with both types of CWP##2##7##(2008-10#2)
seedlings was##7##2##(1993-8#1)(2008-10#6)
seedlings were challenged with##2##4##(2008-10#2)
seedlings were grown in##2##4##(2008-10#2)
seedlings were grown##3##3##(2008-10#2)(2008-5#1)
seedlings were inoculated##4##3##(2008-10#4)
seedlings were transplanted into##2##4##(2008-10#1)(2009-3#1)
seedlings were##31##2##(1996-8#1)(2004-4#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2009-3#1)(2011-10#2)(2011-12#1)
seedlings with##13##2##(1997-2#1)(2008-10#10)(2008-9#1)(2009-8#1)
seedlings##349##1##(1990-11#3)(1990-2#2)(1990-7#1)(1991-12#1)(1992-12#1)(1992-7#1)(1993-8#1)(1994-3#1)(1994-8#3)(1996-10#3)(1996-5#1)(1996-8#2)(1997-2#2)(1997-6#1)(1997-8#1)(2004-4#11)(2006-12#2)(2007-1#3)(2007-3#3)(2008-10#210)(2008-11#3)(2008-12#4)(2008-4#2)(2008-5#26)(2008-7#1)(2008-8#9)(2008-9#10)(2009-10#1)(2009-3#1)(2009-6#2)(2009-8#13)(2011-1#2)(2011-10#5)(2011-12#6)(2011-2#3)(2012-8#1)(2013-1#1)(2013-8#6)
seeds after##3##2##(2008-5#1)(2008-8#1)(2009-6#1)
seeds and insects##2##3##(1991-11#1)(2007-3#1)
seeds and its##2##3##(2008-10#1)(2008-11#1)
seeds and seedlings##2##3##(2008-10#2)
seeds and##21##2##(1991-11#1)(2007-3#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#2)(2009-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
seeds are##2##2##(2008-9#1)(2009-6#1)
seeds as##2##2##(2006-12#1)(2013-1#1)
seeds by fluorescence##2##3##(2006-12#2)
seeds by##6##2##(1992-8#1)(2006-12#2)(2008-5#2)(2008-9#1)
seeds collected on the ground from previous years##2##8##(2012-2#2)
seeds collected##3##2##(2004-4#1)(2012-2#2)
seeds compared##2##2##(2006-12#1)(2008-8#1)
seeds extract on##2##3##(2008-5#1)(2013-7#1)
seeds extract##5##2##(2008-5#4)(2013-7#1)
seeds for##4##2##(1996-9#1)(2008-12#1)(2010-5#1)(2011-2#1)
seeds from crown on the 1st of##2##7##(2012-2#2)
seeds from different locations##2##4##(2012-3#2)
seeds from different##3##3##(2012-3#3)
seeds from the##2##3##(2006-12#1)(2008-10#1)
seeds from##17##2##(2006-12#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-5#5)(2008-9#1)(2012-2#2)(2012-3#4)(2012-9#1)
seeds had##4##2##(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)
seeds has been##2##3##(1993-8#1)(2008-12#1)
seeds in the##2##3##(2008-5#1)(2012-1#1)
seeds in##14##2##(2006-12#3)(2007-5#1)(2008-5#4)(2008-8#1)(2008-9#1)(2009-8#1)(2012-1#1)(2012-12#1)(2012-2#1)
seeds is##2##2##(2006-12#1)(2008-8#1)
seeds of Crotalaria striata##2##4##(1990-2#2)
seeds of P##3##3##(2006-12#1)(2013-7#2)
seeds of a##2##3##(2008-10#1)(2008-8#1)
seeds of improved varieties##4##4##(2008-12#4)
seeds of improved wheat varieties in farms##2##7##(2008-12#2)
seeds of improved##6##3##(2008-12#6)
seeds of the Chinese yew##2##5##(2007-1#2)
seeds of the##9##3##(1994-3#1)(2004-2#1)(2006-12#1)(2007-1#2)(2008-11#1)(2008-5#2)(2011-1#1)
seeds of transgenic##4##3##(1994-3#2)(2006-12#2)
seeds of##75##2##(1990-11#1)(1990-2#2)(1994-12#1)(1994-2#2)(1994-3#4)(1995-6#1)(2004-2#2)(2006-12#5)(2006-9#1)(2007-1#6)(2007-11#1)(2007-3#1)(2008-10#5)(2008-11#1)(2008-12#11)(2008-4#1)(2008-5#4)(2008-6#2)(2008-8#4)(2009-5#1)(2010-1#1)(2010-12#1)(2010-5#2)(2011-1#7)(2012-11#1)(2012-2#2)(2013-7#4)(2013-8#1)
seeds on##2##2##(2008-5#1)(2012-3#1)
seeds per##4##2##(2008-10#2)(2008-12#1)(2013-1#1)
seeds showed##2##2##(2006-12#1)(2008-5#1)
seeds that##2##2##(2006-12#1)(2008-10#1)
seeds to##6##2##(1992-8#1)(2005-11#1)(2006-5#1)(2007-5#1)(2008-10#1)(2008-5#1)
seeds was##10##2##(2006-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#1)(2013-7#2)
seeds were investigated##2##3##(2008-12#1)(2009-3#1)
seeds were planted##2##3##(2008-10#2)
seeds were##16##2##(1990-11#1)(2006-3#1)(2007-7#1)(2008-10#4)(2008-12#3)(2008-5#2)(2009-12#1)(2009-3#1)(2010-2#2)
seeds with##5##2##(2008-10#1)(2008-12#1)(2008-5#1)(2009-12#1)(2012-11#1)
seeds without##2##2##(2006-12#1)(2008-10#1)
seeds##376##1##(1990-11#2)(1990-2#2)(1990-5#4)(1990-6#1)(1991-10#1)(1991-11#2)(1992-3#2)(1992-8#5)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#5)(1995-6#2)(1996-9#1)(1997-4#1)(2004-2#2)(2004-4#2)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#28)(2006-3#3)(2006-5#1)(2006-9#1)(2007-1#6)(2007-11#1)(2007-3#6)(2007-5#2)(2007-7#3)(2008-10#61)(2008-11#4)(2008-12#39)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#47)(2008-6#2)(2008-7#2)(2008-8#16)(2008-9#17)(2009-10#1)(2009-12#4)(2009-3#2)(2009-5#2)(2009-6#6)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#7)(2010-5#4)(2011-1#9)(2011-12#6)(2011-2#5)(2012-1#1)(2012-11#4)(2012-12#1)(2012-2#12)(2012-3#8)(2012-9#1)(2013-1#7)(2013-7#10)(2013-8#1)
seeds)##2##1##(2008-8#1)(2011-2#1)
seeing a##6##2##(1996-4#1)(2006-10#1)(2008-7#1)(2012-1#1)(2012-2#1)(2013-7#1)
seeing an##3##2##(1991-12#1)(2006-10#1)(2007-1#1)
seeing conditions##4##2##(2008-2#3)(2008-3#1)
seeing the##8##2##(1993-8#1)(2006-2#1)(2008-7#1)(2008-8#1)(2009-4#1)(2012-1#1)(2013-7#1)(2013-8#1)
seeing##49##1##(1991-12#1)(1993-2#1)(1993-8#1)(1994-2#2)(1995-12#1)(1996-1#1)(1996-4#1)(1997-3#1)(2005-10#1)(2006-10#2)(2006-2#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-2#4)(2008-3#5)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-4#1)(2012-1#4)(2012-12#2)(2012-2#1)(2013-7#2)(2013-8#3)
seek a second opinion##2##4##(2011-12#2)
seek a second##3##3##(1997-7#1)(2011-12#2)
seek a##16##2##(1992-3#1)(1997-1#1)(1997-7#1)(2005-7#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-12#2)(2012-3#1)
seek advice##3##2##(1992-2#1)(2008-3#1)(2012-3#1)
seek an##2##2##(1991-10#1)(2012-12#1)
seek and##4##2##(2006-10#1)(2007-10#1)(2008-11#1)(2010-11#1)
seek care in##2##3##(2011-2#1)(2012-2#1)
seek care##6##2##(1990-5#1)(2007-10#1)(2007-5#1)(2011-12#1)(2011-2#1)(2012-2#1)
seek for##2##2##(2011-1#1)(2011-2#1)
seek health care##4##3##(2007-10#1)(2010-2#1)(2012-12#2)
seek healthcare##2##2##(2005-10#1)(2008-2#1)
seek help##4##2##(1990-4#1)(2012-1#2)(2012-3#1)
seek information about##2##3##(1995-3#1)(2008-11#1)
seek information##4##2##(1995-3#1)(2006-10#1)(2007-12#1)(2008-11#1)
seek legal advice##2##3##(1993-1#1)(1993-5#1)
seek medical advice##4##3##(1994-12#1)(2007-2#1)(2011-2#2)
seek medical attention##5##3##(2007-7#1)(2008-7#1)(2009-5#1)(2012-12#2)
seek medical##11##2##(1994-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-7#1)(2009-5#1)(2011-2#2)(2012-12#2)
seek out such##2##3##(1992-6#1)(2012-3#1)
seek out##11##2##(1991-11#1)(1992-6#1)(1996-3#1)(2005-10#1)(2007-4#1)(2008-10#1)(2008-7#1)(2009-7#1)(2012-3#1)(2013-1#2)
seek psychiatric##2##2##(2011-12#1)(2013-8#1)
seek reasonable##2##2##(2004-9#2)
seek services##2##2##(1994-3#1)(2011-2#1)
seek to establish##3##3##(1997-2#1)(2010-4#1)(2013-1#1)
seek to identify the##3##4##(2005-7#1)(2008-8#1)(2013-1#1)
seek to improve the##3##4##(1996-12#1)(2008-3#1)(2013-1#1)
seek to improve##7##3##(1993-7#1)(1996-12#1)(1997-2#1)(2008-3#1)(2009-8#1)(2010-11#1)(2013-1#1)
seek to make##2##3##(2007-8#1)(2009-5#1)
seek to preserve##2##3##(1994-2#1)(1996-12#1)
seek to use##2##3##(1991-6#1)(2008-4#1)
seek to##45##2##(1991-6#1)(1991-7#1)(1992-2#1)(1993-2#1)(1993-7#2)(1994-2#1)(1996-12#2)(1997-2#2)(2005-7#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-9#2)(2012-12#1)(2012-3#2)(2013-1#6)(2013-8#1)
seek treatment at the##2##4##(2006-2#1)(2011-1#1)
seek treatment at##3##3##(2006-2#1)(2008-3#1)(2011-1#1)
seek treatment##10##2##(2004-1#1)(2006-10#2)(2006-2#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-11#1)
seek ways to##2##3##(1993-1#1)(1996-12#1)
seek##201##1##(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#2)(1993-9#1)(1994-1#2)(1994-12#2)(1994-2#2)(1994-3#1)(1995-12#3)(1995-3#1)(1995-7#1)(1996-1#2)(1996-12#4)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-7#1)(1997-8#1)(2004-1#1)(2004-12#2)(2004-9#2)(2005-10#2)(2005-7#2)(2005-8#1)(2006-10#6)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-7#1)(2007-10#4)(2007-12#2)(2007-2#3)(2007-3#1)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#3)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#3)(2010-4#2)(2010-7#2)(2010-9#2)(2011-1#2)(2011-12#4)(2011-2#5)(2012-1#3)(2012-11#1)(2012-12#6)(2012-2#4)(2012-3#7)(2013-1#9)(2013-8#2)
seekers in##5##2##(2007-3#2)(2012-11#2)(2012-2#1)
seekers who##2##2##(1996-9#1)(2012-11#1)
seekers##13##1##(1991-10#1)(1993-6#1)(1994-4#1)(1996-9#1)(2007-3#4)(2012-11#4)(2012-2#1)
seeking a##4##2##(1991-5#1)(1992-6#1)(2008-2#1)(2012-12#1)
seeking abortions##2##2##(1993-3#1)(1997-1#1)
seeking advice##2##2##(1990-4#1)(2012-3#1)
seeking an##3##2##(1992-6#1)(2005-7#1)(2010-7#1)
seeking and##5##2##(2009-12#2)(2013-1#3)
seeking assistance##2##2##(2006-8#1)(2007-10#1)
seeking behavior##9##2##(1994-12#1)(2007-7#1)(2009-11#1)(2009-9#1)(2010-8#1)(2011-1#3)(2013-7#1)
seeking behaviors##3##2##(2008-4#2)(2010-9#1)
seeking behaviour of##3##3##(2005-9#1)(2008-3#1)(2010-4#1)
seeking behaviour##6##2##(2005-9#2)(2008-3#1)(2010-4#1)(2011-12#2)
seeking care##2##2##(1993-3#1)(2008-5#1)
seeking dental care##2##3##(2006-10#1)(2008-5#1)
seeking dental##3##2##(2006-10#1)(2008-5#1)(2011-1#1)
seeking for##5##2##(2006-6#1)(2006-8#1)(2008-1#2)(2011-1#1)
seeking health care##3##3##(1993-3#1)(1996-11#1)(2008-7#1)
seeking help for##2##3##(2011-1#1)(2011-2#1)
seeking help##7##2##(1992-5#1)(2006-10#1)(2009-12#1)(2009-9#1)(2011-1#2)(2011-2#1)
seeking information on the##2##4##(2008-4#1)(2009-2#1)
seeking information##3##2##(2008-4#1)(2009-2#1)(2010-6#1)
seeking medical assistance##2##3##(1995-9#1)(2008-5#1)
seeking medical attention##3##3##(1997-2#1)(2006-9#1)(2009-9#1)
seeking medical care##5##3##(1991-4#1)(2011-1#1)(2011-2#1)(2012-12#2)
seeking medical help##2##3##(1992-2#1)(2007-11#1)
seeking medical##15##2##(1991-4#1)(1992-2#1)(1995-9#1)(1997-2#1)(2006-9#2)(2007-11#1)(2007-6#1)(2008-5#2)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#2)
seeking new##2##2##(1993-8#1)(2009-12#1)
seeking out##4##2##(2008-9#1)(2010-8#1)(2012-11#1)(2013-1#1)
seeking reflects##2##2##(2007-8#2)
seeking social support&quot##2##3##(2013-1#2)
seeking social##3##2##(1990-10#1)(2013-1#2)
seeking the##4##2##(1995-11#1)(2006-12#1)(2007-12#1)(2008-4#1)
seeking to apply##2##3##(2008-4#1)(2013-8#1)
seeking to improve##2##3##(2008-5#1)(2013-1#1)
seeking to promote##3##3##(2011-2#1)(2013-1#2)
seeking to provide##2##3##(2010-10#1)(2011-2#1)
seeking to understand how##2##4##(2008-6#1)(2010-5#1)
seeking to##38##2##(1992-3#1)(1993-11#1)(1995-6#1)(1996-12#1)(1997-3#1)(2005-7#1)(2006-10#8)(2006-2#1)(2006-4#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#2)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
seeking treatment at primary##2##4##(2011-1#2)
seeking treatment at##3##3##(2011-1#2)(2012-12#1)
seeking treatment for##5##3##(2008-3#1)(2009-9#1)(2011-2#1)(2013-1#2)
seeking treatment in##2##3##(1997-2#1)(2007-6#1)
seeking treatment##18##2##(1997-2#1)(2007-6#2)(2008-1#1)(2008-12#1)(2008-3#1)(2009-9#1)(2011-1#4)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)
seeking ways to##2##3##(2005-11#1)(2005-12#1)
seeking##247##1##(1990-10#1)(1990-12#1)(1990-4#1)(1991-10#1)(1991-4#1)(1991-5#1)(1992-1#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-10#1)(1993-11#1)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#4)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-5#1)(2005-7#3)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#10)(2006-12#1)(2006-2#2)(2006-4#1)(2006-6#4)(2006-7#1)(2006-8#3)(2006-9#2)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#2)(2007-3#2)(2007-4#2)(2007-5#2)(2007-6#3)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#6)(2008-10#1)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#6)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#2)(2009-12#7)(2009-2#1)(2009-5#6)(2009-7#1)(2009-9#4)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#14)(2011-12#3)(2011-2#7)(2012-11#3)(2012-12#10)(2012-2#3)(2012-3#2)(2013-1#12)(2013-7#2)(2013-8#4)
seeks a##2##2##(1997-3#1)(2012-11#1)
seeks medical##3##2##(2005-12#1)(2006-10#1)(2008-1#1)
seeks the##2##2##(2008-3#1)(2010-12#1)
seeks to clarify##2##3##(1993-9#1)(2007-8#1)
seeks to define##2##3##(1997-3#1)(2006-4#1)
seeks to expand##2##3##(1995-12#1)(2008-11#1)
seeks to extend##2##3##(1990-12#1)(2007-12#1)
seeks to foster##2##3##(2008-11#1)(2008-6#1)
seeks to identify##6##3##(1996-7#1)(2005-10#1)(2005-2#1)(2006-7#1)(2007-10#1)(2008-11#1)
seeks to improve##2##3##(2008-2#1)(2010-12#1)
seeks to understand##2##3##(2008-11#1)(2011-1#1)
seeks to##63##2##(1990-12#1)(1990-4#1)(1991-3#1)(1992-11#2)(1992-5#1)(1993-9#1)(1995-12#2)(1995-3#1)(1996-1#1)(1996-3#1)(1996-7#1)(1997-3#1)(1997-7#1)(2005-10#1)(2005-2#1)(2005-9#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#2)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-8#2)
seeks##85##1##(1990-12#1)(1990-4#1)(1991-3#1)(1991-9#1)(1992-11#2)(1992-5#1)(1992-6#1)(1993-11#1)(1993-9#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-3#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-7#1)(1997-3#2)(1997-7#1)(2005-10#1)(2005-12#1)(2005-2#1)(2005-9#1)(2006-10#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#1)(2009-9#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-2#2)(2012-3#1)(2013-8#2)
seem a##3##2##(1992-4#1)(2006-10#1)(2008-12#1)
seem closely##2##2##(2007-8#1)(2012-2#1)
seem important##2##2##(1995-2#1)(1995-5#1)
seem like##3##2##(1995-7#1)(2006-8#1)(2011-1#1)
seem likely to##4##3##(1990-12#1)(2006-7#1)(2007-11#1)(2007-8#1)
seem likely##5##2##(1990-12#1)(1996-2#1)(2006-7#1)(2007-11#1)(2007-8#1)
seem more##7##2##(1990-11#1)(1992-4#1)(2007-11#1)(2007-4#1)(2008-11#1)(2010-5#1)(2012-3#1)
seem not to##3##3##(1990-8#1)(2009-4#1)(2010-12#1)
seem not##5##2##(1990-5#1)(1990-8#1)(1996-7#1)(2009-4#1)(2010-12#1)
seem particularly##2##2##(2008-11#1)(2008-7#1)
seem promising##5##2##(1991-9#1)(1993-11#1)(1996-6#1)(2008-1#1)(2008-7#1)
seem therefore##2##2##(1996-1#1)(2006-2#1)
seem to acquire##2##3##(1995-4#1)(2008-11#1)
seem to act##2##3##(1992-6#1)(2008-10#1)
seem to affect the##4##4##(1990-2#1)(2008-5#1)(2010-4#1)(2013-1#1)
seem to affect##8##3##(1990-2#1)(2004-10#1)(2004-12#1)(2008-11#1)(2008-5#1)(2010-4#1)(2013-1#2)
seem to be a general##2##5##(1995-3#1)(2007-9#1)
seem to be a promising##3##5##(1992-6#1)(2010-9#1)(2011-2#1)
seem to be a##21##4##(1990-1#1)(1991-4#1)(1991-5#1)(1992-6#1)(1993-6#1)(1994-1#1)(1994-11#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-2#1)(2005-11#1)(2007-9#2)(2008-11#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-9#1)(2011-2#2)
seem to be an##3##4##(1990-12#1)(1995-12#1)(2008-5#1)
seem to be appropriate##3##4##(1997-8#1)(2004-11#1)(2010-1#1)
seem to be as##3##4##(2005-11#1)(2007-11#1)(2008-5#1)
seem to be associated with##3##5##(1992-9#1)(1997-5#1)(2008-2#1)
seem to be associated##5##4##(1992-9#1)(1996-11#1)(1997-5#1)(2008-2#1)(2013-1#1)
seem to be at##2##4##(2008-10#1)(2013-8#1)
seem to be beneficial##2##4##(1995-2#1)(2008-5#1)
seem to be effective in##3##5##(1992-12#1)(2007-11#1)(2013-8#1)
seem to be effective##5##4##(1992-12#1)(2006-7#1)(2007-11#1)(2009-6#1)(2013-8#1)
seem to be free##2##4##(1993-12#1)(2008-10#1)
seem to be implicated##3##4##(1991-5#1)(2007-12#1)(2007-8#1)
seem to be important factors##2##5##(2008-10#1)(2008-11#1)
seem to be important in the##2##6##(1994-6#1)(2008-4#1)
seem to be important##5##4##(1994-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)
seem to be in##3##4##(1994-6#1)(2005-11#1)(2008-12#1)
seem to be involved in the##9##6##(1990-9#1)(1991-2#1)(1993-11#1)(1994-2#1)(1995-12#1)(1995-8#1)(1997-1#1)(2008-4#1)(2008-6#1)
seem to be involved in##13##5##(1990-9#1)(1991-2#1)(1993-11#1)(1993-9#1)(1994-2#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2011-1#1)
seem to be less##2##4##(2008-11#1)(2012-12#1)
seem to be more##10##4##(1990-2#2)(1990-3#1)(1996-9#1)(2005-11#1)(2006-6#1)(2007-12#1)(2008-5#1)(2013-1#1)(2013-7#1)
seem to be necessary##2##4##(1990-10#1)(2008-10#1)
seem to be of##2##4##(2006-10#1)(2006-12#1)
seem to be rare##2##4##(2005-10#1)(2007-11#1)
seem to be related to##3##5##(1991-6#1)(2007-8#1)(2012-12#1)
seem to be related##5##4##(1991-6#1)(1993-8#1)(2007-8#1)(2008-7#1)(2012-12#1)
seem to be responsible##2##4##(1993-2#1)(2008-12#1)
seem to be restricted to the##2##6##(1995-8#1)(2008-7#1)
seem to be sufficient##2##4##(2007-11#1)(2010-11#1)
seem to be the most important##4##6##(1994-12#1)(2007-11#1)(2007-8#1)(2013-1#1)
seem to be the most##7##5##(1990-12#1)(1994-12#1)(2007-11#1)(2007-8#1)(2008-6#1)(2012-3#1)(2013-1#1)
seem to be the##14##4##(1990-12#1)(1994-12#1)(1996-10#1)(1997-8#1)(2006-3#1)(2007-11#1)(2007-8#2)(2008-6#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#1)
seem to be useful##3##4##(1992-2#1)(1994-6#1)(2012-2#1)
seem to be##226##3##(1990-1#1)(1990-10#3)(1990-12#3)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#5)(1990-9#2)(1991-12#1)(1991-2#2)(1991-4#2)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#5)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-8#3)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2004-11#1)(2005-10#1)(2005-11#5)(2006-10#3)(2006-12#1)(2006-2#2)(2006-3#2)(2006-4#3)(2006-6#4)(2006-7#1)(2006-8#1)(2007-1#2)(2007-11#6)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#5)(2007-9#4)(2008-1#2)(2008-10#9)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#7)(2008-6#2)(2008-7#5)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-6#1)(2009-8#3)(2009-9#2)(2010-1#2)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2012-4#1)(2013-1#8)(2013-7#1)(2013-8#2)
seem to cause##3##3##(1992-10#1)(1994-3#1)(2008-8#1)
seem to change##4##3##(1991-12#1)(1995-1#1)(1996-1#1)(2008-5#1)
seem to confer##2##3##(1991-2#1)(2007-12#1)
seem to confirm the##5##4##(1992-6#1)(2006-10#1)(2009-4#1)(2013-1#1)(2013-7#1)
seem to confirm##6##3##(1992-6#1)(2006-10#1)(2009-4#1)(2010-12#1)(2013-1#1)(2013-7#1)
seem to depend on##2##4##(2005-10#1)(2008-2#1)
seem to differ##2##3##(1993-3#1)(2008-5#1)
seem to enhance##2##3##(2011-2#1)(2012-3#1)
seem to favor the##2##4##(2007-5#1)(2008-10#1)
seem to favor##3##3##(2006-2#1)(2007-5#1)(2008-10#1)
seem to have a##11##4##(1990-8#1)(1991-8#1)(1996-9#1)(2006-10#3)(2007-8#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-6#1)
seem to have been##2##4##(2007-7#1)(2008-10#1)
seem to have##38##3##(1990-8#1)(1991-8#2)(1992-1#2)(1992-2#1)(1992-6#1)(1992-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-8#1)(1996-9#1)(2006-10#3)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#3)(2008-8#1)(2009-10#1)(2009-3#1)(2009-6#1)(2010-6#1)(2010-7#1)(2012-12#2)
seem to indicate that this##3##5##(1994-9#1)(2006-6#1)(2007-8#1)
seem to indicate that##9##4##(1994-9#1)(1997-8#1)(2006-4#1)(2006-6#1)(2007-8#2)(2008-2#1)(2013-1#2)
seem to indicate the##2##4##(2008-12#2)
seem to indicate##12##3##(1994-9#1)(1997-8#1)(2006-4#1)(2006-6#1)(2007-8#2)(2008-12#2)(2008-2#1)(2008-7#1)(2013-1#2)
seem to influence##2##3##(2008-12#1)(2008-5#1)
seem to interact directly with the basal transcription##2##8##(1995-6#2)
seem to interact with##2##4##(2008-10#1)(2008-3#1)
seem to interact##5##3##(1995-6#2)(1996-6#1)(2008-10#1)(2008-3#1)
seem to involve##3##3##(1991-4#1)(1994-2#1)(2008-10#1)
seem to occur##4##3##(1992-8#1)(1994-6#1)(1997-5#1)(2007-11#1)
seem to offer a##3##4##(2006-10#1)(2007-2#1)(2010-5#1)
seem to offer the##4##4##(1991-4#1)(1996-6#1)(2005-8#1)(2006-10#1)
seem to offer##10##3##(1991-2#1)(1991-4#1)(1996-6#1)(2005-11#1)(2005-8#1)(2006-10#2)(2007-2#1)(2009-3#1)(2010-5#1)
seem to outweigh##2##3##(2006-12#1)(2009-6#1)
seem to play a##3##4##(1990-3#1)(1990-7#1)(1992-3#1)
seem to play an important role##3##6##(2008-4#1)(2010-12#1)(2011-1#1)
seem to play important roles##2##5##(2006-12#1)(2008-9#1)
seem to play##9##3##(1990-3#1)(1990-7#1)(1992-3#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-12#1)(2011-1#1)
seem to possess##2##3##(1990-5#1)(1995-1#1)
seem to provide##2##3##(1991-2#1)(2007-7#1)
seem to reflect##2##3##(2008-10#1)(2008-5#1)
seem to represent##3##3##(2008-1#1)(2008-5#1)(2009-4#1)
seem to show##3##3##(2007-11#1)(2008-10#1)(2013-1#1)
seem to suggest that the##4##5##(1993-3#1)(1996-7#1)(2007-9#1)(2009-7#1)
seem to suggest that##9##4##(1993-3#1)(1995-12#1)(1996-7#1)(1997-3#1)(2007-9#1)(2008-4#1)(2009-7#2)(2012-12#1)
seem to suggest##10##3##(1993-3#1)(1995-12#1)(1996-7#1)(1997-3#1)(2007-9#1)(2008-4#1)(2009-7#2)(2010-12#1)(2012-12#1)
seem to support the##3##4##(1993-8#1)(2008-9#1)(2011-12#1)
seem to support##4##3##(1993-11#1)(1993-8#1)(2008-9#1)(2011-12#1)
seem to take place##2##4##(2008-7#2)
seem to##470##2##(1990-1#1)(1990-10#3)(1990-12#3)(1990-2#6)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#6)(1990-9#2)(1991-1#1)(1991-12#2)(1991-2#5)(1991-4#4)(1991-5#4)(1991-6#4)(1991-8#4)(1991-9#1)(1992-1#3)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-5#2)(1992-6#4)(1992-7#2)(1992-8#3)(1992-9#3)(1993-11#4)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#2)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#4)(1994-3#2)(1994-6#4)(1994-9#2)(1995-1#3)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#4)(1995-8#6)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#3)(1996-7#1)(1996-8#3)(1996-9#4)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#4)(1997-6#1)(1997-7#2)(1997-8#3)(2004-10#3)(2004-11#1)(2004-12#1)(2005-10#2)(2005-11#8)(2005-8#2)(2005-9#1)(2006-10#11)(2006-11#1)(2006-12#3)(2006-2#4)(2006-3#2)(2006-4#4)(2006-6#6)(2006-7#1)(2006-8#3)(2007-1#3)(2007-11#13)(2007-12#6)(2007-2#4)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#9)(2007-9#6)(2008-1#4)(2008-10#25)(2008-11#11)(2008-12#7)(2008-2#5)(2008-3#3)(2008-4#9)(2008-5#16)(2008-6#3)(2008-7#12)(2008-8#3)(2008-9#3)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-6#4)(2009-7#2)(2009-8#3)(2009-9#2)(2010-1#2)(2010-11#1)(2010-12#5)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#5)(2012-3#8)(2012-4#1)(2012-5#1)(2013-1#15)(2013-7#2)(2013-8#3)
seem useful##2##2##(2008-10#2)
seem very##2##2##(2006-6#1)(2008-2#1)
seem##569##1##(1990-1#1)(1990-10#3)(1990-11#1)(1990-12#6)(1990-2#6)(1990-3#2)(1990-4#1)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#7)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#6)(1991-4#4)(1991-5#5)(1991-6#4)(1991-8#4)(1991-9#2)(1992-1#3)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#3)(1992-4#2)(1992-5#2)(1992-6#4)(1992-7#2)(1992-8#3)(1992-9#3)(1993-11#5)(1993-12#2)(1993-2#3)(1993-3#3)(1993-6#2)(1993-8#3)(1993-9#1)(1994-1#2)(1994-11#2)(1994-12#2)(1994-2#4)(1994-3#2)(1994-6#4)(1994-8#1)(1994-9#2)(1995-1#3)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#4)(1995-6#4)(1995-7#1)(1995-8#6)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#4)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#4)(1996-7#3)(1996-8#3)(1996-9#4)(1997-1#1)(1997-2#2)(1997-3#6)(1997-4#1)(1997-5#4)(1997-6#1)(1997-7#2)(1997-8#3)(2004-10#3)(2004-11#1)(2004-12#1)(2005-10#2)(2005-11#9)(2005-8#2)(2005-9#1)(2006-10#15)(2006-11#1)(2006-12#3)(2006-2#7)(2006-3#2)(2006-4#5)(2006-6#7)(2006-7#2)(2006-8#5)(2007-1#3)(2007-11#16)(2007-12#7)(2007-2#5)(2007-4#3)(2007-5#2)(2007-7#3)(2007-8#13)(2007-9#6)(2008-1#6)(2008-10#30)(2008-11#16)(2008-12#8)(2008-2#7)(2008-3#3)(2008-4#9)(2008-5#16)(2008-6#3)(2008-7#17)(2008-8#5)(2008-9#4)(2009-1#1)(2009-10#4)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#5)(2009-6#4)(2009-7#2)(2009-8#3)(2009-9#2)(2010-1#2)(2010-11#1)(2010-12#8)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#6)(2011-12#2)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#8)(2012-2#6)(2012-3#10)(2012-4#1)(2012-5#1)(2013-1#15)(2013-7#3)(2013-8#3)
seemed a better##2##3##(2007-9#1)(2012-2#1)
seemed less##2##2##(1990-4#1)(2011-2#1)
seemed likely##3##2##(1993-8#1)(1996-9#1)(2007-8#1)
seemed more##3##2##(2006-8#1)(2008-10#1)(2008-4#1)
seemed not to##2##3##(2011-2#1)(2012-3#1)
seemed not##3##2##(2008-9#1)(2011-2#1)(2012-3#1)
seemed that##8##2##(1990-11#1)(1990-12#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-8#2)
seemed the##2##2##(2009-7#1)(2011-2#1)
seemed to act##2##3##(2005-12#1)(2008-10#1)
seemed to adapt##2##3##(1997-2#2)
seemed to be a protective##2##5##(1993-6#1)(2011-1#1)
seemed to be a##4##4##(1993-6#1)(2008-10#1)(2008-11#1)(2011-1#1)
seemed to be an##2##4##(2007-12#1)(2010-8#1)
seemed to be associated with the##2##6##(1995-6#1)(2008-4#1)
seemed to be associated with##3##5##(1992-11#1)(1995-6#1)(2008-4#1)
seemed to be associated##5##4##(1990-6#1)(1992-11#1)(1993-12#1)(1995-6#1)(2008-4#1)
seemed to be caused by##2##5##(1996-6#1)(2008-8#1)
seemed to be different from##2##5##(2008-10#1)(2008-11#1)
seemed to be higher than##2##5##(1990-9#1)(2007-7#1)
seemed to be less##2##4##(2010-4#1)(2011-1#1)
seemed to be more##7##4##(1991-5#1)(1996-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-5#1)
seemed to be related to##5##5##(1990-9#1)(1992-1#1)(1995-12#1)(2008-9#1)(2011-1#1)
seemed to be related##6##4##(1990-9#1)(1992-1#1)(1995-12#1)(1995-2#1)(2008-9#1)(2011-1#1)
seemed to be the main##3##5##(1992-6#1)(2008-11#1)(2011-1#1)
seemed to be the##12##4##(1992-6#1)(1997-2#1)(1997-4#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#1)(2010-8#2)(2011-1#2)
seemed to be##90##3##(1990-3#1)(1990-6#1)(1990-8#2)(1990-9#3)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-12#1)(1993-6#2)(1993-7#1)(1993-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#3)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#2)(1996-8#1)(1996-9#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#9)(2008-11#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-2#1)(2009-7#1)(2010-4#1)(2010-8#3)(2011-1#6)(2012-2#3)
seemed to correlate with##4##4##(1992-1#1)(1992-9#1)(1997-4#1)(2007-4#1)
seemed to engage in##3##4##(2008-12#3)
seemed to function##2##3##(2008-11#1)(2009-8#1)
seemed to have a##3##4##(1995-5#1)(2009-9#1)(2013-8#1)
seemed to have different##2##4##(2008-10#1)(2011-1#1)
seemed to have no##2##4##(1991-2#1)(2007-10#1)
seemed to have##15##3##(1991-2#1)(1995-5#1)(1997-3#1)(2007-10#1)(2008-1#1)(2008-10#1)(2009-2#1)(2009-9#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
seemed to increase##2##3##(1992-6#1)(1996-6#1)
seemed to indicate##2##3##(2005-8#1)(2009-4#1)
seemed to induce##3##3##(2008-10#2)(2011-2#1)
seemed to need##2##3##(1990-10#1)(2010-10#1)
seemed to reflect##2##3##(1990-11#1)(1994-3#1)
seemed to result in##2##4##(1994-11#1)(2008-10#1)
seemed to##165##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#2)(1990-9#3)(1991-10#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-3#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-7#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#5)(1995-6#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#4)(1996-8#1)(1996-9#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(2004-10#1)(2004-12#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2008-1#3)(2008-10#16)(2008-11#7)(2008-12#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-2#2)(2009-4#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#5)(2011-1#8)(2011-2#3)(2012-1#1)(2012-2#3)(2013-1#3)(2013-8#1)
seemed unrelated to##2##3##(2008-8#1)(2010-8#1)
seemed##210##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#2)(1990-6#1)(1990-8#2)(1990-9#4)(1991-10#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-3#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#5)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-5#1)(1996-6#4)(1996-8#2)(1996-9#3)(1997-2#4)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(2004-10#1)(2004-12#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#19)(2008-11#8)(2008-12#3)(2008-2#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#4)(2009-2#2)(2009-4#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#6)(2011-1#9)(2011-2#7)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
seeming##4##1##(1993-12#1)(2007-7#1)(2007-9#1)(2008-4#1)
seemingly benign##3##2##(2009-5#1)(2012-12#2)
seemingly contradictory findings##2##3##(1993-3#1)(2008-11#1)
seemingly contradictory##3##2##(1993-3#1)(2008-11#1)(2009-3#1)
seemingly disparate##3##2##(1996-11#1)(2008-7#1)(2013-1#1)
seemingly minor##3##2##(1992-9#1)(2007-8#1)(2012-12#1)
seemingly normal##2##2##(2008-7#1)(2009-3#1)
seemingly similar##2##2##(2008-7#1)(2010-2#1)
seemingly simple##2##2##(2008-10#1)(2011-1#1)
seemingly small##2##2##(2010-2#1)(2011-2#1)
seemingly unpredictable##3##2##(2007-1#1)(2013-1#2)
seemingly unrelated##5##2##(1991-2#1)(1997-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
seemingly##75##1##(1990-12#1)(1991-2#1)(1992-2#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-3#1)(1993-7#1)(1995-11#1)(1995-2#1)(1995-9#1)(1996-11#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-8#1)(2004-9#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#6)(2008-8#1)(2009-3#4)(2009-5#1)(2009-6#1)(2010-2#3)(2010-3#1)(2011-1#2)(2011-2#4)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#3)
seems a##9##2##(1993-8#1)(2006-3#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-12#1)(2013-8#1)
seems also to be##2##4##(1991-12#1)(1993-11#1)
seems an appropriate##3##3##(2006-10#1)(2008-7#1)(2011-2#1)
seems an##7##2##(1991-3#1)(2006-10#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)
seems appropriate##2##2##(2008-10#2)
seems at##2##2##(2010-7#1)(2012-3#1)
seems clear that##2##3##(2005-10#1)(2009-4#1)
seems clear##3##2##(2005-10#1)(2009-4#1)(2013-8#1)
seems critical in##2##3##(2006-10#1)(2010-4#1)
seems critical##3##2##(2006-10#1)(2008-9#1)(2010-4#1)
seems crucial##2##2##(2011-1#1)(2013-8#1)
seems especially##2##2##(1994-8#1)(2007-2#1)
seems feasible##2##2##(1993-6#1)(2008-11#1)
seems highly##2##2##(2008-10#1)(2009-10#1)
seems incompatible with##2##3##(2007-8#1)(2008-7#1)
seems likely that the##6##4##(1991-8#1)(1994-12#1)(1995-5#1)(1997-6#1)(2006-10#1)(2007-5#1)
seems likely that##23##3##(1990-11#1)(1990-4#1)(1991-8#1)(1992-11#1)(1992-6#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-4#1)(1997-5#1)(1997-6#1)(2005-10#1)(2006-1#1)(2006-10#2)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-4#1)
seems likely to be##2##4##(1991-10#1)(1992-5#1)
seems likely##28##2##(1990-11#1)(1990-4#1)(1991-10#1)(1991-8#1)(1992-11#1)(1992-5#1)(1992-6#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-4#1)(1997-5#1)(1997-6#1)(2005-10#1)(2006-1#1)(2006-10#2)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#1)(2011-2#1)
seems logical to##2##3##(1994-6#1)(2008-9#1)
seems logical##4##2##(1994-6#1)(2008-9#1)(2010-2#1)(2013-1#1)
seems lower than##2##3##(1991-2#1)(1996-4#1)
seems more appropriate##2##3##(2008-10#1)(2009-7#1)
seems more##8##2##(1993-8#1)(1995-5#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2009-4#1)(2009-7#1)
seems most##2##2##(1991-2#1)(2005-11#1)
seems necessary to##2##3##(1993-2#1)(2008-10#1)
seems not to be##3##4##(1992-7#1)(1996-2#1)(1997-1#1)
seems not to depend##2##4##(1994-2#1)(1994-8#1)
seems not to##11##3##(1990-5#1)(1992-7#1)(1994-2#1)(1994-8#1)(1996-12#1)(1996-2#1)(1997-1#1)(2008-5#3)(2008-8#1)
seems possible that##6##3##(1990-2#1)(1995-11#1)(1997-5#1)(2008-1#1)(2009-4#1)(2010-12#1)
seems possible##14##2##(1990-2#1)(1994-4#1)(1995-11#1)(1996-12#1)(1997-5#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-4#1)(2010-12#1)(2011-2#1)
seems preferable to##2##3##(1993-3#1)(2006-10#1)
seems probable that##3##3##(1995-12#1)(1997-8#1)(2007-2#1)
seems probable##4##2##(1995-12#1)(1997-8#1)(2007-2#1)(2008-5#1)
seems promising##4##2##(1990-4#1)(1990-8#1)(1992-3#1)(2006-8#1)
seems quite##5##2##(1990-7#1)(1991-7#1)(1995-12#1)(1995-7#1)(2006-8#1)
seems reasonable to##9##3##(1990-6#1)(1990-8#1)(1990-9#1)(1993-11#1)(1996-6#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-7#1)
seems reasonable##11##2##(1990-6#1)(1990-8#1)(1990-9#1)(1993-11#1)(1996-6#1)(2006-12#1)(2006-7#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)
seems similar to##2##3##(2008-7#1)(2013-7#1)
seems that a##3##3##(1991-11#1)(2004-2#1)(2010-9#1)
seems that more##2##3##(1990-12#1)(2007-3#1)
seems that the##21##3##(1990-12#1)(1992-11#1)(1997-2#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-1#1)
seems that there are##2##4##(2008-2#1)(2012-3#1)
seems that there##4##3##(2008-2#1)(2008-7#1)(2010-8#1)(2012-3#1)
seems that##82##2##(1990-12#3)(1991-11#2)(1992-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-12#1)(1995-12#1)(1995-8#2)(1997-2#1)(1997-8#1)(2004-2#1)(2005-11#2)(2006-1#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#4)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#1)(2009-5#1)(2009-7#2)(2010-12#2)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
seems the best##2##3##(2006-6#1)(2011-2#1)
seems the##4##2##(2006-6#1)(2008-3#1)(2011-2#1)(2012-2#1)
seems therefore##6##2##(1991-12#1)(1992-3#1)(1995-11#1)(1997-5#1)(2008-1#1)(2009-8#1)
seems to act as##2##4##(1993-6#1)(1996-12#1)
seems to act##5##3##(1993-6#1)(1996-12#1)(2005-10#1)(2008-10#1)(2012-2#1)
seems to affect##2##3##(1997-4#1)(2013-1#1)
seems to be a common##2##5##(1993-11#1)(1993-2#1)
seems to be a good##5##5##(2007-8#1)(2008-3#1)(2009-8#1)(2010-4#1)(2013-7#1)
seems to be a growing##2##5##(1996-1#1)(2006-7#1)
seems to be a major##2##5##(1994-11#1)(2006-10#1)
seems to be a more appropriate##2##6##(2006-10#1)(2008-10#1)
seems to be a promising##4##5##(1996-5#1)(2006-12#1)(2008-5#1)(2012-1#1)
seems to be a rare phenomenon##2##6##(2008-1#1)(2010-7#1)
seems to be a safe##2##5##(1992-3#1)(2012-12#1)
seems to be a sensitive##2##5##(2008-7#1)(2012-3#1)
seems to be a slow process##2##6##(1992-3#1)(2008-1#1)
seems to be a useful##2##5##(1994-11#1)(2006-2#1)
seems to be a##74##4##(1990-11#1)(1991-3#2)(1991-6#1)(1992-3#2)(1993-11#1)(1993-2#1)(1993-3#1)(1994-11#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-1#1)(1996-12#3)(1996-5#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-8#2)(2005-10#1)(2005-8#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-12#2)(2007-5#1)(2007-8#3)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-3#1)(2013-7#1)
seems to be able to##2##5##(1990-5#1)(1993-3#1)
seems to be an appropriate##2##5##(2007-10#1)(2008-9#1)
seems to be an effective##5##5##(1991-10#1)(2007-7#1)(2008-12#2)(2008-7#1)
seems to be an important factor in the##2##8##(1990-10#1)(1993-9#1)
seems to be an important factor##4##6##(1990-10#1)(1992-3#1)(1993-9#1)(2007-2#1)
seems to be an important##7##5##(1990-10#1)(1992-3#1)(1993-9#1)(2007-11#1)(2007-2#1)(2008-8#1)(2013-8#1)
seems to be an interesting##2##5##(2007-8#1)(2012-12#1)
seems to be an##26##4##(1990-10#2)(1990-8#1)(1991-10#1)(1992-3#2)(1993-9#1)(1995-3#1)(1996-7#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#2)(2007-8#1)(2008-12#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
seems to be applicable##2##4##(2008-1#1)(2008-7#1)
seems to be appropriate##3##4##(2008-1#1)(2009-2#1)(2011-2#1)
seems to be associated with a##2##6##(2008-7#1)(2013-1#1)
seems to be associated with##6##5##(1990-4#1)(1994-3#1)(2004-1#1)(2005-11#1)(2008-7#1)(2013-1#1)
seems to be common##2##4##(2008-1#1)(2012-3#1)
seems to be crucial for##2##5##(2006-12#1)(2009-6#1)
seems to be decreasing##2##4##(2006-10#1)(2010-12#1)
seems to be determined by##2##5##(2006-5#1)(2009-10#1)
seems to be directly##2##4##(2009-5#1)(2009-8#1)
seems to be due to the##4##6##(2005-8#1)(2007-5#1)(2008-10#1)(2008-11#1)
seems to be due##5##4##(2005-8#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)
seems to be effective against##2##5##(1997-6#1)(2007-11#1)
seems to be effective in##4##5##(1990-5#1)(2006-10#1)(2007-11#1)(2008-7#1)
seems to be effective##8##4##(1990-5#1)(1997-6#1)(2006-10#1)(2006-6#1)(2007-11#2)(2008-7#1)(2010-4#1)
seems to be enhanced##2##4##(1990-11#1)(1991-10#1)
seems to be equivalent to##2##5##(2007-8#1)(2010-12#1)
seems to be essential for##2##5##(1994-8#1)(2011-2#1)
seems to be generally##2##4##(1991-11#1)(2008-8#1)
seems to be higher than##2##5##(1993-8#2)
seems to be highly##2##4##(1997-3#1)(2006-6#1)
seems to be important##2##4##(1990-2#1)(2008-3#1)
seems to be increasing##2##4##(1994-6#1)(2011-2#1)
seems to be influenced by##2##5##(1991-10#1)(2010-2#1)
seems to be involved in the##2##6##(2007-11#1)(2008-8#1)
seems to be involved in##5##5##(1992-8#1)(1997-3#1)(2007-11#2)(2008-8#1)
seems to be justified##3##4##(1992-6#1)(2007-1#1)(2007-8#1)
seems to be less##4##4##(1993-12#1)(2007-10#1)(2012-12#2)
seems to be mediated by##4##5##(1995-5#1)(2008-5#1)(2008-7#1)(2011-1#1)
seems to be mediated##5##4##(1995-5#1)(1997-5#1)(2008-5#1)(2008-7#1)(2011-1#1)
seems to be more##10##4##(1991-4#1)(1996-8#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)
seems to be most##2##4##(2008-10#1)(2009-11#1)
seems to be of##3##4##(1991-12#1)(1995-11#1)(2008-10#1)
seems to be one of the most##2##7##(1990-5#1)(2008-5#1)
seems to be one of the##4##6##(1990-5#1)(2005-7#1)(2008-5#1)(2010-12#1)
seems to be one##5##4##(1990-5#1)(2005-10#1)(2005-7#1)(2008-5#1)(2010-12#1)
seems to be particularly##2##4##(1995-12#1)(2009-6#1)
seems to be possible##2##4##(1997-8#1)(2008-5#1)
seems to be reached##2##4##(1992-3#1)(1996-8#1)
seems to be related to a##3##6##(1994-8#1)(2006-10#1)(2010-12#1)
seems to be related to the##4##6##(1995-3#1)(2006-6#1)(2008-5#1)(2008-6#1)
seems to be related to##12##5##(1994-8#1)(1995-3#1)(1996-12#1)(2006-10#1)(2006-6#1)(2006-7#1)(2008-5#1)(2008-6#3)(2008-9#1)(2010-12#1)
seems to be related##15##4##(1994-8#1)(1995-11#1)(1995-3#1)(1996-12#1)(2005-11#1)(2006-10#1)(2006-6#1)(2006-7#1)(2008-5#2)(2008-6#3)(2008-9#1)(2010-12#1)
seems to be relatively##3##4##(2005-11#1)(2007-3#1)(2007-8#1)
seems to be responsible for the##3##6##(1993-8#1)(1995-1#1)(2007-10#1)
seems to be responsible for##5##5##(1993-6#1)(1993-8#1)(1995-1#1)(2006-8#1)(2007-10#1)
seems to be responsible##7##4##(1993-5#1)(1993-6#1)(1993-8#1)(1995-1#1)(2004-12#1)(2006-8#1)(2007-10#1)
seems to be restricted##2##4##(1994-2#1)(1996-5#1)
seems to be safe and##5##5##(2006-2#1)(2007-8#2)(2008-1#1)(2013-1#1)
seems to be similar to##2##5##(1990-5#1)(2006-10#1)
seems to be similar##4##4##(1990-1#1)(1990-5#1)(2006-10#1)(2010-9#1)
seems to be suitable for##2##5##(1993-12#1)(1995-4#1)
seems to be superior to##2##5##(2006-10#1)(2008-10#1)
seems to be superior##4##4##(2004-2#1)(2006-10#1)(2008-10#1)(2011-2#1)
seems to be supported by results##2##6##(1991-11#1)(1992-3#1)
seems to be supported by##3##5##(1991-11#1)(1992-3#1)(1993-3#1)
seems to be that##4##4##(1994-6#1)(2006-10#1)(2008-5#1)(2011-2#1)
seems to be the best method for##2##7##(2005-1#1)(2007-4#1)
seems to be the best##4##5##(2005-1#1)(2007-4#1)(2008-10#2)
seems to be the first##2##5##(1994-9#1)(1997-1#1)
seems to be the main##4##5##(1991-1#1)(1997-1#1)(2007-8#1)(2008-7#1)
seems to be the major##2##5##(1991-12#1)(1996-1#1)
seems to be the most promising##2##6##(2006-10#1)(2008-10#1)
seems to be the most##11##5##(1992-11#1)(1997-6#1)(2004-2#1)(2005-11#1)(2006-10#1)(2006-6#1)(2006-9#1)(2008-10#2)(2009-7#1)(2013-8#1)
seems to be the treatment of choice##2##7##(2007-11#1)(2007-7#1)
seems to be the##44##4##(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#1)(1992-11#1)(1992-6#1)(1994-9#1)(1996-1#1)(1996-7#1)(1997-1#2)(1997-6#1)(2004-2#1)(2005-1#1)(2005-11#2)(2006-10#2)(2006-2#1)(2006-6#1)(2006-9#1)(2007-11#5)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#5)(2008-7#1)(2009-7#1)(2009-8#1)(2010-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
seems to be triggered##2##4##(1991-2#1)(2008-11#1)
seems to be unrelated to the##2##6##(1995-12#1)(1996-1#1)
seems to be useful for##2##5##(2008-10#1)(2008-5#1)
seems to be useful in##2##5##(1995-6#1)(2007-7#1)
seems to be useful##5##4##(1995-6#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-5#1)
seems to be very##4##4##(2007-12#1)(2008-10#1)(2011-2#1)(2012-12#1)
seems to be well##2##4##(1994-2#1)(2007-2#1)
seems to be within the##2##5##(2010-11#1)(2013-1#1)
seems to be##423##3##(1990-1#1)(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#6)(1990-6#2)(1990-8#1)(1991-1#1)(1991-10#3)(1991-11#4)(1991-12#4)(1991-2#1)(1991-3#2)(1991-4#2)(1991-6#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#7)(1992-5#1)(1992-6#2)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#4)(1993-4#1)(1993-5#3)(1993-6#2)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#3)(1995-1#1)(1995-11#4)(1995-12#4)(1995-2#1)(1995-3#2)(1995-4#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#3)(1996-12#4)(1996-2#1)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#4)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#5)(2004-1#1)(2004-12#1)(2004-2#2)(2005-1#1)(2005-10#3)(2005-11#7)(2005-7#1)(2005-8#2)(2006-10#19)(2006-12#4)(2006-2#5)(2006-4#2)(2006-5#1)(2006-6#5)(2006-7#3)(2006-8#1)(2006-9#2)(2007-1#5)(2007-10#3)(2007-11#13)(2007-12#4)(2007-2#4)(2007-3#1)(2007-4#2)(2007-5#3)(2007-7#5)(2007-8#14)(2007-9#2)(2008-1#9)(2008-10#18)(2008-11#8)(2008-12#5)(2008-2#1)(2008-3#6)(2008-5#16)(2008-6#8)(2008-7#10)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#5)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#10)(2012-1#3)(2012-12#6)(2012-2#4)(2012-3#4)(2012-8#1)(2013-1#4)(2013-7#1)(2013-8#2)
seems to become##2##3##(2009-6#1)(2011-2#1)
seems to bind##2##3##(1994-11#1)(2008-8#1)
seems to confirm the##2##4##(1996-3#1)(2009-8#1)
seems to confirm##3##3##(1991-11#1)(1996-3#1)(2009-8#1)
seems to consist of##3##4##(1990-2#1)(2008-1#1)(2008-2#1)
seems to contain##3##3##(1990-5#1)(1992-12#1)(1993-8#1)
seems to correlate with##2##4##(1990-2#1)(2006-6#1)
seems to correlate##3##3##(1990-2#1)(1990-8#1)(2006-6#1)
seems to correspond to##2##4##(1991-11#1)(2012-12#1)
seems to depend on##5##4##(1992-5#1)(1992-8#1)(1994-12#1)(2008-7#1)(2008-8#1)
seems to depend upon the##2##5##(1992-6#1)(1995-5#1)
seems to depend##9##3##(1992-5#1)(1992-6#1)(1992-8#1)(1994-12#1)(1995-5#1)(2006-9#1)(2007-10#1)(2008-7#1)(2008-8#1)
seems to exert a##2##4##(1992-6#1)(2006-2#1)
seems to exert##3##3##(1992-6#1)(1993-3#1)(2006-2#1)
seems to exist##2##3##(1995-12#1)(2008-1#1)
seems to follow##2##3##(1992-2#1)(2011-1#1)
seems to give##3##3##(2007-8#1)(2008-10#1)(2008-5#1)
seems to have a##5##4##(2008-11#1)(2008-9#2)(2010-12#1)(2010-8#1)
seems to have an##3##4##(1994-9#1)(1997-4#1)(2013-1#1)
seems to have been##3##4##(1990-9#1)(2008-10#1)(2008-7#1)
seems to have more##2##4##(2008-10#1)(2009-11#1)
seems to have no##2##4##(2008-4#1)(2008-7#1)
seems to have the##2##4##(1996-2#1)(1997-8#1)
seems to have##35##3##(1990-5#1)(1990-9#1)(1991-9#1)(1993-11#1)(1993-6#2)(1994-11#1)(1994-2#1)(1994-9#1)(1996-2#1)(1997-4#1)(1997-8#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-11#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#2)
seems to improve##4##3##(2007-6#1)(2008-10#1)(2010-12#1)(2011-2#1)
seems to increase##2##3##(1991-2#1)(2008-3#1)
seems to indicate that##4##4##(1994-2#1)(2008-10#1)(2010-12#1)(2010-8#1)
seems to indicate##5##3##(1993-3#1)(1994-2#1)(2008-10#1)(2010-12#1)(2010-8#1)
seems to induce similar##2##4##(2006-11#1)(2007-9#1)
seems to induce##3##3##(1994-6#1)(2006-11#1)(2007-9#1)
seems to influence##2##3##(1992-9#1)(2013-1#1)
seems to interact with##2##4##(1993-11#1)(1995-6#1)
seems to involve##5##3##(1991-1#1)(1994-11#1)(1996-6#1)(2009-2#1)(2012-12#1)
seems to lie##2##3##(2007-8#1)(2012-2#1)
seems to make##2##3##(1991-4#1)(1997-7#1)
seems to modulate##2##3##(2009-8#1)(2012-3#1)
seems to occur##4##3##(1991-1#1)(1995-7#1)(2006-10#1)(2013-8#1)
seems to play a pivotal role##2##6##(2008-11#1)(2008-4#1)
seems to play a role in##3##6##(2006-4#1)(2008-1#1)(2010-7#1)
seems to play a##7##4##(2006-4#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-12#1)(2010-7#1)
seems to play an important role##2##6##(2008-3#1)(2009-2#1)
seems to play an##4##4##(1991-12#1)(2006-10#1)(2008-3#1)(2009-2#1)
seems to play##14##3##(1991-1#1)(1991-12#1)(2006-10#1)(2006-4#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-2#1)(2010-12#1)(2010-7#1)
seems to predominate##2##3##(2006-10#1)(2008-10#1)
seems to prevent##4##3##(1993-9#1)(1995-8#1)(2008-7#1)(2013-1#1)
seems to produce both##2##4##(1991-1#1)(1991-5#1)
seems to produce##5##3##(1990-4#1)(1991-1#1)(1991-5#1)(1992-10#1)(2006-10#1)
seems to provide##4##3##(2006-10#1)(2007-8#1)(2008-10#1)(2008-4#1)
seems to reduce the##2##4##(1992-12#1)(1996-3#1)
seems to reduce##5##3##(1992-12#1)(1992-5#1)(1996-3#1)(2010-4#1)(2012-2#1)
seems to represent##2##3##(1990-2#1)(2008-7#1)
seems to yield##2##3##(1991-3#1)(1992-10#1)
seems to##650##2##(1990-1#1)(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#6)(1990-3#1)(1990-4#2)(1990-5#8)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#5)(1991-10#4)(1991-11#6)(1991-12#5)(1991-2#2)(1991-3#3)(1991-4#3)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#7)(1992-5#4)(1992-6#4)(1992-8#2)(1992-9#1)(1993-10#1)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#7)(1993-4#1)(1993-5#3)(1993-6#5)(1993-8#4)(1993-9#2)(1994-10#1)(1994-11#5)(1994-12#3)(1994-2#6)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#3)(1994-8#3)(1994-9#4)(1995-1#1)(1995-11#4)(1995-12#8)(1995-2#1)(1995-3#2)(1995-4#2)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#2)(1996-1#3)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#2)(1996-5#3)(1996-6#2)(1996-7#2)(1996-8#5)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#5)(1997-7#3)(1997-8#7)(2004-1#1)(2004-12#1)(2004-2#2)(2005-1#1)(2005-10#5)(2005-11#8)(2005-3#1)(2005-7#2)(2005-8#2)(2006-10#25)(2006-11#1)(2006-12#4)(2006-2#7)(2006-4#5)(2006-5#1)(2006-6#6)(2006-7#3)(2006-8#1)(2006-9#3)(2007-1#5)(2007-10#5)(2007-11#17)(2007-12#7)(2007-2#5)(2007-3#2)(2007-4#2)(2007-5#3)(2007-6#1)(2007-7#8)(2007-8#18)(2007-9#4)(2008-1#15)(2008-10#33)(2008-11#13)(2008-12#5)(2008-2#4)(2008-3#10)(2008-4#3)(2008-5#21)(2008-6#9)(2008-7#17)(2008-8#8)(2008-9#6)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#4)(2009-7#1)(2009-8#7)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#10)(2010-2#2)(2010-3#1)(2010-4#5)(2010-6#1)(2010-7#3)(2010-8#5)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#12)(2012-1#4)(2012-12#9)(2012-2#8)(2012-3#8)(2012-8#1)(2013-1#10)(2013-7#1)(2013-8#3)
seems too##2##2##(1996-8#1)(2011-1#1)
seems unlikely that the##2##4##(2006-8#1)(2008-11#1)
seems unlikely that##5##3##(1990-10#1)(1990-5#1)(2006-8#1)(2008-11#1)(2012-11#1)
seems unlikely to##2##3##(1992-10#1)(1993-11#1)
seems unlikely##9##2##(1990-10#1)(1990-11#1)(1990-5#1)(1992-10#1)(1993-11#1)(2006-8#1)(2008-10#1)(2008-11#1)(2012-11#1)
seems variable##2##2##(2007-12#2)
seems very##3##2##(1992-6#1)(1997-9#1)(2006-5#1)
seems well established##2##3##(2004-12#1)(2009-8#1)
seems well##3##2##(2004-12#1)(2007-8#1)(2009-8#1)
seems##989##1##(1990-1#1)(1990-10#4)(1990-11#5)(1990-12#5)(1990-2#8)(1990-3#1)(1990-4#4)(1990-5#10)(1990-6#3)(1990-7#2)(1990-8#6)(1990-9#2)(1991-1#5)(1991-10#5)(1991-11#10)(1991-12#8)(1991-2#4)(1991-3#6)(1991-4#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#4)(1992-1#3)(1992-10#3)(1992-11#4)(1992-12#3)(1992-2#1)(1992-3#9)(1992-5#5)(1992-6#7)(1992-7#2)(1992-8#2)(1992-9#1)(1993-10#1)(1993-11#6)(1993-12#5)(1993-2#2)(1993-3#8)(1993-4#1)(1993-5#3)(1993-6#7)(1993-8#7)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#5)(1994-12#6)(1994-2#7)(1994-3#2)(1994-4#2)(1994-5#2)(1994-6#5)(1994-8#6)(1994-9#4)(1995-1#1)(1995-11#6)(1995-12#11)(1995-2#2)(1995-3#3)(1995-4#2)(1995-5#6)(1995-6#4)(1995-7#2)(1995-8#4)(1996-1#3)(1996-11#1)(1996-12#8)(1996-2#4)(1996-3#3)(1996-4#3)(1996-5#4)(1996-6#4)(1996-7#2)(1996-8#6)(1996-9#1)(1997-1#4)(1997-2#3)(1997-3#3)(1997-4#3)(1997-5#5)(1997-6#6)(1997-7#3)(1997-8#10)(1997-9#1)(2004-1#1)(2004-12#2)(2004-2#3)(2005-1#1)(2005-10#8)(2005-11#12)(2005-3#1)(2005-4#1)(2005-7#3)(2005-8#2)(2006-1#2)(2006-10#32)(2006-11#2)(2006-12#7)(2006-2#7)(2006-3#2)(2006-4#5)(2006-5#4)(2006-6#8)(2006-7#4)(2006-8#5)(2006-9#6)(2007-1#5)(2007-10#5)(2007-11#25)(2007-12#12)(2007-2#7)(2007-3#4)(2007-4#2)(2007-5#4)(2007-6#1)(2007-7#11)(2007-8#22)(2007-9#7)(2008-1#21)(2008-10#51)(2008-11#21)(2008-12#11)(2008-2#9)(2008-3#17)(2008-4#6)(2008-5#32)(2008-6#14)(2008-7#26)(2008-8#14)(2008-9#10)(2009-10#4)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#5)(2009-5#4)(2009-6#6)(2009-7#4)(2009-8#9)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#14)(2010-2#3)(2010-3#3)(2010-4#6)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#6)(2010-9#2)(2011-1#9)(2011-12#4)(2011-2#22)(2012-1#7)(2012-11#1)(2012-12#11)(2012-2#14)(2012-3#10)(2012-8#1)(2013-1#17)(2013-7#3)(2013-8#6)
seen a considerable##2##3##(2012-12#1)(2013-1#1)
seen a dramatic increase##4##4##(2006-10#1)(2006-12#1)(2006-6#1)(2011-2#1)
seen a large##2##3##(2008-3#1)(2008-7#1)
seen a small##2##3##(1994-8#1)(2005-11#1)
seen a##27##2##(1992-8#1)(1994-8#1)(2005-11#1)(2006-10#5)(2006-12#1)(2006-6#1)(2007-2#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#3)(2009-12#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
seen after injection of##3##4##(1991-8#1)(1993-4#1)(2012-1#1)
seen after the##6##3##(1991-2#1)(1994-8#1)(1996-5#1)(2007-10#1)(2007-12#1)(2011-2#1)
seen after##42##2##(1990-11#2)(1990-2#1)(1991-2#1)(1991-5#1)(1991-8#2)(1992-1#1)(1992-2#1)(1993-4#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#3)(1996-2#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-5#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-7#1)
seen along the##2##3##(2008-5#1)(2012-11#1)
seen among##12##2##(1993-3#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-5#1)(2009-12#1)(2009-5#1)(2013-1#1)
seen an##8##2##(2006-10#1)(2006-11#1)(2008-7#1)(2009-10#1)(2011-2#1)(2013-1#2)(2013-7#1)
seen and##9##2##(1990-9#1)(1997-6#1)(2005-7#1)(2007-5#1)(2007-8#1)(2008-6#1)(2008-8#1)(2010-7#1)(2012-3#1)
seen as a##39##3##(1990-12#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-3#1)(1993-12#1)(1996-9#1)(1997-2#1)(2005-8#1)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#2)(2009-8#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-1#4)(2012-12#1)(2013-1#1)(2013-8#1)
seen as an increase##2##4##(1991-8#1)(2007-8#1)
seen as an opportunity to##2##5##(2008-10#1)(2008-12#1)
seen as an##13##3##(1990-12#1)(1991-8#1)(1992-11#1)(2006-1#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-12#1)(2009-4#1)(2012-1#1)(2012-12#2)
seen as being##2##3##(1992-3#1)(1996-9#1)
seen as having##3##3##(2006-5#1)(2007-8#1)(2011-1#1)
seen as part of##2##4##(2008-12#1)(2010-11#1)
seen as the##13##3##(1993-3#1)(1994-1#1)(1996-2#1)(2004-10#1)(2007-5#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-8#1)(2013-1#2)
seen as##106##2##(1990-12#2)(1991-10#1)(1991-8#2)(1992-1#1)(1992-10#2)(1992-11#2)(1992-3#2)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-8#1)(1995-1#1)(1996-2#1)(1996-9#2)(1997-2#1)(1997-5#1)(1997-7#1)(2004-10#1)(2004-9#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#2)(2006-12#1)(2006-5#2)(2006-7#2)(2006-8#2)(2007-1#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#3)(2008-11#10)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#5)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
seen at 1##3##3##(1993-8#1)(1994-5#1)(2005-7#1)
seen at 3##2##3##(1991-2#1)(2005-8#1)
seen at 7##2##3##(1995-2#1)(2006-3#1)
seen at ACH##4##3##(2007-2#4)
seen at a##4##3##(1991-11#1)(1994-3#1)(2008-6#1)(2011-2#1)
seen at concentrations##4##3##(1991-3#1)(1995-3#1)(1996-5#1)(2008-5#1)
seen at our##5##3##(1994-7#1)(1997-4#1)(2007-10#1)(2007-9#1)(2008-6#1)
seen at the University##2##4##(2006-8#1)(2012-12#1)
seen at the##20##3##(1990-5#1)(1991-10#1)(1991-11#1)(1994-4#1)(1996-5#2)(2006-10#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-3#2)(2008-10#1)(2008-7#1)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
seen at##81##2##(1990-10#1)(1990-12#1)(1990-5#3)(1990-7#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#2)(1993-8#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-2#1)(1995-3#1)(1996-5#3)(1996-9#1)(1997-1#1)(1997-4#1)(2004-11#1)(2005-7#2)(2005-8#1)(2006-10#3)(2006-3#1)(2006-8#3)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#7)(2007-3#5)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)
seen before##2##2##(1991-6#1)(2008-5#1)
seen between January##4##3##(2007-7#1)(2008-7#1)(2008-8#1)(2012-3#1)
seen between groups##3##3##(1993-2#1)(1996-10#1)(2010-11#1)
seen between the groups##2##4##(2010-12#1)(2012-2#1)
seen between the two groups##2##5##(1993-9#1)(1997-6#1)
seen between the two##3##4##(1993-7#1)(1993-9#1)(1997-6#1)
seen between the##9##3##(1993-7#1)(1993-9#1)(1997-1#1)(1997-6#1)(2004-3#1)(2006-8#1)(2008-8#1)(2010-12#1)(2012-2#1)
seen between##35##2##(1991-1#1)(1992-8#1)(1993-2#1)(1993-7#1)(1993-9#1)(1995-10#1)(1996-10#1)(1997-1#1)(1997-2#1)(1997-6#2)(1997-7#1)(2004-3#1)(2006-10#1)(2006-8#2)(2007-3#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#3)(2008-7#2)(2008-8#2)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
seen both in##2##3##(1993-9#1)(2008-10#1)
seen both##6##2##(1993-9#1)(1995-2#1)(2004-11#1)(2006-1#1)(2007-1#1)(2008-10#1)
seen by a neurologist##2##4##(2010-12#2)
seen by a##7##3##(1994-2#1)(1996-11#1)(2007-3#1)(2010-12#2)(2010-2#1)(2012-12#1)
seen by an##2##3##(1994-9#1)(1996-3#1)
seen by the##11##3##(1993-12#1)(1994-6#1)(1995-3#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-7#1)
seen by##46##2##(1990-7#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-2#3)(1994-6#1)(1994-9#2)(1995-2#1)(1995-3#1)(1996-11#2)(1996-3#1)(1997-4#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-8#2)(2007-1#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#3)(2008-7#1)(2008-9#1)(2009-7#1)(2010-12#3)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
seen disorder##2##2##(2007-11#1)(2010-1#1)
seen due to##2##3##(1991-3#1)(2008-3#1)
seen during a##5##3##(1992-6#2)(2007-2#1)(2008-4#1)(2012-2#1)
seen during the##9##3##(1990-12#1)(1990-5#1)(1991-12#1)(1994-2#1)(1994-6#1)(2005-12#1)(2007-7#1)(2012-3#1)(2013-1#1)
seen during water deprivation##2##4##(1995-7#2)
seen during##31##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-6#1)(1992-12#2)(1992-6#2)(1994-2#1)(1994-6#1)(1995-7#2)(1997-4#1)(2004-3#1)(2005-12#1)(2007-10#2)(2007-2#2)(2007-7#2)(2008-1#1)(2008-4#2)(2008-7#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
seen first##2##2##(1990-10#1)(2005-8#1)
seen five##2##2##(1993-11#1)(1993-3#1)
seen following infusion of##2##4##(1991-11#2)
seen following##13##2##(1991-11#4)(1991-3#1)(1993-6#1)(1993-7#1)(1996-1#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)
seen for a##2##3##(1991-9#1)(2008-5#1)
seen for both##4##3##(1997-4#1)(1997-5#1)(1997-7#1)(2011-1#1)
seen for the first time in##2##6##(2005-7#1)(2009-9#1)
seen for the first time##3##5##(2005-7#1)(2008-7#1)(2009-9#1)
seen for the##6##3##(1991-10#1)(1995-6#1)(1997-7#1)(2005-7#1)(2008-7#1)(2009-9#1)
seen for their##2##3##(1991-2#1)(1995-2#1)
seen for up to##2##4##(1995-5#1)(2007-11#1)
seen for##44##2##(1990-4#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-6#1)(1992-7#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-2#2)(1995-5#2)(1995-6#1)(1996-1#2)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#2)(2005-7#1)(2006-2#1)(2006-6#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
seen frequently##2##2##(2008-2#1)(2008-5#1)
seen from a##2##3##(1990-8#1)(2008-2#1)
seen from the##8##3##(1990-5#1)(1992-11#1)(1995-10#1)(1997-6#1)(2007-3#1)(2008-10#1)(2008-2#1)(2012-2#1)
seen from##17##2##(1990-5#1)(1990-8#1)(1992-11#1)(1995-10#1)(1997-6#1)(2006-4#1)(2006-9#1)(2007-3#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2012-2#3)
seen great##2##2##(2008-7#1)(2013-1#1)
seen in 1##2##3##(2006-10#1)(2008-10#1)
seen in 100%##3##3##(1991-2#1)(2012-3#1)(2013-1#1)
seen in 12 cases##3##4##(1992-3#1)(2005-12#1)(2008-3#1)
seen in 12##4##3##(1992-3#1)(2005-12#1)(2006-2#1)(2008-3#1)
seen in 13##2##3##(2006-11#1)(2012-12#1)
seen in 15##2##3##(2007-10#1)(2008-6#1)
seen in 1998##2##3##(2005-9#1)(2008-8#1)
seen in 2 patients##2##4##(2007-8#1)(2008-7#1)
seen in 2##4##3##(2006-10#1)(2007-7#1)(2007-8#1)(2008-7#1)
seen in 2006##2##3##(2010-5#1)(2012-3#1)
seen in 22##2##3##(2007-7#1)(2011-2#1)
seen in 28##3##3##(2007-7#1)(2007-8#1)(2011-2#1)
seen in 29##2##3##(2006-7#1)(2012-2#1)
seen in 4##4##3##(1996-2#1)(2007-7#1)(2007-8#1)(2008-8#1)
seen in 5 patients##2##4##(1993-9#1)(2006-10#1)
seen in 6%##2##3##(2006-2#1)(2008-1#1)
seen in 7##2##3##(1997-8#1)(2007-7#1)
seen in 8##4##3##(1990-11#1)(2007-10#2)(2007-7#1)
seen in Crohn's disease##2##4##(2006-10#1)(2008-4#1)
seen in Western##2##3##(2008-3#1)(2010-6#1)
seen in a patient with##2##5##(2007-7#1)(2008-12#1)
seen in a variety of##3##5##(1996-12#1)(2009-8#1)(2011-2#1)
seen in a##19##3##(1991-11#1)(1994-5#1)(1995-6#1)(1996-12#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-7#1)(2009-8#1)(2010-10#1)(2011-2#2)(2012-2#1)(2012-3#1)
seen in acute##2##3##(1990-10#1)(2006-2#1)
seen in adult##3##3##(1995-11#1)(2006-10#1)(2007-12#1)
seen in adults##4##3##(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)
seen in all cases##2##4##(2007-8#1)(2010-1#1)
seen in all patients##4##4##(1997-1#1)(2005-11#1)(2008-5#1)(2008-6#1)
seen in all the##2##4##(2007-8#1)(2008-1#1)
seen in all##18##3##(1992-9#2)(1995-2#1)(1997-1#1)(2005-11#1)(2006-12#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-5#2)(2008-6#2)(2009-8#1)(2010-1#1)(2011-2#1)
seen in an##4##3##(1997-6#1)(2005-7#1)(2006-10#1)(2012-1#1)
seen in animals##2##3##(1992-10#1)(1995-6#1)
seen in any of the##4##5##(2005-12#1)(2007-7#1)(2008-5#2)
seen in any##7##3##(2005-12#1)(2007-3#1)(2007-7#1)(2008-5#2)(2012-12#1)(2013-8#1)
seen in association with##5##4##(2005-11#1)(2008-10#1)(2009-9#1)(2010-6#1)(2013-1#1)
seen in both the##2##4##(1997-6#1)(2007-12#1)
seen in both##10##3##(1996-12#2)(1997-6#1)(2005-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)
seen in cells##3##3##(1994-8#1)(1995-8#1)(2010-11#1)
seen in certain##2##3##(1996-1#1)(2007-11#1)
seen in childhood##2##3##(2007-8#1)(2009-12#1)
seen in children with##3##4##(2007-7#1)(2011-1#2)
seen in children##11##3##(1996-3#1)(2005-11#1)(2006-5#1)(2007-7#1)(2011-1#3)(2011-2#1)(2012-12#2)(2013-8#1)
seen in chronic##3##3##(1995-1#1)(2006-8#1)(2012-12#1)
seen in clinical##2##3##(2008-12#1)(2012-12#1)
seen in control##3##3##(1993-11#1)(1995-5#1)(2006-11#1)
seen in diabetic##4##3##(1990-12#1)(1994-12#1)(2008-9#1)(2012-3#1)
seen in elderly##2##3##(2006-10#1)(2010-8#1)
seen in emergency departments##3##4##(2007-3#1)(2007-7#1)(2009-9#1)
seen in general##3##3##(2007-7#1)(2010-4#2)
seen in immunocompetent##2##3##(2009-9#1)(2013-8#1)
seen in immunocompromised patients##2##4##(2005-8#1)(2010-9#1)
seen in inflammatory##2##3##(2004-9#1)(2010-12#1)
seen in liver##2##3##(2004-11#1)(2008-12#1)
seen in male or female Tg##3##6##(2008-9#3)
seen in male##8##3##(1992-11#1)(1996-11#1)(2008-9#4)(2012-2#1)(2012-3#1)
seen in males##2##3##(1993-7#1)(2009-1#1)
seen in many##3##3##(2008-12#1)(2008-7#1)(2011-1#1)
seen in mice##3##3##(1996-10#1)(1996-5#1)(2013-8#1)
seen in most##4##3##(1996-5#1)(2008-10#1)(2010-6#2)
seen in normal##2##3##(2006-2#1)(2009-9#1)
seen in one##5##3##(1994-12#1)(2008-5#2)(2008-7#1)(2008-9#1)
seen in other##13##3##(1990-4#1)(1992-2#1)(1992-9#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-7#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-4#1)
seen in our hospital##2##4##(1990-6#1)(2007-7#1)
seen in our patient##2##4##(2006-1#1)(2013-7#1)
seen in our patients##3##4##(2007-4#1)(2008-1#2)
seen in our##11##3##(1990-6#1)(1991-11#1)(2006-1#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2013-1#2)(2013-7#1)
seen in patients in whom##2##5##(1991-11#1)(2007-3#1)
seen in patients with##24##4##(1991-3#1)(1992-5#1)(1993-11#1)(1993-7#1)(1995-1#1)(1995-10#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-1#1)(2012-3#1)(2013-7#1)
seen in patients##34##3##(1990-3#1)(1991-11#1)(1991-3#1)(1992-11#1)(1992-4#1)(1992-5#1)(1993-11#1)(1993-7#1)(1995-1#1)(1995-10#1)(1995-12#1)(2005-10#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-1#1)(2011-11#1)(2012-3#1)(2013-7#1)
seen in previously reported models##2##5##(1994-5#2)
seen in rat##2##3##(1993-3#1)(1995-11#1)
seen in rats##5##3##(1993-7#1)(1995-11#1)(1996-1#1)(2008-9#1)(2011-2#1)
seen in response to##4##4##(1995-6#1)(1995-7#1)(1997-1#1)(2008-11#1)
seen in seven##2##3##(1991-12#1)(2009-8#1)
seen in some##5##3##(1992-9#1)(1993-7#1)(2007-11#1)(2008-9#1)(2013-7#1)
seen in sporadic##2##3##(1992-3#1)(2010-2#1)
seen in surgical##2##3##(1990-4#1)(2012-12#1)
seen in the absence of##2##5##(1990-8#1)(1990-9#1)
seen in the area##2##4##(1991-11#1)(2004-12#1)
seen in the case of##2##5##(1996-10#1)(2012-2#1)
seen in the case##3##4##(1996-10#1)(2008-7#1)(2012-2#1)
seen in the control##2##4##(1994-8#1)(2012-2#1)
seen in the crystal##2##4##(1994-5#1)(1995-1#1)
seen in the emergency department##2##5##(2010-12#1)(2011-2#1)
seen in the emergency##3##4##(2007-3#1)(2010-12#1)(2011-2#1)
seen in the field##3##4##(2007-8#1)(2008-10#1)(2008-8#1)
seen in the first##5##4##(1996-9#1)(2007-7#1)(2008-1#1)(2008-8#1)(2012-2#1)
seen in the frontal##2##4##(1996-12#1)(2008-7#1)
seen in the incidence##2##4##(1994-12#1)(2008-7#1)
seen in the lower##2##4##(2013-8#2)
seen in the mouse##2##4##(1996-5#1)(2013-8#1)
seen in the normal##2##4##(1994-10#1)(1997-2#1)
seen in the nucleus##2##4##(1997-8#1)(2011-2#1)
seen in the past##3##4##(2005-7#1)(2006-8#1)(2008-10#1)
seen in the presence of##2##5##(1993-12#1)(1995-5#1)
seen in the present##2##4##(1997-2#1)(2011-1#1)
seen in the right##2##4##(2008-4#1)(2010-9#1)
seen in the##193##3##(1990-12#2)(1990-2#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-10#3)(1991-11#1)(1991-12#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-4#2)(1993-6#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#2)(1995-1#2)(1995-11#1)(1995-12#1)(1995-4#1)(1995-5#2)(1995-8#2)(1995-9#2)(1996-10#1)(1996-12#7)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#2)(1997-2#4)(1997-3#1)(1997-4#3)(1997-6#2)(1997-8#2)(2004-12#1)(2004-4#1)(2005-10#1)(2005-12#3)(2005-3#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#3)(2006-9#2)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#4)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#8)(2008-8#4)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#9)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#2)(2013-8#5)
seen in their##3##3##(1991-12#1)(2008-3#1)(2008-7#1)
seen in these patients##6##4##(2007-1#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-5#1)(2013-1#1)
seen in these two##2##4##(2007-2#1)(2008-8#1)
seen in these##11##3##(1990-12#1)(2007-1#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#2)(2009-5#1)(2012-2#1)(2013-1#1)
seen in this case##2##4##(2008-8#1)(2012-2#1)
seen in this##9##3##(1991-3#1)(2006-10#1)(2006-4#1)(2006-7#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-5#1)(2012-2#1)
seen in three##5##3##(1993-7#1)(1997-6#1)(2004-1#1)(2007-1#1)(2013-8#1)
seen in various##2##3##(2011-1#1)(2012-3#1)
seen in vertebrates##3##3##(1991-11#1)(1995-5#1)(2008-8#1)
seen in vitro##3##3##(1992-3#1)(1993-9#1)(1997-4#1)
seen in women##4##3##(1991-4#1)(2004-2#1)(2005-3#1)(2013-8#1)
seen in young##7##3##(2006-1#1)(2006-10#1)(2006-3#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#1)
seen in##902##2##(1990-10#2)(1990-11#2)(1990-12#6)(1990-2#3)(1990-3#3)(1990-4#2)(1990-5#2)(1990-6#2)(1990-8#2)(1990-9#2)(1991-10#3)(1991-11#6)(1991-12#10)(1991-2#4)(1991-3#3)(1991-4#1)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#2)(1992-11#4)(1992-12#3)(1992-2#1)(1992-3#5)(1992-4#3)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#7)(1993-11#4)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#3)(1993-5#1)(1993-6#1)(1993-7#6)(1993-8#1)(1993-9#5)(1994-10#1)(1994-11#2)(1994-12#5)(1994-2#3)(1994-5#7)(1994-6#1)(1994-7#2)(1994-8#8)(1995-1#4)(1995-10#2)(1995-11#9)(1995-12#6)(1995-2#4)(1995-3#1)(1995-4#1)(1995-5#5)(1995-6#7)(1995-7#2)(1995-8#7)(1995-9#3)(1996-1#4)(1996-10#3)(1996-11#2)(1996-12#12)(1996-2#3)(1996-3#5)(1996-4#1)(1996-5#8)(1996-6#4)(1996-7#2)(1996-8#2)(1996-9#3)(1997-1#2)(1997-2#5)(1997-3#4)(1997-4#6)(1997-5#1)(1997-6#6)(1997-7#3)(1997-8#7)(2004-1#2)(2004-11#1)(2004-12#1)(2004-2#2)(2004-4#1)(2004-9#1)(2005-10#5)(2005-11#4)(2005-12#7)(2005-3#2)(2005-7#4)(2005-8#5)(2005-9#1)(2006-1#2)(2006-10#21)(2006-11#5)(2006-12#4)(2006-2#4)(2006-3#2)(2006-4#4)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#17)(2006-9#2)(2007-1#2)(2007-10#10)(2007-11#11)(2007-12#19)(2007-2#8)(2007-3#9)(2007-4#6)(2007-5#3)(2007-6#2)(2007-7#37)(2007-8#19)(2007-9#8)(2008-1#16)(2008-10#31)(2008-11#9)(2008-12#11)(2008-2#2)(2008-3#12)(2008-4#14)(2008-5#29)(2008-6#7)(2008-7#23)(2008-8#14)(2008-9#14)(2009-1#2)(2009-12#1)(2009-2#2)(2009-4#2)(2009-5#3)(2009-7#2)(2009-8#5)(2009-9#6)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#7)(2010-2#4)(2010-4#2)(2010-5#2)(2010-6#4)(2010-7#2)(2010-8#4)(2010-9#5)(2011-1#11)(2011-11#2)(2011-12#2)(2011-2#25)(2012-1#5)(2012-11#2)(2012-12#21)(2012-2#26)(2012-3#13)(2012-8#1)(2013-1#15)(2013-7#5)(2013-8#17)
seen limited##2##2##(2011-2#1)(2012-1#1)
seen mainly in##2##3##(1992-11#1)(1996-9#1)
seen many advances##2##3##(2006-10#1)(2013-8#1)
seen many##3##2##(2006-10#1)(2008-1#1)(2013-8#1)
seen more commonly in patients with##2##6##(2005-8#1)(2007-2#1)
seen more commonly in##3##4##(2005-8#1)(2007-2#1)(2008-8#1)
seen more commonly##4##3##(2005-8#1)(2007-2#1)(2008-8#1)(2012-12#1)
seen more frequently in##2##4##(1996-11#1)(2009-5#1)
seen more frequently##4##3##(1996-11#1)(2008-10#1)(2008-7#1)(2009-5#1)
seen more often in##3##4##(2013-1#3)
seen more often##4##3##(2012-2#1)(2013-1#3)
seen more##16##2##(1991-9#1)(1996-11#1)(2005-8#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
seen mostly in##2##3##(2011-2#1)(2012-11#1)
seen much##2##2##(2008-11#2)
seen not##2##2##(1991-5#1)(2005-11#1)
seen often##2##2##(1997-3#1)(2007-3#1)
seen on a##2##3##(1990-8#1)(2008-2#1)
seen on follow-up MR##2##4##(1996-6#2)
seen on follow-up##3##3##(1996-6#2)(2006-12#1)
seen on the##13##3##(1990-2#1)(1991-6#1)(1991-9#1)(1992-12#1)(1996-2#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-6#1)(2010-12#1)(2011-2#2)
seen on ultrasound##3##3##(2007-7#1)(2012-2#2)
seen on##51##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-6#1)(1991-9#1)(1992-12#1)(1993-4#1)(1994-7#1)(1995-12#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-6#2)(1997-3#1)(1997-8#2)(2006-10#2)(2006-12#2)(2006-6#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-4#1)(2007-7#3)(2007-9#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-9#1)(2010-12#2)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#3)(2013-8#1)
seen only in##4##3##(1995-2#1)(1996-1#1)(2008-5#1)(2012-12#1)
seen only when##2##3##(1994-9#1)(1995-11#1)
seen only##10##2##(1990-2#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-6#1)(1997-2#1)(2008-5#1)(2012-12#1)
seen over a period of##4##5##(1997-8#1)(2007-3#1)(2007-7#1)(2008-1#1)
seen over a##5##3##(1997-8#1)(2007-3#1)(2007-7#2)(2008-1#1)
seen over##7##2##(1997-8#1)(2007-2#1)(2007-3#1)(2007-7#2)(2008-1#1)(2011-1#1)
seen predominantly in##2##3##(2007-7#1)(2008-3#1)
seen previously##2##2##(1994-8#1)(2010-12#1)
seen primarily##2##2##(1995-2#1)(2006-10#1)
seen significant##2##2##(2009-3#1)(2013-8#1)
seen some##2##2##(1997-8#1)(2006-10#1)
seen spontaneously##2##2##(2008-7#2)
seen substantial##2##2##(2005-11#1)(2010-5#1)
seen that the##8##3##(1996-1#1)(2007-3#1)(2008-10#1)(2008-2#2)(2008-3#2)(2010-12#1)
seen that##25##2##(1995-4#1)(1996-1#1)(2006-4#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-8#1)(2009-6#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
seen the##10##2##(1993-6#1)(1995-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-9#2)(2009-5#1)(2010-5#1)(2012-1#1)
seen through##4##2##(2008-5#1)(2009-2#1)(2009-4#1)(2011-2#1)
seen throughout the##5##3##(1993-12#1)(1993-3#1)(1997-3#1)(2007-1#1)(2007-9#1)
seen to be a##3##4##(1992-1#1)(2008-10#1)(2012-2#1)
seen to be##25##3##(1990-4#1)(1992-1#1)(1992-2#1)(1993-5#1)(1993-6#1)(1994-7#1)(1995-8#1)(1996-4#1)(1997-2#1)(1997-7#1)(2005-11#1)(2006-1#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-8#1)(2010-8#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-1#1)
seen to contain##3##3##(1994-8#1)(2008-5#1)(2012-3#1)
seen to extend##2##3##(2008-7#1)(2010-2#1)
seen to form##2##3##(1990-4#1)(2006-5#1)
seen to have a##2##4##(2008-12#1)(2008-5#1)
seen to have##5##3##(2008-11#1)(2008-12#1)(2008-5#1)(2011-1#1)(2012-3#1)
seen to increase##3##3##(2005-11#1)(2008-10#1)(2011-2#1)
seen to##61##2##(1990-11#2)(1990-4#2)(1991-12#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-2#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-4#1)(1994-7#1)(1994-8#1)(1995-8#2)(1996-3#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-11#2)(2006-1#1)(2006-5#1)(2007-11#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
seen under the##2##3##(1990-5#1)(2008-5#1)
seen under##5##2##(1990-5#1)(1992-2#1)(1995-7#1)(1996-4#1)(2008-5#1)
seen up to##3##3##(1996-3#1)(2008-1#1)(2008-7#1)
seen upon##8##2##(1991-10#1)(1991-5#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-4#1)(2008-10#1)(2009-10#1)
seen using conventional##2##3##(1995-5#1)(2008-9#1)
seen using##5##2##(1992-9#1)(1995-5#1)(2004-12#1)(2004-9#1)(2008-9#1)
seen very##2##2##(2007-7#1)(2011-1#1)
seen was##3##2##(2007-7#1)(2008-11#1)(2013-1#1)
seen were##4##2##(1991-10#1)(2007-7#1)(2008-5#1)(2010-12#1)
seen when a##2##3##(1992-6#1)(2007-12#1)
seen when##16##2##(1991-4#1)(1991-5#1)(1992-3#1)(1992-5#1)(1992-6#1)(1994-11#1)(1994-2#1)(1996-6#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-3#1)
seen which##3##2##(1997-7#1)(2006-10#1)(2007-11#1)
seen with a##2##3##(2007-1#1)(2008-7#1)
seen with age##2##3##(2004-1#1)(2008-10#1)
seen with any of the##2##5##(1990-5#1)(1994-11#1)
seen with both##2##3##(2008-11#1)(2012-1#1)
seen with increasing frequency##2##4##(1992-4#1)(2013-8#1)
seen with increasing##4##3##(1990-9#1)(1992-4#1)(2012-2#1)(2013-8#1)
seen with light##2##3##(2008-10#1)(2008-5#1)
seen with native##2##3##(1993-8#1)(1996-4#1)
seen with other##4##3##(1990-10#1)(1997-3#1)(2009-5#1)(2013-8#1)
seen with the##30##3##(1990-7#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1993-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-7#1)(1997-5#1)(2004-12#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)
seen with three##2##3##(1990-3#1)(1997-3#1)
seen with##149##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#2)(1990-7#3)(1990-8#1)(1990-9#3)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-2#2)(1992-4#2)(1992-5#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-8#2)(1994-11#2)(1994-5#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#3)(1997-5#1)(1997-6#1)(1997-8#1)(2004-1#1)(2004-12#1)(2004-3#2)(2005-7#2)(2005-8#3)(2005-9#1)(2006-10#3)(2006-12#2)(2006-7#1)(2007-1#3)(2007-10#1)(2007-11#6)(2007-12#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#9)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#5)(2008-8#3)(2009-11#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-2#3)(2012-3#2)(2013-8#2)
seen within a##2##3##(1995-11#1)(2009-11#1)
seen within the##8##3##(1995-3#1)(1997-3#1)(2005-12#1)(2006-1#1)(2007-12#2)(2008-10#1)(2013-1#1)
seen within##13##2##(1993-2#1)(1995-11#1)(1995-3#1)(1997-3#1)(1997-5#1)(2005-12#1)(2006-1#1)(2007-12#2)(2008-10#1)(2009-11#1)(2012-3#1)(2013-1#1)
seen##2091##1##(1990-10#6)(1990-11#7)(1990-12#12)(1990-2#9)(1990-3#5)(1990-4#6)(1990-5#10)(1990-6#4)(1990-7#5)(1990-8#5)(1990-9#8)(1991-1#2)(1991-10#8)(1991-11#14)(1991-12#16)(1991-2#10)(1991-3#9)(1991-4#4)(1991-5#9)(1991-6#8)(1991-7#4)(1991-8#8)(1991-9#8)(1992-1#8)(1992-10#5)(1992-11#9)(1992-12#11)(1992-2#7)(1992-3#11)(1992-4#6)(1992-5#4)(1992-6#8)(1992-7#4)(1992-8#4)(1992-9#12)(1993-1#1)(1993-11#6)(1993-12#8)(1993-2#3)(1993-3#9)(1993-4#5)(1993-5#2)(1993-6#5)(1993-7#9)(1993-8#7)(1993-9#9)(1994-1#1)(1994-10#2)(1994-11#6)(1994-12#8)(1994-2#9)(1994-3#4)(1994-4#2)(1994-5#11)(1994-6#5)(1994-7#5)(1994-8#13)(1994-9#6)(1995-1#6)(1995-10#7)(1995-11#14)(1995-12#14)(1995-2#13)(1995-3#6)(1995-4#2)(1995-5#9)(1995-6#8)(1995-7#6)(1995-8#10)(1995-9#4)(1996-1#11)(1996-10#6)(1996-11#11)(1996-12#16)(1996-2#7)(1996-3#11)(1996-4#6)(1996-5#16)(1996-6#12)(1996-7#3)(1996-8#3)(1996-9#11)(1997-1#7)(1997-2#12)(1997-3#20)(1997-4#10)(1997-5#8)(1997-6#14)(1997-7#10)(1997-8#13)(2004-1#3)(2004-10#1)(2004-11#3)(2004-12#4)(2004-2#2)(2004-3#4)(2004-4#1)(2004-9#3)(2005-10#7)(2005-11#9)(2005-12#10)(2005-3#2)(2005-7#13)(2005-8#12)(2005-9#2)(2006-1#6)(2006-10#52)(2006-11#9)(2006-12#13)(2006-2#8)(2006-3#5)(2006-4#7)(2006-5#5)(2006-6#4)(2006-7#5)(2006-8#31)(2006-9#5)(2007-1#10)(2007-10#20)(2007-11#30)(2007-12#30)(2007-2#24)(2007-3#22)(2007-4#10)(2007-5#6)(2007-6#3)(2007-7#65)(2007-8#39)(2007-9#15)(2008-1#33)(2008-10#78)(2008-11#41)(2008-12#26)(2008-2#21)(2008-3#35)(2008-4#24)(2008-5#58)(2008-6#19)(2008-7#56)(2008-8#29)(2008-9#26)(2009-1#2)(2009-10#2)(2009-11#3)(2009-12#4)(2009-2#4)(2009-3#2)(2009-4#5)(2009-5#8)(2009-6#2)(2009-7#4)(2009-8#7)(2009-9#10)(2010-1#2)(2010-10#1)(2010-11#6)(2010-12#20)(2010-2#8)(2010-3#4)(2010-4#2)(2010-5#5)(2010-6#5)(2010-7#6)(2010-8#10)(2010-9#7)(2011-1#28)(2011-11#2)(2011-12#6)(2011-2#57)(2012-1#17)(2012-11#5)(2012-12#41)(2012-2#47)(2012-3#25)(2012-8#1)(2013-1#41)(2013-7#8)(2013-8#30)
seepage##2##1##(1996-12#1)(2010-6#1)
seeps##5##1##(2007-7#2)(2007-9#2)(2011-2#1)
sees##14##1##(1993-2#1)(1993-4#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-7#1)(2007-1#1)(2007-8#1)(2008-11#1)(2008-7#2)(2008-9#2)(2010-8#1)
sefA##2##1##(1994-12#1)(2011-2#1)
seggregated##2##1##(1992-6#1)(2011-12#1)
segment (residues##3##2##(1995-8#1)(1997-4#1)(1997-8#1)
segment 61-69##2##2##(1992-4#2)
segment Cobb angle decreased in##2##5##(2007-8#2)
segment III##3##2##(2008-3#1)(2013-8#2)
segment ST##4##2##(2008-10#4)
segment a##3##2##(1992-12#3)
segment adjacent to the##3##4##(2005-11#1)(2008-10#1)(2009-10#1)
segment and the##3##3##(1995-8#1)(2005-11#1)(2008-5#1)
segment and##22##2##(1990-3#1)(1992-7#1)(1994-3#1)(1995-8#1)(1996-4#1)(1996-6#2)(2005-11#1)(2005-5#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-3#1)
segment anlagen##2##2##(1994-8#2)
segment are##6##2##(1992-9#1)(1993-8#1)(1995-3#1)(1995-8#2)(1997-4#1)
segment as##2##2##(1990-12#1)(1993-12#1)
segment at the##3##3##(1994-6#1)(2007-12#1)(2008-4#1)
segment at##5##2##(1994-6#1)(2007-12#1)(2008-4#2)(2010-8#1)
segment between##6##2##(1992-4#1)(1994-3#1)(1997-4#1)(2006-1#1)(2008-4#1)(2008-7#1)
segment by##6##2##(1990-3#1)(1996-1#1)(2007-8#1)(2008-2#1)(2008-3#1)(2011-2#1)
segment can##3##2##(1994-8#1)(2008-3#1)(2008-9#1)
segment containing a##2##3##(1996-2#1)(2008-5#1)
segment containing the##3##3##(1990-12#1)(1990-9#1)(2006-6#1)
segment containing##8##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-12#1)(1994-11#1)(1996-2#1)(2006-6#1)(2008-5#1)
segment contains##2##2##(1990-11#1)(1993-4#1)
segment disease (ASD)##3##3##(2012-12#1)(2012-3#2)
segment disease##6##2##(2012-12#3)(2012-3#3)
segment elevation myocardial infarction##6##4##(2006-10#1)(2008-3#5)
segment elevation myocardial##7##3##(2006-10#1)(2008-3#6)
segment elevation on##5##3##(1995-6#1)(2007-5#2)(2011-2#1)(2012-2#1)
segment elevation##25##2##(1993-11#1)(1995-6#2)(1997-8#1)(2006-10#2)(2006-9#2)(2007-5#2)(2008-12#1)(2008-3#11)(2011-2#1)(2012-2#1)(2012-3#1)
segment encoding the##2##3##(1990-5#2)
segment encoding##3##2##(1990-5#2)(2012-12#1)
segment from the##5##3##(1993-12#1)(1996-6#1)(1997-3#1)(2006-12#1)(2008-10#1)
segment from##8##2##(1993-12#1)(1993-3#1)(1995-9#1)(1996-6#1)(1997-3#1)(2006-12#1)(2007-11#1)(2008-10#1)
segment has##2##2##(1994-9#1)(1996-5#1)
segment in a##2##3##(1994-6#1)(2007-12#1)
segment in the##5##3##(1992-11#1)(1995-6#1)(1996-8#1)(2007-12#1)(2008-10#1)
segment in##18##2##(1992-1#1)(1992-11#2)(1994-6#1)(1995-6#1)(1996-3#1)(1996-8#1)(2006-7#1)(2007-12#2)(2007-4#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)
segment is##12##2##(1990-6#1)(1994-3#1)(1996-5#1)(2006-3#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-8#1)
segment length##4##2##(1991-8#1)(1994-2#1)(2008-2#1)(2012-2#1)
segment located in the##2##4##(1996-5#1)(2009-10#1)
segment of DNA##2##3##(1990-8#1)(2012-2#1)
segment of an##4##3##(2008-6#2)(2008-9#2)
segment of chromosome##2##3##(1996-6#1)(2009-10#1)
segment of posterior cerebral artery##2##5##(2011-1#2)
segment of the aorta##2##4##(2007-8#1)(2009-8#1)
segment of the eye##4##4##(2009-3#1)(2010-1#1)(2011-7#2)
segment of the facial nerve##3##5##(2006-11#2)(2006-12#1)
segment of the gene##2##4##(1992-2#1)(2006-5#1)
segment of the human##2##4##(1994-8#1)(2011-7#1)
segment of the internal carotid artery (ICA)##2##7##(2005-5#1)(2006-12#1)
segment of the internal carotid artery##5##6##(2005-5#1)(2006-12#3)(2012-3#1)
segment of the internal##6##4##(2005-5#1)(2006-11#1)(2006-12#3)(2012-3#1)
segment of the left##5##4##(1991-3#1)(2008-4#1)(2008-7#1)(2012-2#1)(2013-8#1)
segment of the population##5##4##(1992-1#1)(1993-12#1)(2008-10#1)(2008-9#1)(2012-3#1)
segment of the protein##2##4##(1991-7#2)
segment of the right##2##4##(2006-6#1)(2008-12#1)
segment of the##91##3##(1990-11#2)(1990-9#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#3)(1991-9#2)(1992-1#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-7#1)(2005-5#3)(2006-10#1)(2006-11#3)(2006-12#4)(2006-5#1)(2006-6#1)(2007-11#3)(2007-12#2)(2007-7#2)(2007-8#3)(2008-10#2)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-8#2)(2010-1#1)(2011-7#3)(2012-12#1)(2012-2#3)(2012-3#3)(2013-7#1)(2013-8#3)
segment of this##2##3##(1990-12#1)(1991-12#1)
segment of##150##2##(1990-11#3)(1990-12#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#4)(1991-8#1)(1991-9#2)(1992-1#1)(1992-2#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#2)(1995-3#2)(1995-8#3)(1995-9#1)(1996-10#2)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-7#1)(2004-11#1)(2005-5#3)(2006-10#1)(2006-11#3)(2006-12#5)(2006-5#1)(2006-6#1)(2007-11#5)(2007-12#4)(2007-7#2)(2007-8#4)(2008-10#7)(2008-11#2)(2008-12#2)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#2)(2009-2#1)(2009-3#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-5#1)(2011-1#2)(2011-7#3)(2012-12#1)(2012-2#4)(2012-3#3)(2013-7#1)(2013-8#5)
segment on the##5##3##(1990-3#1)(1996-9#1)(1997-3#1)(2007-7#1)(2008-3#1)
segment on##6##2##(1990-3#1)(1996-9#1)(1997-3#1)(2007-7#1)(2008-3#1)(2009-10#1)
segment phase error##2##3##(2008-3#2)
segment polarity gene hedgehog##3##4##(1993-12#2)(1994-12#1)
segment polarity gene wingless (wg)##2##5##(1990-8#1)(2007-12#1)
segment polarity gene##10##3##(1990-8#1)(1991-11#1)(1993-12#4)(1994-12#1)(2007-12#3)
segment sets##3##2##(2006-10#3)
segment showed##2##2##(2007-12#1)(2008-6#1)
segment substitution##2##2##(2008-10#1)(2009-10#1)
segment that is##2##3##(1994-12#1)(1996-11#1)
segment that##5##2##(1990-3#1)(1994-12#1)(1996-11#1)(2009-10#1)(2009-4#1)
segment the##6##2##(1992-7#1)(1992-9#1)(2008-2#1)(2008-3#2)(2009-4#1)
segment to the##2##3##(2007-12#2)
segment to##8##2##(2006-5#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-5#1)
segment was long and##2##4##(2007-12#2)
segment was##17##2##(1997-2#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-4#2)(2007-8#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-10#2)(2011-1#1)(2011-2#1)(2012-3#1)
segment were##4##2##(1990-3#1)(2008-5#1)(2008-6#1)(2011-1#1)
segment which##3##2##(1995-8#1)(2007-12#1)(2008-9#1)
segment with a##2##3##(2007-9#1)(2011-2#1)
segment with##7##2##(1991-11#1)(2006-8#1)(2007-7#1)(2007-9#1)(2008-5#1)(2011-2#1)(2013-1#1)
segment without##2##2##(2005-5#1)(2007-8#1)
segment##704##1##(1990-11#8)(1990-12#4)(1990-3#7)(1990-5#6)(1990-6#2)(1990-7#3)(1990-8#3)(1990-9#3)(1991-10#4)(1991-11#4)(1991-12#3)(1991-3#2)(1991-4#1)(1991-5#4)(1991-6#2)(1991-7#4)(1991-8#4)(1991-9#5)(1992-1#2)(1992-11#4)(1992-12#4)(1992-2#1)(1992-4#4)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#4)(1993-1#1)(1993-11#2)(1993-12#9)(1993-2#1)(1993-3#3)(1993-4#2)(1993-6#2)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#8)(1994-2#3)(1994-3#12)(1994-5#1)(1994-6#2)(1994-8#6)(1994-9#7)(1995-1#3)(1995-10#2)(1995-11#3)(1995-12#3)(1995-3#6)(1995-5#5)(1995-6#4)(1995-7#1)(1995-8#9)(1995-9#3)(1996-1#1)(1996-10#3)(1996-11#4)(1996-12#1)(1996-2#1)(1996-3#7)(1996-4#4)(1996-5#8)(1996-6#6)(1996-7#2)(1996-8#3)(1996-9#5)(1997-1#1)(1997-2#7)(1997-3#3)(1997-4#8)(1997-5#1)(1997-7#4)(1997-8#3)(2004-11#1)(2004-9#1)(2005-10#2)(2005-11#7)(2005-5#7)(2006-1#1)(2006-10#8)(2006-11#8)(2006-12#7)(2006-3#1)(2006-5#2)(2006-6#4)(2006-7#2)(2006-8#7)(2006-9#3)(2007-11#11)(2007-12#35)(2007-3#3)(2007-4#7)(2007-5#3)(2007-7#7)(2007-8#20)(2007-9#3)(2008-1#1)(2008-10#33)(2008-11#4)(2008-12#4)(2008-2#10)(2008-3#26)(2008-4#11)(2008-5#19)(2008-6#14)(2008-7#16)(2008-8#6)(2008-9#6)(2009-1#1)(2009-10#10)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-7#1)(2009-8#3)(2010-1#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#11)(2011-12#1)(2011-2#17)(2011-7#4)(2012-11#1)(2012-12#8)(2012-2#10)(2012-3#17)(2013-1#5)(2013-7#4)(2013-8#13)
segment)##3##1##(2007-12#1)(2009-10#2)
segment-polarity gene##4##2##(1993-2#2)(1994-3#2)
segmental NF##2##2##(2007-7#2)
segmental accelerated##2##2##(2011-2#1)(2012-12#1)
segmental accommodation##2##2##(1990-7#2)
segmental analysis##2##2##(2010-9#1)(2012-2#1)
segmental and##4##2##(1995-11#1)(1995-9#1)(1997-1#1)(2006-8#1)
segmental angular##2##2##(2008-6#2)
segmental bone defects##3##3##(2006-3#1)(2008-5#2)
segmental bone##4##2##(2006-3#1)(2008-5#3)
segmental changes##2##2##(2009-7#1)(2011-2#1)
segmental colonic##2##2##(1995-9#1)(2011-2#1)
segmental duplication##3##2##(2009-10#2)(2012-3#1)
segmental duplications##5##2##(2008-8#3)(2009-10#2)
segmental glomerulo-sclerosis##2##2##(2007-7#1)(2008-1#1)
segmental glomerulosclerosis (FSGS)##8##3##(2007-7#1)(2007-8#2)(2008-1#3)(2010-4#1)(2012-2#1)
segmental glomerulosclerosis and##3##3##(2007-11#1)(2008-1#1)(2008-4#1)
segmental glomerulosclerosis was the##2##4##(2007-7#2)
segmental glomerulosclerosis was##3##3##(2007-7#2)(2008-1#1)
segmental glomerulosclerosis##28##2##(1995-2#1)(2007-11#2)(2007-7#7)(2007-8#5)(2008-1#9)(2008-4#1)(2010-4#2)(2012-2#1)
segmental identity in##2##3##(1990-11#1)(1995-11#1)
segmental identity##5##2##(1990-11#2)(1994-8#1)(1995-11#1)(2012-2#1)
segmental liver##3##2##(2008-3#1)(2012-2#2)
segmental motion##8##2##(1991-7#1)(1993-3#1)(1994-9#1)(1995-5#1)(2005-11#1)(2010-8#1)(2012-12#2)
segmental motions##2##2##(1996-6#1)(1997-2#1)
segmental or##4##2##(2008-11#1)(2010-10#1)(2010-8#1)(2012-2#1)
segmental order##2##2##(1990-12#1)(2009-10#1)
segmental relaxation##3##2##(2008-10#3)
segmental resection of the##2##4##(2007-8#1)(2010-5#1)
segmental resection##7##2##(1990-2#1)(1993-12#1)(2006-10#1)(2007-11#1)(2007-8#2)(2010-5#1)
segmental thickening of the##2##4##(1992-5#1)(2007-8#1)
segmental trisomies##2##2##(2008-7#2)
segmental trisomy##2##2##(1997-2#1)(2008-7#1)
segmental wall motion abnormalities##2##4##(1993-12#2)
segmental wire fixation##2##3##(2009-3#2)
segmental##186##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#2)(1991-3#1)(1991-7#1)(1992-11#1)(1992-5#1)(1993-12#3)(1993-3#1)(1994-2#2)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#2)(1995-5#2)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-2#1)(2006-10#5)(2006-3#2)(2006-5#2)(2006-8#4)(2007-11#4)(2007-12#11)(2007-7#12)(2007-8#14)(2007-9#1)(2008-1#13)(2008-10#6)(2008-11#3)(2008-3#1)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#5)(2008-8#4)(2009-10#5)(2009-12#1)(2009-3#5)(2009-7#1)(2010-10#1)(2010-4#2)(2010-5#1)(2010-8#2)(2010-9#1)(2011-2#5)(2012-12#3)(2012-2#7)(2012-3#5)(2013-1#1)(2013-8#1)
segmentally##5##1##(1991-3#1)(1991-9#1)(2007-12#1)(2007-2#1)(2008-4#1)
segmentary resection##2##2##(1990-3#1)(1990-5#1)
segmentary##3##1##(1990-3#1)(1990-5#1)(2012-11#1)
segmentation algorithm is##2##3##(2008-6#1)(2013-1#1)
segmentation algorithm##7##2##(1995-7#1)(2008-2#1)(2008-6#1)(2008-9#1)(2010-3#1)(2013-1#2)
segmentation algorithms for##2##3##(2009-9#1)(2010-12#1)
segmentation algorithms on##2##3##(2010-12#2)
segmentation algorithms##9##2##(1995-5#1)(2008-6#1)(2009-9#1)(2010-12#5)(2010-9#1)
segmentation and classification##2##3##(2008-2#1)(2009-4#1)
segmentation and labeling##4##3##(2008-2#4)
segmentation and##28##2##(1992-7#1)(1992-9#2)(1995-12#2)(2006-10#1)(2006-5#2)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#6)(2008-6#4)(2009-10#2)(2009-4#1)(2010-8#1)(2011-7#2)
segmentation based on##4##3##(2007-11#1)(2007-12#1)(2008-6#1)(2008-9#1)
segmentation by##4##2##(1991-11#1)(2008-1#1)(2008-2#1)(2008-9#1)
segmentation error##2##2##(2010-12#2)
segmentation for##3##2##(2008-2#1)(2008-6#1)(2012-1#1)
segmentation gene##6##2##(1992-4#1)(1994-3#1)(1997-1#1)(2009-4#3)
segmentation in##5##2##(1992-7#1)(2007-12#1)(2008-6#1)(2010-6#1)(2012-3#1)
segmentation is##11##2##(1997-1#1)(2006-5#2)(2007-12#1)(2008-2#6)(2010-2#1)
segmentation method of##2##3##(2007-12#1)(2010-8#1)
segmentation method##8##2##(2007-12#2)(2008-2#2)(2010-4#2)(2010-8#1)(2011-1#1)
segmentation methods##3##2##(2008-2#1)(2010-6#1)(2012-3#1)
segmentation of beef longissimus dorsi##2##5##(2010-4#2)
segmentation of conidia and hyphae##2##5##(2008-3#2)
segmentation of images##2##3##(2008-2#2)
segmentation of objects##2##3##(2007-12#1)(2008-2#1)
segmentation of the image into##2##5##(2008-2#2)
segmentation of the left ventricle##2##5##(2010-3#2)
segmentation of the##8##3##(1994-9#1)(2007-12#1)(2008-2#3)(2010-3#2)(2012-1#1)
segmentation of##43##2##(1992-7#2)(1994-9#1)(2007-12#4)(2008-1#1)(2008-10#1)(2008-2#11)(2008-3#4)(2008-7#2)(2009-10#1)(2009-12#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-8#4)(2011-7#1)(2012-1#1)(2012-3#2)(2013-1#1)
segmentation on the##2##3##(2007-12#1)(2008-2#1)
segmentation on##4##2##(1992-7#1)(2007-12#1)(2008-2#1)(2010-12#1)
segmentation problem##3##2##(2008-2#1)(2009-10#1)(2009-2#1)
segmentation results##4##2##(2008-2#1)(2008-6#1)(2013-1#2)
segmentation technique##2##2##(2008-6#1)(2013-1#1)
segmentation than##2##2##(2008-2#1)(2010-9#1)
segmentation to##2##2##(2009-10#1)(2010-3#1)
segmentation using##2##2##(2008-2#2)
segmentation was##2##2##(1993-12#1)(2008-9#1)
segmentation with a##2##3##(2007-11#1)(2008-3#1)
segmentation with##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2009-11#1)
segmentation##248##1##(1991-11#3)(1991-3#1)(1991-8#1)(1992-4#1)(1992-7#8)(1992-9#3)(1993-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-5#2)(1995-7#1)(1996-2#1)(1997-1#4)(1997-3#1)(2006-10#1)(2006-5#8)(2007-11#9)(2007-12#14)(2007-4#1)(2008-1#2)(2008-10#3)(2008-2#60)(2008-3#7)(2008-6#17)(2008-7#2)(2008-8#1)(2008-9#10)(2009-10#9)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#5)(2009-9#2)(2010-12#11)(2010-2#4)(2010-3#5)(2010-4#4)(2010-6#3)(2010-8#9)(2010-9#3)(2011-1#2)(2011-7#3)(2012-1#2)(2012-12#2)(2012-3#5)(2013-1#7)
segmentations##7##1##(2008-2#2)(2008-9#1)(2010-12#3)(2010-8#1)
segmentectomy##2##1##(2010-8#2)
segmented assimilation##2##2##(2009-7#2)
segmented by##4##2##(1991-8#1)(2008-10#1)(2008-2#1)(2010-2#1)
segmented flow analysis (SFA)##4##4##(2008-10#4)
segmented flow analysis##7##3##(2008-10#6)(2009-6#1)
segmented flow##10##2##(2008-10#9)(2009-6#1)
segmented images##2##2##(2008-7#1)(2012-2#1)
segmented into##8##2##(1996-10#1)(2008-2#2)(2008-3#2)(2008-5#1)(2010-8#1)(2012-1#1)
segmented mirror##4##2##(2008-2#1)(2008-3#3)
segmented mirrors##2##2##(2008-2#1)(2008-3#1)
segmented polyurethanes##2##2##(2005-11#2)
segmented primary mirror##2##3##(2008-3#2)
segmented primary##3##2##(2008-3#3)
segmented using##2##2##(2008-2#1)(2011-2#1)
segmented waveguide##2##2##(2008-2#1)(2008-3#1)
segmented waveguides##5##2##(2008-2#4)(2008-3#1)
segmented##88##1##(1991-11#1)(1991-3#2)(1991-8#1)(1992-7#1)(1995-8#2)(1996-10#1)(2005-11#2)(2005-2#1)(2007-11#3)(2007-12#7)(2008-10#11)(2008-2#18)(2008-3#17)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-6#1)(2009-7#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
segmenting the##2##2##(1990-12#1)(2007-5#1)
segmenting##8##1##(1990-12#1)(1995-12#1)(2007-5#1)(2008-1#1)(2008-2#1)(2008-9#1)(2009-10#1)(2012-3#1)
segments (approximately##3##2##(2008-10#3)
segments (ave##2##2##(2007-8#2)
segments (residues##2##2##(1990-12#1)(1994-3#1)
segments 1 and 2##2##4##(1994-9#2)
segments II##2##2##(2008-3#1)(2008-5#1)
segments V##2##2##(1990-11#1)(2007-12#1)
segments and a##4##3##(1991-6#1)(1994-3#1)(2008-2#1)(2010-9#1)
segments and corresponding gene expression##2##5##(2012-2#2)
segments and on the##2##4##(2007-12#1)(2008-3#1)
segments and their##3##3##(2008-5#1)(2012-1#1)(2013-7#1)
segments and##41##2##(1990-9#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-5#1)(1992-9#1)(1993-4#1)(1994-2#1)(1994-3#3)(1994-6#1)(1996-3#1)(1996-5#2)(1997-4#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2010-12#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#5)(2013-1#1)(2013-7#1)
segments are slightly longer##2##4##(1992-7#2)
segments are##27##2##(1990-2#1)(1991-5#1)(1991-7#1)(1992-7#7)(1993-9#1)(1994-6#1)(1994-9#1)(1995-8#1)(1996-7#3)(2007-1#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-4#1)(2012-12#1)
segments as##3##2##(1994-8#1)(2006-5#1)(2010-5#1)
segments at the##4##3##(1990-6#1)(2005-11#3)
segments between##2##2##(1997-8#1)(2008-4#1)
segments by##6##2##(1995-1#1)(2005-5#1)(2006-12#1)(2008-11#1)(2008-3#1)(2012-12#1)
segments can be##2##3##(1993-4#1)(1994-6#1)
segments can##3##2##(1993-4#1)(1994-6#1)(1996-8#1)
segments caudal to their root entry##2##6##(1992-9#2)
segments caudal to##3##3##(1992-9#3)
segments containing the##2##3##(1995-5#1)(2008-2#1)
segments containing##3##2##(1995-5#1)(2008-2#1)(2013-7#1)
segments encoding the##2##3##(1990-5#1)(1992-4#1)
segments for##3##2##(1992-6#1)(2007-4#1)(2008-3#1)
segments from the##3##3##(1992-2#1)(2008-5#2)
segments from##13##2##(1991-2#1)(1992-2#1)(1994-12#1)(1994-5#1)(1996-12#1)(1997-8#1)(2008-10#4)(2008-5#2)(2010-4#1)
segments have##3##2##(1992-6#1)(1992-7#1)(2011-1#1)
segments in a##2##3##(2006-10#1)(2008-5#1)
segments in single sequences##2##4##(1994-6#2)
segments in the##6##3##(1994-8#1)(1996-7#1)(2006-10#1)(2008-12#1)(2009-10#1)(2013-7#1)
segments in##17##2##(1994-6#3)(1994-8#1)(1995-2#1)(1996-7#1)(2006-10#2)(2006-12#1)(2008-10#1)(2008-12#1)(2008-5#2)(2009-10#1)(2012-1#1)(2013-7#2)
segments including the##2##3##(1997-2#1)(2008-5#1)
segments including##3##2##(1997-2#1)(2008-5#1)(2013-8#1)
segments incubated in continuous##2##4##(2008-10#2)
segments incubated in##3##3##(2008-10#3)
segments incubated##4##2##(2008-10#4)
segments into##3##2##(1997-7#1)(2008-7#2)
segments is##6##2##(1991-8#1)(1992-6#1)(1995-6#1)(1997-2#1)(2006-10#1)(2007-12#1)
segments led to##2##3##(1991-9#1)(2008-5#1)
segments located at##2##3##(2008-5#1)(2008-8#1)
segments located in##2##3##(1992-2#1)(1996-5#1)
segments located##5##2##(1992-2#2)(1996-5#1)(2008-5#1)(2008-8#1)
segments may##3##2##(1991-10#1)(2006-4#1)(2007-12#1)
segments must##2##2##(2008-4#1)(2010-12#1)
segments of DNA##4##3##(1993-9#1)(2008-11#1)(2008-2#1)(2008-9#1)
segments of a population##2##4##(2006-10#2)
segments of a##6##3##(1991-6#1)(1992-3#1)(2006-10#2)(2007-12#1)(2008-3#1)
segments of each##2##3##(2007-12#1)(2012-2#1)
segments of porcine##2##3##(2004-11#1)(2011-1#1)
segments of the liver##3##4##(2007-9#2)(2008-3#1)
segments of the population##5##4##(1997-1#1)(2008-9#3)(2011-1#1)
segments of the thoracic##2##4##(1995-12#1)(2007-11#1)
segments of the##72##3##(1990-10#1)(1990-11#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1992-4#2)(1992-9#1)(1993-6#3)(1994-10#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-5#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#2)(2004-11#2)(2005-11#1)(2006-10#6)(2007-11#1)(2007-7#2)(2007-9#6)(2008-1#1)(2008-10#5)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#3)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
segments of their##2##3##(1995-6#1)(1997-2#1)
segments of##147##2##(1990-10#2)(1990-11#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-6#2)(1991-7#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-4#1)(1993-6#3)(1993-9#1)(1994-10#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-7#2)(1997-8#1)(2004-11#3)(2005-10#2)(2005-11#2)(2006-1#1)(2006-10#8)(2006-12#1)(2006-5#1)(2007-11#2)(2007-12#5)(2007-7#2)(2007-8#2)(2007-9#6)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#5)(2009-8#2)(2010-1#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
segments on the##2##3##(2008-3#1)(2008-8#1)
segments on##3##2##(2007-1#1)(2008-3#1)(2008-8#1)
segments only##2##2##(2007-12#1)(2009-10#1)
segments reduced##2##2##(2008-5#2)
segments showed##2##2##(1993-7#1)(2007-8#1)
segments so that##2##3##(1991-8#1)(1993-12#1)
segments that are##6##3##(1994-3#2)(1997-1#1)(2008-7#1)(2009-8#1)(2012-12#1)
segments that were##2##3##(2007-8#1)(2009-10#1)
segments that##14##2##(1993-12#1)(1994-3#2)(1995-4#1)(1997-1#1)(2006-12#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2012-12#1)
segments to##5##2##(1991-8#1)(1992-7#1)(2007-12#1)(2007-4#1)(2010-10#1)
segments using##2##2##(1995-5#1)(2008-1#1)
segments was##9##2##(1992-11#1)(1995-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2009-5#1)(2012-3#1)
segments were also##2##3##(1996-1#1)(2007-12#1)
segments were built upon##2##4##(2010-4#2)
segments were investigated##2##3##(1993-11#1)(1995-1#1)
segments were isolated from##2##4##(2004-11#1)(2008-10#1)
segments were##28##2##(1993-11#1)(1995-1#1)(1995-6#1)(1996-1#1)(1997-1#1)(1997-8#1)(1997-9#1)(2004-11#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-4#2)(2010-5#1)(2013-1#1)
segments which are##2##3##(1993-10#1)(2010-10#1)
segments which##7##2##(1991-3#1)(1993-10#1)(1993-12#1)(1996-9#1)(1997-1#1)(2010-10#1)(2010-8#1)
segments with the##2##3##(1992-11#1)(1992-2#1)
segments with##14##2##(1992-11#1)(1992-2#1)(1994-9#2)(1995-2#1)(1997-6#1)(1997-8#1)(2007-12#1)(2007-8#1)(2009-11#2)(2009-5#1)(2011-1#1)(2011-2#1)
segments without##4##2##(1997-1#1)(2007-3#1)(2007-7#1)(2009-9#1)
segments##667##1##(1990-10#3)(1990-11#4)(1990-12#2)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#2)(1990-7#2)(1990-8#2)(1990-9#2)(1991-10#5)(1991-12#2)(1991-2#3)(1991-3#4)(1991-5#4)(1991-6#4)(1991-7#2)(1991-8#7)(1991-9#2)(1992-11#5)(1992-12#1)(1992-2#4)(1992-3#1)(1992-4#4)(1992-5#3)(1992-6#5)(1992-7#12)(1992-8#1)(1992-9#6)(1993-10#1)(1993-11#1)(1993-12#5)(1993-3#1)(1993-4#4)(1993-6#4)(1993-7#2)(1993-8#1)(1993-9#3)(1994-10#2)(1994-12#3)(1994-2#7)(1994-3#12)(1994-5#1)(1994-6#6)(1994-8#3)(1994-9#11)(1995-1#4)(1995-10#1)(1995-12#5)(1995-2#3)(1995-3#3)(1995-4#1)(1995-5#5)(1995-6#9)(1995-8#1)(1995-9#2)(1996-1#2)(1996-12#3)(1996-3#2)(1996-4#2)(1996-5#7)(1996-6#2)(1996-7#7)(1996-8#2)(1996-9#2)(1997-1#9)(1997-2#6)(1997-3#2)(1997-4#7)(1997-6#3)(1997-7#5)(1997-8#7)(1997-9#2)(2004-11#6)(2005-10#4)(2005-11#10)(2005-5#2)(2006-1#2)(2006-10#13)(2006-11#3)(2006-12#7)(2006-4#1)(2006-5#3)(2006-8#1)(2007-1#3)(2007-11#6)(2007-12#33)(2007-3#1)(2007-4#5)(2007-5#2)(2007-7#6)(2007-8#17)(2007-9#10)(2008-1#2)(2008-10#51)(2008-11#7)(2008-12#5)(2008-2#11)(2008-3#17)(2008-4#12)(2008-5#18)(2008-6#1)(2008-7#13)(2008-8#6)(2008-9#9)(2009-10#7)(2009-11#3)(2009-12#1)(2009-4#2)(2009-5#4)(2009-6#1)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#3)(2010-12#4)(2010-2#1)(2010-4#6)(2010-5#3)(2010-8#4)(2010-9#2)(2011-1#8)(2011-2#4)(2011-3#1)(2012-1#6)(2012-12#7)(2012-2#12)(2012-3#7)(2013-1#4)(2013-3#1)(2013-7#5)(2013-8#4)
segments) was##2##2##(1990-7#1)(2008-2#1)
segments)##6##1##(1990-7#1)(1996-2#2)(2007-4#1)(2008-2#1)(2011-1#1)
segregant analysis (BSA)##2##3##(2008-10#1)(2008-9#1)
segregant analysis using##3##3##(2008-10#3)
segregant analysis was##3##3##(1995-6#1)(2008-10#1)(2009-12#1)
segregant analysis##22##2##(1995-6#2)(2005-10#1)(2006-9#1)(2008-10#13)(2008-5#3)(2008-9#1)(2009-12#1)
segregant##23##1##(1995-6#3)(2005-10#1)(2006-9#1)(2008-10#13)(2008-5#3)(2008-9#1)(2009-12#1)
segregants##2##1##(2006-12#1)(2008-10#1)
segregate Prospero##2##2##(2008-7#2)
segregate##16##1##(1997-4#2)(2007-6#1)(2008-10#5)(2008-5#1)(2008-7#2)(2009-5#1)(2010-4#1)(2012-12#3)
segregated 1##2##2##(2008-10#2)
segregated as##4##2##(1992-11#1)(1995-2#1)(2008-10#1)(2008-5#1)
segregated at##2##2##(1990-11#1)(1995-8#1)
segregated for the##2##3##(2006-12#1)(2012-3#1)
segregated for##9##2##(2006-12#1)(2008-10#5)(2012-11#1)(2012-3#2)
segregated from the##3##3##(2005-9#1)(2008-4#1)(2011-2#1)
segregated from##6##2##(2005-9#1)(2008-4#1)(2008-5#1)(2011-2#3)
segregated in Mendelian##2##3##(2008-10#2)
segregated in a 1##4##4##(2008-10#4)
segregated in a##8##3##(2008-10#7)(2008-8#1)
segregated in##14##2##(1993-9#1)(2007-9#1)(2008-10#11)(2008-8#1)
segregated into##5##2##(1994-5#1)(1995-11#1)(2008-10#1)(2008-8#2)
segregated on##2##2##(1992-5#1)(1995-2#1)
segregated to##2##2##(2007-8#1)(2010-4#1)
segregated with##2##2##(1996-5#1)(2008-10#1)
segregated##68##1##(1990-11#1)(1992-11#1)(1992-5#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-8#1)(1996-5#1)(1997-7#3)(2005-9#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-10#25)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-8#3)(2008-9#2)(2009-4#1)(2010-4#3)(2011-2#4)(2012-11#3)(2012-3#2)
segregates independently of##3##3##(2008-10#2)(2008-12#1)
segregates##9##1##(1993-2#1)(1995-2#1)(1997-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2009-10#1)(2012-2#1)
segregating F(2)##2##2##(2008-10#2)
segregating for the presence of the##2##6##(2006-12#1)(2008-10#1)
segregating for the presence##3##4##(2006-12#2)(2008-10#1)
segregating for the##4##3##(2006-12#2)(2008-10#2)
segregating for##9##2##(1996-3#1)(2006-12#2)(2008-10#5)(2010-10#1)
segregating in the##5##3##(1996-6#1)(2008-10#2)(2012-3#2)
segregating in##6##2##(1996-6#1)(2008-10#3)(2012-3#2)
segregating progeny##4##2##(2011-2#3)(2012-3#1)
segregating with the##2##3##(2007-7#1)(2011-1#1)
segregating with##4##2##(1997-7#1)(2007-7#1)(2008-9#1)(2011-1#1)
segregating##52##1##(1991-10#1)(1991-3#1)(1991-4#1)(1996-3#1)(1996-6#2)(1997-5#2)(1997-7#1)(2006-10#1)(2006-12#2)(2007-12#1)(2007-7#1)(2008-10#24)(2008-4#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-1#1)(2011-2#4)(2012-3#5)
segregation analysis##7##2##(1996-6#2)(2008-10#4)(2008-11#1)
segregation and##11##2##(1992-3#1)(1993-6#1)(1996-12#1)(1997-2#2)(2008-9#1)(2009-8#1)(2010-4#2)(2012-12#1)(2013-1#1)
segregation by##2##2##(2008-10#1)(2009-5#1)
segregation distortion##3##2##(2008-10#2)(2010-2#1)
segregation for##7##2##(2008-10#6)(2008-8#1)
segregation in the##2##3##(1992-9#1)(2008-10#1)
segregation in##13##2##(1992-7#1)(1992-9#1)(2008-10#4)(2008-11#3)(2008-12#2)(2010-9#1)(2012-2#1)
segregation of a single##2##4##(2008-10#2)
segregation of a##3##3##(2008-10#2)(2008-4#1)
segregation of lipids##2##3##(1992-9#1)(1993-9#1)
segregation of the##10##3##(1992-9#1)(1995-8#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#3)(2012-11#1)
segregation of##51##2##(1992-2#1)(1992-9#2)(1993-9#2)(1995-8#1)(1997-7#1)(2005-11#2)(2006-2#1)(2006-9#1)(2007-12#2)(2007-8#1)(2008-10#15)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#3)(2010-10#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#2)
segregation ratio##4##2##(1996-6#2)(2008-7#1)(2010-2#1)
segregation that##2##2##(2008-2#1)(2012-3#1)
segregation was##3##2##(1992-9#1)(2008-10#1)(2008-5#1)
segregation##144##1##(1992-2#1)(1992-3#1)(1992-7#1)(1992-9#5)(1993-6#1)(1993-9#2)(1995-8#1)(1996-12#1)(1996-6#4)(1997-2#4)(1997-7#1)(2005-11#2)(2006-12#1)(2006-2#2)(2006-9#1)(2007-1#1)(2007-12#3)(2007-8#1)(2007-9#2)(2008-10#40)(2008-11#4)(2008-12#4)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#3)(2008-8#5)(2008-9#5)(2009-5#3)(2009-8#2)(2010-10#1)(2010-2#2)(2010-3#1)(2010-4#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
segregational stability##2##2##(1990-9#1)(1994-2#1)
seine##3##1##(2007-5#1)(2008-5#1)(2013-7#1)
seismic courtship signals##2##3##(2009-6#2)
seismic courtship##4##2##(2009-6#4)
seismic hazard reduction##2##3##(1996-4#2)
seismic network##2##2##(1991-3#2)
seismic signal##3##2##(2009-6#3)
seismic source##2##2##(1996-4#1)(2012-2#1)
seismic##33##1##(1990-11#1)(1991-3#2)(1992-7#1)(1995-3#2)(1996-4#7)(2007-12#1)(2007-9#2)(2008-11#1)(2008-2#3)(2009-6#9)(2012-2#4)
seismicity becomes##2##2##(1996-4#2)
seismicity is##3##2##(1996-4#3)
seismicity##21##1##(1996-4#21)
seismology##3##1##(1996-4#1)(2007-9#1)(2009-2#1)
seize##5##1##(1994-12#1)(1997-8#1)(2007-12#1)(2008-12#1)(2010-4#1)
seized from the##2##3##(2008-10#1)(2011-1#1)
seized in##3##2##(2012-2#2)(2013-7#1)
seized##10##1##(1997-2#1)(2008-10#1)(2010-11#1)(2010-5#1)(2011-1#2)(2012-2#2)(2013-7#2)
seizing##4##1##(2007-12#1)(2008-10#1)(2010-8#1)(2012-2#1)
seizure activity and##2##3##(1995-5#1)(1997-8#1)
seizure activity from##2##3##(1991-3#1)(1996-10#1)
seizure activity in##2##3##(2008-1#1)(2010-2#1)
seizure activity##13##2##(1990-5#1)(1991-3#1)(1995-5#1)(1996-1#1)(1996-10#2)(1997-3#1)(1997-8#1)(2007-10#1)(2008-1#1)(2009-11#1)(2010-2#1)(2010-7#1)
seizure and##6##2##(2004-11#1)(2006-12#1)(2007-9#1)(2008-3#1)(2008-5#1)(2013-1#1)
seizure attacks of P77PMC rat##2##5##(2008-8#2)
seizure control##7##2##(1990-9#1)(1996-1#1)(1997-3#2)(2008-7#2)(2013-7#1)
seizure discharges##3##2##(1996-3#1)(1996-9#1)(2010-11#1)
seizure disorder##3##2##(2008-11#1)(2008-4#1)(2012-12#1)
seizure disorders and##2##3##(2007-10#1)(2012-3#1)
seizure disorders##5##2##(1993-3#1)(1997-3#1)(2006-3#1)(2007-10#1)(2012-3#1)
seizure duration##2##2##(1990-5#1)(1991-8#1)
seizure free##2##2##(1997-3#1)(2010-12#1)
seizure frequency##2##2##(2008-1#1)(2010-4#1)
seizure generation##5##2##(1990-5#1)(2008-12#1)(2009-8#3)
seizure in a##3##3##(1996-3#1)(2008-11#1)(2010-1#1)
seizure in the##2##3##(2006-4#1)(2009-6#1)
seizure in##10##2##(1996-1#1)(1996-3#1)(2006-4#1)(2007-2#3)(2008-11#1)(2008-8#1)(2009-6#1)(2010-1#1)
seizure intensity##4##2##(1992-12#4)
seizure is presented##2##3##(2008-7#1)(2011-2#1)
seizure model##3##2##(1994-2#1)(1995-12#1)(1997-2#1)
seizure or##4##2##(1992-3#1)(1993-2#1)(1996-1#1)(2010-12#1)
seizure recurrence was##3##3##(1997-3#2)(2004-11#1)
seizure recurrence##4##2##(1997-3#2)(2004-11#1)(2010-12#1)
seizure susceptibility of these animals##2##5##(1996-12#2)
seizure susceptibility##5##2##(1990-5#1)(1993-3#1)(1996-10#1)(1996-12#2)
seizure therapy##2##2##(2011-1#1)(2012-2#1)
seizure threshold##5##2##(1996-10#1)(1996-3#1)(1997-5#1)(2008-4#2)
seizure was##2##2##(1992-9#1)(2004-11#1)
seizure##156##1##(1990-5#7)(1990-9#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-12#4)(1992-3#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#3)(1993-4#3)(1994-2#5)(1995-12#1)(1995-3#1)(1995-5#1)(1996-1#6)(1996-10#4)(1996-12#5)(1996-3#3)(1996-9#1)(1997-2#2)(1997-3#8)(1997-5#1)(1997-8#1)(2004-11#4)(2005-1#1)(2005-8#1)(2006-12#1)(2006-3#1)(2006-4#1)(2007-10#2)(2007-12#1)(2007-2#5)(2007-9#5)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#4)(2008-8#3)(2009-11#1)(2009-3#1)(2009-6#2)(2009-8#4)(2009-9#1)(2010-1#4)(2010-11#1)(2010-12#9)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#7)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#2)
seizure-free##4##1##(1990-5#1)(2004-11#3)
seizure-induced##4##1##(1995-12#2)(2009-6#2)
seizure-naive##4##1##(1996-12#4)
seizure-precursors##2##1##(2008-12#2)
seizure-prone##2##1##(1991-5#1)(1993-4#1)
seizure-related genes##2##2##(1996-2#2)
seizure-related##7##1##(1995-12#1)(1996-2#3)(2010-5#1)(2013-1#2)
seizures (AS)##2##2##(1992-11#2)
seizures after##4##2##(1991-12#1)(1991-5#1)(1993-2#1)(2012-12#1)
seizures and SE induced by pilocarpine##2##6##(2010-7#2)
seizures and SE##3##3##(2010-7#3)
seizures and status epilepticus##3##4##(2009-3#1)(2009-9#1)(2010-7#1)
seizures and##39##2##(1991-12#1)(1991-4#1)(1991-9#3)(1992-11#2)(1992-3#1)(1994-2#2)(1995-5#1)(1995-9#1)(1996-3#1)(1996-9#1)(2004-11#2)(2005-8#1)(2006-10#2)(2006-11#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-9#2)(2010-11#1)(2010-7#4)(2011-1#1)(2012-2#3)(2012-3#1)
seizures are independent##2##3##(2007-10#1)(2012-2#1)
seizures are##9##2##(1992-11#1)(1992-3#1)(1994-2#1)(1997-3#1)(2004-11#1)(2007-10#1)(2009-3#1)(2009-9#1)(2012-2#1)
seizures as##3##2##(2006-12#1)(2007-10#1)(2012-2#1)
seizures but##2##2##(1996-1#1)(2010-12#1)
seizures could be##2##3##(1994-2#1)(2008-3#1)
seizures in a##2##3##(2008-10#1)(2008-11#1)
seizures in adults##2##3##(2006-12#1)(2008-7#1)
seizures in children##4##3##(1997-2#1)(2008-4#1)(2011-1#2)
seizures in infants##2##3##(1996-3#1)(2006-10#1)
seizures in mice##3##3##(1994-2#2)(1995-5#1)
seizures in the rat##2##4##(1994-2#1)(2009-9#1)
seizures in the##3##3##(1994-2#1)(2009-9#1)(2011-1#1)
seizures in##33##2##(1992-11#1)(1992-3#3)(1992-9#2)(1994-2#4)(1995-5#1)(1996-3#3)(1997-2#1)(1997-5#1)(2006-10#1)(2006-12#1)(2007-2#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-1#3)(2012-3#1)(2013-1#1)
seizures induced by pilocarpine##3##4##(2010-8#3)
seizures induced by##14##3##(1991-12#1)(1991-8#1)(1992-11#2)(1995-12#2)(1996-10#3)(1996-3#2)(2010-8#3)
seizures induced##15##2##(1990-5#1)(1991-12#1)(1991-8#1)(1992-11#2)(1995-12#2)(1996-10#3)(1996-3#2)(2010-8#3)
seizures is described##2##3##(1990-3#1)(2006-4#1)
seizures is##3##2##(1990-3#1)(1991-4#1)(2006-4#1)
seizures occurred##2##2##(2007-2#2)
seizures occurring in##3##3##(2007-2#1)(2010-12#1)(2011-2#1)
seizures of##5##2##(1991-11#1)(1995-9#1)(2008-10#1)(2008-4#1)(2012-2#1)
seizures on##4##2##(1994-2#2)(1995-5#1)(2009-9#1)
seizures or##4##2##(2007-11#1)(2011-2#2)(2012-3#1)
seizures that##3##2##(1997-5#1)(2007-10#1)(2013-1#1)
seizures was##4##2##(1992-9#1)(1996-1#1)(2010-12#1)(2011-1#1)
seizures were##15##2##(1991-8#1)(1992-11#2)(1992-9#2)(1993-2#1)(1994-2#1)(1995-12#1)(1997-2#1)(1997-3#1)(2004-11#1)(2008-4#1)(2010-12#1)(2011-1#2)
seizures while##2##2##(1990-3#1)(2010-12#1)
seizures with##4##2##(1992-11#1)(1997-5#1)(2007-10#1)(2012-2#1)
seizures##380##1##(1990-12#1)(1990-3#6)(1990-5#2)(1990-9#3)(1991-1#2)(1991-10#1)(1991-11#5)(1991-12#3)(1991-3#1)(1991-4#7)(1991-5#1)(1991-8#3)(1991-9#3)(1992-11#13)(1992-12#1)(1992-3#6)(1992-7#1)(1992-9#10)(1993-11#1)(1993-12#5)(1993-2#3)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#1)(1994-10#1)(1994-2#22)(1994-4#1)(1995-12#9)(1995-5#4)(1995-9#3)(1996-1#6)(1996-10#5)(1996-12#2)(1996-2#1)(1996-3#9)(1996-5#1)(1996-9#2)(1997-2#5)(1997-3#9)(1997-4#1)(1997-5#6)(1997-8#2)(2004-11#7)(2005-10#1)(2005-8#1)(2006-10#5)(2006-11#2)(2006-12#2)(2006-4#5)(2006-5#3)(2006-8#1)(2006-9#1)(2007-10#5)(2007-11#4)(2007-2#10)(2007-3#1)(2007-9#5)(2008-1#2)(2008-10#6)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#1)(2008-4#8)(2008-5#2)(2008-7#9)(2008-8#5)(2009-3#7)(2009-6#1)(2009-8#5)(2009-9#8)(2010-1#1)(2010-11#3)(2010-12#13)(2010-3#1)(2010-5#3)(2010-7#4)(2010-8#10)(2011-1#13)(2011-2#7)(2012-1#1)(2012-12#4)(2012-2#13)(2012-3#3)(2013-1#7)(2013-7#3)(2013-8#4)
seizures)##5##1##(2007-10#1)(2007-9#1)(2008-4#1)(2010-12#1)(2012-3#1)
seje oil##2##2##(2012-2#2)
seje##3##1##(2012-2#3)
seldom been##5##2##(1991-12#1)(2005-10#1)(2008-5#1)(2008-7#1)(2011-1#1)
seldom described##2##2##(2007-6#1)(2013-1#1)
seldom occurs in##2##3##(1992-6#1)(2008-10#1)
seldom performed##2##2##(1990-9#1)(1995-2#1)
seldom referred to in##2##4##(1992-11#1)(1993-10#1)
seldom reported##4##2##(1995-3#1)(2006-10#1)(2006-7#1)(2010-12#1)
seldom yield##2##2##(2007-12#1)(2007-4#1)
seldom##76##1##(1990-10#1)(1990-11#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-7#1)(2004-2#1)(2005-10#1)(2006-10#1)(2006-12#2)(2006-7#2)(2006-8#2)(2006-9#1)(2007-11#2)(2007-12#2)(2007-3#2)(2007-4#2)(2007-6#1)(2007-9#2)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#7)
seldomly##2##1##(2005-12#1)(2011-2#1)
select a##20##2##(1997-2#1)(1997-7#1)(2004-9#1)(2006-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-7#1)
select and##7##2##(2008-12#2)(2008-9#1)(2011-2#1)(2011-3#1)(2012-2#2)
select appropriate##5##2##(1991-2#1)(2006-10#1)(2010-5#1)(2010-8#1)(2012-12#1)
select aspects of##2##3##(2008-4#1)(2011-1#1)
select cases##2##2##(2010-2#1)(2013-1#1)
select for the##2##3##(1994-5#1)(2009-3#1)
select for##18##2##(1994-12#1)(1994-3#1)(1994-5#1)(1997-4#1)(1997-7#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-3#1)(2011-1#3)(2012-3#1)
select genes##3##2##(2007-12#1)(2012-12#1)(2012-3#1)
select group of##6##3##(1995-2#1)(1995-3#1)(2006-11#1)(2009-3#1)(2013-1#1)(2013-7#1)
select it##2##2##(2007-4#1)(2008-7#1)
select new##2##2##(1995-3#1)(2005-7#1)
select one##4##2##(1996-2#1)(2008-10#1)(2008-11#1)(2012-3#1)
select only##2##2##(1995-3#1)(2007-9#1)
select patient##2##2##(2005-10#1)(2007-1#1)
select patients who##2##3##(1991-8#1)(2006-11#1)
select patients##16##2##(1991-8#1)(1994-8#1)(2004-11#1)(2006-11#2)(2006-12#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-6#1)(2010-10#1)(2011-2#3)(2012-1#1)(2012-2#1)
select the best##9##3##(1992-2#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#2)(2010-8#1)(2012-1#1)(2012-3#1)
select the most appropriate##7##4##(1992-8#1)(2007-8#1)(2008-10#2)(2008-3#1)(2011-2#1)(2012-2#1)
select the most##13##3##(1990-12#1)(1992-8#1)(1993-12#1)(2007-8#1)(2008-10#3)(2008-3#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
select the##65##2##(1990-12#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-12#2)(1994-6#1)(1995-11#1)(1995-4#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-6#1)(1997-7#1)(2004-2#1)(2005-10#1)(2005-6#1)(2006-10#1)(2006-2#2)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#13)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2009-12#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#4)(2013-1#4)(2013-8#1)
select variables##3##2##(1995-2#2)(2012-3#1)
select which##2##2##(2008-2#1)(2008-6#1)
select##329##1##(1990-10#2)(1990-12#3)(1991-1#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#3)(1993-4#1)(1993-9#2)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#5)(1995-4#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#5)(2004-11#1)(2004-2#1)(2004-9#1)(2005-10#4)(2005-11#2)(2005-4#1)(2005-6#1)(2005-7#3)(2005-8#2)(2006-10#5)(2006-11#4)(2006-12#1)(2006-2#3)(2006-5#3)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#6)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#4)(2008-1#4)(2008-10#43)(2008-11#6)(2008-12#3)(2008-2#11)(2008-3#6)(2008-4#4)(2008-5#4)(2008-6#6)(2008-7#2)(2008-8#5)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-7#2)(2010-8#7)(2011-1#6)(2011-2#14)(2011-3#2)(2012-1#4)(2012-11#1)(2012-12#11)(2012-2#9)(2012-3#10)(2013-1#12)(2013-7#2)(2013-8#3)
selectable marker gene hph##3##4##(2006-12#2)(2008-10#1)
selectable marker gene##8##3##(2006-12#6)(2008-10#2)
selectable marker in##2##3##(1997-2#1)(2008-10#1)
selectable marker is used to permit isolation of stable transfectants##2##10##(2008-2#1)(2008-4#1)
selectable marker is##4##3##(1993-5#1)(2008-2#1)(2008-4#2)
selectable marker##35##2##(1991-9#1)(1993-5#1)(1994-12#1)(1997-2#2)(1997-4#1)(1997-8#1)(2006-12#7)(2007-6#1)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-2#6)(2008-4#4)
selectable markers##6##2##(1994-3#1)(1995-8#1)(1997-7#1)(2006-12#1)(2008-10#1)(2008-2#1)
selectable##53##1##(1991-6#1)(1991-9#1)(1993-3#2)(1993-5#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-2#3)(1997-4#3)(1997-7#1)(1997-8#1)(2006-11#1)(2006-12#9)(2006-9#1)(2007-6#1)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-2#7)(2008-4#4)
selected 10##2##2##(2005-10#1)(2008-10#1)
selected 9##4##2##(1995-4#1)(1995-7#1)(2013-1#2)
selected Hispanic health beliefs and practices##2##6##(2008-9#2)
selected NCDs##2##2##(2013-8#2)
selected PCBs##3##2##(2008-11#3)
selected SSR##2##2##(2008-12#1)(2008-5#1)
selected a##11##2##(1990-12#2)(1994-2#1)(1994-8#1)(1995-12#1)(1995-8#1)(1997-2#1)(1997-5#1)(2006-11#1)(2008-5#2)
selected abstracts##2##2##(2006-10#1)(2008-5#1)
selected according to the##4##4##(1991-11#1)(1996-12#1)(2008-10#1)(2013-1#1)
selected according to##12##3##(1991-11#1)(1993-12#1)(1996-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
selected after##6##2##(2005-11#1)(2008-10#1)(2009-4#1)(2012-1#1)(2012-12#1)(2012-2#1)
selected age##2##2##(2007-1#2)
selected amino acid##2##3##(1992-4#1)(1995-8#1)
selected amino##3##2##(1992-4#1)(1995-8#1)(2008-5#1)
selected among those##2##3##(1997-7#1)(2008-5#1)
selected among##5##2##(1997-7#1)(2008-10#2)(2008-5#1)(2009-8#1)
selected anaplerotic##2##2##(2008-7#2)
selected and an##2##3##(1994-12#1)(2008-10#1)
selected and tested##2##3##(1994-11#1)(2008-8#1)
selected and used##3##3##(1994-12#1)(2008-10#1)(2013-8#1)
selected and##50##2##(1992-10#1)(1992-9#1)(1994-11#1)(1994-12#2)(1994-6#1)(1996-10#1)(2004-4#1)(2005-11#1)(2006-11#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-4#1)(2009-6#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
selected area##2##2##(2007-5#1)(2008-2#1)
selected areas of the##2##4##(1995-7#1)(2012-1#1)
selected areas of##4##3##(1995-7#1)(2008-10#1)(2012-1#1)(2012-2#1)
selected areas##6##2##(1995-7#1)(1996-6#1)(1997-3#1)(2008-10#1)(2012-1#1)(2012-2#1)
selected as a control group##2##5##(1990-8#1)(1995-10#1)
selected as a potential##3##4##(1992-2#1)(1996-1#1)(2010-4#1)
selected as a##16##3##(1990-8#1)(1992-2#1)(1992-5#1)(1995-10#1)(1996-1#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-4#1)(2013-1#2)(2013-8#1)
selected as per##2##3##(2007-10#1)(2008-10#1)
selected as the best##4##4##(2007-8#1)(2008-10#1)(2011-1#1)(2012-2#1)
selected as the most##3##4##(1991-10#1)(2008-10#1)(2012-2#1)
selected as the##21##3##(1991-10#1)(1996-2#1)(2004-10#1)(2005-12#1)(2007-8#1)(2008-10#6)(2008-5#2)(2010-12#1)(2011-1#3)(2011-2#1)(2012-2#2)(2013-8#1)
selected as##72##2##(1990-8#1)(1991-10#1)(1991-9#1)(1992-2#1)(1992-5#1)(1993-4#1)(1995-10#1)(1996-1#1)(1996-2#1)(1997-3#1)(1997-4#1)(2004-10#2)(2005-10#1)(2005-12#1)(2007-10#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#25)(2008-2#1)(2008-3#2)(2008-5#3)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#4)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#2)
selected aspects of##2##3##(2008-10#1)(2013-7#1)
selected at random from a##2##5##(2005-8#1)(2012-3#1)
selected at random from the##3##5##(1991-7#1)(1991-9#1)(1996-12#1)
selected at random from##6##4##(1991-7#1)(1991-9#1)(1996-12#1)(2005-8#1)(2008-10#1)(2012-3#1)
selected at random##12##3##(1990-11#1)(1991-7#1)(1991-9#1)(1992-5#1)(1994-5#1)(1996-12#1)(2005-8#1)(2007-3#1)(2008-10#2)(2008-5#1)(2012-3#1)
selected at##16##2##(1990-11#1)(1991-7#1)(1991-9#1)(1992-5#1)(1994-5#1)(1995-3#1)(1996-10#1)(1996-12#1)(2005-8#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2012-3#1)
selected bacteria##2##2##(2008-10#1)(2009-5#1)
selected bacterial##3##2##(2006-5#1)(2006-8#1)(2011-1#1)
selected based on the##2##4##(2011-2#1)(2013-1#1)
selected based on##15##3##(1990-5#1)(2006-11#1)(2007-12#1)(2008-12#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
selected based##16##2##(1990-5#1)(2006-11#1)(2007-12#1)(2007-6#1)(2008-12#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
selected because of##2##3##(1990-2#1)(2007-7#1)
selected because##7##2##(1990-2#1)(1995-5#1)(2006-9#1)(2007-7#1)(2008-10#1)(2008-3#1)(2009-3#1)
selected biochemical##3##2##(2007-6#2)(2013-1#1)
selected biological##4##2##(2007-11#1)(2007-8#2)(2009-7#1)
selected blood##2##2##(2008-12#2)
selected branches##2##2##(2008-10#1)(2008-5#1)
selected by a##4##3##(1991-7#1)(2007-3#1)(2008-1#1)(2008-2#1)
selected by its##2##3##(1990-8#1)(1993-3#1)
selected by multistage##2##3##(2006-2#1)(2007-3#1)
selected by stepwise##2##3##(2007-8#1)(2008-10#1)
selected by the##15##3##(1991-11#1)(1995-6#1)(2005-8#1)(2007-11#1)(2007-6#1)(2008-10#3)(2008-6#2)(2008-8#1)(2010-11#1)(2011-2#1)(2013-1#2)
selected by their##2##3##(1994-8#1)(2008-4#1)
selected by##78##2##(1990-8#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-7#2)(1992-6#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1997-4#1)(1997-6#1)(2005-8#2)(2005-9#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#2)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#10)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#3)(2008-7#1)(2008-8#3)(2009-9#1)(2010-11#1)(2010-8#2)(2011-2#3)(2011-3#1)(2012-12#4)(2013-1#5)
selected candidates##2##2##(2011-2#1)(2011-3#1)
selected carrier##2##2##(2008-10#1)(2008-4#1)
selected cases of##10##3##(1990-10#1)(1990-9#1)(1993-11#1)(1993-9#1)(1997-8#1)(2006-2#1)(2007-11#1)(2009-4#1)(2010-8#1)(2012-2#1)
selected cases##44##2##(1990-10#2)(1990-4#1)(1990-9#1)(1991-2#1)(1992-2#1)(1992-5#1)(1993-11#1)(1993-9#1)(1994-9#1)(1995-3#1)(1996-12#1)(1997-8#3)(2004-10#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#2)(2006-7#1)(2007-11#3)(2007-12#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-12#2)(2010-8#1)(2012-12#1)(2012-2#2)
selected cell##3##2##(1995-2#1)(2008-1#1)(2009-10#1)
selected cells##3##2##(1992-11#1)(2007-6#1)(2008-11#1)
selected cellular##3##2##(1995-4#1)(2008-7#1)(2012-12#1)
selected chemical##2##2##(2007-11#1)(2010-4#1)
selected children##3##2##(1996-1#1)(2006-10#1)(2008-10#1)
selected chromatographic conditions##2##3##(2005-12#1)(2010-3#1)
selected chromatographic##3##2##(1996-5#1)(2005-12#1)(2010-3#1)
selected classes of##4##3##(1996-6#1)(1996-7#1)(2007-10#1)(2008-5#1)
selected clinical and##2##3##(2008-7#1)(2012-3#1)
selected clinical##6##2##(2006-8#1)(2008-7#2)(2009-11#1)(2012-3#1)(2013-1#1)
selected colonies##2##2##(2007-11#1)(2008-11#1)
selected common##2##2##(2008-10#1)(2012-2#1)
selected community groups##2##3##(2009-4#2)
selected community##4##2##(2007-10#1)(2009-4#2)(2013-8#1)
selected components##3##2##(2007-12#1)(2008-10#1)(2013-1#1)
selected compounds were##3##3##(1992-5#1)(1994-9#1)(2006-12#1)
selected compounds##10##2##(1992-5#1)(1993-3#1)(1994-9#1)(1997-1#1)(2006-12#2)(2007-11#1)(2007-8#1)(2008-10#1)(2011-2#1)
selected concentrations of##2##3##(1994-9#1)(2008-10#1)
selected conditions for##2##3##(2008-10#2)
selected conditions##14##2##(2007-9#1)(2008-10#12)(2008-5#1)
selected data##2##2##(2008-10#2)
selected dental##2##2##(2008-5#1)(2013-1#1)
selected differentially##2##2##(2010-8#1)(2011-3#1)
selected diseases of the##2##4##(2013-7#2)
selected diseases##5##2##(1993-12#1)(1995-12#1)(1996-6#1)(2013-7#2)
selected donor##2##2##(2008-10#2)
selected drug##3##2##(1996-9#1)(2007-6#1)(2010-4#1)
selected drugs##5##2##(1996-5#1)(1996-7#2)(2007-11#1)(2011-2#1)
selected during##5##2##(1993-3#1)(2006-10#1)(2012-1#1)(2013-1#2)
selected elderly patients##2##3##(1990-5#1)(1992-4#1)
selected elements of the##2##4##(2008-10#1)(2011-1#1)
selected elements##6##2##(2008-10#4)(2010-5#1)(2011-1#1)
selected epidemiological##3##2##(1995-6#1)(2005-11#1)(2008-12#1)
selected evaluation##2##2##(1993-11#1)(1996-12#1)
selected examples of##2##3##(2006-4#1)(2012-12#1)
selected examples##7##2##(1995-7#1)(2006-4#1)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)
selected experimental conditions##3##3##(2008-10#2)(2011-2#1)
selected factors in##2##3##(2010-7#1)(2011-2#1)
selected factors##4##2##(2007-7#2)(2010-7#1)(2011-2#1)
selected features##4##2##(1993-12#1)(2008-10#1)(2008-12#2)
selected fields##2##2##(2008-10#1)(2009-3#1)
selected findings##3##2##(1990-8#1)(1994-12#1)(2011-2#1)
selected fish##2##2##(2010-8#2)
selected five##2##2##(1996-12#1)(2011-2#1)
selected following##2##2##(2005-8#1)(2009-6#1)
selected for a##7##3##(1990-2#1)(1992-2#1)(1994-11#1)(2007-7#1)(2008-5#2)(2012-12#1)
selected for analysis##3##3##(2008-10#1)(2008-11#1)(2010-5#1)
selected for clinical development##2##4##(1994-9#1)(2010-11#1)
selected for clinical##4##3##(1992-12#1)(1994-9#1)(1996-9#1)(2010-11#1)
selected for detailed morphological##2##4##(2005-11#2)
selected for different##3##3##(2008-5#1)(2011-1#1)(2013-1#1)
selected for each case##2##4##(2007-11#1)(2009-9#1)
selected for each##8##3##(1993-12#1)(1996-12#1)(2006-8#1)(2007-11#1)(2007-8#1)(2009-9#1)(2011-2#1)(2012-2#1)
selected for evaluation because of##3##5##(2005-7#2)(2006-12#1)
selected for evaluation##6##3##(1993-4#1)(2005-7#2)(2006-12#1)(2006-8#1)(2008-10#1)
selected for further analysis##2##4##(2008-11#1)(2008-9#1)
selected for further characterization##2##4##(2006-12#1)(2012-2#1)
selected for further study##3##4##(1995-3#1)(1997-3#1)(2008-10#1)
selected for further##12##3##(1992-3#1)(1992-5#1)(1992-7#1)(1995-3#1)(1997-3#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-6#1)(2012-2#1)
selected for high##2##3##(1995-8#1)(2010-2#1)
selected for increased aggressiveness##2##4##(2008-10#2)
selected for increased##4##3##(2008-10#2)(2008-8#2)
selected for laparoscopic##2##3##(2006-6#1)(2012-12#1)
selected for more##2##3##(2008-10#1)(2013-1#1)
selected for resistance to##2##4##(2008-10#2)
selected for resistance##5##3##(1994-6#1)(2008-10#4)
selected for the determination of##5##5##(2008-10#5)
selected for the study##6##4##(1990-3#1)(2007-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
selected for the##38##3##(1990-10#1)(1990-3#1)(1992-12#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#17)(2008-3#3)(2008-5#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-8#1)
selected for their##9##3##(1991-8#1)(1996-12#1)(2007-8#1)(2008-10#3)(2008-6#1)(2008-7#1)(2012-1#1)
selected for this study##8##4##(2007-2#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-3#1)(2013-1#2)
selected for this##12##3##(2007-2#1)(2007-7#2)(2008-10#2)(2008-12#1)(2008-3#1)(2010-7#1)(2013-1#4)
selected for treatment and##2##4##(1996-12#1)(2007-4#1)
selected for treatment##4##3##(1996-12#1)(2006-7#1)(2007-11#1)(2007-4#1)
selected for use##2##3##(1995-5#1)(2006-5#1)
selected for##215##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1991-5#3)(1991-8#1)(1991-9#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#2)(1993-12#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-3#1)(1995-5#1)(1995-8#2)(1996-12#3)(1996-3#1)(1996-9#1)(1997-3#1)(1997-7#2)(1997-8#1)(2004-1#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-7#2)(2005-8#2)(2006-10#1)(2006-11#1)(2006-12#3)(2006-2#1)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#3)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#4)(2008-10#51)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#8)(2008-6#2)(2008-7#2)(2008-8#6)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#4)(2009-4#1)(2009-6#1)(2009-9#2)(2010-11#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#7)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#1)
selected forensic##2##2##(1996-6#1)(2008-10#1)
selected four##2##2##(2004-8#1)(2011-2#1)
selected fractions##2##2##(2007-8#1)(2008-10#1)
selected from 6##2##3##(2011-1#1)(2013-1#1)
selected from a combinatorial##2##4##(1994-8#1)(2008-9#1)
selected from a pool of##2##5##(1992-11#1)(1995-2#1)
selected from a total of##3##5##(2006-8#1)(2008-7#1)(2013-8#1)
selected from a##24##3##(1991-8#1)(1992-11#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-2#1)(1997-5#1)(1997-8#1)(2005-11#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-9#1)(2008-10#2)(2008-5#3)(2008-7#2)(2008-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
selected from an##2##3##(2008-10#1)(2008-9#1)
selected from different##2##3##(1995-12#1)(1996-12#1)
selected from each of##2##4##(2008-10#1)(2008-5#1)
selected from each##8##3##(2006-8#1)(2008-10#2)(2008-5#2)(2011-1#1)(2013-1#2)
selected from eight##2##3##(2006-7#1)(2008-10#1)
selected from our##2##3##(1997-4#1)(2006-8#1)
selected from published##2##3##(1991-12#1)(2009-2#1)
selected from the database##2##4##(1995-6#1)(1997-8#1)
selected from the##28##3##(1994-2#1)(1994-5#1)(1995-6#1)(1997-8#2)(2006-5#1)(2007-10#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#2)
selected from those##2##3##(1994-6#1)(2008-8#1)
selected from three##2##3##(2007-7#1)(2008-10#1)
selected from two##3##3##(2007-11#1)(2008-10#1)(2010-3#1)
selected from##119##2##(1990-10#1)(1990-12#1)(1990-3#1)(1991-1#1)(1991-12#1)(1991-8#1)(1992-11#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#3)(2005-10#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-11#1)(2006-5#2)(2006-7#1)(2006-8#3)(2007-10#2)(2007-11#1)(2007-2#2)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#16)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#10)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-2#2)(2009-3#1)(2009-9#1)(2010-2#1)(2010-3#1)(2011-1#6)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#6)(2013-7#1)(2013-8#4)
selected fungal##3##2##(2008-10#1)(2009-8#1)(2010-5#1)
selected gene##2##2##(2013-8#2)
selected genes##14##2##(2006-10#1)(2006-5#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#2)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)
selected genomic##2##2##(1996-7#1)(2008-5#1)
selected germ plasm##2##3##(2008-10#2)
selected group of patients with##2##5##(2007-2#1)(2011-2#1)
selected group of patients##7##4##(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2010-9#1)(2011-2#1)(2013-1#1)
selected group of##12##3##(1990-9#1)(1994-6#1)(1996-9#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#1)(2010-9#1)(2011-2#1)(2013-1#1)
selected group##14##2##(1990-9#1)(1994-3#1)(1994-6#1)(1996-9#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-12#1)(2010-9#1)(2011-2#1)(2013-1#1)
selected hand##2##2##(2007-10#2)
selected healthy##2##2##(2006-8#1)(2012-12#1)
selected herbicides##2##2##(2007-8#1)(2008-11#1)
selected high##2##2##(2007-4#1)(2008-1#1)
selected hospital##2##2##(1992-1#1)(2010-7#1)
selected hospitals##5##2##(1993-1#1)(1996-3#1)(2007-12#1)(2008-3#1)(2011-2#1)
selected households##2##2##(2005-11#1)(2007-2#1)
selected human##6##2##(1994-9#1)(2008-3#2)(2008-5#1)(2012-3#1)(2013-1#1)
selected immune##2##2##(2006-7#1)(2007-11#1)
selected in a##4##3##(1990-9#1)(2012-3#1)(2013-1#2)
selected in order to avoid##2##5##(2008-10#2)
selected in order to##4##4##(2008-10#3)(2010-11#1)
selected in the##5##3##(2008-10#1)(2008-11#1)(2012-1#1)(2013-1#2)
selected in this study##3##4##(1997-4#1)(2007-2#1)(2011-12#1)
selected in##32##2##(1990-9#1)(1991-2#1)(1992-2#1)(1993-9#2)(1997-4#1)(2007-11#1)(2007-2#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#1)(2009-8#1)(2010-11#1)(2011-12#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#5)
selected individuals##3##2##(1997-4#1)(2009-10#1)(2011-1#1)
selected infectious##3##2##(1997-6#1)(2008-5#1)(2012-3#1)
selected ion monitoring (SIM) mode##5##5##(2007-8#1)(2008-10#4)
selected ion monitoring (SIM)##7##4##(2007-8#1)(2008-10#6)
selected ion monitoring in##2##4##(2008-10#1)(2013-1#1)
selected ion monitoring mode##8##4##(2007-8#1)(2008-10#6)(2008-11#1)
selected ion monitoring##24##3##(1992-7#1)(1993-12#1)(1996-3#1)(2004-2#1)(2007-8#2)(2008-10#16)(2008-11#1)(2013-1#1)
selected ion##26##2##(1992-7#1)(1993-12#1)(1996-3#1)(1996-8#1)(2004-2#1)(2007-8#2)(2008-10#16)(2008-11#1)(2008-8#1)(2013-1#1)
selected ions##2##2##(1996-8#1)(2008-10#1)
selected isolates of##3##3##(2006-8#1)(2008-10#2)
selected isolates##8##2##(2006-5#1)(2006-8#1)(2008-10#6)
selected items##2##2##(2007-12#1)(2013-1#1)
selected laboratory##2##2##(2006-2#1)(2006-5#1)
selected lanthanides##3##2##(2007-8#1)(2008-10#2)
selected lines that##2##3##(1994-2#1)(2008-10#1)
selected lines##9##2##(1992-9#1)(1993-5#1)(1994-2#1)(2006-12#1)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#1)
selected locus##2##2##(2008-8#1)(2012-11#1)
selected manually##2##2##(2011-1#2)
selected markers##4##2##(1990-11#1)(2006-6#1)(2008-10#1)(2008-5#1)
selected materials to##2##3##(2011-1#1)(2013-7#1)
selected materials##3##2##(2008-5#1)(2011-1#1)(2013-7#1)
selected measures of##2##3##(1997-8#1)(2013-8#1)
selected method##2##2##(2008-10#1)(2010-3#1)
selected molecular##3##2##(2008-4#1)(2008-8#1)(2010-1#1)
selected multivariate##2##2##(2008-10#2)
selected municipalities##3##2##(1997-7#3)
selected new##2##2##(2008-11#1)(2008-8#1)
selected on the basis of their##2##6##(1995-8#1)(2006-12#1)
selected on the basis of##14##5##(1990-11#1)(1995-8#1)(1996-11#1)(1996-9#1)(2005-8#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-1#1)(2010-3#1)(2011-3#1)
selected on the##15##3##(1990-11#1)(1995-8#1)(1996-11#1)(1996-9#1)(2005-8#1)(2006-12#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-1#1)(2010-3#1)(2011-3#1)
selected on##22##2##(1990-11#1)(1990-5#1)(1995-4#1)(1995-8#1)(1996-11#1)(1996-9#2)(2005-8#1)(2006-12#2)(2007-2#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-9#2)(2009-1#1)(2010-12#1)(2010-3#1)(2011-12#1)(2011-3#1)
selected or##3##2##(1995-1#1)(1996-12#1)(2006-2#1)
selected organic##2##2##(1997-2#1)(2008-10#1)
selected orientation##2##2##(1994-11#1)(2007-12#1)
selected out of##2##3##(1992-7#1)(2008-6#1)
selected parameters##2##2##(2004-4#1)(2007-9#1)
selected patient groups##2##3##(1996-11#1)(2012-2#1)
selected patient population##2##3##(2011-2#1)(2012-1#1)
selected patient##8##2##(1996-11#1)(2007-11#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
selected patients and##2##3##(2008-3#1)(2013-7#1)
selected patients at risk##2##4##(2008-3#1)(2010-10#1)
selected patients had at least 2##2##6##(2013-8#2)
selected patients had##3##3##(2012-12#1)(2013-8#2)
selected patients in##2##3##(1990-2#1)(2007-8#1)
selected patients to##2##3##(1993-9#1)(2006-2#1)
selected patients with##30##3##(1990-11#1)(1990-3#1)(1992-6#2)(1995-2#1)(1996-9#1)(1997-6#2)(2004-1#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-8#3)(2007-9#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-5#2)(2010-12#1)(2011-2#1)(2012-2#1)
selected patients##105##2##(1990-11#1)(1990-2#1)(1990-3#2)(1990-6#1)(1991-2#1)(1991-9#2)(1992-10#1)(1992-6#2)(1993-2#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-6#2)(1995-2#1)(1995-4#1)(1995-9#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-6#2)(1997-8#1)(2004-1#1)(2005-10#1)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#3)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#2)(2006-9#2)(2007-10#2)(2007-11#4)(2007-12#1)(2007-7#2)(2007-8#6)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#5)(2008-4#1)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#2)(2009-7#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#3)
selected phage##3##2##(2007-2#1)(2008-1#1)(2008-10#1)
selected physico-chemical##2##2##(2009-2#1)(2012-2#1)
selected plant##2##2##(2007-10#1)(2008-10#1)
selected plants##2##2##(2008-10#1)(2008-6#1)
selected points##4##2##(2007-11#1)(2008-10#1)(2012-12#2)
selected population##10##2##(1993-11#1)(1993-9#1)(1996-3#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-12#1)
selected populations##8##2##(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-12#1)(2011-2#1)(2012-12#1)
selected procedures##3##2##(2008-4#2)(2008-9#1)
selected protease##2##2##(2008-10#1)(2011-12#1)
selected proteins##2##2##(1991-2#1)(2008-7#1)
selected purposively from##2##3##(2007-7#1)(2008-4#1)
selected randomly from##3##3##(1993-1#1)(1994-3#1)(2008-10#1)
selected randomly##8##2##(1993-1#1)(1994-3#1)(2006-10#1)(2008-10#1)(2008-3#1)(2010-2#1)(2010-9#1)(2012-1#1)
selected rat lines##2##3##(1996-4#2)
selected rat##3##2##(1996-4#2)(2009-8#1)
selected reference##2##2##(2008-10#1)(2010-8#1)
selected regions##2##2##(1996-12#1)(2010-7#1)
selected resistant##2##2##(2008-10#2)
selected results##2##2##(2008-8#1)(2010-10#1)
selected risk factors##3##3##(2006-8#1)(2007-6#1)(2010-4#1)
selected rural communities in##2##4##(1994-9#1)(2011-1#1)
selected sample##7##2##(1990-5#2)(1994-12#1)(1994-6#1)(2006-10#2)(2012-12#1)
selected samples##6##2##(1992-10#1)(2006-5#1)(2008-10#3)(2012-2#1)
selected schools##3##2##(2007-2#2)(2012-12#1)
selected sets of##2##3##(2009-9#1)(2012-11#1)
selected sites in the##2##4##(1994-12#1)(2005-8#1)
selected sites##3##2##(1994-12#1)(2005-8#1)(2010-3#1)
selected species were##2##3##(2008-5#1)(2011-12#1)
selected species##3##2##(2008-5#1)(2011-12#2)
selected strain##5##2##(1993-7#2)(2008-5#1)(2008-8#1)(2010-8#1)
selected strains##4##2##(2008-6#1)(2009-6#2)(2011-2#1)
selected stress behaviors##2##3##(1991-12#2)
selected structures of##2##3##(2008-11#1)(2013-1#1)
selected surfactants##2##2##(2008-5#2)
selected surgical##3##2##(1991-1#1)(2007-10#1)(2008-10#1)
selected that##8##2##(1991-11#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-4#1)(2012-2#1)
selected the##11##2##(1994-12#1)(2007-12#1)(2008-10#2)(2008-2#1)(2009-10#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-7#1)
selected three##2##2##(1997-2#1)(2007-7#1)
selected through##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
selected tissues##6##2##(1994-5#1)(1995-10#1)(2008-5#1)(2008-7#2)(2010-5#1)
selected to be##4##3##(1993-4#1)(1995-6#1)(2008-5#1)(2013-1#1)
selected to carry out##2##4##(2007-4#1)(2008-10#1)
selected to ensure##2##3##(2008-4#1)(2012-9#1)
selected to obtain##3##3##(2004-12#1)(2006-6#1)(2012-12#1)
selected to participate in this##3##5##(1991-2#1)(2009-7#1)(2010-4#1)
selected to participate in##4##4##(1991-2#1)(2009-7#1)(2010-4#1)(2011-2#1)
selected to produce##2##3##(2008-3#1)(2008-6#1)
selected to represent the##3##4##(2007-2#1)(2008-10#2)
selected to represent##5##3##(1991-12#1)(2006-4#1)(2007-2#1)(2008-10#2)
selected to##64##2##(1991-12#2)(1991-2#1)(1991-5#1)(1993-4#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-2#1)(1997-8#1)(2004-12#1)(2004-8#1)(2006-4#1)(2006-6#1)(2007-1#1)(2007-2#2)(2007-4#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#2)(2012-9#1)(2013-1#1)(2013-8#1)
selected topics##2##2##(1990-7#1)(2012-3#1)
selected traditional##2##2##(1993-12#1)(2012-2#1)
selected types of##2##3##(1994-2#1)(2008-5#1)
selected using a##6##3##(2007-1#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2013-1#1)
selected using##11##2##(2007-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-12#1)(2010-8#1)(2013-1#1)
selected variables was##2##3##(2008-10#1)(2013-8#1)
selected variables##5##2##(2004-11#1)(2008-10#2)(2010-3#1)(2013-8#1)
selected via##3##2##(2008-10#1)(2008-12#1)(2009-10#1)
selected virulent populations##2##3##(2008-10#2)
selected virulent##4##2##(2008-10#4)
selected was##3##2##(2006-2#1)(2008-10#1)(2012-3#1)
selected wastewater protozoa##2##3##(2008-12#2)
selected wavelength##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
selected wavelengths in the##2##4##(2008-2#2)
selected wavelengths##6##2##(2008-2#2)(2008-3#3)(2010-5#1)
selected were##5##2##(1992-3#1)(2008-10#1)(2008-9#1)(2009-5#1)(2011-1#1)
selected with##6##2##(1991-3#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)
selected women##3##2##(1992-8#1)(2007-7#1)(2010-5#1)
selected##2176##1##(1990-10#5)(1990-11#6)(1990-12#4)(1990-2#4)(1990-3#6)(1990-4#1)(1990-5#6)(1990-6#1)(1990-7#5)(1990-8#5)(1990-9#3)(1991-1#3)(1991-10#2)(1991-11#4)(1991-12#9)(1991-2#9)(1991-3#3)(1991-4#1)(1991-5#7)(1991-6#1)(1991-7#4)(1991-8#5)(1991-9#8)(1992-1#3)(1992-10#3)(1992-11#4)(1992-12#3)(1992-2#5)(1992-3#2)(1992-4#2)(1992-5#5)(1992-6#6)(1992-7#4)(1992-8#2)(1992-9#3)(1993-1#5)(1993-10#1)(1993-11#7)(1993-12#12)(1993-2#3)(1993-3#4)(1993-4#4)(1993-5#3)(1993-6#2)(1993-7#3)(1993-8#3)(1993-9#9)(1994-1#3)(1994-10#1)(1994-11#4)(1994-12#9)(1994-2#9)(1994-3#8)(1994-5#7)(1994-6#9)(1994-8#5)(1994-9#8)(1995-1#4)(1995-10#2)(1995-11#1)(1995-12#4)(1995-2#8)(1995-3#5)(1995-4#4)(1995-5#7)(1995-6#6)(1995-7#6)(1995-8#8)(1995-9#2)(1996-1#4)(1996-10#3)(1996-11#3)(1996-12#13)(1996-2#2)(1996-3#4)(1996-4#3)(1996-5#5)(1996-6#9)(1996-7#4)(1996-8#7)(1996-9#9)(1997-1#2)(1997-2#8)(1997-3#7)(1997-4#11)(1997-5#3)(1997-6#9)(1997-7#7)(1997-8#12)(2004-1#2)(2004-10#4)(2004-11#1)(2004-12#1)(2004-2#2)(2004-4#6)(2004-8#2)(2004-9#1)(2005-10#6)(2005-11#8)(2005-12#3)(2005-4#2)(2005-5#1)(2005-7#4)(2005-8#12)(2005-9#2)(2006-10#22)(2006-11#8)(2006-12#15)(2006-2#14)(2006-3#1)(2006-4#7)(2006-5#18)(2006-6#11)(2006-7#10)(2006-8#21)(2006-9#3)(2007-1#10)(2007-10#24)(2007-11#42)(2007-12#23)(2007-2#22)(2007-3#10)(2007-4#7)(2007-5#6)(2007-6#19)(2007-7#26)(2007-8#47)(2007-9#11)(2008-1#18)(2008-10#344)(2008-11#31)(2008-12#26)(2008-2#34)(2008-3#45)(2008-4#26)(2008-5#72)(2008-6#21)(2008-7#35)(2008-8#43)(2008-9#27)(2009-1#1)(2009-10#11)(2009-11#5)(2009-12#9)(2009-2#8)(2009-3#5)(2009-4#17)(2009-5#7)(2009-6#9)(2009-7#7)(2009-8#8)(2009-9#7)(2010-1#1)(2010-10#3)(2010-11#8)(2010-12#16)(2010-2#9)(2010-3#13)(2010-4#11)(2010-5#12)(2010-6#2)(2010-7#8)(2010-8#24)(2010-9#3)(2011-1#38)(2011-12#10)(2011-2#72)(2011-3#6)(2012-1#15)(2012-11#4)(2012-12#33)(2012-2#32)(2012-3#32)(2012-9#1)(2013-1#77)(2013-7#16)(2013-8#35)
selected-ion monitoring (SIM) mode##2##4##(1996-6#1)(2008-5#1)
selected-ion monitoring (SIM)##3##3##(1996-6#1)(2008-10#1)(2008-5#1)
selected-ion monitoring and mass spectrometry##2##5##(1996-8#2)
selected-ion monitoring##7##2##(1996-6#2)(1996-8#2)(2008-10#1)(2008-5#1)(2009-10#1)
selectin binding##2##2##(1993-8#1)(1997-4#1)
selectin functions##2##2##(2008-3#2)
selectin is##3##2##(1991-5#1)(1997-4#2)
selectin##15##1##(1991-12#1)(1991-5#4)(1993-8#1)(1996-2#1)(1997-1#1)(1997-4#5)(2008-3#2)
selecting PK repeat##2##3##(2010-11#2)
selecting a group of##2##4##(2008-10#1)(2012-3#1)
selecting a suitable##4##3##(2008-4#2)(2008-7#1)(2012-5#1)
selecting a##20##2##(1992-12#1)(1995-12#2)(1995-9#1)(1997-8#1)(2006-5#1)(2007-4#1)(2008-10#2)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-9#1)(2010-7#1)(2012-1#1)(2012-3#1)(2012-5#1)
selecting an appropriate##5##3##(2005-12#1)(2006-10#1)(2008-9#2)(2011-2#1)
selecting an##12##2##(1992-4#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#2)(2011-2#1)
selecting and developing##2##3##(1997-3#1)(2008-7#1)
selecting and implementing##3##3##(1994-12#1)(2006-3#1)(2010-8#1)
selecting and##10##2##(1994-12#1)(1995-12#1)(1996-12#1)(1997-3#1)(2006-3#1)(2008-4#2)(2008-7#1)(2010-8#1)(2011-2#1)
selecting appropriate##4##2##(2006-11#1)(2006-12#1)(2008-4#2)
selecting breast cancer patients##2##4##(1992-2#1)(1996-4#1)
selecting for##6##2##(1991-12#1)(1996-10#1)(1997-4#1)(2006-12#1)(2008-10#1)(2008-2#1)
selecting health##2##2##(1995-1#1)(1996-3#1)
selecting only##2##2##(1991-3#1)(2008-3#1)
selecting pairs of glasses for##2##5##(2008-3#2)
selecting patients for##7##3##(1990-10#2)(2007-8#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-3#1)
selecting patients with##3##3##(2007-3#1)(2008-8#1)(2013-1#1)
selecting patients##13##2##(1990-10#2)(2007-3#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
selecting peptides##2##2##(1994-6#2)
selecting software##2##2##(1994-2#1)(2012-3#1)
selecting the appropriate##6##3##(2008-10#1)(2008-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
selecting the best##2##3##(2008-3#1)(2013-1#1)
selecting the most suitable##2##4##(2008-10#1)(2008-12#1)
selecting the most##3##3##(1990-5#1)(2008-10#1)(2008-12#1)
selecting the surgical##2##3##(1990-9#1)(2011-2#1)
selecting the type of##3##4##(1996-1#1)(2007-12#1)(2013-8#1)
selecting the##49##2##(1990-5#1)(1990-9#1)(1992-12#1)(1992-2#1)(1993-3#1)(1994-3#2)(1995-12#1)(1995-2#1)(1995-8#2)(1996-1#1)(1997-3#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#6)(2008-8#1)(2009-11#1)(2009-12#2)(2009-7#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
selecting those##2##2##(1993-1#1)(2006-12#1)
selecting transformants that##2##3##(1990-11#1)(2008-10#1)
selecting treatment##2##2##(2007-11#1)(2009-5#1)
selecting##211##1##(1990-10#2)(1990-11#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#3)(1991-3#1)(1991-5#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-4#1)(1993-1#2)(1993-3#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#3)(1995-1#2)(1995-12#4)(1995-2#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#2)(1996-4#1)(1997-2#2)(1997-3#2)(1997-4#3)(1997-8#1)(2004-11#1)(2005-12#2)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#2)(2007-4#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#19)(2008-11#2)(2008-12#2)(2008-2#6)(2008-3#8)(2008-4#17)(2008-5#4)(2008-7#5)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#4)(2010-2#1)(2010-3#1)(2010-7#3)(2010-8#1)(2011-1#4)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#6)(2012-5#1)(2013-1#4)(2013-8#4)
selectins##10##1##(1993-3#2)(1993-8#1)(1997-1#1)(2008-3#4)(2011-1#2)
selection (MAS)##8##2##(2006-9#1)(2008-10#3)(2008-7#1)(2008-8#1)(2012-3#1)(2013-8#1)
selection (i##2##2##(2004-12#1)(2008-4#1)
selection acting on##3##3##(1995-11#1)(2012-3#1)(2013-1#1)
selection acting##7##2##(1995-11#1)(1995-2#1)(2008-8#1)(2010-4#1)(2012-12#1)(2012-3#1)(2013-1#1)
selection acts##2##2##(2008-8#1)(2013-1#1)
selection after##2##2##(1997-7#1)(2007-3#1)
selection against##12##2##(1994-3#1)(1996-10#1)(1997-7#1)(2008-10#3)(2008-9#2)(2009-2#1)(2009-9#1)(2012-1#1)(2012-2#1)
selection algorithm##4##2##(2008-11#1)(2008-2#1)(2008-6#1)(2012-3#1)
selection among##3##2##(1997-8#1)(2010-12#1)(2012-12#1)
selection and a##2##3##(2008-4#1)(2008-8#1)
selection and assessment##2##3##(1994-6#1)(2011-2#1)
selection and cloning##2##3##(1997-4#1)(2008-4#1)
selection and control of##2##4##(1991-11#1)(2008-5#1)
selection and drift##2##3##(1995-8#1)(2008-11#1)
selection and engagement##2##3##(2011-1#1)(2011-2#1)
selection and evaluation##3##3##(2005-9#1)(2010-8#1)(2013-1#1)
selection and identification of##2##4##(2008-7#1)(2011-3#1)
selection and implementation of##3##4##(1994-2#1)(2008-9#1)(2010-4#1)
selection and management of##3##4##(1992-12#1)(1993-4#1)(2007-12#1)
selection and management##4##3##(1992-12#2)(1993-4#1)(2007-12#1)
selection and optimization##2##3##(2005-9#1)(2008-10#1)
selection and optimum##2##3##(2007-11#2)
selection and prediction of##2##4##(2006-10#1)(2006-3#1)
selection and random##2##3##(1995-5#1)(1996-6#1)
selection and retention##2##3##(1995-3#1)(2009-12#1)
selection and the##11##3##(2008-8#3)(2008-9#2)(2009-4#1)(2010-1#1)(2010-9#1)(2012-2#1)(2012-3#2)
selection and treatment##3##3##(2007-10#1)(2008-7#1)(2010-4#1)
selection and use of##2##4##(2007-11#1)(2008-4#1)
selection and use##4##3##(1996-1#1)(2007-11#1)(2008-4#1)(2013-8#1)
selection and##159##2##(1990-9#1)(1991-11#2)(1991-12#1)(1991-6#1)(1992-12#2)(1993-12#1)(1993-4#1)(1994-1#1)(1994-2#1)(1994-6#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-6#1)(1996-8#2)(1997-2#2)(1997-4#1)(2005-9#2)(2006-10#4)(2006-2#1)(2006-3#1)(2006-5#2)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-4#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#9)(2008-5#3)(2008-7#3)(2008-8#14)(2008-9#7)(2009-10#2)(2009-12#1)(2009-4#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-4#3)(2010-7#1)(2010-8#7)(2010-9#3)(2011-1#4)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#7)(2013-1#7)(2013-8#3)
selection and/or##2##2##(2008-9#1)(2009-5#1)
selection are not##3##3##(2008-12#1)(2011-3#1)(2013-1#1)
selection are proposed##2##3##(2009-12#1)(2010-6#1)
selection are##17##2##(1991-2#2)(1995-2#1)(2006-5#1)(2006-7#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-12#1)(2009-8#1)(2010-6#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
selection as well as##2##4##(1991-2#1)(2008-8#1)
selection as##5##2##(1991-2#1)(1996-3#1)(1996-6#1)(1997-7#1)(2008-8#1)
selection at multiple##2##3##(2010-4#1)(2013-1#1)
selection at the##2##3##(2009-5#1)(2012-3#1)
selection at##12##2##(1997-7#1)(2008-8#4)(2009-5#1)(2010-3#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#2)
selection based on##10##3##(1994-12#1)(1996-6#1)(2006-8#1)(2008-10#4)(2008-8#3)
selection between foods##2##3##(2008-12#2)
selection between the##2##3##(2008-8#1)(2010-8#1)
selection between##7##2##(2008-1#1)(2008-12#2)(2008-8#1)(2010-12#1)(2010-8#1)(2013-1#1)
selection bias in##3##3##(1990-9#1)(1995-2#1)(2013-1#1)
selection bias##25##2##(1990-9#1)(1995-2#1)(1996-1#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#2)(2004-1#2)(2006-12#3)(2006-2#1)(2007-10#1)(2007-8#2)(2008-1#1)(2008-3#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-3#2)(2013-1#1)
selection biases##2##2##(2007-9#1)(2013-8#1)
selection by the host##2##4##(2008-10#2)
selection by the##5##3##(1997-4#1)(2008-10#2)(2010-8#1)(2013-1#1)
selection by two##2##3##(2008-8#2)
selection by##22##2##(1990-8#1)(1995-1#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-8#2)(2010-11#1)(2010-8#2)(2012-2#1)(2013-1#1)(2013-8#1)
selection can be used to##2##5##(1996-8#1)(2006-5#1)
selection can be##5##3##(1996-8#1)(2006-5#1)(2008-10#2)(2013-1#1)
selection can##9##2##(1993-12#1)(1996-8#1)(2006-5#1)(2007-11#1)(2008-10#2)(2008-8#2)(2013-1#1)
selection cannot##2##2##(1995-5#1)(2008-8#1)
selection conditions##2##2##(2008-2#1)(2008-4#1)
selection consistency##2##2##(2012-1#1)(2012-3#1)
selection could##3##2##(2008-10#1)(2008-8#1)(2010-10#1)
selection coupled with##3##3##(2010-8#1)(2013-1#2)
selection criteria and##5##3##(1993-10#1)(2006-12#1)(2008-9#1)(2011-1#1)(2012-12#1)
selection criteria for##5##3##(1990-9#1)(1991-12#1)(1994-9#1)(1997-1#1)(2008-8#1)
selection criteria used in the##2##5##(1993-9#1)(2008-7#1)
selection criteria used##3##3##(1993-9#1)(2006-9#1)(2008-7#1)
selection criteria##39##2##(1990-3#1)(1990-9#1)(1991-12#1)(1992-2#2)(1993-10#1)(1993-11#1)(1993-9#1)(1994-9#2)(1997-1#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-9#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2009-9#1)(2010-2#2)(2011-1#1)(2011-11#1)(2011-3#1)(2012-12#2)(2012-2#2)
selection criterion##4##2##(1996-4#1)(2006-5#1)(2008-10#1)(2008-8#1)
selection device##2##2##(2008-7#1)(2012-12#1)
selection differed##2##2##(2008-8#1)(2012-3#1)
selection during##2##2##(2012-2#2)
selection effects##3##2##(1991-3#2)(2012-2#1)
selection exerted by##2##3##(2013-1#2)
selection experiments##3##2##(2008-10#1)(2008-8#2)
selection favored larger##2##3##(2008-8#1)(2008-9#1)
selection favored##3##2##(1995-8#1)(2008-8#1)(2008-9#1)
selection favoring##5##2##(1995-8#1)(2008-8#2)(2009-8#2)
selection favors##4##2##(1995-2#1)(2008-8#1)(2008-9#1)(2009-8#1)
selection for a##3##3##(1994-3#1)(2006-11#1)(2013-8#1)
selection for bacterial##2##3##(1995-1#1)(2008-2#1)
selection for cardiac##2##3##(1997-4#1)(2011-2#1)
selection for growth##3##3##(1992-12#1)(2008-8#1)(2010-8#1)
selection for quantitative resistance to Sclerotinia trifoliorum in alfalfa also##2##10##(2008-10#2)
selection for resistance to##2##4##(2008-10#2)
selection for resistance##6##3##(2008-10#6)
selection for surgical##2##3##(1990-9#1)(2008-9#1)
selection for the##7##3##(1995-6#1)(2007-5#1)(2008-10#1)(2008-5#1)(2010-7#1)(2011-1#1)(2012-11#1)
selection for these##2##3##(2008-8#1)(2012-2#1)
selection for virulence##2##3##(2008-10#2)
selection for##96##2##(1990-10#1)(1990-11#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-7#1)(1992-12#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-1#1)(1997-4#2)(1997-6#1)(2004-2#1)(2006-11#1)(2006-12#2)(2006-9#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#21)(2008-12#1)(2008-2#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#8)(2008-9#8)(2009-10#2)(2009-2#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#5)
selection forces##3##2##(2007-7#1)(2013-8#2)
selection from##6##2##(1993-11#1)(2006-8#1)(2008-10#1)(2008-4#2)(2012-12#1)
selection gradients##6##2##(2008-8#6)
selection had##2##2##(2008-10#1)(2010-8#1)
selection has been##3##3##(1996-4#1)(2008-8#1)(2012-3#1)
selection has##10##2##(1995-2#1)(1996-4#1)(2006-5#1)(2008-10#1)(2008-8#2)(2012-2#1)(2012-3#3)
selection have been##2##3##(1995-1#1)(1997-6#1)
selection improved##2##2##(2008-10#1)(2011-1#1)
selection in a##2##3##(2008-8#1)(2008-9#1)
selection in all##2##3##(2008-12#1)(2008-8#1)
selection in breeding programs##2##4##(2008-10#1)(2012-3#1)
selection in different##2##3##(1995-2#1)(2013-1#1)
selection in experimental##2##3##(2008-4#1)(2013-1#1)
selection in natural populations##2##4##(2008-8#1)(2012-3#1)
selection in plants##3##3##(1995-2#3)
selection in populations##2##3##(1995-8#1)(2008-6#1)
selection in spontaneous emission##2##4##(2008-1#2)
selection in the##16##3##(1995-5#1)(1997-2#1)(1997-4#1)(2006-5#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-8#2)(2009-5#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#1)
selection in yeast##3##3##(1991-5#1)(1991-6#1)(1991-7#1)
selection in##90##2##(1990-11#1)(1990-9#1)(1991-11#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-9#1)(1993-7#1)(1994-3#1)(1995-1#1)(1995-2#5)(1995-5#2)(1995-6#1)(1995-8#1)(1997-2#2)(1997-4#1)(1997-5#1)(2005-10#1)(2006-12#1)(2006-5#4)(2007-12#2)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#9)(2008-9#7)(2009-5#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)
selection increased##2##2##(2011-2#1)(2013-1#1)
selection intensity##2##2##(2008-10#1)(2008-8#1)
selection is a##2##3##(1993-9#1)(1995-2#1)
selection is also##2##3##(1995-2#1)(2010-4#1)
selection is based on the##2##5##(2007-11#1)(2011-2#1)
selection is based on##3##4##(2007-11#1)(2011-12#1)(2011-2#1)
selection is important##4##3##(2006-5#1)(2008-7#1)(2011-2#1)(2012-12#1)
selection is reduced if dose is##2##6##(2008-10#2)
selection is##33##2##(1991-11#1)(1993-9#1)(1995-2#2)(1997-8#1)(2006-5#2)(2006-6#1)(2006-7#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#3)(2010-4#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
selection led to##2##3##(1994-9#1)(1996-6#1)
selection lines##6##2##(1996-4#3)(2008-8#1)(2009-2#2)
selection marker was##2##3##(2005-11#1)(2008-11#1)
selection marker##11##2##(1990-3#1)(1991-7#1)(1991-8#2)(1997-4#1)(2005-11#1)(2008-11#5)
selection markers##2##2##(1994-12#1)(2006-12#1)
selection may##11##2##(1990-8#1)(1995-2#1)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2010-9#1)(2012-12#1)(2012-3#1)
selection mechanism##4##2##(2008-2#1)(2008-9#1)(2013-1#2)
selection mechanisms##2##2##(2010-12#1)(2012-2#1)
selection medium##9##2##(1992-8#2)(2008-5#1)(2012-2#6)
selection method##4##2##(1995-2#1)(1997-5#1)(2008-1#1)(2008-4#1)
selection methods##11##2##(1993-12#1)(1995-2#1)(1997-2#1)(1997-5#2)(2007-6#1)(2008-10#2)(2008-4#1)(2008-7#1)(2012-3#1)
selection model##2##2##(2008-8#1)(2012-2#1)
selection models##3##2##(2008-10#1)(2008-9#1)(2009-12#1)
selection must##3##2##(2006-10#1)(2008-5#1)(2008-9#1)
selection of a suitable##3##4##(2008-4#1)(2008-5#2)
selection of a##26##3##(1990-11#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-6#1)(1997-2#1)(2006-1#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2009-9#1)(2010-8#2)(2011-1#1)(2011-2#1)(2013-1#1)
selection of an appropriate##5##4##(1990-9#1)(1991-9#1)(2008-2#1)(2008-5#1)(2009-9#1)
selection of an##9##3##(1990-9#1)(1991-9#1)(1992-3#1)(2006-12#1)(2008-2#2)(2008-5#1)(2009-9#1)(2011-2#1)
selection of antibiotic therapy##2##4##(1996-12#1)(2009-4#1)
selection of antihypertensive##2##3##(1992-8#1)(2008-1#1)
selection of appropriate##6##3##(2006-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-9#1)(2012-2#1)
selection of aptamers##2##3##(2008-4#1)(2010-5#1)
selection of articles##2##3##(2006-10#1)(2012-3#1)
selection of candidate##3##3##(2007-7#1)(2008-10#1)(2010-5#1)
selection of different##2##3##(2007-12#1)(2008-11#1)
selection of drug##3##3##(1994-5#1)(2005-8#1)(2011-2#1)
selection of drug-resistant##2##3##(1991-12#1)(2008-5#1)
selection of experimental##2##3##(2008-2#1)(2008-3#1)
selection of full-length cDNA by##2##5##(1997-2#2)
selection of genes for##2##4##(2008-10#1)(2012-11#1)
selection of genes##5##3##(1997-6#1)(2006-12#1)(2008-10#1)(2010-11#1)(2012-11#1)
selection of initial##2##3##(2005-11#1)(2006-8#1)
selection of internal##2##3##(2008-10#2)
selection of materials and##2##4##(1990-4#1)(2008-2#1)
selection of materials##3##3##(1990-4#1)(2008-2#1)(2008-3#1)
selection of other##2##3##(1996-3#1)(2008-1#1)
selection of parameters##2##3##(1996-5#1)(2008-9#1)
selection of patients for adjuvant##2##5##(2006-9#1)(2008-4#1)
selection of patients for##8##4##(1994-2#1)(1995-4#1)(2006-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-11#1)
selection of patients who##4##4##(2007-8#1)(2008-7#1)(2008-8#1)(2012-3#1)
selection of patients with##6##4##(1997-1#1)(1997-2#1)(2005-10#1)(2007-11#1)(2007-8#1)(2011-1#1)
selection of patients##29##3##(1990-11#1)(1991-3#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-4#1)(1996-3#1)(1997-1#1)(1997-2#1)(2005-10#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-8#2)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
selection of projections##2##3##(2006-10#2)
selection of prosthesis##2##3##(2007-11#1)(2011-2#1)
selection of rare##2##3##(2008-10#1)(2012-3#1)
selection of reagents##4##3##(2008-4#2)(2008-9#1)(2012-2#1)
selection of recombinant##2##3##(1995-2#1)(2008-4#1)
selection of recombinants##2##3##(1991-7#1)(2008-2#1)
selection of resistant##4##3##(2008-10#1)(2009-6#1)(2012-1#1)(2013-1#1)
selection of sequences##3##3##(1991-9#1)(1995-8#1)(2006-6#1)
selection of source##2##3##(2008-4#1)(2009-11#1)
selection of specific##3##3##(2008-11#2)(2012-2#1)
selection of strains##2##3##(1992-12#1)(2008-10#1)
selection of students##2##3##(1990-10#1)(2012-2#1)
selection of the appropriate##7##4##(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-2#1)
selection of the best##3##4##(1993-8#1)(2006-10#1)(2007-3#1)
selection of the experimental conditions##2##5##(2008-10#1)(2008-3#1)
selection of the ionization##2##4##(2008-10#1)(2008-3#1)
selection of the most appropriate##4##5##(2004-2#1)(2005-10#1)(2007-9#1)(2011-2#1)
selection of the most##7##4##(1997-7#1)(2004-2#1)(2005-10#1)(2007-9#1)(2008-10#1)(2009-9#1)(2011-2#1)
selection of the optimal##3##4##(2005-1#1)(2006-6#1)(2008-2#1)
selection of the optimum##2##4##(1996-8#1)(2008-10#1)
selection of the proper##4##4##(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)
selection of the variables##2##4##(2008-10#1)(2008-5#1)
selection of the##88##3##(1990-8#1)(1991-10#1)(1991-3#1)(1991-7#1)(1992-2#1)(1993-11#1)(1993-8#2)(1995-8#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-4#2)(1997-7#1)(1997-9#1)(2004-2#1)(2005-1#1)(2005-10#1)(2006-10#3)(2006-6#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#18)(2008-11#2)(2008-2#8)(2008-3#9)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-9#1)(2010-12#1)(2010-2#1)(2011-2#3)(2012-12#2)(2012-3#1)
selection of therapy##2##3##(2006-10#1)(2007-10#1)
selection of these##7##3##(1993-11#1)(2006-1#1)(2007-2#1)(2008-11#2)(2008-8#2)
selection of treatment##4##3##(1992-3#1)(2006-10#1)(2008-12#1)(2010-1#1)
selection of variables##5##3##(1995-9#1)(2008-10#4)
selection of##520##2##(1990-10#3)(1990-11#2)(1990-12#3)(1990-4#1)(1990-5#5)(1990-7#1)(1990-8#4)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#5)(1991-12#2)(1991-3#2)(1991-5#2)(1991-7#2)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-8#3)(1994-1#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#4)(1995-4#1)(1995-5#4)(1995-7#1)(1995-8#4)(1995-9#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-8#3)(1996-9#1)(1997-1#4)(1997-2#5)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#1)(1997-9#2)(2004-2#2)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#2)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#3)(2006-10#14)(2006-11#1)(2006-12#6)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#3)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#4)(2007-11#8)(2007-12#10)(2007-2#2)(2007-3#2)(2007-4#1)(2007-6#2)(2007-7#4)(2007-8#7)(2007-9#2)(2008-1#5)(2008-10#63)(2008-11#14)(2008-12#3)(2008-2#20)(2008-3#24)(2008-4#18)(2008-5#12)(2008-6#2)(2008-7#10)(2008-8#10)(2008-9#13)(2009-10#1)(2009-11#3)(2009-2#2)(2009-4#3)(2009-6#2)(2009-8#2)(2009-9#4)(2010-1#1)(2010-11#2)(2010-12#3)(2010-2#5)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#5)(2011-1#8)(2011-12#2)(2011-2#17)(2011-3#2)(2012-1#6)(2012-11#2)(2012-12#7)(2012-2#7)(2012-3#9)(2013-1#8)(2013-7#3)(2013-8#1)
selection offers##2##2##(2008-4#1)(2012-1#1)
selection often##2##2##(2008-10#1)(2008-9#1)
selection on a heritable##2##4##(2008-8#2)
selection on a##5##3##(2008-8#3)(2008-9#1)(2011-1#1)
selection on attractive traits##3##4##(2008-8#3)
selection on both##2##3##(2008-9#1)(2010-4#1)
selection on maternal seed size##2##5##(2008-9#2)
selection on pollen hoarding##2##4##(2008-10#2)
selection on resistance##2##3##(2008-8#2)
selection on the basis of##3##5##(1993-8#1)(1997-1#1)(2009-2#1)
selection on the##11##3##(1992-2#1)(1993-8#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-8#3)(2009-2#1)(2012-12#1)(2012-3#1)
selection on##72##2##(1992-2#1)(1993-8#1)(1997-1#1)(1997-4#1)(1997-7#1)(2007-6#1)(2008-10#4)(2008-11#3)(2008-8#31)(2008-9#10)(2009-2#4)(2010-2#1)(2010-4#3)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#3)(2013-1#4)
selection or development of##2##4##(2008-5#1)(2009-12#1)
selection or##12##2##(1990-8#1)(1995-2#1)(1997-4#1)(2005-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-12#1)(2012-12#1)(2012-3#2)
selection over##2##2##(2008-4#1)(2008-8#1)
selection pressure and that##2##4##(2008-10#1)(2013-1#1)
selection pressure by##3##3##(1993-9#1)(2007-6#1)(2008-11#1)
selection pressure for##4##3##(2008-10#1)(2010-7#2)(2013-8#1)
selection pressure in##2##3##(2008-10#1)(2008-4#1)
selection pressure on##3##3##(1990-4#1)(2007-6#1)(2008-10#1)
selection pressure##27##2##(1990-3#1)(1990-4#1)(1991-8#1)(1993-9#1)(1994-3#1)(1997-4#1)(1997-6#1)(2007-6#2)(2008-10#9)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-7#2)(2012-3#1)(2013-1#1)(2013-8#1)
selection pressures on##2##3##(2008-3#1)(2012-3#1)
selection pressures##11##2##(1997-7#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#2)(2010-3#1)(2012-3#2)(2013-1#1)
selection procedure was##3##3##(1990-8#1)(1997-4#1)(2007-12#1)
selection procedure##5##2##(1990-8#1)(1997-4#1)(2007-12#1)(2008-4#1)(2012-3#1)
selection procedures##7##2##(1992-8#1)(1993-1#1)(1994-3#1)(2008-10#1)(2009-10#1)(2011-1#1)(2012-3#1)
selection process is##2##3##(2008-10#1)(2008-4#1)
selection process of workers from##2##5##(2006-10#2)
selection process of##4##3##(2006-10#2)(2008-10#1)(2012-3#1)
selection process##16##2##(1993-12#1)(1994-2#1)(1996-3#1)(1997-1#2)(1997-4#1)(2006-10#2)(2008-10#2)(2008-4#1)(2008-6#2)(2009-4#1)(2012-2#1)(2012-3#1)
selection processes that are##2##4##(1997-1#1)(2008-4#1)
selection processes##4##2##(1997-1#2)(2008-4#1)(2008-9#1)
selection responses##2##2##(2008-10#1)(2008-8#1)
selection rule##2##2##(1993-8#1)(2012-2#1)
selection should be##3##3##(2006-3#1)(2010-2#1)(2011-2#1)
selection should##6##2##(2006-3#1)(2008-9#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-3#1)
selection strategies##3##2##(1991-11#1)(2008-8#1)(2012-3#1)
selection strategy was used to##2##5##(1995-2#1)(2008-10#1)
selection strategy##6##2##(1994-12#1)(1995-2#1)(2008-10#1)(2008-9#1)(2012-2#1)(2012-3#1)
selection system for##2##3##(1991-5#1)(2006-8#1)
selection system##7##2##(1991-5#1)(1994-9#1)(1995-1#1)(1995-8#1)(2006-8#1)(2008-11#1)(2008-2#1)
selection systems##3##2##(2006-12#1)(2008-11#1)(2013-8#1)
selection techniques##3##2##(2005-7#1)(2005-9#1)(2008-4#1)
selection that##5##2##(2006-12#1)(2008-3#1)(2009-10#1)(2010-1#1)(2013-1#1)
selection theory##4##2##(2006-7#1)(2008-5#1)(2009-10#1)(2011-1#1)
selection they##2##2##(2008-8#1)(2013-1#1)
selection through##3##2##(2008-10#1)(2008-8#1)(2010-8#1)
selection to achieve##2##3##(2007-11#1)(2008-8#1)
selection to the##2##3##(2006-6#1)(2008-8#1)
selection to##16##2##(1990-7#1)(1995-8#1)(1997-4#1)(2006-6#1)(2007-11#1)(2008-10#3)(2008-8#3)(2008-9#1)(2010-4#1)(2011-12#1)(2012-11#1)(2012-2#1)
selection under##3##2##(1995-7#1)(1995-8#1)(2012-12#1)
selection using the##3##3##(2007-11#1)(2008-6#1)(2012-3#1)
selection using##15##2##(1993-6#1)(1995-7#1)(2007-11#1)(2007-2#1)(2008-4#6)(2008-6#1)(2009-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
selection valve in##2##3##(2008-10#2)
selection valve##8##2##(2008-10#8)
selection valves##2##2##(2007-8#1)(2008-10#1)
selection via##3##2##(1995-2#1)(2008-8#2)
selection was also##4##3##(2008-10#3)(2013-1#1)
selection was performed##2##3##(2008-8#1)(2013-8#1)
selection was##29##2##(1990-12#1)(1990-8#1)(1991-8#1)(1992-2#1)(1993-6#1)(1995-8#1)(2006-12#1)(2008-10#6)(2008-11#1)(2008-8#6)(2008-9#1)(2009-6#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
selection we use##2##3##(2008-11#2)
selection we##3##2##(1994-9#1)(2008-11#2)
selection were##6##2##(1996-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-3#1)(2013-8#1)
selection when##3##2##(1996-3#1)(2009-9#1)(2012-3#1)
selection which##2##2##(2006-1#1)(2008-10#1)
selection with##12##2##(1992-3#1)(1992-8#1)(1994-3#1)(1995-8#1)(2006-12#1)(2007-6#1)(2008-10#2)(2008-9#1)(2012-3#2)(2013-8#1)
selection within##3##2##(2008-10#3)
selection without##2##2##(2008-3#1)(2008-8#1)
selection##2030##1##(1990-10#4)(1990-11#4)(1990-12#5)(1990-3#4)(1990-4#2)(1990-5#5)(1990-7#2)(1990-8#12)(1990-9#8)(1991-1#2)(1991-10#1)(1991-11#12)(1991-12#5)(1991-2#3)(1991-3#4)(1991-5#4)(1991-6#2)(1991-7#6)(1991-8#7)(1991-9#3)(1992-1#1)(1992-12#4)(1992-2#6)(1992-3#3)(1992-4#2)(1992-6#1)(1992-7#1)(1992-8#6)(1992-9#3)(1993-1#4)(1993-10#2)(1993-11#5)(1993-12#8)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#4)(1993-7#1)(1993-8#5)(1993-9#6)(1994-1#3)(1994-11#2)(1994-12#4)(1994-2#3)(1994-3#11)(1994-5#2)(1994-6#5)(1994-8#2)(1994-9#12)(1995-1#8)(1995-11#3)(1995-12#4)(1995-2#26)(1995-3#3)(1995-4#2)(1995-5#8)(1995-6#3)(1995-7#3)(1995-8#13)(1995-9#4)(1996-1#3)(1996-10#1)(1996-12#5)(1996-2#5)(1996-3#6)(1996-4#7)(1996-5#1)(1996-6#8)(1996-8#7)(1996-9#1)(1997-1#18)(1997-2#14)(1997-3#6)(1997-4#20)(1997-5#8)(1997-6#4)(1997-7#10)(1997-8#7)(1997-9#2)(2004-1#3)(2004-12#1)(2004-2#4)(2004-9#1)(2005-1#1)(2005-10#5)(2005-11#3)(2005-12#1)(2005-4#1)(2005-5#1)(2005-6#1)(2005-7#4)(2005-8#2)(2005-9#4)(2006-1#4)(2006-10#26)(2006-11#2)(2006-12#25)(2006-2#3)(2006-3#5)(2006-4#3)(2006-5#20)(2006-6#5)(2006-7#7)(2006-8#7)(2006-9#4)(2007-1#2)(2007-10#7)(2007-11#21)(2007-12#22)(2007-2#3)(2007-3#5)(2007-4#2)(2007-5#2)(2007-6#8)(2007-7#8)(2007-8#21)(2007-9#8)(2008-1#15)(2008-10#224)(2008-11#53)(2008-12#10)(2008-2#36)(2008-3#44)(2008-4#67)(2008-5#27)(2008-6#11)(2008-7#34)(2008-8#199)(2008-9#83)(2009-10#12)(2009-11#4)(2009-12#4)(2009-2#14)(2009-3#1)(2009-4#8)(2009-5#9)(2009-6#4)(2009-7#2)(2009-8#7)(2009-9#11)(2010-1#5)(2010-10#1)(2010-11#4)(2010-12#11)(2010-2#15)(2010-3#3)(2010-4#20)(2010-5#8)(2010-6#6)(2010-7#8)(2010-8#33)(2010-9#6)(2011-1#30)(2011-10#1)(2011-11#1)(2011-12#9)(2011-2#42)(2011-3#6)(2012-1#19)(2012-11#6)(2012-12#32)(2012-2#38)(2012-3#85)(2012-8#1)(2013-1#65)(2013-7#4)(2013-8#24)
selection&quot##3##1##(1993-9#1)(2008-8#2)
selection' by##2##2##(2008-11#2)
selection)##6##1##(1991-12#2)(2008-10#1)(2008-4#1)(2008-8#1)(2011-12#1)
selection?##2##1##(2009-5#1)(2012-3#1)
selections and##2##2##(2008-10#1)(2011-2#1)
selections are##2##2##(1994-3#1)(2008-2#1)
selections for##5##2##(1990-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-4#1)
selections of##5##2##(1991-7#1)(1995-3#1)(2008-10#3)
selections on##2##2##(1992-3#1)(2008-2#1)
selections to##2##2##(2008-10#2)
selections with##3##2##(2008-10#1)(2008-9#1)(2012-12#1)
selections##32##1##(1990-3#1)(1991-2#1)(1991-7#1)(1992-3#2)(1994-3#1)(1995-3#1)(1997-3#2)(2005-7#1)(2006-12#1)(2007-11#1)(2008-10#10)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#3)(2012-12#1)
selective (uptake##2##2##(1993-4#1)(1994-8#1)
selective 5-HT reuptake inhibitors##2##4##(2006-9#1)(2008-8#1)
selective 5-HT reuptake##3##3##(1990-11#1)(2006-9#1)(2008-8#1)
selective 5-HT uptake inhibitor##3##4##(1991-5#2)(1996-5#1)
selective 5-HT##6##2##(1990-11#1)(1991-5#2)(1996-5#1)(2006-9#1)(2008-8#1)
selective 5-HT1A agonist##2##3##(1996-12#1)(1997-7#1)
selective 5-HT1A receptor antagonist##2##4##(1995-12#1)(1996-10#1)
selective 5-HT1A receptor##5##3##(1993-3#2)(1995-12#2)(1996-10#1)
selective 5-HT1A##8##2##(1991-2#1)(1993-3#2)(1995-12#2)(1996-10#1)(1996-12#1)(1997-7#1)
selective 5-HT1B receptor##2##3##(1993-3#1)(1995-12#1)
selective 5-HT1B##3##2##(1993-3#1)(1995-12#2)
selective 5-HT2 antagonist##3##3##(1990-11#2)(1995-3#1)
selective 5-HT2##5##2##(1990-11#2)(1990-5#1)(1993-3#1)(1995-3#1)
selective 5-HT3 receptor agonist##5##4##(1990-2#1)(1993-11#1)(1993-3#1)(1997-5#2)
selective 5-HT3 receptor antagonist##3##4##(1993-3#1)(1994-2#1)(1997-5#1)
selective 5-HT3 receptor##9##3##(1990-2#2)(1993-11#1)(1993-3#2)(1994-2#1)(1997-5#3)
selective A1 adenosine##3##3##(1991-5#1)(1996-7#1)(2004-12#1)
selective A1-adenosine receptor##2##3##(1997-2#2)
selective AMPA receptor antagonist##3##4##(1994-2#2)(1996-5#1)
selective ATP##2##2##(1990-4#1)(2008-5#1)
selective Ang II receptor##3##4##(2007-1#3)
selective CCK-B##2##2##(1992-2#1)(1997-2#1)
selective COX-1 and COX-2 inhibitors##2##5##(2008-4#2)
selective COX-1##4##2##(2008-4#4)
selective COX-2 inhibitor##8##3##(2005-8#2)(2007-8#1)(2008-10#1)(2008-12#2)(2008-4#2)
selective COX-2 inhibitors for##2##4##(2004-12#1)(2008-11#1)
selective COX-2 inhibitors##10##3##(2004-12#1)(2005-11#1)(2005-8#2)(2006-10#1)(2006-2#1)(2007-7#1)(2008-10#2)(2008-11#1)
selective COX-2 inhibitors)##2##3##(2007-11#1)(2008-10#1)
selective COX-2##21##2##(2004-12#1)(2005-11#1)(2005-8#4)(2006-10#1)(2006-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#2)(2010-12#1)
selective D1 agonist##2##3##(1990-5#1)(1996-1#1)
selective D1 receptor##2##3##(1992-3#1)(1995-7#1)
selective D1##6##2##(1990-5#1)(1991-5#1)(1992-3#2)(1995-7#1)(1996-1#1)
selective D2##3##2##(1990-7#1)(1992-3#2)
selective DA D(3) receptor antagonists##3##5##(2008-1#3)
selective DNA##2##2##(1992-5#1)(1995-5#1)
selective IgA deficiency##3##3##(1991-11#1)(1992-8#1)(2006-2#1)
selective M2##3##2##(1990-2#1)(1990-7#1)(1994-9#1)
selective NK-1##2##2##(1991-11#2)
selective NMDA receptor antagonist##2##4##(1997-2#1)(2008-8#1)
selective NMDA receptor##3##3##(1991-3#1)(1997-2#1)(2008-8#1)
selective NMDA##4##2##(1991-3#1)(1996-6#1)(1997-2#1)(2008-8#1)
selective NSAIDs##2##2##(2006-10#1)(2008-4#1)
selective P2Y(1)##3##2##(2008-4#3)
selective PKC##2##2##(1991-10#1)(1991-9#1)
selective RNA-binding protein QKI##2##4##(2009-9#2)
selective V1 antagonist##3##3##(1992-9#1)(1993-4#2)
selective V1##5##2##(1992-9#2)(1993-4#3)
selective access##2##2##(2008-10#1)(2010-8#1)
selective accumulation of##3##3##(1993-4#1)(2008-10#1)(2012-12#1)
selective action##3##2##(1990-2#1)(1990-7#1)(2008-10#1)
selective actions##2##2##(2008-10#2)
selective activation of##3##3##(1990-7#1)(1997-8#1)(2012-1#1)
selective activation##5##2##(1990-7#1)(1995-12#1)(1997-8#1)(2008-4#1)(2012-1#1)
selective activators##2##2##(1991-9#1)(2005-11#1)
selective activity##3##2##(1991-4#1)(1997-2#1)(2010-7#1)
selective adenosine A1 receptor agonist##2##5##(1995-12#1)(2004-12#1)
selective adenosine A1##3##3##(1995-12#2)(2004-12#1)
selective adenosine A2A receptor agonist##2##5##(1995-12#1)(2004-12#1)
selective adenosine##6##2##(1995-12#3)(2004-12#3)
selective adhesion to##2##3##(1990-8#1)(2007-8#1)
selective adhesion##5##2##(1990-8#1)(1994-11#1)(2007-8#1)(2008-11#2)
selective adsorption of heavy metal ions##2##6##(2008-10#2)
selective adsorption of##4##3##(2005-11#1)(2008-10#2)(2009-7#1)
selective adsorption##6##2##(2005-11#2)(2008-10#3)(2009-7#1)
selective advantage of##4##3##(2008-8#2)(2009-5#1)(2012-3#1)
selective advantage over##2##3##(2008-1#1)(2008-11#1)
selective advantage to##2##3##(1993-2#1)(2010-8#1)
selective advantage##14##2##(1993-2#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#4)(2009-5#1)(2010-8#1)(2012-3#1)
selective against##2##2##(1992-5#1)(2012-12#1)
selective agent##2##2##(1991-4#1)(2008-10#1)
selective agents##2##2##(1990-11#1)(1991-2#1)
selective agonist of##2##3##(1994-8#1)(1995-12#1)
selective agonist##8##2##(1990-6#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-3#1)(1995-7#1)(1997-5#1)
selective agonists and antagonists at##2##5##(1995-3#1)(1996-12#1)
selective agonists and antagonists##4##4##(1995-3#1)(1996-12#1)(2008-4#1)(2010-5#1)
selective agonists and##5##3##(1992-8#1)(1995-3#1)(1996-12#1)(2008-4#1)(2010-5#1)
selective agonists##9##2##(1992-8#1)(1995-3#1)(1996-12#1)(1996-2#1)(2004-12#1)(2008-4#3)(2010-5#1)
selective alkylations##2##2##(1996-3#1)(2010-7#1)
selective alpha 1##2##3##(1991-3#2)
selective alpha 2-adrenoceptor antagonist##2##4##(1992-10#1)(1993-11#1)
selective alpha##8##2##(1991-3#3)(1992-10#1)(1993-11#2)(1994-10#1)(1994-12#1)
selective amplification of##2##3##(1996-2#1)(2008-2#1)
selective amplification##3##2##(1996-2#1)(2006-6#1)(2008-2#1)
selective amygdalohippocampectomy##2##2##(1990-9#2)
selective and convenient##2##3##(2005-4#1)(2008-10#1)
selective and differential media##2##4##(1991-8#2)
selective and differential##3##3##(1991-8#2)(1997-3#1)
selective and efficient##3##3##(2005-11#1)(2007-11#1)(2008-10#1)
selective and highly##2##3##(2006-2#1)(2009-7#1)
selective and non-selective##8##3##(2006-8#2)(2008-10#1)(2008-12#1)(2010-7#1)(2011-2#3)
selective and nonselective##6##3##(1995-11#1)(2008-10#2)(2008-12#2)(2013-1#1)
selective and potent##5##3##(1991-9#1)(1993-7#1)(2008-5#2)(2012-2#1)
selective and rapid method for the determination of##2##8##(2008-10#2)
selective and rapid method##3##4##(2008-10#3)
selective and rapid##5##3##(2008-10#4)(2011-3#1)
selective and reproducible##2##3##(2008-10#2)
selective and sensitive assay of##2##5##(2008-10#2)
selective and sensitive determination of##4##5##(2008-10#4)
selective and sensitive fluorescence##3##4##(2008-10#1)(2008-12#2)
selective and sensitive fluorescent##2##4##(2008-10#2)
selective and sensitive method for the determination of##4##8##(1990-8#1)(1993-1#1)(2008-10#2)
selective and sensitive method for the##5##6##(1990-8#1)(1993-1#1)(2008-10#3)
selective and sensitive method for##6##5##(1990-8#1)(1993-1#1)(2007-8#1)(2008-10#3)
selective and sensitive method##8##4##(1990-8#1)(1993-1#1)(2007-8#1)(2008-10#5)
selective and sensitive##35##3##(1990-8#1)(1993-1#1)(2007-8#1)(2008-10#28)(2008-12#2)(2010-12#1)(2011-1#1)
selective and simple##5##3##(2008-10#5)
selective and##116##2##(1990-8#1)(1991-8#2)(1991-9#2)(1993-1#1)(1993-7#1)(1994-2#1)(1995-11#3)(1995-3#1)(1997-3#1)(2005-10#1)(2005-11#1)(2005-4#3)(2005-9#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#2)(2007-11#2)(2007-8#1)(2008-10#60)(2008-12#6)(2008-5#4)(2009-12#1)(2009-2#1)(2009-7#1)(2010-12#1)(2010-4#3)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#2)
selective androgen receptor modulators##2##4##(2007-12#1)(2012-12#1)
selective angiography##9##2##(2007-8#1)(2008-3#1)(2010-12#5)(2011-2#2)
selective angiotensin II receptor blocker (ARB)##2##6##(2007-1#2)
selective angiotensin II receptor blocker##3##5##(2007-1#3)
selective angiotensin II##5##3##(2007-1#5)
selective angiotensin##7##2##(1996-12#1)(2007-1#6)
selective antagonism##2##2##(1991-8#1)(2008-1#1)
selective antagonist##9##2##(1992-8#1)(1993-11#2)(1993-7#1)(1995-7#1)(1997-5#1)(2005-8#1)(2006-2#1)(2008-4#1)
selective antagonists##7##2##(1991-5#1)(1995-12#1)(1997-5#3)(2007-11#1)(2008-4#1)
selective antibody##2##2##(1995-11#1)(1997-5#1)
selective application##2##2##(1995-12#1)(2008-8#1)
selective approach##3##2##(1996-5#1)(2008-11#1)(2013-1#1)
selective arteriography##3##2##(1990-3#1)(1991-5#2)
selective assay of proteins##2##4##(2008-10#2)
selective assay of##3##3##(1993-2#1)(2008-10#2)
selective association##2##2##(1992-12#1)(1993-6#1)
selective attention##12##2##(1992-11#1)(1993-2#2)(1994-2#1)(1995-1#1)(1996-3#2)(1997-8#2)(2005-10#1)(2008-11#1)(2012-1#1)
selective axonal##3##2##(1996-5#3)
selective beta-adrenergic##2##2##(1993-2#1)(1994-6#1)
selective binding of##4##3##(1990-12#1)(1992-6#1)(1995-3#1)(1997-2#1)
selective binding to the##2##4##(1990-12#1)(1992-8#1)
selective binding##9##2##(1990-12#2)(1992-6#1)(1992-8#1)(1995-3#1)(1997-2#1)(2008-10#2)(2009-6#1)
selective blockade of##2##3##(2008-8#1)(2013-1#1)
selective blocker of the##2##4##(1992-8#1)(1996-8#1)
selective blocker of##6##3##(1992-8#1)(1993-7#1)(1996-8#1)(1997-2#1)(1997-7#1)(2008-4#1)
selective brain cooling##3##3##(2010-1#3)
selective brain##9##2##(1994-11#1)(1994-6#3)(2010-1#3)(2012-11#2)
selective breeding and##2##3##(1990-11#1)(1992-11#1)
selective capture of##2##3##(2007-8#2)
selective catalytic##2##2##(2008-10#1)(2008-3#1)
selective cell ablation##2##3##(2007-3#2)
selective cell transplantation and tissue engineering##2##6##(2006-6#2)
selective cell##4##2##(2006-6#2)(2007-3#2)
selective cells##3##2##(2008-8#3)
selective changes in the##2##4##(1995-12#1)(1997-5#1)
selective changes in##4##3##(1991-3#1)(1995-12#1)(1996-1#1)(1997-5#1)
selective chemical##4##2##(1993-11#1)(2006-12#2)(2008-2#1)
selective cholesterol##2##2##(2008-5#1)(2012-2#1)
selective chromogenic##4##2##(2008-10#4)
selective columns##2##2##(2008-10#1)(2009-5#1)
selective compounds##5##2##(1994-3#1)(1995-11#1)(2006-10#1)(2007-12#1)(2008-8#1)
selective concentration of the##2##4##(2006-9#1)(2008-2#1)
selective concentration of##4##3##(1995-8#1)(2006-9#1)(2008-2#1)(2012-3#1)
selective concentration##6##2##(1995-8#2)(2006-9#1)(2008-2#1)(2008-5#1)(2012-3#1)
selective conditions##2##2##(2008-2#1)(2008-4#1)
selective constraints##3##2##(2008-7#1)(2012-2#1)(2013-1#1)
selective contracting##2##2##(1994-12#1)(1994-2#1)
selective control##2##2##(1992-5#1)(2007-8#1)
selective cyclooxygenase##4##2##(1990-12#1)(1991-8#2)(2008-3#1)
selective cyclooxygenase-2 (COX-2)##2##3##(2006-10#1)(2007-7#1)
selective cyclooxygenase-2 inhibitors##3##3##(2006-10#2)(2008-10#1)
selective cyclooxygenase-2##6##2##(1997-5#1)(2006-10#3)(2007-7#1)(2008-10#1)
selective cytotoxicity against##2##3##(1993-6#1)(2008-11#1)
selective cytotoxicity##6##2##(1993-6#1)(1996-6#1)(1997-7#1)(2007-11#1)(2008-11#1)(2011-1#1)
selective deficit##3##2##(2008-4#2)(2009-4#1)
selective degeneration of##3##3##(2005-7#1)(2012-12#2)
selective delivery of##3##3##(2007-11#1)(2008-11#1)(2008-3#1)
selective delta##4##2##(1993-3#2)(1997-2#2)
selective delta-opioid##2##2##(1992-9#1)(1997-2#1)
selective depletion##2##2##(1990-8#1)(1992-9#1)
selective deposition##2##2##(1994-12#2)
selective destruction of##2##3##(2008-4#1)(2008-5#1)
selective destruction##3##2##(2008-4#1)(2008-5#1)(2013-1#1)
selective detection of histidine##3##4##(2008-10#1)(2010-5#2)
selective detection of the##3##4##(1992-3#1)(2008-10#1)(2008-4#1)
selective detection of##16##3##(1990-8#2)(1992-3#1)(1995-6#2)(2008-10#7)(2008-3#1)(2008-4#1)(2010-5#2)
selective detection##23##2##(1990-8#2)(1992-3#1)(1995-6#2)(1996-8#1)(1997-6#1)(1997-8#1)(2008-10#11)(2008-3#1)(2008-4#1)(2010-5#2)
selective detector for##2##3##(2008-10#2)
selective detector##3##2##(2008-10#3)
selective determination of As(III) in##2##5##(2007-8#1)(2008-10#1)
selective determination of Fe(III) in the presence of Fe(II)##2##9##(2008-10#2)
selective determination of trace amounts of metal##2##7##(2008-10#2)
selective determination of trace##3##4##(2008-10#2)(2013-8#1)
selective determination of uric acid in##2##6##(2008-10#2)
selective determination of##30##3##(1997-2#1)(2007-8#2)(2008-10#25)(2010-7#1)(2013-8#1)
selective determination##32##2##(1997-2#1)(2007-8#2)(2008-10#27)(2010-7#1)(2013-8#1)
selective displacement##6##2##(1991-1#1)(2008-7#5)
selective disruption of##2##3##(1996-2#1)(2009-2#1)
selective dopamine D3 receptor antagonist##2##5##(1996-12#1)(2009-2#1)
selective dopamine D3 receptor##3##4##(1996-12#2)(2009-2#1)
selective dopamine##8##2##(1993-11#1)(1996-10#1)(1996-12#2)(2005-7#1)(2008-6#2)(2009-2#1)
selective dorsal rhizotomy##3##3##(2005-10#1)(2006-10#2)
selective double excision##2##3##(1992-2#2)
selective drug##2##2##(1991-2#1)(2013-7#1)
selective drugs##2##2##(2009-4#1)(2013-7#1)
selective dysfunction of##2##3##(1991-2#2)
selective eating##3##2##(2013-1#3)
selective edge##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
selective effect of##3##3##(1993-6#1)(1994-2#1)(2008-10#1)
selective effect on##3##3##(1993-11#1)(1996-12#1)(2007-11#1)
selective effect##7##2##(1993-11#1)(1993-6#1)(1994-2#1)(1996-12#1)(2006-5#1)(2007-11#1)(2008-10#1)
selective electrochemical##2##2##(2008-10#2)
selective electrode based on##5##4##(2008-10#5)
selective electrode is##2##3##(2008-10#2)
selective electrode##32##2##(2006-10#1)(2008-10#30)(2008-5#1)
selective electrodes##19##2##(2006-10#1)(2008-10#17)(2008-6#1)
selective elimination of##3##3##(1995-10#1)(2007-7#1)(2012-3#1)
selective elimination##4##2##(1995-10#1)(2007-7#1)(2008-7#1)(2012-3#1)
selective embolisation##3##2##(1997-6#1)(2008-3#1)(2011-2#1)
selective embolization of the##2##4##(1996-8#1)(2006-10#1)
selective embolization##3##2##(1996-8#2)(2006-10#1)
selective endothelin##2##2##(1994-5#1)(1996-12#1)
selective enhancement of##2##3##(1990-5#1)(1991-6#1)
selective enhancement##5##2##(1990-5#1)(1991-6#1)(1993-6#1)(1997-7#1)(2008-9#1)
selective enrichment of##3##3##(1994-12#1)(2008-10#1)(2013-1#1)
selective enrichment##4##2##(1994-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
selective enzymatic##2##2##(2007-10#2)
selective estrogen receptor modulators##2##4##(2008-10#1)(2008-3#1)
selective excitation##3##2##(1996-7#1)(2007-12#1)(2008-10#1)
selective expression of a##2##4##(1994-5#1)(1995-6#1)
selective expression of##8##3##(1991-9#1)(1992-8#1)(1994-5#1)(1994-6#1)(1995-6#1)(1996-1#1)(2007-10#1)(2012-12#1)
selective extraction and determination of##2##5##(2008-10#2)
selective extraction and##6##3##(2008-10#5)(2008-8#1)
selective extraction of U(VI)##3##4##(2008-10#3)
selective extraction of beta-carotene##2##4##(2007-6#2)
selective extraction of##16##3##(1992-3#1)(1994-12#1)(1996-5#1)(2007-6#2)(2008-10#11)
selective extraction##28##2##(1992-3#1)(1994-12#1)(1996-5#1)(2007-6#2)(2008-10#22)(2008-8#1)
selective factors##2##2##(2013-7#1)(2013-8#1)
selective fashion##2##2##(1990-12#1)(2007-12#1)
selective flow injection##6##3##(2008-10#6)
selective flow##7##2##(1990-11#1)(2008-10#6)
selective fluorescence quenching agent for discriminating between alternant versus nonalternant polycyclic aromatic hydrocarbons##2##13##(2008-10#2)
selective fluorescence quenching agent for##3##5##(2008-10#3)
selective fluorescence quenching agent##4##4##(2008-10#4)
selective fluorescence quenching##5##3##(2008-10#5)
selective fluorescence##6##2##(2008-10#6)
selective for A3 vs A1 receptors##2##6##(1994-9#1)(1995-3#1)
selective for A3 vs##3##4##(1994-9#2)(1995-3#1)
selective for creatinine##2##3##(2008-10#2)
selective for serotonin##2##3##(2008-1#1)(2008-2#1)
selective for the beta I isozyme##2##6##(1993-6#2)
selective for the##22##3##(1990-11#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-10#1)(1992-3#1)(1993-6#2)(1995-11#1)(1995-12#1)(1997-7#1)(2007-9#1)(2008-10#4)(2008-4#2)(2008-5#1)(2008-8#1)(2010-1#1)(2010-5#1)
selective for##78##2##(1990-11#1)(1990-8#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-6#2)(1993-7#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#3)(1995-3#4)(1995-6#2)(1996-11#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-6#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#17)(2008-11#1)(2008-2#1)(2008-4#4)(2008-5#1)(2008-8#2)(2009-10#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-5#1)
selective force##3##2##(2008-10#1)(2008-8#1)(2012-12#1)
selective forces and##2##3##(1992-9#1)(2008-8#1)
selective forces##9##2##(1992-9#1)(2008-10#1)(2008-8#4)(2010-3#1)(2012-12#1)(2013-1#1)
selective growth advantage##3##3##(1994-12#1)(2008-1#1)(2009-12#1)
selective growth##7##2##(1994-12#1)(1994-6#1)(1995-2#1)(1996-10#1)(2008-1#1)(2009-12#1)(2012-2#1)
selective human##3##2##(2005-8#1)(2008-4#2)
selective hydride##2##2##(2009-6#2)
selective hydrogenation of##2##3##(1996-5#1)(2008-12#1)
selective hydrolysis##2##2##(2007-11#1)(2008-4#1)
selective hypersensitivity##3##2##(2013-1#3)
selective identification##2##2##(1992-1#1)(2010-4#1)
selective illumination of##2##3##(1993-3#2)
selective imaging of the##2##4##(1992-1#2)
selective imaging of##3##3##(1992-1#2)(1993-4#1)
selective imaging##5##2##(1992-1#2)(1993-4#1)(2008-2#1)(2012-12#1)
selective immunotherapy##2##2##(1992-10#1)(1995-1#1)
selective impact##2##2##(2008-10#1)(2013-1#1)
selective impairment of##3##3##(1996-2#1)(2008-7#1)(2008-8#1)
selective impairment##4##2##(1996-2#1)(2008-7#1)(2008-8#1)(2009-4#1)
selective in the##2##3##(2008-10#2)
selective in##7##2##(1990-5#1)(1991-4#1)(1995-6#1)(2008-1#1)(2008-10#2)(2009-6#1)
selective inactivation of##3##3##(1991-3#1)(1993-7#1)(1993-9#1)
selective increase in the density of##2##6##(1995-11#2)
selective increase in the##3##4##(1993-12#1)(1995-11#2)
selective increase##4##2##(1992-1#1)(1993-12#1)(1995-11#2)
selective induction of##8##3##(1990-11#1)(1993-4#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-4#1)(2012-1#1)(2012-12#1)
selective inhibition of cyclic AMP phosphodiesterase##2##6##(1997-7#2)
selective inhibition of the##2##4##(1994-3#1)(1995-3#1)
selective inhibition of##20##3##(1991-10#1)(1992-3#1)(1993-5#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-3#2)(1997-7#2)(2005-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)
selective inhibition##22##2##(1991-10#1)(1992-3#1)(1993-5#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-3#2)(1997-7#2)(2005-8#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)
selective inhibitor of protein kinase##2##5##(1993-12#1)(1993-8#1)
selective inhibitor of the##4##4##(1994-6#1)(1995-2#1)(2008-1#1)(2008-4#1)
selective inhibitor of##25##3##(1990-2#1)(1990-8#1)(1991-8#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#1)(1997-5#1)(2006-3#2)(2006-6#1)(2007-1#1)(2008-1#1)(2008-4#3)(2008-5#1)(2012-1#2)
selective inhibitor##32##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-8#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#1)(1997-5#1)(1997-7#1)(2006-12#1)(2006-3#2)(2006-6#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#4)(2008-5#1)(2012-1#2)
selective inhibitors of##8##3##(1990-9#1)(1993-11#1)(1995-6#1)(1996-8#1)(1997-2#1)(1997-7#1)(2008-7#1)(2010-12#1)
selective inhibitors##17##2##(1990-9#1)(1993-11#1)(1993-6#1)(1994-8#1)(1995-6#1)(1996-8#1)(1997-2#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-12#1)
selective interaction and##2##3##(1990-8#2)
selective interaction of##2##3##(1994-5#1)(1995-1#1)
selective interaction##8##2##(1990-8#5)(1994-5#1)(1995-1#1)(2008-10#1)
selective involvement##2##2##(1992-9#1)(1993-6#1)
selective ion monitoring##2##3##(2008-10#2)
selective ion##5##2##(2008-10#4)(2008-2#1)
selective isolation of##3##3##(2008-4#1)(2008-9#1)(2013-8#1)
selective laser trabeculoplasty##3##3##(2011-2#1)(2013-1#2)
selective laser##5##2##(2007-12#1)(2009-7#1)(2011-2#1)(2013-1#2)
selective ligand for##2##3##(1991-12#1)(1992-3#1)
selective ligand##5##2##(1991-12#2)(1992-3#1)(1994-9#1)(2013-7#1)
selective ligands for##3##3##(1996-8#1)(1997-1#1)(1997-5#1)
selective ligands##11##2##(1993-11#1)(1993-8#1)(1994-12#1)(1995-11#2)(1996-10#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-5#1)(2009-7#1)
selective liquid chromatographic##2##3##(1996-3#1)(2007-8#1)
selective loss of##7##3##(1994-10#1)(1995-12#2)(1997-6#1)(2008-1#2)(2008-4#1)
selective loss##9##2##(1993-2#1)(1994-10#1)(1995-12#2)(1997-6#1)(2008-1#2)(2008-4#1)(2009-4#1)
selective losses##2##2##(1995-11#1)(1996-8#1)
selective management##2##2##(1990-2#1)(2006-10#1)
selective manner##3##2##(1996-12#1)(2006-12#1)(2008-6#1)
selective marker##4##2##(1996-5#1)(1996-6#1)(1997-2#1)(2005-11#1)
selective measurement##2##2##(2008-10#1)(2008-5#1)
selective measurements of##2##3##(2008-10#2)
selective media for isolation of##2##5##(2008-10#2)
selective media##10##2##(1991-10#1)(1997-6#1)(2008-10#7)(2008-12#1)
selective medium for##4##3##(1991-5#1)(1997-6#2)(2012-12#1)
selective medium##18##2##(1991-5#1)(1991-8#1)(1995-1#1)(1997-6#2)(2008-10#11)(2008-7#1)(2012-12#1)
selective membrane electrode##2##3##(2008-10#1)(2011-1#1)
selective membrane potentiometric sensor##2##4##(2008-10#2)
selective membrane potentiometric##3##3##(2008-10#3)
selective membrane##10##2##(1995-6#1)(2008-10#8)(2011-1#1)
selective membranes##2##2##(2008-10#2)
selective method for the determination of##6##6##(2008-10#6)
selective method for the##9##4##(2008-10#9)
selective method for##12##3##(2008-10#12)
selective method was##3##3##(2008-10#3)
selective method##32##2##(1996-8#1)(2008-10#30)(2008-5#1)
selective methods##4##2##(2008-10#4)
selective modulation of##2##3##(1994-3#1)(2010-3#1)
selective molecular##2##2##(2008-10#1)(2010-1#1)
selective mu-opioid receptor agonist##2##4##(1993-3#1)(1996-2#1)
selective mu-opioid receptor##3##3##(1993-3#1)(1996-2#2)
selective muscarinic receptor agonists##2##4##(1993-11#2)
selective muscarinic receptor##4##3##(1990-2#1)(1993-11#3)
selective muscarinic##7##2##(1990-2#1)(1993-11#3)(1994-3#1)(1995-12#1)(1996-1#1)
selective mutism##4##2##(2008-4#2)(2009-11#2)
selective neck dissection##2##3##(2010-7#1)(2013-1#1)
selective nerve root blocks##4##4##(2006-8#4)
selective nerve root##6##3##(2006-8#6)
selective neurodegeneration##2##2##(1995-5#1)(1997-7#1)
selective neurokinin-1##2##2##(1995-5#1)(1997-8#1)
selective neuronal injury##2##3##(1995-12#1)(2007-9#1)
selective neuronal necrosis##4##3##(1990-2#1)(1997-8#3)
selective neuronal##8##2##(1990-2#1)(1995-12#1)(1997-8#3)(2007-9#1)(2008-7#1)(2013-1#1)
selective norepinephrine reuptake##2##3##(1996-3#1)(2011-1#1)
selective observation of##2##3##(1992-3#1)(2012-2#1)
selective opioid##2##2##(1995-12#1)(2010-2#1)
selective optical feedback##2##3##(2007-12#2)
selective optical##7##2##(2007-12#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#2)
selective or non-selective##2##3##(1994-3#1)(2011-2#1)
selective or##4##2##(1994-3#1)(1995-5#1)(2007-12#1)(2011-2#1)
selective oxidation of##5##3##(1997-1#1)(2005-11#1)(2007-11#1)(2008-10#2)
selective oxidation##7##2##(1997-1#2)(2005-11#1)(2007-11#1)(2008-10#3)
selective pattern of##2##3##(1992-8#1)(2012-2#1)
selective pecking##2##2##(2008-6#2)
selective peptide##2##2##(1995-3#1)(2005-8#1)
selective permeability##3##2##(2005-11#1)(2008-1#1)(2010-4#1)
selective pharmacological##2##2##(2008-8#1)(2012-2#1)
selective plasma separator##3##3##(2011-1#3)
selective polymeric membrane##2##3##(2008-10#2)
selective pre-concentration and differential pulse anodic stripping voltammetry##2##8##(2008-10#2)
selective precipitation of##2##3##(2008-10#1)(2008-7#1)
selective preconcentration##3##2##(2007-8#1)(2008-10#2)
selective pressure for the##2##4##(2009-8#1)(2010-11#1)
selective pressure of##2##3##(2008-1#1)(2011-2#1)
selective pressure to maintain##2##4##(1991-2#1)(2008-9#1)
selective pressure to##4##3##(1991-2#1)(1994-6#1)(2008-7#1)(2008-9#1)
selective pressure##19##2##(1991-12#1)(1991-2#1)(1994-2#1)(1994-6#1)(1995-8#1)(2005-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-7#2)(2008-9#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
selective pressures on dispersal and##2##5##(2007-3#2)
selective pressures##11##2##(1997-9#1)(2007-3#2)(2008-8#4)(2008-9#1)(2009-8#1)(2010-3#2)
selective protein kinase C inhibitor##2##5##(1993-12#1)(1996-2#1)
selective protein kinase C##3##4##(1993-12#1)(1996-2#1)(2008-9#1)
selective protein##8##2##(1992-12#1)(1993-12#1)(1993-9#2)(1994-10#1)(1994-3#1)(1996-2#1)(2008-9#1)
selective proteolysis##3##2##(1997-4#1)(2008-7#1)(2009-7#1)
selective pulmonary##2##2##(2008-12#1)(2010-12#1)
selective quantification of##2##3##(1993-2#1)(2008-10#1)
selective quencher##3##2##(2008-10#3)
selective quenching##2##2##(2008-10#2)
selective radioligand##2##2##(1996-12#1)(2008-4#1)
selective radioligands##2##2##(1990-2#1)(1995-7#1)
selective reaction monitoring (SRM)##2##4##(2007-8#1)(2008-10#1)
selective reaction##4##2##(2007-8#1)(2008-10#3)
selective reagents##3##2##(2008-10#2)(2012-2#1)
selective receptor antagonist)##2##3##(1991-5#2)
selective receptor##4##2##(1991-5#2)(1996-8#1)(2006-10#1)
selective recognition of##5##3##(1995-3#1)(1996-5#2)(1997-7#1)(2007-8#1)
selective recognition##7##2##(1995-3#1)(1996-5#2)(1997-3#1)(1997-7#1)(2007-8#1)(2008-10#1)
selective reduction of##3##3##(1996-4#1)(2007-11#1)(2008-10#1)
selective reduction##7##2##(1994-6#1)(1995-12#1)(1996-4#1)(2007-11#1)(2008-1#1)(2008-10#1)(2012-2#1)
selective regime##2##2##(2008-8#2)
selective removal of the##2##4##(1990-2#1)(2008-10#1)
selective removal of##5##3##(1990-2#1)(1996-5#1)(2007-8#1)(2008-10#2)
selective renal##2##2##(1991-10#1)(2006-7#1)
selective resistance of##2##3##(1994-11#1)(2011-2#1)
selective response##2##2##(2007-8#1)(2008-10#1)
selective retention of##2##3##(2007-8#1)(2008-10#1)
selective retention##3##2##(1992-1#1)(2007-8#1)(2008-10#1)
selective reuptake inhibitor##2##3##(2008-3#1)(2008-4#1)
selective reuptake##3##2##(2008-3#1)(2008-4#1)(2011-2#1)
selective review##2##2##(2006-10#1)(2009-9#1)
selective sensor##2##2##(2008-10#2)
selective sensors##2##2##(2008-10#2)
selective separation of##3##3##(2008-10#3)
selective separation##8##2##(2008-10#6)(2008-7#1)(2013-8#1)
selective sequential extractions##2##3##(2008-10#2)
selective sequential##3##2##(2008-10#3)
selective serotonin re-uptake##2##3##(2012-2#1)(2012-3#1)
selective serotonin reuptake inhibitor##7##4##(1997-3#1)(2006-10#1)(2008-3#1)(2008-4#1)(2009-6#1)(2010-2#1)(2012-3#1)
selective serotonin reuptake inhibitors (SSRIs)##10##5##(1996-7#1)(2004-3#1)(2005-9#1)(2006-4#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-8#1)(2012-3#1)(2013-8#1)
selective serotonin reuptake inhibitors and##5##5##(1996-12#2)(1997-8#3)
selective serotonin reuptake inhibitors in##2##5##(1996-12#1)(2008-8#1)
selective serotonin reuptake inhibitors##28##4##(1996-1#1)(1996-12#3)(1996-7#1)(1997-8#3)(2004-3#1)(2005-6#1)(2005-7#1)(2005-9#1)(2006-4#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#3)(2008-8#2)(2010-2#1)(2012-3#1)(2013-8#1)
selective serotonin reuptake##36##3##(1996-1#1)(1996-12#3)(1996-7#1)(1997-3#1)(1997-8#3)(2004-3#1)(2005-6#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-4#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-8#2)(2009-6#1)(2010-2#2)(2011-1#1)(2012-3#2)(2013-8#1)
selective serotonin##42##2##(1990-2#1)(1993-4#1)(1996-1#1)(1996-12#3)(1996-7#1)(1996-8#1)(1997-3#1)(1997-8#3)(2004-3#1)(2005-6#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-4#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-8#2)(2009-6#1)(2010-12#1)(2010-2#2)(2011-1#1)(2012-2#1)(2012-3#3)(2013-8#1)
selective serotonin-reuptake inhibitors (SSRIs)##2##4##(2010-12#1)(2011-1#1)
selective serotonin-reuptake inhibitors##3##3##(2010-12#1)(2011-1#2)
selective silver staining##2##3##(1997-3#2)
selective solid phase extraction##2##4##(2008-10#2)
selective solid phase##3##3##(2008-10#3)
selective solid##4##2##(2008-10#4)
selective solubilization##2##2##(1990-5#1)(1991-3#1)
selective spectrofluorimetric determination of##2##4##(2008-10#2)
selective spectrophotometric determination of##2##4##(2007-8#1)(2008-10#1)
selective spectrophotometric method for##3##4##(2007-8#1)(2008-10#2)
selective spectrophotometric method##4##3##(2007-8#1)(2008-10#3)
selective spectrophotometric##8##2##(2007-8#2)(2008-10#6)
selective stable isotope##2##3##(1990-11#1)(2010-5#1)
selective synthesis of##2##3##(1995-8#1)(2007-11#1)
selective synthesis##3##2##(1995-8#1)(2007-11#1)(2008-7#1)
selective system##2##2##(2008-10#1)(2008-11#1)
selective targeting##4##2##(1996-4#1)(2007-11#1)(2009-1#1)(2012-12#1)
selective than##2##2##(2008-10#1)(2008-3#1)
selective to the##3##3##(1992-6#1)(1996-8#1)(2005-11#1)
selective to##23##2##(1991-5#1)(1992-5#1)(1992-6#1)(1993-7#1)(1996-8#1)(2005-11#1)(2007-8#1)(2008-10#16)
selective tools##2##2##(2007-8#1)(2008-5#1)
selective towards##6##2##(1995-11#1)(2006-12#1)(2008-10#3)(2008-7#1)
selective toxicity for hypoxic cells##2##5##(1995-3#2)
selective toxicity##3##2##(1995-3#2)(2006-10#1)
selective transfer of##2##3##(1995-10#1)(2008-3#1)
selective translation of##3##3##(1992-12#2)(1992-8#1)
selective treatment##2##2##(1995-11#1)(2005-1#1)
selective uptake by##2##3##(1994-11#1)(1996-5#1)
selective uptake of the##3##4##(1996-5#2)(2008-2#1)
selective uptake of##6##3##(1996-5#3)(1996-8#1)(2005-8#1)(2008-2#1)
selective uptake##13##2##(1994-11#1)(1996-5#7)(1996-8#2)(2005-8#1)(2008-10#1)(2008-2#1)
selective uterine uptake##2##3##(1993-4#2)
selective vs##2##2##(1995-3#2)
selective vulnerability of the##2##4##(1995-3#1)(2006-5#1)
selective vulnerability of##3##3##(1995-3#1)(1997-1#1)(2006-5#1)
selective vulnerability##6##2##(1990-2#1)(1995-12#1)(1995-3#1)(1996-9#1)(1997-1#1)(2006-5#1)
selective when##2##2##(2005-10#1)(2009-5#1)
selective with##2##2##(2008-10#1)(2013-7#1)
selective##2076##1##(1990-10#2)(1990-11#10)(1990-12#8)(1990-2#19)(1990-3#2)(1990-4#3)(1990-5#10)(1990-6#5)(1990-7#6)(1990-8#14)(1990-9#6)(1991-1#2)(1991-10#5)(1991-11#8)(1991-12#10)(1991-2#10)(1991-3#13)(1991-4#4)(1991-5#15)(1991-6#3)(1991-7#2)(1991-8#10)(1991-9#10)(1992-1#7)(1992-10#6)(1992-11#2)(1992-12#6)(1992-2#6)(1992-3#11)(1992-4#1)(1992-5#7)(1992-6#4)(1992-7#1)(1992-8#9)(1992-9#8)(1993-1#1)(1993-11#19)(1993-12#10)(1993-2#9)(1993-3#12)(1993-4#17)(1993-5#3)(1993-6#10)(1993-7#7)(1993-8#4)(1993-9#5)(1994-1#1)(1994-10#4)(1994-11#10)(1994-12#11)(1994-2#19)(1994-3#7)(1994-5#9)(1994-6#14)(1994-8#13)(1994-9#10)(1995-1#6)(1995-10#3)(1995-11#16)(1995-12#29)(1995-2#2)(1995-3#23)(1995-5#4)(1995-6#11)(1995-7#6)(1995-8#7)(1995-9#1)(1996-1#7)(1996-10#7)(1996-11#3)(1996-12#16)(1996-2#10)(1996-3#7)(1996-4#4)(1996-5#24)(1996-6#11)(1996-7#4)(1996-8#18)(1996-9#4)(1997-1#12)(1997-2#21)(1997-3#9)(1997-4#5)(1997-5#23)(1997-6#10)(1997-7#14)(1997-8#15)(1997-9#1)(2004-12#8)(2004-3#1)(2004-9#2)(2005-1#3)(2005-10#6)(2005-11#12)(2005-12#1)(2005-4#4)(2005-6#2)(2005-7#7)(2005-8#12)(2005-9#4)(2006-10#27)(2006-12#10)(2006-2#5)(2006-3#6)(2006-4#1)(2006-5#2)(2006-6#6)(2006-7#1)(2006-8#11)(2006-9#3)(2007-1#13)(2007-10#3)(2007-11#25)(2007-12#13)(2007-2#2)(2007-3#4)(2007-4#2)(2007-5#2)(2007-6#3)(2007-7#9)(2007-8#31)(2007-9#2)(2008-1#24)(2008-10#506)(2008-11#21)(2008-12#12)(2008-2#20)(2008-3#25)(2008-4#57)(2008-5#28)(2008-6#16)(2008-7#28)(2008-8#40)(2008-9#8)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#3)(2009-2#5)(2009-3#1)(2009-4#7)(2009-5#4)(2009-6#5)(2009-7#8)(2009-8#6)(2009-9#5)(2010-1#6)(2010-11#2)(2010-12#25)(2010-2#4)(2010-3#4)(2010-4#8)(2010-5#10)(2010-6#1)(2010-7#6)(2010-8#5)(2011-1#15)(2011-2#22)(2011-3#2)(2012-1#7)(2012-11#3)(2012-12#23)(2012-2#22)(2012-3#14)(2013-1#30)(2013-7#7)(2013-8#9)
selective&quot##2##1##(2008-11#1)(2012-12#1)
selectively accumulated##2##2##(1996-8#1)(2008-10#1)
selectively acting##2##2##(2008-11#1)(2008-7#1)
selectively activated by##2##3##(1990-9#1)(1992-9#1)
selectively activated##3##2##(1990-9#1)(1992-9#1)(2008-11#1)
selectively active against##2##3##(1993-7#1)(2008-5#1)
selectively affect##3##2##(1990-11#1)(1996-5#1)(2012-2#1)
selectively affected by##2##3##(1994-5#1)(1995-3#1)
selectively affects##2##2##(2007-8#1)(2008-8#1)
selectively amplified##6##2##(1990-5#1)(1990-6#1)(2008-10#3)(2008-5#1)
selectively and reversibly##2##3##(1993-7#1)(2011-1#1)
selectively and sensitively detected by##2##5##(2008-10#2)
selectively and##16##2##(1990-12#1)(1993-7#1)(1994-3#1)(1994-4#1)(1994-5#1)(1995-1#1)(2007-8#1)(2008-1#1)(2008-10#6)(2009-12#1)(2011-1#1)
selectively at##3##2##(1990-5#1)(2008-10#1)(2010-4#1)
selectively attenuate##2##2##(1993-9#1)(2007-11#1)
selectively bind to the##2##4##(1992-6#1)(2008-8#1)
selectively bind to##3##3##(1992-6#1)(2007-8#1)(2008-8#1)
selectively bind##5##2##(1992-6#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-7#1)
selectively binds to the##2##4##(1997-1#1)(2009-8#1)
selectively binds to##4##3##(1992-12#1)(1997-1#1)(2007-10#1)(2009-8#1)
selectively blocked by the##2##4##(1993-11#1)(1994-6#1)
selectively blocked by##3##3##(1993-11#1)(1994-6#1)(2008-8#1)
selectively blocked##7##2##(1993-11#1)(1993-3#1)(1993-6#1)(1994-5#1)(1994-6#1)(2008-10#1)(2008-8#1)
selectively blocking the##2##3##(2007-1#1)(2008-8#1)
selectively blocking##3##2##(2006-10#1)(2007-1#1)(2008-8#1)
selectively blocks##2##2##(1997-3#1)(2007-1#1)
selectively by##5##2##(1990-5#1)(1995-12#1)(2005-11#1)(2006-10#1)(2008-5#1)
selectively cytotoxic##2##2##(1994-2#1)(1995-8#1)
selectively damaged##3##2##(1990-2#1)(2008-4#2)
selectively decreased##2##2##(1990-7#1)(2008-10#1)
selectively dephosphorylates##2##2##(1995-3#2)
selectively deposited##2##2##(1992-12#1)(2007-11#1)
selectively destroy##3##2##(1992-8#1)(1995-5#1)(2007-11#1)
selectively destroys##2##2##(2010-10#1)(2013-1#1)
selectively detected##5##2##(1992-1#1)(2008-10#4)
selectively determined##2##2##(2008-10#2)
selectively eliminate##2##2##(1992-5#1)(2007-11#1)
selectively enhance##2##2##(1996-2#1)(1996-5#1)
selectively enriched and##2##3##(2008-1#1)(2008-10#1)
selectively enriched##3##2##(2008-1#1)(2008-10#1)(2008-2#1)
selectively expressed in##3##3##(1994-6#1)(1995-11#1)(2008-4#1)
selectively expressed##5##2##(1994-6#2)(1995-11#1)(1996-3#1)(2008-4#1)
selectively extracted with##2##3##(1992-7#1)(2008-10#1)
selectively extracted##3##2##(1992-7#1)(2008-10#2)
selectively from##3##2##(1990-3#1)(2008-11#1)(2013-1#1)
selectively in the frontal cortex##2##5##(1997-5#2)
selectively in the##7##3##(1991-7#1)(1994-10#1)(1994-6#1)(1997-2#1)(1997-5#2)(2006-10#1)
selectively in##19##2##(1990-5#1)(1991-12#1)(1991-7#1)(1994-10#1)(1994-6#1)(1995-3#1)(1997-2#2)(1997-5#2)(1997-6#1)(1997-7#1)(2006-10#1)(2007-11#2)(2008-10#2)(2008-5#1)(2008-7#1)
selectively inactivated##2##2##(1991-1#1)(1991-2#1)
selectively inactivates##2##2##(1991-12#1)(1994-3#1)
selectively increase##3##2##(1990-9#1)(1994-5#1)(2009-9#1)
selectively increased##4##2##(1997-3#1)(2011-2#3)
selectively increases##3##2##(1990-10#1)(1992-6#1)(2007-8#1)
selectively induce##2##2##(2005-7#1)(2009-3#1)
selectively induced##2##2##(1992-4#1)(2008-11#1)
selectively inhibit##8##2##(1990-3#1)(1992-3#1)(1993-11#1)(1995-3#1)(2006-10#1)(2008-10#1)(2009-3#1)(2012-3#1)
selectively inhibited by##5##3##(1992-2#1)(1993-11#2)(1993-3#1)(1993-7#1)
selectively inhibited the##2##3##(1991-1#1)(1992-12#1)
selectively inhibited##13##2##(1990-7#1)(1991-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-11#2)(1993-3#1)(1993-7#2)(1994-8#1)(1997-3#1)(2012-2#1)
selectively inhibiting##3##2##(1990-5#1)(1994-2#2)
selectively inhibits the##2##3##(1993-11#1)(2008-6#1)
selectively inhibits##6##2##(1992-8#1)(1993-11#1)(1993-7#1)(1997-8#1)(2008-6#1)(2011-12#1)
selectively killed by##2##3##(2008-10#1)(2012-2#1)
selectively kills##3##2##(1994-12#1)(1994-2#1)(2011-2#1)
selectively labeled##2##2##(1992-8#1)(2008-8#1)
selectively localized##3##2##(1993-7#1)(1994-3#1)(2010-12#1)
selectively measured##2##2##(1994-8#1)(2007-11#1)
selectively modulate##3##2##(2006-11#1)(2007-11#1)(2009-7#1)
selectively modulates##2##2##(1990-11#1)(1991-6#1)
selectively monitored at##2##3##(2008-10#2)
selectively neutral##2##2##(1997-6#1)(2008-10#1)
selectively on the##3##3##(1992-6#1)(1993-6#1)(2007-7#1)
selectively on##6##2##(1992-11#1)(1992-6#1)(1993-6#1)(2007-11#1)(2007-7#1)(2008-10#1)
selectively oxidized by##2##3##(2008-10#1)(2010-12#1)
selectively oxidized##3##2##(2007-12#1)(2008-10#1)(2010-12#1)
selectively performed##2##2##(2007-8#1)(2009-12#1)
selectively potentiated##2##2##(1990-10#1)(2008-11#1)
selectively promote##2##2##(2008-10#1)(2008-4#1)
selectively promoted growth and stability of differentiated phenotype in##2##9##(1995-11#2)
selectively purified##3##2##(1990-4#2)(2008-10#1)
selectively quenches##2##2##(2008-10#2)
selectively reduce##2##2##(1993-9#1)(2005-8#1)
selectively reduced in##2##3##(1990-7#1)(1991-6#1)
selectively reduced the activity##2##4##(1993-4#1)(1996-12#1)
selectively reduced the##3##3##(1993-4#1)(1994-8#1)(1996-12#1)
selectively reduced##6##2##(1990-7#1)(1991-6#1)(1992-7#1)(1993-4#1)(1994-8#1)(1996-12#1)
selectively reduces##5##2##(1991-5#1)(1993-9#1)(1994-8#1)(1995-11#1)(2007-11#1)
selectively retain##2##2##(2008-10#2)
selectively reversed##2##2##(1991-3#1)(2008-2#1)
selectively sensitize##2##2##(1994-11#1)(1995-1#1)
selectively stimulate##2##2##(1995-6#1)(2006-7#1)
selectively synthesized##2##2##(2005-8#1)(2008-7#1)
selectively target##3##2##(1994-5#1)(2007-6#1)(2011-1#1)
selectively targeted to##2##3##(1990-12#1)(1997-7#1)
selectively targeted##4##2##(1990-12#1)(1997-7#1)(2005-10#1)(2010-12#1)
selectively the##5##2##(1990-10#2)(2004-2#1)(2007-8#1)(2008-8#1)
selectively to a##2##3##(2008-10#1)(2008-4#1)
selectively to the##3##3##(1991-5#1)(1995-12#1)(1997-2#1)
selectively to##19##2##(1991-5#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-8#1)(1995-12#1)(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2009-3#1)(2010-5#1)(2012-2#1)
selectively transferred##2##2##(1992-9#1)(1994-11#1)
selectively used##2##2##(1994-9#1)(2005-10#1)
selectively utilizes##2##2##(1994-9#2)
selectively vulnerable##6##2##(1990-2#1)(1995-12#1)(1996-12#1)(1997-8#1)(2011-2#2)
selectively with##8##2##(1990-5#1)(1991-12#1)(1994-3#1)(1994-5#1)(1996-4#1)(2005-11#1)(2008-10#1)(2011-1#1)
selectively within##2##2##(1996-2#1)(1996-9#1)
selectively##537##1##(1990-10#4)(1990-11#4)(1990-12#2)(1990-2#4)(1990-3#2)(1990-4#3)(1990-5#10)(1990-6#1)(1990-7#6)(1990-8#2)(1990-9#3)(1991-1#5)(1991-12#6)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#4)(1991-6#3)(1991-7#1)(1991-9#2)(1992-1#2)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#3)(1992-6#5)(1992-7#4)(1992-8#3)(1992-9#4)(1993-1#1)(1993-11#8)(1993-3#2)(1993-4#2)(1993-6#4)(1993-7#7)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#6)(1994-12#6)(1994-2#6)(1994-3#7)(1994-4#1)(1994-5#7)(1994-6#5)(1994-8#6)(1994-9#3)(1995-1#4)(1995-11#9)(1995-12#5)(1995-2#1)(1995-3#7)(1995-5#1)(1995-6#3)(1995-8#2)(1996-12#4)(1996-2#4)(1996-3#3)(1996-4#2)(1996-5#6)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#5)(1997-4#3)(1997-5#5)(1997-6#2)(1997-7#6)(1997-8#4)(2004-2#1)(2005-10#3)(2005-11#2)(2005-7#3)(2005-8#3)(2006-10#5)(2006-11#1)(2006-12#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#19)(2007-12#2)(2007-3#1)(2007-6#2)(2007-7#1)(2007-8#9)(2008-1#3)(2008-10#73)(2008-11#6)(2008-12#2)(2008-2#6)(2008-3#3)(2008-4#12)(2008-5#9)(2008-6#1)(2008-7#13)(2008-8#8)(2008-9#1)(2009-10#3)(2009-11#2)(2009-12#3)(2009-2#3)(2009-3#5)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-12#7)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#5)(2011-12#3)(2011-2#10)(2012-1#1)(2012-12#6)(2012-2#9)(2012-3#3)(2013-1#5)(2013-7#1)
selectivities and##2##2##(1997-7#1)(2008-2#1)
selectivities for##6##2##(1994-8#1)(2008-10#5)
selectivities of ISEs##2##3##(2008-10#2)
selectivities of the##2##3##(2006-10#1)(2008-2#1)
selectivities of##9##2##(1991-4#1)(1995-5#1)(1995-7#1)(1997-2#1)(2006-10#1)(2008-10#3)(2008-2#1)
selectivities up to##2##3##(2010-5#2)
selectivities##40##1##(1991-4#1)(1993-4#1)(1994-8#1)(1995-5#1)(1995-7#1)(1997-2#1)(1997-7#1)(2006-10#3)(2007-8#1)(2008-10#17)(2008-2#3)(2008-4#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-11#1)(2010-5#3)(2010-7#1)
selectivity =##2##2##(1996-8#2)
selectivity against##5##2##(2008-10#2)(2008-5#1)(2013-7#2)
selectivity and a##2##3##(2008-10#2)
selectivity and in the presence of this cation the host fluorescence intensity was##2##13##(2008-10#2)
selectivity and in##3##3##(2005-8#1)(2008-10#2)
selectivity and potency##2##3##(2008-1#1)(2008-5#1)
selectivity and reproducibility##3##3##(2008-10#3)
selectivity and response time##2##4##(2008-10#2)
selectivity and response##3##3##(2008-10#3)
selectivity and retention##2##3##(2008-10#1)(2009-12#1)
selectivity and sensitivity of##6##4##(1997-5#1)(2007-8#1)(2008-10#4)
selectivity and sensitivity##24##3##(1997-5#1)(1997-6#1)(2007-8#1)(2008-10#17)(2008-11#1)(2010-1#1)(2010-7#1)(2013-1#1)
selectivity and specificity##3##3##(2008-10#2)(2008-7#1)
selectivity and stability##3##3##(2008-10#2)(2013-1#1)
selectivity and the##4##3##(2008-10#3)(2008-8#1)
selectivity and##92##2##(1990-4#1)(1990-8#1)(1991-5#2)(1994-12#1)(1994-6#1)(1995-5#3)(1995-6#1)(1996-5#1)(1996-8#1)(1997-5#1)(1997-6#1)(2004-3#1)(2005-11#2)(2005-12#1)(2005-8#1)(2006-1#1)(2007-11#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#43)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#1)(2009-2#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#1)
selectivity are##12##2##(1994-9#1)(1996-8#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-8#1)(2010-5#1)
selectivity as well as the##2##5##(2008-3#1)(2013-8#1)
selectivity as well as##3##4##(2008-10#1)(2008-3#1)(2013-8#1)
selectivity as##4##2##(2008-10#2)(2008-3#1)(2013-8#1)
selectivity associated with##2##3##(2008-6#1)(2011-2#1)
selectivity at##3##2##(1991-9#1)(1994-10#1)(2007-1#1)
selectivity between##6##2##(1990-11#1)(1994-9#1)(1995-3#1)(2007-8#1)(2008-8#1)(2011-2#1)
selectivity by##4##2##(1995-6#1)(1995-7#1)(2008-10#1)(2008-7#1)
selectivity can be##8##3##(1991-9#1)(1994-9#1)(2007-12#1)(2008-10#3)(2008-11#1)(2013-7#1)
selectivity can##9##2##(1991-9#1)(1994-12#1)(1994-9#1)(2007-12#1)(2008-10#3)(2008-11#1)(2013-7#1)
selectivity coefficient for##2##3##(2008-10#2)
selectivity coefficient values as determined by##4##6##(2008-10#4)
selectivity coefficient values##6##3##(2008-10#6)
selectivity coefficient##14##2##(2005-11#1)(2008-10#13)
selectivity coefficients and##3##3##(2008-10#3)
selectivity coefficients for##5##3##(2008-10#5)
selectivity coefficients of a##2##4##(2008-10#2)
selectivity coefficients of ion-selective electrodes##2##5##(2008-10#2)
selectivity coefficients of ion-selective##3##4##(2008-10#3)
selectivity coefficients of##10##3##(2008-10#10)
selectivity coefficients towards##2##3##(2008-10#2)
selectivity coefficients##27##2##(2008-10#27)
selectivity conferred by the##2##4##(1997-1#1)(2008-10#1)
selectivity control##2##2##(2008-10#2)
selectivity depends on##2##3##(2008-10#1)(2008-3#1)
selectivity differences##2##2##(2007-8#2)
selectivity effects##2##2##(1994-5#1)(1995-3#1)
selectivity factor and##2##3##(2008-10#2)
selectivity factor##5##2##(1992-4#1)(2007-8#1)(2008-10#2)(2013-1#1)
selectivity factors##2##2##(2008-10#2)
selectivity filter and##2##3##(2008-8#1)(2013-8#1)
selectivity filter##7##2##(2008-8#6)(2013-8#1)
selectivity for 5-HT1A versus##2##4##(1991-2#1)(1997-1#1)
selectivity for 5-HT1A##3##3##(1991-2#1)(1996-8#1)(1997-1#1)
selectivity for Ag(+)##2##3##(2008-10#2)
selectivity for Cu(2+)##2##3##(2008-10#2)
selectivity for Cu(II)##2##3##(2008-10#2)
selectivity for Mg(2+) over##2##4##(2008-10#2)
selectivity for Pb(2+) over##2##4##(2008-10#2)
selectivity for Pb(II) over##2##4##(2008-10#2)
selectivity for U(VI) over Fe(III)##2##5##(2008-10#2)
selectivity for Zn(2+)##2##3##(2008-10#1)(2012-11#1)
selectivity for a##3##3##(1994-2#1)(1997-5#1)(2012-1#1)
selectivity for cesium ion over##2##5##(2008-10#2)
selectivity for cesium over##2##4##(2008-10#2)
selectivity for cesium##5##3##(2008-10#5)
selectivity for different##2##3##(1990-8#1)(2005-8#1)
selectivity for headgroup##2##3##(1994-5#2)
selectivity for primary##2##3##(2008-10#1)(2009-3#1)
selectivity for primary-tertiary alkylammonium cations##2##5##(2008-10#2)
selectivity for sodium and potassium picrates##2##6##(2008-10#2)
selectivity for the 5-HT1A##2##4##(1991-2#2)
selectivity for the##18##3##(1991-2#2)(1991-3#1)(1991-9#1)(1992-6#1)(1995-3#1)(1997-2#2)(2008-10#6)(2008-4#1)(2009-11#1)(2009-2#1)(2010-2#1)
selectivity for##129##2##(1990-8#3)(1991-2#3)(1991-3#2)(1991-9#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-4#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-4#1)(1996-8#4)(1997-1#3)(1997-2#5)(1997-5#1)(2005-12#1)(2005-7#1)(2005-8#2)(2006-12#1)(2008-1#1)(2008-10#71)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-5#2)(2012-1#1)(2012-11#1)
selectivity gained##2##2##(2007-12#1)(2008-10#1)
selectivity in the detection of##2##5##(2006-12#1)(2008-10#1)
selectivity in the oxidation of##2##5##(1993-4#1)(2007-11#1)
selectivity in the##12##3##(1993-4#1)(1994-6#1)(1995-2#1)(1997-5#1)(2006-12#1)(2007-11#1)(2008-10#5)(2008-3#1)
selectivity in##38##2##(1990-5#1)(1992-3#1)(1992-5#2)(1993-4#1)(1994-6#1)(1994-9#1)(1995-2#1)(1997-5#1)(2006-12#1)(2007-11#1)(2008-10#15)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#1)(2009-12#3)(2011-2#1)
selectivity index##6##2##(1994-12#1)(1997-6#3)(2006-12#1)(2007-11#1)
selectivity is attributed to##2##4##(2008-10#1)(2010-12#1)
selectivity is not##3##3##(1991-9#1)(1992-3#1)(2008-11#1)
selectivity is##19##2##(1991-9#1)(1992-3#1)(1994-12#1)(1994-9#1)(2005-11#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-12#2)(2010-7#1)
selectivity may##2##2##(1994-9#1)(2008-7#1)
selectivity observed##2##2##(1995-6#1)(2007-11#1)
selectivity obtained##3##2##(2008-10#2)(2008-2#1)
selectivity of a##5##3##(1995-12#1)(2007-12#2)(2008-10#2)
selectivity of flesinoxan##2##3##(1997-1#2)
selectivity of liquid##2##3##(2008-10#2)
selectivity of organic##2##3##(2008-10#2)
selectivity of the developed##2##4##(2008-10#2)
selectivity of the electrode##2##4##(2008-10#2)
selectivity of the method##4##4##(2008-10#4)
selectivity of the modified##2##4##(1995-6#1)(2007-8#1)
selectivity of the proposed method##4##5##(2008-10#3)(2008-3#1)
selectivity of the proposed##6##4##(2008-10#4)(2008-3#2)
selectivity of the sensor##3##4##(2008-10#3)
selectivity of the##64##3##(1990-9#1)(1992-3#1)(1995-1#2)(1995-3#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-8#1)(2006-12#1)(2007-12#3)(2007-8#3)(2008-10#32)(2008-11#1)(2008-2#1)(2008-3#5)(2008-7#1)(2009-11#1)(2010-2#1)(2010-5#1)(2013-1#1)(2013-7#1)
selectivity of these compounds##2##4##(1993-4#1)(2008-10#1)
selectivity of these##3##3##(1991-3#1)(1993-4#1)(2008-10#1)
selectivity of this method##2##4##(2008-10#1)(2010-5#1)
selectivity of this##10##3##(1994-9#1)(1995-11#1)(2008-10#6)(2008-2#1)(2010-5#1)
selectivity of##172##2##(1990-11#1)(1990-4#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-5#2)(1993-3#1)(1993-4#2)(1993-5#1)(1994-6#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#3)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#2)(1997-1#3)(1997-2#4)(1997-5#1)(1997-7#1)(1997-8#1)(2005-8#1)(2006-12#1)(2007-12#5)(2007-8#6)(2008-10#72)(2008-11#2)(2008-2#6)(2008-3#8)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2013-1#2)(2013-7#1)
selectivity over K(+)##2##3##(2008-10#2)
selectivity over##8##2##(1990-9#1)(2008-10#7)
selectivity parameters##2##2##(2007-9#1)(2008-10#1)
selectivity pattern with##3##3##(2008-10#3)
selectivity pattern##5##2##(2008-10#5)
selectivity profile##3##2##(1996-7#1)(2005-7#1)(2012-3#1)
selectivity properties of##2##3##(2008-10#2)
selectivity ratio##5##2##(1997-2#2)(2008-10#2)(2011-2#1)
selectivity relative to##2##3##(2008-10#2)
selectivity seen##2##2##(1996-12#1)(1997-7#1)
selectivity than##4##2##(1993-3#1)(2008-10#2)(2008-2#1)
selectivity that##4##2##(1991-2#1)(1996-5#1)(2006-10#1)(2006-4#1)
selectivity to##13##2##(1996-5#1)(1997-3#1)(2007-8#2)(2008-10#9)
selectivity toward##16##2##(1996-5#1)(2007-8#2)(2008-10#8)(2008-5#1)(2008-7#1)(2009-12#1)(2010-4#1)(2013-1#1)
selectivity towards the##4##3##(1997-3#1)(2007-8#1)(2008-10#1)(2008-11#1)
selectivity towards##15##2##(1997-3#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-7#1)(2013-7#1)
selectivity using##3##2##(2008-10#3)
selectivity versus##2##2##(1997-1#1)(2008-5#1)
selectivity was improved##2##3##(2008-10#2)
selectivity was observed##2##3##(2008-10#2)
selectivity was##17##2##(1992-3#1)(1996-5#1)(2006-10#1)(2007-8#1)(2008-10#10)(2008-11#1)(2009-3#1)(2012-11#1)
selectivity were obtained in##2##4##(2007-8#1)(2008-10#1)
selectivity were##7##2##(1996-5#1)(2007-8#1)(2008-10#4)(2008-5#1)
selectivity when compared with##2##4##(1996-11#1)(2008-10#1)
selectivity when##4##2##(1996-11#1)(2008-10#2)(2011-2#1)
selectivity with respect to##3##4##(1996-2#1)(1996-5#1)(2008-10#1)
selectivity with the##3##3##(2007-8#1)(2008-10#1)(2012-2#1)
selectivity with##8##2##(1994-9#1)(1996-2#1)(1996-5#1)(2007-8#1)(2008-10#3)(2012-2#1)
selectivity within##2##2##(2008-10#1)(2012-2#1)
selectivity##938##1##(1990-11#2)(1990-12#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#5)(1990-9#2)(1991-11#1)(1991-2#6)(1991-3#3)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#5)(1992-12#1)(1992-3#5)(1992-4#1)(1992-5#4)(1992-6#1)(1992-8#1)(1993-11#2)(1993-2#2)(1993-3#2)(1993-4#6)(1993-5#1)(1993-9#1)(1994-10#3)(1994-11#2)(1994-12#5)(1994-2#1)(1994-3#2)(1994-5#4)(1994-6#4)(1994-8#1)(1994-9#16)(1995-1#3)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#8)(1995-5#4)(1995-6#7)(1995-7#1)(1995-8#2)(1996-11#2)(1996-12#3)(1996-2#2)(1996-4#2)(1996-5#10)(1996-6#2)(1996-7#1)(1996-8#13)(1997-1#13)(1997-2#16)(1997-3#2)(1997-5#7)(1997-6#4)(1997-7#2)(1997-8#2)(2004-3#1)(2005-10#1)(2005-11#6)(2005-12#2)(2005-4#2)(2005-7#2)(2005-8#5)(2005-9#1)(2006-1#1)(2006-10#2)(2006-12#4)(2006-4#1)(2007-1#1)(2007-11#6)(2007-12#10)(2007-3#3)(2007-8#30)(2007-9#3)(2008-1#3)(2008-10#435)(2008-11#13)(2008-2#13)(2008-3#18)(2008-4#12)(2008-5#9)(2008-6#3)(2008-7#13)(2008-8#20)(2008-9#9)(2009-10#1)(2009-11#2)(2009-12#5)(2009-2#8)(2009-3#2)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#7)(2010-2#4)(2010-4#3)(2010-5#7)(2010-6#2)(2010-7#7)(2010-8#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#8)(2013-8#6)
selectivity)##5##1##(1996-8#1)(1996-9#1)(1997-2#2)(2008-10#1)
selector genes##2##2##(2007-12#1)(2009-5#1)
selector in the##3##3##(2008-10#2)(2008-3#1)
selector in##5##2##(2008-10#4)(2008-3#1)
selector valve##2##2##(2008-10#1)(2013-1#1)
selector##33##1##(1993-12#2)(1995-1#1)(1996-5#1)(2005-12#1)(2007-12#3)(2008-10#17)(2008-3#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-4#1)(2013-1#3)
selects a##3##2##(2006-7#1)(2008-1#1)(2010-8#1)
selects for##5##2##(1990-8#1)(1996-4#1)(2005-9#1)(2008-8#1)(2009-12#1)
selects older-specific differentially predictive rules##2##5##(2013-1#2)
selects the##7##2##(1992-8#1)(2008-1#1)(2008-3#2)(2008-8#1)(2010-2#1)(2010-8#1)
selects two##2##2##(2008-3#1)(2012-3#1)
selects##37##1##(1990-8#1)(1991-10#1)(1992-8#1)(1996-4#1)(1997-3#2)(1997-4#1)(1997-7#1)(2005-8#1)(2005-9#1)(2006-7#1)(2008-1#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-8#2)(2012-12#1)(2012-3#2)(2013-1#4)
selegiline##7##1##(1993-2#1)(1996-5#1)(2004-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-1#1)
selenate (Se(VI))##3##2##(2008-10#3)
selenate##17##1##(1997-4#1)(2005-12#2)(2008-10#9)(2008-6#1)(2008-7#1)(2011-2#1)(2013-8#2)
selenide##8##1##(1991-9#1)(1993-11#1)(2007-11#1)(2008-2#1)(2009-2#1)(2010-11#1)(2012-2#2)
selenious acid##2##2##(2008-10#2)
selenite (Se(IV))##4##2##(2008-10#4)
selenite and##5##2##(1992-8#1)(1995-11#1)(2008-10#2)(2011-2#1)
selenite ion selective##2##3##(2008-10#2)
selenite ion##4##2##(2008-10#4)
selenite on##2##2##(1992-7#1)(2008-7#1)
selenite was##2##2##(1996-2#1)(2008-10#1)
selenite with##2##2##(1992-7#1)(2008-10#1)
selenite##53##1##(1992-4#1)(1992-7#6)(1992-8#1)(1993-12#2)(1995-1#1)(1995-11#1)(1996-2#2)(2007-7#1)(2008-10#28)(2008-11#1)(2008-7#1)(2010-11#3)(2011-1#4)(2011-2#1)
selenium (IV)##6##2##(2008-10#6)
selenium (Se) on##3##3##(1993-3#2)(2008-10#1)
selenium (Se)##14##2##(1991-12#1)(1993-3#2)(2004-4#1)(2007-8#1)(2008-10#3)(2008-7#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
selenium and lead##2##3##(2008-10#2)
selenium and tin by##2##4##(2008-10#2)
selenium and tin##3##3##(2008-10#3)
selenium and vitamin E##2##4##(2008-5#2)
selenium and zinc##2##3##(1996-7#2)
selenium and##21##2##(1992-4#1)(1994-3#2)(1996-7#2)(2007-2#1)(2008-10#10)(2008-11#1)(2008-5#2)(2010-11#1)(2012-12#1)
selenium at##2##2##(1995-7#1)(2008-10#1)
selenium compounds##4##2##(2008-10#2)(2010-11#2)
selenium concentration##5##2##(1991-1#2)(2005-7#2)(2010-11#1)
selenium concentrations in serum##2##4##(1991-1#1)(1996-7#1)
selenium concentrations in##3##3##(1991-1#1)(1996-7#1)(2005-7#1)
selenium concentrations##6##2##(1991-1#1)(1995-1#1)(1996-7#1)(2005-7#3)
selenium containing##2##2##(2008-10#1)(2012-3#1)
selenium content in##4##3##(1993-12#1)(2005-4#1)(2008-10#2)
selenium content of##2##3##(2008-10#2)
selenium content##7##2##(1993-12#1)(2005-4#1)(2008-10#5)
selenium could##2##2##(2008-10#1)(2008-6#1)
selenium deficiency and##2##3##(1996-11#1)(2005-7#1)
selenium deficiency##9##2##(1992-11#1)(1992-4#1)(1992-5#2)(1996-11#4)(2005-7#1)
selenium determination in##3##3##(2008-10#3)
selenium determination##4##2##(2008-10#4)
selenium determination/speciation##2##2##(2008-10#2)
selenium donor##2##2##(1993-11#2)
selenium from the##2##3##(2008-10#2)
selenium from##3##2##(2008-10#2)(2013-8#1)
selenium hydride generation##2##3##(2008-10#2)
selenium in natural water##2##4##(2008-10#2)
selenium in the atmosphere##3##4##(2008-10#3)
selenium in the##8##3##(2007-4#1)(2008-10#6)(2012-2#1)
selenium in urine##2##3##(2008-10#2)
selenium in##36##2##(1992-11#1)(2005-4#2)(2007-4#1)(2008-10#29)(2010-11#1)(2010-5#1)(2012-2#1)
selenium intake##2##2##(1997-8#1)(2012-2#1)
selenium is##7##2##(1994-3#1)(2008-10#6)
selenium levels and high##2##4##(2007-2#2)
selenium levels and##6##3##(1991-1#2)(1993-12#2)(2007-2#2)
selenium levels were##2##3##(1995-7#1)(2008-10#1)
selenium levels##15##2##(1991-1#3)(1993-12#3)(1995-7#1)(1996-7#4)(1996-8#1)(2007-2#2)(2008-10#1)
selenium metabolism and##2##3##(2010-11#2)
selenium nutritional##2##2##(2008-10#1)(2010-11#1)
selenium or alpha-tocopherol##2##3##(1994-3#2)
selenium or##3##2##(1994-3#2)(2008-7#1)
selenium present in##2##3##(2008-10#2)
selenium present##3##2##(2008-10#3)
selenium speciation##5##2##(2008-10#5)
selenium species in human urine##2##5##(2008-10#2)
selenium species in##5##3##(2008-10#5)
selenium species##23##2##(2008-10#21)(2010-11#2)
selenium status##3##2##(1993-6#1)(1995-1#1)(1996-7#1)
selenium sulphide shampoo##3##3##(2007-7#3)
selenium sulphide##4##2##(2007-7#4)
selenium supplementation on##2##3##(1991-1#1)(1995-1#1)
selenium supplementation##9##2##(1991-1#1)(1992-4#2)(1995-1#4)(2005-7#1)(2008-6#1)
selenium to##3##2##(1992-5#1)(2008-10#1)(2013-8#1)
selenium was found##2##3##(1993-12#1)(2008-10#1)
selenium was##8##2##(1991-1#1)(1993-12#1)(2008-10#5)(2010-11#1)
selenium with the##2##3##(2008-10#2)
selenium with##5##2##(1993-12#1)(2007-11#2)(2008-10#2)
selenium##321##1##(1990-10#1)(1990-12#1)(1990-5#2)(1991-1#9)(1991-12#1)(1991-3#1)(1992-11#2)(1992-4#6)(1992-5#4)(1992-7#1)(1993-11#2)(1993-12#8)(1993-3#2)(1993-6#1)(1994-3#5)(1995-1#6)(1995-7#3)(1996-11#4)(1996-7#10)(1996-8#1)(1997-8#2)(2004-4#1)(2005-4#3)(2005-7#8)(2006-10#1)(2007-11#4)(2007-2#4)(2007-4#2)(2007-7#4)(2007-8#1)(2008-10#155)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#9)(2008-7#9)(2009-10#4)(2009-3#3)(2009-5#1)(2009-8#2)(2010-11#15)(2010-5#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#1)(2013-8#4)
selenium(IV + VI)##2##3##(2008-10#2)
selenium(IV) and (IV + VI)##2##5##(2008-10#2)
selenium(IV) and (VI)##4##3##(2008-10#4)
selenium(IV) and molybdenum(VI)##3##3##(2008-10#3)
selenium(IV) and##11##2##(2008-10#11)
selenium(IV) in##2##2##(2008-10#2)
selenium(IV) uptake onto##2##3##(2008-10#2)
selenium(IV)##25##1##(2008-10#25)
selenium-applied groups##2##2##(2008-7#2)
selenium-containing enzyme##2##2##(2006-8#1)(2007-10#1)
selenium-containing phycocyanin from##2##3##(2008-8#2)
selenium-containing##10##1##(1991-1#1)(1995-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-8#2)(2012-2#1)
selenium-deficient rats##5##2##(1990-12#1)(1991-12#1)(1992-11#2)(1996-11#1)
selenium-deficient##11##1##(1990-12#1)(1991-12#1)(1992-11#4)(1992-5#1)(1996-11#4)
selenium-dependent glutathione peroxidase##3##3##(1991-12#1)(1997-6#1)(2008-7#1)
selenium-dependent##7##1##(1990-12#1)(1991-12#1)(1993-11#1)(1997-6#2)(2008-4#1)(2008-7#1)
selenium-enriched plants##2##2##(2008-10#2)
selenium-rich algae (Spirulina platensis)##2##4##(2008-8#2)
selenium-rich##3##1##(1991-1#1)(2008-8#2)
selenoamino acids##6##2##(2008-10#5)(2010-5#1)
selenocompounds##4##1##(1992-12#1)(2008-10#3)
selenocyanates##2##1##(2007-11#2)
selenocysteine (Sec)##3##2##(1995-8#1)(2008-10#1)(2012-2#1)
selenocysteine in##2##2##(2008-10#1)(2010-11#1)
selenocysteine tRNA[Ser]Sec##3##2##(1995-8#1)(1997-2#2)
selenocysteine##17##1##(1990-12#1)(1990-4#1)(1993-6#1)(1995-8#2)(1997-2#2)(2006-12#1)(2008-10#5)(2008-9#1)(2010-11#1)(2012-2#2)
selenocystine##5##1##(2008-10#4)(2010-11#1)
selenoenzyme##5##1##(1990-12#2)(1991-12#1)(1992-12#2)
selenoethionine##2##1##(2008-10#2)
selenomethionine (SeMet)##3##2##(2008-10#3)
selenomethionine and##2##2##(2008-10#2)
selenomethionine##10##1##(2008-10#10)
selenophosphate##3##1##(1993-11#1)(2012-2#2)
selenoprotein P and##2##3##(1992-5#2)
selenoprotein P##4##2##(1992-5#3)(2009-10#1)
selenoprotein and##2##2##(1990-12#1)(2012-2#1)
selenoprotein mRNA##3##2##(2012-2#3)
selenoprotein mRNAs##2##2##(1992-5#1)(2008-10#1)
selenoprotein transcripts##2##2##(2012-2#2)
selenoprotein##21##1##(1990-12#2)(1992-5#4)(2008-10#1)(2009-10#2)(2010-11#1)(2012-2#11)
selenoproteins##8##1##(1992-5#3)(2008-10#1)(2009-10#1)(2010-11#2)(2012-2#1)
selenospecies##5##1##(2008-10#4)(2010-11#1)
selenosugar in##2##2##(2010-11#2)
selenoxide##2##1##(2008-10#2)
self and non-self##2##3##(2008-1#1)(2008-9#1)
self and others##4##3##(2007-10#1)(2007-2#1)(2008-11#1)(2008-12#1)
self and partner physical attractiveness##2##5##(2007-12#2)
self and peer assessment and##2##5##(2008-11#2)
self and peer assessment##4##4##(2008-11#4)
self and peer##5##3##(2007-1#1)(2008-11#4)
self and##27##2##(1990-8#1)(2006-12#1)(2006-3#1)(2006-7#1)(2007-1#2)(2007-10#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#2)(2008-11#6)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2012-2#1)
self antigens##4##2##(1991-11#1)(2007-11#1)(2008-4#2)
self as a##2##3##(2008-10#1)(2008-6#1)
self as##4##2##(2006-3#1)(2006-9#1)(2008-10#1)(2008-6#1)
self assembled##2##2##(2008-10#2)
self assembly##2##2##(1994-12#1)(2010-2#1)
self care##3##2##(1996-1#1)(1996-3#1)(2011-2#1)
self care]##2##2##(1991-9#1)(1994-6#1)
self catheterisation##3##2##(2008-7#1)(2011-2#2)
self efficacy##2##2##(2008-3#1)(2009-9#1)
self esteem##3##2##(2007-10#1)(2008-11#1)(2011-1#1)
self examination##4##2##(1990-3#1)(1992-4#1)(1994-7#1)(2011-2#1)
self from##4##2##(1990-12#1)(2007-11#1)(2008-11#1)(2009-8#1)
self harm in##2##3##(2007-3#1)(2011-2#1)
self harm##6##2##(2007-3#4)(2011-2#2)
self image##2##2##(1994-8#1)(2009-7#1)
self immolations##2##2##(2005-9#2)
self in the##2##3##(2008-10#1)(2008-11#1)
self in##7##2##(2006-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2012-11#1)
self injury##2##2##(1992-5#1)(2009-9#1)
self interaction##2##2##(2007-9#2)
self is##6##2##(2006-7#1)(2008-11#2)(2008-5#1)(2008-6#1)(2011-1#1)
self limited##2##2##(2007-10#1)(2012-2#1)
self medication##3##2##(1996-3#2)(2007-7#1)
self monitoring##13##2##(1997-3#7)(2008-10#6)
self mutilation in##2##3##(2012-2#2)
self mutilation##4##2##(2010-12#1)(2012-2#3)
self or foreign##2##3##(2007-5#1)(2008-4#1)
self or others##2##3##(2005-6#1)(2013-8#1)
self or##6##2##(2005-6#1)(2006-3#1)(2007-12#1)(2007-5#1)(2008-4#1)(2013-8#1)
self poisoning##2##2##(1992-5#1)(1995-9#1)
self reflection##2##2##(1993-2#1)(2008-11#1)
self renewal and##2##3##(2008-1#1)(2008-11#1)
self renewal##5##2##(2006-10#1)(2008-1#1)(2008-11#2)(2010-12#1)
self report##3##2##(1990-8#2)(2010-2#1)
self reported hematuria or dysuria##4##5##(2007-2#4)
self reported hematuria##6##3##(2007-2#6)
self reported##11##2##(2007-2#6)(2007-7#1)(2008-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
self that##2##2##(2006-12#1)(2013-7#1)
self to standards##2##3##(2012-12#2)
self to##4##2##(2008-5#1)(2008-8#1)(2012-12#2)
self versus##2##2##(1996-11#1)(2006-3#1)
self with##7##2##(1991-12#2)(2008-5#1)(2008-9#3)(2012-12#1)
self worth##2##2##(2007-12#1)(2009-9#1)
self##278##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-8#4)(1991-11#3)(1991-12#3)(1991-2#1)(1991-9#1)(1992-10#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-2#3)(1995-9#1)(1996-1#1)(1996-11#2)(1996-3#3)(1997-3#7)(1997-4#1)(2003-11#1)(2005-6#1)(2005-7#2)(2005-8#2)(2005-9#2)(2006-10#2)(2006-12#2)(2006-3#7)(2006-4#1)(2006-6#3)(2006-7#3)(2006-9#1)(2007-1#2)(2007-10#5)(2007-11#3)(2007-12#5)(2007-2#12)(2007-3#4)(2007-5#1)(2007-7#5)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#13)(2008-11#28)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#5)(2008-5#12)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#5)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#3)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#8)(2011-2#10)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#9)(2012-3#3)(2013-1#3)(2013-7#4)(2013-8#2)
self&quot##3##1##(2006-3#1)(2008-5#1)(2008-7#1)
self- and##9##2##(1991-10#1)(1995-8#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-9#1)(2009-9#1)(2013-1#1)
self- or##3##2##(1993-5#1)(1997-4#1)(2008-11#1)
self-##16##1##(1991-10#1)(1993-5#1)(1994-12#1)(1995-8#1)(1997-4#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-9#1)(2009-9#1)(2013-1#1)
self-Q-switched laser##2##2##(2007-12#2)
self-absorption##3##1##(1997-7#1)(2008-10#1)(2012-2#1)
self-acceptance and##2##2##(2005-10#2)
self-acceptance##5##1##(2005-10#4)(2007-12#1)
self-accepting##2##1##(2007-12#2)
self-adaptive##6##1##(2006-5#2)(2007-12#1)(2008-1#2)(2008-6#1)
self-adhesive resin cement##3##3##(2013-8#3)
self-adhesive##5##1##(2013-8#5)
self-administered questionnaire in##2##3##(2010-4#1)(2012-3#1)
self-administered questionnaire was distributed##2##4##(1991-10#1)(1992-4#1)
self-administered questionnaire was##3##3##(1991-10#1)(1992-4#1)(2011-2#1)
self-administered questionnaire##17##2##(1991-10#1)(1992-1#1)(1992-4#1)(1993-2#1)(2006-10#1)(2006-2#1)(2007-3#1)(2008-11#1)(2010-4#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
self-administered questionnaires to##3##3##(2007-12#1)(2008-6#1)(2009-10#1)
self-administered questionnaires##11##2##(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-6#1)(2009-10#1)(2009-7#1)(2010-4#3)(2011-2#1)
self-administered to##2##2##(2008-10#1)(2012-1#1)
self-administered##45##1##(1991-10#1)(1992-1#1)(1992-4#1)(1993-2#1)(1993-4#1)(1994-12#1)(1997-3#1)(2006-10#2)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2008-10#2)(2008-11#2)(2008-6#1)(2009-10#2)(2009-5#1)(2009-7#1)(2010-4#4)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)
self-administering##3##1##(1993-6#1)(1997-7#1)(2010-2#1)
self-administration (SA)##2##2##(1993-6#1)(1997-7#1)
self-administration behavior in##3##3##(2008-4#2)(2012-3#1)
self-administration in##9##2##(1993-6#1)(2008-4#4)(2012-2#1)(2012-3#3)
self-administration of medication##5##3##(2011-2#5)
self-administration of morphine##2##3##(2008-4#2)
self-administration of##14##2##(1991-1#1)(1992-2#1)(1993-6#1)(2008-10#1)(2008-4#4)(2009-10#1)(2011-2#5)
self-administration##60##1##(1991-1#5)(1992-2#1)(1993-6#7)(1994-12#1)(1997-2#2)(1997-7#4)(2007-11#1)(2008-10#1)(2008-4#16)(2009-10#1)(2009-11#1)(2009-7#1)(2010-2#1)(2011-12#5)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#5)
self-affine fractal silver surfaces##2##4##(2007-12#2)
self-aggregating##2##1##(1992-12#1)(2011-12#1)
self-aggregation of##3##2##(1992-6#1)(1995-11#1)(2011-2#1)
self-aggregation##8##1##(1991-5#1)(1992-6#1)(1995-11#2)(2005-11#1)(2011-2#1)(2012-12#2)
self-aggression##2##1##(2011-2#1)(2013-1#1)
self-aligned##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
self-aligning##3##1##(2008-2#1)(2008-3#2)
self-alignment##4##1##(2007-11#1)(2008-2#1)(2008-7#1)(2012-2#1)
self-amputated colonic##2##2##(2008-10#2)
self-antigen##2##1##(2007-2#1)(2008-8#1)
self-antigens in##2##2##(2006-10#1)(2007-5#1)
self-antigens##9##1##(1995-1#1)(2006-10#1)(2006-5#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2012-1#1)
self-assemble into##5##2##(1995-5#1)(2008-4#1)(2008-7#1)(2009-2#1)(2010-5#1)
self-assemble to form##3##3##(1991-11#1)(2007-8#1)(2009-11#1)
self-assemble##11##1##(1991-11#1)(1995-5#1)(2007-8#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-2#1)(2010-5#1)(2010-8#1)
self-assemble-modified gold electrode##2##3##(2005-4#2)
self-assembled aminoethanethiol monolayer##2##3##(2008-10#2)
self-assembled bilayers##3##2##(2008-10#3)
self-assembled composite layer##2##3##(2007-8#2)
self-assembled electrode##4##2##(2008-10#4)
self-assembled monolayer (SAM) modified gold##2##5##(2008-10#2)
self-assembled monolayer (SAM) of##5##4##(2005-11#1)(2008-10#4)
self-assembled monolayer (SAM)##13##3##(2005-11#1)(2008-10#10)(2008-3#1)(2009-3#1)
self-assembled monolayer film##2##3##(2008-8#2)
self-assembled monolayer modified gold##2##4##(2008-10#2)
self-assembled monolayer modified##3##3##(2008-10#3)
self-assembled monolayer of##7##3##(2007-12#1)(2007-8#1)(2008-10#4)(2008-3#1)
self-assembled monolayer on##3##3##(2007-9#1)(2008-10#2)
self-assembled monolayer##36##2##(2005-11#1)(2005-12#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#24)(2008-3#2)(2008-5#1)(2008-8#2)(2009-3#1)
self-assembled monolayers (SAM)##3##3##(2005-11#1)(2005-4#1)(2008-10#1)
self-assembled monolayers (SAMs) of##4##4##(2007-9#1)(2008-10#1)(2010-4#2)
self-assembled monolayers (SAMs) on##3##4##(1996-5#1)(2006-12#1)(2008-10#1)
self-assembled monolayers (SAMs)##9##3##(1996-5#1)(2005-11#1)(2006-12#1)(2007-9#1)(2008-10#3)(2010-4#2)
self-assembled monolayers and##2##3##(2006-12#1)(2010-7#1)
self-assembled monolayers of##3##3##(2007-9#1)(2008-7#1)(2010-7#1)
self-assembled monolayers surface##2##3##(2008-10#2)
self-assembled monolayers##38##2##(1996-5#1)(2005-11#5)(2005-4#1)(2006-12#4)(2007-12#1)(2007-8#1)(2007-9#2)(2008-10#12)(2008-5#1)(2008-7#1)(2010-4#6)(2010-7#3)
self-assembled on gold##2##3##(2007-8#1)(2008-10#1)
self-assembled on##5##2##(2007-8#2)(2008-10#3)
self-assembled peptide##2##2##(2008-5#1)(2008-7#1)
self-assembled##138##1##(1990-4#1)(1991-11#1)(1995-3#1)(1996-5#1)(1997-4#2)(2005-11#8)(2005-12#1)(2005-4#1)(2006-12#5)(2006-2#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#10)(2007-9#3)(2008-10#56)(2008-3#2)(2008-5#7)(2008-7#8)(2008-8#2)(2009-11#2)(2009-2#3)(2009-3#1)(2010-12#3)(2010-4#8)(2010-5#1)(2010-7#4)(2012-2#1)
self-assembling of##2##2##(2007-8#2)
self-assembling##10##1##(2005-11#2)(2007-8#4)(2008-10#1)(2008-2#1)(2008-4#1)(2012-2#1)
self-assembly and##5##2##(1991-11#2)(2007-8#1)(2008-7#1)(2010-4#1)
self-assembly in##3##2##(2005-11#1)(2006-12#1)(2008-4#1)
self-assembly is##3##2##(1991-11#2)(2008-7#1)
self-assembly monolayer process##4##3##(2007-11#2)(2007-12#2)
self-assembly monolayer##5##2##(2007-11#2)(2007-12#2)(2007-8#1)
self-assembly of NCs##2##3##(2010-4#2)
self-assembly of a##2##3##(2008-3#1)(2010-7#1)
self-assembly of diblock copolymers##2##4##(2008-10#1)(2008-3#1)
self-assembly of oppositely charged polyelectrolytes##2##5##(2008-7#1)(2010-4#1)
self-assembly of peptide amphiphile##2##4##(2008-5#1)(2009-5#1)
self-assembly of the##2##3##(2007-10#1)(2013-8#1)
self-assembly of##31##2##(1992-1#1)(1994-11#1)(1995-8#1)(1996-2#1)(2005-11#4)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-12#1)(2009-5#2)(2010-4#4)(2010-7#2)(2010-9#1)(2013-8#1)
self-assembly process##5##2##(1994-12#1)(2005-11#1)(2006-12#1)(2008-10#2)
self-assembly processes##3##2##(1991-4#1)(2006-12#1)(2008-10#1)
self-assembly properties##2##2##(1990-5#1)(2009-11#1)
self-assembly technique##3##2##(2005-11#2)(2008-7#1)
self-assembly techniques##2##2##(2008-5#1)(2008-7#1)
self-assembly##100##1##(1990-5#3)(1990-7#2)(1991-11#4)(1991-4#1)(1992-1#1)(1994-11#1)(1994-12#1)(1994-7#1)(1995-8#1)(1996-2#1)(2005-11#14)(2006-12#3)(2007-10#1)(2007-11#2)(2007-12#4)(2007-8#2)(2007-9#1)(2008-10#14)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#10)(2009-11#2)(2009-12#3)(2009-4#1)(2009-5#3)(2010-4#5)(2010-7#2)(2010-9#1)(2011-1#1)(2013-7#1)(2013-8#7)
self-assessed health##7##2##(2007-6#1)(2010-9#6)
self-assessed skills##2##2##(2007-12#2)
self-assessed##11##1##(2007-12#3)(2007-6#1)(2008-10#1)(2010-9#6)
self-assessment and##2##2##(2006-8#1)(2008-5#1)
self-assessment of##6##2##(2006-10#2)(2008-1#1)(2008-5#1)(2012-3#1)(2013-8#1)
self-assessment tool##2##2##(1995-3#1)(2007-2#1)
self-assessment##33##1##(1993-2#1)(1995-3#2)(1997-2#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-11#2)(2008-5#3)(2008-9#4)(2009-9#2)(2010-3#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
self-assessments##4##1##(1992-3#2)(2008-5#1)(2008-7#1)
self-associate##2##1##(1992-6#1)(1994-9#1)
self-association and##2##2##(1992-6#1)(1997-4#1)
self-association of human spectrin##2##4##(1991-4#2)
self-association of the phosphorylated and dephosphorylated##2##6##(1990-8#1)(1997-2#1)
self-association of the##3##3##(1990-8#1)(1996-5#1)(1997-2#1)
self-association of##8##2##(1990-8#1)(1991-4#2)(1991-7#2)(1996-5#1)(1997-2#1)(2006-10#1)
self-association##23##1##(1990-8#2)(1991-4#3)(1991-7#4)(1992-6#1)(1993-6#1)(1994-9#3)(1995-8#1)(1996-5#1)(1997-2#1)(1997-4#2)(2005-11#2)(2006-10#2)
self-awareness and##2##2##(2008-1#1)(2008-11#1)
self-awareness##16##1##(2006-3#2)(2008-1#1)(2008-11#4)(2008-12#4)(2012-12#2)(2012-3#1)(2013-1#2)
self-blame and shame##2##3##(2004-12#1)(2008-11#1)
self-blame##4##1##(2004-12#1)(2008-11#1)(2010-1#2)
self-burning##3##1##(2011-2#3)
self-calibrating##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
self-calibration##4##1##(2008-2#2)(2008-3#2)
self-care activities##4##2##(1990-5#2)(2007-11#1)(2010-10#1)
self-care and##4##2##(2006-10#1)(2006-2#1)(2008-6#1)(2011-1#1)
self-care behaviors##2##2##(1995-3#1)(2011-1#1)
self-care behaviour##2##2##(2010-3#2)
self-care behaviours##2##2##(2010-3#2)
self-care self-efficacy##3##2##(2010-2#3)
self-care##53##1##(1990-5#2)(1992-4#1)(1993-2#1)(1995-3#1)(2006-1#2)(2006-10#1)(2006-2#2)(2007-11#1)(2007-2#1)(2007-6#2)(2007-8#1)(2007-9#2)(2008-10#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-6#2)(2009-3#1)(2009-5#2)(2009-7#1)(2010-10#1)(2010-2#4)(2010-3#4)(2010-5#1)(2010-7#1)(2011-1#9)(2011-2#2)(2012-1#1)(2013-8#1)
self-catheterisation##3##1##(1990-4#1)(2008-6#1)(2008-7#1)
self-cleaning##7##1##(1996-12#1)(2008-7#1)(2010-1#2)(2010-4#3)
self-cleavage##3##1##(1991-8#2)(2006-12#1)
self-cleaving##2##1##(2006-12#1)(2008-9#1)
self-compatibility##2##1##(2007-3#1)(2008-10#1)
self-compatible##2##1##(2007-3#1)(2008-10#1)
self-competence and intrinsic value for math and English##2##8##(2009-7#2)
self-competence##3##1##(2009-7#3)
self-complementary duplex##2##2##(1991-7#1)(1996-7#1)
self-complementary##10##1##(1991-7#1)(1992-12#1)(1992-6#2)(1992-9#1)(1996-7#1)(2008-10#1)(2008-4#2)(2008-7#1)
self-completed questionnaires##2##2##(2012-2#1)(2013-1#1)
self-completion questionnaires were##2##3##(2008-4#1)(2008-8#1)
self-completion questionnaires##3##2##(2008-4#1)(2008-8#1)(2010-5#1)
self-concept and depression##2##3##(2010-3#2)
self-concept and self-efficacy##2##3##(2007-2#2)
self-concept and##6##2##(2007-2#2)(2008-5#1)(2010-3#3)
self-concept as well as##2##4##(2007-2#1)(2009-7#1)
self-concept can##2##2##(2008-5#2)
self-concept of##2##2##(2008-11#1)(2009-7#1)
self-concept was##2##2##(2010-3#1)(2010-7#1)
self-concept##40##1##(2005-10#1)(2007-2#7)(2008-11#2)(2008-12#2)(2008-5#6)(2008-9#1)(2009-7#11)(2010-3#9)(2010-7#1)
self-concepts##4##1##(2008-12#1)(2010-3#3)
self-confidence and self-reliance##3##3##(2006-8#3)
self-confidence and##5##2##(2006-2#1)(2006-8#3)(2007-6#1)
self-confidence##9##1##(1990-12#1)(2006-2#2)(2006-8#3)(2007-6#2)(2012-3#1)
self-consciousness##3##1##(2006-6#1)(2007-12#2)
self-consistency##2##1##(1996-4#1)(2007-12#1)
self-consistent method for the##2##4##(2008-2#1)(2008-3#1)
self-consistent method##4##2##(1994-9#1)(2008-2#2)(2008-3#1)
self-consistent##24##1##(1990-8#1)(1991-4#1)(1992-9#1)(1994-9#2)(2006-10#1)(2006-4#2)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#6)(2008-3#3)(2009-4#1)(2009-6#1)
self-consistent-charge density-functional tight-binding method (SCC-DFTB)##2##5##(2012-12#2)
self-contained##13##1##(1992-3#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#2)(2009-11#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
self-control animals##2##2##(2013-7#2)
self-control##17##1##(2007-5#1)(2008-12#7)(2008-5#2)(2011-1#1)(2013-1#1)(2013-7#5)
self-critical##3##1##(2006-6#2)(2008-5#1)
self-cured##2##1##(1996-12#1)(2013-1#1)
self-curing##3##1##(2006-8#1)(2008-11#1)(2012-12#1)
self-cycling fermentation##2##2##(2008-7#2)
self-deception##3##1##(1992-2#1)(1995-4#1)(2006-3#1)
self-defense##4##1##(2008-10#2)(2010-11#1)(2013-1#1)
self-defined##2##1##(2007-2#1)(2009-7#1)
self-defining##2##1##(2010-8#2)
self-defocusing##5##1##(2007-12#2)(2008-1#3)
self-depressive (anxious)##2##2##(2010-8#2)
self-described##2##1##(2007-2#1)(2010-5#1)
self-descriptions and self-evaluations##2##3##(2006-6#2)
self-descriptions##3##1##(2006-6#2)(2007-6#1)
self-descriptors##2##1##(2008-9#2)
self-designed questionnaire##2##2##(2011-2#1)(2013-1#1)
self-determination and##3##2##(1991-2#1)(2006-4#1)(2010-2#1)
self-determination theory##3##2##(2010-2#3)
self-determination##18##1##(1991-2#2)(1997-8#3)(2005-7#1)(2006-4#2)(2008-3#1)(2009-4#3)(2010-12#1)(2010-2#5)
self-determined##4##1##(1991-8#2)(2010-2#1)(2013-7#1)
self-developed##3##1##(2008-1#1)(2008-12#1)(2012-2#1)
self-development##5##1##(1995-12#1)(2008-5#4)
self-diffraction frequency-resolved optical gating##2##4##(2007-12#1)(2008-1#1)
self-diffraction##9##1##(2007-11#1)(2007-12#2)(2008-1#2)(2008-2#1)(2008-3#3)
self-diffusion behavior of the##2##4##(2008-3#2)
self-diffusion behavior of##3##3##(2008-3#3)
self-diffusion##5##1##(1995-3#1)(2008-3#4)
self-directed learning tools##2##3##(2012-2#2)
self-directed learning##9##2##(2006-12#1)(2007-1#1)(2008-11#1)(2008-12#2)(2008-5#1)(2010-2#1)(2012-2#2)
self-directed replication##2##2##(1993-2#2)
self-directed work teams##7##3##(1993-12#5)(1994-1#1)(1994-3#1)
self-directed##28##1##(1993-12#5)(1993-2#2)(1994-1#1)(1994-3#1)(1996-2#1)(2006-12#1)(2007-1#1)(2007-12#1)(2007-4#1)(2008-11#3)(2008-12#2)(2008-5#1)(2009-11#1)(2009-4#1)(2010-2#2)(2011-2#1)(2012-2#2)(2013-1#1)
self-direction##2##1##(2008-11#1)(2010-2#1)
self-disclosure##3##1##(2006-6#1)(2012-12#1)(2013-1#1)
self-doubling##2##1##(2007-11#1)(2008-2#1)
self-efficacy (SE)##2##2##(2006-12#1)(2010-3#1)
self-efficacy (beta =##2##3##(2010-2#1)(2010-9#1)
self-efficacy and outcome##2##3##(2007-10#2)
self-efficacy and##10##2##(1992-1#1)(2007-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2009-5#1)(2010-3#1)(2010-9#2)
self-efficacy for##4##2##(2006-10#1)(2007-2#2)(2010-3#1)
self-efficacy in##4##2##(2011-1#1)(2012-2#2)(2012-3#1)
self-efficacy of##4##2##(2007-2#2)(2008-12#1)(2010-9#1)
self-efficacy to##4##2##(2008-2#1)(2010-2#1)(2010-9#1)(2013-7#1)
self-efficacy were##2##2##(2006-10#1)(2010-2#1)
self-efficacy##89##1##(1992-1#1)(1993-12#4)(2006-10#3)(2006-12#2)(2006-6#1)(2007-10#3)(2007-12#1)(2007-2#8)(2008-11#1)(2008-12#8)(2008-2#2)(2008-4#4)(2008-7#1)(2008-9#2)(2009-3#2)(2009-5#2)(2009-7#1)(2010-2#7)(2010-3#6)(2010-9#6)(2011-1#4)(2011-2#1)(2012-12#5)(2012-2#3)(2012-3#3)(2012-5#1)(2013-1#4)(2013-7#3)
self-efficacy)##2##1##(1994-12#1)(2011-2#1)
self-emission##4##1##(2008-2#3)(2008-3#1)
self-employed##2##1##(2010-8#1)(2010-9#1)
self-employment##2##1##(2006-2#1)(2007-7#1)
self-emulsifying drug delivery systems##2##4##(2008-5#1)(2012-12#1)
self-emulsifying drug delivery##3##3##(2008-5#1)(2012-12#2)
self-enhance##2##1##(2008-5#2)
self-enhancement effect##2##2##(2008-3#1)(2008-5#1)
self-enhancement gain##2##2##(2008-3#2)
self-enhancement in dichromated-gelatin gratings##2##4##(2008-3#2)
self-enhancement in##3##2##(2008-3#3)
self-enhancement##15##1##(2006-9#1)(2007-12#2)(2008-3#8)(2008-5#3)(2010-3#1)
self-esteem and cognitive coping##2##4##(2008-11#2)
self-esteem and##13##2##(1992-10#1)(1994-12#1)(1995-2#1)(2006-6#2)(2008-11#4)(2008-5#1)(2008-7#1)(2010-3#1)(2010-7#1)
self-esteem is##2##2##(1993-3#2)
self-esteem of##4##2##(1990-2#1)(1993-3#1)(2007-12#1)(2008-11#1)
self-esteem was##5##2##(1995-2#1)(2007-12#1)(2007-8#1)(2008-11#1)(2012-2#1)
self-esteem##96##1##(1990-2#1)(1992-10#1)(1992-3#1)(1993-3#4)(1994-12#2)(1995-2#2)(1996-2#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-6#2)(2006-7#5)(2007-12#23)(2007-8#1)(2007-9#1)(2008-11#9)(2008-12#3)(2008-5#2)(2008-7#2)(2008-9#3)(2009-11#2)(2009-2#2)(2009-5#6)(2009-7#6)(2010-1#1)(2010-3#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#3)(2013-1#2)
self-etch adhesive##2##2##(2010-9#1)(2011-1#1)
self-etch##3##1##(2010-9#1)(2011-1#1)(2013-8#1)
self-etching adhesive##2##2##(2013-7#1)(2013-8#1)
self-evaluation or self-improvement##2##3##(2007-12#2)
self-evaluation##11##1##(1990-2#1)(1994-1#1)(1994-6#2)(2006-6#1)(2007-12#4)(2008-5#1)(2012-12#1)
self-evaluations##3##1##(2006-6#2)(2009-7#1)
self-evaluative##2##1##(2007-12#1)(2013-8#1)
self-evident##2##1##(2007-8#1)(2008-1#1)
self-exam##3##1##(2009-3#1)(2009-5#2)
self-examination is##2##2##(1992-4#1)(1994-2#1)
self-examination of the breast##3##4##(1990-12#1)(1990-4#2)
self-examination##23##1##(1990-12#5)(1990-4#2)(1990-8#1)(1992-4#3)(1994-2#1)(2006-8#1)(2007-10#3)(2007-4#1)(2011-2#4)(2013-1#2)
self-exchange in##2##2##(1993-11#1)(1997-7#1)
self-exchange##6##1##(1991-7#1)(1993-11#2)(1994-5#1)(1997-4#1)(1997-7#1)
self-expandable metal##3##2##(2006-2#1)(2008-3#1)(2013-1#1)
self-expandable metallic stent##2##3##(2010-12#1)(2013-1#1)
self-expandable valved stent##2##3##(2007-8#2)
self-expandable##9##1##(2006-2#1)(2007-8#2)(2008-3#1)(2009-5#1)(2010-12#1)(2013-1#3)
self-expanding metal stents##3##3##(2006-10#1)(2006-2#1)(2010-12#1)
self-expanding metallic##3##2##(2006-10#1)(2007-8#2)
self-expanding##12##1##(1990-8#1)(2006-10#2)(2006-2#1)(2007-8#3)(2008-12#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)
self-explanatory##3##1##(2006-5#1)(2008-5#1)(2009-4#1)
self-expression##3##1##(2007-11#1)(2007-6#1)(2012-2#1)
self-fertile##3##1##(2007-12#1)(2008-10#2)
self-fertilization##8##1##(2008-8#4)(2008-9#3)(2013-1#1)
self-fertilizing##3##1##(2007-11#1)(2008-5#2)
self-focus##6##1##(2008-2#2)(2010-10#4)
self-focused dark notches and crosses##3##5##(2008-2#3)
self-focused people made##2##3##(2012-12#2)
self-focused##9##1##(2006-6#1)(2008-11#1)(2008-2#3)(2009-5#1)(2012-11#1)(2012-12#2)
self-focusing and##7##2##(2007-11#1)(2007-12#5)(2008-1#1)
self-focusing in a hollow waveguide##3##5##(2007-12#3)
self-focusing in a##4##3##(2007-12#4)
self-focusing in bulk media##2##4##(2007-12#2)
self-focusing in the##3##3##(2007-12#2)(2008-3#1)
self-focusing in##12##2##(2007-11#1)(2007-12#10)(2008-3#1)
self-focusing of##6##2##(1994-10#1)(2007-11#1)(2007-12#4)
self-focusing to##2##2##(2007-12#1)(2008-1#1)
self-focusing##46##1##(1994-10#1)(2007-11#9)(2007-12#29)(2008-1#4)(2008-2#1)(2008-3#2)
self-formed##2##1##(2007-12#1)(2009-11#1)
self-frequency shift in##2##3##(2007-11#1)(2008-1#1)
self-frequency shift##8##2##(2007-11#5)(2007-12#1)(2008-1#2)
self-frequency##11##1##(2007-11#6)(2007-12#3)(2008-1#2)
self-frequency-doubling##4##1##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
self-generated##6##1##(2006-3#1)(2008-11#2)(2008-4#1)(2009-8#1)(2011-1#1)
self-guided beams##2##2##(2008-1#2)
self-guided##4##1##(2007-12#2)(2008-1#2)
self-guiding##4##1##(2007-12#3)(2008-1#1)
self-harm behavior among those with eating disorders##2##7##(2006-7#2)
self-harm behavior##4##2##(2006-7#4)
self-harm behaviors##7##2##(2006-7#5)(2009-7#1)(2009-9#1)
self-harm in##2##2##(2012-12#1)(2013-1#1)
self-harm##32##1##(2006-7#20)(2008-11#1)(2009-7#2)(2009-9#1)(2011-1#2)(2012-11#1)(2012-12#1)(2013-1#4)
self-harming behaviors and##2##3##(2006-7#2)
self-harming behaviors##10##2##(2006-7#9)(2010-9#1)
self-harming##15##1##(2006-7#11)(2010-9#1)(2011-1#2)(2012-1#1)
self-healing materials##2##2##(2010-12#1)(2010-7#1)
self-healing##8##1##(1991-11#1)(2006-5#1)(2009-12#1)(2009-9#1)(2010-12#1)(2010-7#3)
self-help group##2##2##(1996-3#1)(2007-8#1)
self-help groups and##4##3##(1994-1#1)(1996-3#1)(2008-4#1)(2012-2#1)
self-help groups##17##2##(1991-7#1)(1992-5#1)(1994-1#2)(1994-12#1)(1995-1#2)(1996-3#2)(2007-8#2)(2008-4#4)(2011-2#1)(2012-2#1)
self-help networks##2##2##(1994-1#2)
self-help##37##1##(1991-7#1)(1992-5#1)(1994-1#9)(1994-12#2)(1995-1#2)(1995-3#1)(1996-3#9)(2007-10#1)(2007-8#3)(2008-4#4)(2010-10#1)(2011-2#1)(2012-2#2)
self-heterodyne##4##1##(2007-12#4)
self-homodyne##2##1##(2007-12#2)
self-identification as a##2##3##(2007-12#1)(2009-5#1)
self-identification##6##1##(1990-12#1)(2006-7#1)(2007-12#1)(2009-5#1)(2009-7#2)
self-identified as##4##2##(1996-3#1)(2008-3#1)(2010-11#1)(2010-7#1)
self-identified lesbian and bisexual##2##4##(2008-12#2)
self-identified##8##1##(1996-3#1)(2006-10#1)(2008-12#2)(2008-3#1)(2010-11#1)(2010-7#2)
self-identify as##2##2##(2008-12#1)(2010-7#1)
self-identity##2##1##(2005-7#1)(2009-10#1)
self-image and##6##2##(2006-2#1)(2008-7#1)(2009-1#1)(2011-1#1)(2011-2#1)(2012-2#1)
self-image goals##6##2##(2010-2#6)
self-image##19##1##(1991-2#1)(1995-2#1)(2006-2#2)(2007-12#1)(2008-7#2)(2009-1#1)(2009-2#1)(2010-2#6)(2011-1#1)(2011-2#2)(2012-2#1)
self-imaging effect##2##2##(2007-12#2)
self-imaging of##2##2##(2008-1#1)(2008-3#1)
self-imaging##17##1##(2007-11#3)(2007-12#8)(2008-1#1)(2008-2#3)(2008-3#2)
self-imposed##2##1##(2008-2#1)(2012-11#1)
self-improvement##8##1##(1997-1#2)(2006-8#1)(2007-12#4)(2009-5#1)
self-inactivation##2##1##(1995-5#2)
self-incompatibility##6##1##(1992-8#1)(1996-8#2)(2005-10#1)(2009-10#2)
self-incompatible##3##1##(2008-10#3)
self-induced attitude##2##2##(2008-5#2)
self-induced modulational instability##2##3##(2007-11#2)
self-induced vomiting##3##2##(1990-4#1)(2009-2#1)(2013-1#1)
self-induced##13##1##(1990-4#1)(1993-6#1)(2007-11#3)(2007-12#1)(2008-3#2)(2008-5#2)(2009-2#1)(2010-9#1)(2013-1#1)
self-inflicted injuries##2##2##(1992-2#1)(1995-8#1)
self-inflicted##5##1##(1992-2#1)(1995-8#2)(2007-2#1)(2008-5#1)
self-inhibited##4##1##(1992-4#3)(1993-9#1)
self-initiated behavioral##2##2##(2012-2#2)
self-initiated##3##1##(2007-7#1)(2012-2#2)
self-injection feedback##3##2##(2007-12#3)
self-injection locking##4##2##(2007-12#4)
self-injection of##3##2##(2006-7#1)(2009-3#2)
self-injection##10##1##(2006-7#1)(2007-12#7)(2009-3#2)
self-injurious behavior (SIB)##2##3##(2008-11#1)(2009-10#1)
self-injurious behavior in##2##3##(1997-5#1)(2006-7#1)
self-injurious behavior##5##2##(1997-5#1)(2006-7#1)(2008-11#1)(2009-10#1)(2012-2#1)
self-injurious behaviors##3##2##(2006-7#3)
self-injurious##12##1##(1997-5#2)(2006-7#4)(2008-11#1)(2009-10#1)(2012-2#1)(2013-7#3)
self-injury in##2##2##(1997-5#1)(2008-11#1)
self-injury##8##1##(1997-5#4)(2008-11#4)
self-inserted##2##1##(2013-8#2)
self-insured##6##1##(1993-1#2)(1994-12#1)(1995-12#1)(1997-2#1)(1997-3#1)
self-interest##6##1##(1990-12#2)(1991-2#1)(1994-3#1)(2007-4#1)(2008-10#1)
self-interference##4##1##(2007-12#3)(2008-3#1)
self-knowledge##2##1##(2008-12#1)(2008-8#1)
self-ligated##3##1##(1992-4#1)(1993-9#1)(1997-2#1)
self-ligating brackets##3##2##(2009-7#3)
self-ligating##7##1##(2009-7#4)(2010-10#3)
self-limited disease##2##2##(1991-4#1)(2007-11#1)
self-limited##19##1##(1991-4#1)(1992-9#1)(1993-9#1)(2005-11#1)(2005-8#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-9#1)(2010-12#1)(2011-2#3)(2013-1#3)(2013-8#1)
self-limiting disease##3##2##(1996-6#1)(2008-8#1)(2011-1#1)
self-limiting disorder##2##2##(1991-9#1)(2012-3#1)
self-limiting##24##1##(1991-9#1)(1992-2#1)(1992-6#1)(1994-11#1)(1995-3#1)(1996-6#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-6#1)(2008-8#2)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
self-made capsules##4##2##(2012-3#4)
self-made##9##1##(1990-4#1)(2011-2#1)(2012-3#7)
self-managed##2##1##(1992-1#1)(2012-12#1)
self-management and##6##2##(1992-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#2)
self-management behaviors##2##2##(2008-1#1)(2009-5#1)
self-management interventions##2##2##(2010-3#2)
self-management of health##2##3##(2012-2#2)
self-management of##6##2##(2007-10#1)(2010-4#1)(2012-2#2)(2013-1#2)
self-management plan system of care##2##5##(2006-5#2)
self-management plans##4##2##(2006-5#3)(2008-10#1)
self-management policy##2##2##(2012-12#2)
self-management programme##2##2##(2010-9#2)
self-management programmes##3##2##(2009-1#1)(2010-9#1)(2011-2#1)
self-management##51##1##(1992-12#1)(1993-12#3)(1994-3#2)(2006-5#5)(2007-10#2)(2008-1#2)(2008-10#1)(2009-1#1)(2009-5#1)(2010-11#1)(2010-3#5)(2010-4#1)(2010-5#1)(2010-9#3)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#10)
self-measurement of##2##2##(1991-3#1)(2011-2#1)
self-measurement##5##1##(1991-3#1)(2008-12#3)(2011-2#1)
self-medication for##2##2##(2007-7#1)(2008-8#1)
self-medication were##2##2##(2007-7#2)
self-medication with##3##2##(1993-4#1)(1995-2#1)(2012-2#1)
self-medication##21##1##(1993-4#2)(1995-2#1)(1997-4#1)(2004-3#1)(2007-2#1)(2007-7#7)(2007-8#1)(2008-10#1)(2008-8#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
self-mixing laser diode##3##3##(2008-3#3)
self-mixing laser##5##2##(2008-3#5)
self-mixing##12##1##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#8)
self-mode locking##3##2##(2008-3#3)
self-mode-locked Ti##4##2##(2007-12#2)(2008-1#1)(2008-3#1)
self-mode-locked##7##1##(2007-12#4)(2008-1#1)(2008-3#2)
self-modeling curve resolution##2##3##(2007-12#2)
self-modeling##3##1##(2007-12#2)(2008-10#1)
self-modulation of the##3##3##(2007-12#1)(2007-9#2)
self-modulation##10##1##(2007-11#6)(2007-12#2)(2007-9#2)
self-monitor##3##1##(2008-11#1)(2010-2#2)
self-monitored##2##1##(2008-1#1)(2008-11#1)
self-monitoring at##2##2##(2009-9#1)(2012-12#1)
self-monitoring of blood glucose##3##4##(2008-8#1)(2009-11#1)(2012-12#1)
self-monitoring of##4##2##(1990-3#1)(2008-8#1)(2009-11#1)(2012-12#1)
self-monitoring##19##1##(1990-3#1)(1992-12#1)(1993-5#1)(2006-3#1)(2006-4#1)(2008-11#2)(2008-8#3)(2008-9#3)(2009-11#1)(2009-9#1)(2012-12#2)(2013-1#2)
self-motion detection##2##2##(1990-10#2)
self-motion perception##3##2##(1990-10#1)(1996-5#2)
self-motion##9##1##(1990-10#4)(1996-5#4)(2012-2#1)
self-mutilating behaviour##3##2##(1991-11#3)
self-mutilation in nonpsychotic##2##3##(2009-10#2)
self-mutilation##7##1##(2008-12#1)(2009-10#3)(2013-8#3)
self-ordered ring##2##2##(2008-10#2)
self-ordering of##2##2##(2009-2#2)
self-organization in##4##2##(1990-4#1)(2008-3#1)(2008-8#1)(2008-9#1)
self-organization phenomena##2##2##(2006-10#2)
self-organization##23##1##(1990-4#1)(1996-4#1)(2006-10#2)(2006-12#1)(2006-3#4)(2007-9#3)(2008-3#1)(2008-8#2)(2008-9#2)(2009-5#2)(2009-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
self-organize##2##1##(1995-9#1)(2008-2#1)
self-organized by##2##2##(2007-9#1)(2008-11#1)
self-organized growth of##2##3##(2008-7#2)
self-organized growth##3##2##(1992-3#1)(2008-7#2)
self-organized##12##1##(1992-3#1)(2007-9#2)(2008-1#2)(2008-11#1)(2008-7#4)(2011-2#1)(2012-1#1)
self-organizing emergence of##2##3##(2008-8#2)
self-organizing feature maps##3##3##(2008-2#3)
self-organizing map (SOM)##2##3##(2008-2#2)
self-organizing map##7##2##(2008-2#5)(2008-7#1)(2012-1#1)
self-organizing neural network##7##3##(2008-2#2)(2008-3#5)
self-organizing##30##1##(1997-6#1)(2007-2#1)(2007-9#1)(2008-1#2)(2008-2#11)(2008-3#5)(2008-5#2)(2008-7#1)(2008-8#2)(2009-10#2)(2009-6#1)(2012-1#1)
self-oscillations##3##1##(2007-12#3)
self-other comparison##2##2##(2009-4#2)
self-other matching##3##2##(2009-4#3)
self-other##5##1##(2009-4#5)
self-paced index-finger flexions##2##3##(1996-1#2)
self-paced listening##2##2##(2013-7#2)
self-paced movement##3##2##(1996-1#3)
self-paced reading##3##2##(2013-1#3)
self-paced##20##1##(1991-3#1)(1996-1#6)(1996-3#1)(1996-8#1)(2008-7#1)(2012-1#2)(2013-1#5)(2013-7#2)(2013-8#1)
self-perceived risk of acquiring HIV##3##5##(2012-3#3)
self-perceived##15##1##(1993-2#1)(2006-1#3)(2007-11#1)(2008-5#1)(2008-8#2)(2010-3#2)(2010-8#1)(2012-3#3)(2013-1#1)
self-perception after##2##2##(2013-1#2)
self-perception and##4##2##(2007-12#1)(2007-7#1)(2008-5#1)(2011-1#1)
self-perception in##2##2##(2006-6#1)(2012-2#1)
self-perception of health literacy##2##4##(2013-7#2)
self-perception of health##3##3##(2011-1#1)(2013-7#2)
self-perception of the##2##3##(2008-8#1)(2008-9#1)
self-perception of##10##2##(2007-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#1)(2013-7#2)
self-perception##22##1##(2006-6#2)(2007-12#1)(2007-2#1)(2007-7#2)(2008-10#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-6#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#3)(2013-7#2)
self-perceptions and##2##2##(2007-9#1)(2012-2#1)
self-perceptions in##2##2##(2007-12#1)(2007-9#1)
self-perceptions##10##1##(2007-12#4)(2007-9#2)(2010-7#3)(2012-2#1)
self-perpetuating##2##1##(2005-8#1)(2010-4#1)
self-persuasion##6##1##(2007-5#2)(2008-5#4)
self-phase locking##2##2##(2007-12#2)
self-phase modulation and##6##3##(2007-11#2)(2007-12#3)(2008-1#1)
self-phase modulation in the##2##4##(2007-12#1)(2008-1#1)
self-phase modulation in##7##3##(2007-11#2)(2007-12#4)(2008-1#1)
self-phase modulation is##2##3##(2007-11#2)
self-phase modulation of##3##3##(2007-11#2)(2007-12#1)
self-phase modulation##29##2##(2007-11#12)(2007-12#11)(2008-1#2)(2008-2#3)(2008-3#1)
self-phase##32##1##(2007-11#13)(2007-12#13)(2008-1#2)(2008-2#3)(2008-3#1)
self-pollination and##3##2##(2005-10#1)(2008-9#1)(2013-1#1)
self-pollination##10##1##(2005-10#2)(2008-9#4)(2013-1#4)
self-practice##2##1##(2008-10#1)(2009-6#1)
self-presentation##11##1##(2007-12#10)(2009-11#1)
self-processing##2##1##(1995-6#1)(2008-11#1)
self-produced##2##1##(2006-10#1)(2013-1#1)
self-propagating##2##1##(1992-2#1)(2012-2#1)
self-protection##2##1##(2008-4#1)(2012-3#1)
self-protective##4##1##(2007-8#2)(2010-12#1)(2012-2#1)
self-pulsating laser##2##2##(2007-12#2)
self-pulsating##4##1##(2007-11#1)(2007-12#3)
self-pumped phase conjugation from##2##4##(2008-2#2)
self-pumped phase conjugation##4##3##(2008-2#3)(2008-3#1)
self-pumped phase conjugator##3##3##(2008-2#1)(2008-3#2)
self-pumped phase##8##2##(2008-2#5)(2008-3#3)
self-pumped phase-conjugate mirror##8##3##(2007-12#3)(2008-2#3)(2008-3#2)
self-pumped phase-conjugate##10##2##(2007-12#4)(2008-2#4)(2008-3#2)
self-pumped##18##1##(2007-12#4)(2008-2#9)(2008-3#5)
self-quenching of##2##2##(1993-11#1)(2009-11#1)
self-quenching##3##1##(1993-11#1)(2008-10#1)(2009-11#1)
self-rated health (SRH)##2##3##(2011-2#1)(2013-1#1)
self-rated health##7##2##(2009-11#1)(2011-2#3)(2013-1#2)(2013-8#1)
self-rated perception of health##2##4##(2007-11#2)
self-rated##19##1##(2004-2#2)(2006-10#2)(2007-11#2)(2008-10#1)(2008-3#1)(2008-4#1)(2009-11#1)(2011-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
self-rating##6##1##(1990-3#1)(1992-2#1)(2004-10#1)(2006-6#1)(2008-7#1)(2012-3#1)
self-ratings of##3##2##(1996-7#1)(1996-8#1)(2012-12#1)
self-ratings##4##1##(1995-12#1)(1996-7#1)(1996-8#1)(2012-12#1)
self-reactive##3##1##(1991-11#1)(2008-10#1)(2011-1#1)
self-refer##4##1##(2007-4#3)(2007-6#1)
self-reference##11##1##(2008-10#1)(2008-11#4)(2008-9#5)(2012-1#1)
self-referenced##4##1##(2007-11#2)(2008-10#2)
self-referencing technique for##2##3##(2007-11#2)
self-referencing##6##1##(2007-11#3)(2007-12#2)(2008-2#1)
self-referential##5##1##(2008-11#2)(2008-3#1)(2013-1#1)(2013-8#1)
self-referral by##2##2##(2007-4#2)
self-referral##15##1##(1996-1#1)(2007-4#14)
self-referrals##3##1##(1993-5#1)(1993-8#1)(2006-3#1)
self-referred##7##1##(1991-12#2)(2006-12#1)(2007-4#3)(2013-4#1)
self-referring##2##1##(2007-4#1)(2008-3#1)
self-reflection and##4##2##(2008-11#2)(2012-1#1)(2013-1#1)
self-reflection on learning process##2##4##(2013-1#2)
self-reflection##15##1##(2005-12#1)(2008-11#4)(2008-6#4)(2009-4#1)(2012-1#1)(2012-3#1)(2013-1#3)
self-regenerating##2##1##(2008-10#2)
self-regulate##3##1##(1994-7#1)(2013-8#2)
self-regulated learning and##2##3##(2007-12#2)
self-regulated learning##4##2##(2007-12#3)(2010-4#1)
self-regulated##6##1##(2007-12#3)(2010-1#1)(2010-2#1)(2010-4#1)
self-regulating##3##1##(1995-6#1)(2008-1#1)(2009-9#1)
self-regulation and##2##2##(2006-2#1)(2008-7#1)
self-regulation model##3##2##(2008-3#1)(2009-3#1)(2010-3#1)
self-regulation of##3##2##(2007-4#1)(2010-2#1)(2012-3#1)
self-regulation##27##1##(2004-12#2)(2006-2#4)(2007-4#2)(2008-12#3)(2008-3#1)(2008-7#1)(2009-3#1)(2009-4#1)(2010-2#1)(2010-3#1)(2012-2#1)(2012-3#5)(2013-1#1)(2013-7#3)
self-regulatory##5##1##(2008-5#1)(2009-4#1)(2009-5#1)(2010-9#1)(2012-12#1)
self-reinforced composite poly(methyl methacrylate)##2##4##(2004-9#2)
self-reliance and##2##2##(2008-6#1)(2009-5#1)
self-reliance##6##1##(2006-8#3)(2008-1#1)(2008-6#1)(2009-5#1)
self-reliant##2##1##(2010-10#1)(2010-8#1)
self-renew and differentiate into##3##4##(2008-11#1)(2012-12#2)
self-renew and##5##2##(2008-1#1)(2008-10#1)(2008-11#1)(2012-12#2)
self-renew##7##1##(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-3#1)(2012-12#2)
self-renewal ability##2##2##(2008-11#1)(2012-12#1)
self-renewal and differentiation##6##3##(2006-7#1)(2008-1#1)(2008-9#1)(2009-3#1)(2009-4#1)(2012-12#1)
self-renewal and senescence##3##3##(2013-1#3)
self-renewal and the##2##3##(1990-5#1)(2012-12#1)
self-renewal and##18##2##(1990-5#1)(2006-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#2)(2009-9#1)(2012-12#4)(2013-1#3)
self-renewal capacity##5##2##(1990-9#1)(2008-6#1)(2008-9#1)(2009-12#1)(2012-12#1)
self-renewal divisions##2##2##(2009-12#1)(2012-2#1)
self-renewal in##4##2##(2007-10#1)(2008-8#1)(2009-12#1)(2012-12#1)
self-renewal of##2##2##(2008-9#1)(2011-1#1)
self-renewal##50##1##(1990-5#1)(1990-9#1)(1993-2#1)(1997-4#2)(2006-7#1)(2007-10#1)(2008-1#3)(2008-11#9)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#4)(2009-12#3)(2009-3#2)(2009-4#2)(2009-9#1)(2010-11#1)(2011-1#1)(2012-12#8)(2012-2#1)(2013-1#4)
self-renewing##7##1##(1995-11#1)(2008-1#1)(2012-12#1)(2013-1#4)
self-replicating spots##2##2##(1997-6#1)(2006-10#1)
self-replicating##9##1##(1993-2#1)(1995-12#2)(1997-6#1)(2006-10#1)(2008-11#1)(2008-2#2)(2008-8#1)
self-replication##5##1##(1991-3#1)(1993-2#2)(1995-12#1)(2008-10#1)
self-report and##3##2##(2008-11#1)(2010-2#1)(2011-1#1)
self-report data on##2##3##(2012-12#1)(2013-1#1)
self-report data##6##2##(2008-12#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
self-report instrument##2##2##(2008-12#1)(2013-1#1)
self-report measure of##4##3##(1997-8#1)(2007-12#1)(2010-12#1)(2012-1#1)
self-report measure##7##2##(1996-2#1)(1997-8#1)(2004-3#1)(2007-12#1)(2010-12#1)(2010-4#1)(2012-1#1)
self-report measures of##3##3##(2007-12#1)(2008-12#1)(2010-9#1)
self-report measures##13##2##(2007-12#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-9#1)(2011-2#1)(2013-1#3)
self-report of antisocial behavior##2##4##(2009-7#2)
self-report of##7##2##(1996-1#1)(2006-10#1)(2007-12#1)(2008-10#1)(2009-7#2)(2011-1#1)
self-report questionnaire##5##2##(2006-7#1)(2007-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
self-report questionnaires assessing##2##3##(2007-12#1)(2012-2#1)
self-report questionnaires##12##2##(2006-6#2)(2006-7#3)(2007-12#1)(2010-1#1)(2010-3#1)(2010-8#2)(2011-2#1)(2012-2#1)
self-report scales##5##2##(1995-11#1)(2012-11#1)(2012-2#2)(2013-1#1)
self-report##82##1##(1990-12#1)(1991-10#1)(1995-11#1)(1996-1#1)(1996-2#1)(1997-5#1)(1997-8#1)(2004-3#1)(2006-1#1)(2006-10#2)(2006-6#2)(2006-7#4)(2007-10#1)(2007-12#6)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#6)(2013-1#10)(2013-8#1)
self-reported adverse##2##2##(1991-1#1)(2008-11#1)
self-reported data##2##2##(2006-9#1)(2013-1#1)
self-reported depressed mood##2##3##(1995-1#2)
self-reported diabetes mellitus##3##3##(1990-9#2)(2008-11#1)
self-reported emotional experience##2##3##(1995-1#2)
self-reported function##2##2##(2008-12#1)(2013-1#1)
self-reported functional##2##2##(2008-3#1)(2012-3#1)
self-reported health status##4##3##(1992-9#1)(1995-12#1)(2008-10#1)(2008-8#1)
self-reported health##6##2##(1992-9#1)(1993-1#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
self-reported involvement##2##2##(2009-7#2)
self-reported leisure-time physical activity##2##4##(2010-2#2)
self-reported outcomes##2##2##(2008-2#1)(2008-7#1)
self-reported pain##2##2##(2007-2#1)(2010-12#1)
self-reported physical##5##2##(2008-4#1)(2010-2#1)(2012-2#1)(2013-1#2)
self-reported sleep##3##2##(2012-12#3)
self-reported smoking##2##2##(1994-6#1)(2013-1#1)
self-reported stress and##2##3##(2010-5#1)(2012-1#1)
self-reported stress##4##2##(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
self-reported use of##2##3##(1991-9#1)(2008-12#1)
self-reported##131##1##(1990-9#2)(1991-1#1)(1991-6#1)(1991-9#2)(1992-12#1)(1992-9#1)(1993-1#1)(1993-5#1)(1993-6#1)(1994-2#1)(1994-6#3)(1995-1#4)(1995-12#1)(1996-2#1)(1996-3#1)(2005-10#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-10#2)(2007-12#4)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#8)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-10#1)(2009-11#2)(2009-4#1)(2009-5#2)(2009-7#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#4)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#4)(2012-12#6)(2012-2#2)(2012-3#4)(2013-1#19)(2013-7#1)
self-reporting of##2##2##(1993-3#1)(2012-2#1)
self-reporting##7##1##(1993-3#1)(2010-2#3)(2011-2#1)(2012-2#1)(2013-1#1)
self-reports of##8##2##(2007-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-11#1)(2009-7#1)(2010-2#2)
self-reports were##2##2##(2006-12#1)(2012-12#1)
self-reports##17##1##(1995-12#1)(2006-12#1)(2007-2#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-2#3)(2010-4#1)(2011-2#1)(2012-12#2)
self-representations was##2##2##(2008-9#2)
self-representations##10##1##(2008-7#4)(2008-9#6)
self-reproducing##2##1##(2008-8#1)(2008-9#1)
self-reproduction##2##1##(2006-7#1)(2009-12#1)
self-respect##2##1##(1997-2#1)(2010-10#1)
self-restraint##2##1##(2007-2#1)(2008-12#1)
self-restricted T cell recognition of allo-MHC peptides##2##7##(1995-2#2)
self-restricted##3##1##(1995-2#3)
self-retaining##2##1##(1991-2#1)(1992-1#1)
self-sampling##4##1##(2006-10#4)
self-schemas and##2##2##(2010-8#2)
self-schemas##4##1##(2010-8#4)
self-seeding##3##1##(2007-12#2)(2008-3#1)
self-selected##4##1##(2008-3#1)(2008-8#1)(2011-2#1)(2012-1#1)
self-selection##3##1##(1990-6#1)(2008-8#1)(2010-3#1)
self-serving bias##2##2##(2008-5#1)(2010-2#1)
self-serving judgments##3##2##(2008-6#3)
self-serving##12##1##(2008-5#1)(2008-6#3)(2009-9#6)(2010-2#2)
self-similar##10##1##(1992-11#1)(1996-4#1)(2005-11#1)(2007-12#4)(2008-11#1)(2008-2#2)
self-similarity##6##1##(1996-4#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-8#1)
self-sorted##2##1##(2008-10#2)
self-sorting and##2##2##(2008-10#2)
self-specific##4##1##(2013-8#4)
self-splicing of the Tetrahymena##2##4##(1991-2#1)(1995-1#1)
self-splicing of the##3##3##(1991-2#1)(1995-1#1)(2011-2#1)
self-splicing##7##1##(1990-8#1)(1991-2#2)(1991-3#1)(1995-1#1)(1996-9#1)(2011-2#1)
self-starting Kerr-lens##2##2##(2007-11#1)(2007-12#1)
self-starting and##2##2##(2007-11#1)(2007-12#1)
self-starting mode-locked##3##2##(2007-12#2)(2008-3#1)
self-starting##18##1##(2007-11#3)(2007-12#13)(2008-3#2)
self-statements##7##1##(2006-6#6)(2007-7#1)
self-steepening##4##1##(2007-11#1)(2007-12#3)
self-stimulation neurons##2##2##(1994-2#2)
self-stimulation of##2##2##(1992-11#1)(1996-2#1)
self-stimulation##19##1##(1990-10#2)(1991-2#2)(1992-11#2)(1992-9#1)(1993-6#6)(1994-2#2)(1994-3#1)(1996-1#1)(1996-2#2)
self-strangulation##2##1##(2012-12#2)
self-stretching##3##1##(2010-9#3)
self-sufficiency##4##1##(1992-12#1)(1994-2#2)(2005-1#1)
self-sufficient##6##1##(1992-1#1)(1994-8#1)(1995-2#1)(2007-10#1)(2008-3#1)(2008-4#1)
self-supporting##4##1##(1994-2#1)(1996-3#1)(2010-4#2)
self-sustained oscillations##2##2##(1997-1#1)(2006-10#1)
self-sustained pH oscillations##2##3##(2006-10#2)
self-sustained##6##1##(1997-1#1)(2006-10#3)(2007-11#1)(2009-8#1)
self-sustaining##9##1##(2005-5#1)(2007-2#1)(2008-10#4)(2008-8#1)(2013-1#2)
self-synchronization##2##1##(2008-2#1)(2008-3#1)
self-synchronizing##2##1##(2007-12#1)(2008-2#1)
self-tanning formulations##2##2##(2008-5#2)
self-tanning##4##1##(2008-5#4)
self-testing##2##1##(2007-2#2)
self-tolerance to##2##2##(1995-1#1)(2005-11#1)
self-tolerance##4##1##(1994-6#1)(1995-1#1)(2005-11#1)(2012-3#1)
self-transcendence##3##1##(2006-7#2)(2007-2#1)
self-trapped beams##4##2##(2007-12#2)(2008-1#2)
self-trapped exciton##2##2##(1994-5#1)(2007-11#1)
self-trapped##16##1##(1992-8#1)(1994-5#1)(2007-11#3)(2007-12#8)(2008-1#3)
self-trapping in##2##2##(2007-12#2)
self-trapping of optical beams##2##4##(2007-12#2)
self-trapping of##5##2##(2007-12#4)(2008-1#1)
self-trapping##11##1##(2007-12#9)(2008-1#2)
self-vaginal##2##1##(2004-10#2)
self-weighted alternating trilinear decomposition (SWATLD)##2##5##(2008-10#2)
self-worth was##2##2##(2007-12#1)(2009-9#1)
self-worth##10##1##(2007-12#4)(2007-7#1)(2008-11#1)(2009-7#1)(2009-9#3)
self-written##3##1##(2007-11#1)(2007-12#2)
self/identity##2##1##(2010-4#2)
selfcare##3##1##(2009-4#1)(2011-2#2)
selfed##5##1##(2008-10#4)(2008-8#1)
selfing rate##2##2##(2008-8#2)
selfing rates and##2##3##(2008-8#1)(2008-9#1)
selfing rates##6##2##(2008-8#4)(2008-9#2)
selfing##32##1##(1995-8#1)(2006-12#1)(2007-12#1)(2007-3#1)(2008-10#4)(2008-8#9)(2008-9#10)(2013-1#5)
selfish genetic##2##2##(2012-3#1)(2013-1#1)
selfish##12##1##(2006-4#1)(2008-11#1)(2008-8#3)(2008-9#3)(2009-5#1)(2009-6#1)(2012-3#1)(2013-1#1)
selfishness is##3##2##(2008-9#3)
selfishness##6##1##(2008-9#5)(2010-2#1)
sell the##3##2##(1997-7#1)(2005-7#1)(2007-5#1)
sell##15##1##(1991-4#1)(1991-9#1)(1992-9#1)(1994-10#1)(1995-2#1)(1996-11#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-7#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-5#1)(2009-4#1)
sella syndrome##2##2##(2006-11#1)(2013-1#1)
sella##13##1##(1991-11#1)(1991-6#1)(1997-3#1)(2006-11#1)(2006-12#1)(2011-2#4)(2013-1#4)
sellae and the##2##3##(2006-12#1)(2011-2#1)
sellae##4##1##(2006-12#1)(2006-5#1)(2011-2#2)
sellar enlargement##2##2##(2007-1#2)
sellar volume##3##2##(2011-2#3)
sellar##14##1##(2007-1#3)(2011-2#3)(2012-3#5)(2013-1#2)(2013-8#1)
sellar-parasellar##3##1##(2005-9#3)
seller's##2##1##(1994-5#1)(2008-11#1)
sellers of##2##2##(1990-12#1)(2012-12#1)
sellers##3##1##(1990-12#1)(2007-8#1)(2012-12#1)
selling it##2##2##(2007-9#1)(2009-10#1)
selling medications##2##2##(2008-9#2)
selling their##2##2##(1992-5#1)(2007-2#1)
selling##17##1##(1990-7#1)(1992-2#1)(1992-5#1)(1995-1#1)(1996-1#1)(2006-4#1)(2007-2#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-9#3)(2009-10#1)(2009-6#1)(2012-1#1)(2012-12#1)
sells##6##1##(1992-9#1)(1993-5#1)(1993-8#1)(1994-10#1)(1995-2#1)(1995-8#1)
selon les##2##2##(2012-2#1)(2013-1#1)
selon##4##1##(2012-2#2)(2013-1#2)
selves##11##1##(2008-12#1)(2008-5#1)(2010-6#8)(2013-1#1)
sema##3##1##(1993-12#3)
semagenesis##2##1##(2009-8#2)
semaines##3##1##(2008-5#3)
semantic and##4##2##(1995-11#1)(2008-2#1)(2009-2#1)(2013-8#1)
semantic dementia (SD)##4##3##(2008-4#1)(2009-2#2)(2009-9#1)
semantic dementia##11##2##(2008-4#4)(2008-9#1)(2009-2#4)(2009-9#2)
semantic differential##4##2##(1991-2#1)(1993-2#1)(1993-3#1)(2012-2#1)
semantic information##5##2##(2008-2#2)(2008-4#1)(2008-7#1)(2009-2#1)
semantic intervention##3##2##(2011-1#3)
semantic knowledge##5##2##(1996-7#1)(1997-8#1)(2007-8#1)(2008-4#1)(2009-2#1)
semantic lexicon##7##2##(2008-7#1)(2013-1#6)
semantic lexicons as features##4##4##(2013-1#4)
semantic lexicons##10##2##(2013-1#10)
semantic loss on##2##3##(2008-4#2)
semantic loss##3##2##(2008-4#3)
semantic memory##3##2##(2008-5#2)(2008-6#1)
semantic network of patients with##2##5##(1996-7#2)
semantic network##5##2##(1996-7#3)(2008-7#2)
semantic networks##4##2##(1996-7#3)(2013-7#1)
semantic or##2##2##(1991-2#1)(2007-10#1)
semantic priming##3##2##(2006-3#1)(2008-10#2)
semantic processing##3##2##(1990-8#1)(1991-2#1)(1996-2#1)
semantic relatedness and similarity##4##4##(2013-1#4)
semantic relatedness##7##2##(2009-9#1)(2013-1#6)
semantic resources##4##2##(2013-1#4)
semantic retrieval##3##2##(2007-8#3)
semantic similarity##2##2##(2007-10#1)(2008-8#1)
semantic tasks##2##2##(1996-2#1)(2012-2#1)
semantic terms##4##2##(2013-1#4)
semantic types##6##2##(2008-7#2)(2013-1#4)
semantic web##2##2##(2008-7#1)(2010-8#1)
semantic##180##1##(1990-8#2)(1991-2#4)(1993-2#1)(1993-3#1)(1995-11#3)(1995-8#1)(1996-2#4)(1996-7#7)(1997-8#1)(2006-2#1)(2006-3#1)(2007-10#2)(2007-4#2)(2007-8#5)(2008-10#3)(2008-2#4)(2008-4#21)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#10)(2009-5#1)(2009-9#4)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#3)(2010-8#1)(2011-1#6)(2012-11#2)(2012-2#7)(2012-3#1)(2013-1#56)(2013-7#1)(2013-8#3)
semantically##10##1##(2008-7#1)(2009-10#1)(2009-9#2)(2010-10#1)(2010-2#1)(2010-5#1)(2012-2#1)(2013-1#2)
semantics in##2##2##(2008-4#2)
semantics##13##1##(2008-2#1)(2008-4#2)(2008-6#1)(2009-11#1)(2010-4#1)(2013-1#6)(2013-8#1)
semantics)##2##1##(2013-8#2)
semaphorin##3##1##(1993-12#1)(2008-5#1)(2010-4#1)
semaphorins##2##1##(2009-8#2)
sematilide##3##1##(1993-3#3)
semaxanib##3##1##(2005-6#3)
semen analysis##9##2##(1992-12#1)(1995-8#3)(2006-10#3)(2008-12#1)(2009-6#1)
semen and blood##3##3##(1996-6#1)(2007-8#1)(2009-10#1)
semen and its##2##3##(2009-6#1)(2013-8#1)
semen and##13##2##(1991-12#1)(1994-12#1)(1996-6#2)(2006-5#3)(2007-8#1)(2009-10#1)(2009-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
semen by##2##2##(1990-12#1)(2009-4#1)
semen during the nonbreeding season##2##5##(2006-5#2)
semen during##4##2##(2006-5#3)(2010-7#1)
semen from##3##2##(1991-8#1)(2006-5#1)(2008-6#1)
semen is##2##2##(2006-5#2)
semen of##9##2##(1993-2#1)(2006-5#1)(2007-8#1)(2008-12#2)(2010-8#3)(2013-1#1)
semen on embryo viability and early pregnancy rate##2##8##(2006-5#2)
semen pH##2##2##(2008-7#2)
semen parameters and##2##3##(2006-5#1)(2008-10#1)
semen parameters in##2##3##(2007-10#1)(2010-12#1)
semen parameters##5##2##(1995-8#1)(2006-5#1)(2007-10#1)(2008-10#1)(2010-12#1)
semen prepared from bucks of the Damascus breed than from bucks of##2##12##(2006-5#2)
semen quality##7##2##(1996-9#1)(2006-5#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-2#1)(2010-7#1)
semen sample##3##2##(2006-5#1)(2006-8#1)(2007-12#1)
semen samples were collected##2##4##(2008-10#1)(2008-3#1)
semen samples were##4##3##(2008-10#1)(2008-12#1)(2008-3#1)(2013-8#1)
semen samples##12##2##(2006-5#5)(2007-12#2)(2008-10#1)(2008-12#1)(2008-3#1)(2012-2#1)(2013-8#1)
semen test samples##2##3##(2006-5#2)
semen test##3##2##(2006-5#3)
semen to##2##2##(1991-9#1)(2006-5#1)
semen volume##4##2##(2008-7#4)
semen was##7##2##(2006-5#6)(2012-3#1)
semen with##2##2##(2007-10#1)(2009-6#1)
semen##154##1##(1990-11#1)(1990-12#2)(1991-12#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-2#1)(1993-7#3)(1994-12#1)(1994-8#1)(1995-8#4)(1996-6#2)(1996-9#1)(1997-6#1)(1997-8#1)(2005-7#2)(2006-10#3)(2006-5#59)(2006-8#3)(2007-10#2)(2007-11#1)(2007-12#6)(2007-8#2)(2008-10#3)(2008-12#6)(2008-3#1)(2008-6#1)(2008-7#8)(2009-10#1)(2009-4#2)(2009-6#4)(2010-12#2)(2010-2#1)(2010-7#4)(2010-8#4)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#4)
semen-transport##2##1##(2006-5#2)
semeniperda##7##1##(2008-10#7)
semester of##4##2##(1991-12#1)(2009-3#1)(2012-3#2)
semester##19##1##(1991-12#1)(2007-10#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#1)(2009-3#1)(2010-3#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#3)(2013-8#1)
semesters##3##1##(1996-1#1)(2008-3#1)(2010-3#1)
semi structured##5##2##(2007-10#1)(2008-4#1)(2011-1#1)(2012-12#1)(2013-8#1)
semi##7##1##(1991-2#1)(2007-10#1)(2008-4#1)(2009-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
semi-##2##1##(2007-11#1)(2013-1#1)
semi-analytical##2##1##(2006-10#1)(2007-12#1)
semi-aquatic##2##1##(2007-12#1)(2013-8#1)
semi-arid eco-system##3##2##(2011-12#3)
semi-arid##11##1##(1993-5#1)(2007-3#3)(2008-8#1)(2010-10#1)(2011-12#4)(2012-9#1)
semi-automated##20##1##(1997-8#1)(2006-5#1)(2008-10#6)(2008-4#1)(2009-10#1)(2010-12#1)(2012-12#1)(2013-1#8)
semi-automatic##9##1##(1993-4#1)(1993-8#2)(1995-8#1)(2008-10#1)(2008-9#1)(2012-2#1)(2013-1#2)
semi-batch##7##1##(2007-11#2)(2008-10#3)(2009-10#1)(2010-5#1)
semi-closed##4##1##(2006-6#2)(2011-2#2)
semi-continuous monitoring##2##2##(1996-7#1)(2007-8#1)
semi-continuous##8##1##(1996-7#2)(2006-5#1)(2007-8#2)(2008-10#1)(2008-7#1)(2009-3#1)
semi-controlled##5##1##(1996-12#1)(2008-5#4)
semi-crystalline##2##1##(2007-11#1)(2013-7#1)
semi-deep and deep tillage##3##4##(2008-12#3)
semi-deep tillage##2##2##(2008-12#2)
semi-deep##6##1##(2008-12#6)
semi-defined##2##1##(2008-10#1)(2008-5#1)
semi-definite tensors##2##2##(2013-1#2)
semi-dilute##3##1##(2009-10#3)
semi-dilute&quot##2##1##(1991-7#2)
semi-dwarf##3##1##(2008-9#3)
semi-dwarfing##2##1##(2008-10#2)
semi-empirical##11##1##(1990-9#1)(1992-4#1)(1994-12#1)(1995-3#1)(1997-2#1)(2005-11#2)(2008-7#1)(2008-9#1)(2011-3#1)(2013-8#1)
semi-ground Purina chow food and drinking water##2##7##(1991-2#2)
semi-ground Purina chow food##5##4##(1991-2#5)
semi-implantable##2##1##(2008-9#2)
semi-implicit##2##1##(2008-6#1)(2013-8#1)
semi-independent##2##1##(1992-9#1)(2010-12#1)
semi-infinite and finite-thickness media##2##4##(2008-2#2)
semi-infinite and homogeneous##2##3##(2008-2#2)
semi-infinite and##5##2##(2008-2#4)(2008-3#1)
semi-infinite media##2##2##(2008-2#2)
semi-infinite medium##3##2##(2007-11#1)(2008-2#2)
semi-infinite turbid##3##2##(2008-2#2)(2008-3#1)
semi-infinite##19##1##(2007-11#1)(2008-10#1)(2008-2#13)(2008-3#4)
semi-insulating GaAs##2##2##(2007-12#1)(2008-2#1)
semi-insulating##5##1##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
semi-liquid core microcapsules##2##3##(2008-11#2)
semi-natural conditions##3##2##(2008-7#1)(2010-8#2)
semi-natural##6##1##(1993-9#2)(2008-7#1)(2008-8#1)(2010-8#2)
semi-nomadic##2##1##(2005-9#1)(2011-2#1)
semi-numeric method##3##2##(2008-2#3)
semi-permanent make up##2##3##(2007-1#2)
semi-permanent##4##1##(2007-1#2)(2008-5#1)(2013-7#1)
semi-permeabilized##2##1##(2008-1#2)
semi-preparative scale##2##2##(2008-10#2)
semi-preparative##5##1##(1990-8#1)(2008-10#3)(2008-5#1)
semi-proportional hazards model##2##3##(1996-8#2)
semi-purified diets containing##3##3##(1991-2#1)(1996-11#1)(2009-4#1)
semi-purified##4##1##(1991-2#1)(1994-12#1)(1996-11#1)(2009-4#1)
semi-quantitative PCR technique##2##3##(1993-12#2)
semi-quantitative PCR##5##2##(1993-12#2)(1994-10#1)(1994-11#1)(2011-2#1)
semi-quantitative RT-PCR and##2##3##(2008-8#1)(2011-3#1)
semi-quantitative RT-PCR##10##2##(1994-12#1)(1997-5#1)(2004-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#2)(2011-3#1)(2013-1#1)
semi-quantitative analysis of##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
semi-quantitative analysis##4##2##(2008-10#1)(2008-2#1)(2008-4#1)(2013-7#1)
semi-quantitative calibration##2##2##(2008-10#2)
semi-quantitative detection of##2##3##(2008-10#1)(2013-7#1)
semi-quantitative##46##1##(1993-12#3)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-4#1)(1997-3#1)(1997-5#1)(1997-7#1)(2004-12#1)(2005-10#1)(2006-10#1)(2007-3#1)(2007-6#1)(2008-10#11)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2011-2#4)(2011-3#1)(2013-1#3)(2013-7#2)
semi-quantum dielectric function models##2##4##(2007-12#2)
semi-random mutagenesis##2##2##(1992-8#2)
semi-rigid catheters##2##2##(2007-7#2)
semi-rigid##8##1##(1995-11#2)(1995-5#1)(2006-5#1)(2007-6#1)(2007-7#3)
semi-solid##7##1##(2008-4#1)(2008-5#2)(2008-8#1)(2009-10#1)(2012-12#2)
semi-static and PGA-alginate##3##3##(2011-2#3)
semi-static and##4##2##(2011-2#4)
semi-static seeding##2##2##(2011-2#2)
semi-static##6##1##(2011-2#6)
semi-structured interview guide##2##3##(2008-4#1)(2011-1#1)
semi-structured interview##9##2##(2006-8#1)(2008-1#1)(2008-4#1)(2010-6#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-3#2)
semi-structured interviews and##4##3##(2007-10#1)(2007-9#1)(2011-2#1)(2013-8#1)
semi-structured interviews conducted with##3##4##(2008-1#1)(2013-1#2)
semi-structured interviews were conducted with##3##5##(2008-12#1)(2013-1#2)
semi-structured interviews were##4##3##(2008-1#1)(2008-12#1)(2013-1#2)
semi-structured interviews with##13##3##(1996-1#1)(2006-7#2)(2008-12#2)(2008-6#1)(2009-10#2)(2012-12#1)(2013-1#4)
semi-structured interviews##41##2##(1991-6#1)(1996-1#1)(2005-2#1)(2006-7#2)(2007-10#2)(2007-12#2)(2007-9#1)(2008-1#3)(2008-12#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#2)(2009-12#2)(2009-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#1)
semi-structured questionnaire##4##2##(2007-3#1)(2008-10#1)(2008-2#1)(2012-12#1)
semi-structured questionnaires##2##2##(2008-1#1)(2008-7#1)
semi-structured##70##1##(1991-6#1)(1995-1#1)(1996-1#1)(2005-2#1)(2006-10#1)(2006-7#2)(2006-8#1)(2007-10#2)(2007-12#2)(2007-3#1)(2007-9#1)(2008-1#6)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#2)(2009-12#2)(2009-4#1)(2009-7#1)(2010-6#1)(2011-1#4)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#4)(2012-3#3)(2013-1#11)(2013-7#1)(2013-8#2)
semi-supervised learning based method##2##4##(2010-7#2)
semi-supervised learning##4##2##(2010-7#4)
semi-synthesized##2##1##(2012-3#2)
semi-synthetic##6##1##(1993-2#1)(1994-6#1)(2006-10#1)(2009-8#1)(2012-3#1)(2013-1#1)
semi-thin sections##2##2##(1997-2#1)(2007-12#1)
semi-thin##3##1##(1997-2#2)(2007-12#1)
semi-treated##2##1##(2008-10#1)(2008-5#1)
semi-urban and rural##2##3##(2006-8#1)(2011-2#1)
semi-urban##5##1##(1997-4#1)(2006-8#2)(2008-3#1)(2011-2#1)
semi-volatile##3##1##(2008-10#1)(2009-8#2)
semialdehyde dehydrogenase##3##2##(2006-3#2)(2008-11#1)
semialdehyde reductase##5##2##(1997-2#5)
semialdehyde##15##1##(1991-7#1)(1997-2#7)(2006-3#4)(2008-11#1)(2010-4#2)
semialdehydes##2##1##(2010-4#2)
semianalytical##4##1##(2008-2#3)(2008-3#1)
semiarid##9##1##(2006-10#1)(2007-3#3)(2008-8#3)(2008-9#1)(2013-8#1)
semiautomated##8##1##(1991-3#1)(1994-6#2)(2007-4#2)(2008-4#2)(2008-9#1)
semiautomatic##4##1##(1993-8#1)(1996-1#1)(2008-10#1)(2008-7#1)
semiautonomous##2##1##(2010-2#2)
semicarbazide and hydrazine in##3##4##(2008-10#3)
semicarbazide and hydrazine##6##3##(2008-10#6)
semicarbazide and##7##2##(2007-11#1)(2008-10#6)
semicarbazide##14##1##(1990-12#1)(1991-2#1)(2007-11#2)(2008-10#9)(2010-12#1)
semicarbazide-sensitive amine oxidase##2##3##(1995-1#2)
semicarbazone##4##1##(2006-12#1)(2007-11#1)(2008-5#2)
semicarbazones or hydrazones##2##3##(2007-11#2)
semicarbazones were##2##2##(2008-5#1)(2010-12#1)
semicarbazones##6##1##(2007-11#3)(2008-5#2)(2010-12#1)
semicircular canal##6##2##(2006-12#4)(2011-1#1)(2013-1#1)
semicircular canals##3##2##(1992-9#1)(1995-12#1)(2008-9#1)
semicircular##19##1##(1992-4#1)(1992-9#1)(1995-12#1)(2006-10#1)(2006-12#4)(2006-6#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-2#2)(2013-1#2)
semiclassical##8##1##(1992-8#1)(1995-10#1)(1995-5#1)(1996-5#1)(2007-12#1)(2008-1#1)(2008-2#1)(2010-7#1)
semiconducting and metallic SWNTs##2##4##(2008-10#1)(2010-7#1)
semiconducting and metallic##4##3##(2008-10#1)(2009-6#1)(2010-7#2)
semiconducting and##5##2##(2008-10#1)(2009-6#1)(2010-7#3)
semiconducting behaviour##2##2##(2008-7#1)(2010-12#1)
semiconducting polymer##2##2##(2008-7#2)
semiconducting thin##2##2##(2008-10#1)(2008-2#1)
semiconducting##21##1##(2006-12#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-7#5)(2009-2#1)(2009-6#2)(2010-12#1)(2010-7#5)
semiconductor (CMOS)##2##2##(2008-3#1)(2008-7#1)
semiconductor QDs in##2##3##(2009-10#2)
semiconductor amplifier##3##2##(2007-12#3)
semiconductor coupled-waveguide structures##2##3##(2008-3#2)
semiconductor crystals##4##2##(2007-11#3)(2007-12#1)
semiconductor diode laser##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
semiconductor diode lasers##3##3##(2007-11#1)(2007-12#2)
semiconductor diode##7##2##(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#1)
semiconductor elements##2##2##(1997-3#2)
semiconductor fiber ring laser##2##4##(2007-12#2)
semiconductor guiding layer##2##3##(2008-3#2)
semiconductor industry##5##2##(1997-3#1)(2006-12#1)(2008-10#1)(2008-7#2)
semiconductor is##4##2##(1990-11#1)(2007-11#1)(2007-12#1)(2008-7#1)
semiconductor laser Michelson interferometer##2##4##(2008-3#2)
semiconductor laser and##3##3##(2008-2#1)(2008-3#2)
semiconductor laser arrays##2##3##(2007-11#1)(2007-12#1)
semiconductor laser as a##2##4##(2007-11#1)(2008-10#1)
semiconductor laser by##3##3##(2007-11#1)(2007-12#2)
semiconductor laser diode##3##3##(2007-11#1)(2008-3#2)
semiconductor laser diodes##2##3##(2007-12#1)(2008-3#1)
semiconductor laser locked directly to an##2##6##(2007-12#2)
semiconductor laser radar##2##3##(2008-3#2)
semiconductor laser under intermodal injection locking##2##6##(2007-12#2)
semiconductor laser with an##2##4##(2008-3#2)
semiconductor laser with##5##3##(2007-12#2)(2008-3#3)
semiconductor laser##76##2##(2007-11#12)(2007-12#35)(2007-8#1)(2008-10#2)(2008-2#7)(2008-3#19)
semiconductor lasers is experimentally##2##4##(2007-12#2)
semiconductor lasers is##3##3##(2007-12#3)
semiconductor lasers with optical feedback##3##5##(2007-11#1)(2007-12#2)
semiconductor lasers with##6##3##(2007-11#1)(2007-12#4)(2008-2#1)
semiconductor lasers##35##2##(2007-11#8)(2007-12#19)(2008-2#5)(2008-3#3)
semiconductor material##2##2##(2005-4#1)(2007-12#1)
semiconductor materials##5##2##(1991-11#1)(2007-11#2)(2007-12#1)(2008-3#1)
semiconductor mirror##2##2##(2007-11#1)(2007-12#1)
semiconductor modulator##3##2##(2007-11#1)(2007-12#2)
semiconductor nanocrystals to a fused-silica microsphere##2##6##(2007-12#2)
semiconductor nanocrystals##6##2##(2007-12#5)(2008-7#1)
semiconductor nanostructures##3##2##(2007-12#1)(2008-7#2)
semiconductor optical amplifier (SOA) is##2##5##(2007-12#2)
semiconductor optical amplifier as the##2##5##(2007-12#1)(2008-1#1)
semiconductor optical amplifier as##3##4##(2007-12#2)(2008-1#1)
semiconductor optical amplifier device##2##4##(2007-12#2)
semiconductor optical amplifier##17##3##(2007-11#1)(2007-12#13)(2008-1#2)(2008-3#1)
semiconductor optical amplifier-based##2##3##(2007-12#1)(2008-1#1)
semiconductor optical amplifiers##11##3##(2007-11#2)(2007-12#4)(2008-1#4)(2008-2#1)
semiconductor optical##35##2##(2007-11#3)(2007-12#22)(2008-1#7)(2008-2#1)(2008-3#2)
semiconductor quantum devices##2##3##(2007-12#2)
semiconductor quantum dots##8##3##(1995-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#4)
semiconductor quantum well##2##3##(1995-2#1)(2007-12#1)
semiconductor quantum##13##2##(1995-2#1)(1995-3#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-7#4)(2010-2#1)
semiconductor resonator##3##2##(2007-12#3)
semiconductor ring lasers##2##3##(2007-11#2)
semiconductor saturable absorber mirror##3##4##(2007-11#2)(2007-12#1)
semiconductor saturable absorber##8##3##(2007-11#2)(2007-12#5)(2008-2#1)
semiconductor saturable absorbers##2##3##(2007-12#2)
semiconductor saturable##12##2##(2007-11#3)(2007-12#7)(2008-2#1)(2008-3#1)
semiconductor saturable-absorber mirror and emits##2##5##(2007-11#1)(2007-12#1)
semiconductor saturable-absorber mirror for##2##4##(2007-12#2)
semiconductor saturable-absorber mirror##14##3##(2007-11#2)(2007-12#11)(2008-3#1)
semiconductor saturable-absorber##16##2##(2007-11#2)(2007-12#13)(2008-3#1)
semiconductor sensor for##2##3##(2008-10#2)
semiconductor sensor##4##2##(2008-10#4)
semiconductor superlattices##2##2##(1995-11#2)
semiconductor surface##2##2##(1992-2#1)(2008-3#1)
semiconductor technology##3##2##(1995-11#1)(2008-2#1)(2008-7#1)
semiconductor thin films and##3##4##(2008-2#3)
semiconductor thin films##4##3##(2008-2#4)
semiconductor transducer##2##2##(2008-10#2)
semiconductor wafer##2##2##(2007-12#1)(2008-10#1)
semiconductor waveguide##3##2##(2007-12#2)(2008-3#1)
semiconductor waveguides##2##2##(2008-3#2)
semiconductor with##2##2##(2007-12#1)(2012-2#1)
semiconductor##359##1##(1990-11#1)(1990-12#1)(1991-11#1)(1992-2#1)(1995-11#3)(1995-2#1)(1995-3#1)(1997-3#3)(1997-8#1)(2005-4#1)(2006-12#5)(2007-11#51)(2007-12#147)(2007-8#2)(2008-1#10)(2008-10#18)(2008-11#1)(2008-2#30)(2008-3#46)(2008-5#1)(2008-7#18)(2008-8#4)(2009-10#2)(2009-5#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-7#1)(2012-2#5)
semiconductor-##2##1##(2007-12#1)(2008-3#1)
semiconductor-based##2##1##(2007-12#1)(2008-3#1)
semiconductor-doped##2##1##(2007-11#1)(2007-12#1)
semiconductor-laser-based##2##1##(2008-1#1)(2008-3#1)
semiconductors in##2##2##(2007-12#1)(2008-7#1)
semiconductors on##2##2##(2007-12#1)(2008-7#1)
semiconductors with##2##2##(1995-2#1)(2008-7#1)
semiconductors##37##1##(1990-5#1)(1992-8#1)(1995-2#1)(1996-5#1)(2006-12#7)(2006-2#1)(2006-4#1)(2007-11#3)(2007-12#6)(2007-8#1)(2007-9#3)(2008-3#4)(2008-7#5)(2008-9#1)(2012-2#1)
semiconductors)##2##1##(1990-5#1)(2008-2#1)
semiconfocal##2##1##(2008-2#2)
semicontinuous fermentation with##2##3##(2008-5#2)
semicontinuous fermentation##7##2##(2008-5#4)(2008-6#3)
semicontinuous##12##1##(1992-8#1)(1994-11#1)(2005-11#1)(2008-11#1)(2008-5#4)(2008-6#3)(2008-7#1)
semideciduous tropical forest##2##3##(2008-5#2)
semidefined##2##1##(2008-5#2)
semidehydroascorbate##4##1##(1992-6#4)
semiderivative##3##1##(2008-2#3)
semidian##3##1##(2009-6#3)
semidominant##3##1##(1997-1#1)(2008-10#2)
semiempirical calculations##3##2##(1996-8#1)(1997-1#1)(2008-10#1)
semiempirical molecular orbital method##2##4##(2007-11#1)(2008-11#1)
semiempirical molecular orbital methods##4##4##(2012-12#4)
semiempirical molecular orbital##8##3##(1995-1#1)(2006-10#1)(2007-11#1)(2008-11#1)(2012-12#4)
semiempirical##23##1##(1995-1#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-4#2)(2007-10#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#2)(2012-12#4)
semigestructureerde interviews##2##2##(2012-12#2)
semilaevis##4##1##(2010-8#3)(2013-8#1)
semilobar HPE##2##2##(1996-12#1)(2011-1#1)
semilobar##3##1##(1996-12#1)(2011-1#2)
semilogarithmic##2##1##(1992-8#2)
semilunar##4##1##(2008-4#1)(2009-8#1)(2011-1#1)(2013-1#1)
semimechanistic models##2##2##(2008-9#2)
semimembranosus (SM)##3##2##(2010-4#3)
semimembranosus##4##1##(2010-4#4)
semimonolithic##4##1##(2007-12#1)(2008-3#3)
seminal RNase##4##2##(1990-5#4)
seminal and adventitious roots##2##4##(2008-10#2)
seminal and adventitious##3##3##(2008-10#3)
seminal and##4##2##(2008-10#3)(2013-1#1)
seminal articles that##2##3##(2006-4#1)(2010-7#1)
seminal characteristics of##3##3##(1991-6#1)(2008-5#2)
seminal characteristics##5##2##(1991-6#2)(2008-5#2)(2009-4#1)
seminal fluid##16##2##(1990-2#1)(1991-11#1)(1992-2#1)(1995-1#1)(1997-8#1)(2006-8#3)(2007-7#1)(2010-8#4)(2011-1#2)(2011-2#1)
seminal gamma-GTP##3##2##(1995-11#3)
seminal granules##2##2##(2006-5#2)
seminal or adventitious roots##3##4##(2008-10#3)
seminal plasma by##2##3##(2006-5#1)(2013-8#1)
seminal plasma is##2##3##(1990-5#1)(2013-8#1)
seminal plasma of O##2##4##(2010-8#2)
seminal plasma of##4##3##(2008-10#1)(2010-8#3)
seminal plasma##23##2##(1990-5#2)(1992-2#1)(1994-3#2)(1994-6#1)(1995-5#1)(2006-5#2)(2008-10#4)(2010-4#1)(2010-8#5)(2013-8#4)
seminal receptacle##5##2##(2008-7#5)
seminal roots##4##2##(2008-10#3)(2008-9#1)
seminal vesicle tissue##2##3##(1992-2#2)
seminal vesicle##11##2##(1992-2#2)(1995-3#1)(2008-11#4)(2011-2#4)
seminal vesicles##14##2##(1991-2#1)(1991-4#1)(1992-2#1)(1994-2#1)(1997-8#2)(2008-12#1)(2008-5#1)(2008-7#3)(2012-12#3)
seminal work##2##2##(1995-1#1)(2006-10#1)
seminal##128##1##(1990-2#1)(1990-5#6)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-6#2)(1992-2#5)(1994-2#3)(1994-3#3)(1994-6#1)(1995-1#2)(1995-11#6)(1995-3#1)(1995-5#1)(1997-4#1)(1997-8#4)(2005-10#1)(2005-7#1)(2006-10#3)(2006-4#2)(2006-5#4)(2006-8#4)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#14)(2008-11#4)(2008-12#2)(2008-5#3)(2008-7#8)(2008-9#4)(2009-4#1)(2010-4#1)(2010-7#1)(2010-8#10)(2011-1#4)(2011-2#8)(2012-12#3)(2013-1#1)(2013-8#5)
seminalplasmin##2##1##(1993-3#2)
seminar and##3##2##(1990-3#1)(1994-1#1)(2005-9#1)
seminar in##6##2##(1993-1#1)(2007-9#1)(2010-1#4)
seminar involving##2##2##(1995-1#1)(2008-2#1)
seminar on##3##2##(1996-2#1)(2008-1#1)(2008-4#1)
seminar program##4##2##(1994-1#2)(2010-1#2)
seminar##38##1##(1990-2#1)(1990-3#1)(1993-1#2)(1994-1#5)(1994-2#1)(1995-1#1)(1996-2#1)(1996-3#1)(2005-7#1)(2005-8#1)(2005-9#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-12#3)(2008-2#1)(2008-4#1)(2009-9#1)(2010-1#7)(2010-10#1)(2011-2#1)(2013-8#1)
seminars and##4##2##(1992-3#1)(1993-2#1)(1994-12#1)(2005-9#1)
seminars for##3##2##(1994-12#1)(1996-3#1)(2011-1#1)
seminars on##3##2##(2005-8#1)(2008-1#1)(2010-8#1)
seminars or##2##2##(1994-1#1)(2005-9#1)
seminars##27##1##(1991-2#1)(1992-3#1)(1993-2#1)(1994-1#3)(1994-12#3)(1994-9#3)(1996-3#1)(2004-8#1)(2005-7#1)(2005-8#1)(2005-9#2)(2008-1#1)(2010-1#2)(2010-8#1)(2011-1#2)(2011-2#1)(2013-8#2)
seminiferous epithelium and##3##3##(2006-5#1)(2009-10#1)(2012-2#1)
seminiferous epithelium##31##2##(1990-9#1)(2006-5#1)(2009-10#16)(2012-2#12)(2013-8#1)
seminiferous tubular##3##2##(1995-6#1)(2008-4#2)
seminiferous tubule##6##2##(2008-5#1)(2009-10#2)(2012-2#2)(2013-1#1)
seminiferous tubules from rats of##2##5##(1993-7#1)(1995-6#1)
seminiferous tubules##14##2##(1991-4#1)(1993-7#1)(1995-6#2)(2006-5#1)(2007-9#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#3)(2010-4#1)(2013-8#1)
seminiferous##59##1##(1990-9#1)(1991-4#1)(1993-7#1)(1995-6#3)(2006-5#2)(2007-9#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#23)(2010-4#1)(2012-2#17)(2013-1#1)(2013-8#2)
seminogram parameters##3##2##(2013-8#3)
seminoma and##3##2##(1990-9#1)(1997-3#1)(2008-6#1)
seminoma in##2##2##(2008-5#2)
seminoma of the##2##3##(1994-4#1)(2011-1#1)
seminoma of##3##2##(1994-4#1)(2007-5#1)(2011-1#1)
seminoma patients##2##2##(1991-9#1)(2008-6#1)
seminoma##30##1##(1990-9#1)(1991-9#1)(1994-4#2)(1995-5#1)(1995-8#1)(1996-8#1)(1997-3#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-5#1)(2007-9#1)(2008-5#3)(2008-6#10)(2011-1#3)
seminoma]##3##1##(1994-3#1)(1997-3#1)(1997-6#1)
seminomas and##4##2##(1995-5#2)(2012-2#2)
seminomas##8##1##(1994-4#1)(1995-5#2)(2007-5#1)(2008-6#1)(2011-2#1)(2012-2#2)
semiologic##2##1##(2008-5#2)
semiology of##2##2##(2008-7#1)(2012-2#1)
semiology##3##1##(2008-7#1)(2012-2#1)(2012-3#1)
semiotics of##5##2##(1991-5#1)(2008-7#3)(2013-7#1)
semiotics##6##1##(1991-5#1)(2008-7#4)(2013-7#1)
semiparametric and parametric##2##3##(2010-2#1)(2011-1#1)
semiparametric methods##3##2##(2010-7#3)
semiparametric model##4##2##(1996-2#1)(2010-11#2)(2011-1#1)
semiparametric##24##1##(1996-2#1)(2008-11#1)(2008-8#1)(2009-5#1)(2010-11#2)(2010-2#5)(2010-4#1)(2010-5#2)(2010-7#6)(2010-8#1)(2011-1#2)(2012-3#1)
semiparametrics##2##1##(2010-7#2)
semipenetrans and##2##2##(2008-10#2)
semipenetrans##3##1##(2008-10#3)
semiperiodic zones##3##2##(2007-11#2)(2007-12#1)
semipermanent##4##1##(2006-4#1)(2008-4#1)(2008-5#2)
semipermeable membrane devices##2##3##(2004-4#2)
semipermeable membrane into##2##3##(1997-1#1)(2010-2#1)
semipermeable membrane##7##2##(1997-1#1)(2004-4#2)(2007-9#1)(2008-11#1)(2008-7#1)(2010-2#1)
semipermeable##8##1##(1997-1#1)(2004-4#2)(2007-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-2#1)
semipreparative##3##1##(1990-12#1)(1991-10#1)(2008-11#1)
semipurified##3##1##(1990-5#1)(1990-6#1)(1992-3#1)
semiquantitation of##3##2##(1994-11#1)(2008-4#2)
semiquantitative RT-PCR##2##2##(1991-4#1)(1995-11#1)
semiquantitative analysis of##2##3##(1997-3#1)(2008-10#1)
semiquantitative determination of##2##3##(2008-10#1)(2011-2#1)
semiquantitative evaluation of##2##3##(2007-12#1)(2008-10#1)
semiquantitative morphometric##2##2##(1990-3#1)(1995-12#1)
semiquantitative##22##1##(1990-3#1)(1991-4#1)(1992-11#1)(1993-12#1)(1995-11#2)(1995-12#2)(1997-3#1)(1997-6#1)(2007-12#1)(2007-9#2)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
semiquantitatively##5##1##(1991-5#1)(1996-12#2)(2006-10#1)(2008-5#1)
semiquinone and##2##2##(1991-4#1)(1994-8#1)
semiquinone form##2##2##(1990-7#1)(2008-10#1)
semiquinone radical##2##2##(1990-5#1)(1994-8#1)
semiquinone##13##1##(1990-5#1)(1990-7#1)(1991-4#1)(1992-6#1)(1993-8#1)(1994-8#3)(1995-5#2)(2006-6#1)(2008-10#2)
semiquinones##3##1##(1994-8#1)(1996-2#1)(1997-8#1)
semirigid##6##1##(1991-2#1)(2012-12#5)
semiselective agar medium##3##3##(2008-10#3)
semiselective medium##6##2##(2008-10#6)
semiselective##12##1##(2008-10#12)
semisolid##10##1##(1993-8#1)(1995-2#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-5#5)
semistructured interview##5##2##(2004-3#1)(2007-8#1)(2008-1#1)(2010-9#1)(2011-2#1)
semistructured interviews with##5##3##(2009-4#1)(2010-11#1)(2010-8#1)(2011-1#1)(2013-1#1)
semistructured interviews##11##2##(2006-9#1)(2007-2#1)(2007-3#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#2)(2013-1#1)
semistructured questionnaire##3##2##(2004-12#1)(2006-2#1)(2007-11#1)
semistructured##27##1##(1993-3#1)(1997-2#1)(2004-12#1)(2004-3#1)(2005-10#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#1)(2009-4#1)(2009-5#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#3)(2013-1#1)
semisum##2##1##(2007-11#2)
semisynthesis##2##1##(1991-7#1)(1992-3#1)
semisynthetic derivatives##2##2##(2006-10#1)(2009-12#1)
semisynthetic diet##2##2##(1992-12#1)(1993-9#1)
semisynthetic##15##1##(1992-12#1)(1993-8#2)(1993-9#2)(1994-8#1)(1996-6#1)(2006-10#1)(2008-10#2)(2009-12#1)(2009-2#2)(2010-12#1)(2011-1#1)
semitaeniatus and T##2##3##(2008-7#2)
semitaeniatus and##3##2##(2008-7#3)
semitendinosus##4##1##(2013-1#4)
semithin sections##4##2##(1992-12#1)(1997-5#1)(1997-7#2)
semithin##6##1##(1992-12#1)(1993-11#1)(1997-5#1)(1997-7#2)(2011-2#1)
semitransparent##7##1##(2007-12#1)(2008-2#1)(2008-3#5)
semivariance##2##1##(2008-10#2)
semivariogram analysis##2##2##(2008-10#1)(2008-11#1)
semivariogram parameters##2##2##(2008-10#2)
semivariogram##6##1##(1997-2#1)(2008-10#4)(2008-11#1)
semivolatile compounds##2##2##(2008-10#2)
semivolatile##6##1##(1994-9#1)(2008-10#5)
semivolatiles##3##1##(2008-10#3)
sempervirens##3##1##(2006-12#3)
senS and##2##2##(1993-6#2)
senS##7##1##(1993-6#7)
senators##2##1##(1990-4#1)(1996-11#1)
send information##3##2##(1995-1#1)(1996-9#2)
send their##2##2##(2007-12#1)(2011-2#1)
send to the##2##3##(1990-4#1)(1997-5#1)
send##30##1##(1990-12#1)(1990-4#1)(1990-7#2)(1991-3#1)(1991-9#1)(1993-7#2)(1994-12#1)(1995-1#1)(1995-11#1)(1996-5#1)(1996-9#2)(1997-5#1)(2004-9#1)(2006-10#2)(2006-7#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-4#1)(2008-9#1)(2011-12#1)(2011-2#2)(2012-3#1)
sender and receiver##2##3##(2007-11#1)(2009-4#1)
senders##4##1##(2009-4#2)(2013-1#2)
sending a##2##2##(1995-11#1)(2008-1#1)
sending##9##1##(1991-10#1)(1995-11#1)(1996-9#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-4#2)(2013-1#1)
sends a##2##2##(1992-5#1)(2009-1#1)
sends signals##2##2##(2008-11#2)
sends##14##1##(1990-12#1)(1992-5#1)(1995-11#1)(1997-7#1)(2007-12#2)(2008-11#2)(2008-3#1)(2009-1#3)(2009-10#2)
senecionine in##2##2##(1991-7#2)
senecionine##8##1##(1991-7#7)(2007-1#1)
senegalensis##5##1##(2008-3#1)(2010-8#4)
senesced leaves##3##2##(2008-10#2)(2008-5#1)
senesced##5##1##(2008-10#3)(2008-5#1)(2013-1#1)
senescence accelerated mouse##2##3##(1991-12#2)
senescence accelerated##7##2##(1991-12#2)(1992-10#3)(2008-7#2)
senescence and##13##2##(1990-9#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-8#3)(2010-2#1)
senescence as##2##2##(2008-8#1)(2009-12#1)
senescence at##2##2##(1990-4#1)(2009-8#1)
senescence in vitro is##2##4##(1990-9#2)
senescence in vitro##3##3##(1990-9#2)(2009-8#1)
senescence in##17##2##(1990-5#1)(1990-9#2)(1994-11#1)(1994-9#1)(1997-7#1)(2006-12#2)(2008-1#1)(2008-3#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#2)(2011-2#1)(2012-3#1)
senescence is##4##2##(2006-12#1)(2008-11#2)(2008-9#1)
senescence marker##3##2##(1996-7#2)(2011-2#1)
senescence of human##2##3##(1993-11#1)(1994-5#1)
senescence of the##2##3##(2008-10#2)
senescence of##6##2##(1992-9#1)(1993-11#1)(1994-5#1)(2006-12#1)(2008-10#2)
senescence or##2##2##(2007-11#1)(2008-8#1)
senescence pathways##4##2##(2012-3#2)(2013-1#2)
senescence phenotype##2##2##(1997-7#1)(2006-12#1)
senescence to##2##2##(1991-6#1)(2012-3#1)
senescence was##2##2##(1996-9#1)(2012-12#1)
senescence##166##1##(1990-10#4)(1990-11#1)(1990-4#3)(1990-5#3)(1990-9#3)(1991-1#1)(1991-12#3)(1991-4#1)(1991-6#3)(1991-8#1)(1992-10#3)(1992-12#1)(1992-8#1)(1992-9#3)(1993-11#3)(1993-12#1)(1994-11#1)(1994-5#4)(1994-6#3)(1994-9#1)(1995-11#1)(1995-2#1)(1995-8#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-7#2)(1996-9#1)(1997-6#1)(1997-7#4)(2006-10#2)(2006-12#13)(2007-11#1)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#13)(2008-12#1)(2008-3#4)(2008-7#6)(2008-8#8)(2008-9#8)(2009-12#1)(2009-4#2)(2009-5#2)(2009-8#9)(2010-2#1)(2010-3#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#8)(2013-1#9)(2013-7#1)(2013-8#1)
senescence-accelerated mouse (SAM)-P/8##2##3##(1991-6#2)
senescence-accelerated mouse##7##2##(1991-6#2)(1992-3#2)(1994-5#2)(1995-8#1)
senescence-accelerated##10##1##(1991-6#3)(1992-3#2)(1994-5#2)(1995-8#1)(2012-1#2)
senescence-associated##4##1##(2008-1#2)(2008-10#1)(2012-12#1)
senescence-enhanced promoter##3##2##(2006-12#3)
senescence?##2##1##(1996-3#1)(2008-9#1)
senescent animals##3##2##(1990-7#1)(1993-12#1)(1994-5#1)
senescent cell antigen##8##3##(1994-5#7)(2013-7#1)
senescent cell antigen&quot##2##3##(1994-6#2)
senescent cell##11##2##(1994-5#8)(1994-6#2)(2013-7#1)
senescent cells##6##2##(1994-3#1)(1995-1#1)(1997-7#2)(2008-11#1)(2013-7#1)
senescent compared##3##2##(1993-2#2)(2013-7#1)
senescent human fibroblasts##5##3##(1992-9#2)(1994-3#1)(1997-6#2)
senescent rat##5##2##(1991-4#3)(1994-6#1)(2013-7#1)
senescent rats##8##2##(1991-2#3)(1995-9#1)(2008-3#1)(2013-7#3)
senescent##61##1##(1990-7#1)(1990-9#1)(1991-2#3)(1991-4#3)(1991-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#2)(1994-3#3)(1994-5#10)(1994-6#3)(1995-1#1)(1995-12#1)(1995-9#2)(1996-9#1)(1997-6#2)(1997-7#2)(2006-12#4)(2007-6#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2009-10#1)(2012-2#1)(2013-7#7)
senescing##12##1##(1990-10#1)(1993-11#4)(1995-8#1)(2006-12#3)(2008-10#2)(2008-3#1)
senesence##2##1##(1996-3#2)
senile age##3##2##(2011-1#2)(2012-1#1)
senile dementia of Alzheimer's type##3##5##(1993-4#1)(1994-6#2)
senile dementia of the Alzheimer type##5##6##(1993-11#3)(1994-11#1)(1994-5#1)
senile dementia of##8##3##(1993-11#3)(1993-4#1)(1994-11#1)(1994-5#1)(1994-6#2)
senile dementia##16##2##(1991-9#2)(1992-12#1)(1993-11#3)(1993-4#1)(1994-11#1)(1994-5#2)(1994-6#3)(1995-11#1)(2007-11#1)(2008-7#1)
senile lentigo represents a##2##4##(2011-2#2)
senile lentigo##3##2##(2011-2#3)
senile osteoporosis##4##2##(2006-8#1)(2008-1#1)(2008-7#2)
senile patients##2##2##(1992-7#1)(2006-6#1)
senile plaques and##3##3##(2004-11#1)(2008-7#2)
senile plaques in##5##3##(1990-7#1)(1993-3#1)(1996-1#1)(2008-7#1)(2012-12#1)
senile plaques##17##2##(1990-7#1)(1991-5#1)(1991-7#1)(1992-12#1)(1993-3#1)(1993-4#1)(1995-10#2)(1995-3#1)(1996-1#1)(2004-11#2)(2008-7#4)(2012-12#1)
senile##70##1##(1990-3#4)(1990-7#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#2)(1992-12#2)(1992-7#1)(1992-8#2)(1993-11#4)(1993-3#1)(1993-4#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-6#3)(1995-10#2)(1995-11#1)(1995-3#1)(1996-1#1)(2004-11#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-7#8)(2011-1#2)(2011-2#5)(2012-1#2)(2012-12#2)(2012-3#1)(2013-1#1)
senior administrators##2##2##(1993-12#1)(1994-2#1)
senior and##2##2##(1996-1#1)(2011-2#1)
senior author##9##2##(1993-12#1)(2005-5#1)(2006-11#1)(2008-2#1)(2008-9#1)(2009-10#1)(2010-11#1)(2012-3#1)(2013-1#1)
senior authors##3##2##(2006-8#1)(2008-9#1)(2012-2#1)
senior baccalaureate nursing##2##3##(2005-7#1)(2012-1#1)
senior citizens in##3##3##(1993-5#1)(2005-1#2)
senior citizens##8##2##(1993-5#1)(2005-1#5)(2008-4#1)(2008-7#1)
senior doctors##2##2##(1993-6#1)(1993-7#1)
senior executive##2##2##(1993-12#1)(1996-12#1)
senior executives##2##2##(1993-3#1)(2008-7#1)
senior high school students and university students##2##7##(2010-12#2)
senior high school students and##3##5##(2010-12#3)
senior high school students##4##4##(2005-10#1)(2010-12#3)
senior high school##5##3##(2005-10#2)(2010-12#3)
senior management positions##2##3##(1995-2#2)
senior management##9##2##(1992-12#1)(1992-2#1)(1993-1#2)(1993-2#1)(1995-2#2)(1995-3#1)(1996-1#1)
senior managers##5##2##(1992-3#1)(1993-2#1)(1997-2#1)(1997-3#1)(2008-1#1)
senior nursing##2##2##(2008-1#1)(2010-3#1)
senior secondary##2##2##(2004-8#1)(2011-1#1)
senior staff##2##2##(2010-5#1)(2012-12#1)
senior student nurses##2##3##(2008-11#2)
senior surgeons##3##2##(1996-1#1)(2007-3#1)(2007-5#1)
senior volunteerism##5##2##(1994-2#4)(1996-3#1)
senior##115##1##(1990-10#1)(1990-3#3)(1991-12#1)(1992-1#1)(1992-12#1)(1992-2#3)(1992-3#1)(1993-1#2)(1993-12#5)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-7#1)(1994-2#6)(1995-12#1)(1995-2#2)(1995-3#2)(1996-1#4)(1996-11#1)(1996-12#1)(1996-3#2)(1997-2#3)(1997-3#2)(2004-8#1)(2005-1#5)(2005-10#2)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-8#2)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#3)(2008-1#2)(2008-11#2)(2008-12#5)(2008-2#1)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-4#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
seniority##6##1##(1991-12#1)(2008-10#2)(2011-2#2)(2013-1#1)
seniors have##3##2##(1994-3#1)(2010-8#2)
seniors in##3##2##(2006-2#1)(2008-4#1)(2010-8#1)
seniors##30##1##(1992-3#2)(1993-2#1)(1994-2#1)(1994-3#1)(1997-2#1)(2005-1#1)(2005-11#1)(2006-2#3)(2007-12#1)(2007-8#3)(2008-1#2)(2008-11#2)(2008-4#1)(2008-9#1)(2009-4#1)(2010-5#1)(2010-8#6)(2011-2#1)
seniors'##2##1##(1992-3#1)(2007-10#1)
senktide induced locomotion##2##3##(1991-11#1)(1993-12#1)
senktide##6##1##(1991-11#2)(1992-10#1)(1993-12#2)(1996-12#1)
senna##5##1##(2007-1#3)(2008-10#1)(2010-3#1)
sennoside A + B concentration##3##5##(2007-1#3)
sennoside A + B##6##4##(2007-1#6)
sennoside yields##4##2##(2007-1#4)
sennoside##13##1##(2007-1#13)
senology##2##1##(1990-2#2)
sensation after##2##2##(2008-9#1)(2013-7#1)
sensation and##8##2##(1992-3#1)(2008-12#1)(2008-7#1)(2009-3#2)(2010-3#1)(2010-6#1)(2011-2#1)
sensation in the##4##3##(1990-3#1)(1995-8#1)(2008-7#1)(2013-1#1)
sensation in##6##2##(1990-3#1)(1995-8#1)(2008-7#1)(2008-8#1)(2010-9#1)(2013-1#1)
sensation of##12##2##(1993-2#1)(1995-8#1)(1996-6#1)(2006-10#1)(2007-5#1)(2008-9#1)(2009-6#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
sensation seeking##6##2##(1994-2#1)(2009-12#4)(2013-8#1)
sensation##81##1##(1990-3#1)(1990-5#1)(1990-8#1)(1991-3#1)(1992-3#1)(1993-2#1)(1993-7#1)(1994-2#1)(1994-4#1)(1995-8#2)(1996-1#1)(1996-6#2)(1996-7#1)(1997-3#1)(2004-3#1)(2005-11#4)(2006-10#2)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-2#1)(2007-5#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-12#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#3)(2009-12#4)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#6)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
sensation-seeking##4##1##(2008-1#1)(2008-3#3)
sensational##2##1##(2008-11#1)(2008-3#1)
sensations activated##2##2##(1995-12#2)
sensations are##2##2##(2008-4#1)(2009-10#1)
sensations from##2##2##(1992-4#1)(2007-1#1)
sensations of##4##2##(1994-6#1)(2007-1#1)(2008-10#1)(2009-12#1)
sensations##27##1##(1992-4#5)(1992-5#1)(1994-6#1)(1995-11#1)(1995-12#2)(2007-1#3)(2007-12#2)(2008-10#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-2#1)(2010-3#1)(2010-7#1)
sense RNA##5##2##(1990-2#1)(1992-8#1)(1997-6#1)(2008-5#1)(2012-3#1)
sense and antisense EDRF1 constructs were prepared and transfected into K562 cells##2##12##(2008-8#1)(2008-9#1)
sense and antisense##8##3##(1996-4#1)(1996-5#1)(2006-11#2)(2006-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
sense and respond to##4##4##(2009-8#1)(2010-11#1)(2012-1#1)(2013-8#1)
sense and##27##2##(1993-3#2)(1993-5#1)(1996-4#1)(1996-5#1)(2004-12#5)(2006-11#2)(2006-12#1)(2008-10#1)(2008-2#1)(2008-8#3)(2008-9#2)(2009-8#2)(2009-9#1)(2010-11#1)(2012-1#1)(2013-1#1)(2013-8#1)
sense as##2##2##(2006-12#1)(2011-2#1)
sense but##2##2##(1995-2#1)(2008-5#1)
sense changes in##3##3##(1997-4#1)(2008-4#1)(2009-8#1)
sense codons##3##2##(1993-9#1)(1994-12#1)(1996-3#1)
sense construct##3##2##(1994-10#1)(2008-8#2)
sense disambiguation (WSD)##4##3##(2013-1#4)
sense disambiguation##8##2##(2013-1#8)
sense frequency information##6##3##(2013-1#6)
sense in the##5##3##(1991-10#1)(2011-1#1)(2012-1#3)
sense in##9##2##(1991-10#1)(1997-7#1)(2006-3#1)(2011-1#1)(2011-2#1)(2012-1#4)
sense it##2##2##(2006-12#1)(2012-2#1)
sense of balance##4##3##(1993-5#2)(2008-1#1)(2008-7#1)
sense of being##2##3##(2008-11#2)
sense of belonging##3##3##(1996-4#1)(2010-4#1)(2012-12#1)
sense of community##4##3##(1995-12#1)(1997-1#1)(2009-7#2)
sense of competence##4##3##(2009-9#4)
sense of control##3##3##(1993-12#1)(1994-6#1)(1995-3#1)
sense of isolation##2##3##(1993-12#1)(2010-9#1)
sense of loss##2##3##(1992-1#1)(2010-2#1)
sense of personal control##2##4##(2011-1#2)
sense of personal##4##3##(2007-8#1)(2009-5#1)(2011-1#2)
sense of purpose##2##3##(2007-2#1)(2013-1#1)
sense of security##2##3##(2010-7#1)(2013-1#1)
sense of self is##2##4##(2006-7#1)(2008-11#1)
sense of self##4##3##(2006-7#1)(2008-11#2)(2010-6#1)
sense of smell is##2##4##(2006-12#1)(2008-7#1)
sense of smell##9##3##(2006-12#1)(2007-8#1)(2007-9#2)(2008-7#1)(2012-2#1)(2013-1#3)
sense of taste##2##3##(2008-7#2)
sense of the word##3##4##(1992-8#1)(1995-5#2)
sense of the##26##3##(1992-5#1)(1992-8#1)(1995-5#2)(2005-11#1)(2005-7#1)(2006-10#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-2#3)(2012-1#4)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)
sense of their##4##3##(2007-11#1)(2008-11#1)(2009-5#1)(2012-12#1)
sense of this##3##3##(2009-4#1)(2013-1#2)
sense of touch##3##3##(2007-5#2)(2008-7#1)
sense of well-being##10##3##(1996-4#1)(2006-9#3)(2008-7#5)(2011-2#1)
sense of##178##2##(1990-2#1)(1990-5#1)(1991-12#1)(1992-1#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-5#2)(1994-11#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#2)(1996-1#1)(1996-11#3)(1996-2#3)(1996-4#3)(1996-5#1)(1996-9#1)(1997-1#1)(1997-7#1)(1997-8#1)(2005-10#2)(2005-11#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#3)(2006-9#5)(2007-11#4)(2007-12#3)(2007-2#4)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#4)(2007-9#3)(2008-1#1)(2008-10#1)(2008-11#8)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#14)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#4)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-2#5)(2012-1#6)(2012-11#2)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#11)(2013-8#4)
sense oligonucleotide##2##2##(1995-3#1)(1996-7#1)
sense oligonucleotides##2##2##(1996-3#1)(1996-7#1)
sense or antisense##2##3##(2006-12#1)(2008-10#1)
sense or##5##2##(1995-2#1)(1995-3#1)(2006-12#1)(2007-8#1)(2008-10#1)
sense organ##4##2##(1995-8#1)(2007-12#2)(2008-12#1)
sense organs and##2##3##(2006-8#1)(2007-12#1)
sense organs##8##2##(1990-5#1)(2006-8#1)(2007-12#4)(2008-5#2)
sense orientation##3##2##(1992-12#1)(2008-4#1)(2013-8#1)
sense primers##3##2##(1994-9#1)(2008-10#2)
sense that##26##2##(1990-11#1)(1992-1#1)(1994-10#1)(1994-11#1)(1995-10#1)(1995-12#1)(1996-6#1)(2004-12#1)(2005-10#1)(2005-11#1)(2006-7#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#2)(2011-2#1)
sense the##12##2##(2006-3#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-7#1)(2009-8#1)(2012-1#1)
sense to implement##2##3##(2008-10#1)(2008-11#1)
sense to##10##2##(1996-1#1)(2004-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-2#1)(2013-1#2)(2013-8#1)
sense transcript##2##2##(1994-11#1)(2008-7#1)
sense with##2##2##(1995-12#1)(2008-3#1)
sense##463##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#2)(1991-10#2)(1991-12#2)(1991-2#1)(1991-4#1)(1992-1#3)(1992-12#2)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#3)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-5#3)(1993-9#1)(1994-10#2)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#3)(1995-1#1)(1995-10#2)(1995-12#3)(1995-2#2)(1995-3#4)(1995-5#2)(1995-6#2)(1995-8#2)(1996-1#2)(1996-11#3)(1996-2#3)(1996-3#7)(1996-4#6)(1996-5#3)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#2)(2004-12#10)(2005-10#4)(2005-11#3)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-11#2)(2006-12#8)(2006-3#4)(2006-4#1)(2006-5#1)(2006-7#5)(2006-8#1)(2006-9#5)(2007-11#7)(2007-12#12)(2007-2#6)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#5)(2007-9#4)(2008-1#6)(2008-10#14)(2008-11#13)(2008-12#4)(2008-2#14)(2008-3#9)(2008-4#9)(2008-5#8)(2008-6#4)(2008-7#19)(2008-8#6)(2008-9#10)(2009-10#2)(2009-11#2)(2009-3#1)(2009-4#3)(2009-5#4)(2009-6#2)(2009-7#3)(2009-8#11)(2009-9#5)(2010-11#2)(2010-12#1)(2010-2#3)(2010-3#4)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#2)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#12)(2012-1#18)(2012-11#3)(2012-12#5)(2012-2#8)(2012-3#5)(2013-1#32)(2013-8#8)
sense&quot##2##1##(1991-6#1)(1996-2#1)
sense)##2##1##(2008-2#1)(2009-12#1)
sense-antisense similarity##3##2##(1991-8#3)
sense-antisense##4##1##(1991-2#1)(1991-8#3)
sense?##3##1##(2006-8#1)(2008-6#1)(2008-8#1)
sensed and paced##2##3##(1992-5#1)(2012-2#1)
sensed and##3##2##(1992-5#1)(2008-2#1)(2012-2#1)
sensed by an##2##3##(2008-3#1)(2012-2#1)
sensed by the detector##2##4##(2008-10#2)
sensed by the##7##3##(1992-1#1)(2008-10#4)(2008-2#1)(2008-8#1)
sensed by##11##2##(1992-1#1)(1994-6#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-8#1)(2012-2#1)
sensed through the##2##3##(2010-2#1)(2013-1#1)
sensed with##3##2##(2008-10#1)(2008-3#2)
sensed##42##1##(1992-1#1)(1992-5#1)(1994-6#1)(2006-12#2)(2007-5#2)(2007-9#1)(2008-10#11)(2008-2#5)(2008-3#9)(2008-5#1)(2008-8#3)(2009-11#1)(2010-2#1)(2012-2#2)(2013-1#1)
senses and##3##2##(2010-12#2)(2010-4#1)
senses of##2##2##(2008-2#1)(2012-2#1)
senses##22##1##(1991-10#1)(1992-4#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-2#1)(2008-3#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-2#2)(2013-1#2)
sensibilities##2##1##(2008-11#1)(2008-8#1)
sensibility and##5##2##(1991-9#1)(1992-8#1)(2006-5#1)(2008-10#1)(2010-12#1)
sensibility of##2##2##(1995-1#1)(2008-8#1)
sensibility to auxin##3##3##(2008-8#3)
sensibility to##5##2##(2007-10#1)(2008-10#1)(2008-8#3)
sensibility##21##1##(1991-9#1)(1992-8#2)(1993-10#2)(1995-1#1)(2006-3#1)(2006-5#1)(2007-10#2)(2008-10#4)(2008-8#4)(2008-9#1)(2010-12#1)(2012-3#1)
sensible and##4##2##(2008-10#1)(2008-8#1)(2011-2#1)(2013-8#1)
sensible##25##1##(1990-9#1)(1991-3#1)(1991-4#1)(1993-10#1)(2006-10#3)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-4#1)(2010-8#1)(2011-2#4)(2013-1#1)(2013-8#2)
sensibly##5##1##(1990-5#1)(2008-10#1)(2008-5#1)(2010-8#2)
sensilla and##4##2##(2007-12#4)
sensilla are##2##2##(2007-12#1)(2008-8#1)
sensilla basiconica II##3##3##(2007-12#3)
sensilla basiconica##8##2##(2007-12#8)
sensilla chaetica##4##2##(2007-12#3)(2013-8#1)
sensilla in##4##2##(1995-3#1)(2007-12#3)
sensilla is##3##2##(2007-12#2)(2008-8#1)
sensilla of the##3##3##(2007-12#1)(2008-7#2)
sensilla of##8##2##(2007-12#2)(2008-5#1)(2008-7#3)(2010-11#2)
sensilla on labial palps##2##4##(2007-12#2)
sensilla on the##3##3##(2007-12#3)
sensilla on##5##2##(2007-12#5)
sensilla styloconica##4##2##(2007-12#1)(2008-8#3)
sensilla trichodea##2##2##(2007-12#1)(2013-8#1)
sensilla was##2##2##(2007-12#2)
sensilla##100##1##(1995-3#3)(2007-12#72)(2008-11#1)(2008-5#1)(2008-7#7)(2008-8#6)(2010-11#7)(2013-8#3)
sensilla)##2##1##(2007-12#2)
sensillar setup##2##2##(2007-12#2)
sensillar##6##1##(2007-12#5)(2010-11#1)
sensillum lymph##3##2##(2007-12#3)
sensillum styloconicum##5##2##(2008-8#5)
sensillum was##2##2##(2005-10#1)(2007-12#1)
sensillum##25##1##(2005-10#4)(2007-12#11)(2008-7#2)(2008-8#5)(2010-11#3)
sensillum-lymph cavities##2##2##(2007-12#1)(2008-7#1)
sensillum-lymph cavity##2##2##(2007-12#2)
sensillum-lymph space##2##2##(2007-12#2)
sensillum-lymph spaces##2##2##(2007-12#2)
sensillum-lymph##8##1##(2007-12#7)(2008-7#1)
sensing agent##2##2##(2008-10#2)
sensing and control of##3##4##(2007-12#2)(2008-2#1)
sensing and control##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
sensing and power-delivery applications##2##4##(2008-3#2)
sensing and processing##2##3##(2008-6#2)
sensing and signalling##3##3##(2006-12#3)
sensing and##40##2##(1997-1#1)(2006-12#3)(2007-12#2)(2007-2#1)(2008-10#4)(2008-2#3)(2008-3#8)(2008-6#2)(2008-8#3)(2009-11#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-8#2)(2011-1#4)
sensing application##2##2##(2008-10#1)(2008-2#1)
sensing applications##12##2##(2007-11#1)(2007-12#3)(2007-2#1)(2008-10#2)(2008-2#2)(2008-7#1)(2009-2#1)(2009-6#1)
sensing approach##3##2##(2008-10#2)(2010-2#1)
sensing are##2##2##(2008-10#1)(2008-2#1)
sensing area##2##2##(2008-9#2)
sensing arms##2##2##(2008-3#2)
sensing as##2##2##(2008-10#1)(2008-2#1)
sensing at##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
sensing atmospheric##2##2##(2007-12#1)(2008-3#1)
sensing based on##4##3##(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#1)
sensing beam##3##2##(2008-2#3)
sensing by optical##2##3##(2007-12#1)(2008-3#1)
sensing by use of##2##4##(2007-12#1)(2008-2#1)
sensing by using##2##3##(2008-10#1)(2013-8#1)
sensing by##12##2##(2007-12#4)(2008-10#1)(2008-2#1)(2008-3#1)(2009-12#1)(2010-12#2)(2011-1#1)(2013-8#1)
sensing characteristics of##2##3##(2007-9#1)(2008-10#1)
sensing characteristics##5##2##(2007-9#1)(2008-10#4)
sensing device for##2##3##(2008-10#2)
sensing device##8##2##(1994-6#1)(2008-10#6)(2008-3#1)
sensing devices##7##2##(2007-8#1)(2008-10#2)(2010-2#1)(2010-6#1)(2010-7#1)(2012-2#1)
sensing electrode embedded in-plane nanopore##2##5##(2012-2#2)
sensing electrode##3##2##(2008-10#1)(2012-2#2)
sensing element consists of a##3##5##(2008-3#3)
sensing element##11##2##(2007-9#4)(2008-1#1)(2008-3#6)
sensing elements##6##2##(2007-9#1)(2008-10#4)(2009-11#1)
sensing fiber was##2##3##(2007-11#1)(2008-3#1)
sensing fiber##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
sensing film##14##2##(2007-9#2)(2008-10#12)
sensing for##7##2##(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#1)(2011-12#1)
sensing from##2##2##(2007-11#1)(2008-8#1)
sensing functions##2##2##(2007-8#2)
sensing glass fiber##2##3##(2008-3#2)
sensing has been##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
sensing head##3##2##(2007-12#1)(2008-2#2)
sensing in the##4##3##(1992-5#1)(2008-10#1)(2008-2#2)
sensing in##10##2##(1992-5#1)(2008-10#4)(2008-2#4)(2008-8#1)
sensing is a##2##3##(2008-3#1)(2011-1#1)
sensing is accomplished by##2##4##(2007-12#1)(2008-2#1)
sensing is presented##2##3##(2007-11#1)(2008-10#1)
sensing is##18##2##(2007-11#2)(2007-12#2)(2008-10#4)(2008-2#3)(2008-3#4)(2010-11#1)(2011-1#1)(2012-2#1)
sensing layer##3##2##(1995-3#1)(2008-10#1)(2010-5#1)
sensing length##3##2##(2007-11#1)(2007-12#2)
sensing material for##2##3##(2007-8#1)(2008-10#1)
sensing material is successfully developed##2##5##(2008-10#2)
sensing material is##3##3##(2007-11#1)(2008-10#2)
sensing material##13##2##(2007-11#1)(2007-8#2)(2008-10#10)
sensing materials and##2##3##(2008-10#2)
sensing materials##5##2##(2008-10#3)(2011-1#2)
sensing mechanism of##3##3##(2007-8#1)(2009-3#1)(2010-11#1)
sensing mechanism##7##2##(2007-8#1)(2008-10#3)(2009-3#1)(2010-11#1)(2013-1#1)
sensing membrane##11##2##(2006-2#1)(2008-10#9)(2010-2#1)
sensing membranes##3##2##(2008-10#3)
sensing method##6##2##(2007-8#1)(2008-10#3)(2008-3#1)(2013-8#1)
sensing molecules##5##2##(2008-10#1)(2013-8#4)
sensing of a##2##3##(2007-12#1)(2008-2#1)
sensing of biological##2##3##(2008-10#1)(2012-12#1)
sensing of dopamine at the surface of##2##7##(2008-10#2)
sensing of dopamine##4##3##(2008-10#4)
sensing of nitric oxide##2##4##(2008-10#2)
sensing of ocean color##7##4##(2008-2#3)(2008-3#4)
sensing of ocean##8##3##(2008-2#4)(2008-3#4)
sensing of the##5##3##(2007-11#1)(2008-3#3)(2010-5#1)
sensing of##52##2##(2006-12#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#13)(2008-11#1)(2008-2#11)(2008-3#16)(2009-11#1)(2010-12#1)(2010-5#1)(2012-1#1)(2012-12#1)
sensing parts##2##2##(2008-10#2)
sensing phase##5##2##(2008-10#5)
sensing platform##3##2##(2008-10#2)(2013-1#1)
sensing principle##2##2##(2007-8#1)(2008-2#1)
sensing properties of##3##3##(2007-9#1)(2008-10#2)
sensing properties were##2##3##(2007-8#1)(2008-10#1)
sensing properties##8##2##(2007-8#1)(2007-9#2)(2008-10#5)
sensing scheme##3##2##(2007-8#1)(2008-2#1)(2008-7#1)
sensing strategy##2##2##(2008-3#2)
sensing surface##6##2##(2007-8#1)(2008-10#2)(2008-4#3)
sensing system for##2##3##(2008-10#2)
sensing system has##2##3##(2008-10#2)
sensing system was developed using##2##5##(2008-10#2)
sensing system was##5##3##(2008-10#5)
sensing system##24##2##(2008-10#15)(2008-2#4)(2008-3#5)
sensing systems##6##2##(1995-2#2)(2007-11#1)(2008-2#1)(2012-11#2)
sensing technique##6##2##(2007-12#1)(2008-10#2)(2008-3#2)(2009-11#1)
sensing techniques##2##2##(2008-8#1)(2009-11#1)
sensing technologies##2##2##(2008-10#2)
sensing tip##2##2##(2008-10#2)
sensing using a##2##3##(2008-10#2)
sensing using##4##2##(2007-12#1)(2008-10#2)(2013-1#1)
sensing was obtained for the electrode membrane containing##2##8##(2008-10#2)
sensing with a##3##3##(2008-2#1)(2008-3#2)
sensing with##14##2##(2007-11#1)(2007-12#5)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#5)
sensing zone##4##2##(2008-10#4)
sensing##600##1##(1992-5#1)(1994-6#1)(1995-2#3)(1995-3#1)(1997-1#2)(2005-11#1)(2006-10#2)(2006-12#5)(2006-2#1)(2007-11#17)(2007-12#39)(2007-2#2)(2007-5#1)(2007-8#21)(2007-9#14)(2008-1#3)(2008-10#191)(2008-11#4)(2008-12#3)(2008-2#69)(2008-3#82)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#10)(2008-8#16)(2008-9#2)(2009-11#8)(2009-12#1)(2009-2#3)(2009-3#1)(2009-5#3)(2009-6#3)(2009-8#7)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#6)(2010-2#4)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#11)(2011-12#1)(2012-1#2)(2012-11#6)(2012-12#2)(2012-2#6)(2013-1#5)(2013-8#14)
sensing?##2##1##(2008-3#1)(2009-8#1)
sensitisation by##3##2##(1990-11#1)(1990-9#1)(1996-8#1)
sensitisation of##2##2##(2008-7#2)
sensitisation to##3##2##(1990-11#1)(1997-2#1)(2004-2#1)
sensitisation##17##1##(1990-11#5)(1990-9#1)(1996-1#1)(1996-8#1)(1997-2#1)(2004-2#1)(2006-12#1)(2006-9#1)(2007-11#1)(2008-7#2)(2009-7#1)(2011-2#1)
sensitise##4##1##(2006-2#1)(2007-7#1)(2011-2#1)(2013-8#1)
sensitised guinea-pigs##2##2##(1994-11#2)
sensitised##10##1##(1994-11#2)(1997-2#4)(2006-12#1)(2007-10#1)(2007-8#1)(2009-9#1)
sensitiser and##2##2##(2008-10#2)
sensitiser##3##1##(2007-11#1)(2008-10#2)
sensitises##3##1##(2008-3#1)(2008-7#1)(2013-1#1)
sensitising##2##1##(2008-7#1)(2011-12#1)
sensitive (0##3##2##(1990-2#1)(2008-10#1)(2011-1#1)
sensitive (2##2##2##(2008-10#1)(2008-5#1)
sensitive (detection limit##5##3##(1992-7#1)(2008-10#3)(2008-3#1)
sensitive A(549)##2##2##(2008-9#2)
sensitive C-reactive protein (hs-CRP)##2##4##(2010-4#1)(2012-3#1)
sensitive C-reactive protein##4##3##(2009-7#1)(2010-4#1)(2012-1#1)(2012-3#1)
sensitive CL##2##2##(2008-10#2)
sensitive Ca2+ channels in##2##4##(1994-5#1)(1997-2#1)
sensitive Ca2+ channels##3##3##(1994-5#1)(1996-8#1)(1997-2#1)
sensitive Ca2+##5##2##(1990-10#1)(1994-5#1)(1996-8#1)(1997-2#2)
sensitive DNA##3##2##(1990-4#1)(1995-8#1)(2008-10#1)
sensitive FI-ECL response##2##3##(2008-10#2)
sensitive HPLC method for##3##4##(1997-3#1)(2007-8#1)(2011-1#1)
sensitive HPLC method##5##3##(1994-8#1)(1997-3#1)(2007-8#1)(2011-1#1)(2011-2#1)
sensitive K+##2##2##(1991-9#1)(2008-8#1)
sensitive absorption##4##2##(2007-12#1)(2008-10#3)
sensitive adsorptive stripping##2##3##(2008-10#2)
sensitive adsorptive##4##2##(2008-10#4)
sensitive amperometric sensor for##2##4##(2008-10#2)
sensitive amperometric##3##2##(2008-10#3)
sensitive analysis of complex##2##4##(2006-9#1)(2009-1#1)
sensitive analysis of##6##3##(2006-9#1)(2007-8#1)(2008-10#2)(2009-1#1)(2012-1#1)
sensitive analysis##7##2##(2006-9#1)(2007-8#2)(2008-10#2)(2009-1#1)(2012-1#1)
sensitive analytical method for the##2##5##(2008-10#2)
sensitive analytical techniques##2##3##(2008-10#1)(2008-5#1)
sensitive analytical##6##2##(1996-6#1)(2008-10#4)(2008-5#1)
sensitive and accurate method##3##4##(1993-2#1)(2008-10#2)
sensitive and accurate##13##3##(1993-2#1)(2008-10#7)(2010-4#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)
sensitive and allows##3##3##(1995-11#1)(2007-7#1)(2008-11#1)
sensitive and convenient##5##3##(1994-11#1)(1994-3#1)(2008-10#3)
sensitive and cost-effective##2##3##(2006-10#1)(2008-3#1)
sensitive and effective##3##3##(1994-11#1)(2008-10#1)(2010-10#1)
sensitive and efficient##5##3##(1992-6#1)(2007-8#1)(2008-1#1)(2008-10#2)
sensitive and fast##3##3##(2005-4#1)(2007-8#1)(2008-10#1)
sensitive and free##2##3##(2008-10#1)(2012-2#1)
sensitive and has##4##3##(1991-8#1)(1991-9#1)(2008-10#2)
sensitive and highly specific##2##4##(1997-4#1)(2008-10#1)
sensitive and highly##3##3##(1997-4#1)(2008-10#2)
sensitive and insensitive##3##3##(1992-7#1)(2008-10#2)
sensitive and more##2##3##(1992-6#1)(2008-10#1)
sensitive and permits##2##3##(2008-10#1)(2008-4#1)
sensitive and precise##3##3##(2008-3#1)(2013-8#2)
sensitive and rapid method##3##4##(1990-8#1)(2008-10#2)
sensitive and rapid##11##3##(1990-8#1)(1992-10#1)(2008-10#8)(2010-6#1)
sensitive and reliable detection of##2##5##(1997-2#1)(2013-8#1)
sensitive and reliable detection##3##4##(1997-2#1)(2008-11#1)(2013-8#1)
sensitive and reliable for##2##4##(1990-6#1)(2008-10#1)
sensitive and reliable method for the##2##6##(1997-3#1)(2008-10#1)
sensitive and reliable method for##4##5##(1997-3#1)(1997-7#1)(2008-10#2)
sensitive and reliable##17##3##(1990-6#1)(1991-12#1)(1994-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2008-10#7)(2008-11#1)(2010-11#1)(2013-8#1)
sensitive and reproducible##7##3##(1992-1#1)(1993-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)
sensitive and resistant P388 leukemia cells##2##6##(1991-12#1)(1991-4#1)
sensitive and resistant clinical isolates##2##5##(2010-12#2)
sensitive and resistant sublines of##2##5##(1990-10#1)(1994-3#1)
sensitive and resistant sublines##3##4##(1990-10#1)(1994-3#2)
sensitive and resistant to##3##4##(1992-2#1)(1995-7#1)(2008-7#1)
sensitive and resistant##17##3##(1990-10#1)(1991-12#2)(1991-4#1)(1991-7#2)(1992-2#2)(1994-3#2)(1995-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#2)(2010-5#1)
sensitive and robust##4##3##(2008-10#3)(2008-3#1)
sensitive and selective chemiluminescence (CL) method##2##6##(2008-10#2)
sensitive and selective detection of##4##5##(1990-8#1)(1995-6#1)(2008-10#2)
sensitive and selective determination of##4##5##(2008-10#3)(2010-7#1)
sensitive and selective flow injection##3##5##(2008-10#3)
sensitive and selective method for the determination of##3##8##(2008-10#3)
sensitive and selective method for the##4##6##(2008-10#4)
sensitive and selective method has been developed for the##2##9##(1996-8#1)(2008-10#1)
sensitive and selective method has been developed for##3##8##(1996-8#1)(2008-10#2)
sensitive and selective method has been##4##6##(1996-8#1)(2008-10#3)
sensitive and selective method is described for the determination of##2##10##(2008-10#2)
sensitive and selective method is described for##3##7##(2008-10#3)
sensitive and selective method is##7##5##(2008-10#7)
sensitive and selective method##17##4##(1996-8#1)(2008-10#15)(2008-5#1)
sensitive and selective methods##2##4##(2008-10#2)
sensitive and selective spectrophotometric##4##4##(2007-8#1)(2008-10#3)
sensitive and selective##74##3##(1990-11#1)(1990-8#1)(1990-9#1)(1993-2#1)(1995-6#1)(1996-3#1)(1996-5#1)(1996-8#3)(1997-2#1)(1997-5#1)(2007-8#2)(2008-10#55)(2008-3#1)(2008-5#1)(2009-3#1)(2010-7#1)(2013-1#1)
sensitive and simple method for the##2##6##(2007-8#1)(2008-10#1)
sensitive and simple method for##4##5##(2007-8#1)(2008-10#3)
sensitive and simple method##5##4##(2007-8#1)(2008-10#4)
sensitive and simple##10##3##(2007-8#2)(2008-10#8)
sensitive and simultaneous determination of##3##5##(1990-8#2)(2008-10#1)
sensitive and simultaneous##4##3##(1990-8#2)(2008-10#2)
sensitive and specific assay##4##4##(1990-2#1)(1990-9#1)(1996-8#1)(1997-3#1)
sensitive and specific detection of##3##5##(2008-10#2)(2010-5#1)
sensitive and specific diagnostic##3##4##(2008-1#1)(2011-2#1)(2012-3#1)
sensitive and specific high-performance liquid chromatographic##2##6##(1991-5#1)(1992-2#1)
sensitive and specific identification##2##4##(1996-12#1)(2008-9#1)
sensitive and specific in##2##4##(2007-7#1)(2008-10#1)
sensitive and specific marker for##2##5##(1997-7#1)(2007-8#1)
sensitive and specific marker of##3##5##(1990-10#1)(2006-6#1)(2007-10#1)
sensitive and specific marker##5##4##(1990-10#1)(1997-7#1)(2006-6#1)(2007-10#1)(2007-8#1)
sensitive and specific method for##3##5##(2008-10#2)(2011-3#1)
sensitive and specific technique for##2##5##(1990-7#1)(2007-10#1)
sensitive and specific tests##2##4##(1993-2#1)(2008-4#1)
sensitive and specific tools##2##4##(1992-4#1)(1994-4#1)
sensitive and specific##66##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-5#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-2#1)(1994-4#1)(1995-1#2)(1995-11#1)(1996-12#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-7#1)(2004-11#1)(2005-12#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-10#2)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-3#1)(2008-4#2)(2008-5#2)(2008-9#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#4)(2011-3#1)(2012-3#1)(2013-1#1)
sensitive and the##4##3##(1990-12#1)(2008-10#2)(2008-5#1)
sensitive and##342##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#2)(1991-12#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-12#2)(1992-2#3)(1992-3#1)(1992-4#1)(1992-6#4)(1992-7#1)(1993-12#1)(1993-2#3)(1993-9#1)(1994-11#2)(1994-3#5)(1994-4#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-7#1)(1996-12#1)(1996-3#2)(1996-5#2)(1996-8#4)(1996-9#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(2004-11#1)(2005-10#1)(2005-12#1)(2005-4#2)(2005-9#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#9)(2008-1#4)(2008-10#145)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#8)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-10#2)(2010-11#2)(2010-12#5)(2010-4#2)(2010-5#4)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#4)
sensitive anodic stripping##2##3##(2008-10#2)
sensitive area##2##2##(1995-7#1)(2008-12#1)
sensitive areas##2##2##(1994-5#1)(2010-12#1)
sensitive as##10##2##(1991-3#1)(1992-3#1)(2004-11#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#1)
sensitive assay for the##3##4##(1994-10#1)(1995-5#1)(1995-8#1)
sensitive assay for##10##3##(1992-7#1)(1994-10#1)(1995-5#1)(1995-8#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-7#1)
sensitive assay of##3##3##(1991-2#1)(2008-10#2)
sensitive assay##20##2##(1990-12#1)(1991-2#1)(1992-7#1)(1992-9#1)(1994-10#1)(1994-3#1)(1995-11#1)(1995-5#1)(1995-8#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)
sensitive assays##4##2##(1991-5#1)(2005-11#1)(2008-10#1)(2008-4#1)
sensitive at small distances##2##4##(2008-3#2)
sensitive at##3##2##(1997-2#1)(2008-3#2)
sensitive automatic##2##2##(2008-10#2)
sensitive biomarker##2##2##(2008-10#1)(2010-5#1)
sensitive biosensor based on##2##4##(2008-10#2)
sensitive but##5##2##(1997-3#1)(2005-7#1)(2006-8#1)(2008-4#1)(2008-5#1)
sensitive capillary##4##2##(1990-11#1)(1996-6#1)(2008-10#2)
sensitive catalytic##2##2##(2008-10#2)
sensitive cell lines##2##3##(1991-3#1)(1993-9#1)
sensitive cell##6##2##(1991-3#1)(1991-4#1)(1993-9#1)(1997-1#1)(2008-11#1)(2008-4#1)
sensitive cells##12##2##(1990-10#1)(1990-2#3)(1990-9#2)(1992-2#2)(1994-8#1)(2006-10#1)(2008-8#2)
sensitive chemiluminescent##3##2##(2008-10#3)
sensitive chromium speciation procedure##2##4##(2008-10#2)
sensitive clinical##4##2##(2006-1#1)(2006-11#1)(2008-11#1)(2010-12#1)
sensitive colorimetric##3##2##(1994-3#1)(2008-10#2)
sensitive colour reaction##2##3##(2005-4#1)(2008-10#1)
sensitive consist of (1)##2##4##(1997-2#2)
sensitive cultivars##3##2##(2008-10#2)(2012-2#1)
sensitive derivative spectrophotometric method##2##4##(2008-10#2)
sensitive detection of the##2##4##(2007-8#1)(2008-10#1)
sensitive detection of##29##3##(1990-12#2)(1990-8#1)(1993-2#1)(1994-11#1)(1996-6#1)(2007-12#1)(2007-8#1)(2008-10#13)(2008-3#1)(2008-4#3)(2009-6#1)(2010-12#1)(2012-2#2)
sensitive detection##44##2##(1990-12#2)(1990-8#1)(1993-2#1)(1994-11#1)(1996-6#1)(1997-2#1)(1997-4#1)(2005-8#1)(2007-12#1)(2007-8#3)(2008-10#21)(2008-3#2)(2008-4#3)(2009-6#1)(2010-12#1)(2010-7#1)(2012-2#2)
sensitive detector##5##2##(2008-10#4)(2008-3#1)
sensitive detectors##2##2##(1990-11#1)(2008-10#1)
sensitive determination of##26##3##(1990-11#1)(1990-6#1)(1992-11#1)(1992-3#1)(1993-1#1)(1993-2#1)(2007-8#2)(2008-10#17)(2008-2#1)
sensitive determination##27##2##(1990-11#1)(1990-6#1)(1992-11#1)(1992-3#1)(1993-1#1)(1993-2#1)(2007-8#2)(2008-10#18)(2008-2#1)
sensitive diagnostic technique##2##3##(2008-10#1)(2012-12#1)
sensitive diagnostic tool##2##3##(2005-11#1)(2007-10#1)
sensitive diagnostic##8##2##(1996-12#1)(2005-11#1)(2006-10#1)(2007-10#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
sensitive differential pulse##2##3##(2008-10#1)(2010-2#1)
sensitive differential##4##2##(2007-11#1)(2008-10#2)(2010-2#1)
sensitive direct##2##2##(2008-10#2)
sensitive dye##2##2##(2007-8#1)(2008-10#1)
sensitive electrochemical##3##2##(1997-8#1)(2008-10#2)
sensitive electronic##2##2##(2008-3#2)
sensitive enough to be used in##2##6##(1997-8#2)
sensitive enough to detect##10##4##(1992-8#1)(1995-12#1)(1996-2#1)(1997-1#1)(1997-4#1)(2007-12#1)(2008-10#2)(2011-2#1)(2012-1#1)
sensitive enough to##17##3##(1992-8#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#2)(2007-12#1)(2007-4#1)(2008-10#2)(2008-3#1)(2011-2#1)(2012-1#1)(2013-7#1)
sensitive enough##19##2##(1992-8#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#2)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-3#1)(2011-2#1)(2012-1#1)(2013-7#1)
sensitive enzyme immunoassay##3##3##(1990-2#1)(1990-4#1)(1991-2#1)
sensitive enzyme-linked##2##2##(1990-3#1)(1992-9#1)
sensitive field##2##2##(2008-10#2)
sensitive flow injection chemiluminescence##3##4##(2008-10#3)
sensitive flow injection method with##2##5##(2008-10#2)
sensitive flow injection method##3##4##(2008-10#3)
sensitive flow injection##9##3##(2008-10#9)
sensitive flow##13##2##(1990-12#2)(2008-10#10)(2008-9#1)
sensitive flow-injection method##2##3##(2008-10#2)
sensitive flow-injection##5##2##(2008-10#5)
sensitive fluorescence quenching method##2##4##(2008-10#2)
sensitive fluorescence##15##2##(1991-8#1)(1992-11#1)(1997-8#1)(2008-10#6)(2008-12#2)(2008-2#1)(2008-4#2)(2008-9#1)
sensitive fluorescent dye##2##3##(1992-6#1)(2009-12#1)
sensitive fluorescent##8##2##(1992-6#1)(2008-10#4)(2008-9#2)(2009-12#1)
sensitive fluorimetric method for the determination of##3##7##(2008-10#3)
sensitive for detecting##2##3##(1994-11#1)(2008-10#1)
sensitive for the##4##3##(1995-2#1)(2006-10#1)(2008-10#2)
sensitive for##20##2##(1991-2#1)(1992-2#1)(1994-11#1)(1995-2#1)(1996-3#1)(2006-10#1)(2006-7#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2011-3#1)
sensitive functional##2##2##(1991-2#1)(1996-5#1)
sensitive genotypes##2##2##(2008-10#2)
sensitive heat flux##2##3##(2013-8#2)
sensitive high performance liquid##2##4##(2008-10#2)
sensitive high##3##2##(1994-6#1)(2008-10#2)
sensitive high-performance liquid chromatographic (HPLC) method##2##6##(1990-9#1)(1996-5#1)
sensitive high-performance liquid chromatographic (HPLC)##4##5##(1990-6#1)(1990-9#1)(1996-5#1)(1996-6#1)
sensitive high-performance liquid chromatographic method##6##5##(1991-5#2)(1996-5#1)(1997-8#1)(2008-10#1)(2008-6#1)
sensitive high-performance liquid chromatographic##11##4##(1990-6#1)(1990-9#1)(1991-5#2)(1992-2#1)(1996-5#2)(1996-6#1)(1997-8#1)(2008-10#1)(2008-6#1)
sensitive high-performance liquid##12##3##(1990-6#1)(1990-9#1)(1991-5#2)(1992-2#1)(1996-5#2)(1996-6#1)(1997-8#1)(2008-10#2)(2008-6#1)
sensitive high-resolution##2##2##(2007-12#1)(2008-3#1)
sensitive imaging##3##2##(1994-9#1)(1997-5#1)(2009-9#1)
sensitive immunoassay##4##2##(1994-2#1)(2008-10#3)
sensitive in comparison##2##3##(2008-10#1)(2008-11#1)
sensitive in detecting##3##3##(1991-3#1)(1996-9#1)(2011-2#1)
sensitive in the##3##3##(1990-12#1)(1991-9#1)(1997-5#1)
sensitive in##17##2##(1990-12#1)(1990-3#1)(1991-3#1)(1991-9#1)(1993-5#1)(1996-9#2)(1997-5#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)
sensitive index of##5##3##(1994-8#1)(1997-2#2)(2008-5#1)(2008-7#1)
sensitive index##6##2##(1994-8#1)(1997-2#2)(2008-5#1)(2008-7#1)(2013-8#1)
sensitive indicator of##12##3##(1994-11#1)(1995-3#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#2)(2012-2#1)
sensitive indicator strain in tomato leaf##2##6##(2008-10#2)
sensitive indicator strain in##3##4##(2008-10#3)
sensitive indicator##16##2##(1991-10#1)(1994-11#1)(1995-3#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-12#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-7#2)(2012-2#1)
sensitive indicators of##7##3##(1993-1#1)(1994-5#1)(2006-5#1)(2010-2#2)(2010-5#1)(2013-8#1)
sensitive indicators##10##2##(1993-1#1)(1994-5#1)(1997-4#1)(2006-5#1)(2007-3#1)(2010-2#2)(2010-5#1)(2010-9#1)(2013-8#1)
sensitive indirect spectrophotometric method##2##4##(2008-10#2)
sensitive information##6##2##(1993-3#1)(1996-12#1)(2007-12#1)(2008-4#1)(2013-1#2)
sensitive isoform of##2##3##(1991-1#1)(1994-12#1)
sensitive isolates##6##2##(1997-7#1)(2008-10#5)
sensitive issue##3##2##(2005-12#1)(2007-3#1)(2013-1#1)
sensitive kinetic##2##2##(1992-6#1)(1996-7#1)
sensitive laboratory##2##2##(2007-11#1)(2008-10#1)
sensitive liquid chromatographic method##3##4##(1990-11#1)(1992-3#1)(2010-12#1)
sensitive liquid chromatographic##6##3##(1990-11#1)(1992-3#1)(1992-6#1)(1993-9#1)(2008-10#1)(2010-12#1)
sensitive liquid##7##2##(1990-11#1)(1992-3#1)(1992-6#1)(1993-9#1)(2008-10#1)(2010-12#1)(2012-12#1)
sensitive manner##2##2##(2011-1#2)
sensitive marker for##2##3##(1991-9#1)(2008-10#1)
sensitive marker of##7##3##(1990-2#1)(1993-6#1)(1996-9#1)(2007-11#1)(2008-11#1)(2008-7#1)(2011-2#1)
sensitive marker##10##2##(1990-2#1)(1991-9#1)(1993-6#1)(1996-9#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
sensitive markers##4##2##(2009-10#1)(2010-1#1)(2010-11#1)(2011-12#1)
sensitive mass response##2##3##(2008-10#2)
sensitive materials##2##2##(2007-4#1)(2008-10#1)
sensitive means of##4##3##(1995-3#1)(1997-3#1)(2007-12#1)(2008-10#1)
sensitive means##7##2##(1992-11#1)(1992-6#1)(1995-3#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-4#1)
sensitive measure of##6##3##(1991-5#1)(1993-12#1)(1993-5#1)(1993-7#1)(2007-11#1)(2009-11#1)
sensitive measure##8##2##(1991-5#1)(1993-12#1)(1993-5#1)(1993-7#1)(2004-12#1)(2007-11#1)(2008-5#1)(2009-11#1)
sensitive measurement of##2##3##(2006-4#1)(2008-2#1)
sensitive measurement##4##2##(2006-4#1)(2008-2#1)(2010-7#1)(2010-9#1)
sensitive measurements of##3##3##(2007-12#2)(2008-2#1)
sensitive mechanism##3##2##(1994-3#1)(1994-6#1)(1996-4#1)
sensitive mechanoreceptors##3##2##(1996-1#3)
sensitive method based on##2##4##(1993-5#1)(2011-12#1)
sensitive method for determination of##2##5##(2008-10#2)
sensitive method for measuring##3##4##(1991-9#1)(2006-3#1)(2008-3#1)
sensitive method for the detection of##3##6##(2008-10#2)(2012-2#1)
sensitive method for the determination of trace##6##7##(2005-4#1)(2007-8#1)(2008-10#4)
sensitive method for the determination of##23##6##(1990-8#2)(1993-1#1)(1993-2#1)(2005-4#1)(2007-8#1)(2008-10#17)
sensitive method for the quantitative determination of##2##7##(2008-10#2)
sensitive method for the quantitative##4##5##(1996-8#1)(2008-10#2)(2010-1#1)
sensitive method for the spectrophotometric determination of##2##7##(2008-10#2)
sensitive method for the##48##4##(1990-11#1)(1990-6#1)(1990-8#2)(1993-1#1)(1993-2#2)(1996-8#1)(1997-1#1)(2005-4#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#30)(2008-5#1)(2010-1#1)(2010-4#1)(2010-5#1)(2012-2#1)
sensitive method for##65##3##(1990-11#1)(1990-6#1)(1990-8#2)(1991-2#1)(1991-9#1)(1992-2#1)(1993-1#1)(1993-2#2)(1996-1#1)(1996-12#1)(1996-8#1)(1997-1#1)(2005-4#1)(2006-10#1)(2006-3#1)(2007-7#1)(2007-8#2)(2008-10#35)(2008-3#1)(2008-5#1)(2008-8#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
sensitive method has been developed for the analysis of##2##9##(2005-12#1)(2008-10#1)
sensitive method has been developed for the##4##7##(1991-5#1)(2005-12#1)(2008-10#2)
sensitive method has been developed for##5##6##(1991-5#1)(2005-12#1)(2008-10#3)
sensitive method is described for the determination of##4##8##(2008-10#4)
sensitive method is described for the##5##6##(2008-10#5)
sensitive method is##9##3##(2008-10#8)(2008-4#1)
sensitive method of##6##3##(1990-6#1)(2008-10#4)(2008-4#1)
sensitive method that##2##3##(1991-5#1)(2008-5#1)
sensitive method to##5##3##(1995-2#1)(1997-4#1)(2006-10#1)(2008-10#2)
sensitive method was developed for the##3##6##(2008-10#3)
sensitive method was developed for##4##5##(2008-10#4)
sensitive method was developed##5##4##(2008-10#4)(2011-1#1)
sensitive method was##6##3##(2008-10#5)(2011-1#1)
sensitive method##105##2##(1990-11#1)(1990-6#2)(1990-8#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-2#2)(1993-5#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-4#1)(2005-12#1)(2005-4#1)(2006-10#2)(2006-3#1)(2007-7#1)(2007-8#2)(2008-10#59)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
sensitive methods in##2##3##(2008-10#1)(2008-2#1)
sensitive methods##9##2##(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#2)(2010-8#1)(2011-2#1)
sensitive modality##2##2##(2008-7#1)(2013-7#1)
sensitive molecular##3##2##(1995-11#1)(2008-10#1)(2008-12#1)
sensitive molecules##2##2##(2009-6#2)
sensitive mutations##2##2##(1993-4#1)(2007-11#1)
sensitive nature of the##2##4##(2006-1#1)(2009-2#1)
sensitive nervous formations##2##3##(1990-11#2)
sensitive on-line##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
sensitive only to##2##3##(2007-11#1)(2008-2#1)
sensitive optical humidity probe##2##4##(2008-10#2)
sensitive optical##4##2##(2008-10#4)
sensitive or resistant to the##2##5##(1992-11#1)(2008-10#1)
sensitive or resistant to##5##4##(1992-11#1)(1992-7#1)(2008-10#2)(2012-12#1)
sensitive or specific##2##3##(2006-8#1)(2010-1#1)
sensitive or##9##2##(1992-11#1)(1992-7#1)(2006-12#1)(2006-8#1)(2008-10#2)(2010-1#1)(2012-12#2)
sensitive parameter for the##2##4##(1993-12#1)(2008-10#1)
sensitive parameter for##4##3##(1993-12#1)(1995-1#1)(2008-10#1)(2012-3#1)
sensitive parameter##7##2##(1993-12#1)(1995-1#1)(1997-6#1)(2006-12#1)(2008-10#2)(2012-3#1)
sensitive parental##2##2##(1992-2#1)(1995-1#1)
sensitive pathogen##4##2##(2007-7#1)(2008-10#3)
sensitive pathway##2##2##(1997-7#2)
sensitive patients##2##2##(2007-2#1)(2008-11#1)
sensitive people##2##2##(2007-8#1)(2011-2#1)
sensitive period for learning##2##4##(2007-5#2)
sensitive period for##4##3##(1992-9#1)(2007-5#2)(2008-6#1)
sensitive period##7##2##(1992-7#1)(1992-9#1)(1996-6#1)(2007-5#3)(2008-6#1)
sensitive polymerase chain##2##3##(1990-8#1)(1994-3#1)
sensitive population##2##2##(2007-9#1)(2008-10#1)
sensitive populations##2##2##(2008-10#2)
sensitive positions##3##2##(1991-10#1)(1992-12#2)
sensitive probe##5##2##(1990-2#2)(1997-1#1)(1997-7#1)(2008-9#1)
sensitive probes for##2##3##(1994-11#1)(2008-10#1)
sensitive probes##5##2##(1991-3#1)(1994-11#1)(1996-10#1)(2008-10#1)(2008-4#1)
sensitive procedure for the determination of##3##6##(2008-10#3)
sensitive procedure for the##5##4##(1997-1#1)(2008-10#4)
sensitive procedure for##9##3##(1997-1#1)(2008-1#1)(2008-10#7)
sensitive procedure##13##2##(1997-1#1)(2008-1#1)(2008-10#10)(2010-12#1)
sensitive procedures for##2##3##(1992-9#1)(2008-4#1)
sensitive promoter##2##2##(1992-5#1)(2009-8#1)
sensitive quantification of##2##3##(2008-10#1)(2010-11#1)
sensitive quantitative##2##2##(1990-4#1)(2008-10#1)
sensitive radioimmunoassay (RIA)##3##3##(1992-7#1)(1993-9#1)(1994-12#1)
sensitive radioimmunoassay##5##2##(1990-7#1)(1992-7#1)(1993-9#1)(1994-12#1)(1997-3#1)
sensitive raw##3##2##(2008-10#1)(2013-1#2)
sensitive region##2##2##(1993-3#1)(1995-3#1)
sensitive response to##2##3##(1990-11#1)(2008-10#1)
sensitive response##5##2##(1990-11#1)(2008-10#4)
sensitive reverse##2##2##(1992-11#1)(2008-10#1)
sensitive reversed-phase high-performance liquid chromatographic##2##5##(1991-5#1)(1996-3#1)
sensitive sandwich enzyme immunoassay for##2##5##(1991-2#1)(1996-6#1)
sensitive sandwich##3##2##(1991-2#1)(1991-9#1)(1996-6#1)
sensitive screening##4##2##(2008-11#1)(2011-12#1)(2013-1#2)
sensitive sequential injection##3##3##(2008-10#3)
sensitive site##2##2##(1997-7#1)(2011-2#1)
sensitive spectrophotometric determination of##2##4##(2008-10#2)
sensitive spectrophotometric method for##5##4##(2008-10#5)
sensitive spectrophotometric method##11##3##(2005-4#1)(2008-10#9)(2010-2#1)
sensitive spectrophotometric##21##2##(1991-3#1)(2005-4#1)(2008-10#18)(2010-2#1)
sensitive stage##2##2##(2008-10#1)(2008-6#1)
sensitive strain##4##2##(2008-10#1)(2008-5#3)
sensitive strains##10##2##(1991-1#1)(1997-2#1)(2007-8#1)(2008-10#6)(2010-12#1)
sensitive substrate##2##2##(1993-12#1)(2007-7#1)
sensitive surface##2##2##(2007-11#1)(2008-5#1)
sensitive system##2##2##(2008-10#2)
sensitive target##2##2##(1990-7#1)(1990-9#1)
sensitive technique for the##2##4##(2008-10#2)
sensitive technique for##5##3##(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#1)
sensitive technique of##2##3##(1992-9#1)(1996-12#1)
sensitive technique##11##2##(1992-9#1)(1995-2#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#1)(2009-6#1)
sensitive techniques is##2##3##(2008-4#1)(2010-4#1)
sensitive techniques##7##2##(1995-12#1)(2007-11#1)(2008-4#1)(2010-4#3)(2010-8#1)
sensitive teeth##3##2##(1993-3#1)(2011-1#1)(2011-2#1)
sensitive test for the presence of##2##6##(1993-7#1)(1994-6#1)
sensitive test for##4##3##(1992-7#1)(1993-7#1)(1994-6#1)(1996-3#1)
sensitive test##8##2##(1990-12#1)(1991-8#1)(1992-7#1)(1993-10#1)(1993-7#1)(1994-6#1)(1996-3#1)(2006-10#1)
sensitive tests##2##2##(2006-9#1)(2008-7#1)
sensitive than other##4##3##(1993-2#1)(2006-2#1)(2010-6#1)(2012-2#1)
sensitive than the##24##3##(1990-11#1)(1991-9#1)(1993-12#1)(1993-4#1)(1994-12#1)(1994-5#1)(1996-1#1)(1996-5#1)(1997-2#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#5)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-8#2)
sensitive than those##2##3##(2005-8#1)(2007-12#1)
sensitive than##93##2##(1990-11#2)(1990-12#2)(1990-3#1)(1990-5#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-12#1)(1994-5#1)(1995-1#1)(1996-1#1)(1996-5#1)(1996-8#2)(1997-2#3)(1997-3#3)(1997-4#1)(1997-7#2)(2004-11#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-2#1)(2006-3#1)(2006-7#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#16)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#6)(2008-5#3)(2008-7#1)(2008-8#2)(2009-6#1)(2010-12#2)(2010-6#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-8#2)
sensitive tissue##2##2##(2008-1#1)(2013-1#1)
sensitive tissues##2##2##(2008-3#1)(2008-7#1)
sensitive to Ca2+##2##3##(1990-8#1)(1994-5#1)
sensitive to Cu-Zn superoxide dismutase##2##5##(1990-2#2)
sensitive to a small##2##4##(1990-8#1)(2007-12#1)
sensitive to a##10##3##(1990-8#1)(1991-5#1)(1994-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2011-1#1)(2012-2#1)
sensitive to all of the##2##5##(2008-10#1)(2008-5#1)
sensitive to all##5##3##(2008-10#1)(2008-3#1)(2008-5#2)(2011-2#1)
sensitive to aminoglycosides##3##3##(1995-2#2)(2008-12#1)
sensitive to antibiotics##2##3##(2011-1#1)(2011-12#1)
sensitive to apoptosis##2##3##(1995-3#1)(2003-11#1)
sensitive to assumptions##3##3##(2008-8#1)(2009-9#1)(2010-2#1)
sensitive to background##2##3##(2008-2#1)(2008-9#1)
sensitive to benomyl at##2##4##(2008-10#2)
sensitive to beta##2##3##(2008-3#1)(2009-5#1)
sensitive to both the##2##4##(1990-4#1)(2009-7#1)
sensitive to both##14##3##(1990-4#1)(1992-1#1)(1992-4#1)(1992-9#1)(1995-11#1)(2004-4#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-7#1)(2011-1#1)
sensitive to calcium##3##3##(1990-7#1)(1991-3#1)(1995-8#1)
sensitive to change in##2##4##(2007-7#1)(2008-10#1)
sensitive to change##3##3##(2007-7#1)(2008-10#1)(2009-11#1)
sensitive to changes in the##4##5##(1995-3#1)(2008-8#1)(2009-6#1)(2010-4#1)
sensitive to changes in##15##4##(1990-8#1)(1991-2#1)(1994-2#1)(1995-10#1)(1995-3#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-4#1)
sensitive to changes##16##3##(1990-8#1)(1991-2#1)(1994-2#1)(1995-10#1)(1995-3#1)(1996-2#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-4#1)
sensitive to chemotherapy##3##3##(1991-5#1)(2007-11#1)(2008-7#1)
sensitive to chloramphenicol##2##3##(2007-7#1)(2011-2#1)
sensitive to cold##2##3##(1991-8#1)(2006-5#1)
sensitive to detect##2##3##(2008-1#1)(2008-10#1)
sensitive to different##2##3##(1993-9#1)(2007-11#1)
sensitive to early##2##3##(1996-3#1)(2007-7#1)
sensitive to electric##2##3##(1997-6#1)(1997-7#1)
sensitive to environmental##3##3##(2007-3#1)(2008-5#1)(2010-12#1)
sensitive to errors##2##3##(2008-2#1)(2008-3#1)
sensitive to ethanol than##2##4##(1992-7#1)(1994-5#1)
sensitive to exogenous##2##3##(2008-4#1)(2008-5#1)
sensitive to external##3##3##(1992-4#1)(1994-5#1)(2008-11#1)
sensitive to guanine nucleotide##2##4##(1993-9#2)
sensitive to heat##2##3##(1992-3#1)(2008-7#1)
sensitive to individual##2##3##(1997-8#1)(2007-8#1)
sensitive to inhibition by##5##4##(1994-9#2)(1996-8#1)(1997-4#1)(2010-2#1)
sensitive to inhibition##7##3##(1994-9#2)(1995-7#1)(1995-8#1)(1996-8#1)(1997-4#1)(2010-2#1)
sensitive to ionizing radiation##2##4##(1995-12#1)(1997-7#1)
sensitive to ionizing##3##3##(1995-12#1)(1995-5#1)(1997-7#1)
sensitive to irradiation##2##3##(1992-2#1)(1997-1#1)
sensitive to it##2##3##(1992-9#1)(2009-8#1)
sensitive to its##4##3##(1991-3#1)(1997-2#1)(2008-11#1)(2008-4#1)
sensitive to lipid##2##3##(2010-7#1)(2012-11#1)
sensitive to low##4##3##(1990-3#1)(1990-5#1)(1994-9#1)(2012-3#1)
sensitive to lysis##2##3##(1992-1#1)(1992-2#1)
sensitive to measure##2##3##(2008-10#2)
sensitive to measurement##2##3##(2007-12#1)(2008-11#1)
sensitive to metalaxyl##4##3##(2008-10#4)
sensitive to mismatches##3##3##(2008-4#2)(2008-9#1)
sensitive to model##2##3##(1997-3#1)(2008-3#1)
sensitive to narasin##2##3##(2007-6#2)
sensitive to nitrogen##2##3##(1990-2#1)(1991-7#1)
sensitive to noise and##2##4##(2008-2#1)(2008-3#1)
sensitive to noise##4##3##(2008-2#3)(2008-3#1)
sensitive to nonionic surfactants##2##4##(2008-10#2)
sensitive to omega-conotoxin##2##3##(1990-7#1)(1996-5#1)
sensitive to oxygen##2##3##(1994-6#1)(2009-8#1)
sensitive to pH in the range of##2##7##(1995-2#1)(2008-8#1)
sensitive to pH##5##3##(1990-9#1)(1995-2#1)(2007-8#1)(2008-8#1)(2013-8#1)
sensitive to peptide##2##3##(1993-5#1)(1994-9#1)
sensitive to phase##2##3##(2008-2#1)(2011-1#1)
sensitive to protein##4##3##(1991-2#1)(1993-12#1)(2008-2#1)(2008-4#1)
sensitive to several##5##3##(2006-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-2#1)
sensitive to small changes in##2##5##(1996-7#1)(2008-3#1)
sensitive to small##4##3##(1996-7#1)(2007-11#1)(2008-2#1)(2008-3#1)
sensitive to specific##2##3##(1993-3#1)(2011-1#1)
sensitive to surface##2##3##(2008-2#1)(2008-3#1)
sensitive to temperature than##2##4##(2008-9#1)(2012-2#1)
sensitive to temperature##6##3##(1994-10#1)(1994-12#1)(2007-11#1)(2008-9#2)(2012-2#1)
sensitive to tetracycline##2##3##(2005-10#1)(2007-10#1)
sensitive to the change in##3##5##(2006-11#1)(2007-11#1)(2008-10#1)
sensitive to the choice of##2##5##(2008-3#1)(2013-1#1)
sensitive to the degree of##2##5##(2007-11#1)(2009-5#1)
sensitive to the difference##2##4##(2008-9#1)(2011-2#1)
sensitive to the effect of##2##5##(1991-7#1)(1993-1#1)
sensitive to the effects of##4##5##(1994-5#1)(1996-9#1)(2008-4#1)(2008-9#1)
sensitive to the geometry of the##2##6##(1990-12#1)(2008-2#1)
sensitive to the growth inhibitory##2##5##(1992-3#1)(1995-2#1)
sensitive to the growth##3##4##(1992-3#1)(1995-2#1)(2009-4#1)
sensitive to the inhibitory effect of##2##6##(1992-5#1)(1995-5#1)
sensitive to the numerical##2##4##(2008-10#1)(2008-3#1)
sensitive to the orientation of the##2##6##(1992-6#1)(2007-11#1)
sensitive to the presence of##3##5##(1994-3#1)(1994-9#1)(2008-2#1)
sensitive to the presence##4##4##(1991-4#1)(1994-3#1)(1994-9#1)(2008-2#1)
sensitive to the pyrazine core##2##5##(2010-4#2)
sensitive to the sequence##3##4##(2012-12#2)(2013-1#1)
sensitive to the solvent##2##4##(2007-10#1)(2010-2#1)
sensitive to the stimulatory##2##4##(1992-5#1)(1995-5#1)
sensitive to the toxin##2##4##(2008-10#2)
sensitive to the##162##3##(1990-12#4)(1990-3#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-3#1)(1992-5#2)(1992-6#1)(1992-7#2)(1993-1#2)(1993-11#1)(1993-2#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-8#2)(1996-1#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2004-9#1)(2005-11#1)(2006-11#2)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#7)(2007-7#2)(2008-10#13)(2008-12#1)(2008-2#6)(2008-3#11)(2008-4#5)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#3)(2009-4#2)(2009-5#2)(2009-6#3)(2009-8#2)(2010-1#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#2)
sensitive to thermal##2##3##(1995-2#1)(2007-11#1)
sensitive to these##3##3##(1992-6#1)(2009-9#1)(2011-2#1)
sensitive to this##4##3##(1993-12#1)(1995-1#1)(1996-5#1)(2008-10#1)
sensitive to treatment with##4##4##(1992-8#1)(1993-3#1)(1994-6#1)(1995-1#1)
sensitive to treatment##6##3##(1992-8#1)(1993-3#1)(1994-6#1)(1995-1#1)(2008-10#1)(2011-2#1)
sensitive to trypsin##2##3##(1990-11#1)(1991-8#1)
sensitive to variation in##2##4##(2008-10#1)(2010-1#1)
sensitive to variation##3##3##(2006-12#1)(2008-10#1)(2010-1#1)
sensitive to variations in the##3##5##(2008-2#2)(2008-6#1)
sensitive to vinclozolin (R(T)S(V))##2##4##(2008-10#2)
sensitive to##769##2##(1990-11#3)(1990-12#9)(1990-2#5)(1990-3#3)(1990-4#1)(1990-5#6)(1990-6#3)(1990-7#4)(1990-8#5)(1990-9#3)(1991-1#1)(1991-10#3)(1991-12#1)(1991-2#10)(1991-3#4)(1991-4#2)(1991-5#8)(1991-6#5)(1991-7#5)(1991-8#5)(1991-9#6)(1992-1#3)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#3)(1992-4#3)(1992-5#3)(1992-6#4)(1992-7#3)(1992-8#5)(1992-9#5)(1993-1#3)(1993-11#5)(1993-12#3)(1993-2#3)(1993-3#5)(1993-5#2)(1993-7#2)(1993-8#2)(1993-9#7)(1994-10#1)(1994-11#4)(1994-12#7)(1994-2#3)(1994-3#2)(1994-4#1)(1994-5#5)(1994-6#6)(1994-8#5)(1994-9#8)(1995-1#3)(1995-10#4)(1995-11#3)(1995-12#9)(1995-2#8)(1995-3#4)(1995-5#8)(1995-6#1)(1995-7#2)(1995-8#6)(1996-1#4)(1996-10#2)(1996-12#5)(1996-2#5)(1996-3#3)(1996-4#2)(1996-5#6)(1996-6#2)(1996-7#3)(1996-8#2)(1996-9#3)(1997-1#4)(1997-2#4)(1997-3#2)(1997-4#4)(1997-5#4)(1997-6#5)(1997-7#4)(1997-8#3)(2003-11#1)(2004-4#1)(2004-9#1)(2005-10#2)(2005-11#2)(2006-11#5)(2006-12#4)(2006-5#3)(2006-8#2)(2007-1#1)(2007-10#5)(2007-11#15)(2007-12#17)(2007-3#2)(2007-4#1)(2007-6#3)(2007-7#9)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#79)(2008-11#11)(2008-12#6)(2008-2#32)(2008-3#29)(2008-4#20)(2008-5#14)(2008-6#9)(2008-7#8)(2008-8#19)(2008-9#12)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#5)(2009-6#5)(2009-7#1)(2009-8#7)(2009-9#5)(2010-1#2)(2010-10#1)(2010-12#1)(2010-2#6)(2010-3#2)(2010-4#6)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#9)(2011-12#2)(2011-2#7)(2012-1#2)(2012-11#5)(2012-12#7)(2012-2#16)(2012-3#8)(2012-4#1)(2013-1#10)(2013-8#5)
sensitive tool for the detection##2##5##(2008-10#2)
sensitive tool for##3##3##(2008-10#2)(2012-2#1)
sensitive tool to##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
sensitive tool##8##2##(2006-10#1)(2006-2#1)(2008-10#3)(2008-5#1)(2008-9#1)(2012-2#1)
sensitive tumor##2##2##(1994-2#1)(1994-9#1)
sensitive voltammetric##4##2##(2008-10#4)
sensitive wheat genotypes##2##3##(2008-10#2)
sensitive with a##2##3##(1997-3#1)(2008-2#1)
sensitive with##7##2##(1997-3#1)(2004-4#1)(2005-4#1)(2007-2#1)(2008-10#1)(2008-2#1)(2011-1#1)
sensitive yeasts##2##2##(1993-12#2)
sensitive##2727##1##(1990-10#7)(1990-11#18)(1990-12#26)(1990-2#18)(1990-3#9)(1990-4#7)(1990-5#8)(1990-6#11)(1990-7#8)(1990-8#13)(1990-9#9)(1991-1#5)(1991-10#6)(1991-11#1)(1991-12#7)(1991-2#18)(1991-3#13)(1991-4#6)(1991-5#19)(1991-6#6)(1991-7#7)(1991-8#9)(1991-9#17)(1992-1#5)(1992-10#4)(1992-11#11)(1992-12#10)(1992-2#15)(1992-3#8)(1992-4#6)(1992-5#5)(1992-6#16)(1992-7#11)(1992-8#10)(1992-9#12)(1993-1#7)(1993-10#1)(1993-11#7)(1993-12#13)(1993-2#14)(1993-3#8)(1993-4#2)(1993-5#5)(1993-6#1)(1993-7#5)(1993-8#3)(1993-9#15)(1994-1#1)(1994-10#2)(1994-11#13)(1994-12#14)(1994-2#6)(1994-3#13)(1994-4#2)(1994-5#9)(1994-6#10)(1994-8#12)(1994-9#16)(1995-1#10)(1995-10#5)(1995-11#9)(1995-12#12)(1995-2#11)(1995-3#13)(1995-4#1)(1995-5#14)(1995-6#4)(1995-7#6)(1995-8#13)(1996-1#10)(1996-10#4)(1996-11#2)(1996-12#17)(1996-2#7)(1996-3#8)(1996-4#4)(1996-5#18)(1996-6#9)(1996-7#4)(1996-8#11)(1996-9#10)(1997-1#10)(1997-2#21)(1997-3#15)(1997-4#12)(1997-5#9)(1997-6#10)(1997-7#15)(1997-8#8)(2003-11#1)(2004-11#4)(2004-12#1)(2004-4#5)(2004-9#1)(2005-10#5)(2005-11#5)(2005-12#6)(2005-4#9)(2005-7#1)(2005-8#5)(2005-9#1)(2006-1#3)(2006-10#17)(2006-11#9)(2006-12#12)(2006-2#4)(2006-3#3)(2006-4#2)(2006-5#4)(2006-6#4)(2006-7#2)(2006-8#4)(2006-9#4)(2007-1#3)(2007-10#11)(2007-11#32)(2007-12#45)(2007-2#8)(2007-3#6)(2007-4#7)(2007-5#6)(2007-6#5)(2007-7#23)(2007-8#50)(2007-9#3)(2008-1#17)(2008-10#767)(2008-11#39)(2008-12#14)(2008-2#57)(2008-3#71)(2008-4#64)(2008-5#52)(2008-6#14)(2008-7#27)(2008-8#31)(2008-9#33)(2009-1#1)(2009-10#5)(2009-11#2)(2009-12#6)(2009-2#3)(2009-3#8)(2009-4#6)(2009-5#5)(2009-6#12)(2009-7#3)(2009-8#10)(2009-9#6)(2010-1#5)(2010-10#4)(2010-11#5)(2010-12#18)(2010-2#14)(2010-3#6)(2010-4#14)(2010-5#12)(2010-6#8)(2010-7#7)(2010-8#7)(2010-9#6)(2011-1#24)(2011-12#5)(2011-2#39)(2011-3#4)(2012-1#8)(2012-11#5)(2012-12#18)(2012-2#34)(2012-3#14)(2012-4#1)(2012-5#1)(2013-1#34)(2013-7#5)(2013-8#23)
sensitive)##3##1##(2007-6#1)(2008-9#1)(2010-8#1)
sensitively by##2##2##(2008-10#2)
sensitively detect##2##2##(2007-5#1)(2011-3#1)
sensitively detected##6##2##(1994-9#1)(2007-12#1)(2008-10#3)(2008-7#1)
sensitively on the##3##3##(2008-10#1)(2008-3#1)(2010-4#1)
sensitively on##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2010-4#1)
sensitively to##3##2##(2006-12#1)(2007-8#1)(2013-8#1)
sensitively with##4##2##(2007-12#1)(2008-10#3)
sensitively##38##1##(1994-12#1)(1994-9#1)(2005-1#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#12)(2008-2#2)(2008-3#3)(2008-7#3)(2008-9#1)(2009-7#1)(2010-3#1)(2010-4#1)(2011-3#1)(2012-2#1)(2013-7#1)(2013-8#2)
sensitiveness##5##1##(1990-2#1)(2011-2#3)(2013-7#1)
sensitiveto##2##1##(2008-11#1)(2008-2#1)
sensitivities and specificities##2##3##(1997-7#1)(2009-9#1)
sensitivities and##7##2##(1994-3#1)(1997-7#1)(2008-10#3)(2009-9#1)(2012-12#1)
sensitivities are##4##2##(1990-7#1)(2007-11#1)(2008-10#1)(2008-3#1)
sensitivities for all##2##3##(2008-2#1)(2009-6#1)
sensitivities for the##2##3##(1990-8#1)(2008-10#1)
sensitivities for##13##2##(1990-8#2)(1995-5#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2009-6#1)(2012-12#1)
sensitivities in##2##2##(1996-3#1)(2007-12#1)
sensitivities of 0##2##3##(2008-10#1)(2008-3#1)
sensitivities of the different##2##4##(2008-10#1)(2012-2#1)
sensitivities of the##14##3##(1991-2#1)(1995-7#1)(2004-4#1)(2007-2#1)(2008-10#4)(2008-3#4)(2008-7#1)(2012-2#1)
sensitivities of two##2##3##(1995-8#1)(2008-3#1)
sensitivities of##45##2##(1990-7#1)(1991-2#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-7#2)(1995-8#1)(1997-7#1)(2004-4#2)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#9)(2008-2#1)(2008-3#15)(2008-7#2)(2009-4#1)(2012-2#1)
sensitivities than the##2##3##(1994-12#1)(2008-10#1)
sensitivities to the##2##3##(1991-10#1)(2008-10#1)
sensitivities to##29##2##(1990-11#1)(1991-10#1)(1991-8#1)(1992-12#1)(1992-9#2)(1994-10#1)(1994-4#1)(1996-10#1)(1996-11#1)(1996-9#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-9#1)(2006-5#1)(2007-11#1)(2007-2#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-7#1)(2009-3#1)(2012-2#1)
sensitivities were observed##2##3##(1991-3#1)(2008-10#1)
sensitivities were##8##2##(1991-3#1)(1995-1#1)(2007-11#1)(2008-10#2)(2008-3#2)(2011-1#1)
sensitivities##160##1##(1990-11#1)(1990-6#1)(1990-7#2)(1990-8#3)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-4#2)(1992-9#2)(1993-1#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-9#1)(1995-1#1)(1995-5#1)(1995-7#2)(1995-8#2)(1996-10#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-7#3)(1997-8#1)(2004-11#1)(2004-4#2)(2005-9#1)(2006-12#1)(2006-5#1)(2007-11#6)(2007-12#7)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#32)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#30)(2008-7#5)(2009-1#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-9#1)(2010-12#1)(2010-2#1)(2011-1#5)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#1)
sensitivities/specificities of##2##2##(2007-9#2)
sensitivity (##2##2##(2007-12#1)(2008-10#1)
sensitivity (0##2##2##(2006-10#1)(2008-10#1)
sensitivity (1##2##2##(1995-12#1)(2007-8#1)
sensitivity (87%) and specificity##2##4##(2008-3#1)(2008-5#1)
sensitivity (BRS)##2##2##(1991-10#1)(2008-1#1)
sensitivity (S)##2##2##(2008-10#1)(2010-12#1)
sensitivity (em =##2##3##(2008-10#2)
sensitivity 0##3##2##(1991-12#2)(2008-10#1)
sensitivity 2##3##2##(1993-9#1)(2007-12#1)(2008-10#1)
sensitivity 85%##2##2##(2008-4#1)(2008-5#1)
sensitivity =##2##2##(2008-12#1)(2009-4#1)
sensitivity C-reactive protein##7##3##(2010-12#1)(2011-2#1)(2013-1#1)(2013-7#4)
sensitivity about##3##2##(2008-10#2)(2012-3#1)
sensitivity across##2##2##(2007-6#1)(2008-2#1)
sensitivity after##5##2##(1991-7#1)(2008-10#2)(2008-3#1)(2013-1#1)
sensitivity against##2##2##(1990-3#1)(1995-6#1)
sensitivity allowed##2##2##(2006-3#1)(2008-10#1)
sensitivity among##2##2##(1997-7#1)(2008-10#1)
sensitivity analyses##6##2##(2008-12#1)(2008-2#1)(2009-12#2)(2010-8#1)(2012-12#1)
sensitivity analysis and##2##3##(2008-3#1)(2010-2#1)
sensitivity analysis can##2##3##(2006-5#1)(2008-11#1)
sensitivity analysis of the##3##4##(1991-2#1)(2008-3#1)(2008-7#1)
sensitivity analysis of their##2##4##(2006-5#1)(2007-12#1)
sensitivity analysis of##10##3##(1991-2#1)(1994-6#1)(1997-7#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-3#1)(2008-7#1)(2010-9#1)(2011-1#1)
sensitivity analysis revealed that##2##4##(1991-2#1)(2010-9#1)
sensitivity analysis showed that##2##4##(2008-10#1)(2012-12#1)
sensitivity analysis shows that##2##4##(1994-1#1)(2008-2#1)
sensitivity analysis to##6##3##(1995-12#1)(2006-10#2)(2008-2#1)(2011-1#1)(2013-1#1)
sensitivity analysis was##3##3##(2009-9#1)(2011-2#1)(2012-12#1)
sensitivity analysis##51##2##(1991-2#2)(1994-1#1)(1994-6#1)(1995-12#1)(1995-6#1)(1995-8#2)(1997-7#1)(2006-10#3)(2006-12#1)(2006-5#3)(2006-9#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#4)(2008-7#2)(2009-4#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-9#2)(2011-1#2)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)
sensitivity and 100% specificity##2##4##(2009-8#1)(2010-8#1)
sensitivity and a better##2##4##(2008-10#1)(2011-2#1)
sensitivity and a##8##3##(1996-9#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-9#1)(2011-2#1)(2013-8#1)
sensitivity and accuracy##7##3##(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2010-4#1)
sensitivity and adequate##2##3##(2008-10#2)
sensitivity and analytical##2##3##(2008-10#1)(2008-3#1)
sensitivity and can##3##3##(1992-4#1)(1994-6#1)(2010-9#1)
sensitivity and cross talk##2##4##(2008-2#1)(2008-3#1)
sensitivity and detection##3##3##(2008-10#2)(2013-8#1)
sensitivity and ease of##2##4##(2010-12#1)(2011-2#1)
sensitivity and ease##3##3##(2007-8#1)(2010-12#1)(2011-2#1)
sensitivity and fair##2##3##(2006-10#1)(2006-8#1)
sensitivity and good##9##3##(2005-12#1)(2005-4#1)(2007-8#1)(2008-10#4)(2012-12#2)
sensitivity and high specificity##2##4##(1997-3#1)(2011-1#1)
sensitivity and high##5##3##(1997-3#1)(2006-10#1)(2008-10#1)(2008-9#1)(2011-1#1)
sensitivity and increase##2##3##(1993-2#1)(2008-3#1)
sensitivity and is##2##3##(2008-10#1)(2011-1#1)
sensitivity and its##2##3##(2008-3#1)(2010-7#1)
sensitivity and limit of detection of##2##6##(2008-10#2)
sensitivity and limit of detection##3##5##(2008-10#3)
sensitivity and limited##3##3##(2008-3#1)(2008-4#1)(2009-8#1)
sensitivity and limits of detection##3##5##(2008-10#3)
sensitivity and limits of##4##4##(1996-6#1)(2008-10#3)
sensitivity and linearity##3##3##(1996-2#1)(2008-10#2)
sensitivity and low##2##3##(2008-10#2)
sensitivity and negative predictive value##2##5##(2006-9#2)
sensitivity and negative##3##3##(2006-9#2)(2010-12#1)
sensitivity and positive predictive value##3##5##(2006-12#1)(2007-9#1)(2012-2#1)
sensitivity and positive predictive values of##2##6##(2008-5#1)(2012-12#1)
sensitivity and positive predictive values##3##5##(1994-3#1)(2008-5#1)(2012-12#1)
sensitivity and positive predictive##6##4##(1994-3#1)(2006-12#1)(2007-9#1)(2008-5#1)(2012-12#1)(2012-2#1)
sensitivity and precision of##2##4##(1993-2#1)(2007-8#1)
sensitivity and precision##5##3##(1993-2#1)(2007-8#1)(2008-10#2)(2011-1#1)
sensitivity and preventing##2##3##(1997-4#1)(2008-10#1)
sensitivity and recovery##2##3##(1997-8#1)(2005-4#1)
sensitivity and reliability of##2##4##(2008-10#2)
sensitivity and repeatability##3##3##(2008-10#2)(2013-7#1)
sensitivity and reproducibility##11##3##(1990-2#1)(1993-2#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-8#1)
sensitivity and resistance##3##3##(1992-2#1)(1994-9#1)(2012-1#1)
sensitivity and responsiveness##2##3##(1994-11#1)(1995-12#1)
sensitivity and reversibility##2##3##(1993-6#1)(2008-10#1)
sensitivity and robustness##2##3##(1993-3#1)(2008-10#1)
sensitivity and selectivity in the##2##5##(2008-10#2)
sensitivity and selectivity in##3##4##(2008-10#3)
sensitivity and selectivity of the##5##5##(2007-8#1)(2008-10#3)(2008-3#1)
sensitivity and selectivity of##7##4##(1996-12#1)(2007-8#1)(2008-10#4)(2008-3#1)
sensitivity and selectivity was##2##4##(2008-10#2)
sensitivity and selectivity were##2##4##(2008-10#2)
sensitivity and selectivity##33##3##(1996-12#1)(2005-4#1)(2007-8#2)(2008-10#24)(2008-3#2)(2008-9#1)(2010-11#1)(2012-3#1)
sensitivity and simplicity##2##3##(2008-10#2)
sensitivity and specificity and##4##4##(1994-7#1)(2007-12#1)(2007-9#1)(2008-4#1)
sensitivity and specificity are##4##4##(1991-9#1)(1992-10#1)(2009-2#1)(2009-4#1)
sensitivity and specificity for##9##4##(2005-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
sensitivity and specificity have##2##4##(2007-8#1)(2009-9#1)
sensitivity and specificity in the##3##5##(1996-8#1)(1997-6#1)(2008-6#1)
sensitivity and specificity in##7##4##(1996-8#1)(1997-6#1)(2006-4#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-9#1)
sensitivity and specificity of ELISA##2##5##(1992-8#1)(2011-1#1)
sensitivity and specificity of the procedure##2##6##(1990-7#1)(1993-6#1)
sensitivity and specificity of the##22##5##(1990-7#1)(1993-6#1)(1994-11#1)(1997-3#1)(1997-4#1)(2005-9#1)(2006-10#2)(2006-5#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2009-7#1)(2011-1#3)(2012-12#1)(2012-2#3)
sensitivity and specificity of##65##4##(1990-3#1)(1990-7#1)(1990-9#1)(1991-2#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-11#1)(1996-11#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#1)(2004-4#1)(2005-10#1)(2005-9#1)(2006-10#3)(2006-5#1)(2007-12#1)(2007-2#4)(2007-4#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-7#1)(2010-12#1)(2010-8#3)(2011-1#5)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)
sensitivity and specificity rates##2##4##(1990-10#1)(1992-2#1)
sensitivity and specificity to##3##4##(1992-6#1)(1997-3#1)(2007-2#1)
sensitivity and specificity values##2##4##(2009-7#1)(2010-8#1)
sensitivity and specificity were##4##4##(2008-5#1)(2011-1#1)(2013-1#2)
sensitivity and specificity##157##3##(1990-10#1)(1990-12#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-7#1)(1995-6#1)(1996-11#1)(1996-8#3)(1997-3#2)(1997-4#1)(1997-6#5)(2004-4#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-10#10)(2006-2#2)(2006-4#1)(2006-5#1)(2006-9#1)(2007-11#2)(2007-12#3)(2007-2#5)(2007-4#1)(2007-7#4)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-2#1)(2009-4#2)(2009-7#2)(2009-9#2)(2010-12#4)(2010-4#1)(2010-8#4)(2011-1#9)(2011-2#10)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#1)
sensitivity and speed##2##3##(1990-6#1)(2008-10#1)
sensitivity and stability of##2##4##(1990-8#1)(2008-10#1)
sensitivity and stability##9##3##(1990-8#1)(1997-1#1)(2007-8#1)(2008-10#6)
sensitivity and the specificity of##2##5##(2010-6#1)(2011-1#1)
sensitivity and the specificity##4##4##(1992-8#1)(2010-6#1)(2011-1#1)(2013-1#1)
sensitivity and the##14##3##(1992-3#1)(1992-8#1)(1995-12#1)(2007-12#2)(2008-10#3)(2008-7#1)(2010-3#1)(2010-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
sensitivity and throughput##2##3##(2008-4#1)(2010-2#1)
sensitivity and with an##2##4##(2008-10#1)(2008-3#1)
sensitivity and##466##2##(1990-10#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-2#4)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#1)(1993-12#1)(1993-2#3)(1993-3#2)(1993-6#2)(1994-11#3)(1994-3#3)(1994-4#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-12#3)(1995-3#1)(1995-6#1)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#2)(1996-6#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#5)(1997-4#2)(1997-6#5)(1997-7#1)(1997-8#2)(2004-4#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-4#3)(2005-8#1)(2005-9#1)(2006-10#14)(2006-11#2)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#1)(2006-9#3)(2007-11#5)(2007-12#9)(2007-2#7)(2007-4#1)(2007-7#7)(2007-8#12)(2007-9#6)(2008-1#2)(2008-10#109)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#20)(2008-4#14)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#4)(2009-1#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#18)(2011-12#2)(2011-2#16)(2012-1#2)(2012-12#12)(2012-2#7)(2012-3#10)(2013-1#9)(2013-7#2)(2013-8#6)
sensitivity approaching##2##2##(2006-6#1)(2008-5#1)
sensitivity are##14##2##(1991-4#1)(1992-3#1)(1996-9#1)(1997-4#1)(1997-8#1)(2008-10#6)(2008-3#1)(2010-10#1)(2012-2#1)
sensitivity as a function of the##2##6##(2008-2#1)(2009-5#1)
sensitivity as well as##3##4##(2007-8#1)(2008-10#1)(2008-5#1)
sensitivity as##10##2##(1991-2#1)(1991-6#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-5#1)(2009-5#1)
sensitivity aspects##2##2##(2008-10#1)(2010-4#1)
sensitivity at a##3##3##(1994-6#1)(2007-12#1)(2010-2#1)
sensitivity at the##3##3##(2008-10#2)(2008-2#1)
sensitivity at##15##2##(1990-5#1)(1991-2#1)(1993-9#1)(1994-6#1)(2006-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
sensitivity based on##2##3##(2008-1#1)(2008-5#1)
sensitivity being##2##2##(1991-5#1)(2008-10#1)
sensitivity between##4##2##(1992-11#1)(2008-10#2)(2008-3#1)
sensitivity but##5##2##(1992-11#1)(2008-2#1)(2008-3#1)(2012-12#1)(2013-8#1)
sensitivity by a factor of##4##5##(2006-2#1)(2007-8#1)(2008-10#2)
sensitivity by a##5##3##(2006-2#1)(2007-12#1)(2007-8#1)(2008-10#2)
sensitivity by##24##2##(1991-7#1)(1992-4#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-6#1)(1996-11#1)(1996-9#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#7)(2008-3#2)(2010-4#1)
sensitivity can be##4##3##(1995-2#1)(1997-6#1)(2008-10#1)(2008-2#1)
sensitivity can##7##2##(1995-2#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-2#1)(2008-3#1)
sensitivity characteristics##3##2##(2007-11#1)(2007-12#1)(2007-4#1)
sensitivity comparable with##2##3##(2007-12#1)(2008-3#1)
sensitivity comparable##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
sensitivity compared to##3##3##(1997-5#1)(2007-9#1)(2008-2#1)
sensitivity compared with that of##2##5##(2007-11#2)
sensitivity compared with the##2##4##(2008-10#1)(2008-3#1)
sensitivity compared with##7##3##(2007-11#3)(2008-10#2)(2008-3#1)(2012-11#1)
sensitivity compared##10##2##(1997-5#1)(2007-11#3)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-11#1)
sensitivity correction##2##2##(2008-10#1)(2008-3#1)
sensitivity could be##3##3##(1991-4#1)(1997-3#1)(1997-4#1)
sensitivity could##5##2##(1991-4#1)(1997-3#1)(1997-4#1)(2008-10#1)(2012-2#1)
sensitivity decreased##2##2##(1992-8#1)(2008-5#1)
sensitivity demonstrated##2##2##(2008-5#1)(2009-5#1)
sensitivity depends on##2##3##(2008-10#1)(2008-2#1)
sensitivity down to##2##3##(2008-10#1)(2010-2#1)
sensitivity drift##3##2##(2008-10#3)
sensitivity during##4##2##(2007-3#1)(2008-10#1)(2008-11#1)(2010-4#1)
sensitivity effects##2##2##(2008-2#2)
sensitivity enhanced##2##2##(2008-10#1)(2011-1#1)
sensitivity enhancement in##2##3##(2008-10#2)
sensitivity enhancement of##3##3##(2008-10#3)
sensitivity enhancement with##2##3##(2007-11#1)(2008-10#1)
sensitivity enhancement##12##2##(2007-11#1)(2007-12#2)(2008-10#8)(2008-3#1)
sensitivity for a##3##3##(2008-2#1)(2008-3#2)
sensitivity for all##3##3##(2008-10#2)(2011-1#1)
sensitivity for cell##3##3##(1991-1#2)(2009-5#1)
sensitivity for detecting##2##3##(1995-5#1)(2008-1#1)
sensitivity for detection of##3##4##(1995-2#1)(2007-12#1)(2008-3#1)
sensitivity for diagnosis of##3##4##(2006-7#1)(2008-3#1)(2008-6#1)
sensitivity for histamine##2##3##(1996-5#2)
sensitivity for hydrazine##2##3##(2008-10#2)
sensitivity for low##2##3##(2008-10#2)
sensitivity for some##2##3##(2006-11#1)(2007-8#1)
sensitivity for the detection of##3##5##(2006-10#1)(2008-10#2)
sensitivity for the detection##4##4##(1993-2#1)(2006-10#1)(2008-10#2)
sensitivity for the determination of##3##5##(2008-10#3)
sensitivity for the##14##3##(1993-2#2)(2006-10#1)(2008-10#10)(2008-2#1)
sensitivity for##96##2##(1990-5#1)(1991-1#4)(1991-12#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-6#3)(1993-2#2)(1994-12#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-6#1)(1997-7#1)(2005-3#1)(2005-4#1)(2006-10#2)(2006-11#2)(2006-7#1)(2007-12#2)(2007-6#1)(2007-8#3)(2008-1#2)(2008-10#31)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
sensitivity from##3##2##(1992-7#1)(2008-10#2)
sensitivity function##5##2##(1997-8#1)(2008-8#1)(2009-9#1)(2011-1#2)
sensitivity gene##3##2##(1995-6#2)(2008-10#1)
sensitivity has been developed for##2##5##(2008-10#2)
sensitivity has been##6##3##(2008-1#1)(2008-10#4)(2008-7#1)
sensitivity has decreased##2##3##(2007-7#1)(2008-3#1)
sensitivity has##12##2##(2005-11#1)(2007-7#3)(2008-1#1)(2008-10#4)(2008-3#1)(2008-7#1)(2013-8#1)
sensitivity improvement##2##2##(2008-10#1)(2008-3#1)
sensitivity in a##2##3##(1994-8#1)(2008-2#1)
sensitivity in relation to##2##4##(1992-2#1)(1992-8#1)
sensitivity in the detection of##3##5##(1992-10#1)(2007-12#1)(2008-7#1)
sensitivity in the##25##3##(1992-10#1)(1993-12#1)(1993-4#1)(2006-10#1)(2006-5#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-10#4)(2008-3#4)(2008-7#2)(2009-9#1)(2011-2#2)(2012-2#1)(2013-8#1)
sensitivity in these##2##3##(1991-7#1)(2007-5#1)
sensitivity in vitro##2##3##(2008-10#1)(2008-5#1)
sensitivity in##100##2##(1991-12#1)(1991-4#1)(1991-7#1)(1992-10#1)(1992-2#2)(1992-4#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-1#1)(1997-3#2)(1997-6#1)(1997-7#1)(2006-10#2)(2006-5#1)(2006-6#1)(2007-10#1)(2007-12#7)(2007-4#1)(2007-5#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-2#1)(2008-3#11)(2008-4#4)(2008-5#1)(2008-7#6)(2008-8#4)(2008-9#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-11#2)(2012-2#1)(2013-1#1)(2013-8#1)
sensitivity increase##2##2##(2008-10#2)
sensitivity increased##2##2##(1992-9#1)(2008-7#1)
sensitivity independent of##2##3##(2008-10#1)(2012-11#1)
sensitivity index##6##2##(1996-2#1)(1997-7#1)(2006-6#1)(2008-4#1)(2011-2#1)(2013-8#1)
sensitivity is achieved by##2##4##(2008-10#2)
sensitivity is achieved##5##3##(2007-8#1)(2008-10#2)(2008-3#1)(2008-9#1)
sensitivity is calculated##2##3##(2008-10#1)(2008-3#1)
sensitivity is dependent on the##2##5##(2007-8#1)(2008-4#1)
sensitivity is required##2##3##(2008-10#1)(2010-11#1)
sensitivity is##55##2##(1990-2#1)(1990-4#1)(1990-9#1)(1992-3#1)(1993-5#1)(1996-9#1)(1997-6#1)(2006-10#1)(2006-4#1)(2007-11#3)(2007-12#4)(2007-8#2)(2008-10#12)(2008-11#1)(2008-2#5)(2008-3#7)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-4#1)
sensitivity limitations##2##2##(2007-12#1)(2008-7#1)
sensitivity may##5##2##(1996-4#1)(2006-6#1)(2006-9#1)(2007-11#1)(2012-12#1)
sensitivity occurred##2##2##(1997-4#1)(2007-6#1)
sensitivity occurs##2##2##(2007-12#1)(2008-3#1)
sensitivity of 0##14##3##(1993-2#2)(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#4)(2008-5#1)(2013-1#1)
sensitivity of 1##9##3##(1991-9#1)(1993-2#1)(2007-11#2)(2008-10#4)(2010-4#1)
sensitivity of 2##3##3##(2008-10#2)(2008-3#1)
sensitivity of 3##5##3##(2008-10#2)(2008-3#2)(2013-1#1)
sensitivity of 4##2##3##(2007-12#1)(2007-7#1)
sensitivity of 5##2##3##(2008-3#2)
sensitivity of 8##2##3##(2007-9#1)(2008-10#1)
sensitivity of 88%##2##3##(1993-8#1)(2007-11#1)
sensitivity of 95##3##3##(1990-11#1)(1997-8#1)(2007-7#1)
sensitivity of CT##2##3##(2007-8#1)(2012-1#1)
sensitivity of MRI##2##3##(2006-10#1)(2011-2#1)
sensitivity of PCR##2##3##(1996-12#1)(2008-8#1)
sensitivity of T##2##3##(2008-10#2)
sensitivity of a biosensor##2##4##(2007-8#1)(2008-10#1)
sensitivity of a single##3##4##(1995-6#1)(1996-12#1)(2007-12#1)
sensitivity of a##26##3##(1994-2#1)(1994-9#1)(1995-12#1)(1995-4#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-6#1)(2006-10#1)(2006-7#1)(2007-12#5)(2007-7#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-7#1)(2011-2#1)
sensitivity of all##2##3##(2008-10#2)
sensitivity of an##4##3##(2007-12#1)(2008-1#2)(2011-2#1)
sensitivity of approximately##2##3##(1997-3#1)(2006-5#1)
sensitivity of blood pressure##3##4##(2008-7#3)
sensitivity of blood##4##3##(2008-7#3)(2012-1#1)
sensitivity of both##7##3##(1993-9#1)(1997-7#1)(2008-4#1)(2008-8#1)(2009-4#1)(2010-5#1)(2011-2#1)
sensitivity of cells to##2##4##(2008-11#1)(2008-9#1)
sensitivity of clinical##2##3##(1990-12#1)(1991-4#1)
sensitivity of conventional##3##3##(1997-5#1)(2006-10#1)(2008-10#1)
sensitivity of detection##5##3##(2005-12#1)(2006-10#1)(2008-10#1)(2008-5#1)(2010-7#1)
sensitivity of determination##3##3##(2005-4#1)(2008-10#1)(2011-1#1)
sensitivity of each##2##3##(2008-10#1)(2008-8#1)
sensitivity of fiber distributed-feedback##2##4##(2008-3#2)
sensitivity of fluorescence##2##3##(1991-9#1)(2008-10#1)
sensitivity of gene##2##3##(1994-3#1)(2008-4#1)
sensitivity of highly birefringent fibers to temperature and hydrostatic pressure##2##10##(2008-2#2)
sensitivity of human##4##3##(1993-9#1)(1994-8#1)(1997-7#1)(2008-5#1)
sensitivity of less than##2##4##(2008-10#1)(2008-3#1)
sensitivity of malignant##2##3##(1994-11#1)(2008-11#1)
sensitivity of muscle##3##3##(1996-9#1)(2006-12#1)(2009-5#1)
sensitivity of optical##3##3##(2008-3#2)(2011-1#1)
sensitivity of protein##2##3##(2007-8#1)(2008-4#1)
sensitivity of rat##3##3##(1996-12#1)(1996-5#1)(2008-9#1)
sensitivity of serum##2##3##(1990-2#1)(1995-4#1)
sensitivity of such##2##3##(2008-2#2)
sensitivity of target tissues##2##4##(1994-11#1)(1997-7#1)
sensitivity of target##3##3##(1994-11#1)(1997-7#1)(2010-5#1)
sensitivity of the 'König' reaction##2##5##(1993-8#2)
sensitivity of the Amplitype PM##2##5##(1996-7#2)
sensitivity of the CCD##2##4##(2006-4#1)(2008-5#1)
sensitivity of the ELISA was##2##5##(1990-2#1)(2011-2#1)
sensitivity of the ELISA##5##4##(1990-12#1)(1990-2#1)(1997-3#1)(2005-9#1)(2011-2#1)
sensitivity of the assay was##3##5##(1992-7#1)(1996-9#1)(2008-10#1)
sensitivity of the assay##5##4##(1990-12#1)(1992-7#1)(1993-11#1)(1996-9#1)(2008-10#1)
sensitivity of the biosensor##2##4##(2008-10#2)
sensitivity of the complex##2##4##(2008-10#2)
sensitivity of the determination of##2##5##(2008-10#2)
sensitivity of the device to##2##5##(2007-11#1)(2008-3#1)
sensitivity of the device##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
sensitivity of the electrode##3##4##(2008-10#3)
sensitivity of the fluorescence##3##4##(1990-12#1)(2008-10#1)(2008-3#1)
sensitivity of the human##2##4##(1995-7#1)(2008-3#1)
sensitivity of the instrument##2##4##(2008-2#2)
sensitivity of the isolates##2##4##(2007-7#1)(2008-10#1)
sensitivity of the measured##2##4##(2008-2#1)(2008-3#1)
sensitivity of the method as##2##5##(2008-10#2)
sensitivity of the method can be increased##2##7##(2008-10#2)
sensitivity of the method was##6##5##(2007-11#1)(2008-10#3)(2009-2#2)
sensitivity of the method##31##4##(1990-12#2)(1990-8#1)(1992-6#1)(1996-12#1)(1997-8#1)(2007-11#1)(2008-10#19)(2008-2#1)(2008-3#1)(2008-5#1)(2009-2#2)
sensitivity of the methods##3##4##(1990-6#1)(2008-10#2)
sensitivity of the microprobes##2##4##(2008-2#2)
sensitivity of the proposed method##2##5##(2008-10#2)
sensitivity of the proposed##3##4##(2008-10#2)(2008-2#1)
sensitivity of the protein##2##4##(2008-4#1)(2008-9#1)
sensitivity of the sensor to##2##5##(2008-2#1)(2008-3#1)
sensitivity of the sensor##6##4##(2008-10#3)(2008-2#2)(2008-3#1)
sensitivity of the system##5##4##(2007-12#1)(2008-11#1)(2008-2#2)(2012-2#1)
sensitivity of the target##2##4##(1994-11#1)(2008-10#1)
sensitivity of the technique##2##4##(2007-12#1)(2008-3#1)
sensitivity of the test##4##4##(1991-12#1)(2005-8#1)(2008-3#1)(2010-4#1)
sensitivity of the three##2##4##(2010-8#1)(2013-8#1)
sensitivity of the two##5##4##(1991-6#1)(1996-9#1)(2007-12#1)(2008-10#1)(2010-9#1)
sensitivity of the##268##3##(1990-11#3)(1990-12#7)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-2#1)(1994-4#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-7#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#2)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#3)(2004-10#1)(2005-1#1)(2005-10#1)(2005-4#1)(2005-8#1)(2005-9#1)(2006-10#6)(2006-11#1)(2006-4#1)(2006-5#1)(2007-11#4)(2007-12#10)(2007-7#2)(2007-8#4)(2008-10#77)(2008-11#4)(2008-12#1)(2008-2#18)(2008-3#21)(2008-4#10)(2008-5#5)(2008-8#2)(2008-9#3)(2009-11#1)(2009-2#3)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#5)
sensitivity of thermal##3##3##(2007-12#1)(2008-10#2)
sensitivity of these##16##3##(1990-11#1)(1990-7#1)(1994-11#1)(1997-2#2)(2004-2#1)(2006-11#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-10#3)(2010-4#2)(2012-1#1)
sensitivity of this method##6##4##(1996-8#1)(2008-10#3)(2008-7#1)(2010-12#1)
sensitivity of this technique##2##4##(1993-12#1)(2008-3#1)
sensitivity of this##27##3##(1990-11#1)(1990-4#1)(1991-6#1)(1992-4#1)(1992-7#1)(1993-12#1)(1996-8#1)(1997-8#1)(2006-10#2)(2007-6#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
sensitivity of three##2##3##(2007-12#1)(2009-10#1)
sensitivity of tumors##2##3##(2008-5#1)(2013-7#1)
sensitivity of##815##2##(1990-10#1)(1990-11#7)(1990-12#10)(1990-2#4)(1990-3#1)(1990-4#2)(1990-5#4)(1990-6#2)(1990-7#2)(1990-8#4)(1990-9#2)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#3)(1991-4#3)(1991-6#3)(1991-8#3)(1991-9#3)(1992-1#3)(1992-10#1)(1992-11#2)(1992-2#2)(1992-3#4)(1992-4#4)(1992-5#1)(1992-6#3)(1992-7#4)(1992-8#3)(1993-1#4)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#4)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#4)(1993-9#4)(1994-1#2)(1994-11#5)(1994-2#5)(1994-3#3)(1994-4#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-10#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-4#5)(1995-6#2)(1995-7#4)(1995-8#1)(1996-11#3)(1996-12#7)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#3)(1996-9#5)(1997-1#1)(1997-2#7)(1997-3#8)(1997-4#7)(1997-5#5)(1997-6#4)(1997-7#5)(1997-8#9)(2004-1#1)(2004-10#1)(2004-2#5)(2005-1#2)(2005-10#1)(2005-11#2)(2005-12#3)(2005-4#4)(2005-7#1)(2005-8#2)(2005-9#4)(2006-10#21)(2006-11#3)(2006-12#1)(2006-2#4)(2006-4#1)(2006-5#3)(2006-7#2)(2006-8#3)(2007-1#2)(2007-10#2)(2007-11#12)(2007-12#33)(2007-3#3)(2007-5#1)(2007-6#3)(2007-7#6)(2007-8#13)(2007-9#4)(2008-1#10)(2008-10#158)(2008-11#18)(2008-12#1)(2008-2#31)(2008-3#63)(2008-4#16)(2008-5#14)(2008-6#2)(2008-7#10)(2008-8#10)(2008-9#11)(2009-10#2)(2009-11#1)(2009-2#3)(2009-4#4)(2009-5#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-3#1)(2010-4#4)(2010-5#5)(2010-7#3)(2010-8#4)(2010-9#3)(2011-1#8)(2011-12#3)(2011-2#17)(2012-1#6)(2012-12#2)(2012-2#5)(2012-3#3)(2012-6#1)(2013-1#7)(2013-7#4)(2013-8#10)
sensitivity on the##7##3##(1990-12#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#1)(2013-1#1)
sensitivity on##11##2##(1990-12#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#1)(2013-1#1)
sensitivity or resistance of##2##4##(1993-3#1)(1993-8#1)
sensitivity or resistance##3##3##(1993-3#1)(1993-8#1)(2011-2#1)
sensitivity or##6##2##(1991-3#1)(1993-3#1)(1993-8#1)(2008-3#1)(2009-7#1)(2011-2#1)
sensitivity over a##3##3##(2008-10#1)(2008-2#2)
sensitivity over##5##2##(1997-2#1)(2008-10#1)(2008-2#2)(2009-7#1)
sensitivity pattern##4##2##(2007-7#3)(2013-8#1)
sensitivity patterns##3##2##(2010-4#1)(2013-8#2)
sensitivity provided by the##2##4##(1992-4#1)(2011-2#1)
sensitivity provides##2##2##(1995-2#1)(1996-2#1)
sensitivity required##6##2##(1992-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)
sensitivity results##2##2##(2007-10#1)(2007-12#1)
sensitivity similar to##2##3##(1991-10#1)(2008-10#1)
sensitivity studies##2##2##(2006-11#1)(2008-2#1)
sensitivity study##7##2##(2008-3#7)
sensitivity suggest that##2##3##(1991-9#1)(2012-11#1)
sensitivity suggest##3##2##(1991-9#1)(2008-10#1)(2012-11#1)
sensitivity syndrome##2##2##(1991-3#1)(2007-10#1)
sensitivity test for##3##3##(2007-2#2)(2011-1#1)
sensitivity test##5##2##(2007-2#2)(2008-11#1)(2011-1#1)(2011-2#1)
sensitivity testing of the##2##4##(2007-7#1)(2012-3#1)
sensitivity testing of##3##3##(2007-7#1)(2012-3#1)(2013-8#1)
sensitivity testing##10##2##(1990-12#1)(1991-12#1)(2007-7#2)(2008-12#1)(2008-5#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
sensitivity tests##9##2##(1992-10#1)(1996-6#1)(2006-5#1)(2007-7#3)(2008-10#1)(2008-4#1)(2009-9#1)
sensitivity than the##3##3##(1992-5#1)(2007-12#1)(2008-7#1)
sensitivity than##16##2##(1992-5#1)(1992-8#2)(1997-8#1)(2006-6#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-7#1)(2011-2#2)
sensitivity that corresponds to##2##4##(2008-10#1)(2008-2#1)
sensitivity that is##2##3##(2007-11#1)(2008-10#1)
sensitivity that##9##2##(2007-11#2)(2008-10#6)(2008-2#1)
sensitivity threshold##2##2##(2008-3#1)(2011-2#1)
sensitivity to 2##3##3##(1992-10#1)(2008-10#2)
sensitivity to Ptr ToxA##2##4##(2008-10#2)
sensitivity to Ptr##3##3##(2008-10#3)
sensitivity to a##2##3##(1993-12#1)(1995-2#1)
sensitivity to activation by##2##4##(1990-3#2)
sensitivity to all##2##3##(1994-6#2)
sensitivity to amikacin##2##3##(2007-7#2)
sensitivity to an##2##3##(1997-3#1)(2008-5#1)
sensitivity to both##2##3##(1990-10#1)(2008-10#1)
sensitivity to bryostatin-1##2##3##(1992-6#2)
sensitivity to changes in##3##4##(1992-3#1)(2008-2#1)(2012-11#1)
sensitivity to chemotherapeutic##2##3##(1997-7#1)(2013-7#1)
sensitivity to chemotherapy##2##3##(2006-8#1)(2012-1#1)
sensitivity to convulsions induced by##2##5##(1993-12#1)(1993-4#1)
sensitivity to convulsions##3##3##(1993-12#2)(1993-4#1)
sensitivity to damage##2##3##(1994-12#1)(1997-2#1)
sensitivity to detect##3##3##(2005-8#1)(2008-10#1)(2008-8#1)
sensitivity to dopamine##2##3##(1993-12#1)(2009-12#1)
sensitivity to growth stimulation by estrogen##2##6##(2008-11#2)
sensitivity to growth##4##3##(1995-10#1)(2008-11#3)
sensitivity to inhibition by##4##4##(1990-7#1)(1991-6#1)(1995-11#1)(2007-11#1)
sensitivity to insulin and##2##4##(2008-1#1)(2011-1#1)
sensitivity to insulin##5##3##(1991-7#1)(1996-11#1)(2008-1#1)(2011-1#1)(2013-8#1)
sensitivity to low##2##3##(2007-12#1)(2009-8#1)
sensitivity to lysis##2##3##(1990-11#2)
sensitivity to metalaxyl##4##3##(2008-10#4)
sensitivity to mutation##3##3##(1994-5#1)(1997-3#2)
sensitivity to nicotine-induced seizures##2##4##(1996-12#2)
sensitivity to nicotine-induced##3##3##(1996-12#3)
sensitivity to noise##2##3##(2008-3#2)
sensitivity to optical##2##3##(2007-11#1)(2008-2#1)
sensitivity to pH##2##3##(1997-8#1)(2008-10#1)
sensitivity to propiconazole increased##2##4##(2008-10#2)
sensitivity to propiconazole##3##3##(2008-10#3)
sensitivity to radiation or##2##4##(1991-7#2)
sensitivity to radiation##3##3##(1991-7#2)(1993-12#1)
sensitivity to selenite##3##3##(1992-7#3)
sensitivity to serum##3##3##(1991-8#2)(1995-5#1)
sensitivity to small##3##3##(2008-2#1)(2008-3#2)
sensitivity to surface##2##3##(2007-12#1)(2008-2#1)
sensitivity to temperature##4##3##(2008-2#1)(2008-3#1)(2008-7#1)(2012-6#1)
sensitivity to the fungicide mefenoxam##2##5##(2008-10#2)
sensitivity to the inhibitor##2##4##(1994-9#1)(1996-5#1)
sensitivity to the presence of##3##5##(1992-8#1)(1994-10#1)(2008-7#1)
sensitivity to the toxin##3##4##(2008-10#3)
sensitivity to the##53##3##(1991-8#1)(1992-2#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-10#1)(1994-3#1)(1994-9#2)(1995-12#1)(1996-4#1)(1996-5#1)(2005-11#1)(2005-9#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#7)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-2#1)(2010-5#1)(2010-8#1)(2012-3#1)
sensitivity to their##2##3##(2009-9#1)(2011-12#1)
sensitivity to these##3##3##(1994-3#1)(2008-2#1)(2009-4#1)
sensitivity to this##4##3##(1990-7#1)(2008-10#2)(2008-7#1)
sensitivity to treatment##2##3##(2007-1#1)(2012-2#1)
sensitivity to ultraviolet##2##3##(1990-5#1)(1997-1#1)
sensitivity to vancomycin##3##3##(2006-10#1)(2007-7#2)
sensitivity to various##3##3##(1992-7#1)(2007-6#1)(2009-8#1)
sensitivity to##422##2##(1990-10#1)(1990-11#7)(1990-12#5)(1990-2#1)(1990-3#7)(1990-5#6)(1990-7#2)(1990-8#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#3)(1991-6#2)(1991-7#7)(1991-8#6)(1991-9#3)(1992-1#1)(1992-10#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#8)(1992-8#1)(1992-9#4)(1993-12#6)(1993-3#3)(1993-4#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#4)(1994-9#2)(1995-1#1)(1995-10#2)(1995-11#3)(1995-12#6)(1995-2#3)(1995-5#2)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#6)(1996-2#1)(1996-4#2)(1996-5#3)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#5)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#1)(2004-12#1)(2004-4#2)(2005-11#2)(2005-8#4)(2005-9#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#7)(2007-12#4)(2007-2#1)(2007-3#3)(2007-6#1)(2007-7#4)(2007-8#5)(2007-9#2)(2008-1#9)(2008-10#61)(2008-11#12)(2008-12#3)(2008-2#18)(2008-3#18)(2008-4#4)(2008-5#8)(2008-7#9)(2008-8#6)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#5)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#3)(2010-6#1)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#2)(2012-3#5)(2012-6#1)(2013-1#2)(2013-7#3)(2013-8#2)
sensitivity toward prolactin##2##3##(1994-11#2)
sensitivity toward##4##2##(1994-11#2)(1997-1#1)(2013-1#1)
sensitivity towards##8##2##(1990-7#1)(1993-8#1)(2005-7#1)(2008-10#3)(2008-11#1)(2008-8#1)
sensitivity using a##2##3##(1992-7#1)(2004-2#1)
sensitivity using##6##2##(1992-3#1)(1992-7#1)(2004-2#1)(2009-11#1)(2009-8#1)(2012-2#1)
sensitivity value of##2##3##(2006-1#1)(2012-2#1)
sensitivity versus##2##2##(2008-10#1)(2008-2#1)
sensitivity was 0##3##3##(1992-6#1)(2008-10#1)(2011-1#1)
sensitivity was 65%##2##3##(2005-8#1)(2006-10#1)
sensitivity was achieved##3##3##(2007-8#1)(2008-10#2)
sensitivity was assessed by##2##4##(2008-3#1)(2008-5#1)
sensitivity was assessed in##2##4##(2008-10#1)(2008-7#1)
sensitivity was assessed##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)
sensitivity was determined to be##2##5##(2007-8#1)(2008-3#1)
sensitivity was determined##4##3##(2007-8#1)(2008-3#1)(2010-5#1)(2011-2#1)
sensitivity was evaluated##2##3##(2006-10#1)(2013-8#1)
sensitivity was found for meticlorpindol/ methylbenzoquate##2##6##(2007-6#2)
sensitivity was found for##5##4##(2007-6#5)
sensitivity was found to##2##4##(2007-6#1)(2007-8#1)
sensitivity was found##8##3##(1997-8#1)(2007-6#6)(2007-8#1)
sensitivity was improved##4##3##(1992-3#1)(2008-10#2)(2012-3#1)
sensitivity was investigated##3##3##(1993-9#1)(2008-10#2)
sensitivity was more##2##3##(1997-7#1)(2006-5#1)
sensitivity was obtained by##2##4##(2008-10#2)
sensitivity was obtained using##2##4##(2008-10#1)(2011-12#1)
sensitivity was obtained##7##3##(1990-9#1)(2008-10#5)(2011-12#1)
sensitivity was only##3##3##(1992-5#1)(1996-7#1)(2007-7#1)
sensitivity was shown##2##3##(2008-10#2)
sensitivity was##95##2##(1990-12#1)(1990-2#1)(1990-6#2)(1990-9#1)(1991-2#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1993-9#4)(1994-12#1)(1996-12#1)(1996-2#1)(1996-7#2)(1997-1#1)(1997-7#1)(1997-8#1)(2004-2#1)(2005-11#1)(2005-4#1)(2005-8#1)(2006-10#2)(2006-5#1)(2007-3#1)(2007-6#6)(2007-7#1)(2007-8#4)(2008-10#28)(2008-11#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#2)(2009-8#1)(2010-5#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
sensitivity were##19##2##(1992-2#1)(1994-3#1)(1996-7#1)(2007-8#1)(2008-10#14)(2008-5#1)
sensitivity when##6##2##(1994-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-12#1)(2013-8#1)
sensitivity whereas##2##2##(1996-2#1)(2008-3#1)
sensitivity which##3##2##(1996-1#1)(2008-10#1)(2011-2#1)
sensitivity with no##2##3##(2008-11#1)(2008-12#1)
sensitivity with##14##2##(2005-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-9#1)(2009-9#1)(2012-8#1)(2013-8#1)
sensitivity without##6##2##(2008-10#1)(2008-3#1)(2008-4#1)(2009-11#1)(2010-2#1)(2012-2#1)
sensitivity would##2##2##(2008-3#1)(2012-12#1)
sensitivity##3286##1##(1990-10#6)(1990-11#16)(1990-12#24)(1990-2#11)(1990-3#10)(1990-4#3)(1990-5#12)(1990-6#6)(1990-7#11)(1990-8#6)(1990-9#5)(1991-1#5)(1991-10#7)(1991-11#1)(1991-12#9)(1991-2#13)(1991-3#5)(1991-4#8)(1991-5#2)(1991-6#11)(1991-7#11)(1991-8#9)(1991-9#8)(1992-1#6)(1992-10#5)(1992-11#7)(1992-12#1)(1992-2#18)(1992-3#15)(1992-4#9)(1992-5#8)(1992-6#14)(1992-7#16)(1992-8#13)(1992-9#6)(1993-1#5)(1993-10#3)(1993-11#4)(1993-12#13)(1993-2#11)(1993-3#9)(1993-4#5)(1993-5#1)(1993-6#5)(1993-7#2)(1993-8#6)(1993-9#15)(1994-1#3)(1994-10#2)(1994-11#15)(1994-12#12)(1994-2#8)(1994-3#13)(1994-4#2)(1994-5#5)(1994-6#9)(1994-7#1)(1994-8#2)(1994-9#11)(1995-1#2)(1995-10#4)(1995-11#6)(1995-12#17)(1995-2#10)(1995-3#5)(1995-4#6)(1995-5#4)(1995-6#9)(1995-7#5)(1995-8#4)(1996-1#3)(1996-11#11)(1996-12#21)(1996-2#10)(1996-3#6)(1996-4#4)(1996-5#7)(1996-6#5)(1996-7#7)(1996-8#10)(1996-9#11)(1997-1#9)(1997-2#13)(1997-3#24)(1997-4#18)(1997-5#8)(1997-6#15)(1997-7#16)(1997-8#21)(2004-1#3)(2004-10#1)(2004-12#1)(2004-2#9)(2004-4#4)(2004-9#1)(2005-1#3)(2005-10#3)(2005-11#10)(2005-12#7)(2005-3#1)(2005-4#11)(2005-7#2)(2005-8#9)(2005-9#7)(2006-1#3)(2006-10#68)(2006-11#10)(2006-12#4)(2006-2#10)(2006-3#3)(2006-4#4)(2006-5#12)(2006-6#6)(2006-7#5)(2006-8#7)(2006-9#5)(2007-1#5)(2007-10#12)(2007-11#45)(2007-12#100)(2007-2#15)(2007-3#11)(2007-4#3)(2007-5#4)(2007-6#14)(2007-7#36)(2007-8#64)(2007-9#21)(2008-1#32)(2008-10#735)(2008-11#50)(2008-12#14)(2008-2#118)(2008-3#213)(2008-4#65)(2008-5#56)(2008-6#8)(2008-7#57)(2008-8#29)(2008-9#38)(2009-1#2)(2009-10#4)(2009-11#4)(2009-12#7)(2009-2#7)(2009-3#5)(2009-4#14)(2009-5#11)(2009-6#4)(2009-7#8)(2009-8#13)(2009-9#12)(2010-1#4)(2010-10#8)(2010-11#6)(2010-12#14)(2010-2#13)(2010-3#2)(2010-4#14)(2010-5#20)(2010-6#4)(2010-7#7)(2010-8#14)(2010-9#7)(2011-1#53)(2011-12#8)(2011-2#82)(2012-1#13)(2012-11#9)(2012-12#36)(2012-2#39)(2012-3#32)(2012-6#2)(2012-8#2)(2013-1#35)(2013-7#14)(2013-8#33)
sensitivity) in##2##2##(1997-4#1)(2008-10#1)
sensitivity)##14##1##(1991-4#1)(1997-4#1)(2007-2#2)(2007-9#3)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-1#1)(2013-8#1)
sensitivity/resistance##4##1##(1994-6#1)(2007-7#1)(2012-12#2)
sensitivity/specificity##3##1##(2006-10#1)(2007-9#1)(2010-6#1)
sensitivity?##3##1##(1992-4#1)(2008-1#1)(2012-2#1)
sensitivity]##2##1##(2006-6#1)(2011-2#1)
sensitization and a##3##3##(2007-12#2)(2008-1#1)
sensitization and##11##2##(1991-11#1)(2006-10#1)(2006-8#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-8#1)(2008-9#1)(2009-8#1)
sensitization during##2##2##(1993-3#1)(2009-3#1)
sensitization following##2##2##(1992-12#1)(2008-9#1)
sensitization for##2##2##(1995-5#1)(2007-8#1)
sensitization has##2##2##(2006-10#1)(2009-7#1)
sensitization in##10##2##(1995-5#1)(1996-10#2)(2008-10#4)(2009-8#1)(2009-9#1)(2011-2#1)
sensitization is not##2##3##(1997-8#1)(2013-1#1)
sensitization is##6##2##(1991-6#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-12#1)(2013-1#1)
sensitization may be##2##3##(1994-11#1)(2005-10#1)
sensitization of mice##2##3##(1991-5#1)(2010-5#1)
sensitization of nociceptors##2##3##(1995-12#1)(1996-3#1)
sensitization of the##7##3##(1994-2#1)(1996-11#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-9#1)(2009-7#1)
sensitization of##23##2##(1991-5#2)(1992-5#1)(1993-8#1)(1994-2#1)(1995-12#2)(1996-11#1)(1996-12#1)(1996-3#2)(2006-10#2)(2007-11#1)(2007-3#1)(2008-10#3)(2008-9#2)(2009-7#1)(2009-9#1)(2010-5#1)
sensitization potential in##2##3##(1997-2#1)(2008-10#1)
sensitization potential of##3##3##(2008-10#3)
sensitization potential##6##2##(1997-2#1)(2008-10#5)
sensitization syndrome##3##2##(2009-7#1)(2011-2#1)(2012-12#1)
sensitization test##3##2##(2008-10#1)(2009-2#1)(2012-12#1)
sensitization tests##2##2##(1993-3#1)(2008-10#1)
sensitization to frightening images##3##4##(1996-10#3)
sensitization to methamphetamine was##2##4##(1993-3#2)
sensitization to methamphetamine##3##3##(1993-3#3)
sensitization to the##4##3##(1991-2#1)(1992-8#1)(1993-6#1)(1996-10#1)
sensitization to this##2##3##(1991-8#1)(1993-6#1)
sensitization to##32##2##(1990-3#1)(1991-1#1)(1991-11#3)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-8#1)(1993-3#3)(1993-6#2)(1995-12#2)(1996-10#6)(2007-11#1)(2007-2#1)(2008-10#1)(2008-4#1)(2012-2#1)(2012-3#1)(2013-1#3)
sensitization was##4##2##(1997-7#1)(2006-11#1)(2008-10#1)(2009-9#1)
sensitization with##5##2##(1991-5#2)(1997-1#1)(2008-11#1)(2008-3#1)
sensitization##199##1##(1990-3#1)(1991-1#2)(1991-11#5)(1991-12#1)(1991-2#1)(1991-5#7)(1991-6#6)(1991-8#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-8#1)(1993-3#9)(1993-5#1)(1993-6#2)(1993-8#2)(1994-11#1)(1994-2#1)(1994-3#1)(1995-12#8)(1995-2#1)(1995-3#3)(1995-5#3)(1996-10#12)(1996-11#1)(1996-12#1)(1996-3#2)(1997-1#1)(1997-2#2)(1997-7#2)(1997-8#6)(2005-10#1)(2005-11#2)(2006-10#13)(2006-11#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#2)(2007-8#3)(2008-1#1)(2008-10#25)(2008-11#3)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#1)(2008-8#1)(2008-9#5)(2009-2#1)(2009-3#1)(2009-7#3)(2009-8#4)(2009-9#4)(2010-4#2)(2010-5#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#1)
sensitize##12##1##(1993-9#1)(1994-11#1)(1995-1#1)(1996-3#1)(2006-10#1)(2007-10#2)(2007-11#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-4#1)
sensitized and##5##2##(1992-3#1)(2005-10#1)(2008-10#2)(2012-2#1)
sensitized animals##2##2##(1991-6#2)
sensitized by hypocrellin B##2##4##(2008-8#2)
sensitized by hypocrellin##4##3##(2008-8#4)
sensitized by##22##2##(1990-2#1)(1992-1#1)(1993-3#1)(1993-8#1)(1994-8#1)(2005-10#1)(2005-4#1)(2008-10#8)(2008-8#5)(2010-4#1)(2011-1#1)
sensitized fluorescence##2##2##(2008-10#2)
sensitized gelatin##6##2##(2007-11#1)(2008-2#3)(2008-3#2)
sensitized in##3##2##(1991-12#1)(2005-10#1)(2011-2#1)
sensitized modified##2##2##(2008-10#2)
sensitized ormosil-modified electrodes##2##3##(2008-10#2)
sensitized patients##2##2##(2007-2#1)(2010-5#1)
sensitized rats##3##2##(1996-10#1)(1997-8#1)(2008-5#1)
sensitized recipients##2##2##(1995-2#2)
sensitized the##2##2##(2008-10#1)(2010-2#1)
sensitized to the##2##3##(1991-11#1)(1997-4#1)
sensitized to##14##2##(1991-1#1)(1991-11#1)(1995-5#1)(1997-4#1)(1997-8#6)(2005-10#1)(2007-2#1)(2008-10#1)(2011-1#1)
sensitized with##10##2##(1992-1#2)(1992-12#2)(1995-12#1)(1996-5#1)(1997-5#1)(2008-11#2)(2008-3#1)
sensitized##116##1##(1990-2#3)(1991-1#1)(1991-11#1)(1991-12#2)(1991-6#3)(1992-1#3)(1992-12#3)(1992-3#1)(1992-6#1)(1993-3#2)(1993-8#1)(1994-2#1)(1994-8#1)(1995-11#2)(1995-12#2)(1995-2#5)(1995-5#1)(1995-8#1)(1996-10#2)(1996-12#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#7)(2005-10#4)(2005-4#1)(2005-8#1)(2007-11#1)(2007-2#2)(2007-3#1)(2008-10#30)(2008-11#2)(2008-2#3)(2008-3#3)(2008-5#1)(2008-8#5)(2009-8#1)(2010-2#1)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#2)
sensitizer for##2##2##(1992-1#1)(2007-11#1)
sensitizer in##2##2##(2007-11#1)(2007-3#1)
sensitizer is##2##2##(1992-2#1)(2008-10#1)
sensitizer through##2##2##(2007-12#1)(2009-2#1)
sensitizer##31##1##(1991-3#1)(1992-1#3)(1992-2#2)(1992-6#1)(1992-8#1)(1994-6#1)(1995-8#1)(1997-2#3)(2006-1#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-9#2)(2009-11#1)(2009-2#1)(2012-11#2)(2012-12#1)
sensitizers in##4##2##(2007-3#1)(2008-10#2)(2008-5#1)
sensitizers with##3##2##(1993-12#1)(1993-8#1)(2008-10#1)
sensitizers##26##1##(1993-12#1)(1993-8#2)(1994-3#1)(2005-8#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#9)(2008-3#1)(2008-5#1)(2008-8#1)(2012-12#1)(2013-1#1)
sensitizes cells to##2##3##(1994-5#2)
sensitizes cells##3##2##(1994-5#3)
sensitizes the##5##2##(1997-7#1)(2005-11#1)(2007-12#1)(2008-8#1)(2011-2#1)
sensitizes##13##1##(1993-11#1)(1993-12#1)(1994-5#3)(1997-7#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-4#1)(2011-2#2)
sensitizing agent##3##2##(1990-4#1)(1994-6#1)(2012-12#1)
sensitizing agents##2##2##(2012-12#2)
sensitizing dose##2##2##(2008-10#2)
sensitizing effect of##7##3##(1994-2#1)(2005-4#1)(2008-10#5)
sensitizing effect##8##2##(1994-2#1)(2005-4#1)(2008-10#6)
sensitizing potency##7##2##(2008-5#7)
sensitizing potential##4##2##(1995-11#1)(1997-2#1)(2008-10#1)(2008-9#1)
sensitizing properties##3##2##(1997-2#2)(2007-10#1)
sensitizing reagent##3##2##(2007-8#1)(2008-10#1)(2008-4#1)
sensitizing##57##1##(1990-4#1)(1991-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-3#1)(1997-2#4)(1997-7#1)(2005-4#2)(2005-8#1)(2007-10#1)(2007-12#2)(2007-2#3)(2007-8#1)(2008-10#14)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#11)(2008-9#1)(2010-11#1)(2012-12#3)
sensivity of##3##2##(1995-4#1)(2007-11#1)(2008-10#1)
sensor achieved##2##2##(2008-10#2)
sensor also##3##2##(2008-10#2)(2013-1#1)
sensor and a phase-shifting interferometer for##2##6##(2008-3#2)
sensor and a##11##3##(2007-12#2)(2008-10#3)(2008-2#4)(2008-3#2)
sensor and conventional##2##3##(2007-8#1)(2008-3#1)
sensor and is##2##3##(2006-6#1)(2008-3#1)
sensor and its##2##3##(2008-2#1)(2008-7#1)
sensor and the##6##3##(1992-5#1)(2008-10#3)(2008-3#1)(2010-2#1)
sensor and##49##2##(1992-5#1)(2006-5#1)(2006-6#2)(2007-12#4)(2007-8#1)(2008-10#14)(2008-2#9)(2008-3#12)(2008-5#1)(2008-7#2)(2010-2#1)(2012-3#1)
sensor applications##12##2##(2008-10#5)(2008-2#1)(2008-3#4)(2008-7#1)(2009-11#1)
sensor approach##2##2##(2007-12#1)(2008-3#1)
sensor are described##2##3##(2008-10#1)(2008-3#1)
sensor are discussed##2##3##(2008-2#1)(2008-3#1)
sensor are##11##2##(2007-11#1)(2008-10#2)(2008-2#4)(2008-3#3)(2011-1#1)
sensor array based on##2##4##(2008-10#1)(2008-3#1)
sensor array for##5##3##(2008-10#1)(2008-3#1)(2010-5#1)(2013-1#2)
sensor array to the##2##4##(2008-10#1)(2013-1#1)
sensor array using##3##3##(2007-12#1)(2008-1#1)(2008-10#1)
sensor array with##2##3##(2008-10#2)
sensor array##29##2##(2007-12#3)(2008-1#3)(2008-10#12)(2008-3#2)(2008-7#1)(2009-11#2)(2010-5#1)(2013-1#5)
sensor arrays with##2##3##(2007-12#1)(2008-1#1)
sensor arrays##9##2##(2006-6#1)(2007-12#3)(2007-9#2)(2008-1#1)(2008-2#1)(2008-3#1)
sensor as a##4##3##(2008-10#3)(2008-3#1)
sensor at##5##2##(2007-10#1)(2007-12#1)(2008-10#2)(2008-3#1)
sensor based on 2##2##4##(2008-10#2)
sensor based on a##13##4##(2007-11#1)(2007-12#2)(2008-10#6)(2008-2#1)(2008-3#3)
sensor based on an##2##4##(2008-10#2)
sensor based on optical##2##4##(2007-11#2)
sensor based on the##13##4##(2005-10#1)(2006-12#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#2)
sensor based on##67##3##(2005-10#1)(2006-12#1)(2007-11#4)(2007-12#5)(2007-8#2)(2008-10#40)(2008-2#5)(2008-3#6)(2009-6#1)(2013-1#2)
sensor by use of a##2##5##(2007-12#1)(2008-3#1)
sensor by##10##2##(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#2)
sensor calibration##2##2##(2008-7#1)(2010-4#1)
sensor can be used as a##2##6##(2008-10#1)(2008-3#1)
sensor can be used for##2##5##(2008-10#2)
sensor can be used to##2##5##(2008-10#2)
sensor can be used##6##4##(2008-10#5)(2008-3#1)
sensor can be##12##3##(2006-6#1)(2007-8#1)(2008-10#8)(2008-3#1)(2009-11#1)
sensor can detect##3##3##(2007-11#2)(2008-10#1)
sensor can##19##2##(2006-6#1)(2007-11#2)(2007-8#2)(2008-10#10)(2008-2#2)(2008-3#1)(2009-11#1)
sensor characteristics##5##2##(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)
sensor chip and##2##3##(2007-8#1)(2008-10#1)
sensor chip by##2##3##(2007-8#1)(2008-10#1)
sensor chip surface##2##3##(2008-10#1)(2008-4#1)
sensor chip with##2##3##(2008-10#1)(2008-5#1)
sensor chip##21##2##(2007-8#7)(2008-10#9)(2008-4#3)(2008-5#1)(2008-9#1)
sensor chips##4##2##(1997-4#2)(2008-2#1)(2008-4#1)
sensor components##2##2##(2008-2#1)(2009-11#1)
sensor concept##2##2##(2008-3#1)(2010-5#1)
sensor consisted of a##2##4##(1992-11#1)(1994-2#1)
sensor consists of##2##3##(2007-12#1)(2008-3#1)
sensor construction##3##2##(2008-10#3)
sensor contains##2##2##(2008-10#2)
sensor could be##4##3##(2008-10#4)
sensor could##5##2##(2008-10#5)
sensor data##7##2##(2006-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2013-1#2)
sensor demodulation##2##2##(2008-3#2)
sensor demonstrates##2##2##(2008-10#1)(2008-3#1)
sensor described above##2##3##(2008-10#1)(2008-3#1)
sensor described##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2010-5#1)
sensor design##3##2##(2007-11#1)(2008-2#1)(2010-4#1)
sensor designed for##3##3##(2007-12#1)(2008-7#1)(2010-7#1)
sensor developed##2##2##(2007-8#2)
sensor device##3##2##(2007-9#1)(2008-10#2)
sensor devices##2##2##(2008-10#1)(2008-2#1)
sensor displayed##5##2##(2007-8#1)(2008-10#4)
sensor displays##2##2##(2008-10#2)
sensor electrode##2##2##(2008-10#2)
sensor element##3##2##(2008-10#1)(2011-2#2)
sensor error##3##2##(2008-2#1)(2009-9#2)
sensor errors##8##2##(2009-9#8)
sensor exhibited a##3##3##(2007-9#1)(2008-10#2)
sensor exhibited high selectivity and##2##5##(2008-10#2)
sensor exhibited##9##2##(2007-9#1)(2008-10#6)(2013-1#2)
sensor exhibits a fast##2##4##(2008-10#1)(2008-3#1)
sensor exhibits a linear response##2##5##(2008-10#2)
sensor exhibits a linear##3##4##(2008-10#3)
sensor exhibits a##11##3##(2008-10#10)(2008-3#1)
sensor exhibits##18##2##(2008-10#17)(2008-3#1)
sensor fabricated with##2##3##(2007-8#1)(2007-9#1)
sensor fabrication##3##2##(2008-10#2)(2008-3#1)
sensor for Hg(II)##3##3##(2008-10#3)
sensor for copper##2##3##(2008-10#2)
sensor for detection of##4##4##(2008-10#2)(2008-2#1)(2008-3#1)
sensor for determination of##2##4##(2008-10#2)
sensor for glucose##2##3##(2008-10#2)
sensor for hydrogen##2##3##(2008-10#2)
sensor for isoniazid##2##3##(2008-10#2)
sensor for measurements of##2##4##(2008-2#1)(2008-3#1)
sensor for measuring the##2##4##(2008-10#1)(2008-3#1)
sensor for measuring##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
sensor for mercury(II)##2##3##(2008-10#2)
sensor for nitrite using a glassy carbon electrode modified with##2##10##(2008-10#2)
sensor for pyrogallol##3##3##(2007-8#3)
sensor for simultaneous measurement of##2##5##(2007-11#1)(2007-12#1)
sensor for simultaneous##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
sensor for the detection of##5##5##(2007-12#1)(2008-10#3)(2010-5#1)
sensor for the determination of##9##5##(2008-10#9)
sensor for the potentiometric##2##4##(2008-10#2)
sensor for the##27##3##(2007-12#1)(2007-8#2)(2008-10#21)(2008-3#2)(2010-5#1)
sensor for trace##2##3##(2007-8#1)(2008-2#1)
sensor for##141##2##(1996-5#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#6)(2007-8#9)(2008-10#92)(2008-2#7)(2008-3#16)(2008-7#1)(2010-5#1)(2010-8#2)(2012-1#1)(2013-8#1)
sensor from##2##2##(2008-2#1)(2010-2#1)
sensor has a linear##2##4##(2007-11#1)(2008-10#1)
sensor has a##7##3##(2007-11#1)(2008-10#4)(2008-2#2)
sensor has an##2##3##(2008-3#2)
sensor has been developed for##2##5##(2008-10#1)(2008-2#1)
sensor has been developed##4##4##(1992-4#1)(2008-10#1)(2008-2#2)
sensor has been successfully##2##4##(2008-10#2)
sensor has been used##5##4##(2008-10#5)
sensor has been##21##3##(1992-4#1)(2007-8#1)(2008-10#15)(2008-2#3)(2013-7#1)
sensor has##41##2##(1992-4#1)(2006-5#1)(2007-11#2)(2007-8#1)(2008-10#25)(2008-2#6)(2008-3#3)(2012-1#1)(2013-7#1)
sensor head##4##2##(2008-2#2)(2008-3#2)
sensor in a##4##3##(2008-10#2)(2008-2#2)
sensor in the##4##3##(2008-10#2)(2008-2#1)(2010-9#1)
sensor in##21##2##(1997-4#1)(2008-1#1)(2008-10#7)(2008-2#5)(2008-3#3)(2008-8#2)(2010-9#1)(2011-1#1)
sensor incorporates##2##2##(2008-10#2)
sensor is a##2##3##(2006-6#1)(2008-3#1)
sensor is also capable of##2##5##(2007-12#1)(2008-10#1)
sensor is also##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
sensor is based on the##6##5##(2007-8#1)(2008-10#4)(2008-3#1)
sensor is based on##14##4##(2007-8#1)(2008-10#7)(2008-2#3)(2008-3#3)
sensor is being##2##3##(2008-10#1)(2008-2#1)
sensor is demonstrated##2##3##(2008-10#1)(2008-2#1)
sensor is described##4##3##(2007-12#1)(2007-8#1)(2008-10#2)
sensor is developed##2##3##(2008-10#1)(2009-3#1)
sensor is experimentally##2##3##(2007-8#1)(2008-3#1)
sensor is insensitive to##2##4##(2007-12#1)(2008-2#1)
sensor is proposed##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
sensor is reported##2##3##(2008-10#1)(2008-2#1)
sensor is simple##2##3##(2008-10#1)(2008-2#1)
sensor is suitable for##2##4##(2007-11#1)(2008-10#1)
sensor is used for##3##4##(2007-11#1)(2008-10#2)
sensor is used##5##3##(2007-11#1)(2008-10#3)(2008-3#1)
sensor is##105##2##(2006-6#2)(2007-11#5)(2007-12#3)(2007-8#4)(2008-10#52)(2008-2#20)(2008-3#16)(2009-3#1)(2013-1#2)
sensor kinase##2##2##(1996-4#1)(2009-6#1)
sensor made##2##2##(2008-10#1)(2008-3#1)
sensor material##2##2##(2006-5#1)(2008-10#1)
sensor may##4##2##(2007-11#1)(2008-3#3)
sensor measurements##2##2##(2008-10#1)(2008-2#1)
sensor membrane##2##2##(2008-10#2)
sensor modified with##2##3##(2008-10#2)
sensor module##2##2##(2008-2#1)(2008-3#1)
sensor network##2##2##(2008-2#1)(2008-3#1)
sensor noise##4##2##(2008-2#2)(2008-3#1)(2009-9#1)
sensor of the##4##3##(1990-2#1)(1997-4#1)(2008-10#1)(2008-9#1)
sensor of##19##2##(1990-2#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#2)(2009-8#1)(2010-12#4)(2013-8#1)
sensor on a chip for##3##5##(2008-10#3)
sensor on a##5##3##(2007-12#1)(2008-10#3)(2008-3#1)
sensor on the##2##3##(2008-10#1)(2010-9#1)
sensor on##8##2##(2007-12#1)(2008-10#4)(2008-3#1)(2010-9#1)(2011-1#1)
sensor output##3##2##(2008-10#1)(2008-3#2)
sensor over##2##2##(2008-10#2)
sensor parameters##2##2##(2008-2#2)
sensor performance##13##2##(2007-9#1)(2008-10#5)(2008-2#1)(2008-3#2)(2010-5#1)(2011-1#3)
sensor placed in##2##3##(2008-10#1)(2008-2#1)
sensor platform##3##2##(2010-2#3)
sensor platforms##2##2##(2010-2#2)
sensor presented##2##2##(2008-10#2)
sensor processing##2##2##(2006-2#1)(2008-2#1)
sensor produced##2##2##(2008-10#1)(2008-3#1)
sensor protein##4##2##(1994-12#2)(1994-2#1)(2007-11#1)
sensor provides##3##2##(2008-10#2)(2008-2#1)
sensor responds to##4##3##(2008-10#4)
sensor responds##6##2##(2008-10#6)
sensor response and##2##3##(1996-7#1)(2008-10#1)
sensor response is##3##3##(1992-4#1)(2008-10#2)
sensor response to##4##3##(2008-10#2)(2008-7#1)(2013-7#1)
sensor response##26##2##(1992-4#1)(1996-7#1)(2007-8#2)(2008-10#16)(2008-3#3)(2008-7#1)(2010-5#1)(2013-7#1)
sensor responses##2##2##(2008-10#2)
sensor responsive to##2##3##(2008-10#2)
sensor revealed a##2##3##(2008-10#2)
sensor revealed##3##2##(2008-10#3)
sensor scheme##2##2##(2008-3#2)
sensor sensitivity##4##2##(2008-10#2)(2010-2#2)
sensor showed##7##2##(2007-8#1)(2007-9#1)(2008-10#5)
sensor shows a linear response##2##5##(2008-10#2)
sensor shows a linear##3##4##(2008-10#3)
sensor shows a##4##3##(2007-12#1)(2008-10#3)
sensor shows excellent##2##3##(2008-10#2)
sensor shows##19##2##(2007-12#1)(2008-10#17)(2008-2#1)
sensor signal##4##2##(2008-10#4)
sensor signals##8##2##(2007-11#1)(2008-10#6)(2008-3#1)
sensor suitable for use##3##4##(2008-10#2)(2008-3#1)
sensor surface##11##2##(1997-2#1)(2008-10#7)(2008-11#1)(2008-5#1)(2010-5#1)
sensor system for the##3##4##(2008-10#2)(2008-3#1)
sensor system for##9##3##(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#2)
sensor system is##6##3##(2007-12#1)(2008-10#3)(2008-2#2)
sensor system to##2##3##(2008-10#2)
sensor system using##2##3##(2007-11#1)(2008-10#1)
sensor system was##7##3##(2008-10#4)(2008-3#2)(2008-7#1)
sensor system##46##2##(2006-6#2)(2007-11#2)(2007-12#2)(2007-8#2)(2008-10#22)(2008-2#9)(2008-3#5)(2008-7#1)(2010-8#1)
sensor systems are##2##3##(2006-6#1)(2008-2#1)
sensor systems##6##2##(2006-6#2)(2008-2#3)(2010-10#1)
sensor technique##2##2##(1996-7#1)(2008-3#1)
sensor technologies##2##2##(2008-10#1)(2010-10#1)
sensor technology##3##2##(2008-3#1)(2008-5#1)(2008-7#1)
sensor that is##2##3##(2008-10#1)(2008-3#1)
sensor that measures##2##3##(2006-10#1)(2007-12#1)
sensor that uses a##2##4##(2008-2#1)(2008-7#1)
sensor that uses##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-7#1)
sensor that##16##2##(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#5)(2008-7#1)(2012-11#1)
sensor to be##2##3##(2008-10#1)(2008-3#1)
sensor to determine##2##3##(2008-10#2)
sensor to measure##4##3##(2007-12#1)(2008-3#3)
sensor to monitor##3##3##(2008-2#3)
sensor to the##3##3##(2008-10#2)(2008-3#1)
sensor to##29##2##(2007-11#1)(2007-12#2)(2008-10#14)(2008-2#4)(2008-3#5)(2009-11#1)(2013-1#2)
sensor using a##7##3##(2007-12#1)(2008-10#5)(2013-7#1)
sensor using molecularly imprinted##2##4##(2007-8#1)(2008-10#1)
sensor using##21##2##(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#14)(2008-2#1)(2008-3#1)(2013-7#1)
sensor utilizing##2##2##(2007-9#1)(2008-10#1)
sensor was applied for##3##4##(2008-10#3)
sensor was applied to##3##4##(2008-10#3)
sensor was applied##8##3##(1992-4#1)(2008-10#7)
sensor was constructed by##2##4##(2007-8#1)(2008-10#1)
sensor was demonstrated##2##3##(2007-11#2)
sensor was developed for##2##4##(2008-10#2)
sensor was developed##6##3##(2008-10#5)(2008-7#1)
sensor was evaluated##4##3##(2008-10#4)
sensor was fabricated by immobilizing##2##5##(1992-11#1)(2008-10#1)
sensor was fabricated by##5##4##(1992-11#1)(2008-10#3)(2013-1#1)
sensor was fabricated##6##3##(1992-11#1)(2008-10#4)(2013-1#1)
sensor was found to be##3##5##(2008-10#3)
sensor was found to##5##4##(2008-10#5)
sensor was inserted##2##3##(2007-8#1)(2012-2#1)
sensor was prepared by##2##4##(2008-10#2)
sensor was successfully applied to##2##5##(2008-10#2)
sensor was successfully applied##3##4##(2008-10#3)
sensor was successfully##5##3##(2008-10#5)
sensor was tested in##3##4##(2008-10#1)(2008-3#1)(2008-7#1)
sensor was used for##2##4##(2008-10#2)
sensor was used to detect##2##5##(2008-10#2)
sensor was used to monitor##2##5##(2008-10#1)(2008-7#1)
sensor was used to##4##4##(2008-10#3)(2008-7#1)
sensor was used##8##3##(2008-10#6)(2008-3#1)(2008-7#1)
sensor was##85##2##(1992-11#1)(1992-4#1)(1996-7#1)(2007-11#2)(2007-8#2)(2008-10#66)(2008-2#3)(2008-3#2)(2008-7#4)(2010-5#1)(2012-2#1)(2013-1#1)
sensor were found to##2##4##(2008-10#2)
sensor were investigated##2##3##(2008-10#2)
sensor were##13##2##(2008-10#12)(2013-8#1)
sensor when##3##2##(2007-11#1)(2008-10#1)(2011-1#1)
sensor with PPy-calcion##2##3##(2008-10#2)
sensor with a##10##3##(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#2)(2009-11#1)
sensor with an##2##3##(2006-5#1)(2008-3#1)
sensor with controllable sensitivity##2##4##(2008-3#2)
sensor with fiber Bragg grating##2##5##(2007-11#2)
sensor with optical##2##3##(2007-11#1)(2007-12#1)
sensor with the##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2010-2#1)
sensor with##44##2##(2006-5#1)(2007-11#4)(2007-12#7)(2008-10#16)(2008-2#4)(2008-3#9)(2008-7#1)(2009-11#1)(2010-2#1)
sensor without##3##2##(2008-10#2)(2008-2#1)
sensor works well##3##3##(2008-10#3)
sensor works##7##2##(1992-4#1)(2008-10#5)(2008-2#1)
sensor##1545##1##(1990-2#1)(1992-11#4)(1992-4#5)(1992-5#1)(1993-12#2)(1994-11#1)(1994-12#5)(1994-2#2)(1996-4#1)(1996-5#1)(1996-7#3)(1996-9#1)(1997-2#1)(1997-4#5)(2004-9#2)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#5)(2006-2#4)(2006-5#5)(2006-6#12)(2007-1#1)(2007-10#1)(2007-11#47)(2007-12#76)(2007-3#1)(2007-5#5)(2007-6#1)(2007-8#53)(2007-9#11)(2008-1#6)(2008-10#755)(2008-11#4)(2008-2#157)(2008-3#189)(2008-4#6)(2008-5#5)(2008-6#3)(2008-7#22)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#10)(2009-12#1)(2009-3#2)(2009-5#2)(2009-6#2)(2009-8#4)(2009-9#12)(2010-10#2)(2010-12#9)(2010-2#12)(2010-4#2)(2010-5#13)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#8)(2011-2#3)(2012-1#4)(2012-11#2)(2012-2#2)(2012-3#1)(2013-1#23)(2013-7#3)(2013-8#5)
sensor's##4##1##(2007-11#1)(2008-10#1)(2008-2#2)
sensor-like##3##1##(1994-12#3)
sensor-regulator##2##1##(1996-8#2)
sensor-to-sensor reproducibility##2##2##(2008-10#2)
sensori-motor##2##1##(2006-7#1)(2013-8#1)
sensorial analysis##2##2##(2008-5#1)(2010-4#1)
sensorial characteristics##2##2##(2010-4#1)(2011-2#1)
sensorial functioning##2##2##(2011-2#2)
sensorial##20##1##(1990-4#1)(2006-8#1)(2007-3#1)(2008-5#5)(2009-9#1)(2010-4#3)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)
sensorimotor and auditory##2##3##(2006-8#1)(2012-12#1)
sensorimotor and##6##2##(1991-3#1)(1995-5#1)(2006-8#1)(2007-10#1)(2011-1#1)(2012-12#1)
sensorimotor cortex in##3##3##(1995-11#1)(1995-12#1)(1996-1#1)
sensorimotor cortex##10##2##(1991-9#1)(1992-10#1)(1993-9#1)(1995-11#1)(1995-12#2)(1996-1#2)(1996-2#1)(2006-10#1)
sensorimotor cortices##2##2##(2006-5#1)(2008-7#1)
sensorimotor deficits##2##2##(1993-12#1)(2007-10#1)
sensorimotor gating##3##2##(2008-4#1)(2009-4#1)(2012-2#1)
sensorimotor neuropathy##4##2##(2008-3#2)(2008-8#1)(2013-8#1)
sensorimotor polyneuropathy in##2##3##(1994-6#1)(2005-1#1)
sensorimotor polyneuropathy##6##2##(1994-6#1)(2005-1#1)(2008-1#4)
sensorimotor##63##1##(1991-11#1)(1991-3#2)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#2)(1993-11#2)(1993-12#4)(1993-9#2)(1994-10#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-5#2)(1996-1#2)(1996-2#2)(2005-1#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-10#2)(2007-12#2)(2007-8#1)(2008-1#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-3#1)(2011-1#1)(2012-1#2)(2012-12#4)(2012-2#1)(2013-8#3)
sensorineural deafness and##2##3##(1997-1#1)(2008-7#1)
sensorineural deafness##8##2##(1997-1#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-7#1)(2008-9#1)(2011-1#1)
sensorineural hearing impairment in##2##4##(2006-10#1)(2011-1#1)
sensorineural hearing impairment##4##3##(2006-10#1)(2008-9#2)(2011-1#1)
sensorineural hearing loss and##2##4##(2011-1#1)(2013-1#1)
sensorineural hearing loss in##3##4##(2008-1#1)(2008-4#1)(2011-2#1)
sensorineural hearing loss is##2##4##(2008-4#1)(2008-9#1)
sensorineural hearing loss##22##3##(1992-2#1)(1993-1#1)(1996-12#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-4#4)(2008-9#4)(2011-1#3)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
sensorineural hearing##26##2##(1992-2#1)(1993-1#1)(1996-12#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-4#4)(2008-9#6)(2011-1#4)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
sensorineural##36##1##(1992-2#1)(1993-1#1)(1996-12#1)(1997-1#2)(2006-10#1)(2006-12#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-4#4)(2008-7#1)(2008-9#8)(2011-1#6)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
sensors 1##3##2##(2008-10#3)
sensors and a##2##3##(2008-10#1)(2012-2#1)
sensors and actuators##3##3##(1991-11#1)(2007-9#1)(2008-8#1)
sensors and biosensors##2##3##(2008-10#1)(2008-3#1)
sensors and the##3##3##(2007-9#1)(2008-10#1)(2008-2#1)
sensors and##29##2##(1991-11#2)(2006-2#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-8#1)(2007-9#3)(2008-10#12)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-1#1)(2010-5#1)(2012-2#1)
sensors are based on##3##4##(2007-8#1)(2008-10#1)(2008-3#1)
sensors are based##4##3##(2007-8#1)(2008-10#1)(2008-3#1)(2011-1#1)
sensors are being##2##3##(2011-1#1)(2012-2#1)
sensors are characterized by##2##4##(2008-3#2)
sensors are presented##2##3##(2008-10#2)
sensors are reported##2##3##(2006-6#1)(2010-4#1)
sensors are used##3##3##(2008-10#3)
sensors are##28##2##(1994-11#1)(2006-6#1)(2007-8#2)(2008-10#11)(2008-2#1)(2008-3#6)(2010-4#1)(2010-5#1)(2011-1#2)(2012-1#1)(2012-2#1)
sensors as##4##2##(2008-10#3)(2008-4#1)
sensors based on chemically modified##2##5##(2008-10#2)
sensors based on##33##3##(2007-8#2)(2008-10#21)(2008-2#3)(2008-3#6)(2010-7#1)
sensors by use of##2##4##(2008-2#1)(2008-3#1)
sensors by##8##2##(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-7#1)
sensors can be##2##3##(2008-10#2)
sensors can##3##2##(2008-10#3)
sensors could##5##2##(2004-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-9#1)
sensors enable##2##2##(2006-7#1)(2008-10#1)
sensors exhibit##7##2##(2007-8#1)(2008-10#4)(2008-3#1)(2009-9#1)
sensors exhibited##2##2##(2008-10#1)(2011-1#1)
sensors for detection of##2##4##(2007-9#1)(2011-1#1)
sensors for hydrogen##2##3##(2006-12#1)(2008-10#1)
sensors for some##2##3##(2008-10#2)
sensors for the analysis of##2##5##(2008-10#2)
sensors for the determination of##4##5##(2008-10#4)
sensors for the##10##3##(2007-8#2)(2008-10#8)
sensors for##54##2##(1990-8#1)(2006-12#1)(2007-8#2)(2007-9#2)(2008-10#39)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)
sensors has been##2##3##(2008-10#1)(2010-4#1)
sensors has##3##2##(2007-11#1)(2008-10#1)(2010-4#1)
sensors have##4##2##(2007-5#1)(2008-10#1)(2008-3#1)(2013-1#1)
sensors in the##3##3##(2008-1#1)(2008-10#2)
sensors in##19##2##(2007-5#1)(2008-1#2)(2008-10#6)(2008-3#4)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
sensors is proposed##2##3##(2007-12#1)(2008-3#1)
sensors is##17##2##(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#8)(2008-2#3)(2008-3#1)(2008-7#1)
sensors may##3##2##(2008-10#1)(2013-1#2)
sensors mounted on##2##3##(2006-6#1)(2007-5#1)
sensors of##7##2##(1997-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-3#1)(2009-9#1)
sensors on a##2##3##(2008-3#2)
sensors on the##2##3##(2006-10#1)(2008-2#1)
sensors on##8##2##(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#2)(2009-9#1)(2013-1#2)
sensors operating near 2##2##4##(2008-3#2)
sensors or##3##2##(2008-10#2)(2008-2#1)
sensors responsive to##2##3##(2008-10#2)
sensors sensitive##2##2##(2008-10#2)
sensors show##3##2##(2008-10#2)(2008-3#1)
sensors showed##2##2##(2008-10#2)
sensors that are##2##3##(1997-4#1)(2009-9#1)
sensors that use##3##3##(2007-11#1)(2008-3#2)
sensors that uses##2##3##(2007-11#1)(2008-2#1)
sensors that##15##2##(1997-4#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2009-3#1)(2009-9#1)
sensors to##8##2##(2007-12#2)(2008-10#2)(2008-3#2)(2010-9#1)(2013-1#1)
sensors use##2##2##(2008-10#1)(2008-2#1)
sensors using##8##2##(2007-12#1)(2008-10#7)
sensors was##4##2##(2008-10#2)(2008-3#1)(2012-1#1)
sensors were also##3##3##(2008-10#1)(2008-2#1)(2010-7#1)
sensors were combined##2##3##(2008-10#1)(2010-2#1)
sensors were evaluated##2##3##(2008-10#2)
sensors were used to##2##4##(2008-3#1)(2011-1#1)
sensors were used##3##3##(1993-6#1)(2008-3#1)(2011-1#1)
sensors were##25##2##(1993-6#1)(2004-9#1)(2008-10#14)(2008-2#2)(2008-3#2)(2008-8#1)(2010-2#1)(2010-7#1)(2011-1#2)
sensors will##2##2##(2008-10#2)
sensors with a detection##2##4##(2008-3#2)
sensors with a##6##3##(2008-2#1)(2008-3#5)
sensors with##28##2##(2007-12#1)(2008-10#11)(2008-2#4)(2008-3#9)(2008-5#1)(2008-7#1)(2010-4#1)
sensors##583##1##(1990-8#2)(1991-11#2)(1993-6#1)(1994-11#1)(1997-4#2)(2004-9#5)(2005-10#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#5)(2006-7#2)(2007-1#1)(2007-11#6)(2007-12#23)(2007-2#1)(2007-5#5)(2007-8#15)(2007-9#8)(2008-1#5)(2008-10#259)(2008-11#3)(2008-2#48)(2008-3#73)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#12)(2008-8#3)(2009-1#1)(2009-11#4)(2009-2#1)(2009-3#3)(2009-6#2)(2009-7#1)(2009-9#4)(2010-12#3)(2010-2#5)(2010-4#8)(2010-5#7)(2010-7#9)(2010-9#3)(2011-1#9)(2011-2#2)(2012-1#4)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#9)
sensory &quot##2##2##(1993-2#1)(2008-8#1)
sensory abilities##2##2##(2009-4#1)(2011-1#1)
sensory abnormalities and##2##3##(1995-7#1)(2008-9#1)
sensory abnormalities##5##2##(1995-7#1)(1996-3#1)(2006-8#1)(2008-9#1)(2010-7#1)
sensory activity##2##2##(1993-12#1)(1997-8#1)
sensory adaptation##3##2##(1995-12#2)(2007-12#1)
sensory afferents##2##2##(1996-1#1)(1996-9#1)
sensory analysis##5##2##(2008-6#1)(2009-9#1)(2010-4#1)(2011-2#2)
sensory and motor cortices##2##4##(2006-3#1)(2008-11#1)
sensory and motor neuron##2##4##(2013-1#2)
sensory and motor##13##3##(1990-10#1)(1992-6#1)(1996-3#1)(1996-9#1)(2006-3#1)(2006-7#1)(2008-11#1)(2008-7#2)(2012-2#1)(2013-1#2)(2013-7#1)
sensory and neuronal mechanisms##3##4##(2007-12#3)
sensory and sympathetic##2##3##(1996-3#1)(1997-6#1)
sensory and##41##2##(1990-10#1)(1990-7#1)(1992-6#1)(1993-1#1)(1994-6#1)(1995-11#1)(1995-5#1)(1996-10#1)(1996-3#2)(1996-8#1)(1996-9#2)(1997-6#1)(1997-7#1)(2006-10#1)(2006-3#1)(2006-7#1)(2007-12#4)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-4#4)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
sensory apparatus##3##2##(1990-5#1)(1997-3#1)(2007-12#1)
sensory areas##7##2##(1994-6#1)(1997-8#1)(2008-11#3)(2008-5#2)
sensory aspects##4##2##(2006-12#1)(2008-5#1)(2008-9#2)
sensory assessment##4##2##(2008-5#4)
sensory attention and sensorimotor##2##4##(1993-12#2)
sensory attention##3##2##(1993-12#3)
sensory attributes of##2##3##(2010-4#1)(2011-2#1)
sensory attributes were##3##3##(2010-4#3)
sensory attributes##16##2##(2008-10#2)(2010-4#9)(2011-2#3)(2012-2#2)
sensory axons in##2##3##(2007-12#1)(2013-1#1)
sensory axons##6##2##(1994-2#1)(1995-2#1)(2007-12#2)(2013-1#2)
sensory bias##2##2##(2008-8#2)
sensory block##2##2##(1993-4#1)(2012-3#1)
sensory blockade##2##2##(2006-10#2)
sensory capacity##2##2##(2008-10#2)
sensory cell clusters##2##3##(2007-12#2)
sensory cell##5##2##(2007-12#4)(2008-7#1)
sensory cells of the##2##4##(1993-12#1)(2011-2#1)
sensory cells of##4##3##(1993-12#1)(1997-6#1)(2008-7#1)(2011-2#1)
sensory cells to##2##3##(2007-12#2)
sensory cells##16##2##(1991-3#1)(1993-12#1)(1995-8#1)(1997-6#1)(2007-12#8)(2008-7#3)(2011-2#1)
sensory changes##4##2##(2008-10#2)(2010-4#1)(2012-12#1)
sensory characteristics##11##2##(2010-3#1)(2010-4#9)(2010-7#1)
sensory complex##4##2##(1995-7#1)(2007-12#3)
sensory corpuscles##3##2##(1994-2#3)
sensory cortical##3##2##(1997-8#1)(2008-11#1)(2012-2#1)
sensory cue##2##2##(2009-8#2)
sensory cues##2##2##(2007-12#1)(2012-1#1)
sensory data##4##2##(1992-4#1)(1997-8#1)(2012-1#1)(2013-7#1)
sensory deficit##2##2##(1990-12#1)(2012-12#1)
sensory deficits in##2##3##(2006-6#1)(2008-12#1)
sensory deficits##4##2##(1996-6#1)(2006-6#1)(2007-10#1)(2008-12#1)
sensory deprivation##2##2##(2011-2#1)(2012-12#1)
sensory deterioration##2##2##(2010-4#2)
sensory discrimination##2##2##(2006-10#1)(2009-9#1)
sensory disorders##4##2##(1992-5#1)(2007-10#2)(2007-7#1)
sensory disturbances##2##2##(2006-5#1)(2012-1#1)
sensory division of##2##3##(1990-4#1)(2006-11#1)
sensory dysfunction##2##2##(2006-10#1)(2008-11#1)
sensory epithelium##2##2##(2007-12#1)(2012-2#1)
sensory evaluation of##2##3##(1992-4#1)(2011-2#1)
sensory evaluation##6##2##(1992-4#2)(2010-2#2)(2010-4#1)(2011-2#1)
sensory evoked##3##2##(1992-7#2)(1996-6#1)
sensory experience##5##2##(1995-11#1)(2007-5#2)(2008-4#1)(2009-12#1)
sensory explant##2##2##(1996-3#2)
sensory feedback system##2##3##(2012-1#2)
sensory feedback##5##2##(2007-9#1)(2012-1#4)
sensory fibers##12##2##(1991-3#1)(1992-6#1)(1994-5#1)(1996-3#2)(2006-12#3)(2006-3#1)(2006-7#1)(2006-8#1)(2007-1#1)
sensory fibres##5##2##(1992-9#1)(1996-3#3)(1997-5#1)
sensory function##7##2##(1993-12#1)(1996-6#1)(2007-12#1)(2009-3#1)(2012-1#3)
sensory functions##3##2##(1992-12#1)(1992-4#1)(1997-7#1)
sensory ganglia##6##2##(1996-3#3)(1997-6#1)(2006-7#1)(2008-4#1)
sensory ganglion##2##2##(1993-1#1)(1995-11#1)
sensory hair cells##3##3##(2009-8#1)(2009-9#1)(2013-1#1)
sensory impairments##2##2##(2011-2#1)(2012-1#1)
sensory information in the##2##4##(1996-6#1)(2013-8#1)
sensory information into##2##3##(1990-5#2)
sensory information to##2##3##(1995-1#1)(2008-1#1)
sensory information##14##2##(1990-5#3)(1991-8#1)(1993-2#1)(1995-1#2)(1995-5#2)(1996-6#1)(1996-7#1)(2008-1#1)(2012-1#1)(2013-8#1)
sensory innervation of the##4##4##(1997-3#1)(2007-1#1)(2007-12#2)
sensory innervation##5##2##(1996-5#1)(1997-3#1)(2007-1#1)(2007-12#2)
sensory input from##2##3##(1992-7#1)(2007-12#1)
sensory input is##2##3##(2008-7#1)(2009-12#1)
sensory input##24##2##(1991-3#1)(1992-7#1)(1993-12#1)(1995-11#1)(1995-12#1)(1996-3#2)(1996-5#1)(1996-7#1)(1997-3#1)(1997-8#2)(2007-12#1)(2007-5#3)(2008-11#2)(2008-4#1)(2008-7#1)(2009-12#2)(2012-1#1)(2012-12#1)
sensory inputs and##2##3##(2008-9#1)(2011-12#1)
sensory inputs##7##2##(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#2)(2011-12#1)(2013-1#1)
sensory kinases##2##2##(1997-4#2)
sensory loss##13##2##(1994-9#1)(2006-11#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-5#1)(2009-6#1)(2012-1#4)(2013-1#1)
sensory maps##3##2##(2007-8#3)
sensory messages##2##2##(1996-7#1)(1997-8#1)
sensory modalities##6##2##(1993-2#1)(1996-6#2)(2008-1#1)(2008-12#1)(2012-1#1)
sensory modulation##2##2##(2009-8#2)
sensory motor##4##2##(1995-11#1)(2005-10#1)(2006-7#1)(2007-8#1)
sensory nerve fibers##4##3##(1992-6#1)(2006-8#2)(2007-1#1)
sensory nerve fibres##2##3##(1994-2#1)(1994-9#1)
sensory nerve transfers##2##3##(2008-9#2)
sensory nerve##23##2##(1990-11#1)(1990-4#1)(1992-3#1)(1992-6#1)(1994-2#1)(1994-9#1)(1995-12#1)(2006-12#1)(2006-3#3)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#4)(2008-9#2)(2010-1#1)(2013-8#1)
sensory nerves in the##2##4##(2007-1#1)(2008-4#1)
sensory nerves##14##2##(1990-4#1)(1992-11#2)(1992-6#4)(1996-11#1)(1996-3#1)(1997-1#1)(2007-1#2)(2007-11#1)(2008-4#1)
sensory nervous system##3##3##(2007-12#3)
sensory nervous##5##2##(1990-11#1)(2007-12#4)
sensory neuron##7##2##(1991-1#1)(1996-3#3)(2007-12#2)(2008-4#1)
sensory neurones##6##2##(1992-9#2)(1994-2#1)(1996-3#2)(2007-12#1)
sensory neurons and##5##3##(1995-2#1)(1996-3#1)(2006-11#1)(2007-11#1)(2008-5#1)
sensory neurons are##3##3##(1996-3#2)(2008-4#1)
sensory neurons by##3##3##(1996-3#1)(2008-4#1)(2008-8#1)
sensory neurons can##2##3##(1995-12#1)(1996-12#1)
sensory neurons during##2##3##(1990-7#1)(1996-3#1)
sensory neurons in the##2##4##(1996-8#1)(2007-12#1)
sensory neurons in##4##3##(1992-6#1)(1996-8#1)(2007-12#1)(2008-6#1)
sensory neurons of##3##3##(1996-3#1)(2006-10#1)(2007-12#1)
sensory neurons on##2##3##(1996-3#1)(2007-12#1)
sensory neurons that innervate##2##4##(2007-1#1)(2007-12#1)
sensory neurons that##3##3##(2007-1#1)(2007-12#2)
sensory neurons to the##2##4##(1996-3#1)(2008-11#1)
sensory neurons to##4##3##(1996-3#1)(2008-11#1)(2008-7#1)(2008-8#1)
sensory neurons were##2##3##(1990-7#1)(1997-8#1)
sensory neurons whose##2##3##(1991-1#1)(1991-3#1)
sensory neurons##86##2##(1990-7#8)(1991-1#1)(1991-10#2)(1991-3#2)(1992-6#3)(1993-12#1)(1994-8#1)(1995-12#3)(1995-2#1)(1996-12#2)(1996-3#29)(1996-5#1)(1996-8#1)(1996-9#3)(1997-7#1)(1997-8#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-11#2)(2007-12#7)(2008-11#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2012-1#1)(2013-8#1)
sensory neuropathy associated with##3##4##(2008-7#1)(2009-3#1)(2013-1#1)
sensory neuropathy with##2##3##(2008-3#1)(2008-7#1)
sensory neuropathy##14##2##(1995-5#1)(2007-11#1)(2008-3#2)(2008-7#3)(2009-10#1)(2009-3#3)(2010-11#1)(2012-3#1)(2013-1#1)
sensory neuropeptide##2##2##(1991-2#1)(1996-3#1)
sensory nucleus##2##2##(1990-4#1)(1993-12#1)
sensory or motor##5##3##(1991-6#1)(2006-10#1)(2010-2#1)(2012-12#1)(2013-1#1)
sensory or##6##2##(1991-6#1)(2006-10#1)(2010-2#1)(2010-4#1)(2012-12#1)(2013-1#1)
sensory organ##5##2##(1993-12#2)(2008-5#1)(2009-5#1)(2012-2#1)
sensory organs and##2##3##(2007-12#1)(2008-5#1)
sensory organs##7##2##(1995-12#1)(2007-12#2)(2008-5#1)(2008-7#2)(2009-5#1)
sensory panel##2##2##(2008-6#1)(2010-4#1)
sensory panels##2##2##(2008-10#1)(2010-4#1)
sensory pathways##8##2##(1991-9#2)(2007-12#2)(2007-8#1)(2008-4#3)
sensory perception of##2##3##(2005-11#1)(2008-3#1)
sensory perception##10##2##(1991-4#1)(2005-11#1)(2006-12#1)(2007-12#1)(2008-3#2)(2008-9#2)(2012-1#2)
sensory phenomena##5##2##(2012-2#5)
sensory predictions##2##2##(2013-8#2)
sensory processing and motor##2##4##(2013-7#2)
sensory processing and##3##3##(2013-7#3)
sensory processing areas##2##3##(1997-8#2)
sensory processing##20##2##(1991-3#1)(1993-6#1)(1995-7#2)(1996-7#1)(1997-8#2)(2008-11#1)(2008-4#1)(2008-5#1)(2009-12#2)(2009-8#1)(2013-7#6)(2013-8#1)
sensory profile##2##2##(2008-12#1)(2011-2#1)
sensory properties of the##2##4##(2008-5#1)(2010-4#1)
sensory properties of##5##3##(2008-10#1)(2008-5#1)(2010-4#1)(2011-2#2)
sensory properties##11##2##(2008-10#1)(2008-5#1)(2010-4#6)(2011-2#2)(2012-2#1)
sensory quality and##2##3##(2010-4#2)
sensory quality of the##2##4##(2010-4#2)
sensory quality of##3##3##(2010-4#3)
sensory quality##7##2##(2010-4#7)
sensory receptors##2##2##(1994-10#1)(2009-8#1)
sensory repertoire expansion##2##3##(2013-1#2)
sensory repertoire##3##2##(2013-1#3)
sensory representations##2##2##(2010-5#1)(2013-8#1)
sensory response##2##2##(2008-12#1)(2012-1#1)
sensory responses##5##2##(1993-11#1)(1993-12#2)(2008-12#2)
sensory scores##2##2##(2011-2#1)(2013-1#1)
sensory sensitivities##2##2##(1992-4#2)
sensory signals##4##2##(2007-12#2)(2007-9#1)(2012-2#1)
sensory stimulation and##2##3##(1992-6#1)(1993-6#1)
sensory stimulation to aid in##2##5##(2006-7#2)
sensory stimulation##14##2##(1991-3#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-6#1)(1995-12#1)(1995-5#1)(2006-7#4)(2008-11#1)(2008-7#1)(2010-12#1)
sensory stimuli##7##2##(1990-10#1)(1993-11#1)(1993-2#1)(1995-8#1)(2008-4#1)(2013-1#2)
sensory structures##3##2##(1994-8#1)(1996-3#1)(2007-12#1)
sensory substitution##3##2##(2010-6#1)(2012-1#2)
sensory symptoms and##2##3##(2007-10#1)(2008-7#1)
sensory symptoms##9##2##(2007-10#2)(2008-3#3)(2008-7#1)(2012-12#2)(2012-2#1)
sensory system is##2##3##(2008-10#1)(2009-8#1)
sensory system##16##2##(1990-11#1)(1992-6#1)(1996-10#1)(1996-2#1)(2007-12#1)(2008-10#4)(2009-2#1)(2009-8#1)(2011-2#3)(2013-8#2)
sensory systems##8##2##(1990-11#1)(1996-10#1)(2007-12#1)(2012-1#1)(2013-1#3)(2013-8#1)
sensory testing##5##2##(2008-1#1)(2008-9#1)(2011-1#3)
sensory transduction##2##2##(1995-8#1)(2010-12#1)
sensory trigeminal##3##2##(1996-3#1)(1996-9#1)(1997-3#1)
sensory units##5##2##(1993-12#1)(2007-12#3)(2013-8#1)
sensory##837##1##(1990-10#3)(1990-11#6)(1990-12#1)(1990-3#1)(1990-4#6)(1990-5#5)(1990-7#9)(1990-9#1)(1991-1#2)(1991-10#2)(1991-2#2)(1991-3#8)(1991-4#1)(1991-6#1)(1991-8#2)(1991-9#2)(1992-11#4)(1992-12#2)(1992-3#1)(1992-4#6)(1992-5#1)(1992-6#14)(1992-7#4)(1992-8#2)(1992-9#4)(1993-1#2)(1993-11#3)(1993-12#23)(1993-2#4)(1993-3#1)(1993-4#1)(1993-6#2)(1994-10#1)(1994-2#6)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#3)(1995-1#2)(1995-11#6)(1995-12#11)(1995-2#2)(1995-4#1)(1995-5#6)(1995-7#4)(1995-8#4)(1996-1#2)(1996-10#3)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#57)(1996-5#4)(1996-6#6)(1996-7#4)(1996-8#2)(1996-9#8)(1997-1#1)(1997-3#7)(1997-4#5)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#22)(2005-10#1)(2005-11#1)(2006-10#11)(2006-11#3)(2006-12#7)(2006-3#11)(2006-5#1)(2006-6#1)(2006-7#10)(2006-8#4)(2007-1#6)(2007-10#6)(2007-11#6)(2007-12#64)(2007-5#5)(2007-6#1)(2007-7#3)(2007-8#6)(2007-9#2)(2008-1#3)(2008-10#14)(2008-11#18)(2008-12#6)(2008-2#1)(2008-3#12)(2008-4#15)(2008-5#14)(2008-6#5)(2008-7#20)(2008-8#11)(2008-9#16)(2009-10#1)(2009-12#6)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#13)(2009-9#4)(2010-1#2)(2010-11#2)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#56)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#2)(2011-1#5)(2011-12#2)(2011-2#21)(2012-1#29)(2012-11#1)(2012-12#8)(2012-2#21)(2012-3#3)(2013-1#24)(2013-7#8)(2013-8#12)
sensory)##2##1##(1997-1#1)(1997-3#1)
sensory-evoked##2##1##(1993-12#1)(2009-5#1)
sensory-motor##5##1##(2006-7#1)(2007-10#1)(2008-11#1)(2009-3#1)(2010-3#1)
sensu lato is##3##3##(2008-10#3)
sensu lato##16##2##(2006-10#1)(2006-2#1)(2008-10#10)(2011-2#2)(2012-12#2)
sensu stricto and##2##3##(2008-10#1)(2008-8#1)
sensu stricto with##2##3##(2008-10#1)(2012-12#1)
sensu stricto##15##2##(1994-2#1)(2006-5#1)(2008-10#6)(2008-5#1)(2008-8#1)(2010-10#2)(2012-12#2)(2013-7#1)
sensu##36##1##(1994-2#1)(2006-10#1)(2006-2#1)(2006-5#1)(2008-10#18)(2008-5#1)(2008-8#1)(2010-10#3)(2011-2#4)(2012-12#4)(2013-7#1)
sent a questionnaire to##2##4##(2007-7#1)(2011-2#1)
sent a questionnaire##6##3##(1991-4#1)(1993-12#1)(1996-9#1)(2004-10#1)(2007-7#1)(2011-2#1)
sent a##12##2##(1991-4#1)(1993-12#1)(1996-9#1)(1997-2#1)(1997-5#1)(2004-10#1)(2007-7#1)(2007-9#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-2#1)
sent back##2##2##(1996-6#1)(2008-5#1)
sent by mail to##2##4##(2006-8#1)(2008-8#1)
sent by the##4##3##(1992-2#1)(2008-1#1)(2010-12#1)(2012-12#1)
sent by##14##2##(1992-2#1)(1997-3#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-8#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#4)
sent for##8##2##(1993-8#1)(1995-4#1)(2007-8#1)(2008-1#1)(2008-5#2)(2012-2#1)(2013-1#1)
sent in##3##2##(1992-10#1)(2007-12#1)(2007-8#1)
sent letters##2##2##(2006-8#1)(2010-8#1)
sent their##2##2##(1990-4#1)(1990-7#1)
sent to a##13##3##(1991-6#1)(1993-2#1)(1993-8#1)(1994-2#1)(1995-11#1)(1997-3#1)(2005-5#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-5#1)(2013-1#1)
sent to all the##2##4##(1993-12#1)(2007-7#1)
sent to all##18##3##(1990-10#1)(1992-1#1)(1992-3#1)(1993-12#1)(1995-6#3)(1996-3#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-7#1)(2008-11#1)(2012-2#2)
sent to our##2##3##(1994-3#1)(2007-10#1)
sent to surgery##2##3##(2011-2#1)(2012-3#1)
sent to the laboratory##2##4##(2008-12#1)(2008-5#1)
sent to the nursing##2##4##(2005-10#1)(2010-10#1)
sent to the##18##3##(1993-9#1)(1994-1#1)(1994-3#1)(2005-10#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-12#1)(2013-1#1)
sent to##105##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-6#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-8#2)(1993-9#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-4#1)(1995-11#1)(1995-6#3)(1996-1#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-8#1)(2005-10#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-12#2)(2006-8#2)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#4)(2007-7#4)(2007-9#2)(2008-1#3)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)
sent##174##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-10#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-8#3)(1993-9#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-7#1)(1995-11#1)(1995-4#2)(1995-5#1)(1995-6#3)(1996-1#1)(1996-11#1)(1996-3#1)(1996-6#3)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-5#1)(1997-8#1)(2004-10#1)(2004-9#1)(2005-10#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-12#2)(2006-8#4)(2007-10#4)(2007-11#1)(2007-12#4)(2007-2#6)(2007-7#6)(2007-8#2)(2007-9#3)(2008-1#6)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#6)(2008-5#6)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-5#1)(2010-8#3)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#9)(2011-3#1)(2011-9#1)(2012-12#3)(2012-2#4)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#1)
senta##4##1##(2010-8#4)
sentence and##4##2##(1997-5#1)(2012-1#3)
sentence comprehension and##3##3##(2007-4#1)(2009-9#2)
sentence comprehension##9##2##(2007-4#1)(2008-1#1)(2008-4#2)(2009-9#5)
sentence decreases following the##2##4##(2007-12#2)
sentence in##3##2##(2007-12#1)(2010-12#1)(2012-2#1)
sentence of##2##2##(2008-11#1)(2008-6#1)
sentence processing and##3##3##(2007-4#1)(2012-3#2)
sentence processing in##2##3##(2008-11#2)
sentence processing##8##2##(2007-4#1)(2008-1#2)(2008-11#3)(2012-3#2)
sentence structure##3##2##(2008-7#1)(2008-9#1)(2013-7#1)
sentence structures##2##2##(2007-4#1)(2011-1#1)
sentence types##3##2##(2007-4#1)(2008-8#1)(2013-7#1)
sentence##75##1##(1991-3#1)(1992-10#1)(1996-11#1)(1996-5#1)(1997-5#3)(1997-8#1)(2005-8#1)(2006-1#1)(2007-12#6)(2007-3#1)(2007-4#5)(2008-1#5)(2008-11#7)(2008-2#2)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#6)(2009-9#5)(2010-12#1)(2010-7#1)(2011-1#3)(2012-1#3)(2012-2#1)(2012-3#4)(2013-1#5)(2013-7#3)
sentence-span task##3##2##(2012-3#3)
sentenced##8##1##(1992-2#1)(1993-5#1)(1996-11#1)(1996-5#3)(1997-5#2)
sentences and##3##2##(2006-3#1)(2007-12#1)(2012-12#1)
sentences describing##2##2##(2008-11#1)(2010-2#1)
sentences in##6##2##(2007-4#1)(2008-7#1)(2009-10#1)(2013-1#2)(2013-7#1)
sentences that##2##2##(2007-8#1)(2009-8#1)
sentences to##2##2##(2007-2#1)(2012-3#1)
sentences were##3##2##(2007-4#1)(2013-1#2)
sentences##46##1##(1991-3#1)(1992-10#1)(2004-10#1)(2006-3#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#4)(2007-8#2)(2008-11#3)(2008-2#1)(2008-4#4)(2008-7#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-7#2)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#1)
sentencing##3##1##(1991-3#1)(1996-8#1)(1997-5#1)
sentential Subject##2##2##(2008-11#2)
sentential complements##5##2##(2006-2#5)
sentential##9##1##(2006-2#6)(2008-11#2)(2008-4#1)
sentiment analysis improved the ability to discriminate statements with 93% accuracy##2##11##(2013-1#2)
sentiment analysis##4##2##(2013-1#4)
sentiment##5##1##(1994-3#1)(2013-1#4)
sentiments##2##1##(1995-12#1)(2012-11#1)
sentinel calves##2##2##(1997-6#2)
sentinel event##4##2##(1991-12#1)(2011-2#3)
sentinel events##3##2##(1994-2#1)(2010-8#1)(2011-2#1)
sentinel lymph node (SLN)##2##4##(2012-2#1)(2013-1#1)
sentinel lymph node biopsy##5##4##(2010-7#2)(2011-2#1)(2012-12#1)(2013-8#1)
sentinel lymph node mapping##2##4##(2008-8#1)(2012-2#1)
sentinel lymph node##23##3##(2006-6#1)(2008-8#4)(2010-1#1)(2010-12#1)(2010-7#3)(2011-1#3)(2011-2#2)(2012-12#3)(2012-2#2)(2013-1#1)(2013-8#2)
sentinel lymph nodes biopsy##3##4##(2008-8#3)
sentinel lymph nodes##14##3##(2008-12#2)(2008-8#6)(2011-1#1)(2012-12#3)(2013-1#1)(2013-8#1)
sentinel lymph##37##2##(2006-6#1)(2008-12#2)(2008-8#10)(2010-1#1)(2010-12#1)(2010-7#3)(2011-1#4)(2011-2#2)(2012-12#6)(2012-2#2)(2013-1#2)(2013-8#3)
sentinel marker data##2##3##(2008-1#2)
sentinel node biopsy##5##3##(2005-8#1)(2007-12#1)(2010-7#2)(2012-2#1)
sentinel node##14##2##(2004-2#1)(2005-12#1)(2005-8#1)(2007-12#1)(2008-10#3)(2010-7#3)(2010-8#2)(2012-2#1)(2013-1#1)
sentinel nodes##2##2##(2010-7#1)(2010-8#1)
sentinel observers##2##2##(2007-7#2)
sentinel sheep##4##2##(1997-6#4)
sentinel sites##4##2##(1994-9#1)(2008-1#1)(2012-3#2)
sentinel##105##1##(1990-12#1)(1991-12#1)(1994-2#1)(1994-9#1)(1995-9#1)(1997-6#8)(2004-2#1)(2005-12#1)(2005-8#1)(2006-6#1)(2007-12#2)(2007-7#2)(2008-1#5)(2008-10#4)(2008-11#2)(2008-12#2)(2008-4#1)(2008-8#11)(2008-9#4)(2009-3#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-7#9)(2010-8#4)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#9)(2012-12#9)(2012-2#4)(2012-3#3)(2013-1#4)(2013-8#3)
sentinels of##3##2##(1995-11#1)(2007-5#1)(2009-9#1)
sentinels##10##1##(1995-11#1)(2007-5#1)(2008-9#7)(2009-9#1)
sepals##2##1##(2006-12#1)(2007-1#1)
separability of the##2##3##(2007-12#1)(2008-10#1)
separability of##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
separable diastereomeric##2##2##(1992-5#1)(1996-5#1)
separable from the##4##3##(1990-3#1)(1990-4#1)(1992-2#1)(1992-3#1)
separable from##5##2##(1990-3#1)(1990-4#1)(1992-2#1)(1992-3#1)(2008-1#1)
separable##25##1##(1990-2#1)(1990-3#1)(1990-4#1)(1990-9#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#1)(1994-6#1)(1995-3#1)(1996-5#1)(1996-8#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#1)(2008-5#1)(2012-12#1)(2012-2#1)
separata##11##1##(1992-1#2)(1992-6#1)(2007-12#3)(2008-11#5)
separate a##4##2##(1990-8#1)(2005-11#1)(2006-7#1)(2008-10#1)
separate activities##2##2##(2008-8#1)(2012-2#1)
separate adducts##2##2##(1993-2#2)
separate all##3##2##(1991-8#1)(2011-2#1)(2013-7#1)
separate analyses##2##2##(2007-8#1)(2009-9#1)
separate analysis of##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
separate analysis##6##2##(2004-1#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
separate and determine##2##3##(1997-3#1)(2008-10#1)
separate and distinct##2##3##(1995-4#1)(1997-2#1)
separate and independent##3##3##(1990-10#1)(1991-9#1)(1993-3#1)
separate and##26##2##(1990-10#1)(1991-9#1)(1993-3#1)(1995-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(2004-2#1)(2008-10#9)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#1)(2011-1#1)(2012-12#1)(2013-7#1)
separate as##2##2##(1990-5#1)(2010-8#1)
separate binding##2##2##(1996-2#1)(1997-5#1)
separate brain##2##2##(1993-12#1)(1995-12#1)
separate bureaus##2##2##(1992-1#2)
separate but related##2##3##(2008-11#1)(2008-5#1)
separate but##3##2##(2008-11#1)(2008-4#1)(2008-5#1)
separate capillaries##3##2##(2008-3#3)
separate catheterization##2##2##(2006-6#2)
separate cellular##2##2##(1994-12#2)
separate channels##2##2##(2007-8#1)(2008-4#1)
separate cluster##3##2##(2008-10#2)(2008-5#1)
separate cohorts of##2##3##(1995-2#1)(2012-3#1)
separate columns of##2##3##(1990-11#1)(1995-11#1)
separate columns##3##2##(1990-11#2)(1995-11#1)
separate community##2##2##(2009-4#1)(2012-3#1)
separate compartments##3##2##(2008-10#1)(2013-1#2)
separate components##5##2##(1995-5#2)(2005-8#1)(2008-10#1)(2008-2#1)
separate control##3##2##(1993-2#1)(1994-2#1)(2008-2#1)
separate data##2##2##(2007-11#1)(2008-3#1)
separate days##5##2##(1996-3#1)(1997-5#1)(2007-1#1)(2008-12#1)(2013-1#1)
separate determination of##3##3##(1992-1#1)(1995-4#1)(2008-10#1)
separate domains##4##2##(1992-8#1)(1992-9#1)(2007-10#1)(2011-1#1)
separate domestication##2##2##(1994-3#1)(2006-11#1)
separate effects##4##2##(1990-12#1)(1996-6#1)(2008-10#1)(2008-9#1)
separate entities##6##2##(2005-8#1)(2007-11#1)(2008-10#1)(2008-12#1)(2011-1#1)(2012-3#1)
separate evolutionary##3##2##(2008-9#1)(2009-6#1)(2011-2#1)
separate experimental##2##2##(2007-6#1)(2008-10#1)
separate experiments##21##2##(1990-5#1)(1990-9#1)(1991-5#1)(1992-6#1)(1993-6#1)(1994-2#1)(1995-11#1)(1995-7#2)(1997-3#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)
separate expression##2##2##(1997-1#1)(2008-11#1)
separate factors##2##2##(2008-3#1)(2009-12#1)
separate from the##9##3##(1990-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-7#1)(2012-1#1)
separate from those of##2##4##(2008-9#1)(2009-8#1)
separate from those##3##3##(1991-8#1)(2008-9#1)(2009-8#1)
separate from##26##2##(1990-5#1)(1991-8#1)(1993-11#1)(1993-3#1)(1996-5#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-7#1)(2009-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
separate functional##2##2##(2008-4#1)(2012-12#1)
separate gene##2##2##(2008-10#1)(2010-5#1)
separate genera##3##2##(1995-11#1)(2007-12#1)(2008-6#1)
separate genes##5##2##(1992-6#2)(1992-7#1)(1993-9#1)(1997-7#1)
separate groups of##5##3##(1995-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2012-3#1)
separate groups##7##2##(1995-10#1)(1996-5#1)(2007-9#1)(2008-10#1)(2008-11#1)(2012-2#1)(2012-3#1)
separate imaging##2##2##(2008-7#1)(2012-2#1)
separate in the##2##3##(2009-10#1)(2011-1#1)
separate in##3##2##(1995-6#1)(2009-10#1)(2011-1#1)
separate injections##3##2##(2008-4#3)
separate interferograms##2##2##(2008-2#2)
separate isolates of##2##3##(2005-9#1)(2008-10#1)
separate items##2##2##(1996-8#1)(2007-12#1)
separate laser and detector chips##2##5##(2008-3#2)
separate laser##3##2##(2007-11#1)(2008-3#2)
separate ligation##2##2##(1997-7#1)(2007-8#1)
separate lymphocyte##2##2##(1994-12#1)(1995-12#1)
separate measurement of the refractive##2##5##(2007-12#1)(2008-3#1)
separate mechanisms of##2##3##(1995-8#1)(1996-12#1)
separate mechanisms##6##2##(1990-4#1)(1995-8#2)(1996-11#1)(1996-12#1)(2008-10#1)
separate mental health##2##3##(1994-1#2)
separate mothers and babies##2##4##(2007-2#1)(2008-6#1)
separate occasions from##2##3##(2006-8#1)(2011-1#1)
separate occasions##9##2##(1991-3#1)(1996-5#1)(2006-5#1)(2006-8#3)(2008-8#1)(2010-2#1)(2011-1#1)
separate pairs of##2##3##(1990-2#1)(1997-2#1)
separate parts##2##2##(1993-5#1)(2011-2#1)
separate pathways for##2##3##(1991-4#1)(2008-9#1)
separate pathways##5##2##(1991-4#1)(1995-6#1)(2006-10#1)(2008-9#1)(2009-7#1)
separate peaks##2##2##(1993-7#1)(2012-1#1)
separate phenomena##3##2##(1990-12#1)(2011-2#1)(2012-2#1)
separate plasmid##2##2##(1994-12#1)(2008-11#1)
separate pool##2##2##(1993-3#2)
separate populations of##2##3##(1991-6#1)(1994-5#1)
separate populations##6##2##(1991-6#1)(1994-5#1)(2008-10#2)(2008-8#1)(2009-2#1)
separate processes##4##2##(1996-12#1)(2008-9#1)(2010-3#1)(2012-12#1)
separate proteins##2##2##(2008-4#1)(2009-8#1)
separate regions##4##2##(1990-3#1)(1995-2#1)(1997-1#1)(2008-10#1)
separate resonances##2##2##(1992-9#1)(1996-2#1)
separate samples of##2##3##(2007-12#1)(2009-7#1)
separate samples##4##2##(2007-12#1)(2008-10#1)(2008-12#1)(2009-7#1)
separate sessions##2##2##(2012-2#1)(2013-1#1)
separate sets of##3##3##(2007-8#1)(2008-5#1)(2009-8#1)
separate sets##4##2##(2007-8#1)(2008-10#1)(2008-5#1)(2009-8#1)
separate site##2##2##(1990-7#1)(1991-3#1)
separate sites##3##2##(1994-2#1)(2008-7#1)(2010-6#1)
separate solutions##3##2##(2008-10#2)(2010-7#1)
separate species##9##2##(1993-8#1)(1994-3#1)(1997-4#1)(2005-11#1)(2008-10#4)(2012-11#1)
separate studies are##2##3##(2009-11#1)(2011-1#1)
separate studies##10##2##(1991-11#1)(1994-12#1)(1995-7#1)(2007-1#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-8#1)(2009-11#1)(2011-1#1)
separate study##4##2##(1991-6#1)(1992-4#1)(2006-6#1)(2008-5#1)
separate subpopulations of##2##3##(1991-12#1)(1995-11#1)
separate subunits##2##2##(1990-7#1)(2012-2#1)
separate test##3##2##(1993-6#1)(2009-3#1)(2013-7#1)
separate the cells##2##3##(2011-2#2)
separate the epidermis##2##3##(2008-1#1)(2008-3#1)
separate the presacral##2##3##(1994-3#2)
separate the two##4##3##(1990-3#1)(1996-4#1)(2007-9#1)(2008-2#1)
separate the##52##2##(1990-3#1)(1994-3#2)(1995-1#1)(1996-4#1)(1996-5#1)(1997-2#2)(1997-5#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#13)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#1)(2009-10#2)(2010-12#1)(2010-2#2)(2011-1#2)(2011-2#3)(2013-7#1)(2013-8#1)
separate these##3##2##(2007-11#1)(2008-10#2)
separate this##3##2##(1990-11#1)(2006-10#1)(2007-10#1)
separate two##3##2##(2007-12#1)(2008-10#1)(2008-5#1)
separate yet related##2##3##(2006-6#2)
separate yet##3##2##(2006-6#2)(2009-8#1)
separate##860##1##(1990-10#3)(1990-11#5)(1990-12#4)(1990-2#2)(1990-3#4)(1990-4#1)(1990-5#4)(1990-7#3)(1990-8#2)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#3)(1991-12#3)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#5)(1991-7#2)(1991-8#7)(1991-9#1)(1992-1#8)(1992-10#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#2)(1992-6#4)(1992-7#1)(1992-8#5)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#4)(1993-3#4)(1993-5#1)(1993-6#5)(1993-7#2)(1993-8#1)(1993-9#1)(1994-1#3)(1994-11#1)(1994-12#12)(1994-2#4)(1994-3#6)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#5)(1995-1#3)(1995-10#1)(1995-11#7)(1995-12#2)(1995-2#2)(1995-4#3)(1995-5#5)(1995-6#8)(1995-7#4)(1995-8#3)(1996-1#1)(1996-11#3)(1996-12#5)(1996-2#4)(1996-3#5)(1996-4#2)(1996-5#9)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#7)(1997-3#6)(1997-4#5)(1997-5#7)(1997-6#3)(1997-7#4)(1997-8#6)(2004-1#1)(2004-2#1)(2004-8#1)(2005-11#3)(2005-12#2)(2005-4#1)(2005-8#3)(2005-9#1)(2006-10#8)(2006-11#4)(2006-12#4)(2006-2#1)(2006-3#2)(2006-5#1)(2006-6#6)(2006-7#1)(2006-8#8)(2006-9#1)(2007-1#4)(2007-10#4)(2007-11#10)(2007-12#27)(2007-2#5)(2007-3#1)(2007-5#3)(2007-6#5)(2007-7#1)(2007-8#16)(2007-9#9)(2008-1#5)(2008-10#135)(2008-11#16)(2008-12#7)(2008-2#22)(2008-3#27)(2008-4#22)(2008-5#18)(2008-6#8)(2008-7#13)(2008-8#14)(2008-9#12)(2009-1#1)(2009-10#5)(2009-11#1)(2009-12#2)(2009-2#6)(2009-3#2)(2009-4#5)(2009-5#2)(2009-6#3)(2009-7#4)(2009-8#6)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#4)(2010-3#2)(2010-4#1)(2010-5#5)(2010-6#1)(2010-7#3)(2010-8#4)(2011-1#11)(2011-12#2)(2011-2#17)(2011-3#1)(2011-7#1)(2012-1#3)(2012-11#1)(2012-12#7)(2012-2#14)(2012-3#11)(2012-4#1)(2012-5#1)(2013-1#12)(2013-7#15)(2013-8#3)
separated Al species##2##3##(2008-10#2)
separated P##2##2##(2008-10#2)
separated a##2##2##(2008-9#1)(2010-2#1)
separated according to their##4##4##(1995-1#1)(2008-2#1)(2008-3#1)(2008-4#1)
separated according to##6##3##(1995-1#1)(1996-5#1)(2007-3#1)(2008-2#1)(2008-3#1)(2008-4#1)
separated after##7##2##(1996-5#1)(2005-4#1)(2007-8#2)(2008-10#1)(2008-5#1)(2010-11#1)
separated analytes##3##2##(2008-10#3)
separated and detected##2##3##(2005-12#1)(2008-10#1)
separated and determined by##2##4##(1992-2#1)(2013-8#1)
separated and determined##5##3##(1992-2#1)(2008-10#2)(2011-1#1)(2013-8#1)
separated and quantified by##2##4##(1991-12#1)(2008-10#1)
separated and quantified##4##3##(1990-6#1)(1991-12#1)(1997-2#1)(2008-10#1)
separated and quantitated by##2##4##(1991-5#1)(1994-9#1)
separated and##34##2##(1990-6#2)(1990-8#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-2#2)(1993-4#1)(1993-8#1)(1994-9#2)(1995-2#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-8#1)(2005-12#1)(2007-11#1)(2007-2#1)(2008-10#9)(2008-12#1)(2010-12#1)(2011-1#1)(2013-8#2)
separated areas##2##2##(1995-2#1)(2008-3#1)
separated as##3##2##(1994-9#1)(2008-12#1)(2013-1#1)
separated at##5##2##(1991-3#1)(1996-11#1)(2008-1#1)(2008-10#1)(2012-12#1)
separated both##2##2##(2005-12#1)(2007-8#1)
separated by 1##4##3##(1990-4#1)(2008-10#1)(2010-10#1)(2013-8#1)
separated by 2##3##3##(1991-2#1)(2007-12#1)(2007-8#1)
separated by 4##3##3##(1994-12#1)(2008-7#1)(2009-10#1)
separated by 5##2##3##(2006-4#1)(2008-7#1)
separated by HPLC##6##3##(1991-2#1)(1995-3#1)(1995-8#1)(2008-10#2)(2008-8#1)
separated by SDS-PAGE and the##3##5##(2008-2#1)(2008-4#1)(2008-5#1)
separated by SDS-PAGE##8##3##(1990-11#2)(1990-9#1)(1993-8#1)(1996-12#1)(2008-2#1)(2008-4#1)(2008-5#1)
separated by TLC##2##3##(1996-5#1)(1996-8#1)
separated by a dialysis membrane##2##5##(1996-11#1)(2008-7#1)
separated by a thin##3##4##(2008-3#1)(2009-11#2)
separated by a##40##3##(1990-5#1)(1990-6#1)(1991-11#1)(1991-7#1)(1992-2#2)(1994-9#1)(1996-10#1)(1996-11#1)(1997-1#1)(1997-4#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-3#4)(2008-7#2)(2009-11#2)(2009-7#1)(2010-2#1)(2011-1#1)(2013-1#2)
separated by an interval of##2##5##(1993-11#1)(1996-8#1)
separated by an##13##3##(1990-8#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-9#1)(1996-8#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-8#1)
separated by anion-exchange##3##3##(1990-11#1)(1992-2#1)(2008-10#1)
separated by applying##2##3##(1995-8#1)(2008-10#1)
separated by capillary electrophoresis (CE)##4##5##(1996-5#1)(2005-12#1)(2008-10#1)(2010-5#1)
separated by capillary electrophoresis##6##4##(1996-5#1)(2005-12#1)(2008-10#3)(2010-5#1)
separated by capillary zone electrophoresis (CZE)##2##6##(2008-10#2)
separated by capillary zone electrophoresis##4##5##(1997-8#1)(2008-10#3)
separated by capillary##11##3##(1996-5#1)(1997-8#1)(2005-12#1)(2008-10#6)(2010-5#1)(2011-1#1)
separated by centrifugation and##3##4##(1991-9#1)(2008-10#1)(2008-5#1)
separated by centrifugation##5##3##(1991-9#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-9#1)
separated by column chromatography##2##4##(2007-11#1)(2008-12#1)
separated by column##3##3##(1992-1#1)(2007-11#1)(2008-12#1)
separated by contour-clamped##2##3##(1995-4#1)(2008-10#1)
separated by gas chromatography##2##4##(1991-12#1)(2008-10#1)
separated by high performance liquid chromatography (HPLC)##2##7##(2008-10#2)
separated by high performance liquid chromatography##4##6##(1993-4#1)(2008-10#3)
separated by high##5##3##(1993-4#1)(2008-10#3)(2008-4#1)
separated by high-performance liquid chromatography on a##2##7##(1990-6#1)(1991-11#1)
separated by high-performance liquid chromatography##7##5##(1990-12#1)(1990-6#1)(1990-8#2)(1991-11#1)(2008-10#1)(2012-2#1)
separated by high-performance##8##3##(1990-12#1)(1990-6#1)(1990-8#2)(1991-11#1)(1997-2#1)(2008-10#1)(2012-2#1)
separated by ion##2##3##(1990-8#1)(2008-10#1)
separated by large##3##3##(2008-7#1)(2009-8#1)(2012-1#1)
separated by more than##2##4##(2007-8#1)(2008-4#1)
separated by one##3##3##(1994-11#1)(1995-1#1)(2010-1#1)
separated by polyacrylamide gel electrophoresis##3##5##(1990-7#1)(2008-4#1)(2008-7#1)
separated by reversed phase##2##4##(1993-9#1)(1995-2#1)
separated by reversed-phase HPLC##4##4##(1990-2#1)(1990-5#1)(1996-2#1)(1996-5#1)
separated by reversed-phase high-performance liquid chromatography##2##6##(1993-9#1)(1995-6#1)
separated by reversed-phase liquid chromatography##2##5##(1990-12#1)(1991-1#1)
separated by reversed-phase##9##3##(1990-12#1)(1990-2#1)(1990-5#1)(1991-1#1)(1992-1#1)(1993-9#1)(1995-6#1)(1996-2#1)(1996-5#1)
separated by sodium dodecyl##3##4##(1990-10#1)(1990-7#1)(1996-12#1)
separated by the positively charged##2##5##(1996-5#2)
separated by the##12##3##(1990-8#2)(1992-12#1)(1996-2#1)(1996-5#2)(2005-4#1)(2007-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
separated by this##2##3##(1993-12#1)(1996-6#1)
separated by three##2##3##(1993-4#1)(1995-8#1)
separated by##296##2##(1990-10#3)(1990-11#4)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#4)(1990-8#7)(1990-9#1)(1991-1#3)(1991-11#2)(1991-12#2)(1991-2#2)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#6)(1992-12#2)(1992-2#4)(1992-3#1)(1992-6#1)(1992-7#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-8#2)(1993-9#4)(1994-10#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-9#5)(1995-1#1)(1995-2#1)(1995-3#2)(1995-4#2)(1995-6#3)(1995-8#4)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#1)(1996-5#8)(1996-6#1)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#2)(1997-8#4)(2005-10#1)(2005-11#1)(2005-12#3)(2005-4#1)(2005-8#2)(2006-10#1)(2006-4#1)(2006-6#1)(2007-1#1)(2007-11#4)(2007-12#9)(2007-2#1)(2007-5#1)(2007-8#5)(2008-10#46)(2008-11#7)(2008-12#2)(2008-2#6)(2008-3#6)(2008-4#9)(2008-5#5)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#2)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
separated completely##3##2##(2005-12#1)(2008-10#2)
separated compounds##2##2##(1996-5#1)(2012-12#1)
separated first##2##2##(2005-4#1)(2008-4#1)
separated for##5##2##(1991-12#1)(1995-11#1)(2007-10#1)(2008-10#2)
separated fractions##5##2##(1992-9#1)(2008-10#4)
separated free##2##2##(1992-12#1)(1992-6#1)
separated from Cr(III)##4##3##(2008-10#4)
separated from a##4##3##(1997-4#1)(2008-10#1)(2008-11#1)(2008-8#1)
separated from all##3##3##(2008-10#1)(2010-8#1)(2012-2#1)
separated from each other by##3##5##(1992-6#1)(2007-12#1)(2008-10#1)
separated from each other##8##4##(1990-2#1)(1992-6#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)
separated from large amounts of##2##5##(2005-4#1)(2008-10#1)
separated from large##3##3##(2005-4#1)(2008-10#2)
separated from normal##2##3##(2007-10#1)(2007-2#1)
separated from other##3##3##(1990-5#1)(2008-10#1)(2009-5#1)
separated from that of the##2##5##(1996-12#1)(2008-2#1)
separated from the aqueous phase##2##5##(2008-10#2)
separated from the aqueous##4##4##(2008-10#4)
separated from the bulk##3##4##(2006-8#1)(2008-10#2)
separated from the solution by##2##5##(2008-10#2)
separated from the solution in a gas phase separator##2##9##(2007-8#1)(2008-10#1)
separated from the solution##4##4##(2007-8#1)(2008-10#3)
separated from the##59##3##(1990-8#1)(1991-1#2)(1992-3#2)(1993-9#1)(1994-12#1)(1995-5#1)(1996-8#1)(1997-3#1)(1997-5#1)(2005-11#1)(2006-10#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#21)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
separated from their mothers##2##4##(2006-3#1)(2007-2#1)
separated from their##5##3##(1991-2#1)(2006-3#1)(2007-12#1)(2007-2#1)(2008-9#1)
separated from##154##2##(1990-12#1)(1990-2#2)(1990-5#1)(1990-8#2)(1991-1#2)(1991-2#2)(1992-11#1)(1992-3#2)(1992-6#1)(1993-2#1)(1993-5#1)(1993-9#2)(1994-12#2)(1994-3#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-5#2)(1996-8#2)(1997-2#5)(1997-3#1)(1997-4#2)(1997-5#4)(1997-6#1)(1997-8#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-10#2)(2007-11#1)(2007-12#7)(2007-2#2)(2007-3#1)(2007-8#2)(2007-9#2)(2008-10#52)(2008-11#3)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#2)(2009-8#1)(2010-12#1)(2010-8#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#1)
separated group##2##2##(2008-8#2)
separated in a fused-silica capillary##2##5##(1994-9#1)(1996-5#1)
separated in a single run##2##5##(1996-5#1)(2013-7#1)
separated in a##11##3##(1990-7#1)(1994-9#2)(1996-5#2)(1997-8#1)(2007-8#1)(2008-10#3)(2013-7#1)
separated in less than##2##4##(1996-8#1)(2008-10#1)
separated in the##3##3##(2008-10#1)(2008-3#1)(2008-6#1)
separated in time##3##3##(2007-12#2)(2008-2#1)
separated in two##2##3##(1996-4#1)(2008-10#1)
separated in##37##2##(1990-7#1)(1994-9#2)(1996-4#1)(1996-5#2)(1996-8#1)(1997-8#1)(2006-6#1)(2007-12#2)(2007-8#1)(2008-10#17)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2012-12#2)(2013-7#1)
separated into a##4##3##(1990-2#1)(2006-10#1)(2008-10#1)(2010-10#1)
separated into different##2##3##(2008-10#1)(2008-12#1)
separated into four##3##3##(2008-10#1)(2008-2#1)(2012-2#1)
separated into nine##2##3##(1990-11#1)(2005-11#1)
separated into the##3##3##(1997-4#1)(2008-10#1)(2008-11#1)
separated into three distinct##2##4##(1994-3#1)(2008-12#1)
separated into three groups on the basis of##2##8##(2008-1#1)(2008-10#1)
separated into three groups##3##4##(2005-7#1)(2008-1#1)(2008-10#1)
separated into three##8##3##(1990-7#1)(1991-3#1)(1992-11#1)(1994-3#1)(2005-7#1)(2008-1#1)(2008-10#1)(2008-12#1)
separated into two distinct groups##2##5##(1991-9#1)(2008-10#1)
separated into two groups##6##4##(1991-9#1)(1997-8#1)(2008-10#3)(2008-7#1)
separated into two##15##3##(1990-12#1)(1991-9#2)(1996-12#1)(1997-8#1)(2008-10#7)(2008-3#1)(2008-7#1)(2009-11#1)
separated into##64##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-3#1)(1991-9#2)(1992-11#1)(1993-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-6#1)(1996-12#2)(1996-3#1)(1997-4#1)(1997-8#1)(2004-11#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-11#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-11#1)(2009-7#1)(2010-10#1)(2010-4#1)(2012-2#1)
separated on a reversed-phase column##5##5##(1990-8#3)(1993-2#1)(1997-2#1)
separated on a reversed-phase##7##4##(1990-8#3)(1993-2#1)(1997-2#1)(2008-10#2)
separated on a##32##3##(1990-6#1)(1990-8#4)(1992-1#1)(1992-2#3)(1993-2#2)(1997-2#2)(1997-3#1)(2007-1#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-5#1)(2011-1#3)(2012-12#1)
separated on the column##2##4##(1991-5#1)(2008-10#1)
separated on the##11##3##(1991-5#1)(1996-5#1)(2008-10#7)(2008-2#1)(2008-4#1)
separated on##55##2##(1990-6#1)(1990-8#5)(1991-5#1)(1992-1#2)(1992-2#3)(1993-2#2)(1995-6#1)(1996-2#1)(1996-5#2)(1997-2#3)(1997-3#1)(2007-1#1)(2007-3#1)(2007-7#1)(2008-10#17)(2008-11#1)(2008-2#2)(2008-4#3)(2008-5#1)(2011-1#4)(2011-2#1)(2012-12#1)
separated on-line from##2##3##(2008-10#2)
separated peaks##2##2##(2008-10#2)
separated prior to##2##3##(2008-10#1)(2009-3#1)
separated proteins##2##2##(1990-11#1)(2008-12#1)
separated simultaneously##2##2##(1990-8#1)(2007-1#1)
separated sites##2##2##(2007-12#1)(2008-10#1)
separated species##2##2##(1991-12#1)(2010-5#1)
separated states##2##2##(2007-11#1)(2008-5#1)
separated the effects of##2##4##(2008-8#2)
separated the two species##2##4##(2008-10#1)(2008-9#1)
separated the two##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
separated the##20##2##(1991-10#1)(1995-6#1)(1996-11#1)(2007-8#1)(2008-10#9)(2008-5#2)(2008-8#2)(2008-9#1)(2011-2#1)(2013-1#1)
separated them##2##2##(1996-4#1)(2008-12#1)
separated to##2##2##(2008-9#1)(2012-11#1)
separated under##3##2##(1996-5#1)(1997-5#1)(2008-4#1)
separated using a##3##3##(1996-5#1)(1996-6#2)
separated using##16##2##(1990-8#1)(1990-9#2)(1991-3#1)(1992-8#1)(1995-3#1)(1996-3#1)(1996-5#2)(1996-6#2)(2008-10#3)(2010-2#1)(2012-12#1)
separated via##2##2##(2008-10#1)(2008-5#1)
separated well in##2##3##(2005-11#1)(2008-10#1)
separated well##4##2##(2005-11#1)(2008-10#2)(2012-12#1)
separated with a##5##3##(1990-12#1)(2005-11#1)(2008-10#2)(2013-8#1)
separated with high##3##3##(1995-6#1)(2008-10#2)
separated with##20##2##(1990-12#1)(1990-8#2)(1992-2#1)(1995-6#1)(2005-11#1)(2007-8#1)(2008-10#9)(2008-5#2)(2008-7#1)(2013-8#1)
separated within##14##2##(1994-9#1)(2005-12#1)(2008-10#10)(2008-5#1)(2013-8#1)
separated without any##2##3##(2008-10#2)
separated without##5##2##(2008-10#4)(2010-8#1)
separated##976##1##(1990-10#4)(1990-11#7)(1990-12#6)(1990-2#5)(1990-3#1)(1990-4#2)(1990-5#5)(1990-6#6)(1990-7#6)(1990-8#21)(1990-9#4)(1991-1#5)(1991-10#1)(1991-11#2)(1991-12#5)(1991-2#5)(1991-3#4)(1991-5#3)(1991-7#4)(1991-8#2)(1991-9#3)(1992-1#8)(1992-11#2)(1992-12#3)(1992-2#10)(1992-3#3)(1992-6#4)(1992-7#1)(1992-8#4)(1992-9#1)(1993-11#3)(1993-12#1)(1993-2#4)(1993-3#2)(1993-4#3)(1993-5#2)(1993-8#3)(1993-9#6)(1994-10#1)(1994-11#1)(1994-12#5)(1994-3#4)(1994-8#1)(1994-9#16)(1995-1#2)(1995-11#1)(1995-2#4)(1995-3#5)(1995-4#2)(1995-5#2)(1995-6#7)(1995-7#1)(1995-8#5)(1996-10#1)(1996-11#3)(1996-12#5)(1996-2#6)(1996-3#3)(1996-4#2)(1996-5#23)(1996-6#4)(1996-7#1)(1996-8#6)(1996-9#3)(1997-1#2)(1997-2#13)(1997-3#5)(1997-4#6)(1997-5#7)(1997-6#3)(1997-8#9)(2004-11#1)(2005-10#2)(2005-11#10)(2005-12#7)(2005-4#4)(2005-7#1)(2005-8#3)(2006-10#5)(2006-12#1)(2006-2#2)(2006-3#2)(2006-4#1)(2006-6#3)(2006-7#2)(2006-8#4)(2007-1#4)(2007-10#3)(2007-11#12)(2007-12#26)(2007-2#4)(2007-3#3)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#17)(2007-9#2)(2008-1#3)(2008-10#271)(2008-11#17)(2008-12#10)(2008-2#19)(2008-3#18)(2008-4#23)(2008-5#20)(2008-6#6)(2008-7#16)(2008-8#11)(2008-9#9)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#3)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#2)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#10)(2011-2#10)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#10)(2012-2#7)(2012-3#2)(2013-1#10)(2013-7#3)(2013-8#7)
separately administered##2##2##(1995-5#1)(2008-4#1)
separately and combined##2##3##(1995-8#1)(1996-1#1)
separately and together##3##3##(2008-10#3)
separately and##14##2##(1991-2#1)(1991-3#1)(1994-5#1)(1995-8#1)(1996-1#1)(2006-12#1)(2007-11#1)(2008-10#5)(2008-4#1)(2013-1#1)
separately as##3##2##(1990-11#1)(2008-12#1)(2008-6#1)
separately at##2##2##(2008-10#1)(2012-12#1)
separately by##3##2##(1995-1#1)(1997-7#1)(2008-10#1)
separately determined##2##2##(1996-1#1)(2006-6#1)
separately expressed in##2##3##(1997-4#1)(2013-1#1)
separately expressed##4##2##(1994-9#1)(1997-4#1)(2011-3#1)(2013-1#1)
separately for each##6##3##(1997-2#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2011-1#1)
separately for##22##2##(1990-11#1)(1992-8#1)(1996-12#1)(1996-2#1)(1997-2#1)(2006-1#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-6#1)(2009-7#1)(2010-2#1)(2011-1#1)(2011-2#1)
separately from the##5##3##(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2012-3#1)
separately from##12##2##(1995-4#1)(2005-11#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-8#1)(2012-12#1)(2012-3#1)
separately in the##7##3##(1996-2#1)(2006-6#1)(2007-2#1)(2008-10#1)(2008-5#1)(2012-2#1)(2013-8#1)
separately in this##2##3##(2007-12#1)(2008-4#1)
separately in three##2##3##(1997-1#1)(2008-3#1)
separately in two##2##3##(2006-6#1)(2008-10#1)
separately in##22##2##(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-4#1)(2006-6#2)(2007-12#1)(2007-2#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-2#1)(2013-8#1)
separately into the##2##3##(1991-7#1)(2008-10#1)
separately is##3##2##(2007-2#1)(2012-12#1)(2012-3#1)
separately measured##3##2##(2007-12#1)(2008-3#1)(2012-2#1)
separately on##3##2##(1990-10#1)(2007-12#1)(2008-10#1)
separately or in combination##3##4##(1994-6#1)(2004-4#1)(2011-1#1)
separately or in##5##3##(1994-6#1)(2004-4#1)(2010-11#1)(2011-1#1)(2011-2#1)
separately or##10##2##(1994-3#1)(1994-6#1)(1997-1#1)(2004-4#1)(2008-10#1)(2008-4#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#1)
separately the##2##2##(2008-3#1)(2008-7#1)
separately to##6##2##(1995-8#1)(2007-11#1)(2008-2#2)(2008-8#1)(2012-3#1)
separately under##2##2##(2008-10#1)(2010-5#1)
separately using##2##2##(1992-11#1)(2006-12#1)
separately was##2##2##(1993-6#1)(2011-2#1)
separately when the##2##3##(2006-8#1)(2012-1#1)
separately when##4##2##(2006-5#1)(2006-8#1)(2012-1#1)(2012-3#1)
separately with##5##2##(1990-5#1)(1994-3#1)(1994-8#1)(2008-10#1)(2008-9#1)
separately##288##1##(1990-10#3)(1990-11#2)(1990-12#2)(1990-5#1)(1990-7#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-7#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-5#2)(1993-6#2)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#4)(1995-8#2)(1996-1#2)(1996-12#1)(1996-2#2)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(2004-12#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#3)(2006-1#2)(2006-10#3)(2006-12#3)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#2)(2007-1#2)(2007-10#1)(2007-11#9)(2007-12#9)(2007-2#3)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#41)(2008-11#4)(2008-12#2)(2008-2#9)(2008-3#10)(2008-4#9)(2008-5#9)(2008-6#3)(2008-7#4)(2008-8#5)(2008-9#5)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#7)(2011-3#2)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#9)(2013-1#4)(2013-8#2)
separately)##2##1##(1996-9#1)(2010-10#1)
separates as##2##2##(1990-11#2)
separates on the basis of size##2##6##(2008-4#2)
separates on the basis of##3##5##(2008-4#3)
separates the##11##2##(1990-3#1)(1995-2#1)(1997-6#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-6#1)(2010-7#1)
separates##33##1##(1990-11#3)(1990-3#1)(1991-7#1)(1993-9#1)(1995-2#1)(1997-6#1)(2005-11#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)
separating a##3##2##(2008-11#1)(2008-6#1)(2009-8#1)
separating an##2##2##(1995-3#1)(2008-9#1)
separating and detecting##3##3##(1990-12#1)(2008-10#2)
separating and determining##3##3##(1997-3#1)(2008-10#2)
separating and##11##2##(1990-12#1)(1997-3#1)(2008-10#7)(2008-3#1)(2013-8#1)
separating inorganic##2##2##(1996-11#1)(2008-10#1)
separating normal##2##2##(2009-5#1)(2012-2#1)
separating samples##2##2##(2007-3#1)(2008-4#1)
separating the two##6##3##(1991-12#1)(2007-12#1)(2007-9#1)(2008-12#1)(2010-8#1)(2011-1#1)
separating the##25##2##(1991-12#1)(1991-5#1)(1993-11#1)(1993-12#1)(1994-3#1)(1995-5#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-12#2)(2007-9#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2010-8#2)(2011-1#1)(2012-12#1)
separating them##4##2##(1996-7#1)(2008-10#2)(2008-11#1)
separating these##2##2##(2008-10#1)(2008-4#1)
separating two intermediate regions##2##4##(1990-3#2)
separating two##5##2##(1990-3#2)(1995-10#1)(2005-11#1)(2008-7#1)
separating##122##1##(1990-12#1)(1990-3#2)(1991-12#1)(1991-5#1)(1991-6#1)(1992-6#2)(1993-11#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#1)(2004-8#1)(2004-9#1)(2005-11#3)(2006-12#1)(2006-3#1)(2006-4#1)(2006-7#1)(2007-12#3)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#27)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#11)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
separation and UV absorbance##2##4##(2007-8#1)(2008-10#1)
separation and a##3##3##(2007-12#1)(2008-10#2)
separation and analysis##3##3##(1990-2#1)(1997-8#1)(2008-4#1)
separation and characterization of##2##4##(1996-5#1)(2008-10#1)
separation and characterization##3##3##(1995-1#1)(1996-5#1)(2008-10#1)
separation and detection of##14##4##(1997-1#1)(2008-10#12)(2011-1#1)
separation and detection processes were examined and##3##7##(2008-10#3)
separation and detection processes were##4##5##(2008-10#4)
separation and detection processes##5##4##(2008-10#5)
separation and detection system##2##4##(2008-10#2)
separation and detection were investigated##2##5##(2008-10#2)
separation and detection##37##3##(1997-1#1)(1997-3#1)(2007-8#2)(2008-10#30)(2008-12#1)(2008-7#1)(2011-1#1)
separation and determination of a##2##5##(1991-8#1)(2008-10#1)
separation and determination of enterotoxigenic E##2##6##(2005-12#2)
separation and determination of##40##4##(1990-8#2)(1990-9#1)(1991-8#2)(1996-5#1)(2005-12#2)(2005-4#1)(2007-8#2)(2008-10#26)(2009-8#1)(2012-12#1)(2013-8#1)
separation and determination##45##3##(1990-12#1)(1990-8#2)(1990-9#1)(1991-8#2)(1996-5#1)(2005-12#2)(2005-4#1)(2007-8#2)(2008-10#30)(2009-8#1)(2012-12#1)(2013-8#1)
separation and direct detection of##2##5##(2008-10#2)
separation and enrichment of##4##4##(2005-4#1)(2008-10#2)(2013-8#1)
separation and enrichment##5##3##(2005-4#1)(2008-10#3)(2013-8#1)
separation and estimation of##3##4##(2008-10#3)
separation and identification of##6##4##(1991-8#2)(1996-6#1)(1996-8#1)(2008-1#1)(2010-9#1)
separation and identification##8##3##(1991-8#2)(1996-6#1)(1996-8#1)(2004-12#1)(2008-1#1)(2008-12#1)(2010-9#1)
separation and pre-concentration of inorganic arsenic##2##6##(2008-10#2)
separation and pre-concentration of##5##4##(2008-10#5)
separation and preconcentration of U(VI)##2##5##(2008-10#2)
separation and preconcentration of inorganic##2##5##(2008-10#2)
separation and preconcentration of trace##5##5##(2008-10#5)
separation and preconcentration of##28##4##(2008-10#28)
separation and preconcentration technique##2##4##(2008-10#2)
separation and preconcentration##40##3##(2008-10#40)
separation and purification of##6##4##(1997-2#2)(2008-10#3)(2013-8#1)
separation and quantification of##3##4##(1991-5#1)(1996-8#1)(2008-10#1)
separation and quantitation of the##2##5##(1997-2#1)(1997-8#1)
separation and quantitation of##4##4##(1997-2#1)(1997-8#1)(2008-10#2)
separation and quantitative##3##3##(2008-2#1)(2008-5#2)
separation and resolution##2##3##(2008-10#2)
separation and simultaneous##3##3##(2008-10#1)(2012-11#2)
separation and size##2##3##(2007-12#1)(2008-1#1)
separation and tandem mass##2##4##(1996-6#1)(2010-4#1)
separation and target##2##3##(2008-1#1)(2008-3#1)
separation and the##11##3##(1996-2#1)(2007-12#2)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#1)(2010-2#1)
separation and to##3##3##(2008-10#2)(2008-3#1)
separation and trace determination of##2##5##(2008-10#1)(2008-5#1)
separation and##268##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#5)(1995-1#1)(1995-3#1)(1996-2#1)(1996-5#3)(1996-6#3)(1996-8#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#6)(2004-12#1)(2005-11#1)(2005-12#2)(2005-4#2)(2005-8#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-12#4)(2007-8#6)(2008-1#4)(2008-10#159)(2008-11#1)(2008-12#3)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-11#5)(2012-12#1)(2013-8#3)
separation and/or##2##2##(1992-6#1)(2008-10#1)
separation anxiety##4##2##(1993-1#1)(1993-12#1)(2010-2#1)(2012-2#1)
separation approaches##2##2##(2008-10#2)
separation are##5##2##(1991-6#1)(1996-5#1)(2007-1#1)(2008-10#1)(2008-3#1)
separation as a##3##3##(1994-9#1)(1996-5#1)(2008-12#1)
separation as##6##2##(1990-4#1)(1994-9#1)(1996-5#1)(2005-11#1)(2008-10#1)(2008-12#1)
separation at the##2##3##(2007-12#1)(2007-8#1)
separation at##9##2##(1991-6#1)(2005-7#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-7#1)
separation based on##2##3##(2007-8#1)(2008-10#1)
separation between the peaks##2##4##(1991-5#1)(2008-10#1)
separation between the two##2##4##(2008-3#2)
separation between the##21##3##(1991-5#1)(1991-7#1)(1992-2#1)(1996-5#1)(2007-11#2)(2007-12#2)(2008-10#4)(2008-3#3)(2008-6#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-5#1)(2012-1#1)
separation between##46##2##(1990-12#1)(1990-8#1)(1991-11#2)(1991-5#1)(1991-7#1)(1992-2#2)(1993-11#1)(1996-5#1)(1997-2#2)(1997-6#1)(2005-11#1)(2005-12#2)(2007-11#2)(2007-12#2)(2007-3#1)(2008-10#7)(2008-2#2)(2008-3#5)(2008-6#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-9#1)(2010-2#1)(2010-5#1)(2010-8#1)(2012-1#1)(2013-7#1)
separation but##3##2##(1993-3#1)(2008-6#1)(2009-8#1)
separation by IP-RPHPLC##2##3##(2008-10#2)
separation by capillary electrophoresis##3##4##(1994-9#1)(2008-10#2)
separation by capillary##4##3##(1994-9#1)(1996-5#1)(2008-10#2)
separation by gel##2##3##(2008-11#1)(2010-4#1)
separation by ion##2##3##(2008-10#2)
separation by two-dimensional##2##3##(1997-4#1)(1997-8#1)
separation by##33##2##(1990-12#1)(1991-8#1)(1994-9#2)(1996-5#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2007-8#3)(2008-10#13)(2008-11#1)(2008-4#2)(2010-4#2)(2012-12#1)(2013-8#1)
separation can be##2##3##(2008-10#1)(2011-1#1)
separation capability##2##2##(2008-10#1)(2008-6#1)
separation capillary##4##2##(2008-10#4)
separation cell##3##2##(2007-8#1)(2008-10#2)
separation chamber##3##2##(2008-10#2)(2008-11#1)
separation channel##7##2##(2007-8#1)(2008-10#6)
separation column##4##2##(2008-10#4)
separation condition##3##2##(2008-10#2)(2009-5#1)
separation conditions for##2##3##(2008-10#2)
separation conditions were##4##3##(2008-10#4)
separation conditions##19##2##(1990-8#1)(1994-12#1)(1994-9#1)(1996-5#1)(2007-8#1)(2008-10#13)(2013-8#1)
separation device##3##2##(2008-10#1)(2008-11#2)
separation distance between##4##3##(2005-11#1)(2008-2#2)(2013-1#1)
separation distance##12##2##(2005-11#4)(2008-2#4)(2008-3#1)(2008-4#1)(2013-1#2)
separation during##6##2##(1997-5#1)(2004-9#2)(2008-7#1)(2009-12#1)(2010-4#1)
separation efficiencies for##2##3##(2008-10#1)(2008-11#1)
separation efficiencies##5##2##(1996-5#1)(2008-10#2)(2008-11#2)
separation efficiency and##2##3##(1996-5#1)(2008-10#1)
separation efficiency of##4##3##(1996-5#1)(1997-2#1)(1997-5#1)(2008-10#1)
separation efficiency##15##2##(1991-3#1)(1994-12#1)(1996-11#1)(1996-5#2)(1997-2#1)(1997-5#1)(2008-10#6)(2008-11#1)(2011-1#1)
separation factor (alpha)##2##3##(2008-10#2)
separation factor of##2##3##(2005-12#2)
separation factor##13##2##(1996-5#1)(2005-11#1)(2005-12#4)(2008-10#7)
separation factors between##2##3##(2005-4#1)(2008-10#1)
separation factors of##2##3##(2005-12#1)(2008-10#1)
separation factors##10##2##(1996-5#1)(1997-2#1)(2005-12#1)(2005-4#1)(2008-10#6)
separation for all##2##3##(2008-10#2)
separation for the##2##3##(1990-12#1)(2008-10#1)
separation for##10##2##(1990-12#1)(2007-1#1)(2008-10#6)(2008-2#1)(2013-1#1)
separation from the##4##3##(2006-4#1)(2008-10#2)(2008-3#1)
separation from water##2##3##(2008-10#2)
separation from##16##2##(1990-3#1)(1991-7#1)(1996-3#1)(2006-4#1)(2007-8#1)(2008-10#9)(2008-3#1)(2012-3#1)
separation has been##4##3##(2008-10#2)(2008-11#1)(2012-12#1)
separation has##5##2##(2007-1#1)(2008-10#2)(2008-11#1)(2012-12#1)
separation in a##7##3##(1996-9#1)(1997-2#1)(2008-3#2)(2010-4#1)(2010-7#1)(2011-1#1)
separation in both##2##3##(1991-7#1)(2008-6#1)
separation in the##10##3##(1991-6#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-9#1)(2011-2#1)(2013-8#1)
separation in##38##2##(1991-6#1)(1991-7#1)(1992-6#1)(1995-1#1)(1995-5#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-12#4)(2007-3#1)(2007-4#1)(2008-10#5)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
separation into##5##2##(1994-5#1)(2008-10#2)(2010-4#1)(2011-2#1)
separation is achieved on a##2##5##(1992-2#1)(1996-8#1)
separation is observed##2##3##(2008-10#1)(2011-2#1)
separation is proposed##2##3##(2008-10#1)(2008-2#1)
separation is##33##2##(1990-12#1)(1991-11#1)(1992-2#1)(1994-12#1)(1996-5#1)(1996-8#1)(1997-2#1)(2006-10#1)(2007-12#2)(2008-10#12)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-7#1)(2010-9#1)(2011-2#1)(2012-2#1)
separation length##3##2##(2008-10#3)
separation mechanism##5##2##(1990-8#1)(1991-10#1)(1996-5#1)(1996-8#1)(2011-2#1)
separation mechanisms##4##2##(2008-10#3)(2012-12#1)
separation method based on a novel reversed-phase sequential injection chromatography (SIC)##2##11##(2008-10#2)
separation method##8##2##(1990-11#1)(1996-5#1)(2008-10#6)
separation methods##6##2##(1995-6#1)(2007-8#2)(2008-10#1)(2008-11#1)(2010-7#1)
separation mode was##2##3##(2008-10#1)(2013-8#1)
separation mode##5##2##(1996-5#1)(2008-10#2)(2010-7#1)(2013-8#1)
separation modes##3##2##(1996-5#2)(2005-12#1)
separation of Cu##2##3##(2008-10#2)
separation of DNA and proteins##2##5##(2008-7#2)
separation of DNA fragments##4##4##(2008-10#2)(2008-2#1)(2008-4#1)
separation of DNA##6##3##(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#2)
separation of Fe(III)##3##3##(2008-10#3)
separation of Hf##4##3##(2008-10#4)
separation of K(+)##2##3##(2008-10#2)
separation of PEG##2##3##(2008-10#2)
separation of a complex mixture of##2##6##(2008-10#2)
separation of a mixture of##3##5##(2008-10#3)
separation of a mixture##4##4##(2008-10#4)
separation of a set of##2##5##(2008-10#2)
separation of a##15##3##(1996-8#1)(2006-12#1)(2008-10#12)(2013-8#1)
separation of actinides and##2##4##(2008-10#2)
separation of active##2##3##(1996-5#1)(2008-10#1)
separation of all##3##3##(1996-5#1)(2007-8#1)(2008-10#1)
separation of amino acids##3##4##(1990-6#1)(1991-12#1)(2008-10#1)
separation of amino##4##3##(1990-6#1)(1991-12#1)(2008-10#1)(2008-7#1)
separation of an##2##3##(1997-2#1)(2008-10#1)
separation of anions##4##3##(2005-12#1)(2008-10#3)
separation of any##2##3##(1994-9#1)(2008-11#1)
separation of basic drugs by capillary electrophoresis##2##7##(1996-5#2)
separation of basic drugs##4##4##(1990-8#1)(1995-6#1)(1996-5#2)
separation of basic##6##3##(1990-8#1)(1995-6#1)(1996-5#2)(2008-10#2)
separation of blood##2##3##(1990-3#1)(1992-8#1)
separation of both##3##3##(1993-4#1)(2008-10#2)
separation of bound##3##3##(1995-11#1)(1996-9#1)(2008-11#1)
separation of cadmium##2##3##(2008-10#2)
separation of cell##3##3##(2008-4#1)(2009-6#1)(2011-2#1)
separation of chromium##2##3##(2008-10#2)
separation of closely related peptides##2##5##(1994-9#1)(1996-5#1)
separation of closely related##3##4##(1991-11#1)(1994-9#1)(1996-5#1)
separation of complex samples##2##4##(2013-8#2)
separation of different##3##3##(2008-10#3)
separation of diltiazem##2##3##(1990-8#2)
separation of drugs by electrokinetic chromatography##2##6##(1996-5#2)
separation of drugs##3##3##(1996-5#3)
separation of enantiomeric##2##3##(1994-9#1)(1995-6#1)
separation of enantiomers of##3##4##(1996-5#1)(2008-10#2)
separation of enantiomers##4##3##(1994-9#1)(1996-5#1)(2008-10#2)
separation of extract from aqueous phase##2##6##(2008-10#2)
separation of five##3##3##(2007-8#1)(2008-10#2)
separation of four##2##3##(2008-10#2)
separation of gallium##3##3##(2008-10#3)
separation of human##3##3##(1991-5#1)(1997-2#1)(2008-10#1)
separation of individual##2##3##(1997-3#1)(2008-10#1)
separation of inorganic##6##3##(1994-8#1)(2008-10#5)
separation of inositol phosphates##2##4##(1990-11#1)(2008-4#1)
separation of iron(III)##3##3##(2008-10#3)
separation of large##3##3##(1992-6#1)(1996-5#1)(2009-10#1)
separation of metal ions##5##4##(2008-10#5)
separation of metal##6##3##(2008-10#6)
separation of micron##2##3##(2008-10#2)
separation of non-polar##2##3##(2008-10#1)(2013-8#1)
separation of nucleosides and##2##4##(1993-12#1)(2008-10#1)
separation of oil##2##3##(2005-11#2)
separation of organic##2##3##(2005-12#1)(2008-10#1)
separation of p-sulfonated calix[n]arenes##2##4##(2008-10#2)
separation of palladium(II) from##2##4##(2008-10#2)
separation of palladium(II)##3##3##(2008-10#3)
separation of peptides and##3##4##(2008-2#1)(2008-4#2)
separation of peptides##4##3##(1994-9#1)(2008-2#1)(2008-4#2)
separation of platinum##2##3##(2008-10#2)
separation of platinum(IV) from##2##4##(2008-10#2)
separation of proteins and##2##4##(1996-5#1)(2008-6#1)
separation of proteins by##2##4##(2007-8#1)(2012-2#1)
separation of proteins##8##3##(1996-5#1)(2007-8#2)(2008-6#1)(2008-7#2)(2010-11#1)(2012-2#1)
separation of seven##4##3##(1990-8#1)(1996-5#1)(2008-10#2)
separation of six##4##3##(2008-10#4)
separation of small##3##3##(1990-8#1)(1996-5#1)(2010-7#1)
separation of solasodine glycosides##2##4##(2008-11#2)
separation of some##3##3##(1992-1#1)(1996-5#1)(2008-10#1)
separation of tellurium(IV) from##2##4##(2008-10#2)
separation of the different##2##4##(2008-10#2)
separation of the formed##2##4##(2008-10#2)
separation of the reaction products##3##5##(1991-8#1)(2008-10#1)(2008-4#1)
separation of the same compounds##2##5##(2008-10#2)
separation of the spectral##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
separation of the three##4##4##(2008-10#4)
separation of the two##5##4##(1990-7#1)(1997-6#1)(2008-10#2)(2010-7#1)
separation of the##115##3##(1990-12#2)(1990-4#1)(1990-7#2)(1991-2#1)(1991-3#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1994-11#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-5#5)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#2)(2005-12#2)(2006-11#1)(2006-9#1)(2007-11#3)(2007-12#4)(2008-10#47)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#5)(2008-7#1)(2009-10#1)(2009-8#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#1)(2013-8#1)
separation of these two##2##4##(1990-5#1)(1991-11#1)
separation of these##10##3##(1990-5#1)(1991-11#1)(1992-1#1)(1996-5#1)(2008-10#4)(2008-7#1)(2012-2#1)
separation of this##3##3##(2007-8#1)(2008-10#1)(2008-12#1)
separation of three##3##3##(2007-8#1)(2008-10#2)
separation of trace##7##3##(2008-10#7)
separation of trivalent##3##3##(2008-10#3)
separation of two##7##3##(1991-11#1)(1997-7#1)(2006-2#1)(2007-11#1)(2008-10#1)(2009-12#1)(2010-4#1)
separation of uranium by##2##4##(2008-10#2)
separation of uranium##5##3##(2008-10#5)
separation of uranium(VI)##3##3##(2008-10#3)
separation of zinc compounds##2##4##(2008-10#2)
separation of zinc from##2##4##(2008-10#2)
separation of zinc traces from##2##5##(2008-10#2)
separation of zinc##8##3##(2005-11#1)(2008-10#7)
separation of##666##2##(1990-11#5)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#10)(1990-9#3)(1991-10#1)(1991-11#4)(1991-12#2)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#2)(1991-8#3)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-6#3)(1992-8#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-4#2)(1993-8#1)(1994-11#1)(1994-12#3)(1994-8#3)(1994-9#11)(1995-11#1)(1995-6#4)(1995-7#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#29)(1996-6#4)(1996-8#4)(1996-9#1)(1997-2#5)(1997-3#4)(1997-4#1)(1997-6#3)(1997-7#2)(1997-8#5)(2005-10#1)(2005-11#5)(2005-12#6)(2005-4#2)(2006-10#1)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#7)(2007-12#10)(2007-2#4)(2007-3#2)(2007-7#1)(2007-8#9)(2007-9#2)(2008-1#4)(2008-10#322)(2008-11#9)(2008-12#5)(2008-2#12)(2008-3#7)(2008-4#14)(2008-5#2)(2008-6#2)(2008-7#14)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-6#2)(2009-8#1)(2010-11#2)(2010-2#4)(2010-4#2)(2010-5#1)(2010-7#3)(2011-1#5)(2011-2#5)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#10)
separation on DOWEX 50W-X8 resin##3##5##(2007-8#3)
separation on a##4##3##(1990-6#1)(1996-12#1)(2008-10#2)
separation on the##3##3##(2008-10#1)(2009-2#1)(2012-2#1)
separation on##19##2##(1990-6#1)(1991-3#1)(1996-12#1)(1996-6#1)(2007-8#3)(2008-10#8)(2009-2#1)(2010-4#1)(2012-2#1)(2013-1#1)
separation or##5##2##(2007-11#1)(2007-6#1)(2008-10#1)(2008-4#1)(2010-11#1)
separation parameters##4##2##(1991-11#1)(2008-10#2)(2013-1#1)
separation performance##4##2##(2005-11#1)(2006-2#1)(2007-8#1)(2008-10#1)
separation principle is##2##3##(2010-7#2)
separation principle##3##2##(1996-5#1)(2010-7#2)
separation procedure##10##2##(1994-9#1)(2007-8#1)(2008-10#8)
separation procedures##6##2##(2008-10#5)(2008-11#1)
separation process##9##2##(1992-1#1)(2005-12#1)(2005-4#1)(2008-10#5)(2008-5#1)
separation properties##3##2##(1995-3#2)(2012-12#1)
separation result##2##2##(2008-10#1)(2009-12#1)
separation selectivity and##2##3##(1996-5#1)(2008-10#1)
separation selectivity##5##2##(1996-5#1)(2007-8#1)(2008-10#3)
separation space##3##2##(2008-10#3)
separation step##9##2##(2008-10#7)(2010-8#1)(2011-2#1)
separation steps and##2##3##(2008-10#1)(2012-2#1)
separation steps##11##2##(2008-10#6)(2008-11#1)(2008-4#2)(2008-6#1)(2012-2#1)
separation strategy##2##2##(2008-4#1)(2010-8#1)
separation surgery##6##2##(2010-7#3)(2013-1#3)
separation system was used##2##4##(2008-10#2)
separation system##6##2##(2008-10#3)(2008-7#1)(2012-1#2)
separation systems##3##2##(2007-8#1)(2008-10#2)
separation technique for##4##3##(1994-9#1)(2008-10#2)(2008-9#1)
separation technique##12##2##(1993-12#1)(1994-9#1)(2008-10#7)(2008-12#1)(2008-4#1)(2008-9#1)
separation techniques and##2##3##(1996-8#1)(2008-7#1)
separation techniques such as##3##4##(2008-10#3)
separation techniques##15##2##(1991-9#1)(1996-8#1)(2008-10#9)(2008-4#2)(2008-7#2)
separation temperature##2##2##(1991-3#1)(2013-1#1)
separation that##2##2##(2008-2#1)(2008-3#1)
separation theory##2##2##(1996-5#1)(2008-2#1)
separation time of##2##3##(2008-10#1)(2008-4#1)
separation time##4##2##(1997-3#1)(2008-10#2)(2008-4#1)
separation to##3##2##(2008-4#1)(2008-9#1)(2011-2#1)
separation under##2##2##(2008-10#2)
separation using##7##2##(1990-8#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-4#1)(2009-10#1)
separation via##2##2##(2005-11#1)(2008-10#1)
separation voltage and##4##3##(2008-10#4)
separation voltage of##8##3##(2008-10#8)
separation voltage##14##2##(2008-10#14)
separation was accomplished using a##2##5##(2008-10#1)(2008-6#1)
separation was accomplished##4##3##(1990-8#1)(2008-10#2)(2008-6#1)
separation was achieved by##3##4##(1990-12#1)(2008-10#2)
separation was achieved in##2##4##(2007-8#1)(2008-10#1)
separation was achieved on a Zorbax##2##6##(1996-8#1)(2010-12#1)
separation was achieved on a##5##5##(1996-8#1)(2008-10#1)(2009-10#1)(2010-12#1)(2012-12#1)
separation was achieved on an ODS##2##6##(1996-8#1)(2013-7#1)
separation was achieved on an##5##5##(1996-8#1)(2008-10#1)(2012-12#1)(2013-7#2)
separation was achieved on##12##4##(1996-8#2)(2008-10#4)(2009-10#1)(2010-12#1)(2012-12#2)(2013-7#2)
separation was achieved using a##5##5##(1996-6#1)(1997-3#1)(1997-8#1)(2010-12#1)(2010-2#1)
separation was achieved with##3##4##(2008-10#2)(2010-12#1)
separation was achieved##25##3##(1990-12#1)(1996-6#1)(1996-8#2)(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#9)(2009-10#1)(2010-12#3)(2010-2#1)(2012-12#2)(2013-7#2)
separation was also##3##3##(1992-6#1)(1994-3#1)(2008-10#1)
separation was carried out in##2##5##(1996-5#1)(2008-10#1)
separation was carried out on##4##5##(1990-6#1)(2008-10#1)(2011-1#2)
separation was carried out##11##4##(1990-6#1)(1996-5#1)(2008-10#6)(2010-2#1)(2011-1#2)
separation was not##2##3##(1996-5#1)(2008-10#1)
separation was observed##2##3##(2008-10#2)
separation was obtained##4##3##(1997-3#1)(2008-10#2)(2008-5#1)
separation was performed on a##5##5##(1992-2#1)(2008-10#1)(2011-1#1)(2011-3#1)(2012-12#1)
separation was performed on##7##4##(1992-2#1)(2008-10#1)(2010-12#1)(2011-1#2)(2011-3#1)(2012-12#1)
separation was performed using a##3##5##(2008-10#2)(2013-1#1)
separation was performed using##4##4##(1997-8#1)(2008-10#2)(2013-1#1)
separation was performed with##2##4##(2007-3#1)(2008-12#1)
separation was performed##16##3##(1992-2#1)(1996-5#1)(1997-8#1)(2007-3#1)(2008-10#5)(2008-12#1)(2010-12#1)(2011-1#2)(2011-3#1)(2012-12#1)(2013-1#1)
separation was##87##2##(1990-12#1)(1990-6#1)(1990-8#1)(1991-3#1)(1991-4#1)(1992-2#1)(1992-6#1)(1992-8#1)(1994-3#1)(1996-5#4)(1996-6#2)(1996-8#2)(1997-3#2)(1997-8#2)(2005-4#1)(2006-9#1)(2007-3#1)(2007-8#1)(2008-10#35)(2008-11#2)(2008-12#3)(2008-3#1)(2008-5#1)(2008-6#1)(2009-10#1)(2010-12#4)(2010-2#2)(2011-1#4)(2011-2#1)(2011-3#1)(2012-12#3)(2013-1#1)(2013-7#2)
separation were##6##2##(2008-10#5)(2010-10#1)
separation with Amberlite##3##3##(2008-10#3)
separation with a##3##3##(2008-10#3)
separation with the atomic force microscope##2##6##(2006-10#2)
separation with##24##2##(1990-4#1)(1995-5#1)(1997-1#1)(1997-4#1)(2006-10#2)(2008-10#17)(2008-3#1)
separation within##2##2##(2008-10#1)(2009-8#1)
separation yielded##2##2##(2005-8#1)(2008-10#1)
separation##1944##1##(1990-11#6)(1990-12#10)(1990-2#2)(1990-3#3)(1990-4#8)(1990-5#2)(1990-6#3)(1990-7#3)(1990-8#18)(1990-9#5)(1991-1#1)(1991-10#2)(1991-11#9)(1991-12#2)(1991-2#2)(1991-3#9)(1991-4#2)(1991-5#5)(1991-6#7)(1991-7#4)(1991-8#9)(1991-9#3)(1992-1#5)(1992-11#2)(1992-12#1)(1992-2#10)(1992-3#2)(1992-4#1)(1992-6#6)(1992-8#3)(1993-1#2)(1993-11#2)(1993-12#4)(1993-2#5)(1993-3#3)(1993-4#2)(1993-8#1)(1994-11#1)(1994-12#7)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#17)(1995-1#2)(1995-11#1)(1995-12#1)(1995-3#5)(1995-5#2)(1995-6#6)(1995-7#2)(1996-11#2)(1996-12#3)(1996-2#4)(1996-3#2)(1996-5#66)(1996-6#11)(1996-8#11)(1996-9#2)(1997-1#3)(1997-2#16)(1997-3#11)(1997-4#7)(1997-5#5)(1997-6#4)(1997-7#3)(1997-8#16)(2004-11#1)(2004-12#2)(2004-9#2)(2005-10#2)(2005-11#25)(2005-12#18)(2005-4#10)(2005-7#1)(2005-8#2)(2006-10#11)(2006-11#3)(2006-12#5)(2006-2#4)(2006-3#2)(2006-4#2)(2006-5#4)(2006-6#2)(2006-8#1)(2006-9#4)(2007-1#5)(2007-11#13)(2007-12#34)(2007-2#4)(2007-3#5)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#40)(2007-9#2)(2008-1#12)(2008-10#886)(2008-11#32)(2008-12#15)(2008-2#37)(2008-3#44)(2008-4#41)(2008-5#19)(2008-6#13)(2008-7#32)(2008-8#6)(2008-9#14)(2009-10#5)(2009-11#2)(2009-12#3)(2009-2#3)(2009-5#1)(2009-6#2)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#6)(2010-2#11)(2010-4#13)(2010-5#6)(2010-7#14)(2010-8#6)(2010-9#2)(2011-1#16)(2011-2#16)(2011-3#1)(2012-1#6)(2012-11#5)(2012-12#15)(2012-2#13)(2012-3#4)(2013-1#13)(2013-7#5)(2013-8#23)
separation)##2##1##(2008-10#2)
separation-free##2##1##(2007-2#2)
separation-of-variables method##3##2##(2008-2#1)(2008-3#2)
separation-of-variables##4##1##(2008-2#1)(2008-3#3)
separation/preconcentration##6##1##(2007-8#1)(2008-10#5)
separations and mass spectrometry##2##4##(2008-4#1)(2008-7#1)
separations and##11##2##(1991-3#1)(1991-8#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-7#1)(2010-11#1)
separations are##6##2##(1990-2#1)(1995-3#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-4#1)
separations between##2##2##(2008-10#1)(2008-7#1)
separations by##3##2##(1996-5#1)(1996-6#1)(2008-10#1)
separations for##3##2##(2007-8#1)(2008-7#1)(2011-2#1)
separations in##7##2##(1991-3#1)(2008-10#3)(2008-2#1)(2008-4#1)(2009-3#1)
separations of neuromediators##2##3##(2008-10#2)
separations of organic compounds##2##4##(2008-10#2)
separations of proteins##2##3##(1996-5#1)(2008-4#1)
separations of the##2##3##(1997-3#1)(2011-1#1)
separations of##39##2##(1991-8#2)(1994-8#1)(1994-9#4)(1996-5#2)(1996-8#1)(1997-3#1)(1997-5#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#16)(2008-2#1)(2008-4#2)(2008-5#1)(2011-1#2)
separations on##3##2##(1991-8#1)(1996-8#1)(2008-10#1)
separations or##2##2##(2008-10#1)(2008-2#1)
separations that##3##2##(1997-2#1)(2007-12#1)(2008-3#1)
separations using##5##2##(2008-10#3)(2008-7#2)
separations was##2##2##(1991-3#1)(2008-10#1)
separations were achieved by##2##4##(2008-10#1)(2008-7#1)
separations were carried out on##2##5##(2007-8#1)(2008-10#1)
separations were performed on##2##4##(2008-10#2)
separations were##8##2##(1997-2#1)(2007-8#1)(2008-10#5)(2008-7#1)
separations with##2##2##(2008-10#2)
separations##153##1##(1990-2#1)(1990-4#1)(1990-9#1)(1991-11#1)(1991-3#3)(1991-8#4)(1993-12#1)(1994-11#1)(1994-8#3)(1994-9#7)(1995-1#1)(1995-11#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-5#8)(1996-6#1)(1996-8#4)(1997-1#2)(1997-2#2)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#2)(2005-11#5)(2007-11#2)(2007-12#6)(2007-8#7)(2008-10#47)(2008-2#5)(2008-3#5)(2008-4#7)(2008-5#1)(2008-7#8)(2009-3#1)(2010-11#1)(2010-7#1)(2011-1#2)(2011-2#1)(2013-1#2)
separative##2##1##(2008-10#2)
separator and then##3##3##(2007-8#1)(2008-10#2)
separator and##6##2##(2007-8#1)(2008-10#5)
separator to##2##2##(2008-10#2)
separator##34##1##(2006-8#2)(2007-8#2)(2008-10#23)(2010-12#1)(2010-8#1)(2011-1#4)(2011-2#1)
separators##8##1##(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2011-2#2)
separatrix##2##1##(2007-11#1)(2008-10#1)
sepedonicus##2##1##(2008-10#2)
sephacryl##2##1##(1991-8#1)(1997-4#1)
sephadex##2##1##(1992-12#1)(2010-11#1)
sepharose and##2##2##(1991-12#1)(1997-8#1)
sepharose##6##1##(1990-12#1)(1991-12#1)(1992-5#1)(1994-2#1)(1997-8#1)(2008-7#1)
sepiapterin reductase##3##2##(1991-3#1)(1991-8#2)
sepiapterin##5##1##(1991-3#1)(1991-8#3)(1992-6#1)
sepiolite and determined by flame atomic absorption##2##7##(2008-10#2)
sepiolite and##3##2##(2008-10#3)
sepiolite##8##1##(2008-10#8)
sepsis (p &lt##2##3##(2009-6#2)
sepsis (p##3##2##(2009-6#3)
sepsis after##3##2##(2007-8#1)(2008-8#1)(2008-9#1)
sepsis and meningitis##3##3##(2009-12#3)
sepsis and nephrotoxic##2##3##(2008-4#1)(2010-2#1)
sepsis and septic shock in##3##5##(1996-9#1)(2007-12#1)(2011-2#1)
sepsis and septic shock##19##4##(1993-12#4)(1996-9#1)(2006-10#2)(2007-12#3)(2007-7#1)(2008-12#1)(2008-8#1)(2009-9#2)(2011-2#4)
sepsis and##53##2##(1992-12#2)(1993-12#4)(1993-2#2)(1994-6#1)(1995-8#1)(1996-3#1)(1996-9#1)(2006-10#2)(2006-4#1)(2007-11#2)(2007-12#4)(2007-5#1)(2007-7#2)(2008-12#1)(2008-4#2)(2008-8#3)(2009-12#3)(2009-9#2)(2010-12#1)(2010-2#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-12#2)(2013-1#3)(2013-8#1)
sepsis and/or##2##2##(2007-7#1)(2012-2#1)
sepsis are##5##2##(2006-10#1)(2007-12#1)(2008-12#1)(2012-12#1)(2012-3#1)
sepsis by##2##2##(2008-5#1)(2012-2#1)
sepsis caused by##2##3##(1995-5#1)(2008-5#1)
sepsis has##3##2##(2005-8#1)(2007-11#1)(2013-1#1)
sepsis in cirrhotic patients##2##4##(2011-2#2)
sepsis in the##6##3##(2005-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
sepsis in##21##2##(2005-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-5#1)(2008-1#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
sepsis is##10##2##(1991-5#1)(2008-7#1)(2009-6#2)(2011-2#4)(2012-12#1)(2012-3#1)
sepsis model##4##2##(1997-5#1)(2011-1#3)
sepsis of##2##2##(2007-12#1)(2008-4#1)
sepsis or##5##2##(1995-5#1)(2006-10#1)(2011-2#2)(2012-2#1)
sepsis should##2##2##(2005-8#1)(2006-10#1)
sepsis syndrome##3##2##(2007-11#1)(2007-3#1)(2008-4#1)
sepsis trials##4##2##(2006-10#4)
sepsis was##6##2##(2007-12#1)(2007-7#3)(2008-7#1)(2011-2#1)
sepsis were##2##2##(2013-1#2)
sepsis which were##3##3##(2007-8#1)(2013-1#1)(2013-8#1)
sepsis which##5##2##(2007-8#1)(2009-6#1)(2013-1#2)(2013-8#1)
sepsis##327##1##(1990-3#2)(1990-6#1)(1991-3#5)(1991-5#1)(1991-7#1)(1992-12#2)(1992-2#2)(1992-5#1)(1993-12#4)(1993-2#2)(1993-6#1)(1993-9#1)(1994-6#1)(1995-5#2)(1995-8#1)(1996-10#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-5#1)(1997-6#1)(2005-10#3)(2005-8#5)(2006-1#1)(2006-10#21)(2006-2#3)(2006-4#5)(2006-8#1)(2007-10#1)(2007-11#9)(2007-12#14)(2007-2#1)(2007-3#5)(2007-5#3)(2007-7#8)(2007-8#7)(2007-9#1)(2008-1#3)(2008-12#3)(2008-3#1)(2008-4#4)(2008-5#9)(2008-6#2)(2008-7#4)(2008-8#11)(2008-9#6)(2009-12#3)(2009-5#2)(2009-6#13)(2009-8#3)(2009-9#3)(2010-11#2)(2010-12#4)(2010-2#5)(2010-4#1)(2010-5#1)(2010-7#3)(2010-8#1)(2011-1#9)(2011-12#3)(2011-2#35)(2011-3#1)(2012-12#10)(2012-2#14)(2012-3#10)(2013-1#30)(2013-7#3)(2013-8#7)
sepsis)##3##1##(2008-7#1)(2011-2#1)(2013-8#1)
sepsis-induced tissue injury##2##3##(1995-2#2)
sepsis-induced##3##1##(1995-2#2)(2012-3#1)
sepsis-related mortality##4##2##(2010-2#4)
septa and##2##2##(2008-1#1)(2012-12#1)
septa##13##1##(1990-11#1)(1994-6#1)(1994-9#1)(2005-12#1)(2008-1#1)(2008-7#5)(2010-10#1)(2012-12#1)(2012-2#1)
septae##2##1##(2008-5#1)(2010-11#1)
septal and##2##2##(1994-12#1)(2012-12#1)
septal aneurysm##4##2##(1994-11#3)(2007-10#1)
septal area##5##2##(1991-6#1)(1993-12#2)(1997-2#1)(2013-8#1)
septal button##3##2##(2008-2#3)
septal cholinergic neurons##2##3##(1993-12#1)(1996-12#1)
septal collaterals##2##2##(2012-2#2)
septal defect and##6##3##(2007-8#1)(2008-10#1)(2008-11#2)(2010-9#1)(2012-2#1)
septal defect in adults##2##4##(2007-8#1)(2008-4#1)
septal defect in##5##3##(1992-2#1)(2007-8#1)(2008-4#1)(2012-1#1)(2012-12#1)
septal defect is the most##2##5##(2006-10#1)(2008-4#1)
septal defect is##4##3##(2006-10#1)(2007-8#1)(2008-4#2)
septal defect with a##2##4##(2007-8#2)
septal defect with##4##3##(2007-8#2)(2008-11#1)(2008-4#1)
septal defect##83##2##(1992-10#1)(1992-2#1)(1995-6#1)(1996-6#1)(2005-12#2)(2006-10#1)(2006-12#1)(2006-4#2)(2006-8#3)(2007-8#28)(2008-10#1)(2008-11#11)(2008-2#1)(2008-4#8)(2008-7#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-9#2)(2010-9#2)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#1)
septal defect]##3##2##(1990-10#1)(1996-2#1)(2013-1#1)
septal defects and open##2##4##(1996-6#1)(1997-8#1)
septal defects and##5##3##(1996-6#1)(1997-8#1)(2008-4#1)(2009-10#1)(2012-12#1)
septal defects##27##2##(1993-10#1)(1996-6#1)(1997-8#3)(2005-12#1)(2007-9#1)(2008-11#2)(2008-4#5)(2009-10#2)(2009-12#1)(2010-7#2)(2010-9#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
septal fascicular block##3##3##(2006-9#3)
septal grafts##3##2##(1993-12#3)
septal hypertrophy##2##2##(2007-8#1)(2008-11#1)
septal neurons##8##2##(1993-4#1)(1994-2#2)(1994-5#5)
septal nucleus##4##2##(1992-7#1)(1992-8#1)(1994-2#1)(1995-12#1)
septal obliteration technique##2##3##(2007-8#2)
septal occluder##3##2##(1997-8#1)(2008-4#1)(2009-10#1)
septal perforation##2##2##(2008-2#2)
septal resection##3##2##(2007-8#1)(2013-1#2)
septal reset##2##2##(2010-11#2)
septal rupture in a##2##4##(1993-12#1)(2007-8#1)
septal rupture##7##2##(1993-12#2)(2007-8#3)(2012-1#1)(2013-7#1)
septal stimulation##6##2##(1991-3#1)(1992-8#3)(1994-2#2)
septal thickness##3##2##(1992-5#1)(1995-3#1)(2012-2#1)
septal##230##1##(1990-10#1)(1991-3#3)(1991-5#1)(1991-6#1)(1992-10#2)(1992-2#1)(1992-5#1)(1992-7#2)(1992-8#4)(1992-9#1)(1993-10#1)(1993-12#9)(1993-3#1)(1993-4#1)(1993-5#1)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#9)(1994-5#5)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#5)(1996-2#1)(1996-6#2)(1997-2#1)(1997-3#1)(1997-8#4)(2005-12#3)(2006-10#1)(2006-12#1)(2006-4#2)(2006-8#3)(2006-9#6)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#37)(2007-9#1)(2008-10#3)(2008-11#14)(2008-2#7)(2008-4#16)(2008-7#1)(2009-10#4)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-9#2)(2010-11#3)(2010-7#3)(2010-9#5)(2011-1#2)(2011-2#6)(2012-1#3)(2012-12#5)(2012-2#12)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#2)
septal-preoptic area##3##2##(1993-2#2)(1995-12#1)
septate junctions##7##2##(2008-7#7)
septate uterus##2##2##(1994-9#1)(2011-1#1)
septate##19##1##(1994-9#1)(2008-10#3)(2008-7#7)(2009-8#1)(2011-1#1)(2013-1#6)
septated##3##1##(2006-5#1)(2011-2#1)(2012-2#1)
septation##7##1##(1995-3#1)(2005-11#1)(2007-8#1)(2008-4#1)(2010-10#1)(2010-5#1)(2012-2#1)
septations##2##1##(2012-12#1)(2012-2#1)
septaurelia##4##1##(2008-12#4)
september##7##1##(2006-9#2)(2008-11#1)(2008-7#3)(2009-8#1)
septempunctata##6##1##(2011-12#6)
septentrionalis##3##1##(2012-2#3)
septic and##3##2##(2005-10#1)(2006-4#1)(2008-11#1)
septic arthritis and##6##3##(2006-10#3)(2010-12#1)(2013-8#2)
septic arthritis caused by##5##4##(2006-10#5)
septic arthritis in##2##3##(2006-10#1)(2011-2#1)
septic arthritis of the##2##4##(2009-3#1)(2010-3#1)
septic arthritis of##3##3##(2006-1#1)(2009-3#1)(2010-3#1)
septic arthritis##34##2##(1991-3#1)(1993-11#2)(2006-1#1)(2006-10#13)(2007-11#1)(2007-12#1)(2007-2#2)(2008-7#2)(2008-9#1)(2009-3#2)(2010-12#1)(2010-3#1)(2011-2#1)(2013-8#5)
septic cardiomyopathy##2##2##(2008-7#2)
septic complication##2##2##(1991-4#1)(1992-6#1)
septic complications after##3##3##(2007-11#1)(2007-8#1)(2011-1#1)
septic complications in##2##3##(2007-8#1)(2008-7#1)
septic complications were##2##3##(2007-11#2)
septic complications##10##2##(2007-11#4)(2007-8#2)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)
septic conditions##3##2##(1993-2#1)(1994-11#1)(1994-9#1)
septic embolism##2##2##(2006-2#1)(2012-12#1)
septic loosening##3##2##(2007-11#1)(2009-4#1)(2012-12#1)
septic patients##6##2##(1991-9#1)(1997-8#1)(2010-4#1)(2013-7#2)(2013-8#1)
septic peritonitis##4##2##(2008-4#3)(2013-8#1)
septic shock and##6##3##(2006-10#1)(2007-7#1)(2008-12#1)(2009-5#1)(2011-1#1)(2011-2#1)
septic shock are##2##3##(2008-8#1)(2009-2#1)
septic shock as##2##3##(2007-12#1)(2011-2#1)
septic shock in##5##3##(1995-2#2)(1996-9#1)(2007-12#1)(2011-2#1)
septic shock or##2##3##(1997-5#1)(2008-5#1)
septic shock##78##2##(1992-1#1)(1993-12#4)(1994-8#1)(1995-2#5)(1996-3#3)(1996-9#2)(1997-4#1)(1997-5#1)(2005-7#2)(2006-10#6)(2006-4#2)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-7#2)(2008-1#1)(2008-12#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-12#2)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#11)(2012-12#1)(2013-1#3)(2013-8#1)
septic spondylodiscitis##3##2##(2006-10#3)
septic thrombophlebitis##2##2##(2009-4#1)(2010-2#1)
septic##184##1##(1990-10#1)(1990-6#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-6#1)(1993-10#1)(1993-11#2)(1993-12#4)(1993-2#2)(1993-5#1)(1994-11#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-2#5)(1996-3#4)(1996-9#2)(1997-1#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-7#2)(2006-1#1)(2006-10#23)(2006-2#2)(2006-4#5)(2006-5#1)(2006-8#1)(2007-11#8)(2007-12#5)(2007-2#3)(2007-5#1)(2007-7#4)(2007-8#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#3)(2009-4#4)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-12#2)(2011-2#14)(2012-12#4)(2013-1#6)(2013-7#3)(2013-8#9)
septicaemia and##2##2##(2007-8#1)(2007-9#1)
septicaemia caused by##2##3##(1990-9#1)(1995-5#1)
septicaemia in a##3##3##(2007-7#3)
septicaemia in##4##2##(2007-7#3)(2008-5#1)
septicaemia were##2##2##(2006-2#1)(2007-7#1)
septicaemia##34##1##(1990-6#1)(1990-8#3)(1990-9#1)(1991-8#1)(1992-9#1)(1994-3#1)(1995-11#2)(1995-5#1)(1996-9#1)(2006-2#1)(2006-4#2)(2007-7#8)(2007-8#1)(2007-9#1)(2008-2#1)(2008-5#4)(2008-7#1)(2009-5#1)(2011-12#1)(2013-1#1)
septicaemic##3##1##(2011-1#3)
septicemia and##2##2##(2007-7#1)(2009-6#1)
septicemia caused by##2##3##(1994-9#1)(1995-9#1)
septicemia in##5##2##(1993-5#1)(2006-8#1)(2007-12#1)(2011-2#1)(2012-12#1)
septicemia##38##1##(1993-1#1)(1993-5#1)(1994-9#3)(1995-9#1)(2006-10#1)(2006-7#1)(2006-8#4)(2007-12#3)(2007-5#1)(2007-7#8)(2008-1#1)(2009-6#1)(2010-2#1)(2010-4#1)(2011-2#3)(2012-12#2)(2012-3#3)(2013-8#2)
septicemia]##3##1##(1990-9#1)(1996-3#1)(1996-9#1)
septile##2##1##(2008-7#2)
septo-hippocampal cell cultures##3##3##(1996-12#1)(1996-2#2)
septo-hippocampal cholinergic activation##3##3##(1994-2#3)
septo-hippocampal cholinergic##4##2##(1993-12#1)(1994-2#3)
septo-hippocampal##9##1##(1993-12#2)(1994-2#3)(1996-12#1)(1996-2#3)
septo-optic dysplasia is##2##3##(1997-3#1)(2011-1#1)
septo-optic dysplasia##5##2##(1997-3#2)(2011-1#3)
septohippocampal cholinergic##2##2##(1993-11#1)(2013-8#1)
septohippocampal neurons##2##2##(1990-7#1)(1996-12#1)
septohippocampal##10##1##(1990-7#1)(1991-3#1)(1993-11#1)(1993-12#3)(1996-12#1)(1997-6#1)(2013-8#2)
septoria speckled leaf blotch##3##4##(2008-10#3)
septoria tritici blotch##2##3##(2008-10#2)
septoria##7##1##(2008-10#7)
septosporum and##2##2##(2008-10#2)
septosporum##4##1##(2008-10#4)
septum and amygdala##3##3##(1991-3#2)(1994-2#1)
septum and the##2##3##(1993-12#1)(2008-10#1)
septum and##14##2##(1991-3#2)(1991-5#2)(1992-9#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-2#1)(2006-6#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)
septum in the##2##3##(1993-12#1)(2008-11#1)
septum in##4##2##(1993-12#1)(2008-10#1)(2008-11#1)(2012-12#1)
septum is##4##2##(1991-5#1)(2006-6#2)(2008-7#1)
septum may##2##2##(1994-5#1)(2009-3#1)
septum or##3##2##(1990-6#1)(1991-3#1)(1994-2#1)
septum pellucidotomy##2##2##(2006-5#2)
septum that##2##2##(2010-11#1)(2012-3#1)
septum was##8##2##(1991-5#1)(1995-5#1)(2007-8#2)(2012-12#2)(2013-1#2)
septum with##2##2##(2005-10#1)(2012-12#1)
septum##120##1##(1990-6#4)(1991-3#5)(1991-5#5)(1991-8#1)(1992-7#1)(1992-8#2)(1992-9#4)(1993-12#6)(1994-11#1)(1994-12#1)(1994-2#5)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-12#2)(1996-4#2)(1996-5#1)(1997-3#2)(1997-8#1)(2005-10#2)(2006-4#1)(2006-5#2)(2006-6#5)(2006-8#1)(2007-5#3)(2007-8#7)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-6#2)(2008-7#4)(2008-9#1)(2009-1#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-11#3)(2010-12#2)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#5)(2012-3#4)(2013-1#5)
seqdb_demo##2##1##(2008-4#2)
sequel following##2##2##(2007-11#1)(2008-7#1)
sequel of##5##2##(1991-9#1)(2008-7#3)(2012-3#1)
sequel to##2##2##(1996-11#1)(2013-1#1)
sequel##14##1##(1990-10#1)(1991-9#1)(1996-11#1)(2007-10#1)(2007-11#1)(2008-7#4)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
sequela of##10##2##(1990-9#1)(1992-1#1)(1992-4#1)(1992-8#1)(2006-10#1)(2006-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)
sequela##14##1##(1990-9#1)(1992-1#1)(1992-4#1)(1992-8#1)(1994-5#1)(2006-10#2)(2006-11#1)(2006-5#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)
sequelae after##7##2##(1996-8#1)(2007-11#2)(2007-2#1)(2007-8#2)(2007-9#1)
sequelae and##12##2##(1997-2#1)(2004-1#1)(2005-6#1)(2006-10#3)(2006-7#1)(2007-11#1)(2007-9#1)(2008-3#1)(2008-4#1)(2010-12#1)
sequelae associated with##3##3##(1994-5#1)(2005-10#1)(2008-12#1)
sequelae but##2##2##(1990-12#1)(2011-2#1)
sequelae cause##2##2##(1996-11#1)(2013-1#1)
sequelae for##2##2##(1993-5#1)(2010-12#1)
sequelae in##9##2##(1992-11#1)(1995-2#1)(2004-1#1)(2004-10#1)(2006-11#1)(2008-2#1)(2009-8#1)(2012-2#1)(2013-1#1)
sequelae is##3##2##(2007-11#1)(2008-11#1)(2009-11#1)
sequelae may##2##2##(2007-8#1)(2012-2#1)
sequelae of acute##2##3##(1991-9#1)(2011-2#1)
sequelae of knee arthroscopy##4##4##(2007-11#4)
sequelae of the##5##3##(1994-5#1)(2008-8#1)(2009-4#1)(2011-1#1)(2011-2#1)
sequelae of trauma##2##3##(2007-11#1)(2011-1#1)
sequelae of traumatic brain injury##2##5##(1990-12#1)(1993-12#1)
sequelae of##64##2##(1990-12#2)(1990-3#1)(1991-3#1)(1991-4#2)(1991-9#2)(1992-5#1)(1993-11#1)(1993-12#1)(1994-5#1)(1995-12#1)(1996-3#1)(1996-8#2)(2004-3#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-11#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#7)(2007-12#1)(2007-7#3)(2007-9#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#2)(2009-9#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
sequelae or##3##2##(2005-10#1)(2007-10#1)(2011-2#1)
sequelae that##3##2##(2006-8#1)(2007-11#2)
sequelae were##5##2##(1990-12#1)(1993-7#1)(2006-4#1)(2007-2#1)(2010-9#1)
sequelae##208##1##(1990-10#1)(1990-12#5)(1990-3#2)(1990-6#1)(1990-9#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-9#2)(1992-10#2)(1992-11#1)(1992-5#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-5#3)(1993-7#1)(1994-11#1)(1994-4#2)(1994-5#2)(1994-6#2)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-8#4)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#2)(2004-1#3)(2004-10#2)(2004-3#1)(2005-10#3)(2005-6#1)(2005-7#3)(2006-1#1)(2006-10#9)(2006-11#4)(2006-12#1)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#14)(2007-12#2)(2007-2#2)(2007-3#1)(2007-7#3)(2007-8#7)(2007-9#4)(2008-1#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#4)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#7)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#12)(2013-8#3)
sequelae]##2##1##(1997-3#1)(2007-3#1)
sequels in##2##2##(1991-4#1)(1995-12#1)
sequels of##3##2##(1992-1#1)(2008-12#1)(2011-2#1)
sequels##9##1##(1991-4#1)(1992-1#1)(1995-12#1)(2006-8#1)(2007-3#1)(2007-8#1)(2008-12#1)(2011-2#1)(2013-1#1)
sequence &quot##2##2##(1994-6#1)(1996-7#1)
sequence (&gt##3##2##(1997-9#1)(2008-10#2)
sequence (1 copy/every##2##3##(1997-2#2)
sequence (1##3##2##(1995-2#1)(1997-2#2)
sequence (an 1##2##3##(2008-11#2)
sequence (at position##2##3##(1997-7#2)
sequence (residues##2##2##(1995-1#1)(1997-4#1)
sequence (the##2##2##(2008-4#2)
sequence 1##3##2##(1992-12#1)(1994-12#1)(1997-8#1)
sequence 5##2##2##(1996-2#1)(2004-10#1)
sequence 5'##2##2##(1990-7#1)(1992-3#1)
sequence 5'-d(GNC)##2##2##(1995-1#2)
sequence 5'-pyrimidine-GA-purine-3'##2##2##(1991-7#2)
sequence 5'GCCGGC##2##2##(1994-5#2)
sequence RNA##3##2##(1990-8#2)(1991-2#1)
sequence a##4##2##(1991-7#1)(1992-2#1)(2007-6#1)(2011-2#1)
sequence across##2##2##(1997-9#1)(2008-7#1)
sequence against a##2##3##(2008-4#1)(2011-2#1)
sequence alignment and phylogenetic##2##4##(2008-10#1)(2008-4#1)
sequence alignment and##3##3##(2008-10#1)(2008-4#2)
sequence alignment of the##2##4##(2008-7#1)(2011-1#1)
sequence alignment of##7##3##(1994-3#1)(1994-5#1)(1995-8#1)(2008-10#1)(2008-7#1)(2011-1#1)(2013-1#1)
sequence alignment revealed##2##3##(2008-10#1)(2011-1#1)
sequence alignment using##2##3##(2008-9#1)(2012-2#1)
sequence alignment##32##2##(1990-9#1)(1992-12#1)(1992-8#1)(1993-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-8#1)(2007-8#1)(2008-10#4)(2008-4#8)(2008-7#1)(2008-9#1)(2009-8#1)(2011-1#2)(2012-2#2)(2013-1#3)
sequence alignments of##3##3##(1994-6#1)(2008-4#1)(2009-9#1)
sequence alignments with##2##3##(1997-1#1)(2008-4#1)
sequence alignments##19##2##(1993-11#1)(1994-11#1)(1994-6#2)(1994-9#1)(1995-1#1)(1997-1#1)(2006-10#1)(2008-10#1)(2008-4#5)(2008-7#2)(2009-9#1)(2010-4#1)(2013-8#1)
sequence allows##2##2##(1997-3#1)(2008-10#1)
sequence alone##3##2##(1990-2#1)(1994-8#1)(1997-4#1)
sequence also contains a##2##4##(1993-3#1)(1995-9#1)
sequence also contains##3##3##(1993-3#1)(1995-9#1)(1996-10#1)
sequence also##11##2##(1991-7#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-6#1)(1995-9#1)(1996-10#1)(1997-4#1)(2006-12#1)
sequence alterations in##3##3##(1992-3#1)(1996-7#1)(2011-1#1)
sequence alterations##5##2##(1992-3#1)(1994-11#1)(1996-7#1)(2008-10#1)(2011-1#1)
sequence amplified##3##2##(1996-8#1)(2008-10#1)(2013-1#1)
sequence an##2##2##(1994-10#1)(2008-10#1)
sequence analyses and##3##3##(1996-6#1)(2008-10#1)(2013-1#1)
sequence analyses of the##5##4##(1990-5#1)(1993-12#1)(1995-2#1)(2008-10#2)
sequence analyses of##11##3##(1990-5#1)(1990-7#1)(1993-12#1)(1995-2#1)(2007-6#1)(2008-10#4)(2008-7#2)
sequence analyses revealed##2##3##(1994-12#1)(2008-11#1)
sequence analyses##31##2##(1990-5#1)(1990-7#1)(1991-9#1)(1992-4#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-4#1)(1994-8#1)(1995-2#1)(1996-4#1)(1996-6#1)(1997-4#1)(2007-6#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#2)(2013-1#2)
sequence analysis and comparison with##2##5##(1992-1#1)(2008-10#1)
sequence analysis and expression##2##4##(1993-2#1)(2008-8#1)
sequence analysis and##17##3##(1990-8#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-9#1)(1997-8#1)(2008-10#3)(2008-8#1)(2008-9#1)(2010-10#1)(2012-2#1)
sequence analysis by##3##3##(1992-1#1)(1994-6#1)(2008-4#1)
sequence analysis has##2##3##(1991-9#1)(1994-11#1)
sequence analysis identified##3##3##(1993-11#1)(1996-10#1)(1996-5#1)
sequence analysis in##2##3##(1993-3#1)(2008-7#1)
sequence analysis indicated that##2##4##(2008-10#1)(2008-9#1)
sequence analysis indicated the##2##4##(1992-12#1)(2008-10#1)
sequence analysis indicated##6##3##(1990-10#1)(1992-12#1)(2006-8#1)(2008-10#2)(2008-9#1)
sequence analysis indicates that##4##4##(1992-5#1)(1992-6#1)(2008-6#1)(2008-9#1)
sequence analysis indicates##5##3##(1992-5#1)(1992-6#1)(1993-9#1)(2008-6#1)(2008-9#1)
sequence analysis is##2##3##(2008-4#1)(2009-2#1)
sequence analysis of 16S##2##4##(2006-8#1)(2008-10#1)
sequence analysis of PCR##3##4##(1990-12#1)(1992-12#1)(2006-8#1)
sequence analysis of a gene##2##5##(1993-2#1)(1997-1#1)
sequence analysis of a##14##4##(1990-5#1)(1991-5#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-3#2)(1997-4#1)(2007-6#1)
sequence analysis of cDNA##2##4##(1993-11#1)(1994-2#1)
sequence analysis of cloned##2##4##(1992-11#1)(2006-8#1)
sequence analysis of polymerase chain reaction##2##6##(1992-8#1)(2006-12#1)
sequence analysis of the CP gene##2##6##(1997-6#1)(2008-10#1)
sequence analysis of the clone##2##5##(1990-11#1)(1996-7#1)
sequence analysis of the internal transcribed spacer (ITS)##2##8##(2008-10#2)
sequence analysis of the internal transcribed spacer region 1 (ITS1)##2##10##(2008-10#2)
sequence analysis of the internal transcribed spacer##4##7##(2008-10#4)
sequence analysis of the major##2##5##(1991-9#1)(2009-5#1)
sequence analysis of the protein##2##5##(1990-7#1)(1992-3#1)
sequence analysis of the purified##3##5##(1992-12#1)(1992-8#1)(1997-2#1)
sequence analysis of the##58##4##(1990-11#2)(1990-3#1)(1990-7#3)(1991-1#1)(1991-10#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#3)(1994-5#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-10#2)(1996-12#1)(1996-7#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-6#1)(2005-11#1)(2008-10#15)(2008-5#1)(2008-6#1)(2009-5#1)(2011-1#1)
sequence analysis of their##2##4##(2006-8#1)(2008-10#1)
sequence analysis of these##2##4##(1992-3#1)(1994-6#1)
sequence analysis of two##5##4##(1990-12#1)(1991-8#1)(1993-2#1)(1994-8#1)(1997-4#1)
sequence analysis of##136##3##(1990-11#2)(1990-12#4)(1990-3#1)(1990-5#2)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#2)(1991-2#3)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#2)(1992-12#5)(1992-2#1)(1992-3#2)(1992-8#3)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#2)(1993-4#1)(1993-6#3)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#4)(1994-5#2)(1994-6#2)(1994-8#3)(1995-1#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#3)(1996-12#1)(1996-5#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#2)(1997-6#2)(1997-8#1)(2005-11#1)(2005-6#1)(2006-12#1)(2006-8#4)(2006-9#2)(2007-6#1)(2008-10#23)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-10#1)(2011-1#1)(2013-1#1)
sequence analysis on##2##3##(2005-11#1)(2011-1#1)
sequence analysis revealed an open reading frame (ORF)##2##8##(1994-12#1)(1995-8#1)
sequence analysis revealed an##3##4##(1994-12#1)(1995-8#1)(2008-10#1)
sequence analysis revealed that one##3##5##(1990-2#1)(1992-4#1)(1994-12#1)
sequence analysis revealed that the##7##5##(1992-6#1)(1993-7#1)(1995-3#1)(1997-1#1)(1997-4#1)(2008-10#2)
sequence analysis revealed that##18##4##(1990-2#1)(1991-12#2)(1992-4#1)(1992-6#1)(1993-7#1)(1994-12#2)(1995-3#1)(1997-1#1)(1997-4#2)(1997-7#1)(2008-10#3)(2008-8#1)(2013-8#1)
sequence analysis revealed the##2##4##(1991-2#1)(1995-3#1)
sequence analysis revealed##28##3##(1990-11#1)(1990-2#1)(1991-12#2)(1991-2#2)(1991-9#1)(1992-4#1)(1992-6#1)(1993-7#1)(1994-12#3)(1995-3#2)(1995-8#2)(1996-11#1)(1997-1#1)(1997-4#2)(1997-7#1)(2008-10#4)(2008-8#1)(2013-8#1)
sequence analysis showed that the##3##5##(1990-11#2)(1993-3#1)
sequence analysis showed that##4##4##(1990-11#2)(1993-3#1)(1997-8#1)
sequence analysis showed the presence of##2##6##(1994-8#1)(2008-10#1)
sequence analysis showed##7##3##(1990-11#2)(1993-3#1)(1994-8#1)(1997-8#1)(2008-10#2)
sequence analysis suggests that##2##4##(1991-6#1)(1992-3#1)
sequence analysis was##2##3##(1997-4#1)(2008-6#1)
sequence analysis##307##2##(1990-10#2)(1990-11#5)(1990-12#5)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#4)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#6)(1991-2#6)(1991-3#1)(1991-5#5)(1991-6#3)(1991-7#2)(1991-8#2)(1991-9#5)(1992-1#2)(1992-11#4)(1992-12#8)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#3)(1993-11#4)(1993-12#3)(1993-2#3)(1993-3#5)(1993-4#2)(1993-5#1)(1993-6#5)(1993-7#1)(1993-9#2)(1994-11#4)(1994-12#7)(1994-2#4)(1994-5#3)(1994-6#4)(1994-8#4)(1994-9#1)(1995-1#1)(1995-3#3)(1995-6#1)(1995-8#4)(1995-9#1)(1996-10#4)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#3)(1996-7#2)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#3)(1997-4#6)(1997-6#2)(1997-7#1)(1997-8#3)(1997-9#1)(2005-11#3)(2005-6#1)(2006-12#1)(2006-8#6)(2006-9#2)(2007-1#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#46)(2008-11#2)(2008-2#3)(2008-4#13)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#6)(2008-9#4)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-10#2)(2010-12#2)(2010-8#1)(2011-1#3)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
sequence and 11##2##3##(1990-4#1)(1997-8#1)
sequence and a##12##3##(1990-7#1)(1991-10#1)(1992-3#1)(1993-6#1)(1994-12#1)(1994-8#1)(1997-4#1)(1997-5#1)(1997-7#2)(2007-12#1)(2008-11#1)
sequence and annotation##16##3##(2006-10#1)(2011-2#15)
sequence and by##2##3##(1991-5#1)(1993-3#1)
sequence and characterization of the##3##5##(1990-3#1)(1993-12#1)(1994-12#1)
sequence and characterization of##5##4##(1990-3#1)(1990-5#1)(1991-9#1)(1993-12#1)(1994-12#1)
sequence and chromosomal##3##3##(1994-8#1)(1995-4#1)(1996-10#1)
sequence and comparative##2##3##(1991-6#1)(1994-3#1)
sequence and exon-intron##2##3##(1990-5#1)(1993-3#1)
sequence and expression in Escherichia coli of##2##7##(1990-9#1)(1993-5#1)
sequence and expression in Escherichia coli##3##6##(1990-9#1)(1991-9#1)(1993-5#1)
sequence and expression in##5##4##(1990-8#1)(1990-9#1)(1991-9#1)(1992-3#1)(1993-5#1)
sequence and expression of the##2##5##(1990-11#1)(1993-12#1)
sequence and expression of##6##4##(1990-11#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-2#1)(1997-2#1)
sequence and expression##15##3##(1990-11#1)(1990-8#1)(1990-9#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-5#1)(1994-2#1)(1996-8#1)(1997-2#1)(1997-5#1)(2012-2#1)
sequence and high-level expression in##2##5##(1993-12#1)(1994-12#1)
sequence and homology##2##3##(1993-11#1)(1996-2#1)
sequence and is##3##3##(1992-8#1)(1993-6#1)(1994-12#1)
sequence and its##4##3##(1991-7#1)(1992-11#1)(1992-5#1)(2010-6#1)
sequence and length##2##3##(1990-6#1)(2013-8#1)
sequence and protein##2##3##(1990-9#1)(2008-11#1)
sequence and regulation of##2##4##(1991-5#1)(1995-2#1)
sequence and regulation##3##3##(1991-5#1)(1993-6#1)(1995-2#1)
sequence and relative##2##3##(1990-7#1)(1996-12#1)
sequence and spacing##2##3##(1990-4#1)(1991-8#1)
sequence and structural features##2##4##(1991-6#1)(2012-3#1)
sequence and structural similarities##2##4##(1997-6#1)(2008-10#1)
sequence and structural##10##3##(1991-6#1)(1995-2#1)(1995-3#1)(1996-8#1)(1997-2#1)(1997-6#1)(2008-10#1)(2012-2#1)(2012-3#2)
sequence and structure of##3##4##(1991-12#1)(1993-2#1)(2005-10#1)
sequence and structure##6##3##(1991-12#1)(1993-2#1)(2005-10#1)(2006-10#1)(2007-6#1)(2008-4#1)
sequence and that the##2##4##(1992-11#1)(1996-8#1)
sequence and the##25##3##(1990-5#1)(1991-7#1)(1992-6#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-8#3)(1995-5#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-4#1)(2006-10#1)(2008-10#4)(2008-4#1)(2008-8#2)(2010-6#1)
sequence and to##2##3##(1990-8#1)(2008-2#1)
sequence and was##2##3##(1993-2#1)(1996-12#1)
sequence and##233##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-3#1)(1990-4#4)(1990-5#4)(1990-6#2)(1990-7#4)(1990-8#2)(1990-9#3)(1991-10#1)(1991-12#1)(1991-5#2)(1991-6#5)(1991-7#2)(1991-8#3)(1991-9#5)(1992-11#3)(1992-2#1)(1992-3#3)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#4)(1993-2#3)(1993-3#3)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#6)(1994-2#5)(1994-3#4)(1994-5#1)(1994-8#7)(1995-1#1)(1995-2#6)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#2)(1996-10#3)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-7#3)(1996-8#3)(1996-9#1)(1997-2#6)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#3)(1997-8#2)(2005-10#1)(2006-10#3)(2006-3#1)(2007-12#1)(2007-6#1)(2008-10#11)(2008-11#5)(2008-2#3)(2008-3#1)(2008-4#7)(2008-5#1)(2008-7#6)(2008-8#3)(2008-9#2)(2009-6#1)(2009-9#1)(2010-2#1)(2010-6#2)(2011-2#16)(2012-11#1)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#2)
sequence and/or##2##2##(1997-4#1)(2013-1#1)
sequence annotation##3##2##(2008-7#3)
sequence annotations##2##2##(2008-7#2)
sequence are located##2##3##(1995-8#1)(2008-9#1)
sequence are##16##2##(1990-10#1)(1990-6#1)(1990-8#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-3#2)(1995-8#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-6#1)(2011-2#1)
sequence around the##4##3##(1990-11#1)(1991-7#1)(1992-5#1)(2008-8#1)
sequence as a probe##3##4##(1990-12#1)(1992-3#1)(1993-2#1)
sequence as a##8##3##(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#1)(1992-10#1)(1992-3#1)(1993-2#1)(1994-12#1)
sequence as that##2##3##(1990-10#1)(1991-10#1)
sequence as the##3##3##(1990-12#1)(1992-5#1)(2009-5#1)
sequence as##20##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-5#1)(1991-10#3)(1991-12#1)(1992-10#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-2#1)(1994-12#1)(2008-10#2)(2009-10#1)(2009-5#1)(2013-1#1)
sequence assembly##2##2##(2011-2#1)(2012-11#1)
sequence associated with##2##3##(2008-2#1)(2008-9#1)
sequence at a##2##3##(2007-12#1)(2007-6#1)
sequence at position##2##3##(2008-8#1)(2011-2#1)
sequence at the 3' end##3##5##(1994-3#2)(2008-10#1)
sequence at the NH2 terminus##2##5##(1992-9#1)(1993-3#1)
sequence at the##19##3##(1990-11#1)(1990-12#1)(1990-7#1)(1991-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-3#2)(1993-9#1)(1994-3#2)(1996-5#1)(1996-8#1)(1997-4#2)(2008-10#2)(2008-5#1)
sequence at##40##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-10#2)(1991-11#1)(1991-5#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-8#1)(1996-11#1)(1996-5#1)(1996-7#2)(1996-8#1)(1997-4#2)(1997-9#1)(2007-12#1)(2007-6#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-2#1)
sequence base##3##2##(1996-6#2)(2008-10#1)
sequence based##3##2##(1995-2#1)(2008-4#2)
sequence being##3##2##(1992-6#1)(1994-8#1)(2008-11#1)
sequence between residues##2##3##(1994-9#1)(1997-4#1)
sequence between the two##3##4##(1993-6#1)(1997-4#1)(2007-9#1)
sequence between the##8##3##(1990-9#1)(1993-6#1)(1995-2#1)(1996-9#1)(1997-4#1)(2007-9#1)(2008-11#1)(2013-8#1)
sequence between##17##2##(1990-5#1)(1990-9#1)(1991-3#1)(1992-5#1)(1993-6#1)(1994-12#1)(1994-9#2)(1995-2#1)(1996-9#1)(1997-4#2)(2005-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2013-8#1)
sequence block##3##2##(1992-5#1)(2009-5#2)
sequence but##3##2##(1992-6#1)(2008-10#1)(2008-9#1)
sequence by##10##2##(1991-11#1)(1991-2#1)(1991-5#1)(1993-3#1)(1993-5#1)(1997-9#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-8#1)
sequence can be used to##2##5##(1991-9#1)(2012-2#1)
sequence can be used##3##4##(1991-9#1)(2008-10#1)(2012-2#1)
sequence can be##6##3##(1991-9#1)(1992-2#1)(1997-2#1)(2008-10#1)(2008-4#1)(2012-2#1)
sequence can have##2##3##(1995-3#1)(2008-2#1)
sequence can##10##2##(1991-9#1)(1992-2#1)(1995-3#1)(1996-7#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-2#1)(2008-4#1)(2012-2#1)
sequence causing##2##2##(1990-3#1)(1997-9#1)
sequence change##2##2##(1992-12#1)(1992-8#1)
sequence changes##4##2##(1996-6#1)(1997-3#1)(2008-9#2)
sequence characterized amplified region (SCAR) marker##3##6##(2008-10#2)(2008-5#1)
sequence characterized amplified region (SCAR)##6##5##(2008-10#4)(2008-5#2)
sequence characterized##7##2##(2008-10#4)(2008-5#2)(2012-3#1)
sequence cloned from##2##3##(2008-8#2)
sequence cloned##3##2##(1990-3#1)(2008-8#2)
sequence clusters##2##2##(1997-5#1)(2008-12#1)
sequence coding for##4##3##(1990-5#1)(1991-3#1)(1994-9#1)(1996-10#1)
sequence comparison showed that##2##4##(1991-6#1)(1997-6#1)
sequence comparison##16##2##(1990-3#1)(1991-6#2)(1992-1#1)(1993-8#1)(1994-2#1)(1994-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2008-10#3)(2008-7#1)(2009-6#1)(2011-1#1)
sequence comparisons between##2##3##(1995-2#1)(2008-9#1)
sequence comparisons indicated that the##2##5##(2008-10#2)
sequence comparisons of##2##3##(2006-10#1)(2008-10#1)
sequence comparisons##27##2##(1990-12#1)(1992-6#1)(1993-2#1)(1994-12#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-2#1)(1995-8#1)(1997-6#1)(2006-10#1)(2006-8#1)(2008-10#10)(2008-7#1)(2008-8#1)(2008-9#2)
sequence complementarity to##3##3##(1997-7#1)(2008-7#1)(2009-8#1)
sequence complementary to##3##3##(1994-8#2)(2008-4#1)
sequence composed of##2##3##(1995-3#1)(2007-12#1)
sequence comprises the##2##3##(1991-2#1)(1995-3#1)
sequence comprising##3##2##(1991-2#1)(1994-3#1)(1996-5#1)
sequence conservation among##2##3##(2010-2#1)(2011-1#1)
sequence conservation between the##2##4##(1995-8#1)(1997-8#1)
sequence conservation between##5##3##(1993-6#1)(1995-8#1)(1997-8#1)(2008-7#1)(2012-3#1)
sequence conservation in##2##3##(1995-3#1)(2012-3#1)
sequence conservation information##3##3##(2012-3#3)
sequence conservation of##2##3##(1993-6#1)(2013-8#1)
sequence conservation suggests##2##3##(1990-11#1)(1995-12#1)
sequence conservation##26##2##(1990-11#1)(1992-11#1)(1993-6#2)(1993-9#1)(1994-3#1)(1994-6#2)(1995-12#1)(1995-3#1)(1995-8#1)(1997-2#1)(1997-8#1)(2008-7#2)(2010-2#1)(2011-1#1)(2012-3#7)(2013-8#2)
sequence consisted of##2##3##(1995-6#1)(1997-2#1)
sequence consists of##4##3##(1993-8#1)(1997-3#1)(1997-6#1)(2008-8#1)
sequence contained a##2##3##(1990-7#1)(1990-9#1)
sequence contained an open reading frame##3##6##(1990-11#1)(1993-12#1)(1997-2#1)
sequence contained##7##2##(1990-11#1)(1990-7#1)(1990-9#1)(1993-12#1)(1997-2#1)(1997-4#1)(2011-2#1)
sequence containing the##3##3##(1994-9#1)(2008-4#1)(2008-8#1)
sequence containing##4##2##(1992-3#1)(1994-9#1)(2008-4#1)(2008-8#1)
sequence contains a##5##3##(1994-2#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-3#1)
sequence contains an open reading frame of##2##7##(1990-5#1)(1995-6#1)
sequence contains an open reading frame##4##6##(1990-5#1)(1994-9#1)(1995-6#1)(1995-8#1)
sequence contains an##6##3##(1990-5#1)(1991-11#1)(1991-12#1)(1994-9#1)(1995-6#1)(1995-8#1)
sequence contains several##2##3##(1993-2#1)(1993-6#1)
sequence contains two##3##3##(1991-12#1)(1996-10#1)(1996-5#1)
sequence contains##28##2##(1990-5#1)(1991-11#1)(1991-12#3)(1992-2#1)(1993-2#1)(1993-6#2)(1994-12#3)(1994-2#1)(1994-8#1)(1994-9#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-3#2)(2008-10#1)(2008-4#1)(2008-8#1)
sequence context##9##2##(1990-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-7#3)(2008-4#1)(2010-1#1)
sequence corresponding to the##6##4##(1990-12#1)(1991-4#1)(1996-12#2)(1997-4#1)(2011-2#1)
sequence corresponding to##8##3##(1990-12#1)(1991-4#1)(1995-10#1)(1996-12#3)(1997-4#1)(2011-2#1)
sequence corresponds to the##2##4##(1991-12#1)(1993-11#1)
sequence corresponds to##4##3##(1990-4#1)(1991-12#1)(1993-11#1)(1997-7#1)
sequence could be##4##3##(1990-11#1)(1995-6#1)(2008-11#1)(2008-9#1)
sequence coverage##5##2##(2012-2#1)(2013-8#4)
sequence covering##2##2##(1997-4#1)(2008-10#1)
sequence data and##7##3##(1994-12#1)(1995-7#1)(1996-11#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-7#1)
sequence data are##2##3##(1995-8#1)(2010-3#1)
sequence data banks showed##2##4##(1995-2#1)(2011-2#1)
sequence data for##10##3##(1991-10#1)(1991-4#1)(1991-6#1)(1993-11#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-5#1)(2012-3#1)
sequence data from the##8##4##(1995-8#1)(2008-1#1)(2008-10#4)(2012-3#2)
sequence data from##17##3##(1994-12#1)(1994-3#1)(1995-8#1)(1996-3#1)(2008-1#1)(2008-10#5)(2009-2#1)(2010-4#1)(2012-3#3)(2013-1#1)(2013-7#1)
sequence data have##3##3##(1991-8#1)(1992-4#1)(1993-6#1)
sequence data indicated that##2##4##(1995-8#1)(2012-11#1)
sequence data of the##5##4##(1995-12#1)(2008-10#2)(2008-3#1)(2008-5#1)
sequence data of##11##3##(1995-12#3)(1996-4#1)(1997-6#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-3#1)
sequence data revealed##2##3##(2008-10#2)
sequence data sets##2##3##(2006-10#1)(2008-4#1)
sequence data that##2##3##(2008-7#1)(2010-6#1)
sequence data using##2##3##(2008-4#1)(2009-2#1)
sequence data was##2##3##(2005-11#1)(2008-10#1)
sequence data were##2##3##(1995-3#1)(2008-10#1)
sequence data with##2##3##(2007-6#1)(2012-3#1)
sequence data##137##2##(1990-12#1)(1990-3#1)(1991-10#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-12#3)(1994-3#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#4)(1996-11#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-4#2)(1997-6#7)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-6#2)(2007-9#1)(2008-1#3)(2008-10#21)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#9)(2008-5#1)(2008-7#10)(2008-9#1)(2009-2#2)(2009-5#3)(2010-2#1)(2010-3#3)(2010-4#1)(2010-6#2)(2011-2#1)(2012-11#2)(2012-3#17)(2013-1#2)(2013-7#1)(2013-8#1)
sequence databanks##2##2##(2008-4#2)
sequence database for sequences that are similar to a query##2##10##(2008-9#2)
sequence database with##2##3##(1990-9#1)(1994-2#1)
sequence database##11##2##(1990-9#1)(1994-2#1)(1994-6#1)(1994-9#1)(1997-4#1)(2008-4#3)(2008-7#1)(2008-9#2)
sequence databases and##2##3##(1994-6#1)(2008-4#1)
sequence databases##18##2##(1994-6#1)(1995-6#1)(1996-8#1)(2006-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#4)(2008-9#2)(2009-6#1)(2010-11#1)(2013-8#1)
sequence deduced from the nucleotide sequence of##2##7##(1991-7#1)(1993-11#1)
sequence deduced from the nucleotide sequence##3##6##(1991-7#1)(1993-11#1)(2012-2#1)
sequence deduced from the nucleotide##4##5##(1990-3#1)(1991-7#1)(1993-11#1)(2012-2#1)
sequence deduced from the##9##4##(1990-3#2)(1991-7#1)(1992-11#1)(1993-11#1)(1993-5#1)(1995-6#1)(1997-2#1)(2012-2#1)
sequence deduced from##12##3##(1990-3#2)(1991-7#1)(1992-1#1)(1992-11#1)(1992-4#1)(1993-11#1)(1993-5#1)(1995-6#1)(1995-8#1)(1997-2#1)(2012-2#1)
sequence deduced##15##2##(1990-3#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-4#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-9#1)(1995-6#1)(1995-8#1)(1997-2#1)(2012-2#1)
sequence dependent##2##2##(1992-6#1)(1994-3#1)
sequence derived from the##3##4##(1990-3#1)(1993-6#1)(2009-6#1)
sequence derived from##10##3##(1990-3#1)(1993-12#1)(1993-6#1)(1994-5#2)(1995-5#1)(2007-5#2)(2008-10#1)(2009-6#1)
sequence derived##12##2##(1990-3#1)(1990-6#1)(1991-5#1)(1993-12#1)(1993-6#1)(1994-5#2)(1995-5#1)(2007-5#2)(2008-10#1)(2009-6#1)
sequence design##4##2##(2007-4#1)(2008-4#1)(2008-7#2)
sequence detected in##2##3##(1995-3#1)(1997-1#1)
sequence determinants##2##2##(1996-9#1)(2011-1#1)
sequence determination by##2##3##(1993-8#1)(2008-10#1)
sequence determination of the##6##4##(1991-10#1)(1992-11#1)(1996-6#1)(1997-2#1)(2008-10#1)(2010-6#1)
sequence determination of##9##3##(1991-10#2)(1992-11#1)(1992-7#1)(1996-6#1)(1997-2#1)(2008-10#1)(2010-6#2)
sequence determination##16##2##(1990-4#1)(1990-9#1)(1991-10#2)(1992-11#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-8#1)(1996-6#1)(1997-2#1)(2008-10#2)(2008-8#1)(2010-6#2)
sequence determinations##3##2##(1990-11#1)(1992-3#1)(1994-5#1)
sequence determined by Edman degradation##2##5##(1990-9#1)(1992-1#1)
sequence determined for##2##3##(1990-7#1)(1993-12#1)
sequence determined##14##2##(1990-7#1)(1990-9#3)(1991-2#1)(1991-7#1)(1992-1#1)(1993-12#2)(1994-12#1)(1994-9#1)(1996-7#1)(1996-8#1)(1997-7#1)
sequence did not##2##3##(1990-4#1)(1997-4#1)
sequence differed##2##2##(1991-2#1)(2008-5#1)
sequence difference in the##2##4##(1994-12#1)(2008-10#1)
sequence difference##4##2##(1994-12#1)(1994-5#1)(2008-10#1)(2011-2#1)
sequence differences between the##2##4##(1990-11#1)(1993-6#1)
sequence differences between##4##3##(1990-11#1)(1993-6#1)(1994-6#1)(2008-9#1)
sequence differences in the##2##4##(1996-2#1)(2011-12#1)
sequence differences in##4##3##(1996-2#1)(1997-7#1)(2008-9#1)(2011-12#1)
sequence differences##13##2##(1990-11#1)(1993-6#1)(1994-5#1)(1994-6#2)(1996-2#1)(1997-7#1)(2008-10#2)(2008-9#3)(2011-12#1)
sequence different from##2##3##(1992-8#1)(1994-12#1)
sequence differs from##3##3##(1992-9#1)(1995-5#1)(2010-12#1)
sequence distribution of##3##3##(1992-6#1)(2008-10#1)(2012-2#1)
sequence distribution##5##2##(1992-6#1)(1997-4#1)(2008-10#2)(2012-2#1)
sequence divergence among##3##3##(1996-3#1)(2008-10#1)(2008-7#1)
sequence divergence##13##2##(1991-5#1)(1994-3#1)(1994-9#1)(1996-12#1)(1996-3#2)(2008-10#4)(2008-7#1)(2013-1#2)
sequence diversity in##4##3##(1996-3#1)(2010-12#3)
sequence diversity##12##2##(1992-11#1)(1994-9#1)(1995-3#1)(1996-3#1)(2006-8#1)(2008-10#2)(2008-7#1)(2009-6#1)(2010-12#3)
sequence does not##3##3##(1991-9#1)(2008-11#2)
sequence domain in##2##3##(1991-11#1)(2008-10#1)
sequence during##4##2##(1991-2#1)(1992-2#1)(2008-4#1)(2009-10#1)
sequence element was##2##3##(1993-5#1)(1996-8#1)
sequence element##10##2##(1992-9#1)(1993-5#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-4#1)(1996-8#2)(1997-1#1)(2008-11#1)
sequence elements in the##2##4##(1995-3#1)(1997-5#1)
sequence elements of##2##3##(1991-6#1)(1996-3#1)
sequence elements that are located##2##5##(1991-6#1)(2008-2#1)
sequence elements##22##2##(1991-12#1)(1991-6#2)(1991-7#1)(1992-2#1)(1992-7#1)(1993-5#3)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#2)(1996-3#1)(1996-4#1)(1997-5#1)(2007-12#1)(2008-2#1)(2008-8#1)(2013-1#1)(2013-8#1)
sequence encoded by##2##3##(1994-12#1)(2008-9#1)
sequence encoded##5##2##(1992-9#1)(1994-12#1)(1994-9#1)(1995-8#1)(2008-9#1)
sequence encodes a protein##2##4##(1992-12#1)(1994-3#1)
sequence encodes a##8##3##(1990-11#1)(1992-12#1)(1993-6#1)(1993-9#1)(1994-3#1)(1996-10#1)(1996-2#1)(1997-1#1)
sequence encodes##11##2##(1990-11#1)(1991-11#1)(1992-12#1)(1993-6#1)(1993-9#1)(1994-3#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-2#1)(1997-1#1)
sequence encoding a##3##3##(1991-12#1)(1994-12#1)(1995-8#1)
sequence encoding the##15##3##(1990-11#2)(1992-10#1)(1992-12#1)(1992-4#1)(1993-2#1)(1994-8#1)(1995-5#1)(1995-8#1)(1997-2#1)(1997-6#1)(1997-7#2)(2008-10#2)
sequence encoding##24##2##(1990-11#2)(1991-12#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-4#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-5#1)(1995-8#2)(1996-10#1)(1997-2#1)(1997-6#1)(1997-7#2)(2008-10#2)(2008-11#2)(2008-8#1)
sequence essential for##2##3##(1990-10#1)(1995-6#1)
sequence estimation##2##2##(2008-2#1)(2008-3#1)
sequence evolution##3##2##(2008-4#1)(2008-9#1)(2012-2#1)
sequence exhibited##4##2##(1995-3#1)(1996-7#1)(1997-2#1)(2008-9#1)
sequence exhibits##3##2##(1992-5#1)(1994-11#1)(1997-4#1)
sequence families##3##2##(1991-3#1)(2008-4#1)(2009-3#1)
sequence family##2##2##(1991-5#1)(2008-5#1)
sequence feature##2##2##(1993-8#1)(1997-8#1)
sequence features##11##2##(1995-5#1)(1996-8#2)(1997-4#3)(1997-8#1)(2008-4#2)(2008-8#1)(2010-5#1)
sequence flanking the##4##3##(1992-9#1)(1997-4#1)(2008-12#1)(2013-8#1)
sequence flanking##5##2##(1992-9#1)(1996-8#1)(1997-4#1)(2008-12#1)(2013-8#1)
sequence for a##4##3##(1994-12#1)(1995-2#1)(2011-2#2)
sequence for human##2##3##(1991-6#1)(1992-12#1)
sequence for the V##2##4##(1990-10#2)
sequence for the protein##2##4##(1994-3#1)(1997-6#1)
sequence for the##23##3##(1990-10#3)(1990-12#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-12#1)(1992-10#1)(1993-2#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-1#1)(1997-3#1)(1997-6#1)(2008-11#1)(2008-4#1)(2008-7#1)(2013-7#1)
sequence for##74##2##(1990-10#3)(1990-12#1)(1990-4#1)(1990-5#1)(1990-9#3)(1991-11#2)(1991-12#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#3)(1993-2#1)(1993-3#2)(1993-6#3)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-4#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#3)(1997-8#1)(1997-9#1)(2005-11#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-4#2)(2008-6#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-10#1)(2011-2#2)(2013-1#1)(2013-7#1)
sequence forms##2##2##(1994-9#1)(2008-11#1)
sequence found in a##2##4##(1992-6#1)(1993-6#1)
sequence found in the##2##4##(1991-2#1)(1997-2#1)
sequence found in##6##3##(1991-2#1)(1992-6#1)(1993-6#1)(1994-9#1)(1997-2#1)(2008-10#1)
sequence found##7##2##(1991-2#1)(1992-6#1)(1993-6#1)(1994-9#1)(1997-2#1)(1997-3#1)(2008-10#1)
sequence from -1##2##3##(1997-7#2)
sequence from -192 to +91 bp##2##6##(1997-7#2)
sequence from a different##2##4##(2008-4#2)
sequence from a member of the family##3##7##(2011-2#3)
sequence from a member of the##6##6##(2011-2#6)
sequence from a##14##3##(1991-7#1)(1992-8#1)(1994-12#1)(1994-6#1)(1995-12#1)(2008-4#2)(2011-2#6)(2012-2#1)
sequence from human##4##3##(1993-7#1)(1994-2#1)(1995-8#1)(2006-12#1)
sequence from positions##2##3##(1992-9#1)(1995-6#1)
sequence from the chloroplast##2##4##(1990-7#1)(1991-9#1)
sequence from the family##2##4##(2011-2#2)
sequence from the human##2##4##(1991-9#1)(1994-3#1)
sequence from the##24##3##(1990-7#1)(1991-7#1)(1991-9#2)(1992-2#1)(1992-8#2)(1994-3#1)(1994-9#1)(1995-2#1)(1996-11#1)(1996-4#1)(1997-4#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-8#3)(2011-2#3)(2012-3#1)
sequence from this##2##3##(1996-9#1)(2008-7#1)
sequence from##81##2##(1990-2#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-7#2)(1991-9#2)(1992-1#1)(1992-2#1)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-11#2)(1996-4#2)(1996-5#2)(1996-7#1)(1996-9#2)(1997-4#3)(1997-7#5)(1997-8#1)(2006-12#2)(2008-10#3)(2008-11#2)(2008-4#4)(2008-7#1)(2008-8#3)(2011-2#10)(2012-2#1)(2012-3#1)
sequence functions##2##2##(1991-10#1)(1993-8#1)
sequence generated by##2##3##(1995-1#1)(2007-12#1)
sequence generated##3##2##(1995-1#1)(2007-12#1)(2008-10#1)
sequence had a##3##3##(1992-5#1)(1993-6#1)(2013-1#1)
sequence had no effect##2##4##(1994-11#1)(1996-5#1)
sequence had no##4##3##(1993-12#1)(1994-11#1)(1994-8#1)(1996-5#1)
sequence had##11##2##(1992-5#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-8#1)(1996-5#1)(1996-7#1)(1997-2#1)(2008-4#1)(2013-1#1)
sequence has a##3##3##(1991-12#1)(1992-11#1)(1997-1#1)
sequence has been determined for##2##5##(1990-10#1)(1990-5#1)
sequence has been determined##7##4##(1990-10#1)(1990-5#1)(1991-12#1)(1995-8#1)(1996-10#1)(1997-6#1)(2011-2#1)
sequence has been found##2##4##(1990-5#1)(1991-8#1)
sequence has been identified##3##4##(1991-1#1)(1992-12#1)(2010-1#1)
sequence has been##21##3##(1990-10#1)(1990-5#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-8#1)(1992-12#1)(1993-6#2)(1994-3#1)(1995-8#1)(1996-10#1)(1996-12#1)(1997-5#1)(1997-6#1)(2010-1#1)(2011-2#2)(2012-11#1)
sequence has provided##2##3##(2007-8#1)(2012-11#1)
sequence has revealed the presence of##2##6##(1992-8#1)(1997-3#1)
sequence has revealed##3##3##(1992-8#1)(1994-9#1)(1997-3#1)
sequence has##44##2##(1990-10#1)(1990-5#2)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#3)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-10#1)(1996-12#2)(1996-9#1)(1997-1#2)(1997-3#1)(1997-5#1)(1997-6#1)(2005-11#1)(2007-8#1)(2010-1#1)(2011-2#2)(2012-11#2)
sequence having##2##2##(1996-10#1)(1997-4#1)
sequence highly homologous to the##3##5##(1990-11#1)(1994-12#1)(1995-2#1)
sequence homologies of##2##3##(1996-12#2)
sequence homologies with##4##3##(1990-2#1)(1994-11#1)(2008-10#1)(2010-4#1)
sequence homologies##7##2##(1990-2#1)(1994-11#1)(1996-12#2)(1997-2#1)(2008-10#1)(2010-4#1)
sequence homologous to a##2##4##(1994-12#1)(2008-8#1)
sequence homologous to that##2##4##(1994-8#1)(2013-1#1)
sequence homologous to the##4##4##(1991-12#1)(1991-3#1)(2007-12#1)(2008-10#1)
sequence homologous to##10##3##(1990-11#1)(1991-12#1)(1991-3#1)(1994-12#1)(1994-8#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-8#1)(2013-1#1)
sequence homologous##13##2##(1990-11#1)(1991-12#1)(1991-3#2)(1994-12#1)(1994-8#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-8#1)(2011-1#1)(2013-1#1)
sequence homology analysis##2##3##(1997-2#1)(2008-10#1)
sequence homology and##2##3##(1993-6#1)(2008-10#1)
sequence homology between the##3##4##(1990-12#1)(1993-3#1)(2008-8#1)
sequence homology between##11##3##(1990-12#1)(1991-1#1)(1991-9#1)(1992-2#2)(1992-4#1)(1993-11#1)(1993-3#1)(1997-7#1)(1997-8#1)(2008-8#1)
sequence homology in##2##3##(1990-9#1)(1991-12#1)
sequence homology is##2##3##(1993-11#1)(2011-2#1)
sequence homology of##5##3##(1990-7#1)(1992-3#1)(1997-6#1)(2008-8#2)
sequence homology to a##2##4##(1991-12#1)(1997-3#1)
sequence homology to each other##2##5##(1993-3#1)(1997-7#1)
sequence homology to previously##2##4##(1991-9#1)(1995-3#1)
sequence homology to the##8##4##(1991-10#1)(1993-4#1)(1994-11#1)(1994-8#1)(1995-2#2)(1997-1#1)(1997-7#1)
sequence homology to##28##3##(1991-10#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-7#1)(1996-7#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-7#3)(2009-8#1)
sequence homology with other known##3##5##(1991-2#1)(1995-4#1)(2011-1#1)
sequence homology with other##4##4##(1991-2#1)(1995-4#1)(1997-7#1)(2011-1#1)
sequence homology with previously described##2##5##(1990-11#1)(1993-11#1)
sequence homology with the##6##4##(1990-2#1)(1993-12#1)(1994-8#1)(1996-8#1)(1997-4#2)
sequence homology with those##2##4##(1992-12#1)(2008-9#1)
sequence homology with##28##3##(1990-11#1)(1990-2#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-4#1)(1996-10#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#3)(1997-7#1)(2008-9#2)(2010-5#1)(2011-1#1)
sequence homology##104##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-5#2)(1991-9#4)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#2)(1992-4#2)(1992-6#1)(1993-11#3)(1993-12#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#3)(1995-12#2)(1995-2#3)(1995-3#4)(1995-4#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-7#2)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#4)(1997-5#2)(1997-6#1)(1997-7#6)(1997-8#3)(2007-12#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#1)
sequence identical to that of the##2##6##(1990-5#1)(1991-7#1)
sequence identical to that of##3##5##(1990-5#1)(1991-7#1)(1993-3#1)
sequence identical with##2##3##(1990-4#1)(1997-2#1)
sequence identical##5##2##(1990-4#1)(1990-5#1)(1991-7#1)(1993-3#1)(1997-2#1)
sequence identities with##5##3##(1992-11#1)(1997-1#2)(2008-10#2)
sequence identities##15##2##(1990-7#1)(1992-11#1)(1996-7#1)(1997-1#2)(1997-3#1)(2008-10#7)(2008-11#1)(2011-1#1)
sequence identity (77%)##2##3##(1995-5#1)(2008-10#1)
sequence identity and##4##3##(1993-2#1)(1996-5#1)(2008-8#1)(2013-8#1)
sequence identity between##6##3##(1991-5#1)(1993-11#1)(1996-7#1)(2008-10#2)(2012-3#1)
sequence identity in the##3##4##(1993-6#1)(2008-10#2)
sequence identity in##4##3##(1993-6#1)(2008-10#3)
sequence identity of##7##3##(1990-4#1)(1992-12#1)(1993-3#1)(1993-9#1)(1994-2#2)(2008-5#1)
sequence identity to bovine##2##4##(1992-2#1)(1994-9#1)
sequence identity to mouse##2##4##(1993-7#1)(1994-9#1)
sequence identity to the##4##4##(1991-12#1)(1995-3#1)(1996-10#1)(1997-1#1)
sequence identity to their##2##4##(1997-7#1)(2008-10#1)
sequence identity to##20##3##(1990-12#2)(1991-12#1)(1992-2#1)(1992-8#1)(1993-4#1)(1993-7#1)(1994-9#3)(1995-3#2)(1996-10#1)(1997-1#1)(1997-4#2)(1997-7#1)(2008-10#3)
sequence identity was observed##2##4##(1997-4#1)(2008-10#1)
sequence identity with mouse##2##4##(1993-4#1)(1996-4#1)
sequence identity with other##2##4##(1994-12#1)(1994-3#1)
sequence identity with the maize-type viruses##2##6##(2008-10#2)
sequence identity with the##10##4##(1992-3#1)(1993-2#1)(1993-4#1)(1995-11#2)(1997-2#1)(1997-4#1)(2008-10#3)
sequence identity with##27##3##(1990-5#1)(1992-3#1)(1993-2#1)(1993-4#2)(1994-12#2)(1994-3#2)(1994-8#1)(1994-9#1)(1995-11#2)(1995-3#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-4#1)(2006-12#1)(2008-10#7)(2010-5#1)
sequence identity##104##2##(1990-12#2)(1990-4#1)(1990-5#2)(1991-1#1)(1991-12#1)(1991-5#2)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#3)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-8#1)(1994-9#4)(1995-11#2)(1995-3#5)(1995-5#2)(1995-8#1)(1996-10#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-4#4)(1997-7#1)(2006-12#1)(2008-10#29)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
sequence identity)##5##2##(1993-12#2)(2006-8#1)(2008-10#1)(2010-10#1)
sequence immediately##4##2##(1990-3#1)(1991-12#1)(1992-11#1)(1995-8#1)
sequence implicated in##2##3##(1994-3#1)(1997-1#1)
sequence in a##6##3##(1993-11#1)(1993-8#1)(1995-1#1)(2008-10#2)(2008-3#1)
sequence in an##2##3##(1994-3#1)(1995-11#1)
sequence in human##2##3##(1991-3#1)(1994-5#1)
sequence in one##3##3##(1990-8#1)(1997-9#1)(2006-10#1)
sequence in the 3'##2##4##(1994-3#1)(1997-7#1)
sequence in the databases##2##4##(1996-3#1)(2008-7#1)
sequence in the family##5##4##(2011-2#5)
sequence in the middle##2##4##(1993-6#1)(1994-9#1)
sequence in the##44##3##(1990-8#1)(1991-10#1)(1991-11#2)(1991-6#1)(1991-9#1)(1992-11#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-6#3)(1997-7#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-9#2)(2011-2#6)(2013-8#1)
sequence in this##2##3##(1993-12#1)(1995-3#1)
sequence in which##2##3##(1995-8#1)(2010-9#1)
sequence in##90##2##(1990-3#1)(1990-8#2)(1991-10#1)(1991-11#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#2)(1995-1#1)(1995-11#2)(1995-2#2)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-3#1)(1996-4#2)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#3)(1997-7#4)(1997-9#1)(2006-10#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-5#1)(2009-9#2)(2010-7#1)(2010-9#1)(2011-2#9)(2013-8#2)
sequence included##2##2##(1991-10#1)(1991-2#1)
sequence includes the##3##3##(1994-12#1)(1997-3#1)(2008-10#1)
sequence includes##5##2##(1990-5#1)(1994-12#1)(1994-8#1)(1997-3#1)(2008-10#1)
sequence including a##2##3##(1997-7#1)(2008-9#1)
sequence including the##2##3##(1993-8#1)(2008-8#1)
sequence including##4##2##(1993-8#1)(1997-7#1)(2008-8#1)(2008-9#1)
sequence indicated that##3##3##(1990-4#1)(2006-8#1)(2008-5#1)
sequence indicated##5##2##(1990-4#1)(1997-4#1)(2006-12#1)(2006-8#1)(2008-5#1)
sequence indicates that##2##3##(1990-7#1)(1991-2#1)
sequence information alone##2##3##(1995-3#1)(2008-4#1)
sequence information and##3##3##(1994-6#1)(2008-7#1)(2009-5#1)
sequence information can be used##2##5##(1995-7#1)(2010-4#1)
sequence information can be##3##4##(1991-9#1)(1995-7#1)(2010-4#1)
sequence information for##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
sequence information from##2##3##(2008-7#1)(2011-2#1)
sequence information has##2##3##(1997-4#1)(2008-6#1)
sequence information is available##2##4##(1993-7#1)(1994-12#1)
sequence information is##4##3##(1991-2#1)(1993-7#1)(1994-12#1)(1994-6#1)
sequence information of##3##3##(1995-8#1)(1997-8#1)(2008-10#1)
sequence information on a##2##4##(1995-6#1)(2008-7#1)
sequence information on##4##3##(1995-6#1)(2008-4#1)(2008-7#1)(2012-2#1)
sequence information will##2##3##(1993-2#1)(1993-9#1)
sequence information##39##2##(1990-2#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-2#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-6#2)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#6)(2008-6#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-2#1)
sequence initiated##2##2##(1994-2#1)(1997-7#1)
sequence into a##3##3##(1991-12#1)(2008-3#1)(2011-1#1)
sequence into the##2##3##(1991-10#1)(1991-9#1)
sequence into##11##2##(1991-10#1)(1991-12#1)(1991-9#1)(1992-11#1)(1996-5#3)(2008-3#2)(2008-7#1)(2011-1#1)
sequence involved in##2##3##(1992-8#1)(1995-6#1)
sequence involving##2##2##(2007-10#1)(2009-5#1)
sequence is a##7##3##(1991-2#1)(1991-4#1)(1994-8#1)(1996-10#1)(1996-5#1)(1997-4#1)(2008-12#1)
sequence is also##2##3##(1990-9#1)(1995-6#1)
sequence is closely##2##3##(1991-12#1)(1991-6#1)
sequence is deleted##2##3##(1992-2#1)(2008-8#1)
sequence is different from##2##4##(1991-2#1)(1993-8#1)
sequence is highly conserved##2##4##(1994-2#1)(2008-10#1)
sequence is highly homologous to##5##5##(1991-10#1)(1992-7#1)(1993-12#1)(1993-6#1)(1994-9#1)
sequence is highly##7##3##(1991-10#1)(1992-7#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-9#1)(2008-10#1)
sequence is homologous to##3##4##(1991-11#1)(1992-5#1)(1995-6#1)
sequence is identical to the##2##5##(1994-5#1)(1997-1#1)
sequence is identical to##5##4##(1991-7#1)(1992-12#1)(1994-5#1)(1995-6#1)(1997-1#1)
sequence is in##2##3##(1990-9#1)(1996-6#1)
sequence is located in##2##4##(1991-7#1)(1992-11#1)
sequence is located##4##3##(1991-6#1)(1991-7#1)(1992-11#1)(1993-6#1)
sequence is one of the##2##5##(1995-6#1)(2008-4#1)
sequence is recognized by##2##4##(1994-6#1)(1995-6#1)
sequence is similar to##4##4##(1990-6#1)(1990-9#1)(1995-2#1)(1996-7#1)
sequence is similar##5##3##(1990-6#1)(1990-9#1)(1994-12#1)(1995-2#1)(1996-7#1)
sequence is that of##2##4##(1990-1#1)(1994-8#1)
sequence is the##2##3##(1990-3#1)(2008-8#1)
sequence is used##2##3##(2008-4#1)(2011-1#1)
sequence is##125##2##(1990-1#1)(1990-10#1)(1990-3#3)(1990-6#1)(1990-9#4)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#3)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#5)(1995-8#3)(1996-10#2)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#4)(1997-1#1)(1997-2#2)(1997-4#3)(1997-6#2)(1997-7#1)(2006-12#1)(2007-12#2)(2007-6#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#3)(2008-4#3)(2008-8#3)(2009-12#1)(2009-3#1)(2009-5#1)(2010-1#1)(2011-1#4)(2011-2#1)(2012-2#1)(2012-3#2)(2012-8#1)
sequence isomers##2##2##(1993-3#1)(1995-10#1)
sequence knowledge##2##2##(1997-8#1)(2008-7#1)
sequence length on##2##3##(2008-9#2)
sequence length##3##2##(2008-9#3)
sequence level to the##2##4##(1993-2#1)(1997-4#1)
sequence level##5##2##(1991-4#2)(1993-2#1)(1997-2#1)(1997-4#1)
sequence library##4##2##(1994-6#1)(1996-11#1)(2008-4#1)(2008-7#1)
sequence located in the##3##4##(1994-8#1)(1997-4#1)(2006-8#1)
sequence located##5##2##(1994-6#1)(1994-8#1)(1995-2#1)(1997-4#1)(2006-8#1)
sequence may be##3##3##(1991-2#1)(1996-12#1)(2008-5#1)
sequence may have##2##3##(1993-6#1)(2008-9#1)
sequence may##8##2##(1991-2#1)(1993-6#2)(1996-12#1)(1996-7#1)(1997-7#1)(2008-5#1)(2008-9#1)
sequence motif and##2##3##(1993-11#1)(2012-2#1)
sequence motif for##2##3##(1995-2#1)(1996-5#1)
sequence motif##19##2##(1990-7#1)(1991-2#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-3#1)(1995-2#1)(1995-6#3)(1996-5#1)(1997-2#2)(1997-6#1)(1997-7#1)(2006-2#1)(2007-8#1)(2012-2#2)
sequence motifs in##3##3##(1992-6#1)(1994-8#1)(2008-7#1)
sequence motifs of##3##3##(1990-10#1)(1991-7#1)(1994-8#1)
sequence motifs that##3##3##(1995-8#1)(1996-10#1)(2012-3#1)
sequence motifs##26##2##(1990-10#1)(1990-11#1)(1990-2#1)(1991-7#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-8#1)(1994-8#3)(1995-6#1)(1995-8#2)(1996-10#1)(1996-2#1)(1996-4#2)(1996-5#1)(1996-7#1)(1997-6#1)(1997-7#1)(2008-7#2)(2008-9#1)(2012-3#1)
sequence near##2##2##(1991-6#1)(1996-8#1)
sequence obtained by##2##3##(1997-7#1)(2008-4#1)
sequence obtained##6##2##(1992-7#1)(1993-9#1)(1994-5#1)(1997-7#1)(1997-8#1)(2008-4#1)
sequence of 1##8##3##(1994-8#1)(1995-8#1)(1996-6#1)(1997-2#1)(1997-8#1)(2005-11#1)(2008-8#1)(2010-2#1)
sequence of 2##3##3##(1991-5#1)(1994-12#1)(2008-9#1)
sequence of 333 amino acids##2##5##(1990-4#1)(1994-11#1)
sequence of 5'##2##3##(1996-7#1)(2008-8#1)
sequence of C##3##3##(1997-4#1)(2008-4#1)(2008-7#1)
sequence of DNaseI hypersensitive site 2##2##6##(2008-8#2)
sequence of Drosophila##3##3##(1990-11#1)(1990-12#1)(2011-1#1)
sequence of Escherichia coli##3##4##(1991-2#1)(1994-9#1)(1997-4#1)
sequence of MARs##2##3##(2008-8#2)
sequence of Synechocystis sp##2##4##(1996-12#1)(1996-8#1)
sequence of TMV-B##2##3##(2008-8#2)
sequence of a 1##2##4##(1990-2#1)(1997-1#1)
sequence of a 23##2##4##(1996-9#1)(1997-3#1)
sequence of a 4##2##4##(1993-12#1)(1997-1#1)
sequence of a 7941 bp##2##5##(1995-6#2)
sequence of a 8##2##4##(1997-3#2)
sequence of a cDNA clone encoding##3##6##(1991-5#1)(1992-3#1)(1997-1#1)
sequence of a cDNA clone##5##5##(1990-2#1)(1991-5#1)(1992-3#1)(1993-6#1)(1997-1#1)
sequence of a cDNA encoding the##3##6##(1992-11#1)(1993-3#1)(1994-12#1)
sequence of a cDNA encoding##6##5##(1991-12#1)(1992-11#1)(1992-2#1)(1993-3#1)(1994-12#1)(1997-5#1)
sequence of a cDNA##14##4##(1990-2#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-2#2)(1992-3#1)(1993-3#1)(1993-6#1)(1994-12#1)(1996-2#1)(1997-1#1)(1997-5#1)
sequence of a fragment of##2##5##(1990-5#1)(1996-3#1)
sequence of a human##2##4##(1991-6#1)(2013-1#1)
sequence of a member of the genus##7##7##(2011-2#7)
sequence of a member of the##17##6##(2011-2#17)
sequence of a member##18##4##(2011-2#18)
sequence of a new##3##4##(1990-4#1)(1993-6#1)(2008-9#1)
sequence of a novel peptide from a rat##2##8##(1992-12#2)
sequence of a novel##3##4##(1990-5#1)(1992-12#2)
sequence of a protein##2##4##(1991-8#1)(1994-6#1)
sequence of a putative##2##4##(1994-12#1)(1997-2#1)
sequence of a ras gene from##2##6##(1993-3#1)(1997-4#1)
sequence of a##133##3##(1990-10#1)(1990-11#2)(1990-2#3)(1990-3#1)(1990-4#3)(1990-5#3)(1990-7#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-2#3)(1991-4#1)(1991-5#4)(1991-6#1)(1991-7#3)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#5)(1992-2#2)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#3)(1993-4#1)(1993-6#4)(1993-8#1)(1993-9#1)(1994-12#3)(1994-6#1)(1994-8#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-2#1)(1996-3#3)(1996-6#2)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#6)(1997-4#2)(1997-5#1)(1997-7#1)(2007-11#1)(2007-9#1)(2008-10#9)(2008-7#1)(2008-9#3)(2009-3#1)(2010-12#1)(2011-2#20)(2013-1#1)
sequence of all##3##3##(1990-2#1)(1994-3#1)(2008-4#1)
sequence of amino##3##3##(1994-12#1)(1995-11#1)(2006-10#1)
sequence of an 11##2##4##(1995-9#2)
sequence of an##9##3##(1990-11#1)(1991-9#1)(1993-5#1)(1995-8#1)(1995-9#2)(1996-8#1)(2008-10#2)
sequence of approximately##2##3##(1995-6#1)(1997-1#1)
sequence of both##2##3##(1994-8#1)(1995-6#1)
sequence of chromosome##3##3##(1995-6#2)(2007-12#1)
sequence of cloned##3##3##(1993-6#1)(1997-7#1)(2008-4#1)
sequence of developmental events##2##4##(2007-12#1)(2008-9#1)
sequence of events leading to the##2##6##(1991-5#1)(1993-8#1)
sequence of events leading to##3##5##(1991-5#1)(1993-8#1)(2008-12#1)
sequence of events leading##4##4##(1990-9#1)(1991-5#1)(1993-8#1)(2008-12#1)
sequence of events that##3##4##(1991-3#1)(2008-10#1)(2012-12#1)
sequence of events##20##3##(1990-9#1)(1991-3#1)(1991-5#1)(1993-8#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2009-11#1)(2009-6#2)(2010-12#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
sequence of human##22##3##(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-12#1)(1992-2#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-5#1)(1994-11#1)(1994-8#1)(1995-8#1)(1996-2#2)(1997-6#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#2)
sequence of independent random patterns##2##5##(2008-3#2)
sequence of its##7##3##(1991-8#1)(1993-3#1)(1994-8#1)(1995-8#1)(1997-2#1)(2008-10#1)(2008-8#1)
sequence of matrix attachment##2##4##(2008-8#2)
sequence of mature##3##3##(1990-6#1)(1991-2#1)(1993-3#1)
sequence of mitochondrial##2##3##(1992-11#1)(2010-4#1)
sequence of mouse##7##3##(1990-11#2)(1991-5#1)(1992-11#1)(1994-8#1)(1996-7#1)(1997-4#1)
sequence of multiple##3##3##(1990-5#2)(2009-6#1)
sequence of one of##2##4##(1990-12#1)(1993-5#1)
sequence of one##6##3##(1990-11#1)(1990-12#2)(1990-5#1)(1993-12#1)(1993-5#1)
sequence of operations##4##3##(2007-11#2)(2008-10#2)
sequence of patterns##3##3##(2007-12#1)(2007-9#2)
sequence of peptides##2##3##(1992-12#1)(1994-6#1)
sequence of porcine##2##3##(1996-12#2)
sequence of prolyl endopeptidase##2##4##(1991-2#2)
sequence of protein##2##3##(1993-6#1)(2007-11#1)
sequence of purified##2##3##(1995-3#1)(1996-9#1)
sequence of rat liver##3##4##(1990-4#1)(1991-8#1)(1993-8#1)
sequence of rat##5##3##(1990-4#1)(1991-8#1)(1993-3#1)(1993-8#1)(1995-12#1)
sequence of reactions##4##3##(1991-6#1)(1994-8#2)(2005-8#1)
sequence of recombinant##2##3##(1991-1#1)(1991-7#1)
sequence of regulatory##2##3##(1996-2#1)(2010-2#1)
sequence of several##3##3##(1993-12#1)(1993-6#1)(2007-12#1)
sequence of the 16S-23S##2##4##(2008-10#2)
sequence of the 2##2##4##(1990-4#1)(1993-9#1)
sequence of the 3##2##4##(1996-2#1)(2008-8#1)
sequence of the 3'##2##4##(1996-8#1)(1997-4#1)
sequence of the 5'##2##4##(1994-12#1)(2008-7#1)
sequence of the AngR protein##2##5##(1990-1#2)
sequence of the B##3##4##(1990-11#1)(1994-11#1)(1997-2#1)
sequence of the C-terminal domain##2##5##(1992-7#1)(1996-7#1)
sequence of the C-terminal##4##4##(1992-7#2)(1993-7#1)(1996-7#1)
sequence of the CP##2##4##(1997-6#1)(2008-10#1)
sequence of the E##2##4##(1990-3#1)(1991-2#1)
sequence of the Escherichia coli K-12 genome corresponding to the##8##10##(1996-12#4)(1996-6#3)(1997-4#1)
sequence of the Escherichia coli##10##5##(1991-2#1)(1996-12#4)(1996-6#3)(1997-4#2)
sequence of the ITS region##2##5##(2008-10#1)(2009-2#1)
sequence of the N-terminal##5##4##(1990-7#2)(1991-1#1)(1993-3#1)(1997-8#1)
sequence of the RAD57 gene of Saccharomyces cerevisiae##2##8##(1991-8#2)
sequence of the RNA##2##4##(1993-12#1)(2011-1#1)
sequence of the Xenopus##2##4##(1993-12#1)(1997-7#1)
sequence of the beta subunit##3##5##(1992-11#1)(1992-9#1)(1994-11#1)
sequence of the cDNA encoding the##2##6##(1991-6#1)(1997-2#1)
sequence of the cDNA encoding##3##5##(1991-6#1)(1997-2#2)
sequence of the cDNA##11##4##(1991-6#1)(1991-7#1)(1993-11#1)(1993-3#1)(1994-5#1)(1994-8#2)(1996-7#1)(1997-2#3)
sequence of the clone##2##4##(1994-12#1)(1994-8#1)
sequence of the cloned##7##4##(1990-2#1)(1991-9#1)(1993-11#1)(1994-9#1)(1996-7#1)(1997-4#1)(2008-10#1)
sequence of the coat protein##2##5##(1997-1#1)(1997-2#1)
sequence of the coding region of the##2##7##(1992-11#1)(1993-6#1)
sequence of the coding region of##3##6##(1992-11#1)(1993-2#1)(1993-6#1)
sequence of the coding region##4##5##(1992-11#1)(1993-2#1)(1993-6#1)(1997-8#1)
sequence of the different##2##4##(1992-7#1)(1994-9#1)
sequence of the entire##3##4##(1991-6#1)(1996-11#1)(1996-8#1)
sequence of the enzyme is##2##5##(1990-12#1)(1992-11#1)
sequence of the enzyme##6##4##(1990-12#1)(1990-9#1)(1991-2#1)(1992-11#1)(1994-12#1)(1996-7#1)
sequence of the first##7##4##(1990-10#1)(1990-11#1)(1990-6#1)(1990-7#1)(1991-4#1)(2012-12#2)
sequence of the four##3##4##(1992-3#1)(1993-4#1)(2008-8#1)
sequence of the fragment##2##4##(1995-2#1)(1997-2#1)
sequence of the gene##16##4##(1990-4#2)(1990-9#2)(1991-2#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-9#1)(1994-12#2)(1995-4#1)(1995-5#1)(2006-5#1)(2007-11#1)(2008-4#1)
sequence of the genome of##3##5##(1997-3#1)(2008-10#2)
sequence of the genome##4##4##(1996-7#1)(1997-3#1)(2008-10#2)
sequence of the genomic RNA of##3##6##(2008-10#3)
sequence of the genomic##4##4##(2008-10#4)
sequence of the genus##6##4##(2011-2#6)
sequence of the human##16##4##(1990-3#1)(1990-8#1)(1991-7#1)(1991-9#1)(1994-11#2)(1994-8#1)(1996-10#2)(1996-5#1)(1996-8#1)(1997-6#1)(1997-7#3)(2008-7#1)
sequence of the internal transcribed spacer (ITS)##2##7##(2008-10#2)
sequence of the large##2##4##(1990-9#1)(1994-3#1)
sequence of the lectin##2##4##(1990-2#1)(1990-5#1)
sequence of the luxC gene##2##5##(1993-2#2)
sequence of the lyc gene##2##5##(1991-7#2)
sequence of the mRNA##2##4##(1992-12#1)(2008-9#1)
sequence of the mature protein##3##5##(1991-7#1)(1992-12#1)(1994-12#1)
sequence of the mature##6##4##(1990-3#1)(1991-11#1)(1991-7#1)(1992-12#1)(1994-12#2)
sequence of the mitochondrial##4##4##(1993-2#1)(1996-7#1)(2009-2#1)(2010-8#1)
sequence of the mouse##6##4##(1990-11#1)(1990-4#1)(1991-12#1)(1992-11#1)(1993-3#1)(2008-8#1)
sequence of the ompH gene encoding the 16-kDa##2##8##(1990-3#2)
sequence of the open reading frame##3##6##(1994-12#1)(1994-6#1)(1995-8#1)
sequence of the overlapping##2##4##(1996-12#1)(2008-10#1)
sequence of the peptide##4##4##(1991-1#1)(1993-11#1)(1996-12#1)(1997-4#1)
sequence of the peptides##2##4##(1993-9#1)(2008-4#1)
sequence of the petE gene encoding plastocyanin from the##2##9##(1994-12#2)
sequence of the precursor##2##4##(1993-3#1)(1996-2#1)
sequence of the promoter region of##2##6##(1993-12#1)(1993-2#1)
sequence of the promoter region##3##5##(1993-12#1)(1993-2#1)(1995-1#1)
sequence of the promoter##5##4##(1991-9#1)(1993-12#2)(1993-2#1)(1995-1#1)
sequence of the protein was determined##2##6##(1990-12#1)(1994-3#1)
sequence of the protein was##3##5##(1990-12#1)(1993-9#1)(1994-3#1)
sequence of the protein##14##4##(1990-12#1)(1991-2#1)(1991-6#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-3#1)(1996-7#1)(1997-6#1)(2008-4#2)(2009-2#1)
sequence of the purified##6##4##(1990-4#1)(1991-1#1)(1991-9#1)(1994-12#1)(1997-2#1)(1997-6#1)
sequence of the putative##2##4##(1992-6#1)(1993-2#1)
sequence of the rat##15##4##(1990-11#1)(1990-12#1)(1990-8#1)(1992-12#2)(1992-5#1)(1992-8#1)(1993-4#4)(1994-5#2)(1996-12#1)(1997-5#1)
sequence of the reductase was##2##5##(1996-3#1)(2008-11#1)
sequence of the region##2##4##(1991-7#1)(1995-1#1)
sequence of the two##3##4##(1991-12#1)(1992-12#1)(2008-8#1)
sequence of the yeast##2##4##(1990-4#1)(1992-2#1)
sequence of the##511##3##(1990-1#4)(1990-10#3)(1990-11#11)(1990-12#7)(1990-2#4)(1990-3#9)(1990-4#13)(1990-5#11)(1990-6#3)(1990-7#6)(1990-8#4)(1990-9#7)(1991-1#3)(1991-10#2)(1991-11#2)(1991-12#7)(1991-2#10)(1991-3#1)(1991-4#1)(1991-5#7)(1991-6#6)(1991-7#13)(1991-8#3)(1991-9#6)(1992-10#1)(1992-11#6)(1992-12#8)(1992-2#2)(1992-3#5)(1992-5#1)(1992-6#4)(1992-7#4)(1992-8#6)(1992-9#2)(1993-11#9)(1993-12#9)(1993-2#7)(1993-3#6)(1993-4#6)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#5)(1993-9#8)(1994-11#6)(1994-12#24)(1994-2#3)(1994-3#2)(1994-5#3)(1994-6#2)(1994-8#7)(1994-9#5)(1995-1#2)(1995-2#4)(1995-3#5)(1995-4#1)(1995-5#1)(1995-6#4)(1995-8#8)(1996-10#4)(1996-11#4)(1996-12#7)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#6)(1996-6#4)(1996-7#7)(1996-8#5)(1996-9#3)(1997-1#3)(1997-2#12)(1997-3#2)(1997-4#12)(1997-5#1)(1997-6#6)(1997-7#6)(1997-8#4)(2005-8#1)(2006-11#1)(2006-12#2)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-3#2)(2007-6#1)(2008-10#38)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#2)(2009-2#3)(2009-5#3)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#14)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#1)
sequence of these##4##3##(1990-12#1)(2006-8#1)(2008-10#1)(2008-7#1)
sequence of this ORF##2##4##(1995-4#1)(1996-8#1)
sequence of this cDNA##3##4##(1990-12#1)(1991-7#1)(1994-8#1)
sequence of this clone##2##4##(1990-2#1)(1991-9#1)
sequence of this gene##3##4##(1993-2#1)(1995-1#1)(1997-1#1)
sequence of this protein##4##4##(1992-6#1)(1993-12#1)(1994-12#1)(1997-6#1)
sequence of this region is##2##5##(1995-6#1)(1996-5#1)
sequence of this region##4##4##(1993-3#1)(1995-6#1)(1996-5#1)(2012-12#1)
sequence of this##41##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1994-11#1)(1994-12#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-4#1)(1995-6#1)(1995-8#3)(1996-5#1)(1996-8#1)(1997-1#1)(1997-6#1)(1997-8#2)(2008-10#2)(2008-8#1)(2010-12#1)(2012-12#1)
sequence of two##7##3##(1990-6#1)(1991-8#1)(1993-2#1)(1993-3#1)(1996-10#1)(2006-5#1)(2013-8#1)
sequence of video##2##3##(2008-2#1)(2008-3#1)
sequence of which is##2##4##(1990-7#1)(1994-9#1)
sequence of which was##2##4##(1993-2#1)(1995-8#1)
sequence of which##7##3##(1990-11#1)(1990-7#1)(1993-2#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-12#1)
sequence of##1370##2##(1990-1#6)(1990-10#5)(1990-11#29)(1990-12#16)(1990-2#11)(1990-3#17)(1990-4#24)(1990-5#27)(1990-6#6)(1990-7#17)(1990-8#7)(1990-9#14)(1991-1#5)(1991-10#4)(1991-11#5)(1991-12#15)(1991-2#23)(1991-3#6)(1991-4#3)(1991-5#15)(1991-6#12)(1991-7#21)(1991-8#16)(1991-9#12)(1992-1#1)(1992-10#3)(1992-11#17)(1992-12#19)(1992-2#10)(1992-3#9)(1992-4#7)(1992-5#4)(1992-6#6)(1992-7#8)(1992-8#12)(1992-9#6)(1993-11#14)(1993-12#20)(1993-2#16)(1993-3#21)(1993-4#13)(1993-5#6)(1993-6#16)(1993-7#1)(1993-8#10)(1993-9#15)(1994-10#1)(1994-11#12)(1994-12#45)(1994-2#6)(1994-3#5)(1994-5#7)(1994-6#6)(1994-8#20)(1994-9#17)(1995-1#4)(1995-11#1)(1995-12#4)(1995-2#12)(1995-3#11)(1995-4#3)(1995-5#3)(1995-6#17)(1995-8#23)(1995-9#4)(1996-1#1)(1996-10#8)(1996-11#4)(1996-12#14)(1996-2#9)(1996-3#5)(1996-4#5)(1996-5#8)(1996-6#8)(1996-7#13)(1996-8#10)(1996-9#7)(1997-1#10)(1997-2#20)(1997-3#10)(1997-4#21)(1997-5#3)(1997-6#10)(1997-7#14)(1997-8#8)(2005-11#11)(2005-6#1)(2005-7#1)(2005-8#2)(2006-10#6)(2006-11#1)(2006-12#4)(2006-5#3)(2006-8#2)(2007-11#9)(2007-12#13)(2007-2#2)(2007-3#2)(2007-6#2)(2007-9#3)(2008-1#2)(2008-10#88)(2008-11#9)(2008-12#1)(2008-2#10)(2008-3#11)(2008-4#16)(2008-5#10)(2008-6#3)(2008-7#11)(2008-8#30)(2008-9#16)(2009-10#2)(2009-11#2)(2009-2#4)(2009-3#1)(2009-4#1)(2009-5#5)(2009-6#3)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#5)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#3)(2011-2#84)(2012-1#1)(2012-12#9)(2012-2#4)(2012-3#5)(2013-1#6)(2013-7#2)(2013-8#5)
sequence on the##6##3##(1990-7#1)(1992-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(2008-9#1)
sequence on##15##2##(1990-7#1)(1992-11#1)(1992-12#1)(1995-10#1)(1995-2#1)(1995-6#1)(1995-7#1)(1996-2#1)(1996-4#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)
sequence or##12##2##(1990-8#1)(1993-12#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-7#1)(1997-5#1)(2007-6#1)(2008-4#1)(2008-7#1)(2010-5#1)(2011-1#1)
sequence over##3##2##(1991-4#1)(1995-8#1)(2012-2#1)
sequence overlap##2##2##(1994-8#1)(1995-6#1)
sequence parameters##2##2##(2008-7#2)
sequence pattern##2##2##(1994-12#1)(2008-9#1)
sequence patterns surrounding##2##3##(1997-2#2)
sequence patterns were##2##3##(1991-10#2)
sequence patterns##11##2##(1990-7#1)(1991-10#3)(1994-9#1)(1995-8#1)(1997-2#2)(1997-4#2)(2008-7#1)
sequence polymorphism##3##2##(1994-3#1)(1996-11#1)(1996-4#1)
sequence polymorphisms##6##2##(1996-4#2)(1996-6#1)(2008-10#2)(2008-12#1)
sequence position##3##2##(1990-2#2)(2008-7#1)
sequence positions##2##2##(1991-11#1)(1994-8#1)
sequence preceding the##2##3##(1990-3#1)(1996-4#1)
sequence preceding##3##2##(1990-3#1)(1992-6#1)(1996-4#1)
sequence predicts a protein of##2##5##(1994-2#1)(2008-5#1)
sequence predicts a##6##3##(1992-6#1)(1994-2#1)(1994-8#1)(1994-9#1)(1996-5#1)(2008-5#1)
sequence predicts##7##2##(1992-6#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-5#1)(2008-5#1)
sequence present in the##3##4##(1993-11#1)(1994-8#1)(1995-3#1)
sequence present##4##2##(1993-11#1)(1994-8#1)(1995-3#1)(1996-7#1)
sequence previously reported##2##3##(1992-2#1)(1992-6#1)
sequence previously##3##2##(1992-2#1)(1992-6#1)(1994-12#1)
sequence probe##3##2##(1994-8#1)(1997-6#2)
sequence processing##4##2##(2008-2#2)(2008-7#2)
sequence profile##2##2##(2005-8#1)(2012-3#1)
sequence provides##4##2##(1996-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
sequence published##2##2##(1993-6#1)(2008-12#1)
sequence reads##4##2##(2011-2#1)(2012-3#2)(2013-8#1)
sequence recognized by##4##3##(1990-11#1)(1994-3#1)(1994-6#1)(2003-11#1)
sequence reduced##2##2##(1990-5#1)(1997-2#1)
sequence region##4##2##(1990-2#1)(1990-6#1)(1991-9#1)(1993-3#1)
sequence repeat (SSR)##9##3##(2008-10#4)(2008-5#1)(2008-7#1)(2008-9#2)(2011-12#1)
sequence repeat markers##5##3##(1996-3#2)(2008-10#3)
sequence repeat##23##2##(1995-3#1)(1996-3#4)(2008-10#11)(2008-5#2)(2008-7#1)(2008-9#2)(2010-10#1)(2011-12#1)
sequence repeats (SSRs)##5##3##(1996-8#1)(2007-6#2)(2008-10#1)(2012-2#1)
sequence repeats##18##2##(1995-2#1)(1996-8#2)(2006-2#1)(2007-6#4)(2008-10#4)(2008-7#4)(2012-2#2)
sequence reported here is##2##4##(1992-2#1)(2008-9#1)
sequence reported##3##2##(1992-2#1)(1995-5#1)(2008-9#1)
sequence represents an##2##3##(1992-8#1)(1997-5#1)
sequence represents the##2##3##(1991-12#1)(2008-10#1)
sequence represents##5##2##(1990-8#1)(1991-12#1)(1992-8#1)(1997-5#1)(2008-10#1)
sequence required for##2##3##(1991-7#1)(1993-11#1)
sequence requirement for##2##3##(1992-2#1)(1995-6#1)
sequence respectively##3##2##(2008-8#1)(2010-7#2)
sequence resulted in##2##3##(1991-10#1)(1993-12#1)
sequence resulted##3##2##(1991-10#1)(1993-12#1)(1994-8#1)
sequence results##2##2##(1997-2#1)(2007-11#1)
sequence revealed a##2##3##(1990-3#1)(1994-12#1)
sequence revealed an open reading frame encoding a##2##8##(1994-8#1)(1996-11#1)
sequence revealed an open reading frame##4##6##(1991-10#1)(1994-8#1)(1996-11#1)(1997-2#1)
sequence revealed an##5##3##(1991-10#1)(1994-8#1)(1996-11#1)(1997-2#1)(1997-4#1)
sequence revealed that it##2##4##(1992-9#1)(1997-1#1)
sequence revealed that the##3##4##(1990-2#1)(1991-7#1)(1992-11#1)
sequence revealed that this##2##4##(1994-12#1)(1996-12#1)
sequence revealed that##11##3##(1990-2#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-5#1)(1992-9#1)(1994-12#1)(1996-12#1)(1997-1#1)(2008-10#1)
sequence revealed the presence of the##2##6##(1993-11#1)(1996-6#1)
sequence revealed the presence of##3##5##(1993-11#1)(1996-6#1)(1997-5#1)
sequence revealed the##5##3##(1993-11#1)(1996-6#1)(1997-5#1)(1997-7#1)(2007-1#1)
sequence revealed two##2##3##(1991-7#1)(1997-4#1)
sequence revealed##33##2##(1990-2#1)(1990-3#1)(1991-10#1)(1991-7#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-12#3)(1994-8#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-4#3)(1997-5#1)(1997-7#1)(2007-1#1)(2008-10#2)(2008-7#1)
sequence reveals that##3##3##(1991-8#1)(1996-2#1)(1996-7#1)
sequence reveals the presence of##2##5##(1991-2#1)(1992-9#1)
sequence reveals##9##2##(1990-5#1)(1991-2#1)(1991-8#2)(1992-12#1)(1992-9#1)(1995-8#1)(1996-2#1)(1996-7#1)
sequence segments##7##2##(1990-7#1)(1991-10#1)(1991-7#1)(1996-5#1)(1996-8#1)(2008-10#1)(2008-9#1)
sequence selectivities of##2##3##(1991-4#1)(1995-5#1)
sequence selectivity##4##2##(1991-7#1)(1997-1#3)
sequence separation##2##2##(1993-3#2)
sequence sets##5##2##(1992-2#1)(1995-3#1)(1997-6#1)(2008-4#2)
sequence shared##3##2##(1994-2#1)(1995-8#1)(2008-10#1)
sequence shares##2##2##(1994-12#1)(1994-9#1)
sequence showed a high degree of homology##2##7##(1990-2#1)(1997-1#1)
sequence showed a high degree of##3##6##(1990-2#1)(1996-2#1)(1997-1#1)
sequence showed a high##4##4##(1990-2#1)(1996-2#1)(1996-3#1)(1997-1#1)
sequence showed a##9##3##(1990-2#1)(1992-12#1)(1994-2#1)(1994-3#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-5#1)
sequence showed that the##4##4##(1992-11#1)(1994-12#1)(2008-9#1)(2011-1#1)
sequence showed##26##2##(1990-2#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-7#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-10#1)(1995-6#2)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(2005-11#1)(2008-10#2)(2008-5#1)(2008-9#1)(2011-1#1)
sequence showing##2##2##(1990-10#1)(1994-6#1)
sequence shows high homology to##2##5##(1991-3#1)(1993-12#1)
sequence shows high##3##3##(1991-3#1)(1993-12#1)(1993-3#1)
sequence shows that##3##3##(1991-12#1)(1993-2#1)(2009-10#1)
sequence shows two##2##3##(1992-12#1)(1993-2#1)
sequence shows##20##2##(1991-12#1)(1991-3#1)(1991-7#1)(1992-12#2)(1992-2#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-5#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-2#2)(1996-10#1)(2009-10#1)
sequence significantly##4##2##(1994-11#1)(1995-3#1)(1996-5#1)(2008-10#1)
sequence similar to the##3##4##(1991-9#1)(1994-3#1)(2008-10#1)
sequence similar to##7##3##(1990-7#1)(1991-5#1)(1991-9#1)(1994-3#1)(1997-4#1)(1997-5#1)(2008-10#1)
sequence similarities to the##2##4##(1992-9#1)(1994-9#1)
sequence similarities to##4##3##(1992-9#1)(1994-9#1)(1995-8#2)
sequence similarities with the##2##4##(1992-6#1)(2008-10#1)
sequence similarities with##5##3##(1992-6#1)(1993-9#1)(1995-2#1)(1996-10#1)(2008-10#1)
sequence similarities##16##2##(1990-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-8#2)(1996-10#1)(2006-12#1)(2007-6#1)(2008-10#3)
sequence similarity among##2##3##(2008-10#2)
sequence similarity and##5##3##(1996-10#1)(2005-11#1)(2008-7#1)(2011-1#1)(2011-2#1)
sequence similarity between the##5##4##(1991-6#1)(1995-3#1)(2006-8#1)(2008-10#1)(2012-2#1)
sequence similarity between##6##3##(1991-6#1)(1995-3#1)(2005-11#1)(2006-8#1)(2008-10#1)(2012-2#1)
sequence similarity is##4##3##(1990-3#1)(1991-10#1)(1994-6#1)(2008-7#1)
sequence similarity of##2##3##(1992-8#1)(2008-10#1)
sequence similarity searching and##2##4##(2008-4#2)
sequence similarity searching##3##3##(2008-4#2)(2013-8#1)
sequence similarity to a family of##2##6##(1993-3#1)(1996-9#1)
sequence similarity to a##4##4##(1992-11#1)(1993-3#1)(1996-9#1)(2008-4#1)
sequence similarity to any##3##4##(1995-10#1)(1996-5#1)(2008-7#1)
sequence similarity to known##4##4##(1991-12#1)(2008-10#1)(2008-7#1)(2010-10#1)
sequence similarity to other##3##4##(1994-12#1)(1995-1#1)(1997-6#1)
sequence similarity to the##5##4##(1991-11#1)(1995-8#2)(1996-2#1)(1997-1#1)
sequence similarity to##35##3##(1990-6#1)(1990-7#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-11#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-8#2)(1996-2#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-6#1)(2008-10#2)(2008-4#1)(2008-7#2)(2010-10#1)(2012-3#1)
sequence similarity with the##5##4##(1990-7#1)(1991-11#1)(1992-2#1)(1994-3#1)(1995-6#1)
sequence similarity with##19##3##(1990-7#1)(1990-8#1)(1991-11#1)(1991-5#1)(1992-11#2)(1992-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-4#1)(1997-6#1)(2008-10#1)(2008-4#1)
sequence similarity##106##2##(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#3)(1990-8#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-11#3)(1992-2#1)(1992-5#1)(1992-8#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#4)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#2)(1995-6#2)(1995-8#3)(1996-10#1)(1996-2#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#3)(1997-7#1)(2005-11#2)(2006-8#1)(2007-6#1)(2008-10#12)(2008-4#5)(2008-6#1)(2008-7#5)(2008-9#1)(2009-10#2)(2009-5#1)(2010-10#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
sequence so that the##2##4##(1992-6#1)(2011-2#1)
sequence so that##3##3##(1992-6#1)(1992-7#1)(2011-2#1)
sequence so##4##2##(1992-6#1)(1992-7#1)(2011-2#2)
sequence space##7##2##(1997-6#3)(2007-6#1)(2007-9#1)(2008-7#2)
sequence spanning the##2##3##(1990-11#1)(2008-10#1)
sequence specific and##2##3##(1996-7#1)(2012-3#1)
sequence specific to the##2##4##(1993-11#1)(2009-10#1)
sequence specific##25##2##(1990-11#1)(1991-2#1)(1993-11#1)(1994-6#1)(1994-7#1)(1995-10#1)(1996-2#1)(1996-7#3)(1997-1#1)(1997-2#1)(2005-7#1)(2007-11#2)(2008-10#1)(2008-12#2)(2008-2#1)(2008-9#1)(2009-10#1)(2009-7#2)(2011-1#1)(2012-3#1)
sequence specifically inhibited##2##3##(1992-3#1)(1992-5#1)
sequence specifically##3##2##(1992-3#1)(1992-5#1)(2008-10#1)
sequence specificities of human##2##4##(1993-6#2)
sequence specificities of##3##3##(1993-6#2)(1997-2#1)
sequence specificity for##2##3##(1995-3#1)(2008-11#1)
sequence specificity of the##2##4##(1997-2#1)(2008-1#1)
sequence specificity of##5##3##(1991-11#1)(1993-3#1)(1993-6#1)(1997-2#1)(2008-1#1)
sequence specificity##19##2##(1991-11#2)(1992-11#3)(1993-3#1)(1993-6#1)(1994-11#1)(1994-8#2)(1995-3#1)(1997-2#2)(1997-5#2)(2008-1#1)(2008-11#1)(2008-7#1)(2010-2#1)
sequence still##2##2##(1996-5#1)(2010-7#1)
sequence such##2##2##(1990-7#1)(1996-4#1)
sequence suggested that##2##3##(1993-12#1)(2008-10#1)
sequence suggesting a##2##3##(1990-5#1)(2008-2#1)
sequence suggests that the##2##4##(1992-6#1)(1994-12#1)
sequence suggests that##3##3##(1992-6#1)(1993-2#1)(1994-12#1)
sequence suggests##4##2##(1992-6#1)(1993-2#1)(1994-12#1)(1995-2#1)
sequence surrounding the##5##3##(1991-2#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-8#1)
sequence surrounding##7##2##(1990-3#1)(1991-2#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-8#1)(1997-2#1)
sequence tag (EST)##5##3##(1997-6#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-9#1)
sequence tag##8##2##(1996-5#1)(1997-6#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-1#1)
sequence tagged##4##2##(1994-12#1)(1995-6#1)(2008-10#1)(2011-12#1)
sequence tags##31##2##(1994-3#2)(1994-6#1)(1995-8#1)(1995-9#1)(1996-6#1)(1997-2#2)(1997-6#1)(1997-7#2)(2006-12#1)(2006-3#1)(2008-7#7)(2008-8#1)(2009-10#1)(2009-12#1)(2010-10#1)(2010-4#5)(2012-3#1)(2013-8#1)
sequence tags)##2##2##(2005-8#1)(2008-9#1)
sequence that binds##2##3##(1992-6#1)(1993-6#1)
sequence that could be##2##4##(1996-5#1)(2009-2#1)
sequence that functions##2##3##(1990-8#1)(1991-10#1)
sequence that is removed##2##4##(1994-12#1)(1997-7#1)
sequence that is##15##3##(1993-12#1)(1993-2#1)(1994-12#3)(1994-9#1)(1995-3#2)(1997-2#2)(1997-4#1)(1997-7#1)(2006-10#1)(2008-11#1)(2008-4#1)
sequence that may##2##3##(1992-11#1)(2007-6#1)
sequence that overlaps##2##3##(1994-8#1)(1996-10#1)
sequence that provides##2##3##(2008-10#2)
sequence that was##3##3##(1994-9#1)(1996-10#1)(1996-5#1)
sequence that##52##2##(1990-10#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1992-11#1)(1992-6#2)(1993-12#2)(1993-2#1)(1993-4#1)(1993-6#1)(1994-12#4)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#3)(1995-6#1)(1995-8#1)(1996-10#2)(1996-5#4)(1997-2#2)(1997-4#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#2)(2009-2#1)
sequence the##5##2##(1992-3#1)(1993-3#1)(1994-6#1)(2006-10#1)(2008-9#1)
sequence through##2##2##(1995-8#1)(2008-11#1)
sequence to be##5##3##(1997-6#1)(2008-2#1)(2008-4#1)(2011-2#2)
sequence to that of##3##4##(1990-12#1)(1994-12#1)(1995-8#1)
sequence to the##8##3##(1991-3#1)(1992-12#1)(1992-2#1)(1994-11#1)(1994-5#1)(1994-8#2)(1996-5#1)
sequence to##53##2##(1990-12#1)(1990-4#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#2)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-5#1)(1994-8#3)(1994-9#2)(1995-8#1)(1996-3#1)(1996-5#3)(1996-6#2)(1997-6#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-9#1)(2009-11#1)(2009-9#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
sequence types##6##2##(2008-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
sequence typing##3##2##(2007-12#1)(2011-2#1)(2012-12#1)
sequence unique##2##2##(1995-6#1)(2009-9#1)
sequence up to##2##3##(1991-12#1)(2013-1#1)
sequence upstream from the##2##4##(1990-11#1)(1992-12#1)
sequence upstream of the##3##4##(1991-2#1)(1994-3#1)(1997-2#1)
sequence upstream of##5##3##(1991-2#1)(1994-3#1)(1997-2#1)(2008-10#1)(2008-2#1)
sequence upstream##8##2##(1990-11#1)(1991-2#1)(1992-12#1)(1993-3#1)(1994-3#1)(1997-2#1)(2008-10#1)(2008-2#1)
sequence used for##2##3##(2007-11#1)(2007-6#1)
sequence used to##2##3##(2008-6#1)(2013-1#1)
sequence used##5##2##(2007-11#1)(2007-6#1)(2008-6#1)(2011-1#1)(2013-1#1)
sequence using a##2##3##(1993-5#1)(2008-10#1)
sequence using##3##2##(1991-2#1)(1993-5#1)(2008-10#1)
sequence variability##3##2##(1992-11#1)(2008-10#2)
sequence variant##4##2##(1992-8#1)(1993-11#1)(2008-10#1)(2012-3#1)
sequence variants in##4##3##(1996-11#1)(2008-4#3)
sequence variants##22##2##(1992-2#1)(1993-9#1)(1994-12#1)(1996-11#1)(2005-9#1)(2008-10#10)(2008-3#1)(2008-4#3)(2008-5#1)(2011-2#1)(2012-3#1)
sequence variation among##3##3##(1997-9#1)(2009-8#1)(2010-6#1)
sequence variation at##2##3##(1993-2#1)(2010-10#1)
sequence variation in the##3##4##(1993-8#1)(1997-3#1)(2013-8#1)
sequence variation in##5##3##(1993-8#1)(1997-3#1)(2008-12#1)(2008-6#1)(2013-8#1)
sequence variation of a##2##4##(1996-6#1)(2008-10#1)
sequence variation was##3##3##(1992-8#1)(2006-5#1)(2010-8#1)
sequence variation##25##2##(1991-6#1)(1992-8#2)(1993-2#1)(1993-8#1)(1996-6#1)(1997-3#1)(1997-9#1)(2006-10#1)(2006-5#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-6#1)(2010-8#1)(2012-3#1)(2013-8#2)
sequence variations in the##3##4##(1997-4#1)(2008-5#1)(2008-8#1)
sequence variations##7##2##(1995-8#1)(1997-4#1)(2006-10#2)(2008-5#2)(2008-8#1)
sequence via##3##2##(2007-3#1)(2010-7#2)
sequence was also##3##3##(1991-7#1)(1994-12#1)(1996-6#1)
sequence was amplified##2##3##(1992-11#1)(2008-11#1)
sequence was cloned into a##2##5##(1991-5#1)(1993-6#1)
sequence was cloned into##3##4##(1991-5#1)(1993-6#1)(2008-8#1)
sequence was cloned##4##3##(1991-5#1)(1993-6#1)(1996-6#1)(2008-8#1)
sequence was compared with##2##4##(1991-9#1)(2006-8#1)
sequence was compared##3##3##(1991-9#1)(1995-8#1)(2006-8#1)
sequence was deleted##2##3##(1990-4#1)(1991-2#1)
sequence was determined for the##2##5##(1991-11#1)(1993-12#1)
sequence was determined for##3##4##(1991-11#1)(1992-1#1)(1993-12#1)
sequence was determined to be##3##5##(1993-3#1)(2008-10#2)
sequence was determined##24##3##(1990-10#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-12#1)(1995-6#1)(1995-8#1)(1996-10#1)(1997-4#1)(1997-7#1)(2005-11#1)(2008-10#2)(2008-8#2)
sequence was found in##2##4##(1993-12#1)(2008-9#1)
sequence was found to be##6##5##(1990-7#1)(1992-5#1)(1993-9#1)(1994-9#1)(1995-8#1)(1997-3#1)
sequence was found to##8##4##(1990-7#1)(1992-5#1)(1993-9#1)(1994-9#1)(1995-6#1)(1995-8#1)(1997-3#2)
sequence was found##11##3##(1990-7#1)(1992-5#1)(1993-12#2)(1993-9#1)(1994-9#1)(1995-6#1)(1995-8#1)(1997-3#2)(2008-9#1)
sequence was highly homologous to##2##5##(1991-9#1)(1994-12#1)
sequence was homologous to##2##4##(1991-10#1)(1995-8#1)
sequence was identical to that##2##5##(1990-2#1)(2008-11#1)
sequence was identical to##3##4##(1990-2#1)(2008-11#1)(2008-5#1)
sequence was identical##4##3##(1990-2#1)(1990-3#1)(2008-11#1)(2008-5#1)
sequence was inserted into the##2##5##(2008-8#1)(2013-1#1)
sequence was introduced##2##3##(1997-6#1)(2012-12#1)
sequence was isolated##2##3##(1993-12#1)(2008-10#1)
sequence was not##3##3##(1991-10#1)(1997-2#1)(1997-5#1)
sequence was obtained##8##3##(1992-2#1)(1992-7#1)(1993-6#2)(1994-5#1)(1996-4#1)(2008-10#1)(2008-9#1)
sequence was shown to##3##4##(1993-3#1)(1994-11#1)(2008-10#1)
sequence was used to design##2##5##(2006-5#1)(2012-2#1)
sequence was used to##7##4##(1990-10#1)(1990-2#1)(1992-9#1)(1994-9#1)(2006-5#1)(2008-10#1)(2012-2#1)
sequence was used##10##3##(1990-10#1)(1990-2#1)(1992-9#1)(1994-9#1)(2006-5#1)(2007-11#1)(2008-10#3)(2012-2#1)
sequence was##162##2##(1990-10#2)(1990-11#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-9#1)(1991-10#5)(1991-11#1)(1991-2#1)(1991-5#1)(1991-7#3)(1991-9#6)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#2)(1993-11#2)(1993-12#7)(1993-2#1)(1993-3#2)(1993-6#4)(1993-9#3)(1994-11#2)(1994-12#5)(1994-5#1)(1994-8#1)(1994-9#4)(1995-1#2)(1995-3#2)(1995-6#5)(1995-8#4)(1996-10#2)(1996-12#1)(1996-4#2)(1996-5#1)(1996-6#5)(1997-2#3)(1997-3#3)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#1)(2003-11#1)(2005-11#3)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#1)(2008-10#16)(2008-11#4)(2008-5#1)(2008-8#7)(2008-9#3)(2009-8#1)(2010-10#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
sequence we##3##2##(1990-4#1)(1990-8#1)(2013-8#1)
sequence were##17##2##(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-6#1)(1995-8#1)(1996-8#1)(2008-10#3)(2010-4#1)(2011-2#1)(2013-7#1)
sequence which contains##2##3##(1992-9#1)(1993-11#1)
sequence which is##7##3##(1990-12#1)(1992-3#1)(1995-2#1)(1996-12#1)(1997-1#1)(2006-8#1)(2008-8#1)
sequence which##18##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1992-3#1)(1992-9#1)(1993-11#1)(1994-12#1)(1995-2#2)(1996-12#1)(1996-7#1)(1997-1#2)(1997-2#1)(2006-8#1)(2008-8#2)
sequence while the##2##3##(1990-2#1)(1992-3#1)
sequence will##4##2##(1991-5#1)(1995-1#1)(2006-10#1)(2008-7#1)
sequence with a##9##3##(1990-5#1)(1990-7#1)(1994-12#1)(1996-4#1)(1996-5#1)(2006-1#1)(2007-12#1)(2008-10#1)(2008-4#1)
sequence with an##4##3##(1990-6#1)(1995-8#1)(1997-4#1)(2008-10#1)
sequence with that of##2##4##(1991-7#1)(2008-8#1)
sequence with the N-terminal sequence of the##2##7##(1991-11#1)(1993-3#1)
sequence with the##13##3##(1990-3#1)(1990-5#1)(1990-7#2)(1991-11#1)(1991-9#1)(1993-3#1)(1994-12#1)(1995-8#1)(1996-7#1)(1997-7#1)(2008-2#1)(2009-2#1)
sequence with those from##2##4##(1990-6#1)(1991-6#1)
sequence with those of##3##4##(1990-7#1)(2008-10#2)
sequence with those##6##3##(1990-4#1)(1990-6#1)(1990-7#1)(1991-6#1)(2008-10#2)
sequence with##49##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#4)(1991-11#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-9#1)(1993-12#1)(1993-3#1)(1994-12#2)(1994-8#1)(1995-8#2)(1996-11#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-1#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-2#1)
sequence within the##7##3##(1991-4#1)(1993-9#1)(1994-12#1)(1995-3#1)(1996-4#1)(2008-10#1)(2011-2#1)
sequence within##8##2##(1991-4#1)(1993-9#2)(1994-12#1)(1995-3#1)(1996-4#1)(2008-10#1)(2011-2#1)
sequence would##2##2##(1993-11#1)(2008-7#1)
sequence##5951##1##(1990-1#8)(1990-10#27)(1990-11#74)(1990-12#44)(1990-2#33)(1990-3#49)(1990-4#46)(1990-5#69)(1990-6#19)(1990-7#57)(1990-8#29)(1990-9#49)(1991-1#13)(1991-10#42)(1991-11#39)(1991-12#64)(1991-2#67)(1991-3#21)(1991-4#15)(1991-5#54)(1991-6#44)(1991-7#64)(1991-8#35)(1991-9#70)(1992-1#14)(1992-10#14)(1992-11#57)(1992-12#65)(1992-2#56)(1992-3#46)(1992-4#19)(1992-5#28)(1992-6#46)(1992-7#23)(1992-8#56)(1992-9#32)(1993-11#59)(1993-12#74)(1993-2#52)(1993-3#63)(1993-4#28)(1993-5#23)(1993-6#79)(1993-7#8)(1993-8#37)(1993-9#52)(1994-10#2)(1994-11#36)(1994-12#150)(1994-2#33)(1994-3#53)(1994-4#1)(1994-5#30)(1994-6#48)(1994-7#2)(1994-8#99)(1994-9#83)(1995-1#30)(1995-10#11)(1995-11#17)(1995-12#18)(1995-2#64)(1995-3#82)(1995-4#12)(1995-5#20)(1995-6#69)(1995-7#5)(1995-8#117)(1995-9#9)(1996-1#2)(1996-10#42)(1996-11#22)(1996-12#43)(1996-2#27)(1996-3#20)(1996-4#37)(1996-5#60)(1996-6#36)(1996-7#57)(1996-8#38)(1996-9#17)(1997-1#45)(1997-2#90)(1997-3#38)(1997-4#115)(1997-5#26)(1997-6#65)(1997-7#69)(1997-8#36)(1997-9#11)(2003-11#2)(2004-1#1)(2004-10#1)(2005-10#2)(2005-11#28)(2005-6#3)(2005-7#2)(2005-8#5)(2005-9#1)(2006-1#2)(2006-10#26)(2006-11#2)(2006-12#22)(2006-2#3)(2006-3#4)(2006-5#11)(2006-6#4)(2006-8#22)(2006-9#2)(2007-1#3)(2007-10#3)(2007-11#18)(2007-12#44)(2007-2#3)(2007-3#6)(2007-4#2)(2007-5#3)(2007-6#28)(2007-7#6)(2007-8#11)(2007-9#7)(2008-1#9)(2008-10#460)(2008-11#58)(2008-12#21)(2008-2#47)(2008-3#25)(2008-4#162)(2008-5#44)(2008-6#16)(2008-7#122)(2008-8#119)(2008-9#86)(2009-10#18)(2009-11#4)(2009-12#5)(2009-2#9)(2009-3#6)(2009-4#1)(2009-5#23)(2009-6#13)(2009-7#4)(2009-8#14)(2009-9#8)(2010-1#6)(2010-10#12)(2010-11#4)(2010-12#16)(2010-2#6)(2010-3#4)(2010-4#12)(2010-5#9)(2010-6#16)(2010-7#10)(2010-8#6)(2010-9#2)(2011-1#39)(2011-10#1)(2011-12#7)(2011-2#173)(2011-3#2)(2012-1#4)(2012-11#8)(2012-12#23)(2012-2#48)(2012-3#53)(2012-8#1)(2013-1#39)(2013-7#7)(2013-8#42)
sequence'##2##1##(1995-12#1)(1996-6#1)
sequence(s)##2##1##(1990-10#1)(1993-8#1)
sequence)##8##1##(1991-6#1)(1992-11#1)(1993-6#1)(1997-2#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-7#1)
sequence-##4##1##(2008-10#1)(2008-8#1)(2008-9#1)(2010-7#1)
sequence-based##15##1##(2007-11#1)(2008-10#8)(2008-4#2)(2008-7#1)(2011-1#2)(2012-3#1)
sequence-binding protein##2##2##(1992-11#1)(2008-9#1)
sequence-characterized amplified##2##2##(2008-10#2)
sequence-characterized##3##1##(2008-10#3)
sequence-dependent##6##1##(1991-3#1)(1993-3#1)(1995-12#1)(2008-10#1)(2008-4#1)(2012-2#1)
sequence-directed bending of the helix axis##2##6##(1992-4#2)
sequence-directed##4##1##(1992-4#2)(1993-11#2)
sequence-independent DNA binding proteins in##2##5##(2008-8#2)
sequence-independent DNA##3##2##(1995-3#1)(2008-8#2)
sequence-independent##4##1##(1995-3#1)(1997-4#1)(2008-8#2)
sequence-ready##2##1##(1997-8#1)(2008-7#1)
sequence-selective##3##1##(2008-10#3)
sequence-specific DNA binding by##2##4##(1995-6#2)
sequence-specific DNA binding proteins##2##4##(1992-6#1)(1994-11#1)
sequence-specific DNA binding##9##3##(1990-11#1)(1992-12#1)(1992-6#1)(1994-11#1)(1995-6#3)(1996-4#1)(2005-12#1)
sequence-specific DNA##11##2##(1990-11#1)(1991-2#1)(1992-12#1)(1992-6#1)(1994-11#1)(1995-6#3)(1996-4#1)(2005-12#1)(2008-4#1)
sequence-specific DNA-binding protein##2##3##(1991-5#2)
sequence-specific DNA-binding proteins and##2##4##(1991-11#1)(1991-5#1)
sequence-specific DNA-binding proteins##7##3##(1991-11#1)(1991-5#1)(1991-8#1)(1993-12#2)(2008-4#2)
sequence-specific DNA-binding##11##2##(1991-11#1)(1991-5#3)(1991-8#1)(1993-12#2)(1995-8#1)(1997-4#1)(2008-4#2)
sequence-specific and##5##2##(1995-3#1)(1995-8#1)(2005-11#1)(2008-4#1)(2008-9#1)
sequence-specific antibodies##2##2##(1994-2#1)(1995-6#1)
sequence-specific cleavage##2##2##(1992-7#1)(2008-4#1)
sequence-specific interactions##3##2##(2007-11#2)(2008-7#1)
sequence-specific primer (SSP)##2##3##(2007-2#1)(2011-2#1)
sequence-specific primer##3##2##(2005-10#1)(2007-2#1)(2011-2#1)
sequence-specific propensity for a right-handed supercoil##2##6##(1992-12#2)
sequence-specific proteases##2##2##(2008-4#2)
sequence-specific protein-DNA interactions##2##3##(1996-11#2)
sequence-specific protein-DNA##3##2##(1996-11#3)
sequence-specific##84##1##(1990-11#2)(1991-11#2)(1991-2#1)(1991-5#3)(1991-8#2)(1991-9#1)(1992-12#3)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#2)(1993-12#2)(1993-6#1)(1994-11#2)(1994-2#1)(1994-5#1)(1995-3#1)(1995-6#5)(1995-8#3)(1996-10#1)(1996-11#5)(1996-4#1)(1996-8#1)(1997-2#1)(1997-4#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-12#1)(2007-11#2)(2007-2#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-4#12)(2008-7#2)(2008-8#1)(2008-9#4)(2009-3#1)(2010-2#1)(2011-1#2)(2011-2#1)(2013-8#1)
sequence-tagged site (STS) markers##7##4##(1996-10#1)(1996-12#2)(1997-4#2)(1997-8#1)(2008-10#1)
sequence-tagged site##8##2##(1994-12#1)(1996-10#1)(1996-12#2)(1997-4#2)(1997-8#1)(2008-10#1)
sequence-tagged sites##3##2##(1993-3#1)(1995-6#1)(1997-4#1)
sequence-tagged##11##1##(1993-3#1)(1994-12#1)(1995-6#1)(1996-10#1)(1996-12#2)(1997-4#3)(1997-8#1)(2008-10#1)
sequence/structure##2##1##(2008-10#1)(2008-4#1)
sequenced BAC clones##2##3##(2008-7#1)(2010-3#1)
sequenced LCAT cDNA##2##3##(1993-6#2)
sequenced a cDNA##6##3##(1990-4#1)(1991-3#1)(1991-8#1)(1992-4#1)(1993-6#1)(1994-12#1)
sequenced a##20##2##(1990-1#1)(1990-4#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#2)(1995-6#1)(1996-5#1)(2005-8#1)(2008-5#1)
sequenced after##2##2##(1992-1#1)(1992-3#1)
sequenced and analyzed##4##3##(1992-3#1)(1993-2#1)(1995-5#1)(2013-1#1)
sequenced and assembled##2##3##(1996-2#1)(2012-3#1)
sequenced and characterized##4##3##(1991-9#1)(1997-4#1)(2008-5#1)(2008-8#1)
sequenced and compared with##3##4##(2005-11#2)(2008-10#1)
sequenced and compared##5##3##(1990-11#1)(2005-11#2)(2008-10#1)(2009-10#1)
sequenced and expressed in Escherichia coli##2##6##(1992-2#1)(2008-9#1)
sequenced and expressed in##3##4##(1990-11#1)(1992-2#1)(2008-9#1)
sequenced and found to be##3##5##(1996-12#1)(2008-10#1)(2013-1#1)
sequenced and found to##5##4##(1995-2#1)(1996-12#1)(1996-7#1)(2008-10#1)(2013-1#1)
sequenced and its##2##3##(1994-2#1)(2008-10#1)
sequenced and the##8##3##(1990-12#1)(1990-7#1)(1991-9#1)(1993-11#1)(1994-12#1)(1994-9#1)(2008-10#1)(2008-8#1)
sequenced and used##2##3##(1995-8#1)(1996-7#1)
sequenced and##60##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-7#1)(1991-1#1)(1991-9#2)(1992-2#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-2#2)(1995-5#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-6#1)(1996-7#3)(1997-4#1)(2005-11#2)(2007-12#1)(2008-10#11)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
sequenced at##2##2##(1993-2#1)(2013-7#1)
sequenced by automated Edman degradation##2##5##(1991-8#1)(1996-5#1)
sequenced by the dideoxy method##2##5##(1991-7#1)(1992-1#1)
sequenced by##14##2##(1990-12#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#2)(1993-3#1)(1994-12#1)(1995-12#2)(1995-2#1)(1996-5#1)(1997-3#1)(2008-7#1)
sequenced cDNA##2##2##(1992-12#1)(1997-5#1)
sequenced directly##3##2##(1991-7#1)(2008-10#1)(2008-4#1)
sequenced for each##4##3##(1993-2#1)(2008-10#2)(2012-1#1)
sequenced for##12##2##(1993-2#1)(1996-11#1)(1997-4#2)(2008-1#1)(2008-10#4)(2009-5#1)(2010-8#1)(2012-1#1)
sequenced from a##5##3##(1992-2#1)(1992-6#1)(1997-2#1)(2008-10#1)(2008-5#1)
sequenced from rat##2##3##(1990-12#1)(1997-3#1)
sequenced from the##2##3##(1992-3#1)(1997-3#1)
sequenced from##21##2##(1990-12#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-6#2)(1994-5#1)(1997-2#2)(1997-3#2)(1997-4#2)(2005-11#1)(2008-10#4)(2008-12#1)(2008-5#1)
sequenced genome##7##2##(2007-8#1)(2008-10#1)(2008-2#2)(2008-7#2)(2012-2#1)
sequenced genomes of##3##3##(2007-12#1)(2008-7#1)(2011-1#1)
sequenced genomes##6##2##(2007-12#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-5#1)(2011-1#1)
sequenced human##3##2##(1994-9#1)(1997-1#1)(2007-9#1)
sequenced in this study##4##4##(1996-4#1)(1997-8#1)(2008-10#1)(2010-3#1)
sequenced in##15##2##(1990-12#1)(1994-3#1)(1996-4#1)(1997-4#1)(1997-8#1)(2006-12#1)(2006-8#1)(2008-10#3)(2008-7#1)(2008-8#1)(2010-3#1)(2012-1#1)(2012-11#1)
sequenced is##2##2##(1990-12#1)(1992-12#1)
sequenced it##3##2##(2008-10#1)(2008-8#2)
sequenced open reading##2##3##(1996-6#1)(2008-10#1)
sequenced part of##2##3##(1992-12#1)(2008-10#1)
sequenced region##5##2##(1991-7#1)(1993-11#2)(1994-12#1)(1995-8#1)
sequenced regions##3##2##(1997-6#1)(1997-8#2)
sequenced samples##2##2##(2012-3#1)(2013-8#1)
sequenced the cDNAs##2##3##(1994-3#1)(2006-12#1)
sequenced the entire##4##3##(1993-6#1)(1994-11#1)(1994-12#1)(1995-1#1)
sequenced the gene##2##3##(1990-8#1)(1994-12#1)
sequenced the human##2##3##(1992-4#1)(1997-5#1)
sequenced the##36##2##(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-9#1)(1992-12#1)(1992-4#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-5#1)(1995-1#1)(1995-11#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-12#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2006-12#1)(2008-10#1)(2011-2#1)(2013-1#1)
sequenced to date##2##3##(2006-10#1)(2009-6#1)
sequenced to##13##2##(1993-7#1)(1993-9#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-4#1)(2012-12#1)(2012-2#1)
sequenced using##4##2##(1992-11#1)(2006-8#1)(2008-2#1)(2011-2#1)
sequenced##541##1##(1990-1#2)(1990-10#4)(1990-11#4)(1990-12#9)(1990-2#1)(1990-3#4)(1990-4#2)(1990-5#5)(1990-7#4)(1990-8#2)(1990-9#2)(1991-1#3)(1991-10#2)(1991-11#3)(1991-12#6)(1991-2#6)(1991-3#2)(1991-5#2)(1991-6#4)(1991-7#6)(1991-8#4)(1991-9#6)(1992-1#4)(1992-10#1)(1992-11#2)(1992-12#9)(1992-2#2)(1992-3#5)(1992-4#5)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#10)(1993-12#8)(1993-2#7)(1993-3#4)(1993-5#3)(1993-6#10)(1993-7#1)(1993-8#2)(1993-9#5)(1994-11#5)(1994-12#15)(1994-2#1)(1994-3#5)(1994-5#4)(1994-6#1)(1994-8#1)(1994-9#6)(1995-1#2)(1995-10#1)(1995-11#5)(1995-12#3)(1995-2#5)(1995-5#1)(1995-6#6)(1995-8#11)(1995-9#1)(1996-10#8)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#4)(1996-7#5)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#7)(1997-3#4)(1997-4#12)(1997-5#3)(1997-6#3)(1997-7#5)(1997-8#4)(1997-9#2)(2004-12#2)(2005-11#6)(2005-8#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-8#2)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#76)(2008-11#1)(2008-12#5)(2008-2#6)(2008-4#5)(2008-5#13)(2008-6#1)(2008-7#17)(2008-8#13)(2008-9#4)(2009-10#3)(2009-5#4)(2009-6#2)(2010-10#2)(2010-12#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#4)(2012-3#6)(2013-1#5)(2013-7#3)(2013-8#8)
sequencer##6##1##(1992-9#1)(1993-3#1)(1994-11#2)(2008-9#1)(2010-9#1)
sequencers##3##1##(1995-7#1)(1997-2#1)(2011-1#1)
sequences (0##2##2##(2008-10#1)(2013-1#1)
sequences (1##2##2##(2008-5#2)
sequences (e##3##2##(2008-4#1)(2008-8#1)(2013-8#1)
sequences 5' to the##2##4##(1991-6#1)(1993-12#1)
sequences a##2##2##(1991-8#1)(1992-12#1)
sequences accompanied##2##2##(1996-10#1)(2008-11#1)
sequences adjacent to##2##3##(1991-8#1)(1994-8#1)
sequences after##3##2##(1996-4#1)(2008-9#1)(2011-2#1)
sequences allowed##3##2##(1995-2#1)(2006-8#1)(2010-10#1)
sequences also##2##2##(2010-10#1)(2013-8#1)
sequences among##5##2##(1993-12#1)(1994-12#1)(1995-8#1)(2008-10#2)
sequences amplified by##2##3##(1992-5#1)(2008-10#1)
sequences analysed in this##2##4##(2006-8#1)(2008-9#1)
sequences analysis##4##2##(1996-6#1)(2006-8#2)(2008-8#1)
sequences analyzed##3##2##(1991-8#1)(2008-10#2)
sequences and a##3##3##(1992-6#1)(1997-2#1)(1997-8#1)
sequences and an##2##3##(1994-9#1)(1997-8#1)
sequences and deduced##2##3##(1993-6#1)(1996-10#1)
sequences and gene##2##3##(2008-11#1)(2008-4#1)
sequences and have##2##3##(1992-5#1)(1994-10#1)
sequences and identified##2##3##(2010-1#1)(2011-2#1)
sequences and more##2##3##(2012-1#1)(2012-2#1)
sequences and on##2##3##(2008-10#1)(2008-7#1)
sequences and one##2##3##(2008-10#1)(2013-1#1)
sequences and secondary structures##2##4##(1991-1#1)(1995-9#1)
sequences and the##9##3##(1990-7#1)(1995-1#1)(1995-5#1)(1996-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2012-11#1)
sequences and##124##2##(1990-1#1)(1990-10#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-4#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-6#2)(1993-8#2)(1993-9#2)(1994-10#1)(1994-3#1)(1994-6#4)(1994-8#1)(1994-9#3)(1995-1#2)(1995-11#1)(1995-2#3)(1995-5#2)(1995-6#1)(1995-9#1)(1996-10#2)(1996-12#1)(1996-3#1)(1996-4#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-12#2)(2006-5#1)(2006-6#1)(2007-12#1)(2007-6#1)(2008-10#10)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#11)(2008-5#2)(2008-7#8)(2008-8#1)(2008-9#2)(2009-11#1)(2009-5#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
sequences and/or##3##2##(1995-8#1)(2008-7#1)(2013-8#1)
sequences are available##2##3##(2007-12#1)(2008-7#1)
sequences are compared##2##3##(1996-4#1)(2009-3#1)
sequences are conserved##2##3##(2008-7#1)(2012-2#1)
sequences are contained##2##3##(1992-6#1)(1993-2#1)
sequences are highly homologous to each other##2##7##(1993-9#1)(1996-2#1)
sequences are highly homologous to##4##5##(1990-8#1)(1993-5#1)(1993-9#1)(1996-2#1)
sequences are highly##6##3##(1990-8#1)(1991-4#1)(1993-5#1)(1993-9#1)(1994-10#1)(1996-2#1)
sequences are involved##2##3##(1994-8#1)(2013-1#1)
sequences are often##2##3##(1991-7#1)(2007-9#1)
sequences are present in##2##4##(1992-6#1)(1996-11#1)
sequences are present##3##3##(1990-9#1)(1992-6#1)(1996-11#1)
sequences are rapidly##2##3##(1991-9#1)(2008-4#1)
sequences are shown to be##2##5##(1996-4#1)(2010-5#1)
sequences are the most##2##4##(1990-5#1)(1996-8#1)
sequences are used to construct##2##5##(2008-2#1)(2008-9#1)
sequences are very##2##3##(1997-7#1)(2008-2#1)
sequences are##90##2##(1990-12#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-12#2)(1991-3#2)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-3#2)(1994-8#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-4#3)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-7#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#6)(2008-4#4)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#2)(2009-3#1)(2010-5#1)(2011-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
sequences around the##3##3##(1991-5#1)(1992-11#1)(1992-4#1)
sequences around##5##2##(1991-5#1)(1992-11#1)(1992-4#1)(1994-11#1)(1997-2#1)
sequences as a##2##3##(1991-4#1)(1996-6#1)
sequences as##13##2##(1991-11#1)(1991-4#1)(1993-3#1)(1994-12#1)(1994-6#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-6#1)(1997-4#2)(2008-4#1)(2013-1#1)
sequences associated with##4##3##(1996-3#1)(2006-12#1)(2008-4#1)(2012-3#1)
sequences at both##3##3##(1990-3#1)(1991-2#1)(2008-4#1)
sequences at positions##2##3##(1990-12#1)(1994-3#1)
sequences at the end of##2##5##(2008-9#2)
sequences at the##5##3##(2008-10#1)(2008-5#1)(2008-9#2)(2010-2#1)
sequences at their##2##3##(1990-1#1)(1996-8#1)
sequences at##23##2##(1990-1#1)(1990-10#1)(1990-12#1)(1990-3#1)(1991-2#1)(1993-12#1)(1994-3#2)(1994-9#1)(1996-12#1)(1996-4#2)(1996-8#2)(2007-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-2#1)(2013-1#1)
sequences available in##4##3##(1990-11#1)(1991-1#1)(1994-12#1)(2008-10#1)
sequences available##6##2##(1990-11#1)(1991-1#1)(1991-2#1)(1994-12#1)(1994-8#1)(2008-10#1)
sequences based on##4##3##(2008-2#1)(2008-7#1)(2009-3#1)(2013-8#1)
sequences because##2##2##(2008-9#1)(2010-3#1)
sequences beginning##2##2##(1994-8#1)(1995-8#1)
sequences belong to##2##3##(2008-8#1)(2013-1#1)
sequences belonging to##2##3##(1990-4#1)(1996-10#1)
sequences between the##6##3##(1990-5#1)(1991-4#1)(1994-12#1)(2008-10#1)(2008-4#2)
sequences between##18##2##(1990-5#1)(1991-12#1)(1991-4#1)(1992-5#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-10#1)(1996-8#4)(2008-10#2)(2008-4#3)(2013-8#1)
sequences bound##2##2##(1995-3#1)(1996-11#1)
sequences but are##2##3##(1992-3#2)
sequences but##6##2##(1990-3#1)(1990-9#1)(1992-3#2)(1993-3#1)(2008-7#1)
sequences by hybridization##2##3##(1993-12#1)(2008-10#1)
sequences by polymerase chain reaction##2##5##(1990-4#1)(1997-6#1)
sequences by the##2##3##(1995-8#1)(2006-12#1)
sequences by using##2##3##(1995-8#1)(2012-2#1)
sequences by##25##2##(1990-4#1)(1991-12#1)(1991-9#1)(1993-12#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-6#1)(1995-8#2)(1996-4#1)(1997-6#1)(2006-12#1)(2008-10#2)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#2)(2011-12#1)(2012-2#2)
sequences can be##9##3##(1990-5#1)(1991-1#1)(1994-6#1)(1995-10#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-12#1)(2011-1#1)
sequences can function as##2##4##(1993-4#1)(1997-4#1)
sequences can##16##2##(1990-5#1)(1991-1#2)(1993-4#1)(1994-6#2)(1994-9#1)(1995-10#1)(1996-3#1)(1997-4#2)(2008-10#1)(2008-4#1)(2008-9#1)(2009-12#1)(2011-1#1)
sequences coding for the##6##4##(1990-5#1)(1992-2#1)(1993-9#1)(1994-5#2)(1997-4#1)
sequences coding for##7##3##(1990-5#1)(1992-2#1)(1993-9#1)(1994-5#2)(1996-6#1)(1997-4#1)
sequences coding##8##2##(1990-5#1)(1992-2#1)(1993-9#1)(1994-5#2)(1996-6#1)(1997-4#1)(1997-6#1)
sequences common to##2##3##(1990-9#1)(2008-2#1)
sequences complementary to##5##3##(1991-9#3)(1996-11#1)(1997-4#1)
sequences comprising the##2##3##(1990-5#1)(1995-2#1)
sequences comprising##3##2##(1990-5#1)(1995-2#1)(2007-8#1)
sequences conserved in##2##3##(1991-4#1)(2006-11#1)
sequences conserved##3##2##(1991-4#1)(1994-11#1)(2006-11#1)
sequences contain a##2##3##(2005-11#1)(2011-2#1)
sequences contain##4##2##(1990-8#1)(1991-6#1)(2005-11#1)(2011-2#1)
sequences contained##5##2##(1991-12#2)(1992-6#1)(1997-2#1)(2008-10#1)
sequences containing the##2##3##(1994-8#1)(2008-10#1)
sequences containing##10##2##(1990-11#1)(1990-3#2)(1990-5#1)(1991-6#1)(1992-9#1)(1994-8#1)(2008-10#1)(2008-2#2)
sequences corresponding to the##4##4##(1991-2#1)(1993-6#1)(1994-12#1)(2012-2#1)
sequences corresponding to##6##3##(1990-7#1)(1991-2#1)(1993-12#1)(1993-6#1)(1994-12#1)(2012-2#1)
sequences could be##4##3##(1990-9#1)(1991-4#1)(2008-10#1)(2011-2#1)
sequences could not be##2##4##(1997-4#1)(2011-2#1)
sequences could##6##2##(1990-9#1)(1991-4#1)(1997-4#1)(2008-10#1)(2011-2#2)
sequences covering##2##2##(1991-4#1)(2013-1#1)
sequences decreased##2##2##(1991-7#1)(2009-9#1)
sequences deleted##2##2##(1990-5#1)(2008-9#1)
sequences demonstrated##3##2##(1991-9#1)(1993-6#1)(2008-9#1)
sequences demonstrates##2##2##(1991-9#1)(1993-3#1)
sequences derived from the##2##4##(1992-4#1)(1997-4#1)
sequences derived from##8##3##(1990-7#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-4#2)(1997-4#1)(2013-8#1)
sequences derived##10##2##(1990-7#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-4#2)(1996-4#2)(1997-4#1)(2013-8#1)
sequences described in##2##3##(1995-9#1)(1996-11#1)
sequences determined from##2##3##(1992-8#1)(1994-8#1)
sequences determined##6##2##(1990-4#1)(1990-7#1)(1992-1#1)(1992-8#1)(1994-8#1)(1996-7#1)
sequences displayed##2##2##(1991-6#1)(2006-8#1)
sequences distal to##2##3##(1991-5#1)(1991-9#1)
sequences do not##2##3##(1991-11#1)(1995-2#1)
sequences downstream from##2##3##(1993-12#1)(1995-3#1)
sequences downstream##3##2##(1993-12#1)(1995-3#1)(1996-5#1)
sequences due to##2##3##(2008-4#1)(2008-8#1)
sequences during##4##2##(1992-11#1)(2008-10#2)(2009-10#1)
sequences encoded by##2##3##(1993-6#1)(1996-5#1)
sequences encoded##4##2##(1993-6#1)(1993-9#1)(1996-5#1)(1997-7#1)
sequences encoding a##2##3##(1997-7#1)(2006-12#1)
sequences encoding human##2##3##(1992-3#1)(1996-10#1)
sequences encoding the##7##3##(1990-11#1)(1993-3#2)(1993-9#1)(1994-3#1)(1996-10#1)(2008-9#1)
sequences encoding##20##2##(1990-11#1)(1991-6#1)(1992-3#1)(1992-6#1)(1993-3#2)(1993-5#1)(1993-9#1)(1994-3#2)(1994-9#1)(1996-10#2)(1996-2#1)(1997-7#1)(2006-12#1)(2008-9#1)(2009-10#1)(2010-5#1)(2012-3#1)
sequences essential for##2##3##(1990-6#1)(1995-1#1)
sequences established##2##2##(1990-2#1)(2008-10#1)
sequences except##2##2##(1991-10#1)(2005-10#1)
sequences exhibited##4##2##(1991-3#1)(1995-3#1)(2008-10#1)(2009-6#1)
sequences flanking the##4##3##(1991-7#1)(1994-12#1)(1995-2#1)(2008-10#1)
sequences flanking##7##2##(1991-7#1)(1993-11#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-4#1)(2008-10#1)
sequences following##2##2##(1995-8#1)(2007-11#1)
sequences for a##5##3##(1996-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-12#1)
sequences for each##2##3##(1997-4#1)(2009-5#1)
sequences for human and##2##4##(1990-5#1)(1996-4#1)
sequences for several##2##3##(1993-12#1)(1994-6#1)
sequences for the##18##3##(1990-5#1)(1991-9#1)(1992-6#1)(1993-2#1)(1993-5#1)(1994-11#1)(1994-5#1)(1995-6#1)(1995-8#2)(1997-7#1)(1997-8#1)(2006-3#1)(2008-5#1)(2009-10#1)(2010-12#1)(2010-3#1)(2010-4#1)
sequences for these##2##3##(1990-12#1)(1991-12#1)
sequences for three##2##3##(1990-12#1)(2008-10#1)
sequences for##71##2##(1990-11#1)(1990-12#2)(1990-4#1)(1990-5#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-11#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-4#3)(1996-7#1)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#1)(2006-3#1)(2007-12#1)(2008-10#6)(2008-2#4)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-5#2)(2010-12#1)(2010-3#1)(2010-4#1)(2012-12#1)(2012-3#1)
sequences found in the##2##4##(1992-6#1)(1994-6#1)
sequences found in##6##3##(1990-5#1)(1992-6#1)(1994-6#1)(2007-6#1)(2008-10#1)(2008-7#1)
sequences from a##11##3##(1991-1#1)(1991-9#1)(1992-11#1)(1994-12#1)(1996-10#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-3#1)
sequences from all##2##3##(2008-10#2)
sequences from both##2##3##(1995-3#1)(1997-2#1)
sequences from different##2##3##(1994-12#1)(2008-9#1)
sequences from human##4##3##(1995-2#1)(1995-6#1)(1996-2#1)(2008-7#1)
sequences from mouse##2##3##(1995-10#1)(1996-11#1)
sequences from other##4##3##(1991-12#1)(1991-6#1)(1992-2#1)(1995-11#1)
sequences from the nuclear##2##4##(2008-10#2)
sequences from the##27##3##(1990-12#1)(1991-7#1)(1992-2#1)(1993-11#1)(1993-5#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#2)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-12#1)(2008-5#2)(2008-7#1)(2012-2#1)
sequences from yeast##2##3##(1995-6#1)(1996-10#1)
sequences from##101##2##(1990-1#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#2)(1993-11#1)(1993-2#1)(1993-4#1)(1993-5#1)(1994-12#3)(1994-3#2)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-6#3)(1995-8#2)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-4#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-8#3)(2007-11#2)(2007-12#1)(2007-3#1)(2008-10#23)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#4)(2008-9#2)(2009-10#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
sequences had##6##2##(1995-8#1)(1997-4#1)(1997-9#1)(2005-11#1)(2008-9#1)(2010-4#1)
sequences has been used to##2##5##(1992-12#1)(1992-6#1)
sequences has been##5##3##(1992-12#1)(1992-3#1)(1992-6#2)(2008-10#1)
sequences has greatly##2##3##(2007-1#1)(2008-7#1)
sequences has##10##2##(1990-3#1)(1992-12#1)(1992-3#1)(1992-6#2)(1993-6#1)(2007-1#1)(2008-10#1)(2008-7#2)
sequences have been determined##4##4##(1990-5#1)(1991-2#1)(1995-10#1)(2008-8#1)
sequences have been mapped##2##4##(2008-8#2)
sequences have been reported##3##4##(1992-6#1)(1992-7#1)(2012-2#1)
sequences have been##19##3##(1990-5#1)(1991-2#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-6#2)(1995-10#1)(1995-8#1)(1996-9#1)(2006-10#1)(2006-2#1)(2008-5#1)(2008-8#3)(2008-9#1)(2012-2#1)
sequences have##29##2##(1990-2#1)(1990-5#1)(1991-2#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#2)(1993-6#2)(1995-10#1)(1995-8#1)(1996-9#1)(1997-6#1)(2006-10#1)(2006-2#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2010-4#1)(2012-2#1)
sequences homologous to##6##3##(1991-6#1)(1991-7#1)(1993-12#1)(1993-8#1)(1996-6#1)(1997-4#1)
sequences identified##4##2##(1991-9#1)(1993-12#1)(2008-5#1)(2012-3#1)
sequences in RNA##5##3##(2008-2#1)(2008-4#4)
sequences in a##5##3##(1996-12#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-1#1)
sequences in an##2##3##(1991-7#1)(1996-11#1)
sequences in both##2##3##(2008-5#1)(2010-2#1)
sequences in protein##3##3##(1994-8#1)(1997-6#1)(1997-8#1)
sequences in public##2##3##(1996-2#1)(2010-7#1)
sequences in the 3'##2##4##(1991-11#1)(1993-5#1)
sequences in the 5'##2##4##(1991-3#1)(1992-12#1)
sequences in the absence##2##4##(1994-9#1)(1995-8#1)
sequences in the databases##2##4##(1997-3#1)(2008-10#1)
sequences in the##58##3##(1990-12#1)(1990-2#1)(1990-4#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#2)(2005-10#1)(2006-12#3)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#2)(2011-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
sequences in these##2##3##(1995-5#1)(2008-10#1)
sequences in two##3##3##(1993-12#1)(1995-2#1)(2008-9#1)
sequences in vivo##6##3##(1996-5#1)(2008-1#2)(2008-2#3)
sequences in which the##2##4##(1992-12#1)(1992-7#1)
sequences in##155##2##(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#3)(1990-6#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-7#1)(1991-9#3)(1992-11#1)(1992-12#2)(1992-2#4)(1992-5#1)(1992-6#2)(1992-7#3)(1992-9#1)(1993-11#2)(1993-12#2)(1993-5#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-11#2)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-4#5)(1997-6#3)(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-12#4)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#7)(2008-11#3)(2008-2#5)(2008-4#8)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#7)(2009-10#1)(2009-12#1)(2009-2#1)(2010-2#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
sequences including##2##2##(1992-3#1)(1997-7#1)
sequences indicate that##4##3##(1993-9#1)(1994-8#1)(2008-10#1)(2013-1#1)
sequences indicated that the##3##4##(1994-3#1)(1995-8#1)(1996-4#1)
sequences indicated that##8##3##(1994-3#1)(1995-8#1)(1996-4#1)(1997-6#1)(2008-10#2)(2008-5#1)(2010-8#1)
sequences indicated##10##2##(1994-3#1)(1995-8#1)(1996-4#1)(1997-6#1)(2008-10#4)(2008-5#1)(2010-8#1)
sequences indicates that##3##3##(1994-12#1)(1997-2#1)(2012-2#1)
sequences indicates##4##2##(1994-12#1)(1997-2#1)(2012-2#1)(2013-1#1)
sequences influence##2##2##(1997-4#1)(2008-10#1)
sequences into a##3##3##(1990-9#2)(2008-11#1)
sequences into the##2##3##(1990-3#1)(1997-7#1)
sequences into##11##2##(1990-3#1)(1990-9#2)(1992-2#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2012-2#1)(2013-8#1)
sequences involved in##4##3##(1994-8#1)(1997-2#1)(2008-10#1)(2013-8#1)
sequences is described##2##3##(1993-8#1)(2008-6#1)
sequences is##24##2##(1990-11#1)(1990-12#1)(1990-4#1)(1991-10#1)(1991-5#1)(1991-7#1)(1992-6#1)(1993-8#1)(1994-11#1)(1994-5#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-3#1)(1996-6#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-3#1)(2013-8#1)
sequences known as##2##3##(1993-9#1)(1995-6#1)
sequences leading to##2##3##(1996-4#1)(2004-4#1)
sequences ligated##2##2##(1994-6#1)(1997-4#1)
sequences located in the##5##4##(1991-3#1)(1993-2#1)(1994-9#1)(1995-6#1)(2008-10#1)
sequences located in##7##3##(1991-3#1)(1992-12#1)(1993-2#1)(1994-9#1)(1995-2#1)(1995-6#1)(2008-10#1)
sequences located upstream##2##3##(1993-11#1)(1995-8#1)
sequences located##12##2##(1991-3#1)(1992-12#3)(1993-11#1)(1993-2#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-7#1)(2008-10#1)
sequences lying between##2##3##(1994-8#1)(2008-10#1)
sequences may be##4##3##(1993-12#1)(1995-8#1)(1996-11#1)(1997-3#1)
sequences may play##2##3##(1993-9#1)(2012-3#1)
sequences may##9##2##(1993-12#1)(1993-5#1)(1993-9#1)(1995-8#1)(1996-11#1)(1996-12#1)(1997-3#1)(2008-10#1)(2012-3#1)
sequences might be##2##3##(1995-2#1)(1997-3#1)
sequences near the##2##3##(1993-5#1)(1995-2#1)
sequences nor the##2##3##(1994-11#1)(2008-7#1)
sequences nor##3##2##(1994-11#1)(1997-3#1)(2008-7#1)
sequences normally##2##2##(1990-11#1)(2009-10#1)
sequences obtained from##4##3##(1990-4#1)(1994-8#1)(2008-10#1)(2012-3#1)
sequences obtained##9##2##(1990-4#1)(1990-9#1)(1994-8#1)(1995-1#1)(2008-10#1)(2008-2#1)(2010-3#1)(2012-12#1)(2012-3#1)
sequences occur##3##2##(1993-3#1)(1996-8#1)(1997-4#1)
sequences of 100##2##3##(1997-4#2)
sequences of 13##3##3##(1995-8#1)(2006-8#1)(2009-5#1)
sequences of 22##3##3##(1994-6#1)(1996-10#1)(2013-8#1)
sequences of 40##5##3##(1995-8#2)(1996-2#3)
sequences of 80##2##3##(1996-10#2)
sequences of DNA##2##3##(1992-3#1)(2008-7#1)
sequences of PVV##2##3##(2008-10#2)
sequences of RNA##3##3##(2008-1#1)(2008-10#2)
sequences of a##10##3##(1992-7#1)(1994-11#3)(1996-8#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)
sequences of all four##2##4##(1993-6#1)(1995-6#1)
sequences of all##4##3##(1990-11#1)(1993-6#1)(1995-6#1)(2008-10#1)
sequences of both##9##3##(1990-11#1)(1990-7#1)(1991-2#1)(1992-8#1)(2006-12#1)(2008-7#1)(2009-5#1)(2011-1#1)(2013-1#1)
sequences of cytochrome##2##3##(1992-3#1)(1997-3#1)
sequences of different##4##3##(1991-9#1)(1996-6#1)(2008-6#1)(2013-1#1)
sequences of elements##2##3##(1996-10#2)
sequences of events##4##3##(1995-12#1)(2007-10#1)(2007-8#1)(2012-1#1)
sequences of four##5##3##(1991-2#1)(1992-12#1)(1995-8#1)(2008-10#1)(2009-10#1)
sequences of fracture events##2##4##(2008-8#2)
sequences of gene##2##3##(1990-5#1)(1993-11#1)
sequences of genes encoding##2##4##(1990-9#1)(1995-1#1)
sequences of genes##4##3##(1990-1#1)(1990-9#1)(1995-1#1)(2013-8#1)
sequences of groups I and II##2##6##(2008-10#2)
sequences of groups I##3##4##(2008-10#3)
sequences of human##5##3##(1991-12#1)(1994-8#1)(1995-11#1)(2007-8#1)(2008-4#1)
sequences of interest##2##3##(2008-10#1)(2008-2#1)
sequences of known##2##3##(1993-12#1)(1994-11#1)
sequences of mouse##3##3##(1990-4#1)(1991-9#1)(1993-2#1)
sequences of other##7##3##(1990-3#1)(1991-10#1)(1991-12#1)(1991-2#1)(1994-8#1)(1995-3#1)(2008-8#1)
sequences of proteins##3##3##(1993-12#1)(2008-10#1)(2008-4#1)
sequences of putative##2##3##(2008-4#1)(2013-1#1)
sequences of rat##3##3##(1990-12#1)(1991-6#1)(1994-9#1)
sequences of rice##2##3##(2008-8#2)
sequences of several bacteria##2##4##(1996-4#1)(2005-7#1)
sequences of several##4##3##(1996-4#1)(2005-7#1)(2008-10#1)(2008-3#1)
sequences of six##2##3##(1993-6#1)(1995-6#1)
sequences of the 16S rRNA genes##2##6##(2008-10#2)
sequences of the A##2##4##(1990-4#1)(2008-10#1)
sequences of the BoNT/E genes##2##5##(1992-2#2)
sequences of the G- and H-helices of myoglobin##2##8##(1993-6#2)
sequences of the RNA##2##4##(2008-10#2)
sequences of the Rep##2##4##(2008-10#2)
sequences of the cleavage site of##2##6##(2005-9#2)
sequences of the cloned##3##4##(1990-2#1)(2008-10#1)(2008-11#1)
sequences of the coat protein (CP)##2##6##(2008-10#2)
sequences of the coding##3##4##(1991-9#1)(1992-7#1)(2009-10#1)
sequences of the complete##2##4##(2008-10#1)(2008-6#1)
sequences of the corresponding genes##4##5##(1995-8#1)(1996-10#1)(1996-2#1)(1997-6#1)
sequences of the first##2##4##(1994-12#1)(2008-9#1)
sequences of the gene##2##4##(1994-8#1)(1996-8#1)
sequences of the genes encoding##2##5##(1993-12#1)(2010-7#1)
sequences of the genes##4##4##(1993-12#1)(1997-8#1)(2008-11#1)(2010-7#1)
sequences of the human##4##4##(1992-3#1)(1994-8#1)(2007-10#1)(2010-5#1)
sequences of the intergenic##2##4##(2008-10#2)
sequences of the internal transcribed spacer (ITS) region of the##2##10##(2008-10#1)(2008-5#1)
sequences of the internal transcribed spacer (ITS) region of##3##9##(2008-10#2)(2008-5#1)
sequences of the internal transcribed spacer (ITS)##4##7##(2008-10#3)(2008-5#1)
sequences of the internal transcribed spacer##7##6##(2008-10#6)(2008-5#1)
sequences of the large##2##4##(1991-9#1)(1997-6#1)
sequences of the mitochondrial##3##4##(1991-6#1)(1995-11#1)(2008-6#1)
sequences of the other##2##4##(1991-6#1)(1991-7#1)
sequences of the proteins##2##4##(1997-7#1)(2008-10#1)
sequences of the rat and##2##5##(1993-3#1)(1994-9#1)
sequences of the rat##4##4##(1993-3#1)(1994-9#1)(1995-3#1)(2008-9#1)
sequences of the same##2##4##(2008-9#1)(2011-2#1)
sequences of the three subunits##2##5##(1994-12#1)(1995-3#1)
sequences of the three##3##4##(1990-3#1)(1994-12#1)(1995-3#1)
sequences of the two##4##4##(1990-7#1)(1993-3#1)(1996-10#1)(2006-8#1)
sequences of the viral##2##4##(2008-10#1)(2008-4#1)
sequences of the##194##3##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#3)(1991-7#3)(1991-9#2)(1992-12#2)(1992-2#4)(1992-3#1)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#3)(1993-6#3)(1993-8#1)(1993-9#2)(1994-12#6)(1994-2#2)(1994-5#1)(1994-8#4)(1994-9#1)(1995-10#1)(1995-11#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-8#2)(1996-10#2)(1996-2#2)(1996-4#1)(1996-6#2)(1996-7#2)(1996-8#3)(1997-2#1)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#1)(2005-11#3)(2005-8#1)(2005-9#2)(2006-10#1)(2006-5#1)(2006-8#3)(2007-10#2)(2007-12#1)(2007-6#2)(2007-8#1)(2008-10#44)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#1)(2009-5#1)(2010-3#1)(2010-5#2)(2010-7#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#3)
sequences of these two##2##4##(1990-6#1)(1996-4#1)
sequences of these##14##3##(1990-6#1)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-7#1)(1992-8#1)(1993-6#1)(1993-8#1)(1996-10#1)(1996-4#1)(1997-8#1)(2008-10#2)
sequences of three##4##3##(1992-7#1)(2007-12#1)(2008-10#2)
sequences of toxin##2##3##(2006-8#2)
sequences of two##10##3##(1990-12#1)(1991-6#2)(1991-8#1)(1993-6#1)(1995-7#1)(1996-10#1)(1997-2#1)(1997-7#1)(2006-8#1)
sequences of which##3##3##(1997-7#1)(2006-12#1)(2013-8#1)
sequences of##558##2##(1990-1#1)(1990-11#6)(1990-12#5)(1990-2#4)(1990-3#5)(1990-4#5)(1990-5#4)(1990-6#2)(1990-7#3)(1990-8#3)(1990-9#5)(1991-1#1)(1991-10#1)(1991-12#6)(1991-2#8)(1991-5#3)(1991-6#7)(1991-7#7)(1991-8#3)(1991-9#7)(1992-11#3)(1992-12#5)(1992-2#4)(1992-3#3)(1992-4#1)(1992-6#3)(1992-7#8)(1992-8#5)(1992-9#2)(1993-1#1)(1993-11#6)(1993-12#11)(1993-2#3)(1993-3#4)(1993-5#3)(1993-6#9)(1993-8#3)(1993-9#3)(1994-11#6)(1994-12#7)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#6)(1994-9#6)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#7)(1995-3#5)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#9)(1996-10#13)(1996-2#10)(1996-3#1)(1996-4#6)(1996-6#4)(1996-7#4)(1996-8#7)(1997-1#1)(1997-2#6)(1997-3#2)(1997-4#10)(1997-5#3)(1997-6#6)(1997-7#7)(1997-8#6)(2005-11#6)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#3)(2006-12#4)(2006-5#2)(2006-6#1)(2006-8#7)(2007-10#3)(2007-12#5)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#93)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#6)(2008-5#6)(2008-6#4)(2008-7#6)(2008-8#14)(2008-9#10)(2009-10#3)(2009-4#1)(2009-5#3)(2009-8#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#4)(2011-1#4)(2011-2#5)(2012-1#1)(2012-11#1)(2012-2#6)(2012-3#1)(2013-1#5)(2013-8#8)
sequences on the basis of##2##5##(1996-6#1)(2008-9#1)
sequences on the##8##3##(1993-3#1)(1995-6#1)(1996-6#1)(1997-2#1)(1997-4#1)(2008-5#1)(2008-9#1)(2012-2#1)
sequences on##14##2##(1991-10#2)(1992-4#1)(1993-3#1)(1995-6#1)(1996-6#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-5#1)(2012-2#1)
sequences or##4##2##(1996-7#1)(2008-4#1)(2008-8#1)(2008-9#1)
sequences preceding##2##2##(1990-6#1)(1992-9#1)
sequences predicted##3##2##(1990-7#1)(1996-10#1)(2009-12#1)
sequences present in the type##2##5##(1995-1#1)(1995-3#1)
sequences present in the##4##4##(1990-4#1)(1995-1#1)(1995-3#1)(1995-9#1)
sequences present in##10##3##(1990-4#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-9#1)(1997-3#1)(1997-6#1)(2006-8#2)
sequences present##12##2##(1990-4#1)(1994-12#1)(1994-8#2)(1995-1#1)(1995-3#1)(1995-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-8#2)
sequences previously reported##2##3##(2008-10#1)(2009-9#1)
sequences previously##6##2##(1990-9#1)(1994-12#1)(1994-9#1)(2008-10#2)(2009-9#1)
sequences provided##2##2##(2008-5#1)(2011-1#1)
sequences recently##2##2##(1995-11#1)(2008-8#1)
sequences recognized by##2##3##(1994-12#1)(1995-1#1)
sequences recognized##3##2##(1990-3#1)(1994-12#1)(1995-1#1)
sequences regulating expression of the##2##5##(1991-4#1)(1992-5#1)
sequences related to the##2##4##(1990-11#1)(2008-10#1)
sequences reported##5##2##(1991-5#1)(1993-2#1)(1997-2#1)(2007-3#1)(2008-11#1)
sequences represent##3##2##(1990-1#1)(2008-6#1)(2010-8#1)
sequences representing##5##2##(1991-6#1)(2006-2#1)(2011-1#1)(2013-1#2)
sequences required for##2##3##(1997-3#1)(2008-4#1)
sequences required to##2##3##(1990-9#1)(1994-12#1)
sequences required##4##2##(1990-9#1)(1994-12#1)(1997-3#1)(2008-4#1)
sequences resembling##2##2##(1990-11#1)(1991-12#1)
sequences respectively##2##2##(1991-10#1)(2005-11#1)
sequences responsible for##2##3##(1997-2#1)(2006-12#1)
sequences retrieved from##2##3##(2012-2#1)(2013-8#1)
sequences revealed a##2##3##(1994-11#1)(1994-9#1)
sequences revealed that the##4##4##(1990-12#1)(1993-11#1)(1996-7#1)(1996-9#1)
sequences revealed that##10##3##(1990-12#1)(1991-12#1)(1992-2#1)(1993-11#1)(1993-8#1)(1996-7#1)(1996-9#1)(2008-10#2)(2012-12#1)
sequences revealed the##3##3##(1992-1#1)(1997-5#1)(2013-1#1)
sequences revealed two##2##3##(2008-10#1)(2010-10#1)
sequences revealed##23##2##(1990-12#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-2#1)(1996-10#1)(1996-7#1)(1996-9#1)(1997-5#1)(2008-10#4)(2008-7#1)(2010-10#1)(2012-12#1)(2013-1#1)
sequences reveals that##4##3##(1991-6#1)(1992-3#1)(1993-12#1)(2011-2#1)
sequences reveals##5##2##(1991-6#1)(1992-3#2)(1993-12#1)(2011-2#1)
sequences share##3##2##(1994-12#1)(1995-3#1)(1996-11#1)
sequences show##3##2##(1990-5#1)(1992-4#1)(1992-8#1)
sequences showed that##5##3##(1990-5#1)(1996-3#1)(1996-7#1)(2008-10#1)(2008-12#1)
sequences showed the##2##3##(1992-8#1)(2013-1#1)
sequences showed##12##2##(1990-12#1)(1990-5#1)(1992-8#1)(1995-1#1)(1996-3#1)(1996-7#1)(2006-12#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
sequences similar to the##2##4##(1994-12#1)(2006-12#1)
sequences similar to##5##3##(1993-2#1)(1994-12#1)(2006-12#1)(2006-8#1)(2007-12#1)
sequences specific##2##2##(2006-3#1)(2008-10#1)
sequences strongly##2##2##(1993-8#1)(2008-10#1)
sequences such as##2##3##(1995-4#1)(2013-8#1)
sequences such that##2##3##(1991-9#1)(2013-8#1)
sequences such##4##2##(1991-9#1)(1995-4#1)(2013-8#2)
sequences suggest a##2##3##(1992-2#1)(1992-6#1)
sequences suggest##3##2##(1992-2#1)(1992-6#1)(1994-8#1)
sequences suggests##2##2##(1991-7#1)(2008-1#1)
sequences surrounding the##4##3##(1991-7#1)(1996-5#1)(1996-8#1)(1997-4#1)
sequences surrounding##7##2##(1991-5#1)(1991-7#1)(1995-3#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-4#1)
sequences than##4##2##(1995-8#1)(1996-11#1)(1996-4#1)(2008-10#1)
sequences that are similar to##3##5##(1995-2#1)(2008-9#2)
sequences that are##18##3##(1990-8#1)(1991-6#1)(1992-11#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-3#1)(1994-9#1)(1995-2#2)(1996-3#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#2)(2009-9#1)
sequences that bind##2##3##(1995-8#1)(2006-10#1)
sequences that can##4##3##(1990-11#1)(1996-8#1)(2009-12#1)(2012-2#1)
sequences that cross-link with a given protein are##3##8##(2008-1#1)(2008-2#2)
sequences that differ by##2##4##(2004-1#1)(2008-10#1)
sequences that have##2##3##(2006-12#1)(2009-10#1)
sequences that lie between##2##4##(1994-8#2)
sequences that may##2##3##(1990-9#1)(1996-11#1)
sequences that mediate##2##3##(1995-3#1)(2013-7#1)
sequences that share##2##3##(2007-6#1)(2011-2#1)
sequences that were##4##3##(1990-2#1)(2007-8#1)(2008-10#1)(2010-2#1)
sequences that##62##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-8#2)(1994-9#2)(1995-2#2)(1995-3#1)(1995-8#1)(1996-11#1)(1996-3#2)(1996-4#1)(1996-8#1)(2004-1#1)(2006-10#1)(2006-12#2)(2007-2#1)(2007-6#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-4#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
sequences the##3##2##(1995-3#1)(2008-4#1)(2008-8#1)
sequences to a##2##3##(1994-11#1)(2008-10#1)
sequences to be##4##3##(1991-1#1)(1991-11#1)(2008-8#1)(2011-1#1)
sequences to the##9##3##(1991-5#1)(1992-8#1)(1994-12#1)(1995-3#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)
sequences to##36##2##(1991-1#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-10#1)(1995-3#1)(1996-4#1)(1997-4#1)(2007-8#1)(2008-10#5)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#2)(2009-2#1)(2009-8#1)(2010-7#1)(2011-1#1)(2012-2#1)
sequences up to##5##3##(1991-2#1)(1994-12#1)(1997-2#1)(1997-4#1)(2008-4#1)
sequences upstream from the##2##4##(1990-5#1)(1993-11#1)
sequences upstream of lacZ##2##4##(1997-4#2)
sequences upstream of##3##3##(1995-3#1)(1997-4#2)
sequences upstream##6##2##(1990-5#1)(1993-11#1)(1995-12#1)(1995-3#1)(1997-4#2)
sequences used in##2##3##(1992-6#1)(2008-5#1)
sequences used##3##2##(1992-6#1)(2008-5#1)(2011-2#1)
sequences using fat saturation##2##4##(2007-11#2)
sequences using network BLAST searches##2##5##(2008-4#1)(2008-9#1)
sequences using the##5##3##(1997-7#1)(2008-2#1)(2008-7#1)(2008-9#1)(2012-2#1)
sequences using##18##2##(1997-7#1)(2006-12#1)(2007-11#2)(2007-4#1)(2008-11#1)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-9#2)(2009-8#1)(2012-2#2)
sequences versus##2##2##(1996-4#1)(2011-1#1)
sequences was determined by##2##4##(1996-10#1)(2008-10#1)
sequences was found##3##3##(1992-8#1)(1993-2#1)(1995-6#1)
sequences was isolated##2##3##(1994-12#1)(1994-9#1)
sequences was used to##2##4##(2008-10#1)(2010-3#1)
sequences was##23##2##(1990-5#1)(1991-2#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#2)(1996-4#1)(1996-8#1)(1997-4#1)(2008-10#5)(2010-3#1)
sequences were aligned##2##3##(2008-10#1)(2011-1#1)
sequences were analysed##3##3##(2006-8#2)(2008-7#1)
sequences were analyzed##2##3##(2011-1#1)(2012-2#1)
sequences were collected##2##3##(1995-3#1)(2013-1#1)
sequences were compared to##2##4##(1997-1#1)(1997-2#1)
sequences were compared with##4##4##(1991-5#1)(2008-10#1)(2013-8#2)
sequences were compared##9##3##(1991-5#1)(1997-1#1)(1997-2#1)(2008-10#3)(2008-2#1)(2013-8#2)
sequences were derived from##2##4##(1995-8#1)(2010-2#1)
sequences were designed to##2##4##(1994-9#1)(2008-10#1)
sequences were detected as showing##2##5##(2008-9#2)
sequences were detected##8##3##(1993-4#1)(1993-9#1)(2008-5#1)(2008-9#2)(2009-3#1)(2010-5#1)(2011-2#1)
sequences were determined by##5##4##(1992-3#1)(1994-11#1)(1996-2#1)(1996-5#1)(2008-8#1)
sequences were determined##14##3##(1990-2#1)(1992-11#1)(1992-3#1)(1994-11#1)(1994-12#2)(1996-10#1)(1996-2#1)(1996-5#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-8#2)
sequences were evaluated##2##3##(2006-5#1)(2013-1#1)
sequences were found in##3##4##(1992-2#1)(1993-9#1)(1996-10#1)
sequences were found##6##3##(1992-2#1)(1993-11#1)(1993-5#1)(1993-9#1)(1995-6#1)(1996-10#1)
sequences were generated##3##3##(2008-12#2)(2008-5#1)
sequences were identical##2##3##(2008-12#1)(2011-2#1)
sequences were identified from##2##4##(2008-10#1)(2008-9#1)
sequences were identified##5##3##(1994-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-10#1)
sequences were located in##2##4##(1996-8#1)(2012-3#1)
sequences were not##4##3##(1992-2#1)(1995-2#1)(1996-8#1)(2009-5#1)
sequences were observed##2##3##(1996-4#1)(1996-7#1)
sequences were obtained for##3##4##(1993-6#1)(1996-2#1)(2008-10#1)
sequences were obtained from##3##4##(1997-4#1)(2009-12#1)(2013-8#1)
sequences were obtained##9##3##(1993-2#1)(1993-6#1)(1996-2#1)(1997-3#1)(1997-4#1)(2008-10#1)(2009-12#2)(2013-8#1)
sequences were present in##2##4##(1993-3#1)(2005-10#1)
sequences were related to##2##4##(2006-8#2)
sequences were shown to##3##4##(1993-3#1)(1994-12#1)(1994-9#1)
sequences were tested##3##3##(1995-2#1)(2008-10#1)(2013-1#1)
sequences were used to##4##4##(1997-4#1)(2008-10#1)(2008-5#1)(2012-2#1)
sequences were used##6##3##(1997-4#1)(1997-8#1)(1997-9#1)(2008-10#1)(2008-5#1)(2012-2#1)
sequences were very similar to##2##5##(1992-11#1)(1996-10#1)
sequences were##151##2##(1990-11#1)(1990-2#1)(1991-5#1)(1991-8#2)(1992-11#2)(1992-2#4)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#3)(1994-11#3)(1994-12#6)(1994-3#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#2)(1995-2#4)(1995-3#1)(1995-6#3)(1995-8#3)(1996-10#4)(1996-2#3)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#5)(1997-6#1)(1997-8#2)(1997-9#2)(2005-10#1)(2005-11#1)(2006-12#1)(2006-5#1)(2006-8#6)(2008-10#14)(2008-11#1)(2008-12#3)(2008-2#1)(2008-5#5)(2008-7#2)(2008-8#2)(2008-9#4)(2009-12#2)(2009-3#1)(2009-5#2)(2010-10#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#3)(2013-8#3)
sequences when##2##2##(1995-2#1)(2012-2#1)
sequences whereas##3##2##(1993-3#1)(2008-9#1)(2009-5#1)
sequences which are##6##3##(1991-3#1)(1992-6#1)(1992-9#1)(1994-12#1)(1995-5#1)(2010-7#1)
sequences which##20##2##(1991-12#1)(1991-3#1)(1991-6#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-7#2)(2006-8#1)(2010-7#1)
sequences with a##4##3##(1990-10#1)(1995-7#1)(1997-4#1)(2006-12#1)
sequences with the##6##3##(1992-6#1)(1993-6#1)(1994-12#1)(1995-1#1)(1996-8#2)
sequences with those of##3##4##(1991-12#1)(1995-2#1)(2008-10#1)
sequences with##50##2##(1990-10#1)(1990-11#1)(1991-12#1)(1991-7#3)(1991-8#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-6#3)(1994-12#1)(1995-1#1)(1995-2#3)(1995-7#1)(1996-11#1)(1996-6#1)(1996-8#2)(1997-3#1)(1997-4#2)(2006-12#2)(2006-5#1)(2007-12#1)(2007-8#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#5)(2008-7#3)(2009-2#1)(2009-6#1)(2009-9#1)(2011-3#1)
sequences within a##2##3##(2008-4#1)(2009-3#1)
sequences within the##9##3##(1992-9#1)(1994-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-11#1)(2008-9#1)(2012-2#1)(2012-3#1)
sequences within this##2##3##(1995-3#1)(2008-7#1)
sequences within##22##2##(1990-5#1)(1991-12#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-2#1)(2012-3#1)
sequences##3003##1##(1990-1#7)(1990-10#5)(1990-11#23)(1990-12#20)(1990-2#11)(1990-3#15)(1990-4#16)(1990-5#32)(1990-6#7)(1990-7#11)(1990-8#9)(1990-9#20)(1991-1#8)(1991-10#12)(1991-11#9)(1991-12#33)(1991-2#25)(1991-3#7)(1991-4#11)(1991-5#19)(1991-6#28)(1991-7#27)(1991-8#13)(1991-9#30)(1992-1#4)(1992-10#3)(1992-11#15)(1992-12#23)(1992-2#23)(1992-3#15)(1992-4#9)(1992-5#8)(1992-6#30)(1992-7#18)(1992-8#17)(1992-9#13)(1993-1#2)(1993-11#25)(1993-12#43)(1993-2#17)(1993-3#20)(1993-4#4)(1993-5#18)(1993-6#35)(1993-7#1)(1993-8#15)(1993-9#22)(1994-1#1)(1994-10#3)(1994-11#29)(1994-12#58)(1994-2#4)(1994-3#19)(1994-5#10)(1994-6#27)(1994-8#35)(1994-9#36)(1995-1#16)(1995-10#9)(1995-11#19)(1995-12#9)(1995-2#51)(1995-3#26)(1995-4#6)(1995-5#7)(1995-6#25)(1995-7#2)(1995-8#49)(1995-9#3)(1996-10#39)(1996-11#20)(1996-12#13)(1996-2#22)(1996-3#12)(1996-4#42)(1996-5#11)(1996-6#18)(1996-7#16)(1996-8#29)(1996-9#4)(1997-1#8)(1997-2#39)(1997-3#20)(1997-4#59)(1997-5#11)(1997-6#24)(1997-7#25)(1997-8#17)(1997-9#5)(2004-1#2)(2004-4#1)(2005-10#4)(2005-11#18)(2005-12#2)(2005-7#2)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#16)(2006-11#1)(2006-12#28)(2006-2#3)(2006-3#2)(2006-5#9)(2006-6#2)(2006-8#30)(2007-1#2)(2007-10#3)(2007-11#11)(2007-12#15)(2007-2#3)(2007-3#4)(2007-4#2)(2007-5#2)(2007-6#14)(2007-7#2)(2007-8#14)(2007-9#3)(2008-1#13)(2008-10#281)(2008-11#35)(2008-12#12)(2008-2#48)(2008-3#14)(2008-4#129)(2008-5#45)(2008-6#16)(2008-7#72)(2008-8#52)(2008-9#71)(2009-10#19)(2009-11#1)(2009-12#11)(2009-2#3)(2009-3#5)(2009-4#2)(2009-5#16)(2009-6#3)(2009-8#6)(2009-9#7)(2010-1#1)(2010-10#9)(2010-11#1)(2010-12#6)(2010-2#4)(2010-3#10)(2010-4#9)(2010-5#6)(2010-6#1)(2010-7#12)(2010-8#5)(2010-9#3)(2011-1#18)(2011-10#1)(2011-12#6)(2011-2#31)(2011-3#2)(2012-1#4)(2012-11#2)(2012-12#11)(2012-2#46)(2012-3#18)(2012-7#1)(2013-1#36)(2013-3#1)(2013-7#7)(2013-8#36)
sequences)##6##1##(1990-8#1)(1993-12#1)(1993-8#1)(2008-10#1)(2008-4#1)(2010-12#1)
sequencing a##3##2##(1992-7#1)(2006-10#1)(2010-6#1)
sequencing after##6##2##(1990-2#1)(1990-7#1)(1990-8#1)(1992-3#1)(2012-3#2)
sequencing an##2##2##(1993-2#1)(1996-6#1)
sequencing analysis of##4##3##(1997-1#1)(1997-4#1)(1997-9#1)(2007-12#1)
sequencing analysis revealed##2##3##(1991-2#1)(1992-8#1)
sequencing analysis##8##2##(1991-2#1)(1992-8#1)(1997-1#1)(1997-4#1)(1997-9#1)(2006-12#1)(2007-12#1)(2012-3#1)
sequencing and Southern##3##3##(1992-7#1)(1997-2#1)(2009-12#1)
sequencing and analysis##2##3##(1994-3#1)(2008-8#1)
sequencing and assembly##2##3##(2008-4#1)(2012-3#1)
sequencing and expression of##2##4##(1994-8#1)(1995-6#1)
sequencing and expression##3##3##(1991-5#1)(1994-8#1)(1995-6#1)
sequencing and mass spectrometry##3##4##(1992-6#1)(1993-12#1)(2012-2#1)
sequencing and mass##4##3##(1992-6#1)(1993-12#1)(2011-12#1)(2012-2#1)
sequencing and memory##2##3##(2009-10#2)
sequencing and the##3##3##(1993-9#1)(1994-6#1)(2012-2#1)
sequencing and##68##2##(1990-10#1)(1990-11#1)(1990-12#1)(1991-10#1)(1991-5#1)(1992-6#1)(1992-7#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-10#1)(1995-6#1)(1996-10#1)(1996-4#3)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-5#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#2)(2009-12#1)(2010-10#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-11#1)(2012-2#7)(2012-3#1)(2013-8#3)
sequencing are##4##2##(2008-10#1)(2011-2#1)(2012-11#1)(2012-2#1)
sequencing as##3##2##(1994-2#1)(2008-10#1)(2012-11#1)
sequencing based on##2##3##(1995-7#1)(2012-3#1)
sequencing batch reactors##2##3##(2005-11#1)(2007-6#1)
sequencing batch##3##2##(2005-11#1)(2007-6#1)(2008-5#1)
sequencing by##7##2##(1990-4#1)(1991-2#1)(1993-4#1)(2007-8#1)(2008-2#1)(2009-9#1)(2010-5#1)
sequencing data from##3##3##(2006-5#1)(2012-3#2)
sequencing data##20##2##(1994-6#1)(2006-5#1)(2007-1#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-3#11)
sequencing depth##2##2##(2011-2#1)(2012-2#1)
sequencing device##2##2##(1995-7#1)(2009-7#1)
sequencing effort##3##2##(2008-5#1)(2008-7#1)(2012-3#1)
sequencing efforts##6##2##(2008-10#1)(2008-4#1)(2008-8#1)(2009-5#1)(2011-10#1)(2012-3#1)
sequencing for##4##2##(1990-5#1)(1990-9#1)(1997-7#1)(2012-2#1)
sequencing gel electrophoresis##3##3##(1990-5#1)(1991-4#1)(1994-12#1)
sequencing gel##6##2##(1990-5#1)(1991-4#1)(1994-12#1)(1995-1#1)(2008-4#2)
sequencing gels##2##2##(1991-7#1)(2008-4#1)
sequencing has the potential to##3##5##(2010-6#1)(2012-3#1)(2013-1#1)
sequencing has##9##2##(1994-12#1)(2009-5#1)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#3)(2013-1#1)
sequencing have been##3##3##(1992-3#1)(2008-4#1)(2010-10#1)
sequencing have##6##2##(1992-3#1)(1995-12#1)(2006-10#1)(2008-4#1)(2010-10#1)(2012-3#1)
sequencing identified##2##2##(1992-8#1)(1996-4#1)
sequencing in##6##2##(1995-5#1)(2008-10#1)(2008-11#1)(2009-10#1)(2011-2#1)(2013-1#1)
sequencing indicated that##2##3##(1995-2#1)(2005-11#1)
sequencing is##6##2##(1994-6#1)(1995-8#1)(2005-8#1)(2008-4#1)(2008-7#1)(2010-10#1)
sequencing ladders##2##2##(1995-10#1)(1995-6#1)
sequencing libraries##2##2##(2012-2#2)
sequencing method which uses##2##4##(1995-10#1)(1995-6#1)
sequencing method##8##2##(1992-8#1)(1995-10#2)(1995-12#1)(1995-6#1)(2008-7#1)(2010-4#1)(2011-1#1)
sequencing methods##4##2##(1991-7#1)(1994-6#1)(2008-2#1)(2008-3#1)
sequencing of 16S rDNA##2##4##(2008-10#2)
sequencing of 16S##3##3##(2008-10#2)(2012-2#1)
sequencing of PCR##3##3##(1991-6#1)(2006-8#1)(2008-2#1)
sequencing of a novel##2##4##(1994-2#1)(1995-3#1)
sequencing of a tryptic##2##4##(1991-1#1)(1991-8#1)
sequencing of a##28##3##(1990-11#1)(1990-9#1)(1991-1#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-12#1)(1993-12#1)(1994-12#4)(1994-2#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-2#1)(2008-10#2)(2008-9#1)(2013-1#1)
sequencing of all##2##3##(2008-11#1)(2008-12#1)
sequencing of amplified##2##3##(1994-2#1)(2011-2#1)
sequencing of human##2##3##(1991-3#1)(2008-2#1)
sequencing of its##4##3##(1992-8#1)(1994-3#1)(1997-2#1)(2008-8#1)
sequencing of peptides##2##3##(1990-5#1)(1994-11#1)
sequencing of rat liver##3##4##(1990-5#1)(1991-12#1)(1994-9#1)
sequencing of rat##4##3##(1990-5#1)(1991-12#1)(1994-9#1)(1996-2#1)
sequencing of the amplified fragment##2##5##(1996-8#1)(2008-12#1)
sequencing of the amplified##4##4##(1992-8#1)(1996-8#1)(1997-6#1)(2008-12#1)
sequencing of the cloned##3##4##(1991-1#1)(1991-3#1)(2008-10#1)
sequencing of the entire coding##3##5##(1994-12#1)(1996-2#1)(2011-2#1)
sequencing of the entire##5##4##(1992-7#1)(1994-12#1)(1995-12#1)(1996-2#1)(2011-2#1)
sequencing of the first##2##4##(1995-3#1)(2010-8#1)
sequencing of the fragment##2##4##(1996-4#1)(2008-10#1)
sequencing of the genome##2##4##(2005-8#1)(2012-2#1)
sequencing of the genomes of##3##5##(2008-4#1)(2008-7#1)(2008-8#1)
sequencing of the human genome##5##5##(2005-7#1)(2007-8#1)(2008-4#3)
sequencing of the internal transcribed spacer (ITS)##2##7##(2008-10#1)(2010-10#1)
sequencing of the internal transcribed##3##5##(2008-10#1)(2009-2#1)(2010-10#1)
sequencing of the isolated##2##4##(1992-5#1)(1994-12#1)
sequencing of the large subunit##2##5##(1992-8#1)(2008-10#1)
sequencing of the whole genome##2##5##(2007-3#1)(2012-3#1)
sequencing of the whole##3##4##(2007-3#1)(2008-3#1)(2012-3#1)
sequencing of the##91##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-3#1)(1991-7#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-7#1)(1992-8#3)(1993-11#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-10#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#2)(1997-3#1)(1997-6#2)(1997-7#1)(2005-7#1)(2005-8#1)(2006-6#1)(2007-3#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-4#7)(2008-5#1)(2008-7#3)(2008-8#2)(2009-2#1)(2010-10#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)
sequencing of these##4##3##(1993-11#1)(1995-3#1)(2006-10#1)(2008-10#1)
sequencing of this##4##3##(1990-12#1)(1992-9#1)(1994-12#1)(2008-8#1)
sequencing of two##3##3##(1990-1#1)(1993-5#1)(1996-9#1)
sequencing of whole genomes and##2##5##(2006-11#1)(2012-3#1)
sequencing of##211##2##(1990-1#3)(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#1)(1990-5#3)(1990-9#5)(1991-1#3)(1991-10#4)(1991-11#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#3)(1991-9#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#2)(1992-8#4)(1992-9#1)(1993-11#2)(1993-12#3)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#9)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#2)(1995-3#3)(1995-4#3)(1995-5#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#3)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-8#1)(2008-1#2)(2008-10#17)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#7)(2008-5#2)(2008-7#6)(2008-8#4)(2008-9#1)(2009-2#1)(2010-10#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#3)
sequencing offers a##2##3##(1995-2#1)(2008-3#1)
sequencing on##3##2##(1995-7#1)(2007-8#1)(2013-1#1)
sequencing or##6##2##(1991-6#1)(1992-5#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)
sequencing phase##2##2##(1995-7#1)(2008-7#1)
sequencing primer##2##2##(1990-9#1)(1991-7#1)
sequencing primers##4##2##(1990-11#1)(1991-12#1)(2008-12#2)
sequencing procedure##3##2##(1990-5#1)(1992-7#1)(2011-2#1)
sequencing process##2##2##(2007-1#1)(2008-4#1)
sequencing project##7##2##(1994-11#1)(1995-4#1)(1995-7#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-4#1)
sequencing projects for##2##3##(2007-12#1)(2011-2#1)
sequencing projects##11##2##(1990-9#1)(1995-7#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-8#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
sequencing protocol##3##2##(1995-6#2)(1997-6#1)
sequencing reactions##4##2##(1995-6#2)(1995-7#1)(2008-2#1)
sequencing reads##4##2##(2011-2#1)(2013-8#3)
sequencing results##6##2##(1991-2#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2013-8#1)
sequencing revealed that##3##3##(1990-4#1)(1996-7#1)(1997-3#1)
sequencing revealed##8##2##(1990-4#1)(1992-3#1)(1996-7#1)(1997-3#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
sequencing showed that##5##3##(1991-10#1)(1994-9#1)(1996-9#1)(2006-8#1)(2011-1#1)
sequencing showed the##2##3##(1992-8#1)(1994-9#1)
sequencing showed##8##2##(1990-2#1)(1991-10#1)(1992-8#1)(1994-9#2)(1996-9#1)(2006-8#1)(2011-1#1)
sequencing strategies##3##2##(1995-7#1)(1997-7#1)(2011-2#1)
sequencing strategy##4##2##(1995-7#2)(2008-3#1)(2008-7#1)
sequencing studies##2##2##(1990-11#1)(1995-11#1)
sequencing study##2##2##(2012-2#1)(2012-3#1)
sequencing system##2##2##(1996-4#2)
sequencing technique##6##2##(1990-5#1)(1991-10#1)(1991-7#2)(2013-1#2)
sequencing techniques##4##2##(1997-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
sequencing technologies has##2##3##(2012-2#1)(2013-1#1)
sequencing technologies have##3##3##(2012-12#1)(2012-3#2)
sequencing technologies now##2##3##(2012-2#1)(2012-3#1)
sequencing technologies##19##2##(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#8)(2013-1#3)
sequencing technology##8##2##(2008-4#1)(2010-10#1)(2011-1#1)(2012-3#5)
sequencing the entire##2##3##(1990-8#1)(2012-12#1)
sequencing the genome of##2##4##(2007-9#1)(2012-3#1)
sequencing the genome##3##3##(2007-9#1)(2008-7#1)(2012-3#1)
sequencing the##20##2##(1990-10#1)(1990-8#1)(1992-9#1)(1997-7#1)(2005-8#1)(2007-9#2)(2008-10#3)(2008-7#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#2)
sequencing to identify##3##3##(1997-4#1)(2012-3#1)(2013-8#1)
sequencing to##8##2##(1992-7#1)(1997-4#1)(2011-2#1)(2012-3#4)(2013-8#1)
sequencing using##7##2##(1990-11#1)(1990-5#1)(1995-10#1)(1995-12#1)(2009-11#1)(2012-3#2)
sequencing vector##2##2##(1990-9#2)
sequencing was performed on##2##4##(1994-12#1)(2012-2#1)
sequencing was performed##4##3##(1994-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
sequencing was##5##2##(1994-12#1)(2008-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
sequencing were##4##2##(1992-3#1)(2005-11#1)(2008-12#1)(2008-4#1)
sequencing will##2##2##(2008-10#1)(2009-5#1)
sequencing with##3##2##(1990-7#1)(1995-7#1)(2008-4#1)
sequencing##856##1##(1990-1#3)(1990-10#3)(1990-11#11)(1990-12#6)(1990-2#5)(1990-3#1)(1990-4#3)(1990-5#17)(1990-6#1)(1990-7#4)(1990-8#2)(1990-9#13)(1991-1#3)(1991-10#7)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#6)(1991-7#8)(1991-8#4)(1991-9#5)(1992-11#3)(1992-12#4)(1992-2#2)(1992-3#7)(1992-4#2)(1992-5#3)(1992-6#2)(1992-7#7)(1992-8#8)(1992-9#2)(1993-11#2)(1993-12#6)(1993-2#1)(1993-3#5)(1993-4#3)(1993-5#3)(1993-6#1)(1993-8#2)(1993-9#4)(1994-10#1)(1994-11#4)(1994-12#17)(1994-2#5)(1994-3#6)(1994-5#2)(1994-6#9)(1994-8#6)(1994-9#7)(1995-1#3)(1995-10#7)(1995-11#2)(1995-12#6)(1995-2#4)(1995-3#4)(1995-4#4)(1995-5#3)(1995-6#11)(1995-7#12)(1995-8#7)(1996-10#5)(1996-12#3)(1996-2#3)(1996-3#1)(1996-4#12)(1996-5#2)(1996-6#3)(1996-7#2)(1996-8#5)(1996-9#3)(1997-1#3)(1997-2#7)(1997-3#4)(1997-4#9)(1997-6#6)(1997-7#11)(1997-8#2)(1997-9#1)(2004-2#1)(2005-10#1)(2005-11#8)(2005-12#1)(2005-6#1)(2005-7#1)(2005-8#3)(2006-10#6)(2006-11#2)(2006-12#2)(2006-5#3)(2006-6#1)(2006-8#7)(2007-1#2)(2007-10#1)(2007-12#7)(2007-2#5)(2007-3#2)(2007-6#1)(2007-8#4)(2007-9#3)(2008-1#2)(2008-10#47)(2008-11#5)(2008-12#7)(2008-2#13)(2008-3#7)(2008-4#37)(2008-5#10)(2008-7#28)(2008-8#21)(2008-9#7)(2009-10#5)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#5)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#6)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#2)(2010-8#1)(2011-1#13)(2011-10#1)(2011-12#4)(2011-2#29)(2012-1#2)(2012-11#4)(2012-12#5)(2012-2#33)(2012-3#63)(2013-1#18)(2013-7#3)(2013-8#12)
sequencing)##3##1##(2006-12#1)(2008-4#1)(2010-5#1)
sequential PSCT in LABC##2##4##(2007-5#2)
sequential PSCT##3##2##(2007-5#3)
sequential activation of##4##3##(1994-8#1)(1995-2#1)(2007-9#1)(2011-2#1)
sequential addition of##3##3##(1991-8#1)(1991-9#1)(2006-12#1)
sequential adsorption##2##2##(2005-11#2)
sequential age groups##2##3##(2007-8#2)
sequential analysis of Cd and Zn on the same##2##9##(2008-10#2)
sequential analysis of##5##3##(1996-4#1)(2008-10#4)
sequential analysis##7##2##(1996-4#1)(2008-10#6)
sequential and##12##2##(1990-6#1)(1992-3#1)(1993-2#1)(1993-3#1)(2008-10#2)(2008-7#2)(2009-11#1)(2011-2#1)(2012-1#1)(2012-3#1)
sequential application of##2##3##(2008-10#2)
sequential approach to##2##3##(2006-9#1)(2007-7#1)
sequential approach##5##2##(1997-4#1)(2006-9#1)(2007-7#1)(2008-10#1)(2008-4#1)
sequential arm movements##2##3##(2008-7#2)
sequential assignment of 1H##2##4##(1995-2#1)(1995-5#1)
sequential assignment of##3##3##(1992-12#1)(1995-2#1)(1995-5#1)
sequential assignments##2##2##(1991-4#1)(2008-8#1)
sequential binding##2##2##(1990-7#1)(1994-8#1)
sequential changes in##3##3##(1995-12#1)(2006-4#1)(2007-10#1)
sequential changes##4##2##(1995-12#1)(2006-4#1)(2007-10#1)(2007-9#1)
sequential chemotherapy##6##2##(2007-11#1)(2007-5#2)(2008-5#1)(2010-8#1)(2012-3#1)
sequential chromatographies##2##2##(1992-11#1)(1993-9#1)
sequential chromatography##5##2##(1990-4#1)(1991-12#1)(1991-8#1)(1994-12#1)(1994-8#1)
sequential clinical##2##2##(1994-11#1)(1996-8#1)
sequential column chromatographies##3##3##(1990-3#1)(1997-7#2)
sequential cooperativity##2##2##(1997-2#2)
sequential deletions##2##2##(1990-9#2)
sequential deposition##2##2##(2007-10#1)(2008-10#1)
sequential designs##4##2##(1995-2#2)(1996-12#1)(1997-2#1)
sequential determination of cadmium and lead##2##6##(2008-10#2)
sequential determination of copper and mercury ions in river-water samples##2##10##(2008-10#2)
sequential determination of##16##3##(2008-10#16)
sequential determination##17##2##(2008-10#17)
sequential determinations##2##2##(2008-10#2)
sequential double##2##2##(2008-12#1)(2008-5#1)
sequential elution##3##2##(2008-10#3)
sequential extraction procedure (SEP)##3##4##(2008-10#3)
sequential extraction procedure for##6##4##(2008-10#6)
sequential extraction procedure##17##3##(2008-10#16)(2011-2#1)
sequential extraction procedures##3##3##(2008-10#3)
sequential extraction protocol##2##3##(2008-10#2)
sequential extraction scheme##2##3##(2008-10#2)
sequential extraction test##3##3##(2008-10#3)
sequential extraction to##2##3##(2007-10#1)(2008-10#1)
sequential extraction##41##2##(2007-10#1)(2008-10#39)(2011-2#1)
sequential flow injection##2##3##(2008-10#2)
sequential flow##4##2##(2008-10#4)
sequential formation of##2##3##(1995-6#1)(1997-7#1)
sequential fractionation##2##2##(1996-8#1)(2008-4#1)
sequential inductively coupled plasma atomic emission##2##6##(2008-10#2)
sequential inductively coupled plasma##3##4##(2008-10#3)
sequential information##2##2##(2008-11#1)(2012-3#1)
sequential injection (SI)##7##3##(2008-10#7)
sequential injection (SIA)##3##3##(2008-10#3)
sequential injection analysis (SIA) and##3##5##(2008-10#3)
sequential injection analysis (SIA) methodology for the fluorimetric determination of##2##10##(2008-10#2)
sequential injection analysis (SIA) system is proposed for the determination of##2##11##(2008-10#2)
sequential injection analysis (SIA) system is##4##6##(2008-10#4)
sequential injection analysis (SIA) system##8##5##(2008-10#8)
sequential injection analysis (SIA) technique##2##5##(2008-10#2)
sequential injection analysis (SIA) was##2##5##(2008-10#2)
sequential injection analysis (SIA)##29##4##(2007-8#1)(2008-10#28)
sequential injection analysis for##2##4##(2008-10#2)
sequential injection analysis system##9##4##(2008-10#6)(2008-5#3)
sequential injection analysis technique##3##4##(2007-8#1)(2008-10#2)
sequential injection analysis using##2##4##(2008-10#2)
sequential injection analysis was##2##4##(2008-10#2)
sequential injection analysis##65##3##(2007-8#2)(2008-10#60)(2008-5#3)
sequential injection chromatography (SIC)##3##4##(2008-10#3)
sequential injection chromatography##5##3##(2008-10#5)
sequential injection determination of##2##4##(2008-10#2)
sequential injection extraction##2##3##(2008-10#2)
sequential injection lab-on-valve (SI-LOV) system##2##5##(2008-10#2)
sequential injection method##3##3##(2008-10#3)
sequential injection mode##2##3##(2008-10#2)
sequential injection of##2##3##(2008-10#1)(2008-4#1)
sequential injection spectrophotometric determination of##2##5##(2008-10#2)
sequential injection spectrophotometric method for the assay of##2##8##(2008-10#2)
sequential injection spectrophotometric method for the determination of##2##8##(2008-10#2)
sequential injection spectrophotometric method for the##4##6##(2008-10#4)
sequential injection spectrophotometric method##5##4##(2008-10#5)
sequential injection spectrophotometric##8##3##(2008-10#8)
sequential injection system for the##4##5##(2008-10#4)
sequential injection system for trace mercury determination##2##7##(2008-10#2)
sequential injection system for##8##4##(2008-10#8)
sequential injection system##20##3##(2008-10#20)
sequential injection systems##3##3##(2008-10#3)
sequential injection technique##4##3##(2007-8#1)(2008-10#3)
sequential injection titration system##2##4##(2008-10#2)
sequential injection titration##4##3##(2008-10#4)
sequential injection##160##2##(2007-8#6)(2008-10#150)(2008-4#1)(2008-5#3)
sequential inoculations with the##2##4##(2008-10#2)
sequential integration##3##2##(2009-9#3)
sequential leaching##5##2##(2007-8#1)(2008-10#4)
sequential manner##5##2##(1994-9#1)(1995-6#1)(2007-12#1)(2008-10#1)(2011-12#1)
sequential method##3##2##(1992-3#1)(2007-8#1)(2008-10#1)
sequential methods##2##2##(1994-9#1)(2006-4#1)
sequential monitoring##3##2##(1993-4#1)(1995-2#1)(1997-3#1)
sequential or##5##2##(1992-8#1)(1996-10#1)(2010-12#1)(2011-2#1)(2012-2#1)
sequential patients##2##2##(1991-1#1)(2008-6#1)
sequential probability ratio##3##3##(1996-12#1)(2008-10#2)
sequential procedure##2##2##(2008-10#1)(2012-2#1)
sequential procedures##2##2##(1994-9#1)(1996-12#1)
sequential reaction of##2##3##(2008-10#1)(2009-3#1)
sequential reaction##4##2##(1990-7#1)(2008-10#1)(2009-3#2)
sequential reactions##2##2##(1995-12#1)(2008-10#1)
sequential sampling##4##2##(2008-10#4)
sequential schedule##2##2##(2004-12#2)
sequential separation##4##2##(2008-10#4)
sequential simplex optimization##2##3##(2008-10#2)
sequential simplex##4##2##(2008-10#4)
sequential stages##2##2##(1993-1#1)(2006-9#1)
sequential steps of##3##3##(1991-9#1)(1994-9#1)(2010-4#1)
sequential steps##8##2##(1991-9#1)(1994-9#2)(2005-11#1)(2008-10#1)(2009-11#1)(2010-4#1)(2011-2#1)
sequential stereoselective action##2##3##(1992-11#2)
sequential studies##2##2##(2007-5#1)(2007-6#1)
sequential tandem mass spectrometry##2##4##(2007-1#2)
sequential test##2##2##(1996-12#1)(2008-10#1)
sequential tests##2##2##(1994-9#1)(1997-2#1)
sequential therapy##3##2##(1996-11#1)(2010-11#2)
sequential transcription##3##2##(2008-11#3)
sequential treatment with##2##3##(1992-12#1)(2012-1#1)
sequential treatment##5##2##(1992-12#1)(2007-8#1)(2008-5#1)(2012-1#1)(2012-2#1)
sequential treatments of##2##3##(2007-6#2)
sequential treatments with##2##3##(2005-7#1)(2011-2#1)
sequential treatments##4##2##(2005-7#1)(2007-6#2)(2011-2#1)
sequential use of a##3##4##(2007-12#1)(2008-10#1)(2008-12#1)
sequential use of the##3##4##(1993-6#1)(2005-8#1)(2007-7#1)
sequential use of##8##3##(1993-12#1)(1993-6#1)(2005-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2010-12#1)
sequential use##10##2##(1993-12#1)(1993-6#1)(2005-8#1)(2007-12#1)(2007-6#2)(2007-7#1)(2008-10#1)(2008-12#1)(2010-12#1)
sequential##697##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#5)(1991-9#4)(1992-1#1)(1992-11#5)(1992-12#5)(1992-3#3)(1992-5#2)(1992-7#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#2)(1993-9#4)(1994-10#1)(1994-11#4)(1994-12#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#7)(1994-9#7)(1995-1#2)(1995-11#1)(1995-12#4)(1995-2#10)(1995-3#2)(1995-4#2)(1995-5#1)(1995-6#4)(1995-8#2)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#6)(1996-2#4)(1996-4#2)(1996-5#3)(1996-7#3)(1996-8#2)(1997-1#2)(1997-2#5)(1997-3#7)(1997-4#1)(1997-6#1)(1997-7#5)(1997-8#3)(2004-12#2)(2005-11#4)(2005-7#2)(2005-8#3)(2006-10#1)(2006-12#1)(2006-4#3)(2006-6#2)(2006-9#3)(2007-1#2)(2007-10#3)(2007-11#9)(2007-12#7)(2007-2#1)(2007-3#1)(2007-5#10)(2007-6#5)(2007-7#2)(2007-8#16)(2007-9#4)(2008-1#1)(2008-10#304)(2008-11#11)(2008-12#3)(2008-2#6)(2008-3#4)(2008-4#11)(2008-5#9)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#2)(2009-3#4)(2009-8#1)(2009-9#5)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#12)(2012-1#2)(2012-12#2)(2012-2#17)(2012-3#6)(2013-1#8)
sequential-injection analysis##3##2##(2008-10#3)
sequential-injection system##2##2##(2008-10#2)
sequential-injection##5##1##(2008-10#5)
sequential-stage ultrafiltration##3##2##(2008-10#3)
sequentially and##2##2##(2007-12#1)(2013-7#1)
sequentially at##2##2##(2007-10#1)(2008-3#1)
sequentially by##3##2##(1990-9#1)(2008-3#2)
sequentially deleted peptides##2##3##(1997-6#2)
sequentially deleted##3##2##(1993-11#1)(1997-6#2)
sequentially denatured##2##2##(1990-7#1)(1995-5#1)
sequentially diverged##2##2##(1991-4#1)(1991-5#1)
sequentially in the##2##3##(1990-9#1)(1992-11#1)
sequentially in##7##2##(1990-9#1)(1992-11#1)(1992-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-8#1)
sequentially inserted as##2##3##(2008-10#1)(2008-9#1)
sequentially to##3##2##(1991-9#1)(1994-5#1)(2011-12#1)
sequentially with##3##2##(1992-8#1)(1993-7#1)(2008-8#1)
sequentially##115##1##(1990-10#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-4#1)(1991-5#2)(1991-9#1)(1992-11#4)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-7#2)(1994-3#1)(1994-5#1)(1994-6#2)(1995-5#1)(1995-8#1)(1996-3#2)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#2)(2005-11#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#21)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-12#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#4)(2012-3#2)(2013-7#1)(2013-8#1)
sequester##15##1##(1990-7#1)(1991-3#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-1#1)(1996-10#1)(1996-7#1)(2008-10#3)(2008-5#1)(2009-12#1)(2010-6#1)(2012-1#1)
sequestered Ca2+ was##2##3##(1991-8#2)
sequestered Ca2+##3##2##(1991-6#1)(1991-8#2)
sequestered by##5##2##(1990-2#1)(1995-2#1)(1997-6#1)(2008-10#2)
sequestered disc##2##2##(2006-8#1)(2007-1#1)
sequestered in##3##2##(1996-12#1)(1996-5#1)(2013-1#1)
sequestered into##4##2##(1994-8#1)(2008-11#1)(2009-3#1)(2010-11#1)
sequestered intracellular##2##2##(1994-8#1)(2013-1#1)
sequestered##33##1##(1990-2#1)(1990-5#1)(1990-7#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-12#1)(1992-6#3)(1994-11#1)(1994-8#2)(1995-11#1)(1995-2#1)(1996-12#2)(1996-5#1)(1997-6#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-8#1)(2008-10#3)(2008-11#1)(2009-3#1)(2010-11#1)(2013-1#2)
sequestering of##2##2##(1994-3#1)(2009-7#1)
sequestering resin was##2##3##(2008-10#2)
sequestering##20##1##(1990-11#1)(1992-8#1)(1993-9#2)(1994-12#1)(1994-3#1)(2006-10#1)(2006-12#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#1)(2009-7#1)(2012-2#1)
sequesters the##2##2##(1991-9#1)(2008-11#1)
sequesters##6##1##(1991-9#2)(1994-8#1)(1995-2#1)(1996-2#1)(2008-11#1)
sequestrant##5##1##(1991-6#1)(2005-9#2)(2006-5#1)(2008-7#1)
sequestrate##2##1##(2010-6#1)(2013-8#1)
sequestrated##2##1##(2009-3#2)
sequestration and##5##2##(1993-12#2)(1995-11#1)(2007-8#1)(2008-10#1)
sequestration by##4##2##(1990-2#1)(1996-1#2)(2013-1#1)
sequestration in##3##2##(1991-6#1)(1997-1#1)(2013-8#1)
sequestration is a##2##3##(2007-8#1)(2010-12#1)
sequestration is##3##2##(2006-8#1)(2007-8#1)(2010-12#1)
sequestration of the##2##3##(1995-11#1)(2009-12#1)
sequestration of##16##2##(1992-2#1)(1994-8#2)(1995-11#3)(1996-3#1)(1996-4#1)(1997-4#1)(2006-5#2)(2008-5#1)(2009-12#1)(2010-1#1)(2012-12#2)
sequestration with##4##2##(2013-1#4)
sequestration##66##1##(1990-2#1)(1991-6#3)(1992-2#1)(1993-12#2)(1994-8#2)(1995-11#6)(1996-1#4)(1996-3#1)(1996-4#1)(1997-1#1)(1997-4#2)(2006-5#2)(2006-7#2)(2006-8#3)(2007-10#1)(2007-2#3)(2007-8#4)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2009-12#1)(2010-1#1)(2010-12#4)(2012-12#3)(2012-2#1)(2013-1#9)(2013-8#1)
ser##6##1##(1994-3#1)(1997-3#4)(2005-11#1)
ser/thr##2##1##(1997-3#1)(2007-12#1)
sera (n =##3##3##(1990-8#1)(1996-12#1)(2010-4#1)
sera after##3##2##(1991-9#2)(2008-5#1)
sera also##2##2##(1990-10#1)(1993-8#1)
sera and##13##2##(1990-8#1)(1991-5#1)(1992-8#1)(1994-6#1)(1995-2#1)(1996-8#1)(2006-2#1)(2007-2#2)(2007-8#1)(2008-10#2)(2008-11#1)
sera as##2##2##(1992-12#1)(2008-8#1)
sera at##2##2##(1992-3#1)(2006-10#1)
sera by##3##2##(2008-3#2)(2010-6#1)
sera collected at##2##3##(2008-1#1)(2008-8#1)
sera collected from##3##3##(2008-3#1)(2008-4#1)(2011-1#1)
sera collected##7##2##(2005-7#1)(2007-2#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-1#1)
sera contain##2##2##(1992-9#1)(1993-11#1)
sera contained##2##2##(1992-9#1)(2005-12#1)
sera did not##2##3##(1992-12#1)(1995-6#1)
sera diluted##2##2##(2008-10#1)(2010-4#1)
sera for the##2##3##(1992-12#1)(2008-11#1)
sera for##7##2##(1992-12#1)(2005-10#1)(2006-10#1)(2008-11#1)(2008-4#1)(2009-4#1)(2011-2#1)
sera from all##2##3##(1991-5#1)(2011-2#1)
sera from cancer patients##2##4##(1994-3#1)(2008-4#1)
sera from dogs with##2##4##(2005-8#2)
sera from experimentally vaccinated##2##4##(1996-12#1)(2008-5#1)
sera from healthy controls##2##4##(1996-8#1)(2005-10#1)
sera from healthy##5##3##(1992-11#1)(1992-4#1)(1996-1#1)(1996-8#1)(2005-10#1)
sera from normal##2##3##(1996-12#1)(2005-8#1)
sera from patients in##2##4##(1991-12#1)(1993-11#1)
sera from patients with##16##4##(1990-1#1)(1990-5#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1994-3#1)(1995-1#1)(1996-11#1)(1996-12#1)(1996-4#1)(2007-1#1)
sera from patients##22##3##(1990-1#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1993-11#2)(1993-12#1)(1993-2#2)(1994-3#1)(1995-1#1)(1996-11#1)(1996-12#1)(1996-4#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-5#1)
sera from the##2##3##(1994-3#1)(2011-1#1)
sera from##85##2##(1990-1#1)(1990-10#2)(1990-4#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#3)(1991-7#2)(1991-8#1)(1991-9#3)(1992-11#3)(1992-3#1)(1992-4#1)(1993-10#2)(1993-11#3)(1993-12#1)(1993-2#2)(1993-8#1)(1994-11#1)(1994-3#3)(1994-6#1)(1995-1#1)(1996-1#1)(1996-11#3)(1996-12#3)(1996-4#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-7#1)(2005-10#1)(2005-8#3)(2005-9#1)(2006-10#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#4)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-5#1)(2013-8#1)
sera in##7##2##(1992-8#1)(1994-5#1)(1996-4#1)(2005-12#1)(2007-11#1)(2008-5#1)(2010-12#1)
sera obtained from##2##3##(1992-3#1)(2007-10#1)
sera obtained##4##2##(1992-3#1)(2007-10#1)(2008-11#2)
sera of 50 patients##2##4##(1995-4#1)(2009-9#1)
sera of healthy blood bank donors##2##6##(1994-3#2)
sera of patients with##12##4##(1990-1#1)(1990-12#2)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-3#2)(2007-1#1)(2008-10#1)
sera of patients##15##3##(1990-1#1)(1990-11#1)(1990-12#2)(1991-2#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-3#2)(2007-1#1)(2007-8#1)(2008-10#1)
sera of##54##2##(1990-1#1)(1990-11#1)(1990-12#2)(1990-4#1)(1991-2#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-1#2)(1993-10#2)(1993-11#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-3#8)(1995-2#1)(1995-4#1)(1996-10#1)(1996-3#1)(1996-4#2)(1997-4#1)(2005-8#1)(2006-10#1)(2006-9#2)(2007-1#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-9#1)(2011-12#1)(2013-8#1)
sera or##2##2##(1992-8#1)(1992-9#1)
sera positive for##3##3##(2007-8#3)
sera recognize##2##2##(1995-2#2)
sera samples##3##2##(2006-10#1)(2008-12#1)(2008-3#1)
sera showed a##2##3##(1993-10#1)(2008-11#1)
sera showed##5##2##(1993-10#1)(1996-12#1)(2005-9#1)(2008-11#1)(2012-12#1)
sera taken##2##2##(2008-5#2)
sera to##4##2##(1997-5#1)(1997-6#1)(2012-3#1)(2013-7#1)
sera using##3##2##(1990-12#1)(2007-8#1)(2008-10#1)
sera was##2##2##(1996-4#1)(2012-12#1)
sera were negative##2##3##(1997-6#1)(2007-2#1)
sera were positive for##2##4##(2006-10#1)(2007-8#1)
sera were positive##3##3##(2006-10#1)(2007-2#1)(2007-8#1)
sera were tested for##3##4##(2007-7#1)(2008-9#1)(2012-2#1)
sera were tested##4##3##(1996-12#1)(2007-7#1)(2008-9#1)(2012-2#1)
sera were##18##2##(1990-12#1)(1992-4#1)(1995-2#2)(1996-12#1)(1997-6#1)(2006-10#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-9#1)(2012-2#1)(2013-8#2)
sera with##5##2##(1990-12#1)(1995-2#2)(1995-6#1)(2008-3#1)
sera##383##1##(1990-1#2)(1990-10#3)(1990-11#1)(1990-12#10)(1990-2#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#7)(1991-12#1)(1991-2#3)(1991-5#4)(1991-7#4)(1991-8#5)(1991-9#8)(1992-1#2)(1992-11#4)(1992-12#6)(1992-2#1)(1992-3#6)(1992-4#4)(1992-6#2)(1992-8#10)(1992-9#4)(1993-1#3)(1993-10#6)(1993-11#7)(1993-12#2)(1993-2#3)(1993-3#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#12)(1994-5#3)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#3)(1995-12#1)(1995-2#16)(1995-3#1)(1995-4#1)(1995-6#2)(1996-1#3)(1996-10#1)(1996-11#3)(1996-12#10)(1996-3#1)(1996-4#7)(1996-8#3)(1997-2#5)(1997-3#4)(1997-4#3)(1997-5#4)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#2)(2005-11#1)(2005-12#4)(2005-7#1)(2005-8#5)(2005-9#3)(2006-10#9)(2006-2#1)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#5)(2007-12#2)(2007-2#10)(2007-7#3)(2007-8#10)(2008-1#2)(2008-10#16)(2008-11#12)(2008-12#2)(2008-3#7)(2008-4#4)(2008-5#15)(2008-7#1)(2008-8#6)(2008-9#3)(2009-4#1)(2009-6#1)(2009-9#2)(2010-12#3)(2010-4#5)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#3)(2013-7#1)(2013-8#4)
sera)##2##1##(1995-2#1)(2008-10#1)
serendipitous discovery##2##2##(1994-11#1)(2008-7#1)
serendipitous##5##1##(1993-11#1)(1994-11#1)(2006-10#1)(2008-7#2)
serendipitously##2##1##(1996-5#1)(2007-2#1)
sergenti##3##1##(2004-11#3)
sergentii##4##1##(2011-1#4)
serglycin##4##1##(1995-3#4)
serial CT scans##2##3##(1990-12#1)(2010-1#1)
serial CT##3##2##(1990-12#1)(2010-1#1)(2010-12#1)
serial ECGs##3##2##(2007-2#1)(2009-3#1)(2012-12#1)
serial HBV DNA##2##3##(2012-1#2)
serial MR##2##2##(1996-6#1)(2005-10#1)
serial PET##2##2##(1996-5#1)(1997-8#1)
serial analysis of gene expression##2##5##(2008-1#1)(2008-4#1)
serial analysis##4##2##(1995-1#2)(2008-1#1)(2008-4#1)
serial angiography##2##2##(1993-6#1)(2008-7#1)
serial assessment of##2##3##(2009-10#1)(2012-5#1)
serial block-based##2##2##(2008-2#2)
serial blood collections##2##3##(1994-3#1)(2007-2#1)
serial blood samples##4##3##(1992-3#1)(1994-3#1)(2008-6#1)(2008-8#1)
serial blood##8##2##(1992-3#1)(1994-3#2)(1996-12#1)(2007-2#1)(2008-6#1)(2008-8#1)(2009-4#1)
serial deletants and chimeras of##2##5##(2008-8#2)
serial determination of##2##3##(1991-6#1)(2006-8#1)
serial diluted##2##2##(2008-11#1)(2008-4#1)
serial dilution assay##2##3##(1992-6#1)(2008-10#1)
serial dilution##4##2##(1992-6#1)(2008-10#2)(2012-3#1)
serial dilutions of##4##3##(1994-3#2)(2008-6#1)(2013-8#1)
serial dilutions##9##2##(1994-3#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#1)(2012-2#1)(2013-8#1)
serial fiber-optic##2##2##(2007-10#1)(2008-3#1)
serial imaging##2##2##(2005-5#1)(2006-12#1)
serial lectin column chromatography##2##4##(1991-2#1)(1993-11#1)
serial magnetic resonance imaging##2##4##(2006-10#1)(2007-10#1)
serial magnetic resonance##3##3##(2006-10#1)(2006-12#1)(2007-10#1)
serial measurements##2##2##(1993-11#1)(2004-11#1)
serial monitoring of##2##3##(2010-1#1)(2012-2#1)
serial number##2##2##(2010-12#1)(2011-2#1)
serial passage in##4##3##(2008-10#2)(2013-8#2)
serial passage of the virus##2##5##(1994-10#2)
serial passage##7##2##(1990-5#1)(1994-10#2)(2008-10#2)(2013-8#2)
serial passages in##3##3##(1991-7#1)(2008-10#1)(2013-1#1)
serial passages##5##2##(1991-7#1)(1994-8#1)(1995-5#1)(2008-10#1)(2013-1#1)
serial pattern##2##2##(1995-12#2)
serial plaque transfers##2##3##(1996-11#2)
serial positions##2##2##(1994-3#1)(2007-12#1)
serial samples##2##2##(1990-1#2)
serial search##4##2##(2008-1#4)
serial section analysis##2##3##(1991-9#1)(1996-9#1)
serial section##3##2##(1991-9#1)(1996-9#1)(2009-11#1)
serial sectioning##6##2##(1990-6#1)(1995-10#1)(2008-4#1)(2010-7#1)(2011-2#1)(2012-3#1)
serial sections and##2##3##(2008-10#1)(2008-7#1)
serial sections##9##2##(1990-12#1)(1995-8#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-3#1)
serial subtraction##2##2##(2008-7#2)
serial transplantation##3##2##(1992-2#1)(1994-3#1)(2011-2#1)
serial transverse sections##2##3##(2011-2#2)
serial ultrathin sections##2##3##(1995-7#1)(1997-2#1)
serial##224##1##(1990-1#3)(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-2#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-6#1)(1993-8#1)(1994-10#2)(1994-3#6)(1994-5#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#3)(2004-11#1)(2005-10#2)(2005-12#1)(2005-5#1)(2006-10#4)(2006-12#3)(2006-5#1)(2006-8#1)(2007-10#8)(2007-11#1)(2007-12#6)(2007-2#2)(2007-7#2)(2007-8#3)(2008-1#8)(2008-10#14)(2008-11#6)(2008-12#1)(2008-2#8)(2008-3#5)(2008-4#9)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#6)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-1#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#11)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#3)(2012-5#1)(2013-1#4)(2013-8#4)
serial-to-parallel##2##1##(2008-2#2)
serialis infection##2##2##(1991-9#1)(2012-2#1)
serialis##3##1##(1991-9#1)(2007-2#1)(2012-2#1)
serially connected##2##2##(2008-10#2)
serially correlated##2##2##(1992-2#1)(1994-10#1)
serially diluted##2##2##(2008-10#1)(2008-11#1)
serially homologous##3##2##(2007-12#3)
serially passaged##2##2##(2013-1#2)
serially sectioned##3##2##(1993-12#1)(2006-11#1)(2011-2#1)
serially##33##1##(1990-9#1)(1991-12#1)(1991-6#1)(1992-2#1)(1992-6#1)(1993-12#1)(1994-10#1)(1996-3#1)(1997-2#1)(1997-7#1)(1997-8#2)(2006-11#1)(2006-9#1)(2007-12#4)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#1)(2011-2#2)(2012-2#3)(2013-1#2)
serials budget##2##2##(1996-1#2)
serials retrenchment##3##2##(1996-1#3)
serials##7##1##(1996-1#7)
sericata and##2##2##(2010-3#2)
sericata##4##1##(2010-3#2)(2013-1#2)
sericea##4##1##(2005-10#4)
sericin was##2##2##(2008-11#2)
sericin##10##1##(2008-11#10)
series a##2##2##(2007-11#1)(2011-2#1)
series and literature##2##3##(2007-7#1)(2012-12#1)
series and the##4##3##(1995-11#1)(1995-3#1)(2007-11#1)(2008-10#1)
series and##26##2##(1991-12#1)(1993-5#1)(1995-11#1)(1995-3#1)(2005-11#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-7#4)(2008-10#2)(2008-2#4)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-2#1)(2012-12#1)(2012-2#1)
series approach##3##2##(1994-6#2)(2010-9#1)
series are also##2##3##(1992-5#1)(2005-8#1)
series are##9##2##(1992-2#1)(1992-5#1)(1995-3#1)(2005-8#2)(2007-11#1)(2007-5#1)(2008-3#1)(2010-12#1)
series as##4##2##(1996-9#1)(1997-4#1)(2008-10#1)(2013-8#1)
series at##6##2##(1995-11#1)(1995-8#1)(2006-11#1)(2008-10#1)(2012-2#1)(2013-7#1)
series before the##2##3##(2008-10#1)(2008-7#1)
series bulk acoustic wave##3##4##(2008-10#3)
series by##3##2##(2008-2#1)(2008-6#1)(2010-1#1)
series consisted of##6##3##(1996-9#1)(2005-11#1)(2006-10#1)(2007-7#1)(2008-7#1)(2013-1#1)
series data##7##2##(1992-2#1)(1993-3#1)(2007-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-2#1)
series designed to provide emergency physicians with the background necessary to locate##2##12##(2007-5#2)
series elastic##3##2##(2012-1#3)
series expansion##8##2##(2008-10#1)(2008-2#4)(2008-3#1)(2009-9#1)(2011-1#1)
series for an##2##3##(2006-12#1)(2008-3#1)
series for the##2##3##(1993-2#1)(2010-8#1)
series for##11##2##(1990-6#1)(1990-7#2)(1993-2#1)(1994-12#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#1)(2011-1#1)
series from##6##2##(1994-6#1)(2006-12#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
series had##3##2##(1995-3#2)(2010-2#1)
series have been##2##3##(2008-11#2)
series have suggested that##2##4##(2006-11#2)
series have##8##2##(1996-2#1)(2005-8#1)(2006-11#2)(2008-11#2)(2008-6#1)(2008-8#1)
series in the##3##3##(1995-3#2)(2005-11#1)
series in which##4##3##(2006-3#1)(2006-7#2)(2013-1#1)
series in##18##2##(1992-4#1)(1995-3#2)(1996-2#1)(1997-3#1)(2005-11#1)(2006-3#1)(2006-7#2)(2008-2#3)(2008-3#2)(2011-2#2)(2012-2#1)(2013-1#1)
series included##2##2##(2011-1#1)(2013-8#1)
series is##13##2##(1991-12#1)(1993-2#1)(1994-7#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-1#1)(2013-8#1)
series learning##2##2##(2008-3#2)
series method##3##2##(2008-2#1)(2008-3#2)
series model##4##2##(1994-8#1)(2007-3#1)(2008-6#1)(2011-2#1)
series of 1##6##3##(1995-4#1)(1996-3#1)(2007-11#2)(2008-10#1)(2008-11#1)
series of 10 patients##3##4##(2006-5#1)(2006-9#1)(2009-4#1)
series of 10 procedures##2##4##(2007-8#2)
series of 10##10##3##(1994-8#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-8#2)(2008-10#2)(2009-4#1)(2010-2#1)
series of 100 consecutive##2##4##(2006-12#1)(2007-1#1)
series of 14##2##3##(1990-12#1)(1991-9#1)
series of 15##2##3##(2008-10#1)(2009-3#1)
series of 150##3##3##(1990-12#2)(1996-2#1)
series of 16##2##3##(1995-11#1)(2008-5#1)
series of 18##3##3##(1990-2#1)(2004-1#1)(2008-10#1)
series of 19##2##3##(2007-11#1)(2008-10#1)
series of 20##6##3##(2008-10#2)(2008-7#2)(2008-9#1)(2011-2#1)
series of 22##2##3##(2007-11#1)(2007-12#1)
series of 25##3##3##(2006-12#1)(2008-2#1)(2008-9#1)
series of 250##2##3##(2008-7#1)(2012-5#1)
series of 3##2##3##(1993-4#1)(2008-4#1)
series of 30##5##3##(1990-3#1)(1990-8#1)(2006-5#1)(2008-7#1)(2010-8#1)
series of 31##2##3##(1990-11#1)(2008-6#1)
series of 41 patients with##2##5##(1990-12#1)(2006-12#1)
series of 45##2##3##(1996-3#1)(2013-1#1)
series of 49 patients##2##4##(1996-1#1)(2007-7#1)
series of 66##3##3##(2006-5#1)(2009-5#1)(2012-12#1)
series of 7##3##3##(1991-12#1)(1991-2#1)(1994-7#1)
series of 76##2##3##(1990-6#1)(2008-7#1)
series of 8##2##3##(2007-10#1)(2009-4#1)
series of Chinese##2##3##(1993-9#1)(2008-10#1)
series of DNA##3##3##(1990-4#1)(1992-2#1)(2008-7#1)
series of N##3##3##(2005-11#1)(2007-10#1)(2009-4#1)
series of N-terminal##3##3##(1990-6#1)(1995-3#1)(1997-6#1)
series of acyclic##2##3##(2008-10#2)
series of alkyl##2##3##(1992-3#1)(1995-3#1)
series of analogs of##3##4##(1990-3#1)(1990-5#1)(1994-9#1)
series of analogs##4##3##(1990-3#1)(1990-5#1)(1994-9#1)(1995-3#1)
series of analogues##3##3##(1991-7#1)(1994-8#1)(1995-7#1)
series of animal##3##3##(2006-6#1)(2007-11#1)(2010-4#1)
series of aqueous solutions##2##4##(2008-10#1)(2008-5#1)
series of arecoline##2##3##(1992-10#2)
series of articles##8##3##(1992-4#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-12#1)(2007-11#1)(2007-2#1)(2010-2#1)
series of blood##3##3##(1992-1#1)(1995-1#1)(1996-6#1)
series of case##3##3##(2006-7#1)(2006-8#1)(2012-1#1)
series of case-control studies conducted in##2##6##(1990-8#1)(1991-5#1)
series of case-control studies##3##4##(1990-8#1)(1991-5#1)(2009-12#1)
series of cases and##2##4##(1993-10#1)(2012-12#1)
series of cases##9##3##(1990-10#1)(1991-12#1)(1993-10#1)(2005-8#1)(2005-9#1)(2006-12#1)(2007-8#1)(2007-9#1)(2012-12#1)
series of cloning vectors##2##4##(1995-8#2)
series of complexes##3##3##(1996-2#1)(2008-3#2)
series of compounds as##2##4##(1994-8#1)(1995-1#1)
series of compounds in##2##4##(1992-1#1)(2008-3#1)
series of compounds were##2##4##(1992-8#1)(2013-8#1)
series of compounds##19##3##(1990-8#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-8#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-7#2)(2008-10#1)(2008-3#2)(2008-8#1)(2009-2#1)(2010-11#1)(2012-12#1)(2013-8#1)
series of criteria##2##3##(1996-3#1)(2011-2#1)
series of cultured##3##3##(1990-10#1)(2012-11#2)
series of cyclic##2##3##(1996-8#1)(2009-8#1)
series of deletion mutants##3##4##(1996-5#1)(1996-8#1)(1997-7#1)
series of deletion##4##3##(1995-3#1)(1996-5#1)(1996-8#1)(1997-7#1)
series of deletions##3##3##(1991-10#1)(2008-9#1)(2011-1#1)
series of derivatives##2##3##(1997-7#1)(2008-5#1)
series of developmental##2##3##(2008-11#1)(2008-7#1)
series of dinuclear complexes is##2##5##(1997-7#2)
series of dinuclear complexes##3##4##(1997-7#3)
series of dinuclear##6##3##(1995-11#1)(1997-7#3)(2010-5#2)
series of eight##2##3##(2007-11#1)(2007-9#1)
series of events leading##2##4##(1990-6#1)(2010-3#1)
series of events##11##3##(1990-6#1)(1992-8#1)(1997-1#1)(2005-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)
series of experimental##5##3##(2006-11#1)(2006-6#1)(2007-5#1)(2008-7#1)(2012-12#1)
series of experiments conducted##2##4##(2008-10#1)(2008-12#1)
series of experiments in##2##4##(1992-9#1)(1993-7#1)
series of experiments on##2##4##(1997-8#1)(2010-4#1)
series of experiments the##2##4##(2008-11#1)(2008-2#1)
series of experiments was conducted##3##5##(1997-4#1)(1997-8#1)(2009-4#1)
series of experiments was then##2##5##(1994-3#1)(2005-11#1)
series of experiments was##7##4##(1993-8#1)(1994-3#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-9#1)(2009-4#1)
series of experiments were conducted##2##5##(2008-10#1)(2008-11#1)
series of experiments were##4##4##(1994-9#1)(2008-10#1)(2008-11#1)(2011-2#1)
series of experiments with##4##4##(1996-1#1)(1997-7#1)(2007-4#1)(2008-1#1)
series of experiments##46##3##(1990-9#1)(1991-12#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-4#1)(1997-7#2)(1997-8#4)(2005-11#1)(2005-9#1)(2007-4#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-4#1)(2011-2#3)(2013-8#1)
series of families##2##3##(1997-5#1)(2006-5#1)
series of fatal##2##3##(2006-7#1)(2010-4#1)
series of field##4##3##(2008-10#1)(2008-12#1)(2011-12#1)(2011-8#1)
series of five##3##3##(1994-5#1)(2008-5#1)(2012-2#1)
series of four##12##3##(1990-8#1)(1993-4#1)(1996-1#1)(1996-9#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#2)(2010-2#1)(2011-1#1)(2012-11#1)
series of greenhouse##2##3##(2008-10#1)(2008-12#1)
series of hierarchical linear##2##4##(2007-8#1)(2012-1#1)
series of hierarchical##4##3##(2007-8#1)(2008-4#1)(2010-10#1)(2012-1#1)
series of human##3##3##(2007-11#1)(2007-5#1)(2010-12#1)
series of images##3##3##(2006-8#1)(2008-2#1)(2008-3#1)
series of imaging##2##3##(2010-5#1)(2010-6#1)
series of in vitro##2##4##(1993-11#1)(2008-4#1)
series of in##3##3##(1993-11#1)(2008-2#1)(2008-4#1)
series of kinetic##2##3##(1992-8#1)(1995-10#1)
series of known##2##3##(2008-10#1)(2008-3#1)
series of lectures to##2##4##(1993-11#1)(1994-9#1)
series of lectures##3##3##(1993-11#1)(1994-9#1)(2012-2#1)
series of measurements##5##3##(1995-12#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
series of metal##2##3##(2008-10#1)(2010-5#1)
series of methods##2##3##(2005-10#1)(2008-9#1)
series of microarray##2##3##(2010-1#1)(2012-3#1)
series of modified##4##3##(1992-6#1)(2008-2#1)(2012-11#2)
series of mono- and##2##4##(1993-4#1)(2009-4#1)
series of monoclonal antibodies##2##4##(1994-5#1)(1996-5#1)
series of mutant##2##3##(1990-3#1)(1996-4#1)
series of mutations##2##3##(1995-12#1)(2010-3#1)
series of neutral##2##3##(1994-9#1)(2008-3#1)
series of new##20##3##(1992-3#1)(1992-9#1)(1993-4#1)(1995-5#1)(1997-1#1)(2007-10#2)(2007-11#4)(2008-4#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-12#1)(2010-8#1)(2012-2#1)(2012-3#2)
series of nine##3##3##(1996-5#1)(2006-11#1)(2008-10#1)
series of normal##2##3##(1997-3#1)(2006-6#1)
series of novel aminosubstituted xantheno[1##2##5##(2008-2#2)
series of novel##13##3##(1991-3#1)(1992-3#1)(1993-6#1)(1994-9#1)(2006-10#1)(2007-10#1)(2007-11#3)(2008-2#2)(2011-1#1)(2011-3#1)
series of overlapping cDNA clones##2##5##(1991-5#1)(1996-10#1)
series of overlapping##6##3##(1990-9#1)(1991-5#1)(1992-12#1)(1995-8#1)(1996-10#1)(2008-10#1)
series of papers##5##3##(2008-10#3)(2008-2#1)(2009-3#1)
series of patients and##2##4##(1992-10#1)(1993-6#1)
series of patients with chronic##2##5##(2006-8#2)
series of patients with##8##4##(1993-7#1)(1997-7#1)(2006-8#2)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
series of patients##20##3##(1992-10#1)(1992-9#1)(1993-6#1)(1993-7#1)(1996-9#1)(1997-7#1)(2006-10#1)(2006-8#4)(2007-8#1)(2008-2#1)(2008-4#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
series of peptide fragments##2##4##(1993-6#2)
series of peptides##11##3##(1990-10#1)(1990-2#1)(1990-6#1)(1992-5#1)(1993-6#1)(1995-3#5)(2008-9#1)
series of phase##3##3##(2007-11#1)(2008-3#1)(2009-11#1)
series of physiological##2##3##(2008-9#1)(2009-8#1)
series of platelet-derived growth factor##2##5##(1996-6#2)
series of platinum##2##3##(2008-10#1)(2008-5#1)
series of polypyridyl complexes##2##4##(2008-5#2)
series of potent##2##3##(1994-9#1)(1996-8#1)
series of potential##2##3##(2008-10#2)
series of projects##4##3##(1995-12#1)(1995-8#1)(1996-10#1)(1997-4#1)
series of protocols##4##3##(2008-4#1)(2008-9#3)
series of protonated##2##3##(2006-3#1)(2010-5#1)
series of questions##7##3##(1993-1#1)(1993-3#1)(2005-8#1)(2005-9#1)(2008-6#1)(2013-1#2)
series of reactions##2##3##(1990-9#1)(2008-1#1)
series of recommendations to##2##4##(1997-3#1)(2008-3#1)
series of recommendations##3##3##(1997-3#1)(2008-12#1)(2008-3#1)
series of reference##3##3##(1997-2#1)(2009-9#2)
series of samples##5##3##(2008-10#5)
series of selection##2##3##(2008-4#1)(2008-5#1)
series of simulations##2##3##(2007-9#1)(2008-3#1)
series of single##2##3##(1990-9#1)(1996-5#1)
series of single-##2##3##(1994-11#1)(2006-11#1)
series of six##7##3##(2007-1#1)(2008-10#3)(2008-5#3)
series of studies##8##3##(1995-12#1)(2007-11#1)(2007-4#1)(2008-11#1)(2008-5#1)(2009-10#1)(2012-11#1)(2013-7#1)
series of substances##2##3##(1990-2#1)(1990-3#1)
series of substituted##4##3##(2007-11#2)(2008-12#1)(2010-2#1)
series of substrates##4##3##(1992-11#1)(1994-5#1)(2005-11#1)(2008-4#1)
series of such##3##3##(2006-12#1)(2008-7#1)(2010-11#1)
series of synthetic##7##3##(1991-3#1)(1994-9#1)(1995-11#1)(1996-9#1)(2008-10#2)(2008-2#1)
series of techniques##2##3##(2008-8#1)(2008-9#1)
series of ten##4##3##(1991-2#1)(1991-5#1)(2008-10#1)(2009-8#1)
series of tests##8##3##(1995-10#1)(2007-4#2)(2007-5#1)(2008-10#3)(2008-2#1)
series of the##9##3##(1996-3#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-3#2)(2010-12#1)(2010-7#1)(2011-2#1)
series of three##10##3##(1990-8#1)(1991-7#1)(1996-12#1)(1996-3#1)(1996-5#1)(2006-7#1)(2007-10#1)(2008-8#1)(2012-12#1)(2012-2#1)
series of three-dimensional##2##3##(2008-2#1)(2010-10#1)
series of truncated##2##3##(1991-9#1)(2008-9#1)
series of twenty##2##3##(2012-2#1)(2012-3#1)
series of two-dimensional (2D)##2##4##(1991-4#1)(2008-1#1)
series of vectors##2##3##(1994-12#1)(2008-11#1)
series of workshops##4##3##(2005-8#1)(2006-4#1)(2008-12#1)(2008-5#1)
series of##1424##2##(1990-10#5)(1990-11#2)(1990-12#11)(1990-2#5)(1990-3#6)(1990-4#4)(1990-5#3)(1990-6#6)(1990-7#5)(1990-8#11)(1990-9#8)(1991-1#2)(1991-10#7)(1991-11#2)(1991-12#4)(1991-2#4)(1991-3#3)(1991-4#4)(1991-5#6)(1991-6#2)(1991-7#7)(1991-8#5)(1991-9#6)(1992-1#4)(1992-10#4)(1992-11#9)(1992-12#9)(1992-2#2)(1992-3#8)(1992-4#1)(1992-5#6)(1992-6#5)(1992-7#3)(1992-8#13)(1992-9#9)(1993-1#2)(1993-10#1)(1993-11#4)(1993-12#1)(1993-3#4)(1993-4#8)(1993-5#6)(1993-6#12)(1993-7#2)(1993-8#3)(1993-9#8)(1994-10#1)(1994-11#3)(1994-12#5)(1994-2#3)(1994-3#4)(1994-5#7)(1994-6#3)(1994-7#1)(1994-8#4)(1994-9#26)(1995-1#6)(1995-10#4)(1995-11#6)(1995-12#5)(1995-2#5)(1995-3#25)(1995-4#2)(1995-5#4)(1995-6#4)(1995-7#2)(1995-8#8)(1995-9#3)(1996-1#6)(1996-10#5)(1996-11#2)(1996-12#5)(1996-2#5)(1996-3#9)(1996-4#2)(1996-5#14)(1996-6#4)(1996-7#4)(1996-8#15)(1996-9#6)(1997-1#6)(1997-2#14)(1997-3#7)(1997-4#8)(1997-5#2)(1997-6#4)(1997-7#14)(1997-8#6)(2004-1#1)(2004-10#2)(2004-12#1)(2004-2#3)(2004-4#1)(2004-7#1)(2004-9#2)(2005-10#4)(2005-11#22)(2005-12#1)(2005-4#3)(2005-6#1)(2005-7#2)(2005-8#9)(2005-9#4)(2006-1#1)(2006-10#17)(2006-11#4)(2006-12#10)(2006-2#4)(2006-3#3)(2006-4#1)(2006-5#4)(2006-6#4)(2006-7#4)(2006-8#8)(2006-9#1)(2007-1#7)(2007-10#11)(2007-11#48)(2007-12#17)(2007-2#7)(2007-3#6)(2007-4#12)(2007-5#6)(2007-6#4)(2007-7#4)(2007-8#20)(2007-9#8)(2008-1#13)(2008-10#117)(2008-11#29)(2008-12#11)(2008-2#30)(2008-3#39)(2008-4#30)(2008-5#49)(2008-6#8)(2008-7#22)(2008-8#19)(2008-9#22)(2009-1#1)(2009-10#5)(2009-11#4)(2009-12#6)(2009-2#4)(2009-3#5)(2009-4#8)(2009-5#5)(2009-6#2)(2009-7#7)(2009-8#4)(2009-9#10)(2010-1#3)(2010-10#4)(2010-11#4)(2010-12#9)(2010-2#6)(2010-3#6)(2010-4#8)(2010-5#10)(2010-6#4)(2010-7#3)(2010-8#5)(2010-9#1)(2011-1#10)(2011-12#3)(2011-2#23)(2011-3#1)(2011-4#2)(2011-8#1)(2012-1#5)(2012-11#9)(2012-12#11)(2012-2#22)(2012-3#10)(2012-5#1)(2013-1#20)(2013-7#3)(2013-8#11)
series on the##3##3##(1992-12#1)(2007-2#1)(2008-3#1)
series on##13##2##(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(2005-8#1)(2006-12#1)(2007-2#1)(2008-1#1)(2008-3#1)(2010-9#2)(2011-1#1)(2012-2#1)
series only##2##2##(1991-5#1)(1992-11#1)
series or##2##2##(2009-8#1)(2010-5#1)
series over##2##2##(1994-6#1)(2012-12#1)
series performed##2##2##(1996-3#1)(2011-2#1)
series provides##2##2##(1996-8#1)(2010-4#1)
series ranged##2##2##(2005-11#1)(2008-10#1)
series reported##3##2##(1997-3#1)(2006-11#1)(2008-3#1)
series reporting##3##2##(2006-10#1)(2006-7#1)(2012-12#1)
series reviewing the##2##3##(2008-10#2)
series reviewing##3##2##(2008-10#2)(2011-1#1)
series showed a##2##3##(2007-8#1)(2011-2#1)
series showed##3##2##(1995-3#1)(2007-8#1)(2011-2#1)
series so that##2##3##(2006-7#1)(2008-10#1)
series study##3##2##(2008-12#1)(2010-2#1)(2012-1#1)
series suggests##2##2##(1990-12#1)(1997-1#1)
series that##5##2##(2004-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)
series the##2##2##(2008-3#1)(2008-5#1)
series to##12##2##(1990-8#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-3#1)(2008-4#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-7#1)
series using##4##2##(2006-7#1)(2007-8#1)(2008-8#1)(2011-2#1)
series was##26##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-10#1)(1991-4#1)(1992-12#1)(1996-11#1)(1997-1#1)(2006-11#1)(2006-7#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-3#1)(2008-6#2)(2009-9#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
series were##11##2##(1992-10#1)(1993-5#1)(1995-3#1)(1997-1#1)(2007-1#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-7#1)(2012-12#1)
series with a##5##3##(1993-3#1)(1997-1#1)(2006-1#1)(2008-11#1)(2010-11#1)
series with the##4##3##(1995-5#1)(2008-11#1)(2011-12#1)(2012-1#1)
series with##15##2##(1993-3#1)(1995-5#1)(1997-1#1)(2004-11#1)(2006-1#1)(2008-10#3)(2008-11#2)(2010-11#1)(2011-12#2)(2012-1#1)(2013-1#1)
series##2184##1##(1990-10#5)(1990-11#2)(1990-12#19)(1990-2#6)(1990-3#7)(1990-4#7)(1990-5#4)(1990-6#10)(1990-7#9)(1990-8#14)(1990-9#8)(1991-1#3)(1991-10#10)(1991-11#2)(1991-12#9)(1991-2#5)(1991-3#4)(1991-4#6)(1991-5#8)(1991-6#2)(1991-7#9)(1991-8#6)(1991-9#8)(1992-1#5)(1992-10#7)(1992-11#11)(1992-12#11)(1992-2#6)(1992-3#10)(1992-4#4)(1992-5#7)(1992-6#7)(1992-7#3)(1992-8#14)(1992-9#11)(1993-1#2)(1993-10#2)(1993-11#4)(1993-12#2)(1993-2#4)(1993-3#10)(1993-4#10)(1993-5#10)(1993-6#12)(1993-7#2)(1993-8#4)(1993-9#8)(1994-1#2)(1994-10#1)(1994-11#3)(1994-12#9)(1994-2#4)(1994-3#7)(1994-5#8)(1994-6#8)(1994-7#3)(1994-8#6)(1994-9#29)(1995-1#6)(1995-10#6)(1995-11#13)(1995-12#5)(1995-2#6)(1995-3#42)(1995-4#3)(1995-5#6)(1995-6#4)(1995-7#2)(1995-8#9)(1995-9#5)(1996-1#8)(1996-10#5)(1996-11#3)(1996-12#5)(1996-2#10)(1996-3#10)(1996-4#2)(1996-5#14)(1996-6#5)(1996-7#4)(1996-8#17)(1996-9#8)(1997-1#11)(1997-2#25)(1997-3#9)(1997-4#10)(1997-5#2)(1997-6#5)(1997-7#19)(1997-8#7)(2004-1#2)(2004-10#4)(2004-11#2)(2004-12#1)(2004-2#3)(2004-4#1)(2004-7#1)(2004-9#4)(2005-10#5)(2005-11#31)(2005-12#1)(2005-4#3)(2005-6#2)(2005-7#7)(2005-8#17)(2005-9#4)(2006-1#2)(2006-10#33)(2006-11#11)(2006-12#19)(2006-2#8)(2006-3#4)(2006-4#1)(2006-5#8)(2006-6#9)(2006-7#11)(2006-8#12)(2006-9#4)(2007-1#10)(2007-10#20)(2007-11#59)(2007-12#24)(2007-2#10)(2007-3#9)(2007-4#16)(2007-5#12)(2007-6#4)(2007-7#18)(2007-8#35)(2007-9#11)(2008-1#20)(2008-10#165)(2008-11#37)(2008-12#16)(2008-2#57)(2008-3#65)(2008-4#44)(2008-5#57)(2008-6#20)(2008-7#33)(2008-8#30)(2008-9#28)(2009-1#1)(2009-10#10)(2009-11#4)(2009-12#6)(2009-2#6)(2009-3#8)(2009-4#11)(2009-5#8)(2009-6#4)(2009-7#7)(2009-8#15)(2009-9#18)(2010-1#7)(2010-10#4)(2010-11#8)(2010-12#12)(2010-2#11)(2010-3#10)(2010-4#10)(2010-5#16)(2010-6#6)(2010-7#6)(2010-8#12)(2010-9#7)(2011-1#24)(2011-12#10)(2011-2#57)(2011-3#1)(2011-4#2)(2011-8#1)(2012-1#16)(2012-11#9)(2012-12#24)(2012-2#47)(2012-3#19)(2012-5#1)(2013-1#38)(2013-7#5)(2013-8#18)
series) and##2##2##(1997-7#1)(2006-12#1)
series)##16##1##(1992-12#1)(1993-10#1)(1993-12#1)(1994-9#1)(1995-3#1)(1995-8#1)(1997-2#1)(1997-7#2)(2004-1#1)(2004-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2010-12#1)
series-expansion method##3##2##(2008-2#3)
series-expansion##5##1##(2008-2#5)
series]##4##1##(1992-10#1)(1992-6#1)(1993-6#1)(2009-8#1)
serine (PS)##2##2##(1991-8#1)(2006-10#1)
serine (S)##2##2##(1991-2#2)
serine 129##6##2##(1994-11#6)
serine 143##4##2##(1994-11#4)
serine adduct##2##2##(1992-12#1)(1993-11#1)
serine adducts##3##2##(1992-12#2)(1993-11#1)
serine and histidine##2##3##(1992-12#2)
serine and the##2##3##(1990-7#1)(2008-11#1)
serine and threonine residues##13##4##(1991-10#1)(1991-11#1)(1991-3#1)(1991-4#1)(1992-7#1)(1993-3#1)(1994-8#2)(1994-9#2)(1995-10#1)(2006-9#1)(2008-4#1)
serine and threonine##16##3##(1990-10#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-7#1)(1993-3#1)(1994-8#2)(1994-9#2)(1995-10#1)(2006-9#1)(2008-4#2)
serine and tyrosine residues##3##4##(1991-2#3)
serine and tyrosine##6##3##(1990-12#1)(1990-8#1)(1991-2#4)
serine and##36##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#6)(1991-3#1)(1991-4#1)(1992-10#1)(1992-12#2)(1992-7#1)(1993-3#1)(1994-8#2)(1994-9#2)(1995-10#1)(1997-1#1)(2006-9#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-5#1)(2009-10#1)
serine as##2##2##(1994-5#1)(2008-11#1)
serine at##4##2##(1990-5#1)(1995-2#1)(2005-10#1)(2007-7#1)
serine binding to##2##3##(1994-5#2)
serine binding##3##2##(1994-5#3)
serine by##2##2##(1990-2#1)(2012-2#1)
serine dehydratase was##2##3##(1990-7#2)
serine dehydratase##5##2##(1990-7#4)(2008-10#1)
serine esterase##4##2##(1991-8#1)(1994-6#2)(2008-4#1)
serine esterases##2##2##(1993-6#1)(2008-4#1)
serine for##3##2##(1991-9#1)(1994-5#1)(1994-9#1)
serine in##5##2##(1993-6#1)(1994-2#1)(1995-10#1)(1995-8#1)(1996-7#1)
serine isotopomers##2##2##(1997-1#2)
serine kinase##3##2##(1993-12#1)(1993-6#1)(1994-9#1)
serine of##2##2##(1991-2#1)(1997-1#1)
serine on##2##2##(1992-12#1)(1997-6#1)
serine or threonine residues##4##4##(1991-12#1)(1994-9#1)(2008-11#1)(2008-8#1)
serine or##8##2##(1990-10#1)(1991-12#1)(1993-12#1)(1993-3#1)(1994-9#1)(2006-9#1)(2008-11#1)(2008-8#1)
serine phosphorylation of##3##3##(1996-5#1)(2008-4#1)(2011-1#1)
serine phosphorylation##11##2##(1991-7#2)(1993-6#1)(1995-10#1)(1995-3#4)(1996-5#1)(2008-4#1)(2011-1#1)
serine protease activities in##2##4##(2008-5#1)(2012-3#1)
serine protease activities##3##3##(2008-5#2)(2012-3#1)
serine protease and##5##3##(1991-9#1)(1994-12#1)(1994-6#2)(2009-9#1)
serine protease from##2##3##(1993-3#1)(1994-12#1)
serine protease in the##2##4##(1992-6#1)(1994-12#1)
serine protease inhibitor##10##3##(1990-3#1)(1991-11#1)(1991-2#1)(1994-11#1)(1995-1#1)(1995-5#1)(1996-9#1)(2008-7#1)(2008-8#2)
serine protease inhibitors and##2##4##(1996-5#1)(1997-7#1)
serine protease inhibitors##8##3##(1992-5#1)(1995-1#1)(1995-8#1)(1996-5#1)(1997-7#1)(2005-10#1)(2006-6#1)(2010-12#1)
serine protease##62##2##(1990-3#1)(1991-11#1)(1991-2#3)(1991-4#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-5#1)(1992-6#2)(1993-12#1)(1993-3#5)(1994-11#1)(1994-12#6)(1994-6#2)(1995-1#2)(1995-3#2)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-6#1)(2008-11#2)(2008-5#5)(2008-7#1)(2008-8#2)(2009-9#1)(2010-12#1)(2012-12#2)(2012-3#1)
serine proteases and their##3##4##(2008-4#3)
serine proteases and##5##3##(1991-2#1)(1994-6#1)(2008-4#3)
serine proteases in the##3##4##(2008-1#3)
serine proteases that##2##3##(1991-3#1)(2006-10#1)
serine proteases were##3##3##(1992-12#1)(1996-2#1)(2010-5#1)
serine proteases##48##2##(1990-9#3)(1991-2#8)(1991-3#4)(1991-6#2)(1991-9#1)(1992-12#2)(1993-11#1)(1993-3#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-2#1)(1995-5#2)(1995-6#2)(1996-2#1)(2006-10#1)(2008-1#5)(2008-4#6)(2008-5#1)(2008-9#1)(2010-5#1)(2011-2#1)
serine proteinase from##4##3##(1991-3#2)(1994-12#1)(2008-10#1)
serine proteinase inhibitors##3##3##(1990-12#1)(2008-5#1)(2009-4#1)
serine proteinase##21##2##(1990-12#2)(1990-5#2)(1991-3#2)(1992-11#1)(1992-7#1)(1993-3#1)(1994-12#2)(1995-5#1)(1995-6#1)(1995-7#1)(1996-5#1)(2005-8#1)(2008-10#1)(2008-5#3)(2009-4#1)
serine proteinases from##2##3##(1993-11#1)(1996-9#1)
serine proteinases##23##2##(1990-5#1)(1990-7#1)(1991-5#1)(1991-8#2)(1992-6#1)(1993-11#3)(1993-3#2)(1994-12#2)(1994-3#1)(1994-9#1)(1995-5#2)(1995-7#2)(1996-9#1)(2009-4#1)(2012-3#2)
serine racemase##2##2##(2006-3#2)
serine receptor of##2##3##(1994-5#2)
serine receptor##3##2##(1994-5#3)
serine residue##6##2##(1992-6#3)(1994-2#1)(2006-10#1)(2011-2#1)
serine residues and##2##3##(1990-12#1)(2012-12#1)
serine residues at positions##2##4##(2008-5#2)
serine residues by##2##3##(1990-7#1)(1995-3#1)
serine residues in##6##3##(1992-11#1)(1993-8#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-8#1)
serine residues were##2##3##(1992-6#1)(1995-10#1)
serine residues##29##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-7#2)(1991-1#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-6#1)(1993-8#2)(1994-11#1)(1994-9#1)(1995-10#2)(1995-3#3)(1995-5#1)(1996-5#1)(1996-8#2)(2005-6#1)(2008-5#2)(2011-2#2)(2012-12#1)
serine synthesis##2##2##(1992-10#1)(1997-1#1)
serine to##4##2##(1994-5#1)(1997-1#1)(2006-8#1)(2011-12#1)
serine using##3##2##(1993-6#1)(2008-10#2)
serine was##2##2##(1991-2#1)(1994-5#1)
serine whereas##2##2##(1992-12#1)(2006-8#1)
serine##449##1##(1990-10#3)(1990-11#4)(1990-12#5)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#6)(1990-7#11)(1990-8#1)(1990-9#3)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#23)(1991-3#7)(1991-4#4)(1991-5#2)(1991-6#2)(1991-7#5)(1991-8#6)(1991-9#4)(1992-10#3)(1992-11#2)(1992-12#12)(1992-5#1)(1992-6#9)(1992-7#2)(1992-9#1)(1993-11#9)(1993-12#5)(1993-3#12)(1993-5#1)(1993-6#6)(1993-8#4)(1994-11#15)(1994-12#15)(1994-2#2)(1994-3#2)(1994-5#11)(1994-6#7)(1994-8#9)(1994-9#9)(1995-1#4)(1995-10#5)(1995-12#1)(1995-2#6)(1995-3#14)(1995-5#8)(1995-6#6)(1995-7#5)(1995-8#4)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#8)(1996-7#1)(1996-8#4)(1996-9#2)(1997-1#15)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-10#2)(2005-6#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-3#2)(2006-6#2)(2006-8#5)(2006-9#2)(2007-11#1)(2007-12#1)(2007-7#2)(2008-1#5)(2008-10#12)(2008-11#7)(2008-4#13)(2008-5#14)(2008-7#4)(2008-8#5)(2008-9#2)(2009-10#1)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#4)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-12#4)(2012-2#3)(2012-3#3)
serine-##2##1##(1991-3#1)(1993-3#1)
serine-1177##2##1##(2011-1#2)
serine-143##3##1##(1994-5#3)
serine-protease##2##1##(1992-12#2)
serine-rich##2##1##(1990-7#1)(2008-6#1)
serine-threonine kinase##3##2##(1996-8#2)(2008-7#1)
serine-threonine kinases##3##2##(1990-5#2)(2008-4#1)
serine-threonine##7##1##(1990-5#2)(1995-6#1)(1996-8#2)(2008-4#1)(2008-7#1)
serine/threonine and tyrosine##4##3##(1990-3#1)(1996-6#1)(2013-7#2)
serine/threonine and##5##2##(1990-3#2)(1996-6#1)(2013-7#2)
serine/threonine kinase Akt##2##3##(2009-3#1)(2012-12#1)
serine/threonine kinase receptor##2##3##(1994-12#2)
serine/threonine kinase receptors##3##3##(1995-12#1)(1995-2#1)(1996-5#1)
serine/threonine kinase##30##2##(1991-11#2)(1993-11#1)(1994-12#3)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#3)(1996-2#2)(1996-4#1)(1996-5#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-4#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-7#1)(2012-1#2)(2012-12#2)
serine/threonine kinases that##3##3##(1995-2#1)(1995-3#1)(2013-1#1)
serine/threonine kinases##10##2##(1991-11#2)(1993-3#1)(1993-6#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-11#1)(2008-4#1)(2013-1#1)
serine/threonine phosphatase inhibitors##2##3##(1994-6#1)(1995-2#1)
serine/threonine phosphatase##4##2##(1992-12#1)(1994-6#1)(1995-2#1)(1997-6#1)
serine/threonine phosphatases##3##2##(1994-11#1)(1995-8#1)(2009-9#1)
serine/threonine phosphorylation of##2##3##(1990-3#1)(1993-6#1)
serine/threonine phosphorylation##5##2##(1990-3#1)(1990-8#1)(1991-9#1)(1993-6#1)(1994-11#1)
serine/threonine protein kinase family##2##4##(1991-2#1)(2008-10#1)
serine/threonine protein kinase##9##3##(1990-8#1)(1991-2#1)(1994-8#1)(1995-6#1)(1997-4#2)(2008-10#1)(2008-4#1)(2011-2#1)
serine/threonine protein phosphatase##2##3##(1994-12#1)(1996-2#1)
serine/threonine protein phosphatases##3##3##(1990-8#1)(1993-7#1)(1994-11#1)
serine/threonine protein##18##2##(1990-8#2)(1991-2#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-6#2)(1996-2#1)(1997-4#2)(2006-5#1)(2008-10#1)(2008-4#1)(2011-2#1)
serine/threonine##82##1##(1990-3#3)(1990-8#3)(1991-11#4)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-3#2)(1993-6#3)(1993-7#1)(1994-11#3)(1994-12#4)(1994-6#1)(1994-8#1)(1994-9#3)(1995-12#1)(1995-2#4)(1995-3#5)(1995-6#2)(1995-8#2)(1996-11#1)(1996-2#3)(1996-4#1)(1996-5#1)(1996-6#1)(1997-4#3)(1997-6#4)(1997-7#1)(2006-5#2)(2008-10#1)(2008-4#3)(2008-9#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-1#2)(2012-12#2)(2013-1#1)(2013-7#2)
serine/threonine-specific protein##2##2##(1990-9#1)(2008-4#1)
serine/threonine-specific##3##1##(1990-4#1)(1990-9#1)(2008-4#1)
serine36--&gt##2##1##(1996-11#2)
serine727##2##1##(2011-2#2)
serines 345 and 346##2##4##(1996-8#2)
serines##7##1##(1990-10#1)(1991-2#1)(1991-7#1)(1992-6#1)(1994-5#1)(1996-8#2)
serious CV events##2##3##(2008-11#2)
serious adverse drug reactions##2##4##(2011-2#1)(2013-8#1)
serious adverse drug##3##3##(2007-11#1)(2011-2#1)(2013-8#1)
serious adverse effect##2##3##(1993-11#1)(2012-1#1)
serious adverse effects##7##3##(1994-6#1)(1996-8#1)(2007-7#2)(2011-2#2)(2013-1#1)
serious adverse event reported##2##4##(2007-11#1)(2012-12#1)
serious adverse event##6##3##(2007-11#3)(2010-12#1)(2012-12#1)(2012-2#1)
serious adverse events are##2##4##(2008-10#1)(2008-8#1)
serious adverse events occurred##2##4##(2006-8#1)(2008-3#1)
serious adverse events##19##3##(1996-1#1)(2005-7#1)(2006-8#1)(2007-11#2)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#5)(2009-10#1)(2011-12#1)(2013-1#1)
serious adverse reactions##3##3##(1992-1#1)(2005-10#1)(2008-11#1)
serious adverse##44##2##(1992-1#1)(1993-11#1)(1994-6#1)(1996-1#1)(1996-8#1)(1997-1#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-7#1)(2006-8#1)(2007-11#6)(2007-2#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#5)(2009-10#1)(2010-12#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
serious and life threatening##2##4##(2007-7#1)(2012-3#1)
serious and life-threatening##2##3##(1995-12#1)(2011-2#1)
serious and often fatal##2##4##(2005-12#1)(2012-1#1)
serious and potentially##4##3##(2007-12#1)(2007-7#1)(2007-8#1)(2012-3#1)
serious and##36##2##(1990-4#1)(1991-2#1)(1992-3#1)(1993-7#1)(1995-12#1)(1997-4#1)(1997-6#1)(2005-12#1)(2005-6#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#1)
serious associated##3##2##(1990-6#1)(2008-9#1)(2010-11#1)
serious attention##2##2##(2008-1#1)(2008-2#1)
serious bacterial##3##2##(1994-9#1)(2008-10#1)(2008-11#1)
serious blood loss##2##3##(1996-12#1)(2012-2#1)
serious bone##2##2##(1991-12#1)(2011-12#1)
serious but##2##2##(2007-8#1)(2010-1#1)
serious cardiac##2##2##(1992-8#1)(2013-8#1)
serious cardiovascular##3##2##(2008-8#2)(2013-1#1)
serious case of##2##3##(1991-2#1)(2011-2#1)
serious cases##3##2##(1990-5#1)(2008-9#1)(2011-1#1)
serious cause of##3##3##(1991-4#1)(2008-11#1)(2009-9#1)
serious cause##4##2##(1991-4#1)(2006-12#1)(2008-11#1)(2009-9#1)
serious challenge##3##2##(2007-5#1)(2008-9#1)(2011-12#1)
serious challenges##2##2##(2007-5#1)(2013-1#1)
serious chronic##2##2##(2008-7#1)(2013-1#1)
serious clinical problem##2##3##(2007-11#1)(2011-2#1)
serious clinical##10##2##(2005-1#1)(2007-11#2)(2007-12#1)(2008-6#2)(2008-7#1)(2010-11#1)(2010-2#1)(2011-2#1)
serious complication of##24##3##(1991-11#1)(1991-8#1)(1993-10#1)(2006-10#3)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2009-2#1)(2010-2#1)(2010-5#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
serious complication##42##2##(1991-11#1)(1991-8#1)(1993-10#1)(1994-6#1)(1995-11#1)(1996-2#1)(1996-3#1)(2006-10#3)(2007-11#1)(2007-12#3)(2007-3#1)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#2)(2008-7#1)(2008-9#1)(2009-2#1)(2010-2#1)(2010-5#2)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
serious complications and##5##3##(1996-1#1)(2006-10#1)(2007-11#1)(2009-12#1)(2012-12#1)
serious complications in##4##3##(1990-2#1)(2007-8#1)(2013-1#2)
serious complications of##6##3##(1993-4#1)(2008-4#1)(2010-10#1)(2010-7#1)(2011-3#1)(2012-2#1)
serious complications such as##5##4##(1990-11#1)(2007-7#1)(2011-2#1)(2013-1#2)
serious complications that##2##3##(1991-3#1)(2009-3#1)
serious complications##60##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-3#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-4#1)(1993-8#1)(1995-4#1)(1996-1#1)(2005-1#1)(2005-8#2)(2006-10#3)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-10#2)(2010-12#1)(2010-7#1)(2010-8#2)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#4)(2013-1#7)
serious concerns for the##2##4##(2007-6#1)(2013-8#1)
serious concerns##5##2##(1991-9#1)(2006-5#1)(2007-6#1)(2011-2#1)(2013-8#1)
serious condition with##3##3##(2005-1#1)(2011-2#1)(2012-12#1)
serious condition##9##2##(1993-8#1)(1995-6#1)(1997-8#1)(2005-1#1)(2009-3#1)(2010-5#1)(2011-2#2)(2012-12#1)
serious conditions##2##2##(2010-12#1)(2011-2#1)
serious consequence of##2##3##(1993-11#1)(2012-1#1)
serious consequences for##2##3##(2008-6#1)(2012-11#1)
serious consequences of##4##3##(2007-11#1)(2010-1#1)(2010-12#1)(2013-8#1)
serious consequences##18##2##(1991-2#1)(1993-7#1)(2006-10#1)(2007-11#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-6#1)(2010-1#1)(2010-12#1)(2010-8#1)(2012-11#1)(2012-2#2)(2013-1#1)(2013-8#1)
serious consideration##5##2##(1996-11#1)(2008-3#1)(2008-5#1)(2009-12#1)(2010-2#1)
serious contamination##2##2##(1996-2#1)(2008-7#1)
serious criticism##2##2##(2011-12#1)(2012-2#1)
serious damage to the##2##4##(1990-5#1)(2008-11#1)
serious damage##5##2##(1990-5#1)(2008-10#1)(2008-11#2)(2011-2#1)
serious danger##3##2##(1994-4#1)(2007-2#1)(2008-10#1)
serious diagnostic and##2##3##(2007-11#2)
serious difficulties##2##2##(1990-11#1)(2008-10#1)
serious disadvantages##2##2##(2004-9#1)(2008-5#1)
serious disease with the##2##4##(2005-1#1)(2008-7#1)
serious disease with##3##3##(2005-1#1)(2008-7#1)(2010-6#1)
serious disease##24##2##(1991-4#1)(1992-2#1)(1993-12#1)(1993-9#2)(1994-3#1)(2005-1#1)(2006-10#1)(2006-8#1)(2007-5#1)(2008-10#10)(2008-7#1)(2010-6#1)(2011-2#1)(2012-2#1)
serious diseases##12##2##(2005-11#1)(2006-10#1)(2008-10#3)(2009-9#2)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
serious disorder##4##2##(1991-6#1)(2009-4#1)(2010-1#1)(2012-2#1)
serious drawback##2##2##(2008-2#1)(2012-12#1)
serious drawbacks##3##2##(1992-9#1)(2008-2#1)(2008-7#1)
serious drug##2##2##(1991-12#1)(2013-1#1)
serious dysfunction##2##2##(2006-5#1)(2009-4#1)
serious economic##3##2##(2008-10#1)(2010-9#1)(2011-2#1)
serious effect##2##2##(2009-2#1)(2011-1#1)
serious errors in##2##3##(2008-1#1)(2010-7#1)
serious errors##3##2##(2008-1#1)(2008-10#1)(2010-7#1)
serious ethical##2##2##(1995-1#1)(2008-3#1)
serious flaws##2##2##(2010-7#1)(2013-8#1)
serious food##2##2##(2006-4#1)(2011-2#1)
serious form##2##2##(2010-11#1)(2011-2#1)
serious fungal##4##2##(2008-10#3)(2008-3#1)
serious gastrointestinal##3##2##(1991-4#1)(2006-10#1)(2011-12#1)
serious health effects##2##3##(1997-1#1)(2008-4#1)
serious health problem in##2##4##(1991-6#1)(2005-8#1)
serious health problem##7##3##(1991-3#1)(1991-6#1)(2005-8#1)(2007-11#1)(2007-2#1)(2013-1#2)
serious health problems##3##3##(2010-1#1)(2010-7#1)(2013-8#1)
serious health##19##2##(1991-3#1)(1991-6#1)(1993-9#1)(1997-1#1)(2005-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-12#1)(2008-4#1)(2010-1#1)(2010-7#1)(2011-2#1)(2013-1#3)(2013-8#1)
serious illness and##2##3##(1993-8#1)(2006-8#1)
serious illness of##2##3##(2007-5#1)(2007-6#1)
serious illness##12##2##(1991-4#1)(1993-8#2)(1995-3#1)(2006-8#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-11#1)(2010-8#1)(2012-12#1)(2013-1#1)
serious illnesses##2##2##(2005-6#1)(2011-12#1)
serious impediment to##2##3##(1996-3#1)(2006-7#1)
serious implications##2##2##(1991-2#1)(2006-8#1)
serious in##6##2##(1991-4#1)(1993-12#2)(2008-2#1)(2008-8#1)(2012-12#1)
serious infections and##2##3##(2008-5#1)(2009-11#1)
serious infections in the##3##4##(2008-5#1)(2008-7#2)
serious infections in##5##3##(2007-8#1)(2008-5#1)(2008-7#3)
serious infections like##2##3##(2007-8#1)(2009-9#1)
serious infections##19##2##(1990-8#1)(1993-1#1)(1995-3#1)(2005-8#2)(2007-8#2)(2008-3#1)(2008-5#2)(2008-7#3)(2009-11#1)(2009-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
serious infectious##4##2##(1994-9#1)(2006-10#2)(2007-2#1)
serious injuries##3##2##(2007-2#1)(2008-1#1)(2011-2#1)
serious injury to the##2##4##(2007-1#1)(2012-12#1)
serious injury##8##2##(1990-10#1)(2007-1#1)(2007-2#1)(2007-3#1)(2009-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
serious interference was##3##3##(2007-8#1)(2008-10#2)
serious interference##7##2##(2007-12#1)(2007-8#1)(2008-10#5)
serious is##3##2##(1994-12#1)(2007-7#1)(2010-12#1)
serious ischemic##2##2##(1992-3#1)(2008-1#1)
serious juvenile offenders##2##3##(2009-7#2)
serious late##2##2##(1995-10#1)(2011-2#1)
serious life-threatening complications##2##3##(2009-2#1)(2011-2#1)
serious limitations for##2##3##(1995-2#1)(2012-11#1)
serious limitations in##2##3##(1993-6#1)(2007-11#1)
serious limitations##7##2##(1993-6#1)(1995-2#1)(2005-7#1)(2006-3#1)(2007-11#1)(2008-10#1)(2012-11#1)
serious liver##3##2##(1992-2#1)(2007-12#1)(2008-9#1)
serious manifestation##2##2##(2007-7#1)(2012-3#1)
serious medical problem##2##3##(1997-3#1)(2011-2#1)
serious medical##9##2##(1994-2#1)(1994-3#1)(1997-3#1)(1997-6#1)(2007-7#1)(2009-5#1)(2011-2#2)(2012-3#1)
serious mental illness##10##3##(2004-3#1)(2006-9#1)(2008-7#1)(2009-6#3)(2010-2#1)(2011-2#3)
serious mental##14##2##(1991-1#1)(1997-3#1)(2004-3#1)(2006-9#1)(2008-2#1)(2008-7#1)(2009-6#3)(2010-2#1)(2011-2#3)(2013-1#1)
serious morbidity and mortality##3##4##(2007-11#1)(2010-7#2)
serious morbidity##8##2##(2004-2#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2010-7#2)
serious nature##2##2##(1991-9#1)(2008-3#1)
serious neurological##2##2##(2007-7#1)(2008-7#1)
serious obstetrical complications##2##3##(2004-10#1)(2006-6#1)
serious obstetrical##3##2##(2004-10#1)(2006-6#1)(2008-4#1)
serious of##2##2##(2009-2#1)(2010-7#1)
serious ones##2##2##(1990-11#1)(2010-5#1)
serious or##5##2##(1997-6#1)(2007-11#1)(2008-11#1)(2010-8#1)(2012-2#1)
serious outbreak##2##2##(2008-10#2)
serious outcome##2##2##(2008-11#1)(2008-8#1)
serious pests of##2##3##(2008-10#1)(2012-11#1)
serious practical##2##2##(2008-7#1)(2012-3#1)
serious problem in##9##3##(1993-11#1)(1995-5#1)(2005-8#1)(2007-4#1)(2008-1#1)(2008-7#1)(2012-3#1)(2013-1#2)
serious problem##35##2##(1991-1#1)(1991-2#1)(1991-3#1)(1992-10#1)(1993-11#1)(1995-5#1)(1996-12#2)(1997-4#1)(1997-5#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-3#1)(2010-9#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#2)
serious problems for##5##3##(1993-3#1)(2004-10#1)(2007-2#1)(2008-10#1)(2008-9#1)
serious problems in##6##3##(1991-5#1)(1996-3#1)(2005-8#1)(2007-8#1)(2012-2#1)(2013-1#1)
serious problems##18##2##(1991-5#1)(1993-3#1)(1996-3#1)(2004-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-11#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
serious prognosis##2##2##(1995-8#1)(1996-1#1)
serious psychiatric illness##2##3##(2005-7#1)(2012-11#1)
serious psychiatric##3##2##(2005-7#1)(2007-1#1)(2012-11#1)
serious psychological##2##2##(1990-6#1)(2008-2#1)
serious public health problem##8##4##(2007-3#1)(2007-4#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-12#1)(2012-12#1)(2012-2#1)
serious public health##11##3##(2007-3#1)(2007-4#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-10#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)
serious questions about##2##3##(1996-11#1)(2011-2#1)
serious reproductive##2##2##(2007-12#1)(2013-1#1)
serious risk to the##2##4##(2012-2#1)(2012-3#1)
serious risk##8##2##(1994-6#1)(2005-10#1)(2008-11#1)(2009-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
serious risks##2##2##(1996-3#1)(2013-1#1)
serious sequelae##3##2##(1994-9#1)(2007-11#1)(2011-2#1)
serious side effect of##3##4##(2006-8#1)(2009-6#1)(2012-12#1)
serious side effect##5##3##(2006-8#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-12#1)
serious side effects and##2##4##(1995-5#1)(2009-3#1)
serious side effects or##2##4##(2008-7#1)(2008-8#1)
serious side effects##12##3##(1992-8#1)(1993-11#2)(1994-2#1)(1995-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-11#1)(2011-2#1)
serious side##17##2##(1992-8#1)(1993-11#2)(1994-2#1)(1995-5#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-4#1)(2011-2#2)(2012-12#1)
serious side-effects##2##2##(1995-9#1)(2007-7#1)
serious social##2##2##(1990-3#1)(2010-8#1)
serious symptoms##2##2##(1992-4#1)(1997-6#1)
serious systemic##2##2##(2007-12#1)(2008-7#1)
serious threat to##7##3##(1994-3#1)(1995-9#1)(2005-8#1)(2008-10#2)(2010-9#1)(2013-8#1)
serious threat##10##2##(1994-3#1)(1995-9#1)(2005-8#1)(2008-10#2)(2008-11#1)(2010-9#1)(2011-2#2)(2013-8#1)
serious threats to##4##3##(1992-5#1)(2012-2#2)(2013-7#1)
serious toxic##2##2##(1991-6#1)(2011-2#1)
serious toxicity##4##2##(1993-12#1)(1994-8#1)(1996-1#1)(2009-6#1)
serious underlying##2##2##(2006-10#1)(2011-2#1)
serious vascular##3##2##(1993-10#1)(2006-10#1)(2011-2#1)
serious##941##1##(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#7)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#6)(1991-3#4)(1991-4#5)(1991-5#1)(1991-6#5)(1991-8#1)(1991-9#2)(1992-1#2)(1992-10#2)(1992-11#1)(1992-12#2)(1992-2#8)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#1)(1992-8#5)(1992-9#2)(1993-1#1)(1993-10#2)(1993-11#5)(1993-12#7)(1993-3#2)(1993-4#2)(1993-6#2)(1993-7#2)(1993-8#6)(1993-9#4)(1994-12#1)(1994-2#2)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#6)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#3)(1995-4#2)(1995-5#3)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#3)(1996-1#5)(1996-11#2)(1996-12#5)(1996-2#3)(1996-3#5)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#4)(1997-8#3)(2004-10#2)(2004-11#1)(2004-2#1)(2004-3#1)(2004-9#1)(2005-1#5)(2005-10#3)(2005-11#4)(2005-12#2)(2005-6#2)(2005-7#3)(2005-8#12)(2005-9#2)(2006-1#2)(2006-10#23)(2006-11#1)(2006-12#3)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#4)(2006-7#2)(2006-8#8)(2006-9#1)(2007-1#4)(2007-10#5)(2007-11#25)(2007-12#14)(2007-2#13)(2007-3#3)(2007-4#6)(2007-5#4)(2007-6#3)(2007-7#21)(2007-8#19)(2007-9#7)(2008-1#13)(2008-10#66)(2008-11#19)(2008-12#7)(2008-2#10)(2008-3#17)(2008-4#9)(2008-5#11)(2008-6#4)(2008-7#19)(2008-8#14)(2008-9#10)(2009-10#3)(2009-11#3)(2009-12#2)(2009-2#5)(2009-3#4)(2009-4#5)(2009-5#2)(2009-6#10)(2009-7#4)(2009-8#1)(2009-9#7)(2010-1#5)(2010-10#2)(2010-11#5)(2010-12#6)(2010-2#6)(2010-3#3)(2010-4#1)(2010-5#6)(2010-6#2)(2010-7#8)(2010-8#8)(2010-9#4)(2011-1#10)(2011-12#11)(2011-2#64)(2011-3#1)(2012-1#4)(2012-11#5)(2012-12#25)(2012-2#29)(2012-3#11)(2012-6#1)(2013-1#43)(2013-7#8)(2013-8#12)
seriously affected##3##2##(1995-9#1)(2007-8#1)(2008-10#1)
seriously affects##2##2##(2008-1#1)(2010-7#1)
seriously by##3##2##(1996-12#1)(2008-10#1)(2008-4#1)
seriously damaged by##2##3##(2006-8#1)(2013-8#1)
seriously flawed##2##2##(1995-12#1)(2009-4#1)
seriously ill and##2##3##(1992-5#1)(2013-1#1)
seriously ill patients##2##3##(1995-2#1)(2006-6#1)
seriously ill##8##2##(1992-5#1)(1993-12#1)(1995-2#1)(2005-7#1)(2006-6#1)(2008-8#1)(2012-12#1)(2013-1#1)
seriously injured##2##2##(1990-3#1)(2012-12#1)
seriously limits##2##2##(2008-5#1)(2010-10#1)
seriously mentally ill##3##3##(2006-9#1)(2011-2#1)(2013-1#1)
seriously the##2##2##(2008-10#1)(2008-5#1)
seriously##87##1##(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-2#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#2)(1996-6#1)(1996-8#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#3)(2007-8#2)(2008-1#2)(2008-10#10)(2008-11#4)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#2)(2009-10#1)(2009-4#1)(2010-1#2)(2010-10#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#3)
seriousness of##10##2##(1990-3#1)(1995-6#1)(1997-5#1)(2006-8#1)(2008-2#1)(2009-4#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
seriousness##16##1##(1990-3#1)(1991-6#1)(1995-6#1)(1997-5#1)(2005-12#1)(2006-8#1)(2008-1#1)(2008-2#1)(2008-7#1)(2009-4#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
sermorelin and##2##2##(2007-11#2)
sermorelin##13##1##(2007-11#13)
sero##2##1##(2007-2#1)(2013-8#1)
sero--positive##2##1##(2007-8#2)
sero-conversion##5##1##(2007-12#3)(2012-12#1)(2012-2#1)
sero-converted##3##1##(2007-12#3)
sero-discordance##2##1##(2007-12#2)
sero-negative##3##1##(1990-6#1)(2007-12#1)(2012-2#1)
sero-positive##3##1##(2007-12#1)(2008-3#1)(2012-3#1)
sero-positivity##2##1##(2007-7#1)(2012-12#1)
sero-survey##2##1##(2011-2#2)
sero-surveys##2##1##(1994-9#1)(2007-12#1)
serocomplex##3##1##(1992-12#1)(1993-11#1)(2013-8#1)
seroconversion and##3##2##(2008-12#1)(2010-12#1)(2010-3#1)
seroconversion for##2##2##(1990-9#1)(2009-8#1)
seroconversion incidence##4##2##(1993-1#4)
seroconversion or##2##2##(1997-6#1)(2008-11#1)
seroconversion rate of##4##3##(2007-7#4)
seroconversion rate##6##2##(1997-8#1)(2007-7#5)
seroconversion rates##4##2##(2007-7#3)(2012-2#1)
seroconversion to##2##2##(2007-11#1)(2007-7#1)
seroconversion was##3##2##(1991-3#2)(2007-7#1)
seroconversion##48##1##(1990-3#3)(1990-9#1)(1991-3#3)(1993-1#4)(1993-11#2)(1997-6#1)(1997-8#1)(2005-9#1)(2007-11#2)(2007-2#2)(2007-7#10)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-8#2)(2010-12#1)(2010-3#1)(2011-2#1)(2012-1#5)(2012-2#1)(2013-1#1)(2013-8#1)
seroconversions##2##1##(1996-9#1)(2007-10#1)
seroconverted##7##1##(1991-3#1)(1995-9#1)(1997-6#2)(2005-9#1)(2008-1#1)(2013-1#1)
seroconverters##2##1##(1993-11#2)
serodiagnosis of tuberculosis##2##3##(1996-11#1)(2007-7#1)
serodiagnosis of##6##2##(1991-11#1)(1996-11#1)(1996-12#2)(2007-7#1)(2008-5#1)
serodiagnosis##7##1##(1991-11#1)(1996-11#1)(1996-12#2)(2007-7#1)(2008-5#1)(2011-1#1)
serodiscordant##3##1##(2012-11#1)(2013-7#1)(2013-8#1)
seroepidemiologic surveys##2##2##(1994-4#1)(1997-3#1)
seroepidemiologic##3##1##(1994-4#1)(1997-3#1)(2012-2#1)
seroepidemiological studies##2##2##(2005-7#1)(2006-10#1)
seroepidemiological survey of##2##3##(2006-10#1)(2011-2#1)
seroepidemiological##9##1##(1991-11#1)(1991-7#1)(2005-7#2)(2006-10#2)(2011-1#1)(2011-2#1)(2013-7#1)
serogroup A##3##2##(2007-2#1)(2008-12#1)(2009-5#1)
serogroup B meningococcal disease in##4##5##(1992-10#4)
serogroup B meningococcal disease##8##4##(1992-10#7)(2012-12#1)
serogroup B meningococcal vaccine##3##4##(1992-10#3)
serogroup B meningococcal##14##3##(1992-10#13)(2012-12#1)
serogroup B##24##2##(1992-10#13)(2011-1#3)(2012-12#6)(2013-8#2)
serogroup C##11##2##(1997-5#1)(2007-12#1)(2008-11#2)(2008-5#1)(2010-10#3)(2012-12#3)
serogroup O1##3##2##(1992-5#1)(1995-4#2)
serogroup W135##3##2##(2007-2#2)(2008-12#1)
serogroup Y isolates##2##3##(2007-12#2)
serogroup Y meningococci in##2##4##(2007-12#2)
serogroup Y meningococci##4##3##(2007-12#4)
serogroup Y strains##2##3##(2007-12#2)
serogroup Y##11##2##(2007-12#11)
serogroup##78##1##(1991-8#1)(1992-10#13)(1992-5#1)(1993-10#1)(1995-4#2)(1996-10#2)(1996-2#1)(1997-5#1)(2007-12#12)(2007-2#3)(2007-4#1)(2007-7#1)(2008-10#8)(2008-11#2)(2008-12#3)(2008-5#3)(2009-5#1)(2010-10#3)(2010-12#1)(2011-1#3)(2011-2#1)(2012-12#9)(2012-2#3)(2013-8#2)
serogroups A##7##2##(2009-9#1)(2010-10#3)(2011-1#1)(2012-12#1)(2013-1#1)
serogroups B##3##2##(2007-12#3)
serogroups of Neisseria meningitidis##3##4##(2007-12#2)(2011-1#1)
serogroups of##5##2##(2007-12#2)(2007-8#1)(2008-5#1)(2011-1#1)
serogroups##33##1##(1993-10#4)(2005-7#1)(2007-12#5)(2007-7#1)(2007-8#1)(2008-10#4)(2008-5#1)(2009-9#1)(2010-10#4)(2011-1#2)(2012-11#1)(2012-12#3)(2012-2#4)(2013-1#1)
serologic and##4##2##(1992-12#1)(1992-6#1)(1994-4#1)(2007-2#1)
serologic assays##3##2##(2008-5#2)(2011-2#1)
serologic markers##3##2##(2006-10#1)(2008-12#2)
serologic reactions##2##2##(2008-5#2)
serologic reactivity##3##2##(1993-3#1)(1993-9#2)
serologic studies##3##2##(1994-9#1)(2010-7#1)(2012-1#1)
serologic study##3##2##(1993-3#1)(1994-5#1)(1996-12#1)
serologic test##3##2##(1993-3#1)(1996-9#1)(2008-4#1)
serologic testing##5##2##(2006-10#3)(2009-9#1)(2012-3#1)
serologic tests for##4##3##(1992-1#1)(1995-5#2)(2007-8#1)
serologic tests were##3##3##(2012-3#1)(2013-1#2)
serologic tests##19##2##(1991-12#1)(1992-1#1)(1992-6#1)(1994-12#1)(1995-5#5)(1997-2#1)(2007-8#1)(2008-12#1)(2008-5#1)(2012-3#3)(2013-1#2)(2013-8#1)
serologic##80##1##(1990-3#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#3)(1992-6#3)(1993-3#3)(1993-6#1)(1993-9#2)(1994-12#2)(1994-2#1)(1994-4#2)(1994-5#1)(1994-6#1)(1994-9#2)(1995-5#7)(1996-12#2)(1996-9#1)(1997-2#2)(1997-8#2)(2006-10#4)(2006-9#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-12#3)(2008-4#1)(2008-5#7)(2009-8#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-2#5)(2012-1#1)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#2)
serological analysis of##2##3##(2008-4#2)
serological and molecular##2##3##(2007-12#1)(2008-10#1)
serological and##9##2##(1990-6#1)(1991-9#1)(1994-6#1)(1995-12#1)(2007-12#1)(2008-10#2)(2011-2#1)(2012-2#1)
serological assay##2##2##(1995-1#1)(1997-8#1)
serological assays##5##2##(1992-5#1)(1993-1#1)(2008-10#2)(2008-4#1)
serological comparisons and##2##3##(2008-10#2)
serological correlation##2##2##(2007-2#1)(2008-1#1)
serological data##2##2##(2008-10#1)(2008-8#1)
serological detection of##4##3##(2008-10#3)(2013-1#1)
serological diagnosis of##7##3##(1991-5#1)(1994-7#1)(1996-11#1)(2005-8#1)(2008-5#1)(2011-1#1)(2012-3#1)
serological diagnosis##8##2##(1991-5#1)(1994-7#1)(1995-4#1)(1996-11#1)(2005-8#1)(2008-5#1)(2011-1#1)(2012-3#1)
serological evidence of previous HBV infection##2##6##(2007-12#2)
serological evidence of##4##3##(1991-8#1)(2007-12#2)(2007-2#1)
serological evidence##5##2##(1991-8#1)(2006-10#1)(2007-12#2)(2007-2#1)
serological features##2##2##(2006-10#1)(2008-10#1)
serological findings##3##2##(1993-3#1)(2008-3#1)(2008-7#1)
serological follow-up##2##2##(1995-2#1)(2008-4#1)
serological marker of##2##3##(1991-4#1)(2010-12#1)
serological marker##4##2##(1991-4#1)(1995-9#1)(2010-12#1)(2012-2#1)
serological markers of HBV##2##4##(2007-12#1)(2007-8#1)
serological markers of##4##3##(1993-6#1)(2007-12#1)(2007-8#1)(2008-12#1)
serological markers##8##2##(1992-3#1)(1993-6#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-12#1)(2008-5#1)
serological methods##7##2##(1990-12#1)(1995-12#1)(2007-8#1)(2008-4#2)(2008-5#1)(2013-8#1)
serological prevalence##2##2##(2006-10#1)(2010-4#1)
serological properties##4##2##(2008-10#4)
serological reactions##2##2##(2008-10#1)(2008-5#1)
serological relatedness##2##2##(2007-6#1)(2008-10#1)
serological relationship##3##2##(2008-10#3)
serological responses##3##2##(2005-9#1)(2008-12#1)(2008-5#1)
serological screening##2##2##(2008-8#1)(2013-8#1)
serological study of##3##3##(2007-7#3)
serological study##4##2##(2007-7#4)
serological surveillance of##2##3##(1992-5#1)(2010-4#1)
serological survey for##2##3##(2006-10#1)(2006-2#1)
serological survey of##3##3##(2005-8#1)(2008-4#1)(2008-5#1)
serological survey##6##2##(2005-8#1)(2006-10#1)(2006-2#1)(2008-4#2)(2008-5#1)
serological surveys##2##2##(1996-7#1)(1997-3#1)
serological techniques##2##2##(1996-12#1)(2008-10#1)
serological test for##3##3##(1996-12#1)(2008-4#1)(2010-12#1)
serological test##9##2##(1993-8#2)(1996-12#1)(2006-10#1)(2007-8#1)(2008-4#2)(2010-12#1)(2011-2#1)
serological testing##5##2##(1990-6#1)(1992-10#1)(2005-11#1)(2006-10#2)
serological tests for##5##3##(1991-4#1)(1991-6#1)(1997-3#1)(2007-11#1)(2007-7#1)
serological tests##18##2##(1991-2#1)(1991-4#1)(1991-6#1)(1997-3#1)(1997-4#1)(2005-11#1)(2005-7#1)(2007-11#1)(2007-2#1)(2007-7#3)(2007-8#1)(2008-10#1)(2011-2#2)(2013-1#1)(2013-8#1)
serological typing##2##2##(2008-10#2)
serological##175##1##(1990-12#1)(1990-3#2)(1990-6#2)(1991-2#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-5#2)(1993-1#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#4)(1995-4#1)(1995-8#1)(1995-9#2)(1996-11#1)(1996-12#2)(1996-7#2)(1997-3#2)(1997-4#1)(1997-8#1)(2005-11#2)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#8)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#6)(2007-6#1)(2007-7#8)(2007-8#7)(2008-1#1)(2008-10#33)(2008-12#2)(2008-3#1)(2008-4#12)(2008-5#7)(2008-7#1)(2008-8#3)(2010-12#2)(2010-4#2)(2011-1#1)(2011-2#5)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#3)
serologically and##3##2##(1996-12#1)(2006-10#1)(2007-2#1)
serologically confirmed##3##2##(1992-9#1)(2006-8#1)(2007-12#1)
serologically defined##3##2##(1990-12#1)(1992-9#1)(2006-6#1)
serologically distinct from all##2##4##(2008-10#2)
serologically distinct from##5##3##(1992-10#1)(2008-10#4)
serologically distinct##6##2##(1992-10#1)(2008-10#5)
serologically proven##2##2##(1997-6#1)(2008-1#1)
serologically related to##2##3##(2008-10#2)
serologically related viruses##2##3##(2007-6#1)(2008-10#1)
serologically related##4##2##(2007-6#1)(2008-10#3)
serologically##39##1##(1990-12#1)(1992-10#2)(1992-9#2)(1993-1#1)(1993-5#2)(1994-12#1)(1996-12#2)(1997-6#1)(2004-11#1)(2005-7#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-4#1)(2008-5#1)(2012-2#2)(2013-1#1)
serologies##2##1##(2006-7#1)(2011-2#1)
serology and polymerase chain reaction##2##5##(1991-3#1)(2007-3#1)
serology and##8##2##(1990-6#1)(1991-3#1)(1994-7#1)(1997-6#1)(1997-7#1)(2007-2#1)(2007-3#1)(2010-12#1)
serology for##4##2##(2007-12#1)(2007-2#1)(2007-5#1)(2008-7#1)
serology in##9##2##(1991-9#1)(1993-3#1)(1993-9#1)(2006-10#1)(2007-7#1)(2007-8#1)(2009-7#1)(2012-11#2)
serology is##3##2##(2007-12#2)(2009-5#1)
serology of##4##2##(1992-12#1)(1993-3#1)(2008-10#1)(2008-4#1)
serology was positive##3##3##(1996-8#1)(2009-8#1)(2012-2#1)
serology was##4##2##(1996-8#1)(2007-12#1)(2009-8#1)(2012-2#1)
serology were##2##2##(1992-10#1)(2007-2#1)
serology##90##1##(1990-6#1)(1991-11#1)(1991-3#2)(1991-9#2)(1992-10#1)(1992-12#1)(1993-11#1)(1993-3#2)(1993-5#3)(1993-9#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1996-6#1)(1996-8#1)(1997-6#2)(1997-7#2)(2005-9#1)(2006-10#4)(2006-2#1)(2007-12#5)(2007-2#7)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#7)(2008-4#3)(2008-5#5)(2008-7#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#2)(2011-2#5)(2012-11#4)(2012-12#2)(2012-2#4)(2012-3#2)
seroma and##2##2##(2007-8#2)
seroma##8##1##(2004-9#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-6#1)(2012-3#1)
seromarkers##2##1##(1991-9#1)(1995-9#1)
seronegative controls##2##2##(2007-11#1)(2013-8#1)
seronegative for##3##2##(2007-2#1)(2009-5#1)(2012-2#1)
seronegative individuals##3##2##(2006-10#1)(2013-8#2)
seronegative samples##3##2##(1991-9#1)(1993-1#2)
seronegative spondyloarthropathies##2##2##(2006-10#1)(2008-9#1)
seronegative women##10##2##(1990-9#1)(1991-9#1)(1994-6#3)(2006-10#4)(2007-4#1)
seronegative##47##1##(1990-2#1)(1990-9#1)(1991-8#1)(1991-9#2)(1993-1#2)(1994-6#3)(1995-1#1)(1995-9#2)(1996-7#1)(1997-6#1)(2006-10#9)(2006-4#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2008-5#2)(2008-9#1)(2009-10#1)(2009-5#2)(2011-2#1)(2012-2#4)(2013-1#1)(2013-8#3)
seronegetive##2##1##(2008-8#2)
seropositive and seronegative##2##3##(1996-7#1)(2013-8#1)
seropositive cases##4##2##(2007-7#1)(2007-8#1)(2011-2#1)(2013-8#1)
seropositive for##9##2##(1991-11#1)(2006-10#1)(2007-2#2)(2007-8#1)(2008-11#1)(2008-5#1)(2011-1#1)(2013-8#1)
seropositive individuals##4##2##(1991-12#1)(2013-8#3)
seropositive patients in##2##3##(2008-3#1)(2008-4#1)
seropositive patients##8##2##(1990-2#1)(1990-9#1)(2006-7#1)(2007-7#2)(2008-3#1)(2008-4#1)(2013-8#1)
seropositive persons##6##2##(1990-6#1)(2007-7#4)(2012-3#1)
seropositive results##2##2##(1995-1#1)(2005-8#1)
seropositive rheumatoid arthritis who##2##4##(2006-10#2)
seropositive rheumatoid arthritis##5##3##(2006-10#3)(2007-7#2)
seropositive samples##2##2##(1991-9#1)(1994-12#1)
seropositive subjects##2##2##(1993-5#1)(1993-8#1)
seropositive women and##3##3##(1994-6#1)(2006-10#2)
seropositive women##7##2##(1990-5#1)(1994-6#3)(2006-10#3)
seropositive##88##1##(1990-2#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-11#2)(1991-12#2)(1991-8#2)(1991-9#1)(1992-4#1)(1993-1#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-6#5)(1995-1#2)(1996-7#1)(1997-2#2)(1997-4#1)(1997-5#1)(2005-8#1)(2006-10#10)(2006-7#1)(2007-12#1)(2007-2#4)(2007-7#9)(2007-8#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#3)(2009-11#2)(2009-5#2)(2010-12#1)(2010-7#4)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-8#7)
seropositives##2##1##(1991-6#1)(2009-5#1)
seropositivity for##3##2##(1996-11#1)(2008-8#1)(2010-6#1)
seropositivity in##6##2##(1991-1#1)(1991-11#1)(1992-2#1)(1997-2#1)(2007-7#1)(2013-7#1)
seropositivity to##2##2##(2006-10#1)(2013-8#1)
seropositivity was found among##2##4##(1994-6#1)(2007-7#1)
seropositivity was found##3##3##(1994-6#1)(2007-7#2)
seropositivity was##7##2##(1994-6#1)(1996-3#2)(2007-2#1)(2007-7#3)
seropositivity##41##1##(1990-3#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-5#1)(1992-2#1)(1993-11#2)(1993-3#1)(1994-6#2)(1995-1#2)(1996-11#1)(1996-3#3)(1997-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#7)(2008-1#1)(2008-5#3)(2008-8#1)(2010-12#1)(2010-6#1)(2013-7#1)(2013-8#3)
seroprevalence among##4##2##(1992-5#1)(1996-2#2)(2007-2#1)
seroprevalence and##2##2##(2007-7#1)(2011-2#1)
seroprevalence data##4##2##(1994-9#3)(2012-2#1)
seroprevalence in males was##2##4##(1995-9#1)(2011-2#1)
seroprevalence in##14##2##(1994-4#1)(1995-9#3)(1997-3#1)(1997-7#1)(2008-8#1)(2009-10#1)(2011-2#5)(2013-8#1)
seroprevalence of trypanozoon infection##2##4##(2011-2#2)
seroprevalence of##20##2##(1994-6#1)(2006-1#1)(2007-12#1)(2007-2#4)(2007-7#2)(2007-8#1)(2008-4#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-2#1)
seroprevalence was##3##2##(2007-2#2)(2012-12#1)
seroprevalence were##2##2##(2011-2#2)
seroprevalence##62##1##(1991-2#1)(1991-9#1)(1992-5#1)(1994-4#1)(1994-6#1)(1994-9#3)(1995-9#4)(1996-2#2)(1997-3#1)(1997-7#4)(2006-1#1)(2007-12#1)(2007-2#9)(2007-7#3)(2007-8#2)(2008-4#2)(2008-8#1)(2009-10#1)(2010-8#2)(2011-1#2)(2011-2#15)(2012-12#1)(2012-2#2)(2013-8#1)
serosa and##3##2##(1990-10#2)(2012-2#1)
serosa##15##1##(1990-10#4)(1991-5#1)(1992-8#1)(2007-12#2)(2007-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2012-2#3)
serosal surfaces##2##2##(2012-3#2)
serosal##10##1##(1994-3#1)(1994-9#1)(2006-6#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-6#2)(2012-3#2)
serositis in##2##2##(2006-10#1)(2008-5#1)
serositis##5##1##(1995-11#1)(1997-3#1)(2006-10#1)(2008-5#1)(2009-10#1)
serostatus##7##1##(1995-9#2)(2008-10#1)(2009-4#2)(2012-2#2)
serosurvey##2##1##(1992-5#1)(2005-7#1)
serotonergic activity##2##2##(1993-12#1)(2010-12#1)
serotonergic agents##2##2##(2008-5#1)(2008-9#1)
serotonergic and dopaminergic systems##2##4##(1993-5#1)(1994-9#1)
serotonergic and dopaminergic##5##3##(1993-5#1)(1994-9#2)(1996-8#1)(1997-5#1)
serotonergic and##11##2##(1993-5#1)(1994-11#1)(1994-6#2)(1994-9#2)(1996-8#1)(1997-5#1)(2008-7#3)
serotonergic cell firing##2##3##(2005-9#2)
serotonergic cells##7##2##(1994-2#2)(1997-3#5)
serotonergic dysfunction##2##2##(1992-11#1)(2008-5#1)
serotonergic function##4##2##(1993-3#1)(1996-1#1)(1996-7#1)(2009-10#1)
serotonergic innervation##3##2##(2007-12#3)
serotonergic mechanisms##2##2##(1996-7#1)(2006-10#1)
serotonergic nerve terminals##2##3##(1996-5#1)(1997-8#1)
serotonergic neuronal##3##2##(1992-3#1)(1992-7#1)(1995-12#1)
serotonergic neurons##9##2##(1994-2#2)(1995-12#1)(1996-12#1)(1996-4#1)(1996-5#1)(2005-8#1)(2008-6#1)(2008-7#1)
serotonergic neurotoxicity##2##2##(1990-5#1)(1997-8#1)
serotonergic responsivity in##2##3##(1996-7#2)
serotonergic signaling##6##2##(2012-3#6)
serotonergic system and##2##3##(1997-5#1)(2008-12#1)
serotonergic system##5##2##(1996-4#1)(1997-5#1)(2005-9#1)(2008-12#1)(2012-3#1)
serotonergic systems##3##2##(1993-7#1)(1996-3#1)(2007-12#1)
serotonergic##112##1##(1990-5#2)(1991-1#1)(1991-5#2)(1991-7#2)(1992-10#1)(1992-11#1)(1992-3#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-5#2)(1993-7#2)(1994-10#1)(1994-11#1)(1994-2#6)(1994-6#3)(1994-9#2)(1995-1#1)(1995-12#3)(1995-7#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#3)(1996-7#5)(1996-8#1)(1997-2#1)(1997-3#5)(1997-5#4)(1997-8#2)(2005-8#1)(2005-9#3)(2006-10#1)(2007-12#4)(2007-7#1)(2008-12#1)(2008-2#1)(2008-5#4)(2008-6#2)(2008-7#7)(2008-9#1)(2009-10#4)(2009-2#1)(2010-12#1)(2012-12#1)(2012-3#8)(2013-8#1)
serotonin &gt##2##2##(2005-11#1)(2006-10#1)
serotonin (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA)##2##6##(1992-1#1)(1997-8#1)
serotonin (5-HT) and##7##3##(1992-1#1)(1993-11#1)(1996-4#1)(1997-5#1)(1997-8#1)(2008-3#1)(2008-5#1)
serotonin (5-HT) in the##2##4##(2008-6#1)(2013-1#1)
serotonin (5-HT) in##4##3##(1993-3#1)(1996-10#1)(2008-6#1)(2013-1#1)
serotonin (5-HT) on##4##3##(1990-4#1)(1990-7#1)(1993-12#1)(1997-5#1)
serotonin (5-HT) receptor##3##3##(1991-5#1)(1994-2#1)(2012-12#1)
serotonin (5-HT)##39##2##(1990-2#1)(1990-4#1)(1990-7#1)(1991-5#1)(1992-1#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-2#3)(1995-1#1)(1995-3#1)(1996-10#1)(1996-4#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-9#1)(2007-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2012-12#1)(2013-1#1)
serotonin (5-hydroxytryptamine##13##2##(1992-7#1)(1993-2#1)(1995-12#3)(1996-12#2)(1996-3#1)(1996-7#2)(1997-1#1)(2008-2#1)(2012-12#1)
serotonin (5HT)##3##2##(1993-7#1)(1996-12#1)(2008-6#1)
serotonin 1A (5-HT1A)##2##3##(1993-12#1)(2005-9#1)
serotonin 1A##3##2##(1993-12#1)(1997-5#1)(2005-9#1)
serotonin 5-HT(2A) receptors##2##3##(2008-11#1)(2010-6#1)
serotonin 5-HT(2A)##3##2##(2008-11#1)(2008-9#1)(2010-6#1)
serotonin 5-HT1A receptor##3##3##(1993-3#1)(1994-9#1)(1996-8#1)
serotonin 5-HT1A##4##2##(1993-3#1)(1994-9#1)(1996-8#2)
serotonin 5-HT2##4##2##(1991-12#2)(1995-7#1)(1996-5#1)
serotonin agonists##4##2##(1993-9#1)(1995-1#1)(1995-12#1)(2008-7#1)
serotonin and dopamine##4##3##(1992-6#1)(2009-10#1)(2012-2#1)(2013-1#1)
serotonin and its##2##3##(1992-11#1)(1995-12#1)
serotonin and norepinephrine reuptake inhibitor##2##5##(2007-4#1)(2011-1#1)
serotonin and paroxetine##2##3##(1997-3#2)
serotonin and the##2##3##(2011-2#1)(2013-8#1)
serotonin and their##2##3##(1996-10#1)(1996-12#1)
serotonin and##29##2##(1990-11#1)(1990-7#1)(1992-11#1)(1992-6#1)(1993-9#1)(1995-12#1)(1996-10#2)(1996-12#1)(1997-1#1)(1997-3#2)(1997-6#1)(1997-7#1)(2007-12#1)(2007-4#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#5)
serotonin antagonists##2##2##(1993-12#1)(2004-12#1)
serotonin antiserum##3##2##(1995-12#3)
serotonin are##2##2##(1992-1#1)(2008-7#1)
serotonin content in the##3##4##(2008-4#1)(2008-5#1)(2008-6#1)
serotonin function##3##2##(2008-11#3)
serotonin have##2##2##(2007-12#1)(2007-6#1)
serotonin in the##11##3##(1990-5#2)(1990-7#1)(1992-11#1)(1993-7#1)(1995-12#2)(2006-1#1)(2006-12#1)(2010-12#1)(2013-7#1)
serotonin in##20##2##(1990-5#2)(1990-7#1)(1992-11#1)(1993-7#1)(1995-12#2)(1995-7#2)(1997-3#2)(1997-6#1)(2006-1#1)(2006-12#2)(2007-8#1)(2008-8#1)(2010-12#1)(2013-7#1)(2013-8#1)
serotonin level##2##2##(2009-10#1)(2010-12#1)
serotonin levels were increased##2##4##(1992-1#2)
serotonin levels were##6##3##(1992-1#4)(1994-12#1)(1996-10#1)
serotonin levels##8##2##(1992-1#4)(1994-12#1)(1995-12#1)(1996-10#1)(2007-6#1)
serotonin metabolism in##3##3##(1990-5#1)(1997-7#1)(2013-1#1)
serotonin metabolism##9##2##(1990-5#1)(1991-6#1)(1993-12#1)(1993-6#1)(1997-7#2)(2006-9#1)(2013-1#1)(2013-8#1)
serotonin neurotransmission##2##2##(2012-3#2)
serotonin or its##2##3##(2012-2#2)
serotonin or##3##2##(2008-1#1)(2012-2#2)
serotonin organelles from rabbit platelets##2##5##(1990-12#2)
serotonin organelles##4##2##(1990-12#4)
serotonin receptor gene##2##3##(1996-2#1)(2009-5#1)
serotonin receptor subtypes##2##3##(2005-9#2)
serotonin receptor##11##2##(1995-3#1)(1996-12#2)(1996-2#1)(1997-5#1)(2005-11#1)(2005-9#2)(2008-3#1)(2008-5#1)(2009-5#1)
serotonin receptors##7##2##(1991-5#1)(1996-2#1)(2005-8#1)(2005-9#1)(2010-5#1)(2012-2#2)
serotonin release and##2##3##(1990-7#1)(1995-12#1)
serotonin release##13##2##(1990-7#2)(1990-8#1)(1992-12#1)(1995-12#8)(2008-4#1)
serotonin reuptake inhibitor##9##3##(1996-8#1)(1997-3#1)(2006-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-2#1)(2012-3#1)
serotonin reuptake inhibitors (SRIs)##2##4##(2005-7#1)(2006-4#1)
serotonin reuptake inhibitors (SSRIs) for##2##5##(1996-7#1)(2013-8#1)
serotonin reuptake inhibitors (SSRIs) have##3##5##(2004-3#1)(2013-1#1)(2013-8#1)
serotonin reuptake inhibitors (SSRIs)##14##4##(1996-7#1)(2004-3#1)(2005-9#1)(2006-4#1)(2007-8#1)(2008-11#1)(2008-6#2)(2008-8#1)(2012-3#1)(2013-1#1)(2013-8#3)
serotonin reuptake inhibitors and##6##4##(1996-12#2)(1997-8#3)(2004-3#1)
serotonin reuptake inhibitors on##2##4##(2005-6#1)(2012-3#1)
serotonin reuptake inhibitors or##2##4##(2006-12#1)(2008-9#1)
serotonin reuptake inhibitors##40##3##(1996-1#1)(1996-12#3)(1996-7#1)(1997-8#3)(2004-3#2)(2005-6#1)(2005-7#3)(2005-9#1)(2006-12#1)(2006-4#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#4)(2008-8#2)(2008-9#1)(2010-2#1)(2012-3#3)(2013-1#1)(2013-8#3)
serotonin reuptake##57##2##(1991-1#1)(1996-1#1)(1996-12#3)(1996-4#1)(1996-7#2)(1996-8#1)(1997-3#1)(1997-8#3)(2004-3#2)(2005-6#1)(2005-7#3)(2005-9#1)(2006-10#2)(2006-12#1)(2006-4#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#5)(2008-8#2)(2008-9#1)(2009-6#1)(2010-2#2)(2011-1#2)(2012-3#4)(2013-1#1)(2013-8#3)
serotonin selective reuptake##2##3##(2008-3#1)(2011-2#1)
serotonin syndrome##2##2##(2007-7#1)(2013-1#1)
serotonin synthesis##7##2##(1992-11#2)(1993-12#1)(1994-10#1)(1995-7#1)(1996-5#1)(1996-7#1)
serotonin system##3##2##(2006-9#1)(2008-7#1)(2012-3#1)
serotonin to##2##2##(1996-10#1)(2006-12#1)
serotonin transmission##2##2##(2008-11#1)(2008-8#1)
serotonin transporter (SERT)##3##3##(1996-12#1)(1997-2#1)(2010-12#1)
serotonin transporter##18##2##(1995-11#4)(1995-5#2)(1996-10#1)(1996-12#2)(1996-5#3)(1996-7#1)(1997-2#1)(2010-12#1)(2012-2#1)(2012-3#2)
serotonin turnover in##2##3##(2013-1#2)
serotonin turnover##3##2##(2013-1#3)
serotonin type##2##2##(1996-5#1)(2010-12#1)
serotonin uptake##3##2##(1993-4#1)(1995-7#1)(2008-7#1)
serotonin was##2##2##(1991-5#1)(1995-7#1)
serotonin were##4##2##(1990-7#1)(1992-1#2)(2010-12#1)
serotonin##416##1##(1990-11#1)(1990-12#5)(1990-2#1)(1990-4#2)(1990-5#6)(1990-7#7)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-5#6)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#9)(1992-11#4)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#3)(1992-8#4)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#7)(1993-2#1)(1993-3#4)(1993-4#2)(1993-6#1)(1993-7#2)(1993-9#2)(1994-10#2)(1994-11#1)(1994-12#2)(1994-2#4)(1994-6#2)(1994-9#1)(1995-1#2)(1995-11#6)(1995-12#21)(1995-3#2)(1995-5#2)(1995-7#10)(1996-1#4)(1996-10#6)(1996-12#15)(1996-2#2)(1996-3#2)(1996-4#3)(1996-5#10)(1996-7#7)(1996-8#3)(1997-1#2)(1997-2#1)(1997-3#6)(1997-5#6)(1997-6#4)(1997-7#4)(1997-8#4)(2004-12#1)(2004-3#2)(2005-10#1)(2005-11#3)(2005-6#1)(2005-7#5)(2005-8#1)(2005-9#7)(2006-1#1)(2006-10#5)(2006-12#9)(2006-4#2)(2006-9#3)(2007-11#1)(2007-12#6)(2007-4#2)(2007-6#3)(2007-7#2)(2007-8#4)(2008-1#3)(2008-10#1)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#6)(2008-5#8)(2008-6#8)(2008-7#10)(2008-8#6)(2008-9#4)(2009-10#3)(2009-5#1)(2009-6#2)(2009-8#4)(2010-12#9)(2010-2#2)(2010-5#2)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-12#3)(2012-2#8)(2012-3#11)(2013-1#8)(2013-7#2)(2013-8#14)
serotonin)##5##1##(1996-7#1)(2008-3#1)(2008-4#1)(2012-12#1)(2012-3#1)
serotonin-evoked currents##2##2##(1996-11#2)
serotonin-evoked##5##1##(1996-11#3)(2010-12#2)
serotonin-norepinephrine reuptake inhibitor##2##3##(2011-1#1)(2013-1#1)
serotonin3 receptors##2##2##(1996-2#2)
serotonin3##4##1##(1996-2#2)(1996-8#2)
serotonine##2##1##(1996-8#1)(2011-2#1)
serotoninergic neurons##2##2##(1995-12#2)
serotoninergic system##5##2##(1995-12#1)(2008-6#2)(2010-12#2)
serotoninergic##12##1##(1993-12#2)(1994-10#1)(1994-2#1)(1995-12#3)(2008-11#1)(2008-6#2)(2010-12#2)
serotype 1 Marek's disease virus (MDV)##2##6##(2008-5#1)(2013-8#1)
serotype 1 Marek's disease##3##4##(2008-5#1)(2013-8#2)
serotype 1##15##2##(1993-2#1)(1996-12#3)(2008-4#1)(2008-5#6)(2013-8#4)
serotype 2##7##2##(1993-2#1)(2009-6#4)(2010-12#1)(2013-8#1)
serotype 3##4##2##(2006-8#3)(2013-8#1)
serotype 4##2##2##(2008-5#2)
serotype 6B##2##2##(2011-2#2)
serotype 7F##2##2##(2012-12#2)
serotype A##7##2##(1991-3#2)(2007-10#1)(2007-7#1)(2008-5#3)
serotype A-specific epitope##2##3##(1991-3#2)
serotype B##3##2##(2008-5#3)
serotype G1##3##2##(2007-11#3)
serotype Inaba##2##2##(1992-5#1)(1996-10#1)
serotype distribution##4##2##(2007-12#1)(2008-5#2)(2011-2#1)
serotype e##3##2##(2006-8#3)
serotype in##4##2##(1992-5#1)(2008-10#2)(2008-5#1)
serotype is##2##2##(2008-10#1)(2008-5#1)
serotype of C##2##3##(2008-5#2)
serotype of infectious bronchitis virus##2##5##(2008-5#2)
serotype of the##2##3##(1994-9#1)(2008-10#1)
serotype of##12##2##(1994-9#1)(1997-3#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#5)(2011-1#1)
serotype prevalence##2##2##(2007-8#2)
serotype was##3##2##(2008-5#1)(2010-9#1)(2013-8#1)
serotype##138##1##(1990-4#1)(1991-12#1)(1991-3#4)(1992-10#1)(1992-2#2)(1992-5#2)(1992-8#2)(1993-12#1)(1993-2#2)(1994-8#1)(1994-9#1)(1995-5#1)(1996-10#1)(1996-12#4)(1996-8#2)(1997-3#1)(2005-7#1)(2006-6#1)(2006-8#9)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#5)(2007-6#1)(2007-7#4)(2007-8#3)(2008-1#3)(2008-10#10)(2008-2#1)(2008-4#1)(2008-5#34)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#4)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-12#2)(2013-8#9)
serotype-cross-reactivity##2##1##(2012-2#2)
serotypes 1 and##2##3##(1993-2#1)(2007-2#1)
serotypes 1##8##2##(1993-2#1)(1996-12#4)(1997-6#1)(2007-2#1)(2013-8#1)
serotypes and their##2##3##(1993-2#1)(1996-12#1)
serotypes and##6##2##(1991-12#1)(1993-2#1)(1995-5#1)(1996-12#1)(2012-12#1)(2012-3#1)
serotypes are##2##2##(2005-12#1)(2013-8#1)
serotypes differed in##2##3##(2008-10#2)
serotypes in the##3##3##(2007-5#1)(2007-7#1)(2008-10#1)
serotypes in##5##2##(2007-5#1)(2007-7#1)(2008-10#1)(2008-5#1)(2011-2#1)
serotypes not##3##2##(2011-2#1)(2012-12#2)
serotypes of##10##2##(2007-8#1)(2008-10#3)(2011-1#2)(2012-12#3)(2013-8#1)
serotypes other than##2##3##(2007-11#1)(2008-5#1)
serotypes than the##2##3##(2007-11#2)
serotypes was##2##2##(1995-5#1)(2009-5#1)
serotypes were##5##2##(1993-6#1)(1994-9#1)(1996-12#1)(2013-8#2)
serotypes##97##1##(1990-5#1)(1991-12#1)(1993-2#3)(1993-6#2)(1994-3#1)(1994-9#1)(1995-5#3)(1996-12#7)(1996-8#1)(1997-3#5)(1997-6#1)(2005-12#3)(2005-7#1)(2006-8#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-5#2)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#11)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#1)(2009-5#1)(2010-6#1)(2011-1#4)(2011-2#5)(2012-12#10)(2012-3#1)(2013-8#8)
serotypic switch##2##2##(2012-12#2)
serotyping and##2##2##(1994-12#1)(2008-5#1)
serotyping of staphylocoagulase##2##3##(2010-6#2)
serotyping of##3##2##(2010-6#2)(2011-1#1)
serotyping##13##1##(1994-12#2)(1997-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-5#1)(2010-6#3)(2011-1#1)(2012-3#2)
serous and##3##2##(2008-7#2)(2011-2#1)
serous carcinomas##3##2##(2012-12#3)
serous cavities##2##2##(1993-6#1)(2008-4#1)
serous chorioretinopathy##5##2##(2006-4#2)(2013-7#2)(2013-8#1)
serous cystadenocarcinoma of the ovary##2##5##(1993-9#1)(2012-2#1)
serous cystadenocarcinoma##5##2##(1993-9#1)(2007-12#1)(2012-2#3)
serous cystadenoma of##4##3##(2008-11#1)(2012-2#3)
serous cystadenoma##6##2##(2008-11#1)(2012-11#1)(2012-2#4)
serous detachment associated with latanoprost/timolol fixed combination##4##7##(2013-1#4)
serous detachment##5##2##(2011-1#1)(2013-1#4)
serous effusion##2##2##(1992-2#1)(2013-1#1)
serous epithelial ovarian cancers##2##4##(2009-4#2)
serous fat atrophy##2##3##(2007-2#2)
serous hepatic##2##2##(2007-9#2)
serous otitis##2##2##(2007-12#1)(2011-1#1)
serous ovarian adenocarcinoma##3##3##(2010-12#3)
serous ovarian##5##2##(1990-10#1)(2007-2#1)(2010-12#3)
serous papillary cystadenoma of the##2##5##(2013-7#2)
serous papillary##3##2##(1994-9#1)(2013-7#2)
serous##69##1##(1990-10#2)(1992-2#2)(1993-6#1)(1993-9#2)(1994-9#1)(2004-10#1)(2006-4#2)(2007-12#2)(2007-2#3)(2007-6#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#5)(2009-2#1)(2009-4#2)(2010-11#1)(2010-12#4)(2010-9#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#4)(2012-2#7)(2013-1#8)(2013-7#4)(2013-8#1)
serovar 25##2##2##(1992-12#2)
serovar B strains of##2##4##(1997-6#2)
serovar B strains##3##3##(1997-6#3)
serovar B##6##2##(1997-6#5)(2008-5#1)
serovar Enteritidis and##2##3##(1997-3#1)(2010-4#1)
serovar Enteritidis##4##2##(1997-3#2)(2008-6#1)(2010-4#1)
serovar L2##2##2##(1990-5#1)(2005-11#1)
serovar diversity in##2##3##(1994-3#2)
serovar typhimurium##3##2##(1991-1#2)(2010-4#1)
serovar##55##1##(1990-5#1)(1991-1#2)(1991-8#3)(1992-12#4)(1994-3#2)(1996-9#1)(1997-3#6)(1997-6#5)(2005-11#1)(2005-7#1)(2006-10#2)(2007-6#5)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-5#6)(2008-6#1)(2010-4#5)(2012-3#2)(2013-1#1)(2013-7#1)
serovars and##2##2##(1993-9#1)(2013-1#1)
serovars belonging to##2##3##(2007-8#2)
serovars of##2##2##(1990-5#1)(2012-2#1)
serovars##24##1##(1990-5#1)(1992-12#1)(1993-9#3)(1994-3#2)(1997-6#2)(2005-7#2)(2007-7#2)(2007-8#3)(2008-9#1)(2011-2#1)(2012-2#2)(2013-1#4)
serpentine##7##1##(2007-7#1)(2007-9#1)(2008-10#3)(2008-6#1)(2010-3#1)
serpentis##3##1##(1996-12#1)(2012-3#2)
serpin BSZx##2##2##(1996-9#2)
serpin##14##1##(1991-6#1)(1993-11#1)(1995-5#3)(1995-6#1)(1995-8#1)(1996-9#2)(1997-2#1)(1997-5#1)(2006-9#1)(2008-4#1)(2009-4#1)
serpins##8##1##(1994-12#2)(1995-1#1)(1995-5#1)(1995-6#1)(2008-4#2)(2009-4#1)
serpyllum##5##1##(2007-1#3)(2012-2#2)
serralysin##2##1##(1994-10#1)(1997-2#1)
serrata and##3##2##(2008-5#1)(2008-9#2)
serrata was##2##2##(1992-4#1)(2013-1#1)
serrata##12##1##(1992-4#1)(2008-5#1)(2008-9#3)(2013-1#7)
serrated adenoma##2##2##(2009-12#2)
serrated##12##1##(2007-3#1)(2009-12#8)(2009-3#3)
serratus anterior muscle flap##2##4##(2007-8#1)(2011-2#1)
serratus anterior##8##2##(2007-8#2)(2010-9#3)(2011-2#2)(2012-2#1)
serratus##10##1##(1992-6#1)(1993-9#1)(2007-8#2)(2010-9#3)(2011-2#2)(2012-2#1)
sertindole##3##1##(2005-7#2)(2005-8#1)
sertoli cells##2##2##(2008-4#1)(2010-11#1)
sertraline in##2##2##(2012-12#1)(2012-3#1)
sertraline##11##1##(1990-2#1)(2005-7#1)(2006-5#1)(2007-8#1)(2008-8#1)(2012-12#4)(2012-2#1)(2012-3#1)
serum (1##2##2##(1997-3#1)(2009-3#1)
serum (5##2##2##(2008-10#1)(2009-10#1)
serum (FBS)##12##2##(1990-11#1)(1992-11#1)(1995-3#1)(2004-11#1)(2007-11#1)(2008-11#6)(2012-3#1)
serum (p##3##2##(1991-9#1)(2008-7#2)
serum +##3##2##(1994-6#1)(1996-10#2)
serum 1##3##2##(1995-2#1)(2006-10#1)(2008-5#1)
serum 17beta-estradiol##2##2##(1996-3#1)(2009-7#1)
serum 25(OH)D##4##2##(2011-1#2)(2011-2#2)
serum 25-hydroxyvitamin D levels##4##4##(2010-7#3)(2011-2#1)
serum 25-hydroxyvitamin D##9##3##(2008-1#1)(2010-7#3)(2011-2#3)(2012-1#1)(2012-2#1)
serum A1AT level##2##3##(2007-11#2)
serum ACE level##2##3##(1990-2#1)(1993-12#1)
serum ACE levels##3##3##(2007-11#1)(2010-6#2)
serum ACE##5##2##(1990-2#1)(1993-12#1)(2007-11#1)(2010-6#2)
serum ACTH##2##2##(1995-12#2)
serum AFP##4##2##(1995-4#2)(2008-10#1)(2009-8#1)
serum ALT levels##3##3##(2007-11#1)(2007-7#2)
serum ALT##8##2##(2007-11#2)(2007-2#1)(2007-7#2)(2009-11#1)(2010-4#1)(2011-2#1)
serum AST##4##2##(2006-4#1)(2008-10#1)(2008-6#1)(2013-1#1)
serum BDNF levels##2##3##(2011-2#2)
serum C-reactive protein##3##3##(1993-11#1)(1996-9#1)(2008-10#1)
serum C3##4##2##(1991-12#1)(1992-7#1)(2007-2#1)(2007-7#1)
serum CA 125##5##3##(1991-4#1)(1996-11#1)(2007-4#3)
serum CA##6##2##(1991-4#1)(1996-11#1)(2007-4#3)(2008-8#1)
serum CA-125 level##2##3##(2008-10#1)(2012-3#1)
serum CA-125##4##2##(2006-9#1)(2008-10#1)(2012-3#1)(2013-8#1)
serum CA19-9##2##2##(2006-10#1)(2011-2#1)
serum CEA levels##2##3##(2008-2#2)
serum CEA##5##2##(2008-2#5)
serum CRP##5##2##(1997-7#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)
serum D-dimer level##3##3##(2010-8#2)(2011-2#1)
serum DC-SIGNR##2##2##(2013-7#2)
serum DNA##4##2##(2007-11#4)
serum EC-SOD in Group##2##4##(1992-11#2)
serum EC-SOD##3##2##(1992-11#3)
serum FDP was##2##3##(1993-2#2)
serum FSH##3##2##(2011-2#2)(2012-12#1)
serum GTH-II levels##2##3##(2008-5#2)
serum HA concentration in patients with disseminated neoplasm##2##8##(1996-12#2)
serum HA##4##2##(1996-12#2)(2006-2#2)
serum HAE activity and the##2##5##(1996-12#2)
serum HAE activity##3##3##(1996-12#3)
serum HBV DNA level##3##4##(2008-5#1)(2009-11#1)(2012-1#1)
serum HBV DNA levels after##2##5##(2009-8#2)
serum HBV DNA##5##3##(2008-5#1)(2009-11#1)(2009-8#2)(2012-1#1)
serum HBV-DNA ≥ 1##2##4##(2011-1#2)
serum HBV-DNA##4##2##(2011-1#4)
serum HCO3(-) and##2##3##(2007-8#2)
serum HCV##2##2##(1996-2#1)(2013-1#1)
serum HCY level##2##3##(2007-9#2)
serum HCY##4##2##(2007-9#4)
serum HDL cholesterol##2##3##(1991-10#2)
serum HDL##3##2##(1991-10#2)(1997-1#1)
serum IFN-gamma##3##2##(1996-10#1)(2006-4#1)(2011-1#1)
serum IGF-I concentration##2##3##(1994-8#1)(2008-9#1)
serum IGF-I levels##2##3##(1994-8#1)(2012-3#1)
serum IGF-I to##2##3##(1994-8#2)
serum IGF-I##8##2##(1994-8#5)(2008-9#1)(2012-3#1)(2013-1#1)
serum IL-10##2##2##(2008-4#1)(2012-12#1)
serum IL-2 level##2##3##(2010-4#2)
serum IL-5##3##2##(2008-1#1)(2010-12#1)(2011-1#1)
serum IL-6 and##2##3##(1995-7#1)(2011-1#1)
serum IL-6##9##2##(1995-7#1)(1997-7#3)(1997-8#1)(2011-1#3)(2012-12#1)
serum IgA##3##2##(1990-12#1)(2006-2#1)(2008-5#1)
serum IgE concentration##4##3##(1993-4#1)(1997-2#1)(2008-11#1)(2008-4#1)
serum IgE elevation##2##3##(2010-12#1)(2013-1#1)
serum IgE##16##2##(1993-4#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2010-12#1)(2011-1#3)(2012-2#1)(2012-3#1)(2013-1#2)
serum IgG and##2##3##(2008-11#1)(2011-1#1)
serum IgG concentration##2##3##(1992-3#1)(2008-10#1)
serum IgG from##2##3##(1994-11#1)(2011-1#1)
serum IgG levels##2##3##(1992-3#1)(2012-12#1)
serum IgG##16##2##(1991-3#1)(1992-3#2)(1994-11#1)(1997-7#1)(2006-4#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-7#2)(2011-1#2)(2012-12#1)
serum IgM was##2##3##(1992-12#1)(2008-5#1)
serum IgM##4##2##(1992-12#1)(1995-2#1)(2008-10#1)(2008-5#1)
serum KM01 levels##2##3##(1995-4#2)
serum KM01##5##2##(1995-4#5)
serum LDL cholesterol##2##3##(1997-6#1)(2013-8#1)
serum LDL##3##2##(1997-1#1)(1997-6#1)(2013-8#1)
serum LH levels##2##3##(1995-3#2)
serum LIF levels##2##3##(1995-2#2)
serum LPH##2##2##(1990-10#2)
serum Lp(a) levels##2##3##(1991-12#1)(1993-12#1)
serum Lp(a)##6##2##(1991-12#2)(1993-12#1)(2007-7#2)(2013-7#1)
serum MBP##3##2##(1991-6#2)(1997-2#1)
serum MPA concentrations were##2##4##(1995-10#2)
serum MPA concentrations##4##3##(1995-10#4)
serum MPA##6##2##(1995-10#6)
serum MT levels##2##3##(1996-7#2)
serum MT##3##2##(1996-7#3)
serum NAA levels##2##3##(2007-10#2)
serum NSE levels in##2##4##(1990-8#1)(1996-1#1)
serum NSE levels were also recorded in##2##7##(1990-8#1)(1994-10#1)
serum NSE levels##6##3##(1990-8#2)(1994-10#2)(1996-1#2)
serum NSE##12##2##(1990-6#3)(1990-8#3)(1994-10#3)(1996-1#3)
serum PEDF##2##2##(2012-5#2)
serum PG I##2##3##(2007-8#2)
serum PG II##2##3##(2007-8#2)
serum PG##4##2##(2007-8#4)
serum PNIIIP##2##2##(2006-2#2)
serum PRL levels##3##3##(2008-5#1)(2011-2#1)(2013-8#1)
serum PRL##6##2##(2008-5#4)(2011-2#1)(2013-8#1)
serum PSA##6##2##(1990-9#1)(2006-9#3)(2009-5#1)(2012-12#1)
serum PTH##4##2##(2007-7#3)(2008-1#1)
serum T during##2##3##(2013-8#2)
serum T levels##2##3##(2013-8#2)
serum T##5##2##(2013-8#5)
serum T3##2##2##(2006-9#1)(2008-6#1)
serum T4 and T3##2##4##(1990-3#2)
serum T4 levels##2##3##(1996-12#2)
serum T4##7##2##(1990-3#2)(1991-12#2)(1996-12#2)(2006-9#1)
serum TARC##2##2##(2012-1#2)
serum TBARS##2##2##(2008-10#2)
serum TSH and##3##3##(2008-6#1)(2013-1#2)
serum TSH levels##2##3##(2013-8#2)
serum TSH##12##2##(2006-6#1)(2006-9#2)(2008-6#2)(2011-12#2)(2013-1#2)(2013-8#3)
serum TT4##2##2##(1995-3#2)
serum Zn(++) levels##2##3##(2008-5#2)
serum [total CO2]##3##3##(2007-8#3)
serum [total##4##2##(2007-8#4)
serum a##2##2##(1990-2#1)(1996-5#1)
serum activities of##3##3##(1993-7#1)(2008-5#1)(2009-8#1)
serum activity of##3##3##(2005-7#1)(2007-6#1)(2008-10#1)
serum activity##5##2##(1990-4#1)(2005-7#1)(2006-6#1)(2007-6#1)(2008-10#1)
serum adiponectin and##3##3##(2011-1#1)(2012-11#1)(2013-1#1)
serum adiponectin level##4##3##(2007-8#2)(2011-1#1)(2013-8#1)
serum adiponectin levels and##2##4##(2012-11#1)(2013-8#1)
serum adiponectin levels in##3##4##(2011-1#3)
serum adiponectin levels##5##3##(2011-1#3)(2012-11#1)(2013-8#1)
serum adiponectin##13##2##(2007-8#3)(2011-1#5)(2012-11#2)(2013-1#1)(2013-8#2)
serum after##5##2##(1991-2#1)(1997-3#1)(2008-10#2)(2013-8#1)
serum against##4##2##(1994-11#1)(1997-5#1)(1997-6#1)(2012-12#1)
serum agglutination test##4##3##(2005-9#1)(2008-5#1)(2011-2#1)(2012-2#1)
serum alanine aminotransferase (ALT) activity##2##5##(1995-3#1)(1997-8#1)
serum alanine aminotransferase (ALT)##6##4##(1995-3#1)(1997-8#1)(2007-11#1)(2009-11#1)(2010-4#1)(2012-3#1)
serum alanine aminotransferase##9##3##(1995-3#1)(1997-8#1)(2005-12#1)(2007-11#1)(2007-8#1)(2009-11#1)(2010-4#1)(2012-3#1)(2013-1#1)
serum albumen##4##2##(2006-5#1)(2008-10#3)
serum albumin (BSA) and##8##4##(1996-11#1)(2006-12#1)(2007-8#1)(2008-10#4)(2008-7#1)
serum albumin (BSA) is##5##4##(1992-11#1)(2008-10#1)(2008-5#1)(2010-4#1)(2013-1#1)
serum albumin (BSA) was##9##4##(1993-11#1)(1995-12#1)(1997-2#1)(2007-8#1)(2008-10#3)(2008-5#1)(2013-8#1)
serum albumin (BSA)##66##3##(1990-12#1)(1990-2#1)(1991-6#1)(1992-11#1)(1993-11#1)(1994-8#1)(1995-12#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(2004-9#1)(2005-11#3)(2006-10#1)(2006-12#2)(2007-2#1)(2007-8#2)(2008-10#25)(2008-11#3)(2008-3#2)(2008-5#3)(2008-7#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-4#1)(2013-1#1)(2013-8#2)
serum albumin (HSA)##30##3##(1992-8#1)(1994-8#2)(1996-1#1)(1996-11#1)(1997-2#1)(1997-8#1)(2005-11#3)(2006-11#1)(2006-12#1)(2007-8#1)(2008-10#16)(2008-5#1)
serum albumin (SA) in##2##4##(1995-12#1)(2012-12#1)
serum albumin and ovalbumin were##2##5##(1991-3#1)(2008-10#1)
serum albumin and##20##3##(1991-2#1)(1991-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(2005-11#1)(2006-4#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-7#1)
serum albumin as a##2##4##(2008-10#1)(2009-9#1)
serum albumin as the##2##4##(1991-12#1)(2008-10#1)
serum albumin as##9##3##(1991-12#1)(1992-8#1)(1996-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-9#1)(2012-2#1)
serum albumin by##5##3##(1990-10#1)(1993-12#1)(1997-2#1)(2008-10#1)(2008-5#1)
serum albumin concentration and##2##4##(1997-7#1)(1997-8#1)
serum albumin concentration##5##3##(1993-9#1)(1997-7#1)(1997-8#1)(2008-1#2)
serum albumin conjugate##4##3##(1990-12#1)(2008-11#2)(2010-5#1)
serum albumin conjugates of##2##4##(1995-11#1)(1997-3#1)
serum albumin conjugates##3##3##(1995-11#1)(1997-3#2)
serum albumin did not##2##4##(1991-2#1)(1992-7#1)
serum albumin from##2##3##(2005-11#1)(2012-12#1)
serum albumin in the olfactory bulb of##2##7##(2008-7#2)
serum albumin in the##6##4##(1993-4#1)(1995-12#1)(2006-11#1)(2008-7#3)
serum albumin in##9##3##(1993-4#1)(1995-12#1)(2006-11#1)(2008-11#1)(2008-7#3)(2010-11#1)(2012-3#1)
serum albumin injected##2##3##(1994-3#1)(2008-7#1)
serum albumin is##3##3##(1996-11#1)(2012-11#2)
serum albumin level##2##3##(2007-12#1)(2008-1#1)
serum albumin solution and##2##4##(1990-6#1)(1996-6#1)
serum albumin was##4##3##(1990-12#1)(1993-12#1)(1996-11#1)(2005-12#1)
serum albumin were measured##2##4##(1991-3#1)(2007-9#1)
serum albumin were##4##3##(1991-3#1)(1994-9#1)(2005-12#1)(2007-9#1)
serum albumin##287##2##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#1)(1990-4#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#3)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#4)(1992-9#1)(1993-11#3)(1993-12#2)(1993-2#2)(1993-4#1)(1993-8#2)(1993-9#1)(1994-12#2)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#5)(1994-9#3)(1995-11#1)(1995-12#8)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#2)(1996-1#2)(1996-10#1)(1996-11#9)(1996-12#2)(1996-2#1)(1996-6#2)(1996-7#1)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#3)(1997-7#1)(1997-8#2)(2004-9#1)(2005-10#1)(2005-11#13)(2005-12#3)(2005-8#1)(2006-10#2)(2006-11#2)(2006-12#4)(2006-2#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#6)(2007-9#1)(2008-1#4)(2008-10#63)(2008-11#10)(2008-2#1)(2008-3#5)(2008-5#9)(2008-7#11)(2008-9#1)(2009-11#1)(2009-6#1)(2009-9#2)(2010-1#2)(2010-11#2)(2010-4#4)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#5)
serum albumin)##6##2##(1997-6#1)(2008-10#3)(2008-3#2)
serum alkaline phosphatase##10##3##(1990-6#1)(1991-3#2)(1991-8#1)(1995-1#1)(1995-6#1)(2007-11#1)(2007-7#1)(2010-12#1)(2013-8#1)
serum alkaline##11##2##(1990-6#1)(1991-3#2)(1991-8#1)(1995-1#1)(1995-6#1)(2007-11#1)(2007-7#1)(2010-12#1)(2013-8#2)
serum alone##3##2##(1991-10#1)(1991-7#1)(1994-12#1)
serum alpha##2##2##(2009-4#1)(2010-12#1)
serum alpha-GST and##2##3##(1996-9#2)
serum alpha-GST##5##2##(1996-9#5)
serum alpha-fetoprotein##3##2##(1990-9#1)(2009-8#1)(2011-2#1)
serum also##4##2##(1991-8#1)(1992-6#2)(1994-12#1)
serum aluminum concentrations##3##3##(1992-11#3)
serum aluminum##5##2##(1992-11#3)(1992-4#2)
serum amylase##5##2##(1993-12#1)(2010-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
serum amyloid A (SAA)##6##4##(1991-12#1)(1993-11#1)(1995-3#1)(1996-2#1)(2008-5#1)(2009-10#1)
serum amyloid A gene##2##4##(1993-6#1)(1995-3#1)
serum amyloid A##12##3##(1991-12#1)(1993-11#1)(1993-6#1)(1995-3#2)(1996-2#2)(2005-7#1)(2008-5#2)(2009-10#1)(2009-8#1)
serum amyloid P component##4##4##(1991-8#1)(1996-6#2)(2010-12#1)
serum amyloid P##5##3##(1991-8#1)(1996-6#2)(2010-12#1)(2012-12#1)
serum amyloid P-component (SAP)##2##4##(1992-12#2)
serum amyloid protein##2##3##(2008-7#1)(2010-12#1)
serum amyloid##22##2##(1991-12#1)(1991-8#1)(1992-12#2)(1993-11#1)(1993-6#1)(1995-3#2)(1996-2#2)(1996-6#2)(2005-7#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-8#1)(2010-12#2)(2012-12#1)
serum analysis##3##2##(2008-10#1)(2008-6#1)(2009-9#1)
serum and CSF##5##3##(1995-3#2)(2007-10#1)(2007-8#1)(2008-3#1)
serum and a##3##3##(2005-8#1)(2008-10#1)(2008-5#1)
serum and an eluate##2##4##(1994-6#2)
serum and an##3##3##(1994-6#2)(2008-7#1)
serum and animal##2##3##(2008-11#2)
serum and bFGF##2##3##(1995-1#2)
serum and bile##2##3##(1991-3#1)(2010-12#1)
serum and cerebrospinal fluid##5##4##(1995-3#1)(1996-2#1)(1997-8#1)(2009-6#1)(2011-2#1)
serum and cervical secretion from patients with condyloma acuminatum##2##9##(2011-1#2)
serum and cervical secretion##3##4##(2011-1#3)
serum and dried blood spot##2##5##(1992-4#2)
serum and dried blood##4##4##(1992-4#3)(1997-3#1)
serum and dried##5##3##(1992-4#3)(1997-3#1)(2008-1#1)
serum and extraembryonic##2##3##(1993-2#2)
serum and in the##4##4##(1991-10#1)(1995-3#2)(2007-2#1)
serum and in##10##3##(1990-11#1)(1990-12#1)(1990-4#1)(1991-10#1)(1992-4#1)(1994-6#1)(1995-3#3)(2007-2#1)
serum and liver##7##3##(2004-11#2)(2005-7#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#1)
serum and milk##2##3##(1990-10#1)(2011-2#1)
serum and muscle##3##3##(1996-6#3)
serum and pharmaceutical formulations##3##4##(2008-10#3)
serum and pharmaceutical##5##3##(2008-10#5)
serum and plasma are##2##4##(1995-2#2)
serum and plasma of##2##4##(2005-8#2)
serum and plasma##17##3##(1992-8#1)(1995-2#4)(2005-8#3)(2008-10#1)(2008-4#4)(2010-11#1)(2011-2#3)
serum and saliva##6##3##(1992-2#1)(2006-2#1)(2008-3#2)(2011-12#2)
serum and the##9##3##(1991-8#1)(1992-6#1)(1997-3#2)(1997-5#1)(2008-11#1)(2008-7#2)(2013-8#1)
serum and tissue##2##3##(1995-12#1)(2009-11#1)
serum and to##2##3##(2008-10#1)(2011-1#1)
serum and urinary##2##3##(1991-12#1)(2006-10#1)
serum and urine by capillary isotachophoresis##2##6##(1996-5#2)
serum and urine by##6##4##(1992-11#1)(1996-5#3)(2006-10#1)(2008-7#1)
serum and urine citrulline levels (p &lt##2##7##(2006-10#2)
serum and urine citrulline levels##3##5##(2006-10#3)
serum and urine of##11##4##(1992-3#1)(1992-8#2)(1995-1#1)(1995-3#2)(2008-10#2)(2008-7#2)(2013-7#1)
serum and urine samples##5##4##(2008-10#4)(2010-4#1)
serum and urine##45##3##(1990-2#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-11#2)(1992-3#2)(1992-8#3)(1995-1#1)(1995-3#2)(1996-5#4)(1996-8#1)(2006-10#5)(2008-1#1)(2008-10#10)(2008-7#5)(2009-3#1)(2010-4#1)(2010-5#1)(2013-7#1)
serum and whole blood samples##2##5##(2008-10#1)(2008-3#1)
serum and whole blood##6##4##(1996-12#1)(2005-8#1)(2008-10#3)(2008-3#1)
serum and##245##2##(1990-10#2)(1990-11#2)(1990-12#5)(1990-2#1)(1990-4#2)(1990-8#1)(1991-10#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#3)(1991-9#2)(1992-11#4)(1992-2#1)(1992-3#2)(1992-4#6)(1992-6#1)(1992-7#1)(1992-8#4)(1993-12#1)(1993-2#3)(1993-6#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-6#4)(1995-1#4)(1995-12#1)(1995-2#6)(1995-3#9)(1995-5#1)(1995-8#1)(1996-1#2)(1996-12#4)(1996-2#2)(1996-5#4)(1996-6#3)(1996-8#2)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#2)(2004-11#2)(2004-9#1)(2005-12#1)(2005-4#1)(2005-7#1)(2005-8#6)(2006-10#6)(2006-12#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-2#3)(2007-8#2)(2008-1#3)(2008-10#36)(2008-11#12)(2008-12#1)(2008-3#4)(2008-4#5)(2008-5#5)(2008-7#8)(2008-8#4)(2009-11#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#4)(2011-12#3)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
serum and/or##2##2##(1991-8#1)(2007-8#1)
serum anti-PRP antibody##2##3##(1995-5#2)
serum antibodies against##2##3##(1997-3#1)(2008-10#1)
serum antibodies##6##2##(1997-3#1)(2005-11#1)(2008-10#2)(2008-4#2)
serum antibody levels##2##3##(2008-10#1)(2008-4#1)
serum antibody titers##2##3##(1995-12#1)(2012-1#1)
serum antibody titres##3##3##(1991-12#1)(2008-5#2)
serum antibody##14##2##(1991-10#1)(1991-12#3)(1995-12#2)(1995-5#2)(2008-10#1)(2008-4#1)(2008-5#2)(2010-12#1)(2012-1#1)
serum antioxidant capacity##2##3##(2008-7#1)(2012-2#1)
serum antioxidant##4##2##(2007-11#1)(2008-7#2)(2012-2#1)
serum are##4##2##(1990-2#1)(1991-3#1)(2008-10#1)(2012-12#1)
serum arylesterase##3##2##(1990-4#1)(1991-10#2)
serum as##5##2##(1994-3#1)(1996-1#1)(1997-3#1)(2008-10#2)
serum aspartate aminotransferase##3##3##(1997-3#1)(2009-5#1)(2013-8#1)
serum aspartate##4##2##(1997-3#1)(2008-6#1)(2009-5#1)(2013-8#1)
serum assays##3##2##(1992-12#1)(2006-2#2)
serum at a##2##3##(2008-10#1)(2008-11#1)
serum at##9##2##(1990-2#2)(1992-9#2)(1996-4#1)(2008-10#3)(2008-11#1)
serum bactericidal activity##3##3##(2008-4#1)(2013-8#2)
serum based on##3##3##(1995-3#1)(1996-6#1)(2008-10#1)
serum based##4##2##(1995-3#1)(1996-6#1)(2008-10#1)(2008-6#1)
serum beta-hCG##2##2##(2009-8#2)
serum beta-human chorionic##2##3##(2007-10#1)(2009-6#1)
serum beta2-microglobulin##2##2##(2007-12#1)(2011-2#1)
serum bicarbonate##3##2##(2007-8#3)
serum bile acid##2##3##(1993-7#1)(2005-10#1)
serum bile acids in##3##4##(1991-5#1)(1995-9#1)(1996-7#1)
serum bile acids##5##3##(1991-5#1)(1993-11#1)(1995-9#1)(1996-7#1)(2013-1#1)
serum bile##8##2##(1991-5#1)(1993-11#1)(1993-7#1)(1995-9#1)(1996-7#1)(2005-10#1)(2008-8#1)(2013-1#1)
serum bilirubin##10##2##(1990-8#1)(1992-8#1)(1995-4#1)(2004-11#1)(2005-10#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-1#2)
serum binding##2##2##(1991-10#1)(1992-5#1)
serum biochemical##7##2##(2006-10#1)(2010-6#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-8#1)
serum biochemistry##4##2##(2005-7#1)(2007-2#1)(2007-7#1)(2013-1#1)
serum biotinidase##2##2##(1990-1#1)(1991-3#1)
serum blocking factors##2##3##(1991-12#2)
serum bone##2##2##(1990-2#1)(1991-5#1)
serum butyrylcholinesterase in##2##3##(1990-3#1)(1995-2#1)
serum butyrylcholinesterase##5##2##(1990-3#3)(1992-12#1)(1995-2#1)
serum by a##3##3##(2005-9#1)(2008-10#2)
serum by capillary##2##3##(1990-11#1)(2008-10#1)
serum by high-performance liquid chromatography with##2##6##(1990-8#1)(1993-2#1)
serum by high-performance liquid chromatography##3##5##(1990-8#1)(1993-2#2)
serum by using##3##3##(2008-10#2)(2013-1#1)
serum by##40##2##(1990-11#1)(1990-12#1)(1990-4#2)(1990-8#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-3#1)(1993-12#1)(1993-2#3)(1993-3#1)(1994-11#1)(1995-12#1)(1995-3#1)(1996-6#1)(1997-4#1)(2005-4#1)(2005-8#1)(2005-9#1)(2007-8#1)(2008-10#14)(2008-4#1)(2013-1#1)
serum c-erbB-2 protein##3##3##(1993-1#3)
serum calcitonin level##2##3##(1993-6#1)(2010-12#1)
serum calcium and phosphorus##2##4##(2008-3#2)
serum calcium and##3##3##(1994-7#1)(2008-3#2)
serum calcium level was##2##4##(1995-11#1)(2012-2#1)
serum calcium level##4##3##(1995-11#1)(2005-3#1)(2010-7#1)(2012-2#1)
serum calcium levels were##3##4##(1991-8#1)(2013-7#2)
serum calcium levels##6##3##(1991-8#1)(2008-12#1)(2008-6#2)(2013-7#2)
serum calcium##30##2##(1991-8#1)(1994-7#2)(1995-11#1)(1996-1#2)(1996-9#1)(2005-3#3)(2006-10#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#2)(2008-6#2)(2009-6#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#2)
serum carcinoembryonic antigen##4##3##(1995-10#1)(2005-10#1)(2012-1#1)(2013-1#1)
serum cardiac##2##2##(1997-8#1)(2006-6#1)
serum carnitine##3##2##(1994-5#3)
serum caused##2##2##(1991-8#1)(1992-1#1)
serum cholesterol among##2##3##(1993-10#1)(2011-1#1)
serum cholesterol and triglyceride##2##4##(2007-1#1)(2007-11#1)
serum cholesterol and triglycerides##2##4##(1991-6#1)(2008-5#1)
serum cholesterol and##12##3##(1990-11#1)(1990-12#1)(1991-6#2)(1993-12#1)(1993-5#1)(2006-2#1)(2007-1#1)(2007-11#1)(2008-5#1)(2010-8#2)
serum cholesterol concentrations##3##3##(1991-6#1)(2007-11#1)(2007-8#1)
serum cholesterol content##2##3##(2013-8#2)
serum cholesterol in##4##3##(1992-6#1)(1996-3#1)(2007-11#1)(2010-3#1)
serum cholesterol level##8##3##(1991-6#2)(1994-11#1)(2007-10#1)(2007-8#1)(2008-7#1)(2010-10#1)(2010-3#1)
serum cholesterol levels are##2##4##(1993-9#1)(2007-1#1)
serum cholesterol levels in rats##2##5##(1994-5#1)(1996-2#1)
serum cholesterol levels in##4##4##(1991-6#1)(1994-5#1)(1994-9#1)(1996-2#1)
serum cholesterol levels##17##3##(1990-11#1)(1991-1#1)(1991-11#1)(1991-6#2)(1991-7#1)(1993-9#2)(1994-5#1)(1994-9#1)(1995-12#1)(1996-2#1)(1997-1#1)(1997-4#1)(2007-1#1)(2008-5#1)(2008-7#1)
serum cholesterol was##3##3##(1991-6#2)(2008-10#1)
serum cholesterol##77##2##(1990-11#2)(1990-12#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-6#11)(1991-7#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-12#4)(1993-5#2)(1993-9#3)(1994-11#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-7#1)(2006-2#2)(2007-1#3)(2007-10#1)(2007-11#4)(2007-8#3)(2008-10#1)(2008-12#3)(2008-3#2)(2008-5#2)(2008-7#4)(2009-4#1)(2010-10#2)(2010-3#2)(2010-8#2)(2011-1#1)(2012-2#1)(2013-8#3)
serum cholinesterase##2##2##(2011-2#1)(2013-1#1)
serum clearance##2##2##(1992-12#1)(1995-4#1)
serum collagenase##2##2##(1994-3#2)
serum complement levels##2##3##(2011-1#2)
serum complement##8##2##(1991-8#1)(1997-2#2)(2005-8#1)(2007-7#1)(2011-1#3)
serum components examined##2##3##(2006-4#2)
serum components##7##2##(1992-6#1)(2006-2#1)(2006-4#3)(2008-11#2)
serum compounds##2##2##(1990-2#1)(1991-1#1)
serum concentration and##3##3##(1995-4#1)(2006-6#1)(2007-8#1)
serum concentration in patients with##2##5##(2006-6#1)(2012-2#1)
serum concentration in##5##3##(1993-12#1)(2005-10#1)(2006-6#1)(2008-9#1)(2012-2#1)
serum concentration of ss2-microglobulin##2##4##(2007-3#2)
serum concentration of##24##3##(1990-9#1)(1991-12#1)(1992-10#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-4#1)(2005-1#1)(2005-7#1)(2005-8#2)(2006-6#2)(2007-3#2)(2007-7#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
serum concentration##43##2##(1990-9#1)(1991-12#1)(1992-10#1)(1992-8#1)(1993-12#1)(1993-8#2)(1995-2#2)(1995-3#1)(1995-4#3)(1996-4#1)(1997-5#1)(2005-1#1)(2005-10#1)(2005-7#2)(2005-8#2)(2006-6#4)(2007-3#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#2)(2011-2#2)(2012-2#2)(2013-1#1)
serum concentrations and##2##3##(1995-4#1)(2008-3#1)
serum concentrations in##3##3##(1993-1#1)(2008-7#1)(2010-1#1)
serum concentrations of a##2##4##(1996-3#1)(2009-4#1)
serum concentrations of all##3##4##(1990-11#1)(1991-8#1)(2007-8#1)
serum concentrations of calcium##2##4##(1997-5#1)(2011-1#1)
serum concentrations of procalcitonin##2##4##(1993-2#2)
serum concentrations of testosterone were##2##5##(1992-12#1)(1995-1#1)
serum concentrations of##32##3##(1990-11#1)(1990-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-2#2)(1995-1#1)(1995-12#1)(1995-2#2)(1996-11#1)(1996-2#1)(1996-3#1)(1997-5#1)(2004-11#1)(2005-8#1)(2006-4#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-4#1)(2009-5#1)(2010-12#1)(2011-1#1)
serum concentrations were##2##3##(2007-10#1)(2007-8#1)
serum concentrations##51##2##(1990-11#1)(1990-3#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-2#1)(1993-1#1)(1993-2#2)(1993-8#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-4#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-5#1)(2004-11#1)(2005-8#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-1#1)(2009-4#2)(2009-5#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-1#2)
serum conditions##2##2##(1994-10#1)(2008-11#1)
serum contained##3##2##(1992-4#1)(1993-12#1)(1993-3#1)
serum containing medium##6##3##(2008-11#6)
serum containing##14##2##(1990-12#1)(1990-4#1)(1993-12#1)(1997-7#1)(2008-10#1)(2008-11#9)
serum contains a##4##3##(1991-12#1)(1992-9#1)(1996-4#1)(2008-11#1)
serum contains##6##2##(1991-12#1)(1991-5#1)(1992-9#1)(1994-12#1)(1996-4#1)(2008-11#1)
serum content##4##2##(2008-7#3)(2010-12#1)
serum copper and##2##3##(1992-12#1)(2013-8#1)
serum copper concentrations##3##3##(2005-7#3)
serum copper##7##2##(1991-3#1)(1992-12#1)(2005-7#3)(2007-2#1)(2013-8#1)
serum corticosterone levels##2##3##(1994-11#1)(2008-7#1)
serum corticosterone##6##2##(1994-11#1)(2008-10#3)(2008-7#2)
serum cortisol binding capacity##3##4##(1996-9#3)
serum cortisol level##3##3##(2006-6#1)(2011-2#2)
serum cortisol levels##3##3##(2006-9#1)(2008-10#1)(2011-2#1)
serum cortisol suppression##2##3##(2011-2#2)
serum cortisol##15##2##(1992-6#1)(1996-9#3)(2006-6#1)(2006-9#1)(2008-10#2)(2011-2#6)(2013-1#1)
serum cotinine##2##2##(1994-2#1)(2008-12#1)
serum could be##4##3##(1990-8#1)(1994-8#1)(1997-3#1)(2011-2#1)
serum could##5##2##(1990-8#1)(1994-8#1)(1997-3#1)(2011-2#1)(2012-12#1)
serum creatine kinase##3##3##(1990-2#1)(1992-10#1)(1994-12#1)
serum creatine##5##2##(1990-2#1)(1992-10#1)(1994-12#1)(1996-6#1)(2008-3#1)
serum creatinine (r =##2##4##(2007-7#1)(2008-1#1)
serum creatinine and##7##3##(1994-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-5#1)(2013-8#1)
serum creatinine at one year and##2##6##(2008-1#2)
serum creatinine at##4##3##(1997-2#1)(2008-1#3)
serum creatinine concentration (r = 0##2##6##(2008-4#2)
serum creatinine concentration##6##3##(1992-7#1)(1995-2#1)(2008-4#4)
serum creatinine concentrations##2##3##(2011-12#2)
serum creatinine is 1##2##4##(2010-12#1)(2011-12#1)
serum creatinine is##3##3##(2010-12#1)(2010-7#1)(2011-12#1)
serum creatinine level##6##3##(1994-6#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-1#1)(2012-2#1)
serum creatinine levels and##3##4##(1995-2#1)(2008-4#1)(2012-2#1)
serum creatinine levels which##2##4##(2007-2#2)
serum creatinine levels##12##3##(1990-6#1)(1995-2#3)(2007-2#3)(2008-4#3)(2008-8#1)(2012-2#1)
serum creatinine of 1##2##4##(1992-7#1)(2013-8#1)
serum creatinine of##6##3##(1992-7#1)(2007-7#1)(2007-8#1)(2008-1#2)(2013-8#1)
serum creatinine or##2##3##(2007-8#1)(2008-1#1)
serum creatinine phosphokinase##2##3##(2005-12#1)(2005-7#1)
serum creatinine values##2##3##(1992-1#1)(2007-7#1)
serum creatinine was 0##2##4##(2010-4#2)
serum creatinine was##6##3##(1995-2#1)(2008-1#1)(2010-4#2)(2011-11#2)
serum creatinine##102##2##(1990-12#1)(1990-6#1)(1991-8#1)(1992-1#1)(1992-7#3)(1994-12#1)(1994-6#1)(1995-2#7)(1995-7#1)(1996-12#1)(1997-2#2)(2005-12#1)(2005-7#1)(2006-10#4)(2006-4#1)(2007-10#1)(2007-11#1)(2007-2#3)(2007-7#5)(2007-8#5)(2008-1#15)(2008-10#2)(2008-4#9)(2008-7#3)(2008-8#4)(2009-5#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-7#1)(2011-11#4)(2011-12#3)(2011-2#2)(2012-12#1)(2012-2#5)(2013-1#4)(2013-8#2)
serum culture##2##2##(2008-11#2)
serum cystatin C##3##3##(2011-11#3)
serum cystatin##4##2##(2011-11#4)
serum cytokine concentrations##2##3##(2007-8#2)
serum cytokine levels and##2##4##(2006-2#1)(2008-10#1)
serum cytokine levels##4##3##(2006-2#1)(2006-4#1)(2008-10#1)(2010-12#1)
serum cytokine profiles##2##3##(2005-8#1)(2011-1#1)
serum cytokine##10##2##(2005-8#1)(2006-2#1)(2006-4#1)(2007-8#3)(2008-10#1)(2010-12#2)(2011-1#1)
serum cytokines##4##2##(2006-4#1)(2008-10#1)(2012-11#1)(2013-1#1)
serum depletion and##2##3##(1991-2#1)(1992-9#1)
serum depletion##3##2##(1991-2#1)(1992-9#1)(2008-11#1)
serum deprivation##6##2##(1992-11#1)(2007-6#2)(2008-11#1)(2008-8#1)(2008-9#1)
serum deprived##2##2##(1994-11#1)(1996-12#1)
serum did not##3##3##(1990-11#1)(1994-6#1)(1995-8#1)
serum dilution##3##2##(1992-6#1)(1997-2#1)(1997-3#1)
serum directed against##2##3##(1992-1#1)(1992-12#1)
serum during##2##2##(1993-12#1)(2008-7#1)
serum electrolytes##4##2##(1996-6#1)(2007-2#1)(2012-2#2)
serum enzyme##5##2##(1990-4#1)(1991-3#2)(1994-10#1)(1997-3#1)
serum enzymes##6##2##(1990-6#2)(1994-3#3)(2013-1#1)
serum esterase##2##2##(1990-4#1)(2010-2#1)
serum factor##4##2##(1992-3#1)(1993-6#2)(1995-8#1)
serum factors##6##2##(1990-2#1)(1995-3#1)(1995-9#1)(1996-9#1)(2007-7#2)
serum fatty##2##2##(1990-8#1)(2009-4#1)
serum ferritin (SF)##2##3##(2008-10#1)(2009-3#1)
serum ferritin concentration##2##3##(1996-2#1)(2006-4#1)
serum ferritin concentrations##2##3##(2006-9#1)(2008-3#1)
serum ferritin level##2##3##(2012-12#1)(2012-2#1)
serum ferritin levels in##2##4##(2009-8#1)(2013-8#1)
serum ferritin levels##4##3##(2009-8#1)(2013-8#3)
serum ferritin##18##2##(1993-5#1)(1996-2#1)(1996-3#1)(2006-4#1)(2006-9#1)(2008-1#2)(2008-10#1)(2008-3#1)(2009-10#1)(2009-3#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
serum folate##4##2##(1991-2#1)(2007-2#1)(2009-4#2)
serum following##2##2##(1990-12#1)(1993-2#1)
serum for##12##2##(1994-8#1)(1995-3#1)(1995-5#1)(1996-2#1)(2007-2#1)(2007-7#1)(2008-11#3)(2008-7#1)(2010-4#1)(2012-6#1)
serum free T3 levels##2##4##(1996-12#2)
serum free conditions##3##3##(1990-5#1)(1992-11#1)(2008-11#1)
serum free media and##2##4##(2008-11#1)(2009-10#1)
serum free media##4##3##(2008-11#3)(2009-10#1)
serum free medium##6##3##(1992-2#1)(1994-5#1)(2008-11#4)
serum free##23##2##(1990-5#1)(1992-11#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-5#1)(1995-12#1)(1996-12#2)(2008-11#10)(2008-6#1)(2009-10#1)(2011-1#1)(2012-3#1)
serum from 0##2##3##(1993-2#1)(2009-2#1)
serum from a##2##3##(1990-4#1)(2008-11#1)
serum from patients with##4##4##(1991-10#1)(1991-12#1)(1993-1#1)(2010-12#1)
serum from patients##5##3##(1991-10#1)(1991-12#1)(1993-1#1)(2010-12#1)(2011-2#1)
serum from the horse##2##4##(1992-12#2)
serum from the##3##3##(1992-12#2)(1995-2#1)
serum from these##2##3##(2008-7#1)(2010-6#1)
serum from##28##2##(1990-3#1)(1990-4#1)(1991-10#1)(1991-12#1)(1992-11#1)(1992-12#3)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#1)(1994-10#1)(1995-2#1)(1996-10#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-6#1)(2011-2#1)(2013-8#1)
serum fructosamine and HbA1##3##4##(1991-5#3)
serum fructosamine and##4##3##(1991-12#1)(1991-5#3)
serum fructosamine##7##2##(1990-10#1)(1991-12#3)(1991-5#3)
serum gamma-glutamyl transferase##2##3##(2006-6#2)
serum ghrelin levels##2##3##(2006-6#2)
serum globulin##2##2##(1990-3#2)
serum globulins##2##2##(1990-3#1)(1997-8#1)
serum glucose and insulin##2##4##(2009-6#1)(2012-5#1)
serum glucose and##6##3##(1991-10#1)(2005-8#1)(2009-6#1)(2010-2#1)(2010-7#1)(2012-5#1)
serum glucose level##2##3##(2007-10#1)(2009-6#1)
serum glucose levels##2##3##(2008-7#1)(2009-3#1)
serum glucose##28##2##(1991-10#1)(1991-2#1)(1992-3#1)(1996-9#1)(2005-8#1)(2007-1#2)(2007-10#6)(2008-11#1)(2008-3#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-6#2)(2010-2#1)(2010-7#2)(2011-1#1)(2012-12#2)(2012-5#1)(2013-1#1)
serum glutamate pyruvate transaminase##3##4##(2010-12#1)(2012-2#2)
serum glutamate##4##2##(2010-12#2)(2012-2#2)
serum had##2##2##(1994-9#1)(1995-12#1)
serum half-lives of##2##3##(1991-2#1)(1992-12#1)
serum has been##4##3##(1991-10#1)(1993-2#1)(1994-3#1)(2008-3#1)
serum has##6##2##(1991-10#1)(1993-2#2)(1994-3#1)(2006-10#1)(2008-3#1)
serum have##2##2##(1990-8#1)(2008-1#1)
serum high##2##2##(1992-3#1)(2011-2#1)
serum high-density lipoprotein##2##3##(2008-3#1)(2011-1#1)
serum homocysteine levels##2##3##(2008-11#2)
serum homocysteine##6##2##(2007-9#1)(2008-11#3)(2010-1#1)(2013-7#1)
serum immunoglobulin G (IgG)##2##4##(2008-7#1)(2009-8#1)
serum immunoglobulin M##2##3##(1996-12#1)(2009-7#1)
serum immunoglobulin##8##2##(1990-8#1)(1996-12#1)(2006-2#1)(2007-7#1)(2008-7#1)(2009-7#1)(2009-8#1)(2013-1#1)
serum immunoglobulins##3##2##(2007-10#1)(2008-4#1)(2012-3#1)
serum in the culture medium##2##5##(1991-10#1)(2008-1#1)
serum in the##6##3##(1991-10#1)(1991-5#1)(2006-8#1)(2008-1#1)(2008-11#1)(2008-5#1)
serum in##24##2##(1990-6#1)(1991-10#1)(1991-5#1)(1991-7#1)(1992-3#1)(1992-6#1)(1993-12#1)(1995-8#1)(1996-2#2)(2006-8#1)(2007-8#1)(2008-1#1)(2008-11#6)(2008-5#1)(2010-12#1)(2010-4#2)(2013-1#1)
serum increased##3##2##(1991-2#1)(1995-1#1)(2005-8#1)
serum indicated that##2##3##(1992-3#1)(1996-8#1)
serum induced##2##2##(2008-5#2)
serum insulin levels##2##3##(2008-5#1)(2009-6#1)
serum insulin##8##2##(1992-6#1)(1994-12#1)(2008-3#1)(2008-5#1)(2009-4#1)(2009-6#2)(2010-10#1)
serum insulin-like growth##2##3##(1997-5#1)(2011-1#1)
serum integrin levels were##2##4##(1991-10#2)
serum interleukin (IL)-6##2##3##(2008-10#1)(2012-11#1)
serum interleukin 6##2##3##(1991-3#2)
serum interleukin##4##2##(1991-3#2)(2008-10#1)(2012-11#1)
serum interleukin-6 and##2##3##(2013-1#1)(2013-7#1)
serum interleukin-6##3##2##(2011-1#1)(2013-1#1)(2013-7#1)
serum iron concentration##4##3##(1996-2#2)(2006-9#1)(2013-1#1)
serum iron concentrations##2##3##(1992-8#1)(2007-2#1)
serum iron##13##2##(1992-8#1)(1996-2#2)(1996-8#1)(2006-9#3)(2007-2#4)(2013-1#2)
serum is described##3##3##(1990-8#1)(2008-10#2)
serum is reported##2##3##(1995-2#1)(2008-10#1)
serum is##23##2##(1990-8#4)(1992-2#1)(1992-9#1)(1994-9#1)(1995-2#1)(1995-5#1)(2005-11#2)(2006-4#1)(2008-1#1)(2008-10#7)(2008-4#1)(2008-7#1)(2013-1#1)
serum lactate dehydrogenase activity##2##4##(2012-2#2)
serum lactate dehydrogenase##5##3##(1992-3#1)(2008-5#1)(2012-2#2)(2012-3#1)
serum lactate##6##2##(1992-3#1)(2005-12#1)(2008-5#1)(2012-2#2)(2012-3#1)
serum laminin P1##5##3##(1996-8#5)
serum leptin and adiponectin levels were##2##6##(2011-1#2)
serum leptin and adiponectin levels##3##5##(2011-1#3)
serum leptin and adiponectin##4##4##(2011-1#4)
serum leptin and##5##3##(2011-1#4)(2011-2#1)
serum leptin levels were##2##4##(2006-6#1)(2011-2#1)
serum leptin levels##7##3##(2006-6#1)(2008-3#2)(2011-1#1)(2011-2#3)
serum leptin##17##2##(2006-6#1)(2008-3#3)(2008-9#1)(2011-1#6)(2011-2#5)(2013-8#1)
serum level and##5##3##(2006-6#4)(2013-1#1)
serum level in##6##3##(1990-11#1)(1990-4#1)(1992-1#1)(2006-6#1)(2012-3#1)(2013-7#1)
serum level measurements##2##3##(1997-5#2)
serum level of 1##3##4##(1992-5#1)(2006-10#2)
serum level of IL-6 and IL-8##2##6##(2008-8#2)
serum level of cholesterol##2##4##(1990-8#1)(2008-1#1)
serum level of##27##3##(1990-8#1)(1992-1#1)(1992-5#1)(1995-10#1)(1996-4#1)(1996-6#1)(1996-7#1)(2006-10#3)(2006-6#2)(2007-2#1)(2008-1#1)(2008-4#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-4#1)(2010-10#2)(2012-2#2)
serum level was##3##3##(1990-8#1)(1993-11#1)(2006-6#1)
serum level were##3##3##(1993-11#1)(2006-6#1)(2012-3#1)
serum level##62##2##(1990-11#1)(1990-4#1)(1990-8#2)(1991-11#1)(1992-1#2)(1992-5#1)(1993-11#3)(1993-2#1)(1993-7#1)(1994-8#1)(1995-10#1)(1995-4#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-5#2)(2004-10#1)(2006-10#3)(2006-6#12)(2007-2#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-4#1)(2010-10#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)
serum levels below##2##3##(1991-2#1)(1997-5#1)
serum levels did not##2##4##(1993-12#1)(2008-11#1)
serum levels for##2##3##(1990-1#1)(2006-10#1)
serum levels in patients with##2##5##(1994-10#1)(2006-6#1)
serum levels in the##2##4##(1993-4#1)(2009-2#1)
serum levels in##7##3##(1991-2#1)(1993-4#1)(1994-10#1)(1995-10#1)(1995-4#1)(2006-6#1)(2009-2#1)
serum levels of DC-SIGNR##2##4##(2013-7#2)
serum levels of IFN-gamma##2##4##(2005-10#1)(2008-8#1)
serum levels of NO in##2##5##(2013-8#2)
serum levels of folate##2##4##(2013-8#2)
serum levels of hydroxylysyl pyridinoline and lysyl pyridinoline##3##8##(1995-2#3)
serum levels of immunoglobulins##2##4##(2007-2#2)
serum levels of interleukin##2##4##(1994-5#1)(2008-6#1)
serum levels of the##6##4##(1990-10#1)(2006-10#3)(2007-1#1)(2008-5#1)
serum levels of thyroxine (T4)##2##5##(1991-10#1)(2008-7#1)
serum levels of thyroxine##3##4##(1991-10#1)(2008-7#2)
serum levels of total##3##4##(1993-12#1)(2007-2#1)(2008-4#1)
serum levels of vitamin##2##4##(1991-2#1)(1995-3#1)
serum levels of##100##3##(1990-10#2)(1990-2#1)(1990-9#1)(1991-10#1)(1991-2#2)(1991-6#1)(1991-8#1)(1992-3#1)(1993-1#1)(1993-12#3)(1993-3#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-2#3)(1995-3#1)(1995-4#1)(1996-1#1)(1996-11#1)(1996-3#1)(2005-10#1)(2006-10#5)(2006-2#3)(2006-4#1)(2006-6#2)(2007-1#3)(2007-11#4)(2007-2#7)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#2)(2009-5#1)(2009-8#2)(2010-11#1)(2010-12#3)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#5)
serum levels were measured##2##4##(1991-4#1)(2006-6#1)
serum levels were significantly increased in the##2##7##(2006-6#1)(2008-10#1)
serum levels were significantly##5##4##(2006-6#1)(2008-10#2)(2008-8#1)(2013-7#1)
serum levels were##16##3##(1991-2#1)(1991-4#1)(1993-3#1)(1994-3#1)(2006-10#1)(2006-6#3)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-7#1)
serum levels##162##2##(1990-1#1)(1990-10#2)(1990-12#2)(1990-2#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#5)(1991-4#3)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#2)(1992-3#1)(1993-1#1)(1993-12#4)(1993-3#2)(1993-4#1)(1994-10#2)(1994-3#2)(1994-5#1)(1994-6#1)(1995-10#2)(1995-2#3)(1995-3#1)(1995-4#2)(1995-5#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-5#3)(2005-10#3)(2006-10#8)(2006-2#3)(2006-4#1)(2006-6#6)(2007-1#3)(2007-11#6)(2007-2#7)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#6)(2008-8#4)(2009-2#2)(2009-5#1)(2009-8#2)(2010-11#1)(2010-12#4)(2010-2#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#3)(2013-7#3)(2013-8#5)
serum lipase##2##2##(2011-2#1)(2012-2#1)
serum lipid fractions##2##3##(2007-8#2)
serum lipid levels and##2##4##(2004-11#1)(2008-12#1)
serum lipid levels in##3##4##(1993-8#1)(2007-10#2)
serum lipid levels##8##3##(1993-8#1)(1996-9#1)(2004-11#1)(2007-10#4)(2008-12#1)
serum lipid peroxidation##2##3##(1995-1#2)
serum lipid profile of##3##4##(2007-1#1)(2008-10#1)(2011-11#1)
serum lipid profile##6##3##(1995-11#1)(2005-3#1)(2006-10#1)(2007-1#1)(2008-10#1)(2011-11#1)
serum lipid profiles##4##3##(2004-11#1)(2008-3#2)(2009-12#1)
serum lipid was##2##3##(2007-8#1)(2008-9#1)
serum lipid##37##2##(1993-8#1)(1994-10#1)(1994-12#1)(1995-1#2)(1995-11#1)(1995-3#1)(1996-9#1)(2004-11#2)(2005-3#1)(2006-10#1)(2007-1#1)(2007-10#4)(2007-8#6)(2008-10#1)(2008-12#1)(2008-3#3)(2008-9#2)(2009-12#1)(2011-11#1)(2011-2#1)(2013-1#3)(2013-8#1)
serum lipids and##7##3##(1992-4#1)(1996-2#1)(2004-11#1)(2011-2#1)(2013-1#3)
serum lipids in##3##3##(2007-7#1)(2008-3#1)(2012-1#1)
serum lipids##17##2##(1992-4#2)(1994-12#1)(1994-2#1)(1995-4#1)(1996-2#1)(2004-11#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#3)
serum lipoprotein (a)##2##3##(1990-12#1)(1992-11#1)
serum lipoprotein##4##2##(1990-12#1)(1992-11#1)(2007-8#1)(2008-3#1)
serum lipoproteins in##4##3##(1991-10#2)(2010-12#2)
serum lipoproteins##10##2##(1990-8#1)(1991-10#2)(1992-4#1)(1994-3#1)(2008-10#1)(2010-12#4)
serum liver enzymes##2##3##(2008-4#1)(2009-11#1)
serum liver##3##2##(2008-3#1)(2008-4#1)(2009-11#1)
serum luteinizing hormone##2##3##(1995-3#2)
serum lysozyme activity##2##3##(2008-10#2)
serum magnesium and hs-CRP##2##4##(2011-2#2)
serum magnesium level##2##3##(2011-2#1)(2012-2#1)
serum magnesium##8##2##(2007-8#1)(2011-2#6)(2012-2#1)
serum marker for##2##3##(1990-9#1)(1991-9#1)
serum marker of##3##3##(1996-4#1)(2006-9#1)(2007-10#1)
serum marker##12##2##(1990-9#1)(1991-9#2)(1995-1#1)(1995-3#1)(1996-12#1)(1996-4#1)(2006-9#1)(2007-10#1)(2007-12#1)(2008-3#1)(2012-12#1)
serum markers of hepatitis B virus##2##6##(1993-2#1)(2009-11#1)
serum markers of##7##3##(1993-2#1)(2007-10#1)(2007-8#1)(2008-3#1)(2009-11#1)(2011-2#1)(2012-12#1)
serum markers##13##2##(1991-12#1)(1992-9#1)(1993-2#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-3#1)(2009-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
serum matrix##2##2##(2008-10#2)
serum may##4##2##(1992-6#1)(1993-2#1)(1993-3#1)(2012-1#1)
serum melatonin levels##5##3##(1990-5#1)(1995-3#2)(2008-3#2)
serum melatonin##11##2##(1990-5#1)(1992-12#1)(1992-8#3)(1995-3#2)(1996-7#1)(2008-3#3)
serum microsamples##2##2##(1996-6#2)
serum neopterin##5##2##(1990-2#3)(1993-11#1)(2009-12#1)
serum neutralisation test##2##3##(1991-3#2)
serum neutralisation##4##2##(1991-3#4)
serum neutralization test##3##3##(2005-9#2)(2008-5#1)
serum neutralization##5##2##(2005-9#2)(2007-6#1)(2008-5#2)
serum neutralizing activity##4##3##(1992-6#4)
serum neutralizing##5##2##(1992-6#4)(1992-8#1)
serum nitrate level##2##3##(2009-8#2)
serum nitrate##5##2##(2004-11#1)(2009-8#4)
serum nitrite and citrulline levels##2##5##(2006-10#1)(2008-7#1)
serum nitrite##3##2##(2006-10#2)(2008-7#1)
serum obtained##2##2##(2008-11#1)(2013-8#1)
serum oestradiol levels##2##3##(2011-2#2)
serum oestradiol##3##2##(1991-8#1)(2011-2#2)
serum of all##2##3##(1991-12#1)(2008-5#1)
serum of cancer patients##3##4##(2005-4#3)
serum of patients with ovarian##2##5##(1996-10#1)(2010-12#1)
serum of patients with##17##4##(1990-6#1)(1991-8#1)(1991-9#1)(1992-9#1)(1994-8#2)(1996-1#1)(1996-10#1)(1996-7#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-2#1)(2010-12#1)(2012-1#2)
serum of patients##19##3##(1990-6#1)(1991-8#1)(1991-9#1)(1992-9#1)(1994-8#2)(1996-1#1)(1996-10#1)(1996-7#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-2#1)(2010-12#1)(2012-1#2)(2013-1#2)
serum of rats##3##3##(1991-5#1)(2012-3#1)(2013-1#1)
serum of the##8##3##(1993-1#1)(1993-2#1)(1994-12#1)(1995-3#1)(1997-4#1)(1997-5#1)(2007-11#1)(2008-7#1)
serum of##76##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-2#2)(1993-6#1)(1994-12#1)(1994-3#1)(1994-8#2)(1995-3#2)(1995-4#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-5#1)(2005-11#1)(2005-4#3)(2006-9#1)(2007-11#1)(2007-2#2)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#3)(2009-2#1)(2009-8#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-1#3)(2012-2#1)(2012-3#2)(2013-1#5)
serum on the##4##3##(1992-6#3)(2008-10#1)
serum on##10##2##(1992-6#3)(1997-6#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-11#2)(2013-8#1)
serum or plasma##13##3##(1990-2#1)(1990-4#2)(1990-8#1)(1991-2#1)(1994-2#1)(1996-12#1)(1997-8#1)(2007-2#1)(2008-4#2)(2009-6#1)(2011-2#1)
serum or serum-free##2##3##(1996-5#1)(2008-11#1)
serum or urine##2##3##(1990-2#1)(2009-5#1)
serum or##42##2##(1990-12#1)(1990-2#3)(1990-4#2)(1990-8#1)(1991-1#1)(1991-10#3)(1991-2#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#2)(1992-7#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-3#3)(1996-12#1)(1996-5#2)(1997-8#1)(2007-2#1)(2008-11#4)(2008-4#3)(2009-5#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
serum origin##3##2##(1990-12#1)(1991-10#2)
serum osteocalcin##6##2##(1990-12#2)(1996-12#1)(2009-3#1)(2010-12#1)(2013-8#1)
serum p53 Abs were##2##4##(2011-2#2)
serum p53 Abs##5##3##(2011-2#5)
serum p53##6##2##(2011-2#6)
serum parameters of##2##3##(1996-12#1)(2006-4#1)
serum parameters##6##2##(1996-12#1)(2005-10#1)(2006-10#1)(2006-4#2)(2009-6#1)
serum parathormone##3##2##(2007-7#2)(2008-1#1)
serum phosphate levels##2##3##(2011-1#1)(2012-2#1)
serum phosphate##5##2##(2007-2#1)(2007-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
serum phospholipids##3##2##(2008-3#3)
serum plasma##2##2##(1990-2#1)(2008-1#1)
serum potassium and##3##3##(1990-11#2)(1996-12#1)
serum potassium level##3##3##(1994-6#1)(2007-11#1)(2012-12#1)
serum potassium levels##2##3##(1995-10#1)(2007-9#1)
serum potassium##15##2##(1990-11#2)(1991-10#1)(1992-4#1)(1994-6#1)(1995-10#1)(1995-6#1)(1996-12#1)(1996-9#1)(1997-8#1)(2007-11#1)(2007-9#3)(2012-12#1)
serum progesterone##2##2##(2006-12#1)(2006-5#1)
serum proinsulin##2##2##(1996-3#2)
serum prolactin concentration##3##3##(1991-11#3)
serum prolactin levels##4##3##(1995-12#1)(1995-3#1)(2010-10#2)
serum prolactin##11##2##(1991-11#3)(1995-12#1)(1995-3#1)(2006-9#1)(2010-10#2)(2011-1#2)(2013-8#1)
serum prostate-specific antigen in##2##4##(1995-4#1)(2006-9#1)
serum prostate-specific antigen##5##3##(1995-4#1)(1995-8#1)(2006-9#2)(2007-7#1)
serum protein concentration##2##3##(1991-12#1)(1992-10#1)
serum protein electrophoresis##3##3##(1993-9#1)(1996-6#1)(2006-10#1)
serum protein##27##2##(1990-12#1)(1990-4#2)(1991-12#1)(1992-10#1)(1992-11#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-9#1)(1994-12#1)(1996-6#2)(2005-11#2)(2006-10#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-1#1)(2013-1#1)
serum proteins and##3##3##(1990-11#1)(1991-10#1)(1995-2#1)
serum proteins by##2##3##(1990-11#1)(1990-6#1)
serum proteins were##2##3##(1990-12#1)(1997-5#1)
serum proteins##41##2##(1990-1#1)(1990-11#3)(1990-12#1)(1990-4#2)(1990-6#2)(1991-10#3)(1991-12#1)(1992-12#1)(1992-4#1)(1992-6#2)(1993-12#3)(1993-6#1)(1993-9#1)(1994-10#2)(1994-12#1)(1995-2#1)(1996-11#4)(1996-2#1)(1996-6#1)(1997-5#1)(2008-8#1)(2010-12#3)(2010-4#1)(2010-6#1)(2013-8#2)
serum reacted##2##2##(1993-6#1)(1994-12#1)
serum reduction##2##2##(2008-7#2)
serum removal##2##2##(1995-6#2)
serum resistance##8##2##(1990-8#1)(1991-8#4)(2007-8#2)(2008-5#1)
serum resistin##3##2##(2008-1#2)(2012-12#1)
serum response element (SRE)##3##4##(1993-6#1)(1994-11#1)(1995-6#1)
serum response element##5##3##(1991-7#1)(1993-6#1)(1994-11#1)(1995-6#1)(1996-5#1)
serum response##8##2##(1991-7#1)(1993-6#2)(1994-11#1)(1995-3#1)(1995-6#1)(1996-5#2)
serum resulted in a##2##4##(1991-2#1)(1997-2#1)
serum resulted in##4##3##(1991-2#2)(1992-3#1)(1997-2#1)
serum sample are##2##3##(1990-8#1)(2005-9#1)
serum sample##13##2##(1990-8#1)(1991-11#1)(2005-9#1)(2006-2#1)(2008-10#7)(2008-4#1)(2011-11#1)
serum samples after##2##3##(2008-10#2)
serum samples analyzed##2##3##(2008-10#2)
serum samples and##6##3##(2007-2#3)(2008-10#1)(2008-4#1)(2008-5#1)
serum samples by##4##3##(2008-10#4)
serum samples collected from##4##4##(1996-12#1)(2008-10#1)(2008-5#1)(2013-8#1)
serum samples collected##7##3##(1996-12#1)(2008-10#2)(2008-5#1)(2011-2#1)(2013-8#2)
serum samples could be##2##4##(1990-6#1)(2008-10#1)
serum samples could##3##3##(1990-6#1)(2008-10#2)
serum samples from patients##3##4##(1992-2#1)(1993-9#1)(2008-10#1)
serum samples from##23##3##(1990-1#1)(1990-3#1)(1991-8#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-9#1)(1996-12#1)(1997-4#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#2)(2010-4#1)(2011-2#1)(2013-1#2)(2013-8#2)
serum samples in##3##3##(1995-1#1)(2008-10#1)(2008-3#1)
serum samples of##13##3##(1994-8#1)(1996-7#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-5#3)(2009-2#1)(2010-4#1)(2010-6#1)(2013-8#1)
serum samples taken##2##3##(1992-4#1)(2006-10#1)
serum samples was illustrated##2##4##(2008-10#2)
serum samples was##6##3##(1992-2#1)(1992-8#1)(1995-2#1)(2005-4#1)(2008-10#2)
serum samples were collected from##3##5##(2007-7#1)(2011-2#1)(2013-8#1)
serum samples were collected##4##4##(2007-2#1)(2007-7#1)(2011-2#1)(2013-8#1)
serum samples were determined##2##4##(2008-10#2)
serum samples were spiked with known amount of##2##8##(2008-10#2)
serum samples were tested##2##4##(2007-7#1)(2008-3#1)
serum samples were##20##3##(1990-8#1)(1995-2#1)(2007-2#1)(2007-7#3)(2008-10#7)(2008-3#3)(2008-4#1)(2011-2#1)(2013-8#2)
serum samples with##3##3##(1990-2#1)(1996-3#1)(2008-10#1)
serum samples##159##2##(1990-1#2)(1990-12#3)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-8#1)(1992-12#1)(1992-2#4)(1992-4#1)(1992-5#1)(1992-8#2)(1993-1#2)(1993-9#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-2#2)(1996-1#1)(1996-11#1)(1996-12#4)(1996-3#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-10#1)(2005-11#1)(2005-4#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#8)(2007-7#5)(2007-8#3)(2008-10#54)(2008-3#5)(2008-4#4)(2008-5#9)(2009-2#1)(2009-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2011-2#3)(2013-1#5)(2013-8#7)
serum selenium levels##4##3##(1991-1#1)(1996-7#1)(1996-8#1)(2007-2#1)
serum selenium##6##2##(1991-1#3)(1996-7#1)(1996-8#1)(2007-2#1)
serum serotonin##3##2##(2013-8#3)
serum showed that##2##3##(1994-11#1)(2012-12#1)
serum showed##3##2##(1991-2#1)(1994-11#1)(2012-12#1)
serum sickness arteritis in##2##4##(1997-8#2)
serum sickness##4##2##(1997-8#3)(2007-5#1)
serum skin test in##2##4##(2007-7#1)(2012-3#1)
serum sodium concentration##3##3##(1996-12#1)(2010-1#2)
serum sodium level##2##3##(2007-11#1)(2010-6#1)
serum sodium##14##2##(1992-11#1)(1995-6#1)(1996-12#1)(1996-7#1)(2006-1#1)(2007-11#1)(2008-1#1)(2008-12#1)(2009-10#1)(2010-1#2)(2010-6#1)(2012-12#1)(2012-2#1)
serum specimen##2##2##(1992-8#1)(2007-12#1)
serum specimens##8##2##(1991-12#1)(1992-5#1)(1994-3#1)(2005-10#1)(2007-8#1)(2008-10#2)(2012-1#1)
serum ss2-microglobulin concentration##2##3##(2007-3#2)
serum ss2-microglobulin##4##2##(2007-3#4)
serum stability of##2##3##(2012-2#1)(2013-8#1)
serum stability##3##2##(2012-2#1)(2013-8#2)
serum starvation of donor cells##2##5##(2008-9#2)
serum starvation of##3##3##(2008-9#3)
serum starvation only##2##3##(2012-2#2)
serum starvation##19##2##(1991-2#1)(1992-3#1)(1993-9#1)(1995-5#1)(1996-1#1)(1996-2#1)(2008-4#3)(2008-9#4)(2012-12#1)(2012-2#5)
serum stimulation##5##2##(1991-2#1)(1996-3#1)(1997-1#3)
serum substitute##2##2##(2007-11#1)(2008-11#1)
serum testing##2##2##(2008-3#1)(2011-2#1)
serum testosterone and##2##3##(2004-1#1)(2008-1#1)
serum testosterone concentrations##2##3##(2012-12#2)
serum testosterone levels##4##3##(1996-11#1)(2004-1#1)(2008-5#1)(2009-9#1)
serum testosterone##15##2##(1996-11#2)(2004-1#2)(2006-10#2)(2008-1#1)(2008-5#3)(2008-6#1)(2009-9#1)(2012-12#3)
serum than##4##2##(1992-8#1)(1993-1#1)(2008-11#1)(2010-4#1)
serum that##3##2##(1990-12#1)(1997-2#1)(2011-1#1)
serum thromboxane##3##2##(1990-12#2)(2008-5#1)
serum through##2##2##(1996-8#1)(2008-10#1)
serum thyroglobulin##4##2##(2006-1#1)(2006-9#1)(2013-1#2)
serum thyroid hormone levels##2##4##(1995-10#1)(2008-4#1)
serum thyroid hormone##3##3##(1990-3#1)(1995-10#1)(2008-4#1)
serum thyroid##4##2##(1990-3#1)(1995-10#1)(2008-4#1)(2008-6#1)
serum thyroxine##4##2##(2006-9#1)(2008-11#2)(2008-7#1)
serum titers against##2##3##(1997-7#2)
serum titers##4##2##(1997-7#3)(2007-10#1)
serum to##3##2##(1991-8#1)(1995-9#1)(2008-10#1)
serum total and##5##3##(1990-10#1)(1993-10#1)(1997-6#1)(2007-8#1)(2011-2#1)
serum total bilirubin##2##3##(2012-2#1)(2013-8#1)
serum total cholesterol and##4##4##(1990-8#1)(1991-10#1)(2008-6#1)(2010-10#1)
serum total cholesterol levels##2##4##(1993-12#2)
serum total cholesterol##13##3##(1990-8#1)(1991-10#1)(1993-12#3)(1997-1#2)(1997-2#1)(2008-6#1)(2010-10#3)(2013-8#1)
serum total lipids and serum cholesterol##2##6##(2008-12#2)
serum total lipids##4##3##(2008-12#4)
serum total protein##7##3##(2008-10#2)(2012-12#1)(2012-2#1)(2013-8#3)
serum total##40##2##(1990-10#1)(1990-8#1)(1991-10#1)(1993-10#1)(1993-12#3)(1995-12#1)(1997-1#2)(1997-2#1)(1997-6#1)(2007-2#1)(2007-8#2)(2007-9#3)(2008-10#2)(2008-12#4)(2008-6#1)(2010-10#3)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#5)
serum transferrin##3##2##(1994-3#1)(1995-3#1)(1996-2#1)
serum triglyceride and##2##3##(1992-3#1)(1993-11#1)
serum triglyceride level##2##3##(2007-7#1)(2013-8#1)
serum triglyceride levels##3##3##(1995-12#1)(2007-11#1)(2008-11#1)
serum triglyceride##19##2##(1991-12#4)(1991-9#1)(1992-3#1)(1993-11#1)(1995-12#1)(1996-2#1)(2004-11#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#3)(2013-8#1)
serum triglycerides and##2##3##(1991-10#1)(2004-1#1)
serum triglycerides##19##2##(1991-10#1)(1991-6#1)(1991-8#1)(1992-6#4)(1993-12#1)(1993-9#1)(2004-1#2)(2006-9#2)(2008-3#3)(2008-5#1)(2012-2#1)(2012-3#1)
serum triiodothyronine##2##2##(2006-9#1)(2008-6#1)
serum tumor markers##5##3##(1994-7#1)(2007-3#1)(2010-12#1)(2010-8#1)(2011-2#1)
serum tumor necrosis##2##3##(1995-2#1)(2006-10#1)
serum tumor##8##2##(1994-7#1)(1995-2#1)(2006-10#1)(2007-3#2)(2010-12#1)(2010-8#1)(2011-2#1)
serum urate and phosphate levels##2##5##(2006-10#2)
serum urea nitrogen##2##3##(1990-12#1)(1995-12#1)
serum urea##7##2##(1990-12#1)(1995-12#1)(2007-7#2)(2008-1#2)(2012-2#1)
serum uric acid and##2##4##(2006-10#1)(2011-1#1)
serum uric acid levels##5##4##(1996-9#1)(2011-1#4)
serum uric acid##9##3##(1996-9#1)(2006-10#2)(2011-1#5)(2013-1#1)
serum using a new##2##4##(1991-3#1)(1996-6#1)
serum using a##5##3##(1991-3#1)(1996-1#1)(1996-6#2)(2008-10#1)
serum using an##2##3##(1991-3#1)(2008-10#1)
serum using##20##2##(1990-10#1)(1990-8#1)(1991-3#2)(1991-5#1)(1993-12#2)(1996-1#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-3#2)(2008-10#5)(2008-3#1)
serum valproate##2##2##(2006-4#2)
serum values of##2##3##(2008-4#1)(2013-1#1)
serum viral##2##2##(2006-10#1)(2013-8#1)
serum vitamin B12 and##2##4##(1991-2#2)
serum vitamin B12 levels were##2##5##(1990-3#2)
serum vitamin B12##6##3##(1990-3#2)(1991-2#2)(2005-7#1)(2013-7#1)
serum vitamin C##3##3##(1992-9#1)(1996-1#2)
serum vitamin##12##2##(1990-3#2)(1991-2#2)(1991-7#2)(1992-9#1)(1996-1#2)(2005-7#1)(2007-11#1)(2013-7#1)
serum was developed##4##3##(1996-8#1)(1997-3#1)(2010-5#1)(2012-12#1)
serum was established##3##3##(1990-3#1)(1991-8#1)(2013-8#1)
serum was found##2##3##(1990-4#1)(1990-7#1)
serum was measured by ELISA##2##5##(2007-10#1)(2008-10#1)
serum was measured##3##3##(2007-10#1)(2008-10#1)(2008-7#1)
serum was obtained##2##3##(2006-10#1)(2008-10#1)
serum was studied##2##3##(1990-12#1)(1991-4#1)
serum was used##3##3##(1990-11#1)(2007-11#1)(2013-1#1)
serum was##56##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-7#1)(1991-4#1)(1991-8#2)(1992-11#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-5#1)(1994-10#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-8#2)(1997-3#2)(2004-1#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#13)(2008-11#2)(2008-7#2)(2010-5#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
serum weaning##2##2##(2008-11#2)
serum were significantly higher##2##4##(1995-3#1)(1997-1#1)
serum were##24##2##(1990-8#2)(1991-1#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#2)(1994-6#1)(1995-3#1)(1995-8#1)(1997-1#1)(2005-8#1)(2006-10#1)(2006-9#1)(2008-10#3)(2008-7#2)(2010-5#1)
serum while##2##2##(1996-2#1)(2012-2#1)
serum with a##5##3##(1991-12#1)(1992-3#1)(2005-7#1)(2008-10#1)(2010-5#1)
serum with##17##2##(1990-10#1)(1990-12#1)(1990-7#1)(1991-12#1)(1991-7#1)(1992-3#1)(1994-9#1)(1996-8#1)(1997-2#1)(2005-11#1)(2005-7#1)(2008-10#4)(2008-3#1)(2010-5#1)
serum withdrawal##3##2##(1992-3#1)(1995-2#1)(2007-6#1)
serum within 2##2##3##(1996-2#1)(2012-2#1)
serum zinc and calcium##3##4##(2013-7#3)
serum zinc and##5##3##(1990-8#1)(2007-2#1)(2013-7#3)
serum zinc concentration##3##3##(1994-10#3)
serum zinc level##2##3##(2010-6#2)
serum zinc levels##2##3##(2008-5#1)(2013-8#1)
serum zinc##16##2##(1990-8#2)(1991-3#1)(1994-10#4)(2007-2#1)(2008-5#1)(2010-6#2)(2013-7#4)(2013-8#1)
serum##3990##1##(1990-1#7)(1990-10#14)(1990-11#24)(1990-12#43)(1990-2#27)(1990-3#17)(1990-4#25)(1990-5#2)(1990-6#19)(1990-7#3)(1990-8#46)(1990-9#8)(1991-1#11)(1991-10#35)(1991-11#9)(1991-12#43)(1991-2#28)(1991-3#30)(1991-4#7)(1991-5#17)(1991-6#21)(1991-7#10)(1991-8#34)(1991-9#19)(1992-1#9)(1992-10#4)(1992-11#26)(1992-12#33)(1992-2#20)(1992-3#26)(1992-4#24)(1992-5#5)(1992-6#38)(1992-7#12)(1992-8#27)(1992-9#14)(1993-1#10)(1993-10#2)(1993-11#19)(1993-12#51)(1993-2#40)(1993-3#8)(1993-4#3)(1993-5#4)(1993-6#16)(1993-7#3)(1993-8#12)(1993-9#12)(1994-10#19)(1994-11#16)(1994-12#27)(1994-2#4)(1994-3#19)(1994-5#10)(1994-6#17)(1994-7#3)(1994-8#24)(1994-9#18)(1995-1#15)(1995-10#12)(1995-11#4)(1995-12#28)(1995-2#45)(1995-3#52)(1995-4#21)(1995-5#12)(1995-6#9)(1995-7#6)(1995-8#17)(1995-9#5)(1996-1#20)(1996-10#9)(1996-11#21)(1996-12#37)(1996-2#29)(1996-3#13)(1996-4#11)(1996-5#11)(1996-6#25)(1996-7#12)(1996-8#23)(1996-9#20)(1997-1#12)(1997-2#20)(1997-3#24)(1997-4#9)(1997-5#17)(1997-6#11)(1997-7#16)(1997-8#17)(2004-1#5)(2004-10#1)(2004-11#13)(2004-9#2)(2005-1#1)(2005-10#14)(2005-11#23)(2005-12#8)(2005-3#5)(2005-4#7)(2005-7#14)(2005-8#25)(2005-9#5)(2006-1#2)(2006-10#57)(2006-11#2)(2006-12#10)(2006-2#23)(2006-4#21)(2006-5#6)(2006-6#36)(2006-7#2)(2006-8#5)(2006-9#29)(2007-1#10)(2007-10#25)(2007-11#46)(2007-12#10)(2007-2#50)(2007-3#10)(2007-4#3)(2007-5#2)(2007-6#7)(2007-7#41)(2007-8#77)(2007-9#16)(2008-1#50)(2008-10#374)(2008-11#129)(2008-12#20)(2008-2#6)(2008-3#59)(2008-4#57)(2008-5#81)(2008-6#22)(2008-7#81)(2008-8#34)(2008-9#17)(2009-1#2)(2009-10#6)(2009-11#8)(2009-12#2)(2009-2#5)(2009-3#9)(2009-4#12)(2009-5#7)(2009-6#15)(2009-7#4)(2009-8#20)(2009-9#6)(2010-1#9)(2010-10#12)(2010-11#6)(2010-12#46)(2010-2#5)(2010-3#3)(2010-4#26)(2010-5#10)(2010-6#11)(2010-7#10)(2010-8#5)(2011-1#66)(2011-11#10)(2011-12#13)(2011-2#92)(2012-1#21)(2012-11#7)(2012-12#43)(2012-2#63)(2012-3#30)(2012-5#4)(2012-6#1)(2013-1#83)(2013-7#24)(2013-8#94)
serum)##17##1##(1990-12#1)(1990-6#1)(1991-11#1)(1992-12#1)(1993-2#2)(2007-11#2)(2008-10#4)(2008-11#2)(2008-4#1)(2008-9#1)(2009-7#1)
serum- and##3##2##(1991-1#1)(1996-10#1)(1997-4#1)
serum-##5##1##(1991-1#1)(1996-10#1)(1997-4#1)(2008-11#1)(2013-1#1)
serum-cholesterol measurements in##2##3##(1990-6#2)
serum-cholesterol##9##1##(1990-6#9)
serum-containing and serum-free media##2##4##(2007-5#1)(2008-11#1)
serum-containing media##3##2##(2008-11#3)
serum-containing medium##14##2##(1990-8#1)(1993-7#1)(1995-1#1)(1996-2#2)(1997-5#1)(2005-8#1)(2008-11#7)
serum-containing##26##1##(1990-8#1)(1991-11#1)(1993-7#1)(1994-9#1)(1995-1#1)(1996-2#2)(1997-5#1)(2005-8#1)(2007-5#1)(2008-11#15)(2010-3#1)
serum-containingmedium##3##1##(2008-11#3)
serum-deprived##10##1##(1990-12#3)(1992-11#1)(1994-6#1)(1994-8#1)(1996-2#2)(2008-4#1)(2008-8#1)
serum-derived##4##1##(1990-7#1)(1990-9#1)(1991-7#1)(2008-11#1)
serum-fed SMC##2##2##(1994-11#2)
serum-free Vero##2##2##(2008-11#2)
serum-free and##2##2##(2008-11#2)
serum-free cell cultures of embryonic chick##2##6##(1997-3#2)
serum-free cell line McCoy-Plovdiv##3##4##(2008-11#3)
serum-free cell##7##2##(1992-11#1)(1997-3#2)(2008-11#4)
serum-free condition##2##2##(1991-12#1)(2008-11#1)
serum-free conditioned medium of##2##4##(1991-8#1)(1994-6#1)
serum-free conditioned##3##2##(1990-12#1)(1991-8#1)(1994-6#1)
serum-free conditions##11##2##(1990-7#1)(1992-12#1)(1992-8#1)(1993-3#1)(2007-6#1)(2008-11#5)(2008-7#1)
serum-free culture conditions##2##3##(1991-12#1)(2008-11#1)
serum-free culture media##4##3##(1991-7#1)(1994-5#1)(2008-11#2)
serum-free culture medium##2##3##(1991-9#1)(1994-6#1)
serum-free culture##17##2##(1990-10#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-9#1)(1994-5#1)(1994-6#1)(2007-6#2)(2008-11#8)
serum-free cultures##2##2##(1994-6#1)(2008-11#1)
serum-free defined medium##4##3##(1993-7#2)(1996-5#2)
serum-free media in##2##3##(2008-11#2)
serum-free media##26##2##(1990-10#1)(1991-4#1)(1994-11#1)(1996-6#1)(1997-5#1)(2007-5#2)(2008-11#17)(2008-7#2)
serum-free medium (SFM)##5##3##(1991-2#1)(1992-8#1)(1994-9#1)(2008-11#1)(2008-7#1)
serum-free medium and##5##3##(1992-3#1)(1992-9#1)(2008-11#3)
serum-free medium containing the##2##4##(2008-11#1)(2012-12#1)
serum-free medium containing##6##3##(1997-4#1)(2006-5#1)(2008-11#1)(2008-7#1)(2012-12#2)
serum-free medium for##3##3##(1994-6#1)(1994-9#1)(2008-11#1)
serum-free medium or##2##3##(2008-11#1)(2008-4#1)
serum-free medium was##3##3##(2008-11#3)
serum-free medium with##3##3##(1991-8#1)(1993-6#1)(2006-5#1)
serum-free medium##75##2##(1990-11#1)(1990-12#1)(1990-7#2)(1991-2#3)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-8#1)(1992-9#4)(1993-11#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-6#3)(1994-9#2)(1995-11#1)(1995-3#1)(1996-2#1)(1997-4#1)(2006-5#2)(2008-11#33)(2008-4#1)(2008-7#2)(2008-9#2)(2012-12#3)(2012-3#1)
serum-free mouse embryo##2##3##(1990-10#2)
serum-free process##2##2##(2008-11#2)
serum-free quality and quantity control culture##2##6##(2012-12#2)
serum-free quality and quantity##3##4##(2012-12#3)
serum-free suspension process##2##3##(2008-11#2)
serum-free suspension##9##2##(2008-11#9)
serum-free system##2##2##(1992-8#2)
serum-free##209##1##(1990-10#4)(1990-11#1)(1990-12#2)(1990-7#5)(1990-9#1)(1991-12#2)(1991-2#3)(1991-4#1)(1991-7#3)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-8#7)(1992-9#5)(1993-11#1)(1993-3#1)(1993-6#1)(1993-7#2)(1993-8#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#6)(1994-9#2)(1995-11#2)(1995-3#1)(1996-11#1)(1996-2#1)(1996-5#2)(1996-6#1)(1997-3#2)(1997-4#1)(1997-5#1)(2006-5#2)(2007-5#2)(2007-6#3)(2008-11#106)(2008-4#2)(2008-7#8)(2008-9#3)(2012-12#6)(2012-3#1)
serum-independent##5##1##(1997-7#1)(2008-11#4)
serum-induced mitogenesis##4##2##(1990-8#2)(1991-9#2)
serum-induced##13##1##(1990-8#3)(1991-1#1)(1991-9#5)(1992-8#1)(1992-9#1)(1995-2#1)(1997-6#1)
serum-starved##5##1##(1991-10#1)(1993-12#1)(1993-8#1)(1994-12#1)(2008-4#1)
serum-stimulated human fibroblasts##2##3##(1995-2#2)
serum-stimulated##5##1##(1992-8#1)(1995-2#2)(1997-1#1)(1997-7#1)
serum-supplemented medium##9##2##(1990-4#1)(1994-6#1)(1994-9#1)(2008-11#6)
serum-supplemented##18##1##(1990-4#1)(1992-1#1)(1994-5#1)(1994-6#2)(1994-9#2)(2007-5#1)(2008-11#10)
serum/plasma##5##1##(1990-11#1)(1994-10#1)(1996-3#1)(2011-2#2)
serum]##4##1##(1997-8#1)(2005-8#1)(2013-8#2)
serums and vaccines##2##3##(2006-5#1)(2009-7#1)
serums of##4##2##(1992-1#1)(2011-2#3)
serums##8##1##(1992-1#1)(2006-5#1)(2008-10#1)(2009-7#1)(2011-2#4)
servants##3##1##(1990-3#1)(2008-11#1)(2008-9#1)
serve a protective##2##3##(2006-8#1)(2008-5#1)
serve a secondary##2##3##(1990-11#1)(2006-8#1)
serve a variety of functions##2##5##(2008-11#1)(2012-2#1)
serve a##16##2##(1990-11#1)(1990-2#1)(1992-12#1)(1992-6#1)(1992-9#1)(1995-3#2)(1995-7#1)(2006-12#1)(2006-8#2)(2008-11#1)(2008-5#1)(2008-8#1)(2010-8#1)(2012-2#1)
serve an##5##2##(1991-9#1)(1995-1#1)(1995-11#1)(1997-2#1)(2007-12#1)
serve and##2##2##(2011-2#1)(2012-3#1)
serve as a baseline for future##2##6##(2006-4#1)(2011-2#1)
serve as a basis for the development of##2##8##(1994-2#1)(2008-11#1)
serve as a basis for the##3##6##(1994-2#1)(2008-11#1)(2010-6#1)
serve as a basis for##9##5##(1992-7#1)(1994-2#1)(1994-6#1)(1994-9#1)(1997-3#1)(2006-8#2)(2008-11#1)(2010-6#1)
serve as a bridge##3##4##(2008-4#1)(2011-2#1)(2012-1#1)
serve as a convenient model##2##5##(1994-9#1)(2010-12#1)
serve as a cue for##2##5##(1991-8#1)(1995-5#1)
serve as a diagnostic##2##4##(2008-9#1)(2013-8#1)
serve as a foundation for##3##5##(1996-1#1)(2010-4#1)(2011-1#1)
serve as a general##2##4##(1990-2#1)(2008-3#1)
serve as a good##5##4##(1996-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
serve as a guide for##4##5##(1991-12#1)(2006-2#1)(2007-2#1)(2013-8#1)
serve as a guide in the##2##6##(1990-9#1)(2011-1#1)
serve as a guide##7##4##(1990-9#1)(1991-12#1)(1994-3#1)(2006-2#1)(2007-2#1)(2011-1#1)(2013-8#1)
serve as a guideline for##2##5##(2008-6#1)(2010-9#1)
serve as a guideline##3##4##(2008-3#1)(2008-6#1)(2010-9#1)
serve as a means##2##4##(1992-3#1)(2007-8#1)
serve as a model for the##2##6##(1990-5#1)(2008-11#1)
serve as a model for##7##5##(1990-5#1)(1991-9#1)(1993-11#1)(2008-11#1)(2008-3#1)(2008-4#1)(2012-12#1)
serve as a model system##2##5##(1990-12#1)(2006-12#1)
serve as a model##11##4##(1990-12#1)(1990-5#1)(1991-9#1)(1993-11#1)(2006-10#1)(2006-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-11#1)(2012-12#1)
serve as a new##3##4##(2008-10#1)(2008-11#1)(2010-4#1)
serve as a novel##4##4##(2007-12#1)(2011-12#1)(2011-2#1)(2013-1#1)
serve as a paradigm##2##4##(2012-12#1)(2013-1#1)
serve as a potential##9##4##(1991-9#1)(1994-2#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-2#1)
serve as a predictive##2##4##(1991-7#1)(2010-12#1)
serve as a protective factor##3##5##(2009-11#1)(2009-7#1)(2013-8#1)
serve as a reservoir for##2##5##(1997-5#1)(2011-2#1)
serve as a reservoir##4##4##(1995-2#1)(1997-5#1)(2011-12#1)(2011-2#1)
serve as a resource##2##4##(2008-4#1)(2012-3#1)
serve as a sensitive##3##4##(1991-10#1)(1993-6#1)(2008-10#1)
serve as a source of##5##5##(1996-5#1)(2007-2#1)(2008-10#1)(2008-9#1)(2011-2#1)
serve as a starting point for##2##6##(2010-11#1)(2012-12#1)
serve as a suitable model for##2##6##(2008-1#1)(2008-10#1)
serve as a suitable##4##4##(2008-1#1)(2008-10#1)(2008-5#1)(2012-1#1)
serve as a surrogate##4##4##(2007-5#1)(2009-11#1)(2010-12#1)(2013-8#1)
serve as a template for##2##5##(2007-3#1)(2010-1#1)
serve as a tool to##2##5##(2008-7#1)(2012-2#1)
serve as a trigger##2##4##(2006-6#1)(2007-11#1)
serve as a tumor##2##4##(2008-4#1)(2010-10#1)
serve as a useful guide##2##5##(2007-10#1)(2013-7#1)
serve as a useful##11##4##(1994-9#1)(1995-5#1)(2004-9#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-9#1)(2009-11#1)(2009-4#1)(2012-12#1)(2013-7#1)
serve as a valuable##2##4##(1991-6#1)(2008-12#1)
serve as a viable##2##4##(2004-3#1)(2011-2#1)
serve as a##219##3##(1990-12#2)(1990-2#2)(1990-3#3)(1990-5#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#3)(1992-7#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-8#2)(1994-1#1)(1994-10#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-2#1)(1995-4#1)(1995-5#2)(1995-8#1)(1996-1#2)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-3#1)(2004-8#1)(2004-9#1)(2005-10#1)(2005-12#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#4)(2007-12#6)(2007-2#3)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#7)(2008-12#1)(2008-3#3)(2008-4#6)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#6)(2009-11#4)(2009-2#1)(2009-4#3)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-6#1)(2010-8#5)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#8)(2012-1#6)(2012-11#4)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#5)
serve as an additional##4##4##(2008-3#1)(2009-8#1)(2011-1#1)(2011-2#1)
serve as an alternative to##5##5##(1992-11#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-3#1)
serve as an alternative##6##4##(1992-11#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
serve as an effective##3##4##(1992-11#1)(2007-12#1)(2008-9#1)
serve as an example##2##4##(1995-6#1)(2009-3#1)
serve as an excellent##3##4##(1991-2#1)(2007-2#1)(2008-7#1)
serve as an important tool for##2##6##(2008-11#1)(2010-3#1)
serve as an important tool##4##5##(1992-5#1)(1997-6#1)(2008-11#1)(2010-3#1)
serve as an important##9##4##(1992-5#1)(1997-6#1)(2006-5#1)(2008-11#1)(2008-6#1)(2008-8#1)(2010-3#1)(2011-2#2)
serve as an indicator of##2##5##(2008-5#1)(2012-2#1)
serve as an indicator##3##4##(2008-12#1)(2008-5#1)(2012-2#1)
serve as an internal##2##4##(1990-11#1)(2008-10#1)
serve as an##54##3##(1990-11#1)(1991-2#1)(1992-11#2)(1992-5#1)(1993-2#1)(1995-11#1)(1995-12#1)(1995-6#2)(1996-3#1)(1996-5#1)(1997-6#1)(1997-8#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
serve as biomarkers for##2##4##(2007-11#1)(2012-2#1)
serve as biomarkers##4##3##(2007-11#1)(2008-6#1)(2011-1#1)(2012-2#1)
serve as centerpieces##2##3##(1996-12#1)(1997-2#1)
serve as effective##2##3##(1996-10#1)(2010-7#1)
serve as either##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
serve as evidence of##2##4##(1992-3#1)(2011-2#1)
serve as future##2##3##(2006-10#1)(2008-11#1)
serve as good##2##3##(1994-8#1)(2009-5#1)
serve as hospital trustees##2##4##(1994-2#2)
serve as indicators of the##2##5##(2007-11#1)(2008-5#1)
serve as intracellular##2##3##(2008-11#1)(2008-4#1)
serve as markers for the##3##5##(1990-5#1)(2005-10#1)(2008-3#1)
serve as markers for##4##4##(1990-5#1)(2005-10#1)(2008-3#1)(2008-9#1)
serve as markers of##3##4##(2006-2#1)(2008-2#1)(2012-2#1)
serve as markers##7##3##(1990-5#1)(2005-10#1)(2006-2#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-2#1)
serve as mentors##2##3##(2005-12#1)(2008-3#1)
serve as models for##3##4##(1990-12#1)(1995-7#1)(2006-2#1)
serve as new##2##3##(1994-9#1)(2006-10#1)
serve as potential##6##3##(1993-2#1)(2008-10#1)(2009-6#1)(2010-12#1)(2010-5#1)(2012-3#1)
serve as precursors for##2##4##(1995-3#1)(2010-12#1)
serve as precursors##3##3##(1992-6#1)(1995-3#1)(2010-12#1)
serve as receptors##2##3##(1995-3#1)(1996-9#1)
serve as scaffolds##2##3##(2010-10#2)
serve as sensitive probes of##2##5##(1991-3#1)(2008-4#1)
serve as substrates##2##3##(1992-3#1)(2007-12#1)
serve as surrogate##2##3##(1993-2#1)(2009-4#1)
serve as targets for##2##4##(1997-7#1)(2011-2#1)
serve as templates for##3##4##(1994-8#1)(2008-10#1)(2008-2#1)
serve as the basis for##4##5##(1990-12#1)(1992-12#1)(1993-12#1)(2012-3#1)
serve as the basis##5##4##(1990-12#1)(1992-12#1)(1993-12#1)(2012-3#2)
serve as the foundation for##3##5##(2008-1#1)(2010-9#1)(2013-8#1)
serve as the foundation##4##4##(2007-12#1)(2008-1#1)(2010-9#1)(2013-8#1)
serve as the primary##2##4##(2006-8#1)(2011-2#1)
serve as the##29##3##(1990-12#1)(1992-12#1)(1993-12#1)(1994-9#1)(1995-12#1)(1995-3#1)(1997-8#1)(2005-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#2)(2008-1#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2009-12#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
serve as transcriptional##2##3##(1990-9#1)(1991-12#1)
serve as useful##2##3##(1995-8#2)
serve as##499##2##(1990-11#2)(1990-12#4)(1990-2#2)(1990-3#3)(1990-5#3)(1990-8#1)(1990-9#2)(1991-1#3)(1991-10#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#4)(1992-12#3)(1992-3#8)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#4)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#2)(1994-1#1)(1994-10#1)(1994-12#2)(1994-2#5)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#4)(1994-9#6)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#5)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#2)(1996-10#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#4)(1996-9#2)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#3)(2004-3#1)(2004-8#1)(2004-9#1)(2005-10#3)(2005-12#2)(2006-10#8)(2006-11#1)(2006-12#3)(2006-2#4)(2006-4#1)(2006-5#2)(2006-6#2)(2006-8#3)(2007-10#2)(2007-11#9)(2007-12#13)(2007-2#5)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#3)(2008-1#6)(2008-10#33)(2008-11#14)(2008-12#2)(2008-2#11)(2008-3#12)(2008-4#11)(2008-5#9)(2008-6#4)(2008-7#11)(2008-8#9)(2008-9#9)(2009-10#3)(2009-11#6)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#7)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#7)(2010-9#2)(2011-1#5)(2011-12#3)(2011-2#20)(2012-1#7)(2012-11#6)(2012-12#11)(2012-2#10)(2012-3#8)(2013-1#8)(2013-7#3)(2013-8#9)
serve both as##3##3##(2006-10#1)(2007-11#1)(2008-10#1)
serve both to##2##3##(1997-6#1)(2007-12#1)
serve both##8##2##(1991-12#1)(1996-2#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2009-10#1)
serve for##3##2##(2007-8#1)(2008-11#1)(2012-2#1)
serve in the##3##3##(1995-2#1)(2008-5#2)
serve in##7##2##(1994-2#1)(1995-2#1)(2007-12#1)(2008-2#1)(2008-5#2)(2010-12#1)
serve many##3##2##(1994-9#1)(1995-12#1)(2010-10#1)
serve not only##2##3##(1991-12#1)(2010-4#1)
serve rural##2##2##(1997-3#1)(2010-11#1)
serve the purpose of##2##4##(1990-6#1)(2011-2#1)
serve the purpose##3##3##(1990-6#1)(2010-1#1)(2011-2#1)
serve the##15##2##(1990-11#1)(1990-6#1)(1997-1#1)(1997-3#1)(2005-8#1)(2006-4#1)(2006-5#1)(2007-4#1)(2008-1#1)(2008-5#1)(2008-8#1)(2010-1#1)(2010-2#1)(2011-2#1)(2012-3#1)
serve their##2##2##(1997-2#1)(2006-8#1)
serve these##2##2##(2006-10#1)(2007-9#1)
serve this##3##2##(2005-7#1)(2008-12#1)(2012-12#1)
serve to concentrate##2##3##(1997-7#2)
serve to identify##2##3##(2006-2#1)(2013-8#1)
serve to illustrate##2##3##(1992-1#1)(1996-7#1)
serve to improve the##2##4##(1994-5#1)(2006-8#1)
serve to improve##3##3##(1994-5#1)(1996-12#1)(2006-8#1)
serve to limit##2##3##(1991-8#1)(1995-1#1)
serve to maintain##2##3##(1995-12#1)(2008-11#1)
serve to provide##2##3##(2005-7#1)(2008-8#1)
serve to support the##2##4##(2008-5#1)(2011-2#1)
serve to##64##2##(1990-12#2)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-4#1)(1992-5#1)(1993-11#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-7#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#2)(2005-7#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-12#2)(2008-1#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#4)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
serve##702##1##(1990-11#4)(1990-12#6)(1990-2#3)(1990-3#3)(1990-5#3)(1990-6#1)(1990-8#1)(1990-9#3)(1991-1#4)(1991-10#1)(1991-12#7)(1991-2#5)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#4)(1992-12#4)(1992-2#1)(1992-3#9)(1992-4#1)(1992-5#2)(1992-6#3)(1992-7#1)(1992-9#2)(1993-1#1)(1993-11#4)(1993-12#3)(1993-2#5)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-1#2)(1994-10#1)(1994-12#4)(1994-2#8)(1994-3#5)(1994-5#2)(1994-6#2)(1994-8#4)(1994-9#8)(1995-1#4)(1995-11#2)(1995-12#5)(1995-2#3)(1995-3#8)(1995-4#2)(1995-5#4)(1995-6#2)(1995-7#2)(1995-8#4)(1995-9#1)(1996-1#3)(1996-10#1)(1996-12#5)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#4)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#6)(1997-3#8)(1997-4#2)(1997-5#1)(1997-6#5)(1997-7#4)(1997-8#4)(2004-3#1)(2004-8#1)(2004-9#1)(2005-10#3)(2005-12#2)(2005-7#2)(2005-8#1)(2006-10#11)(2006-11#1)(2006-12#4)(2006-2#5)(2006-4#3)(2006-5#3)(2006-6#2)(2006-8#7)(2007-10#2)(2007-11#12)(2007-12#19)(2007-2#6)(2007-3#2)(2007-4#2)(2007-5#3)(2007-6#2)(2007-7#3)(2007-8#7)(2007-9#4)(2008-1#12)(2008-10#36)(2008-11#20)(2008-12#4)(2008-2#15)(2008-3#12)(2008-4#15)(2008-5#15)(2008-6#4)(2008-7#15)(2008-8#15)(2008-9#10)(2009-10#4)(2009-11#7)(2009-12#4)(2009-2#1)(2009-3#3)(2009-4#5)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#4)(2010-1#2)(2010-10#5)(2010-11#3)(2010-12#8)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#9)(2010-9#2)(2011-1#5)(2011-12#4)(2011-2#26)(2012-1#9)(2012-11#6)(2012-12#12)(2012-2#18)(2012-3#13)(2013-1#8)(2013-7#4)(2013-8#10)
served a##3##2##(2008-8#2)(2009-5#1)
served an##3##2##(1997-1#1)(1997-4#1)(2009-4#1)
served as a control group##4##5##(1996-2#1)(1997-2#1)(1997-6#1)(2007-2#1)
served as a control##8##4##(1992-9#1)(1996-2#1)(1997-2#1)(1997-6#1)(2007-2#1)(2007-3#1)(2009-4#1)(2010-11#1)
served as a model system for##2##6##(2008-10#1)(2011-1#1)
served as a model##3##4##(2008-10#1)(2011-1#1)(2011-12#1)
served as a protective##2##4##(2009-12#1)(2013-1#1)
served as a substrate for##2##5##(1990-7#1)(1993-8#1)
served as a useful##2##4##(2006-12#1)(2007-4#1)
served as a##45##3##(1990-12#1)(1990-7#1)(1992-9#1)(1993-8#1)(1994-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#3)(1997-6#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-11#1)(2011-1#2)(2011-12#1)(2013-1#5)(2013-8#1)
served as an##10##3##(2004-9#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#2)(2010-11#1)
served as both##3##3##(2007-8#1)(2008-10#2)
served as control##15##3##(1995-12#1)(2007-1#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-4#3)(2009-5#2)(2009-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
served as controls and##2##4##(1997-6#1)(2008-7#1)
served as controls##18##3##(1990-5#1)(1991-5#1)(1991-8#1)(1995-4#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#2)(2011-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
served as normal##2##3##(2008-4#1)(2011-2#1)
served as reference##2##3##(2006-8#1)(2007-8#1)
served as subjects##3##3##(1993-2#1)(2006-10#1)(2008-6#1)
served as the control and##2##5##(2007-1#1)(2008-3#1)
served as the control group##3##5##(1991-8#1)(1993-1#1)(1994-5#1)
served as the control##8##4##(1991-8#1)(1993-1#1)(1994-5#1)(2007-1#2)(2007-2#1)(2008-3#1)(2009-5#1)
served as the##28##3##(1990-1#1)(1991-4#1)(1991-8#1)(1992-2#1)(1993-1#1)(1994-5#1)(1994-8#1)(1997-2#1)(2006-10#1)(2007-1#2)(2007-11#1)(2007-2#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-4#3)(2008-7#1)(2009-2#1)(2009-5#1)(2013-8#2)
served as##170##2##(1990-1#1)(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-4#1)(1991-5#1)(1991-8#2)(1992-2#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-2#2)(1995-4#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-4#1)(1997-2#2)(1997-4#3)(1997-6#2)(1997-7#1)(2004-9#1)(2006-10#2)(2006-12#1)(2006-8#2)(2007-1#4)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#25)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#8)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#2)(2009-10#2)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#4)(2009-6#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-11#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#4)
served at##2##2##(2007-1#1)(2010-6#1)
served by a##4##3##(1991-2#1)(1997-2#1)(2010-2#1)(2012-12#1)
served by the##13##3##(1991-11#1)(1991-3#1)(1991-6#1)(1993-3#1)(1996-3#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-7#1)(2012-2#1)(2013-1#2)
served by##33##2##(1991-11#2)(1991-2#1)(1991-3#2)(1991-6#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-8#1)(1995-2#2)(1995-3#1)(1996-3#3)(1997-2#2)(2005-7#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)(2009-7#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
served for the##2##3##(1996-5#1)(2008-10#1)
served for##3##2##(1993-2#1)(1996-5#1)(2008-10#1)
served in contracted##2##3##(1995-2#2)
served in##5##2##(1995-2#2)(1997-2#1)(2010-11#1)(2011-2#1)
served on##2##2##(1995-4#1)(2008-1#1)
served the##6##2##(1995-1#1)(1997-7#1)(2007-7#1)(2008-7#1)(2010-12#1)(2012-12#1)
served to highlight##2##3##(2006-10#1)(2012-2#1)
served to##24##2##(1991-2#1)(1992-12#1)(1992-6#1)(1993-7#1)(1996-6#1)(1997-3#1)(2004-12#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-2#1)(2009-12#1)(2009-2#1)(2011-1#1)(2012-2#1)
served##280##1##(1990-1#1)(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-11#2)(1991-2#2)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#3)(1993-12#1)(1993-2#4)(1993-3#1)(1993-7#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#3)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#7)(1995-3#2)(1995-4#2)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#6)(1997-3#2)(1997-4#4)(1997-6#2)(1997-7#2)(2004-12#1)(2004-9#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#6)(2006-12#2)(2006-4#2)(2006-5#1)(2006-8#2)(2007-1#5)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#3)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#32)(2008-11#6)(2008-12#2)(2008-2#4)(2008-3#6)(2008-4#8)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#6)(2009-10#2)(2009-12#3)(2009-2#2)(2009-4#2)(2009-5#5)(2009-6#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-11#1)(2011-12#1)(2011-2#4)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#11)(2013-7#1)(2013-8#4)
server and##3##2##(2008-4#2)(2012-2#1)
server for##5##2##(2008-1#1)(2008-4#2)(2008-7#1)(2012-3#1)
server is##4##2##(2007-6#1)(2012-2#1)(2012-3#2)
server named##2##2##(2007-6#1)(2012-3#1)
server provides##2##2##(2012-3#2)
server with##3##2##(1997-3#1)(2008-7#1)(2012-3#1)
server##42##1##(1993-12#1)(1997-3#1)(2007-10#2)(2007-12#1)(2007-6#5)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#9)(2008-7#3)(2008-9#1)(2010-5#1)(2012-2#3)(2012-3#9)(2013-1#2)
servers and##3##2##(1992-2#1)(2008-2#1)(2008-4#1)
servers##8##1##(1992-2#2)(2007-12#2)(2008-2#1)(2008-4#2)(2010-3#1)
serves a##7##2##(1991-9#1)(2007-12#1)(2008-1#1)(2008-11#1)(2010-10#1)(2010-8#1)(2012-3#1)
serves an important##4##3##(1995-12#1)(2008-1#2)(2012-2#1)
serves an##7##2##(1995-12#1)(1997-2#1)(1997-3#1)(2006-10#1)(2008-1#2)(2012-2#1)
serves as a binding##2##4##(1996-5#1)(2009-10#1)
serves as a bridge##2##4##(2011-2#1)(2012-3#1)
serves as a case##2##4##(1996-3#1)(2008-11#1)
serves as a guideline##2##4##(2007-12#1)(2008-1#1)
serves as a hydrogen bond acceptor##2##6##(1993-3#1)(2010-7#1)
serves as a hydrogen bond##3##5##(1993-3#1)(2010-7#2)
serves as a link between##3##5##(1994-12#1)(1994-6#1)(1996-5#1)
serves as a link##4##4##(1994-12#1)(1994-6#2)(1996-5#1)
serves as a marker of##2##5##(2007-2#1)(2010-12#1)
serves as a marker##3##4##(2007-2#1)(2010-12#1)(2012-2#1)
serves as a measure of##3##5##(2008-3#1)(2008-4#1)(2009-7#1)
serves as a model for##4##5##(1996-5#1)(2007-12#1)(2012-12#2)
serves as a model of##2##5##(1991-5#1)(1994-9#1)
serves as a model##7##4##(1991-5#1)(1994-9#1)(1996-5#1)(2007-12#1)(2011-2#1)(2012-12#2)
serves as a negative regulator of##3##6##(2007-10#1)(2009-8#1)(2013-1#1)
serves as a negative##4##4##(1994-8#1)(2007-10#1)(2009-8#1)(2013-1#1)
serves as a permanent##2##4##(1994-3#1)(2008-10#1)
serves as a possible##2##4##(1992-12#1)(1992-2#1)
serves as a reminder##3##4##(1994-3#1)(2008-10#1)(2011-1#1)
serves as a scaffold##2##4##(2008-7#1)(2010-2#1)
serves as a substrate for##3##5##(1994-5#1)(1995-5#1)(2008-5#1)
serves as a useful##3##4##(1991-1#1)(2008-12#1)(2008-4#1)
serves as a##122##3##(1990-12#1)(1990-4#1)(1991-1#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#2)(1995-1#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-3#1)(1996-5#4)(1997-2#1)(1997-4#1)(1997-6#3)(1997-8#1)(1997-9#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-2#2)(2007-5#1)(2008-1#2)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#6)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#1)
serves as an &quot##2##4##(1997-1#1)(2005-11#1)
serves as an electron##2##4##(1991-5#1)(2008-5#1)
serves as an example of##2##5##(2011-1#1)(2012-1#1)
serves as an important##2##4##(2007-8#1)(2010-8#1)
serves as an introduction to this##2##6##(1990-12#1)(2006-10#1)
serves as an##27##3##(1990-12#1)(1991-4#1)(1991-5#1)(1994-12#1)(1996-1#1)(1997-1#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#3)(2008-5#1)(2009-9#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)
serves as the main##2##4##(1995-2#1)(2012-12#1)
serves as the##21##3##(1992-2#2)(1993-2#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-8#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)(2008-7#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#1)
serves as##182##2##(1990-12#2)(1990-4#1)(1991-1#1)(1991-4#1)(1991-5#2)(1992-10#1)(1992-12#1)(1992-2#3)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#5)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#4)(1994-9#2)(1995-1#1)(1995-2#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-5#4)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#3)(1997-8#1)(1997-9#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-3#1)(2006-5#1)(2006-8#2)(2007-10#2)(2007-11#2)(2007-12#7)(2007-2#2)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#9)(2008-4#6)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-2#4)(2010-5#2)(2010-7#2)(2010-8#2)(2011-1#6)(2011-2#9)(2012-1#2)(2012-11#2)(2012-12#6)(2012-2#5)(2012-3#2)(2013-1#1)(2013-8#1)
serves both##3##2##(1994-3#1)(1996-5#1)(2010-5#1)
serves for the##2##3##(2008-10#1)(2008-2#1)
serves for##3##2##(2008-10#2)(2008-2#1)
serves multiple##2##2##(1993-12#1)(1997-3#1)
serves the##4##2##(1991-3#1)(2007-12#1)(2010-5#1)(2011-1#1)
serves to determine##2##3##(1995-6#1)(2008-3#1)
serves to enhance the##2##4##(2007-8#1)(2008-9#1)
serves to enhance##3##3##(2006-12#1)(2007-8#1)(2008-9#1)
serves to highlight##2##3##(1997-4#1)(2008-2#1)
serves to reinforce##2##3##(1994-2#1)(2008-12#1)
serves to remind##2##3##(1997-3#1)(2006-8#1)
serves to##50##2##(1990-10#1)(1990-5#3)(1990-7#1)(1990-9#1)(1991-9#1)(1992-3#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-6#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-5#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-6#1)(2008-9#1)(2010-4#1)(2010-6#1)(2010-8#1)(2012-12#2)(2013-1#2)(2013-8#1)
serves##279##1##(1990-10#1)(1990-12#2)(1990-4#2)(1990-5#3)(1990-7#1)(1990-9#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#3)(1992-3#3)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#5)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#3)(1994-8#5)(1994-9#4)(1995-1#1)(1995-12#1)(1995-2#3)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#5)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#4)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#1)(1997-9#1)(2005-11#2)(2005-5#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#2)(2006-8#4)(2007-10#3)(2007-11#3)(2007-12#10)(2007-2#2)(2007-3#1)(2007-4#3)(2007-5#1)(2007-8#2)(2008-1#7)(2008-10#14)(2008-11#6)(2008-12#2)(2008-2#7)(2008-3#11)(2008-4#10)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#4)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-12#2)(2010-2#4)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#4)(2011-1#7)(2011-2#11)(2012-1#2)(2012-11#2)(2012-12#8)(2012-2#6)(2012-3#3)(2013-1#3)(2013-8#2)
service agencies##3##2##(1992-12#1)(1992-3#1)(1995-3#1)
service agreement##2##2##(1996-2#1)(2007-4#1)
service agreements##4##2##(1994-1#1)(1996-2#1)(2007-4#2)
service and education##2##3##(2008-1#1)(2008-12#1)
service and research##2##3##(2007-7#1)(2011-1#1)
service and the##8##3##(1991-1#1)(1993-3#1)(1995-3#1)(1996-11#1)(1997-8#1)(2012-12#1)(2013-1#2)
service and to##2##3##(2008-1#1)(2011-1#1)
service and##49##2##(1991-1#2)(1992-3#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#2)(1996-11#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-8#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)
service are##7##2##(1990-12#1)(1990-8#1)(1991-1#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-2#1)
service area##3##2##(1992-2#1)(2006-8#1)(2007-4#1)
service areas##11##2##(1992-12#2)(1995-3#2)(1996-3#6)(2009-4#1)
service as well as##3##4##(1995-1#1)(1995-2#1)(2008-6#1)
service as##8##2##(1992-2#1)(1995-1#2)(1995-12#1)(1995-2#2)(1997-5#1)(2008-6#1)
service assistant##2##2##(1996-2#1)(1997-3#1)
service at the center##2##4##(2008-8#2)
service at the##7##3##(1990-11#1)(1996-2#1)(2006-10#1)(2007-7#1)(2008-2#1)(2008-8#2)
service at##12##2##(1990-11#1)(1991-1#1)(1996-11#1)(1996-2#1)(2006-10#1)(2007-7#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#2)
service based##2##2##(2006-8#1)(2012-3#1)
service being##3##2##(1995-6#1)(2011-2#2)
service between##2##2##(2008-7#1)(2011-2#1)
service by##3##2##(1993-2#1)(1997-2#1)(2013-1#1)
service call##3##2##(1993-12#1)(2013-1#2)
service can##2##2##(1993-2#1)(2010-5#1)
service data##2##2##(2012-2#1)(2012-3#1)
service delivery and##6##3##(1992-12#1)(1995-3#1)(2004-12#1)(2006-12#1)(2012-3#1)(2013-1#1)
service delivery for##2##3##(1997-1#1)(2005-10#1)
service delivery in##2##3##(1993-1#1)(2011-1#1)
service delivery models##2##3##(1994-2#1)(2012-12#1)
service delivery system##4##3##(1991-12#1)(1992-1#1)(1996-2#1)(2008-6#1)
service delivery systems##3##3##(1994-2#1)(1995-2#1)(1996-1#1)
service delivery to##2##3##(1996-3#1)(2008-1#1)
service delivery##87##2##(1991-12#2)(1991-3#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#4)(1993-3#1)(1994-1#2)(1994-2#3)(1995-1#2)(1995-12#2)(1995-2#2)(1995-3#4)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-2#2)(2004-10#1)(2004-12#1)(2005-10#1)(2005-5#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-4#2)(2009-7#1)(2010-10#2)(2010-2#1)(2010-3#4)(2010-9#1)(2011-1#4)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#10)
service demand##2##2##(1994-1#1)(2006-10#1)
service department##2##2##(1994-3#1)(1997-6#1)
service development##2##2##(1997-3#1)(2013-1#1)
service education##2##2##(1991-2#1)(2004-8#1)
service effectiveness##2##2##(1994-12#1)(1997-1#1)
service encounter##3##2##(1992-3#1)(1993-12#1)(1997-2#1)
service excellence##3##2##(1994-1#2)(2008-8#1)
service extension##3##2##(2008-1#3)
service facilities##2##2##(1994-12#1)(1997-8#1)
service firm##2##2##(1992-3#2)
service firms##4##2##(1992-3#2)(1993-1#2)
service for the management of##2##5##(1991-11#1)(1991-7#1)
service for the##7##3##(1991-11#1)(1991-7#1)(1992-9#1)(1994-2#1)(2008-7#1)(2013-1#2)
service for##23##2##(1990-12#1)(1990-6#2)(1991-11#3)(1991-12#2)(1991-7#1)(1992-9#1)(1994-2#1)(1997-5#1)(1997-8#1)(2007-4#1)(2008-11#1)(2008-7#2)(2009-12#1)(2009-3#1)(2011-1#1)(2012-11#1)(2013-1#2)
service from##2##2##(2006-8#1)(2008-12#1)
service had##2##2##(2006-11#1)(2012-3#1)
service has been##3##3##(1993-5#1)(2008-1#1)(2008-10#1)
service has##5##2##(1993-5#1)(1995-6#1)(2008-1#1)(2008-10#1)(2009-2#1)
service hospitals##2##2##(1997-3#1)(2007-7#1)
service improvement##5##2##(1993-12#1)(1994-3#1)(2008-3#1)(2012-2#1)(2013-8#1)
service in a##2##3##(2007-7#1)(2011-2#1)
service in the community##2##4##(1996-7#1)(2005-12#1)
service in the##7##3##(1991-2#1)(1992-2#1)(1995-4#1)(1996-2#1)(1996-7#1)(2005-12#1)(2013-8#1)
service in##38##2##(1990-3#1)(1991-2#1)(1992-2#2)(1992-3#2)(1993-3#1)(1994-6#1)(1995-11#1)(1995-4#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-8#1)(2005-12#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2010-4#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#3)(2013-8#3)
service industries##3##2##(1995-1#1)(2009-6#1)(2009-8#1)
service industry##2##2##(1991-3#1)(1993-12#1)
service integration##7##2##(1996-12#2)(2006-8#1)(2008-2#3)(2012-3#1)
service interventions##2##2##(2010-5#1)(2012-3#1)
service is a##4##3##(1995-2#1)(1996-1#1)(2008-7#1)(2011-1#1)
service is being##2##3##(1994-3#1)(2005-5#1)
service is##19##2##(1992-11#1)(1994-1#2)(1994-3#1)(1995-2#1)(1995-9#1)(1996-1#1)(2005-12#1)(2005-5#1)(2006-10#1)(2007-4#1)(2008-1#3)(2008-2#1)(2008-7#1)(2011-1#2)(2012-2#1)
service itself##2##2##(1993-12#1)(2012-3#1)
service life##2##2##(2008-1#1)(2009-6#1)
service limitation##3##2##(1993-12#3)
service management##3##2##(1994-1#1)(1997-2#1)(2013-1#1)
service managers and##3##3##(1992-1#1)(2012-3#2)
service managers##10##2##(1992-1#3)(1994-12#1)(1996-1#2)(1997-2#1)(2012-3#3)
service may##2##2##(1992-1#1)(1994-2#1)
service members##5##2##(1995-6#3)(1996-5#1)(2012-12#1)
service menu##2##2##(1996-2#2)
service models##2##2##(1995-2#1)(2013-1#1)
service needs and##3##3##(1992-3#1)(1994-12#1)(1997-1#1)
service needs##15##2##(1992-1#1)(1992-3#1)(1994-1#2)(1994-12#1)(1995-1#1)(1995-3#1)(1997-1#2)(2008-1#1)(2009-9#1)(2010-8#1)(2013-1#1)(2013-8#2)
service networks##2##2##(1995-1#1)(1996-3#1)
service of a##3##3##(1994-5#1)(1996-9#1)(2010-8#1)
service of##23##2##(1991-1#1)(1991-6#1)(1994-5#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-8#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
service on a##3##3##(1996-2#1)(2013-1#2)
service on##5##2##(1996-2#1)(2005-11#1)(2007-9#1)(2013-1#2)
service or##5##2##(1994-2#2)(1995-12#1)(2005-5#1)(2005-8#1)
service orders##2##2##(2005-5#2)
service organization##6##2##(1991-9#1)(1996-2#1)(1997-3#1)(2007-10#1)(2008-8#1)(2010-2#1)
service organizations manage their funding##2##5##(1991-12#2)
service organizations##17##2##(1991-12#3)(1993-12#2)(1993-2#1)(1994-12#2)(1995-1#1)(1995-12#2)(1996-2#2)(1996-3#2)(1997-2#1)(2005-8#1)
service patterns were##2##3##(1991-1#1)(2011-2#1)
service patterns##3##2##(1991-1#1)(1995-3#1)(2011-2#1)
service professionals##3##2##(1994-1#1)(2008-3#1)(2011-2#1)
service programs to##2##3##(2004-12#1)(2011-2#1)
service programs##5##2##(1990-12#1)(1992-2#1)(2004-12#1)(2011-2#2)
service provided by##3##3##(1994-2#1)(1994-8#1)(2008-10#1)
service provided##9##2##(1994-2#1)(1994-8#1)(1995-9#1)(1996-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-3#1)
service provider##8##2##(1994-2#1)(1995-6#1)(1996-5#1)(2007-2#1)(2007-4#1)(2008-11#1)(2010-2#1)(2011-2#1)
service providers and##4##3##(2008-11#2)(2008-12#1)(2012-3#1)
service providers in the##3##4##(1995-3#1)(2005-11#1)(2008-11#1)
service providers in##4##3##(1995-3#1)(2005-11#1)(2007-3#1)(2008-11#1)
service providers to ensure##2##4##(1993-12#1)(2008-11#1)
service providers to##3##3##(1993-12#1)(2008-11#1)(2012-3#1)
service providers##31##2##(1993-1#1)(1993-12#2)(1994-12#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(2005-11#1)(2007-3#3)(2008-11#6)(2008-12#1)(2010-8#1)(2012-2#2)(2012-3#5)(2013-1#1)
service providing##2##2##(1990-12#1)(1993-12#1)
service provision for##4##3##(2008-11#1)(2008-12#1)(2008-7#1)(2011-1#1)
service provision##20##2##(1992-1#1)(1996-1#1)(1996-2#1)(1996-3#1)(2005-5#2)(2006-9#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#2)(2009-3#1)(2009-9#1)(2011-1#2)(2012-11#1)(2012-2#1)
service quality and patient satisfaction##2##5##(1995-1#1)(1995-3#1)
service quality and##5##3##(1993-12#1)(1995-1#1)(1995-3#2)(2012-3#1)
service quality expectations##2##3##(1995-2#1)(2013-8#1)
service quality in health##2##4##(1995-1#1)(1995-3#1)
service quality in##6##3##(1993-12#1)(1995-1#1)(1995-2#1)(1995-3#1)(2006-4#1)(2008-8#1)
service quality were##2##3##(1995-3#1)(2008-8#1)
service quality##45##2##(1992-3#1)(1993-1#1)(1993-12#6)(1993-2#1)(1994-12#1)(1994-2#4)(1995-1#4)(1995-2#7)(1995-3#6)(1996-3#3)(1997-1#1)(1997-3#1)(2006-4#1)(2007-5#2)(2008-8#2)(2010-11#1)(2010-8#1)(2012-3#1)(2013-8#1)
service redeployment##5##2##(1993-1#3)(1995-1#1)(1995-2#1)
service referrals##2##2##(2010-10#1)(2011-2#1)
service rendered##3##2##(1992-12#1)(1995-9#2)
service sector##2##2##(2005-9#1)(2008-12#1)
service should##2##2##(1992-5#1)(2011-12#1)
service showed##2##2##(1992-5#1)(2008-8#1)
service system has##2##3##(1997-2#1)(1997-5#1)
service system in##2##3##(1992-1#1)(1994-1#1)
service system##9##2##(1992-1#2)(1993-12#1)(1994-1#1)(1995-3#1)(1997-2#1)(1997-5#1)(2012-2#1)(2013-8#1)
service systems##4##2##(1994-1#2)(2006-10#1)(2008-12#1)
service that##4##2##(1991-12#1)(1995-9#1)(2005-11#1)(2011-2#1)
service to patients##3##3##(1990-10#1)(2007-4#1)(2007-9#1)
service to the##4##3##(1997-2#1)(2008-11#1)(2009-10#1)(2009-3#1)
service to##25##2##(1990-10#1)(1991-12#1)(1994-1#3)(1994-2#1)(1995-1#2)(1995-3#1)(1996-1#1)(1997-2#1)(2006-10#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-9#1)(2009-10#1)(2009-3#1)(2012-11#1)(2013-8#1)
service use and expenditures##2##4##(1990-12#1)(1995-3#1)
service use and##3##3##(1990-12#1)(1992-1#1)(1995-3#1)
service use patterns##4##3##(1991-1#1)(2010-2#1)(2012-3#2)
service use##27##2##(1990-12#1)(1991-1#5)(1991-3#2)(1992-1#1)(1993-1#1)(1995-3#2)(1997-2#1)(2006-8#1)(2010-11#1)(2010-2#5)(2011-1#1)(2012-2#2)(2012-3#4)
service user and carer##2##4##(2008-12#1)(2009-6#1)
service user and##3##3##(2008-12#2)(2009-6#1)
service user involvement##3##3##(2008-12#3)
service user##7##2##(2008-12#5)(2009-6#1)(2012-11#1)
service users and carers##3##4##(2009-6#3)
service users and their carers##2##5##(2008-11#1)(2008-12#1)
service users and##7##3##(2008-11#1)(2008-12#2)(2009-6#3)(2012-11#1)
service users as##3##3##(2008-12#2)(2012-3#1)
service users in##7##3##(2008-12#5)(2012-11#1)(2012-3#1)
service users were more##2##4##(2012-3#2)
service users##30##2##(2008-11#1)(2008-12#11)(2009-12#1)(2009-6#4)(2011-1#1)(2012-11#3)(2012-3#9)
service users'##3##2##(2008-11#1)(2012-11#1)(2012-3#1)
service utilisation##2##2##(2007-7#1)(2012-12#1)
service utilization and##4##3##(1994-2#2)(2011-1#2)
service utilization##12##2##(1994-2#3)(2008-7#1)(2010-11#3)(2011-1#3)(2012-1#1)(2012-3#1)
service volume##3##2##(1992-12#1)(1994-12#1)(2010-2#1)
service was##8##2##(1991-5#1)(1995-11#1)(1997-8#1)(2006-8#1)(2007-1#1)(2008-11#1)(2010-8#1)(2013-1#1)
service were##2##2##(1994-2#1)(2008-9#1)
service which##2##2##(2008-2#1)(2011-2#1)
service with##6##2##(1995-2#1)(1996-2#2)(2007-3#1)(2007-8#1)(2008-5#1)
service workers##8##2##(1993-1#1)(1995-1#2)(1996-2#1)(2007-10#2)(2008-10#1)(2012-3#1)
service##1165##1##(1990-10#2)(1990-11#1)(1990-12#6)(1990-3#1)(1990-6#2)(1990-8#2)(1991-1#14)(1991-11#5)(1991-12#13)(1991-2#4)(1991-3#12)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#14)(1992-11#2)(1992-12#10)(1992-2#9)(1992-3#16)(1992-4#1)(1992-5#6)(1992-8#1)(1992-9#1)(1993-1#17)(1993-10#1)(1993-12#30)(1993-2#9)(1993-3#10)(1993-5#1)(1993-6#1)(1993-8#1)(1994-1#20)(1994-12#13)(1994-2#30)(1994-3#13)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#2)(1995-1#30)(1995-10#1)(1995-11#2)(1995-12#12)(1995-2#24)(1995-3#31)(1995-4#1)(1995-6#9)(1995-9#8)(1996-1#15)(1996-11#2)(1996-12#6)(1996-2#27)(1996-3#32)(1996-5#3)(1996-6#2)(1996-7#3)(1996-9#2)(1997-1#12)(1997-2#12)(1997-3#12)(1997-5#3)(1997-6#1)(1997-8#8)(2004-10#1)(2004-12#3)(2004-3#3)(2004-7#1)(2004-8#1)(2004-9#4)(2005-10#1)(2005-11#5)(2005-12#3)(2005-5#12)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#11)(2006-11#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#4)(2006-8#9)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#4)(2007-12#3)(2007-2#8)(2007-3#9)(2007-4#13)(2007-5#2)(2007-6#2)(2007-7#7)(2007-8#6)(2007-9#5)(2008-1#23)(2008-10#5)(2008-11#26)(2008-12#28)(2008-2#15)(2008-3#13)(2008-4#5)(2008-5#2)(2008-6#5)(2008-7#13)(2008-8#16)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#4)(2009-3#5)(2009-4#3)(2009-5#1)(2009-6#8)(2009-7#2)(2009-8#6)(2009-9#2)(2010-10#4)(2010-11#5)(2010-2#10)(2010-3#4)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#16)(2010-9#4)(2011-1#26)(2011-12#5)(2011-2#32)(2012-1#2)(2012-11#12)(2012-12#11)(2012-2#22)(2012-3#48)(2013-1#57)(2013-8#35)
service&quot##4##1##(1990-9#1)(1992-3#1)(2007-1#1)(2007-10#1)
service'##2##1##(1994-12#1)(2008-11#1)
service's strategies##2##2##(2012-12#2)
service's##4##1##(2008-6#1)(2012-12#3)
service-learning##3##1##(2008-1#3)
service-oriented CDS##4##2##(2013-1#4)
service-oriented architecture for clinical decision support (CDS) has the potential to significantly enhance CDS scalability and robustness##2##17##(2013-1#2)
service-oriented architecture##4##2##(2010-8#2)(2013-1#2)
service-oriented##11##1##(1992-12#1)(1993-1#1)(2010-8#2)(2012-12#1)(2013-1#6)
service-rich and service-poor communities##2##4##(2010-8#2)
service-rich communities##2##2##(2010-8#2)
service-rich##5##1##(2010-8#5)
service]##9##1##(1992-5#1)(1992-9#1)(1994-3#1)(1995-10#1)(1995-9#1)(1996-3#1)(1997-5#1)(2006-2#1)(2007-1#1)
serviced##3##1##(1995-1#1)(2006-8#1)(2008-11#1)
servicemen of the enlisted staff##2##5##(2006-6#2)
servicemen##3##1##(2005-8#1)(2006-6#2)
services (e##2##2##(1994-3#1)(2010-11#1)
services a##3##2##(1992-3#1)(1994-1#1)(2011-2#1)
services across##3##2##(1996-2#1)(2004-12#1)(2008-2#1)
services administration and##2##3##(1991-12#1)(1993-3#1)
services administration education##4##3##(1993-1#1)(1993-2#1)(1994-2#1)(1997-2#1)
services administration programs must##2##4##(1997-2#2)
services administration programs##3##3##(1996-3#1)(1997-2#2)
services administration##16##2##(1991-12#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-2#1)(1996-3#3)(1997-2#3)(1997-3#1)
services after##2##2##(2006-1#1)(2008-8#1)
services agencies##2##2##(1994-1#1)(1996-4#1)
services among##4##2##(1991-4#1)(1996-3#1)(2007-5#1)(2007-7#1)
services and a##3##3##(2004-12#1)(2006-9#1)(2012-12#1)
services and capabilities##4##3##(2013-1#4)
services and care##2##3##(2007-3#1)(2008-1#1)
services and examine##2##3##(1992-12#1)(1993-12#1)
services and health care##3##4##(1994-1#1)(1995-2#1)(2006-10#1)
services and health##5##3##(1991-2#1)(1994-1#1)(1995-2#1)(1996-3#1)(2006-10#1)
services and human resources in Puerto Rico##2##7##(2010-9#2)
services and more##3##3##(1997-5#1)(2008-9#1)(2011-1#1)
services and programs##2##3##(1991-1#1)(1995-1#1)
services and the##23##3##(1991-2#1)(1992-1#2)(1992-5#1)(1993-1#1)(1994-1#1)(1996-11#1)(1996-9#1)(2004-12#1)(2005-5#1)(2006-1#1)(2006-8#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-6#1)(2009-6#1)(2011-1#4)(2012-3#1)(2013-1#1)
services and their##2##3##(2011-2#1)(2012-3#1)
services and to##3##3##(1991-2#1)(2008-11#1)(2012-1#1)
services and treatment##2##3##(1994-8#1)(2010-6#1)
services and##154##2##(1990-12#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-6#1)(1992-1#2)(1992-12#3)(1992-3#1)(1992-5#1)(1993-1#5)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-1#3)(1994-12#1)(1994-8#2)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#1)(1996-1#4)(1996-11#1)(1996-2#5)(1996-3#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-5#1)(1997-8#1)(2004-12#2)(2004-7#1)(2005-10#1)(2005-5#1)(2006-1#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#3)(2006-9#3)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#2)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#3)(2008-11#2)(2008-12#2)(2008-2#2)(2008-6#3)(2008-7#1)(2008-9#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#2)(2010-10#1)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#7)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#7)(2013-1#9)
services are available##4##3##(1992-12#1)(1996-3#1)(2007-3#1)(2011-2#1)
services are being##3##3##(1991-12#1)(2005-5#1)(2013-7#1)
services are delivered##2##3##(2008-2#1)(2013-8#1)
services are discussed##5##3##(1991-12#1)(1991-2#2)(1993-12#1)(1997-1#1)
services are important for##2##4##(1995-4#1)(1996-8#1)
services are important##5##3##(1995-4#1)(1996-8#1)(2006-8#1)(2007-6#1)(2010-5#1)
services are limited##2##3##(1996-12#1)(2008-9#1)
services are often##2##3##(2008-2#1)(2008-7#1)
services are##55##2##(1991-1#1)(1991-12#3)(1991-2#2)(1992-11#1)(1992-12#2)(1993-12#1)(1993-3#1)(1993-8#1)(1994-6#1)(1995-1#1)(1995-4#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(2005-5#1)(2006-10#1)(2006-8#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-2#2)(2008-7#2)(2008-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#2)
services around##2##2##(2007-4#1)(2012-3#1)
services as a##5##3##(1992-3#1)(2005-5#1)(2008-2#1)(2010-4#1)(2012-1#1)
services as well as##3##4##(1990-11#1)(1991-3#1)(1994-1#1)
services as##17##2##(1990-11#1)(1991-3#1)(1991-9#1)(1992-2#1)(1992-3#1)(1994-1#1)(1994-2#1)(2005-5#1)(2006-5#1)(2007-9#1)(2008-2#1)(2008-4#1)(2010-4#1)(2012-1#1)(2012-3#3)
services at Nyanza Provincial Hospital##2##5##(2007-7#2)
services at a##4##3##(1991-2#1)(1992-12#1)(2011-2#1)(2013-8#1)
services at the##7##3##(1993-12#1)(1993-3#1)(1994-3#2)(2008-4#1)(2011-2#1)(2012-12#1)
services at##25##2##(1991-2#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-3#2)(2007-12#1)(2007-7#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-3#3)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
services available for##3##3##(2012-12#1)(2013-1#2)
services available in##2##3##(1993-12#1)(2008-1#1)
services available to##4##3##(1993-6#1)(1994-2#1)(1995-12#1)(2008-11#1)
services available##12##2##(1993-12#1)(1993-6#1)(1994-2#2)(1995-12#1)(2005-8#1)(2008-1#1)(2008-11#1)(2010-8#1)(2012-12#1)(2013-1#2)
services based on##2##3##(2007-4#1)(2010-5#1)
services be##3##2##(1993-11#1)(1993-4#1)(2005-7#1)
services between##2##2##(1996-3#1)(2007-5#1)
services by the elderly##2##4##(1995-12#1)(1995-3#1)
services by the##3##3##(1992-2#1)(1995-12#1)(1995-3#1)
services by##23##2##(1992-2#2)(1992-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#2)(1996-1#1)(1996-2#2)(1996-3#1)(2005-5#1)(2006-3#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-2#1)(2010-2#1)(2010-9#1)(2012-2#1)
services can be##3##3##(1995-12#1)(1995-2#1)(2007-7#1)
services can provide##2##3##(2009-6#1)(2012-2#1)
services can##8##2##(1990-8#1)(1995-12#1)(1995-2#1)(2007-7#1)(2008-7#1)(2009-6#1)(2012-2#1)(2013-7#1)
services could be##2##3##(1995-1#1)(1997-2#1)
services covered by the##2##4##(1996-12#1)(2006-8#1)
services delivered to##3##3##(1997-2#1)(2007-7#1)(2012-3#1)
services delivered##6##2##(1997-2#2)(1997-3#1)(2007-12#1)(2007-7#1)(2012-3#1)
services delivery##6##2##(1992-3#1)(1993-2#1)(1997-1#1)(2007-12#1)(2008-8#1)(2011-1#1)
services depends##2##2##(2008-1#1)(2012-3#1)
services despite##2##2##(2008-3#1)(2013-1#1)
services did not##3##3##(1994-2#1)(2012-3#1)(2013-7#1)
services do not##3##3##(1996-9#1)(2007-8#1)(2011-1#1)
services during the##3##3##(1993-3#1)(1995-1#1)(2008-7#1)
services during##6##2##(1990-12#1)(1991-3#1)(1993-3#1)(1995-1#1)(2007-5#1)(2008-7#1)
services following##2##2##(1994-1#1)(1996-3#1)
services for children and##2##4##(1992-1#1)(1995-2#1)
services for children##5##3##(1992-1#1)(1995-12#1)(1995-2#1)(2010-12#1)(2012-12#1)
services for older people##2##4##(1991-2#1)(2013-8#1)
services for patients with##4##4##(2007-6#1)(2008-6#1)(2012-11#2)
services for patients##5##3##(2007-6#1)(2008-6#1)(2012-11#2)(2012-12#1)
services for people with##2##4##(1993-1#1)(1996-1#1)
services for people##4##3##(1993-1#1)(1996-1#1)(2008-4#1)(2012-2#1)
services for persons with##3##4##(1995-3#1)(1996-4#1)(2013-7#1)
services for the aged##2##4##(1990-12#1)(1994-1#1)
services for the elderly##4##4##(1991-3#1)(1994-1#1)(2008-2#2)
services for the##28##3##(1990-12#3)(1990-5#1)(1991-3#1)(1991-4#1)(1992-1#1)(1992-11#1)(1994-1#3)(1994-3#1)(1997-1#1)(1997-2#1)(1997-5#5)(1997-8#1)(2007-6#1)(2008-1#1)(2008-2#3)(2008-3#1)(2009-6#1)(2012-11#1)
services for their children with##3##5##(1993-1#1)(1993-3#1)(1996-1#1)
services for their##4##3##(1993-1#1)(1993-3#1)(1995-1#1)(1996-1#1)
services for those##2##3##(1996-2#1)(2007-2#1)
services for urban##2##3##(2004-10#1)(2012-2#1)
services for women##3##3##(1997-1#1)(2011-2#1)(2013-1#1)
services for##112##2##(1990-12#3)(1990-5#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#1)(1992-1#3)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#4)(1993-11#1)(1993-2#1)(1993-3#1)(1994-1#4)(1994-2#1)(1994-3#2)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#1)(1997-1#2)(1997-2#2)(1997-5#5)(1997-7#1)(1997-8#1)(2004-10#1)(2005-1#1)(2006-2#1)(2006-6#1)(2006-9#2)(2007-2#1)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#1)(2008-1#3)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#4)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
services from the##7##3##(1991-6#1)(2007-1#1)(2007-2#1)(2008-2#1)(2011-1#1)(2012-11#1)(2012-3#1)
services from##12##2##(1991-6#1)(1992-12#1)(1994-12#1)(1994-2#1)(2004-11#1)(2007-1#1)(2007-2#1)(2008-2#2)(2011-1#1)(2012-11#1)(2012-3#1)
services given##2##2##(2006-10#1)(2008-2#1)
services has been##3##3##(1996-5#1)(1997-5#1)(2006-8#1)
services has##11##2##(1991-2#1)(1993-12#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-5#1)(2006-8#1)(2007-4#1)(2010-11#1)(2010-8#1)(2011-7#1)
services have been##2##3##(2011-2#1)(2012-11#1)
services have led to##2##4##(1992-2#1)(2008-2#1)
services have##13##2##(1992-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-8#1)(2009-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)
services if##4##2##(1992-2#1)(1995-12#2)(2012-3#1)
services in 2004##2##3##(2012-3#2)
services in Canada##3##3##(1994-1#1)(2010-11#1)(2010-9#1)
services in Nepal##2##3##(2008-7#1)(2010-4#1)
services in New##2##3##(1996-3#1)(2010-4#1)
services in Norway##4##3##(1990-11#1)(1992-11#2)(1995-2#1)
services in Ontario##3##3##(1995-2#2)(2007-7#1)
services in Tanzania##4##3##(2010-8#4)
services in a large##2##4##(1997-1#1)(2009-9#1)
services in a##8##3##(1990-3#1)(1993-12#2)(1995-12#1)(1997-1#1)(2006-1#1)(2007-2#1)(2009-9#1)
services in an##7##3##(1994-3#1)(1995-1#1)(1997-3#1)(2004-3#1)(2007-5#1)(2008-11#1)(2010-9#1)
services in demand##2##3##(1995-7#1)(2005-5#1)
services in general##2##3##(1992-3#1)(1993-6#1)
services in hospital##2##3##(1991-3#1)(2010-8#1)
services in order to##2##4##(2007-11#1)(2008-2#1)
services in response to##2##4##(2010-3#1)(2010-8#1)
services in rural##2##3##(1996-3#1)(2008-10#1)
services in the community##2##4##(1993-1#1)(2006-5#1)
services in the##35##3##(1991-2#1)(1991-9#1)(1993-1#1)(1993-7#1)(1994-1#2)(1994-8#1)(1995-1#2)(1995-12#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-8#1)(2005-8#1)(2005-9#1)(2006-5#1)(2007-11#1)(2007-2#2)(2008-1#1)(2008-12#1)(2009-3#1)(2010-3#1)(2010-4#1)(2011-1#3)(2011-2#2)(2012-11#1)(2012-12#2)(2012-3#1)
services in this population##2##4##(1993-12#1)(2007-5#1)
services in this##4##3##(1991-2#1)(1993-12#2)(2007-5#1)
services in##164##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1991-12#3)(1991-2#4)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-3#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#2)(1993-6#2)(1993-7#1)(1994-1#4)(1994-2#1)(1994-3#3)(1994-6#1)(1994-8#1)(1995-1#3)(1995-12#3)(1995-2#4)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#2)(1997-8#2)(2004-12#1)(2004-3#1)(2005-5#2)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#3)(2007-3#2)(2007-5#2)(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#5)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#8)(2010-9#2)(2011-1#5)(2011-2#5)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#7)(2013-1#3)(2013-7#2)(2013-8#1)
services increased##2##2##(1991-2#1)(1994-1#1)
services into the##2##3##(1991-2#1)(1997-2#1)
services into##7##2##(1991-2#1)(1995-2#1)(1997-2#1)(2004-2#1)(2005-11#1)(2011-1#1)(2012-12#1)
services is found##2##3##(1996-3#1)(2006-4#1)
services is not##2##3##(1993-12#1)(2011-2#1)
services is one of the##2##5##(2007-1#1)(2008-11#1)
services is one##3##3##(1995-3#1)(2007-1#1)(2008-11#1)
services is to##2##3##(1990-12#1)(1996-1#1)
services is##34##2##(1990-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-3#1)(1997-2#1)(2006-4#1)(2006-7#1)(2007-1#1)(2007-3#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-3#5)
services mainly##2##2##(2012-3#2)
services management development##2##3##(1994-3#1)(1995-3#1)
services management education##3##3##(1992-1#1)(1992-12#1)(1995-3#1)
services management##15##2##(1992-1#4)(1992-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#2)(1996-1#1)(1996-2#1)(2009-4#1)(2012-12#1)
services marketing##3##2##(1996-1#1)(2008-12#1)(2010-12#1)
services may be##5##3##(1990-12#2)(1995-9#1)(2008-7#1)(2012-12#1)
services may##12##2##(1990-12#2)(1990-7#1)(1990-8#1)(1992-1#1)(1995-9#1)(2005-10#1)(2008-7#1)(2009-8#1)(2010-6#1)(2012-12#1)(2012-3#1)
services more##3##2##(1994-3#1)(1997-4#1)(2006-8#1)
services must be##2##3##(1996-12#1)(2013-8#1)
services must##3##2##(1996-12#1)(2012-12#1)(2013-8#1)
services need to be##2##4##(1991-2#1)(2006-12#1)
services need##3##2##(1991-2#1)(1991-4#1)(2006-12#1)
services of a##4##3##(1995-3#2)(1995-9#1)(2008-1#1)
services of the##8##3##(1994-1#1)(1994-3#1)(1996-2#1)(2008-2#2)(2008-9#1)(2010-9#1)(2011-2#1)
services of##22##2##(1994-1#2)(1994-3#1)(1995-3#2)(1995-9#1)(1996-2#1)(2004-12#1)(2006-8#2)(2008-1#2)(2008-2#2)(2008-9#3)(2009-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
services offered by a##2##4##(1993-12#1)(2006-7#1)
services offered by##4##3##(1993-12#1)(1994-12#1)(1996-12#1)(2006-7#1)
services offered to##5##3##(2008-2#3)(2011-2#1)(2012-12#1)
services offered##17##2##(1992-3#1)(1993-12#1)(1994-12#1)(1994-2#2)(1995-1#1)(1996-12#1)(2006-7#1)(2007-7#1)(2008-2#4)(2011-2#1)(2012-12#1)(2013-1#2)
services often##2##2##(1992-3#1)(2012-11#1)
services on a##3##3##(1990-12#1)(1996-2#1)(2008-2#1)
services on the Internet##2##4##(1996-12#1)(2004-12#1)
services on the##3##3##(1990-12#1)(1996-12#1)(2004-12#1)
services on##14##2##(1990-12#2)(1993-12#1)(1994-12#1)(1996-12#1)(1996-2#1)(2004-12#1)(2008-12#1)(2008-2#1)(2011-1#1)(2013-1#4)
services or##7##2##(1992-3#1)(1992-5#1)(1994-3#1)(1996-12#1)(2007-4#1)(2008-5#1)(2009-4#1)
services organization##2##2##(1991-9#1)(1994-3#1)
services organizations##4##2##(1990-12#1)(1995-1#1)(1996-3#1)(2005-8#1)
services outside of the##2##4##(1996-2#1)(2008-11#1)
services over the past##2##4##(1995-3#1)(2010-5#1)
services over the##3##3##(1995-3#1)(2006-8#1)(2010-5#1)
services over##5##2##(1995-3#1)(1996-2#1)(1997-1#1)(2006-8#1)(2010-5#1)
services program##2##2##(1991-3#1)(1994-2#1)
services programs##3##2##(1991-1#2)(1997-3#1)
services provide##3##2##(2012-11#2)(2012-3#1)
services provided by the##4##4##(1992-2#1)(1995-1#1)(1996-2#1)(2011-2#1)
services provided by these##2##4##(1992-1#1)(2007-7#1)
services provided by##11##3##(1992-1#1)(1992-2#1)(1995-1#1)(1996-1#1)(1996-2#1)(2006-1#1)(2007-1#2)(2007-7#1)(2010-8#1)(2011-2#1)
services provided during##2##3##(1992-12#1)(2007-7#1)
services provided in##3##3##(1994-12#1)(1994-3#2)
services provided more##2##3##(2012-11#2)
services provided to##8##3##(1991-3#1)(1992-2#1)(1995-1#1)(1995-12#1)(1995-3#1)(2010-5#2)(2012-2#1)
services provided##39##2##(1991-2#1)(1991-3#1)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#1)(1994-12#1)(1994-3#2)(1994-4#1)(1995-1#3)(1995-12#2)(1995-3#2)(1996-1#1)(1996-2#1)(2006-1#1)(2006-12#1)(2007-1#2)(2007-4#1)(2007-7#2)(2008-8#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-2#2)(2013-1#1)
services providing##2##2##(2012-11#2)
services received by##3##3##(1992-2#1)(1994-2#1)(1995-12#1)
services rendered##2##2##(1992-1#1)(2010-9#1)
services research and##4##3##(1992-3#1)(2012-2#3)
services research in Canada##5##4##(1993-3#2)(2009-4#3)
services research to##2##3##(1993-12#1)(2009-4#1)
services research##34##2##(1991-1#1)(1991-12#1)(1992-3#2)(1993-12#1)(1993-3#3)(1994-3#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-6#1)(2005-9#1)(2007-7#1)(2008-7#1)(2009-4#12)(2011-1#1)(2012-1#1)(2012-2#4)
services researchers##4##2##(1995-2#1)(2007-10#1)(2009-4#2)
services should be available##2##4##(1991-12#1)(2007-12#1)
services should be##7##3##(1991-12#2)(1991-6#1)(1995-1#1)(1996-1#1)(2006-7#1)(2007-12#1)
services should not be##3##4##(1995-1#1)(1997-1#1)(2012-1#1)
services should##13##2##(1991-12#2)(1991-6#1)(1995-1#2)(1996-1#1)(1997-1#1)(1997-8#1)(2005-10#1)(2006-7#1)(2007-12#1)(2009-5#1)(2012-1#1)
services showed##2##2##(1993-2#1)(2012-3#1)
services since the##3##3##(1997-2#1)(2007-2#1)(2010-8#1)
services specifically##2##2##(1996-9#1)(1997-1#1)
services staff##2##2##(2007-12#1)(2010-2#1)
services such as##7##3##(1991-10#1)(1994-3#1)(1997-3#1)(2007-4#1)(2008-1#1)(2010-12#1)(2012-2#1)
services system##2##2##(1994-3#1)(2008-2#1)
services than##7##2##(1991-1#1)(1992-5#1)(1993-2#1)(1994-1#1)(1996-3#1)(2006-10#1)(2010-4#1)
services that are not##2##4##(2007-4#1)(2008-12#1)
services that are##8##3##(1990-12#1)(2006-8#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-6#1)(2012-12#1)
services that can##3##3##(1992-1#1)(1996-1#1)(1996-3#1)
services that is##2##3##(2008-7#1)(2008-8#1)
services that##31##2##(1990-12#2)(1992-1#2)(1992-2#1)(1993-1#1)(1993-12#2)(1994-12#2)(1994-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(2006-8#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#2)(2009-9#1)(2010-3#1)(2012-1#1)(2012-12#1)(2013-1#2)
services through##6##2##(1994-2#1)(1996-3#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-11#1)
services to Medicare beneficiaries##3##4##(1991-3#2)(1992-2#1)
services to an##3##3##(1994-3#2)(1996-11#1)
services to be##2##3##(1993-6#1)(2005-5#1)
services to better##2##3##(1996-2#1)(2012-12#1)
services to children##3##3##(1991-3#1)(1992-1#1)(2008-11#1)
services to help##2##3##(1996-3#1)(2007-3#1)
services to high-risk##2##3##(2007-3#1)(2012-3#1)
services to meet the needs of##2##6##(1993-1#1)(1994-1#1)
services to meet##3##3##(1993-1#1)(1994-1#1)(2005-12#1)
services to offenders##2##3##(2008-11#1)(2010-6#1)
services to patients##2##3##(1993-12#1)(2004-11#1)
services to people with##4##4##(1993-1#1)(1996-3#1)(2008-2#1)(2011-1#1)
services to reduce##2##3##(1997-2#1)(2006-8#1)
services to remote##2##3##(1995-1#1)(1997-4#1)
services to support##2##3##(1990-12#1)(2010-12#1)
services to the community##2##4##(2004-12#1)(2008-7#1)
services to the elderly##3##4##(1994-1#2)(2008-2#1)
services to the medical##2##4##(1995-12#1)(2007-2#1)
services to the##17##3##(1990-12#1)(1991-1#1)(1994-1#2)(1995-12#1)(1996-12#1)(2004-12#1)(2005-10#1)(2007-1#1)(2007-2#1)(2008-1#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-6#1)(2012-2#1)(2013-1#1)
services to their##2##3##(1995-3#2)
services to##111##2##(1990-12#3)(1991-1#1)(1991-3#4)(1992-1#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-1#2)(1993-12#2)(1993-6#1)(1993-8#1)(1994-1#4)(1994-2#2)(1994-3#3)(1995-1#2)(1995-12#2)(1995-3#3)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#4)(1997-2#1)(1997-4#1)(1997-8#1)(2004-11#1)(2004-12#1)(2005-10#2)(2005-12#1)(2005-5#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-2#2)(2007-3#2)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#5)(2008-6#4)(2008-7#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#10)
services under Medicare##2##3##(1991-2#1)(1991-3#1)
services under the##2##3##(1991-1#1)(2006-8#1)
services under##13##2##(1991-1#1)(1991-2#1)(1991-3#1)(1992-2#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-2#2)(2006-8#1)
services use in##2##3##(2009-7#2)
services use##5##2##(2005-10#1)(2009-7#3)(2010-2#1)
services used by##3##3##(1991-3#1)(1995-12#1)(1997-3#1)
services used##4##2##(1991-3#1)(1995-12#1)(1997-3#1)(2007-10#1)
services utilization##8##2##(1990-12#1)(1994-2#1)(2006-2#1)(2008-12#1)(2009-12#1)(2011-1#1)(2012-3#2)
services was examined##2##3##(1993-6#1)(2007-5#1)
services was##13##2##(1991-5#1)(1992-2#1)(1993-10#1)(1993-6#1)(1995-12#1)(2005-7#1)(2006-8#1)(2007-5#1)(2008-8#1)(2009-4#1)(2012-12#1)(2013-1#2)
services were found to have marginal or no impact##2##9##(1991-4#1)(1993-6#1)
services were identified##2##3##(2008-1#1)(2010-8#1)
services were offered##2##3##(2006-4#1)(2008-9#1)
services were provided to##2##4##(1995-3#1)(1996-1#1)
services were##29##2##(1990-12#1)(1991-3#1)(1991-4#1)(1992-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-3#2)(1996-6#1)(2005-8#1)(2006-10#1)(2006-4#1)(2008-1#1)(2008-9#1)(2009-5#2)(2010-3#1)(2010-8#1)(2012-11#2)(2012-12#2)(2012-2#2)(2012-3#1)
services which can be##2##4##(1992-2#1)(1992-3#1)
services which##6##2##(1992-2#1)(1992-3#1)(1996-3#1)(1997-2#1)(2008-2#1)(2009-7#1)
services while##3##2##(1990-12#1)(1992-2#1)(2007-10#1)
services will be##6##3##(1993-3#1)(1995-12#2)(1996-12#1)(1997-3#1)(2008-7#1)
services will##10##2##(1993-3#1)(1994-1#1)(1995-12#2)(1996-12#1)(1997-1#1)(1997-3#1)(2008-7#2)(2012-2#1)
services with low market penetration##2##5##(1997-1#2)
services with the##3##3##(1993-1#1)(1994-12#1)(1996-3#1)
services with##18##2##(1992-3#1)(1992-6#1)(1993-1#2)(1993-3#1)(1994-1#3)(1994-12#1)(1996-12#1)(1996-3#1)(1997-1#2)(2007-9#1)(2011-2#1)(2012-12#1)(2013-1#2)
services within the##2##3##(1996-2#1)(2007-11#1)
services within##5##2##(1993-1#1)(1995-2#1)(1996-2#1)(2007-11#1)(2010-12#1)
services would be##2##3##(1995-1#1)(1996-1#1)
services would##5##2##(1995-1#1)(1996-1#1)(2007-2#1)(2011-2#1)(2012-3#1)
services##2307##1##(1990-11#2)(1990-12#32)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#3)(1990-7#3)(1990-8#5)(1990-9#1)(1991-1#22)(1991-10#4)(1991-11#1)(1991-12#26)(1991-2#31)(1991-3#28)(1991-4#5)(1991-5#2)(1991-6#13)(1991-8#2)(1991-9#6)(1992-1#32)(1992-10#2)(1992-11#11)(1992-12#24)(1992-2#29)(1992-3#30)(1992-5#6)(1992-6#1)(1992-8#1)(1992-9#5)(1993-1#26)(1993-10#3)(1993-11#4)(1993-12#34)(1993-2#25)(1993-3#22)(1993-4#2)(1993-6#13)(1993-7#2)(1993-8#5)(1994-1#42)(1994-11#1)(1994-12#27)(1994-2#44)(1994-3#49)(1994-4#1)(1994-6#5)(1994-8#4)(1994-9#1)(1995-1#23)(1995-10#1)(1995-11#1)(1995-12#40)(1995-2#26)(1995-3#37)(1995-4#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#5)(1996-1#40)(1996-11#5)(1996-12#26)(1996-2#46)(1996-3#44)(1996-4#2)(1996-5#1)(1996-6#6)(1996-8#3)(1996-9#8)(1997-1#21)(1997-2#38)(1997-3#27)(1997-4#3)(1997-5#8)(1997-6#2)(1997-7#2)(1997-8#9)(2004-10#1)(2004-11#2)(2004-12#7)(2004-2#2)(2004-3#1)(2004-7#1)(2005-1#1)(2005-10#12)(2005-11#4)(2005-12#3)(2005-5#15)(2005-7#3)(2005-8#6)(2005-9#5)(2006-1#8)(2006-10#13)(2006-11#2)(2006-12#4)(2006-2#6)(2006-3#3)(2006-4#5)(2006-5#8)(2006-6#3)(2006-7#6)(2006-8#34)(2006-9#9)(2007-1#7)(2007-10#16)(2007-11#8)(2007-12#12)(2007-2#19)(2007-3#16)(2007-4#25)(2007-5#12)(2007-6#6)(2007-7#29)(2007-8#5)(2007-9#6)(2008-1#35)(2008-10#6)(2008-11#37)(2008-12#26)(2008-2#70)(2008-3#8)(2008-4#10)(2008-5#11)(2008-6#12)(2008-7#22)(2008-8#17)(2008-9#21)(2009-10#1)(2009-11#2)(2009-12#3)(2009-3#4)(2009-4#28)(2009-5#11)(2009-6#14)(2009-7#8)(2009-8#4)(2009-9#2)(2010-1#5)(2010-10#8)(2010-11#9)(2010-12#12)(2010-2#13)(2010-3#13)(2010-4#7)(2010-5#13)(2010-6#6)(2010-7#2)(2010-8#38)(2010-9#12)(2011-1#51)(2011-2#63)(2011-7#3)(2012-1#13)(2012-11#27)(2012-12#44)(2012-2#34)(2012-3#104)(2013-1#47)(2013-7#12)(2013-8#22)
services&quot##2##1##(2006-7#1)(2008-9#1)
services'##2##1##(2008-9#1)(2011-1#1)
services)##2##1##(1992-3#1)(2008-2#1)
services? The##2##2##(1994-8#1)(1995-12#1)
services?##3##1##(1994-8#1)(1995-12#1)(2012-2#1)
services?]##3##1##(1991-4#1)(1993-6#1)(1995-8#1)
services]##25##1##(1990-5#1)(1990-8#1)(1991-2#1)(1992-11#2)(1992-5#1)(1993-5#1)(1993-6#3)(1993-9#2)(1994-10#1)(1994-6#1)(1995-4#1)(1995-8#1)(1996-11#1)(1996-9#2)(1997-4#1)(1997-5#2)(2007-9#1)(2008-9#1)(2011-2#1)
servicing##5##1##(1991-12#1)(1991-4#1)(2008-2#1)(2011-2#2)
serving Medicaid##2##2##(1996-2#1)(1997-6#1)
serving a##4##2##(1991-12#1)(1995-5#1)(2007-8#1)(2010-12#1)
serving an##2##2##(1990-12#1)(2008-1#1)
serving as a##15##3##(1994-3#1)(1994-8#1)(1995-10#1)(1996-3#1)(1996-8#1)(2005-8#1)(2006-12#1)(2006-5#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-5#1)(2010-8#1)
serving as an##7##3##(2004-4#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-2#1)(2010-3#1)
serving as the control##2##4##(2006-8#1)(2011-2#1)
serving as the##11##3##(1990-10#1)(1991-3#1)(1993-2#1)(1996-1#1)(2006-8#2)(2008-10#3)(2011-2#1)(2011-3#1)
serving as##58##2##(1990-10#1)(1990-5#1)(1991-3#1)(1992-12#1)(1992-4#1)(1992-5#1)(1993-12#1)(1993-2#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-10#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(2004-3#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#2)(2008-10#9)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
serving children##3##2##(1994-1#1)(2005-9#1)(2013-1#1)
serving for##2##2##(1990-7#1)(2010-9#1)
serving multiple##2##2##(1991-2#1)(2008-5#1)
serving of##3##2##(1997-1#1)(2006-10#1)(2007-6#1)
serving on##2##2##(1996-1#1)(2008-4#1)
serving sizes and##2##3##(2009-2#2)
serving specific needs that traditional excipients are unable to provide and for which safety studies are necessary to support a novel excipient for marketing applications##2##25##(2012-2#2)
serving the needs and##2##4##(2008-12#1)(2011-1#1)
serving the##8##2##(1992-2#1)(1993-8#1)(1996-1#1)(2007-8#1)(2008-12#1)(2009-4#1)(2011-1#1)(2012-3#1)
serving their##2##2##(2007-2#1)(2009-11#1)
serving to##4##2##(2006-10#1)(2008-3#1)(2009-11#1)(2013-8#1)
serving##129##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-5#1)(1995-6#2)(1996-1#3)(1996-12#1)(1996-2#3)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#1)(2004-3#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-12#2)(2006-5#1)(2006-8#2)(2007-2#3)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#9)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#2)(2009-2#4)(2009-4#1)(2009-7#1)(2010-1#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#4)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
servings of fruits and vegetables##4##5##(1993-12#1)(2005-10#1)(2011-1#2)
servings of fruits##6##3##(1993-12#1)(1994-2#1)(2005-10#1)(2010-8#1)(2011-1#2)
servings of vegetables and whole grains##2##6##(2012-12#2)
servings of##11##2##(1993-12#1)(1994-2#1)(1997-1#1)(2005-10#1)(2010-8#1)(2011-1#2)(2012-12#2)(2012-2#1)(2013-1#1)
servings##19##1##(1993-12#1)(1994-2#1)(1995-2#1)(1996-3#1)(1997-1#1)(2005-10#1)(2009-2#2)(2010-1#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#3)(2012-12#2)(2012-2#1)(2013-1#1)
servlet##2##1##(2008-9#2)
servo control to##2##3##(2008-2#1)(2008-3#1)
servo control##3##2##(2008-2#2)(2008-3#1)
servo signals##2##2##(2008-2#2)
servo system##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
servo##20##1##(2007-11#2)(2007-12#5)(2008-2#8)(2008-3#5)
servo-hydraulic##2##1##(2007-1#1)(2007-4#1)
servus##2##1##(2011-2#2)
seryl##5##1##(1990-2#1)(1990-6#1)(1991-2#1)(1994-9#1)(2012-2#1)
seryl-tRNA synthetases##2##2##(2009-3#2)
seryl-tRNA##3##1##(2009-3#2)(2012-2#1)
serylation##3##1##(2009-3#3)
ses##5##1##(2006-10#1)(2009-4#3)(2012-2#1)
sesame oil substitution##3##3##(2007-9#3)
sesame oil##18##2##(2007-8#2)(2007-9#10)(2009-10#1)(2010-5#2)(2012-12#2)(2012-2#1)
sesame##21##1##(1991-8#1)(2007-8#2)(2007-9#10)(2008-10#1)(2008-11#1)(2009-10#1)(2010-5#2)(2012-12#2)(2012-2#1)
sesami and cannabina##2##3##(2008-10#2)
sesami##6##1##(2008-10#6)
sesamin##5##1##(2009-10#5)
sesamoid bone##2##2##(2011-2#1)(2012-2#1)
sesamoid position##2##2##(2009-10#1)(2009-5#1)
sesamoid##10##1##(2006-1#3)(2007-2#2)(2009-10#1)(2009-5#1)(2011-2#1)(2012-2#2)
sesamoids##2##1##(2007-2#2)
sesamol##4##1##(2010-4#4)
sesamol&gt##2##1##(2010-4#2)
sesquiterpene cyclase##5##2##(1995-3#4)(2008-8#1)
sesquiterpene lactone##10##2##(1991-6#1)(2007-1#6)(2007-11#2)(2008-7#1)
sesquiterpene lactones##9##2##(1992-2#1)(2006-12#2)(2007-1#6)
sesquiterpene##39##1##(1991-6#1)(1992-2#1)(1995-2#1)(1995-3#6)(2006-12#3)(2007-1#13)(2007-11#6)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#3)
sesquiterpenes from##3##2##(2006-12#1)(2007-1#1)(2008-11#1)
sesquiterpenes##17##1##(2006-12#5)(2007-1#4)(2008-10#3)(2008-11#1)(2011-10#2)(2013-1#1)(2013-8#1)
sesquiterpenoid extract of Phellinus##3##4##(2008-8#3)
sesquiterpenoid extract of##4##3##(2008-8#4)
sesquiterpenoids##5##1##(2006-12#3)(2007-1#2)
sessile drop##3##2##(2005-11#3)
sessile##22##1##(1992-6#1)(1993-9#1)(2005-11#4)(2005-5#1)(2006-11#2)(2006-6#1)(2007-3#2)(2008-10#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-12#1)(2011-1#1)(2013-7#1)(2013-8#1)
sessiliflorus increased##2##2##(2013-8#2)
sessiliflorus##5##1##(2013-8#5)
session &quot##2##2##(2008-10#1)(2009-6#1)
session and##14##2##(1993-5#1)(2005-7#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#3)(2009-10#1)(2012-1#1)(2013-1#2)
session consisted of##3##3##(2009-10#1)(2013-1#1)(2013-8#1)
session could##2##2##(1990-10#1)(2008-9#1)
session from##2##2##(1992-9#1)(2005-8#1)
session in##2##2##(1994-8#1)(2007-4#1)
session is##2##2##(1991-12#1)(2007-10#1)
session of day 2 for the music group (change##2##9##(2012-2#2)
session of the##2##3##(2007-9#1)(2010-1#1)
session of##20##2##(1993-9#3)(1994-2#1)(2005-7#1)(2007-9#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-7#1)
session on one##2##3##(1994-8#1)(2008-5#1)
session on pediatric nurses' perspectives toward providing spiritual care##2##9##(2011-1#2)
session on##9##2##(1994-2#1)(1994-8#1)(1995-12#1)(2005-7#1)(2008-5#2)(2011-1#2)(2011-2#1)
session to##2##2##(2008-10#1)(2011-2#1)
session was maintained##2##3##(1991-2#1)(2008-1#1)
session was##17##2##(1991-2#1)(1994-1#1)(1997-7#1)(2005-8#4)(2005-9#1)(2008-1#1)(2008-5#3)(2010-12#1)(2012-3#1)(2013-1#3)
session##210##1##(1990-10#1)(1990-2#2)(1990-7#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#2)(1992-5#1)(1992-9#2)(1993-12#2)(1993-5#1)(1993-6#3)(1993-9#3)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#1)(1994-6#1)(1994-8#4)(1995-10#1)(1995-12#2)(1995-7#2)(1995-9#2)(1996-5#1)(1997-7#1)(1997-8#1)(2005-1#1)(2005-7#5)(2005-8#10)(2005-9#2)(2006-6#1)(2006-7#2)(2007-10#2)(2007-11#3)(2007-12#3)(2007-4#2)(2007-6#1)(2007-7#9)(2007-8#4)(2007-9#4)(2008-1#7)(2008-10#5)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#14)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#6)(2009-1#1)(2009-10#2)(2009-6#1)(2009-9#2)(2010-1#2)(2010-11#3)(2010-12#3)(2010-4#1)(2010-7#3)(2010-8#5)(2011-1#4)(2011-2#9)(2012-1#4)(2012-10#1)(2012-2#4)(2012-3#1)(2013-1#13)(2013-7#3)(2013-8#2)
session)##3##1##(1993-9#1)(2008-5#1)(2009-9#1)
sessions addressed the##2##3##(2005-7#1)(2005-8#1)
sessions addressed##3##2##(2005-7#1)(2005-8#1)(2008-5#1)
sessions and to##2##3##(2011-2#1)(2012-3#1)
sessions and##22##2##(1993-6#1)(2005-10#1)(2005-8#3)(2006-12#1)(2006-7#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-11#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
sessions are##4##2##(1992-9#1)(2005-9#1)(2007-2#1)(2008-5#1)
sessions at a##2##3##(1996-9#1)(2011-2#1)
sessions at##6##2##(1995-8#1)(1996-9#1)(2005-8#1)(2008-5#1)(2010-12#1)(2011-2#1)
sessions correlated##3##2##(2012-3#1)(2013-8#2)
sessions covering##2##2##(1995-3#1)(2008-5#1)
sessions did##2##2##(2007-10#1)(2007-9#1)
sessions for##4##2##(2006-10#1)(2007-11#1)(2008-10#1)(2008-6#1)
sessions in the##3##3##(2008-10#1)(2008-7#1)(2009-9#1)
sessions in##8##2##(1993-12#1)(1995-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-9#1)(2010-10#1)
sessions of a##2##3##(1994-5#1)(2008-10#1)
sessions of the conference##2##4##(2005-7#1)(2005-8#1)
sessions of the##6##3##(2004-11#1)(2005-7#1)(2005-8#1)(2007-5#1)(2008-5#1)(2012-1#1)
sessions of##36##2##(1991-5#1)(1992-3#1)(1994-5#1)(1994-6#1)(1996-8#1)(2004-11#1)(2005-10#1)(2005-7#1)(2005-8#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#1)(2010-11#1)(2010-12#1)(2010-3#2)(2011-12#2)(2011-2#1)(2012-1#3)(2012-2#1)(2012-3#1)(2013-1#1)
sessions on the##2##3##(2005-7#1)(2007-2#1)
sessions on##8##2##(2005-7#1)(2005-8#1)(2007-2#1)(2008-7#2)(2008-8#1)(2011-2#1)(2013-7#1)
sessions over##2##2##(2010-9#1)(2013-1#1)
sessions per week##3##3##(2006-8#2)(2010-12#1)
sessions that##3##2##(1994-3#1)(2006-10#1)(2008-5#1)
sessions to##3##2##(1994-11#1)(2008-12#1)(2008-9#1)
sessions using##2##2##(2008-1#1)(2012-1#1)
sessions was##6##2##(1995-1#1)(1996-8#1)(2007-7#1)(2009-11#1)(2010-12#1)(2012-12#1)
sessions were held with##2##4##(2010-8#1)(2011-2#1)
sessions were required to obtain a##2##6##(1995-11#1)(2008-9#1)
sessions were##14##2##(1995-11#1)(2005-7#2)(2005-8#2)(2007-7#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-7#1)
sessions which##3##2##(1994-12#1)(2008-5#1)(2008-7#1)
sessions with a##3##3##(2007-7#1)(2008-12#1)(2010-2#1)
sessions with the##2##3##(2007-4#1)(2010-12#1)
sessions with##8##2##(1992-1#1)(2007-4#1)(2007-7#1)(2008-12#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-2#1)
sessions within the##2##3##(2008-7#1)(2008-9#1)
sessions##329##1##(1990-3#1)(1991-10#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-12#3)(1993-3#1)(1993-6#3)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-8#3)(1996-9#1)(2004-11#1)(2004-12#1)(2005-10#3)(2005-12#1)(2005-7#9)(2005-8#32)(2005-9#6)(2006-10#3)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#5)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#14)(2007-8#4)(2007-9#2)(2008-1#9)(2008-10#9)(2008-11#5)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#26)(2008-6#6)(2008-7#6)(2008-8#2)(2008-9#7)(2009-10#3)(2009-11#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#5)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#1)(2010-8#3)(2010-9#2)(2011-12#8)(2011-2#14)(2012-1#17)(2012-12#3)(2012-2#6)(2012-3#5)(2013-1#17)(2013-7#3)(2013-8#4)
sessions)##4##1##(1993-9#1)(1996-11#1)(2009-9#1)(2012-12#1)
set (n =##2##3##(2008-10#1)(2013-8#1)
set S##2##2##(2006-10#1)(2010-2#1)
set a##10##2##(1996-3#1)(2005-7#1)(2006-12#1)(2007-4#1)(2007-9#1)(2008-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
set about##2##2##(2007-12#1)(2008-11#1)
set an agenda##2##3##(1994-10#1)(2009-4#1)
set an##3##2##(1994-10#1)(2007-12#1)(2009-4#1)
set and a##2##3##(2008-10#1)(2008-4#1)
set and its##2##3##(2008-10#2)
set and##30##2##(1990-11#1)(1990-12#2)(1996-12#1)(1996-3#1)(1996-7#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#10)(2008-2#3)(2008-4#1)(2008-7#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-8#2)
set apart##3##2##(2007-12#1)(2008-1#1)(2008-5#1)
set are discussed##2##3##(2008-3#1)(2008-8#1)
set are given##2##3##(1990-2#1)(2008-3#1)
set are##13##2##(1990-2#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-8#1)(2010-8#4)(2012-3#1)
set as a##2##3##(1994-9#1)(2010-12#1)
set as##6##2##(1994-9#1)(2008-11#1)(2009-4#1)(2010-12#1)(2010-4#1)(2012-3#1)
set aside for##4##3##(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)
set aside##8##2##(1995-2#1)(1995-6#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-5#1)
set at -##2##3##(2007-8#2)
set at 0##2##3##(2008-6#1)(2012-12#1)
set at 220 nm##2##4##(1997-8#1)(2008-10#1)
set at a##4##3##(1992-3#1)(1996-12#2)(2012-2#1)
set at p &lt##3##4##(2011-2#2)(2013-1#1)
set at p##4##3##(2005-10#1)(2011-2#2)(2013-1#1)
set at p&lt##3##3##(2011-1#2)(2012-12#1)
set at the##2##3##(1995-1#1)(2008-9#1)
set at##48##2##(1991-2#1)(1992-3#1)(1995-1#1)(1996-12#2)(1996-6#1)(1997-1#1)(1997-8#1)(2005-10#1)(2005-12#1)(2006-5#2)(2006-7#1)(2006-8#2)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#11)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-7#1)(2010-1#1)(2011-1#4)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)
set based on##4##3##(2006-12#1)(2008-10#1)(2008-2#1)(2008-7#1)
set between##2##2##(2008-10#1)(2008-2#1)
set by the##12##3##(1991-2#1)(1991-5#1)(1996-2#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2010-4#1)(2013-8#1)
set by##28##2##(1991-2#1)(1991-5#1)(1996-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-9#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
set can be used for##2##5##(2008-5#1)(2013-1#1)
set can##3##2##(2007-12#1)(2008-5#1)(2013-1#1)
set comprising##2##2##(1995-5#1)(2008-10#1)
set consisted of##4##3##(2008-10#1)(2008-3#1)(2009-9#2)
set consisting of##8##3##(1994-8#1)(1996-12#1)(2007-12#1)(2008-10#3)(2008-2#1)(2011-2#1)
set consists of##5##3##(2008-12#1)(2009-7#1)(2012-12#2)(2012-3#1)
set containing##9##2##(2008-10#3)(2008-6#1)(2011-2#1)(2012-3#2)(2013-1#2)
set criteria##2##2##(2006-8#1)(2011-2#1)
set during##3##2##(1990-2#1)(2008-2#1)(2010-9#1)
set for the##8##3##(1991-2#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-5#1)
set for##23##2##(1991-2#1)(1997-1#1)(2005-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#3)(2008-7#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
set forth during##2##3##(1991-4#1)(2008-1#1)
set forth in the##3##4##(1991-2#1)(1997-5#1)(2007-12#1)
set forth##12##2##(1991-2#1)(1991-4#1)(1993-2#1)(1993-3#1)(1994-12#1)(1997-5#1)(2007-12#2)(2008-1#1)(2009-11#1)(2010-9#1)(2012-1#1)
set from##8##2##(1996-9#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-12#1)(2012-3#1)
set goals and##2##3##(1994-12#1)(1997-1#1)
set goals##3##2##(1994-12#1)(1996-2#1)(1997-1#1)
set in a##2##3##(2008-1#1)(2008-3#1)
set in the##6##3##(2004-9#1)(2011-2#1)(2012-12#2)(2013-1#2)
set in##23##2##(1997-3#1)(2004-9#1)(2006-8#2)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#4)(2008-5#1)(2009-11#1)(2010-9#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#1)
set is a##2##3##(2007-7#1)(2009-12#1)
set is that##2##3##(2008-3#1)(2012-3#1)
set is##17##2##(1991-4#1)(1996-5#1)(2006-5#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-12#1)(2011-2#1)(2012-3#1)
set limit##2##2##(1995-9#1)(2008-10#1)
set new##2##2##(2008-8#1)(2010-11#1)
set of 100##2##3##(2008-10#1)(2008-6#1)
set of 11##4##3##(1997-4#1)(2008-10#2)(2012-3#1)
set of 15##6##3##(1995-2#1)(1995-8#1)(2008-10#1)(2009-2#1)(2010-12#1)(2012-2#1)
set of 16##3##3##(2008-10#2)(2008-9#1)
set of 202##2##3##(2007-8#1)(2008-10#1)
set of 2D##3##3##(2008-3#1)(2008-5#1)(2008-6#1)
set of 43##2##3##(1997-2#1)(2008-11#1)
set of 5##3##3##(2006-12#1)(2009-1#1)(2009-3#1)
set of 50##2##3##(2005-11#1)(2013-1#1)
set of Escherichia coli##2##4##(1993-9#1)(2008-7#1)
set of absorption spectra##2##4##(2008-10#1)(2008-3#1)
set of absorption##4##3##(2008-10#2)(2008-3#2)
set of all##3##3##(1996-1#1)(2013-8#2)
set of analytical##3##3##(2008-10#2)(2008-9#1)
set of animals##2##3##(1993-7#1)(2010-4#1)
set of atmospheric##2##3##(2008-3#2)
set of beams##2##3##(2007-11#2)
set of brain##2##3##(1995-11#1)(2009-9#1)
set of building blocks##2##4##(2008-2#1)(2008-4#1)
set of candidate##2##3##(2007-12#1)(2013-1#1)
set of cases##4##3##(2013-1#4)
set of cells##2##3##(2007-12#2)
set of challenges##2##3##(2008-12#1)(2013-1#1)
set of clinical documents##4##4##(2013-1#4)
set of clinical##10##3##(1996-3#1)(2008-3#1)(2009-4#1)(2010-8#1)(2013-1#6)
set of competencies##2##3##(2008-1#1)(2012-12#1)
set of competing models##2##4##(2006-5#1)(2008-11#1)
set of compounds##7##3##(1995-6#1)(2004-2#1)(2006-12#2)(2008-10#1)(2008-8#1)(2009-4#1)
set of conditions##7##3##(1996-11#1)(1997-1#1)(2006-6#1)(2008-10#2)(2008-11#1)(2009-6#1)
set of criteria for##3##4##(2008-10#2)(2008-3#1)
set of criteria##6##3##(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)
set of cultivars##2##3##(2008-10#1)(2012-4#1)
set of data in##2##4##(1993-6#1)(2008-11#1)
set of data##13##3##(1993-11#1)(1993-6#1)(1994-11#1)(1996-2#1)(2005-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-10#1)
set of different##3##3##(1997-5#1)(2006-2#1)(2008-1#1)
set of drugs##2##3##(2007-11#1)(2009-4#1)
set of eight##4##3##(2008-10#1)(2013-1#2)(2013-7#1)
set of electrodes##2##3##(2008-2#2)
set of environmental##2##3##(2007-9#1)(2008-10#1)
set of equations##7##3##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)
set of essential genes##2##4##(2012-2#2)
set of essential##3##3##(2007-12#1)(2012-2#2)
set of ethical principles##2##4##(1993-7#1)(2008-1#1)
set of experimental data##2##4##(1994-11#1)(2013-8#1)
set of experimental##9##3##(1994-11#1)(1997-7#1)(2005-12#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-11#1)(2011-1#1)(2013-8#1)
set of experiments was##2##4##(2008-6#1)(2008-8#1)
set of experiments##21##3##(1990-10#3)(1991-12#1)(1994-2#1)(1995-12#2)(1997-2#2)(1997-6#1)(2004-9#2)(2008-10#1)(2008-2#2)(2008-5#1)(2008-6#2)(2008-8#1)(2009-10#1)(2011-3#1)
set of features##3##3##(2008-2#1)(2011-2#1)(2012-1#1)
set of four##6##3##(1994-9#1)(1995-10#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-9#1)
set of fractional orders##2##4##(2008-2#1)(2008-3#1)
set of genes that##2##4##(2008-7#1)(2012-3#1)
set of genes##10##3##(1992-6#1)(1996-12#1)(1996-5#1)(1997-4#1)(2006-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2012-3#1)
set of genetic##2##3##(1996-9#1)(1997-4#1)
set of glasses##2##3##(2008-10#2)
set of gratings##2##3##(2007-12#1)(2008-2#1)
set of greenhouse isolates##2##4##(2008-10#2)
set of guiding##2##3##(2008-11#2)
set of hypotheses##2##3##(2007-12#1)(2010-6#1)
set of ideas##2##3##(2008-1#1)(2012-3#1)
set of images was##2##4##(2013-1#2)
set of images##6##3##(2007-12#2)(2008-2#1)(2008-3#1)(2013-1#2)
set of indicators##3##3##(1996-2#1)(2007-12#1)(2008-11#1)
set of information##5##3##(1995-12#1)(2008-4#1)(2011-1#1)(2013-1#2)
set of issues##3##3##(1991-3#1)(2004-12#1)(2008-1#1)
set of items##3##3##(2010-1#1)(2013-1#2)
set of key##3##3##(2008-10#1)(2008-3#1)(2009-8#1)
set of laboratory##2##3##(2008-8#1)(2013-8#1)
set of lidar##2##3##(2008-2#1)(2008-3#1)
set of management##2##3##(1996-3#1)(2010-6#1)
set of matrix##2##3##(2008-10#1)(2008-2#1)
set of measurements##5##3##(1994-11#1)(2008-3#2)(2009-11#1)(2012-2#1)
set of measures##3##3##(1993-1#1)(2008-6#1)(2010-12#1)
set of mechanisms##2##3##(2006-10#1)(2007-8#1)
set of metabolites##2##3##(1993-12#1)(2012-3#1)
set of mirrors##3##3##(2007-12#1)(2008-3#2)
set of model##2##3##(2007-11#1)(2008-7#1)
set of molecular descriptors##2##4##(2007-8#1)(2008-10#1)
set of molecular##6##3##(2007-8#1)(2007-9#1)(2008-10#3)(2009-10#1)
set of molecules##2##3##(1994-2#1)(1996-8#1)
set of neurons##3##3##(2007-9#1)(2012-2#2)
set of nonlinear##2##3##(2008-2#1)(2010-12#1)
set of numerical##2##3##(2005-11#1)(2006-11#1)
set of objects##2##3##(1997-8#1)(2008-3#1)
set of operating##2##3##(1997-8#1)(2008-2#1)
set of optical##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
set of original ganoderma lucidum##2##5##(2013-8#2)
set of orthogonal##3##3##(2008-2#2)(2009-11#1)
set of p##2##3##(1997-8#1)(2008-10#1)
set of parallel##3##3##(2006-5#1)(2008-2#1)(2008-3#1)
set of parameter values##2##4##(1997-1#1)(2006-10#1)
set of parameters##7##3##(2005-11#1)(2007-4#1)(2008-2#1)(2008-3#2)(2008-7#1)(2013-8#1)
set of performance##2##3##(1994-2#1)(1995-12#1)
set of photons that##2##4##(2008-3#2)
set of plasmid##2##3##(1994-12#1)(1995-8#1)
set of points##4##3##(2007-11#1)(2008-2#2)(2009-8#1)
set of polymers##2##3##(2011-2#2)
set of possible##2##3##(1996-7#1)(2012-3#1)
set of primers that##2##4##(1993-12#1)(1993-6#1)
set of primers##8##3##(1990-7#1)(1993-12#1)(1993-6#1)(1994-5#1)(1994-9#1)(1995-8#1)(2008-10#1)(2008-5#1)
set of problems##3##3##(1992-5#1)(2011-2#1)(2013-1#1)
set of processes##2##3##(1997-8#1)(2010-2#1)
set of protein##2##3##(2008-10#2)
set of proteins##4##3##(1991-12#1)(1994-9#1)(2011-3#2)
set of protocols##5##3##(2008-4#5)
set of published##2##3##(1991-4#1)(2012-12#1)
set of questions##3##3##(2008-10#1)(2010-9#1)(2012-12#1)
set of reactions##4##3##(1991-7#2)(2008-10#2)
set of reagents &quot##2##4##(2013-1#2)
set of recommendations for##2##4##(1993-12#1)(1996-6#1)
set of recommendations##6##3##(1993-12#1)(1996-6#1)(2007-9#1)(2008-4#1)(2009-5#1)(2013-8#1)
set of reference##2##3##(2008-2#1)(2011-1#1)
set of regions##2##3##(2008-11#1)(2009-12#1)
set of relations between##2##4##(2008-7#1)(2010-6#1)
set of relations##4##3##(2006-2#1)(2007-12#1)(2008-7#1)(2010-6#1)
set of requirements##2##3##(1994-3#1)(2008-1#1)
set of rules##8##3##(1990-11#1)(1995-6#1)(2005-10#1)(2006-1#1)(2006-10#1)(2008-10#1)(2008-3#1)(2009-5#1)
set of samples##2##3##(1994-3#1)(2008-10#1)
set of scaled wavelet mother functions##2##6##(2008-2#2)
set of sequences##2##3##(2006-10#1)(2008-4#1)
set of several##2##3##(1996-7#1)(2007-11#1)
set of signals##2##3##(1994-10#1)(1994-12#1)
set of signs and symptoms##2##5##(2006-9#1)(2013-1#1)
set of simple##4##3##(2008-2#2)(2008-8#1)(2011-2#1)
set of six prisms after the##2##6##(2007-12#1)(2008-3#1)
set of six##7##3##(1992-1#1)(1994-8#1)(2007-12#1)(2008-3#1)(2008-8#1)(2010-10#1)(2013-7#1)
set of size##3##3##(1995-12#1)(2008-10#2)
set of spectra##2##3##(2008-10#2)
set of standard##3##3##(2008-10#1)(2008-7#1)(2010-8#1)
set of standards and##2##4##(2008-10#1)(2012-12#1)
set of standards##6##3##(2004-3#1)(2008-10#3)(2008-9#1)(2012-12#1)
set of statistical##3##3##(2008-10#1)(2008-3#1)(2008-6#1)
set of steady state##2##4##(2008-7#2)
set of strategies##2##3##(2009-4#1)(2013-8#1)
set of studies examines the##2##5##(2007-3#2)
set of studies##7##3##(1995-2#1)(2007-3#3)(2010-10#1)(2010-12#1)(2010-2#1)
set of such##2##3##(2008-2#1)(2010-2#1)
set of symptoms##3##3##(1992-4#1)(2008-12#1)(2008-2#1)
set of tests##2##3##(2007-4#1)(2012-2#1)
set of the core histone##3##5##(1996-4#3)
set of the##15##3##(1995-12#1)(1996-4#3)(1997-1#1)(2005-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)(2012-2#1)
set of three##8##3##(1991-4#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-10#1)
set of tools for##2##4##(2007-12#1)(2012-3#1)
set of tools that##2##4##(1996-2#1)(2008-11#1)
set of tools##6##3##(1994-3#1)(1996-2#1)(2007-12#1)(2008-11#1)(2008-9#1)(2012-3#1)
set of unrelated##2##3##(2012-3#2)
set of values that##2##4##(2008-1#1)(2008-2#1)
set of values##4##3##(2008-1#1)(2008-2#2)(2008-3#1)
set of variables##3##3##(2008-3#1)(2013-1#2)
set of wheat differentials##2##4##(2008-10#2)
set of##1132##2##(1990-1#1)(1990-10#3)(1990-11#2)(1990-12#1)(1990-2#2)(1990-4#2)(1990-5#2)(1990-7#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#5)(1991-6#4)(1991-7#4)(1991-9#2)(1992-1#1)(1992-12#4)(1992-2#5)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#3)(1992-7#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#7)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#3)(1993-7#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#2)(1994-11#4)(1994-12#6)(1994-2#4)(1994-3#6)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#4)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#8)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#6)(1995-8#8)(1996-1#3)(1996-10#1)(1996-11#2)(1996-12#5)(1996-2#4)(1996-3#4)(1996-4#3)(1996-5#7)(1996-6#2)(1996-7#5)(1996-8#3)(1996-9#2)(1997-1#5)(1997-2#8)(1997-3#2)(1997-4#6)(1997-5#3)(1997-6#1)(1997-7#5)(1997-8#4)(2004-12#2)(2004-2#1)(2004-3#1)(2004-8#1)(2004-9#2)(2005-10#5)(2005-11#8)(2005-12#1)(2005-4#2)(2005-5#3)(2005-9#1)(2006-1#1)(2006-10#14)(2006-11#2)(2006-12#7)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#8)(2006-6#1)(2006-7#3)(2006-8#2)(2006-9#1)(2007-1#4)(2007-10#3)(2007-11#20)(2007-12#32)(2007-3#4)(2007-4#7)(2007-5#1)(2007-6#3)(2007-8#7)(2007-9#8)(2008-1#11)(2008-10#124)(2008-11#24)(2008-12#5)(2008-2#82)(2008-3#76)(2008-4#24)(2008-5#15)(2008-6#15)(2008-7#36)(2008-8#25)(2008-9#26)(2009-1#1)(2009-10#14)(2009-11#10)(2009-12#2)(2009-2#3)(2009-3#5)(2009-4#11)(2009-5#7)(2009-6#1)(2009-7#2)(2009-8#8)(2009-9#4)(2010-1#4)(2010-10#7)(2010-11#1)(2010-12#8)(2010-2#8)(2010-3#2)(2010-4#6)(2010-5#4)(2010-6#3)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#15)(2011-12#2)(2011-2#16)(2011-3#3)(2012-1#11)(2012-11#1)(2012-12#13)(2012-2#16)(2012-3#23)(2012-4#1)(2013-1#56)(2013-7#4)(2013-8#18)
set off##2##2##(2007-8#1)(2007-9#1)
set on the##6##3##(1990-1#1)(1990-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2013-7#1)
set on##11##2##(1990-1#1)(1990-11#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-9#1)(2012-12#1)(2013-7#2)
set or##3##2##(2007-11#1)(2009-6#1)(2010-2#1)
set out in##6##3##(1991-12#1)(1996-2#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
set out the##3##3##(1991-2#1)(2006-5#1)(2009-2#1)
set out to assess the##2##5##(2007-7#1)(2008-3#1)
set out to compare##2##4##(1990-9#1)(2007-3#1)
set out to determine##5##4##(2007-12#1)(2010-12#2)(2012-12#1)(2012-5#1)
set out to establish##2##4##(2009-10#1)(2010-11#1)
set out to evaluate##2##4##(2008-12#1)(2011-2#1)
set out to##27##3##(1990-9#1)(1996-11#1)(1996-7#1)(2004-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2012-5#1)(2013-1#2)
set out##44##2##(1990-9#1)(1991-12#1)(1991-2#1)(1996-11#1)(1996-2#1)(1996-7#1)(2004-10#1)(2005-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-7#2)(2009-10#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#1)
set parameters##2##2##(2006-12#1)(2010-10#1)
set partitioning in hierarchical trees (SPIHT) algorithm##2##7##(2008-2#2)
set point##10##2##(1991-9#1)(1992-4#4)(2006-8#1)(2008-6#2)(2013-1#2)
set ranged between##2##3##(2008-10#2)
set samples##2##2##(2008-10#2)
set sequences##2##2##(2008-10#1)(2008-9#1)
set shifting tasks##2##3##(2008-11#2)
set shifting##5##2##(1995-5#1)(2008-11#4)
set showed##3##2##(1990-12#1)(2008-10#2)
set size##2##2##(2008-1#1)(2008-6#1)
set specific for##2##3##(2008-4#2)
set standards for##2##3##(1996-3#1)(2005-8#1)
set standards##3##2##(1996-3#1)(2005-8#1)(2013-1#1)
set that##8##2##(1994-12#1)(2005-10#1)(2007-12#1)(2007-7#1)(2008-2#2)(2008-9#1)(2012-12#1)
set the scene for##2##4##(2010-2#1)(2012-2#1)
set the stage for##11##4##(1994-4#1)(1995-12#1)(1997-2#1)(2006-2#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-11#1)(2010-4#1)(2011-2#1)(2012-2#1)
set the##33##2##(1994-4#1)(1995-1#1)(1995-12#1)(1996-4#1)(1997-2#1)(1997-6#1)(2006-12#1)(2006-2#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-3#3)(2008-4#1)(2008-6#1)(2009-10#1)(2010-1#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-2#3)(2013-7#1)
set theoretic##2##2##(2008-2#2)
set time##3##2##(2008-3#1)(2011-2#2)
set to 0##2##3##(2008-10#2)
set to be##2##3##(2013-1#2)
set to increase##2##3##(2008-2#1)(2010-12#1)
set to the##3##3##(2007-12#3)
set to##41##2##(1990-9#1)(1992-3#1)(1993-3#2)(1994-11#1)(1995-1#1)(1995-11#1)(1996-8#1)(2006-11#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#6)(2008-1#1)(2008-10#5)(2008-2#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-5#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#3)
set up a##21##3##(1991-3#1)(1993-11#1)(1993-3#1)(1993-7#1)(1996-5#1)(1997-4#1)(2004-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-2#2)(2013-1#1)(2013-8#1)
set up and##10##3##(1996-1#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-1#1)(2013-8#1)
set up as a##2##4##(2008-10#1)(2008-2#1)
set up at##3##3##(2008-1#1)(2008-10#1)(2008-2#1)
set up based on##3##4##(2008-10#2)(2013-1#1)
set up for the##3##4##(2008-10#2)(2008-3#1)
set up for##6##3##(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)
set up in a##2##4##(2008-3#1)(2011-11#1)
set up in##9##3##(1992-11#1)(1996-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-11#1)(2011-2#2)
set up the##2##3##(2008-10#1)(2012-1#1)
set up to investigate##3##4##(1991-4#1)(1993-5#1)(2007-11#1)
set up to##10##3##(1990-3#1)(1991-11#1)(1991-4#1)(1992-10#1)(1993-5#1)(2007-11#1)(2008-11#1)(2008-2#1)(2010-2#1)(2012-2#1)
set up with##2##3##(2008-5#1)(2010-5#1)
set up##118##2##(1990-12#1)(1990-3#1)(1991-11#1)(1991-3#2)(1991-4#1)(1992-10#1)(1992-11#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-7#1)(1994-6#1)(1996-1#1)(1996-5#1)(1996-6#1)(1997-4#1)(2004-11#1)(2004-7#1)(2005-12#1)(2005-5#2)(2005-8#1)(2006-7#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#21)(2008-11#3)(2008-12#1)(2008-2#8)(2008-3#6)(2008-4#3)(2008-5#2)(2008-7#5)(2008-9#5)(2009-10#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-11#1)(2011-2#3)(2012-1#1)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#4)
set used##3##2##(2008-10#3)
set using##2##2##(2008-10#1)(2010-4#1)
set value##2##2##(1992-9#1)(1993-12#1)
set was randomly##2##3##(1995-9#1)(2008-10#1)
set was used for##4##4##(1995-9#1)(1996-5#1)(2008-10#1)(2009-2#1)
set was used##5##3##(1995-9#1)(1996-5#1)(2007-9#1)(2008-10#1)(2009-2#1)
set was##27##2##(1993-9#1)(1995-9#2)(1996-3#1)(1996-5#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#12)(2009-2#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
set we have##2##3##(1994-2#1)(1997-4#1)
set were##12##2##(1993-3#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-12#1)(2009-4#1)(2013-1#2)
set with the##3##3##(2008-2#1)(2008-3#1)(2009-5#1)
set with##12##2##(1990-7#1)(1997-4#1)(2006-4#1)(2008-10#2)(2008-2#2)(2008-3#1)(2009-5#1)(2012-3#1)(2013-8#2)
set within##3##2##(1991-9#1)(2008-5#1)(2009-7#1)
set would##4##2##(2007-12#1)(2007-7#1)(2013-1#2)
set##2153##1##(1990-1#2)(1990-10#3)(1990-11#6)(1990-12#8)(1990-2#7)(1990-3#1)(1990-4#2)(1990-5#2)(1990-7#2)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#8)(1991-3#3)(1991-4#8)(1991-5#1)(1991-6#4)(1991-7#4)(1991-9#4)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#6)(1992-2#8)(1992-3#4)(1992-4#5)(1992-5#3)(1992-6#5)(1992-7#1)(1992-9#3)(1993-1#1)(1993-11#3)(1993-12#10)(1993-2#2)(1993-3#7)(1993-5#2)(1993-6#3)(1993-7#3)(1993-8#1)(1993-9#3)(1994-1#1)(1994-10#3)(1994-11#7)(1994-12#9)(1994-2#6)(1994-3#7)(1994-4#1)(1994-5#1)(1994-6#3)(1994-8#5)(1994-9#7)(1995-1#6)(1995-10#1)(1995-11#2)(1995-12#9)(1995-2#4)(1995-3#6)(1995-4#2)(1995-5#6)(1995-6#8)(1995-8#9)(1995-9#6)(1996-1#4)(1996-10#1)(1996-11#3)(1996-12#9)(1996-2#9)(1996-3#8)(1996-4#5)(1996-5#11)(1996-6#4)(1996-7#8)(1996-8#4)(1996-9#3)(1997-1#8)(1997-2#9)(1997-3#4)(1997-4#11)(1997-5#4)(1997-6#3)(1997-7#5)(1997-8#6)(2004-10#1)(2004-11#1)(2004-12#2)(2004-2#1)(2004-3#1)(2004-5#1)(2004-7#1)(2004-8#1)(2004-9#3)(2005-10#7)(2005-11#11)(2005-12#4)(2005-4#2)(2005-5#6)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#18)(2006-11#3)(2006-12#13)(2006-2#4)(2006-3#2)(2006-4#2)(2006-5#13)(2006-6#3)(2006-7#6)(2006-8#8)(2006-9#1)(2007-1#7)(2007-10#6)(2007-11#35)(2007-12#75)(2007-2#1)(2007-3#8)(2007-4#13)(2007-5#4)(2007-6#4)(2007-7#9)(2007-8#22)(2007-9#14)(2008-1#25)(2008-10#291)(2008-11#49)(2008-12#19)(2008-2#149)(2008-3#124)(2008-4#37)(2008-5#24)(2008-6#27)(2008-7#59)(2008-8#30)(2008-9#41)(2009-1#1)(2009-10#19)(2009-11#14)(2009-12#8)(2009-2#5)(2009-3#6)(2009-4#17)(2009-5#11)(2009-6#3)(2009-7#6)(2009-8#10)(2009-9#11)(2010-1#6)(2010-10#8)(2010-11#3)(2010-12#16)(2010-2#17)(2010-3#3)(2010-4#16)(2010-5#6)(2010-6#5)(2010-7#3)(2010-8#10)(2010-9#5)(2011-1#27)(2011-11#1)(2011-12#4)(2011-2#42)(2011-3#3)(2012-1#14)(2012-11#1)(2012-12#32)(2012-2#33)(2012-3#57)(2012-4#1)(2012-5#1)(2013-1#105)(2013-7#17)(2013-8#37)
set) and##3##2##(2008-2#1)(2008-7#1)(2011-1#1)
set) in##2##2##(2008-2#1)(2008-7#1)
set)##11##1##(1995-6#1)(2007-3#1)(2008-10#2)(2008-2#4)(2008-7#2)(2011-1#1)
set-point##2##1##(2005-11#1)(2007-10#1)
set-shifting##3##1##(2007-8#1)(2007-9#2)
set-up and the##3##3##(2008-10#1)(2008-11#2)
set-up and##4##2##(2008-10#2)(2008-11#2)
set-up for##3##2##(2006-4#1)(2007-8#1)(2008-12#1)
set-up has been##3##3##(1997-4#1)(2008-10#2)
set-up has##4##2##(1997-4#1)(1997-8#1)(2008-10#2)
set-up the##2##2##(2007-5#1)(2008-7#1)
set-up time##2##2##(2006-6#1)(2012-1#1)
set-up was##3##2##(2007-8#1)(2008-10#1)(2012-2#1)
set-up##46##1##(1993-9#1)(1997-4#1)(1997-8#2)(2006-4#2)(2006-5#1)(2006-6#1)(2007-12#1)(2007-5#1)(2007-8#6)(2008-10#13)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#4)(2008-9#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)
set-ups##3##1##(1996-12#1)(2007-4#1)(2007-9#1)
seta on##2##2##(2007-12#2)
seta##4##1##(2007-12#3)(2008-4#1)
setae and##2##2##(2007-12#1)(2013-1#1)
setae are##2##2##(2007-12#2)
setae on the##3##3##(2007-12#2)(2008-5#1)
setae on##5##2##(2007-12#4)(2008-5#1)
setae##21##1##(2007-12#13)(2007-3#2)(2008-4#1)(2008-5#1)(2013-1#3)(2013-7#1)
setal##3##1##(2007-12#1)(2013-1#2)
setation##3##1##(2007-12#3)
setbacks and##2##2##(2005-5#1)(2008-12#1)
setbacks##5##1##(1990-6#1)(2005-5#1)(2007-8#1)(2008-12#1)(2009-2#1)
seton##2##1##(2006-10#1)(2008-7#1)
setosus##5##1##(2008-10#5)
setpoint##2##1##(2008-7#1)(2009-2#1)
sets a##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
sets an upper##2##3##(2007-12#1)(2009-5#1)
sets and the##4##3##(1995-9#1)(1997-6#1)(2008-2#1)(2012-2#1)
sets and##27##2##(1995-9#1)(1997-6#2)(2004-11#1)(2005-9#1)(2007-4#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-5#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)
sets are##15##2##(1992-3#1)(2007-11#2)(2008-10#3)(2008-2#2)(2008-3#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-6#1)(2010-8#1)
sets as##7##2##(1995-1#1)(1996-7#1)(2006-8#1)(2008-7#1)(2010-12#1)(2013-1#2)
sets at the##6##3##(2008-10#4)(2013-1#2)
sets at##8##2##(1996-12#1)(2008-10#4)(2008-2#1)(2013-1#2)
sets based on##2##3##(1995-3#1)(2008-10#1)
sets can be##5##3##(1994-6#1)(1996-12#1)(2006-5#1)(2008-4#1)(2010-2#1)
sets can##6##2##(1994-6#1)(1996-12#1)(2006-5#1)(2008-3#1)(2008-4#1)(2010-2#1)
sets could be##2##3##(2008-10#1)(2011-1#1)
sets could##3##2##(2008-10#2)(2011-1#1)
sets designed##3##2##(1997-4#1)(2006-10#1)(2008-3#1)
sets examined##2##2##(2008-9#1)(2012-3#1)
sets exhibited##2##2##(2008-10#1)(2008-11#1)
sets for the##3##3##(2006-10#1)(2008-12#1)(2011-1#1)
sets for##22##2##(1994-11#1)(1995-2#1)(1996-2#1)(2006-10#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-9#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
sets forth a##2##3##(2007-10#1)(2008-11#1)
sets forth rules on the##3##5##(1991-10#3)
sets forth rules on##6##4##(1991-10#6)
sets forth##10##2##(1990-12#1)(1991-10#6)(1992-3#1)(2007-10#1)(2008-11#1)
sets from the##4##3##(2006-10#1)(2008-6#1)(2012-2#1)(2013-1#1)
sets from##11##2##(2006-10#1)(2006-4#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2012-2#1)(2013-1#1)
sets have been##2##3##(2006-5#1)(2008-10#1)
sets in the##3##3##(2010-2#1)(2011-2#1)(2012-3#1)
sets in##9##2##(1992-12#1)(1993-5#1)(1995-1#1)(1996-7#1)(2008-1#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-3#1)
sets into##2##2##(2007-12#1)(2008-7#1)
sets is##4##2##(2008-11#1)(2008-12#1)(2008-3#1)(2011-1#1)
sets of PCR##2##3##(1993-12#1)(2008-10#1)
sets of behavioral##2##3##(2008-8#2)
sets of biologically##2##3##(2007-11#1)(2008-9#1)
sets of biopsies##2##3##(1991-12#2)
sets of children##2##3##(2008-9#1)(2009-10#1)
sets of conditions##7##3##(1994-9#1)(2008-10#3)(2008-2#1)(2008-4#1)(2010-12#1)
sets of data##5##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2011-3#1)
sets of diagnostic##2##3##(1995-11#1)(1995-3#1)
sets of experiments##5##3##(1990-10#1)(1993-8#1)(2009-8#1)(2013-1#2)
sets of five##2##3##(1991-8#1)(2008-5#1)
sets of genes in##3##4##(1995-2#1)(2008-7#1)(2012-3#1)
sets of genes##11##3##(1992-2#1)(1992-7#1)(1994-12#1)(1995-2#1)(2008-4#2)(2008-7#2)(2008-8#1)(2009-8#1)(2012-3#1)
sets of genetic##2##3##(1993-8#1)(2010-2#1)
sets of highly##2##3##(1991-9#1)(2006-5#1)
sets of input##2##3##(2008-3#2)
sets of models##2##3##(2008-10#2)
sets of molecular##2##3##(2007-12#1)(2008-2#1)
sets of optical##2##3##(2007-12#1)(2008-3#1)
sets of parameter##2##3##(1997-2#1)(2008-10#1)
sets of primers##5##3##(2008-10#4)(2011-2#1)
sets of proteins##4##3##(1993-8#1)(2007-12#1)(2008-9#1)(2009-9#1)
sets of random##2##3##(2008-10#1)(2008-3#1)
sets of reactions##2##3##(2008-10#2)
sets of resonances##2##3##(1991-2#1)(2008-5#1)
sets of results##4##3##(1995-11#1)(2008-11#1)(2008-7#1)(2009-9#1)
sets of samples##2##3##(2008-10#2)
sets of the##4##3##(1997-6#1)(2007-10#1)(2008-3#1)(2011-2#1)
sets of twin##2##3##(1993-1#1)(2004-10#1)
sets of##290##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#3)(1991-2#2)(1991-3#4)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-12#2)(1993-5#1)(1993-8#5)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#4)(1995-2#2)(1995-3#3)(1995-6#2)(1995-8#2)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#1)(1996-7#3)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-10#1)(2004-11#1)(2004-12#1)(2005-10#1)(2005-3#1)(2005-8#2)(2006-10#4)(2006-12#1)(2006-2#1)(2006-5#2)(2007-10#1)(2007-11#4)(2007-12#9)(2007-4#1)(2007-5#1)(2007-6#2)(2007-8#4)(2007-9#1)(2008-10#36)(2008-11#7)(2008-2#19)(2008-3#12)(2008-4#9)(2008-5#4)(2008-6#3)(2008-7#9)(2008-8#5)(2008-9#8)(2009-1#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-8#4)(2009-9#2)(2010-1#1)(2010-11#2)(2010-12#2)(2010-2#3)(2010-4#2)(2010-5#2)(2010-6#1)(2011-1#6)(2011-2#4)(2011-3#1)(2012-1#1)(2012-11#3)(2012-12#3)(2012-3#8)(2013-1#6)(2013-8#2)
sets off a##2##3##(2007-6#1)(2012-2#1)
sets on the##2##3##(2006-5#1)(2010-12#1)
sets on##3##2##(2006-5#1)(2010-12#1)(2012-2#1)
sets out to review##2##4##(2008-11#1)(2010-11#1)
sets out to##8##3##(2006-12#1)(2007-12#2)(2007-3#1)(2008-11#1)(2009-5#1)(2010-11#1)(2011-1#1)
sets out##12##2##(1990-12#1)(2006-12#1)(2007-12#2)(2007-3#1)(2008-11#1)(2009-5#1)(2010-11#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-8#1)
sets per##2##2##(2008-10#1)(2012-3#1)
sets showing##2##2##(1996-2#1)(2012-11#1)
sets technique##4##2##(1997-6#4)
sets that are##5##3##(2006-3#1)(2007-12#1)(2010-2#1)(2013-1#2)
sets that##14##2##(1995-2#1)(1997-8#1)(2006-3#1)(2006-5#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-7#1)(2010-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
sets the stage for the##2##5##(2008-7#1)(2008-9#1)
sets the stage for##3##4##(2008-7#1)(2008-9#1)(2012-3#1)
sets the##8##2##(1992-1#1)(1997-4#1)(2007-8#1)(2008-7#1)(2008-9#1)(2012-1#2)(2012-3#1)
sets theory##2##2##(2007-3#1)(2008-10#1)
sets to##3##2##(1996-12#1)(2007-4#1)(2010-11#1)
sets used##2##2##(2008-10#1)(2008-2#1)
sets using##9##2##(1995-3#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-6#1)(2012-3#1)(2013-1#2)
sets was##5##2##(2008-10#4)(2008-11#1)
sets were also##2##3##(2008-10#1)(2012-2#1)
sets were designed##3##3##(2008-10#3)
sets were##19##2##(1992-12#1)(1995-3#1)(1995-5#1)(2006-5#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2012-2#1)(2013-1#3)
sets with##7##2##(2008-10#1)(2010-1#1)(2010-2#1)(2010-7#1)(2010-9#1)(2012-3#2)
sets##771##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#1)(1991-10#7)(1991-12#3)(1991-2#2)(1991-3#4)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#8)(1992-2#2)(1992-3#3)(1992-5#2)(1992-6#1)(1992-7#1)(1993-1#2)(1993-12#2)(1993-5#3)(1993-8#5)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#4)(1995-11#4)(1995-2#4)(1995-3#7)(1995-5#1)(1995-6#2)(1995-8#4)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#5)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#5)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#4)(1997-6#9)(1997-7#1)(1997-8#4)(2004-10#1)(2004-11#2)(2004-12#2)(2004-9#1)(2005-10#1)(2005-3#1)(2005-8#2)(2005-9#1)(2006-10#11)(2006-11#1)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#7)(2006-7#3)(2006-8#3)(2007-10#5)(2007-11#8)(2007-12#18)(2007-3#2)(2007-4#6)(2007-5#3)(2007-6#3)(2007-8#6)(2007-9#2)(2008-1#3)(2008-10#126)(2008-11#21)(2008-12#4)(2008-2#41)(2008-3#37)(2008-4#20)(2008-5#8)(2008-6#9)(2008-7#22)(2008-8#11)(2008-9#17)(2009-1#3)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#10)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#7)(2010-1#2)(2010-10#1)(2010-11#5)(2010-12#5)(2010-2#9)(2010-4#4)(2010-5#5)(2010-6#6)(2010-7#5)(2010-8#1)(2010-9#3)(2011-1#11)(2011-2#9)(2011-3#1)(2012-1#6)(2012-11#5)(2012-12#6)(2012-2#8)(2012-3#27)(2013-1#46)(2013-7#2)(2013-8#3)
sets&quot##2##1##(1993-12#1)(2013-7#1)
setting a##5##2##(1992-3#1)(2006-10#1)(2007-7#1)(2008-7#1)(2013-1#1)
setting an##2##2##(2007-11#1)(2008-6#1)
setting and a##2##3##(1997-2#1)(2006-10#1)
setting and illustrated in biomedical articles using &quot##2##8##(2013-1#2)
setting and that##3##3##(1993-12#1)(2004-10#1)(2008-9#1)
setting and the##4##3##(2007-10#1)(2007-2#1)(2007-3#1)(2013-8#1)
setting and##43##2##(1991-11#1)(1992-1#1)(1993-12#1)(1994-1#2)(1994-12#1)(1997-2#1)(1997-5#1)(2004-10#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-8#1)(2008-11#1)(2008-12#2)(2008-5#2)(2008-7#1)(2008-9#1)(2010-10#1)(2010-7#1)(2010-8#1)(2010-9#1)(2012-12#2)(2012-2#3)(2013-1#4)(2013-8#2)
setting are##9##2##(1996-2#1)(2006-10#2)(2007-12#2)(2008-1#1)(2008-11#1)(2010-7#1)(2012-12#1)
setting as##5##2##(2006-6#1)(2008-4#2)(2008-8#1)(2011-2#1)
setting by##7##2##(1994-2#1)(2007-11#1)(2008-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
setting can##2##2##(2007-11#1)(2008-4#1)
setting following##2##2##(2010-11#1)(2012-12#1)
setting for psychiatric##2##3##(2006-9#1)(2007-1#1)
setting for the##4##3##(2005-8#1)(2007-6#1)(2008-1#1)(2008-9#1)
setting for##22##2##(1991-1#1)(1994-12#2)(2005-10#1)(2005-8#1)(2006-9#1)(2007-1#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-2#3)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-8#1)
setting has been##2##3##(2008-12#1)(2009-10#1)
setting has##7##2##(2005-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-10#1)(2011-2#1)(2012-3#1)
setting have##4##2##(2006-1#1)(2011-1#2)(2012-2#1)
setting in Cameroon##2##3##(2007-7#2)
setting in New Zealand##2##4##(2007-3#1)(2011-2#1)
setting in New##3##3##(2007-3#1)(2011-2#2)
setting in a##2##3##(1993-1#1)(2006-8#1)
setting in order to##2##4##(2008-7#1)(2012-12#1)
setting in the##2##3##(2006-10#1)(2008-5#1)
setting in##27##2##(1993-1#1)(1993-2#1)(1996-9#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-11#1)(2007-3#2)(2007-7#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2011-12#1)(2011-2#3)(2012-12#1)(2013-7#1)
setting include##2##2##(2008-11#1)(2008-7#1)
setting injury was##2##3##(2013-1#2)
setting injury##3##2##(2013-1#3)
setting is a##4##3##(1993-7#1)(1996-2#1)(2007-10#1)(2008-10#1)
setting is##25##2##(1993-7#1)(1994-2#1)(1996-2#1)(1996-9#1)(2005-8#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
setting it##2##2##(1995-5#1)(2010-7#1)
setting more##2##2##(1993-12#1)(1993-7#1)
setting must##4##2##(1993-2#1)(1994-3#2)(2012-3#1)
setting needs to be##2##4##(1991-12#1)(2007-3#1)
setting of a##12##3##(2005-10#1)(2006-10#1)(2007-5#1)(2007-6#1)(2008-4#2)(2008-9#1)(2010-10#1)(2010-2#1)(2010-6#1)(2013-8#2)
setting of the branch cuts##2##5##(2008-3#2)
setting of the##14##3##(1991-6#2)(2006-9#1)(2008-1#1)(2008-2#1)(2008-3#5)(2008-7#2)(2010-4#1)(2010-9#1)
setting of##139##2##(1990-12#1)(1991-2#1)(1991-6#2)(1992-12#1)(1993-7#1)(1996-12#2)(1996-2#1)(1996-9#1)(1997-2#1)(1997-8#1)(2004-1#1)(2005-10#5)(2005-7#2)(2006-10#8)(2006-11#1)(2006-2#1)(2006-4#1)(2006-8#2)(2006-9#3)(2007-10#2)(2007-11#4)(2007-12#1)(2007-5#7)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#7)(2008-4#4)(2008-5#3)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-4#4)(2010-5#1)(2010-6#2)(2010-8#3)(2010-9#2)(2011-1#2)(2011-2#7)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#6)(2013-8#2)
setting on##3##2##(1991-3#1)(2009-11#1)(2012-12#1)
setting or##3##2##(1995-2#1)(2007-11#1)(2008-8#1)
setting over##3##2##(1995-1#1)(2010-2#2)
setting priorities for##2##3##(1996-3#1)(1997-3#1)
setting priorities##3##2##(1996-3#1)(1997-3#1)(2008-9#1)
setting quality standards##2##3##(1992-11#1)(2009-4#1)
setting quality##3##2##(1992-11#1)(2008-7#1)(2009-4#1)
setting reaction##4##2##(2004-9#4)
setting remains##2##2##(2007-8#1)(2011-2#1)
setting should be##2##3##(1990-9#1)(1997-2#1)
setting specific##2##2##(2010-6#1)(2012-2#1)
setting standards##2##2##(1996-9#1)(2006-5#1)
setting such##2##2##(2005-12#1)(2008-12#1)
setting that##5##2##(1992-2#1)(2005-11#1)(2007-4#1)(2008-6#1)(2009-3#1)
setting the stage for##2##4##(2008-7#1)(2010-3#1)
setting the stage##3##3##(2008-5#1)(2008-7#1)(2010-3#1)
setting the##17##2##(1996-12#1)(2006-8#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-3#1)(2010-9#1)(2011-1#2)(2013-8#1)
setting time and##2##3##(2004-9#2)
setting time of##2##3##(2008-5#1)(2008-7#1)
setting time##9##2##(2004-9#5)(2008-5#3)(2008-7#1)
setting to##13##2##(2006-4#1)(2006-6#1)(2007-2#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-2#1)(2009-4#1)(2010-11#1)(2011-2#1)(2013-1#2)
setting up a##14##3##(1992-1#1)(1992-6#1)(1995-12#1)(2005-8#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-4#2)(2009-6#1)(2012-12#1)(2013-8#2)
setting up and##5##3##(1996-11#2)(2008-11#1)(2008-4#1)(2011-2#1)
setting up of##5##3##(2005-8#1)(2008-11#1)(2008-7#1)(2010-3#1)(2012-12#1)
setting up the##4##3##(2008-4#2)(2009-6#1)(2011-2#1)
setting up##45##2##(1990-10#1)(1990-2#1)(1992-1#1)(1992-6#1)(1995-12#1)(1996-11#2)(1997-7#1)(2005-8#2)(2007-1#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-11#3)(2008-4#6)(2008-7#1)(2008-9#2)(2009-6#2)(2010-3#1)(2011-2#2)(2012-12#2)(2013-7#1)(2013-8#2)
setting was##9##2##(1996-12#1)(2006-5#1)(2007-7#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#2)(2013-1#1)
setting were##7##2##(1995-5#1)(2006-8#2)(2009-3#1)(2010-12#1)(2010-3#1)(2013-7#1)
setting where##3##2##(1994-2#1)(2007-8#1)(2008-9#1)
setting with a##2##3##(2007-11#1)(2012-12#1)
setting with low##2##3##(2007-8#1)(2011-2#1)
setting with##14##2##(1996-3#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-12#1)(2008-3#2)(2010-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
setting##1077##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-1#6)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1992-1#4)(1992-11#2)(1992-12#3)(1992-2#6)(1992-3#5)(1992-6#2)(1992-9#2)(1993-1#3)(1993-11#1)(1993-12#7)(1993-2#9)(1993-3#1)(1993-7#4)(1993-9#1)(1994-1#5)(1994-12#6)(1994-2#7)(1994-3#6)(1994-6#1)(1995-1#3)(1995-10#1)(1995-12#6)(1995-2#4)(1995-3#3)(1995-4#1)(1995-5#2)(1996-1#4)(1996-11#2)(1996-12#11)(1996-2#11)(1996-3#6)(1996-4#1)(1996-8#1)(1996-9#5)(1997-1#3)(1997-2#10)(1997-3#3)(1997-5#2)(1997-7#1)(1997-8#2)(2004-1#1)(2004-10#2)(2004-3#3)(2004-9#11)(2005-10#8)(2005-11#2)(2005-12#1)(2005-4#1)(2005-5#1)(2005-7#6)(2005-8#11)(2005-9#3)(2006-1#9)(2006-10#34)(2006-11#3)(2006-12#4)(2006-2#4)(2006-3#2)(2006-4#5)(2006-5#9)(2006-6#5)(2006-7#9)(2006-8#16)(2006-9#9)(2007-1#3)(2007-10#11)(2007-11#24)(2007-12#17)(2007-2#6)(2007-3#7)(2007-4#6)(2007-5#13)(2007-6#5)(2007-7#14)(2007-8#16)(2007-9#9)(2008-1#12)(2008-10#11)(2008-11#40)(2008-12#20)(2008-2#10)(2008-3#30)(2008-4#21)(2008-5#20)(2008-6#13)(2008-7#29)(2008-8#20)(2008-9#17)(2009-1#2)(2009-10#5)(2009-11#6)(2009-12#1)(2009-2#3)(2009-3#8)(2009-4#5)(2009-5#3)(2009-6#9)(2009-7#3)(2009-8#4)(2009-9#7)(2010-1#3)(2010-10#2)(2010-11#12)(2010-12#12)(2010-2#10)(2010-3#4)(2010-4#5)(2010-5#4)(2010-6#4)(2010-7#5)(2010-8#9)(2010-9#8)(2011-1#18)(2011-12#1)(2011-2#38)(2011-7#3)(2012-1#4)(2012-10#1)(2012-11#3)(2012-12#28)(2012-2#35)(2012-3#17)(2013-1#52)(2013-7#6)(2013-8#23)
setting)##2##1##(2008-8#1)(2010-4#1)
setting-independent and machine-interpretable declarative specification frameworks for modeling and reasoning on biomedical problems##2##13##(2013-1#2)
setting]##4##1##(1993-3#1)(2005-3#1)(2006-6#1)(2009-6#1)
settings across the##2##3##(2007-2#1)(2008-9#1)
settings across##3##2##(2007-2#1)(2008-9#1)(2010-3#1)
settings and how##2##3##(2007-8#1)(2010-6#1)
settings and managed##2##3##(1996-1#1)(2006-8#1)
settings and with##2##3##(1992-12#1)(2009-9#1)
settings and##35##2##(1991-1#1)(1992-1#1)(1992-12#1)(1994-2#1)(1996-1#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-6#3)(2010-8#1)(2010-9#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#2)
settings are##15##2##(1991-12#2)(1994-3#1)(2004-10#1)(2008-1#1)(2008-11#3)(2008-2#2)(2008-4#1)(2013-1#4)
settings as##3##2##(2007-8#1)(2013-1#2)
settings at##2##2##(2006-8#1)(2008-8#1)
settings by##5##2##(1996-12#1)(2007-11#1)(2007-2#1)(2008-10#1)(2013-1#1)
settings can##2##2##(2012-10#1)(2012-3#1)
settings during##3##2##(2007-2#1)(2008-10#1)(2011-2#1)
settings for each##2##3##(2008-3#1)(2008-8#1)
settings for the##7##3##(1995-9#1)(2006-9#1)(2008-10#1)(2008-2#1)(2012-2#1)(2013-1#2)
settings for##18##2##(1992-6#1)(1993-7#1)(1995-9#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-5#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-6#1)(2009-7#1)(2012-12#1)(2012-2#1)(2013-1#2)
settings has##4##2##(2005-8#1)(2012-12#1)(2013-1#2)
settings in the##4##3##(1995-6#1)(2006-10#1)(2008-10#1)(2010-4#1)
settings in which the##2##4##(1991-12#1)(2013-8#1)
settings in which##7##3##(1991-12#1)(2005-6#1)(2005-9#1)(2007-11#1)(2008-2#1)(2009-6#1)(2013-8#1)
settings in##25##2##(1991-12#1)(1995-6#1)(2005-6#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#1)(2009-6#2)(2010-4#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-7#2)(2013-8#1)
settings is##9##2##(1994-3#1)(2006-10#1)(2006-4#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-8#2)(2012-2#1)
settings of a##3##3##(2007-4#1)(2010-9#2)
settings of care##2##3##(2008-2#1)(2012-3#1)
settings of##10##2##(1993-7#1)(2007-4#1)(2008-2#1)(2010-9#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
settings often##2##2##(2009-6#1)(2011-2#1)
settings or##3##2##(2009-5#1)(2010-2#1)(2012-2#1)
settings provide##2##2##(2007-1#1)(2011-2#1)
settings required for##2##3##(2008-3#1)(2013-8#1)
settings such as##4##3##(1996-3#1)(2007-12#2)(2011-1#1)
settings than##2##2##(2013-1#1)(2013-8#1)
settings that##9##2##(2005-9#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-2#1)(2008-6#1)(2009-10#1)(2010-11#1)(2011-2#1)
settings to##10##2##(1995-12#1)(1997-3#1)(2005-8#1)(2007-12#1)(2008-2#3)(2008-8#1)(2013-1#1)(2013-8#1)
settings was##4##2##(1996-12#1)(2008-11#1)(2010-8#1)(2012-1#1)
settings were##5##2##(1991-9#1)(2008-10#2)(2010-8#1)(2013-1#1)
settings when##2##2##(1996-2#1)(2007-2#1)
settings where##7##2##(2006-10#1)(2008-11#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#2)
settings which were##2##3##(1991-9#1)(2008-11#1)
settings will be##2##3##(1997-2#1)(2010-8#1)
settings with one##2##3##(2008-8#1)(2013-1#1)
settings with##7##2##(1993-1#1)(2006-9#1)(2008-8#2)(2009-6#1)(2009-9#1)(2013-1#1)
settings within the##2##3##(2010-4#1)(2012-3#1)
settings without##3##2##(1993-1#1)(2011-2#1)(2012-3#1)
settings##608##1##(1990-12#2)(1990-2#1)(1990-8#1)(1991-1#2)(1991-12#6)(1991-2#1)(1991-3#1)(1991-9#2)(1992-1#4)(1992-12#4)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-4#1)(1993-5#1)(1993-7#2)(1994-1#1)(1994-2#2)(1994-3#7)(1995-1#4)(1995-11#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-1#7)(1996-12#4)(1996-2#2)(1996-3#2)(1996-7#2)(1996-8#1)(1997-1#4)(1997-2#2)(1997-3#2)(2004-10#1)(2004-3#2)(2005-11#2)(2005-12#1)(2005-6#1)(2005-8#5)(2005-9#3)(2006-1#3)(2006-10#15)(2006-12#1)(2006-2#1)(2006-4#4)(2006-5#4)(2006-6#1)(2006-7#2)(2006-8#11)(2006-9#2)(2007-1#3)(2007-10#8)(2007-11#6)(2007-12#11)(2007-2#7)(2007-3#1)(2007-4#6)(2007-5#2)(2007-7#3)(2007-8#8)(2007-9#2)(2008-1#9)(2008-10#11)(2008-11#31)(2008-12#15)(2008-2#16)(2008-3#13)(2008-4#5)(2008-5#6)(2008-6#3)(2008-7#2)(2008-8#11)(2008-9#4)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#3)(2009-4#12)(2009-5#2)(2009-6#11)(2009-7#7)(2009-8#3)(2009-9#7)(2010-1#1)(2010-10#6)(2010-11#3)(2010-12#6)(2010-2#8)(2010-3#3)(2010-4#4)(2010-5#5)(2010-6#6)(2010-7#3)(2010-8#15)(2010-9#8)(2011-1#10)(2011-12#2)(2011-2#26)(2011-9#1)(2012-1#8)(2012-10#1)(2012-11#2)(2012-12#22)(2012-2#23)(2012-3#11)(2013-1#36)(2013-7#4)(2013-8#15)
settings)##4##1##(2008-4#1)(2009-9#1)(2010-11#1)(2010-8#1)
settings?##2##1##(2009-11#1)(2010-9#1)
settle for##3##2##(1992-2#1)(1996-5#1)(1997-5#1)
settle in patches of##2##4##(2008-8#1)(2008-9#1)
settle in##6##2##(2008-8#2)(2008-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
settle##28##1##(1990-6#1)(1991-9#1)(1992-2#1)(1992-6#1)(1992-9#1)(1995-6#1)(1996-11#1)(1996-5#1)(1997-5#2)(2005-11#1)(2006-12#1)(2006-2#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2011-1#1)(2013-1#2)(2013-8#1)
settled a##2##2##(1997-5#1)(2010-12#1)
settled and##2##2##(1991-2#1)(2013-1#1)
settled down##2##2##(2011-1#1)(2012-2#1)
settled in an##2##3##(2011-2#1)(2013-1#1)
settled in##7##2##(2007-8#1)(2008-5#2)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
settled on##2##2##(2007-9#1)(2012-2#1)
settled out of court##2##4##(1996-11#1)(1996-6#1)
settled the##2##2##(2006-12#1)(2008-8#1)
settled##35##1##(1991-2#1)(1991-5#1)(1992-8#1)(1993-7#1)(1996-11#2)(1996-6#1)(1996-9#1)(1997-5#1)(2006-12#1)(2007-11#1)(2007-5#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-8#2)(2010-12#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#2)(2013-8#2)
settlement and##3##2##(2007-5#1)(2010-8#2)
settlement in the##2##3##(1997-4#1)(2008-8#1)
settlement in##6##2##(1994-3#1)(1997-4#1)(2006-11#1)(2008-8#1)(2011-2#1)(2013-8#1)
settlement of a##2##3##(1993-9#1)(2008-10#1)
settlement of the##3##3##(1990-12#1)(2008-10#1)(2011-2#1)
settlement of##12##2##(1990-12#2)(1991-11#1)(1993-9#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-8#1)(2010-1#1)(2010-4#1)(2011-2#1)
settlement was##2##2##(2010-12#1)(2010-8#1)
settlement##58##1##(1990-12#2)(1991-11#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-12#3)(1995-6#2)(1996-12#1)(1996-5#2)(1997-2#1)(1997-4#1)(1997-5#3)(2005-5#1)(2006-11#1)(2007-5#6)(2007-8#1)(2008-10#3)(2008-5#1)(2008-8#2)(2008-9#3)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#4)(2011-2#4)(2012-1#1)(2012-3#1)(2013-8#1)
settlement-stage##3##1##(2010-8#3)
settlements and##2##2##(2006-12#2)
settlements##11##1##(1993-3#1)(1995-6#1)(1997-4#1)(2006-12#3)(2008-12#1)(2008-4#2)(2008-6#1)(2013-7#1)
settlers and##2##2##(2006-2#1)(2008-7#1)
settlers##8##1##(2006-2#1)(2008-11#1)(2008-7#1)(2008-9#4)(2012-1#1)
settles##7##1##(1990-1#1)(1995-11#1)(1995-8#1)(1997-5#1)(1997-7#1)(2007-5#1)(2011-1#1)
settling after##2##2##(2006-9#1)(2013-1#1)
settling particle samples##2##3##(2008-10#2)
settling rate##2##2##(2005-11#2)
settling rates and##2##3##(2005-11#2)
settling rates##5##2##(2005-11#5)
settling rig##2##2##(2005-11#2)
settling##36##1##(1990-3#2)(1990-5#1)(1995-12#1)(1996-2#1)(1996-5#1)(2005-11#14)(2006-9#3)(2007-10#1)(2007-9#1)(2008-10#4)(2008-7#1)(2008-8#1)(2010-4#1)(2011-1#2)(2011-2#1)(2013-1#1)
setup and the##6##3##(2005-4#1)(2006-2#1)(2007-11#1)(2008-2#2)(2008-3#1)
setup and##21##2##(2005-4#1)(2006-2#1)(2007-11#3)(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)
setup are also##2##3##(2008-9#1)(2009-3#1)
setup are##5##2##(2008-3#1)(2008-4#1)(2008-9#1)(2009-3#1)(2010-12#1)
setup as##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
setup at##2##2##(1993-12#1)(2007-4#1)
setup based on a##2##4##(2008-3#1)(2009-4#1)
setup based on##3##3##(2008-3#2)(2009-4#1)
setup can be##5##3##(2008-2#3)(2008-3#1)(2012-1#1)
setup can##7##2##(2007-1#1)(2008-2#3)(2008-3#2)(2012-1#1)
setup errors##5##2##(2007-4#1)(2007-6#1)(2009-11#1)(2010-9#1)(2012-12#1)
setup for a##2##3##(2006-6#1)(2008-3#1)
setup for the recording of##2##5##(2008-2#1)(2008-3#1)
setup for the##10##3##(2007-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2010-12#1)(2013-7#1)(2013-8#1)
setup for three-dimensional##2##3##(2008-2#2)
setup for##22##2##(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#4)(2008-3#7)(2009-2#1)(2009-6#1)(2010-12#1)(2013-7#1)(2013-8#1)
setup have been##2##3##(2008-2#1)(2008-3#1)
setup is compact##2##3##(2007-11#1)(2007-12#1)
setup is demonstrated##2##3##(2007-12#1)(2010-12#1)
setup is described that##2##4##(2008-2#1)(2008-3#1)
setup is described##5##3##(2008-2#3)(2008-3#2)
setup is used to##2##4##(2007-12#2)
setup is used##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
setup is##38##2##(2006-6#1)(2007-11#3)(2007-12#11)(2008-10#1)(2008-2#8)(2008-3#12)(2009-4#1)(2010-12#1)
setup makes use of##2##4##(2008-2#1)(2008-3#1)
setup makes##4##2##(2006-3#1)(2008-2#2)(2008-3#1)
setup mistakes##2##2##(2007-10#2)
setup of a##3##3##(2007-12#1)(2008-3#1)(2011-2#1)
setup of the system and##2##5##(2006-6#1)(2010-12#1)
setup of the##4##3##(2006-6#1)(2007-11#1)(2008-2#1)(2010-12#1)
setup of##12##2##(2006-11#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-8#1)
setup that can##2##3##(2008-3#2)
setup that is##2##3##(2008-2#1)(2008-3#1)
setup that uses a##2##4##(2007-11#1)(2008-3#1)
setup that uses##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
setup that##13##2##(2007-11#3)(2008-2#4)(2008-3#5)(2011-12#1)
setup to##7##2##(2007-12#2)(2008-3#2)(2008-6#1)(2011-2#1)(2013-7#1)
setup uses##2##2##(2007-12#1)(2008-1#1)
setup verification procedure##2##3##(2010-9#2)
setup verification##3##2##(2010-9#3)
setup was used to##2##4##(2007-12#1)(2008-10#1)
setup was used##3##3##(2007-12#1)(2008-10#1)(2010-5#1)
setup was##9##2##(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#1)(2008-2#1)(2010-5#1)(2012-12#2)
setup we##2##2##(2008-2#1)(2008-3#1)
setup with##6##2##(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#2)(2012-12#1)
setup working##2##2##(2007-11#1)(2008-2#1)
setup##302##1##(1993-12#1)(1993-9#1)(1994-2#1)(1995-4#1)(1996-12#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-11#2)(2006-2#1)(2006-3#1)(2006-4#2)(2006-6#5)(2007-1#4)(2007-10#2)(2007-11#21)(2007-12#36)(2007-3#1)(2007-4#2)(2007-5#5)(2007-6#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-2#50)(2008-3#79)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#3)(2009-9#2)(2010-10#1)(2010-12#7)(2010-2#1)(2010-4#1)(2010-5#1)(2010-9#4)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#9)(2012-2#1)(2013-7#2)(2013-8#3)
setups are##2##2##(1994-2#1)(2008-2#1)
setups for##6##2##(1997-6#1)(2008-2#1)(2008-3#3)(2013-1#1)
setups have##2##2##(2008-2#1)(2012-12#1)
setups used##2##2##(2007-1#1)(2007-12#1)
setups##32##1##(1994-2#1)(1997-6#1)(2006-11#1)(2007-1#1)(2007-12#6)(2008-1#1)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#6)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#2)
sev##2##1##(1991-12#2)
sev-expressing##2##1##(1991-12#2)
sevelamer##3##1##(2007-8#1)(2012-12#2)
seven (47%)##2##2##(2008-5#2)
seven Eimeria species##3##3##(2005-9#1)(2008-5#2)
seven European##4##2##(2008-10#1)(2008-5#1)(2008-7#1)(2009-5#1)
seven SNPs##3##2##(2006-9#2)(2012-5#1)
seven advisors##2##2##(1995-12#2)
seven amino acid residues##2##4##(1994-2#1)(2005-11#1)
seven amino acids##3##3##(1994-11#1)(1994-12#1)(2006-12#1)
seven amino##5##2##(1994-11#1)(1994-12#1)(1994-2#1)(2005-11#1)(2006-12#1)
seven and##4##2##(2007-7#1)(2009-10#1)(2010-7#1)(2012-3#1)
seven apparent equilibrium constants for##2##5##(1997-1#2)
seven apparent equilibrium constants##4##4##(1997-1#4)
seven areas##2##2##(1994-1#1)(1997-3#1)
seven barley##2##2##(2008-10#2)
seven cases of##9##3##(1997-5#1)(2006-6#1)(2006-8#1)(2007-12#2)(2008-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
seven cases we##2##3##(1993-8#1)(2008-3#1)
seven cases##27##2##(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1993-8#1)(1997-5#1)(2005-12#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-12#2)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#1)
seven chemical markers##2##3##(2012-3#2)
seven children who##2##3##(2007-7#1)(2007-8#1)
seven children with##2##3##(1992-7#1)(2007-8#1)
seven children##6##2##(1992-7#1)(1997-8#1)(2006-10#1)(2007-7#1)(2007-8#2)
seven chromosomes##3##2##(1996-11#1)(2008-10#1)(2012-3#1)
seven clinical##3##2##(1996-2#1)(1997-2#1)(2006-8#1)
seven commercial##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
seven compounds##7##2##(2008-10#2)(2008-12#1)(2008-5#1)(2011-1#1)(2012-3#2)
seven consecutive days##2##3##(2008-10#1)(2009-2#1)
seven consecutive measurements##2##3##(2008-10#2)
seven consecutive##7##2##(1994-5#1)(2008-10#4)(2009-2#1)(2011-12#1)
seven conserved##2##2##(1994-11#1)(1997-6#1)
seven countries##3##2##(1992-4#1)(2007-7#1)(2008-10#1)
seven cultivars##2##2##(2008-10#2)
seven cysteine residues in the##2##5##(1990-11#1)(1997-7#1)
seven days after the first##2##5##(1996-9#1)(2008-7#1)
seven days after the##5##4##(1996-9#1)(2006-6#1)(2007-12#1)(2008-7#1)(2013-1#1)
seven days after##6##3##(1992-5#1)(1996-9#1)(2006-6#1)(2007-12#1)(2008-7#1)(2013-1#1)
seven days from##2##3##(1994-7#1)(1995-4#1)
seven days of##2##3##(2008-5#1)(2012-3#1)
seven days prior to##4##4##(2004-9#1)(2006-10#1)(2008-7#1)(2008-8#1)
seven days##34##2##(1990-3#1)(1991-2#1)(1992-5#2)(1992-8#1)(1994-5#1)(1994-7#2)(1995-4#1)(1996-9#1)(1997-2#1)(2004-9#1)(2006-10#2)(2006-4#1)(2006-6#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-4#1)(2009-5#2)(2009-6#1)(2010-11#1)(2012-3#1)(2013-1#2)(2013-7#1)
seven decades##2##2##(2006-7#1)(2012-3#1)
seven different##26##2##(1990-8#1)(1992-6#1)(1993-2#1)(1994-9#1)(1995-5#1)(1995-6#1)(1997-3#1)(1997-6#1)(2005-11#1)(2007-7#1)(2008-10#7)(2008-3#2)(2008-5#2)(2008-6#1)(2010-2#1)(2011-12#1)(2011-2#1)(2013-7#1)
seven distinct##5##2##(1994-8#1)(1995-8#1)(2008-10#1)(2008-5#2)
seven elements##3##2##(2008-2#1)(2008-3#1)(2013-8#1)
seven exons and six introns##2##5##(1991-9#1)(1996-7#1)
seven exons##5##2##(1991-12#1)(1991-9#1)(1995-3#1)(1996-7#1)(1997-2#1)
seven expression##2##2##(1996-2#1)(2007-12#1)
seven females##4##2##(2004-1#1)(2007-7#1)(2010-8#2)
seven field trials##3##3##(2008-10#3)
seven field##5##2##(2008-10#5)
seven fragments##2##2##(1997-2#1)(2008-10#1)
seven from##3##2##(1991-9#1)(1997-8#1)(2008-10#1)
seven genes##4##2##(1991-6#1)(1991-8#1)(1996-10#1)(1996-6#1)
seven group##2##2##(2008-10#1)(2013-1#1)
seven groups##3##2##(1997-6#1)(2008-5#1)(2008-6#1)
seven had##6##2##(1990-2#1)(1994-3#1)(2007-2#1)(2008-4#1)(2008-5#1)(2009-2#1)
seven have##2##2##(2006-11#1)(2008-4#1)
seven healthy##2##2##(1995-12#1)(1996-2#1)
seven hospitals##2##2##(1991-3#1)(1996-9#1)
seven hours##2##2##(1992-3#1)(1993-10#1)
seven human##11##2##(1994-11#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-4#1)(1996-6#1)(2005-7#1)(2007-4#1)(2008-3#1)(2008-5#2)
seven hundred##2##2##(2004-12#1)(2008-8#1)
seven infants##4##2##(1990-8#1)(1995-5#1)(1997-4#1)(2009-8#1)
seven introns##3##2##(1993-12#1)(1995-6#1)(1997-4#1)
seven isolates from##2##3##(1994-3#1)(2007-6#1)
seven isolates##8##2##(1994-3#1)(1997-8#1)(2007-6#1)(2008-10#5)
seven items##2##2##(2012-2#2)
seven known##2##2##(2007-1#1)(2007-2#1)
seven locations in the##2##4##(2008-10#1)(2010-8#1)
seven locations in##4##3##(2008-10#3)(2010-8#1)
seven loci##2##2##(2011-2#2)
seven major phenolic compounds##2##4##(2011-1#2)
seven major##6##2##(1994-1#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-3#1)
seven management and planning tools##3##5##(1994-1#1)(1994-2#2)
seven members of##2##3##(1992-6#1)(2008-4#1)
seven membrane-spanning##2##2##(1993-12#1)(1995-8#1)
seven men##5##2##(1991-3#1)(1992-2#1)(2006-11#1)(2011-2#1)(2012-3#1)
seven months##11##2##(1990-11#1)(1990-3#1)(1992-1#1)(2005-11#1)(2005-12#1)(2007-2#1)(2007-7#1)(2008-4#1)(2008-5#1)(2009-9#1)(2010-9#1)
seven new##5##2##(1997-1#1)(1997-2#1)(2006-10#1)(2008-10#1)(2008-11#1)
seven normal##3##2##(1995-5#1)(1996-2#1)(2004-11#1)
seven of eight##4##3##(1990-5#1)(2007-3#1)(2008-10#1)(2008-4#1)
seven of ten##2##3##(1991-2#1)(1992-1#1)
seven of the 13##2##4##(1991-12#1)(2008-9#1)
seven of the eight##3##4##(1994-9#1)(1997-3#1)(2007-8#1)
seven of the ten##2##4##(2007-12#1)(2008-5#1)
seven of the##23##3##(1990-6#1)(1990-9#1)(1991-12#1)(1992-6#1)(1994-9#1)(1996-1#1)(1997-3#1)(2004-11#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-2#1)(2013-7#1)(2013-8#1)
seven of them had##3##4##(1993-5#1)(2007-2#1)(2008-5#1)
seven of them##10##3##(1991-10#1)(1992-6#1)(1993-5#1)(1994-9#1)(2005-11#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-5#1)(2010-3#1)
seven of these##3##3##(1990-5#1)(1993-2#1)(2013-8#1)
seven of which were##2##4##(2006-6#1)(2008-10#1)
seven of which##7##3##(1995-1#1)(1995-9#1)(2006-6#1)(2008-10#1)(2008-8#1)(2010-5#2)
seven of##57##2##(1990-10#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-6#2)(1993-2#1)(1993-5#1)(1993-8#1)(1994-9#2)(1995-1#1)(1995-9#1)(1996-1#2)(1996-9#1)(1997-3#1)(2004-11#1)(2005-11#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-2#2)(2007-3#3)(2007-7#1)(2007-8#2)(2008-10#6)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-4#1)(2010-5#2)(2012-2#1)(2013-7#1)(2013-8#2)
seven orders of magnitude##2##4##(1997-4#1)(2010-8#1)
seven orders##3##2##(1997-4#1)(2008-10#1)(2010-8#1)
seven other##7##2##(1992-8#1)(1993-12#1)(1993-2#1)(1996-5#1)(2008-10#1)(2008-6#1)(2013-7#1)
seven out of ten##3##4##(1997-6#1)(2006-8#1)(2010-7#1)
seven out of the##2##4##(1996-11#1)(1996-12#1)
seven out of##11##3##(1992-11#1)(1994-8#1)(1996-11#1)(1996-12#1)(1997-6#1)(2006-7#1)(2006-8#1)(2007-6#1)(2008-5#1)(2008-8#1)(2010-7#1)
seven overlapping##2##2##(1991-12#1)(1993-3#1)
seven participants##4##2##(2007-12#1)(2010-10#3)
seven patients (29%)##2##3##(1991-9#1)(2007-3#1)
seven patients and##3##3##(1993-2#1)(1994-7#1)(2011-2#1)
seven patients had##2##3##(1993-5#1)(2007-12#1)
seven patients on##2##3##(2008-1#1)(2011-2#1)
seven patients treated with##2##4##(1992-9#1)(2013-8#1)
seven patients were##4##3##(1993-12#1)(2007-7#1)(2007-8#2)
seven patients who had##2##4##(2007-7#1)(2008-1#1)
seven patients who##10##3##(1996-6#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-7#2)(2008-1#2)(2011-1#1)(2012-12#1)
seven patients with a variety of##2##6##(1991-12#1)(2006-12#1)
seven patients with##20##3##(1990-12#1)(1991-12#1)(1991-2#1)(1993-12#1)(1993-3#2)(1994-2#1)(1994-7#1)(1995-4#1)(2006-12#1)(2006-3#1)(2007-2#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-8#1)(2011-1#1)
seven patients##80##2##(1990-12#2)(1991-12#2)(1991-2#1)(1991-8#1)(1991-9#1)(1992-9#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-5#2)(1994-2#1)(1994-6#1)(1994-7#2)(1995-4#1)(1995-9#1)(1996-1#1)(1996-6#2)(2004-1#1)(2004-10#1)(2006-10#1)(2006-11#2)(2006-12#2)(2006-3#2)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#4)(2007-7#3)(2007-8#7)(2008-1#5)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#3)(2012-12#3)(2013-8#1)
seven per cent##2##3##(2007-3#2)
seven per##3##2##(2007-3#2)(2008-10#1)
seven percent of##4##3##(2007-7#1)(2013-1#3)
seven percent##6##2##(1997-2#1)(2007-7#1)(2013-1#4)
seven populations##4##2##(1990-9#1)(2008-10#1)(2008-8#1)(2011-2#1)
seven position##2##2##(1991-10#1)(1996-1#1)
seven possible##3##2##(1990-11#1)(2008-5#1)(2012-2#1)
seven potential##5##2##(1990-5#1)(1994-9#1)(1996-7#1)(1997-4#1)(2008-10#1)
seven putative transmembrane##3##3##(1990-5#1)(1991-3#1)(1992-12#1)
seven putative##6##2##(1990-5#1)(1991-2#1)(1991-3#1)(1992-12#1)(2008-5#1)(2008-8#1)
seven regions##3##2##(1995-1#1)(2008-10#1)(2012-3#1)
seven replicate##3##2##(2008-10#3)
seven replicates##6##2##(2008-10#6)
seven residues##2##2##(1991-12#1)(1994-9#1)
seven samples##6##2##(1992-9#1)(2007-3#1)(2007-5#1)(2008-10#3)
seven sampling##2##2##(2008-10#2)
seven segments##2##2##(2008-10#1)(2008-11#1)
seven sessions##2##2##(2008-5#1)(2010-3#1)
seven sites##7##2##(1991-4#1)(1995-8#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-9#1)
seven small##2##2##(1992-12#1)(2008-5#1)
seven species of##7##3##(1993-12#1)(2005-9#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-12#1)
seven species##12##2##(1993-12#1)(2005-9#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-5#3)(2008-8#2)(2011-12#1)
seven specimens##2##2##(2007-12#1)(2008-12#1)
seven squabs##2##2##(2008-5#2)
seven states and##2##3##(2008-10#1)(2013-1#1)
seven states##4##2##(2006-4#1)(2007-6#1)(2008-10#1)(2013-1#1)
seven strains from##2##3##(2011-2#2)
seven strains of##3##3##(2006-5#1)(2006-8#2)
seven strains were##2##3##(2008-10#2)
seven strains##8##2##(2006-5#1)(2006-8#2)(2008-10#3)(2011-2#2)
seven studies##2##2##(2010-7#1)(2012-3#1)
seven subjects##3##2##(1990-6#1)(2007-2#1)(2007-4#1)
seven tests##2##2##(2007-4#2)
seven times higher##2##3##(1990-10#1)(2013-8#1)
seven times more##3##3##(2007-3#1)(2009-5#1)(2012-12#1)
seven times##9##2##(1990-10#1)(2006-10#1)(2007-3#1)(2008-10#1)(2008-3#1)(2009-12#1)(2009-5#1)(2012-12#1)(2013-8#1)
seven tissues##2##2##(1990-11#1)(1994-11#1)
seven to eight##2##3##(1992-9#1)(1997-4#1)
seven to##10##2##(1992-11#1)(1992-9#1)(1993-3#1)(1995-6#1)(1996-11#1)(1997-4#1)(2007-8#2)(2008-8#1)(2010-8#1)
seven traditional##2##2##(2013-7#2)
seven transmembrane domains##2##3##(1992-5#1)(1994-12#1)
seven transmembrane regions##2##3##(1993-3#1)(2009-6#1)
seven transmembrane segments##2##3##(1991-5#1)(1994-12#1)
seven transmembrane##8##2##(1991-5#1)(1992-5#1)(1993-3#1)(1994-12#2)(1995-11#1)(1997-2#1)(2009-6#1)
seven trials##3##2##(2008-10#2)(2008-3#1)
seven types of##2##3##(2006-10#1)(2008-7#1)
seven variables##2##2##(2008-10#2)
seven variants##3##2##(1991-7#1)(1997-4#1)(2008-10#1)
seven viruses##2##2##(2008-10#2)
seven week##2##2##(2008-11#1)(2008-12#1)
seven weeks##4##2##(1997-5#1)(2008-12#1)(2008-3#1)(2013-8#1)
seven were of grade##2##4##(2013-8#2)
seven were##12##2##(1990-2#1)(1991-7#1)(1992-10#1)(1993-1#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-7#2)(2008-8#1)(2013-8#2)
seven with##3##2##(1991-2#1)(1995-6#1)(2008-9#1)
seven women##5##2##(1994-3#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
seven year-old##2##2##(2010-4#1)(2010-6#1)
seven years after##2##3##(1990-12#1)(2011-1#1)
seven years ago##2##3##(1993-4#1)(2010-12#1)
seven years of##5##3##(1996-3#1)(2007-7#1)(2008-1#1)(2008-9#1)(2013-8#1)
seven years##23##2##(1990-12#1)(1993-10#1)(1993-4#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-2#1)(2006-4#1)(2007-7#2)(2008-1#1)(2008-4#1)(2008-9#1)(2009-8#1)(2010-12#2)(2011-1#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
seven##1126##1##(1990-10#3)(1990-11#4)(1990-12#4)(1990-2#3)(1990-3#2)(1990-4#2)(1990-5#6)(1990-6#2)(1990-7#2)(1990-8#5)(1990-9#3)(1991-1#1)(1991-10#2)(1991-12#10)(1991-2#8)(1991-3#3)(1991-4#3)(1991-5#2)(1991-6#3)(1991-7#3)(1991-8#3)(1991-9#6)(1992-1#3)(1992-10#3)(1992-11#4)(1992-12#2)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#5)(1992-6#6)(1992-7#1)(1992-8#5)(1992-9#3)(1993-1#2)(1993-10#4)(1993-12#10)(1993-2#4)(1993-3#6)(1993-4#7)(1993-5#3)(1993-6#1)(1993-8#5)(1994-1#3)(1994-11#6)(1994-12#5)(1994-2#6)(1994-3#6)(1994-4#1)(1994-5#2)(1994-6#2)(1994-7#5)(1994-8#4)(1994-9#5)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#8)(1995-2#1)(1995-3#9)(1995-4#2)(1995-5#4)(1995-6#7)(1995-7#2)(1995-8#6)(1995-9#4)(1996-1#5)(1996-10#2)(1996-11#6)(1996-12#5)(1996-2#6)(1996-3#2)(1996-4#3)(1996-5#3)(1996-6#7)(1996-7#5)(1996-8#3)(1996-9#4)(1997-1#6)(1997-2#10)(1997-3#8)(1997-4#8)(1997-5#3)(1997-6#5)(1997-7#1)(1997-8#5)(2004-1#2)(2004-10#1)(2004-11#4)(2004-12#1)(2004-2#1)(2004-9#2)(2005-10#3)(2005-11#6)(2005-12#3)(2005-4#1)(2005-7#1)(2005-8#2)(2005-9#2)(2006-10#10)(2006-11#5)(2006-12#6)(2006-3#4)(2006-4#3)(2006-5#5)(2006-6#4)(2006-7#3)(2006-8#13)(2006-9#2)(2007-1#3)(2007-10#3)(2007-11#2)(2007-12#21)(2007-2#13)(2007-3#17)(2007-4#7)(2007-5#7)(2007-6#3)(2007-7#19)(2007-8#28)(2008-1#15)(2008-10#163)(2008-11#12)(2008-12#10)(2008-2#4)(2008-3#14)(2008-4#13)(2008-5#52)(2008-6#10)(2008-7#19)(2008-8#19)(2008-9#10)(2009-10#2)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#9)(2009-6#4)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#5)(2010-11#2)(2010-12#8)(2010-2#4)(2010-3#2)(2010-4#8)(2010-5#3)(2010-6#1)(2010-7#5)(2010-8#8)(2010-9#1)(2011-1#15)(2011-12#5)(2011-2#27)(2011-3#1)(2012-11#1)(2012-12#12)(2012-2#14)(2012-3#25)(2012-5#1)(2013-1#29)(2013-7#9)(2013-8#14)
seven)##2##1##(1990-11#1)(2008-5#1)
seven- to##3##2##(1996-11#1)(1997-7#1)(2006-10#1)
seven-day-old##2##1##(1994-2#1)(2008-8#1)
seven-fold##3##1##(1996-2#1)(2008-10#1)(2008-7#1)
seven-item##3##1##(2012-2#2)(2013-1#1)
seven-membered-ring benzolactams##2##2##(2013-8#2)
seven-step##3##1##(2006-1#1)(2010-11#1)(2010-8#1)
seven-transmembrane##5##1##(1991-5#1)(1992-2#1)(1995-11#1)(1995-6#1)(2008-9#1)
seven-year experience with 240 cases##2##5##(2012-12#2)
seven-year experience##3##2##(2008-3#1)(2012-12#2)
seven-year##10##1##(1992-5#1)(1996-12#1)(1996-3#1)(2008-3#1)(2009-4#1)(2010-3#1)(2011-3#2)(2012-12#2)
seven-year-old##2##1##(2009-8#1)(2012-2#1)
sevenfold increase in##3##3##(2008-3#2)(2013-7#1)
sevenfold##11##1##(1995-4#2)(1997-1#1)(2006-12#1)(2006-9#1)(2007-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2013-7#1)
sevenless##8##1##(1991-12#2)(1992-1#3)(1993-6#2)(1994-12#1)
seventeen amino##2##2##(1990-8#1)(1992-5#1)
seventeen healthy##2##2##(2011-2#1)(2012-12#1)
seventeen of##2##2##(2007-11#1)(2012-3#1)
seventeen##24##1##(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-9#1)(1995-12#1)(2006-11#1)(2007-10#2)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-3#1)
seventeenth century##11##2##(2008-10#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-7#3)(2010-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
seventeenth##14##1##(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-7#3)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
seventeenth-century New Spain##2##3##(2008-11#2)
seventeenth-century##8##1##(2008-10#4)(2008-11#2)(2008-9#2)
seventh and eighth##3##3##(2007-12#1)(2008-10#1)(2011-2#1)
seventh and##5##2##(1993-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2011-2#1)
seventh cervical vertebra##2##3##(2007-10#1)(2011-12#1)
seventh day##5##2##(2004-4#1)(2007-8#1)(2008-5#1)(2010-8#1)(2011-2#1)
seventh decade##2##2##(2008-1#1)(2013-8#1)
seventh generation##2##2##(2008-10#2)
seventh genome sequence in the family##2##6##(2011-2#2)
seventh transmembrane domain of the##2##5##(1994-6#1)(1995-11#1)
seventh transmembrane domain of##3##4##(1994-6#2)(1995-11#1)
seventh transmembrane domains##2##3##(1991-9#1)(1995-8#1)
seventh transmembrane##5##2##(1991-9#1)(1994-6#2)(1995-11#1)(1995-8#1)
seventh##58##1##(1990-4#1)(1991-1#1)(1991-7#1)(1991-9#1)(1992-1#1)(1993-8#1)(1994-11#1)(1994-6#2)(1995-11#1)(1995-4#1)(1995-8#1)(1996-7#1)(1997-5#2)(2004-4#1)(2006-10#1)(2006-12#1)(2007-10#2)(2007-12#4)(2007-3#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#5)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#2)(2009-8#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
seventh-grade##2##1##(2008-2#1)(2008-8#1)
seventh-order nonlinear optical##3##3##(2007-12#3)
seventh-order##4##1##(2007-12#3)(2008-2#1)
seventies and eighties##2##3##(1990-2#1)(1993-3#1)
seventies and##4##2##(1990-2#1)(1993-3#1)(2007-5#1)(2008-4#1)
seventies##10##1##(1990-2#1)(1991-12#1)(1993-3#2)(1997-8#1)(2007-5#2)(2007-6#1)(2007-7#1)(2008-4#1)
seventy seven##2##2##(2006-10#1)(2007-12#1)
seventy six##3##2##(2006-10#1)(2008-9#1)(2013-8#1)
seventy three##4##2##(2007-3#1)(2008-10#1)(2008-12#2)
seventy two##2##2##(2007-7#1)(2010-12#1)
seventy##24##1##(1990-3#1)(1993-11#1)(1993-8#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-12#2)(2008-7#1)(2008-9#2)(2009-10#1)(2010-12#1)(2011-1#1)(2013-8#2)
seventy-five##2##1##(1993-2#1)(2006-8#1)
seventy-seven##4##1##(2006-8#1)(2007-4#1)(2008-1#1)(2013-8#1)
seventy-six##5##1##(2005-4#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
seventy-two##7##1##(1996-8#1)(1997-2#1)(2007-3#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-8#1)
sever##7##1##(1995-1#1)(2006-3#1)(2007-8#1)(2008-12#2)(2008-8#1)(2012-2#1)
several &quot##3##2##(2007-1#1)(2008-10#1)(2013-1#1)
several 7-substituted##2##2##(1991-3#1)(1996-8#1)
several Brassica spp##2##3##(2008-10#2)
several CNS##2##2##(2008-4#1)(2012-12#1)
several DNA and RNA##2##4##(1994-11#1)(2011-3#1)
several DNA##6##2##(1994-11#1)(1996-11#1)(1996-2#1)(2011-1#1)(2011-3#2)
several DNA-binding##2##2##(1991-5#1)(1993-12#1)
several European countries##2##3##(1993-3#1)(2012-12#1)
several European##5##2##(1991-12#1)(1993-3#1)(1997-4#1)(2008-1#1)(2012-12#1)
several QTLs##2##2##(2008-9#1)(2012-11#1)
several Web##2##2##(2007-2#1)(2008-2#1)
several abiotic##2##2##(2006-11#1)(2006-5#1)
several abnormalities##2##2##(2008-10#1)(2008-3#1)
several active compounds##2##3##(2012-2#2)
several active##4##2##(2008-10#2)(2012-2#2)
several additional##10##2##(1993-8#1)(1994-9#1)(1997-7#1)(2007-8#1)(2008-10#2)(2008-7#2)(2009-3#1)(2012-2#1)
several additives##2##2##(2004-9#1)(2006-11#1)
several advances##4##2##(2006-10#2)(2006-2#1)(2008-3#1)
several advantages for##2##3##(2007-8#1)(2008-4#1)
several advantages including##2##3##(2008-5#1)(2009-10#1)
several advantages over conventional##6##4##(1994-9#1)(2008-1#1)(2008-10#3)(2011-2#1)
several advantages over previous##2##4##(1990-8#1)(2008-2#1)
several advantages over the conventional##2##5##(1997-8#1)(2007-8#1)
several advantages over the traditional##2##5##(2004-2#1)(2008-11#1)
several advantages over the##8##4##(1994-6#1)(1997-8#1)(2004-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)
several advantages over##29##3##(1990-8#1)(1991-9#1)(1994-6#1)(1994-9#2)(1997-2#1)(1997-7#1)(1997-8#2)(2004-12#1)(2004-2#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2010-4#1)(2011-1#1)(2011-2#1)
several advantages##54##2##(1990-8#1)(1991-9#1)(1994-6#1)(1994-9#2)(1997-2#1)(1997-7#1)(1997-8#2)(2004-12#1)(2004-2#1)(2005-11#1)(2005-5#1)(2006-12#1)(2007-11#1)(2007-8#3)(2008-1#3)(2008-10#7)(2008-11#1)(2008-2#4)(2008-3#4)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-3#1)
several agents have been##2##4##(2006-10#1)(2008-5#1)
several agents##10##2##(1990-2#1)(1990-8#1)(1992-12#1)(1992-6#1)(2005-9#1)(2006-10#1)(2008-1#2)(2008-5#1)(2008-8#1)
several algorithms##2##2##(1990-9#1)(2008-9#1)
several allelic##2##2##(2008-4#1)(2008-5#1)
several alpha##2##2##(1992-11#1)(2008-10#1)
several alternative##9##2##(1993-4#1)(2007-5#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-6#1)(2010-12#2)
several alternatively spliced##2##3##(1995-6#1)(2004-2#1)
several amino acid##2##3##(1990-12#1)(1997-1#1)
several amino acids##5##3##(1993-7#1)(1995-8#1)(1996-2#1)(1997-4#1)(2012-12#1)
several amino##7##2##(1990-12#1)(1993-7#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-4#1)(2012-12#1)
several analogs##3##2##(1994-6#1)(1994-8#1)(2006-12#1)
several analogues of##3##3##(1991-4#1)(1991-9#1)(2008-5#1)
several analytical techniques##2##3##(2008-10#1)(2010-5#1)
several analytical##3##2##(2008-10#1)(2010-5#1)(2013-8#1)
several animal models##4##3##(1994-5#1)(2006-10#1)(2007-11#1)(2008-1#1)
several animal studies##2##3##(2007-9#1)(2008-3#1)
several animal##11##2##(1991-9#1)(1993-9#2)(1994-5#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2012-2#1)
several anionic##2##2##(1994-9#1)(2008-5#1)
several apple varieties##2##3##(2008-10#2)
several applications in##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
several applications of the##2##4##(2006-10#1)(2008-10#1)
several applications of##4##3##(2006-10#1)(2008-10#3)
several applications such as##3##4##(2008-2#1)(2008-3#2)
several applications##13##2##(2006-10#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-7#1)(2012-2#1)
several approaches for##3##3##(1994-6#1)(2008-7#1)(2008-9#1)
several approaches that##2##3##(1994-12#1)(2006-7#1)
several approaches to the##2##4##(1997-8#1)(2008-7#1)
several approaches to##8##3##(1992-12#1)(1994-5#1)(1997-8#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)
several approaches##18##2##(1992-12#1)(1994-12#1)(1994-5#1)(1994-6#1)(1996-12#2)(1997-8#1)(2006-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-4#1)
several areas in##2##3##(2012-2#1)(2012-3#1)
several areas of##7##3##(1990-12#1)(1992-1#1)(1994-11#1)(2006-5#1)(2008-10#1)(2008-6#1)(2011-3#1)
several areas where##2##3##(1990-8#1)(2005-11#1)
several areas##23##2##(1990-12#1)(1990-8#1)(1992-1#1)(1993-3#1)(1994-11#1)(1994-12#1)(1996-9#1)(2005-11#1)(2006-10#2)(2006-4#1)(2006-5#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-6#1)(2009-4#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
several aromatic compounds##2##3##(2005-12#1)(2008-3#1)
several arthropod##2##2##(2007-12#1)(2010-10#1)
several articles##3##2##(2005-7#1)(2009-5#1)(2012-3#1)
several aspects of the##7##4##(1994-3#1)(1994-5#1)(1996-9#1)(2008-10#1)(2008-7#1)(2012-3#1)(2013-1#1)
several aspects of##19##3##(1994-3#1)(1994-5#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(2005-8#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-7#1)(2011-1#1)(2012-3#2)(2013-1#1)
several aspects##27##2##(1994-3#2)(1994-5#2)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(2005-8#1)(2006-12#2)(2007-2#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-3#2)(2012-5#1)(2013-1#1)
several assay##2##2##(1997-5#1)(2008-4#1)
several assays##5##2##(1992-11#1)(1993-2#1)(1995-2#1)(2008-8#1)(2010-7#1)
several attempts##2##2##(1993-7#1)(2009-4#1)
several authors have##3##3##(2006-7#1)(2009-8#2)
several authors##11##2##(1993-11#1)(1994-6#1)(2006-7#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-4#1)(2009-8#2)(2011-2#2)
several autoimmune diseases##4##3##(1995-2#1)(2006-5#1)(2008-10#1)(2011-2#1)
several autoimmune disorders##4##3##(2005-8#2)(2006-10#1)(2010-12#1)
several autoimmune##11##2##(1995-2#1)(2005-8#2)(2006-10#1)(2006-5#1)(2008-10#1)(2009-2#1)(2010-12#2)(2011-1#1)(2011-2#1)
several bacterial##3##2##(2007-11#1)(2008-5#1)(2010-6#1)
several bands##5##2##(1991-4#1)(1994-9#1)(2007-12#1)(2008-10#1)(2008-12#1)
several barriers to##2##3##(2005-9#1)(2011-2#1)
several barriers##4##2##(1994-1#2)(2005-9#1)(2011-2#1)
several basic analytes on the##2##5##(2013-8#2)
several basic##5##2##(2008-4#1)(2008-9#2)(2013-8#2)
several batches##2##2##(1993-9#1)(2008-10#1)
several behavioral and##2##3##(2008-11#1)(2012-2#1)
several behavioral##4##2##(1997-3#1)(2008-11#1)(2008-9#1)(2012-2#1)
several benefits##5##2##(2008-11#1)(2008-3#1)(2008-6#1)(2012-2#1)(2013-8#1)
several beverage samples##2##3##(2008-10#1)(2008-5#1)
several binding sites##2##3##(1994-5#1)(2008-10#1)
several binding##3##2##(1994-5#1)(1995-12#1)(2008-10#1)
several biochemical and##2##3##(2008-3#1)(2012-2#1)
several biochemical##7##2##(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#3)(2012-2#1)
several biological activities##2##3##(2007-3#1)(2008-5#1)
several biological and##3##3##(2008-1#1)(2012-12#2)
several biological properties##2##3##(2005-7#1)(2008-10#1)
several biological##11##2##(1992-3#1)(2005-7#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-4#1)(2012-12#2)
several biologically##2##2##(2008-10#1)(2008-3#1)
several brain regions##6##3##(1994-2#1)(1997-7#1)(1997-8#1)(2008-7#1)(2010-12#1)(2012-3#1)
several brain##7##2##(1994-2#1)(1996-4#1)(1997-7#1)(1997-8#1)(2008-7#1)(2010-12#1)(2012-3#1)
several cDNA##2##2##(1993-4#1)(1996-8#1)
several cancer cell lines##2##4##(2008-11#1)(2013-1#1)
several cancer##4##2##(2008-11#2)(2009-12#1)(2013-1#1)
several cancers##8##2##(1991-7#1)(2006-6#1)(2008-7#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
several candidates##2##2##(2008-3#1)(2008-4#1)
several capillary##3##2##(1996-5#1)(2007-8#1)(2008-10#1)
several carbohydrates##3##2##(2008-10#3)
several carcinomas##4##2##(2008-12#1)(2009-4#1)(2010-1#1)(2012-2#1)
several cardiac##3##2##(2005-12#1)(2009-6#1)(2013-1#1)
several cardiovascular##2##2##(2008-10#1)(2010-6#1)
several case studies have been performed demonstrating the efficacy of the submental approach##2##13##(2013-1#2)
several case studies##3##3##(2008-7#1)(2013-1#2)
several case##5##2##(1997-5#1)(2008-3#1)(2008-7#1)(2013-1#2)
several cases of##11##3##(1990-8#1)(1994-10#1)(1996-3#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-7#1)
several cases##25##2##(1990-8#1)(1992-1#1)(1994-10#1)(1994-3#1)(1995-5#1)(1996-3#1)(1996-6#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#2)(2011-2#2)(2012-2#1)(2013-7#1)
several caspase-like activities##2##3##(2009-10#2)
several cationic##2##2##(1991-9#1)(2008-11#1)
several causes##5##2##(1996-7#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-7#1)
several cell lines##5##3##(1992-2#1)(1992-6#1)(1994-12#1)(1997-2#1)(2005-8#1)
several cell surface##2##3##(2008-4#1)(2012-2#1)
several cell types##9##3##(1992-11#1)(1992-12#1)(1994-8#1)(1996-9#1)(2006-10#1)(2008-11#1)(2008-4#2)(2008-6#1)
several cell##21##2##(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#1)(1994-12#1)(1994-6#1)(1994-8#1)(1996-9#1)(1997-2#1)(2005-8#1)(2006-10#1)(2006-2#1)(2008-11#2)(2008-4#3)(2008-6#1)(2012-12#1)(2012-2#1)(2013-8#1)
several cells##3##2##(2008-5#1)(2008-7#1)(2013-8#1)
several cellular proteins##5##3##(1990-12#1)(1992-8#1)(1994-6#1)(1994-9#1)(1997-1#1)
several cellular##10##2##(1990-12#1)(1992-8#1)(1994-3#1)(1994-6#1)(1994-9#1)(1997-1#1)(1997-3#1)(2006-5#1)(2008-8#1)(2013-8#1)
several centers in##2##3##(2006-6#1)(2007-3#1)
several centimeters##3##2##(2008-3#2)(2011-1#1)
several centres##3##2##(1992-10#1)(2007-11#1)(2013-1#1)
several cerebral##2##2##(1996-1#1)(1997-2#1)
several certified reference materials##4##4##(2008-10#4)
several challenges##7##2##(2007-5#2)(2007-8#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
several changes in the##2##4##(1992-2#1)(1997-4#1)
several changes in##3##3##(1992-2#1)(1997-4#1)(2008-10#1)
several changes##5##2##(1992-2#1)(1997-4#1)(2005-10#1)(2008-10#1)(2012-3#1)
several characteristic##2##2##(1993-11#1)(2013-1#1)
several characteristics of##2##3##(1991-11#1)(1992-5#1)
several characteristics that make##2##4##(1996-12#1)(2008-4#1)
several characteristics that##5##3##(1996-12#1)(2008-4#2)(2008-8#1)(2012-3#1)
several characteristics##9##2##(1991-11#1)(1992-5#1)(1996-12#1)(2008-4#2)(2008-8#1)(2010-12#1)(2012-12#1)(2012-3#1)
several characters##3##2##(2008-1#1)(2010-8#1)(2013-7#1)
several chemical and physical##2##4##(2008-10#1)(2013-1#1)
several chemical##4##2##(2007-9#1)(2008-10#2)(2013-1#1)
several chemicals##2##2##(2008-10#1)(2011-1#1)
several chemotherapeutic##3##2##(1997-7#1)(2010-3#1)(2012-12#1)
several chronic diseases##2##3##(2008-10#1)(2009-3#1)
several chronic##5##2##(2008-10#2)(2009-3#1)(2011-1#1)(2012-2#1)
several classes of functional##2##4##(1995-1#1)(2009-10#1)
several classes of##10##3##(1994-9#1)(1995-1#1)(1997-1#1)(2007-11#2)(2007-12#1)(2008-5#1)(2009-10#1)(2010-6#1)(2012-1#1)
several classic##2##2##(2007-8#1)(2010-7#1)
several clinical trials##4##3##(1996-3#1)(2006-1#1)(2008-3#1)(2008-5#1)
several clinical##24##2##(1994-12#1)(1995-1#1)(1995-3#1)(1995-4#1)(1996-3#1)(2006-1#1)(2006-7#1)(2007-10#1)(2008-3#3)(2008-4#1)(2008-5#2)(2010-10#1)(2010-2#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
several clinicopathological##2##2##(2006-6#1)(2012-2#1)
several clones##3##2##(1992-6#1)(1993-4#1)(2008-10#1)
several closely related species##2##4##(2008-10#1)(2008-7#1)
several closely spaced##2##3##(2006-3#1)(2007-12#1)
several closely##5##2##(2006-3#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-7#1)
several clusters of##3##3##(2008-10#2)(2008-11#1)
several clusters##4##2##(2006-8#1)(2008-10#2)(2008-11#1)
several collagens##2##2##(1991-10#1)(1992-8#1)
several commercial##5##2##(2004-9#1)(2008-10#2)(2008-4#1)(2008-5#1)
several common characteristics##3##3##(1993-11#1)(1996-7#1)(1997-2#1)
several common##20##2##(1991-12#1)(1991-5#1)(1993-11#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-10#3)(2010-10#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
several commonly used methods for##2##5##(2008-1#1)(2008-3#1)
several commonly used##6##3##(2008-1#1)(2008-3#2)(2008-5#1)(2008-6#2)
several comorbidities##2##2##(2008-12#1)(2013-7#1)
several competing##3##2##(1993-6#1)(2006-5#1)(2009-10#1)
several complementary##5##2##(1995-3#1)(1997-8#1)(2005-10#1)(2007-8#1)(2008-10#1)
several complex##4##2##(2008-2#1)(2010-5#1)(2011-1#1)(2012-2#1)
several complexes##4##2##(1994-12#1)(1995-2#1)(2008-10#1)(2008-5#1)
several complications##5##2##(2007-2#1)(2008-5#1)(2013-7#1)(2013-8#2)
several components including##2##3##(1996-8#1)(2010-6#1)
several components of the##5##4##(1992-9#1)(1995-8#1)(2007-12#1)(2008-10#1)(2008-7#1)
several components of##10##3##(1992-9#1)(1995-8#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-7#1)(2012-3#1)
several components such as##2##4##(2008-5#1)(2009-10#1)
several components##23##2##(1992-9#1)(1995-8#1)(1996-8#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2010-6#1)(2012-3#1)(2013-1#1)
several compounds were##2##3##(1990-7#1)(2008-10#1)
several compounds##8##2##(1990-7#1)(1992-8#1)(1995-8#1)(2005-8#1)(2008-10#4)
several computer##2##2##(2008-3#1)(2008-6#1)
several concentrations of##2##3##(2006-5#1)(2008-5#1)
several concentrations##3##2##(2006-5#1)(2008-5#2)
several conditions##7##2##(1992-3#1)(1994-9#1)(1996-9#1)(2006-12#1)(2007-11#2)(2008-6#1)
several conformational##3##2##(1992-12#1)(1995-2#1)(1996-7#1)
several conserved##5##2##(1993-12#1)(1993-5#1)(1993-6#1)(2008-10#1)(2008-4#1)
several contiguous##2##2##(1997-3#1)(2008-3#1)
several controversies still##2##3##(2006-2#1)(2008-3#1)
several copies of##2##3##(1997-6#1)(2012-3#1)
several copies##3##2##(1995-8#1)(1997-6#1)(2012-3#1)
several core##4##2##(2008-10#1)(2012-3#1)(2013-1#2)
several cortical##2##2##(1992-7#1)(1996-2#1)
several corticosteroids##2##2##(1997-8#2)
several countries##12##2##(1990-6#1)(1993-2#1)(1993-3#1)(2004-11#1)(2005-5#1)(2007-8#1)(2008-5#1)(2010-12#1)(2011-2#3)(2013-1#1)
several criteria to##2##3##(1992-12#1)(1992-3#1)
several criteria##5##2##(1992-12#2)(1992-3#1)(1996-9#1)(2012-12#1)
several critical##2##2##(2008-3#1)(2013-8#1)
several crucial##2##2##(2008-10#1)(2009-12#1)
several cultivars##2##2##(2008-10#2)
several current##2##2##(1993-9#1)(2012-8#1)
several cycles of##5##3##(1991-8#1)(1994-12#1)(1997-2#1)(2010-12#1)(2013-7#1)
several cytokines##6##2##(1991-4#2)(2008-8#1)(2010-12#1)(2010-2#1)(2011-2#1)
several data##3##2##(1995-1#1)(2013-1#2)
several days after infection##2##4##(1992-7#1)(2009-3#1)
several days after inoculation##2##4##(2008-10#2)
several days after##8##3##(1992-7#1)(2006-3#1)(2008-10#2)(2008-4#1)(2009-3#1)(2011-2#1)(2013-1#1)
several days in##2##3##(2006-8#1)(2008-5#1)
several days or##2##3##(1991-3#1)(2013-1#1)
several days to##3##3##(2006-11#2)(2008-10#1)
several days##40##2##(1990-8#1)(1991-2#1)(1991-3#1)(1992-7#1)(1995-1#1)(1995-7#2)(1996-5#1)(1996-9#1)(2005-11#1)(2006-10#2)(2006-11#2)(2006-3#1)(2006-8#1)(2007-12#2)(2007-7#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2011-1#2)(2011-2#1)(2013-1#3)
several decades and##2##3##(2008-10#1)(2010-5#1)
several decades have##2##3##(2011-2#1)(2012-2#1)
several decades in##3##3##(2007-12#1)(2010-2#1)(2012-2#1)
several decades of##2##3##(2008-2#1)(2012-12#1)
several decades##33##2##(1992-12#1)(1994-11#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-4#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-7#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#4)(2012-2#2)(2013-7#1)
several degrees##2##2##(1990-8#1)(1996-5#1)
several derivatives of##2##3##(1997-8#1)(2008-2#1)
several described##2##2##(2006-3#1)(2008-10#1)
several designs of##2##3##(2008-10#1)(2008-2#1)
several desirable properties##3##3##(1997-4#1)(2013-1#2)
several developmental processes##2##3##(2003-11#1)(2009-8#1)
several developmental##4##2##(2003-11#1)(2009-11#1)(2009-8#1)(2010-2#1)
several developments in the##2##4##(2006-6#1)(2013-1#1)
several devices##2##2##(2006-6#1)(2011-2#1)
several diagnostic##4##2##(1993-5#1)(2006-10#1)(2007-7#1)(2008-10#1)
several differences between the##2##4##(1991-8#1)(2006-5#1)
several differences between##5##3##(1991-8#1)(1996-8#1)(1997-7#1)(2006-5#1)(2009-5#1)
several differences##6##2##(1990-5#1)(1991-8#1)(1996-8#1)(1997-7#1)(2006-5#1)(2009-5#1)
several different amino acids##2##4##(1994-11#1)(2008-4#1)
several different cell types##2##4##(1991-2#1)(1993-5#1)
several different indices##2##3##(1997-5#1)(2010-8#1)
several different locations##2##3##(2008-10#1)(2011-1#1)
several different mechanisms##3##3##(1992-7#1)(1993-3#1)(2007-11#1)
several different methods##3##3##(2006-10#1)(2008-4#1)(2012-12#1)
several different species##2##3##(1991-6#1)(2008-4#1)
several different types of##7##4##(1990-5#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)
several different##110##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-2#1)(1992-3#2)(1992-7#1)(1993-3#2)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-3#2)(1996-8#2)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#2)(1997-7#1)(2004-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#2)(2006-12#2)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#4)(2008-1#5)(2008-10#12)(2008-11#5)(2008-2#2)(2008-4#11)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
several difficult##2##2##(2008-3#1)(2009-12#1)
several dimensions of##2##3##(2010-7#1)(2010-9#1)
several dimensions##4##2##(2007-12#1)(2010-7#1)(2010-9#1)(2013-8#1)
several directions##4##2##(2008-11#1)(2008-2#2)(2008-3#1)
several disciplines##4##2##(1996-1#1)(2007-2#1)(2008-10#1)(2010-2#1)
several discrepancies##3##2##(1990-10#1)(2008-10#1)(2008-7#1)
several disease states##4##3##(1992-4#1)(2005-8#1)(2009-7#1)(2012-3#1)
several disease##6##2##(1992-4#1)(2005-8#1)(2006-10#1)(2009-7#1)(2012-3#1)(2013-8#1)
several diseases##12##2##(1995-6#1)(2007-11#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#2)
several disorders##4##2##(2006-10#1)(2006-2#1)(2008-12#1)(2013-8#1)
several distinct##15##2##(1990-11#1)(1992-3#1)(1992-5#1)(1993-6#1)(1994-9#1)(1996-1#1)(1996-4#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2010-12#1)(2012-3#1)
several distinctive##2##2##(2011-1#1)(2011-2#1)
several domains##3##2##(1994-10#1)(2008-4#1)(2012-3#1)
several dominant##2##2##(1994-6#1)(2008-10#1)
several dozen##2##2##(2006-10#1)(2008-9#1)
several drawbacks##4##2##(1990-5#1)(1996-8#1)(2008-5#1)(2012-3#1)
several drug##3##2##(1993-12#1)(2006-10#1)(2012-3#1)
several drugs##7##2##(1997-4#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-3#1)(2011-12#1)
several earlier##2##2##(1992-6#1)(2010-8#1)
several early##3##2##(2006-9#1)(2013-1#2)
several ecological##3##2##(2008-6#1)(2008-9#1)(2013-7#1)
several economic##4##2##(1991-12#1)(2008-11#1)(2008-6#1)(2008-7#1)
several effective##2##2##(2006-10#1)(2009-12#1)
several elements##5##2##(1992-1#1)(1996-10#1)(2008-10#3)
several endogenous##3##2##(1990-4#1)(2010-4#1)(2011-2#1)
several environmental factors##3##3##(2006-9#1)(2012-12#2)
several environmental##8##2##(1997-6#1)(2006-9#1)(2008-10#3)(2008-2#1)(2012-12#2)
several enzyme##3##2##(1991-5#1)(2008-10#1)(2008-4#1)
several enzymes active against##2##4##(2010-3#2)
several enzymes##8##2##(1990-12#1)(1994-3#1)(2008-10#1)(2008-7#2)(2010-3#2)(2012-12#1)
several epidemics##3##2##(2008-12#1)(2008-5#1)(2012-2#1)
several epidemiological studies have shown##2##5##(2007-5#1)(2008-3#1)
several epidemiological##4##2##(2007-5#1)(2008-3#1)(2008-7#2)
several episodes of##3##3##(2006-12#1)(2006-4#1)(2008-2#1)
several epithelial##2##2##(1992-5#1)(1995-3#1)
several error##2##2##(2008-11#1)(2008-2#1)
several essential##2##2##(2008-11#1)(2012-12#1)
several ethical##3##2##(1994-1#2)(2008-12#1)
several evidence-based##2##2##(2008-7#1)(2008-9#1)
several evolutionarily##2##2##(1994-11#1)(2005-12#1)
several examples of##4##3##(2008-10#1)(2008-3#1)(2008-4#1)(2010-6#1)
several examples where the##2##4##(2012-12#1)(2012-2#1)
several examples which##2##3##(2006-10#1)(2013-8#1)
several examples##16##2##(1997-7#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
several excellent##2##2##(1994-12#1)(2008-11#1)
several experimental parameters##3##3##(2005-11#1)(2008-10#2)
several experimental##8##2##(1994-11#1)(1997-7#1)(2005-11#1)(2008-10#4)(2008-5#1)
several experiments##6##2##(1990-11#1)(1991-3#1)(1997-5#1)(2007-9#1)(2008-3#1)(2012-1#1)
several extensive##2##2##(2006-8#1)(2009-12#1)
several extracellular##2##2##(2008-11#1)(2011-1#1)
several extraction methods##2##3##(2005-4#1)(2008-12#1)
several extraction##3##2##(2005-4#1)(2008-10#1)(2008-12#1)
several factors are##2##3##(1995-3#1)(2006-12#1)
several factors associated with##2##4##(2008-5#1)(2013-1#1)
several factors such as##2##4##(1996-7#1)(2005-11#1)
several factors that##6##3##(2006-1#1)(2006-2#1)(2008-1#1)(2008-7#1)(2010-1#1)(2011-2#1)
several factors were##2##3##(2008-3#1)(2011-2#1)
several factors##46##2##(1990-12#1)(1990-8#2)(1991-1#1)(1992-3#1)(1992-4#1)(1994-11#1)(1995-11#1)(1995-3#1)(1996-7#1)(1997-5#1)(1997-8#1)(2005-11#1)(2006-1#1)(2006-12#1)(2006-2#2)(2006-6#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2009-11#1)(2009-5#2)(2010-1#1)(2010-11#1)(2010-12#1)(2011-2#4)(2012-3#1)(2013-1#2)
several families of##4##3##(1993-8#1)(2008-8#1)(2012-12#1)(2013-1#1)
several features of the##3##4##(1994-5#1)(2006-10#1)(2008-3#1)
several features of##8##3##(1992-1#1)(1994-5#1)(1996-7#1)(2006-10#1)(2008-3#2)(2008-8#1)(2013-8#1)
several features##13##2##(1992-1#1)(1994-12#1)(1994-5#1)(1996-7#1)(2006-10#1)(2008-3#2)(2008-8#1)(2010-11#1)(2011-10#1)(2013-1#2)(2013-8#1)
several field##2##2##(2006-10#1)(2008-10#1)
several fields##5##2##(1992-3#1)(2004-12#1)(2008-10#1)(2009-2#1)(2011-2#1)
several fish species##4##3##(2008-10#1)(2008-7#1)(2010-8#2)
several fold##7##2##(1990-11#1)(1990-9#1)(1991-4#1)(1992-1#1)(1992-12#1)(1996-5#1)(2010-12#1)
several folds##2##2##(1992-9#1)(2008-10#1)
several forms of##10##3##(1991-2#1)(1995-3#1)(1997-7#1)(2005-7#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2010-11#1)(2010-12#1)
several forms##12##2##(1991-2#1)(1991-3#1)(1995-3#1)(1995-6#1)(1997-7#1)(2005-7#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2010-11#1)(2010-12#1)
several fragments##4##2##(1991-4#1)(1997-3#1)(2007-12#1)(2008-10#1)
several functional##5##2##(1991-8#1)(1995-8#1)(2008-10#1)(2009-5#1)(2012-1#1)
several functions of##3##3##(1992-3#1)(2008-9#1)(2011-1#1)
several functions##7##2##(1990-5#1)(1992-3#1)(1994-9#1)(2008-2#1)(2008-9#1)(2011-1#1)(2011-3#1)
several fungi##4##2##(1996-6#1)(2007-12#1)(2008-10#1)(2008-7#1)
several gastrointestinal##3##2##(2006-2#1)(2007-12#1)(2012-2#1)
several gene##2##2##(1992-9#1)(2010-5#1)
several general##4##2##(1995-10#1)(2005-8#1)(2013-1#2)
several generations of##2##3##(2008-7#1)(2010-9#1)
several generations##10##2##(1995-11#1)(1995-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-9#1)(2012-2#2)
several genes in##3##3##(2008-11#1)(2008-8#1)(2012-12#1)
several genes known##2##3##(2008-10#1)(2012-12#1)
several genes that##3##3##(1993-3#1)(1997-7#1)(2010-4#1)
several genes were##2##3##(2008-5#1)(2012-3#1)
several genes##26##2##(1990-11#1)(1991-5#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-2#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-3#1)
several genetic loci##2##3##(1994-5#1)(2012-3#1)
several genetic##6##2##(1994-5#1)(2006-1#1)(2007-7#1)(2008-10#1)(2008-11#1)(2012-3#1)
several glass##2##2##(2008-10#1)(2008-3#1)
several glycoproteins of##2##3##(1994-2#2)
several group##2##2##(1994-9#1)(2009-8#1)
several groups have##2##3##(2010-2#1)(2011-7#1)
several groups of##6##3##(1996-9#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-7#1)(2013-1#1)
several groups##17##2##(1992-6#1)(1993-2#1)(1996-9#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-2#1)(2011-2#1)(2011-7#1)(2013-1#1)
several growth factors or##2##4##(1995-11#1)(1996-4#1)
several growth factors##4##3##(1992-12#1)(1995-11#1)(1996-4#1)(2006-10#1)
several growth##6##2##(1992-12#1)(1995-11#1)(1996-4#1)(2006-10#1)(2007-11#1)(2008-10#1)
several health##3##2##(2007-12#1)(2009-1#1)(2012-1#1)
several heat shock proteins##2##4##(1991-9#1)(1994-10#1)
several high-risk##2##2##(2007-12#1)(2012-2#1)
several highly##4##2##(1990-7#1)(1991-6#1)(1997-8#1)(2013-1#1)
several histopathological features##2##3##(1990-2#1)(2011-2#1)
several hormones##2##2##(2010-9#1)(2012-12#1)
several host species##3##3##(2008-8#2)(2008-9#1)
several host##6##2##(2008-8#2)(2008-9#1)(2012-11#1)(2013-1#1)(2013-7#1)
several hosts##5##2##(2008-10#5)
several hours after##4##3##(1995-1#1)(2004-9#1)(2008-10#1)(2008-7#1)
several hours and##3##3##(1995-2#1)(1997-4#1)(2012-2#1)
several hours in the##2##4##(1991-7#1)(2007-11#1)
several hours of##5##3##(1992-8#1)(1996-3#1)(2006-12#1)(2008-3#1)(2010-9#1)
several hours to##3##3##(1990-6#1)(2008-10#1)(2008-2#1)
several hours##42##2##(1990-6#1)(1991-2#1)(1991-7#1)(1992-1#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-6#1)(2004-9#1)(2005-11#2)(2006-12#1)(2006-7#1)(2006-8#1)(2007-11#4)(2007-12#1)(2007-7#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)
several human cancer cell lines##6##5##(1994-12#1)(1996-2#1)(2008-3#1)(2010-6#1)(2011-2#1)(2011-3#1)
several human cell lines##2##4##(1993-5#1)(2008-11#1)
several human diseases##4##3##(1997-3#1)(2012-1#1)(2012-12#2)
several human##29##2##(1990-2#1)(1990-5#1)(1991-6#1)(1992-3#1)(1993-5#1)(1994-12#1)(1995-10#1)(1995-3#1)(1995-5#1)(1996-2#1)(1997-3#1)(1997-8#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2010-12#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#2)
several hundred genes##2##3##(2008-7#1)(2013-8#1)
several hundred hertz##2##3##(2008-3#2)
several hundred thousand##2##3##(1990-4#1)(2008-2#1)
several hundred years##3##3##(2013-1#2)(2013-8#1)
several hundred##37##2##(1990-4#1)(1990-8#1)(1991-9#1)(1993-12#1)(1994-9#1)(1997-6#1)(2007-11#2)(2007-12#3)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)(2010-7#1)(2012-2#1)(2013-1#3)(2013-8#2)
several hundreds of##7##3##(1997-4#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-6#1)(2008-7#1)
several hypotheses about##2##3##(2008-9#1)(2013-8#1)
several hypotheses have been##2##4##(2005-11#1)(2008-1#1)
several hypotheses that##2##3##(2008-8#1)(2011-2#1)
several hypotheses##8##2##(1993-1#1)(2005-11#1)(2008-1#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)(2013-8#1)
several identical##2##2##(1997-6#1)(2008-2#1)
several immune##4##2##(2008-10#1)(2008-5#1)(2009-9#1)(2012-12#1)
several immunological##2##2##(1990-12#1)(1994-6#1)
several immunomodulating##2##2##(2007-11#2)
several important issues##3##3##(1997-3#1)(2009-5#1)(2010-12#1)
several important##38##2##(1992-8#1)(1993-3#1)(1996-8#1)(1997-3#1)(2005-8#1)(2006-10#3)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-5#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)
several improvements##3##2##(1997-1#1)(2008-11#1)(2008-4#1)
several in vitro##6##3##(1992-2#1)(1997-4#1)(2008-10#1)(2008-4#2)(2012-2#1)
several in##8##2##(1992-2#1)(1997-4#1)(2008-10#1)(2008-4#2)(2012-2#1)(2012-3#1)(2013-8#1)
several incidents##2##2##(2008-10#1)(2010-5#1)
several inconsistencies##2##2##(1993-8#1)(1995-3#1)
several independent variables##2##3##(2008-10#1)(2012-3#1)
several independent##10##2##(1991-12#1)(1994-9#1)(2006-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2012-3#2)
several indications##2##2##(1995-4#1)(2010-2#1)
several indicators of##2##3##(2009-8#1)(2013-1#1)
several indicators##3##2##(2008-11#1)(2009-8#1)(2013-1#1)
several inflammatory conditions##2##3##(2009-10#1)(2010-12#1)
several inflammatory##6##2##(1995-12#1)(1995-7#1)(2004-3#1)(2009-10#1)(2010-12#1)(2013-1#1)
several inherent##2##2##(2004-7#1)(2012-3#1)
several inherited##4##2##(1995-1#1)(2008-10#1)(2008-5#1)(2011-2#1)
several inhibitors of##2##3##(2006-11#1)(2008-10#1)
several innovations##2##2##(2008-3#1)(2009-5#1)
several inorganic##2##2##(1993-4#1)(2008-10#1)
several instances of##3##3##(2011-1#2)(2012-12#1)
several instances##6##2##(1993-6#1)(2008-10#2)(2011-1#2)(2012-12#1)
several institutions##2##2##(1994-1#1)(2012-12#1)
several instrumental##2##2##(2008-10#2)
several intensities##2##2##(2008-10#1)(2008-2#1)
several interesting features##2##3##(1996-4#1)(2008-2#1)
several interesting##6##2##(1996-4#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-2#1)(2012-3#1)
several interfering ions##2##3##(2008-10#2)
several interfering##4##2##(2008-10#3)(2013-1#1)
several internal##2##2##(1991-7#1)(2005-4#1)
several international##2##2##(1996-7#1)(2010-5#1)
several interventions##2##2##(2006-4#1)(2012-2#1)
several intriguing features##2##3##(1993-12#1)(2006-11#1)
several intriguing##3##2##(1993-12#1)(2006-11#1)(2008-5#1)
several investigations##4##2##(2004-11#1)(2007-5#1)(2008-5#1)(2009-2#1)
several investigators##3##2##(1995-2#1)(2008-2#1)(2012-3#1)
several ions##3##2##(1993-12#1)(2008-10#2)
several isoforms##3##2##(1991-10#1)(1992-2#1)(2009-8#1)
several isolates of##3##3##(2008-10#2)(2012-12#1)
several issues including##2##3##(2008-5#1)(2010-5#1)
several issues that##2##3##(2008-4#1)(2010-7#1)
several issues##12##2##(1993-9#1)(1997-2#1)(2007-10#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
several items##2##2##(1993-12#1)(2012-3#1)
several key elements##2##3##(2008-9#1)(2011-2#1)
several key enzymes##3##3##(2004-11#1)(2008-5#2)
several key##22##2##(1990-4#1)(1994-2#1)(1995-2#1)(1996-11#1)(1996-8#1)(1997-2#1)(2004-11#1)(2006-10#1)(2008-1#1)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
several kilometers##3##2##(2007-12#1)(2008-3#2)
several kinases##2##2##(1994-8#1)(1996-2#1)
several kinds of cell##2##4##(1997-4#1)(2008-2#1)
several kinds of##13##3##(1990-7#1)(1993-4#1)(1997-4#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-8#1)(2010-10#1)(2010-6#1)(2013-8#1)
several known##5##2##(2006-12#1)(2007-1#1)(2008-10#1)(2008-2#1)(2013-1#1)
several laboratories have##5##3##(1995-1#1)(2004-12#1)(2006-10#1)(2008-1#1)(2008-4#1)
several laboratories##14##2##(1992-11#1)(1995-1#1)(1995-12#1)(1996-2#1)(2004-12#1)(2005-11#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-4#2)(2008-7#1)(2011-2#1)
several laboratory##2##2##(1996-11#1)(2008-2#1)
several languages##3##2##(1993-11#1)(2010-5#1)(2011-1#1)
several large studies have##2##4##(2007-10#1)(2007-8#1)
several large##6##2##(1996-4#1)(2007-10#1)(2007-12#1)(2007-8#1)(2010-5#1)(2012-11#1)
several large-scale studies##2##3##(1993-12#1)(2008-5#1)
several large-scale##3##2##(1993-12#1)(2008-5#1)(2010-12#1)
several layers of##2##3##(1990-3#1)(2011-2#1)
several layers##6##2##(1990-3#1)(1995-5#1)(2008-2#2)(2008-5#1)(2011-2#1)
several leading##3##2##(1993-3#1)(2008-2#1)(2011-2#1)
several levels##13##2##(1991-6#1)(1992-2#1)(1993-2#1)(1995-12#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-12#1)(2008-10#2)(2012-12#1)(2012-2#1)(2012-3#1)
several ligands##2##2##(1991-1#1)(2006-10#1)
several limitations##6##2##(2006-10#1)(2007-10#1)(2008-10#1)(2009-3#1)(2012-2#1)(2013-1#1)
several lines of evidence indicate that##6##6##(1994-11#1)(1995-2#1)(1997-8#1)(2008-7#2)(2013-8#1)
several lines of evidence indicate##7##5##(1994-11#1)(1995-2#1)(1997-8#1)(2008-7#2)(2010-3#1)(2013-8#1)
several lines of evidence suggest that##2##6##(1991-9#1)(2010-9#1)
several lines of evidence##12##4##(1991-9#1)(1994-11#1)(1995-2#1)(1996-4#1)(1997-8#2)(2008-7#2)(2010-3#1)(2010-9#1)(2012-3#1)(2013-8#1)
several lines of##14##3##(1991-9#1)(1994-11#1)(1995-2#1)(1996-4#1)(1997-8#2)(2008-10#1)(2008-11#1)(2008-7#2)(2010-3#1)(2010-9#1)(2012-3#1)(2013-8#1)
several local##3##2##(1994-3#2)(2006-10#1)
several localities##2##2##(2007-5#1)(2007-6#1)
several locations##7##2##(1995-8#1)(2006-10#1)(2007-6#1)(2008-10#2)(2008-2#1)(2009-10#1)
several loci##2##2##(2008-4#1)(2012-3#1)
several low molecular weight proteins##2##5##(1991-4#1)(2007-6#1)
several low##3##2##(1991-4#1)(1994-12#1)(2007-6#1)
several main##3##2##(2006-10#1)(2008-8#1)(2013-1#1)
several major##8##2##(1995-1#1)(1995-5#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-5#1)
several males##3##2##(2008-8#3)
several mammalian cell lines##2##4##(2008-11#1)(2008-9#1)
several mammalian cell##3##3##(1993-9#1)(2008-11#1)(2008-9#1)
several mammalian species##4##3##(1990-3#1)(1991-2#1)(1993-11#1)(2005-6#1)
several mammalian##9##2##(1990-3#1)(1991-2#1)(1993-11#1)(1993-9#1)(1996-6#1)(2005-6#1)(2008-10#1)(2008-11#1)(2008-9#1)
several management##2##2##(2008-10#1)(2012-2#1)
several markers of##3##3##(1993-11#1)(1995-11#1)(2005-10#1)
several means of##2##3##(2008-10#1)(2012-2#1)
several measurements##2##2##(1994-2#1)(2008-3#1)
several measures of##4##3##(1990-3#1)(1995-10#1)(1997-1#1)(2010-2#1)
several measures##7##2##(1990-3#1)(1995-10#1)(1997-1#1)(1997-7#1)(2008-2#1)(2010-2#1)(2011-1#1)
several mechanisms of action##2##4##(2008-1#1)(2008-6#1)
several mechanisms of##3##3##(2008-1#1)(2008-10#1)(2008-6#1)
several mechanisms that##4##3##(1996-5#1)(2008-7#1)(2011-1#1)(2011-2#1)
several mechanisms to##2##3##(2008-8#1)(2012-1#1)
several mechanisms##23##2##(1990-11#1)(1994-9#2)(1996-5#1)(1997-1#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-7#1)
several mediators##2##2##(1994-11#1)(2011-2#1)
several medical conditions##2##3##(1993-12#1)(2009-1#1)
several medical##6##2##(1993-12#1)(1994-12#1)(2006-10#1)(2009-1#1)(2011-12#1)(2013-8#1)
several medicinal##2##2##(2008-10#1)(2011-1#1)
several members of the same family##2##6##(1997-4#1)(2010-3#1)
several members of the##11##4##(1992-3#1)(1994-8#2)(1995-12#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-4#1)(2008-11#1)(2008-4#1)(2010-3#1)
several members of##14##3##(1990-4#1)(1992-3#1)(1994-8#2)(1995-12#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-3#1)
several members##16##2##(1990-4#1)(1992-3#1)(1994-8#2)(1995-12#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-7#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-4#1)(2010-3#1)
several membranes##2##2##(1994-10#1)(2008-10#1)
several metabolic pathways##2##3##(2010-12#1)(2012-1#1)
several metabolic##5##2##(2008-7#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-8#1)
several metal ions##3##3##(1992-12#1)(2008-10#1)(2008-8#1)
several meters##3##2##(2008-3#3)
several methodological##2##2##(2006-2#2)
several methods for##11##3##(1995-8#1)(1995-9#1)(2007-8#1)(2008-4#5)(2011-2#1)(2012-3#1)(2013-1#1)
several methods have been##4##4##(1991-6#1)(2006-10#2)(2013-1#1)
several methods of##4##3##(1992-3#1)(2008-12#1)(2008-7#2)
several methods to##2##3##(2008-7#1)(2011-2#1)
several methods##31##2##(1991-6#1)(1992-3#1)(1995-8#1)(1995-9#1)(1996-12#1)(1997-4#1)(2006-10#3)(2007-8#1)(2008-12#1)(2008-3#1)(2008-4#6)(2008-7#3)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
several micrometers##6##2##(2005-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
several millimeters##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
several million##2##2##(1996-12#1)(2008-2#1)
several milliwatts##2##2##(2007-12#2)
several minor##4##2##(1990-2#1)(1990-7#1)(1993-9#1)(2008-10#1)
several minutes after##2##3##(1993-12#1)(2013-1#1)
several minutes of##2##3##(2005-11#1)(2010-7#1)
several minutes##14##2##(1990-2#1)(1992-8#1)(1993-12#1)(1997-6#1)(1997-7#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-6#1)(2010-7#1)(2013-1#1)(2013-8#1)
several mixtures of##2##3##(2008-10#2)
several mixtures##4##2##(2008-10#4)
several mm##2##2##(1990-4#1)(2008-1#1)
several modalities##2##2##(2008-3#1)(2012-2#1)
several model parameters##2##3##(2007-8#1)(2008-10#1)
several model systems##2##3##(2006-12#1)(2008-10#1)
several model##4##2##(2006-12#1)(2007-8#1)(2008-10#2)
several models of##5##3##(1995-12#1)(1997-7#1)(2006-10#1)(2007-9#1)(2008-7#1)
several models##12##2##(1995-12#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-9#1)(2008-2#2)(2008-7#1)(2009-8#1)
several modes of##3##3##(1993-11#1)(2008-10#2)
several modifications##5##2##(2007-8#1)(2009-5#1)(2010-8#1)(2011-1#2)
several modified##2##2##(2006-12#1)(2009-2#1)
several molecular markers##2##3##(2008-10#1)(2008-4#1)
several molecular##9##2##(1997-6#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-3#1)(2012-11#1)
several months after removal of##2##5##(2007-11#1)(2008-1#1)
several months after##8##3##(1991-10#1)(1992-2#1)(2007-11#3)(2008-1#1)(2008-7#1)(2008-9#1)
several months and##3##3##(1996-12#1)(1997-6#1)(2008-10#1)
several months of##4##3##(1995-2#1)(2006-10#1)(2007-7#1)(2009-12#1)
several months##49##2##(1990-2#1)(1990-4#1)(1990-6#1)(1991-10#1)(1991-8#1)(1992-11#1)(1992-2#1)(1995-2#2)(1995-9#1)(1996-12#1)(1996-8#1)(1997-6#1)(2005-11#1)(2006-10#3)(2006-8#1)(2007-11#5)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#3)(2009-8#1)(2010-2#2)(2010-6#1)(2011-1#1)(2012-2#4)(2013-7#1)
several more decades##2##3##(1990-2#1)(2008-5#1)
several more##6##2##(1990-2#1)(1990-5#1)(2005-7#1)(2008-2#1)(2008-5#1)(2013-7#1)
several mouse Bgp cDNAs##2##4##(1993-5#2)
several mouse##5##2##(1991-9#1)(1993-5#2)(2007-10#1)(2012-2#1)
several multiple##3##2##(1996-12#1)(2007-10#1)(2009-10#1)
several murine##2##2##(1992-8#1)(1995-6#1)
several mutants##3##2##(1993-6#1)(1993-8#1)(2008-10#1)
several mutations##2##2##(1997-3#1)(2011-2#1)
several nanoseconds##2##2##(2008-3#2)
several national##2##2##(2010-12#1)(2010-9#1)
several natural products##2##3##(1995-3#1)(2009-3#1)
several natural##5##2##(1994-9#1)(1995-3#1)(2008-10#1)(2009-3#1)(2011-12#1)
several neurochemical##2##2##(1994-5#1)(2008-2#1)
several neurodegenerative diseases##4##3##(2006-4#1)(2008-8#1)(2009-3#1)(2011-2#1)
several neurodegenerative disorders##2##3##(1997-8#1)(2009-10#1)
several neurodegenerative##7##2##(1997-8#1)(2006-4#1)(2008-8#1)(2009-10#1)(2009-3#1)(2011-1#1)(2011-2#1)
several neurological disorders##2##3##(1994-11#1)(2010-12#1)
several neurological##3##2##(1994-11#1)(2008-11#1)(2010-12#1)
several neuronal##3##2##(1996-10#2)(1996-5#1)
several neuropsychiatric disorders##3##3##(1997-5#1)(2012-12#1)(2013-8#1)
several neuropsychiatric##4##2##(1997-5#1)(2008-1#1)(2012-12#1)(2013-8#1)
several neurotoxic##2##2##(1995-3#1)(1996-11#1)
several neurotransmitter##2##2##(1992-8#1)(2008-1#1)
several neurotransmitters##4##2##(2006-10#1)(2007-1#1)(2008-11#1)(2008-7#1)
several neutral##2##2##(1994-6#1)(2008-10#1)
several new and##2##3##(2008-12#1)(2008-3#1)
several new antifungal agents##2##4##(2008-7#2)
several new compounds##2##3##(2005-8#1)(2008-1#1)
several new drugs##3##3##(2005-7#1)(2008-12#1)(2008-2#1)
several new##38##2##(1994-9#1)(1996-11#1)(1996-6#1)(1997-4#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-7#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#1)
several non-specific##3##2##(1994-2#1)(1994-8#1)(2006-10#1)
several nonlinear##2##2##(2007-2#1)(2009-8#1)
several novel approaches##2##3##(2005-8#1)(2007-8#1)
several novel proteins##2##3##(1990-8#1)(2006-10#1)
several novel##18##2##(1990-6#1)(1990-8#1)(1994-5#1)(1994-9#1)(1996-10#1)(1997-4#1)(2005-8#2)(2006-10#3)(2007-8#2)(2008-8#1)(2009-11#1)(2009-12#1)(2010-7#1)(2013-1#1)
several nuclear##3##2##(1994-11#1)(1994-2#1)(1996-5#1)
several nuclei##2##2##(1990-7#1)(1995-5#1)
several nucleotide##2##2##(1992-7#1)(1997-3#1)
several nutrients##3##2##(1992-8#2)(2008-5#1)
several observations##3##2##(2006-10#1)(2010-12#1)(2011-3#1)
several of its##5##3##(1996-5#1)(1996-7#1)(2011-2#1)(2012-12#2)
several of the##43##3##(1990-11#1)(1992-12#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-6#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-4#1)(2005-11#2)(2006-10#2)(2007-11#1)(2007-4#1)(2007-5#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2012-8#1)(2013-1#1)
several of them##6##3##(1991-9#1)(1992-3#1)(1996-12#1)(2007-11#1)(2008-12#1)(2008-2#1)
several of these mines##2##4##(2008-10#2)
several of these proteins##2##4##(1994-8#1)(1994-9#1)
several of these##24##3##(1992-12#1)(1994-8#1)(1994-9#1)(1996-10#1)(1997-1#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-12#2)(2010-2#1)(2012-1#1)(2012-3#1)
several of which##2##3##(1996-5#1)(2010-5#1)
several of##84##2##(1990-11#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#4)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-11#2)(2006-10#3)(2007-11#3)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#4)(2008-8#2)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#2)(2012-8#1)(2013-1#1)
several operational parameters##2##3##(2008-10#2)
several operational##3##2##(2008-10#2)(2008-11#1)
several opportunities for##2##3##(1992-2#1)(2007-2#1)
several opportunities##4##2##(1992-2#1)(1992-3#1)(2007-2#1)(2008-11#1)
several optical##5##2##(2008-2#4)(2008-3#1)
several options for##3##3##(1996-2#1)(2010-11#1)(2013-7#1)
several options##7##2##(1996-2#1)(2008-4#1)(2009-8#1)(2010-11#2)(2012-2#1)(2013-7#1)
several orders of magnitude higher than##2##6##(2008-10#2)
several orders of magnitude larger than##2##6##(2008-10#1)(2008-3#1)
several orders of magnitude more sensitive than##2##7##(2007-12#1)(2008-11#1)
several orders of magnitude more##4##5##(1991-4#1)(1995-8#1)(2007-12#1)(2008-11#1)
several orders of magnitude##21##4##(1991-4#1)(1991-7#1)(1994-5#2)(1995-8#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#4)(2010-8#1)(2012-2#1)
several orders of##23##3##(1991-4#1)(1991-7#1)(1994-5#2)(1995-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#5)(2010-8#1)(2012-2#1)
several organ systems##3##3##(1990-8#1)(1993-6#1)(1994-10#1)
several organic##6##2##(1993-12#1)(1997-4#1)(2008-10#2)(2008-3#1)(2010-4#1)
several organisms##3##2##(2008-11#1)(2008-4#1)(2008-7#1)
several organizations##3##2##(2008-3#1)(2009-11#1)(2010-5#1)
several organs##6##2##(1993-7#1)(2008-10#2)(2010-10#1)(2010-11#2)
several other amino acids##2##4##(1997-6#1)(2006-12#1)
several other cell lines##2##4##(1992-7#1)(2008-11#1)
several other cell##3##3##(1992-7#1)(1997-6#1)(2008-11#1)
several other diseases of##2##4##(2006-8#1)(2008-10#1)
several other diseases##5##3##(2006-7#1)(2006-8#2)(2008-10#1)(2012-2#1)
several other groups##2##3##(1993-11#1)(2008-11#1)
several other important##2##3##(2007-11#1)(2010-8#1)
several other proteins##5##3##(1990-9#1)(1996-11#1)(2009-7#1)(2012-2#2)
several other recently##2##3##(1995-6#1)(2008-2#1)
several other species##4##3##(1991-12#1)(1993-12#1)(2008-4#1)(2008-7#1)
several other studies##4##3##(2006-11#1)(2007-4#1)(2008-5#1)(2008-6#1)
several other viral##2##3##(2007-11#1)(2013-1#1)
several other##110##2##(1990-2#2)(1990-3#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-7#2)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#2)(1994-1#1)(1994-12#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-9#1)(1997-4#1)(1997-6#2)(1997-7#1)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-5#2)(2006-7#1)(2006-8#2)(2007-11#2)(2007-12#2)(2007-4#1)(2007-6#1)(2007-8#3)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-9#3)(2009-7#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#4)(2013-1#3)
several others##4##2##(1997-3#1)(2006-10#1)(2008-7#1)(2009-5#1)
several overlapping##2##2##(1995-3#1)(1996-9#1)
several pH##3##2##(1992-10#1)(2008-10#2)
several papers##5##2##(1994-9#1)(2006-10#1)(2012-3#1)(2013-1#2)
several parameters of the##2##4##(1996-4#1)(2008-7#1)
several parameters of##6##3##(1996-4#1)(2008-10#1)(2008-7#1)(2009-10#1)(2011-1#1)(2013-1#1)
several parameters such as macroscopic##2##5##(2008-5#2)
several parameters such as##3##4##(2008-10#1)(2008-5#2)
several parameters##18##2##(1992-7#1)(1996-4#1)(1997-2#1)(1997-7#1)(2006-12#1)(2008-10#3)(2008-4#1)(2008-5#3)(2008-7#3)(2009-10#1)(2011-1#1)(2013-1#1)
several parasites##3##2##(2005-7#1)(2008-12#1)(2012-2#1)
several parts of##5##3##(2005-8#1)(2006-2#1)(2007-3#1)(2008-7#1)(2008-9#1)
several parts##7##2##(2005-8#1)(2006-2#1)(2007-3#1)(2007-8#1)(2008-7#1)(2008-9#1)(2012-3#1)
several passages##3##2##(1990-5#1)(1991-10#1)(2008-10#1)
several pathogens##2##2##(2008-10#1)(2013-1#1)
several pathologic conditions##2##3##(1991-9#1)(2006-10#1)
several pathologic##3##2##(1991-9#1)(2006-10#1)(2011-2#1)
several pathological pathways##2##3##(2010-10#1)(2012-3#1)
several pathological##5##2##(1992-8#1)(2005-8#1)(2010-10#1)(2010-12#1)(2012-3#1)
several pathovars of##2##3##(2008-10#1)(2013-1#1)
several pathways##5##2##(1996-10#1)(2008-1#1)(2008-5#1)(2010-12#1)(2012-3#1)
several patients##4##2##(1996-3#1)(1996-6#1)(1997-1#1)(2013-8#1)
several peaks##2##2##(1995-6#1)(2008-10#1)
several peptide##3##2##(1990-2#1)(1994-12#1)(2012-2#1)
several peptides##3##2##(1997-4#1)(2008-10#1)(2010-2#1)
several percent##4##2##(2008-10#2)(2008-3#1)(2011-12#1)
several personality##2##2##(2008-5#2)
several persons##2##2##(1994-9#1)(2006-2#1)
several pharmaceutical##3##2##(2004-12#1)(2008-10#1)(2012-12#1)
several phase##3##2##(2004-1#2)(2008-3#1)
several physiological and pathological##2##4##(1994-2#1)(1995-4#1)
several physiological processes##2##3##(1995-2#1)(2009-12#1)
several physiological##7##2##(1994-2#1)(1995-2#1)(1995-4#1)(2006-10#1)(2008-12#1)(2009-12#1)(2013-1#1)
several plant extracts##2##3##(2008-10#1)(2008-5#1)
several plant species##3##3##(2006-12#1)(2008-10#1)(2009-8#1)
several plant##10##2##(1994-6#1)(2006-12#1)(2008-10#4)(2008-5#1)(2008-7#2)(2009-8#1)
several plasmids##2##2##(1996-5#1)(1997-2#1)
several points##5##2##(1992-6#1)(2006-10#1)(2008-3#1)(2010-5#1)(2010-6#1)
several policy##2##2##(1992-3#1)(1994-4#1)
several population##2##2##(2008-4#1)(2009-5#1)
several populations##4##2##(2008-1#1)(2008-11#1)(2011-2#1)(2012-3#1)
several positive clones##2##3##(1993-6#1)(1994-12#1)
several positive##5##2##(1993-6#1)(1994-12#1)(2008-8#1)(2012-3#2)
several possible causes##2##3##(1996-7#1)(2007-12#1)
several possible##12##2##(1990-11#1)(1990-12#1)(1995-6#1)(1996-1#1)(1996-7#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-2#1)(2013-7#1)
several post##2##2##(1990-11#1)(2008-8#1)
several potent##4##2##(1996-4#1)(2008-5#1)(2012-12#1)(2012-3#1)
several potential advantages##2##3##(2008-2#1)(2011-7#1)
several potential regulatory##3##3##(1990-3#1)(1992-9#1)(1993-2#1)
several potential##26##2##(1990-3#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-9#1)(1995-3#1)(1997-4#1)(2006-11#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2009-5#1)(2010-6#1)(2011-7#1)
several potentially##2##2##(1992-5#1)(1993-7#1)
several practical applications##2##3##(1997-2#1)(2009-12#1)
several practical##4##2##(1993-4#1)(1997-2#1)(2009-12#1)(2013-1#1)
several pre-clinical##2##2##(2008-8#1)(2009-3#1)
several preclinical studies##2##3##(2005-9#1)(2012-2#1)
several previously##7##2##(1990-10#1)(1992-6#1)(1994-3#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-3#1)
several primary##4##2##(1995-8#1)(1997-7#1)(2008-10#1)(2008-8#1)
several principles##2##2##(1995-2#1)(2007-5#1)
several proapoptotic##2##2##(2013-1#1)(2013-7#1)
several problems in##3##3##(2007-10#1)(2007-8#1)(2008-7#1)
several problems##12##2##(1994-3#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-2#2)(2008-7#2)(2008-8#1)(2010-2#1)(2011-2#1)
several procedures##2##2##(2008-10#1)(2008-3#1)
several processes##2##2##(1996-3#1)(1997-2#1)
several production##2##2##(2007-6#1)(2012-2#1)
several products of##2##3##(1991-1#1)(1994-3#1)
several prognostic##2##2##(1991-4#1)(2008-9#1)
several proinflammatory##2##2##(2007-9#1)(2008-10#1)
several projections##3##2##(2007-5#1)(2008-3#1)(2009-5#1)
several projects##2##2##(1994-12#1)(2011-1#1)
several prokaryotic and eukaryotic##2##4##(1997-4#1)(1997-7#1)
several promising##3##2##(2008-1#2)(2010-9#1)
several properties##2##2##(2007-8#1)(2008-3#1)
several protease inhibitors##2##3##(1996-2#1)(2013-1#1)
several proteases##2##2##(1991-2#1)(2008-5#1)
several protein bands##2##3##(2008-11#2)
several protein##6##2##(1994-5#1)(1995-2#1)(2008-10#2)(2008-11#2)
several proteins in##3##3##(1994-12#1)(1994-2#1)(2006-10#1)
several proteins including##2##3##(1993-11#1)(1996-11#1)
several proteins of##3##3##(1991-10#1)(1993-6#1)(2012-12#1)
several proteins that##2##3##(1994-6#2)
several proteins was##2##3##(1991-5#1)(2010-12#1)
several proteins##20##2##(1991-10#1)(1991-5#3)(1993-11#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-6#2)(1994-9#1)(1995-12#1)(1996-11#1)(2006-10#1)(2007-9#1)(2008-10#1)(2010-12#1)(2011-12#1)(2012-12#1)
several protocols for##3##3##(1991-5#1)(2008-4#1)(2008-9#1)
several protocols##6##2##(1991-5#1)(2008-1#1)(2008-4#2)(2008-9#1)(2010-2#1)
several psychiatric disorders##2##3##(1996-10#1)(2012-2#1)
several psychiatric##3##2##(1996-10#1)(2009-8#1)(2012-2#1)
several public health##2##3##(2007-12#1)(2012-2#1)
several publications##2##2##(2006-10#1)(2009-6#1)
several published##3##2##(2006-5#1)(2010-9#1)(2011-2#1)
several putative##10##2##(1992-12#2)(1993-2#1)(1993-3#1)(1994-2#1)(1994-9#1)(1997-8#1)(2007-12#1)(2008-10#2)
several questions##7##2##(1995-12#1)(1996-11#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-1#1)
several randomized controlled trials##3##4##(1993-12#1)(2008-9#1)(2011-1#1)
several randomized##5##2##(1993-12#1)(2008-12#1)(2008-3#1)(2008-9#1)(2011-1#1)
several rare##2##2##(2007-4#1)(2008-10#1)
several rat##2##2##(1993-6#1)(1997-2#1)
several reactions##2##2##(1990-12#1)(2008-10#1)
several real##2##2##(2007-8#1)(2008-10#1)
several reasons##19##2##(1991-8#1)(1996-3#1)(1997-3#1)(2004-1#1)(2005-7#1)(2006-10#2)(2007-8#1)(2008-10#2)(2008-2#2)(2009-11#1)(2009-6#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
several recent studies have##4##4##(1997-7#1)(2006-10#1)(2008-7#1)(2009-10#1)
several recent studies##12##3##(1997-7#1)(2005-11#1)(2006-10#2)(2008-1#2)(2008-3#2)(2008-7#1)(2009-10#1)(2009-5#1)(2011-2#1)
several recent##24##2##(1996-5#1)(1997-7#1)(2005-11#1)(2006-10#5)(2006-9#1)(2007-10#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#2)(2009-5#1)(2011-2#1)
several recently developed##4##3##(1996-3#1)(2008-4#1)(2013-1#2)
several recently##5##2##(1996-3#1)(2008-4#1)(2008-7#1)(2013-1#2)
several receptors##2##2##(1991-8#1)(1994-8#1)
several recombinant##6##2##(1993-6#1)(1994-12#1)(1997-4#1)(2006-2#1)(2007-2#1)(2008-10#1)
several recommendations for##2##3##(1996-3#1)(2009-9#1)
several recommendations##5##2##(1996-3#1)(2007-2#1)(2008-9#1)(2009-9#1)(2012-1#1)
several reference##5##2##(1994-3#1)(2006-12#1)(2008-10#2)(2011-2#1)
several regions of the##4##4##(1992-9#1)(2008-10#1)(2008-11#1)(2008-4#1)
several regions of##8##3##(1992-9#1)(1993-11#1)(1993-9#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-4#1)
several regions##14##2##(1992-11#1)(1992-9#1)(1993-11#1)(1993-9#1)(1995-2#1)(1996-3#1)(1997-5#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-4#1)(2009-4#1)
several regulatory mechanisms##2##3##(1995-12#1)(2011-2#1)
several regulatory##7##2##(1991-9#1)(1995-12#1)(1996-12#1)(1997-7#1)(2005-8#1)(2011-2#1)(2012-1#1)
several related##5##2##(1990-12#1)(2007-4#1)(2008-4#1)(2008-7#1)(2012-3#1)
several relevant##2##2##(1995-2#1)(2007-9#1)
several renal##2##2##(2006-10#1)(2007-5#1)
several reports have##7##3##(1992-12#1)(1994-8#1)(1996-11#1)(2006-10#2)(2007-7#1)(2008-7#1)
several reports of##4##3##(2006-2#1)(2008-5#1)(2010-6#1)(2012-3#1)
several reports on##2##3##(1997-8#1)(2011-11#1)
several reports##24##2##(1992-12#1)(1993-12#1)(1994-8#1)(1996-11#1)(1997-8#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-6#2)(2011-11#1)(2011-2#2)(2012-3#1)
several representative##2##2##(1997-8#1)(2008-10#1)
several research groups##8##3##(1991-6#1)(1996-12#1)(2005-7#1)(2007-4#1)(2008-7#1)(2009-3#1)(2010-10#1)(2012-11#1)
several research##10##2##(1991-6#1)(1996-12#1)(2005-7#1)(2007-4#1)(2008-11#1)(2008-7#1)(2009-3#1)(2010-10#1)(2011-2#1)(2012-11#1)
several researchers##2##2##(2006-11#1)(2008-12#1)
several residues of##2##3##(1992-11#1)(1995-5#1)
several residues##8##2##(1991-4#1)(1992-11#1)(1993-6#1)(1995-2#1)(1995-5#1)(1997-1#1)(1997-9#1)(2006-12#1)
several resistance##2##2##(2008-10#1)(2008-11#1)
several respiratory##2##2##(2008-12#1)(2012-1#1)
several restriction##2##2##(1997-4#1)(2008-8#1)
several risk factors for##5##4##(2005-11#1)(2007-10#1)(2008-3#1)(2013-1#2)
several risk factors##8##3##(2005-11#1)(2007-10#1)(2007-8#1)(2008-3#1)(2011-2#1)(2013-1#3)
several risk##9##2##(2005-11#1)(2007-10#1)(2007-8#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#3)
several risks##2##2##(2012-3#1)(2013-1#1)
several river##2##2##(2008-10#2)
several root##2##2##(2006-5#1)(2008-10#1)
several rounds of##2##3##(1995-7#1)(2008-10#1)
several routes##4##2##(1992-11#1)(1996-8#1)(2008-11#1)(2008-5#1)
several samples##12##2##(1992-5#1)(2007-3#1)(2007-8#3)(2008-10#4)(2008-2#1)(2008-7#1)(2009-3#1)
several scales##3##2##(1990-5#1)(2008-10#1)(2008-7#1)
several scenarios##4##2##(2007-4#1)(2007-5#1)(2009-2#1)(2012-2#1)
several scientific##2##2##(2007-12#1)(2008-10#1)
several secondary##3##2##(1993-8#1)(2005-11#1)(2008-9#1)
several seconds##5##2##(1996-6#1)(2007-11#1)(2008-10#1)(2009-5#1)(2012-2#1)
several segments of##2##3##(2008-2#1)(2010-9#1)
several sensory##2##2##(1994-6#1)(2007-12#1)
several sequences of##2##3##(1990-5#1)(2008-8#1)
several sequences##6##2##(1990-5#1)(1991-11#1)(1994-8#1)(2008-8#1)(2012-12#1)(2012-3#1)
several series of##3##3##(2005-8#1)(2007-10#1)(2008-3#1)
several serine##2##2##(1995-10#1)(2009-4#1)
several serious##2##2##(2005-9#1)(2009-11#1)
several sessions of##2##3##(2010-12#1)(2011-12#1)
several sexual##3##2##(1994-2#1)(2008-5#1)(2013-1#1)
several shapes##2##2##(2007-9#1)(2008-2#1)
several short##3##2##(1992-11#1)(1993-3#1)(2008-8#1)
several shortcomings##2##2##(2008-8#1)(2012-1#1)
several side##2##2##(1991-2#1)(2007-10#1)
several significant##4##2##(2006-12#1)(2007-7#1)(2011-2#1)(2012-1#1)
several similar##2##2##(1992-6#1)(2008-10#1)
several similarities##3##2##(1991-4#1)(1997-8#1)(2011-2#1)
several simple##5##2##(2006-8#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)
several single##2##2##(2007-12#1)(2009-4#1)
several sites##8##2##(1993-6#1)(1994-2#1)(2007-11#1)(2007-2#1)(2007-5#2)(2008-8#1)(2008-9#1)
several sizes##3##2##(1993-4#1)(1993-9#1)(2008-10#1)
several skin##5##2##(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#2)
several small##7##2##(1990-1#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
several social##2##2##(2012-2#2)
several soil samples##3##3##(2006-12#1)(2008-10#2)
several soil##5##2##(2006-12#1)(2007-3#1)(2008-10#3)
several solid##3##2##(2008-10#2)(2008-5#1)
several sources of##5##3##(1990-2#1)(2008-1#1)(2008-10#1)(2008-8#1)(2012-1#1)
several sources##7##2##(1990-2#1)(2008-1#1)(2008-10#2)(2008-8#1)(2012-1#1)(2012-12#1)
several spatial##2##2##(2007-5#1)(2008-9#1)
several special##2##2##(1995-10#1)(2007-12#1)
several species are##2##3##(1996-7#1)(2011-2#1)
several species of primates##2##4##(1991-8#1)(1992-11#1)
several species of##15##3##(1990-3#1)(1991-8#1)(1992-11#1)(2007-3#1)(2008-10#6)(2008-5#1)(2008-7#1)(2009-5#1)(2010-2#1)(2012-3#1)
several species was##2##3##(1992-10#1)(1994-12#1)
several species with higher##2##4##(1997-2#1)(2008-5#1)
several species##34##2##(1990-2#1)(1990-3#1)(1991-1#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-6#1)(1994-12#1)(1995-1#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-8#2)(2005-10#1)(2007-3#2)(2008-10#9)(2008-5#2)(2008-7#1)(2009-5#1)(2009-6#1)(2010-2#1)(2011-2#1)(2012-3#1)
several specific##6##2##(1990-4#1)(1996-3#1)(2005-6#1)(2005-8#1)(2008-4#1)(2008-5#1)
several stages of##3##3##(1990-8#1)(1992-12#1)(2008-5#1)
several stages##8##2##(1990-8#1)(1992-12#1)(1995-6#1)(1996-2#1)(2008-5#1)(2010-8#1)(2010-9#1)(2013-1#1)
several staging systems have been developed##4##6##(2013-8#4)
several standardized##2##2##(2007-12#1)(2013-1#1)
several states##3##2##(2008-10#1)(2008-11#1)(2010-8#1)
several statistical##4##2##(1995-6#1)(2008-10#1)(2008-4#1)(2011-2#1)
several steps in the##2##4##(1995-2#1)(2008-5#1)
several steps of##4##3##(1994-10#1)(1994-8#1)(2008-3#1)(2008-8#1)
several steps##15##2##(1990-8#1)(1992-5#1)(1994-10#1)(1994-8#1)(1995-2#1)(2005-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#1)(2012-12#2)
several stimuli##3##2##(1995-12#1)(1995-6#1)(1995-8#1)
several strains of mice##2##4##(2008-12#1)(2008-4#1)
several strains of##11##3##(1994-12#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-9#2)
several strains##13##2##(1994-12#1)(2008-10#6)(2008-12#1)(2008-4#2)(2008-8#1)(2008-9#2)
several strategies for##2##3##(2008-7#1)(2012-3#1)
several strategies##5##2##(2007-11#1)(2008-10#1)(2008-7#1)(2009-3#1)(2012-3#1)
several structural and##2##3##(2006-10#1)(2010-5#1)
several structural features of##2##4##(1993-1#1)(1994-3#1)
several structural features##5##3##(1993-1#1)(1993-11#1)(1994-3#1)(1996-7#1)(1997-6#1)
several structural##12##2##(1993-1#1)(1993-11#1)(1994-3#1)(1994-8#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-6#1)(2006-10#2)(2008-10#1)(2010-5#1)
several structures##2##2##(1992-9#1)(2009-3#1)
several studies and##2##3##(2007-2#1)(2008-1#1)
several studies have demonstrated that##2##5##(1996-9#1)(2010-12#1)
several studies have demonstrated the##2##5##(1997-6#1)(2010-12#1)
several studies have demonstrated##5##4##(1996-9#1)(1997-6#1)(2008-3#1)(2010-12#2)
several studies have reported##6##4##(1996-7#1)(2006-2#1)(2008-1#1)(2011-2#1)(2013-1#2)
several studies have shown that##2##5##(1995-4#1)(2008-12#1)
several studies have shown##5##4##(1993-2#1)(1995-4#1)(2005-11#1)(2008-12#1)(2008-3#1)
several studies have suggested a##2##5##(2006-7#1)(2013-1#1)
several studies have##26##3##(1993-2#1)(1994-6#1)(1995-4#1)(1996-7#1)(1996-9#1)(1997-6#1)(2005-11#1)(2006-10#2)(2006-2#2)(2006-7#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#3)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#3)
several studies in##3##3##(1990-5#1)(2006-10#1)(2009-5#1)
several studies indicate##4##3##(1995-12#1)(2007-12#1)(2008-5#1)(2009-9#1)
several studies investigating the##2##4##(2012-2#1)(2013-1#1)
several studies suggest that##2##4##(2006-10#1)(2011-2#1)
several studies suggest##3##3##(2006-10#1)(2008-3#1)(2011-2#1)
several studies that##4##3##(2005-7#1)(2007-10#2)(2012-12#1)
several studies were##2##3##(2008-10#1)(2009-4#1)
several studies##81##2##(1990-5#1)(1990-6#1)(1992-10#1)(1993-12#1)(1993-2#1)(1994-6#1)(1995-12#1)(1995-4#1)(1996-7#1)(1996-9#1)(1997-6#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#7)(2006-2#2)(2006-5#1)(2006-7#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-9#1)(2010-12#3)(2010-5#1)(2010-7#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#2)(2012-4#1)(2013-1#4)(2013-8#4)
several substances##5##2##(2006-2#1)(2008-10#2)(2010-5#1)(2013-1#1)
several subtypes of##2##3##(2008-11#1)(2008-5#1)
several subtypes##5##2##(2008-11#1)(2008-5#2)(2010-6#1)(2012-2#1)
several successful##4##2##(2008-10#2)(2010-7#1)(2011-1#1)
several such##4##2##(2007-2#1)(2009-10#1)(2010-12#1)(2011-2#1)
several surgical##3##2##(2006-7#1)(2008-10#1)(2011-2#1)
several synthetic##14##2##(1993-12#1)(1994-9#1)(1996-9#1)(1997-8#1)(2004-11#1)(2008-10#8)(2008-3#1)
several systems##4##2##(1990-9#1)(1995-5#1)(2008-10#1)(2011-2#1)
several targets##2##2##(2008-1#1)(2008-2#1)
several taxa##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)
several technical##2##2##(1992-9#1)(2009-12#1)
several techniques to##2##3##(2006-10#1)(2008-1#1)
several techniques##13##2##(1992-12#1)(1992-9#1)(2006-10#1)(2006-5#1)(2007-12#2)(2008-1#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-9#1)(2010-8#1)
several tens of micrometers##2##4##(2008-1#1)(2008-2#1)
several tens of times##2##4##(2007-11#1)(2008-2#1)
several tens of##11##3##(2005-11#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#2)(2008-7#1)
several tens##12##2##(2005-11#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)
several test##4##2##(2006-11#1)(2008-10#1)(2009-10#1)(2013-7#1)
several tests##3##2##(1996-7#1)(1997-7#1)(2005-11#1)
several themes##2##2##(2009-4#1)(2010-8#1)
several theoretical##3##2##(2006-10#1)(2008-11#1)(2008-3#1)
several theories##4##2##(1995-3#1)(2010-6#1)(2013-1#2)
several therapeutic modalities##2##3##(2008-1#1)(2010-7#1)
several therapeutic options##2##3##(2008-5#1)(2013-1#1)
several therapeutic##9##2##(2007-11#1)(2008-1#2)(2008-10#1)(2008-5#1)(2009-4#1)(2010-5#1)(2010-7#1)(2013-1#1)
several therapies##4##2##(1993-2#1)(2009-7#1)(2010-12#1)(2012-2#1)
several thousand cells##2##3##(2008-9#1)(2011-1#1)
several thousand##14##2##(1990-1#1)(1991-9#1)(1995-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#1)
several thousands of##4##3##(2007-5#1)(2008-10#1)(2008-3#2)
several thromboembolic##2##2##(1990-9#1)(2006-10#1)
several time##7##2##(1991-9#1)(1995-12#1)(2007-9#1)(2008-10#2)(2008-7#1)(2011-1#1)
several times during##2##3##(1991-5#1)(1993-9#1)
several times greater##2##3##(1997-1#1)(2010-8#1)
several times in##2##3##(1992-12#1)(1996-5#1)
several times more##2##3##(1990-5#1)(2008-5#1)
several times per year##2##4##(2005-8#1)(2005-9#1)
several times per##3##3##(2005-8#1)(2005-9#1)(2010-6#1)
several times to##2##3##(2010-3#1)(2013-8#1)
several times##34##2##(1990-5#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-9#1)(1994-3#1)(1994-5#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
several tissues and##2##3##(2008-12#1)(2013-8#1)
several tissues##12##2##(1991-12#1)(1993-5#1)(1994-12#1)(1997-1#1)(2007-10#1)(2008-12#1)(2008-5#2)(2008-7#3)(2013-8#1)
several to##2##2##(2008-10#1)(2008-2#1)
several tools##3##2##(2005-5#1)(2008-10#1)(2008-4#1)
several toxic##2##2##(2006-10#1)(2006-2#1)
several trace##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
several traits##2##2##(2010-8#1)(2012-11#1)
several transcription factors##4##3##(1995-3#1)(2008-5#1)(2008-7#1)(2011-1#1)
several transcription initiation sites##2##4##(1991-4#1)(1996-5#1)
several transcription##6##2##(1991-4#1)(1995-3#1)(1996-5#1)(2008-5#1)(2008-7#1)(2011-1#1)
several transition##2##2##(1991-4#1)(2008-10#1)
several treatment options##2##3##(2011-1#1)(2013-1#1)
several treatments##2##2##(2006-6#1)(2012-2#1)
several tree species##2##3##(2008-3#1)(2008-5#1)
several trends##2##2##(1994-5#1)(1997-3#1)
several trials##8##2##(2006-10#2)(2007-11#1)(2008-11#1)(2008-7#1)(2009-6#1)(2011-12#1)(2013-8#1)
several tumor cell##2##3##(1990-11#1)(2007-12#1)
several tumor##6##2##(1990-11#1)(2007-12#1)(2009-3#1)(2011-1#1)(2013-1#1)(2013-8#1)
several tumour##3##2##(2008-7#2)(2013-1#1)
several types of cancer and##2##5##(2008-7#1)(2010-4#1)
several types of cancer##6##4##(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-12#1)(2010-4#1)
several types of##59##3##(1990-6#1)(1991-1#2)(1991-12#1)(1991-5#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-3#2)(1995-6#1)(1996-3#1)(1997-3#1)(2005-8#1)(2006-10#2)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#2)(2009-7#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2012-1#1)(2012-11#1)(2013-1#3)(2013-8#1)
several types##61##2##(1990-6#1)(1991-1#2)(1991-12#1)(1991-5#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-3#2)(1995-6#1)(1996-3#1)(1997-3#1)(2005-8#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#2)(2009-7#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2012-1#1)(2012-11#1)(2013-1#3)(2013-8#1)
several typical##3##2##(1993-2#1)(2009-5#1)(2012-3#1)
several unique characteristics##2##3##(1994-6#1)(2007-11#1)
several unique features##2##3##(2006-5#1)(2008-2#1)
several unique##10##2##(1990-3#1)(1991-4#1)(1994-6#1)(1996-12#1)(2006-5#1)(2007-11#1)(2008-2#1)(2008-4#2)(2013-1#1)
several universities##2##2##(1993-8#1)(2009-4#1)
several unknown##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2012-11#1)
several urine##2##2##(2008-10#2)
several variables that##3##3##(2006-1#1)(2009-5#1)(2009-8#1)
several variables##18##2##(1991-12#1)(1995-11#1)(1995-3#1)(1996-1#1)(1997-2#1)(1997-3#1)(2006-1#1)(2008-10#8)(2008-8#1)(2009-5#1)(2009-8#1)
several variants##4##2##(1992-7#1)(1996-9#1)(1997-2#1)(2008-2#1)
several varieties of##4##3##(1993-2#1)(2008-10#2)(2011-2#1)
several varieties##5##2##(1993-2#1)(2007-3#1)(2008-10#2)(2011-2#1)
several vascular##3##2##(2008-1#1)(2009-10#2)
several vectors##2##2##(1990-5#1)(2007-7#1)
several versions of##3##3##(2007-4#1)(2008-3#1)(2008-9#1)
several versions##4##2##(2007-4#1)(2008-3#2)(2008-9#1)
several very##2##2##(2005-8#2)
several viral##3##2##(1995-2#1)(2005-8#1)(2011-2#1)
several virulence##2##2##(2008-10#1)(2013-8#1)
several water samples with##2##4##(2007-8#1)(2008-10#1)
several water samples##3##3##(2007-8#1)(2008-10#2)
several water-soluble##2##2##(1990-9#1)(2008-10#1)
several ways in which##2##4##(1991-3#1)(2007-1#1)
several ways that##2##3##(2006-10#1)(2006-5#1)
several ways##17##2##(1990-8#1)(1991-3#3)(1996-3#1)(1996-6#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-2#1)(2011-1#1)
several weeks and##2##3##(2008-10#1)(2010-12#1)
several weeks to##3##3##(2006-10#1)(2006-11#1)(2008-10#1)
several weeks##32##2##(1990-11#1)(1992-2#1)(1993-3#2)(1994-3#1)(1996-11#1)(1996-5#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-2#1)
several well##2##2##(1993-5#1)(1994-8#1)
several widely##2##2##(1994-10#1)(2006-10#1)
several wild##2##2##(1990-5#1)(2008-10#1)
several with##2##2##(1991-10#1)(1997-1#1)
several years ago##3##3##(2005-12#1)(2008-10#1)(2012-1#1)
several years and##4##3##(2005-11#1)(2008-10#2)(2008-4#1)
several years as a##2##4##(1997-5#1)(2005-9#1)
several years before##2##3##(1997-6#1)(2012-2#1)
several years in##2##3##(2004-12#1)(2010-4#1)
several years later##3##3##(1997-7#1)(2008-4#1)(2013-1#1)
several years now##3##3##(2006-11#1)(2007-11#1)(2007-9#1)
several years of##7##3##(1995-11#1)(1995-6#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-3#1)
several years the##5##3##(2005-8#1)(2007-11#1)(2008-1#1)(2008-12#1)(2010-3#1)
several years there##2##3##(2006-10#1)(2008-9#1)
several years to##5##3##(1997-3#1)(2006-10#1)(2007-4#1)(2008-2#1)(2013-1#1)
several years with##2##3##(1993-11#1)(2012-12#1)
several years##113##2##(1990-3#1)(1991-1#1)(1991-12#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1993-11#1)(1993-2#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-10#1)(2004-12#1)(2005-11#2)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#6)(2006-11#2)(2006-5#1)(2006-8#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-4#4)(2007-7#1)(2007-9#5)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-12#1)(2009-3#2)(2010-10#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
several##5093##1##(1990-1#3)(1990-10#2)(1990-11#13)(1990-12#14)(1990-2#14)(1990-3#10)(1990-4#11)(1990-5#23)(1990-6#12)(1990-7#11)(1990-8#18)(1990-9#9)(1991-1#9)(1991-10#7)(1991-11#5)(1991-12#17)(1991-2#13)(1991-3#14)(1991-4#17)(1991-5#18)(1991-6#11)(1991-7#8)(1991-8#16)(1991-9#24)(1992-1#8)(1992-10#5)(1992-11#17)(1992-12#25)(1992-2#15)(1992-3#25)(1992-4#6)(1992-5#10)(1992-6#14)(1992-7#9)(1992-8#17)(1992-9#17)(1993-1#9)(1993-11#18)(1993-12#24)(1993-2#19)(1993-3#23)(1993-4#9)(1993-5#10)(1993-6#20)(1993-7#5)(1993-8#10)(1993-9#14)(1994-1#6)(1994-10#11)(1994-11#18)(1994-12#31)(1994-2#20)(1994-3#23)(1994-4#2)(1994-5#19)(1994-6#25)(1994-7#1)(1994-8#18)(1994-9#34)(1995-1#17)(1995-10#7)(1995-11#13)(1995-12#26)(1995-2#32)(1995-3#30)(1995-4#6)(1995-5#14)(1995-6#21)(1995-7#7)(1995-8#14)(1995-9#3)(1996-1#11)(1996-10#11)(1996-11#14)(1996-12#18)(1996-2#18)(1996-3#23)(1996-4#13)(1996-5#33)(1996-6#11)(1996-7#15)(1996-8#19)(1996-9#18)(1997-1#24)(1997-2#23)(1997-3#29)(1997-4#28)(1997-5#15)(1997-6#19)(1997-7#27)(1997-8#27)(1997-9#1)(2003-11#1)(2004-1#3)(2004-10#3)(2004-11#5)(2004-12#6)(2004-2#2)(2004-3#3)(2004-4#2)(2004-7#1)(2004-9#4)(2005-1#1)(2005-10#9)(2005-11#30)(2005-12#6)(2005-4#4)(2005-5#3)(2005-6#2)(2005-7#18)(2005-8#34)(2005-9#10)(2006-1#5)(2006-10#132)(2006-11#21)(2006-12#39)(2006-2#26)(2006-3#4)(2006-4#8)(2006-5#20)(2006-6#11)(2006-7#13)(2006-8#13)(2006-9#9)(2007-1#6)(2007-10#19)(2007-11#80)(2007-12#97)(2007-2#25)(2007-3#12)(2007-4#18)(2007-5#18)(2007-6#8)(2007-7#25)(2007-8#59)(2007-9#31)(2008-1#78)(2008-10#593)(2008-11#106)(2008-12#42)(2008-2#127)(2008-3#162)(2008-4#135)(2008-5#120)(2008-6#24)(2008-7#133)(2008-8#85)(2008-9#63)(2009-1#3)(2009-10#28)(2009-11#11)(2009-12#29)(2009-2#9)(2009-3#24)(2009-4#21)(2009-5#31)(2009-6#11)(2009-7#8)(2009-8#21)(2009-9#12)(2010-1#5)(2010-10#11)(2010-11#10)(2010-12#56)(2010-2#33)(2010-3#12)(2010-4#14)(2010-5#23)(2010-6#19)(2010-7#20)(2010-8#26)(2010-9#16)(2011-1#54)(2011-10#1)(2011-11#1)(2011-12#16)(2011-2#123)(2011-3#9)(2011-7#2)(2012-1#30)(2012-11#17)(2012-12#78)(2012-2#97)(2012-3#75)(2012-4#1)(2012-5#3)(2012-8#2)(2013-1#122)(2013-7#21)(2013-8#51)
several-fold higher##4##2##(1991-6#1)(1992-6#1)(2008-7#1)(2011-1#1)
several-fold##10##1##(1991-6#1)(1992-2#1)(1992-6#1)(1997-4#1)(1997-7#1)(2006-10#1)(2008-5#1)(2008-7#2)(2011-1#1)
severalfold##10##1##(1990-10#1)(1992-5#1)(1995-2#1)(1995-8#1)(1996-5#2)(1997-1#2)(2008-11#1)(2008-7#1)
severance of the##2##3##(2007-11#1)(2007-8#1)
severance of##3##2##(1997-4#1)(2007-11#1)(2007-8#1)
severance##4##1##(1996-3#1)(1997-4#1)(2007-11#1)(2007-8#1)
severe &quot##2##2##(1991-3#1)(1992-11#1)
severe (grade 3)##2##3##(2008-10#1)(2008-6#1)
severe (grade##3##2##(2008-10#2)(2008-6#1)
severe AAH##3##2##(2013-8#3)
severe AD##3##2##(2012-1#1)(2012-2#2)
severe CHF##2##2##(2005-12#1)(2008-5#1)
severe COPD##2##2##(2010-5#1)(2010-7#1)
severe Crohn's disease##4##3##(2009-6#1)(2009-8#1)(2012-2#2)
severe LV dysfunction##2##3##(2006-9#1)(2007-8#1)
severe PEM##3##2##(2008-2#3)
severe SLE##2##2##(2006-10#1)(2010-12#1)
severe VUR##2##2##(2012-11#2)
severe abdominal pain##4##3##(1993-10#1)(1995-7#1)(2011-2#1)(2013-8#1)
severe abdominal##6##2##(1990-6#1)(1992-8#1)(1993-10#1)(1995-7#1)(2011-2#1)(2013-8#1)
severe abnormalities in##2##3##(1990-8#2)
severe abnormalities##3##2##(1990-8#2)(1995-1#1)
severe abnormality##2##2##(2010-8#1)(2012-12#1)
severe acne##3##2##(2009-6#1)(2010-5#2)
severe acute asthma in black Africans##2##6##(1992-10#2)
severe acute asthma##7##3##(1992-10#3)(1992-3#1)(1997-1#1)(2007-2#1)(2008-8#1)
severe acute cholestatic hepatitis##3##4##(2010-5#3)
severe acute pancreatitis and##3##4##(2005-10#2)(2008-3#1)
severe acute pancreatitis has##3##4##(2008-3#2)(2012-12#1)
severe acute pancreatitis##21##3##(2005-10#3)(2006-10#2)(2006-6#1)(2008-3#6)(2009-8#2)(2012-12#3)(2013-1#3)(2013-8#1)
severe acute rejection##2##3##(1995-2#1)(2007-11#1)
severe acute respiratory syndrome (SARS)##4##5##(2008-10#1)(2008-5#1)(2008-7#1)(2010-2#1)
severe acute respiratory syndrome##12##4##(2005-10#1)(2007-12#2)(2008-10#1)(2008-5#3)(2008-7#2)(2009-5#1)(2010-2#1)(2011-1#1)
severe acute respiratory##13##3##(2005-10#1)(2007-12#2)(2008-10#1)(2008-5#3)(2008-7#2)(2009-5#1)(2009-7#1)(2010-2#1)(2011-1#1)
severe acute##66##2##(1990-12#1)(1992-10#3)(1992-3#1)(1995-2#1)(1996-8#1)(1997-1#1)(2005-10#4)(2006-10#2)(2006-12#1)(2006-4#1)(2006-6#2)(2006-7#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#6)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-2#1)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
severe adult respiratory##2##3##(2006-10#1)(2006-4#1)
severe adult##3##2##(2006-10#1)(2006-4#1)(2007-8#1)
severe adverse effects##11##3##(1991-12#1)(1992-10#1)(2006-8#2)(2007-11#2)(2008-7#2)(2008-9#1)(2012-2#2)
severe adverse events##2##3##(2007-9#1)(2011-2#1)
severe adverse reactions##3##3##(1994-3#1)(1996-1#1)(2012-3#1)
severe adverse##19##2##(1991-12#1)(1992-10#1)(1994-3#1)(1996-1#1)(1996-11#1)(2006-8#2)(2007-11#2)(2007-9#1)(2008-11#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-2#3)(2012-3#1)
severe airways##4##2##(2007-9#1)(2008-7#3)
severe allergic##4##2##(2007-11#1)(2008-5#1)(2010-1#1)(2010-6#1)
severe alopecia##4##2##(2007-7#2)(2007-8#2)
severe alterations##2##2##(2008-4#1)(2012-11#1)
severe among isolates grouped by markers with the##2##8##(2008-10#2)
severe anaemia##8##2##(2005-7#1)(2006-10#1)(2006-2#4)(2012-1#1)(2013-1#1)
severe and 2##2##3##(1993-5#1)(2007-2#1)
severe and complex##2##3##(2012-12#1)(2013-1#1)
severe and complicated##2##3##(1990-12#1)(2012-12#1)
severe and debilitating##2##3##(2007-11#1)(2008-5#1)
severe and irreversible##2##3##(2007-11#1)(2008-1#1)
severe and life-threatening##2##3##(1995-3#1)(2010-1#1)
severe and mild cases##2##4##(2010-12#2)
severe and mild##4##3##(1993-7#1)(1996-6#1)(2010-12#2)
severe and of##2##3##(2008-5#1)(2011-2#1)
severe and persistent mental illness (SPMI)##2##6##(2006-7#1)(2008-11#1)
severe and persistent mental illness##5##5##(2006-5#1)(2006-7#2)(2008-11#1)(2008-2#1)
severe and persistent mental illnesses##2##5##(2008-2#1)(2008-6#1)
severe and persistent mental##7##4##(2006-5#1)(2006-7#2)(2008-11#1)(2008-2#2)(2008-6#1)
severe and persistent##8##3##(1991-8#1)(2006-5#1)(2006-7#2)(2008-11#1)(2008-2#2)(2008-6#1)
severe and potentially##2##3##(1996-2#1)(2013-8#1)
severe and prolonged##2##3##(1994-11#1)(1996-10#1)
severe and refractory##3##3##(2006-10#1)(2006-4#1)(2012-11#1)
severe and sometimes fatal##2##4##(2006-5#1)(2008-11#1)
severe and sometimes##3##3##(1996-11#1)(2006-5#1)(2008-11#1)
severe and##79##2##(1990-12#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-8#1)(1992-9#1)(1993-5#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-3#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-2#2)(1997-8#1)(2005-10#2)(2005-11#1)(2006-10#2)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#2)(2007-11#4)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-10#3)(2009-6#1)(2010-1#1)(2010-12#4)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
severe anemia and##5##3##(1990-5#1)(2007-7#1)(2008-7#1)(2009-7#1)(2012-1#1)
severe anemia##18##2##(1990-5#1)(1991-5#1)(1992-3#1)(1994-5#1)(2006-10#1)(2007-12#2)(2007-7#1)(2008-7#1)(2009-7#1)(2010-11#1)(2010-12#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)
severe angina##2##2##(1991-3#1)(2007-8#1)
severe anxiety##3##2##(2006-10#1)(2008-6#1)(2012-11#1)
severe aortic regurgitation##10##3##(1997-5#1)(1997-8#4)(2007-8#4)(2008-11#1)
severe aortic stenosis##7##3##(2007-8#6)(2011-2#1)
severe aortic valve##2##3##(2007-8#1)(2009-5#1)
severe aortic##21##2##(1997-5#1)(1997-8#4)(2007-8#12)(2008-11#1)(2009-5#1)(2011-2#1)(2013-1#1)
severe aplastic anemia##3##3##(2007-8#1)(2012-3#2)
severe aplastic##4##2##(2007-8#1)(2009-2#1)(2012-3#2)
severe arch atheroma##3##3##(2008-8#3)
severe arrhythmias##2##2##(1991-3#1)(2009-5#1)
severe arthritis##2##2##(1996-10#1)(2006-10#1)
severe as##4##2##(1990-5#1)(2007-5#1)(2008-10#2)
severe asthma in##3##3##(2007-8#1)(2012-2#2)
severe asthma##17##2##(1993-5#1)(2005-8#1)(2006-2#1)(2007-8#4)(2008-11#3)(2008-3#2)(2008-5#1)(2010-5#1)(2012-2#2)(2013-8#1)
severe at higher##2##3##(2008-5#1)(2008-6#1)
severe at##4##2##(1995-11#1)(2007-9#1)(2008-5#1)(2008-6#1)
severe ataxia##3##2##(1990-8#1)(2008-11#1)(2008-9#1)
severe atheroma##2##2##(2007-8#1)(2008-8#1)
severe atherosclerotic##2##2##(2006-6#1)(2008-1#1)
severe atopic dermatitis##3##3##(2007-7#1)(2007-8#1)(2012-3#1)
severe auto-inflammatory disease##2##3##(2012-2#2)
severe back pain##7##3##(1993-9#1)(2006-8#1)(2007-8#2)(2009-3#1)(2011-2#1)(2012-12#1)
severe bacterial and fungal infections##2##5##(2013-1#2)
severe bacterial infections##5##3##(1993-2#1)(1993-6#1)(1995-9#1)(2007-11#1)(2007-5#1)
severe bacterial##7##2##(1993-2#1)(1993-6#1)(1995-9#1)(2007-11#1)(2007-5#1)(2013-1#2)
severe bilateral##3##2##(2007-2#1)(2011-2#1)(2013-8#1)
severe black##2##2##(2008-10#2)
severe bleeding##4##2##(1995-11#1)(2008-11#1)(2008-8#1)(2010-4#1)
severe bone##4##2##(2008-7#2)(2011-2#1)(2012-3#1)
severe brain##3##2##(1996-4#1)(2007-8#1)(2008-7#1)
severe burn##2##2##(2006-10#1)(2010-4#1)
severe burns##6##2##(2005-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#1)(2012-12#1)
severe but##3##2##(2007-8#1)(2008-1#1)(2010-12#1)
severe caloric restriction##2##3##(2013-7#2)
severe cancer pain##4##3##(2008-3#2)(2008-7#1)(2010-7#1)
severe cardiac failure##3##3##(2005-10#1)(2006-4#1)(2013-1#1)
severe cardiac##5##2##(2005-10#1)(2006-4#1)(2012-12#1)(2012-3#1)(2013-1#1)
severe cardiopulmonary##3##2##(2006-4#2)(2007-7#1)
severe cardiovascular##3##2##(1995-11#1)(1996-3#1)(2010-7#1)
severe carotid stenosis##2##3##(2007-9#1)(2008-8#1)
severe carotid##3##2##(2007-9#1)(2008-7#1)(2008-8#1)
severe case of##2##3##(2007-6#1)(2008-8#1)
severe case##3##2##(2007-6#1)(2008-8#1)(2013-1#1)
severe cases and##2##3##(2008-5#1)(2010-12#1)
severe cases of##10##3##(1993-5#1)(1993-6#1)(1995-5#1)(1996-3#1)(2007-12#1)(2008-5#2)(2011-2#1)(2013-8#2)
severe cases were##3##3##(2004-10#1)(2010-12#1)(2013-8#1)
severe cases##43##2##(1992-8#1)(1993-5#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-5#1)(1996-3#2)(1996-8#2)(2004-10#1)(2005-11#1)(2006-4#1)(2006-8#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#3)(2008-8#2)(2009-2#1)(2009-5#1)(2010-12#3)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#5)(2013-8#5)
severe cerebral##3##2##(2006-10#2)(2007-8#1)
severe cervical inflammation##2##3##(2007-2#2)
severe cervical##4##2##(2007-11#1)(2007-2#2)(2013-8#1)
severe challenge##2##2##(1996-12#1)(1997-6#1)
severe changes in the##2##4##(2008-8#1)(2008-9#1)
severe changes##3##2##(1990-9#1)(2008-8#1)(2008-9#1)
severe chest pain##3##3##(2007-8#1)(2013-1#1)(2013-7#1)
severe chest trauma##2##3##(2006-10#1)(2006-4#1)
severe chest##6##2##(2006-10#1)(2006-4#1)(2007-8#1)(2011-12#1)(2013-1#1)(2013-7#1)
severe childhood##5##2##(1995-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2009-11#1)
severe cholera##3##2##(2007-2#3)
severe cholestasis##2##2##(1996-6#1)(2013-1#1)
severe chronic obstructive pulmonary disease (COPD) patients##2##7##(1996-1#1)(2007-8#1)
severe chronic obstructive pulmonary disease##3##5##(1996-1#1)(2007-8#1)(2011-2#1)
severe chronic pancreatitis##3##3##(2006-10#1)(2008-3#1)(2008-6#1)
severe chronic##23##2##(1990-12#1)(1991-3#1)(1992-5#1)(1993-12#1)(1994-6#1)(1995-3#1)(1996-1#1)(2006-10#4)(2007-8#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-10#1)(2011-2#1)(2012-2#1)
severe clinical##9##2##(1991-3#1)(1992-5#1)(1997-1#1)(2006-7#1)(2008-2#1)(2008-5#1)(2012-2#1)(2013-1#1)(2013-7#1)
severe cognitive impairment##3##3##(2008-2#1)(2010-11#1)(2010-2#1)
severe cognitive##5##2##(2008-2#1)(2008-7#1)(2010-11#1)(2010-2#1)(2012-11#1)
severe colitis##3##2##(1992-9#1)(2009-5#1)(2010-12#1)
severe combined immunodeficiency (SCID) mice##2##5##(1995-8#1)(2008-4#1)
severe combined immunodeficiency (SCID)##4##4##(1995-8#1)(2007-2#1)(2008-4#2)
severe combined immunodeficiency##8##3##(1995-8#2)(1996-11#1)(1997-4#1)(2007-2#1)(2008-4#2)(2012-12#1)
severe combined immunodeficient (SCID)##2##4##(1994-2#1)(2008-4#1)
severe combined immunodeficient##4##3##(1994-2#2)(2008-11#1)(2008-4#1)
severe combined##12##2##(1994-2#2)(1995-8#2)(1996-11#1)(1997-4#1)(2007-2#1)(2008-11#1)(2008-4#3)(2012-12#1)
severe comorbidities##2##2##(2008-10#1)(2009-5#1)
severe complication##4##2##(2006-10#1)(2007-11#1)(2010-1#1)(2013-8#1)
severe complications and##3##3##(1992-9#1)(2010-8#1)(2011-2#1)
severe complications of##2##3##(2006-10#1)(2010-12#1)
severe complications##21##2##(1990-3#1)(1992-12#1)(1992-9#1)(1993-5#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2009-12#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#1)
severe condition##4##2##(1993-3#1)(2006-10#1)(2008-10#1)(2011-1#1)
severe conditions##3##2##(1996-6#1)(2007-12#1)(2010-12#1)
severe congenital neutropenia##4##3##(2008-7#3)(2011-1#1)
severe congenital##7##2##(2006-10#1)(2008-7#3)(2011-1#1)(2013-1#1)(2013-8#1)
severe consequences for##2##3##(2008-12#1)(2010-11#1)
severe consequences of##2##3##(1996-11#1)(1997-3#1)
severe consequences##7##2##(1996-11#1)(1997-3#1)(2006-10#1)(2008-12#1)(2010-11#1)(2012-12#2)
severe constipation##2##2##(1992-3#1)(1995-9#1)
severe coronary artery disease##5##4##(1991-10#1)(2008-8#1)(2011-2#3)
severe coronary artery##6##3##(1991-10#1)(2008-8#1)(2011-2#3)(2013-1#1)
severe coronary##8##2##(1991-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#3)(2013-1#1)
severe cortical lens opacification##2##4##(2006-8#2)
severe course of the disease##2##5##(1994-6#2)
severe curly top virus##2##4##(2008-10#2)
severe cutaneous##2##2##(2010-12#1)(2011-2#1)
severe damage to the##2##4##(2006-10#1)(2008-7#1)
severe damage to##4##3##(2006-10#1)(2007-9#1)(2008-10#1)(2008-7#1)
severe damage##8##2##(1992-10#1)(1996-5#1)(2006-10#1)(2006-9#1)(2007-9#1)(2008-10#2)(2008-7#1)
severe damages##3##2##(2008-10#1)(2009-6#1)(2011-1#1)
severe decubitus ulcers in a##2##5##(2007-7#2)
severe deficiency of##3##3##(1997-1#1)(2007-11#1)(2010-10#1)
severe deficits##3##2##(1994-12#1)(2007-9#1)(2009-4#1)
severe deformities##3##2##(2007-7#2)(2008-4#1)
severe degree##4##2##(1990-3#1)(2006-6#1)(2007-7#1)(2011-12#1)
severe dehydration##2##2##(2007-6#1)(2008-2#1)
severe dementia##3##2##(1991-11#1)(1994-11#1)(2008-6#1)
severe dental##2##2##(2009-11#1)(2009-8#1)
severe depression during##2##3##(2004-3#2)
severe depression##14##2##(2004-3#2)(2004-4#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-3#1)(2013-8#2)
severe depressive##3##2##(1995-5#1)(2006-6#1)(2012-3#1)
severe destruction of the##2##4##(2007-11#1)(2010-2#1)
severe destruction of##3##3##(1990-5#1)(2007-11#1)(2010-2#1)
severe diarrhea##3##2##(1993-2#1)(2008-4#1)(2011-2#1)
severe diarrhea-predominant irritable bowel syndrome##2##5##(2010-12#2)
severe diarrhoeal##2##2##(2007-2#1)(2008-2#1)
severe difficulties##2##2##(2008-4#1)(2009-4#1)
severe disabilities##3##2##(1993-3#1)(1996-1#1)(2007-8#1)
severe disability and##3##3##(1997-1#1)(2006-8#1)(2011-2#1)
severe disability##7##2##(1997-1#1)(2006-8#1)(2007-9#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-2#1)
severe disease and##4##3##(2008-10#1)(2011-2#2)(2013-1#1)
severe disease by##2##3##(2012-2#1)(2013-8#1)
severe disease in##4##3##(2008-10#1)(2010-12#1)(2011-1#1)(2011-2#1)
severe disease on##2##3##(2008-10#2)
severe disease with##4##3##(2006-4#1)(2010-12#1)(2013-1#2)
severe disease##48##2##(1990-8#1)(1992-10#1)(1996-10#1)(2005-7#1)(2006-10#4)(2006-2#2)(2006-4#1)(2006-6#1)(2007-11#5)(2007-9#1)(2008-10#7)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#6)(2012-2#2)(2013-1#5)(2013-8#3)
severe disruption of##2##3##(1992-7#1)(2007-9#1)
severe distortion of##2##3##(2008-3#1)(2008-6#1)
severe distortion##3##2##(2007-11#1)(2008-3#1)(2008-6#1)
severe drought##4##2##(2004-4#1)(2005-7#1)(2012-2#1)(2012-8#1)
severe due to the##2##4##(1991-9#1)(2009-3#1)
severe dysphagia##2##2##(1990-6#1)(2007-10#1)
severe dysplasia##3##2##(1992-8#2)(1993-8#1)
severe dyspnea##2##2##(2008-1#1)(2012-2#1)
severe early onset obesity##3##4##(2011-2#3)
severe early##5##2##(2006-8#1)(2011-2#4)
severe edema##2##2##(2007-9#1)(2010-8#1)
severe effects on##3##3##(1995-11#1)(2008-12#1)(2008-9#1)
severe emotional stress##2##3##(1991-5#1)(2007-6#1)
severe emotional##4##2##(1991-5#1)(2007-2#1)(2007-6#1)(2012-2#1)
severe endothelial##2##2##(2007-8#1)(2007-9#1)
severe enough to cause##3##4##(2007-11#1)(2007-9#1)(2010-12#1)
severe enough to require##2##4##(2008-1#1)(2012-2#1)
severe enough to##9##3##(1990-12#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-2#1)(2012-3#1)
severe enough##10##2##(1990-12#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-2#2)(2012-3#1)
severe environmental##4##2##(2005-10#1)(2008-10#1)(2008-12#1)(2013-8#1)
severe epidemics in##2##3##(2008-10#2)
severe epidemics of##2##3##(2008-10#2)
severe epidemics##10##2##(2008-10#10)
severe episodic##2##2##(1995-2#1)(2009-6#1)
severe erythema##2##2##(2006-12#1)(2007-8#1)
severe events##2##2##(1997-3#1)(2008-2#1)
severe exercise##3##2##(2008-1#1)(2008-4#1)(2008-5#1)
severe face##2##2##(2008-11#1)(2008-4#1)
severe facial trauma##2##3##(2006-4#1)(2008-5#1)
severe facial##4##2##(2006-4#1)(2008-5#1)(2008-9#1)(2012-12#1)
severe factor##2##2##(1992-2#1)(1992-5#1)
severe fibrosis (T4-T5)##2##3##(2013-8#2)
severe fibrosis##9##2##(2006-10#1)(2006-6#1)(2008-3#1)(2013-1#2)(2013-8#4)
severe food insecurity##8##3##(2011-1#8)
severe form of disease##2##4##(2013-1#2)
severe form of the disease##3##5##(2008-4#1)(2008-7#2)
severe form of##14##3##(1996-8#1)(1997-3#1)(2006-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-7#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#2)
severe form##20##2##(1995-9#1)(1996-8#1)(1997-3#1)(2006-2#1)(2006-6#2)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-7#1)(2011-1#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
severe forms of##10##3##(1990-9#1)(2006-2#1)(2007-7#1)(2008-12#1)(2008-5#2)(2009-5#1)(2013-1#1)(2013-8#2)
severe forms##15##2##(1990-9#1)(1996-3#1)(2005-10#1)(2006-2#1)(2007-10#1)(2007-7#1)(2008-12#1)(2008-4#1)(2008-5#2)(2009-5#1)(2010-12#1)(2013-1#1)(2013-8#2)
severe frontal impacts##2##3##(2007-4#2)
severe functional##3##2##(1991-6#1)(1995-2#1)(2009-10#1)
severe fungal##2##2##(1992-5#1)(2012-3#1)
severe gastrointestinal##3##2##(1990-10#1)(1996-2#1)(2007-7#1)
severe genetic##2##2##(1990-3#1)(1997-5#1)
severe gigantomastia##3##2##(2011-2#3)
severe grades##4##2##(2011-2#2)(2012-2#2)
severe growth hormone##2##3##(2006-1#1)(2008-3#1)
severe growth retardation and##2##4##(1995-2#1)(2006-9#1)
severe growth retardation##3##3##(1995-2#1)(2006-9#1)(2009-11#1)
severe growth##5##2##(1995-2#1)(2006-1#1)(2006-9#1)(2008-3#1)(2009-11#1)
severe haemoptysis##2##2##(1991-11#1)(1992-9#1)
severe haemorrhage##3##2##(1992-1#1)(2006-10#2)
severe hand##4##2##(2008-2#1)(2008-9#1)(2010-12#2)
severe head injury (GCS##2##4##(2008-7#2)
severe head injury##9##3##(2006-10#2)(2008-7#4)(2009-10#1)(2013-8#2)
severe head##11##2##(2006-10#3)(2007-4#1)(2008-7#4)(2009-10#1)(2013-8#2)
severe headache and##2##3##(1992-2#1)(2012-12#1)
severe headache##10##2##(1992-2#1)(1997-6#1)(2004-12#1)(2006-1#1)(2006-10#2)(2007-2#1)(2007-9#1)(2008-7#1)(2012-12#1)
severe headaches##2##2##(2004-12#1)(2006-8#1)
severe health##2##2##(2012-1#1)(2012-2#1)
severe heart failure is##2##4##(2005-10#1)(2007-8#1)
severe heart failure##11##3##(1992-6#2)(1995-6#1)(2005-10#2)(2007-7#1)(2007-8#2)(2008-4#1)(2010-5#1)(2011-2#1)
severe heart##12##2##(1992-6#2)(1995-6#1)(1997-8#1)(2005-10#2)(2007-7#1)(2007-8#2)(2008-4#1)(2010-5#1)(2011-2#1)
severe hemiparesis##2##2##(2008-5#1)(2012-1#1)
severe hemophilia A##3##3##(2012-12#1)(2012-2#2)
severe hemophilia##6##2##(1990-11#2)(2009-3#1)(2012-12#1)(2012-2#2)
severe hemorrhage##2##2##(1994-2#1)(2012-3#1)
severe hepatic##2##2##(2006-10#1)(2008-9#1)
severe histological##2##2##(1991-8#1)(2007-11#1)
severe homocyst(e)inemia##2##2##(1995-2#2)
severe hot##2##2##(2008-7#1)(2012-12#1)
severe human diseases##2##3##(2008-5#1)(2008-8#1)
severe human##5##2##(2007-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2013-8#1)
severe hydrocephalus##2##2##(2008-12#1)(2011-2#1)
severe hydronephrosis##3##2##(2007-10#1)(2008-4#2)
severe hyperammonemia##2##2##(1990-4#1)(2009-8#1)
severe hyperlipidemia##2##2##(2008-4#1)(2009-12#1)
severe hyperpyrexia##4##2##(2005-8#1)(2006-4#3)
severe hypertension group (group##2##4##(2008-1#2)
severe hypertension##17##2##(1990-12#1)(1991-2#3)(1991-6#1)(1993-8#1)(1995-11#1)(2005-7#1)(2006-9#1)(2008-1#2)(2009-5#1)(2010-7#1)(2011-2#3)(2013-8#1)
severe hypertonicity##2##2##(1996-3#2)
severe hypocalcaemia##2##2##(1997-8#2)
severe hypoglycemia##5##2##(2006-1#3)(2007-5#1)(2007-7#1)
severe hypokalemia##2##2##(1990-11#1)(2008-1#1)
severe hypospadias##4##2##(2006-10#2)(2008-1#1)(2009-5#1)
severe hypotension##8##2##(1990-12#1)(1990-8#2)(2006-1#1)(2008-4#1)(2013-1#3)
severe hypothermia##7##2##(1993-3#1)(1993-8#1)(2007-3#1)(2011-2#4)
severe hypothyroidism##4##2##(2011-1#4)
severe hypoxaemia##4##2##(1994-7#2)(2006-10#1)(2007-8#1)
severe hypoxemia##2##2##(1990-11#1)(2012-2#1)
severe hypoxia##4##2##(1994-5#1)(2006-10#1)(2006-4#2)
severe idiopathic pulmonary arterial hypertension##2##5##(2010-12#2)
severe idiopathic##4##2##(1992-5#1)(2007-6#1)(2010-12#2)
severe illness##8##2##(1990-6#1)(1993-5#1)(2005-10#1)(2005-6#1)(2005-8#1)(2007-12#1)(2010-4#1)(2011-2#1)
severe immunosuppression in##2##3##(1992-7#1)(2012-2#1)
severe immunosuppression##6##2##(1990-12#1)(1992-7#1)(2007-11#1)(2007-7#1)(2012-12#1)(2012-2#1)
severe impact on##2##3##(1992-11#1)(2008-8#1)
severe impairment of##4##3##(1990-9#1)(1995-6#1)(1996-1#1)(1997-7#1)
severe impairment##8##2##(1990-9#1)(1995-6#1)(1996-1#1)(1997-7#1)(2005-8#1)(2008-10#1)(2008-4#1)(2010-2#1)
severe impairments in##2##3##(1993-9#1)(1997-2#1)
severe impairments##3##2##(1993-3#1)(1993-9#1)(1997-2#1)
severe in the##15##3##(1990-3#1)(1990-7#1)(1992-11#1)(1993-4#1)(1994-6#1)(1994-8#1)(1996-5#3)(1997-8#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-5#1)(2011-12#1)
severe in##37##2##(1990-2#1)(1990-3#1)(1990-7#1)(1992-11#1)(1992-9#1)(1993-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-6#1)(1996-5#3)(1997-2#1)(1997-8#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-8#1)(2011-12#1)(2011-2#3)(2012-2#1)
severe infantile##2##2##(1996-3#1)(2010-12#1)
severe infection##5##2##(1997-6#1)(2008-5#1)(2008-8#1)(2011-12#2)
severe infections and##2##3##(2006-8#1)(2008-3#1)
severe infections in##2##3##(1993-5#1)(2008-5#1)
severe infections##16##2##(1993-5#1)(1994-5#1)(2005-8#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#2)(2008-3#2)(2008-5#1)(2009-4#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
severe infectious##3##2##(2007-11#1)(2011-2#2)
severe inflammation##3##2##(2004-9#1)(2008-2#1)(2010-9#1)
severe inflammatory##2##2##(2008-1#1)(2011-1#1)
severe injuries##3##2##(1993-11#1)(2007-4#1)(2012-11#1)
severe injury of##2##3##(2004-11#1)(2010-8#1)
severe injury to the##2##4##(2005-11#1)(2008-4#1)
severe injury##11##2##(1990-6#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-4#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-8#1)
severe insulin resistance##2##3##(1993-7#1)(1994-6#1)
severe interference##2##2##(2008-10#2)
severe interferences##2##2##(2008-10#2)
severe invasive##2##2##(2006-10#1)(2013-1#1)
severe involvement of##2##3##(1992-8#1)(2012-2#1)
severe ischemia##3##2##(1996-12#2)(1997-7#1)
severe ischemic injury##2##3##(2007-9#1)(2009-10#1)
severe kidney##2##2##(1996-11#1)(2009-5#1)
severe lactic acidosis##2##3##(2006-4#1)(2009-6#1)
severe left ventricular dysfunction##4##4##(1997-1#3)(2012-2#1)
severe left ventricular##6##3##(1997-1#3)(1997-3#1)(2012-2#1)(2013-1#1)
severe left##11##2##(1996-5#1)(1997-1#3)(1997-3#1)(2007-2#1)(2007-8#1)(2008-5#1)(2010-12#1)(2012-2#1)(2013-1#1)
severe lesions##10##2##(1992-10#2)(1992-6#2)(2006-8#1)(2007-8#1)(2007-9#1)(2008-5#1)(2009-5#1)(2010-12#1)
severe levels of##2##3##(1991-1#1)(2008-10#1)
severe levels##3##2##(1991-1#1)(1994-9#1)(2008-10#1)
severe limb ischemia##2##3##(2009-7#2)
severe limb##3##2##(1991-3#1)(2009-7#2)
severe limitations##3##2##(1991-9#1)(2006-10#1)(2008-2#1)
severe liver cirrhosis##2##3##(2013-8#2)
severe liver disease##4##3##(2006-10#2)(2006-2#1)(2008-12#1)
severe liver graft##2##3##(2013-7#2)
severe liver##11##2##(1994-6#1)(2004-11#1)(2006-10#2)(2006-2#1)(2008-12#2)(2013-7#2)(2013-8#2)
severe local##2##2##(2008-10#1)(2008-6#1)
severe loss of##7##3##(1991-3#1)(1995-12#1)(2007-1#1)(2008-1#2)(2010-12#1)(2011-1#1)
severe losses##3##2##(2008-10#3)
severe low##2##2##(2007-8#1)(2012-2#1)
severe lower##3##2##(1996-3#1)(2007-3#1)(2009-3#1)
severe lung##2##2##(2005-11#1)(2011-2#1)
severe lupus nephritis##3##3##(2007-7#2)(2008-1#1)
severe malaria in##3##3##(2007-2#2)(2012-12#1)
severe malaria##12##2##(1996-8#1)(2007-2#5)(2008-2#1)(2009-6#2)(2009-9#1)(2012-12#2)
severe malformations##2##2##(1990-8#1)(1993-5#1)
severe malnutrition in##2##3##(2006-2#1)(2013-1#1)
severe malnutrition##10##2##(2006-2#1)(2007-2#1)(2008-2#6)(2013-1#1)(2013-8#1)
severe manifestations of##2##3##(2005-11#1)(2008-6#1)
severe manifestations##3##2##(1996-12#1)(2005-11#1)(2008-6#1)
severe medical and##3##3##(2008-1#1)(2009-7#1)(2010-9#1)
severe medical##4##2##(2008-1#1)(2009-7#1)(2010-9#1)(2011-2#1)
severe mental disorders##7##3##(2008-2#7)
severe mental illness##18##3##(1992-5#1)(2006-5#2)(2008-2#6)(2008-6#1)(2010-8#2)(2010-9#2)(2011-1#3)(2012-2#1)
severe mental retardation##10##3##(1991-3#1)(1992-1#1)(1992-2#1)(1993-3#1)(1995-10#1)(1996-3#1)(1997-1#1)(2006-1#1)(2009-11#1)(2010-2#1)
severe mental##43##2##(1991-3#1)(1992-1#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-3#1)(1993-7#1)(1995-10#1)(1995-8#1)(1996-3#1)(1997-1#1)(2005-8#1)(2006-1#1)(2006-5#2)(2008-2#13)(2008-6#1)(2009-11#1)(2010-1#1)(2010-2#1)(2010-8#2)(2010-9#3)(2011-1#4)(2012-11#1)(2012-2#1)
severe metabolic##3##2##(1992-11#1)(2007-5#1)(2008-5#1)
severe microcephaly##2##2##(2010-9#1)(2012-12#1)
severe micrognathia##2##2##(1996-3#2)
severe middle##2##2##(2006-7#1)(2012-2#1)
severe mitral regurgitation and##4##4##(2007-8#2)(2010-5#1)(2012-12#1)
severe mitral regurgitation##7##3##(2007-8#2)(2007-9#2)(2008-4#1)(2010-5#1)(2012-12#1)
severe mitral stenosis##3##3##(2007-9#1)(2011-2#1)(2012-2#1)
severe mitral##12##2##(2007-8#2)(2007-9#4)(2008-4#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
severe morbidity in##2##3##(2006-9#1)(2012-2#1)
severe morbidity##6##2##(2006-10#1)(2006-2#1)(2006-9#1)(2007-2#1)(2007-8#1)(2012-2#1)
severe morphological##2##2##(1990-2#1)(2008-10#1)
severe motor##2##2##(1991-3#1)(2010-7#1)
severe mucositis##2##2##(2008-7#1)(2012-2#1)
severe myocardial##2##2##(2006-4#1)(2012-12#1)
severe necrosis and##2##3##(2004-4#1)(2010-8#1)
severe necrosis##5##2##(1992-9#1)(2004-4#1)(2007-7#1)(2010-8#1)(2013-8#1)
severe negative##2##2##(1995-6#1)(2013-1#1)
severe neglect##5##2##(1993-9#5)
severe neurologic##4##2##(2007-10#2)(2009-3#1)(2012-12#1)
severe neurological abnormalities##3##3##(2004-11#3)
severe neurological disease##3##3##(2006-10#1)(2007-11#1)(2007-2#1)
severe neurological disorder##2##3##(1992-5#1)(2012-12#1)
severe neurological symptoms##2##3##(1996-8#1)(2010-12#1)
severe neurological##19##2##(1991-2#1)(1992-5#1)(1992-7#1)(1996-11#1)(1996-8#1)(2004-11#3)(2005-12#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-7#1)(2010-12#1)(2012-12#2)
severe neuronal##2##2##(1990-2#1)(2012-2#1)
severe neuropsychiatric##2##2##(1993-11#1)(2010-11#1)
severe neutropenia and##2##3##(2008-10#1)(2008-5#1)
severe neutropenia that##2##3##(1996-12#1)(2008-11#1)
severe neutropenia##8##2##(1996-12#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#1)(2012-2#1)
severe obesity##7##2##(2006-8#6)(2008-12#1)
severe obstructive##3##2##(1990-3#1)(1996-5#1)(1997-3#1)
severe occipitalgia##2##2##(2007-12#2)
severe ocular surface disease##2##4##(2006-11#1)(2007-1#1)
severe ocular##3##2##(2006-11#1)(2007-1#1)(2011-2#1)
severe or recurrent##2##3##(2005-11#1)(2007-11#1)
severe or##12##2##(1990-4#1)(1995-12#1)(1995-5#1)(2005-11#1)(2007-11#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-4#1)(2009-5#1)(2010-2#1)(2011-1#1)
severe oral##4##2##(2007-11#1)(2012-2#1)(2013-1#2)
severe osteoporosis##2##2##(2008-8#1)(2013-1#1)
severe pain and##9##3##(1991-8#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-7#1)(2008-12#1)(2010-11#1)(2010-12#1)(2011-1#1)
severe pain but##2##3##(2008-7#1)(2013-1#1)
severe pain in##4##3##(2008-5#1)(2008-7#1)(2009-3#1)(2012-1#1)
severe pain on the left##2##5##(2007-8#1)(2012-3#1)
severe pain##33##2##(1991-8#1)(1993-10#1)(1993-5#1)(1996-7#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-12#1)(2008-5#1)(2008-7#3)(2009-3#2)(2010-11#1)(2010-12#3)(2011-1#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
severe pallor##2##2##(2007-2#1)(2012-2#1)
severe pancreatitis##6##2##(2006-10#1)(2006-7#2)(2007-5#1)(2007-8#1)(2008-7#1)
severe pancytopenia##4##2##(2006-10#2)(2010-11#1)(2012-3#1)
severe pelvic endometriosis##4##3##(1991-3#3)(2008-3#1)
severe pelvic##7##2##(1991-2#1)(1991-3#3)(2008-3#1)(2011-1#1)(2012-12#1)
severe performance##2##2##(2008-2#1)(2012-2#1)
severe periodontitis##6##2##(2006-2#1)(2008-10#5)
severe peripheral##3##2##(1992-8#1)(2006-10#1)(2006-8#1)
severe persistent asthma##3##3##(1996-7#1)(2010-5#1)(2011-2#1)
severe persistent##6##2##(1996-7#1)(2005-7#1)(2006-10#1)(2008-5#1)(2010-5#1)(2011-2#1)
severe personality pathology##2##3##(2006-8#2)
severe physical##3##2##(1997-1#1)(2007-11#1)(2010-11#1)
severe plucking##2##2##(1990-9#2)
severe pneumonia and##2##3##(1997-4#1)(2006-4#1)
severe pneumonia##4##2##(1997-4#1)(2006-4#1)(2010-11#1)(2011-2#1)
severe pre-capillary##2##2##(2010-10#2)
severe pre-eclampsia##4##2##(2006-10#2)(2011-1#1)(2011-12#1)
severe preeclampsia##9##2##(2004-10#1)(2007-10#3)(2008-11#1)(2009-1#1)(2012-2#3)
severe primary##4##2##(1992-11#1)(2007-8#1)(2009-5#1)(2011-3#1)
severe problems##4##2##(1990-5#1)(2007-10#1)(2008-10#1)(2009-11#1)
severe progressive##4##2##(1993-8#1)(1996-3#1)(2007-2#1)(2009-8#1)
severe pruritus in##2##3##(1993-3#1)(2007-2#1)
severe pruritus##4##2##(1993-3#1)(2005-10#1)(2007-2#1)(2010-6#1)
severe psoriasis##5##2##(1992-6#1)(2005-11#1)(2007-11#1)(2008-5#2)
severe psychiatric##4##2##(2006-4#1)(2008-6#1)(2008-9#1)(2011-3#1)
severe pulmonary artery##2##3##(1994-3#1)(2008-11#1)
severe pulmonary hypertension##8##3##(1993-8#1)(2006-10#2)(2007-9#1)(2008-10#1)(2010-10#1)(2010-6#1)(2012-3#1)
severe pulmonary##19##2##(1991-9#1)(1993-8#1)(1994-3#1)(2006-10#5)(2006-4#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-4#1)(2010-10#1)(2010-6#1)(2011-2#1)(2012-3#1)
severe reaction##2##2##(2008-8#1)(2012-2#1)
severe recurrent##4##2##(2006-1#1)(2006-10#1)(2007-11#1)(2012-2#1)
severe reduction of##2##3##(2007-8#1)(2008-10#1)
severe reflux##2##2##(2008-4#1)(2012-11#1)
severe refractory##7##2##(2007-11#1)(2010-12#1)(2010-5#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
severe renal insufficiency##3##3##(2007-11#1)(2008-4#1)(2013-1#1)
severe renal##11##2##(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-4#1)(2008-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
severe respiratory distress##7##3##(1992-2#1)(1994-6#1)(1996-6#1)(2006-4#1)(2007-12#1)(2013-1#2)
severe respiratory failure##5##3##(1996-12#1)(1997-3#1)(2006-10#1)(2012-2#2)
severe respiratory illness##2##3##(2008-8#1)(2012-12#1)
severe respiratory symptoms##2##3##(1997-5#2)
severe respiratory##23##2##(1991-8#1)(1992-2#1)(1994-6#3)(1996-12#1)(1996-6#1)(1997-3#1)(1997-5#2)(2006-10#1)(2006-4#1)(2007-12#1)(2008-8#1)(2010-9#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)
severe right##4##2##(2006-10#1)(2008-5#1)(2010-9#1)(2013-8#1)
severe rigidity and altered sensorium##2##5##(2009-11#2)
severe safety##2##2##(2008-10#1)(2010-12#1)
severe secondary##2##2##(1993-11#1)(2008-5#1)
severe sepsis (p##2##3##(2009-6#2)
severe sepsis and septic shock##7##5##(2007-7#1)(2008-12#1)(2009-9#1)(2011-2#4)
severe sepsis and##10##3##(2006-4#1)(2007-12#1)(2007-7#1)(2008-12#1)(2009-9#1)(2011-1#1)(2011-2#4)
severe sepsis in##4##3##(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
severe sepsis which##2##3##(2009-6#1)(2013-1#1)
severe sepsis##46##2##(2006-4#2)(2007-12#6)(2007-3#2)(2007-7#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-5#2)(2009-6#9)(2009-9#2)(2011-1#2)(2011-12#2)(2011-2#8)(2012-2#4)(2013-1#3)
severe septic shock##3##3##(1996-3#1)(2013-1#2)
severe septic##4##2##(1996-3#1)(2013-1#2)(2013-8#1)
severe sequelae##3##2##(2007-8#1)(2008-3#1)(2008-9#1)
severe side effects##6##3##(1992-8#1)(2004-2#1)(2005-11#1)(2006-10#2)(2006-6#1)
severe side##7##2##(1992-8#1)(2004-2#1)(2005-11#1)(2006-10#2)(2006-6#1)(2013-1#1)
severe side-effects##3##2##(2006-12#1)(2008-7#1)(2013-7#1)
severe signs##3##2##(1997-3#1)(2006-2#1)(2008-10#1)
severe skeletal changes##2##3##(1996-12#2)
severe skeletal##3##2##(1996-12#2)(2009-5#1)
severe skin##2##2##(1995-4#1)(2010-12#1)
severe social##2##2##(2006-3#1)(2010-12#1)
severe soft tissue##2##3##(1995-5#1)(2007-8#1)
severe spatial learning deficits##2##4##(1993-11#1)(1997-5#1)
severe state##2##2##(2007-7#1)(2013-7#1)
severe stenosis in the##2##4##(2007-10#1)(2007-8#1)
severe stenosis##4##2##(2006-2#1)(2007-10#1)(2007-8#1)(2013-1#1)
severe stenotic lesion##2##3##(2008-5#2)
severe strain of##2##3##(2008-10#2)
severe strain##4##2##(2008-10#4)
severe stroke##4##2##(2007-10#2)(2007-9#1)(2010-7#1)
severe strokes##2##2##(2007-10#1)(2007-9#1)
severe stromal##2##2##(2006-11#1)(2011-2#1)
severe stunting##2##2##(1990-12#1)(2008-10#1)
severe surgical##2##2##(1991-6#1)(2011-2#1)
severe symptom##3##2##(2006-10#1)(2008-10#1)(2008-7#1)
severe symptomatic##5##2##(2006-9#1)(2008-5#1)(2012-12#2)(2013-7#1)
severe symptoms and##4##3##(2007-2#1)(2008-10#1)(2010-6#1)(2012-2#1)
severe symptoms in##3##3##(2008-10#3)
severe symptoms of##3##3##(2006-9#1)(2013-1#2)
severe symptoms on##3##3##(2008-10#3)
severe symptoms##24##2##(1995-8#1)(1996-1#1)(2004-3#1)(2006-9#1)(2007-2#1)(2007-8#1)(2008-10#9)(2008-3#1)(2008-6#1)(2010-6#1)(2012-2#1)(2013-1#3)(2013-8#2)
severe systemic diseases##2##3##(1993-2#2)
severe systemic##8##2##(1993-2#2)(1996-11#1)(2006-10#2)(2006-8#1)(2007-2#1)(2011-1#1)
severe systolic##2##2##(2008-3#1)(2013-1#1)
severe than##17##2##(1992-10#1)(1996-12#1)(2004-10#1)(2006-11#1)(2007-11#1)(2007-3#2)(2007-4#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
severe thoracic##9##2##(1997-6#1)(2005-12#1)(2006-4#1)(2007-10#1)(2007-4#1)(2009-3#4)
severe throat pain##2##3##(2012-12#2)
severe thrombocytopenia##5##2##(1990-10#1)(1993-6#1)(2006-2#1)(2007-11#1)(2012-12#1)
severe tibial fractures##2##3##(2007-8#2)
severe to profound##2##3##(2008-9#2)
severe to##5##2##(1997-8#1)(2008-9#2)(2009-3#1)(2010-4#1)
severe toxic##2##2##(2008-1#1)(2011-2#1)
severe toxicity and##2##3##(1992-4#1)(2007-2#1)
severe toxicity to##2##3##(1991-1#1)(2008-7#1)
severe toxicity##13##2##(1990-10#1)(1990-12#1)(1991-1#1)(1992-4#2)(1994-11#1)(1997-8#1)(2006-4#1)(2006-6#1)(2007-2#1)(2008-12#1)(2008-7#1)(2010-8#1)
severe trauma and##2##3##(1991-4#1)(2007-11#1)
severe trauma##4##2##(1991-4#1)(2007-11#2)(2009-3#1)
severe traumatic brain injury##6##4##(2006-4#1)(2006-7#2)(2008-9#1)(2012-1#2)
severe traumatic injury##2##3##(2007-11#2)
severe traumatic##11##2##(2006-4#1)(2006-7#2)(2007-11#2)(2008-1#1)(2008-9#1)(2009-3#1)(2012-1#2)(2012-2#1)
severe tricuspid##2##2##(2007-8#1)(2007-9#1)
severe type of##4##3##(2007-8#1)(2008-7#1)(2012-12#1)(2013-1#1)
severe type##6##2##(1995-4#1)(2007-8#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#1)
severe ultrastructural alterations##2##3##(2008-10#1)(2012-11#1)
severe underlying pulmonary disease##2##4##(2007-7#1)(2010-6#1)
severe underlying##5##2##(2005-8#1)(2007-7#1)(2008-5#1)(2010-6#1)(2011-2#1)
severe upper##3##2##(1990-9#1)(2008-1#1)(2013-1#1)
severe valvular##4##2##(2007-8#1)(2008-4#1)(2011-2#1)(2013-1#1)
severe varicella##2##2##(2007-2#1)(2007-7#1)
severe ventricular##2##2##(1991-8#1)(1991-9#1)
severe victimization experiences##3##3##(2012-12#3)
severe viral disease##2##3##(2006-10#1)(2008-10#1)
severe vision loss##2##3##(2008-1#1)(2013-1#1)
severe visual##3##2##(2007-1#1)(2009-2#1)(2011-2#1)
severe vomiting##2##2##(1993-2#1)(1996-8#1)
severe weakness##3##2##(2004-11#1)(2005-10#1)(2012-3#1)
severe weight loss##3##3##(1996-9#1)(2005-12#1)(2011-1#1)
severe with##4##2##(2007-2#1)(2008-6#1)(2009-4#1)(2013-1#1)
severe withdrawal##2##2##(1991-12#2)
severe##2728##1##(1990-10#4)(1990-11#4)(1990-12#12)(1990-2#6)(1990-3#11)(1990-4#3)(1990-5#6)(1990-6#9)(1990-7#1)(1990-8#10)(1990-9#11)(1991-1#3)(1991-10#2)(1991-11#8)(1991-12#5)(1991-2#13)(1991-3#14)(1991-4#1)(1991-5#4)(1991-6#5)(1991-8#9)(1991-9#7)(1992-1#4)(1992-10#9)(1992-11#9)(1992-12#1)(1992-2#6)(1992-3#4)(1992-4#2)(1992-5#9)(1992-6#7)(1992-7#5)(1992-8#11)(1992-9#7)(1993-1#1)(1993-10#4)(1993-11#5)(1993-12#8)(1993-2#9)(1993-3#6)(1993-4#2)(1993-5#14)(1993-6#6)(1993-7#3)(1993-8#8)(1993-9#8)(1994-11#3)(1994-12#2)(1994-2#6)(1994-3#6)(1994-5#6)(1994-6#14)(1994-7#2)(1994-8#3)(1994-9#3)(1995-1#2)(1995-10#2)(1995-11#6)(1995-12#6)(1995-2#6)(1995-3#2)(1995-4#3)(1995-5#10)(1995-6#5)(1995-7#1)(1995-8#4)(1995-9#3)(1996-1#6)(1996-10#6)(1996-11#7)(1996-12#13)(1996-2#3)(1996-3#16)(1996-4#2)(1996-5#6)(1996-6#9)(1996-7#2)(1996-8#10)(1996-9#3)(1997-1#10)(1997-2#7)(1997-3#12)(1997-4#12)(1997-5#7)(1997-6#7)(1997-7#5)(1997-8#13)(2004-10#4)(2004-11#8)(2004-12#6)(2004-2#2)(2004-3#3)(2004-4#3)(2004-9#1)(2005-10#19)(2005-11#10)(2005-12#7)(2005-6#1)(2005-7#10)(2005-8#16)(2005-9#1)(2006-1#8)(2006-10#95)(2006-11#9)(2006-12#16)(2006-2#21)(2006-3#2)(2006-4#33)(2006-5#7)(2006-6#15)(2006-7#17)(2006-8#38)(2006-9#7)(2007-1#5)(2007-10#25)(2007-11#79)(2007-12#32)(2007-2#42)(2007-3#13)(2007-4#10)(2007-5#8)(2007-6#6)(2007-7#38)(2007-8#91)(2007-9#36)(2008-1#36)(2008-10#132)(2008-11#26)(2008-12#16)(2008-2#49)(2008-3#32)(2008-4#46)(2008-5#68)(2008-6#23)(2008-7#66)(2008-8#33)(2008-9#30)(2009-1#2)(2009-10#9)(2009-11#8)(2009-12#3)(2009-2#9)(2009-3#20)(2009-4#7)(2009-5#19)(2009-6#25)(2009-7#10)(2009-8#9)(2009-9#8)(2010-1#5)(2010-10#6)(2010-11#11)(2010-12#51)(2010-2#12)(2010-3#2)(2010-4#8)(2010-5#19)(2010-6#10)(2010-7#14)(2010-8#14)(2010-9#12)(2011-1#60)(2011-10#1)(2011-12#9)(2011-2#108)(2011-3#3)(2012-1#21)(2012-11#13)(2012-12#74)(2012-2#86)(2012-3#31)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#104)(2013-7#15)(2013-8#59)
severe)##2##1##(2007-10#1)(2012-11#1)
severe-to-profound##5##1##(2008-2#3)(2011-1#1)(2012-2#1)
severed axon##3##2##(1991-10#1)(1997-4#1)(2008-11#1)
severed##11##1##(1991-10#3)(1993-9#1)(1995-11#1)(1997-4#2)(2007-11#1)(2008-11#1)(2008-9#1)(2011-3#1)
severely active##2##2##(2006-10#1)(2008-3#1)
severely affect the##3##3##(2008-10#1)(2008-8#2)
severely affected by##7##3##(1995-9#1)(1997-6#1)(2005-8#1)(2007-10#1)(2008-10#2)(2012-2#1)
severely affected in##2##3##(1997-4#1)(2008-7#1)
severely affected patients##2##3##(2007-10#1)(2008-7#1)
severely affected son##2##3##(1996-12#2)
severely affected##34##2##(1991-6#1)(1992-10#1)(1995-9#1)(1996-12#3)(1996-2#3)(1997-4#1)(1997-6#1)(2005-11#1)(2005-7#1)(2005-8#1)(2007-10#3)(2008-10#7)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-2#1)
severely altered##2##2##(2006-11#1)(2007-3#1)
severely attenuated##2##2##(1995-3#1)(1997-7#1)
severely burned patients##2##3##(1993-2#1)(1997-3#1)
severely burned##5##2##(1993-2#1)(1997-3#1)(2005-9#1)(2008-5#2)
severely compromised in##2##3##(2011-2#1)(2012-12#1)
severely compromised##5##2##(2006-10#1)(2007-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
severely damaged by##2##3##(2008-10#2)
severely damaged cells##2##3##(2008-10#1)(2010-10#1)
severely damaged in the##2##4##(2007-7#1)(2008-8#1)
severely damaged in##3##3##(2007-7#1)(2008-10#1)(2008-8#1)
severely damaged##15##2##(1997-2#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-8#1)(2010-10#1)(2011-12#1)(2012-2#1)(2013-8#2)
severely debilitated##2##2##(1996-11#1)(2008-10#1)
severely decreased##3##2##(1992-9#2)(2007-9#1)
severely defective##2##2##(1990-11#1)(2009-8#1)
severely deficient in##2##3##(1990-5#1)(1995-1#1)
severely degraded##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2013-8#2)
severely depleted##2##2##(1995-3#1)(2008-8#1)
severely depressed##5##2##(1994-11#1)(2004-3#1)(2008-10#1)(2008-4#1)(2008-8#1)
severely deteriorate the##2##3##(2008-3#1)(2013-8#1)
severely disabled##4##2##(1992-12#1)(1995-1#1)(1997-3#1)(2007-7#1)
severely disabling##3##2##(1995-12#1)(2005-10#1)(2012-2#1)
severely diseased##3##2##(2008-10#3)
severely disrupt##2##2##(1992-10#1)(1993-3#1)
severely handicapped##3##2##(1990-5#1)(2004-11#1)(2008-1#1)
severely hypometabolic tissue##2##3##(1997-8#2)
severely ill patients##6##3##(2006-10#2)(2006-12#1)(2007-11#1)(2008-1#1)(2008-11#1)
severely ill##11##2##(1990-1#1)(1990-8#1)(1992-3#1)(2005-11#1)(2006-10#3)(2006-12#1)(2007-11#1)(2008-1#1)(2008-11#1)
severely immunocompromised##3##2##(1990-5#1)(1991-8#1)(2006-10#1)
severely impacted##2##2##(2011-2#1)(2013-1#1)
severely impaired in##5##3##(1990-4#1)(1994-10#1)(1994-12#1)(2007-8#1)(2008-1#1)
severely impaired##28##2##(1990-4#1)(1993-5#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-3#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-6#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#2)
severely impairs##3##2##(1995-6#1)(2007-3#1)(2008-8#1)
severely infected##3##2##(2008-10#2)(2010-4#1)
severely inhibited##8##2##(1991-12#1)(1993-8#1)(1994-8#1)(1996-9#1)(1997-7#1)(2007-10#1)(2009-6#1)(2011-12#1)
severely injured patients##3##3##(2006-10#1)(2007-11#1)(2012-1#1)
severely injured##7##2##(1992-9#1)(2006-10#1)(2007-11#1)(2007-5#1)(2009-9#2)(2012-1#1)
severely insulin resistant##2##3##(1993-7#1)(2008-3#1)
severely involved##2##2##(2006-10#1)(2012-2#1)
severely limit##3##2##(1997-2#1)(2006-10#1)(2008-10#1)
severely limited by the##6##4##(1996-2#1)(2008-3#1)(2010-11#1)(2011-1#1)(2013-1#2)
severely limited by##7##3##(1996-2#1)(2007-8#1)(2008-3#1)(2010-11#1)(2011-1#1)(2013-1#2)
severely limited##11##2##(1996-2#1)(2005-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2009-4#1)(2010-11#1)(2010-8#1)(2011-1#1)(2013-1#2)
severely limits the##2##3##(2007-12#1)(2008-3#1)
severely malnourished##3##2##(2007-12#1)(2007-7#1)(2008-2#1)
severely obese##4##2##(1993-2#1)(2006-2#1)(2011-2#1)(2013-1#1)
severely reduced by##2##3##(1996-8#1)(2008-3#1)
severely reduced##9##2##(1990-3#1)(1992-9#1)(1994-12#1)(1995-6#1)(1996-8#1)(2007-9#1)(2008-3#1)(2008-7#1)(2009-7#1)
severely reduces##2##2##(1991-3#1)(2007-8#1)
severely restrict##2##2##(1993-4#1)(2007-12#1)
severely restricted##3##2##(1996-11#1)(1997-8#1)(2008-2#1)
severely##325##1##(1990-1#1)(1990-11#2)(1990-3#1)(1990-4#1)(1990-5#5)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-10#2)(1992-12#1)(1992-3#2)(1992-9#4)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#3)(1994-1#1)(1994-10#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#3)(1995-5#2)(1995-6#3)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#6)(1996-3#2)(1996-8#2)(1996-9#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#3)(2004-11#2)(2004-3#1)(2004-8#1)(2005-10#1)(2005-11#3)(2005-7#3)(2005-8#1)(2005-9#1)(2006-10#12)(2006-11#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-1#2)(2007-10#4)(2007-11#7)(2007-12#3)(2007-3#3)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#6)(2007-9#3)(2008-1#6)(2008-10#36)(2008-11#4)(2008-12#1)(2008-2#7)(2008-3#14)(2008-4#4)(2008-5#5)(2008-7#5)(2008-8#9)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#2)(2010-10#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#5)(2011-12#3)(2011-2#5)(2012-1#4)(2012-12#5)(2012-2#6)(2012-3#2)(2013-1#6)(2013-8#8)
severely-affected##2##1##(1996-12#2)
severing activity##2##2##(1990-4#1)(1993-9#1)
severing of##3##2##(1991-3#1)(1994-12#2)
severing##9##1##(1990-4#1)(1991-3#1)(1993-9#1)(1994-12#4)(1994-2#1)(2009-2#1)
severities and##2##2##(2006-9#1)(2007-4#1)
severities of##9##2##(1996-6#1)(2008-10#1)(2008-7#1)(2008-9#4)(2010-12#2)
severities##23##1##(1996-6#1)(2006-11#2)(2006-9#1)(2007-11#1)(2007-4#2)(2008-10#5)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-4#1)(2010-12#2)(2012-2#1)
severity (P##3##2##(2008-10#3)
severity (i##4##2##(1997-3#1)(2008-10#3)
severity accurately##2##2##(2008-10#2)
severity after##3##2##(2008-10#3)
severity and a##2##3##(2008-10#1)(2013-1#1)
severity and change in persons with compulsive buying##2##8##(1996-8#2)
severity and change in##3##4##(1996-8#2)(2006-8#1)
severity and duration of##4##4##(2005-8#1)(2007-7#1)(2009-5#1)(2010-3#1)
severity and duration##5##3##(2005-8#1)(2007-7#1)(2008-7#1)(2009-5#1)(2010-3#1)
severity and extent of##2##4##(1990-12#1)(2013-1#1)
severity and frequency of##2##4##(1995-11#1)(2008-10#1)
severity and impact##2##3##(2008-10#1)(2008-12#1)
severity and outcome##4##3##(2007-10#3)(2011-2#1)
severity and pathogen population##3##4##(2008-10#3)
severity and pathogen##4##3##(2008-10#4)
severity and possible##2##3##(2006-10#1)(2012-3#1)
severity and soil##2##3##(2008-10#2)
severity and the##4##3##(2008-10#2)(2013-1#1)(2013-8#1)
severity and yield##2##3##(2008-10#2)
severity and##110##2##(1990-12#1)(1990-3#1)(1990-8#1)(1992-2#1)(1994-11#1)(1995-1#1)(1995-11#1)(1996-8#2)(1997-6#1)(1997-8#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-7#3)(2006-8#1)(2006-9#1)(2007-10#4)(2007-11#1)(2007-12#5)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#31)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-7#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
severity and/or##2##2##(2008-10#1)(2012-11#1)
severity are##4##2##(1990-8#1)(2007-12#1)(2007-9#1)(2008-10#1)
severity as a##2##3##(2006-11#1)(2008-10#1)
severity as##8##2##(1996-11#1)(2006-11#1)(2008-10#4)(2008-3#1)(2012-2#1)
severity assessment##3##2##(2006-2#1)(2012-1#2)
severity at##8##2##(2008-10#7)(2012-12#1)
severity based on##2##3##(2008-10#2)
severity between##3##2##(2008-10#3)
severity burnt area##3##3##(2013-8#3)
severity but was##2##3##(2008-7#1)(2011-2#1)
severity by##10##2##(2008-10#7)(2008-5#1)(2012-1#1)(2013-1#1)
severity can be##2##3##(2008-10#1)(2013-8#1)
severity can##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
severity caused by##2##3##(2008-10#2)
severity classes##2##2##(2008-10#2)
severity classifications##2##2##(2009-8#1)(2013-8#1)
severity compared with##4##3##(2008-10#4)
severity data##3##2##(1995-2#1)(2008-10#2)
severity decreased##2##2##(2008-10#2)
severity did not##2##3##(2008-10#1)(2013-1#1)
severity factor##4##2##(2013-8#4)
severity for##7##2##(2008-10#6)(2008-11#1)
severity from a##2##3##(2008-10#1)(2008-2#1)
severity from##8##2##(1995-10#1)(2004-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2010-9#1)
severity grading##2##2##(1992-2#1)(2005-10#1)
severity in a##2##3##(1996-12#1)(2013-8#1)
severity in the##5##3##(2008-10#3)(2010-11#1)(2013-1#1)
severity in##49##2##(1996-12#1)(2005-8#1)(2006-7#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#27)(2008-5#1)(2008-9#2)(2009-10#1)(2009-2#1)(2010-11#1)(2011-1#1)(2012-12#1)(2013-1#4)(2013-7#1)(2013-8#2)
severity increased##6##2##(2008-10#6)
severity index in##3##3##(2009-8#1)(2010-5#1)(2012-2#1)
severity index##13##2##(1990-12#1)(2008-10#6)(2009-8#1)(2010-5#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
severity indicated that##2##3##(2008-10#2)
severity is##7##2##(1990-9#1)(1997-5#1)(2006-8#1)(2007-1#1)(2008-5#1)(2012-1#1)(2012-12#1)
severity level##5##2##(2006-7#1)(2008-10#1)(2009-6#2)(2012-1#1)
severity levels and##2##3##(2012-12#2)
severity levels##8##2##(2007-2#5)(2010-8#1)(2012-12#2)
severity measures##2##2##(2008-10#1)(2008-8#1)
severity of AP##3##3##(2013-1#3)
severity of CAD##2##3##(2008-10#1)(2011-1#1)
severity of Fusarium wilt##4##4##(2008-10#4)
severity of Fusarium##6##3##(2008-10#6)
severity of Verticillium wilt##3##4##(2008-10#3)
severity of a##4##3##(2008-10#1)(2008-7#2)(2012-12#1)
severity of abuse##3##3##(1995-11#1)(2012-12#2)
severity of acute##9##3##(1992-10#1)(1995-9#1)(2006-10#2)(2007-11#1)(2007-7#2)(2010-7#1)(2012-2#1)
severity of airsacculitis##2##3##(2008-5#2)
severity of asthma are##2##4##(1993-2#2)
severity of asthma##6##3##(1993-2#2)(1997-1#1)(2007-11#1)(2007-6#1)(2010-8#1)
severity of atherosclerosis##4##3##(1991-9#2)(2007-8#1)(2008-1#1)
severity of burnt area in Huzhong forest region of##2##9##(2013-8#2)
severity of changes##2##3##(2007-11#2)
severity of chronic##3##3##(1997-6#1)(2007-8#1)(2011-2#1)
severity of clinical signs##2##4##(1997-6#1)(1997-8#1)
severity of clinical##5##3##(1997-6#1)(1997-8#2)(2010-11#1)(2010-12#1)
severity of cognitive impairment##2##4##(1996-3#1)(2008-2#1)
severity of cognitive##3##3##(1996-3#1)(2008-2#1)(2008-4#1)
severity of coronary artery disease##5##5##(1993-12#2)(1997-2#2)(2013-8#1)
severity of coronary artery lesions##3##5##(1993-12#2)(2008-3#1)
severity of coronary artery##9##4##(1991-2#1)(1993-12#4)(1997-2#2)(2008-3#1)(2013-8#1)
severity of dementia and##3##4##(1994-11#2)(2008-7#1)
severity of dementia##4##3##(1994-11#3)(2008-7#1)
severity of depression in mothers##2##5##(2011-2#2)
severity of depression##3##3##(1996-7#1)(2011-2#2)
severity of depressive symptoms##2##4##(1995-11#1)(2004-12#1)
severity of diabetes##2##3##(1993-12#1)(2008-1#1)
severity of disease##15##3##(1994-6#1)(1994-9#1)(1996-12#1)(1996-7#1)(2006-2#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-1#1)
severity of dystonia##2##3##(1996-3#1)(2008-7#1)
severity of each##2##3##(1997-8#1)(2011-2#1)
severity of episodes##2##3##(2006-10#1)(2010-12#1)
severity of fruit russet##2##4##(2008-10#2)
severity of hemodynamic##2##3##(1997-5#1)(2012-1#1)
severity of hepatocyte cytoplasmic vacuolization##2##5##(2008-9#2)
severity of his##2##3##(2006-4#2)
severity of hypertension in##3##4##(2007-7#2)(2013-1#1)
severity of hypertension##7##3##(1992-5#1)(2007-7#2)(2010-12#1)(2013-1#3)
severity of illness and##3##4##(1993-12#1)(1994-2#1)(1996-1#1)
severity of illness##19##3##(1992-3#1)(1993-12#3)(1994-12#2)(1994-2#1)(1995-2#1)(1995-9#1)(1996-1#1)(2005-8#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-8#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-2#1)
severity of impairment##2##3##(2009-9#2)
severity of infections##5##3##(1992-11#1)(2006-8#1)(2007-11#2)(2008-7#1)
severity of inflammation##2##3##(1997-1#1)(2008-4#1)
severity of injuries##3##3##(1992-2#1)(2007-11#1)(2008-2#1)
severity of injury##8##3##(1992-3#1)(1992-6#2)(2005-8#1)(2006-8#1)(2007-3#1)(2007-6#1)(2011-2#1)
severity of knee##3##3##(2006-10#2)(2007-4#1)
severity of lesions##4##3##(1991-8#2)(2005-7#1)(2008-5#1)
severity of liver disease##4##4##(1995-4#1)(1996-8#1)(2006-10#1)(2009-9#1)
severity of liver fibrosis in patients with chronic##2##8##(2006-6#1)(2013-1#1)
severity of liver##6##3##(1995-4#1)(1996-8#1)(2006-10#1)(2006-6#1)(2009-9#1)(2013-1#1)
severity of microbial##2##3##(1993-2#1)(2012-12#1)
severity of myocardial##2##3##(2008-6#1)(2008-7#1)
severity of neurologic deficits##2##4##(2008-3#2)
severity of neurological##5##3##(2005-1#1)(2007-9#1)(2008-3#1)(2008-4#2)
severity of other##2##3##(2008-7#1)(2013-7#1)
severity of pain##8##3##(2007-11#1)(2008-3#1)(2008-5#1)(2010-12#1)(2012-2#4)
severity of panicle##2##3##(2008-10#2)
severity of patients##2##3##(2013-1#1)(2013-8#1)
severity of poverty##2##3##(2007-7#2)
severity of psychopathology##2##3##(2009-10#1)(2013-1#1)
severity of soybean rust##3##4##(2008-10#3)
severity of spinal cord##3##4##(1992-6#1)(2006-2#1)(2007-11#1)
severity of spinal##4##3##(1992-6#1)(2006-2#1)(2007-11#2)
severity of stenosis##2##3##(2008-1#1)(2008-5#1)
severity of symptoms and##3##4##(2004-3#1)(2007-3#1)(2008-10#1)
severity of symptoms##14##3##(1990-9#1)(1993-9#1)(2004-3#1)(2007-3#1)(2008-10#5)(2008-6#1)(2008-7#1)(2011-2#2)(2012-2#1)
severity of the disease and##3##5##(2005-11#1)(2007-10#1)(2008-5#1)
severity of the disease in##4##5##(1990-9#1)(2008-10#2)(2011-2#1)
severity of the disease is##2##5##(2010-6#1)(2011-2#1)
severity of the disease##30##4##(1990-9#1)(1991-2#1)(1993-11#1)(1997-3#1)(1997-6#1)(2005-1#1)(2005-11#3)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
severity of the effects is##3##5##(1991-12#1)(1996-6#1)(1996-8#1)
severity of the effects##4##4##(1991-12#1)(1996-6#1)(1996-8#1)(2009-7#1)
severity of the inflammatory##2##4##(1993-1#1)(2006-10#1)
severity of the injury and##2##5##(2011-12#1)(2012-12#1)
severity of the injury##3##4##(2011-12#2)(2012-12#1)
severity of the lesions##3##4##(2006-10#1)(2008-4#1)(2008-5#1)
severity of the problem##2##4##(1997-7#1)(2007-11#1)
severity of the underlying disease##2##5##(2012-2#1)(2013-7#1)
severity of the##101##3##(1990-11#1)(1990-9#1)(1991-12#2)(1991-2#1)(1992-11#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-3#1)(1995-2#1)(1995-7#1)(1996-6#1)(1996-8#2)(1997-2#2)(1997-3#3)(1997-6#3)(1997-7#1)(2004-1#1)(2004-12#1)(2005-1#1)(2005-10#1)(2005-11#4)(2006-10#3)(2006-2#1)(2007-10#1)(2007-11#4)(2007-2#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#1)(2009-7#2)(2010-12#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-12#2)(2011-2#10)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#2)
severity of their##10##3##(1995-11#1)(2005-11#1)(2006-10#1)(2007-6#1)(2007-8#1)(2008-11#1)(2011-1#2)(2012-1#1)(2012-2#1)
severity of these##5##3##(1991-12#1)(2006-10#1)(2006-4#1)(2008-7#1)(2012-7#1)
severity of this##8##3##(1993-2#1)(2008-10#2)(2009-5#1)(2010-1#1)(2010-8#1)(2011-2#1)(2013-1#1)
severity of translation##2##3##(2011-2#2)
severity of underlying##2##3##(1995-9#1)(2008-7#1)
severity of##605##2##(1990-11#1)(1990-3#4)(1990-8#1)(1990-9#3)(1991-1#1)(1991-11#2)(1991-12#4)(1991-2#3)(1991-3#1)(1991-8#2)(1991-9#3)(1992-10#3)(1992-11#2)(1992-2#1)(1992-3#3)(1992-5#2)(1992-6#4)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#9)(1993-2#4)(1993-3#3)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#2)(1994-9#1)(1995-11#3)(1995-12#3)(1995-2#3)(1995-4#2)(1995-7#1)(1995-9#3)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-5#1)(1996-6#2)(1996-7#4)(1996-8#3)(1997-1#3)(1997-2#4)(1997-3#4)(1997-4#1)(1997-5#2)(1997-6#5)(1997-7#1)(1997-8#6)(2004-1#1)(2004-10#1)(2004-11#1)(2004-12#2)(2004-3#1)(2004-4#2)(2005-1#2)(2005-10#1)(2005-11#9)(2005-7#2)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#16)(2006-11#1)(2006-12#1)(2006-2#4)(2006-3#1)(2006-4#4)(2006-6#3)(2006-8#3)(2007-1#2)(2007-10#5)(2007-11#23)(2007-12#3)(2007-2#3)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#5)(2007-7#11)(2007-8#10)(2007-9#5)(2008-1#4)(2008-10#69)(2008-11#3)(2008-12#4)(2008-2#3)(2008-3#7)(2008-4#12)(2008-5#21)(2008-6#7)(2008-7#24)(2008-8#7)(2008-9#6)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#5)(2009-7#3)(2009-9#3)(2010-1#1)(2010-10#5)(2010-11#1)(2010-12#11)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#6)(2011-1#13)(2011-12#3)(2011-2#32)(2012-1#6)(2012-11#1)(2012-12#12)(2012-2#15)(2012-3#8)(2012-7#1)(2013-1#21)(2013-7#3)(2013-8#8)
severity on leaves and##2##4##(2008-10#1)(2011-12#1)
severity on the##6##3##(2008-10#4)(2010-6#1)(2012-2#1)
severity on##24##2##(1993-5#1)(1995-2#1)(2008-10#17)(2008-12#1)(2010-4#1)(2010-6#1)(2011-12#1)(2012-2#1)
severity or the##2##3##(1995-11#1)(2008-5#1)
severity or##11##2##(1990-5#1)(1991-6#1)(1995-11#1)(2006-3#1)(2007-11#1)(2008-10#3)(2008-5#1)(2010-12#1)(2012-3#1)
severity over##2##2##(1992-11#1)(2013-1#1)
severity ranging from##2##3##(2006-11#1)(2013-1#1)
severity rating scale##2##3##(2008-10#1)(2013-7#1)
severity ratings##4##2##(1990-5#1)(1997-3#1)(2008-10#1)(2009-8#1)
severity scale##2##2##(2007-10#1)(2008-10#1)
severity score##8##2##(1991-2#1)(1994-9#1)(2007-7#1)(2008-10#2)(2008-3#2)(2009-9#1)
severity scores for##2##3##(2010-1#2)
severity scores were##2##3##(2010-2#1)(2011-1#1)
severity scores##9##2##(1994-9#1)(2008-3#1)(2008-7#1)(2010-1#2)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#1)
severity scoring systems##2##3##(2006-10#1)(2006-7#1)
severity scoring##5##2##(1997-1#1)(2006-10#1)(2006-2#1)(2006-7#1)(2011-1#1)
severity showed##2##2##(2008-10#2)
severity significantly##3##2##(1993-12#1)(2008-10#2)
severity staging scores##2##3##(2008-9#2)
severity system##3##2##(1992-3#1)(1994-12#1)(1995-2#1)
severity than did plants##2##4##(2008-10#2)
severity than##6##2##(2007-11#1)(2008-10#4)(2010-2#1)
severity that##2##2##(2012-2#1)(2013-8#1)
severity to##5##2##(1992-3#1)(1993-9#1)(2009-4#1)(2013-1#1)(2013-8#1)
severity using##2##2##(2007-5#1)(2012-12#1)
severity values##4##2##(2008-10#4)
severity varied##2##2##(2008-10#2)
severity was assessed using the##2##5##(2005-7#1)(2007-10#1)
severity was assessed##3##3##(2005-7#1)(2007-10#1)(2008-10#1)
severity was associated with##2##4##(2008-10#1)(2013-8#1)
severity was estimated##3##3##(2008-10#2)(2008-6#1)
severity was measured by##2##4##(1997-5#1)(2013-1#1)
severity was reduced##3##3##(2008-10#3)
severity was significantly reduced##2##4##(2008-10#2)
severity was significantly##6##3##(1997-8#1)(2008-10#4)(2012-2#1)
severity was##49##2##(1996-12#1)(1997-1#1)(1997-5#1)(1997-8#1)(2005-7#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#34)(2008-6#2)(2008-7#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
severity were assessed##2##3##(2006-10#1)(2008-10#1)
severity were##14##2##(2006-10#1)(2006-7#1)(2008-10#11)(2013-1#1)
severity when##2##2##(2008-10#1)(2008-7#1)
severity with the##2##3##(2008-7#1)(2009-3#1)
severity with##6##2##(2008-10#1)(2008-7#1)(2009-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
severity within##2##2##(1992-3#1)(2006-3#1)
severity##1436##1##(1990-11#1)(1990-12#3)(1990-3#5)(1990-5#2)(1990-8#4)(1990-9#5)(1991-1#1)(1991-11#2)(1991-12#5)(1991-2#4)(1991-3#2)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#4)(1992-10#3)(1992-11#3)(1992-12#1)(1992-2#4)(1992-3#7)(1992-5#2)(1992-6#5)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#11)(1993-2#4)(1993-3#3)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#4)(1994-1#1)(1994-11#4)(1994-12#4)(1994-2#4)(1994-3#1)(1994-5#2)(1994-6#2)(1994-7#1)(1994-9#4)(1995-1#1)(1995-10#3)(1995-11#5)(1995-12#5)(1995-2#8)(1995-4#2)(1995-5#1)(1995-6#1)(1995-7#1)(1995-9#3)(1996-1#4)(1996-11#1)(1996-12#5)(1996-2#3)(1996-3#6)(1996-5#1)(1996-6#2)(1996-7#4)(1996-8#8)(1996-9#1)(1997-1#6)(1997-2#5)(1997-3#6)(1997-4#1)(1997-5#6)(1997-6#6)(1997-7#2)(1997-8#8)(2004-1#1)(2004-10#1)(2004-11#2)(2004-12#3)(2004-2#1)(2004-3#1)(2004-4#2)(2005-1#2)(2005-10#2)(2005-11#10)(2005-12#1)(2005-7#5)(2005-8#6)(2005-9#1)(2006-1#2)(2006-10#25)(2006-11#6)(2006-12#2)(2006-2#8)(2006-3#3)(2006-4#4)(2006-6#4)(2006-7#12)(2006-8#5)(2006-9#1)(2007-1#5)(2007-10#17)(2007-11#31)(2007-12#20)(2007-2#13)(2007-3#2)(2007-4#4)(2007-5#2)(2007-6#6)(2007-7#16)(2007-8#12)(2007-9#10)(2008-1#5)(2008-10#411)(2008-11#12)(2008-12#6)(2008-2#4)(2008-3#16)(2008-4#14)(2008-5#28)(2008-6#17)(2008-7#36)(2008-8#9)(2008-9#17)(2009-10#5)(2009-11#2)(2009-2#8)(2009-3#3)(2009-4#11)(2009-5#6)(2009-6#3)(2009-7#4)(2009-8#9)(2009-9#6)(2010-1#4)(2010-10#5)(2010-11#7)(2010-12#17)(2010-2#3)(2010-3#5)(2010-4#3)(2010-5#4)(2010-6#6)(2010-7#4)(2010-8#9)(2010-9#1)(2011-1#23)(2011-12#6)(2011-2#51)(2011-3#1)(2012-1#15)(2012-11#2)(2012-12#26)(2012-2#25)(2012-3#14)(2012-7#1)(2013-1#57)(2013-7#6)(2013-8#33)
severity) and##2##2##(2008-10#2)
severity) were##3##2##(2008-10#2)(2008-7#1)
severity)##9##1##(2008-10#8)(2008-7#1)
severity-adjusted data##2##2##(1995-2#1)(1997-1#1)
severity-adjusted##3##1##(1991-2#1)(1995-2#1)(1997-1#1)
severity-of-illness##2##1##(1994-1#1)(1996-9#1)
severs##3##1##(1993-9#1)(1994-12#1)(2009-10#1)
sevoflurane anaesthesia##3##2##(2006-10#3)
sevoflurane and desflurane##2##3##(2006-10#1)(2013-1#1)
sevoflurane and##10##2##(2006-10#1)(2007-9#3)(2008-10#1)(2011-12#1)(2012-12#2)(2013-1#1)(2013-8#1)
sevoflurane combined with N2O##3##4##(2007-2#3)
sevoflurane for##3##2##(2007-9#3)
sevoflurane in 100% O2##3##4##(2007-2#3)
sevoflurane in O2##2##3##(2007-2#2)
sevoflurane in##12##2##(2006-10#1)(2007-2#8)(2007-9#2)(2012-3#1)
sevoflurane or##2##2##(2007-2#2)
sevoflurane to##2##2##(2006-10#2)
sevoflurane##57##1##(2006-10#11)(2007-2#19)(2007-9#13)(2008-10#1)(2010-7#1)(2011-12#1)(2011-2#6)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
sevrage de la ventilation mécanique##2##5##(2013-1#2)
sevrage##5##1##(2013-1#5)
sewage and##7##2##(1992-6#1)(2006-3#1)(2007-2#1)(2007-5#1)(2009-12#1)(2009-6#1)(2013-8#1)
sewage effluent##3##2##(2007-5#1)(2008-10#2)
sewage management##2##2##(2008-3#2)
sewage samples##4##2##(2008-10#4)
sewage sludge amended soil##2##4##(2008-10#2)
sewage sludge production##2##3##(1997-4#2)
sewage sludge##26##2##(1997-4#12)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#4)(2008-2#1)
sewage sludges and##2##3##(2008-11#2)
sewage sludges##4##2##(2008-10#1)(2008-11#3)
sewage treatment facilities##2##3##(2008-1#1)(2008-10#1)
sewage treatment plant##4##3##(1992-6#1)(2007-12#2)(2008-12#1)
sewage treatment##10##2##(1992-6#2)(2007-12#3)(2008-1#1)(2008-10#1)(2008-12#1)(2013-1#2)
sewage water samples##2##3##(2007-8#1)(2008-10#1)
sewage##85##1##(1991-11#1)(1991-7#1)(1992-6#3)(1993-8#1)(1994-3#1)(1994-9#1)(1997-4#12)(2005-11#2)(2006-3#1)(2007-12#4)(2007-2#1)(2007-5#4)(2007-8#1)(2008-1#1)(2008-10#25)(2008-11#4)(2008-12#6)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2009-12#1)(2009-6#1)(2013-1#7)(2013-8#1)
sewn##4##1##(2004-9#2)(2007-8#2)
sex (P = 0##2##4##(2008-6#1)(2009-3#1)
sex (P =##4##3##(2007-10#2)(2008-6#1)(2009-3#1)
sex acts##4##2##(2012-3#3)(2013-1#1)
sex after##3##2##(1996-2#1)(2007-12#1)(2013-1#1)
sex allocation##11##2##(2008-8#8)(2008-9#3)
sex among##2##2##(2007-7#1)(2010-8#1)
sex and age in##2##4##(1995-12#1)(2011-2#1)
sex and age##23##3##(1990-11#1)(1991-6#1)(1992-2#1)(1993-1#1)(1993-9#1)(1994-6#1)(1995-12#1)(2005-10#1)(2006-2#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-6#2)(2011-1#1)(2011-2#5)(2012-2#1)(2013-1#2)
sex and body mass##2##4##(1996-3#1)(1997-2#1)
sex and ethnic groups##3##4##(2010-4#3)
sex and family history of##2##5##(2009-9#2)
sex and performance level##2##4##(2009-1#2)
sex and sexual risk behavior##2##5##(2010-5#2)
sex and the##4##3##(1993-12#1)(2008-7#1)(2009-11#1)(2010-8#1)
sex and##97##2##(1990-11#1)(1990-2#1)(1991-2#1)(1991-6#3)(1991-9#2)(1992-2#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-8#1)(1993-9#1)(1994-4#1)(1994-6#2)(1994-8#1)(1995-12#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-3#2)(1997-1#1)(1997-2#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#1)(2009-1#3)(2009-11#1)(2009-2#1)(2009-9#3)(2010-2#1)(2010-4#5)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#2)
sex are##2##2##(2007-12#1)(2011-2#1)
sex as##5##2##(2008-8#1)(2008-9#1)(2013-1#3)
sex at##2##2##(2012-3#1)(2013-1#1)
sex behavior##2##2##(2008-11#1)(2012-3#1)
sex behaviors##3##2##(2009-5#1)(2012-3#2)
sex biases in gene flow##2##5##(2009-2#2)
sex biases in##3##3##(1997-3#1)(2009-2#2)
sex biases##4##2##(1997-3#2)(2009-2#2)
sex by##3##2##(2007-12#1)(2010-3#1)(2013-1#1)
sex change##6##2##(2008-8#1)(2009-10#1)(2010-5#3)(2010-8#1)
sex chromosomal##4##2##(1990-3#1)(1993-10#1)(2013-1#2)
sex chromosome system##4##3##(2008-12#1)(2010-8#3)
sex chromosome systems##2##3##(2010-3#2)
sex chromosome##22##2##(1997-5#1)(2005-10#1)(2007-12#1)(2007-9#1)(2008-12#2)(2008-7#1)(2010-3#6)(2010-5#4)(2010-8#3)(2012-3#1)(2013-7#1)
sex chromosomes and the##2##4##(1995-11#1)(2010-3#1)
sex chromosomes and##5##3##(1995-11#2)(2010-3#3)
sex chromosomes are##2##3##(1990-11#1)(2012-2#1)
sex chromosomes in##2##3##(2005-10#1)(2010-3#1)
sex chromosomes of mammals##2##4##(1995-11#1)(2010-3#1)
sex chromosomes of##3##3##(1995-11#1)(2008-5#1)(2010-3#1)
sex chromosomes was##3##3##(1990-11#1)(2008-12#1)(2012-1#1)
sex chromosomes##43##2##(1990-11#4)(1995-11#4)(1997-5#2)(2005-10#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2010-3#17)(2010-5#3)(2010-8#1)(2012-1#1)(2012-2#1)
sex concordance and##2##3##(1995-11#2)
sex cord##3##2##(2010-9#2)(2013-8#1)
sex crimes in##2##3##(2008-11#1)(2008-7#1)
sex crimes##3##2##(2008-11#1)(2008-7#2)
sex determination (GSD)##2##3##(1995-11#1)(2010-3#1)
sex determination and dosage compensation##2##5##(2007-12#2)
sex determination and##4##3##(1995-11#1)(2007-12#2)(2012-2#1)
sex determination from##2##3##(1996-6#1)(2012-12#1)
sex determination in##2##3##(1995-11#1)(2010-3#1)
sex determination is##3##3##(1995-11#1)(2007-12#2)
sex determination or##2##3##(2008-4#1)(2010-5#1)
sex determination##59##2##(1990-11#3)(1994-7#1)(1995-11#9)(1996-6#2)(1997-5#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-12#11)(2007-5#1)(2008-4#2)(2008-5#2)(2008-8#2)(2010-3#15)(2010-5#1)(2012-12#5)(2012-2#1)
sex determining##5##2##(1995-11#3)(2010-3#2)
sex did not##2##3##(1991-10#1)(2009-6#1)
sex difference in the##4##4##(1990-4#2)(2008-9#1)(2010-6#1)
sex difference in##11##3##(1990-4#2)(1993-2#1)(1993-4#3)(1994-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-6#1)
sex difference##15##2##(1990-4#2)(1991-10#1)(1993-11#1)(1993-2#2)(1993-4#3)(1994-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-6#1)(2011-2#1)
sex differences and similarities##3##4##(2008-7#2)(2009-7#1)
sex differences and##4##3##(1994-8#1)(2008-7#2)(2009-7#1)
sex differences in depressive symptoms and delinquent behavior##2##8##(2009-7#2)
sex differences in immune##3##4##(2008-8#1)(2008-9#2)
sex differences in striatal##2##4##(1993-4#2)
sex differences in the##3##4##(1990-4#1)(1997-7#1)(2006-10#1)
sex differences in##36##3##(1990-4#1)(1993-12#1)(1993-4#4)(1996-1#2)(1996-12#1)(1996-5#2)(1997-5#2)(1997-7#1)(2006-10#1)(2006-3#1)(2007-12#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-8#4)(2008-9#6)(2009-7#2)(2012-1#1)(2012-12#1)
sex differences were##4##3##(1994-2#1)(2008-12#1)(2008-7#2)
sex differences##59##2##(1990-4#1)(1991-3#1)(1993-12#1)(1993-4#4)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-7#1)(1996-1#2)(1996-12#2)(1996-5#3)(1997-3#1)(1997-5#2)(1997-7#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#5)(2008-8#4)(2008-9#6)(2009-1#1)(2009-4#1)(2009-7#3)(2012-1#1)(2012-11#2)(2012-12#1)(2012-3#1)
sex differentiation in##2##3##(1995-11#1)(2008-5#1)
sex differentiation of dopaminergic neurons##2##5##(1996-5#2)
sex differentiation of##3##3##(1995-3#1)(1996-5#2)
sex differentiation##9##2##(1995-11#1)(1995-3#1)(1996-5#2)(2008-5#2)(2010-5#2)(2012-3#1)
sex discrimination##2##2##(1996-6#1)(2006-3#1)
sex distribution was##2##3##(1990-8#1)(2007-10#1)
sex distribution##11##2##(1990-8#1)(1991-6#1)(1991-7#1)(1996-1#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-7#1)(2010-12#1)(2011-1#2)
sex drive##2##2##(1997-6#1)(2008-6#1)
sex during##2##2##(1994-7#1)(2010-7#1)
sex education in##2##3##(1993-8#1)(2007-7#1)
sex education##10##2##(1990-9#1)(1991-1#1)(1992-2#1)(1993-8#1)(1995-12#1)(2006-7#1)(2007-6#1)(2007-7#2)(2012-3#1)
sex for##5##2##(1995-5#1)(2007-3#2)(2008-1#1)(2008-4#1)
sex from the##2##3##(1995-6#1)(2012-12#1)
sex from##3##2##(1995-6#2)(2012-12#1)
sex glands##2##2##(2008-10#2)
sex glandular##2##2##(2008-10#2)
sex hormone binding globulin (SHBG)##5##5##(1990-11#1)(1990-4#1)(2007-7#1)(2008-3#1)(2011-2#1)
sex hormone binding globulin##7##4##(1990-11#1)(1990-4#1)(2006-1#1)(2006-8#1)(2007-7#1)(2008-3#1)(2011-2#1)
sex hormone##12##2##(1990-11#1)(1990-4#1)(2006-1#1)(2006-8#2)(2007-1#1)(2007-7#1)(2008-10#1)(2008-3#2)(2011-2#1)(2012-2#1)
sex hormone-binding globulin (SHBG)##2##4##(2008-3#2)
sex hormone-binding globulin##6##3##(1990-2#1)(1990-9#1)(1995-1#1)(2008-3#3)
sex hormone-binding##7##2##(1990-2#1)(1990-9#2)(1995-1#1)(2008-3#3)
sex hormone-dependent##5##2##(2007-6#1)(2008-11#2)(2010-12#2)
sex hormones and##3##3##(1993-5#1)(2008-11#1)(2009-4#1)
sex hormones in##4##3##(1996-4#1)(2006-9#1)(2007-1#1)(2011-2#1)
sex hormones on##4##3##(1993-5#1)(1996-4#2)(2007-9#1)
sex hormones were##2##3##(1993-5#1)(2007-1#1)
sex hormones##33##2##(1991-12#1)(1992-5#1)(1993-5#5)(1994-3#1)(1996-4#4)(1997-5#1)(2006-8#1)(2006-9#1)(2007-1#4)(2007-9#2)(2008-11#2)(2008-7#3)(2009-4#1)(2010-12#1)(2010-5#1)(2010-6#2)(2011-2#1)(2012-2#1)
sex in places of##2##4##(2012-3#2)
sex in the context of relationships##2##6##(2013-1#2)
sex in the context of##3##5##(2006-7#1)(2013-1#2)
sex in the##5##3##(2006-4#1)(2006-7#1)(2012-3#1)(2013-1#2)
sex in##19##2##(1990-11#1)(1991-6#1)(1993-1#1)(1997-7#1)(2006-10#1)(2006-4#1)(2006-7#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-3#3)(2013-1#2)
sex incidence##2##2##(2007-8#2)
sex is determined##2##3##(1995-11#1)(2007-12#1)
sex is##7##2##(1992-7#1)(1995-11#1)(1997-7#1)(2007-12#1)(2008-5#1)(2009-2#1)(2012-3#1)
sex life##2##2##(2004-10#1)(2008-4#1)
sex linkage of##2##3##(2012-3#2)
sex linked##2##2##(2008-4#1)(2008-9#1)
sex of patients##2##3##(1991-8#1)(2008-1#1)
sex of the patient##2##4##(2008-1#1)(2009-2#1)
sex of the##9##3##(1994-7#1)(2005-10#1)(2007-2#1)(2008-1#1)(2008-5#2)(2009-11#1)(2009-2#1)(2013-8#1)
sex of##19##2##(1991-8#2)(1994-7#3)(1996-5#1)(2005-10#1)(2007-2#1)(2008-1#2)(2008-4#1)(2008-5#2)(2008-8#1)(2009-11#1)(2009-2#1)(2011-12#1)(2013-1#1)(2013-8#1)
sex on the prevalence of##2##5##(2006-12#1)(2010-4#1)
sex on the##6##3##(1996-5#1)(2006-12#1)(2008-7#1)(2009-2#1)(2010-4#2)
sex on##15##2##(1991-3#1)(1994-7#1)(1996-5#1)(1997-7#1)(2006-12#1)(2008-5#1)(2008-7#1)(2009-2#2)(2010-2#1)(2010-4#2)(2010-6#1)(2012-12#1)(2013-7#1)
sex or age##5##3##(1996-1#1)(2004-12#1)(2006-12#1)(2009-9#1)(2013-8#1)
sex or##13##2##(1990-4#1)(1991-6#1)(1994-8#1)(1995-3#1)(1996-1#1)(2004-12#1)(2006-12#1)(2007-7#1)(2007-9#1)(2008-5#1)(2009-9#2)(2013-8#1)
sex organs##2##2##(1991-5#1)(2008-4#1)
sex partners and##5##3##(2009-4#3)(2011-1#2)
sex partners are also related to##2##6##(2009-4#2)
sex partners in the past##3##5##(2007-12#1)(2012-12#1)(2013-1#1)
sex partners in the##4##4##(2007-12#1)(2012-12#2)(2013-1#1)
sex partners in##5##3##(1994-12#1)(2007-12#1)(2012-12#2)(2013-1#1)
sex partners##30##2##(1992-2#1)(1993-6#1)(1994-12#1)(1996-4#1)(2007-12#1)(2008-10#1)(2008-12#3)(2009-4#6)(2009-5#3)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#2)
sex pheromone components##3##3##(2008-10#3)
sex pheromone gland##2##3##(2008-10#2)
sex pheromone glands of Lutzomyia cruzi male sand flies (Diptera##2##10##(2007-12#2)
sex pheromone glands##3##3##(2007-12#3)
sex pheromone in##2##3##(2008-10#1)(2011-2#1)
sex pheromone of the##2##4##(2007-11#1)(2008-10#1)
sex pheromone of##3##3##(2007-11#1)(2008-10#2)
sex pheromone##23##2##(1990-8#1)(1992-1#1)(1992-7#1)(1995-1#3)(2007-11#1)(2007-12#4)(2008-10#10)(2011-2#1)(2013-8#1)
sex pheromones##3##2##(1990-8#1)(2007-12#1)(2008-10#1)
sex predominance##2##2##(2008-3#1)(2008-6#1)
sex ratio =##2##3##(1990-4#2)
sex ratio distortion##3##3##(2008-8#3)
sex ratio in##3##3##(1991-11#1)(2006-12#1)(2007-11#1)
sex ratio of the##2##4##(1997-7#1)(2004-4#1)
sex ratio of##5##3##(1990-3#1)(1990-4#1)(1997-7#1)(2004-4#1)(2007-2#1)
sex ratio was 1##2##4##(2007-3#1)(2008-5#1)
sex ratio was##8##3##(2006-8#1)(2007-3#1)(2007-8#1)(2008-5#2)(2008-7#1)(2010-8#1)(2012-12#1)
sex ratio##59##2##(1990-3#1)(1990-4#5)(1991-11#1)(1991-8#1)(1993-5#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-4#1)(2006-10#3)(2006-12#1)(2006-8#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#18)(2008-9#7)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)
sex ratios of##4##3##(1997-7#1)(2006-10#1)(2010-8#1)(2011-2#1)
sex ratios##16##2##(1990-4#1)(1997-7#1)(2006-10#2)(2008-8#2)(2008-9#3)(2010-3#1)(2010-8#2)(2011-2#4)
sex regulatory##2##2##(2007-12#2)
sex related##4##2##(1994-2#1)(2008-7#1)(2011-12#1)(2012-3#1)
sex reversal and campomelic dysplasia##2##5##(1995-11#2)
sex reversal in##2##3##(1993-2#1)(1995-11#1)
sex reversal##15##2##(1990-11#2)(1991-11#1)(1993-2#1)(1995-11#9)(2008-4#1)(2008-5#1)
sex reversed campomelic##2##3##(1995-11#2)
sex specific##4##2##(1995-8#1)(2006-10#1)(2007-10#1)(2009-3#1)
sex steroid binding protein##2##4##(1992-5#1)(1996-4#1)
sex steroid hormones##6##3##(1990-9#2)(2010-10#1)(2010-8#3)
sex steroid receptors##2##3##(2006-5#1)(2010-12#1)
sex steroid synthesis##2##3##(2008-5#1)(2011-2#1)
sex steroid##19##2##(1990-11#1)(1990-9#2)(1992-5#1)(1996-4#2)(1996-5#1)(2006-5#1)(2008-3#1)(2008-5#2)(2010-10#2)(2010-12#1)(2010-8#3)(2011-2#1)(2013-1#1)
sex steroids and##2##3##(1990-11#1)(2006-6#1)
sex steroids are##2##3##(2008-5#1)(2008-6#1)
sex steroids##24##2##(1990-11#1)(1990-2#1)(1991-3#1)(1991-6#1)(1992-6#1)(1993-5#1)(1995-12#1)(1996-11#1)(1996-4#1)(1997-6#2)(2005-3#1)(2006-1#1)(2006-6#2)(2007-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-3#1)(2009-6#1)(2009-7#1)(2011-1#2)
sex than##3##2##(2007-7#2)(2010-8#1)
sex to##3##2##(1993-6#1)(2007-12#1)(2008-12#1)
sex was##8##2##(1996-9#1)(1997-4#1)(2006-10#1)(2007-2#1)(2008-12#1)(2008-5#1)(2012-3#1)(2013-1#1)
sex were##10##2##(2007-3#1)(2007-8#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-7#1)(2012-3#1)(2013-1#2)
sex while symptomatic were##2##4##(2007-7#2)
sex while symptomatic##8##3##(2007-7#8)
sex while##11##2##(1997-5#1)(2007-7#8)(2012-1#1)(2012-3#1)
sex with a##3##3##(1995-8#1)(2007-7#1)(2013-1#1)
sex with men##32##3##(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#2)(2009-5#11)(2009-7#1)(2010-12#2)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#3)
sex with multiple partners##3##4##(2009-5#2)(2013-1#1)
sex with paid partners##2##4##(2012-3#2)
sex with paid##3##3##(2012-3#3)
sex with sex workers##3##4##(2012-3#3)
sex with three or more women##2##6##(2009-5#2)
sex with##59##2##(1995-8#1)(1996-5#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2009-5#16)(2009-7#1)(2010-12#2)(2010-5#2)(2010-9#1)(2011-1#4)(2011-12#3)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#2)(2012-3#10)(2013-1#5)
sex within##2##2##(2008-9#1)(2012-3#1)
sex work in##3##3##(2008-12#1)(2012-3#2)
sex work##19##2##(2008-11#1)(2008-12#5)(2010-8#2)(2012-1#2)(2012-3#9)
sex worker rights activists##2##4##(2012-3#2)
sex worker##4##2##(2012-3#4)
sex workers and##5##3##(2007-7#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-7#1)
sex workers in##13##3##(2010-8#1)(2012-3#11)(2013-8#1)
sex workers##51##2##(2007-12#1)(2007-6#1)(2007-7#2)(2008-12#2)(2009-7#1)(2010-12#1)(2010-8#3)(2011-12#2)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#1)(2012-3#30)(2013-7#1)(2013-8#1)
sex workers' rights and##2##4##(2012-3#2)
sex workers' rights##3##3##(2012-3#3)
sex workers'##5##2##(2012-3#5)
sex##1402##1##(1990-11#17)(1990-12#4)(1990-2#4)(1990-3#2)(1990-4#11)(1990-8#5)(1990-9#7)(1991-1#1)(1991-10#3)(1991-11#3)(1991-12#3)(1991-2#2)(1991-3#6)(1991-5#3)(1991-6#12)(1991-7#1)(1991-8#4)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#4)(1992-12#1)(1992-2#4)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#4)(1992-7#5)(1992-8#1)(1992-9#1)(1993-1#2)(1993-10#5)(1993-11#4)(1993-12#8)(1993-2#5)(1993-3#4)(1993-4#7)(1993-5#7)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#2)(1994-12#1)(1994-2#5)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#7)(1994-7#7)(1994-8#4)(1995-1#4)(1995-11#36)(1995-12#5)(1995-3#4)(1995-4#1)(1995-5#4)(1995-6#4)(1995-7#1)(1995-8#3)(1995-9#2)(1996-1#6)(1996-10#2)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#4)(1996-4#10)(1996-5#14)(1996-6#5)(1996-8#1)(1996-9#4)(1997-1#1)(1997-2#4)(1997-3#5)(1997-4#1)(1997-5#10)(1997-6#9)(1997-7#11)(1997-8#3)(2004-10#2)(2004-12#5)(2004-4#1)(2005-10#6)(2005-3#1)(2006-1#2)(2006-10#17)(2006-12#9)(2006-2#5)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#4)(2006-7#13)(2006-8#8)(2006-9#4)(2007-1#8)(2007-10#12)(2007-11#6)(2007-12#37)(2007-2#11)(2007-3#6)(2007-4#3)(2007-5#1)(2007-6#6)(2007-7#29)(2007-8#11)(2007-9#8)(2008-1#12)(2008-10#28)(2008-11#21)(2008-12#22)(2008-3#16)(2008-4#20)(2008-5#36)(2008-6#12)(2008-7#39)(2008-8#61)(2008-9#33)(2009-1#7)(2009-10#2)(2009-11#4)(2009-12#1)(2009-2#8)(2009-3#3)(2009-4#9)(2009-5#29)(2009-6#4)(2009-7#9)(2009-8#1)(2009-9#5)(2010-10#5)(2010-12#8)(2010-2#6)(2010-3#45)(2010-4#13)(2010-5#21)(2010-6#5)(2010-7#6)(2010-8#24)(2010-9#4)(2011-1#24)(2011-11#1)(2011-12#13)(2011-2#46)(2012-1#12)(2012-11#5)(2012-12#22)(2012-2#15)(2012-3#99)(2013-1#46)(2013-7#10)(2013-8#16)
sex) and##2##2##(2010-11#1)(2012-3#1)
sex)##10##1##(1991-8#1)(1996-7#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#3)
sex- and age-specific##2##3##(2012-3#2)
sex- and##3##2##(2008-10#1)(2012-3#2)
sex-##5##1##(1995-11#1)(2008-10#1)(2008-12#1)(2012-3#2)
sex-based##3##1##(2007-11#1)(2009-2#1)(2009-4#1)
sex-biased##3##1##(1997-3#1)(2009-5#1)(2012-3#1)
sex-changing fish##2##2##(2010-8#2)
sex-changing##4##1##(2008-8#1)(2010-8#3)
sex-concordance##2##1##(1995-11#2)
sex-dependent##3##1##(1991-1#1)(1991-9#1)(1996-4#1)
sex-determining mechanisms##4##2##(2010-3#4)
sex-determining region of the##2##4##(1990-11#2)
sex-determining region##5##2##(1990-11#4)(2010-5#1)
sex-determining##13##1##(1990-11#5)(1995-11#1)(2008-4#1)(2010-3#5)(2010-5#1)
sex-difference in EPC number in##2##5##(2009-11#2)
sex-difference##3##1##(1994-5#1)(2009-11#2)
sex-linked##13##1##(1993-9#1)(1995-11#1)(1997-6#1)(2008-4#2)(2008-5#2)(2008-7#2)(2011-2#1)(2012-3#2)(2013-8#1)
sex-matched healthy control subjects##2##4##(1993-9#1)(2007-10#1)
sex-matched healthy##5##2##(1993-9#1)(1995-11#1)(2007-10#1)(2008-7#2)
sex-matched##29##1##(1990-12#1)(1992-8#1)(1993-7#1)(1993-9#1)(1995-11#1)(1995-6#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-12#1)(2006-10#1)(2007-10#3)(2007-2#1)(2007-8#2)(2007-9#1)(2008-3#2)(2008-6#1)(2008-7#4)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
sex-ratio##7##1##(1994-8#4)(2008-8#1)(2012-3#2)
sex-related differences in liver##3##4##(1995-12#3)
sex-related differences in##4##3##(1995-12#3)(2006-10#1)
sex-related differences##6##2##(1992-4#1)(1995-12#4)(2006-10#1)
sex-related##8##1##(1992-4#1)(1994-11#1)(1995-12#4)(2006-10#1)(2008-3#1)
sex-reversal##2##1##(1992-5#2)
sex-reversed##2##1##(1990-11#1)(2008-6#1)
sex-selection##3##1##(2006-12#3)
sex-specific and pseudoautosomal##2##3##(1990-11#2)
sex-specific characteristics##2##2##(1996-5#1)(2008-11#1)
sex-specific differences in##2##3##(2006-7#1)(2008-11#1)
sex-specific differences##3##2##(2006-7#1)(2008-11#1)(2008-4#1)
sex-specific genetic##2##2##(1997-5#1)(2013-8#1)
sex-specific##31##1##(1990-1#1)(1990-11#3)(1992-11#1)(1993-7#1)(1994-2#1)(1995-6#1)(1995-8#1)(1996-5#2)(1997-5#2)(2006-7#1)(2007-12#1)(2007-6#1)(2008-11#2)(2008-4#1)(2009-3#1)(2010-5#2)(2010-6#2)(2010-8#1)(2012-3#3)(2013-7#1)(2013-8#2)
sex-typed##3##1##(2013-8#3)
sex?]##2##1##(1991-6#1)(1994-2#1)
sexangularis##3##1##(2008-10#3)
sexe##2##1##(2011-2#1)(2012-2#1)
sexed##3##1##(1996-12#1)(2007-11#1)(2008-10#1)
sexes and all##2##3##(2008-1#1)(2012-12#1)
sexes and the##2##3##(2008-8#1)(2013-7#1)
sexes and##15##2##(1991-6#1)(1991-7#1)(1995-12#1)(2006-10#2)(2006-8#1)(2007-12#1)(2008-1#1)(2008-8#2)(2009-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
sexes are##4##2##(1997-6#1)(2004-11#1)(2009-5#1)(2010-3#1)
sexes as##3##2##(1991-6#1)(2009-10#1)(2009-5#1)
sexes in the##4##3##(1991-6#1)(1997-8#1)(2006-4#1)(2013-1#1)
sexes in##15##2##(1991-6#1)(1997-4#1)(1997-8#1)(2006-1#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-8#1)(2008-9#2)(2012-3#1)(2013-1#1)(2013-8#1)
sexes may be##3##3##(1991-1#1)(2008-9#2)
sexes may##4##2##(1991-1#1)(2008-9#2)(2010-8#1)
sexes of rats##3##3##(2006-1#2)(2008-9#1)
sexes of##9##2##(2006-1#2)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-8#1)(2013-8#1)
sexes or between##2##3##(1992-4#1)(2008-3#1)
sexes or##4##2##(1991-10#1)(1992-4#1)(2008-12#1)(2008-3#1)
sexes was##3##2##(1995-8#1)(2007-7#1)(2012-3#1)
sexes were##8##2##(1990-2#1)(1995-4#1)(1995-8#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2013-7#1)
sexes##217##1##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#3)(1991-12#1)(1991-6#6)(1991-7#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-8#2)(1993-9#2)(1994-2#1)(1995-1#1)(1995-10#2)(1995-12#2)(1995-2#2)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#4)(1996-10#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#4)(1997-8#1)(2004-11#1)(2005-10#2)(2006-1#3)(2006-10#4)(2006-4#3)(2006-5#2)(2006-7#1)(2006-8#8)(2007-1#1)(2007-11#1)(2007-12#11)(2007-3#4)(2007-5#3)(2007-6#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#4)(2008-3#3)(2008-4#1)(2008-5#10)(2008-7#10)(2008-8#7)(2008-9#11)(2009-1#1)(2009-10#1)(2009-11#1)(2009-5#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#3)(2011-11#1)(2011-12#1)(2011-2#8)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#3)(2013-7#5)(2013-8#3)
sexes) and##2##2##(2010-3#1)(2013-1#1)
sexes)##7##1##(1990-10#1)(1992-6#1)(2008-5#1)(2008-8#1)(2010-3#1)(2010-8#1)(2013-1#1)
sexism in##2##2##(1991-6#1)(2011-1#1)
sexism##7##1##(1991-6#1)(2011-1#6)
sexta##24##1##(1991-12#5)(1992-1#1)(1992-3#1)(1994-9#2)(1995-11#2)(1995-6#1)(2007-12#5)(2008-7#2)(2008-9#1)(2009-6#2)(2009-8#2)
sextants with##2##2##(2006-2#1)(2008-10#1)
sextants##5##1##(2006-2#3)(2008-10#1)(2011-2#1)
sexting behavior##2##2##(2013-1#2)
sexting##21##1##(2013-1#21)
sexual IPV##2##2##(2008-12#2)
sexual abuse and##6##3##(2007-12#1)(2009-7#2)(2009-9#2)(2010-4#1)
sexual abuse can##3##3##(1996-2#1)(2009-9#1)(2010-10#1)
sexual abuse in a day care##2##6##(1995-6#2)
sexual abuse in a##4##4##(1992-1#1)(1995-6#2)(1996-11#1)
sexual abuse in##9##3##(1992-1#1)(1995-6#2)(1996-11#1)(2007-12#1)(2008-3#3)(2009-9#1)
sexual abuse is##2##3##(1995-11#1)(2009-9#1)
sexual abuse of children##2##4##(1993-5#2)
sexual abuse of##7##3##(1990-5#1)(1993-5#2)(1995-5#1)(1996-11#2)(2009-9#1)
sexual abuse or##3##3##(1993-5#1)(2007-7#1)(2010-4#1)
sexual abuse##72##2##(1990-5#1)(1992-1#6)(1992-2#1)(1993-12#1)(1993-5#3)(1995-11#3)(1995-5#2)(1995-6#2)(1995-9#1)(1996-1#1)(1996-11#5)(1996-2#2)(2005-8#2)(2006-10#1)(2006-2#1)(2007-12#2)(2007-3#4)(2007-7#3)(2008-2#1)(2008-3#4)(2009-10#1)(2009-4#1)(2009-7#2)(2009-9#11)(2010-10#4)(2010-2#1)(2010-4#4)(2012-1#1)(2012-3#1)
sexual abuse]##2##2##(1995-5#1)(2010-6#1)
sexual activity and##2##3##(2008-6#1)(2012-3#1)
sexual activity in##3##3##(2007-8#1)(2011-2#1)(2013-8#1)
sexual activity was##2##3##(2009-7#1)(2012-12#1)
sexual activity##25##2##(1995-12#1)(1997-1#1)(1997-6#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-7#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#7)
sexual addiction and##3##3##(2007-7#3)
sexual addiction##4##2##(2007-7#3)(2008-1#1)
sexual aggression##5##2##(2006-7#1)(2008-10#1)(2009-10#1)(2010-11#1)(2010-6#1)
sexual and affective behavior##2##4##(2009-4#2)
sexual and asexual##6##3##(2008-10#5)(2013-7#1)
sexual and natural selection##3##4##(2012-3#3)
sexual and nonsexual##2##3##(2008-9#2)
sexual and reproductive health and rights (SRHR)##2##7##(2012-3#2)
sexual and reproductive health and rights##3##6##(2012-3#3)
sexual and reproductive health and##5##5##(2008-9#1)(2012-3#4)
sexual and reproductive health rights##3##5##(2012-3#3)
sexual and reproductive health services##2##5##(2008-11#1)(2012-3#1)
sexual and reproductive health##27##4##(1995-9#1)(1996-12#1)(2008-11#3)(2008-9#1)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#13)(2013-1#1)(2013-8#1)
sexual and reproductive##35##3##(1991-9#1)(1995-9#1)(1996-12#1)(2006-4#1)(2008-11#3)(2008-9#1)(2009-5#2)(2011-2#2)(2012-12#5)(2012-2#1)(2012-3#15)(2013-1#1)(2013-8#1)
sexual and##62##2##(1991-9#1)(1995-9#1)(1996-12#1)(1997-7#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-11#1)(2008-10#5)(2008-11#4)(2008-9#4)(2009-2#1)(2009-4#2)(2009-5#2)(2009-7#2)(2010-2#1)(2011-2#2)(2012-12#5)(2012-2#1)(2012-3#20)(2013-1#1)(2013-7#1)(2013-8#1)
sexual arousal##2##2##(2009-1#1)(2012-3#1)
sexual asphyxia##2##2##(2005-9#2)
sexual assault and##5##3##(2007-12#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-9#1)
sexual assault cases##2##3##(1996-5#1)(2011-2#1)
sexual assault in##3##3##(2009-5#1)(2011-2#1)(2012-3#1)
sexual assault perpetration##3##3##(2009-5#3)
sexual assault##37##2##(1990-12#1)(1996-12#2)(1996-5#1)(2004-10#1)(2007-12#2)(2008-10#1)(2008-12#2)(2008-2#1)(2008-6#4)(2008-8#1)(2009-5#10)(2009-9#1)(2010-12#1)(2010-3#3)(2011-2#2)(2012-3#3)(2013-8#1)
sexual attitudes##3##2##(2009-5#1)(2011-1#1)(2012-3#1)
sexual behavior and HIV##2##4##(2005-10#1)(2009-7#1)
sexual behavior and contraceptive use##3##5##(2012-11#3)
sexual behavior and##12##3##(1991-11#1)(1991-2#1)(2005-10#1)(2008-12#1)(2008-4#1)(2009-7#2)(2011-2#1)(2012-11#3)(2013-1#1)
sexual behavior in##8##3##(1991-11#1)(1992-1#1)(1993-6#1)(1994-10#1)(2007-7#1)(2012-1#1)(2012-3#1)(2013-1#1)
sexual behavior is##2##3##(1992-12#1)(1997-5#1)
sexual behavior of##4##3##(1993-8#1)(1994-6#1)(1995-12#1)(2011-2#1)
sexual behavior##81##2##(1991-10#1)(1991-11#2)(1991-2#9)(1991-8#1)(1992-1#1)(1992-12#3)(1993-5#1)(1993-6#1)(1993-8#2)(1994-10#1)(1994-2#1)(1994-6#3)(1995-1#2)(1995-12#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-5#2)(1997-8#1)(2004-11#1)(2005-10#1)(2007-5#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-12#4)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#4)(2009-8#1)(2010-12#1)(2011-1#2)(2011-12#2)(2011-2#5)(2012-1#3)(2012-11#3)(2012-12#1)(2012-3#2)(2013-1#6)(2013-8#1)
sexual behaviors in this##2##4##(2005-10#1)(2009-5#1)
sexual behaviors in##7##3##(2005-10#1)(2009-5#3)(2010-2#1)(2012-3#2)
sexual behaviors##24##2##(2005-10#1)(2007-12#3)(2007-7#1)(2009-5#7)(2009-7#1)(2010-2#2)(2012-12#1)(2012-3#5)(2013-1#1)(2013-8#2)
sexual behaviour and##8##3##(1993-8#1)(1996-6#1)(2006-7#1)(2007-6#1)(2007-7#1)(2011-1#1)(2012-3#2)
sexual behaviour of male rats##2##5##(2008-11#2)
sexual behaviour of##8##3##(1990-9#1)(1996-1#1)(1996-11#1)(2006-7#1)(2008-11#2)(2009-4#1)(2011-2#1)
sexual behaviour##34##2##(1990-9#1)(1993-8#1)(1993-9#2)(1994-2#3)(1994-6#1)(1996-1#3)(1996-11#1)(1996-6#1)(1997-2#1)(2006-10#2)(2006-7#2)(2007-3#1)(2007-6#1)(2007-7#4)(2008-11#2)(2008-2#1)(2009-4#1)(2011-1#2)(2011-2#1)(2012-3#3)
sexual behavioural##3##2##(1991-2#1)(2007-3#1)(2007-7#1)
sexual changes##4##2##(2008-7#4)
sexual characteristics##2##2##(2006-10#1)(2006-7#1)
sexual characters##8##2##(1995-2#5)(2007-7#1)(2012-3#2)
sexual coercion##2##2##(2009-11#1)(2012-2#1)
sexual concerns##3##2##(2008-7#3)
sexual conduct##2##2##(2006-10#1)(2006-7#1)
sexual conflict##7##2##(2006-5#1)(2008-8#4)(2010-3#1)(2012-3#1)
sexual contact##5##2##(1993-6#1)(1995-12#1)(2006-10#1)(2007-8#1)(2009-10#1)
sexual contacts##6##2##(1993-5#1)(2006-10#1)(2008-3#1)(2011-1#2)(2011-2#1)
sexual cross##2##2##(2008-10#2)
sexual cycle of##2##3##(2008-10#1)(2012-2#1)
sexual debut among##2##3##(1990-9#1)(2009-10#1)
sexual debut is##2##3##(2011-1#2)
sexual debut timing##3##3##(2009-10#3)
sexual debut was##3##3##(2007-3#1)(2009-10#1)(2012-1#1)
sexual debut##23##2##(1990-9#2)(2007-3#1)(2009-10#6)(2011-1#10)(2012-1#2)(2012-12#1)(2013-8#1)
sexual development and##3##3##(2008-1#1)(2010-12#1)(2010-3#1)
sexual development##15##2##(1990-11#1)(1995-11#4)(1995-6#1)(2006-9#1)(2007-5#1)(2008-1#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)
sexual difference##2##2##(1990-12#1)(1995-5#1)
sexual differences##3##2##(1995-6#1)(2008-5#1)(2008-7#1)
sexual differentiation and##2##3##(2006-10#1)(2012-3#1)
sexual differentiation in##3##3##(2006-10#1)(2007-12#1)(2008-5#1)
sexual differentiation of the brain##2##5##(1990-11#1)(2009-3#1)
sexual differentiation of the##3##4##(1990-11#1)(1994-2#1)(2009-3#1)
sexual differentiation of##7##3##(1990-11#1)(1991-3#2)(1994-2#1)(1994-6#1)(2008-5#1)(2009-3#1)
sexual differentiation##24##2##(1990-11#1)(1991-3#3)(1994-2#1)(1994-6#1)(1995-11#2)(1995-3#1)(1997-3#1)(1997-5#1)(2006-10#3)(2007-12#4)(2007-3#1)(2008-5#2)(2009-3#1)(2012-3#2)
sexual dimorphism in growth##2##4##(2010-8#2)
sexual dimorphism in the##2##4##(1997-8#1)(2007-12#1)
sexual dimorphism in##11##3##(1994-6#1)(1995-6#2)(1996-11#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-8#1)(2010-8#2)(2012-3#1)
sexual dimorphism of##2##3##(1994-6#1)(2009-2#1)
sexual dimorphism was found in##2##5##(2007-12#1)(2012-3#1)
sexual dimorphism was observed##2##4##(1993-4#1)(2007-12#1)
sexual dimorphism was##4##3##(1993-4#1)(2007-12#2)(2012-3#1)
sexual dimorphism##31##2##(1993-4#1)(1994-6#2)(1995-6#3)(1996-11#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-12#4)(2007-3#1)(2008-3#1)(2008-5#1)(2008-8#3)(2009-2#1)(2010-8#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-7#1)
sexual disorders##2##2##(2007-7#1)(2011-2#1)
sexual displays##4##2##(2008-8#1)(2010-2#1)(2013-1#2)
sexual division of labor##3##4##(1991-6#2)(2006-2#1)
sexual division of leadership in volunteer emergency medical service##2##9##(1996-3#2)
sexual division of leadership in##3##5##(1996-3#3)
sexual division of##6##3##(1991-6#2)(1996-3#3)(2006-2#1)
sexual dysfunction##15##2##(1992-4#1)(2004-3#1)(2006-10#1)(2006-9#2)(2007-11#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
sexual encounter##2##2##(2008-12#1)(2012-3#1)
sexual encounters##7##2##(2007-7#2)(2011-2#2)(2012-3#1)(2013-8#2)
sexual exhaustion##4##2##(1994-6#4)
sexual experiences##4##2##(2009-12#1)(2009-5#2)(2009-9#1)
sexual experimentation and the##2##4##(2006-7#2)
sexual experimentation and##3##3##(2006-7#2)(2012-12#1)
sexual exploitation##2##2##(2008-9#1)(2012-3#1)
sexual exposure##2##2##(2006-9#1)(2007-11#1)
sexual fruiting##2##2##(2008-10#1)(2008-8#1)
sexual function and##2##3##(2008-6#1)(2009-5#1)
sexual function##19##2##(1995-9#1)(2004-10#1)(2006-9#4)(2008-1#1)(2008-6#1)(2008-7#1)(2009-5#2)(2010-8#1)(2011-2#4)(2012-1#1)(2013-8#2)
sexual function)##2##2##(1995-9#1)(2012-1#1)
sexual harassment##7##2##(1992-9#1)(1993-2#1)(1996-2#1)(1996-3#1)(2006-5#1)(2009-9#1)(2012-3#1)
sexual health among##4##3##(2009-5#2)(2010-9#2)
sexual health education##3##3##(2007-3#1)(2008-4#1)(2008-6#1)
sexual health in##2##3##(2006-7#1)(2012-3#1)
sexual health promotion##7##3##(2010-9#1)(2013-1#6)
sexual health##37##2##(1990-12#1)(1994-4#1)(1995-4#1)(2006-7#1)(2007-3#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#5)(2009-5#3)(2010-5#1)(2010-9#3)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#6)
sexual history##4##2##(1990-12#1)(1991-6#1)(2004-10#1)(2012-1#1)
sexual hormone binding globulin##2##4##(1991-3#2)
sexual hormones##3##2##(1990-12#1)(1993-3#1)(2011-2#1)
sexual identities##2##2##(2006-7#2)
sexual identity development##2##3##(2009-7#2)
sexual identity##10##2##(2006-7#1)(2007-12#1)(2008-10#1)(2008-12#2)(2009-5#2)(2009-7#2)(2012-3#1)
sexual initiation##3##2##(2012-1#2)(2012-3#1)
sexual intercourse among##2##3##(2012-11#1)(2012-2#1)
sexual intercourse and##2##3##(2010-8#1)(2011-2#1)
sexual intercourse with a##2##4##(1997-5#1)(2012-3#1)
sexual intercourse with##7##3##(1992-2#1)(1997-5#1)(2007-2#1)(2008-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
sexual intercourse##40##2##(1992-2#2)(1992-6#1)(1996-12#1)(1997-5#3)(1997-7#4)(2004-3#1)(2005-8#1)(2006-12#1)(2006-6#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-12#2)(2010-8#1)(2011-1#2)(2011-2#3)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#1)
sexual isolation between##2##3##(2008-9#2)
sexual isolation##4##2##(2008-8#1)(2008-9#3)
sexual knowledge##2##2##(2010-5#1)(2010-9#1)
sexual life##2##2##(1996-12#1)(2008-7#1)
sexual lives##2##2##(1997-3#1)(2008-7#1)
sexual maturation of##3##3##(2006-10#1)(2007-2#1)(2012-2#1)
sexual maturation##13##2##(1990-7#1)(1993-12#1)(1995-6#1)(2006-10#3)(2006-9#1)(2007-2#1)(2010-12#1)(2010-8#1)(2010-9#1)(2012-2#1)(2013-7#1)
sexual maturity and##2##3##(2008-5#2)
sexual maturity##14##2##(1997-5#1)(2006-7#1)(2007-3#1)(2008-5#4)(2008-7#1)(2008-8#2)(2010-8#1)(2011-2#1)(2013-7#2)
sexual minorities##3##2##(2008-12#1)(2013-1#2)
sexual minority##5##2##(2008-12#3)(2009-7#1)(2013-1#1)
sexual morph##8##2##(2013-7#8)
sexual morph-typified##2##2##(2013-7#2)
sexual motivation and##2##3##(1994-2#1)(2012-1#1)
sexual motivation##4##2##(1994-2#1)(2012-1#1)(2013-1#2)
sexual network data##3##3##(2010-2#3)
sexual network##4##2##(2010-2#4)
sexual networks in sub-Saharan##2##4##(2010-2#2)
sexual networks##4##2##(2010-2#4)
sexual offenses##3##2##(1992-9#1)(1996-5#1)(2011-2#1)
sexual or parasexual##2##3##(2008-10#2)
sexual or##8##2##(1993-4#1)(2008-10#3)(2008-7#1)(2012-11#1)(2012-3#1)(2013-7#1)
sexual organs##2##2##(2008-8#1)(2010-9#1)
sexual orientation and##5##3##(1995-12#1)(1996-5#1)(2008-12#2)(2013-1#1)
sexual orientation identity##2##3##(2013-1#2)
sexual orientation over time may##2##5##(2013-1#2)
sexual orientation##25##2##(1991-8#2)(1995-12#2)(1996-5#1)(2007-7#1)(2008-12#8)(2010-8#1)(2012-2#2)(2013-1#8)
sexual ornaments##2##2##(2008-8#2)
sexual partner within##2##3##(1990-12#2)
sexual partner##9##2##(1990-12#2)(1993-9#1)(2007-12#1)(2008-5#1)(2010-2#2)(2012-2#1)(2012-3#1)
sexual partners and##5##3##(2008-2#1)(2009-4#2)(2011-1#1)(2012-2#1)
sexual partners in the previous##2##5##(2007-3#1)(2011-1#1)
sexual partners in the##5##4##(2007-3#1)(2011-1#1)(2011-12#2)(2013-1#1)
sexual partners in##7##3##(2007-3#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-3#1)(2013-1#1)
sexual partners of##4##3##(1991-2#2)(2008-1#1)(2012-3#1)
sexual partners##43##2##(1990-9#1)(1991-2#3)(1993-9#1)(1996-1#2)(2006-10#1)(2007-3#2)(2007-7#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-4#3)(2009-5#2)(2010-12#1)(2010-4#1)(2011-1#5)(2011-12#3)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)
sexual partnership##2##2##(2008-10#1)(2011-3#1)
sexual partnerships##7##2##(2007-7#1)(2010-12#2)(2011-2#4)
sexual performance##3##2##(1995-12#1)(2006-9#1)(2008-11#1)
sexual pleasure##2##2##(2006-7#1)(2009-5#1)
sexual practice##2##2##(2006-7#1)(2009-5#1)
sexual practices among##3##3##(2008-2#1)(2012-2#1)(2012-3#1)
sexual practices and##2##3##(2012-1#1)(2012-3#1)
sexual practices##17##2##(1994-12#1)(1995-6#2)(1996-5#1)(2007-12#2)(2007-7#1)(2008-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#4)
sexual problems##5##2##(1992-10#1)(1996-11#1)(2008-8#3)
sexual recombinants##2##2##(2008-10#2)
sexual recombination between##2##3##(2008-10#2)
sexual recombination##21##2##(2008-10#19)(2008-8#2)
sexual regulators##2##2##(2007-12#2)
sexual relation##2##2##(1991-6#1)(2011-1#1)
sexual relations##5##2##(2006-2#1)(2007-7#1)(2009-5#1)(2012-2#1)(2012-3#1)
sexual relationships and##2##3##(2012-12#1)(2012-3#1)
sexual relationships##7##2##(1992-10#1)(1993-5#1)(2007-7#1)(2012-12#3)(2012-3#1)
sexual reproduction and##3##3##(2008-10#1)(2008-9#1)(2010-3#1)
sexual reproduction between##2##3##(2008-10#2)
sexual reproduction in##3##3##(2006-10#1)(2010-12#1)(2012-3#1)
sexual reproduction of##3##3##(1990-7#1)(2008-10#2)
sexual reproduction##35##2##(1990-7#1)(2006-10#1)(2008-10#16)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-5#1)(2010-12#1)(2010-3#1)(2012-3#5)(2013-1#1)
sexual responsiveness##2##2##(1992-10#2)
sexual risk among##2##3##(2008-12#1)(2013-1#1)
sexual risk and##2##3##(2008-12#1)(2013-1#1)
sexual risk behavior##8##3##(2008-12#3)(2010-5#2)(2012-3#1)(2013-1#2)
sexual risk behaviors and##2##4##(2008-12#1)(2008-4#1)
sexual risk behaviors in##2##4##(2008-4#1)(2008-8#1)
sexual risk behaviors##12##3##(2008-12#1)(2008-4#5)(2008-8#1)(2010-7#1)(2012-1#1)(2012-3#1)(2013-1#2)
sexual risk##32##2##(2007-7#1)(2008-12#7)(2008-4#6)(2008-8#1)(2009-12#1)(2009-8#3)(2010-5#2)(2010-7#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#6)
sexual risk-reduction##3##2##(1996-2#2)(2013-1#1)
sexual risk-taking##2##2##(2006-7#1)(2012-2#1)
sexual risks##2##2##(2013-1#1)(2013-8#1)
sexual satisfaction##2##2##(1992-10#1)(2007-7#1)
sexual selection and the##3##4##(2008-8#2)(2012-3#1)
sexual selection and##6##3##(2008-8#3)(2012-3#1)(2013-1#2)
sexual selection are##2##3##(1995-2#1)(2012-3#1)
sexual selection can##2##3##(2008-8#1)(2013-1#1)
sexual selection in plants##2##4##(1995-2#2)
sexual selection in##6##3##(1995-2#2)(2008-8#2)(2008-9#1)(2010-8#1)
sexual selection is##4##3##(1995-2#1)(2006-5#1)(2008-9#2)
sexual selection on signals of health##3##6##(2008-8#3)
sexual selection on##8##3##(2008-8#6)(2010-2#1)(2010-8#1)
sexual selection was##3##3##(2008-8#2)(2012-3#1)
sexual selection##64##2##(1995-2#5)(2006-5#2)(2008-5#1)(2008-8#30)(2008-9#7)(2009-9#1)(2010-2#1)(2010-3#1)(2010-8#2)(2011-1#1)(2012-3#7)(2013-1#6)
sexual signalling##7##2##(2009-9#7)
sexual signalling) and##2##3##(2009-9#1)(2010-8#1)
sexual situations with##2##3##(2008-12#2)
sexual species##5##2##(2008-8#3)(2009-2#2)
sexual stage##8##2##(1991-5#1)(2007-5#1)(2008-10#6)
sexual status##2##2##(1995-12#1)(2010-8#1)
sexual to##3##2##(2008-10#1)(2008-9#2)
sexual trait expression##3##3##(2012-3#3)
sexual trait##6##2##(2008-9#1)(2012-3#5)
sexual traits##5##2##(2008-8#1)(2008-9#1)(2012-3#3)
sexual transmission and##2##3##(1991-6#1)(2008-9#1)
sexual transmission##6##2##(1991-6#1)(1996-2#1)(2006-10#1)(2008-9#3)
sexual transmitted##3##2##(1992-12#1)(2008-11#1)(2011-1#1)
sexual types##2##2##(2008-5#2)
sexual versus asexual##2##3##(2009-5#1)(2010-12#1)
sexual versus##3##2##(2008-9#1)(2009-5#1)(2010-12#1)
sexual violence##12##2##(2006-7#5)(2007-12#1)(2009-5#3)(2010-3#3)
sexual##1290##1##(1990-11#3)(1990-12#8)(1990-5#1)(1990-6#2)(1990-7#2)(1990-9#4)(1991-10#1)(1991-11#2)(1991-2#13)(1991-3#5)(1991-5#1)(1991-6#5)(1991-8#4)(1991-9#1)(1992-1#7)(1992-10#6)(1992-12#4)(1992-2#6)(1992-4#1)(1992-6#1)(1992-9#3)(1993-12#3)(1993-2#4)(1993-3#1)(1993-4#2)(1993-5#7)(1993-6#3)(1993-8#3)(1993-9#4)(1994-10#1)(1994-12#1)(1994-2#7)(1994-3#1)(1994-4#1)(1994-6#13)(1995-1#2)(1995-11#10)(1995-12#7)(1995-2#10)(1995-3#2)(1995-4#2)(1995-5#5)(1995-6#13)(1995-9#4)(1996-1#6)(1996-11#8)(1996-12#6)(1996-2#7)(1996-3#4)(1996-4#1)(1996-5#5)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#8)(1997-6#1)(1997-7#6)(1997-8#2)(2004-10#3)(2004-11#1)(2004-3#2)(2005-10#2)(2005-7#1)(2005-8#4)(2005-9#2)(2006-10#21)(2006-12#3)(2006-2#5)(2006-4#2)(2006-5#4)(2006-6#1)(2006-7#24)(2006-8#1)(2006-9#11)(2007-1#1)(2007-11#4)(2007-12#27)(2007-2#2)(2007-3#16)(2007-4#1)(2007-5#5)(2007-6#2)(2007-7#31)(2007-8#3)(2008-1#7)(2008-10#72)(2008-11#12)(2008-12#35)(2008-2#6)(2008-3#7)(2008-4#9)(2008-5#21)(2008-6#14)(2008-7#22)(2008-8#70)(2008-9#38)(2009-1#1)(2009-10#13)(2009-11#3)(2009-12#3)(2009-2#4)(2009-3#1)(2009-4#7)(2009-5#51)(2009-6#1)(2009-7#16)(2009-8#4)(2009-9#25)(2010-1#1)(2010-10#4)(2010-11#3)(2010-12#12)(2010-2#16)(2010-3#12)(2010-4#6)(2010-5#5)(2010-6#3)(2010-7#2)(2010-8#13)(2010-9#7)(2011-1#30)(2011-12#5)(2011-2#43)(2011-3#1)(2012-1#14)(2012-11#6)(2012-12#25)(2012-2#18)(2012-3#97)(2013-1#56)(2013-7#17)(2013-8#23)
sexual/gender identity formation##2##3##(2009-7#2)
sexualities##2##1##(2009-4#1)(2012-3#1)
sexuality and##6##2##(2006-7#1)(2009-4#1)(2010-8#1)(2012-3#1)(2013-8#2)
sexuality becomes##2##2##(2006-7#1)(2008-1#1)
sexuality education##3##2##(2007-3#2)(2012-11#1)
sexuality in the##2##3##(2007-2#1)(2008-10#1)
sexuality in##8##2##(1992-10#1)(2006-7#3)(2007-2#1)(2008-10#2)(2012-3#1)
sexuality with##4##2##(2009-5#1)(2011-2#1)(2013-1#2)
sexuality##57##1##(1990-5#1)(1991-5#1)(1992-10#2)(1994-4#1)(1996-9#1)(1997-5#1)(1997-7#2)(2006-7#8)(2007-2#2)(2007-3#3)(2007-7#1)(2008-1#3)(2008-10#3)(2008-3#2)(2008-4#1)(2009-10#2)(2009-12#1)(2009-4#2)(2009-5#4)(2009-7#2)(2010-8#1)(2011-2#2)(2012-11#1)(2012-3#6)(2013-1#2)(2013-8#2)
sexuality]##2##1##(1995-3#1)(2013-8#1)
sexually abused children##5##3##(1995-5#1)(2008-2#2)(2010-10#1)(2012-3#1)
sexually abused##12##2##(1990-11#1)(1995-5#2)(1996-11#1)(1996-6#1)(2006-2#1)(2008-2#2)(2009-9#1)(2010-10#1)(2012-3#2)
sexually active adolescents##2##3##(1996-12#1)(2008-1#1)
sexually active adults##2##3##(2007-11#1)(2013-1#1)
sexually active females in##3##4##(2007-7#3)
sexually active females of age group 20-40 years##2##8##(2007-7#2)
sexually active females##5##3##(2007-7#5)
sexually active men##2##3##(2007-7#1)(2008-8#1)
sexually active young##2##3##(2008-11#1)(2012-2#1)
sexually active##43##2##(1996-12#1)(1997-5#1)(1997-6#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#10)(2008-1#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-7#4)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#2)(2013-1#7)(2013-8#1)
sexually antagonistic genes##2##3##(2008-8#1)(2010-3#1)
sexually antagonistic##3##2##(2008-8#2)(2010-3#1)
sexually dimorphic areas##2##3##(1995-5#2)
sexually dimorphic in##2##3##(1993-4#1)(2012-12#1)
sexually dimorphic manner##2##3##(1994-10#2)
sexually dimorphic spinal nucleus of the bulbocavernosus (SNB)##2##8##(1992-7#1)(1996-9#1)
sexually dimorphic##29##2##(1990-4#2)(1992-3#4)(1992-7#1)(1993-4#1)(1993-5#2)(1993-8#1)(1994-10#3)(1994-3#2)(1995-2#1)(1995-5#5)(1996-9#3)(1997-7#1)(2007-12#1)(2008-8#1)(2012-12#1)
sexually experienced##3##2##(1995-12#2)(2011-2#1)
sexually explicit##2##2##(1996-6#1)(2013-1#1)
sexually mature sea urchins##2##4##(2007-5#2)
sexually mature##6##2##(1996-8#1)(2007-12#1)(2007-3#1)(2007-5#2)(2008-7#1)
sexually naive##3##2##(1993-7#1)(1995-12#2)
sexually receptive female rats##5##4##(1993-7#2)(2013-8#3)
sexually receptive female##6##3##(1993-7#2)(2009-6#1)(2013-8#3)
sexually receptive##7##2##(1993-7#3)(2009-6#1)(2013-8#3)
sexually selected##6##2##(2008-8#1)(2008-9#2)(2012-3#2)(2013-1#1)
sexually transmitted HCV infection##2##4##(2007-11#1)(2011-2#1)
sexually transmitted disease (STD)##4##4##(1992-2#1)(1992-5#1)(1996-12#1)(2009-5#1)
sexually transmitted disease##12##3##(1992-2#1)(1992-5#1)(1995-4#1)(1996-12#2)(2007-11#1)(2008-4#2)(2009-5#1)(2011-2#1)(2012-1#1)(2012-3#1)
sexually transmitted diseases (STD)##2##4##(1990-3#1)(1990-6#1)
sexually transmitted diseases are##3##4##(2006-10#2)(2010-7#1)
sexually transmitted diseases in##4##4##(2006-10#1)(2007-7#3)
sexually transmitted diseases##44##3##(1990-3#1)(1990-6#1)(1991-12#3)(1991-5#1)(1991-6#1)(1992-2#2)(1992-4#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-3#1)(1995-9#2)(1996-11#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-7#2)(2005-11#1)(2006-10#3)(2007-2#1)(2007-7#4)(2009-10#1)(2009-12#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
sexually transmitted infection (STI)##2##4##(2007-12#1)(2008-12#1)
sexually transmitted infection rates##2##4##(2009-5#2)
sexually transmitted infection##8##3##(2007-12#3)(2007-7#2)(2008-12#1)(2009-5#2)
sexually transmitted infections (STI)##5##4##(2007-3#1)(2010-2#1)(2011-2#2)(2012-3#1)
sexually transmitted infections (STIs)##8##4##(2007-7#4)(2011-2#1)(2012-3#3)
sexually transmitted infections among##5##4##(2008-12#1)(2008-7#1)(2010-11#1)(2012-12#1)(2012-3#1)
sexually transmitted infections and HIV infection##2##6##(2008-1#1)(2012-12#1)
sexually transmitted infections and HIV##3##5##(2008-1#1)(2012-12#1)(2013-1#1)
sexually transmitted infections and unwanted pregnancies##2##6##(2008-11#1)(2012-2#1)
sexually transmitted infections and##8##4##(2008-1#1)(2008-11#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
sexually transmitted infections in##5##4##(2007-12#3)(2007-7#1)(2012-12#1)
sexually transmitted infections##49##3##(1994-3#1)(2006-10#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-7#6)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-5#3)(2010-11#1)(2010-2#1)(2011-1#1)(2011-12#2)(2011-2#6)(2012-12#4)(2012-2#1)(2012-3#6)(2013-1#2)(2013-8#1)
sexually transmitted viral##2##3##(2008-11#1)(2013-1#1)
sexually transmitted##131##2##(1990-3#1)(1990-6#1)(1991-12#3)(1991-5#1)(1991-6#1)(1992-2#4)(1992-4#1)(1992-5#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-3#2)(1995-11#1)(1995-4#1)(1995-9#2)(1996-11#1)(1996-12#3)(1996-6#2)(1996-9#1)(1997-3#2)(1997-6#1)(1997-7#2)(2005-11#1)(2006-10#6)(2007-11#2)(2007-12#7)(2007-2#2)(2007-3#1)(2007-7#13)(2008-1#1)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#2)(2009-5#6)(2010-11#1)(2010-12#1)(2010-2#2)(2010-7#1)(2011-1#2)(2011-12#2)(2011-2#12)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#7)(2013-1#4)(2013-8#2)
sexually##287##1##(1990-11#1)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#2)(1991-12#3)(1991-5#1)(1991-6#1)(1992-2#4)(1992-3#4)(1992-4#1)(1992-5#1)(1992-7#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#3)(1993-6#1)(1993-7#4)(1993-8#1)(1993-9#1)(1994-10#3)(1994-3#4)(1995-11#1)(1995-12#7)(1995-2#1)(1995-4#1)(1995-5#8)(1995-9#2)(1996-11#2)(1996-12#4)(1996-4#2)(1996-5#1)(1996-6#4)(1996-8#3)(1996-9#4)(1997-3#2)(1997-5#1)(1997-6#2)(1997-7#3)(2004-2#1)(2005-11#1)(2006-10#6)(2006-2#1)(2007-11#3)(2007-12#12)(2007-2#2)(2007-3#3)(2007-5#2)(2007-7#25)(2008-1#2)(2008-10#7)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#9)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-5#9)(2009-6#1)(2009-7#4)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-12#2)(2011-2#15)(2012-1#2)(2012-12#11)(2012-2#4)(2012-3#12)(2013-1#14)(2013-8#7)
sexually-transmitted##2##1##(2006-6#1)(2008-9#1)
sexuals##5##1##(2008-5#1)(2008-8#4)
sf/s##2##1##(1992-1#2)
sfGFP-TEV##3##1##(2010-2#3)
sfr-7DS##6##1##(2008-10#6)
sfu##4##1##(2008-2#4)
sgcD is##3##2##(2008-9#3)
sgcD##8##1##(2008-9#8)
sgk##5##1##(1997-4#2)(2008-8#3)
sgp130##3##1##(1997-7#3)
sgs1 top3##3##2##(2010-2#3)
sgs1##6##1##(2010-2#6)
sgv1##2##1##(1991-5#2)
shAIC##4##1##(2012-2#4)
shRNA##9##1##(2010-12#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#4)
shRNA-mediated##2##1##(2010-12#1)(2012-12#1)
shRNAs##2##1##(2012-2#1)(2013-1#1)
shack-hartmann wave-front##2##2##(2008-3#2)
shack-hartmann##3##1##(2008-3#3)
shade and##4##2##(2008-10#1)(2008-12#1)(2009-8#2)
shade avoidance##2##2##(2009-8#2)
shade of##2##2##(1991-5#1)(2007-7#1)
shade##45##1##(1991-5#1)(1992-6#1)(2004-11#1)(2006-12#2)(2007-3#7)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-12#7)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#8)(2010-2#3)(2012-2#1)(2012-6#1)(2013-1#1)(2013-8#1)
shaded##10##1##(1991-2#1)(2007-3#2)(2007-8#1)(2008-10#2)(2008-3#1)(2008-9#3)
shades A1##2##2##(2008-12#1)(2010-2#1)
shades and##3##2##(2008-12#2)(2012-12#1)
shades of##3##2##(1990-4#1)(1997-1#1)(2008-5#1)
shades##21##1##(1990-4#1)(1995-6#1)(1997-1#1)(2007-12#1)(2008-1#3)(2008-12#4)(2008-5#2)(2009-8#1)(2010-2#5)(2012-12#2)
shading##12##1##(2005-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#5)
shadow in the left lower lung##2##6##(2008-1#1)(2008-5#1)
shadow in the left lower##3##5##(2008-1#2)(2008-5#1)
shadow in the left##4##4##(2007-8#1)(2008-1#2)(2008-5#1)
shadow in##5##2##(2007-10#1)(2007-8#1)(2008-1#2)(2008-5#1)
shadow moiré##3##2##(2008-3#3)
shadow nanosphere lithography##2##3##(2006-12#2)
shadow of##10##2##(1990-5#1)(2007-8#1)(2007-9#1)(2008-2#3)(2008-3#1)(2008-6#2)(2012-1#1)
shadow on the##2##3##(2007-10#1)(2008-11#1)
shadow on##3##2##(2007-10#1)(2008-1#1)(2008-11#1)
shadow was##2##2##(1991-12#1)(2007-8#1)
shadow with##2##2##(1994-7#1)(2008-1#1)
shadow##55##1##(1990-5#1)(1991-12#2)(1994-7#2)(1997-8#1)(2006-12#2)(2007-10#2)(2007-8#3)(2007-9#1)(2008-1#7)(2008-11#1)(2008-2#6)(2008-3#10)(2008-4#1)(2008-5#2)(2008-6#5)(2008-7#2)(2008-9#3)(2012-1#1)(2013-7#2)(2013-8#1)
shadow-moiré topography is##2##3##(2008-3#2)
shadow-moiré topography##3##2##(2008-3#3)
shadowed##4##1##(1991-3#1)(2008-2#1)(2008-4#1)(2008-6#1)
shadowing function##3##2##(2008-3#3)
shadowing##11##1##(1994-8#2)(2008-2#1)(2008-3#5)(2008-5#2)(2010-12#1)
shadows and##5##2##(1996-3#1)(2008-1#1)(2008-2#2)(2008-3#1)
shadows from##2##2##(2008-1#1)(2008-6#1)
shadows in the##4##3##(1993-1#1)(2008-1#2)(2008-3#1)
shadows in##7##2##(1993-1#1)(2006-6#1)(2008-1#3)(2008-3#1)(2008-6#1)
shadows on##4##2##(2007-8#1)(2008-1#1)(2008-6#1)(2013-8#1)
shadows##35##1##(1991-12#1)(1992-1#1)(1993-1#1)(1996-3#1)(1997-8#3)(2006-6#1)(2007-8#2)(2008-1#10)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#4)(2008-8#1)(2009-10#1)(2009-12#1)(2010-1#1)(2013-8#1)
shaft and distal##2##3##(2006-11#1)(2007-11#1)
shaft and the##2##3##(2007-7#2)
shaft and##8##2##(1991-6#1)(2006-11#1)(2006-6#1)(2007-11#1)(2007-7#2)(2008-9#1)(2012-11#1)
shaft defects##2##2##(2007-7#1)(2008-11#1)
shaft fracture##7##2##(1995-3#1)(2008-12#1)(2009-3#5)
shaft fractures in##4##3##(2007-11#1)(2012-2#3)
shaft fractures##9##2##(2007-11#3)(2009-9#2)(2012-2#4)
shaft is##6##2##(2006-12#1)(2007-7#1)(2008-2#1)(2009-3#1)(2012-1#1)(2013-8#1)
shaft localisation##2##2##(2007-11#2)
shaft metastatic##2##2##(2007-11#2)
shaft of femur##2##3##(2007-11#1)(2008-7#1)
shaft of##9##2##(2004-9#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-5#1)(2008-7#1)(2011-12#1)(2012-2#1)
shaft or##2##2##(1991-2#1)(2007-8#1)
shaft were##2##2##(2007-7#2)
shaft with##2##2##(2008-12#1)(2012-1#1)
shaft##92##1##(1991-2#1)(1991-6#1)(1995-3#1)(2004-9#1)(2006-11#2)(2006-12#1)(2006-3#1)(2006-6#2)(2006-9#1)(2007-11#14)(2007-12#1)(2007-5#1)(2007-7#13)(2007-8#2)(2008-10#2)(2008-11#2)(2008-12#3)(2008-2#3)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#6)(2009-5#1)(2009-9#4)(2010-11#2)(2011-12#1)(2011-2#2)(2012-1#3)(2012-11#5)(2012-2#5)(2013-1#1)(2013-8#1)
shafts and spines##2##3##(1996-4#1)(1997-7#1)
shafts and##4##2##(1996-4#1)(1997-7#1)(2008-5#1)(2010-6#1)
shafts##12##1##(1991-9#1)(1996-4#1)(1997-7#3)(2007-8#1)(2008-5#3)(2010-6#1)(2012-11#2)
shaggy product##2##2##(1993-11#2)
shaggy##3##1##(1993-11#2)(1995-8#1)
shake flasks##6##2##(2005-11#1)(2008-11#2)(2008-12#1)(2011-2#2)
shake test##3##2##(2006-2#3)
shake##16##1##(1996-12#1)(2005-11#1)(2006-2#3)(2008-10#3)(2008-11#3)(2008-12#1)(2008-5#1)(2011-2#2)(2013-7#1)
shake-flask culture##2##2##(2008-11#1)(2008-7#1)
shake-flask##7##1##(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#3)
shaken in##2##2##(1997-6#1)(2008-5#1)
shaken##10##1##(1997-6#1)(2004-9#1)(2006-8#1)(2006-9#1)(2008-10#3)(2008-5#1)(2008-6#1)(2011-2#1)
shaker at##2##2##(2008-5#1)(2013-7#1)
shaker with##2##2##(2008-11#1)(2011-2#1)
shaker##9##1##(2007-11#1)(2008-10#1)(2008-11#2)(2008-5#3)(2011-2#1)(2013-7#1)
shaker-Schott##2##1##(2008-11#2)
shakes (WDS)##2##2##(1993-2#2)
shakes##12##1##(1991-11#1)(1991-5#2)(1993-12#2)(1993-2#3)(1995-12#3)(1996-10#1)
shaking at 150 rpm##2##4##(2008-5#2)
shaking of##2##2##(2005-11#1)(2011-2#1)
shaking speed##3##2##(2013-1#3)
shaking time after addition of##2##5##(2008-10#2)
shaking time and##2##3##(2008-10#2)
shaking time##13##2##(1997-1#1)(2008-10#12)
shaking with##6##2##(2005-12#1)(2007-11#2)(2008-10#3)
shaking##48##1##(1994-11#1)(1996-12#2)(1997-1#1)(2004-3#1)(2005-11#1)(2005-12#1)(2007-11#2)(2007-9#1)(2008-10#19)(2008-4#4)(2008-5#3)(2008-7#2)(2011-2#1)(2012-2#3)(2013-1#6)
shall be##6##2##(1990-12#1)(1991-3#1)(1995-3#1)(1996-12#1)(1997-8#1)(2008-5#1)
shall continue to##2##3##(1992-4#1)(2008-10#1)
shall discuss##2##2##(2008-5#1)(2008-9#1)
shall not be##2##3##(2006-5#1)(2007-12#1)
shall review##3##2##(2004-7#1)(2008-12#1)(2009-10#1)
shall we##3##2##(1992-8#1)(2006-7#1)(2013-8#1)
shall##43##1##(1990-12#1)(1991-3#1)(1992-4#1)(1992-8#1)(1995-3#1)(1996-12#1)(1997-8#1)(2004-7#3)(2006-10#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-12#3)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#2)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
shallot (Allium##2##2##(2012-12#1)(2012-2#1)
shallot##5##1##(2008-10#2)(2012-12#2)(2012-2#1)
shallow and##7##2##(1991-9#1)(1994-1#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-9#1)(2011-2#1)
shallow aquifers##2##2##(2009-11#2)
shallow areas##2##2##(2007-5#1)(2011-2#1)
shallow bottoms##3##2##(2007-5#3)
shallow groove##2##2##(1993-3#1)(2008-5#1)
shallow or##2##2##(2006-2#1)(2007-3#1)
shallow pockets##2##2##(2006-2#1)(2008-11#1)
shallow pool##2##2##(2008-5#2)
shallow reef##8##2##(2007-3#1)(2007-5#2)(2011-2#5)
shallow slopes##2##2##(2008-9#1)(2012-2#1)
shallow subtidal##2##2##(2008-5#1)(2013-7#1)
shallow tillage##3##2##(2008-12#3)
shallow water species##2##3##(1992-1#1)(2007-5#1)
shallow water##9##2##(1992-1#2)(2007-11#1)(2007-5#3)(2008-10#1)(2008-3#1)(2008-5#1)
shallow waters##6##2##(2007-3#1)(2008-2#3)(2008-3#1)(2011-2#1)
shallow##100##1##(1991-10#1)(1991-2#1)(1991-9#1)(1992-1#2)(1992-3#1)(1992-6#1)(1993-3#1)(1994-1#1)(1994-11#1)(1996-5#1)(1997-1#1)(2005-11#1)(2006-11#1)(2006-12#1)(2006-2#2)(2007-11#2)(2007-12#1)(2007-3#3)(2007-5#13)(2007-7#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-2#4)(2008-3#7)(2008-4#2)(2008-5#7)(2008-7#1)(2008-9#3)(2009-11#2)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#14)(2012-1#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#4)
shallow-water marine##2##2##(2007-5#1)(2008-5#1)
shallow-water##8##1##(1992-1#1)(2007-5#3)(2008-2#1)(2008-3#1)(2008-5#2)
shallower##6##1##(1992-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-8#2)
sham ECS##2##2##(1996-12#2)
sham OVARX##4##2##(1993-5#4)
sham and SCLP or CLP##2##5##(2012-3#2)
sham and##9##2##(1991-1#1)(1993-12#1)(1994-5#1)(1995-11#2)(1995-12#1)(1997-1#1)(2012-3#2)
sham animals##3##2##(1995-12#1)(2008-7#1)(2009-12#1)
sham control##4##2##(1996-9#3)(2008-5#1)
sham controlled##2##2##(2008-6#1)(2012-1#1)
sham controls##2##2##(1993-4#1)(1995-12#1)
sham group##5##2##(2012-12#2)(2012-2#2)(2012-7#1)
sham lesions##3##2##(1993-7#1)(1994-2#1)(2004-11#1)
sham operated and##2##3##(1993-5#1)(2007-1#1)
sham operated controls##3##3##(1993-3#1)(1997-3#2)
sham operated##8##2##(1993-12#1)(1993-3#1)(1993-5#1)(1994-3#1)(1997-3#2)(2007-1#1)(2008-12#1)
sham operation##6##2##(1991-1#1)(1992-4#1)(1997-5#1)(2007-10#1)(2008-7#1)(2011-2#1)
sham operations##2##2##(1994-5#1)(2011-2#1)
sham or##3##2##(1995-11#1)(2008-10#1)(2012-2#1)
sham procedures##2##2##(2007-1#1)(2009-10#1)
sham stimulation##2##2##(2011-2#1)(2013-1#1)
sham surgery##4##2##(1993-5#1)(2009-3#1)(2013-1#2)
sham##96##1##(1991-1#2)(1991-11#1)(1991-5#2)(1992-4#1)(1992-7#2)(1993-12#3)(1993-3#1)(1993-4#1)(1993-5#7)(1993-6#1)(1993-7#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1995-11#4)(1995-12#4)(1995-5#2)(1996-12#2)(1996-9#3)(1997-1#1)(1997-3#2)(1997-5#1)(2004-11#1)(2005-10#1)(2006-10#2)(2007-1#2)(2007-10#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#6)(2012-7#2)(2013-1#9)
sham-controlled##2##1##(2011-2#2)
sham-exposed animals##2##2##(1993-7#2)
sham-exposed rats##2##2##(1993-7#2)
sham-exposed##7##1##(1992-11#1)(1993-7#5)(1994-2#1)
sham-irradiated rings##2##2##(2008-11#2)
sham-irradiated##3##1##(2008-11#3)
sham-operated (SO)##4##2##(1997-4#3)(2008-5#1)
sham-operated and lesioned rats##2##4##(1994-8#2)
sham-operated and##5##2##(1992-8#1)(1994-8#2)(1997-6#2)
sham-operated animals and##4##3##(1990-10#1)(1992-1#1)(1993-2#1)(2012-1#1)
sham-operated animals##10##2##(1990-10#1)(1990-5#3)(1992-1#1)(1993-2#1)(1994-9#1)(1996-9#1)(2012-1#2)
sham-operated control##3##2##(1990-7#1)(1996-12#1)(2013-1#1)
sham-operated controls##6##2##(1990-10#1)(1990-7#1)(1992-8#1)(1993-6#1)(1997-2#1)(1997-7#1)
sham-operated group##3##2##(1995-12#2)(2010-12#1)
sham-operated or##2##2##(1993-3#1)(1995-12#1)
sham-operated rats##6##2##(1990-3#1)(1992-7#1)(1993-3#1)(1996-10#1)(2008-6#1)(2012-1#1)
sham-operated##44##1##(1990-10#2)(1990-3#1)(1990-5#4)(1990-7#2)(1992-1#1)(1992-7#1)(1992-8#2)(1993-2#1)(1993-3#2)(1993-6#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-12#4)(1996-10#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-4#3)(1997-6#2)(1997-7#1)(1997-8#1)(2008-5#1)(2008-6#1)(2010-12#1)(2012-1#3)(2013-1#1)
sham-operation##2##1##(1993-12#1)(1993-3#1)
shame and appearance##2##3##(2007-12#2)
shame and##8##2##(1997-7#1)(2007-12#3)(2008-1#1)(2008-11#1)(2010-5#1)(2011-2#1)
shame##15##1##(1997-7#1)(2004-12#1)(2007-12#5)(2007-7#1)(2008-1#3)(2008-11#2)(2010-5#1)(2011-2#1)
shame-proneness##2##1##(2009-11#2)
shameful##2##1##(2007-2#1)(2007-9#1)
shampoo (20 patients)##2##3##(2007-7#2)
shampoo and##3##2##(2008-10#2)(2008-5#1)
shampoo containing the##2##3##(2008-5#2)
shampoo containing##5##2##(2008-5#5)
shampoo formulations##3##2##(2008-5#3)
shampoo in pityriasis versicolor##2##4##(2007-7#2)
shampoo in the##2##3##(2007-7#1)(2008-5#1)
shampoo in##5##2##(2007-7#3)(2008-5#2)
shampoo products##2##2##(2008-5#2)
shampoo viscosity##4##2##(2008-5#4)
shampoo was##4##2##(2007-7#1)(2008-5#3)
shampoo were##2##2##(2007-7#1)(2008-5#1)
shampoo with##2##2##(2008-5#2)
shampoo##65##1##(1991-2#1)(2007-7#8)(2008-10#7)(2008-5#48)(2012-3#1)
shampoo)##2##1##(2008-10#1)(2008-5#1)
shampooing (dE##2##2##(2008-5#2)
shampooing##6##1##(2008-10#1)(2008-5#4)(2011-1#1)
shampooings)##2##1##(2008-5#2)
shampoos and##3##2##(2008-10#1)(2008-5#2)
shampoos are##3##2##(2008-5#3)
shampoos using##2##2##(2008-5#2)
shampoos were##4##2##(2008-5#4)
shampoos with##2##2##(2008-10#1)(2008-5#1)
shampoos##38##1##(2008-10#4)(2008-5#34)
shams##2##1##(2008-11#1)(2013-1#1)
shank##4##1##(2008-10#3)(2009-8#1)
shape =##2##2##(2007-12#2)
shape a##4##2##(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)
shape after##3##2##(2007-12#1)(2008-11#2)
shape analysis##10##2##(1992-9#1)(1994-11#1)(1996-5#2)(2005-11#3)(2008-2#1)(2013-8#2)
shape and a##3##3##(2008-2#1)(2008-5#1)(2008-7#1)
shape and an##2##3##(2008-3#2)
shape and are##2##3##(2004-9#1)(2005-11#1)
shape and deformation##2##3##(2008-2#1)(2008-3#1)
shape and intensity##4##3##(1994-6#1)(2007-12#1)(2008-3#1)(2008-5#1)
shape and location of integrin clusters##2##6##(2010-10#2)
shape and location of##3##4##(2007-11#1)(2010-10#2)
shape and orientation of##2##4##(2005-11#2)
shape and orientation##4##3##(1997-8#1)(2005-11#2)(2008-3#1)
shape and position##5##3##(2008-10#1)(2008-3#1)(2008-4#1)(2009-10#1)(2012-2#1)
shape and reflection##2##3##(2008-3#2)
shape and size of the##3##5##(2007-8#1)(2008-5#1)(2010-8#1)
shape and size of##6##4##(2007-12#1)(2007-8#1)(2008-4#1)(2008-5#1)(2010-3#1)(2010-8#1)
shape and size##20##3##(1992-7#1)(1996-7#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-5#3)(2010-3#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-8#1)
shape and structure##3##3##(2005-1#1)(2007-12#1)(2007-4#1)
shape and the##16##3##(1991-11#1)(1994-9#1)(1997-1#1)(1997-5#1)(2005-11#1)(2006-4#1)(2006-5#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-6#1)(2010-3#1)
shape and volume##2##3##(1992-6#1)(2010-8#1)
shape and##156##2##(1991-11#1)(1992-2#1)(1992-6#2)(1992-7#1)(1993-4#1)(1994-6#1)(1994-9#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-3#1)(1997-5#1)(1997-8#2)(2004-9#1)(2005-1#1)(2005-11#8)(2006-1#1)(2006-11#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#12)(2007-4#1)(2007-7#2)(2007-8#4)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#16)(2008-3#18)(2008-4#4)(2008-5#7)(2008-6#2)(2008-7#5)(2008-8#2)(2009-10#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#3)(2010-1#1)(2010-10#2)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#2)(2012-2#4)(2013-1#2)(2013-8#2)
shape are##6##2##(2007-11#1)(2008-11#1)(2008-3#2)(2008-9#1)(2009-10#1)
shape as##9##2##(1994-8#1)(1997-3#1)(2007-12#2)(2008-2#3)(2008-6#1)(2013-7#1)
shape at##2##2##(2007-12#1)(2008-3#1)
shape between the two##2##4##(1992-6#1)(2011-1#1)
shape between##4##2##(1992-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
shape by use of##2##4##(2008-2#1)(2008-3#1)
shape by##4##2##(2008-2#1)(2008-3#2)(2009-12#1)
shape can##4##2##(2006-5#1)(2008-2#1)(2008-4#1)(2009-2#1)
shape change of##3##3##(1997-1#1)(2010-5#1)(2012-12#1)
shape change##11##2##(1994-10#1)(1997-1#1)(2006-10#1)(2009-5#2)(2009-9#2)(2010-5#2)(2011-2#1)(2012-12#1)
shape changes of the##2##4##(2007-12#1)(2013-8#1)
shape changes were##2##3##(1995-10#1)(2007-11#1)
shape changes##12##2##(1995-10#1)(1996-11#1)(2007-11#1)(2007-12#3)(2007-5#1)(2011-2#2)(2012-12#2)(2013-8#1)
shape children's##2##2##(2009-6#1)(2011-2#1)
shape classification accuracy was##2##4##(2008-6#2)
shape comparison##2##2##(1993-4#2)
shape component##3##2##(2008-2#3)
shape components##3##2##(2008-2#3)
shape concerns##3##2##(2006-7#1)(2007-12#1)(2007-7#1)
shape dependence##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
shape descriptors##2##2##(2008-2#1)(2008-5#1)
shape detection##3##2##(2008-2#3)
shape deviates from##2##3##(2007-12#2)
shape deviations##2##2##(2007-12#2)
shape differences##2##2##(2011-1#2)
shape discrimination##2##2##(1992-9#2)
shape dramatically##2##2##(2008-3#1)(2011-2#1)
shape during the##4##3##(1993-9#1)(2008-3#1)(2011-2#1)(2012-2#1)
shape during##6##2##(1993-9#1)(2007-12#1)(2007-3#1)(2008-3#1)(2011-2#1)(2012-2#1)
shape effects##3##2##(2008-3#1)(2008-7#2)
shape for##7##2##(1997-7#1)(2007-1#1)(2007-12#1)(2008-3#1)(2010-1#1)(2012-11#2)
shape formation##3##2##(2012-2#3)
shape from a##2##3##(1994-4#1)(2011-1#1)
shape from the##3##3##(2008-3#2)(2010-5#1)
shape from##6##2##(1994-4#1)(2008-3#3)(2010-5#1)(2011-1#1)
shape function##3##2##(1995-9#3)
shape had##2##2##(1997-1#1)(2008-10#1)
shape how##3##2##(2012-2#2)(2012-3#1)
shape if##2##2##(1997-1#1)(2008-2#1)
shape in the##5##3##(2007-12#1)(2007-4#1)(2009-3#1)(2009-4#1)(2013-7#1)
shape in##15##2##(1992-9#1)(1997-6#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-2#1)(2008-3#3)(2009-3#1)(2009-4#1)(2010-7#1)(2013-7#2)
shape index##3##2##(2011-1#2)(2013-8#1)
shape information of##2##3##(2008-2#1)(2013-7#1)
shape information##6##2##(1995-9#1)(2008-2#2)(2009-4#1)(2010-12#1)(2013-7#1)
shape invariant model##2##3##(1995-9#2)
shape is described##3##3##(2006-12#1)(2008-11#1)(2008-2#1)
shape is##27##2##(2006-12#2)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#7)(2008-3#4)(2008-6#1)(2009-6#1)(2010-6#1)(2010-8#1)(2012-1#1)(2012-11#2)
shape measurement is##2##3##(2007-12#1)(2008-3#1)
shape measurement of a diffusing surface by use of a##2##10##(2008-3#2)
shape measurement of##4##3##(2008-3#4)
shape measurement with##2##3##(2008-2#1)(2008-3#1)
shape measurement##13##2##(2007-12#1)(2008-2#1)(2008-3#11)
shape measurements##3##2##(2007-12#1)(2008-3#2)
shape memory alloy (SMA)##3##4##(2006-6#1)(2008-2#1)(2009-7#1)
shape memory alloy##4##3##(2006-6#1)(2008-2#1)(2009-7#2)
shape memory alloys in medical##2##5##(2006-6#2)
shape memory alloys in##3##4##(2006-6#2)(2008-2#1)
shape memory alloys##5##3##(2006-6#4)(2008-2#1)
shape memory effect##3##3##(2006-6#2)(2009-7#1)
shape memory polymers##2##3##(2008-5#1)(2011-1#1)
shape memory##18##2##(2006-6#8)(2008-2#2)(2008-5#1)(2009-7#4)(2010-10#1)(2011-1#2)
shape of a##21##3##(1994-5#1)(1997-7#1)(2006-12#1)(2007-1#1)(2007-12#3)(2007-9#1)(2008-2#3)(2008-3#4)(2008-4#1)(2009-4#1)(2009-7#1)(2012-11#2)(2012-2#1)
shape of an##2##3##(2008-2#1)(2008-3#1)
shape of each##2##3##(2008-3#1)(2010-8#1)
shape of growth##3##3##(1992-6#1)(2008-11#1)(2008-12#1)
shape of the current-voltage##2##4##(1997-5#1)(2005-11#1)
shape of the distribution##3##4##(1996-1#1)(2008-3#1)(2008-8#1)
shape of the exposure response##2##5##(2008-7#2)
shape of the lumbar spine in the sagittal plane##2##9##(2012-1#2)
shape of the lumbar##3##4##(2007-7#1)(2012-1#2)
shape of the##152##3##(1990-8#1)(1991-5#1)(1992-3#2)(1993-10#1)(1994-11#1)(1994-4#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-4#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(2004-2#1)(2004-9#1)(2005-11#11)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#11)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-2#20)(2008-3#22)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#2)(2009-10#1)(2009-2#2)(2009-4#2)(2009-5#1)(2010-12#3)(2010-6#1)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
shape of this##4##3##(2005-10#1)(2008-10#1)(2008-2#1)(2008-8#1)
shape of##262##2##(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-3#2)(1992-6#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-4#1)(1994-5#2)(1994-7#1)(1994-8#2)(1994-9#2)(1995-3#1)(1995-4#1)(1995-5#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#12)(2006-10#2)(2006-11#2)(2006-12#2)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#21)(2007-5#2)(2007-7#3)(2007-8#4)(2007-9#3)(2008-1#4)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#33)(2008-3#38)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#11)(2008-8#5)(2008-9#2)(2009-10#2)(2009-11#1)(2009-2#4)(2009-4#4)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2010-12#4)(2010-6#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#4)(2012-1#3)(2012-11#4)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
shape on the##5##3##(1997-1#1)(2008-2#1)(2008-7#1)(2012-11#2)
shape on##10##2##(1997-1#1)(2007-11#1)(2008-2#1)(2008-7#1)(2010-2#1)(2010-7#1)(2012-11#4)
shape or##8##2##(1993-11#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-2#1)(2010-2#1)(2010-8#1)(2011-2#1)
shape over##3##2##(1995-9#1)(2006-11#1)(2007-11#1)
shape parameter##6##2##(2008-10#3)(2008-2#1)(2008-8#1)(2012-2#1)
shape parameters##3##2##(2008-10#2)(2008-3#1)
shape part##2##2##(2008-2#2)
shape particles##2##2##(2008-2#1)(2013-8#1)
shape perception##3##2##(1991-1#1)(2008-6#1)(2009-4#1)
shape permits the##2##3##(2008-2#2)
shape practice##2##2##(2010-9#1)(2012-1#1)
shape recognition is proposed##2##4##(2008-3#2)
shape recognition##3##2##(1995-8#1)(2008-3#2)
shape remains##2##2##(2007-12#1)(2008-1#1)
shape representation##2##2##(2008-2#1)(2008-6#1)
shape similar to##4##3##(1996-5#1)(2008-10#1)(2008-2#1)(2010-5#1)
shape similarity##3##2##(1993-4#3)
shape space##2##2##(2008-2#2)
shape than##2##2##(2010-2#1)(2013-7#1)
shape that is not##2##4##(2006-10#1)(2012-2#1)
shape that is##4##3##(1995-6#1)(2006-10#1)(2007-12#1)(2012-2#1)
shape that##10##2##(1995-6#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#2)(2009-5#1)(2012-1#1)(2012-2#1)
shape the future of##5##4##(1991-1#1)(2005-10#1)(2008-1#3)
shape the way##2##3##(2008-12#1)(2011-2#1)
shape the##40##2##(1991-1#1)(1991-2#1)(1993-12#1)(1995-1#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#1)(2007-9#1)(2008-1#3)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#2)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#1)
shape their##3##2##(2008-9#1)(2009-5#1)(2011-2#1)
shape to be##2##3##(2008-2#1)(2008-6#1)
shape to##12##2##(1995-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-6#1)(2008-8#1)(2009-10#1)(2010-8#1)(2011-1#1)
shape up##3##2##(1991-1#1)(1995-7#1)(2008-7#1)
shape variation##6##2##(2007-11#1)(2008-8#1)(2010-5#1)(2012-3#3)
shape was##5##2##(1994-4#1)(1997-1#1)(2005-11#1)(2008-11#1)(2008-4#1)
shape were calculated##2##3##(2007-12#1)(2008-2#1)
shape were##9##2##(1997-1#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-4#1)
shape when##2##2##(2008-7#1)(2011-1#1)
shape which##2##2##(1997-8#1)(2005-11#1)
shape while##2##2##(2005-11#1)(2007-11#1)
shape with a##2##3##(1993-2#1)(2008-10#1)
shape with##13##2##(1993-2#1)(1994-2#1)(1996-7#1)(1997-7#1)(2006-11#1)(2006-5#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-10#1)(2012-12#1)
shape##1148##1##(1990-11#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-1#8)(1991-11#2)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#1)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#4)(1992-6#4)(1992-7#1)(1992-9#5)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#8)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-4#5)(1994-5#3)(1994-6#1)(1994-7#1)(1994-8#4)(1994-9#3)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#2)(1995-8#2)(1995-9#7)(1996-1#2)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#5)(1996-5#6)(1996-6#3)(1996-7#2)(1996-8#3)(1997-1#15)(1997-3#6)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#5)(1997-8#5)(2004-2#1)(2004-9#3)(2005-1#2)(2005-10#2)(2005-11#36)(2005-12#1)(2006-1#4)(2006-10#7)(2006-11#5)(2006-12#6)(2006-2#1)(2006-4#1)(2006-5#3)(2006-6#12)(2006-7#3)(2006-8#2)(2006-9#1)(2007-1#4)(2007-10#3)(2007-11#22)(2007-12#97)(2007-2#1)(2007-3#3)(2007-4#5)(2007-5#3)(2007-7#14)(2007-8#12)(2007-9#10)(2008-1#11)(2008-10#42)(2008-11#15)(2008-12#6)(2008-2#138)(2008-3#127)(2008-4#15)(2008-5#29)(2008-6#19)(2008-7#25)(2008-8#16)(2008-9#8)(2009-10#8)(2009-11#2)(2009-12#3)(2009-2#8)(2009-3#1)(2009-4#12)(2009-5#10)(2009-6#5)(2009-7#10)(2009-8#7)(2009-9#3)(2010-1#4)(2010-10#5)(2010-12#9)(2010-2#6)(2010-3#2)(2010-4#2)(2010-5#7)(2010-6#6)(2010-7#5)(2010-8#9)(2010-9#2)(2011-1#16)(2011-12#1)(2011-2#25)(2012-1#14)(2012-11#16)(2012-12#7)(2012-2#21)(2012-3#10)(2013-1#11)(2013-7#10)(2013-8#14)
shape)##2##1##(2007-12#2)
shape-controlled##2##1##(2005-11#1)(2010-2#1)
shape-error curves##2##2##(2008-3#2)
shape-memory##4##1##(2009-7#3)(2012-3#1)
shaped and##7##2##(1995-5#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-9#1)(2009-5#1)
shaped beam##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
shaped by a##2##3##(2007-12#2)
shaped by the##4##3##(2008-10#1)(2008-5#1)(2012-1#1)(2012-2#1)
shaped by##25##2##(1995-12#1)(2006-10#1)(2007-12#3)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-11#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)
shaped capillaries##2##2##(2005-11#1)(2008-7#1)
shaped epidural cavernomas##2##3##(2007-8#2)
shaped femtosecond pulses##2##3##(2007-11#1)(2007-12#1)
shaped like##2##2##(2007-8#1)(2008-3#1)
shaped objects##2##2##(2008-2#1)(2008-3#1)
shaped pulse##2##2##(2007-11#1)(2008-3#1)
shaped pulses are##2##3##(2007-12#2)
shaped pulses in the##3##4##(2007-11#1)(2007-12#2)
shaped pulses##9##2##(2007-11#2)(2007-12#5)(2008-2#1)(2012-11#1)
shaped signal##2##2##(2008-3#2)
shaped the##7##2##(1993-2#1)(1994-1#1)(2008-12#1)(2009-10#1)(2009-4#1)(2010-1#1)(2012-12#1)
shaped with a##2##3##(2007-12#1)(2008-3#1)
shaped with##3##2##(2007-12#1)(2008-3#2)
shaped##159##1##(1990-11#1)(1990-12#1)(1993-2#1)(1994-1#1)(1995-12#1)(1995-5#1)(1997-3#2)(1997-8#1)(2005-11#4)(2006-10#1)(2006-12#1)(2006-3#1)(2006-4#2)(2006-5#2)(2006-8#1)(2007-11#7)(2007-12#17)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#4)(2008-1#3)(2008-10#11)(2008-11#4)(2008-12#3)(2008-2#13)(2008-3#20)(2008-5#3)(2008-7#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-6#1)(2011-1#1)(2011-12#3)(2011-2#3)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#9)(2012-3#1)(2013-1#2)(2013-8#2)
shaper and##2##2##(2008-1#1)(2008-3#1)
shaper##20##1##(2007-11#3)(2007-12#11)(2008-1#1)(2008-2#1)(2008-3#1)(2012-11#3)
shapes and sizes##6##3##(2005-11#1)(2007-12#1)(2008-10#1)(2009-2#1)(2009-8#1)(2013-1#1)
shapes and the##3##3##(2008-3#1)(2008-4#1)(2008-9#1)
shapes and##38##2##(1991-7#1)(1994-3#1)(1994-7#1)(1994-9#1)(2005-11#4)(2007-12#2)(2007-8#2)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#6)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-4#1)(2010-6#1)(2011-2#1)(2013-1#1)
shapes are##9##2##(2008-2#2)(2008-3#1)(2008-9#2)(2009-10#1)(2010-12#1)(2012-11#2)
shapes as##2##2##(2007-12#1)(2008-2#1)
shapes by##7##2##(1993-4#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-2#1)
shapes can be##4##3##(1994-8#1)(2007-12#1)(2008-2#1)(2008-3#1)
shapes in##10##2##(1994-5#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-3#3)(2008-6#1)(2008-7#1)(2009-6#1)
shapes is##2##2##(2007-8#1)(2008-3#1)
shapes of objects##5##3##(2008-1#1)(2008-2#3)(2009-10#1)
shapes of optical##2##3##(2007-11#1)(2008-3#1)
shapes of the fitness gain functions##2##6##(2008-9#2)
shapes of the##19##3##(1990-9#1)(1992-3#1)(1992-4#1)(1994-6#1)(1997-2#1)(1997-7#1)(2004-9#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-2#4)(2008-3#1)(2008-9#2)(2010-5#1)(2013-1#1)
shapes of##53##2##(1990-9#1)(1991-7#1)(1992-3#1)(1992-4#1)(1994-6#1)(1994-8#1)(1995-10#1)(1996-6#1)(1997-2#1)(1997-7#1)(2004-9#1)(2005-10#1)(2005-11#2)(2006-10#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-2#8)(2008-3#8)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-10#2)(2009-5#1)(2009-6#1)(2010-5#1)(2012-11#2)(2013-1#1)
shapes were observed##2##3##(2008-10#1)(2011-1#1)
shapes were##10##2##(2004-9#2)(2006-11#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)(2012-1#1)
shapes while##2##2##(2008-11#1)(2008-2#1)
shapes with##3##2##(2008-6#2)(2009-12#1)
shapes##237##1##(1990-11#1)(1990-9#1)(1991-7#3)(1992-3#1)(1992-4#1)(1992-6#2)(1992-9#3)(1993-4#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-10#2)(1995-5#1)(1996-6#1)(1997-2#1)(1997-7#1)(1997-8#3)(2004-9#7)(2005-10#1)(2005-11#8)(2006-10#2)(2006-11#2)(2006-12#1)(2006-4#2)(2006-5#1)(2007-11#4)(2007-12#17)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#32)(2008-3#30)(2008-4#2)(2008-5#3)(2008-6#8)(2008-7#5)(2008-9#9)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#4)(2012-2#1)(2012-3#2)(2013-1#4)
shaping a##2##2##(2008-2#2)
shaping and polishing##2##3##(2008-2#2)
shaping and##11##2##(2005-11#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-2#5)(2008-3#1)(2008-9#1)
shaping by use of##2##4##(2007-11#1)(2007-12#1)
shaping by##5##2##(2007-11#2)(2007-12#2)(2008-2#1)
shaping can##2##2##(2007-11#1)(2008-2#1)
shaping health##2##2##(1990-12#1)(1996-2#1)
shaping in a##2##3##(2007-11#1)(2007-12#1)
shaping in##7##2##(2007-11#3)(2007-12#3)(2008-2#1)
shaping of a##2##3##(2007-11#2)
shaping of the##5##3##(2007-11#3)(2007-12#1)(2008-11#1)
shaping of##22##2##(2006-11#1)(2007-10#1)(2007-11#6)(2007-12#9)(2008-11#2)(2008-2#1)(2008-3#2)
shaping the##12##2##(1995-11#1)(1996-8#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-8#2)(2009-6#1)(2011-2#1)(2011-3#1)(2012-12#1)
shaping their##2##2##(1996-6#1)(2013-7#1)
shaping was##2##2##(2008-1#1)(2008-3#1)
shaping##146##1##(1990-12#1)(1991-11#1)(1993-1#1)(1994-1#1)(1994-12#1)(1995-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-1#1)(2005-11#4)(2006-11#2)(2006-5#1)(2007-10#1)(2007-11#27)(2007-12#26)(2007-2#1)(2007-9#1)(2008-1#4)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#19)(2008-3#8)(2008-4#2)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-2#1)(2009-6#2)(2009-7#2)(2009-8#2)(2010-8#2)(2010-9#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#2)
sharable##2##1##(2013-1#2)
shards##3##1##(2008-10#3)
share a common ancestor##2##4##(1991-6#1)(2012-2#1)
share a common mechanism of action##2##6##(1994-5#1)(1997-5#1)
share a common mechanism##3##4##(1990-2#1)(1994-5#1)(1997-5#1)
share a common##32##3##(1990-2#2)(1990-9#1)(1991-6#2)(1992-5#1)(1992-7#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-6#1)(1997-1#1)(1997-5#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-8#3)(2008-9#1)(2010-10#1)(2012-12#2)(2012-2#1)
share a conserved##2##3##(2010-12#1)(2012-12#1)
share a high degree of##2##5##(1994-11#1)(2008-10#1)
share a high##3##3##(1994-11#1)(1997-6#1)(2008-10#1)
share a similar##5##3##(1991-7#1)(1996-6#1)(2007-12#1)(2008-1#1)(2008-8#1)
share a##71##2##(1990-12#1)(1990-2#2)(1990-5#1)(1990-9#1)(1991-6#2)(1991-7#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-6#2)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-6#2)(1996-12#1)(1996-6#1)(1997-1#1)(1997-5#1)(1997-6#1)(2006-12#1)(2007-10#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#7)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)
share about##3##2##(1994-12#1)(2008-7#1)(2011-1#1)
share an##5##2##(1995-6#1)(1996-12#1)(2006-8#1)(2008-10#1)(2013-1#1)
share and##7##2##(1993-1#1)(1996-1#1)(1996-3#1)(2007-4#1)(2007-7#1)(2008-12#1)(2008-8#1)
share any##2##2##(2008-10#1)(2008-4#1)
share approximately##2##2##(2008-10#2)
share clinical##2##2##(1996-3#1)(2012-12#1)
share common biological##2##3##(1994-5#1)(2008-9#1)
share common mechanisms##2##3##(2011-2#1)(2012-2#1)
share common##19##2##(1990-3#1)(1990-6#1)(1991-5#1)(1991-9#1)(1994-11#1)(1994-5#2)(1994-8#1)(1997-1#1)(2008-10#2)(2008-9#1)(2010-11#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
share data about##3##3##(1996-12#1)(2013-1#2)
share each##2##2##(1996-12#1)(2008-2#1)
share extensive##2##2##(1994-2#1)(1994-9#1)
share findings##2##2##(2006-5#1)(2012-3#1)
share for##3##2##(1993-10#1)(2006-5#2)
share from##3##2##(1991-3#1)(1993-10#1)(1997-1#1)
share greater##3##2##(2008-10#3)
share high homology##2##3##(1994-12#1)(2009-8#1)
share high##4##2##(1994-12#1)(2007-6#1)(2008-10#1)(2009-8#1)
share homology with known##2##4##(1991-12#1)(1993-9#1)
share homology with##5##3##(1991-12#2)(1993-9#1)(1995-3#1)(1996-8#1)
share identical##2##2##(2009-12#1)(2011-2#1)
share in the##6##3##(1996-3#1)(2008-8#1)(2008-9#2)(2009-9#1)(2012-11#1)
share in their##2##3##(1995-12#1)(2008-7#1)
share in##12##2##(1993-1#1)(1995-12#1)(1996-3#1)(2006-10#1)(2007-9#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-9#1)(2012-11#1)
share is##2##2##(1993-5#1)(2008-12#1)
share low amino acid identities##2##5##(2008-10#2)
share many characteristics##2##3##(1997-4#1)(2008-9#1)
share many clinical##2##3##(1997-5#1)(2009-5#1)
share many features##2##3##(1997-3#2)
share many##14##2##(1996-3#1)(1997-3#2)(1997-4#1)(1997-5#1)(2004-2#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-5#1)(2012-2#1)(2012-3#1)(2013-8#1)
share more than##2##3##(1991-5#1)(1996-10#1)
share more##4##2##(1991-5#1)(1993-12#1)(1996-10#1)(2007-4#1)
share morphological features##2##3##(2008-10#1)(2013-1#1)
share no##3##2##(1995-8#1)(1997-6#1)(2008-8#1)
share of gross domestic product##2##5##(1991-2#1)(1992-12#1)
share of gross##3##3##(1991-2#1)(1992-12#1)(1992-3#1)
share of health care##2##4##(1990-12#1)(1997-1#1)
share of health##6##3##(1990-12#1)(1995-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-7#1)
share of the Nation's health##2##5##(1992-3#1)(1995-3#1)
share of the Nation's##3##4##(1992-12#1)(1992-3#1)(1995-3#1)
share of the##14##3##(1990-12#1)(1990-4#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-1#1)(1995-3#1)(1997-2#2)(2006-4#1)(2008-8#1)(2009-4#1)(2010-8#1)(2011-12#1)
share of total##4##3##(1991-2#1)(1996-2#1)(2007-3#1)(2008-10#1)
share of##46##2##(1990-12#2)(1990-4#1)(1991-12#1)(1991-2#2)(1992-12#2)(1992-2#1)(1992-3#2)(1993-11#1)(1993-12#1)(1994-1#2)(1994-3#1)(1995-1#2)(1995-3#3)(1996-1#1)(1996-2#1)(1997-1#2)(1997-2#3)(1997-3#1)(2006-4#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
share one##2##2##(2008-1#1)(2008-10#1)
share only##4##2##(1994-9#1)(1996-10#1)(2006-12#1)(2008-7#1)
share our##3##2##(1995-12#1)(2008-12#2)
share relatively##3##2##(1995-11#1)(2011-2#2)
share responsibility for the##2##4##(1992-3#1)(1992-5#1)
share sequence##2##2##(1991-9#1)(2010-4#1)
share several common##3##3##(1997-2#1)(1997-4#1)(2010-10#1)
share several##8##2##(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2009-10#1)(2010-10#1)(2011-2#2)
share significant##3##2##(1993-12#1)(1995-2#1)(2009-8#1)
share similar##10##2##(1992-11#1)(1994-8#1)(1995-2#1)(2005-8#1)(2007-4#1)(2008-1#2)(2009-9#1)(2011-1#1)(2011-2#1)
share six##2##2##(1991-8#1)(1994-12#1)
share some of the##3##4##(1995-11#1)(2008-6#1)(2012-2#1)
share some##10##2##(1990-7#1)(1991-11#1)(1991-6#1)(1995-11#1)(1996-4#1)(2007-7#1)(2007-9#1)(2008-6#1)(2008-8#1)(2012-2#1)
share structural##3##2##(1990-12#1)(2008-4#1)(2008-5#1)
share the ability to##3##4##(1993-9#1)(1994-12#1)(2006-10#1)
share the common##4##3##(1991-2#1)(1995-3#1)(1997-1#1)(2006-12#1)
share the motif of##2##4##(1995-8#1)(2007-12#1)
share the same##23##3##(1992-6#1)(1993-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1997-4#1)(2006-12#1)(2006-6#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-8#2)
share the##60##2##(1991-2#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-3#1)(1995-8#1)(1997-1#1)(1997-4#1)(2005-9#1)(2006-10#1)(2006-12#2)(2006-6#2)(2006-7#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#3)
share their views on##2##4##(1992-3#1)(2008-12#1)
share their##18##2##(1992-3#2)(1994-10#1)(2007-8#1)(2008-11#3)(2008-12#2)(2008-7#1)(2008-9#2)(2010-11#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)
share this##3##2##(1996-1#1)(2008-3#1)(2012-3#1)
share various##2##2##(2005-10#1)(2008-8#1)
share very##2##2##(1995-5#1)(2011-1#1)
share with##7##2##(1992-11#1)(1994-1#1)(1995-5#1)(2007-12#2)(2008-6#1)(2010-9#1)
share##479##1##(1990-11#1)(1990-12#4)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#7)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#5)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#7)(1992-5#3)(1992-6#2)(1992-7#1)(1992-8#1)(1993-1#2)(1993-10#2)(1993-11#2)(1993-12#3)(1993-2#2)(1993-5#1)(1993-6#4)(1993-9#2)(1994-1#4)(1994-10#1)(1994-11#2)(1994-12#7)(1994-2#3)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#4)(1994-9#4)(1995-1#5)(1995-11#4)(1995-12#4)(1995-2#5)(1995-3#7)(1995-5#2)(1995-6#3)(1995-8#3)(1996-1#4)(1996-10#2)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#6)(1996-4#1)(1996-6#1)(1996-8#1)(1997-1#8)(1997-2#5)(1997-3#4)(1997-4#3)(1997-5#2)(1997-6#4)(1997-7#3)(2004-2#1)(2005-10#1)(2005-11#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#2)(2006-12#4)(2006-4#1)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#9)(2007-2#1)(2007-3#3)(2007-4#5)(2007-6#1)(2007-7#6)(2007-8#2)(2007-9#2)(2008-1#11)(2008-10#30)(2008-11#7)(2008-12#9)(2008-2#4)(2008-3#4)(2008-4#8)(2008-5#3)(2008-6#9)(2008-7#9)(2008-8#16)(2008-9#10)(2009-10#3)(2009-12#1)(2009-4#1)(2009-5#2)(2009-8#3)(2009-9#4)(2010-10#3)(2010-11#4)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#19)(2011-4#1)(2012-11#2)(2012-12#6)(2012-2#11)(2012-3#7)(2013-1#15)(2013-7#3)(2013-8#7)
shared (OR##2##2##(2008-7#2)
shared 98##3##2##(2010-4#1)(2010-5#2)
shared a##12##2##(1990-11#1)(1993-8#1)(1994-11#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-8#1)(2012-1#1)(2012-12#1)
shared across##3##2##(2006-3#1)(2008-10#1)(2010-2#1)
shared among##8##2##(1992-2#1)(1993-4#1)(2008-10#3)(2008-2#1)(2008-8#1)(2012-3#1)
shared and##6##2##(1990-7#1)(1992-3#1)(1995-1#1)(2011-12#1)(2013-1#2)
shared between##7##2##(1991-4#1)(1992-7#1)(1993-6#1)(1994-8#1)(1997-9#1)(2009-3#1)(2010-5#1)
shared brokering concept##2##3##(2005-10#2)
shared brokering##4##2##(2005-10#4)
shared by a##3##3##(1994-3#1)(1996-3#1)(1997-7#1)
shared by all known##2##4##(1995-8#1)(2008-4#1)
shared by all members of the##2##6##(1993-6#1)(2008-10#1)
shared by all##13##3##(1990-11#1)(1991-1#1)(1993-6#1)(1995-11#1)(1995-8#1)(1996-7#1)(1997-3#1)(1997-9#1)(2008-10#1)(2008-4#1)(2012-12#1)(2012-2#1)(2013-8#1)
shared by both##4##3##(1990-12#1)(2007-12#1)(2008-7#1)(2011-2#1)
shared by humans and##2##4##(1994-2#1)(2008-9#1)
shared by members of the##2##5##(1993-8#1)(2013-8#1)
shared by other##4##3##(1992-6#1)(1993-6#1)(1994-9#1)(2007-3#1)
shared by several##2##3##(2008-10#1)(2008-2#1)
shared by the##10##3##(1991-11#1)(1992-9#1)(1994-2#1)(1995-11#1)(1995-2#1)(1996-12#1)(1997-4#1)(2005-7#1)(2007-8#1)(2008-10#1)
shared by these two##2##4##(1997-2#1)(2008-4#1)
shared by these##4##3##(1994-3#1)(1997-2#1)(2008-4#1)(2008-5#1)
shared by##82##2##(1990-10#1)(1990-11#1)(1990-12#1)(1991-1#1)(1991-11#1)(1991-5#1)(1991-6#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#2)(1993-8#1)(1994-2#2)(1994-3#2)(1994-9#1)(1995-11#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#3)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-9#1)(2005-7#1)(2006-10#1)(2006-12#2)(2007-1#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-7#1)(2013-8#2)
shared care planning##4##3##(2013-1#4)
shared care##8##2##(2006-8#1)(2008-2#1)(2011-2#1)(2013-1#4)(2013-8#1)
shared common##2##2##(1992-2#1)(2012-12#1)
shared components##2##2##(2008-11#1)(2010-5#1)
shared decision making##5##3##(2007-4#3)(2008-1#1)(2011-1#1)
shared epitopes##2##2##(1990-7#2)
shared experiences##2##2##(1996-4#1)(2010-11#1)
shared extensive homology with##2##4##(1990-7#1)(1994-12#1)
shared genetic##4##2##(2006-9#2)(2011-2#1)(2012-3#1)
shared goals##2##2##(2009-7#1)(2012-2#1)
shared governance##3##2##(1993-2#1)(1994-10#1)(2012-3#1)
shared high homology##2##3##(1994-12#1)(2005-11#1)
shared highest nucleotide sequence identity with##3##6##(2008-10#3)
shared highest nucleotide sequence##4##4##(2008-10#4)
shared identical##2##2##(2008-10#2)
shared in the##2##3##(2007-12#1)(2009-6#1)
shared in##4##2##(2007-12#1)(2008-10#2)(2009-6#1)
shared information##2##2##(2011-2#1)(2013-8#1)
shared leadership in##2##3##(1995-1#2)
shared learning and##2##3##(1995-12#1)(2008-11#1)
shared learning##3##2##(1995-12#1)(2008-11#2)
shared lymphoma idiotypes are##2##4##(1990-7#2)
shared lymphoma idiotypes##5##3##(1990-7#5)
shared memory##2##2##(2011-1#1)(2012-2#1)
shared more##3##2##(2008-11#1)(2012-12#1)(2013-7#1)
shared on##2##2##(1992-12#1)(2010-10#1)
shared only##5##2##(1990-11#1)(1991-2#1)(1993-3#1)(2008-10#1)(2008-5#1)
shared or##4##2##(2008-7#2)(2009-6#1)(2012-2#1)
shared partner##2##2##(2008-3#1)(2008-5#1)
shared resources##2##2##(1995-2#1)(2013-1#1)
shared responsibility and##2##3##(2007-10#1)(2013-8#1)
shared responsibility##5##2##(2007-10#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
shared risk factors for internalizing##2##5##(2012-12#2)
shared risk factors##3##3##(1995-4#1)(2012-12#2)
shared services##3##2##(1992-2#3)
shared similar##6##2##(1997-6#1)(2006-10#1)(2008-10#1)(2008-9#1)(2009-6#1)(2009-8#1)
shared structural##2##2##(1995-3#1)(2006-10#1)
shared the same##6##3##(1990-11#1)(1993-11#1)(1993-2#1)(2007-7#1)(2008-10#1)(2012-1#1)
shared the##9##2##(1990-11#1)(1993-11#1)(1993-2#1)(1994-3#1)(2007-7#1)(2008-10#2)(2012-1#1)(2013-8#1)
shared understanding of##3##3##(1997-3#1)(2008-12#1)(2008-7#1)
shared understanding##5##2##(1997-3#1)(2008-12#1)(2008-7#1)(2010-2#1)(2013-1#1)
shared vision and##2##3##(1993-12#1)(1996-12#1)
shared vision of##2##3##(1995-2#1)(2008-1#1)
shared vision##8##2##(1993-12#1)(1995-1#1)(1995-2#1)(1996-12#1)(2008-1#2)(2010-10#1)(2012-11#1)
shared with other##2##3##(2004-11#1)(2012-1#1)
shared with the##4##3##(1993-2#1)(2008-6#2)(2013-1#1)
shared with##18##2##(1991-6#1)(1993-2#1)(1995-2#1)(2004-11#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-9#1)(2012-1#1)(2012-3#1)(2013-1#2)
shared##413##1##(1990-10#1)(1990-11#4)(1990-12#1)(1990-7#9)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#2)(1992-12#1)(1992-2#5)(1992-3#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#4)(1993-3#2)(1993-4#2)(1993-6#3)(1993-8#2)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#4)(1994-3#5)(1994-8#1)(1994-9#6)(1995-1#5)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#4)(1996-7#2)(1997-2#1)(1997-3#2)(1997-4#3)(1997-6#2)(1997-7#3)(1997-8#2)(1997-9#2)(2004-11#1)(2004-3#1)(2005-10#4)(2005-11#2)(2005-7#2)(2006-10#7)(2006-12#4)(2006-3#3)(2006-5#1)(2006-8#1)(2006-9#3)(2007-1#1)(2007-10#2)(2007-12#6)(2007-2#2)(2007-3#2)(2007-4#6)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#7)(2008-10#35)(2008-11#11)(2008-12#3)(2008-2#7)(2008-3#3)(2008-4#8)(2008-5#9)(2008-6#2)(2008-7#12)(2008-8#10)(2008-9#6)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#7)(2010-6#1)(2010-8#2)(2011-1#6)(2011-12#3)(2011-2#8)(2012-1#3)(2012-11#2)(2012-12#12)(2012-2#8)(2012-3#6)(2013-1#20)(2013-7#2)(2013-8#8)
shared-medium##2##1##(2008-2#2)
shareholder and partnership agreements##2##4##(1993-3#2)
shareholder relationships##3##2##(1993-2#1)(1993-3#1)(1994-1#1)
shareholder value##4##2##(2005-8#2)(2013-8#2)
shareholder##12##1##(1993-2#1)(1993-3#3)(1994-1#1)(1997-7#1)(2005-8#3)(2007-4#1)(2013-8#2)
shares 78%##2##2##(1993-9#1)(1996-4#1)
shares 92##2##2##(1993-2#1)(2008-10#1)
shares a common##5##3##(1990-2#1)(1991-6#1)(2007-3#1)(2008-10#1)(2010-2#1)
shares a more recent##2##4##(1995-11#1)(2008-10#1)
shares a most recent common ancestor with##3##7##(2008-10#3)
shares a similar##2##3##(1992-12#1)(2008-6#1)
shares a##28##2##(1990-2#1)(1991-6#1)(1992-12#1)(1993-8#1)(1994-2#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-5#1)(1996-6#1)(1997-6#2)(2007-3#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-2#1)(2012-2#1)(2013-8#1)
shares amino acid##2##3##(2008-10#1)(2011-1#1)
shares an##2##2##(1990-5#1)(2012-12#1)
shares common##2##2##(1993-6#1)(1997-1#1)
shares features with##3##3##(1990-5#1)(2008-7#1)(2009-8#1)
shares high##3##2##(1994-9#1)(1995-6#1)(2008-9#1)
shares his##2##2##(1992-2#1)(2007-8#1)
shares homology with##3##3##(1994-3#1)(2008-9#1)(2010-3#1)
shares its##3##2##(1997-1#1)(2008-4#2)
shares many features##3##3##(2008-4#1)(2009-11#1)(2012-12#1)
shares many similarities##2##3##(2007-12#1)(2008-4#1)
shares many##8##2##(1990-12#1)(2007-12#1)(2008-4#2)(2008-6#1)(2009-11#1)(2011-2#1)(2012-12#1)
shares no sequence homology with##2##5##(1990-11#1)(1997-7#1)
shares no sequence##3##3##(1990-11#1)(1994-3#1)(1997-7#1)
shares no##6##2##(1990-11#1)(1990-9#1)(1994-12#1)(1994-3#1)(1997-7#1)(2008-7#1)
shares one##2##2##(1990-5#1)(2005-12#1)
shares overall##2##2##(1996-10#1)(2008-10#1)
shares sequence homology with##2##4##(1997-3#1)(1997-4#1)
shares sequence similarities with##2##4##(1993-9#1)(1995-2#1)
shares sequence##6##2##(1993-9#1)(1995-2#1)(1995-3#1)(1996-9#1)(1997-3#1)(1997-4#1)
shares significant homology with##3##4##(1997-3#1)(1997-6#1)(2008-10#1)
shares significant##6##2##(1994-3#1)(1997-1#1)(1997-3#2)(1997-6#1)(2008-10#1)
shares similar##2##2##(1994-2#1)(2010-10#1)
shares similarities to##2##3##(1995-2#1)(1997-4#1)
shares similarities##4##2##(1995-2#2)(1997-4#1)(2008-4#1)
shares some##8##2##(1991-6#1)(1994-3#1)(1995-9#1)(1996-2#1)(1997-4#1)(1997-7#1)(2011-1#1)(2013-8#1)
shares structural homology with##2##4##(1993-9#1)(1994-12#1)
shares structural##4##2##(1990-5#1)(1992-9#1)(1993-9#1)(1994-12#1)
shares the same##2##3##(2008-4#1)(2008-9#1)
shares the##11##2##(1993-7#1)(1995-6#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
shares this##2##2##(1993-12#1)(1994-2#1)
shares with##4##2##(2008-10#1)(2008-8#1)(2009-5#1)(2009-9#1)
shares##175##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#4)(1990-6#1)(1990-9#1)(1991-6#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#3)(1994-1#4)(1994-12#7)(1994-2#3)(1994-3#4)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#3)(1995-3#2)(1995-6#5)(1995-8#2)(1995-9#1)(1996-10#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#4)(1997-3#3)(1997-4#5)(1997-6#3)(1997-7#3)(2005-12#2)(2006-12#1)(2007-12#1)(2007-3#1)(2007-8#2)(2008-10#16)(2008-12#2)(2008-3#1)(2008-4#7)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#6)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#2)(2010-3#1)(2011-1#4)(2011-12#1)(2011-2#2)(2012-12#3)(2012-2#3)(2013-1#1)(2013-8#4)
sharing (P &lt##2##3##(1997-5#2)
sharing (P = 0##4##4##(1997-5#4)
sharing (P##6##2##(1997-5#6)
sharing a##8##2##(1990-4#1)(1997-2#1)(2008-10#2)(2008-8#1)(2009-11#1)(2012-2#2)
sharing among##4##2##(1997-2#1)(1997-5#2)(2012-3#1)
sharing and##8##2##(2008-4#1)(2009-6#1)(2010-5#1)(2011-12#1)(2011-9#1)(2012-2#2)(2012-3#1)
sharing as##2##2##(1996-12#1)(2008-2#1)
sharing between##2##2##(2006-11#1)(2006-5#1)
sharing common##5##2##(2007-6#1)(2008-10#1)(2009-12#1)(2009-9#1)(2012-2#1)
sharing in the##3##3##(1992-2#1)(1996-3#1)(1997-5#1)
sharing in##9##2##(1992-2#1)(1994-3#1)(1995-3#1)(1996-3#1)(1997-3#1)(1997-5#1)(2009-6#1)(2012-11#1)(2012-12#1)
sharing information##2##2##(1995-12#1)(2008-12#1)
sharing is##2##2##(1991-11#1)(2008-11#1)
sharing its##2##2##(1994-1#1)(2013-8#1)
sharing knowledge##2##2##(2008-4#2)
sharing losses##2##2##(1997-8#2)
sharing more##2##2##(2011-2#2)
sharing needles##3##2##(2007-6#1)(2012-3#2)
sharing of experiences##2##3##(2007-4#2)
sharing of losses##2##3##(1993-12#1)(1997-8#1)
sharing of the##2##3##(2007-3#1)(2013-8#1)
sharing of##30##2##(1993-12#1)(1994-12#1)(1995-3#1)(1996-1#1)(1997-8#1)(2005-10#1)(2007-1#1)(2007-3#1)(2007-4#2)(2008-11#3)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
sharing on##2##2##(1995-2#1)(2012-2#1)
sharing several##3##2##(1993-11#1)(1997-1#1)(2013-1#1)
sharing that##2##2##(2008-10#1)(2011-2#1)
sharing the same##5##3##(1990-5#1)(2008-1#1)(2008-10#1)(2009-6#1)(2012-2#1)
sharing the##15##2##(1990-5#1)(1993-1#1)(1995-8#1)(1997-2#2)(2006-10#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-6#1)(2010-3#1)(2011-1#1)(2012-2#1)
sharing their##4##2##(2007-2#1)(2008-11#1)(2008-6#1)(2013-1#1)
sharing this##2##2##(1993-3#1)(2006-8#1)
sharing through##2##2##(1997-2#1)(2008-1#1)
sharing were##2##2##(1997-5#1)(2006-5#1)
sharing with the##2##3##(2010-2#1)(2013-1#1)
sharing with##4##2##(1992-11#1)(2010-2#1)(2010-7#1)(2013-1#1)
sharing##220##1##(1990-4#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#1)(1992-11#1)(1992-2#2)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-3#1)(1994-1#1)(1994-12#1)(1994-3#3)(1994-4#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#3)(1995-3#4)(1995-8#1)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#4)(1996-3#1)(1997-1#1)(1997-2#5)(1997-3#3)(1997-5#15)(1997-7#1)(1997-8#3)(2005-10#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-2#3)(2006-4#2)(2006-5#3)(2006-7#2)(2006-8#1)(2007-1#3)(2007-10#1)(2007-2#2)(2007-3#1)(2007-4#3)(2007-6#3)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#11)(2008-11#6)(2008-12#3)(2008-2#2)(2008-4#3)(2008-5#4)(2008-6#2)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#5)(2009-8#2)(2009-9#3)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#4)(2011-9#2)(2012-11#1)(2012-12#3)(2012-2#10)(2012-3#5)(2013-1#20)(2013-8#6)
shark fishing##2##2##(2007-5#2)
shark landings##2##2##(2007-5#2)
shark##16##1##(1990-4#2)(1994-11#3)(1994-2#1)(1994-5#1)(2007-5#7)(2008-11#1)(2008-5#1)
sharks##6##1##(2008-5#2)(2010-8#4)
sharp and##8##2##(1997-4#1)(2006-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-8#1)(2012-2#1)
sharp at##3##2##(1991-11#1)(1994-12#1)(2010-4#1)
sharp band##2##2##(1990-7#1)(1993-12#1)
sharp boundaries##5##2##(1991-11#1)(1991-3#1)(1995-12#1)(2008-3#1)(2012-12#1)
sharp changes##2##2##(2009-2#1)(2010-1#1)
sharp contrast to the##9##4##(1991-10#1)(1995-7#1)(1996-8#1)(2005-11#1)(2006-10#2)(2008-11#1)(2008-7#1)(2009-8#1)
sharp contrast to##12##3##(1990-5#1)(1991-10#1)(1991-4#1)(1992-9#1)(1995-7#1)(1996-8#1)(2005-11#1)(2006-10#2)(2008-11#1)(2008-7#1)(2009-8#1)
sharp contrast##18##2##(1990-5#1)(1991-10#1)(1991-4#1)(1992-9#1)(1994-11#1)(1995-7#1)(1996-8#1)(2005-11#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-8#1)
sharp correlation##2##2##(2008-2#1)(2008-3#1)
sharp decline in##4##3##(2007-7#1)(2008-7#1)(2009-6#1)(2013-8#1)
sharp decline##7##2##(1990-2#1)(1991-3#1)(2007-7#1)(2008-11#1)(2008-7#1)(2009-6#1)(2013-8#1)
sharp decrease##9##2##(1997-1#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-7#1)(2010-5#1)(2012-2#1)
sharp decreases##2##2##(2007-7#1)(2008-12#1)
sharp dissection##2##2##(1993-12#1)(2008-7#1)
sharp edges##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
sharp features##2##2##(2008-2#1)(2008-3#1)
sharp focus##2##2##(2005-8#1)(2010-12#1)
sharp increase in the##3##4##(2008-11#1)(2010-12#1)(2012-12#1)
sharp increase in##11##3##(1993-12#1)(1993-6#1)(1995-8#1)(1997-1#1)(1997-3#1)(2004-4#1)(2005-11#1)(2007-8#1)(2008-11#1)(2010-12#1)(2012-12#1)
sharp increase##15##2##(1993-12#1)(1993-6#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-3#1)(2004-4#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-12#1)(2012-12#1)
sharp metallic##2##2##(2008-2#1)(2008-3#1)
sharp objects##2##2##(2005-12#1)(2011-2#1)
sharp peak##4##2##(1995-10#1)(2008-10#2)(2008-7#1)
sharp peaks in##2##3##(2008-2#1)(2008-5#1)
sharp peaks##4##2##(1995-3#1)(2008-2#2)(2008-5#1)
sharp spectral features##2##3##(2008-2#1)(2008-7#1)
sharp spectral##3##2##(2007-11#1)(2008-2#1)(2008-7#1)
sharp violence##2##2##(1995-3#1)(1996-5#1)
sharp waves##4##2##(1990-5#3)(2006-12#1)
sharp##203##1##(1990-2#1)(1990-3#2)(1990-5#5)(1990-7#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-3#5)(1991-4#1)(1991-7#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-3#3)(1995-6#1)(1995-7#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-7#2)(2004-4#1)(2004-9#1)(2005-1#1)(2005-11#2)(2005-12#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-6#1)(2006-7#1)(2007-11#7)(2007-12#11)(2007-2#1)(2007-7#2)(2007-8#3)(2007-9#3)(2008-10#16)(2008-11#4)(2008-12#2)(2008-2#16)(2008-3#13)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#2)(2009-11#2)(2009-2#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#2)(2012-11#1)(2012-12#5)(2012-2#2)(2012-3#1)(2013-8#1)
sharp-interface##2##1##(2009-11#2)
sharpen##3##1##(1996-3#1)(2008-2#1)(2008-3#1)
sharpened##3##1##(1991-7#1)(1994-6#1)(2012-12#1)
sharpeners are##2##2##(2008-2#2)
sharpeners##5##1##(1994-6#1)(2008-2#4)
sharpening is##2##2##(1994-6#2)
sharpening of##3##2##(1992-12#1)(2008-2#2)
sharpening the##2##2##(2008-3#1)(2008-5#1)
sharpening##17##1##(1992-12#1)(1994-6#5)(2008-10#1)(2008-2#5)(2008-3#2)(2008-5#1)(2011-1#2)
sharpens##2##1##(1996-2#1)(2008-2#1)
sharper peaks##2##2##(1996-8#1)(2008-3#1)
sharper##15##1##(1996-8#2)(1997-7#1)(2006-11#1)(2008-10#2)(2008-2#6)(2008-3#2)(2008-5#1)
sharply and##5##2##(1992-6#1)(2007-12#1)(2008-3#1)(2012-1#1)(2012-12#1)
sharply at##2##2##(1995-1#1)(2008-10#1)
sharply contrasts with##2##3##(1995-12#1)(2007-10#1)
sharply defined##5##2##(1990-4#1)(2007-12#1)(2008-1#1)(2008-2#1)(2012-12#1)
sharply demarcated##3##2##(2005-12#1)(2009-3#1)(2010-6#1)
sharply enhanced##2##2##(2008-11#1)(2008-2#1)
sharply from##4##2##(1993-6#1)(2006-10#1)(2008-10#1)(2009-3#1)
sharply in##3##2##(2007-8#1)(2008-1#1)(2012-12#1)
sharply increased##6##2##(1990-7#1)(1995-11#1)(2007-3#1)(2007-8#1)(2010-12#1)(2012-1#1)
sharply peaked##3##2##(1990-10#1)(2007-12#1)(2009-9#1)
sharply reduced##3##2##(1992-12#1)(2008-10#1)(2012-1#1)
sharply separated##2##2##(2007-10#1)(2008-6#1)
sharply##79##1##(1990-10#1)(1990-12#1)(1990-4#1)(1990-7#1)(1991-4#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-12#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-5#2)(1995-6#1)(1996-2#1)(1996-5#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#2)(2007-12#4)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#2)(2009-3#2)(2009-4#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-5#1)(2010-6#1)(2011-2#1)(2012-1#3)(2012-12#3)(2012-2#1)
sharpness##18##1##(1994-8#1)(2007-12#3)(2008-2#4)(2008-3#8)(2013-1#2)
sharps injuries##2##2##(2006-7#1)(2008-9#1)
sharps injury##2##2##(2006-8#2)
sharps##9##1##(2006-7#1)(2006-8#4)(2007-7#2)(2008-9#1)(2010-9#1)
sharpshooter##11##1##(2007-12#4)(2008-10#5)(2011-12#2)
shatter##2##1##(1995-1#1)(2005-11#1)
shattering resistance##3##2##(2012-11#3)
shattering##7##1##(2009-10#2)(2012-11#3)(2013-1#2)
shave##5##1##(2006-12#2)(2008-4#1)(2008-5#1)(2013-1#1)
shaved##6##1##(2008-11#1)(2008-4#1)(2008-5#4)
shaver is##2##2##(2007-5#2)
shaver##10##1##(2007-5#8)(2008-9#2)
shaving##19##1##(2006-12#1)(2007-7#1)(2008-2#1)(2008-5#14)(2009-9#1)(2012-2#1)
she also##4##2##(2006-10#1)(2006-11#1)(2007-12#1)(2010-7#1)
she appears to be healthy##2##5##(1996-6#2)
she can##5##2##(1994-12#1)(1995-4#1)(1996-11#1)(2007-2#2)
she could not##2##3##(1990-2#1)(1994-11#1)
she could##4##2##(1990-2#1)(1990-3#1)(1994-11#1)(2008-4#1)
she defended the thesis for the##2##6##(2008-8#2)
she delivered a##2##3##(1994-12#1)(2009-6#1)
she delivered##3##2##(1994-12#1)(2006-9#1)(2009-6#1)
she developed a##5##3##(1996-6#1)(2005-11#1)(2006-10#1)(2008-7#1)(2009-3#1)
she developed an##2##3##(2006-10#1)(2007-11#1)
she developed diffuse##2##3##(2005-11#1)(2012-2#1)
she developed features of disseminated##2##5##(2012-2#2)
she developed symptoms of##2##4##(2008-4#1)(2011-1#1)
she developed##26##2##(1991-11#1)(1996-6#1)(2005-11#2)(2006-10#5)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-2#4)(2012-3#1)
she did not##4##3##(1991-7#1)(1996-11#1)(1996-6#1)(2008-1#1)
she died of##4##3##(1996-12#1)(1997-6#1)(2006-8#1)(2011-2#1)
she died##11##2##(1996-12#1)(1997-6#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#1)(2009-3#1)(2011-2#1)(2012-12#1)
she experienced##3##2##(2007-8#1)(2009-12#1)(2010-3#1)
she feared##2##2##(1995-12#1)(1996-11#1)
she first##2##2##(1994-4#1)(2012-3#1)
she had a##6##3##(1992-3#1)(1993-6#1)(1996-6#1)(2006-4#1)(2007-12#1)(2011-2#1)
she had been##9##3##(2006-10#1)(2006-12#1)(2006-4#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)
she had no##2##3##(1997-3#1)(2006-7#1)
she had normal##2##3##(2006-10#1)(2012-12#1)
she had suffered##2##3##(1993-7#1)(2006-7#1)
she had undergone##3##3##(1994-7#1)(2005-9#1)(2006-10#1)
she had##51##2##(1992-2#1)(1992-3#1)(1992-6#1)(1993-6#1)(1993-7#2)(1994-7#1)(1995-11#1)(1995-2#1)(1996-12#3)(1996-6#1)(1997-3#1)(2005-11#1)(2005-9#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-4#2)(2006-7#2)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2010-6#1)(2010-9#1)(2011-12#1)(2011-2#5)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#2)
she has a##4##3##(2004-3#1)(2011-12#1)(2013-1#2)
she has suffered##2##3##(2004-1#1)(2012-3#1)
she has##15##2##(1997-1#1)(2004-1#1)(2004-3#1)(2007-2#2)(2007-4#1)(2008-2#1)(2009-5#1)(2011-12#2)(2012-3#2)(2013-1#2)(2013-8#1)
she is##16##2##(1996-1#1)(1996-6#1)(1997-8#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-12#1)(2009-8#1)(2010-9#1)(2011-2#2)(2012-11#1)
she must##4##2##(1993-6#1)(2004-1#1)(2008-8#1)(2011-2#1)
she needed##2##2##(1996-11#1)(2008-9#1)
she or he##2##3##(2006-2#2)
she practiced##2##2##(2010-7#1)(2011-2#1)
she presented with##10##3##(2006-10#2)(2007-9#1)(2008-1#1)(2008-3#2)(2010-6#1)(2012-12#1)(2013-1#2)
she presented##13##2##(1992-3#1)(2006-10#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-3#2)(2010-6#1)(2012-12#1)(2013-1#2)
she received##3##2##(2008-7#1)(2010-2#1)(2013-1#1)
she returned##2##2##(1996-5#1)(2008-4#1)
she says##2##2##(1993-2#1)(2013-8#1)
she started##2##2##(2007-8#1)(2012-2#1)
she suffered from##2##3##(2008-5#1)(2010-7#1)
she suffered##4##2##(1995-12#1)(2006-9#1)(2008-5#1)(2010-7#1)
she then##2##2##(1996-5#1)(2013-8#1)
she underwent a new##2##4##(2008-7#1)(2012-3#1)
she underwent a##3##3##(2007-7#1)(2008-7#1)(2012-3#1)
she underwent##13##2##(1992-12#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-7#1)(2009-2#1)(2009-3#1)(2010-10#1)(2010-6#1)(2012-3#1)(2013-1#1)
she was a##3##3##(1996-12#1)(2012-12#1)(2012-3#1)
she was admitted for##2##4##(2006-10#1)(2009-3#1)
she was admitted##5##3##(2006-10#1)(2006-2#1)(2007-6#1)(2009-3#1)(2010-12#1)
she was classified as##2##4##(2007-10#1)(2009-4#1)
she was diagnosed as##2##4##(2011-1#1)(2011-2#1)
she was diagnosed with##3##4##(2007-12#1)(2010-6#1)(2012-2#1)
she was diagnosed##5##3##(2007-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
she was discharged##3##3##(2006-10#2)(2012-12#1)
she was found to have##5##5##(2006-10#1)(2008-12#1)(2008-7#1)(2013-1#1)(2013-8#1)
she was found to##6##4##(2006-10#2)(2008-12#1)(2008-7#1)(2013-1#1)(2013-8#1)
she was given##4##3##(2008-1#1)(2008-7#1)(2012-3#2)
she was on##2##3##(2007-7#1)(2012-3#1)
she was put on##2##4##(2007-5#1)(2012-3#1)
she was referred##2##3##(2008-12#1)(2010-2#1)
she was taken##3##3##(1995-12#1)(1996-12#1)(2009-3#1)
she was transferred to##2##4##(2012-12#1)(2013-1#1)
she was treated with##7##4##(1992-10#1)(2006-10#1)(2006-4#1)(2007-12#1)(2010-7#1)(2011-1#1)(2011-2#1)
she was treated##9##3##(1992-10#1)(2006-10#2)(2006-4#1)(2007-12#1)(2007-9#1)(2010-7#1)(2011-1#1)(2011-2#1)
she was##87##2##(1990-6#1)(1992-10#1)(1992-11#1)(1992-5#1)(1993-7#1)(1994-11#1)(1994-4#1)(1994-6#1)(1995-11#1)(1995-12#2)(1996-12#3)(1996-5#1)(2006-10#11)(2006-2#1)(2006-4#2)(2007-10#1)(2007-12#3)(2007-5#1)(2007-6#1)(2007-7#2)(2007-9#2)(2008-1#1)(2008-12#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#2)(2009-4#4)(2009-6#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#8)(2012-12#4)(2012-2#3)(2012-3#5)(2013-1#2)(2013-8#1)
she will##3##2##(2006-7#1)(2008-10#1)(2013-7#1)
she##371##1##(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#1)(1990-7#1)(1991-11#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-2#2)(1993-5#2)(1993-6#2)(1993-7#3)(1994-1#1)(1994-11#3)(1994-12#2)(1994-4#3)(1994-6#1)(1994-7#1)(1995-11#2)(1995-12#6)(1995-2#2)(1995-3#1)(1995-4#2)(1995-6#2)(1996-1#1)(1996-11#7)(1996-12#9)(1996-5#5)(1996-6#9)(1997-1#1)(1997-3#2)(1997-6#1)(1997-8#1)(2004-1#2)(2004-3#1)(2005-11#4)(2005-9#1)(2006-1#2)(2006-10#27)(2006-11#2)(2006-12#5)(2006-2#3)(2006-4#4)(2006-7#4)(2006-8#2)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#11)(2007-2#7)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#9)(2007-9#3)(2008-1#5)(2008-10#1)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#7)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#5)(2009-4#5)(2009-5#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#2)(2010-3#2)(2010-5#1)(2010-6#5)(2010-7#4)(2010-8#1)(2010-9#3)(2011-1#3)(2011-12#4)(2011-2#22)(2012-1#1)(2012-11#2)(2012-12#10)(2012-2#19)(2012-3#13)(2013-1#13)(2013-7#1)(2013-8#7)
she/he##2##1##(2006-2#1)(2012-12#1)
shear and##3##2##(2008-2#1)(2008-3#1)(2011-3#1)
shear bond strength (SBS)##2##4##(2006-8#1)(2013-8#1)
shear bond strength of##3##4##(2008-12#1)(2011-1#1)(2013-1#1)
shear bond strength##7##3##(2006-8#1)(2008-12#1)(2008-5#1)(2011-1#1)(2013-1#1)(2013-8#2)
shear bond##8##2##(2006-8#1)(2008-12#1)(2008-5#1)(2009-8#1)(2011-1#1)(2013-1#1)(2013-8#2)
shear conditions##2##2##(2006-6#2)
shear displacement##3##2##(2005-11#1)(2007-4#2)
shear flow field##2##3##(1994-11#1)(2008-8#1)
shear flow##9##2##(1994-11#1)(1995-5#1)(2005-11#2)(2008-11#1)(2008-8#1)(2009-12#1)(2012-2#1)(2013-1#1)
shear flows##2##2##(2013-1#2)
shear force and##2##3##(2010-4#2)
shear force of##2##3##(2010-4#2)
shear force results##2##3##(2013-1#2)
shear force value##2##3##(2010-4#2)
shear force##21##2##(2005-11#1)(2008-11#2)(2009-11#1)(2010-4#13)(2013-1#4)
shear forces##6##2##(2007-4#1)(2008-11#1)(2008-2#1)(2008-6#1)(2011-2#2)
shear in a##2##3##(1992-9#1)(2008-2#1)
shear in##5##2##(1992-9#1)(2008-11#1)(2008-2#1)(2011-2#2)
shear interferometry##2##2##(2008-2#2)
shear is##3##2##(2007-12#1)(2008-10#1)(2008-7#1)
shear layer##2##2##(1996-5#1)(2008-3#1)
shear modulus##6##2##(2005-11#1)(2007-10#1)(2007-4#1)(2008-2#1)(2009-7#2)
shear plane thickness##2##3##(2005-11#2)
shear properties of##2##3##(2006-11#2)
shear rate and##2##3##(2005-11#1)(2009-6#1)
shear rate is##2##3##(2005-11#1)(2007-12#1)
shear rate##16##2##(1990-12#3)(2005-11#2)(2007-12#1)(2008-2#1)(2008-5#1)(2008-9#3)(2009-10#1)(2009-6#1)(2012-3#1)(2013-1#2)
shear rates##8##2##(1990-12#1)(1993-7#1)(2007-12#1)(2008-11#4)(2009-4#1)
shear rupture##6##2##(1996-4#6)
shear sensitive insect##2##3##(2008-11#2)
shear softening##3##2##(2007-1#1)(2007-4#2)
shear strain and##2##3##(2006-11#1)(2006-6#1)
shear strain##9##2##(2006-11#4)(2006-6#1)(2007-1#1)(2007-4#2)(2012-2#1)
shear strains##4##2##(2006-11#3)(2007-4#1)
shear strength##6##2##(2005-11#4)(2007-12#1)(2008-12#1)
shear stress and##6##3##(2008-11#1)(2008-2#1)(2008-5#1)(2010-10#1)(2010-4#1)(2010-9#1)
shear stress at##2##3##(1990-12#1)(2009-6#1)
shear stress distribution##2##3##(2008-11#1)(2008-5#1)
shear stress dynamic conditions##2##4##(1992-12#2)
shear stress in protein##2##4##(2006-6#2)
shear stress in the##2##4##(2008-5#1)(2010-9#1)
shear stress in##4##3##(2006-6#2)(2008-5#1)(2010-9#1)
shear stress is##2##3##(2007-9#1)(2008-2#1)
shear stress of##2##3##(2009-7#1)(2010-1#1)
shear stress on the##4##4##(1990-8#1)(1991-9#1)(2008-11#1)(2010-8#1)
shear stress on##6##3##(1990-8#1)(1991-9#1)(1993-11#1)(2008-11#1)(2009-12#1)(2010-8#1)
shear stress to##2##3##(2008-1#1)(2011-2#1)
shear stress##68##2##(1990-12#3)(1990-8#1)(1991-5#1)(1991-9#1)(1992-12#3)(1993-11#2)(1994-8#1)(1995-6#1)(2004-10#1)(2006-10#1)(2006-6#2)(2007-1#1)(2007-9#2)(2008-1#2)(2008-11#10)(2008-2#3)(2008-5#5)(2008-7#1)(2009-11#2)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#3)(2010-1#4)(2010-10#1)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
shear stresses##8##2##(1991-5#1)(2004-9#1)(2005-11#1)(2007-4#1)(2008-11#1)(2009-4#2)(2009-7#1)
shear test##2##2##(2008-12#1)(2009-7#1)
shear thinning##4##2##(2008-5#4)
shear to##2##2##(2008-11#1)(2008-6#1)
shear tolerance of hybridoma and insect cells##2##7##(1994-11#2)
shear tolerance##4##2##(1994-11#4)
shear wave##2##2##(2008-5#1)(2009-5#1)
shear yield##2##2##(2005-11#2)
shear##301##1##(1990-11#1)(1990-12#7)(1990-8#1)(1991-12#1)(1991-5#3)(1991-9#1)(1992-12#3)(1992-9#1)(1993-11#3)(1993-7#2)(1994-11#5)(1994-12#1)(1994-8#1)(1995-5#1)(1995-6#1)(1996-4#7)(1996-5#1)(1997-6#1)(2004-10#1)(2004-9#1)(2005-11#21)(2006-10#1)(2006-11#16)(2006-12#1)(2006-6#8)(2006-8#1)(2007-1#5)(2007-10#1)(2007-11#1)(2007-12#5)(2007-4#16)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#2)(2008-11#29)(2008-12#3)(2008-2#14)(2008-3#10)(2008-5#18)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#3)(2009-12#2)(2009-4#5)(2009-5#1)(2009-6#2)(2009-7#9)(2009-8#1)(2009-9#2)(2010-1#4)(2010-10#1)(2010-2#1)(2010-4#16)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#12)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#11)(2013-8#2)
shear-enhanced##2##1##(2004-8#2)
shear-force value of raw pork##3##5##(2010-2#3)
shear-force value##4##2##(2010-2#4)
shear-force##7##1##(2008-2#3)(2010-2#4)
shear-induced platelet##2##2##(2006-6#2)
shear-rate##3##1##(1992-12#1)(2007-12#2)
sheared wave front##2##3##(2008-3#2)
sheared##11##1##(1993-12#1)(1996-7#2)(2008-2#2)(2008-3#5)(2009-7#1)
shearing displacement##2##2##(2007-4#2)
shearing forces##3##2##(2005-9#1)(2007-11#1)(2007-6#1)
shearing interferograms with##2##3##(2008-3#2)
shearing interferograms##7##2##(2008-3#7)
shearing interferometer that##2##3##(2007-11#1)(2008-3#1)
shearing interferometer##22##2##(2007-11#7)(2007-12#1)(2008-2#6)(2008-3#8)
shearing interferometry in##2##3##(2007-11#1)(2008-2#1)
shearing interferometry with regulated sensitivity##2##5##(2008-2#2)
shearing interferometry##10##2##(2007-11#3)(2007-12#1)(2008-2#3)(2008-3#3)
shearing motion##2##2##(1995-5#2)
shearing of##3##2##(2005-11#1)(2007-8#1)(2008-4#1)
shearing osteochondral fracture##2##3##(2008-8#2)
shearing##75##1##(1990-2#2)(1993-7#2)(1995-5#2)(1995-6#1)(1995-7#1)(2005-11#3)(2005-9#1)(2007-11#13)(2007-12#2)(2007-4#2)(2007-6#1)(2007-8#1)(2008-2#13)(2008-3#27)(2008-4#1)(2008-8#2)(2013-1#1)
shearographic carrier fringes##3##3##(2008-3#3)
shearographic##7##1##(2008-2#2)(2008-3#5)
shearography is##2##2##(2008-3#2)
shearography##10##1##(2008-2#3)(2008-3#7)
shears and##2##2##(2008-2#1)(2008-3#1)
shears##12##1##(1992-7#1)(2008-12#1)(2008-2#3)(2008-3#5)(2008-6#1)(2012-3#1)
sheath and the##2##3##(1990-4#1)(2010-6#1)
sheath and##10##2##(1990-4#1)(1997-4#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-8#1)(2010-6#1)
sheath blight development##2##3##(2008-10#2)
sheath blight##16##2##(2008-10#15)(2008-9#1)
sheath cells##5##2##(1990-6#1)(1994-8#1)(2010-11#2)(2013-8#1)
sheath fenestration##3##2##(2009-8#3)
sheath ganglion##5##2##(2007-11#2)(2008-9#3)
sheath is##6##2##(1996-2#1)(2007-12#3)(2008-7#1)(2010-5#1)
sheath of the##4##3##(1996-2#1)(2006-4#1)(2008-10#1)(2011-2#1)
sheath of##10##2##(1996-2#1)(2006-4#1)(2008-10#3)(2008-6#1)(2009-6#1)(2011-2#1)(2012-12#2)
sheath protein##7##2##(1990-5#7)
sheath to the##2##3##(2008-10#1)(2008-7#1)
sheath with##2##2##(1997-7#1)(2006-6#1)
sheath##156##1##(1990-4#1)(1990-5#15)(1990-6#1)(1991-2#2)(1994-8#1)(1996-2#2)(1997-4#1)(1997-7#2)(1997-8#1)(2006-10#5)(2006-3#2)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#5)(2007-12#11)(2007-5#2)(2007-7#2)(2007-8#2)(2007-9#5)(2008-10#36)(2008-2#3)(2008-5#4)(2008-6#4)(2008-7#9)(2008-8#1)(2008-9#6)(2009-1#1)(2009-5#1)(2009-6#1)(2009-8#8)(2010-11#3)(2010-12#1)(2010-5#3)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#6)(2013-7#1)(2013-8#1)
sheaths and##4##2##(1993-12#1)(2006-10#1)(2008-10#1)(2008-4#1)
sheaths in##4##2##(2007-12#2)(2009-6#1)(2011-12#1)
sheaths##24##1##(1990-5#1)(1993-12#3)(2005-7#1)(2006-10#1)(2007-12#4)(2007-7#1)(2008-10#4)(2008-4#2)(2009-6#1)(2010-3#1)(2011-12#2)(2011-2#2)(2013-8#1)
shed additional light on##2##4##(2006-10#1)(2011-12#1)
shed and##2##2##(1996-3#1)(2009-9#1)
shed at##2##2##(2008-11#1)(2012-3#1)
shed by##3##2##(1995-4#1)(2006-8#1)(2013-8#1)
shed doubt on##2##3##(2007-8#1)(2008-11#1)
shed from leukocytes##2##3##(1992-12#2)
shed from the##3##3##(2008-4#1)(2012-12#1)(2013-8#1)
shed from##7##2##(1992-12#2)(2006-10#1)(2008-4#1)(2009-6#1)(2012-12#1)(2013-8#1)
shed further light on##2##4##(2009-3#1)(2012-11#1)
shed light on how##3##4##(1994-12#1)(2006-2#1)(2012-3#1)
shed light on some##2##4##(2008-12#1)(2013-1#1)
shed light on the evolution of the##2##7##(1995-11#1)(1997-9#1)
shed light on the molecular mechanisms##2##6##(2009-5#1)(2010-12#1)
shed light on the pathophysiology of##2##6##(2007-6#1)(2008-4#1)
shed light on the##28##4##(1994-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1997-9#1)(2006-10#1)(2006-12#2)(2007-4#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-5#2)(2009-7#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
shed light on these##2##4##(2009-5#1)(2012-2#1)
shed light on##48##3##(1991-9#1)(1994-1#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-3#1)(1997-2#1)(1997-9#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#4)(2009-10#1)(2009-3#1)(2009-5#3)(2009-7#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#3)
shed light##50##2##(1991-9#1)(1994-1#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-3#1)(1997-2#1)(1997-9#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#4)(2009-10#1)(2009-3#1)(2009-5#3)(2009-7#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#2)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#3)
shed more light on the##3##5##(1992-9#1)(2008-1#2)
shed more light on##5##4##(1992-9#1)(2008-1#2)(2008-3#1)(2008-8#1)
shed more light##6##3##(1992-9#1)(2008-1#2)(2008-3#1)(2008-8#1)(2011-1#1)
shed new light on the##10##5##(2006-10#1)(2006-12#1)(2008-2#1)(2008-9#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#3)
shed new light on##16##4##(2006-10#1)(2006-12#1)(2008-2#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-7#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)
shed new light##17##3##(2006-10#1)(2006-12#1)(2007-12#1)(2008-2#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-7#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)
shed new##19##2##(2006-10#1)(2006-12#1)(2007-12#1)(2008-2#2)(2008-7#2)(2008-9#1)(2009-3#1)(2010-12#2)(2010-7#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)
shed some light##5##3##(1993-12#1)(2006-8#1)(2008-11#1)(2011-2#1)(2012-12#1)
shed##125##1##(1990-11#1)(1990-2#1)(1990-3#1)(1991-9#1)(1992-12#3)(1992-4#1)(1992-9#1)(1993-12#1)(1994-1#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-3#1)(1997-2#1)(1997-9#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-12#3)(2006-2#1)(2006-8#3)(2007-12#4)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#4)(2008-11#7)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#5)(2008-9#1)(2009-10#1)(2009-3#3)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-12#3)(2010-2#1)(2010-7#2)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#8)(2012-3#3)(2013-1#4)(2013-8#5)
shedding and##6##2##(1994-6#1)(2005-9#2)(2006-10#1)(2008-5#1)(2010-12#1)
shedding at intake##2##3##(2013-8#2)
shedding by##2##2##(2007-5#1)(2008-5#1)
shedding could##2##2##(2008-5#1)(2012-2#1)
shedding in##2##2##(1996-9#1)(2012-3#1)
shedding light on the##3##4##(1995-3#1)(2008-6#1)(2010-2#1)
shedding light on##5##3##(1995-3#1)(2007-12#1)(2007-9#1)(2008-6#1)(2010-2#1)
shedding of revertant virus##3##4##(1995-5#3)
shedding of the##3##3##(1996-11#1)(2012-2#1)(2012-3#1)
shedding of##22##2##(1995-5#5)(1996-11#1)(1996-2#1)(1996-9#1)(1997-6#1)(2006-10#1)(2006-5#1)(2008-5#2)(2009-6#1)(2011-12#1)(2012-2#1)(2012-3#1)(2012-9#1)(2013-8#4)
shedding patterns of##2##3##(2012-3#2)
shedding patterns##5##2##(2012-3#4)(2013-8#1)
shedding rate##2##2##(2013-8#2)
shedding was##5##2##(1995-5#1)(2008-10#1)(2008-5#2)(2009-6#1)
shedding##100##1##(1992-11#1)(1994-6#1)(1995-3#1)(1995-5#7)(1996-11#1)(1996-12#2)(1996-2#1)(1996-7#1)(1996-9#9)(1997-2#1)(1997-6#1)(2005-7#1)(2005-9#3)(2006-10#5)(2006-5#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-5#11)(2008-6#1)(2009-6#3)(2009-7#2)(2009-8#2)(2010-12#5)(2010-2#1)(2010-5#1)(2011-12#1)(2012-12#1)(2012-2#4)(2012-3#9)(2012-9#1)(2013-8#18)
sheds light on the##8##4##(1997-1#1)(2006-10#1)(2009-4#1)(2010-1#1)(2011-1#1)(2012-2#1)(2013-1#2)
sheds light on##9##3##(1997-1#1)(2006-10#1)(2008-4#1)(2009-4#1)(2010-1#1)(2011-1#1)(2012-2#1)(2013-1#2)
sheds new light on##3##4##(1994-12#1)(2007-6#1)(2008-9#1)
sheds some light on this##3##5##(2007-3#1)(2008-8#1)(2012-2#1)
sheds some light on##5##4##(2006-10#1)(2007-3#1)(2008-5#1)(2008-8#1)(2012-2#1)
sheds##24##1##(1990-4#1)(1994-12#1)(1997-1#1)(2006-10#2)(2006-12#4)(2007-3#1)(2007-6#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-1#1)(2010-4#2)(2011-1#1)(2012-2#2)(2013-1#2)
sheds)##2##1##(2010-4#2)
sheep (Ovis ammon)##2##3##(2009-4#2)
sheep (Ovis##4##2##(1995-2#1)(1997-7#1)(2009-4#2)
sheep (n =##2##3##(1996-12#1)(1997-1#1)
sheep against##2##2##(1994-6#1)(1997-4#1)
sheep and calves##2##3##(1997-6#2)
sheep and goat##3##3##(1992-1#1)(2006-8#1)(2011-2#1)
sheep and goats##8##3##(1996-5#1)(1997-5#1)(2006-8#1)(2007-3#1)(2008-12#3)(2011-2#1)
sheep and the##2##3##(1993-8#1)(1997-6#1)
sheep and##25##2##(1992-1#1)(1993-12#1)(1993-8#1)(1996-3#2)(1996-5#1)(1997-5#1)(1997-6#5)(1997-8#1)(2006-4#1)(2006-8#2)(2007-11#1)(2007-3#1)(2008-12#3)(2008-8#1)(2009-4#1)(2011-2#2)
sheep blood##3##2##(1991-8#1)(1993-4#1)(2013-1#1)
sheep brain and##2##3##(1990-7#1)(1996-5#1)
sheep brain##5##2##(1990-7#2)(1996-11#1)(1996-5#2)
sheep breed##3##2##(2008-12#2)(2008-4#1)
sheep breeding##2##2##(2011-2#1)(2012-1#1)
sheep breeds##7##2##(2005-7#1)(2011-1#4)(2012-1#2)
sheep by##6##2##(1991-11#1)(1991-8#1)(1993-8#1)(1995-6#1)(2006-5#2)
sheep cells##2##2##(1990-5#1)(1997-6#1)
sheep choroid plexus##3##3##(1997-6#1)(1997-8#2)
sheep dips##2##2##(1992-10#1)(1994-7#1)
sheep during##2##2##(2007-11#1)(2007-8#1)
sheep erythrocytes (SRBC)##2##3##(2005-9#1)(2008-10#1)
sheep erythrocytes##6##2##(1996-5#1)(1997-2#1)(2005-9#1)(2008-10#2)(2008-4#1)
sheep flock##2##2##(1993-8#1)(1993-9#1)
sheep flocks##2##2##(1993-9#1)(2006-10#1)
sheep for##2##2##(1997-8#1)(2008-10#1)
sheep from##2##2##(1995-6#1)(2008-8#1)
sheep heart##3##2##(2007-8#3)
sheep in New Zealand##2##4##(2005-7#2)
sheep in the##3##3##(1991-8#1)(1997-5#1)(2005-7#1)
sheep in##11##2##(1991-5#1)(1991-8#1)(1997-5#1)(2005-7#4)(2007-2#1)(2008-12#1)(2008-4#1)(2011-1#1)
sheep is##3##2##(1997-6#1)(2006-8#2)
sheep liver mitochondria##2##3##(2008-5#2)
sheep liver##6##2##(1990-2#1)(1992-12#1)(2008-12#1)(2008-5#3)
sheep meat##3##2##(2010-4#1)(2013-1#2)
sheep model##5##2##(2005-8#1)(2007-10#1)(2007-8#1)(2012-1#2)
sheep on##2##2##(1993-12#1)(1996-6#1)
sheep over a##2##3##(1996-12#1)(2011-2#1)
sheep population##3##2##(1993-8#1)(2008-12#2)
sheep re-excreted BHV1##2##3##(1997-6#2)
sheep red blood cells (SRBC) and##2##6##(1991-12#1)(2008-10#1)
sheep red blood cells (SRBC)##12##5##(1991-12#1)(1992-2#1)(1995-2#1)(2008-10#4)(2008-4#4)(2008-7#1)
sheep red blood cells (SRBCs) and##2##6##(1993-12#1)(2008-6#1)
sheep red blood cells (sRBC)##2##5##(1995-2#1)(2008-10#1)
sheep red blood cells##28##4##(1991-12#1)(1991-8#2)(1992-2#1)(1993-12#2)(1993-4#1)(1995-2#2)(2008-10#11)(2008-4#4)(2008-6#1)(2008-7#2)(2013-1#1)
sheep red blood##29##3##(1991-12#1)(1991-8#2)(1992-2#1)(1993-12#2)(1993-4#1)(1995-2#2)(2008-10#12)(2008-4#4)(2008-6#1)(2008-7#2)(2013-1#1)
sheep slaughtered##2##2##(2010-4#2)
sheep to##4##2##(1991-12#1)(1996-12#2)(2011-1#1)
sheep using##3##2##(2008-7#1)(2009-4#1)(2013-1#1)
sheep was significantly different##2##4##(2008-12#2)
sheep was##6##2##(2005-7#1)(2006-8#1)(2008-12#2)(2008-8#1)(2012-1#1)
sheep were challenged with##2##4##(1991-8#2)
sheep were##7##2##(1991-8#2)(1992-1#1)(1997-6#2)(2008-12#1)(2009-4#1)
sheep with##5##2##(1997-5#2)(2008-12#1)(2011-1#1)(2012-12#1)
sheep##326##1##(1990-11#2)(1990-2#1)(1990-4#1)(1990-5#6)(1990-6#1)(1990-7#2)(1991-11#1)(1991-12#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#9)(1991-9#1)(1992-1#5)(1992-10#1)(1992-12#3)(1992-2#1)(1992-7#2)(1993-10#3)(1993-11#1)(1993-12#7)(1993-2#2)(1993-4#2)(1993-6#1)(1993-8#9)(1993-9#3)(1994-5#1)(1994-6#1)(1994-7#1)(1995-2#3)(1995-6#4)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#10)(1996-3#2)(1996-5#4)(1996-6#4)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#7)(1997-6#18)(1997-7#3)(1997-8#6)(2005-7#16)(2005-8#1)(2005-9#1)(2006-10#3)(2006-4#1)(2006-5#3)(2006-7#1)(2006-8#8)(2007-10#1)(2007-11#3)(2007-2#3)(2007-3#1)(2007-8#9)(2008-10#24)(2008-11#1)(2008-12#17)(2008-3#1)(2008-4#10)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#11)(2009-4#6)(2009-5#1)(2010-4#9)(2010-6#1)(2010-7#1)(2011-1#12)(2011-2#8)(2012-1#8)(2012-12#2)(2012-2#1)(2013-1#6)(2013-8#1)
sheep's##2##1##(2007-3#1)(2009-4#1)
sheer##3##1##(2005-4#1)(2008-12#1)(2010-10#1)
sheet and a##2##3##(2007-8#1)(2008-3#1)
sheet and##13##2##(1991-4#1)(1995-6#1)(2005-11#1)(2007-8#2)(2008-3#2)(2009-11#1)(2009-7#1)(2010-9#1)(2011-2#2)(2013-1#1)
sheet bed##6##2##(2008-11#6)
sheet for##3##2##(2013-1#3)
sheet is##4##2##(1991-6#1)(1997-8#2)(2008-3#1)
sheet of##5##2##(2006-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2011-1#1)
sheet structure##2##2##(1995-4#1)(1997-7#1)
sheet to##3##2##(1994-9#1)(2007-2#1)(2013-1#1)
sheet was##3##2##(2007-8#1)(2008-1#1)(2013-8#1)
sheet with##4##2##(2005-11#1)(2007-8#1)(2008-2#1)(2008-3#1)
sheet##120##1##(1990-3#3)(1991-4#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-8#1)(1992-9#1)(1994-9#1)(1995-10#1)(1995-4#2)(1995-6#1)(1996-11#1)(1996-4#1)(1997-4#1)(1997-7#2)(1997-8#2)(1997-9#3)(2004-9#1)(2005-11#5)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#3)(2007-2#4)(2007-4#1)(2007-8#9)(2007-9#2)(2008-1#2)(2008-10#5)(2008-11#8)(2008-12#1)(2008-2#9)(2008-3#9)(2008-5#1)(2008-7#2)(2009-11#5)(2009-12#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#9)(2013-8#1)
sheet-like##3##1##(2006-10#1)(2009-8#1)(2012-1#1)
sheeting##5##1##(2008-10#1)(2008-3#1)(2008-9#3)
sheetlike##2##1##(1992-3#1)(2007-11#1)
sheets and##5##2##(1995-3#1)(2007-8#1)(2008-6#1)(2008-9#1)(2013-1#1)
sheets are##5##2##(1990-9#1)(2008-3#1)(2010-8#2)(2011-2#1)
sheets by##2##2##(1997-7#1)(2009-2#1)
sheets from##2##2##(2008-11#1)(2010-8#1)
sheets of large##2##3##(2005-7#1)(2008-5#1)
sheets of##14##2##(1993-2#1)(2005-5#1)(2005-7#1)(2006-10#1)(2006-11#1)(2008-1#1)(2008-5#3)(2008-7#1)(2009-8#1)(2010-4#1)(2010-9#1)(2013-8#1)
sheets were studied##2##3##(2008-3#1)(2010-8#1)
sheets were##7##2##(1995-11#1)(2004-9#1)(2008-1#1)(2008-3#1)(2010-8#3)
sheets##77##1##(1990-12#1)(1990-2#2)(1990-5#1)(1990-9#1)(1991-2#3)(1991-6#1)(1991-9#1)(1992-8#1)(1993-2#1)(1994-3#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-4#1)(1997-7#2)(1997-9#1)(2004-9#1)(2005-11#1)(2005-12#1)(2005-5#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#5)(2008-5#5)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-8#1)(2010-4#1)(2010-7#1)(2010-8#6)(2010-9#2)(2011-12#2)(2011-2#1)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
shelf and##3##2##(1992-1#1)(2007-5#2)
shelf life of the##2##4##(2007-3#1)(2008-11#1)
shelf life of##16##3##(2007-3#4)(2008-10#2)(2008-11#1)(2010-4#4)(2010-7#1)(2012-2#2)(2013-1#1)(2013-7#1)
shelf life##30##2##(2005-10#1)(2007-3#4)(2008-10#7)(2008-11#1)(2008-12#1)(2010-4#7)(2010-7#2)(2011-2#2)(2012-2#3)(2013-1#1)(2013-7#1)
shelf##54##1##(1992-1#1)(2005-10#1)(2005-11#1)(2006-6#2)(2007-3#4)(2007-5#5)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2010-4#8)(2010-7#2)(2010-8#7)(2011-2#3)(2012-1#1)(2012-2#3)(2013-1#1)(2013-7#1)
shelf-edge##3##1##(2011-2#3)
shelf-life of##7##2##(1997-4#1)(2007-3#1)(2008-5#3)(2013-1#2)
shelf-life##22##1##(1994-3#1)(1997-4#6)(2007-3#1)(2008-10#2)(2008-5#3)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#1)
shelf-lives##2##1##(2008-5#1)(2011-2#1)
shell and core##2##3##(1996-12#1)(2008-7#1)
shell and iron##2##3##(2008-10#1)(2010-6#1)
shell and##12##2##(1995-8#1)(1996-12#2)(2005-11#1)(2006-1#2)(2008-10#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)(2013-1#1)
shell around##2##2##(2005-11#1)(2009-2#1)
shell at##3##2##(1994-2#1)(2008-11#1)(2008-2#1)
shell bridges the##2##3##(1996-2#2)
shell crosslinked##2##2##(2009-9#1)(2010-2#1)
shell eggs##4##2##(1992-5#3)(1996-8#1)
shell for##3##2##(2007-10#1)(2008-3#1)(2012-2#1)
shell gland##2##2##(2008-12#2)
shell in##2##2##(2005-11#1)(2010-5#1)
shell is a##2##3##(2006-3#1)(2008-8#1)
shell is##5##2##(1995-1#1)(2006-3#1)(2008-11#1)(2008-8#1)(2010-4#1)
shell layer##2##2##(2009-9#1)(2010-4#1)
shell length##4##2##(2008-5#4)
shell of the##3##3##(1995-2#1)(1997-7#1)(2005-11#1)
shell of##5##2##(1992-2#1)(1995-2#1)(1997-7#1)(2005-11#2)
shell oil in##2##3##(1992-2#2)
shell oil##4##2##(1992-2#4)
shell showed##2##2##(1991-4#1)(2013-1#1)
shell that##2##2##(2007-12#1)(2008-10#1)
shell thickness##3##2##(2005-11#2)(2008-10#1)
shell was##4##2##(1996-12#1)(2007-10#1)(2008-5#1)(2010-4#1)
shell with##3##2##(1996-7#1)(2008-8#1)(2012-2#1)
shell##158##1##(1990-3#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-2#5)(1992-5#3)(1992-8#1)(1993-4#1)(1994-10#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-4#2)(1996-7#1)(1996-8#2)(1997-3#1)(1997-7#2)(2004-9#1)(2005-10#1)(2005-11#11)(2006-1#6)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#2)(2006-5#3)(2006-7#1)(2007-10#3)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#3)(2008-10#9)(2008-11#4)(2008-12#4)(2008-2#3)(2008-3#3)(2008-5#8)(2008-7#1)(2008-8#9)(2008-9#2)(2009-10#1)(2009-2#3)(2009-3#5)(2009-7#1)(2009-9#4)(2010-1#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#5)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-11#2)(2012-2#6)(2013-1#4)
shellac than when applied by##2##5##(2008-10#2)
shellac than when##3##3##(2008-10#3)
shellac##4##1##(2008-10#4)
shellacked fruit##2##2##(2008-10#2)
shellfish from##2##2##(1997-4#1)(2007-5#1)
shellfish poisoning toxins##2##3##(1994-12#1)(1997-4#1)
shellfish poisoning##8##2##(1991-5#1)(1994-12#2)(1997-4#2)(2009-12#3)
shellfish##28##1##(1991-5#1)(1992-8#1)(1994-12#2)(1994-4#1)(1997-4#6)(2006-8#1)(2007-11#1)(2007-2#1)(2007-5#3)(2008-10#1)(2008-11#1)(2008-4#2)(2009-12#4)(2010-9#1)(2012-12#1)(2013-7#1)
shells and cassava stalks##2##4##(2008-5#2)
shells and##6##2##(1994-3#1)(2006-10#1)(2006-5#1)(2008-5#2)(2012-12#1)
shells in the##2##3##(2007-8#1)(2008-12#1)
shells of##5##2##(1996-2#2)(2008-11#1)(2008-12#2)
shells were##5##2##(1995-1#1)(2008-10#1)(2010-4#3)
shells##54##1##(1994-3#2)(1995-1#5)(1996-2#2)(1997-4#1)(2005-11#6)(2006-10#1)(2006-12#1)(2006-5#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#3)(2008-5#5)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-7#3)(2010-2#1)(2010-3#1)(2010-4#3)(2012-12#1)
shells)##2##1##(1990-3#1)(2008-1#1)
shelter and##4##2##(1993-7#1)(2007-12#1)(2012-2#2)
shelter in the##2##3##(2006-8#1)(2013-8#1)
shelter in##4##2##(2006-8#1)(2012-3#1)(2013-8#2)
shelter##23##1##(1993-7#1)(1995-11#1)(1996-12#1)(2004-11#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-7#2)(2009-5#1)(2010-2#1)(2012-2#6)(2012-3#1)(2013-1#1)(2013-8#2)
sheltered battered##2##2##(2010-2#2)
sheltered##9##1##(2008-10#3)(2008-9#1)(2010-2#3)(2011-1#1)(2011-2#1)
shelters##12##1##(1994-12#1)(1996-3#1)(2004-11#2)(2008-12#1)(2008-2#1)(2008-9#2)(2010-2#3)(2012-3#1)
shelved##2##1##(1992-9#1)(2006-10#1)
shelves##3##1##(1995-2#1)(2006-10#1)(2008-1#1)
shelving##2##1##(2007-12#2)
shepherd##3##1##(2009-4#1)(2013-8#2)
shepherds##2##1##(1993-7#1)(2007-12#1)
sherds##2##1##(2008-10#2)
shergottite##2##1##(1995-3#2)
shergottites##2##1##(1995-3#2)
shermanii methylmalonyl-CoA##2##2##(1995-10#2)
shermanii##4##1##(1995-10#2)(1996-9#2)
shh in##2##2##(1993-12#2)
shh##4##1##(1993-12#3)(2011-1#1)
shibatae##7##1##(1997-7#1)(2008-9#6)
shield and##2##2##(2008-10#1)(2008-3#1)
shield for##2##2##(2009-11#1)(2009-2#1)
shield the##4##2##(1991-2#1)(2006-5#1)(2008-7#1)(2009-10#1)
shield to##2##2##(2008-11#1)(2010-9#1)
shield was##3##2##(2009-10#1)(2009-11#2)
shield##28##1##(1990-5#1)(1991-2#1)(1991-5#1)(1994-6#1)(2005-11#1)(2006-5#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-10#4)(2009-11#7)(2009-2#1)(2010-9#1)(2011-2#1)
shielded by##2##2##(2008-10#1)(2008-8#1)
shielded from##3##2##(1995-10#1)(1997-1#1)(1997-7#1)
shielded the##2##2##(1994-8#1)(2008-3#1)
shielded##10##1##(1994-8#1)(1995-10#1)(1996-6#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#1)
shielding effects##2##2##(2005-11#1)(2008-3#1)
shielding from the##3##3##(1996-9#1)(2006-8#2)
shielding from##4##2##(1996-9#1)(2006-8#2)(2008-2#1)
shielding of##3##2##(1990-5#1)(1996-8#1)(2007-11#1)
shielding tensors##2##2##(2010-5#1)(2010-7#1)
shielding##31##1##(1990-5#1)(1990-9#1)(1993-12#1)(1993-8#1)(1996-8#1)(1996-9#1)(2005-11#2)(2006-8#2)(2007-11#2)(2007-6#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#1)(2009-10#2)(2009-4#1)(2009-7#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#2)(2013-1#1)
shields the##2##2##(1991-8#1)(2007-11#1)
shields##9##1##(1991-8#1)(2006-7#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-11#1)
shift (&gt##2##2##(2008-10#1)(2009-6#1)
shift against##2##2##(2008-3#1)(2009-5#1)
shift alternative##2##2##(2013-1#2)
shift analyses##2##2##(1993-12#1)(1995-3#1)
shift analysis##8##2##(1991-12#1)(1993-12#1)(1993-8#1)(1994-9#1)(1995-10#1)(1997-1#1)(2008-9#2)
shift and a##2##3##(1992-12#1)(1994-9#1)
shift and its##2##3##(1990-2#1)(2008-10#1)
shift and scale##2##3##(1995-9#1)(1996-3#1)
shift and the##4##3##(2007-12#2)(2008-10#1)(2009-8#1)
shift and##51##2##(1990-2#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-12#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-9#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-7#1)(2005-8#1)(2006-1#1)(2006-12#1)(2006-5#1)(2007-11#2)(2007-12#12)(2007-8#1)(2008-10#3)(2008-2#4)(2008-3#3)(2008-5#2)(2009-8#1)(2011-1#1)(2012-12#1)
shift are used##2##3##(2006-1#1)(2008-2#1)
shift are##3##2##(2006-1#1)(2007-12#1)(2008-2#1)
shift as a##2##3##(2008-3#1)(2012-2#1)
shift as##5##2##(1990-7#1)(1992-9#1)(2007-11#1)(2008-3#1)(2012-2#1)
shift assay (EMSA)##5##3##(1993-12#1)(1994-8#1)(1996-10#1)(1997-5#1)(2008-9#1)
shift assay and##3##3##(1991-10#1)(1996-5#1)(2008-11#1)
shift assay has##2##3##(1993-6#1)(1995-3#1)
shift assay##45##2##(1991-10#1)(1991-11#2)(1991-3#1)(1991-6#1)(1991-7#1)(1992-12#3)(1993-12#1)(1993-6#2)(1993-8#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-2#1)(1995-3#3)(1995-8#1)(1996-10#1)(1996-4#1)(1996-5#3)(1997-1#2)(1997-5#1)(1997-6#1)(2008-11#4)(2008-4#2)(2008-9#3)(2011-2#1)
shift assays with##6##3##(1994-6#1)(1994-8#1)(1995-3#1)(1996-5#1)(1997-7#1)(2008-10#1)
shift assays##39##2##(1991-11#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-6#2)(1994-8#2)(1994-9#4)(1995-1#1)(1995-10#1)(1995-3#4)(1995-6#2)(1995-8#1)(1996-11#1)(1996-5#2)(1996-8#3)(1997-2#3)(1997-7#2)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)
shift assignments of the##2##4##(2009-7#2)
shift assignments of##6##3##(2007-1#1)(2009-7#5)
shift assignments##14##2##(1993-11#1)(2007-1#1)(2009-7#12)
shift at##5##2##(1990-10#1)(1992-6#1)(2007-12#2)(2008-2#1)
shift away from hospital##2##4##(1993-12#1)(2005-9#1)
shift away from##7##3##(1993-12#1)(1994-6#1)(2005-7#1)(2005-9#1)(2008-9#1)(2010-12#1)(2010-4#1)
shift between the##7##3##(2007-11#1)(2008-1#2)(2008-3#4)
shift between##18##2##(1991-7#1)(2007-11#5)(2008-1#3)(2008-11#1)(2008-2#2)(2008-3#6)
shift both reactions towards##2##4##(1994-9#2)
shift but##2##2##(1990-7#1)(2007-12#1)
shift by##7##2##(1994-6#1)(2007-11#2)(2007-12#2)(2008-11#1)(2008-9#1)
shift calculations##2##2##(2007-10#1)(2010-7#1)
shift can be observed##2##4##(1990-5#1)(2010-7#1)
shift can be##7##3##(1990-5#1)(1991-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2010-7#1)
shift caused by##4##3##(1995-5#2)(2007-11#1)(2008-1#1)
shift changes are##2##3##(1996-6#2)
shift changes##4##2##(1995-10#1)(1996-6#2)(2008-2#1)
shift curves##3##2##(2008-10#3)
shift data##7##2##(1991-9#1)(1992-12#1)(1995-1#2)(1997-7#1)(2008-10#1)(2011-1#1)
shift differences##3##2##(1990-7#1)(1995-3#1)(1996-5#1)
shift during##4##2##(1996-3#1)(2006-8#1)(2007-12#1)(2012-2#1)
shift for a given##2##4##(2007-12#1)(2008-2#1)
shift for the##7##3##(1995-5#1)(1996-2#1)(2009-5#1)(2010-1#1)(2011-1#1)(2012-12#2)
shift for##13##2##(1990-7#1)(1995-5#1)(1996-2#1)(2007-10#1)(2007-12#2)(2008-12#1)(2008-2#1)(2009-5#1)(2010-1#1)(2011-1#1)(2012-12#2)
shift from a##6##3##(1993-12#1)(1995-11#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
shift from inpatient to outpatient services##2##6##(1992-2#1)(1993-1#1)
shift from inpatient to outpatient##3##5##(1992-2#1)(1993-1#1)(1993-12#1)
shift from the##7##3##(1990-4#1)(1992-6#1)(1993-1#1)(2008-11#1)(2008-7#1)(2009-3#1)(2012-3#1)
shift from##44##2##(1990-4#1)(1990-5#1)(1991-11#1)(1992-2#1)(1992-6#1)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#2)(1994-11#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-6#1)(1996-11#1)(2005-12#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2012-2#1)(2012-3#1)
shift has been##2##3##(2006-6#1)(2008-8#1)
shift has##4##2##(2006-6#1)(2007-12#1)(2008-7#1)(2008-8#1)
shift in a##5##3##(1994-6#1)(2007-11#1)(2007-12#2)(2008-3#1)
shift in an##3##3##(2007-12#1)(2008-2#2)
shift in baseline##2##3##(2008-10#2)
shift in care##3##3##(1996-2#1)(2007-10#1)(2008-3#1)
shift in distribution##2##3##(1990-10#1)(1990-6#1)
shift in healthcare##2##3##(2007-12#1)(2008-12#1)
shift in its##4##3##(1991-8#1)(1994-9#1)(2006-1#1)(2008-7#1)
shift in our##2##3##(2010-7#1)(2013-1#1)
shift in pH##3##3##(1990-12#1)(1996-11#2)
shift in polyribosomal distribution of##2##5##(1990-10#2)
shift in public health##2##4##(2011-1#1)(2012-1#1)
shift in the absorption spectrum##2##5##(2007-11#1)(2008-5#1)
shift in the absorption##5##4##(1990-3#1)(2007-11#2)(2008-2#1)(2008-5#1)
shift in the presence of##2##5##(1995-1#1)(2005-11#1)
shift in the reading frame##2##5##(1990-7#1)(1994-12#1)
shift in the##79##3##(1990-10#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#1)(1991-2#1)(1991-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-3#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#1)(2005-11#2)(2005-9#1)(2006-4#1)(2007-11#4)(2007-12#3)(2007-4#1)(2007-9#2)(2008-1#3)(2008-10#5)(2008-11#1)(2008-2#5)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#1)(2009-2#1)(2009-8#1)(2010-12#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
shift in thinking##2##3##(2008-12#1)(2010-8#1)
shift in this##2##3##(2006-10#1)(2007-7#1)
shift in virulence##2##3##(2008-10#2)
shift in##191##2##(1990-10#4)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-7#1)(1992-8#1)(1992-9#4)(1993-11#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#4)(1995-5#2)(1996-11#2)(1996-2#3)(1996-3#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#1)(2004-10#1)(2005-11#3)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#2)(2006-4#1)(2006-9#1)(2007-10#1)(2007-11#8)(2007-12#10)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#11)(2008-11#4)(2008-12#2)(2008-2#10)(2008-3#9)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#3)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-12#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
shift indicates a##2##3##(1990-3#1)(1992-6#1)
shift into##2##2##(2008-2#1)(2013-7#1)
shift invariance##3##2##(2008-2#3)
shift invariant##3##2##(2008-2#1)(2008-3#2)
shift is shown to be##2##5##(2008-2#1)(2008-3#1)
shift is shown to##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
shift is##30##2##(1991-7#1)(1994-9#1)(1995-5#1)(2005-8#1)(2006-10#1)(2007-11#3)(2007-12#10)(2008-10#2)(2008-2#4)(2008-3#2)(2008-8#1)(2009-12#1)(2012-2#1)(2013-1#1)
shift may##2##2##(1997-7#1)(2007-12#1)
shift measurement##2##2##(2008-2#2)
shift measurements##3##2##(1992-7#1)(2006-10#1)(2008-3#1)
shift observed##2##2##(1992-4#1)(2007-8#1)
shift occurred##3##2##(1997-4#1)(2008-7#1)(2008-9#1)
shift of a##4##3##(2007-12#2)(2009-5#2)
shift of absorption##2##3##(2007-8#1)(2008-10#1)
shift of attention##2##3##(2008-1#1)(2008-11#1)
shift of care##2##3##(1991-12#1)(2011-7#1)
shift of equilibrium between the two fluorescent forms of a synthetic##2##11##(2008-10#2)
shift of light##3##3##(1991-10#1)(2007-12#1)(2008-2#1)
shift of pH##2##3##(2008-10#2)
shift of temperature##2##3##(2008-11#2)
shift of the absorption##2##4##(1991-9#1)(2009-9#1)
shift of the generated##2##4##(2007-12#1)(2008-2#1)
shift of the maximum##2##4##(2008-10#2)
shift of the optimum pH##2##5##(1990-7#1)(2008-9#1)
shift of the##71##3##(1990-10#1)(1990-3#1)(1990-7#3)(1991-1#1)(1991-12#2)(1991-5#1)(1991-9#1)(1992-12#2)(1992-4#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-1#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-8#1)(2005-11#2)(2006-12#1)(2006-2#1)(2006-3#1)(2007-11#2)(2007-12#6)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#6)(2008-3#7)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-1#1)
shift of##160##2##(1990-10#1)(1990-2#2)(1990-3#2)(1990-5#1)(1990-7#4)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-12#3)(1992-4#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-1#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-8#1)(2005-11#3)(2006-12#2)(2006-2#1)(2006-3#1)(2007-11#5)(2007-12#16)(2007-8#2)(2008-1#3)(2008-10#19)(2008-11#5)(2008-2#13)(2008-3#14)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#3)(2009-2#1)(2009-5#3)(2009-6#1)(2009-9#1)(2010-1#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-1#1)(2013-1#1)(2013-8#1)
shift on SDS-polyacrylamide##2##3##(1992-12#1)(1996-5#1)
shift on##10##2##(1992-12#1)(1995-1#1)(1996-5#1)(2007-12#2)(2008-2#5)
shift parameter##2##2##(1991-9#1)(1996-3#1)
shift parameters##3##2##(2008-2#1)(2008-3#1)(2009-3#1)
shift perturbations##2##2##(1995-10#1)(2012-2#1)
shift rate##2##2##(2008-3#1)(2012-1#1)
shift reagent##5##2##(1994-3#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-5#1)
shift register##4##2##(1996-4#2)(2008-1#2)
shift relative to the##2##4##(1995-6#1)(2008-2#1)
shift relative to##4##3##(1995-6#1)(2007-11#1)(2007-12#1)(2008-2#1)
shift resulting from the##2##4##(2008-2#1)(2008-3#1)
shift selectivity##2##2##(2007-12#2)
shift some of their##2##4##(1995-1#1)(2008-11#1)
shift substantially##2##2##(1992-9#1)(2009-5#1)
shift that is due to##2##5##(2007-12#1)(2008-2#1)
shift that is##3##3##(2007-12#2)(2008-2#1)
shift that##6##2##(2007-12#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)
shift the potential of Uf more##2##6##(1991-8#2)
shift the##24##2##(1991-2#1)(1991-5#1)(1991-8#2)(1992-4#1)(1994-2#2)(1996-12#1)(1997-1#2)(1997-2#1)(2006-12#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-3#3)(2009-5#1)(2010-1#1)(2012-3#1)(2013-8#1)
shift their focus##2##3##(2008-10#1)(2008-8#1)
shift their##3##2##(1997-1#1)(2008-10#1)(2008-8#1)
shift to a more##3##4##(1993-2#1)(2006-12#1)(2008-10#1)
shift to a##9##3##(1992-2#1)(1993-2#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-2#1)
shift to be##2##3##(2007-11#1)(2008-10#1)
shift to the left##2##4##(1997-4#1)(2007-12#1)
shift to the##11##3##(1993-9#1)(1994-5#2)(1995-3#2)(1997-4#1)(2004-12#1)(2007-12#2)(2008-10#1)(2008-5#1)
shift to##45##2##(1990-5#1)(1992-2#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-5#2)(1995-3#2)(1996-2#1)(1997-2#1)(1997-4#1)(2004-12#1)(2005-4#2)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-2#1)
shift toward a##2##3##(2011-1#1)(2012-3#1)
shift toward the##2##3##(1994-8#1)(2006-10#1)
shift toward##14##2##(1991-5#1)(1993-12#1)(1994-8#1)(1996-2#1)(1996-3#1)(2006-10#2)(2006-9#1)(2008-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
shift towards less chlorinated congeners##2##5##(2007-5#2)
shift towards##8##2##(1992-7#1)(1995-3#1)(2006-10#1)(2007-5#2)(2007-8#1)(2008-9#1)(2009-4#1)
shift type##4##2##(2011-2#4)
shift was not##2##3##(1995-3#1)(2010-10#1)
shift was observed##2##3##(1992-6#1)(1995-6#1)
shift was##17##2##(1992-12#1)(1992-6#1)(1995-3#2)(1995-6#1)(2005-11#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-3#2)(2008-8#1)(2009-5#1)(2010-10#1)
shift with##6##2##(1997-7#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-4#1)
shift work disorder##5##3##(2010-7#1)(2012-12#4)
shift work exposure##3##3##(2011-2#3)
shift work##19##2##(1990-2#1)(1991-12#1)(2008-11#1)(2008-8#2)(2010-7#3)(2011-2#7)(2012-12#4)
shift workers in Shahid Tondgoyan##2##5##(2013-7#2)
shift workers in##3##3##(2008-8#1)(2013-7#2)
shift workers with##2##3##(2010-7#1)(2013-7#1)
shift workers##12##2##(2008-8#3)(2010-7#1)(2011-2#5)(2013-7#3)
shift##1191##1##(1990-10#6)(1990-11#2)(1990-12#1)(1990-2#5)(1990-3#5)(1990-4#3)(1990-5#7)(1990-6#2)(1990-7#9)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#3)(1991-11#7)(1991-12#6)(1991-2#6)(1991-3#4)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#5)(1991-8#3)(1991-9#5)(1992-1#2)(1992-11#2)(1992-12#12)(1992-2#3)(1992-3#1)(1992-4#6)(1992-6#6)(1992-7#4)(1992-8#2)(1992-9#7)(1993-1#2)(1993-11#8)(1993-12#13)(1993-2#4)(1993-3#3)(1993-4#1)(1993-6#4)(1993-8#4)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#6)(1994-12#5)(1994-2#5)(1994-3#6)(1994-5#9)(1994-6#10)(1994-8#6)(1994-9#14)(1995-1#10)(1995-10#10)(1995-11#2)(1995-12#2)(1995-2#8)(1995-3#20)(1995-5#9)(1995-6#6)(1995-7#1)(1995-8#3)(1995-9#2)(1996-1#2)(1996-10#1)(1996-11#5)(1996-12#5)(1996-2#6)(1996-3#10)(1996-4#3)(1996-5#11)(1996-6#3)(1996-7#2)(1996-8#3)(1997-1#8)(1997-2#8)(1997-4#8)(1997-5#2)(1997-6#3)(1997-7#12)(1997-8#3)(2004-10#1)(2004-11#1)(2004-12#1)(2005-11#10)(2005-12#1)(2005-4#2)(2005-7#1)(2005-8#7)(2005-9#3)(2006-1#4)(2006-10#14)(2006-12#6)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#3)(2006-6#3)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#5)(2007-11#48)(2007-12#93)(2007-2#1)(2007-4#5)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#7)(2007-9#3)(2008-1#20)(2008-10#69)(2008-11#31)(2008-12#3)(2008-2#84)(2008-3#75)(2008-4#6)(2008-5#11)(2008-6#5)(2008-7#14)(2008-8#17)(2008-9#15)(2009-10#1)(2009-11#5)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#10)(2009-6#6)(2009-7#15)(2009-8#3)(2009-9#8)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#8)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#3)(2010-7#8)(2010-8#4)(2010-9#2)(2011-1#10)(2011-12#2)(2011-2#28)(2011-7#1)(2012-1#7)(2012-11#2)(2012-12#13)(2012-2#15)(2012-3#7)(2013-1#13)(2013-7#6)(2013-8#5)
shift)##6##1##(1990-11#1)(1997-7#1)(2007-7#1)(2008-1#1)(2008-2#1)(2010-4#1)
shift- and scale-invariant optical##2##4##(2008-3#2)
shift-##4##1##(2007-12#2)(2008-3#2)
shift-invariant##9##1##(2008-2#3)(2008-3#6)
shift-multiplexed holographic##3##2##(2008-3#3)
shift?##3##1##(1994-11#1)(2008-3#1)(2010-12#1)
shifted and##7##2##(1992-3#1)(2008-12#1)(2008-2#1)(2008-3#4)
shifted apparently##2##2##(1996-1#1)(2008-10#1)
shifted at a##2##3##(1994-12#1)(2007-12#1)
shifted at##3##2##(1994-12#1)(2007-12#1)(2008-3#1)
shifted by the##2##3##(2007-12#1)(2008-2#1)
shifted by##13##2##(1990-12#1)(1990-9#1)(1991-10#1)(1993-4#1)(1995-7#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-7#1)(2013-7#1)
shifted concentration-response curves##2##3##(1992-6#1)(1995-12#1)
shifted excitation##2##2##(2006-12#1)(2008-9#1)
shifted feedback##2##2##(2008-4#2)
shifted from the##5##3##(1993-7#1)(1995-12#1)(2006-12#1)(2008-5#1)(2011-2#1)
shifted from##21##2##(1990-3#1)(1993-7#1)(1994-3#2)(1995-12#1)(1997-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-2#1)(2011-2#2)(2011-7#1)
shifted in##4##2##(1994-2#1)(1997-2#1)(2008-10#1)(2008-2#1)
shifted into the##2##3##(1991-11#1)(1996-8#1)
shifted into##3##2##(1991-11#1)(1996-8#1)(1997-1#1)
shifted its##3##2##(1997-7#1)(2010-8#1)(2012-2#1)
shifted linearly##2##2##(2008-10#2)
shifted negatively##4##2##(2005-11#1)(2008-10#3)
shifted over the past##2##4##(1995-12#1)(2011-2#1)
shifted the concentration-response curve for##2##5##(1993-11#1)(1996-10#1)
shifted the optimum##2##3##(1992-12#1)(2008-5#1)
shifted the steady-state inactivation curve##2##5##(1996-10#1)(1997-5#1)
shifted the##23##2##(1990-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-2#1)(1995-12#1)(1995-5#1)(1996-10#3)(1996-2#1)(1997-2#1)(1997-5#1)(2005-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2012-2#2)(2013-1#2)
shifted to a lower##2##4##(1995-8#1)(2007-12#1)
shifted to a##10##3##(1991-4#1)(1991-9#1)(1992-7#1)(1993-12#1)(1994-8#1)(1995-6#1)(1995-8#1)(2007-12#1)(2007-7#1)(2010-5#1)
shifted to higher frequency##2##4##(1992-9#2)
shifted to higher##3##3##(1992-9#2)(1995-8#1)
shifted to more negative##2##4##(1995-12#1)(2008-10#1)
shifted to more positive values##2##5##(1993-12#1)(2008-10#1)
shifted to more##4##3##(1993-12#1)(1995-12#1)(2008-10#2)
shifted to target##2##3##(2010-7#1)(2013-1#1)
shifted to the right in the presence of##3##8##(1997-5#1)(2008-4#1)(2009-5#1)
shifted to the right in##5##5##(1995-3#1)(1996-10#1)(1997-5#1)(2008-4#1)(2009-5#1)
shifted to the right##11##4##(1990-12#1)(1990-5#1)(1993-12#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-12#1)(1997-5#1)(2008-4#1)(2009-5#2)
shifted to the##20##3##(1990-12#1)(1990-5#1)(1992-6#1)(1993-12#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-5#1)(1997-5#1)(1997-6#1)(2008-4#2)(2009-5#2)(2010-5#1)(2010-9#1)(2013-1#1)
shifted to##67##2##(1990-12#2)(1990-3#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-12#3)(1993-8#1)(1994-5#2)(1994-8#1)(1995-12#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#5)(1996-10#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-11#3)(2007-11#2)(2007-12#2)(2007-7#2)(2008-10#3)(2008-3#1)(2008-4#2)(2008-7#1)(2009-5#2)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
shifted toward##4##2##(2005-11#1)(2008-10#2)(2008-9#1)
shifted towards higher##2##3##(1993-9#1)(1994-6#1)
shifted towards##12##2##(1990-12#1)(1993-9#1)(1994-6#1)(1995-7#1)(1997-4#1)(1997-5#1)(2007-2#1)(2008-10#1)(2008-8#1)(2009-9#1)(2012-12#2)
shifted upfield##2##2##(1993-8#1)(1994-5#1)
shifted with##2##2##(1992-4#1)(2005-12#1)
shifted##253##1##(1990-12#4)(1990-3#2)(1990-5#2)(1990-7#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#3)(1992-6#3)(1992-7#2)(1992-9#2)(1993-11#1)(1993-12#9)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#3)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#6)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#4)(1995-6#1)(1995-7#2)(1995-8#6)(1996-1#1)(1996-10#4)(1996-11#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-4#3)(1997-5#3)(1997-6#2)(1997-7#2)(2004-5#1)(2005-11#5)(2005-12#2)(2006-1#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2007-11#5)(2007-12#10)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#19)(2008-11#2)(2008-12#3)(2008-2#13)(2008-3#11)(2008-4#5)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#5)(2009-2#3)(2009-4#2)(2009-5#3)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#6)(2011-7#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
shifter##16##1##(2007-11#3)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#9)
shifters##7##1##(2008-2#5)(2008-3#2)
shifting and##9##2##(1995-5#1)(2007-12#1)(2008-2#3)(2008-3#1)(2010-11#1)(2010-4#1)(2011-2#1)
shifting from##4##2##(1994-8#1)(2009-5#1)(2010-8#1)(2011-1#1)
shifting in##4##2##(2008-11#1)(2008-3#2)(2011-1#1)
shifting is##2##2##(2008-10#1)(2008-3#1)
shifting of a##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
shifting of the##13##3##(1994-11#1)(2007-11#3)(2008-10#1)(2008-2#2)(2008-3#5)(2008-5#1)
shifting of##19##2##(1994-11#1)(2005-8#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#6)(2008-5#1)
shifting selectivity of##2##3##(2008-3#2)
shifting selectivity##4##2##(2008-3#4)
shifting the equilibrium between##2##4##(1992-12#1)(1993-9#1)
shifting the##37##2##(1990-12#1)(1990-3#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-3#1)(1997-1#1)(2005-7#1)(2007-12#4)(2008-10#4)(2008-2#5)(2008-3#6)(2008-6#1)(2008-8#2)(2009-9#1)(2011-2#1)(2012-12#1)
shifting to the##2##3##(1993-6#1)(2007-9#1)
shifting to##6##2##(1992-2#1)(1993-6#1)(2007-12#1)(2007-9#1)(2008-8#1)(2011-1#1)
shifting tolerance of##2##3##(2008-3#2)
shifting tolerance##3##2##(2008-3#3)
shifting##144##1##(1990-12#1)(1990-3#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-10#1)(1997-1#1)(1997-3#1)(1997-5#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-2#1)(2006-4#1)(2007-11#4)(2007-12#12)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#8)(2008-2#17)(2008-3#31)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#5)(2008-9#1)(2009-5#2)(2009-9#1)(2010-11#1)(2010-4#1)(2010-8#2)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
shifts (n =##2##3##(2011-2#2)
shifts and line##3##3##(1995-10#2)(2009-2#1)
shifts and##18##2##(1990-10#1)(1992-4#1)(1992-8#1)(1993-2#1)(1995-10#2)(1995-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-10#1)(2009-2#1)(2009-3#3)(2010-1#1)(2010-7#1)(2010-8#1)
shifts are consistent with##2##4##(1991-8#1)(1992-5#1)
shifts are##13##2##(1991-8#1)(1992-5#1)(1992-8#2)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-5#1)(2009-6#1)
shifts as##4##2##(2007-10#1)(2008-11#1)(2008-2#1)(2012-2#1)
shifts associated with##2##3##(2007-11#1)(2008-2#1)
shifts at##2##2##(1991-4#1)(1993-8#1)
shifts between##4##2##(1990-10#1)(1991-5#1)(1992-2#1)(2007-8#1)
shifts by##3##2##(2007-12#2)(2009-3#1)
shifts caused by the##3##4##(1995-5#1)(2007-8#1)(2008-3#1)
shifts caused by##4##3##(1995-5#1)(2007-12#1)(2007-8#1)(2008-3#1)
shifts due to##2##3##(2007-10#1)(2008-1#1)
shifts for the##3##3##(1990-7#1)(1991-4#1)(1995-5#1)
shifts for##10##2##(1990-7#1)(1991-2#1)(1991-4#1)(1992-1#2)(1994-5#1)(1995-5#2)(1997-4#1)(2010-7#1)
shifts from##10##2##(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#2)(2010-7#1)(2012-2#1)
shifts have##3##2##(2008-2#2)(2008-9#1)
shifts in a##3##3##(2007-12#1)(2008-2#1)(2008-4#1)
shifts in both##2##3##(2007-11#1)(2008-5#1)
shifts in diversification rates##2##4##(2008-9#2)
shifts in reimbursement##3##3##(1992-1#1)(1995-3#1)(2007-4#1)
shifts in the timing of##2##5##(1992-3#1)(2012-6#1)
shifts in the##23##3##(1990-3#1)(1992-3#2)(1992-9#1)(1993-2#1)(1993-3#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2011-2#2)(2012-1#2)(2012-6#1)(2013-8#1)
shifts in their##4##3##(1991-4#1)(1995-5#1)(1997-7#1)(2009-10#1)
shifts in women's##2##3##(2008-11#2)
shifts in##81##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-4#1)(1992-1#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-4#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#2)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#3)(2009-10#2)(2009-6#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-2#2)(2012-3#1)(2012-6#2)(2013-8#2)
shifts induced by##5##3##(1997-2#1)(1997-7#1)(2007-12#1)(2008-2#1)(2008-3#1)
shifts induced##6##2##(1997-2#1)(1997-7#1)(2007-12#2)(2008-2#1)(2008-3#1)
shifts is##6##2##(1992-2#1)(1992-8#1)(2005-11#1)(2008-11#1)(2008-3#2)
shifts observed for##3##3##(1993-8#2)(1997-7#1)
shifts observed##4##2##(1992-4#1)(1993-8#2)(1997-7#1)
shifts of Co(en)(3)(3+)##2##3##(1997-7#2)
shifts of attention##2##3##(1995-5#1)(2008-7#1)
shifts of the protons##2##4##(2006-10#1)(2009-3#1)
shifts of the##30##3##(1990-10#2)(1990-11#1)(1991-4#2)(1991-7#2)(1994-2#1)(1995-1#2)(1996-5#1)(1997-1#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-9#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2009-3#2)(2009-7#1)(2010-8#1)(2013-1#1)
shifts of these peaks##2##4##(2008-9#1)(2009-6#1)
shifts of these##3##3##(2008-10#1)(2008-9#1)(2009-6#1)
shifts of##66##2##(1990-10#2)(1990-11#1)(1991-2#1)(1991-4#2)(1991-7#2)(1991-8#1)(1992-9#1)(1993-12#1)(1994-2#1)(1994-8#1)(1995-1#3)(1995-2#2)(1995-3#1)(1995-5#2)(1995-8#1)(1996-5#2)(1997-1#2)(1997-7#2)(2005-11#1)(2005-4#1)(2006-10#1)(2007-1#1)(2007-12#3)(2007-9#2)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#5)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#3)(2009-6#1)(2009-7#1)(2010-5#2)(2010-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
shifts on##5##2##(1992-11#1)(2007-10#1)(2007-9#1)(2008-3#1)(2010-6#1)
shifts or##3##2##(1995-12#1)(2009-1#1)(2010-10#1)
shifts significantly##2##2##(1997-4#1)(2008-10#1)
shifts that are##3##3##(1992-8#1)(2007-11#1)(2007-12#1)
shifts that occur##2##3##(2007-11#1)(2007-12#1)
shifts that##10##2##(1992-8#1)(1994-8#1)(2007-11#3)(2007-12#3)(2008-4#1)(2010-6#1)
shifts the focus##2##3##(2008-8#1)(2009-4#1)
shifts the##20##2##(1990-4#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-6#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-8#2)(2009-4#1)(2010-5#1)(2011-1#1)(2013-1#2)
shifts to a more##2##4##(1994-3#1)(2008-10#1)
shifts to more##2##3##(2008-10#2)
shifts to the##3##3##(2005-11#1)(2008-2#1)(2010-12#1)
shifts to##19##2##(1990-10#1)(1991-10#1)(1991-2#1)(1992-12#1)(1994-3#1)(1995-10#1)(2005-11#2)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#1)(2010-12#1)(2013-8#1)
shifts toward##5##2##(1990-10#1)(1992-9#1)(2007-12#2)(2008-10#1)
shifts towards##4##2##(1992-8#1)(2007-9#1)(2008-11#1)(2013-8#1)
shifts up to##2##3##(1991-4#1)(2008-10#1)
shifts upon##2##2##(1996-8#1)(2006-4#1)
shifts using the##2##3##(2005-8#1)(2008-8#1)
shifts was##5##2##(1992-4#1)(2006-2#1)(2007-10#1)(2008-3#2)
shifts were##11##2##(1992-7#1)(1997-7#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2010-6#2)
shifts when##2##2##(1995-10#1)(2008-3#1)
shifts with a##2##3##(1995-1#1)(2008-10#1)
shifts with respect to##2##4##(1991-4#1)(2008-2#1)
shifts with##8##2##(1991-4#1)(1995-1#1)(1996-2#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)
shifts within the##2##3##(1995-2#1)(2011-1#1)
shifts##472##1##(1990-10#6)(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-2#4)(1991-3#2)(1991-4#9)(1991-5#3)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#3)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#3)(1992-5#1)(1992-7#1)(1992-8#8)(1992-9#3)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-8#3)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-1#4)(1995-10#5)(1995-12#4)(1995-2#6)(1995-3#3)(1995-5#8)(1995-6#3)(1995-8#3)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#4)(1996-5#4)(1996-6#2)(1996-8#2)(1997-1#3)(1997-2#3)(1997-4#8)(1997-5#1)(1997-7#6)(2005-11#6)(2005-4#2)(2005-8#1)(2006-10#3)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#2)(2007-1#1)(2007-10#9)(2007-11#14)(2007-12#36)(2007-4#1)(2007-8#2)(2007-9#8)(2008-1#5)(2008-10#31)(2008-11#19)(2008-12#3)(2008-2#32)(2008-3#31)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#8)(2009-1#1)(2009-10#2)(2009-2#2)(2009-3#7)(2009-4#1)(2009-5#2)(2009-6#4)(2009-7#2)(2010-1#2)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#3)(2010-4#2)(2010-5#4)(2010-6#6)(2010-7#5)(2010-8#2)(2011-1#4)(2011-2#6)(2012-1#3)(2012-12#1)(2012-2#5)(2012-3#3)(2012-6#2)(2013-1#3)(2013-7#2)(2013-8#6)
shiga toxin##8##2##(2008-8#6)(2013-1#2)
shigella##4##1##(2006-10#2)(2007-11#1)(2007-12#1)
shigellosis##3##1##(2006-10#1)(2008-1#1)(2008-10#1)
shih##2##1##(1991-8#1)(2012-2#1)
shiitake##5##1##(2008-10#5)
shikimate pathway##3##2##(1996-7#1)(2008-6#1)(2008-9#1)
shikimate##4##1##(1992-5#1)(1996-7#1)(2008-6#1)(2008-9#1)
shikimic acid##2##2##(2008-10#1)(2010-2#1)
shikimic and quinic##2##3##(2008-10#2)
shikimic##4##1##(2008-10#3)(2010-2#1)
shikonin production##4##2##(1994-11#4)
shikonin##7##1##(1994-11#7)
shimming by##2##2##(2012-3#2)
shimming##7##1##(2012-3#7)
shin##4##1##(2007-11#1)(2007-8#1)(2010-12#1)(2011-1#1)
shine on##3##2##(1996-7#1)(2008-5#2)
shine##6##1##(1991-1#1)(1996-7#1)(2007-8#1)(2007-9#1)(2008-5#2)
shingles##6##1##(2007-2#1)(2007-9#1)(2008-5#2)(2009-12#1)(2010-1#1)
shining##4##1##(1993-1#1)(2008-1#1)(2008-4#1)(2009-7#1)
shinny##2##1##(2012-11#2)
shins##2##1##(2007-7#1)(2010-6#1)
shiny cowbirds##2##2##(1996-1#2)
shiny##5##1##(1996-1#2)(2007-8#1)(2008-5#1)(2008-7#1)
ship and##2##2##(1991-12#1)(2008-3#1)
ship of##2##2##(2008-10#1)(2009-7#1)
ship##21##1##(1990-6#2)(1991-12#1)(1992-1#1)(1992-6#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-5#2)(2009-7#3)(2011-2#2)
shipboard##4##1##(2008-10#3)(2008-3#1)
shipbuilding##3##1##(2010-9#3)
shipment##3##1##(2006-5#1)(2008-10#1)(2008-4#1)
shipped to##3##2##(1995-11#1)(2008-10#1)(2008-4#1)
shipped##4##1##(1995-11#1)(2007-5#1)(2008-10#1)(2008-4#1)
shipping##7##1##(1992-9#1)(1993-6#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-6#1)
ships and the##2##3##(2008-11#1)(2011-2#1)
ships and##3##2##(2008-11#2)(2011-2#1)
ships##14##1##(2006-10#1)(2008-10#1)(2008-11#6)(2008-2#1)(2009-7#1)(2011-2#4)
shipyard workers##2##2##(1991-12#1)(2008-7#1)
shipyard##5##1##(1991-12#1)(2008-10#1)(2008-7#1)(2009-7#1)(2011-2#1)
shipyards##2##1##(2008-10#1)(2008-11#1)
shisha##2##1##(2010-2#2)
shiver##3##1##(1997-6#2)(2013-1#1)
shivering in##3##2##(2006-10#2)(2010-7#1)
shivering##23##1##(1991-8#1)(2006-10#7)(2007-10#2)(2010-4#1)(2010-7#11)(2013-1#1)
shm1##2##1##(1996-9#2)
shoal area##2##2##(2010-12#2)
shoal bass##4##2##(2012-3#4)
shoal##12##1##(2008-11#4)(2010-12#2)(2010-8#2)(2012-3#4)
shoaling behaviour##3##2##(2008-11#2)(2010-8#1)
shoaling preference##3##2##(2008-11#3)
shoaling was##2##2##(2010-12#2)
shoaling##14##1##(2008-11#6)(2010-12#4)(2010-8#3)(2012-12#1)
shock (CS)##2##2##(2007-9#1)(2008-3#1)
shock absorption##3##2##(2008-12#1)(2011-2#1)(2013-1#1)
shock after##5##2##(1997-5#1)(2007-3#1)(2007-9#2)(2012-3#1)
shock and even##2##3##(2008-4#1)(2013-8#1)
shock and the##3##3##(2007-7#1)(2008-1#1)(2009-8#1)
shock and##29##2##(1992-1#1)(1993-10#1)(1994-11#1)(1994-9#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-10#2)(2007-4#1)(2007-5#1)(2007-7#2)(2008-1#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-5#1)(2009-8#2)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
shock are##3##2##(2008-8#1)(2009-11#1)(2009-2#1)
shock as a##2##3##(1996-6#1)(2007-12#1)
shock as##4##2##(1994-11#1)(1996-6#1)(2007-12#1)(2011-2#1)
shock at##2##2##(2007-8#1)(2009-9#1)
shock but##2##2##(1997-7#1)(2006-6#1)
shock by##2##2##(2008-4#1)(2012-2#1)
shock can##2##2##(2008-12#1)(2008-4#1)
shock due to##3##3##(1994-2#1)(2007-8#1)(2008-1#1)
shock element##3##2##(1993-8#2)(1994-8#1)
shock from##3##2##(2006-4#1)(2008-7#1)(2011-1#1)
shock had##2##2##(1996-9#1)(1997-7#1)
shock in mice##3##3##(1995-2#1)(2008-5#2)
shock in the##2##3##(1996-9#1)(2009-4#1)
shock in##22##2##(1990-1#1)(1990-11#1)(1991-9#1)(1992-1#1)(1994-8#1)(1995-2#2)(1995-3#2)(1996-9#1)(2006-10#1)(2007-12#2)(2007-8#2)(2008-5#2)(2008-7#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-3#1)
shock induced##3##2##(1990-4#1)(1992-3#1)(2010-12#1)
shock is the most##2##4##(1990-10#1)(2006-10#1)
shock is##8##2##(1990-10#1)(1994-11#1)(1995-11#1)(2006-10#4)(2011-2#1)
shock may##2##2##(2006-10#1)(2011-2#1)
shock occurs##2##2##(1993-5#1)(2013-1#1)
shock of the cells##2##4##(1994-11#1)(1996-9#1)
shock of##4##2##(1992-1#1)(1994-11#1)(1996-9#1)(2007-8#1)
shock on a##2##3##(2008-2#1)(2008-7#1)
shock on##3##2##(1994-5#1)(2008-2#1)(2008-7#1)
shock or##6##2##(1997-5#1)(2008-5#1)(2009-10#1)(2009-11#1)(2010-9#1)(2012-3#1)
shock pretreatment##2##2##(1996-9#2)
shock protein (HSP)##6##3##(1993-8#1)(1994-11#1)(1997-2#1)(2008-7#1)(2009-8#1)(2013-1#1)
shock protein (HSP-70)##2##3##(1994-2#1)(1995-12#1)
shock protein 47 (HSP47)##2##4##(2008-11#1)(2012-2#1)
shock protein 47##3##3##(2008-11#1)(2012-2#2)
shock protein 56##2##3##(1992-11#1)(1993-8#1)
shock protein 60 (HSP60)##2##4##(2008-4#2)
shock protein 60##4##3##(1994-11#1)(2008-4#2)(2008-7#1)
shock protein 90##8##3##(1994-3#2)(1995-6#1)(2005-10#1)(2009-8#1)(2012-1#1)(2012-12#1)(2013-8#1)
shock protein##110##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-11#4)(1991-12#1)(1991-2#2)(1991-8#2)(1992-1#1)(1992-11#4)(1992-12#1)(1992-5#1)(1992-9#2)(1993-11#2)(1993-4#1)(1993-8#3)(1993-9#1)(1994-11#6)(1994-2#1)(1994-3#2)(1994-8#4)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#3)(1996-12#4)(1996-2#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#4)(1997-7#1)(1997-8#1)(2005-10#2)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#3)(2008-7#4)(2009-8#2)(2010-12#5)(2010-2#2)(2010-4#1)(2011-1#2)(2011-12#1)(2012-1#5)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#2)
shock proteins (HSPs)##6##3##(1991-9#1)(1996-9#1)(2005-10#1)(2006-8#1)(2008-7#1)(2013-1#1)
shock proteins (Hsp)##2##3##(2009-5#1)(2013-1#1)
shock proteins and skin##2##4##(2006-10#2)
shock proteins and##7##3##(1994-11#1)(2006-10#3)(2008-7#1)(2010-4#1)(2013-1#1)
shock proteins are##4##3##(1990-5#1)(2006-10#3)
shock proteins in immune response##2##5##(1994-11#2)
shock proteins in the##4##4##(1994-11#2)(2008-5#1)(2012-3#1)
shock proteins in##12##3##(1991-3#2)(1992-11#1)(1992-6#1)(1994-10#1)(1994-11#4)(2008-5#1)(2012-1#1)(2012-3#1)
shock proteins##79##2##(1990-11#1)(1990-4#1)(1990-5#2)(1991-11#2)(1991-3#2)(1991-9#1)(1992-11#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#3)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-10#2)(1994-11#9)(1996-10#1)(1996-2#1)(1996-9#3)(1997-4#1)(2005-10#1)(2006-10#15)(2006-8#1)(2008-1#2)(2008-4#1)(2008-5#2)(2008-7#3)(2009-5#2)(2009-8#2)(2010-4#1)(2012-1#3)(2012-12#1)(2012-3#2)(2013-1#4)
shock requiring##3##2##(2007-9#1)(2013-1#2)
shock response##17##2##(1993-8#1)(1994-11#4)(1994-6#1)(1994-8#3)(1997-4#1)(2008-5#1)(2008-7#3)(2009-8#1)(2010-2#2)
shock syndrome toxin-1 (TSST-1)##2##4##(1993-3#1)(1997-2#1)
shock syndrome toxin-1##3##3##(1993-3#1)(1997-2#2)
shock syndrome##25##2##(1993-3#2)(1993-6#1)(1994-8#1)(1995-2#1)(1997-2#2)(2006-10#4)(2006-12#1)(2006-4#3)(2007-12#1)(2007-2#1)(2008-5#1)(2009-9#1)(2011-1#3)(2011-2#3)
shock to the##2##3##(1996-2#1)(1996-3#1)
shock treatment##5##2##(1990-7#1)(1991-3#2)(1995-12#1)(2008-7#1)
shock was##5##2##(1992-8#1)(1995-2#1)(1996-2#1)(2007-5#1)(2008-4#1)
shock wave lithotripsy (ESWL)##7##4##(1990-11#1)(1991-12#1)(1996-12#2)(2007-7#1)(2007-9#1)(2009-5#1)
shock wave lithotripsy##17##3##(1990-11#1)(1990-8#1)(1991-12#1)(1993-2#1)(1996-12#2)(2006-9#1)(2007-10#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#1)(2009-5#2)(2011-2#1)(2012-12#1)(2013-1#1)
shock wave therapy##5##3##(1997-6#2)(2011-12#1)(2012-12#1)(2013-8#1)
shock wave##26##2##(1990-11#1)(1990-8#1)(1991-12#1)(1993-2#1)(1996-12#2)(1997-6#2)(2006-9#1)(2007-10#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)(2009-5#2)(2011-12#2)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
shock waves generated extracorporeally##2##4##(1994-5#1)(2007-11#1)
shock waves in##2##3##(2007-11#1)(2008-2#1)
shock waves##10##2##(1994-5#2)(1997-5#1)(2007-11#4)(2007-9#1)(2008-2#1)(2011-1#1)
shock were##2##2##(2007-8#1)(2008-7#1)
shock with##6##2##(1991-8#1)(1993-12#1)(2006-9#1)(2008-8#1)(2010-12#1)(2013-1#1)
shock##725##1##(1990-1#1)(1990-10#4)(1990-11#12)(1990-12#1)(1990-4#2)(1990-5#4)(1990-7#3)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#6)(1991-12#2)(1991-2#2)(1991-3#5)(1991-7#1)(1991-8#4)(1991-9#3)(1992-1#11)(1992-11#7)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#3)(1992-6#1)(1992-7#4)(1992-8#2)(1992-9#3)(1993-10#2)(1993-11#6)(1993-12#6)(1993-2#3)(1993-3#5)(1993-4#3)(1993-5#3)(1993-6#2)(1993-8#11)(1993-9#3)(1994-10#2)(1994-11#32)(1994-2#2)(1994-3#2)(1994-5#6)(1994-6#1)(1994-8#23)(1994-9#2)(1995-1#1)(1995-11#4)(1995-12#4)(1995-2#13)(1995-3#6)(1995-5#1)(1995-6#4)(1995-7#2)(1996-10#1)(1996-12#9)(1996-2#5)(1996-3#6)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#11)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#6)(1997-5#7)(1997-6#7)(1997-7#7)(1997-8#2)(2004-10#1)(2005-10#5)(2005-7#2)(2006-10#40)(2006-12#2)(2006-4#6)(2006-5#2)(2006-6#2)(2006-8#4)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#10)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#8)(2007-6#1)(2007-7#4)(2007-8#8)(2007-9#7)(2008-1#7)(2008-10#14)(2008-11#12)(2008-12#6)(2008-2#9)(2008-3#10)(2008-4#15)(2008-5#11)(2008-6#3)(2008-7#27)(2008-8#3)(2008-9#1)(2009-10#2)(2009-11#5)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#6)(2009-7#1)(2009-8#16)(2009-9#4)(2010-10#1)(2010-12#15)(2010-2#5)(2010-4#2)(2010-5#3)(2010-9#2)(2011-1#15)(2011-12#6)(2011-2#24)(2012-1#9)(2012-12#7)(2012-2#7)(2012-3#9)(2013-1#23)(2013-7#1)(2013-8#13)
shock) and##2##2##(2008-11#1)(2013-1#1)
shock)##3##1##(2008-11#1)(2010-12#1)(2013-1#1)
shock-induced##2##1##(1994-5#1)(2013-1#1)
shock-melted glass##2##2##(1995-3#2)
shock-probe##7##1##(1993-3#5)(1994-2#2)
shock-wave amplitudes##2##2##(2008-2#2)
shock-wave##8##1##(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#5)
shock?##2##1##(2006-4#1)(2009-6#1)
shock]##3##1##(1990-2#1)(1992-11#1)(2013-1#1)
shocked##9##1##(1995-12#3)(1997-5#1)(2006-10#1)(2008-5#1)(2008-6#2)(2013-8#1)
shocking the cells with glycerol or DMSO improves transfection efficiency##2##10##(2008-1#1)(2008-2#1)
shocking the cells with glycerol or##3##6##(2008-1#1)(2008-2#1)(2008-4#1)
shocking##5##1##(2007-11#1)(2008-1#1)(2008-2#1)(2008-4#1)(2010-8#1)
shocks in##2##2##(1996-4#2)
shocks on##2##2##(1994-3#1)(2008-9#1)
shocks##25##1##(1990-12#1)(1991-6#1)(1994-3#1)(1996-4#5)(1997-1#1)(2006-10#2)(2007-7#1)(2008-1#1)(2008-2#1)(2008-7#1)(2008-9#4)(2010-8#1)(2011-1#1)(2011-2#4)
shockwave lithotripsy (ESWL)##2##3##(1991-8#1)(2007-7#1)
shockwave lithotripsy of##2##3##(1991-3#1)(1992-5#1)
shockwave lithotripsy##14##2##(1991-3#1)(1991-8#1)(1992-5#1)(2006-10#1)(2007-6#1)(2007-7#1)(2013-1#8)
shockwave therapy##4##2##(1992-5#1)(1997-6#1)(2006-10#2)
shockwave##28##1##(1991-3#1)(1991-8#3)(1992-5#4)(1997-6#1)(2006-10#3)(2006-9#1)(2007-6#1)(2007-7#1)(2008-11#5)(2013-1#8)
shockwaves##2##1##(1992-5#1)(2008-11#1)
shoe##12##1##(1990-6#1)(1994-12#1)(1997-4#2)(2007-2#1)(2007-4#1)(2008-10#1)(2010-10#1)(2010-11#1)(2012-1#2)(2013-1#1)
shoe-surface##5##1##(2013-1#5)
shoes and##4##2##(1990-6#1)(1993-6#1)(2008-4#1)(2010-11#1)
shoes##13##1##(1990-6#1)(1993-6#1)(2006-10#1)(2008-10#1)(2008-4#1)(2010-11#1)(2010-3#1)(2013-1#1)(2013-8#5)
shook##3##1##(1993-5#1)(2007-9#1)(2012-12#1)
shoot and root stem##2##4##(2009-8#2)
shoot and root##10##3##(2004-4#2)(2008-10#1)(2008-12#1)(2009-8#4)(2011-12#1)(2012-12#1)
shoot and##12##2##(2004-4#2)(2008-10#2)(2008-12#1)(2008-5#1)(2009-8#4)(2011-12#1)(2012-12#1)
shoot apex##3##2##(2008-10#1)(2008-5#1)(2009-8#1)
shoot apical meristem (SAM)##3##4##(2009-8#2)(2012-2#1)
shoot apical meristem##6##3##(2009-8#4)(2012-12#1)(2012-2#1)
shoot apices##2##2##(2008-8#1)(2012-12#1)
shoot blight##14##2##(2008-10#14)
shoot buds##3##2##(2013-1#3)
shoot competition##3##2##(2008-9#3)
shoot cultures of Digitalis lanata##2##5##(2007-1#2)
shoot cultures##7##2##(2007-1#7)
shoot dieback##2##2##(2008-10#2)
shoot elongation##5##2##(2006-12#2)(2011-12#3)
shoot growth or##2##3##(2008-10#1)(2008-11#1)
shoot growth##6##2##(2008-10#3)(2008-11#1)(2011-12#2)
shoot length and##2##3##(2006-9#1)(2008-12#1)
shoot tip and##2##3##(2008-10#1)(2008-12#1)
shoot tip meristems##2##3##(2008-8#1)(2008-9#1)
shoot tip##5##2##(2007-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)
shoot tips##5##2##(2008-10#1)(2008-8#4)
shoot virus##3##2##(2008-10#3)
shoot##137##1##(2004-4#2)(2006-12#4)(2006-9#1)(2007-1#12)(2007-3#1)(2007-8#1)(2008-10#50)(2008-11#1)(2008-12#8)(2008-2#1)(2008-5#4)(2008-8#8)(2008-9#8)(2009-6#2)(2009-8#12)(2011-12#6)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#3)
shoot)##2##1##(2008-10#2)
shoot/root ratio##2##2##(2008-10#1)(2008-12#1)
shooting mechanics##2##2##(2007-10#2)
shooting##22##1##(1991-3#1)(1994-12#1)(1995-11#2)(1995-2#1)(2007-10#4)(2007-12#1)(2007-2#1)(2007-4#2)(2008-12#2)(2008-4#1)(2009-2#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#2)
shoots and roots##8##3##(2007-8#1)(2008-10#2)(2008-12#3)(2009-8#2)
shoots and##14##2##(2007-8#1)(2008-10#6)(2008-12#3)(2009-8#4)
shoots are##3##2##(2008-10#1)(2008-12#1)(2008-2#1)
shoots as##3##2##(2008-10#2)(2008-9#1)
shoots by##4##2##(2008-10#3)(2008-2#1)
shoots contained##2##2##(2008-10#2)
shoots for##3##2##(2008-10#3)
shoots in the##3##3##(2006-12#1)(2008-10#1)(2008-12#1)
shoots in##4##2##(1991-11#1)(2006-12#1)(2008-10#1)(2008-12#1)
shoots increased##2##2##(2008-10#1)(2008-12#1)
shoots m(-2) in##2##3##(2008-5#2)
shoots of##4##2##(2006-12#1)(2008-10#1)(2008-12#1)(2009-8#1)
shoots was##7##2##(2008-10#3)(2008-11#1)(2008-12#1)(2009-8#1)(2012-8#1)
shoots were##6##2##(2006-12#1)(2008-10#4)(2008-12#1)
shoots##104##1##(1991-11#2)(1991-2#1)(1993-8#1)(1996-10#1)(1997-6#1)(2004-4#3)(2006-12#4)(2006-9#1)(2007-8#1)(2008-10#53)(2008-11#1)(2008-12#14)(2008-2#2)(2008-5#4)(2008-9#1)(2009-10#1)(2009-8#9)(2011-2#1)(2012-8#1)(2013-1#2)
shoots) and##2##2##(2008-10#2)
shoots)##5##1##(2008-10#2)(2011-2#1)(2013-1#2)
shoots/m2##2##1##(2008-5#2)
shop for the##2##3##(1991-7#1)(1995-2#1)
shop##13##1##(1991-7#1)(1992-12#1)(1992-2#1)(1992-3#1)(1994-1#2)(1994-3#1)(1995-2#1)(1996-3#1)(1997-1#1)(2005-8#1)(2006-10#1)(2012-1#1)
shopper##3##1##(1990-9#1)(1994-1#1)(1996-5#1)
shopping at##2##2##(1994-9#1)(2008-9#1)
shopping for##3##2##(2007-8#1)(2008-1#1)(2013-1#1)
shopping##19##1##(1990-12#1)(1994-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-3#3)(2006-5#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
shops##3##1##(1993-1#1)(1997-3#1)(2007-3#1)
shore crab##3##2##(1992-12#1)(1994-11#1)(2007-12#1)
shore flies##2##2##(2008-10#2)
shore##15##1##(1992-12#1)(1994-1#1)(1994-11#1)(1995-5#1)(1996-6#1)(2007-12#1)(2007-3#3)(2008-10#2)(2008-5#3)(2013-7#1)
shorebirds##4##1##(2013-7#4)
shoreline of##2##2##(2008-10#1)(2012-3#1)
shoreline##5##1##(2007-3#1)(2008-10#2)(2008-5#1)(2012-3#1)
shores of the##2##3##(1996-6#1)(2010-1#1)
shores##7##1##(1996-6#1)(2007-5#2)(2008-10#1)(2010-1#1)(2010-8#2)
short &quot##3##2##(1994-9#1)(1997-4#1)(2004-9#1)
short (&lt##6##2##(1993-2#1)(2006-8#1)(2007-12#2)(2008-2#1)(2012-2#1)
short (6##2##2##(2008-10#1)(2008-7#1)
short (approximately 1##2##3##(1997-2#1)(2009-8#1)
short (approximately##3##2##(1997-2#1)(2008-3#1)(2009-8#1)
short (mev-1) life##2##3##(2008-3#2)
short -##2##2##(2011-1#1)(2012-2#1)
short 3(10)-helix##2##2##(1997-2#1)(2008-9#1)
short Barrett's esophagus##2##3##(2013-8#2)
short CDSs##4##2##(1996-12#4)
short DNA and fibrous DNA##2##5##(2008-11#2)
short DNA sequences##2##3##(2008-4#1)(2012-1#1)
short DNA strands##2##3##(2009-6#1)(2010-7#1)
short DNA##17##2##(1990-12#1)(1992-9#1)(1993-3#1)(1995-8#1)(2008-10#1)(2008-11#5)(2008-3#1)(2008-4#1)(2009-6#1)(2009-8#1)(2010-7#1)(2012-1#1)(2012-3#1)
short ORFs##2##2##(1995-12#1)(2008-10#1)
short QT syndrome##2##3##(2006-9#1)(2013-1#1)
short RNA species##2##3##(1995-1#1)(2012-12#1)
short RNA##3##2##(1991-3#1)(1995-1#1)(2012-12#1)
short a period##2##3##(2006-10#1)(2006-12#1)
short a##5##2##(1992-1#1)(1992-6#1)(2006-10#1)(2006-12#1)(2010-12#1)
short acquisition##2##2##(2006-10#1)(2008-7#1)
short actin##2##2##(2008-9#1)(2009-10#1)
short acting beta agonist use but only among children who##2##10##(2012-1#2)
short acting beta agonist use even after adjusting for##2##9##(2012-1#2)
short acting beta agonist use##9##5##(2012-1#9)
short acting##15##2##(1990-8#1)(2006-8#2)(2008-8#1)(2010-7#2)(2012-1#9)
short alkyl chains##2##3##(2007-9#1)(2008-5#1)
short analysis time##4##3##(2008-10#4)
short analysis times##2##3##(1996-11#1)(2008-10#1)
short analysis##6##2##(1996-11#1)(2008-10#5)
short analytical##2##2##(2007-8#1)(2008-10#1)
short and long term treatment##4##5##(2006-12#1)(2007-12#1)(2008-1#1)(2008-8#1)
short and long term##11##4##(2006-12#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#3)(2010-12#1)
short and long##21##3##(1992-11#1)(1993-12#1)(1996-5#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#3)(2010-12#1)(2012-12#1)
short and long-term complications##2##4##(2006-10#1)(2008-4#1)
short and long-term##9##3##(2006-10#1)(2006-6#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-3#1)(2011-2#1)(2012-2#1)
short and medium-term##2##3##(2011-2#2)
short and the##7##3##(1992-2#1)(2004-11#1)(2006-11#1)(2007-9#1)(2008-3#3)
short and##60##2##(1991-3#1)(1992-11#1)(1992-2#1)(1993-12#1)(1994-11#2)(1996-12#2)(1996-5#1)(2004-11#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#3)(2007-12#4)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#3)(2009-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#1)
short and/or##2##2##(1997-3#1)(2007-12#1)
short arm of the##5##4##(1990-11#1)(1995-11#1)(1997-5#2)(2008-10#1)
short arm of##34##3##(1990-11#1)(1990-12#1)(1990-4#1)(1990-8#1)(1995-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-5#2)(2006-12#1)(2006-8#1)(2007-12#2)(2008-10#15)(2008-4#1)(2012-3#2)
short arm##44##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-8#1)(1990-9#1)(1995-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-5#2)(2006-12#1)(2006-8#1)(2007-12#2)(2007-2#1)(2008-10#16)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#4)(2009-10#1)(2012-3#2)
short arms of chromosome##2##4##(2008-5#1)(2009-10#1)
short arms##5##2##(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2012-2#1)
short article##5##2##(1997-4#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-12#1)
short as##42##2##(1994-2#1)(1994-6#1)(1996-11#1)(1997-1#1)(1997-5#1)(2007-11#9)(2007-12#13)(2008-1#4)(2008-2#4)(2008-3#3)(2009-3#1)(2009-4#1)(2010-8#1)(2011-12#1)
short axis##4##2##(1995-6#1)(2007-8#1)(2008-5#1)(2010-3#1)
short bowel syndrome##10##3##(1990-9#1)(1991-12#3)(1993-5#1)(1994-3#1)(2006-10#2)(2007-7#1)(2008-10#1)
short bowel##11##2##(1990-9#1)(1991-12#3)(1993-5#1)(1994-3#1)(2006-10#2)(2007-7#1)(2008-10#2)
short broad neck##2##3##(1996-12#2)
short but##4##2##(1995-1#1)(2007-2#1)(2008-7#1)(2010-7#1)
short calls##2##2##(1994-8#1)(2008-8#1)
short capillary and##2##3##(2008-10#2)
short case##2##2##(1996-12#1)(2010-11#1)
short cattle tendons##3##3##(2008-5#3)
short chain fatty acids in##2##5##(1990-6#1)(2011-2#1)
short chain fatty acids##4##4##(1990-6#1)(2006-8#1)(2009-3#1)(2011-2#1)
short chain fatty##5##3##(1990-6#1)(2006-8#1)(2008-7#1)(2009-3#1)(2011-2#1)
short chain lengths##2##3##(2005-11#1)(2012-2#1)
short chain##11##2##(1990-6#1)(2005-11#2)(2006-8#1)(2008-3#2)(2008-7#1)(2009-3#1)(2009-6#1)(2011-2#1)(2012-2#1)
short coherence length##6##3##(1992-9#1)(2007-11#3)(2008-1#2)
short column##2##2##(1997-3#1)(2008-10#1)
short compared with the##3##4##(2007-12#2)(2008-2#1)
short compared with##4##3##(1993-9#1)(2007-12#2)(2008-2#1)
short coupling length##2##3##(2008-3#2)
short course of##3##3##(2008-6#1)(2011-1#1)(2012-2#1)
short course##6##2##(1993-3#1)(1994-1#1)(2006-10#1)(2008-6#1)(2011-1#1)(2012-2#1)
short cut to##2##3##(2009-8#1)(2011-12#1)
short cut##4##2##(2009-8#1)(2010-4#1)(2010-8#1)(2011-12#1)
short delay##2##2##(1993-12#1)(2007-12#1)
short delayed##2##2##(2013-7#2)
short delays##3##2##(1993-12#2)(1995-12#1)
short deletions##3##2##(1993-2#1)(1996-11#1)(1997-7#1)
short description of the##5##4##(1990-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)
short discussion##2##2##(1992-3#1)(2007-11#1)
short distance to##2##3##(1997-6#1)(2008-8#1)
short distance##8##2##(1996-6#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-7#1)
short distances##11##2##(2006-10#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2013-8#1)
short duration and##4##3##(2006-2#1)(2008-11#1)(2008-9#1)(2011-2#1)
short duration in##2##3##(2005-11#1)(2008-3#1)
short duration of follow-up##3##4##(2007-7#1)(2008-1#1)(2009-10#1)
short duration of the##3##4##(1993-5#1)(2006-10#1)(2007-12#1)
short duration of##14##3##(1990-10#1)(1993-4#1)(1993-5#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
short duration##35##2##(1990-10#2)(1990-2#1)(1992-5#1)(1992-8#1)(1993-4#1)(1993-5#2)(1995-11#1)(1996-11#1)(2005-11#1)(2006-10#2)(2006-2#1)(2007-12#2)(2007-7#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-12#1)(2011-2#2)(2012-2#2)(2013-1#1)
short dynamic##2##2##(1992-4#1)(2009-10#1)
short dystrophin##2##2##(2013-8#2)
short electrical pulses##2##3##(2008-11#1)(2009-11#1)
short example##2##2##(2008-10#1)(2008-2#1)
short exposure to##4##3##(1990-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
short exposure##7##2##(1990-8#1)(1994-10#1)(2008-10#1)(2008-2#2)(2008-7#1)(2011-2#1)
short exposures##2##2##(2008-10#1)(2008-7#1)
short external##2##2##(2008-3#1)(2008-8#1)
short fibers##3##2##(2008-3#1)(2009-11#1)(2009-7#1)
short fluorescence lifetime##2##3##(1996-8#1)(2009-4#1)
short follow-up period##2##3##(2007-8#1)(2013-7#1)
short follow-up##4##2##(2006-6#1)(2007-6#1)(2007-8#1)(2013-7#1)
short for##4##2##(1990-12#1)(1995-6#1)(1995-7#1)(2008-10#1)
short form was##2##3##(1997-2#1)(1997-8#1)
short form##9##2##(1990-3#1)(1994-8#2)(1997-2#1)(1997-8#3)(2006-8#1)(2007-8#1)
short forms##5##2##(1997-8#5)
short fragments of DNA##2##4##(1997-1#1)(2008-4#1)
short fragments of##4##3##(1993-5#1)(1997-1#1)(2008-4#1)(2008-7#1)
short fragments##6##2##(1993-5#1)(1993-6#1)(1997-1#1)(2008-4#1)(2008-7#1)(2013-1#1)
short fusion##2##2##(1994-9#2)
short galls##2##2##(2008-10#2)
short gaps##4##2##(1997-4#1)(2011-2#2)(2012-12#1)
short generation time##4##3##(2007-12#1)(2008-4#1)(2013-1#2)
short generation times##3##3##(2008-10#1)(2008-8#1)(2010-12#1)
short generation##7##2##(2007-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-12#1)(2013-1#2)
short glass fibers##2##3##(2009-7#2)
short hairpin RNA (shRNA)##2##4##(2010-12#1)(2011-2#1)
short hairpin RNA##3##3##(2010-12#1)(2011-2#1)(2013-1#1)
short half-life and##2##3##(2007-11#1)(2010-12#1)
short half-life in##2##3##(1996-9#1)(2009-4#1)
short half-life of##2##3##(2007-11#1)(2012-2#1)
short half-life##14##2##(1991-8#1)(1996-5#1)(1996-9#1)(2007-11#3)(2008-11#1)(2008-4#1)(2009-11#1)(2009-4#1)(2010-12#1)(2010-7#1)(2012-2#2)
short half-lives and##2##3##(1995-1#1)(2007-11#1)
short half-lives##3##2##(1995-1#1)(2007-11#1)(2010-10#1)
short helix##2##2##(1996-7#1)(2011-2#1)
short history of##7##3##(1993-12#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-5#1)(2008-7#1)
short history##8##2##(1993-12#1)(1997-5#1)(2006-10#1)(2007-11#2)(2007-3#1)(2008-5#1)(2008-7#1)
short homologies##2##2##(1993-6#2)
short homologous##2##2##(1993-9#1)(1994-9#1)
short hospital stay##2##3##(2007-8#1)(2009-6#1)
short hydrophobic##2##2##(1991-10#1)(2005-11#1)
short in##5##2##(1991-4#1)(1997-5#1)(2007-10#1)(2012-2#1)(2013-1#1)
short incubation##4##2##(1995-7#1)(2008-10#1)(2008-11#1)(2012-11#1)
short initial##3##2##(1994-11#1)(2007-11#1)(2010-12#1)
short interfering RNA (siRNA)##2##4##(2008-1#1)(2008-2#1)
short interfering RNA##3##3##(2008-1#1)(2008-2#1)(2011-2#1)
short interfering RNAs##2##3##(2008-2#1)(2008-4#1)
short interfering##5##2##(2008-1#1)(2008-2#2)(2008-4#1)(2011-2#1)
short interruption of the##2##4##(1991-3#1)(2008-1#1)
short interspersed nucleotide##2##3##(1992-12#1)(2012-2#1)
short intervals##2##2##(1992-12#1)(1996-10#1)
short introns##3##2##(1990-4#1)(1997-4#1)(1997-6#1)
short laser pulse##4##3##(1993-3#1)(1995-5#1)(2007-12#1)(2008-10#1)
short laser pulses##3##3##(1993-8#1)(2007-11#1)(2008-3#1)
short laser##8##2##(1993-3#1)(1993-8#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
short lasting##4##2##(1992-6#1)(1994-2#1)(2005-7#1)(2009-10#1)
short latencies##2##2##(1991-3#1)(2009-3#1)
short latency##12##2##(1991-8#1)(1992-7#1)(1992-8#1)(1994-11#1)(1994-2#2)(1994-6#1)(1996-2#2)(1996-5#2)(2011-1#1)
short length scales##3##3##(2008-2#1)(2008-7#2)
short length##9##2##(2006-1#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#1)(2008-7#2)
short lengths of stay##2##4##(1992-3#1)(1995-1#1)
short lengths of##5##3##(1992-3#1)(1995-1#1)(2006-10#1)(2008-3#1)(2008-7#1)
short lengths##6##2##(1992-3#1)(1995-1#1)(2006-10#1)(2008-1#1)(2008-3#1)(2008-7#1)
short life cycle##2##3##(2012-11#1)(2012-3#1)
short life expectancy##2##3##(1995-9#1)(2006-10#1)
short life##6##2##(1995-9#1)(2006-10#1)(2010-11#1)(2012-11#1)(2012-3#1)(2013-7#1)
short lifetime##3##2##(1990-4#1)(1991-7#1)(1994-3#1)
short light##2##2##(2008-2#1)(2010-8#1)
short linear##3##2##(1995-2#1)(2008-10#1)(2013-1#1)
short linkage##2##2##(2006-12#1)(2008-10#1)
short list of##2##3##(2008-2#1)(2013-7#1)
short lived##3##2##(2007-12#1)(2008-5#1)(2010-6#1)
short loop##3##2##(1993-11#1)(1994-11#2)
short motif search##3##3##(2012-2#3)
short motifs##2##2##(2008-4#1)(2012-2#1)
short neck##4##2##(1996-12#2)(1996-3#1)(2010-4#1)
short of the##5##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#1)
short of##17##2##(1991-3#1)(1995-10#1)(1995-2#1)(1996-6#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2012-12#1)
short oligonucleotides##5##2##(1993-3#1)(1994-11#1)(1994-6#1)(2008-10#1)(2008-4#1)
short optical pulses##3##3##(2007-12#2)(2008-2#1)
short optical##5##2##(2007-12#2)(2008-1#1)(2008-2#2)
short or long##4##3##(2007-12#1)(2008-5#1)(2009-2#1)(2009-5#1)
short or##12##2##(1992-3#1)(1992-5#1)(1994-2#1)(1996-9#1)(2007-12#1)(2007-4#1)(2008-5#1)(2009-2#1)(2009-5#1)(2010-2#1)(2013-1#2)
short overview##6##2##(1993-8#1)(1994-6#1)(2006-6#1)(2007-9#1)(2012-2#2)
short palindromic##2##2##(1990-11#1)(2012-1#1)
short path length##2##3##(2008-10#1)(2008-3#1)
short peptide sequence##2##3##(1992-8#1)(1995-2#1)
short peptide##9##2##(1992-5#1)(1992-8#1)(1993-4#1)(1995-11#1)(1995-2#1)(2009-3#1)(2012-1#1)(2012-12#1)(2013-1#1)
short peptides derived from the##2##5##(1992-4#1)(2008-8#1)
short peptides##14##2##(1991-2#1)(1991-5#1)(1992-4#2)(1997-4#1)(2008-10#1)(2008-4#2)(2008-8#1)(2010-11#1)(2011-3#1)(2012-2#1)(2013-1#2)
short period of time##25##4##(1993-3#1)(1994-10#1)(1995-3#1)(1995-5#1)(1996-3#2)(2006-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-4#1)(2008-8#1)(2009-2#1)(2010-11#1)(2011-11#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
short period of##37##3##(1992-6#1)(1993-3#1)(1994-10#2)(1995-3#1)(1995-5#1)(1996-3#2)(1997-2#1)(2005-8#1)(2006-6#1)(2006-8#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-8#1)(2010-11#1)(2011-11#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#4)
short period##61##2##(1990-10#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-7#1)(1992-6#2)(1992-9#1)(1993-3#1)(1994-10#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-3#2)(1997-2#1)(2005-8#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#4)(2008-11#3)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-11#1)(2011-12#1)(2011-2#2)(2012-1#1)(2013-1#6)(2013-8#1)
short periods of time##5##4##(1991-9#1)(1992-5#1)(2005-10#1)(2009-6#1)(2011-2#1)
short periods of##9##3##(1991-9#1)(1992-3#1)(1992-5#1)(1993-4#1)(2005-10#1)(2006-10#1)(2007-8#1)(2009-6#1)(2011-2#1)
short periods##14##2##(1990-9#1)(1991-9#1)(1992-3#1)(1992-5#1)(1993-4#1)(1996-3#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2009-6#1)(2011-2#1)(2013-1#1)
short plasma half-life of##2##4##(1993-8#1)(2008-3#1)
short plasma half-life##6##3##(1993-8#1)(2007-11#1)(2008-3#1)(2008-5#2)(2012-2#1)
short posterior ciliary##3##3##(2009-8#2)(2012-3#1)
short presentations from##2##3##(2007-11#1)(2011-2#1)
short presentations##3##2##(2006-11#1)(2007-11#1)(2011-2#1)
short propagation##2##2##(2008-3#2)
short pulse##10##2##(2007-11#1)(2007-12#4)(2008-2#4)(2008-3#1)
short pulses of##4##3##(1991-8#1)(1995-6#1)(2007-12#2)
short pulses##12##2##(1991-8#1)(1995-6#1)(2007-11#1)(2007-12#5)(2008-1#1)(2008-2#2)(2008-3#1)
short questionnaire##2##2##(2006-10#1)(2008-1#1)
short ragweed##2##2##(2007-11#2)
short range##4##2##(1994-9#1)(2006-2#1)(2008-10#1)(2008-3#1)
short reaction time##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
short reaction times##4##3##(2007-11#1)(2008-10#1)(2008-6#1)(2012-12#1)
short reaction##7##2##(2007-11#1)(2008-10#2)(2008-6#1)(2008-9#1)(2011-2#1)(2012-12#1)
short regions of##3##3##(1990-4#1)(2008-4#1)(2012-3#1)
short regions##5##2##(1990-4#1)(1995-5#1)(2008-10#1)(2008-4#1)(2012-3#1)
short relative##2##2##(1993-8#1)(2010-8#1)
short report##2##2##(1997-7#1)(2011-12#1)
short response time and##2##4##(2007-8#1)(2008-10#1)
short response time##16##3##(1992-4#1)(2007-8#2)(2008-10#12)(2010-5#1)
short response##17##2##(1992-4#1)(1997-3#1)(2007-8#2)(2008-10#12)(2010-5#1)
short review of the##5##4##(2006-10#1)(2006-8#1)(2007-5#1)(2008-6#1)(2010-2#1)
short review of##8##3##(2006-10#1)(2006-11#1)(2006-8#1)(2007-5#1)(2008-10#1)(2008-6#1)(2010-2#1)(2012-12#1)
short review we##2##3##(2008-7#2)
short review##32##2##(1990-5#1)(1995-5#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-8#1)(2007-10#1)(2007-5#2)(2008-10#4)(2008-11#2)(2008-6#1)(2008-7#6)(2009-3#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-8#1)
short rods##2##2##(2008-7#1)(2011-2#1)
short roots##2##2##(2012-12#2)
short run of##2##3##(2006-9#1)(2010-10#1)
short run##3##2##(2006-9#1)(2010-10#1)(2011-2#1)
short section##2##2##(2007-11#1)(2008-11#1)
short segment##4##2##(1990-3#1)(1992-8#1)(2006-1#1)(2012-2#1)
short segments##4##2##(1991-6#1)(1991-8#2)(1994-9#1)
short separation time##2##3##(2008-10#1)(2008-4#1)
short sequence##3##2##(1994-9#1)(2008-8#1)(2009-6#1)
short sequences##3##2##(1990-2#1)(2007-12#1)(2008-9#1)
short single##2##2##(1995-6#2)
short solarization##2##2##(2008-10#2)
short source##2##2##(2008-11#1)(2008-2#1)
short stature and delayed puberty##2##5##(2010-12#2)
short stature and##4##3##(1996-12#1)(2008-4#1)(2010-12#2)
short stature in##3##3##(1993-6#1)(1996-6#1)(2008-9#1)
short stature##44##2##(1991-5#1)(1993-6#1)(1996-12#4)(1996-3#3)(1996-6#2)(1996-8#1)(1997-1#1)(2007-11#2)(2007-8#5)(2008-1#1)(2008-4#2)(2008-9#1)(2010-12#3)(2010-3#1)(2010-6#1)(2011-1#4)(2012-2#4)(2012-3#2)(2013-1#5)
short stay##3##2##(1997-4#1)(2008-3#1)(2013-1#1)
short stretches of the##4##4##(2006-12#1)(2008-2#1)(2008-4#2)
short stretches of##7##3##(1992-3#1)(1993-6#1)(1996-9#1)(2006-12#1)(2008-2#1)(2008-4#2)
short study##2##2##(2008-5#1)(2011-2#1)
short summaries##2##2##(2008-5#1)(2011-1#1)
short supply of##2##3##(2007-2#1)(2010-12#1)
short supply##7##2##(1996-8#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-12#1)
short survey##3##2##(1993-2#1)(2013-1#1)(2013-7#1)
short survival##5##2##(1994-6#1)(1996-3#1)(1996-9#1)(2008-9#1)(2010-5#1)
short synthetic##2##2##(1994-12#1)(1995-3#1)
short tandem repeat (STR) loci##4##5##(1995-11#1)(1996-12#1)(2008-12#2)
short tandem repeat (STR)##7##4##(1995-11#1)(1996-12#1)(2008-12#5)
short tandem repeat loci##2##4##(2008-12#1)(2008-4#1)
short tandem repeat##14##3##(1994-9#1)(1995-11#1)(1996-12#2)(1996-7#1)(2008-11#1)(2008-12#6)(2008-4#1)(2010-9#1)
short tandem repeats##2##3##(2008-12#1)(2008-4#1)
short tandem##16##2##(1994-9#1)(1995-11#1)(1996-12#2)(1996-7#1)(2008-11#1)(2008-12#7)(2008-4#2)(2010-9#1)
short term and in##2##4##(1995-3#1)(2006-5#1)
short term and##5##3##(1993-11#2)(1995-3#1)(2006-5#1)(2007-1#1)
short term benefits##2##3##(2012-2#1)(2013-1#1)
short term culture##2##3##(1994-2#1)(1994-9#1)
short term event##3##3##(2013-1#3)
short term human##2##3##(1994-2#2)
short term memory status in##3##5##(2012-2#3)
short term outcome##2##3##(2009-9#1)(2013-1#1)
short term reconstitution##2##3##(1994-2#2)
short term treatment##2##3##(1992-3#1)(2007-11#1)
short term##81##2##(1991-12#1)(1992-2#1)(1992-3#3)(1993-11#2)(1993-3#1)(1993-6#2)(1993-9#1)(1994-2#5)(1994-8#1)(1994-9#3)(1995-12#1)(1995-3#1)(1995-9#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-2#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-11#7)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#3)(2012-12#1)(2012-2#6)(2013-1#7)(2013-8#2)
short term&quot##2##2##(1992-6#2)
short terrestrial duathlon##4##3##(2008-5#4)
short time and##4##3##(2006-10#1)(2006-6#1)(2008-10#1)(2008-11#1)
short time frame##3##3##(2005-5#1)(2008-11#1)(2010-11#1)
short time frames##2##3##(2008-11#1)(2012-3#1)
short time intervals##2##3##(2008-3#1)(2012-12#1)
short time of##3##3##(2006-10#1)(2008-10#1)(2009-4#1)
short time period##6##3##(2006-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)
short time periods##2##3##(2010-4#1)(2012-2#1)
short time scale##2##3##(1996-4#1)(2007-12#1)
short time span##2##3##(1994-3#1)(2007-11#1)
short time to##2##3##(1996-1#1)(2008-3#1)
short time##85##2##(1990-12#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-3#1)(1991-8#1)(1991-9#1)(1993-1#1)(1993-7#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-7#1)(1996-1#1)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#1)(2004-9#1)(2005-1#1)(2005-11#1)(2005-5#1)(2006-10#2)(2006-2#2)(2006-6#3)(2006-8#1)(2007-11#2)(2007-12#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#9)(2008-11#7)(2008-2#1)(2008-3#9)(2008-5#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
short times of flight##3##4##(2008-2#3)
short times of##4##3##(2008-2#3)(2008-6#1)
short times##9##2##(1997-6#1)(2005-11#2)(2008-11#1)(2008-2#4)(2008-6#1)
short to##4##2##(1992-3#1)(1992-9#1)(2006-2#1)(2008-3#1)
short treatment##4##2##(1995-6#1)(2008-12#1)(2008-5#1)(2010-11#1)
short tubular bones##2##3##(1993-4#1)(1996-12#1)
short tubular##3##2##(1993-4#1)(1994-6#1)(1996-12#1)
short turnaround##2##2##(2009-11#1)(2012-3#1)
short version of the##2##4##(2006-10#1)(2011-1#1)
short version of##3##3##(2006-10#1)(2008-7#1)(2011-1#1)
short volatile##2##2##(2008-7#2)
short wavelength##3##2##(2005-4#1)(2007-6#1)(2008-8#1)
short wavelengths##3##2##(2008-3#3)
short years##2##2##(2008-5#1)(2009-4#1)
short##1686##1##(1990-10#4)(1990-11#7)(1990-12#5)(1990-2#5)(1990-3#5)(1990-4#4)(1990-5#4)(1990-6#5)(1990-7#4)(1990-8#5)(1990-9#7)(1991-1#2)(1991-10#1)(1991-12#6)(1991-2#2)(1991-3#7)(1991-4#5)(1991-5#6)(1991-6#3)(1991-7#3)(1991-8#6)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#5)(1992-12#4)(1992-2#3)(1992-3#10)(1992-4#4)(1992-5#4)(1992-6#6)(1992-7#1)(1992-8#5)(1992-9#4)(1993-1#1)(1993-10#1)(1993-11#4)(1993-12#7)(1993-2#5)(1993-3#9)(1993-4#4)(1993-5#5)(1993-6#8)(1993-7#4)(1993-8#4)(1993-9#6)(1994-1#2)(1994-10#3)(1994-11#11)(1994-12#6)(1994-2#11)(1994-3#8)(1994-6#7)(1994-8#9)(1994-9#17)(1995-1#5)(1995-10#2)(1995-11#7)(1995-12#5)(1995-2#5)(1995-3#3)(1995-4#2)(1995-5#6)(1995-6#8)(1995-7#3)(1995-8#4)(1995-9#2)(1996-1#4)(1996-10#1)(1996-11#5)(1996-12#26)(1996-2#9)(1996-3#12)(1996-4#2)(1996-5#6)(1996-6#5)(1996-7#2)(1996-8#4)(1996-9#9)(1997-1#4)(1997-2#14)(1997-3#6)(1997-4#6)(1997-5#6)(1997-6#4)(1997-7#5)(1997-8#11)(1997-9#1)(2004-1#1)(2004-11#1)(2004-3#1)(2004-9#3)(2005-1#1)(2005-10#1)(2005-11#12)(2005-4#2)(2005-5#1)(2005-7#2)(2005-8#5)(2006-1#3)(2006-10#26)(2006-11#4)(2006-12#7)(2006-2#8)(2006-3#1)(2006-4#4)(2006-5#3)(2006-6#11)(2006-7#3)(2006-8#10)(2006-9#2)(2007-1#1)(2007-10#6)(2007-11#55)(2007-12#75)(2007-2#7)(2007-3#7)(2007-4#2)(2007-5#6)(2007-6#3)(2007-7#11)(2007-8#27)(2007-9#10)(2008-1#30)(2008-10#126)(2008-11#41)(2008-12#17)(2008-2#51)(2008-3#58)(2008-4#34)(2008-5#46)(2008-6#10)(2008-7#41)(2008-8#18)(2008-9#25)(2009-10#12)(2009-11#6)(2009-12#2)(2009-2#5)(2009-3#5)(2009-4#8)(2009-5#5)(2009-6#12)(2009-7#4)(2009-8#10)(2009-9#6)(2010-1#1)(2010-10#3)(2010-11#9)(2010-12#16)(2010-2#3)(2010-3#8)(2010-4#8)(2010-5#10)(2010-6#2)(2010-7#6)(2010-8#10)(2010-9#4)(2011-1#15)(2011-11#1)(2011-12#10)(2011-2#36)(2011-3#2)(2012-1#16)(2012-11#4)(2012-12#18)(2012-2#48)(2012-3#14)(2012-8#1)(2013-1#49)(2013-7#9)(2013-8#14)
short&quot##3##1##(2008-4#3)
short)##3##1##(2008-5#2)(2008-8#1)
short- and long-term outcomes##3##4##(2009-10#1)(2010-11#1)(2013-1#1)
short- and long-term##35##3##(1991-6#1)(1993-12#1)(1994-2#2)(1994-5#1)(1995-8#1)(1996-7#1)(1997-4#1)(2004-2#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-4#1)(2007-9#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
short- and medium-term##2##3##(2008-4#1)(2010-11#1)
short- and##49##2##(1991-11#1)(1991-6#1)(1993-12#2)(1994-2#2)(1994-5#1)(1995-8#1)(1996-7#1)(1997-4#1)(1997-5#1)(2004-2#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-11#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#1)
short- or long-term##3##3##(2007-8#1)(2011-2#1)(2012-5#1)
short-##61##1##(1991-11#1)(1991-6#1)(1993-12#2)(1994-2#2)(1994-5#1)(1995-8#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-2#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-4#2)(2007-8#2)(2007-9#2)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-11#2)(2010-5#1)(2011-1#1)(2011-2#6)(2012-11#1)(2012-12#1)(2012-2#4)(2012-5#1)(2013-1#4)(2013-7#1)(2013-8#1)
short-acting bronchodilators##2##2##(2007-11#2)
short-acting versus long-acting##2##3##(2009-9#2)
short-acting##21##1##(1990-7#1)(1991-3#1)(1993-9#1)(1997-4#2)(2005-8#1)(2006-10#5)(2007-11#2)(2009-9#2)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
short-and long-term##2##2##(2006-10#1)(2010-5#1)
short-bowel##3##1##(1994-3#1)(2008-9#2)
short-chain acyl groups##2##3##(1996-5#2)
short-chain alcohol dehydrogenase##2##3##(1994-3#1)(1995-5#1)
short-chain alcohol##5##2##(1994-3#1)(1995-1#1)(1995-5#2)(2008-10#1)
short-chain alcohols##4##2##(1990-12#1)(1992-6#1)(2006-10#1)(2008-6#1)
short-chain and##2##2##(1991-5#1)(1994-8#1)
short-chain carboxylic acid##2##3##(2007-12#2)
short-chain fatty acid##4##3##(1996-9#1)(2008-5#1)(2009-4#1)(2011-2#1)
short-chain fatty acids##7##3##(1996-9#1)(2006-10#2)(2006-5#1)(2008-5#1)(2011-2#1)(2012-1#1)
short-chain fatty##11##2##(1996-9#2)(2006-10#2)(2006-5#1)(2008-5#2)(2009-4#1)(2011-2#2)(2012-1#1)
short-chain##50##1##(1990-1#1)(1990-12#1)(1990-4#1)(1990-8#1)(1991-5#3)(1992-1#1)(1992-6#1)(1993-4#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-5#2)(1995-6#1)(1996-5#4)(1996-9#2)(1997-4#1)(2004-2#1)(2005-11#1)(2006-10#3)(2006-5#1)(2007-12#3)(2008-10#4)(2008-5#6)(2008-6#1)(2009-4#1)(2011-2#2)(2012-1#1)
short-circuit current##9##2##(1990-5#1)(1991-5#1)(1995-6#1)(2006-8#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-4#1)
short-circuit##10##1##(1990-5#1)(1991-5#1)(1995-6#1)(2006-8#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-4#1)(2013-8#1)
short-course##4##1##(1991-5#1)(1994-7#1)(2006-6#1)(2009-2#1)
short-cutter##2##1##(1994-12#2)
short-day##2##1##(2008-5#1)(2012-2#1)
short-distance##5##1##(1990-11#1)(2008-10#2)(2008-3#1)(2011-2#1)
short-duration##7##1##(1991-5#1)(1996-3#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-3#1)
short-exposure images##2##2##(2007-12#1)(2008-3#1)
short-exposure##5##1##(2007-12#1)(2008-2#1)(2008-3#3)
short-form##2##1##(2008-10#1)(2011-2#1)
short-hypocotyl phenotype##2##2##(1995-8#2)
short-lasting and##2##2##(2005-7#1)(2006-6#1)
short-lasting##11##1##(1990-10#1)(1990-5#1)(1991-4#1)(1994-2#1)(1994-6#1)(1995-5#1)(1995-6#1)(1997-5#1)(2005-7#1)(2006-6#1)(2010-12#1)
short-latency##4##1##(1992-8#1)(1994-2#2)(2009-5#1)
short-limbed##2##1##(1996-12#1)(2009-9#1)
short-lived and##4##2##(1992-12#1)(1995-5#1)(1997-2#1)(2006-8#1)
short-lived##43##1##(1990-2#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-4#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-10#1)(1996-3#5)(1997-2#1)(1997-7#1)(2004-11#3)(2005-10#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2009-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2012-4#1)
short-path##2##1##(2008-10#1)(2008-2#1)
short-period##7##1##(1990-2#1)(1990-8#1)(1990-9#1)(1995-6#1)(2007-12#2)(2008-2#1)
short-pitch ferroelectric liquid##2##3##(2008-3#2)
short-pulse generation##2##2##(2007-12#1)(2008-2#1)
short-pulse laser##6##2##(2007-11#3)(2007-12#1)(2008-2#1)(2012-2#1)
short-pulse##25##1##(1992-9#1)(1993-5#1)(2007-11#7)(2007-12#7)(2008-1#1)(2008-2#3)(2008-3#4)(2012-2#1)
short-pulse-duration##3##1##(2007-11#1)(2008-2#2)
short-pulsed laser##2##2##(2007-11#1)(2008-2#1)
short-range interactions between##2##3##(1994-8#1)(2006-10#1)
short-range interactions##4##2##(1994-8#1)(2006-10#2)(2007-12#1)
short-range order##2##2##(1990-4#1)(2013-8#1)
short-range##24##1##(1990-4#1)(1991-4#1)(1992-1#1)(1992-5#2)(1994-8#1)(1995-5#1)(2005-11#1)(2006-10#6)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-5#1)(2012-1#1)(2013-8#1)
short-run##3##1##(1992-2#1)(1994-12#1)(2008-9#1)
short-scale##3##1##(2007-11#1)(2007-12#2)
short-segment caustic strictures##2##3##(2006-6#2)
short-segment##4##1##(2006-10#1)(2006-6#2)(2008-8#1)
short-stay hospital inpatient##2##3##(1991-1#1)(1991-3#1)
short-stay hospital services##3##3##(1991-1#1)(1991-3#1)(1992-2#1)
short-stay hospital##6##2##(1991-1#2)(1991-3#2)(1992-2#2)
short-stay hospitals##2##2##(1992-2#2)
short-stay##9##1##(1991-1#2)(1991-3#2)(1992-2#4)(2008-3#1)
short-tailed##2##1##(2006-11#1)(2008-8#1)
short-term (1##4##2##(2008-5#1)(2010-1#1)(2012-12#2)
short-term GC##2##2##(2006-9#2)
short-term adaptation##2##2##(1993-7#1)(2010-5#1)
short-term administration##2##2##(1990-4#1)(1993-4#1)
short-term and long-term memory##3##4##(1992-11#2)(2007-8#1)
short-term and long-term##20##3##(1992-11#2)(1996-4#1)(2005-10#1)(2005-9#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2009-3#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-8#2)
short-term and##30##2##(1990-8#1)(1992-11#2)(1994-2#1)(1996-4#1)(2004-11#1)(2005-10#1)(2005-9#1)(2006-8#3)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-3#1)(2010-10#1)(2010-12#2)(2011-2#1)(2012-2#2)(2013-8#2)
short-term antibiotic##2##2##(1990-6#1)(1994-3#1)
short-term assays##3##2##(1995-11#1)(2008-10#1)(2008-11#1)
short-term assessment##2##2##(2006-8#1)(2008-8#1)
short-term basis##3##2##(1996-3#1)(2008-1#1)(2008-2#1)
short-term benefits##6##2##(1995-5#1)(2007-11#1)(2010-11#2)(2011-2#2)
short-term biomarkers of styrene exposure##2##5##(2010-2#2)
short-term central venous catheter##3##4##(2007-7#3)
short-term changes##2##2##(1994-12#1)(2008-2#1)
short-term chaos##2##2##(2008-9#2)
short-term clinical##4##2##(2006-11#1)(2007-8#1)(2008-8#1)(2009-12#1)
short-term cognitive-behavioral##2##2##(2004-3#1)(2010-2#1)
short-term colony assays##2##3##(2008-11#2)
short-term control##3##2##(2007-12#1)(2008-8#1)(2013-8#1)
short-term culture##3##2##(2006-8#1)(2008-6#2)
short-term cultured astrocytes##3##3##(1995-5#3)
short-term cultures##3##2##(1993-9#1)(1994-4#1)(2007-3#1)
short-term depression at##3##3##(1997-3#3)
short-term depression##4##2##(1997-3#3)(2008-6#1)
short-term effect##5##2##(1997-1#1)(2008-5#1)(2008-6#1)(2012-1#2)
short-term effective##2##2##(2007-11#1)(2008-10#1)
short-term effects of EGF on##2##5##(1994-6#2)
short-term effects of##7##3##(1994-6#2)(1995-12#1)(1997-1#1)(2008-9#1)(2013-1#2)
short-term effects##10##2##(1994-6#2)(1995-12#1)(1997-1#1)(1997-3#1)(2006-10#1)(2008-9#1)(2013-1#3)
short-term efficacy and##2##3##(2006-10#1)(2007-8#1)
short-term efficacy of##4##3##(1991-2#1)(2011-2#2)(2013-1#1)
short-term efficacy##8##2##(1991-2#1)(2006-10#2)(2006-2#1)(2007-8#1)(2011-2#2)(2013-1#1)
short-term exposure to##5##3##(1992-8#1)(1995-12#1)(1996-10#1)(2008-2#1)(2010-2#1)
short-term exposure##8##2##(1992-8#1)(1995-12#1)(1996-10#1)(2006-3#1)(2008-10#1)(2008-2#1)(2008-6#1)(2010-2#1)
short-term feeding##2##2##(1992-9#1)(1996-2#1)
short-term follow-up##6##2##(1996-12#1)(2006-10#2)(2006-6#1)(2007-8#1)(2011-2#1)
short-term goals##2##2##(1993-12#1)(2008-11#1)
short-term growth of FDC-P2 cells##2##5##(1991-12#2)
short-term growth of##3##3##(1991-12#2)(2008-4#1)
short-term hibernating##2##2##(1996-9#2)
short-term high##2##2##(1990-6#1)(1994-11#1)
short-term hypoxia##2##2##(2011-12#2)
short-term in vitro##2##3##(1995-11#1)(1995-3#1)
short-term incubations##2##2##(1996-5#1)(2006-8#1)
short-term inpatient##2##2##(1992-3#1)(1993-12#1)
short-term linewidth of##2##3##(2007-12#2)
short-term longitudinal study##3##3##(2008-3#1)(2009-7#1)(2010-3#1)
short-term longitudinal##4##2##(2008-3#1)(2009-7#2)(2010-3#1)
short-term memory (STM) and##2##4##(1993-11#1)(2013-7#1)
short-term memory (STM)##4##3##(1993-11#1)(1993-12#1)(2008-4#1)(2013-7#1)
short-term memory and##2##3##(1991-10#1)(2009-8#1)
short-term memory for##2##3##(1992-11#1)(2008-4#1)
short-term memory in monkeys##2##4##(1992-11#1)(1993-12#1)
short-term memory in##4##3##(1992-11#1)(1993-12#1)(1995-11#1)(2008-11#1)
short-term memory##24##2##(1991-10#1)(1992-1#1)(1992-11#4)(1993-11#1)(1993-12#2)(1995-11#3)(1997-7#1)(2006-5#1)(2007-8#2)(2008-11#1)(2008-4#4)(2009-8#1)(2011-2#1)(2013-7#1)
short-term neurological improvement##2##3##(2006-11#2)
short-term or long-term##2##3##(1991-9#1)(1996-3#1)
short-term or##3##2##(1991-9#1)(1996-3#1)(2012-12#1)
short-term oral##3##2##(2008-4#1)(2012-2#2)
short-term outcome of##2##3##(2008-6#1)(2012-12#1)
short-term outcome##6##2##(2006-11#1)(2008-1#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-12#1)
short-term outcomes##3##2##(2008-12#1)(2009-7#1)(2012-3#1)
short-term pain relief##2##3##(2006-10#1)(2013-1#1)
short-term pain##3##2##(2006-10#1)(2013-1#2)
short-term plasticity##2##2##(1997-5#1)(2007-8#1)
short-term potentiation (STP)##2##3##(1991-9#1)(1995-12#1)
short-term potentiation in the##2##4##(1991-9#1)(1997-5#1)
short-term potentiation##6##2##(1991-9#2)(1995-12#3)(1997-5#1)
short-term prediction##2##2##(1996-4#2)
short-term predictions##2##2##(1996-4#1)(2008-11#1)
short-term prognosis in##2##3##(2005-10#1)(2006-12#1)
short-term recovery##2##2##(2006-10#1)(2013-1#1)
short-term relief of##2##3##(2008-10#1)(2010-8#1)
short-term relief##3##2##(2006-8#1)(2008-10#1)(2010-8#1)
short-term results##10##2##(1993-3#1)(2006-8#1)(2007-7#1)(2007-8#2)(2008-7#1)(2010-10#1)(2010-12#1)(2011-2#2)
short-term stability (at##2##3##(2010-2#1)(2010-3#1)
short-term stability##5##2##(2007-12#1)(2008-9#1)(2010-2#1)(2010-3#2)
short-term standard##2##2##(2008-10#1)(2012-3#1)
short-term storage##2##2##(1990-11#1)(2008-11#1)
short-term studies##2##2##(1990-11#1)(2010-4#1)
short-term study##2##2##(2007-7#1)(2007-8#1)
short-term success##2##2##(1995-3#1)(2008-10#1)
short-term survival of##3##3##(2006-10#1)(2007-12#1)(2010-8#1)
short-term survival##7##2##(1992-9#3)(2006-10#1)(2007-11#1)(2007-12#1)(2010-8#1)
short-term synaptic dynamics##2##3##(2008-6#2)
short-term synaptic##4##2##(1997-5#1)(2008-11#1)(2008-6#2)
short-term therapies##2##2##(1995-11#1)(2010-12#1)
short-term therapy##2##2##(1993-4#1)(2008-1#1)
short-term treatment of##3##3##(1994-12#1)(2007-6#1)(2008-3#1)
short-term treatment with##5##3##(1995-12#1)(1996-12#2)(2007-8#2)
short-term treatment##10##2##(1994-12#1)(1995-1#1)(1995-12#1)(1995-4#1)(1996-12#2)(2007-6#1)(2007-8#2)(2008-3#1)
short-term variability##2##2##(1994-4#1)(2012-2#1)
short-term verbal memory in patients with##2##6##(1995-11#1)(2008-4#1)
short-term##475##1##(1990-11#3)(1990-2#2)(1990-3#1)(1990-4#3)(1990-6#3)(1990-8#1)(1990-9#3)(1991-10#2)(1991-12#2)(1991-2#2)(1991-7#1)(1991-9#3)(1992-1#3)(1992-11#6)(1992-12#1)(1992-3#1)(1992-4#4)(1992-8#1)(1992-9#5)(1993-10#1)(1993-11#1)(1993-12#6)(1993-3#1)(1993-4#4)(1993-7#1)(1993-9#2)(1994-1#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#2)(1994-6#3)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#10)(1995-12#10)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#4)(1995-6#1)(1996-1#1)(1996-10#2)(1996-12#3)(1996-2#2)(1996-3#3)(1996-4#7)(1996-5#2)(1996-7#2)(1996-8#1)(1996-9#5)(1997-1#2)(1997-2#2)(1997-3#7)(1997-5#3)(1997-7#1)(1997-8#1)(2004-11#1)(2004-12#1)(2004-3#1)(2005-10#2)(2005-5#1)(2005-8#2)(2005-9#2)(2006-10#11)(2006-11#4)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#2)(2006-8#9)(2006-9#2)(2007-10#2)(2007-11#3)(2007-12#12)(2007-2#2)(2007-3#3)(2007-4#3)(2007-5#3)(2007-6#1)(2007-7#8)(2007-8#15)(2007-9#1)(2008-1#11)(2008-10#19)(2008-11#14)(2008-12#2)(2008-2#5)(2008-3#9)(2008-4#13)(2008-5#5)(2008-6#13)(2008-7#4)(2008-8#7)(2008-9#6)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#4)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#5)(2010-2#6)(2010-3#4)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#4)(2011-12#3)(2011-2#17)(2011-3#1)(2012-1#7)(2012-12#5)(2012-2#9)(2012-3#5)(2012-5#1)(2013-1#14)(2013-7#3)(2013-8#5)
short-time boundary layer solution##2##4##(2006-6#2)
short-time##5##1##(2005-11#1)(2006-6#2)(2007-12#1)(2012-2#1)
short-wave cone cells##2##3##(1994-3#2)
short-wave cones##2##2##(1994-3#2)
short-wave##10##1##(1994-3#6)(2007-5#1)(2008-2#1)(2008-3#2)
short-wavelength##15##1##(1991-9#1)(2007-11#3)(2007-12#4)(2008-1#1)(2008-2#1)(2008-3#5)
shortage and##4##2##(1991-11#1)(1991-2#1)(2007-4#1)(2008-4#1)
shortage by##2##2##(2009-3#1)(2013-1#1)
shortage in##6##2##(1990-12#1)(1994-5#1)(2007-4#1)(2008-10#1)(2008-11#1)(2009-4#1)
shortage is##2##2##(2010-10#1)(2010-5#1)
shortage of all##2##3##(2006-12#1)(2007-4#1)
shortage of blood##2##3##(2011-1#1)(2013-8#1)
shortage of doctors##2##3##(1991-7#1)(2012-12#1)
shortage of donor organs##6##4##(1993-11#1)(2006-10#1)(2007-11#1)(2008-1#1)(2009-3#1)(2010-6#1)
shortage of food##2##3##(1996-11#1)(2013-7#1)
shortage of human##2##3##(2005-7#2)
shortage of nurses##2##3##(2007-8#1)(2009-4#1)
shortage of nursing##2##3##(1995-2#1)(2012-2#1)
shortage of organ donors##2##4##(2006-10#1)(2010-11#1)
shortage of organs##3##3##(1993-2#1)(2006-10#1)(2008-1#1)
shortage of physicians##3##3##(1991-5#1)(1997-5#1)(2010-5#1)
shortage of radiologists##2##3##(2007-4#2)
shortage of##75##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-1#2)(1993-11#1)(1993-2#1)(1993-6#1)(1994-1#2)(1995-2#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-6#1)(2005-11#1)(2005-5#1)(2005-7#2)(2005-9#1)(2006-10#4)(2006-12#2)(2007-11#1)(2007-4#7)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#4)(2008-12#3)(2008-7#2)(2009-3#1)(2009-4#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#1)(2013-7#1)(2013-8#1)
shortage##134##1##(1990-12#5)(1990-3#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#2)(1991-5#1)(1991-7#1)(1992-1#3)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#3)(1994-5#2)(1995-2#3)(1996-11#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-6#1)(2005-11#1)(2005-5#1)(2005-7#2)(2005-9#2)(2006-10#4)(2006-12#2)(2007-10#2)(2007-11#1)(2007-2#1)(2007-3#3)(2007-4#19)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#3)(2008-11#5)(2008-12#5)(2008-2#1)(2008-4#4)(2008-7#2)(2009-3#2)(2009-4#2)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-5#1)(2012-7#1)(2013-1#2)(2013-7#1)(2013-8#1)
shortages have##2##2##(2007-4#1)(2012-12#1)
shortages in##2##2##(2008-11#1)(2011-1#1)
shortages of##4##2##(1991-3#1)(2007-4#1)(2008-1#1)(2008-4#1)
shortages##25##1##(1991-3#1)(1992-3#1)(1996-1#1)(1997-1#1)(2006-2#1)(2006-4#1)(2007-4#8)(2008-1#1)(2008-11#1)(2008-4#1)(2009-4#1)(2010-6#1)(2010-9#1)(2011-1#3)(2012-12#1)(2013-7#1)
shortcoming in the##2##3##(2008-2#1)(2008-3#1)
shortcoming of##3##2##(2008-10#1)(2008-2#1)(2010-1#1)
shortcoming##6##1##(1996-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-1#1)
shortcomings and##2##2##(2008-9#1)(2013-1#1)
shortcomings associated with##2##3##(2005-2#1)(2011-1#1)
shortcomings in adipose tissue##2##4##(2012-8#2)
shortcomings in the##3##3##(1990-5#1)(2008-3#1)(2013-7#1)
shortcomings in##11##2##(1990-5#1)(1994-11#1)(1994-12#1)(1995-3#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-1#1)(2012-8#2)(2013-7#1)
shortcomings of the##4##3##(2008-3#2)(2010-11#1)(2012-3#1)
shortcomings of##17##2##(1992-6#1)(1994-3#1)(1997-3#1)(2005-11#1)(2005-9#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-3#2)(2008-6#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
shortcomings that##3##2##(1991-1#1)(2006-6#1)(2013-1#1)
shortcomings to##2##2##(2008-10#2)
shortcomings were##2##2##(1993-1#1)(2007-12#1)
shortcomings##59##1##(1990-5#1)(1991-1#1)(1991-9#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-12#1)(1997-3#3)(2005-11#1)(2005-2#1)(2005-9#1)(2006-10#2)(2006-6#2)(2007-10#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-12#2)(2008-3#4)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-4#1)(2012-8#2)(2013-1#3)(2013-7#1)
shortcut##4##1##(2008-1#1)(2008-5#3)
shortcuts##7##1##(2007-4#1)(2008-3#2)(2008-5#1)(2013-7#3)
shorten the duration of the##3##5##(2005-10#1)(2008-12#1)(2012-3#1)
shorten the duration of treatment##2##5##(2007-8#1)(2011-1#1)
shorten the duration of##6##4##(1992-6#1)(2005-10#1)(2007-8#1)(2008-12#1)(2011-1#1)(2012-3#1)
shorten the length of##3##4##(1991-1#1)(2006-8#1)(2009-10#1)
shorten the pulse##2##3##(2007-11#1)(2007-12#1)
shorten the time to##2##4##(2008-8#1)(2012-12#1)
shorten the time##6##3##(1992-2#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
shorten the##31##2##(1991-1#1)(1992-11#1)(1992-2#1)(1992-6#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2012-8#1)(2013-1#2)
shorten this##2##2##(1994-3#1)(2012-2#1)
shorten time to##2##3##(2007-9#1)(2012-3#1)
shorten##54##1##(1990-5#1)(1991-1#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-6#1)(1994-3#1)(1994-5#1)(1995-10#1)(2005-10#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-8#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#2)(2012-8#1)(2013-1#2)
shortened and##2##2##(2006-9#1)(2007-11#1)
shortened by##6##2##(1990-11#1)(1996-9#1)(2006-8#1)(2008-10#1)(2010-8#1)(2013-8#1)
shortened from##3##2##(1994-9#1)(2008-10#1)(2008-5#1)
shortened hospital stay##2##3##(2006-10#1)(2013-1#1)
shortened hospital##3##2##(2006-10#1)(2008-12#1)(2013-1#1)
shortened in##2##2##(1991-2#1)(2008-1#1)
shortened life##2##2##(2006-10#1)(2008-10#1)
shortened postpartum stays##2##3##(2007-2#2)
shortened survival##3##2##(2006-7#1)(2008-1#1)(2012-12#1)
shortened the duration of##3##4##(1990-2#1)(1997-1#1)(2008-4#1)
shortened the time to##2##4##(1990-7#1)(2008-5#1)
shortened the time##6##3##(1990-7#1)(1993-9#1)(2006-12#1)(2008-10#1)(2008-5#1)(2008-9#1)
shortened the##17##2##(1990-2#1)(1990-7#1)(1991-12#1)(1993-2#1)(1993-9#1)(1994-9#1)(1997-1#1)(2004-11#1)(2006-12#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-9#1)
shortened to##3##2##(1990-5#1)(1993-9#1)(2007-8#1)
shortened with##2##2##(1992-3#1)(2007-5#1)
shortened##109##1##(1990-10#1)(1990-11#3)(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#3)(1991-4#1)(1992-3#1)(1992-5#2)(1993-12#2)(1993-2#2)(1993-7#1)(1993-9#2)(1994-9#2)(1995-1#2)(1995-10#1)(1995-9#1)(1996-12#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-11#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#6)(2007-2#4)(2007-5#1)(2007-8#1)(2008-1#5)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-8#1)(2008-9#4)(2009-3#1)(2010-2#2)(2010-3#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
shortening and##10##2##(1991-2#1)(1993-7#1)(1996-7#1)(2007-11#1)(2008-4#1)(2008-5#1)(2010-2#1)(2012-2#2)(2013-1#1)
shortening during##2##2##(2007-11#1)(2007-12#1)
shortening in the duration of##2##5##(1994-10#1)(2007-11#1)
shortening in the##3##3##(1994-10#1)(2007-11#1)(2010-3#1)
shortening in##6##2##(1994-10#1)(1994-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2010-3#1)
shortening is##5##2##(1996-9#1)(2006-3#2)(2012-2#2)
shortening of the affected limb##2##5##(2007-7#1)(2009-3#1)
shortening of the leg##2##4##(2007-8#2)
shortening of the##26##3##(1990-11#1)(1992-1#2)(1992-3#1)(1992-5#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-6#1)(1997-8#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-7#2)(2007-8#2)(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-3#1)(2012-1#1)(2012-7#1)
shortening of##42##2##(1990-11#2)(1992-1#2)(1992-3#1)(1992-5#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-1#1)(1997-4#1)(1997-8#2)(2005-9#1)(2006-3#2)(2006-6#1)(2006-8#1)(2007-11#4)(2007-7#2)(2007-8#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-7#1)(2013-8#1)
shortening or##3##2##(1994-3#1)(1997-4#1)(2007-8#1)
shortening osteotomy##7##2##(2006-3#2)(2006-4#1)(2013-1#4)
shortening the duration of##2##4##(2007-11#1)(2007-8#1)
shortening the##13##2##(1991-11#1)(1996-5#1)(2006-12#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-5#1)(2009-8#1)(2012-12#1)(2012-2#1)
shortening velocity##2##2##(1995-5#2)
shortening was##7##2##(1990-11#1)(1993-7#1)(1995-12#1)(2007-8#2)(2009-3#1)(2013-1#1)
shortening with##2##2##(2006-3#1)(2009-5#1)
shortening##157##1##(1990-11#3)(1991-11#1)(1991-2#1)(1992-1#2)(1992-3#1)(1992-5#2)(1993-12#1)(1993-3#1)(1993-7#2)(1993-9#2)(1994-10#1)(1994-3#8)(1994-9#1)(1995-1#4)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-5#1)(1996-7#2)(1996-9#1)(1997-1#2)(1997-4#2)(1997-8#2)(2005-4#1)(2005-9#1)(2006-12#1)(2006-3#10)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#12)(2007-12#3)(2007-7#5)(2007-8#11)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#4)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#2)(2010-5#1)(2012-1#2)(2012-12#4)(2012-2#8)(2012-7#1)(2013-1#8)(2013-8#3)
shortening)##2##1##(1994-11#1)(1995-1#1)
shortenings##3##1##(1995-5#2)(2007-8#1)
shortens the period of##2##4##(1996-9#2)
shortens the##14##2##(1990-11#2)(1992-3#2)(1994-2#1)(1996-12#1)(1996-9#2)(2007-8#1)(2008-4#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
shortens##24##1##(1990-11#2)(1991-2#1)(1991-4#1)(1992-3#2)(1994-2#1)(1996-11#1)(1996-12#1)(1996-9#2)(2006-6#1)(2006-9#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
shorter (p##2##2##(1990-8#1)(1997-4#1)
shorter LOS##2##2##(2007-8#2)
shorter RNA molecules##2##3##(2008-7#2)
shorter VEP##2##2##(1995-12#2)
shorter analysis time##5##3##(1997-8#1)(2008-10#4)
shorter and less##2##3##(2008-5#1)(2008-9#1)
shorter and lighter##2##3##(2008-11#1)(2010-6#1)
shorter and the##2##3##(2006-5#1)(2008-10#1)
shorter and##9##2##(1993-11#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-6#1)(2011-1#2)
shorter at##4##2##(1990-12#1)(1995-8#1)(2008-10#1)(2008-12#1)
shorter chain##6##2##(1992-1#1)(1992-2#1)(1995-1#1)(2005-11#1)(2008-5#1)(2013-1#1)
shorter disease-free and overall survival##2##5##(1994-6#1)(1995-4#1)
shorter disease-free##3##2##(1993-11#1)(1994-6#1)(1995-4#1)
shorter distances##5##2##(1994-2#1)(2007-12#1)(2008-8#1)(2009-9#1)(2012-2#1)
shorter duration of##7##3##(2006-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)(2012-2#1)
shorter duration than##2##3##(2010-12#1)(2012-2#1)
shorter duration##13##2##(1995-12#1)(2006-8#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#1)(2012-2#2)
shorter follow-up##2##2##(2007-8#1)(2010-8#1)
shorter for the##3##3##(2004-11#1)(2006-6#1)(2008-10#1)
shorter for##8##2##(1996-3#1)(1996-6#1)(2004-11#1)(2006-6#1)(2007-6#1)(2008-10#2)(2009-9#1)
shorter form is##2##3##(1991-1#1)(1991-8#1)
shorter form of##2##3##(1990-11#1)(1990-3#1)
shorter form##7##2##(1990-11#1)(1990-3#1)(1990-7#1)(1991-1#3)(1991-8#1)
shorter fragment##2##2##(1992-9#1)(2008-3#1)
shorter hospital stay (3##2##4##(1996-2#2)
shorter hospital stay than##2##4##(1993-2#1)(2006-6#1)
shorter hospital stay##6##3##(1993-2#1)(1996-2#2)(2006-6#2)(2008-3#1)
shorter hospital stays##3##3##(2006-10#1)(2007-8#1)(2007-9#1)
shorter hospital##9##2##(1993-2#1)(1996-2#2)(2006-10#1)(2006-6#2)(2007-8#1)(2007-9#1)(2008-3#1)
shorter hospitalization##4##2##(1997-3#1)(2006-6#1)(2008-10#1)(2008-11#1)
shorter in group##2##3##(2007-9#1)(2013-1#1)
shorter in patients##2##3##(2006-2#1)(2011-2#1)
shorter in the##8##3##(1991-6#1)(1992-1#1)(1993-1#1)(1997-4#1)(2008-10#1)(2009-10#1)(2011-2#1)(2012-2#1)
shorter in##27##2##(1991-6#1)(1992-1#1)(1993-1#1)(1993-4#1)(1994-9#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-4#1)(2006-2#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-3#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#1)
shorter intervals##3##2##(1996-12#1)(2006-5#1)(2012-2#1)
shorter latencies to##2##3##(1994-6#2)
shorter latencies##6##2##(1992-7#2)(1993-12#1)(1994-6#2)(2013-7#1)
shorter latency##4##2##(1990-8#1)(1993-3#1)(1994-2#1)(2009-12#1)
shorter leaf wetness##2##3##(2008-10#2)
shorter length of hospital stay##2##5##(2007-8#1)(2013-1#1)
shorter length of stay##3##4##(2007-9#1)(2013-1#2)
shorter length of##6##3##(2007-8#1)(2007-9#1)(2008-9#1)(2013-1#3)
shorter length##8##2##(2007-8#1)(2007-9#1)(2008-12#1)(2008-9#1)(2013-1#4)
shorter lengths of stay##2##4##(1991-3#1)(2006-10#1)
shorter one##2##2##(1993-4#1)(1995-8#1)
shorter or longer##3##3##(1996-6#1)(1997-6#1)(2008-3#1)
shorter overall##2##2##(2011-2#1)(2012-2#1)
shorter peptide##4##2##(1992-5#1)(1993-6#1)(1995-2#1)(1996-5#1)
shorter peptides##4##2##(1991-10#1)(1992-9#1)(1993-4#1)(1995-2#1)
shorter periods of##2##3##(1990-12#1)(2008-10#1)
shorter periods##6##2##(1990-12#1)(1994-6#1)(2008-10#3)(2008-3#1)
shorter postoperative##2##2##(1996-3#1)(2009-2#1)
shorter processes##2##2##(1997-6#1)(2007-12#1)
shorter reaction times##2##3##(2008-12#1)(2010-12#1)
shorter reaction##5##2##(1990-6#1)(2007-11#1)(2008-12#1)(2008-4#1)(2010-12#1)
shorter relaxation##2##2##(1995-11#1)(1997-7#1)
shorter response##3##2##(2007-12#2)(2009-9#1)
shorter sleep##2##2##(2010-7#1)(2012-12#1)
shorter stay##2##2##(1992-3#1)(2007-1#1)
shorter survival##3##2##(2007-8#1)(2008-4#1)(2012-3#1)
shorter than 1##3##3##(2007-12#1)(2008-3#2)
shorter than 10##3##3##(1990-10#1)(2007-12#1)(2013-1#1)
shorter than that of the##3##5##(1993-3#1)(2008-5#1)(2010-4#1)
shorter than that of##8##4##(1991-3#1)(1993-3#1)(2006-12#1)(2008-5#1)(2010-2#2)(2010-4#1)(2010-8#1)
shorter than that with##2##4##(2011-1#1)(2013-8#1)
shorter than that##12##3##(1991-2#1)(1991-3#1)(1993-3#1)(2006-12#1)(2008-5#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2013-8#1)
shorter than the acoustic relaxation time##2##6##(2007-12#2)
shorter than the##16##3##(1991-12#1)(1995-11#1)(1996-2#1)(2006-12#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-10#1)
shorter than those of##2##4##(1996-6#1)(2008-5#1)
shorter than those##6##3##(1996-6#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)
shorter than##64##2##(1990-10#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-2#2)(1996-6#1)(2005-11#1)(2005-5#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-11#4)(2007-12#8)(2007-7#1)(2008-10#5)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#3)(2009-2#1)(2010-10#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2013-1#1)(2013-8#2)
shorter time (p##2##3##(1990-2#1)(2007-8#1)
shorter time of##4##3##(1991-3#1)(2008-4#2)(2009-4#1)
shorter time to##3##3##(2007-11#1)(2008-8#1)(2013-1#1)
shorter time##22##2##(1990-2#1)(1991-3#1)(1994-11#1)(1994-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-11#1)(2013-1#1)
shorter times##3##2##(1990-5#1)(2008-10#2)
shorter treatment time##2##3##(2011-1#1)(2013-1#1)
shorter treatment##3##2##(2008-7#1)(2011-1#1)(2013-1#1)
shorter waiting##3##2##(2006-8#1)(2007-8#1)(2011-1#1)
shorter wavelength##6##2##(1992-8#1)(2007-11#1)(2008-2#3)(2010-5#1)
shorter wavelengths##7##2##(1990-3#1)(2007-12#2)(2008-2#1)(2008-3#2)(2012-2#1)
shorter##469##1##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#2)(1990-5#3)(1990-6#1)(1990-7#3)(1990-8#2)(1991-1#4)(1991-10#1)(1991-12#2)(1991-2#3)(1991-3#4)(1991-5#1)(1991-6#2)(1991-8#2)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#1)(1992-9#4)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#4)(1993-4#3)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-2#4)(1994-3#1)(1994-6#5)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#6)(1995-2#3)(1995-3#1)(1995-4#1)(1995-6#2)(1995-8#3)(1995-9#1)(1996-1#1)(1996-12#4)(1996-2#6)(1996-3#3)(1996-4#2)(1996-5#1)(1996-6#5)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-11#1)(2004-2#2)(2005-10#1)(2005-11#5)(2005-5#1)(2005-7#1)(2005-9#1)(2006-10#4)(2006-12#4)(2006-2#1)(2006-5#3)(2006-6#7)(2006-8#4)(2006-9#1)(2007-1#1)(2007-11#12)(2007-12#24)(2007-2#2)(2007-3#1)(2007-6#2)(2007-7#3)(2007-8#13)(2007-9#3)(2008-1#1)(2008-10#31)(2008-11#4)(2008-12#4)(2008-2#9)(2008-3#13)(2008-4#7)(2008-5#13)(2008-6#4)(2008-7#11)(2008-8#11)(2008-9#6)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#4)(2009-4#1)(2009-5#1)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#6)(2011-1#7)(2011-12#1)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#12)(2012-3#3)(2013-1#19)(2013-7#3)(2013-8#6)
shorter-lived##3##1##(2008-10#1)(2008-3#1)(2013-8#1)
shorter-living##2##1##(2009-5#2)
shorter-than-average calls##2##2##(2009-9#2)
shorter-than-average##3##1##(2009-9#3)
shorter-wavelength##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
shortest and##2##2##(2008-5#1)(2013-8#1)
shortest fragment##2##2##(1992-11#1)(1995-12#1)
shortest path##2##2##(2008-2#2)
shortest paths##2##2##(2008-4#1)(2008-6#1)
shortest##56##1##(1990-12#2)(1991-2#2)(1991-8#1)(1992-11#1)(1992-12#2)(1992-5#1)(1995-12#1)(1995-2#1)(1996-5#1)(1996-6#1)(1997-8#1)(2005-10#1)(2006-8#1)(2007-11#4)(2007-12#9)(2007-6#1)(2007-8#3)(2008-10#3)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#1)(2009-4#1)(2011-2#1)(2012-3#2)(2013-7#1)(2013-8#2)
shortfall in##2##2##(1991-11#1)(2008-8#1)
shortfall##3##1##(1991-11#1)(2008-12#1)(2008-8#1)
shortfalls##2##1##(2009-3#1)(2010-6#1)
shorthead redhorse (Moxostoma macrolepidotum) and##2##5##(2009-4#2)
shorting##2##1##(2008-9#1)(2010-3#1)
shortly after awakening##2##3##(1995-1#1)(2012-12#1)
shortly after birth##9##3##(1991-12#1)(1992-2#1)(1996-2#1)(2007-2#2)(2008-4#1)(2010-7#2)(2012-2#1)
shortly after diagnosis##3##3##(1992-6#1)(1993-7#1)(1993-8#1)
shortly after drug##2##3##(2006-10#1)(2013-8#1)
shortly after surgery##3##3##(2006-9#1)(2007-7#2)
shortly after the initiation of##2##5##(2011-1#1)(2012-3#1)
shortly after the##11##3##(1992-8#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-10#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
shortly after their##2##3##(1996-3#1)(2012-2#1)
shortly after##75##2##(1990-11#1)(1990-6#1)(1990-8#1)(1991-12#2)(1991-3#1)(1991-9#1)(1992-2#1)(1992-6#1)(1992-8#2)(1993-7#1)(1993-8#1)(1995-1#2)(1995-12#2)(1995-2#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-5#2)(2006-10#4)(2006-4#1)(2006-9#1)(2007-11#1)(2007-2#2)(2007-7#3)(2007-8#1)(2007-9#1)(2008-10#7)(2008-12#1)(2008-3#2)(2008-4#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-7#2)(2013-8#1)
shortly afterward##2##2##(1990-6#1)(2006-10#1)
shortly before the##2##3##(1992-10#1)(1995-5#1)
shortly before##3##2##(1992-10#1)(1995-5#1)(2008-10#1)
shortly by##2##2##(2008-1#1)(2008-11#1)
shortly following##3##2##(1991-12#1)(1995-8#1)(2010-12#1)
shortly review the##2##3##(2007-11#1)(2008-11#1)
shortly thereafter##7##2##(1993-7#1)(2006-7#1)(2007-12#1)(2007-6#2)(2009-3#1)(2013-1#1)
shortly to be##2##3##(1997-4#1)(2005-7#1)
shortly##107##1##(1990-11#1)(1990-5#1)(1990-6#2)(1990-8#1)(1991-12#3)(1991-3#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-6#1)(1992-8#2)(1993-7#2)(1993-8#2)(1995-1#2)(1995-12#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#3)(1997-1#1)(1997-4#1)(1997-5#2)(2005-7#3)(2006-10#5)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-6#2)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-11#2)(2010-12#2)(2010-7#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
shortness of breath and##3##4##(2006-10#1)(2007-8#2)
shortness of breath is##2##4##(1994-7#1)(2005-9#1)
shortness of breath on##2##4##(2008-1#1)(2008-7#1)
shortness of breath##24##3##(1994-7#1)(2005-9#1)(2006-10#2)(2006-6#2)(2007-12#1)(2007-8#3)(2008-1#1)(2008-12#1)(2008-7#4)(2009-6#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
shortness of##28##2##(1994-7#1)(1996-12#1)(1997-1#1)(2005-9#1)(2006-10#2)(2006-6#2)(2007-12#1)(2007-8#3)(2008-1#1)(2008-12#1)(2008-7#4)(2009-5#1)(2009-6#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-3#2)(2013-1#1)(2013-8#2)
shortness##30##1##(1994-7#1)(1996-12#1)(1997-1#2)(2005-9#1)(2006-10#2)(2006-6#2)(2007-12#1)(2007-8#3)(2008-1#1)(2008-12#1)(2008-7#4)(2009-5#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-3#2)(2013-1#1)(2013-8#2)
shortterm##2##1##(1990-6#1)(2007-4#1)
shortwave radiometers##2##2##(2008-3#2)
shortwave##5##1##(2008-3#3)(2008-5#2)
shot noise in##2##3##(1995-10#1)(2008-3#1)
shot noise that is##2##4##(2008-3#2)
shot noise##15##2##(1995-10#1)(2007-11#1)(2008-2#1)(2008-3#11)(2008-4#1)
shot per shot##2##3##(2008-2#2)
shot to##2##2##(2007-11#1)(2011-2#1)
shot wounds##3##2##(1995-11#1)(2007-3#1)(2013-1#1)
shot##57##1##(1993-3#1)(1993-6#1)(1995-10#1)(1995-11#3)(1997-8#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-2#2)(2007-3#1)(2007-9#1)(2008-10#1)(2008-2#5)(2008-3#18)(2008-4#1)(2009-4#1)(2010-7#2)(2011-2#2)(2012-1#2)(2012-3#1)(2013-1#1)(2013-7#1)
shot&quot##2##1##(2006-5#1)(2009-4#1)
shot-by-shot##3##1##(2007-12#2)(2008-3#1)
shot-noise limit##11##2##(2007-11#3)(2007-12#3)(2008-1#2)(2008-2#1)(2008-3#2)
shot-noise##15##1##(2007-11#3)(2007-12#6)(2008-1#3)(2008-2#1)(2008-3#2)
shot-noise-limited detection##3##2##(2007-12#1)(2008-3#2)
shot-noise-limited##9##1##(2007-12#1)(2008-2#4)(2008-3#4)
shot-to-shot##6##1##(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#2)
shotgun metagenomics##2##2##(2011-2#2)
shotgun proteomic##2##2##(2010-12#1)(2011-1#1)
shotgun proteomics##3##2##(2010-1#1)(2010-12#1)(2013-8#1)
shotgun sequencing##4##2##(1996-6#1)(2008-4#1)(2008-7#1)(2011-2#1)
shotgun##15##1##(1996-6#1)(2008-2#1)(2008-4#1)(2008-7#3)(2010-1#1)(2010-12#2)(2011-1#1)(2011-2#3)(2012-2#1)(2013-8#1)
shots in##2##2##(1995-11#1)(2011-2#1)
shots was##2##2##(2007-10#1)(2007-12#1)
shots were fired##2##3##(2013-7#2)
shots with a##2##3##(2011-2#2)
shots with##3##2##(2011-2#2)(2013-7#1)
shots##29##1##(1995-11#1)(1995-5#1)(2007-10#3)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#4)(2011-2#5)(2012-1#2)(2013-7#8)
shots)##2##1##(2008-10#1)(2011-2#1)
should I##6##2##(1995-3#1)(2003-11#1)(2009-4#2)(2010-11#1)(2010-12#1)
should a##10##2##(1993-10#1)(2006-10#1)(2007-12#1)(2007-5#2)(2007-7#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-11#1)
should abandon##2##2##(2008-8#1)(2008-9#1)
should accelerate##2##2##(2007-11#1)(2008-11#1)
should acquire##3##2##(1994-2#1)(2007-12#1)(2012-12#1)
should act as##2##3##(1991-7#1)(1995-5#1)
should act##4##2##(1991-7#1)(1991-9#1)(1995-5#1)(2009-2#1)
should actively##2##2##(1995-12#1)(2008-11#1)
should address the##5##3##(1997-2#1)(2007-3#1)(2008-4#1)(2009-5#1)(2010-2#1)
should address##13##2##(1997-2#1)(2006-5#1)(2007-3#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-2#2)(2010-8#1)(2013-1#1)
should adopt a##4##3##(1996-2#1)(1997-7#1)(2009-5#1)(2013-1#1)
should adopt##8##2##(1993-11#1)(1996-12#1)(1996-2#1)(1997-7#1)(2008-3#1)(2008-5#1)(2009-5#1)(2013-1#1)
should advocate for##2##3##(2009-7#1)(2012-2#1)
should affect##3##2##(2007-8#1)(2008-7#1)(2009-3#1)
should aid in##3##3##(1993-11#1)(2007-9#1)(2013-8#1)
should aid##4##2##(1993-11#1)(1995-6#1)(2007-9#1)(2013-8#1)
should aim to address##2##4##(2006-10#1)(2012-12#1)
should aim to##7##3##(2006-10#1)(2007-1#1)(2007-12#1)(2008-11#1)(2008-8#1)(2009-7#1)(2012-12#1)
should aim##9##2##(2006-10#2)(2007-1#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-8#1)(2009-7#1)(2012-12#1)
should alert the clinician to the possibility##2##7##(2006-10#1)(2006-4#1)
should alert the clinician to##4##5##(2006-10#1)(2006-4#1)(2008-12#1)(2008-8#1)
should alert##7##2##(1996-2#1)(2005-10#1)(2006-10#1)(2006-4#1)(2008-12#1)(2008-6#1)(2008-8#1)
should all be considered##2##4##(1994-12#1)(1996-9#1)
should all be##4##3##(1994-12#1)(1996-9#1)(2005-8#1)(2008-2#1)
should all##5##2##(1994-12#1)(1996-9#1)(2005-8#1)(2007-8#1)(2008-2#1)
should allow a##2##3##(2006-9#1)(2013-8#1)
should allow for the##5##4##(1991-8#1)(1992-12#1)(1995-3#1)(2008-10#1)(2008-2#1)
should allow rapid##2##3##(1993-12#1)(2008-4#1)
should allow the##2##3##(1997-7#1)(2006-6#1)
should allow them to##2##4##(1995-2#1)(2008-4#1)
should allow##25##2##(1991-7#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-12#2)(1995-2#1)(1995-3#1)(1995-7#1)(1997-1#1)(1997-7#1)(1997-8#1)(2006-6#2)(2006-9#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-4#2)(2008-9#1)(2013-8#1)
should also affect##2##3##(2008-10#1)(2012-3#1)
should also be applicable to##3##5##(2008-10#1)(2008-11#1)(2008-3#1)
should also be assessed##2##4##(1996-12#1)(2011-1#1)
should also be considered as a##2##6##(2010-4#1)(2012-2#1)
should also be considered for##3##5##(2007-11#1)(2008-6#1)(2010-12#1)
should also be considered##11##4##(1995-12#1)(1996-3#1)(2007-11#1)(2008-6#1)(2008-7#2)(2010-12#1)(2010-2#1)(2010-4#1)(2012-2#1)(2013-7#1)
should also be encouraged##2##4##(2008-10#1)(2010-11#1)
should also be evaluated##2##4##(2005-12#1)(2010-11#1)
should also be given##2##4##(1995-9#1)(2010-10#1)
should also be made to##2##5##(2006-7#1)(2007-6#1)
should also be referred##2##4##(2008-3#1)(2013-8#1)
should also be taken into account##2##6##(1992-6#1)(2013-7#1)
should also be taken into##3##5##(1992-4#1)(1992-6#1)(2013-7#1)
should also be taken##5##4##(1992-4#1)(1992-6#1)(2007-2#1)(2009-4#1)(2013-7#1)
should also be##56##3##(1990-12#1)(1990-3#1)(1991-12#1)(1991-2#1)(1992-4#1)(1992-6#1)(1993-1#1)(1993-11#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-4#1)(1995-9#1)(1996-12#1)(1996-3#1)(2005-12#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-7#2)(2013-8#2)
should also consider##2##3##(2008-1#1)(2012-12#1)
should also play a##2##4##(1997-3#1)(2008-3#1)
should also take##2##3##(2012-2#1)(2013-8#1)
should also##86##2##(1990-12#1)(1990-3#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-4#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-5#1)(2004-9#1)(2005-12#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-7#2)(2013-8#3)
should always be confirmed by##2##5##(2007-12#1)(2008-6#1)
should always be considered in##3##5##(2006-10#1)(2011-12#1)(2012-3#1)
should always be considered when##2##5##(2008-10#1)(2011-2#1)
should always be considered##10##4##(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-10#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-3#1)
should always be given##2##4##(2007-11#1)(2011-2#1)
should always be kept in mind##2##6##(2007-11#1)(2012-2#1)
should always be performed##3##4##(1990-9#1)(2011-1#1)(2012-2#1)
should always be the##2##4##(2010-6#1)(2012-12#1)
should always be##34##3##(1990-2#1)(1990-9#1)(1996-12#1)(1996-6#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-9#1)(2008-10#3)(2008-5#1)(2008-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
should always##41##2##(1990-2#1)(1990-9#1)(1996-12#1)(1996-6#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#3)(2007-9#2)(2008-10#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
should and##2##2##(1997-2#1)(2007-7#1)
should apply in##2##3##(1996-11#1)(2008-7#1)
should apply to##2##3##(2008-10#1)(2008-3#1)
should apply##7##2##(1996-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-3#1)(2010-12#1)
should approach the##2##3##(2008-10#1)(2012-12#1)
should ask##3##2##(1995-1#1)(2006-10#1)(2007-7#1)
should assess the##2##3##(2007-4#1)(2012-2#1)
should assess##5##2##(2007-4#1)(2010-8#1)(2011-2#1)(2012-2#2)
should assist in##2##3##(2011-2#2)
should assist the##3##3##(1997-1#1)(2006-1#1)(2008-7#1)
should assist##9##2##(1992-5#1)(1997-1#1)(2006-1#1)(2008-10#1)(2008-7#1)(2011-2#3)(2013-1#1)
should assume##2##2##(2007-2#1)(2010-9#1)
should at##2##2##(2009-4#1)(2009-9#1)
should attempt to##2##3##(2009-3#1)(2012-12#1)
should attempt##3##2##(1994-2#1)(2009-3#1)(2012-12#1)
should avoid##6##2##(1993-1#1)(1993-10#1)(1995-12#1)(1996-1#1)(2008-10#1)(2010-12#1)
should be &gt##2##3##(1995-6#1)(2007-7#1)
should be 0##2##3##(2011-2#1)(2013-1#1)
should be a central##2##4##(1995-2#1)(2012-2#1)
should be a diagnostic##2##4##(2007-7#1)(2008-10#1)
should be a focus for##2##5##(2007-8#1)(2008-4#1)
should be a high priority##2##5##(2005-8#1)(2008-11#1)
should be a high##4##4##(2005-8#1)(2007-11#1)(2008-11#1)(2012-12#1)
should be a part of the##2##6##(2008-1#1)(2008-9#1)
should be a part of##3##5##(1994-2#1)(2008-1#1)(2008-9#1)
should be a partial defense##2##5##(2005-3#2)
should be a useful tool for##2##6##(1993-9#1)(2008-10#1)
should be a useful##3##4##(1993-9#1)(2008-10#2)
should be a##57##3##(1990-4#1)(1991-10#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-7#1)(1993-9#1)(1994-2#1)(1995-2#2)(1996-3#1)(2005-11#3)(2005-3#2)(2005-8#1)(2006-2#1)(2006-7#1)(2007-11#2)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#5)(2008-11#3)(2008-3#1)(2008-4#2)(2008-7#2)(2008-9#7)(2009-12#1)(2010-5#1)(2010-9#1)(2011-12#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
should be abandoned for##3##4##(1991-1#2)(2009-3#1)
should be abandoned##6##3##(1991-1#2)(1995-7#1)(2005-8#1)(2006-7#1)(2009-3#1)
should be able to achieve##2##5##(2008-9#1)(2011-2#1)
should be able to detect##2##5##(1996-12#1)(2013-1#1)
should be able to diagnose##2##5##(2007-8#1)(2011-1#1)
should be able to modify##2##5##(2008-12#1)(2008-2#1)
should be able to recognize##3##5##(2005-8#1)(2010-9#1)(2011-3#1)
should be able to reduce##2##5##(2005-11#1)(2008-10#1)
should be able to##31##4##(1992-3#1)(1994-3#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-3#1)(2005-8#1)(2006-8#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-9#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2013-1#1)
should be able##32##3##(1992-3#1)(1994-3#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-3#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-9#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2013-1#1)
should be accompanied by##3##4##(2008-12#1)(2009-4#1)(2009-7#1)
should be accomplished##3##3##(2006-12#1)(2008-10#1)(2008-7#1)
should be acknowledged##3##3##(1994-11#1)(1996-9#1)(2012-11#1)
should be actively sought##2##4##(2008-1#1)(2013-1#1)
should be adapted in##2##4##(2008-8#1)(2012-1#1)
should be adapted to the##4##5##(2007-8#1)(2008-2#1)(2008-3#1)(2008-9#1)
should be adapted##8##3##(2007-8#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2012-1#1)
should be added to the list of##3##7##(2006-10#1)(2009-1#1)(2009-3#1)
should be added to the##8##5##(1996-1#1)(2006-10#1)(2006-3#1)(2008-2#1)(2009-1#1)(2009-3#1)(2011-2#1)(2012-11#1)
should be added to##9##4##(1992-1#1)(1996-1#1)(2006-10#1)(2006-3#1)(2008-2#1)(2009-1#1)(2009-3#1)(2011-2#1)(2012-11#1)
should be added##11##3##(1992-1#1)(1996-1#1)(2006-10#1)(2006-3#1)(2008-2#1)(2009-1#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-11#1)(2012-12#1)
should be addressed at##2##4##(2008-1#1)(2009-7#1)
should be addressed by##3##4##(2010-6#1)(2012-12#1)(2013-1#1)
should be addressed for##2##4##(2009-9#1)(2012-2#1)
should be addressed in future##2##5##(2006-10#1)(2013-1#1)
should be addressed in##5##4##(2006-10#1)(2008-3#1)(2010-2#1)(2013-1#2)
should be addressed to##2##4##(2007-6#1)(2012-3#1)
should be addressed##20##3##(1991-9#1)(1992-12#1)(2006-10#1)(2007-12#2)(2007-4#1)(2007-6#1)(2008-1#1)(2008-3#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-6#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
should be adequately##3##3##(2008-11#1)(2009-5#1)(2012-5#1)
should be adjusted according to the##2##6##(1997-5#1)(2008-7#1)
should be adjusted to##3##4##(2006-6#1)(2008-2#1)(2008-7#1)
should be adjusted##9##3##(1997-4#1)(1997-5#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-7#2)(2012-12#1)(2012-3#1)
should be administered early in the course of##2##8##(2007-11#1)(2009-4#1)
should be administered in##2##4##(1990-1#1)(2013-8#1)
should be administered to##3##4##(1996-12#1)(2008-3#1)(2013-1#1)
should be administered##17##3##(1990-1#1)(1996-12#1)(1996-3#1)(2006-10#3)(2006-4#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-3#1)(2008-6#1)(2009-4#1)(2010-2#1)(2013-1#1)(2013-8#1)
should be adopted as##2##4##(2007-7#1)(2009-5#1)
should be adopted for##2##4##(2007-7#1)(2012-2#1)
should be adopted##9##3##(1990-6#1)(1994-1#1)(2007-7#3)(2008-12#1)(2009-5#1)(2012-2#2)
should be advised to##6##4##(1991-6#1)(1996-11#1)(2006-2#1)(2007-2#1)(2011-2#1)(2012-12#1)
should be advised##10##3##(1991-6#1)(1994-3#1)(1996-11#1)(2004-10#1)(2006-2#1)(2007-2#2)(2008-4#1)(2011-2#1)(2012-12#1)
should be advocated to##2##4##(2007-7#1)(2012-2#1)
should be advocated##4##3##(2007-7#1)(2008-4#1)(2010-10#1)(2012-2#1)
should be aimed at preventing##3##5##(1993-7#1)(1996-2#1)(2007-12#1)
should be aimed at##7##4##(1993-7#1)(1996-2#1)(2006-2#1)(2007-12#1)(2007-7#1)(2009-9#1)(2011-2#1)
should be aimed##8##3##(1993-7#1)(1996-2#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-5#1)(2009-9#1)(2011-2#1)
should be alert to the##2##5##(1990-12#1)(2012-2#1)
should be alert to##4##4##(1990-12#1)(2008-3#1)(2010-12#1)(2012-2#1)
should be alert##5##3##(1990-12#1)(2006-10#1)(2008-3#1)(2010-12#1)(2012-2#1)
should be alerted to the##2##5##(2008-12#1)(2008-7#1)
should be aligned##4##3##(2008-4#2)(2008-9#1)(2011-1#1)
should be allowed to##4##4##(1991-2#1)(2007-2#1)(2007-7#1)(2008-12#1)
should be also##5##3##(1990-3#1)(1991-3#1)(2007-5#1)(2011-2#1)(2013-8#1)
should be always##3##3##(2007-7#1)(2008-5#1)(2009-4#1)
should be amenable to##2##4##(1997-7#1)(2008-10#1)
should be an appropriate##2##4##(1997-4#1)(2013-1#1)
should be an important part of##3##6##(2012-1#1)(2013-1#2)
should be an important##6##4##(2006-12#1)(2008-8#1)(2012-1#1)(2012-3#1)(2013-1#2)
should be an##20##3##(1991-9#1)(1997-4#1)(2005-8#1)(2006-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-8#2)(2010-7#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#3)
should be analyzed in##2##4##(1994-8#1)(2011-1#1)
should be analyzed##7##3##(1990-3#1)(1994-8#1)(1997-4#1)(2008-10#1)(2008-4#1)(2011-1#1)(2011-2#1)
should be anticipated##3##3##(1994-4#1)(2008-7#1)(2012-2#1)
should be applicable for##4##4##(1990-10#1)(1991-2#1)(1996-8#1)(2012-11#1)
should be applicable to a range of##2##7##(2008-10#2)
should be applicable to a##4##5##(1994-9#1)(2008-10#2)(2011-2#1)
should be applicable to the##2##5##(1990-5#1)(2008-10#1)
should be applicable to##13##4##(1990-5#1)(1991-5#1)(1991-8#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-2#1)(2008-10#3)(2010-12#1)(2011-2#1)(2012-2#1)
should be applicable##19##3##(1990-10#1)(1990-5#1)(1991-2#1)(1991-5#1)(1991-8#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-2#1)(1996-8#1)(2008-1#1)(2008-10#3)(2010-12#1)(2011-2#1)(2012-11#1)(2012-2#1)
should be applied in##5##4##(1997-6#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-8#1)
should be applied to the##2##5##(2005-5#1)(2007-10#1)
should be applied to##7##4##(1992-12#1)(2005-5#1)(2007-10#1)(2007-7#2)(2008-10#1)(2013-8#1)
should be applied with caution##2##5##(2008-2#1)(2008-9#1)
should be applied##24##3##(1991-4#1)(1992-12#1)(1993-1#1)(1994-4#1)(1994-5#1)(1997-6#1)(2005-5#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-7#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#3)(2010-12#1)(2010-8#2)(2013-8#1)
should be appointed##2##3##(1993-3#1)(2012-2#1)
should be approached with caution##2##5##(1996-6#1)(2008-6#1)
should be approached##6##3##(1993-3#1)(1995-12#1)(1996-2#1)(1996-6#1)(2006-10#1)(2008-6#1)
should be as##7##3##(1995-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2012-12#1)(2012-2#1)
should be ascribed to the##3##5##(1992-8#1)(2008-10#2)
should be assessed for##2##4##(2010-8#1)(2013-1#1)
should be assessed in##3##4##(2005-9#1)(2008-8#1)(2012-2#1)
should be assessed##14##3##(1996-8#1)(1997-8#1)(2005-9#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-8#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#1)
should be associated with low approach##2##6##(2009-2#2)
should be associated with##6##4##(1992-8#1)(1995-1#1)(1996-7#1)(2006-10#1)(2009-2#2)
should be assumed##2##3##(1997-8#1)(2008-7#1)
should be assured##2##3##(1997-6#1)(2010-8#1)
should be at least##4##4##(1990-10#1)(2008-10#1)(2013-8#2)
should be at the##2##4##(2008-8#1)(2009-6#1)
should be at##7##3##(1990-10#1)(1997-1#1)(2008-10#1)(2008-8#1)(2009-6#1)(2013-8#2)
should be attempted##4##3##(2007-4#1)(2008-7#1)(2009-3#1)(2012-2#1)
should be attended##2##3##(2006-6#1)(2010-3#1)
should be attractive##3##3##(2008-10#2)(2008-7#1)
should be attributed to the##3##5##(1993-12#1)(2007-9#1)(2008-10#1)
should be attributed to##4##4##(1993-12#1)(2007-9#1)(2008-10#1)(2010-9#1)
should be available to##4##4##(1991-12#1)(1993-9#1)(2007-12#1)(2012-2#1)
should be available##10##3##(1991-12#1)(1993-9#1)(1994-3#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-4#1)(2008-8#1)(2012-2#1)
should be avoided and##3##4##(2006-1#1)(2008-1#2)
should be avoided because##2##4##(2007-11#1)(2008-7#1)
should be avoided in##6##4##(2006-12#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-12#1)
should be avoided##33##3##(1991-12#1)(1992-6#1)(1995-9#1)(1996-2#1)(1996-9#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#2)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#1)(2010-12#1)(2013-1#1)
should be aware of its##3##5##(2006-10#1)(2010-1#1)(2013-1#1)
should be aware of the possibility of##3##7##(2007-3#1)(2007-8#1)(2011-2#1)
should be aware of the possible##2##6##(2011-2#2)
should be aware of the##25##5##(1991-8#1)(1992-11#1)(1992-3#1)(1994-7#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-6#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-3#1)(2011-2#3)(2012-11#1)(2012-12#1)
should be aware of these##5##5##(1992-12#1)(1995-9#1)(2006-10#1)(2010-1#1)(2011-1#1)
should be aware of this##7##5##(2005-10#1)(2006-10#2)(2007-12#1)(2007-3#1)(2008-12#2)
should be aware of##52##4##(1991-2#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1994-7#1)(1995-9#1)(2005-10#1)(2005-8#1)(2006-1#1)(2006-10#7)(2006-12#1)(2006-2#2)(2007-12#2)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#3)(2008-10#2)(2008-12#2)(2008-6#1)(2008-7#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-1#2)(2010-3#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#3)
should be aware that##15##4##(1991-3#2)(2005-10#1)(2005-12#1)(2006-10#2)(2006-5#1)(2008-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-9#1)(2012-12#1)(2012-2#1)(2012-3#1)
should be aware##70##3##(1991-2#1)(1991-3#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1994-7#1)(1995-9#1)(2005-10#2)(2005-12#1)(2005-8#1)(2006-1#1)(2006-10#9)(2006-12#1)(2006-2#2)(2006-5#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-12#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-1#2)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)
should be based on a combination of##2##7##(2008-7#1)(2011-2#1)
should be based on a thorough##2##6##(2008-3#1)(2010-5#1)
should be based on a##7##5##(1992-1#1)(2007-9#1)(2008-3#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-2#1)
should be based on an##2##5##(1990-6#1)(2008-7#1)
should be based on the##9##5##(1991-7#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-10#1)(2012-12#1)
should be based on##30##4##(1990-6#1)(1991-2#1)(1991-7#2)(1992-1#1)(1995-11#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#3)(2010-10#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
should be based##33##3##(1990-1#1)(1990-6#1)(1991-2#1)(1991-7#2)(1992-1#1)(1995-11#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#4)(2010-10#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
should be beneficial to##2##4##(2008-1#1)(2008-9#1)
should be better##2##3##(2008-7#1)(2009-2#1)
should be borne in mind##4##5##(2004-4#1)(2008-1#1)(2008-12#1)(2009-6#1)
should be both##2##3##(1990-12#1)(2011-12#1)
should be capable of##8##4##(1992-3#1)(1992-6#1)(1994-2#1)(2007-12#3)(2008-2#1)(2008-4#1)
should be careful to##2##4##(1990-12#1)(1992-3#1)
should be careful##5##3##(1990-12#1)(1992-3#1)(2007-8#1)(2008-5#1)(2012-2#1)
should be carefully considered##6##4##(1993-10#1)(1994-6#1)(1995-12#1)(2008-7#1)(2009-5#1)(2012-2#1)
should be carefully evaluated##4##4##(2004-10#1)(2004-3#1)(2008-1#1)(2013-1#1)
should be carefully followed##2##4##(1991-2#1)(2008-7#1)
should be carefully monitored in##2##5##(1991-8#1)(2011-1#1)
should be carefully monitored##7##4##(1991-8#1)(2009-3#1)(2010-7#2)(2011-1#1)(2012-2#1)(2013-8#1)
should be carefully observed##2##4##(1995-9#1)(2008-6#1)
should be carefully selected##2##4##(2007-10#1)(2011-1#1)
should be carefully##31##3##(1991-2#1)(1991-8#1)(1993-10#1)(1994-6#1)(1995-12#1)(1995-9#1)(2004-10#1)(2004-3#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-3#1)(2009-5#2)(2010-4#1)(2010-7#2)(2011-1#2)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
should be carried out for##2##5##(1992-6#1)(1994-3#1)
should be carried out in order to##2##7##(1994-6#1)(2007-11#1)
should be carried out in##4##5##(1994-6#1)(2005-9#1)(2006-10#1)(2007-11#1)
should be carried out on##4##5##(1992-5#1)(2007-2#1)(2010-11#1)(2013-8#1)
should be carried out to##5##5##(2006-8#1)(2007-3#1)(2008-4#1)(2012-12#1)(2012-2#1)
should be carried out with##3##5##(1992-6#1)(2008-6#1)(2009-9#1)
should be carried out##33##4##(1990-2#1)(1992-12#1)(1992-5#1)(1992-6#2)(1993-8#1)(1994-3#2)(1994-6#1)(1996-12#1)(1997-4#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#2)(2008-4#1)(2008-5#2)(2008-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
should be cautioned##2##3##(1996-3#1)(2013-1#1)
should be cautious##4##3##(2007-3#1)(2008-10#1)(2008-5#1)(2008-7#1)
should be cautiously##2##3##(2005-10#1)(2011-2#1)
should be centralized##2##3##(1992-3#1)(1993-8#1)
should be changed##6##3##(1990-8#1)(1991-6#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)
should be characterized##2##3##(2009-1#1)(2013-8#1)
should be checked for##2##4##(2005-11#1)(2008-10#1)
should be checked##4##3##(1996-3#1)(2005-11#1)(2008-10#1)(2009-6#1)
should be chosen in##2##4##(1990-11#1)(2007-7#1)
should be chosen##10##3##(1990-11#1)(1996-8#1)(2005-3#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-2#1)(2008-8#1)(2010-12#1)(2012-11#1)
should be classified as##3##4##(1993-1#1)(2008-10#1)(2012-2#1)
should be classified##7##3##(1993-1#1)(2006-3#1)(2008-10#3)(2011-2#1)(2012-2#1)
should be clearly##3##3##(1996-1#1)(2007-12#1)(2010-11#1)
should be close to##2##4##(1995-8#1)(2005-5#1)
should be closely monitored and##2##5##(2005-12#1)(2007-11#1)
should be closely monitored##3##4##(2005-12#1)(2007-11#1)(2012-2#1)
should be collected##3##3##(1994-6#1)(2007-12#1)(2008-12#1)
should be combined with##6##4##(1996-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)(2013-1#1)
should be combined##7##3##(1992-11#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)(2013-1#1)
should be communicated##2##3##(2008-7#1)(2010-12#1)
should be compared##2##3##(2007-11#1)(2007-4#1)
should be compatible with##2##4##(2008-11#1)(2008-2#1)
should be completed##5##3##(1992-2#1)(2007-10#1)(2008-5#1)(2010-9#2)
should be conducted and##3##4##(2007-9#1)(2010-12#1)(2012-2#1)
should be conducted as##2##4##(2009-4#1)(2009-9#1)
should be conducted before##3##4##(2006-7#1)(2012-3#1)(2013-8#1)
should be conducted in##4##4##(2009-6#1)(2010-11#1)(2011-1#1)(2011-2#1)
should be conducted to##4##4##(2008-5#1)(2008-8#1)(2009-12#1)(2010-8#1)
should be conducted##22##3##(1991-3#1)(1996-11#1)(2006-7#1)(2006-8#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-6#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
should be confirmed by##7##4##(1996-2#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-10#2)
should be confirmed in larger##4##5##(1995-11#1)(2008-7#1)(2012-12#2)
should be confirmed in##5##4##(1995-11#1)(2006-6#1)(2008-7#1)(2012-12#2)
should be confirmed##13##3##(1992-8#1)(1995-11#1)(1996-2#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-7#1)(2012-12#2)
should be considered a##10##4##(1993-1#1)(1995-12#1)(1996-8#1)(1997-3#1)(2005-8#1)(2008-10#1)(2011-2#2)(2012-12#1)(2013-1#1)
should be considered an important##3##5##(2008-10#1)(2009-9#1)(2011-2#1)
should be considered an##7##4##(2006-6#1)(2008-10#1)(2009-9#1)(2011-2#2)(2012-12#1)(2013-1#1)
should be considered and##3##4##(2007-2#1)(2009-12#1)(2011-12#1)
should be considered as a differential diagnosis##3##7##(2006-10#1)(2011-1#1)(2012-12#1)
should be considered as a possible##7##6##(1990-8#1)(1992-8#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-5#1)(2012-12#1)
should be considered as a##24##5##(1990-8#1)(1992-8#1)(2005-12#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#2)
should be considered as an alternative to##2##7##(2011-2#2)
should be considered as an##5##5##(1997-2#1)(2006-10#1)(2008-4#1)(2011-2#2)
should be considered as one##2##5##(2007-7#1)(2011-1#1)
should be considered as part of the##2##7##(1990-6#1)(2008-4#1)
should be considered as part of##3##6##(1990-6#1)(2007-11#1)(2008-4#1)
should be considered as possible##2##5##(2010-1#1)(2010-8#1)
should be considered as the initial##2##6##(2007-3#1)(2007-6#1)
should be considered as the##4##5##(2006-5#1)(2007-3#1)(2007-6#1)(2012-2#1)
should be considered as##57##4##(1990-6#1)(1990-8#1)(1992-8#1)(1995-4#1)(1996-12#1)(1997-2#1)(2005-12#1)(2006-10#3)(2006-2#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#2)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
should be considered at##4##4##(1991-2#1)(1993-7#1)(2009-7#1)(2012-6#1)
should be considered before##4##4##(1991-12#1)(2006-10#1)(2010-8#1)(2011-12#1)
should be considered carefully##2##4##(2007-8#1)(2013-7#1)
should be considered during##2##4##(1997-4#1)(2007-12#1)
should be considered for a##2##5##(1993-11#1)(2008-10#1)
should be considered for patients with##3##6##(1996-9#1)(2007-8#1)(2012-12#1)
should be considered for patients##4##5##(1996-9#1)(2007-8#1)(2008-7#1)(2012-12#1)
should be considered for the##4##5##(2007-6#1)(2008-10#1)(2008-12#1)(2008-7#1)
should be considered for##30##4##(1992-5#1)(1992-9#1)(1993-11#1)(1993-7#1)(1995-3#1)(1996-9#1)(2004-11#1)(2006-10#1)(2007-12#1)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
should be considered if##5##4##(1995-7#1)(1996-6#1)(2008-9#1)(2009-12#1)(2009-3#1)
should be considered in a##2##5##(2007-12#1)(2008-11#1)
should be considered in all patients##2##6##(2010-10#1)(2012-11#1)
should be considered in all##3##5##(2010-10#1)(2012-11#1)(2013-8#1)
should be considered in any##3##5##(2007-11#1)(2013-1#1)(2013-7#1)
should be considered in cases##3##5##(2008-7#1)(2011-1#1)(2013-8#1)
should be considered in clinical##2##5##(2006-10#1)(2008-6#1)
should be considered in designing##2##5##(1997-4#1)(2008-11#1)
should be considered in every##2##5##(1992-8#1)(2008-7#1)
should be considered in future##2##5##(1991-5#1)(2009-2#1)
should be considered in lupus patients with##2##7##(1993-11#1)(2006-10#1)
should be considered in patients at##2##6##(2006-10#2)
should be considered in patients presenting with##2##7##(2007-10#1)(2013-7#1)
should be considered in patients with##7##6##(1992-11#1)(1996-12#1)(2006-10#1)(2006-2#1)(2008-8#1)(2009-8#1)(2013-1#1)
should be considered in patients##15##5##(1992-11#1)(1996-12#1)(2005-10#1)(2006-10#4)(2006-2#1)(2007-10#1)(2008-8#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
should be considered in the design of##2##7##(1992-12#1)(2013-1#1)
should be considered in the design##3##6##(1992-12#1)(2006-2#1)(2013-1#1)
should be considered in the differential diagnosis of an##3##9##(2007-4#1)(2008-12#1)(2008-3#1)
should be considered in the differential diagnosis of##19##8##(2006-10#2)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-3#3)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
should be considered in the differential diagnosis##23##7##(1991-3#1)(2006-10#2)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-3#3)(2010-12#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
should be considered in the presence of##2##7##(2008-4#1)(2010-9#1)
should be considered in the treatment of##4##7##(1995-5#1)(2004-12#1)(2006-10#1)(2006-5#1)
should be considered in the##47##5##(1991-3#1)(1992-12#1)(1995-5#2)(2004-12#1)(2005-12#1)(2006-10#3)(2006-2#1)(2006-5#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-3#3)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#1)
should be considered in treating##2##5##(2007-10#1)(2008-12#1)
should be considered in young##2##5##(1990-3#1)(2011-2#1)
should be considered in##126##4##(1990-3#1)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-8#1)(1993-11#1)(1993-12#1)(1994-6#1)(1995-5#2)(1996-12#2)(1997-4#1)(2004-12#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-10#11)(2006-12#1)(2006-2#2)(2006-5#2)(2007-10#3)(2007-11#2)(2007-12#4)(2007-2#4)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-2#1)(2009-3#3)(2009-8#2)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-11#1)(2012-2#5)(2012-3#5)(2013-1#6)(2013-7#2)(2013-8#5)
should be considered the##6##4##(2006-10#2)(2006-5#1)(2007-8#1)(2008-8#1)(2012-2#1)
should be considered to##2##4##(1993-6#1)(2013-8#1)
should be considered when choosing##2##5##(2008-8#1)(2011-1#1)
should be considered when designing##2##5##(1996-3#1)(2011-1#1)
should be considered when developing##2##5##(2008-11#1)(2012-2#1)
should be considered when evaluating##3##5##(1994-5#1)(2007-7#1)(2008-4#1)
should be considered when##30##4##(1990-10#1)(1992-4#1)(1993-3#1)(1993-6#1)(1994-5#1)(1995-1#2)(1995-7#1)(1996-3#1)(2005-7#1)(2005-8#1)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-4#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
should be considered with caution##2##5##(1993-4#1)(2008-10#1)
should be considered with##3##4##(1993-1#1)(1993-4#1)(2008-10#1)
should be considered within the##2##5##(1990-6#1)(2006-8#1)
should be considered within##3##4##(1990-6#1)(2006-8#1)(2007-3#1)
should be considered##389##3##(1990-10#1)(1990-2#3)(1990-3#2)(1990-6#2)(1990-8#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#3)(1991-9#1)(1992-11#2)(1992-12#2)(1992-4#1)(1992-5#1)(1992-8#3)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#2)(1994-1#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#3)(1995-10#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-7#2)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#2)(2004-11#1)(2004-12#1)(2005-10#2)(2005-11#2)(2005-12#2)(2005-7#1)(2005-8#4)(2006-10#24)(2006-11#1)(2006-12#1)(2006-2#4)(2006-4#1)(2006-5#4)(2006-6#2)(2006-7#1)(2006-8#2)(2007-10#5)(2007-11#8)(2007-12#7)(2007-2#8)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#5)(2007-7#10)(2007-8#15)(2007-9#2)(2008-1#5)(2008-10#15)(2008-11#4)(2008-12#6)(2008-3#8)(2008-4#6)(2008-5#3)(2008-6#2)(2008-7#11)(2008-8#3)(2008-9#3)(2009-12#2)(2009-2#1)(2009-3#6)(2009-4#3)(2009-5#3)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#6)(2010-9#1)(2011-1#7)(2011-12#3)(2011-2#24)(2012-11#2)(2012-12#9)(2012-2#11)(2012-3#6)(2012-6#1)(2013-1#9)(2013-7#5)(2013-8#12)
should be consulted##3##3##(1993-9#1)(2008-4#1)(2012-2#1)
should be continued for##4##4##(1990-9#1)(1992-11#1)(2007-11#1)(2009-12#1)
should be continued in##2##4##(1993-11#1)(2006-10#1)
should be continued##9##3##(1990-12#1)(1990-9#1)(1992-11#1)(1993-11#1)(1994-4#1)(2006-10#1)(2007-11#1)(2007-6#1)(2009-12#1)
should be controlled##3##3##(1993-3#1)(1996-1#1)(2008-10#1)
should be corrected##3##3##(1990-12#1)(2007-11#1)(2010-8#1)
should be counseled##4##3##(2007-6#1)(2008-11#1)(2009-3#1)(2012-2#1)
should be cultivated##2##3##(1993-2#1)(2006-10#1)
should be defined as##2##4##(2008-8#1)(2009-5#1)
should be defined by##2##4##(1996-6#1)(2008-8#1)
should be defined##8##3##(1991-12#1)(1996-6#1)(2006-6#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-9#1)
should be designed to##3##4##(2012-11#1)(2013-1#2)
should be designed##6##3##(1996-1#1)(2007-10#1)(2012-11#1)(2012-3#1)(2013-1#2)
should be detected##3##3##(1992-8#1)(2006-10#2)
should be determined by the##2##5##(1994-6#1)(2006-3#1)
should be determined##12##3##(1990-12#1)(1994-6#1)(1996-8#1)(2005-3#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-5#1)(2008-10#1)(2008-8#1)(2010-8#1)(2012-3#1)
should be developed and##3##4##(2008-3#2)(2010-3#1)
should be developed to##2##4##(1992-12#1)(2013-1#1)
should be developed##20##3##(1991-12#1)(1992-12#1)(1993-2#1)(1994-6#1)(1995-5#1)(1997-2#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-3#2)(2008-5#1)(2008-6#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
should be diagnosed##4##3##(1992-3#1)(1997-8#1)(2006-10#1)(2008-1#1)
should be differentiated from other##2##5##(2010-6#1)(2010-7#1)
should be differentiated from##5##4##(2006-3#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#1)
should be differentiated##6##3##(1991-2#1)(2006-3#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#1)
should be directed at##4##4##(2006-1#1)(2007-7#1)(2007-9#1)(2013-8#1)
should be directed toward##3##4##(1996-1#1)(1996-8#1)(2007-11#1)
should be directed towards##5##4##(1995-5#1)(1995-8#1)(2007-7#1)(2008-1#2)
should be directed##15##3##(1995-5#1)(1995-8#1)(1996-1#1)(1996-8#1)(2006-1#1)(2007-11#2)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#1)(2011-2#1)(2013-8#1)
should be directly##2##3##(1996-12#1)(2008-5#1)
should be discontinued##4##3##(1992-1#1)(2007-12#1)(2011-1#1)(2013-7#1)
should be discouraged in##2##4##(1992-3#1)(2007-12#1)
should be discouraged##6##3##(1992-3#2)(2006-2#1)(2007-12#1)(2007-3#1)(2008-10#1)
should be discussed##3##3##(1993-9#1)(2009-3#1)(2013-8#1)
should be distinguished from##4##4##(1992-2#1)(1992-6#1)(2007-11#1)(2013-1#1)
should be distinguished##5##3##(1992-2#1)(1992-6#1)(2007-11#1)(2010-12#1)(2013-1#1)
should be distributed##2##3##(2006-7#2)
should be divided into##2##4##(2006-6#1)(2008-5#1)
should be done and##2##4##(2012-2#2)
should be done as##2##4##(1997-3#1)(2007-7#1)
should be done if##2##4##(2007-1#1)(2012-12#1)
should be done in##4##4##(1991-4#1)(1996-8#1)(2006-6#1)(2007-7#1)
should be done on##2##4##(1991-11#1)(2009-9#1)
should be done only##2##4##(1993-12#1)(2007-5#1)
should be done routinely##2##4##(2007-2#1)(2012-2#1)
should be done to##5##4##(1991-7#1)(2007-7#1)(2008-10#1)(2009-7#1)(2010-5#1)
should be done with caution##2##5##(1992-12#1)(1994-8#1)
should be done with##3##4##(1992-12#1)(1994-8#1)(2010-12#1)
should be done##38##3##(1991-11#1)(1991-4#1)(1991-7#1)(1992-12#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-5#1)(1996-11#2)(1996-8#1)(1997-3#2)(1997-5#1)(2006-10#1)(2006-6#1)(2007-1#2)(2007-2#1)(2007-5#1)(2007-7#3)(2008-10#2)(2008-8#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#3)(2013-1#1)
should be easily##2##3##(2007-9#1)(2008-1#1)
should be educated about the##3##5##(1993-9#1)(2007-10#1)(2012-12#1)
should be educated about##4##4##(1993-9#1)(2007-10#1)(2007-7#1)(2012-12#1)
should be educated##6##3##(1993-9#1)(2007-10#1)(2007-2#1)(2007-7#1)(2010-2#1)(2012-12#1)
should be effective in##2##4##(1996-3#1)(2010-2#1)
should be effective##5##3##(1994-6#1)(1996-3#1)(2008-10#2)(2010-2#1)
should be emphasized that the##3##5##(1993-12#1)(2010-12#1)(2012-1#1)
should be emphasized that##5##4##(1993-12#1)(2008-4#1)(2009-4#1)(2010-12#1)(2012-1#1)
should be emphasized##15##3##(1992-6#1)(1993-12#1)(1994-4#1)(1996-12#1)(1996-3#1)(2006-10#1)(2008-4#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)
should be employed in the##2##5##(1990-12#1)(2007-8#1)
should be employed in##4##4##(1990-12#1)(1991-12#1)(1995-12#1)(2007-8#1)
should be employed to##2##4##(2008-10#1)(2012-1#1)
should be employed##11##3##(1990-12#1)(1991-12#1)(1991-3#1)(1991-6#1)(1995-12#1)(1997-2#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-4#1)(2012-1#1)
should be encouraged for##2##4##(2012-1#1)(2012-2#1)
should be encouraged to become##2##5##(1994-1#1)(2006-4#1)
should be encouraged to increase##2##5##(1993-2#1)(2007-2#1)
should be encouraged to maintain##2##5##(1990-10#1)(2011-2#1)
should be encouraged to##13##4##(1990-10#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-1#1)(1995-3#1)(2006-4#1)(2006-9#1)(2007-2#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
should be encouraged##26##3##(1990-10#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-1#1)(1995-3#1)(1996-12#1)(1996-3#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-2#1)(2007-6#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-11#1)(2010-12#1)(2011-11#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#2)
should be enhanced##2##3##(2007-10#1)(2011-2#1)
should be enrolled in##2##4##(1994-2#1)(2008-11#1)
should be entitled to##2##4##(1991-3#1)(1994-3#1)
should be especially##3##3##(2006-10#1)(2008-5#1)(2009-2#1)
should be established in##2##4##(2006-10#1)(2009-4#1)
should be established##8##3##(1990-6#1)(2006-10#1)(2007-7#1)(2009-4#1)(2010-7#1)(2011-2#1)(2013-1#2)
should be estimated##2##3##(2008-3#1)(2010-12#1)
should be evaluated and##2##4##(2007-12#1)(2009-6#1)
should be evaluated as a##2##5##(2008-3#1)(2008-9#1)
should be evaluated as##5##4##(2008-3#1)(2008-9#1)(2009-8#1)(2013-1#2)
should be evaluated before##2##4##(2008-8#1)(2011-2#1)
should be evaluated carefully##3##4##(1996-1#1)(2007-12#1)(2012-3#1)
should be evaluated for their##2##5##(2006-4#1)(2013-8#1)
should be evaluated for##7##4##(2005-11#1)(2006-4#1)(2009-11#1)(2009-9#1)(2010-6#1)(2012-12#1)(2013-8#1)
should be evaluated in terms of##2##6##(2007-4#1)(2013-7#1)
should be evaluated in the##2##5##(2007-10#1)(2012-2#1)
should be evaluated in##11##4##(1992-2#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-4#1)(2011-1#1)(2012-2#1)(2013-7#1)
should be evaluated to##2##4##(2004-9#1)(2006-9#1)
should be evaluated with##4##4##(2006-5#1)(2009-8#1)(2013-1#2)
should be evaluated##52##3##(1990-2#1)(1992-2#1)(1995-1#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-3#1)(2006-1#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
should be examined from##3##4##(1996-2#1)(1996-4#1)(2011-2#1)
should be examined in##2##4##(2007-11#1)(2007-8#1)
should be examined to##2##4##(2007-12#1)(2013-1#1)
should be examined##11##3##(1990-8#1)(1990-9#1)(1996-2#1)(1996-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#1)
should be excluded from##2##4##(2005-7#1)(2013-1#1)
should be excluded in##3##4##(2006-10#1)(2007-2#1)(2007-9#1)
should be excluded##7##3##(2005-7#1)(2006-10#1)(2007-2#1)(2007-9#1)(2011-8#1)(2012-2#1)(2013-1#1)
should be exercised in##2##4##(1991-6#1)(1993-6#1)
should be exercised##4##3##(1991-6#1)(1993-6#1)(2007-11#1)(2012-11#1)
should be expanded to include##4##5##(1991-9#1)(2008-7#1)(2009-5#1)(2013-1#1)
should be expanded##6##3##(1991-9#1)(1993-1#1)(2008-7#1)(2009-5#1)(2010-7#1)(2013-1#1)
should be expected##3##3##(2006-5#1)(2007-8#1)(2008-9#1)
should be explored in cases##2##5##(2006-10#1)(2011-1#1)
should be explored in##3##4##(2006-10#1)(2008-1#1)(2011-1#1)
should be explored##5##3##(2006-10#1)(2008-1#1)(2009-9#1)(2011-1#1)(2012-2#1)
should be expressed##2##3##(2007-4#1)(2009-6#1)
should be extended##3##3##(2006-10#1)(2007-10#1)(2010-4#1)
should be facilitated##2##3##(1990-11#1)(1997-8#1)
should be familiar with the##4##5##(2005-8#1)(2006-10#1)(2006-2#1)(2007-9#1)
should be familiar with##6##4##(1994-5#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-9#1)(2009-6#1)
should be familiar##9##3##(1994-5#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-2#1)(2007-9#1)(2009-6#1)(2009-9#1)(2012-12#1)
should be feasible##4##3##(1992-10#1)(2007-11#1)(2008-8#1)(2011-1#1)
should be first##2##3##(2005-10#1)(2007-11#1)
should be focused on these##2##5##(1991-5#1)(1996-3#1)
should be focused on##11##4##(1991-5#1)(1994-10#1)(1996-3#1)(2006-10#1)(2007-9#1)(2008-10#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
should be followed by##3##4##(1994-2#1)(2008-10#1)(2008-9#1)
should be followed closely##4##4##(2004-3#1)(2006-9#1)(2007-12#1)(2007-3#1)
should be followed up##2##4##(1997-8#1)(2008-10#1)
should be followed##16##3##(1994-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-3#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-4#2)(2008-9#1)(2009-11#1)
should be found##2##3##(2008-9#1)(2012-3#1)
should be founded##2##3##(1993-9#1)(2011-4#1)
should be free from##2##4##(2010-11#1)(2011-1#1)
should be fulfilled##2##3##(2006-4#1)(2013-7#1)
should be fully##3##3##(1991-12#1)(2008-5#1)(2008-7#1)
should be further explored##2##4##(2007-9#1)(2010-10#1)
should be further investigated in##2##5##(2006-2#1)(2006-8#1)
should be further investigated##7##4##(1990-8#1)(2006-2#1)(2006-8#1)(2007-9#1)(2008-11#1)(2012-2#1)(2013-1#1)
should be further strengthened##3##4##(2012-3#2)(2013-8#1)
should be further studied##3##4##(2011-2#1)(2012-2#1)(2013-8#1)
should be further##20##3##(1990-8#1)(1993-8#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-9#2)(2008-11#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#3)
should be generally useful##2##4##(1992-1#1)(1993-6#1)
should be generally##4##3##(1991-2#1)(1992-1#1)(1993-1#1)(1993-6#1)
should be given in##4##4##(2006-10#1)(2007-11#2)(2008-4#1)
should be given the##2##4##(1994-12#1)(2010-12#1)
should be given to the##3##5##(1990-11#1)(2007-12#1)(2012-2#1)
should be given to##18##4##(1990-11#1)(1992-11#1)(1994-9#1)(1995-4#1)(1996-12#1)(1997-2#1)(1997-6#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-8#4)(2007-9#1)(2008-9#1)(2011-1#1)(2012-2#1)
should be given##51##3##(1990-11#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-5#1)(1992-6#1)(1994-12#1)(1994-9#3)(1995-4#1)(1995-7#1)(1995-9#1)(1996-11#2)(1996-12#1)(1997-2#1)(1997-6#1)(1997-8#2)(2006-1#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#4)(2007-9#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
should be governed by##2##4##(1996-12#1)(2012-3#1)
should be greater##2##3##(1995-8#1)(1997-8#1)
should be guided by##7##4##(1992-10#1)(1992-4#1)(1993-3#1)(1997-3#1)(2011-2#2)(2012-12#1)
should be handled##3##3##(1991-4#2)(2008-9#1)
should be helped##2##3##(2008-9#1)(2009-6#1)
should be helpful in the##2##5##(1992-12#1)(1996-4#1)
should be helpful in##4##4##(1992-12#1)(1996-4#1)(2008-10#1)(2011-2#1)
should be helpful##7##3##(1992-12#1)(1993-12#1)(1996-4#1)(2008-10#2)(2011-2#1)(2012-2#1)
should be high##2##3##(1994-3#1)(2007-11#1)
should be higher than##2##4##(1993-9#1)(2005-11#1)
should be highly##6##3##(2005-11#1)(2007-11#1)(2007-3#1)(2008-11#1)(2008-8#1)(2011-1#1)
should be ideally##2##3##(1991-9#1)(2008-10#1)
should be identified and##2##4##(2011-1#1)(2012-11#1)
should be identified as##2##4##(2008-10#1)(2008-7#1)
should be identified##12##3##(1996-9#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-7#2)(2011-1#2)(2012-11#1)
should be implemented for##2##4##(1995-5#1)(2012-1#1)
should be implemented in a##2##5##(1995-1#1)(2006-8#1)
should be implemented in##6##4##(1995-1#1)(2005-10#1)(2006-8#1)(2007-9#1)(2010-5#1)(2013-1#1)
should be implemented to##2##4##(2006-12#1)(2007-7#1)
should be implemented##15##3##(1993-9#1)(1995-1#1)(1995-5#1)(1996-12#1)(2005-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-7#1)(2007-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
should be important in##2##4##(2008-11#1)(2008-8#1)
should be important##4##3##(2008-11#1)(2008-8#1)(2010-6#1)(2010-8#1)
should be improved by##3##4##(1993-1#1)(1993-8#1)(2010-7#1)
should be improved##11##3##(1993-1#1)(1993-8#1)(1995-9#1)(1996-3#1)(1996-6#1)(2005-11#1)(2005-7#1)(2006-7#1)(2008-5#1)(2010-7#1)(2011-12#1)
should be in a##2##4##(2005-8#1)(2008-11#1)
should be in place##2##4##(2007-4#1)(2010-2#1)
should be in the##3##4##(1991-2#1)(2006-4#1)(2010-7#1)
should be in##11##3##(1991-2#1)(2005-8#1)(2006-4#1)(2007-4#1)(2008-11#1)(2010-2#1)(2010-7#3)(2012-12#2)
should be included in the differential diagnosis of##11##8##(1990-11#1)(1994-4#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
should be included in the differential diagnosis##14##7##(1990-11#1)(1994-4#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-12#1)(2009-3#1)(2010-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
should be included in the differential##15##6##(1990-11#1)(1992-3#1)(1994-4#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-12#1)(2009-3#1)(2010-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
should be included in the##26##5##(1990-11#1)(1992-3#1)(1994-4#1)(1996-1#1)(1996-6#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-8#2)(2010-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
should be included in##37##4##(1990-11#1)(1992-3#1)(1994-4#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-6#2)(1997-6#1)(1997-7#1)(2004-1#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-5#1)(2009-8#2)(2010-11#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
should be included##43##3##(1990-11#1)(1990-6#1)(1991-11#1)(1992-3#1)(1994-4#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-6#2)(1997-6#1)(1997-7#1)(2004-1#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#1)(2009-8#2)(2010-11#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
should be incorporated in##2##4##(1995-1#1)(2007-7#1)
should be incorporated into the##5##5##(1992-12#1)(2004-9#1)(2007-4#2)(2008-5#1)
should be incorporated into##10##4##(1992-12#2)(1997-3#2)(2004-9#1)(2007-11#1)(2007-4#2)(2008-5#1)(2010-3#1)
should be incorporated##13##3##(1992-12#2)(1995-1#1)(1997-3#2)(2004-9#1)(2007-11#1)(2007-4#2)(2007-7#1)(2008-5#1)(2010-3#1)(2012-12#1)
should be increased##2##3##(2007-10#1)(2012-12#1)
should be indicated##2##3##(2008-5#1)(2010-6#1)
should be individualized##5##3##(2007-12#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-2#1)
should be individually##2##3##(2008-10#1)(2011-2#1)
should be influenced by##2##4##(2008-11#1)(2012-1#1)
should be informed of the##2##5##(2007-7#1)(2008-8#1)
should be informed of##4##4##(2006-10#1)(2007-2#1)(2007-7#1)(2008-8#1)
should be informed##8##3##(2006-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-6#1)(2008-8#1)(2011-2#1)
should be initiated at the##2##5##(1994-4#1)(2008-11#1)
should be initiated immediately in##2##5##(1994-9#1)(2008-10#1)
should be initiated in##3##4##(2010-7#2)(2011-2#1)
should be initiated to##2##4##(1992-12#1)(2011-2#1)
should be initiated##16##3##(1992-12#1)(1992-9#1)(1994-4#1)(1994-9#1)(1996-2#1)(1996-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#1)(2010-7#2)(2011-2#2)(2012-1#1)
should be instituted to##3##4##(1996-11#1)(2011-11#1)(2013-1#1)
should be instituted##5##3##(1996-11#1)(2006-10#1)(2011-11#1)(2013-1#1)(2013-8#1)
should be integrated into##2##4##(1993-6#1)(2013-1#1)
should be integrated##5##3##(1992-2#1)(1993-6#1)(1995-12#1)(2008-6#1)(2013-1#1)
should be intensified##4##3##(1992-11#1)(1994-2#1)(2006-6#1)(2009-7#1)
should be intensively##2##3##(2006-8#1)(2011-2#1)
should be interpreted as##4##4##(2005-10#1)(2010-3#1)(2013-1#2)
should be interpreted cautiously##4##4##(1994-11#1)(1995-4#1)(1995-5#1)(2008-8#1)
should be interpreted in##2##4##(2008-8#1)(2011-1#1)
should be interpreted with caution##9##5##(1990-2#1)(1994-12#1)(1995-1#1)(1997-1#1)(2006-10#1)(2007-2#1)(2010-2#1)(2011-1#1)(2012-3#1)
should be interpreted with##11##4##(1990-2#1)(1991-4#1)(1994-12#1)(1995-1#1)(1997-1#1)(2006-10#1)(2006-2#1)(2007-2#1)(2010-2#1)(2011-1#1)(2012-3#1)
should be interpreted##24##3##(1990-2#1)(1991-4#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-4#1)(1995-5#1)(1997-1#2)(2005-10#1)(2006-10#1)(2006-2#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-8#2)(2010-2#1)(2010-3#1)(2011-1#2)(2012-3#1)(2013-1#2)
should be introduced as##2##4##(2007-10#1)(2007-8#1)
should be introduced##5##3##(2007-10#1)(2007-8#1)(2008-12#1)(2010-3#1)(2011-12#1)
should be investigated for the presence of##2##7##(2010-9#1)(2012-3#1)
should be investigated for##3##4##(1996-11#1)(2010-9#1)(2012-3#1)
should be investigated further##3##4##(1990-4#1)(1990-8#1)(2009-12#1)
should be investigated in##3##4##(2010-12#1)(2010-2#1)(2012-2#1)
should be involved in##5##4##(1991-7#1)(2004-3#1)(2008-11#1)(2008-5#2)
should be involved##10##3##(1991-7#1)(1994-3#1)(1994-7#1)(2004-3#1)(2008-11#1)(2008-5#2)(2008-8#1)(2010-7#2)
should be judged##2##3##(2006-5#1)(2012-2#1)
should be kept in mind as a possible##2##8##(2006-2#1)(2010-3#1)
should be kept in mind as a##3##7##(2005-11#1)(2006-2#1)(2010-3#1)
should be kept in mind when##3##6##(2005-9#1)(2008-7#1)(2013-8#1)
should be kept in mind##12##5##(2005-11#2)(2005-9#1)(2006-2#1)(2008-7#1)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
should be kept in##13##4##(2005-11#2)(2005-9#1)(2006-2#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
should be kept##22##3##(1996-6#1)(1996-8#1)(2005-11#2)(2005-12#2)(2005-9#1)(2006-2#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
should be known##3##3##(1997-7#1)(2008-10#1)(2008-7#1)
should be left to##2##4##(1996-4#1)(2005-7#1)
should be left##3##3##(1996-4#1)(2005-7#1)(2008-9#1)
should be less than##2##4##(1995-7#1)(2008-2#1)
should be less##6##3##(1991-4#1)(1995-7#1)(1996-1#1)(1997-8#1)(2006-10#1)(2008-2#1)
should be limited to a##2##5##(2007-7#1)(2008-6#1)
should be limited to##11##4##(1991-6#1)(1991-9#1)(1996-9#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-6#1)
should be limited##12##3##(1991-6#1)(1991-9#1)(1996-9#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-7#2)(2007-8#1)(2008-11#1)(2008-6#1)
should be looked##2##3##(2007-8#1)(2008-7#1)
should be made at##2##4##(2008-3#2)
should be made available##4##4##(2007-4#1)(2013-1#2)(2013-8#1)
should be made aware of##2##5##(2006-9#1)(2007-8#1)
should be made aware##3##4##(2006-9#1)(2007-8#1)(2012-12#1)
should be made between##3##4##(1992-7#1)(2008-9#1)(2011-1#1)
should be made clear##2##4##(1992-8#1)(2011-2#1)
should be made in##2##4##(2007-7#1)(2008-10#1)
should be made of##2##4##(1993-8#1)(2008-7#1)
should be made to##15##4##(1991-8#1)(1994-6#1)(1995-9#1)(2006-10#1)(2007-11#1)(2007-7#2)(2008-3#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-11#1)(2013-1#2)
should be made##47##3##(1990-3#1)(1991-8#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-8#1)(1994-2#1)(1994-6#1)(1995-9#1)(1997-8#1)(2006-10#2)(2006-5#1)(2006-9#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#3)(2008-7#1)(2008-9#2)(2009-5#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-11#2)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#1)
should be maintained##11##3##(2005-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
should be managed##4##3##(2006-10#1)(2007-2#1)(2008-1#1)(2008-3#1)
should be mandatory##2##3##(2011-2#2)
should be measured in##2##4##(1996-12#1)(2008-8#1)
should be measured##11##3##(1990-8#1)(1991-3#1)(1994-9#1)(1996-12#1)(2006-2#1)(2006-7#1)(2007-4#1)(2008-3#1)(2008-8#2)(2012-1#1)
should be minimised##2##3##(1996-1#1)(2005-12#1)
should be minimized to##2##4##(2008-2#1)(2008-3#1)
should be minimized##3##3##(2008-2#1)(2008-3#1)(2012-12#1)
should be monitored and##4##4##(2005-1#1)(2010-9#1)(2011-12#1)(2013-1#1)
should be monitored closely##2##4##(2007-11#1)(2008-9#1)
should be monitored during##2##4##(2007-2#1)(2008-10#1)
should be monitored for##2##4##(2011-1#1)(2012-2#1)
should be monitored in##4##4##(2008-3#1)(2008-5#1)(2008-8#1)(2013-8#1)
should be monitored##23##3##(1996-2#1)(2005-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-6#1)(2007-7#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
should be more##15##3##(1994-2#1)(1995-1#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-11#1)(2008-5#1)(2008-9#2)
should be multidisciplinary##4##3##(2006-11#1)(2006-2#1)(2007-11#1)(2011-2#1)
should be no##3##3##(1991-7#1)(1992-12#1)(1992-3#1)
should be noted that the##8##5##(1993-9#1)(2006-12#1)(2008-10#2)(2008-11#1)(2010-6#1)(2012-1#1)(2012-2#1)
should be noted that##16##4##(1991-9#1)(1993-9#1)(2006-12#2)(2007-12#1)(2008-10#3)(2008-11#2)(2008-5#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
should be noted##18##3##(1991-9#1)(1993-9#1)(2006-12#2)(2006-3#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-5#2)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
should be observable##3##3##(1996-1#1)(2007-12#1)(2008-2#1)
should be observed for##2##4##(1995-8#1)(2005-12#1)
should be observed##9##3##(1992-8#1)(1993-2#2)(1995-8#1)(2005-12#1)(2007-11#1)(2008-6#1)(2008-9#1)(2010-9#1)
should be obtained##11##3##(1992-2#1)(1993-9#1)(1994-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-7#1)(2009-11#1)(2011-12#1)
should be of great##2##4##(1997-2#1)(2008-9#1)
should be of value##4##4##(1990-12#1)(1993-4#1)(2007-11#1)(2012-3#1)
should be of##17##3##(1990-12#1)(1990-9#1)(1992-8#1)(1993-4#1)(1994-8#1)(1997-2#1)(2005-1#1)(2006-10#2)(2007-11#1)(2007-5#1)(2008-2#1)(2008-9#1)(2009-6#1)(2010-9#1)(2012-3#1)(2013-1#1)
should be offered a##2##4##(1992-8#1)(2010-10#1)
should be offered to patients##2##5##(1994-3#1)(2008-5#1)
should be offered to##3##4##(1994-3#1)(2006-6#1)(2008-5#1)
should be offered##14##3##(1992-8#1)(1992-9#2)(1994-3#1)(1994-9#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-5#2)(2010-10#1)(2010-5#1)(2011-1#1)(2013-1#1)
should be omitted##2##3##(1991-3#1)(2005-8#1)
should be on the##2##4##(1990-8#1)(1992-2#1)
should be on##4##3##(1990-8#1)(1992-2#1)(1997-2#1)(2008-7#1)
should be one of the##3##5##(2006-6#1)(2008-7#1)(2012-2#1)
should be one of##4##4##(1996-1#1)(2006-6#1)(2008-7#1)(2012-2#1)
should be one##6##3##(1996-1#1)(2006-10#1)(2006-6#1)(2008-7#1)(2012-2#2)
should be only##2##3##(1990-5#1)(2008-5#1)
should be operated on##2##4##(1992-3#1)(2010-12#1)
should be operated##5##3##(1992-3#1)(1996-11#1)(2007-11#1)(2010-12#1)(2010-2#1)
should be optimized##4##3##(2008-7#1)(2010-7#2)(2012-12#1)
should be paid more attention##2##5##(1997-4#1)(2012-3#1)
should be paid to the##6##5##(1993-12#1)(2007-2#1)(2008-9#1)(2009-8#1)(2012-2#2)
should be paid to##20##4##(1990-2#1)(1990-7#1)(1991-11#1)(1992-10#1)(1992-12#1)(1992-8#1)(1993-12#1)(1995-3#1)(2005-11#1)(2006-11#1)(2006-6#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-1#1)(2009-8#1)(2011-2#1)(2012-2#2)
should be paid##25##3##(1990-2#1)(1990-7#1)(1991-11#1)(1992-10#1)(1992-12#1)(1992-8#1)(1993-12#1)(1995-3#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-1#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-2#2)(2012-3#1)
should be part of a##2##5##(2007-12#2)
should be part of the##4##5##(1996-3#1)(1997-3#1)(2007-12#1)(2012-2#1)
should be part of##8##4##(1996-3#1)(1997-3#1)(2005-8#1)(2007-12#3)(2009-1#1)(2012-2#1)
should be particularly useful to##2##5##(1993-3#1)(2008-2#1)
should be particularly useful##4##4##(1991-1#1)(1993-3#1)(2008-10#1)(2008-2#1)
should be performed as early as possible##2##7##(2012-2#1)(2013-1#1)
should be performed as##5##4##(2008-7#1)(2010-5#1)(2012-2#2)(2013-1#1)
should be performed at##4##4##(1995-9#1)(2006-1#1)(2010-7#2)
should be performed before##2##4##(1996-11#1)(2010-6#1)
should be performed by##3##4##(2005-10#1)(2006-10#1)(2008-7#1)
should be performed for##4##4##(2007-12#1)(2008-7#1)(2010-3#1)(2012-12#1)
should be performed if##2##4##(2005-12#1)(2006-3#1)
should be performed in all##2##5##(2007-8#1)(2008-4#1)
should be performed in conjunction##2##5##(2007-8#1)(2008-10#1)
should be performed in the##4##5##(1990-12#1)(2006-5#1)(2006-9#1)(2007-11#1)
should be performed in##20##4##(1990-12#1)(1990-2#1)(1990-4#1)(1991-4#1)(1993-10#1)(1996-12#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-6#1)(2011-2#1)
should be performed on the##3##5##(2007-8#1)(2008-4#2)
should be performed on##4##4##(2007-8#1)(2008-10#1)(2008-4#2)
should be performed only in##3##5##(2012-12#2)(2012-2#1)
should be performed only when##2##5##(1997-3#1)(2008-7#1)
should be performed only##9##4##(1994-2#1)(1994-3#1)(1997-3#1)(2006-8#1)(2008-4#1)(2008-7#1)(2012-12#2)(2012-2#1)
should be performed prior to##3##5##(2006-8#1)(2007-8#1)(2008-10#1)
should be performed regularly##2##4##(2007-11#1)(2010-10#1)
should be performed routinely in##2##5##(1990-8#1)(2011-12#1)
should be performed to##14##4##(1991-9#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-9#2)(2012-12#1)(2012-2#1)(2013-8#1)
should be performed under##2##4##(2007-4#1)(2012-3#1)
should be performed using##2##4##(2004-9#1)(2007-12#1)
should be performed whenever##4##4##(1990-10#1)(1992-3#1)(2008-3#1)(2008-6#1)
should be performed##105##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-8#1)(1991-12#2)(1991-4#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-10#2)(1993-5#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#2)(1997-3#1)(2004-9#1)(2005-10#2)(2005-11#1)(2005-12#1)(2006-1#2)(2006-10#3)(2006-3#2)(2006-5#1)(2006-8#2)(2006-9#1)(2007-11#3)(2007-12#2)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#9)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#6)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-9#2)(2011-12#1)(2011-2#1)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#1)
should be placed on the##2##5##(1997-3#1)(2013-1#1)
should be placed on##7##4##(1996-3#1)(1996-8#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2013-1#1)
should be placed##8##3##(1996-3#1)(1996-8#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
should be planned in##3##4##(2012-2#1)(2013-1#2)
should be planned##8##3##(1991-12#1)(2006-10#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
should be pointed out##2##4##(1991-8#1)(2007-8#1)
should be possible to##16##4##(1990-4#1)(1990-5#1)(1994-12#1)(1994-5#1)(1997-4#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-11#1)(2012-12#1)(2012-2#1)
should be possible##20##3##(1990-4#1)(1990-5#1)(1991-11#1)(1993-6#1)(1994-12#1)(1994-5#1)(1995-2#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-11#1)(2012-12#1)(2012-2#1)
should be preceded by##2##4##(2007-11#2)
should be preferentially##3##3##(1990-10#1)(2009-6#1)(2009-8#1)
should be preferred to##2##4##(1991-4#1)(2006-5#1)
should be preferred##8##3##(1991-4#1)(1991-7#1)(2006-5#1)(2007-10#1)(2007-8#1)(2008-10#1)(2010-12#1)(2012-12#1)
should be prepared for##2##4##(2008-10#1)(2008-9#1)
should be prepared to##2##4##(1991-8#1)(2008-2#1)
should be prepared##5##3##(1991-8#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-11#1)
should be prescribed##4##3##(2007-11#2)(2008-8#1)(2008-9#1)
should be present in##2##4##(2008-10#1)(2008-6#1)
should be present##6##3##(2006-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-8#1)(2012-2#1)
should be presented in##2##4##(1993-3#1)(2012-1#1)
should be presented##4##3##(1993-3#2)(1996-8#1)(2012-1#1)
should be preserved##2##3##(2007-6#1)(2012-12#1)
should be prevented by##2##4##(1990-11#1)(1991-4#1)
should be prevented##4##3##(1990-11#1)(1991-4#1)(2008-4#1)(2010-4#1)
should be promoted to##2##4##(2006-9#1)(2008-1#1)
should be promoted##3##3##(2006-9#1)(2008-1#1)(2008-10#1)
should be promptly##5##3##(1993-12#1)(2009-11#1)(2010-11#1)(2012-12#1)(2012-2#1)
should be proposed##2##3##(2006-10#1)(2008-3#1)
should be protected##3##3##(1994-12#1)(1997-5#1)(2013-8#1)
should be provided by##3##4##(1991-2#1)(1992-10#1)(2005-3#1)
should be provided with##3##4##(1992-3#1)(1995-8#1)(2010-8#1)
should be provided##11##3##(1991-2#1)(1992-10#1)(1992-3#1)(1994-12#1)(1995-8#1)(1995-9#1)(2005-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-8#1)
should be published##2##3##(1993-11#1)(1997-5#1)
should be pursued##5##3##(2006-10#1)(2007-4#1)(2010-4#1)(2012-11#1)(2013-1#1)
should be put in place##2##5##(1991-3#1)(2012-12#1)
should be put##4##3##(1991-3#1)(2010-11#1)(2012-12#2)
should be quantified##3##3##(2008-10#1)(2008-8#1)(2013-8#1)
should be raised in##2##4##(2008-9#2)
should be raised##5##3##(1997-8#1)(2007-11#1)(2008-3#1)(2008-9#2)
should be re-evaluated##2##3##(1995-3#1)(2010-2#1)
should be readily##7##3##(1992-4#1)(2007-12#2)(2008-1#1)(2008-3#1)(2008-9#1)(2010-11#1)
should be recognised as a##2##5##(2006-8#1)(2012-12#1)
should be recognised as##3##4##(1993-2#1)(2006-8#1)(2012-12#1)
should be recognised##5##3##(1993-2#1)(1994-7#1)(2006-8#1)(2012-1#1)(2012-12#1)
should be recognized and##2##4##(2009-8#1)(2010-3#1)
should be recognized as##3##4##(1996-1#1)(2005-7#1)(2008-10#1)
should be recognized##7##3##(1996-1#1)(2005-7#1)(2007-2#1)(2008-10#1)(2009-8#1)(2010-3#1)(2011-2#1)
should be recommended for##2##4##(2007-8#1)(2013-1#1)
should be recommended in##3##4##(2006-7#1)(2007-11#1)(2009-2#1)
should be recommended##11##3##(2006-2#1)(2006-7#1)(2007-11#1)(2007-7#2)(2007-8#1)(2009-2#2)(2012-11#1)(2013-1#1)(2013-8#1)
should be reconsidered##3##3##(1990-6#1)(1994-9#1)(2007-12#1)
should be reduced to &lt##2##5##(2006-5#1)(2013-1#1)
should be reduced to##4##4##(1996-6#1)(2006-5#1)(2013-1#2)
should be reduced##7##3##(1995-1#1)(1995-6#1)(1996-6#1)(2006-5#1)(2007-11#1)(2013-1#2)
should be reexamined##2##3##(1993-10#1)(2007-4#1)
should be referred to a specialist##3##6##(2008-11#1)(2009-11#1)(2013-8#1)
should be referred to a##6##5##(1990-2#1)(2008-11#1)(2009-11#1)(2010-9#1)(2011-2#1)(2013-8#1)
should be referred to as##2##5##(1997-5#1)(2008-7#1)
should be referred to##12##4##(1990-2#1)(1990-6#1)(1993-9#1)(1997-5#1)(2008-11#1)(2008-7#1)(2009-11#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-8#1)
should be referred##14##3##(1990-2#1)(1990-6#1)(1993-9#1)(1997-5#1)(2007-6#1)(2008-11#1)(2008-7#1)(2009-11#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-8#2)
should be reflected in##2##4##(2011-2#1)(2012-11#1)
should be reflected##3##3##(2008-1#1)(2011-2#1)(2012-11#1)
should be regarded as a##6##5##(1992-3#1)(1992-8#1)(2005-9#1)(2007-8#1)(2008-10#1)(2012-3#1)
should be regarded as an##3##5##(1992-12#1)(1997-4#1)(2005-8#1)
should be regarded as##17##4##(1991-4#1)(1992-12#1)(1992-3#1)(1992-8#2)(1996-12#2)(1997-4#1)(2005-8#1)(2005-9#1)(2007-11#1)(2007-8#2)(2008-10#2)(2012-2#1)(2012-3#1)
should be regarded with##2##4##(1990-2#1)(1994-2#1)
should be regarded##20##3##(1990-2#1)(1991-4#1)(1992-12#1)(1992-3#1)(1992-8#2)(1994-2#1)(1996-12#2)(1997-4#1)(2005-8#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-10#2)(2012-2#1)(2012-3#1)
should be regularly checked##2##4##(1993-1#1)(1993-5#1)
should be regularly##5##3##(1992-1#1)(1993-1#1)(1993-5#1)(2013-1#2)
should be rejected##2##3##(2006-12#1)(2006-5#1)
should be related to##4##4##(1996-12#1)(2007-11#1)(2010-6#1)(2010-9#1)
should be remembered that##2##4##(2006-4#1)(2009-6#1)
should be remembered##3##3##(2006-4#1)(2009-6#1)(2010-1#1)
should be removed from##2##4##(1994-3#1)(2012-10#1)
should be removed##3##3##(1994-3#1)(2007-8#1)(2012-10#1)
should be replaced by##5##4##(1992-10#1)(1997-6#1)(1997-7#1)(2006-1#1)(2008-11#1)
should be replaced with##4##4##(1994-12#1)(2007-12#1)(2010-7#1)(2012-2#1)
should be replaced##9##3##(1992-10#1)(1994-12#1)(1997-6#1)(1997-7#1)(2006-1#1)(2007-12#1)(2008-11#1)(2010-7#1)(2012-2#1)
should be reported##2##3##(2008-11#1)(2010-6#1)
should be representative of##2##4##(1993-12#1)(2008-5#1)
should be required##4##3##(1992-6#1)(2007-8#1)(2008-9#2)
should be reserved for patients with##5##6##(1991-4#1)(1991-6#1)(2006-10#1)(2011-2#1)(2012-3#1)
should be reserved for patients##9##5##(1990-6#1)(1991-4#1)(1991-6#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-6#1)(2011-2#1)(2012-3#1)
should be reserved for the##2##5##(1993-10#1)(2006-9#1)
should be reserved for##18##4##(1990-6#1)(1991-4#1)(1991-6#1)(1993-10#1)(1993-11#1)(1997-3#1)(2006-10#2)(2006-9#1)(2007-11#1)(2007-7#1)(2008-6#1)(2008-8#1)(2010-7#2)(2011-2#1)(2012-12#1)(2012-3#1)
should be reserved##19##3##(1990-6#1)(1991-4#1)(1991-6#1)(1993-10#1)(1993-11#1)(1997-3#1)(2006-10#2)(2006-9#1)(2007-11#1)(2007-7#1)(2008-6#1)(2008-8#1)(2010-7#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
should be responsible for the##2##5##(2008-3#1)(2008-6#1)
should be responsible for##3##4##(1997-6#1)(2008-3#1)(2008-6#1)
should be responsible##4##3##(1992-5#1)(1997-6#1)(2008-3#1)(2008-6#1)
should be restricted to##6##4##(1992-8#1)(1995-5#1)(2007-3#1)(2007-5#1)(2008-6#1)(2011-2#1)
should be restricted##9##3##(1992-8#1)(1995-11#1)(1995-5#1)(2007-3#1)(2007-5#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#1)
should be retained as##2##4##(2008-10#2)
should be retained##3##3##(2008-1#1)(2008-10#2)
should be retrieved##2##3##(2008-3#1)(2008-7#1)
should be reviewed##2##3##(1993-1#1)(2006-3#1)
should be revised##4##3##(1994-2#1)(1996-3#1)(1996-5#1)(2006-7#1)
should be routinely##5##3##(2007-2#1)(2007-7#1)(2008-10#1)(2012-2#1)(2013-8#1)
should be safe##2##3##(1996-12#1)(2010-7#1)
should be screened for this##2##5##(2007-8#1)(2013-8#1)
should be screened for##9##4##(1990-2#1)(2005-7#1)(2006-1#1)(2007-8#1)(2008-11#1)(2010-10#1)(2011-1#1)(2011-12#1)(2013-8#1)
should be screened##14##3##(1990-2#1)(2005-7#1)(2006-1#1)(2006-10#3)(2007-8#1)(2008-11#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-8#1)
should be seen as##2##4##(1994-2#1)(2007-5#1)
should be seen##7##3##(1991-9#1)(1994-2#1)(1995-10#1)(1996-3#1)(1997-5#1)(2007-5#1)(2010-5#1)
should be selected for##2##4##(2007-11#1)(2008-5#1)
should be selected in##3##4##(2009-8#1)(2013-1#2)
should be selected##10##3##(1991-11#1)(2006-12#1)(2007-11#1)(2007-4#1)(2008-5#1)(2009-8#1)(2012-12#1)(2012-3#1)(2013-1#2)
should be sent to##2##4##(1994-3#1)(1997-2#1)
should be sent##4##3##(1994-3#1)(1997-2#1)(2008-1#1)(2010-9#1)
should be separated from##2##4##(1997-4#1)(2008-10#1)
should be separated##4##3##(1991-3#1)(1997-4#1)(2008-10#2)
should be seriously considered as##2##5##(1991-2#1)(1994-6#1)
should be seriously considered##4##4##(1991-2#1)(1992-8#1)(1994-6#1)(2010-1#1)
should be simplified##2##3##(1994-2#1)(1997-3#1)
should be sought to##2##4##(2008-3#1)(2013-1#1)
should be sought##9##3##(2005-10#1)(2005-11#2)(2006-10#1)(2007-12#1)(2007-2#1)(2008-3#1)(2011-2#1)(2013-1#1)
should be specifically##5##3##(1996-6#1)(2006-9#1)(2007-7#1)(2008-1#1)(2008-11#1)
should be spent##2##3##(1996-3#1)(2006-8#1)
should be standard##3##3##(1996-9#1)(2007-8#1)(2011-2#1)
should be standardized##2##3##(1995-7#1)(2007-12#1)
should be started at a low dose and##2##8##(2007-11#1)(2010-12#1)
should be started##11##3##(1991-7#1)(1995-6#1)(2007-11#1)(2007-7#1)(2008-10#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#2)
should be stimulated##2##3##(1991-11#1)(1991-6#1)
should be stopped##6##3##(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2013-1#2)
should be strengthened##5##3##(2011-12#2)(2011-2#1)(2012-3#1)(2013-1#1)
should be stressed##2##3##(2008-1#1)(2008-10#1)
should be strictly##3##3##(1996-12#1)(2008-5#1)(2009-9#1)
should be strongly considered##2##4##(2006-10#1)(2013-7#1)
should be strongly##3##3##(2004-10#1)(2006-10#1)(2013-7#1)
should be structured##2##3##(1996-2#1)(2008-8#1)
should be studied in##4##4##(1996-6#1)(2005-11#1)(2008-10#1)(2011-2#1)
should be studied##8##3##(1996-6#1)(2005-11#1)(2006-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-2#1)
should be subject to##5##4##(1992-11#1)(1996-1#1)(1997-3#1)(2006-12#1)(2007-10#1)
should be submitted to##3##4##(1992-3#1)(1992-8#1)(2010-12#1)
should be sufficient to##2##4##(2007-5#1)(2008-10#1)
should be sufficient##3##3##(1996-8#1)(2007-5#1)(2008-10#1)
should be suitable for##4##4##(1993-12#1)(1996-5#1)(2008-10#1)(2008-11#1)
should be supplemented with##2##4##(1995-5#1)(2013-1#1)
should be supplemented##3##3##(1995-5#1)(1995-9#1)(2013-1#1)
should be supported##2##3##(2006-7#1)(2008-6#1)
should be suspect##2##3##(2007-12#1)(2012-12#1)
should be suspected if the##2##5##(1997-4#1)(2006-9#1)
should be suspected if##5##4##(1997-4#1)(2005-11#1)(2006-9#1)(2009-2#1)(2012-2#1)
should be suspected in any##2##5##(2009-10#1)(2012-2#1)
should be suspected in patients##2##5##(2006-10#1)(2008-4#1)
should be suspected in##8##4##(1995-7#1)(2006-10#1)(2008-4#1)(2009-10#1)(2010-10#1)(2012-12#1)(2012-2#2)
should be suspected when##4##4##(2011-1#1)(2011-11#1)(2013-1#2)
should be suspected##19##3##(1995-7#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-8#1)(2006-9#1)(2008-11#1)(2008-4#1)(2009-10#1)(2009-2#1)(2010-10#1)(2011-1#1)(2011-11#1)(2012-12#1)(2012-2#3)(2013-1#2)
should be tailored to the individual patient##2##7##(2007-4#1)(2010-12#1)
should be tailored to the##4##5##(1994-7#1)(2007-3#1)(2007-4#1)(2010-12#1)
should be tailored to##5##4##(1992-2#1)(1994-7#1)(2007-3#1)(2007-4#1)(2010-12#1)
should be tailored##6##3##(1992-2#1)(1994-7#1)(2007-3#1)(2007-4#1)(2010-10#1)(2010-12#1)
should be taken as##2##4##(2005-10#1)(2008-10#1)
should be taken in##3##4##(2008-7#1)(2009-12#1)(2011-12#1)
should be taken into account for the##2##7##(2006-4#1)(2008-5#1)
should be taken into account for##3##6##(2006-4#1)(2008-5#1)(2013-7#1)
should be taken into account in any##2##7##(1995-1#1)(2008-2#1)
should be taken into account in the##2##7##(1994-12#1)(2006-1#1)
should be taken into account in##12##6##(1992-3#1)(1994-12#1)(1995-1#1)(1996-3#1)(2006-1#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-2#1)(2013-1#2)
should be taken into account when##13##6##(1991-8#1)(2005-7#1)(2006-7#1)(2007-11#2)(2008-2#1)(2008-3#1)(2009-4#1)(2009-6#1)(2012-11#1)(2012-2#1)(2013-7#1)(2013-8#1)
should be taken into account##36##5##(1991-1#1)(1991-8#1)(1992-3#1)(1993-6#1)(1994-12#1)(1995-1#1)(1996-3#2)(2005-7#1)(2006-1#1)(2006-12#1)(2006-4#1)(2006-7#2)(2007-11#3)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2012-11#1)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#1)
should be taken into consideration and##2##6##(2006-10#1)(2008-7#1)
should be taken into consideration in the##2##7##(2008-6#1)(2013-8#1)
should be taken into consideration in##4##6##(2007-12#1)(2008-6#1)(2008-7#1)(2013-8#1)
should be taken into consideration when designing##2##7##(1992-7#1)(2010-8#1)
should be taken into consideration when using##2##7##(2010-5#1)(2013-1#1)
should be taken into consideration when##8##6##(1992-7#1)(1994-4#1)(1995-5#1)(2008-10#1)(2010-5#1)(2010-8#1)(2013-1#1)(2013-7#1)
should be taken into consideration##20##5##(1992-7#1)(1994-4#1)(1995-5#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#1)(2008-6#1)(2008-7#2)(2009-4#1)(2010-11#1)(2010-5#1)(2010-8#1)(2013-1#1)(2013-7#1)(2013-8#1)
should be taken into##57##4##(1991-1#1)(1991-12#1)(1991-8#1)(1992-3#1)(1992-7#1)(1993-6#1)(1994-12#1)(1994-4#1)(1995-1#1)(1995-5#1)(1996-3#2)(2005-7#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-7#2)(2007-11#4)(2007-12#3)(2007-8#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-8#1)(2012-11#1)(2012-2#1)(2013-1#3)(2013-7#3)(2013-8#2)
should be taken seriously##2##4##(1996-6#1)(2008-4#1)
should be taken to##7##4##(1993-9#1)(1994-3#1)(1995-12#1)(1996-2#1)(2008-10#1)(2011-1#1)(2011-2#1)
should be taken under consideration##2##5##(2007-11#1)(2008-6#1)
should be taken when using##3##5##(2006-10#1)(2011-1#1)(2013-8#1)
should be taken when##4##4##(2006-10#1)(2008-6#1)(2011-1#1)(2013-8#1)
should be taken with##2##4##(2011-2#1)(2012-12#1)
should be taken##90##3##(1990-3#1)(1991-1#1)(1991-12#1)(1991-8#1)(1992-3#1)(1992-7#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-4#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-3#2)(1996-6#1)(2005-10#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-7#2)(2007-11#5)(2007-12#3)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#4)(2008-9#1)(2009-12#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#3)(2013-8#3)
should be targeted for##3##4##(2007-3#1)(2010-12#1)(2010-4#1)
should be targeted##8##3##(2007-3#1)(2007-4#1)(2008-10#1)(2010-12#2)(2010-4#1)(2011-1#1)(2013-7#1)
should be taught##2##3##(1992-6#1)(2011-2#1)
should be tested as##3##4##(2007-5#1)(2007-8#1)(2013-8#1)
should be tested in##3##4##(1990-3#1)(1996-4#1)(2011-1#1)
should be tested##12##3##(1990-3#1)(1993-5#1)(1994-8#1)(1996-4#1)(2006-10#1)(2007-5#1)(2007-7#1)(2007-8#1)(2009-11#1)(2011-1#1)(2012-12#1)(2013-8#1)
should be the basis for##2##5##(1993-2#1)(2006-7#1)
should be the first##5##4##(1990-2#1)(1993-6#1)(2006-8#1)(2007-1#1)(2010-11#1)
should be the focus of##2##5##(2008-11#1)(2012-2#1)
should be the goal of##3##5##(1992-3#1)(2013-1#2)
should be the initial##3##4##(1990-9#1)(2008-4#1)(2011-2#1)
should be the main##2##4##(1991-6#1)(2011-1#1)
should be the primary goal##2##5##(2006-5#1)(2008-3#1)
should be the primary##4##4##(2005-7#1)(2006-5#1)(2006-6#1)(2008-3#1)
should be the procedure of choice##2##6##(2008-4#1)(2012-2#1)
should be the standard##2##4##(1991-8#1)(2006-12#1)
should be the treatment##2##4##(2007-6#1)(2012-2#1)
should be the##53##3##(1990-12#1)(1990-2#1)(1990-9#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-1#1)(1994-6#1)(1996-1#1)(1996-12#1)(1996-8#1)(2005-7#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-8#2)(2009-5#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
should be to##9##3##(1993-12#1)(1996-9#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#2)
should be trained in##3##4##(1997-8#1)(2008-1#1)(2012-2#1)
should be trained##6##3##(1993-10#1)(1994-7#1)(1997-8#1)(2008-1#1)(2012-2#1)(2012-3#1)
should be treated as a##3##5##(2006-12#2)(2013-7#1)
should be treated by##5##4##(1991-8#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-8#1)
should be treated in##5##4##(1991-3#1)(1993-3#1)(2005-10#1)(2008-6#1)(2013-1#1)
should be treated surgically##2##4##(1991-4#1)(2007-8#1)
should be treated with a##3##5##(2007-8#1)(2009-4#1)(2009-8#1)
should be treated with##19##4##(1990-8#1)(1991-6#1)(1992-2#1)(1993-5#1)(1996-11#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-8#2)(2009-4#1)(2009-8#1)(2010-11#1)(2011-2#3)(2013-1#1)(2013-8#1)
should be treated##49##3##(1990-2#1)(1990-8#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-2#2)(1992-6#1)(1993-2#1)(1993-3#1)(1993-5#2)(1993-6#1)(1996-11#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-10#1)(2005-5#1)(2006-10#2)(2006-12#2)(2007-11#1)(2007-8#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-4#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
should be tried##3##3##(1992-8#1)(2005-11#1)(2007-7#1)
should be understood##2##3##(1991-1#1)(2013-8#1)
should be undertaken at##2##4##(1996-6#1)(2008-5#1)
should be undertaken by##2##4##(2009-11#1)(2012-2#1)
should be undertaken in##4##4##(1990-2#1)(1991-8#1)(2007-8#1)(2009-10#1)
should be undertaken to##4##4##(1993-6#1)(2006-10#1)(2012-12#1)(2013-8#1)
should be undertaken##17##3##(1990-2#1)(1991-8#1)(1992-12#1)(1993-1#1)(1993-6#1)(1996-6#1)(2006-10#2)(2007-8#1)(2008-5#1)(2009-10#1)(2009-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
should be urgently##2##3##(2008-7#1)(2012-2#1)
should be used after##2##4##(2008-6#1)(2012-12#1)
should be used as a first-line##2##6##(2008-2#1)(2011-2#1)
should be used as prophylaxis##2##5##(2007-11#1)(2012-11#1)
should be used as##8##4##(1993-10#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-11#1)
should be used by##2##4##(2007-10#1)(2008-11#1)
should be used cautiously##3##4##(1996-12#1)(2011-2#1)(2012-12#1)
should be used for##9##4##(1990-2#1)(2008-10#1)(2008-4#1)(2010-11#1)(2010-12#1)(2010-7#2)(2011-2#1)(2013-1#1)
should be used in the##6##5##(1990-11#1)(2007-9#1)(2008-4#1)(2008-6#1)(2010-11#1)(2013-8#1)
should be used in##21##4##(1990-11#2)(1990-7#1)(1991-2#1)(1992-11#1)(1993-7#1)(1994-2#1)(1996-6#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-4#2)(2008-6#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
should be used instead of##2##5##(1995-12#1)(2008-7#1)
should be used on##2##4##(2007-7#1)(2008-2#1)
should be used only in##3##5##(1993-2#1)(2004-12#1)(2007-11#1)
should be used only##7##4##(1991-4#1)(1993-2#1)(1994-12#1)(2004-12#1)(2007-11#2)(2007-7#1)
should be used to##18##4##(1995-12#1)(1996-6#1)(1997-7#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-3#1)(2010-11#1)(2010-7#2)(2011-2#1)(2013-1#1)
should be used when##2##4##(2008-10#1)(2010-3#1)
should be used with caution in##2##6##(2008-3#1)(2012-2#1)
should be used with caution##8##5##(1990-5#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
should be used with##9##4##(1990-5#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
should be used##112##3##(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-10#1)(1993-2#1)(1993-5#1)(1993-7#1)(1994-12#1)(1994-2#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#2)(1996-9#1)(1997-4#1)(1997-7#1)(2004-12#1)(2005-3#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2007-10#2)(2007-11#5)(2007-4#1)(2007-7#5)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#6)(2008-6#2)(2008-7#4)(2008-9#2)(2009-3#1)(2009-6#1)(2010-1#1)(2010-11#3)(2010-12#2)(2010-3#1)(2010-7#4)(2011-1#1)(2011-2#9)(2012-11#1)(2012-12#4)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#1)
should be useful as##2##4##(1992-6#1)(2008-5#1)
should be useful for the##4##5##(1996-8#1)(2006-10#1)(2008-10#1)(2008-5#1)
should be useful for##18##4##(1992-1#1)(1992-8#1)(1995-2#2)(1995-5#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-5#1)(2013-7#1)
should be useful in studying the##3##6##(1992-7#1)(1993-6#1)(1996-12#1)
should be useful in the##8##5##(1993-12#1)(1994-6#1)(1995-6#1)(1996-12#1)(2006-2#1)(2008-10#1)(2008-2#1)(2010-4#1)
should be useful in understanding the##2##6##(1995-11#1)(2008-10#1)
should be useful in##28##4##(1992-7#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-6#1)(1995-11#1)(1995-6#1)(1996-12#2)(1996-8#1)(2004-11#1)(2006-2#1)(2007-8#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2010-4#2)
should be useful to##3##4##(1994-1#1)(2008-10#1)(2008-8#1)
should be useful##54##3##(1991-9#1)(1992-1#1)(1992-10#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-6#1)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-8#2)(1997-4#2)(2004-11#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-8#1)(2010-4#2)(2013-7#1)
should be utilized to##3##4##(2012-3#1)(2013-1#2)
should be utilized##5##3##(1991-12#1)(2011-1#1)(2012-3#1)(2013-1#2)
should be vaccinated##2##3##(1990-11#1)(2008-4#1)
should be valuable##2##3##(1995-12#1)(2008-9#1)
should be very useful for##4##5##(1995-2#1)(1997-2#1)(1997-8#1)(2008-10#1)
should be very##6##3##(1995-2#1)(1995-6#1)(1997-2#1)(1997-8#1)(2008-10#2)
should be viewed as a##4##5##(1995-2#1)(1995-3#1)(2005-8#1)(2006-8#1)
should be viewed as##6##4##(1995-2#1)(1995-3#1)(2005-8#1)(2006-8#1)(2007-9#1)(2013-1#1)
should be viewed with##2##4##(1991-2#1)(2010-8#1)
should be viewed##8##3##(1991-2#1)(1995-2#1)(1995-3#1)(2005-8#1)(2006-8#1)(2007-9#1)(2010-8#1)(2013-1#1)
should be weighed against the##2##5##(1995-9#1)(2010-8#1)
should be weighed against##3##4##(1995-9#1)(2006-9#1)(2010-8#1)
should be weighed##6##3##(1991-11#1)(1995-9#1)(2006-9#1)(2008-10#1)(2010-8#1)(2011-2#1)
should be well informed##2##4##(2008-9#1)(2011-2#1)
should be well##8##3##(1990-4#1)(1997-8#1)(2006-10#1)(2007-7#1)(2008-9#1)(2009-4#1)(2009-6#1)(2011-2#1)
should be within##2##3##(1992-5#1)(2007-4#1)
should be##3530##2##(1990-1#2)(1990-10#8)(1990-11#8)(1990-12#12)(1990-2#16)(1990-3#7)(1990-4#6)(1990-5#6)(1990-6#9)(1990-7#2)(1990-8#11)(1990-9#7)(1991-1#6)(1991-10#2)(1991-11#8)(1991-12#16)(1991-2#14)(1991-3#17)(1991-4#16)(1991-5#4)(1991-6#11)(1991-7#8)(1991-8#14)(1991-9#13)(1992-1#7)(1992-10#7)(1992-11#9)(1992-12#25)(1992-2#12)(1992-3#19)(1992-4#5)(1992-5#8)(1992-6#13)(1992-7#3)(1992-8#21)(1992-9#6)(1993-1#13)(1993-10#7)(1993-11#6)(1993-12#15)(1993-2#11)(1993-3#13)(1993-4#2)(1993-5#7)(1993-6#12)(1993-7#6)(1993-8#6)(1993-9#14)(1994-1#6)(1994-10#1)(1994-11#2)(1994-12#12)(1994-2#15)(1994-3#20)(1994-4#7)(1994-5#4)(1994-6#12)(1994-7#5)(1994-8#4)(1994-9#12)(1995-1#12)(1995-10#3)(1995-11#5)(1995-12#11)(1995-2#10)(1995-3#7)(1995-4#3)(1995-5#12)(1995-6#6)(1995-7#7)(1995-8#6)(1995-9#10)(1996-1#17)(1996-10#1)(1996-11#19)(1996-12#26)(1996-2#16)(1996-3#26)(1996-4#5)(1996-5#2)(1996-6#17)(1996-7#1)(1996-8#18)(1996-9#8)(1997-1#4)(1997-2#10)(1997-3#16)(1997-4#16)(1997-5#8)(1997-6#10)(1997-7#7)(1997-8#21)(2004-1#1)(2004-10#3)(2004-11#2)(2004-12#2)(2004-2#1)(2004-3#3)(2004-4#2)(2004-9#4)(2005-1#2)(2005-10#16)(2005-11#24)(2005-12#13)(2005-3#8)(2005-5#3)(2005-7#12)(2005-8#17)(2005-9#5)(2006-1#14)(2006-10#111)(2006-11#5)(2006-12#25)(2006-2#26)(2006-3#8)(2006-4#11)(2006-5#18)(2006-6#20)(2006-7#19)(2006-8#19)(2006-9#11)(2007-1#7)(2007-10#23)(2007-11#91)(2007-12#67)(2007-2#36)(2007-3#17)(2007-4#30)(2007-5#12)(2007-6#19)(2007-7#67)(2007-8#79)(2007-9#18)(2008-1#44)(2008-10#161)(2008-11#60)(2008-12#22)(2008-2#36)(2008-3#59)(2008-4#56)(2008-5#62)(2008-6#33)(2008-7#86)(2008-8#49)(2008-9#62)(2009-1#4)(2009-10#3)(2009-11#9)(2009-12#9)(2009-2#9)(2009-3#19)(2009-4#17)(2009-5#16)(2009-6#24)(2009-7#8)(2009-8#18)(2009-9#12)(2010-1#7)(2010-10#13)(2010-11#27)(2010-12#41)(2010-2#13)(2010-3#11)(2010-4#11)(2010-5#11)(2010-6#10)(2010-7#31)(2010-8#28)(2010-9#18)(2011-1#49)(2011-11#3)(2011-12#22)(2011-2#130)(2011-3#1)(2011-4#1)(2011-7#1)(2011-8#1)(2012-1#16)(2012-10#2)(2012-11#22)(2012-12#71)(2012-2#95)(2012-3#45)(2012-5#1)(2012-6#1)(2013-1#109)(2013-7#19)(2013-8#61)
should become a##2##3##(2008-10#1)(2013-1#1)
should become part of the##2##5##(1993-4#1)(2007-11#1)
should become##9##2##(1993-4#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-11#2)(2013-1#1)
should begin with##6##3##(2004-3#1)(2006-10#1)(2007-12#1)(2011-12#1)(2012-11#1)(2013-1#1)
should begin##13##2##(1993-2#1)(1994-8#1)(2004-3#1)(2006-10#1)(2007-1#1)(2007-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-7#1)
should benefit from##2##3##(1996-6#1)(2010-5#1)
should benefit##6##2##(1996-6#1)(2008-10#1)(2008-3#1)(2010-5#1)(2011-1#1)(2012-3#1)
should block##3##2##(1992-12#1)(1997-7#2)
should bring##2##2##(2008-10#1)(2009-5#1)
should carefully consider the##2##4##(2007-4#1)(2008-7#1)
should carefully consider##3##3##(2007-4#1)(2008-7#1)(2010-6#1)
should carefully##4##2##(1994-3#1)(2007-4#1)(2008-7#1)(2010-6#1)
should carry##2##2##(1994-5#1)(2008-11#1)
should change rapidly##2##3##(2005-11#1)(2008-8#1)
should change##5##2##(1994-2#1)(2005-11#1)(2008-8#1)(2009-10#1)(2010-9#1)
should choose##2##2##(2010-8#1)(2012-1#1)
should clarify##2##2##(1996-12#1)(2008-6#1)
should coincide##2##2##(2005-11#1)(2011-1#1)
should collect information from##2##4##(1997-3#1)(2008-10#1)
should concentrate on##2##3##(1993-7#1)(2010-3#1)
should conduct##2##2##(1997-3#1)(2013-8#1)
should consider how##2##3##(2008-10#1)(2011-2#1)
should consider the possibility of##4##5##(2009-6#1)(2013-1#3)
should consider the##14##3##(2006-10#2)(2006-6#1)(2008-10#2)(2008-9#1)(2009-6#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-7#1)
should consider using##2##3##(1992-3#1)(2007-11#1)
should consider##53##2##(1991-1#1)(1992-3#2)(1993-1#1)(1994-6#1)(1995-3#2)(2005-4#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-5#1)(2011-2#7)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)
should consist of##3##3##(1997-2#1)(2008-12#1)(2008-5#1)
should consult##2##2##(2006-8#1)(2013-1#1)
should contain##2##2##(2008-8#1)(2012-11#1)
should continue to be monitored##2##5##(1997-4#1)(2008-11#1)
should continue to be##10##4##(1996-6#2)(1997-4#1)(2004-2#1)(2006-10#2)(2007-3#1)(2008-11#1)(2008-8#1)(2009-5#1)
should continue to##16##3##(1990-12#1)(1992-8#1)(1996-6#2)(1997-4#1)(2004-2#1)(2006-10#2)(2007-3#1)(2008-11#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-1#1)(2013-7#1)(2013-8#1)
should continue##21##2##(1990-12#1)(1992-8#1)(1996-6#2)(1997-4#1)(2004-2#1)(2004-3#1)(2006-10#2)(2007-3#1)(2008-10#1)(2008-11#2)(2008-8#2)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#1)(2013-7#1)(2013-8#1)
should contribute to##2##3##(2008-3#1)(2008-7#1)
should contribute##5##2##(1991-5#1)(1993-12#1)(2008-3#1)(2008-7#1)(2012-2#1)
should correspond to##2##3##(1997-4#1)(2007-12#1)
should cover##3##2##(1995-1#1)(2006-7#1)(2008-9#1)
should decrease or##2##3##(1994-3#1)(2008-8#1)
should decrease the##3##3##(2007-11#1)(2007-8#1)(2008-5#1)
should decrease##5##2##(1994-3#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-8#1)
should depend on the##2##4##(2007-12#1)(2007-6#1)
should depend on##4##3##(1994-6#1)(2007-12#1)(2007-6#1)(2008-3#1)
should depend##5##2##(1994-6#1)(2007-12#1)(2007-6#1)(2008-3#1)(2008-8#1)
should design##2##2##(1997-2#1)(2008-7#1)
should determine##2##2##(2008-5#1)(2012-3#1)
should develop a##2##3##(1994-1#1)(1996-3#1)
should develop##7##2##(1994-1#1)(1995-8#1)(1996-3#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
should devote##2##2##(1994-3#1)(2012-12#1)
should do to##2##3##(1991-3#1)(2012-11#1)
should do##6##2##(1991-3#1)(1993-12#1)(1993-7#1)(2007-8#1)(2009-9#1)(2012-11#1)
should elicit##2##2##(1992-12#1)(1995-5#1)
should emphasize##3##2##(1997-2#1)(2006-10#1)(2012-3#1)
should employ##4##2##(1990-2#1)(2008-10#1)(2009-4#1)(2010-8#1)
should enable detection##2##3##(2006-6#1)(2008-2#1)
should enable the##3##3##(1992-9#1)(2006-5#1)(2011-2#1)
should enable##12##2##(1992-9#1)(2006-5#1)(2006-6#1)(2006-8#1)(2008-10#1)(2008-2#3)(2010-6#1)(2011-2#2)(2013-8#1)
should encourage the##2##3##(2008-2#1)(2012-11#1)
should encourage##12##2##(1994-2#1)(1994-3#1)(1996-2#1)(2007-10#1)(2007-2#1)(2008-2#1)(2008-8#1)(2010-10#1)(2012-11#1)(2012-12#1)(2013-1#2)
should enhance the##5##3##(1991-9#1)(1992-2#1)(2007-4#2)(2013-1#1)
should enhance##10##2##(1991-9#1)(1992-2#1)(1994-9#1)(2007-10#1)(2007-4#2)(2007-7#1)(2008-8#2)(2013-1#1)
should ensure that the##2##4##(1992-11#1)(2011-2#1)
should ensure that##10##3##(1990-3#1)(1992-11#1)(1993-12#1)(2006-5#1)(2007-4#1)(2008-8#1)(2010-8#1)(2010-9#1)(2011-2#2)
should ensure##12##2##(1990-3#1)(1992-11#1)(1993-12#1)(2006-5#1)(2006-6#1)(2007-4#1)(2008-8#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-3#1)
should establish the##2##3##(2005-3#1)(2006-10#1)
should evaluate the##3##3##(2012-1#2)(2012-3#1)
should evaluate##4##2##(2006-10#1)(2012-1#2)(2012-3#1)
should eventually##2##2##(1990-3#1)(1992-4#1)
should evolve##3##2##(2006-5#1)(2008-9#1)(2010-10#1)
should examine the##6##3##(1996-10#1)(2007-7#1)(2008-8#1)(2009-9#1)(2010-9#1)(2011-2#1)
should examine##8##2##(1996-10#1)(2005-10#1)(2007-7#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-9#1)(2011-2#1)
should exclude##3##2##(1991-11#1)(2007-6#1)(2008-1#1)
should exercise##2##2##(1992-11#1)(1995-8#1)
should exhibit##2##2##(1992-6#1)(1995-9#1)
should exist##6##2##(2004-7#1)(2006-6#1)(2007-3#1)(2007-7#1)(2008-2#1)(2009-8#1)
should expand##2##2##(2006-9#1)(2010-2#1)
should expect##2##2##(1996-2#1)(2013-1#1)
should facilitate the development of##2##5##(1996-9#1)(2008-7#1)
should facilitate the##7##3##(1995-6#1)(1996-9#1)(2004-11#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
should facilitate##25##2##(1992-8#1)(1993-2#2)(1993-3#1)(1994-11#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-9#1)(2004-11#1)(2006-12#1)(2006-6#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#3)(2009-8#1)(2010-2#1)(2011-1#1)
should favor##4##2##(2008-8#1)(2008-9#2)(2012-3#1)
should find a wide range of##2##6##(2008-10#2)
should find wide##2##3##(1995-2#1)(2008-10#1)
should find##9##2##(1995-2#1)(1996-3#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)
should first be##2##3##(2007-5#1)(2010-5#1)
should first##3##2##(1996-12#1)(2007-5#1)(2010-5#1)
should focus more on##2##4##(1992-3#1)(2010-7#1)
should focus more##3##3##(1992-3#1)(2008-11#1)(2010-7#1)
should focus on the##4##4##(2010-11#1)(2010-12#1)(2012-12#1)(2012-2#1)
should focus on##28##3##(1990-12#1)(1994-12#1)(1995-11#1)(1996-11#1)(1997-2#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-8#2)(2009-5#1)(2009-7#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-7#1)(2011-1#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
should focus##37##2##(1990-12#1)(1992-3#1)(1994-12#1)(1995-11#1)(1996-11#1)(1997-1#1)(1997-2#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#2)(2009-5#1)(2009-7#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-7#4)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
should follow##8##2##(1990-10#1)(1994-12#1)(1997-1#1)(2008-6#1)(2009-5#1)(2009-7#1)(2010-12#1)(2013-1#1)
should forage##2##2##(2008-9#2)
should form the basis##2##4##(2008-10#1)(2009-4#1)
should form the##3##3##(1996-12#1)(2008-10#1)(2009-4#1)
should form##4##2##(1996-12#1)(2008-10#1)(2009-4#1)(2009-9#1)
should foster##2##2##(2008-3#1)(2008-8#1)
should further enhance##2##3##(1992-12#1)(2008-7#1)
should further##8##2##(1992-12#1)(1992-2#1)(1994-5#1)(1996-1#1)(2006-9#1)(2008-3#1)(2008-7#1)(2012-3#1)
should gain##3##2##(1995-3#1)(2007-8#1)(2008-1#1)
should generally be avoided##2##4##(2008-9#1)(2010-8#1)
should generally be##3##3##(2007-6#1)(2008-9#1)(2010-8#1)
should get##2##2##(2006-2#1)(2007-8#1)
should give##6##2##(1993-1#1)(1995-3#1)(1996-3#1)(1997-8#1)(2008-5#1)(2009-6#1)
should go to##2##3##(1993-9#1)(2012-2#1)
should go##5##2##(1993-9#1)(1997-3#1)(2006-10#1)(2008-8#1)(2012-2#1)
should greatly##4##2##(1997-4#1)(2008-10#1)(2008-9#1)(2011-2#1)
should guide##4##2##(2006-10#1)(2007-12#1)(2011-1#1)(2011-2#1)
should happen##2##2##(1994-2#1)(2008-8#1)
should have a clear##2##4##(2005-8#1)(2007-4#1)
should have a greater##3##4##(1997-3#2)(2005-10#1)
should have a thorough##4##4##(2007-4#1)(2008-4#2)(2008-9#1)
should have a##29##3##(1992-8#1)(1993-1#1)(1995-5#1)(1997-3#2)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-6#1)(2007-12#2)(2007-4#2)(2008-1#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-9#2)(2010-10#2)(2011-1#1)(2011-2#2)
should have access to##2##4##(2006-7#2)
should have an##2##3##(2007-12#1)(2008-10#1)
should have at##2##3##(1992-12#1)(1993-3#1)
should have been##18##3##(1990-12#1)(1990-3#2)(1990-9#1)(1991-11#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-5#1)(1993-7#1)(1994-8#1)(2006-3#1)(2007-11#1)(2011-2#1)(2012-2#1)(2013-1#2)
should have fewer##2##3##(1995-1#1)(2009-6#1)
should have high##3##3##(1994-5#1)(1994-7#1)(2007-9#1)
should have higher##2##3##(1994-3#1)(2012-2#1)
should have implications for##2##4##(2008-5#1)(2013-1#1)
should have in##3##3##(1993-12#1)(1996-6#1)(2012-2#1)
should have little##2##3##(2008-8#1)(2010-12#1)
should have positive##2##3##(2008-7#1)(2011-1#1)
should have read##2##3##(1990-3#1)(1990-9#1)
should have the##6##3##(1992-4#1)(1993-11#2)(1995-11#1)(1997-3#1)(2008-8#1)
should have their##3##3##(1996-12#1)(2007-12#1)(2011-1#1)
should have##130##2##(1990-12#1)(1990-3#3)(1990-6#1)(1990-9#2)(1991-10#2)(1991-11#2)(1991-3#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-5#1)(1992-8#2)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-7#1)(1994-3#1)(1994-5#1)(1994-7#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-12#1)(1996-5#2)(1996-6#2)(1996-9#1)(1997-3#3)(1997-5#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#2)(2006-1#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-7#3)(2007-11#2)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#4)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#4)(2009-6#1)(2010-10#3)(2010-12#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#4)(2012-11#1)(2012-2#4)(2012-3#1)(2013-1#3)
should help in the##4##4##(1991-3#2)(1993-7#1)(2008-10#1)
should help to guide##2##4##(2012-2#1)(2013-1#1)
should help to understand the complex##2##6##(2008-11#1)(2008-4#1)
should help to##13##3##(1991-7#1)(2005-10#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
should help us to##2##4##(1993-5#1)(2007-8#1)
should help with##2##3##(2007-11#1)(2008-4#1)
should help##33##2##(1991-12#1)(1991-3#2)(1991-7#1)(1993-1#1)(1993-5#1)(1993-7#1)(1996-1#1)(1997-1#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
should ideally be##3##3##(2007-1#1)(2009-10#1)(2012-3#1)
should ideally##6##2##(2006-4#1)(2007-1#1)(2007-12#1)(2009-10#1)(2010-12#1)(2012-3#1)
should identify##4##2##(2005-10#1)(2007-10#1)(2007-12#1)(2010-2#1)
should implement##3##2##(2007-10#1)(2010-9#1)(2013-1#1)
should imply a##2##3##(2007-12#1)(2007-2#1)
should imply##4##2##(2007-12#1)(2007-2#1)(2008-10#1)(2012-12#1)
should improve and##2##3##(2008-11#1)(2010-1#1)
should improve patient##2##3##(1994-3#1)(2007-12#1)
should improve the quality of##2##5##(1990-4#1)(2006-6#1)
should improve the##6##3##(1990-4#1)(1990-5#1)(2006-6#1)(2008-1#1)(2008-4#1)(2008-5#1)
should improve##21##2##(1990-4#1)(1990-5#1)(1991-11#1)(1992-12#1)(1993-11#1)(1993-6#1)(1994-3#2)(2006-10#1)(2006-6#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-11#1)(2010-1#1)(2011-2#1)
should in##4##2##(2005-11#1)(2005-7#1)(2008-11#1)(2008-8#1)
should include a thorough history and physical examination##2##8##(2008-7#1)(2010-7#1)
should include a##6##3##(1996-2#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-7#1)(2013-1#1)
should include an##4##3##(1990-12#1)(1997-5#1)(2007-10#1)(2008-10#1)
should include approaches##2##3##(2012-2#1)(2013-1#1)
should include blood##2##3##(2005-11#1)(2005-8#1)
should include both##2##3##(1997-8#1)(2008-10#1)
should include consideration of the##2##5##(2006-10#1)(2012-11#1)
should include consideration of##3##4##(2006-10#1)(2008-12#1)(2012-11#1)
should include the##9##3##(1994-5#1)(1996-11#1)(2006-8#1)(2007-12#1)(2008-2#1)(2008-7#1)(2009-6#1)(2010-12#1)(2011-2#1)
should include##75##2##(1990-12#1)(1990-3#1)(1991-1#1)(1991-7#1)(1992-2#1)(1993-1#1)(1994-3#1)(1994-4#1)(1994-5#1)(1995-10#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-11#2)(1996-2#2)(1997-5#1)(1997-8#1)(2004-10#1)(2005-10#1)(2005-11#2)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-12#3)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#3)(2009-12#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#6)(2013-1#2)
should incorporate##10##2##(1994-3#1)(1995-9#1)(2006-5#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-4#1)(2010-6#1)(2013-1#2)
should increase the##3##3##(1992-12#1)(1996-1#1)(2010-3#1)
should increase##14##2##(1990-10#1)(1992-12#1)(1996-1#1)(2005-11#1)(2006-10#2)(2007-4#1)(2008-10#1)(2008-8#1)(2009-4#1)(2010-3#1)(2012-1#1)(2013-1#2)
should induce##2##2##(1995-5#1)(2009-4#1)
should inform future##2##3##(2011-3#1)(2012-12#1)
should inform the##2##3##(2010-9#1)(2011-2#1)
should inform##6##2##(2008-5#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)
should initially be##3##3##(1990-11#1)(1990-3#1)(2011-2#1)
should initially##4##2##(1990-11#1)(1990-3#1)(2008-9#1)(2011-2#1)
should instead be##2##3##(1991-4#1)(1995-6#1)
should investigate##2##2##(2008-12#1)(2008-8#1)
should involve a##2##3##(2006-10#1)(2012-2#1)
should involve##8##2##(1993-3#1)(1994-3#1)(2006-10#2)(2006-7#1)(2007-11#1)(2012-2#1)(2013-1#1)
should it be treated?##3##4##(2008-4#1)(2008-7#1)(2008-9#1)
should it be##7##3##(1994-4#1)(2006-10#1)(2006-6#1)(2007-4#1)(2008-4#1)(2008-7#1)(2008-9#1)
should it##11##2##(1993-11#1)(1994-4#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-12#1)(2007-4#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)
should keep in mind that##4##5##(2007-11#1)(2010-12#1)(2010-8#1)(2012-12#1)
should keep in mind##7##4##(1995-9#1)(2006-10#1)(2007-11#1)(2010-12#1)(2010-8#1)(2012-1#1)(2012-12#1)
should keep##11##2##(1995-9#1)(2006-10#2)(2007-11#2)(2010-12#1)(2010-6#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-8#1)
should know about##5##3##(1995-1#1)(2008-4#1)(2012-12#1)(2012-3#1)(2013-7#1)
should know##16##2##(1995-1#1)(1996-11#3)(2006-2#1)(2006-8#1)(2007-3#1)(2008-4#1)(2009-5#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
should lead to a##7##4##(1996-12#1)(2006-2#1)(2007-8#1)(2008-5#2)(2012-12#1)(2012-2#1)
should lead to new insights into the##2##7##(1996-7#1)(2006-10#1)
should lead to new##3##4##(1996-7#1)(2006-10#2)
should lead to the development of novel deodorant systems##2##9##(2008-5#2)
should lead to the##5##4##(2008-10#2)(2008-5#2)(2010-12#1)
should lead to##34##3##(1992-6#1)(1994-3#1)(1996-12#1)(1996-7#1)(2004-11#1)(2006-10#3)(2006-2#1)(2006-6#2)(2007-11#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#4)(2008-8#1)(2010-12#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)
should lead##36##2##(1992-6#1)(1994-3#1)(1996-12#1)(1996-7#1)(2004-11#1)(2006-10#4)(2006-2#1)(2006-6#2)(2007-11#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#4)(2008-8#1)(2010-12#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)
should learn##4##2##(2006-10#1)(2010-1#1)(2011-2#1)(2013-1#1)
should leave##2##2##(2007-9#1)(2008-4#1)
should lie##2##2##(1990-12#1)(2008-8#1)
should live##2##2##(2007-12#1)(2011-2#1)
should look##3##2##(1994-12#1)(2008-7#1)(2013-1#1)
should mainly be attributed to the##2##6##(1992-9#1)(2008-6#1)
should mainly##3##2##(1992-9#1)(2008-10#1)(2008-6#1)
should maintain##2##2##(2007-12#1)(2011-2#1)
should make a##2##3##(2007-12#1)(2007-2#1)
should make it possible to##3##5##(2007-12#1)(2008-10#1)(2012-1#1)
should make it##7##3##(2007-12#3)(2008-10#1)(2008-7#1)(2010-12#1)(2012-1#1)
should make standardizing CS a high priority for targeted funding##2##10##(2013-1#2)
should make that##2##3##(2008-5#1)(2012-12#1)
should make##20##2##(1990-8#1)(1995-1#1)(2006-4#2)(2007-11#1)(2007-12#4)(2007-2#1)(2008-10#2)(2008-5#2)(2008-7#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-1#2)
should measure##3##2##(1995-3#1)(2008-8#1)(2010-11#1)
should meet##5##2##(1997-8#1)(2009-4#1)(2011-2#3)
should minimize the risk of##2##5##(1992-12#1)(2006-10#1)
should minimize the##3##3##(1992-12#1)(2006-10#1)(2008-1#1)
should minimize##4##2##(1992-12#1)(2005-11#1)(2006-10#1)(2008-1#1)
should more##4##2##(2006-10#1)(2006-7#2)(2007-11#1)
should move##4##2##(1997-2#1)(2008-3#1)(2010-8#1)(2011-1#1)
should never be##6##3##(1996-1#1)(1996-6#1)(2006-10#1)(2006-4#1)(2007-2#1)(2012-10#1)
should nevertheless be##2##3##(1993-11#1)(1996-1#1)
should no longer be##5##4##(2006-10#2)(2006-5#1)(2008-1#1)(2011-7#1)
should no##6##2##(1997-5#1)(2006-10#2)(2006-5#1)(2008-1#1)(2011-7#1)
should not alter the indications##2##5##(2006-10#1)(2012-2#1)
should not be a##3##4##(1995-12#1)(1996-9#1)(2007-4#1)
should not be administered##2##4##(2007-11#1)(2008-5#1)
should not be applied##2##4##(1997-3#1)(2008-9#1)
should not be based on##3##5##(1995-1#1)(2006-10#1)(2008-2#1)
should not be combined##2##4##(2006-10#2)
should not be confused with##6##5##(1992-11#1)(1992-4#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-8#1)
should not be considered a##4##5##(2008-10#1)(2008-11#1)(2009-8#1)(2013-8#1)
should not be considered as##3##5##(1995-12#1)(2008-8#1)(2011-2#1)
should not be considered##15##4##(1991-2#1)(1995-12#1)(1996-9#1)(2006-12#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-8#1)(2011-2#3)(2012-3#1)(2013-8#1)
should not be construed as legal advice or an opinion on specific situations##3##13##(2006-8#3)
should not be construed as##6##5##(2006-7#1)(2006-8#5)
should not be continued##2##4##(1990-11#1)(2009-12#1)
should not be discounted##2##4##(2012-3#1)(2013-1#1)
should not be dismissed as##2##5##(2007-12#1)(2008-1#1)
should not be dismissed##3##4##(2007-12#1)(2008-1#1)(2008-12#1)
should not be given##3##4##(1990-9#1)(1996-1#1)(2005-12#1)
should not be ignored##4##4##(1994-7#1)(2006-11#1)(2008-10#1)(2013-8#1)
should not be implemented##3##4##(1993-9#1)(2006-10#1)(2010-12#1)
should not be neglected##5##4##(1995-10#1)(2007-8#1)(2008-11#1)(2008-9#1)(2012-12#1)
should not be overlooked##4##4##(1997-3#1)(2006-8#1)(2007-1#1)(2010-6#1)
should not be recommended##2##4##(2007-2#1)(2007-7#1)
should not be regarded as##2##5##(1996-6#1)(2010-3#1)
should not be stopped##2##4##(1996-6#1)(2007-11#1)
should not be the only##2##5##(1997-3#1)(2006-10#1)
should not be the##4##4##(1997-3#1)(2006-10#1)(2008-10#1)(2011-2#1)
should not be treated##3##4##(1993-11#1)(2006-10#1)(2006-8#1)
should not be underestimated##4##4##(2006-5#1)(2007-7#1)(2008-8#1)(2013-1#1)
should not be used for##2##5##(2007-12#1)(2008-4#1)
should not be used in##8##5##(1992-6#1)(1993-2#1)(1993-3#1)(1997-5#1)(2007-8#1)(2008-11#1)(2008-8#2)
should not be used to##5##5##(2006-10#1)(2007-7#1)(2008-4#1)(2008-7#1)(2010-11#1)
should not be used##21##4##(1992-6#1)(1993-2#1)(1993-3#1)(1994-3#1)(1997-5#1)(2006-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#2)(2009-6#1)(2010-11#1)(2012-12#1)(2012-2#1)
should not be viewed as##2##5##(2006-12#1)(2007-3#1)
should not be viewed##4##4##(1996-1#2)(2006-12#1)(2007-3#1)
should not be withheld##2##4##(2007-11#1)(2010-8#1)
should not be##183##3##(1990-11#1)(1990-8#1)(1990-9#1)(1991-2#2)(1991-6#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#2)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-7#1)(1995-9#1)(1996-1#4)(1996-11#2)(1996-2#1)(1996-3#1)(1996-6#3)(1996-8#1)(1996-9#2)(1997-1#1)(1997-3#4)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#2)(2005-12#1)(2005-7#1)(2005-9#1)(2006-10#9)(2006-11#2)(2006-12#3)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#7)(2007-1#1)(2007-11#5)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#6)(2008-9#3)(2009-12#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#3)(2011-1#2)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#8)(2013-7#2)(2013-8#4)
should not contain##2##3##(1990-11#1)(1994-3#1)
should not exceed##4##3##(1990-5#1)(1997-5#1)(2007-7#1)(2007-8#1)
should not have any adverse##2##5##(2008-11#1)(2013-8#1)
should not have##5##3##(1996-1#1)(2008-11#1)(2008-2#1)(2009-10#1)(2013-8#1)
should not lead to##3##4##(1993-2#1)(2006-11#1)(2007-2#1)
should not necessarily be##2##4##(2008-3#1)(2008-7#1)
should not necessarily##3##3##(2006-2#1)(2008-3#1)(2008-7#1)
should not only be##2##4##(2007-8#1)(2011-1#1)
should not only##7##3##(1993-11#1)(2007-12#1)(2007-8#2)(2009-9#1)(2010-4#1)(2011-1#1)
should not rely##2##3##(1992-6#1)(2008-8#1)
should not replace##2##3##(2006-8#1)(2007-10#1)
should not take##2##3##(2008-11#1)(2011-2#1)
should not underestimate the importance of##2##6##(2007-9#1)(2008-9#1)
should not use##2##3##(2007-11#1)(2012-3#1)
should not##272##2##(1990-11#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-2#2)(1991-6#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#3)(1994-6#2)(1994-7#2)(1995-1#1)(1995-10#1)(1995-12#3)(1995-2#2)(1995-4#1)(1995-7#2)(1995-9#1)(1996-1#5)(1996-11#3)(1996-2#1)(1996-3#2)(1996-6#3)(1996-8#1)(1996-9#2)(1997-1#2)(1997-3#4)(1997-4#1)(1997-5#3)(1997-6#2)(1997-8#2)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#12)(2006-11#3)(2006-12#3)(2006-2#2)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#8)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#6)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#4)(2007-7#6)(2007-8#7)(2007-9#3)(2008-1#2)(2008-10#9)(2008-11#7)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#8)(2008-9#5)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#3)(2011-2#7)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#11)(2013-7#2)(2013-8#5)
should now be##5##3##(1995-6#1)(1996-12#1)(1997-7#1)(2008-11#1)(2010-12#1)
should now##6##2##(1995-6#1)(1996-12#1)(1997-7#1)(2008-11#1)(2009-2#1)(2010-12#1)
should nurses##2##2##(1991-12#1)(2008-2#1)
should occur in the##2##4##(1991-6#1)(2008-9#1)
should occur##8##2##(1990-3#1)(1991-6#1)(1994-9#1)(2005-11#1)(2005-8#1)(2007-8#1)(2008-9#1)(2012-2#1)
should offer##2##2##(2007-2#1)(2007-8#1)
should one##5##2##(1993-8#1)(2007-5#1)(2008-8#2)(2011-1#1)
should only be applied##2##4##(2008-10#1)(2013-1#1)
should only be carried out##2##5##(1993-8#1)(2007-7#1)
should only be performed in##2##5##(2006-10#1)(2008-8#1)
should only be used for##2##5##(2006-10#1)(2007-2#1)
should only be used##8##4##(1993-8#1)(1994-8#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-2#1)(2012-2#2)
should only be##20##3##(1993-8#2)(1994-8#1)(1997-3#1)(2006-10#3)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)(2010-11#1)(2012-2#2)(2013-1#1)
should open##3##2##(2008-7#1)(2010-12#1)(2011-12#1)
should optimize##4##2##(1997-3#2)(2008-8#1)(2012-2#1)
should or should not be##2##5##(1990-11#1)(2008-9#1)
should participate in the##2##4##(1996-2#1)(2011-2#1)
should participate in##6##3##(1994-2#1)(1996-2#1)(2007-7#1)(2011-2#2)(2013-7#1)
should pass##2##2##(2007-9#1)(2012-2#1)
should pay more attention to##2##5##(2008-1#1)(2010-1#1)
should pay more##3##3##(1996-1#1)(2008-1#1)(2010-1#1)
should pay##6##2##(1993-7#1)(1996-1#1)(2008-1#1)(2008-9#1)(2010-1#1)(2011-2#1)
should perform the##2##3##(1994-11#1)(2011-2#1)
should perform##7##2##(1994-11#1)(1995-11#3)(2007-4#1)(2008-3#1)(2011-2#1)
should permit the##3##3##(1992-11#1)(2008-11#1)(2009-6#1)
should permit##5##2##(1992-11#1)(2007-12#1)(2008-11#1)(2008-7#1)(2009-6#1)
should plan##2##2##(2007-12#1)(2009-9#1)
should play a##4##3##(1990-8#1)(1993-1#1)(2008-6#1)(2011-1#1)
should play an important role in the##2##7##(2008-3#1)(2009-10#1)
should play an important##3##4##(2007-11#1)(2008-3#1)(2009-10#1)
should play##7##2##(1990-8#1)(1993-1#1)(2007-11#1)(2008-3#1)(2008-6#1)(2009-10#1)(2011-1#1)
should possess##3##2##(1991-12#1)(2006-2#1)(2010-8#1)
should precede##4##2##(1990-2#1)(2005-11#1)(2008-7#1)(2012-1#1)
should preferably be##5##3##(1991-5#1)(1991-7#1)(1993-2#1)(1993-6#1)(2008-4#1)
should preferably##8##2##(1991-2#1)(1991-5#1)(1991-7#1)(1993-2#1)(1993-6#1)(2008-4#1)(2008-8#2)
should prepare##3##2##(1991-4#1)(1996-3#1)(2007-2#1)
should present##2##2##(1993-5#1)(2008-10#1)
should prevail##2##2##(2007-1#1)(2013-1#1)
should prevent##3##2##(1993-3#1)(2008-4#1)(2011-2#1)
should primarily##2##2##(1992-2#1)(2006-12#1)
should probably be##7##3##(1990-9#1)(1996-3#1)(1996-9#1)(1997-4#1)(2008-10#1)(2008-5#1)(2008-6#1)
should proceed##3##2##(1990-5#1)(2006-9#1)(2011-1#1)
should produce##4##2##(1993-3#1)(2008-2#1)(2008-7#1)(2008-8#1)
should prohibit##2##2##(2007-12#1)(2012-1#1)
should promote##3##2##(1993-7#1)(1994-1#1)(2009-3#1)
should prompt a##2##3##(2005-10#1)(2009-4#1)
should prompt the##2##3##(2006-10#1)(2013-1#1)
should prompt##13##2##(1993-10#1)(1997-3#1)(2005-10#1)(2006-10#2)(2006-4#1)(2007-2#1)(2009-11#1)(2009-4#1)(2012-12#2)(2013-1#1)(2013-8#1)
should protect them##2##3##(1993-12#1)(2008-5#1)
should protect##3##2##(1993-12#1)(1997-5#1)(2008-5#1)
should prove to be a##2##5##(1994-6#1)(2005-7#1)
should prove to be##4##4##(1993-11#1)(1994-6#1)(2005-6#1)(2005-7#1)
should prove useful as a##3##5##(2007-10#1)(2008-10#2)
should prove useful for researchers and clinicians interested in##2##9##(2007-12#2)
should prove useful for the##2##5##(1995-1#1)(2007-12#1)
should prove useful for##6##4##(1995-1#1)(2007-12#3)(2008-10#2)
should prove useful in the##2##5##(2012-2#1)(2013-8#1)
should prove useful in##4##4##(1990-7#1)(1994-8#1)(2012-2#1)(2013-8#1)
should prove useful##16##3##(1990-7#1)(1992-12#1)(1994-8#1)(1995-1#1)(1995-4#1)(2007-10#1)(2007-12#3)(2008-10#4)(2008-3#1)(2012-2#1)(2013-8#1)
should prove##26##2##(1990-7#1)(1992-12#1)(1992-7#1)(1993-11#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-4#1)(2005-6#1)(2005-7#1)(2007-10#2)(2007-12#3)(2008-10#4)(2008-3#1)(2008-4#1)(2009-8#1)(2010-1#1)(2012-2#1)(2013-8#1)
should provide a powerful##2##4##(1990-7#1)(2008-10#1)
should provide a valuable tool for##2##6##(1993-12#1)(2008-11#1)
should provide a##10##3##(1990-7#1)(1993-12#1)(1993-2#1)(1994-5#1)(1996-3#1)(2005-11#1)(2005-6#1)(2008-10#1)(2008-11#1)(2012-3#1)
should provide additional##2##3##(1994-8#1)(2008-10#1)
should provide an##2##3##(2008-10#1)(2008-3#1)
should provide further##2##3##(1993-12#1)(2008-7#1)
should provide insight##2##3##(2008-9#1)(2010-12#1)
should provide new##2##3##(1997-3#1)(2006-10#1)
should provide the##5##3##(2005-3#1)(2007-4#1)(2008-3#1)(2010-7#1)(2011-2#1)
should provide##53##2##(1990-7#1)(1991-2#1)(1993-10#1)(1993-12#2)(1993-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-3#1)(2005-11#1)(2005-3#1)(2005-6#1)(2005-7#2)(2006-10#2)(2006-4#2)(2007-1#1)(2007-10#2)(2007-2#1)(2007-4#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
should pursue##2##2##(2007-4#1)(2008-2#1)
should put##2##2##(2008-5#1)(2012-3#1)
should raise concern##2##3##(2007-12#1)(2007-6#1)
should raise the suspicion of##3##5##(2011-1#1)(2012-1#1)(2012-12#1)
should raise the##5##3##(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#2)
should raise##8##2##(2007-12#1)(2007-6#1)(2011-1#2)(2012-1#1)(2012-12#1)(2013-1#2)
should rather be##2##3##(1996-12#1)(2007-8#1)
should rather##3##2##(1996-12#1)(2007-8#1)(2008-5#1)
should read as follows##3##4##(2006-3#1)(2007-12#2)
should read as##7##3##(2006-3#1)(2007-12#6)
should read##8##2##(2006-3#2)(2007-12#6)
should receive a##2##3##(1992-10#1)(1996-2#1)
should receive greater##3##3##(1997-8#1)(2013-1#2)
should receive the##2##3##(1994-9#1)(2010-9#1)
should receive##32##2##(1992-10#1)(1992-12#2)(1993-11#1)(1993-12#1)(1994-2#1)(1994-4#1)(1994-9#1)(1995-10#1)(1995-8#1)(1996-2#1)(1997-8#2)(2004-12#1)(2005-10#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-11#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-2#1)(2010-9#1)(2012-2#1)(2013-1#5)
should recognise##2##2##(1996-11#1)(2007-3#1)
should recognize that##2##3##(1994-2#1)(2008-2#1)
should recognize##3##2##(1994-2#1)(2008-2#1)(2008-3#1)
should reduce the risk of##2##5##(1993-11#1)(1996-8#1)
should reduce##9##2##(1993-11#1)(1994-12#1)(1996-8#1)(2005-12#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-8#1)(2008-9#1)
should refer##2##2##(2006-5#1)(2008-9#1)
should reflect the##4##3##(1990-3#1)(1991-12#1)(2008-3#1)(2009-9#1)
should reflect##9##2##(1990-3#1)(1991-12#1)(1992-9#1)(1993-10#1)(1996-8#1)(2006-12#1)(2007-1#1)(2008-3#1)(2009-9#1)
should rely on##3##3##(2008-8#1)(2010-7#1)(2010-9#1)
should remain a##2##3##(2005-11#1)(2007-2#1)
should remain in##2##3##(1995-1#1)(2008-12#1)
should remain the##4##3##(1990-2#1)(2004-1#1)(2007-7#1)(2013-8#1)
should remain##12##2##(1990-2#1)(1992-3#1)(1995-1#1)(1997-8#1)(2004-1#1)(2005-11#1)(2007-2#1)(2007-7#1)(2008-12#1)(2010-12#1)(2013-8#2)
should remember##2##2##(2008-9#1)(2013-7#1)
should remove##3##2##(2008-12#1)(2011-1#1)(2011-2#1)
should replace##3##2##(1991-8#1)(1994-4#1)(2008-2#1)
should represent the##3##3##(2006-8#2)(2008-1#1)
should represent##4##2##(2006-8#2)(2007-4#1)(2008-1#1)
should require##2##2##(2008-7#1)(2009-4#1)
should resolve##2##2##(2006-10#1)(2006-4#1)
should respond to##2##3##(2007-8#1)(2008-8#1)
should rest##2##2##(2006-12#1)(2008-1#1)
should result in a##4##4##(1991-12#1)(1994-3#1)(1995-5#1)(1996-2#1)
should result in##14##3##(1990-3#1)(1991-12#1)(1993-9#1)(1994-3#1)(1995-5#1)(1996-2#1)(1997-1#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-11#1)
should result##15##2##(1990-3#1)(1991-12#1)(1993-9#1)(1994-3#1)(1994-7#1)(1995-5#1)(1996-2#1)(1997-1#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-11#1)
should reveal##2##2##(1993-5#1)(2006-3#1)
should review##2##2##(1993-5#1)(2004-9#1)
should save##2##2##(1990-4#1)(2011-12#1)
should see##4##2##(1994-4#1)(1996-6#1)(2006-10#1)(2007-9#1)
should seek to##3##3##(2008-5#1)(2009-4#1)(2009-8#1)
should seek##6##2##(1992-6#1)(2004-9#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-8#1)
should serve as a##2##4##(2006-12#1)(2012-2#1)
should serve as##4##3##(2006-12#1)(2009-3#1)(2012-2#2)
should serve to##2##3##(2008-12#1)(2013-8#1)
should serve##6##2##(2006-12#1)(2008-12#1)(2009-3#1)(2012-2#2)(2013-8#1)
should show##3##2##(2006-12#1)(2006-4#1)(2008-1#1)
should significantly##3##2##(1994-12#1)(2008-7#1)(2010-10#1)
should simultaneously##2##2##(1992-3#1)(2008-2#1)
should stand##2##2##(1990-2#1)(2008-10#1)
should start from##2##3##(2008-11#1)(2013-1#1)
should start in##2##3##(1993-2#1)(2008-3#1)
should start with##2##3##(1990-2#1)(1993-1#1)
should start##8##2##(1990-2#1)(1993-1#1)(1993-2#1)(2007-7#1)(2008-11#1)(2008-3#1)(2011-2#1)(2013-1#1)
should stay##2##2##(1994-6#1)(1995-5#1)
should still be considered##2##4##(2006-10#1)(2008-6#1)
should still be##6##3##(1994-2#1)(2006-10#1)(2007-9#1)(2008-6#1)(2010-12#1)(2011-2#1)
should stimulate##4##2##(1997-5#1)(2006-6#1)(2011-1#1)(2011-2#1)
should stop##6##2##(1995-12#1)(2007-7#2)(2008-10#1)(2008-2#1)(2011-2#1)
should store##3##2##(2008-8#3)
should strengthen the##3##3##(2012-3#3)
should strengthen##6##2##(2007-12#1)(2009-7#1)(2011-2#1)(2012-3#3)
should study##2##2##(2007-1#1)(2010-2#1)
should substantially##2##2##(2007-12#1)(2010-1#1)
should such##2##2##(2004-10#1)(2007-12#1)
should suggest the diagnosis##3##4##(1997-3#1)(2006-10#1)(2007-7#1)
should suggest##5##2##(1997-1#1)(1997-3#1)(2006-10#2)(2007-7#1)
should support a##2##3##(2008-2#1)(2008-9#1)
should support##3##2##(2008-2#1)(2008-9#1)(2012-12#1)
should survive##2##2##(2009-6#2)
should take an active role in##2##6##(1994-1#1)(1995-3#1)
should take into account the##3##5##(1995-10#1)(2008-7#1)(2010-12#1)
should take into account##10##4##(1993-8#1)(1995-10#1)(2007-10#1)(2008-7#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-9#1)(2013-1#2)
should take into consideration##3##4##(1993-7#1)(1996-6#1)(2012-3#1)
should take into##13##3##(1993-7#1)(1993-8#1)(1995-10#1)(1996-6#1)(2007-10#1)(2008-7#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-9#1)(2012-3#1)(2013-1#2)
should take place##4##3##(1992-2#1)(1992-4#1)(1996-11#1)(2008-8#1)
should take##36##2##(1992-2#1)(1992-3#1)(1992-4#1)(1993-7#2)(1993-8#1)(1994-1#3)(1995-10#1)(1995-3#1)(1996-11#1)(1996-6#2)(1996-9#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-4#1)(2009-9#1)(2010-12#2)(2010-4#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#2)
should target the##3##3##(2007-6#1)(2010-8#1)(2011-2#1)
should target these##2##3##(2006-7#1)(2011-2#1)
should target##9##2##(1995-12#1)(2006-7#1)(2007-6#1)(2008-7#1)(2010-8#1)(2011-2#2)(2012-11#1)(2013-1#1)
should terminate the##2##3##(2008-4#2)
should the ACC/AHA Guidelines be##2##5##(2008-3#2)
should the physician##2##3##(2007-2#1)(2008-3#1)
should the##26##2##(1991-11#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-2#1)(1993-5#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1997-4#1)(2007-2#3)(2007-3#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
should then be##2##3##(2006-4#1)(2010-2#1)
should then##4##2##(2006-4#1)(2006-5#1)(2010-2#1)(2012-12#1)
should theoretically##2##2##(1991-12#1)(2008-8#1)
should therefore be considered##3##4##(2008-8#1)(2009-3#1)(2010-2#1)
should therefore be given##2##4##(1996-11#1)(1997-3#1)
should therefore be##20##3##(1992-6#1)(1993-11#1)(1993-3#1)(1994-3#1)(1996-11#1)(1997-3#2)(2006-10#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-2#1)
should therefore not##2##3##(1996-3#1)(2010-7#1)
should therefore##35##2##(1990-11#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-3#1)(1994-7#1)(1996-11#1)(1996-3#1)(1997-3#2)(2006-10#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#2)(2009-3#1)(2009-5#1)(2010-12#1)(2010-2#2)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)
should they##6##2##(1991-12#1)(1992-12#1)(1992-5#1)(1993-8#1)(2007-2#1)(2012-3#1)
should thus be##3##3##(2008-3#1)(2008-4#1)(2013-1#1)
should thus##7##2##(1994-2#1)(2006-6#1)(2007-8#1)(2008-3#1)(2008-4#1)(2011-1#1)(2013-1#1)
should train##2##2##(2004-12#1)(2008-11#1)
should treat##2##2##(1993-9#2)
should try to##2##3##(2007-2#1)(2009-11#1)
should ultimately##2##2##(1991-12#1)(2006-6#1)
should undergo a##2##3##(2006-9#1)(2007-8#1)
should undergo further testing##3##4##(2012-12#1)(2013-1#2)
should undergo further##5##3##(2011-8#1)(2012-12#1)(2013-1#3)
should undergo##25##2##(1990-6#1)(1990-7#1)(1991-3#1)(1995-3#1)(1996-12#1)(1996-3#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-6#1)(2009-10#1)(2009-11#1)(2010-2#1)(2011-2#1)(2011-8#1)(2012-12#2)(2012-2#2)(2013-1#3)
should understand##3##2##(2006-8#1)(2008-7#1)(2010-8#1)
should use the##3##3##(1997-5#1)(2012-2#2)
should use##15##2##(1990-12#1)(1997-5#1)(2005-8#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-6#2)(2010-8#1)(2011-1#1)(2012-2#2)
should usually be##5##3##(2005-11#1)(2006-5#1)(2007-2#1)(2008-3#1)(2008-8#1)
should vary##4##2##(1994-1#1)(2007-8#1)(2008-9#2)
should view##2##2##(1992-2#1)(2010-5#1)
should we be concerned?##2##4##(2006-12#1)(2008-11#1)
should we not##2##3##(1993-2#1)(2010-3#1)
should we use##2##3##(2008-11#1)(2013-7#1)
should we use?##2##3##(2008-7#1)(2008-8#1)
should we##31##2##(1993-2#1)(1996-1#1)(2006-12#1)(2006-4#4)(2006-5#1)(2007-10#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#4)(2008-8#2)(2009-5#1)(2010-2#1)(2010-3#1)(2012-1#1)(2013-7#1)
should wear##3##2##(1997-3#1)(2008-4#1)(2009-5#1)
should work in##2##3##(2008-7#1)(2012-12#1)
should work together##2##3##(1995-2#1)(2007-4#1)
should work##7##2##(1995-2#1)(2007-3#1)(2007-4#1)(2008-7#1)(2009-11#1)(2010-9#1)(2012-12#1)
should yield##3##2##(2008-2#1)(2010-12#1)(2012-3#1)
should you##5##2##(2007-4#2)(2007-9#1)(2008-1#1)(2009-4#1)
should##5902##1##(1990-1#3)(1990-10#11)(1990-11#13)(1990-12#19)(1990-2#24)(1990-3#20)(1990-4#9)(1990-5#10)(1990-6#11)(1990-7#6)(1990-8#14)(1990-9#13)(1991-1#8)(1991-10#4)(1991-11#13)(1991-12#31)(1991-2#19)(1991-3#26)(1991-4#20)(1991-5#8)(1991-6#13)(1991-7#15)(1991-8#17)(1991-9#15)(1992-1#8)(1992-10#8)(1992-11#14)(1992-12#41)(1992-2#22)(1992-3#30)(1992-4#10)(1992-5#13)(1992-6#23)(1992-7#4)(1992-8#26)(1992-9#9)(1993-1#23)(1993-10#15)(1993-11#22)(1993-12#28)(1993-2#22)(1993-3#22)(1993-4#6)(1993-5#14)(1993-6#14)(1993-7#15)(1993-8#12)(1993-9#20)(1994-1#13)(1994-10#1)(1994-11#6)(1994-12#20)(1994-2#27)(1994-3#39)(1994-4#13)(1994-5#10)(1994-6#19)(1994-7#13)(1994-8#11)(1994-9#17)(1995-1#22)(1995-10#7)(1995-11#12)(1995-12#21)(1995-2#16)(1995-3#18)(1995-4#9)(1995-5#19)(1995-6#11)(1995-7#10)(1995-8#11)(1995-9#18)(1996-1#33)(1996-10#2)(1996-11#32)(1996-12#39)(1996-2#30)(1996-3#38)(1996-4#5)(1996-5#5)(1996-6#31)(1996-7#3)(1996-8#22)(1996-9#16)(1997-1#13)(1997-2#18)(1997-3#38)(1997-4#26)(1997-5#20)(1997-6#12)(1997-7#14)(1997-8#34)(2003-11#1)(2004-1#2)(2004-10#5)(2004-11#4)(2004-12#5)(2004-2#2)(2004-3#5)(2004-4#3)(2004-7#1)(2004-9#7)(2005-1#2)(2005-10#27)(2005-11#40)(2005-12#16)(2005-3#10)(2005-4#1)(2005-5#3)(2005-6#2)(2005-7#17)(2005-8#24)(2005-9#7)(2006-1#16)(2006-10#184)(2006-11#9)(2006-12#43)(2006-2#37)(2006-3#12)(2006-4#29)(2006-5#31)(2006-6#38)(2006-7#33)(2006-8#37)(2006-9#17)(2007-1#18)(2007-10#40)(2007-11#126)(2007-12#131)(2007-2#70)(2007-3#28)(2007-4#52)(2007-5#20)(2007-6#31)(2007-7#95)(2007-8#111)(2007-9#35)(2008-1#71)(2008-10#252)(2008-11#114)(2008-12#38)(2008-2#67)(2008-3#106)(2008-4#95)(2008-5#96)(2008-6#51)(2008-7#139)(2008-8#123)(2008-9#108)(2009-1#5)(2009-10#13)(2009-11#15)(2009-12#14)(2009-2#14)(2009-3#28)(2009-4#36)(2009-5#30)(2009-6#37)(2009-7#17)(2009-8#24)(2009-9#23)(2010-1#13)(2010-10#25)(2010-11#37)(2010-12#73)(2010-2#31)(2010-3#18)(2010-4#17)(2010-5#17)(2010-6#16)(2010-7#43)(2010-8#49)(2010-9#29)(2011-1#83)(2011-11#3)(2011-12#28)(2011-2#209)(2011-3#3)(2011-4#1)(2011-7#2)(2011-8#2)(2012-1#30)(2012-10#3)(2012-11#32)(2012-12#105)(2012-2#150)(2012-3#81)(2012-5#1)(2012-6#1)(2013-1#179)(2013-7#32)(2013-8#89)
shoulder abduction loading##4##3##(2010-7#3)(2012-1#1)
shoulder abduction##10##2##(2007-7#3)(2010-7#3)(2012-1#3)(2013-1#1)
shoulder after##3##2##(2004-1#1)(2006-3#1)(2008-7#1)
shoulder and elbow movements##2##4##(2012-1#2)
shoulder and elbow##8##3##(2007-10#1)(2007-8#1)(2008-9#1)(2012-1#5)
shoulder and##20##2##(1990-12#1)(1991-5#1)(1997-5#1)(1997-8#1)(2006-10#2)(2006-11#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-7#2)(2008-9#1)(2009-7#1)(2012-1#5)
shoulder arthrodesis##2##2##(2008-6#2)
shoulder arthroplasty##7##2##(2007-7#2)(2007-8#2)(2008-6#3)
shoulder arthroscopy##3##2##(2007-11#3)
shoulder at##4##2##(1991-7#1)(2007-1#1)(2008-10#2)
shoulder belt forces##2##3##(2006-11#2)
shoulder belt##6##2##(2006-11#5)(2013-1#1)
shoulder discomfort##2##2##(1995-3#1)(1996-9#1)
shoulder diseases##2##2##(2007-11#2)
shoulder dislocation##8##2##(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-8#2)(2009-4#2)
shoulder dislocations##11##2##(2007-11#6)(2007-3#5)
shoulder during##5##2##(2007-10#1)(2009-1#1)(2009-3#1)(2013-1#2)
shoulder dystocia##8##2##(2004-10#7)(2011-2#1)
shoulder flexion##7##2##(2007-10#1)(2010-9#6)
shoulder function is##2##3##(2007-7#1)(2008-9#1)
shoulder function##10##2##(2006-7#1)(2007-7#1)(2007-8#1)(2008-9#4)(2009-4#1)(2012-2#1)(2013-1#1)
shoulder girdle movement##4##3##(2012-1#4)
shoulder girdle##13##2##(1994-7#1)(2006-3#1)(2006-9#2)(2007-4#1)(2009-3#1)(2012-1#5)(2012-2#2)
shoulder in the##2##3##(1991-8#1)(2008-10#1)
shoulder in##9##2##(1991-8#1)(1997-6#1)(2007-4#5)(2008-10#1)(2010-12#1)
shoulder injuries in soccer##4##4##(2013-1#4)
shoulder injuries in##7##3##(2013-1#7)
shoulder injuries##10##2##(2007-4#1)(2007-7#2)(2013-1#7)
shoulder injury##5##2##(2007-4#2)(2007-7#2)(2013-1#1)
shoulder instability##7##2##(2007-11#6)(2007-7#1)
shoulder is##6##2##(2006-12#1)(2007-11#2)(2007-4#1)(2008-8#1)(2012-1#1)
shoulder joint##14##2##(1991-4#1)(1996-9#1)(2006-3#1)(2007-1#1)(2007-11#6)(2007-7#1)(2007-8#1)(2008-7#1)(2008-8#1)
shoulder joints were##2##3##(2007-1#1)(2008-11#1)
shoulder joints##4##2##(2007-1#1)(2007-11#1)(2008-11#1)(2012-1#1)
shoulder loads##2##2##(2007-10#1)(2008-12#1)
shoulder mechanism##2##2##(2012-1#2)
shoulder muscles in##2##3##(2010-9#1)(2012-2#1)
shoulder muscles##6##2##(2008-12#1)(2010-9#2)(2012-2#3)
shoulder of the##2##3##(2008-12#1)(2008-8#1)
shoulder of##6##2##(1997-5#1)(2006-11#1)(2007-10#1)(2008-12#2)(2008-8#1)
shoulder pain and##8##3##(1992-9#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-1#1)
shoulder pain during##2##3##(2007-10#1)(2010-9#1)
shoulder pain that##2##3##(2006-12#2)
shoulder pain##30##2##(1992-9#1)(1996-2#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-7#2)(2006-8#4)(2007-10#3)(2007-11#2)(2008-10#2)(2008-12#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-3#1)(2010-9#1)(2011-2#1)(2012-1#1)
shoulder pathology##4##2##(2006-12#1)(2009-3#3)
shoulder rotators in##2##3##(2007-7#2)
shoulder rotators##4##2##(2007-7#4)
shoulder surgery##7##2##(2006-10#2)(2007-11#3)(2007-12#2)
shoulder to the##2##3##(1994-8#1)(2006-12#1)
shoulder to##3##2##(1994-8#1)(2006-11#1)(2006-12#1)
shoulder was##7##2##(2006-11#1)(2007-1#1)(2007-10#1)(2007-4#2)(2007-7#2)
shoulder##422##1##(1990-11#1)(1990-12#1)(1990-3#2)(1990-5#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#4)(1992-9#3)(1993-10#1)(1994-7#1)(1994-8#1)(1995-3#3)(1995-4#2)(1995-8#1)(1996-2#1)(1996-3#1)(1996-9#4)(1997-5#4)(1997-6#1)(1997-8#1)(2004-1#1)(2004-10#7)(2005-10#1)(2006-10#6)(2006-11#20)(2006-12#12)(2006-3#5)(2006-7#4)(2006-8#6)(2006-9#2)(2007-1#7)(2007-10#13)(2007-11#60)(2007-12#3)(2007-2#2)(2007-3#7)(2007-4#33)(2007-7#23)(2007-8#14)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#7)(2008-6#7)(2008-7#8)(2008-8#10)(2008-9#7)(2009-1#3)(2009-3#7)(2009-4#5)(2009-7#1)(2009-9#1)(2010-12#7)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#4)(2010-9#10)(2011-12#4)(2011-2#6)(2012-1#27)(2012-12#1)(2012-2#8)(2013-1#20)(2013-7#2)
shoulder-hand syndrome in##2##3##(2007-8#1)(2013-1#1)
shoulder-hand syndrome##3##2##(2007-8#2)(2013-1#1)
shoulder-hand##8##1##(2006-12#4)(2007-8#2)(2008-1#1)(2013-1#1)
shoulder-level-front&quot##3##1##(2007-4#3)
shoulder-level-side&quot##3##1##(2007-4#3)
shoulders and##6##2##(1993-9#1)(2007-10#1)(2007-7#1)(2011-2#2)(2013-7#1)
shoulders of##3##2##(2006-11#1)(2007-10#1)(2010-9#1)
shoulders were##5##2##(1991-8#1)(2007-1#1)(2007-11#1)(2009-3#1)(2013-7#1)
shoulders with##3##2##(2009-3#2)(2009-6#1)
shoulders##34##1##(1991-8#1)(1993-9#1)(1994-2#1)(2006-1#1)(2006-11#1)(2007-1#2)(2007-10#2)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-12#2)(2008-7#1)(2009-3#5)(2009-5#2)(2009-6#1)(2009-9#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-7#2)
shoulders)##2##1##(2007-7#1)(2008-5#1)
shouldn't##2##1##(2008-8#1)(2010-4#1)
shovelers##3##1##(2008-6#3)
show &quot##2##2##(1997-5#1)(2011-12#1)
show a better##2##3##(2006-11#1)(2013-8#1)
show a change of##2##4##(2004-9#1)(2005-11#1)
show a characteristic##3##3##(1997-7#1)(2008-11#1)(2012-2#1)
show a clear##12##3##(1990-5#1)(1992-7#1)(1997-7#1)(2006-11#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-7#1)
show a close##2##3##(1991-5#1)(2008-11#1)
show a common##2##3##(2006-2#1)(2010-6#1)
show a complex##2##3##(1992-1#1)(2008-10#1)
show a considerable increase in##2##5##(2008-2#1)(2008-4#1)
show a considerable##4##3##(1996-5#1)(2008-2#1)(2008-4#1)(2012-12#1)
show a consistent##5##3##(1993-11#1)(1994-2#1)(2007-11#1)(2008-5#1)(2009-1#1)
show a correlation##4##3##(1995-12#1)(2004-9#1)(2006-12#1)(2008-4#1)
show a decline of##2##4##(2006-10#1)(2009-12#1)
show a decline##3##3##(2006-10#1)(2008-7#1)(2009-12#1)
show a decrease in##3##4##(1996-11#1)(2008-10#1)(2012-1#1)
show a decrease##4##3##(1996-11#1)(2008-10#1)(2008-3#1)(2012-1#1)
show a decreased##4##3##(1994-5#1)(1997-3#1)(1997-5#1)(2008-1#1)
show a difference in##3##4##(1996-6#1)(2007-11#1)(2008-11#1)
show a different##3##3##(2006-11#1)(2008-9#1)(2011-2#1)
show a differential##2##3##(1991-9#1)(2008-3#1)
show a dramatic##2##3##(1990-2#1)(1993-11#1)
show a genetic##2##3##(1994-2#1)(1996-3#1)
show a good agreement##2##4##(1997-3#1)(2008-11#1)
show a good correlation##3##4##(1991-10#1)(1995-12#1)(2011-1#1)
show a good##7##3##(1991-10#1)(1995-12#1)(1997-3#1)(2005-11#1)(2008-11#1)(2008-2#1)(2011-1#1)
show a gradual##2##3##(2006-10#1)(2009-5#1)
show a greater##6##3##(1990-11#1)(1990-6#1)(1993-5#1)(1994-2#2)(2008-7#1)
show a high degree of##6##5##(1990-11#1)(1993-3#1)(1996-8#1)(2007-11#1)(2007-8#1)(2008-5#1)
show a high prevalence of##2##5##(2008-11#1)(2011-1#1)
show a high##18##3##(1990-11#1)(1992-3#1)(1993-3#1)(1993-8#1)(1996-8#2)(2006-10#2)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#3)(2011-1#1)
show a higher incidence of##2##5##(1990-5#1)(2011-2#1)
show a higher##8##3##(1990-5#1)(1991-1#1)(1992-4#1)(1997-8#1)(2005-8#1)(2010-6#1)(2011-2#1)(2012-1#1)
show a highly##2##3##(1995-12#1)(2008-10#1)
show a homology##2##3##(1992-5#1)(2008-11#1)
show a large increase##2##4##(2007-12#1)(2008-10#1)
show a large##3##3##(1992-7#1)(2007-12#1)(2008-10#1)
show a larger##2##3##(2005-11#1)(2007-1#1)
show a limited##2##3##(1992-1#1)(2010-5#1)
show a linear relationship between the##2##6##(2005-11#1)(2011-2#1)
show a linear relationship between##3##5##(2005-11#1)(2010-4#1)(2011-2#1)
show a linear response##2##4##(2008-10#1)(2008-2#1)
show a linear##6##3##(2005-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-4#1)(2011-2#1)
show a loss of##2##4##(1992-7#1)(1996-12#1)
show a low level of agreement between the participants'##2##9##(2011-2#2)
show a low level of##3##5##(2011-1#1)(2011-2#2)
show a low##7##3##(1990-6#1)(1993-5#1)(2008-10#1)(2008-9#1)(2011-1#1)(2011-2#2)
show a marked##3##3##(2005-11#1)(2011-12#1)(2013-1#1)
show a maximum##5##3##(1994-5#1)(2004-9#1)(2005-11#1)(2008-10#2)
show a more##4##3##(1996-5#1)(2008-4#1)(2012-3#1)(2013-8#1)
show a negative##3##3##(2005-11#1)(2008-5#1)(2010-12#1)
show a new##3##3##(1997-6#1)(2008-12#1)(2008-7#1)
show a novel##5##3##(1991-7#1)(1995-11#1)(1997-6#1)(2007-12#1)(2008-7#1)
show a pattern of##3##4##(2008-5#1)(2008-9#1)(2009-4#1)
show a positive correlation##3##4##(1993-11#1)(1995-5#1)(2004-4#1)
show a positive##5##3##(1993-11#1)(1995-5#1)(2004-4#1)(2006-10#1)(2010-9#1)
show a potential##2##3##(2008-2#1)(2012-12#1)
show a preference##3##3##(1996-1#1)(2010-2#2)
show a profound##2##3##(1996-4#1)(1997-6#1)
show a reduced##3##3##(1994-11#1)(2005-9#1)(2006-2#1)
show a reduction in their##2##5##(2008-7#1)(2011-2#1)
show a reduction##3##3##(2008-7#2)(2011-2#1)
show a relationship between##3##4##(1994-10#1)(2009-10#1)(2012-3#1)
show a relative decrease in the##2##6##(1990-2#1)(2008-2#1)
show a relatively##3##3##(1991-6#1)(1997-6#1)(2009-11#1)
show a remarkable##4##3##(1991-1#1)(1994-5#1)(2006-10#2)
show a satisfactory##2##3##(1992-6#1)(2006-11#1)
show a significant change in##2##5##(2008-11#1)(2011-2#1)
show a significant change##3##4##(2008-11#1)(2009-6#1)(2011-2#1)
show a significant effect##3##4##(2008-12#1)(2008-3#1)(2009-11#1)
show a significant improvement in##2##5##(2007-5#1)(2011-2#1)
show a significant improvement##4##4##(2007-11#1)(2007-5#1)(2008-5#1)(2011-2#1)
show a significant##31##3##(1993-1#1)(1994-12#2)(1995-2#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-6#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#2)(2009-11#1)(2009-6#1)(2011-12#1)(2011-2#3)(2012-3#1)(2012-5#1)(2013-1#1)
show a significantly##3##3##(1992-8#1)(1997-7#1)(2007-11#1)
show a similar##5##3##(1997-7#1)(2006-6#1)(2008-1#1)(2008-6#1)(2010-5#1)
show a similarity between##2##4##(2007-7#1)(2011-1#1)
show a slight##3##3##(2007-3#1)(2008-3#1)(2008-5#1)
show a slightly##2##3##(1997-5#1)(2013-1#1)
show a small but##2##4##(2008-2#1)(2008-7#1)
show a somewhat##2##3##(2005-11#1)(2008-10#1)
show a statistically significant##4##4##(1991-9#1)(1992-7#1)(2007-6#1)(2011-2#1)
show a statistically##5##3##(1991-9#1)(1992-7#1)(1997-5#1)(2007-6#1)(2011-2#1)
show a strong correlation between##2##5##(2008-3#1)(2009-10#1)
show a strong correlation with the##2##6##(2005-11#1)(2008-3#1)
show a strong correlation##4##4##(2005-11#1)(2008-3#2)(2009-10#1)
show a strong##11##3##(1990-2#1)(1994-3#1)(1997-8#1)(2005-11#1)(2007-5#1)(2008-10#1)(2008-3#2)(2008-5#1)(2009-10#1)(2009-12#1)
show a substantial##2##3##(2007-12#1)(2008-3#1)
show a sufficient antimicrobial effect##3##5##(2008-5#3)
show a susceptibility##2##3##(1993-11#1)(2013-8#1)
show a tendency to##3##4##(2004-4#1)(2007-9#1)(2012-2#1)
show a time##2##3##(1991-5#1)(2008-3#1)
show a trend##2##3##(2008-7#1)(2013-8#1)
show a variety of##2##4##(2006-10#1)(2009-9#1)
show a very##2##3##(2007-12#1)(2013-8#1)
show a wide range of##2##5##(2008-1#1)(2011-2#1)
show a wide##3##3##(2008-1#1)(2011-2#2)
show a##422##2##(1990-11#2)(1990-2#4)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#1)(1990-9#1)(1991-1#3)(1991-10#1)(1991-3#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#3)(1992-1#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#5)(1992-8#2)(1992-9#4)(1993-1#1)(1993-11#4)(1993-3#1)(1993-5#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#5)(1994-2#6)(1994-3#3)(1994-5#3)(1994-6#2)(1994-8#1)(1994-9#3)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#2)(1996-9#1)(1997-1#2)(1997-3#3)(1997-5#3)(1997-6#4)(1997-7#5)(1997-8#2)(2004-4#3)(2004-9#3)(2005-11#16)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#10)(2006-11#4)(2006-12#3)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#10)(2007-2#1)(2007-3#3)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#6)(2008-10#29)(2008-11#12)(2008-12#6)(2008-2#11)(2008-3#15)(2008-4#3)(2008-5#21)(2008-6#5)(2008-7#15)(2008-8#2)(2008-9#5)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#3)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#1)(2010-9#1)(2011-1#7)(2011-12#2)(2011-2#12)(2012-1#4)(2012-12#5)(2012-2#4)(2012-3#4)(2012-5#1)(2013-1#5)(2013-8#7)
show abnormalities in##2##3##(1996-7#1)(2008-8#1)
show accelerated##2##2##(2011-2#1)(2013-8#1)
show activity against##2##3##(1992-6#1)(2008-5#1)
show additional##3##2##(1993-8#1)(2008-5#1)(2009-8#1)
show age-related##2##2##(1992-7#1)(2009-4#1)
show agonist##2##2##(1990-8#1)(1992-3#1)
show also that##3##3##(1996-8#1)(2007-11#1)(2008-10#1)
show also##4##2##(1996-8#1)(1997-3#1)(2007-11#1)(2008-10#1)
show altered##2##2##(2008-3#1)(2009-6#1)
show an almost##3##3##(1991-7#1)(2007-11#1)(2008-12#1)
show an association between##5##4##(1990-8#1)(1992-5#1)(2008-2#1)(2011-2#1)(2013-8#1)
show an association##7##3##(1990-8#1)(1992-5#1)(2007-7#1)(2008-2#1)(2011-2#1)(2012-2#1)(2013-8#1)
show an average##2##3##(2008-10#1)(2008-2#1)
show an enhancement of##2##4##(2008-2#1)(2008-9#1)
show an important##3##3##(1995-12#1)(2008-10#1)(2013-1#1)
show an improvement##3##3##(1992-9#1)(2008-2#1)(2012-1#1)
show an increase in##4##4##(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)
show an increase##6##3##(1996-3#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-8#1)
show an increased##6##3##(1994-10#1)(1994-5#1)(1997-6#1)(2008-4#1)(2008-6#1)(2013-1#1)
show an increasing##2##3##(2008-7#1)(2008-8#1)
show an interaction between##2##4##(2009-8#1)(2012-1#1)
show an interaction##3##3##(2009-8#1)(2012-1#1)(2013-8#1)
show an overall##4##3##(2008-1#1)(2008-10#1)(2010-12#1)(2011-2#1)
show an unexpected##2##3##(1994-6#1)(2008-3#1)
show an##92##2##(1990-10#1)(1990-8#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-10#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-3#1)(1997-6#1)(2006-5#1)(2007-11#5)(2007-12#6)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-12#2)(2008-2#6)(2008-3#5)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#2)(2009-5#2)(2009-8#2)(2010-10#1)(2010-12#1)(2010-5#2)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
show analytically the existence of##2##5##(2007-11#1)(2007-12#1)
show analytically##3##2##(2007-11#1)(2007-12#1)(2008-8#1)
show any beneficial##2##3##(2008-3#1)(2010-2#1)
show any benefit##2##3##(1990-6#1)(2006-10#1)
show any change in the##2##5##(1990-5#1)(2011-2#1)
show any change##5##3##(1990-5#1)(2007-7#2)(2011-2#1)(2013-8#1)
show any effect on##2##4##(1997-6#1)(2005-8#1)
show any effect##3##3##(1997-6#1)(2005-8#1)(2008-8#1)
show any relationship##2##3##(1991-9#1)(2007-6#1)
show any significant difference between##3##5##(2005-10#2)(2007-2#1)
show any significant difference##5##4##(2005-10#2)(2007-2#1)(2007-8#1)(2013-1#1)
show any significant##23##3##(1992-11#2)(1993-12#1)(1994-5#1)(1995-6#1)(1996-9#1)(1997-2#1)(1997-8#1)(2005-10#2)(2006-12#1)(2007-2#2)(2007-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
show any statistical##2##3##(2008-7#1)(2010-4#1)
show any##117##2##(1990-11#1)(1990-2#3)(1990-3#2)(1990-5#2)(1990-6#1)(1991-5#2)(1991-9#2)(1992-11#2)(1992-4#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#3)(2005-10#2)(2005-11#2)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#2)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#10)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-2#1)(2010-4#4)(2010-5#1)(2010-6#2)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
show approximately##4##2##(1991-10#1)(1992-8#1)(2007-9#1)(2008-4#1)
show areas of##2##3##(2007-10#1)(2010-12#1)
show at##3##2##(1994-6#1)(2008-3#1)(2010-6#1)
show better##4##2##(2008-10#1)(2008-2#1)(2011-1#1)(2013-1#1)
show both##11##2##(1990-3#1)(1996-3#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-8#1)(2009-10#1)(2011-2#1)
show by##16##2##(1990-12#1)(1991-2#1)(1991-3#1)(1994-11#1)(1995-1#1)(1995-8#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-12#3)
show can##2##2##(1990-5#1)(1993-3#1)
show changes in the##3##4##(1994-3#1)(1996-4#1)(2008-7#1)
show changes in##4##3##(1991-3#1)(1994-3#1)(1996-4#1)(2008-7#1)
show clear##2##2##(2011-2#1)(2013-7#1)
show clearly that##7##3##(1991-5#1)(1995-6#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)
show clearly##9##2##(1991-5#1)(1995-6#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
show clinical##9##2##(1995-1#1)(2005-7#1)(2006-10#1)(2007-1#1)(2007-7#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
show comparable##2##2##(2012-2#1)(2013-1#1)
show complete##4##2##(1992-4#1)(1995-6#1)(2008-2#1)(2012-11#1)
show considerable##6##2##(1991-9#1)(1995-2#1)(2007-11#1)(2008-5#2)(2012-2#1)
show consistent##4##2##(2010-10#2)(2010-2#1)(2011-1#1)
show correction##2##2##(2007-12#2)
show decreased##3##2##(1994-9#1)(2006-9#1)(2013-1#1)
show decreasing##2##2##(1996-2#1)(2008-3#1)
show differences in##4##3##(1994-9#1)(1997-3#1)(2008-10#1)(2013-1#1)
show differences##6##2##(1994-9#1)(1997-3#1)(2007-8#1)(2008-10#2)(2013-1#1)
show different patterns##2##3##(2008-8#1)(2009-11#1)
show different##23##2##(1991-11#1)(1991-5#2)(1994-3#1)(1995-6#1)(2004-4#1)(2005-11#2)(2007-11#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-11#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)
show differential##4##2##(1994-12#1)(1996-10#1)(2011-2#1)(2013-8#1)
show direct##3##2##(1994-9#1)(2008-5#1)(2008-7#1)
show directional##2##2##(2007-12#1)(2008-10#1)
show dissociative##2##2##(1992-10#1)(2006-3#1)
show distinct##8##2##(1997-4#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-3#1)(2008-5#1)(2012-2#1)(2013-8#1)
show dramatic##4##2##(1992-12#1)(1995-9#1)(1996-3#1)(2013-1#1)
show early##3##2##(1990-10#1)(1997-2#1)(2008-1#1)
show either##6##2##(1996-3#1)(1997-1#1)(2008-10#1)(2008-9#1)(2009-5#1)(2012-2#1)
show elevated##3##2##(1997-5#1)(2008-11#1)(2011-2#1)
show encouraging results##2##3##(1997-1#1)(2006-10#1)
show encouraging##3##2##(1997-1#1)(2006-10#1)(2012-1#1)
show enhanced##9##2##(1994-3#1)(1997-4#1)(1997-5#1)(2005-11#1)(2007-12#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-12#1)
show enough##2##2##(2007-11#1)(2008-5#1)
show equivalent##2##2##(2005-7#1)(2007-12#1)
show even greater##2##3##(1996-5#1)(2006-12#1)
show even##3##2##(1990-12#1)(1996-5#1)(2006-12#1)
show evidence for the##2##4##(2005-7#1)(2008-2#1)
show evidence for##3##3##(2005-7#1)(2008-2#1)(2013-1#1)
show evidence of##15##3##(1990-8#1)(1993-6#1)(1997-3#1)(2006-12#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)
show evidence##19##2##(1990-8#1)(1993-6#1)(1997-3#1)(2005-11#1)(2005-7#1)(2006-12#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
show excellent agreement with##2##4##(2007-9#1)(2008-3#1)
show excellent agreement##5##3##(2007-9#1)(2008-2#2)(2008-3#2)
show excellent##14##2##(2005-7#1)(2006-8#1)(2007-9#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2010-1#1)(2011-2#1)
show experimental results##2##3##(2008-2#1)(2008-3#1)
show experimental##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
show experimentally that the##3##4##(2007-11#1)(2007-12#1)(2008-1#1)
show experimentally that##8##3##(2007-11#2)(2007-12#3)(2008-1#1)(2008-2#1)(2009-11#1)
show experimentally##9##2##(2007-11#2)(2007-12#4)(2008-1#1)(2008-2#1)(2009-11#1)
show extensive##2##2##(1995-11#1)(1995-8#1)
show feasibility##2##2##(2007-8#1)(2013-1#1)
show fluorescence##2##2##(1991-9#1)(2008-2#1)
show for the first time that the##3##7##(1992-11#1)(1997-1#1)(2011-2#1)
show for the first time that##7##6##(1990-9#1)(1992-11#1)(1995-12#1)(1997-1#1)(2009-8#1)(2011-2#1)(2012-12#1)
show for the first time##13##5##(1990-9#1)(1992-11#1)(1995-11#1)(1995-12#1)(1996-8#1)(1997-1#1)(2009-8#1)(2011-2#1)(2012-12#3)(2012-2#2)
show for##17##2##(1990-9#1)(1992-10#1)(1992-11#1)(1995-10#1)(1995-11#1)(1995-12#1)(1996-11#1)(1996-8#1)(1997-1#1)(2007-9#1)(2009-8#1)(2011-2#1)(2012-12#3)(2012-2#2)
show functional##2##2##(1993-12#1)(2008-10#1)
show further that##2##3##(2008-8#1)(2011-2#1)
show further##3##2##(1992-11#1)(2008-8#1)(2011-2#1)
show good agreement between##3##4##(2007-12#2)(2008-2#1)
show good agreement for##2##4##(2008-2#2)
show good agreement of##2##4##(2008-10#1)(2008-3#1)
show good agreement with the measured##2##6##(1996-12#1)(2008-2#1)
show good agreement with the theory##2##6##(2007-12#1)(2008-3#1)
show good agreement with the##9##5##(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)
show good agreement with those##2##5##(2007-12#1)(2011-12#1)
show good agreement with##18##4##(1996-11#1)(1996-12#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#3)(2008-3#4)(2008-7#1)(2010-2#1)(2011-12#1)
show good agreement##32##3##(1996-11#1)(1996-12#1)(2007-11#1)(2007-12#6)(2008-10#4)(2008-2#8)(2008-3#8)(2008-7#1)(2010-2#1)(2011-12#1)
show good correlation with##3##4##(2007-11#1)(2007-12#1)(2008-10#1)
show good##46##2##(1992-7#1)(1994-9#1)(1996-11#1)(1996-12#1)(1997-2#1)(2007-11#2)(2007-12#7)(2007-9#1)(2008-10#7)(2008-2#10)(2008-3#9)(2008-7#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-12#1)
show great##5##2##(1994-12#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
show greater##4##2##(1990-2#1)(2008-11#2)(2008-5#1)
show here how##3##3##(2009-6#1)(2012-11#2)
show here that##55##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-12#1)(1991-5#2)(1991-7#1)(1992-11#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-5#5)(1996-7#2)(1996-8#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-5#1)(2010-11#1)(2010-12#1)(2010-4#1)(2012-12#4)(2012-2#1)
show here##63##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-12#1)(1991-5#2)(1991-7#1)(1992-11#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-5#5)(1996-7#2)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2012-11#2)(2012-12#4)(2012-2#1)
show herein that##3##3##(1994-8#1)(1995-1#1)(1997-4#1)
show high affinity##2##3##(1992-5#1)(2008-4#1)
show high potential for##2##4##(2011-2#2)
show high##19##2##(1990-5#1)(1991-6#1)(1992-5#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
show higher##8##2##(1994-2#1)(1997-7#1)(2008-10#1)(2008-5#3)(2008-8#1)(2012-2#1)
show homology to##2##3##(1992-5#1)(2009-10#1)
show how a WDM##2##4##(2008-2#2)
show how a##11##3##(1996-3#1)(2007-11#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)
show how an##2##3##(2008-2#1)(2008-3#1)
show how it is##2##4##(2008-10#1)(2008-11#1)
show how it##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
show how migration##2##3##(2008-8#2)
show how such##5##3##(2005-11#1)(2007-11#1)(2008-11#1)(2008-3#1)(2012-2#1)
show how the##34##3##(1991-1#1)(1994-6#1)(1997-7#1)(2007-10#1)(2007-12#4)(2007-8#1)(2008-10#4)(2008-2#5)(2008-3#5)(2008-5#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-2#1)(2010-4#1)(2012-1#2)(2012-2#3)
show how these new##2##4##(2008-2#1)(2008-3#1)
show how these##7##3##(2006-3#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2013-8#1)
show how they##4##3##(1991-3#1)(2006-5#1)(2007-12#1)(2008-2#1)
show how this approach can##3##5##(1993-9#1)(2006-3#1)(2008-9#1)
show how this##12##3##(1993-9#1)(2006-3#1)(2006-5#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#2)(2011-1#1)(2013-1#1)
show how to estimate the##2##5##(1996-8#1)(2008-10#1)
show how to quantify the##2##5##(2006-7#1)(2008-10#1)
show how to use##4##4##(1993-12#1)(1997-3#1)(2008-11#1)(2008-3#1)
show how to##32##3##(1993-12#1)(1995-12#1)(1996-8#1)(1997-3#1)(2005-11#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-2#3)(2008-3#8)(2008-4#2)(2008-6#1)(2009-12#1)
show how##161##2##(1991-1#1)(1991-12#1)(1991-3#1)(1993-12#1)(1993-2#1)(1993-9#2)(1994-6#1)(1995-12#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-11#3)(2005-8#1)(2006-12#2)(2006-3#2)(2006-4#1)(2006-5#2)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#8)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#9)(2008-11#9)(2008-2#23)(2008-3#20)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#7)(2008-9#3)(2009-11#2)(2009-12#3)(2009-2#1)(2009-5#2)(2010-1#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-4#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-2#5)(2013-1#6)(2013-8#1)
show identical##2##2##(1994-8#1)(1995-3#1)
show impaired##2##2##(1996-7#1)(2009-2#1)
show important##4##2##(2008-5#2)(2010-5#1)(2012-9#1)
show improved##3##2##(2005-11#1)(2006-2#1)(2009-10#1)
show improvement in##2##3##(2007-8#1)(2008-3#1)
show improvement##3##2##(2007-8#1)(2008-11#1)(2008-3#1)
show in##15##2##(1990-10#1)(1991-9#1)(1995-12#1)(1997-4#1)(2007-11#2)(2008-2#1)(2008-3#1)(2008-8#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-12#2)
show incomplete##2##2##(2006-10#1)(2012-2#1)
show increase##2##2##(2007-6#1)(2013-1#1)
show increased##18##2##(1992-2#1)(1992-8#1)(1995-1#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#1)(1997-1#1)(1997-5#1)(1997-7#1)(2008-11#2)(2010-11#2)(2010-4#1)(2011-10#1)(2012-12#1)(2012-2#1)
show inhibitory activities##2##3##(2008-10#1)(2011-3#1)
show inhibitory##3##2##(2008-10#1)(2008-5#1)(2011-3#1)
show interesting##4##2##(1995-11#1)(2006-10#1)(2007-8#1)(2008-2#1)
show interfacial stability##2##3##(2012-11#2)
show ionic##2##2##(1992-3#1)(2008-10#1)
show it to be##2##4##(1990-7#1)(1993-9#1)
show it##3##2##(1990-7#1)(1993-9#1)(2010-4#1)
show its##8##2##(1994-6#1)(2006-2#1)(2006-4#1)(2008-2#3)(2010-1#1)(2012-12#1)
show large##5##2##(1994-2#1)(2008-2#1)(2010-8#1)(2012-2#1)(2013-8#1)
show less than##2##3##(1995-12#1)(2008-2#1)
show less##7##2##(1995-12#1)(2007-6#1)(2008-10#1)(2008-2#1)(2009-6#1)(2009-8#1)(2011-2#1)
show linear##2##2##(1996-2#1)(2008-10#1)
show little##6##2##(1991-8#1)(1994-2#1)(1995-11#2)(2005-11#1)(2009-10#1)
show low##5##2##(1995-5#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-2#1)
show lower##4##2##(2006-10#1)(2008-5#1)(2008-7#1)(2012-2#1)
show marked##5##2##(1992-9#2)(2007-11#1)(2008-7#1)(2010-3#1)
show minimal##2##2##(1990-8#1)(2004-9#1)
show moderate to##2##3##(2007-12#1)(2008-5#1)
show moderate##4##2##(2007-12#1)(2007-5#1)(2008-5#1)(2009-10#1)
show more##11##2##(1992-3#1)(1993-3#1)(1994-9#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#2)
show much lower##2##3##(1990-11#1)(1990-12#1)
show much weaker##2##3##(2005-10#1)(2008-8#1)
show much##7##2##(1990-11#1)(1990-12#1)(1995-8#1)(2005-10#1)(2008-10#1)(2008-8#1)(2012-2#1)
show nearly##2##2##(1990-10#1)(2011-1#1)
show negligible##3##2##(1990-8#1)(2008-10#2)
show new##2##2##(2006-6#1)(2009-8#1)
show no evidence for##2##4##(1994-9#1)(1996-5#1)
show no evidence of##5##4##(1993-11#1)(2008-10#1)(2008-2#1)(2008-6#1)(2010-8#1)
show no evidence##7##3##(1993-11#1)(1994-9#1)(1996-5#1)(2008-10#1)(2008-2#1)(2008-6#1)(2010-8#1)
show no increase in##2##4##(2006-10#1)(2008-3#1)
show no significant difference##2##4##(2007-4#1)(2007-6#1)
show no significant##6##3##(1994-5#1)(1995-9#1)(1997-4#1)(2007-4#1)(2007-6#1)(2008-5#1)
show no signs of##2##4##(1995-5#1)(2008-9#1)
show no symptoms##2##3##(2006-4#1)(2010-7#1)
show no##50##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-4#1)(1993-11#2)(1993-6#1)(1994-12#1)(1994-5#1)(1994-9#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-6#1)(2007-9#1)(2008-10#5)(2008-2#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
show non-linear##2##2##(2008-10#1)(2008-7#1)
show normal##3##2##(1993-6#1)(1994-12#1)(2007-8#1)
show normal-incidence##2##2##(2007-12#1)(2008-2#1)
show not only##2##3##(2008-2#1)(2008-3#1)
show on##2##2##(1996-3#1)(2007-11#1)
show only##5##2##(1994-9#1)(1995-8#1)(1996-11#1)(2007-11#1)(2008-7#1)
show optimal##2##2##(2006-9#1)(2008-10#1)
show overall##2##2##(2008-3#1)(2010-4#1)
show overlap##2##2##(2008-10#1)(2011-2#1)
show polymorphism##2##2##(1992-4#1)(2008-8#1)
show poor##2##2##(1991-6#1)(2010-12#1)
show positive##5##2##(2007-2#1)(2008-5#1)(2010-3#1)(2013-7#1)(2013-8#1)
show potent##3##2##(2007-11#1)(2011-3#1)(2012-12#1)
show potential for##2##3##(2008-3#1)(2012-2#1)
show potential##4##2##(2008-10#1)(2008-3#1)(2009-1#1)(2012-2#1)
show promise as##4##3##(2006-11#1)(2009-5#1)(2010-2#1)(2010-5#1)
show promise for##7##3##(2007-4#1)(2008-2#2)(2008-4#1)(2008-7#1)(2011-2#1)(2012-1#1)
show promise in##3##3##(1996-5#1)(2006-1#1)(2010-10#1)
show promise##16##2##(1996-5#1)(2006-1#1)(2006-10#1)(2006-11#1)(2007-4#1)(2008-1#1)(2008-2#2)(2008-4#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-1#1)
show promising results in##4##4##(1993-3#1)(1996-12#1)(2013-1#2)
show promising##7##2##(1993-3#1)(1996-12#1)(2006-10#1)(2008-2#1)(2008-5#1)(2013-1#2)
show qualitatively##2##2##(1995-11#1)(2006-11#1)
show quantitative##2##2##(1993-12#1)(2008-3#1)
show rapid##4##2##(1990-7#1)(2008-4#1)(2008-7#1)(2009-10#1)
show rather##2##2##(1991-11#1)(2010-4#1)
show recovery##2##2##(2005-8#1)(2007-12#1)
show reduced##8##2##(1995-11#1)(2006-5#1)(2007-11#1)(2008-4#2)(2008-7#1)(2010-2#1)(2012-3#1)
show relative standard deviations##2##4##(1997-2#1)(2008-10#1)
show relative##3##2##(1997-2#1)(2008-10#1)(2008-5#1)
show relatively high##3##3##(1994-2#1)(2010-12#2)
show relatively##5##2##(1994-2#1)(2008-5#1)(2010-12#3)
show reliable##3##2##(2008-4#1)(2013-1#2)
show remarkable##4##2##(1990-7#1)(2007-10#1)(2008-10#1)(2012-3#1)
show resistance to##2##3##(2008-10#1)(2011-1#1)
show rms##2##2##(2008-2#1)(2008-3#1)
show selective##3##2##(2006-10#1)(2007-8#1)(2011-2#1)
show selectivity##2##2##(1992-5#1)(2008-10#1)
show severe##4##2##(1995-1#1)(1997-2#1)(2008-10#1)(2008-11#1)
show significant alteration##2##3##(1996-1#1)(2008-11#1)
show significant changes##4##3##(1990-7#1)(1992-3#1)(1996-1#1)(2012-2#1)
show significant difference in the##2##5##(2007-9#1)(2008-10#1)
show significant difference##5##3##(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#1)(2011-2#1)
show significant differences between the##3##5##(1995-10#1)(2011-2#1)(2013-7#1)
show significant differences between##4##4##(1995-10#1)(2010-4#1)(2011-2#1)(2013-7#1)
show significant differences in the##2##5##(2006-8#1)(2009-9#1)
show significant differences in##6##4##(1996-4#1)(2006-8#1)(2008-10#1)(2009-9#1)(2013-1#2)
show significant differences with##2##4##(1995-12#1)(2006-11#1)
show significant differences##16##3##(1991-7#1)(1995-10#1)(1995-12#1)(1996-4#1)(2004-11#1)(2006-11#1)(2006-8#1)(2007-10#1)(2008-10#1)(2009-9#1)(2010-4#1)(2011-2#2)(2013-1#2)(2013-7#1)
show significant improvement##3##3##(2006-2#1)(2007-12#1)(2008-2#1)
show significant improvements in##2##4##(2008-3#1)(2009-8#1)
show significant in vitro##2##4##(2007-11#1)(2009-3#1)
show significant##78##2##(1990-6#1)(1990-7#2)(1991-12#1)(1991-7#1)(1992-3#1)(1993-11#1)(1994-11#1)(1994-9#1)(1995-10#1)(1995-12#2)(1995-2#1)(1996-1#2)(1996-12#1)(1996-4#2)(1997-1#1)(1997-3#2)(2004-11#1)(2005-11#1)(2006-11#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#2)(2007-9#2)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-4#1)(2011-2#5)(2012-11#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#9)
show significantly reduced##2##3##(1995-10#1)(1997-7#1)
show significantly##8##2##(1991-8#1)(1992-1#1)(1995-10#1)(1997-7#1)(2006-2#1)(2007-12#1)(2008-5#2)
show signs of##9##3##(2006-10#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-4#1)(2011-12#1)
show signs##11##2##(2006-10#1)(2006-8#1)(2006-9#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-5#1)(2011-12#1)
show similar patterns of##2##4##(1996-12#1)(2012-3#1)
show similar##19##2##(1991-12#1)(1991-9#1)(1992-6#1)(1993-7#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-9#1)(1996-12#1)(1997-6#1)(2005-11#1)(2007-9#1)(2008-5#1)(2009-4#1)(2009-8#1)(2012-3#1)(2012-8#1)(2013-1#1)
show similarity##4##2##(1990-1#1)(1995-2#1)(1995-5#1)(1995-6#1)
show simple##3##2##(1990-7#1)(1995-2#1)(2008-2#1)
show slight##4##2##(1990-2#1)(1993-7#1)(1994-5#1)(2008-5#1)
show small event complexity##2##4##(1996-4#2)
show small##3##2##(1992-7#1)(1996-4#2)
show some of the##2##4##(2007-8#1)(2009-10#1)
show some of##3##3##(2007-8#1)(2008-11#1)(2009-10#1)
show some similarities to##3##4##(1992-12#1)(1996-10#1)(1996-2#1)
show some##25##2##(1990-11#1)(1990-8#1)(1992-12#1)(1994-5#1)(1994-6#1)(1996-10#1)(1996-2#1)(1997-6#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
show spatial##2##2##(2004-4#1)(2011-1#1)
show specific##5##2##(1995-12#1)(1997-4#1)(2012-12#3)
show spontaneous resolution##2##3##(2008-12#2)
show spontaneous##6##2##(1997-1#1)(2008-11#1)(2008-12#2)(2009-8#1)(2010-8#1)
show stable##2##2##(2008-3#2)
show statistical significance##2##3##(2009-3#1)(2011-1#1)
show statistical##3##2##(2008-10#1)(2009-3#1)(2011-1#1)
show statistically##3##2##(1994-8#1)(2008-8#1)(2010-5#1)
show striking similarities##2##3##(2009-4#1)(2009-5#1)
show strong##18##2##(1990-12#1)(1990-3#1)(1994-3#1)(1995-2#1)(1996-5#1)(2005-11#1)(2006-12#1)(2007-11#3)(2007-12#1)(2007-4#1)(2008-10#1)(2008-8#1)(2009-5#2)(2009-6#1)(2011-2#1)
show strongly##2##2##(1995-8#1)(2008-8#1)
show substantial differences in##2##4##(2007-11#1)(2008-3#1)
show substantial##3##2##(1990-5#1)(2007-11#1)(2008-3#1)
show substantially##2##2##(1996-11#1)(2006-5#1)
show such##4##2##(1991-10#1)(1992-3#1)(1995-2#1)(1995-3#1)
show sufficient##3##2##(1994-6#1)(1996-1#1)(2012-2#1)
show superior##4##2##(2009-8#1)(2011-12#1)(2012-2#1)(2012-3#1)
show symptoms of a##2##4##(1996-6#1)(2007-8#1)
show symptoms of##3##3##(1996-6#1)(2007-7#1)(2007-8#1)
show symptoms##4##2##(1996-6#1)(2007-7#1)(2007-8#1)(2011-2#1)
show that (1)##3##3##(1996-3#1)(2008-3#1)(2009-9#1)
show that (a)##2##3##(2007-12#1)(2009-6#1)
show that (i)##2##3##(1995-2#1)(1996-4#1)
show that 2##3##3##(2008-11#1)(2008-8#1)(2011-2#1)
show that A##2##3##(2008-10#1)(2008-5#1)
show that C##2##3##(2008-10#1)(2013-1#1)
show that CBF-C##2##3##(1995-2#2)
show that CsA##2##3##(1994-8#2)
show that D##2##3##(1995-2#1)(2007-3#1)
show that DNA##3##3##(1993-6#1)(1997-7#1)(2008-7#1)
show that G##4##3##(1992-9#1)(1996-2#1)(2008-3#1)(2010-8#1)
show that GC7##2##3##(1997-1#2)
show that HLH-29##4##3##(2012-12#4)
show that I##2##3##(1995-2#1)(2008-10#1)
show that Medicare##2##3##(2007-2#1)(2010-2#1)
show that T##4##3##(1990-6#1)(1996-2#1)(2008-10#1)(2013-8#1)
show that TGF-beta increases##2##4##(1993-12#2)
show that TPA##2##3##(1991-7#1)(1992-9#1)
show that a critical##2##4##(1994-2#1)(2010-7#1)
show that a large##2##4##(2007-4#1)(2009-6#1)
show that a number of##2##5##(1995-8#1)(2009-4#1)
show that a phase##2##4##(2008-2#2)
show that a reduction##2##4##(2008-9#1)(2011-2#1)
show that a single##7##4##(1990-11#1)(1993-4#1)(1995-11#1)(2006-6#1)(2007-12#1)(2008-7#1)(2011-1#1)
show that a##113##3##(1990-11#4)(1990-12#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-8#1)(1993-4#1)(1993-8#1)(1994-2#3)(1994-6#1)(1994-9#2)(1995-11#1)(1995-8#2)(1996-12#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-9#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#4)(2007-12#12)(2007-4#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-2#7)(2008-3#11)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#3)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#2)
show that accurate##2##3##(1996-6#1)(2006-8#1)
show that activation of##5##4##(1994-2#1)(1995-2#1)(1995-3#1)(2008-4#1)(2011-2#1)
show that activity##3##3##(1990-6#1)(2008-11#1)(2008-2#1)
show that acute##2##3##(1995-12#1)(2008-10#1)
show that adipocyte##2##3##(1994-11#1)(2008-3#1)
show that all of##3##4##(1995-7#1)(1995-9#1)(2007-11#1)
show that all the##4##4##(1992-11#1)(1992-3#1)(2007-12#1)(2008-2#1)
show that all three##2##4##(1991-1#1)(2008-5#1)
show that all##15##3##(1990-12#1)(1991-1#1)(1992-11#1)(1992-3#1)(1993-4#1)(1995-7#1)(1995-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-5#1)(2009-8#2)(2009-9#1)
show that although the##3##4##(1990-7#1)(1995-11#1)(2013-7#1)
show that although##7##3##(1990-7#1)(1995-1#1)(1995-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2013-7#1)
show that an##21##3##(1990-5#1)(1992-8#1)(1994-2#1)(1994-3#2)(1996-11#1)(1997-8#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-7#1)(2009-1#1)(2010-12#1)(2011-2#1)(2012-3#1)
show that approximately##3##3##(1993-9#1)(1994-9#1)(2013-1#1)
show that at least##5##4##(1992-3#1)(1994-3#1)(1995-5#1)(2008-1#1)(2008-10#1)
show that at##12##3##(1992-3#1)(1994-3#1)(1995-11#1)(1995-5#1)(2004-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)(2012-3#1)(2013-8#1)
show that beta-CD reacts with##2##5##(2008-10#2)
show that binding of##2##4##(1994-9#1)(1997-6#1)
show that bombesin##3##3##(1991-7#1)(1997-7#2)
show that bone##2##3##(2010-10#1)(2013-1#1)
show that both the phosphorylated and dephosphorylated forms of##2##9##(1990-8#1)(1997-2#1)
show that both the##7##4##(1990-8#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2012-12#1)
show that both##39##3##(1990-8#1)(1991-11#1)(1991-9#2)(1992-1#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-8#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#1)(2006-11#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-2#3)(2008-3#2)(2008-8#1)(2009-10#1)(2010-3#1)(2010-7#1)(2011-12#1)(2012-1#2)(2012-12#2)
show that by##9##3##(1996-7#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)
show that carbon##2##3##(2008-7#1)(2012-2#1)
show that cells##3##3##(1993-6#1)(1995-6#1)(2011-2#1)
show that certain##3##3##(1997-4#1)(2008-12#1)(2008-5#1)
show that changes in##5##4##(1991-1#1)(1994-2#1)(1995-12#1)(2008-3#1)(2012-1#1)
show that changes##6##3##(1991-1#1)(1994-2#1)(1995-12#1)(2008-11#1)(2008-3#1)(2012-1#1)
show that children##3##3##(1994-6#1)(2005-10#1)(2007-2#1)
show that copper##2##3##(1995-11#1)(2008-5#1)
show that dental##2##3##(2007-1#1)(2008-9#1)
show that depletion of##3##4##(1994-12#1)(2012-12#2)
show that differences##2##3##(1993-1#1)(2009-5#1)
show that different##6##3##(1990-7#1)(1994-2#1)(2008-1#1)(2010-9#1)(2011-1#1)(2012-3#1)
show that dimerization of##2##4##(1992-12#1)(1995-5#1)
show that during##5##3##(1990-3#1)(1992-3#1)(1996-9#1)(2007-10#1)(2007-12#1)
show that each##4##3##(1996-9#1)(2007-7#1)(2008-3#1)(2008-6#1)
show that early##2##3##(1994-6#1)(1995-3#1)
show that even after##2##4##(1997-4#1)(2009-11#1)
show that even in the##2##5##(1994-12#1)(2008-9#1)
show that even##7##3##(1994-12#1)(1997-4#1)(2007-12#1)(2008-7#1)(2008-9#1)(2009-11#1)(2012-1#1)
show that exogenous##3##3##(1990-2#1)(1996-10#1)(1996-2#1)
show that expression of the##2##5##(1994-9#1)(1997-4#1)
show that expression of##5##4##(1994-9#1)(1995-1#1)(1996-9#1)(1997-4#1)(2011-2#1)
show that family##2##3##(1997-8#1)(2009-12#1)
show that female##2##3##(1995-3#1)(2012-3#1)
show that finite##2##3##(2007-12#1)(2008-8#1)
show that fluorescence##2##3##(2008-2#1)(2010-2#1)
show that for a##2##4##(2008-3#1)(2013-8#1)
show that for these##2##4##(2007-2#1)(2008-9#1)
show that for##14##3##(1996-8#1)(2007-12#3)(2007-2#1)(2008-2#2)(2008-3#5)(2008-9#1)(2013-8#1)
show that further##2##3##(1994-9#1)(2008-5#1)
show that good##2##3##(2008-2#1)(2008-3#1)
show that heparin##2##3##(1993-8#1)(1995-5#1)
show that hepoxilin A3##2##4##(1990-9#1)(1991-8#1)
show that heterologous##2##3##(1990-10#1)(2013-1#1)
show that high concentrations of##2##5##(1994-12#1)(1994-5#1)
show that high##7##3##(1994-12#1)(1994-5#1)(2005-7#1)(2007-12#2)(2008-10#1)(2008-11#1)
show that higher##3##3##(1992-3#1)(2008-2#1)(2008-3#1)
show that highly##2##3##(1995-2#1)(2008-5#1)
show that human##8##3##(1991-9#1)(1994-3#1)(1995-11#1)(1995-8#1)(2004-9#1)(2008-5#1)(2009-12#1)(2009-4#1)
show that if the##4##4##(2007-12#2)(2008-2#1)(2008-3#1)
show that if##11##3##(2005-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-12#1)(2010-7#1)(2013-1#1)
show that in P##2##4##(1997-7#1)(2008-5#1)
show that in a##2##4##(1997-1#1)(2008-3#1)
show that in addition to the##3##6##(2008-10#1)(2012-12#2)
show that in addition to##6##5##(1992-6#1)(2008-10#1)(2012-12#2)(2013-1#2)
show that in practice##2##4##(2005-11#1)(2008-2#1)
show that in the##13##4##(1991-7#1)(1993-3#1)(1994-8#1)(1996-10#1)(1997-1#1)(2004-4#1)(2005-4#1)(2006-2#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-1#1)
show that in vitro##3##4##(1994-8#1)(1995-2#1)(2012-12#1)
show that in vivo##3##4##(1995-10#1)(1997-2#1)(2012-2#1)
show that in##67##3##(1990-11#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-7#2)(1992-6#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-12#1)(1994-4#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-1#2)(1997-2#1)(1997-7#2)(2004-4#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-3#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#3)
show that inclusion of##3##4##(1992-5#1)(2008-9#1)(2012-2#1)
show that increased##2##3##(2008-1#1)(2008-8#1)
show that increases in##2##4##(2008-10#1)(2011-2#1)
show that increasing##2##3##(2007-9#1)(2009-8#1)
show that individuals with##2##4##(2010-2#1)(2012-2#1)
show that inhibition of##2##4##(1995-3#1)(1997-5#1)
show that injection##2##3##(1992-9#1)(2007-12#1)
show that it can##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
show that it is a##2##5##(1992-7#1)(1994-6#1)
show that it is possible to derive##2##7##(2008-2#1)(2008-3#1)
show that it is possible to##13##6##(1990-5#1)(2008-10#1)(2008-2#5)(2008-3#3)(2008-4#1)(2009-2#1)(2011-1#1)
show that it is possible##16##5##(1990-5#1)(1994-6#1)(2007-12#1)(2008-10#1)(2008-2#6)(2008-3#3)(2008-4#1)(2009-2#1)(2011-1#1)
show that it is##33##4##(1990-5#1)(1992-7#1)(1994-6#2)(1995-1#1)(1995-10#1)(1995-3#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#8)(2008-3#4)(2008-4#2)(2009-2#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
show that it may be possible to##2##7##(1993-7#1)(2006-10#1)
show that it##52##3##(1990-5#1)(1990-6#1)(1992-7#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-6#2)(1995-1#1)(1995-10#1)(1995-3#1)(1995-6#1)(1996-3#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#4)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#9)(2008-3#6)(2008-4#2)(2009-10#1)(2009-2#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
show that its##5##3##(1992-2#1)(2005-8#1)(2007-11#1)(2009-5#1)(2010-5#1)
show that little or no##2##5##(1992-3#1)(1992-8#1)
show that little##3##3##(1992-3#1)(1992-8#1)(2011-1#1)
show that low##5##3##(1996-8#1)(2006-12#1)(2007-10#1)(2008-3#1)(2008-7#1)
show that male##2##3##(1993-8#1)(2011-2#1)
show that many of the features##2##6##(2007-12#1)(2008-3#1)
show that many of the##4##5##(2007-12#1)(2008-3#3)
show that many##8##3##(1992-6#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-3#3)
show that mean##2##3##(2010-4#1)(2011-2#1)
show that membrane##2##3##(2005-11#1)(2009-8#1)
show that more than##2##4##(1993-8#1)(2008-10#1)
show that more##3##3##(1993-8#1)(2008-10#1)(2010-12#1)
show that most##4##3##(1996-8#1)(2010-12#1)(2010-2#1)(2011-2#1)
show that mutant##2##3##(1991-5#1)(2006-12#1)
show that negative##2##3##(1990-8#1)(2010-10#1)
show that neither##2##3##(1991-3#1)(1993-12#1)
show that no##4##3##(1991-12#1)(1993-8#1)(2008-9#1)(2010-3#1)
show that normal##3##3##(1991-3#1)(1991-5#1)(1995-8#1)
show that not only##2##4##(1992-3#1)(2013-1#1)
show that nurses##2##3##(1992-3#1)(2007-10#1)
show that obesity##2##3##(2006-1#1)(2007-11#1)
show that of all##2##4##(2006-2#1)(2007-12#1)
show that of##3##3##(2006-2#1)(2007-12#1)(2013-8#1)
show that older adults##2##4##(2007-12#1)(2012-11#1)
show that one can##2##4##(2008-1#1)(2008-2#1)
show that one of##2##4##(1997-4#1)(2008-2#1)
show that one##7##3##(1991-4#1)(1995-5#1)(1997-4#2)(2008-1#1)(2008-2#2)
show that only a small##2##5##(1991-9#1)(2008-3#1)
show that only the##2##4##(1995-3#1)(2007-12#1)
show that only##9##3##(1990-12#1)(1991-9#1)(1995-3#1)(2006-12#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-3#2)
show that optical##2##3##(1992-4#1)(2007-12#1)
show that oral administration of##2##5##(2008-10#1)(2008-11#1)
show that oral##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
show that our algorithm##2##4##(2008-2#1)(2009-12#1)
show that our methods##3##4##(2012-3#1)(2013-1#2)
show that our##14##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-12#1)(2009-3#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#2)
show that overexpression of##2##4##(1996-5#1)(2003-11#1)
show that parasites##2##3##(2008-8#1)(2010-2#1)
show that particles##2##3##(2005-11#1)(2008-10#1)
show that pathogenic##2##3##(2008-10#1)(2008-7#1)
show that persons with##3##4##(1990-4#1)(1997-2#1)(2008-7#1)
show that plasma##2##3##(2007-9#1)(2012-2#1)
show that plasmids##2##3##(1994-12#1)(1996-7#1)
show that polystyrene##2##3##(2005-11#1)(2009-5#1)
show that population##3##3##(1993-1#1)(2008-8#1)(2010-5#1)
show that positive##4##3##(1994-12#1)(2008-9#1)(2011-12#1)(2012-3#1)
show that primary##2##3##(1991-5#1)(2006-4#1)
show that protein##4##3##(1990-7#1)(1992-7#1)(2009-6#1)(2012-3#1)
show that rat##2##3##(1993-3#1)(1993-8#1)
show that resistance##2##3##(1994-8#1)(2008-10#1)
show that resveratrol##2##3##(2008-5#1)(2009-12#1)
show that risk##2##3##(2007-8#1)(2012-11#1)
show that significant##2##3##(2007-11#1)(2008-8#1)
show that simultaneous##2##3##(2008-3#2)
show that single##3##3##(1993-1#1)(2007-12#1)(2008-3#1)
show that small##2##3##(1990-8#1)(2008-4#1)
show that some##7##3##(2008-10#1)(2008-7#1)(2008-9#2)(2012-12#1)(2012-2#2)
show that spatial##6##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#3)
show that species##3##3##(2008-8#1)(2009-8#1)(2012-6#1)
show that standard##3##3##(1995-3#1)(2008-2#1)(2011-2#1)
show that such a##4##4##(2007-11#1)(2008-11#1)(2008-2#1)(2012-2#1)
show that such##16##3##(2007-11#2)(2007-12#1)(2007-9#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-12#1)(2012-2#1)(2013-1#3)
show that tau##2##3##(1995-2#2)
show that temperature##2##3##(2008-10#1)(2008-2#1)
show that the &quot##2##4##(1994-8#1)(1994-9#1)
show that the Lee##2##4##(2008-2#2)
show that the STELLS algorithm is##2##6##(2012-3#2)
show that the absorption and scattering##2##6##(2008-3#1)(2009-12#1)
show that the activation of##2##5##(1990-8#1)(1997-4#1)
show that the activation##3##4##(1990-8#1)(1997-4#1)(2008-10#1)
show that the activity of the##2##6##(1993-12#1)(1995-3#1)
show that the activity of##3##5##(1993-12#1)(1995-3#1)(1997-2#1)
show that the addition of##2##5##(1996-1#1)(1996-11#1)
show that the algorithm can##2##5##(2006-10#1)(2008-2#1)
show that the algorithm##6##4##(2006-10#1)(2008-2#5)
show that the amount##2##4##(1990-1#1)(1990-5#1)
show that the analysis of##3##5##(2008-10#2)(2012-3#1)
show that the analysis##4##4##(2008-10#2)(2008-3#1)(2012-3#1)
show that the apparent##2##4##(1996-11#1)(1997-8#1)
show that the application of##2##5##(2008-11#1)(2008-3#1)
show that the behavior of##2##5##(1992-4#1)(2008-10#1)
show that the best##2##4##(2007-7#1)(2008-2#1)
show that the binding of##2##5##(1993-6#1)(1993-8#1)
show that the classic##2##4##(2008-5#1)(2008-8#1)
show that the combination##3##4##(1995-5#1)(2007-12#1)(2009-6#1)
show that the common##2##4##(1990-11#1)(2007-7#1)
show that the concentrations of##2##5##(2008-10#1)(2010-5#1)
show that the contribution to##2##5##(2008-2#2)
show that the contribution##3##4##(2008-2#2)(2008-3#1)
show that the conversion efficiency##2##5##(2007-12#1)(2008-2#1)
show that the conversion##3##4##(2007-12#2)(2008-2#1)
show that the crystal##2##4##(2013-1#1)(2013-8#1)
show that the decrease in##2##5##(1993-12#1)(2006-10#1)
show that the delivered##2##4##(1996-2#1)(2008-11#1)
show that the development of##2##5##(1995-1#1)(2009-3#1)
show that the differences in##2##5##(2008-2#1)(2012-2#1)
show that the differences##3##4##(2008-2#1)(2012-2#1)(2013-8#1)
show that the different##4##4##(1990-8#1)(1996-2#1)(2008-10#1)(2010-4#1)
show that the distribution##2##4##(1997-4#1)(2011-1#1)
show that the dynamic range##2##5##(2008-1#1)(2008-3#1)
show that the dynamic##3##4##(2008-1#1)(2008-3#1)(2012-2#1)
show that the effect of##3##5##(1997-6#1)(2007-12#1)(2008-8#1)
show that the effect##4##4##(1997-6#1)(2007-12#2)(2008-8#1)
show that the effects of##3##5##(2008-2#1)(2008-3#1)(2008-8#1)
show that the effects##4##4##(2008-2#1)(2008-3#2)(2008-8#1)
show that the enhancement##2##4##(1997-2#1)(2008-1#1)
show that the error##2##4##(2008-2#1)(2008-3#1)
show that the evolution of##2##5##(2008-8#1)(2012-3#1)
show that the experimental##4##4##(1997-7#1)(2005-11#1)(2008-2#1)(2008-3#1)
show that the expression of##4##5##(1992-6#1)(1994-6#1)(2010-2#1)(2011-1#1)
show that the expression##6##4##(1992-6#1)(1994-12#1)(1994-6#1)(2007-11#1)(2010-2#1)(2011-1#1)
show that the extent of##5##5##(1990-5#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-6#1)
show that the far-field##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
show that the fat##2##4##(1991-11#1)(2007-12#1)
show that the films##2##4##(2008-2#2)
show that the final##2##4##(2008-5#2)
show that the first##5##4##(1996-7#1)(2007-12#1)(2008-3#1)(2011-2#1)(2012-2#1)
show that the fluorescence##2##4##(1994-11#1)(2005-11#1)
show that the fraction of occupied##2##6##(2008-8#2)
show that the fraction of##4##5##(2007-12#1)(2008-10#1)(2008-8#2)
show that the gain##2##4##(2008-1#1)(2008-2#1)
show that the geometric##2##4##(2008-2#1)(2008-3#1)
show that the greater##2##4##(2005-11#1)(2009-8#1)
show that the heat##3##4##(1991-2#1)(2006-10#1)(2008-5#1)
show that the heterogeneity##2##4##(2008-8#1)(2009-4#1)
show that the high##2##4##(2007-11#1)(2008-4#1)
show that the highest##2##4##(2008-11#1)(2012-12#1)
show that the human##2##4##(1995-10#1)(1996-8#1)
show that the hybrid##2##4##(1995-8#1)(2013-7#1)
show that the information##2##4##(1997-8#1)(2008-3#1)
show that the inhibition of##2##5##(2008-11#1)(2008-5#1)
show that the inhibition##3##4##(1994-6#1)(2008-11#1)(2008-5#1)
show that the initial##4##4##(1994-5#1)(2007-12#2)(2008-3#1)
show that the interaction##2##4##(1994-6#1)(2008-8#1)
show that the introduction of##3##5##(2006-2#1)(2008-11#2)
show that the iron##2##4##(2008-10#1)(2010-2#1)
show that the latter##2##4##(2008-3#1)(2011-2#1)
show that the levels of##2##5##(1991-12#1)(1995-8#1)
show that the main##3##4##(1996-6#1)(2008-10#1)(2008-3#1)
show that the major##2##4##(1991-5#1)(1995-2#1)
show that the majority of##4##5##(2005-8#1)(2006-10#1)(2007-12#1)(2008-9#1)
show that the maximum##6##4##(2007-12#2)(2008-10#1)(2008-2#1)(2009-3#1)(2010-6#1)
show that the maximum-likelihood##2##4##(2008-2#1)(2010-6#1)
show that the mean##2##4##(2006-10#1)(2008-2#1)
show that the measured##2##4##(2007-12#1)(2008-3#1)
show that the method is##5##5##(2007-11#1)(2008-10#2)(2008-3#1)(2012-1#1)
show that the method##7##4##(2005-4#1)(2007-11#1)(2008-10#2)(2008-3#2)(2012-1#1)
show that the methods##2##4##(1995-9#1)(1996-12#1)
show that the model can##2##5##(2006-10#1)(2008-3#1)
show that the model##5##4##(2006-10#1)(2007-9#1)(2008-2#1)(2008-3#1)(2013-8#1)
show that the most frequent##2##5##(2011-2#1)(2012-2#1)
show that the most##3##4##(2010-8#1)(2011-2#1)(2012-2#1)
show that the new method##4##5##(2008-2#2)(2008-3#1)(2013-1#1)
show that the new##8##4##(2008-2#3)(2008-3#1)(2009-6#1)(2012-12#1)(2012-3#1)(2013-1#1)
show that the nonlinear##4##4##(2007-11#1)(2007-12#2)(2008-3#1)
show that the number of##5##5##(1995-12#1)(2006-10#1)(2007-9#1)(2008-3#1)(2011-2#1)
show that the number##6##4##(1995-12#1)(2006-10#1)(2007-9#1)(2008-3#2)(2011-2#1)
show that the observed##3##4##(1994-12#1)(1995-3#1)(1996-11#1)
show that the optical##6##4##(2007-12#1)(2008-2#3)(2008-3#1)(2013-8#1)
show that the optimal##4##4##(1996-8#1)(2008-10#1)(2008-3#2)
show that the oxidative##2##4##(2008-10#1)(2010-4#1)
show that the oxidized##2##4##(2007-12#1)(2008-10#1)
show that the performance##2##4##(2008-2#2)
show that the polarization##3##4##(1990-9#1)(2007-12#1)(2008-3#1)
show that the position of##2##5##(2007-11#1)(2007-12#1)
show that the presence of the##2##6##(2008-5#1)(2011-2#1)
show that the presence of##9##5##(1996-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-12#1)(2011-2#1)
show that the prevalence of##2##5##(2010-12#1)(2013-8#1)
show that the previously##2##4##(1990-5#1)(1995-9#1)
show that the probability of##2##5##(2007-5#1)(2011-2#1)
show that the proposed##21##4##(1995-9#1)(2008-2#9)(2008-3#2)(2008-7#1)(2009-9#1)(2010-8#3)(2012-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
show that the protein##4##4##(1990-5#1)(2008-11#1)(2012-12#2)
show that the quantitative##2##4##(1991-9#1)(1996-12#1)
show that the ratio of##3##5##(2008-10#1)(2008-11#1)(2008-4#1)
show that the relationship between##2##5##(1994-2#1)(2008-8#1)
show that the relative##2##4##(2008-10#1)(2010-4#1)
show that the results are##2##5##(2008-2#2)
show that the results obtained##2##5##(2005-11#1)(2007-12#1)
show that the results##4##4##(2005-11#1)(2007-12#1)(2008-2#2)
show that the return##2##4##(2008-3#1)(2008-8#1)
show that the role of##2##5##(1992-1#1)(2007-10#1)
show that the same##4##4##(1994-8#1)(1996-1#1)(2008-10#1)(2012-11#1)
show that the selectivity of the##2##6##(2008-10#2)
show that the sensitivity of##3##5##(2005-4#1)(2007-11#1)(2008-3#1)
show that the sensitivity##5##4##(1997-6#1)(2005-4#1)(2007-11#1)(2008-2#1)(2008-3#1)
show that the sensor can##2##5##(2008-10#1)(2008-3#1)
show that the sensor##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
show that the size##2##4##(1995-3#1)(2008-8#1)
show that the spectral##5##4##(2007-12#2)(2008-3#1)(2013-1#1)(2013-8#1)
show that the spherical##3##4##(2008-2#1)(2012-11#2)
show that the system can##3##5##(2008-2#1)(2008-3#1)(2013-1#1)
show that the technique##2##4##(2008-3#2)
show that the three##4##4##(1994-9#1)(2008-10#1)(2012-1#1)(2012-12#1)
show that the total##4##4##(1997-7#1)(2007-12#1)(2008-2#1)(2012-2#1)
show that the transcriptional##2##4##(1994-9#1)(2011-2#1)
show that the transverse##2##4##(2007-12#1)(2008-3#1)
show that the two##6##4##(1990-7#1)(1993-1#1)(1994-8#1)(2005-4#2)(2008-8#1)
show that the use of this##2##6##(2008-3#1)(2013-1#1)
show that the use of##9##5##(1991-9#1)(1992-2#1)(2007-12#2)(2008-3#1)(2010-6#1)(2011-2#1)(2011-3#1)(2013-1#1)
show that the yeast##2##4##(1994-10#1)(1995-8#1)
show that the##1064##3##(1990-1#2)(1990-11#3)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#8)(1990-7#4)(1990-8#9)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#5)(1991-2#5)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#2)(1991-9#5)(1992-1#4)(1992-12#4)(1992-2#3)(1992-3#1)(1992-4#4)(1992-5#3)(1992-6#5)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#5)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#8)(1993-8#1)(1993-9#4)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#5)(1994-2#5)(1994-3#5)(1994-4#1)(1994-5#3)(1994-6#3)(1994-8#9)(1994-9#6)(1995-1#4)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#10)(1995-4#1)(1995-5#6)(1995-6#3)(1995-7#1)(1995-8#9)(1995-9#5)(1996-1#4)(1996-10#1)(1996-11#6)(1996-12#8)(1996-2#10)(1996-5#7)(1996-6#2)(1996-7#3)(1996-8#4)(1996-9#1)(1997-1#4)(1997-2#7)(1997-3#1)(1997-4#8)(1997-6#5)(1997-7#9)(1997-8#5)(2004-11#1)(2005-10#1)(2005-11#21)(2005-12#1)(2005-4#12)(2005-7#1)(2005-8#2)(2006-10#10)(2006-11#2)(2006-12#5)(2006-2#3)(2006-4#1)(2006-5#3)(2006-6#5)(2006-7#3)(2006-8#3)(2007-1#4)(2007-10#3)(2007-11#29)(2007-12#60)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#5)(2008-1#9)(2008-10#77)(2008-11#23)(2008-12#3)(2008-2#102)(2008-3#119)(2008-4#4)(2008-5#17)(2008-6#6)(2008-7#14)(2008-8#30)(2008-9#5)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#4)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#4)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#6)(2010-3#5)(2010-4#3)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#7)(2010-9#2)(2011-1#6)(2011-12#3)(2011-2#14)(2011-3#1)(2012-1#12)(2012-11#3)(2012-12#16)(2012-2#20)(2012-3#13)(2013-1#15)(2013-7#3)(2013-8#21)
show that there are no##2##5##(1994-9#1)(2008-10#1)
show that there are two##4##5##(2006-10#1)(2008-3#1)(2008-8#1)(2011-3#1)
show that there are##12##4##(1993-4#1)(1994-9#1)(1996-6#1)(2006-10#2)(2008-10#1)(2008-3#2)(2008-8#1)(2009-10#1)(2009-9#1)(2011-3#1)
show that there is a##9##5##(1991-9#1)(1994-5#1)(1996-6#1)(1997-1#1)(2008-10#1)(2008-3#2)(2008-9#1)(2012-2#1)
show that there is an##6##5##(1993-2#1)(1994-5#1)(2007-12#1)(2008-2#2)(2012-2#1)
show that there is no##6##5##(1990-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-6#1)(2012-3#1)
show that there is##28##4##(1990-8#1)(1991-9#1)(1992-8#1)(1993-2#1)(1994-5#2)(1996-6#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#4)(2008-7#1)(2008-9#1)(2009-6#1)(2012-12#1)(2012-2#2)(2012-3#2)
show that there was a##3##5##(1991-12#1)(2009-5#1)(2012-12#1)
show that there was##4##4##(1991-12#1)(2009-5#2)(2012-12#1)
show that there##48##3##(1990-8#1)(1991-12#1)(1991-9#1)(1992-8#1)(1993-2#1)(1993-4#1)(1994-5#2)(1994-9#1)(1996-6#2)(1997-1#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#2)
show that these and##2##4##(1995-4#1)(2006-12#1)
show that these##41##3##(1990-8#1)(1993-2#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-8#2)(1995-1#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-5#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-12#2)(2007-11#2)(2007-12#3)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
show that they are##3##4##(1996-2#1)(2005-11#1)(2013-7#1)
show that they have##2##4##(1997-8#1)(2009-8#1)
show that they##11##3##(1996-2#1)(1997-8#1)(2005-11#1)(2007-12#3)(2008-10#1)(2008-2#1)(2009-8#1)(2012-3#1)(2013-7#1)
show that this approach can##2##5##(2008-2#1)(2008-6#1)
show that this approach is##4##5##(1992-9#1)(2007-12#1)(2008-2#1)(2009-5#1)
show that this approach##7##4##(1992-9#1)(2007-12#2)(2008-2#2)(2008-6#1)(2009-5#1)
show that this combination##3##4##(2013-1#2)(2013-7#1)
show that this is a##3##5##(2006-10#1)(2007-12#1)(2008-10#1)
show that this is due##2##5##(2008-2#1)(2012-3#1)
show that this is##7##4##(1993-1#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2012-2#1)(2012-3#1)
show that this method##2##4##(2008-10#1)(2008-2#1)
show that this model##4##4##(1995-4#1)(2007-12#1)(2008-10#1)(2013-8#1)
show that this procedure##2##4##(2009-8#1)(2012-2#1)
show that this results in the##2##6##(2008-2#1)(2008-6#1)
show that this technique can##3##5##(2007-11#1)(2008-3#2)
show that this technique is##2##5##(2007-11#1)(2012-2#1)
show that this technique##7##4##(2007-11#3)(2008-3#3)(2012-2#1)
show that this##98##3##(1991-11#1)(1991-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-3#1)(1994-2#1)(1994-8#1)(1994-9#2)(1995-4#1)(1995-6#1)(1995-8#2)(1996-2#1)(1996-5#2)(1996-6#1)(1997-6#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-7#1)(2007-11#7)(2007-12#8)(2007-7#1)(2007-8#1)(2008-10#8)(2008-2#11)(2008-3#7)(2008-4#1)(2008-5#3)(2008-6#3)(2008-8#3)(2008-9#1)(2009-5#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
show that three-dimensional##2##3##(2007-12#1)(2008-2#1)
show that tissue##2##3##(1995-2#1)(2011-1#1)
show that to##2##3##(2008-10#1)(2010-5#1)
show that transcription of the##2##5##(1990-11#1)(1995-8#1)
show that transmission##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
show that treatment of##3##4##(1994-8#1)(2008-10#2)
show that treatment##4##3##(1994-8#1)(2008-10#2)(2008-5#1)
show that two##2##3##(1995-12#1)(2008-9#1)
show that under##2##3##(1997-4#1)(2008-7#1)
show that upon##2##3##(1993-3#1)(1995-3#1)
show that using the##2##4##(2012-1#1)(2012-3#1)
show that using##8##3##(1996-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2012-1#1)(2012-3#1)(2013-8#1)
show that vitamin A##2##4##(1994-12#1)(2012-1#1)
show that we can##3##4##(1996-7#1)(2007-12#1)(2008-12#1)
show that we##4##3##(1996-7#1)(2007-12#1)(2008-12#1)(2010-2#1)
show that when##16##3##(1992-2#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-4#1)(2005-10#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#2)(2010-2#1)(2012-2#2)(2012-3#1)
show that while##6##3##(1990-5#1)(1991-12#1)(1996-5#1)(2010-9#1)(2012-11#1)(2012-3#1)
show that with this##2##4##(2007-12#1)(2008-1#1)
show that with##8##3##(1993-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2013-1#1)
show that women##2##3##(1996-4#1)(2008-9#1)
show that workers'##2##3##(2007-10#1)(2010-5#1)
show that zinc##4##3##(1992-9#1)(1994-11#1)(1994-6#1)(2008-10#1)
show that##3309##2##(1990-1#3)(1990-10#4)(1990-11#14)(1990-12#7)(1990-2#9)(1990-3#5)(1990-4#3)(1990-5#18)(1990-6#8)(1990-7#10)(1990-8#20)(1990-9#5)(1991-1#4)(1991-10#8)(1991-11#8)(1991-12#13)(1991-2#13)(1991-3#8)(1991-4#7)(1991-5#12)(1991-6#1)(1991-7#7)(1991-8#5)(1991-9#15)(1992-1#8)(1992-10#3)(1992-11#4)(1992-12#9)(1992-2#5)(1992-3#14)(1992-4#6)(1992-5#8)(1992-6#10)(1992-7#9)(1992-8#15)(1992-9#15)(1993-1#7)(1993-11#4)(1993-12#14)(1993-2#8)(1993-3#11)(1993-4#9)(1993-5#1)(1993-6#18)(1993-7#3)(1993-8#12)(1993-9#13)(1994-1#4)(1994-10#4)(1994-11#17)(1994-12#22)(1994-2#23)(1994-3#20)(1994-4#2)(1994-5#11)(1994-6#16)(1994-8#36)(1994-9#28)(1995-1#12)(1995-10#6)(1995-11#13)(1995-12#13)(1995-2#26)(1995-3#25)(1995-4#3)(1995-5#17)(1995-6#18)(1995-7#5)(1995-8#29)(1995-9#7)(1996-1#9)(1996-10#6)(1996-11#11)(1996-12#14)(1996-2#20)(1996-3#4)(1996-4#5)(1996-5#24)(1996-6#10)(1996-7#8)(1996-8#16)(1996-9#6)(1997-1#16)(1997-2#15)(1997-3#6)(1997-4#25)(1997-5#4)(1997-6#20)(1997-7#30)(1997-8#10)(1997-9#1)(2003-11#1)(2004-10#1)(2004-11#1)(2004-12#1)(2004-4#3)(2004-9#3)(2005-10#4)(2005-11#39)(2005-12#2)(2005-3#1)(2005-4#15)(2005-7#2)(2005-8#8)(2006-1#1)(2006-10#33)(2006-11#7)(2006-12#22)(2006-2#8)(2006-3#1)(2006-4#5)(2006-5#6)(2006-6#8)(2006-7#8)(2006-8#8)(2006-9#4)(2007-1#6)(2007-10#11)(2007-11#78)(2007-12#181)(2007-2#7)(2007-3#7)(2007-4#3)(2007-5#4)(2007-6#1)(2007-7#7)(2007-8#14)(2007-9#18)(2008-1#32)(2008-10#197)(2008-11#54)(2008-12#18)(2008-2#205)(2008-3#256)(2008-4#20)(2008-5#62)(2008-6#18)(2008-7#65)(2008-8#86)(2008-9#42)(2009-1#1)(2009-10#16)(2009-11#7)(2009-12#9)(2009-2#11)(2009-3#9)(2009-4#8)(2009-5#11)(2009-6#12)(2009-7#6)(2009-8#20)(2009-9#15)(2010-1#3)(2010-10#7)(2010-11#2)(2010-12#17)(2010-2#29)(2010-3#9)(2010-4#8)(2010-5#12)(2010-6#12)(2010-7#7)(2010-8#13)(2010-9#7)(2011-1#28)(2011-12#8)(2011-2#49)(2011-3#3)(2012-1#27)(2012-11#9)(2012-12#64)(2012-2#66)(2012-3#41)(2012-6#1)(2012-7#1)(2013-1#73)(2013-7#9)(2013-8#65)
show the ability of##2##4##(2008-5#1)(2012-2#1)
show the ability##3##3##(2008-5#1)(2008-7#1)(2012-2#1)
show the capability of##3##4##(2007-12#1)(2009-5#1)(2013-1#1)
show the chemical##2##3##(2006-10#1)(2008-5#1)
show the correct##3##3##(1990-3#1)(2008-2#1)(2008-3#1)
show the current##2##3##(1992-10#1)(2008-7#1)
show the different##3##3##(2007-8#1)(2008-10#1)(2008-3#1)
show the effect of##5##4##(1994-2#1)(2007-8#1)(2008-11#1)(2008-2#1)(2012-2#1)
show the effect##6##3##(1994-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2012-2#1)
show the effectiveness of##4##4##(1996-12#1)(2008-1#1)(2010-4#1)(2012-2#1)
show the effectiveness##5##3##(1996-12#1)(2008-1#1)(2010-4#1)(2010-8#1)(2012-2#1)
show the effects of##5##4##(1997-7#1)(1997-8#1)(2007-12#2)(2008-1#1)
show the efficacy of##3##4##(2006-10#1)(2013-1#2)
show the excellent##3##3##(2007-7#1)(2008-10#1)(2008-2#1)
show the existence of a##3##5##(2007-12#2)(2010-10#1)
show the existence of two##3##5##(1991-1#1)(1996-6#1)(2004-9#1)
show the existence of##13##4##(1991-1#1)(1991-11#1)(1994-6#1)(1996-6#1)(2004-9#1)(2007-12#3)(2008-10#2)(2008-3#1)(2010-10#1)(2013-8#1)
show the expected##3##3##(1992-9#1)(2009-11#1)(2012-12#1)
show the expression of##2##4##(1995-3#1)(2008-7#1)
show the feasibility and##2##4##(2009-12#1)(2012-3#1)
show the feasibility of the##2##5##(2008-3#2)
show the feasibility of##7##4##(2008-10#2)(2008-3#4)(2010-5#1)
show the feasibility##10##3##(2008-10#3)(2008-3#4)(2009-12#1)(2010-5#1)(2012-3#1)
show the following##2##3##(1990-5#1)(1991-4#1)
show the formation of##2##4##(2005-11#1)(2008-7#1)
show the greatest##2##3##(1993-11#1)(2007-5#1)
show the highest##4##3##(1995-6#2)(2007-1#1)(2010-4#1)
show the importance of##10##4##(1994-9#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-5#2)(2008-7#1)(2009-4#1)(2010-10#1)(2011-2#1)
show the influence of##3##4##(2008-10#1)(2008-8#1)(2012-3#1)
show the involvement of##3##4##(2006-12#1)(2009-8#1)(2013-1#1)
show the magnitude##2##3##(2005-11#1)(2007-12#1)
show the merits of##2##4##(2006-6#1)(2008-3#1)
show the need for##3##4##(2008-10#1)(2008-8#1)(2012-11#1)
show the need##4##3##(2008-10#1)(2008-8#1)(2011-1#1)(2012-11#1)
show the possibility of##4##4##(2006-10#1)(2008-2#1)(2008-3#2)
show the possibility##5##3##(2006-10#1)(2007-8#1)(2008-2#1)(2008-3#2)
show the possible##2##3##(1990-8#1)(1997-8#1)
show the potential of the##2##5##(2006-10#1)(2011-1#1)
show the potential of this technique##2##6##(2007-11#1)(2007-12#1)
show the potential of##4##4##(2006-10#1)(2007-11#1)(2007-12#1)(2011-1#1)
show the potential##7##3##(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2011-1#1)
show the presence of##8##4##(1990-12#1)(1995-10#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-12#1)
show the proposed##2##3##(1995-4#1)(2008-2#1)
show the relative##2##3##(2008-10#2)
show the results of a##2##5##(1991-9#1)(2007-12#1)
show the results of##4##4##(1991-9#1)(2007-12#1)(2008-3#2)
show the results##6##3##(1991-9#1)(2007-12#1)(2008-1#1)(2008-3#3)
show the role of##3##4##(1991-6#1)(2008-6#1)(2011-1#1)
show the same##7##3##(1990-5#1)(1993-9#1)(1994-9#1)(2007-1#1)(2007-3#1)(2008-10#2)
show the sensitivity of##2##4##(1995-12#1)(2008-2#1)
show the significant##2##3##(2008-11#1)(2008-2#1)
show the suitability of the##2##5##(2008-2#1)(2008-9#1)
show the usefulness and##2##4##(1992-5#1)(2008-3#1)
show the usefulness of the##2##5##(2007-11#1)(2008-10#1)
show the usefulness of##3##4##(2007-11#1)(2008-10#2)
show the usefulness##5##3##(1992-5#1)(2007-11#1)(2008-10#2)(2008-3#1)
show the utility of the##5##5##(2008-3#5)
show the utility##6##3##(2008-10#1)(2008-3#5)
show the validity of##2##4##(2008-5#1)(2009-10#1)
show the##342##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#3)(1990-6#1)(1990-8#2)(1991-1#2)(1991-10#1)(1991-11#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-10#2)(1995-11#1)(1995-12#2)(1995-3#1)(1995-4#2)(1995-6#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#3)(1997-8#3)(2004-9#1)(2005-10#1)(2005-11#2)(2005-7#2)(2006-10#4)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#2)(2007-1#3)(2007-11#9)(2007-12#18)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#5)(2008-1#6)(2008-10#33)(2008-11#5)(2008-12#2)(2008-2#27)(2008-3#36)(2008-4#3)(2008-5#14)(2008-6#3)(2008-7#9)(2008-8#4)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-8#3)(2011-1#4)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#2)(2012-8#1)(2013-1#6)(2013-3#1)(2013-7#2)(2013-8#2)
show their##2##2##(2008-7#1)(2009-12#1)
show theoretically##6##2##(2007-11#1)(2007-12#3)(2008-1#1)(2008-7#1)
show there is##2##3##(2008-10#1)(2012-3#1)
show there##4##2##(2008-10#2)(2011-2#1)(2012-3#1)
show these##3##2##(1991-5#1)(1996-11#1)(2008-8#1)
show they##2##2##(1990-1#1)(2008-3#1)
show this##11##2##(1992-7#1)(1996-7#1)(1997-3#1)(2005-11#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2011-12#1)(2012-11#2)
show through##4##2##(1993-6#1)(2007-12#2)(2009-9#1)
show to be##4##3##(1995-10#1)(2007-12#1)(2008-2#1)(2008-8#1)
show transient##2##2##(2006-10#1)(2007-8#1)
show two##7##2##(1992-7#1)(2008-10#2)(2008-2#1)(2008-5#2)(2010-5#1)
show typical##2##2##(2007-10#1)(2008-10#1)
show unusual##2##2##(1991-5#1)(1995-12#1)
show up as##2##3##(2007-12#1)(2008-3#1)
show up##9##2##(1992-5#1)(1993-3#1)(1996-1#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)
show variable##2##2##(2008-5#1)(2011-2#1)
show various##2##2##(2006-6#1)(2007-11#1)
show varying##3##2##(1995-11#1)(2008-1#1)(2010-8#1)
show very good agreement##2##4##(2006-5#1)(2008-10#1)
show very good##3##3##(2006-5#1)(2008-10#1)(2008-3#1)
show very little##2##3##(1990-6#1)(2008-9#1)
show very##12##2##(1990-6#1)(1994-11#1)(1996-3#1)(2006-5#1)(2007-1#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-5#1)(2010-6#1)(2012-2#1)
show via##2##2##(2009-9#1)(2013-8#1)
show weak##3##2##(1997-7#1)(2010-5#1)(2011-3#1)
show well defined##2##3##(2006-5#1)(2008-2#1)
show well##3##2##(2006-5#1)(2007-8#1)(2008-2#1)
show white##2##2##(2008-10#1)(2008-3#1)
show why##3##2##(2009-5#1)(2011-12#1)(2012-3#1)
show wide##2##2##(1994-8#1)(1996-3#1)
show with##3##2##(2007-12#1)(2008-10#1)(2008-5#1)
show##5997##1##(1990-1#6)(1990-10#9)(1990-11#23)(1990-12#15)(1990-2#21)(1990-3#14)(1990-4#5)(1990-5#33)(1990-6#16)(1990-7#21)(1990-8#28)(1990-9#7)(1991-1#10)(1991-10#14)(1991-11#14)(1991-12#17)(1991-2#17)(1991-3#15)(1991-4#9)(1991-5#27)(1991-6#7)(1991-7#14)(1991-8#12)(1991-9#30)(1992-1#13)(1992-10#7)(1992-11#10)(1992-12#12)(1992-2#9)(1992-3#23)(1992-4#13)(1992-5#17)(1992-6#15)(1992-7#22)(1992-8#20)(1992-9#26)(1993-1#10)(1993-10#1)(1993-11#13)(1993-12#20)(1993-2#10)(1993-3#20)(1993-4#10)(1993-5#4)(1993-6#25)(1993-7#5)(1993-8#18)(1993-9#19)(1994-1#4)(1994-10#7)(1994-11#26)(1994-12#33)(1994-2#37)(1994-3#31)(1994-4#2)(1994-5#21)(1994-6#27)(1994-8#45)(1994-9#48)(1995-1#22)(1995-10#14)(1995-11#29)(1995-12#32)(1995-2#35)(1995-3#33)(1995-4#6)(1995-5#23)(1995-6#30)(1995-7#8)(1995-8#42)(1995-9#12)(1996-1#17)(1996-10#13)(1996-11#20)(1996-12#22)(1996-2#31)(1996-3#19)(1996-4#16)(1996-5#38)(1996-6#17)(1996-7#15)(1996-8#25)(1996-9#12)(1997-1#29)(1997-2#27)(1997-3#23)(1997-4#41)(1997-5#12)(1997-6#38)(1997-7#52)(1997-8#21)(1997-9#1)(2003-11#1)(2004-10#1)(2004-11#2)(2004-12#1)(2004-4#8)(2004-9#10)(2005-10#8)(2005-11#78)(2005-12#2)(2005-3#1)(2005-4#17)(2005-6#1)(2005-7#11)(2005-8#15)(2005-9#2)(2006-1#3)(2006-10#64)(2006-11#16)(2006-12#44)(2006-2#20)(2006-3#6)(2006-4#11)(2006-5#16)(2006-6#15)(2006-7#11)(2006-8#16)(2006-9#10)(2007-1#14)(2007-10#25)(2007-11#147)(2007-12#291)(2007-2#17)(2007-3#15)(2007-4#10)(2007-5#13)(2007-6#7)(2007-7#20)(2007-8#46)(2007-9#36)(2008-1#60)(2008-10#370)(2008-11#106)(2008-12#35)(2008-2#329)(2008-3#389)(2008-4#47)(2008-5#166)(2008-6#35)(2008-7#131)(2008-8#135)(2008-9#69)(2009-1#4)(2009-10#32)(2009-11#21)(2009-12#20)(2009-2#18)(2009-3#13)(2009-4#25)(2009-5#26)(2009-6#23)(2009-7#8)(2009-8#37)(2009-9#20)(2010-1#9)(2010-10#14)(2010-11#8)(2010-12#32)(2010-2#41)(2010-3#14)(2010-4#27)(2010-5#32)(2010-6#25)(2010-7#10)(2010-8#27)(2010-9#9)(2011-1#54)(2011-10#1)(2011-12#19)(2011-2#120)(2011-3#6)(2012-1#46)(2012-11#18)(2012-12#107)(2012-2#121)(2012-3#64)(2012-5#1)(2012-6#1)(2012-7#1)(2012-8#2)(2012-9#1)(2013-1#129)(2013-3#1)(2013-7#20)(2013-8#105)
show?##2##1##(1993-7#1)(2009-4#1)
showcase the##3##2##(2012-12#1)(2013-1#2)
showcase##4##1##(2009-4#1)(2012-12#1)(2013-1#2)
showed &gt##5##2##(1994-9#2)(1997-2#1)(2007-7#1)(2013-8#1)
showed 1##2##2##(1990-11#1)(2010-4#1)
showed 10##2##2##(2008-5#1)(2013-1#1)
showed 100% sensitivity##2##3##(2007-7#2)
showed 100%##7##2##(2006-10#1)(2007-11#1)(2007-7#3)(2008-10#1)(2013-8#1)
showed 2##2##2##(1992-2#1)(2008-5#1)
showed 20##2##2##(2008-7#1)(2013-1#1)
showed 3##5##2##(1990-5#1)(1992-1#1)(2007-8#1)(2008-7#1)(2012-1#1)
showed 4##2##2##(1994-5#1)(2011-2#1)
showed 50%##4##2##(1991-4#1)(1992-3#1)(1996-1#1)(2013-1#1)
showed 62%##2##2##(1995-10#1)(2008-10#1)
showed 80%##2##2##(1992-10#1)(2011-2#1)
showed 81##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
showed 85%##2##2##(1992-7#1)(2008-6#1)
showed 88% homology##2##3##(1993-12#1)(1996-10#1)
showed 93%##3##2##(1993-12#1)(2006-8#1)(2007-9#1)
showed 98%##2##2##(2008-7#1)(2011-2#1)
showed 99% homology##2##3##(1993-12#1)(2007-12#1)
showed 99%##3##2##(1993-12#1)(2007-12#1)(2008-10#1)
showed Barrett's##2##2##(2008-6#1)(2012-2#1)
showed CD44##2##2##(2007-10#1)(2007-11#1)
showed CGPR##2##2##(2010-12#2)
showed Group##2##2##(2006-8#1)(2012-2#1)
showed NF##2##2##(1995-5#1)(1995-6#1)
showed NP##2##2##(2013-8#2)
showed a 1##3##3##(1992-11#1)(1997-2#1)(1997-4#1)
showed a 10%##2##3##(1995-5#1)(2009-4#1)
showed a 13##2##3##(1994-9#1)(2008-1#1)
showed a 2##2##3##(2005-11#1)(2008-5#1)
showed a 20##2##3##(2008-5#1)(2009-5#1)
showed a 50%##2##3##(1995-3#1)(1997-1#1)
showed a 50-kDa protein##2##4##(1993-6#2)
showed a band##2##3##(2007-12#1)(2013-1#1)
showed a better##6##3##(1990-9#1)(2008-10#1)(2008-6#1)(2011-2#1)(2013-1#1)(2013-7#1)
showed a big##2##3##(1997-8#1)(2008-10#1)
showed a bimodal##3##3##(1990-10#1)(2008-10#1)(2008-6#1)
showed a biphasic##5##3##(1990-10#1)(1994-2#1)(2009-5#1)(2010-5#1)(2011-2#1)
showed a broad##3##3##(1990-11#1)(2008-10#1)(2008-5#1)
showed a carryover effect##2##4##(2012-1#2)
showed a characteristic##2##3##(1992-12#1)(1995-2#1)
showed a clear##16##3##(1991-2#1)(1993-3#1)(1994-6#1)(1996-2#1)(1997-6#1)(2008-10#1)(2008-5#2)(2008-8#1)(2009-4#1)(2010-1#1)(2010-2#1)(2012-11#2)(2013-1#1)(2013-8#1)
showed a clearly##2##3##(2008-10#1)(2008-5#1)
showed a close association##2##4##(2008-10#2)
showed a close##7##3##(1991-9#1)(1993-11#1)(2006-8#1)(2008-10#2)(2008-11#1)(2012-2#1)
showed a complete##6##3##(1990-2#1)(1997-6#1)(2007-11#1)(2008-4#1)(2008-5#1)(2012-3#1)
showed a complex##2##3##(2007-11#1)(2009-3#1)
showed a considerable##2##3##(2008-10#1)(2010-4#1)
showed a consistent##6##3##(1994-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2012-12#1)
showed a constant##3##3##(1990-8#1)(1993-12#1)(2010-8#1)
showed a correlation coefficient##2##4##(2007-8#1)(2008-10#1)
showed a correlation##5##3##(1994-12#1)(2007-11#1)(2007-8#1)(2008-10#2)
showed a cytotoxic##2##3##(1995-3#1)(2008-11#1)
showed a decrease in anxiety and##2##6##(1997-7#1)(2006-10#1)
showed a decrease in the enzyme##2##6##(1994-8#1)(2013-8#1)
showed a decrease in the##5##5##(1994-8#2)(1997-1#1)(2008-5#1)(2013-8#1)
showed a decrease in##19##4##(1991-7#1)(1993-9#1)(1994-8#2)(1997-1#1)(1997-3#1)(1997-7#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-8#1)(2011-12#1)(2012-1#1)(2013-1#2)(2013-8#1)
showed a decrease of##3##4##(1994-8#1)(1996-6#1)(2008-7#1)
showed a decrease with##2##4##(2008-3#1)(2008-5#1)
showed a decrease##27##3##(1991-1#1)(1991-7#1)(1993-9#1)(1994-8#3)(1996-6#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-2#1)(2010-8#1)(2011-12#1)(2012-1#1)(2013-1#2)(2013-8#1)
showed a decreased##3##3##(2009-12#1)(2009-7#1)(2011-1#1)
showed a decreasing##3##3##(1996-3#1)(2007-9#1)(2008-10#1)
showed a delay in##3##4##(1994-12#1)(2009-8#1)(2011-2#1)
showed a delayed##4##3##(1990-7#1)(1992-8#1)(2005-12#1)(2006-12#1)
showed a detection limit for##2##5##(1991-10#1)(2008-10#1)
showed a detection limit##4##4##(1991-10#1)(1993-1#1)(2007-8#1)(2008-10#1)
showed a difference##2##3##(1992-12#1)(2009-10#1)
showed a different##4##3##(1992-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
showed a differential##2##3##(1997-6#1)(2007-12#1)
showed a diffuse##5##3##(1994-6#1)(1995-2#1)(1997-4#1)(2006-4#1)(2013-8#1)
showed a direct relationship between##2##5##(1993-5#2)
showed a direct##3##3##(1993-5#2)(1997-8#1)
showed a distinct##4##3##(1994-2#1)(1996-8#1)(2007-8#1)(2008-11#1)
showed a dose- and##2##4##(1993-6#1)(2007-12#1)
showed a dose-dependent increase##2##4##(1996-10#1)(2011-2#1)
showed a dose-dependent reduction##2##4##(1993-9#1)(1995-12#1)
showed a dose-dependent##7##3##(1993-6#1)(1993-9#1)(1995-12#3)(1996-10#1)(2011-2#1)
showed a dramatic increase in##2##5##(1995-2#1)(2007-12#1)
showed a dramatic##5##3##(1995-2#1)(1997-4#1)(2007-12#1)(2008-10#1)(2013-1#1)
showed a fairly##2##3##(1997-7#1)(2012-3#1)
showed a favorable##2##3##(2007-8#1)(2010-12#1)
showed a favourable##2##3##(1991-6#1)(2013-1#1)
showed a good agreement with##2##5##(2008-10#2)
showed a good agreement##5##4##(2008-10#5)
showed a good correlation##3##4##(1991-3#1)(2007-5#1)(2008-10#1)
showed a good fit to##2##5##(1994-8#1)(2006-9#1)
showed a good fit##3##4##(1994-8#1)(2006-9#1)(2008-8#1)
showed a good linearity##3##4##(2008-10#1)(2011-3#1)(2012-12#1)
showed a good response to##2##5##(1992-10#1)(2007-7#1)
showed a good##39##3##(1990-10#1)(1991-3#1)(1992-10#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-8#1)(1996-9#1)(2005-11#1)(2006-9#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#13)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-4#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-7#2)
showed a gradual##2##3##(1990-3#1)(2013-1#1)
showed a great##4##3##(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
showed a greater##11##3##(1993-11#1)(2005-10#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-10#1)(2012-12#1)(2013-8#1)
showed a growth##2##3##(2008-11#1)(2013-1#1)
showed a high affinity for the##2##6##(1994-11#1)(1995-11#1)
showed a high degree of homology##3##6##(1990-2#1)(1997-1#1)(2008-10#1)
showed a high degree of similarity##2##6##(1993-9#1)(2008-10#1)
showed a high degree of##17##5##(1990-2#1)(1990-5#1)(1992-2#2)(1993-2#1)(1993-9#1)(1996-2#1)(1997-1#1)(2006-12#1)(2006-3#1)(2008-10#4)(2010-12#1)(2012-1#1)(2013-7#1)
showed a high level of##9##5##(1995-11#1)(1997-3#1)(2006-2#1)(2007-5#1)(2008-5#1)(2008-8#1)(2012-1#1)(2013-1#1)(2013-8#1)
showed a high sequence homology with##2##6##(1992-12#1)(1997-4#1)
showed a high##56##3##(1990-2#1)(1990-3#1)(1990-5#1)(1992-12#1)(1992-2#2)(1992-8#1)(1993-2#1)(1993-9#1)(1994-11#2)(1994-6#1)(1994-9#1)(1995-11#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(2004-9#2)(2006-10#3)(2006-12#1)(2006-2#1)(2006-3#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#8)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-7#1)(2010-12#1)(2010-4#2)(2011-2#1)(2012-1#3)(2013-1#1)(2013-7#1)(2013-8#1)
showed a higher activity##2##4##(2007-7#1)(2009-3#1)
showed a higher frequency##2##4##(1997-8#1)(2008-7#1)
showed a higher percentage of##2##5##(2007-7#1)(2013-8#1)
showed a higher prevalence of##4##5##(1990-12#1)(1996-12#1)(2008-12#1)(2013-1#1)
showed a higher proportion of##2##5##(2009-3#1)(2010-4#1)
showed a higher rate of##2##5##(1997-8#1)(2012-12#1)
showed a higher sensitivity##2##4##(2007-9#1)(2008-10#1)
showed a higher##40##3##(1990-10#2)(1990-12#1)(1991-12#2)(1992-8#1)(1994-11#1)(1995-12#1)(1996-11#1)(1996-12#1)(1997-8#2)(2004-4#1)(2006-11#1)(2006-12#1)(2006-9#1)(2007-7#2)(2007-9#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#2)(2010-4#1)(2012-12#3)(2013-1#1)(2013-8#1)
showed a highly significant##3##4##(1994-3#1)(1997-8#1)(2008-7#1)
showed a highly##6##3##(1994-2#1)(1994-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
showed a homogeneous##3##3##(2008-2#1)(2008-5#1)(2008-7#1)
showed a huge##7##3##(2007-8#3)(2008-7#1)(2010-3#1)(2012-2#2)
showed a large##9##3##(1990-6#1)(1994-12#1)(2006-10#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
showed a larger##3##3##(2005-10#1)(2008-11#1)(2008-7#1)
showed a left##2##3##(2007-8#1)(2010-2#1)
showed a lesion##5##3##(1990-6#1)(2007-8#1)(2008-5#1)(2010-12#1)(2011-2#1)
showed a linear calibration curve in the range##2##8##(2008-10#2)
showed a linear correlation with##2##5##(1996-7#1)(2008-10#1)
showed a linear dependence##2##4##(1997-8#1)(2008-10#1)
showed a linear range of##3##5##(2007-8#1)(2008-10#2)
showed a linear range##4##4##(2007-8#1)(2008-10#3)
showed a linear relationship with##2##5##(1990-11#1)(2008-10#1)
showed a linear response##5##4##(2008-10#4)(2010-12#1)
showed a linear##21##3##(1990-11#2)(1992-7#1)(1996-7#1)(1997-8#2)(2007-8#1)(2008-10#13)(2010-12#1)
showed a little##2##3##(2008-10#1)(2008-11#1)
showed a longer##2##3##(1993-7#2)
showed a low##8##3##(1991-11#1)(1991-8#1)(1993-6#1)(2006-8#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-2#1)
showed a lower sensitivity##2##4##(1991-6#1)(1995-7#1)
showed a lower##17##3##(1991-10#1)(1991-3#1)(1991-4#1)(1991-6#1)(1995-7#1)(2006-2#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-5#1)(2013-8#1)
showed a major##3##3##(1992-12#1)(1993-1#1)(1993-11#1)
showed a marginally significant##2##4##(1991-8#1)(1994-2#1)
showed a marginally##3##3##(1991-8#1)(1994-2#1)(2011-2#1)
showed a marked decrease in##2##5##(1995-10#1)(2008-7#1)
showed a marked improvement##2##4##(1990-12#1)(2008-8#1)
showed a marked increase in the##2##6##(1990-5#1)(1995-5#1)
showed a marked increase in##5##5##(1990-5#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-5#1)
showed a marked increase##6##4##(1990-5#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-5#1)(2007-12#1)
showed a marked##23##3##(1990-12#2)(1990-5#1)(1991-9#1)(1992-10#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-5#1)(2007-10#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-8#1)
showed a mass##5##3##(2008-1#1)(2008-5#2)(2011-2#1)(2012-2#1)
showed a massive##2##3##(1995-3#1)(1995-6#1)
showed a maximum##6##3##(1994-6#1)(1996-1#1)(1997-8#1)(2005-11#1)(2007-3#1)(2008-3#1)
showed a mean##7##3##(2005-10#1)(2006-2#1)(2007-10#2)(2008-10#1)(2010-1#1)(2012-1#1)
showed a mild##3##3##(1993-2#1)(1996-8#1)(2009-8#1)
showed a minimum##2##3##(1993-6#1)(2005-11#1)
showed a mixed##3##3##(2007-7#2)(2008-10#1)
showed a moderate##5##3##(1996-5#1)(2008-10#1)(2008-5#1)(2010-1#1)(2011-2#1)
showed a modest##3##3##(1997-5#1)(1997-7#1)(2011-1#1)
showed a more##5##3##(1994-8#1)(1995-2#1)(2006-3#1)(2008-6#1)(2009-4#1)
showed a much lower##2##4##(1995-5#1)(2008-2#1)
showed a much stronger##2##4##(2008-10#1)(2011-1#1)
showed a much##7##3##(1991-4#1)(1995-5#1)(2005-10#1)(2008-10#1)(2008-2#1)(2011-1#2)
showed a near##2##3##(2008-7#1)(2010-8#1)
showed a near-Nernstian response over the##2##6##(2008-10#2)
showed a negative correlation##3##4##(1991-11#1)(2006-8#1)(2011-2#1)
showed a negative##6##3##(1991-11#1)(2006-8#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
showed a non##2##3##(1991-12#1)(2011-1#1)
showed a non-linear##2##3##(1990-11#1)(1997-1#1)
showed a nonsignificant##3##3##(1995-11#1)(2007-9#1)(2008-3#1)
showed a normal##7##3##(1992-10#1)(1997-3#1)(2007-3#1)(2007-8#1)(2008-7#1)(2008-9#1)(2011-2#1)
showed a novel##3##3##(1992-9#1)(2008-11#1)(2010-2#1)
showed a number of##3##4##(1992-7#1)(1995-2#1)(2008-3#1)
showed a pair of well-defined##2##5##(2008-10#2)
showed a partial response##3##4##(2008-6#1)(2010-12#1)(2013-8#1)
showed a partial##5##3##(2008-10#1)(2008-6#1)(2010-12#1)(2011-2#1)(2013-8#1)
showed a pattern##3##3##(1993-7#1)(2007-2#1)(2008-1#1)
showed a peak##3##3##(1993-11#1)(1996-12#1)(2011-2#1)
showed a perfusion##2##3##(1992-10#1)(2010-12#1)
showed a picture##2##3##(2009-8#1)(2012-3#1)
showed a poor##2##3##(2008-10#1)(2011-2#1)
showed a positive correlation between##2##5##(2005-11#1)(2013-1#1)
showed a positive correlation with##2##5##(2006-9#1)(2013-1#1)
showed a positive correlation##5##4##(2005-11#1)(2006-9#1)(2008-4#1)(2013-1#2)
showed a positive reaction##3##4##(1996-3#1)(2008-10#1)(2011-2#1)
showed a positive##20##3##(1990-7#1)(1991-2#1)(1992-6#1)(1993-5#1)(1996-3#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#2)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-7#1)
showed a posterior##2##3##(1996-5#1)(2013-1#1)
showed a potent##2##3##(2007-1#1)(2011-3#1)
showed a potential##2##3##(2011-2#1)(2013-8#1)
showed a precision##2##3##(2008-10#2)
showed a preference for##4##4##(2007-5#1)(2008-11#2)(2012-2#1)
showed a preference##5##3##(1994-12#1)(2007-5#1)(2008-11#2)(2012-2#1)
showed a profound##3##3##(1993-12#1)(1994-6#1)(2008-7#1)
showed a prognostic##2##3##(1992-10#1)(1996-9#1)
showed a progressive increase in##3##5##(1993-7#1)(1996-10#1)(2011-1#1)
showed a progressive increase##5##4##(1993-7#1)(1996-10#1)(1997-8#1)(2007-2#1)(2011-1#1)
showed a progressive##6##3##(1993-7#1)(1995-8#1)(1996-10#1)(1997-8#1)(2007-2#1)(2011-1#1)
showed a prolonged##2##3##(1991-4#1)(2010-8#1)
showed a protective effect##2##4##(2008-11#1)(2010-7#1)
showed a raised##3##3##(2007-7#1)(2011-2#1)(2013-1#1)
showed a range of##6##4##(1997-3#1)(2008-10#2)(2008-5#2)(2008-7#1)
showed a rapid##7##3##(1990-5#1)(1992-4#1)(1993-4#1)(1996-12#1)(2008-1#1)(2011-2#1)(2013-1#1)
showed a rather##2##3##(2007-2#1)(2008-10#1)
showed a reduced##7##3##(1991-5#1)(1994-6#2)(2006-12#1)(2008-10#1)(2008-4#1)(2008-9#1)
showed a reduction in##11##4##(1993-11#1)(1993-3#1)(1994-12#1)(2006-2#1)(2007-4#1)(2008-8#1)(2009-10#1)(2012-2#1)(2013-8#3)
showed a reduction of the##3##5##(2006-2#1)(2007-5#1)(2011-2#1)
showed a reduction of##7##4##(1991-11#1)(1994-9#1)(1995-2#1)(2006-2#1)(2007-5#1)(2008-10#1)(2011-2#1)
showed a reduction##20##3##(1990-12#1)(1991-11#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-2#1)(2006-2#2)(2007-4#1)(2007-5#1)(2008-10#2)(2008-8#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-8#3)
showed a relationship between##2##4##(1992-7#1)(2009-8#1)
showed a relative standard deviation of##2##6##(2008-10#2)
showed a relative##5##3##(1990-2#1)(1992-4#1)(1996-9#1)(2008-10#2)
showed a relatively##4##3##(2008-10#1)(2008-11#1)(2008-5#2)
showed a remarkable increase in the##2##6##(1993-11#1)(2012-3#1)
showed a remarkable increase##3##4##(1993-11#1)(2008-8#1)(2012-3#1)
showed a remarkable##8##3##(1993-11#1)(2004-9#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)
showed a response##3##3##(1997-6#1)(2008-10#1)(2008-5#1)
showed a right##4##3##(2007-8#1)(2008-8#1)(2010-9#1)(2011-1#1)
showed a rise##2##3##(1994-6#1)(2008-1#1)
showed a round opacity##2##4##(1993-6#1)(2008-1#1)
showed a satisfactory##2##3##(2007-8#1)(2008-10#1)
showed a selective##2##3##(1995-9#1)(2007-11#1)
showed a sensitivity of##5##4##(1994-2#1)(1996-11#1)(2006-10#2)(2007-10#1)
showed a severe##4##3##(1993-2#1)(2006-10#1)(2011-1#1)(2012-2#1)
showed a shallow##2##3##(2005-11#1)(2010-8#1)
showed a sharp##2##3##(1992-12#1)(2007-8#1)
showed a shift##3##3##(1996-3#1)(2007-5#1)(2009-12#1)
showed a short##2##3##(2005-8#2)
showed a significant association between##2##5##(2010-2#1)(2011-2#1)
showed a significant association with a##2##6##(1992-3#1)(2009-5#1)
showed a significant association with##3##5##(1992-3#1)(2007-10#1)(2009-5#1)
showed a significant association##7##4##(1992-3#1)(1996-6#1)(2007-10#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-12#1)
showed a significant change##3##4##(1997-8#1)(2006-8#1)(2008-8#1)
showed a significant correlation between##3##5##(1991-5#1)(2006-11#1)(2010-4#1)
showed a significant correlation in##2##5##(2008-3#1)(2012-2#1)
showed a significant correlation with##5##5##(1991-12#1)(1994-9#1)(1996-5#1)(2007-9#1)(2013-1#1)
showed a significant correlation##13##4##(1991-12#1)(1991-5#1)(1994-12#1)(1994-5#1)(1994-9#1)(1996-5#1)(2006-11#1)(2007-9#1)(2008-3#1)(2008-8#1)(2010-4#1)(2012-2#1)(2013-1#1)
showed a significant decrease in the##2##6##(1995-7#1)(2012-2#1)
showed a significant decrease in total##2##6##(1992-2#1)(2008-12#1)
showed a significant decrease in##9##5##(1992-2#1)(1995-3#1)(1995-7#1)(1996-2#1)(2005-8#1)(2008-12#1)(2011-2#1)(2012-2#2)
showed a significant decrease of the##2##6##(1992-6#1)(2008-1#1)
showed a significant decrease of##5##5##(1992-6#1)(1997-4#1)(2008-1#1)(2008-10#1)(2009-6#1)
showed a significant decrease##18##4##(1992-10#1)(1992-2#1)(1992-6#1)(1995-3#1)(1995-7#1)(1996-2#1)(1997-1#1)(1997-4#1)(2005-8#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2009-6#1)(2011-2#1)(2012-2#2)(2013-8#1)
showed a significant dependence##2##4##(1996-3#1)(2009-4#1)
showed a significant difference between the##2##6##(2006-8#1)(2007-10#1)
showed a significant difference between##3##5##(2006-8#1)(2007-10#1)(2010-8#1)
showed a significant difference in##3##5##(1990-12#1)(2005-10#1)(2007-8#1)
showed a significant difference##12##4##(1990-12#1)(1997-1#1)(2005-10#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-4#1)(2010-8#1)(2013-8#1)
showed a significant down-regulation of##2##5##(1994-11#1)(2013-1#1)
showed a significant excess##2##4##(1997-8#1)(2006-8#1)
showed a significant impact on##2##5##(2006-11#1)(2012-3#1)
showed a significant improvement in##3##5##(1991-8#1)(1996-2#1)(2006-5#1)
showed a significant improvement of##2##5##(2008-10#1)(2013-1#1)
showed a significant improvement##6##4##(1991-8#1)(1996-2#1)(2006-5#1)(2008-10#1)(2008-7#1)(2013-1#1)
showed a significant increase (P &lt##2##6##(2006-12#1)(2009-5#1)
showed a significant increase in the##8##6##(1995-11#1)(1996-1#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-6#1)(2013-7#1)(2013-8#1)
showed a significant increase in##20##5##(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#2)(1995-11#1)(1996-1#1)(1997-1#1)(1997-2#1)(2007-2#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2011-12#1)(2012-7#1)(2013-7#1)(2013-8#1)
showed a significant increase of##2##5##(2008-10#1)(2008-6#1)
showed a significant increase##30##4##(1991-6#1)(1992-9#1)(1993-4#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#2)(1995-11#1)(1995-12#1)(1996-1#1)(1997-1#1)(1997-2#1)(2006-12#1)(2007-2#2)(2008-10#4)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-5#1)(2011-12#1)(2012-7#1)(2013-7#1)(2013-8#1)
showed a significant negative correlation with age##2##7##(1990-5#1)(2011-12#1)
showed a significant negative correlation with##4##6##(1990-5#1)(2007-10#1)(2011-12#1)(2011-2#1)
showed a significant negative##5##4##(1990-5#1)(2007-10#1)(2011-12#1)(2011-2#1)(2012-2#1)
showed a significant positive correlation with##3##6##(1991-12#1)(2009-6#1)(2013-1#1)
showed a significant positive correlation##4##5##(1991-12#1)(2008-7#1)(2009-6#1)(2013-1#1)
showed a significant positive relationship##2##5##(2007-5#1)(2011-1#1)
showed a significant positive##7##4##(1991-12#1)(2007-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-1#1)(2013-1#1)
showed a significant reduction in the##2##6##(1995-1#1)(1997-2#1)
showed a significant reduction in##7##5##(1995-1#1)(1997-2#1)(1997-5#1)(2005-7#1)(2008-10#1)(2012-2#1)(2013-7#1)
showed a significant reduction of##3##5##(1996-3#1)(2008-10#1)(2009-3#1)
showed a significant reduction##12##4##(1993-7#1)(1995-1#1)(1996-3#1)(1997-2#1)(1997-5#1)(2005-7#1)(2008-10#2)(2008-5#1)(2009-3#1)(2012-2#1)(2013-7#1)
showed a significant shade change between##2##6##(2009-8#2)
showed a significant##168##3##(1990-12#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-12#3)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#2)(1992-11#1)(1992-2#3)(1992-3#1)(1992-6#1)(1992-9#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#3)(1997-2#2)(1997-4#1)(1997-5#1)(1997-8#2)(2005-10#1)(2005-7#1)(2005-8#1)(2006-11#2)(2006-12#2)(2006-5#1)(2006-8#3)(2007-10#3)(2007-11#1)(2007-2#3)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#12)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-8#2)(2010-1#1)(2010-12#1)(2010-2#2)(2010-4#3)(2010-5#2)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#7)(2012-3#1)(2012-7#1)(2013-1#4)(2013-7#3)(2013-8#4)
showed a significantly decreased##2##4##(1990-3#1)(2006-8#1)
showed a significantly higher frequency of##2##6##(1990-9#1)(2007-10#1)
showed a significantly higher level of##2##6##(2008-10#2)
showed a significantly higher##10##4##(1990-9#1)(1992-7#1)(2007-10#2)(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)
showed a significantly lower##4##4##(1990-8#1)(2007-1#1)(2007-11#1)(2008-3#1)
showed a significantly##23##3##(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#1)(1992-7#1)(1995-11#1)(1995-5#1)(1997-8#1)(2004-11#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
showed a similar pattern of##2##5##(1996-12#1)(2011-2#1)
showed a similar pattern##4##4##(1990-12#1)(1996-12#1)(2011-2#2)
showed a similar potency to##2##5##(1995-12#1)(2008-5#1)
showed a similar##22##3##(1990-12#1)(1990-6#1)(1994-10#1)(1995-12#1)(1995-2#2)(1996-12#1)(1996-5#1)(2004-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-8#1)(2010-8#1)(2011-12#1)(2011-2#3)(2012-2#1)
showed a single band of##2##5##(1993-4#1)(1994-12#1)
showed a single band##7##4##(1990-2#1)(1991-5#1)(1991-9#1)(1992-7#1)(1993-4#1)(1994-12#1)(1996-9#1)
showed a single peak##2##4##(2006-10#1)(2013-8#1)
showed a single protein band##2##5##(1995-5#1)(1996-5#1)
showed a single##22##3##(1990-2#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-3#2)(1993-4#1)(1994-12#1)(1994-8#1)(1995-5#1)(1996-5#1)(1996-9#1)(2006-10#1)(2008-10#2)(2012-1#1)(2013-8#1)
showed a slight decrease in##2##5##(1992-11#1)(1993-11#1)
showed a slight increase in##2##5##(1991-10#1)(2010-5#1)
showed a slight increase with##2##5##(2008-2#1)(2008-7#1)
showed a slight increase##4##4##(1991-10#1)(2008-2#1)(2008-7#1)(2010-5#1)
showed a slight##13##3##(1991-10#1)(1992-11#1)(1993-11#1)(1993-2#1)(1997-5#1)(2007-5#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-4#1)(2010-5#1)(2012-12#1)
showed a slightly better##2##4##(2008-10#1)(2013-1#1)
showed a slightly##7##3##(1990-3#1)(1992-5#1)(1995-3#1)(1997-4#1)(1997-6#1)(2008-10#1)(2013-1#1)
showed a slow##2##3##(2008-11#1)(2011-1#1)
showed a small but significant##2##5##(1993-1#1)(2007-9#1)
showed a small##7##3##(1993-1#1)(1995-1#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-9#1)(2013-8#1)
showed a smaller##5##3##(1995-5#1)(1996-11#1)(2008-5#1)(2008-7#1)(2011-1#1)
showed a solid##3##3##(1990-3#1)(1997-3#1)(2009-5#1)
showed a solitary##3##3##(2012-12#2)(2012-2#1)
showed a specific##6##3##(1991-3#1)(1995-2#1)(1996-5#1)(1997-1#1)(2007-4#1)(2008-9#1)
showed a stable##3##3##(1991-10#1)(2008-11#1)(2013-1#1)
showed a statistical significance##2##4##(1994-9#1)(2013-8#1)
showed a statistical##4##3##(1994-9#1)(2006-7#1)(2012-12#1)(2013-8#1)
showed a statistically significant decrease##3##5##(1991-2#1)(2006-7#1)(2008-3#1)
showed a statistically significant difference between##2##6##(2008-12#1)(2010-12#1)
showed a statistically significant difference##3##5##(1990-10#1)(2008-12#1)(2010-12#1)
showed a statistically significant positive##2##5##(1994-2#1)(2012-3#1)
showed a statistically significant##17##4##(1990-10#1)(1990-8#1)(1991-2#1)(1994-2#1)(1995-12#1)(2006-7#1)(2007-12#1)(2008-12#1)(2008-3#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
showed a statistically##20##3##(1990-10#2)(1990-12#1)(1990-8#1)(1991-2#1)(1994-2#1)(1995-12#1)(2006-7#1)(2007-12#1)(2008-12#1)(2008-3#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
showed a steady rise##2##4##(2007-1#1)(2008-3#1)
showed a steady##5##3##(2006-6#1)(2007-1#1)(2008-3#2)(2009-10#1)
showed a steep##2##3##(1992-8#1)(1995-5#1)
showed a stimulatory##2##3##(1996-5#1)(2008-5#1)
showed a striking similarity##2##4##(1990-2#1)(1995-2#1)
showed a striking##6##3##(1990-11#2)(1990-2#1)(1991-10#1)(1995-2#1)(2008-10#1)
showed a strong correlation between##2##5##(2007-2#1)(2007-8#1)
showed a strong correlation with##2##5##(2006-11#1)(2013-8#1)
showed a strong correlation##5##4##(2006-11#1)(2007-2#1)(2007-8#1)(2009-8#1)(2013-8#1)
showed a strong##27##3##(1991-6#1)(1991-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1996-2#1)(1996-3#1)(1996-6#1)(2005-11#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2009-4#1)(2009-8#2)(2010-10#1)(2012-2#1)(2013-7#2)(2013-8#2)
showed a stronger##3##3##(1993-11#1)(2009-12#1)(2010-4#1)
showed a substantial increase in##2##5##(2010-3#1)(2013-1#1)
showed a substantial##4##3##(1994-3#1)(2008-10#1)(2010-3#1)(2013-1#1)
showed a synergism##2##3##(2009-3#1)(2010-11#1)
showed a tendency to increase##2##5##(2008-10#1)(2008-3#1)
showed a tendency to##6##4##(1991-1#1)(1991-5#1)(2008-10#1)(2008-3#1)(2010-2#1)(2012-2#1)
showed a tendency towards##2##4##(1993-3#1)(2011-2#1)
showed a tendency##11##3##(1991-1#1)(1991-5#1)(1993-3#1)(1993-8#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-3#1)(2010-2#1)(2011-2#1)(2012-2#1)
showed a time##3##3##(1996-1#1)(2006-4#1)(2008-10#1)
showed a time-dependent##2##3##(2006-5#1)(2008-11#1)
showed a total##2##3##(2007-11#1)(2013-1#1)
showed a transient##4##3##(1996-1#1)(1997-7#1)(2007-11#1)(2010-11#1)
showed a trend toward##4##4##(1990-5#1)(2006-2#1)(2006-7#1)(2011-2#1)
showed a trend towards##2##4##(2008-7#1)(2009-3#1)
showed a trend##8##3##(1990-5#1)(2006-2#1)(2006-7#1)(2008-7#2)(2009-3#1)(2011-2#1)(2012-1#1)
showed a typical##9##3##(1990-4#1)(1994-8#2)(1997-2#1)(2008-10#3)(2008-11#1)(2008-12#1)
showed a uniform##2##3##(2010-8#1)(2013-1#1)
showed a variable##5##3##(1992-6#2)(1994-12#1)(2008-5#1)(2010-12#1)
showed a variation##2##3##(2012-2#2)
showed a variety of##2##4##(1997-3#1)(2008-11#1)
showed a very good##5##4##(2006-10#1)(2007-11#1)(2008-10#2)(2008-12#1)
showed a very high##2##4##(2008-10#1)(2012-6#1)
showed a very low##2##4##(2006-8#1)(2011-2#1)
showed a very##13##3##(1991-4#1)(1992-9#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-5#1)(2011-2#1)(2012-6#1)
showed a weak##3##3##(1991-7#1)(1996-4#1)(2007-11#1)
showed a wide range##2##4##(1997-3#1)(2006-12#1)
showed a wide##5##3##(1992-4#1)(1997-3#1)(2006-12#1)(2007-3#2)
showed a worse##2##3##(1990-8#1)(2008-3#1)
showed a##1510##2##(1990-10#9)(1990-11#7)(1990-12#11)(1990-2#7)(1990-3#8)(1990-4#3)(1990-5#6)(1990-6#5)(1990-7#3)(1990-8#4)(1990-9#4)(1991-1#5)(1991-10#8)(1991-11#4)(1991-12#10)(1991-2#3)(1991-3#5)(1991-4#4)(1991-5#5)(1991-6#7)(1991-7#3)(1991-8#6)(1991-9#9)(1992-1#1)(1992-10#7)(1992-11#4)(1992-12#7)(1992-2#5)(1992-3#4)(1992-4#3)(1992-5#1)(1992-6#7)(1992-7#7)(1992-8#7)(1992-9#4)(1993-1#3)(1993-10#1)(1993-11#10)(1993-12#7)(1993-2#6)(1993-3#7)(1993-4#4)(1993-5#4)(1993-6#10)(1993-7#6)(1993-8#3)(1993-9#8)(1994-10#2)(1994-11#9)(1994-12#13)(1994-2#10)(1994-3#9)(1994-5#2)(1994-6#10)(1994-7#1)(1994-8#14)(1994-9#6)(1995-1#4)(1995-10#1)(1995-11#5)(1995-12#11)(1995-2#12)(1995-3#8)(1995-5#7)(1995-6#3)(1995-7#3)(1995-8#2)(1995-9#2)(1996-1#5)(1996-10#2)(1996-11#4)(1996-12#7)(1996-2#7)(1996-3#11)(1996-4#4)(1996-5#7)(1996-6#6)(1996-7#2)(1996-8#2)(1996-9#6)(1997-1#8)(1997-2#5)(1997-3#9)(1997-4#11)(1997-5#6)(1997-6#7)(1997-7#7)(1997-8#16)(2004-11#4)(2004-4#2)(2004-9#3)(2005-10#5)(2005-11#12)(2005-12#4)(2005-7#2)(2005-8#5)(2005-9#1)(2006-1#1)(2006-10#15)(2006-11#4)(2006-12#11)(2006-2#6)(2006-3#2)(2006-4#2)(2006-5#3)(2006-6#4)(2006-7#3)(2006-8#13)(2006-9#7)(2007-1#4)(2007-10#11)(2007-11#19)(2007-12#11)(2007-2#11)(2007-3#5)(2007-4#2)(2007-5#8)(2007-6#1)(2007-7#13)(2007-8#25)(2007-9#9)(2008-1#12)(2008-10#139)(2008-11#40)(2008-12#9)(2008-2#11)(2008-3#17)(2008-4#12)(2008-5#52)(2008-6#16)(2008-7#32)(2008-8#19)(2008-9#13)(2009-1#3)(2009-10#4)(2009-12#5)(2009-2#2)(2009-3#7)(2009-4#9)(2009-5#8)(2009-6#4)(2009-7#3)(2009-8#18)(2010-1#7)(2010-10#2)(2010-11#2)(2010-12#15)(2010-2#7)(2010-3#5)(2010-4#10)(2010-5#5)(2010-7#1)(2010-8#14)(2010-9#2)(2011-1#23)(2011-10#1)(2011-12#5)(2011-2#44)(2011-3#3)(2012-1#12)(2012-11#3)(2012-12#26)(2012-2#29)(2012-3#10)(2012-5#1)(2012-6#1)(2012-7#1)(2013-1#45)(2013-7#12)(2013-8#33)
showed abnormal##9##2##(1997-7#2)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-1#1)(2013-7#1)
showed about##2##2##(1993-12#1)(2009-3#1)
showed absorbance maxima at##2##4##(2010-2#2)
showed absorbance##3##2##(2008-5#1)(2010-2#2)
showed abundant##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
showed acceptable agreement##2##3##(2008-10#2)
showed acceptable##6##2##(1997-5#1)(2008-10#2)(2010-4#1)(2012-11#1)(2013-1#1)
showed accumulation of##3##3##(1996-3#1)(2008-10#1)(2008-5#1)
showed activation of the##2##4##(1990-11#1)(2008-2#1)
showed active##2##2##(2012-12#1)(2013-1#1)
showed activity##6##2##(1995-6#1)(2006-3#1)(2007-6#1)(2008-11#1)(2008-7#1)(2010-2#1)
showed adenocarcinoma##2##2##(2010-9#2)
showed adequate##2##2##(2008-5#1)(2011-2#1)
showed agreement with##2##3##(2008-10#1)(2008-3#1)
showed all##4##2##(1995-2#1)(2006-8#1)(2007-7#1)(2009-3#1)
showed almost identical##2##3##(1992-3#1)(1992-6#1)
showed almost##6##2##(1990-6#1)(1991-10#1)(1992-3#1)(1992-6#1)(1993-3#1)(2008-8#1)
showed also##5##2##(1990-12#1)(1990-7#1)(1991-2#1)(1995-10#1)(1995-3#1)
showed alterations##2##2##(1995-6#1)(1997-2#1)
showed altered##4##2##(1993-2#1)(2008-10#2)(2012-1#1)
showed an abnormal##2##3##(2007-2#1)(2008-10#1)
showed an absorption##2##3##(1995-3#1)(2008-10#1)
showed an accumulation##2##3##(1991-10#1)(1995-8#1)
showed an age-related increase in##2##5##(1996-11#1)(1996-4#1)
showed an almost complete##2##4##(1995-5#1)(2007-11#1)
showed an almost##6##3##(1990-3#1)(1990-8#1)(1995-5#1)(2007-11#1)(2007-6#1)(2012-3#1)
showed an aneurysm of the##2##5##(2010-9#2)
showed an apparent Km of##2##5##(1992-3#1)(2008-11#1)
showed an apparent molecular##2##4##(1993-9#1)(1997-2#1)
showed an apparent##10##3##(1990-12#1)(1992-3#1)(1993-3#1)(1993-9#1)(1997-2#1)(2006-10#1)(2008-10#2)(2008-11#1)(2012-1#1)
showed an association##4##3##(2009-2#1)(2011-2#1)(2012-12#1)(2012-3#1)
showed an average of##3##4##(2008-5#1)(2011-2#1)(2013-1#1)
showed an average##10##3##(1992-3#1)(2006-8#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-8#1)(2011-2#2)(2013-1#1)
showed an effect of##2##4##(2006-11#1)(2008-11#1)
showed an effect##4##3##(1991-9#1)(2006-11#1)(2008-11#1)(2011-2#1)
showed an elevation##2##3##(1990-6#1)(2007-11#1)
showed an enhanced##5##3##(1994-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2012-3#1)
showed an excellent fit to##2##5##(2008-2#1)(2012-1#1)
showed an excellent##9##3##(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-4#1)(2011-2#1)(2012-1#1)
showed an expansive##2##3##(2007-12#1)(2008-7#1)
showed an identical##2##3##(1995-10#1)(2007-6#1)
showed an improvement in the##2##5##(2007-11#1)(2012-12#1)
showed an improvement in##9##4##(1994-11#1)(2007-11#1)(2008-10#1)(2008-6#2)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#1)
showed an improvement of##3##4##(2007-5#1)(2008-10#1)(2008-3#1)
showed an improvement##15##3##(1994-11#1)(1997-6#1)(2005-9#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-6#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#1)
showed an increase in the##7##5##(1996-3#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-8#1)
showed an increase in##32##4##(1991-8#1)(1993-2#1)(1994-11#1)(1994-9#1)(1996-3#1)(1996-5#1)(2005-11#1)(2007-2#1)(2007-8#3)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-11#2)(2012-12#2)(2013-8#1)
showed an increase of##4##4##(1993-2#1)(1993-3#1)(1996-1#1)(2008-3#1)
showed an increase##43##3##(1991-1#1)(1991-8#1)(1993-2#2)(1993-3#1)(1993-4#1)(1994-11#1)(1994-9#1)(1996-1#1)(1996-3#1)(1996-5#1)(2003-11#1)(2005-11#1)(2007-2#1)(2007-8#3)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-11#2)(2012-12#2)(2013-8#1)
showed an increased sensitivity##2##4##(1991-4#1)(1995-5#1)
showed an increased##17##3##(1990-11#1)(1991-4#1)(1991-5#1)(1992-3#1)(1992-5#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-5#1)(1996-1#1)(2008-4#1)(2008-7#1)(2010-8#1)(2012-12#2)(2012-2#1)
showed an increasing trend##2##4##(1993-6#1)(2008-3#1)
showed an increasing##3##3##(1993-6#1)(2008-3#1)(2012-3#1)
showed an inhibitory effect##2##4##(2005-8#1)(2008-11#1)
showed an initial increase##2##4##(1990-7#1)(2004-9#1)
showed an initial##4##3##(1990-7#1)(2004-9#1)(2008-10#1)(2008-11#1)
showed an intact##2##3##(2008-8#1)(2013-1#1)
showed an interaction between##2##4##(1991-2#1)(2009-1#1)
showed an interesting##2##3##(1996-1#1)(2012-2#1)
showed an intermediate##4##3##(2004-11#1)(2007-5#1)(2011-2#1)(2013-8#1)
showed an invasive##2##3##(1996-3#1)(2013-7#1)
showed an inverse relationship with the##2##6##(1996-6#1)(2008-7#1)
showed an inverse relationship with##4##5##(1996-6#2)(2008-7#1)(2012-2#1)
showed an inverse##6##3##(1996-3#1)(1996-6#2)(2005-11#1)(2008-7#1)(2012-2#1)
showed an open reading frame of##2##6##(1992-12#1)(1995-8#1)
showed an open reading frame##3##5##(1992-12#1)(1994-12#1)(1995-8#1)
showed an optimum##2##3##(2008-10#2)
showed an overall##8##3##(1992-9#1)(1994-6#2)(1996-7#1)(1997-5#1)(2006-10#1)(2008-11#2)
showed an unusual##2##3##(1991-6#1)(2008-9#1)
showed an##285##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-4#2)(1992-5#2)(1992-7#1)(1992-8#3)(1992-9#1)(1993-2#2)(1993-3#2)(1993-4#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#3)(1994-2#1)(1994-6#6)(1994-7#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-12#1)(1995-3#3)(1995-5#2)(1995-8#2)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(2003-11#1)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#3)(2005-5#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#2)(2006-5#1)(2006-8#2)(2007-11#4)(2007-12#2)(2007-2#2)(2007-3#2)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#6)(2007-9#2)(2008-10#25)(2008-11#11)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#10)(2008-8#2)(2008-9#3)(2009-1#1)(2009-2#2)(2009-4#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-8#3)(2010-9#3)(2011-1#1)(2011-2#16)(2012-1#4)(2012-11#2)(2012-12#7)(2012-2#4)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#5)
showed and##2##2##(1993-10#1)(1994-7#1)
showed anti-inflammatory activity##2##3##(2010-12#1)(2011-1#1)
showed antifungal activity##2##3##(2005-8#1)(2008-5#1)
showed antimicrobial activity against##3##4##(2008-11#1)(2008-2#1)(2010-5#1)
showed antimicrobial activity##5##3##(2008-11#1)(2008-2#1)(2010-2#1)(2010-5#1)(2011-12#1)
showed antiviral##2##2##(1996-4#1)(2013-1#1)
showed any evidence of##2##4##(1991-3#1)(2008-8#1)
showed any significant##3##3##(1990-11#1)(1993-11#1)(2006-2#1)
showed any##22##2##(1990-11#1)(1991-3#1)(1992-12#1)(1993-11#2)(1993-6#1)(1995-3#1)(1996-9#1)(2006-2#1)(2006-9#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)
showed appreciable##4##2##(1994-12#1)(2006-12#1)(2008-10#1)(2008-4#1)
showed approximately##5##2##(1990-12#1)(1995-1#1)(2005-11#1)(2009-12#1)(2010-1#1)
showed association with##2##3##(2011-2#1)(2012-11#1)
showed at least two##2##4##(1994-6#1)(1995-11#1)
showed at least##7##3##(1994-6#1)(1995-1#1)(1995-11#1)(1996-5#1)(1996-8#1)(2007-7#1)(2008-6#1)
showed atrophy##2##2##(2008-5#1)(2011-1#1)
showed baseline##2##2##(1991-3#1)(2011-2#1)
showed beneficial effects##2##3##(1994-2#1)(2010-2#1)
showed benefit##2##2##(2007-8#1)(2008-10#1)
showed best##3##2##(2012-3#1)(2013-1#2)
showed better performance##3##3##(2008-10#1)(2010-8#1)(2013-1#1)
showed better response##3##3##(2007-7#1)(2007-8#1)(2008-10#1)
showed better##25##2##(1990-3#1)(1991-7#1)(1993-12#1)(1995-2#1)(1997-8#2)(2005-9#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#7)(2008-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-7#1)
showed bilateral##10##2##(1990-3#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2010-11#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
showed binding##2##2##(2007-1#1)(2008-8#1)
showed bone##2##2##(1994-7#1)(2010-12#1)
showed both##15##2##(1991-9#1)(1992-7#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-9#1)(2011-2#2)(2012-11#1)
showed broad-spectrum##2##2##(2008-10#1)(2012-11#1)
showed by the##3##3##(2007-5#1)(2008-2#1)(2008-8#1)
showed by##7##2##(1991-6#1)(2007-3#1)(2007-5#1)(2008-2#1)(2008-8#1)(2010-11#1)(2012-2#1)
showed c-Kit##2##2##(2009-12#2)
showed calcium##2##2##(2010-12#1)(2010-5#1)
showed cell##2##2##(1995-5#1)(2008-10#1)
showed cells##2##2##(2006-10#1)(2010-8#1)
showed changes in the##2##4##(2007-7#1)(2008-10#1)
showed changes in their##2##4##(2009-6#1)(2011-2#1)
showed changes in##7##3##(1993-11#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-7#1)(2009-6#1)(2011-2#1)
showed changes##11##2##(1991-7#1)(1992-1#1)(1993-11#1)(1995-12#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-7#1)(2009-6#1)(2011-2#1)
showed characteristic##6##2##(1993-12#1)(2006-10#2)(2008-10#1)(2008-2#1)(2011-1#1)
showed characteristics##2##2##(2008-10#1)(2010-1#1)
showed chronic##5##2##(1992-9#1)(1997-5#1)(2006-12#1)(2007-7#1)(2008-1#1)
showed clear##15##2##(1990-4#1)(1993-11#1)(1994-8#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)(2009-10#1)(2009-8#1)
showed clearly that##2##3##(1997-7#1)(2007-12#1)
showed clearly##3##2##(1994-11#1)(1997-7#1)(2007-12#1)
showed clinical improvement##2##3##(1990-2#1)(2008-5#1)
showed clinical signs of##2##4##(1992-11#1)(2005-7#1)
showed clinical##10##2##(1990-2#1)(1991-2#1)(1991-6#1)(1992-11#1)(1993-9#1)(2005-7#1)(2008-5#1)(2009-10#1)(2009-5#1)(2010-12#1)
showed clonal##2##2##(1992-8#1)(1992-9#1)
showed close##4##2##(1992-8#1)(1996-7#1)(2006-5#1)(2010-5#1)
showed closest##2##2##(2008-10#2)
showed comparable activity##2##3##(1995-12#1)(2007-11#1)
showed comparable##12##2##(1990-12#1)(1991-6#1)(1994-3#1)(1994-6#1)(1995-12#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)
showed comparatively##2##2##(2007-12#1)(2008-11#1)
showed complete##14##2##(1992-7#1)(1995-2#1)(1995-3#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-7#1)(2008-8#1)(2012-1#1)(2013-1#3)
showed concentrations##2##2##(2008-3#1)(2008-5#1)
showed conclusively that##3##3##(1995-2#1)(2007-3#1)(2008-10#1)
showed concurrent##2##2##(1991-10#1)(2006-10#1)
showed conservation of##2##3##(1993-12#1)(2008-5#1)
showed considerable activity##2##3##(1992-9#1)(2008-5#1)
showed considerable##17##2##(1992-1#1)(1992-4#1)(1992-9#1)(1993-4#1)(1995-4#2)(2004-4#1)(2005-11#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-5#2)(2008-9#1)(2009-6#1)(2011-2#1)(2013-7#1)
showed considerably##3##2##(1990-9#1)(2008-5#1)(2012-12#1)
showed consistent improvement##2##3##(2008-7#1)(2012-3#1)
showed consistent##8##2##(1990-7#1)(1992-7#1)(1994-9#1)(1996-2#1)(2005-11#1)(2008-7#1)(2008-8#1)(2012-3#1)
showed continuous##2##2##(1991-3#1)(2010-4#1)
showed correlation##2##2##(2008-10#1)(2011-2#1)
showed cortical##2##2##(1996-1#1)(2006-10#1)
showed cross-reactivity with##2##3##(1991-5#1)(2009-4#1)
showed cross-resistance to##2##3##(1991-7#2)
showed cytotoxic##3##2##(1992-2#1)(1994-9#1)(2008-3#1)
showed cytotoxicity against K562 cells##2##5##(2008-11#2)
showed cytotoxicity against##3##3##(2008-11#2)(2011-3#1)
showed cytotoxicity##4##2##(1992-2#1)(2008-11#2)(2011-3#1)
showed damage##2##2##(2008-5#1)(2008-7#1)
showed decrease in##2##3##(2006-8#1)(2007-2#1)
showed decrease##3##2##(1990-10#1)(2006-8#1)(2007-2#1)
showed decreased##19##2##(1991-1#1)(1991-11#1)(1991-4#1)(1993-2#1)(1993-8#1)(1994-6#1)(1995-1#1)(1995-6#1)(1996-2#2)(1997-4#1)(1997-7#1)(2006-10#1)(2007-2#1)(2008-4#1)(2008-5#1)(2009-3#1)(2009-8#1)(2011-12#1)
showed decreases##2##2##(2008-5#1)(2013-1#1)
showed defects##2##2##(1996-3#1)(2012-12#1)
showed deficiencies##3##2##(2007-3#1)(2010-12#1)(2011-2#1)
showed deficits##2##2##(1997-8#1)(2009-4#1)
showed degeneration##3##2##(2008-5#1)(2011-1#1)(2013-1#1)
showed degradation of##2##3##(2008-7#2)
showed degradation##3##2##(2008-7#2)(2010-2#1)
showed delayed##2##2##(1993-2#1)(2010-3#1)
showed dense##2##2##(2008-11#2)
showed depression##2##2##(2008-5#2)
showed detectable##2##2##(1994-8#1)(2006-10#1)
showed deterioration##2##2##(2007-10#1)(2009-8#1)
showed differences between the##4##4##(1993-11#1)(2006-7#2)(2013-8#1)
showed differences between##6##3##(1993-11#1)(2006-7#2)(2006-8#1)(2008-11#1)(2013-8#1)
showed differences in the##2##4##(1993-12#1)(2010-3#1)
showed differences in##3##3##(1991-4#1)(1993-12#1)(2010-3#1)
showed differences##10##2##(1991-4#1)(1993-11#1)(1993-12#2)(2006-7#2)(2006-8#1)(2008-11#1)(2010-3#1)(2013-8#1)
showed different distribution##2##3##(1995-11#1)(2008-10#1)
showed different levels of##2##4##(2008-10#2)
showed different patterns of##2##4##(1994-6#1)(1997-7#1)
showed different##23##2##(1990-9#1)(1992-8#1)(1993-4#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-3#1)(1997-1#1)(1997-7#1)(2005-11#1)(2006-6#1)(2008-10#8)(2009-3#1)(2013-1#2)
showed differential expression##3##3##(2010-12#1)(2010-4#1)(2013-8#1)
showed differential##5##2##(2008-10#1)(2010-12#1)(2010-4#1)(2012-3#1)(2013-8#1)
showed diffuse##10##2##(1991-12#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-7#2)(2010-10#1)(2010-12#1)(2011-1#1)(2013-1#1)
showed dilated##2##2##(1992-10#1)(2010-6#1)
showed diminished##2##2##(1994-6#1)(2008-10#1)
showed discrimination##2##2##(2008-10#1)(2012-2#1)
showed disease##2##2##(2006-10#1)(2008-10#1)
showed distinct##12##2##(1994-2#1)(1995-5#1)(2006-10#1)(2007-12#1)(2007-2#2)(2008-10#2)(2008-2#1)(2008-8#1)(2009-8#1)(2013-1#1)
showed dose-dependent inhibition of##2##4##(1990-12#1)(1992-12#1)
showed dose-dependent##3##2##(1990-12#1)(1992-12#1)(2008-10#1)
showed early##3##2##(2007-7#1)(2008-10#1)(2012-12#1)
showed effective##2##2##(2008-5#2)
showed either##3##2##(1995-11#1)(2005-11#1)(2012-2#1)
showed elevated eIF4E in##2##4##(1997-7#2)
showed elevated levels of##2##4##(1993-6#1)(2010-12#1)
showed elevated##6##2##(1993-6#1)(1993-8#1)(1994-11#1)(1997-7#2)(2010-12#1)
showed encouraging##2##2##(1995-9#1)(2008-1#1)
showed enhanced##15##2##(1994-5#1)(1995-3#1)(1997-1#1)(2008-10#5)(2008-11#2)(2008-5#1)(2009-4#1)(2010-11#1)(2011-2#1)(2013-1#1)
showed enlarged##2##2##(2008-3#1)(2008-6#1)
showed enlargement##2##2##(2007-8#1)(2012-3#1)
showed enough##2##2##(2005-11#1)(2013-8#1)
showed enrichment##2##2##(1994-12#1)(2005-11#1)
showed enzymatic##2##2##(1994-8#1)(2009-8#1)
showed equivalent##3##2##(1992-3#1)(2008-5#1)(2009-5#1)
showed erosive##2##2##(1993-7#1)(2009-10#1)
showed essentially##2##2##(1990-6#1)(2006-10#1)
showed even##3##2##(1994-12#1)(1994-3#1)(2010-4#1)
showed evidence of a##5##4##(1991-4#1)(1991-9#1)(2010-8#1)(2011-2#2)
showed evidence of scarring##3##4##(2004-2#1)(2008-4#2)
showed evidence of##33##3##(1991-12#1)(1991-4#1)(1991-9#1)(1992-7#1)(1992-8#2)(1994-5#1)(1997-6#1)(2004-2#1)(2005-7#1)(2005-9#1)(2006-8#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#3)(2008-8#2)(2008-9#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#2)
showed evidence that##2##3##(1997-8#1)(2013-7#1)
showed evidence##35##2##(1991-12#1)(1991-4#1)(1991-9#1)(1992-7#1)(1992-8#2)(1994-5#1)(1997-6#1)(1997-8#1)(2004-2#1)(2005-7#1)(2005-9#1)(2006-8#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#3)(2008-8#2)(2008-9#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)
showed excellent activities##2##3##(1992-5#1)(2010-4#1)
showed excellent agreement##2##3##(2007-12#1)(2008-10#1)
showed excellent electrocatalytic##2##3##(2008-10#2)
showed excellent linearity##3##3##(2008-10#2)(2011-3#1)
showed excellent performance##2##3##(2008-10#1)(2012-3#1)
showed excellent precision##3##3##(1990-6#1)(2008-10#1)(2010-8#1)
showed excellent response##2##3##(2007-2#1)(2008-7#1)
showed excellent sensitivity##2##3##(2008-10#1)(2012-2#1)
showed excellent##35##2##(1990-6#1)(1991-12#1)(1991-2#1)(1992-5#1)(1993-1#1)(1995-12#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#12)(2008-3#1)(2008-5#1)(2008-7#3)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-3#1)(2012-2#2)(2012-3#1)
showed extensive##13##2##(1990-12#1)(1991-7#1)(1993-6#1)(1994-12#1)(1995-3#2)(1995-7#1)(1996-2#1)(2006-2#1)(2007-2#1)(2008-10#1)(2009-3#1)(2010-12#1)
showed faint##2##2##(1995-8#1)(2009-8#1)
showed fairly good##2##3##(2007-7#1)(2011-1#1)
showed fairly##4##2##(1993-5#1)(1994-3#1)(2007-7#1)(2011-1#1)
showed false##3##2##(1993-10#1)(2006-8#1)(2007-7#1)
showed faster engraftment##2##3##(2010-4#2)
showed faster##3##2##(1992-7#1)(2010-4#2)
showed fatty##2##2##(2008-5#1)(2012-12#1)
showed favorable##2##2##(2006-5#1)(2008-10#1)
showed features of##6##3##(2007-7#2)(2007-8#1)(2008-3#1)(2010-12#1)(2011-12#1)
showed features##12##2##(2007-7#3)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-12#1)(2010-6#1)(2011-12#1)(2013-8#1)
showed few##2##2##(1992-10#1)(2008-11#1)
showed fewer##3##2##(1990-12#1)(2008-3#1)(2011-1#1)
showed fibrosis##2##2##(2006-2#1)(2008-6#1)
showed findings##3##2##(2006-4#1)(2008-1#1)(2010-12#1)
showed fine##2##2##(1995-2#1)(2012-1#1)
showed focal##3##2##(2009-7#1)(2009-8#1)(2012-2#1)
showed for the first time a##2##6##(2009-8#1)(2012-2#1)
showed for the first time that##2##6##(1990-4#1)(1992-12#1)
showed for the first time##4##5##(1990-4#1)(1992-12#1)(2009-8#1)(2012-2#1)
showed for##8##2##(1990-4#1)(1992-12#1)(2008-10#2)(2008-5#1)(2009-8#1)(2011-2#1)(2012-2#1)
showed formation of##3##3##(1994-9#1)(2013-1#2)
showed four##4##2##(1990-11#1)(2008-5#1)(2011-2#1)(2012-3#1)
showed free##2##2##(1993-6#1)(2008-11#1)
showed full##4##2##(1992-8#1)(1994-11#1)(1996-11#1)(2011-1#1)
showed fungal##2##2##(2008-10#1)(2013-8#1)
showed further clearing of the pigmentation to the next lower grade##2##11##(2007-7#2)
showed further##4##2##(1991-12#1)(2007-7#2)(2008-10#1)
showed generally##5##2##(1991-1#1)(1992-6#1)(1996-8#1)(2007-1#1)(2010-10#1)
showed genotypic##2##2##(2008-10#2)
showed global##3##2##(2007-8#2)(2007-9#1)
showed good agreement and##2##4##(2008-10#1)(2011-1#1)
showed good agreement between the##2##5##(2008-10#2)
showed good agreement between##4##4##(2008-10#3)(2008-5#1)
showed good agreement with the certified value##2##7##(2008-10#2)
showed good agreement with the certified##3##6##(2008-10#3)
showed good agreement with the##4##5##(2008-10#3)(2008-3#1)
showed good agreement with those##2##5##(1993-9#1)(2008-10#1)
showed good agreement with##12##4##(1993-9#1)(2004-4#1)(2007-12#1)(2008-10#6)(2008-3#1)(2008-5#1)(2012-12#1)
showed good agreement##27##3##(1993-9#1)(2004-4#1)(2007-12#1)(2008-10#15)(2008-2#1)(2008-3#2)(2008-5#3)(2011-1#2)(2012-12#1)
showed good correlation in the concentration##2##6##(2008-10#2)
showed good correlation in##3##4##(2008-10#2)(2008-5#1)
showed good correlation with the##2##5##(2008-2#1)(2010-2#1)
showed good correlation with##4##4##(1992-11#1)(2007-10#1)(2008-2#1)(2010-2#1)
showed good correlation##9##3##(1992-11#1)(2007-10#1)(2008-10#4)(2008-2#1)(2008-5#1)(2010-2#1)
showed good linear relationship##4##4##(2008-10#2)(2011-2#1)(2012-12#1)
showed good linearity in the concentration range##2##7##(2008-10#2)
showed good linearity in the##3##5##(2008-10#2)(2011-1#1)
showed good linearity##8##3##(1993-8#1)(1996-5#1)(2008-10#4)(2011-1#1)(2012-3#1)
showed good patency of the##2##5##(1990-4#1)(2007-8#1)
showed good precision##2##3##(2008-10#1)(2011-2#1)
showed good recovery##2##3##(2007-10#1)(2007-8#1)
showed good reproducibility##3##3##(1993-11#1)(2008-10#1)(2012-12#1)
showed good response to##5##4##(2007-7#1)(2008-10#1)(2008-4#1)(2009-2#1)(2013-1#1)
showed good response##6##3##(2007-7#1)(2008-10#2)(2008-4#1)(2009-2#1)(2013-1#1)
showed good results##3##3##(2008-11#2)(2008-6#1)
showed good sensitivity and##2##4##(2008-10#2)
showed good sensitivity in the##2##5##(2008-10#1)(2012-2#1)
showed good sensitivity##6##3##(2008-10#4)(2012-2#2)
showed good stability##3##3##(2005-12#1)(2008-10#1)(2008-3#1)
showed good##113##2##(1990-11#1)(1990-4#1)(1990-6#1)(1992-11#1)(1992-5#1)(1993-11#1)(1993-8#1)(1993-9#1)(1995-3#1)(1995-5#1)(1996-5#1)(2004-4#2)(2005-12#1)(2006-11#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-7#3)(2007-8#2)(2008-10#45)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#1)(2009-2#1)(2010-12#1)(2010-2#2)(2010-5#2)(2011-1#3)(2011-2#3)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#3)(2013-1#1)
showed grade III or greater##3##5##(1996-6#3)
showed grade##4##2##(1996-6#4)
showed gradual improvement##2##3##(2006-8#1)(2010-12#1)
showed gradual##4##2##(2006-8#1)(2008-11#1)(2010-12#1)(2013-1#1)
showed granulomatous inflammation with##2##4##(2012-2#2)
showed granulomatous inflammation##3##3##(2006-10#1)(2012-2#2)
showed granulomatous##4##2##(2006-10#1)(2011-1#1)(2012-2#2)
showed great variability##2##3##(2008-11#1)(2008-5#1)
showed great##8##2##(1991-9#1)(1992-2#1)(2005-6#1)(2006-9#1)(2007-6#1)(2008-11#1)(2008-5#1)(2012-12#1)
showed greater improvement in##3##4##(1992-5#1)(2010-12#1)(2010-4#1)
showed greater improvement##4##3##(1992-5#1)(2008-9#1)(2010-12#1)(2010-4#1)
showed greater performance duration in##2##5##(2012-12#2)
showed greater than##3##3##(2006-8#1)(2008-10#1)(2008-9#1)
showed greater##42##2##(1991-12#1)(1992-5#1)(1993-3#1)(1994-3#2)(1996-6#1)(1997-6#1)(2006-8#1)(2007-12#2)(2007-2#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#3)(2009-11#1)(2010-12#1)(2010-2#4)(2010-4#1)(2010-8#1)(2012-12#3)(2012-2#1)(2013-7#2)
showed greatest##2##2##(1992-8#1)(2008-7#1)
showed growth retardation##2##3##(2006-4#1)(2008-4#1)
showed growth##10##2##(1997-4#1)(2005-12#1)(2006-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2009-6#1)
showed here that##3##3##(1997-7#1)(2008-11#2)
showed here##4##2##(1991-9#1)(1997-7#1)(2008-11#2)
showed heterogeneity##2##2##(2008-12#1)(2008-9#1)
showed heterogeneous##2##2##(2012-12#1)(2013-8#1)
showed high affinity for the##3##5##(1994-11#1)(1994-9#1)(1997-4#1)
showed high affinity for##4##4##(1992-7#1)(1994-11#1)(1994-9#1)(1997-4#1)
showed high affinity##8##3##(1992-7#1)(1994-11#1)(1994-8#1)(1994-9#1)(1997-4#1)(2008-10#1)(2009-12#1)(2009-6#1)
showed high and low##2##4##(1992-8#1)(1993-3#1)
showed high concentrations of##2##4##(1996-3#1)(2007-5#1)
showed high degree of##2##4##(2007-7#1)(2010-5#1)
showed high expression##2##3##(2008-10#1)(2010-3#1)
showed high genetic##2##3##(2008-10#1)(2010-8#1)
showed high homology to##5##4##(1990-5#1)(1993-12#1)(1994-6#1)(1996-8#1)(1997-2#1)
showed high homology with the##2##5##(1992-7#1)(1993-8#1)
showed high homology with##4##4##(1992-7#1)(1993-8#1)(2008-10#1)(2008-8#1)
showed high homology##10##3##(1990-5#1)(1992-7#1)(1993-12#1)(1993-8#1)(1994-6#1)(1996-8#1)(1997-2#1)(2008-10#1)(2008-8#1)(2012-2#1)
showed high levels of##8##4##(1993-5#1)(1993-6#1)(1996-2#1)(2006-9#1)(2008-10#1)(2011-10#1)(2013-1#1)(2013-8#1)
showed high potential##2##3##(2008-10#1)(2010-4#1)
showed high prevalence of##2##4##(2006-10#1)(2011-1#1)
showed high reliability##2##3##(2008-10#1)(2013-1#1)
showed high selectivity##4##3##(2008-10#3)(2008-5#1)
showed high sensitivity and##2##4##(2008-10#2)
showed high sensitivity##4##3##(2007-9#1)(2008-10#3)
showed high similarity to##2##4##(1991-5#1)(1996-4#1)
showed high##97##2##(1990-5#1)(1991-5#1)(1992-2#1)(1992-7#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-6#1)(1994-8#2)(1994-9#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2005-11#3)(2005-7#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-1#2)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#18)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2009-12#1)(2009-6#2)(2010-3#2)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#1)(2012-11#1)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#3)
showed high-grade##2##2##(2007-9#1)(2011-2#1)
showed higher bond##2##3##(2008-12#1)(2013-1#1)
showed higher effect##2##3##(1994-11#1)(2010-9#1)
showed higher efficiency than##2##4##(1992-9#1)(2010-5#1)
showed higher efficiency##3##3##(1992-9#1)(2010-5#1)(2010-9#1)
showed higher expression##2##3##(2008-11#1)(2010-7#1)
showed higher levels of##2##4##(2008-10#1)(2008-9#1)
showed higher levels##3##3##(2008-10#1)(2008-9#1)(2012-12#1)
showed higher prevalence of##2##4##(2006-10#1)(2013-8#1)
showed higher prevalence##3##3##(2006-10#1)(2008-5#1)(2013-8#1)
showed higher##66##2##(1990-9#1)(1992-2#2)(1992-8#1)(1992-9#2)(1993-9#1)(1994-11#1)(1994-6#1)(1995-2#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#3)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#2)(2009-2#2)(2009-3#1)(2009-4#2)(2009-7#1)(2010-12#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-9#2)(2011-12#1)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#5)
showed highest##5##2##(1994-8#1)(2008-10#1)(2008-5#1)(2011-2#2)
showed highly significant##2##3##(2008-5#1)(2009-2#1)
showed highly##3##2##(1996-6#1)(2008-5#1)(2009-2#1)
showed histological##2##2##(1991-2#1)(2013-7#1)
showed homology with##4##3##(1990-3#1)(1996-3#1)(2006-8#1)(2013-1#1)
showed homology##6##2##(1990-3#1)(1995-2#1)(1996-3#1)(1997-2#1)(2006-8#1)(2013-1#1)
showed how##4##2##(2007-12#1)(2008-12#1)(2008-7#1)(2010-7#1)
showed hydrocephalus##2##2##(1990-9#1)(2008-7#1)
showed identical##4##2##(1990-10#1)(1991-1#1)(2008-10#1)(2008-7#1)
showed immediate##2##2##(2007-1#1)(2012-3#1)
showed immunoreactivity for##2##3##(1991-6#1)(2007-9#1)
showed immunoreactivity with##2##3##(1990-11#1)(1992-12#1)
showed immunoreactivity##4##2##(1990-11#1)(1991-6#1)(1992-12#1)(2007-9#1)
showed impaired##5##2##(1993-12#1)(1996-3#1)(1996-7#1)(2011-1#1)(2013-1#1)
showed impairment of##2##3##(1990-3#1)(2013-1#1)
showed impairment##3##2##(1990-3#1)(2004-10#1)(2013-1#1)
showed impressive##2##2##(2008-7#1)(2012-1#1)
showed improved##10##2##(1993-11#1)(1994-8#1)(1995-3#1)(2007-1#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2012-2#1)(2012-3#1)
showed improvement in##5##3##(1990-12#1)(1996-5#1)(2007-9#1)(2012-1#1)(2012-11#1)
showed improvement of##2##3##(2007-10#1)(2011-1#1)
showed improvement##14##2##(1990-12#1)(1996-5#1)(2005-10#1)(2006-11#1)(2006-3#1)(2007-10#1)(2007-7#1)(2007-8#1)(2007-9#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#1)
showed improvements in##2##3##(2012-1#2)
showed in general##2##3##(2005-11#1)(2008-4#1)
showed in the##2##3##(2008-12#1)(2012-3#1)
showed in this##2##3##(2008-11#1)(2009-8#1)
showed in vitro##3##3##(2006-12#1)(2008-10#1)(2009-10#1)
showed in vivo##2##3##(2008-11#1)(2013-8#1)
showed in##23##2##(1992-6#1)(1995-10#1)(1996-5#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-4#1)(2009-10#1)(2009-8#1)(2009-9#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
showed increase in##2##3##(2012-3#1)(2013-8#1)
showed increase##4##2##(1992-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
showed increased allele sharing##2##4##(1997-5#2)
showed increased expression##2##3##(2011-2#1)(2012-2#1)
showed increased inhibition##2##3##(1994-9#1)(1995-6#1)
showed increased levels of##2##4##(1995-2#1)(2008-1#1)
showed increased muscle##2##3##(2009-6#1)(2010-8#1)
showed increased##65##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#2)(1991-3#1)(1992-8#1)(1993-12#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-6#1)(1995-7#1)(1996-2#2)(1997-2#2)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#2)(2004-2#1)(2004-4#1)(2006-10#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-6#1)(2008-9#2)(2009-4#1)(2009-6#1)(2009-7#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
showed increases in##2##3##(1995-12#1)(1996-5#1)
showed increases##3##2##(1995-12#1)(1996-5#1)(2008-7#1)
showed inferior##2##2##(2008-10#1)(2011-1#1)
showed inflated##2##2##(1992-2#1)(2010-4#1)
showed inhibition in##2##3##(2006-5#1)(2008-5#1)
showed inhibition of##4##3##(1995-2#1)(2008-11#1)(2008-5#2)
showed inhibition##8##2##(1993-3#1)(1995-2#1)(2005-11#1)(2006-5#1)(2008-11#1)(2008-5#3)
showed inhibitory activity against##2##4##(2007-11#1)(2012-2#1)
showed inhibitory##5##2##(2007-11#1)(2008-10#1)(2008-11#1)(2011-12#1)(2012-2#1)
showed initial##3##2##(2007-11#1)(2008-1#1)(2013-1#1)
showed intense##5##2##(1994-3#1)(1996-6#1)(1997-2#1)(2007-9#1)(2008-9#1)
showed interesting##2##2##(2012-11#1)(2012-3#1)
showed intermediate##3##2##(1990-2#1)(1994-10#1)(2011-1#1)
showed interstitial##4##2##(1991-8#1)(1994-6#1)(2007-7#1)(2008-1#1)
showed irregular##2##2##(1994-3#1)(2008-2#1)
showed isolated##2##2##(1993-4#1)(2011-2#1)
showed it to be a##2##5##(2008-10#1)(2009-9#1)
showed it to be##5##4##(1991-9#1)(2007-9#1)(2008-10#1)(2008-9#1)(2009-9#1)
showed it to##7##3##(1991-9#1)(1995-7#1)(2007-9#1)(2008-10#2)(2008-9#1)(2009-9#1)
showed it##9##2##(1990-11#1)(1991-9#1)(1995-7#1)(2006-2#1)(2007-9#1)(2008-10#2)(2008-9#1)(2009-9#1)
showed its##7##2##(1992-3#1)(1993-11#1)(1993-8#1)(2010-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
showed labeling##2##2##(2008-10#1)(2011-1#1)
showed large differences in##2##4##(1990-2#1)(2008-8#1)
showed large##8##2##(1990-2#1)(1991-6#1)(1993-7#1)(1995-12#1)(1996-10#1)(2006-12#1)(2008-8#1)(2010-12#1)
showed left##2##2##(2007-7#1)(2009-5#1)
showed lesions##4##2##(2008-7#1)(2012-12#1)(2013-1#2)
showed less than 10% of##2##5##(1992-6#1)(2008-10#1)
showed less than 5%##3##4##(2005-7#1)(2007-8#1)(2008-5#1)
showed less than##9##3##(1990-12#1)(1992-6#1)(2005-7#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#2)
showed less##35##2##(1990-12#1)(1992-6#1)(1994-2#1)(1995-5#1)(1996-1#1)(1996-2#1)(1997-5#2)(1997-7#1)(2005-7#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#3)(2009-3#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
showed levels of##2##3##(1991-5#1)(1997-8#1)
showed levels##3##2##(1991-5#1)(1992-2#1)(1997-8#1)
showed lexical##2##2##(2008-2#1)(2012-1#1)
showed limited##2##2##(2008-10#1)(2010-4#1)
showed linear calibration within##2##4##(2008-10#2)
showed linear calibration##3##3##(2008-10#3)
showed linear response##2##3##(2008-10#2)
showed linear##10##2##(1993-8#1)(2008-10#8)(2011-2#1)
showed linearity in the range of##4##6##(2007-8#1)(2008-10#2)(2012-1#1)
showed linkage##2##2##(2006-9#1)(2007-6#1)
showed little difference in##2##4##(1991-2#1)(2008-5#1)
showed little effect on the##2##5##(1994-2#1)(1996-12#1)
showed little or no##10##4##(1990-11#1)(1990-5#1)(1991-2#2)(1993-7#1)(1996-8#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-4#1)
showed little or##11##3##(1990-11#1)(1990-5#1)(1991-2#2)(1993-7#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-4#1)
showed little variability##2##3##(2008-10#1)(2008-5#1)
showed little variation in##2##4##(1990-9#1)(2008-9#1)
showed little##39##2##(1990-11#2)(1990-5#1)(1990-9#1)(1991-2#3)(1991-6#1)(1992-11#1)(1992-6#1)(1993-6#1)(1993-7#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-6#1)(2006-3#1)(2008-10#5)(2008-4#1)(2008-5#4)(2008-9#1)(2010-11#1)(2012-12#1)(2012-2#1)(2012-3#2)
showed longer##2##2##(1993-7#1)(2008-4#1)
showed loss of##2##3##(1994-6#1)(2007-2#1)
showed low affinity##2##3##(1990-5#1)(1997-5#1)
showed low levels of##2##4##(1993-7#1)(1996-12#1)
showed low##23##2##(1990-4#1)(1990-5#1)(1993-7#1)(1994-11#1)(1996-1#1)(1996-12#1)(1997-5#1)(2005-9#1)(2006-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-9#1)(2013-8#1)
showed lower levels of##4##4##(1995-9#1)(2004-2#1)(2008-10#1)(2012-5#1)
showed lower levels##5##3##(1995-9#1)(2004-2#1)(2007-2#1)(2008-10#1)(2012-5#1)
showed lower sleep efficiency##2##4##(2012-3#2)
showed lower toxicity##2##3##(1997-4#1)(2012-12#1)
showed lower values than##2##4##(1991-5#1)(1996-3#1)
showed lower values##3##3##(1991-5#1)(1996-3#1)(2008-7#1)
showed lower##40##2##(1990-12#1)(1991-5#1)(1992-12#1)(1995-10#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-4#1)(2004-2#1)(2006-10#1)(2006-5#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-10#6)(2008-12#1)(2008-7#1)(2009-7#2)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#3)(2012-5#1)(2013-1#1)(2013-8#1)
showed male##2##2##(2007-8#1)(2009-7#1)
showed malignant lymphoma##2##3##(2008-10#1)(2009-1#1)
showed malignant##3##2##(2008-10#1)(2009-1#1)(2012-2#1)
showed many##4##2##(1993-10#1)(1996-3#1)(2008-10#1)(2009-8#1)
showed marginal##3##2##(2007-8#1)(2009-2#1)(2012-11#1)
showed marked dilation of the##2##5##(2010-10#2)
showed marked elevations##2##3##(1990-1#1)(1997-1#1)
showed marked improvement in all the##2##6##(2005-7#1)(2013-1#1)
showed marked improvement in##5##4##(2005-7#1)(2007-7#2)(2011-1#1)(2013-1#1)
showed marked increase##2##3##(1990-10#1)(2007-2#1)
showed marked inhibitory##2##3##(1990-5#1)(1991-12#1)
showed marked reduction##2##3##(1995-12#1)(2013-1#1)
showed marked##38##2##(1990-1#1)(1990-10#1)(1990-5#1)(1991-12#1)(1992-1#1)(1992-8#1)(1993-3#1)(1994-8#1)(1995-12#1)(1995-7#1)(1996-10#1)(1996-3#1)(1997-1#1)(1997-8#1)(2005-7#1)(2007-2#1)(2007-3#2)(2007-7#2)(2008-10#3)(2008-6#1)(2008-7#2)(2010-10#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#4)(2013-8#1)
showed markedly elevated##2##3##(1992-12#1)(2008-5#1)
showed markedly##6##2##(1992-12#1)(1992-8#1)(1995-5#1)(1997-2#1)(1997-6#1)(2008-5#1)
showed maximal##5##2##(1990-3#1)(1994-12#1)(1996-5#1)(2008-11#2)
showed maximum drug##2##3##(2010-5#1)(2012-12#1)
showed maximum protection##3##3##(1993-11#1)(2007-11#2)
showed maximum##14##2##(1991-7#1)(1993-11#1)(1994-3#1)(1997-1#1)(2007-11#2)(2007-7#1)(2008-10#1)(2010-3#2)(2010-5#2)(2012-12#1)(2013-1#1)
showed mean##2##2##(2007-7#1)(2008-8#1)
showed measurable##2##2##(1994-9#1)(2008-10#1)
showed mediastinal##2##2##(2008-7#1)(2013-1#1)
showed mild##7##2##(1996-1#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)
showed minimal##13##2##(1992-3#1)(1994-8#1)(2005-12#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-1#1)(2013-1#2)
showed minor##3##2##(1997-2#1)(2008-6#1)(2013-1#1)
showed mixed##3##2##(2007-12#1)(2007-6#1)(2008-7#1)
showed moderate activity##2##3##(2008-10#1)(2010-3#1)
showed moderate and##2##3##(1990-12#1)(2012-1#1)
showed moderate resistance##2##3##(2008-10#2)
showed moderate to##2##3##(1994-5#1)(2012-12#1)
showed moderate##24##2##(1990-12#1)(1991-3#1)(1993-12#1)(1993-7#1)(1994-5#1)(1995-3#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-3#1)(2006-12#1)(2007-11#1)(2008-10#5)(2009-3#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
showed modest improvements##2##3##(2008-5#1)(2012-12#1)
showed modest##6##2##(1997-5#1)(2008-5#1)(2009-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
showed modulatory actions on##2##4##(1990-2#1)(1991-7#1)
showed more activity in##2##4##(1993-7#1)(2008-11#1)
showed more potent##2##3##(2008-11#1)(2008-5#1)
showed more severe##2##3##(2004-4#1)(2008-5#1)
showed more than 60%##2##4##(2007-7#1)(2010-5#1)
showed more than##8##3##(1994-11#1)(2007-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-12#1)(2010-5#1)(2013-8#1)
showed more##44##2##(1993-11#1)(1993-12#1)(1993-2#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#1)(1996-8#1)(1997-5#1)(1997-6#1)(2004-11#1)(2004-4#1)(2005-10#1)(2006-1#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#2)(2009-2#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#3)
showed morphological##3##2##(1997-4#1)(2008-10#1)(2013-7#1)
showed most##3##2##(2007-8#1)(2008-10#1)(2008-5#1)
showed much less##2##3##(1994-9#1)(2008-10#1)
showed much##8##2##(1990-10#1)(1992-7#1)(1994-9#1)(2007-2#1)(2008-10#3)(2008-8#1)
showed multifocal##2##2##(2007-2#1)(2012-2#1)
showed multiple nodular##2##3##(1990-2#1)(2013-8#1)
showed multiple##10##2##(1990-2#1)(2007-7#1)(2008-7#1)(2009-10#1)(2009-6#1)(2009-8#1)(2011-1#1)(2013-7#1)(2013-8#2)
showed near##3##2##(1996-12#1)(2008-12#1)(2011-2#1)
showed nearly##3##2##(1992-8#1)(1996-9#1)(2010-2#1)
showed negative correlation##2##3##(2006-8#1)(2013-7#1)
showed negative##13##2##(1991-11#1)(1992-5#1)(1996-10#1)(1996-12#1)(1996-9#1)(1997-1#1)(2006-10#1)(2006-8#1)(2008-5#1)(2010-2#1)(2013-1#1)(2013-7#2)
showed negligible##5##2##(1994-12#1)(1996-9#1)(2007-12#1)(2007-8#1)(2008-2#1)
showed neither##4##2##(1997-7#1)(2008-5#1)(2009-10#1)(2012-2#1)
showed new##2##2##(1994-7#1)(1997-1#1)
showed no abnormalities##4##3##(1993-10#1)(1996-6#1)(2006-11#1)(2007-8#1)
showed no abnormality##2##3##(1995-10#1)(2005-10#1)
showed no activity##2##3##(1991-7#1)(2010-12#1)
showed no adverse##2##3##(2008-5#1)(2010-2#1)
showed no alteration in BT or BB and was insignificantly increased in##2##12##(2007-7#2)
showed no apparent##4##3##(1995-8#1)(2005-11#1)(2008-11#2)
showed no appreciable##2##3##(2008-10#1)(2008-5#1)
showed no association##3##3##(2004-10#1)(2007-8#1)(2012-12#1)
showed no benefit##2##3##(1991-6#1)(2007-9#1)
showed no change in##5##4##(1990-3#1)(1993-6#1)(1996-1#1)(1996-3#1)(2008-11#1)
showed no change##14##3##(1990-3#1)(1990-4#1)(1991-12#1)(1993-6#1)(1994-2#1)(1996-1#1)(1996-3#1)(1996-6#1)(2007-7#2)(2007-8#1)(2008-11#1)(2010-1#1)(2011-1#1)
showed no changes in response to##2##6##(1990-11#1)(2009-4#1)
showed no changes in##6##4##(1990-11#1)(1995-3#1)(2008-10#1)(2008-4#1)(2009-4#1)(2011-2#1)
showed no changes##8##3##(1990-11#1)(1995-3#1)(2004-4#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-4#1)(2011-2#1)
showed no clear##2##3##(2008-10#2)
showed no clinical signs of##2##5##(1993-6#1)(2008-5#1)
showed no clinical signs##3##4##(1991-3#1)(1993-6#1)(2008-5#1)
showed no clinical##5##3##(1991-3#1)(1993-6#1)(1997-3#1)(2006-5#1)(2008-5#1)
showed no consistent##3##3##(1991-10#1)(2008-10#1)(2011-2#1)
showed no correlation between##2##4##(1990-3#1)(1991-5#1)
showed no correlation##4##3##(1990-3#1)(1991-5#1)(1995-5#1)(2013-1#1)
showed no dependence on##2##4##(1990-3#1)(1991-2#1)
showed no detectable##4##3##(1990-11#1)(1994-2#1)(1996-3#1)(1996-6#1)
showed no difference between the two##2##6##(1995-9#1)(1996-9#1)
showed no difference between##5##4##(1993-7#1)(1995-9#2)(1996-6#1)(1996-9#1)
showed no difference in the##3##5##(2007-12#1)(2008-5#2)
showed no difference in##7##4##(1995-5#1)(1997-6#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-5#2)
showed no difference##16##3##(1993-7#1)(1995-5#1)(1995-8#1)(1995-9#2)(1996-6#1)(1996-9#1)(1997-6#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-5#2)(2008-6#1)(2008-7#1)(2012-2#1)
showed no differences between##2##4##(2008-10#2)
showed no differences##4##3##(2006-6#1)(2008-10#3)
showed no distinct##2##3##(2008-10#1)(2009-4#1)
showed no effect on##9##4##(1993-12#1)(1993-2#1)(1994-2#2)(1994-3#1)(2008-10#2)(2011-12#1)(2011-2#1)
showed no effect##13##3##(1990-12#1)(1993-12#1)(1993-2#1)(1994-2#3)(1994-3#1)(2008-10#2)(2008-11#1)(2011-12#1)(2011-2#1)(2013-8#1)
showed no effects on##2##4##(1993-5#1)(1997-7#1)
showed no effects##4##3##(1991-9#1)(1993-5#1)(1996-8#1)(1997-7#1)
showed no evidence of a##2##5##(1994-8#1)(2007-8#1)
showed no evidence of tumor recurrence##2##6##(2006-12#1)(2007-12#1)
showed no evidence of##19##4##(1991-4#1)(1991-9#1)(1992-3#1)(1994-2#1)(1994-8#1)(1996-12#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#3)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
showed no evidence##21##3##(1991-2#1)(1991-4#1)(1991-9#1)(1992-3#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-12#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#3)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
showed no further##4##3##(1991-11#1)(1993-12#1)(1996-4#1)(2005-11#1)
showed no gross##2##3##(1991-12#1)(1994-6#1)
showed no homology with any##2##5##(1990-4#1)(1994-12#1)
showed no homology##3##3##(1990-4#1)(1994-12#1)(1997-4#1)
showed no improvement##3##3##(2006-12#1)(2006-2#1)(2007-7#1)
showed no increase##2##3##(1996-5#1)(1996-6#1)
showed no inhibitory##2##3##(1991-4#1)(2008-10#1)
showed no interaction with##2##4##(1991-5#1)(1996-7#1)
showed no interference##2##3##(2008-10#2)
showed no malignancy##2##3##(1997-3#1)(2010-2#1)
showed no negative##2##3##(2008-9#2)
showed no obvious##3##3##(2007-6#1)(2008-10#1)(2011-2#1)
showed no or only##2##4##(1993-7#1)(1995-3#1)
showed no or##3##3##(1993-11#1)(1993-7#1)(1995-3#1)
showed no other abnormalities##2##4##(1991-3#1)(2012-3#1)
showed no other##3##3##(1991-3#1)(2012-12#1)(2012-3#1)
showed no preference##2##3##(2008-10#1)(2012-2#1)
showed no protection##2##3##(1995-5#1)(2007-11#1)
showed no recurrence##2##3##(2007-2#1)(2008-6#1)
showed no reflux##2##3##(2008-10#2)
showed no relationship between##3##4##(1990-5#1)(1996-7#1)(2011-2#1)
showed no response to##4##4##(1991-4#1)(2007-12#1)(2007-7#1)(2008-7#1)
showed no response##6##3##(1991-4#1)(1997-5#1)(2007-12#1)(2007-7#1)(2008-7#1)(2013-1#1)
showed no sequence##2##3##(1991-2#1)(1996-6#1)
showed no significant alteration in##2##5##(2007-7#1)(2008-5#1)
showed no significant alteration##3##4##(1995-2#1)(2007-7#1)(2008-5#1)
showed no significant change in##2##5##(1992-5#1)(1997-8#1)
showed no significant change##5##4##(1992-5#1)(1995-9#1)(1997-8#1)(2006-8#1)(2008-7#1)
showed no significant changes##2##4##(2012-2#1)(2013-7#1)
showed no significant correlation with##3##5##(2008-8#1)(2010-10#1)(2011-11#1)
showed no significant correlation##4##4##(2006-8#1)(2008-8#1)(2010-10#1)(2011-11#1)
showed no significant difference between the##3##6##(2008-5#1)(2009-3#1)(2011-1#1)
showed no significant difference between##5##5##(2007-9#1)(2008-12#1)(2008-5#1)(2009-3#1)(2011-1#1)
showed no significant difference from##2##5##(2008-4#1)(2010-8#1)
showed no significant difference in the##2##6##(2004-1#1)(2008-12#1)
showed no significant difference in##9##5##(1991-8#1)(1994-11#1)(1995-9#1)(1996-9#1)(2004-1#1)(2006-12#1)(2008-11#1)(2008-12#1)(2013-7#1)
showed no significant difference##20##4##(1991-8#1)(1994-11#1)(1994-5#1)(1995-9#1)(1996-9#1)(2004-1#1)(2006-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2009-3#1)(2010-8#1)(2011-1#1)(2013-7#1)
showed no significant differences at##2##5##(1993-12#1)(2008-10#1)
showed no significant differences between##3##5##(1997-2#1)(2008-10#1)(2013-1#1)
showed no significant differences in the##3##6##(2008-10#1)(2008-12#1)(2013-7#1)
showed no significant differences in##5##5##(2007-10#1)(2008-10#1)(2008-12#1)(2012-2#1)(2013-7#1)
showed no significant differences##14##4##(1990-10#1)(1993-12#1)(1997-2#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-4#1)(2012-2#1)(2013-1#2)(2013-7#1)
showed no significant effect at##2##5##(2008-6#1)(2009-4#1)
showed no significant effect##3##4##(2004-11#1)(2008-6#1)(2009-4#1)
showed no significant effects##3##4##(1991-2#1)(2006-5#1)(2008-11#1)
showed no significant homology##2##4##(1996-7#1)(1997-2#1)
showed no significant similarity to##2##5##(1995-2#1)(1997-4#1)
showed no significant##82##3##(1990-10#1)(1991-1#1)(1991-2#1)(1991-8#1)(1992-5#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-5#2)(1994-6#1)(1995-2#2)(1995-5#1)(1995-9#2)(1996-2#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-8#1)(2004-1#1)(2004-11#1)(2004-4#1)(2004-9#1)(2006-12#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#2)(2008-12#4)(2008-2#2)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-9#2)(2010-10#1)(2010-8#2)(2011-1#1)(2011-11#1)(2011-2#1)(2012-2#3)(2013-1#4)(2013-7#3)
showed no signs of##6##4##(1993-9#1)(2011-2#1)(2012-12#3)(2012-3#1)
showed no signs##7##3##(1993-9#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-3#1)
showed no statistical##2##3##(2006-7#1)(2010-2#1)
showed no statistically significant difference between the##2##7##(2005-11#1)(2008-1#1)
showed no statistically significant difference in##4##6##(2007-11#1)(2007-7#1)(2009-6#1)(2009-7#1)
showed no statistically significant difference##7##5##(2005-11#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-4#1)(2009-6#1)(2009-7#1)
showed no statistically significant##9##4##(1996-12#1)(2005-11#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-4#1)(2009-6#1)(2009-7#1)
showed no such##4##3##(1990-4#1)(1997-2#1)(2008-10#1)(2008-5#1)
showed no##381##2##(1990-10#1)(1990-11#4)(1990-12#3)(1990-3#4)(1990-4#3)(1990-5#2)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#6)(1991-3#3)(1991-4#3)(1991-5#5)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#2)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#2)(1993-5#1)(1993-6#4)(1993-7#2)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#6)(1994-3#1)(1994-5#3)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#4)(1995-8#2)(1995-9#4)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-4#2)(1996-5#2)(1996-6#8)(1996-7#3)(1996-8#2)(1996-9#4)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#2)(2004-1#1)(2004-10#1)(2004-11#1)(2004-4#2)(2004-9#2)(2005-10#1)(2005-11#4)(2006-10#2)(2006-11#1)(2006-12#3)(2006-2#1)(2006-5#4)(2006-6#1)(2006-7#1)(2006-8#3)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#2)(2007-5#1)(2007-6#2)(2007-7#8)(2007-8#10)(2007-9#4)(2008-1#1)(2008-10#32)(2008-11#8)(2008-12#4)(2008-2#3)(2008-3#2)(2008-4#5)(2008-5#10)(2008-6#5)(2008-7#5)(2008-8#2)(2008-9#5)(2009-3#1)(2009-4#5)(2009-6#1)(2009-7#2)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-3#1)(2010-5#3)(2010-6#1)(2010-8#3)(2011-1#2)(2011-11#1)(2011-12#2)(2011-2#9)(2012-11#1)(2012-12#5)(2012-2#7)(2012-3#4)(2013-1#12)(2013-7#3)(2013-8#4)
showed non-significant##2##2##(2006-7#1)(2012-2#1)
showed non-specific##5##2##(1997-4#1)(1997-8#1)(2007-8#1)(2011-12#1)(2013-7#1)
showed normal growth##2##3##(2006-12#1)(2008-10#1)
showed normal##20##2##(1990-11#1)(1992-11#1)(1993-3#1)(1994-10#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-4#1)(1996-6#1)(1996-8#1)(1997-5#1)(2006-12#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
showed normalization of##3##3##(1992-3#1)(1993-7#1)(2006-1#1)
showed not only the##2##4##(2008-10#1)(2013-7#1)
showed not only##3##3##(2007-1#1)(2008-10#1)(2013-7#1)
showed numerous##7##2##(1997-8#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-9#1)(2013-8#1)
showed occurrence of##2##3##(2007-7#1)(2008-8#1)
showed one major##2##3##(1990-6#1)(1996-7#1)
showed one##6##2##(1990-6#1)(1993-9#1)(1994-3#1)(1996-7#1)(2007-2#1)(2007-7#1)
showed only a few##2##4##(1993-7#1)(2010-6#1)
showed only a partial##2##4##(1997-7#1)(2008-10#1)
showed only a small##2##4##(2005-11#1)(2012-1#1)
showed only a##11##3##(1993-7#1)(1994-2#1)(1996-10#1)(1997-2#1)(1997-7#1)(2005-11#1)(2007-1#1)(2008-10#1)(2010-2#1)(2010-6#1)(2012-1#1)
showed only limited##2##3##(1992-7#1)(2009-8#1)
showed only minor##2##3##(1997-3#1)(2008-11#1)
showed only one##2##3##(2008-10#1)(2012-3#1)
showed only slight##2##3##(1990-12#1)(2009-6#1)
showed only two##3##3##(1994-2#2)(2007-12#1)
showed only weak##2##3##(1990-6#1)(2007-1#1)
showed only##45##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-12#1)(1991-9#1)(1992-7#1)(1993-12#1)(1993-7#1)(1994-2#4)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1996-10#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-11#1)(2006-11#1)(2006-2#1)(2007-1#2)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-3#1)
showed optimal##2##2##(2008-5#1)(2013-1#1)
showed other##4##2##(2006-10#1)(2008-12#1)(2011-2#1)(2012-1#1)
showed over##3##2##(1992-7#2)(2010-12#1)
showed overall##2##2##(1991-12#1)(2008-5#1)
showed pH-dependent##2##2##(1992-6#1)(2008-5#1)
showed partial##12##2##(1990-6#1)(1994-3#1)(1995-7#1)(1996-10#1)(1996-4#1)(1997-2#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-8#1)
showed patent grafts##2##3##(2007-8#1)(2013-1#1)
showed pathological changes##2##3##(2007-12#1)(2008-5#1)
showed pathological##5##2##(1992-3#1)(1993-6#1)(1996-2#1)(2007-12#1)(2008-5#1)
showed plasma##2##2##(1994-3#1)(1997-7#1)
showed pleomorphic##2##2##(2009-7#1)(2013-8#1)
showed polymorphism##2##2##(2008-10#1)(2013-8#1)
showed poor##6##2##(1995-8#2)(2008-3#2)(2008-6#1)(2010-2#1)
showed poorer##4##2##(2006-2#1)(2007-12#1)(2012-11#1)(2013-7#1)
showed positive associations##2##3##(1997-8#1)(2008-10#1)
showed positive but##2##3##(2007-12#1)(2013-7#1)
showed positive cultures##2##3##(2008-4#1)(2011-2#1)
showed positive effects##2##3##(2009-4#1)(2013-8#1)
showed positive results##7##3##(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2010-8#1)(2011-1#1)(2011-2#1)
showed positive##35##2##(1992-3#1)(1992-6#1)(1993-4#1)(1995-3#1)(1996-2#1)(1997-4#1)(1997-8#1)(2005-10#1)(2006-8#3)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#3)(2009-4#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
showed positivity for##3##3##(1997-7#1)(2007-3#1)(2010-12#1)
showed potent inhibitory##2##3##(1997-1#1)(2011-1#1)
showed potent##10##2##(1992-8#1)(1995-3#1)(1997-1#2)(2006-12#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
showed presence of##4##3##(1995-11#1)(2008-10#1)(2008-3#1)(2012-2#1)
showed prevalence of##2##3##(2006-8#1)(2008-6#1)
showed primarily##2##2##(1993-11#1)(2008-8#1)
showed profound##2##2##(1995-5#1)(2012-2#1)
showed progression of disease##2##4##(1990-10#1)(1994-8#1)
showed progression of##3##3##(1990-10#1)(1994-8#1)(2008-7#1)
showed progression##5##2##(1990-10#1)(1992-10#1)(1994-8#1)(2008-7#1)(2011-2#1)
showed progressive##2##2##(2008-5#1)(2008-9#1)
showed proliferation of##2##3##(2011-2#1)(2013-8#1)
showed prolonged##3##2##(2008-7#1)(2010-1#1)(2010-6#1)
showed prominent##3##2##(1993-11#1)(2008-11#1)(2012-12#1)
showed promising results in##2##4##(2006-10#1)(2013-8#1)
showed promising results##4##3##(2006-10#1)(2010-7#1)(2012-1#1)(2013-8#1)
showed promising##6##2##(2006-10#2)(2010-7#1)(2012-1#1)(2013-7#1)(2013-8#1)
showed pronounced##3##2##(1990-9#1)(1997-7#1)(2007-7#1)
showed protection##3##2##(2008-11#1)(2008-5#1)(2013-8#1)
showed purely##2##2##(2010-7#1)(2012-3#1)
showed raised##2##2##(1995-8#1)(2008-9#1)
showed rapid clinical##2##3##(2008-7#1)(2009-6#1)
showed rapid##4##2##(2005-7#1)(2007-8#1)(2008-7#1)(2009-6#1)
showed reasonable##3##2##(2008-11#1)(2008-3#1)(2008-5#1)
showed reduced pathogenicity##2##3##(2008-10#2)
showed reduced##22##2##(1990-7#1)(1993-3#1)(1993-6#1)(1995-10#1)(1995-6#1)(1996-9#1)(1997-2#1)(1997-7#1)(2006-9#1)(2007-2#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-9#1)(2009-11#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
showed reductions in##3##3##(1991-9#1)(2008-10#1)(2012-3#1)
showed reductions##4##2##(1991-9#1)(1993-4#1)(2008-10#1)(2012-3#1)
showed regression##2##2##(2007-8#1)(2010-12#1)
showed relationships##2##2##(1997-6#1)(2013-7#1)
showed relatively high##3##3##(1993-4#1)(1996-1#1)(2012-3#1)
showed relatively lower##2##3##(1994-12#1)(2008-10#1)
showed relatively##18##2##(1993-4#1)(1994-12#1)(1996-1#1)(1996-5#1)(1996-6#2)(2007-1#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#2)(2010-8#1)(2011-2#1)(2012-3#1)
showed remarkable##7##2##(1990-11#1)(1996-8#1)(2006-12#1)(2007-12#1)(2007-7#1)(2010-12#1)(2011-1#1)
showed remarkably##3##2##(1991-11#1)(1995-8#1)(2005-11#1)
showed residual##4##2##(1993-2#1)(2008-6#1)(2009-11#1)(2011-1#1)
showed resistance to the##2##4##(2008-10#1)(2008-9#1)
showed resistance to##14##3##(2007-6#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
showed resistance##17##2##(2007-6#3)(2007-8#1)(2008-10#7)(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
showed respiratory##3##2##(1997-3#1)(2006-8#1)(2008-5#1)
showed restriction##2##2##(1991-8#1)(2008-10#1)
showed results##2##2##(1997-3#1)(2012-2#1)
showed retarded##2##2##(2006-9#1)(2008-5#1)
showed retention##2##2##(2012-2#2)
showed reversal##3##2##(2008-3#1)(2008-5#1)(2009-6#1)
showed reversible##2##2##(1991-7#1)(1992-3#1)
showed right##4##2##(2007-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
showed satisfactory results##2##3##(1997-4#1)(2013-1#1)
showed satisfactory##5##2##(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-1#1)
showed saturation##2##2##(1996-1#1)(2008-2#1)
showed seasonal variation##2##3##(2007-2#1)(2012-3#1)
showed seasonal##3##2##(2007-2#1)(2008-5#1)(2012-3#1)
showed segmental##2##2##(2007-8#2)
showed selective##5##2##(1993-4#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-3#1)
showed sensitivity##3##2##(1996-12#1)(2008-8#1)(2012-2#1)
showed separate##2##2##(1992-9#1)(1994-8#1)
showed serious##2##2##(1990-6#1)(1991-6#1)
showed several clusters of##2##4##(2008-10#1)(2008-11#1)
showed several##11##2##(1991-8#1)(1993-11#1)(1993-3#1)(1994-8#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2010-4#1)(2011-2#1)
showed severe chronic##2##3##(1992-5#1)(2010-10#1)
showed severe toxicity##2##3##(2008-12#1)(2008-7#1)
showed severe##18##2##(1990-11#1)(1992-5#2)(1993-9#1)(1995-10#1)(1996-12#1)(1997-5#2)(1997-6#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-4#1)(2010-10#1)(2010-6#1)(2012-2#1)
showed significant (p&lt##2##3##(2007-12#1)(2010-4#1)
showed significant accumulation of##2##4##(1991-5#1)(2007-8#1)
showed significant and##2##3##(2005-11#1)(2008-1#1)
showed significant association between##3##4##(2008-10#1)(2008-8#1)(2011-2#1)
showed significant association with##2##4##(2008-10#2)
showed significant association##7##3##(2008-10#3)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)
showed significant changes in##2##4##(1992-1#1)(2011-2#1)
showed significant changes##3##3##(1992-1#1)(2008-10#1)(2011-2#1)
showed significant correlation##2##3##(2006-2#1)(2007-2#1)
showed significant correlations with##3##4##(2008-11#1)(2008-7#1)(2009-4#1)
showed significant correlations##6##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#1)(2013-1#1)
showed significant cytotoxicity to##2##4##(2008-10#1)(2011-2#1)
showed significant cytotoxicity##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
showed significant decrease in##3##4##(2007-1#1)(2008-12#1)(2012-2#1)
showed significant decrease##7##3##(1992-7#1)(2007-1#1)(2008-12#1)(2009-10#1)(2011-12#1)(2011-2#1)(2012-2#1)
showed significant difference (P &lt##3##5##(2013-1#3)
showed significant difference in##2##4##(2008-12#1)(2011-2#1)
showed significant difference##8##3##(2007-9#1)(2008-12#1)(2008-9#1)(2011-12#1)(2011-2#1)(2013-1#3)
showed significant differences between the two##3##6##(1995-8#1)(2010-8#1)(2012-11#1)
showed significant differences between the##4##5##(1995-8#1)(2008-6#1)(2010-8#1)(2012-11#1)
showed significant differences between##7##4##(1995-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-8#1)(2012-11#1)(2013-1#1)
showed significant differences in the##2##5##(2008-4#1)(2010-9#1)
showed significant differences in##3##4##(1992-2#1)(2008-4#1)(2010-9#1)
showed significant differences##16##3##(1992-2#1)(1995-8#1)(2007-10#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-2#1)(2010-8#1)(2010-9#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
showed significant effects##2##3##(1995-11#1)(2009-12#1)
showed significant homology to##2##4##(1997-7#1)(2008-10#1)
showed significant homology with the##2##5##(1990-5#1)(1995-10#1)
showed significant homology with##3##4##(1990-5#1)(1991-11#1)(1995-10#1)
showed significant homology##6##3##(1990-5#1)(1991-11#1)(1995-10#1)(1997-7#1)(2008-10#2)
showed significant improvement in the##2##5##(2010-5#1)(2013-1#1)
showed significant improvement in##9##4##(1995-8#1)(2006-8#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-5#1)(2010-6#1)(2013-1#1)
showed significant improvement##16##3##(1990-7#1)(1995-8#1)(1996-3#1)(2005-9#1)(2006-8#3)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-5#1)(2010-6#1)(2011-2#1)(2013-1#1)
showed significant improvements in##2##4##(2006-10#1)(2013-1#1)
showed significant improvements##3##3##(2006-10#1)(2009-11#1)(2013-1#1)
showed significant increase in##3##4##(1995-1#1)(2007-1#1)(2007-8#1)
showed significant increases in##6##4##(1991-2#1)(1992-1#1)(2008-10#1)(2008-12#1)(2010-8#2)
showed significant increases##7##3##(1991-2#1)(1992-1#1)(1995-12#1)(2008-10#1)(2008-12#1)(2010-8#2)
showed significant interaction##2##3##(2008-12#1)(2010-12#1)
showed significant levels##2##3##(1991-12#1)(2008-10#1)
showed significant positive correlations with##3##5##(2010-10#1)(2011-1#2)
showed significant positive correlations##4##4##(2010-10#1)(2010-8#1)(2011-1#2)
showed significant positive##6##3##(2009-6#1)(2010-10#1)(2010-8#1)(2011-1#2)(2012-2#1)
showed significant reduction in##4##4##(2007-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
showed significant reduction##5##3##(2007-7#1)(2010-12#1)(2012-2#1)(2013-1#2)
showed significant reductions##2##3##(1993-2#1)(1995-5#1)
showed significant resistance to##3##4##(2006-12#1)(2008-10#1)(2008-12#1)
showed significant sequence##2##3##(1995-8#1)(1997-6#1)
showed significant similarity to##2##4##(1995-8#1)(1996-4#1)
showed significant##202##2##(1990-3#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-2#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-8#4)(1996-1#1)(1996-10#1)(1996-3#1)(1996-4#1)(1997-6#2)(1997-7#2)(2005-11#1)(2005-9#1)(2006-10#1)(2006-12#4)(2006-2#1)(2006-8#3)(2007-1#4)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#18)(2008-11#3)(2008-12#5)(2008-2#1)(2008-4#3)(2008-5#10)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#3)(2010-10#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#6)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#9)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#8)(2012-3#1)(2013-1#13)(2013-7#2)
showed significantly better##2##3##(2007-11#1)(2011-2#1)
showed significantly decreased##3##3##(1991-7#1)(1996-7#1)(2007-1#1)
showed significantly greater improvements##2##4##(2004-3#1)(2008-8#1)
showed significantly greater##5##3##(2004-3#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-11#1)
showed significantly higher (P &lt##2##5##(2009-4#2)
showed significantly higher levels of##3##5##(2008-10#1)(2009-12#1)(2010-3#1)
showed significantly higher levels##4##4##(2006-12#1)(2008-10#1)(2009-12#1)(2010-3#1)
showed significantly higher scores##2##4##(2008-8#1)(2010-1#1)
showed significantly higher##21##3##(1995-1#2)(1996-4#1)(1997-8#1)(2006-12#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-12#1)(2009-4#2)(2010-1#1)(2010-3#2)(2012-11#1)(2012-2#1)(2013-7#2)
showed significantly improved##2##3##(2006-12#1)(2008-11#1)
showed significantly increased##3##3##(1993-6#1)(2008-3#1)(2010-10#1)
showed significantly larger##3##3##(2008-5#1)(2012-2#1)(2013-7#1)
showed significantly less##6##3##(1992-6#1)(1993-12#1)(2004-3#1)(2007-6#1)(2008-7#1)(2013-1#1)
showed significantly lower scores##2##4##(2012-12#1)(2013-8#1)
showed significantly lower##10##3##(1991-12#1)(1997-8#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2012-12#1)(2012-3#1)(2013-8#2)
showed significantly more leakage at##2##5##(2006-8#2)
showed significantly more##5##3##(1990-12#1)(2006-8#2)(2007-10#2)
showed significantly reduced##3##3##(1990-5#1)(2011-12#1)(2013-8#1)
showed significantly##78##2##(1990-12#1)(1990-5#1)(1991-12#2)(1991-7#1)(1992-1#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-6#1)(1993-9#2)(1994-9#1)(1995-1#2)(1996-4#1)(1996-7#1)(1997-8#2)(2004-3#2)(2006-12#2)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-6#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-4#2)(2010-1#2)(2010-10#1)(2010-2#2)(2010-3#2)(2011-12#2)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#4)(2013-8#3)
showed signs of##19##3##(1991-6#2)(1993-5#1)(1994-3#1)(1994-4#1)(1994-5#1)(1996-11#1)(1996-12#1)(2006-1#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-7#1)(2012-3#1)(2013-1#1)
showed signs##20##2##(1991-6#2)(1993-5#1)(1994-3#1)(1994-4#1)(1994-5#1)(1996-11#1)(1996-12#1)(2006-1#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
showed similar behavior##3##3##(1991-2#1)(1991-6#1)(2005-11#1)
showed similar changes##2##3##(2013-8#2)
showed similar levels of##3##4##(1997-1#1)(2006-12#1)(2006-7#1)
showed similar levels##4##3##(1994-5#1)(1997-1#1)(2006-12#1)(2006-7#1)
showed similar or##2##3##(1992-8#1)(2008-11#1)
showed similar patterns of##2##4##(1994-12#1)(2008-5#1)
showed similar properties##2##3##(1991-5#1)(1994-8#1)
showed similar rates of##2##4##(2010-2#1)(2013-1#1)
showed similar responses##2##3##(2006-12#1)(2009-2#1)
showed similar results##6##3##(1991-8#1)(1994-12#1)(1997-6#1)(2008-5#1)(2011-2#1)(2012-12#1)
showed similar toxicity##2##3##(1992-3#1)(2008-7#1)
showed similar trends in both##2##5##(2007-9#1)(2013-8#1)
showed similar##73##2##(1990-2#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-12#4)(1994-5#1)(1994-8#2)(1996-1#2)(1996-2#2)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-6#2)(2005-11#3)(2005-9#1)(2006-12#2)(2006-7#1)(2006-9#1)(2007-1#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-5#5)(2008-7#4)(2009-2#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#1)(2013-1#3)(2013-8#3)
showed similarities with##3##3##(2005-11#1)(2008-5#1)(2011-12#1)
showed similarities##6##2##(1992-9#1)(1995-3#1)(2005-11#1)(2008-5#1)(2010-3#1)(2011-12#1)
showed similarity to##2##3##(1996-6#2)
showed similarity##4##2##(1996-6#2)(2008-8#1)(2013-1#1)
showed simultaneous##3##2##(1993-7#1)(2007-7#1)(2011-12#1)
showed single##3##2##(1992-8#1)(2008-10#1)(2010-8#1)
showed six##3##2##(1996-10#1)(2007-12#1)(2008-4#1)
showed slight##6##2##(1992-11#1)(1997-8#1)(2006-9#1)(2008-10#2)(2008-5#1)
showed slightly##2##2##(1997-5#1)(2008-5#1)
showed small##2##2##(2006-12#1)(2008-10#1)
showed small-vessel##2##2##(2006-10#1)(2007-10#1)
showed smaller##3##2##(2005-10#1)(2008-3#1)(2013-8#1)
showed some degree of##2##4##(2008-10#1)(2008-8#1)
showed some differences in##3##4##(2008-10#2)(2013-7#1)
showed some differences##5##3##(1994-3#1)(2008-10#2)(2008-5#1)(2013-7#1)
showed some improvement##2##3##(2006-8#1)(2007-9#1)
showed some##35##2##(1991-4#1)(1993-2#1)(1993-7#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-8#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-6#1)(2006-8#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-10#6)(2008-12#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#1)(2010-12#1)(2012-3#1)(2013-7#1)
showed specific labeling of##2##4##(1992-6#1)(2012-3#1)
showed specific##10##2##(1991-12#1)(1992-6#1)(1993-6#1)(1997-6#1)(2004-9#1)(2008-10#2)(2011-2#1)(2012-3#1)(2013-8#1)
showed specificity towards##2##3##(1990-12#1)(1994-5#1)
showed specificity##3##2##(1990-12#1)(1991-3#1)(1994-5#1)
showed spontaneous##3##2##(2012-1#1)(2012-11#1)(2013-7#1)
showed stable##2##2##(1997-5#1)(2008-9#1)
showed staining of the##2##4##(1992-3#1)(1995-11#1)
showed staining of##3##3##(1992-3#1)(1995-11#1)(1995-12#1)
showed statistical##2##2##(2006-8#1)(2008-10#1)
showed statistically significant changes##2##4##(2008-5#1)(2011-2#1)
showed statistically significant differences (p&lt##2##5##(2004-9#1)(2008-12#1)
showed statistically significant differences##8##4##(1990-9#1)(1997-6#1)(2004-9#1)(2006-10#1)(2007-4#1)(2008-12#1)(2008-7#1)(2011-2#1)
showed statistically significant##14##3##(1990-9#1)(1997-6#1)(2004-9#1)(2006-10#1)(2007-4#1)(2007-5#1)(2008-12#1)(2008-5#2)(2008-7#1)(2010-4#1)(2011-2#2)(2012-12#1)
showed statistically##15##2##(1990-9#1)(1997-6#1)(2004-9#1)(2006-10#1)(2007-4#1)(2007-5#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-4#1)(2011-2#2)(2012-12#1)
showed striking##3##2##(1993-11#1)(2006-5#1)(2007-8#1)
showed strong homology##2##3##(1992-8#1)(1995-6#1)
showed strong immunoreactivity##2##3##(1996-1#1)(1997-6#1)
showed strong inhibitory##2##3##(2011-3#1)(2013-1#1)
showed strong positive##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
showed strong resistance##2##3##(2008-10#2)
showed strong##39##2##(1991-2#1)(1991-9#2)(1992-8#2)(1993-12#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-6#1)(2007-5#1)(2008-10#9)(2008-11#2)(2008-5#1)(2008-9#1)(2009-4#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-3#1)(2012-1#1)(2012-3#1)(2013-1#3)
showed stronger##7##2##(1996-5#1)(2005-11#1)(2006-12#1)(2008-11#1)(2009-1#1)(2011-2#1)(2012-3#1)
showed strongest##2##2##(1991-3#1)(2008-5#1)
showed strongly positive immunoreactivity for##2##5##(1996-3#2)
showed strongly##3##2##(1996-3#2)(2008-6#1)
showed substantial##2##2##(2008-10#1)(2008-6#1)
showed substantially##2##2##(1994-3#1)(1994-9#1)
showed substrate##2##2##(1994-8#1)(1995-2#1)
showed sufficient##2##2##(2008-5#1)(2008-7#1)
showed superior binding affinity for U(VI) over Th(IV) and##2##9##(2008-10#2)
showed superior extractability of uranium##2##5##(2008-10#2)
showed superior extraction##2##3##(2008-10#2)
showed superior##11##2##(2008-10#8)(2010-4#1)(2011-12#1)(2012-2#1)
showed surface##2##2##(2005-11#1)(2008-10#1)
showed surprisingly##2##2##(1994-9#1)(2008-8#1)
showed sustained##2##2##(1997-5#1)(2012-2#1)
showed symptomatic##2##2##(2008-10#1)(2008-3#1)
showed symptoms of##5##3##(1995-6#1)(2007-8#1)(2008-10#1)(2009-8#1)(2012-1#1)
showed symptoms##7##2##(1995-6#1)(2007-8#1)(2008-10#3)(2009-8#1)(2012-1#1)
showed temperature##2##2##(1995-5#1)(1997-6#1)
showed that &gt##2##3##(1994-8#1)(2008-10#1)
showed that (1) the##2##4##(1995-11#1)(2008-10#1)
showed that (1)##4##3##(1993-3#1)(1995-11#1)(1996-7#1)(2008-10#1)
showed that (i) the##3##4##(1997-4#1)(2008-9#2)
showed that (i)##5##3##(1997-4#1)(2008-10#1)(2008-8#1)(2008-9#2)
showed that 19##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
showed that 21##2##3##(2007-7#1)(2008-6#1)
showed that 25%##2##3##(2005-10#1)(2008-7#1)
showed that 27##3##3##(2006-8#1)(2008-7#1)(2012-1#1)
showed that 29##2##3##(1990-12#1)(2007-8#1)
showed that 2H##2##3##(1992-9#2)
showed that 31% of##2##4##(2008-2#1)(2010-12#1)
showed that 43##2##3##(1992-8#1)(2008-12#1)
showed that A##2##3##(1996-2#1)(2012-11#1)
showed that AG##2##3##(1995-9#1)(2007-11#1)
showed that BRP##2##3##(2007-12#2)
showed that DNA##4##3##(1991-7#1)(1995-11#1)(1995-4#1)(2008-11#1)
showed that FSTRAP##2##3##(2008-8#2)
showed that GH##2##3##(2010-5#1)(2013-7#1)
showed that GSH##2##3##(1995-1#2)
showed that HIV/AIDS##2##3##(2007-2#1)(2007-7#1)
showed that IL-1##2##3##(1992-8#1)(1994-10#1)
showed that IgG##2##3##(1996-12#1)(2007-2#1)
showed that MPTP##2##3##(1995-7#1)(2012-1#1)
showed that MacMARCKS##2##3##(1996-5#2)
showed that New##2##3##(1990-2#1)(2006-1#1)
showed that P##2##3##(2008-10#2)
showed that RAPD##2##3##(2005-11#1)(2007-1#1)
showed that T##4##3##(2007-3#1)(2008-10#2)(2008-8#1)
showed that YY1 was##2##4##(2008-11#2)
showed that a good##3##4##(1993-6#1)(2011-1#1)(2012-12#1)
showed that a majority of the respondents##2##7##(1996-3#1)(2007-10#1)
showed that a portion of the##2##6##(2006-8#1)(2007-12#1)
showed that a single##4##4##(1991-2#1)(1992-6#1)(1995-12#1)(2008-10#1)
showed that a##63##3##(1990-5#1)(1990-9#1)(1991-1#2)(1991-2#1)(1992-10#1)(1992-11#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#5)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#3)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
showed that about##5##3##(1997-2#2)(2007-3#2)(2011-1#1)
showed that addition of##3##4##(1995-3#1)(2007-3#1)(2009-3#1)
showed that after##12##3##(1993-2#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-8#1)
showed that age##2##3##(2008-1#1)(2008-7#1)
showed that all of the##2##5##(2008-5#1)(2008-9#1)
showed that all of##4##4##(1996-7#1)(2008-10#1)(2008-5#1)(2008-9#1)
showed that all the##8##4##(2004-2#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-12#1)(2013-1#1)
showed that all three##5##4##(1990-12#1)(1991-10#1)(1994-3#1)(2007-12#1)(2008-10#1)
showed that all##41##3##(1990-12#1)(1991-10#1)(1991-5#1)(1991-7#1)(1993-8#1)(1994-3#1)(1996-4#1)(1996-7#1)(2004-2#1)(2006-8#2)(2007-12#1)(2007-2#1)(2008-10#7)(2008-5#2)(2008-7#2)(2008-9#2)(2009-10#1)(2009-5#1)(2010-12#2)(2010-3#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#3)(2013-8#1)
showed that almost all##3##4##(1993-6#1)(1996-4#1)(2012-2#1)
showed that almost##5##3##(1993-6#1)(1996-4#1)(2005-8#1)(2007-10#1)(2012-2#1)
showed that although the##2##4##(2008-8#1)(2008-9#1)
showed that although##5##3##(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)
showed that among the##2##4##(2007-10#1)(2008-5#1)
showed that among##3##3##(2005-10#1)(2007-10#1)(2008-5#1)
showed that an increase in##2##5##(1997-8#1)(2009-6#1)
showed that an increase of##2##5##(2008-5#1)(2010-10#1)
showed that an increase##4##4##(1997-8#1)(2008-5#1)(2009-6#1)(2010-10#1)
showed that an##10##3##(1991-4#1)(1997-8#1)(2007-10#1)(2007-4#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-6#1)(2010-10#1)(2012-3#1)
showed that another##2##3##(1996-9#1)(2008-10#1)
showed that antibody##2##3##(1990-12#1)(1994-3#1)
showed that application of##2##4##(2008-10#1)(2013-8#1)
showed that approximately##2##3##(2008-10#1)(2008-12#1)
showed that as##4##3##(1994-11#1)(1996-2#1)(2008-10#1)(2011-1#1)
showed that assessment##2##3##(2007-7#1)(2008-10#1)
showed that at a##2##4##(2006-3#1)(2010-4#1)
showed that at accumulation potential of##2##6##(2007-8#2)
showed that at least##5##4##(1990-2#1)(1994-9#1)(2008-8#1)(2013-1#2)
showed that at low##2##4##(2006-6#1)(2010-6#1)
showed that at##20##3##(1990-2#1)(1994-9#1)(1995-3#1)(2005-10#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-8#2)(2008-10#2)(2008-4#1)(2008-5#2)(2008-8#1)(2010-4#1)(2010-6#1)(2013-1#2)
showed that average##2##3##(2004-4#1)(2008-11#1)
showed that axons##2##3##(2008-11#1)(2011-2#1)
showed that before##2##3##(1995-3#1)(2010-3#1)
showed that beta##2##3##(1993-12#1)(1997-4#1)
showed that beta-amylase##2##3##(2008-9#2)
showed that beta-galactosidase##2##3##(1990-5#1)(2011-2#1)
showed that blockade of##2##4##(1992-5#1)(1997-8#1)
showed that blood##2##3##(2009-5#1)(2011-2#1)
showed that both forms##2##4##(1990-3#1)(1991-9#1)
showed that both of the##2##5##(1991-8#1)(2009-8#1)
showed that both the##10##4##(1990-12#1)(1991-6#1)(2005-11#2)(2008-10#1)(2008-7#1)(2008-9#2)(2010-8#1)(2012-2#1)
showed that both##48##3##(1990-12#1)(1990-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-8#3)(1995-6#1)(1997-2#1)(1997-8#1)(2005-11#2)(2006-12#1)(2006-3#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
showed that by##2##3##(1993-11#1)(2008-10#1)
showed that cell##5##3##(1996-3#1)(2008-11#3)(2011-12#1)
showed that cells##3##3##(2008-5#2)(2008-8#1)
showed that changes in##2##4##(2004-9#1)(2011-1#1)
showed that cigarette smoke##2##4##(1991-9#1)(2008-5#1)
showed that cigarette##3##3##(1991-9#1)(2008-12#1)(2008-5#1)
showed that cleavage##2##3##(1991-2#1)(1996-9#1)
showed that clinical##3##3##(2006-10#1)(2006-8#1)(2008-12#1)
showed that compared to##2##4##(1992-11#1)(2011-3#1)
showed that compared with##2##4##(2010-10#1)(2010-7#1)
showed that compared##4##3##(1992-11#1)(2010-10#1)(2010-7#1)(2011-3#1)
showed that complete##2##3##(2008-10#1)(2010-12#1)
showed that compounds##3##3##(2006-12#1)(2012-11#1)(2012-3#1)
showed that continuous##3##3##(1991-2#1)(1995-5#1)(2009-8#1)
showed that copper##2##3##(2005-11#1)(2008-10#1)
showed that daily##2##3##(1990-7#1)(2009-7#1)
showed that deletion of##2##4##(1997-3#1)(2012-2#1)
showed that detection##2##3##(1997-7#1)(2013-8#1)
showed that dietary##3##3##(1997-1#1)(2008-11#1)(2008-7#1)
showed that differences in##2##4##(1994-2#1)(2013-8#1)
showed that different##2##3##(1995-12#1)(2008-12#1)
showed that drug treatment##2##4##(1990-3#1)(1993-7#1)
showed that drug##3##3##(1990-3#1)(1993-7#1)(2010-5#1)
showed that each of the##3##5##(1991-7#1)(2006-9#1)(2008-12#1)
showed that each of##4##4##(1991-7#1)(2006-9#1)(2008-12#1)(2008-7#1)
showed that each##8##3##(1991-7#1)(1994-6#1)(1997-8#1)(2006-9#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-7#1)
showed that efavirenz##2##3##(2008-5#2)
showed that eight##2##3##(1997-3#1)(2005-11#1)
showed that expression levels of##2##5##(2008-11#1)(2008-9#1)
showed that expression##3##3##(1997-1#1)(2008-11#1)(2008-9#1)
showed that extracellular##3##3##(1994-11#1)(2007-3#1)(2008-8#1)
showed that five##2##3##(2008-9#1)(2011-2#1)
showed that for a##2##4##(2005-11#1)(2007-6#1)
showed that for every##2##4##(2007-10#1)(2008-10#1)
showed that for##11##3##(1995-6#1)(1997-2#1)(2004-4#1)(2005-11#1)(2007-10#1)(2007-6#1)(2008-10#3)(2008-8#1)(2013-8#1)
showed that full##2##3##(1994-8#1)(1997-3#1)
showed that genetic##3##3##(2004-11#1)(2008-10#2)
showed that glutathione##2##3##(1996-12#1)(2012-2#1)
showed that greater than##2##4##(1990-8#1)(1997-1#1)
showed that greater##4##3##(1990-8#1)(1997-1#1)(2007-8#1)(2008-9#1)
showed that high##3##3##(1995-3#1)(2006-12#1)(2009-5#1)
showed that higher##2##3##(1995-3#1)(2009-10#1)
showed that host##2##3##(2008-10#2)
showed that human##8##3##(1991-11#1)(1991-2#1)(1993-11#1)(1994-2#1)(1995-3#1)(2008-11#2)(2012-3#1)
showed that hydroxyl##2##3##(1997-8#1)(2013-8#1)
showed that in all##3##4##(1992-3#1)(1996-3#1)(2008-8#1)
showed that in human##2##4##(1992-8#1)(1993-1#1)
showed that in the##6##4##(1991-5#1)(1997-1#2)(2008-10#1)(2008-5#1)(2009-6#1)
showed that in vitro##2##4##(1990-7#1)(2008-9#1)
showed that in##35##3##(1990-7#1)(1991-5#1)(1992-3#1)(1992-8#1)(1993-1#1)(1995-1#1)(1995-12#1)(1996-3#1)(1997-1#2)(1997-2#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#2)(2013-7#2)
showed that incidence##2##3##(2008-10#1)(2011-2#1)
showed that increased##4##3##(1990-4#1)(2005-10#1)(2008-2#1)(2010-8#1)
showed that increasing##4##3##(1997-7#1)(2008-10#1)(2008-12#1)(2008-9#1)
showed that individuals##2##3##(2008-1#1)(2013-1#1)
showed that instruction##2##3##(2009-11#1)(2013-1#1)
showed that insulin##2##3##(1997-7#1)(2010-12#1)
showed that irradiation power##2##4##(2008-10#1)(2012-1#1)
showed that irradiation##3##3##(1995-6#1)(2008-10#1)(2012-1#1)
showed that isolates##2##3##(2008-10#2)
showed that it contained##2##4##(1991-9#1)(1995-12#1)
showed that it could recover##2##5##(1990-5#1)(2013-8#1)
showed that it had approximately##2##5##(1990-2#1)(2009-7#1)
showed that it had##3##4##(1990-2#1)(1994-9#1)(2009-7#1)
showed that it has##2##4##(2008-10#2)
showed that it is possible to##4##6##(2005-9#1)(2006-6#1)(2007-12#1)(2010-4#1)
showed that it is the##3##5##(1991-10#1)(1997-2#1)(2007-9#1)
showed that it is##18##4##(1990-2#1)(1991-10#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-2#1)(1997-1#1)(1997-2#1)(2005-9#1)(2006-6#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-12#1)(2010-12#1)(2010-4#1)
showed that it was a##2##5##(2008-10#1)(2013-7#1)
showed that it was##12##4##(1990-12#1)(1993-3#1)(1994-8#1)(1995-1#1)(1995-8#1)(2007-8#1)(2008-10#3)(2008-8#1)(2011-2#1)(2013-7#1)
showed that it##45##3##(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#1)(1991-10#1)(1991-9#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-8#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(2005-9#1)(2006-6#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-12#1)(2008-8#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-7#1)(2013-8#1)
showed that its##4##3##(1991-8#1)(1994-6#1)(1996-10#1)(1997-7#1)
showed that lack of##2##4##(1995-2#1)(2010-5#1)
showed that larger##2##3##(2010-8#1)(2013-8#1)
showed that lead##3##3##(1997-2#1)(2008-8#1)(2013-8#1)
showed that liquid##2##3##(2008-11#1)(2011-1#1)
showed that local##3##3##(1994-5#1)(1996-10#1)(2008-5#1)
showed that low dose##2##4##(1992-4#1)(2008-7#1)
showed that low##4##3##(1992-4#1)(2005-3#1)(2008-7#1)(2012-12#1)
showed that male##2##3##(1995-8#1)(2008-8#1)
showed that males##2##3##(2008-5#1)(2013-8#1)
showed that many of the##2##5##(1996-10#1)(2010-1#1)
showed that many##3##3##(1996-10#1)(2007-9#1)(2010-1#1)
showed that mean##3##3##(1991-6#1)(2008-9#1)(2010-8#1)
showed that membranes##2##3##(1992-7#1)(2009-7#1)
showed that mitochondria##2##3##(1990-8#1)(2008-7#1)
showed that mitoxantrone##2##3##(1993-3#1)(2012-3#1)
showed that monkeys with V4 lesions##2##6##(1993-2#2)
showed that more than##2##4##(1997-3#1)(2007-10#1)
showed that more##4##3##(1997-3#1)(2007-10#1)(2008-5#1)(2011-2#1)
showed that most of the##4##5##(2006-12#1)(2008-10#1)(2010-2#1)(2013-1#1)
showed that most of##7##4##(1995-1#1)(1997-2#1)(2006-12#1)(2008-10#1)(2010-12#1)(2010-2#1)(2013-1#1)
showed that most##14##3##(1990-2#1)(1992-4#1)(1992-9#1)(1995-1#1)(1995-6#1)(1997-2#1)(2006-12#1)(2008-10#3)(2008-5#1)(2010-12#1)(2010-2#1)(2013-1#1)
showed that much##2##3##(1990-2#1)(2008-8#1)
showed that multiple freeze-thaw##2##4##(2010-4#2)
showed that multiple##4##3##(1992-11#1)(2008-10#1)(2010-4#2)
showed that neither##6##3##(1991-5#2)(2007-11#1)(2008-6#1)(2008-7#1)(2010-8#1)
showed that no significant##2##4##(2008-10#1)(2009-9#1)
showed that no##12##3##(1992-2#1)(1995-12#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-9#1)(2009-9#1)(2010-2#1)(2011-2#1)
showed that none of the##2##5##(2008-3#1)(2011-1#1)
showed that one of the##2##5##(1990-5#1)(1995-4#1)
showed that one of##3##4##(1990-5#1)(1995-4#1)(2009-8#1)
showed that one##7##3##(1990-5#1)(1995-4#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-8#1)
showed that only the##5##4##(1994-3#1)(1994-8#1)(2008-10#1)(2009-8#1)(2010-2#1)
showed that only##20##3##(1990-11#1)(1990-5#1)(1990-9#1)(1992-3#1)(1993-11#1)(1994-3#1)(1994-8#1)(1997-8#1)(2007-7#1)(2008-10#6)(2008-3#1)(2009-8#1)(2010-2#1)(2011-2#1)(2013-1#1)
showed that our##4##3##(1993-9#1)(2007-7#1)(2008-3#1)(2013-8#1)
showed that out of##2##4##(2007-9#1)(2008-1#1)
showed that over##2##3##(1994-12#1)(1997-8#1)
showed that patients with##5##4##(1995-2#1)(1997-8#1)(2007-10#1)(2011-2#1)(2012-2#1)
showed that patients##10##3##(1993-2#1)(1995-2#1)(1997-8#1)(2006-10#1)(2007-10#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#2)
showed that performance##2##3##(1992-12#1)(2009-4#1)
showed that phenolics##2##3##(2008-10#1)(2012-11#1)
showed that placental##2##3##(1995-11#1)(2007-7#1)
showed that plants##2##3##(2008-10#1)(2012-7#1)
showed that plasma##2##3##(1992-9#1)(2008-12#1)
showed that pol delta##2##4##(1994-9#2)
showed that preincubation with##2##4##(1993-11#1)(1995-5#1)
showed that propranolol##2##3##(2008-10#1)(2009-8#1)
showed that protein##2##3##(2008-10#1)(2008-5#1)
showed that purified##3##3##(1990-11#1)(1991-3#1)(2012-2#1)
showed that rat##3##3##(1993-3#1)(2008-10#1)(2013-1#1)
showed that rates of##2##4##(2008-10#1)(2008-7#1)
showed that recombinant##2##3##(1995-11#1)(1996-5#1)
showed that resistance to##2##4##(2007-7#1)(2007-9#1)
showed that resistance##3##3##(2007-7#1)(2007-9#1)(2008-10#1)
showed that results##2##3##(2006-2#1)(2007-7#1)
showed that salt stress##2##4##(2008-9#1)(2009-6#1)
showed that selected##2##3##(1992-4#1)(2007-8#1)
showed that serum##2##3##(1997-5#1)(2005-12#1)
showed that several genes##2##4##(2009-10#1)(2009-8#1)
showed that several##9##3##(1991-6#1)(1991-9#1)(2008-1#1)(2008-3#1)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
showed that significant##2##3##(2008-10#2)
showed that significantly more##2##4##(2006-8#1)(2011-12#1)
showed that single##4##3##(2008-10#2)(2008-11#1)(2012-1#1)
showed that some##11##3##(1990-8#1)(1994-2#1)(2005-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#2)(2010-11#1)(2013-1#1)(2013-8#1)
showed that species of##2##4##(2008-10#1)(2008-12#1)
showed that specimens##2##3##(2008-10#2)
showed that sperm##2##3##(1990-10#1)(2008-12#1)
showed that stimulation##2##3##(1991-6#1)(1994-11#1)
showed that strain##3##3##(2006-8#1)(2008-10#1)(2012-2#1)
showed that subjects##2##3##(1995-5#1)(2008-10#1)
showed that substitution of a##2##5##(1996-8#1)(2006-12#1)
showed that such a##2##4##(2008-11#1)(2009-10#1)
showed that such##3##3##(2008-11#1)(2009-10#1)(2009-9#1)
showed that the 2##2##4##(2008-10#2)
showed that the C-terminal##4##4##(1990-7#1)(1991-7#1)(1993-11#1)(1997-6#1)
showed that the E##2##4##(1995-2#1)(2009-8#1)
showed that the HAP nanoparticles##2##5##(2008-5#2)
showed that the N-terminal##2##4##(1993-3#1)(1997-6#1)
showed that the ability of##3##5##(1991-2#1)(1995-10#1)(1997-2#1)
showed that the above##2##4##(2004-9#1)(2008-10#1)
showed that the activation##2##4##(1991-12#1)(1997-1#1)
showed that the activity of##4##5##(1994-12#1)(1996-8#1)(2008-9#1)(2012-2#1)
showed that the activity##6##4##(1993-2#1)(1994-12#1)(1995-3#1)(1996-8#1)(2008-9#1)(2012-2#1)
showed that the amplitude of##2##5##(2007-1#1)(2010-6#1)
showed that the area##2##4##(2008-10#1)(2008-11#1)
showed that the average##4##4##(1992-2#1)(2008-10#1)(2008-7#1)(2008-8#1)
showed that the binding##3##4##(1995-2#1)(2008-10#1)(2008-8#1)
showed that the cell##3##4##(2008-9#1)(2009-3#1)(2012-1#1)
showed that the channel##2##4##(1990-11#1)(1995-5#1)
showed that the combination of##2##5##(2008-5#1)(2008-8#1)
showed that the common##2##4##(2007-12#1)(2008-1#1)
showed that the complexes##2##4##(2008-3#1)(2009-8#1)
showed that the culture##2##4##(2006-10#1)(2008-5#1)
showed that the current##2##4##(2005-11#1)(2008-10#1)
showed that the deformation##2##4##(2005-11#1)(2013-1#1)
showed that the degree of##2##5##(1990-11#1)(1990-12#1)
showed that the density##2##4##(1996-5#1)(2008-6#1)
showed that the developed##2##4##(2005-11#1)(2011-1#1)
showed that the development of##2##5##(2005-7#1)(2012-1#1)
showed that the dominant##2##4##(2008-10#1)(2011-1#1)
showed that the drug was##2##5##(2008-5#2)
showed that the drug##7##4##(2008-10#1)(2008-11#1)(2008-5#4)(2012-3#1)
showed that the early##2##4##(1990-11#1)(2008-10#1)
showed that the effect of##4##5##(1991-2#1)(2007-12#1)(2008-2#1)(2008-4#1)
showed that the effects of##3##5##(1990-7#1)(2008-5#1)(2010-12#1)
showed that the effects##4##4##(1990-7#1)(1997-1#1)(2008-5#1)(2010-12#1)
showed that the enzyme was##3##5##(1991-5#1)(1991-8#1)(1995-3#1)
showed that the enzyme##9##4##(1991-5#1)(1991-8#2)(1992-8#1)(1994-11#2)(1995-3#1)(2008-4#1)(2008-7#1)
showed that the expression of##2##5##(1994-12#1)(1996-11#1)
showed that the expression##6##4##(1994-12#1)(1994-2#1)(1996-11#1)(2008-10#1)(2008-6#1)(2008-9#1)
showed that the extract##3##4##(2009-6#1)(2013-7#2)
showed that the extraction##2##4##(2008-10#1)(2012-1#1)
showed that the first##3##4##(1994-8#1)(2007-8#1)(2008-9#1)
showed that the fragment##2##4##(1992-6#1)(2005-11#1)
showed that the frequency##2##4##(2007-2#1)(2008-10#1)
showed that the fungus##3##4##(2008-10#3)
showed that the gene##2##4##(1995-5#1)(2008-7#1)
showed that the graft##2##4##(2005-11#1)(2013-1#1)
showed that the growth of##2##5##(2008-10#1)(2008-8#1)
showed that the highest##2##4##(2008-10#1)(2008-12#1)
showed that the immobilized##2##4##(2008-5#1)(2008-7#1)
showed that the incidence of##3##5##(2008-1#1)(2011-2#1)(2012-3#1)
showed that the incidence##4##4##(2008-1#1)(2010-5#1)(2011-2#1)(2012-3#1)
showed that the increase in##2##5##(1992-7#1)(1994-8#1)
showed that the increased##2##4##(2009-5#1)(2011-1#1)
showed that the inhibition of##2##5##(1993-4#1)(1997-8#1)
showed that the interaction##2##4##(2006-10#1)(2008-10#1)
showed that the iron##3##4##(1996-9#1)(2006-10#1)(2012-12#1)
showed that the isolates##2##4##(1996-12#1)(2008-10#1)
showed that the level of##5##5##(1993-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
showed that the levels of##4##5##(1990-3#1)(1996-10#1)(1996-11#1)(2011-12#1)
showed that the mRNA##2##4##(1994-10#1)(1994-9#1)
showed that the main##4##4##(2008-11#1)(2011-12#1)(2012-12#1)(2012-3#1)
showed that the major##8##4##(1992-2#1)(1992-7#1)(1993-5#1)(1994-3#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-6#1)
showed that the majority of the##3##6##(1997-3#1)(2007-6#1)(2008-6#1)
showed that the majority of##8##5##(1995-3#1)(1997-3#1)(2005-8#1)(2007-3#1)(2007-6#1)(2008-6#1)(2008-8#1)(2011-12#1)
showed that the majority##9##4##(1995-3#1)(1997-3#1)(2005-8#1)(2007-3#1)(2007-6#1)(2008-6#1)(2008-8#1)(2010-8#1)(2011-12#1)
showed that the mean##9##4##(1992-11#1)(2006-3#1)(2006-9#1)(2007-2#1)(2008-10#1)(2008-3#2)(2010-7#1)(2012-3#1)
showed that the method is##3##5##(2005-12#1)(2008-3#1)(2008-9#1)
showed that the method was##3##5##(2007-8#1)(2008-10#1)(2013-8#1)
showed that the method##7##4##(2005-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-9#1)(2013-8#1)
showed that the modified##2##4##(2007-10#1)(2008-10#1)
showed that the monoclonal##2##4##(1990-5#1)(1994-3#1)
showed that the most common##3##5##(2007-10#1)(2007-2#1)(2011-2#1)
showed that the most##8##4##(1990-4#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-6#1)(2011-2#1)
showed that the mutations##3##4##(1994-9#1)(2008-8#1)(2009-3#1)
showed that the new##5##4##(1996-11#1)(2007-7#1)(2008-4#1)(2009-5#1)(2012-12#1)
showed that the number of##6##5##(1990-7#1)(2004-2#1)(2008-1#1)(2008-8#1)(2010-4#1)(2013-8#1)
showed that the occurrence of##2##5##(2008-8#1)(2010-5#1)
showed that the occurrence##3##4##(2008-7#1)(2008-8#1)(2010-5#1)
showed that the only##2##4##(1990-10#1)(1991-7#1)
showed that the optimal##2##4##(1994-11#1)(2008-8#1)
showed that the optimum##3##4##(2008-10#2)(2012-12#1)
showed that the order of##2##5##(2007-7#1)(2013-8#1)
showed that the overall##3##4##(2010-2#1)(2010-4#1)(2010-6#1)
showed that the peptides##2##4##(1990-7#1)(2008-9#1)
showed that the percentage of##2##5##(1991-8#1)(2011-12#1)
showed that the pineal##2##4##(1992-12#1)(1994-9#1)
showed that the presence of a##2##6##(2004-9#1)(2008-4#1)
showed that the presence of##9##5##(1990-7#1)(1992-12#1)(1994-6#1)(2004-9#1)(2005-11#1)(2008-10#1)(2008-4#1)(2012-12#1)(2013-8#1)
showed that the prevalence of##5##5##(2006-4#1)(2006-8#1)(2007-10#1)(2007-3#1)(2010-12#1)
showed that the prevalence##6##4##(2006-4#1)(2006-8#2)(2007-10#1)(2007-3#1)(2010-12#1)
showed that the probability of##2##5##(2007-10#1)(2008-10#1)
showed that the procedure##2##4##(2008-10#1)(2008-3#1)
showed that the proposed method could##3##6##(2008-10#2)(2008-5#1)
showed that the proposed method##5##5##(2008-10#4)(2008-5#1)
showed that the proposed##9##4##(2008-10#7)(2008-5#1)(2012-1#1)
showed that the protein was##3##5##(1990-5#1)(1990-6#1)(1991-9#1)
showed that the protein##5##4##(1990-5#1)(1990-6#1)(1991-9#1)(1993-7#1)(1996-10#1)
showed that the purification##2##4##(2005-4#1)(2012-12#1)
showed that the purified##5##4##(1990-10#1)(1996-4#1)(1997-7#1)(2008-9#1)(2012-2#1)
showed that the rate of##3##5##(2007-8#1)(2008-8#1)(2011-1#1)
showed that the recombinant##2##4##(1991-7#1)(2008-8#1)
showed that the recovery##2##4##(2008-10#1)(2013-8#1)
showed that the relationship between##2##5##(2006-7#1)(2013-8#1)
showed that the relative##3##4##(2007-11#1)(2008-5#1)(2013-8#1)
showed that the response##3##4##(1994-10#1)(2008-10#1)(2008-11#1)
showed that the results of##2##5##(2008-8#1)(2012-2#1)
showed that the results##3##4##(2008-8#1)(2012-2#2)
showed that the retention of##2##5##(2005-12#1)(2008-10#1)
showed that the retention##3##4##(2005-12#1)(2008-10#2)
showed that the risk of##3##5##(2011-2#1)(2013-1#1)(2013-8#1)
showed that the same##4##4##(1990-8#1)(2008-10#1)(2008-8#1)(2012-1#1)
showed that the second##2##4##(2009-5#1)(2009-6#1)
showed that the sensitivity of##2##5##(2008-2#1)(2008-7#1)
showed that the sensitivity##3##4##(2008-2#1)(2008-7#1)(2011-1#1)
showed that the size of##2##5##(1993-11#1)(2011-2#1)
showed that the specific##2##4##(1994-3#1)(2010-12#1)
showed that the steady-state##2##4##(1994-12#1)(2008-8#1)
showed that the strength of##2##5##(2008-11#2)
showed that the strong##2##4##(2008-8#1)(2011-1#1)
showed that the structural##2##4##(2007-12#1)(2008-8#1)
showed that the surface##2##4##(2013-8#2)
showed that the three##6##4##(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2012-3#1)(2013-1#1)
showed that the threshold##2##4##(2009-9#1)(2010-4#1)
showed that the thyroid##2##4##(1990-8#1)(2010-11#1)
showed that the time##2##4##(1994-9#1)(2005-4#1)
showed that the total##6##4##(1991-7#1)(2006-4#2)(2012-11#1)(2013-7#1)(2013-8#1)
showed that the transcription##2##4##(1994-12#1)(2008-9#1)
showed that the transgene##2##4##(2008-10#1)(2008-12#1)
showed that the tumor was##4##5##(2006-12#1)(2007-12#2)(2013-8#1)
showed that the tumor##7##4##(2006-12#1)(2007-12#2)(2009-8#1)(2010-12#1)(2013-7#1)(2013-8#1)
showed that the two##4##4##(1990-11#1)(1994-9#1)(2008-2#1)(2009-8#1)
showed that the use of##6##5##(2006-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
showed that the##924##3##(1990-1#2)(1990-10#2)(1990-11#5)(1990-12#5)(1990-2#6)(1990-3#3)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#9)(1990-8#3)(1991-1#2)(1991-10#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-4#3)(1991-5#2)(1991-6#2)(1991-7#7)(1991-8#4)(1991-9#2)(1992-1#1)(1992-10#3)(1992-11#4)(1992-12#4)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#5)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#2)(1993-5#2)(1993-6#3)(1993-7#2)(1993-8#3)(1993-9#6)(1994-10#2)(1994-11#6)(1994-12#8)(1994-2#4)(1994-3#7)(1994-6#2)(1994-8#4)(1994-9#7)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#3)(1995-2#5)(1995-3#3)(1995-5#3)(1995-6#4)(1995-8#4)(1996-10#4)(1996-11#8)(1996-12#4)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#3)(1996-8#3)(1996-9#3)(1997-1#3)(1997-2#10)(1997-3#3)(1997-4#2)(1997-6#4)(1997-7#6)(1997-8#4)(2004-11#1)(2004-2#1)(2004-9#3)(2005-10#1)(2005-11#19)(2005-12#4)(2005-4#5)(2005-7#1)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#6)(2006-2#1)(2006-3#3)(2006-4#3)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#4)(2006-9#1)(2007-1#5)(2007-10#7)(2007-11#4)(2007-12#14)(2007-2#7)(2007-3#4)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#10)(2007-9#1)(2008-1#7)(2008-10#116)(2008-11#21)(2008-12#9)(2008-2#7)(2008-3#16)(2008-4#12)(2008-5#45)(2008-6#9)(2008-7#22)(2008-8#39)(2008-9#20)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#4)(2009-4#2)(2009-5#5)(2009-6#4)(2009-7#1)(2009-8#7)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#7)(2010-2#2)(2010-3#1)(2010-4#5)(2010-5#3)(2010-6#4)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#23)(2011-10#1)(2011-12#4)(2011-2#21)(2011-3#3)(2012-1#9)(2012-11#1)(2012-12#14)(2012-2#12)(2012-3#12)(2012-8#1)(2013-1#19)(2013-7#7)(2013-8#30)
showed that their##4##3##(1994-8#1)(2008-10#1)(2008-8#1)(2010-8#1)
showed that there are two##3##5##(1992-3#1)(1993-3#1)(2008-8#1)
showed that there are##7##4##(1990-12#1)(1992-3#1)(1992-8#1)(1993-3#1)(2008-5#1)(2008-8#2)
showed that there is a##3##5##(2005-11#1)(2008-5#1)(2008-9#1)
showed that there is no##2##5##(1996-7#1)(2009-3#1)
showed that there is##8##4##(1996-7#1)(2005-11#1)(2006-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)
showed that there was a significant##3##6##(1990-8#1)(2008-12#1)(2013-1#1)
showed that there was a##13##5##(1990-8#1)(1997-3#1)(2005-11#1)(2005-4#1)(2007-10#1)(2008-1#1)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#1)
showed that there was an##3##5##(1997-8#1)(2012-2#1)(2013-8#1)
showed that there was no##7##5##(1992-7#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-7#1)(2011-1#1)(2012-2#1)
showed that there was significant##2##5##(2008-9#1)(2010-4#1)
showed that there was##27##4##(1990-8#1)(1992-7#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-4#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-12#3)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
showed that there were no differences in the##2##8##(1992-10#1)(2008-7#1)
showed that there were no differences in##3##7##(1992-10#1)(2008-10#1)(2008-7#1)
showed that there were no differences##4##6##(1992-10#1)(2008-10#1)(2008-7#1)(2008-9#1)
showed that there were no significant differences in##2##8##(1996-11#1)(2006-8#1)
showed that there were no##10##5##(1992-10#1)(1995-3#1)(1996-11#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-12#1)(2012-3#1)
showed that there were significant differences between##2##7##(2008-10#1)(2008-12#1)
showed that there were significant differences in##2##7##(2007-12#1)(2007-7#1)
showed that there were significant differences##5##6##(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2012-3#1)
showed that there were##22##4##(1992-10#1)(1994-12#1)(1995-3#1)(1996-11#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-12#3)(2008-4#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-12#1)(2012-1#1)(2012-3#2)
showed that there##67##3##(1990-12#1)(1990-8#1)(1991-5#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-3#1)(1994-12#1)(1995-3#1)(1996-11#1)(1996-7#1)(1997-3#1)(1997-8#1)(2005-11#2)(2005-4#1)(2006-4#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-12#6)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#4)(2009-3#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
showed that these compounds##4##4##(2008-10#2)(2008-5#1)(2012-2#1)
showed that these##27##3##(1990-4#1)(1990-5#2)(1990-7#1)(1994-11#1)(1994-6#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-9#2)(1997-4#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-6#1)(2010-10#1)(2012-2#1)
showed that they are##6##4##(1990-1#1)(1992-9#1)(1996-10#1)(2007-11#1)(2008-1#1)(2008-10#1)
showed that they##10##3##(1990-1#1)(1992-9#1)(1996-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-8#1)(2011-2#1)
showed that this antibody##2##4##(1991-4#1)(2008-6#1)
showed that this effect##2##4##(1994-8#1)(2008-10#1)
showed that this is##2##4##(2006-8#1)(2008-10#1)
showed that this method##3##4##(2005-4#1)(2012-12#1)(2013-8#1)
showed that this new##2##4##(2008-5#1)(2008-8#1)
showed that this was##2##4##(2006-9#1)(2008-10#1)
showed that this##44##3##(1990-12#1)(1990-2#1)(1990-6#1)(1991-4#1)(1992-12#1)(1992-4#1)(1992-9#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-3#1)(1996-7#1)(2005-11#1)(2005-4#1)(2006-8#1)(2006-9#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#2)(2010-6#1)(2012-11#1)(2012-12#2)(2012-2#3)(2013-7#2)(2013-8#1)
showed that three##3##3##(1997-7#1)(2008-12#1)(2011-1#1)
showed that tissue##2##3##(1993-2#1)(2008-10#1)
showed that transient##3##3##(1991-5#1)(2006-10#1)(2008-9#1)
showed that treatment of##3##4##(2007-8#1)(2008-4#2)
showed that treatment with##4##4##(1995-1#1)(2009-10#1)(2011-1#1)(2011-2#1)
showed that treatment##7##3##(1995-1#1)(2007-8#1)(2008-4#2)(2009-10#1)(2011-1#1)(2011-2#1)
showed that trophic##2##3##(2008-8#1)(2010-8#1)
showed that tumor##4##3##(1996-11#1)(2007-8#1)(2013-1#1)(2013-8#1)
showed that two##13##3##(1991-2#1)(1992-11#1)(1995-3#1)(1997-2#2)(1997-8#1)(2005-11#1)(2007-8#2)(2008-10#3)(2008-9#1)
showed that type##2##3##(1991-4#1)(2008-8#1)
showed that ultrasound##2##3##(2008-10#1)(2008-8#1)
showed that under##2##3##(2008-8#1)(2010-12#1)
showed that using##2##3##(1993-2#1)(1997-1#1)
showed that vaccination##2##3##(2007-2#1)(2011-2#1)
showed that virus replication was##2##5##(1997-3#1)(2008-10#1)
showed that virus##3##3##(1997-3#1)(2008-10#2)
showed that when##8##3##(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#2)(2009-6#1)(2009-9#1)(2012-2#1)
showed that while the##3##4##(1996-8#1)(2013-1#2)
showed that while##14##3##(1994-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-4#1)(2006-8#1)(2008-4#1)(2008-8#1)(2009-7#1)(2011-2#1)(2013-1#4)
showed that with a##2##4##(1990-12#1)(2008-7#1)
showed that with##7##3##(1990-12#1)(2006-12#1)(2006-8#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
showed that women had##2##4##(2006-10#1)(2006-12#1)
showed that women##3##3##(2006-10#1)(2006-12#1)(2007-12#1)
showed that##2942##2##(1990-1#4)(1990-10#7)(1990-11#9)(1990-12#16)(1990-2#18)(1990-3#9)(1990-4#5)(1990-5#12)(1990-6#4)(1990-7#13)(1990-8#8)(1990-9#2)(1991-1#5)(1991-10#5)(1991-11#1)(1991-12#4)(1991-2#11)(1991-3#3)(1991-4#7)(1991-5#11)(1991-6#9)(1991-7#15)(1991-8#8)(1991-9#11)(1992-1#4)(1992-10#9)(1992-11#12)(1992-12#10)(1992-2#6)(1992-3#9)(1992-4#7)(1992-5#6)(1992-6#9)(1992-7#6)(1992-8#11)(1992-9#15)(1993-1#3)(1993-11#12)(1993-12#4)(1993-2#10)(1993-3#13)(1993-4#5)(1993-5#2)(1993-6#10)(1993-7#4)(1993-8#8)(1993-9#12)(1994-10#5)(1994-11#16)(1994-12#12)(1994-2#17)(1994-3#14)(1994-5#3)(1994-6#11)(1994-7#1)(1994-8#21)(1994-9#19)(1995-1#11)(1995-10#4)(1995-11#6)(1995-12#19)(1995-2#13)(1995-3#19)(1995-4#3)(1995-5#12)(1995-6#15)(1995-7#6)(1995-8#14)(1995-9#2)(1996-1#5)(1996-10#12)(1996-11#11)(1996-12#15)(1996-2#14)(1996-3#9)(1996-4#5)(1996-5#13)(1996-6#2)(1996-7#11)(1996-8#8)(1996-9#7)(1997-1#15)(1997-2#31)(1997-3#11)(1997-4#15)(1997-5#8)(1997-6#12)(1997-7#19)(1997-8#19)(2004-11#5)(2004-12#1)(2004-2#2)(2004-4#3)(2004-7#1)(2004-8#1)(2004-9#8)(2005-1#1)(2005-10#6)(2005-11#45)(2005-12#6)(2005-3#1)(2005-4#8)(2005-6#1)(2005-7#2)(2005-8#6)(2005-9#1)(2006-1#2)(2006-10#16)(2006-11#2)(2006-12#17)(2006-2#2)(2006-3#6)(2006-4#4)(2006-5#5)(2006-6#8)(2006-7#5)(2006-8#29)(2006-9#4)(2007-1#13)(2007-10#18)(2007-11#17)(2007-12#33)(2007-2#21)(2007-3#13)(2007-4#4)(2007-5#6)(2007-6#6)(2007-7#17)(2007-8#30)(2007-9#9)(2008-1#19)(2008-10#354)(2008-11#77)(2008-12#47)(2008-2#14)(2008-3#38)(2008-4#35)(2008-5#104)(2008-6#24)(2008-7#54)(2008-8#112)(2008-9#90)(2009-1#2)(2009-10#11)(2009-11#4)(2009-12#7)(2009-2#3)(2009-3#10)(2009-4#8)(2009-5#11)(2009-6#16)(2009-7#11)(2009-8#24)(2009-9#9)(2010-1#4)(2010-10#8)(2010-11#6)(2010-12#32)(2010-2#9)(2010-3#6)(2010-4#18)(2010-5#13)(2010-6#6)(2010-7#8)(2010-8#23)(2010-9#3)(2011-1#51)(2011-10#2)(2011-12#11)(2011-2#68)(2011-3#9)(2012-1#27)(2012-11#5)(2012-12#40)(2012-2#43)(2012-3#37)(2012-7#1)(2012-8#1)(2013-1#73)(2013-7#23)(2013-8#77)
showed the ability to##3##4##(1995-11#1)(2008-10#1)(2012-2#1)
showed the ability##4##3##(1995-11#1)(2007-8#1)(2008-10#1)(2012-2#1)
showed the absence of##2##4##(1992-3#1)(2008-10#1)
showed the best##11##3##(1995-3#1)(2006-2#1)(2007-8#1)(2008-10#5)(2008-12#1)(2012-2#1)(2013-8#1)
showed the characteristic##4##3##(1990-11#1)(1990-5#1)(1997-8#1)(2008-6#1)
showed the complex##2##3##(2008-4#1)(2013-8#1)
showed the difference##2##3##(2008-11#1)(2008-5#1)
showed the distribution of##2##4##(2008-10#2)
showed the effect of##2##4##(2010-5#1)(2011-1#1)
showed the efficacy of##2##4##(2006-6#1)(2012-1#1)
showed the exact##2##3##(2008-4#1)(2012-12#1)
showed the existence of##6##4##(1990-7#2)(1992-8#1)(1993-2#1)(1994-2#1)(2005-4#1)
showed the expected##10##3##(1990-11#1)(1996-2#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-4#2)(2009-8#2)
showed the following characteristics##2##4##(1991-9#1)(2008-10#1)
showed the following##4##3##(1991-9#1)(1993-5#1)(2005-11#1)(2008-10#1)
showed the formation of##2##4##(1994-8#1)(2011-2#1)
showed the greatest##17##3##(1991-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1995-12#1)(1997-2#2)(2007-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)
showed the high##6##3##(1990-10#1)(1992-12#1)(1992-2#1)(2007-11#1)(2008-10#1)(2008-7#1)
showed the higher##4##3##(1992-3#1)(2008-10#1)(2008-5#1)(2011-2#1)
showed the highest activity against##2##5##(2009-6#1)(2010-3#1)
showed the highest activity##4##4##(2005-11#1)(2009-6#1)(2010-3#1)(2010-4#1)
showed the highest binding##2##4##(1992-11#1)(1997-1#1)
showed the highest fluorescence##2##4##(2007-11#2)
showed the highest level of##3##5##(2008-10#1)(2008-8#1)(2010-3#1)
showed the highest level##4##4##(2008-10#1)(2008-8#1)(2010-3#1)(2010-4#1)
showed the highest rate##2##4##(2011-2#1)(2013-1#1)
showed the highest sensitivity##4##4##(1990-10#1)(2007-7#1)(2008-10#1)(2008-11#1)
showed the highest similarity##2##4##(2008-10#1)(2012-2#1)
showed the highest values of##2##5##(2012-12#2)
showed the highest##61##3##(1990-10#1)(1990-2#1)(1991-1#1)(1992-1#1)(1992-10#1)(1992-11#1)(1997-1#1)(1997-2#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-11#3)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#11)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#4)(2008-8#1)(2009-3#1)(2009-6#2)(2009-7#1)(2010-3#2)(2010-4#2)(2010-5#1)(2011-2#2)(2012-12#3)(2012-2#2)(2013-1#5)
showed the importance of##4##4##(1993-10#1)(2010-8#1)(2011-1#1)(2012-3#1)
showed the increased##2##3##(2008-5#1)(2012-2#1)
showed the influence of the##2##5##(2008-10#1)(2008-5#1)
showed the largest##5##3##(2007-3#1)(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
showed the least##5##3##(2006-8#1)(2007-4#1)(2008-12#1)(2009-3#1)(2011-2#1)
showed the localization of##2##4##(1993-7#1)(2008-10#1)
showed the lowest##8##3##(1990-9#1)(1997-2#1)(2007-1#1)(2007-3#1)(2009-7#1)(2010-5#1)(2013-1#2)
showed the maximal##2##3##(1994-11#1)(2008-4#1)
showed the maximum##4##3##(2005-11#1)(2008-8#1)(2009-3#1)(2013-7#1)
showed the minimum##2##3##(2005-11#1)(2008-10#1)
showed the most important##2##4##(2007-8#1)(2013-8#1)
showed the most potent##3##4##(1992-5#1)(1994-12#1)(2011-1#1)
showed the most##17##3##(1990-11#1)(1991-4#1)(1992-5#1)(1994-12#1)(1996-2#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-7#1)(2011-1#3)(2012-3#1)(2013-7#1)(2013-8#1)
showed the need for a##2##5##(2011-2#1)(2013-1#1)
showed the need for##4##4##(1992-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
showed the normal##2##3##(1993-6#1)(1993-9#1)
showed the opposite trend##2##4##(2009-10#1)(2009-2#1)
showed the opposite##6##3##(1993-8#1)(1995-6#1)(2009-10#1)(2009-2#1)(2009-7#1)(2011-1#1)
showed the percentage of##2##4##(2007-7#1)(2007-8#1)
showed the possibility of##3##4##(2006-12#1)(2008-5#1)(2013-1#1)
showed the possibility##5##3##(1994-9#1)(2006-12#1)(2008-10#1)(2008-5#1)(2013-1#1)
showed the potential##2##3##(2008-10#1)(2013-7#1)
showed the presence of a single##2##6##(1994-6#1)(1994-9#1)
showed the presence of a##13##5##(1992-2#1)(1994-6#1)(1994-9#2)(1996-10#1)(1997-1#1)(1997-7#1)(2006-12#1)(2006-8#1)(2008-10#2)(2009-7#1)(2011-2#1)
showed the presence of an##2##5##(2006-8#1)(2013-1#1)
showed the presence of the##4##5##(1992-4#1)(2006-8#1)(2007-11#1)(2012-2#1)
showed the presence of three##2##5##(2007-6#1)(2008-10#1)
showed the presence of two##5##5##(1990-7#1)(1994-8#1)(2006-12#1)(2013-1#2)
showed the presence of##70##4##(1990-2#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-2#1)(1992-2#1)(1992-4#1)(1992-9#1)(1994-12#1)(1994-6#2)(1994-8#1)(1994-9#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-10#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-7#1)(2005-11#1)(2005-12#2)(2006-10#1)(2006-12#2)(2006-8#4)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#2)(2007-7#1)(2008-1#1)(2008-10#7)(2008-3#1)(2008-5#2)(2009-10#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#5)(2012-2#2)(2013-1#4)(2013-7#1)
showed the presence##72##3##(1990-2#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-2#1)(1992-2#1)(1992-4#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-6#2)(1994-8#1)(1994-9#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-10#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-7#1)(2005-11#1)(2005-12#2)(2006-10#1)(2006-12#2)(2006-8#4)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#2)(2007-7#1)(2008-1#1)(2008-10#7)(2008-3#1)(2008-5#2)(2009-10#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#5)(2012-2#2)(2013-1#4)(2013-7#1)
showed the primary##2##3##(1992-6#1)(2008-10#1)
showed the same pattern of##4##5##(1991-2#1)(1995-1#1)(2008-10#1)(2008-11#1)
showed the same pattern##6##4##(1990-5#1)(1991-2#1)(1995-1#1)(2008-10#1)(2008-11#1)(2010-8#1)
showed the same results##2##4##(2008-9#1)(2013-8#1)
showed the same##34##3##(1990-12#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1993-1#1)(1994-2#2)(1994-3#2)(1994-9#1)(1995-1#1)(1995-3#1)(1996-5#1)(1997-8#2)(2004-2#1)(2006-11#1)(2006-2#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
showed the similar##2##3##(2008-10#1)(2013-8#1)
showed the smallest##2##3##(2007-9#1)(2008-11#1)
showed the specific##2##3##(1992-9#1)(2008-11#1)
showed the strongest##4##3##(1995-5#1)(2008-10#2)(2009-6#1)
showed the superiority of##2##4##(1995-2#1)(2008-5#1)
showed the typical##6##3##(1992-11#1)(1995-8#1)(2007-12#2)(2007-3#1)(2008-1#1)
showed the##516##2##(1990-10#3)(1990-11#5)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#6)(1990-9#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#4)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#1)(1993-7#3)(1993-8#2)(1993-9#2)(1994-1#1)(1994-11#3)(1994-12#3)(1994-2#3)(1994-3#2)(1994-6#2)(1994-8#4)(1994-9#6)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#3)(1995-3#4)(1995-4#1)(1995-5#3)(1995-6#2)(1995-7#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-2#3)(1996-4#1)(1996-5#2)(1996-7#1)(1997-1#3)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#2)(1997-8#3)(2004-2#1)(2004-9#1)(2005-11#6)(2005-12#2)(2005-4#1)(2005-8#2)(2005-9#1)(2006-10#3)(2006-11#2)(2006-12#5)(2006-2#2)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#7)(2007-1#2)(2007-11#6)(2007-12#6)(2007-2#3)(2007-3#7)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#4)(2007-8#6)(2007-9#2)(2008-1#2)(2008-10#75)(2008-11#10)(2008-12#6)(2008-2#3)(2008-3#3)(2008-4#5)(2008-5#27)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#7)(2009-10#4)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#4)(2009-6#3)(2009-7#5)(2009-8#3)(2010-12#2)(2010-3#2)(2010-4#4)(2010-5#3)(2010-8#3)(2011-1#11)(2011-12#1)(2011-2#15)(2012-1#3)(2012-12#13)(2012-2#14)(2012-3#5)(2013-1#17)(2013-7#7)(2013-8#12)
showed their##5##2##(2007-10#1)(2008-11#2)(2008-4#1)(2013-1#1)
showed them to be of the##2##6##(1991-12#1)(1991-5#1)
showed them to be##3##4##(1991-12#1)(1991-5#1)(2010-5#1)
showed there was no##2##4##(1990-5#1)(2010-4#1)
showed there was##3##3##(1990-5#1)(1991-8#1)(2010-4#1)
showed there##4##2##(1990-5#1)(1991-8#1)(2008-10#1)(2010-4#1)
showed these cells##2##3##(1994-11#1)(2012-2#1)
showed these##8##2##(1994-11#1)(1996-9#1)(2008-10#2)(2008-9#1)(2009-4#1)(2012-2#1)(2013-8#1)
showed this##8##2##(1990-11#1)(1992-11#1)(1996-11#1)(1997-3#1)(2006-12#1)(2007-7#1)(2011-12#1)(2013-8#1)
showed three##5##2##(1991-4#1)(1993-7#1)(1994-9#1)(1997-8#1)(2012-12#1)
showed to be##10##3##(1992-1#1)(2008-10#6)(2008-4#1)(2009-4#1)(2012-12#1)
showed to have##3##3##(2008-10#1)(2008-3#2)
showed to##14##2##(1992-1#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-4#1)(2009-4#1)(2012-12#1)
showed total##4##2##(1992-3#1)(2006-8#1)(2007-7#1)(2008-12#1)
showed transient##2##2##(1996-4#1)(2010-6#1)
showed two distinct##2##3##(1991-8#1)(2008-10#1)
showed two groups##2##3##(2007-2#1)(2008-5#1)
showed two maxima##2##3##(1990-8#1)(2008-10#1)
showed two peaks##2##3##(1990-2#1)(1996-3#1)
showed two##26##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-8#2)(1992-2#1)(1993-12#1)(1993-6#1)(1996-2#1)(1996-3#1)(1997-7#1)(2006-2#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-4#1)(2008-5#1)(2010-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
showed type##2##2##(2007-9#2)
showed typical##8##2##(1994-3#1)(1994-8#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-7#1)(2012-12#1)(2012-3#1)
showed uniform##4##2##(2008-8#1)(2010-3#1)(2011-1#1)(2013-7#1)
showed unique##5##2##(1997-4#1)(2006-8#2)(2008-11#1)(2012-3#1)
showed unusual##3##2##(2007-12#1)(2008-12#1)(2012-3#1)
showed up as significant##2##4##(2008-10#2)
showed up as##3##3##(1994-3#1)(2008-10#2)
showed up to##2##3##(1992-12#1)(2008-11#1)
showed up##6##2##(1992-12#1)(1994-3#1)(1995-6#1)(2008-10#2)(2008-11#1)
showed up-regulation of##2##3##(1994-9#1)(2008-10#1)
showed values of##3##3##(1990-4#1)(1993-3#1)(2008-10#1)
showed values##5##2##(1990-4#1)(1992-4#1)(1993-3#1)(2008-10#1)(2008-3#1)
showed variable activities##2##3##(1997-8#1)(2008-10#1)
showed variable##7##2##(1994-2#1)(1997-8#1)(2005-9#1)(2008-10#2)(2012-11#1)(2012-2#1)
showed variation in##2##3##(1990-5#1)(2006-5#1)
showed variations in##2##3##(1992-8#1)(2008-11#1)
showed variations##5##2##(1992-8#1)(1997-2#1)(2008-11#1)(2008-5#1)(2011-2#1)
showed various##4##2##(1997-1#1)(2008-10#1)(2008-7#1)(2009-2#1)
showed varying degrees of##4##4##(1992-9#1)(2008-10#1)(2008-5#1)(2013-8#1)
showed varying##5##2##(1992-9#1)(2008-10#1)(2008-5#1)(2013-1#1)(2013-8#1)
showed vasculitis##2##2##(2006-10#1)(2008-1#1)
showed very different##2##3##(1993-9#1)(2008-4#1)
showed very good##6##3##(2005-10#1)(2007-11#1)(2008-10#1)(2008-5#2)(2010-10#1)
showed very high##5##3##(2007-10#1)(2008-7#1)(2009-5#1)(2010-8#1)(2011-1#1)
showed very little##3##3##(1990-11#1)(1996-8#1)(2008-7#1)
showed very low##4##3##(1995-10#1)(1995-2#1)(2008-10#1)(2010-2#1)
showed very similar##2##3##(1997-2#1)(2008-12#1)
showed very strong##2##3##(2005-11#1)(2008-10#1)
showed very##28##2##(1990-11#1)(1993-9#1)(1995-10#1)(1995-2#1)(1996-8#2)(1997-2#1)(2005-10#1)(2005-11#1)(2007-10#1)(2007-11#2)(2008-10#5)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-5#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-1#1)
showed virtually no##2##3##(1991-10#1)(1992-10#1)
showed virtually##3##2##(1991-10#1)(1992-10#1)(2004-11#1)
showed weak or##2##3##(1992-5#1)(2011-1#1)
showed weak##13##2##(1990-11#1)(1991-8#1)(1992-5#1)(1994-8#1)(1995-4#1)(1995-8#1)(1996-1#1)(2006-8#1)(2008-10#2)(2010-5#1)(2011-1#1)(2011-2#1)
showed wide##3##2##(1990-4#1)(1994-11#1)(2007-12#1)
showed##9477##1##(1990-1#6)(1990-10#27)(1990-11#47)(1990-12#52)(1990-2#38)(1990-3#34)(1990-4#20)(1990-5#36)(1990-6#21)(1990-7#34)(1990-8#17)(1990-9#21)(1991-1#21)(1991-10#22)(1991-11#12)(1991-12#32)(1991-2#35)(1991-3#24)(1991-4#25)(1991-5#33)(1991-6#33)(1991-7#34)(1991-8#28)(1991-9#36)(1992-1#16)(1992-10#28)(1992-11#30)(1992-12#29)(1992-2#29)(1992-3#40)(1992-4#16)(1992-5#22)(1992-6#31)(1992-7#29)(1992-8#45)(1992-9#35)(1993-1#9)(1993-10#6)(1993-11#38)(1993-12#40)(1993-2#30)(1993-3#35)(1993-4#19)(1993-5#11)(1993-6#42)(1993-7#29)(1993-8#24)(1993-9#35)(1994-1#1)(1994-10#12)(1994-11#47)(1994-12#59)(1994-2#51)(1994-3#48)(1994-4#1)(1994-5#20)(1994-6#42)(1994-7#8)(1994-8#69)(1994-9#61)(1995-1#31)(1995-10#17)(1995-11#30)(1995-12#53)(1995-2#49)(1995-3#56)(1995-4#10)(1995-5#43)(1995-6#35)(1995-7#18)(1995-8#38)(1995-9#13)(1996-1#30)(1996-10#25)(1996-11#25)(1996-12#41)(1996-2#45)(1996-3#43)(1996-4#21)(1996-5#40)(1996-6#36)(1996-7#30)(1996-8#24)(1996-9#28)(1997-1#41)(1997-2#73)(1997-3#39)(1997-4#48)(1997-5#38)(1997-6#46)(1997-7#56)(1997-8#58)(2003-11#1)(2004-1#1)(2004-10#2)(2004-11#15)(2004-12#1)(2004-2#7)(2004-3#2)(2004-4#14)(2004-7#1)(2004-8#1)(2004-9#20)(2005-1#1)(2005-10#19)(2005-11#109)(2005-12#18)(2005-3#1)(2005-4#9)(2005-5#1)(2005-6#2)(2005-7#11)(2005-8#18)(2005-9#10)(2006-1#7)(2006-10#77)(2006-11#13)(2006-12#70)(2006-2#22)(2006-3#11)(2006-4#11)(2006-5#22)(2006-6#20)(2006-7#20)(2006-8#86)(2006-9#21)(2007-1#38)(2007-10#55)(2007-11#73)(2007-12#105)(2007-2#71)(2007-3#42)(2007-4#14)(2007-5#28)(2007-6#26)(2007-7#123)(2007-8#143)(2007-9#52)(2008-1#61)(2008-10#1028)(2008-11#236)(2008-12#113)(2008-2#53)(2008-3#103)(2008-4#95)(2008-5#351)(2008-6#89)(2008-7#193)(2008-8#179)(2008-9#156)(2009-1#12)(2009-10#28)(2009-11#10)(2009-12#21)(2009-2#18)(2009-3#35)(2009-4#43)(2009-5#26)(2009-6#42)(2009-7#30)(2009-8#65)(2009-9#18)(2010-1#21)(2010-10#21)(2010-11#16)(2010-12#103)(2010-2#55)(2010-3#34)(2010-4#69)(2010-5#48)(2010-6#20)(2010-7#14)(2010-8#68)(2010-9#15)(2011-1#147)(2011-10#4)(2011-11#1)(2011-12#41)(2011-2#264)(2011-3#17)(2012-1#86)(2012-11#34)(2012-12#156)(2012-2#186)(2012-3#110)(2012-5#2)(2012-6#1)(2012-7#3)(2012-8#1)(2012-9#1)(2013-1#281)(2013-7#79)(2013-8#205)
shower curtain effect##2##3##(2008-2#2)
shower gel##2##2##(2008-5#2)
shower##8##1##(1990-4#1)(2008-2#3)(2008-5#3)(2012-2#1)
showering##4##1##(2006-12#1)(2008-5#2)(2009-3#1)
showers##6##1##(1995-6#1)(2008-10#5)
showing &quot##2##2##(1990-3#1)(2007-8#1)
showing CGE##2##2##(2010-4#2)
showing a clear##2##3##(2006-3#1)(2007-12#1)
showing a constant##2##3##(2008-2#1)(2008-7#1)
showing a few##2##3##(2010-12#1)(2012-11#1)
showing a good##3##3##(2008-10#1)(2008-2#1)(2012-3#1)
showing a high##4##3##(2004-9#1)(2008-10#1)(2008-5#1)(2011-2#1)
showing a higher##2##3##(2007-7#1)(2010-4#1)
showing a linear##2##3##(1997-7#1)(2011-1#1)
showing a pH##2##3##(1991-2#1)(2011-1#1)
showing a pattern##2##3##(1991-10#1)(1996-4#1)
showing a positive##2##3##(1997-6#1)(2008-4#1)
showing a rapid##2##3##(2007-12#1)(2009-8#1)
showing a remarkable##2##3##(1991-8#1)(1996-5#1)
showing a significant##4##3##(1994-11#1)(2007-10#1)(2007-4#1)(2008-9#1)
showing a single##2##3##(1990-10#1)(2007-12#1)
showing a strong##2##3##(2008-7#1)(2008-9#1)
showing a##117##2##(1990-10#1)(1990-5#1)(1991-10#1)(1991-11#1)(1991-2#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-2#1)(1993-9#1)(1994-11#2)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-9#1)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#3)(2004-9#1)(2005-11#2)(2005-8#1)(2006-10#3)(2006-3#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#4)(2008-9#4)(2009-12#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-11#1)(2012-3#1)(2013-1#1)(2013-7#1)
showing activation of##2##3##(2012-2#2)
showing an increase in##2##4##(1992-6#1)(2007-11#1)
showing an increase of##3##4##(1994-6#1)(2011-2#1)(2012-2#1)
showing an increase##6##3##(1992-6#1)(1994-2#1)(1994-6#1)(2007-11#1)(2011-2#1)(2012-2#1)
showing an##25##2##(1990-2#1)(1991-2#1)(1992-2#1)(1992-6#1)(1994-2#1)(1994-6#2)(1995-12#1)(2005-11#1)(2006-10#2)(2007-1#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-1#1)(2012-2#3)
showing at the##2##3##(1993-8#1)(1994-9#1)
showing at##3##2##(1993-8#1)(1994-9#1)(1996-1#1)
showing benefit##2##2##(2006-10#1)(2006-8#1)
showing better##2##2##(2008-7#1)(2008-9#1)
showing both##4##2##(1991-4#1)(2006-9#1)(2007-5#1)(2011-2#1)
showing characteristics of a##2##4##(1992-12#1)(1993-3#1)
showing close##2##2##(1990-4#1)(2007-12#1)
showing concern##2##2##(2008-1#1)(2008-11#1)
showing different##4##2##(2006-7#1)(2009-6#1)(2010-6#1)(2012-1#1)
showing differential expression##2##3##(2006-12#1)(2008-10#1)
showing direct##2##2##(1990-5#1)(1997-4#1)
showing either##5##2##(1997-7#1)(2006-12#1)(2008-10#3)
showing enhanced##2##2##(2008-9#2)
showing evidence of##2##3##(2008-9#1)(2012-2#1)
showing evidence##3##2##(2008-9#1)(2012-2#1)(2013-1#1)
showing excellent##2##2##(1997-1#1)(2013-8#1)
showing expression of##2##3##(1992-7#1)(2011-2#1)
showing expression##3##2##(1992-7#1)(2008-7#1)(2011-2#1)
showing extensive##3##2##(1994-6#1)(2010-12#1)(2013-8#1)
showing focal##2##2##(2004-11#1)(2012-2#1)
showing for the first time##2##5##(2008-10#1)(2009-2#1)
showing good agreement##2##3##(2005-11#1)(2008-3#1)
showing good repeatability##2##3##(2008-10#2)
showing good##8##2##(2005-11#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2013-8#1)
showing greater##5##2##(2008-10#2)(2008-5#1)(2012-2#1)(2013-7#1)
showing high homology##2##3##(1994-6#1)(2008-8#1)
showing high##10##2##(1993-1#1)(1993-9#1)(1994-6#1)(1997-1#2)(2007-6#1)(2008-6#1)(2008-8#1)(2009-12#1)(2013-1#1)
showing homology to mouse##2##4##(1994-12#1)(1995-2#1)
showing homology to##3##3##(1994-12#1)(1995-2#1)(2006-12#1)
showing how it is possible to protect the privacy of individuals and of institutions using a distributed strategy##2##18##(2013-1#2)
showing how the##5##3##(1997-2#1)(2006-6#1)(2008-12#1)(2008-7#1)(2010-2#1)
showing how to##2##3##(1997-2#1)(2008-8#1)
showing how##14##2##(1997-2#2)(2006-6#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-2#1)(2012-2#1)(2013-1#2)
showing improved##2##2##(2008-5#1)(2009-11#1)
showing improvement in##2##3##(2006-10#1)(2007-11#1)
showing improvement##3##2##(2006-10#1)(2007-11#1)(2007-12#1)
showing increased##6##2##(1996-12#1)(1996-4#1)(2006-10#1)(2008-5#1)(2009-8#1)(2011-2#1)
showing intense##2##2##(2008-10#1)(2012-12#1)
showing intermediate##3##2##(1990-12#1)(1991-7#1)(1994-8#1)
showing its##3##2##(1991-7#1)(2008-10#1)(2010-6#1)
showing large##2##2##(2008-7#1)(2009-10#1)
showing less##2##2##(2007-12#1)(2008-11#1)
showing little##2##2##(1995-12#1)(2012-12#1)
showing low##2##2##(1993-1#1)(2010-12#1)
showing marked##2##2##(2008-5#1)(2012-2#1)
showing mild##3##2##(2007-3#1)(2008-10#1)(2008-6#1)
showing more than##2##3##(1994-6#1)(1996-2#1)
showing more##5##2##(1994-6#1)(1996-12#1)(1996-2#1)(2009-10#1)(2013-1#1)
showing morphological##2##2##(1996-1#2)
showing multiple##2##2##(2008-12#1)(2010-12#1)
showing no homology with##2##4##(1994-12#1)(2008-9#1)
showing no significant difference##2##4##(2006-8#1)(2008-5#1)
showing no significant##3##3##(2006-8#1)(2008-10#1)(2008-5#1)
showing no##16##2##(1990-4#1)(1991-12#1)(1991-9#1)(1994-12#1)(1995-2#1)(2006-8#1)(2007-6#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-9#1)(2010-4#1)(2013-1#2)
showing only a##2##3##(2006-12#1)(2008-3#1)
showing only##4##2##(1990-3#1)(1996-10#1)(2006-12#1)(2008-3#1)
showing partial##2##2##(2008-7#1)(2009-2#1)
showing perchlorate present at##2##4##(2007-8#2)
showing positive##3##2##(1997-5#1)(2008-9#1)(2011-2#1)
showing preferential##2##2##(1995-12#1)(1995-3#1)
showing promise in##2##3##(2007-11#1)(2007-9#1)
showing promise##4##2##(2005-8#1)(2007-11#2)(2007-9#1)
showing promising results in##2##4##(2007-5#1)(2011-2#1)
showing promising results##3##3##(2007-5#1)(2011-2#1)(2012-1#1)
showing recent##2##2##(2005-9#1)(2012-12#1)
showing reduced##2##2##(2008-11#1)(2011-2#1)
showing relatively##2##2##(1996-4#1)(1996-5#1)
showing severe##2##2##(2008-10#1)(2012-3#1)
showing significant##7##2##(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-3#1)(2011-1#1)(2013-1#1)
showing significantly##5##2##(2007-3#1)(2007-9#1)(2008-4#1)(2008-9#1)(2012-3#1)
showing signs of##3##3##(1993-8#1)(1997-3#1)(2006-10#1)
showing similar##2##2##(2007-7#1)(2013-1#1)
showing some degree of##2##4##(2005-7#1)(2008-1#1)
showing some##7##2##(1990-11#1)(2005-7#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-6#1)(2010-6#1)
showing specific##2##2##(2007-9#1)(2008-7#1)
showing stimulation##2##2##(1991-3#1)(2008-7#1)
showing strong##8##2##(1990-10#1)(2007-8#1)(2008-10#2)(2010-7#1)(2011-3#1)(2012-1#1)(2012-2#1)
showing such##2##2##(2006-2#1)(2009-9#1)
showing that a##5##3##(1993-12#1)(1997-1#1)(2007-12#1)(2008-3#1)(2008-7#1)
showing that an##2##3##(1996-12#1)(2010-8#1)
showing that at##2##3##(1992-10#1)(2008-9#1)
showing that both##2##3##(1995-6#1)(2010-12#1)
showing that each##2##3##(1993-4#1)(2008-10#1)
showing that in##2##3##(1995-11#1)(2008-5#1)
showing that it is possible##2##5##(1995-5#1)(2008-7#1)
showing that it is##4##4##(1995-5#1)(1996-5#1)(2008-7#1)(2011-2#1)
showing that the two##2##4##(1996-2#1)(2008-2#1)
showing that the##60##3##(1990-12#1)(1990-2#2)(1990-5#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-11#3)(1994-12#2)(1994-2#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-7#2)(2005-11#2)(2005-9#1)(2006-10#1)(2006-3#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#3)(2008-7#1)(2008-9#1)(2009-2#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
showing that there is##2##4##(1990-2#1)(1994-3#1)
showing that there##3##3##(1990-2#1)(1994-3#1)(2006-7#1)
showing that these##4##3##(2005-8#1)(2009-8#1)(2011-2#1)(2013-8#1)
showing that they can##2##4##(2007-12#1)(2010-8#1)
showing that this was##2##4##(1995-5#1)(2007-2#1)
showing that this##7##3##(1995-5#1)(1996-12#1)(1996-8#1)(1997-4#1)(2007-2#1)(2008-10#1)(2008-6#1)
showing that treatment with##2##4##(2008-10#1)(2008-7#1)
showing that treatment##5##3##(1997-5#1)(2007-4#1)(2008-10#1)(2008-7#1)(2010-8#1)
showing that with##2##3##(1994-10#1)(2010-4#1)
showing that##208##2##(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#1)(1990-9#1)(1991-11#2)(1991-2#2)(1991-3#2)(1991-4#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#2)(1994-10#1)(1994-11#4)(1994-12#3)(1994-2#2)(1994-3#2)(1994-8#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-5#3)(1995-6#3)(1996-11#2)(1996-12#2)(1996-2#1)(1996-5#3)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2005-11#2)(2005-8#1)(2005-9#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-7#1)(2007-11#4)(2007-12#8)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#12)(2008-11#3)(2008-2#9)(2008-3#6)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#2)(2010-10#2)(2010-12#2)(2010-3#1)(2010-4#2)(2010-7#2)(2010-8#4)(2011-1#2)(2011-10#1)(2011-2#6)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#1)(2013-7#2)(2013-8#3)
showing the effect of##2##4##(2006-12#1)(2008-1#1)
showing the good##2##3##(1992-10#1)(2008-10#1)
showing the great##2##3##(1993-5#1)(2007-5#1)
showing the highest##7##3##(1993-6#1)(2007-12#1)(2007-8#1)(2008-3#1)(2011-1#1)(2012-2#1)(2013-7#1)
showing the impact of##2##4##(1996-10#1)(2013-8#1)
showing the importance of##2##4##(1991-6#1)(2008-10#1)
showing the involvement of##2##4##(1990-3#1)(2009-10#1)
showing the lowest##3##3##(2008-5#1)(2011-2#2)
showing the most significant effect##2##5##(2008-10#1)(2008-11#1)
showing the most significant##3##4##(2008-1#1)(2008-10#1)(2008-11#1)
showing the most##6##3##(1995-5#1)(2008-1#1)(2008-10#1)(2008-11#2)(2012-12#1)
showing the need##2##3##(2009-5#1)(2011-2#1)
showing the possibility of##2##4##(2008-10#1)(2012-2#1)
showing the presence of##3##4##(1992-11#1)(1992-9#1)(2007-11#1)
showing the same##2##3##(2009-10#1)(2009-4#1)
showing the severe##2##3##(2006-10#1)(2008-10#1)
showing the typical clinical##2##4##(2008-5#1)(2008-7#1)
showing the usefulness of##2##4##(2008-10#1)(2008-2#1)
showing the##117##2##(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-5#1)(1993-6#1)(1995-5#1)(1996-10#1)(1996-5#1)(1996-6#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#16)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#2)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2010-2#1)(2010-5#2)(2010-6#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
showing their##2##2##(2008-10#1)(2008-7#1)
showing this##2##2##(2009-1#1)(2010-11#1)
showing two##4##2##(1990-12#1)(2007-12#2)(2008-5#1)
showing typical##4##2##(2007-1#1)(2008-10#2)(2009-8#1)
showing up##4##2##(2008-7#1)(2010-7#1)(2010-9#1)(2012-3#1)
showing various##2##2##(2008-6#1)(2012-2#1)
showing very##2##2##(1997-7#1)(2008-3#1)
showing where##2##2##(2008-9#1)(2010-12#1)
showing##962##1##(1990-10#3)(1990-11#1)(1990-12#3)(1990-2#7)(1990-3#5)(1990-4#2)(1990-5#5)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-10#3)(1991-11#4)(1991-12#1)(1991-2#5)(1991-3#3)(1991-4#3)(1991-5#1)(1991-6#4)(1991-7#4)(1991-8#1)(1991-9#4)(1992-1#2)(1992-10#3)(1992-11#3)(1992-12#3)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#8)(1992-7#2)(1992-8#1)(1992-9#3)(1993-1#3)(1993-11#4)(1993-12#1)(1993-2#4)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#4)(1993-8#2)(1993-9#5)(1994-1#1)(1994-10#1)(1994-11#6)(1994-12#7)(1994-2#4)(1994-3#2)(1994-6#6)(1994-8#3)(1994-9#3)(1995-10#1)(1995-11#5)(1995-12#8)(1995-2#7)(1995-3#2)(1995-4#1)(1995-5#7)(1995-6#3)(1996-1#3)(1996-10#3)(1996-11#4)(1996-12#5)(1996-2#8)(1996-3#2)(1996-4#5)(1996-5#7)(1996-6#2)(1996-7#1)(1996-8#3)(1996-9#4)(1997-1#8)(1997-2#6)(1997-3#6)(1997-4#6)(1997-5#2)(1997-6#3)(1997-7#8)(1997-8#5)(2004-11#2)(2004-12#1)(2004-2#1)(2004-9#1)(2005-11#8)(2005-6#1)(2005-7#1)(2005-8#6)(2005-9#4)(2006-10#17)(2006-11#1)(2006-12#10)(2006-2#2)(2006-3#2)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#3)(2006-9#1)(2007-1#4)(2007-10#2)(2007-11#17)(2007-12#25)(2007-2#4)(2007-3#3)(2007-4#4)(2007-5#6)(2007-6#6)(2007-7#8)(2007-8#10)(2007-9#7)(2008-1#15)(2008-10#88)(2008-11#18)(2008-12#12)(2008-2#20)(2008-3#21)(2008-4#14)(2008-5#40)(2008-6#10)(2008-7#22)(2008-8#9)(2008-9#22)(2009-1#2)(2009-10#5)(2009-11#3)(2009-12#4)(2009-2#5)(2009-3#2)(2009-4#3)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#12)(2010-2#4)(2010-3#2)(2010-4#9)(2010-5#6)(2010-6#5)(2010-7#5)(2010-8#7)(2010-9#2)(2011-1#8)(2011-10#1)(2011-12#1)(2011-2#28)(2011-3#1)(2012-1#5)(2012-11#2)(2012-12#9)(2012-2#21)(2012-3#12)(2013-1#20)(2013-7#6)(2013-8#15)
shown a close##2##3##(2006-10#1)(2008-10#1)
shown a dramatic increase in##2##5##(2007-8#1)(2011-1#1)
shown a genetic effect##2##4##(1994-2#2)
shown a genetic##3##3##(1994-2#2)(1997-1#1)
shown a linear relationship between##2##5##(1992-4#1)(2005-10#1)
shown a major##2##3##(2006-10#1)(2008-3#1)
shown a positive correlation between##2##5##(2006-10#1)(2011-2#1)
shown a positive correlation##4##4##(1995-9#1)(2006-10#1)(2008-12#1)(2011-2#1)
shown a positive##6##3##(1992-4#1)(1993-3#1)(1995-9#1)(2006-10#1)(2008-12#1)(2011-2#1)
shown a remarkable##2##3##(2006-11#1)(2008-1#1)
shown a significant##4##3##(1994-2#1)(2008-1#1)(2008-10#1)(2008-3#1)
shown a very##2##3##(1991-3#1)(2013-8#1)
shown a##92##2##(1990-10#1)(1991-12#1)(1991-3#2)(1991-5#3)(1992-11#1)(1992-12#1)(1992-4#2)(1993-3#1)(1994-2#3)(1994-8#1)(1995-3#1)(1995-6#1)(1995-9#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-10#1)(2005-12#1)(2005-7#1)(2005-9#1)(2006-10#10)(2006-11#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-12#3)(2007-2#1)(2007-5#2)(2007-8#1)(2007-9#4)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#3)(2008-3#4)(2008-5#2)(2008-8#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-11#2)(2012-12#1)(2013-1#1)(2013-8#2)
shown above##3##2##(2007-12#1)(2007-4#1)(2008-10#1)
shown activity##2##2##(2007-11#2)
shown after##4##2##(1994-6#1)(2008-11#2)(2008-7#1)
shown against##2##2##(2005-8#1)(2006-1#1)
shown an appreciable##2##3##(2008-10#2)
shown an association##3##3##(1994-3#1)(2008-3#1)(2009-6#1)
shown an influence##2##3##(1990-5#1)(1991-5#1)
shown an##21##2##(1990-5#1)(1991-5#1)(1991-6#1)(1994-3#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2009-6#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
shown and discussed##2##3##(2008-2#1)(2008-3#1)
shown and##7##2##(1991-8#1)(2007-8#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)
shown anti-tumor activity##2##3##(2008-1#1)(2008-3#1)
shown any##7##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#2)(2012-3#2)
shown as a##6##3##(1990-6#1)(1996-12#1)(2007-12#1)(2008-3#1)(2008-8#1)(2009-5#1)
shown as##13##2##(1990-6#1)(1991-10#1)(1992-2#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-1#1)
shown at the##2##3##(2006-6#1)(2008-10#1)
shown at##10##2##(1995-12#1)(1995-2#1)(2005-10#1)(2005-11#1)(2006-6#1)(2008-10#2)(2008-11#2)(2008-2#1)
shown benefit in##3##3##(2007-11#1)(2008-5#1)(2009-11#1)
shown between the##5##3##(2008-10#2)(2008-4#1)(2012-2#1)(2013-1#1)
shown between##10##2##(1993-3#1)(1993-9#1)(1995-1#1)(2008-10#2)(2008-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
shown both##9##2##(1991-7#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-5#1)(2010-1#1)
shown by 1-day-old chicks##2##4##(2008-5#2)
shown by FTIR##2##3##(2008-10#2)
shown by PCR##2##3##(1997-7#1)(2006-8#1)
shown by SDS-PAGE in the##2##5##(1991-9#1)(1995-11#1)
shown by UV##2##3##(1990-7#1)(2006-12#1)
shown by a##10##3##(1990-5#1)(1992-10#1)(1993-2#1)(1996-1#1)(1997-7#1)(2006-10#1)(2006-9#1)(2008-10#3)
shown by all##2##3##(1992-11#1)(2008-7#1)
shown by an increase in##2##5##(1992-8#1)(1996-12#1)
shown by both##2##3##(1993-5#1)(2008-2#1)
shown by decreases in##4##4##(1996-10#1)(2007-1#1)(2008-3#1)(2008-9#1)
shown by diffusion##2##3##(1991-5#1)(2007-12#1)
shown by flow cytometry##3##4##(1993-9#1)(1995-2#1)(1995-8#1)
shown by flow##4##3##(1990-9#1)(1993-9#1)(1995-2#1)(1995-8#1)
shown by fluorescence##3##3##(1992-10#1)(1994-3#1)(1995-10#1)
shown by further##2##3##(2007-11#1)(2008-9#1)
shown by immunoblotting##2##3##(1991-5#1)(1993-9#1)
shown by immunoelectron microscopy##2##4##(1996-3#1)(2011-1#1)
shown by immunoprecipitation##2##3##(1990-10#1)(1997-2#1)
shown by its##2##3##(1993-8#1)(1995-12#1)
shown by molecular##2##3##(1996-2#1)(2006-12#1)
shown by nuclear##4##3##(1990-4#1)(1991-7#1)(1992-12#1)(2010-3#1)
shown by our##2##3##(1994-8#1)(2008-9#1)
shown by randomized##2##3##(2006-12#1)(2011-2#1)
shown by studies##2##3##(1995-5#1)(2011-2#1)
shown by the##47##3##(1990-12#2)(1990-2#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-5#1)(1992-7#1)(1993-6#2)(1994-3#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-7#1)(1996-4#1)(2005-11#1)(2006-4#1)(2007-1#2)(2007-7#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-5#4)(2008-6#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-3#1)(2012-6#1)(2013-1#1)(2013-7#1)
shown by their##2##3##(1994-5#1)(2012-1#1)
shown by use of##3##4##(1994-8#1)(2007-12#1)(2008-3#1)
shown by using##4##3##(1990-4#2)(1994-12#1)(2006-5#1)
shown by various##2##3##(1995-2#1)(2006-10#1)
shown by##269##2##(1990-10#3)(1990-11#3)(1990-12#9)(1990-2#2)(1990-3#1)(1990-4#4)(1990-5#1)(1990-7#3)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#5)(1991-9#3)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-7#2)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#3)(1994-12#3)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#2)(1994-8#3)(1994-9#2)(1995-1#1)(1995-10#4)(1995-11#2)(1995-12#4)(1995-2#5)(1995-3#3)(1995-5#4)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-11#3)(2005-7#2)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#3)(2006-4#1)(2006-5#4)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#3)(2007-9#5)(2008-1#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#16)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#5)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#3)(2012-12#3)(2012-2#1)(2012-3#2)(2012-5#1)(2012-6#1)(2013-1#4)(2013-7#1)(2013-8#1)
shown capable of##3##3##(1990-3#1)(1993-11#1)(2008-10#1)
shown conflicting results##2##3##(2007-11#1)(2009-8#1)
shown considerable##4##2##(2005-11#1)(2007-11#1)(2013-1#1)(2013-8#1)
shown directly##2##2##(1992-4#1)(1994-11#1)
shown distinct##2##2##(2008-10#1)(2008-5#1)
shown encouraging results##2##3##(2006-9#1)(2007-7#1)
shown encouraging##3##2##(2006-9#1)(2007-7#1)(2013-8#1)
shown enormous potential in##2##4##(2008-10#1)(2009-7#1)
shown evidence of##3##3##(2006-12#1)(2007-6#1)(2008-7#1)
shown excellent results##2##3##(1993-3#1)(2009-5#1)
shown excellent##5##2##(1993-3#1)(2006-10#1)(2009-5#1)(2010-8#1)(2013-7#1)
shown experimentally and theoretically that the##2##6##(1997-1#1)(1997-2#1)
shown experimentally and##3##3##(1997-1#1)(1997-2#1)(2007-11#1)
shown experimentally##7##2##(1991-1#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#1)
shown for a##6##3##(1996-3#1)(1997-8#1)(2005-11#1)(2008-2#2)(2008-3#1)
shown for both##2##3##(1993-2#1)(2007-3#1)
shown for several##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
shown for the first time that##2##6##(1996-2#1)(2006-5#1)
shown for the first time##6##5##(1994-3#1)(1996-2#1)(2006-5#1)(2008-10#2)(2008-3#1)
shown for the##10##3##(1990-11#1)(1994-3#1)(1996-2#1)(2006-5#1)(2008-10#2)(2008-2#2)(2008-3#2)
shown for##52##2##(1990-11#1)(1990-3#2)(1990-5#1)(1991-10#1)(1991-9#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-3#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-8#2)(2005-11#1)(2006-5#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#8)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
shown from##2##2##(2006-12#1)(2006-5#1)
shown good##8##2##(1995-12#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-12#1)(2008-10#2)(2010-9#1)
shown great##4##2##(1994-3#1)(1996-8#1)(2008-1#1)(2010-4#1)
shown here that##10##3##(1990-11#1)(1990-12#1)(1992-3#1)(1992-7#1)(1993-2#1)(1997-4#1)(2008-10#2)(2008-3#2)
shown here##25##2##(1990-11#1)(1990-12#1)(1991-5#1)(1991-9#1)(1992-11#2)(1992-3#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-2#1)(1995-6#1)(1995-7#1)(1996-1#1)(1997-4#1)(2007-9#1)(2008-10#3)(2008-3#3)(2009-8#1)(2010-5#1)
shown high##2##2##(2007-2#1)(2010-8#1)
shown higher##5##2##(1992-4#1)(2006-9#1)(2007-4#1)(2008-12#1)(2008-6#1)
shown how the##13##3##(1992-10#1)(1992-6#1)(1992-9#1)(1994-8#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#2)(2008-8#1)(2009-2#1)
shown how##28##2##(1992-10#1)(1992-6#1)(1992-9#2)(1994-8#1)(2006-10#1)(2006-5#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2010-4#1)
shown improvements in##2##3##(2006-10#1)(2008-3#1)
shown in Figure##2##3##(2009-3#2)
shown in a##14##3##(1994-6#1)(1996-3#1)(1996-8#1)(2005-4#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-2#1)
shown in all patients##2##4##(1991-7#1)(2006-8#1)
shown in all##3##3##(1991-7#1)(1992-9#1)(2006-8#1)
shown in an earlier##2##4##(1991-1#1)(2005-8#1)
shown in an##5##3##(1991-1#1)(1991-2#1)(1991-9#1)(2005-8#1)(2008-4#1)
shown in animal studies##2##4##(1995-8#1)(2007-11#1)
shown in both##2##3##(1991-12#1)(2011-2#1)
shown in comparison with a##2##5##(2008-3#1)(2011-2#1)
shown in comparison##3##3##(2008-3#1)(2008-5#1)(2011-2#1)
shown in previous##2##3##(2007-12#1)(2008-7#1)
shown in several##2##3##(2006-1#1)(2012-12#1)
shown in the rat##2##4##(1990-7#1)(1991-12#1)
shown in the young adult##2##5##(1995-3#1)(2010-4#1)
shown in the##37##3##(1990-12#1)(1990-7#1)(1991-12#1)(1991-8#1)(1993-2#1)(1993-4#1)(1995-11#1)(1995-3#1)(1995-5#1)(1997-2#1)(2005-4#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-11#2)(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#2)(2010-5#1)(2011-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
shown in this article##2##4##(2007-12#1)(2008-4#1)
shown in this paper##2##4##(2008-10#1)(2012-12#1)
shown in this study##6##4##(1991-9#1)(1997-8#1)(2006-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
shown in this##15##3##(1991-9#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2012-12#1)(2013-1#1)
shown in various##2##3##(2007-9#1)(2012-3#1)
shown in##156##2##(1990-10#2)(1990-12#1)(1990-5#1)(1990-7#1)(1991-1#2)(1991-12#2)(1991-2#1)(1991-7#2)(1991-8#1)(1991-9#3)(1992-12#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-2#1)(1993-4#2)(1993-7#1)(1994-11#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-8#2)(1997-2#4)(1997-4#1)(1997-8#1)(2005-12#2)(2005-4#2)(2005-8#2)(2006-1#2)(2006-10#4)(2006-11#2)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#2)(2006-8#4)(2007-10#1)(2007-11#5)(2007-12#6)(2007-7#1)(2007-9#1)(2008-10#10)(2008-11#3)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#3)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-5#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#4)
shown increased##3##2##(2005-12#1)(2006-10#1)(2006-7#1)
shown individually##2##2##(1996-9#1)(2009-4#1)
shown it to be##3##4##(1991-2#1)(1996-2#1)(2006-8#1)
shown it##5##2##(1991-2#1)(1996-2#1)(2006-8#1)(2008-7#1)(2011-2#1)
shown its efficacy##2##3##(2008-3#1)(2010-12#1)
shown its##5##2##(2008-3#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-8#1)
shown itself to##2##3##(1993-5#1)(2007-12#1)
shown itself##3##2##(1993-5#1)(2007-12#1)(2007-8#1)
shown large##2##2##(1990-6#1)(1997-2#1)
shown less##2##2##(2008-5#1)(2011-2#1)
shown limited##3##2##(2007-3#1)(2008-1#1)(2008-5#1)
shown little##4##2##(1991-4#1)(1992-3#1)(1996-2#1)(2005-10#1)
shown many##2##2##(2006-5#1)(2008-3#1)
shown marked##2##2##(2008-1#1)(2008-5#1)
shown minimal##2##2##(2006-10#1)(2007-11#1)
shown more##2##2##(2007-9#1)(2008-5#1)
shown mortality##2##2##(2006-9#1)(2008-3#1)
shown mostly##2##2##(1991-5#1)(2008-5#1)
shown no benefit##2##3##(2007-11#1)(2007-8#1)
shown no##11##2##(1991-12#1)(1991-6#1)(1992-9#1)(1993-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-5#1)
shown not only to##2##4##(2011-2#1)(2012-12#1)
shown not only##5##3##(1992-8#1)(2006-2#1)(2008-2#1)(2011-2#1)(2012-12#1)
shown not to be##3##4##(1990-11#1)(1991-2#1)(2008-7#1)
shown not to##9##3##(1990-11#1)(1990-12#1)(1990-2#1)(1991-2#1)(2005-11#1)(2005-9#1)(2008-1#1)(2008-3#1)(2008-7#1)
shown not##14##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-2#1)(1992-8#1)(2005-11#1)(2005-9#1)(2006-2#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)
shown on##8##2##(1990-3#1)(1993-4#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-2#2)
shown only##3##2##(2006-10#1)(2008-8#1)(2011-1#1)
shown positive effects##2##3##(2007-1#1)(2012-2#1)
shown previously by##2##3##(1997-5#1)(2007-12#1)
shown previously that the##2##4##(1991-5#1)(2008-2#1)
shown previously that these##2##4##(1993-11#1)(1996-5#1)
shown previously that##14##3##(1991-5#1)(1992-9#1)(1993-11#1)(1993-4#1)(1994-11#1)(1995-11#1)(1995-3#1)(1996-5#3)(1997-5#1)(2007-12#1)(2008-2#1)(2009-8#1)
shown previously to be##4##4##(1991-2#1)(1992-7#1)(1995-8#1)(1996-12#1)
shown previously to inhibit##2##4##(1994-10#1)(1994-3#1)
shown previously to##19##3##(1990-11#1)(1990-8#1)(1991-2#1)(1992-10#1)(1992-12#1)(1992-7#1)(1993-12#1)(1993-8#1)(1994-10#1)(1994-3#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(2007-6#1)(2009-4#1)
shown previously##39##2##(1990-11#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-10#1)(1992-12#2)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#3)(1997-5#2)(2007-12#2)(2007-6#1)(2008-10#1)(2008-2#1)(2009-4#1)(2009-8#1)
shown promise in the##2##4##(2006-10#2)
shown promise in##12##3##(2006-10#3)(2008-3#1)(2008-8#2)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#1)(2012-3#1)
shown promise to##2##3##(2006-8#1)(2010-12#1)
shown promise##21##2##(2006-10#3)(2006-8#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-12#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-8#1)(2012-3#2)
shown promising activity in##2##4##(2008-7#1)(2009-4#1)
shown promising activity##3##3##(2007-11#1)(2008-7#1)(2009-4#1)
shown promising results in##8##4##(2007-11#2)(2007-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
shown promising results##12##3##(1996-1#1)(2007-11#3)(2007-7#1)(2010-12#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)
shown promising##22##2##(1996-1#1)(2007-11#7)(2007-7#1)(2008-5#1)(2008-7#3)(2009-4#1)(2010-12#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#1)
shown recently that##2##3##(2007-12#1)(2008-1#1)
shown recently##6##2##(1990-11#1)(1992-3#1)(1995-11#1)(2007-12#1)(2008-1#1)(2009-8#1)
shown short-term##2##2##(2006-10#1)(2008-3#1)
shown significant efficacy in##2##4##(2006-2#1)(2007-11#1)
shown significant##11##2##(1995-1#1)(2005-10#1)(2006-2#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-3#2)(2010-12#1)(2010-2#1)
shown significantly##2##2##(2006-10#1)(2013-1#1)
shown signs of##2##3##(1990-3#1)(1997-5#1)
shown similar##2##2##(2007-11#1)(2008-5#1)
shown simultaneously##2##2##(1996-7#1)(2006-6#1)
shown some##12##2##(2007-11#1)(2008-10#2)(2008-11#2)(2008-3#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)
shown superiority to##5##3##(2008-7#1)(2013-8#4)
shown than##3##2##(2006-8#1)(2007-11#1)(2009-10#1)
shown that (i)##4##3##(1991-10#2)(1993-8#1)(2008-8#1)
shown that DNA##5##3##(1994-3#1)(1994-8#1)(1996-7#1)(1997-1#1)(1997-6#1)
shown that a highly##3##4##(1993-11#1)(1994-9#1)(2008-1#1)
shown that a number of##2##5##(1995-9#1)(2008-5#1)
shown that a single##2##4##(2011-2#1)(2012-3#1)
shown that a##62##3##(1990-3#1)(1990-8#1)(1991-10#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-9#1)(1996-1#1)(1997-1#2)(1997-2#1)(2005-12#1)(2006-11#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#6)(2007-4#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#8)(2008-5#4)(2008-7#3)(2008-8#2)(2010-12#1)(2010-4#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-7#1)
shown that activated##2##3##(2006-7#1)(2008-1#1)
shown that administration of##2##4##(1993-7#1)(2011-2#1)
shown that all##5##3##(1995-8#1)(2007-11#1)(2008-2#2)(2008-5#1)
shown that although##2##3##(2007-10#1)(2008-8#1)
shown that an optimal##2##4##(2008-11#1)(2008-3#1)
shown that an##10##3##(1991-12#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2011-12#1)
shown that as##2##3##(1995-4#1)(2008-1#1)
shown that at least##4##4##(2008-1#2)(2008-3#2)
shown that at##8##3##(1994-11#1)(2007-12#1)(2008-1#2)(2008-3#3)(2010-12#1)
shown that bone mineral##2##4##(2007-11#1)(2011-2#1)
shown that both the##2##4##(1992-7#1)(2008-3#1)
shown that both##15##3##(1990-11#1)(1992-7#1)(1994-12#2)(1995-1#1)(1995-8#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2013-1#1)(2013-8#1)
shown that breast##2##3##(1992-8#1)(2008-3#1)
shown that by##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
shown that cell##2##3##(1994-5#1)(2008-11#1)
shown that cellular##2##3##(1991-10#1)(2008-7#1)
shown that children##2##3##(2007-8#1)(2013-7#1)
shown that combination##2##3##(2008-5#1)(2012-2#1)
shown that combinations##2##3##(2008-10#1)(2009-6#1)
shown that different##2##3##(2007-5#1)(2008-2#1)
shown that during##2##3##(2008-4#1)(2011-2#1)
shown that each##2##3##(1991-5#1)(2008-5#1)
shown that early##3##3##(1992-3#1)(2006-10#1)(2009-8#1)
shown that environmental##2##3##(1992-4#1)(2008-10#1)
shown that exposure of the##2##5##(2005-11#1)(2012-2#1)
shown that exposure##5##3##(1991-4#1)(1994-2#1)(1997-3#1)(2005-11#1)(2012-2#1)
shown that for a##4##4##(1997-7#1)(2005-11#1)(2008-2#2)
shown that for##13##3##(1997-7#1)(2005-11#2)(2007-12#1)(2008-2#5)(2008-3#3)(2010-12#1)
shown that high##2##3##(1990-12#1)(1990-6#1)
shown that human##5##3##(1990-5#1)(1994-5#1)(1997-6#1)(2007-2#1)(2008-5#1)
shown that if the##3##4##(1995-3#1)(2008-3#2)
shown that if##5##3##(1995-3#1)(2007-6#1)(2008-3#2)(2009-6#1)
shown that in the first##2##5##(1990-5#1)(2013-7#1)
shown that in the presence of##2##6##(1991-5#1)(2008-10#1)
shown that in the##12##4##(1990-5#1)(1991-5#1)(1994-8#1)(1996-5#1)(2007-11#1)(2008-10#2)(2009-9#1)(2012-12#2)(2013-7#2)
shown that in##31##3##(1990-5#1)(1991-5#1)(1992-10#1)(1994-8#1)(1996-10#1)(1996-5#1)(1997-6#1)(2004-11#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#1)(2009-9#1)(2011-1#1)(2012-12#2)(2013-7#2)
shown that inclusion of##2##4##(1990-11#1)(1995-12#1)
shown that increased##5##3##(1992-12#1)(2006-10#1)(2009-2#1)(2012-1#1)(2013-7#1)
shown that is##3##3##(2006-5#1)(2008-2#1)(2010-12#1)
shown that it is possible to##3##6##(2008-10#2)(2008-3#1)
shown that it is possible##5##5##(2006-10#1)(2007-12#1)(2008-10#2)(2008-3#1)
shown that it is##12##4##(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#1)
shown that it##18##3##(1990-11#1)(1993-6#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
shown that long-term##4##3##(1996-3#1)(2009-2#1)(2012-11#2)
shown that loss of##3##4##(2013-1#2)(2013-7#1)
shown that low levels of##2##5##(2008-11#1)(2008-7#1)
shown that low##5##3##(1997-6#1)(2008-11#2)(2008-7#1)(2012-2#1)
shown that many##4##3##(2007-11#1)(2008-10#1)(2009-4#1)(2012-2#1)
shown that most of##2##4##(1995-7#1)(2012-2#1)
shown that most##6##3##(1995-7#1)(1995-8#1)(1997-4#1)(2007-8#1)(2008-3#1)(2012-2#1)
shown that one of the##2##5##(1990-5#1)(2013-1#1)
shown that one##8##3##(1990-5#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-3#1)(2013-1#1)
shown that only##9##3##(1994-9#1)(1995-4#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2013-7#1)
shown that optimal##2##3##(2008-12#1)(2008-2#1)
shown that oral administration of##2##5##(1997-4#1)(2008-11#1)
shown that oral##3##3##(1997-4#1)(2008-11#1)(2008-5#1)
shown that our##3##3##(2007-11#1)(2008-2#1)(2012-2#1)
shown that patients with an##2##5##(2008-6#1)(2010-4#1)
shown that patients with##3##4##(2006-10#1)(2008-6#1)(2010-4#1)
shown that patients##5##3##(2006-10#1)(2007-2#1)(2008-6#1)(2010-4#1)(2012-3#1)
shown that polar##2##3##(2008-10#1)(2009-8#1)
shown that proteins##2##3##(1996-5#1)(2010-4#1)
shown that regulatory##2##3##(2006-11#1)(2007-12#1)
shown that removal of##2##4##(2008-4#1)(2008-6#1)
shown that retinoic acid increases the##2##6##(1993-3#1)(2006-10#1)
shown that selecting##2##3##(1997-2#1)(2008-3#1)
shown that several##4##3##(1997-2#1)(2008-10#1)(2008-5#1)(2011-2#1)
shown that small##3##3##(1994-11#1)(2008-3#1)(2008-7#1)
shown that some##5##3##(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
shown that specific##2##3##(1997-8#1)(2008-2#1)
shown that such##3##3##(1995-2#1)(2007-12#1)(2008-7#1)
shown that surgery##3##3##(1991-9#1)(2008-5#1)(2008-8#1)
shown that the N-terminal##2##4##(1994-3#1)(1994-5#1)
shown that the activation##2##4##(2008-10#1)(2008-8#1)
shown that the addition of##2##5##(2007-11#1)(2010-4#1)
shown that the bacterium##2##4##(1990-11#1)(1991-11#1)
shown that the detection limit##2##5##(2005-4#1)(2008-10#1)
shown that the detection##3##4##(2005-4#1)(2008-10#1)(2008-7#1)
shown that the different##2##4##(2008-11#2)
shown that the distribution of the##3##6##(2006-6#1)(2008-11#1)(2013-1#1)
shown that the distribution of##4##5##(2006-10#1)(2006-6#1)(2008-11#1)(2013-1#1)
shown that the effect##2##4##(1992-6#1)(1993-12#1)
shown that the human##2##4##(1994-8#1)(1997-4#1)
shown that the induction of hsp70 expression by heat shock##2##10##(1994-11#2)
shown that the induction of##3##5##(1994-11#2)(2008-5#1)
shown that the instrument is##3##5##(2008-10#1)(2008-3#1)(2010-12#1)
shown that the interaction##2##4##(1996-9#1)(2005-11#1)
shown that the introduction of##2##5##(1996-2#1)(2005-10#1)
shown that the longer##2##4##(1995-8#1)(1996-2#1)
shown that the maximum##4##4##(2007-11#1)(2008-2#3)
shown that the method##6##4##(2008-10#2)(2008-2#2)(2008-3#1)(2010-6#1)
shown that the model##2##4##(2006-11#1)(2008-7#1)
shown that the molecular##3##4##(1995-3#1)(2005-11#1)(2012-2#1)
shown that the most##2##4##(2007-10#1)(2008-8#1)
shown that the new##2##4##(1995-2#1)(2009-2#1)
shown that the number of##2##5##(1990-6#1)(2006-10#1)
shown that the number##3##4##(1990-6#1)(2006-10#1)(2008-12#1)
shown that the presence of##6##5##(1995-6#1)(2005-11#1)(2008-1#1)(2008-3#1)(2009-1#1)(2013-1#1)
shown that the proposed##5##4##(2007-8#1)(2008-10#1)(2008-2#3)
shown that the protein##2##4##(1990-9#1)(1994-3#1)
shown that the relationship between##2##5##(1994-5#1)(2007-12#1)
shown that the same##2##4##(2008-3#1)(2009-8#1)
shown that the temperature##3##4##(2008-10#2)(2008-3#1)
shown that the transfer##2##4##(2008-11#1)(2009-11#1)
shown that the two##3##4##(1993-11#1)(2008-10#1)(2008-2#1)
shown that the use of##5##5##(2008-10#1)(2008-3#1)(2008-7#1)(2012-3#2)
shown that the##418##3##(1990-10#2)(1990-11#2)(1990-2#2)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#3)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#2)(1991-9#3)(1992-1#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#4)(1992-6#2)(1992-8#3)(1992-9#1)(1993-11#4)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#3)(1994-3#4)(1994-5#5)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#1)(1995-6#6)(1995-8#3)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#5)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-4#1)(1997-6#3)(1997-7#5)(2004-8#1)(2005-10#1)(2005-11#9)(2005-12#1)(2005-4#2)(2006-10#4)(2006-11#2)(2006-12#2)(2006-3#1)(2006-6#2)(2006-8#2)(2006-9#2)(2007-10#1)(2007-11#15)(2007-12#19)(2007-2#1)(2007-4#2)(2007-7#2)(2007-8#2)(2008-1#6)(2008-10#35)(2008-11#9)(2008-12#3)(2008-2#37)(2008-3#44)(2008-4#5)(2008-5#5)(2008-6#5)(2008-7#6)(2008-8#11)(2009-1#1)(2009-10#2)(2009-11#2)(2009-2#2)(2009-3#3)(2009-5#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#2)(2012-2#6)(2012-3#4)(2013-1#5)(2013-7#3)(2013-8#4)
shown that there are##3##4##(1993-7#1)(2005-4#1)(2007-10#1)
shown that there is a##8##5##(1993-11#1)(1994-3#1)(1996-5#1)(2005-7#1)(2007-12#1)(2008-2#1)(2008-9#1)(2010-8#1)
shown that there is##12##4##(1991-3#1)(1993-11#1)(1994-3#1)(1996-5#1)(2004-12#1)(2005-7#1)(2006-1#1)(2007-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-8#1)
shown that there##17##3##(1991-3#1)(1993-11#1)(1993-7#1)(1994-3#1)(1996-5#1)(2004-12#1)(2005-4#1)(2005-7#1)(2006-1#1)(2007-10#1)(2007-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
shown that these##20##3##(1990-11#1)(1990-6#1)(1990-7#1)(1991-8#1)(1993-9#1)(1995-2#1)(1996-5#1)(2006-1#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#1)(2010-11#1)(2011-2#1)
shown that they are##2##4##(1995-1#1)(2008-2#1)
shown that they##8##3##(1992-3#1)(1993-12#1)(1995-1#1)(1997-4#1)(2006-7#1)(2008-1#1)(2008-2#1)(2009-3#1)
shown that this is##4##4##(1992-4#1)(1994-2#1)(2007-8#1)(2008-3#1)
shown that this problem##2##4##(1997-8#1)(2008-1#1)
shown that this##48##3##(1990-10#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-9#2)(1992-11#1)(1992-4#1)(1993-6#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1997-8#1)(2004-2#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#5)(2008-7#2)(2009-7#1)(2011-2#3)
shown that those##2##3##(1991-3#1)(2008-2#1)
shown that three##3##3##(1992-8#1)(2008-12#1)(2008-3#1)
shown that timing##2##3##(2007-12#1)(2008-1#1)
shown that treatment of##2##4##(1990-5#1)(1997-1#1)
shown that treatment##5##3##(1990-5#1)(1990-6#1)(1996-5#1)(1997-1#1)(2007-4#1)
shown that two##2##3##(1992-2#1)(1993-12#1)
shown that up to##2##4##(2008-11#1)(2008-6#1)
shown that variations##2##3##(2006-10#1)(2010-12#1)
shown that when##6##3##(1991-3#1)(2006-10#1)(2007-4#1)(2008-3#2)(2010-2#1)
shown that while##2##3##(1996-5#1)(2012-2#1)
shown that with##5##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)
shown that women##3##3##(2007-12#1)(2008-12#1)(2008-4#1)
shown that##1546##2##(1990-10#4)(1990-11#8)(1990-12#2)(1990-2#6)(1990-3#2)(1990-4#1)(1990-5#7)(1990-6#5)(1990-7#3)(1990-8#6)(1990-9#7)(1991-1#1)(1991-10#5)(1991-11#2)(1991-12#5)(1991-2#3)(1991-3#7)(1991-4#2)(1991-5#7)(1991-7#1)(1991-8#2)(1991-9#8)(1992-1#1)(1992-10#1)(1992-11#4)(1992-12#6)(1992-2#3)(1992-3#5)(1992-4#4)(1992-5#5)(1992-6#6)(1992-7#2)(1992-8#10)(1992-9#3)(1993-11#9)(1993-12#7)(1993-2#2)(1993-3#3)(1993-4#4)(1993-6#7)(1993-7#3)(1993-8#3)(1993-9#5)(1994-10#1)(1994-11#17)(1994-12#8)(1994-2#5)(1994-3#11)(1994-5#10)(1994-6#3)(1994-8#14)(1994-9#13)(1995-1#5)(1995-10#1)(1995-11#3)(1995-12#10)(1995-2#9)(1995-3#9)(1995-4#3)(1995-5#4)(1995-6#8)(1995-7#2)(1995-8#9)(1995-9#3)(1996-1#1)(1996-10#9)(1996-11#2)(1996-12#6)(1996-2#8)(1996-3#4)(1996-4#4)(1996-5#13)(1996-6#4)(1996-7#2)(1996-8#3)(1996-9#4)(1997-1#10)(1997-2#11)(1997-3#4)(1997-4#8)(1997-5#2)(1997-6#12)(1997-7#8)(1997-8#8)(2003-11#1)(2004-11#2)(2004-12#3)(2004-2#2)(2004-8#1)(2004-9#1)(2005-10#1)(2005-11#20)(2005-12#2)(2005-4#3)(2005-6#1)(2005-7#1)(2006-1#3)(2006-10#24)(2006-11#7)(2006-12#7)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#4)(2006-7#5)(2006-8#7)(2006-9#4)(2007-1#2)(2007-10#7)(2007-11#43)(2007-12#69)(2007-2#5)(2007-3#1)(2007-4#7)(2007-5#3)(2007-6#3)(2007-7#4)(2007-8#12)(2007-9#3)(2008-1#25)(2008-10#106)(2008-11#35)(2008-12#8)(2008-2#108)(2008-3#127)(2008-4#14)(2008-5#40)(2008-6#10)(2008-7#34)(2008-8#34)(2008-9#10)(2009-1#1)(2009-10#6)(2009-11#4)(2009-12#2)(2009-2#8)(2009-3#5)(2009-4#3)(2009-5#7)(2009-6#4)(2009-7#3)(2009-8#17)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#13)(2010-2#3)(2010-3#8)(2010-4#7)(2010-5#6)(2010-6#1)(2010-7#4)(2010-8#4)(2010-9#1)(2011-1#15)(2011-12#5)(2011-2#30)(2012-1#5)(2012-11#3)(2012-12#10)(2012-2#19)(2012-3#19)(2013-1#25)(2013-7#10)(2013-8#16)
shown the benefits of##2##4##(2008-5#1)(2011-1#1)
shown the best selectivity##2##4##(2008-10#2)
shown the best##4##3##(2007-8#1)(2008-10#3)
shown the effect of##3##4##(2007-4#1)(2008-10#1)(2012-2#1)
shown the presence of##3##4##(1992-8#1)(1994-12#1)(2013-8#1)
shown the##62##2##(1990-2#1)(1991-1#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-12#2)(1993-9#1)(1994-12#1)(1994-3#1)(1995-1#1)(1997-6#2)(2004-3#1)(2005-9#1)(2006-10#2)(2006-3#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#4)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#1)(2009-11#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#3)
shown their##2##2##(2008-6#1)(2010-12#1)
shown theoretically##5##2##(2007-11#2)(2007-12#2)(2008-3#1)
shown these##3##2##(2008-11#1)(2008-6#1)(2011-2#1)
shown through##3##2##(1995-11#1)(2008-10#1)(2008-2#1)
shown to account for##2##4##(1995-6#1)(2012-12#1)
shown to accumulate in##3##4##(1991-10#1)(2008-11#1)(2008-6#1)
shown to accumulate##5##3##(1990-1#1)(1991-10#1)(2008-11#1)(2008-6#1)(2012-3#1)
shown to achieve##3##3##(1992-4#1)(1995-12#1)(2009-8#1)
shown to acquire##2##3##(2008-10#2)
shown to act as an##2##5##(1994-12#1)(2010-2#1)
shown to act as##3##4##(1994-12#1)(2009-3#1)(2010-2#1)
shown to act##11##3##(1991-5#1)(1991-8#1)(1991-9#1)(1993-12#1)(1994-12#1)(1997-8#1)(2007-12#1)(2008-3#1)(2008-8#1)(2009-3#1)(2010-2#1)
shown to activate##12##3##(1992-4#1)(1994-12#1)(1995-2#1)(1996-2#1)(2008-1#1)(2008-11#1)(2008-7#2)(2009-6#1)(2010-8#1)(2011-2#1)(2012-2#1)
shown to adequately##2##3##(2007-3#1)(2010-11#1)
shown to affect the cellular##2##5##(1992-5#1)(2012-2#1)
shown to affect the##8##4##(1992-5#1)(1995-6#1)(2007-7#1)(2008-5#1)(2009-9#1)(2012-2#3)
shown to affect##15##3##(1990-12#1)(1992-5#1)(1995-6#1)(1996-4#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-5#2)(2009-9#1)(2012-12#2)(2012-2#3)
shown to afford##3##3##(2007-11#3)
shown to agree with##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
shown to agree##6##3##(2007-12#1)(2008-2#1)(2008-3#4)
shown to allow##3##3##(2007-9#1)(2009-2#1)(2013-1#1)
shown to alter the##4##4##(2006-8#1)(2008-11#1)(2008-7#1)(2010-12#1)
shown to alter##6##3##(1994-9#1)(2006-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-12#1)
shown to arise from##5##4##(1997-7#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
shown to associate##2##3##(1995-3#1)(2005-8#1)
shown to be a convenient##2##5##(1992-8#1)(1996-8#1)
shown to be a function of##5##6##(2006-10#1)(2008-10#2)(2008-2#2)
shown to be a functional##2##5##(1990-9#1)(1993-11#1)
shown to be a good##3##5##(1994-9#1)(1996-11#1)(2008-3#1)
shown to be a major##5##5##(1990-8#1)(1992-9#1)(1993-11#1)(2006-10#1)(2008-1#1)
shown to be a more##2##5##(2008-5#1)(2012-1#1)
shown to be a potent##4##5##(1990-10#1)(1993-12#1)(2006-12#1)(2008-8#1)
shown to be a powerful tool for##2##7##(2007-12#1)(2008-10#1)
shown to be a powerful##7##5##(1990-11#1)(1992-8#1)(1994-9#1)(2007-12#1)(2008-10#1)(2008-3#2)
shown to be a sensitive##2##5##(1996-9#1)(2005-8#1)
shown to be a suitable##2##5##(1994-10#1)(2007-11#1)
shown to be a useful##4##5##(1994-12#1)(2008-2#1)(2010-7#1)(2012-2#1)
shown to be a very##4##5##(1990-11#1)(1996-8#1)(2006-10#1)(2007-12#1)
shown to be a##101##4##(1990-10#1)(1990-11#3)(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-6#1)(1992-3#1)(1992-6#2)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#3)(1995-1#2)(1995-2#1)(1996-11#1)(1996-12#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-2#1)(2004-8#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#6)(2008-2#6)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
shown to be able to##8##5##(1990-3#1)(1994-9#1)(1995-5#1)(1996-8#1)(2006-2#1)(2008-3#1)(2009-7#1)(2013-1#1)
shown to be achievable##2##4##(2007-12#1)(2008-2#1)
shown to be activated by##4##5##(1995-6#1)(1996-8#1)(1997-6#1)(2013-8#1)
shown to be activated##5##4##(1995-6#1)(1996-5#1)(1996-8#1)(1997-6#1)(2013-8#1)
shown to be active against##2##5##(1996-2#1)(2008-5#1)
shown to be active in##2##5##(2006-8#1)(2008-5#1)
shown to be active##5##4##(1995-3#1)(1996-2#1)(2006-8#1)(2008-5#2)
shown to be an effective means of##2##7##(1994-11#1)(2006-10#1)
shown to be an effective method##2##6##(1992-1#1)(2005-11#1)
shown to be an effective##10##5##(1992-1#1)(1993-7#1)(1994-11#1)(2004-11#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-10#1)(2010-8#1)
shown to be an efficient mechanism for##2##7##(1991-7#1)(2007-11#1)
shown to be an efficient##3##5##(1991-7#1)(2007-11#1)(2008-2#1)
shown to be an important determinant of##2##7##(1990-2#1)(1994-9#1)
shown to be an important step##2##6##(1995-6#1)(2006-2#1)
shown to be an important tool##2##6##(1991-3#1)(2009-7#1)
shown to be an important##9##5##(1990-2#1)(1991-3#1)(1992-1#1)(1994-9#1)(1995-6#1)(2006-2#1)(2008-10#1)(2009-7#1)(2012-12#1)
shown to be an##33##4##(1990-2#1)(1990-5#1)(1991-3#1)(1991-7#1)(1992-1#2)(1993-7#1)(1994-11#1)(1994-9#1)(1995-6#1)(1996-12#1)(1997-1#1)(2004-11#1)(2004-4#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-2#1)(2008-8#1)(2009-7#1)(2010-8#1)(2012-12#1)(2013-8#1)
shown to be applicable to##2##5##(1995-1#1)(2008-5#1)
shown to be appropriate for##2##5##(2007-12#1)(2010-2#1)
shown to be appropriate##4##4##(2007-12#1)(2010-2#2)(2013-1#1)
shown to be approximately##2##4##(2007-12#1)(2008-2#1)
shown to be as##4##4##(1994-12#1)(1995-6#1)(2004-11#1)(2006-9#1)
shown to be associated with a##3##6##(1992-8#1)(1997-1#1)(2008-4#1)
shown to be associated with the##2##6##(2005-6#1)(2007-11#1)
shown to be associated with##20##5##(1992-8#1)(1997-1#1)(2005-10#1)(2005-6#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-4#2)(2009-4#1)(2009-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)
shown to be associated##21##4##(1992-8#1)(1997-1#1)(2005-10#1)(2005-6#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#2)(2009-4#1)(2009-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)
shown to be at##3##4##(1990-5#1)(2007-10#1)(2010-12#1)
shown to be beneficial##5##4##(2007-11#2)(2007-8#1)(2008-3#1)(2013-8#1)
shown to be better than##3##5##(2007-12#1)(2008-3#2)
shown to be capable of separating##2##6##(2008-10#1)(2008-11#1)
shown to be capable of##9##5##(1993-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)
shown to be caused by##4##5##(1996-6#1)(2008-5#1)(2008-8#1)(2009-4#1)
shown to be characterized##2##4##(2008-10#1)(2012-1#1)
shown to be closely related##2##5##(1992-9#1)(1996-7#1)
shown to be closely##3##4##(1992-9#1)(1995-6#1)(1996-7#1)
shown to be compatible with##2##5##(2008-10#2)
shown to be consistent with##3##5##(2008-2#1)(2009-2#1)(2013-8#1)
shown to be covalently##3##4##(1991-6#1)(1993-6#1)(2008-5#1)
shown to be decreased##2##4##(1993-3#1)(1995-3#1)
shown to be defective in##3##5##(1996-10#1)(2003-11#1)(2009-5#1)
shown to be dependent on the##3##6##(1991-5#1)(1995-1#1)(2008-11#1)
shown to be dependent on##6##5##(1990-11#1)(1991-5#1)(1995-1#1)(1995-9#1)(2008-10#1)(2008-11#1)
shown to be dependent upon the##2##6##(1992-6#1)(1996-1#1)
shown to be dependent upon##3##5##(1992-6#1)(1996-1#1)(2010-7#1)
shown to be dependent##9##4##(1990-11#1)(1991-5#1)(1992-6#1)(1995-1#1)(1995-9#1)(1996-1#1)(2008-10#1)(2008-11#1)(2010-7#1)
shown to be derived from##2##5##(1991-8#1)(1992-6#1)
shown to be dramatically##2##4##(1992-8#1)(1995-1#1)
shown to be due to##3##5##(2008-11#1)(2008-2#1)(2008-5#1)
shown to be due##4##4##(1990-2#1)(2008-11#1)(2008-2#1)(2008-5#1)
shown to be effective as##2##5##(2008-10#1)(2008-11#1)
shown to be effective at##2##5##(2007-11#1)(2013-1#1)
shown to be effective for the##3##6##(2008-11#1)(2012-12#1)(2013-1#1)
shown to be effective for##6##5##(2007-8#1)(2007-9#1)(2008-11#1)(2008-2#1)(2012-12#1)(2013-1#1)
shown to be effective in reducing##4##6##(1994-7#1)(2006-12#1)(2012-12#1)(2013-8#1)
shown to be effective in the##2##6##(2006-10#1)(2008-3#1)
shown to be effective in##27##5##(1993-12#1)(1994-7#1)(1995-9#1)(2005-10#1)(2006-10#4)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-4#1)(2009-8#2)(2010-4#1)(2011-2#1)(2012-12#3)(2013-8#1)
shown to be effective##46##4##(1990-10#1)(1993-12#1)(1994-7#1)(1995-3#2)(1995-9#1)(2005-10#1)(2006-10#4)(2006-12#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#3)(2008-4#1)(2009-10#1)(2009-8#2)(2010-4#2)(2011-2#1)(2012-12#4)(2013-1#2)(2013-8#1)
shown to be efficient##2##4##(2008-10#1)(2008-3#1)
shown to be elevated##3##4##(1994-2#1)(2010-11#1)(2010-6#1)
shown to be encoded by##2##5##(1994-3#1)(1996-5#1)
shown to be equal to##2##5##(1991-5#1)(2008-10#1)
shown to be equally##3##4##(1996-2#1)(2007-8#1)(2008-11#1)
shown to be equivalent to##4##5##(2008-10#2)(2008-3#2)
shown to be essential for##7##5##(1990-6#1)(1993-12#2)(2007-11#1)(2008-11#1)(2008-5#2)
shown to be essential##10##4##(1990-11#1)(1990-6#1)(1993-12#2)(1995-8#1)(2007-11#1)(2008-11#1)(2008-5#2)(2010-7#1)
shown to be expressed in a##2##6##(1992-3#1)(2010-12#1)
shown to be expressed in##5##5##(1992-3#1)(1995-6#1)(2010-12#1)(2010-5#2)
shown to be expressed##8##4##(1992-12#1)(1992-3#1)(1993-2#1)(1995-6#1)(2008-9#1)(2010-12#1)(2010-5#2)
shown to be fairly##2##4##(1991-2#1)(2008-3#1)
shown to be feasible##2##4##(2009-5#1)(2011-2#1)
shown to be functionally##2##4##(1992-8#1)(1995-2#1)
shown to be genetically##2##4##(1990-11#1)(2008-10#1)
shown to be greater##3##4##(1996-8#1)(2011-2#1)(2012-11#1)
shown to be highly effective##4##5##(2007-11#1)(2007-8#1)(2012-11#1)(2012-2#1)
shown to be highly immunogenic in##2##6##(2007-11#1)(2008-4#1)
shown to be highly significant##2##5##(1997-6#1)(2007-7#1)
shown to be highly specific for##2##6##(1990-2#1)(1996-2#1)
shown to be highly##18##4##(1990-2#1)(1991-4#1)(1991-5#1)(1993-3#1)(1995-1#1)(1996-2#1)(1997-6#1)(2005-8#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2010-4#1)(2012-11#1)(2012-2#1)(2012-3#1)
shown to be homogeneous as judged by SDS-gel electrophoresis##2##9##(1992-8#1)(1994-6#1)
shown to be identical to##2##5##(1991-10#1)(1991-6#1)
shown to be identical with##2##5##(1990-5#1)(1991-8#1)
shown to be identical##4##4##(1990-5#1)(1991-10#1)(1991-6#1)(1991-8#1)
shown to be important for##4##5##(1992-12#1)(1995-6#1)(1997-6#1)(2008-2#1)
shown to be important in##3##5##(1996-3#1)(2010-5#1)(2011-2#1)
shown to be important to##3##5##(2007-2#1)(2008-6#1)(2012-3#1)
shown to be important##14##4##(1990-8#1)(1992-12#1)(1995-6#1)(1996-3#1)(1997-6#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-6#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
shown to be in good agreement with the numerical##2##9##(2006-2#1)(2007-12#1)
shown to be in good agreement with the##3##8##(2006-2#1)(2007-12#2)
shown to be in good agreement with##9##7##(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)(2008-8#1)
shown to be in good##10##5##(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-2#1)(2008-3#2)(2008-8#1)
shown to be in##13##4##(1996-1#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)
shown to be increased at##2##5##(1995-8#1)(2008-5#1)
shown to be increased in##3##5##(1992-8#1)(1994-8#1)(2007-11#1)
shown to be increased##7##4##(1992-8#1)(1994-8#1)(1995-8#1)(2004-12#1)(2007-11#1)(2008-5#1)(2011-2#1)
shown to be independent of the##3##6##(2006-7#1)(2008-3#1)(2008-7#1)
shown to be independent of##5##5##(2006-7#1)(2008-1#1)(2008-3#2)(2008-7#1)
shown to be independent##6##4##(1995-2#1)(2006-7#1)(2008-1#1)(2008-3#2)(2008-7#1)
shown to be ineffective##3##4##(2005-11#1)(2007-11#1)(2009-9#1)
shown to be invalid##2##4##(2010-2#1)(2013-1#1)
shown to be involved in the##6##6##(1997-4#1)(2007-8#1)(2008-10#2)(2010-10#1)(2010-12#1)
shown to be involved in##14##5##(1992-11#1)(1994-2#1)(1994-5#1)(1995-4#1)(1997-4#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-3#1)(2009-10#1)(2010-10#1)(2010-12#1)(2010-8#1)
shown to be larger than##2##5##(2007-3#1)(2008-2#1)
shown to be larger##3##4##(2007-3#1)(2008-1#1)(2008-2#1)
shown to be less sensitive to##2##6##(2008-2#2)
shown to be less##4##4##(2007-3#1)(2008-2#2)(2008-9#1)
shown to be located##3##4##(1991-7#1)(1994-12#1)(2007-8#1)
shown to be mediated by##2##5##(1996-12#1)(1997-1#1)
shown to be mediated##3##4##(1996-12#1)(1997-1#1)(1997-6#1)
shown to be more effective in##2##6##(2006-2#1)(2008-5#1)
shown to be more effective than##5##6##(1992-9#1)(2007-10#3)(2008-3#1)
shown to be more effective##7##5##(1992-9#1)(2006-2#1)(2007-10#3)(2008-3#1)(2008-5#1)
shown to be more##19##4##(1992-9#1)(2005-8#1)(2006-2#1)(2006-8#1)(2007-10#3)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)
shown to be necessary for##5##5##(1993-12#1)(1993-9#1)(1994-6#1)(2008-7#1)(2008-9#1)
shown to be negligible##5##4##(1992-9#1)(2007-12#2)(2008-10#1)(2008-3#1)
shown to be of great##2##5##(2007-9#1)(2008-2#1)
shown to be of##12##4##(1991-12#1)(1993-2#1)(1994-3#1)(1994-6#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-12#1)(2010-8#1)
shown to be one of the##3##6##(1995-8#1)(2012-1#1)(2013-1#1)
shown to be one of##4##5##(1995-8#1)(1997-3#1)(2012-1#1)(2013-1#1)
shown to be part of##2##5##(1992-6#1)(1994-10#1)
shown to be phosphorylated##2##4##(1996-5#1)(2008-5#1)
shown to be possible##2##4##(2008-2#1)(2013-8#1)
shown to be potentially##2##4##(2007-12#1)(2010-1#1)
shown to be predictive##3##4##(2006-10#1)(2007-12#1)(2007-2#1)
shown to be preferable to##2##5##(2008-10#1)(2008-7#1)
shown to be preferable##3##4##(2008-10#2)(2008-7#1)
shown to be present as##2##5##(1991-5#1)(1995-2#1)
shown to be present in##7##5##(1990-5#1)(1990-7#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-12#1)(2010-12#1)
shown to be present##13##4##(1990-10#1)(1990-5#1)(1990-7#1)(1991-5#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-12#1)(1996-8#1)(2008-4#1)(2010-12#1)
shown to be produced##3##4##(1990-3#1)(1994-9#1)(1997-3#1)
shown to be promising##2##4##(2010-4#1)(2012-2#1)
shown to be proportional to the##3##6##(1991-9#1)(1992-6#1)(2008-10#1)
shown to be proportional to##4##5##(1991-9#1)(1992-6#1)(2008-10#1)(2008-2#1)
shown to be quite##2##4##(2008-11#1)(2010-11#1)
shown to be readily##2##4##(1990-3#1)(1995-11#1)
shown to be reduced##2##4##(1994-5#1)(2008-3#1)
shown to be regulated by##5##5##(1991-2#1)(1993-6#1)(1993-8#1)(1997-2#1)(2008-8#1)
shown to be regulated##9##4##(1991-2#1)(1993-6#1)(1993-8#1)(1995-2#1)(1997-2#1)(2008-8#2)(2010-3#1)(2011-2#1)
shown to be related to the##4##6##(1994-5#1)(2008-10#1)(2008-2#1)(2008-5#1)
shown to be related to##12##5##(1991-8#1)(1992-12#1)(1994-5#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)
shown to be released##4##4##(1992-3#1)(1997-4#1)(2008-10#1)(2008-5#1)
shown to be reliable##3##4##(1992-3#2)(2008-10#1)
shown to be removed##2##4##(2007-12#1)(2008-12#1)
shown to be required for##8##5##(1991-7#1)(1992-11#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-4#1)(2004-11#1)(2008-9#1)
shown to be responsible for the##2##6##(2004-9#1)(2008-10#1)
shown to be responsible for##6##5##(1991-12#1)(1995-11#1)(1996-4#1)(2004-9#1)(2008-10#1)(2009-5#1)
shown to be safe and effective##3##6##(2008-3#1)(2009-4#1)(2013-1#1)
shown to be safe and##8##5##(1995-5#1)(2005-7#1)(2006-10#1)(2008-3#1)(2009-2#1)(2009-4#1)(2009-5#1)(2013-1#1)
shown to be safe##11##4##(1995-5#1)(2005-7#2)(2006-10#1)(2008-3#1)(2008-5#1)(2009-2#1)(2009-4#1)(2009-5#1)(2013-1#2)
shown to be sensitive to##5##5##(1990-7#1)(1994-12#1)(1997-1#1)(2008-3#1)(2009-4#1)
shown to be significant##4##4##(2007-1#1)(2007-11#1)(2008-2#1)(2008-3#1)
shown to be significantly more##2##5##(1996-7#1)(2008-3#1)
shown to be significantly##9##4##(1990-3#1)(1992-6#1)(1994-7#1)(1996-7#1)(2005-11#1)(2006-8#1)(2008-3#2)(2009-1#1)
shown to be similar to##3##5##(1994-11#1)(1997-8#1)(2007-11#1)
shown to be similar##5##4##(1994-11#1)(1997-8#1)(2007-11#1)(2008-3#1)(2011-1#1)
shown to be stable##4##4##(1997-1#1)(2007-11#1)(2008-11#1)(2008-3#1)
shown to be statistically significant##2##5##(1993-12#1)(2008-5#1)
shown to be statistically##3##4##(1993-12#1)(2007-8#1)(2008-5#1)
shown to be strongly associated with##2##6##(2009-4#1)(2011-2#1)
shown to be strongly dependent##2##5##(1994-12#1)(1997-1#1)
shown to be strongly##6##4##(1991-2#1)(1994-12#1)(1997-1#1)(2007-12#1)(2009-4#1)(2011-2#1)
shown to be suitable for the##2##6##(1990-12#1)(2008-3#1)
shown to be suitable for##4##5##(1990-12#1)(1997-8#1)(2008-3#2)
shown to be superior to##5##5##(2006-10#1)(2007-11#1)(2008-3#2)(2012-3#1)
shown to be the major##4##5##(1991-6#1)(2008-11#1)(2008-4#1)(2008-7#1)
shown to be the most effective##3##6##(1996-5#1)(2008-11#1)(2008-9#1)
shown to be the most##5##5##(1991-7#1)(1996-5#1)(2008-11#1)(2008-8#1)(2008-9#1)
shown to be the result of##3##6##(1990-12#1)(2008-10#1)(2008-3#1)
shown to be the##22##4##(1990-12#1)(1990-4#1)(1990-9#1)(1991-6#2)(1991-7#1)(1996-12#1)(1996-5#1)(2006-12#1)(2006-5#1)(2006-8#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)
shown to be tolerant##2##4##(2008-10#1)(2008-8#1)
shown to be useful for##8##5##(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-1#1)
shown to be useful in##4##5##(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)
shown to be useful##13##4##(2006-4#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#3)(2008-3#1)(2008-8#1)(2011-1#1)
shown to be very sensitive##3##5##(1990-7#1)(1992-7#1)(2008-2#1)
shown to be very##11##4##(1990-7#1)(1991-12#1)(1992-7#1)(1997-6#1)(1997-8#1)(2007-5#1)(2008-10#1)(2008-2#1)(2009-7#1)(2012-11#2)
shown to be well##2##4##(2007-12#1)(2012-12#1)
shown to be##932##3##(1990-10#4)(1990-11#8)(1990-12#5)(1990-2#5)(1990-3#6)(1990-4#1)(1990-5#6)(1990-6#1)(1990-7#6)(1990-8#2)(1990-9#3)(1991-1#1)(1991-10#1)(1991-12#5)(1991-2#6)(1991-3#1)(1991-4#1)(1991-5#8)(1991-6#5)(1991-7#4)(1991-8#4)(1991-9#2)(1992-1#3)(1992-11#3)(1992-12#6)(1992-3#8)(1992-4#1)(1992-5#1)(1992-6#9)(1992-7#1)(1992-8#11)(1992-9#7)(1993-11#4)(1993-12#9)(1993-2#2)(1993-3#4)(1993-5#1)(1993-6#5)(1993-7#1)(1993-8#3)(1993-9#4)(1994-10#2)(1994-11#7)(1994-12#8)(1994-2#5)(1994-3#5)(1994-4#1)(1994-5#5)(1994-6#4)(1994-7#2)(1994-8#2)(1994-9#9)(1995-1#8)(1995-11#2)(1995-12#1)(1995-2#8)(1995-3#6)(1995-4#2)(1995-5#2)(1995-6#7)(1995-8#3)(1995-9#2)(1996-1#4)(1996-10#2)(1996-11#4)(1996-12#9)(1996-2#6)(1996-3#5)(1996-4#3)(1996-5#5)(1996-6#2)(1996-7#4)(1996-8#8)(1996-9#4)(1997-1#7)(1997-2#2)(1997-3#3)(1997-4#3)(1997-6#5)(1997-7#2)(1997-8#6)(2003-11#1)(2004-11#4)(2004-12#2)(2004-4#1)(2004-8#1)(2004-9#1)(2005-10#5)(2005-11#5)(2005-6#1)(2005-7#3)(2005-8#5)(2006-1#1)(2006-10#19)(2006-12#6)(2006-2#5)(2006-3#1)(2006-4#1)(2006-5#2)(2006-7#2)(2006-8#12)(2006-9#2)(2007-1#5)(2007-10#8)(2007-11#29)(2007-12#28)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#3)(2007-6#3)(2007-7#1)(2007-8#8)(2007-9#3)(2008-1#8)(2008-10#67)(2008-11#18)(2008-12#2)(2008-2#38)(2008-3#48)(2008-4#8)(2008-5#27)(2008-6#3)(2008-7#8)(2008-8#10)(2008-9#6)(2009-1#1)(2009-10#3)(2009-12#2)(2009-2#3)(2009-4#6)(2009-5#7)(2009-7#3)(2009-8#6)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#5)(2010-12#6)(2010-2#6)(2010-3#2)(2010-4#6)(2010-5#4)(2010-6#1)(2010-7#5)(2010-8#5)(2011-1#7)(2011-12#1)(2011-2#18)(2012-1#5)(2012-11#5)(2012-12#15)(2012-2#14)(2012-3#5)(2013-1#16)(2013-8#10)
shown to belong to the##3##5##(1994-6#1)(2008-10#1)(2008-5#1)
shown to belong to##4##4##(1994-6#1)(2008-10#2)(2008-5#1)
shown to bind and##2##4##(1991-5#1)(1992-7#1)
shown to bind the##2##4##(1992-8#1)(2011-1#1)
shown to bind to the##3##5##(1991-6#1)(1993-3#1)(1996-3#1)
shown to bind to##12##4##(1991-6#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-4#1)(2008-5#1)(2008-6#1)
shown to bind##30##3##(1990-10#1)(1990-8#1)(1991-1#1)(1991-5#1)(1991-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-12#2)(1995-6#2)(1995-8#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(2008-5#1)(2008-6#1)(2011-1#1)
shown to block the##2##4##(1995-6#1)(1996-4#1)
shown to block##3##3##(1992-9#1)(1995-6#1)(1996-4#1)
shown to carry the##2##4##(1990-1#1)(2006-10#1)
shown to carry##3##3##(1990-1#1)(2006-10#1)(2008-10#1)
shown to catalyze##2##3##(1991-3#1)(1997-2#1)
shown to cause a##4##4##(1997-4#1)(2007-12#1)(2008-8#1)(2012-12#1)
shown to cause##19##3##(1990-11#1)(1993-12#1)(1993-6#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-1#1)(2007-12#1)(2008-10#3)(2008-5#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#1)
shown to change##2##3##(1991-4#1)(2010-2#1)
shown to compare well with##2##5##(2007-11#1)(2008-3#1)
shown to completely##2##3##(1991-6#1)(2006-11#1)
shown to concentrate##2##3##(1990-12#1)(2008-3#1)
shown to confer##5##3##(1992-5#1)(1993-11#1)(1993-12#1)(2008-4#1)(2011-2#1)
shown to consist of##3##4##(1992-5#1)(1994-9#1)(2008-10#1)
shown to contain a##4##4##(1992-12#1)(1992-2#1)(1992-5#1)(1994-12#1)
shown to contain an##4##4##(1991-2#1)(1992-3#1)(1994-11#1)(1997-6#1)
shown to contain the##4##4##(1991-6#1)(1994-6#1)(1995-8#1)(1996-2#1)
shown to contain##32##3##(1990-5#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#2)(1993-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-9#1)(1997-6#1)(2006-9#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2012-12#1)
shown to contribute to##7##4##(1991-9#1)(2007-11#1)(2008-8#1)(2008-9#1)(2009-12#1)(2012-1#1)(2012-12#1)
shown to correctly##2##3##(2005-11#1)(2010-5#1)
shown to correlate with##10##4##(1994-8#1)(1995-2#1)(1996-1#1)(1996-12#1)(2007-9#1)(2009-11#1)(2009-12#1)(2009-8#1)(2011-1#1)(2013-1#1)
shown to correlate##11##3##(1993-9#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-12#1)(2007-9#1)(2009-11#1)(2009-12#1)(2009-8#1)(2011-1#1)(2013-1#1)
shown to correspond to the##2##5##(1994-5#1)(2006-12#1)
shown to correspond to##4##4##(1994-5#2)(1997-4#1)(2006-12#1)
shown to correspond##5##3##(1994-5#2)(1997-4#1)(2006-12#1)(2007-4#1)
shown to decrease in##4##4##(1995-1#1)(2004-11#1)(2007-9#1)(2008-10#1)
shown to decrease the##6##4##(1992-6#1)(1997-4#1)(2008-1#1)(2008-3#1)(2008-5#1)(2010-4#1)
shown to decrease##24##3##(1992-6#1)(1995-1#1)(1997-4#1)(1997-6#1)(2004-11#1)(2004-9#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-7#1)(2010-11#1)(2010-4#1)(2012-1#1)(2012-12#2)(2012-2#1)
shown to depend on the##6##5##(1992-12#1)(1994-11#1)(2007-12#1)(2008-10#2)(2008-2#1)
shown to depend on##11##4##(1991-6#1)(1992-12#1)(1994-11#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-9#1)(2012-2#1)
shown to depend strongly on the##2##6##(2007-11#1)(2008-2#1)
shown to depend##14##3##(1991-2#1)(1991-6#1)(1992-12#1)(1994-11#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-9#1)(2012-2#1)
shown to differ##5##3##(1990-9#1)(1991-5#1)(1995-5#1)(1996-12#1)(2011-12#1)
shown to direct##2##3##(1995-8#1)(1996-7#1)
shown to directly##3##3##(1990-6#1)(2008-5#1)(2008-9#1)
shown to display##5##3##(1990-12#2)(1996-10#1)(2008-10#1)(2008-6#1)
shown to effectively##2##3##(2007-12#1)(2008-5#1)
shown to elicit##3##3##(1992-2#1)(1996-12#2)
shown to eliminate##3##3##(1997-7#1)(2007-10#1)(2008-10#1)
shown to encode a##4##4##(1993-12#1)(1997-4#1)(1997-6#1)(2007-7#1)
shown to encode##7##3##(1993-12#1)(1995-2#1)(1996-5#1)(1997-4#1)(1997-6#1)(2007-7#1)(2008-11#1)
shown to enhance the sensitivity##2##5##(2008-2#1)(2009-4#1)
shown to enhance the##6##4##(1991-10#1)(1995-3#1)(2008-2#1)(2008-5#1)(2009-4#1)(2012-12#1)
shown to enhance##12##3##(1990-2#1)(1991-10#1)(1991-8#1)(1994-8#1)(1995-3#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-4#1)(2012-12#1)
shown to establish##2##3##(2005-12#1)(2009-2#1)
shown to exceed the##2##4##(2007-5#1)(2008-3#1)
shown to exceed##3##3##(2007-5#1)(2008-10#1)(2008-3#1)
shown to exert##10##3##(1996-8#1)(1997-5#1)(2005-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-9#1)(2012-12#1)(2013-1#1)
shown to exhibit##15##3##(1990-11#1)(1990-5#1)(1993-4#1)(1993-9#1)(1995-8#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-7#2)(2009-9#1)(2010-3#1)(2010-5#1)
shown to exist in##4##4##(1993-8#1)(1995-11#1)(2008-9#2)
shown to exist##7##3##(1991-2#1)(1993-8#1)(1995-11#1)(1995-8#1)(2008-8#1)(2008-9#2)
shown to express##3##3##(1993-12#1)(1995-12#1)(1995-3#1)
shown to form stable##2##4##(1991-6#1)(2010-11#1)
shown to form##8##3##(1991-6#1)(1994-5#1)(1997-4#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-3#1)(2010-11#1)
shown to function as a##6##5##(1990-9#1)(1995-8#1)(1996-11#1)(2008-10#1)(2010-10#1)(2013-1#1)
shown to function as##8##4##(1990-11#1)(1990-9#1)(1993-3#1)(1995-8#1)(1996-11#1)(2008-10#1)(2010-10#1)(2013-1#1)
shown to function in##3##4##(1994-12#1)(2007-12#1)(2012-1#1)
shown to function##15##3##(1990-11#1)(1990-9#1)(1993-3#1)(1994-12#2)(1995-8#1)(1996-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-10#1)(2012-1#1)(2013-1#1)
shown to generate##3##3##(1991-9#1)(1994-6#1)(2007-12#1)
shown to give##8##3##(1995-5#1)(2005-10#1)(2008-10#2)(2008-2#3)(2009-2#1)
shown to grow##4##3##(2007-10#1)(2007-12#2)(2008-11#1)
shown to have a significant##2##5##(2006-8#1)(2007-12#1)
shown to have a##28##4##(1991-5#1)(1991-7#1)(1993-12#2)(1993-3#1)(1993-4#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(2005-10#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-7#1)(2010-4#1)(2010-8#1)
shown to have an important##2##5##(2008-3#1)(2009-12#1)
shown to have an##7##4##(1990-12#1)(1991-8#1)(1997-1#1)(2008-3#1)(2009-12#1)(2009-7#1)(2012-3#1)
shown to have different substrate##2##5##(1992-11#1)(2011-1#1)
shown to have different##4##4##(1992-11#1)(1993-9#2)(2011-1#1)
shown to have good##2##4##(1996-7#1)(2008-3#1)
shown to have increased##2##4##(2005-7#1)(2006-7#1)
shown to have little##2##4##(1996-7#1)(2008-2#1)
shown to have no##5##4##(1992-8#1)(1993-8#1)(1997-7#1)(2006-7#1)(2008-10#1)
shown to have strong##3##4##(1992-8#1)(2008-10#1)(2008-8#1)
shown to have the##6##4##(1992-12#1)(1993-6#1)(1995-3#1)(2008-10#1)(2008-4#1)(2008-5#1)
shown to have##126##3##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-8#2)(1993-11#2)(1993-12#3)(1993-3#1)(1993-4#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-1#1)(1995-10#1)(1995-3#1)(1995-7#1)(1996-12#1)(1996-4#1)(1996-7#2)(1996-8#3)(1997-1#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-9#1)(2005-10#1)(2005-3#1)(2005-7#1)(2006-3#1)(2006-6#1)(2006-7#3)(2006-8#2)(2007-11#4)(2007-12#4)(2007-6#1)(2008-10#7)(2008-11#1)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#3)(2010-2#1)(2010-4#2)(2010-5#2)(2010-8#3)(2011-1#2)(2012-12#2)(2012-3#1)(2013-1#3)(2013-7#1)
shown to hybridize to##2##4##(1990-4#1)(1993-9#1)
shown to imply##2##3##(1997-5#1)(2007-12#1)
shown to improve survival in##2##5##(2006-10#1)(2008-5#1)
shown to improve survival##3##4##(2004-11#1)(2006-10#1)(2008-5#1)
shown to improve the accuracy of##2##6##(2008-10#1)(2008-6#1)
shown to improve the##14##4##(1991-2#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#1)
shown to improve##40##3##(1991-2#1)(1994-9#1)(2004-11#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-6#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#2)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
shown to inactivate the##2##4##(1993-11#1)(1993-3#1)
shown to increase as the##2##5##(2008-2#1)(2008-7#1)
shown to increase the efficiency of##2##6##(2008-7#1)(2012-1#1)
shown to increase the percentage of##2##6##(2008-1#1)(2008-10#1)
shown to increase the##17##4##(1990-10#1)(1991-1#1)(1994-8#1)(1996-2#1)(2006-7#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-7#1)(2010-10#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-1#1)
shown to increase with##5##4##(2006-9#1)(2007-1#1)(2007-12#1)(2008-7#1)(2013-7#1)
shown to increase##45##3##(1990-10#1)(1990-8#1)(1991-1#1)(1994-8#1)(1995-5#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#4)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-5#2)(2008-7#3)(2009-10#1)(2010-10#1)(2010-12#1)(2010-8#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
shown to independently##2##3##(1994-9#1)(2011-2#1)
shown to induce a##5##4##(1993-2#1)(1994-12#1)(1997-1#1)(2008-1#1)(2008-11#1)
shown to induce cell##2##4##(2008-8#1)(2013-1#1)
shown to induce effective##2##4##(2005-10#1)(2007-11#1)
shown to induce##41##3##(1990-11#1)(1991-1#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#2)(1996-1#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#2)(2005-10#2)(2006-10#1)(2006-5#1)(2007-11#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-8#1)(2013-1#1)
shown to influence the##3##4##(2008-2#1)(2008-7#1)(2009-10#1)
shown to influence##9##3##(1991-6#1)(1996-9#1)(1997-1#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-7#1)(2009-10#1)
shown to inhibit both##2##4##(1997-6#1)(2008-4#1)
shown to inhibit growth of##2##5##(2010-11#1)(2010-12#1)
shown to inhibit growth##3##4##(1995-1#1)(2010-11#1)(2010-12#1)
shown to inhibit the##11##4##(1990-11#1)(1991-9#1)(1992-6#1)(1993-6#1)(1994-10#1)(1997-1#1)(1997-8#1)(2005-3#1)(2008-11#1)(2010-9#1)(2012-11#1)
shown to inhibit##39##3##(1990-10#1)(1990-11#1)(1990-2#1)(1991-11#1)(1991-9#2)(1992-11#1)(1992-5#1)(1992-6#1)(1993-5#1)(1993-6#1)(1994-10#1)(1994-2#1)(1994-6#1)(1995-1#3)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#2)(1996-1#1)(1997-1#1)(1997-6#1)(1997-8#2)(2005-3#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-9#1)(2012-1#1)(2012-11#1)(2013-1#1)
shown to initiate##2##3##(1991-7#1)(2005-10#1)
shown to interact with##12##4##(1993-8#2)(1994-5#1)(1995-2#2)(1995-4#1)(1997-4#1)(2005-10#1)(2006-10#1)(2008-10#1)(2009-7#1)(2013-1#1)
shown to interact##15##3##(1991-12#1)(1993-8#2)(1994-5#1)(1995-2#2)(1995-4#1)(1997-4#2)(2005-10#1)(2006-10#1)(2008-10#1)(2008-4#1)(2009-7#1)(2013-1#1)
shown to involve the##3##4##(1990-7#1)(1995-6#1)(1997-8#1)
shown to involve##4##3##(1990-7#1)(1995-6#1)(1997-8#1)(2006-10#1)
shown to lead to##4##4##(1994-3#1)(2007-11#1)(2007-12#1)(2012-1#1)
shown to lyse##2##3##(1994-3#1)(2009-6#1)
shown to maintain##4##3##(1992-10#1)(2008-1#1)(2008-11#1)(2008-3#1)
shown to markedly##4##3##(1991-5#1)(2008-12#1)(2008-3#1)(2013-8#1)
shown to mediate##4##3##(1992-8#1)(1996-12#1)(2008-5#1)(2010-6#1)
shown to minimise##2##3##(2005-7#1)(2007-11#1)
shown to modulate the##4##4##(2005-7#1)(2007-11#1)(2008-10#1)(2008-11#1)
shown to modulate##13##3##(1993-3#1)(1995-12#1)(1997-6#1)(2005-7#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-8#1)(2012-12#1)(2013-8#1)
shown to negatively##2##3##(1997-7#1)(2006-10#1)
shown to occur at##2##4##(2006-11#1)(2008-5#1)
shown to occur in##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
shown to occur##16##3##(1990-7#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-2#1)(1996-5#1)(2005-11#1)(2006-10#1)(2006-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)
shown to operate##2##3##(2008-10#1)(2008-3#1)
shown to partially##2##3##(1996-3#1)(2009-6#1)
shown to perform##2##3##(1997-3#1)(2007-12#1)
shown to play a role in##6##6##(1992-8#1)(2006-2#1)(2008-10#1)(2008-4#2)(2008-8#1)
shown to play a##10##4##(1992-8#1)(1995-1#1)(2005-8#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-4#2)(2008-8#1)(2009-4#1)
shown to play important roles in##5##6##(2007-11#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-4#1)
shown to play##23##3##(1992-8#1)(1995-1#1)(2005-8#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-4#2)(2009-8#1)(2011-1#1)
shown to possess potent##2##4##(1994-5#1)(2008-8#1)
shown to possess the##3##4##(1993-8#1)(2008-10#2)
shown to possess##27##3##(1991-11#1)(1991-12#1)(1991-5#1)(1992-3#2)(1992-7#2)(1993-8#2)(1994-12#1)(1994-5#1)(1995-1#1)(1995-8#1)(1996-9#1)(2004-9#1)(2005-7#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-12#1)(2009-2#1)(2010-12#1)
shown to potentiate the##3##4##(1990-12#1)(1996-5#1)(2012-1#1)
shown to potentiate##4##3##(1990-12#1)(1996-5#1)(2010-12#1)(2012-1#1)
shown to predict the##4##4##(2007-12#1)(2008-2#3)
shown to predict##8##3##(1995-12#1)(2007-12#1)(2008-2#3)(2008-3#1)(2008-8#1)(2008-9#1)
shown to prevent##8##3##(1994-11#1)(1995-5#1)(2006-10#1)(2007-11#1)(2008-8#1)(2010-7#1)(2010-8#1)(2011-12#1)
shown to proceed by##3##4##(1990-12#2)(1996-2#1)
shown to proceed##4##3##(1990-12#2)(1995-3#1)(1996-2#1)
shown to produce a##5##4##(1991-1#1)(1993-9#2)(1997-7#1)(2008-10#1)
shown to produce##21##3##(1990-4#1)(1990-7#1)(1991-1#1)(1992-5#1)(1993-3#1)(1993-9#2)(1994-8#1)(1997-7#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2011-1#1)(2012-12#1)
shown to promote the##3##4##(1995-3#1)(1995-8#1)(2013-1#1)
shown to promote##12##3##(1990-12#1)(1992-6#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-5#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
shown to protect##5##3##(2006-10#2)(2007-12#1)(2007-9#1)(2008-10#1)
shown to provide a##9##4##(1994-12#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)
shown to provide greater robustness##3##5##(2008-2#3)
shown to provide substantial##2##4##(2010-12#1)(2011-1#1)
shown to provide the##2##4##(2008-11#1)(2008-2#1)
shown to provide##29##3##(1994-12#1)(1996-2#1)(2006-1#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-2#5)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-1#1)(2010-10#2)(2010-12#1)(2011-1#2)(2012-12#1)
shown to rapidly##3##3##(1993-9#1)(1995-5#1)(2005-11#1)
shown to react with##2##4##(1992-8#1)(2010-4#1)
shown to reduce the incidence of##9##6##(1993-12#1)(2007-11#2)(2008-10#1)(2008-6#1)(2008-8#3)(2009-6#1)
shown to reduce the##20##4##(1991-10#1)(1992-4#1)(1993-12#1)(1994-10#1)(1994-11#1)(2006-10#1)(2006-8#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#3)(2009-5#1)(2009-6#1)(2010-12#1)(2011-12#1)
shown to reduce##50##3##(1991-10#1)(1992-4#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-6#1)(1995-7#1)(1996-6#1)(1996-9#1)(1997-8#1)(2005-10#1)(2006-10#3)(2006-2#2)(2006-8#1)(2007-11#6)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#4)(2008-5#3)(2008-6#1)(2008-8#4)(2009-3#1)(2009-5#1)(2009-6#1)(2010-10#2)(2010-12#1)(2011-12#1)
shown to reflect##4##3##(1991-3#1)(1992-7#1)(2007-11#1)(2012-12#1)
shown to regulate##9##3##(1995-12#1)(1996-8#1)(2008-11#1)(2008-9#3)(2009-10#1)(2010-8#1)(2011-2#1)
shown to release##2##3##(2006-12#1)(2008-11#1)
shown to relieve##2##3##(1990-5#1)(2008-3#1)
shown to remain##2##3##(2008-10#1)(2008-7#1)
shown to repress the##2##4##(2008-11#1)(2008-4#1)
shown to result from##5##4##(1991-2#1)(1994-5#1)(2006-10#1)(2008-10#1)(2008-2#1)
shown to result in##9##4##(1991-8#1)(2006-10#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-7#1)
shown to result##16##3##(1991-2#1)(1991-8#1)(1994-5#1)(1995-2#1)(2006-10#3)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-3#1)(2010-7#1)
shown to retain the##2##4##(1994-11#1)(1994-2#1)
shown to retain##5##3##(1992-9#1)(1994-11#1)(1994-2#1)(1994-8#1)(2010-4#1)
shown to selectively##3##3##(1994-12#2)(2009-3#1)
shown to share the##2##4##(1994-2#1)(2013-1#1)
shown to significantly reduce##4##4##(2007-2#1)(2008-3#1)(2008-7#1)(2009-7#1)
shown to significantly##7##3##(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-7#2)
shown to specifically bind##2##4##(1994-9#1)(1996-8#1)
shown to stimulate the hydrolysis##2##5##(1993-12#1)(1997-1#1)
shown to stimulate the##7##4##(1990-12#1)(1990-6#1)(1991-6#1)(1993-12#1)(1995-3#1)(1997-1#1)(2007-3#1)
shown to stimulate##15##3##(1990-12#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-6#1)(1993-12#1)(1994-8#1)(1995-3#1)(1996-8#1)(1997-1#2)(2007-3#1)(2008-3#2)(2012-2#1)
shown to strongly##3##3##(2007-12#1)(2008-9#1)(2012-12#1)
shown to substantially reduce the##2##5##(2008-3#2)
shown to suppress##10##3##(1990-8#1)(1994-12#1)(1995-3#1)(2007-12#2)(2008-10#2)(2008-7#1)(2010-12#1)(2010-7#1)
shown to synergize with##2##4##(1996-10#1)(2009-12#1)
shown to transmit##2##3##(2008-10#2)
shown to undergo##5##3##(1991-3#1)(1992-7#1)(1996-5#1)(2010-6#1)(2012-3#1)
shown to vary##3##3##(2008-10#1)(2008-2#1)(2010-2#1)
shown to work##4##3##(1990-5#1)(1991-1#1)(2008-10#1)(2008-3#1)
shown to yield a##2##4##(1995-8#1)(2010-4#1)
shown to yield##5##3##(1995-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2010-4#1)
shown to##2199##2##(1990-1#3)(1990-10#8)(1990-11#15)(1990-12#17)(1990-2#9)(1990-3#7)(1990-4#3)(1990-5#12)(1990-6#3)(1990-7#9)(1990-8#5)(1990-9#8)(1991-1#7)(1991-10#5)(1991-11#3)(1991-12#9)(1991-2#11)(1991-3#4)(1991-4#4)(1991-5#17)(1991-6#12)(1991-7#7)(1991-8#8)(1991-9#11)(1992-1#4)(1992-10#3)(1992-11#5)(1992-12#12)(1992-2#2)(1992-3#12)(1992-4#4)(1992-5#9)(1992-6#14)(1992-7#8)(1992-8#20)(1992-9#10)(1993-11#11)(1993-12#23)(1993-2#5)(1993-3#13)(1993-4#5)(1993-5#2)(1993-6#9)(1993-7#1)(1993-8#9)(1993-9#13)(1994-10#4)(1994-11#14)(1994-12#23)(1994-2#14)(1994-3#10)(1994-4#1)(1994-5#16)(1994-6#11)(1994-7#2)(1994-8#13)(1994-9#16)(1995-1#18)(1995-10#1)(1995-11#4)(1995-12#12)(1995-2#18)(1995-3#15)(1995-4#4)(1995-5#12)(1995-6#17)(1995-7#3)(1995-8#16)(1995-9#2)(1996-1#7)(1996-10#4)(1996-11#5)(1996-12#17)(1996-2#13)(1996-3#7)(1996-4#6)(1996-5#13)(1996-6#4)(1996-7#8)(1996-8#19)(1996-9#9)(1997-1#17)(1997-2#5)(1997-3#7)(1997-4#15)(1997-5#8)(1997-6#16)(1997-7#10)(1997-8#14)(2003-11#1)(2004-11#8)(2004-12#3)(2004-4#1)(2004-8#1)(2004-9#5)(2005-10#13)(2005-11#13)(2005-12#1)(2005-3#2)(2005-6#1)(2005-7#8)(2005-8#9)(2005-9#1)(2006-1#2)(2006-10#41)(2006-11#3)(2006-12#12)(2006-2#10)(2006-3#2)(2006-4#2)(2006-5#3)(2006-6#2)(2006-7#6)(2006-8#17)(2006-9#5)(2007-1#9)(2007-10#12)(2007-11#69)(2007-12#70)(2007-2#5)(2007-3#4)(2007-4#3)(2007-5#4)(2007-6#6)(2007-7#4)(2007-8#16)(2007-9#8)(2008-1#19)(2008-10#137)(2008-11#49)(2008-12#3)(2008-2#81)(2008-3#99)(2008-4#21)(2008-5#65)(2008-6#10)(2008-7#37)(2008-8#32)(2008-9#22)(2009-1#2)(2009-10#11)(2009-11#2)(2009-12#8)(2009-2#11)(2009-3#7)(2009-4#12)(2009-5#9)(2009-6#4)(2009-7#11)(2009-8#13)(2009-9#5)(2010-1#1)(2010-10#9)(2010-11#11)(2010-12#20)(2010-2#12)(2010-3#4)(2010-4#15)(2010-5#9)(2010-6#3)(2010-7#8)(2010-8#14)(2010-9#3)(2011-1#19)(2011-12#4)(2011-2#27)(2012-1#16)(2012-11#7)(2012-12#40)(2012-2#23)(2012-3#9)(2013-1#35)(2013-7#3)(2013-8#14)
shown unchanged##2##2##(2008-10#1)(2008-9#1)
shown unsatisfactory##2##2##(2007-9#1)(2013-1#1)
shown using the##2##3##(1992-4#1)(2008-10#1)
shown using##6##2##(1992-4#1)(1994-12#1)(2005-11#1)(2008-10#1)(2008-2#1)(2012-2#1)
shown varied##2##2##(2007-11#1)(2009-5#1)
shown when##2##2##(1992-11#1)(1992-3#1)
shown which##2##2##(2008-2#1)(2012-12#1)
shown with a##2##3##(2007-12#1)(2008-3#1)
shown with the##2##3##(2008-1#1)(2008-10#1)
shown with##13##2##(1993-7#1)(1994-3#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-8#1)
shown##5233##1##(1990-1#3)(1990-10#21)(1990-11#32)(1990-12#32)(1990-2#19)(1990-3#15)(1990-4#8)(1990-5#24)(1990-6#12)(1990-7#18)(1990-8#14)(1990-9#18)(1991-1#12)(1991-10#13)(1991-11#7)(1991-12#20)(1991-2#19)(1991-3#15)(1991-4#8)(1991-5#35)(1991-6#18)(1991-7#17)(1991-8#12)(1991-9#29)(1992-1#7)(1992-10#9)(1992-11#16)(1992-12#26)(1992-2#7)(1992-3#22)(1992-4#14)(1992-5#16)(1992-6#24)(1992-7#14)(1992-8#35)(1992-9#20)(1993-1#1)(1993-10#1)(1993-11#26)(1993-12#36)(1993-2#13)(1993-3#22)(1993-4#13)(1993-5#4)(1993-6#18)(1993-7#7)(1993-8#17)(1993-9#25)(1994-10#6)(1994-11#35)(1994-12#36)(1994-2#24)(1994-3#31)(1994-4#2)(1994-5#28)(1994-6#20)(1994-7#2)(1994-8#34)(1994-9#33)(1995-1#27)(1995-10#6)(1995-11#15)(1995-12#29)(1995-2#35)(1995-3#33)(1995-4#8)(1995-5#23)(1995-6#30)(1995-7#7)(1995-8#31)(1995-9#7)(1996-1#13)(1996-10#15)(1996-11#7)(1996-12#26)(1996-2#29)(1996-3#19)(1996-4#11)(1996-5#32)(1996-6#10)(1996-7#14)(1996-8#27)(1996-9#15)(1997-1#35)(1997-2#27)(1997-3#14)(1997-4#27)(1997-5#13)(1997-6#32)(1997-7#23)(1997-8#28)(2003-11#3)(2004-11#11)(2004-12#6)(2004-2#2)(2004-3#1)(2004-4#2)(2004-8#2)(2004-9#7)(2005-10#18)(2005-11#46)(2005-12#10)(2005-3#2)(2005-4#7)(2005-6#3)(2005-7#13)(2005-8#14)(2005-9#5)(2006-1#9)(2006-10#114)(2006-11#18)(2006-12#31)(2006-2#16)(2006-3#5)(2006-4#6)(2006-5#14)(2006-6#13)(2006-7#13)(2006-8#34)(2006-9#19)(2007-1#17)(2007-10#25)(2007-11#158)(2007-12#185)(2007-2#13)(2007-3#7)(2007-4#15)(2007-5#10)(2007-6#14)(2007-7#19)(2007-8#44)(2007-9#26)(2008-1#65)(2008-10#342)(2008-11#114)(2008-12#22)(2008-2#245)(2008-3#309)(2008-4#43)(2008-5#158)(2008-6#34)(2008-7#101)(2008-8#89)(2008-9#41)(2009-1#4)(2009-10#22)(2009-11#8)(2009-12#13)(2009-2#25)(2009-3#19)(2009-4#22)(2009-5#24)(2009-6#11)(2009-7#19)(2009-8#38)(2009-9#9)(2010-1#7)(2010-10#13)(2010-11#20)(2010-12#50)(2010-2#21)(2010-3#15)(2010-4#31)(2010-5#19)(2010-6#4)(2010-7#15)(2010-8#25)(2010-9#8)(2011-1#48)(2011-12#10)(2011-2#89)(2012-1#30)(2012-11#14)(2012-12#65)(2012-2#62)(2012-3#44)(2012-5#1)(2012-6#1)(2013-1#81)(2013-7#18)(2013-8#55)
shows 100%##3##2##(1995-6#1)(1997-4#1)(2005-11#1)
shows 48%##2##2##(1993-6#1)(1996-10#1)
shows 80%##2##2##(1993-12#2)
shows 84% identity##2##3##(1993-3#1)(1996-12#1)
shows 86% identity with##2##4##(1990-4#1)(1993-8#1)
shows Na(+)##2##2##(2008-10#2)
shows a clear##5##3##(1991-8#1)(1992-2#1)(2006-5#1)(2008-2#1)(2011-2#1)
shows a close##2##3##(1993-11#1)(2008-5#1)
shows a complex##2##3##(1994-4#1)(2009-7#1)
shows a considerable##2##3##(1990-7#1)(1991-6#1)
shows a decrease##4##3##(2005-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
shows a distinct##2##3##(1995-11#1)(2010-2#1)
shows a fast response##2##4##(2008-10#2)
shows a fast##3##3##(2008-10#3)
shows a few##2##3##(2008-10#1)(2008-9#1)
shows a good stability##2##4##(2008-10#2)
shows a good##8##3##(2008-10#7)(2008-3#1)
shows a gradual decrease##2##4##(1993-9#1)(1994-5#1)
shows a gradual##3##3##(1993-9#1)(1994-5#1)(1996-5#1)
shows a great##3##3##(2005-10#1)(2009-4#1)(2012-12#1)
shows a high degree of homology to##3##7##(1991-5#1)(1993-2#1)(1995-8#1)
shows a high degree of homology##4##6##(1991-5#1)(1992-12#1)(1993-2#1)(1995-8#1)
shows a high incidence of##2##5##(2007-8#1)(2013-1#1)
shows a high##14##3##(1991-5#1)(1992-12#2)(1993-2#1)(1995-11#1)(1995-7#1)(1995-8#1)(1996-3#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#1)(2012-2#1)(2013-1#1)
shows a higher##4##3##(1992-6#1)(1994-10#1)(2007-10#1)(2008-11#1)
shows a large##4##3##(1991-4#1)(1991-9#1)(1997-2#1)(2007-12#1)
shows a linear range between##4##5##(2008-10#4)
shows a linear response for##3##5##(2008-10#3)
shows a linear response##7##4##(2007-8#1)(2008-10#5)(2008-3#1)
shows a linear variation##2##4##(2008-10#2)
shows a linear##17##3##(2007-8#1)(2008-10#14)(2008-3#1)(2009-11#1)
shows a low##3##3##(1991-1#1)(1995-11#1)(2008-7#1)
shows a maximum##2##3##(2008-10#2)
shows a more##3##3##(1996-9#1)(2008-2#1)(2011-2#1)
shows a promising##2##3##(2008-11#1)(2008-5#1)
shows a reduced##2##3##(2008-10#1)(2008-3#1)
shows a reduction of##2##4##(1997-4#1)(2009-7#1)
shows a relative##2##3##(1993-7#1)(1995-9#1)
shows a remarkable##4##3##(1997-4#1)(2005-11#1)(2008-10#1)(2008-3#1)
shows a selective##2##3##(1990-12#1)(2009-7#1)
shows a sequence##2##3##(1992-12#1)(1992-4#1)
shows a significant homology with##2##5##(1994-12#1)(1997-3#1)
shows a significant##9##3##(1994-12#1)(1997-3#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-4#1)
shows a similar##3##3##(2005-11#1)(2009-7#1)(2013-8#1)
shows a single##6##3##(1991-1#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-6#1)(1996-6#1)
shows a slight##3##3##(1996-5#1)(2008-10#1)(2010-5#1)
shows a small##2##3##(1990-3#1)(1996-11#1)
shows a steady increase##2##4##(1997-3#1)(2007-12#1)
shows a steady##3##3##(1997-3#1)(2007-12#1)(2008-3#1)
shows a striking##3##3##(1990-9#1)(1993-12#1)(2008-3#1)
shows a strong correlation with the##2##6##(1992-8#1)(2008-10#1)
shows a strong correlation with##3##5##(1992-8#1)(2007-12#1)(2008-10#1)
shows a strong dependence##2##4##(2008-10#1)(2008-3#1)
shows a strong similarity##2##4##(1992-2#1)(1994-8#1)
shows a strong##12##3##(1991-11#1)(1991-5#1)(1992-2#1)(1992-8#1)(1994-8#1)(2007-12#2)(2008-10#3)(2008-3#1)(2008-8#1)
shows a synergistic effect##2##4##(1997-4#1)(2008-3#1)
shows a time dependent##2##4##(1991-9#1)(2013-1#1)
shows a time##3##3##(1991-9#1)(1994-9#1)(2013-1#1)
shows a typical##2##3##(1991-3#2)
shows a very low##2##4##(1995-8#1)(1997-8#1)
shows a very##5##3##(1991-12#1)(1991-6#1)(1995-8#1)(1997-8#1)(2008-10#1)
shows a well defined##2##4##(1996-6#1)(2008-10#1)
shows a wide##3##3##(2006-10#1)(2008-1#1)(2008-10#1)
shows a##298##2##(1990-11#2)(1990-12#2)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#4)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#3)(1991-4#2)(1991-5#3)(1991-6#2)(1991-8#1)(1991-9#3)(1992-12#5)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#3)(1993-2#2)(1993-6#3)(1993-7#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-4#1)(1994-5#1)(1994-8#2)(1994-9#4)(1995-11#4)(1995-2#1)(1995-3#2)(1995-6#2)(1995-7#1)(1995-8#3)(1995-9#1)(1996-10#3)(1996-11#2)(1996-12#1)(1996-3#1)(1996-5#3)(1996-6#2)(1996-7#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#5)(1997-5#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#7)(2005-7#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#10)(2007-3#1)(2007-8#5)(2007-9#1)(2008-1#5)(2008-10#52)(2008-11#4)(2008-2#7)(2008-3#13)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#3)(2009-4#2)(2009-5#1)(2009-7#4)(2009-8#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#5)(2011-7#1)(2012-12#5)(2012-2#4)(2012-7#1)(2013-1#4)(2013-8#1)
shows advantages##2##2##(2007-2#1)(2010-3#1)
shows an absorption maximum at##2##5##(2008-10#2)
shows an absorption##4##3##(1990-7#1)(2006-4#1)(2008-10#2)
shows an excellent##4##3##(1990-6#1)(1995-2#1)(2006-5#1)(2008-10#1)
shows an extensive##2##3##(1990-2#1)(2005-10#1)
shows an increase in the##3##5##(1997-4#1)(2006-10#1)(2008-3#1)
shows an increase##7##3##(1995-5#1)(1997-4#1)(2005-11#1)(2005-9#1)(2006-10#1)(2007-12#1)(2008-3#1)
shows an overall##2##3##(1991-9#1)(2006-9#1)
shows an unusual##3##3##(1992-9#1)(1994-2#1)(1995-6#1)
shows an unusually##2##3##(1990-9#1)(2013-7#1)
shows an##55##2##(1990-11#1)(1990-2#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-12#1)(1997-4#1)(2005-10#1)(2005-11#3)(2005-9#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-11#6)(2007-12#2)(2008-10#6)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#2)(2009-11#1)(2012-2#1)(2013-7#1)
shows better##3##2##(2007-12#1)(2008-10#2)
shows both the##2##3##(1990-11#1)(2008-4#1)
shows both##4##2##(1990-11#1)(1997-5#1)(2008-12#1)(2008-4#1)
shows broad##2##2##(2008-11#1)(2009-3#1)
shows characteristic##3##2##(2008-3#1)(2012-11#1)(2012-12#1)
shows clinical##2##2##(2005-8#1)(2008-12#1)
shows complete##2##2##(2007-12#2)
shows considerable promise##3##3##(1991-2#1)(1996-9#1)(2005-8#1)
shows considerable##8##2##(1991-2#1)(1996-9#1)(2005-8#1)(2006-5#1)(2007-10#1)(2008-10#1)(2008-11#1)(2012-3#1)
shows cooperativity in O2 binding##2##5##(1991-10#2)
shows different##4##2##(1992-12#1)(2008-2#1)(2010-3#1)(2012-2#1)
shows direct##2##2##(1993-6#1)(2009-8#1)
shows distinct##2##2##(2009-2#1)(2013-8#1)
shows efficacy##4##2##(2006-2#2)(2007-11#1)(2008-1#1)
shows enhanced##2##2##(1991-7#1)(1997-1#1)
shows evidence of a##2##4##(1991-2#1)(1993-6#1)
shows evidence of##6##3##(1991-2#1)(1993-6#1)(2008-10#1)(2008-12#1)(2008-3#2)
shows evidence##7##2##(1991-2#1)(1993-6#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-9#1)
shows excellent agreement##3##3##(2007-12#1)(2008-10#2)
shows excellent##15##2##(1994-5#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-3#2)(2008-5#1)(2009-3#1)(2012-12#1)
shows extensive homology to the##2##5##(1990-12#1)(1995-6#1)
shows extensive homology with##2##4##(1990-12#1)(2005-10#1)
shows extensive homology##4##3##(1990-12#2)(1995-6#1)(2005-10#1)
shows extensive##5##2##(1990-12#2)(1992-12#1)(1995-6#1)(2005-10#1)
shows fairly good##3##3##(2007-8#1)(2008-10#2)
shows fairly##4##2##(2007-8#1)(2008-10#3)
shows five##2##2##(1996-10#1)(1997-7#1)
shows four##3##2##(1990-3#1)(1991-6#1)(2008-10#1)
shows good agreement for##2##4##(2005-11#1)(2008-2#1)
shows good agreement with the##3##5##(2008-1#1)(2008-3#2)
shows good agreement with##5##4##(1995-3#1)(2008-1#1)(2008-3#3)
shows good agreement##7##3##(1995-3#1)(2005-11#1)(2008-1#1)(2008-2#1)(2008-3#3)
shows good performance for##2##4##(2008-10#1)(2012-1#1)
shows good performance##4##3##(2008-10#2)(2012-1#2)
shows good repeatability##3##3##(2007-4#1)(2008-10#2)
shows good results##3##3##(2008-2#1)(2008-4#1)(2008-5#1)
shows good selectivity for##5##4##(2008-10#5)
shows good selectivity##6##3##(2008-10#6)
shows good sensitivity##2##3##(2008-10#2)
shows good stability##2##3##(2008-10#2)
shows good##46##2##(1992-10#1)(1995-3#1)(2005-11#1)(2005-9#1)(2007-4#1)(2008-1#2)(2008-10#22)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#1)(2013-8#1)
shows great potential for##2##4##(2010-4#1)(2013-1#1)
shows great potential##3##3##(2008-10#1)(2010-4#1)(2013-1#1)
shows great promise##2##3##(2004-2#1)(2007-9#1)
shows great##7##2##(2004-2#1)(2007-9#1)(2008-10#1)(2009-4#1)(2010-4#1)(2011-2#1)(2013-1#1)
shows greater##5##2##(1996-12#1)(2007-7#2)(2009-10#1)(2013-7#1)
shows high homology to##3##4##(1991-3#1)(1993-12#1)(1994-2#1)
shows high##20##2##(1991-3#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1997-2#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)
shows higher##3##2##(1991-12#1)(1994-2#1)(2008-8#1)
shows homology in##2##3##(1995-3#1)(1996-5#1)
shows homology to##3##3##(1992-12#1)(1992-8#1)(1995-8#1)
shows homology##5##2##(1992-12#1)(1992-8#1)(1995-3#1)(1995-8#1)(1996-5#1)
shows how a##2##3##(2006-7#1)(2009-5#1)
shows how the##7##3##(1993-1#1)(1993-2#1)(1996-3#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)
shows how to##3##3##(2008-11#1)(2012-2#1)(2013-1#1)
shows how##43##2##(1992-1#1)(1993-1#1)(1993-2#2)(1994-9#1)(1995-12#1)(1996-3#3)(1997-2#1)(2006-5#1)(2006-7#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#5)(2009-11#1)(2009-3#2)(2009-5#1)(2009-9#1)(2010-5#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
shows improved##3##2##(2008-10#2)(2008-9#1)
shows in##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
shows increased expression##2##3##(1995-2#1)(2007-8#1)
shows increased##5##2##(1994-3#1)(1995-2#1)(2007-12#1)(2007-8#1)(2010-2#1)
shows increasing##2##2##(1993-9#1)(2011-1#1)
shows interesting##2##2##(1997-6#1)(2007-12#1)
shows its##5##2##(2005-11#2)(2008-10#2)(2008-3#1)
shows large##6##2##(1996-8#1)(2007-12#2)(2008-11#1)(2008-3#1)(2011-12#1)
shows larger##2##2##(1991-4#1)(2006-11#1)
shows left-side dominance in controlling##2##5##(2008-9#2)
shows less##4##2##(1992-2#1)(1992-8#1)(2007-7#1)(2010-2#1)
shows little##5##2##(1990-7#1)(1991-2#1)(2005-11#2)(2011-1#1)
shows low##5##2##(2007-12#1)(2008-10#2)(2008-3#1)(2013-1#1)
shows many##2##2##(1996-8#1)(2010-12#1)
shows marked##2##2##(1993-2#1)(1997-8#1)
shows maximum absorbance at##4##4##(2008-10#3)(2010-2#1)
shows nearly##2##2##(1990-9#1)(1992-1#1)
shows no evidence##2##3##(2005-11#1)(2012-11#1)
shows no obvious##3##3##(2005-4#1)(2008-10#1)(2008-4#1)
shows no or##2##3##(2005-10#1)(2005-9#1)
shows no significant##7##3##(1990-2#1)(1991-11#1)(1992-9#1)(1994-8#1)(1997-4#1)(2006-4#1)(2008-10#1)
shows no##44##2##(1990-2#1)(1990-4#1)(1990-8#1)(1991-11#1)(1991-2#2)(1991-7#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-8#1)(2005-10#2)(2005-11#1)(2005-4#1)(2005-9#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2010-2#1)(2010-3#1)(2012-11#1)(2013-1#1)(2013-8#1)
shows normal##2##2##(1994-5#1)(2012-2#1)
shows not only##2##3##(1991-1#1)(2013-8#1)
shows on##2##2##(2006-10#1)(2007-2#1)
shows one##3##2##(1991-7#1)(2005-7#1)(2010-2#1)
shows only a##4##3##(1990-8#1)(1991-7#1)(1994-8#1)(2008-3#1)
shows only##14##2##(1990-6#1)(1990-8#1)(1991-12#1)(1991-7#1)(1992-12#1)(1992-5#1)(1994-2#1)(1994-8#1)(1995-2#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-12#1)(2012-3#1)
shows optimum##2##2##(2008-3#1)(2008-8#1)
shows parallels##2##2##(2008-11#1)(2011-2#1)
shows patterns of##2##3##(1992-6#1)(2008-11#1)
shows poor##4##2##(1991-3#1)(1997-7#1)(2009-7#1)(2013-8#1)
shows potent##3##2##(1996-10#1)(2005-9#1)(2008-11#1)
shows potential as##2##3##(2008-12#1)(2012-1#1)
shows potential for##2##3##(2005-7#1)(2008-10#1)
shows potential##5##2##(2005-7#1)(2008-10#1)(2008-12#1)(2012-1#1)(2012-3#1)
shows preference for##2##3##(1991-2#1)(1996-12#1)
shows presence of##2##3##(1994-8#1)(2009-3#1)
shows promise as a##4##4##(2006-9#1)(2007-12#1)(2008-11#1)(2010-4#1)
shows promise for improving##2##4##(2008-3#1)(2011-2#1)
shows promise for##3##3##(2008-3#2)(2011-2#1)
shows promise in##6##3##(1991-12#1)(1997-2#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-7#1)
shows promise##13##2##(1991-12#1)(1997-2#1)(2006-9#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#3)(2010-4#1)(2010-7#1)(2011-2#1)
shows promising results in##2##4##(2008-7#1)(2010-8#1)
shows promising##4##2##(2006-10#1)(2008-5#1)(2008-7#1)(2010-8#1)
shows reduced##2##2##(2007-4#1)(2011-2#1)
shows remarkable##3##2##(1991-2#1)(1992-1#1)(2008-5#1)
shows resistance to##4##3##(1994-10#1)(1994-6#1)(2008-10#1)(2011-2#1)
shows satisfactory agreement##2##3##(2008-2#1)(2008-3#1)
shows satisfactory results##2##3##(2007-8#1)(2008-10#1)
shows satisfactory##5##2##(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)
shows sequence similarity to##2##4##(1995-1#1)(1996-2#1)
shows sequence##3##2##(1995-1#1)(1995-2#1)(1996-2#1)
shows several structural##2##3##(1996-7#1)(1997-1#1)
shows several##5##2##(1995-6#1)(1996-7#1)(1997-1#1)(2007-7#1)(2012-1#1)
shows significant differences##3##3##(1991-6#1)(2008-5#1)(2011-1#1)
shows significant homology to##3##4##(1992-2#1)(1995-5#1)(1997-1#1)
shows significant homology with##4##4##(1990-9#2)(1991-6#1)(1994-12#1)
shows significant homology##8##3##(1990-9#2)(1991-6#1)(1992-2#1)(1994-12#1)(1995-5#1)(1995-8#1)(1997-1#1)
shows significant improvement##3##3##(2008-2#1)(2008-3#2)
shows significant sequence##2##3##(1991-11#1)(1992-3#1)
shows significant similarity##2##3##(1991-8#1)(1997-3#1)
shows significant##26##2##(1990-9#2)(1991-11#1)(1991-6#2)(1991-8#1)(1992-2#1)(1992-3#1)(1994-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1997-1#1)(1997-3#1)(1997-7#1)(2006-4#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)
shows significantly##4##2##(1990-4#1)(1992-3#1)(2007-12#1)(2008-7#1)
shows signs of##2##3##(2006-9#1)(2010-12#1)
shows similar##4##2##(1994-1#1)(2007-1#1)(2008-10#2)
shows similarity to the##2##4##(1995-2#1)(1995-6#1)
shows similarity to##4##3##(1995-2#1)(1995-6#1)(1997-3#2)
shows similarity##5##2##(1994-11#1)(1995-2#1)(1995-6#1)(1997-3#2)
shows six##2##2##(1997-8#1)(2007-7#1)
shows some differences##2##3##(1991-4#1)(2008-10#1)
shows some##8##2##(1991-4#1)(1993-8#1)(1996-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)
shows specific##2##2##(1997-7#1)(2009-2#1)
shows strong homology##2##3##(1993-12#1)(1995-5#1)
shows strong potential##2##3##(2008-3#1)(2008-5#1)
shows strong similarities within##2##4##(1993-2#1)(1993-6#1)
shows strong##14##2##(1993-12#1)(1993-2#1)(1993-6#1)(1995-5#1)(1996-6#1)(2005-11#1)(2005-4#1)(2006-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2012-3#1)
shows structural##2##2##(1995-3#1)(2011-12#1)
shows substantial##3##2##(2005-11#1)(2008-10#1)(2013-8#1)
shows superior##2##2##(2008-10#1)(2008-2#1)
shows that (1)##2##3##(2006-7#1)(2008-3#1)
shows that DDSP##2##3##(2008-3#2)
shows that a high##2##4##(2005-11#1)(2006-10#1)
shows that a##27##3##(1990-12#1)(1991-8#1)(1992-3#1)(1993-2#1)(1994-12#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#2)(2010-6#1)
shows that activation of##2##4##(1994-6#1)(1994-8#1)
shows that an##7##3##(1991-11#1)(1994-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2013-1#1)
shows that any##3##3##(1991-2#1)(2004-12#1)(2010-6#1)
shows that at##3##3##(1990-8#1)(1995-10#1)(2006-7#1)
shows that both##9##3##(1990-4#1)(1990-9#1)(1991-12#1)(1993-5#1)(1994-12#2)(1996-9#1)(2005-11#1)(2006-11#1)
shows that by##4##3##(2007-12#1)(2008-12#1)(2009-3#1)(2010-3#1)
shows that during##2##3##(1996-5#1)(2008-8#1)
shows that each of##2##4##(2008-10#1)(2008-11#1)
shows that each##3##3##(1990-12#1)(2008-10#1)(2008-11#1)
shows that even##3##3##(1997-8#1)(2007-9#1)(2011-2#1)
shows that for##3##3##(2008-2#1)(2011-2#1)(2013-8#1)
shows that human##2##3##(1994-5#1)(2006-10#1)
shows that in the##2##4##(1993-8#1)(2007-12#1)
shows that in##6##3##(1993-8#1)(1994-2#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)
shows that it is possible to##4##6##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)
shows that it is##9##4##(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-10#1)(2012-3#1)
shows that it##14##3##(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-10#1)(2012-3#1)
shows that many##4##3##(2004-1#1)(2009-10#1)(2010-12#1)(2013-8#1)
shows that mitochondrial##2##3##(1991-2#1)(2009-8#1)
shows that more##2##3##(1996-9#1)(2009-6#1)
shows that most of the##2##5##(1990-8#1)(1993-3#1)
shows that most##4##3##(1990-8#1)(1993-3#1)(2007-11#1)(2008-11#1)
shows that multiple##2##3##(1997-4#1)(2009-6#1)
shows that only##2##3##(1994-8#1)(2009-10#1)
shows that other##2##3##(1993-11#1)(2010-11#1)
shows that our##4##3##(1997-7#1)(2008-2#1)(2008-3#2)
shows that protection##2##3##(2007-11#1)(2010-4#1)
shows that several##2##3##(1992-8#1)(1994-3#1)
shows that significant##2##3##(2008-5#1)(2011-2#1)
shows that sim##2##3##(1991-12#2)
shows that such##2##3##(1990-3#1)(2006-7#1)
shows that the aqueous##2##4##(2006-12#1)(2007-1#1)
shows that the complex##2##4##(1992-11#1)(1995-1#1)
shows that the dependence of the##2##6##(2008-2#2)
shows that the effect of##2##5##(1994-8#1)(2008-2#1)
shows that the effects of##2##5##(1994-3#1)(2008-3#1)
shows that the host shift##2##5##(2008-8#2)
shows that the measurement##2##4##(2006-4#1)(2008-2#1)
shows that the most##2##4##(2008-10#1)(2012-3#1)
shows that the proposed##3##4##(2010-8#1)(2013-1#1)(2013-8#1)
shows that the protein##2##4##(1994-9#1)(1997-1#1)
shows that the putative##2##4##(1997-8#1)(2008-7#1)
shows that the rate of##2##5##(1992-1#1)(2005-11#1)
shows that the relative##2##4##(1994-10#1)(1997-2#1)
shows that the risk of##2##5##(2006-10#1)(2006-11#1)
shows that the risk##3##4##(1994-3#1)(2006-10#1)(2006-11#1)
shows that the size##2##4##(1992-8#1)(2008-10#1)
shows that the two##3##4##(1997-6#1)(2007-12#1)(2008-4#1)
shows that the use of the##2##6##(1995-3#1)(2006-6#1)
shows that the use of##3##5##(1990-7#1)(1995-3#1)(2006-6#1)
shows that the volume##2##4##(2008-3#2)
shows that the##231##3##(1990-11#3)(1990-12#1)(1990-5#2)(1990-7#1)(1991-11#1)(1991-2#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-3#2)(1992-6#1)(1992-8#3)(1992-9#3)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#1)(1994-10#1)(1994-3#5)(1994-5#1)(1994-7#1)(1994-8#3)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-2#3)(1995-3#3)(1995-5#2)(1995-6#3)(1995-7#1)(1996-1#1)(1996-11#2)(1996-3#1)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2004-4#1)(2005-11#6)(2005-4#2)(2005-5#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2007-1#3)(2007-10#1)(2007-11#5)(2007-12#6)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#15)(2008-11#4)(2008-2#15)(2008-3#18)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#4)(2009-2#1)(2009-4#2)(2009-8#1)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#2)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#3)
shows that their misoriented hair cells correlate with misaligned divisions of hair-cell precursors and an inability to complete rearrangements accurately##2##20##(2012-12#2)
shows that their##5##3##(1991-6#1)(1994-5#1)(2010-3#1)(2012-12#2)
shows that there are##5##4##(1990-3#1)(1992-8#1)(2008-10#1)(2013-1#2)
shows that there is##7##4##(1992-5#1)(1992-6#1)(1993-2#1)(2007-2#1)(2007-7#1)(2009-11#1)(2011-2#1)
shows that there##15##3##(1990-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-2#1)(1994-3#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-8#1)(2009-11#1)(2011-2#1)(2013-1#2)
shows that these##15##3##(1992-6#1)(1993-12#1)(1993-2#1)(1994-1#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-5#1)(1997-4#1)(1997-7#1)(2008-10#2)(2009-2#1)(2011-2#1)(2013-7#1)
shows that they are##2##4##(1995-2#1)(2008-10#1)
shows that they differ##2##4##(1993-5#1)(2008-7#1)
shows that they##5##3##(1993-5#1)(1995-2#1)(1997-8#1)(2008-10#1)(2008-7#1)
shows that this was##2##4##(1993-5#1)(2010-8#1)
shows that this##20##3##(1990-3#1)(1990-4#1)(1990-5#1)(1991-12#1)(1993-3#1)(1993-5#1)(1995-3#2)(1996-5#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-5#1)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
shows that under##2##3##(2008-10#1)(2013-8#1)
shows that when##2##3##(1995-1#1)(2007-12#1)
shows that with##2##3##(2007-11#1)(2011-2#1)
shows that##770##2##(1990-11#5)(1990-12#4)(1990-3#4)(1990-4#3)(1990-5#6)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#4)(1991-10#1)(1991-11#5)(1991-12#7)(1991-2#7)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#6)(1992-4#1)(1992-5#2)(1992-6#5)(1992-7#1)(1992-8#7)(1992-9#4)(1993-1#1)(1993-11#3)(1993-12#6)(1993-2#9)(1993-3#4)(1993-5#7)(1993-6#1)(1993-8#1)(1994-1#1)(1994-10#1)(1994-12#8)(1994-2#3)(1994-3#11)(1994-4#1)(1994-5#5)(1994-6#4)(1994-7#1)(1994-8#11)(1994-9#4)(1995-1#6)(1995-10#2)(1995-11#1)(1995-2#7)(1995-3#8)(1995-5#6)(1995-6#6)(1995-7#2)(1995-8#3)(1995-9#3)(1996-1#2)(1996-11#3)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#6)(1996-7#1)(1996-8#1)(1996-9#5)(1997-1#6)(1997-2#4)(1997-3#1)(1997-4#5)(1997-5#1)(1997-6#4)(1997-7#5)(1997-8#6)(1997-9#1)(2004-1#3)(2004-12#1)(2004-4#2)(2004-9#2)(2005-10#1)(2005-11#13)(2005-12#1)(2005-4#2)(2005-5#1)(2006-1#2)(2006-10#14)(2006-11#2)(2006-12#8)(2006-2#2)(2006-3#1)(2006-4#1)(2006-6#2)(2006-7#3)(2006-8#7)(2006-9#1)(2007-1#4)(2007-10#2)(2007-11#13)(2007-12#21)(2007-2#1)(2007-3#3)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#3)(2007-9#3)(2008-1#7)(2008-10#45)(2008-11#14)(2008-12#8)(2008-2#31)(2008-3#47)(2008-4#4)(2008-5#19)(2008-6#5)(2008-7#9)(2008-8#21)(2008-9#13)(2009-10#4)(2009-11#1)(2009-2#3)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#5)(2009-7#1)(2009-8#7)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#4)(2010-3#3)(2010-4#4)(2010-5#5)(2010-6#2)(2010-7#5)(2010-8#4)(2010-9#1)(2011-1#8)(2011-12#3)(2011-2#16)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#8)(2012-3#8)(2012-9#1)(2013-1#14)(2013-7#2)(2013-8#11)
shows the ability##2##3##(2008-5#1)(2008-7#1)
shows the characteristic##2##3##(2006-4#1)(2013-1#1)
shows the effectiveness of##2##4##(2007-12#1)(2013-1#1)
shows the existence of a##2##5##(1992-4#1)(2012-2#1)
shows the existence of##3##4##(1991-5#1)(1992-4#1)(2012-2#1)
shows the existence##4##3##(1991-5#1)(1992-11#1)(1992-4#1)(2012-2#1)
shows the highest##5##3##(1997-6#1)(2010-12#1)(2010-5#1)(2010-8#1)(2013-1#1)
shows the importance of the##2##5##(2006-12#1)(2012-2#1)
shows the importance of##12##4##(1990-8#1)(1991-9#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-3#1)(2008-8#2)(2012-2#1)(2013-1#2)
shows the influence of##2##4##(1991-10#1)(2008-10#1)
shows the limitations##2##3##(1994-6#1)(2008-5#1)
shows the maximum##2##3##(2009-10#1)(2009-3#1)
shows the most##2##3##(1996-4#1)(2009-3#1)
shows the possibility of##3##4##(1991-8#1)(2011-2#1)(2013-7#1)
shows the potential of##4##4##(2007-7#1)(2008-10#2)(2008-2#1)
shows the potential##6##3##(1996-2#1)(2007-7#1)(2008-10#3)(2008-2#1)
shows the presence of an##2##5##(1994-12#1)(1994-8#1)
shows the presence of##8##4##(1990-7#1)(1990-8#1)(1994-12#1)(1994-8#1)(1995-3#1)(2008-10#1)(2008-2#1)(2008-3#1)
shows the results of##2##4##(1991-7#1)(2008-9#1)
shows the results##3##3##(1991-7#1)(2008-10#1)(2008-9#1)
shows the role of##3##4##(1991-6#1)(2007-8#1)(2008-4#1)
shows the same##9##3##(1990-4#1)(1990-5#1)(1991-8#1)(1991-9#1)(1996-9#1)(2007-11#2)(2008-10#1)(2008-11#1)
shows the superiority of the##2##5##(2008-2#1)(2008-3#1)
shows the##154##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#2)(1992-11#2)(1992-3#1)(1992-4#1)(1992-7#1)(1992-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-6#1)(1997-8#2)(2005-11#1)(2005-4#1)(2005-6#1)(2005-9#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-4#3)(2007-11#2)(2007-12#7)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#7)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#4)(2009-12#1)(2009-3#2)(2009-7#1)(2009-8#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#3)(2012-6#1)(2013-1#8)(2013-7#2)
shows their##2##2##(2006-11#1)(2006-7#1)
shows there is a##2##4##(2008-8#1)(2010-2#1)
shows these##2##2##(1992-3#1)(1996-6#1)
shows this to be##2##4##(2007-5#2)
shows this##3##2##(1992-5#1)(2007-5#2)
shows three##2##2##(1993-8#1)(2013-7#1)
shows two potential##2##3##(1993-2#1)(2012-1#1)
shows two##11##2##(1992-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1995-9#1)(1996-7#1)(2006-12#1)(2008-10#1)(2008-4#1)(2011-1#1)(2012-1#1)
shows typical##2##2##(1990-9#1)(2012-2#1)
shows up##2##2##(2006-10#1)(2006-5#1)
shows us##2##2##(2008-2#1)(2011-2#1)
shows various##2##2##(2008-11#1)(2010-6#1)
shows very good##2##3##(2008-10#1)(2008-3#1)
shows very high##2##3##(2008-10#2)
shows very little##4##3##(1995-11#1)(1995-5#1)(1995-6#1)(2008-10#1)
shows very##12##2##(1993-7#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-2#1)(2005-4#1)(2008-10#4)(2008-3#1)
shows why##3##2##(1991-3#1)(1991-9#1)(1992-2#1)
shows##2097##1##(1990-1#1)(1990-11#10)(1990-12#13)(1990-2#2)(1990-3#8)(1990-4#8)(1990-5#8)(1990-6#4)(1990-7#7)(1990-8#9)(1990-9#12)(1991-1#6)(1991-10#4)(1991-11#9)(1991-12#14)(1991-2#17)(1991-3#7)(1991-4#5)(1991-5#8)(1991-6#8)(1991-7#7)(1991-8#6)(1991-9#11)(1992-1#6)(1992-10#2)(1992-11#7)(1992-12#13)(1992-2#8)(1992-3#18)(1992-4#4)(1992-5#8)(1992-6#10)(1992-7#4)(1992-8#10)(1992-9#11)(1993-1#2)(1993-11#7)(1993-12#14)(1993-2#16)(1993-3#9)(1993-4#2)(1993-5#8)(1993-6#11)(1993-7#3)(1993-8#6)(1993-9#3)(1994-1#3)(1994-10#5)(1994-11#3)(1994-12#16)(1994-2#10)(1994-3#15)(1994-4#2)(1994-5#12)(1994-6#9)(1994-7#1)(1994-8#18)(1994-9#11)(1995-1#9)(1995-10#4)(1995-11#6)(1995-12#1)(1995-2#16)(1995-3#17)(1995-5#11)(1995-6#15)(1995-7#4)(1995-8#11)(1995-9#6)(1996-1#3)(1996-10#8)(1996-11#5)(1996-12#8)(1996-2#5)(1996-3#6)(1996-4#4)(1996-5#12)(1996-6#4)(1996-7#4)(1996-8#4)(1996-9#10)(1997-1#15)(1997-2#12)(1997-3#9)(1997-4#14)(1997-5#3)(1997-6#8)(1997-7#12)(1997-8#13)(1997-9#1)(2004-1#3)(2004-12#1)(2004-2#1)(2004-4#2)(2004-9#4)(2005-10#7)(2005-11#36)(2005-12#1)(2005-4#6)(2005-5#1)(2005-6#1)(2005-7#3)(2005-8#3)(2005-9#6)(2006-1#2)(2006-10#26)(2006-11#4)(2006-12#16)(2006-2#6)(2006-3#3)(2006-4#10)(2006-5#7)(2006-6#4)(2006-7#6)(2006-8#9)(2006-9#5)(2007-1#8)(2007-10#6)(2007-11#38)(2007-12#62)(2007-2#4)(2007-3#6)(2007-4#5)(2007-5#6)(2007-6#1)(2007-7#17)(2007-8#22)(2007-9#9)(2008-1#18)(2008-10#229)(2008-11#36)(2008-12#16)(2008-2#66)(2008-3#105)(2008-4#13)(2008-5#51)(2008-6#11)(2008-7#29)(2008-8#41)(2008-9#26)(2009-10#12)(2009-11#5)(2009-12#3)(2009-2#8)(2009-3#12)(2009-4#7)(2009-5#3)(2009-6#6)(2009-7#8)(2009-8#12)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#11)(2010-2#14)(2010-3#6)(2010-4#9)(2010-5#12)(2010-6#4)(2010-7#6)(2010-8#8)(2010-9#1)(2011-1#21)(2011-12#6)(2011-2#40)(2011-3#1)(2011-7#1)(2012-1#8)(2012-11#2)(2012-12#22)(2012-2#29)(2012-3#15)(2012-6#1)(2012-7#1)(2012-9#1)(2013-1#35)(2013-7#9)(2013-8#22)
shrank##3##1##(1990-2#1)(1990-8#1)(2004-3#1)
shredded##3##1##(1996-9#1)(2013-1#2)
shrew##3##1##(2005-10#1)(2008-12#2)
shrimp (Farfantepenaeus##2##2##(2008-5#2)
shrimp Litopenaeus vannamei (Boone##2##4##(2008-5#2)
shrimp Litopenaeus vannamei##4##3##(2008-5#4)
shrimp and##2##2##(2013-7#2)
shrimp species##2##2##(2008-5#1)(2013-7#1)
shrimp stock##2##2##(2008-5#1)(2013-8#1)
shrimp trawl fishery##2##3##(2008-5#2)
shrimp trawl##3##2##(2008-5#3)
shrimp##77##1##(1992-4#1)(1994-8#1)(2006-12#3)(2007-12#4)(2007-3#3)(2007-5#3)(2008-10#1)(2008-12#4)(2008-3#1)(2008-5#20)(2008-8#2)(2008-9#2)(2010-2#5)(2010-4#7)(2010-8#1)(2011-12#5)(2011-2#1)(2012-12#1)(2013-7#6)(2013-8#6)
shrimps from the Pantanal##2##4##(2013-7#2)
shrimps from##3##2##(2013-7#3)
shrimps##13##1##(2008-5#6)(2008-8#3)(2013-7#4)
shrink and##2##2##(1992-5#1)(1994-8#1)
shrink film##2##2##(2008-10#2)
shrink##15##1##(1992-5#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-6#1)(1997-8#1)(2008-10#2)(2008-7#1)(2009-10#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
shrinkage and##13##2##(1992-11#1)(1992-7#1)(1995-8#1)(1996-1#1)(1997-4#1)(2008-3#1)(2008-8#1)(2012-3#6)
shrinkage due to##3##3##(2005-11#1)(2010-10#1)(2012-2#1)
shrinkage during##2##2##(2006-12#1)(2010-4#1)
shrinkage estimators##3##2##(2008-2#3)
shrinkage in##4##2##(1996-12#1)(1997-2#1)(2008-8#1)(2011-1#1)
shrinkage of the##9##3##(1992-12#1)(1994-8#1)(2005-11#2)(2007-1#2)(2012-2#1)(2013-8#2)
shrinkage of##14##2##(1992-12#1)(1994-8#1)(1996-12#1)(2005-11#3)(2007-1#2)(2009-3#1)(2012-2#3)(2013-8#2)
shrinkage on##2##2##(1995-8#1)(2006-12#1)
shrinkage was##4##2##(1991-1#1)(2009-3#1)(2012-2#1)(2013-8#1)
shrinkage##84##1##(1990-3#1)(1991-1#2)(1992-11#1)(1992-12#1)(1992-7#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#2)(1997-2#1)(1997-4#1)(2005-11#6)(2006-12#3)(2007-1#2)(2007-11#2)(2007-12#2)(2008-1#1)(2008-2#7)(2008-3#2)(2008-4#1)(2008-8#7)(2009-3#2)(2010-10#3)(2010-4#4)(2011-1#1)(2012-2#9)(2012-3#7)(2013-8#5)
shrinking##17##1##(1991-5#1)(1992-3#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-8#1)(2005-11#2)(2006-12#1)(2007-2#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2013-1#1)
shrinks to##2##2##(2005-11#1)(2008-7#1)
shrinks##8##1##(1997-2#1)(2005-11#3)(2008-7#1)(2011-1#1)(2012-11#1)(2012-12#1)
shriveling##2##1##(2006-10#1)(2008-10#1)
shrub Psychotria limonensis##2##3##(2007-3#2)
shrub species##2##2##(2008-8#1)(2010-2#1)
shrub##11##1##(2007-1#1)(2007-3#2)(2008-10#1)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-2#1)(2011-12#1)
shrubs in##2##2##(2008-10#1)(2010-2#1)
shrubs##13##1##(2007-3#1)(2007-6#1)(2008-10#3)(2008-8#1)(2008-9#2)(2010-2#1)(2010-5#1)(2010-6#1)(2011-12#1)(2013-8#1)
shrunk to##2##2##(2005-11#1)(2008-5#1)
shrunk##5##1##(1990-10#1)(1992-8#1)(2005-11#1)(2008-5#1)(2011-2#1)
shrunken##5##1##(1997-8#1)(2007-9#1)(2008-12#1)(2010-1#1)(2013-7#1)
shuffle interconnection##2##2##(2007-12#2)
shuffle##5##1##(1992-1#1)(2007-12#4)
shuffling from##2##2##(1997-4#1)(1997-9#1)
shuffling or##2##2##(1995-7#1)(2007-12#1)
shuffling##16##1##(1991-5#1)(1992-3#1)(1995-7#1)(1995-8#1)(1996-10#1)(1997-4#4)(1997-9#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)
shun##3##1##(1993-6#1)(2005-5#1)(2009-7#1)
shunt and##8##2##(1996-3#1)(2006-5#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-4#1)(2011-2#1)(2013-1#1)
shunt as a##2##3##(2007-8#1)(2013-1#1)
shunt at the##2##3##(2007-8#1)(2008-7#1)
shunt at##3##2##(2007-8#1)(2008-11#1)(2008-7#1)
shunt by##2##2##(1991-11#1)(1993-3#1)
shunt catheter##2##2##(2012-2#2)
shunt for hydrocephalus##2##3##(2008-7#1)(2012-12#1)
shunt for##5##2##(2006-5#1)(2007-8#1)(2008-7#1)(2010-5#1)(2012-12#1)
shunt in a##3##3##(2007-7#1)(2008-7#2)
shunt in the##2##3##(1991-11#1)(2007-8#1)
shunt in##9##2##(1990-10#1)(1991-11#1)(2006-8#1)(2007-7#2)(2007-8#2)(2008-7#2)
shunt insertion##3##2##(2008-10#1)(2012-12#1)(2012-2#1)
shunt is##2##2##(2012-12#2)
shunt of##4##2##(1991-4#1)(2008-2#3)
shunt or##4##2##(1990-3#1)(2005-12#1)(2006-10#1)(2006-5#1)
shunt placement##6##2##(2006-5#4)(2006-6#1)(2006-8#1)
shunt system in which##2##4##(2006-8#2)
shunt system##4##2##(2005-10#1)(2006-8#3)
shunt to##2##2##(1996-6#1)(2007-8#1)
shunt vessels##3##2##(2011-2#3)
shunt was placed##2##3##(2006-12#1)(2012-12#1)
shunt was##4##2##(2006-12#1)(2011-2#2)(2012-12#1)
shunt with##2##2##(2007-8#2)
shunt##155##1##(1990-10#1)(1990-3#1)(1991-1#2)(1991-11#3)(1991-12#2)(1991-4#1)(1991-6#1)(1992-6#1)(1993-3#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-5#2)(1996-11#1)(1996-3#1)(1996-4#2)(1996-6#1)(1996-9#6)(1997-2#1)(2005-10#1)(2005-12#1)(2006-10#3)(2006-12#1)(2006-5#12)(2006-6#1)(2006-8#10)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#21)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-4#2)(2008-5#4)(2008-7#10)(2009-3#3)(2009-4#1)(2009-6#3)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#3)(2010-8#1)(2011-2#8)(2012-12#12)(2012-2#5)(2012-3#1)(2013-1#5)(2013-7#1)
shunt)##2##1##(1995-10#1)(1996-3#1)
shunt]##2##1##(1992-10#1)(2007-3#1)
shunted##4##1##(1992-10#2)(1992-4#1)(1994-8#1)
shunting and##4##2##(2006-10#1)(2009-10#1)(2013-1#2)
shunting in the##2##3##(1997-6#1)(2011-2#1)
shunting of##2##2##(1990-11#1)(1996-4#1)
shunting##27##1##(1990-11#1)(1991-9#1)(1992-10#1)(1996-4#1)(1996-9#3)(1997-6#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-5#2)(2006-7#1)(2007-10#2)(2008-10#1)(2008-2#1)(2008-9#1)(2009-10#1)(2010-10#1)(2011-2#1)(2012-12#2)(2013-1#2)
shunts and##3##2##(1990-6#1)(2006-8#1)(2007-8#1)
shunts during##2##2##(2007-8#1)(2010-10#1)
shunts in the##2##3##(2008-7#2)
shunts in##5##2##(1996-9#2)(2006-5#1)(2008-7#2)
shunts of##2##2##(2007-8#1)(2008-2#1)
shunts were##3##2##(1993-7#1)(2006-5#1)(2007-8#1)
shunts##49##1##(1990-11#1)(1990-6#1)(1993-6#1)(1993-7#1)(1995-11#1)(1996-11#1)(1996-3#2)(1996-9#7)(2005-10#2)(2006-10#1)(2006-11#1)(2006-5#3)(2006-8#1)(2007-7#1)(2007-8#11)(2008-1#1)(2008-11#1)(2008-2#2)(2008-7#3)(2009-9#2)(2010-10#1)(2010-2#1)(2010-6#1)(2012-12#2)
shut down##6##2##(1991-1#1)(1992-9#1)(1993-6#1)(1995-11#1)(1996-10#1)(2007-9#1)
shut off##2##2##(1990-11#1)(1992-11#1)
shut times##4##2##(1992-9#4)
shut##16##1##(1990-11#3)(1991-1#1)(1992-11#1)(1992-9#6)(1993-6#1)(1995-11#1)(1996-10#1)(2005-7#1)(2007-9#1)
shut-off##4##1##(1990-2#2)(1990-8#1)(2012-2#1)
shutdown periods##2##2##(2008-11#2)
shutdown##8##1##(1993-12#2)(1995-2#1)(1996-12#1)(1996-4#1)(2008-11#2)(2008-7#1)
shutdowns##4##1##(2006-8#1)(2008-11#3)
shuts down##3##2##(2007-2#1)(2007-5#1)(2008-8#1)
shutter and##2##2##(2008-1#1)(2008-3#1)
shutter was developed##2##3##(2006-5#1)(2008-3#1)
shutter##14##1##(2006-5#5)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#4)(2010-11#1)
shutters and##2##2##(2008-3#2)
shutters##5##1##(2007-12#1)(2008-3#4)
shutting down##3##2##(1993-6#1)(2007-9#1)(2008-11#1)
shutting##5##1##(1993-6#1)(2007-11#1)(2007-9#1)(2008-11#1)(2009-8#1)
shuttle between the##4##3##(2008-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
shuttle box##4##2##(1993-5#1)(1993-9#1)(1994-6#2)
shuttle cloning vectors##2##3##(1993-12#2)
shuttle plasmid##6##2##(1990-12#1)(1995-5#1)(2008-11#2)(2008-8#2)
shuttle vector for Escherichia coli and##2##6##(1990-10#1)(1994-12#1)
shuttle vector system##2##3##(1990-5#1)(1995-3#1)
shuttle vector##21##2##(1990-10#1)(1990-11#1)(1990-5#1)(1990-9#1)(1991-7#1)(1994-12#3)(1994-5#1)(1995-3#1)(1995-6#1)(1996-7#1)(1996-8#1)(1997-2#3)(2005-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)
shuttle vectors for##5##3##(1990-3#1)(1991-7#2)(1997-4#2)
shuttle vectors##12##2##(1990-3#1)(1991-7#4)(1993-12#1)(1993-3#3)(1994-12#1)(1997-4#2)
shuttle##72##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-9#2)(1991-7#5)(1993-12#3)(1993-3#3)(1993-5#1)(1993-9#1)(1994-12#4)(1994-2#1)(1994-5#1)(1994-6#2)(1995-10#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-7#2)(1996-8#1)(1997-2#4)(1997-4#2)(1997-6#1)(2005-11#1)(2006-12#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#2)(2009-7#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
shuttles##3##1##(2008-1#1)(2008-11#1)(2008-9#1)
shuttling in##2##2##(2011-2#2)
shuttling of##6##2##(1995-2#1)(1996-7#1)(2012-12#4)
shuttling##15##1##(1991-3#1)(1995-2#1)(1996-7#3)(2006-6#1)(2011-2#2)(2012-12#6)(2012-2#1)
shy children with##2##3##(2012-12#2)
shy children##4##2##(2012-12#4)
shy##7##1##(2008-4#1)(2010-8#1)(2012-12#4)(2013-8#1)
shyness and##3##2##(2008-1#1)(2008-4#2)
shyness##9##1##(2008-1#1)(2008-4#5)(2012-12#3)
si##3##1##(1996-7#1)(2011-2#1)(2012-2#1)
siRNA for 24 h##2##4##(2010-10#2)
siRNA in##2##2##(2009-9#1)(2013-8#1)
siRNA inhibited##2##2##(2006-12#1)(2010-1#1)
siRNA is##3##2##(2012-3#3)
siRNA knockdown##2##2##(2012-12#1)(2012-2#1)
siRNA on##2##2##(2010-12#1)(2012-2#1)
siRNA targeting##3##2##(2008-11#1)(2009-3#1)(2013-1#1)
siRNA transfection##2##2##(2011-2#1)(2012-3#1)
siRNA##55##1##(2006-12#1)(2008-1#3)(2008-11#1)(2008-2#3)(2008-4#2)(2009-3#7)(2009-4#2)(2009-9#1)(2010-1#3)(2010-10#2)(2010-12#3)(2010-2#1)(2011-2#2)(2012-12#2)(2012-2#7)(2012-3#8)(2013-1#2)(2013-8#5)
siRNA-mediated##3##1##(2008-11#1)(2012-12#1)(2013-1#1)
siRNAs targeting Hmga2 gene##2##4##(2012-3#2)
siRNAs targeting Hmga2##3##3##(2012-3#3)
siRNAs##12##1##(2008-2#1)(2008-4#1)(2009-3#3)(2010-2#1)(2012-12#1)(2012-3#5)
sialadenitis##4##1##(2011-1#4)
sialic acid (SA)##2##3##(1996-8#1)(2008-12#1)
sialic acid (Sia)##2##3##(1995-3#2)
sialic acid and##6##3##(1990-12#1)(1993-7#1)(1994-3#1)(1996-4#1)(2008-5#1)(2011-2#1)
sialic acid content##6##3##(1993-11#3)(1994-9#1)(2008-11#1)(2008-6#1)
sialic acid from##2##3##(1990-12#2)
sialic acid in the##2##4##(1994-6#1)(1996-3#1)
sialic acid levels in##2##4##(1993-1#1)(2010-12#1)
sialic acid plasma level##2##4##(2008-12#2)
sialic acid residues in##2##4##(1994-12#1)(2008-11#1)
sialic acid residues##8##3##(1992-12#1)(1993-11#1)(1994-11#2)(1994-12#2)(1994-9#1)(2008-11#1)
sialic acid was##2##3##(1992-7#1)(2008-7#1)
sialic acid##74##2##(1990-12#5)(1990-5#2)(1991-9#2)(1992-12#1)(1992-7#1)(1993-1#2)(1993-11#5)(1993-7#1)(1994-11#4)(1994-12#2)(1994-3#1)(1994-6#1)(1994-9#5)(1995-1#2)(1995-12#5)(1995-3#6)(1995-5#1)(1996-3#4)(1996-4#1)(1996-8#1)(1997-3#2)(2008-11#6)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-12#4)(2011-2#2)(2012-1#1)
sialic acid-containing##2##2##(1994-9#1)(2012-1#1)
sialic acid-dependent binding to##2##4##(1995-3#2)
sialic acid-dependent binding##3##3##(1995-3#3)
sialic acid-dependent##4##2##(1995-3#3)(2012-1#1)
sialic acids and##2##3##(1996-4#1)(1996-8#1)
sialic acids to IFN##2##4##(2008-11#2)
sialic acids##18##2##(1992-11#1)(1993-11#2)(1994-11#1)(1994-2#1)(1995-3#4)(1996-4#1)(1996-8#1)(1997-2#1)(1997-7#1)(2008-11#4)(2008-7#1)
sialic##104##1##(1990-11#1)(1990-12#5)(1990-5#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-7#1)(1993-1#2)(1993-11#7)(1993-7#1)(1994-11#6)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#6)(1995-1#2)(1995-12#5)(1995-3#14)(1995-5#1)(1996-3#4)(1996-4#3)(1996-8#2)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#1)(2008-11#10)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#2)(2009-2#1)(2010-12#4)(2011-2#2)(2012-1#3)
sialic-acid##2##1##(1992-5#1)(2008-8#1)
sialidase activity in##2##3##(2008-11#1)(2008-4#1)
sialidase and the##2##3##(2008-11#2)
sialidase from Bacteroides fragilis SBT3182##2##5##(1992-11#2)
sialidase release and##2##3##(2008-11#2)
sialidase##28##1##(1991-8#1)(1992-11#4)(1992-9#2)(1993-11#1)(1993-4#3)(1994-11#1)(1994-3#7)(1995-3#1)(1995-5#1)(1996-3#1)(2008-11#5)(2008-4#1)
sialidases and##3##2##(1992-12#2)(2008-11#1)
sialidases##5##1##(1992-12#2)(1994-11#1)(1997-3#1)(2008-11#1)
sialo-cutaneous fistula##2##2##(2009-5#2)
sialoglycoconjugates##6##1##(1990-12#1)(1992-11#1)(1994-3#2)(1996-3#1)(2012-1#1)
sialoglycopeptide from bovine brain##2##4##(1994-9#2)
sialoglycopeptide##4##1##(1994-11#1)(1994-9#3)
sialoglycoprotein##4##1##(1991-7#1)(1993-12#1)(1994-11#2)
sialoglycoproteins##4##1##(1994-3#1)(1995-3#3)
sialolithiasis##5##1##(1992-5#1)(2008-10#1)(2011-2#3)
sialoliths##3##1##(2008-10#3)
sialometaplasia of the##2##3##(1991-11#1)(2009-1#1)
sialometaplasia##6##1##(1991-11#3)(2007-10#1)(2009-1#2)
sialomucin##2##1##(1990-2#1)(2005-12#1)
sialoside##3##1##(1991-9#2)(1994-9#1)
sialosides##7##1##(1991-9#7)
sialosyl##2##1##(1991-12#1)(1992-12#1)
sialosyl-Le(x)##2##1##(1991-12#2)
sialyl Lewis##2##2##(1995-1#1)(1996-3#1)
sialyl and##4##2##(1993-11#2)(1993-8#1)(1997-4#1)
sialyl dimeric Le(x)##2##3##(1991-12#1)(1995-4#1)
sialyl ligands##4##2##(1997-4#4)
sialyl oligosaccharides##2##2##(1997-8#2)
sialyl##22##1##(1991-12#1)(1992-11#1)(1992-8#1)(1993-11#4)(1993-8#3)(1995-1#2)(1995-4#1)(1996-3#2)(1997-4#5)(1997-8#2)
sialyl-Lewis x##2##2##(1992-8#2)
sialyl-Lewis(a)##2##1##(1997-7#2)
sialylated N-glycans##2##2##(1993-4#2)
sialylated oligosaccharides##2##2##(1993-11#2)
sialylated products##2##2##(2006-12#2)
sialylated##17##1##(1992-12#1)(1992-8#1)(1993-11#2)(1993-4#2)(1995-2#1)(1995-3#3)(1997-4#1)(1997-7#2)(2006-12#2)(2008-7#1)(2012-3#1)
sialylation and increased##2##3##(1992-6#2)
sialylation in##2##2##(1993-11#1)(1995-3#1)
sialylation of##7##2##(1990-8#1)(1991-9#1)(1995-3#2)(2008-11#1)(2008-7#2)
sialylation pattern of##4##3##(1995-3#1)(2008-11#3)
sialylation was observed at##2##4##(2008-7#2)
sialylation was##5##2##(1990-12#1)(2008-7#3)(2008-8#1)
sialylation##34##1##(1990-12#1)(1990-8#1)(1991-9#1)(1992-6#2)(1993-11#1)(1993-4#1)(1994-2#1)(1995-3#6)(1996-4#1)(1997-7#1)(2006-12#1)(2008-11#9)(2008-7#7)(2008-8#1)
sialyllactosylceramide##2##1##(1994-3#2)
sialyloligosaccharide##2##1##(1994-2#1)(1995-3#1)
sialyloligosaccharides##2##1##(1991-9#2)
sialyltransferase##5##1##(1990-12#1)(1991-2#1)(1992-12#1)(1993-11#1)(2008-11#1)
sialyltransferases##2##1##(1991-2#1)(2010-12#1)
sialytransferase##4##1##(1991-3#4)
siamangs##4##1##(2012-12#4)
sib pairs##3##2##(2010-2#2)(2012-3#1)
sib##9##1##(1996-6#1)(1997-5#3)(2008-10#2)(2010-2#2)(2012-3#1)
sib-pair##8##1##(1997-5#5)(2008-4#1)(2012-3#2)
sib-pairs##2##1##(1996-6#1)(1997-5#1)
sibirica##3##1##(2006-2#1)(2008-6#1)(2009-2#1)
sibiricus##2##1##(2008-10#2)
siblicide in##2##2##(2008-9#2)
siblicide##3##1##(2008-9#3)
sibling and##2##2##(2007-11#1)(2009-5#1)
sibling cases##2##2##(1990-5#2)
sibling donor##2##2##(2007-11#1)(2010-10#1)
sibling group##2##2##(1993-12#2)
sibling is##2##2##(2010-2#1)(2012-11#1)
sibling jealousy##2##2##(2008-12#2)
sibling pairs##5##2##(1997-5#4)(2011-2#1)
sibling pathogens with##3##3##(2008-10#3)
sibling pathogens##6##2##(2008-10#6)
sibling species of##2##3##(1995-8#1)(2004-11#1)
sibling species##10##2##(1995-8#1)(2004-11#2)(2008-10#4)(2008-9#1)(2012-3#1)(2013-7#1)
sibling voles in##2##3##(2013-1#2)
sibling were used##2##3##(2004-11#1)(2011-1#1)
sibling##75##1##(1990-5#2)(1992-7#2)(1993-12#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-6#2)(1997-5#4)(2004-11#4)(2005-10#1)(2005-7#1)(2005-8#1)(2006-7#2)(2007-11#3)(2007-12#1)(2007-6#1)(2008-10#11)(2008-11#1)(2008-12#5)(2008-9#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-2#4)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
siblings (6 to 18 years##2##5##(2008-9#2)
siblings and##6##2##(2004-11#2)(2007-5#1)(2008-1#1)(2009-5#1)(2010-2#1)
siblings from##2##2##(2010-9#1)(2011-1#1)
siblings had##4##2##(1995-12#1)(2007-8#1)(2010-2#1)(2011-1#1)
siblings have##3##2##(2007-8#1)(2011-1#1)(2011-12#1)
siblings in##6##2##(1994-6#1)(2006-10#1)(2007-7#1)(2008-8#1)(2008-9#1)(2010-5#1)
siblings of children with##4##4##(1995-3#1)(2011-2#2)(2013-1#1)
siblings of children##5##3##(1993-12#1)(1995-3#1)(2011-2#2)(2013-1#1)
siblings of the##2##3##(1994-12#1)(2008-8#1)
siblings of##12##2##(1993-12#2)(1994-12#1)(1995-12#1)(1995-3#1)(1997-5#1)(2007-8#1)(2008-8#1)(2010-2#1)(2011-2#2)(2013-1#1)
siblings or##2##2##(2006-10#1)(2007-11#1)
siblings were##5##2##(1993-12#1)(1995-12#1)(2006-7#1)(2007-8#1)(2008-12#1)
siblings who##2##2##(2008-5#1)(2011-1#1)
siblings with a##2##3##(2007-7#1)(2007-8#1)
siblings with##9##2##(1996-5#1)(2006-10#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-7#1)(2009-3#1)(2010-2#2)
siblings##126##1##(1993-12#3)(1993-7#1)(1994-12#1)(1994-6#1)(1995-11#2)(1995-12#6)(1995-2#1)(1995-3#2)(1995-6#2)(1995-9#1)(1996-1#2)(1996-3#1)(1996-5#2)(1997-5#1)(1997-7#4)(1997-8#1)(2004-11#6)(2006-10#5)(2006-7#3)(2006-8#1)(2006-9#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#7)(2008-1#2)(2008-10#1)(2008-12#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#4)(2009-1#1)(2009-3#2)(2009-5#1)(2010-10#1)(2010-2#5)(2010-5#1)(2010-9#5)(2011-1#6)(2011-12#10)(2011-2#4)(2012-1#1)(2012-11#2)(2013-1#2)(2013-8#1)
siblings' fertility##2##2##(2011-2#2)
siblings' relationship quality##2##3##(2010-8#2)
siblings'##9##1##(1995-12#1)(2008-9#1)(2009-7#1)(2010-8#2)(2011-2#3)(2013-7#1)
siboglinid##3##1##(2009-8#3)
siboglinids##3##1##(2009-8#3)
sibpair##4##1##(1996-2#1)(2008-9#3)
sibs and##2##2##(1996-3#1)(1996-5#1)
sibs of##3##2##(1996-6#2)(1997-1#1)
sibs with##4##2##(1996-3#3)(1996-5#1)
sibs##16##1##(1996-3#4)(1996-5#5)(1996-6#4)(1997-1#3)
sibships with##3##2##(1995-11#1)(2008-8#2)
sibships##8##1##(1994-8#1)(1995-11#3)(1996-5#1)(2008-4#1)(2008-8#2)
sibutramine and##4##2##(2006-10#1)(2012-3#3)
sibutramine##8##1##(2006-10#1)(2006-2#2)(2008-8#1)(2011-2#1)(2012-3#3)
sicca symptoms##7##2##(2006-10#7)
sicca syndrome and##3##3##(1992-11#1)(2007-7#2)
sicca syndrome with##2##3##(1992-11#1)(2006-4#1)
sicca syndrome##5##2##(1992-11#2)(2006-4#1)(2007-7#2)
sicca##19##1##(1992-11#2)(1992-8#2)(2006-10#11)(2006-4#1)(2007-10#1)(2007-7#2)
sick and##4##2##(1990-12#1)(1991-3#1)(1997-6#1)(2007-11#1)
sick at##2##2##(1991-11#1)(1993-2#1)
sick building syndrome##6##3##(1992-4#6)
sick building##7##2##(1992-4#6)(2006-5#1)
sick children and##2##3##(1992-3#1)(2011-2#1)
sick children##4##2##(1992-3#1)(1994-6#1)(2005-7#1)(2011-2#1)
sick controls in the community##4##5##(2009-7#4)
sick for##3##2##(1990-4#2)(2013-7#1)
sick leave notification##2##3##(1990-4#2)
sick leave was##3##3##(1990-4#3)
sick leave##23##2##(1990-4#12)(1991-3#1)(1991-4#1)(1991-8#3)(1994-4#2)(1997-6#2)(2008-7#1)(2012-2#1)
sick neonates##2##2##(2011-2#1)(2013-1#1)
sick patients##2##2##(1990-4#1)(2008-8#1)
sick persons##3##2##(2006-6#1)(2009-7#2)
sick role behavior##5##3##(1990-8#5)
sick role##6##2##(1990-8#6)
sick sinus syndrome and##2##4##(1990-12#1)(1993-10#1)
sick sinus syndrome##7##3##(1990-12#1)(1993-10#2)(1997-1#2)(2007-8#1)(2010-12#1)
sick syndrome##2##2##(2006-10#1)(2007-9#1)
sick##102##1##(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#17)(1990-8#6)(1991-11#1)(1991-3#3)(1991-4#1)(1991-8#4)(1991-9#2)(1992-12#1)(1992-3#2)(1992-4#6)(1993-10#2)(1993-2#1)(1993-9#1)(1994-4#2)(1994-6#2)(1995-5#1)(1995-9#1)(1996-1#2)(1996-6#2)(1996-8#1)(1997-1#2)(1997-6#3)(2005-7#1)(2006-10#2)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#7)(2010-12#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)
sick-leave##3##1##(1992-9#1)(1994-4#1)(1997-6#1)
sick-listed##3##1##(1991-11#1)(1991-9#1)(1992-11#1)
sicked of cancer##4##3##(2011-2#4)
sicker##4##1##(1995-2#1)(1995-9#1)(1996-3#1)(2009-6#1)
sickle RBC membranes##2##3##(1991-10#1)(1992-1#1)
sickle RBC##4##2##(1991-10#1)(1992-1#3)
sickle cell anaemia patients##4##4##(2013-8#4)
sickle cell anaemia##12##3##(1992-8#2)(1995-5#1)(2009-10#1)(2009-4#3)(2012-12#1)(2013-8#4)
sickle cell anemia##5##3##(1993-9#2)(2005-7#1)(2010-3#1)(2013-8#1)
sickle cell crisis##3##3##(2005-9#2)(2006-10#1)
sickle cell disease (SCD)##4##4##(2007-2#1)(2007-3#1)(2007-7#1)(2009-4#1)
sickle cell disease and##5##4##(1992-3#2)(2008-8#1)(2012-12#1)(2013-8#1)
sickle cell disease in##4##4##(2006-12#1)(2007-2#1)(2012-12#2)
sickle cell disease is##2##4##(2007-3#1)(2013-8#1)
sickle cell disease##46##3##(1991-6#2)(1992-3#5)(2005-10#1)(2005-11#1)(2006-12#1)(2006-7#2)(2007-2#3)(2007-3#5)(2007-7#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-2#1)(2009-4#2)(2009-7#1)(2010-11#1)(2010-12#2)(2011-2#1)(2012-12#4)(2012-2#1)(2013-1#2)(2013-8#4)
sickle cell hemoglobin##2##3##(1996-6#2)
sickle cell hemoglobinopathy##3##3##(2013-8#3)
sickle cell painful##3##3##(2007-2#1)(2007-3#2)
sickle cell trait##6##3##(1993-9#1)(2007-7#1)(2009-6#1)(2012-12#1)(2013-1#2)
sickle cell##89##2##(1991-6#2)(1992-3#5)(1992-6#1)(1992-8#2)(1993-9#3)(1995-5#1)(1996-6#2)(2005-10#1)(2005-11#1)(2005-7#2)(2005-9#2)(2006-10#1)(2006-12#1)(2006-7#2)(2007-2#5)(2007-3#7)(2007-7#2)(2007-9#1)(2008-11#1)(2008-5#1)(2008-8#3)(2009-10#2)(2009-2#1)(2009-4#5)(2009-6#1)(2009-7#1)(2010-11#2)(2010-12#2)(2010-3#1)(2011-2#1)(2012-12#9)(2012-2#1)(2013-1#5)(2013-8#12)
sickle cells##3##2##(1991-8#2)(1992-1#1)
sickle##104##1##(1991-10#2)(1991-6#2)(1991-8#2)(1992-1#7)(1992-3#5)(1992-6#1)(1992-8#2)(1992-9#1)(1993-9#3)(1995-5#1)(1996-6#3)(2005-10#1)(2005-11#1)(2005-7#2)(2005-9#2)(2006-10#1)(2006-12#1)(2006-7#2)(2007-2#6)(2007-3#8)(2007-7#2)(2007-9#1)(2008-11#1)(2008-5#1)(2008-8#3)(2009-10#2)(2009-2#1)(2009-4#5)(2009-6#1)(2009-7#1)(2010-11#2)(2010-12#2)(2010-3#1)(2011-2#1)(2012-12#9)(2012-2#1)(2013-1#5)(2013-8#12)
sickle-cell anemia##2##2##(2007-3#1)(2013-1#1)
sickle-cell disease##4##2##(2006-5#1)(2008-10#2)(2008-4#1)
sickle-cell##9##1##(1992-2#1)(2006-5#1)(2007-3#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-10#1)(2013-1#1)
sickness absence##2##2##(2011-1#2)
sickness and##11##2##(1992-2#3)(1994-3#1)(1994-6#1)(2005-8#1)(2007-4#1)(2008-3#1)(2008-9#1)(2010-1#1)(2012-2#1)
sickness certificate##3##2##(1990-4#2)(1991-9#1)
sickness fund##2##2##(1992-1#1)(2008-7#1)
sickness funds##6##2##(1992-12#1)(1995-1#1)(2008-7#4)
sickness in##2##2##(1990-6#1)(2010-12#1)
sickness is a##2##3##(1991-6#1)(2010-4#1)
sickness is##4##2##(1991-6#1)(2007-2#1)(2008-2#1)(2010-4#1)
sickness##83##1##(1990-4#4)(1990-6#1)(1990-9#2)(1991-2#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#3)(1992-8#1)(1993-9#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-7#1)(1995-1#1)(1995-9#1)(1996-1#1)(1997-6#1)(1997-8#3)(2005-8#1)(2006-10#2)(2007-10#1)(2007-2#8)(2007-4#1)(2007-5#1)(2007-6#1)(2008-2#11)(2008-3#2)(2008-5#1)(2008-7#7)(2008-8#1)(2008-9#3)(2010-1#4)(2010-12#1)(2010-4#2)(2011-1#2)(2012-2#2)
sickness-related absence##2##2##(2007-10#2)
sickness-related absences##4##2##(2007-10#4)
sickness-related##6##1##(2007-10#6)
sickness]##4##1##(1991-6#1)(1994-3#1)(2010-12#2)
sicknessrelated absences##2##2##(2007-10#2)
sicula##2##1##(2010-12#1)(2013-8#1)
sida##2##1##(2008-10#1)(2010-12#1)
side (5##2##2##(2007-7#1)(2008-8#1)
side after##2##2##(1997-7#1)(2013-1#1)
side airbag deployments##2##3##(2007-1#2)
side airbag##15##2##(2006-11#1)(2007-1#10)(2007-4#4)
side airbags##2##2##(2007-1#1)(2007-4#1)
side and a##5##3##(1996-8#1)(2005-10#1)(2008-11#1)(2008-5#2)
side and no visceral pleural invasion##2##6##(2007-8#2)
side and the##4##3##(2006-11#1)(2008-10#1)(2008-2#1)(2013-8#1)
side and to##2##3##(2006-6#1)(2008-10#1)
side and##43##2##(1993-12#1)(1993-6#1)(1995-5#1)(1996-2#1)(1996-5#1)(1996-8#1)(2004-11#2)(2004-9#1)(2005-10#2)(2005-11#1)(2006-11#1)(2006-6#1)(2007-10#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#4)(2013-1#2)(2013-8#1)
side as compared##2##3##(1990-7#1)(1993-12#1)
side as##4##2##(1990-7#1)(1993-12#1)(2011-2#1)(2013-1#1)
side at##4##2##(1992-6#2)(1993-4#1)(2008-3#1)
side bands##2##2##(2008-10#2)
side branch ostial##2##3##(2008-11#1)(2010-12#1)
side branch##8##2##(2007-8#1)(2008-11#3)(2008-5#1)(2009-5#1)(2010-12#2)
side by side and##2##4##(2008-10#1)(2008-7#1)
side by side comparison of##2##5##(1993-12#1)(2008-10#1)
side by side with the##4##5##(2008-3#1)(2008-8#1)(2011-1#1)(2013-8#1)
side by side##15##3##(1993-12#1)(2004-9#1)(2006-10#1)(2006-6#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#1)(2013-8#1)
side by##17##2##(1993-12#1)(1994-8#1)(2004-9#1)(2006-10#1)(2006-6#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#1)(2013-8#1)
side chain and the##2##4##(1993-11#1)(2006-10#1)
side chain and##6##3##(1991-2#1)(1993-11#1)(2005-11#1)(2006-10#1)(2006-3#2)
side chain at position##3##4##(1996-2#1)(1997-2#1)(1997-3#1)
side chain at##6##3##(1995-5#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-8#1)
side chain attached to##3##4##(1995-7#1)(1997-2#1)(2005-3#1)
side chain cleavage activity of cytochrome P450SCC##2##7##(1996-5#1)(1997-2#1)
side chain cleavage##3##3##(1991-9#1)(1996-5#1)(1997-2#1)
side chain in the##5##4##(1995-5#2)(2008-9#2)(2009-12#1)
side chain in##8##3##(1994-9#1)(1995-11#2)(1995-5#2)(2008-9#2)(2009-12#1)
side chain is##3##3##(1993-3#1)(1995-3#1)(1995-8#1)
side chain of dihydrozamoranic acid##2##5##(2007-11#2)
side chain of the##9##4##(1994-11#1)(1994-8#1)(1995-3#1)(1996-6#1)(1997-2#1)(2006-10#1)(2008-10#1)(2009-3#1)(2013-8#1)
side chain of##44##3##(1990-8#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-3#2)(1992-9#5)(1993-2#1)(1993-6#4)(1994-10#1)(1994-11#4)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-6#1)(1997-2#2)(2005-11#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-11#2)(2008-10#1)(2008-8#1)(2009-3#2)(2010-12#1)(2013-8#1)
side chain on##3##3##(1993-11#1)(1994-9#1)(2007-8#1)
side chain or##2##3##(1991-10#1)(2007-12#1)
side chain resonances##2##3##(2009-7#2)
side chain rotates##2##3##(1991-2#1)(1991-7#1)
side chain size##2##3##(1995-5#2)
side chain structure##2##3##(1992-3#1)(1997-6#1)
side chain to##3##3##(1995-11#1)(2007-11#2)
side chain was##4##3##(1991-9#1)(1992-12#1)(1995-3#1)(1997-4#1)
side chain were##3##3##(1994-9#2)(2008-7#1)
side chain##161##2##(1990-10#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#2)(1991-4#2)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#3)(1992-1#2)(1992-12#2)(1992-3#4)(1992-6#1)(1992-8#2)(1992-9#5)(1993-11#3)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#5)(1993-8#2)(1994-10#1)(1994-11#5)(1994-3#1)(1994-5#3)(1994-8#1)(1994-9#9)(1995-1#1)(1995-10#2)(1995-11#5)(1995-3#5)(1995-4#1)(1995-5#5)(1995-7#1)(1995-8#3)(1996-2#1)(1996-5#3)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#9)(1997-3#1)(1997-4#2)(1997-6#1)(2005-11#4)(2005-3#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-3#2)(2007-1#1)(2007-11#6)(2007-12#4)(2007-8#2)(2008-10#3)(2008-12#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#2)(2009-7#7)(2010-12#1)(2010-5#1)(2012-2#1)(2013-8#1)
side chain-side chain##3##3##(1991-11#1)(2008-10#2)
side chains and##6##3##(1990-4#1)(1997-7#1)(2005-7#1)(2007-11#1)(2008-10#1)(2009-12#1)
side chains are##8##3##(1990-4#1)(1990-5#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-11#1)(1995-1#1)
side chains at position##2##4##(1995-1#1)(1997-6#1)
side chains at the##2##4##(1991-2#1)(2008-10#1)
side chains at##7##3##(1990-12#1)(1991-2#1)(1993-11#1)(1995-1#1)(1997-6#1)(2008-10#1)(2008-2#1)
side chains can be##2##4##(1993-11#1)(1994-2#1)
side chains can##4##3##(1990-7#1)(1993-11#1)(1994-2#1)(1997-7#1)
side chains in the##5##4##(1990-8#1)(1991-12#1)(1991-6#1)(1996-5#1)(1997-4#1)
side chains in##9##3##(1990-8#1)(1991-12#1)(1991-6#1)(1993-11#1)(1993-6#1)(1994-3#1)(1996-5#1)(1997-4#1)(2008-4#1)
side chains of subunits##2##4##(1992-8#2)
side chains of the##7##4##(1991-10#1)(1992-3#1)(1992-6#1)(1993-7#1)(2006-8#1)(2008-3#1)(2009-7#1)
side chains of##33##3##(1990-5#1)(1991-10#1)(1991-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#2)(1997-1#1)(1997-4#1)(2005-11#1)(2006-12#1)(2006-8#2)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-3#1)(2009-7#1)(2013-8#1)
side chains on##2##3##(1994-9#1)(2006-8#1)
side chains that##3##3##(1996-8#1)(2004-12#1)(2009-8#1)
side chains were##6##3##(1990-11#1)(1991-9#1)(1993-11#1)(2005-11#2)(2009-7#1)
side chains with##2##3##(1991-2#1)(1995-8#1)
side chains##141##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-4#2)(1990-5#2)(1990-7#2)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-4#2)(1991-6#1)(1991-7#1)(1991-9#2)(1992-12#1)(1992-3#5)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#3)(1993-11#6)(1993-12#3)(1993-3#1)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#3)(1994-2#1)(1994-3#1)(1994-9#3)(1995-1#3)(1995-11#2)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#5)(1996-5#1)(1996-8#3)(1997-1#1)(1997-4#2)(1997-6#1)(1997-7#4)(2004-12#1)(2005-11#6)(2005-3#1)(2005-7#1)(2006-10#1)(2006-12#4)(2006-8#6)(2007-11#4)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#4)(2009-12#1)(2009-3#2)(2009-7#3)(2009-8#2)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-8#1)
side compared to##2##3##(1993-4#1)(1994-3#1)
side compared##3##2##(1993-4#1)(1994-3#1)(2008-9#1)
side coupled##3##2##(2007-12#3)
side during##3##2##(1991-2#1)(2010-2#2)
side effect and##3##3##(1996-9#1)(2008-3#1)(2013-8#1)
side effect associated with##2##4##(2004-3#1)(2008-7#1)
side effect frequency and severity##2##5##(2008-6#2)
side effect in##3##3##(1991-2#1)(1997-3#1)(2008-3#1)
side effect is##4##3##(1990-10#1)(1990-4#1)(2008-8#1)(2011-1#1)
side effect of this##3##4##(1993-11#1)(2006-6#1)(2010-4#1)
side effect of##39##3##(1990-6#1)(1990-9#1)(1993-11#1)(1994-11#1)(1995-10#1)(1997-2#1)(2006-10#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-3#1)(2010-4#2)(2011-1#1)(2011-10#1)(2011-2#2)(2012-11#2)(2012-12#4)(2012-3#1)(2013-8#1)
side effect on##2##3##(2010-4#1)(2011-2#1)
side effect profile##12##3##(1993-5#1)(1996-3#1)(2007-8#1)(2008-1#1)(2008-3#2)(2008-7#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-1#1)
side effect profiles##5##3##(2008-1#1)(2008-3#1)(2010-12#1)(2011-10#2)
side effect that##2##3##(2006-9#1)(2008-7#1)
side effect was##5##3##(2005-7#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-7#1)
side effect##113##2##(1990-10#2)(1990-4#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-2#1)(1993-11#1)(1993-5#1)(1994-11#1)(1995-10#1)(1996-3#2)(1996-9#1)(1997-2#1)(1997-3#3)(2004-12#1)(2004-3#1)(2005-7#2)(2006-10#4)(2006-6#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-3#8)(2008-5#1)(2008-6#6)(2008-7#7)(2008-8#5)(2009-10#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#3)(2010-9#1)(2011-1#4)(2011-10#3)(2011-2#4)(2012-1#1)(2012-11#4)(2012-12#5)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
side effects after##6##3##(1990-10#1)(2006-8#1)(2007-7#1)(2008-6#1)(2011-2#1)(2012-12#1)
side effects and can be##2##5##(1995-5#1)(2004-2#1)
side effects and can##3##4##(1995-5#1)(2004-2#1)(2007-7#1)
side effects and complications##2##4##(2007-8#1)(2012-2#1)
side effects and is##2##4##(2010-12#1)(2012-12#1)
side effects and the##7##4##(1991-4#1)(1996-1#1)(1997-1#1)(1997-8#1)(2006-9#1)(2007-12#1)(2012-2#1)
side effects and##58##3##(1990-5#2)(1991-4#1)(1992-3#1)(1993-2#1)(1993-5#1)(1993-9#1)(1995-5#1)(1996-1#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-8#1)(2004-2#1)(2005-10#1)(2005-11#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#3)(2008-8#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-1#3)(2010-12#2)(2010-5#2)(2010-6#2)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
side effects and/or events##2##4##(1993-2#2)
side effects and/or##3##3##(1993-2#2)(2008-7#1)
side effects are##21##3##(1990-10#1)(1990-5#1)(1996-1#1)(1996-9#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#4)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#1)
side effects as##2##3##(1995-5#1)(2012-3#1)
side effects associated with the use of##2##7##(2007-8#1)(2010-10#1)
side effects associated with the##3##5##(1997-8#1)(2007-8#1)(2010-10#1)
side effects associated with##9##4##(1995-12#1)(1997-3#1)(1997-8#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-10#2)
side effects but##3##3##(2007-3#1)(2008-3#1)(2010-12#1)
side effects can be##2##4##(1992-11#1)(1994-4#1)
side effects can limit##2##4##(2007-8#1)(2011-1#1)
side effects can##5##3##(1992-11#1)(1994-4#1)(1995-4#1)(2007-8#1)(2011-1#1)
side effects due to##2##4##(1997-3#1)(1997-5#1)
side effects for##2##3##(1991-6#1)(2005-10#1)
side effects from##5##3##(1997-2#1)(2006-10#1)(2006-8#1)(2008-7#1)(2011-2#1)
side effects has been##2##4##(2008-10#1)(2008-8#1)
side effects have been reported##3##5##(1993-11#1)(1993-3#1)(2006-9#1)
side effects in the##5##4##(1993-8#1)(1996-5#1)(2005-11#1)(2009-7#1)(2010-7#1)
side effects in##16##3##(1992-11#1)(1992-8#1)(1993-8#1)(1996-5#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-6#1)(2008-10#1)(2009-7#1)(2010-7#1)(2010-9#2)(2011-2#2)
side effects included##2##3##(2006-4#1)(2007-7#1)
side effects including##2##3##(1993-11#1)(2011-1#1)
side effects is##9##3##(1995-1#1)(1997-3#1)(2006-12#1)(2007-7#2)(2008-8#2)(2009-10#1)(2013-1#1)
side effects limit##2##3##(2009-12#1)(2010-11#1)
side effects may##3##3##(1992-8#1)(2007-1#1)(2011-2#1)
side effects observed##2##3##(1993-1#1)(2008-5#1)
side effects occurred##2##3##(1990-12#1)(1991-4#1)
side effects of antipsychotic drugs##2##5##(1992-6#1)(2010-6#1)
side effects of drugs##2##4##(1995-12#1)(1997-3#1)
side effects of immunosuppressive drugs##2##5##(2010-4#1)(2011-3#1)
side effects of immunosuppressive##3##4##(1994-5#1)(2010-4#1)(2011-3#1)
side effects of oral##2##4##(1992-5#1)(2007-6#1)
side effects of the vaccination were##2##6##(2011-2#2)
side effects of the##10##4##(1993-10#1)(1995-6#1)(2008-3#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#3)(2013-1#1)
side effects of these##2##4##(2008-9#1)(2013-1#1)
side effects of treatment##2##4##(1992-8#1)(2008-12#1)
side effects of##85##3##(1990-4#1)(1990-9#1)(1991-6#3)(1991-8#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-3#1)(2004-3#1)(2005-11#1)(2006-10#2)(2006-8#2)(2007-11#2)(2007-12#1)(2007-2#2)(2007-6#1)(2007-8#3)(2008-1#1)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-6#2)(2011-1#1)(2011-2#7)(2011-3#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#3)
side effects on##5##3##(1993-12#1)(2008-9#2)(2011-2#2)
side effects or##7##3##(1995-8#1)(2006-10#1)(2008-5#1)(2008-7#2)(2008-8#2)
side effects profile and##2##4##(1996-2#1)(2013-7#1)
side effects should##2##3##(1996-2#1)(2007-6#1)
side effects such as##9##4##(2007-11#1)(2008-1#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-7#1)(2011-1#2)
side effects than##5##3##(2007-10#1)(2009-8#1)(2010-12#1)(2010-4#1)(2012-12#1)
side effects that are##3##4##(2007-8#1)(2008-3#1)(2008-7#1)
side effects that may##2##4##(2007-9#1)(2008-7#1)
side effects that##11##3##(2007-8#1)(2007-9#1)(2008-3#1)(2008-6#2)(2008-7#3)(2008-8#1)(2010-11#1)(2013-1#1)
side effects to##3##3##(2004-3#1)(2007-7#1)(2008-1#1)
side effects was##3##3##(1993-2#1)(2006-2#1)(2010-4#1)
side effects were minimal##2##4##(1991-8#1)(2007-6#1)
side effects were monitored##2##4##(2007-11#1)(2007-3#1)
side effects were noted##2##4##(2007-11#1)(2007-2#1)
side effects were observed and##2##5##(1991-3#1)(2013-7#1)
side effects were observed##6##4##(1990-11#1)(1990-12#1)(1990-6#1)(1991-3#1)(1991-4#1)(2013-7#1)
side effects were recorded##2##4##(1992-10#1)(2011-2#1)
side effects were reported##3##4##(1996-1#1)(2011-2#1)(2013-1#1)
side effects were##35##3##(1990-11#2)(1990-12#1)(1990-5#1)(1990-6#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#2)(1992-10#2)(1993-2#1)(1996-1#1)(1996-11#2)(1996-8#1)(2004-9#1)(2006-1#1)(2006-10#2)(2006-6#1)(2007-11#2)(2007-2#2)(2007-3#1)(2007-6#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
side effects which are##2##4##(2008-3#1)(2013-8#1)
side effects which##5##3##(1996-3#1)(2007-8#1)(2008-3#1)(2008-8#1)(2013-8#1)
side effects while##2##3##(1996-9#1)(2007-2#1)
side effects with##3##3##(2004-3#1)(2008-3#1)(2008-7#1)
side effects without compromising the##2##5##(2009-8#1)(2011-1#1)
side effects##635##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#6)(1990-6#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#4)(1991-3#4)(1991-4#4)(1991-6#10)(1991-7#2)(1991-8#4)(1992-10#3)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#4)(1992-9#1)(1993-1#3)(1993-10#1)(1993-11#4)(1993-12#1)(1993-2#7)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#3)(1994-11#1)(1994-2#1)(1994-3#1)(1994-4#3)(1994-5#1)(1994-6#2)(1995-1#1)(1995-12#2)(1995-2#2)(1995-4#1)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#6)(1996-11#6)(1996-12#1)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#2)(1996-8#3)(1996-9#4)(1997-1#2)(1997-2#1)(1997-3#7)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#4)(2004-2#1)(2004-3#6)(2004-9#1)(2005-10#3)(2005-11#9)(2005-3#1)(2005-5#2)(2005-6#3)(2005-7#1)(2005-8#4)(2006-1#2)(2006-10#23)(2006-12#5)(2006-2#3)(2006-4#2)(2006-5#1)(2006-6#4)(2006-7#1)(2006-8#9)(2006-9#2)(2007-1#21)(2007-10#3)(2007-11#10)(2007-12#7)(2007-2#8)(2007-3#2)(2007-6#10)(2007-7#13)(2007-8#15)(2007-9#3)(2008-1#15)(2008-10#9)(2008-11#3)(2008-12#4)(2008-2#6)(2008-3#11)(2008-4#4)(2008-5#11)(2008-6#13)(2008-7#19)(2008-8#24)(2008-9#4)(2009-1#4)(2009-10#1)(2009-11#1)(2009-12#4)(2009-3#2)(2009-4#1)(2009-5#3)(2009-7#9)(2009-8#6)(2009-9#1)(2010-1#3)(2010-10#3)(2010-11#3)(2010-12#8)(2010-3#2)(2010-4#3)(2010-5#4)(2010-6#4)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#9)(2011-2#29)(2011-3#2)(2012-1#3)(2012-11#1)(2012-12#12)(2012-2#8)(2012-3#2)(2013-1#17)(2013-7#7)(2013-8#11)
side effects]##2##2##(1991-3#1)(1992-10#1)
side for##6##2##(1990-3#1)(2005-10#1)(2007-5#1)(2008-3#1)(2008-7#1)(2009-6#1)
side groups##8##2##(1991-5#1)(2009-11#3)(2010-4#1)(2012-11#2)(2012-3#1)
side impact crash##3##3##(2006-11#3)
side impact dummies##8##3##(2006-11#6)(2007-4#2)
side impact dummy##2##3##(2006-11#1)(2007-1#1)
side impact injury##3##3##(2006-11#2)(2007-4#1)
side impact protection##3##3##(2006-11#1)(2007-1#1)(2007-4#1)
side impact sled tests were##2##5##(2006-11#1)(2007-4#1)
side impact sled##3##3##(2006-11#1)(2007-4#2)
side impact##36##2##(2006-11#23)(2007-1#3)(2007-4#10)
side impacts##4##2##(2007-4#4)
side in a##2##3##(2008-6#1)(2008-7#1)
side in the##5##3##(1993-4#1)(1994-3#1)(2007-12#1)(2009-10#1)(2010-4#1)
side in##16##2##(1993-4#1)(1994-3#1)(1994-9#1)(1995-12#2)(1996-3#1)(2006-12#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-4#1)(2011-1#1)
side is not##2##3##(2005-10#1)(2008-2#1)
side is presented##2##3##(2007-12#1)(2008-3#1)
side is##6##2##(2005-10#1)(2007-12#2)(2008-2#2)(2008-3#1)
side modes##2##2##(2008-2#2)
side of a##9##3##(1990-11#2)(1991-1#1)(1995-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-11#1)
side of an##3##3##(1991-11#1)(2008-3#1)(2008-8#1)
side of both arches were sealed with##2##7##(2012-12#2)
side of her##3##3##(1991-3#1)(2010-4#1)(2013-1#1)
side of its##2##3##(2008-5#1)(2012-1#1)
side of membrane##2##3##(2011-2#2)
side of space##3##3##(1995-12#2)(2006-3#1)
side of the aperture##2##4##(2008-2#2)
side of the body##2##4##(2008-5#1)(2008-7#1)
side of the developing##2##4##(2007-12#2)
side of the face##7##4##(2005-5#1)(2008-5#1)(2009-9#1)(2011-1#1)(2012-12#3)
side of the heart##4##4##(1991-6#1)(1993-6#1)(1996-3#1)(2007-8#1)
side of the kidney##2##4##(2008-11#1)(2011-2#1)
side of the lipoylation site##2##5##(1996-5#2)
side of the membrane##9##4##(1990-11#1)(1991-11#1)(1991-3#1)(1991-5#1)(1992-11#1)(1993-3#1)(1995-6#1)(2008-10#1)(2011-2#1)
side of the neck##8##4##(1990-3#1)(1995-8#1)(2007-7#2)(2007-8#1)(2011-2#1)(2012-12#2)
side of the nuclear##2##4##(2008-9#1)(2009-8#1)
side of the slab##2##4##(2008-3#2)
side of the spinal cord##4##5##(1990-7#1)(1995-7#3)
side of the subesophageal ganglion##2##5##(2008-5#2)
side of the triquinacene framework##2##5##(1996-5#2)
side of the##205##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#5)(1992-7#1)(1993-12#1)(1993-3#3)(1993-5#1)(1993-6#1)(1993-7#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-7#3)(1995-8#2)(1996-1#1)(1996-10#1)(1996-2#4)(1996-3#1)(1996-5#4)(1996-8#2)(1997-1#3)(1997-4#1)(1997-6#1)(1997-8#3)(2005-10#1)(2005-5#1)(2005-8#1)(2006-3#2)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#11)(2007-5#2)(2007-7#5)(2007-8#4)(2007-9#5)(2008-10#12)(2008-11#6)(2008-12#3)(2008-2#5)(2008-3#10)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#4)(2008-9#3)(2009-10#1)(2009-6#3)(2009-8#1)(2009-9#1)(2010-12#6)(2010-4#1)(2010-5#1)(2011-1#3)(2011-12#3)(2011-2#8)(2012-12#7)(2012-2#2)(2012-3#1)(2013-1#1)(2013-2#1)(2013-7#2)(2013-8#1)
side of##298##2##(1990-11#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#2)(1991-11#3)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#5)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#7)(1992-7#1)(1993-12#1)(1993-3#3)(1993-5#1)(1993-6#1)(1993-7#1)(1994-2#3)(1994-5#4)(1994-6#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#3)(1995-12#5)(1995-3#1)(1995-5#1)(1995-6#2)(1995-7#3)(1995-8#3)(1996-1#1)(1996-10#1)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#4)(1996-8#2)(1997-1#4)(1997-4#1)(1997-6#1)(1997-8#3)(2005-10#4)(2005-5#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-3#3)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#13)(2007-3#2)(2007-5#2)(2007-6#1)(2007-7#7)(2007-8#4)(2007-9#5)(2008-1#1)(2008-10#12)(2008-11#10)(2008-12#3)(2008-2#5)(2008-3#12)(2008-4#2)(2008-5#11)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#3)(2009-10#1)(2009-2#2)(2009-3#1)(2009-6#4)(2009-8#3)(2009-9#3)(2010-10#1)(2010-12#6)(2010-4#2)(2010-5#1)(2011-1#3)(2011-12#3)(2011-2#12)(2012-1#2)(2012-12#11)(2012-2#5)(2012-3#1)(2013-1#2)(2013-2#1)(2013-7#3)(2013-8#2)
side on the##2##3##(1990-5#1)(2008-6#1)
side or##6##2##(1991-3#1)(1991-5#1)(1993-7#1)(1994-7#1)(2006-9#1)(2007-8#1)
side peaks##2##2##(2008-2#2)
side population (SP)##2##3##(2008-9#1)(2010-6#1)
side population cells are capable of##2##6##(2008-1#1)(2010-6#1)
side population cells are##3##4##(2008-1#1)(2010-6#2)
side population cells##9##3##(2008-1#1)(2010-6#8)
side population##13##2##(2008-1#1)(2008-9#2)(2010-6#10)
side product##2##2##(2009-12#2)
side products##2##2##(1996-5#1)(2007-11#1)
side pumped by a##2##4##(2007-12#1)(2008-3#1)
side pumped by three diode##2##5##(2007-12#1)(2008-2#1)
side pumped by##7##3##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#1)
side pumped##8##2##(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#1)
side reaction of##2##3##(2008-10#2)
side reaction##11##2##(1994-10#1)(1996-2#1)(2006-6#2)(2007-8#1)(2008-10#4)(2008-12#1)(2009-3#1)
side reactions were observed##2##4##(1996-8#1)(2005-8#1)
side reactions were##3##3##(1996-8#1)(2005-8#1)(2012-2#1)
side reactions##14##2##(1996-8#1)(2005-8#1)(2007-3#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-4#3)(2009-12#1)(2011-1#1)(2012-2#2)
side region of##2##3##(1993-7#1)(2008-6#1)
side scatter##2##2##(2008-2#1)(2008-9#1)
side showed##2##2##(2008-9#2)
side that##2##2##(1992-12#1)(2012-3#1)
side the##2##2##(1994-10#1)(2006-10#1)
side to side##5##3##(1990-5#1)(2009-9#3)(2011-12#1)
side to##9##2##(1990-5#1)(1994-3#1)(2006-6#1)(2008-8#1)(2009-9#3)(2010-2#1)(2011-12#1)
side walls##2##2##(2006-12#1)(2008-10#1)
side was##12##2##(1991-2#2)(1991-6#1)(1992-10#1)(1996-6#2)(1997-8#1)(2007-8#2)(2009-9#1)(2011-12#1)(2013-1#1)
side were##6##2##(1993-3#1)(2004-11#1)(2006-9#1)(2008-2#1)(2011-2#1)(2013-1#1)
side when the knee was##2##5##(1997-8#2)
side when##3##2##(1990-10#1)(1997-8#2)
side window##2##2##(2006-6#2)
side with the##5##3##(2006-9#1)(2008-3#1)(2008-8#1)(2011-1#1)(2013-8#1)
side with##9##2##(1990-3#1)(1995-6#1)(2006-9#2)(2008-3#1)(2008-6#1)(2008-8#1)(2011-1#1)(2013-8#1)
side##1989##1##(1990-10#6)(1990-11#8)(1990-12#4)(1990-2#3)(1990-3#7)(1990-4#7)(1990-5#12)(1990-6#5)(1990-7#9)(1990-8#5)(1990-9#3)(1991-1#3)(1991-10#2)(1991-11#6)(1991-12#6)(1991-2#16)(1991-3#8)(1991-4#9)(1991-5#8)(1991-6#20)(1991-7#5)(1991-8#8)(1991-9#7)(1992-1#6)(1992-10#6)(1992-11#4)(1992-12#9)(1992-2#2)(1992-3#12)(1992-4#5)(1992-5#3)(1992-6#14)(1992-7#3)(1992-8#8)(1992-9#9)(1993-1#3)(1993-10#1)(1993-11#14)(1993-12#12)(1993-2#8)(1993-3#9)(1993-4#7)(1993-5#3)(1993-6#14)(1993-7#5)(1993-8#5)(1993-9#4)(1994-1#1)(1994-10#7)(1994-11#10)(1994-12#3)(1994-2#11)(1994-3#8)(1994-4#3)(1994-5#9)(1994-6#3)(1994-7#1)(1994-8#6)(1994-9#14)(1995-1#5)(1995-10#4)(1995-11#11)(1995-12#10)(1995-2#6)(1995-3#9)(1995-4#3)(1995-5#13)(1995-6#11)(1995-7#8)(1995-8#14)(1995-9#1)(1996-1#9)(1996-10#1)(1996-11#6)(1996-12#3)(1996-2#11)(1996-3#7)(1996-4#3)(1996-5#16)(1996-6#3)(1996-8#12)(1996-9#9)(1997-1#11)(1997-2#12)(1997-3#11)(1997-4#7)(1997-5#1)(1997-6#4)(1997-7#7)(1997-8#13)(2004-11#5)(2004-12#2)(2004-2#1)(2004-3#7)(2004-9#5)(2005-10#14)(2005-11#22)(2005-3#3)(2005-5#3)(2005-6#3)(2005-7#4)(2005-8#7)(2006-1#2)(2006-10#35)(2006-11#31)(2006-12#14)(2006-2#5)(2006-3#5)(2006-4#2)(2006-5#2)(2006-6#14)(2006-7#4)(2006-8#17)(2006-9#9)(2007-1#42)(2007-10#11)(2007-11#29)(2007-12#41)(2007-2#9)(2007-3#7)(2007-4#20)(2007-5#4)(2007-6#11)(2007-7#33)(2007-8#44)(2007-9#9)(2008-1#25)(2008-10#56)(2008-11#24)(2008-12#11)(2008-2#29)(2008-3#49)(2008-4#17)(2008-5#40)(2008-6#26)(2008-7#48)(2008-8#48)(2008-9#26)(2009-1#4)(2009-10#4)(2009-11#6)(2009-12#9)(2009-2#4)(2009-3#10)(2009-4#1)(2009-5#5)(2009-6#13)(2009-7#23)(2009-8#16)(2009-9#9)(2010-1#3)(2010-10#4)(2010-11#5)(2010-12#22)(2010-2#8)(2010-3#6)(2010-4#11)(2010-5#10)(2010-6#14)(2010-7#5)(2010-8#3)(2010-9#5)(2011-1#33)(2011-10#3)(2011-12#9)(2011-2#61)(2011-3#2)(2012-1#8)(2012-11#7)(2012-12#31)(2012-2#24)(2012-3#13)(2012-7#1)(2013-1#31)(2013-2#1)(2013-7#13)(2013-8#27)
side&quot##5##1##(1995-8#1)(2004-4#1)(2009-5#1)(2011-1#1)(2012-2#1)
side) and##2##2##(1991-1#1)(2008-8#1)
side) of##3##2##(1993-6#1)(1995-3#1)(2010-12#1)
side)##18##1##(1991-1#2)(1993-6#1)(1995-3#1)(1996-1#1)(2006-9#1)(2007-10#3)(2007-12#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
side-by-side to##2##2##(2008-6#1)(2012-1#1)
side-by-side##12##1##(1995-2#1)(2006-11#1)(2006-12#1)(2007-4#2)(2007-5#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2012-1#1)
side-chain cleavage of cholesterol in##2##5##(1990-3#1)(1991-10#1)
side-chain cleavage of##4##3##(1990-3#3)(1991-10#1)
side-chain cleavage##11##2##(1990-11#2)(1990-3#4)(1991-10#3)(1992-12#1)(1994-2#1)
side-chain conformations##2##2##(1997-4#1)(2012-3#1)
side-chain groups##2##2##(1996-4#1)(2006-12#1)
side-chain in##3##2##(1997-1#1)(1997-2#1)(2009-12#1)
side-chain of##4##2##(1994-9#1)(1996-11#1)(2008-4#1)(2008-8#1)
side-chain packing##4##2##(1992-6#1)(1994-9#1)(1995-8#1)(2012-3#1)
side-chain prediction methods##2##3##(2012-3#2)
side-chain prediction##5##2##(2012-3#5)
side-chain structure at##3##3##(1992-12#1)(1992-3#2)
side-chain volumes##3##2##(2006-10#3)
side-chain was##2##2##(1997-8#1)(2007-10#1)
side-chain##91##1##(1990-10#3)(1990-11#2)(1990-12#1)(1990-3#4)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#3)(1991-4#1)(1991-5#1)(1991-8#1)(1992-12#4)(1992-3#4)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-3#1)(1995-5#3)(1995-8#3)(1996-11#2)(1996-4#1)(1996-6#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-4#1)(2006-10#4)(2006-12#1)(2007-10#1)(2007-11#2)(2008-3#2)(2008-4#4)(2008-8#2)(2009-12#2)(2009-3#1)(2009-7#3)(2010-4#1)(2010-7#1)(2012-3#8)
side-chains in##2##2##(1990-9#1)(1997-7#1)
side-chains of Val37 and Trp103 are##2##6##(1996-6#2)
side-chains of##6##2##(1995-3#1)(1996-5#1)(1996-6#3)(2006-10#1)
side-chains##12##1##(1990-9#1)(1991-7#1)(1995-3#1)(1996-5#1)(1996-6#3)(1997-7#1)(2005-7#1)(2006-10#1)(2006-4#1)(2008-8#1)
side-diffraction##2##1##(2008-2#1)(2008-3#1)
side-effect of##8##2##(1990-6#1)(1993-4#1)(2006-1#1)(2006-2#1)(2008-12#1)(2008-4#1)(2008-6#1)(2012-3#1)
side-effect profile with##2##3##(1996-9#1)(2005-7#1)
side-effect profile##10##2##(1992-8#1)(1993-12#1)(1996-9#1)(2005-6#1)(2005-7#1)(2006-10#1)(2008-1#1)(2008-3#1)(2012-12#1)(2012-2#1)
side-effect profiles##4##2##(2006-10#2)(2009-6#1)(2011-1#1)
side-effect##29##1##(1990-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-4#2)(1996-9#1)(2005-6#1)(2005-7#1)(2006-1#1)(2006-10#4)(2006-2#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
side-effects and toxicity##3##3##(2008-8#1)(2008-9#2)
side-effects and##10##2##(2004-2#1)(2006-12#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-12#1)(2013-7#1)
side-effects are##6##2##(1993-8#1)(2005-7#4)(2008-3#1)
side-effects associated with##2##3##(2005-9#1)(2008-7#1)
side-effects in the##5##3##(1990-12#1)(1991-11#1)(2008-3#1)(2008-5#1)(2010-12#1)
side-effects in##8##2##(1990-12#1)(1991-11#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)
side-effects is##2##2##(1997-6#1)(2006-2#1)
side-effects may##2##2##(1995-7#1)(2010-12#1)
side-effects of opioids##2##3##(1995-5#1)(2006-10#1)
side-effects of the##2##3##(1993-11#1)(2013-8#1)
side-effects of these##2##3##(1993-11#1)(1995-5#1)
side-effects of##28##2##(1992-3#1)(1992-4#1)(1993-11#2)(1993-12#1)(1995-5#2)(1996-12#1)(1997-5#1)(1997-6#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-5#1)(2008-6#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
side-effects such as##3##3##(2006-10#1)(2008-5#1)(2010-12#1)
side-effects that##4##2##(2006-10#1)(2007-8#1)(2008-7#2)
side-effects were detected##2##3##(2004-10#1)(2008-10#1)
side-effects were observed in##2##4##(1990-6#1)(1994-12#1)
side-effects were observed##4##3##(1990-6#1)(1991-3#1)(1991-9#1)(1994-12#1)
side-effects were##12##2##(1990-6#1)(1991-11#1)(1991-3#1)(1991-9#1)(1993-2#1)(1994-12#1)(1995-9#1)(2004-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
side-effects##154##1##(1990-1#1)(1990-12#1)(1990-2#2)(1990-6#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-9#1)(1992-3#1)(1992-4#1)(1993-11#6)(1993-12#1)(1993-2#2)(1993-8#1)(1994-12#1)(1994-4#1)(1995-5#2)(1995-7#1)(1995-9#2)(1996-10#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#3)(2004-10#1)(2004-2#1)(2005-7#7)(2005-8#2)(2005-9#1)(2006-10#15)(2006-12#4)(2006-2#2)(2006-8#1)(2007-11#1)(2007-4#1)(2007-7#3)(2007-8#8)(2008-1#3)(2008-10#2)(2008-11#4)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#11)(2008-6#1)(2008-7#10)(2008-8#2)(2008-9#2)(2010-1#1)(2010-12#5)(2010-5#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#2)
side-impact airbag tests with##2##4##(2006-11#2)
side-impact airbag##3##2##(2006-11#3)
side-impact##4##1##(2006-11#3)(2007-4#1)
side-mode suppression ratio##3##3##(2007-11#1)(2007-12#2)
side-mode##5##1##(2007-11#1)(2007-12#3)(2008-3#1)
side-on##2##1##(2008-9#1)(2010-8#1)
side-port incision##2##2##(2007-1#2)
side-port##3##1##(2007-1#3)
side-pumped Nd##5##2##(2007-11#1)(2008-2#4)
side-pumped solid-state laser##3##3##(2008-3#3)
side-pumped solid-state lasers##2##3##(2008-3#2)
side-pumped solid-state##5##2##(2008-3#5)
side-pumped##13##1##(2007-11#2)(2007-12#2)(2008-2#4)(2008-3#5)
side-pumping scheme##2##2##(2007-12#1)(2008-2#1)
side-pumping##5##1##(2007-12#3)(2008-2#2)
side-to-side anastomosis##3##2##(1991-9#1)(2013-1#2)
side-to-side##9##1##(1990-5#1)(1991-9#2)(2007-7#1)(2012-2#1)(2012-3#1)(2013-1#3)
side-viewed faces##2##2##(2008-11#2)
side-ways##3##1##(2006-6#3)
sidearm##3##1##(2008-10#1)(2008-3#2)
sideband extraction##5##2##(2008-2#5)
sideband generation in##2##3##(2007-12#2)
sideband generation##6##2##(2007-11#2)(2007-12#4)
sideband instability in soliton transmissions##2##5##(2008-1#2)
sideband##36##1##(2007-11#7)(2007-12#14)(2008-1#3)(2008-2#8)(2008-3#4)
sidebands are##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
sidebands from##2##2##(2007-11#1)(2007-12#1)
sidebands in an##2##3##(2007-11#1)(2007-12#1)
sidebands in the##3##3##(2007-12#2)(2008-10#1)
sidebands in##6##2##(2007-11#2)(2007-12#3)(2008-10#1)
sidebands that##2##2##(2007-11#1)(2008-3#1)
sidebands##29##1##(2007-11#7)(2007-12#11)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#4)
sidechain##12##1##(1990-7#2)(1991-12#3)(1994-11#1)(1995-4#2)(2008-2#1)(2008-9#1)(2009-7#1)(2010-8#1)
sidechains##4##1##(1995-4#2)(2008-4#1)(2013-8#1)
sided chest##2##2##(1997-8#1)(2007-8#1)
sided endocarditis##2##2##(2007-8#1)(2011-2#1)
sided hemiplegia##2##2##(2006-4#1)(2011-1#1)
sided pleural effusion##4##3##(2008-1#1)(2010-11#1)(2012-2#2)
sided##35##1##(1997-6#1)(1997-8#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-8#7)(2007-9#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-11#2)(2010-12#1)(2011-1#2)(2011-2#4)(2012-2#5)(2013-1#2)(2013-8#2)
sidelines##2##1##(1995-1#1)(1997-5#1)
sidelobe control##2##2##(2008-3#2)
sidelobe suppression##3##2##(2008-2#1)(2008-3#2)
sidelobe##7##1##(2008-2#2)(2008-3#4)(2012-3#1)
sidelobes and##2##2##(2008-2#1)(2008-3#1)
sidelobes of##2##2##(2008-2#2)
sidelobes##7##1##(2007-11#2)(2008-2#4)(2008-3#1)
sideroblastic anemia##2##2##(1994-9#1)(2005-8#1)
sideroblastic##3##1##(1994-9#1)(2005-8#1)(2007-5#1)
siderophore biosynthesis##2##2##(1996-10#1)(2008-10#1)
siderophore complexation##2##2##(2013-1#2)
siderophore production##3##2##(2008-10#2)(2013-1#1)
siderophore##25##1##(1995-10#1)(1996-10#3)(1996-2#1)(1996-4#1)(1997-4#2)(2008-10#9)(2011-2#3)(2013-1#5)
siderophores production##2##2##(2006-10#2)
siderophores##5##1##(1996-8#1)(2006-10#2)(2008-10#1)(2013-1#1)
siderosis of the central nervous system secondary to a thalamic hamartoma##2##11##(2008-7#2)
siderosis of the central nervous system##3##6##(2007-10#1)(2008-7#2)
siderosis##4##1##(2007-10#1)(2008-7#3)
sideroxol##2##1##(2007-10#2)
sides after##2##2##(2007-7#1)(2013-1#1)
sides and##6##2##(1996-2#1)(2006-10#2)(2007-4#1)(2007-5#1)(2012-2#1)
sides are##2##2##(2007-12#1)(2008-3#1)
sides at##3##2##(2007-7#1)(2008-10#1)(2013-1#1)
sides of the membrane##5##4##(1990-11#1)(1993-3#1)(1995-1#1)(1995-6#1)(2008-10#1)
sides of the root system##2##5##(2008-10#2)
sides of the root##3##4##(2008-10#3)
sides of the same##2##4##(2012-4#1)(2013-8#1)
sides of the spinal cord##4##5##(1990-7#1)(1995-11#1)(1995-7#1)(2008-7#1)
sides of the triangle##2##4##(2010-12#1)(2011-2#1)
sides of the##71##3##(1990-11#1)(1990-2#1)(1990-7#1)(1991-2#2)(1991-6#1)(1991-8#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-6#1)(1995-7#1)(1995-8#1)(1997-1#2)(2005-11#1)(2005-7#1)(2006-11#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#4)(2008-4#3)(2008-6#1)(2008-7#2)(2009-10#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-4#1)(2013-7#1)(2013-8#2)
sides of##85##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-2#3)(1991-6#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#1)(1997-1#2)(1997-8#1)(2004-11#1)(2005-11#2)(2005-4#1)(2005-7#1)(2006-11#1)(2006-4#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#6)(2008-3#4)(2008-4#3)(2008-6#1)(2008-7#2)(2009-10#2)(2009-12#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-4#1)(2013-7#1)(2013-8#2)
sides was##2##2##(2007-8#2)
sides were##3##2##(2007-3#1)(2008-8#1)(2010-4#1)
sides with##4##2##(1993-3#1)(1995-10#1)(2007-8#1)(2008-3#1)
sides##163##1##(1990-11#1)(1990-2#1)(1990-7#1)(1991-10#1)(1991-2#3)(1991-6#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#3)(1994-12#1)(1994-2#1)(1995-1#3)(1995-10#1)(1995-11#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-6#1)(1997-8#1)(2004-11#1)(2005-10#2)(2005-11#2)(2005-4#1)(2005-7#1)(2006-10#4)(2006-11#3)(2006-4#1)(2006-6#1)(2006-8#4)(2007-10#3)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#2)(2007-8#6)(2007-9#2)(2008-1#4)(2008-10#12)(2008-11#2)(2008-2#7)(2008-3#7)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#3)(2009-1#1)(2009-10#2)(2009-12#1)(2009-6#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#3)(2013-7#2)(2013-8#2)
sidewall##6##1##(2006-6#1)(2007-11#1)(2007-12#1)(2008-3#3)
sidewalls and##2##2##(2008-11#1)(2008-3#1)
sidewalls##10##1##(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2010-7#1)
sideways##6##1##(1994-9#1)(2007-12#1)(2008-10#3)(2008-11#1)
sieboldii##2##1##(2007-1#1)(2011-1#1)
siege##3##1##(1996-12#1)(2013-7#2)
sieve elements##4##2##(2008-10#4)
sieve tubes##2##2##(2008-10#1)(2009-8#1)
sieve##27##1##(1990-9#3)(1991-2#1)(1996-8#1)(2005-11#3)(2007-6#1)(2008-10#10)(2008-11#2)(2008-5#2)(2009-8#2)(2010-6#1)(2013-7#1)
sieve-plate occlusion##2##2##(2009-8#2)
sieved to obtain##2##3##(2004-9#1)(2008-10#1)
sieved##5##1##(2004-9#1)(2008-10#4)
sieves##6##1##(1994-3#1)(2007-2#1)(2007-6#1)(2008-10#3)
sieving coefficient##3##2##(2010-5#2)(2011-1#1)
sieving on##2##2##(1990-2#2)
sieving structure for##2##3##(2008-7#2)
sieving structure##3##2##(2008-7#3)
sieving##21##1##(1990-2#2)(1991-1#1)(1996-8#1)(2004-9#1)(2007-8#1)(2008-10#6)(2008-7#6)(2010-5#2)(2011-1#1)
sight and##6##2##(1991-5#4)(2010-8#1)(2011-2#1)
sight in##3##2##(1993-11#1)(2008-9#1)(2011-2#1)
sight of the##4##3##(2008-3#1)(2008-5#2)(2009-5#1)
sight of their##3##3##(1992-10#1)(2008-2#1)(2008-3#1)
sight of##12##2##(1992-10#1)(1993-6#3)(1994-6#1)(2008-2#1)(2008-3#2)(2008-5#2)(2009-5#1)(2012-2#1)
sight threatening##4##2##(2005-11#1)(2009-4#1)(2010-10#1)(2011-1#1)
sight##56##1##(1990-3#1)(1991-2#1)(1991-5#6)(1992-1#1)(1992-10#1)(1993-11#1)(1993-6#3)(1994-6#1)(1995-8#1)(1996-11#1)(1996-3#1)(1997-6#1)(2005-11#3)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-2#4)(2008-3#5)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#2)(2009-5#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)
sight-threatening##6##1##(2005-8#1)(2007-11#1)(2008-4#1)(2012-3#1)(2013-7#2)
sighted##4##1##(1990-11#2)(2009-3#2)
sighting of##2##2##(2008-3#1)(2008-4#1)
sighting##3##1##(2007-3#1)(2008-3#1)(2008-4#1)
sights##3##1##(1997-2#1)(2006-7#1)(2009-4#1)
siginificantly##2##1##(2006-9#1)(2011-2#1)
sigma 1##5##2##(1990-8#2)(1993-11#1)(1993-9#1)(1994-9#1)
sigma 32##3##2##(1990-3#1)(1992-4#1)(1993-11#1)
sigma 35##2##2##(1993-12#2)
sigma 70 and NusA##2##4##(1990-8#2)
sigma 70 and##3##3##(1990-8#2)(1992-4#1)
sigma 70 subunit##3##3##(1995-2#2)(1995-8#1)
sigma 70##9##2##(1990-3#1)(1990-8#2)(1992-4#1)(1993-12#1)(1994-12#1)(1995-2#2)(1995-8#1)
sigma 70-dependent##2##2##(1995-2#2)
sigma = 0##2##3##(1996-12#1)(2008-3#1)
sigma = 3##2##3##(1996-12#2)
sigma =##5##2##(1996-12#4)(2008-3#1)
sigma A##2##2##(1993-9#2)
sigma B2 has##2##3##(1996-3#2)
sigma B2##4##2##(1996-3#4)
sigma H##4##2##(1990-12#4)
sigma and dopamine##2##3##(1990-2#1)(1996-10#1)
sigma and##5##2##(1990-2#1)(1991-6#1)(1994-3#1)(1996-10#1)(2006-10#1)
sigma binding in##2##3##(1994-3#2)
sigma binding##5##2##(1992-12#1)(1994-3#3)(1996-8#1)
sigma factor##11##2##(1990-12#1)(1990-3#1)(1990-6#1)(1991-7#1)(1993-12#3)(1997-4#1)(1997-5#1)(2005-11#1)(2012-2#1)
sigma factors##2##2##(1990-11#1)(1996-4#1)
sigma is##2##2##(1994-9#1)(2008-10#1)
sigma ligand##4##2##(1991-2#1)(1993-11#1)(1994-5#1)(1996-8#1)
sigma ligands in##3##3##(1991-2#1)(1994-5#2)
sigma ligands##16##2##(1990-2#1)(1991-1#2)(1991-2#2)(1993-11#1)(1994-5#7)(1997-5#3)
sigma receptor##13##2##(1990-2#1)(1993-11#1)(1994-9#1)(1995-12#1)(1996-10#2)(1996-12#2)(1996-8#1)(1997-5#1)(1997-7#1)(2008-3#2)
sigma receptors##10##2##(1990-2#4)(1993-11#1)(1996-10#1)(1996-12#4)
sigma sites in##3##3##(1994-3#3)
sigma sites##9##2##(1992-12#1)(1994-3#5)(1995-12#1)(1996-8#1)(1997-5#1)
sigma subunit of##2##3##(1991-5#1)(1994-12#1)
sigma subunit##3##2##(1991-5#1)(1992-4#1)(1994-12#1)
sigma##171##1##(1990-11#1)(1990-12#6)(1990-2#9)(1990-3#5)(1990-6#1)(1990-7#1)(1990-8#4)(1991-1#2)(1991-2#5)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-4#5)(1992-5#1)(1993-11#8)(1993-12#9)(1993-8#2)(1993-9#3)(1994-12#3)(1994-3#11)(1994-5#10)(1994-9#3)(1995-12#3)(1995-2#7)(1995-3#3)(1995-6#3)(1995-8#1)(1996-10#5)(1996-12#10)(1996-3#5)(1996-4#1)(1996-8#4)(1997-4#2)(1997-5#6)(1997-7#2)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-3#4)(2009-2#1)(2010-12#1)(2012-2#4)
sigma(0)##4##1##(2006-7#1)(2008-5#3)
sigma(2)##3##1##(2007-12#3)
sigma(I))##3##1##(1997-7#2)(2008-5#1)
sigma(X)##2##1##(2008-1#2)
sigma(c) =##2##2##(2006-7#1)(2007-12#1)
sigma)##3##1##(1990-7#1)(1991-12#1)(2007-12#1)
sigma-1 and sigma-2##2##3##(1996-8#1)(2008-3#1)
sigma-1 receptor##5##2##(2008-3#4)(2011-2#1)
sigma-1 receptors##6##2##(2008-3#6)
sigma-1##15##1##(1996-8#3)(2008-3#11)(2011-2#1)
sigma-2##3##1##(1996-8#2)(2008-3#1)
sigma-70##2##1##(1995-8#2)
sigma-ADH##2##1##(1994-8#2)
sigma-bonded##2##1##(1994-12#1)(1996-2#1)
sigma-factor##2##1##(1990-4#1)(2009-8#1)
sigma1 binding##2##2##(1995-12#1)(1995-9#1)
sigma1 receptor ligand##2##3##(1996-12#2)
sigma1 receptor##4##2##(1995-12#2)(1996-12#2)
sigma1 receptors##4##2##(1995-12#2)(1996-12#1)(1997-5#1)
sigma1##13##1##(1995-12#7)(1995-9#1)(1996-12#3)(1997-5#2)
sigma2 binding##2##2##(1995-12#1)(1997-5#1)
sigma2 receptor##2##2##(1995-12#1)(1997-5#1)
sigma2 sites##2##2##(1995-12#2)
sigma2##8##1##(1995-12#5)(1997-5#3)
sigma3 protein##3##2##(1997-6#3)
sigmoid adenocarcinoma##2##2##(1994-10#1)(2013-1#1)
sigmoid and##3##2##(1991-6#1)(2006-2#1)(2008-10#1)
sigmoid carcinoma##2##2##(1990-6#1)(2006-4#1)
sigmoid colon and rectum##3##4##(1991-6#1)(1993-9#1)(2013-8#1)
sigmoid colon and##4##3##(1991-6#1)(1993-9#1)(2011-11#1)(2013-8#1)
sigmoid colon cancer##3##3##(2008-10#1)(2012-12#1)(2013-1#1)
sigmoid colon fistula##2##3##(2012-12#2)
sigmoid colon was##2##3##(2011-11#1)(2011-2#1)
sigmoid colon##34##2##(1991-4#2)(1991-6#1)(1993-10#1)(1993-9#1)(1997-5#1)(2004-10#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-5#1)(2008-10#1)(2008-12#2)(2008-4#1)(2009-6#1)(2010-12#2)(2010-5#2)(2011-11#3)(2011-2#3)(2012-1#2)(2012-12#3)(2013-1#2)(2013-8#1)
sigmoid diverticular disease##2##3##(2010-2#2)
sigmoid diverticular##3##2##(2010-2#3)
sigmoid function##2##2##(2008-10#1)(2008-2#1)
sigmoid notch##8##2##(2008-9#1)(2012-2#7)
sigmoid sinus##3##2##(1996-6#1)(1996-9#1)(2008-7#1)
sigmoid volvulus##4##2##(1993-5#2)(2011-11#2)
sigmoid##88##1##(1990-6#1)(1991-10#1)(1991-4#2)(1991-6#2)(1992-5#1)(1993-10#1)(1993-5#2)(1993-9#1)(1994-10#1)(1994-8#1)(1996-6#1)(1996-9#1)(1997-5#1)(2004-10#1)(2006-2#2)(2006-4#4)(2006-8#1)(2007-5#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-6#1)(2010-10#1)(2010-12#3)(2010-2#4)(2010-5#3)(2010-8#3)(2011-11#5)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#7)(2013-1#4)(2013-8#1)
sigmoidal in shape##2##3##(1997-1#1)(1997-7#1)
sigmoidal kinetics with##2##3##(1991-7#1)(1995-3#1)
sigmoidal kinetics##3##2##(1990-5#1)(1991-7#1)(1995-3#1)
sigmoidal##21##1##(1990-5#1)(1991-1#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-6#1)(1994-2#1)(1995-2#1)(1995-3#1)(1997-1#1)(1997-6#1)(1997-7#1)(2008-10#4)(2008-8#1)(2010-5#1)(2013-8#2)
sigmoidectomy for##2##2##(2008-10#1)(2009-1#1)
sigmoidectomy##4##1##(2008-10#1)(2009-1#3)
sigmoidoscopy##7##1##(1995-10#1)(1995-9#2)(2007-7#1)(2010-6#1)(2011-1#1)(2013-7#1)
sign and magnitude of the##4##5##(1994-11#1)(1997-7#1)(2008-10#1)(2008-8#1)
sign and the##2##3##(2006-4#1)(2008-2#1)
sign and##15##2##(1991-8#1)(1994-11#1)(1995-4#1)(1997-7#1)(2006-1#1)(2006-4#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-12#1)(2012-12#2)(2013-8#1)
sign are##2##2##(2007-11#1)(2009-2#1)
sign disappeared in##2##3##(2007-7#1)(2008-9#1)
sign for##3##2##(2007-12#1)(2008-10#1)(2012-12#1)
sign in##7##2##(2005-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-6#1)(2012-12#1)
sign indicating##2##2##(2012-12#2)
sign is a##2##3##(1990-6#1)(2013-7#1)
sign is##9##2##(1990-6#1)(1991-10#1)(2006-10#1)(2007-11#1)(2007-7#1)(2012-12#1)(2013-1#2)(2013-7#1)
sign language##6##2##(1997-5#1)(1997-8#1)(2010-5#2)(2011-2#1)(2012-1#1)
sign languages##2##2##(2010-5#1)(2012-1#1)
sign of a possible##2##4##(1993-5#1)(1994-6#1)
sign of a##8##3##(1991-2#1)(1993-5#1)(1994-6#1)(2006-9#1)(2007-8#1)(2008-9#1)(2012-12#1)(2013-8#1)
sign of an##5##3##(1996-1#1)(1996-3#1)(2005-11#1)(2011-1#1)(2011-2#1)
sign of disease##2##3##(2007-2#1)(2013-1#1)
sign of recurrence##3##3##(2006-2#1)(2011-2#1)(2012-3#1)
sign of such##2##3##(1991-11#1)(2006-3#1)
sign of the CD##2##4##(1995-4#2)
sign of the##24##3##(1995-4#2)(1997-1#1)(2007-11#2)(2007-12#2)(2007-8#1)(2007-9#1)(2008-3#6)(2008-7#1)(2008-8#1)(2009-4#1)(2009-7#1)(2009-8#1)(2011-2#3)(2013-8#1)
sign of urinary##2##3##(2007-2#1)(2009-7#1)
sign of##135##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-4#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-2#1)(1993-5#1)(1994-3#1)(1994-6#1)(1994-7#1)(1995-11#2)(1995-4#2)(1995-8#1)(1996-1#1)(1996-3#1)(1997-1#1)(2005-11#1)(2005-12#1)(2006-10#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-11#3)(2007-12#7)(2007-2#4)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#7)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#9)(2012-12#4)(2012-2#6)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
sign on##2##2##(2007-8#1)(2009-2#1)
sign rule##2##2##(2007-11#2)
sign score regression method is##2##5##(1995-2#2)
sign score regression method##3##4##(1995-2#3)
sign score regression##5##3##(1995-2#5)
sign that##2##2##(1997-8#1)(2010-6#1)
sign to##2##2##(1995-3#1)(2008-9#1)
sign was##3##2##(1991-8#1)(2013-7#2)
sign##266##1##(1990-11#2)(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#4)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-5#3)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-11#2)(1995-2#5)(1995-3#1)(1995-4#4)(1995-6#1)(1995-8#2)(1996-1#3)(1996-11#2)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#2)(2005-11#2)(2005-12#2)(2005-7#2)(2005-9#3)(2006-1#1)(2006-10#5)(2006-2#1)(2006-3#1)(2006-4#2)(2006-7#1)(2006-8#2)(2006-9#2)(2007-11#11)(2007-12#11)(2007-2#6)(2007-5#1)(2007-7#5)(2007-8#10)(2007-9#2)(2008-1#4)(2008-10#7)(2008-11#1)(2008-12#3)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#5)(2009-10#1)(2009-2#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-5#3)(2010-6#2)(2010-7#4)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#11)(2012-1#2)(2012-12#14)(2012-2#10)(2012-3#2)(2013-1#8)(2013-7#4)(2013-8#4)
sign&quot##4##1##(1993-9#1)(2005-11#2)(2012-12#1)
sign)##5##1##(1995-3#1)(2006-2#1)(2008-3#2)(2009-7#1)
sign-out note content##3##3##(2011-1#3)
sign-out note##4##2##(2011-1#4)
sign-out notes##2##2##(2011-1#2)
sign-out##13##1##(2010-12#4)(2011-1#9)
signal a##4##2##(1997-2#1)(2005-11#1)(2006-7#1)(2011-1#1)
signal abnormalities##2##2##(2008-7#1)(2009-10#1)
signal across the plasma membrane##3##5##(2008-9#2)(2009-6#1)
signal across the##4##3##(2008-3#1)(2008-9#2)(2009-6#1)
signal after##3##2##(1992-2#1)(1996-6#1)(2010-4#1)
signal alterations in##3##3##(2008-1#1)(2011-1#1)(2012-12#1)
signal amplification##14##2##(1994-6#1)(1996-2#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-4#2)(2008-9#3)(2010-2#1)(2011-1#1)
signal amplitude##6##2##(1990-5#1)(1996-2#1)(2008-3#3)(2009-11#1)
signal amplitudes##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
signal analysis##7##2##(2007-12#3)(2008-2#1)(2008-7#1)(2008-8#1)(2011-1#1)
signal and 2##2##3##(2007-11#1)(2007-12#1)
signal and a##5##3##(2006-7#1)(2007-12#1)(2008-3#2)(2011-2#1)
signal and coding##3##3##(1995-1#1)(1997-7#1)(2013-1#1)
signal and has##3##3##(1991-11#1)(1992-6#1)(2008-3#1)
signal and idler beams##2##4##(2008-1#1)(2008-2#1)
signal and idler pulses##2##4##(2007-11#1)(2007-12#1)
signal and idler wavelengths##3##4##(2007-11#1)(2008-1#1)(2008-2#1)
signal and idler waves are##2##5##(2007-12#2)
signal and idler##19##3##(2007-11#4)(2007-12#10)(2008-1#2)(2008-2#3)
signal and noise##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
signal and pump beams##2##4##(2008-1#2)
signal and reference##2##3##(2007-1#1)(2008-2#1)
signal and the idler output##2##5##(2007-12#2)
signal and the idler##10##4##(2007-11#1)(2007-12#6)(2008-1#1)(2008-2#1)(2008-3#1)
signal and the local oscillator##2##5##(2008-1#1)(2008-2#1)
signal and the##31##3##(1992-12#1)(1994-12#1)(2007-11#5)(2007-12#7)(2008-1#2)(2008-10#1)(2008-2#6)(2008-3#5)(2010-8#1)(2012-1#1)(2013-1#1)
signal and to##2##3##(2008-1#1)(2008-2#1)
signal and##121##2##(1990-3#1)(1991-11#1)(1991-12#1)(1992-12#1)(1992-6#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-4#1)(1997-2#1)(1997-7#1)(1997-8#2)(2006-7#1)(2007-1#1)(2007-11#11)(2007-12#26)(2007-8#1)(2008-1#9)(2008-10#3)(2008-11#1)(2008-2#15)(2008-3#19)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)
signal are##11##2##(1994-12#3)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#1)
signal as a function of##3##5##(2008-1#1)(2008-2#1)(2008-3#1)
signal as a##4##3##(2008-1#1)(2008-2#1)(2008-3#1)(2011-1#1)
signal as the##2##3##(2007-11#1)(2007-12#1)
signal as well##2##3##(2008-10#1)(2008-5#1)
signal as##11##2##(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#1)
signal at 1##3##3##(1997-2#1)(2007-12#1)(2008-3#1)
signal at a##4##3##(2006-4#1)(2007-12#1)(2007-3#1)(2008-3#1)
signal at g = 2##2##5##(1990-7#2)
signal at g =##5##4##(1990-7#4)(1995-10#1)
signal at g##7##3##(1990-3#1)(1990-7#4)(1992-9#1)(1995-10#1)
signal at the##5##3##(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
signal at##36##2##(1990-3#1)(1990-6#1)(1990-7#4)(1992-9#1)(1993-8#1)(1994-5#1)(1995-10#1)(1995-12#1)(1997-2#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-8#1)(2008-10#5)(2008-2#2)(2008-3#8)
signal attenuation measured##4##3##(2013-1#4)
signal averaging##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
signal bandwidth##4##2##(2007-3#1)(2008-2#2)(2008-3#1)
signal based##2##2##(2008-10#2)
signal beam and##2##3##(2007-12#2)
signal beam can be##2##4##(2007-12#2)
signal beam##14##2##(2007-12#7)(2008-1#1)(2008-2#1)(2008-3#5)
signal beams in##2##3##(2007-12#2)
signal beams##5##2##(2007-12#3)(2008-1#1)(2008-2#1)
signal becomes##3##2##(2008-2#1)(2008-3#2)
signal behavior##2##2##(1997-8#1)(2008-3#1)
signal between##4##2##(2007-12#2)(2008-10#1)(2012-3#1)
signal binding##2##2##(1995-1#1)(2007-11#1)
signal by the##3##3##(2008-3#2)(2011-2#1)
signal by##16##2##(1993-6#1)(2007-11#2)(2007-12#2)(2007-9#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-9#1)(2009-4#1)(2011-2#1)
signal can be##13##3##(1991-12#1)(1995-4#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-4#1)(2008-5#1)(2012-12#1)
signal can##17##2##(1991-12#1)(1995-4#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-6#1)(2012-12#1)
signal cascade##3##2##(2009-8#1)(2011-1#1)(2012-12#1)
signal caused by##2##3##(2007-11#1)(2008-2#1)
signal chain##2##2##(1990-5#1)(2008-10#1)
signal change##10##2##(1994-8#1)(2008-10#1)(2008-2#2)(2008-7#1)(2010-5#2)(2011-1#1)(2012-1#1)(2012-12#1)
signal changes in the spinal cord##2##6##(2008-5#2)
signal changes in##3##3##(2008-5#2)(2008-6#1)
signal changes##10##2##(2007-10#1)(2008-10#1)(2008-5#3)(2008-6#1)(2011-1#1)(2012-12#2)(2013-8#1)
signal characteristics##9##2##(1991-12#1)(1996-12#1)(2007-11#1)(2008-2#2)(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
signal classification##2##2##(2008-2#1)(2009-10#1)
signal collected##2##2##(2008-10#1)(2012-2#1)
signal components##2##2##(2009-6#1)(2010-5#1)
signal contains##2##2##(2008-2#1)(2008-3#1)
signal contamination##2##2##(2008-3#2)
signal contrast##3##2##(2007-12#2)(2009-6#1)
signal contributions##2##2##(2007-12#1)(2008-2#1)
signal correction (OSC)##2##3##(2008-10#2)
signal correction##3##2##(2007-8#1)(2008-10#2)
signal corresponding to##2##3##(2005-12#1)(2007-2#1)
signal cost is inversely related to the##2##7##(2008-9#2)
signal cost is##4##3##(2008-9#2)(2013-8#2)
signal costs##4##2##(2008-8#1)(2013-8#3)
signal could be##4##3##(1992-8#1)(2008-2#1)(2008-7#1)(2008-9#1)
signal could##5##2##(1992-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)
signal data##3##2##(2008-10#1)(2010-8#2)
signal decrease that was due to photobleaching##2##7##(2008-3#2)
signal decreased##2##2##(2008-10#2)
signal decreases##2##2##(2008-2#1)(2011-2#1)
signal delay##2##2##(2008-3#2)
signal demodulation at##2##3##(2006-12#1)(2007-12#1)
signal depends on the##2##4##(2007-11#1)(2008-10#1)
signal depends on##3##3##(2007-11#1)(2008-10#2)
signal depends##5##2##(2007-11#1)(2007-12#1)(2008-10#3)
signal derived from##2##3##(1997-7#1)(2007-12#1)
signal detected##4##2##(2007-11#1)(2008-10#2)(2008-11#1)
signal detection in##2##3##(2007-12#1)(2008-9#1)
signal detection is##3##3##(2008-2#1)(2013-1#2)
signal detection of##2##3##(2008-3#1)(2010-6#1)
signal detection theory##3##3##(1992-11#1)(1994-3#1)(1997-5#1)
signal detection##22##2##(1992-11#1)(1994-3#1)(1997-5#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#4)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-6#1)(2013-1#2)
signal deterioration##2##2##(2008-10#2)
signal differentiation##3##2##(2008-3#1)(2008-4#2)
signal directly##2##2##(1994-12#1)(2008-3#1)
signal does not##2##3##(1995-1#1)(2008-2#1)
signal dominance##2##2##(2009-6#2)
signal drift##2##2##(2010-7#1)(2013-8#1)
signal due to##3##3##(1997-2#1)(2008-4#1)(2011-1#1)
signal during##5##2##(1994-5#1)(2007-12#1)(2008-10#2)(2008-11#1)
signal energy##3##2##(2008-2#3)
signal enhancement##3##2##(2007-12#1)(2008-10#2)
signal evolution##2##2##(1995-5#1)(2008-9#1)
signal exhibits##2##2##(2008-3#2)
signal extraction##3##2##(2008-1#2)(2008-2#1)
signal fidelity##3##2##(2007-12#1)(2008-2#2)
signal fields##2##2##(2007-12#2)
signal fluctuation##5##2##(2008-10#1)(2008-2#4)
signal for phase-change##2##3##(2008-2#2)
signal for the##7##3##(1994-12#1)(2005-8#1)(2008-10#3)(2008-2#1)(2008-9#1)
signal for##45##2##(1990-12#1)(1991-6#1)(1991-7#2)(1992-2#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-3#1)(1997-1#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-5#1)(2008-10#9)(2008-11#3)(2008-2#4)(2008-3#1)(2008-4#1)(2008-9#1)(2009-8#2)(2012-3#1)
signal frequency##3##2##(2007-12#2)(2008-3#1)
signal from a##9##3##(2005-11#1)(2007-12#4)(2008-10#1)(2008-2#2)(2008-3#1)
signal from any##2##3##(2008-12#1)(2008-4#1)
signal from the sample##3##4##(2007-12#1)(2008-10#2)
signal from the##25##3##(1990-12#1)(1990-9#1)(1992-12#1)(1993-6#2)(2007-11#2)(2007-12#3)(2007-6#1)(2008-10#4)(2008-11#2)(2008-2#4)(2008-8#1)(2009-6#1)(2012-12#2)
signal from which##2##3##(2007-11#1)(2008-2#1)
signal from##59##2##(1990-12#1)(1990-3#1)(1990-9#1)(1992-12#1)(1993-6#2)(1994-12#2)(1995-1#1)(1995-2#2)(1996-8#1)(1997-4#1)(2005-11#1)(2007-11#4)(2007-12#8)(2007-6#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#8)(2008-3#2)(2008-4#2)(2008-8#1)(2009-6#2)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#1)
signal function##3##2##(2008-8#1)(2008-9#1)(2009-6#1)
signal gain and##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
signal gain of##2##3##(2007-12#1)(2008-2#1)
signal gain##6##2##(2007-12#2)(2008-2#2)(2008-3#1)(2010-9#1)
signal generated by the##5##4##(1991-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)
signal generated by##8##3##(1991-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-12#2)
signal generated##11##2##(1991-3#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#1)(2012-12#2)
signal generation and##4##3##(1993-3#1)(2006-6#1)(2007-8#1)(2011-2#1)
signal generation##11##2##(1992-12#1)(1993-3#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2009-2#1)(2009-8#1)(2010-9#1)(2011-2#1)
signal generator##4##2##(2006-6#1)(2008-7#3)
signal has been investigated##2##4##(2008-10#1)(2008-3#1)
signal has been##6##3##(2005-4#1)(2008-10#1)(2008-3#2)(2010-8#1)(2013-8#1)
signal has##10##2##(1997-7#1)(2005-4#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-7#1)(2010-8#1)(2013-8#1)
signal have been proposed##2##4##(2008-2#1)(2012-2#1)
signal have been##3##3##(2008-2#1)(2008-4#1)(2012-2#1)
signal height and the##2##4##(2007-8#1)(2008-10#1)
signal height##6##2##(1993-8#1)(2007-8#2)(2008-10#3)
signal in a##4##3##(2007-11#2)(2007-9#1)(2013-1#1)
signal in an optical disk drive##2##6##(2008-2#1)(2008-3#1)
signal in an optical##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
signal in an##6##3##(2007-12#2)(2008-2#2)(2008-3#2)
signal in plants##3##3##(1994-3#1)(2008-8#2)
signal in the presence of##2##5##(1993-12#1)(2011-1#1)
signal in the##27##3##(1991-12#1)(1993-12#1)(1995-3#1)(1996-12#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-3#5)(2011-1#1)(2012-12#2)
signal in tissue##2##3##(2012-12#2)
signal in##74##2##(1991-12#2)(1991-2#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-2#3)(1995-3#1)(1996-12#1)(1996-5#1)(1997-6#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-11#4)(2007-12#4)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#5)(2008-2#5)(2008-3#9)(2008-8#3)(2009-10#1)(2009-3#1)(2009-5#1)(2009-9#1)(2011-1#2)(2012-12#6)(2013-1#1)
signal increase##3##2##(1996-2#1)(1997-8#1)(2008-10#1)
signal increased##3##2##(1994-8#1)(2008-9#1)(2010-4#1)
signal increases##3##2##(1992-9#1)(2008-2#1)(2009-3#1)
signal induced by##3##3##(1990-11#1)(1994-3#1)(2008-10#1)
signal integration##3##2##(2008-3#1)(2009-8#1)(2010-12#1)
signal intensities are used to measure##2##6##(2008-3#2)
signal intensities are##4##3##(2008-3#4)
signal intensities of the##2##4##(2012-3#1)(2013-8#1)
signal intensities of##3##3##(2006-8#1)(2012-3#1)(2013-8#1)
signal intensities on##2##3##(2006-1#1)(2009-11#1)
signal intensities##13##2##(2006-1#1)(2006-8#1)(2008-10#3)(2008-2#1)(2008-3#4)(2009-11#1)(2012-3#1)(2013-8#1)
signal intensity (SI) on different pulse sequences##2##7##(1997-8#1)(2012-2#1)
signal intensity and##10##3##(1992-3#1)(2008-2#1)(2008-3#3)(2013-1#5)
signal intensity appeared on T1-weighted images##2##6##(2006-5#2)
signal intensity at b = 0##2##6##(2009-11#2)
signal intensity enhancement##2##3##(2008-7#2)
signal intensity in the##5##4##(1991-11#2)(2007-10#1)(2007-11#1)(2009-3#1)
signal intensity in##7##3##(1991-11#2)(2007-10#1)(2007-11#1)(2009-3#1)(2010-2#1)(2013-8#1)
signal intensity is##3##3##(1995-1#1)(2007-12#1)(2013-1#1)
signal intensity of##2##3##(2008-3#1)(2012-3#1)
signal intensity on T1-weighted##2##4##(1991-11#1)(2012-2#1)
signal intensity on T2-weighted images##3##5##(1991-11#1)(2008-6#2)
signal intensity on##12##3##(1991-11#2)(1997-8#3)(2008-2#1)(2008-6#2)(2009-11#2)(2011-2#1)(2012-2#1)
signal intensity was##2##3##(2008-10#1)(2008-2#1)
signal intensity with##2##3##(2008-3#1)(2013-1#1)
signal intensity##74##2##(1991-11#6)(1992-3#1)(1992-9#1)(1995-1#1)(1996-2#1)(1997-8#4)(2006-1#1)(2006-5#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#6)(2008-2#4)(2008-3#10)(2008-6#2)(2008-7#4)(2009-11#5)(2009-3#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#8)(2013-8#1)
signal into a##2##3##(2007-12#1)(2010-12#1)
signal into##7##2##(1990-12#1)(1997-3#1)(2007-12#1)(2008-11#1)(2008-9#1)(2010-12#1)(2011-1#1)
signal is a##3##3##(1993-6#1)(2008-10#2)
signal is also##5##3##(1991-7#1)(1994-5#1)(2006-5#1)(2008-2#1)(2008-3#1)
signal is an##3##3##(1992-6#1)(2008-2#1)(2008-3#1)
signal is collected##2##3##(2008-3#2)
signal is converted##2##3##(2008-10#1)(2008-3#1)
signal is correlated##2##3##(1991-7#1)(2008-10#1)
signal is demonstrated##2##3##(2007-12#1)(2008-3#1)
signal is derived##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
signal is detected by use of a##3##7##(1995-3#1)(2007-12#1)(2008-3#1)
signal is detected by##4##4##(1995-3#1)(2007-12#1)(2008-3#2)
signal is detected##7##3##(1995-3#1)(2007-12#3)(2008-2#1)(2008-3#2)
signal is directly##3##3##(2008-10#2)(2008-11#1)
signal is measured##2##3##(2007-11#1)(2008-10#1)
signal is not##5##3##(1994-5#1)(2007-5#1)(2008-2#3)
signal is obtained##3##3##(1990-9#1)(2008-10#1)(2008-3#1)
signal is required##2##3##(1995-1#1)(2010-11#1)
signal is sensitive to##2##4##(2008-2#1)(2008-4#1)
signal is sufficient to##2##4##(1994-11#1)(2008-2#1)
signal is the##2##3##(1990-6#1)(2008-2#1)
signal is thought to lead##2##5##(1990-5#2)
signal is transmitted##2##3##(1993-3#1)(2008-3#1)
signal is##127##2##(1990-5#2)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-7#3)(1992-12#1)(1992-5#1)(1992-6#1)(1993-3#2)(1993-6#3)(1994-11#1)(1994-5#3)(1995-1#2)(1995-2#1)(1995-3#1)(1996-4#1)(1997-3#1)(2006-5#1)(2007-11#6)(2007-12#10)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#13)(2008-11#1)(2008-2#28)(2008-3#23)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-3#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-12#2)
signal level in##3##3##(1997-1#1)(2008-3#1)(2009-5#1)
signal level##4##2##(1997-1#1)(2008-2#1)(2008-3#1)(2009-5#1)
signal levels##10##2##(1990-9#1)(2008-2#2)(2008-3#6)(2009-4#1)
signal ligand-dependent##2##2##(1995-3#2)
signal light##7##2##(2007-12#4)(2008-2#2)(2008-3#1)
signal loss##2##2##(2008-2#1)(2011-2#1)
signal magnitude##2##2##(2008-10#2)
signal may be##2##3##(2007-11#1)(2008-3#1)
signal may##8##2##(1997-1#1)(2007-11#1)(2008-10#1)(2008-3#3)(2008-8#1)(2009-6#1)
signal measured##2##2##(2008-10#1)(2008-2#1)
signal measurements##4##2##(2007-8#1)(2008-10#3)
signal modulation##3##2##(2007-11#1)(2008-2#1)(2009-3#1)
signal molecule##4##2##(1990-7#1)(1996-5#1)(2008-10#1)(2008-9#1)
signal molecules##13##2##(1994-3#1)(1994-8#1)(1997-4#1)(2007-12#3)(2008-10#2)(2008-8#1)(2008-9#1)(2011-1#2)(2013-1#1)
signal networks##2##2##(1997-2#2)
signal noise##4##2##(2008-10#1)(2008-2#2)(2010-8#1)
signal obtained##4##2##(1996-2#1)(2008-10#1)(2008-2#1)(2008-3#1)
signal occurs##2##2##(2008-11#1)(2008-4#1)
signal of a##3##3##(2008-2#1)(2009-9#1)(2010-7#1)
signal of an##3##3##(2008-10#2)(2008-2#1)
signal of ca##2##3##(1996-7#2)
signal of interfering species##2##4##(2008-2#2)
signal of the##18##3##(1991-2#1)(1994-5#1)(1996-2#1)(1997-7#1)(2007-12#2)(2008-10#8)(2008-3#1)(2010-2#1)(2010-9#1)(2013-1#1)
signal of##85##2##(1990-3#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-7#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-7#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(2005-4#2)(2006-10#1)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#24)(2008-11#2)(2008-2#5)(2008-3#4)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#1)(2009-2#1)(2009-9#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-2#1)(2013-1#1)(2013-7#1)
signal on the##10##3##(1994-12#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#1)(2008-8#1)(2012-3#1)
signal on##20##2##(1993-3#1)(1994-12#1)(1997-8#1)(2005-10#1)(2006-12#1)(2007-12#2)(2008-10#2)(2008-2#4)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-8#1)(2012-3#1)
signal optical##2##2##(2008-3#1)(2013-7#1)
signal or##2##2##(2008-12#1)(2008-2#1)
signal originating from##2##3##(2008-3#1)(2009-6#1)
signal output##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2010-1#1)
signal over##3##2##(1994-5#1)(2008-2#1)(2011-2#1)
signal pathway in##4##3##(2011-2#2)(2011-3#2)
signal pathway of##2##3##(2008-3#1)(2013-1#1)
signal pathway##21##2##(1992-6#2)(1993-3#1)(1994-3#1)(1997-2#2)(2005-10#1)(2007-12#1)(2008-3#1)(2008-8#1)(2010-9#1)(2011-2#3)(2011-3#4)(2012-2#1)(2013-1#1)(2013-8#1)
signal pathways of##2##3##(2012-2#1)(2013-7#1)
signal pathways##5##2##(1996-2#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#1)
signal peak##2##2##(2008-2#1)(2008-3#1)
signal peptidase I##4##3##(1993-12#2)(1997-7#2)
signal peptidase##10##2##(1991-10#1)(1991-11#1)(1993-12#3)(1994-12#1)(1997-7#2)(2007-7#1)(2008-10#1)
signal peptide (SP)##2##3##(1993-11#1)(1997-4#1)
signal peptide and a##3##4##(1992-8#1)(2008-11#2)
signal peptide and the##5##4##(1990-12#1)(1990-6#1)(1993-3#1)(1993-4#1)(2010-6#1)
signal peptide and##18##3##(1990-12#1)(1990-6#1)(1991-9#1)(1992-5#1)(1992-8#2)(1993-12#1)(1993-3#1)(1993-4#1)(1996-9#1)(1997-2#1)(2008-11#2)(2008-4#1)(2008-8#1)(2009-12#1)(2010-5#1)(2010-6#1)
signal peptide at the NH2 terminus##2##6##(1991-7#1)(1992-4#1)
signal peptide at the##4##4##(1990-12#1)(1991-7#1)(1992-4#1)(1994-9#1)
signal peptide cleavage site##4##4##(1991-8#1)(1995-2#1)(2008-10#1)(2008-12#1)
signal peptide cleavage##7##3##(1991-8#1)(1991-9#1)(1994-9#1)(1995-2#1)(2006-12#1)(2008-10#1)(2008-12#1)
signal peptide for##3##3##(1991-12#1)(1991-7#1)(1995-6#1)
signal peptide of 22 aa##2##5##(1993-2#1)(1995-2#1)
signal peptide of 22##3##4##(1993-2#1)(1994-12#1)(1995-2#1)
signal peptide of the##3##4##(1990-12#1)(1992-7#1)(1995-10#1)
signal peptide of##22##3##(1990-12#1)(1990-2#1)(1990-4#2)(1992-12#1)(1992-2#1)(1992-7#2)(1992-8#2)(1993-2#1)(1994-12#2)(1995-10#1)(1995-2#1)(1997-2#1)(1997-7#1)(2006-11#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-8#1)
signal peptide polymorphism##3##3##(1996-9#1)(1997-8#2)
signal peptide sequence##2##3##(2010-6#2)
signal peptide to##2##3##(1991-8#1)(1992-7#1)
signal peptide was##2##3##(1997-7#1)(2010-6#1)
signal peptide##112##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#1)(1990-4#5)(1990-5#3)(1990-6#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#4)(1991-8#3)(1991-9#2)(1992-11#3)(1992-12#3)(1992-2#1)(1992-4#1)(1992-5#1)(1992-7#4)(1992-8#5)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#2)(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-9#2)(1995-10#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-6#1)(1996-9#2)(1997-2#3)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2006-11#2)(2006-12#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#3)(2009-12#1)(2009-2#1)(2010-5#1)(2010-6#4)(2011-2#1)(2013-8#1)
signal peptides with##2##3##(1996-8#1)(1997-7#1)
signal peptides##11##2##(1990-10#1)(1991-9#1)(1993-3#2)(1994-11#1)(1995-11#1)(1995-2#1)(1996-8#1)(1997-6#1)(1997-7#1)(2008-10#1)
signal per##2##2##(2008-10#1)(2008-3#1)
signal power and##2##3##(2008-2#1)(2008-3#1)
signal power at##2##3##(2007-11#1)(2007-12#1)
signal power is##2##3##(2008-3#2)
signal power over the range gate##2##6##(2008-3#2)
signal power##17##2##(2007-11#2)(2007-12#3)(2008-2#3)(2008-3#9)
signal powers of##2##3##(2007-12#2)
signal processing and##5##3##(2008-2#1)(2009-9#2)(2013-1#1)(2013-7#1)
signal processing by##3##3##(1990-7#1)(2007-12#2)
signal processing for##2##3##(2006-12#1)(2008-9#1)
signal processing is##2##3##(2008-2#1)(2008-3#1)
signal processing method##4##3##(1994-12#1)(2011-1#1)(2012-12#1)(2012-3#1)
signal processing technique is##2##4##(1991-12#1)(2008-3#1)
signal processing techniques##5##3##(1990-9#1)(1994-12#1)(2008-2#1)(2008-3#1)(2010-8#1)
signal processing##71##2##(1990-7#1)(1990-9#1)(1991-12#1)(1991-6#1)(1994-12#2)(2006-12#2)(2007-12#9)(2007-3#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-2#11)(2008-3#14)(2008-4#1)(2008-6#1)(2008-9#4)(2009-9#3)(2010-10#1)(2010-8#1)(2011-1#1)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
signal processor##9##2##(2006-6#1)(2007-12#1)(2008-2#4)(2008-3#3)
signal processors##3##2##(2008-3#2)(2008-9#1)
signal produced by the##4##4##(1990-8#1)(1994-12#1)(2008-10#2)
signal produced by##5##3##(1990-8#1)(1994-12#1)(1995-2#1)(2008-10#2)
signal profiles##3##2##(2007-8#1)(2008-10#2)
signal propagation mechanism##2##3##(2008-1#1)(2011-1#1)
signal propagation##3##2##(2008-1#1)(2008-2#1)(2011-1#1)
signal properties##2##2##(2010-12#1)(2010-9#1)
signal pulse##11##2##(2007-12#9)(2008-3#2)
signal pulses are##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
signal pulses of##2##3##(2007-12#2)
signal pulses##13##2##(2007-11#2)(2007-12#8)(2008-2#1)(2008-3#2)
signal quality##6##2##(2008-10#1)(2008-3#2)(2008-8#1)(2010-5#1)(2010-8#1)
signal radiation is##2##3##(2007-12#1)(2008-3#1)
signal radiation##4##2##(2007-12#2)(2008-3#2)
signal range##4##2##(2007-12#2)(2008-10#2)
signal rather than##2##3##(2008-3#2)
signal reception##3##2##(2008-2#1)(2009-6#1)(2009-8#1)
signal recognition particle (SRP)##6##4##(1992-6#1)(1993-8#1)(1994-11#1)(1995-6#1)(1996-5#2)
signal recognition particle receptor##2##4##(1995-6#2)
signal recognition particle##13##3##(1992-6#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-6#3)(1996-5#2)(2009-7#2)
signal recognition##15##2##(1992-6#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-6#4)(1996-5#2)(2009-5#1)(2009-7#2)
signal recorded##2##2##(1996-7#1)(2008-10#1)
signal recording##3##2##(2007-12#1)(2008-10#1)(2010-12#1)
signal recycling##3##2##(2007-11#1)(2008-2#2)
signal regulated##2##2##(1995-3#1)(2008-4#1)
signal regulating##2##2##(2006-1#1)(2011-1#1)
signal represented##2##2##(1990-3#1)(2008-2#1)
signal response##6##2##(1992-3#1)(1996-2#1)(2006-10#1)(2008-10#3)
signal responses##2##2##(2009-6#1)(2012-1#1)
signal resulting from the##2##4##(1997-4#1)(2008-3#1)
signal results##2##2##(2008-2#1)(2008-3#1)
signal separation and##2##3##(2008-2#1)(2008-3#1)
signal separation##4##2##(2008-2#2)(2008-3#1)(2008-4#1)
signal sequence and a##4##4##(1994-12#1)(1997-7#2)(2008-11#1)
signal sequence and##11##3##(1991-6#1)(1992-3#1)(1993-9#1)(1994-12#1)(1997-6#1)(1997-7#2)(1997-8#1)(2008-11#3)
signal sequence at the##2##4##(1992-8#1)(1993-3#1)
signal sequence at##3##3##(1992-8#1)(1993-3#1)(1995-1#1)
signal sequence followed by a##2##5##(1992-2#1)(1994-12#1)
signal sequence from##3##3##(1996-7#1)(1996-9#1)(2008-11#1)
signal sequence fused##2##3##(1990-5#1)(1991-10#1)
signal sequence of##8##3##(1990-1#1)(1990-3#1)(1991-1#1)(1991-8#1)(1993-12#1)(1993-9#2)(1997-6#1)
signal sequence polymorphisms##2##3##(1996-4#2)
signal sequence that##2##3##(1991-10#1)(1993-2#1)
signal sequence trap##2##3##(1996-8#2)
signal sequence##80##2##(1990-1#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#3)(1991-1#1)(1991-10#7)(1991-11#1)(1991-2#1)(1991-6#4)(1991-8#2)(1992-1#1)(1992-2#3)(1992-3#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-9#5)(1994-11#1)(1994-12#4)(1994-5#1)(1994-9#2)(1995-1#2)(1995-3#1)(1996-2#1)(1996-4#3)(1996-7#1)(1996-8#4)(1996-9#1)(1997-4#3)(1997-6#2)(1997-7#2)(1997-8#1)(2006-5#1)(2006-8#1)(2008-11#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)
signal sequences of##5##3##(1993-6#1)(1995-3#1)(1996-8#1)(1997-4#1)(2005-11#1)
signal sequences##21##2##(1990-3#1)(1990-5#1)(1991-12#1)(1991-7#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-3#1)(1995-6#3)(1996-4#1)(1996-8#4)(1997-4#2)(1997-7#1)(2005-11#1)(2006-12#1)
signal showed a##3##3##(2008-10#3)
signal shows##2##2##(2008-2#1)(2009-2#1)
signal size##3##2##(2008-3#3)
signal source##2##2##(2008-2#1)(2010-8#1)
signal spectrum##4##2##(2007-12#1)(2008-3#2)(2010-8#1)
signal statistics##6##2##(1990-9#1)(2008-2#1)(2008-3#4)
signal stimulating##2##2##(1995-3#1)(2008-4#1)
signal strength##4##2##(2006-10#1)(2008-10#1)(2008-3#2)
signal structure##2##2##(2008-10#1)(2008-2#1)
signal subspace##3##2##(2008-2#3)
signal such as##2##3##(1993-2#1)(2011-1#1)
signal suppression##4##2##(2008-10#3)(2012-1#1)
signal termination##3##2##(1991-2#3)
signal than##2##2##(1997-4#1)(2008-3#1)
signal that could##3##3##(2009-4#1)(2009-7#1)(2010-10#1)
signal that is##9##3##(1991-12#1)(1994-3#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2010-8#1)(2011-2#1)
signal that results from the##2##5##(2007-11#2)
signal that results##3##3##(1991-8#1)(2007-11#2)
signal that triggers##2##3##(1996-5#1)(2007-11#1)
signal that##42##2##(1991-12#1)(1991-8#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-5#1)(2007-11#4)(2007-12#3)(2008-10#1)(2008-2#5)(2008-3#4)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#2)(2010-10#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)
signal the presence of##2##4##(1994-8#1)(2006-10#1)
signal the##12##2##(1990-3#1)(1994-8#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2010-12#1)(2012-3#1)(2013-8#1)
signal through##6##2##(1994-2#1)(2006-11#1)(2008-3#1)(2008-9#2)(2010-2#1)
signal to a##2##3##(1997-6#1)(2007-3#1)
signal to be observed##2##4##(2008-1#1)(2010-4#1)
signal to be##8##3##(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-4#1)(2011-1#1)
signal to increase##2##3##(1991-3#1)(2009-8#1)
signal to noise ratio of 3##2##6##(2007-8#1)(2008-10#1)
signal to noise ratio of##4##5##(2007-8#1)(2008-10#2)(2011-1#1)
signal to noise ratio##11##4##(2005-4#2)(2007-1#1)(2007-8#1)(2008-10#4)(2008-9#1)(2011-1#2)
signal to noise ratios##2##4##(2007-11#1)(2010-2#1)
signal to noise##14##3##(2005-4#2)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-9#1)(2010-2#1)(2010-8#1)(2011-1#2)
signal to the##9##3##(2007-12#2)(2007-9#1)(2008-10#3)(2008-2#3)
signal to##71##2##(1991-12#1)(1991-3#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-6#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-6#1)(2005-4#2)(2007-1#1)(2007-11#2)(2007-12#3)(2007-3#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#12)(2008-2#7)(2008-3#7)(2008-4#2)(2008-8#3)(2008-9#1)(2009-6#1)(2009-8#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#3)(2012-2#1)(2013-1#1)
signal transducer and activator of transcription##3##6##(2008-10#1)(2008-8#1)(2012-3#1)
signal transducer and activator of##4##5##(2008-10#1)(2008-8#1)(2012-1#1)(2012-3#1)
signal transducer and##5##3##(2008-10#1)(2008-7#1)(2008-8#1)(2012-1#1)(2012-3#1)
signal transducer gp130##8##3##(1994-5#2)(1996-5#4)(1996-9#1)(1997-7#1)
signal transducer of##2##3##(2008-1#1)(2009-5#1)
signal transducer##27##2##(1991-1#1)(1992-8#1)(1994-5#2)(1995-2#1)(1996-2#2)(1996-4#1)(1996-5#4)(1996-9#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-8#1)(2010-10#1)(2011-1#1)(2012-1#1)(2012-3#1)
signal transducers and activators of transcription (STAT)##2##7##(2011-2#1)(2012-3#1)
signal transducers and activators of transcription##7##6##(1995-3#1)(1996-2#1)(2009-3#1)(2011-12#1)(2011-2#2)(2012-3#1)
signal transducers in the genome of##2##6##(1996-12#1)(1997-4#1)
signal transducers in##5##3##(1996-12#2)(1997-4#2)(2012-1#1)
signal transducers that##2##3##(2008-7#1)(2010-4#1)
signal transducers##18##2##(1991-5#1)(1995-3#1)(1995-6#1)(1996-12#3)(1996-2#1)(1997-4#3)(2008-7#1)(2009-3#1)(2010-4#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-3#1)
signal transducing##8##2##(1993-6#1)(1993-8#1)(1994-11#1)(1995-8#1)(1996-11#1)(1996-5#1)(1997-7#1)(2009-4#1)
signal transduction and gene expression##2##5##(2010-11#1)(2012-1#1)
signal transduction and##25##3##(1991-9#1)(1992-8#1)(1994-8#1)(1995-2#1)(1996-5#2)(1997-2#1)(1997-5#1)(2003-11#1)(2005-7#2)(2006-10#1)(2006-12#1)(2006-4#1)(2008-11#3)(2008-9#2)(2010-11#1)(2010-4#1)(2011-12#1)(2012-1#3)
signal transduction associated with##2##4##(1994-3#1)(2012-2#1)
signal transduction by the##2##4##(1992-2#1)(2010-2#1)
signal transduction by##14##3##(1992-12#1)(1992-2#4)(1993-8#1)(1994-12#2)(1995-12#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-2#1)
signal transduction cascades##4##3##(1996-2#1)(2009-12#1)(2009-6#1)(2011-1#1)
signal transduction chain##2##3##(2008-4#2)
signal transduction enzymes##2##3##(1992-6#1)(2008-5#1)
signal transduction events and##2##4##(2008-4#1)(2012-12#1)
signal transduction events##7##3##(1994-6#1)(1994-9#4)(2008-4#1)(2012-12#1)
signal transduction from##2##3##(1995-3#1)(1997-7#1)
signal transduction in response to##2##5##(1996-2#1)(2010-1#1)
signal transduction in the##4##4##(1991-10#1)(1991-2#1)(1995-8#1)(2009-12#1)
signal transduction in##26##3##(1991-10#1)(1991-2#2)(1993-6#3)(1994-10#1)(1994-12#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-8#2)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-4#2)(1997-7#1)(2008-10#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-5#1)(2013-1#1)
signal transduction inhibitors##4##3##(2005-7#1)(2008-11#1)(2008-8#1)(2009-8#1)
signal transduction is##3##3##(2008-2#1)(2010-5#1)(2011-12#1)
signal transduction leading to the##2##5##(1990-12#1)(1995-6#1)
signal transduction leading to##3##4##(1990-12#1)(1995-2#1)(1995-6#1)
signal transduction may##2##3##(1994-6#1)(2010-12#1)
signal transduction mechanism##3##3##(1994-3#1)(1994-9#1)(2008-4#1)
signal transduction mechanisms##10##3##(1991-10#1)(1993-8#1)(1995-11#2)(1995-5#1)(1995-8#1)(1996-12#1)(2005-8#1)(2007-12#2)
signal transduction mediated by the##2##5##(1993-11#1)(1993-6#1)
signal transduction mediated by##3##4##(1993-11#1)(1993-6#1)(1994-9#1)
signal transduction molecules and##2##4##(1993-8#1)(2008-11#1)
signal transduction molecules##3##3##(1993-8#1)(1995-3#1)(2008-11#1)
signal transduction network that##2##4##(1995-2#1)(2011-2#1)
signal transduction network##4##3##(1995-2#1)(2008-8#1)(2010-1#1)(2011-2#1)
signal transduction networks and##2##4##(2010-1#1)(2011-3#1)
signal transduction networks##6##3##(2006-10#1)(2009-5#1)(2010-1#2)(2011-3#2)
signal transduction of the##4##4##(1990-7#1)(1991-10#1)(2008-1#1)(2008-3#1)
signal transduction of##14##3##(1990-7#1)(1991-10#1)(1991-12#1)(1993-3#1)(1993-9#1)(1995-12#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-4#2)(2008-5#1)(2010-5#1)
signal transduction pathway is##2##4##(2007-12#1)(2008-7#1)
signal transduction pathway of the##2##5##(1996-7#1)(2009-8#1)
signal transduction pathway of##3##4##(1996-7#1)(1997-6#1)(2009-8#1)
signal transduction pathway other than##2##5##(1993-4#1)(2004-12#1)
signal transduction pathway that##2##4##(1997-2#1)(2008-10#1)
signal transduction pathway##38##3##(1990-11#1)(1991-12#1)(1991-5#1)(1993-4#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-9#2)(1995-6#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#2)(2004-12#1)(2006-9#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-7#2)(2008-8#2)(2009-4#1)(2009-8#1)(2011-3#1)
signal transduction pathways and##3##4##(2008-2#1)(2008-5#1)(2009-6#1)
signal transduction pathways are##2##4##(1991-3#1)(2006-10#1)
signal transduction pathways by leptin in colorectal cancer##2##8##(2012-3#2)
signal transduction pathways by leptin##3##5##(2012-3#3)
signal transduction pathways by##6##4##(1993-7#1)(1994-11#1)(1994-5#1)(2012-3#3)
signal transduction pathways in##12##4##(1992-1#1)(1993-7#1)(1996-5#2)(1997-4#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)
signal transduction pathways including##2##4##(1993-4#1)(1996-5#1)
signal transduction pathways known to be##2##6##(1992-7#1)(2008-5#1)
signal transduction pathways leading to##3##5##(1992-12#1)(1996-8#1)(2008-4#1)
signal transduction pathways or##2##4##(1994-3#2)
signal transduction pathways that##3##4##(1992-2#1)(1997-1#1)(2009-10#1)
signal transduction pathways triggered by##2##5##(2008-11#1)(2008-9#1)
signal transduction pathways upon##2##4##(2007-12#1)(2008-8#1)
signal transduction pathways##87##3##(1990-11#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-7#3)(1993-4#1)(1993-6#1)(1993-7#2)(1994-11#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#4)(1995-3#1)(1996-5#4)(1996-8#1)(1997-1#1)(1997-4#2)(1997-6#2)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#3)(2006-5#1)(2006-9#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#7)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#2)(2009-5#1)(2009-6#2)(2009-8#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)
signal transduction proteins##4##3##(1996-12#1)(1996-8#1)(1997-4#1)(2008-6#1)
signal transduction system##6##3##(1990-4#1)(1992-11#1)(1992-8#1)(1995-3#1)(1995-9#1)(2009-8#1)
signal transduction systems in##2##4##(1994-3#1)(1995-3#1)
signal transduction systems##8##3##(1991-5#1)(1992-9#2)(1994-2#1)(1994-3#1)(1995-3#1)(1997-4#1)(2007-12#1)
signal transduction through##5##3##(1991-12#1)(1994-5#1)(1995-7#1)(1997-4#1)(2008-7#1)
signal transduction to##4##3##(1991-8#1)(1997-4#1)(2010-11#1)(2012-2#1)
signal transduction triggers##2##3##(1997-7#1)(2011-2#1)
signal transduction via##2##3##(1994-5#1)(1996-5#1)
signal transduction was##2##3##(2005-8#1)(2008-9#1)
signal transduction##428##2##(1990-11#4)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-10#4)(1991-12#4)(1991-2#3)(1991-3#1)(1991-5#2)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#5)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#3)(1992-9#3)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#2)(1993-6#9)(1993-7#4)(1993-8#4)(1993-9#2)(1994-10#1)(1994-11#7)(1994-12#4)(1994-2#2)(1994-3#9)(1994-5#4)(1994-6#6)(1994-8#3)(1994-9#12)(1995-1#1)(1995-10#3)(1995-11#4)(1995-12#3)(1995-2#10)(1995-3#6)(1995-5#1)(1995-6#5)(1995-7#1)(1995-8#6)(1995-9#1)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#11)(1996-7#1)(1996-8#4)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#11)(1997-5#2)(1997-6#4)(1997-7#3)(1997-8#1)(2003-11#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-7#7)(2005-8#5)(2006-10#9)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-9#2)(2007-11#4)(2007-12#10)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#12)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#21)(2008-5#6)(2008-6#1)(2008-7#10)(2008-8#10)(2008-9#8)(2009-10#2)(2009-12#2)(2009-4#2)(2009-5#2)(2009-6#5)(2009-8#11)(2009-9#1)(2010-1#4)(2010-11#3)(2010-12#3)(2010-2#1)(2010-4#2)(2010-5#5)(2010-7#2)(2011-1#1)(2011-12#2)(2011-2#4)(2011-3#4)(2012-1#4)(2012-12#7)(2012-2#7)(2012-3#5)(2013-1#1)
signal transduction)##2##2##(2005-7#1)(2008-1#1)
signal transduction]##2##2##(1993-3#1)(2008-11#1)
signal transductions##2##2##(1992-9#2)
signal transfer##3##2##(2008-3#1)(2008-8#1)(2012-3#1)
signal transmission and##2##3##(2006-10#1)(2008-11#1)
signal transmission##18##2##(1992-10#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#1)(1996-5#1)(1996-8#1)(2006-10#1)(2007-11#3)(2007-12#1)(2008-11#2)(2008-2#1)(2008-3#1)(2009-6#1)(2011-7#1)
signal traveling##2##2##(2008-3#2)
signal triggered##2##2##(1991-9#1)(2009-9#1)
signal tuning##3##2##(2007-12#3)
signal upon##2##2##(1994-3#1)(2010-5#1)
signal used for##2##3##(2007-12#1)(2008-2#1)
signal used##3##2##(2007-12#1)(2008-2#2)
signal using a##2##3##(1994-9#1)(2008-10#1)
signal using##5##2##(1994-9#1)(2008-10#3)(2012-3#1)
signal values##2##2##(2007-12#1)(2008-2#1)
signal versus the##2##3##(2008-2#1)(2011-1#1)
signal versus##5##2##(2007-12#1)(2008-10#2)(2008-2#1)(2011-1#1)
signal via##4##2##(1994-12#1)(1994-3#1)(1995-3#1)(1997-5#1)
signal was also##2##3##(1994-8#1)(2007-10#1)
signal was detected##6##3##(1992-8#1)(1994-5#1)(1994-6#1)(2007-12#1)(2008-3#1)(2012-3#1)
signal was found to be##3##5##(2008-10#1)(2008-6#1)(2009-8#1)
signal was found to##4##4##(2008-10#2)(2008-6#1)(2009-8#1)
signal was found##6##3##(1993-12#1)(1997-2#1)(2008-10#2)(2008-6#1)(2009-8#1)
signal was investigated##2##3##(2008-10#1)(2010-5#1)
signal was observed and##2##4##(2008-10#2)
signal was observed in##3##4##(2008-10#1)(2008-11#2)
signal was observed##7##3##(1993-11#1)(2008-10#4)(2008-11#2)
signal was obtained by##2##4##(2005-4#1)(2013-8#1)
signal was obtained for##4##4##(1996-12#1)(2008-10#3)
signal was obtained##7##3##(1996-12#1)(2005-4#1)(2008-10#3)(2008-3#1)(2013-8#1)
signal was recorded##2##3##(2007-12#1)(2013-8#1)
signal was studied##2##3##(2007-12#1)(2008-10#1)
signal was##77##2##(1991-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-7#1)(1997-2#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-4#1)(2006-10#1)(2007-10#1)(2007-12#5)(2007-8#1)(2007-9#1)(2008-10#20)(2008-11#2)(2008-2#3)(2008-3#5)(2008-6#2)(2008-7#2)(2008-8#1)(2009-6#3)(2009-8#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
signal wave and##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
signal wave in##2##3##(2008-3#2)
signal wave with##2##3##(2008-1#2)
signal wave##11##2##(2007-11#1)(2007-12#1)(2008-1#3)(2008-2#2)(2008-3#4)
signal wavelength##5##2##(2007-12#2)(2008-1#2)(2008-3#1)
signal wavelengths##3##2##(2007-12#1)(2008-3#2)
signal waves##2##2##(2007-12#1)(2008-3#1)
signal were##6##2##(1990-3#1)(2008-10#4)(2008-2#1)
signal when##4##2##(2008-10#2)(2008-2#1)(2008-8#1)
signal which##7##2##(1992-8#1)(1993-3#1)(1993-6#1)(1996-4#1)(2008-4#1)(2010-5#1)(2010-8#1)
signal while minimizing##2##3##(2008-10#2)
signal while##3##2##(2007-12#1)(2008-10#2)
signal whose amplitude##2##3##(2008-3#1)(2008-9#1)
signal with a##7##3##(1994-9#1)(2007-11#1)(2008-10#2)(2008-3#3)
signal with an##2##3##(2008-3#2)
signal with only a##2##4##(2008-10#1)(2008-2#1)
signal with the##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)
signal with##25##2##(1991-12#1)(1991-7#1)(1994-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#10)(2008-4#1)(2011-1#1)(2012-3#1)
signal within##3##2##(1993-9#1)(2007-11#1)(2008-3#1)
signal without##2##2##(2008-11#1)(2008-3#1)
signal yields##2##2##(2008-2#2)
signal##3151##1##(1990-1#2)(1990-10#2)(1990-11#10)(1990-12#10)(1990-2#3)(1990-3#12)(1990-4#6)(1990-5#15)(1990-6#7)(1990-7#7)(1990-8#4)(1990-9#9)(1991-1#3)(1991-10#15)(1991-11#10)(1991-12#25)(1991-2#13)(1991-3#6)(1991-5#5)(1991-6#9)(1991-7#17)(1991-8#10)(1991-9#6)(1992-1#2)(1992-10#1)(1992-11#8)(1992-12#15)(1992-2#12)(1992-3#4)(1992-4#1)(1992-5#3)(1992-6#9)(1992-7#9)(1992-8#16)(1992-9#8)(1993-11#8)(1993-12#14)(1993-2#7)(1993-3#18)(1993-4#3)(1993-5#1)(1993-6#22)(1993-7#6)(1993-8#10)(1993-9#12)(1994-10#1)(1994-11#20)(1994-12#33)(1994-2#10)(1994-3#27)(1994-5#16)(1994-6#10)(1994-8#10)(1994-9#25)(1995-1#13)(1995-10#5)(1995-11#5)(1995-12#6)(1995-2#25)(1995-3#23)(1995-4#1)(1995-5#5)(1995-6#21)(1995-7#1)(1995-8#11)(1995-9#1)(1996-10#3)(1996-11#2)(1996-12#13)(1996-2#18)(1996-3#2)(1996-4#12)(1996-5#25)(1996-6#2)(1996-7#7)(1996-8#16)(1996-9#6)(1997-1#4)(1997-2#18)(1997-3#6)(1997-4#30)(1997-5#9)(1997-6#14)(1997-7#23)(1997-8#16)(2003-11#1)(2004-11#2)(2004-12#1)(2005-10#4)(2005-11#5)(2005-12#1)(2005-4#7)(2005-7#8)(2005-8#6)(2005-9#2)(2006-1#4)(2006-10#21)(2006-11#6)(2006-12#12)(2006-2#1)(2006-4#5)(2006-5#7)(2006-6#3)(2006-7#3)(2006-8#2)(2006-9#5)(2007-1#2)(2007-10#5)(2007-11#95)(2007-12#242)(2007-2#2)(2007-3#5)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#27)(2007-9#7)(2008-1#53)(2008-10#327)(2008-11#60)(2008-12#5)(2008-2#272)(2008-3#316)(2008-4#56)(2008-5#19)(2008-6#11)(2008-7#39)(2008-8#50)(2008-9#49)(2009-10#7)(2009-11#8)(2009-12#3)(2009-2#7)(2009-3#14)(2009-4#10)(2009-5#8)(2009-6#32)(2009-7#6)(2009-8#32)(2009-9#12)(2010-1#5)(2010-10#4)(2010-11#5)(2010-12#9)(2010-2#9)(2010-3#3)(2010-4#7)(2010-5#20)(2010-6#7)(2010-7#7)(2010-8#25)(2010-9#12)(2011-1#39)(2011-12#7)(2011-2#30)(2011-3#8)(2011-7#2)(2012-1#16)(2012-11#2)(2012-12#41)(2012-2#26)(2012-3#27)(2013-1#32)(2013-7#7)(2013-8#16)
signal's##2##1##(2007-12#1)(2008-2#1)
signal(s)##3##1##(1995-11#1)(1995-3#1)(2005-8#1)
signal)##6##1##(2007-12#1)(2008-10#3)(2008-3#1)(2011-2#1)
signal-##2##1##(2007-11#1)(2008-3#1)
signal-amplification##2##1##(1997-4#1)(2008-10#1)
signal-anchor sequence##2##2##(1991-10#1)(1996-3#1)
signal-anchor##4##1##(1991-10#3)(1996-3#1)
signal-averaged ECG##2##2##(1995-6#1)(2010-12#1)
signal-averaged##3##1##(1995-6#2)(2010-12#1)
signal-dependent noise##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
signal-dependent##6##1##(2007-12#1)(2008-2#2)(2008-3#3)
signal-detection tasks##2##2##(2008-3#2)
signal-detection##3##1##(2008-3#2)(2011-2#1)
signal-gain##2##1##(2007-12#2)
signal-idler##3##1##(2007-12#3)
signal-induced noise##3##2##(2008-2#1)(2008-3#2)
signal-induced##7##1##(1990-8#1)(2008-2#1)(2008-3#3)(2009-8#1)(2013-1#1)
signal-noise ratio and the##2##4##(2007-12#1)(2008-1#1)
signal-processing##6##1##(2007-12#1)(2008-2#3)(2008-3#2)
signal-regulated kinase (ERK)##6##3##(1995-3#1)(1996-5#1)(2009-8#1)(2009-9#1)(2011-2#1)(2013-1#1)
signal-regulated kinase 1/2##4##3##(2008-10#1)(2008-4#1)(2010-12#1)(2011-2#1)
signal-regulated kinase kinase (MEK)##2##4##(1996-5#2)
signal-regulated kinase##18##2##(1995-3#1)(1996-5#3)(2008-10#1)(2008-4#2)(2008-5#1)(2009-8#1)(2009-9#1)(2010-12#2)(2011-2#3)(2012-12#1)(2013-1#2)
signal-regulated kinases##5##2##(1995-6#1)(2008-4#2)(2011-2#1)(2013-8#1)
signal-regulated##28##1##(1995-3#1)(1995-6#1)(1996-11#1)(1996-5#4)(2008-10#1)(2008-4#4)(2008-5#1)(2009-8#1)(2009-9#2)(2010-12#2)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
signal-related##3##1##(1991-6#2)(2008-7#1)
signal-to-background ratio and##2##3##(2008-2#1)(2010-5#1)
signal-to-background ratio##10##2##(1997-6#1)(2006-6#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#1)(2010-5#1)(2013-8#1)
signal-to-background##14##1##(1997-6#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2010-5#1)(2013-8#1)
signal-to-noise and##3##2##(2008-2#1)(2008-3#1)(2010-5#1)
signal-to-noise characteristics##2##2##(2008-10#2)
signal-to-noise is##2##2##(2005-11#1)(2008-10#1)
signal-to-noise level##3##2##(2007-12#1)(2008-10#2)
signal-to-noise ratio (SNR) of##4##4##(2007-12#1)(2008-10#1)(2010-8#1)(2013-8#1)
signal-to-noise ratio (SNR)##21##3##(2007-12#3)(2008-10#2)(2008-2#4)(2008-3#5)(2009-5#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
signal-to-noise ratio and the##2##4##(2007-11#1)(2008-3#1)
signal-to-noise ratio and##11##3##(2007-11#2)(2008-2#2)(2008-3#4)(2010-8#1)(2011-12#1)(2013-8#1)
signal-to-noise ratio are##2##3##(2007-12#2)
signal-to-noise ratio as##2##3##(2007-12#1)(2008-3#1)
signal-to-noise ratio compared with##2##4##(2007-12#1)(2008-3#1)
signal-to-noise ratio compared##3##3##(2006-10#1)(2007-12#1)(2008-3#1)
signal-to-noise ratio for the##2##4##(2006-12#1)(2007-12#1)
signal-to-noise ratio for##5##3##(1996-12#1)(2006-12#1)(2007-12#1)(2008-3#2)
signal-to-noise ratio in the##4##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
signal-to-noise ratio in##10##3##(2007-11#2)(2007-12#2)(2008-2#3)(2008-3#2)(2009-10#1)
signal-to-noise ratio is##10##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#5)(2009-4#1)
signal-to-noise ratio of &gt##2##4##(2007-12#1)(2008-3#1)
signal-to-noise ratio of 2##2##4##(2007-12#1)(2008-10#1)
signal-to-noise ratio of 3##15##4##(1990-8#1)(1991-5#1)(1996-8#1)(2007-12#1)(2008-10#8)(2008-3#1)(2012-12#1)(2013-1#1)
signal-to-noise ratio of the##10##4##(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#4)
signal-to-noise ratio of##48##3##(1990-8#1)(1990-9#1)(1991-5#1)(1993-2#1)(1996-8#1)(2007-12#9)(2008-1#1)(2008-10#14)(2008-2#3)(2008-3#13)(2008-5#1)(2012-12#1)(2013-1#1)
signal-to-noise ratio than##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
signal-to-noise ratio to be##2##4##(2007-12#1)(2008-2#1)
signal-to-noise ratio was improved##2##4##(1993-7#1)(2007-12#1)
signal-to-noise ratio was##4##3##(1993-7#1)(1997-8#1)(2007-12#1)(2008-2#1)
signal-to-noise ratio with##6##3##(2008-2#2)(2008-3#4)
signal-to-noise ratio##203##2##(1990-8#1)(1990-9#1)(1991-2#1)(1991-5#1)(1992-7#1)(1993-2#1)(1993-7#1)(1994-2#1)(1996-12#2)(1996-8#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#8)(2007-12#32)(2007-8#2)(2008-1#3)(2008-10#20)(2008-11#1)(2008-2#42)(2008-3#58)(2008-4#1)(2008-5#1)(2009-10#2)(2009-4#1)(2009-5#1)(2010-2#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#2)
signal-to-noise ratio)##2##2##(2008-10#1)(2012-2#1)
signal-to-noise ratios (SNR's)##2##3##(2008-3#2)
signal-to-noise ratios and##2##3##(2008-2#1)(2008-3#1)
signal-to-noise ratios of##4##3##(2007-8#1)(2008-10#1)(2008-3#2)
signal-to-noise ratios##27##2##(1996-5#1)(1996-6#1)(2007-11#1)(2007-12#3)(2007-8#4)(2008-10#2)(2008-2#3)(2008-3#9)(2008-4#1)(2008-8#1)(2012-2#1)
signal-to-noise values##2##2##(2008-3#1)(2008-8#1)
signal-to-noise##256##1##(1990-8#1)(1990-9#1)(1991-2#1)(1991-5#1)(1992-7#1)(1993-2#1)(1993-7#1)(1994-2#1)(1996-12#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-8#1)(2005-11#2)(2006-10#1)(2006-12#1)(2007-11#10)(2007-12#36)(2007-8#8)(2008-1#3)(2008-10#31)(2008-11#1)(2008-2#50)(2008-3#71)(2008-4#2)(2008-5#1)(2008-8#2)(2009-10#2)(2009-4#1)(2009-5#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
signal-transducing##2##1##(1992-11#1)(1996-4#1)
signal-transduction mechanisms##2##2##(1994-3#1)(2008-4#1)
signal-transduction pathway##3##2##(1997-4#2)(2007-8#1)
signal-transduction pathways##5##2##(1994-6#1)(1994-8#1)(1995-1#1)(1995-8#1)(2007-8#1)
signal-transduction##11##1##(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-8#1)(1997-4#2)(2007-8#2)(2008-4#1)(2008-9#1)
signal-voltage symmetry##2##2##(2008-2#2)
signal-wave##3##1##(2007-11#1)(2007-12#2)
signal/noise ratio##4##2##(1990-12#1)(2007-12#1)(2008-10#1)(2008-2#1)
signal/noise##5##1##(1990-12#2)(2007-12#1)(2008-10#1)(2008-2#1)
signaled a##2##2##(2008-10#1)(2013-1#1)
signaled through##2##2##(1997-4#1)(2010-4#1)
signaled##9##1##(1995-12#1)(1997-4#1)(2007-8#1)(2008-10#2)(2010-2#1)(2010-4#1)(2011-2#1)(2013-1#1)
signaler##4##1##(2008-9#4)
signalers##5##1##(2008-1#1)(2008-8#4)
signaling activities##2##2##(2008-4#1)(2008-9#1)
signaling activity##4##2##(2008-1#1)(2012-12#1)(2013-1#2)
signaling and cell-cell##2##3##(1997-6#1)(2008-11#1)
signaling and in##2##3##(2008-1#2)
signaling and the##5##3##(2007-8#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-2#1)
signaling and transcriptional##2##3##(2006-10#1)(2012-12#1)
signaling and##52##2##(1997-6#1)(2006-10#2)(2007-12#5)(2007-8#1)(2008-1#4)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#2)(2009-4#1)(2009-6#2)(2009-8#2)(2010-12#1)(2010-3#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
signaling are##3##2##(2007-12#1)(2012-3#2)
signaling arrest of##2##3##(2011-1#2)
signaling as##3##2##(2005-7#1)(2008-1#1)(2010-6#1)
signaling assemblies##2##2##(2012-12#2)
signaling at##4##2##(2008-10#1)(2008-4#1)(2009-9#1)(2013-1#1)
signaling axis##2##2##(2010-4#1)(2012-2#1)
signaling between cells##2##3##(2007-12#1)(2008-11#1)
signaling between neurons and##2##4##(2008-5#1)(2009-3#1)
signaling between##4##2##(2007-12#1)(2008-11#1)(2008-5#1)(2009-3#1)
signaling but not##2##3##(1994-3#1)(2008-11#1)
signaling but##3##2##(1994-3#1)(2008-11#1)(2009-4#1)
signaling by P2Y receptors##2##4##(2008-4#1)(2009-3#1)
signaling by the##5##3##(1992-2#1)(1997-6#1)(1997-7#1)(2008-5#1)(2008-8#1)
signaling by##29##2##(1992-2#2)(1993-6#1)(1994-3#1)(1994-9#1)(1995-8#1)(1996-5#2)(1997-6#1)(1997-7#1)(2007-10#1)(2008-10#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#2)(2009-8#3)(2012-2#1)(2013-1#2)
signaling cascade and##2##3##(1995-6#1)(2009-8#1)
signaling cascade in##3##3##(2006-9#1)(2012-12#2)
signaling cascade of##2##3##(2008-10#1)(2013-1#1)
signaling cascade that##2##3##(1997-6#1)(2008-4#1)
signaling cascade##20##2##(1995-6#2)(1996-5#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-12#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-9#1)(2009-4#1)(2009-8#2)(2010-2#1)(2012-12#2)(2013-1#1)
signaling cascades and##2##3##(2008-7#1)(2012-12#1)
signaling cascades in##2##3##(2008-1#1)(2009-4#1)
signaling cascades that##3##3##(2008-4#1)(2008-7#1)(2009-8#1)
signaling cascades were##2##3##(2008-11#1)(2009-6#1)
signaling cascades##21##2##(1996-8#1)(1997-2#1)(2008-1#3)(2008-11#2)(2008-2#2)(2008-4#1)(2008-7#4)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-4#1)(2012-12#1)
signaling centers##3##2##(1993-12#1)(2012-12#2)
signaling complex##3##2##(2008-9#1)(2012-2#1)(2013-1#1)
signaling complexes##5##2##(1997-4#1)(2008-11#1)(2008-7#2)(2010-8#1)
signaling component##3##2##(1994-8#1)(1995-8#1)(2010-7#1)
signaling components and##3##3##(2008-11#1)(2009-10#1)(2009-6#1)
signaling components##8##2##(2008-11#2)(2009-10#1)(2009-6#3)(2009-8#1)(2010-2#1)
signaling compounds##2##2##(2008-10#1)(2009-8#1)
signaling costs have##2##3##(2008-8#2)
signaling cues##3##2##(2009-3#1)(2012-11#2)
signaling domains##4##2##(1996-12#1)(1997-4#1)(2012-2#2)
signaling drives##2##2##(2007-12#1)(2010-7#1)
signaling during cell##2##3##(2007-12#1)(2010-1#1)
signaling during##10##2##(2007-12#1)(2008-4#1)(2008-9#1)(2009-8#3)(2010-1#1)(2010-9#1)(2012-12#1)(2012-2#1)
signaling enzymes##2##2##(2008-8#1)(2010-12#1)
signaling equilibrium##2##2##(2008-9#2)
signaling event in##3##3##(1992-8#1)(1994-8#1)(2011-1#1)
signaling event##6##2##(1991-5#1)(1992-8#1)(1994-8#1)(2008-10#1)(2011-1#2)
signaling events activated by##2##4##(1995-2#1)(2008-8#1)
signaling events and##3##3##(2006-9#1)(2010-4#1)(2012-3#1)
signaling events are##2##3##(2008-1#1)(2012-12#1)
signaling events associated with##2##4##(1991-3#1)(2008-1#1)
signaling events in##4##3##(2006-5#1)(2008-4#2)(2009-9#1)
signaling events may##2##3##(2008-8#1)(2011-1#1)
signaling events that##4##3##(1997-6#1)(2008-1#1)(2009-4#1)(2011-1#1)
signaling events##42##2##(1991-3#2)(1991-5#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-4#1)(1997-6#1)(2006-4#1)(2006-5#1)(2006-9#1)(2008-1#5)(2008-10#3)(2008-4#6)(2008-6#1)(2008-8#2)(2009-4#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)
signaling factors in##2##3##(2008-3#1)(2008-4#1)
signaling for##5##2##(1994-3#1)(1996-9#1)(2010-11#1)(2010-3#1)(2010-7#1)
signaling from the##2##3##(2012-2#2)
signaling function##3##2##(1990-9#1)(2008-4#1)(2008-8#1)
signaling functions of##2##3##(2011-2#1)(2012-2#1)
signaling functions##3##2##(2009-6#1)(2011-2#1)(2012-2#1)
signaling has been##3##3##(2010-2#1)(2012-1#1)(2013-1#1)
signaling has##6##2##(2008-5#1)(2009-5#1)(2009-9#1)(2010-2#1)(2012-1#1)(2013-1#1)
signaling in C##3##3##(1995-3#1)(2007-12#2)
signaling in Drosophila##2##3##(2007-12#1)(2012-3#1)
signaling in a##2##3##(2007-12#1)(2008-8#1)
signaling in cardiac##2##3##(2008-6#1)(2012-12#1)
signaling in human##2##3##(1996-2#1)(1997-8#1)
signaling in mouse##2##3##(2008-11#1)(2008-8#1)
signaling in neural##2##3##(2008-1#1)(2008-11#1)
signaling in opioid functions and receptor gene expression##2##8##(2007-11#2)
signaling in plant##2##3##(2008-4#1)(2009-8#1)
signaling in plants##2##3##(2008-8#1)(2011-1#1)
signaling in postsynaptic##2##3##(2008-11#1)(2009-8#1)
signaling in response to##3##4##(2008-7#1)(2008-9#1)(2011-1#1)
signaling in the##14##3##(2007-12#3)(2008-4#2)(2008-5#1)(2009-12#1)(2009-3#1)(2010-11#1)(2011-1#1)(2012-12#2)(2013-1#2)
signaling in these##2##3##(2010-3#2)
signaling in vitro##4##3##(1994-12#1)(2008-11#1)(2009-9#1)(2012-2#1)
signaling in β-cells##3##3##(2010-11#3)
signaling in##98##2##(1992-5#2)(1994-12#2)(1994-8#1)(1995-2#1)(1995-3#2)(1996-2#1)(1996-8#4)(1997-4#1)(1997-8#2)(2005-10#1)(2006-9#1)(2007-11#2)(2007-12#8)(2008-1#2)(2008-11#6)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#2)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#2)(2009-8#8)(2009-9#1)(2010-11#4)(2010-12#1)(2010-3#3)(2010-4#1)(2010-5#1)(2011-1#5)(2011-2#2)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
signaling induces##2##2##(2007-12#1)(2012-3#1)
signaling is a##2##3##(2008-8#1)(2009-6#1)
signaling is regulated by##2##4##(2009-8#1)(2013-1#1)
signaling is to##2##3##(2008-11#2)
signaling is##31##2##(1994-3#1)(1995-2#1)(1995-3#1)(1996-5#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-7#1)(2011-2#1)(2013-1#2)(2013-8#1)
signaling leads to##2##3##(2007-12#1)(2013-1#1)
signaling leads##3##2##(2007-12#1)(2011-2#1)(2013-1#1)
signaling may##4##2##(2009-8#1)(2010-12#1)(2010-3#1)(2012-12#1)
signaling mechanism##9##2##(1991-8#1)(1993-4#1)(1994-12#1)(1995-3#2)(1995-6#1)(2008-4#1)(2010-5#1)(2012-1#1)
signaling mechanisms in##3##3##(2008-5#2)(2009-3#1)
signaling mechanisms involved in##2##4##(1991-4#1)(2008-4#1)
signaling mechanisms of##2##3##(1994-3#1)(2010-7#1)
signaling mechanisms that##3##3##(2008-10#2)(2010-11#1)
signaling mechanisms##26##2##(1991-4#1)(1993-5#1)(1994-2#1)(1994-3#1)(1996-5#1)(1997-4#1)(2006-10#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#3)(2009-11#1)(2009-3#1)(2009-6#2)(2010-11#1)(2010-7#1)(2010-8#1)(2012-2#1)
signaling mediated by##3##3##(2007-12#1)(2008-9#1)(2011-2#1)
signaling mediates##2##2##(2009-10#1)(2013-8#1)
signaling molecule for##2##3##(2009-6#2)
signaling molecule##15##2##(1994-9#1)(1995-2#1)(1997-4#1)(2006-1#1)(2006-11#1)(2008-10#1)(2009-6#3)(2009-8#1)(2010-3#2)(2010-4#1)(2011-2#1)(2012-12#1)
signaling molecules are##2##3##(1994-12#1)(2013-8#1)
signaling molecules for##2##3##(1995-3#1)(2010-11#1)
signaling molecules in##3##3##(2009-10#1)(2010-1#1)(2010-7#1)
signaling molecules that##7##3##(1995-3#1)(2007-12#1)(2008-1#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-1#1)
signaling molecules##42##2##(1993-12#1)(1993-3#1)(1994-12#2)(1995-3#2)(2005-8#1)(2007-12#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#1)(2009-10#3)(2009-12#1)(2009-2#1)(2009-4#2)(2009-8#3)(2010-1#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#2)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
signaling network involved in##3##4##(2010-3#1)(2012-12#2)
signaling network##8##2##(2008-11#1)(2009-12#2)(2009-8#2)(2010-3#1)(2012-12#2)
signaling networks##6##2##(2006-10#1)(2008-4#1)(2012-12#1)(2012-2#2)(2013-8#1)
signaling of the##3##3##(1995-1#1)(2007-11#1)(2008-7#1)
signaling of##20##2##(1995-1#1)(1995-3#2)(1996-5#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#4)(2009-3#1)(2009-8#2)(2009-9#1)(2010-5#1)(2011-2#1)
signaling on##4##2##(2007-11#1)(2008-10#1)(2009-4#1)(2011-1#1)
signaling pathway and the##2##4##(2008-11#1)(2008-8#1)
signaling pathway and##10##3##(1994-11#1)(1995-3#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-8#1)(2010-4#1)(2013-1#1)(2013-8#1)
signaling pathway as##2##3##(1994-8#1)(2008-1#1)
signaling pathway has been##4##4##(2007-12#1)(2010-3#2)(2012-1#1)
signaling pathway in##16##3##(1990-3#1)(1993-11#1)(1994-11#2)(1995-8#1)(1996-5#1)(2009-4#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
signaling pathway involved in##2##4##(2010-12#1)(2011-2#1)
signaling pathway is##5##3##(1995-6#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
signaling pathway may be##2##4##(2009-6#1)(2013-1#1)
signaling pathway might##2##3##(2008-11#1)(2011-2#1)
signaling pathway of apoptosis##2##4##(2008-11#1)(2009-9#1)
signaling pathway of##6##3##(1992-12#2)(1992-6#1)(1994-11#1)(2008-11#1)(2009-9#1)
signaling pathway plays an important role in##3##7##(2009-5#1)(2010-4#1)(2011-2#1)
signaling pathway plays##4##3##(2009-5#1)(2010-4#1)(2011-2#1)(2013-1#1)
signaling pathway required##2##3##(2009-8#1)(2010-11#1)
signaling pathway that##6##3##(1994-12#1)(2005-11#1)(2009-3#1)(2010-2#1)(2010-3#1)(2010-7#1)
signaling pathway to##4##3##(1997-1#1)(2009-10#2)(2009-8#1)
signaling pathway##149##2##(1990-12#1)(1990-3#1)(1992-12#2)(1992-6#1)(1993-11#1)(1993-3#1)(1994-11#6)(1994-12#1)(1994-5#1)(1994-8#3)(1995-3#5)(1995-6#5)(1995-8#2)(1996-5#3)(1996-8#2)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-11#1)(2007-12#6)(2008-1#5)(2008-11#7)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#4)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#2)(2009-8#8)(2009-9#1)(2010-11#2)(2010-12#7)(2010-2#2)(2010-3#5)(2010-4#3)(2010-7#2)(2011-1#1)(2011-2#15)(2012-1#2)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#7)(2013-7#3)(2013-8#3)
signaling pathway(s)##2##2##(2009-6#1)(2009-8#1)
signaling pathways allows a plant to finely tune its response to the attacker encountered##2##14##(2009-6#1)(2009-8#1)
signaling pathways and cellular##2##4##(2012-12#2)
signaling pathways and##18##3##(1991-9#1)(1995-6#1)(1996-12#1)(1997-7#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-4#2)(2008-8#1)(2010-12#1)(2010-9#1)(2012-1#1)(2012-12#3)(2013-1#1)
signaling pathways are##11##3##(2006-10#1)(2007-12#2)(2007-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-12#1)(2010-12#1)(2010-2#1)(2011-2#1)
signaling pathways associated with##3##4##(2008-1#1)(2008-11#1)(2010-2#1)
signaling pathways by##5##3##(1996-5#1)(2008-9#1)(2009-5#1)(2009-6#1)(2012-12#1)
signaling pathways contributes to##2##4##(2009-5#1)(2013-7#1)
signaling pathways could##2##3##(2008-4#1)(2013-1#1)
signaling pathways downstream of##2##4##(1995-8#1)(2012-3#1)
signaling pathways for##3##3##(1995-6#1)(2007-3#1)(2009-8#1)
signaling pathways have##2##3##(2011-2#1)(2013-8#1)
signaling pathways in the##2##4##(2011-2#2)
signaling pathways in##17##3##(1992-1#1)(1994-5#1)(1994-8#2)(1995-3#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-6#1)(2011-2#4)(2013-1#2)
signaling pathways including##2##3##(1995-2#1)(2013-7#1)
signaling pathways involved in##3##4##(2006-1#1)(2008-1#1)(2008-10#1)
signaling pathways involved##6##3##(2006-1#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2012-1#1)
signaling pathways involving##2##3##(2007-12#1)(2008-4#1)
signaling pathways leading to##4##4##(1994-6#1)(1997-6#1)(2012-12#2)
signaling pathways leading##5##3##(1994-6#1)(1997-6#1)(2007-11#1)(2012-12#2)
signaling pathways may contribute##2##4##(1995-12#1)(2007-12#1)
signaling pathways may##5##3##(1995-12#1)(2007-12#1)(2008-1#1)(2008-4#1)(2009-4#1)
signaling pathways of##5##3##(1992-5#1)(1994-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
signaling pathways regulate##2##3##(2008-9#1)(2012-2#1)
signaling pathways regulating##2##3##(2008-10#1)(2011-12#1)
signaling pathways related to##3##4##(2008-11#1)(2012-12#2)
signaling pathways that are##2##4##(2008-9#1)(2009-8#1)
signaling pathways that lead to##3##5##(1996-5#1)(2008-4#1)(2009-5#1)
signaling pathways that regulate##2##4##(2008-7#1)(2012-3#1)
signaling pathways that##19##3##(1996-11#1)(1996-5#1)(2005-10#1)(2008-1#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-3#1)(2009-5#1)(2009-8#2)(2010-3#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-3#1)(2013-8#1)
signaling pathways through##3##3##(2007-11#1)(2010-12#1)(2012-12#1)
signaling pathways to##3##3##(1997-5#1)(2009-8#1)(2012-2#1)
signaling pathways was##2##3##(2008-11#1)(2010-12#1)
signaling pathways were##2##3##(2008-11#1)(2010-8#1)
signaling pathways##240##2##(1991-7#1)(1991-9#1)(1992-1#2)(1992-5#1)(1993-4#1)(1994-12#3)(1994-5#1)(1994-6#1)(1994-8#4)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#2)(1995-8#2)(1996-11#3)(1996-12#1)(1996-4#1)(1996-5#5)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#3)(2005-10#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#6)(2006-2#1)(2007-11#4)(2007-12#10)(2007-3#3)(2008-1#9)(2008-10#7)(2008-11#12)(2008-12#1)(2008-2#1)(2008-4#17)(2008-5#3)(2008-7#3)(2008-8#7)(2008-9#7)(2009-10#4)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#4)(2009-6#6)(2009-8#17)(2010-1#1)(2010-11#1)(2010-12#6)(2010-2#2)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#13)(2012-1#3)(2012-12#10)(2012-2#4)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#3)
signaling plays a role in##2##5##(2012-12#1)(2013-1#1)
signaling plays a##5##3##(2008-10#1)(2012-12#1)(2013-1#3)
signaling process##3##2##(2007-12#1)(2008-10#1)(2008-8#1)
signaling processes##6##2##(1995-5#1)(2008-10#1)(2008-5#1)(2009-3#1)(2010-5#1)(2012-3#1)
signaling promotes##2##2##(2008-11#1)(2011-1#1)
signaling properties of##3##3##(2008-4#1)(2010-3#1)(2012-1#1)
signaling properties##5##2##(1991-2#1)(2008-4#1)(2010-3#2)(2012-1#1)
signaling proteins##8##2##(1991-12#1)(1994-9#1)(1997-7#1)(2006-10#1)(2008-1#1)(2008-11#1)(2009-6#1)(2012-2#1)
signaling provides##2##2##(2009-12#1)(2011-1#1)
signaling receptors##2##2##(2011-2#1)(2012-12#1)
signaling responses##2##2##(1995-2#1)(2010-12#1)
signaling results in##4##3##(1995-1#1)(2012-12#3)
signaling system and##2##3##(1994-8#1)(1996-10#1)
signaling system for##2##3##(2008-1#1)(2009-5#1)
signaling system##13##2##(1994-8#1)(1996-10#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-9#1)(2009-5#2)(2011-1#1)(2012-12#1)
signaling systems for eliciting a variety of adaptive responses to their environment##2##12##(1996-12#1)(1997-4#1)
signaling systems in##2##3##(2009-8#1)(2012-2#1)
signaling systems##12##2##(1991-8#1)(1992-2#1)(1996-12#1)(1996-4#2)(1997-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#2)(2012-2#1)
signaling that##3##2##(2008-11#1)(2010-12#1)(2012-1#1)
signaling the##2##2##(2008-10#2)
signaling through Ras##2##3##(1992-7#1)(1996-8#1)
signaling through a##2##3##(2006-10#1)(2010-12#1)
signaling through the##4##3##(2008-9#1)(2012-12#1)(2012-2#2)
signaling through##16##2##(1992-7#1)(1995-3#1)(1996-5#1)(1996-8#1)(2006-10#1)(2008-11#1)(2008-9#2)(2010-11#1)(2010-12#1)(2011-1#1)(2012-12#2)(2012-2#2)(2012-3#1)
signaling to the cytoskeleton##2##4##(2012-12#2)
signaling to the##6##3##(1995-6#1)(2009-12#2)(2012-12#3)
signaling to##14##2##(1995-2#1)(1995-6#4)(2006-10#1)(2009-12#2)(2009-8#1)(2010-3#1)(2012-12#4)
signaling transduction##4##2##(2009-6#1)(2012-2#1)(2012-3#2)
signaling under##2##2##(2009-6#2)
signaling using##2##2##(1995-3#1)(2012-11#1)
signaling via the##3##3##(1996-5#1)(1997-6#1)(2008-1#1)
signaling via##6##2##(1996-5#2)(1997-6#1)(2008-1#1)(2009-8#2)
signaling was##3##2##(2008-7#1)(2009-12#1)(2010-2#1)
signaling were##3##2##(2010-5#1)(2013-8#2)
signaling when##2##2##(2009-9#1)(2010-8#1)
signaling with the##2##3##(2008-7#1)(2013-1#1)
signaling with##4##2##(1993-1#1)(2008-1#1)(2008-7#1)(2013-1#1)
signaling##1433##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#3)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#3)(1992-12#2)(1992-2#3)(1992-3#1)(1992-5#3)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#3)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#2)(1994-10#1)(1994-11#6)(1994-12#11)(1994-2#1)(1994-3#7)(1994-5#3)(1994-6#2)(1994-8#12)(1994-9#7)(1995-1#6)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#8)(1995-3#22)(1995-5#1)(1995-6#17)(1995-8#8)(1996-10#6)(1996-11#3)(1996-12#4)(1996-2#1)(1996-4#3)(1996-5#26)(1996-8#9)(1996-9#1)(1997-1#3)(1997-2#5)(1997-4#12)(1997-5#2)(1997-6#8)(1997-7#8)(1997-8#2)(2004-12#1)(2005-10#4)(2005-11#3)(2005-7#2)(2005-8#4)(2006-1#2)(2006-10#20)(2006-11#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-9#6)(2007-1#1)(2007-10#1)(2007-11#12)(2007-12#62)(2007-3#4)(2007-8#2)(2007-9#2)(2008-1#48)(2008-10#40)(2008-11#52)(2008-12#1)(2008-2#8)(2008-3#4)(2008-4#73)(2008-5#19)(2008-6#3)(2008-7#24)(2008-8#35)(2008-9#37)(2009-10#19)(2009-11#2)(2009-12#18)(2009-2#3)(2009-3#22)(2009-4#18)(2009-5#11)(2009-6#37)(2009-7#2)(2009-8#99)(2009-9#16)(2010-1#6)(2010-10#3)(2010-11#13)(2010-12#28)(2010-2#8)(2010-3#23)(2010-4#12)(2010-5#9)(2010-6#3)(2010-7#10)(2010-8#7)(2010-9#3)(2011-1#34)(2011-12#4)(2011-2#53)(2012-1#13)(2012-11#4)(2012-12#67)(2012-2#43)(2012-3#27)(2013-1#49)(2013-7#10)(2013-8#21)
signaling)##5##1##(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)
signalized intersections##8##2##(2012-12#8)
signalized##9##1##(2012-12#9)
signalled the##2##2##(1990-7#1)(1993-6#1)
signalled##4##1##(1990-7#1)(1993-6#1)(1997-8#1)(2009-9#1)
signallers##2##1##(1995-5#2)
signalling a##2##2##(2008-9#2)
signalling and the##3##3##(1996-8#1)(2008-7#1)(2012-1#1)
signalling and##15##2##(1990-10#1)(1993-8#1)(1996-8#1)(2005-7#1)(2007-11#1)(2008-7#3)(2009-8#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
signalling between the##2##3##(1994-10#1)(2006-1#1)
signalling by the##2##3##(1991-8#1)(2006-10#1)
signalling by##6##2##(1991-8#1)(1994-6#1)(2006-10#1)(2009-8#1)(2012-12#1)(2013-1#1)
signalling cascade##3##2##(2008-4#1)(2011-12#1)(2012-2#1)
signalling cascades##5##2##(1996-2#1)(2008-10#2)(2009-3#1)(2011-2#1)
signalling complex##2##2##(1996-2#1)(2007-8#1)
signalling effects##2##2##(2009-6#1)(2009-8#1)
signalling events##7##2##(1990-8#1)(1991-8#1)(1995-8#1)(1996-10#1)(1997-7#1)(2008-1#1)(2009-6#1)
signalling for##2##2##(1997-3#1)(2011-2#1)
signalling function##2##2##(1992-9#1)(2012-12#1)
signalling have been##3##3##(2007-8#1)(2011-12#1)(2011-2#1)
signalling in pelvic afferent neurons##3##5##(2008-4#3)
signalling in the##9##3##(1994-2#1)(1994-5#1)(2006-10#1)(2006-11#1)(2008-3#1)(2008-4#3)(2009-9#1)
signalling in##24##2##(1991-8#1)(1993-6#1)(1994-2#1)(1994-5#1)(2006-10#1)(2006-11#2)(2006-12#1)(2008-11#1)(2008-3#1)(2008-4#8)(2008-7#1)(2009-9#1)(2011-2#2)(2012-2#2)
signalling is to##2##3##(2006-10#1)(2008-4#1)
signalling is##7##2##(1995-5#2)(2005-11#1)(2006-10#1)(2007-8#1)(2008-4#1)(2010-10#1)
signalling mechanism##3##2##(1991-8#1)(1992-3#1)(1993-6#1)
signalling models##2##2##(2010-10#1)(2013-8#1)
signalling molecule##4##2##(2008-1#1)(2008-4#1)(2010-10#1)(2012-2#1)
signalling molecules and##3##3##(2008-4#1)(2008-7#1)(2010-3#1)
signalling molecules in the##2##4##(1993-7#1)(2007-11#1)
signalling molecules##13##2##(1993-7#1)(1994-9#1)(1995-8#1)(1996-2#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-7#2)(2010-3#1)(2010-7#1)(2012-6#2)
signalling networks##4##2##(2006-7#1)(2008-4#1)(2008-7#1)(2011-2#1)
signalling of##2##2##(1991-7#1)(1992-7#1)
signalling pathway and##3##3##(1996-3#1)(2011-10#1)(2012-2#1)
signalling pathway by##2##3##(2009-7#1)(2011-2#1)
signalling pathway in##4##3##(1994-6#1)(1997-2#1)(2008-10#1)(2009-6#1)
signalling pathway is##2##3##(1996-2#1)(2013-1#1)
signalling pathway##34##2##(1990-4#1)(1991-8#1)(1993-4#1)(1994-6#1)(1995-11#1)(1995-8#2)(1996-11#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-7#1)(2006-10#2)(2006-11#1)(2008-10#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-2#1)(2011-10#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
signalling pathways and##3##3##(1997-7#1)(2008-10#1)(2009-6#1)
signalling pathways are involved in##2##5##(1994-11#1)(1996-1#1)
signalling pathways are##5##3##(1994-11#1)(1994-4#1)(1996-1#1)(1996-2#1)(2009-3#1)
signalling pathways in##5##3##(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(2013-8#1)
signalling pathways that##6##3##(1994-4#1)(1994-6#1)(1997-7#1)(2009-5#1)(2012-12#1)(2013-8#1)
signalling pathways which##2##3##(1992-7#1)(2008-7#1)
signalling pathways##45##2##(1992-7#1)(1993-6#2)(1993-8#1)(1994-10#1)(1994-11#2)(1994-2#3)(1994-4#4)(1994-6#2)(1996-1#1)(1996-2#4)(1996-5#1)(1997-7#2)(2003-11#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#2)(2008-7#3)(2009-3#1)(2009-5#1)(2009-6#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-8#3)
signalling protein##2##2##(2013-7#1)(2013-8#1)
signalling proteins which##2##3##(1996-2#2)
signalling proteins##6##2##(1996-2#2)(2009-7#1)(2012-12#2)(2013-7#1)
signalling receptors##2##2##(1996-3#1)(2008-4#1)
signalling system in##2##3##(1992-3#1)(2010-10#1)
signalling system##9##2##(1992-3#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-8#1)(2006-10#1)(2010-10#1)
signalling systems##3##2##(2006-12#2)(2009-8#1)
signalling through##2##2##(2007-8#2)
signalling to##5##2##(2009-10#2)(2009-8#1)(2010-11#1)(2013-7#1)
signalling was studied in##2##4##(2009-9#2)
signalling was##4##2##(2009-9#3)(2013-7#1)
signalling##352##1##(1990-10#1)(1990-4#1)(1990-8#2)(1991-1#2)(1991-5#1)(1991-7#1)(1991-8#5)(1991-9#1)(1992-11#2)(1992-3#2)(1992-7#2)(1992-8#2)(1992-9#1)(1993-3#1)(1993-4#3)(1993-6#7)(1993-7#1)(1993-8#3)(1993-9#2)(1994-10#2)(1994-11#3)(1994-12#1)(1994-2#5)(1994-4#5)(1994-5#2)(1994-6#9)(1994-9#2)(1995-11#2)(1995-12#2)(1995-5#4)(1995-8#7)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#11)(1996-3#4)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#3)(1997-7#4)(2003-11#1)(2005-11#1)(2005-7#4)(2006-1#1)(2006-10#11)(2006-11#6)(2006-12#5)(2006-7#1)(2007-11#2)(2007-8#12)(2008-1#5)(2008-10#6)(2008-11#3)(2008-3#1)(2008-4#26)(2008-7#17)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#3)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#6)(2009-7#6)(2009-8#7)(2009-9#12)(2010-10#8)(2010-11#1)(2010-2#4)(2010-3#2)(2010-7#1)(2011-10#2)(2011-12#4)(2011-2#13)(2012-1#1)(2012-12#21)(2012-2#9)(2012-3#1)(2012-6#2)(2013-1#4)(2013-7#5)(2013-8#11)
signalling)##4##1##(2008-7#2)(2009-9#1)(2010-8#1)
signalment##3##1##(2010-2#1)(2012-1#1)(2013-1#1)
signalosomes##2##1##(2009-4#2)
signals (e##4##2##(1991-4#1)(1993-2#1)(2008-2#1)(2012-12#1)
signals a##3##2##(2008-8#1)(2009-4#1)(2010-2#1)
signals acquired##3##2##(2008-10#1)(2008-3#1)(2010-8#1)
signals across the##2##3##(2009-8#1)(2012-2#1)
signals act##3##2##(1993-12#1)(2007-8#1)(2010-12#1)
signals after##2##2##(2008-2#2)
signals along##2##2##(1996-1#1)(2010-8#1)
signals and DNA##2##3##(1994-5#1)(1995-2#1)
signals and a##4##3##(1992-11#1)(1994-8#1)(2008-3#2)
signals and that##2##3##(1994-12#1)(2008-10#1)
signals and the##6##3##(1997-7#1)(2007-12#1)(2008-10#2)(2008-3#1)(2012-3#1)
signals and their##2##3##(2010-4#1)(2012-2#1)
signals and##51##2##(1990-12#1)(1992-11#1)(1992-2#1)(1994-10#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-10#1)(1997-2#1)(1997-5#1)(1997-7#1)(2007-12#3)(2007-8#1)(2008-10#6)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#3)(2009-9#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
signals are also##3##3##(1995-4#1)(2007-2#1)(2011-1#1)
signals are calculated##3##3##(2008-2#2)(2008-3#1)
signals are consistent with##2##4##(1992-6#1)(2008-3#1)
signals are converted##2##3##(2007-12#1)(2008-1#1)
signals are detected##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
signals are integrated##2##3##(2007-9#1)(2008-3#1)
signals are measured##2##3##(2007-12#1)(2008-10#1)
signals are not##3##3##(2008-11#1)(2008-2#1)(2009-6#1)
signals are obtained for##2##4##(1990-8#1)(2008-10#1)
signals are used to##2##4##(2008-3#2)
signals are used##3##3##(2008-2#1)(2008-3#2)
signals are##75##2##(1990-10#1)(1990-11#1)(1990-8#1)(1991-6#1)(1992-6#4)(1994-2#1)(1994-5#1)(1994-9#1)(1995-4#1)(1995-8#1)(1996-1#1)(1996-5#1)(2006-10#1)(2007-12#3)(2007-2#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-2#15)(2008-3#10)(2008-4#3)(2008-8#1)(2009-6#1)(2009-8#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
signals arising from the##2##4##(1990-3#1)(2008-10#1)
signals arising from##9##3##(1990-3#1)(1995-11#1)(2008-10#1)(2009-4#3)(2009-9#3)
signals as##5##2##(1996-8#1)(2007-11#1)(2008-3#2)(2012-12#1)
signals at the##6##3##(1994-9#1)(2006-9#1)(2008-2#2)(2008-3#1)(2013-1#1)
signals at##19##2##(1990-8#1)(1994-9#1)(1995-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#4)(2008-3#2)(2010-1#1)(2013-1#1)
signals back to##2##3##(2007-12#1)(2008-11#1)
signals based##2##2##(2008-10#1)(2008-2#1)
signals between the##3##3##(2008-2#1)(2012-12#2)
signals between##5##2##(1997-6#1)(2008-2#2)(2012-12#2)
signals but##2##2##(2008-3#1)(2010-6#1)
signals by the##3##3##(1990-3#1)(2008-2#1)(2013-1#1)
signals by use of##5##4##(2007-12#3)(2008-2#2)
signals by##21##2##(1990-3#1)(1992-12#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(2006-10#1)(2006-4#1)(2007-12#5)(2008-2#5)(2008-7#1)(2009-8#1)(2013-1#1)
signals calculated##2##2##(2008-3#2)
signals can be used to##3##5##(2008-2#1)(2010-8#1)(2012-1#1)
signals can be##14##3##(2006-4#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-4#1)(2009-3#1)(2010-8#1)(2012-1#1)(2012-2#1)
signals can##24##2##(1992-11#1)(1994-3#1)(1997-6#1)(2006-4#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#1)(2009-3#1)(2009-8#1)(2010-2#1)(2010-8#1)(2012-1#1)(2012-2#1)
signals caused by##3##3##(2008-10#3)
signals characteristic of the##2##4##(1992-12#1)(1992-3#1)
signals characteristic of##3##3##(1992-12#1)(1992-3#2)
signals characteristic##4##2##(1992-12#1)(1992-3#2)(2008-10#1)
signals characterized at##2##3##(2008-10#2)
signals collected##2##2##(2008-2#1)(2009-3#1)
signals control##2##2##(1995-6#1)(2008-10#1)
signals corresponding##2##2##(2007-8#1)(2008-10#1)
signals derived from##2##3##(1994-12#1)(2007-11#1)
signals derived##3##2##(1994-12#1)(2007-11#1)(2012-3#1)
signals detected by##2##3##(2008-10#1)(2008-3#1)
signals detected##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
signals due to##4##3##(1994-2#2)(1997-6#1)(2008-10#1)
signals during##8##2##(1991-12#1)(1992-2#1)(1995-5#1)(1996-6#1)(2007-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
signals elicited by##2##3##(1997-6#1)(2013-8#1)
signals elicited##4##2##(1997-6#1)(2012-12#2)(2013-8#1)
signals for all##2##3##(1990-3#1)(2008-2#1)
signals for the##11##3##(1992-12#1)(1993-9#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#1)(2010-8#1)(2011-12#1)
signals for##51##2##(1990-2#1)(1990-3#1)(1990-9#1)(1992-12#1)(1993-9#1)(1994-12#1)(1994-3#2)(1995-12#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#2)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#3)(2008-10#10)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
signals from a##9##3##(2008-10#1)(2008-3#8)
signals from both##2##3##(1990-3#1)(2007-12#1)
signals from clouds##2##3##(2008-10#1)(2008-3#1)
signals from different##3##3##(2007-12#1)(2008-3#2)
signals from many##2##3##(1996-11#1)(2008-4#1)
signals from multiple##2##3##(2008-3#1)(2009-8#1)
signals from surrounding##2##3##(1990-2#1)(2009-3#1)
signals from the external##2##4##(1997-2#1)(2008-11#1)
signals from the##25##3##(1990-3#1)(1994-3#1)(1995-2#1)(1996-1#2)(1996-10#1)(1997-2#1)(1997-5#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-3#2)(2009-8#1)(2012-2#1)
signals from this##3##3##(2006-12#2)(2009-7#1)
signals from##94##2##(1990-10#1)(1990-2#2)(1990-3#3)(1992-1#2)(1992-2#1)(1993-12#1)(1993-4#1)(1994-3#1)(1995-2#1)(1996-1#2)(1996-10#1)(1996-11#1)(1997-2#1)(1997-5#1)(2006-12#2)(2007-11#2)(2007-12#6)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#7)(2008-3#16)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#5)(2009-7#1)(2009-8#3)(2010-1#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
signals generated by##3##3##(1993-9#1)(2008-10#1)(2013-1#1)
signals generated from##3##3##(2007-12#3)
signals generated##9##2##(1993-9#1)(2007-12#4)(2008-10#1)(2008-4#1)(2009-3#1)(2013-1#1)
signals give information about##2##4##(1997-7#1)(2010-8#1)
signals has##2##2##(1992-12#1)(2008-2#1)
signals have a##2##3##(2008-3#1)(2010-7#1)
signals have been##4##3##(2007-12#1)(2008-10#2)(2008-2#1)
signals have##6##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-7#1)
signals in a##6##3##(1993-4#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2013-1#1)
signals in both##2##3##(2008-1#2)
signals in real time##2##4##(2008-3#1)(2012-3#1)
signals in the##26##3##(1991-5#1)(1992-6#1)(1994-5#1)(1995-7#1)(1996-3#1)(2006-10#1)(2006-9#2)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#7)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)
signals in these##2##3##(2008-11#1)(2011-2#1)
signals in wavelength-modulation spectrometry##2##4##(2008-3#2)
signals in##81##2##(1991-5#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-4#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-7#1)(1995-9#1)(1996-3#1)(1997-7#2)(2006-10#1)(2006-9#2)(2007-11#2)(2007-12#2)(2007-8#2)(2008-1#4)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#15)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-2#1)(2009-4#2)(2009-9#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
signals include##4##2##(1993-6#1)(1997-5#1)(2008-2#1)(2008-8#1)
signals induced by##3##3##(1994-6#2)(1997-7#1)
signals into##7##2##(1994-11#1)(1995-3#1)(1997-7#1)(2007-3#1)(2009-10#1)(2010-4#1)(2011-1#1)
signals involved##2##2##(1995-3#1)(2008-2#1)
signals is also##2##3##(2008-2#2)
signals is described##2##3##(2008-2#1)(2008-3#1)
signals is##24##2##(1993-9#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#7)(2008-3#5)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)
signals may be##5##3##(1992-9#1)(1997-6#1)(2008-7#1)(2012-2#1)(2013-8#1)
signals may##12##2##(1990-4#1)(1992-9#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#2)(2012-2#1)(2013-8#1)
signals must be##2##3##(1991-1#1)(2006-4#1)
signals necessary for##3##3##(1992-7#1)(2009-12#1)(2012-3#1)
signals observed##2##2##(1997-6#1)(1997-7#1)
signals obtained from##4##3##(2008-1#1)(2008-10#2)(2008-3#1)
signals obtained in##2##3##(2008-3#1)(2008-4#1)
signals obtained##9##2##(2008-1#1)(2008-10#5)(2008-3#2)(2008-4#1)
signals occurs##2##2##(1997-8#1)(2006-6#1)
signals of LHR mRNA##2##4##(2008-8#2)
signals of a##3##3##(1997-2#1)(2008-2#1)(2012-1#1)
signals of adverse drug##3##4##(2008-8#1)(2013-1#2)
signals of previously unrecognised adverse##2##5##(2008-8#2)
signals of rare##2##3##(2008-10#1)(2012-3#1)
signals of the ratio spectra##2##5##(2008-10#2)
signals of the##21##3##(1991-7#1)(1993-2#1)(1994-5#1)(1996-7#1)(2005-4#1)(2006-10#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-9#1)(2010-8#3)(2012-2#1)(2013-8#2)
signals of two##2##3##(2007-12#1)(2008-3#1)
signals of##80##2##(1991-7#2)(1991-8#1)(1993-2#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-12#1)(1996-10#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-5#1)(2005-4#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-12#2)(2008-10#16)(2008-11#1)(2008-2#5)(2008-3#9)(2008-8#10)(2008-9#4)(2009-8#1)(2010-8#3)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#4)
signals on the##4##3##(1996-4#1)(2007-12#1)(2008-2#1)(2013-1#1)
signals on##10##2##(1996-12#1)(1996-4#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
signals or the##2##3##(1993-2#1)(1995-5#1)
signals or##4##2##(1993-2#1)(1995-5#1)(2010-12#1)(2011-1#1)
signals over##2##2##(2007-12#1)(2011-1#1)
signals play key roles in##2##5##(2008-5#1)(2009-9#1)
signals proportional to the##2##4##(2006-12#1)(2008-2#1)
signals provided by##3##3##(2007-8#2)(2008-3#1)
signals provides##2##2##(1997-7#1)(2007-11#1)
signals received at##2##3##(2007-12#1)(2008-3#1)
signals received##3##2##(2007-12#1)(2008-11#1)(2008-3#1)
signals recorded##3##2##(2008-10#1)(2010-5#1)(2010-8#1)
signals required##2##2##(1991-7#1)(1991-9#1)
signals result in##2##3##(1996-7#1)(2008-1#1)
signals should be##2##3##(2008-10#1)(2008-8#1)
signals shows##2##2##(2007-12#1)(2008-2#1)
signals similar to##2##3##(1996-8#1)(2012-1#1)
signals such as##5##3##(1990-3#1)(1995-8#1)(2007-1#1)(2010-3#1)(2013-7#1)
signals such##6##2##(1990-3#1)(1995-8#1)(2007-1#1)(2007-11#1)(2010-3#1)(2013-7#1)
signals than##2##2##(2007-8#1)(2008-10#1)
signals that activate##2##3##(1995-6#1)(2007-11#1)
signals that are##11##3##(1990-5#1)(1995-5#1)(1997-5#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#2)(2010-10#1)(2010-8#1)
signals that control##3##3##(2008-10#1)(2008-5#1)(2012-1#1)
signals that drive##2##3##(2008-9#1)(2009-3#1)
signals that induce##2##3##(1994-3#1)(2008-10#1)
signals that lead to##2##4##(1994-12#1)(2009-8#1)
signals that regulate##2##3##(2003-11#1)(2008-7#1)
signals that##45##2##(1990-5#1)(1990-9#1)(1991-5#2)(1994-12#1)(1994-3#1)(1995-5#1)(1995-6#1)(1996-4#1)(1996-8#1)(1997-4#1)(1997-5#1)(2003-11#1)(2006-10#2)(2007-11#4)(2007-12#2)(2007-9#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-8#1)(2011-1#1)(2012-1#2)
signals the##4##2##(1994-11#1)(1995-3#1)(2008-9#1)(2011-2#1)
signals they##2##2##(1994-6#1)(2012-2#1)
signals through a##2##3##(1995-2#1)(2008-3#1)
signals through##12##2##(1995-11#1)(1995-2#1)(1996-5#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-10#1)(2011-12#1)(2012-12#2)
signals to be##2##3##(2008-3#1)(2012-1#1)
signals to determine the##2##4##(2008-11#1)(2008-2#1)
signals to determine##4##3##(2008-11#1)(2008-2#3)
signals to regulate##2##3##(2009-8#1)(2010-9#1)
signals to the##14##3##(1991-8#1)(1994-11#1)(1994-8#1)(1996-7#1)(1997-6#3)(2006-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-1#1)
signals to##53##2##(1990-6#1)(1991-8#1)(1994-10#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-7#1)(1996-8#1)(1997-6#3)(2006-10#4)(2007-11#2)(2007-12#3)(2008-11#3)(2008-2#4)(2008-3#6)(2008-4#2)(2009-8#3)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)
signals transduced by##3##3##(2008-2#1)(2008-4#2)
signals transmitted##2##2##(1996-8#1)(2008-3#1)
signals under##3##2##(2008-2#3)
signals using##3##2##(2007-10#1)(2008-10#1)(2008-2#1)
signals via the##3##3##(1990-3#1)(1994-10#1)(2008-11#1)
signals was##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
signals were detected##5##3##(1995-11#1)(2008-5#1)(2008-8#3)
signals were found##4##3##(1990-3#1)(1991-12#1)(2005-9#1)(2007-12#1)
signals were observed in the##3##5##(2006-1#1)(2008-10#2)
signals were observed in##6##4##(2006-1#1)(2007-12#1)(2008-10#3)(2010-8#1)
signals were observed##7##3##(2006-1#1)(2007-12#1)(2008-10#3)(2008-11#1)(2010-8#1)
signals were obtained for##2##4##(1996-12#1)(2008-10#1)
signals were obtained##6##3##(1996-12#3)(2007-5#1)(2008-10#2)
signals were processed by##2##4##(2008-10#1)(2008-3#1)
signals were recorded from##2##4##(1996-12#1)(2008-11#1)
signals were recorded##3##3##(1996-12#1)(2008-11#1)(2012-2#1)
signals were##58##2##(1990-3#1)(1991-12#1)(1992-3#1)(1994-12#2)(1994-5#1)(1994-9#2)(1995-11#1)(1996-12#5)(2005-9#1)(2006-1#1)(2006-12#2)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#20)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#4)(2009-2#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#1)
signals when##5##2##(1991-6#1)(2008-10#1)(2008-3#1)(2008-8#1)(2013-7#1)
signals which##7##2##(1990-7#1)(1994-8#1)(2006-10#1)(2009-8#1)(2010-5#1)(2013-1#2)
signals whose##2##2##(2007-12#1)(2008-2#1)
signals will##2##2##(2006-4#1)(2010-3#1)
signals with a##2##3##(2007-12#1)(2008-3#1)
signals with the##2##3##(2008-10#2)
signals with##15##2##(1996-9#2)(2006-4#2)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-5#1)(2009-3#1)
signals within a##3##3##(1990-4#1)(2005-8#1)(2009-12#1)
signals within the##4##3##(1991-11#1)(2006-5#1)(2007-12#1)(2008-10#1)
signals within##8##2##(1990-4#1)(1991-11#1)(2005-8#1)(2006-5#1)(2007-12#1)(2008-10#1)(2009-12#1)(2012-2#1)
signals without##2##2##(2008-2#1)(2008-3#1)
signals##1465##1##(1990-10#4)(1990-11#2)(1990-12#1)(1990-2#5)(1990-3#12)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#8)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#5)(1991-2#1)(1991-4#1)(1991-5#5)(1991-6#2)(1991-7#6)(1991-8#4)(1991-9#2)(1992-1#2)(1992-11#4)(1992-12#9)(1992-2#4)(1992-3#5)(1992-6#9)(1992-7#3)(1992-8#1)(1992-9#1)(1993-12#3)(1993-2#4)(1993-3#2)(1993-4#3)(1993-5#1)(1993-6#3)(1993-9#6)(1994-10#5)(1994-11#6)(1994-12#14)(1994-2#6)(1994-3#8)(1994-5#8)(1994-6#4)(1994-8#9)(1994-9#8)(1995-1#1)(1995-11#3)(1995-12#5)(1995-2#8)(1995-3#9)(1995-4#2)(1995-5#6)(1995-6#3)(1995-7#2)(1995-8#4)(1995-9#1)(1996-1#5)(1996-10#6)(1996-11#2)(1996-12#10)(1996-2#1)(1996-3#1)(1996-4#5)(1996-5#6)(1996-6#1)(1996-7#6)(1996-8#7)(1996-9#3)(1997-1#2)(1997-2#8)(1997-3#3)(1997-4#2)(1997-5#8)(1997-6#12)(1997-7#11)(1997-8#1)(2003-11#1)(2005-10#3)(2005-4#1)(2005-8#3)(2005-9#2)(2006-1#2)(2006-10#17)(2006-12#8)(2006-4#8)(2006-5#1)(2006-6#2)(2006-7#1)(2006-9#4)(2007-1#3)(2007-10#3)(2007-11#32)(2007-12#75)(2007-2#4)(2007-3#2)(2007-5#2)(2007-8#17)(2007-9#6)(2008-1#14)(2008-10#175)(2008-11#40)(2008-12#4)(2008-2#123)(2008-3#160)(2008-4#22)(2008-5#9)(2008-7#15)(2008-8#44)(2008-9#24)(2009-10#6)(2009-12#5)(2009-2#2)(2009-3#13)(2009-4#7)(2009-5#4)(2009-6#9)(2009-7#2)(2009-8#30)(2009-9#8)(2010-1#2)(2010-10#6)(2010-11#1)(2010-12#5)(2010-2#7)(2010-3#5)(2010-4#3)(2010-5#5)(2010-6#3)(2010-7#5)(2010-8#23)(2010-9#2)(2011-1#14)(2011-12#3)(2011-2#11)(2012-1#18)(2012-11#1)(2012-12#19)(2012-2#17)(2012-3#15)(2012-9#1)(2013-1#19)(2013-7#6)(2013-8#14)
signals)##5##1##(1991-12#1)(1992-12#1)(1996-7#1)(2008-2#1)(2008-7#1)
signature chemicals##5##2##(2008-10#5)
signature for the##3##3##(1992-8#1)(2007-1#1)(2009-8#1)
signature for##8##2##(1992-8#1)(2007-1#1)(2007-11#1)(2008-4#1)(2009-8#2)(2011-1#1)(2013-1#1)
signature in##2##2##(2008-7#1)(2009-12#1)
signature ion peak##2##3##(2008-4#2)
signature is##3##2##(2006-12#1)(2007-11#1)(2008-2#1)
signature of a##2##3##(1996-4#1)(2007-12#1)
signature of positive diversifying selection##2##5##(2012-12#2)
signature of positive##3##3##(2012-12#3)
signature of the##2##3##(2008-3#2)
signature of##21##2##(1993-11#1)(1996-4#1)(2005-11#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)
signature patterns##3##2##(2008-10#1)(2008-2#2)
signature sequence##4##2##(1990-12#1)(2008-8#1)(2013-1#2)
signature sequencing (MPSS)##2##3##(2008-7#1)(2009-10#1)
signature that##4##2##(2010-3#2)(2013-1#2)
signature to##2##2##(2008-3#1)(2013-8#1)
signature##92##1##(1990-12#2)(1992-8#1)(1993-11#1)(1994-12#1)(1996-10#1)(1996-4#1)(1996-9#1)(2005-11#1)(2006-12#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-2#8)(2008-3#7)(2008-4#5)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-3#2)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#11)(2013-8#5)
signatures and##4##2##(2008-3#1)(2008-4#1)(2010-5#1)(2011-12#1)
signatures are##4##2##(1997-5#1)(2008-3#1)(2012-2#1)(2013-8#1)
signatures as##2##2##(2009-6#1)(2010-11#1)
signatures associated with##3##3##(2008-7#1)(2010-10#1)(2010-4#1)
signatures for##5##2##(2008-3#1)(2010-3#1)(2011-1#1)(2012-1#1)(2013-8#1)
signatures from##4##2##(1997-2#1)(2007-11#1)(2008-10#1)(2010-11#1)
signatures in##6##2##(1995-3#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-7#1)(2010-8#1)
signatures is##2##2##(2008-4#1)(2009-6#1)
signatures of the##4##3##(2008-3#1)(2008-6#1)(2012-2#1)(2012-3#1)
signatures of##22##2##(1991-12#1)(1995-3#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#2)(2008-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-8#3)
signatures that##2##2##(2008-7#1)(2009-12#1)
signatures to##5##2##(2009-6#1)(2011-12#2)(2012-2#1)(2013-8#1)
signatures were##2##2##(2008-10#1)(2008-3#1)
signatures with##2##2##(2008-7#1)(2013-8#1)
signatures##98##1##(1991-12#1)(1995-3#3)(1995-9#1)(1997-2#1)(1997-5#3)(2006-10#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#7)(2008-4#3)(2008-6#2)(2008-7#7)(2008-9#2)(2009-12#1)(2009-3#2)(2009-4#2)(2009-6#4)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#3)(2011-2#2)(2012-1#1)(2012-2#7)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#7)
signed a consent to adoption##2##5##(1991-7#2)
signed a consent##3##3##(1991-7#2)(1996-11#1)
signed a##4##2##(1991-7#2)(1996-11#1)(2008-5#1)
signed an agreement with##2##4##(2005-8#1)(2008-5#1)
signed an##3##2##(2005-8#1)(2007-8#1)(2008-5#1)
signed into law##7##3##(1991-12#2)(1991-3#1)(1993-1#1)(1994-3#1)(1996-5#1)(2006-8#1)
signed ranks##2##2##(2008-10#1)(2008-3#1)
signed the##4##2##(1994-1#1)(1996-1#1)(1996-5#1)(2009-4#1)
signed##41##1##(1991-12#2)(1991-3#1)(1991-6#1)(1991-7#2)(1993-1#1)(1994-1#1)(1994-3#1)(1994-9#1)(1996-1#1)(1996-11#1)(1996-5#2)(1997-5#1)(1997-8#1)(2004-3#1)(2005-8#1)(2006-10#3)(2006-8#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-6#1)(2010-8#2)(2011-1#1)(2013-8#1)
signed-digit (TSD)##3##2##(2008-2#3)
signed-digit##10##1##(2008-2#6)(2008-3#4)
signers##2##1##(2010-5#2)
signes##3##1##(2009-4#1)(2011-2#1)(2012-2#1)
signet ring cell##3##3##(1993-12#3)
signet ring cells##2##3##(2012-2#2)
signet ring##6##2##(1993-12#3)(2006-8#1)(2012-2#2)
signet##7##1##(1993-12#3)(2006-8#1)(2007-7#1)(2012-2#2)
signet-ring cell##2##2##(1992-6#1)(1993-8#1)
signet-ring##4##1##(1992-6#2)(1993-8#1)(2008-5#1)
significally##2##1##(2006-8#1)(2011-2#1)
significance (P &lt##2##3##(2008-10#1)(2012-3#1)
significance (P = 0##2##4##(1992-11#1)(2011-2#1)
significance (P##5##2##(1991-2#1)(1992-11#1)(2008-10#1)(2011-2#1)(2012-3#1)
significance (p = 0##2##4##(2007-5#1)(2008-5#1)
significance (p =##3##3##(2007-5#1)(2008-11#1)(2008-5#1)
significance (p less than 0##2##5##(1990-9#1)(1991-4#1)
significance (p##7##2##(1990-9#1)(1991-4#1)(2007-5#1)(2008-11#1)(2008-5#1)(2009-4#1)(2009-8#1)
significance among##2##2##(1997-1#1)(2007-12#1)
significance and interpretation##2##3##(2007-7#1)(2008-4#1)
significance and potential##2##3##(2008-10#1)(2011-12#1)
significance and the##3##3##(2012-1#1)(2013-1#1)(2013-2#1)
significance and##38##2##(1991-2#1)(1991-7#1)(1993-8#1)(1994-8#1)(1995-4#1)(1995-8#1)(1997-2#1)(2005-7#1)(2006-1#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-4#3)(2008-5#1)(2008-9#1)(2010-7#1)(2011-12#1)(2012-1#2)(2012-11#1)(2012-2#2)(2013-1#3)(2013-2#1)(2013-8#1)
significance are the##2##3##(2006-10#1)(2011-12#1)
significance are##6##2##(1990-4#1)(1996-12#1)(2006-10#1)(2011-1#1)(2011-12#1)(2012-3#1)
significance as a##5##3##(1993-9#1)(2005-10#1)(2007-12#1)(2008-10#1)(2012-3#1)
significance as it##3##3##(2008-3#1)(2013-1#2)
significance as risk##2##3##(1996-8#1)(2008-4#1)
significance as##14##2##(1993-9#1)(1996-8#1)(2005-10#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-4#1)(2009-4#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#2)
significance at##5##2##(1993-9#1)(1995-8#2)(2006-10#1)(2007-9#1)
significance because of the##2##4##(1996-6#1)(2008-7#1)
significance because##4##2##(1996-6#1)(2007-8#1)(2008-7#1)(2011-2#1)
significance between##7##2##(1990-12#1)(1993-2#1)(2006-10#1)(2006-6#1)(2008-10#1)(2011-2#1)(2013-1#1)
significance by##4##2##(1996-5#1)(2007-8#1)(2008-1#1)(2009-2#1)
significance can be##3##3##(1991-12#1)(1996-12#1)(2006-8#1)
significance for a##3##3##(1993-5#1)(2009-10#1)(2009-5#1)
significance for the##13##3##(1990-11#1)(1990-3#1)(1990-4#2)(1990-9#1)(1993-3#1)(1995-12#1)(1997-3#1)(2011-3#1)(2012-2#2)(2013-8#2)
significance for understanding the##2##4##(1992-11#1)(2008-10#1)
significance for##40##2##(1990-11#1)(1990-3#1)(1990-4#3)(1990-9#1)(1991-7#1)(1992-11#1)(1993-3#2)(1993-5#1)(1994-2#1)(1995-12#1)(1995-8#1)(1996-6#1)(1997-3#1)(2005-11#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#2)(2009-10#1)(2009-5#1)(2010-11#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#3)
significance in determining##2##3##(1991-3#1)(1997-3#1)
significance in diagnosis##2##3##(2009-2#1)(2012-2#1)
significance in patients##2##3##(2006-9#1)(2010-12#1)
significance in the##13##3##(1990-10#2)(1993-12#1)(1993-2#1)(1996-11#1)(2005-10#1)(2005-12#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-8#1)(2011-1#1)
significance in##66##2##(1990-10#2)(1990-12#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-8#1)(1995-12#1)(1996-11#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-7#1)(2005-10#1)(2005-12#1)(2006-1#1)(2006-10#4)(2006-4#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-3#1)(2007-6#2)(2007-7#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#2)(2009-4#1)(2010-12#2)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
significance is##8##2##(1994-8#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-3#1)(2008-6#1)(2009-5#1)(2011-1#1)
significance level of 0##2##4##(2007-8#1)(2008-10#1)
significance level of##4##3##(2007-11#1)(2007-8#1)(2008-10#1)(2012-12#1)
significance level was##2##3##(2005-10#1)(2013-8#1)
significance level##18##2##(1996-1#1)(1996-12#1)(1997-3#1)(2005-10#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-12#1)(2011-2#1)(2012-12#2)(2013-1#4)(2013-8#1)
significance levels##5##2##(1990-8#1)(2007-9#1)(2012-3#2)(2013-1#1)
significance of a##4##3##(1991-6#1)(2006-10#1)(2012-12#1)(2012-3#1)
significance of antibodies to##2##4##(2007-11#2)
significance of cathepsin-D expression##3##4##(1993-9#3)
significance of cell##3##3##(2006-10#2)(2009-8#1)
significance of certain##2##3##(1990-9#1)(2006-6#1)
significance of cyclin D1 expression in##2##6##(2007-8#2)
significance of dental##2##3##(2010-7#1)(2012-12#1)
significance of differences between##2##4##(2007-10#1)(2008-10#1)
significance of differences##5##3##(2006-9#1)(2007-10#2)(2008-10#1)(2008-7#1)
significance of difficulties in mobility##2##5##(2008-7#2)
significance of each##2##3##(2008-10#1)(2010-6#1)
significance of flow##2##3##(1993-1#2)
significance of hepatitis##2##3##(1992-5#1)(2005-10#1)
significance of identifying##2##3##(2010-2#1)(2012-2#1)
significance of positive##3##3##(1992-11#1)(2011-1#1)(2011-2#1)
significance of serum##2##3##(1991-12#1)(1993-10#1)
significance of several##2##3##(2008-10#1)(2011-2#1)
significance of sex chromosome##2##4##(2007-12#1)(2012-3#1)
significance of some##2##3##(1996-11#1)(2009-2#1)
significance of specific##2##3##(1990-12#1)(2007-7#1)
significance of such##6##3##(1991-5#1)(1994-3#1)(1994-8#1)(2004-11#1)(2011-2#2)
significance of supporting##2##3##(2008-12#1)(2010-8#1)
significance of the difference##2##4##(1994-4#1)(2008-7#1)
significance of the observed##2##4##(1991-5#1)(1993-12#1)
significance of the proposed##3##4##(2008-10#1)(2008-2#1)(2008-9#1)
significance of the results##3##4##(2007-11#2)(2009-5#1)
significance of the##112##3##(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-12#3)(1993-6#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#2)(1996-9#2)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-7#2)(2005-8#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#4)(2013-1#5)(2013-8#2)
significance of their##2##3##(1996-2#1)(2007-11#1)
significance of these findings##5##4##(1991-10#1)(1996-5#1)(1996-8#1)(2008-3#1)(2009-9#1)
significance of these observations##5##4##(1990-2#1)(1992-3#1)(1992-7#1)(2005-8#1)(2008-3#1)
significance of these results for##2##5##(1994-2#1)(1996-2#1)
significance of these results is discussed##2##6##(1993-8#1)(2007-12#1)
significance of these results##6##4##(1993-8#1)(1994-2#1)(1996-2#1)(2007-12#1)(2008-10#2)
significance of these##42##3##(1990-2#1)(1991-10#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-9#1)(1996-2#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-12#3)(2006-6#1)(2006-8#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-7#1)
significance of this finding##2##4##(2009-3#1)(2010-12#1)
significance of this interaction##2##4##(1995-2#1)(1995-3#1)
significance of this observation is##2##5##(1992-9#1)(1993-6#1)
significance of this relationship##2##4##(2007-6#1)(2008-9#1)
significance of this##37##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-9#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-3#1)(2005-7#1)(2005-8#1)(2006-2#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-5#1)(2008-9#3)(2009-3#1)(2009-4#1)(2010-12#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
significance of various##3##3##(1993-5#1)(2006-10#1)(2010-3#1)
significance of vascular##2##3##(2007-10#1)(2009-8#1)
significance of which is##2##4##(2006-8#1)(2007-11#1)
significance of which##4##3##(2006-8#1)(2007-11#1)(2007-12#1)(2011-2#1)
significance of##553##2##(1990-10#3)(1990-11#2)(1990-12#4)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#5)(1991-1#1)(1991-10#3)(1991-11#3)(1991-12#3)(1991-2#4)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-1#4)(1993-10#2)(1993-11#1)(1993-12#7)(1993-2#2)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#5)(1994-10#1)(1994-11#3)(1994-12#4)(1994-2#2)(1994-3#2)(1994-4#3)(1994-5#2)(1994-6#3)(1994-8#3)(1994-9#4)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#3)(1995-9#2)(1996-1#1)(1996-11#4)(1996-12#2)(1996-2#3)(1996-3#4)(1996-4#1)(1996-5#5)(1996-7#1)(1996-8#2)(1996-9#5)(1997-1#3)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#2)(2004-1#1)(2004-10#1)(2004-11#1)(2004-4#1)(2005-10#8)(2005-11#4)(2005-3#1)(2005-5#1)(2005-7#3)(2005-8#6)(2005-9#1)(2006-10#13)(2006-12#6)(2006-2#3)(2006-4#2)(2006-5#2)(2006-6#5)(2006-8#2)(2006-9#5)(2007-10#5)(2007-11#12)(2007-12#11)(2007-2#2)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#8)(2007-8#10)(2007-9#1)(2008-1#7)(2008-10#26)(2008-11#8)(2008-12#5)(2008-2#7)(2008-3#5)(2008-4#3)(2008-5#4)(2008-6#4)(2008-7#16)(2008-8#5)(2008-9#9)(2009-1#3)(2009-10#4)(2009-11#1)(2009-2#5)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#4)(2009-7#3)(2009-8#6)(2009-9#4)(2010-11#2)(2010-12#7)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#4)(2011-1#8)(2011-12#1)(2011-2#16)(2012-1#3)(2012-11#1)(2012-12#7)(2012-2#16)(2012-3#14)(2013-1#19)(2013-7#2)(2013-8#7)
significance only##2##2##(2006-10#1)(2008-4#1)
significance or##3##2##(2006-1#1)(2006-10#1)(2006-8#1)
significance remains to be##2##4##(1990-10#1)(1995-2#1)
significance remains##3##2##(1990-10#1)(1995-2#1)(2009-8#1)
significance set at##2##3##(2011-1#1)(2011-2#1)
significance should not be##2##4##(1997-4#1)(2010-6#1)
significance test##2##2##(1996-6#1)(1997-2#1)
significance tests##3##2##(1994-11#1)(1997-4#1)(2008-10#1)
significance that##2##2##(1990-8#1)(1996-7#1)
significance threshold##2##2##(2008-10#1)(2012-2#1)
significance to##16##2##(1992-2#1)(1993-12#1)(1995-3#1)(1996-5#1)(2005-8#1)(2006-8#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-12#1)(2012-2#1)
significance was observed in##2##4##(2007-8#1)(2011-1#1)
significance was observed##3##3##(2007-8#1)(2008-7#1)(2011-1#1)
significance was set at##5##4##(2008-10#1)(2009-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
significance was##20##2##(1993-11#1)(1993-3#1)(1994-9#2)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-7#1)(2011-1#2)(2012-12#1)(2013-1#1)
significance were##2##2##(1990-10#1)(2008-11#1)
significance with##4##2##(2007-11#1)(2008-10#1)(2012-11#2)
significance##1115##1##(1990-10#7)(1990-11#4)(1990-12#7)(1990-2#2)(1990-3#4)(1990-4#5)(1990-5#4)(1990-6#4)(1990-7#3)(1990-8#5)(1990-9#7)(1991-1#1)(1991-10#3)(1991-11#4)(1991-12#6)(1991-2#8)(1991-3#4)(1991-4#2)(1991-5#2)(1991-6#3)(1991-7#5)(1991-8#1)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#5)(1992-12#1)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-1#4)(1993-10#2)(1993-11#2)(1993-12#9)(1993-2#4)(1993-3#6)(1993-4#1)(1993-5#3)(1993-6#2)(1993-8#2)(1993-9#7)(1994-10#2)(1994-11#5)(1994-12#6)(1994-2#3)(1994-3#3)(1994-4#3)(1994-5#3)(1994-6#5)(1994-8#7)(1994-9#7)(1995-1#1)(1995-10#1)(1995-12#6)(1995-2#5)(1995-3#4)(1995-4#2)(1995-5#2)(1995-6#4)(1995-8#8)(1995-9#2)(1996-1#3)(1996-10#1)(1996-11#5)(1996-12#6)(1996-2#5)(1996-3#4)(1996-4#3)(1996-5#7)(1996-6#5)(1996-7#2)(1996-8#4)(1996-9#10)(1997-1#5)(1997-2#6)(1997-3#3)(1997-4#5)(1997-5#5)(1997-6#3)(1997-7#8)(1997-8#4)(2004-1#1)(2004-10#2)(2004-11#1)(2004-4#1)(2005-10#14)(2005-11#6)(2005-12#1)(2005-3#1)(2005-5#1)(2005-7#4)(2005-8#8)(2005-9#1)(2006-1#5)(2006-10#30)(2006-11#1)(2006-12#8)(2006-2#3)(2006-4#4)(2006-5#4)(2006-6#8)(2006-7#1)(2006-8#7)(2006-9#7)(2007-10#10)(2007-11#19)(2007-12#23)(2007-2#4)(2007-3#4)(2007-4#5)(2007-5#1)(2007-6#7)(2007-7#16)(2007-8#19)(2007-9#8)(2008-1#16)(2008-10#59)(2008-11#18)(2008-12#12)(2008-2#10)(2008-3#10)(2008-4#17)(2008-5#14)(2008-6#11)(2008-7#26)(2008-8#13)(2008-9#16)(2009-1#3)(2009-10#5)(2009-11#2)(2009-12#2)(2009-2#9)(2009-3#2)(2009-4#5)(2009-5#6)(2009-6#4)(2009-7#7)(2009-8#11)(2009-9#4)(2010-1#2)(2010-11#5)(2010-12#13)(2010-2#3)(2010-3#4)(2010-4#6)(2010-5#5)(2010-6#2)(2010-7#7)(2010-8#4)(2010-9#2)(2011-1#25)(2011-12#7)(2011-2#31)(2011-3#2)(2011-7#1)(2012-1#5)(2012-11#4)(2012-12#14)(2012-2#30)(2012-3#25)(2013-1#43)(2013-2#1)(2013-7#4)(2013-8#20)
significance-testing##2##1##(1994-4#1)(2008-3#1)
significance?##2##1##(2006-9#1)(2008-7#1)
significance]##4##1##(1992-4#1)(1997-3#1)(2012-2#1)(2013-7#1)
significances of##4##2##(1992-8#1)(2008-10#1)(2012-2#1)(2013-8#1)
significant (&gt##3##2##(2007-10#2)(2009-6#1)
significant (1##3##2##(1990-3#1)(1992-4#1)(2008-8#1)
significant (P &gt##3##3##(2007-7#1)(2008-10#1)(2009-6#1)
significant (P &lt##64##3##(1993-12#2)(1993-2#1)(1994-12#2)(1994-8#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-6#2)(1996-9#2)(1997-5#2)(1997-8#1)(2006-12#1)(2007-6#2)(2008-1#4)(2008-10#17)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#4)(2009-2#1)(2009-5#7)(2009-6#2)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#2)
significant (P = 0##17##4##(1992-7#1)(1996-3#2)(2008-10#10)(2008-6#1)(2008-8#1)(2009-6#2)
significant (P less than 0##6##5##(1990-3#1)(1991-5#1)(1992-3#1)(1992-7#1)(1992-8#2)
significant (P##91##2##(1990-3#1)(1991-5#1)(1992-3#1)(1992-7#2)(1992-8#2)(1993-12#2)(1993-2#1)(1994-12#2)(1994-8#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-6#2)(1996-9#2)(1997-5#2)(1997-8#1)(2006-12#1)(2007-6#2)(2007-7#1)(2008-1#4)(2008-10#28)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#5)(2009-2#1)(2009-5#7)(2009-6#5)(2010-3#1)(2011-2#2)(2012-1#1)(2012-2#2)
significant (P&gt##6##2##(2008-7#1)(2009-3#2)(2011-2#1)(2013-1#2)
significant (P&lt##20##2##(1993-7#1)(1997-6#1)(2005-10#1)(2006-4#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-2#1)(2010-4#1)(2010-5#4)(2011-1#1)(2012-11#2)
significant (RR##2##2##(1991-7#1)(2010-12#1)
significant (chi2 =##2##3##(2008-12#1)(2009-6#1)
significant (odds##2##2##(1992-12#1)(2007-9#1)
significant (p &gt##6##3##(2007-6#1)(2008-12#3)(2008-3#1)(2010-9#1)
significant (p &lt##33##3##(1993-9#1)(1995-12#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-9#3)(2010-7#1)(2011-2#2)(2012-2#2)
significant (p = 0##13##4##(1991-4#1)(1993-1#1)(1997-6#1)(2005-10#1)(2006-12#1)(2007-1#1)(2007-2#1)(2008-1#1)(2008-9#1)(2012-2#2)(2013-1#2)
significant (p =##14##3##(1991-4#1)(1993-1#1)(1997-6#1)(2005-10#1)(2006-12#1)(2007-1#1)(2007-2#1)(2008-1#1)(2008-9#1)(2010-10#1)(2012-2#2)(2013-1#2)
significant (p less than 0##5##5##(1990-11#1)(1990-12#1)(1991-11#1)(1991-7#1)(1992-8#1)
significant (p##61##2##(1990-11#1)(1990-12#1)(1991-11#1)(1991-4#1)(1991-7#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-9#2)(1995-12#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#6)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-9#4)(2010-10#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-2#4)(2013-1#2)
significant (p&gt##3##2##(2008-12#1)(2008-5#1)(2010-7#1)
significant (p&lt##23##2##(2004-4#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-12#4)(2009-2#1)(2010-12#1)(2010-2#3)(2010-4#1)(2011-12#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#3)
significant (p=##3##2##(1992-10#1)(2013-1#2)
significant (p=0##4##2##(2004-9#1)(2006-1#1)(2006-6#1)(2008-12#1)
significant CAD##3##2##(2011-1#1)(2012-2#2)
significant CAG##2##2##(2006-10#2)
significant DNA##2##2##(2007-10#1)(2008-8#1)
significant FA increase##2##3##(2013-7#2)
significant FA##3##2##(2013-7#3)
significant GH response over time##2##5##(1996-2#2)
significant PARP inhibition##2##3##(1993-11#2)
significant PL induction##2##3##(2004-8#2)
significant QTL##2##2##(2012-11#1)(2012-3#1)
significant SNP effects##2##3##(2010-2#2)
significant [P &lt##4##3##(2007-1#2)(2008-4#2)
significant ability to##2##3##(2008-9#1)(2012-3#1)
significant according to##2##3##(2006-7#1)(2008-7#1)
significant accumulation in##2##3##(1994-11#1)(2012-2#1)
significant accumulation of##6##3##(1991-5#1)(1994-11#1)(1997-1#1)(2007-8#1)(2008-4#1)(2008-8#1)
significant accumulation##9##2##(1991-5#1)(1994-11#2)(1997-1#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-8#1)(2012-2#1)
significant achievements##2##2##(2006-2#1)(2008-10#1)
significant activating##2##2##(1995-6#1)(2008-10#1)
significant activation in##2##3##(2008-11#1)(2008-9#1)
significant activation of##3##3##(1990-3#1)(1994-3#1)(2012-2#1)
significant activation##8##2##(1990-3#1)(1994-3#1)(2008-11#1)(2008-2#1)(2008-7#2)(2008-9#1)(2012-2#1)
significant activities##2##2##(2006-12#1)(2009-4#1)
significant activity against##2##3##(1997-2#1)(2008-4#1)
significant activity for##2##3##(1996-10#1)(2007-10#1)
significant activity in##4##3##(2008-5#1)(2008-6#1)(2009-3#1)(2010-11#1)
significant activity of##2##3##(1992-11#1)(1995-3#1)
significant activity was##2##3##(1996-11#1)(2008-11#1)
significant activity with##2##3##(2004-1#1)(2008-3#1)
significant activity##21##2##(1991-2#1)(1992-11#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-3#1)(1996-10#1)(1996-11#1)(1997-2#1)(2004-1#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2009-3#1)(2010-11#1)
significant acute##2##2##(1995-5#1)(2010-6#1)
significant additional##4##2##(1995-8#1)(2008-1#1)(2008-10#1)(2008-2#1)
significant additive##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
significant advance in##8##3##(1997-7#1)(2005-10#1)(2006-5#1)(2007-11#1)(2007-9#1)(2008-1#1)(2011-2#1)(2012-12#1)
significant advance##10##2##(1995-12#1)(1997-7#1)(2005-10#2)(2006-5#1)(2007-11#1)(2007-9#1)(2008-1#1)(2011-2#1)(2012-12#1)
significant advancement in the##2##4##(2008-10#1)(2009-5#1)
significant advancement in##4##3##(2006-10#1)(2008-10#1)(2009-5#1)(2010-11#1)
significant advancement##5##2##(2006-10#1)(2008-10#1)(2008-6#1)(2009-5#1)(2010-11#1)
significant advances have been made in the##4##7##(1996-4#1)(2008-12#1)(2008-8#1)(2012-12#1)
significant advances have been made in##8##6##(1992-12#1)(1996-4#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-8#1)(2012-12#1)
significant advances have been made##9##5##(1992-12#1)(1996-4#1)(2006-10#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-8#1)(2012-12#1)
significant advances in our understanding of the##2##7##(2005-8#1)(2009-3#1)
significant advances in our##3##4##(2005-8#1)(2009-3#1)(2013-7#1)
significant advances in sensing oxidative stress have been made by taking advantage of specific chemistry between cellular oxidants such as H(2) O(2)##2##22##(2012-11#2)
significant advances in the understanding of the##2##7##(2008-9#1)(2009-3#1)
significant advances in the##6##4##(1990-11#1)(2006-8#1)(2007-12#1)(2008-11#1)(2008-9#1)(2009-3#1)
significant advances in understanding the pathophysiology of##2##7##(2008-1#1)(2011-1#1)
significant advances in##22##3##(1990-11#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-11#2)(2013-7#1)
significant advances##37##2##(1990-11#1)(1992-12#1)(1996-4#1)(2005-8#1)(2006-10#5)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-12#1)(2013-7#1)
significant advantage for##2##3##(2007-12#1)(2008-6#1)
significant advantage in the##2##4##(2008-3#1)(2010-9#1)
significant advantage in##3##3##(2007-11#1)(2008-3#1)(2010-9#1)
significant advantage of##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)
significant advantage over##5##3##(2007-11#1)(2008-10#2)(2008-9#1)(2010-8#1)
significant advantage##19##2##(1990-4#1)(1996-1#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-1#1)(2010-8#1)(2010-9#1)
significant advantages for##3##3##(2006-4#1)(2008-7#1)(2010-12#1)
significant advantages in these##2##4##(1994-2#1)(2005-8#1)
significant advantages in##5##3##(1993-8#1)(1994-2#1)(2005-8#1)(2006-7#1)(2008-10#1)
significant advantages of##3##3##(2007-12#1)(2008-10#2)
significant advantages over##7##3##(1996-12#1)(1997-4#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#1)(2009-6#1)
significant advantages##24##2##(1993-8#1)(1994-2#1)(1996-12#1)(1997-4#1)(1997-6#1)(2005-8#1)(2006-4#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-2#2)(2008-4#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-2#1)
significant adverse effect##2##3##(2008-4#1)(2011-2#1)
significant adverse effects##8##3##(1992-2#1)(1995-12#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-12#1)(2010-8#1)(2012-12#1)
significant adverse events##2##3##(1991-6#1)(2007-11#1)
significant adverse##14##2##(1991-6#1)(1992-2#1)(1995-12#1)(2006-2#1)(2006-5#1)(2007-11#2)(2008-10#1)(2008-12#1)(2008-4#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#1)
significant affect on##3##3##(2005-11#1)(2006-8#1)(2010-4#1)
significant after adjusting for other##2##5##(1990-6#1)(2012-5#1)
significant after adjusting for##5##4##(1990-6#1)(1995-12#1)(2012-5#2)(2013-1#1)
significant after##10##2##(1990-6#1)(1992-12#1)(1994-8#1)(1995-12#1)(2007-11#1)(2007-12#1)(2009-4#1)(2012-5#2)(2013-1#1)
significant age##2##2##(1991-12#1)(2008-7#1)
significant age-dependent changes##2##3##(1995-8#1)(1996-3#1)
significant age-dependent##5##2##(1992-12#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-5#1)
significant age-related##4##2##(1990-4#1)(1996-5#1)(1996-9#1)(2008-7#1)
significant aggregation##2##2##(1991-2#1)(2005-11#1)
significant alleviation##2##2##(2012-1#1)(2012-11#1)
significant alteration in##7##3##(1996-1#1)(2004-4#1)(2007-12#1)(2007-7#1)(2008-5#1)(2011-2#1)(2013-8#1)
significant alteration of##4##3##(1991-4#1)(1994-6#1)(1995-2#1)(2008-4#1)
significant alteration##12##2##(1991-4#1)(1994-6#1)(1995-2#1)(1996-1#1)(2004-4#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#1)(2013-8#1)
significant alterations in the##5##4##(1991-4#1)(1994-3#1)(1996-5#1)(2013-8#2)
significant alterations in##10##3##(1991-4#1)(1994-3#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-5#1)(2007-8#1)(2009-6#1)(2013-8#2)
significant alterations were##2##3##(2007-9#1)(2008-5#1)
significant alterations##15##2##(1991-4#1)(1994-3#1)(1995-12#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-5#1)(2004-4#1)(2007-8#1)(2007-9#1)(2008-5#1)(2009-6#1)(2013-1#1)(2013-8#2)
significant amino acid##2##3##(2008-10#2)
significant among the##2##3##(1990-12#1)(2008-6#1)
significant among##5##2##(1990-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-3#1)
significant amount of the##7##4##(1991-1#1)(1991-4#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-3#1)
significant amount of work##2##4##(2006-10#1)(2007-12#1)
significant amount of##29##3##(1991-1#1)(1991-2#1)(1991-4#1)(1994-9#2)(1995-1#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-10#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
significant amounts in the##3##4##(1992-8#1)(1993-4#1)(1995-2#1)
significant amounts of the##2##4##(2008-10#1)(2010-9#1)
significant amounts of##33##3##(1990-5#1)(1991-1#1)(1992-12#2)(1993-11#2)(1993-9#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-3#2)(1996-5#1)(1997-4#1)(2006-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#2)(2009-10#1)(2009-2#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
significant amounts##44##2##(1990-11#1)(1990-3#2)(1990-5#1)(1991-1#1)(1992-12#3)(1992-4#1)(1992-8#2)(1993-11#2)(1993-4#1)(1993-9#2)(1994-12#1)(1994-6#1)(1994-9#1)(1995-2#2)(1995-3#2)(1996-5#1)(1997-4#1)(2004-11#1)(2006-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#2)(2009-10#1)(2009-2#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
significant analgesic activity##2##3##(2008-5#1)(2011-1#1)
significant analgesic##3##2##(2008-5#2)(2011-1#1)
significant and comparable##4##3##(1992-11#1)(1995-3#1)(2005-11#1)(2013-1#1)
significant and dose-dependent##2##3##(1991-7#1)(1995-1#1)
significant and growing##3##3##(2006-9#1)(2008-5#1)(2010-6#1)
significant and insignificant##4##3##(2007-8#1)(2008-10#3)
significant and long-lasting##3##3##(1992-5#1)(1996-10#1)(2007-2#1)
significant and novel##2##3##(2007-12#1)(2012-11#1)
significant and positive##3##3##(1995-7#1)(2011-2#2)
significant and##71##2##(1990-5#1)(1990-7#1)(1991-7#1)(1992-11#1)(1992-5#1)(1993-10#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-7#1)(1996-10#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(2004-2#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-8#1)(2006-9#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2009-4#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
significant antagonistic effect##2##3##(2008-10#1)(2008-7#1)
significant anti-HSV##2##2##(2006-12#1)(2008-5#1)
significant antibacterial##4##2##(2006-12#1)(2008-12#1)(2010-2#1)(2012-3#1)
significant antibody##3##2##(1997-6#1)(2006-2#1)(2007-2#1)
significant antimicrobial activity##2##3##(1996-4#1)(2008-11#1)
significant antioxidant activity##5##3##(2006-12#1)(2008-10#1)(2011-2#2)(2012-2#1)
significant antiproliferative activity##3##3##(2006-12#1)(2007-11#1)(2010-12#1)
significant antiproliferative##4##2##(2006-12#2)(2007-11#1)(2010-12#1)
significant antitumor activity##2##3##(1997-2#1)(2011-1#1)
significant antitumor effect##2##3##(1994-5#1)(2013-8#1)
significant antitumor effects##2##3##(1996-10#1)(2007-11#1)
significant antitumor##7##2##(1994-5#1)(1995-8#1)(1996-10#1)(1997-2#1)(2007-11#1)(2011-1#1)(2013-8#1)
significant aortic stenosis##2##3##(2007-8#1)(2012-2#1)
significant applications in##3##3##(2008-3#1)(2008-7#1)(2012-11#1)
significant applications##4##2##(2006-5#1)(2008-3#1)(2008-7#1)(2012-11#1)
significant are##3##2##(2007-12#1)(2008-4#1)(2010-7#1)
significant areas##3##2##(1997-7#1)(2008-1#1)(2008-12#1)
significant as##6##2##(2006-10#1)(2007-2#1)(2008-10#2)(2008-3#1)(2008-9#1)
significant aspect of##4##3##(1992-1#1)(2006-6#1)(2008-7#1)(2012-12#1)
significant associated##2##2##(2006-8#1)(2010-2#1)
significant association between H##2##4##(2008-5#2)
significant association between the##6##4##(2008-8#1)(2011-2#2)(2013-1#1)(2013-8#2)
significant association between##34##3##(1994-7#1)(1996-12#1)(1997-8#1)(2004-1#1)(2007-10#1)(2008-1#2)(2008-10#3)(2008-5#3)(2008-8#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-2#1)(2011-1#3)(2011-2#6)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#3)
significant association of primary##2##4##(2013-1#2)
significant association of##11##3##(1990-6#1)(1996-6#1)(1996-8#1)(2007-2#1)(2008-10#2)(2008-7#2)(2012-2#1)(2013-1#2)
significant association was found between##3##5##(2011-2#2)(2012-12#1)
significant association was found##4##4##(2006-12#1)(2011-2#2)(2012-12#1)
significant association was observed##2##4##(1991-6#1)(2012-2#1)
significant association was##9##3##(1991-6#1)(1993-1#1)(1993-7#1)(2006-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
significant association with the##2##4##(1994-12#1)(2007-12#1)
significant association with##22##3##(1992-2#1)(1992-3#1)(1994-12#1)(1995-8#2)(1996-8#1)(1997-4#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-12#2)(2008-4#1)(2009-5#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-12#1)(2012-2#1)(2013-1#1)
significant association##84##2##(1990-6#1)(1990-8#1)(1991-6#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-7#1)(1994-12#1)(1994-7#1)(1995-8#2)(1996-12#1)(1996-6#1)(1996-8#2)(1997-4#1)(1997-8#1)(2004-1#1)(2006-12#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#7)(2008-12#2)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#1)(2011-1#4)(2011-12#1)(2011-2#8)(2012-12#5)(2012-2#4)(2013-1#4)(2013-8#3)
significant associations between##13##3##(2006-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#2)(2009-7#1)(2010-1#1)(2011-2#2)(2012-12#2)(2012-3#1)
significant associations were found between##4##5##(1997-3#1)(2010-2#1)(2012-5#1)(2013-7#1)
significant associations were found with##2##5##(1993-9#1)(2009-5#1)
significant associations were found##6##4##(1993-9#1)(1997-3#1)(2009-5#1)(2010-2#1)(2012-5#1)(2013-7#1)
significant associations were##9##3##(1993-9#1)(1996-5#1)(1997-3#1)(2009-5#1)(2010-2#1)(2012-12#1)(2012-5#1)(2013-7#1)(2013-8#1)
significant associations with##4##3##(1995-10#1)(2011-12#1)(2011-2#1)(2013-1#1)
significant associations##30##2##(1993-9#1)(1995-10#1)(1996-5#1)(1997-3#1)(2006-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-2#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-3#1)(2012-5#1)(2013-1#2)(2013-7#1)(2013-8#1)
significant at P&lt##2##3##(2008-12#1)(2008-7#1)
significant at day 1##2##4##(2006-7#2)
significant at the##8##3##(1995-5#1)(1996-5#1)(2004-4#2)(2006-5#1)(2007-1#1)(2008-6#1)(2010-8#1)
significant at##33##2##(1993-11#1)(1993-12#1)(1993-9#1)(1994-11#1)(1995-5#1)(1996-10#1)(1996-5#1)(1996-8#1)(2004-4#2)(2006-10#1)(2006-5#1)(2006-7#2)(2007-1#1)(2007-2#2)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#3)
significant atrial##2##2##(1996-6#1)(2012-12#1)
significant attention##4##2##(2009-7#1)(2010-3#1)(2011-2#2)
significant attenuation of##4##3##(1992-7#1)(1994-5#1)(2008-4#1)(2011-2#1)
significant attenuation##6##2##(1992-7#1)(1994-5#1)(2007-10#1)(2008-4#1)(2011-2#1)(2013-8#1)
significant background##4##2##(1991-12#1)(2007-2#1)(2008-10#1)(2008-3#1)
significant backwardness in##2##3##(2007-9#2)
significant bacteria##2##2##(1993-12#1)(2007-8#1)
significant bacteriostatic##2##2##(2012-11#1)(2012-2#1)
significant bacteriuria##2##2##(1993-8#1)(2006-12#1)
significant barriers to##3##3##(1995-12#1)(1997-1#1)(2007-6#1)
significant barriers##6##2##(1995-12#2)(1997-1#1)(2007-6#1)(2008-11#1)(2013-1#1)
significant because##4##2##(2006-5#1)(2008-11#1)(2009-10#1)(2010-7#1)
significant behavioral##4##2##(1997-1#1)(2007-3#1)(2009-12#1)(2013-8#1)
significant bend##2##2##(1991-4#1)(2007-12#1)
significant beneficial effects##2##3##(1996-2#1)(2008-7#1)
significant beneficial##5##2##(1991-2#1)(1996-2#1)(2004-11#1)(2008-7#1)(2011-2#1)
significant benefit in##3##3##(2008-1#2)(2008-6#1)
significant benefit##12##2##(1991-2#1)(2005-9#1)(2006-11#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-1#2)(2008-6#2)(2013-1#1)(2013-8#1)
significant benefits for the##2##4##(2006-10#1)(2012-3#1)
significant benefits for##5##3##(2005-10#1)(2006-10#1)(2007-11#1)(2009-11#1)(2012-3#1)
significant benefits from##2##3##(2008-7#1)(2010-8#1)
significant benefits in##2##3##(2005-7#1)(2008-5#1)
significant benefits of##3##3##(2006-12#1)(2013-8#2)
significant benefits##14##2##(2005-10#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-3#1)(2010-8#1)(2012-3#1)(2013-8#2)
significant better##2##2##(1990-6#1)(2011-2#1)
significant between the two groups##2##5##(2007-8#2)
significant between the##7##3##(2007-8#2)(2008-10#1)(2008-6#1)(2010-12#1)(2011-2#1)(2012-2#1)
significant between##12##2##(2006-9#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-6#1)(2010-12#1)(2011-2#3)(2012-2#1)(2013-8#1)
significant between-group##2##2##(2011-2#1)(2013-1#1)
significant bias##2##2##(2008-10#2)
significant biases##2##2##(2008-10#1)(2008-3#1)
significant binding to##2##3##(1990-12#1)(2008-3#1)
significant binding##8##2##(1990-12#1)(1992-8#1)(1994-6#1)(1997-2#1)(1997-5#1)(2005-11#1)(2008-3#1)(2009-7#1)
significant biological##2##2##(2007-7#1)(2008-5#1)
significant blood##3##2##(2007-11#1)(2007-8#1)(2008-7#1)
significant body of evidence##2##4##(2009-6#1)(2011-12#1)
significant body of##3##3##(2008-8#1)(2009-6#1)(2011-12#1)
significant body##5##2##(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-12#1)
significant bone##4##2##(2007-8#1)(2009-10#1)(2011-12#1)(2011-2#1)
significant both in##2##3##(2007-2#1)(2008-10#1)
significant broadening##2##2##(2007-11#1)(2008-10#1)
significant burden of##2##3##(2007-2#1)(2011-1#1)
significant burden##5##2##(2007-2#1)(2008-11#1)(2008-3#1)(2010-9#1)(2011-1#1)
significant but##17##2##(1990-7#1)(1993-11#1)(2006-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-1#1)
significant by##3##2##(1995-12#1)(2008-9#1)(2012-2#1)
significant carotid artery stenosis##3##4##(2007-8#3)
significant carotid##4##2##(2007-8#3)(2008-3#1)
significant cause of##22##3##(1993-3#1)(1994-5#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-2#1)(2007-4#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#3)
significant causes of##3##3##(2006-10#1)(2009-9#1)(2010-5#1)
significant cell death##2##3##(1994-5#1)(2007-2#1)
significant cell loss##2##3##(2008-7#1)(2010-11#1)
significant cell##9##2##(1993-8#1)(1994-5#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-7#1)(2010-11#1)(2010-8#1)(2011-2#1)
significant challenge to the##2##4##(2007-12#1)(2010-8#1)
significant challenge##10##2##(1994-5#1)(2005-9#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-7#1)
significant challenges in managing##2##4##(1992-1#1)(2008-8#1)
significant challenges in##6##3##(1992-1#1)(2006-10#1)(2007-12#1)(2008-7#1)(2008-8#1)(2010-12#1)
significant challenges to the##2##4##(2006-10#1)(2013-1#1)
significant challenges to##4##3##(2006-10#1)(2008-5#1)(2009-12#1)(2013-1#1)
significant challenges##19##2##(1992-1#1)(1995-12#1)(2006-10#2)(2006-8#1)(2007-12#2)(2007-8#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
significant change (&gt##2##3##(2013-8#2)
significant change between the##2##4##(1994-6#1)(2007-10#1)
significant change between##5##3##(1994-6#1)(2006-8#1)(2007-10#1)(2008-7#1)(2013-1#1)
significant change in either##3##4##(1995-3#1)(1997-4#1)(2008-11#1)
significant change in plasma##2##4##(2008-6#1)(2009-5#1)
significant change in relative##2##4##(2008-3#1)(2011-2#1)
significant change in the number of##2##6##(1993-12#1)(2007-10#1)
significant change in the##37##4##(1990-2#1)(1990-3#1)(1991-2#1)(1992-5#1)(1993-12#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-5#1)(2005-10#1)(2006-10#3)(2007-10#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#1)
significant change in##92##3##(1990-12#1)(1990-2#1)(1990-3#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-8#1)(1991-9#1)(1992-5#2)(1992-8#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-5#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-3#1)(2005-10#1)(2006-10#5)(2006-8#2)(2007-10#3)(2007-2#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-12#2)(2010-3#1)(2010-7#2)(2011-2#5)(2012-12#1)(2013-1#4)(2013-8#1)
significant change of the##3##4##(1992-9#1)(2008-5#1)(2010-5#1)
significant change of##4##3##(1992-9#1)(1996-12#1)(2008-5#1)(2010-5#1)
significant change was observed in the##3##6##(1991-2#1)(2010-5#1)(2011-1#1)
significant change was observed in##7##5##(1991-2#1)(1993-12#1)(1994-2#1)(2006-10#1)(2007-10#1)(2010-5#1)(2011-1#1)
significant change was##10##3##(1991-1#1)(1991-2#1)(1993-12#1)(1994-2#1)(1995-9#1)(2004-11#1)(2006-10#1)(2007-10#1)(2010-5#1)(2011-1#1)
significant change##131##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-1#2)(1991-2#3)(1991-3#1)(1991-8#1)(1991-9#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-12#3)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-9#2)(1996-12#1)(1996-5#1)(1996-9#3)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2004-11#1)(2004-3#1)(2005-10#1)(2005-3#1)(2005-9#1)(2006-10#6)(2006-8#4)(2006-9#1)(2007-10#5)(2007-2#1)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-9#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-7#2)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#1)(2013-1#6)(2013-7#1)(2013-8#3)
significant changes (&gt##2##3##(2013-8#2)
significant changes are##3##3##(1997-8#1)(2008-10#1)(2008-5#1)
significant changes between##2##3##(2008-10#1)(2012-2#1)
significant changes from baseline##3##4##(1990-7#1)(1993-1#1)(2011-2#1)
significant changes in clinical##2##4##(2008-5#2)
significant changes in expression##2##4##(1997-8#1)(2008-8#1)
significant changes in its##2##4##(1991-7#1)(1994-9#1)
significant changes in lipid##2##4##(2008-10#1)(2012-12#1)
significant changes in the total##2##5##(1996-12#1)(2009-9#1)
significant changes in the##34##4##(1990-2#1)(1990-5#1)(1990-7#1)(1991-2#2)(1992-1#1)(1992-6#1)(1993-2#1)(1993-5#1)(1994-10#1)(1994-11#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-3#1)(1997-7#1)(2006-12#1)(2006-2#1)(2006-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-7#1)
significant changes in their##2##4##(1997-4#1)(2010-12#1)
significant changes in##118##3##(1990-2#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-7#2)(1992-1#2)(1992-11#1)(1992-3#1)(1992-6#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-10#2)(1994-11#1)(1994-2#3)(1994-5#1)(1994-9#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-7#2)(1997-8#2)(2005-8#1)(2006-12#4)(2006-2#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-7#2)
significant changes occurred in the##3##5##(1992-12#1)(1996-3#1)(2008-11#1)
significant changes occurred in##4##4##(1992-12#1)(1993-12#1)(1996-3#1)(2008-11#1)
significant changes of the##2##4##(2008-10#1)(2012-2#1)
significant changes of##9##3##(1991-12#1)(1991-6#1)(1993-2#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-8#1)(2012-2#1)(2013-1#1)
significant changes over##3##3##(2007-7#1)(2010-1#1)(2011-2#1)
significant changes were found in##2##5##(2009-2#1)(2013-1#1)
significant changes were found##6##4##(2003-11#1)(2009-2#1)(2009-8#1)(2012-3#2)(2013-1#1)
significant changes were observed in the##3##6##(1994-2#1)(1996-2#1)(2008-5#1)
significant changes were observed in##7##5##(1994-2#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-9#1)(2008-5#1)(2009-5#1)
significant changes were observed##9##4##(1994-11#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-9#1)(2008-5#1)(2009-5#1)(2012-12#1)
significant changes were##24##3##(1991-12#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-9#1)(2003-11#1)(2008-10#1)(2008-5#3)(2009-2#1)(2009-5#1)(2009-8#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)
significant changes with##2##3##(2008-7#1)(2009-8#1)
significant changes##187##2##(1990-2#1)(1990-5#1)(1990-7#2)(1991-1#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-6#1)(1991-7#2)(1992-1#2)(1992-11#2)(1992-12#1)(1992-3#2)(1992-6#1)(1993-1#1)(1993-12#3)(1993-2#2)(1993-5#1)(1993-6#1)(1994-1#1)(1994-10#2)(1994-11#2)(1994-2#4)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#4)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-9#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#2)(1997-8#3)(2003-11#1)(2005-8#1)(2006-12#4)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#12)(2008-11#2)(2008-3#4)(2008-4#1)(2008-5#9)(2008-7#5)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#11)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#9)(2012-3#3)(2013-1#2)(2013-7#2)(2013-8#3)
significant chest pain##2##3##(1992-6#1)(2012-2#1)
significant clinical and research##2##4##(1993-9#1)(2010-8#1)
significant clinical and##3##3##(1993-9#1)(2006-10#1)(2010-8#1)
significant clinical benefit##3##3##(2006-10#1)(2007-11#1)(2007-9#1)
significant clinical benefits##3##3##(2007-11#1)(2008-7#1)(2008-8#1)
significant clinical impact##2##3##(2007-8#1)(2008-8#1)
significant clinical##30##2##(1990-6#1)(1993-9#1)(1994-1#1)(1994-2#1)(1995-3#1)(2006-10#2)(2007-10#1)(2007-11#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-7#1)
significant commercial##3##2##(2008-4#2)(2008-5#1)
significant comorbidities##2##2##(2006-12#1)(2010-10#1)
significant compared to##2##3##(2007-7#1)(2009-5#1)
significant complication of##3##3##(2008-4#1)(2011-2#2)
significant complication##8##2##(1990-5#1)(2008-4#1)(2008-6#1)(2010-2#1)(2011-2#3)(2013-1#1)
significant complications##14##2##(1993-1#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-7#1)(2007-8#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
significant component of the##5##4##(1995-3#1)(2008-10#2)(2008-12#1)(2009-11#1)
significant component of##7##3##(1994-12#1)(1995-3#1)(2006-12#1)(2008-10#2)(2008-12#1)(2009-11#1)
significant component##9##2##(1993-7#1)(1994-12#1)(1995-3#1)(2006-12#1)(2008-10#2)(2008-12#1)(2009-11#1)(2011-2#1)
significant components##3##2##(1995-5#1)(2009-4#1)(2013-1#1)
significant computation##2##2##(2007-11#1)(2008-2#1)
significant concentration##5##2##(1991-3#2)(1991-4#1)(2008-10#2)
significant concentration-dependent##2##2##(1992-2#1)(2008-7#1)
significant concern##3##2##(2007-4#1)(2008-3#1)(2013-1#1)
significant conformational##3##2##(1993-8#1)(2008-4#1)(2012-2#1)
significant confusion##2##2##(2006-8#1)(2007-11#1)
significant connection could be demonstrated between##2##6##(1990-4#2)
significant connection##3##2##(1990-4#3)
significant consequences of##2##3##(1991-12#1)(1996-2#1)
significant consequences##4##2##(1991-12#1)(1996-2#1)(2011-12#1)(2013-1#1)
significant conservation##2##2##(2007-9#1)(2009-9#1)
significant contamination##2##2##(1994-12#1)(2008-4#1)
significant contrast##3##2##(2008-2#1)(2011-1#1)(2012-2#1)
significant contribution of the##2##4##(1993-11#1)(1996-11#1)
significant contribution of##9##3##(1993-11#1)(1996-11#1)(1996-6#1)(1997-5#1)(2006-10#1)(2007-8#1)(2009-9#1)(2011-12#1)(2013-7#1)
significant contribution to the global##2##5##(2011-2#2)
significant contribution to the##8##4##(1993-11#1)(1997-8#1)(2007-12#1)(2011-2#2)(2013-1#3)
significant contribution to##16##3##(1992-12#1)(1993-11#1)(1994-12#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-11#2)(2008-3#1)(2011-1#1)(2011-2#2)(2013-1#3)
significant contribution##28##2##(1992-12#1)(1993-11#2)(1994-12#1)(1996-11#1)(1996-6#1)(1997-5#1)(1997-8#1)(2006-10#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-11#2)(2008-3#1)(2009-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2013-1#3)(2013-7#1)(2013-8#1)
significant contributions##6##2##(1993-9#1)(1995-8#1)(2008-10#1)(2008-8#1)(2009-8#1)(2013-1#1)
significant contributor to the##2##4##(1994-12#1)(2008-10#1)
significant contributor to##4##3##(1994-12#2)(2006-10#1)(2008-10#1)
significant contributor##5##2##(1994-12#2)(2006-10#1)(2008-10#1)(2011-3#1)
significant contributors to##3##3##(1991-4#1)(1996-3#1)(2012-2#1)
significant control##2##2##(2007-12#1)(2008-10#1)
significant cooperativity##2##2##(1993-6#1)(1993-8#1)
significant coronary artery##5##3##(1993-12#1)(2008-11#1)(2008-7#1)(2009-10#1)(2013-1#1)
significant coronary##7##2##(1992-1#1)(1993-12#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-5#1)(2013-1#1)
significant correlates##2##2##(2007-10#1)(2013-1#1)
significant correlation (r = 0##3##5##(2008-10#1)(2008-8#1)(2010-2#1)
significant correlation between a##2##4##(2007-10#1)(2007-2#1)
significant correlation between genetic and geographic##2##6##(2008-10#2)
significant correlation between serum##2##4##(1991-5#1)(2013-7#1)
significant correlation between the size of##2##6##(1996-12#1)(1997-6#1)
significant correlation between the##23##4##(1992-11#1)(1994-3#1)(1994-5#1)(1995-10#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-5#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2009-6#1)(2010-3#1)(2011-2#2)(2013-1#3)
significant correlation between##90##3##(1990-5#1)(1990-9#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#2)(1995-10#1)(1995-11#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-2#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-12#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-10#3)(2007-2#3)(2007-7#6)(2007-8#3)(2008-1#2)(2008-10#9)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#4)(2009-10#2)(2009-6#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-11#1)(2012-2#1)(2013-1#9)(2013-7#1)(2013-8#1)
significant correlation existed between the##2##5##(1992-3#1)(2008-12#1)
significant correlation existed between##3##4##(1992-3#1)(1993-12#1)(2008-12#1)
significant correlation of##13##3##(1990-1#1)(1994-5#1)(1996-7#1)(1997-7#1)(2006-11#1)(2006-8#1)(2008-10#2)(2008-6#1)(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#1)
significant correlation was found between the##4##6##(2004-4#1)(2006-5#1)(2013-1#2)
significant correlation was found between##16##5##(1993-4#1)(1994-5#1)(1995-5#1)(1996-9#1)(2004-4#2)(2006-5#1)(2007-1#1)(2007-4#1)(2008-10#2)(2008-3#1)(2010-4#1)(2013-1#3)
significant correlation was found##18##4##(1993-4#1)(1994-5#1)(1995-5#1)(1996-9#1)(2004-4#2)(2006-5#1)(2007-1#1)(2007-4#1)(2008-10#2)(2008-3#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#3)
significant correlation was observed between the##2##6##(2007-8#1)(2008-10#1)
significant correlation was observed between##4##5##(1991-6#1)(2007-8#1)(2008-10#1)(2008-5#1)
significant correlation was observed##5##4##(1991-6#1)(1995-6#1)(2007-8#1)(2008-10#1)(2008-5#1)
significant correlation was##29##3##(1990-5#1)(1991-6#1)(1993-4#1)(1994-5#1)(1995-5#1)(1995-6#1)(1996-9#1)(2004-4#2)(2006-5#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-5#1)(2010-12#1)(2010-4#1)(2011-2#3)(2012-2#1)(2013-1#3)
significant correlation with the##7##4##(1993-11#1)(1996-1#1)(2006-6#1)(2007-8#1)(2009-4#1)(2010-8#1)(2013-8#1)
significant correlation with##21##3##(1991-12#1)(1993-11#2)(1994-9#1)(1996-1#1)(1996-5#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
significant correlation##172##2##(1990-1#1)(1990-5#2)(1990-9#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-4#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-5#4)(1994-7#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-4#2)(2004-9#1)(2005-12#1)(2006-11#2)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#2)(2006-8#4)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#4)(2007-4#2)(2007-7#6)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#16)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#5)(2008-7#1)(2008-8#3)(2009-10#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-7#1)(2010-8#1)(2011-1#2)(2011-11#1)(2011-2#10)(2012-11#1)(2012-2#3)(2013-1#14)(2013-7#1)(2013-8#2)
significant correlations (p &lt##2##4##(2010-10#1)(2013-1#1)
significant correlations among##2##3##(2008-8#1)(2009-11#1)
significant correlations between the##6##4##(1992-2#1)(2008-10#1)(2011-2#2)(2012-12#1)(2012-3#1)
significant correlations between##26##3##(1992-2#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-3#1)(2004-11#1)(2005-9#1)(2007-10#2)(2007-11#1)(2007-2#3)(2008-10#2)(2008-7#1)(2009-7#1)(2010-5#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
significant correlations in##2##3##(2008-8#1)(2013-8#1)
significant correlations of##2##3##(1992-6#1)(1997-7#1)
significant correlations were found between the##2##6##(1995-12#1)(2012-1#1)
significant correlations were found between##3##5##(1995-12#1)(2011-1#1)(2012-1#1)
significant correlations were found##5##4##(1990-12#1)(1994-11#1)(1995-12#1)(2011-1#1)(2012-1#1)
significant correlations were##7##3##(1990-12#1)(1994-11#1)(1995-12#1)(2008-8#1)(2009-3#1)(2011-1#1)(2012-1#1)
significant correlations with the##2##4##(2008-11#1)(2012-1#1)
significant correlations with##9##3##(2006-12#1)(2007-12#1)(2008-11#1)(2008-7#1)(2009-4#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
significant correlations##54##2##(1990-12#1)(1992-2#1)(1992-6#1)(1993-11#1)(1994-11#2)(1994-2#1)(1995-1#1)(1995-12#1)(1995-3#1)(1997-7#1)(2004-10#1)(2004-11#1)(2005-9#1)(2006-12#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#3)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#3)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
significant cost savings##2##3##(1992-2#1)(1995-12#1)
significant cost##5##2##(1992-2#1)(1995-12#1)(2008-7#1)(2010-10#1)(2010-5#1)
significant costs##3##2##(2007-2#1)(2010-2#1)(2011-1#1)
significant coupling##2##2##(1991-7#1)(2010-5#1)
significant covariate##2##2##(1994-2#1)(2012-12#1)
significant covariates##2##2##(2008-10#1)(2013-1#1)
significant cross-reactivity##2##2##(1991-9#1)(2009-3#1)
significant cytotoxic activity##2##3##(2010-6#1)(2011-2#1)
significant cytotoxic##4##2##(2007-1#1)(2010-6#1)(2011-2#1)(2013-1#1)
significant cytotoxicity against##3##3##(2008-7#2)(2013-1#1)
significant cytotoxicity##9##2##(2006-12#1)(2007-8#1)(2008-10#1)(2008-7#2)(2011-2#1)(2012-11#1)(2013-1#2)
significant damage to##3##3##(2007-9#1)(2008-10#2)
significant damage##4##2##(1994-3#1)(2007-9#1)(2008-10#2)
significant data##4##2##(2005-8#1)(2006-2#1)(2006-8#1)(2012-2#1)
significant decline in##5##3##(1995-12#1)(2008-7#1)(2009-2#1)(2009-6#1)(2012-12#1)
significant decline of##3##3##(1991-11#1)(1993-7#1)(2011-1#1)
significant decline##10##2##(1991-11#1)(1993-7#1)(1995-12#1)(1995-9#1)(2006-10#1)(2008-7#1)(2009-2#1)(2009-6#1)(2011-1#1)(2012-12#1)
significant declines in##5##3##(2007-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-2#1)
significant decrease (P &lt##7##4##(1997-2#1)(2006-12#3)(2008-1#1)(2009-5#2)
significant decrease (p&lt##2##3##(2008-11#1)(2008-3#1)
significant decrease compared with##2##4##(1997-1#1)(2011-12#1)
significant decrease during##3##3##(1992-7#1)(2008-5#1)(2013-8#1)
significant decrease in mean##3##4##(2007-9#1)(2012-12#1)(2012-2#1)
significant decrease in postoperative##2##4##(1996-3#1)(2005-8#1)
significant decrease in the number of##5##6##(1990-4#1)(2006-8#1)(2008-10#1)(2009-2#1)(2012-3#1)
significant decrease in the##51##4##(1990-3#1)(1990-4#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-4#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-12#2)(1993-2#1)(1994-3#1)(1994-6#1)(1995-7#1)(1996-8#1)(1996-9#1)(1997-8#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-7#2)(2007-9#4)(2008-10#5)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
significant decrease in total##4##4##(1992-2#1)(1993-6#1)(2007-8#1)(2008-12#1)
significant decrease in##178##3##(1990-11#1)(1990-2#2)(1990-3#1)(1990-4#4)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#1)(1993-6#2)(1993-7#1)(1994-3#3)(1994-5#1)(1994-6#1)(1995-1#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-7#3)(1996-10#1)(1996-12#2)(1996-2#3)(1996-3#2)(1996-4#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-6#2)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-8#3)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#4)(2007-8#1)(2007-9#6)(2008-10#10)(2008-11#5)(2008-12#6)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-8#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#9)(2012-11#1)(2012-12#6)(2012-2#7)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#4)
significant decrease of##41##3##(1990-10#1)(1990-11#1)(1990-12#1)(1992-4#1)(1992-6#3)(1992-8#1)(1993-12#1)(1994-12#1)(1995-3#1)(1995-7#1)(1996-2#1)(1997-4#1)(1997-6#1)(2004-11#1)(2006-1#1)(2006-12#1)(2006-2#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
significant decrease was##2##3##(1992-4#1)(2008-6#1)
significant decrease with##3##3##(1996-7#1)(2009-10#1)(2010-4#1)
significant decrease##254##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#5)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#3)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#5)(1993-2#3)(1993-3#1)(1993-6#2)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1995-1#2)(1995-2#1)(1995-3#3)(1995-5#1)(1995-7#4)(1996-10#1)(1996-12#2)(1996-2#4)(1996-3#2)(1996-4#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#1)(1997-4#1)(1997-6#3)(1997-8#1)(2004-11#1)(2005-10#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#8)(2006-2#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#4)(2007-8#1)(2007-9#7)(2008-1#2)(2008-10#13)(2008-11#9)(2008-12#8)(2008-3#3)(2008-4#2)(2008-5#7)(2008-6#3)(2008-8#3)(2009-10#3)(2009-11#1)(2009-2#1)(2009-5#2)(2009-6#2)(2009-8#1)(2010-1#1)(2010-3#2)(2010-4#2)(2010-5#1)(2011-1#2)(2011-12#2)(2011-2#12)(2012-11#1)(2012-12#7)(2012-2#8)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#7)
significant decreased##2##2##(2011-1#1)(2012-12#1)
significant decreases in body##2##4##(2007-12#1)(2008-5#1)
significant decreases in the levels of##2##6##(1995-9#1)(1996-12#1)
significant decreases in the##6##4##(1993-6#1)(1994-2#1)(1995-12#1)(1995-9#1)(1996-12#1)(2006-8#1)
significant decreases in##27##3##(1990-3#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-12#1)(1995-9#1)(1996-1#2)(1996-12#1)(1997-2#1)(1997-8#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#2)(2008-5#3)(2009-5#1)(2010-12#1)(2010-6#1)(2012-12#2)
significant decreases of##4##3##(1994-10#1)(1995-2#1)(2008-5#2)
significant decreases were##2##3##(1991-2#1)(2008-7#1)
significant decreases##36##2##(1990-3#1)(1991-2#1)(1991-8#1)(1993-12#1)(1993-6#1)(1994-10#1)(1994-2#1)(1995-12#2)(1995-2#1)(1995-9#1)(1996-1#2)(1996-12#1)(1997-2#1)(1997-8#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#2)(2008-5#5)(2008-7#1)(2009-5#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#2)
significant decreasing##3##2##(2008-10#1)(2009-8#1)(2012-12#1)
significant deficiencies in##2##3##(2008-10#1)(2008-3#1)
significant deficiencies##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
significant deficits in##4##3##(1993-4#2)(2007-6#1)(2012-2#1)
significant deficits##7##2##(1991-1#1)(1993-4#2)(2007-6#1)(2008-4#1)(2012-2#1)(2013-1#1)
significant degree of##5##3##(1990-5#1)(1996-5#1)(1997-1#1)(2006-10#1)(2011-2#1)
significant degree##11##2##(1990-5#1)(1994-8#1)(1995-11#1)(1996-5#1)(1997-1#1)(2006-10#1)(2007-7#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-3#1)
significant delay in the##2##4##(1995-1#1)(2007-11#1)
significant delay in##4##3##(1995-1#1)(2006-7#1)(2007-11#1)(2008-10#1)
significant delays##4##2##(2007-12#1)(2008-10#1)(2013-1#2)
significant deleterious##2##2##(2010-3#1)(2011-2#1)
significant departure##5##2##(1993-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
significant dependence of##2##3##(1996-3#1)(2007-4#1)
significant dependence on##4##3##(2008-10#1)(2009-2#1)(2009-4#1)(2010-4#1)
significant dependence##6##2##(1996-3#1)(2007-4#1)(2008-10#1)(2009-2#1)(2009-4#1)(2010-4#1)
significant depletion of##5##3##(1995-6#1)(1995-8#1)(1996-10#2)(2008-7#1)
significant depression##3##2##(1994-3#1)(2008-12#1)(2012-12#1)
significant depressive symptoms##2##3##(2013-1#1)(2013-8#1)
significant design##2##2##(2008-3#1)(2012-1#1)
significant destruction of##2##3##(1990-11#1)(2008-8#1)
significant deterioration in##4##3##(2006-11#1)(2007-8#1)(2008-7#1)(2013-1#1)
significant deterioration of##3##3##(1991-10#1)(1997-8#1)(2005-1#1)
significant deterioration##7##2##(1991-10#1)(1997-8#1)(2005-1#1)(2006-11#1)(2007-8#1)(2008-7#1)(2013-1#1)
significant determinant of the##2##4##(1993-11#1)(1995-3#1)
significant determinant of##3##3##(1993-11#1)(1995-3#1)(2010-10#1)
significant development##4##2##(1993-11#1)(2006-10#1)(2006-12#1)(2013-1#1)
significant developments in the##3##4##(2006-10#1)(2013-7#1)(2013-8#1)
significant developments in##4##3##(2006-10#1)(2008-11#1)(2013-7#1)(2013-8#1)
significant deviation from the##2##4##(1991-11#1)(2013-8#1)
significant deviation from##5##3##(1991-11#1)(1991-2#1)(1997-2#1)(2008-10#1)(2013-8#1)
significant deviation in the##2##4##(2008-7#1)(2012-12#1)
significant deviation##8##2##(1991-11#1)(1991-2#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-7#1)(2012-12#1)(2013-8#1)
significant deviations##2##2##(1997-2#1)(2013-8#1)
significant diagnostic##5##2##(2007-8#1)(2008-10#1)(2009-10#1)(2009-7#1)(2013-7#1)
significant difference (P &lt##4##4##(2011-1#1)(2013-1#3)
significant difference (P = 0##5##5##(2006-10#1)(2006-8#2)(2008-10#1)(2013-1#1)
significant difference (P##12##3##(1991-7#1)(2006-10#1)(2006-8#2)(2007-2#1)(2008-10#1)(2011-1#2)(2013-1#4)
significant difference (P&gt##2##3##(2007-10#1)(2012-2#1)
significant difference (P&lt##3##3##(2006-12#1)(2008-10#1)(2013-8#1)
significant difference (p &lt##4##4##(2004-3#1)(2008-5#2)(2013-1#1)
significant difference (p = 0##2##5##(2008-7#1)(2010-7#1)
significant difference (p##9##3##(2004-3#1)(2007-2#1)(2008-5#2)(2008-7#1)(2010-12#1)(2010-7#1)(2011-1#1)(2013-1#1)
significant difference (p&gt##3##3##(2008-5#1)(2013-1#2)
significant difference among the##10##4##(1990-12#1)(1994-3#1)(1996-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2010-8#1)(2012-12#1)
significant difference among##14##3##(1990-12#1)(1994-3#1)(1996-10#1)(2006-2#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#3)(2010-8#1)(2012-12#1)(2013-1#1)
significant difference at 95% confidence level was observed##3##8##(2007-10#1)(2008-10#2)
significant difference at 95% confidence level##5##6##(2007-10#1)(2008-10#4)
significant difference at the 95% confidence level was observed##3##9##(2008-10#3)
significant difference at##10##3##(2007-10#1)(2008-10#8)(2011-1#1)
significant difference between group A and##2##6##(2007-7#2)
significant difference between groups regarding##2##5##(2008-12#1)(2013-1#1)
significant difference between groups##4##4##(2007-9#1)(2008-12#1)(2012-2#1)(2013-1#1)
significant difference between men and women##2##6##(1997-2#1)(2007-7#1)
significant difference between patients and##2##5##(1995-5#1)(2013-8#1)
significant difference between patients##3##4##(1995-5#1)(2011-2#1)(2013-8#1)
significant difference between the 2 groups##2##6##(2006-2#1)(2007-7#1)
significant difference between the 2##3##5##(2005-8#1)(2006-2#1)(2007-7#1)
significant difference between the bFGF and saline groups##2##8##(2007-10#2)
significant difference between the groups##6##5##(1993-7#1)(2005-10#2)(2008-7#1)(2009-3#1)(2012-3#1)
significant difference between the mean##4##5##(2006-8#1)(2007-5#1)(2008-8#1)(2009-5#1)
significant difference between the two groups for##2##7##(1992-1#1)(2008-12#1)
significant difference between the two groups in##2##7##(2006-8#1)(2007-2#1)
significant difference between the two groups##10##6##(1992-1#1)(1992-12#1)(1992-8#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-12#1)(2010-8#1)(2011-1#1)
significant difference between the two##17##5##(1991-6#1)(1992-1#1)(1992-12#1)(1992-8#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-1#2)
significant difference between the##84##4##(1990-9#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-4#1)(1993-7#1)(1993-8#1)(1996-10#1)(1996-3#1)(1997-4#1)(1997-8#2)(1997-9#1)(2004-10#1)(2005-10#4)(2005-11#1)(2005-8#1)(2006-2#2)(2006-5#1)(2006-8#3)(2007-10#2)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-9#2)(2008-1#1)(2008-10#5)(2008-12#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#4)(2009-10#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
significant difference between these two##2##5##(2006-7#1)(2008-8#1)
significant difference between##158##3##(1990-5#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-8#2)(1993-10#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-7#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-4#1)(1995-5#1)(1995-8#2)(1996-10#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-8#2)(1997-9#1)(2004-10#1)(2004-3#2)(2005-10#5)(2005-11#1)(2005-8#1)(2006-2#2)(2006-5#1)(2006-7#1)(2006-8#3)(2007-10#2)(2007-12#2)(2007-2#4)(2007-5#1)(2007-6#1)(2007-7#8)(2007-8#1)(2007-9#4)(2008-1#1)(2008-10#10)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#6)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-8#2)(2011-1#4)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#6)(2013-7#5)(2013-8#3)
significant difference could be found##3##5##(1993-2#1)(2006-5#1)(2006-7#1)
significant difference exists##2##3##(1996-4#1)(2009-9#1)
significant difference for all##2##4##(2006-2#1)(2011-12#1)
significant difference for##9##3##(2006-2#1)(2007-4#1)(2008-10#2)(2008-12#1)(2009-7#1)(2011-1#1)(2011-12#1)(2011-2#1)
significant difference from the##2##4##(2010-8#1)(2012-1#1)
significant difference from##4##3##(1997-1#1)(2008-4#1)(2010-8#1)(2012-1#1)
significant difference in 5-year##2##4##(1991-8#1)(1995-10#1)
significant difference in age##2##4##(2007-12#1)(2008-1#1)
significant difference in both##2##4##(2007-8#1)(2013-7#1)
significant difference in clinical##2##4##(2006-11#1)(2012-2#1)
significant difference in disease-free survival##2##5##(2004-2#2)
significant difference in mean##3##4##(1990-12#1)(2012-12#1)(2013-8#1)
significant difference in prevalence##2##4##(2006-2#1)(2011-2#1)
significant difference in sensitivity to##2##5##(1992-6#1)(2012-6#1)
significant difference in survival was found between the##2##8##(1992-12#1)(2007-8#1)
significant difference in the characteristics##2##5##(1996-7#1)(2007-11#1)
significant difference in the latency##2##5##(1996-1#1)(2008-11#1)
significant difference in the mean##7##5##(2006-9#1)(2007-1#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-8#1)(2013-1#1)
significant difference in the number of##3##6##(1993-1#1)(1996-6#1)(2011-2#1)
significant difference in the prevalence of##2##6##(2008-1#1)(2008-7#1)
significant difference in the prevalence##3##5##(2007-3#1)(2008-1#1)(2008-7#1)
significant difference in the proportion of##3##6##(2011-2#1)(2012-3#1)(2013-1#1)
significant difference in the rate##3##5##(2007-12#1)(2011-2#1)(2013-1#1)
significant difference in the##95##4##(1990-7#1)(1991-12#1)(1991-2#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-2#1)(1996-1#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-4#1)(2004-1#1)(2005-10#1)(2006-10#3)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#2)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#4)
significant difference in their##3##4##(1992-7#1)(1996-6#1)(2009-7#1)
significant difference in total##4##4##(2008-5#1)(2009-2#1)(2012-12#1)(2013-1#1)
significant difference in weight change##2##5##(2011-2#2)
significant difference in weight##3##4##(2008-7#1)(2011-2#2)
significant difference in##244##3##(1990-10#2)(1990-12#2)(1990-5#1)(1990-7#1)(1991-10#2)(1991-12#1)(1991-2#2)(1991-7#1)(1991-8#3)(1991-9#1)(1992-12#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#2)(1994-2#3)(1994-3#1)(1994-6#1)(1994-7#1)(1995-10#2)(1995-11#1)(1995-4#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#3)(1996-7#1)(1996-9#1)(1997-4#1)(1997-8#2)(2004-1#1)(2004-2#2)(2004-9#1)(2005-10#3)(2005-7#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#3)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#6)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#6)(2007-8#7)(2007-9#1)(2008-1#4)(2008-10#12)(2008-11#5)(2008-12#4)(2008-3#3)(2008-4#2)(2008-5#9)(2008-6#3)(2008-7#6)(2008-8#1)(2008-9#4)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#3)(2010-9#4)(2011-1#5)(2011-12#1)(2011-2#17)(2012-1#1)(2012-12#6)(2012-2#5)(2012-3#4)(2012-6#1)(2012-7#1)(2013-1#10)(2013-7#1)(2013-8#6)
significant difference is##4##3##(1992-3#1)(1992-4#1)(2007-1#1)(2007-8#1)
significant difference observed##3##3##(2008-12#1)(2013-1#2)
significant difference of the##4##4##(2008-10#1)(2008-9#1)(2009-10#1)(2012-12#1)
significant difference of##13##3##(1994-3#1)(1996-2#1)(1996-7#1)(2007-2#1)(2008-10#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#4)(2012-12#1)
significant difference only##2##3##(2008-4#1)(2011-1#1)
significant difference to the##2##4##(2008-10#1)(2011-1#1)
significant difference to##3##3##(2005-11#1)(2008-10#1)(2011-1#1)
significant difference was detected##2##4##(2008-11#1)(2008-7#1)
significant difference was found among the##4##6##(2006-1#1)(2008-7#1)(2011-1#1)(2012-2#1)
significant difference was found among##5##5##(2006-1#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
significant difference was found between the two##2##7##(2010-12#1)(2012-12#1)
significant difference was found between the##8##6##(1993-2#2)(2008-12#1)(2010-12#1)(2011-2#1)(2012-12#2)(2013-8#1)
significant difference was found between##16##5##(1990-3#1)(1990-8#1)(1993-2#2)(2004-12#1)(2006-8#1)(2008-10#2)(2008-12#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-12#2)(2013-8#1)
significant difference was found in the##4##6##(1990-12#1)(1994-7#1)(2006-1#1)(2008-10#1)
significant difference was found in##7##5##(1990-12#1)(1994-7#1)(2006-1#1)(2007-3#1)(2008-10#1)(2008-11#1)(2012-12#1)
significant difference was found##36##4##(1990-12#1)(1990-3#1)(1990-8#1)(1993-2#2)(1994-7#1)(2004-12#1)(2006-1#2)(2006-2#1)(2006-8#1)(2007-3#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#2)
significant difference was not observed in##2##6##(2008-4#1)(2012-12#1)
significant difference was noted##3##4##(1996-12#1)(2007-7#1)(2008-9#1)
significant difference was observed between the##2##6##(1996-12#1)(2004-12#1)
significant difference was observed between##6##5##(1990-2#1)(1995-11#1)(1996-1#1)(1996-12#1)(2004-12#1)(2013-1#1)
significant difference was observed in the##4##6##(2007-7#1)(2009-11#1)(2013-8#2)
significant difference was observed in##7##5##(1993-11#1)(1996-9#1)(2007-7#1)(2009-11#1)(2013-8#3)
significant difference was observed##18##4##(1990-2#1)(1992-2#1)(1993-1#1)(1993-11#2)(1995-11#1)(1996-1#1)(1996-12#1)(1996-9#1)(2004-12#1)(2007-7#1)(2009-11#1)(2013-1#3)(2013-8#3)
significant difference was revealed##2##4##(2005-1#1)(2007-8#1)
significant difference was seen between##2##5##(1993-9#1)(2008-5#1)
significant difference was##71##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#1)(1992-2#1)(1993-1#1)(1993-11#2)(1993-2#2)(1993-9#1)(1994-7#1)(1995-11#1)(1996-1#1)(1996-12#2)(1996-9#1)(2004-12#2)(2005-1#1)(2005-8#1)(2006-1#2)(2006-2#1)(2006-8#1)(2007-3#1)(2007-7#2)(2007-8#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-11#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-12#4)(2012-2#1)(2013-1#5)(2013-8#7)
significant difference with respect to##2##5##(1993-3#1)(2012-2#1)
significant difference with##4##3##(1990-8#1)(1992-8#1)(1993-3#1)(2012-2#1)
significant difference##613##2##(1990-10#2)(1990-12#4)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#2)(1990-8#2)(1990-9#1)(1991-10#3)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-7#2)(1991-8#6)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#2)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#1)(1993-1#3)(1993-10#1)(1993-11#3)(1993-12#1)(1993-2#7)(1993-3#2)(1993-4#2)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#2)(1994-2#4)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#2)(1995-1#1)(1995-10#3)(1995-11#2)(1995-12#1)(1995-4#1)(1995-5#1)(1995-8#2)(1995-9#1)(1996-1#4)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-4#1)(1996-6#3)(1996-7#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#2)(1997-8#5)(1997-9#1)(2004-1#1)(2004-10#1)(2004-12#2)(2004-2#2)(2004-3#3)(2004-9#1)(2005-1#1)(2005-10#8)(2005-11#2)(2005-7#1)(2005-8#2)(2006-1#2)(2006-10#5)(2006-11#1)(2006-12#3)(2006-2#8)(2006-5#3)(2006-6#2)(2006-7#2)(2006-8#9)(2006-9#2)(2007-1#4)(2007-10#7)(2007-11#5)(2007-12#5)(2007-2#13)(2007-3#3)(2007-4#3)(2007-5#2)(2007-6#2)(2007-7#16)(2007-8#15)(2007-9#6)(2008-1#7)(2008-10#45)(2008-11#8)(2008-12#12)(2008-2#3)(2008-3#5)(2008-4#8)(2008-5#17)(2008-6#3)(2008-7#11)(2008-8#5)(2008-9#12)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#5)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#2)(2010-10#1)(2010-12#4)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#7)(2010-9#5)(2011-1#22)(2011-12#2)(2011-2#36)(2011-3#1)(2012-1#2)(2012-12#13)(2012-2#12)(2012-3#7)(2012-6#1)(2012-7#1)(2013-1#31)(2013-7#6)(2013-8#22)
significant differences (P &lt##4##4##(2006-10#1)(2007-2#1)(2008-5#2)
significant differences (P##7##3##(1992-8#1)(1995-12#1)(1996-12#1)(2006-10#1)(2007-2#1)(2008-5#2)
significant differences (P&lt##3##3##(2008-10#1)(2010-3#1)(2012-12#1)
significant differences (p &lt##2##4##(2008-5#1)(2011-2#1)
significant differences (p##3##3##(2008-5#2)(2011-2#1)
significant differences (p&gt##2##3##(2007-10#1)(2008-5#1)
significant differences (p&lt##4##3##(2004-9#1)(2006-7#1)(2008-12#1)(2013-7#1)
significant differences among different##2##4##(2008-10#1)(2010-4#1)
significant differences among populations##2##4##(2008-10#1)(2013-1#1)
significant differences among the three groups##3##6##(2008-9#2)(2013-8#1)
significant differences among the##6##4##(2006-10#1)(2006-12#1)(2006-8#1)(2008-9#2)(2013-8#1)
significant differences among##29##3##(1993-1#1)(1993-2#1)(1994-2#1)(1995-12#1)(1996-12#1)(2004-11#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-3#1)(2007-6#1)(2008-10#6)(2008-5#1)(2008-9#2)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
significant differences are observed##2##4##(2008-10#1)(2008-3#1)
significant differences are##6##3##(1994-12#1)(1994-5#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)
significant differences as##2##3##(2007-10#1)(2010-12#1)
significant differences at##4##3##(1990-8#1)(1993-12#1)(2008-10#2)
significant differences between all##2##4##(1992-9#1)(2008-10#1)
significant differences between groups in##4##5##(2005-1#1)(2007-8#1)(2011-2#1)(2013-1#1)
significant differences between groups on##3##5##(1996-2#1)(2006-7#1)(2013-1#1)
significant differences between groups with##2##5##(1993-4#1)(2013-8#1)
significant differences between groups##15##4##(1993-4#1)(1994-5#1)(1996-2#1)(1997-2#1)(2004-12#1)(2005-1#1)(2006-7#1)(2007-8#1)(2007-9#1)(2011-2#1)(2013-1#4)(2013-8#1)
significant differences between men and women##2##6##(1993-2#2)
significant differences between patients and controls in##2##7##(1997-2#1)(1997-5#1)
significant differences between patients and##4##5##(1995-2#1)(1997-2#1)(1997-5#1)(2009-2#1)
significant differences between the 2 groups##3##6##(1990-7#1)(2007-9#1)(2009-10#1)
significant differences between the groups##6##5##(1990-9#1)(1995-1#1)(2007-2#2)(2008-6#1)(2009-12#1)
significant differences between the mean##2##5##(2009-5#1)(2012-2#1)
significant differences between the proposed##2##5##(2008-10#2)
significant differences between the three##2##5##(2012-12#1)(2013-7#1)
significant differences between the two groups with##2##7##(1995-10#1)(2013-1#1)
significant differences between the two groups##11##6##(1992-11#1)(1995-10#1)(1995-4#1)(1996-12#1)(2006-7#1)(2007-9#1)(2008-9#1)(2012-12#1)(2013-1#3)
significant differences between the two##20##5##(1991-3#1)(1992-11#1)(1993-8#1)(1995-10#2)(1995-4#1)(1995-8#1)(1996-12#1)(2006-7#1)(2007-2#1)(2007-9#1)(2008-3#1)(2008-9#1)(2009-4#1)(2010-8#1)(2012-11#1)(2012-12#1)(2013-1#3)
significant differences between the##58##4##(1990-7#1)(1990-9#1)(1991-3#1)(1991-9#1)(1992-11#1)(1993-8#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-4#1)(1995-7#1)(1995-8#1)(1996-12#1)(2006-10#1)(2006-7#1)(2007-2#3)(2007-5#1)(2007-8#2)(2007-9#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
significant differences between them##2##4##(2006-10#1)(2008-10#1)
significant differences between treatment groups##2##5##(1992-10#1)(2008-7#1)
significant differences between treatments##2##4##(2006-5#1)(2008-12#1)
significant differences between##147##3##(1990-12#1)(1990-7#1)(1990-9#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-9#1)(1993-2#2)(1993-4#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-1#2)(1995-10#2)(1995-2#1)(1995-4#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-5#1)(1997-7#2)(2004-12#1)(2005-1#1)(2005-4#1)(2006-10#2)(2006-5#1)(2006-7#2)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#6)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#3)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2010-12#2)(2010-3#1)(2010-4#2)(2010-8#4)(2011-1#2)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#13)(2013-7#2)(2013-8#7)
significant differences both##2##3##(2006-12#1)(2006-9#1)
significant differences by##3##3##(1993-11#1)(2011-2#1)(2012-2#1)
significant differences could be##2##4##(2008-5#1)(2013-1#1)
significant differences exist##3##3##(1996-2#1)(1997-4#1)(2007-8#1)
significant differences existed between##2##4##(2006-5#1)(2012-12#1)
significant differences for total##2##4##(1993-1#1)(2008-10#1)
significant differences for##7##3##(1993-1#1)(2008-10#1)(2008-12#1)(2013-1#1)(2013-8#3)
significant differences found among the 9 fish species##2##8##(2008-12#2)
significant differences found##5##3##(2007-2#2)(2007-6#1)(2008-12#2)
significant differences from the##2##4##(2012-2#2)
significant differences from##5##3##(1991-8#1)(1992-5#1)(2008-7#1)(2012-2#2)
significant differences have been found##2##5##(1996-9#1)(2008-2#1)
significant differences in a##2##4##(1994-5#1)(1997-5#1)
significant differences in age##3##4##(2012-12#1)(2012-5#1)(2013-1#1)
significant differences in allele frequencies##2##5##(2008-10#2)
significant differences in allele##3##4##(2008-10#2)(2008-12#1)
significant differences in diagnostic##2##4##(1991-8#1)(2012-2#1)
significant differences in efficacy##2##4##(2008-5#1)(2010-12#1)
significant differences in genotype##2##4##(2006-9#1)(2011-2#1)
significant differences in optical##2##4##(1994-11#1)(1997-6#1)
significant differences in prevalence##2##4##(1996-12#1)(2007-7#1)
significant differences in serum##3##4##(1997-2#1)(1997-4#1)(2011-12#1)
significant differences in terms of##3##5##(2008-7#1)(2011-1#1)(2013-8#1)
significant differences in the distribution of##2##6##(1990-12#1)(2008-5#1)
significant differences in the frequency of##5##6##(1991-8#1)(2004-3#1)(2008-10#1)(2008-12#1)(2012-3#1)
significant differences in the level of##2##6##(1996-12#1)(2006-8#1)
significant differences in the mean##2##5##(2006-9#1)(2011-2#1)
significant differences in the number##2##5##(1991-3#1)(1997-5#1)
significant differences in the overall##2##5##(1996-3#1)(1996-7#1)
significant differences in the prevalence of##2##6##(2007-3#1)(2007-7#1)
significant differences in the proportion of##2##6##(1997-8#1)(2007-8#1)
significant differences in the size##2##5##(1991-12#1)(2010-9#1)
significant differences in the specific##2##5##(1990-5#1)(2005-11#1)
significant differences in the##83##4##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-11#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-12#2)(1996-3#1)(1996-7#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-3#1)(2004-4#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-9#2)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#1)
significant differences in their##3##4##(1996-7#1)(2007-11#1)(2010-2#1)
significant differences in##255##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#2)(1993-1#1)(1993-12#3)(1993-6#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-5#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#2)(1996-11#1)(1996-12#3)(1996-3#1)(1996-4#1)(1996-7#4)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#1)(2004-11#1)(2004-3#1)(2004-4#1)(2005-11#2)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-8#2)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#4)(2007-3#1)(2007-4#1)(2007-7#6)(2007-8#8)(2007-9#2)(2008-10#27)(2008-11#4)(2008-12#7)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#6)(2008-7#7)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-10#1)(2011-12#1)(2011-2#8)(2011-3#1)(2012-12#3)(2012-2#7)(2012-3#5)(2012-5#1)(2013-1#16)(2013-7#3)(2013-8#5)
significant differences occur##2##3##(1995-8#1)(2008-2#1)
significant differences of##3##3##(2008-6#1)(2008-7#1)(2012-1#1)
significant differences regarding##2##3##(1997-8#1)(2011-2#1)
significant differences to##5##3##(2004-11#1)(2007-2#1)(2008-10#1)(2009-5#1)(2010-10#1)
significant differences were also##2##4##(2008-2#1)(2010-1#1)
significant differences were between##2##4##(2010-12#1)(2011-1#1)
significant differences were detected##2##4##(1992-9#1)(2013-7#1)
significant differences were determined##2##4##(1996-7#1)(2008-10#1)
significant differences were found among##4##5##(1993-2#1)(1997-4#1)(2008-10#1)(2012-3#1)
significant differences were found between the two groups##2##8##(1992-11#1)(2007-7#1)
significant differences were found between the two##3##7##(1992-11#1)(1992-12#1)(2007-7#1)
significant differences were found between the##6##6##(1992-11#1)(1992-12#1)(1992-3#1)(1993-2#1)(2007-7#1)(2008-10#1)
significant differences were found between##20##5##(1992-11#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-9#1)(1995-12#1)(1997-8#1)(2004-11#1)(2006-11#1)(2006-6#1)(2006-8#1)(2007-7#1)(2008-10#2)(2008-5#1)(2010-12#1)(2010-6#1)(2011-3#1)(2013-1#1)
significant differences were found in all##2##6##(2008-10#1)(2013-7#1)
significant differences were found in the##5##6##(1995-5#1)(2007-10#1)(2007-7#1)(2008-10#1)(2013-8#1)
significant differences were found in##14##5##(1992-12#1)(1995-5#1)(1997-3#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-7#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
significant differences were found##46##4##(1992-11#1)(1992-12#2)(1992-3#1)(1993-11#1)(1993-2#2)(1993-9#2)(1995-12#1)(1995-5#1)(1996-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-11#1)(2006-11#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-7#2)(2008-10#7)(2008-12#1)(2008-5#2)(2008-7#1)(2010-12#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
significant differences were not##2##4##(2008-8#1)(2012-12#1)
significant differences were noted in##2##5##(1996-7#1)(2013-1#1)
significant differences were noted##5##4##(1994-1#1)(1996-7#1)(2007-2#2)(2013-1#1)
significant differences were observed at##2##5##(2007-4#1)(2008-5#1)
significant differences were observed between the two groups##2##8##(2008-3#1)(2011-2#1)
significant differences were observed between the##5##6##(1990-10#1)(1994-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
significant differences were observed between##8##5##(1990-10#1)(1992-1#1)(1994-12#1)(1996-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
significant differences were observed for##2##5##(2008-10#1)(2010-12#1)
significant differences were observed in the##9##6##(1992-9#1)(1995-11#1)(1996-7#1)(2005-8#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
significant differences were observed in##13##5##(1992-2#1)(1992-3#1)(1992-9#1)(1995-11#1)(1996-7#1)(2005-8#1)(2008-10#1)(2008-5#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
significant differences were observed##31##4##(1990-10#1)(1992-1#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-6#1)(1994-12#1)(1995-11#1)(1996-11#1)(1996-7#1)(2005-8#1)(2007-4#1)(2008-10#6)(2008-3#1)(2008-5#3)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
significant differences were recorded##2##4##(2008-10#1)(2008-3#1)
significant differences were seen in##6##5##(1997-6#1)(2007-11#1)(2008-12#1)(2008-5#2)(2013-1#1)
significant differences were seen##8##4##(1993-2#1)(1997-6#1)(2007-11#1)(2008-12#1)(2008-5#3)(2013-1#1)
significant differences were##108##3##(1990-10#1)(1990-5#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-9#2)(1993-11#1)(1993-2#3)(1993-6#1)(1993-9#2)(1994-1#1)(1994-12#1)(1994-2#2)(1995-11#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-7#3)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-8#1)(2006-11#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-4#1)(2007-7#2)(2008-10#16)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#8)(2008-7#1)(2008-8#2)(2010-1#1)(2010-12#3)(2010-6#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#3)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#3)
significant differences when##2##3##(2008-8#1)(2013-1#1)
significant differences with respect to the##2##6##(1991-6#1)(2012-2#1)
significant differences with respect to##4##5##(1991-6#1)(1995-12#1)(2008-12#1)(2012-2#1)
significant differences with##6##3##(1991-6#1)(1994-3#1)(1995-12#1)(2006-11#1)(2008-12#1)(2012-2#1)
significant differences##679##2##(1990-10#3)(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#3)(1990-6#2)(1990-7#3)(1990-8#2)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#2)(1992-1#4)(1992-10#2)(1992-11#3)(1992-12#3)(1992-2#3)(1992-3#3)(1992-4#2)(1992-5#1)(1992-8#1)(1992-9#4)(1993-1#4)(1993-11#2)(1993-12#4)(1993-2#7)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#5)(1994-3#1)(1994-5#4)(1994-9#1)(1995-1#4)(1995-10#2)(1995-11#2)(1995-12#5)(1995-2#4)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#2)(1995-8#5)(1996-1#4)(1996-11#3)(1996-12#6)(1996-2#3)(1996-3#1)(1996-4#1)(1996-7#7)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#2)(1997-4#3)(1997-5#4)(1997-6#4)(1997-7#4)(1997-8#3)(2004-11#5)(2004-12#1)(2004-3#1)(2004-4#1)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#2)(2005-4#1)(2005-8#1)(2006-1#1)(2006-10#6)(2006-11#2)(2006-12#3)(2006-2#2)(2006-4#1)(2006-5#5)(2006-6#1)(2006-7#5)(2006-8#7)(2006-9#4)(2007-1#1)(2007-10#6)(2007-11#5)(2007-12#7)(2007-2#17)(2007-3#2)(2007-4#3)(2007-5#2)(2007-6#3)(2007-7#10)(2007-8#13)(2007-9#6)(2008-1#2)(2008-10#70)(2008-11#6)(2008-12#17)(2008-2#5)(2008-3#9)(2008-4#5)(2008-5#32)(2008-6#3)(2008-7#12)(2008-8#5)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#5)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-12#8)(2010-2#2)(2010-3#3)(2010-4#5)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#6)(2011-10#1)(2011-12#2)(2011-2#22)(2011-3#2)(2012-1#1)(2012-11#1)(2012-12#11)(2012-2#18)(2012-3#11)(2012-5#1)(2013-1#41)(2013-7#8)(2013-8#20)
significant different between##2##3##(2008-5#1)(2012-3#1)
significant different in##2##3##(2007-8#1)(2008-8#1)
significant different##8##2##(2007-8#2)(2008-10#1)(2008-5#1)(2008-8#1)(2011-1#1)(2012-1#1)(2012-3#1)
significant differential##3##2##(1996-1#1)(1997-7#1)(2009-6#1)
significant difficulties in##2##3##(2008-11#1)(2013-1#1)
significant digenic##2##2##(2008-10#1)(2008-4#1)
significant direct correlation between##3##4##(2006-8#2)(2008-7#1)
significant direct correlation##4##3##(2006-8#2)(2008-7#2)
significant direct##5##2##(2006-8#2)(2007-9#1)(2008-7#2)
significant disagreement##2##2##(2008-10#1)(2008-6#1)
significant discrepancy between##2##3##(2008-1#1)(2008-3#1)
significant discrepancy##3##2##(1994-2#1)(2008-1#1)(2008-3#1)
significant disease control##2##3##(2008-10#2)
significant disease in##2##3##(1996-6#1)(2013-1#1)
significant disease##12##2##(1995-12#1)(1996-6#1)(2006-10#1)(2007-2#1)(2008-10#6)(2011-2#1)(2013-1#1)
significant disparity##2##2##(1992-1#1)(2008-1#1)
significant distortion##3##2##(2005-8#1)(2007-12#1)(2008-2#1)
significant distortions##2##2##(2008-7#1)(2011-1#1)
significant distress##3##2##(1995-12#1)(2006-4#1)(2007-2#1)
significant disturbances##2##2##(1997-6#1)(2008-8#1)
significant diurnal##2##2##(1991-2#1)(1997-1#1)
significant diversity##2##2##(2008-10#1)(2010-12#1)
significant dose##3##2##(1992-5#1)(2007-7#1)(2013-7#1)
significant dose-dependent##5##2##(1993-11#1)(1994-12#1)(1997-4#1)(2008-4#1)(2012-2#1)
significant dose-response##2##2##(1997-4#1)(2012-3#1)
significant down-regulation of##4##3##(1992-6#1)(1994-11#1)(2012-12#1)(2013-1#1)
significant drift##2##2##(2006-2#1)(2008-10#1)
significant drop##6##2##(1993-3#1)(1993-7#1)(1994-6#2)(2007-11#1)(2007-8#1)
significant drug##3##2##(2007-11#1)(2008-3#2)
significant during##2##2##(1997-6#1)(2007-6#1)
significant dynamic##2##2##(2008-3#1)(2008-7#1)
significant early##2##2##(2007-10#1)(2010-4#1)
significant ecological##2##2##(2008-8#1)(2008-9#1)
significant economic losses##4##3##(2008-10#3)(2010-4#1)
significant economic##11##2##(1994-12#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2009-5#1)(2010-4#1)(2012-3#1)(2013-1#1)
significant effect (P&lt##2##3##(2008-10#1)(2010-4#1)
significant effect for##2##3##(2009-12#1)(2011-1#1)
significant effect in patients##2##4##(1990-10#1)(2007-9#1)
significant effect in##8##3##(1990-10#1)(1991-8#2)(2006-3#1)(2007-9#2)(2008-11#1)(2012-12#1)
significant effect of the##4##4##(1996-12#1)(2007-12#1)(2008-11#1)(2013-8#1)
significant effect of##29##3##(1990-2#1)(1990-9#1)(1992-6#1)(1995-11#1)(1995-12#1)(1996-10#1)(1996-12#2)(2004-11#1)(2006-10#1)(2006-6#1)(2007-12#2)(2007-6#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
significant effect on LAT cell viability##2##6##(1990-6#2)
significant effect on both##4##4##(1995-12#1)(2007-9#1)(2008-10#1)(2008-4#1)
significant effect on survival##3##4##(2004-1#1)(2004-10#1)(2008-5#1)
significant effect on the body size##2##6##(2012-2#2)
significant effect on the rate of 3H-thymidine##2##7##(1995-3#2)
significant effect on the rate of##3##6##(1995-3#2)(2008-10#1)
significant effect on the##71##4##(1990-2#1)(1990-4#1)(1990-5#1)(1991-6#1)(1992-8#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1995-3#2)(1995-6#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-5#2)(2006-1#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-7#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#2)(2009-1#1)(2009-12#1)(2009-8#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#2)
significant effect on##153##3##(1990-10#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#3)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-12#1)(1992-4#2)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#2)(1995-6#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#1)(2004-1#1)(2004-10#1)(2006-1#1)(2006-10#1)(2006-5#1)(2007-10#2)(2007-11#4)(2007-2#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-10#18)(2008-11#2)(2008-12#6)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2009-1#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-2#5)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#4)(2013-7#1)
significant effect was observed in##2##5##(1994-9#1)(2008-10#1)
significant effect was observed##5##4##(1994-9#1)(2004-11#1)(2007-10#1)(2008-10#1)(2008-5#1)
significant effect was##6##3##(1993-6#1)(1994-9#1)(2004-11#1)(2007-10#1)(2008-10#1)(2008-5#1)
significant effect##247##2##(1990-10#2)(1990-2#3)(1990-4#1)(1990-5#1)(1990-6#3)(1990-9#1)(1991-11#1)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#3)(1992-11#1)(1992-12#1)(1992-4#2)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#3)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-4#1)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#4)(1995-11#1)(1995-12#2)(1995-3#2)(1995-6#3)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#2)(1997-7#1)(2004-1#1)(2004-10#1)(2004-11#2)(2005-11#1)(2006-1#1)(2006-10#2)(2006-3#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-10#3)(2007-11#5)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#4)(2008-10#33)(2008-11#7)(2008-12#7)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-8#2)(2010-3#1)(2010-4#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#6)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
significant effects are##2##3##(1996-3#1)(2011-2#1)
significant effects in##3##3##(1991-2#1)(1991-6#1)(2013-8#1)
significant effects of##12##3##(1993-2#1)(1994-1#1)(1995-11#1)(2005-11#1)(2006-5#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
significant effects on the activity##2##5##(2006-10#1)(2008-11#1)
significant effects on the##15##4##(1990-10#1)(1990-7#1)(1991-12#1)(1991-9#1)(1993-6#1)(1997-2#1)(2006-10#1)(2008-11#2)(2008-4#1)(2010-12#1)(2013-1#1)(2013-8#3)
significant effects on##45##3##(1990-10#1)(1990-7#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-11#1)(1992-5#1)(1993-6#1)(1994-6#1)(1995-12#1)(1995-7#1)(1996-1#1)(1996-12#1)(1997-2#1)(2005-9#1)(2006-10#2)(2006-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-12#2)(2012-11#1)(2013-1#1)(2013-8#3)
significant effects upon##2##3##(1991-1#1)(2008-11#1)
significant effects were found##2##4##(1991-2#1)(1996-12#1)
significant effects were observed##2##4##(1990-5#1)(2008-7#1)
significant effects were##6##3##(1990-5#1)(1990-6#1)(1991-2#1)(1993-2#1)(1996-12#1)(2008-7#1)
significant effects##77##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-6#1)(1991-9#1)(1992-11#2)(1992-5#1)(1993-2#2)(1993-6#1)(1994-1#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-7#1)(1996-1#1)(1996-12#2)(1996-3#1)(1997-2#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-5#2)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-12#1)(2009-5#1)(2010-12#3)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#2)(2013-8#4)
significant efficacy in##3##3##(2006-2#1)(2007-11#1)(2008-9#1)
significant efficacy##5##2##(2006-2#1)(2007-11#1)(2008-9#1)(2010-5#1)(2011-2#1)
significant effort##2##2##(2006-10#1)(2008-11#1)
significant efforts##3##2##(2006-11#1)(2008-10#1)(2012-2#1)
significant elevation in##5##3##(2007-10#1)(2007-2#1)(2009-10#1)(2012-2#1)(2013-8#1)
significant elevation of##9##3##(1990-8#1)(1993-4#1)(1994-4#1)(1995-3#1)(1996-5#1)(2006-10#1)(2007-11#1)(2008-4#1)(2008-5#1)
significant elevation##15##2##(1990-8#1)(1993-4#1)(1994-4#1)(1995-3#1)(1996-5#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-4#1)(2008-5#1)(2009-10#1)(2012-2#1)(2013-8#1)
significant elevations in##5##3##(1992-12#1)(1993-9#1)(2006-5#1)(2008-10#1)(2008-5#1)
significant elevations##6##2##(1992-12#1)(1993-9#1)(1996-1#1)(2006-5#1)(2008-10#1)(2008-5#1)
significant emotional##3##2##(2008-11#1)(2009-7#1)(2013-7#1)
significant energy##2##2##(2010-4#1)(2010-8#1)
significant enhancement in the##5##4##(1993-2#1)(1997-2#2)(2007-12#1)(2008-5#1)
significant enhancement in##8##3##(1993-2#1)(1997-2#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-4#1)
significant enhancement of the##12##4##(1990-3#1)(2007-11#1)(2007-12#3)(2008-10#5)(2008-11#1)(2011-1#1)
significant enhancement of##16##3##(1990-3#1)(1994-9#1)(1995-8#1)(2007-11#1)(2007-12#3)(2008-10#6)(2008-11#1)(2008-5#1)(2011-1#1)
significant enhancement##28##2##(1990-10#1)(1990-3#1)(1993-2#1)(1993-9#1)(1994-9#1)(1995-8#1)(1997-2#3)(2007-11#1)(2007-12#4)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2010-4#1)(2011-1#1)
significant enhancements in##3##3##(1997-4#1)(2005-5#1)(2008-10#1)
significant enough to##2##3##(1991-9#1)(2007-11#1)
significant enough##3##2##(1991-9#1)(1997-7#1)(2007-11#1)
significant environmental##2##2##(2007-5#1)(2008-8#1)
significant enzyme##3##2##(1992-11#1)(2007-6#1)(2008-7#1)
significant error##3##2##(1992-9#1)(2008-10#1)(2008-6#1)
significant errors##4##2##(2008-2#1)(2008-3#2)(2008-6#1)
significant ethical issues##2##3##(2006-11#1)(2013-8#1)
significant ethical##4##2##(2006-11#1)(2009-4#1)(2013-8#2)
significant even##3##2##(1993-4#1)(2008-3#1)(2010-5#1)
significant evidence for##3##3##(1994-12#1)(2008-7#1)(2008-9#1)
significant evidence of##5##3##(1993-7#1)(1997-1#1)(2008-7#1)(2008-8#1)(2009-4#1)
significant evidence that the##2##4##(2008-3#1)(2008-7#1)
significant evidence that##3##3##(2008-3#1)(2008-7#1)(2010-5#1)
significant evidence##13##2##(1993-7#1)(1994-12#1)(1997-1#1)(1997-5#1)(1997-7#1)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2010-5#1)
significant except##2##2##(2007-2#1)(2008-12#1)
significant excess##8##2##(1990-2#1)(1991-11#1)(1991-7#1)(1992-2#1)(1993-9#1)(1997-8#1)(2006-8#1)(2008-5#1)
significant expression##2##2##(1996-12#1)(2008-11#1)
significant extension of##2##3##(1994-5#1)(2008-7#1)
significant extension##3##2##(1994-5#1)(2008-3#1)(2008-7#1)
significant extent##12##2##(1990-4#2)(1991-6#1)(1993-9#1)(1994-11#1)(1995-1#1)(1996-7#1)(2008-4#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#1)
significant factor affecting##2##3##(1994-3#1)(2005-11#1)
significant factor in the##4##4##(1996-7#1)(2006-2#1)(2013-8#2)
significant factor in##10##3##(1995-4#1)(1996-7#1)(2006-2#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2013-8#2)
significant factor##23##2##(1990-4#1)(1994-3#1)(1995-4#1)(1996-7#1)(1997-8#1)(2004-11#1)(2005-11#1)(2006-2#1)(2006-8#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2013-1#1)(2013-8#2)
significant factors affecting##3##3##(1997-2#1)(2008-6#1)(2011-2#1)
significant factors contributing to##2##4##(2006-12#1)(2008-7#1)
significant factors for total inorganic##2##5##(2008-10#2)
significant factors for##4##3##(2008-10#3)(2012-3#1)
significant factors were##2##3##(2008-10#1)(2011-2#1)
significant factors##23##2##(1993-9#1)(1997-2#1)(2004-10#1)(2004-4#1)(2006-12#1)(2007-10#1)(2007-4#1)(2008-10#8)(2008-6#1)(2008-7#1)(2011-2#3)(2012-3#1)(2013-8#2)
significant fall in the##5##4##(1993-4#1)(2006-10#1)(2008-5#1)(2010-8#1)(2012-3#1)
significant fall in##9##3##(1990-5#1)(1993-4#1)(2006-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-8#1)(2012-3#1)
significant feature of##2##3##(1997-2#1)(2008-10#1)
significant features##3##2##(1995-6#1)(2008-10#1)(2009-9#1)
significant finding##5##2##(1997-1#1)(1997-6#1)(2008-12#1)(2008-9#1)(2013-1#1)
significant findings##2##2##(1990-8#1)(2012-3#1)
significant fit##4##2##(2004-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
significant fluctuations in##2##3##(1995-10#1)(2006-10#1)
significant for all##6##3##(1991-12#1)(1991-5#1)(2008-10#1)(2008-4#1)(2010-4#1)(2012-2#1)
significant for the##15##3##(1992-5#1)(1992-6#1)(1994-8#1)(1996-11#1)(1997-6#1)(1997-8#2)(2007-10#1)(2007-12#1)(2008-2#1)(2008-5#2)(2011-2#1)(2012-3#1)(2013-8#1)
significant for##71##2##(1990-2#2)(1990-3#1)(1991-1#1)(1991-12#2)(1991-5#1)(1992-5#1)(1992-6#2)(1993-1#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-6#1)(1997-8#2)(2005-1#1)(2005-10#2)(2006-12#1)(2007-10#1)(2007-12#1)(2007-3#3)(2007-9#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#2)(2008-8#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
significant formation of##2##3##(1995-10#1)(2012-12#1)
significant fragments##3##2##(1995-6#3)
significant frequency##3##2##(1990-3#1)(2006-10#1)(2013-1#1)
significant function in##2##3##(1991-9#1)(2011-1#1)
significant functional##8##2##(1991-5#1)(1997-9#1)(2005-10#1)(2006-10#1)(2006-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
significant functions##2##2##(1996-3#1)(2012-2#1)
significant future##2##2##(1993-9#1)(2007-4#1)
significant gain in##2##3##(2008-2#1)(2011-1#1)
significant gain##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2011-1#1)
significant gains in##4##3##(1992-1#1)(2004-10#1)(2006-10#1)(2012-2#1)
significant gains##8##2##(1992-1#1)(1997-4#1)(2004-10#1)(2006-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2012-2#1)
significant gaps in##12##3##(2009-10#1)(2010-4#1)(2013-8#10)
significant gastrointestinal##4##2##(1996-8#1)(2006-10#1)(2008-6#1)(2011-2#1)
significant gender difference in##2##4##(2008-1#1)(2008-11#1)
significant gender difference##5##3##(2006-1#1)(2008-1#1)(2008-11#1)(2010-2#1)(2010-3#1)
significant gender differences for##2##4##(2004-3#1)(2008-11#1)
significant gender differences in##5##4##(2004-12#1)(2007-12#1)(2007-2#1)(2008-12#1)(2008-5#1)
significant gender differences##7##3##(2004-12#1)(2004-3#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-5#1)
significant gender##12##2##(2004-12#1)(2004-3#1)(2006-1#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-5#1)(2010-2#1)(2010-3#1)
significant gene##4##2##(2008-6#1)(2009-2#1)(2010-5#1)(2011-1#1)
significant genes were##2##3##(2010-4#1)(2012-3#1)
significant genes##5##2##(2008-7#1)(2009-9#1)(2010-4#1)(2012-3#2)
significant genetic differentiation among##2##4##(2008-10#2)
significant genetic differentiation##3##3##(2008-10#3)
significant genetic effect##3##3##(1994-2#3)
significant genetic##17##2##(1994-10#1)(1994-2#4)(2005-8#1)(2007-5#1)(2008-10#4)(2008-12#1)(2008-8#1)(2012-1#1)(2012-11#1)(2012-3#1)(2013-8#1)
significant geographical##2##2##(2008-10#1)(2010-8#1)
significant group difference##2##3##(2013-7#2)
significant group differences in##4##4##(1993-3#1)(1994-6#1)(2012-1#1)(2012-2#1)
significant group differences were##2##4##(1993-9#1)(2008-2#1)
significant group differences##11##3##(1993-3#1)(1993-9#1)(1994-6#1)(2006-2#1)(2007-12#1)(2008-2#1)(2009-4#1)(2012-1#1)(2012-2#2)(2013-8#1)
significant group##16##2##(1993-3#1)(1993-9#1)(1994-6#1)(2006-2#1)(2007-12#1)(2008-2#1)(2008-5#1)(2009-2#1)(2009-4#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-7#2)(2013-8#1)
significant growth in the##2##4##(1997-2#1)(2007-11#1)
significant growth in##4##3##(1995-2#1)(1997-2#1)(2007-11#1)(2011-2#1)
significant growth inhibition of##2##4##(1990-12#1)(2013-7#1)
significant growth inhibition##3##3##(1990-12#1)(2008-5#1)(2013-7#1)
significant growth of##2##3##(2008-12#1)(2012-3#1)
significant growth was##2##3##(2012-3#2)
significant growth##21##2##(1990-12#1)(1993-1#1)(1994-6#1)(1995-2#1)(1997-2#1)(2004-4#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-3#3)(2013-7#1)
significant hallmark##2##2##(2005-12#1)(2012-12#1)
significant health and economic##2##4##(2008-1#1)(2009-8#1)
significant health and##3##3##(2008-1#1)(2008-11#1)(2009-8#1)
significant health care##2##3##(2006-12#1)(2008-1#1)
significant health problem in##5##4##(2006-2#2)(2008-5#1)(2011-1#1)(2011-2#1)
significant health problem##6##3##(1991-4#1)(2006-2#2)(2008-5#1)(2011-1#1)(2011-2#1)
significant health risk##3##3##(2005-8#1)(2007-1#1)(2013-7#1)
significant health##20##2##(1991-4#1)(1996-12#1)(2005-8#1)(2006-12#1)(2006-2#2)(2007-1#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#1)(2013-7#1)
significant health-care##3##2##(2012-12#1)(2013-1#2)
significant hemodynamic changes##2##3##(2006-10#1)(2009-8#1)
significant hemodynamic##5##2##(2006-10#2)(2009-8#2)(2010-7#1)
significant hemolysis##3##2##(1992-12#2)(1993-6#1)
significant heterogeneity of##2##3##(1990-3#1)(2008-10#1)
significant heterogeneity##4##2##(1990-3#1)(2008-10#2)(2010-2#1)
significant higher levels of##2##4##(1990-7#1)(1996-10#1)
significant higher risk##2##3##(1996-12#1)(2008-12#1)
significant higher##16##2##(1990-7#2)(1990-8#1)(1996-10#1)(1996-12#1)(1996-3#1)(2006-8#1)(2007-9#1)(2008-1#1)(2008-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-4#1)
significant history of hot flashes##2##5##(2008-7#2)
significant homologies to##2##3##(1991-9#1)(1996-4#1)
significant homologies##4##2##(1990-11#1)(1991-9#1)(1996-4#1)(1997-3#1)
significant homology to a##2##4##(1994-5#1)(1995-5#1)
significant homology to known proteins##2##5##(1995-12#1)(1995-9#1)
significant homology to that of##2##5##(1993-12#1)(1997-7#1)
significant homology to the##5##4##(1992-3#1)(1993-12#1)(1995-2#1)(1997-1#1)(1997-2#1)
significant homology to those##2##4##(1992-2#1)(1994-2#1)
significant homology to##23##3##(1992-2#2)(1992-3#1)(1993-12#4)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-9#1)(1997-1#3)(1997-2#3)(1997-6#1)(1997-7#2)(2008-10#1)
significant homology with a##2##4##(1994-12#1)(1995-1#1)
significant homology with known##2##4##(1994-8#1)(1997-3#1)
significant homology with other##2##4##(1991-6#1)(1997-6#1)
significant homology with the product of the##2##7##(1991-5#1)(1997-3#1)
significant homology with the##6##4##(1990-5#1)(1991-5#1)(1994-12#1)(1995-10#1)(1995-2#1)(1997-3#1)
significant homology with##18##3##(1990-5#1)(1990-9#2)(1991-11#1)(1991-5#1)(1991-6#1)(1994-12#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-2#1)(1996-7#1)(1997-3#2)(1997-6#1)(2008-10#1)(2008-8#1)
significant homology##48##2##(1990-5#2)(1990-9#2)(1991-11#1)(1991-5#1)(1991-6#1)(1992-2#2)(1992-3#1)(1993-12#4)(1993-3#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-5#2)(1995-8#1)(1995-9#1)(1996-7#1)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#2)(1997-6#2)(1997-7#2)(2007-1#1)(2008-10#3)(2008-8#1)
significant human##3##2##(2008-10#1)(2008-9#1)(2013-8#1)
significant identity to##2##3##(1995-3#1)(1997-3#1)
significant immune##4##2##(1997-4#1)(2007-11#1)(2008-8#1)(2008-9#1)
significant impact in##3##3##(2007-11#1)(2010-12#1)(2010-7#1)
significant impact of##4##3##(2008-1#1)(2008-10#2)(2011-12#1)
significant impact on quality of life##3##6##(2009-5#1)(2010-12#1)(2011-12#1)
significant impact on the quality of##2##6##(2011-2#1)(2012-2#1)
significant impact on the##28##4##(1992-1#1)(1996-1#1)(2005-11#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#2)
significant impact on##71##3##(1990-2#1)(1992-1#1)(1993-2#1)(1994-12#1)(1996-1#1)(1996-7#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-7#3)(2007-8#3)(2008-1#3)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#3)(2009-11#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-6#1)(2011-12#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#3)
significant impact upon the##2##4##(1990-12#1)(1997-2#1)
significant impact upon##3##3##(1990-12#1)(1997-2#1)(2006-10#1)
significant impact##85##2##(1990-12#1)(1990-2#1)(1991-12#1)(1992-1#1)(1993-2#1)(1994-12#1)(1996-1#1)(1996-7#1)(1997-2#1)(2005-11#1)(2006-10#3)(2006-11#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-7#3)(2007-8#3)(2008-1#4)(2008-10#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#3)(2009-11#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#4)
significant impacts##6##2##(1991-12#2)(2008-10#1)(2008-9#1)(2011-1#1)(2012-2#1)
significant impairment in##4##3##(1992-10#1)(2009-7#2)(2012-2#1)
significant impairment of##6##3##(1994-12#1)(2008-2#1)(2009-6#1)(2010-9#1)(2012-2#2)
significant impairment##10##2##(1992-10#1)(1994-12#1)(2008-2#1)(2009-6#1)(2009-7#2)(2010-9#1)(2012-2#3)
significant implication##2##2##(2010-12#1)(2011-1#1)
significant implications for##5##3##(1991-3#1)(2008-7#1)(2009-12#1)(2013-1#2)
significant implications in the##2##4##(2008-10#2)
significant implications in##3##3##(2006-9#1)(2008-10#2)
significant implications##10##2##(1991-3#1)(2006-9#1)(2007-3#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-12#1)(2013-1#2)
significant improvement in clinical##2##4##(1994-12#1)(2011-2#1)
significant improvement in exercise##2##4##(1993-2#1)(2008-10#1)
significant improvement in its##2##4##(2008-2#1)(2010-6#1)
significant improvement in long term##2##5##(2005-9#1)(2007-7#1)
significant improvement in pain and##2##5##(2008-8#2)
significant improvement in pain##3##4##(2006-12#1)(2008-8#2)
significant improvement in the management of##2##6##(1991-2#1)(2008-4#1)
significant improvement in the number of##2##6##(2006-5#1)(2006-6#1)
significant improvement in the##19##4##(1991-2#1)(1995-4#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
significant improvement in##103##3##(1990-2#2)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-2#1)(2004-2#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#4)(2008-3#7)(2008-4#3)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#1)(2009-8#1)(2010-5#2)(2010-6#1)(2010-8#2)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#8)(2013-8#1)
significant improvement of the##10##4##(2006-11#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2012-2#1)(2013-1#1)
significant improvement of##26##3##(1995-1#1)(1996-12#1)(2005-1#2)(2006-11#1)(2006-2#1)(2006-6#1)(2007-11#3)(2007-12#2)(2007-7#1)(2008-10#5)(2008-11#1)(2008-3#1)(2010-12#1)(2012-2#2)(2012-7#1)(2013-1#2)
significant improvement over time##2##4##(2008-9#1)(2011-2#1)
significant improvement over##7##3##(1994-1#1)(2008-3#3)(2008-9#1)(2010-5#1)(2011-2#1)
significant improvement vs##2##3##(2008-5#1)(2013-1#1)
significant improvement was observed##2##4##(1995-4#1)(2012-12#1)
significant improvement was##4##3##(1995-4#1)(2006-8#1)(2012-12#1)(2013-1#1)
significant improvement with##2##3##(2004-10#1)(2006-8#1)
significant improvement##172##2##(1990-2#2)(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-4#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(2004-10#1)(2004-2#1)(2005-1#2)(2005-6#1)(2005-9#3)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#6)(2007-1#1)(2007-11#6)(2007-12#5)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#13)(2008-4#3)(2008-5#6)(2008-7#4)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-8#1)(2010-12#3)(2010-5#3)(2010-6#1)(2010-8#2)(2011-2#8)(2012-1#2)(2012-12#5)(2012-2#3)(2012-3#2)(2012-7#1)(2013-1#12)(2013-8#1)
significant improvements have##2##3##(2006-10#1)(2008-3#1)
significant improvements in progression-free survival##2##5##(2009-8#1)(2012-2#1)
significant improvements in the##9##4##(1991-2#1)(1996-3#1)(2004-10#1)(2006-10#1)(2006-5#1)(2008-2#1)(2008-3#1)(2009-9#1)(2011-2#1)
significant improvements in##31##3##(1991-2#1)(1993-1#1)(1994-8#1)(1995-10#1)(1996-2#2)(1996-3#1)(1996-7#1)(2004-10#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-2#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2011-2#2)(2012-2#2)(2013-1#2)
significant improvements over##2##3##(2008-2#1)(2009-3#1)
significant improvements##47##2##(1991-2#2)(1993-1#1)(1994-8#1)(1995-10#1)(1996-2#2)(1996-3#2)(1996-7#1)(2004-10#2)(2006-10#3)(2006-5#1)(2006-7#1)(2007-11#2)(2007-2#1)(2008-2#4)(2008-3#4)(2008-5#3)(2008-6#2)(2008-7#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2011-2#2)(2012-2#2)(2013-1#2)
significant in a##2##3##(2008-10#1)(2009-4#1)
significant in all##3##3##(1991-10#1)(2007-7#1)(2011-1#1)
significant in both##5##3##(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
significant in comparison with##2##4##(1994-11#1)(2008-2#1)
significant in the##26##3##(1990-2#1)(1992-4#1)(1995-10#1)(1995-8#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#2)(2010-1#1)(2010-3#1)(2010-7#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-7#1)
significant in vitro cytotoxicity against##2##5##(2007-11#1)(2009-3#1)
significant in vitro##8##3##(1991-12#1)(2006-8#1)(2007-11#3)(2008-5#1)(2009-3#1)(2012-12#1)
significant in##98##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-4#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-4#1)(1994-11#1)(1995-10#1)(1995-8#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-6#1)(2004-2#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-2#2)(2009-3#2)(2009-4#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#3)(2011-11#1)(2011-2#2)(2012-12#4)(2012-2#2)(2012-3#3)(2013-7#3)(2013-8#2)
significant increase (&gt##2##3##(2007-11#1)(2013-8#1)
significant increase (P##10##3##(1991-3#1)(1994-6#1)(1994-7#1)(1997-2#1)(1997-5#1)(2006-12#2)(2009-5#3)
significant increase (by about##2##4##(2009-8#2)
significant increase after##3##3##(1995-12#1)(2006-7#1)(2013-1#1)
significant increase both##2##3##(2008-7#1)(2012-2#1)
significant increase in DA##3##4##(1990-2#1)(1996-1#1)(2011-1#1)
significant increase in IOP##2##4##(2013-1#1)(2013-7#1)
significant increase in average##2##4##(1991-8#1)(2008-5#1)
significant increase in both##2##4##(1995-1#1)(2008-8#1)
significant increase in cell##3##4##(1996-4#1)(2008-5#1)(2012-1#1)
significant increase in comet tail length##2##6##(2010-5#2)
significant increase in liver##2##4##(1992-8#1)(2012-1#1)
significant increase in local##2##4##(1992-10#1)(2008-4#1)
significant increase in proliferative##2##4##(2005-8#1)(2007-2#1)
significant increase in the average##3##5##(1990-4#1)(2007-8#1)(2008-12#1)
significant increase in the frequency of micronucleated##2##7##(1996-12#1)(2008-9#1)
significant increase in the frequency of##3##6##(1994-2#1)(1996-12#1)(2008-9#1)
significant increase in the incidence of##6##6##(1995-2#2)(2008-1#1)(2008-6#1)(2011-12#2)
significant increase in the level of##6##6##(2007-1#1)(2009-4#1)(2009-8#2)(2012-2#1)(2013-8#1)
significant increase in the number of##9##6##(1993-3#1)(1994-5#1)(2006-10#1)(2008-10#1)(2008-6#1)(2009-12#1)(2010-10#1)(2011-2#1)(2012-3#1)
significant increase in the proportion of##6##6##(1991-9#1)(1995-11#1)(1995-6#1)(1996-12#1)(2006-10#1)(2006-4#1)
significant increase in the##101##4##(1990-11#1)(1990-4#1)(1991-10#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-4#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#2)(2006-10#3)(2006-4#1)(2007-1#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#5)(2008-6#3)(2008-9#1)(2009-12#1)(2009-4#1)(2009-8#3)(2010-10#2)(2010-12#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#4)
significant increase in##285##3##(1990-11#2)(1990-2#3)(1990-3#1)(1990-4#4)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-8#3)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-4#1)(1993-7#4)(1994-10#1)(1994-11#3)(1994-2#3)(1994-3#8)(1994-5#4)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#5)(1995-5#2)(1995-6#3)(1995-8#2)(1996-1#2)(1996-12#3)(1996-4#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#3)(1997-8#1)(2004-1#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#8)(2007-12#1)(2007-2#7)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#4)(2007-9#3)(2008-1#4)(2008-10#16)(2008-11#4)(2008-12#3)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#13)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#8)(2010-1#1)(2010-10#3)(2010-12#1)(2010-2#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-12#3)(2011-2#4)(2012-1#6)(2012-11#3)(2012-12#1)(2012-2#5)(2012-3#3)(2012-7#1)(2013-1#9)(2013-7#6)(2013-8#5)
significant increase of intracellular##2##4##(1995-8#1)(2008-8#1)
significant increase of resistance##2##4##(2007-7#1)(2008-11#1)
significant increase of the signal intensity##2##6##(2008-10#1)(2008-3#1)
significant increase of the##12##4##(1990-10#1)(1992-8#1)(1994-6#2)(2006-4#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2012-2#1)
significant increase of##49##3##(1990-10#1)(1990-12#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-3#1)(1992-12#1)(1992-6#1)(1992-8#2)(1993-7#1)(1994-6#3)(1995-8#1)(1996-10#1)(1997-1#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-7#3)(2007-9#1)(2008-10#4)(2008-11#4)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#3)(2009-8#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#2)
significant increase was detected in##2##5##(2008-2#1)(2013-1#1)
significant increase was found in the##2##6##(1991-5#1)(2008-7#1)
significant increase was observed##3##4##(1994-5#1)(1994-9#1)(1995-8#1)
significant increase was##8##3##(1991-5#1)(1994-5#1)(1994-9#1)(1995-8#1)(2006-10#1)(2008-2#1)(2008-7#1)(2013-1#1)
significant increase##388##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#4)(1990-6#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#2)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#5)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-4#2)(1993-7#5)(1994-10#1)(1994-11#3)(1994-2#3)(1994-3#8)(1994-5#5)(1994-6#6)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#6)(1995-5#2)(1995-6#3)(1995-8#4)(1996-1#2)(1996-10#1)(1996-12#3)(1996-4#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#4)(1997-8#1)(2004-1#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#5)(2006-12#4)(2006-4#2)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#9)(2007-12#1)(2007-2#7)(2007-4#1)(2007-6#2)(2007-7#5)(2007-8#5)(2007-9#4)(2008-1#4)(2008-10#22)(2008-11#10)(2008-12#4)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#17)(2008-6#4)(2008-7#6)(2008-8#4)(2008-9#3)(2009-12#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#11)(2010-1#1)(2010-10#3)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#4)(2011-2#6)(2012-1#6)(2012-11#3)(2012-12#4)(2012-2#8)(2012-3#3)(2012-7#1)(2013-1#14)(2013-7#6)(2013-8#7)
significant increased risk of##2##4##(1990-6#1)(2007-8#1)
significant increased risk##3##3##(1990-6#2)(2007-8#1)
significant increased##12##2##(1990-6#2)(1996-9#1)(1997-6#1)(2007-4#1)(2007-8#1)(2008-6#1)(2008-8#2)(2009-10#1)(2011-2#1)(2012-1#1)
significant increases in both##2##4##(1990-9#1)(1997-4#1)
significant increases in serum##3##4##(1992-10#1)(1995-12#1)(2007-1#1)
significant increases in the##9##4##(1992-1#1)(1993-4#1)(1995-12#1)(1996-12#1)(1997-1#1)(2004-11#1)(2006-9#1)(2008-7#1)(2008-9#1)
significant increases in##65##3##(1990-3#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-2#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-4#2)(1992-7#1)(1992-8#2)(1993-12#2)(1993-4#1)(1993-6#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-5#1)(1996-12#3)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(2004-11#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#2)(2010-6#1)(2010-7#1)(2010-8#4)(2012-1#1)(2013-1#4)(2013-7#1)(2013-8#1)
significant increases of##7##3##(1994-10#1)(1996-3#1)(1996-8#1)(1996-9#1)(2008-7#1)(2011-2#1)(2013-8#1)
significant increases were##3##3##(2008-9#2)(2010-1#1)
significant increases##81##2##(1990-3#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-2#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-4#2)(1992-7#1)(1992-8#2)(1993-12#2)(1993-4#1)(1993-6#1)(1994-10#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-5#1)(1996-12#3)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(2004-11#1)(2006-12#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-5#1)(2010-1#1)(2010-12#2)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#4)(2013-7#1)(2013-8#2)
significant increasing##2##2##(2011-1#2)
significant independent predictor of##4##4##(1997-8#1)(2007-10#2)(2012-12#1)
significant independent predictors of##4##4##(1993-12#1)(2006-7#1)(2011-2#2)
significant independent##12##2##(1993-12#1)(1997-8#1)(2006-7#1)(2007-10#2)(2009-7#1)(2010-4#1)(2011-2#2)(2012-12#2)(2013-8#1)
significant indicator##2##2##(2006-9#1)(2007-1#1)
significant indicators of##2##3##(2010-12#1)(2011-1#1)
significant induction of##3##3##(1990-7#1)(1994-5#1)(2007-12#1)
significant infection##2##2##(2008-9#1)(2011-1#1)
significant influence of the##2##4##(2005-10#1)(2008-10#1)
significant influence of##12##3##(1992-9#1)(1996-12#1)(2005-10#1)(2007-4#1)(2008-10#1)(2008-3#1)(2009-12#1)(2009-4#2)(2009-5#1)(2011-2#1)(2012-6#1)
significant influence on the##20##4##(1990-2#1)(1991-2#1)(1996-2#1)(1997-7#1)(2005-11#1)(2007-1#1)(2007-12#1)(2008-3#1)(2008-5#2)(2009-2#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-2#2)(2011-3#1)(2012-3#2)
significant influence on##47##3##(1990-12#1)(1990-2#1)(1991-10#1)(1991-2#1)(1992-8#1)(1994-12#1)(1995-10#1)(1996-2#1)(1997-7#1)(2005-11#1)(2006-11#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-5#4)(2008-7#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#3)(2011-2#4)(2011-3#1)(2012-3#3)(2013-1#1)(2013-8#3)
significant influence##66##2##(1990-12#1)(1990-2#1)(1991-10#1)(1991-2#1)(1992-8#1)(1992-9#1)(1994-12#1)(1995-10#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-11#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#4)(2008-5#5)(2008-7#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-9#1)(2010-12#1)(2010-2#3)(2011-2#6)(2011-3#1)(2012-3#3)(2012-6#1)(2013-1#1)(2013-7#1)(2013-8#3)
significant information##4##2##(2006-6#1)(2007-11#1)(2008-11#1)(2013-7#1)
significant inhibition activity##2##3##(2008-11#1)(2008-4#1)
significant inhibition in the##3##4##(1992-6#2)(1994-8#1)
significant inhibition of the##2##4##(1992-6#1)(1996-1#1)
significant inhibition of tumor##2##4##(1994-11#1)(1997-7#1)
significant inhibition of##20##3##(1990-12#2)(1990-3#1)(1991-10#1)(1992-6#1)(1994-11#1)(1995-10#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-12#1)(1997-3#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-1#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)
significant inhibition##31##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-9#1)(1991-10#1)(1992-6#3)(1994-11#1)(1994-8#1)(1995-10#2)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1997-3#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-1#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)
significant inhibitory activity##2##3##(1990-11#1)(2012-2#1)
significant inhibitory effect on##2##4##(1994-11#1)(2008-11#1)
significant inhibitory effect##4##3##(1990-5#1)(1994-11#1)(2008-11#1)(2008-2#1)
significant inhibitory effects on##2##4##(1994-8#1)(2012-12#1)
significant inhibitory effects##5##3##(1994-3#1)(1994-8#1)(2008-10#1)(2008-5#1)(2012-12#1)
significant inhibitory##11##2##(1990-11#1)(1990-5#1)(1994-11#1)(1994-3#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2012-12#1)(2012-2#1)
significant insight into the roles of##2##6##(2008-7#1)(2011-2#1)
significant insight into the##6##4##(2007-3#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-8#1)(2011-2#1)
significant interaction between the##3##4##(1993-3#1)(2008-10#1)(2008-3#1)
significant interaction between##10##3##(1993-3#1)(2004-4#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-4#1)(2012-4#1)
significant interaction by##2##3##(2011-2#1)(2013-1#1)
significant interaction for##2##3##(2008-10#1)(2008-12#1)
significant interaction of##5##3##(1996-1#1)(2004-11#1)(2006-9#1)(2008-10#2)
significant interaction was found between##2##5##(2009-2#1)(2011-2#1)
significant interaction was##3##3##(1991-9#1)(2009-2#1)(2011-2#1)
significant interaction##29##2##(1990-12#1)(1991-9#1)(1993-3#1)(1996-1#1)(1997-4#1)(2004-11#1)(2004-4#1)(2006-9#1)(2007-12#1)(2007-4#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-12#1)(2011-2#2)(2012-4#1)(2012-6#2)(2013-1#1)
significant interactions among##2##3##(2004-11#1)(2008-10#1)
significant interactions were##2##3##(2008-10#1)(2008-5#1)
significant interactions##7##2##(1994-10#1)(2004-11#1)(2008-10#3)(2008-11#1)(2008-5#1)
significant interest in##2##3##(2008-2#1)(2008-4#1)
significant interest##10##2##(2005-7#1)(2005-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#2)(2013-1#1)
significant interference from##4##3##(1990-2#1)(2008-10#2)(2010-5#1)
significant interference in##2##3##(2008-10#1)(2008-3#1)
significant interference##10##2##(1990-2#2)(2008-10#6)(2008-3#1)(2010-5#1)
significant interferences##3##2##(1990-2#1)(2008-10#2)
significant intracranial hypertension##2##3##(2010-5#2)
significant inverse associations##2##3##(2007-8#1)(2008-12#1)
significant inverse correlation with##3##4##(1991-12#1)(2012-1#1)(2013-1#1)
significant inverse correlation##8##3##(1991-12#1)(1995-8#1)(1997-8#1)(2005-8#1)(2008-7#2)(2012-1#1)(2013-1#1)
significant inverse relationship was##3##4##(2011-1#2)(2012-1#1)
significant inverse relationship with##2##4##(1993-2#1)(1995-6#1)
significant inverse relationship##6##3##(1993-2#1)(1995-6#1)(2006-12#1)(2011-1#2)(2012-1#1)
significant inverse##19##2##(1991-12#1)(1993-12#1)(1993-2#1)(1994-2#1)(1995-6#1)(1995-8#1)(1997-8#1)(2005-8#1)(2006-12#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-7#2)(2011-1#2)(2012-1#2)(2013-1#1)
significant investment##3##2##(1993-12#1)(2008-11#1)(2008-4#1)
significant involvement of##4##3##(1996-2#1)(1996-9#1)(2006-5#1)(2007-10#1)
significant is##2##2##(1997-6#1)(2006-10#1)
significant isotope##2##2##(1994-11#1)(1994-5#1)
significant issues##6##2##(1991-3#1)(2007-10#1)(2007-12#1)(2007-4#2)(2008-6#1)
significant joint##2##2##(2007-11#1)(2007-2#1)
significant lactose accumulation##2##3##(1993-11#1)(1995-1#1)
significant lag positions discontinuous from##2##5##(2008-10#2)
significant lag##3##2##(1990-12#1)(2008-10#2)
significant lateral##2##2##(1990-4#1)(2009-4#1)
significant lesions##3##2##(2008-5#2)(2008-7#1)
significant level of activity##2##4##(1992-9#1)(2006-8#1)
significant level of##8##3##(1992-9#2)(1994-8#1)(1996-2#1)(1996-7#1)(2006-8#1)(2009-10#1)(2010-4#1)
significant level##14##2##(1991-5#1)(1992-9#2)(1994-8#1)(1996-2#1)(1996-7#1)(2006-8#1)(2008-5#3)(2009-10#1)(2010-11#1)(2010-4#1)(2012-2#1)
significant level)##2##2##(1997-8#1)(2010-11#1)
significant levels of genetic differentiation##2##5##(2008-10#2)
significant levels of##17##3##(1991-12#1)(1994-11#1)(1995-6#1)(1996-1#1)(1996-5#1)(1997-2#1)(2006-2#1)(2007-12#1)(2008-10#6)(2008-7#1)(2009-7#1)(2013-1#1)
significant levels##25##2##(1991-12#1)(1994-11#1)(1995-6#1)(1996-1#1)(1996-5#1)(1997-2#1)(2006-2#1)(2007-12#1)(2008-10#8)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-7#1)(2010-12#1)(2010-4#1)(2013-1#1)
significant limitations##7##2##(1992-12#1)(2006-10#1)(2006-12#1)(2007-6#1)(2007-9#1)(2012-12#1)(2013-8#1)
significant linear correlation between##2##4##(1997-8#1)(2009-3#1)
significant linear correlation##3##3##(1995-1#1)(1997-8#1)(2009-3#1)
significant linear relationship##4##3##(1992-4#1)(2008-10#1)(2010-4#1)(2011-2#1)
significant linear##10##2##(1992-4#1)(1995-1#1)(1996-5#1)(1997-8#1)(2008-10#1)(2008-5#1)(2009-3#2)(2010-4#1)(2011-2#1)
significant linkage##3##2##(1997-5#1)(2012-3#1)(2012-5#1)
significant local##3##2##(1994-9#1)(1995-6#1)(2007-7#1)
significant long-term##2##2##(2007-10#1)(2010-3#1)
significant loss in##2##3##(1996-12#1)(1997-8#1)
significant loss of activity##2##4##(2006-12#1)(2007-8#1)
significant loss of the##2##4##(2008-10#1)(2008-2#1)
significant loss of##19##3##(1990-12#1)(1994-2#1)(1994-5#1)(1995-8#1)(1996-12#1)(1997-5#1)(2006-12#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-12#1)(2011-2#1)(2012-2#1)
significant loss##22##2##(1990-12#1)(1994-2#1)(1994-5#1)(1995-8#1)(1996-12#2)(1997-5#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-12#1)(2011-2#1)(2012-2#1)
significant losses in##2##3##(1993-12#1)(2012-2#1)
significant losses##4##2##(1993-12#1)(1994-4#1)(2008-10#1)(2012-2#1)
significant low##2##2##(2006-8#1)(2011-1#1)
significant lower serum##3##3##(1991-6#1)(2008-4#1)(2013-1#1)
significant lower##14##2##(1991-6#2)(1992-10#1)(2007-4#1)(2007-9#2)(2008-4#1)(2009-10#1)(2010-3#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
significant main effects##2##3##(2008-10#1)(2013-1#1)
significant main##4##2##(1994-3#1)(2007-12#1)(2008-10#1)(2013-1#1)
significant matches##2##2##(2008-10#1)(2008-7#1)
significant maternal and foetal##2##4##(2007-2#1)(2008-7#1)
significant maternal and##3##3##(2007-2#1)(2008-7#1)(2012-3#1)
significant maternal##4##2##(2007-2#1)(2008-7#1)(2010-8#1)(2012-3#1)
significant mean##6##2##(2005-7#1)(2008-12#1)(2008-5#1)(2010-5#1)(2012-12#1)(2013-7#1)
significant mechanism overlaps assessed by information-theory similarity were detected between the two GO-signatures (Fischer Exact Test p=0##2##17##(2013-1#2)
significant mediator##2##2##(2004-10#1)(2010-1#1)
significant medical and##2##3##(2005-6#1)(2006-8#1)
significant medical comorbidities##3##3##(2007-12#1)(2008-6#1)(2010-9#1)
significant medical##9##2##(2005-6#1)(2005-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-6#1)(2010-9#1)(2013-1#1)
significant metabolic##3##2##(1996-9#1)(2006-10#1)(2007-11#1)
significant methodological##3##2##(1993-6#1)(1997-1#1)(2012-2#1)
significant model##2##2##(2008-8#1)(2009-3#1)
significant modification##3##2##(2007-11#1)(2008-10#1)(2008-11#1)
significant modifications##3##2##(1993-12#1)(1997-2#1)(2005-11#1)
significant modulatory##2##2##(1992-7#1)(1995-6#1)
significant morbidity and mortality in patients##2##6##(2006-10#1)(2007-8#1)
significant morbidity and mortality in##6##5##(2006-10#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-9#1)
significant morbidity and mortality##29##4##(2005-11#1)(2006-10#7)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-6#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#2)
significant morbidity and##36##3##(1993-7#1)(1997-3#1)(2005-11#1)(2006-10#8)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-6#1)(2010-10#2)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#2)
significant morbidity to##2##3##(2008-7#1)(2013-1#1)
significant morbidity##65##2##(1993-7#1)(1994-3#1)(1996-7#1)(1997-3#1)(2005-11#1)(2006-10#12)(2006-4#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#1)(2009-6#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#2)(2011-2#4)(2012-1#1)(2012-2#2)(2012-8#1)(2013-1#1)(2013-8#2)
significant morphological##4##2##(1990-11#1)(2005-11#1)(2007-12#1)(2008-2#1)
significant mortality and morbidity##4##4##(2006-5#1)(2007-8#2)(2009-5#1)
significant mortality##13##2##(1993-8#1)(2005-6#1)(2006-5#1)(2007-5#1)(2007-8#2)(2008-7#1)(2009-5#1)(2011-11#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
significant mutual##2##2##(1993-9#1)(2007-11#1)
significant negative correlation between##13##4##(1992-11#1)(1994-2#1)(1994-6#1)(2005-10#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-6#1)
significant negative correlation##27##3##(1990-12#1)(1990-5#1)(1992-11#1)(1994-2#1)(1994-6#1)(1996-5#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-7#2)(2009-6#1)(2010-6#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-6#1)(2013-1#1)(2013-8#2)
significant negative correlations##4##3##(1997-2#1)(2008-9#1)(2011-1#1)(2012-1#1)
significant negative effects on##3##4##(1992-3#1)(2010-8#1)(2012-12#1)
significant negative relationship between##2##4##(2007-6#1)(2008-5#1)
significant negative##48##2##(1990-12#1)(1990-5#1)(1992-11#1)(1992-3#1)(1993-1#1)(1994-2#1)(1994-6#1)(1996-5#1)(1997-2#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-6#1)(2013-1#1)(2013-8#2)
significant nephrotoxicity##3##2##(2006-8#1)(2007-11#1)(2008-8#1)
significant neurological##2##2##(2005-2#1)(2006-5#1)
significant neuroprotective effect##2##3##(1997-5#1)(2007-9#1)
significant new research##2##3##(2009-2#1)(2012-1#1)
significant new##7##2##(1995-2#1)(1995-7#1)(2008-7#1)(2009-2#1)(2011-1#1)(2012-1#1)(2012-3#1)
significant noise##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
significant nonrandom##2##2##(2008-10#2)
significant number have##2##3##(1993-8#1)(2007-8#1)
significant number of individuals with##2##5##(2007-11#1)(2013-8#1)
significant number of patients with##3##5##(2007-7#1)(2008-8#1)(2013-8#1)
significant number of patients##14##4##(1990-2#1)(2006-10#1)(2006-8#2)(2007-7#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-12#2)(2013-8#1)
significant number of the##2##4##(1995-3#1)(2007-11#1)
significant number of these##3##4##(1993-12#1)(2005-11#1)(2009-5#1)
significant number of##57##3##(1990-2#1)(1990-5#1)(1993-12#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-7#1)(1997-4#1)(1997-5#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-11#3)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-5#2)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2013-8#2)
significant number##59##2##(1990-2#1)(1990-5#1)(1993-12#1)(1993-8#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-7#1)(1997-4#1)(1997-5#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-11#3)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#2)(2007-8#4)(2008-1#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-5#2)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2013-8#2)
significant numbers of##8##3##(1996-3#1)(2006-9#1)(2008-1#2)(2008-10#1)(2008-3#1)(2010-10#1)(2011-1#1)
significant obstacle to##3##3##(2004-2#1)(2006-10#1)(2007-11#1)
significant obstacle##4##2##(2004-2#1)(2006-10#1)(2007-11#1)(2008-10#1)
significant odds##3##2##(2008-3#1)(2013-8#2)
significant of##2##2##(1995-8#1)(1996-6#1)
significant on##3##2##(2007-7#1)(2008-10#1)(2010-9#1)
significant only for##5##3##(2006-7#1)(2007-3#1)(2007-4#1)(2009-7#1)(2010-12#1)
significant only in the##4##4##(1992-4#2)(2005-4#1)(2008-10#1)
significant only in##7##3##(1992-4#2)(1993-4#1)(2004-1#1)(2005-4#1)(2008-10#1)(2013-1#1)
significant only##14##2##(1992-4#2)(1993-4#1)(1994-12#1)(2004-1#1)(2005-4#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-10#1)(2009-7#1)(2010-12#1)(2013-1#1)
significant optical##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
significant or##6##2##(1993-9#1)(2004-1#1)(2005-10#1)(2007-11#1)(2008-10#1)(2008-9#1)
significant osseous healing of the periradicular region and lateral periodontium had occurred with arrest of external root resorption##2##18##(2013-1#2)
significant osseous##3##2##(2008-5#1)(2013-1#2)
significant other##2##2##(2008-9#1)(2011-2#1)
significant others##6##2##(2005-7#1)(2006-9#1)(2007-2#1)(2009-5#1)(2010-2#1)(2011-2#1)
significant outcomes##2##2##(2011-1#1)(2012-2#1)
significant output##4##2##(2007-8#2)(2008-2#1)(2008-3#1)
significant overall homology##2##3##(1991-11#1)(1995-2#1)
significant overall##8##2##(1991-11#1)(1993-3#1)(1994-12#2)(1995-2#1)(2007-7#1)(2007-9#1)(2008-1#1)
significant overlap between##2##3##(2006-12#1)(2007-12#1)
significant overlap##3##2##(2006-12#1)(2007-12#1)(2008-8#1)
significant pain relief##3##3##(2006-11#1)(2009-3#1)(2012-2#1)
significant pain##9##2##(2006-10#1)(2006-11#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-7#1)(2009-3#1)(2012-2#1)
significant parameter##2##2##(2008-6#1)(2010-8#1)
significant parameters##4##2##(2007-1#1)(2007-12#1)(2008-10#1)(2013-1#1)
significant parametric##2##2##(2008-2#1)(2010-2#1)
significant parts##2##2##(1997-2#1)(2010-7#1)
significant pathology##2##2##(2008-9#1)(2012-1#1)
significant patient discomfort##2##3##(2008-7#1)(2010-2#1)
significant patient##5##2##(1995-3#1)(2007-8#1)(2008-7#1)(2009-10#1)(2010-2#1)
significant peaks##3##2##(1992-12#1)(2009-3#1)(2013-1#1)
significant penetration##2##2##(2008-5#2)
significant percentage of##11##3##(1990-12#1)(1994-11#1)(1994-8#1)(1997-7#1)(2004-10#1)(2007-8#1)(2008-3#1)(2010-10#1)(2010-4#1)(2012-12#1)(2013-1#1)
significant percentage##12##2##(1990-12#1)(1994-11#1)(1994-8#1)(1997-7#1)(2004-10#1)(2007-8#1)(2008-12#1)(2008-3#1)(2010-10#1)(2010-4#1)(2012-12#1)(2013-1#1)
significant perioperative morbidity##2##3##(2007-9#1)(2008-7#1)
significant perioperative##3##2##(2007-8#1)(2007-9#1)(2008-7#1)
significant perturbation in the##2##4##(1993-6#1)(2008-10#1)
significant phase##3##2##(1997-5#1)(2007-12#1)(2008-3#1)
significant phosphorylation of##2##3##(1994-8#1)(1995-6#1)
significant phosphorylation##4##2##(1990-7#1)(1994-8#1)(1995-3#1)(1995-6#1)
significant place##2##2##(1996-12#1)(2007-8#1)
significant population of##4##3##(1990-5#1)(1995-5#1)(1997-4#1)(2008-11#1)
significant population##10##2##(1990-5#1)(1993-6#1)(1994-8#1)(1995-5#1)(1997-4#1)(1997-6#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-9#1)
significant portion of the##13##4##(1990-5#1)(1992-8#1)(1994-12#2)(1997-6#1)(2006-10#1)(2008-10#2)(2008-5#1)(2010-4#1)(2010-9#1)(2012-2#1)(2013-8#1)
significant portion of##24##3##(1990-5#1)(1991-12#1)(1992-8#1)(1994-12#2)(1997-6#1)(2005-12#1)(2006-10#1)(2006-8#1)(2008-10#4)(2008-11#2)(2008-5#1)(2010-4#1)(2010-9#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
significant portion##25##2##(1990-5#1)(1991-12#1)(1992-8#1)(1994-12#2)(1997-6#1)(2005-12#1)(2006-10#1)(2006-8#1)(2008-10#4)(2008-11#2)(2008-5#1)(2009-10#1)(2010-4#1)(2010-9#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
significant positive association between##2##4##(2011-2#1)(2012-2#1)
significant positive association with##2##4##(2008-8#1)(2012-2#1)
significant positive association##5##3##(1994-2#1)(2008-8#1)(2011-2#1)(2012-2#2)
significant positive associations between##2##4##(1993-12#1)(2007-5#1)
significant positive associations##3##3##(1993-12#1)(2007-12#1)(2007-5#1)
significant positive correlation between##14##4##(2004-11#1)(2007-7#4)(2008-11#1)(2008-8#1)(2009-4#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)
significant positive correlation was found between##5##6##(1992-10#1)(2006-4#1)(2008-6#1)(2008-8#1)(2013-8#1)
significant positive correlation was##6##4##(1992-10#1)(2006-4#1)(2008-6#1)(2008-8#1)(2013-8#2)
significant positive correlation with##6##4##(1991-12#1)(1996-2#1)(2008-1#1)(2009-6#1)(2011-12#1)(2013-1#1)
significant positive correlation##32##3##(1991-12#1)(1992-10#1)(1996-2#1)(1996-7#1)(2004-11#1)(2006-4#1)(2007-7#4)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#2)(2010-10#1)(2010-12#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#2)
significant positive correlations between##4##4##(2007-6#1)(2007-8#1)(2010-8#2)
significant positive correlations##8##3##(2007-1#1)(2007-6#1)(2007-8#1)(2010-10#1)(2010-8#2)(2011-1#2)
significant positive effect##4##3##(1997-8#1)(2008-10#1)(2008-11#1)(2011-1#1)
significant positive relationship##6##3##(2007-5#1)(2008-10#2)(2010-11#1)(2011-1#1)(2013-1#1)
significant positive##71##2##(1991-11#1)(1991-12#1)(1992-10#1)(1993-12#1)(1994-11#1)(1994-2#1)(1996-2#1)(1996-7#1)(1997-8#1)(2004-11#1)(2006-4#1)(2007-1#1)(2007-12#1)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#3)(2009-4#1)(2009-6#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-8#2)(2011-1#6)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#4)
significant potential as a##2##4##(2010-8#1)(2011-1#1)
significant potential as##4##3##(2007-11#1)(2010-8#1)(2011-1#1)(2011-2#1)
significant potential for##3##3##(2006-6#1)(2007-12#1)(2010-1#1)
significant potential in##2##3##(2008-12#1)(2008-6#1)
significant potential##16##2##(1993-11#1)(1995-2#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2010-1#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)
significant potentiation of##2##3##(1992-3#1)(1992-6#1)
significant potentiation##4##2##(1992-3#2)(1992-6#1)(1996-6#1)
significant practical##3##2##(2010-3#1)(2013-1#2)
significant pre-##3##2##(2008-12#2)(2008-4#1)
significant prediction##2##2##(2008-10#1)(2009-4#1)
significant predictive##2##2##(1994-2#1)(2007-7#1)
significant predictor for##3##3##(2007-10#1)(2011-2#1)(2013-7#1)
significant predictor of##21##3##(1990-12#1)(1990-4#1)(1991-3#1)(1993-9#1)(1995-6#1)(1996-3#1)(2005-12#1)(2005-8#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-6#1)(2011-2#1)(2012-3#2)(2013-1#1)
significant predictor##28##2##(1990-12#1)(1990-4#1)(1991-3#1)(1993-1#1)(1993-9#1)(1995-6#1)(1996-3#1)(2005-12#1)(2005-8#1)(2007-10#2)(2007-12#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
significant predictors for##2##3##(2012-2#2)
significant predictors in the##2##4##(2007-12#1)(2008-6#1)
significant predictors of a positive##2##5##(2011-2#1)(2012-2#1)
significant predictors of mortality##3##4##(2008-7#3)
significant predictors of##29##3##(1994-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-8#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-6#1)(2007-8#1)(2008-11#2)(2008-6#1)(2008-7#3)(2008-8#1)(2010-10#1)(2010-3#1)(2011-2#3)(2012-2#2)(2013-1#3)
significant predictors##41##2##(1994-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-8#1)(2006-2#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-6#1)(2007-8#1)(2008-11#3)(2008-12#1)(2008-6#2)(2008-7#3)(2008-8#1)(2010-10#1)(2010-3#1)(2010-4#1)(2011-2#4)(2012-2#4)(2013-1#4)
significant preference for##2##3##(1993-11#1)(2010-12#1)
significant preference##3##2##(1992-7#1)(1993-11#1)(2010-12#1)
significant prevalence in both##2##4##(2011-2#2)
significant prevalence##4##2##(1990-6#1)(2007-11#1)(2011-2#2)
significant previous##2##2##(2008-7#1)(2009-2#1)
significant primary##2##2##(1994-8#1)(2008-10#1)
significant probability of##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
significant problem for##6##3##(2005-6#1)(2008-1#1)(2008-10#1)(2009-12#1)(2010-12#1)(2012-12#1)
significant problem##25##2##(1991-1#1)(1996-12#1)(2005-3#1)(2005-6#2)(2006-10#5)(2006-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-8#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-4#1)(2012-12#1)
significant problems in##3##3##(1996-12#1)(2006-4#1)(2013-1#1)
significant problems##8##2##(1996-12#1)(2006-4#1)(2008-1#2)(2008-2#1)(2009-4#1)(2010-8#1)(2013-1#1)
significant production##2##2##(2008-5#1)(2010-6#1)
significant prognostic factor##3##3##(1991-10#1)(2009-10#1)(2011-2#1)
significant prognostic factors##4##3##(1990-6#1)(1994-7#1)(1995-4#1)(2008-1#1)
significant prognostic value##2##3##(1994-7#1)(2011-1#1)
significant prognostic##14##2##(1990-6#2)(1991-10#1)(1992-6#1)(1993-9#1)(1994-7#2)(1995-4#1)(2006-8#1)(2008-1#1)(2009-10#1)(2010-9#1)(2011-1#1)(2011-2#1)
significant progress has been made in the##2##7##(2006-8#1)(2009-12#1)
significant progress has been made in##3##6##(2006-8#1)(2009-12#1)(2009-8#1)
significant progress has been made##8##5##(1993-6#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-7#1)(2009-12#1)(2009-8#1)(2013-8#1)
significant progress has been##9##4##(1993-6#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-12#1)(2013-8#1)
significant progress has##11##3##(1993-6#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-12#1)(2011-1#1)(2013-8#1)
significant progress in the##6##4##(2006-10#2)(2008-10#1)(2009-8#1)(2011-1#1)(2012-3#1)
significant progress in##14##3##(2005-10#1)(2006-10#3)(2008-10#1)(2008-5#1)(2009-5#1)(2009-8#1)(2010-10#2)(2010-4#1)(2011-1#1)(2012-3#1)(2013-8#1)
significant progress##35##2##(1993-6#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-8#1)(2007-11#2)(2008-1#2)(2008-10#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-5#1)(2009-8#2)(2010-10#2)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#3)
significant progress?]##2##2##(1994-4#1)(1994-6#1)
significant progression of##2##3##(2011-2#1)(2012-2#1)
significant proliferation##2##2##(2007-12#1)(2010-3#1)
significant prolongation of the CSP duration##2##6##(2011-2#2)
significant prolongation of the##4##4##(1991-2#1)(1996-9#1)(2011-2#2)
significant prolongation of##5##3##(1991-2#1)(1992-10#1)(1996-9#1)(2011-2#2)
significant promise for the##2##4##(2005-7#1)(2012-12#1)
significant proportion of the##11##4##(1993-3#2)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2009-9#1)(2011-2#1)(2012-2#1)
significant proportion of##43##3##(1990-2#1)(1993-3#2)(1995-1#1)(1995-7#1)(1996-12#1)(2006-5#1)(2006-8#3)(2006-9#2)(2007-11#2)(2007-2#1)(2007-3#2)(2007-7#1)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#3)(2013-1#1)
significant proportion##47##2##(1990-2#1)(1993-3#2)(1995-1#1)(1995-7#1)(1996-12#1)(2004-9#1)(2006-5#1)(2006-8#3)(2006-9#2)(2007-11#2)(2007-2#1)(2007-3#3)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#5)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#3)(2013-1#1)
significant proportions##2##2##(1990-3#1)(2007-12#1)
significant protection against##9##3##(1991-2#1)(1992-2#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-5#1)(2008-10#1)(2008-11#1)
significant protection in##2##3##(1994-5#1)(2008-12#1)
significant protection to##3##3##(1992-6#1)(2008-10#1)(2009-12#1)
significant protection##21##2##(1991-2#1)(1992-2#1)(1992-6#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-3#1)(1994-5#1)(1995-12#3)(1995-2#1)(1995-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2009-12#1)(2010-12#1)
significant protective effect##4##3##(1992-10#1)(2008-5#1)(2010-6#1)(2011-1#1)
significant protective##6##2##(1992-10#1)(2008-5#1)(2009-7#2)(2010-6#1)(2011-1#1)
significant protein##3##2##(1990-5#1)(1995-2#1)(1995-8#1)
significant proteinuria in##2##3##(2011-1#2)
significant proteinuria##3##2##(2011-1#3)
significant proton##2##2##(1994-12#2)
significant public health##9##3##(1997-1#1)(1997-3#1)(2005-11#1)(2006-4#1)(2008-1#1)(2008-11#1)(2010-8#1)(2011-1#1)(2013-1#1)
significant pulmonary##2##2##(2007-9#2)
significant quantities of##4##3##(1990-5#1)(1996-1#1)(2004-11#1)(2005-11#1)
significant quantities##7##2##(1990-5#1)(1993-6#1)(1996-1#1)(2004-11#1)(2005-11#1)(2006-3#1)(2013-8#1)
significant questions##2##2##(1994-6#1)(2008-7#1)
significant radiation-induced##2##2##(2011-2#1)(2012-12#1)
significant ramifications##2##2##(2007-10#1)(2008-3#1)
significant range##2##2##(2006-3#1)(2007-3#1)
significant recent##4##2##(2006-10#2)(2006-2#1)(2009-7#1)
significant recurrence##2##2##(2011-2#2)
significant reduction in binding##2##4##(1991-9#1)(1995-7#1)
significant reduction in febrile##2##4##(2008-10#1)(2008-7#1)
significant reduction in incidence of##2##5##(2009-10#1)(2011-1#1)
significant reduction in its##2##4##(1992-6#1)(2010-12#1)
significant reduction in pain##4##4##(2005-7#1)(2006-12#1)(2006-7#1)(2007-8#1)
significant reduction in the incidence of##4##6##(1992-9#1)(1993-3#1)(1993-7#1)(2013-1#1)
significant reduction in the levels of##2##6##(2008-6#1)(2009-12#1)
significant reduction in the number of##4##6##(1996-12#1)(2006-5#1)(2007-7#1)(2008-11#1)
significant reduction in the number##5##5##(1991-9#1)(1996-12#1)(2006-5#1)(2007-7#1)(2008-11#1)
significant reduction in the percentage of##2##6##(2007-9#1)(2008-10#1)
significant reduction in the##54##4##(1990-4#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-9#2)(1992-9#2)(1993-11#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-7#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-7#1)(2006-12#1)(2006-5#2)(2007-11#1)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#4)(2008-7#1)(2009-12#1)(2010-6#1)(2010-7#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#1)
significant reduction in their##3##4##(1996-12#1)(2008-7#1)(2010-12#1)
significant reduction in##150##3##(1990-3#1)(1990-4#1)(1990-5#2)(1991-12#2)(1991-3#1)(1991-9#3)(1992-10#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#2)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#2)(1995-7#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-9#2)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-2#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-5#2)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-2#2)(2007-5#1)(2007-7#3)(2007-8#5)(2007-9#4)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#5)(2008-7#6)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-12#4)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-10#1)(2011-12#1)(2012-11#1)(2012-12#1)(2012-2#5)(2013-1#7)(2013-7#1)(2013-8#1)
significant reduction of the##18##4##(1992-1#1)(1992-3#1)(1992-8#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1997-5#1)(2007-11#1)(2008-2#1)(2008-3#1)(2009-1#1)(2011-1#1)(2011-2#3)
significant reduction of##57##3##(1990-2#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-3#1)(1997-4#1)(1997-5#1)(2005-10#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2009-1#1)(2009-3#1)(2010-12#1)(2011-1#2)(2011-10#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#2)
significant reduction was##3##3##(2007-9#1)(2008-6#2)
significant reduction##222##2##(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1991-12#2)(1991-3#1)(1991-6#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-7#3)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-1#2)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#2)(1995-7#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#1)(1996-9#2)(1997-2#1)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#1)(2004-2#1)(2005-10#2)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-5#2)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#2)(2007-2#2)(2007-5#1)(2007-7#4)(2007-8#6)(2007-9#5)(2008-10#19)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#3)(2008-5#7)(2008-6#8)(2008-7#7)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#2)(2010-12#5)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#5)(2011-10#2)(2011-12#2)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#9)(2013-1#11)(2013-7#1)(2013-8#3)
significant reductions in both##2##4##(2007-10#1)(2008-10#1)
significant reductions in lesion##2##4##(2007-11#1)(2008-10#1)
significant reductions in the##4##4##(1995-1#1)(1995-12#1)(1997-2#1)(2008-10#1)
significant reductions in yield##2##4##(2008-10#2)
significant reductions in##31##3##(1993-10#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-9#2)(1997-2#1)(1997-5#1)(2006-11#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#9)(2008-3#2)(2008-5#1)(2010-12#1)(2012-1#1)
significant reductions of the##2##4##(1996-3#1)(2008-10#1)
significant reductions of##7##3##(1993-3#1)(1995-5#1)(1996-3#1)(2008-10#2)(2009-9#1)(2013-1#1)
significant reductions were##2##3##(1997-3#1)(2008-10#1)
significant reductions##43##2##(1993-10#1)(1993-2#1)(1993-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#2)(1996-3#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-5#1)(2006-11#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#12)(2008-3#2)(2008-5#1)(2009-9#1)(2010-12#1)(2012-1#1)(2013-1#1)(2013-8#1)
significant refractive error##2##3##(2011-1#1)(2013-7#1)
significant refractive##3##2##(2008-10#1)(2011-1#1)(2013-7#1)
significant region##2##2##(2012-1#2)
significant regional##4##2##(1996-3#1)(1997-5#1)(2007-4#1)(2008-10#1)
significant regions##3##2##(2008-10#1)(2010-2#1)(2012-3#1)
significant regression of##2##3##(2010-8#1)(2011-2#1)
significant regression##3##2##(2006-10#1)(2010-8#1)(2011-2#1)
significant relation was##3##3##(1991-4#1)(1992-3#1)(2011-12#1)
significant relation##9##2##(1991-4#1)(1992-3#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-12#2)
significant relationship among the##2##4##(2010-9#1)(2011-2#1)
significant relationship between the presence of##2##6##(1991-8#1)(2012-2#1)
significant relationship between the##9##4##(1991-8#1)(1993-11#1)(1993-12#2)(1996-3#1)(1997-8#1)(2006-1#1)(2008-8#1)(2012-2#1)
significant relationship between##29##3##(1991-8#1)(1993-11#1)(1993-12#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-8#3)(2006-1#1)(2006-10#1)(2006-8#1)(2007-3#1)(2007-5#1)(2007-6#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-8#2)(2011-2#1)(2012-1#1)(2012-2#1)
significant relationship of##2##3##(2006-4#1)(2008-10#1)
significant relationship to##4##3##(2007-12#1)(2007-2#1)(2007-9#1)(2009-5#1)
significant relationship was found between the##2##6##(2007-2#1)(2013-8#1)
significant relationship was found between##5##5##(2006-8#1)(2007-12#1)(2007-2#1)(2012-3#1)(2013-8#1)
significant relationship was##9##3##(2006-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-5#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
significant relationship##51##2##(1991-8#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-12#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-8#3)(2006-1#1)(2006-10#1)(2006-4#1)(2006-8#2)(2007-12#3)(2007-2#3)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-5#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
significant relationships between##9##3##(1995-10#1)(1997-7#1)(2007-1#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-7#1)(2012-12#1)(2012-2#1)
significant relationships were found between##3##5##(2008-10#1)(2008-8#1)(2011-2#1)
significant relationships were##4##3##(1991-2#1)(2008-10#1)(2008-8#1)(2011-2#1)
significant relationships##16##2##(1991-2#1)(1995-10#1)(1997-7#1)(2007-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
significant relative##4##2##(1991-5#1)(2008-3#1)(2010-10#1)(2010-2#1)
significant release of##2##3##(1995-8#1)(2008-4#1)
significant relevance in##2##3##(2007-11#1)(2008-10#1)
significant relevance##3##2##(2005-11#1)(2007-11#1)(2008-10#1)
significant relief at##2##3##(2006-8#2)
significant relief##7##2##(1993-2#1)(2006-10#1)(2006-8#4)(2008-3#1)
significant renal##9##2##(1995-12#1)(1997-7#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-7#1)(2011-2#1)(2013-1#1)
significant reporter gene expression##2##4##(1997-4#1)(2008-8#1)
significant research##5##2##(1993-8#1)(2006-10#1)(2006-5#1)(2008-11#1)(2012-3#1)
significant residual tumour##2##3##(2009-4#2)
significant residual##9##2##(1996-6#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-4#2)
significant resistance to##4##3##(2005-10#1)(2006-12#1)(2008-10#1)(2008-12#1)
significant respiratory##2##2##(2005-12#1)(2007-5#1)
significant response##6##2##(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#2)(2012-3#1)
significant restriction of##2##3##(2007-7#1)(2012-12#1)
significant result##3##2##(1990-5#1)(1997-5#1)(2005-11#1)
significant results for##2##3##(2012-3#2)
significant results were obtained##2##4##(2006-7#1)(2007-11#1)
significant results were##3##3##(2006-7#1)(2007-11#1)(2012-3#1)
significant results##22##2##(1994-3#1)(2006-5#1)(2006-7#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-9#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-3#5)(2013-1#3)
significant reversal##3##2##(1992-6#1)(2008-5#1)(2009-6#1)
significant rise in the##4##4##(2006-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
significant rise in##17##3##(1992-2#1)(1993-4#2)(1996-12#1)(1996-3#1)(2005-9#1)(2006-10#1)(2008-10#2)(2008-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
significant rise of##5##3##(1990-5#1)(1992-1#1)(2006-6#1)(2007-8#1)(2008-5#1)
significant rise##24##2##(1990-5#1)(1992-1#1)(1992-2#1)(1993-4#2)(1996-12#1)(1996-3#1)(2005-9#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
significant risk factor for##14##4##(1997-3#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#1)(2008-2#1)(2011-12#1)(2011-2#2)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#1)
significant risk factor##17##3##(1993-5#1)(1997-3#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#1)(2008-2#1)(2009-6#1)(2010-2#1)(2011-12#1)(2011-2#2)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#1)
significant risk factors for##5##4##(2007-11#1)(2008-8#1)(2012-1#1)(2013-7#1)(2013-8#1)
significant risk factors##10##3##(2004-3#1)(2007-11#1)(2008-5#1)(2008-8#2)(2012-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
significant risk for##4##3##(2004-2#1)(2010-4#1)(2011-2#1)(2012-2#1)
significant risk of neurological##2##4##(2007-11#1)(2010-8#1)
significant risk of##10##3##(1996-9#1)(2005-8#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2010-8#1)(2012-2#1)(2013-1#1)
significant risk##46##2##(1993-5#1)(1996-9#1)(1997-3#1)(2004-2#1)(2004-3#1)(2005-8#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-11#3)(2007-2#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-6#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#4)(2013-7#1)(2013-8#1)
significant risks##4##2##(2007-7#1)(2007-8#1)(2008-3#1)(2013-1#1)
significant role for reduced##3##4##(2008-10#3)
significant role for##6##3##(1993-12#1)(1997-2#1)(2008-10#3)(2008-7#1)
significant role in the##36##4##(1990-7#2)(1990-8#2)(1991-10#1)(1993-2#1)(1994-10#1)(1994-12#1)(1995-5#1)(1995-6#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-4#3)(2008-5#2)(2008-7#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#5)(2013-1#1)(2013-8#2)
significant role in##84##3##(1990-7#2)(1990-8#2)(1991-10#1)(1991-8#1)(1992-1#1)(1993-1#1)(1993-2#1)(1993-4#1)(1994-10#1)(1994-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-7#1)(1997-1#1)(1997-4#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-4#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#9)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#6)(2011-2#2)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#4)
significant role of the##2##4##(1995-6#1)(2007-12#1)
significant role of##9##3##(1992-12#1)(1995-10#1)(1995-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2009-4#1)(2011-1#1)(2013-8#1)
significant role played by##2##4##(1996-4#1)(2008-6#1)
significant role##119##2##(1990-7#2)(1990-8#2)(1991-10#1)(1991-8#1)(1992-1#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-4#2)(1994-10#1)(1994-12#1)(1995-10#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-4#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#14)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#1)(2009-1#1)(2009-10#1)(2009-3#1)(2009-4#2)(2009-8#1)(2010-1#1)(2010-2#2)(2010-3#1)(2010-4#1)(2011-1#8)(2011-2#2)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#6)
significant roles in##9##3##(1990-8#1)(1994-8#1)(1995-2#1)(1997-6#1)(2007-7#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-1#1)
significant roles##16##2##(1990-4#1)(1990-8#1)(1994-8#2)(1995-2#1)(1996-1#1)(1997-6#1)(2007-11#1)(2007-7#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-1#1)(2013-1#1)
significant saving in time and effort in future phases of the two projects can be anticipated##2##16##(2013-1#2)
significant savings of##2##3##(1994-12#1)(2008-10#1)
significant savings##3##2##(1994-12#1)(1994-3#1)(2008-10#1)
significant seasonal##4##2##(1995-7#1)(2010-8#2)(2013-1#1)
significant secondary##3##2##(1994-11#1)(2008-5#1)(2013-1#1)
significant selection##2##2##(2008-3#1)(2008-8#1)
significant selectivity##2##2##(1994-5#1)(1997-2#1)
significant sequelae##2##2##(1993-12#1)(2007-11#1)
significant sequence homology##3##3##(1992-3#1)(1995-3#1)(1996-12#1)
significant sequence identity with##2##4##(1994-12#1)(1994-3#1)
significant sequence identity##5##3##(1992-4#1)(1994-12#2)(1994-3#1)(1995-3#1)
significant sequence similarity to##2##4##(1996-5#1)(1997-6#1)
significant sequence similarity with the catalytic##2##6##(1991-11#1)(1994-3#1)
significant sequence similarity##7##3##(1991-11#1)(1992-5#1)(1994-3#1)(1996-5#1)(1997-6#1)(2008-10#1)(2011-1#1)
significant sequence##20##2##(1991-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-8#1)(1994-12#2)(1994-3#2)(1995-3#2)(1995-8#1)(1996-12#1)(1996-5#1)(1997-5#1)(1997-6#2)(2008-10#1)(2010-10#1)(2011-1#1)
significant sex##5##2##(1990-4#1)(1993-9#1)(1994-8#1)(1996-12#1)(2007-1#1)
significant shift##2##2##(1995-3#1)(2006-6#1)
significant shifts##2##2##(1997-4#1)(2012-3#1)
significant short-term##3##2##(2005-8#1)(2008-6#1)(2012-1#1)
significant side effect##3##3##(2004-3#1)(2005-7#1)(2011-10#1)
significant side effects##12##3##(1990-5#1)(1991-2#1)(1993-11#1)(1993-9#1)(1995-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-5#1)(2008-6#1)(2013-8#1)
significant side##15##2##(1990-5#1)(1991-2#1)(1993-11#1)(1993-9#1)(1995-2#1)(2004-3#1)(2005-7#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-5#1)(2008-6#1)(2011-10#1)(2013-8#1)
significant side-effects##3##2##(2006-8#1)(2007-8#1)(2012-2#1)
significant signal##2##2##(1996-6#1)(2009-2#1)
significant similarities to##2##3##(1990-11#1)(2008-10#1)
significant similarities##4##2##(1990-11#1)(1990-7#1)(1997-1#1)(2008-10#1)
significant similarity to any other##4##5##(1996-12#2)(1996-6#1)(1997-4#1)
significant similarity to any##5##4##(1996-12#2)(1996-6#1)(1997-4#1)(2008-10#1)
significant similarity to the##4##4##(1991-6#1)(1991-8#1)(1995-8#1)(1997-4#1)
significant similarity to##19##3##(1991-6#1)(1991-8#1)(1992-7#1)(1994-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#2)(1997-7#1)(2005-11#1)(2008-10#1)
significant similarity was##2##3##(1994-5#1)(1996-10#1)
significant similarity with##5##3##(1991-5#1)(1991-7#1)(1993-11#1)(1995-9#1)(1997-3#1)
significant similarity##27##2##(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-7#1)(1993-11#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#2)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-3#2)(1997-4#2)(1997-7#1)(2005-11#1)(2008-10#1)(2009-8#1)
significant since##2##2##(1994-12#1)(1997-7#1)
significant skin##2##2##(1994-1#1)(2007-11#1)
significant social##2##2##(2005-10#1)(2008-5#1)
significant socio-economic##2##2##(2007-7#1)(2008-3#1)
significant sources of##5##3##(1993-9#1)(2008-10#2)(2008-2#1)(2011-2#1)
significant spatial differences##2##3##(2007-3#1)(2008-5#1)
significant spatial##3##2##(2007-3#1)(2008-10#1)(2008-5#1)
significant species##2##2##(1990-4#1)(2011-1#1)
significant spectral##2##2##(2008-2#1)(2008-5#1)
significant standing height##2##3##(2010-3#2)
significant statistical difference compared to the##2##6##(2013-1#2)
significant statistical difference was found##4##5##(1994-3#1)(1996-7#1)(2010-8#1)(2013-8#1)
significant statistical difference##9##3##(1994-3#1)(1996-7#1)(2006-6#1)(2008-12#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
significant statistical differences between the##2##5##(2008-1#1)(2008-7#1)
significant statistical differences##4##3##(2008-1#2)(2008-7#1)(2011-2#1)
significant statistical##16##2##(1994-3#1)(1996-7#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-1#2)(2008-12#1)(2008-7#1)(2010-8#1)(2011-2#3)(2013-1#2)(2013-8#1)
significant stenosis##7##2##(1990-6#1)(1992-9#1)(1993-8#1)(2006-6#1)(2011-2#1)(2013-4#2)
significant stimulation of##3##3##(1995-2#1)(2008-10#1)(2008-7#1)
significant strain##4##2##(1991-1#1)(1994-8#1)(2011-1#1)(2012-12#1)
significant stress##4##2##(2006-10#1)(2006-6#1)(2008-1#1)(2012-1#1)
significant stretching##2##2##(1995-6#1)(2011-1#1)
significant structural changes##2##3##(1991-3#1)(1994-11#1)
significant structural similarity to##2##4##(1994-9#1)(1996-2#1)
significant structural##7##2##(1990-8#1)(1991-3#1)(1993-8#1)(1994-11#1)(1994-9#1)(1996-2#1)(2012-2#1)
significant subjective##2##2##(2004-3#1)(2008-1#1)
significant suppression of##5##3##(1994-12#1)(1994-2#1)(2008-4#1)(2011-2#1)(2012-2#1)
significant suppression##7##2##(1994-12#1)(1994-2#1)(2008-10#2)(2008-4#1)(2011-2#1)(2012-2#1)
significant surrounding##2##2##(1991-2#1)(2012-2#1)
significant survival advantage in##5##4##(2009-4#1)(2013-8#4)
significant survival advantage##6##3##(2008-7#1)(2009-4#1)(2013-8#4)
significant survival benefit##2##3##(2004-2#1)(2013-1#1)
significant survival benefits##2##3##(2004-1#1)(2008-11#1)
significant survival##12##2##(2004-1#1)(2004-2#1)(2008-11#1)(2008-7#1)(2009-4#1)(2013-1#2)(2013-8#5)
significant symptoms of depression##2##4##(2010-7#2)
significant symptoms of##3##3##(2010-7#2)(2011-12#1)
significant symptoms##4##2##(2010-12#1)(2010-7#2)(2011-12#1)
significant synergistic##2##2##(2008-10#1)(2013-7#1)
significant system##2##2##(2007-11#1)(2009-3#1)
significant technical##2##2##(2006-5#1)(2008-7#1)
significant technological##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
significant temperature##2##2##(2005-11#1)(2008-8#1)
significant temporal##3##2##(2010-5#1)(2012-3#1)(2013-1#1)
significant tendency for##2##3##(1992-2#1)(2010-8#1)
significant tendency##3##2##(1992-2#1)(2010-8#1)(2011-2#1)
significant test##2##2##(2008-5#1)(2012-12#1)
significant than##8##2##(1992-3#1)(2005-11#2)(2008-3#2)(2008-9#1)(2011-1#1)(2011-2#1)
significant that the##2##3##(2007-7#1)(2012-2#1)
significant that##3##2##(2007-7#1)(2008-7#1)(2012-2#1)
significant therapeutic##6##2##(1992-3#1)(1993-9#1)(2006-10#1)(2010-2#1)(2010-7#1)(2013-1#1)
significant threat##4##2##(1994-1#1)(2006-2#1)(2008-5#1)(2013-8#1)
significant threats##2##2##(2007-4#1)(2011-12#1)
significant time##6##2##(2008-1#1)(2008-10#1)(2008-9#1)(2010-5#1)(2012-2#1)(2013-8#1)
significant titers of##2##3##(1996-11#1)(2012-3#1)
significant to the##2##3##(2011-1#2)
significant to##11##2##(1993-3#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-7#1)(2011-1#2)(2013-1#2)
significant toxicities##4##2##(2005-7#1)(2006-10#1)(2008-8#1)(2009-11#1)
significant toxicity and##3##3##(2006-10#1)(2008-6#1)(2010-4#1)
significant toxicity##8##2##(1990-10#1)(2006-10#1)(2008-3#1)(2008-6#2)(2010-12#1)(2010-4#1)(2011-2#1)
significant treatment effect##2##3##(2005-9#1)(2008-8#1)
significant treatment##5##2##(2005-9#1)(2007-11#1)(2008-6#1)(2008-8#1)(2009-12#1)
significant trend in##2##3##(1990-6#1)(1992-9#1)
significant trend##6##2##(1990-6#1)(1990-7#1)(1992-9#1)(2005-8#1)(2006-12#1)(2008-8#1)
significant tumor##8##2##(2008-10#1)(2009-5#1)(2011-2#5)(2012-2#1)
significant two-way##2##2##(2008-11#1)(2010-2#1)
significant uncertainty##2##2##(2008-8#1)(2009-8#1)
significant unique##3##2##(2010-1#1)(2012-1#1)(2012-2#1)
significant univariate##2##2##(1992-6#1)(1995-6#1)
significant up-regulation of##2##3##(2010-12#1)(2012-12#1)
significant up-regulation##3##2##(1997-3#1)(2010-12#1)(2012-12#1)
significant upregulation##3##2##(2006-9#1)(2008-10#1)(2012-7#1)
significant use of illicit drugs##2##5##(2006-8#2)
significant use##3##2##(2006-8#2)(2008-10#1)
significant using##3##2##(2008-5#1)(2012-12#2)
significant value##4##2##(2008-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
significant variability##6##2##(1990-2#1)(2007-11#1)(2008-10#1)(2010-9#1)(2011-12#1)(2011-3#1)
significant variables##13##2##(2008-10#6)(2008-2#1)(2008-6#1)(2010-1#1)(2010-4#1)(2011-2#1)(2013-7#1)(2013-8#1)
significant variance##3##2##(1993-2#1)(2007-12#1)(2009-3#1)
significant variation among##3##3##(2007-12#1)(2008-5#1)(2012-12#1)
significant variation in the##6##4##(1994-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
significant variation in##12##3##(1991-8#1)(1994-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-7#1)(2011-2#1)(2013-1#1)
significant variation of##4##3##(2005-11#1)(2007-8#1)(2008-10#2)
significant variation was observed##2##4##(2010-12#1)(2012-3#1)
significant variation##23##2##(1990-5#1)(1991-8#1)(1994-11#1)(2005-11#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#2)(2009-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
significant variations in the##2##4##(2008-10#1)(2011-12#1)
significant variations in##6##3##(2006-1#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-12#1)
significant variations were##2##3##(1994-3#1)(2012-3#1)
significant variations with##2##3##(2004-9#1)(2009-5#1)
significant variations##16##2##(1991-12#1)(1993-6#1)(1994-3#1)(1995-12#1)(2004-9#1)(2006-1#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-12#1)(2012-3#1)
significant ventricular##2##2##(1993-2#1)(1996-3#1)
significant versus##2##2##(1992-4#1)(2007-11#1)
significant visual loss##2##3##(2011-2#1)(2013-8#1)
significant volumetric##2##2##(2006-9#1)(2011-2#1)
significant way##5##2##(1994-6#1)(1996-4#1)(2006-6#1)(2008-11#1)(2012-3#1)
significant weight gain##3##3##(2004-3#1)(2006-8#1)(2011-2#1)
significant weight loss##5##3##(2006-10#1)(2006-2#1)(2008-3#1)(2010-3#1)(2011-12#1)
significant weight##12##2##(2004-3#1)(2006-10#1)(2006-2#1)(2006-8#1)(2008-10#1)(2008-3#3)(2010-3#1)(2011-12#1)(2011-2#2)
significant when the##2##3##(1997-5#1)(2008-3#1)
significant when##14##2##(1997-1#1)(1997-5#2)(2005-7#1)(2006-6#1)(2007-1#2)(2008-3#1)(2008-7#1)(2009-2#1)(2010-6#1)(2011-2#1)(2011-3#1)(2013-1#1)
significant whitening##2##2##(2008-5#2)
significant with the##3##3##(1992-5#1)(2008-10#1)(2011-1#1)
significant with##10##2##(1992-5#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2010-7#1)(2011-1#1)(2013-1#2)
significant work##4##2##(2006-10#1)(2008-5#1)(2010-12#1)(2011-2#1)
significant worsening##2##2##(2009-12#1)(2011-2#1)
significant yield losses##2##3##(2008-10#2)
significant##9084##1##(1990-1#1)(1990-10#15)(1990-11#21)(1990-12#29)(1990-2#31)(1990-3#24)(1990-4#29)(1990-5#36)(1990-6#26)(1990-7#23)(1990-8#18)(1990-9#11)(1991-1#14)(1991-10#14)(1991-11#18)(1991-12#27)(1991-2#39)(1991-3#23)(1991-4#15)(1991-5#16)(1991-6#27)(1991-7#15)(1991-8#24)(1991-9#19)(1992-1#20)(1992-10#13)(1992-11#22)(1992-12#32)(1992-2#27)(1992-3#28)(1992-4#26)(1992-5#12)(1992-6#30)(1992-7#17)(1992-8#29)(1992-9#24)(1993-1#25)(1993-10#5)(1993-11#35)(1993-12#58)(1993-2#40)(1993-3#23)(1993-4#23)(1993-5#6)(1993-6#18)(1993-7#27)(1993-8#17)(1993-9#38)(1994-1#9)(1994-10#11)(1994-11#43)(1994-12#46)(1994-2#44)(1994-3#45)(1994-4#6)(1994-5#36)(1994-6#30)(1994-7#8)(1994-8#27)(1994-9#19)(1995-1#31)(1995-10#28)(1995-11#21)(1995-12#59)(1995-2#42)(1995-3#32)(1995-4#8)(1995-5#27)(1995-6#37)(1995-7#15)(1995-8#36)(1995-9#11)(1996-1#41)(1996-10#18)(1996-11#12)(1996-12#64)(1996-2#30)(1996-3#37)(1996-4#15)(1996-5#26)(1996-6#15)(1996-7#32)(1996-8#18)(1996-9#33)(1997-1#40)(1997-2#49)(1997-3#25)(1997-4#36)(1997-5#41)(1997-6#35)(1997-7#32)(1997-8#40)(1997-9#2)(2003-11#1)(2004-1#9)(2004-10#13)(2004-11#22)(2004-12#6)(2004-2#9)(2004-3#11)(2004-4#13)(2004-7#1)(2004-8#2)(2004-9#8)(2005-1#9)(2005-10#34)(2005-11#39)(2005-12#6)(2005-2#1)(2005-3#2)(2005-4#2)(2005-5#1)(2005-6#5)(2005-7#16)(2005-8#24)(2005-9#11)(2006-1#13)(2006-10#150)(2006-11#21)(2006-12#71)(2006-2#41)(2006-3#4)(2006-4#19)(2006-5#43)(2006-6#31)(2006-7#29)(2006-8#94)(2006-9#33)(2007-1#38)(2007-10#78)(2007-11#162)(2007-12#124)(2007-2#97)(2007-3#32)(2007-4#40)(2007-5#27)(2007-6#29)(2007-7#114)(2007-8#153)(2007-9#79)(2008-1#98)(2008-10#721)(2008-11#147)(2008-12#135)(2008-2#93)(2008-3#164)(2008-4#118)(2008-5#265)(2008-6#101)(2008-7#222)(2008-8#140)(2008-9#96)(2009-1#5)(2009-10#34)(2009-11#15)(2009-12#25)(2009-2#26)(2009-3#37)(2009-4#40)(2009-5#52)(2009-6#41)(2009-7#35)(2009-8#46)(2009-9#23)(2010-1#17)(2010-10#33)(2010-11#13)(2010-12#84)(2010-2#50)(2010-3#34)(2010-4#48)(2010-5#35)(2010-6#22)(2010-7#33)(2010-8#62)(2010-9#24)(2011-1#159)(2011-10#4)(2011-11#3)(2011-12#35)(2011-2#348)(2011-3#12)(2011-7#1)(2012-1#56)(2012-11#27)(2012-12#159)(2012-2#205)(2012-3#118)(2012-4#1)(2012-5#8)(2012-6#6)(2012-7#4)(2012-8#1)(2013-1#341)(2013-4#3)(2013-7#68)(2013-8#202)
significant&quot##5##1##(1993-12#2)(1993-2#1)(2009-11#1)(2010-7#1)
significant)##16##1##(1990-11#1)(1990-7#1)(1992-5#1)(1992-7#1)(2005-10#1)(2007-10#2)(2007-3#1)(2007-8#3)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)(2013-8#1)
significant?##3##1##(1995-5#1)(2005-10#1)(2009-4#1)
significantly (P &gt##6##3##(2008-10#3)(2010-2#1)(2012-2#2)
significantly (P &lt##102##3##(1993-1#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-12#4)(1996-3#1)(1996-6#1)(1997-2#3)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#2)(2004-12#1)(2006-10#2)(2006-5#2)(2006-6#1)(2007-10#1)(2007-8#2)(2008-1#1)(2008-10#34)(2008-11#2)(2008-4#1)(2008-5#3)(2008-7#2)(2009-5#12)(2009-6#3)(2010-1#1)(2010-2#5)(2010-7#1)(2011-12#1)(2012-2#1)(2012-3#2)(2013-1#4)
significantly (P = 0##13##4##(1995-3#1)(1996-8#2)(1996-9#1)(2005-10#1)(2007-8#1)(2008-10#6)(2008-5#1)
significantly (P =##14##3##(1995-3#1)(1996-8#2)(1996-9#1)(2005-10#1)(2007-8#1)(2008-10#6)(2008-5#1)(2008-8#1)
significantly (P less than 0##7##5##(1990-11#2)(1990-12#1)(1990-4#1)(1991-3#1)(1992-1#2)
significantly (P##129##2##(1990-11#2)(1990-12#1)(1990-4#1)(1991-3#1)(1992-1#2)(1993-1#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-3#2)(1996-12#4)(1996-3#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-2#3)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#2)(2004-12#1)(2005-10#1)(2006-10#2)(2006-5#2)(2006-6#1)(2007-10#1)(2007-8#3)(2008-1#1)(2008-10#43)(2008-11#2)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2009-5#12)(2009-6#3)(2010-1#1)(2010-2#6)(2010-7#1)(2011-12#1)(2012-2#3)(2012-3#2)(2013-1#4)
significantly (P&gt##2##2##(2008-7#1)(2010-12#1)
significantly (P&lt##19##2##(1993-7#1)(1997-6#1)(2007-2#1)(2008-10#5)(2008-12#1)(2008-5#2)(2010-12#1)(2010-4#2)(2010-8#1)(2012-12#2)(2012-3#1)(2013-1#1)
significantly (P &lt##2##2##(2012-2#2)
significantly (P = 0##2##2##(2012-2#2)
significantly (from##2##2##(2008-3#2)
significantly (p &lt##32##3##(1993-3#1)(1997-4#2)(1997-8#1)(2004-3#1)(2006-11#1)(2007-6#1)(2007-8#3)(2008-11#2)(2008-12#5)(2008-3#4)(2008-9#1)(2009-5#2)(2009-9#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-2#2)(2013-1#1)
significantly (p = 0##3##4##(1991-5#1)(2008-12#2)
significantly (p =##4##3##(1991-5#1)(2008-12#2)(2013-1#1)
significantly (p less than 0##3##5##(1990-12#1)(1990-4#1)(1991-3#1)
significantly (p##41##2##(1990-12#1)(1990-4#1)(1991-3#1)(1991-5#1)(1993-3#1)(1997-4#2)(1997-8#1)(2004-3#1)(2006-11#1)(2007-6#1)(2007-8#5)(2008-11#2)(2008-12#7)(2008-3#4)(2008-9#1)(2009-5#2)(2009-9#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-2#2)(2013-1#2)
significantly (p&lt##19##2##(2004-4#1)(2006-11#1)(2006-8#3)(2007-3#1)(2008-10#1)(2008-12#1)(2009-2#1)(2010-12#1)(2010-4#2)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#2)
significantly (p &lt##4##2##(2012-1#1)(2012-2#1)(2013-1#2)
significantly 8 h after##2##4##(1990-2#1)(1995-12#1)
significantly [P &lt##8##3##(2007-1#1)(2008-4#5)(2009-5#2)
significantly above##7##2##(1991-12#2)(1993-6#1)(1994-2#1)(1997-2#1)(2006-9#1)(2008-9#1)
significantly accelerated by##4##3##(1993-4#1)(2006-5#1)(2008-4#1)(2012-2#1)
significantly accelerated##8##2##(1993-4#1)(1996-1#1)(1996-5#1)(2005-11#1)(2006-5#1)(2008-4#1)(2010-12#1)(2012-2#1)
significantly accelerates the##2##3##(2007-8#1)(2010-6#1)
significantly according to##2##3##(2007-7#1)(2008-12#1)
significantly across##7##2##(1996-7#1)(2007-5#1)(2008-9#2)(2009-7#1)(2010-4#1)(2011-12#1)
significantly activated##2##2##(2004-4#1)(2013-1#1)
significantly advanced##2##2##(1992-11#1)(2006-10#1)
significantly affect the powder##2##4##(2004-9#2)
significantly affect the results##2##4##(1992-8#1)(2007-11#1)
significantly affect the##35##3##(1990-7#1)(1990-8#1)(1991-9#1)(1992-8#1)(1993-7#1)(1993-9#1)(1994-6#1)(1995-10#1)(1995-5#1)(1995-8#1)(1997-7#1)(2004-1#1)(2004-9#4)(2006-5#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-7#1)
significantly affect##62##2##(1990-7#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-9#1)(1992-10#1)(1992-8#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-10#1)(1995-5#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1997-7#1)(2004-1#1)(2004-9#4)(2005-7#1)(2006-10#2)(2006-12#1)(2006-5#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-8#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-7#1)(2013-8#1)
significantly affected (P &gt##2##3##(2010-11#2)
significantly affected as##2##3##(1995-8#1)(2008-8#1)
significantly affected by gypsum application##2##5##(2008-12#2)
significantly affected by the presence of##3##6##(1993-3#1)(1995-12#1)(1995-3#1)
significantly affected by the##13##4##(1990-12#1)(1993-3#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-6#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-1#1)
significantly affected by##59##3##(1990-12#2)(1990-5#1)(1991-1#1)(1991-8#1)(1993-12#1)(1993-3#2)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-10#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#2)(2004-9#1)(2005-11#1)(2005-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#12)(2008-11#1)(2008-12#5)(2008-2#1)(2008-5#2)(2009-12#1)(2010-2#3)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#1)
significantly affected in##2##3##(1994-2#1)(2010-11#1)
significantly affected the##14##3##(1993-12#1)(1995-5#1)(1997-5#1)(2004-9#1)(2005-11#2)(2008-10#2)(2008-12#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
significantly affected##107##2##(1990-12#2)(1990-4#1)(1990-5#1)(1991-1#1)(1991-8#1)(1992-1#1)(1992-2#1)(1993-12#2)(1993-3#2)(1994-2#2)(1994-3#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#3)(1996-10#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#2)(2004-1#1)(2004-9#2)(2005-11#3)(2005-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#22)(2008-11#2)(2008-12#6)(2008-2#1)(2008-5#3)(2008-6#3)(2008-8#1)(2009-12#1)(2010-11#3)(2010-12#1)(2010-2#4)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#2)
significantly affecting the##5##3##(2006-10#1)(2008-5#1)(2010-3#1)(2011-1#1)(2012-12#1)
significantly affecting##6##2##(2006-10#1)(2008-5#1)(2009-7#1)(2010-3#1)(2011-1#1)(2012-12#1)
significantly affects the##6##3##(1995-12#1)(1997-6#1)(2008-3#1)(2008-9#1)(2010-4#1)(2012-3#1)
significantly affects##8##2##(1995-12#1)(1997-6#1)(1997-7#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-4#1)(2012-3#1)
significantly after administration of##2##4##(1991-6#1)(2011-2#1)
significantly after replacement with cilostazol##2##5##(2007-10#2)
significantly after the##7##3##(1992-12#1)(1996-8#1)(2007-8#1)(2008-1#1)(2011-1#1)(2013-1#1)(2013-8#1)
significantly after treatment##3##3##(2011-1#3)
significantly after##35##2##(1990-10#1)(1990-5#1)(1991-3#1)(1991-6#1)(1992-12#1)(1993-11#1)(1994-12#1)(1994-6#1)(1995-2#1)(1996-5#1)(1996-8#1)(1997-1#1)(2004-9#1)(2005-1#1)(2005-11#1)(2007-10#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-11#1)(2011-1#4)(2011-2#1)(2012-12#1)(2012-2#3)(2012-5#1)(2013-1#1)(2013-8#1)
significantly along##2##2##(1994-6#1)(2008-5#1)
significantly already##3##2##(1990-12#1)(1996-12#1)(2006-6#1)
significantly alter the##9##3##(1992-3#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-6#1)(2007-11#1)(2008-10#2)
significantly alter##22##2##(1991-2#1)(1991-3#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-6#1)(1994-9#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-6#1)(1997-2#1)(1997-4#1)(1997-5#1)(2007-11#1)(2008-10#2)(2009-6#1)(2011-2#1)(2012-12#1)
significantly altered after##2##3##(1996-12#1)(2012-12#1)
significantly altered by##7##3##(1991-2#1)(1992-1#1)(1992-3#1)(1992-8#1)(1994-9#1)(1995-12#1)(2006-9#1)
significantly altered in##6##3##(1995-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
significantly altered the##3##3##(1990-3#1)(2006-5#1)(2008-7#1)
significantly altered##39##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-2#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-3#1)(1994-9#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-6#1)(2010-12#2)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
significantly altering##3##2##(1994-11#1)(1995-5#1)(2013-1#1)
significantly alters the##2##3##(2007-7#1)(2008-3#1)
significantly ameliorated##2##2##(1993-12#1)(2008-10#1)
significantly among the##4##3##(2007-2#1)(2008-10#2)(2008-5#1)
significantly among##15##2##(1997-8#1)(2005-11#1)(2007-2#2)(2008-10#5)(2008-3#1)(2008-5#1)(2009-4#1)(2009-7#1)(2011-2#1)(2012-11#1)
significantly and dose dependently##2##4##(1993-3#1)(1994-2#1)
significantly and independently##3##3##(1990-12#1)(1997-8#1)(2011-2#1)
significantly and negatively##2##3##(1996-7#1)(2008-10#1)
significantly and positively related to##3##5##(1995-7#1)(2006-10#1)(2009-7#1)
significantly and positively##6##3##(1995-7#1)(2006-10#1)(2008-1#1)(2008-10#1)(2009-7#1)(2013-8#1)
significantly and specifically##2##3##(1991-6#1)(2006-12#1)
significantly and the##5##3##(2008-1#1)(2008-8#2)(2008-9#1)(2012-1#1)
significantly and##43##2##(1990-12#3)(1991-6#1)(1992-10#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-10#2)(1995-5#1)(1995-7#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
significantly antagonized##4##2##(1991-3#1)(1994-2#1)(1995-12#1)(1996-12#1)
significantly as compared with the##2##5##(1993-2#1)(1994-12#1)
significantly as compared with##3##4##(1993-2#1)(1994-12#1)(2008-7#1)
significantly as the##3##3##(1997-7#1)(2008-10#1)(2008-6#1)
significantly as##14##2##(1992-7#1)(1993-2#1)(1994-12#1)(1997-7#1)(2006-12#1)(2006-8#1)(2007-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-3#1)
significantly assist##3##2##(1994-5#1)(2006-7#1)(2008-8#1)
significantly associated to##4##3##(1991-6#1)(2007-8#1)(2013-1#2)
significantly associated with a higher death risk##2##7##(2011-11#2)
significantly associated with a##7##4##(1997-4#1)(2007-8#2)(2008-12#1)(2011-11#2)(2013-8#1)
significantly associated with all##2##4##(2007-7#1)(2013-7#1)
significantly associated with atherothrombotic infarction##2##5##(2007-10#2)
significantly associated with chronic bronchitis##3##5##(2013-1#3)
significantly associated with chronic##4##4##(2004-4#1)(2013-1#3)
significantly associated with disease##2##4##(2007-5#1)(2012-3#1)
significantly associated with fewer##3##4##(2011-1#1)(2012-2#2)
significantly associated with high##4##4##(1997-2#1)(2008-4#1)(2009-9#1)(2011-1#1)
significantly associated with higher##2##4##(2011-1#1)(2013-1#1)
significantly associated with increased##3##4##(2008-4#1)(2009-7#1)(2012-2#1)
significantly associated with increasing age##2##5##(2012-2#2)
significantly associated with increasing##3##4##(2007-3#1)(2012-2#2)
significantly associated with lower##4##4##(2008-4#1)(2011-1#2)(2013-1#1)
significantly associated with nature of response##2##6##(2012-2#2)
significantly associated with severe##3##4##(2007-7#1)(2007-8#1)(2008-10#1)
significantly associated with the increase of##2##6##(2011-1#2)
significantly associated with the##19##4##(1990-4#1)(1991-9#1)(1996-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-10#1)(2011-1#4)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
significantly associated with##166##3##(1990-4#1)(1990-9#2)(1991-9#1)(1994-7#1)(1995-11#1)(1995-9#1)(1996-11#1)(1997-2#3)(1997-4#2)(1997-7#2)(2004-4#1)(2005-10#2)(2006-10#1)(2006-2#2)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#5)(2007-12#4)(2007-2#2)(2007-3#2)(2007-5#1)(2007-7#6)(2007-8#5)(2007-9#3)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#2)(2009-4#4)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#2)(2011-1#12)(2011-11#2)(2011-12#1)(2011-2#9)(2012-1#3)(2012-12#5)(2012-2#12)(2012-3#7)(2013-1#11)(2013-7#1)(2013-8#4)
significantly associated##184##2##(1990-4#1)(1990-9#2)(1991-6#1)(1991-9#1)(1994-7#1)(1995-11#1)(1995-9#1)(1996-11#1)(1997-2#3)(1997-4#3)(1997-7#2)(2004-4#1)(2005-10#2)(2005-3#1)(2006-10#1)(2006-2#2)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#5)(2007-12#4)(2007-2#2)(2007-3#2)(2007-5#1)(2007-7#6)(2007-8#6)(2007-9#3)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#2)(2009-4#5)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#3)(2011-1#12)(2011-11#2)(2011-12#1)(2011-2#12)(2012-1#3)(2012-12#6)(2012-2#13)(2012-3#8)(2013-1#13)(2013-7#1)(2013-8#4)
significantly at 1 and##2##4##(1994-9#1)(2007-10#1)
significantly at 1##3##3##(1994-9#1)(1995-2#1)(2007-10#1)
significantly at##17##2##(1991-4#1)(1992-2#1)(1994-9#1)(1995-2#1)(1997-7#2)(2007-10#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#3)
significantly attenuate##2##2##(2011-1#1)(2013-1#1)
significantly attenuated after##2##3##(1996-8#1)(1997-7#1)
significantly attenuated by pretreatment##2##4##(1990-9#1)(1996-12#1)
significantly attenuated by##7##3##(1990-9#1)(1991-5#1)(1993-11#1)(1993-3#1)(1994-9#1)(1996-12#1)(2008-7#1)
significantly attenuated in wa2##2##4##(2008-7#2)
significantly attenuated in##3##3##(1997-8#1)(2008-7#2)
significantly attenuated the increase in##2##5##(1994-8#1)(1997-3#1)
significantly attenuated the increase##3##4##(1994-8#1)(1995-10#1)(1997-3#1)
significantly attenuated the##15##3##(1990-12#1)(1991-5#1)(1994-11#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-8#1)(1997-3#1)(1997-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
significantly attenuated with##2##3##(1994-11#1)(1997-7#1)
significantly attenuated##41##2##(1990-12#1)(1990-9#1)(1991-3#2)(1991-5#2)(1992-3#1)(1993-11#1)(1993-3#1)(1994-11#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-7#2)(1997-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
significantly attracted##3##2##(2007-11#1)(2007-6#1)(2008-5#1)
significantly augmented by##2##3##(1991-6#1)(1993-3#1)
significantly augmented the##2##3##(1996-12#1)(1996-5#1)
significantly augmented##13##2##(1990-2#1)(1991-6#2)(1991-9#1)(1993-3#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-2#1)
significantly below the##3##3##(2006-8#1)(2007-12#1)(2011-2#1)
significantly below##5##2##(1992-3#1)(1997-2#1)(2006-8#1)(2007-12#1)(2011-2#1)
significantly better at##4##3##(2006-4#1)(2009-10#1)(2012-2#1)(2013-7#1)
significantly better for##3##3##(1994-2#1)(2007-9#1)(2008-7#1)
significantly better in terms of##2##5##(2007-7#1)(2008-2#1)
significantly better in the##4##4##(1995-9#1)(2006-8#1)(2007-2#1)(2007-6#1)
significantly better in##9##3##(1995-9#1)(1997-1#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-6#1)(2007-7#2)(2008-2#1)
significantly better outcomes##2##3##(2007-11#1)(2011-2#1)
significantly better performance##4##3##(1993-9#1)(2007-11#1)(2008-2#1)(2008-3#1)
significantly better results by##3##4##(2007-12#1)(2012-2#2)
significantly better results than##2##4##(1997-7#1)(2007-11#1)
significantly better results##8##3##(1997-7#1)(2007-11#2)(2007-12#1)(2012-2#2)(2013-1#2)
significantly better than reading performance##2##5##(2008-4#2)
significantly better than that##2##4##(2007-12#1)(2007-7#1)
significantly better than the##5##4##(2008-10#1)(2008-2#1)(2008-7#1)(2009-9#1)(2010-3#1)
significantly better than their##2##4##(2006-11#1)(2007-3#1)
significantly better than##20##3##(1995-8#1)(2006-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#3)(2008-2#2)(2008-4#2)(2008-7#2)(2009-4#1)(2009-9#1)(2010-3#2)(2011-2#1)(2013-8#1)
significantly better with##4##3##(1992-1#1)(2007-10#1)(2007-11#1)(2008-2#1)
significantly better##84##2##(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-6#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-8#1)(1995-9#1)(1997-1#1)(1997-7#1)(2004-11#1)(2005-11#1)(2006-11#1)(2006-2#1)(2006-4#1)(2006-8#2)(2007-10#3)(2007-11#5)(2007-12#2)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-10#8)(2008-2#6)(2008-3#3)(2008-4#2)(2008-7#7)(2009-10#1)(2009-4#1)(2009-9#1)(2010-3#2)(2010-9#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
significantly between age groups##2##4##(2008-7#1)(2012-3#1)
significantly between males and females##3##5##(2004-4#1)(2012-1#1)(2013-7#1)
significantly between patients##2##3##(2007-8#1)(2008-7#1)
significantly between the groups##4##4##(1993-4#1)(1997-7#2)(2008-6#1)
significantly between the three groups##3##5##(1996-12#1)(2009-10#2)
significantly between the three##6##4##(1996-12#1)(2008-5#1)(2009-10#3)(2011-1#1)
significantly between the two##6##4##(1993-12#1)(1994-8#1)(2006-7#1)(2007-5#1)(2008-6#1)(2011-2#1)
significantly between the##28##3##(1993-12#1)(1993-4#1)(1994-8#1)(1996-12#1)(1997-7#2)(2006-10#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-10#2)(2007-5#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-10#4)(2009-9#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#2)
significantly between##65##2##(1992-1#1)(1992-12#1)(1993-12#1)(1993-4#1)(1994-2#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-12#1)(1997-7#2)(2004-4#1)(2006-10#1)(2006-12#1)(2006-4#2)(2006-5#1)(2006-7#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#2)(2009-10#4)(2009-8#1)(2009-9#1)(2010-3#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#3)(2013-8#1)
significantly blocked##6##2##(1991-4#1)(1991-5#1)(1995-11#1)(1996-10#1)(1996-2#1)(2006-9#1)
significantly both in##2##3##(2008-10#1)(2009-6#1)
significantly bound to##2##3##(1990-5#1)(1990-8#1)
significantly but##3##2##(2008-10#1)(2009-6#1)(2011-1#1)
significantly by the##12##3##(1991-2#1)(1991-4#1)(1995-5#1)(1996-11#1)(2004-11#2)(2007-4#1)(2008-10#2)(2008-4#1)(2008-7#2)
significantly by##50##2##(1990-12#3)(1990-7#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-3#1)(1992-8#1)(1995-3#1)(1995-5#1)(1996-11#1)(1997-2#1)(1997-7#3)(1997-8#1)(2004-11#3)(2004-9#1)(2007-4#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-1#1)
significantly canceled the stimulatory actions of L-leucine and KIC on protein synthesis##2##12##(2008-11#2)
significantly change the##8##3##(1990-5#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-9#1)(2007-11#1)(2007-8#1)(2008-10#1)
significantly change##18##2##(1990-5#1)(1992-3#1)(1994-5#2)(1995-1#1)(1995-12#1)(1995-9#1)(1996-6#1)(1996-7#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#2)(2009-4#1)(2010-8#1)
significantly changed as##2##3##(1992-6#1)(1995-3#1)
significantly changed by the##3##4##(2008-10#1)(2008-5#1)(2011-1#1)
significantly changed by##9##3##(1990-12#1)(1991-5#1)(1992-7#1)(1993-3#1)(1996-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)
significantly changed in##2##3##(2006-12#1)(2010-11#1)
significantly changed the##3##3##(1995-10#1)(2008-5#1)(2010-4#1)
significantly changed##29##2##(1990-12#1)(1991-5#2)(1992-6#1)(1992-7#1)(1993-12#2)(1993-3#1)(1994-2#1)(1995-10#1)(1995-3#1)(1995-6#2)(1996-4#1)(2005-11#1)(2005-8#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2009-8#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-3#1)
significantly changing##3##2##(1990-11#1)(1993-2#1)(2009-4#1)
significantly closer##3##2##(1997-5#2)(2009-4#1)
significantly coincident with##2##3##(2008-7#1)(2012-2#1)
significantly compared to the##2##4##(2005-11#1)(2007-10#1)
significantly compared to##6##3##(1990-12#1)(1997-2#1)(2005-11#1)(2007-10#1)(2007-11#1)(2008-10#1)
significantly compared with the##3##4##(2008-10#1)(2011-3#1)(2012-2#1)
significantly compared with##9##3##(2007-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-7#2)(2011-3#1)(2012-2#1)
significantly compared##15##2##(1990-12#1)(1997-2#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-7#2)(2011-3#1)(2012-2#1)
significantly compromised##2##2##(2006-6#1)(2013-1#1)
significantly connected with##2##3##(2010-12#2)
significantly contribute to the##6##4##(1994-11#1)(1994-9#1)(1997-8#1)(2006-2#1)(2010-12#1)(2012-3#1)
significantly contribute to##11##3##(1994-11#1)(1994-9#1)(1997-8#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
significantly contribute##12##2##(1993-9#1)(1994-11#1)(1994-9#1)(1997-8#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
significantly contributed to the##3##4##(2005-5#1)(2010-9#1)(2012-3#1)
significantly contributed to##5##3##(1991-2#1)(2005-5#1)(2008-10#1)(2010-9#1)(2012-3#1)
significantly contributes to the##2##4##(1995-12#1)(2007-12#1)
significantly contributes to##3##3##(1995-12#1)(2007-12#1)(2010-8#1)
significantly correlate with the##2##4##(1994-6#1)(2007-8#1)
significantly correlate##4##2##(1991-9#1)(1994-6#1)(2007-8#1)(2008-12#1)
significantly correlated (r = 0##3##5##(1992-12#1)(1992-8#1)(2006-5#1)
significantly correlated to##5##3##(1990-4#1)(1994-6#1)(2007-4#1)(2008-3#1)(2012-2#1)
significantly correlated with age##3##4##(1995-4#1)(2007-10#1)(2013-1#1)
significantly correlated with an improvement in##2##6##(1991-8#1)(1995-10#1)
significantly correlated with frequency##2##4##(2008-10#1)(2012-1#1)
significantly correlated with geographic distance##2##5##(2008-10#2)
significantly correlated with high##2##4##(2008-6#1)(2012-1#1)
significantly correlated with increased##2##4##(2011-2#2)
significantly correlated with the presence of##4##6##(1995-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
significantly correlated with the##26##4##(1990-8#1)(1992-1#1)(1993-3#1)(1995-5#1)(1996-5#1)(1997-2#1)(2005-8#1)(2006-4#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#3)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-5#1)(2013-1#1)(2013-8#1)
significantly correlated with##95##3##(1990-10#1)(1990-8#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-10#1)(1995-3#1)(1995-4#2)(1995-5#1)(1995-7#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-8#2)(2005-8#1)(2006-4#3)(2006-7#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#9)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#4)(2012-12#1)(2012-3#1)(2012-5#2)(2012-7#1)(2013-1#4)(2013-8#3)
significantly correlated##112##2##(1990-10#1)(1990-4#1)(1990-8#3)(1991-8#1)(1992-1#1)(1992-12#2)(1992-8#2)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-3#1)(1995-4#2)(1995-5#1)(1995-7#1)(1996-11#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-8#2)(2005-8#1)(2006-4#3)(2006-5#1)(2006-7#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#11)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#9)(2008-8#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#9)(2012-1#4)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#2)(2012-7#1)(2013-1#4)(2013-8#3)
significantly declined##5##2##(1994-6#1)(2008-10#1)(2008-11#1)(2011-12#1)(2011-2#1)
significantly decrease in##2##3##(1990-12#1)(2008-6#1)
significantly decrease the##6##3##(1990-5#1)(2008-9#1)(2009-3#1)(2011-1#1)(2011-12#1)(2013-1#1)
significantly decrease##19##2##(1990-12#1)(1990-5#1)(1991-9#1)(1994-12#1)(1996-12#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
significantly decreased (P &lt##5##4##(1993-2#1)(1996-6#1)(2008-10#1)(2008-7#1)(2009-5#1)
significantly decreased (P &lt##2##3##(2011-1#2)
significantly decreased (from##2##3##(1997-5#1)(2007-8#1)
significantly decreased (p &lt##2##4##(2008-11#1)(2008-12#1)
significantly decreased (p&lt##2##3##(2012-1#1)(2013-8#1)
significantly decreased [3H]NE release##2##4##(1992-3#2)
significantly decreased after##9##3##(1994-2#1)(1995-12#2)(1995-5#1)(2005-11#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
significantly decreased and##2##3##(2008-10#1)(2008-5#1)
significantly decreased as##6##3##(1992-9#1)(1993-2#1)(1995-12#1)(1995-7#1)(2008-9#1)(2009-5#1)
significantly decreased at##6##3##(1994-11#1)(1995-12#2)(2008-5#1)(2008-8#1)(2013-1#1)
significantly decreased by##9##3##(1991-1#1)(1992-11#1)(1993-3#2)(1995-12#1)(1996-2#1)(2006-8#1)(2007-9#1)(2008-5#1)
significantly decreased compared##4##3##(1993-1#1)(1995-6#1)(2004-11#1)(2004-9#1)
significantly decreased during##4##3##(1990-5#1)(2008-4#2)(2008-6#1)
significantly decreased from##6##3##(1996-2#1)(2008-4#1)(2008-6#1)(2011-1#2)(2013-1#1)
significantly decreased growth##2##3##(1990-7#1)(2012-12#1)
significantly decreased in all##2##4##(1995-6#1)(1997-2#1)
significantly decreased in both groups##2##5##(2007-8#1)(2013-1#1)
significantly decreased in both##3##4##(2007-8#1)(2008-10#1)(2013-1#1)
significantly decreased in patients with##4##5##(2006-1#1)(2007-11#1)(2007-9#1)(2008-7#1)
significantly decreased in the Resection group (p&lt##2##7##(2008-4#2)
significantly decreased in the hippocampus##2##5##(1990-7#1)(1995-12#1)
significantly decreased in the presence of##2##6##(1996-5#1)(2008-10#1)
significantly decreased in the##18##4##(1990-11#1)(1990-7#2)(1993-12#1)(1995-12#1)(1995-5#1)(1996-5#1)(1996-9#1)(1997-2#1)(2006-6#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-7#2)(2013-8#1)
significantly decreased in this##2##4##(2008-12#1)(2008-9#1)
significantly decreased in##50##3##(1990-11#1)(1990-7#3)(1993-12#1)(1993-3#2)(1995-12#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#2)(2006-1#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-12#3)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#4)(2009-6#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
significantly decreased platelet##2##3##(2008-3#1)(2008-7#1)
significantly decreased serum##3##3##(1996-12#1)(2012-11#1)(2012-2#1)
significantly decreased the duration of##2##5##(1992-3#1)(1993-2#1)
significantly decreased the labeling index of##2##6##(2008-4#2)
significantly decreased the level of##2##5##(1996-12#1)(2013-1#1)
significantly decreased the levels of##2##5##(1996-1#1)(2007-11#1)
significantly decreased the rate of##2##5##(1994-8#1)(1996-8#1)
significantly decreased the##42##3##(1990-2#1)(1990-8#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-2#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1996-1#1)(1996-12#2)(1996-8#1)(1997-3#1)(1997-5#2)(2005-8#1)(2006-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-4#4)(2008-5#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
significantly decreased with age##2##4##(2008-11#1)(2010-8#1)
significantly decreased with##7##3##(1994-8#1)(1996-12#1)(1997-5#1)(2008-11#1)(2010-2#1)(2010-5#1)(2010-8#1)
significantly decreased##264##2##(1990-11#1)(1990-2#2)(1990-3#4)(1990-4#1)(1990-5#1)(1990-7#4)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#2)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#3)(1993-3#6)(1993-6#1)(1993-7#2)(1993-8#1)(1994-10#1)(1994-11#1)(1994-2#6)(1994-5#3)(1994-6#3)(1994-8#3)(1995-11#1)(1995-12#8)(1995-4#1)(1995-5#3)(1995-6#2)(1995-7#1)(1995-9#1)(1996-1#2)(1996-12#4)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#3)(1996-8#1)(1996-9#3)(1997-2#3)(1997-3#1)(1997-5#4)(1997-6#2)(1997-7#4)(2004-11#2)(2004-9#1)(2005-11#1)(2005-8#1)(2006-1#2)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#3)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#4)(2007-8#4)(2007-9#3)(2008-10#12)(2008-11#3)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#10)(2008-5#7)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#11)(2009-1#1)(2009-12#1)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-2#2)(2010-4#2)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#8)(2013-7#2)(2013-8#5)
significantly decreases the##5##3##(1990-9#1)(1992-8#1)(2007-8#1)(2007-9#1)(2008-3#1)
significantly decreases##10##2##(1990-7#1)(1990-9#1)(1992-8#1)(1994-3#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-3#2)(2011-1#1)
significantly decreasing the##3##3##(1993-9#1)(1995-3#1)(2010-7#1)
significantly degrade##3##2##(2008-11#1)(2008-3#1)(2008-6#1)
significantly delayed in the##2##4##(1993-7#1)(2012-12#1)
significantly delayed in##4##3##(1993-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
significantly delayed the##3##3##(1994-12#1)(2007-3#1)(2010-3#1)
significantly delayed##15##2##(1993-7#1)(1994-12#1)(1997-3#2)(1997-6#1)(2007-3#3)(2007-8#1)(2008-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)
significantly dependent on the##2##4##(2007-8#2)
significantly dependent##3##2##(2007-7#1)(2007-8#2)
significantly depending on##3##3##(2008-1#1)(2008-10#1)(2008-2#1)
significantly depressed compared with##2##4##(1991-9#1)(2004-11#1)
significantly depressed in##3##3##(1992-8#1)(2006-10#1)(2011-1#1)
significantly depressed the##2##3##(1992-3#1)(1997-7#1)
significantly depressed##13##2##(1990-3#1)(1990-7#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-8#1)(1994-11#1)(1994-4#1)(1996-5#1)(1997-7#1)(2004-11#1)(2006-10#1)(2011-1#1)
significantly determined by##2##3##(1996-7#1)(2010-4#1)
significantly differ (P##2##3##(2008-7#1)(2013-1#1)
significantly differ##16##2##(1992-1#1)(1995-12#1)(2005-10#1)(2005-11#1)(2007-11#1)(2008-10#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-2#1)(2012-12#1)(2013-1#1)
significantly differed between##2##3##(1996-1#1)(2010-2#1)
significantly differed##6##2##(1996-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-2#1)(2012-12#1)
significantly difference between##3##3##(2008-12#2)(2011-2#1)
significantly differences##2##2##(2007-12#1)(2013-7#1)
significantly different (P &lt##3##4##(2008-10#1)(2011-1#2)
significantly different (P = 0##2##5##(2008-10#2)
significantly different (P =##3##4##(2008-10#2)(2012-2#1)
significantly different (P##8##3##(1992-7#1)(2008-10#4)(2011-1#2)(2012-2#1)
significantly different (p &lt##4##4##(1994-3#1)(2007-10#1)(2008-3#1)(2008-7#1)
significantly different (p&lt##5##3##(2006-4#1)(2008-12#2)(2008-5#1)(2013-1#1)
significantly different across##3##3##(2010-4#1)(2010-7#1)(2010-8#1)
significantly different among concentrations for##2##5##(2008-10#2)
significantly different among the four##3##5##(2007-2#1)(2008-7#1)(2010-4#1)
significantly different among the##7##4##(2007-2#1)(2008-10#1)(2008-12#1)(2008-7#2)(2010-4#1)(2013-1#1)
significantly different among##15##3##(2004-11#1)(2007-2#1)(2008-10#5)(2008-12#1)(2008-7#2)(2008-9#2)(2010-4#1)(2010-7#1)(2013-1#1)
significantly different at##3##3##(1991-10#1)(2006-10#1)(2008-10#1)
significantly different between case and control##2##6##(2011-2#1)(2012-3#1)
significantly different between the groups##3##5##(2008-5#1)(2008-8#1)(2012-12#1)
significantly different between the two groups##6##6##(1992-10#1)(1995-12#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-5#1)
significantly different between the two##8##5##(1992-10#1)(1995-12#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-5#2)(2013-1#1)
significantly different between the##21##4##(1990-7#1)(1992-10#1)(1995-12#1)(1995-4#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-5#3)(2008-8#1)(2011-2#1)(2012-11#1)(2012-12#2)(2013-1#1)
significantly different between##51##3##(1990-7#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-10#1)(1993-11#1)(1993-7#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-4#1)(1995-5#1)(1996-12#1)(1996-7#1)(1997-2#1)(2005-8#2)(2006-10#1)(2007-1#2)(2007-12#2)(2007-4#1)(2007-7#1)(2008-10#5)(2008-5#3)(2008-7#1)(2008-8#2)(2009-11#1)(2011-12#4)(2011-2#3)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
significantly different for each##2##4##(1990-11#1)(2007-4#1)
significantly different for the two##2##5##(1992-8#1)(1995-9#1)
significantly different for the##3##4##(1992-8#1)(1995-9#1)(2008-2#1)
significantly different for##10##3##(1990-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1994-2#1)(1995-9#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#1)
significantly different from a binomial distribution (P##2##7##(2008-10#2)
significantly different from controls##4##4##(1991-12#1)(1995-8#1)(2008-7#1)(2011-2#1)
significantly different from each other##6##5##(1993-3#1)(1995-2#1)(2005-11#1)(2006-9#1)(2008-10#1)(2008-5#1)
significantly different from one another##2##5##(1992-2#1)(2008-10#1)
significantly different from that of the##7##6##(1992-4#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
significantly different from that of##12##5##(1990-8#1)(1992-4#1)(1992-7#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)
significantly different from that##17##4##(1990-8#1)(1992-4#1)(1992-5#1)(1992-7#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)
significantly different from the control##4##5##(1993-1#1)(1994-3#1)(2007-8#1)(2012-2#1)
significantly different from the results##2##5##(1994-5#1)(2008-10#1)
significantly different from the##33##4##(1992-1#1)(1992-11#1)(1992-6#1)(1993-1#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-3#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#5)(2008-6#2)(2008-8#2)(2009-10#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
significantly different from those of##8##5##(1993-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1997-6#1)(2008-5#1)(2010-8#1)(2011-2#1)
significantly different from those##17##4##(1990-12#1)(1991-12#1)(1992-3#1)(1993-2#1)(1993-8#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-9#1)(1997-6#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-2#2)(2012-3#1)
significantly different from zero (P &lt##3##6##(2008-10#3)
significantly different from zero##8##4##(1991-12#1)(1995-1#1)(2008-10#5)(2010-2#1)
significantly different from##113##3##(1990-12#1)(1990-8#1)(1991-12#3)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-12#1)(1996-9#2)(1997-6#1)(2005-11#1)(2006-10#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-12#2)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#27)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#2)(2009-3#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)
significantly different in the two groups##4##6##(1992-3#1)(1993-11#1)(2006-9#1)(2007-1#1)
significantly different in the##14##4##(1990-11#1)(1992-3#1)(1993-11#1)(1995-6#1)(1997-7#1)(1997-8#1)(2006-9#1)(2007-1#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-1#1)
significantly different in##27##3##(1990-11#1)(1992-3#1)(1993-11#1)(1993-6#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-7#1)(1997-8#1)(2006-9#1)(2007-1#1)(2007-4#1)(2008-10#4)(2008-11#1)(2008-12#4)(2008-5#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
significantly different only##3##3##(2008-5#1)(2010-8#1)(2013-1#1)
significantly different than the##2##4##(2008-3#1)(2013-1#1)
significantly different than##6##3##(2008-10#1)(2008-3#1)(2009-12#1)(2009-2#1)(2010-8#1)(2013-1#1)
significantly different to##2##3##(1996-12#1)(2008-10#1)
significantly different when##3##3##(1996-3#1)(2008-5#1)(2011-12#1)
significantly different with##2##3##(1991-6#1)(2011-1#1)
significantly different within the tertiles##2##5##(2008-3#2)
significantly different##346##2##(1990-11#2)(1990-12#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#5)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#2)(1993-1#2)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#2)(1993-7#2)(1993-8#2)(1993-9#1)(1994-2#3)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#4)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#3)(1997-2#1)(1997-6#2)(1997-7#1)(1997-8#2)(2004-11#2)(2004-12#1)(2005-10#1)(2005-11#2)(2005-8#2)(2006-10#5)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-1#3)(2007-10#2)(2007-11#1)(2007-12#6)(2007-2#5)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#59)(2008-11#2)(2008-12#10)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#15)(2008-6#2)(2008-7#7)(2008-8#10)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#6)(2011-12#5)(2011-2#12)(2012-11#1)(2012-12#7)(2012-2#6)(2012-3#6)(2013-1#12)(2013-7#1)(2013-8#3)
significantly differentiated##8##2##(2006-6#1)(2008-10#5)(2010-7#1)(2012-5#1)
significantly differs##2##2##(1993-6#1)(2012-3#1)
significantly diminished by##2##3##(1993-9#1)(2013-1#1)
significantly diminished in##4##3##(1991-7#1)(2008-10#1)(2008-12#1)(2008-8#1)
significantly diminished the##4##3##(1995-12#1)(1995-3#1)(1997-5#1)(2012-2#1)
significantly diminished##20##2##(1991-12#1)(1991-2#1)(1991-7#1)(1993-9#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-3#1)(1995-7#1)(1996-5#1)(1997-3#1)(1997-5#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2012-2#1)(2013-1#1)
significantly down regulated##2##3##(1996-4#1)(2013-1#1)
significantly down-regulated##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2013-8#1)
significantly dropped##2##2##(2008-11#1)(2009-8#1)
significantly during the first##3##4##(2008-9#1)(2012-3#1)(2013-1#1)
significantly during the study period##2##5##(2006-10#1)(2006-7#1)
significantly during the study##4##4##(1991-10#1)(2006-10#1)(2006-7#1)(2012-2#1)
significantly during the##17##3##(1991-10#1)(1993-7#1)(1997-2#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-7#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
significantly during this##3##3##(1990-11#1)(1991-11#1)(1991-12#1)
significantly during treatment##3##3##(2008-7#1)(2012-3#2)
significantly during##37##2##(1990-11#1)(1991-10#1)(1991-11#1)(1991-12#1)(1992-7#1)(1993-7#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-11#1)(1997-2#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-12#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)
significantly earlier than##3##3##(1993-12#1)(1995-11#1)(2011-2#1)
significantly earlier##6##2##(1991-9#1)(1993-12#1)(1995-11#2)(1995-12#1)(2011-2#1)
significantly effect the##3##3##(2004-1#1)(2007-9#1)(2008-10#1)
significantly effective in##2##3##(2005-8#1)(2007-6#1)
significantly effective##4##2##(2005-11#1)(2005-8#1)(2007-6#1)(2012-2#1)
significantly either##2##2##(1990-12#1)(1997-2#1)
significantly elevated and##3##3##(1991-2#1)(2005-7#1)(2010-4#1)
significantly elevated in the##8##4##(1991-2#1)(1995-12#1)(1996-12#1)(1997-2#1)(2004-10#1)(2008-10#2)(2008-4#1)
significantly elevated in##18##3##(1991-2#1)(1992-7#1)(1993-12#1)(1993-8#1)(1994-4#1)(1995-12#1)(1996-12#2)(1997-2#1)(2004-10#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
significantly elevated levels of##2##4##(1994-8#1)(2007-12#1)
significantly elevated levels##3##3##(1994-8#1)(2007-12#1)(2007-3#1)
significantly elevated plasma##2##3##(1996-4#1)(2008-5#1)
significantly elevated risk##3##3##(2007-1#1)(2012-12#2)
significantly elevated the##2##3##(2008-8#1)(2011-2#1)
significantly elevated##78##2##(1990-10#1)(1990-11#1)(1990-12#2)(1991-10#1)(1991-2#2)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-8#1)(1995-12#2)(1995-6#1)(1996-12#3)(1996-4#2)(1996-9#1)(1997-2#2)(1997-7#1)(2004-10#1)(2005-7#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#2)(2013-1#2)(2013-8#1)
significantly eliminated##3##2##(1993-12#1)(2008-10#1)(2008-7#1)
significantly enhance the##6##3##(2007-12#1)(2008-10#2)(2008-11#1)(2008-6#1)(2013-1#1)
significantly enhance##18##2##(1994-10#1)(1995-12#1)(1996-8#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-6#1)(2008-7#1)(2011-2#2)(2013-1#3)
significantly enhanced and##2##3##(1992-1#1)(2008-2#1)
significantly enhanced by the addition of##2##6##(1992-12#1)(2008-11#1)
significantly enhanced by the##7##4##(1992-12#1)(1995-12#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)
significantly enhanced by##12##3##(1990-5#1)(1992-12#1)(1994-9#1)(1995-12#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)
significantly enhanced cell##2##3##(1991-7#1)(2008-11#1)
significantly enhanced contrast##2##3##(2007-12#1)(2012-11#1)
significantly enhanced growth of##2##4##(1992-8#1)(2008-10#1)
significantly enhanced in##4##3##(1993-9#1)(1996-12#1)(1996-7#1)(2008-10#1)
significantly enhanced our understanding of##2##5##(2005-10#1)(2006-10#1)
significantly enhanced resistance##2##3##(2008-10#2)
significantly enhanced response towards##2##4##(2008-10#2)
significantly enhanced sensitivity##2##3##(2007-11#1)(2011-1#1)
significantly enhanced the release##2##4##(1991-3#1)(1991-6#1)
significantly enhanced the##16##3##(1991-3#1)(1991-6#1)(1992-2#1)(1992-8#1)(1994-3#1)(1995-6#1)(1995-7#1)(1997-4#1)(1997-6#1)(2008-10#2)(2008-6#2)(2008-7#1)(2011-2#1)(2012-1#1)
significantly enhanced##91##2##(1990-5#1)(1990-7#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-12#1)(1992-2#3)(1992-8#2)(1993-3#1)(1993-9#2)(1994-11#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-4#2)(1997-6#1)(1997-7#2)(2005-10#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-11#3)(2007-12#3)(2008-10#19)(2008-11#4)(2008-2#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#2)
significantly enhances its##2##3##(2007-12#1)(2008-3#1)
significantly enhances the##3##3##(2007-11#1)(2008-10#1)(2008-9#1)
significantly enhances##10##2##(1990-2#1)(1996-11#1)(1996-9#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)
significantly expanded##2##2##(2009-4#1)(2009-8#1)
significantly expressed genes##2##3##(2008-8#1)(2010-4#1)
significantly expressed in##3##3##(1990-2#1)(2006-2#1)(2009-3#1)
significantly expressed##7##2##(1990-2#1)(2006-2#1)(2007-6#2)(2008-8#1)(2009-3#1)(2010-4#1)
significantly extends the##3##3##(2007-12#1)(2008-10#1)(2012-3#1)
significantly extends##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2012-3#1)
significantly facilitated##2##2##(1991-5#1)(2008-5#1)
significantly faster in##5##3##(1991-5#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-8#1)
significantly faster than##3##3##(2007-2#1)(2008-10#1)(2008-2#1)
significantly faster##13##2##(1991-5#1)(1992-7#2)(2005-8#1)(2007-11#1)(2007-2#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)
significantly fewer adverse##3##3##(1992-2#1)(2005-7#1)(2006-10#1)
significantly fewer##40##2##(1991-1#1)(1991-3#1)(1992-2#2)(1993-4#1)(1994-2#2)(1995-12#1)(1995-5#1)(1996-12#1)(1996-7#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-8#1)(2008-10#6)(2008-11#1)(2008-4#2)(2008-7#1)(2009-11#1)(2009-2#1)(2010-10#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#1)
significantly following treatment##2##3##(1990-3#1)(2012-3#1)
significantly following##6##2##(1990-3#1)(1996-3#1)(2008-10#1)(2010-7#1)(2010-8#1)(2012-3#1)
significantly for RAPD##2##3##(2008-10#2)
significantly for all##3##3##(1997-4#1)(2007-8#1)(2008-12#1)
significantly for the two##2##4##(1994-5#1)(2008-10#1)
significantly for the##3##3##(1994-5#1)(2008-10#1)(2009-12#1)
significantly for young women in the##2##6##(2007-2#2)
significantly for##20##2##(1991-12#1)(1991-5#1)(1993-12#1)(1994-5#1)(1996-2#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-2#3)(2007-8#1)(2008-10#5)(2008-12#1)(2009-12#1)(2010-3#1)
significantly from 97##2##3##(2008-1#1)(2008-12#1)
significantly from a mean##3##4##(2008-1#2)(2013-1#1)
significantly from a##6##3##(2008-1#2)(2008-10#2)(2008-3#1)(2013-1#1)
significantly from baseline##4##3##(2006-8#1)(2008-1#1)(2012-3#2)
significantly from mean##2##3##(2006-7#1)(2006-9#1)
significantly from one##2##3##(2008-10#2)
significantly from other##3##3##(1994-3#1)(2006-10#1)(2013-7#1)
significantly from that of the##5##5##(1994-2#1)(1996-7#2)(1997-4#1)(2008-3#1)
significantly from that of##11##4##(1994-2#1)(1995-9#1)(1996-7#2)(1997-4#1)(2005-7#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-3#1)
significantly from that##16##3##(1991-6#1)(1992-1#1)(1993-11#1)(1994-2#1)(1994-5#1)(1995-9#1)(1996-7#2)(1997-4#1)(2005-7#1)(2008-10#1)(2008-3#2)(2008-8#1)(2009-10#1)(2009-3#1)
significantly from the classical Hofmeister##2##5##(2007-8#1)(2008-10#1)
significantly from the##22##3##(1990-4#1)(1990-5#1)(1991-4#1)(1991-6#1)(1992-6#1)(1993-7#1)(1994-4#1)(1994-8#1)(1995-4#1)(1997-2#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-5#1)(2008-7#1)(2009-4#1)(2011-1#1)
significantly from those in the##2##5##(1996-3#1)(2008-2#1)
significantly from those in##3##4##(1995-11#1)(1996-3#1)(2008-2#1)
significantly from those of##6##4##(1996-6#1)(1997-8#1)(2007-12#1)(2008-8#1)(2009-8#1)(2013-1#1)
significantly from those##14##3##(1995-11#1)(1996-3#1)(1996-6#1)(1997-8#1)(2007-12#1)(2008-2#2)(2008-7#1)(2008-8#2)(2009-8#1)(2012-1#1)(2013-1#1)(2013-8#1)
significantly from##110##2##(1990-4#1)(1990-5#1)(1990-8#1)(1991-4#1)(1991-6#2)(1992-1#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-7#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-4#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#2)(1996-7#4)(1997-2#1)(1997-4#1)(1997-8#2)(2005-7#1)(2006-10#3)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#12)(2008-12#4)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#5)(2013-1#4)(2013-7#3)(2013-8#2)
significantly greater (P &lt##3##4##(1997-8#1)(2008-10#2)
significantly greater (P##4##3##(1996-9#1)(1997-8#1)(2008-10#2)
significantly greater (p##2##3##(1991-5#1)(2007-4#1)
significantly greater and##2##3##(1995-12#1)(2007-4#1)
significantly greater degree of##3##4##(1994-11#1)(1996-3#1)(2008-10#1)
significantly greater degree##4##3##(1994-11#1)(1996-3#1)(2007-12#1)(2008-10#1)
significantly greater difficulty##2##3##(2008-11#1)(2012-11#1)
significantly greater during##2##3##(1994-3#1)(2013-1#1)
significantly greater for##6##3##(1993-9#1)(1995-1#1)(1995-2#1)(1997-4#1)(2009-7#1)(2013-1#1)
significantly greater improvements##3##3##(2004-3#1)(2008-3#1)(2008-8#1)
significantly greater in males versus##2##5##(2012-11#2)
significantly greater in mulch##2##4##(2008-10#2)
significantly greater in patients with##2##5##(1990-4#1)(2010-11#1)
significantly greater in patients##3##4##(1990-4#1)(1991-8#1)(2010-11#1)
significantly greater in the##16##4##(1992-8#1)(1992-9#1)(1994-7#1)(1996-10#1)(1996-5#1)(1997-4#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#3)(2011-2#2)(2012-12#1)
significantly greater in##40##3##(1990-4#1)(1991-8#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-7#1)(1995-5#1)(1996-10#1)(1996-5#1)(1997-4#1)(2004-2#1)(2006-2#1)(2006-6#1)(2007-10#3)(2007-7#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#4)(2010-11#1)(2011-2#2)(2012-11#2)(2012-12#1)(2013-1#1)
significantly greater mean values##2##4##(2008-5#1)(2012-12#1)
significantly greater mean##3##3##(2006-10#1)(2008-5#1)(2012-12#1)
significantly greater number of##3##4##(1996-5#1)(2006-8#1)(2007-11#1)
significantly greater preservation of##2##4##(1996-1#2)
significantly greater pressor##2##3##(1990-7#1)(1997-5#1)
significantly greater proportion of##2##4##(2008-6#1)(2010-5#1)
significantly greater reduction in##3##4##(1996-12#1)(1997-8#1)(2007-11#1)
significantly greater risk of##2##4##(2008-11#1)(2011-2#1)
significantly greater risk##4##3##(2008-11#1)(2009-8#1)(2011-2#1)(2012-3#1)
significantly greater than 0 (P &lt##2##6##(2008-10#2)
significantly greater than in##3##4##(1991-8#1)(2006-2#1)(2009-2#1)
significantly greater than that in the vehicle control group##3##9##(2008-9#3)
significantly greater than that in the vehicle##4##7##(2008-9#4)
significantly greater than that in the##5##6##(2008-9#5)
significantly greater than that in##6##5##(2008-5#1)(2008-9#5)
significantly greater than that of the##2##6##(1996-12#1)(2009-7#1)
significantly greater than that of##4##5##(1990-12#1)(1996-12#1)(2008-10#1)(2009-7#1)
significantly greater than that##15##4##(1990-12#1)(1991-11#1)(1991-9#1)(1996-12#1)(2006-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#5)(2009-7#1)(2013-8#1)
significantly greater than the##14##4##(1995-1#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-3#1)(2006-12#1)(2006-4#1)(2008-1#1)(2008-10#1)(2010-1#1)(2010-9#1)(2011-1#1)(2012-3#1)(2013-7#1)
significantly greater than those from the##2##6##(2008-5#1)(2011-12#1)
significantly greater than those from##3##5##(1996-11#1)(2008-5#1)(2011-12#1)
significantly greater than those of##9##5##(1990-4#1)(1991-2#1)(2008-2#1)(2008-5#2)(2008-9#3)(2010-4#1)
significantly greater than those##18##4##(1990-12#1)(1990-4#1)(1991-2#1)(1996-11#1)(2008-2#1)(2008-5#3)(2008-9#8)(2010-4#1)(2011-12#1)
significantly greater than zero##3##4##(1994-2#2)(2008-9#1)
significantly greater than##67##3##(1990-12#2)(1990-4#1)(1991-11#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-5#1)(1992-6#1)(1993-3#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-6#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-5#5)(2008-8#1)(2008-9#14)(2009-2#1)(2009-7#1)(2010-1#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
significantly greater total##2##3##(1994-6#1)(2009-4#1)
significantly greater with##4##3##(1994-6#1)(2005-11#1)(2007-4#1)(2010-4#1)
significantly greater##229##2##(1990-12#2)(1990-4#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#2)(1991-5#1)(1991-7#1)(1991-8#3)(1991-9#2)(1992-10#2)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-6#2)(1994-7#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#4)(1995-9#1)(1996-1#4)(1996-10#2)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#2)(1997-9#1)(2004-2#1)(2004-3#1)(2005-10#1)(2005-11#2)(2005-7#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#2)(2006-4#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#1)(2007-3#1)(2007-4#3)(2007-6#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#25)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#7)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#16)(2009-1#1)(2009-2#2)(2009-4#1)(2009-7#2)(2009-8#2)(2010-1#1)(2010-11#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-11#5)(2012-12#4)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#2)
significantly high incidence of##2##4##(2007-9#1)(2010-12#1)
significantly high levels of##3##4##(1994-6#1)(2005-12#1)(2008-10#1)
significantly high levels##6##3##(1990-10#1)(1994-6#1)(2005-12#1)(2006-6#1)(2008-10#1)(2008-11#1)
significantly high##30##2##(1990-10#1)(1993-12#1)(1994-6#1)(1995-3#1)(2005-12#1)(2006-6#1)(2007-1#1)(2007-6#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
significantly higher (3##2##3##(1997-3#1)(2007-1#1)
significantly higher (P &lt##19##4##(1992-12#1)(1995-3#1)(1996-1#1)(1996-12#2)(1996-9#1)(1997-6#1)(2006-5#3)(2007-1#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-4#1)(2009-4#2)
significantly higher (P##21##3##(1991-2#1)(1991-8#1)(1992-12#1)(1995-3#1)(1996-1#1)(1996-12#2)(1996-9#1)(1997-6#1)(2006-5#3)(2007-1#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-4#1)(2009-4#2)
significantly higher (P&lt##4##3##(2007-2#2)(2007-3#2)
significantly higher (p &lt##8##4##(1997-7#1)(2005-12#1)(2006-11#1)(2006-8#1)(2007-2#1)(2007-9#1)(2008-6#1)(2011-2#1)
significantly higher (p less than 0##3##6##(1990-7#1)(1991-2#1)(1991-6#1)
significantly higher (p##12##3##(1990-7#1)(1991-2#1)(1991-6#1)(1993-11#1)(1997-7#1)(2005-12#1)(2006-11#1)(2006-8#1)(2007-2#1)(2007-9#1)(2008-6#1)(2011-2#1)
significantly higher (p&lt##6##3##(2006-6#1)(2008-7#1)(2012-12#1)(2013-1#1)(2013-8#2)
significantly higher [P &lt##2##4##(2007-1#1)(2008-4#1)
significantly higher activity##6##3##(1994-10#1)(2004-11#1)(2008-4#1)(2008-7#1)(2012-11#1)(2012-2#1)
significantly higher among patients with##2##5##(2008-7#1)(2013-1#1)
significantly higher among patients##4##4##(1995-9#1)(2008-7#1)(2011-2#1)(2013-1#1)
significantly higher among the##5##4##(1990-6#1)(2006-10#1)(2012-2#1)(2013-1#2)
significantly higher among those##3##4##(2006-2#1)(2009-4#1)(2009-7#1)
significantly higher among##32##3##(1990-10#1)(1990-6#1)(1991-8#1)(1993-10#1)(1994-5#1)(1995-9#1)(1996-2#1)(1996-5#1)(1997-1#3)(1997-4#1)(2006-10#2)(2006-2#2)(2007-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#3)(2013-8#1)
significantly higher amounts of##3##4##(1993-12#1)(2008-10#1)(2008-11#1)
significantly higher and##4##3##(1992-1#1)(1994-4#1)(1994-7#1)(2009-10#1)
significantly higher antibody##2##3##(1992-2#1)(2012-2#1)
significantly higher at##8##3##(1995-12#1)(2006-10#3)(2006-2#1)(2008-10#2)(2011-1#1)
significantly higher body##3##3##(1990-5#1)(2006-12#1)(2007-12#1)
significantly higher cell##2##3##(1994-2#1)(2008-10#1)
significantly higher compared with##2##4##(2008-3#1)(2008-6#1)
significantly higher compared##3##3##(1994-8#1)(2008-3#1)(2008-6#1)
significantly higher concentration of##2##4##(1994-12#1)(2008-4#1)
significantly higher concentration##3##3##(1994-12#1)(2008-4#1)(2012-2#1)
significantly higher concentrations of##3##4##(1994-6#1)(2004-4#1)(2008-10#1)
significantly higher deficit##2##3##(2009-9#2)
significantly higher during##3##3##(1995-11#2)(2008-11#1)
significantly higher for both##3##4##(1997-2#1)(2008-10#1)(2009-1#1)
significantly higher for the##6##4##(2006-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2010-2#2)
significantly higher for##28##3##(1990-4#2)(1992-12#1)(1996-11#1)(1997-2#1)(1997-8#1)(2004-10#1)(2006-4#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#2)(2009-1#1)(2010-12#1)(2010-2#2)(2011-1#1)(2011-2#3)
significantly higher in 62 women taking low-estrogen##2##7##(1990-11#2)
significantly higher in Group A##2##5##(2013-7#2)
significantly higher in Group##3##4##(2011-1#1)(2013-7#2)
significantly higher in breast milk-fed newborns##2##6##(1991-4#2)
significantly higher in breast##3##4##(1991-4#2)(1996-3#1)
significantly higher in cases##3##4##(1990-12#1)(1997-8#1)(2007-10#1)
significantly higher in comparison to##2##5##(2008-12#1)(2008-8#1)
significantly higher in diabetics##2##4##(2006-6#1)(2011-11#1)
significantly higher in females than in males##3##7##(2007-12#2)(2008-11#1)
significantly higher in females##5##4##(2007-1#1)(2007-12#2)(2008-11#1)(2012-11#1)
significantly higher in group##6##4##(1993-4#1)(2007-2#2)(2007-8#1)(2008-7#1)(2009-6#1)
significantly higher in male##3##4##(1996-6#1)(2007-6#1)(2011-2#1)
significantly higher in obese##2##4##(1995-5#1)(2013-8#1)
significantly higher in patients with##18##5##(1990-7#1)(1992-12#1)(1993-11#2)(1996-12#1)(1997-7#2)(2007-7#1)(2008-1#1)(2008-5#1)(2008-7#2)(2009-2#1)(2010-12#1)(2010-4#1)(2011-1#1)(2013-1#2)
significantly higher in patients##24##4##(1990-7#1)(1991-6#1)(1991-8#1)(1992-12#1)(1993-11#2)(1993-12#1)(1996-11#1)(1996-12#1)(1997-7#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-2#1)(2010-12#1)(2010-4#1)(2011-1#1)(2013-1#2)
significantly higher in rats##2##4##(1994-2#1)(1997-6#1)
significantly higher in the former##2##5##(1995-10#1)(2012-2#1)
significantly higher in the group##2##5##(2007-2#1)(2008-7#1)
significantly higher in the patients with##3##6##(1990-3#1)(1996-1#1)(2007-8#1)
significantly higher in the patients##4##5##(1990-3#1)(1996-1#1)(2007-8#1)(2008-7#1)
significantly higher in the resistant##2##5##(2008-10#2)
significantly higher in the##84##4##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-4#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-6#1)(1997-7#1)(2004-11#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#2)(2007-8#7)(2007-9#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#5)(2009-3#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
significantly higher in these##3##4##(1991-11#1)(2008-3#1)(2008-4#1)
significantly higher in type 1##2##5##(1993-2#1)(2008-1#1)
significantly higher in women with##2##5##(2008-3#1)(2011-2#1)
significantly higher in women##4##4##(1991-3#1)(2008-3#2)(2011-2#1)
significantly higher in##253##3##(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#2)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#2)(1992-7#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#2)(1994-2#1)(1994-3#2)(1994-6#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-9#1)(1997-2#2)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#1)(2004-11#1)(2004-4#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-5#1)(2006-6#3)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#3)(2007-2#5)(2007-6#1)(2007-7#4)(2007-8#8)(2007-9#1)(2008-1#4)(2008-10#18)(2008-11#5)(2008-12#2)(2008-3#8)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#11)(2008-8#3)(2008-9#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#4)(2009-9#1)(2010-12#3)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#7)(2011-11#1)(2011-12#1)(2011-2#11)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#7)(2012-5#1)(2013-1#7)(2013-7#4)(2013-8#4)
significantly higher incidence in##2##4##(1997-8#1)(2005-8#1)
significantly higher incidence of##4##4##(1992-7#1)(2005-10#1)(2007-8#1)(2008-8#1)
significantly higher incidence##9##3##(1992-7#1)(1993-8#1)(1996-8#2)(1997-8#1)(2005-10#1)(2005-8#1)(2007-8#1)(2008-8#1)
significantly higher levels in##2##4##(2008-10#1)(2010-7#1)
significantly higher levels of##19##4##(1990-12#1)(1992-2#1)(1992-9#1)(2004-12#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-2#2)(2008-10#1)(2008-3#1)(2008-7#2)(2009-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#1)(2013-1#1)
significantly higher levels##23##3##(1990-12#1)(1992-2#1)(1992-9#1)(2004-12#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-2#2)(2008-10#3)(2008-3#1)(2008-7#2)(2009-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#1)(2013-1#1)
significantly higher mean age##2##4##(2008-10#1)(2013-8#1)
significantly higher mean##10##3##(1993-11#1)(1997-4#1)(2005-8#1)(2006-10#1)(2007-5#1)(2007-6#1)(2008-10#1)(2013-1#1)(2013-7#1)(2013-8#1)
significantly higher number of##7##4##(2008-5#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-2#2)(2013-1#1)
significantly higher numbers of##2##4##(2008-10#1)(2008-12#1)
significantly higher numbers##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
significantly higher on day##2##4##(1990-9#1)(1992-5#1)
significantly higher on the##3##4##(2006-7#1)(2008-5#1)(2011-2#1)
significantly higher on##11##3##(1990-9#1)(1992-5#1)(2006-7#2)(2008-10#2)(2008-5#2)(2009-5#1)(2011-2#1)(2012-9#1)
significantly higher percentage of patients##2##5##(2011-2#1)(2013-1#1)
significantly higher percentage of##14##4##(1991-2#1)(1994-6#2)(2007-11#1)(2007-7#1)(2008-10#4)(2008-5#1)(2009-4#1)(2011-2#1)(2013-1#2)
significantly higher plasma##3##3##(1997-8#1)(2011-2#1)(2012-2#1)
significantly higher prevalence##4##3##(2008-1#1)(2009-12#1)(2010-2#1)(2011-1#1)
significantly higher proportions of##2##4##(2006-8#1)(2013-8#1)
significantly higher response rates and##2##5##(2008-5#1)(2010-12#1)
significantly higher response##3##3##(2008-3#1)(2008-5#1)(2010-12#1)
significantly higher risk for##2##4##(2008-10#1)(2008-7#1)
significantly higher risk of##3##4##(1990-2#1)(2007-7#1)(2013-1#1)
significantly higher risk##5##3##(1990-2#1)(2007-7#1)(2008-10#1)(2008-7#1)(2013-1#1)
significantly higher scores for##2##4##(1996-12#1)(2008-8#1)
significantly higher scores in##2##4##(2007-2#1)(2009-4#1)
significantly higher scores##8##3##(1996-12#1)(2007-2#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-1#1)(2013-1#1)
significantly higher serum##3##3##(1997-7#1)(2008-11#1)(2011-1#1)
significantly higher than among##2##4##(1993-10#1)(2009-2#1)
significantly higher than control##3##4##(2008-11#1)(2008-5#1)(2009-11#1)
significantly higher than in controls##5##5##(1991-2#1)(2009-2#1)(2011-1#2)(2012-1#1)
significantly higher than in patients with##2##6##(2006-6#1)(2012-1#1)
significantly higher than in patients##3##5##(2006-6#1)(2012-1#2)
significantly higher than in the control group##2##7##(1991-4#1)(2011-2#1)
significantly higher than in the controls##2##6##(1991-4#1)(2010-12#1)
significantly higher than in the##12##5##(1991-4#2)(1991-5#1)(1992-11#1)(1992-5#1)(1997-8#1)(2006-6#1)(2009-5#1)(2010-12#1)(2011-2#2)(2012-2#1)
significantly higher than in##39##4##(1990-11#1)(1991-11#1)(1991-2#1)(1991-4#2)(1991-5#2)(1992-10#1)(1992-11#1)(1992-5#1)(1993-1#1)(1994-10#1)(1995-3#1)(1996-4#1)(1997-8#1)(2006-6#2)(2007-10#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-12#1)(2011-1#3)(2011-2#2)(2012-1#3)(2012-2#1)(2013-1#1)
significantly higher than normal##3##4##(1991-8#1)(1992-8#1)(2008-1#1)
significantly higher than on##2##4##(1993-11#1)(1995-11#1)
significantly higher than that in healthy##2##6##(2008-10#1)(2011-1#1)
significantly higher than that in the control group##3##8##(1990-9#1)(2007-8#1)(2012-2#1)
significantly higher than that in the control##6##7##(1990-9#1)(1995-3#1)(2007-8#1)(2012-2#1)(2013-8#2)
significantly higher than that in the controls##2##7##(2010-10#1)(2011-2#1)
significantly higher than that in the##9##6##(1990-9#1)(1995-3#1)(2007-10#1)(2007-8#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-8#2)
significantly higher than that in##20##5##(1990-9#1)(1994-6#1)(1995-3#1)(2005-4#1)(2007-10#1)(2007-8#4)(2008-10#2)(2008-9#1)(2010-10#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-8#2)
significantly higher than that observed in##2##6##(1993-11#1)(2008-2#1)
significantly higher than that of patients##2##6##(2006-6#1)(2007-8#1)
significantly higher than that of the##6##6##(1997-2#1)(2007-4#1)(2007-7#1)(2008-10#1)(2011-2#1)(2012-2#1)
significantly higher than that of##18##5##(1992-3#1)(1992-7#1)(1993-4#1)(1997-2#1)(2006-12#1)(2006-6#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-5#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-7#2)
significantly higher than that##47##4##(1990-9#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-4#1)(1994-11#1)(1994-6#1)(1994-7#1)(1995-3#1)(1997-2#1)(1997-7#1)(2004-10#1)(2005-4#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-4#1)(2007-7#2)(2007-8#5)(2008-10#4)(2008-2#1)(2008-5#1)(2008-9#1)(2010-10#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#2)(2013-7#2)(2013-8#2)
significantly higher than the control##3##5##(2006-12#1)(2009-10#1)(2009-6#1)
significantly higher than the mean##2##5##(2007-8#1)(2011-2#1)
significantly higher than the##24##4##(1991-2#1)(1991-5#1)(1993-3#1)(1995-12#1)(1996-1#1)(1996-10#1)(1997-8#1)(2004-2#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-8#1)(2008-10#3)(2008-5#1)(2009-10#1)(2009-6#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#2)
significantly higher than those in the control##2##7##(1997-1#1)(2011-2#1)
significantly higher than those in the##7##6##(1994-3#1)(1996-7#2)(1997-1#1)(2004-11#1)(2007-2#1)(2011-2#1)
significantly higher than those in##15##5##(1993-3#1)(1994-3#1)(1995-2#1)(1996-7#2)(1997-1#2)(2004-11#1)(2005-10#1)(2007-2#3)(2011-2#1)(2013-1#1)(2013-8#1)
significantly higher than those of##18##5##(1992-12#1)(1992-3#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-4#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-5#1)(2009-4#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2013-1#1)
significantly higher than those##41##4##(1990-8#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-4#1)(1996-1#1)(1996-7#2)(1997-1#2)(2004-11#1)(2005-10#1)(2007-2#3)(2008-10#3)(2008-12#2)(2008-2#1)(2008-5#1)(2009-4#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
significantly higher than##199##3##(1990-11#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-4#2)(1991-5#3)(1991-8#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-2#2)(1993-3#3)(1993-4#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#3)(1994-7#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-4#1)(1996-1#3)(1996-10#1)(1996-4#1)(1996-7#4)(1997-1#2)(1997-2#2)(1997-7#1)(1997-8#3)(2004-10#1)(2004-11#1)(2004-2#2)(2005-10#1)(2005-4#1)(2005-7#1)(2006-12#2)(2006-2#1)(2006-6#3)(2006-7#1)(2006-9#1)(2007-10#2)(2007-2#4)(2007-4#1)(2007-7#4)(2007-8#9)(2007-9#1)(2008-1#3)(2008-10#13)(2008-11#2)(2008-12#4)(2008-2#3)(2008-4#1)(2008-5#5)(2008-7#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-8#4)(2011-1#9)(2011-12#1)(2011-2#6)(2011-3#1)(2012-1#4)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#3)(2013-7#4)(2013-8#6)
significantly higher total##2##3##(2008-12#1)(2008-5#1)
significantly higher under##2##3##(2008-10#2)
significantly higher values of##4##4##(2008-4#1)(2008-7#1)(2013-7#2)
significantly higher values##6##3##(1994-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-7#2)
significantly higher with the##2##4##(2007-10#1)(2007-11#1)
significantly higher with##6##3##(2006-12#1)(2007-10#1)(2007-11#1)(2008-9#1)(2009-4#1)(2010-12#1)
significantly higher##944##2##(1990-10#1)(1990-11#3)(1990-12#4)(1990-2#2)(1990-3#1)(1990-4#4)(1990-5#2)(1990-6#1)(1990-7#5)(1990-8#2)(1990-9#4)(1991-1#2)(1991-11#2)(1991-12#5)(1991-2#5)(1991-3#2)(1991-4#4)(1991-5#4)(1991-6#4)(1991-7#1)(1991-8#6)(1991-9#1)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#6)(1992-2#3)(1992-3#3)(1992-5#4)(1992-7#3)(1992-8#3)(1992-9#2)(1993-1#2)(1993-10#2)(1993-11#6)(1993-12#5)(1993-2#4)(1993-3#5)(1993-4#6)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-10#2)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#4)(1994-4#1)(1994-5#1)(1994-6#8)(1994-7#2)(1994-8#1)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#5)(1995-12#5)(1995-2#3)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-9#2)(1996-1#5)(1996-10#2)(1996-11#3)(1996-12#7)(1996-2#2)(1996-3#3)(1996-4#3)(1996-5#2)(1996-6#2)(1996-7#7)(1996-8#2)(1996-9#3)(1997-1#6)(1997-2#8)(1997-3#4)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#7)(1997-8#7)(2004-10#2)(2004-11#4)(2004-12#1)(2004-2#3)(2004-3#1)(2004-4#3)(2005-10#2)(2005-11#2)(2005-12#1)(2005-4#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#10)(2006-11#3)(2006-12#7)(2006-2#7)(2006-4#2)(2006-5#5)(2006-6#9)(2006-7#4)(2006-8#6)(2006-9#2)(2007-1#6)(2007-10#11)(2007-11#5)(2007-12#10)(2007-2#17)(2007-3#3)(2007-4#2)(2007-5#6)(2007-6#7)(2007-7#13)(2007-8#23)(2007-9#6)(2008-1#8)(2008-10#73)(2008-11#14)(2008-12#11)(2008-2#7)(2008-3#16)(2008-4#10)(2008-5#24)(2008-6#8)(2008-7#26)(2008-8#9)(2008-9#11)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#4)(2009-4#11)(2009-5#4)(2009-6#5)(2009-7#2)(2009-8#2)(2009-9#4)(2010-1#1)(2010-10#2)(2010-12#10)(2010-2#5)(2010-3#3)(2010-4#5)(2010-6#1)(2010-7#2)(2010-8#5)(2010-9#2)(2011-1#24)(2011-11#2)(2011-12#3)(2011-2#41)(2011-3#1)(2012-1#7)(2012-11#5)(2012-12#10)(2012-2#21)(2012-3#14)(2012-5#2)(2012-9#1)(2013-1#32)(2013-7#16)(2013-8#17)
significantly highest with##2##3##(2008-12#2)
significantly homologous to##3##3##(1992-6#1)(1996-4#1)(2008-9#1)
significantly if##3##2##(1993-3#1)(1997-2#1)(2008-2#1)
significantly impact on##3##3##(2008-1#1)(2013-1#2)
significantly impact##6##2##(2008-1#1)(2008-8#1)(2009-8#1)(2010-12#1)(2013-1#2)
significantly impacted##5##2##(2006-12#1)(2010-4#1)(2012-3#1)(2013-1#2)
significantly impacting the##2##3##(2012-1#1)(2013-8#1)
significantly impair the##3##3##(1990-12#1)(1996-11#1)(2011-12#1)
significantly impair##6##2##(1990-12#1)(1993-9#1)(1996-11#1)(2007-12#1)(2008-3#1)(2011-12#1)
significantly impaired in##7##3##(1993-11#1)(1994-3#1)(1996-7#1)(1997-2#1)(2006-8#1)(2008-3#1)(2009-4#1)
significantly impaired performance##2##3##(1991-2#1)(1996-1#1)
significantly impaired##20##2##(1991-2#2)(1992-12#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-3#2)(1994-8#1)(1995-2#1)(1996-1#1)(1996-7#1)(1997-2#1)(2006-8#1)(2008-10#1)(2008-3#1)(2009-4#1)(2010-11#1)(2011-1#1)(2013-1#1)
significantly improve patient##2##3##(1994-2#1)(2013-8#1)
significantly improve the clinical##2##4##(2005-7#1)(2008-8#1)
significantly improve the performance of##2##5##(1993-7#1)(2007-12#1)
significantly improve the quality##2##4##(2007-12#1)(2008-8#1)
significantly improve the##14##3##(1992-8#1)(1993-7#1)(1997-1#1)(2004-10#1)(2004-9#1)(2005-7#1)(2006-6#1)(2007-12#2)(2008-12#1)(2008-8#2)(2010-12#1)(2013-1#1)
significantly improve##32##2##(1992-8#1)(1993-7#1)(1994-2#1)(1995-2#1)(1997-1#1)(1997-5#1)(2004-10#1)(2004-9#1)(2005-7#1)(2006-6#2)(2007-11#2)(2007-12#2)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-8#1)(2010-12#2)(2012-1#1)(2013-1#3)(2013-8#1)
significantly improved by##8##3##(1995-1#1)(2005-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2011-3#1)
significantly improved compared with##2##4##(2008-3#1)(2010-7#1)
significantly improved from##2##3##(2004-3#1)(2008-3#1)
significantly improved in the##5##4##(2007-5#1)(2008-7#1)(2012-1#2)(2012-12#1)
significantly improved in##8##3##(2007-5#1)(2008-3#1)(2008-6#1)(2008-7#1)(2012-1#2)(2012-11#1)(2012-12#1)
significantly improved its##2##3##(2008-10#1)(2008-3#1)
significantly improved patient##3##3##(2008-3#1)(2013-1#2)
significantly improved patients##2##3##(2005-10#1)(2013-1#1)
significantly improved recovery##2##3##(1990-7#1)(1996-1#1)
significantly improved the performance of the##4##6##(2013-1#4)
significantly improved the quality of##2##5##(2006-6#1)(2012-12#1)
significantly improved the##24##3##(1990-10#1)(1990-9#1)(1991-4#1)(1993-11#1)(2006-6#2)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#3)(2009-2#1)(2009-9#1)(2010-12#2)(2010-4#1)(2012-12#1)(2013-1#4)
significantly improved when##2##3##(2008-2#1)(2009-5#1)
significantly improved##120##2##(1990-10#1)(1990-7#3)(1990-9#1)(1991-4#1)(1991-8#1)(1993-11#1)(1993-5#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-9#1)(1996-1#1)(2004-1#1)(2004-3#1)(2005-10#2)(2005-11#1)(2005-4#1)(2006-10#2)(2006-12#1)(2006-6#2)(2007-1#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-2#3)(2008-3#13)(2008-5#5)(2008-6#1)(2008-7#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#16)(2013-7#2)(2013-8#1)
significantly improves the##8##3##(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2013-1#2)
significantly improves##19##2##(1991-12#1)(1994-2#1)(1995-8#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#2)
significantly improving its performance##2##4##(2013-1#2)
significantly improving##6##2##(1997-3#1)(2008-2#1)(2010-5#1)(2012-12#1)(2013-1#2)
significantly in a dose-dependent manner##3##5##(1992-8#1)(2008-10#1)(2008-5#1)
significantly in a##6##3##(1992-8#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-5#2)
significantly in advanced##2##3##(2005-7#1)(2008-7#1)
significantly in all##6##3##(1996-10#1)(2007-8#1)(2008-4#1)(2008-7#1)(2011-3#1)(2012-2#1)
significantly in any of the##2##5##(1996-1#1)(2013-7#1)
significantly in both groups##4##4##(1992-10#1)(1992-3#1)(1994-7#1)(2007-11#1)
significantly in both##8##3##(1992-10#1)(1992-3#1)(1994-7#1)(2006-9#1)(2007-11#1)(2009-3#1)(2011-2#1)(2013-7#1)
significantly in males##2##3##(1993-7#2)
significantly in patients with##2##4##(2007-10#1)(2007-11#1)
significantly in rats##2##3##(2008-9#1)(2012-2#1)
significantly in response to##3##4##(1995-12#1)(2008-10#1)(2010-11#1)
significantly in the past##3##4##(2006-10#1)(2008-8#1)(2013-8#1)
significantly in the patients##2##4##(2006-8#1)(2007-7#1)
significantly in the presence of##3##5##(1993-6#1)(2008-10#1)(2008-9#1)
significantly in the##44##3##(1990-11#1)(1991-10#1)(1992-11#1)(1992-8#2)(1993-12#1)(1993-6#1)(1994-11#1)(1994-7#1)(1995-11#1)(1996-10#2)(1996-11#1)(1997-7#1)(2006-10#1)(2006-8#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
significantly in their##4##3##(2007-12#1)(2008-10#1)(2010-8#2)
significantly in##134##2##(1990-10#1)(1990-11#1)(1991-10#1)(1992-10#1)(1992-11#1)(1992-3#2)(1992-8#3)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-7#2)(1993-8#2)(1994-1#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-7#2)(1995-11#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-10#3)(1996-11#1)(1996-5#1)(1996-9#1)(1997-7#1)(2004-11#1)(2004-3#1)(2005-7#1)(2006-10#1)(2006-4#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#13)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#3)(2008-7#6)(2008-8#3)(2008-9#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-7#2)(2010-8#4)(2011-1#4)(2011-12#2)(2011-2#2)(2011-3#1)(2012-1#3)(2012-2#7)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#2)
significantly increase in##2##3##(1995-1#1)(2011-2#1)
significantly increase the incidence of##2##5##(1992-5#1)(2007-1#1)
significantly increase the overall##2##4##(1995-10#1)(2009-7#1)
significantly increase the risk of##2##5##(1995-6#1)(2007-11#1)
significantly increase the risk##3##4##(1995-6#1)(2007-11#1)(2007-7#1)
significantly increase the##28##3##(1992-5#1)(1995-10#1)(1995-6#1)(1996-5#1)(2005-12#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-9#1)(2009-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
significantly increase##46##2##(1990-11#1)(1991-10#1)(1991-12#1)(1991-9#1)(1992-5#1)(1995-1#1)(1995-10#1)(1995-6#1)(1996-5#1)(2005-10#1)(2005-12#1)(2005-9#1)(2006-12#2)(2006-5#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
significantly increased (P &lt##3##4##(1992-12#1)(1996-1#1)(1996-7#1)
significantly increased (P&lt##2##3##(2007-3#1)(2009-10#1)
significantly increased (from##2##3##(1996-11#1)(1997-5#1)
significantly increased (p &lt##5##4##(1994-6#1)(1994-9#1)(2006-8#1)(2008-4#2)
significantly increased [P &lt##2##4##(2008-4#2)
significantly increased acid secretion##2##4##(2007-1#2)
significantly increased acid##3##3##(2007-1#3)
significantly increased affinity##2##3##(1996-7#1)(2012-2#1)
significantly increased after##11##3##(1991-6#1)(1995-3#2)(2007-10#1)(2008-11#1)(2008-5#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
significantly increased and##3##3##(1996-6#1)(2005-4#1)(2008-7#1)
significantly increased arthropod##2##3##(2008-9#2)
significantly increased at##6##3##(1995-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2013-1#1)(2013-8#1)
significantly increased between##2##3##(1990-4#1)(2008-6#1)
significantly increased body weight##2##4##(2008-5#1)(2013-1#1)
significantly increased both##3##3##(1990-10#1)(2008-1#1)(2009-4#1)
significantly increased by the##3##4##(2005-11#1)(2008-4#1)(2013-1#1)
significantly increased by##34##3##(1990-2#1)(1990-5#1)(1990-7#2)(1992-3#1)(1992-8#1)(1994-5#1)(1995-12#2)(1995-3#1)(1996-11#2)(1996-12#1)(1997-5#1)(2005-11#2)(2005-8#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-8#1)(2010-3#1)(2012-2#2)(2012-6#1)(2013-1#2)
significantly increased cell##2##3##(2008-7#1)(2012-1#1)
significantly increased compared to that##2##5##(1992-12#1)(2012-1#1)
significantly increased compared to##3##4##(1992-12#1)(1997-5#1)(2012-1#1)
significantly increased compared with##4##4##(2008-4#1)(2008-5#2)(2011-2#1)
significantly increased compared##7##3##(1992-12#1)(1997-5#1)(2008-4#1)(2008-5#2)(2011-2#1)(2012-1#1)
significantly increased during the##2##4##(1992-12#1)(2008-6#1)
significantly increased during##4##3##(1992-12#2)(1995-5#1)(2008-6#1)
significantly increased for##3##3##(1993-2#1)(1996-4#1)(2010-5#1)
significantly increased from 1##2##4##(2008-10#1)(2009-11#1)
significantly increased from##13##3##(1994-3#1)(1995-2#1)(1995-6#1)(1996-4#1)(2006-12#1)(2008-10#2)(2009-11#1)(2010-7#2)(2011-2#2)(2013-1#1)
significantly increased in 256 mg/kg males at##2##7##(2008-9#2)
significantly increased in 800 mg/L##2##5##(2008-9#2)
significantly increased in all##5##4##(1995-11#1)(2008-9#3)(2010-12#1)
significantly increased in both##6##4##(1994-11#1)(1994-3#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-9#1)
significantly increased in comparison##2##4##(2007-1#1)(2008-12#1)
significantly increased in patients with##2##5##(2007-11#1)(2012-11#1)
significantly increased in patients##4##4##(1997-8#1)(2007-11#1)(2007-8#1)(2012-11#1)
significantly increased in the patients##2##5##(1997-8#1)(2010-4#1)
significantly increased in the##28##4##(1990-2#1)(1991-8#1)(1992-11#1)(1993-2#1)(1993-8#1)(1995-12#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-6#1)(2006-9#2)(2007-10#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-10#1)(2010-4#1)(2012-6#1)(2013-8#1)
significantly increased in these##2##4##(1994-12#1)(2007-2#1)
significantly increased in those##2##4##(2008-11#1)(2011-2#1)
significantly increased in##112##3##(1990-12#2)(1990-2#2)(1991-12#1)(1991-2#1)(1991-8#2)(1992-11#1)(1992-7#1)(1993-2#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#2)(2005-12#1)(2006-10#1)(2006-6#1)(2006-8#2)(2006-9#3)(2007-1#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-10#5)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#22)(2009-10#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#2)(2011-2#3)(2012-1#1)(2012-11#2)(2012-2#1)(2012-6#1)(2013-1#1)(2013-8#2)
significantly increased incidences of##5##4##(2008-9#5)
significantly increased incidences##7##3##(2008-9#7)
significantly increased levels of##4##4##(1991-5#1)(1992-1#1)(1995-12#1)(2009-5#1)
significantly increased locomotion##2##3##(1993-6#2)
significantly increased number of##2##4##(1995-6#1)(2008-12#1)
significantly increased on day##3##4##(1994-5#2)(2004-11#1)
significantly increased on##4##3##(1993-12#1)(1994-5#2)(2004-11#1)
significantly increased only##2##3##(1997-4#1)(2012-1#1)
significantly increased over##2##3##(2008-10#1)(2012-2#1)
significantly increased plasma##4##3##(1994-11#1)(1997-8#1)(2008-3#1)(2008-7#1)
significantly increased platelet##2##3##(1990-12#1)(1992-9#1)
significantly increased resistance to M##2##5##(2008-10#2)
significantly increased response##2##3##(1992-11#1)(2010-8#1)
significantly increased risk for##2##4##(2008-11#1)(2012-11#1)
significantly increased risk of##5##4##(1992-10#1)(2005-10#1)(2008-1#1)(2011-2#1)(2013-1#1)
significantly increased risk##8##3##(1992-10#1)(1994-2#1)(2005-10#1)(2008-1#1)(2008-11#1)(2011-2#1)(2012-11#1)(2013-1#1)
significantly increased the activity of##2##5##(1990-4#1)(2008-3#1)
significantly increased the activity##3##4##(1990-4#1)(1993-9#1)(2008-3#1)
significantly increased the final##2##4##(2007-11#1)(2008-10#1)
significantly increased the frequency##2##4##(1995-9#1)(2010-3#1)
significantly increased the levels of##2##5##(2012-2#1)(2012-3#1)
significantly increased the maximum loads and yield points and reduced the stiffness coefficients in the femurs of female rats with osteoporosis caused by bilateral oophorectomy##2##25##(2013-1#2)
significantly increased the maximum##4##4##(2013-1#4)
significantly increased the number of errors (attempts to pass through two incorrect panels of the three##2##16##(1993-12#1)(1993-3#1)
significantly increased the number of metastatic nodules##2##7##(1993-7#2)
significantly increased the number of working memory errors##2##8##(1993-3#1)(1996-12#1)
significantly increased the number of##11##5##(1991-11#1)(1992-4#1)(1993-12#1)(1993-3#2)(1993-7#2)(1996-12#1)(2008-10#1)(2008-6#1)(2012-3#1)
significantly increased the proportion of##2##5##(1990-5#1)(2007-11#1)
significantly increased the rate of##2##5##(2006-3#1)(2010-8#1)
significantly increased the sensitivity of##3##5##(1997-4#1)(1997-7#1)(2005-11#1)
significantly increased the##79##3##(1990-3#1)(1990-4#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-2#1)(1992-12#1)(1992-4#2)(1992-5#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-7#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-2#2)(1994-5#1)(1994-6#2)(1995-1#2)(1995-12#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-8#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-11#1)(2005-11#1)(2006-3#1)(2006-5#2)(2007-11#2)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#5)
significantly increased their##3##3##(2006-2#1)(2008-11#1)(2013-1#1)
significantly increased this##2##3##(1994-12#1)(1995-3#1)
significantly increased to##2##3##(1997-1#1)(1997-7#1)
significantly increased total##2##3##(2005-8#1)(2008-12#1)
significantly increased when##4##3##(1992-1#1)(1992-12#1)(1993-3#1)(1994-3#1)
significantly increased with the##2##4##(1993-9#1)(2007-10#1)
significantly increased with##3##3##(1993-9#1)(2007-10#1)(2013-1#1)
significantly increased##531##2##(1990-10#1)(1990-12#3)(1990-2#4)(1990-3#1)(1990-4#2)(1990-5#2)(1990-7#3)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-5#6)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#6)(1992-3#2)(1992-4#2)(1992-5#1)(1992-7#3)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#3)(1993-3#5)(1993-6#2)(1993-7#3)(1993-8#2)(1993-9#2)(1994-10#3)(1994-11#4)(1994-12#2)(1994-2#4)(1994-3#4)(1994-5#5)(1994-6#5)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#4)(1995-12#14)(1995-2#5)(1995-3#6)(1995-5#1)(1995-6#2)(1995-7#2)(1995-8#1)(1995-9#2)(1996-1#2)(1996-11#3)(1996-12#4)(1996-2#2)(1996-3#5)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#7)(1997-3#2)(1997-4#3)(1997-5#4)(1997-6#3)(1997-7#5)(1997-8#3)(2004-1#1)(2004-11#3)(2004-4#1)(2005-10#2)(2005-11#3)(2005-12#1)(2005-4#1)(2005-8#5)(2006-10#1)(2006-12#2)(2006-2#1)(2006-3#2)(2006-5#4)(2006-6#1)(2006-8#4)(2006-9#3)(2007-1#4)(2007-10#5)(2007-11#7)(2007-2#2)(2007-3#1)(2007-6#2)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#30)(2008-11#11)(2008-12#9)(2008-2#2)(2008-3#4)(2008-4#16)(2008-5#16)(2008-6#6)(2008-7#9)(2008-8#4)(2008-9#43)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#3)(2009-4#4)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#5)(2010-2#2)(2010-3#2)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#2)(2011-2#13)(2012-1#5)(2012-11#4)(2012-12#4)(2012-2#9)(2012-3#4)(2012-4#1)(2012-6#2)(2013-1#20)(2013-8#3)
significantly increases the risk of##4##5##(1992-4#1)(2011-2#2)(2012-12#1)
significantly increases the##22##3##(1990-8#1)(1992-4#1)(1994-9#2)(1995-5#1)(2006-10#1)(2007-11#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-9#2)(2009-4#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)
significantly increases##36##2##(1990-8#1)(1992-4#1)(1994-9#2)(1995-5#1)(1996-3#1)(2006-10#1)(2007-11#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#1)(2010-1#1)(2010-11#1)(2010-3#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)
significantly increasing the##4##3##(2008-3#1)(2010-9#1)(2012-2#2)
significantly increasing##8##2##(1991-4#1)(1997-8#1)(2008-3#1)(2010-9#1)(2012-12#1)(2012-2#3)
significantly induced in##2##3##(2008-10#1)(2008-9#1)
significantly induced the##2##3##(2011-10#1)(2011-3#1)
significantly induced##13##2##(1992-5#1)(1996-2#1)(2006-9#1)(2008-10#3)(2008-9#1)(2009-4#1)(2011-10#2)(2011-12#1)(2011-3#1)(2013-8#1)
significantly inferior to##3##3##(1993-1#1)(1993-5#1)(2010-3#1)
significantly influence the##20##3##(1990-3#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-8#1)(1995-1#1)(1995-12#1)(2004-2#1)(2007-1#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-6#1)
significantly influence##30##2##(1990-3#1)(1991-2#2)(1992-12#1)(1992-9#1)(1993-1#1)(1993-8#1)(1995-1#1)(1995-12#1)(1997-2#1)(2004-11#1)(2004-2#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-6#1)(2010-10#1)(2010-7#1)(2012-2#1)
significantly influenced by the##15##4##(1990-11#1)(1990-8#1)(1992-5#1)(2005-7#1)(2006-12#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-8#1)(2010-4#1)(2011-2#2)(2012-11#2)
significantly influenced by##26##3##(1990-11#1)(1990-8#1)(1991-2#1)(1992-5#1)(1996-10#1)(1996-9#1)(2005-11#1)(2005-7#1)(2006-12#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-2#1)
significantly influenced the##11##3##(1992-2#1)(1995-1#1)(1995-5#1)(2005-11#1)(2006-11#1)(2008-10#1)(2009-5#2)(2009-8#1)(2010-2#1)(2013-8#1)
significantly influenced##46##2##(1990-11#1)(1990-3#1)(1990-8#1)(1991-2#1)(1992-2#1)(1992-5#1)(1993-6#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-10#1)(1996-5#1)(1996-9#1)(2005-11#2)(2005-7#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-5#2)(2009-7#1)(2009-8#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-2#1)(2013-8#2)
significantly influences the##2##3##(2007-12#1)(2009-5#1)
significantly influences##8##2##(1990-8#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2009-5#1)
significantly influencing the##2##3##(1997-5#1)(2008-4#1)
significantly inhibit cell##2##3##(2008-11#1)(2013-8#1)
significantly inhibit the##9##3##(1990-10#1)(1991-11#1)(1992-7#1)(1993-12#1)(1996-10#1)(2007-1#1)(2008-5#1)(2011-11#1)(2012-2#1)
significantly inhibit##21##2##(1990-10#1)(1991-11#1)(1991-8#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-12#1)(1996-10#1)(1997-4#1)(1997-8#1)(2007-1#1)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#2)(2011-11#1)(2012-2#2)(2013-8#1)
significantly inhibited by the##2##4##(1990-7#1)(1993-7#1)
significantly inhibited by##15##3##(1990-7#1)(1992-3#1)(1993-7#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-3#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-4#1)(2013-8#1)
significantly inhibited in the##4##4##(1992-3#1)(1994-3#1)(1996-5#1)(1997-1#1)
significantly inhibited in vitro fertilization of##2##6##(1994-12#1)(1995-6#1)
significantly inhibited in##9##3##(1992-1#1)(1992-3#1)(1994-12#1)(1994-3#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-1#1)(2010-8#1)
significantly inhibited proliferation##2##3##(1995-2#1)(2011-2#1)
significantly inhibited the##28##3##(1990-11#1)(1990-2#1)(1990-5#1)(1991-9#1)(1992-11#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-2#2)(1995-12#1)(1996-10#1)(1996-12#1)(1996-8#1)(1997-4#1)(1997-8#1)(2006-9#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#2)(2011-2#2)
significantly inhibited##101##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-7#2)(1991-1#1)(1991-5#2)(1991-7#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-7#2)(1993-9#2)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#2)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#2)(1995-6#1)(1995-8#2)(1996-10#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-8#1)(2005-11#1)(2006-9#1)(2007-11#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#1)
significantly inhibiting##2##2##(1990-6#1)(1997-2#1)
significantly inhibits##2##2##(2008-10#1)(2013-1#1)
significantly inversely correlated with##2##4##(1995-2#1)(2007-8#1)
significantly involved in##4##3##(2008-1#1)(2008-7#1)(2010-3#1)(2011-2#1)
significantly larger (P &lt##2##4##(1994-5#1)(2008-10#1)
significantly larger areas##2##3##(2006-4#1)(2013-7#1)
significantly larger for##4##3##(1991-8#1)(2005-10#1)(2007-12#1)(2008-2#1)
significantly larger in the group of subjects with PD##2##9##(2008-7#2)
significantly larger in the group of##3##6##(1997-7#1)(2008-7#2)
significantly larger in the##7##4##(1991-8#2)(1993-7#1)(1997-7#1)(2008-7#2)(2011-1#1)
significantly larger in##13##3##(1991-8#2)(1993-7#1)(1997-7#2)(2007-10#1)(2007-8#1)(2008-5#1)(2008-7#2)(2011-1#1)(2012-3#1)(2013-8#1)
significantly larger than for##2##4##(1997-1#1)(2006-3#1)
significantly larger than that of##2##5##(1993-2#1)(2009-2#1)
significantly larger than that##5##4##(1990-7#1)(1993-2#1)(2008-2#1)(2008-9#1)(2009-2#1)
significantly larger than those##2##4##(1994-11#1)(2011-2#1)
significantly larger than##14##3##(1990-7#1)(1991-9#1)(1993-2#1)(1994-11#1)(1995-3#1)(1997-1#1)(2005-11#1)(2006-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-2#1)(2011-2#1)
significantly larger when##2##3##(1993-7#1)(2007-12#1)
significantly larger##59##2##(1990-7#1)(1991-8#3)(1991-9#1)(1992-3#3)(1993-11#1)(1993-2#1)(1993-7#2)(1994-11#1)(1994-3#1)(1994-4#1)(1994-5#1)(1995-2#1)(1995-3#1)(1997-1#1)(1997-7#2)(2005-10#1)(2005-11#1)(2006-3#1)(2006-4#1)(2007-10#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-7#1)(2013-8#1)
significantly later##2##2##(1992-2#1)(2007-8#1)
significantly less active than the##2##5##(1992-6#1)(2008-5#1)
significantly less disease##5##3##(2008-10#5)
significantly less effective in##2##4##(2008-10#2)
significantly less frequent in##2##4##(2011-2#2)
significantly less frequent##5##3##(1995-2#1)(1997-1#1)(2007-8#1)(2011-2#2)
significantly less frequently##2##3##(2008-12#1)(2011-2#1)
significantly less in Group##2##4##(2010-7#2)
significantly less in LP group##2##5##(2009-6#2)
significantly less in##16##3##(1992-5#1)(1994-10#1)(1994-8#1)(1996-3#1)(2005-8#1)(2006-12#1)(2006-6#1)(2007-6#1)(2008-10#2)(2009-6#2)(2010-7#2)(2012-2#2)
significantly less likely than##2##4##(1995-12#1)(2004-12#1)
significantly less likely##5##3##(1995-12#1)(2004-12#1)(2007-11#1)(2013-1#2)
significantly less than in either##2##5##(1996-3#1)(2008-10#1)
significantly less than in##5##4##(1992-9#1)(1995-12#1)(1996-3#1)(2008-10#2)
significantly less than that##6##4##(1990-4#1)(1991-2#1)(1994-12#1)(1997-4#1)(1997-6#1)(2004-11#1)
significantly less than the##6##4##(2008-10#1)(2008-8#1)(2009-6#1)(2009-7#1)(2011-2#1)(2012-2#1)
significantly less than those of##14##5##(1991-11#1)(1995-10#1)(2008-9#12)
significantly less than those##15##4##(1991-11#1)(1995-10#1)(2007-9#1)(2008-9#12)
significantly less than##41##3##(1990-4#1)(1991-11#1)(1991-2#1)(1992-9#1)(1994-12#1)(1995-10#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-4#1)(1997-6#1)(2004-11#1)(2006-10#1)(2007-9#1)(2008-10#6)(2008-7#1)(2008-8#1)(2008-9#12)(2009-5#1)(2009-6#1)(2009-7#1)(2011-2#1)(2012-2#2)
significantly less toxic than##2##4##(2008-8#1)(2013-1#1)
significantly less when##2##3##(1995-12#1)(2007-9#1)
significantly less##160##2##(1990-2#1)(1990-4#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-2#2)(1992-2#1)(1992-3#1)(1992-5#3)(1992-6#2)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-4#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#1)(2004-11#2)(2004-12#1)(2004-3#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-6#2)(2006-9#1)(2007-11#1)(2007-12#2)(2007-6#2)(2007-7#1)(2007-8#3)(2007-9#4)(2008-1#1)(2008-10#30)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#13)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-2#6)(2012-12#1)(2012-2#7)(2013-1#4)(2013-8#1)
significantly lesser##4##2##(1993-9#1)(1994-6#1)(2009-6#1)(2010-7#1)
significantly limited##2##2##(2007-11#1)(2010-12#1)
significantly longer and##2##3##(1997-8#1)(2006-4#1)
significantly longer in patients##4##4##(1995-6#1)(2007-11#1)(2009-4#1)(2012-2#1)
significantly longer in the##9##4##(1990-3#1)(2006-6#1)(2007-2#1)(2007-8#3)(2009-4#1)(2010-2#1)(2011-2#1)
significantly longer in##18##3##(1990-3#1)(1990-6#1)(1994-2#1)(1995-6#1)(1996-5#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-8#3)(2008-5#1)(2009-4#2)(2010-2#1)(2010-4#1)(2011-2#1)(2012-2#1)
significantly longer survival##2##3##(1996-6#1)(2011-2#1)
significantly longer than for##2##4##(1990-3#1)(2006-8#1)
significantly longer than the##3##4##(2008-10#1)(2010-3#1)(2013-8#1)
significantly longer than##12##3##(1990-3#1)(1994-11#1)(1995-5#1)(2004-11#2)(2006-6#1)(2006-7#1)(2006-8#1)(2008-10#1)(2009-10#1)(2010-3#1)(2013-8#1)
significantly longer##57##2##(1990-3#2)(1990-6#1)(1993-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-8#1)(2004-11#2)(2006-10#1)(2006-4#2)(2006-6#3)(2006-7#1)(2006-8#3)(2007-11#2)(2007-2#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-10#2)(2009-4#2)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-8#1)
significantly low in##4##3##(1994-8#1)(2007-6#1)(2012-2#1)(2013-8#1)
significantly low##11##2##(1994-8#2)(2007-12#1)(2007-6#1)(2008-2#1)(2012-2#3)(2012-3#1)(2013-8#2)
significantly lower (P &lt##3##4##(1993-12#1)(1996-9#1)(2009-5#1)
significantly lower (P less than 0##3##6##(1991-3#1)(1992-4#2)
significantly lower (P##7##3##(1991-3#1)(1992-4#2)(1993-12#1)(1996-9#1)(2008-10#1)(2009-5#1)
significantly lower among white##2##4##(2012-12#2)
significantly lower among##8##3##(2004-12#1)(2006-10#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-8#1)
significantly lower amounts##2##3##(1994-2#1)(2008-10#1)
significantly lower as compared with##2##5##(2006-6#2)
significantly lower at##8##3##(2007-8#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)
significantly lower body##2##3##(2013-8#2)
significantly lower compared to##2##4##(1995-10#1)(2009-3#1)
significantly lower compared with##3##4##(2007-10#1)(2011-2#2)
significantly lower compared##5##3##(1995-10#1)(2007-10#1)(2009-3#1)(2011-2#2)
significantly lower disease severity##2##4##(2008-10#2)
significantly lower disease##3##3##(2008-10#3)
significantly lower doses##2##3##(2008-1#1)(2012-12#1)
significantly lower expenditures for##2##4##(1994-2#1)(2009-9#1)
significantly lower flux##2##3##(2008-7#2)
significantly lower for the##3##4##(2006-7#1)(2008-7#1)(2009-9#1)
significantly lower for##12##3##(1990-12#2)(1993-11#1)(2006-10#1)(2006-7#1)(2008-10#4)(2008-7#1)(2009-9#1)(2011-2#1)
significantly lower fraction of##2##4##(1991-11#2)
significantly lower in PE##2##4##(1995-9#2)
significantly lower in children##2##4##(2005-8#1)(2008-5#1)
significantly lower in gamblers##2##4##(2008-3#2)
significantly lower in group##2##4##(1990-9#1)(2007-8#1)
significantly lower in patients with##8##5##(1990-2#1)(1997-7#1)(2005-8#1)(2007-10#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-3#1)
significantly lower in patients##10##4##(1990-2#1)(1995-11#1)(1997-7#1)(2005-8#1)(2007-10#1)(2008-7#1)(2009-6#1)(2011-1#1)(2012-1#1)(2012-3#1)
significantly lower in the preoperative##3##5##(1997-1#2)(2007-9#1)
significantly lower in the##31##4##(1990-3#1)(1993-10#1)(1993-7#1)(1993-9#1)(1994-4#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-3#1)(1997-1#2)(1997-2#1)(2007-1#1)(2007-10#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-6#1)(2009-8#1)(2012-2#1)(2013-7#3)(2013-8#2)
significantly lower in women##3##4##(1991-8#1)(1992-3#1)(2009-11#1)
significantly lower in##96##3##(1990-2#3)(1990-3#1)(1990-9#1)(1991-12#2)(1991-8#1)(1992-2#1)(1992-3#1)(1993-10#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-4#1)(1995-10#1)(1995-11#2)(1995-5#1)(1995-7#2)(1995-9#3)(1996-1#1)(1996-3#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-6#2)(1997-7#1)(2005-8#3)(2007-1#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-12#2)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#3)(2013-8#2)
significantly lower incidence of postoperative##2##5##(1990-12#1)(2007-8#1)
significantly lower incidence of##7##4##(1990-12#1)(2005-9#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#1)
significantly lower incidence##8##3##(1990-12#1)(1992-9#1)(2005-9#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#1)
significantly lower level##5##3##(1992-11#1)(1997-3#1)(2007-9#1)(2008-11#1)(2013-7#1)
significantly lower levels of##9##4##(1992-8#1)(1995-2#1)(1996-1#1)(2005-10#1)(2008-10#1)(2010-6#1)(2012-1#1)(2013-1#1)(2013-8#1)
significantly lower levels##11##3##(1991-8#1)(1992-8#1)(1993-3#1)(1995-2#1)(1996-1#1)(2005-10#1)(2008-10#1)(2010-6#1)(2012-1#1)(2013-1#1)(2013-8#1)
significantly lower mean values of##2##5##(1990-2#1)(1991-12#1)
significantly lower mean##4##3##(1990-2#1)(1991-12#1)(2008-4#1)(2013-1#1)
significantly lower numbers of##2##4##(1990-5#1)(2008-10#1)
significantly lower odds##2##3##(2008-3#1)(2012-3#1)
significantly lower on##5##3##(1990-9#1)(2008-10#1)(2010-8#3)
significantly lower plasma##2##3##(1992-4#1)(2008-7#1)
significantly lower scores than the##2##5##(2010-10#1)(2013-8#1)
significantly lower scores##5##3##(1995-11#1)(2010-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
significantly lower survival##2##3##(2007-9#1)(2012-3#1)
significantly lower than for##2##4##(1993-5#1)(2006-2#1)
significantly lower than in control subjects##2##6##(1991-11#1)(1996-7#1)
significantly lower than in control##4##5##(1991-11#1)(1996-7#1)(2007-10#1)(2010-1#1)
significantly lower than in patients with##3##6##(1993-2#1)(2006-11#1)(2007-3#1)
significantly lower than in patients##4##5##(1993-2#1)(2006-11#1)(2007-3#1)(2008-7#1)
significantly lower than in the controls##2##6##(1995-8#1)(2010-12#1)
significantly lower than in the##13##5##(1995-11#1)(1995-8#1)(1996-2#1)(1997-2#2)(2006-9#1)(2007-10#1)(2007-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)
significantly lower than in##32##4##(1990-11#1)(1991-11#2)(1992-7#1)(1993-2#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-2#2)(1997-3#1)(2006-11#1)(2006-9#1)(2007-10#2)(2007-3#1)(2007-5#1)(2008-10#2)(2008-7#3)(2008-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
significantly lower than that in the##5##6##(1995-4#1)(1995-8#1)(1996-11#1)(2008-2#1)(2012-2#1)
significantly lower than that in##8##5##(1991-3#1)(1995-4#1)(1995-8#1)(1996-11#1)(2005-4#1)(2008-2#1)(2012-2#1)(2013-1#1)
significantly lower than that obtained##2##5##(2007-1#1)(2009-10#1)
significantly lower than that of##10##5##(1990-8#1)(1994-8#1)(2004-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-4#1)(2011-1#1)(2012-2#1)(2012-3#1)
significantly lower than that##26##4##(1990-8#1)(1991-3#1)(1993-11#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-4#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#1)(2004-8#1)(2005-4#1)(2007-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-4#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
significantly lower than the calculated##2##5##(2008-10#2)
significantly lower than the normal##2##5##(2004-11#1)(2008-10#1)
significantly lower than the##20##4##(1990-7#1)(1991-11#1)(1994-7#1)(1995-7#1)(1996-12#1)(2004-11#1)(2005-8#1)(2006-9#1)(2008-10#4)(2008-5#2)(2008-7#2)(2010-12#1)(2010-7#1)(2012-2#1)(2013-1#1)
significantly lower than those in Group##2##6##(2007-2#1)(2013-1#1)
significantly lower than those in the control##4##7##(1997-1#1)(2007-8#1)(2011-2#1)(2013-8#1)
significantly lower than those in the##5##6##(1997-1#1)(2007-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
significantly lower than those in##10##5##(1990-12#1)(1990-3#1)(1997-1#1)(2005-4#1)(2007-2#1)(2007-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
significantly lower than those of##9##5##(1990-3#1)(1997-3#1)(2004-9#1)(2007-2#1)(2007-3#1)(2008-10#2)(2008-12#1)(2011-2#1)
significantly lower than those##22##4##(1990-12#1)(1990-3#2)(1997-1#1)(1997-3#1)(2004-9#1)(2005-4#1)(2007-10#1)(2007-2#2)(2007-3#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-8#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
significantly lower than##117##3##(1990-11#1)(1990-12#1)(1990-3#2)(1990-7#1)(1990-8#1)(1991-11#3)(1991-3#1)(1991-9#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-7#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#2)(2004-11#1)(2004-8#1)(2004-9#1)(2005-4#2)(2005-8#1)(2006-11#1)(2006-2#1)(2006-9#2)(2007-1#1)(2007-10#3)(2007-2#3)(2007-3#2)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#11)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#2)(2010-1#1)(2010-12#2)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#2)
significantly lower values of##2##4##(2006-11#1)(2008-12#1)
significantly lower values##4##3##(2006-11#1)(2007-9#1)(2008-12#1)(2008-7#1)
significantly lower##461##2##(1990-11#1)(1990-12#4)(1990-2#4)(1990-3#3)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-11#5)(1991-12#4)(1991-3#2)(1991-6#1)(1991-8#4)(1991-9#3)(1992-11#2)(1992-2#1)(1992-3#2)(1992-4#3)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-10#1)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#2)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-4#1)(1994-6#2)(1994-7#1)(1994-8#1)(1995-10#2)(1995-11#5)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#2)(1995-7#3)(1995-8#2)(1995-9#3)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-7#2)(1996-9#2)(1997-1#5)(1997-2#6)(1997-3#3)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2004-11#2)(2004-12#3)(2004-8#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-4#2)(2005-8#4)(2005-9#1)(2006-10#6)(2006-11#4)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#2)(2006-9#3)(2007-1#3)(2007-10#9)(2007-11#3)(2007-12#2)(2007-2#7)(2007-3#2)(2007-5#2)(2007-7#1)(2007-8#12)(2007-9#7)(2008-1#3)(2008-10#48)(2008-11#5)(2008-12#4)(2008-2#4)(2008-3#6)(2008-4#8)(2008-5#10)(2008-6#1)(2008-7#15)(2008-8#6)(2008-9#4)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-12#6)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#8)(2011-11#2)(2011-2#15)(2012-1#3)(2012-12#8)(2012-2#9)(2012-3#7)(2013-1#16)(2013-7#5)(2013-8#13)
significantly lowered (P &lt##2##4##(2009-6#1)(2013-1#1)
significantly lowered in##3##3##(2006-8#1)(2010-5#1)(2011-2#1)
significantly lowered##19##2##(1992-8#1)(1994-6#1)(1994-8#1)(2006-8#2)(2007-11#1)(2007-6#1)(2007-8#2)(2008-11#1)(2008-5#1)(2009-6#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#1)
significantly lowers##2##2##(1996-2#1)(2007-7#1)
significantly moderated the##3##3##(2008-8#1)(2010-3#1)(2012-2#1)
significantly modified by##2##3##(1991-9#1)(2013-1#1)
significantly modified the relationship between##2##5##(2009-7#2)
significantly modified the##3##3##(2008-10#1)(2009-7#2)
significantly modified##15##2##(1991-9#1)(1995-12#1)(1995-2#1)(1997-3#1)(1997-7#1)(2006-10#2)(2008-10#3)(2008-5#1)(2009-2#1)(2009-7#2)(2013-1#1)
significantly modify the##3##3##(1994-5#1)(2008-8#1)(2011-10#1)
significantly modify##4##2##(1994-5#1)(1996-12#1)(2008-8#1)(2011-10#1)
significantly more abundant in##2##4##(2007-6#1)(2008-8#1)
significantly more abundant##3##3##(2007-6#1)(2008-10#1)(2008-8#1)
significantly more accurate##3##3##(2008-3#1)(2013-1#2)
significantly more activation##2##3##(1997-7#1)(2012-12#1)
significantly more active##5##3##(1995-1#1)(1996-7#1)(2008-5#1)(2012-11#2)
significantly more agency attributes##2##4##(2008-7#2)
significantly more alate##2##3##(2011-12#2)
significantly more and##3##3##(1990-8#1)(2007-2#1)(2012-2#1)
significantly more attractive than the##2##5##(2004-2#1)(2008-10#1)
significantly more attractive than##3##4##(2004-2#1)(2007-12#1)(2008-10#1)
significantly more common among##3##4##(2006-10#1)(2011-1#1)(2012-3#1)
significantly more common in##7##4##(2007-9#1)(2008-7#2)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)
significantly more common##11##3##(2006-10#1)(2007-9#1)(2008-6#1)(2008-7#2)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
significantly more communion attributes##2##4##(2008-7#2)
significantly more difficult##4##3##(2006-12#1)(2007-12#1)(2007-6#1)(2010-12#1)
significantly more disabled##2##3##(2007-10#1)(2013-8#1)
significantly more effective at##2##4##(2008-10#1)(2008-5#1)
significantly more effective than placebo and as effective as##2##9##(2007-11#2)
significantly more effective than placebo in the##2##7##(2007-11#1)(2008-3#1)
significantly more effective than placebo in##3##6##(2007-11#1)(2008-3#2)
significantly more effective than placebo##5##5##(2007-11#3)(2008-3#2)
significantly more effective than##11##4##(2005-7#1)(2006-5#1)(2007-11#4)(2008-10#1)(2008-3#2)(2010-12#1)(2011-12#1)
significantly more effective##17##3##(1992-2#1)(1995-7#1)(2005-7#1)(2006-5#1)(2007-11#4)(2008-10#3)(2008-3#2)(2008-5#1)(2010-12#1)(2011-12#1)(2013-1#1)
significantly more efficient##3##3##(2008-10#2)(2011-2#1)
significantly more efficiently than##2##4##(2011-2#1)(2012-2#1)
significantly more females##2##3##(2008-1#1)(2010-4#1)
significantly more frequent among##2##4##(1990-6#1)(1991-5#1)
significantly more frequent in##5##4##(1990-4#1)(1997-1#1)(2007-8#2)(2011-1#1)
significantly more frequent than##3##4##(1994-3#1)(2004-1#1)(2012-2#1)
significantly more frequent##13##3##(1990-4#1)(1990-6#1)(1991-5#1)(1994-3#1)(1997-1#2)(2004-1#1)(2007-8#2)(2008-1#1)(2011-1#1)(2012-2#1)(2013-1#1)
significantly more frequently than##3##4##(1996-11#1)(2011-1#1)(2012-12#1)
significantly more frequently##7##3##(1991-3#1)(1991-5#1)(1996-11#2)(2008-5#1)(2011-1#1)(2012-12#1)
significantly more in group##2##4##(2011-12#2)
significantly more in group-I than in group-II (p &lt##2##9##(2007-6#2)
significantly more in patients##2##4##(1992-12#1)(2007-2#1)
significantly more in##9##3##(1992-12#1)(2007-2#1)(2007-6#2)(2007-7#1)(2008-1#1)(2011-12#2)(2012-2#1)
significantly more knowledgeable than##3##4##(2006-2#1)(2007-3#1)(2007-9#1)
significantly more likely to be##3##5##(2008-2#1)(2010-7#1)(2011-1#1)
significantly more likely to have##6##5##(2006-7#1)(2007-11#1)(2008-7#1)(2010-12#1)(2010-9#1)(2012-3#1)
significantly more likely to report##2##5##(1997-8#1)(2009-5#1)
significantly more likely to##23##4##(1997-8#2)(2006-7#1)(2007-1#1)(2007-11#1)(2007-7#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-7#2)(2010-9#1)(2011-1#2)(2012-3#3)
significantly more likely##29##3##(1997-8#2)(2004-12#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-7#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#2)(2010-9#1)(2011-1#4)(2012-3#3)(2013-1#2)
significantly more new##2##3##(2008-5#1)(2012-2#1)
significantly more often than##5##4##(1992-2#1)(1996-12#1)(2011-12#2)(2013-8#1)
significantly more often##10##3##(1992-2#1)(1996-12#1)(1997-3#1)(2007-2#1)(2007-7#1)(2011-12#2)(2011-2#1)(2013-8#2)
significantly more patients##3##3##(1990-5#1)(1991-2#1)(2007-3#1)
significantly more positive##3##3##(2006-8#1)(2007-10#1)(2008-8#1)
significantly more potent than##2##4##(1991-5#1)(1994-10#1)
significantly more potent##6##3##(1991-5#1)(1994-10#1)(1995-1#1)(1997-5#1)(1997-7#1)(2008-7#1)
significantly more pronounced##5##3##(1992-6#1)(2006-7#2)(2010-4#1)(2011-2#1)
significantly more recommended##2##3##(2010-2#2)
significantly more resistant to##5##4##(1992-11#1)(1993-12#1)(1995-6#1)(2008-10#1)(2009-4#1)
significantly more resistant##6##3##(1992-11#1)(1993-12#1)(1995-6#1)(2008-10#1)(2008-5#1)(2009-4#1)
significantly more satisfied with their life##2##6##(2007-1#2)
significantly more satisfied with their##4##5##(1993-3#1)(2007-1#2)(2007-2#1)
significantly more sensitive than##3##4##(1991-9#1)(1997-4#1)(2008-10#1)
significantly more sensitive##5##3##(1990-3#1)(1991-9#1)(1993-9#1)(1997-4#1)(2008-10#1)
significantly more severe##2##3##(2007-7#1)(2008-10#1)
significantly more slowly##2##3##(1994-8#1)(2007-12#1)
significantly more than did##2##4##(2008-10#1)(2009-11#1)
significantly more than##9##3##(1992-4#1)(1997-7#1)(2007-5#1)(2008-10#2)(2008-2#1)(2009-11#1)(2011-2#2)
significantly more variable##4##3##(2008-3#1)(2008-9#1)(2012-12#2)
significantly more weight than##2##4##(2006-6#1)(2012-2#1)
significantly more##330##2##(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-4#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-7#1)(1993-9#2)(1994-10#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-1#3)(1995-11#2)(1995-12#1)(1995-3#1)(1995-4#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-10#2)(1996-11#2)(1996-12#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#2)(1997-7#3)(1997-8#2)(2004-1#2)(2004-12#1)(2004-2#2)(2005-11#1)(2005-7#2)(2005-9#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#6)(2006-8#8)(2007-1#5)(2007-10#4)(2007-11#6)(2007-12#8)(2007-2#4)(2007-3#3)(2007-5#1)(2007-6#4)(2007-7#5)(2007-8#3)(2007-9#3)(2008-1#3)(2008-10#33)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#10)(2008-8#3)(2008-9#3)(2009-10#2)(2009-11#2)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#3)(2010-12#4)(2010-2#5)(2010-3#1)(2010-4#4)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#9)(2011-12#8)(2011-2#10)(2012-1#3)(2012-11#2)(2012-12#6)(2012-2#8)(2012-3#5)(2013-1#8)(2013-8#5)
significantly narrowed##3##2##(2006-11#1)(2007-12#1)(2012-12#1)
significantly negative##5##2##(2007-2#2)(2008-5#1)(2010-8#1)(2011-2#1)
significantly negatively correlated with##4##4##(1994-2#1)(2012-3#1)(2013-8#2)
significantly negatively##5##2##(1994-2#1)(2010-1#1)(2012-3#1)(2013-8#2)
significantly new##2##2##(2006-12#1)(2006-5#1)
significantly observed##3##2##(1996-8#1)(2008-10#1)(2008-11#1)
significantly older than patients##2##4##(2007-3#1)(2011-2#1)
significantly older than##3##3##(2007-3#1)(2007-8#1)(2011-2#1)
significantly older##6##2##(1996-9#1)(2007-3#1)(2007-8#2)(2010-11#1)(2011-2#1)
significantly on the##5##3##(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)
significantly on##17##2##(1991-12#1)(1991-3#1)(1992-3#1)(2006-8#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-4#1)(2009-9#1)(2010-5#1)(2011-1#1)(2012-2#1)
significantly only##5##2##(2006-6#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-7#1)
significantly or##2##2##(1993-9#1)(2013-1#1)
significantly outperform##2##2##(2008-3#1)(2012-3#1)
significantly over the past##2##4##(2006-10#1)(2013-8#1)
significantly over the##4##3##(2006-10#1)(2008-6#1)(2012-12#1)(2013-8#1)
significantly over time##6##3##(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)(2011-3#1)(2013-8#1)
significantly over##11##2##(2006-10#1)(2008-10#1)(2008-6#2)(2008-7#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-8#2)
significantly over-represented##2##2##(2009-8#1)(2011-1#1)
significantly overestimated##2##2##(1995-2#1)(2010-8#1)
significantly overrepresented##2##2##(1995-8#1)(2007-7#1)
significantly poorer prognosis##2##3##(1991-2#1)(1993-9#1)
significantly poorer##9##2##(1991-2#1)(1993-9#1)(1994-3#1)(1995-10#1)(1996-2#1)(2006-7#1)(2007-8#1)(2008-11#1)(2013-1#1)
significantly populated##3##2##(1991-2#1)(1994-8#1)(1995-10#1)
significantly positive correlation##2##3##(1991-12#1)(2011-1#1)
significantly positive##5##2##(1991-12#1)(1996-9#1)(2010-8#1)(2011-1#1)(2013-1#1)
significantly positively##4##2##(2005-11#1)(2009-7#1)(2013-8#2)
significantly potentiated NMDA-induced##2##3##(1996-1#1)(2008-4#1)
significantly potentiated the##4##3##(1991-1#1)(1991-2#1)(1996-2#1)(1997-5#1)
significantly potentiated##13##2##(1990-12#1)(1991-1#1)(1991-2#1)(1992-8#1)(1994-2#1)(1996-1#1)(1996-2#2)(1996-8#1)(1997-5#1)(2004-12#1)(2008-4#2)
significantly potentiates the##2##3##(1993-3#2)
significantly predict##4##2##(2007-12#1)(2007-9#1)(2008-12#1)(2009-6#1)
significantly predicted##16##2##(1996-1#1)(1997-8#1)(2004-10#1)(2007-12#3)(2008-11#2)(2008-8#1)(2010-4#1)(2011-1#1)(2012-1#3)(2012-12#1)(2013-1#1)
significantly predictive of##2##3##(1996-3#1)(2008-5#1)
significantly predicts##2##2##(2008-12#1)(2011-1#1)
significantly prevented increases in the urinary excretion of protein##2##9##(1994-5#2)
significantly prevented the##3##3##(1994-5#2)(2013-1#1)
significantly prevented##9##2##(1991-2#1)(1994-5#4)(1995-2#1)(1996-12#1)(1997-3#1)(2013-1#1)
significantly prevents the##2##3##(2008-5#1)(2010-6#1)
significantly prolong the##2##3##(1990-3#1)(2010-7#1)
significantly prolonged survival##2##3##(1995-2#1)(2009-5#1)
significantly prolonged the##3##3##(1996-2#1)(2005-7#1)(2008-8#1)
significantly prolonged##13##2##(1991-1#1)(1991-2#1)(1992-3#1)(1995-2#1)(1996-2#1)(1997-5#1)(2005-7#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-5#1)(2011-12#1)
significantly protected##2##2##(1997-4#1)(2006-10#1)
significantly raised##8##2##(1990-12#1)(1991-12#1)(1992-12#1)(1993-7#1)(1993-8#1)(2007-10#1)(2007-8#1)(2009-6#1)
significantly reduce mortality##4##3##(2005-8#1)(2006-4#1)(2008-10#1)(2011-1#1)
significantly reduce the risk of##3##5##(1992-10#1)(2005-10#1)(2012-2#1)
significantly reduce the risk##4##4##(1992-10#1)(2005-10#1)(2006-10#1)(2012-2#1)
significantly reduce the##21##3##(1992-10#1)(1992-8#1)(1995-8#1)(1997-4#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-2#1)
significantly reduce##50##2##(1992-10#1)(1992-8#1)(1994-12#1)(1994-9#1)(1995-8#1)(1996-3#2)(1997-4#1)(1997-5#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-1#1)(2009-2#2)(2009-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
significantly reduced (p &lt##3##4##(2006-8#1)(2010-4#1)(2010-5#1)
significantly reduced (p##4##3##(1991-7#1)(2006-8#1)(2010-4#1)(2010-5#1)
significantly reduced NK activity##2##4##(1991-7#2)
significantly reduced activity##2##3##(1995-2#1)(2012-2#1)
significantly reduced after##2##3##(1990-9#1)(2008-10#1)
significantly reduced at##5##3##(1996-5#1)(2008-10#3)(2008-7#1)
significantly reduced blood##2##3##(2008-4#1)(2009-10#1)
significantly reduced both##2##3##(1995-12#1)(2008-10#1)
significantly reduced by the addition of##2##6##(1991-4#1)(1996-12#1)
significantly reduced by the##6##4##(1991-4#1)(1992-10#1)(1996-12#1)(1996-3#1)(2008-10#1)(2008-2#1)
significantly reduced by##48##3##(1990-11#1)(1990-5#1)(1991-2#1)(1991-4#1)(1991-8#2)(1992-10#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1995-11#2)(1995-12#2)(1995-3#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-7#1)(1997-8#3)(2007-12#2)(2007-6#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-11#1)(2010-10#1)(2012-12#1)(2012-3#1)
significantly reduced compared to that##2##5##(1992-10#1)(2008-5#1)
significantly reduced compared to##3##4##(1992-10#1)(2008-4#1)(2008-5#1)
significantly reduced compared with the##6##5##(1994-9#1)(1995-12#1)(2006-5#1)(2008-10#1)(2008-3#1)(2011-2#1)
significantly reduced compared with##8##4##(1994-9#1)(1995-12#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#1)
significantly reduced compared##11##3##(1992-10#1)(1994-9#1)(1995-12#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2011-2#1)
significantly reduced disease severity##2##4##(2008-10#2)
significantly reduced disease##5##3##(2008-10#5)
significantly reduced expression##2##3##(2007-11#1)(2011-12#1)
significantly reduced from##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
significantly reduced if##2##3##(1996-8#1)(2008-7#1)
significantly reduced in Alzheimer's disease##2##5##(1991-9#1)(1996-12#1)
significantly reduced in HD patients##2##5##(1996-3#1)(2009-7#1)
significantly reduced in both groups##2##5##(2012-2#2)
significantly reduced in both##4##4##(1992-12#1)(2009-5#1)(2012-2#2)
significantly reduced in hippocampus and##2##5##(1997-2#1)(2007-8#1)
significantly reduced in the##15##4##(1990-5#1)(1990-8#1)(1993-12#1)(1993-7#1)(1995-11#1)(1997-2#1)(1997-5#1)(1997-8#1)(2007-10#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-11#1)(2013-1#2)
significantly reduced in##73##3##(1990-5#2)(1990-8#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-3#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-7#1)(1994-4#1)(1994-7#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-8#1)(1996-12#5)(1996-3#1)(1996-5#1)(1997-2#2)(1997-5#2)(1997-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#11)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
significantly reduced levels of##2##4##(2011-2#1)(2012-12#1)
significantly reduced levels##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
significantly reduced pain##2##3##(2008-7#1)(2013-1#1)
significantly reduced production of##2##4##(1990-5#1)(1994-6#1)
significantly reduced serum##3##3##(1996-9#1)(2005-1#1)(2012-12#1)
significantly reduced the EFS-evoked contractile response in##2##7##(2008-2#2)
significantly reduced the amplitude##2##4##(1991-5#1)(1992-8#1)
significantly reduced the development of lesions caused by##2##8##(2008-10#2)
significantly reduced the development of##3##5##(1996-1#1)(2008-10#2)
significantly reduced the duration of##2##5##(1991-2#1)(2010-3#1)
significantly reduced the extent of##3##5##(1990-11#1)(1995-10#1)(2008-10#1)
significantly reduced the formation of##2##5##(1991-5#1)(2013-7#1)
significantly reduced the growth##2##4##(1995-6#1)(2008-10#1)
significantly reduced the incidence of##4##5##(2007-11#1)(2008-10#2)(2008-6#1)
significantly reduced the incidence##5##4##(1991-12#1)(2007-11#1)(2008-10#2)(2008-6#1)
significantly reduced the infarct size##2##5##(2011-2#2)
significantly reduced the infarct##3##4##(1995-12#1)(2011-2#2)
significantly reduced the inhibitory effect of##2##6##(1993-9#1)(1995-12#1)
significantly reduced the levels of##2##5##(2012-2#1)(2013-1#1)
significantly reduced the number of##5##5##(1993-11#2)(2008-1#1)(2008-10#2)
significantly reduced the number##6##4##(1993-11#2)(2008-1#1)(2008-10#2)(2008-4#1)
significantly reduced the promoter activity##2##5##(1995-3#1)(1997-2#1)
significantly reduced the severity of##2##5##(2008-10#2)
significantly reduced the size##2##4##(2008-4#1)(2009-10#1)
significantly reduced the##105##3##(1990-11#2)(1990-2#1)(1990-6#1)(1990-7#3)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#3)(1992-6#2)(1992-8#2)(1993-1#1)(1993-11#2)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#3)(1995-6#2)(1996-1#1)(1996-12#1)(1996-3#2)(1996-6#1)(1997-2#2)(2004-2#1)(2006-5#1)(2007-10#2)(2007-11#1)(2007-3#2)(2008-1#2)(2008-10#18)(2008-2#3)(2008-3#2)(2008-4#4)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-7#2)(2013-8#1)
significantly reduced to##4##3##(1990-11#1)(2008-5#1)(2010-8#1)(2012-2#1)
significantly reduced toxicity##2##3##(1995-10#1)(2008-9#1)
significantly reduced when##6##3##(1996-9#1)(1997-7#1)(2008-7#1)(2009-9#1)(2010-12#1)(2011-2#1)
significantly reduced with##8##3##(1991-10#1)(1991-6#1)(1995-12#1)(2005-10#1)(2007-11#1)(2008-3#1)(2008-6#1)(2010-4#1)
significantly reduced##472##2##(1990-11#4)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#2)(1990-7#4)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#5)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#8)(1991-6#3)(1991-7#4)(1991-8#4)(1991-9#3)(1992-10#2)(1992-11#1)(1992-12#4)(1992-3#2)(1992-6#2)(1992-8#2)(1993-1#1)(1993-11#5)(1993-12#2)(1993-2#1)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#6)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#2)(1995-11#6)(1995-12#11)(1995-2#1)(1995-3#2)(1995-5#4)(1995-6#3)(1995-8#2)(1996-1#3)(1996-12#12)(1996-2#1)(1996-3#4)(1996-5#4)(1996-6#2)(1996-8#2)(1996-9#3)(1997-2#5)(1997-3#2)(1997-4#2)(1997-5#4)(1997-6#1)(1997-7#3)(1997-8#5)(2004-2#1)(2004-3#1)(2005-1#1)(2005-10#2)(2006-1#1)(2006-11#1)(2006-12#3)(2006-3#1)(2006-5#3)(2006-8#1)(2007-1#2)(2007-10#5)(2007-11#5)(2007-12#6)(2007-3#2)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#78)(2008-11#4)(2008-12#2)(2008-2#7)(2008-3#11)(2008-4#10)(2008-5#11)(2008-6#3)(2008-7#11)(2008-8#1)(2008-9#3)(2009-10#3)(2009-11#1)(2009-3#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#2)(2010-12#6)(2010-3#2)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#2)(2011-10#1)(2011-11#1)(2011-12#1)(2011-2#10)(2012-1#2)(2012-11#1)(2012-12#7)(2012-2#9)(2012-3#2)(2013-1#19)(2013-7#4)(2013-8#4)
significantly reduces both##2##3##(2008-2#1)(2008-8#1)
significantly reduces the incidence of##9##5##(1992-9#1)(1994-6#1)(2006-10#1)(2007-8#5)(2008-1#1)
significantly reduces the risk of##2##5##(1991-11#1)(2008-5#1)
significantly reduces the time required##2##5##(1997-4#1)(2008-10#1)
significantly reduces the##27##3##(1991-11#1)(1991-2#1)(1992-9#1)(1993-1#1)(1994-6#1)(1995-11#2)(1997-4#1)(2006-10#1)(2007-1#1)(2007-12#2)(2007-8#6)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)(2013-8#1)
significantly reduces##44##2##(1991-11#1)(1991-2#1)(1992-9#1)(1993-1#1)(1994-6#1)(1995-11#2)(1995-12#1)(1996-7#1)(1997-4#2)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-8#7)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
significantly reducing the##2##3##(2007-11#1)(2008-6#1)
significantly reducing##12##2##(1996-9#1)(2007-11#2)(2008-10#3)(2008-4#1)(2008-6#1)(2008-9#1)(2013-1#2)(2013-8#1)
significantly related to Medicaid##2##4##(1996-1#2)
significantly related to each##2##4##(2009-7#1)(2011-1#1)
significantly related to personality##2##4##(2007-10#1)(2008-1#1)
significantly related to the presence of##3##6##(2007-7#1)(2007-8#1)(2008-10#1)
significantly related to the##12##4##(1993-9#1)(1995-2#1)(1996-12#2)(1996-3#1)(2004-11#1)(2005-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2011-1#1)(2012-2#1)
significantly related to these progressive levels of##2##7##(2008-8#2)
significantly related to##63##3##(1991-8#1)(1991-9#1)(1992-4#1)(1993-12#1)(1993-4#1)(1993-9#1)(1995-1#1)(1995-2#1)(1996-1#2)(1996-12#2)(1996-3#3)(1997-5#1)(1997-8#1)(2004-11#1)(2005-5#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#3)(2009-7#3)(2010-1#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
significantly related with the##2##4##(2007-6#1)(2009-8#1)
significantly related##65##2##(1991-8#1)(1991-9#1)(1992-4#1)(1993-12#1)(1993-4#1)(1993-9#1)(1995-1#1)(1995-2#1)(1996-1#2)(1996-12#2)(1996-3#3)(1997-5#1)(1997-8#1)(2004-11#1)(2005-5#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-6#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#3)(2009-7#3)(2009-8#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
significantly relieved##3##2##(2008-11#2)(2010-12#1)
significantly restored##2##2##(2013-1#2)
significantly retarded##6##2##(1993-12#1)(1995-12#1)(2005-12#1)(2008-10#3)
significantly reversed the##2##3##(1994-3#1)(1995-6#1)
significantly shortened##7##2##(1990-11#1)(1993-2#1)(1993-7#1)(2004-11#1)(2007-5#1)(2008-5#1)(2010-2#1)
significantly shorter than the##2##4##(2008-10#1)(2008-8#1)
significantly shorter than##6##3##(1991-2#1)(1996-12#1)(2006-10#1)(2008-10#1)(2008-8#2)
significantly shorter##36##2##(1991-2#1)(1992-11#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-4#1)(2006-10#1)(2006-6#2)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#3)(2009-9#1)(2010-1#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#5)(2013-8#1)
significantly similar to##4##3##(1994-10#1)(1995-2#1)(2008-10#2)
significantly since##3##2##(2008-7#1)(2011-2#1)(2011-3#1)
significantly slowed the##3##3##(2007-9#1)(2008-10#1)(2008-8#1)
significantly slowed##5##2##(1991-8#2)(2007-9#1)(2008-10#1)(2008-8#1)
significantly slower in##5##3##(2008-10#1)(2008-4#1)(2009-1#1)(2011-2#1)(2012-12#1)
significantly slower than##6##3##(2008-10#1)(2008-4#1)(2008-9#1)(2009-1#1)(2011-2#1)(2013-8#1)
significantly slower##22##2##(1990-2#1)(1991-2#1)(1992-10#1)(1992-9#1)(2005-11#1)(2006-4#1)(2008-10#5)(2008-4#2)(2008-9#2)(2009-1#2)(2009-4#1)(2011-2#2)(2012-12#1)(2013-8#1)
significantly smaller and##3##3##(2012-12#2)(2012-3#1)
significantly smaller for##2##3##(2008-5#1)(2012-3#1)
significantly smaller in old than in young rats##2##8##(1995-12#2)
significantly smaller in##12##3##(1991-11#1)(1991-12#1)(1994-10#1)(1994-2#1)(1995-12#3)(1996-7#1)(1997-2#1)(2007-11#1)(2008-5#1)(2011-2#1)
significantly smaller than in##3##4##(1994-9#1)(1995-12#1)(2013-8#1)
significantly smaller than that in##3##5##(1995-10#1)(2012-12#2)
significantly smaller than that of##2##5##(2008-10#1)(2008-11#1)
significantly smaller than that##7##4##(1990-3#1)(1995-10#1)(2008-10#2)(2008-11#1)(2012-12#2)
significantly smaller than the##4##4##(2007-8#2)(2008-3#1)(2013-7#1)
significantly smaller than those##5##4##(2007-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
significantly smaller than##20##3##(1990-3#1)(1994-9#1)(1995-10#1)(1995-12#1)(2007-3#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
significantly smaller##55##2##(1990-3#1)(1991-11#1)(1991-12#2)(1992-9#1)(1994-10#1)(1994-2#1)(1994-9#1)(1995-10#1)(1995-12#4)(1995-6#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-2#1)(2004-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#2)(2012-12#5)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
significantly so##2##2##(1991-5#1)(1992-5#1)
significantly sooner than##2##3##(1991-8#1)(2008-9#1)
significantly steeper##2##2##(2008-10#1)(2008-8#1)
significantly stimulate##4##2##(1991-10#1)(1995-10#1)(2006-6#1)(2008-9#1)
significantly stimulated by the##2##4##(1993-9#1)(1996-11#1)
significantly stimulated by##6##3##(1993-3#1)(1993-9#1)(1994-3#1)(1996-11#1)(1996-9#1)(2004-4#1)
significantly stimulated the##3##3##(1991-5#1)(1992-4#1)(1997-8#1)
significantly stimulated##13##2##(1990-8#1)(1991-5#1)(1992-4#1)(1993-3#1)(1993-9#1)(1994-3#1)(1996-1#1)(1996-11#1)(1996-9#1)(1997-8#1)(2004-4#1)(2006-9#1)(2009-12#1)
significantly stronger than##4##3##(1991-5#1)(2004-9#1)(2006-9#1)(2011-2#1)
significantly stronger##5##2##(1991-5#1)(2004-9#1)(2006-9#1)(2008-4#1)(2011-2#1)
significantly superior to##6##3##(2006-4#1)(2007-11#2)(2008-3#1)(2010-3#1)(2010-9#1)
significantly superior##9##2##(2006-4#1)(2007-11#2)(2008-3#1)(2008-5#2)(2010-3#1)(2010-9#1)(2011-2#1)
significantly suppress the##2##3##(2008-10#1)(2013-8#1)
significantly suppress##5##2##(1992-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2013-8#1)
significantly suppressed by##4##3##(1991-12#1)(1994-8#1)(1997-1#1)(2008-11#1)
significantly suppressed in##3##3##(1992-8#1)(1996-11#1)(2011-2#1)
significantly suppressed the##7##3##(1994-2#1)(1994-8#1)(1997-8#1)(2008-10#2)(2008-6#1)(2013-8#1)
significantly suppressed##27##2##(1991-12#1)(1992-8#1)(1994-2#2)(1994-8#3)(1995-12#1)(1995-3#1)(1996-11#1)(1997-1#1)(1997-8#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-6#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
significantly suppressing##2##2##(1990-2#1)(2007-12#1)
significantly the adrenal secretion of epinephrine##2##6##(1991-8#2)
significantly the computational##2##3##(2008-2#2)
significantly the results##2##3##(2005-11#1)(2009-9#1)
significantly the##48##2##(1990-2#1)(1991-8#2)(1992-5#1)(1993-11#1)(1994-2#1)(1995-7#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-7#2)(2005-11#1)(2005-12#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#3)(2008-8#1)(2009-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
significantly thereafter##2##2##(1994-9#1)(2010-4#1)
significantly thicker##2##2##(2005-1#2)
significantly to our##2##3##(2009-2#1)(2012-2#1)
significantly to reduce##2##3##(1992-5#1)(2006-10#1)
significantly to the##37##3##(1990-5#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-4#1)(1996-12#2)(1997-2#2)(2004-2#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-9#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
significantly to##73##2##(1990-12#1)(1990-3#1)(1990-5#1)(1992-12#1)(1992-5#2)(1993-2#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-3#1)(1997-2#2)(1997-3#1)(1997-7#2)(1997-8#1)(2004-2#1)(2005-10#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-5#1)(2006-9#1)(2007-2#1)(2007-6#1)(2007-7#4)(2007-8#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)
significantly towards term##2##3##(1992-2#2)
significantly towards##3##2##(1992-2#2)(2008-7#1)
significantly under##7##2##(1995-1#1)(2008-10#2)(2008-11#1)(2010-8#1)(2012-12#2)
significantly underestimates##2##2##(1997-5#1)(2012-2#1)
significantly until##2##2##(1991-8#1)(2008-10#1)
significantly up-regulated in the##2##4##(2009-9#1)(2011-2#1)
significantly up-regulated##3##2##(2005-10#1)(2009-9#1)(2011-2#1)
significantly upfield##2##2##(1992-3#1)(2008-10#1)
significantly upon##7##2##(1991-12#1)(1996-10#1)(1997-4#1)(2008-10#1)(2008-11#1)(2012-12#1)(2013-8#1)
significantly upregulated##5##2##(1993-12#1)(2008-10#2)(2013-1#2)
significantly weaker than##2##3##(1995-10#1)(2008-8#1)
significantly weaker##4##2##(1991-12#1)(1994-4#1)(1995-10#1)(2008-8#1)
significantly when compared to the##2##5##(2008-11#1)(2010-4#1)
significantly when compared to##3##4##(2008-11#1)(2008-4#1)(2010-4#1)
significantly when compared##5##3##(2005-10#1)(2008-11#1)(2008-4#1)(2010-4#1)(2011-2#1)
significantly when the##4##3##(1991-3#1)(1992-3#1)(1992-9#1)(2008-2#1)
significantly when##18##2##(1991-10#1)(1991-3#1)(1992-3#1)(1992-9#1)(1997-3#1)(2005-10#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-4#2)(2011-2#1)(2012-1#1)
significantly wider##2##2##(2006-4#1)(2008-11#1)
significantly with a##2##3##(2008-12#1)(2008-3#1)
significantly with age in##2##4##(1990-3#1)(1994-11#1)
significantly with age##11##3##(1990-3#2)(1991-9#1)(1993-2#1)(1994-11#1)(1996-8#1)(2006-10#1)(2007-9#1)(2008-7#2)(2013-7#1)
significantly with both atorvastatin and rosuvastatin##2##6##(2011-1#2)
significantly with both##4##3##(2005-11#1)(2007-10#1)(2011-1#2)
significantly with duration of##2##4##(2011-2#2)
significantly with increasing##9##3##(1991-10#1)(1992-6#1)(2007-12#1)(2007-5#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-6#1)(2013-7#1)
significantly with respect to##3##4##(1991-7#1)(2008-7#1)(2013-1#1)
significantly with the##21##3##(1990-4#1)(1991-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1994-11#1)(1995-11#1)(1997-6#1)(2004-4#1)(2005-1#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-6#1)(2010-2#2)(2010-9#1)
significantly with time##2##3##(1992-8#1)(1993-7#1)
significantly with##115##2##(1990-3#2)(1990-4#1)(1990-6#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-6#2)(1992-8#2)(1993-11#1)(1993-12#4)(1993-2#1)(1993-7#1)(1994-11#4)(1994-12#1)(1995-11#1)(1995-2#1)(1995-8#2)(1995-9#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-6#1)(2004-4#1)(2005-1#1)(2005-11#2)(2006-10#2)(2006-12#1)(2007-10#2)(2007-12#3)(2007-4#1)(2007-5#1)(2007-7#4)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#3)(2008-7#8)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-2#4)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-12#2)(2012-2#1)(2012-4#1)(2013-1#1)(2013-7#3)(2013-8#3)
significantly within##3##2##(1992-2#1)(2009-2#1)(2009-6#1)
significantly worse in the##2##4##(1996-1#1)(2008-1#1)
significantly worse in##3##3##(1996-1#1)(2008-1#1)(2013-8#1)
significantly worse##14##2##(1996-1#1)(1996-7#1)(1997-8#1)(2005-10#1)(2006-9#1)(2007-8#1)(2008-1#1)(2009-10#1)(2009-4#1)(2009-7#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
significantly younger##7##2##(2004-12#1)(2007-10#2)(2007-8#1)(2008-12#1)(2010-12#1)(2011-2#1)
significantly##7955##1##(1990-10#10)(1990-11#22)(1990-12#43)(1990-2#24)(1990-3#27)(1990-4#21)(1990-5#26)(1990-6#12)(1990-7#31)(1990-8#22)(1990-9#17)(1991-1#16)(1991-10#11)(1991-11#17)(1991-12#45)(1991-2#39)(1991-3#20)(1991-4#16)(1991-5#40)(1991-6#23)(1991-7#13)(1991-8#42)(1991-9#31)(1992-1#20)(1992-10#13)(1992-11#17)(1992-12#28)(1992-2#26)(1992-3#43)(1992-4#14)(1992-5#21)(1992-6#15)(1992-7#21)(1992-8#39)(1992-9#16)(1993-1#11)(1993-10#3)(1993-11#32)(1993-12#44)(1993-2#27)(1993-3#45)(1993-4#12)(1993-5#8)(1993-6#15)(1993-7#27)(1993-8#19)(1993-9#36)(1994-1#1)(1994-10#14)(1994-11#31)(1994-12#25)(1994-2#56)(1994-3#37)(1994-4#11)(1994-5#24)(1994-6#37)(1994-7#11)(1994-8#27)(1994-9#24)(1995-1#28)(1995-10#22)(1995-11#44)(1995-12#79)(1995-2#38)(1995-3#38)(1995-4#11)(1995-5#26)(1995-6#28)(1995-7#15)(1995-8#23)(1995-9#18)(1996-1#35)(1996-10#15)(1996-11#23)(1996-12#68)(1996-2#28)(1996-3#40)(1996-4#14)(1996-5#34)(1996-6#19)(1996-7#32)(1996-8#19)(1996-9#33)(1997-1#28)(1997-2#65)(1997-3#28)(1997-4#38)(1997-5#35)(1997-6#25)(1997-7#61)(1997-8#51)(1997-9#1)(2004-1#8)(2004-10#6)(2004-11#32)(2004-12#15)(2004-2#9)(2004-3#7)(2004-4#10)(2004-8#1)(2004-9#13)(2005-1#5)(2005-10#26)(2005-11#39)(2005-12#6)(2005-3#1)(2005-4#7)(2005-5#2)(2005-7#14)(2005-8#22)(2005-9#3)(2006-1#7)(2006-10#77)(2006-11#15)(2006-12#41)(2006-2#20)(2006-3#5)(2006-4#21)(2006-5#28)(2006-6#41)(2006-7#21)(2006-8#50)(2006-9#27)(2007-1#39)(2007-10#76)(2007-11#94)(2007-12#104)(2007-2#63)(2007-3#24)(2007-4#15)(2007-5#20)(2007-6#33)(2007-7#67)(2007-8#132)(2007-9#52)(2008-1#58)(2008-10#770)(2008-11#127)(2008-12#108)(2008-2#88)(2008-3#156)(2008-4#106)(2008-5#195)(2008-6#58)(2008-7#192)(2008-8#108)(2008-9#153)(2009-1#8)(2009-10#30)(2009-11#15)(2009-12#13)(2009-2#19)(2009-3#20)(2009-4#51)(2009-5#42)(2009-6#35)(2009-7#34)(2009-8#26)(2009-9#28)(2010-1#12)(2010-10#16)(2010-11#16)(2010-12#81)(2010-2#44)(2010-3#25)(2010-4#57)(2010-5#16)(2010-6#9)(2010-7#36)(2010-8#55)(2010-9#20)(2011-1#128)(2011-10#4)(2011-11#8)(2011-12#35)(2011-2#237)(2011-3#10)(2012-1#65)(2012-10#1)(2012-11#25)(2012-12#109)(2012-2#171)(2012-3#94)(2012-4#2)(2012-5#7)(2012-6#2)(2012-7#1)(2012-9#1)(2013-1#266)(2013-7#52)(2013-8#132)
signification##2##1##(2008-9#1)(2010-6#1)
significative##11##1##(1990-9#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-6#1)(2009-4#3)
signifies that##2##2##(1991-5#1)(2010-2#1)
signifies##3##1##(1991-5#1)(2008-7#1)(2010-2#1)
signify##6##1##(1990-2#1)(1993-12#1)(2007-10#1)(2007-12#1)(2010-7#1)(2013-8#1)
signifying that##2##2##(2008-8#1)(2012-3#1)
signifying##9##1##(1995-10#1)(2007-3#1)(2007-7#1)(2008-8#1)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
signing the##2##2##(1996-1#1)(2007-9#1)
signing##12##1##(1996-1#1)(1996-3#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#2)
signouts##2##1##(1991-12#1)(1993-12#1)
signs and lesions##2##3##(2008-5#2)
signs and symptoms and the##2##5##(1990-6#1)(2010-9#1)
signs and symptoms and##9##4##(1990-6#1)(1991-8#1)(1997-8#1)(2006-11#1)(2006-5#1)(2008-7#1)(2010-9#1)(2012-2#2)
signs and symptoms are##3##4##(2006-7#1)(2012-2#1)(2013-1#1)
signs and symptoms in##4##4##(2006-8#1)(2007-7#2)(2008-10#1)
signs and symptoms may##2##4##(2006-4#1)(2008-9#1)
signs and symptoms of RA##2##5##(2006-10#1)(2008-3#1)
signs and symptoms of leprosy##2##5##(2007-7#2)
signs and symptoms of##46##4##(1992-1#1)(1994-7#2)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#7)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-8#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-2#1)(2011-12#1)(2011-2#2)(2013-1#2)
signs and symptoms related to##3##5##(2006-11#2)(2008-11#1)
signs and symptoms were##3##4##(1990-12#1)(1994-2#1)(2011-12#1)
signs and symptoms##126##3##(1990-10#1)(1990-12#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-9#1)(1994-2#1)(1994-7#2)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#3)(2005-11#1)(2005-4#1)(2005-5#1)(2005-8#1)(2006-10#4)(2006-11#3)(2006-12#3)(2006-3#1)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#3)(2007-7#12)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#7)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#2)(2009-4#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-5#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#6)
signs and the##4##3##(1990-9#1)(1992-5#1)(2007-2#1)(2008-7#1)
signs and##160##2##(1990-10#1)(1990-12#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-10#1)(1994-2#1)(1994-7#3)(1995-4#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#4)(2005-11#2)(2005-12#1)(2005-4#1)(2005-5#1)(2005-8#1)(2006-10#4)(2006-11#3)(2006-12#3)(2006-3#1)(2006-4#1)(2006-5#2)(2006-7#2)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#4)(2007-3#1)(2007-5#1)(2007-7#12)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#8)(2008-4#1)(2008-5#9)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#2)(2009-4#1)(2009-6#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#6)(2013-8#1)
signs appeared##2##2##(1993-8#1)(1994-5#1)
signs appearing in##2##3##(2007-11#1)(2008-6#1)
signs are the##2##3##(2010-9#1)(2012-12#1)
signs are##18##2##(1990-5#1)(1992-8#1)(1993-2#1)(1996-2#1)(2005-8#1)(2007-7#1)(2008-11#2)(2008-6#1)(2010-9#2)(2011-1#1)(2011-12#1)(2012-12#3)(2012-3#1)(2013-1#1)
signs associated with##4##3##(1990-3#1)(1991-8#1)(2005-9#1)(2006-5#1)
signs at##4##2##(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#1)
signs became##2##2##(1992-2#1)(1997-6#1)
signs by##2##2##(2008-5#1)(2012-12#1)
signs consistent with##2##3##(2008-7#1)(2010-5#1)
signs could be observed##2##4##(2008-5#2)
signs could be##3##3##(2008-5#2)(2010-8#1)
signs could##4##2##(2007-2#1)(2008-5#2)(2010-8#1)
signs during##5##2##(1996-10#1)(1997-6#1)(2007-2#1)(2008-7#1)(2011-12#1)
signs for severe##2##3##(2008-8#1)(2012-12#1)
signs for##7##2##(1993-4#1)(1995-1#1)(1996-6#1)(2008-1#1)(2008-8#1)(2011-2#1)(2012-12#1)
signs from##4##2##(2007-8#1)(2008-10#1)(2009-9#1)(2010-8#1)
signs improved##2##2##(1993-8#1)(2010-2#1)
signs in addition to##2##4##(1991-4#2)
signs in patients with malaria##2##5##(2012-12#2)
signs in patients with##4##4##(2007-11#1)(2012-12#2)(2013-1#1)
signs in patients##5##3##(1992-2#1)(2007-11#1)(2012-12#2)(2013-1#1)
signs in the##3##3##(1992-5#1)(2006-2#1)(2007-10#1)
signs in##25##2##(1991-4#2)(1992-2#1)(1992-5#1)(1995-2#1)(1995-5#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-7#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-5#2)(2009-7#1)(2010-11#1)(2010-9#1)(2012-12#2)(2013-1#2)
signs included##4##2##(1993-7#1)(1997-3#1)(1997-5#1)(2011-1#1)
signs like##2##2##(2013-1#1)(2013-8#1)
signs of AN##4##3##(1993-5#4)
signs of MD##3##3##(2013-8#3)
signs of a##10##3##(1994-6#2)(1994-9#1)(2007-12#1)(2007-9#1)(2008-7#1)(2010-9#1)(2013-1#3)
signs of active##4##3##(1991-12#1)(1994-7#1)(2006-2#1)(2012-2#1)
signs of acute##7##3##(1991-11#2)(1994-4#1)(2007-11#1)(2007-7#1)(2013-1#2)
signs of alveolitis##2##3##(1994-6#2)
signs of an##6##3##(1995-5#2)(2006-9#1)(2007-8#1)(2008-10#1)(2010-5#1)
signs of apoptosis and##2##4##(2008-4#1)(2008-7#1)
signs of apoptosis##4##3##(1996-1#1)(1997-6#1)(2008-4#1)(2008-7#1)
signs of aseptic##2##3##(2007-7#1)(2013-1#1)
signs of autoimmunity##2##3##(2006-7#1)(2008-10#1)
signs of bacterial##2##3##(1992-10#1)(2009-3#1)
signs of bone##2##3##(2007-11#1)(2009-2#1)
signs of cardiac failure##2##4##(2012-2#2)
signs of cardiac##4##3##(1991-3#1)(2007-8#1)(2012-2#2)
signs of cerebral##2##3##(2008-6#1)(2011-2#1)
signs of chronic##3##3##(1992-9#1)(1996-10#1)(2006-7#1)
signs of congestive##2##3##(2010-5#1)(2012-2#1)
signs of depression##3##3##(2008-5#1)(2008-7#1)(2013-1#1)
signs of disc##2##3##(2007-11#1)(2007-5#1)
signs of disease##4##3##(2006-9#1)(2008-5#3)
signs of early##2##3##(2008-7#1)(2009-3#1)
signs of eating disorders##2##4##(2006-7#1)(2010-9#1)
signs of ethanol withdrawal##2##4##(2008-3#1)(2009-3#1)
signs of heart failure##2##4##(2008-3#1)(2010-2#1)
signs of heart##4##3##(2008-3#2)(2010-2#1)(2011-1#1)
signs of herniation##2##3##(2006-7#1)(2008-7#1)
signs of improvement##3##3##(2007-2#1)(2011-2#1)(2012-3#1)
signs of increased##2##3##(2008-7#1)(2011-1#1)
signs of infection were##3##4##(1993-10#1)(2008-10#1)(2012-2#1)
signs of infection##12##3##(1993-10#1)(1993-2#1)(1994-2#1)(2005-7#1)(2005-9#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#3)(2013-1#1)
signs of inflammation##8##3##(1995-4#1)(2006-10#1)(2006-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2012-3#1)
signs of inflammatory arthritis##2##4##(2006-10#2)
signs of intestinal##2##3##(1990-5#1)(1993-8#1)
signs of left##2##3##(2008-3#1)(2008-7#1)
signs of local##4##3##(1993-1#1)(2006-12#1)(2006-6#1)(2009-4#1)
signs of lung##2##3##(2006-10#1)(2008-7#1)
signs of malignancy were##2##4##(1997-1#1)(2012-12#1)
signs of malignancy##3##3##(1997-1#1)(2012-12#2)
signs of mechanical##3##3##(1993-4#1)(2008-1#1)(2008-6#1)
signs of mixed##2##3##(2005-1#2)
signs of neurofibromatosis##2##3##(2012-3#1)(2013-7#1)
signs of neuromuscular##2##3##(1990-8#1)(2012-3#1)
signs of neuropathic pain##3##4##(1993-4#2)(2009-12#1)
signs of oral cancer##3##4##(2011-2#3)
signs of osteomalacia##2##3##(2006-10#2)
signs of puberty##3##3##(2006-10#2)(2006-9#1)
signs of recurrence and##2##4##(1996-6#1)(2008-6#1)
signs of recurrence##12##3##(1991-9#1)(1996-6#1)(2007-2#1)(2008-6#3)(2011-12#1)(2012-12#3)(2012-2#1)(2012-3#1)
signs of recurrent##2##3##(2007-8#1)(2010-12#1)
signs of scrapie##3##3##(1993-8#2)(1996-6#1)
signs of secondary##3##3##(1993-8#1)(2013-1#2)
signs of septicaemia##2##3##(1990-8#1)(2007-7#1)
signs of severe##3##3##(1990-6#1)(1997-5#1)(2012-2#1)
signs of significant##2##3##(2011-2#2)
signs of skin ageing##2##4##(2008-5#2)
signs of skin##3##3##(2008-5#3)
signs of spinal cord##2##4##(1991-6#1)(2008-10#1)
signs of stress##2##3##(2008-7#1)(2012-2#1)
signs of the disease##4##4##(2005-7#1)(2008-5#1)(2012-12#1)(2013-1#1)
signs of the##17##3##(1993-5#1)(1996-3#1)(1996-5#1)(2005-7#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-5#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#2)(2013-1#2)
signs of this##2##3##(1992-1#1)(1996-2#1)
signs of tolerance##3##3##(1990-5#2)(1993-5#1)
signs of toxicity##7##3##(1990-5#1)(1991-6#1)(1996-12#2)(2005-7#1)(2008-10#1)(2008-5#1)
signs of tuberculosis##2##3##(2008-4#2)
signs of venous##2##3##(2007-8#1)(2009-8#1)
signs of##459##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#6)(1990-6#1)(1990-8#2)(1990-9#4)(1991-11#6)(1991-12#3)(1991-2#1)(1991-3#2)(1991-6#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#3)(1992-11#1)(1992-12#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-10#4)(1993-2#1)(1993-3#2)(1993-4#3)(1993-5#7)(1993-6#3)(1993-7#1)(1993-8#6)(1993-9#1)(1994-10#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#4)(1994-7#2)(1994-9#2)(1995-12#1)(1995-2#2)(1995-3#3)(1995-4#2)(1995-5#2)(1995-7#1)(1995-9#2)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#2)(1997-1#1)(1997-3#4)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#1)(2005-1#3)(2005-10#1)(2005-11#1)(2005-5#1)(2005-7#4)(2005-8#1)(2005-9#1)(2006-1#3)(2006-10#17)(2006-12#4)(2006-2#4)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#5)(2006-8#3)(2006-9#3)(2007-10#1)(2007-11#9)(2007-12#2)(2007-2#3)(2007-5#6)(2007-6#1)(2007-7#9)(2007-8#11)(2007-9#4)(2008-1#3)(2008-10#13)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#9)(2008-4#8)(2008-5#22)(2008-6#7)(2008-7#14)(2008-8#2)(2008-9#2)(2009-1#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#2)(2009-6#2)(2009-7#1)(2009-8#3)(2010-12#5)(2010-2#2)(2010-3#2)(2010-5#2)(2010-8#1)(2010-9#2)(2011-1#5)(2011-11#1)(2011-12#5)(2011-2#21)(2011-3#1)(2012-1#7)(2012-12#11)(2012-2#15)(2012-3#10)(2013-1#23)(2013-7#4)(2013-8#6)
signs or symptoms of##7##4##(1991-8#1)(2006-8#1)(2007-8#1)(2008-7#2)(2010-8#1)(2012-11#1)
signs or symptoms##9##3##(1991-8#1)(2006-8#1)(2007-8#1)(2008-7#2)(2010-8#1)(2011-2#1)(2012-11#1)(2012-2#1)
signs or##13##2##(1991-8#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-7#2)(2010-6#1)(2010-8#3)(2011-2#1)(2012-11#1)(2012-2#1)
signs related to##3##3##(1997-3#1)(2006-10#1)(2011-1#1)
signs such as##2##3##(1996-9#1)(2010-1#1)
signs suggestive of##3##3##(1994-2#1)(2011-1#1)(2011-2#1)
signs than##2##2##(1996-8#1)(2008-5#1)
signs that##10##2##(1993-2#1)(2005-11#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-12#1)(2009-9#1)(2010-2#1)(2011-1#1)(2013-8#1)
signs to##3##2##(2009-10#1)(2010-12#1)(2011-2#1)
signs were not##3##3##(2006-12#1)(2007-11#1)(2011-1#1)
signs were##20##2##(1992-10#1)(1992-5#1)(1993-2#1)(2006-12#1)(2007-11#2)(2007-9#1)(2008-5#4)(2008-7#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#2)(2013-1#2)
signs with##2##2##(2006-8#1)(2012-12#1)
signs##944##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#7)(1990-4#1)(1990-5#7)(1990-6#3)(1990-8#3)(1990-9#6)(1991-10#1)(1991-11#7)(1991-12#5)(1991-2#2)(1991-3#3)(1991-4#3)(1991-6#3)(1991-8#4)(1991-9#1)(1992-1#2)(1992-10#6)(1992-11#2)(1992-12#1)(1992-2#3)(1992-4#2)(1992-5#5)(1992-8#4)(1992-9#2)(1993-1#3)(1993-10#5)(1993-2#5)(1993-3#4)(1993-4#4)(1993-5#8)(1993-6#3)(1993-7#3)(1993-8#10)(1993-9#2)(1994-10#2)(1994-12#1)(1994-2#3)(1994-3#2)(1994-4#3)(1994-5#4)(1994-6#5)(1994-7#5)(1994-9#2)(1995-1#1)(1995-10#2)(1995-12#1)(1995-2#3)(1995-3#4)(1995-4#3)(1995-5#3)(1995-7#1)(1995-9#3)(1996-1#3)(1996-10#2)(1996-11#2)(1996-12#4)(1996-2#2)(1996-3#2)(1996-5#2)(1996-6#3)(1996-8#2)(1996-9#6)(1997-1#1)(1997-2#2)(1997-3#8)(1997-5#6)(1997-6#6)(1997-7#2)(1997-8#8)(2004-4#1)(2005-1#3)(2005-10#1)(2005-11#5)(2005-12#2)(2005-4#1)(2005-5#2)(2005-7#6)(2005-8#4)(2005-9#3)(2006-1#4)(2006-10#26)(2006-11#3)(2006-12#10)(2006-2#7)(2006-3#1)(2006-4#4)(2006-5#4)(2006-6#5)(2006-7#7)(2006-8#12)(2006-9#5)(2007-1#1)(2007-10#6)(2007-11#19)(2007-12#4)(2007-2#12)(2007-3#1)(2007-5#7)(2007-6#1)(2007-7#30)(2007-8#17)(2007-9#10)(2008-1#11)(2008-10#19)(2008-11#17)(2008-12#6)(2008-2#3)(2008-3#22)(2008-4#10)(2008-5#49)(2008-6#15)(2008-7#27)(2008-8#4)(2008-9#6)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#6)(2009-4#4)(2009-5#1)(2009-6#4)(2009-7#2)(2009-8#3)(2009-9#5)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#11)(2010-2#7)(2010-3#3)(2010-4#3)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#10)(2010-9#6)(2011-1#18)(2011-11#1)(2011-12#11)(2011-2#38)(2011-3#1)(2012-1#8)(2012-11#1)(2012-12#22)(2012-2#21)(2012-3#17)(2013-1#41)(2013-7#5)(2013-8#16)
signs/symptoms of##2##2##(2005-10#1)(2008-2#1)
signs/symptoms##5##1##(2005-10#1)(2008-2#1)(2011-2#1)(2013-1#2)
sika deer##5##2##(2008-5#4)(2009-5#1)
sila##2##1##(1992-11#1)(2006-12#1)
silage preparation##2##2##(2012-2#2)
silage quality at##2##3##(2012-2#2)
silage##28##1##(1990-6#2)(2005-7#3)(2008-10#6)(2008-12#4)(2012-2#11)(2013-1#2)
silanated HA##3##2##(2004-9#3)
silanated##4##1##(2004-9#3)(2009-7#1)
silane and##3##2##(2008-10#1)(2008-12#2)
silane coupling agent##3##3##(2004-9#2)(2005-12#1)
silane coupling##6##2##(2004-9#2)(2005-11#2)(2005-12#1)(2009-7#1)
silane film##4##2##(2008-10#4)
silane grafting##3##2##(2005-11#3)
silane layers##4##2##(2005-11#4)
silane##43##1##(2004-9#2)(2005-11#19)(2005-12#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2009-7#4)(2010-3#1)(2010-4#1)(2013-8#1)
silanes##5##1##(2005-11#3)(2009-5#1)(2010-7#1)
silanide##2##1##(2010-5#2)
silanization##5##1##(2008-10#1)(2008-8#3)(2009-8#1)
silanized##8##1##(2005-11#1)(2008-10#4)(2008-4#1)(2008-5#2)
silanol and##2##2##(2008-10#1)(2013-8#1)
silanol groups##2##2##(2005-11#1)(2008-10#1)
silanol##9##1##(2005-11#2)(2008-1#3)(2008-10#2)(2009-5#1)(2013-8#1)
silanols##6##1##(1997-3#1)(2005-11#2)(2008-1#1)(2008-10#2)
silastic catheter##2##2##(2006-6#1)(2006-8#1)
silastic tube##2##2##(2008-7#2)
silastic##10##1##(1990-11#1)(1994-2#1)(1996-3#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-7#1)(2008-7#2)
sildenafil are##2##2##(2008-11#1)(2010-5#1)
sildenafil may##2##2##(2007-8#1)(2009-10#1)
sildenafil##21##1##(2006-12#2)(2006-9#1)(2007-11#1)(2007-8#4)(2008-10#5)(2008-11#2)(2008-4#1)(2009-10#1)(2010-12#1)(2010-5#3)
silence##17##1##(1990-4#4)(2004-12#1)(2007-4#1)(2008-1#1)(2008-2#1)(2008-9#1)(2011-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
silenced by##2##2##(1997-4#1)(2013-8#1)
silenced dataset##3##2##(2008-7#3)
silenced genes##3##2##(2007-11#1)(2008-5#1)(2009-4#1)
silenced imprinted genes##2##3##(2008-7#2)
silenced imprinted##3##2##(2008-7#3)
silenced in##2##2##(2006-12#1)(2008-9#1)
silenced plants##2##2##(2006-12#1)(2008-9#1)
silenced##28##1##(1997-4#1)(2006-12#3)(2007-11#2)(2007-8#1)(2008-5#1)(2008-7#7)(2008-8#2)(2008-9#4)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-11#1)(2013-8#1)
silencer elements##2##2##(1995-8#2)
silencer##8##1##(1991-8#2)(1994-12#2)(1995-1#1)(1995-8#2)(2008-2#1)
silences##4##1##(2006-7#1)(2008-9#1)(2009-3#1)(2012-12#1)
silencing and##8##2##(2007-11#1)(2008-10#1)(2008-9#1)(2009-3#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
silencing as a tool##2##4##(2010-2#1)(2012-11#1)
silencing as##3##2##(2010-2#1)(2011-2#1)(2012-11#1)
silencing by RNAi##2##3##(2008-1#1)(2008-2#1)
silencing by##7##2##(1995-2#1)(2008-1#1)(2008-2#1)(2009-3#1)(2009-8#1)(2012-2#1)(2012-3#1)
silencing in a##3##3##(2007-11#1)(2008-2#1)(2008-4#1)
silencing in##16##2##(2006-12#3)(2007-11#1)(2008-2#3)(2008-4#1)(2008-9#2)(2009-3#2)(2011-1#1)(2012-11#2)(2013-1#1)
silencing is##6##2##(2007-12#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-8#1)
silencing of human##2##3##(1995-2#1)(2007-10#1)
silencing of the##3##3##(2009-3#1)(2011-1#2)
silencing of tumor suppressor##2##4##(1997-4#1)(2011-2#1)
silencing of##23##2##(1995-2#1)(1997-4#1)(2006-12#1)(2007-10#1)(2008-1#1)(2008-7#2)(2008-9#1)(2009-3#2)(2009-4#1)(2009-8#1)(2010-12#2)(2010-2#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-3#1)
silencing pathway##2##2##(2006-12#1)(2009-8#1)
silencing suppression##3##2##(2008-10#3)
silencing suppressor##3##2##(2008-10#1)(2009-8#1)(2012-2#1)
silencing system##2##2##(2006-12#1)(2011-1#1)
silencing technology##2##2##(2008-2#1)(2012-11#1)
silencing the##2##2##(2008-2#1)(2011-1#1)
silencing triggering##3##2##(2011-1#3)
silencing##166##1##(1995-1#1)(1995-2#2)(1997-4#1)(2006-10#1)(2006-12#9)(2007-10#4)(2007-11#3)(2007-12#1)(2008-1#2)(2008-10#14)(2008-11#1)(2008-2#8)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#19)(2009-10#1)(2009-3#13)(2009-4#1)(2009-8#7)(2010-1#1)(2010-12#2)(2010-2#4)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#17)(2011-2#10)(2012-11#9)(2012-12#5)(2012-2#6)(2012-3#8)(2013-1#4)
silent ST segment depression##2##4##(2008-7#2)
silent amino acid substitutions##5##4##(2008-4#5)
silent and##4##2##(1991-11#1)(1995-3#1)(1996-10#1)(2008-1#1)
silent at##3##2##(1993-2#1)(2007-11#1)(2008-6#1)
silent behavior##2##2##(2009-8#2)
silent but##2##2##(1990-6#1)(2008-10#1)
silent circulation##2##2##(2007-10#2)
silent during##2##2##(1994-10#1)(2007-12#1)
silent epidemic##2##2##(2005-10#1)(2007-7#1)
silent in##2##2##(1991-9#1)(2012-2#1)
silent ischemia##3##2##(1990-2#1)(1991-7#1)(2008-7#1)
silent mating loci##2##3##(2008-8#2)
silent mating##4##2##(1995-1#2)(2008-8#2)
silent mutations were##2##3##(1994-2#1)(1997-9#1)
silent mutations##4##2##(1994-2#1)(1996-11#1)(1997-9#1)(2008-10#1)
silent myocardial ischaemia##2##3##(1990-3#1)(2012-2#1)
silent myocardial ischemia##8##3##(1991-7#1)(1992-6#1)(1996-9#1)(2008-7#3)(2010-11#2)
silent myocardial##12##2##(1990-3#2)(1991-7#1)(1992-6#1)(1996-9#1)(2008-12#1)(2008-7#3)(2010-11#2)(2012-2#1)
silent neuropathy##2##2##(2007-7#2)
silent nucleotide##2##2##(1990-4#1)(2009-10#1)
silent period##2##2##(2006-12#1)(2011-2#1)
silent state##4##2##(1997-7#2)(2007-12#1)(2008-11#1)
silent##120##1##(1990-11#1)(1990-2#2)(1990-3#2)(1990-4#2)(1990-6#1)(1991-11#2)(1991-4#1)(1991-7#2)(1991-9#3)(1992-6#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-10#3)(1994-12#1)(1994-2#2)(1995-1#2)(1995-11#1)(1995-2#5)(1995-3#2)(1995-5#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-9#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#2)(2007-10#3)(2007-11#1)(2007-12#2)(2007-5#1)(2007-6#1)(2007-7#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-8#4)(2010-11#2)(2010-12#1)(2010-3#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#1)(2013-8#1)
silent&quot##6##1##(1990-11#2)(1991-12#1)(1992-3#1)(2006-10#1)(2012-2#1)
silently##4##1##(2007-9#1)(2012-12#1)(2013-1#2)
silhouette##2##1##(1994-4#1)(2011-2#1)
silica (C18)##2##2##(1992-2#1)(1997-1#1)
silica (SiO(2))##2##2##(2007-12#1)(2011-1#1)
silica aerogels##4##2##(1990-7#1)(2010-4#3)
silica and a##2##3##(2008-10#1)(2008-2#1)
silica and##27##2##(1990-8#1)(1991-8#1)(1993-7#1)(1997-2#1)(2005-11#2)(2005-12#1)(2007-11#1)(2007-12#3)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#5)(2009-12#1)(2010-7#1)
silica as the shell##2##4##(2008-10#1)(2010-5#1)
silica as the##3##3##(2008-10#2)(2010-5#1)
silica as##6##2##(2005-11#1)(2007-11#1)(2008-10#3)(2010-5#1)
silica at##3##2##(2008-10#1)(2008-3#2)
silica based##2##2##(2008-10#2)
silica beads##3##2##(2008-10#3)
silica binding##2##2##(2008-12#2)
silica by a##2##3##(2005-11#1)(2007-11#1)
silica by##10##2##(2005-11#2)(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
silica can##2##2##(2008-10#1)(2008-2#1)
silica capillaries##2##2##(2008-10#2)
silica capillary and##2##3##(2008-10#2)
silica capillary columns##2##3##(2008-10#2)
silica capillary##10##2##(1996-5#2)(2005-11#1)(2007-8#1)(2008-10#6)
silica cartridge##2##2##(2008-10#2)
silica charge##3##2##(2005-11#3)
silica chromatography##3##2##(2008-10#3)
silica coating##2##2##(2005-11#1)(2009-8#1)
silica column and##2##3##(1997-3#1)(2008-10#1)
silica column##15##2##(1996-5#1)(1996-8#1)(1997-3#1)(2007-8#1)(2008-10#10)(2008-4#1)
silica columns##4##2##(2007-8#1)(2008-10#3)
silica content##3##2##(2008-10#3)
silica core##7##2##(2007-12#2)(2007-8#1)(2008-2#2)(2010-4#1)(2013-1#1)
silica during##2##2##(1995-2#1)(2008-10#1)
silica exposure##3##2##(2008-10#3)
silica extraction##2##2##(1997-8#1)(2008-10#1)
silica fiber and##2##3##(2007-11#1)(2008-2#1)
silica fiber laser##6##3##(2007-11#2)(2007-12#2)(2008-2#2)
silica fiber##23##2##(2007-11#5)(2007-12#5)(2008-1#2)(2008-2#11)
silica fibers##7##2##(2007-11#3)(2007-12#3)(2008-2#1)
silica fillers##3##2##(2009-7#3)
silica films for##2##3##(2007-11#1)(2008-2#1)
silica films##7##2##(2007-11#3)(2007-12#1)(2008-2#3)
silica for##3##2##(2008-10#1)(2008-2#2)
silica fume##3##2##(2008-10#3)
silica gel 60##2##3##(1994-3#1)(2008-10#1)
silica gel G##2##3##(1990-9#1)(2005-12#1)
silica gel TLC##2##3##(2008-11#1)(2010-4#1)
silica gel and estimated##2##4##(2008-10#2)
silica gel and the##2##4##(2007-1#1)(2008-10#1)
silica gel and##20##3##(1992-2#1)(2005-11#2)(2007-1#1)(2007-11#1)(2008-10#12)(2008-5#1)(2011-2#1)(2013-8#1)
silica gel as a solid##2##5##(2008-10#2)
silica gel as a##4##4##(2008-10#4)
silica gel as##5##3##(2008-10#5)
silica gel chemically modified with zirconium##2##6##(2008-10#2)
silica gel column chromatography##3##4##(1997-8#1)(2008-11#1)(2008-5#1)
silica gel column##11##3##(1991-5#1)(1991-9#1)(1995-1#2)(1997-5#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-5#2)
silica gel for the##2##4##(2008-10#2)
silica gel for##4##3##(2008-10#4)
silica gel has been##2##4##(2008-10#2)
silica gel in##2##3##(2008-10#2)
silica gel modified with niobium(V) oxide##3##6##(2008-10#1)(2008-3#2)
silica gel modified with##10##4##(2008-10#8)(2008-3#2)
silica gel modified##11##3##(2007-8#1)(2008-10#8)(2008-3#2)
silica gel phases##4##3##(2008-10#4)
silica gel stationary phase##9##4##(2008-10#9)
silica gel surface##3##3##(2008-10#3)
silica gel using##2##3##(1992-1#1)(1996-5#1)
silica gel was investigated##2##4##(2008-10#2)
silica gel was##10##3##(2005-11#1)(2007-12#1)(2008-10#8)
silica gel with##3##3##(2008-10#3)
silica gel##171##2##(1990-9#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1994-3#1)(1995-1#2)(1996-5#2)(1996-6#1)(1997-5#1)(1997-8#1)(2005-11#5)(2005-12#1)(2007-1#1)(2007-11#6)(2007-12#1)(2007-8#4)(2008-10#119)(2008-11#3)(2008-3#2)(2008-5#4)(2009-12#1)(2009-6#1)(2010-2#2)(2010-4#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#2)
silica gel)##2##2##(2008-10#2)
silica gels modified with##2##4##(2008-10#2)
silica gels were##2##3##(2005-11#1)(2008-10#1)
silica gels##17##2##(1990-12#1)(1990-8#1)(2005-11#1)(2007-11#1)(2008-10#11)(2010-4#2)
silica glass and##2##3##(2007-12#1)(2008-3#1)
silica glass microspheres##3##3##(2004-9#3)
silica glass plate##2##3##(2008-2#1)(2008-3#1)
silica glass##16##2##(2004-9#4)(2007-11#2)(2007-12#6)(2008-10#1)(2008-2#1)(2008-3#2)
silica glasses##3##2##(2007-12#3)
silica in aqueous##2##3##(2008-10#2)
silica in the##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
silica in##12##2##(2005-12#1)(2006-12#1)(2007-12#1)(2008-10#7)(2008-11#1)(2012-2#1)
silica incorporated##2##2##(2008-5#2)
silica is##7##2##(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#1)
silica matrix##4##2##(1990-7#1)(2007-12#1)(2008-10#2)
silica membrane disks modified with##5##5##(2008-10#5)
silica membrane disks modified##10##4##(2008-10#10)
silica membrane##11##2##(2008-10#11)
silica microspheres##9##2##(2006-12#2)(2007-11#1)(2007-12#2)(2009-2#3)(2013-8#1)
silica modified by organofunctional silane##2##5##(2009-7#2)
silica modified by##3##3##(2007-11#1)(2009-7#2)
silica modified with N-propylsalicylaldimine##2##4##(2008-10#2)
silica modified with##4##3##(2008-10#4)
silica modified##7##2##(2007-11#1)(2008-10#4)(2009-7#2)
silica monoliths##4##2##(2007-12#1)(2008-10#3)
silica nanoparticle##3##2##(2008-7#1)(2010-4#1)(2011-1#1)
silica nanoparticle-supported lipid bilayers##4##4##(2012-11#4)
silica nanoparticles##24##2##(2007-8#2)(2008-7#2)(2009-2#3)(2010-12#4)(2010-4#4)(2011-1#1)(2012-11#8)
silica nanospheres##4##2##(2008-10#2)(2012-11#2)
silica network##4##2##(2005-11#3)(2007-12#1)
silica on##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
silica optical fiber##2##3##(2007-11#1)(2007-12#1)
silica optical##3##2##(2007-11#2)(2007-12#1)
silica or##4##2##(2005-11#2)(2007-12#1)(2008-10#1)
silica particles were##2##3##(2010-4#1)(2013-8#1)
silica particles##21##2##(1990-12#1)(1990-8#1)(2005-11#8)(2006-12#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-4#1)(2012-11#2)(2013-8#1)
silica planar waveguide##2##3##(2008-1#2)
silica precursor##2##2##(2010-4#2)
silica sample##2##2##(2007-12#1)(2008-1#1)
silica samples##3##2##(2005-11#1)(2007-12#1)(2008-10#1)
silica shell##3##2##(2005-11#1)(2009-2#1)(2010-3#1)
silica shells doped with##2##4##(2009-7#1)(2010-3#1)
silica shells##4##2##(2006-12#1)(2009-7#2)(2010-3#1)
silica slabs##2##2##(2008-3#2)
silica sol-gel modified##2##3##(2008-10#2)
silica sol-gel##5##2##(2007-8#1)(2008-10#4)
silica sol-gels##2##2##(2010-7#2)
silica source and##2##3##(2010-2#2)
silica spheres##3##2##(2005-11#3)
silica stationary phase##4##3##(2008-10#3)(2013-8#1)
silica stationary phases##3##3##(2007-8#1)(2008-10#2)
silica stationary##7##2##(2007-8#1)(2008-10#5)(2013-8#1)
silica submicrospheres as cores##2##4##(2005-11#2)
silica submicrospheres##3##2##(2005-11#3)
silica substrate##7##2##(1995-3#1)(2008-10#1)(2008-2#3)(2008-3#2)
silica substrates##2##2##(2007-11#1)(2008-2#1)
silica support##6##2##(1990-8#1)(1996-8#1)(1997-2#1)(2008-10#3)
silica supports##3##2##(1990-12#2)(1990-8#1)
silica surface and##2##3##(1993-12#1)(2008-10#1)
silica surface were obtained##2##4##(2008-10#2)
silica surface were##3##3##(2008-10#3)
silica surface##22##2##(1993-12#2)(1996-8#1)(1997-2#1)(1997-3#1)(2005-11#4)(2007-11#1)(2008-10#11)(2008-3#1)
silica surfaces##11##2##(2005-11#5)(2008-10#3)(2010-2#2)(2010-7#1)
silica that##2##2##(2005-11#1)(2012-12#1)
silica to##2##2##(1996-5#1)(2008-3#1)
silica using a##3##3##(2008-3#1)(2009-7#2)
silica using##6##2##(2005-11#2)(2008-3#1)(2009-7#2)(2012-2#1)
silica was##12##2##(1991-8#1)(2005-11#1)(2005-12#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-8#2)(2012-12#1)
silica were##3##2##(2005-11#1)(2005-12#1)(2010-4#1)
silica with##7##2##(2007-12#2)(2008-10#2)(2008-12#1)(2008-3#1)(2010-2#1)
silica##836##1##(1990-11#1)(1990-12#5)(1990-6#1)(1990-7#2)(1990-8#5)(1990-9#1)(1991-5#1)(1991-8#4)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#3)(1993-12#2)(1993-2#1)(1993-7#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-2#2)(1995-3#1)(1996-5#6)(1996-6#1)(1996-8#3)(1997-1#1)(1997-2#3)(1997-3#3)(1997-5#1)(1997-8#4)(2004-9#5)(2005-11#78)(2005-12#8)(2006-12#6)(2007-1#1)(2007-11#49)(2007-12#59)(2007-3#1)(2007-8#15)(2008-1#7)(2008-10#312)(2008-11#4)(2008-12#5)(2008-2#41)(2008-3#36)(2008-4#1)(2008-5#9)(2008-6#2)(2008-7#7)(2008-8#2)(2009-12#4)(2009-2#10)(2009-3#1)(2009-6#1)(2009-7#12)(2009-8#3)(2010-12#6)(2010-2#8)(2010-3#3)(2010-4#24)(2010-5#1)(2010-7#5)(2010-8#1)(2011-1#3)(2011-2#1)(2011-3#1)(2012-11#23)(2012-12#3)(2012-2#5)(2013-1#3)(2013-8#9)
silica)##5##1##(1992-2#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
silica- and polymer-based packing materials in##2##6##(1990-12#2)
silica-based adsorbents##2##2##(1996-8#2)
silica-based and##2##2##(1991-3#1)(2008-10#1)
silica-based##24##1##(1990-12#1)(1991-3#4)(1992-1#1)(1996-8#6)(1997-2#2)(1997-8#1)(2007-8#1)(2008-10#4)(2008-2#3)(2008-4#1)
silica-coated gold##2##2##(2008-10#1)(2009-7#1)
silica-coated##6##1##(2008-10#4)(2009-7#1)(2009-8#1)
silica-fiber##2##1##(2007-12#1)(2008-10#1)
silica-gel##4##1##(2006-12#2)(2007-12#1)(2008-10#1)
silica-immobilized##3##1##(1992-2#1)(2008-10#2)
silica-organic##2##1##(2010-4#1)(2010-7#1)
silica-porphyrin hybrid##2##2##(2010-7#2)
silica-surfactant nanochannels##3##2##(2007-8#3)
silicagel##3##1##(2008-10#2)(2008-5#1)
silicalite##2##1##(2008-10#2)
silicas with##2##2##(1990-8#1)(2005-11#1)
silicas##13##1##(1990-12#1)(1990-8#2)(1992-7#1)(1996-8#1)(2005-11#5)(2008-1#2)(2008-10#1)
silicate film##3##2##(2008-10#3)
silicate gel##3##2##(2005-11#3)
silicate glass##5##2##(2007-12#2)(2008-3#3)
silicate glasses##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
silicate in the##2##3##(2008-10#1)(2010-2#1)
silicate in##3##2##(2008-10#2)(2010-2#1)
silicate interference in##2##3##(2008-10#2)
silicate interference##4##2##(2008-10#4)
silicate liquid##2##2##(1992-1#2)
silicate materials##2##2##(2005-11#1)(2007-12#1)
silicate surface##4##2##(2005-11#4)
silicate##74##1##(1991-3#1)(1992-1#2)(1995-6#1)(2005-11#13)(2007-11#3)(2007-12#10)(2008-1#2)(2008-10#26)(2008-2#2)(2008-3#5)(2008-6#1)(2009-7#2)(2009-8#1)(2010-2#2)(2010-5#1)(2010-9#1)(2011-2#1)
silicates in##2##2##(2008-10#2)
silicates with##2##2##(2005-11#2)
silicates##10##1##(1992-7#1)(2005-11#5)(2008-10#4)
siliceous##4##1##(1997-8#1)(2008-10#2)(2012-2#1)
silicic acid and##2##3##(2005-11#1)(2008-5#1)
silicic acid##12##2##(1990-10#1)(2005-11#8)(2008-10#1)(2008-5#1)(2010-4#1)
silicic sol solution##3##3##(2005-11#3)
silicic##16##1##(1990-10#1)(2005-11#12)(2008-10#1)(2008-5#1)(2010-4#1)
silico analysis##4##2##(2008-7#1)(2009-8#1)(2011-2#1)(2013-1#1)
silico and in vitro##2##4##(2008-10#1)(2013-1#1)
silico docking##2##2##(2013-1#1)(2013-8#1)
silico methods##2##2##(2009-8#1)(2009-9#1)
silico prediction##4##2##(2008-4#2)(2012-3#2)
silico##57##1##(2007-11#1)(2008-10#3)(2008-4#3)(2008-7#12)(2008-8#2)(2009-2#1)(2009-8#3)(2009-9#5)(2010-11#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#6)
silicon (Si)##10##2##(1996-3#1)(1996-8#1)(2008-10#5)(2008-3#1)(2008-9#1)(2012-2#1)
silicon CCD camera##2##3##(2007-11#2)
silicon CCD##4##2##(2006-12#1)(2007-11#3)
silicon and alkali##2##3##(2013-8#2)
silicon and germanium containing##3##4##(2008-3#2)(2008-5#1)
silicon and silicon##2##3##(2008-2#1)(2008-3#1)
silicon and##18##2##(1993-4#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#5)(2008-5#3)(2013-8#2)
silicon are##2##2##(2007-12#1)(2008-2#1)
silicon area##3##2##(2008-2#3)
silicon as##2##2##(2008-3#2)
silicon atom##3##2##(2008-5#1)(2010-12#2)
silicon atoms##4##2##(2007-12#2)(2010-12#2)
silicon by##4##2##(2008-10#2)(2008-2#1)(2012-2#1)
silicon carbide##3##2##(1996-5#1)(2008-2#2)
silicon chip##2##2##(2006-12#1)(2008-2#1)
silicon content##3##2##(2008-10#3)
silicon dioxide##12##2##(1992-7#1)(1996-8#1)(2005-11#1)(2006-6#1)(2007-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-12#1)(2012-12#3)
silicon has been##2##3##(2005-11#1)(2008-10#1)
silicon has##3##2##(2005-11#1)(2008-10#1)(2012-12#1)
silicon in##8##2##(2006-12#1)(2008-10#5)(2008-2#1)(2012-12#1)
silicon is##3##2##(2007-8#1)(2008-10#1)(2008-2#1)
silicon layers##3##2##(2008-10#2)(2008-2#1)
silicon microlenses##3##2##(2008-2#3)
silicon micromachined##2##2##(2007-11#1)(2008-3#1)
silicon micromachining##2##2##(2006-5#1)(2008-2#1)
silicon mirror##2##2##(2008-2#1)(2008-3#1)
silicon nanoparticles##6##2##(2012-11#6)
silicon nanowire##3##2##(2009-11#2)(2010-7#1)
silicon nanowires##5##2##(2008-7#2)(2010-3#2)(2010-7#1)
silicon nitride deformable##2##3##(2007-12#2)
silicon nitride membrane##2##3##(2006-5#1)(2007-12#1)
silicon nitride##9##2##(2006-2#1)(2006-5#1)(2007-12#3)(2008-10#1)(2008-3#2)(2009-2#1)
silicon oil##4##2##(2008-10#3)(2008-5#1)
silicon on##3##2##(2008-10#2)(2008-9#1)
silicon oxide##19##2##(2005-11#1)(2006-12#6)(2006-2#1)(2007-12#3)(2008-10#3)(2008-2#1)(2008-3#3)(2008-7#1)
silicon oxynitride material##2##3##(2008-3#1)(2013-8#1)
silicon oxynitride##4##2##(2008-3#1)(2013-8#3)
silicon photodetector##3##2##(2007-11#1)(2008-3#2)
silicon photodetectors##2##2##(2008-2#1)(2008-3#1)
silicon photodiode##5##2##(2008-2#2)(2008-3#3)
silicon photodiodes##2##2##(2007-11#1)(2008-2#1)
silicon retina##3##2##(2008-2#3)
silicon rubber##2##2##(2006-11#1)(2007-7#1)
silicon structures##2##2##(2008-2#1)(2008-7#1)
silicon substrate by##2##3##(2007-12#2)
silicon substrate##12##2##(2007-12#5)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)
silicon substrates##9##2##(2007-12#4)(2007-9#1)(2008-10#1)(2009-11#2)(2010-9#1)
silicon surface##3##2##(2007-12#1)(2008-10#1)(2012-2#1)
silicon surfaces##5##2##(2008-10#1)(2008-7#4)
silicon technology##2##2##(2007-12#1)(2008-7#1)
silicon tethers##2##2##(2008-8#2)
silicon tetrafluoride##3##2##(2008-10#3)
silicon wafer surface##2##3##(2005-11#1)(2008-5#1)
silicon wafer##13##2##(2005-11#2)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)
silicon wafers with##3##3##(2007-2#1)(2012-11#2)
silicon wafers##11##2##(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-11#2)(2012-2#1)
silicon was##3##2##(2006-12#1)(2006-4#1)(2008-10#1)
silicon were##4##2##(2008-10#3)(2009-10#1)
silicon with a##2##3##(2007-12#1)(2008-1#1)
silicon with##3##2##(2007-12#1)(2008-1#1)(2008-10#1)
silicon##421##1##(1991-5#1)(1991-9#1)(1992-11#2)(1992-5#2)(1992-7#1)(1993-4#1)(1993-8#1)(1994-2#1)(1995-5#1)(1995-9#1)(1996-3#1)(1996-5#2)(1996-8#2)(1997-6#1)(2004-9#1)(2005-11#11)(2006-11#1)(2006-12#13)(2006-2#5)(2006-4#5)(2006-5#4)(2006-6#1)(2007-1#1)(2007-11#17)(2007-12#36)(2007-2#2)(2007-7#2)(2007-8#5)(2007-9#3)(2008-1#3)(2008-10#91)(2008-11#7)(2008-12#1)(2008-2#50)(2008-3#51)(2008-4#1)(2008-5#13)(2008-7#15)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#7)(2009-2#1)(2009-5#1)(2010-1#1)(2010-12#6)(2010-3#2)(2010-4#3)(2010-5#1)(2010-7#2)(2010-9#2)(2011-2#1)(2012-11#8)(2012-12#8)(2012-2#7)(2013-1#2)(2013-8#6)
silicon-based materials##2##2##(1997-3#1)(2007-8#1)
silicon-based technologies##2##2##(2008-7#1)(2012-2#1)
silicon-based##12##1##(1997-3#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-2#1)(2010-6#1)(2012-2#1)
silicon-on-insulator (SOI)##2##2##(2007-12#1)(2013-8#1)
silicon-on-insulator##7##1##(2007-11#2)(2007-12#3)(2008-3#1)(2013-8#1)
silicon-treated plants##3##2##(2008-10#3)
silicone and##3##2##(2004-9#1)(2008-10#1)(2011-2#1)
silicone catheter##4##2##(2013-1#4)
silicone catheters##4##2##(2007-7#4)
silicone gel##10##2##(2006-11#1)(2007-1#2)(2007-4#4)(2008-9#1)(2010-2#2)
silicone gel-filled implants##2##3##(1996-3#2)
silicone gel-filled##3##2##(1992-2#1)(1996-3#2)
silicone intraocular##2##2##(2008-3#2)
silicone membrane##2##2##(2008-10#1)(2008-11#1)
silicone membranes##2##2##(2008-11#1)(2008-6#1)
silicone oil##10##2##(1997-2#1)(2005-11#3)(2008-10#3)(2008-3#1)(2008-5#1)(2010-4#1)
silicone only##2##2##(2004-9#1)(2012-2#1)
silicone rubber##11##2##(1994-11#1)(2004-9#2)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)
silicone stent##2##2##(2007-8#1)(2013-1#1)
silicone tracheal stent##2##3##(2007-8#2)
silicone tracheal##3##2##(2007-8#2)(2012-12#1)
silicone tubing##3##2##(2007-1#1)(2008-10#2)
silicone##122##1##(1992-2#2)(1993-2#1)(1994-11#1)(1995-12#1)(1996-12#2)(1996-3#3)(1996-6#1)(1997-2#1)(2004-9#7)(2005-11#4)(2006-11#1)(2006-6#1)(2006-8#2)(2007-1#3)(2007-10#1)(2007-11#1)(2007-4#4)(2007-7#8)(2007-8#8)(2008-10#11)(2008-11#7)(2008-2#3)(2008-3#4)(2008-5#11)(2008-6#1)(2008-7#2)(2008-9#7)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-2#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#7)
silicone-oil##2##1##(1992-4#1)(2007-12#1)
silicone-rubber##2##1##(1994-10#1)(2007-4#1)
silicones##5##1##(1996-3#1)(2008-5#3)(2013-1#1)
silicosis and##4##2##(2009-12#3)(2010-12#1)
silicosis in##2##2##(1992-11#1)(2012-2#1)
silicosis with##2##2##(2008-7#1)(2012-2#1)
silicosis##16##1##(1992-11#1)(1997-1#1)(2008-7#4)(2009-12#3)(2010-12#2)(2012-2#5)
silicotuberculosis##3##1##(2010-12#3)
silicotungstic acid##4##2##(2008-10#4)
siliqua##6##1##(2011-12#6)
silk emergence##2##2##(2008-10#2)
silk fibroin (SF)##2##3##(2008-5#2)
silk fibroin films##2##3##(2008-5#2)
silk fibroin##16##2##(2008-11#2)(2008-5#7)(2010-3#2)(2012-2#1)(2012-8#4)
silk glands##5##2##(2007-12#5)
silk moth##2##2##(1991-2#1)(1996-7#1)
silk press##3##2##(2007-12#3)
silk proteins##4##2##(1995-8#3)(2008-7#1)
silk suture##2##2##(2004-9#1)(2006-2#1)
silk##75##1##(1990-9#2)(1991-2#2)(1992-1#2)(1995-8#5)(1996-7#1)(2004-9#1)(2006-2#1)(2007-12#15)(2008-10#4)(2008-11#2)(2008-5#7)(2008-6#2)(2008-7#5)(2008-9#1)(2010-3#3)(2011-1#2)(2012-2#16)(2012-8#4)
silk-producing##3##1##(2007-12#3)
silks were inoculated##2##3##(2008-10#2)
silks##9##1##(1995-8#2)(2008-10#7)
silkworm eclosion hormone##5##3##(1990-12#5)
silkworm larvae##4##2##(1996-2#1)(1997-3#1)(1997-4#1)(2008-11#1)
silkworm##35##1##(1990-12#6)(1990-3#1)(1991-10#4)(1992-11#1)(1993-12#1)(1993-3#2)(1995-11#5)(1996-2#1)(1997-3#1)(1997-4#1)(1997-8#2)(2008-10#2)(2008-11#2)(2008-5#2)(2008-9#2)(2010-3#1)(2012-2#1)
silkworms##3##1##(2008-11#1)(2008-5#2)
sill values##2##2##(2008-10#2)
sill##5##1##(1991-11#1)(2008-10#4)
sillenite##2##1##(2007-12#2)
sillenites##2##1##(2007-12#2)
sillimanite##4##1##(2005-11#4)
silo##2##1##(2007-7#1)(2008-10#1)
silorane##2##1##(2011-2#2)
silos##3##1##(2007-7#1)(2008-7#1)(2009-4#1)
siloxane##8##1##(2005-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-5#1)(2010-4#2)(2011-1#1)
siloxane)##2##1##(2008-11#1)(2008-5#1)
silt (0##2##2##(2008-10#2)
silt + leaf mold##3##4##(2008-12#3)
silt loam soil##3##3##(2008-10#3)
silt loam##9##2##(2004-4#2)(2008-10#7)
silt##19##1##(2004-4#2)(2008-10#11)(2008-12#5)(2013-8#1)
silthiofam##2##1##(2008-10#2)
silty clay loam##3##3##(2008-10#3)
silty clay##6##2##(2008-10#3)(2010-12#1)(2012-12#2)
silty##7##1##(2008-10#4)(2010-12#1)(2012-12#2)
silvanus##3##1##(2011-2#3)
silver (Ag)##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2010-4#1)
silver administration##3##2##(1997-8#3)
silver amalgam##2##2##(2008-10#1)(2013-1#1)
silver and cadmium##3##3##(1997-2#2)(2008-10#1)
silver and copper##3##3##(2008-10#2)(2008-5#1)
silver and manganese##3##3##(2008-10#3)
silver and the##2##3##(2007-12#1)(2012-2#1)
silver and##16##2##(1992-12#1)(1997-2#2)(1997-8#1)(2007-12#2)(2008-10#7)(2008-3#1)(2008-5#1)(2012-2#1)
silver as##4##2##(2008-10#3)(2010-6#1)
silver at##4##2##(2007-8#1)(2008-10#3)
silver birch (Betula pendula)##2##4##(2004-4#1)(2012-5#1)
silver birch##3##2##(2004-4#2)(2012-5#1)
silver bromide crystals##3##3##(2008-2#3)
silver by##3##2##(2008-10#2)(2008-3#1)
silver chloride activated surface-silver##2##4##(2008-10#2)
silver chloride##5##2##(2008-10#4)(2010-5#1)
silver coating##2##2##(2007-12#2)
silver colloid##5##2##(2007-8#4)(2008-2#1)
silver colloidal##3##2##(2005-11#1)(2008-10#2)
silver deposits##2##2##(2008-7#2)
silver diethyldithiocarbamate##4##2##(2008-10#4)
silver electrode##7##2##(2008-10#7)
silver enhancement##4##2##(2008-10#2)(2010-1#2)
silver film##6##2##(2007-12#1)(2008-2#2)(2008-3#3)
silver films##2##2##(2008-3#1)(2009-5#1)
silver grain##3##2##(1997-5#2)(2008-4#1)
silver grains##4##2##(1993-11#1)(2008-3#2)(2008-5#1)
silver halide sensitized gelatin##2##4##(2007-11#1)(2008-3#1)
silver halide##7##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)
silver hollow glass waveguides##2##4##(2008-2#2)
silver impregnation and sequence specific fluorochromes CMA3 and DAPI##2##9##(2008-12#2)
silver impregnation##3##2##(2008-12#2)(2008-7#1)
silver in environmental samples##2##4##(2008-10#2)
silver in environmental##3##3##(2008-10#3)
silver in##15##2##(2005-11#1)(2007-8#2)(2008-10#11)(2010-4#1)
silver ion##10##2##(2007-8#4)(2008-10#6)
silver ions##16##2##(2008-10#11)(2008-3#1)(2008-5#1)(2010-1#1)(2010-7#2)
silver island films##2##3##(2008-10#1)(2008-3#1)
silver island##5##2##(2008-10#1)(2008-3#4)
silver jewelry##2##2##(2007-12#2)
silver leaf whitefly##2##3##(2008-10#1)(2011-12#1)
silver mirror reaction glass##2##4##(2009-4#2)
silver mottle virus##10##3##(2008-10#10)
silver nanocrystals##2##2##(2008-7#2)
silver nanocubes##6##2##(2008-5#3)(2013-1#3)
silver nanoparticle##3##2##(2005-11#1)(2008-3#1)(2010-7#1)
silver nanoparticles and##5##3##(2008-3#1)(2012-11#3)(2013-7#1)
silver nanoparticles by##2##3##(2010-1#2)
silver nanoparticles in##4##3##(2008-10#1)(2010-1#2)(2011-2#1)
silver nanoparticles is##2##3##(2010-1#2)
silver nanoparticles synthesized in##2##4##(2005-11#2)
silver nanoparticles synthesized##3##3##(2005-11#2)(2010-1#1)
silver nanoparticles were##5##3##(2009-4#1)(2011-2#1)(2013-7#3)
silver nanoparticles with##2##3##(2005-11#1)(2009-3#1)
silver nanoparticles##50##2##(2005-11#8)(2007-11#1)(2007-12#1)(2008-10#5)(2008-3#2)(2009-3#7)(2009-4#1)(2010-1#11)(2010-11#1)(2011-2#5)(2012-11#3)(2013-7#5)
silver nitrate and##2##3##(2008-10#2)
silver nitrate##15##2##(1997-8#1)(2005-11#4)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#5)(2013-1#1)(2013-7#1)
silver on##2##2##(2005-11#1)(2008-10#1)
silver or##3##2##(2008-10#1)(2008-4#1)(2010-6#1)
silver oxide##3##2##(2008-10#3)
silver particles in##2##3##(2005-11#1)(2010-6#1)
silver particles##4##2##(2005-11#1)(2008-10#2)(2010-6#1)
silver pomfret##2##2##(2008-12#2)
silver preconcentration##2##2##(2008-10#2)
silver scurf of##3##3##(2008-10#3)
silver sea bream##3##3##(2009-5#1)(2010-5#2)
silver solution##2##2##(2008-10#1)(2008-2#1)
silver stain##2##2##(2008-4#1)(2012-3#1)
silver staining and##4##3##(1991-11#1)(1992-8#1)(1994-6#1)(2008-7#1)
silver staining in the##2##4##(1992-8#1)(1994-6#1)
silver staining in##3##3##(1991-1#1)(1992-8#1)(1994-6#1)
silver staining methods##2##3##(1997-3#1)(2008-2#1)
silver staining##43##2##(1990-11#1)(1990-3#1)(1990-8#1)(1991-1#1)(1991-10#4)(1991-11#2)(1992-8#2)(1994-6#3)(1995-12#1)(1997-3#2)(2005-8#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-4#6)(2008-5#1)(2008-7#3)(2008-8#3)(2010-1#2)(2010-3#1)(2010-9#1)(2012-12#1)(2012-2#1)
silver stains##2##2##(1991-1#2)
silver surface##5##2##(2005-4#3)(2008-10#2)
silver surfaces##3##2##(2007-12#3)
silver were##3##2##(2008-10#3)
silver##444##1##(1990-11#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-1#3)(1991-10#4)(1991-11#2)(1992-12#5)(1992-8#3)(1993-11#1)(1994-6#3)(1995-12#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-4#1)(1997-2#2)(1997-3#3)(1997-5#2)(1997-8#6)(2004-4#2)(2004-9#1)(2005-11#30)(2005-4#4)(2005-8#1)(2006-12#2)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#20)(2007-7#3)(2007-8#13)(2008-10#141)(2008-12#6)(2008-2#18)(2008-3#25)(2008-4#10)(2008-5#18)(2008-7#8)(2008-8#4)(2009-2#2)(2009-3#8)(2009-4#3)(2009-5#2)(2010-1#17)(2010-11#4)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#7)(2010-7#3)(2010-9#1)(2011-12#1)(2011-2#7)(2012-11#3)(2012-12#1)(2012-2#5)(2012-3#1)(2012-5#1)(2013-1#7)(2013-7#7)(2013-8#4)
silver(I) and##4##2##(2008-10#3)(2008-5#1)
silver(I) at##2##2##(2008-10#2)
silver(I) by##2##2##(2008-10#2)
silver(I) complexes of the##2##4##(2008-5#2)
silver(I) complexes##5##2##(2008-10#1)(2008-5#4)
silver(I) was##2##2##(2008-10#2)
silver(I)##31##1##(2008-10#23)(2008-5#6)(2010-5#2)
silver(i)##3##1##(2008-5#3)
silver-bound##2##1##(1997-8#2)
silver-coated##6##1##(2004-9#1)(2008-2#1)(2008-3#2)(2010-7#2)
silver-containing##2##1##(2005-11#1)(2012-3#1)
silver-cysteine##3##1##(1992-12#3)
silver-enhanced immunogold##2##2##(1997-6#1)(1997-7#1)
silver-enhanced##3##1##(1997-6#1)(1997-7#1)(2008-10#1)
silver-nitrate##2##1##(1992-12#2)
silver-resistance##2##1##(2008-5#2)
silver-stained##2##1##(1990-3#1)(1994-5#1)
silvicultural##2##1##(2008-5#1)(2011-2#1)
silybin##2##1##(2008-11#1)(2008-5#1)
silyl acetal##2##2##(2008-4#2)
silyl##9##1##(1990-10#1)(2008-4#5)(2008-5#1)(2009-5#1)(2009-7#1)
silylated carbon nanotubes##2##3##(2008-3#2)
silylated##10##1##(1996-5#5)(2008-3#2)(2008-4#1)(2008-5#1)(2012-3#1)
silylation of the##2##3##(1996-5#1)(2007-8#1)
silylation##7##1##(1996-5#1)(2007-8#1)(2008-10#3)(2008-5#1)(2010-11#1)
silymarin##5##1##(2005-6#1)(2005-8#1)(2010-11#1)(2010-12#2)
sim##5##1##(1991-12#5)
simazine and##3##2##(2008-10#3)
simazine in##4##2##(2008-10#4)
simazine##22##1##(2007-8#1)(2008-10#19)(2008-2#2)
simian gastroepiploic##3##2##(1993-3#3)
simian immunodeficiency virus (SIV) was##2##5##(1992-6#1)(1995-8#1)
simian immunodeficiency virus (SIV)##8##4##(1992-12#1)(1992-6#1)(1995-2#2)(1995-8#1)(1997-3#1)(1997-6#1)(2007-11#1)
simian immunodeficiency virus protease##2##4##(1991-9#1)(1992-6#1)
simian immunodeficiency virus##18##3##(1991-9#1)(1992-12#1)(1992-6#2)(1993-9#2)(1995-2#4)(1995-8#1)(1997-3#2)(1997-6#1)(2007-11#1)(2009-4#2)(2013-7#1)
simian immunodeficiency##21##2##(1991-9#1)(1992-12#1)(1992-6#2)(1993-9#2)(1995-2#4)(1995-8#1)(1996-4#1)(1997-3#2)(1997-6#2)(2007-11#1)(2007-3#1)(2009-4#2)(2013-7#1)
simian virus 40 (SV40) early##2##5##(1993-4#1)(1997-8#1)
simian virus 40 DNA##2##4##(1990-12#1)(1997-1#1)
simian virus 40 large##3##4##(1990-6#1)(2008-11#1)(2013-1#1)
simian virus 40##16##3##(1990-12#1)(1990-6#1)(1993-4#1)(1994-3#1)(1994-6#2)(1994-8#2)(1995-2#1)(1995-6#1)(1997-1#1)(1997-7#1)(1997-8#1)(2008-11#2)(2013-1#1)
simian virus##20##2##(1990-12#1)(1990-6#1)(1993-4#1)(1994-3#1)(1994-6#2)(1994-8#2)(1995-2#1)(1995-6#1)(1997-1#3)(1997-7#1)(1997-8#1)(2008-11#2)(2010-12#2)(2013-1#1)
simian##54##1##(1990-12#1)(1990-6#1)(1991-9#1)(1992-12#1)(1992-6#2)(1992-8#2)(1993-3#4)(1993-4#1)(1993-9#2)(1994-3#1)(1994-6#2)(1994-8#2)(1995-11#1)(1995-2#5)(1995-6#1)(1995-8#1)(1996-12#1)(1996-4#1)(1997-1#3)(1997-3#2)(1997-6#2)(1997-7#1)(1997-8#1)(2007-11#1)(2007-3#1)(2008-11#3)(2008-4#2)(2008-9#1)(2009-4#2)(2010-12#2)(2012-12#1)(2013-1#1)(2013-7#1)
simii in a##3##3##(2008-5#3)
simii##5##1##(2008-5#5)
similar &quot##2##2##(1994-6#1)(2008-10#1)
similar (0##2##2##(1992-11#1)(2008-5#1)
similar (P&gt##3##2##(2010-4#2)(2012-12#1)
similar (p&gt##2##2##(2007-10#1)(2013-1#1)
similar DNA binding##2##3##(1994-8#1)(1995-1#1)
similar DNA sequences##4##3##(1996-7#1)(2008-4#1)(2008-9#2)
similar DNA##9##2##(1994-8#1)(1995-1#1)(1996-7#1)(1997-1#1)(2007-1#1)(2008-4#1)(2008-5#1)(2008-9#2)
similar EC50 values##2##3##(1995-12#2)
similar HPLC##2##2##(1990-3#1)(1991-3#1)
similar Km values##2##3##(1994-6#1)(1995-5#1)
similar Km##5##2##(1990-11#1)(1990-12#1)(1992-6#1)(1994-6#1)(1995-5#1)
similar Mr##3##2##(1990-9#1)(1991-1#1)(1991-2#1)
similar P##2##2##(2008-10#1)(2012-3#1)
similar Vmax##2##2##(1990-12#1)(1993-6#1)
similar a##2##2##(2008-2#1)(2010-2#1)
similar abnormalities##2##2##(2007-10#1)(2009-8#1)
similar according to##2##3##(2010-12#1)(2013-1#1)
similar accuracy##2##2##(2012-3#1)(2013-8#1)
similar across different##2##3##(2008-5#1)(2013-8#1)
similar across the##2##3##(2008-3#1)(2013-1#1)
similar across##14##2##(1991-3#1)(1994-3#1)(1997-2#1)(2008-1#1)(2008-3#1)(2008-5#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-11#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
similar activation##2##2##(1996-12#1)(1997-7#1)
similar activity##4##2##(1996-2#1)(2006-8#1)(2008-5#1)(2010-7#1)
similar affinities##7##2##(1990-5#1)(1993-9#1)(1994-2#1)(1995-6#1)(1996-12#1)(1996-7#1)(1996-8#1)
similar affinity for##3##3##(1995-2#1)(1996-12#1)(2008-5#1)
similar affinity to##3##3##(1993-8#1)(1994-10#1)(1997-6#1)
similar affinity##7##2##(1992-6#1)(1993-8#1)(1994-10#1)(1995-2#1)(1996-12#1)(1997-6#1)(2008-5#1)
similar after##2##2##(1995-5#1)(2008-10#1)
similar age and##2##3##(2008-1#1)(2013-1#1)
similar age##9##2##(1992-8#1)(1994-11#1)(1996-5#1)(2008-1#1)(2008-4#1)(2009-12#1)(2010-2#1)(2012-3#1)(2013-1#1)
similar amino acids##2##3##(1995-9#2)
similar amino##3##2##(1995-9#2)(1997-1#1)
similar among all##2##3##(1995-12#1)(2007-11#1)
similar among the##6##3##(1992-9#1)(1994-11#1)(2006-10#1)(2006-5#1)(2007-10#1)(2008-10#1)
similar among##21##2##(1992-9#1)(1994-11#1)(1995-11#1)(1995-12#2)(2006-10#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-5#2)(2009-9#1)(2011-11#1)(2012-11#1)(2013-8#1)
similar amounts of##10##3##(1993-6#1)(1994-8#1)(2007-10#1)(2007-2#1)(2008-11#2)(2008-5#1)(2009-3#1)(2010-2#1)(2010-8#1)
similar amounts##13##2##(1993-6#1)(1994-7#1)(1994-8#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-2#1)(2008-11#2)(2008-5#1)(2009-3#1)(2010-2#1)(2010-8#1)
similar and the##4##3##(1996-3#1)(2007-11#1)(2008-10#1)(2008-7#1)
similar and##27##2##(1991-4#1)(1993-4#1)(1994-8#1)(1995-1#1)(1996-2#1)(1996-3#1)(1996-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-12#1)(2012-3#1)(2013-8#1)
similar antibody##2##2##(1996-12#1)(2011-2#1)
similar antiviral##2##2##(1991-7#1)(2005-7#1)
similar approach##8##2##(1993-11#2)(1997-4#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-8#1)
similar approaches to##2##3##(2010-3#1)(2010-6#1)
similar approaches##6##2##(2008-8#1)(2010-3#1)(2010-6#1)(2011-2#1)(2013-1#2)
similar area##2##2##(2006-12#1)(2008-7#1)
similar arrangement##3##2##(1995-8#1)(1996-2#1)(1997-7#1)
similar as##6##2##(1990-3#1)(1996-7#1)(1997-8#1)(2008-5#1)(2009-4#1)(2010-6#1)
similar association between##3##3##(1996-5#1)(1996-8#1)(1996-9#1)
similar at both##3##3##(1997-7#1)(2008-4#1)(2010-12#1)
similar at the amino acid##2##5##(1991-4#1)(1995-8#1)
similar at the##5##3##(1991-4#2)(1995-12#1)(1995-8#1)(2011-2#1)
similar at##15##2##(1990-5#1)(1991-4#2)(1993-7#1)(1995-12#1)(1995-8#1)(1997-7#2)(2006-10#1)(2007-1#1)(2007-8#1)(2008-4#1)(2009-2#1)(2010-12#1)(2011-2#1)
similar bacterial##2##2##(2005-12#1)(2013-1#1)
similar banding pattern##2##3##(2008-10#1)(2008-12#1)
similar banding##3##2##(2005-12#1)(2008-10#1)(2008-12#1)
similar behavior to##2##3##(1994-8#1)(2006-5#1)
similar behavior##9##2##(1991-2#1)(1991-6#1)(1994-8#1)(1994-9#1)(2005-11#1)(2006-5#1)(2008-11#1)(2008-3#1)(2012-12#1)
similar behavioral##2##2##(1991-9#1)(1996-6#1)
similar benefit##2##2##(1993-11#1)(2008-3#1)
similar between groups##2##3##(2006-12#1)(2013-1#1)
similar between the two groups##2##5##(2007-8#1)(2008-8#1)
similar between the##9##3##(1996-7#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-8#1)(2011-2#1)(2013-1#1)
similar between treatment groups##2##4##(2010-4#1)(2012-12#1)
similar between treatment##3##3##(2010-4#1)(2012-12#1)(2012-3#1)
similar between##40##2##(1991-9#1)(1992-12#1)(1993-5#1)(1994-11#1)(1994-5#1)(1995-5#1)(1995-8#2)(1996-5#1)(1996-7#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-8#2)(2009-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2012-5#1)(2013-1#4)(2013-8#1)
similar binding properties##2##3##(1991-5#1)(2008-10#1)
similar binding##9##2##(1991-5#2)(1992-5#1)(1993-6#1)(1994-8#1)(1995-2#1)(1997-6#1)(2008-10#1)(2012-2#1)
similar biochemical##3##2##(1994-8#1)(1995-11#1)(2006-7#1)
similar biological activities##2##3##(1991-10#1)(1995-1#1)
similar biological properties##3##3##(1993-12#1)(1993-8#1)(2008-5#1)
similar biological##9##2##(1990-7#1)(1991-10#1)(1991-2#1)(1993-12#1)(1993-8#1)(1995-1#1)(2008-3#1)(2008-5#1)(2013-8#1)
similar biomechanical##2##2##(2008-9#1)(2009-1#1)
similar biosynthetic##2##2##(1996-10#1)(2012-2#1)
similar body##2##2##(2008-9#1)(2012-2#1)
similar both##3##2##(1991-7#1)(1995-10#1)(2006-9#1)
similar but different##2##3##(1993-6#1)(2008-3#1)
similar but not identical to##2##5##(1991-3#1)(2006-10#1)
similar but not identical##3##4##(1991-3#1)(1991-4#1)(2006-10#1)
similar but not##4##3##(1991-3#1)(1991-4#1)(2006-10#1)(2008-7#1)
similar but separate##2##3##(1992-7#1)(2012-12#1)
similar but##24##2##(1991-3#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-7#1)(1993-5#1)(1993-6#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-7#1)(2006-10#2)(2006-4#2)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#2)(2011-1#1)(2012-12#1)
similar capacities##2##2##(1990-3#1)(1991-9#1)
similar case has been reported in##2##6##(1991-4#1)(2012-12#1)
similar case reports##2##3##(2008-7#1)(2011-2#1)
similar case##10##2##(1991-4#1)(1996-3#1)(2007-11#2)(2008-7#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)
similar cases in the##2##4##(1997-3#1)(2012-12#1)
similar cases in##3##3##(1997-3#1)(2012-12#2)
similar cases##13##2##(1992-2#1)(1997-3#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-12#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
similar catalytic activity##2##3##(2008-10#1)(2010-2#1)
similar catalytic##3##2##(1994-8#1)(2008-10#1)(2010-2#1)
similar cell##6##2##(1990-4#1)(1994-11#1)(2008-11#2)(2008-4#1)(2008-5#1)
similar cellular##2##2##(2011-2#1)(2012-12#1)
similar change in##2##3##(1990-3#1)(1994-5#1)
similar change##3##2##(1990-3#1)(1994-3#1)(1994-5#1)
similar changes in the##2##4##(1991-7#1)(1995-10#1)
similar changes in##5##3##(1991-7#1)(1995-10#1)(2006-11#1)(2008-10#1)(2010-12#1)
similar changes to##2##3##(1991-6#1)(2013-1#1)
similar changes were##3##3##(2010-11#1)(2010-12#1)(2010-2#1)
similar changes##15##2##(1991-6#1)(1991-7#1)(1994-9#1)(1995-10#1)(1995-2#1)(2006-11#1)(2008-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2012-11#1)(2013-1#1)(2013-8#2)
similar characteristics in##2##3##(2009-9#1)(2010-8#1)
similar characteristics to##3##3##(2007-4#1)(2007-5#1)(2007-7#1)
similar characteristics##15##2##(1990-2#1)(1990-8#1)(1992-4#1)(1992-6#1)(1994-12#1)(1995-11#1)(2006-4#1)(2007-4#1)(2007-5#1)(2007-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#1)
similar chemical##4##2##(2008-10#4)
similar children##2##2##(1992-7#1)(2009-12#1)
similar circumstances##3##2##(1991-3#1)(1993-3#1)(1993-5#1)
similar clinical features##2##3##(2006-10#1)(2012-11#1)
similar clinical presentations##2##3##(1993-7#1)(2006-10#1)
similar clinical##13##2##(1992-4#1)(1993-7#1)(1995-2#1)(2006-10#2)(2006-5#1)(2007-11#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#1)
similar compliance##2##2##(2007-4#1)(2007-7#1)
similar composition with##2##3##(1993-3#1)(2008-10#1)
similar composition##4##2##(1993-3#1)(2008-10#2)(2010-8#1)
similar compounds##7##2##(1990-12#1)(1990-8#1)(1991-4#1)(1996-2#1)(2007-11#1)(2008-10#1)(2010-5#1)
similar concentration of##2##3##(2008-10#1)(2008-6#1)
similar concentration##6##2##(1992-2#1)(1993-7#1)(1995-10#1)(2008-10#1)(2008-12#1)(2008-6#1)
similar concentration-dependent##2##2##(1995-12#1)(1995-5#1)
similar concentrations of##5##3##(1990-8#1)(1994-6#1)(1994-9#1)(1997-4#1)(2008-10#1)
similar concentrations##10##2##(1990-8#1)(1992-8#1)(1992-9#1)(1994-6#2)(1994-9#1)(1996-8#1)(1997-2#1)(1997-4#1)(2008-10#1)
similar concerning mortality##2##3##(2007-8#2)
similar conclusions##2##2##(2008-5#1)(2008-7#1)
similar conditions in the##2##4##(1991-5#1)(2008-10#1)
similar conditions of##2##3##(1997-4#1)(2008-10#1)
similar conditions was##2##3##(2008-10#1)(2010-4#1)
similar conditions##34##2##(1990-11#1)(1990-9#1)(1991-10#1)(1991-3#1)(1991-5#1)(1992-1#2)(1993-11#1)(1994-8#1)(1995-2#1)(1997-4#1)(1997-7#1)(2004-8#1)(2006-11#1)(2007-11#1)(2008-10#8)(2008-12#1)(2008-5#1)(2008-8#1)(2009-6#1)(2009-7#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2012-3#1)
similar configurations##3##2##(2006-11#1)(2008-10#1)(2009-8#1)
similar conformational##2##2##(1991-5#1)(1996-9#1)
similar conformations##2##2##(1992-8#1)(1996-8#1)
similar course##2##2##(2007-9#1)(2009-8#1)
similar criteria##2##2##(1995-6#1)(2008-7#1)
similar culture##2##2##(2008-2#1)(2008-7#1)
similar data from the##2##4##(1991-12#1)(2006-10#1)
similar data from##4##3##(1991-12#1)(1997-1#1)(2006-10#1)(2008-4#1)
similar data##7##2##(1991-12#1)(1996-2#1)(1997-1#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-4#1)
similar database##2##2##(2008-6#1)(2010-12#1)
similar decision##2##2##(2007-10#1)(2008-3#1)
similar decrease##4##2##(1990-3#1)(1994-8#1)(2008-11#1)(2008-2#1)
similar defect##2##2##(1993-7#1)(1996-3#1)
similar degree of##6##3##(1990-7#1)(1992-10#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-8#1)
similar degree##14##2##(1990-7#1)(1992-10#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-8#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-12#1)
similar degrees of##3##3##(1990-8#1)(1993-11#1)(1997-2#1)
similar density##3##2##(1996-12#1)(2005-10#2)
similar dependence on letter spacing##2##5##(2008-1#2)
similar dependence##3##2##(2008-1#2)(2008-2#1)
similar design##2##2##(2007-11#1)(2008-2#1)
similar developmental##4##2##(2007-12#1)(2008-5#1)(2010-2#1)(2010-6#1)
similar devices##3##2##(2006-6#1)(2007-8#1)(2009-6#1)
similar dimensions##2##2##(2009-2#1)(2013-8#1)
similar disease##5##2##(1991-2#1)(2007-8#1)(2008-10#3)
similar disorder##2##2##(2008-10#1)(2012-3#1)
similar dissociation##2##2##(1990-8#1)(2009-4#1)
similar distribution and##2##3##(1992-4#1)(2008-8#1)
similar distribution patterns##2##3##(2008-9#1)(2010-1#1)
similar distribution##9##2##(1990-12#1)(1991-10#1)(1992-4#1)(1996-12#1)(2008-1#1)(2008-8#1)(2008-9#1)(2010-1#1)(2013-1#1)
similar distributions##3##2##(1995-9#1)(2008-5#2)
similar dose##2##2##(2006-6#1)(2008-11#1)
similar doses##2##2##(2004-3#1)(2005-11#1)
similar educational##2##2##(2008-9#2)
similar effect as##3##3##(1992-6#1)(2008-10#1)(2008-12#1)
similar effect is##3##3##(1994-11#1)(2008-2#1)(2008-3#1)
similar effect on##4##3##(1992-7#1)(2004-11#1)(2008-5#1)(2010-2#1)
similar effect##27##2##(1991-5#2)(1992-6#1)(1992-7#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#2)(1995-5#1)(1996-12#1)(1997-7#1)(2004-11#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-2#1)(2011-1#2)
similar effects as##2##3##(1992-3#1)(2006-10#1)
similar effects in##3##3##(1994-7#1)(1995-2#1)(2008-2#1)
similar effects on morning peak##2##5##(1996-1#1)(1996-2#1)
similar effects on the##2##4##(1990-3#1)(1990-9#1)
similar effects on##9##3##(1990-3#1)(1990-9#1)(1996-1#1)(1996-2#1)(1996-6#1)(2008-10#1)(2008-8#1)(2010-4#1)(2011-2#1)
similar effects to##2##3##(2007-11#1)(2012-2#1)
similar effects##22##2##(1990-3#1)(1990-9#1)(1992-3#1)(1994-12#1)(1994-7#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-2#1)
similar efficacy and##2##3##(2007-1#1)(2008-5#1)
similar efficacy but##2##3##(1994-3#1)(2007-7#1)
similar efficacy to##5##3##(2005-7#1)(2007-11#1)(2007-7#1)(2008-10#1)(2009-6#1)
similar efficacy with##2##3##(2005-7#1)(2008-3#1)
similar efficacy##16##2##(1994-3#1)(2005-7#2)(2007-1#1)(2007-11#2)(2007-7#3)(2008-10#1)(2008-3#1)(2008-5#3)(2009-6#1)(2009-8#1)
similar efficiency##5##2##(1997-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-4#1)
similar elevations##2##2##(1993-2#1)(2007-11#1)
similar enhancement of##2##3##(1996-6#1)(2008-10#1)
similar enhancement##4##2##(1991-6#1)(1996-6#1)(2008-10#1)(2008-4#1)
similar enzymatic properties##2##3##(1990-7#1)(1991-2#1)
similar experiment##4##2##(1990-2#1)(2006-4#1)(2008-10#1)(2008-7#1)
similar experimental##3##2##(1990-2#1)(2008-11#1)(2008-4#1)
similar experiments in##2##3##(2008-11#1)(2008-8#1)
similar experiments##6##2##(1992-9#1)(1995-8#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-8#1)
similar exposure##2##2##(1992-11#1)(2011-2#1)
similar exposures##2##2##(2007-1#1)(2008-10#1)
similar expression##6##2##(1996-12#1)(2007-9#1)(2008-2#2)(2008-3#1)(2008-8#1)
similar extent##15##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-1#1)(1992-5#1)(1993-6#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1997-4#1)(1997-8#1)(2006-8#1)(2009-12#1)(2013-8#1)
similar fashion to##4##3##(1990-7#1)(1993-3#1)(1994-5#1)(2012-2#1)
similar fashion##21##2##(1990-10#1)(1990-2#1)(1990-7#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-3#2)(1995-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-3#1)(2012-2#1)
similar features##3##2##(1994-2#1)(2008-10#1)(2012-8#1)
similar findings##5##2##(1997-3#1)(2006-10#1)(2010-2#1)(2010-4#1)(2012-3#1)
similar fluorescence##3##2##(1991-9#1)(2008-11#1)(2008-5#1)
similar fold##2##2##(1992-5#1)(1995-1#1)
similar folding##2##2##(1994-5#1)(2011-1#1)
similar for all treatments##2##4##(1990-12#1)(2008-10#1)
similar for all##12##3##(1990-12#1)(1996-3#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#2)
similar for both##22##3##(1990-10#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-7#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-11#1)(2005-11#2)(2008-10#4)(2008-11#1)(2008-4#1)(2009-11#1)(2010-12#1)(2013-7#1)
similar for men and women##3##5##(2006-10#1)(2012-12#2)
similar for most##2##3##(1995-12#1)(2008-10#1)
similar for patients##2##3##(2007-8#2)
similar for the three##4##4##(1992-1#1)(1995-6#1)(2008-10#1)(2008-8#1)
similar for the two##7##4##(1991-4#1)(1992-3#1)(1994-3#1)(2005-11#1)(2006-7#1)(2008-10#1)(2008-3#1)
similar for the##16##3##(1991-4#1)(1992-1#1)(1992-3#1)(1993-7#1)(1994-3#1)(1994-9#1)(1995-6#1)(2005-11#1)(2006-7#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-8#1)(2010-3#1)
similar for##101##2##(1990-10#3)(1990-12#1)(1990-2#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-12#2)(1992-3#2)(1992-7#1)(1993-2#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-4#1)(1994-6#2)(1994-9#1)(1995-12#2)(1995-3#2)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-8#1)(2004-11#1)(2005-11#3)(2006-10#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#4)(2008-10#17)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-8#2)(2008-9#2)(2009-11#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#2)(2010-4#1)(2011-10#1)(2011-2#3)(2012-12#3)(2013-7#3)(2013-8#1)
similar forms of##2##3##(2006-10#1)(2008-2#1)
similar free##3##2##(1990-10#1)(1996-12#1)(2008-4#1)
similar frequencies##3##2##(1992-9#1)(2008-10#1)(2012-2#1)
similar frequency of##2##3##(1996-6#1)(2011-12#1)
similar frequency##6##2##(1990-8#1)(1991-7#1)(1996-6#1)(2008-10#1)(2011-12#1)(2012-2#1)
similar from##2##2##(1991-10#1)(2008-8#1)
similar function##4##2##(1995-3#1)(2006-1#1)(2008-9#1)(2009-5#1)
similar functional##3##2##(1991-12#1)(1994-11#1)(2008-4#1)
similar functions##3##2##(1995-12#1)(2009-8#2)
similar gene structure##2##3##(1995-10#1)(2010-5#1)
similar gene##7##2##(1991-7#1)(1992-5#1)(1995-10#1)(2008-10#1)(2008-9#1)(2009-5#1)(2010-5#1)
similar genes##2##2##(1995-2#1)(2007-12#1)
similar genetic##6##2##(1994-12#1)(1996-8#1)(1997-2#1)(2008-10#2)(2008-2#1)
similar genomic##2##2##(2008-5#1)(2009-5#1)
similar group of##3##3##(1990-6#1)(2009-10#1)(2010-10#1)
similar group##4##2##(1990-6#1)(1992-7#1)(2009-10#1)(2010-10#1)
similar growth##2##2##(2008-11#1)(2009-4#1)
similar hemodynamic##2##2##(1990-2#1)(1996-2#1)
similar high##2##2##(1994-9#1)(2008-10#1)
similar histologic##2##2##(2007-12#1)(2012-2#1)
similar histological features##2##3##(2005-11#1)(2012-12#1)
similar histological##4##2##(2005-11#2)(2008-5#1)(2012-12#1)
similar if not identical##2##4##(1990-7#1)(1993-9#1)
similar if not##3##3##(1990-7#1)(1993-9#1)(1995-3#1)
similar improvement in##2##3##(2007-12#1)(2008-7#1)
similar improvement##3##2##(2007-12#1)(2008-7#1)(2010-2#1)
similar improvements##2##2##(2008-2#1)(2008-5#1)
similar in a##2##3##(1996-11#1)(2009-8#1)
similar in all groups##5##4##(1993-4#1)(1996-8#1)(2006-5#1)(2008-10#1)(2010-4#1)
similar in all the##5##4##(1993-4#1)(1994-5#1)(2008-10#1)(2008-5#2)
similar in all##18##3##(1992-1#1)(1993-4#2)(1993-7#1)(1994-12#1)(1994-5#1)(1994-8#1)(1996-3#1)(1996-8#1)(2006-5#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-7#1)(2010-12#1)(2010-4#1)
similar in both cases##3##4##(1990-4#1)(1997-2#1)(2008-5#1)
similar in both cell types##2##5##(1991-1#1)(1991-8#1)
similar in both cell##3##4##(1991-1#1)(1991-8#1)(1997-7#1)
similar in both groups##31##4##(1990-12#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-10#1)(1992-3#1)(1994-12#1)(1997-2#1)(2006-1#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-5#2)(2009-10#1)(2009-3#1)(2010-11#3)(2011-2#1)(2013-1#1)
similar in both populations##2##4##(2007-10#1)(2013-7#1)
similar in both schizophrenic##2##4##(1995-11#1)(1996-1#1)
similar in both sexes##2##4##(2008-3#1)(2010-12#1)
similar in both tests##2##4##(1991-10#1)(2008-5#1)
similar in both the##5##4##(2004-10#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-3#1)
similar in both##77##3##(1990-10#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-1#2)(1991-10#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-3#1)(1992-4#1)(1993-2#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-7#1)(1996-1#1)(1996-6#2)(1997-2#3)(1997-7#1)(2004-10#1)(2006-1#1)(2006-10#2)(2006-3#1)(2006-6#2)(2006-8#2)(2007-10#2)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#4)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#1)(2010-11#3)(2010-12#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
similar in composition to##3##4##(1993-6#1)(2008-10#1)(2008-11#1)
similar in each##3##3##(1992-4#1)(2010-4#1)(2013-8#1)
similar in groups##2##3##(1997-6#1)(2008-11#1)
similar in magnitude to that##3##5##(1991-6#1)(2006-10#1)(2010-4#1)
similar in magnitude to##6##4##(1991-6#1)(2006-10#1)(2008-7#1)(2009-10#1)(2010-4#1)(2011-2#1)
similar in magnitude##8##3##(1991-6#1)(2006-10#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-4#1)(2011-2#1)
similar in males and##2##4##(1991-5#1)(1993-7#1)
similar in many##2##3##(1991-5#1)(2008-11#1)
similar in nature to the##2##5##(1990-7#2)
similar in patients with##5##4##(1996-12#1)(2005-7#1)(2006-6#1)(2007-11#1)(2013-8#1)
similar in patients##8##3##(1992-11#1)(1994-12#1)(1996-12#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-11#1)(2013-8#1)
similar in principle to##2##4##(2006-6#1)(2008-10#1)
similar in rats of##2##4##(1996-4#2)
similar in shape and##2##4##(2007-11#1)(2012-2#1)
similar in size to the##3##5##(1995-2#1)(1997-6#1)(2008-5#1)
similar in size to those##2##5##(1995-8#1)(2008-8#1)
similar in size to##5##4##(1995-2#1)(1995-8#1)(1997-6#1)(2008-5#1)(2008-8#1)
similar in size##7##3##(1995-2#1)(1995-8#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-5#1)(2008-8#1)
similar in structure and##5##4##(1992-3#1)(1995-12#1)(1996-11#1)(2006-10#1)(2007-4#1)
similar in structure##6##3##(1990-5#1)(1992-3#1)(1995-12#1)(1996-11#1)(2006-10#1)(2007-4#1)
similar in surviving##2##3##(1990-9#1)(2010-4#1)
similar in terms of age##2##5##(2007-9#1)(2013-1#1)
similar in terms of##7##4##(2005-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
similar in that both##2##4##(1990-11#1)(1991-4#1)
similar in that##3##3##(1990-11#1)(1991-4#1)(1993-8#1)
similar in the 2 groups##3##5##(1991-11#1)(1993-4#1)(2007-10#1)
similar in the 2##4##4##(1991-11#1)(1993-4#1)(2007-10#1)(2008-10#1)
similar in the groups##3##4##(2006-10#1)(2006-7#2)
similar in the two groups of patients##2##7##(1990-12#1)(2007-8#1)
similar in the two groups of##3##6##(1990-12#1)(1993-11#1)(2007-8#1)
similar in the two groups##15##5##(1990-12#1)(1991-4#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-11#1)(1995-9#1)(2007-8#5)(2011-1#1)(2012-2#1)
similar in the two##19##4##(1990-12#1)(1991-11#1)(1991-12#1)(1991-4#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#1)(1995-9#1)(2007-8#5)(2011-1#1)(2012-2#1)(2012-3#1)
similar in the##61##3##(1990-12#1)(1991-11#3)(1991-12#1)(1991-4#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-4#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-12#1)(1997-2#3)(1997-4#1)(2005-11#1)(2006-10#1)(2006-7#2)(2006-8#1)(2007-10#1)(2007-7#2)(2007-8#5)(2008-10#7)(2008-12#1)(2008-5#1)(2008-8#1)(2009-4#2)(2009-5#1)(2010-12#1)(2011-1#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
similar in their##4##3##(2006-10#1)(2008-2#1)(2010-10#1)(2011-2#1)
similar in these##3##3##(1991-3#1)(2008-7#1)(2010-2#1)
similar in vivo##2##3##(1993-7#1)(2008-5#1)
similar in##339##2##(1990-1#1)(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#3)(1991-12#5)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#4)(1992-4#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#5)(1993-6#1)(1993-7#3)(1993-8#3)(1993-9#2)(1994-11#2)(1994-12#6)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#3)(1995-12#5)(1995-2#3)(1995-3#1)(1995-5#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#3)(1996-3#1)(1996-4#2)(1996-6#5)(1996-7#1)(1996-8#1)(1997-2#8)(1997-3#1)(1997-4#2)(1997-6#3)(1997-7#1)(2004-10#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#7)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#5)(2006-7#2)(2006-8#6)(2006-9#1)(2007-10#5)(2007-11#7)(2007-12#1)(2007-2#2)(2007-4#3)(2007-7#5)(2007-8#9)(2007-9#6)(2008-1#2)(2008-10#26)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#11)(2008-6#1)(2008-7#10)(2008-8#3)(2008-9#2)(2009-10#2)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#3)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#4)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#8)(2011-3#1)(2012-12#6)(2012-2#2)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#4)
similar incidence of##2##3##(2007-11#1)(2012-2#1)
similar incidence##3##2##(2007-11#1)(2011-2#1)(2012-2#1)
similar increase in##7##3##(1992-1#1)(1993-12#1)(1994-1#1)(1994-2#1)(1996-3#1)(1997-1#1)(2008-3#1)
similar increased##2##2##(2008-3#1)(2013-1#1)
similar increases in##6##3##(1990-2#1)(1990-8#1)(1995-11#1)(1997-5#1)(2004-4#1)(2008-7#1)
similar information on##2##3##(1993-3#1)(2006-6#1)
similar information##3##2##(1993-12#1)(1993-3#1)(2006-6#1)
similar inhibition of##3##3##(1995-11#1)(1997-8#1)(2006-1#1)
similar inhibition##6##2##(1991-4#1)(1994-8#1)(1995-11#1)(1997-8#1)(2006-1#1)(2008-5#1)
similar inhibitory effects on##2##4##(1990-7#1)(1990-9#1)
similar inhibitory effects##3##3##(1990-7#1)(1990-9#1)(2008-10#1)
similar inhibitory##4##2##(1990-7#1)(1990-9#1)(1995-5#1)(2008-10#1)
similar initial##2##2##(2008-2#1)(2008-4#1)
similar injuries in##2##3##(1992-4#1)(2007-7#1)
similar injuries##3##2##(1992-4#1)(2006-11#1)(2007-7#1)
similar injury##2##2##(2011-12#1)(2011-2#1)
similar intensity##4##2##(1997-5#1)(2007-12#1)(2008-10#1)(2010-2#1)
similar interactions##2##2##(1995-8#1)(2012-2#1)
similar intervals##3##2##(2007-9#1)(2010-7#2)
similar irrespective of##3##3##(1990-12#1)(2007-7#1)(2008-3#1)
similar isolates of##3##3##(2007-1#2)(2008-10#1)
similar isolates##4##2##(2007-1#2)(2008-10#2)
similar kinetic##3##2##(1994-6#1)(1997-2#1)(2008-6#1)
similar large##3##2##(2006-3#1)(2008-1#1)(2008-2#1)
similar legislation##2##2##(1996-5#1)(1996-6#1)
similar length##2##2##(2010-8#1)(2011-1#1)
similar lengths##2##2##(2008-4#1)(2009-6#1)
similar lesion##3##2##(1993-3#1)(2007-2#1)(2008-10#1)
similar lesions##7##2##(1995-2#1)(1996-11#1)(2005-11#1)(2007-7#1)(2008-1#1)(2009-12#1)(2012-3#1)
similar level of##10##3##(1990-5#1)(1994-5#1)(1996-2#1)(1997-6#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-11#1)(2012-11#1)
similar levels in##4##3##(1991-6#1)(1994-5#1)(2008-10#2)
similar levels of##24##3##(1990-10#1)(1992-12#1)(1992-6#1)(1993-4#1)(1994-8#1)(1995-2#1)(1995-8#3)(1997-1#1)(2006-11#1)(2006-12#1)(2006-7#1)(2007-2#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)(2012-3#1)(2013-7#1)
similar levels##36##2##(1990-10#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-4#1)(1993-5#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-8#3)(1997-1#1)(2006-11#1)(2006-12#1)(2006-7#1)(2007-2#1)(2007-6#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-7#2)
similar ligand##2##2##(1997-2#1)(1997-4#1)
similar light##3##2##(1996-5#1)(2008-11#1)(2008-9#1)
similar locations##2##2##(2008-10#1)(2008-9#1)
similar long-term##2##2##(1996-9#1)(2013-1#1)
similar low levels of##2##4##(2008-10#1)(2009-7#1)
similar low##5##2##(1990-7#1)(1992-11#1)(1994-3#1)(2008-10#1)(2009-7#1)
similar magnitude and##3##3##(1990-7#1)(1997-4#1)(2008-10#1)
similar magnitude##10##2##(1990-7#1)(1992-8#1)(1994-12#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-11#2)
similar manner to##8##3##(1990-10#1)(1990-4#1)(1991-1#1)(1991-7#1)(1992-1#1)(1996-4#1)(1997-2#1)(2008-11#1)
similar manner##31##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1991-1#1)(1991-7#1)(1991-9#1)(1992-1#2)(1993-6#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-6#1)(2004-9#1)(2005-10#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#2)(2009-10#1)(2011-2#1)(2013-8#1)
similar mass##4##2##(1991-2#1)(1995-1#1)(2008-8#1)(2008-9#1)
similar mean changes##2##3##(2006-10#1)(2008-7#1)
similar mean##3##2##(2006-10#1)(2008-7#1)(2013-1#1)
similar measurements##2##2##(2007-12#1)(2008-2#1)
similar mechanism##6##2##(1990-12#1)(1995-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)
similar mechanisms of action##2##4##(2008-10#1)(2010-2#1)
similar mechanisms of##6##3##(1991-8#1)(1991-9#1)(2008-10#2)(2010-2#1)(2012-2#1)
similar mechanisms##11##2##(1991-8#1)(1991-9#2)(1997-2#1)(2006-3#1)(2008-10#2)(2008-9#1)(2010-2#1)(2011-1#1)(2012-2#1)
similar medical##2##2##(2009-4#1)(2010-10#1)
similar membrane##2##2##(1992-11#1)(1994-12#1)
similar method##4##2##(2008-2#1)(2008-4#1)(2008-8#1)(2010-2#1)
similar methods##3##2##(2004-9#1)(2008-11#1)(2008-2#1)
similar mobility##3##2##(1994-9#1)(2008-10#1)(2009-8#1)
similar model##2##2##(1997-2#1)(2008-10#1)
similar modifications##2##2##(1994-12#1)(1994-9#1)
similar molecular mass##5##3##(1990-10#1)(1990-11#1)(1993-12#1)(1993-9#1)(2008-10#1)
similar molecular structures##2##3##(1992-2#1)(2008-6#1)
similar molecular weight and##2##4##(1990-12#1)(1995-11#1)
similar molecular weight##4##3##(1990-11#1)(1990-12#1)(1995-11#1)(2006-8#1)
similar molecular weights##2##3##(1992-5#1)(1994-6#1)
similar molecular##15##2##(1990-10#1)(1990-11#2)(1990-12#2)(1992-2#1)(1992-5#1)(1993-12#1)(1993-9#1)(1994-6#1)(1995-11#1)(1997-6#1)(2006-8#1)(2008-10#1)(2008-6#1)
similar morphological##4##2##(1994-8#1)(1996-5#1)(2008-10#1)(2008-9#1)
similar nature##2##2##(2008-10#1)(2012-3#1)
similar negative##4##2##(1996-5#1)(2007-8#1)(2008-10#1)(2013-8#1)
similar numbers of##2##3##(1991-12#1)(2008-5#1)
similar numbers##4##2##(1991-12#2)(2008-5#2)
similar on the##3##3##(1997-8#1)(2008-10#1)(2008-8#1)
similar on##8##2##(1992-3#1)(1997-8#1)(2006-6#1)(2008-10#3)(2008-8#1)(2012-12#1)
similar or different##2##3##(2005-8#1)(2008-10#1)
similar or enhanced##2##3##(2008-11#1)(2009-5#1)
similar or identical##2##3##(1991-8#1)(1992-4#1)
similar or less##2##3##(1992-8#1)(2008-10#1)
similar or slightly##3##3##(1990-12#1)(2012-12#2)
similar or superior to those##2##5##(2007-9#1)(2013-8#1)
similar or superior##3##3##(1995-5#1)(2007-9#1)(2013-8#1)
similar or##29##2##(1990-12#1)(1991-5#1)(1991-8#1)(1992-4#1)(1992-8#1)(1995-11#1)(1995-5#1)(1997-1#1)(1997-5#1)(2005-8#1)(2006-11#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-3#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#1)
similar order##3##2##(1992-1#1)(1994-6#1)(2008-1#1)
similar organization##2##2##(2008-8#1)(2008-9#1)
similar outcomes to##2##3##(2009-6#1)(2010-10#1)
similar outcomes##5##2##(1995-2#1)(2006-3#1)(2006-8#1)(2009-6#1)(2010-10#1)
similar over##2##2##(2008-3#1)(2011-2#1)
similar overall##6##2##(1994-2#1)(1996-5#1)(2007-11#2)(2009-2#1)(2011-2#1)
similar pH##2##2##(1990-8#1)(1997-8#1)
similar pH-dependent##2##2##(1992-12#1)(2008-6#1)
similar patients##4##2##(1997-3#1)(2007-11#1)(2013-1#2)
similar pattern in##2##3##(1996-10#1)(2010-8#1)
similar pattern of##15##3##(1991-2#1)(1991-7#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-7#1)(1996-12#1)(1997-2#1)(2005-11#1)(2011-2#1)(2012-2#1)
similar pattern was observed##2##4##(1994-8#1)(2008-10#1)
similar pattern was##6##3##(1993-6#1)(1994-8#1)(1995-12#1)(1995-6#1)(2008-10#1)(2008-4#1)
similar pattern##34##2##(1990-12#1)(1990-8#1)(1991-2#1)(1991-7#1)(1993-12#1)(1993-6#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-6#1)(1995-7#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-7#1)(2005-11#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-4#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)
similar patterns of##11##3##(1993-9#1)(1994-12#1)(1994-3#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-12#1)(2010-4#1)(2012-3#1)
similar patterns to those##2##4##(2008-8#1)(2009-5#1)
similar patterns##24##2##(1991-5#1)(1993-9#1)(1994-12#1)(1994-3#1)(1996-12#1)(1996-3#1)(1997-5#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-8#4)(2008-9#2)(2009-12#1)(2009-5#1)(2010-4#1)(2012-3#1)(2013-1#1)
similar percentages of##2##3##(2008-10#1)(2013-8#1)
similar performance to##2##3##(2008-10#1)(2013-1#1)
similar performance##5##2##(1994-9#1)(2008-10#1)(2008-2#1)(2012-3#1)(2013-1#1)
similar perturbations##2##2##(1992-6#1)(2011-2#1)
similar phenomena##5##2##(2006-6#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-7#1)
similar physical##2##2##(1990-2#1)(1991-3#1)
similar physico-chemical##2##2##(1994-12#1)(2008-10#1)
similar physicochemical##2##2##(1992-6#1)(2010-4#1)
similar physiological##2##2##(2005-8#1)(2008-10#1)
similar polypeptide##3##2##(1990-7#1)(1992-6#1)(2008-12#1)
similar population##2##2##(2006-8#1)(2008-10#1)
similar populations and##2##3##(1994-1#1)(1997-7#1)
similar populations##6##2##(1994-1#1)(1996-2#1)(1996-3#1)(1997-6#1)(1997-7#1)(2010-4#1)
similar positions##5##2##(1990-8#1)(1992-2#1)(1997-3#1)(2008-10#1)(2008-11#1)
similar positive##2##2##(1997-4#1)(2011-12#1)
similar potencies##3##2##(1990-6#1)(1991-5#1)(1993-4#1)
similar potency and##4##3##(1993-8#2)(1996-8#1)(1997-1#1)
similar potency to that of##2##5##(1990-2#1)(1994-8#1)
similar potency to##6##3##(1990-2#1)(1994-8#1)(1995-12#1)(2006-10#1)(2008-5#1)(2008-9#1)
similar potency##14##2##(1990-2#1)(1990-7#1)(1991-3#1)(1993-8#2)(1994-8#1)(1995-12#2)(1996-8#1)(1997-1#1)(2006-10#1)(2008-12#1)(2008-5#1)(2008-9#1)
similar practice patterns##2##3##(2007-1#1)(2007-10#1)
similar precision##3##2##(2008-10#3)
similar pregnancy rates##2##3##(1991-12#1)(1991-3#1)
similar pregnancy##3##2##(1991-12#1)(1991-3#1)(2006-5#1)
similar prevalence##2##2##(2006-10#1)(2007-2#1)
similar previous##2##2##(2007-4#1)(2013-1#1)
similar primary##2##2##(2007-1#1)(2013-8#1)
similar principles##2##2##(2008-1#1)(2008-4#1)
similar problems##6##2##(1997-3#1)(2004-3#1)(2008-7#1)(2009-3#1)(2009-9#1)(2012-11#1)
similar procedures##2##2##(2007-11#1)(2012-3#1)
similar processes##2##2##(1996-8#1)(2008-1#1)
similar processing##2##2##(1991-8#1)(2006-3#1)
similar products##2##2##(2011-2#1)(2012-12#1)
similar profile##5##2##(1990-6#1)(1991-4#1)(1993-11#1)(1993-8#1)(1996-1#1)
similar programmes##2##2##(2005-5#1)(2008-11#1)
similar programs##4##2##(1991-2#1)(2006-10#2)(2007-3#1)
similar proline-rich##2##2##(1994-12#1)(1994-9#1)
similar properties to##2##3##(1991-3#1)(1991-5#1)
similar properties##7##2##(1991-3#1)(1991-5#1)(1994-8#1)(1997-4#1)(1997-6#1)(2008-10#2)
similar proportion of##2##3##(2008-4#1)(2013-1#1)
similar proportion##3##2##(2007-4#1)(2008-4#1)(2013-1#1)
similar protection##2##2##(1995-5#1)(2005-7#1)
similar protein##4##2##(1993-4#1)(1994-2#1)(2011-1#1)(2013-8#1)
similar proteins##3##2##(1991-11#1)(1992-8#1)(2012-2#1)
similar qualitative##2##2##(1997-3#1)(2007-9#1)
similar quantities of##2##3##(2011-2#1)(2012-12#1)
similar quantities##4##2##(2008-10#1)(2008-3#1)(2011-2#1)(2012-12#1)
similar ranking##2##2##(1990-6#1)(1993-3#1)
similar rate constants##2##3##(1992-9#1)(1997-1#1)
similar rate in##2##3##(1990-3#1)(2006-8#1)
similar rate##8##2##(1990-3#1)(1990-9#1)(1991-9#1)(1992-9#1)(1994-2#1)(1995-2#1)(1997-1#1)(2006-8#1)
similar rates of##5##3##(1992-10#1)(2008-8#1)(2010-2#1)(2013-1#2)
similar rates##10##2##(1992-10#1)(1994-11#1)(1995-6#1)(2005-11#1)(2006-5#1)(2008-11#1)(2008-8#1)(2010-2#1)(2013-1#2)
similar reaction##4##2##(1996-5#1)(2006-4#1)(2008-6#1)(2010-5#1)
similar reactions##2##2##(1995-11#1)(2008-7#1)
similar records of##3##3##(1990-6#1)(2008-12#2)
similar recoveries of##2##3##(2007-5#1)(2008-10#1)
similar reduction in##5##3##(1992-3#1)(1992-4#1)(1994-8#1)(1997-5#1)(2008-5#1)
similar reduction of##2##3##(2008-7#1)(2010-5#1)
similar reduction##8##2##(1992-3#1)(1992-4#1)(1993-12#1)(1994-8#1)(1997-5#1)(2008-5#1)(2008-7#1)(2010-5#1)
similar regarding##4##2##(2005-10#1)(2006-8#2)(2011-2#1)
similar regimen of##2##3##(1993-6#1)(2007-11#1)
similar regimen##4##2##(1993-6#1)(1994-11#1)(1997-4#1)(2007-11#1)
similar regions of##2##3##(1994-8#1)(2010-3#1)
similar regions##4##2##(1990-9#1)(1994-8#1)(2008-4#1)(2010-3#1)
similar regulation of##2##3##(1995-3#1)(2008-7#1)
similar regulatory##4##2##(1990-11#1)(1992-12#1)(1993-6#1)(2008-7#1)
similar research##2##2##(2006-2#1)(2008-3#1)
similar resolution##2##2##(1994-12#1)(2010-7#1)
similar response##8##2##(1995-12#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-5#1)(2009-9#1)
similar responses for##2##3##(2008-10#1)(2009-2#1)
similar responses to##2##3##(1995-12#1)(2006-12#1)
similar responses##10##2##(1990-10#1)(1990-5#1)(1990-7#1)(1995-12#1)(1996-7#2)(2006-12#1)(2008-10#1)(2009-2#1)(2013-8#1)
similar result##8##2##(1991-9#1)(1994-9#1)(1995-10#1)(1996-3#1)(1997-4#1)(2008-11#2)(2008-5#1)
similar results and##2##3##(2008-10#1)(2008-3#1)
similar results are##2##3##(1995-1#1)(2006-6#1)
similar results for##5##3##(2007-5#1)(2008-1#1)(2008-2#2)(2010-12#1)
similar results in the##3##4##(1990-4#1)(2008-10#1)(2008-2#1)
similar results in##10##3##(1990-4#1)(1990-6#1)(1996-2#1)(2006-5#1)(2006-8#1)(2008-10#1)(2008-2#1)(2010-9#1)(2011-2#1)(2012-12#1)
similar results to the##2##4##(2010-10#1)(2012-3#1)
similar results to##4##3##(2010-10#1)(2012-12#2)(2012-3#1)
similar results were obtained with##5##5##(1990-8#1)(1991-10#1)(1992-8#1)(2008-10#2)
similar results were obtained##8##4##(1990-8#1)(1991-10#1)(1992-8#1)(1993-2#1)(2008-10#3)(2008-11#1)
similar results were##10##3##(1990-8#1)(1991-10#1)(1992-3#1)(1992-8#1)(1993-2#1)(2008-10#3)(2008-11#1)(2013-1#1)
similar results with##2##3##(2008-4#1)(2013-1#1)
similar results##70##2##(1990-4#1)(1990-6#2)(1990-8#2)(1991-10#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-6#1)(2004-8#1)(2005-8#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-5#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2009-6#2)(2010-10#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#5)(2012-3#1)(2012-7#1)(2013-1#3)
similar risk##5##2##(2005-10#1)(2008-3#2)(2008-7#1)(2011-1#1)
similar sample##3##2##(2006-8#1)(2008-10#2)
similar sensitivities to##2##3##(1997-7#1)(2008-10#1)
similar sensitivities##3##2##(1997-7#1)(2008-10#1)(2008-2#1)
similar sensitivity and specificity##2##4##(1992-5#1)(2012-1#1)
similar sensitivity##6##2##(1992-5#1)(1995-2#1)(1997-1#1)(2008-4#1)(2012-1#1)(2013-8#1)
similar sequence##4##2##(1990-9#1)(1996-1#1)(1997-4#1)(2009-6#1)
similar sequences##7##2##(1991-11#1)(1993-11#1)(1994-6#1)(1995-2#1)(1996-8#1)(2008-4#1)(2010-7#1)
similar set of##6##3##(1995-3#1)(1996-1#1)(2008-10#1)(2009-8#1)(2010-3#1)(2013-1#1)
similar side##3##2##(1993-11#1)(2005-11#1)(2008-10#1)
similar signals##2##2##(1992-7#1)(1996-4#1)
similar sites in the##2##4##(1991-7#1)(2007-5#1)
similar sites##5##2##(1991-7#1)(1993-6#1)(1993-9#1)(2007-5#2)
similar situation##6##2##(1996-8#1)(2006-4#1)(2006-8#2)(2007-2#1)(2008-11#1)
similar situations##3##2##(1995-6#1)(2006-10#1)(2007-2#1)
similar size to##2##3##(1993-12#1)(2005-11#1)
similar size##15##2##(1991-11#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-6#1)(1996-2#1)(1996-3#1)(2005-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-8#1)(2009-10#1)(2010-2#1)
similar sizes##3##2##(1990-5#1)(2007-3#1)(2009-5#1)
similar slopes##2##2##(1997-5#1)(2008-10#1)
similar sounding words##2##3##(2008-9#2)
similar spatial##4##2##(1993-5#1)(2006-4#1)(2007-10#1)(2008-10#1)
similar species##6##2##(1996-7#1)(2006-10#1)(2006-4#1)(2008-5#1)(2008-8#1)(2008-9#1)
similar specificity##2##2##(1993-6#1)(1995-1#1)
similar spectral behavior##2##3##(1990-2#1)(2008-2#1)
similar spectral##6##2##(1990-2#1)(2008-2#1)(2008-3#2)(2010-12#1)(2013-1#1)
similar spectrum of##2##3##(1994-6#1)(2008-10#1)
similar spectrum##3##2##(1991-2#1)(1994-6#1)(2008-10#1)
similar stability ([Gdn##2##3##(1992-6#2)
similar stability in##2##3##(1996-9#1)(2008-10#1)
similar stability##4##2##(1992-6#2)(1996-9#1)(2008-10#1)
similar standard##2##2##(2005-4#1)(2010-5#1)
similar stimulation##2##2##(1990-5#1)(1995-8#1)
similar stimulatory##2##2##(1996-9#1)(2004-12#1)
similar strategies##2##2##(2008-1#1)(2008-6#1)
similar structural organization##2##3##(1991-9#1)(1996-10#1)
similar structural##5##2##(1991-9#1)(1994-9#1)(1996-10#1)(2008-10#2)
similar structure##7##2##(1993-2#1)(2007-12#1)(2008-10#4)(2012-3#1)
similar structures with##2##3##(1995-8#1)(2008-5#1)
similar structures##7##2##(1995-8#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
similar studies in##2##3##(1995-10#1)(2008-10#1)
similar studies with##2##3##(1993-12#1)(2008-5#1)
similar studies##14##2##(1990-2#1)(1993-12#1)(1995-10#1)(2006-1#1)(2006-8#1)(2008-10#3)(2008-11#2)(2008-5#3)(2010-5#1)
similar study was##2##3##(1992-5#1)(2008-9#1)
similar study##10##2##(1992-5#1)(1996-11#1)(1996-3#1)(2006-12#1)(2006-8#1)(2008-7#2)(2008-9#1)(2011-12#1)(2012-12#1)
similar substrate specificity##2##3##(1992-3#1)(2006-12#1)
similar survival##2##2##(2007-8#1)(2008-10#1)
similar symptoms##10##2##(1993-8#1)(1997-3#1)(2005-12#1)(2005-8#1)(2006-10#1)(2008-10#3)(2010-12#1)(2010-4#1)
similar systems##4##2##(2005-8#1)(2007-12#1)(2008-10#1)(2008-2#1)
similar technique##3##2##(1991-3#1)(2008-3#1)(2008-5#1)
similar tendency was also##2##4##(1993-9#1)(1996-6#1)
similar tendency was observed in the##2##6##(1995-7#1)(2012-12#1)
similar tendency was observed in##4##5##(1995-7#1)(2010-2#1)(2011-1#1)(2012-12#1)
similar tendency was##7##3##(1993-9#1)(1995-7#1)(1996-6#1)(2007-11#1)(2010-2#1)(2011-1#1)(2012-12#1)
similar tendency##9##2##(1993-9#1)(1995-7#1)(1996-6#1)(2005-10#1)(2007-11#1)(2008-10#1)(2010-2#1)(2011-1#1)(2012-12#1)
similar test conditions##2##3##(2006-11#1)(2007-4#1)
similar texture##2##2##(2007-12#1)(2012-6#1)
similar thickness##2##2##(2008-10#1)(2009-7#1)
similar throughout##2##2##(2010-4#1)(2013-7#1)
similar time course of##2##4##(1991-6#1)(1997-7#1)
similar time course##6##3##(1991-6#1)(1995-2#1)(1996-3#1)(1997-3#1)(1997-7#1)(2013-1#1)
similar time##11##2##(1991-6#1)(1995-2#1)(1996-3#1)(1997-3#1)(1997-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-3#1)(2012-2#1)(2013-1#1)
similar to F##2##3##(2008-10#2)
similar to P##4##3##(2006-8#1)(2008-10#1)(2010-3#1)(2013-8#1)
similar to V##2##3##(2008-10#2)
similar to a previously##2##4##(1995-1#1)(2008-3#1)
similar to a##31##3##(1990-11#2)(1991-7#1)(1992-9#1)(1993-11#1)(1993-5#1)(1994-9#1)(1995-1#1)(1995-2#1)(1997-3#1)(2006-11#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2008-9#3)(2009-7#1)(2010-12#1)(2010-5#2)(2010-9#2)(2012-2#1)
similar to acute##3##3##(1995-3#1)(2008-3#1)(2013-1#1)
similar to adult##2##3##(2006-10#1)(2008-1#1)
similar to an##8##3##(1994-6#1)(1995-12#1)(2008-10#3)(2008-2#1)(2011-1#1)(2012-2#1)
similar to and##3##3##(1994-6#1)(2008-10#1)(2012-3#1)
similar to another##2##3##(1991-11#1)(1996-3#1)
similar to apoptosis##2##3##(2013-1#2)
similar to but##6##3##(1990-10#1)(1990-4#1)(1991-5#1)(1994-10#1)(1996-5#1)(2009-10#1)
similar to changes##2##3##(1992-11#1)(1992-4#1)
similar to control##4##3##(1996-11#1)(1997-2#1)(2010-4#1)(2012-6#1)
similar to controls##2##3##(2004-11#1)(2004-4#1)
similar to conventional##2##3##(2008-3#1)(2009-12#1)
similar to corresponding##2##3##(1991-1#1)(1997-3#1)
similar to duck##2##3##(1992-12#1)(1993-4#1)
similar to each other and to the##2##7##(1991-5#1)(2008-10#1)
similar to each other and##3##5##(1991-5#1)(2008-10#2)
similar to each other##15##4##(1991-5#1)(1992-5#1)(1993-6#2)(1994-6#1)(1997-8#1)(2006-5#1)(2008-10#7)(2008-9#1)
similar to either##2##3##(2008-10#1)(2008-5#1)
similar to findings##2##3##(1994-12#1)(2012-3#1)
similar to gunshot residue##2##4##(2012-2#2)
similar to human##7##3##(1991-2#1)(1992-11#1)(1992-9#1)(2006-9#1)(2008-6#1)(2013-1#2)
similar to influenza##2##3##(1992-6#1)(2010-12#1)
similar to its##8##3##(1991-7#1)(1996-10#1)(1997-1#1)(2007-12#1)(2007-6#1)(2008-10#3)
similar to known##3##3##(1991-11#1)(2008-10#2)
similar to levels##2##3##(2005-10#1)(2010-12#1)
similar to low##2##3##(2006-8#1)(2008-10#1)
similar to macular translocation##2##4##(2012-12#2)
similar to most CARICOMP sites##2##5##(2008-5#1)(2011-2#1)
similar to native##3##3##(1993-8#1)(2009-9#2)
similar to nucleus##2##3##(1992-8#1)(2007-11#1)
similar to one another##4##4##(1995-6#1)(2008-1#1)(2008-10#2)
similar to one##8##3##(1995-6#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2013-7#1)
similar to or##8##3##(1995-1#1)(1995-12#1)(1995-3#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-8#1)
similar to other proteins##2##4##(1994-9#1)(1996-10#1)
similar to other rodents##2##4##(2010-11#2)
similar to other##38##3##(1990-11#1)(1990-7#1)(1991-9#1)(1993-9#1)(1994-12#2)(1994-5#1)(1994-9#1)(1996-10#1)(1996-12#1)(2006-10#2)(2007-3#2)(2007-8#1)(2007-9#1)(2008-10#5)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-11#2)(2010-8#1)(2011-2#1)(2013-7#1)
similar to our##4##3##(1992-10#1)(2006-8#1)(2008-10#1)(2008-5#1)
similar to patients with##2##4##(2011-2#1)(2013-1#1)
similar to patients##3##3##(2007-8#1)(2011-2#1)(2013-1#1)
similar to placebo##2##3##(1992-8#1)(1996-9#1)
similar to previous results##2##4##(1997-5#1)(2008-6#1)
similar to previous##5##3##(1997-5#1)(2007-5#1)(2008-6#1)(2011-1#1)(2012-2#1)
similar to previously reported##4##4##(1991-1#1)(1993-1#1)(2008-10#1)(2009-4#1)
similar to previously##6##3##(1991-1#1)(1993-1#1)(2008-10#1)(2009-10#1)(2009-12#1)(2009-4#1)
similar to recent##2##3##(1991-11#1)(2008-11#1)
similar to respiratory##2##3##(1990-9#1)(1997-7#1)
similar to results from##2##4##(1996-3#1)(2010-4#1)
similar to results##7##3##(1992-8#1)(1995-11#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-4#1)
similar to some##4##3##(1991-12#1)(1992-8#1)(1994-6#1)(2007-10#1)
similar to that achieved##2##4##(2007-11#1)(2010-12#1)
similar to that associated with##2##5##(2008-10#1)(2008-2#1)
similar to that by##9##4##(1990-4#1)(2008-8#2)(2008-9#6)
similar to that caused by the##3##6##(1991-10#1)(1993-11#1)(2008-2#1)
similar to that derived##2##4##(1994-5#1)(1997-5#1)
similar to that described for the##3##6##(1990-5#1)(2008-10#1)(2009-12#1)
similar to that described for##4##5##(1990-5#1)(1992-9#1)(2008-10#1)(2009-12#1)
similar to that described##5##4##(1990-5#1)(1992-9#1)(2007-2#1)(2008-10#1)(2009-12#1)
similar to that elicited by##2##5##(1996-9#1)(1997-3#1)
similar to that exhibited by##2##5##(1992-12#1)(1994-12#1)
similar to that experienced by##2##5##(2007-1#1)(2007-2#1)
similar to that for other##2##5##(1991-7#1)(2007-11#1)
similar to that for##12##4##(1990-4#1)(1991-7#1)(1993-2#1)(1993-8#1)(1994-9#2)(1995-11#1)(1996-8#1)(2007-11#1)(2008-10#1)(2008-9#1)(2010-9#1)
similar to that found for##3##5##(1994-9#1)(1995-8#1)(2007-11#1)
similar to that found in other##3##6##(1997-5#1)(2007-2#1)(2007-3#1)
similar to that found in the##2##6##(1995-1#1)(2012-12#1)
similar to that found in##15##5##(1991-5#1)(1991-6#1)(1994-8#1)(1995-1#1)(1997-4#1)(1997-5#1)(2007-1#1)(2007-2#1)(2007-3#1)(2008-5#1)(2008-7#2)(2010-10#1)(2010-4#1)(2012-12#1)
similar to that found##20##4##(1991-3#1)(1991-5#1)(1991-6#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-8#1)(1997-4#1)(1997-5#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-5#1)(2008-7#2)(2010-10#1)(2010-4#1)(2012-12#1)
similar to that in control##2##5##(1992-4#1)(2008-7#1)
similar to that in normal##2##5##(1996-5#1)(1996-8#1)
similar to that in other##2##5##(2007-2#1)(2007-8#1)
similar to that in the##10##5##(1990-10#1)(1991-12#1)(1991-7#1)(1992-2#1)(1994-11#1)(1995-5#1)(1997-8#1)(2008-7#1)(2008-9#1)(2009-10#1)
similar to that in##34##4##(1990-10#1)(1990-8#1)(1991-11#3)(1991-12#1)(1991-7#1)(1992-2#1)(1992-4#1)(1994-11#1)(1995-5#3)(1995-7#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-8#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-10#1)(2010-11#1)(2012-1#1)
similar to that induced by the##2##6##(1993-3#1)(2008-10#1)
similar to that induced by##5##5##(1993-3#1)(1995-9#1)(1996-8#1)(2008-10#1)(2009-10#1)
similar to that measured##3##4##(1992-9#2)(2013-1#1)
similar to that observed during the##2##6##(1993-11#1)(2009-5#1)
similar to that observed during##3##5##(1990-11#1)(1993-11#1)(2009-5#1)
similar to that observed for the##2##6##(1991-3#1)(1993-5#1)
similar to that observed for##9##5##(1990-2#1)(1991-3#1)(1991-4#1)(1993-5#1)(1996-5#1)(2008-10#1)(2008-7#1)(2009-3#1)(2011-2#1)
similar to that observed in the##6##6##(1991-6#1)(1991-8#1)(1994-9#1)(1995-12#1)(1996-6#1)(2008-10#1)
similar to that observed in##25##5##(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-5#1)(1996-6#2)(1997-2#1)(2005-11#1)(2008-10#2)(2008-7#2)(2010-10#1)(2012-2#1)(2013-1#1)
similar to that observed with##6##5##(1993-11#1)(1994-8#1)(1996-6#1)(2008-10#1)(2008-5#1)(2008-7#1)
similar to that observed##47##4##(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-6#1)(1991-8#1)(1993-11#2)(1993-5#1)(1993-8#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-8#2)(1996-5#2)(1996-6#3)(1997-2#1)(2005-11#1)(2007-12#1)(2008-10#5)(2008-5#1)(2008-7#4)(2009-3#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
similar to that obtained for##2##5##(1990-7#1)(2008-5#1)
similar to that obtained from##2##5##(1991-2#1)(1992-6#1)
similar to that obtained in##2##5##(1993-6#1)(2008-10#1)
similar to that obtained with##5##5##(1991-2#1)(1995-12#1)(2008-10#1)(2010-2#1)(2013-7#1)
similar to that obtained##13##4##(1990-7#1)(1991-2#2)(1992-6#1)(1993-6#1)(1995-12#1)(2005-11#1)(2008-10#3)(2008-5#1)(2010-2#1)(2013-7#1)
similar to that of a##5##5##(1990-2#1)(1992-8#1)(1995-10#1)(2008-10#1)(2008-3#1)
similar to that of chicken##2##5##(1993-2#1)(2008-5#1)
similar to that of cyclosporin##2##5##(2007-11#2)
similar to that of human##5##5##(1993-11#1)(1993-6#1)(1996-4#1)(2008-4#1)(2008-6#1)
similar to that of insulin##2##5##(1992-10#1)(1994-3#1)
similar to that of mature##2##5##(1992-12#1)(2008-5#1)
similar to that of native##4##5##(1991-4#1)(1992-6#1)(1993-12#1)(1994-8#1)
similar to that of natural##2##5##(1994-12#1)(2013-8#1)
similar to that of normal##2##5##(1990-12#1)(1990-4#1)
similar to that of other##12##5##(1990-11#1)(1991-2#1)(1993-2#1)(1995-1#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-7#1)(2010-8#1)(2012-2#1)
similar to that of the control##7##6##(1994-8#1)(2008-8#1)(2008-9#5)
similar to that of the human##3##6##(1990-12#1)(2008-4#1)(2010-12#1)
similar to that of the intact##2##6##(1993-6#1)(1995-5#1)
similar to that of the mouse##2##6##(1992-9#1)(1996-2#1)
similar to that of the rat##2##6##(1991-7#1)(1994-8#1)
similar to that of the wild type##3##7##(1991-8#1)(1993-3#1)(1995-1#1)
similar to that of the wild-type enzyme##2##7##(1994-11#1)(1996-11#1)
similar to that of the wild-type##7##6##(1992-4#1)(1994-11#1)(1995-5#1)(1995-8#1)(1996-11#1)(1997-2#2)
similar to that of the##100##5##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-2#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-4#2)(1992-6#3)(1992-9#1)(1993-3#2)(1993-6#2)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-1#4)(1995-2#1)(1995-5#3)(1995-8#2)(1996-11#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-2#6)(1997-4#1)(1997-5#1)(2005-11#1)(2006-11#1)(2006-5#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-8#5)(2008-9#11)(2009-12#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-11#1)(2012-12#1)(2013-1#1)
similar to that of wild-type##3##5##(1994-11#1)(1994-8#1)(1996-11#1)
similar to that of##268##4##(1990-10#2)(1990-11#1)(1990-12#3)(1990-2#3)(1990-3#1)(1990-4#3)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-2#4)(1991-4#1)(1991-7#3)(1991-8#2)(1991-9#2)(1992-10#1)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#4)(1992-4#2)(1992-6#4)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#3)(1993-4#1)(1993-6#4)(1993-8#3)(1993-9#1)(1994-11#4)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#5)(1994-9#1)(1995-1#5)(1995-10#1)(1995-11#2)(1995-2#2)(1995-3#3)(1995-5#5)(1995-8#3)(1996-1#1)(1996-11#2)(1996-12#4)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#7)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#3)(2005-10#1)(2005-11#4)(2006-10#3)(2006-11#2)(2006-12#1)(2006-5#2)(2006-8#3)(2007-10#1)(2007-11#6)(2007-12#6)(2007-2#3)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#14)(2008-11#5)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#11)(2008-6#2)(2008-7#1)(2008-8#6)(2008-9#16)(2009-10#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-10#1)(2011-12#1)(2011-2#2)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
similar to that on##2##4##(1991-5#1)(2005-11#1)
similar to that produced by##4##5##(1993-3#1)(1996-5#1)(2006-10#1)(2008-3#1)
similar to that proposed##2##4##(1995-10#1)(2008-8#1)
similar to that reported for other##2##6##(2004-11#1)(2007-12#1)
similar to that reported for the##4##6##(1991-6#1)(1993-9#1)(1994-2#1)(1995-1#1)
similar to that reported for##10##5##(1991-6#1)(1992-12#1)(1993-9#1)(1994-2#1)(1995-1#1)(2004-11#1)(2007-12#1)(2008-11#1)(2008-7#1)(2011-11#1)
similar to that reported in the literature##2##7##(1996-9#1)(2008-1#1)
similar to that reported in##4##5##(1996-9#1)(2008-1#1)(2008-6#1)(2012-12#1)
similar to that reported##16##4##(1990-2#1)(1991-6#1)(1992-12#1)(1993-9#1)(1994-2#1)(1995-1#1)(1996-9#1)(2004-11#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-11#1)(2012-12#1)
similar to that seen in other##2##6##(1996-4#1)(2008-10#1)
similar to that seen in patients with##2##7##(2008-11#1)(2012-3#1)
similar to that seen in the##3##6##(1995-1#1)(2007-12#1)(2012-2#1)
similar to that seen in##10##5##(1994-5#2)(1995-1#1)(1996-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-2#1)(2012-3#1)(2013-7#1)
similar to that seen with##4##5##(1990-5#1)(1993-8#1)(1995-1#1)(1997-3#1)
similar to that seen##16##4##(1990-5#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#2)(1995-1#2)(1996-4#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-2#1)(2012-3#1)(2013-7#1)
similar to that##505##3##(1990-10#3)(1990-11#2)(1990-12#3)(1990-2#6)(1990-3#1)(1990-4#5)(1990-5#6)(1990-6#1)(1990-7#3)(1990-8#3)(1990-9#2)(1991-10#1)(1991-11#3)(1991-12#3)(1991-2#10)(1991-3#4)(1991-4#2)(1991-5#2)(1991-6#3)(1991-7#5)(1991-8#3)(1991-9#2)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#2)(1992-3#4)(1992-4#4)(1992-6#5)(1992-8#1)(1992-9#6)(1993-11#5)(1993-12#1)(1993-2#4)(1993-3#5)(1993-4#1)(1993-5#1)(1993-6#5)(1993-8#6)(1993-9#2)(1994-11#5)(1994-12#6)(1994-2#2)(1994-3#3)(1994-5#4)(1994-6#1)(1994-8#7)(1994-9#5)(1995-1#9)(1995-10#2)(1995-11#4)(1995-12#3)(1995-2#3)(1995-3#3)(1995-5#9)(1995-7#1)(1995-8#7)(1995-9#2)(1996-1#1)(1996-11#2)(1996-12#6)(1996-2#4)(1996-3#2)(1996-4#3)(1996-5#7)(1996-6#5)(1996-7#1)(1996-8#5)(1996-9#3)(1997-2#8)(1997-3#4)(1997-4#3)(1997-5#3)(1997-7#4)(1997-8#1)(2004-11#1)(2004-12#1)(2005-10#1)(2005-11#7)(2006-10#4)(2006-11#2)(2006-12#1)(2006-5#2)(2006-8#3)(2007-1#2)(2007-10#1)(2007-11#11)(2007-12#9)(2007-2#7)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#33)(2008-11#7)(2008-2#5)(2008-3#4)(2008-4#5)(2008-5#15)(2008-6#4)(2008-7#13)(2008-8#9)(2008-9#25)(2009-10#4)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-10#1)(2011-11#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#2)
similar to the &quot##2##4##(1993-11#1)(2005-11#1)
similar to the N-terminal##2##4##(1990-4#1)(1991-5#1)
similar to the characteristic##2##4##(1990-11#1)(1997-4#1)
similar to the common alphabeta type##2##6##(2009-8#2)
similar to the conserved##2##4##(1994-9#1)(2008-10#1)
similar to the content##2##4##(1993-6#1)(2007-1#1)
similar to the control##3##4##(2008-11#2)(2010-4#1)
similar to the counts##2##4##(2008-12#1)(2013-8#1)
similar to the data##2##4##(1996-5#1)(2009-4#1)
similar to the distribution##3##4##(1997-2#1)(2008-5#1)(2010-11#1)
similar to the effect of##3##5##(1991-5#1)(1992-12#1)(2006-8#1)
similar to the effect##4##4##(1991-5#1)(1992-11#1)(1992-12#1)(2006-8#1)
similar to the effects of##3##5##(1991-6#1)(1993-6#1)(2012-2#1)
similar to the enzyme##2##4##(1997-8#1)(2008-10#1)
similar to the equivalent##2##4##(1994-12#1)(2008-2#1)
similar to the expression##2##4##(1997-6#1)(2006-12#1)
similar to the frequency##2##4##(2008-10#1)(2009-10#1)
similar to the general population##3##5##(1991-9#1)(2010-2#1)(2010-8#1)
similar to the human##4##4##(1992-3#1)(1995-11#1)(1997-6#1)(2008-9#1)
similar to the hypersensitive##2##4##(2008-10#1)(2008-11#1)
similar to the one##5##4##(1992-1#1)(1995-4#1)(2007-8#1)(2010-7#1)(2011-2#1)
similar to the ones##4##4##(1992-9#1)(2007-1#1)(2008-11#1)(2008-4#1)
similar to the original##4##4##(2008-11#1)(2008-4#1)(2013-1#1)(2013-8#1)
similar to the other##3##4##(1990-12#1)(2006-12#1)(2008-10#1)
similar to the parent##2##4##(1997-2#1)(2008-11#1)
similar to the pattern##2##4##(1990-2#1)(1995-11#1)
similar to the previous##2##4##(1995-6#1)(2008-6#1)
similar to the previously identified##2##5##(1996-12#1)(2008-10#1)
similar to the previously##4##4##(1993-12#1)(1996-12#1)(2008-10#2)
similar to the primary##2##4##(2008-8#1)(2013-8#1)
similar to the rat and human UGT1##2##7##(1994-8#2)
similar to the recently##2##4##(1993-12#1)(2010-9#1)
similar to the results of##3##5##(2006-8#2)(2008-3#1)
similar to the sequence##2##4##(1990-11#1)(2007-12#1)
similar to the situation##2##4##(1994-2#1)(2008-7#1)
similar to the slow##2##4##(1997-2#1)(1997-7#1)
similar to the total##2##4##(1991-7#1)(1997-8#1)
similar to the value of##2##5##(1990-5#1)(1996-12#1)
similar to the value##4##4##(1990-5#1)(1990-8#1)(1995-11#1)(1996-12#1)
similar to the values##3##4##(1991-2#1)(1992-2#1)(1992-3#1)
similar to the wild-type##2##4##(1992-3#1)(1996-8#1)
similar to the##358##3##(1990-10#3)(1990-11#6)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#4)(1991-3#1)(1991-4#4)(1991-5#3)(1991-6#3)(1991-7#2)(1991-9#2)(1992-1#2)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#5)(1992-6#2)(1992-7#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#3)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#6)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#4)(1995-10#1)(1995-11#4)(1995-12#4)(1995-2#2)(1995-3#2)(1995-4#2)(1995-5#2)(1995-6#3)(1995-8#2)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#5)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#5)(1997-4#6)(1997-6#2)(1997-7#2)(1997-8#5)(2004-9#2)(2005-10#2)(2005-11#2)(2005-4#1)(2006-10#2)(2006-12#4)(2006-3#2)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#5)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#3)(2007-12#10)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#32)(2008-11#10)(2008-12#1)(2008-2#6)(2008-3#9)(2008-4#6)(2008-5#10)(2008-6#2)(2008-7#6)(2008-8#7)(2008-9#3)(2009-1#1)(2009-10#3)(2009-2#1)(2009-3#3)(2009-4#2)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-7#3)(2013-8#3)
similar to their##4##3##(1990-12#1)(2009-7#1)(2010-5#1)(2013-1#1)
similar to these##2##3##(2007-11#1)(2008-10#1)
similar to this##2##3##(2008-12#1)(2011-2#1)
similar to those achieved##2##4##(2007-7#1)(2008-8#1)
similar to those associated with##2##5##(1993-7#1)(2008-2#1)
similar to those at##2##4##(1994-12#1)(1995-9#1)
similar to those based on##2##5##(2008-10#1)(2008-5#1)
similar to those being##2##4##(2008-3#1)(2010-5#1)
similar to those caused by##3##5##(2008-10#2)(2008-5#1)
similar to those corresponding to the##2##6##(2005-11#1)(2008-10#1)
similar to those described in##4##5##(2006-10#1)(2007-2#1)(2008-6#1)(2011-2#1)
similar to those described##6##4##(1990-5#1)(1994-3#1)(2006-10#1)(2007-2#1)(2008-6#1)(2011-2#1)
similar to those determined##2##4##(1994-8#1)(1996-2#1)
similar to those employed##2##4##(1993-3#1)(2008-8#1)
similar to those evoked by##2##5##(1990-9#1)(1992-11#1)
similar to those following##2##4##(1993-7#1)(2008-10#1)
similar to those for the##2##5##(1991-8#1)(1997-6#1)
similar to those for##14##4##(1990-3#1)(1991-8#1)(1991-9#1)(1993-12#1)(1994-11#1)(1995-1#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-6#1)(2005-7#1)(2008-3#1)(2011-1#1)(2012-1#1)
similar to those found for the##2##6##(1994-3#1)(1997-6#1)
similar to those found for##3##5##(1994-3#1)(1997-6#1)(2011-12#1)
similar to those found in other##4##6##(2006-8#1)(2007-12#1)(2008-11#1)(2012-1#1)
similar to those found in the##4##6##(1993-12#1)(1994-9#1)(2008-4#1)(2008-7#1)
similar to those found in##19##5##(1991-5#1)(1993-1#1)(1993-12#1)(1994-9#2)(1996-2#1)(1997-5#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2012-1#1)
similar to those found##23##4##(1991-5#1)(1993-1#1)(1993-12#1)(1994-3#1)(1994-9#2)(1996-2#1)(1997-5#1)(1997-6#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-12#1)(2012-1#1)
similar to those in adults##2##5##(2011-2#1)(2013-1#1)
similar to those in the##6##5##(1991-2#1)(1993-12#1)(1994-3#1)(2008-10#1)(2008-3#1)(2008-7#1)
similar to those in##25##4##(1991-2#1)(1991-3#1)(1991-7#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1996-12#1)(1996-6#1)(2006-11#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-7#1)(2009-12#1)(2009-5#1)(2011-2#1)(2013-1#1)
similar to those induced by##4##5##(1996-12#1)(2008-10#2)(2011-2#1)
similar to those measured in##3##5##(1992-4#1)(1994-8#1)(1996-12#1)
similar to those observed by the##2##6##(2008-7#2)
similar to those observed by##3##5##(2007-1#1)(2008-7#2)
similar to those observed for##3##5##(2008-5#2)(2009-11#1)
similar to those observed in the field##3##7##(2008-10#3)
similar to those observed in the##6##6##(1990-7#1)(1996-8#1)(1997-8#1)(2008-10#3)
similar to those observed in##24##5##(1990-2#1)(1990-7#1)(1991-2#1)(1993-11#2)(1994-5#1)(1994-6#1)(1996-10#1)(1996-8#1)(1997-8#2)(2007-9#1)(2008-10#7)(2008-5#1)(2008-7#1)(2010-10#1)(2011-12#1)(2011-2#1)
similar to those observed with##2##5##(1992-3#1)(2008-10#1)
similar to those observed##36##4##(1990-2#1)(1990-7#1)(1991-2#1)(1992-12#1)(1992-3#1)(1993-11#2)(1993-9#1)(1994-5#1)(1994-6#1)(1996-10#1)(1996-8#1)(1997-8#2)(2006-10#1)(2007-1#1)(2007-9#1)(2008-10#8)(2008-5#3)(2008-7#3)(2008-9#1)(2009-11#1)(2010-10#1)(2011-12#1)(2011-2#1)
similar to those obtained by the##2##6##(2008-10#2)
similar to those obtained by##3##5##(2008-10#3)
similar to those obtained for##2##5##(1993-8#1)(2007-11#1)
similar to those obtained in##7##5##(1990-4#1)(1990-5#1)(1990-8#1)(2007-12#1)(2007-5#1)(2008-10#2)
similar to those obtained previously##2##5##(1993-11#1)(2006-12#1)
similar to those obtained with the##2##6##(1994-3#1)(2008-10#1)
similar to those obtained with##8##5##(1992-6#1)(1994-3#1)(1996-8#1)(2008-1#1)(2008-10#3)(2008-5#1)
similar to those obtained##23##4##(1990-4#1)(1990-5#1)(1990-8#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-3#1)(1996-8#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#8)(2008-5#1)
similar to those of IL-1##2##5##(2007-12#2)
similar to those of human##2##5##(1993-5#1)(1994-12#1)
similar to those of native##2##5##(1991-9#1)(1993-9#1)
similar to those of natural##2##5##(1994-3#1)(2006-6#1)
similar to those of normal##3##5##(1990-2#1)(1992-12#1)(1994-12#1)
similar to those of other##7##5##(1991-2#1)(1991-8#1)(1994-5#1)(1997-2#1)(2007-2#1)(2008-10#1)(2009-4#1)
similar to those of the 25 degrees C-grown C##2##9##(2008-5#2)
similar to those of the control##2##6##(2008-9#1)(2012-2#1)
similar to those of the controls##2##6##(2006-1#1)(2008-8#1)
similar to those of the corresponding##3##6##(1992-3#1)(2008-3#1)(2009-3#1)
similar to those of the native##3##6##(1992-3#1)(1995-10#1)(1995-12#1)
similar to those of the patients##2##6##(1991-7#1)(2007-8#1)
similar to those of the wild-type##5##6##(1990-10#1)(1993-6#1)(1993-8#1)(1995-10#1)(1996-7#1)
similar to those of the##67##5##(1990-10#2)(1990-5#2)(1991-1#1)(1991-2#1)(1991-5#1)(1991-7#2)(1992-3#2)(1992-8#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-10#2)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#2)(1996-11#1)(1996-6#1)(1996-7#1)(1997-4#1)(2005-9#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#12)(2009-3#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-7#1)
similar to those of wild-type##4##5##(1993-11#1)(1994-11#2)(1995-2#1)
similar to those of##173##4##(1990-10#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#1)(1991-1#2)(1991-2#2)(1991-3#1)(1991-5#2)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#4)(1992-4#1)(1992-8#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#3)(1994-11#3)(1994-12#3)(1994-3#3)(1994-5#1)(1994-8#3)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#1)(2005-4#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-6#1)(2007-11#5)(2007-12#7)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#16)(2009-11#1)(2009-3#2)(2009-4#1)(2009-8#1)(2010-4#4)(2011-1#2)(2011-2#3)(2012-2#1)(2013-7#1)
similar to those present##2##4##(1991-9#1)(2012-11#1)
similar to those previously described in##2##6##(2011-2#1)(2012-3#1)
similar to those previously described##4##5##(1991-6#1)(1995-3#1)(2011-2#1)(2012-3#1)
similar to those previously##8##4##(1991-12#1)(1991-4#1)(1991-6#1)(1995-3#1)(2004-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
similar to those produced by##3##5##(1990-10#2)(1997-7#1)
similar to those produced##4##4##(1990-10#2)(1997-7#1)(2008-10#1)
similar to those provided by the BLAST package##2##8##(2008-4#2)
similar to those reported for the##2##6##(1994-2#1)(1995-11#1)
similar to those reported for##8##5##(1990-2#1)(1990-3#1)(1994-2#1)(1995-11#1)(1997-4#1)(2007-11#1)(2008-3#1)(2008-6#1)
similar to those reported in##5##5##(1995-12#1)(1997-2#2)(2007-12#1)(2007-3#1)
similar to those reported##17##4##(1990-2#1)(1990-3#1)(1993-4#1)(1994-2#1)(1995-11#1)(1995-12#1)(1996-2#1)(1997-2#2)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-3#1)(2008-6#1)(2013-1#1)
similar to those seen in the##2##6##(1996-12#1)(2012-3#1)
similar to those seen in##5##5##(1992-9#1)(1995-12#1)(1996-12#1)(2012-12#1)(2012-3#1)
similar to those seen with##4##5##(2006-10#1)(2008-5#1)(2011-2#1)(2012-3#1)
similar to those seen##10##4##(1992-9#1)(1995-11#1)(1995-12#1)(1996-12#1)(2006-10#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-3#2)
similar to those that are##2##5##(2007-11#1)(2007-12#1)
similar to those that##5##4##(1994-2#1)(2007-11#1)(2007-12#2)(2008-10#1)
similar to those used for##3##5##(1990-11#1)(1994-11#1)(2011-2#1)
similar to those used##5##4##(1990-11#1)(1994-11#1)(2007-12#1)(2008-3#1)(2011-2#1)
similar to those which##2##4##(1995-6#1)(2007-4#1)
similar to those with##3##4##(1996-9#1)(2007-3#1)(2008-3#1)
similar to those##425##3##(1990-10#4)(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#3)(1990-4#2)(1990-5#4)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#3)(1992-1#1)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#5)(1992-4#3)(1992-6#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#4)(1993-12#4)(1993-2#2)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#3)(1993-9#4)(1994-11#5)(1994-12#5)(1994-2#3)(1994-3#7)(1994-5#3)(1994-6#1)(1994-8#6)(1994-9#3)(1995-1#2)(1995-10#3)(1995-11#5)(1995-12#3)(1995-2#3)(1995-3#3)(1995-5#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#4)(1996-6#2)(1996-7#3)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#2)(2004-9#1)(2005-11#2)(2005-4#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#5)(2006-11#2)(2006-12#3)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#8)(2007-12#13)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#46)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#13)(2008-4#9)(2008-5#14)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#20)(2009-11#2)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-8#1)(2010-10#2)(2010-12#2)(2010-4#6)(2010-5#1)(2011-1#4)(2011-12#2)(2011-2#11)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#4)(2013-7#1)
similar to two##3##3##(1992-7#1)(2006-5#1)(2010-3#1)
similar to type##3##3##(1991-9#1)(1997-6#1)(2007-6#1)
similar to what has been reported from other Nordic countries and countries in Western-Europe##2##14##(2006-10#2)
similar to what has been reported from other##3##8##(2006-10#2)(2007-2#1)
similar to what has been reported##5##6##(1994-9#1)(2006-10#2)(2007-12#1)(2007-2#1)
similar to what has been##6##5##(1994-9#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-2#1)
similar to what is##4##4##(1993-11#1)(1995-12#1)(2005-11#1)(2008-8#1)
similar to what##13##3##(1993-11#1)(1994-9#2)(1995-12#1)(2005-11#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-8#1)
similar to wild type##2##4##(1994-10#1)(1995-1#1)
similar to wild##3##3##(1994-10#1)(1995-1#1)(2005-9#1)
similar to wild-type##4##3##(1994-5#1)(1995-5#1)(1996-11#1)(1997-1#1)
similar to##1866##2##(1990-10#12)(1990-11#14)(1990-12#10)(1990-2#12)(1990-3#6)(1990-4#10)(1990-5#15)(1990-6#4)(1990-7#14)(1990-8#6)(1990-9#5)(1991-1#5)(1991-10#5)(1991-11#8)(1991-12#5)(1991-2#21)(1991-3#9)(1991-4#7)(1991-5#11)(1991-6#9)(1991-7#15)(1991-8#6)(1991-9#12)(1992-1#4)(1992-10#2)(1992-11#13)(1992-12#13)(1992-2#7)(1992-3#15)(1992-4#8)(1992-5#1)(1992-6#9)(1992-7#3)(1992-8#8)(1992-9#13)(1993-1#3)(1993-11#13)(1993-12#10)(1993-2#10)(1993-3#12)(1993-4#3)(1993-5#3)(1993-6#15)(1993-7#3)(1993-8#14)(1993-9#10)(1994-10#3)(1994-11#12)(1994-12#23)(1994-2#9)(1994-3#14)(1994-5#12)(1994-6#10)(1994-8#19)(1994-9#18)(1995-1#15)(1995-10#6)(1995-11#15)(1995-12#14)(1995-2#13)(1995-3#12)(1995-4#3)(1995-5#16)(1995-6#9)(1995-7#2)(1995-8#13)(1995-9#4)(1996-1#4)(1996-10#8)(1996-11#6)(1996-12#20)(1996-2#10)(1996-3#5)(1996-4#6)(1996-5#13)(1996-6#8)(1996-7#4)(1996-8#9)(1996-9#8)(1997-1#5)(1997-2#20)(1997-3#9)(1997-4#14)(1997-5#5)(1997-6#6)(1997-7#12)(1997-8#11)(2004-11#3)(2004-12#1)(2004-2#1)(2004-4#1)(2004-9#3)(2005-10#5)(2005-11#13)(2005-4#3)(2005-7#1)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#22)(2006-11#5)(2006-12#12)(2006-2#1)(2006-3#2)(2006-5#7)(2006-6#2)(2006-7#3)(2006-8#18)(2006-9#2)(2007-1#6)(2007-10#5)(2007-11#29)(2007-12#43)(2007-2#12)(2007-3#6)(2007-4#2)(2007-5#4)(2007-6#3)(2007-7#11)(2007-8#11)(2007-9#3)(2008-1#10)(2008-10#187)(2008-11#30)(2008-12#10)(2008-2#23)(2008-3#41)(2008-4#23)(2008-5#61)(2008-6#11)(2008-7#34)(2008-8#29)(2008-9#59)(2009-1#1)(2009-10#12)(2009-11#5)(2009-12#6)(2009-2#1)(2009-3#7)(2009-4#7)(2009-5#4)(2009-6#4)(2009-7#4)(2009-8#6)(2009-9#4)(2010-10#5)(2010-11#5)(2010-12#13)(2010-2#3)(2010-3#3)(2010-4#16)(2010-5#8)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#5)(2011-1#13)(2011-10#1)(2011-11#1)(2011-12#3)(2011-2#26)(2012-1#5)(2012-11#5)(2012-12#10)(2012-2#18)(2012-3#15)(2012-6#1)(2013-1#23)(2013-7#9)(2013-8#10)
similar topologies##3##2##(2008-10#3)
similar transient##2##2##(1996-11#1)(2007-5#1)
similar treatment of##3##3##(1990-5#1)(1995-8#1)(2008-9#1)
similar treatment##6##2##(1990-5#1)(1990-6#1)(1995-8#1)(2007-10#1)(2008-9#1)(2011-12#1)
similar trend was observed##2##4##(2007-7#1)(2008-5#1)
similar trend was##4##3##(2007-7#2)(2008-5#1)(2008-7#1)
similar trend##11##2##(1995-10#1)(1997-7#1)(2006-2#1)(2007-7#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2012-11#2)
similar trends in both##3##4##(2007-9#1)(2010-5#1)(2013-8#1)
similar trends##8##2##(1994-9#1)(2006-12#1)(2007-9#1)(2008-10#1)(2009-2#1)(2010-5#1)(2012-1#1)(2013-8#1)
similar trials##3##2##(2008-5#1)(2010-1#1)(2010-2#1)
similar under##3##2##(1991-2#1)(2008-10#2)
similar underlying##2##2##(2005-8#1)(2011-2#1)
similar values were##2##3##(1990-8#1)(2008-10#1)
similar values##6##2##(1990-2#1)(1990-8#1)(1994-12#1)(2008-10#1)(2008-5#1)(2013-1#1)
similar vascular##2##2##(1993-3#1)(2007-10#1)
similar way##18##2##(1990-10#1)(1990-12#1)(1991-7#1)(1991-9#1)(1992-11#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-6#1)(1997-6#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-8#1)(2008-9#1)
similar ways##5##2##(1990-10#1)(1996-7#1)(2006-7#1)(2009-12#1)(2010-6#1)
similar when##4##2##(1993-7#1)(1995-1#1)(2006-10#1)(2008-3#1)
similar whether##3##2##(1991-3#1)(2006-10#1)(2008-7#1)
similar with respect to##5##4##(1991-2#1)(2006-9#1)(2007-8#1)(2008-10#1)(2011-2#1)
similar with that##2##3##(1992-11#1)(1992-3#1)
similar with the##4##3##(1990-2#1)(1992-11#1)(1994-12#1)(2008-3#1)
similar with those##2##3##(1997-7#1)(2011-2#1)
similar with##26##2##(1990-2#1)(1990-5#1)(1991-2#1)(1992-11#3)(1992-3#1)(1993-5#1)(1994-12#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-3#1)(2006-1#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#2)
similar within##3##2##(2008-10#1)(2009-3#1)(2012-2#1)
similar yields##2##2##(2008-11#1)(2008-7#1)
similar##5239##1##(1990-1#1)(1990-10#29)(1990-11#29)(1990-12#28)(1990-2#31)(1990-3#17)(1990-4#17)(1990-5#32)(1990-6#15)(1990-7#35)(1990-8#25)(1990-9#14)(1991-1#16)(1991-10#14)(1991-11#19)(1991-12#25)(1991-2#39)(1991-3#27)(1991-4#21)(1991-5#32)(1991-6#20)(1991-7#29)(1991-8#20)(1991-9#30)(1992-1#15)(1992-10#10)(1992-11#28)(1992-12#25)(1992-2#16)(1992-3#31)(1992-4#17)(1992-5#11)(1992-6#26)(1992-7#16)(1992-8#18)(1992-9#26)(1993-1#7)(1993-11#26)(1993-12#23)(1993-2#16)(1993-3#25)(1993-4#13)(1993-5#13)(1993-6#35)(1993-7#14)(1993-8#28)(1993-9#26)(1994-1#5)(1994-10#5)(1994-11#32)(1994-12#57)(1994-2#26)(1994-3#30)(1994-4#1)(1994-5#31)(1994-6#29)(1994-7#3)(1994-8#50)(1994-9#42)(1995-1#27)(1995-10#20)(1995-11#38)(1995-12#41)(1995-2#42)(1995-3#35)(1995-4#3)(1995-5#30)(1995-6#21)(1995-7#7)(1995-8#36)(1995-9#11)(1996-1#16)(1996-10#11)(1996-11#15)(1996-12#44)(1996-2#30)(1996-3#22)(1996-4#13)(1996-5#32)(1996-6#24)(1996-7#20)(1996-8#25)(1996-9#15)(1997-1#24)(1997-2#50)(1997-3#25)(1997-4#34)(1997-5#16)(1997-6#26)(1997-7#33)(1997-8#29)(2004-1#2)(2004-10#1)(2004-11#8)(2004-12#2)(2004-2#2)(2004-3#2)(2004-4#4)(2004-7#1)(2004-8#2)(2004-9#7)(2005-1#1)(2005-10#15)(2005-11#41)(2005-12#3)(2005-3#1)(2005-4#4)(2005-5#3)(2005-7#12)(2005-8#13)(2005-9#8)(2006-1#6)(2006-10#64)(2006-11#19)(2006-12#33)(2006-2#4)(2006-3#9)(2006-4#10)(2006-5#20)(2006-6#18)(2006-7#13)(2006-8#49)(2006-9#7)(2007-1#17)(2007-10#28)(2007-11#80)(2007-12#79)(2007-2#32)(2007-3#16)(2007-4#16)(2007-5#12)(2007-6#8)(2007-7#36)(2007-8#48)(2007-9#25)(2008-1#39)(2008-10#519)(2008-11#95)(2008-12#39)(2008-2#75)(2008-3#95)(2008-4#62)(2008-5#152)(2008-6#34)(2008-7#109)(2008-8#77)(2008-9#99)(2009-1#2)(2009-10#22)(2009-11#8)(2009-12#17)(2009-2#11)(2009-3#17)(2009-4#21)(2009-5#15)(2009-6#18)(2009-7#15)(2009-8#25)(2009-9#10)(2010-1#3)(2010-10#15)(2010-11#15)(2010-12#33)(2010-2#28)(2010-3#14)(2010-4#48)(2010-5#20)(2010-6#8)(2010-7#8)(2010-8#20)(2010-9#8)(2011-1#36)(2011-10#2)(2011-11#2)(2011-12#13)(2011-2#97)(2011-3#1)(2012-1#17)(2012-11#15)(2012-12#56)(2012-2#49)(2012-3#47)(2012-5#1)(2012-6#2)(2012-7#1)(2012-8#1)(2013-1#95)(2013-7#22)(2013-8#49)
similar)##3##1##(1996-5#1)(1997-3#1)(2009-6#1)
similar-sized##4##1##(1995-3#1)(2009-5#1)(2010-4#1)(2013-8#1)
similarities among species##3##3##(2007-3#1)(2011-12#2)
similarities among##5##2##(2007-3#2)(2008-10#1)(2011-12#2)
similarities and differences between the##8##5##(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2011-1#1)(2013-1#1)
similarities and differences between##17##4##(1990-5#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
similarities and differences in the##3##5##(1994-12#1)(2007-2#1)(2009-3#1)
similarities and differences in##8##4##(1991-9#1)(1994-12#1)(2005-4#1)(2006-12#1)(2007-2#1)(2008-2#1)(2008-8#1)(2009-3#1)
similarities and differences of##2##4##(2007-12#1)(2008-2#1)
similarities and differences##36##3##(1990-5#1)(1991-3#1)(1991-9#1)(1993-3#1)(1994-12#1)(1997-3#1)(2005-4#1)(2006-12#1)(2007-12#2)(2007-2#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#2)(2009-9#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-5#1)(2013-1#1)
similarities and dissimilarities##2##3##(1996-5#1)(2008-10#1)
similarities and##47##2##(1990-5#1)(1991-3#1)(1991-9#1)(1992-8#1)(1993-3#1)(1994-12#1)(1996-5#1)(1997-3#1)(2005-11#1)(2005-4#1)(2006-12#1)(2006-3#1)(2007-12#2)(2007-2#1)(2007-6#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#2)(2009-9#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-5#1)(2013-1#1)
similarities are##4##2##(1990-5#1)(1991-5#1)(1992-8#1)(2006-12#1)
similarities between the two##3##4##(1993-3#1)(1994-3#1)(2008-7#1)
similarities between the##16##3##(1990-2#1)(1991-5#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-3#1)(1996-8#1)(2006-3#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-12#1)(2009-3#1)(2011-12#1)
similarities between these##3##3##(1993-3#1)(2007-11#1)(2008-7#1)
similarities between##49##2##(1990-2#1)(1990-4#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-5#1)(1991-8#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-3#2)(1994-11#1)(1994-2#1)(1994-3#1)(1996-8#1)(1997-4#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#4)(2008-7#3)(2008-8#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2011-1#2)(2011-12#1)
similarities exist##2##2##(1990-4#1)(1990-7#1)
similarities for##2##2##(1991-6#1)(2008-10#1)
similarities in structure##3##3##(1997-7#1)(2006-7#1)(2008-4#1)
similarities in the##8##3##(1991-1#1)(1993-9#1)(1996-12#1)(1996-5#1)(1997-1#1)(2007-12#1)(2008-7#1)(2010-9#1)
similarities in their##3##3##(1992-7#1)(2008-1#1)(2008-3#1)
similarities in##32##2##(1990-7#1)(1991-1#1)(1991-5#1)(1992-1#1)(1992-7#1)(1992-8#2)(1993-9#1)(1994-11#1)(1995-3#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-7#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2010-2#1)(2010-9#1)(2012-12#1)
similarities include the##2##3##(1993-3#1)(2008-5#1)
similarities of the##5##3##(2006-12#1)(2007-11#1)(2008-10#2)(2008-5#1)
similarities of##13##2##(1990-2#1)(1993-3#1)(1997-3#1)(1997-7#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-5#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-2#1)
similarities or##2##2##(1997-1#1)(2008-11#1)
similarities that##2##2##(2008-3#1)(2008-7#1)
similarities to human##3##3##(1995-9#1)(2008-10#1)(2008-9#1)
similarities to known proteins##2##4##(1990-11#1)(1997-4#1)
similarities to known##6##3##(1990-11#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-3#1)(1997-4#1)
similarities to the##13##3##(1990-11#1)(1991-6#1)(1992-12#2)(1992-9#1)(1994-9#1)(1996-6#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-4#1)
similarities to##56##2##(1990-11#2)(1990-5#2)(1991-10#1)(1991-2#1)(1991-6#1)(1992-12#2)(1992-9#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#3)(1995-2#1)(1995-8#4)(1995-9#1)(1996-10#3)(1996-12#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-3#2)(1997-4#2)(1997-7#1)(1997-8#2)(2004-11#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2010-10#1)(2011-2#1)(2012-9#1)
similarities were found between the##3##5##(1990-7#1)(2008-10#1)(2010-5#1)
similarities were found between##4##4##(1990-7#1)(2008-10#2)(2010-5#1)
similarities were##8##2##(1990-7#1)(1995-2#1)(2006-3#1)(2008-10#4)(2010-5#1)
similarities with a##5##3##(1992-9#1)(1995-1#1)(1996-10#1)(1997-1#1)(2009-2#1)
similarities with several##3##3##(1993-9#1)(1997-7#1)(2008-10#1)
similarities with that of##2##4##(1990-12#1)(1995-11#1)
similarities with the##10##3##(1991-12#1)(1991-2#1)(1992-6#1)(1995-4#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#1)
similarities with those##2##3##(1995-2#1)(2008-5#1)
similarities with##39##2##(1990-12#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-4#1)(1995-9#2)(1996-10#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-7#1)(2005-11#1)(2005-8#1)(2007-12#2)(2007-6#1)(2008-10#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2009-12#1)(2009-2#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)
similarities within the##3##3##(1993-2#1)(2008-10#1)(2008-4#1)
similarities within##6##2##(1991-9#1)(1993-2#1)(1993-6#1)(2008-10#1)(2008-4#1)(2010-5#1)
similarities##328##1##(1990-11#2)(1990-12#3)(1990-2#2)(1990-4#2)(1990-5#5)(1990-7#3)(1990-9#2)(1991-1#2)(1991-10#3)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#3)(1991-8#1)(1991-9#5)(1992-1#1)(1992-11#1)(1992-12#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#6)(1992-9#4)(1993-2#1)(1993-3#6)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-2#4)(1995-3#1)(1995-4#1)(1995-8#4)(1995-9#3)(1996-10#4)(1996-12#2)(1996-2#2)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-3#5)(1997-4#4)(1997-6#2)(1997-7#4)(1997-8#2)(2004-11#1)(2005-11#2)(2005-4#1)(2005-8#1)(2006-10#2)(2006-12#6)(2006-3#3)(2006-5#1)(2006-7#2)(2006-8#2)(2007-1#1)(2007-11#3)(2007-12#9)(2007-2#3)(2007-3#2)(2007-4#1)(2007-6#2)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#26)(2008-11#7)(2008-12#3)(2008-2#3)(2008-3#4)(2008-4#14)(2008-5#3)(2008-7#14)(2008-8#5)(2008-9#6)(2009-12#2)(2009-2#2)(2009-3#4)(2009-4#3)(2009-5#3)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#5)(2011-2#7)(2012-12#3)(2012-2#3)(2012-5#1)(2012-9#1)(2013-1#3)(2013-8#3)
similarity (&gt##2##2##(2008-10#1)(2010-6#1)
similarity across##3##2##(2008-2#2)(2010-12#1)
similarity among isolates of##2##4##(2008-10#2)
similarity among strains##2##3##(2008-10#2)
similarity among##11##2##(2006-10#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-8#1)(2011-12#1)
similarity analysis##6##2##(2005-11#2)(2008-10#1)(2012-2#3)
similarity and low##2##3##(2008-7#1)(2008-9#1)
similarity and relatedness##4##3##(2013-1#4)
similarity and were##2##3##(2008-10#1)(2008-5#1)
similarity and##19##2##(1993-9#1)(1995-4#1)(1996-10#1)(1996-6#1)(2005-11#1)(2007-10#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#2)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#4)
similarity at the##2##3##(1995-6#1)(2006-8#1)
similarity at##4##2##(1995-6#1)(2006-8#1)(2008-10#1)(2013-1#1)
similarity between EAS and ENA##2##5##(2008-8#2)
similarity between EAS##3##3##(2008-8#3)
similarity between a##2##3##(1994-3#1)(2007-7#1)
similarity between the two##3##4##(1995-7#1)(2008-10#1)(2012-12#1)
similarity between the##22##3##(1990-11#2)(1990-4#1)(1991-6#1)(1992-8#1)(1994-8#1)(1995-3#3)(1995-7#1)(1996-7#1)(1997-6#1)(2006-8#1)(2007-3#1)(2008-10#3)(2008-2#1)(2009-3#1)(2011-1#1)(2012-12#1)(2012-2#1)
similarity between these##2##3##(2007-7#1)(2008-10#1)
similarity between this##3##3##(1990-9#1)(1992-8#1)(2008-2#1)
similarity between##68##2##(1990-11#2)(1990-4#2)(1990-9#1)(1991-2#1)(1991-4#2)(1991-6#1)(1992-5#1)(1992-8#3)(1993-2#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-3#3)(1995-7#1)(1996-10#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#2)(2006-8#2)(2007-12#2)(2007-3#1)(2007-7#3)(2008-10#7)(2008-2#4)(2008-5#2)(2008-8#6)(2009-10#1)(2009-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
similarity coefficient##3##2##(2008-10#2)(2010-4#1)
similarity coefficients##2##2##(2008-10#1)(2013-7#1)
similarity factor##4##2##(2005-10#1)(2010-3#2)(2011-2#1)
similarity for two##2##3##(1996-6#1)(2008-10#1)
similarity function is##3##3##(1995-8#3)
similarity has##2##2##(1997-6#1)(2013-8#1)
similarity in properties##2##3##(2008-10#1)(2008-8#1)
similarity in the##10##3##(1990-11#1)(1991-3#1)(1994-10#1)(1995-2#1)(1995-4#1)(1997-1#1)(2008-10#2)(2008-7#1)(2008-8#1)
similarity in their##3##3##(2006-12#2)(2008-10#1)
similarity in##44##2##(1990-11#1)(1991-11#1)(1991-3#1)(1991-8#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-8#2)(1994-10#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-4#2)(1995-5#1)(1996-7#1)(1997-1#1)(2005-8#1)(2006-12#2)(2007-12#1)(2007-3#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#4)(2011-2#2)(2012-2#1)(2013-8#1)
similarity index##5##2##(2008-10#2)(2008-5#1)(2010-8#1)(2013-8#1)
similarity indices##3##2##(2008-10#1)(2010-5#1)(2011-2#1)
similarity is found##2##3##(1990-2#1)(2008-7#1)
similarity is##9##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-10#1)(1991-7#1)(1992-4#1)(1994-6#1)(2008-2#1)(2008-7#1)
similarity matrix##3##2##(2008-10#1)(2008-4#1)(2012-2#1)
similarity may##2##2##(1991-11#1)(2008-9#1)
similarity measures##3##2##(2007-8#1)(2008-2#1)(2011-2#1)
similarity metrics for##2##3##(2008-10#2)
similarity of nucleic acid##2##4##(1996-6#1)(2005-11#1)
similarity of the primary##2##4##(1992-1#1)(1992-12#1)
similarity of the two##2##4##(1990-10#1)(2008-9#1)
similarity of the##23##3##(1990-10#1)(1990-2#1)(1990-8#1)(1991-7#1)(1992-1#1)(1992-12#1)(1994-6#1)(1995-5#1)(1995-8#1)(1996-7#1)(1997-3#1)(2007-11#1)(2008-10#4)(2008-9#1)(2009-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
similarity of their##3##3##(1994-9#1)(2008-10#2)
similarity of these##4##3##(1994-2#1)(1996-4#1)(1996-6#1)(2007-12#1)
similarity of##72##2##(1990-10#1)(1990-2#1)(1990-7#2)(1990-8#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-4#1)(1994-2#2)(1994-6#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-4#2)(1996-6#2)(1996-7#2)(1997-1#2)(1997-3#1)(1997-4#1)(2005-11#2)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#11)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-2#1)(2009-8#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#2)
similarity or##5##2##(1994-2#1)(1995-1#1)(1995-5#1)(2006-8#1)(2011-1#1)
similarity search##2##2##(1996-6#1)(2008-4#1)
similarity searches##3##2##(2008-4#1)(2009-10#1)(2013-1#1)
similarity searching##6##2##(2008-4#4)(2008-9#1)(2013-8#1)
similarity solutions##3##2##(2005-11#3)
similarity to a##13##3##(1992-11#1)(1993-3#1)(1994-5#1)(1994-9#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-7#2)(2008-10#1)(2008-4#1)(2009-11#1)(2009-12#1)
similarity to any other##6##4##(1996-12#2)(1996-6#1)(1997-4#1)(2005-6#1)(2008-7#1)
similarity to any##13##3##(1995-10#1)(1995-8#1)(1996-12#2)(1996-5#1)(1996-6#2)(1997-3#1)(1997-4#1)(2005-6#1)(2008-10#1)(2008-7#1)(2013-1#1)
similarity to each other##5##4##(1991-7#1)(1992-7#1)(1994-9#1)(1996-10#1)(1996-8#1)
similarity to genes in other##2##5##(2008-7#2)
similarity to genes##4##3##(1993-9#1)(2008-7#3)
similarity to human skin##2##4##(2008-5#2)
similarity to human##4##3##(1993-12#1)(1995-2#1)(2008-5#2)
similarity to known genes were also predicted##2##7##(1997-6#1)(1997-8#1)
similarity to known genes##3##4##(1995-12#1)(1997-6#1)(1997-8#1)
similarity to known##10##3##(1991-12#1)(1995-12#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-7#1)(2010-10#1)
similarity to lipoprotein##2##3##(1995-2#1)(2010-10#1)
similarity to mammalian##2##3##(1993-2#1)(1997-2#1)
similarity to other known##2##4##(1991-5#1)(1995-2#1)
similarity to other##6##3##(1991-5#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-8#1)(1997-6#1)
similarity to proteins##2##3##(1993-9#1)(1995-6#1)
similarity to rat##2##3##(1994-9#1)(1996-7#1)
similarity to sequences##4##3##(1997-3#1)(1997-4#1)(2008-10#2)
similarity to that of the yeast##2##6##(1991-6#1)(1996-2#1)
similarity to that of the##3##5##(1991-6#1)(1992-11#1)(1996-2#1)
similarity to that of##6##4##(1991-6#1)(1992-11#1)(1993-12#1)(1993-6#1)(1996-2#1)(1997-2#1)
similarity to that##7##3##(1991-6#1)(1992-11#1)(1993-12#1)(1993-6#1)(1996-2#1)(1997-2#1)(2007-10#1)
similarity to the gene encoding##2##5##(1991-6#1)(1995-3#1)
similarity to the human##2##4##(1991-8#1)(1993-12#1)
similarity to the putative##2##4##(1990-11#1)(1995-8#1)
similarity to the##45##3##(1990-11#1)(1990-3#1)(1991-11#1)(1991-6#1)(1991-8#2)(1992-12#1)(1993-12#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#2)(1995-8#5)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-4#1)(1997-7#2)(2007-10#1)(2008-10#3)(2008-7#1)(2011-1#1)(2012-3#1)(2013-8#2)
similarity to those of##3##4##(1991-5#1)(1994-8#1)(1995-6#1)
similarity to those##4##3##(1991-5#1)(1993-9#1)(1994-8#1)(1995-6#1)
similarity to vertebrate##2##3##(1993-9#1)(1997-2#1)
similarity to vinculin##2##3##(1991-5#2)
similarity to##190##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#2)(1992-11#2)(1992-12#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#2)(1993-9#5)(1994-10#1)(1994-12#7)(1994-2#1)(1994-5#1)(1994-6#4)(1994-8#4)(1994-9#5)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#6)(1995-3#2)(1995-4#1)(1995-6#5)(1995-8#7)(1996-10#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#3)(1996-5#2)(1996-6#6)(1996-7#3)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#4)(1997-6#2)(1997-7#5)(1997-8#1)(2005-11#1)(2005-6#2)(2006-8#2)(2007-10#2)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#16)(2008-4#1)(2008-5#2)(2008-7#7)(2008-8#1)(2009-11#1)(2009-12#2)(2009-6#1)(2010-10#3)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
similarity values##2##2##(2008-10#1)(2011-3#1)
similarity was found between##2##4##(1991-9#1)(1994-5#1)
similarity was found##5##3##(1991-9#1)(1994-5#2)(2008-10#1)(2013-7#1)
similarity was observed between##2##4##(1994-12#1)(2008-10#1)
similarity was observed##3##3##(1994-12#1)(2008-10#1)(2009-5#1)
similarity was##12##2##(1991-8#1)(1991-9#1)(1994-12#1)(1994-5#2)(1996-10#1)(2005-11#1)(2008-10#3)(2009-5#1)(2013-7#1)
similarity with a##3##3##(1990-4#1)(1994-11#1)(2008-10#1)
similarity with amino acid sequences##2##5##(1994-11#1)(1995-9#1)
similarity with human##2##3##(1991-2#1)(1992-11#1)
similarity with isolates from##2##4##(2008-10#2)
similarity with known##2##3##(1993-3#1)(2006-8#1)
similarity with one another##2##4##(2008-10#2)
similarity with other##3##3##(1991-5#1)(1994-8#1)(2009-4#1)
similarity with strains##2##3##(2008-10#1)(2008-5#1)
similarity with that of##2##4##(1995-3#1)(1995-8#1)
similarity with the N-terminal##2##4##(1990-2#1)(1991-7#1)
similarity with the other##2##4##(1990-5#1)(1992-2#1)
similarity with the##20##3##(1990-1#1)(1990-2#2)(1990-5#1)(1990-7#1)(1991-11#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-3#1)(1995-6#2)(1997-1#1)(2008-5#2)(2010-3#1)
similarity with those##2##3##(1990-4#1)(1994-3#1)
similarity with##80##2##(1990-1#3)(1990-2#2)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-5#3)(1991-7#1)(1991-9#1)(1992-11#2)(1992-2#2)(1992-3#1)(1992-5#1)(1993-11#2)(1993-3#2)(1993-6#2)(1994-11#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#4)(1995-2#1)(1995-3#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2004-12#1)(2006-8#2)(2007-6#1)(2008-10#12)(2008-4#1)(2008-5#3)(2008-8#1)(2009-4#1)(2010-3#1)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#1)
similarity##700##1##(1990-1#3)(1990-10#1)(1990-11#5)(1990-12#2)(1990-2#5)(1990-3#2)(1990-4#4)(1990-5#3)(1990-6#2)(1990-7#5)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#5)(1991-12#2)(1991-2#4)(1991-3#2)(1991-4#2)(1991-5#8)(1991-6#7)(1991-7#4)(1991-8#5)(1991-9#3)(1992-1#1)(1992-11#4)(1992-12#2)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#5)(1992-6#1)(1992-7#2)(1992-8#6)(1992-9#1)(1993-11#3)(1993-12#5)(1993-2#4)(1993-3#8)(1993-4#3)(1993-6#3)(1993-8#4)(1993-9#8)(1994-10#2)(1994-11#2)(1994-12#10)(1994-2#5)(1994-3#5)(1994-5#5)(1994-6#9)(1994-8#10)(1994-9#8)(1995-1#2)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#10)(1995-3#9)(1995-4#4)(1995-5#5)(1995-6#10)(1995-7#1)(1995-8#13)(1995-9#1)(1996-10#6)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#7)(1996-5#3)(1996-6#14)(1996-7#7)(1996-8#2)(1996-9#1)(1997-1#5)(1997-2#4)(1997-3#5)(1997-4#9)(1997-6#5)(1997-7#10)(1997-8#1)(1997-9#1)(2004-12#1)(2005-10#1)(2005-11#12)(2005-6#2)(2005-8#1)(2006-10#2)(2006-12#4)(2006-7#1)(2006-8#9)(2007-10#4)(2007-11#2)(2007-12#7)(2007-3#2)(2007-6#2)(2007-7#4)(2007-8#5)(2008-10#90)(2008-11#1)(2008-12#4)(2008-2#15)(2008-3#5)(2008-4#14)(2008-5#11)(2008-6#3)(2008-7#12)(2008-8#18)(2008-9#11)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#2)(2010-10#3)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#2)(2010-6#2)(2010-8#2)(2011-1#7)(2011-12#2)(2011-2#12)(2011-3#2)(2012-1#1)(2012-12#4)(2012-2#11)(2012-3#6)(2013-1#15)(2013-7#4)(2013-8#10)
similarity) and##2##2##(1994-12#1)(2012-2#1)
similarity)##7##1##(1991-3#1)(1994-12#1)(2006-8#1)(2008-10#1)(2010-1#1)(2012-2#1)(2013-8#1)
similarly affect##2##2##(1990-2#1)(2004-11#1)
similarly affected by##4##3##(1994-12#1)(1996-8#2)(2008-11#1)
similarly and##2##2##(2006-12#1)(2008-6#1)
similarly as##4##2##(2006-6#2)(2008-10#2)
similarly atypical in these##2##4##(2009-4#2)
similarly declined during##2##3##(2008-7#1)(2010-2#1)
similarly decreased##2##2##(1994-8#1)(2006-12#1)
similarly demonstrated##2##2##(1991-3#1)(2008-5#1)
similarly effective in##3##3##(1990-11#1)(2007-11#1)(2012-3#1)
similarly effective##6##2##(1990-11#1)(2006-12#1)(2007-11#1)(2008-12#1)(2011-2#1)(2012-3#1)
similarly high##3##2##(1997-2#1)(2008-12#1)(2012-3#1)
similarly in the##2##3##(1990-11#1)(2005-11#1)
similarly in##6##2##(1990-11#1)(1995-11#1)(2005-11#1)(2006-9#1)(2008-4#1)(2011-2#1)
similarly increased##3##2##(1991-5#1)(1994-6#1)(2012-2#1)
similarly induced##2##2##(1994-2#1)(1996-5#1)
similarly inhibited by##3##3##(1990-8#1)(1991-7#1)(1993-3#1)
similarly inhibited##5##2##(1990-8#1)(1991-7#1)(1993-3#1)(1995-8#1)(2012-3#1)
similarly injected##4##2##(1993-5#1)(1997-8#1)(2008-10#1)(2013-1#1)
similarly on##2##2##(2008-12#1)(2013-1#1)
similarly reduced the##2##3##(1996-2#1)(2008-10#1)
similarly reduced##4##2##(1990-3#1)(1992-3#1)(1996-2#1)(2008-10#1)
similarly regulated##3##2##(1991-5#1)(1993-2#1)(2009-3#1)
similarly sized##3##2##(1995-8#1)(1997-7#1)(2008-2#1)
similarly stimulated##2##2##(1992-8#1)(2013-1#1)
similarly structured##2##2##(1997-5#1)(2008-5#1)
similarly tested##2##2##(2009-7#1)(2012-3#1)
similarly to a##4##3##(1991-2#1)(1994-5#1)(2008-11#1)(2009-9#1)
similarly to other##2##3##(1996-4#1)(1996-9#1)
similarly to patients with##2##4##(2007-8#1)(2013-1#1)
similarly to that of##2##4##(1996-7#1)(2008-10#1)
similarly to that##3##3##(1996-7#1)(2008-10#1)(2009-2#1)
similarly to the##9##3##(1991-4#1)(1991-5#1)(1995-1#1)(1996-12#1)(1996-5#2)(2007-11#1)(2008-10#1)(2012-1#1)
similarly to those##2##3##(1997-4#1)(2008-10#1)
similarly to##53##2##(1990-11#1)(1991-2#1)(1991-4#1)(1991-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-5#2)(1994-9#1)(1995-1#2)(1996-12#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-4#2)(2006-1#1)(2006-8#1)(2007-11#1)(2007-8#2)(2008-10#7)(2008-11#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#3)(2013-1#1)
similarly treated##5##2##(1996-1#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-3#1)
similarly with the##3##3##(1990-4#1)(1991-2#1)(2008-3#1)
similarly##265##1##(1990-11#4)(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#2)(1990-8#3)(1990-9#1)(1991-1#3)(1991-2#2)(1991-3#2)(1991-4#3)(1991-5#5)(1991-7#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-3#2)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#4)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-5#3)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#3)(1995-2#2)(1995-5#1)(1995-7#2)(1995-8#4)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#5)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#4)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#2)(2004-11#1)(2005-10#1)(2005-11#4)(2005-8#1)(2006-1#1)(2006-11#2)(2006-12#4)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#2)(2007-9#4)(2008-10#23)(2008-11#4)(2008-12#3)(2008-2#4)(2008-3#7)(2008-4#2)(2008-5#5)(2008-6#6)(2008-7#4)(2008-8#5)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-2#3)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-1#4)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#8)(2013-1#8)(2013-8#2)
similars##4##1##(1997-6#3)(2011-2#1)
similis##3##1##(2008-10#3)
similitude##4##1##(2008-10#1)(2013-7#3)
simple 1##3##2##(2005-11#1)(2010-7#2)
simple DNA##3##2##(2008-10#1)(2008-4#1)(2013-1#1)
simple ELISA##3##2##(1994-9#1)(1996-6#1)(2008-4#1)
simple Fabry-Perot##2##2##(2007-11#2)
simple Fourier##2##2##(2007-12#1)(2008-3#1)
simple HPLC##2##2##(1994-12#1)(1997-3#1)
simple Michaelis-Menten type##2##3##(1990-11#1)(1990-7#1)
simple Michaelis-Menten##3##2##(1990-11#2)(1990-7#1)
simple PCR##2##2##(1994-11#1)(2012-12#1)
simple RT##3##2##(2008-7#1)(2010-1#2)
simple X-ray##2##2##(1992-8#1)(2008-1#1)
simple adaptive##4##2##(2008-11#1)(2008-2#2)(2010-4#1)
simple addition of##4##3##(2007-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
simple additive and logistic scores##2##5##(2007-8#2)
simple additive##5##2##(1995-11#1)(2007-1#1)(2007-8#3)
simple aimless##2##2##(1993-9#2)
simple algorithm for the##2##4##(2008-2#1)(2013-1#1)
simple algorithm for##3##3##(2008-2#1)(2010-7#1)(2013-1#1)
simple algorithm##7##2##(2007-12#2)(2008-2#1)(2008-3#1)(2009-4#1)(2010-7#1)(2013-1#1)
simple algorithms##2##2##(2005-11#1)(2007-9#1)
simple alternative to##3##3##(2006-7#1)(2008-10#1)(2010-12#1)
simple alternative##6##2##(1994-7#1)(2005-11#1)(2006-7#1)(2008-10#1)(2010-12#1)(2011-1#1)
simple analgesics##2##2##(1991-8#1)(2011-1#1)
simple analyses##2##2##(1994-11#1)(1995-12#1)
simple analysis of the##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
simple analytic##2##2##(2007-11#1)(2008-2#1)
simple analytical formulas##2##3##(2008-2#1)(2008-3#1)
simple analytical model##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
simple analytical technique##2##3##(2008-10#2)
simple analytical##20##2##(2005-11#1)(2007-11#3)(2007-12#3)(2007-4#1)(2008-10#5)(2008-2#1)(2008-3#6)
simple and accurate method for measuring the##2##7##(2008-2#1)(2008-3#1)
simple and accurate method for##4##5##(2005-12#1)(2007-12#1)(2008-2#1)(2008-3#1)
simple and accurate##8##3##(1995-6#1)(2005-11#2)(2005-12#1)(2007-12#1)(2008-2#2)(2008-3#1)
simple and affordable##2##3##(2006-10#1)(2010-5#1)
simple and applicable##2##3##(2007-2#1)(2008-3#1)
simple and automated##2##3##(1995-2#1)(2008-10#1)
simple and can be##4##4##(2008-10#2)(2008-3#1)(2013-7#1)
simple and can easily be##2##5##(2007-12#1)(2008-2#1)
simple and can##6##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2013-7#1)
simple and compact##4##3##(2007-12#2)(2008-2#2)
simple and complex reaction##2##4##(2010-1#1)(2012-1#1)
simple and complex visual##2##4##(2006-8#1)(2012-1#1)
simple and complex##12##3##(1994-2#1)(2006-8#1)(2008-12#1)(2008-4#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#2)(2012-12#1)
simple and convenient method for the##2##6##(2007-11#2)
simple and convenient method for##3##5##(2007-11#2)(2008-10#1)
simple and convenient##7##3##(2007-11#2)(2008-10#3)(2008-11#1)(2008-5#1)
simple and cost effective##3##4##(2007-11#1)(2007-12#1)(2013-8#1)
simple and cost-effective##5##3##(1997-4#1)(2008-5#1)(2010-5#1)(2013-1#2)
simple and direct##5##3##(1995-12#1)(2007-12#1)(2008-10#2)(2010-4#1)
simple and easy to##4##4##(2008-10#1)(2008-3#1)(2011-2#1)(2013-7#1)
simple and easy##6##3##(2008-10#2)(2008-3#1)(2011-2#1)(2012-2#1)(2013-7#1)
simple and economical##5##3##(1992-8#1)(2007-7#1)(2008-10#2)(2012-12#1)
simple and effective chromatographic##2##4##(1990-5#1)(2008-10#1)
simple and effective method of##2##5##(2007-2#1)(2013-8#1)
simple and effective tool##2##4##(2008-10#1)(2010-5#1)
simple and effective##16##3##(1990-5#1)(1991-5#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2009-3#1)(2009-5#1)(2010-5#1)(2013-8#1)
simple and efficient method for the##4##6##(1995-6#1)(2007-11#1)(2008-9#1)(2010-3#1)
simple and efficient method for##8##5##(1993-4#1)(1995-6#1)(2006-11#1)(2007-11#1)(2008-4#1)(2008-9#1)(2009-3#1)(2010-3#1)
simple and efficient method##12##4##(1990-11#1)(1993-4#1)(1994-8#1)(1995-6#1)(2006-11#1)(2007-11#1)(2008-4#1)(2008-9#1)(2009-3#1)(2010-3#1)(2012-12#1)(2013-8#1)
simple and efficient##23##3##(1990-11#1)(1993-4#1)(1994-8#1)(1994-9#1)(1995-6#1)(2006-11#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-9#3)(2009-3#1)(2009-5#1)(2010-2#1)(2010-3#1)(2010-4#1)(2012-12#1)(2013-8#1)
simple and fast method for the##3##6##(2008-10#3)
simple and fast method for##5##5##(2008-10#4)(2008-11#1)
simple and fast method is proposed##2##6##(2008-10#2)
simple and fast method is##3##5##(1997-1#1)(2008-10#2)
simple and fast method##8##4##(1997-1#1)(2008-10#6)(2008-11#1)
simple and fast procedure##2##4##(2008-10#1)(2008-6#1)
simple and fast##25##3##(1997-1#1)(2008-10#17)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2012-3#1)
simple and general##3##3##(1996-5#1)(2008-4#1)(2008-8#1)
simple and highly selective##3##4##(2008-10#3)
simple and highly##10##3##(1991-3#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-4#1)(2010-12#1)
simple and inexpensive##13##3##(1991-4#1)(1991-6#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-6#2)(2013-8#1)
simple and is##2##3##(2007-7#1)(2008-3#1)
simple and low cost##3##4##(2007-12#1)(2008-10#1)(2008-7#1)
simple and low-cost##4##3##(2008-10#3)(2008-3#1)
simple and need##2##3##(2008-10#1)(2011-2#1)
simple and non-invasive##2##3##(1996-2#1)(2006-6#1)
simple and powerful##3##3##(1994-9#1)(1996-8#1)(2008-3#1)
simple and practical method for the determination of##2##8##(2005-12#1)(2008-10#1)
simple and practical method for##3##5##(1993-8#1)(2005-12#1)(2008-10#1)
simple and practical method##4##4##(1993-8#1)(2005-12#1)(2008-10#1)(2008-4#1)
simple and practical##11##3##(1993-8#1)(1997-8#1)(2005-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2011-2#1)
simple and precise method##2##4##(1995-7#1)(2007-9#1)
simple and precise##4##3##(1995-7#1)(2007-9#1)(2008-10#1)(2010-12#1)
simple and provides##3##3##(2007-12#1)(2008-3#1)(2012-2#1)
simple and rapid method for the##3##6##(1997-3#1)(2008-10#2)
simple and rapid method for##9##5##(1990-12#1)(1995-2#1)(1997-1#1)(1997-3#1)(2008-10#5)
simple and rapid method##15##4##(1990-12#1)(1995-2#1)(1996-8#1)(1997-1#1)(1997-3#1)(2008-10#8)(2008-4#1)(2008-5#1)
simple and rapid procedure##4##4##(1994-8#1)(1996-12#1)(2008-10#2)
simple and rapid spectrophotometric##3##4##(2008-10#3)
simple and rapid##55##3##(1990-12#2)(1991-9#1)(1992-1#1)(1993-2#1)(1994-8#1)(1995-2#1)(1996-12#1)(1996-8#2)(1997-1#2)(1997-3#1)(1997-4#1)(2005-4#4)(2005-9#1)(2006-8#1)(2007-12#1)(2008-10#26)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-3#1)(2012-2#1)
simple and relatively##2##3##(2008-10#2)
simple and reliable method for the##2##6##(2008-10#2)
simple and reliable method for##7##5##(1997-8#1)(2008-10#4)(2008-2#1)(2008-8#1)
simple and reliable method##11##4##(1997-8#1)(2008-10#6)(2008-2#1)(2008-8#1)(2008-9#1)(2012-2#1)
simple and reliable##22##3##(1992-12#1)(1994-3#1)(1996-3#1)(1997-8#1)(2008-10#10)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#1)(2010-2#1)(2012-2#1)(2012-3#1)
simple and reproducible technique##2##4##(1993-11#1)(2006-7#1)
simple and reproducible##11##3##(1990-9#1)(1992-3#1)(1993-11#1)(1996-8#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-11#1)(2013-8#1)
simple and robust and##2##4##(2008-10#1)(2008-3#1)
simple and robust##10##3##(2008-10#4)(2008-11#1)(2008-3#3)(2008-4#1)(2010-12#1)
simple and safe and##2##4##(2007-9#1)(2010-7#1)
simple and safe procedure##2##4##(1994-9#1)(2006-5#1)
simple and safe##9##3##(1994-9#1)(2006-5#1)(2006-6#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-7#1)(2010-1#1)(2010-7#1)
simple and satisfactory##2##3##(2005-4#1)(2008-10#1)
simple and selective method for##3##5##(2008-10#3)
simple and selective method##5##4##(2008-10#5)
simple and selective##10##3##(1996-6#1)(2007-8#1)(2008-10#7)(2008-3#1)
simple and sensitive flow cytometric assay for the determination of the cytotoxic activity of human natural killer cells##2##18##(1990-12#2)
simple and sensitive flow##4##4##(1990-12#2)(2008-10#2)
simple and sensitive fluorometric method##2##5##(2008-10#2)
simple and sensitive method for the##6##6##(2008-10#5)(2010-5#1)
simple and sensitive method for##7##5##(1992-2#1)(2008-10#5)(2010-5#1)
simple and sensitive method of nonaqueous capillary electrophoresis with laser-induced native fluorescence##2##12##(2008-10#2)
simple and sensitive method##14##4##(1991-3#1)(1992-2#1)(1995-2#1)(2008-10#9)(2010-5#1)(2011-1#1)
simple and sensitive spectrophotometric##3##4##(2008-10#2)(2010-2#1)
simple and sensitive visible spectrophotometric methods##4##6##(2008-10#3)(2010-2#1)
simple and sensitive##53##3##(1990-11#1)(1990-12#2)(1991-3#1)(1992-2#1)(1995-2#1)(1997-8#1)(2007-8#2)(2008-10#35)(2008-3#1)(2008-4#1)(2008-9#1)(2010-2#2)(2010-5#1)(2011-1#1)(2011-2#2)
simple and small##2##3##(2006-8#1)(2012-11#1)
simple and straightforward##6##3##(2007-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)
simple and the##4##3##(1991-8#1)(2007-11#1)(2008-10#2)
simple and understandable##2##3##(1995-12#1)(1996-3#1)
simple and useful##3##3##(1995-4#1)(1997-3#1)(2008-10#1)
simple and versatile##6##3##(1990-3#1)(2007-12#1)(2008-10#3)(2010-4#1)
simple and##483##2##(1990-11#3)(1990-12#4)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#3)(1995-12#2)(1995-2#3)(1995-4#1)(1995-6#2)(1995-7#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#4)(1997-1#4)(1997-3#2)(1997-4#2)(1997-8#3)(2005-11#3)(2005-12#2)(2005-4#6)(2005-5#1)(2005-9#1)(2006-10#3)(2006-11#2)(2006-12#2)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#3)(2007-1#2)(2007-10#1)(2007-11#8)(2007-12#21)(2007-2#3)(2007-7#5)(2007-8#7)(2007-9#2)(2008-1#1)(2008-10#161)(2008-11#13)(2008-12#2)(2008-2#16)(2008-3#25)(2008-4#14)(2008-5#6)(2008-6#4)(2008-7#6)(2008-8#3)(2008-9#7)(2009-2#1)(2009-3#2)(2009-5#3)(2009-6#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#4)(2010-2#6)(2010-3#2)(2010-4#5)(2010-5#5)(2010-7#1)(2011-1#1)(2011-2#6)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#8)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#7)
simple application of##3##3##(2008-10#2)(2008-8#1)
simple approach for##4##3##(2007-8#1)(2008-7#1)(2008-9#1)(2012-3#1)
simple approach to the##4##4##(1993-5#1)(2006-10#1)(2008-11#1)(2012-2#1)
simple approach to##13##3##(1993-5#1)(1994-3#1)(1997-8#1)(2005-10#2)(2006-10#1)(2006-4#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2012-2#1)
simple approach##21##2##(1993-5#1)(1994-3#1)(1997-8#1)(2005-10#2)(2006-10#1)(2006-12#1)(2006-4#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
simple approaches##3##2##(1995-8#1)(2008-7#1)(2012-3#1)
simple aqueous solutions##2##3##(2008-7#1)(2008-8#1)
simple aqueous##7##2##(2006-11#1)(2008-10#4)(2008-7#1)(2008-8#1)
simple as it##2##3##(2008-10#1)(2008-6#1)
simple as##4##2##(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)
simple assay for##2##3##(1993-11#1)(1995-1#1)
simple assay##7##2##(1993-11#2)(1995-1#1)(1996-12#1)(2008-7#1)(2008-9#1)(2009-10#1)
simple assays##2##2##(2007-2#1)(2008-4#1)
simple associations##2##2##(1995-2#1)(2010-8#1)
simple bead injection##2##3##(2008-10#2)
simple bromophenols in fish meat##2##5##(2008-10#2)
simple bromophenols in##3##3##(2008-10#3)
simple but effective way to##2##5##(2008-2#1)(2008-4#1)
simple but effective##4##3##(2008-2#1)(2008-3#2)(2008-4#1)
simple but sensitive##2##3##(2005-11#1)(2007-12#1)
simple but useful##2##3##(2008-11#1)(2013-8#1)
simple but##16##2##(1990-4#1)(2005-11#1)(2006-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2010-11#1)(2013-1#1)(2013-8#1)
simple calculation##5##2##(1995-8#1)(2007-12#1)(2008-2#1)(2009-11#1)(2011-2#1)
simple calibration##2##2##(2008-10#2)
simple carbohydrates##3##2##(2005-7#1)(2008-10#1)(2012-12#1)
simple cell##4##2##(2008-5#1)(2008-8#2)(2008-9#1)
simple cells in##4##3##(1996-2#1)(2008-11#1)(2008-8#2)
simple cells##7##2##(1996-2#1)(2007-8#1)(2008-11#1)(2008-8#4)
simple chaotic##2##2##(2007-12#1)(2008-2#1)
simple chemical##9##2##(1991-8#1)(1995-5#1)(2006-12#2)(2008-1#1)(2008-10#1)(2010-4#1)(2012-11#2)
simple classification system of##2##4##(2008-12#2)
simple classification##6##2##(2006-2#1)(2008-12#2)(2008-2#1)(2008-7#2)
simple clinical##5##2##(1990-12#1)(1995-9#1)(1996-3#1)(2004-1#1)(2005-10#1)
simple closure##3##2##(1990-6#3)
simple cognitive##2##2##(2007-2#1)(2009-8#1)
simple communities##2##2##(2008-10#1)(2008-8#1)
simple competitive##2##2##(1995-1#1)(2008-1#1)
simple computer##2##2##(1996-12#1)(1997-1#1)
simple concentration##2##2##(2008-2#1)(2009-6#1)
simple concept##3##2##(2011-2#1)(2013-1#2)
simple construction##2##2##(2008-10#1)(2008-4#1)
simple counts##3##2##(2007-11#3)
simple culture##2##2##(1994-11#1)(2008-5#1)
simple cysts##2##2##(1990-10#1)(2011-1#1)
simple data##3##2##(1990-8#1)(2008-2#1)(2008-3#1)
simple design##7##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)
simple designs##2##2##(1996-2#1)(2007-12#1)
simple determination of##5##3##(1992-3#1)(2007-8#1)(2008-10#3)
simple deterministic##2##2##(2007-9#1)(2008-8#1)
simple device for##4##3##(2006-6#1)(2006-7#1)(2008-10#1)(2008-3#1)
simple device that##3##3##(2007-11#1)(2008-11#1)(2009-11#1)
simple device##9##2##(2006-6#1)(2006-7#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-11#1)
simple diffusion##4##2##(1991-1#1)(2008-9#1)(2009-12#1)(2011-12#1)
simple dilution of##2##3##(2008-10#2)
simple dilution##5##2##(1990-6#1)(2008-10#4)
simple discrete##2##2##(2008-8#1)(2009-4#1)
simple discrimination##2##2##(1992-12#1)(1993-11#1)
simple disjoining solid-state##2##3##(2008-10#2)
simple displacement##2##2##(1996-2#1)(2008-2#1)
simple drug##2##2##(2008-1#1)(2012-11#1)
simple electron##2##2##(2008-10#1)(2009-10#1)
simple electronic##2##2##(2007-11#1)(2008-3#1)
simple emulsion##3##2##(2008-5#2)(2012-11#1)
simple enough##2##2##(2006-10#1)(2008-2#1)
simple equation is##2##3##(1992-2#1)(2008-3#1)
simple equation##6##2##(1991-5#1)(1992-2#1)(2008-10#1)(2008-3#2)(2011-2#1)
simple equations##2##2##(2008-2#2)
simple equipment##2##2##(2008-10#1)(2008-3#1)
simple example of##2##3##(2007-12#1)(2013-8#1)
simple example##7##2##(1994-6#1)(2007-12#3)(2008-10#1)(2010-2#1)(2013-8#1)
simple examples##2##2##(2006-10#1)(2008-2#1)
simple excision##2##2##(1996-10#1)(2007-8#1)
simple experiment##5##2##(1994-6#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#1)
simple experimental method to##3##4##(2008-2#1)(2008-3#1)(2008-5#1)
simple experimental method##4##3##(2008-2#1)(2008-3#1)(2008-5#2)
simple experimental model##2##3##(2005-10#1)(2008-5#1)
simple experimental setup##2##3##(2008-2#1)(2008-3#1)
simple experimental##13##2##(2005-10#1)(2007-12#2)(2008-2#2)(2008-3#2)(2008-5#3)(2009-2#1)(2012-12#1)(2012-2#1)
simple experiments##2##2##(2008-3#1)(2008-9#1)
simple explanation for##2##3##(2008-9#1)(2011-1#1)
simple explanation of##2##3##(2005-10#1)(2008-2#1)
simple explanation##4##2##(2005-10#1)(2008-2#1)(2008-9#1)(2011-1#1)
simple exposure##3##2##(2008-4#3)
simple expression##3##2##(2005-11#1)(2008-2#1)(2008-3#1)
simple expressions##2##2##(2008-3#2)
simple extension##4##2##(2007-11#1)(2007-9#1)(2008-12#1)(2008-3#1)
simple extraction procedure and##2##4##(2008-10#2)
simple extraction##6##2##(1996-5#1)(1997-3#1)(2007-10#1)(2008-10#3)
simple extrapolation of##2##3##(1991-6#1)(1996-4#1)
simple extrapolation##3##2##(1991-6#1)(1996-4#2)
simple fabrication##5##2##(2007-12#1)(2008-2#2)(2008-3#1)(2009-5#1)
simple firing-rate model##2##3##(2009-8#2)
simple first-order##2##2##(2008-10#1)(2008-2#1)
simple flow cytometry##2##3##(2008-9#1)(2012-2#1)
simple flow injection (FI)##2##4##(2008-10#2)
simple flow injection##9##3##(2008-10#9)
simple flow##15##2##(2008-10#10)(2008-3#2)(2008-9#1)(2011-2#1)(2012-2#1)
simple fluorescence##2##2##(2008-10#1)(2008-3#1)
simple form of##3##3##(1995-12#1)(2008-9#1)(2009-6#1)
simple form##4##2##(1995-12#1)(2008-12#1)(2008-9#1)(2009-6#1)
simple formula##4##2##(2005-9#1)(2008-2#2)(2011-2#1)
simple formulas##2##2##(2007-12#1)(2008-3#1)
simple frequency##2##2##(1991-12#1)(2008-9#1)
simple function##2##2##(1991-4#1)(2008-2#1)
simple functions##2##2##(1991-4#1)(2008-2#1)
simple generic infection model##2##4##(2008-10#2)
simple genetic##6##2##(1991-6#1)(2007-6#1)(2008-11#2)(2008-2#1)(2008-5#1)
simple geometric##3##2##(2008-2#2)(2010-9#1)
simple geometrical##4##2##(2006-10#1)(2008-2#1)(2008-3#1)(2008-4#1)
simple gradient##2##2##(2008-4#1)(2010-4#1)
simple graphic##2##2##(2007-12#1)(2008-3#1)
simple grid##2##2##(2008-7#1)(2009-11#1)
simple guidelines##2##2##(1994-1#1)(1996-1#1)
simple harvest##2##2##(2008-11#2)
simple heuristic##2##2##(2008-2#1)(2012-2#1)
simple hyperplasia##2##2##(1992-8#1)(2007-5#1)
simple hysterectomy##2##2##(1993-8#2)
simple in situ##2##3##(2008-10#1)(2008-2#1)
simple in##8##2##(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#2)(2013-1#1)
simple inheritance##2##2##(1994-9#1)(2008-10#1)
simple instrumentation##2##2##(2008-10#1)(2010-11#1)
simple interpolation##3##2##(2008-2#1)(2008-3#2)
simple interrupted##2##2##(1991-2#2)
simple investigations##2##2##(2007-3#2)
simple kinetic method##2##3##(2008-10#2)
simple kinetic##6##2##(1991-2#1)(1995-6#1)(2008-10#2)(2012-12#2)
simple linear regression##8##3##(1993-6#2)(1995-2#1)(1997-2#1)(2008-10#1)(2011-1#1)(2012-3#2)
simple linear##18##2##(1991-10#1)(1993-6#2)(1995-2#1)(1996-2#1)(1997-2#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-11#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-3#2)
simple manner##3##2##(2007-8#1)(2008-2#1)(2008-3#1)
simple manufacturing##2##2##(2004-1#1)(2010-5#1)
simple mastectomy##2##2##(1990-3#1)(2007-6#1)
simple mathematical model of##2##4##(2007-4#1)(2008-9#1)
simple mathematical model##8##3##(1994-8#1)(2007-12#2)(2007-4#1)(2008-9#2)(2009-8#1)(2013-1#1)
simple mathematical models of the##2##5##(2008-2#1)(2008-3#1)
simple mathematical models##3##3##(1994-11#1)(2008-2#1)(2008-3#1)
simple mathematical##17##2##(1994-11#1)(1994-8#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-9#2)(2009-8#1)(2013-1#1)
simple means for##2##3##(2006-6#1)(2008-8#1)
simple means of##3##3##(1990-9#1)(2007-8#1)(2008-10#1)
simple means##8##2##(1990-9#1)(1992-4#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-11#1)
simple measures##4##2##(2005-8#1)(2006-8#1)(2008-7#1)(2009-9#1)
simple mechanical##3##2##(2007-12#1)(2008-10#2)
simple method based on multiple alignment and phylogeny to derive a correlation between the protein##2##15##(2010-7#2)
simple method based on##3##4##(2008-3#1)(2010-7#2)
simple method can be##2##4##(2008-10#1)(2012-12#1)
simple method for detection of##2##5##(2008-9#1)(2012-3#1)
simple method for determining the##4##5##(1997-7#1)(2008-10#2)(2008-3#1)
simple method for estimation of##2##5##(1997-3#1)(2008-10#1)
simple method for rapid##2##4##(2008-10#2)
simple method for the determination of##3##6##(2005-4#1)(2007-8#1)(2008-10#1)
simple method for the##23##4##(1990-9#1)(1995-3#1)(1996-3#1)(2005-4#1)(2007-11#2)(2007-8#1)(2008-10#11)(2008-2#1)(2008-5#1)(2009-10#1)(2012-11#2)
simple method for##71##3##(1990-9#1)(1991-5#1)(1991-6#1)(1992-7#1)(1995-3#1)(1996-3#1)(1997-3#1)(1997-5#1)(1997-7#1)(2005-11#1)(2005-4#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-11#6)(2007-12#3)(2007-8#2)(2008-10#21)(2008-2#5)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-6#1)(2012-11#2)(2012-2#1)(2012-3#1)
simple method has been developed for the##3##7##(2008-10#3)
simple method has been developed for##5##6##(1992-7#1)(2008-10#4)
simple method has been##7##4##(1992-7#1)(1997-7#1)(2008-10#4)(2010-8#1)
simple method is proposed for##2##5##(2008-10#2)
simple method is##8##3##(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)
simple method of##26##3##(1990-4#1)(1995-12#1)(1996-5#1)(2005-11#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#1)(2010-7#1)
simple method that allows##2##4##(1992-8#1)(2010-4#1)
simple method that##3##3##(1992-8#1)(2008-3#1)(2010-4#1)
simple method to correct##2##4##(2009-5#1)(2013-1#1)
simple method to detect##3##4##(1991-7#1)(2008-12#1)(2008-5#1)
simple method to determine the##2##5##(2008-2#1)(2008-8#1)
simple method to evaluate##2##4##(2005-11#1)(2013-8#1)
simple method to measure the##2##5##(2007-12#2)
simple method to study##2##4##(1996-11#1)(2008-10#1)
simple method to##24##3##(1991-7#2)(1995-3#1)(1996-11#1)(1997-7#1)(2005-11#1)(2007-12#3)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-5#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
simple method was developed for the##4##6##(2008-10#4)
simple method was developed##5##4##(2008-10#5)
simple method was used to##2##5##(2008-10#1)(2008-5#1)
simple method was##7##3##(2008-10#6)(2008-5#1)
simple method##164##2##(1990-4#1)(1990-9#1)(1991-5#1)(1991-6#1)(1991-7#2)(1992-3#1)(1992-6#1)(1992-7#3)(1992-8#1)(1994-12#1)(1995-12#1)(1995-3#2)(1996-11#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-7#3)(2005-11#3)(2005-4#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-11#9)(2007-12#8)(2007-8#4)(2008-1#2)(2008-10#43)(2008-11#2)(2008-12#1)(2008-2#12)(2008-3#18)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
simple methodology and##2##3##(2008-10#1)(2010-5#1)
simple methodology to##2##3##(1996-3#1)(2008-10#1)
simple methodology##7##2##(1993-6#1)(1996-3#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-5#1)
simple methods to##2##3##(1993-9#1)(2008-2#1)
simple methods##6##2##(1993-9#1)(2008-2#2)(2008-4#1)(2010-2#1)(2013-1#1)
simple model and##2##3##(2007-11#1)(2009-8#1)
simple model based on##3##4##(2007-12#3)
simple model describing the##3##4##(1990-7#1)(2008-10#1)(2009-10#1)
simple model describing##4##3##(1990-7#1)(2007-12#1)(2008-10#1)(2009-10#1)
simple model for solvation in mixed solvents##2##7##(1990-8#2)
simple model for the evolution of##2##6##(1994-8#1)(2008-9#1)
simple model for the##5##4##(1992-9#2)(1994-8#1)(1997-8#1)(2008-9#1)
simple model for##15##3##(1990-8#2)(1991-6#1)(1991-7#1)(1992-9#2)(1994-8#1)(1996-2#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-8#1)(2012-12#1)
simple model is presented to##2##5##(2008-2#2)
simple model is presented##3##4##(2008-11#1)(2008-2#2)
simple model is##6##3##(1990-11#1)(2005-11#1)(2008-11#1)(2008-2#3)
simple model of##24##3##(1991-6#1)(2005-10#2)(2006-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#2)(2010-10#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
simple model that##6##3##(1994-2#1)(2005-11#1)(2008-1#1)(2008-7#2)(2008-8#1)
simple model to##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
simple model##80##2##(1990-11#1)(1990-7#1)(1990-8#2)(1991-6#2)(1991-7#1)(1992-4#1)(1992-9#2)(1993-8#1)(1994-2#1)(1994-8#1)(1995-11#1)(1996-2#1)(1997-6#1)(1997-8#1)(2004-12#1)(2005-10#2)(2005-11#3)(2006-12#1)(2006-7#1)(2007-11#2)(2007-12#7)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-2#7)(2008-3#5)(2008-5#1)(2008-7#5)(2008-8#4)(2008-9#2)(2009-10#1)(2009-8#1)(2010-10#1)(2010-7#1)(2010-8#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
simple models of##2##3##(1996-6#1)(2008-8#1)
simple models##5##2##(1996-1#1)(1996-6#1)(2008-10#1)(2008-8#2)
simple modification of##2##3##(1995-3#1)(2009-7#1)
simple modification##3##2##(1995-3#1)(2009-7#1)(2011-2#1)
simple modifications##2##2##(2009-9#1)(2011-2#1)
simple molecular##3##2##(1994-5#1)(2012-2#2)
simple molecule##2##2##(1992-12#1)(1994-6#1)
simple needle aspiration##2##3##(2008-5#1)(2009-6#1)
simple network##2##2##(2008-11#1)(2013-8#1)
simple networks of##2##3##(1996-4#1)(1997-7#1)
simple networks##4##2##(1991-6#1)(1996-4#1)(1997-7#1)(2006-10#1)
simple neural##4##2##(1997-7#1)(2006-7#1)(2007-12#1)(2008-4#1)
simple new##5##2##(1991-3#1)(2007-12#3)(2007-8#1)
simple nonlinear##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
simple numerical##6##2##(1993-9#1)(2005-11#1)(2005-5#1)(2008-2#1)(2008-3#2)
simple objects##2##2##(2007-12#1)(2008-3#1)
simple on/off##2##2##(1990-6#1)(2007-12#1)
simple one-step##6##2##(1990-11#1)(1992-11#1)(2008-3#1)(2008-5#1)(2009-11#1)(2013-1#1)
simple operation##3##2##(2006-12#1)(2008-10#1)(2012-12#1)
simple optical detection scheme##2##4##(2007-12#1)(2008-3#1)
simple optical##8##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#3)
simple or##6##2##(1990-12#1)(1991-4#1)(2006-10#1)(2007-7#1)(2008-5#1)(2008-9#1)
simple organic##3##2##(1990-1#1)(2008-10#2)
simple organisms##2##2##(2008-10#2)
simple patch##2##2##(2008-5#1)(2008-8#1)
simple pathotypes##2##2##(2008-10#2)
simple pattern##3##2##(2008-3#1)(2008-4#1)(2008-8#1)
simple photoreceptors##2##2##(2008-9#2)
simple physical##5##2##(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2011-12#1)
simple practical##3##2##(2007-7#1)(2008-10#1)(2008-3#1)
simple predictions##2##2##(2008-8#1)(2012-2#1)
simple preparation##2##2##(2008-10#2)
simple procedure for the determination of##3##6##(2008-10#3)
simple procedure for the##7##4##(1992-1#1)(2008-10#5)(2010-4#1)
simple procedure for##10##3##(1992-1#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-4#1)(2010-4#1)
simple procedure is##3##3##(2008-10#3)
simple procedure of##3##3##(2005-11#1)(2008-4#1)(2010-4#1)
simple procedure to##5##3##(2007-12#1)(2007-8#1)(2008-2#2)(2008-4#1)
simple procedure##34##2##(1990-11#1)(1990-4#1)(1992-1#1)(1993-3#1)(1996-12#1)(2005-11#1)(2005-7#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#10)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#1)(2010-4#2)(2010-7#1)(2012-12#1)
simple procedures for##3##3##(1995-7#1)(2008-2#1)(2008-4#1)
simple procedures##6##2##(1995-7#1)(1997-3#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)
simple process##7##2##(1992-12#1)(1996-2#1)(2008-10#1)(2009-6#1)(2010-7#1)(2011-1#1)(2013-8#1)
simple product##2##2##(2008-2#1)(2009-7#1)
simple proof##2##2##(2007-12#1)(2008-2#1)
simple protocol for the##2##4##(2008-10#1)(2008-9#1)
simple protocol for##4##3##(1990-3#1)(2008-10#1)(2008-11#1)(2008-9#1)
simple protocol##6##2##(1990-3#1)(2008-10#1)(2008-11#1)(2008-9#2)(2009-5#1)
simple protonated##2##2##(2006-4#2)
simple quantitative##6##2##(1991-7#1)(2008-10#2)(2008-5#1)(2009-6#1)(2012-1#1)
simple questions##2##2##(1996-7#1)(2007-12#1)
simple random##6##2##(1992-6#1)(1993-11#1)(1996-1#1)(2008-2#1)(2008-5#1)(2012-2#1)
simple rapid##3##2##(1991-11#1)(2007-8#1)(2008-10#1)
simple recycling##2##2##(2008-11#1)(2013-1#1)
simple reduction##3##2##(1992-3#1)(2010-12#1)(2012-2#1)
simple reflex##2##2##(1995-6#1)(2008-7#1)
simple regression##2##2##(1997-8#1)(2012-2#1)
simple relationship between the##4##4##(1993-3#1)(2005-11#1)(2007-12#1)(2012-12#1)
simple relationship##6##2##(1993-3#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2012-12#1)
simple repeat##2##2##(2008-6#2)
simple reversed-phase##2##2##(2008-10#1)(2010-12#1)
simple route to the##2##4##(1996-5#1)(2008-8#1)
simple routine##2##2##(1993-11#1)(2008-10#1)
simple routines##2##2##(1993-3#1)(1993-5#1)
simple rule for##2##3##(2007-12#1)(2008-8#1)
simple rule##3##2##(1992-12#1)(2007-12#1)(2008-8#1)
simple rules can##2##3##(1995-5#1)(2008-8#1)
simple rules##4##2##(1995-5#1)(2008-2#1)(2008-8#1)(2011-2#1)
simple sample preparation##2##3##(2007-8#1)(2008-10#1)
simple sample##3##2##(2007-8#1)(2008-10#2)
simple scheme for##2##3##(2007-12#2)
simple scheme##5##2##(2007-11#2)(2007-12#3)
simple screening tool##2##3##(2007-11#1)(2008-10#1)
simple screening##5##2##(1997-1#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-3#1)
simple sensor##2##2##(2010-4#1)(2010-5#1)
simple sequence repeat (SSR) markers in##2##6##(2008-10#1)(2008-9#1)
simple sequence repeat (SSR) markers##6##5##(2008-10#3)(2008-9#2)(2011-12#1)
simple sequence repeat (SSR)##8##4##(2008-10#4)(2008-7#1)(2008-9#2)(2011-12#1)
simple sequence repeat markers flanking the##2##6##(1996-3#1)(2008-10#1)
simple sequence repeat markers##4##4##(1996-3#2)(2008-10#2)
simple sequence repeat##19##3##(1996-3#4)(2008-10#10)(2008-7#1)(2008-9#2)(2010-10#1)(2011-12#1)
simple sequence repeats (SSRs)##3##4##(1996-8#1)(2008-10#1)(2012-2#1)
simple sequence repeats database##2##4##(2008-7#2)
simple sequence repeats##12##3##(1996-8#2)(2006-2#1)(2007-6#2)(2008-10#2)(2008-7#3)(2012-2#2)
simple sequence##33##2##(1992-6#1)(1996-3#4)(1996-5#1)(1996-8#2)(2006-2#1)(2007-6#2)(2008-10#12)(2008-7#4)(2008-9#2)(2010-10#1)(2011-12#1)(2012-2#2)
simple set of rules##2##4##(2006-10#1)(2008-3#1)
simple set of##3##3##(1994-9#1)(2006-10#1)(2008-3#1)
simple setup##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
simple shape##2##2##(2008-10#1)(2008-2#1)
simple shear##2##2##(2005-11#2)
simple single-step##3##2##(2008-3#1)(2012-12#2)
simple solution##4##2##(2006-6#1)(2008-2#1)(2008-3#1)(2009-2#1)
simple solutions##2##2##(2008-10#1)(2008-3#1)
simple spatial##4##2##(1992-9#1)(2007-12#1)(2008-3#1)(2008-8#1)
simple spectrophotometer##2##2##(2008-10#2)
simple spectrophotometric method##4##3##(1990-8#2)(2008-10#2)
simple spectrophotometric##7##2##(1990-8#2)(2007-8#1)(2008-10#4)
simple steps##3##2##(2006-12#1)(2006-7#1)(2007-10#1)
simple stochastic##5##2##(1990-11#1)(1994-4#1)(2006-10#1)(2006-4#1)(2008-10#1)
simple strategies##2##2##(2008-7#1)(2010-8#1)
simple strategy for##3##3##(2008-10#2)(2008-5#1)
simple strategy to##4##3##(1990-12#1)(2006-4#1)(2007-8#1)(2013-7#1)
simple strategy##9##2##(1990-12#2)(1992-12#1)(2006-4#1)(2007-8#1)(2008-10#2)(2008-5#1)(2013-7#1)
simple structural##3##2##(2006-12#1)(2008-3#1)(2010-3#1)
simple structure##7##2##(2007-12#2)(2008-10#1)(2008-2#2)(2009-5#1)(2010-9#1)
simple sugar##2##2##(2008-4#1)(2009-10#1)
simple sugars##5##2##(2006-10#1)(2006-2#1)(2008-10#3)
simple surface##3##2##(1993-6#1)(2005-11#1)(2008-2#1)
simple surgical technique##2##3##(2007-7#1)(2013-1#1)
simple surgical##5##2##(1990-9#1)(2007-7#1)(2007-8#1)(2010-12#1)(2013-1#1)
simple suture##3##2##(1990-6#1)(1996-2#1)(2011-1#1)
simple synchronous fluorimetric method##2##4##(2008-10#2)
simple synthesis of##3##3##(1992-9#1)(1997-8#1)(2007-11#1)
simple system for##5##3##(1997-6#1)(2007-8#1)(2008-2#1)(2008-3#2)
simple system of##2##3##(2008-2#1)(2008-3#1)
simple system##15##2##(1997-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#4)(2008-5#3)
simple systems##2##2##(1990-10#1)(1996-11#1)
simple task##4##2##(2007-12#1)(2008-12#1)(2008-5#1)(2009-4#1)
simple taste analyzing system##2##4##(2008-10#2)
simple technique for fabrication of##2##5##(2007-12#1)(2008-1#1)
simple technique for the##2##4##(2008-10#1)(2008-2#1)
simple technique for##14##3##(2006-4#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#4)(2011-2#1)
simple technique that##3##3##(1993-11#1)(2007-7#2)
simple technique to##5##3##(1992-4#1)(2006-3#1)(2007-12#1)(2007-8#1)(2009-2#1)
simple technique##35##2##(1992-4#1)(1993-11#1)(1994-3#1)(2006-3#1)(2006-4#1)(2007-11#3)(2007-12#5)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#3)(2008-2#2)(2008-3#5)(2008-4#1)(2009-2#1)(2011-2#1)(2013-7#1)
simple techniques for##2##3##(2007-8#1)(2008-4#1)
simple techniques##7##2##(1992-3#1)(1992-8#1)(1997-4#1)(2007-7#1)(2007-8#1)(2008-4#1)(2011-1#1)
simple terms##4##2##(1991-12#1)(1997-8#1)(2005-11#1)(2008-7#1)
simple test for##5##3##(1990-11#2)(1994-5#1)(1995-6#1)(2011-1#1)
simple test##11##2##(1990-11#2)(1994-5#1)(1995-6#1)(2005-1#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-8#1)(2011-1#1)(2012-2#1)
simple tests##4##2##(1995-12#1)(2006-4#1)(2007-7#2)
simple theoretical model##4##3##(1990-12#1)(2008-10#1)(2008-2#2)
simple theoretical##9##2##(1990-12#1)(2008-10#1)(2008-2#3)(2008-3#4)
simple theory##4##2##(2006-10#1)(2007-11#2)(2008-2#1)
simple thermodynamic##2##2##(2008-10#1)(2009-3#1)
simple threshold##2##2##(2008-2#1)(2008-3#1)
simple thresholding##4##2##(2008-2#1)(2008-3#1)(2010-4#1)(2011-1#1)
simple to be##3##3##(2008-10#1)(2010-8#2)
simple to control##2##3##(2007-12#1)(2008-11#1)
simple to implement##5##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)
simple to perform##7##3##(1990-2#1)(1990-8#1)(1992-8#1)(1993-11#1)(1993-6#1)(2009-10#1)(2011-12#1)
simple to use and##3##4##(2008-4#1)(2008-5#1)(2010-5#1)
simple to use##5##3##(1993-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-5#1)
simple to##39##2##(1990-2#1)(1990-5#1)(1990-8#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-6#1)(1996-2#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-5#1)(2010-8#2)(2011-12#1)
simple tool for##4##3##(1996-12#1)(2008-10#2)(2011-2#1)
simple tool##5##2##(1996-12#1)(2008-10#2)(2011-2#1)(2012-12#1)
simple tools that are##3##4##(2009-10#1)(2010-2#1)(2011-2#1)
simple tools##4##2##(2009-10#1)(2010-2#1)(2010-8#1)(2011-2#1)
simple transcriptional##2##2##(1993-2#1)(2008-11#1)
simple tube##2##2##(1990-8#1)(2012-12#1)
simple two-site##2##2##(1996-7#1)(2008-10#1)
simple two-state##3##2##(1992-9#1)(1996-11#1)(1997-2#1)
simple two-step procedure##3##3##(1994-11#1)(1997-8#1)(2008-12#1)
simple user interface##2##3##(2007-5#1)(2012-1#1)
simple verification##2##2##(2008-3#1)(2012-12#1)
simple visual##6##2##(1995-12#1)(1995-4#1)(1997-8#1)(2006-3#1)(2008-10#2)
simple way by##2##3##(2008-1#1)(2008-3#1)
simple way of##2##3##(1992-3#1)(2008-2#1)
simple way to##14##3##(1994-6#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)
simple way##24##2##(1992-3#1)(1993-12#1)(1994-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)
simple ways##2##2##(1995-8#1)(1997-8#1)
simple with##4##2##(2005-4#1)(2007-10#1)(2007-12#1)(2008-10#1)
simple yet efficient##2##3##(2007-12#1)(2012-3#1)
simple yet##12##2##(1995-12#1)(1995-4#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#2)(2012-3#1)
simple##3161##1##(1990-1#1)(1990-10#5)(1990-11#17)(1990-12#16)(1990-2#4)(1990-3#5)(1990-4#5)(1990-5#6)(1990-6#7)(1990-7#5)(1990-8#10)(1990-9#6)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#4)(1991-2#4)(1991-3#7)(1991-4#7)(1991-5#5)(1991-6#7)(1991-7#7)(1991-8#4)(1991-9#4)(1992-1#7)(1992-10#3)(1992-11#2)(1992-12#12)(1992-2#7)(1992-3#9)(1992-4#3)(1992-6#7)(1992-7#4)(1992-8#10)(1992-9#9)(1993-1#1)(1993-10#2)(1993-11#11)(1993-12#12)(1993-2#3)(1993-3#3)(1993-4#3)(1993-5#5)(1993-6#9)(1993-7#2)(1993-8#5)(1993-9#7)(1994-1#1)(1994-11#7)(1994-12#3)(1994-2#5)(1994-3#6)(1994-4#1)(1994-5#3)(1994-6#7)(1994-7#1)(1994-8#9)(1994-9#8)(1995-1#4)(1995-10#1)(1995-11#4)(1995-12#9)(1995-2#7)(1995-3#5)(1995-4#4)(1995-5#4)(1995-6#8)(1995-7#4)(1995-8#5)(1995-9#1)(1996-1#5)(1996-10#2)(1996-11#7)(1996-12#11)(1996-2#12)(1996-3#13)(1996-4#8)(1996-5#7)(1996-6#6)(1996-7#6)(1996-8#9)(1996-9#3)(1997-1#9)(1997-2#9)(1997-3#13)(1997-4#9)(1997-5#2)(1997-6#6)(1997-7#8)(1997-8#15)(2004-1#2)(2004-10#1)(2004-12#1)(2004-4#1)(2004-9#3)(2005-1#1)(2005-10#10)(2005-11#28)(2005-12#4)(2005-4#21)(2005-5#3)(2005-7#2)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#23)(2006-11#3)(2006-12#20)(2006-2#10)(2006-3#5)(2006-4#12)(2006-5#12)(2006-6#11)(2006-7#11)(2006-8#6)(2006-9#4)(2007-1#8)(2007-10#10)(2007-11#86)(2007-12#163)(2007-2#11)(2007-3#5)(2007-4#4)(2007-5#7)(2007-6#7)(2007-7#21)(2007-8#77)(2007-9#10)(2008-1#29)(2008-10#668)(2008-11#63)(2008-12#15)(2008-2#205)(2008-3#226)(2008-4#84)(2008-5#60)(2008-6#20)(2008-7#60)(2008-8#57)(2008-9#55)(2009-10#10)(2009-11#7)(2009-12#2)(2009-2#8)(2009-3#5)(2009-4#4)(2009-5#12)(2009-6#9)(2009-7#6)(2009-8#8)(2009-9#4)(2010-1#6)(2010-10#3)(2010-11#5)(2010-12#19)(2010-2#24)(2010-3#9)(2010-4#17)(2010-5#23)(2010-6#7)(2010-7#17)(2010-8#10)(2010-9#3)(2011-1#31)(2011-12#7)(2011-2#31)(2012-1#11)(2012-11#9)(2012-12#33)(2012-2#40)(2012-3#19)(2012-7#1)(2013-1#32)(2013-7#9)(2013-8#25)
simple&quot##2##1##(2007-12#1)(2013-8#1)
simple)##2##1##(2008-3#1)(2009-9#1)
simple-repeat##2##1##(2008-10#2)
simpler alternative##2##2##(2008-4#1)(2008-9#1)
simpler and faster##3##3##(1996-8#1)(2008-10#1)(2008-2#1)
simpler and less##2##3##(1993-9#1)(2008-2#1)
simpler and more##4##3##(2008-10#1)(2008-3#1)(2011-2#2)
simpler and##14##2##(1993-9#1)(1996-8#1)(2007-9#1)(2008-10#4)(2008-2#3)(2008-3#1)(2010-12#1)(2011-2#2)
simpler for##3##2##(2008-10#1)(2008-9#1)(2009-6#1)
simpler procedure##2##2##(2007-2#1)(2008-3#1)
simpler systems##2##2##(1997-4#1)(2008-7#1)
simpler technique for##2##3##(1994-9#1)(2008-2#1)
simpler technique##3##2##(1994-9#1)(2008-2#1)(2009-8#1)
simpler than previous##2##3##(2007-8#1)(2008-2#1)
simpler than the##4##3##(2008-10#2)(2008-2#1)(2008-9#1)
simpler than##14##2##(1993-2#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-9#1)(2009-8#1)
simpler to perform##2##3##(2008-1#1)(2008-4#1)
simpler to##6##2##(2007-9#1)(2008-1#1)(2008-4#1)(2008-9#1)(2009-9#1)(2010-9#1)
simpler##102##1##(1990-7#1)(1991-3#1)(1991-7#1)(1992-6#1)(1993-11#1)(1993-2#3)(1993-6#1)(1993-9#1)(1994-9#1)(1996-8#1)(1997-2#1)(1997-4#1)(2006-11#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#18)(2008-11#2)(2008-2#8)(2008-3#9)(2008-4#2)(2008-7#2)(2008-9#4)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-12#1)(2010-2#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#5)(2012-1#2)(2012-2#1)(2012-3#2)
simples##4##1##(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
simplest and##8##2##(1990-5#1)(2006-2#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-7#1)
simplest model##2##2##(1995-11#1)(2008-8#1)
simplest version##2##2##(2008-4#1)(2010-3#1)
simplest##51##1##(1990-10#1)(1990-5#1)(1992-10#1)(1993-1#1)(1995-11#1)(1995-2#1)(1995-3#3)(1995-5#1)(2006-10#1)(2006-12#1)(2006-2#2)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-3#1)(2011-12#1)(2012-2#1)(2013-8#1)
simplex algorithm was##2##3##(2008-10#2)
simplex algorithm##4##2##(2008-10#3)(2008-3#1)
simplex and##3##2##(2006-12#1)(2008-10#1)(2011-2#1)
simplex centroid##3##2##(2008-5#1)(2010-4#1)(2010-5#1)
simplex in##3##2##(1997-7#1)(1997-8#1)(2008-10#1)
simplex method to##2##3##(2008-10#2)
simplex method was used##2##4##(2008-10#1)(2008-5#1)
simplex method were##2##3##(2008-10#2)
simplex method##12##2##(2008-10#11)(2008-5#1)
simplex optimization##3##2##(2008-10#3)
simplex recidivans##2##2##(2005-11#2)
simplex virus (HSV) infection##2##4##(2005-7#1)(2008-11#1)
simplex virus (HSV)##10##3##(1996-12#2)(1996-6#1)(2005-7#1)(2007-12#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-3#1)
simplex virus - 1 encephalitis (HSE)##2##6##(2007-8#2)
simplex virus infections##2##3##(2007-12#1)(2007-8#1)
simplex virus thymidine kinase##3##4##(1996-5#1)(2005-6#1)(2007-3#1)
simplex virus type 1 (HSV-1) and##3##6##(1997-2#1)(2008-10#2)
simplex virus type 1 (HSV-1)##11##5##(1994-3#1)(1995-3#1)(1996-8#1)(1997-2#4)(2007-12#1)(2008-10#2)(2012-2#1)
simplex virus type 1##19##4##(1994-3#1)(1995-3#2)(1995-7#1)(1996-8#2)(1997-2#4)(1997-7#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)(2012-2#1)
simplex virus type 2##8##4##(1991-9#2)(2006-10#1)(2008-4#1)(2009-1#1)(2010-12#1)(2012-3#1)(2013-1#1)
simplex virus type##28##3##(1991-9#2)(1994-3#1)(1995-3#2)(1995-7#1)(1996-8#2)(1997-2#4)(1997-7#1)(2006-10#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-4#2)(2008-9#1)(2009-1#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
simplex virus type-1 (HSV-1)##2##4##(1990-7#1)(2009-12#1)
simplex virus type-1##10##3##(1990-7#2)(1994-9#1)(1995-3#1)(1996-8#3)(2007-6#1)(2009-12#1)(2013-1#1)
simplex virus type-specific serology##2##4##(2008-10#2)
simplex virus##103##2##(1990-12#1)(1990-4#1)(1990-7#2)(1991-7#1)(1991-9#2)(1994-3#1)(1994-9#2)(1995-2#3)(1995-3#3)(1995-7#1)(1996-12#3)(1996-2#3)(1996-5#1)(1996-6#1)(1996-8#5)(1997-1#2)(1997-2#4)(1997-5#1)(1997-7#2)(2005-11#1)(2005-6#1)(2005-7#1)(2006-10#8)(2007-12#4)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-10#4)(2008-11#5)(2008-4#4)(2008-8#1)(2008-9#3)(2009-1#1)(2009-12#1)(2009-4#2)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#4)(2012-2#6)(2012-3#3)(2013-1#3)
simplex was##3##2##(2005-11#1)(2008-10#1)(2008-5#1)
simplex##189##1##(1990-11#2)(1990-12#1)(1990-4#1)(1990-7#2)(1991-12#2)(1991-4#1)(1991-7#1)(1991-9#2)(1994-11#1)(1994-3#1)(1994-4#1)(1994-9#2)(1995-2#5)(1995-3#4)(1995-7#1)(1995-9#1)(1996-12#3)(1996-2#4)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#5)(1997-1#2)(1997-2#4)(1997-5#1)(1997-7#3)(1997-8#1)(2005-11#5)(2005-6#1)(2005-7#1)(2006-10#9)(2006-12#1)(2007-11#1)(2007-12#10)(2007-2#4)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#4)(2008-10#34)(2008-11#5)(2008-3#1)(2008-4#4)(2008-5#7)(2008-8#1)(2008-9#3)(2009-1#1)(2009-12#1)(2009-4#3)(2010-1#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#4)(2012-2#6)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#1)
simplicifolia##5##1##(1990-7#1)(1992-11#1)(1994-2#1)(1996-8#1)(1997-2#1)
simplicity and ability##2##3##(1996-6#1)(2008-10#1)
simplicity and accuracy##2##3##(2008-2#1)(2010-2#1)
simplicity and efficiency##2##3##(2008-2#1)(2010-8#1)
simplicity and generality of##2##4##(2006-5#1)(2013-7#1)
simplicity and high sensitivity##2##4##(2008-10#2)
simplicity and rapidity##3##3##(1990-7#1)(2008-10#2)
simplicity and speed##2##3##(1994-6#1)(2008-1#1)
simplicity and##42##2##(1990-2#1)(1990-7#1)(1991-10#1)(1994-12#1)(1994-6#1)(1996-6#1)(1996-7#1)(2005-8#1)(2006-5#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2013-7#1)
simplicity but also##2##3##(2007-11#2)
simplicity in##2##2##(2007-8#1)(2008-10#1)
simplicity makes it##2##3##(2005-4#1)(2012-3#1)
simplicity makes##4##2##(2005-4#1)(2008-3#1)(2009-4#1)(2012-3#1)
simplicity of data##2##3##(2008-1#1)(2010-4#1)
simplicity of implementation##2##3##(2007-12#1)(2008-3#1)
simplicity of preparation##2##3##(2008-10#2)
simplicity of the method##3##4##(1990-10#1)(2008-10#1)(2009-10#1)
simplicity of the procedure##2##4##(2005-11#2)
simplicity of the##25##3##(1990-10#1)(1991-1#1)(1994-2#1)(1995-5#1)(2005-11#3)(2006-10#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#2)(2009-10#1)(2010-10#1)(2010-5#1)(2011-2#1)
simplicity of this##3##3##(2008-10#3)
simplicity of use##3##3##(1992-4#1)(2006-8#1)(2008-7#1)
simplicity of##50##2##(1990-10#1)(1991-1#1)(1992-4#1)(1994-2#1)(1995-5#1)(1996-12#1)(1997-7#1)(2005-11#3)(2006-10#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#4)(2009-10#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)
simplicity##173##1##(1990-10#1)(1990-2#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-10#2)(1991-2#1)(1992-4#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-5#1)(1996-12#1)(1996-6#2)(1996-7#1)(1997-7#2)(2005-11#3)(2005-12#1)(2005-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#3)(2006-8#1)(2007-10#2)(2007-11#7)(2007-12#9)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#44)(2008-11#6)(2008-12#1)(2008-2#9)(2008-3#10)(2008-4#7)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)
simplification is##3##2##(2005-11#1)(2008-6#1)(2011-2#1)
simplification of the##4##3##(1990-11#1)(1991-2#1)(2006-10#1)(2008-2#1)
simplification of##10##2##(1990-11#1)(1991-2#1)(1992-6#1)(2005-11#1)(2006-10#2)(2008-2#1)(2011-2#1)(2013-1#2)
simplification on##3##2##(2012-12#1)(2013-1#2)
simplification##29##1##(1990-11#1)(1991-2#1)(1992-6#1)(1992-9#1)(1996-3#1)(2005-11#3)(2005-8#1)(2006-10#2)(2006-8#1)(2007-11#1)(2008-2#2)(2008-5#1)(2008-6#3)(2009-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#4)
simplifications##3##1##(2007-4#1)(2008-12#1)(2011-1#1)
simplified analysis##3##2##(2005-11#1)(2007-11#1)(2007-12#1)
simplified and##6##2##(1996-7#1)(2006-10#2)(2006-2#1)(2008-2#1)(2012-1#1)
simplified approach##5##2##(2007-11#1)(2008-1#1)(2008-4#1)(2011-2#1)(2012-3#1)
simplified approaches##2##2##(2005-11#1)(2008-6#1)
simplified by##5##2##(1990-2#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#1)
simplified chemical##2##2##(1995-6#1)(2008-10#1)
simplified conditions##2##2##(2008-2#1)(2011-2#1)
simplified device##2##2##(2007-11#1)(2008-3#1)
simplified dose regimen##2##3##(1994-2#2)
simplified form of the##2##4##(2008-3#1)(2012-2#1)
simplified form of##4##3##(1994-3#1)(2008-2#1)(2008-3#1)(2012-2#1)
simplified form##7##2##(1994-3#1)(2006-11#1)(2007-11#1)(2008-2#1)(2008-3#2)(2012-2#1)
simplified icELISA##6##2##(2007-8#6)
simplified if##2##2##(1997-3#1)(2008-3#1)
simplified in##3##2##(1990-6#1)(2008-3#1)(2008-5#1)
simplified method##8##2##(1991-8#1)(1992-12#1)(2007-11#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-4#1)
simplified model for##3##3##(1990-10#1)(2008-3#1)(2008-5#1)
simplified model of the##2##4##(2007-11#1)(2008-2#1)
simplified model of##4##3##(1992-9#1)(2007-11#1)(2008-2#1)(2008-7#1)
simplified model##13##2##(1990-10#1)(1992-9#1)(2005-4#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-8#1)(2012-2#1)
simplified morphologically##2##2##(2008-4#1)(2009-10#1)
simplified preventative disclosure of TTM##2##5##(2007-12#2)
simplified procedure for##2##3##(2005-11#1)(2008-11#1)
simplified procedure##3##2##(2005-11#1)(2008-11#1)(2008-4#1)
simplified reaction scheme##2##3##(1991-2#2)
simplified read-out##2##2##(2005-9#2)
simplified technique##3##2##(2005-5#1)(2010-9#1)(2013-1#1)
simplified the##3##2##(1992-5#1)(1992-8#1)(2006-10#1)
simplified theoretical##2##2##(1994-11#1)(2008-2#1)
simplified to##9##2##(1996-11#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-6#1)(2013-1#4)
simplified version of the##4##4##(2008-2#2)(2008-3#1)(2008-8#1)
simplified version##5##2##(2008-2#2)(2008-3#1)(2008-8#1)(2011-1#1)
simplified##200##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#2)(1991-12#1)(1991-2#2)(1991-4#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-3#1)(1994-11#2)(1994-2#5)(1994-3#2)(1995-6#1)(1996-1#1)(1996-11#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-6#1)(2005-11#6)(2005-4#1)(2005-5#1)(2005-9#2)(2006-10#7)(2006-11#2)(2006-2#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#9)(2007-12#8)(2007-2#1)(2007-4#1)(2007-5#2)(2007-8#9)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#1)(2008-2#20)(2008-3#22)(2008-4#5)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-1#2)(2012-2#4)(2012-3#1)(2013-1#7)(2013-8#2)
simplifies the analysis##2##3##(2007-12#2)
simplifies the analytical procedure and##2##5##(2008-10#2)
simplifies the##22##2##(1990-3#1)(1992-2#1)(1995-5#1)(1996-12#1)(2006-6#1)(2007-11#1)(2007-12#4)(2008-10#3)(2008-2#3)(2008-3#3)(2008-4#2)(2010-5#1)
simplifies##33##1##(1990-3#1)(1992-2#1)(1994-3#1)(1995-5#1)(1996-12#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-10#5)(2008-2#3)(2008-3#5)(2008-4#2)(2010-5#2)(2011-2#1)(2012-2#1)
simplify and##3##2##(2006-10#1)(2008-10#1)(2008-3#1)
simplify its##2##2##(2008-6#1)(2012-1#1)
simplify the##31##2##(1990-10#1)(1991-2#1)(1991-7#1)(1992-2#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-4#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-2#1)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#2)(2008-5#1)(2009-5#1)(2009-9#1)(2010-4#1)(2010-8#1)(2012-3#1)(2013-1#1)
simplify to##2##2##(2007-3#1)(2010-2#1)
simplify##66##1##(1990-10#1)(1990-8#1)(1991-2#1)(1991-7#1)(1992-2#1)(1992-3#1)(1993-12#1)(1994-12#2)(1994-6#1)(1994-9#1)(1995-1#2)(1995-6#1)(1996-12#1)(1996-4#1)(1996-9#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-10#3)(2006-2#1)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#4)(2008-2#8)(2008-3#3)(2008-5#1)(2008-6#1)(2009-11#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-3#1)(2013-1#2)
simplifying assumptions##3##2##(2008-10#1)(2008-2#2)
simplifying the##11##2##(1991-2#1)(1994-12#1)(1996-4#1)(2006-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2011-2#2)
simplifying their##2##2##(1994-6#1)(2008-3#1)
simplifying##33##1##(1990-3#1)(1991-2#1)(1994-12#1)(1994-6#1)(1995-8#1)(1996-1#1)(1996-4#1)(2004-9#1)(2006-10#1)(2006-9#1)(2008-10#5)(2008-11#1)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#2)(2011-2#2)(2012-1#1)(2013-1#2)
simplistic##5##1##(1997-2#1)(2006-7#1)(2008-5#1)(2010-6#1)(2010-7#1)
simply a##15##2##(1990-6#1)(1991-5#1)(2005-8#1)(2006-12#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-11#1)(2011-2#2)(2012-12#2)(2013-8#1)
simply adding##2##2##(2007-4#1)(2012-2#1)
simply an##3##2##(1996-3#1)(2006-8#1)(2009-7#1)
simply and effectively##2##3##(2008-10#1)(2013-1#1)
simply and rapidly##3##3##(2008-10#3)
simply and##7##2##(2008-10#5)(2011-2#1)(2013-1#1)
simply as##3##2##(1994-3#1)(2008-10#1)(2010-1#1)
simply be##5##2##(2006-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-12#1)
simply because##4##2##(1994-12#1)(2007-8#1)(2008-2#1)(2008-5#1)
simply being##3##2##(2009-4#1)(2009-6#1)(2011-2#1)
simply by the##2##3##(1992-9#1)(1997-6#1)
simply by##25##2##(1992-9#1)(1994-1#1)(1994-8#1)(1996-12#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#3)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#5)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-5#1)
simply caused by##2##3##(2008-7#1)(2011-2#1)
simply constructed##2##2##(2007-12#1)(2007-6#1)
simply controlled by##2##3##(1994-12#1)(2007-12#1)
simply do not##2##3##(2006-10#1)(2007-10#1)
simply due to##3##3##(1992-7#1)(1997-4#1)(2008-11#1)
simply explained##2##2##(1990-11#1)(2009-12#1)
simply in terms of##2##4##(1994-8#1)(2009-12#1)
simply in##4##2##(1991-8#1)(1994-8#1)(2009-12#1)(2010-8#1)
simply increases##2##2##(1996-11#1)(2012-2#1)
simply increasing the##3##3##(1996-5#1)(2008-10#1)(2009-12#1)
simply increasing##5##2##(1993-2#1)(1996-5#1)(2008-10#1)(2008-4#1)(2009-12#1)
simply involved##2##2##(2008-4#1)(2013-1#1)
simply means##2##2##(2007-8#1)(2008-10#1)
simply not##4##2##(1995-1#1)(2007-2#1)(2008-2#1)(2012-11#1)
simply on the basis of##2##5##(1995-1#1)(2008-2#1)
simply on the##3##3##(1991-12#1)(1995-1#1)(2008-2#1)
simply on##4##2##(1991-12#1)(1995-1#1)(2008-2#1)(2008-3#1)
simply reflect the##2##3##(2008-10#1)(2009-4#1)
simply reflect##3##2##(2008-10#1)(2009-4#1)(2012-1#1)
simply related to##2##3##(1991-2#1)(2008-3#1)
simply represent##2##2##(2008-4#1)(2008-7#1)
simply the##4##2##(1992-7#1)(1993-12#1)(2006-7#1)(2008-2#1)
simply through##2##2##(2008-2#1)(2009-8#1)
simply to a##2##3##(1990-6#1)(1995-4#1)
simply to##9##2##(1990-11#1)(1990-3#1)(1990-6#1)(1991-12#1)(1995-4#1)(1995-8#1)(1997-3#1)(2005-11#1)(2006-7#1)
simply##252##1##(1990-11#3)(1990-3#1)(1990-6#2)(1990-7#1)(1991-12#4)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-7#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#3)(1994-3#4)(1994-8#3)(1994-9#1)(1995-1#4)(1995-12#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-1#2)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-2#1)(2005-11#3)(2005-8#1)(2006-10#5)(2006-12#2)(2006-2#1)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-8#3)(2008-1#1)(2008-10#35)(2008-11#7)(2008-2#15)(2008-3#4)(2008-4#7)(2008-5#4)(2008-6#4)(2008-7#7)(2008-8#3)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#4)(2009-3#1)(2009-4#4)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-8#1)(2011-1#3)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#6)(2013-1#4)(2013-8#1)
simulans##10##1##(2006-10#2)(2012-3#8)
simulant for##2##2##(2008-10#1)(2012-12#1)
simulant of##2##2##(2007-8#1)(2010-1#1)
simulant##15##1##(2005-4#2)(2007-8#1)(2008-10#5)(2010-1#1)(2012-12#6)
simulants##4##1##(2008-10#3)(2012-12#1)
simulata##2##1##(2008-2#2)
simulate a##7##2##(1995-6#2)(2007-12#1)(2008-9#1)(2009-7#1)(2010-1#1)(2013-8#1)
simulate an##2##2##(1992-10#1)(2008-6#1)
simulate both##2##2##(1990-8#1)(2007-4#1)
simulate chemical##2##2##(2006-10#1)(2008-2#1)
simulate different##3##2##(1995-3#1)(2006-11#1)(2008-8#1)
simulate natural##2##2##(2009-5#1)(2011-2#1)
simulate the effects##4##3##(1994-1#1)(2008-3#2)(2012-1#1)
simulate the nonlinear##2##3##(2008-2#1)(2008-6#1)
simulate the##73##2##(1992-3#1)(1994-1#1)(1994-5#1)(1995-8#1)(1996-12#1)(1996-4#1)(1997-7#1)(2005-12#1)(2006-11#1)(2007-11#2)(2007-12#3)(2007-4#3)(2008-10#5)(2008-11#5)(2008-2#7)(2008-3#21)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#1)(2009-4#2)(2009-8#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-1#2)
simulate this##2##2##(1997-2#1)(2008-5#1)
simulate##179##1##(1990-11#1)(1990-4#1)(1990-8#1)(1991-11#1)(1991-5#1)(1992-10#1)(1992-3#1)(1994-1#1)(1994-12#1)(1994-5#1)(1995-3#1)(1995-6#4)(1995-8#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-12#1)(2006-1#2)(2006-10#3)(2006-11#3)(2006-6#1)(2007-11#3)(2007-12#5)(2007-4#7)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#10)(2008-2#17)(2008-3#29)(2008-5#2)(2008-6#7)(2008-7#8)(2008-8#3)(2008-9#4)(2009-11#2)(2009-4#3)(2009-5#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-2#3)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#4)(2011-2#3)(2012-1#5)(2012-2#1)(2013-8#2)
simulated I/R##2##2##(2013-7#2)
simulated a##2##2##(1992-8#2)
simulated action potential of the##2##5##(2008-11#2)
simulated and experimental data##6##4##(2008-10#2)(2008-2#2)(2008-3#1)(2009-7#1)
simulated and experimental##10##3##(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#3)(2009-7#1)
simulated and experimentally##2##3##(2005-11#1)(2007-11#1)
simulated and real data##3##4##(2008-10#1)(2008-3#1)(2009-9#1)
simulated and real##9##3##(2008-10#3)(2008-3#2)(2008-7#1)(2009-9#1)(2010-12#1)(2011-1#1)
simulated and##35##2##(2005-11#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#5)(2008-2#4)(2008-3#7)(2008-5#2)(2008-7#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
simulated annealing algorithm##4##3##(2008-2#2)(2008-3#2)
simulated annealing and##7##3##(1996-6#1)(2008-2#4)(2008-3#1)(2009-2#1)
simulated annealing calculations##2##3##(1991-4#1)(1992-12#1)
simulated annealing optimization algorithm##2##4##(2008-3#2)
simulated annealing optimization##3##3##(2008-3#2)(2012-1#1)
simulated annealing with##2##3##(2008-2#1)(2008-3#1)
simulated annealing##45##2##(1991-11#1)(1991-4#1)(1992-1#1)(1992-12#3)(1994-11#1)(1994-5#3)(1995-3#1)(1995-5#1)(1995-8#1)(1996-6#2)(2008-2#14)(2008-3#12)(2008-4#1)(2009-2#1)(2011-1#1)(2012-1#1)
simulated based on##2##3##(2005-11#1)(2008-3#1)
simulated body fluid (SBF)##5##4##(2006-7#1)(2008-5#3)(2012-2#1)
simulated body fluid##11##3##(2006-7#1)(2008-5#7)(2010-8#1)(2012-2#1)(2013-8#1)
simulated body##14##2##(2004-9#2)(2006-7#1)(2008-5#7)(2010-8#2)(2012-2#1)(2013-8#1)
simulated by a##8##3##(2005-11#1)(2007-9#2)(2008-3#4)(2013-1#1)
simulated by computer##2##3##(2008-2#2)
simulated by the##2##3##(1995-1#1)(2013-8#1)
simulated by use of the##2##5##(2007-11#1)(2008-2#1)
simulated by##27##2##(1995-1#2)(2005-11#3)(2007-11#1)(2007-9#2)(2008-10#5)(2008-2#4)(2008-3#5)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
simulated case##2##2##(2008-2#1)(2011-1#1)
simulated clinical##2##2##(1997-7#1)(2008-11#1)
simulated curves##2##2##(1990-9#1)(2008-10#1)
simulated data and##4##3##(1995-8#1)(2008-7#1)(2011-1#2)
simulated data from##3##3##(2008-3#1)(2012-3#2)
simulated data in##3##3##(2008-2#1)(2010-2#1)(2011-2#1)
simulated data sets of unrelated individuals##2##6##(2012-3#2)
simulated data sets##6##3##(2012-3#6)
simulated data##42##2##(1991-12#1)(1993-9#1)(1994-5#1)(1995-6#1)(1995-8#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#7)(2008-7#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-2#3)(2011-1#2)(2011-2#1)(2012-3#11)
simulated detector##2##2##(2010-12#2)
simulated disease##3##2##(2008-10#1)(2012-3#2)
simulated epidemics##3##2##(2008-10#3)
simulated example##3##2##(1996-12#1)(2009-4#1)(2012-3#1)
simulated examples##2##2##(2010-12#1)(2010-3#1)
simulated field temperatures##2##3##(2008-10#2)
simulated for the##2##3##(2004-8#1)(2008-3#1)
simulated for##8##2##(1991-12#1)(2004-8#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2010-9#1)
simulated from##2##2##(1995-9#1)(2008-5#1)
simulated fusions##2##2##(2008-8#2)
simulated gastric and intestinal##2##4##(2004-12#1)(2010-1#1)
simulated gastric fluid (SGF)##2##4##(2004-12#1)(2010-12#1)
simulated gastric fluid##4##3##(2004-12#1)(2010-1#1)(2010-12#2)
simulated gastric##7##2##(2004-12#2)(2008-11#1)(2010-1#2)(2010-12#2)
simulated images##2##2##(2008-2#1)(2008-3#1)
simulated impact conditions##2##3##(2006-11#2)
simulated in the##2##3##(1994-6#1)(2008-10#1)
simulated in##7##2##(1990-8#1)(1991-2#1)(1994-6#1)(2007-4#1)(2008-10#1)(2008-3#1)(2009-3#1)
simulated internal##2##2##(2008-2#2)
simulated ischemia##6##2##(1994-2#6)
simulated lidar##2##2##(2008-3#2)
simulated measurements##2##2##(2008-10#1)(2008-3#1)
simulated microgravity conditions##2##3##(2009-7#2)
simulated microgravity##9##2##(2008-9#7)(2009-7#2)
simulated numerically##2##2##(2007-11#1)(2008-9#1)
simulated on a##2##3##(1993-9#1)(2008-3#1)
simulated on##3##2##(1993-9#1)(2008-3#2)
simulated patient##2##2##(1997-3#1)(2011-1#1)
simulated phenotype and##2##3##(2012-3#2)
simulated phenotype data##2##3##(2012-3#2)
simulated phenotype##4##2##(2012-3#4)
simulated phenotypes##4##2##(2012-3#4)
simulated quenching##2##2##(2008-3#2)
simulated radiances##2##2##(2008-2#2)
simulated rain##3##2##(2008-10#3)
simulated rainfall##2##2##(2008-10#2)
simulated rear##2##2##(2007-4#2)
simulated replicates##3##2##(2007-1#1)(2012-3#2)
simulated results showed that##2##4##(2007-12#1)(2008-2#1)
simulated results##8##2##(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#3)(2012-2#1)
simulated retrieval##2##2##(2008-3#1)(2013-8#1)
simulated saliva##2##2##(2008-5#2)
simulated samples##2##2##(2008-10#2)
simulated second-order##2##2##(2008-2#1)(2010-5#1)
simulated solar light##3##3##(2008-10#1)(2008-8#2)
simulated solar##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#2)
simulated spectra##4##2##(1994-3#1)(2008-2#1)(2008-3#1)(2012-3#1)
simulated sunlight##5##2##(2008-11#3)(2008-3#1)(2008-5#1)
simulated system##2##2##(2006-10#2)
simulated temperature##4##2##(1996-12#1)(2007-8#1)(2008-10#1)(2009-11#1)
simulated that##4##2##(1997-4#3)(2008-2#1)
simulated the##10##2##(1990-6#1)(1993-12#1)(2005-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2011-1#1)(2011-2#1)
simulated to##2##2##(2008-3#1)(2012-3#1)
simulated under##2##2##(2008-7#1)(2008-9#1)
simulated using a##6##3##(2006-11#1)(2008-10#3)(2013-1#1)(2013-7#1)
simulated using the##2##3##(2009-8#1)(2013-1#1)
simulated using##13##2##(1994-11#2)(2006-11#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-8#1)(2013-1#2)(2013-7#1)(2013-8#1)
simulated van't Hoff plots##2##4##(1997-2#2)
simulated with a##3##3##(2008-3#2)(2011-1#1)
simulated with the##3##3##(1996-11#1)(2008-2#1)(2008-7#1)
simulated with##16##2##(1991-2#1)(1996-11#1)(1996-2#1)(2008-2#3)(2008-3#4)(2008-7#2)(2011-1#1)(2012-3#1)(2013-1#2)
simulated##591##1##(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-4#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-8#2)(1993-12#2)(1993-9#3)(1994-1#1)(1994-11#3)(1994-2#7)(1994-3#1)(1994-5#4)(1994-6#1)(1995-1#3)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#3)(1995-9#1)(1996-11#1)(1996-12#5)(1996-2#1)(1996-4#1)(1996-6#2)(1996-7#1)(1997-2#3)(1997-3#3)(1997-4#5)(1997-5#1)(1997-7#2)(2004-12#4)(2004-8#1)(2004-9#5)(2005-11#5)(2005-8#1)(2006-10#6)(2006-11#5)(2006-2#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#11)(2007-2#1)(2007-4#5)(2007-5#2)(2007-7#3)(2007-8#2)(2007-9#6)(2008-1#4)(2008-10#63)(2008-11#19)(2008-12#3)(2008-2#62)(2008-3#72)(2008-4#1)(2008-5#22)(2008-6#1)(2008-7#10)(2008-8#11)(2008-9#14)(2009-1#1)(2009-10#1)(2009-11#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#6)(2009-8#2)(2009-9#4)(2010-1#4)(2010-12#10)(2010-2#8)(2010-3#3)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#3)(2010-9#5)(2011-1#11)(2011-2#4)(2012-1#6)(2012-12#3)(2012-2#5)(2012-3#43)(2012-5#1)(2013-1#14)(2013-7#5)(2013-8#8)
simulated-annealing##3##1##(2008-2#2)(2008-3#1)
simulated-annealing-based genetic##2##2##(2008-2#2)
simulates a natural##2##3##(1996-3#1)(2008-8#1)
simulates a##6##2##(1996-3#1)(2007-8#1)(2008-10#2)(2008-8#1)(2011-2#1)
simulates the##18##2##(1994-6#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-9#2)(2008-10#5)(2008-2#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-4#1)(2012-1#2)
simulates##36##1##(1994-6#1)(1996-3#1)(2006-4#1)(2007-11#1)(2007-3#1)(2007-4#2)(2007-8#1)(2007-9#2)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#1)(2008-8#2)(2009-10#2)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#4)(2013-8#2)
simulating a##10##2##(1993-2#1)(1997-8#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-12#2)(2010-9#1)(2011-2#1)(2012-12#1)
simulating acute##2##2##(1993-11#1)(2007-2#1)
simulating model##3##2##(2012-3#3)
simulating physical##2##2##(2007-9#1)(2008-10#1)
simulating the##15##2##(1993-10#1)(1993-3#1)(1994-3#1)(1995-6#1)(2006-11#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#3)(2011-2#1)(2012-3#1)(2013-8#1)
simulating##94##1##(1990-3#2)(1991-9#1)(1993-10#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-7#1)(1997-8#1)(2004-1#1)(2006-11#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#4)(2007-7#5)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#3)(2008-2#7)(2008-3#4)(2008-5#1)(2008-7#7)(2008-8#1)(2009-5#2)(2009-6#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#4)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#2)
simulation algorithm##2##2##(1994-4#1)(2010-7#1)
simulation and a##2##3##(2008-3#1)(2008-9#1)
simulation and empirical studies##2##4##(2012-12#1)(2013-1#1)
simulation and experimental investigation of##2##5##(2008-2#1)(2008-3#1)
simulation and experimental results are presented##2##6##(2008-2#1)(2008-3#1)
simulation and experimental results##6##4##(2008-2#2)(2008-3#3)(2008-7#1)
simulation and experimental##11##3##(2008-2#5)(2008-3#4)(2008-7#1)(2011-2#1)
simulation and experiments##2##3##(2008-3#1)(2008-7#1)
simulation and optical##2##3##(2008-2#1)(2008-3#1)
simulation and registration##2##3##(2007-5#2)
simulation and the experimental results##3##5##(2008-2#2)(2008-3#1)
simulation and the##5##3##(2008-2#3)(2008-3#1)(2010-6#1)
simulation and##49##2##(2006-11#1)(2006-6#1)(2007-12#1)(2007-5#2)(2008-10#1)(2008-2#13)(2008-3#16)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
simulation approach##6##2##(2008-3#1)(2010-6#2)(2010-8#1)(2013-1#2)
simulation are##5##2##(1991-2#1)(1992-1#1)(2006-10#1)(2008-2#1)(2008-3#1)
simulation as a##2##3##(2013-1#1)(2013-7#1)
simulation as##4##2##(2006-6#1)(2008-2#1)(2013-1#1)(2013-7#1)
simulation based on a##2##4##(2007-12#2)
simulation based on the generalized Lorenz-Mie theory##2##7##(2008-2#1)(2008-3#1)
simulation based on the##3##4##(2008-2#1)(2008-3#2)
simulation based on##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
simulation by a##2##3##(2006-5#1)(2007-11#1)
simulation by##3##2##(2006-5#1)(2007-11#1)(2008-2#1)
simulation can##4##2##(1995-6#1)(2006-10#1)(2008-2#1)(2013-7#1)
simulation code##4##2##(2008-2#1)(2008-3#3)
simulation data##8##2##(1991-5#1)(2008-3#2)(2009-2#1)(2012-3#4)
simulation examples##3##2##(2008-2#1)(2009-3#1)(2012-1#1)
simulation experiments are##2##3##(2008-7#1)(2010-2#1)
simulation experiments with##2##3##(2008-10#1)(2009-4#1)
simulation experiments##11##2##(1995-9#1)(2008-10#4)(2008-7#1)(2008-8#1)(2009-4#1)(2010-2#2)(2012-3#1)
simulation for the##3##3##(1996-7#1)(2008-10#1)(2008-3#1)
simulation for##10##2##(1993-11#1)(1996-7#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-3#3)(2012-1#1)
simulation has been##4##3##(2006-10#1)(2008-3#1)(2008-7#1)(2010-8#1)
simulation has##7##2##(2006-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-8#1)
simulation in the##4##3##(2008-10#1)(2009-4#1)(2009-5#1)(2009-8#1)
simulation in##14##2##(1990-2#1)(1997-1#2)(1997-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-7#1)
simulation indicates that##2##3##(1995-6#1)(2008-2#1)
simulation is based on##2##4##(2008-3#1)(2013-8#1)
simulation is generally##2##3##(2006-10#1)(2008-3#1)
simulation is presented##2##3##(1991-2#1)(2008-3#1)
simulation is used to##2##4##(2008-2#1)(2008-9#1)
simulation is##21##2##(1991-2#1)(2006-10#2)(2006-6#2)(2007-12#1)(2007-5#1)(2008-11#1)(2008-2#6)(2008-3#3)(2008-9#1)(2009-12#1)(2010-7#1)(2013-8#1)
simulation it is##2##3##(2008-2#1)(2008-3#1)
simulation method##5##2##(1994-3#1)(2007-12#1)(2008-3#2)(2012-2#1)
simulation methods##5##2##(1995-6#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#1)
simulation model for##3##3##(2006-4#1)(2012-12#2)
simulation model is used to##2##5##(2006-12#1)(2007-9#1)
simulation model of##2##3##(2008-9#1)(2010-8#1)
simulation model that##2##3##(2008-8#1)(2012-1#1)
simulation model to##5##3##(1991-12#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-3#1)
simulation model was##2##3##(1991-12#2)
simulation model##40##2##(1991-12#3)(2006-12#1)(2006-4#1)(2007-12#2)(2007-5#1)(2007-9#1)(2008-10#5)(2008-2#1)(2008-7#1)(2008-8#6)(2008-9#3)(2010-8#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#9)
simulation modeling##2##2##(1997-4#1)(2010-8#1)
simulation models to##3##3##(2007-6#1)(2008-9#2)
simulation models##11##2##(2006-6#1)(2007-6#1)(2007-9#1)(2008-8#2)(2008-9#3)(2010-8#1)(2012-3#1)(2013-1#1)
simulation module##2##2##(2010-9#2)
simulation of a##17##3##(1991-2#1)(1992-3#1)(1994-7#1)(1996-12#1)(1996-9#1)(2006-10#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#1)(2010-2#1)(2012-3#1)
simulation of an##7##3##(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#3)(2013-1#1)
simulation of atmospheric##2##3##(2008-2#1)(2008-3#1)
simulation of blood flow##2##4##(2009-4#1)(2010-3#1)
simulation of large##3##3##(2008-11#1)(2008-5#1)(2009-5#1)
simulation of light scattering##3##4##(2008-3#3)
simulation of light##4##3##(2008-3#4)
simulation of protein##3##3##(1994-8#1)(2006-10#1)(2006-5#1)
simulation of soft##4##3##(2007-5#2)(2011-1#2)
simulation of such##2##3##(1997-6#1)(2007-12#1)
simulation of the full##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
simulation of the##39##3##(1990-3#1)(1991-11#1)(1991-12#1)(1992-3#1)(1992-8#1)(1993-8#1)(1995-2#1)(1996-12#1)(1996-7#1)(1997-4#3)(2005-11#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#7)(2008-5#1)(2009-11#1)(2010-3#1)(2010-8#1)
simulation of##160##2##(1990-3#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1992-3#2)(1992-8#1)(1993-11#2)(1993-2#1)(1993-8#1)(1994-7#1)(1994-8#2)(1995-10#1)(1995-2#2)(1995-6#1)(1995-7#1)(1996-12#2)(1996-7#1)(1996-9#1)(1997-4#4)(1997-6#1)(2005-11#2)(2006-10#9)(2006-11#1)(2006-5#2)(2006-6#1)(2007-11#3)(2007-12#9)(2007-5#6)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-10#11)(2008-11#2)(2008-2#18)(2008-3#33)(2008-4#2)(2008-5#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-8#1)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
simulation output##2##2##(2008-10#2)
simulation packages##3##2##(2008-2#1)(2013-1#2)
simulation parameters##3##2##(2008-2#1)(2012-3#2)
simulation platform##2##2##(2008-11#1)(2009-9#1)
simulation procedure##2##2##(1993-3#1)(2008-2#1)
simulation process##2##2##(2008-11#1)(2010-9#1)
simulation program##3##2##(1995-2#1)(2007-9#1)(2008-3#1)
simulation result##3##2##(2008-2#1)(2011-1#1)(2013-8#1)
simulation results and##3##3##(2008-3#1)(2009-10#1)(2012-1#1)
simulation results are given to##2##5##(2007-12#1)(2008-2#1)
simulation results are presented##2##4##(2008-2#1)(2008-3#1)
simulation results are##7##3##(2006-2#1)(2007-12#1)(2008-2#2)(2008-3#2)(2012-1#1)
simulation results for##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)
simulation results show that the##4##5##(2008-3#3)(2012-3#1)
simulation results show that##7##4##(2008-2#1)(2008-3#4)(2011-1#1)(2012-3#1)
simulation results that##2##3##(2007-11#1)(2008-2#1)
simulation results were##2##3##(2006-11#1)(2008-11#1)
simulation results##51##2##(1997-3#1)(2006-11#1)(2006-2#1)(2007-11#2)(2007-12#3)(2007-8#2)(2008-10#2)(2008-11#2)(2008-2#12)(2008-3#14)(2008-8#1)(2009-10#1)(2009-5#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-1#3)(2012-3#1)(2013-8#1)
simulation run##2##2##(2006-10#1)(2008-10#1)
simulation show that the##3##4##(1996-12#1)(2007-11#1)(2008-7#1)
simulation show that##4##3##(1996-12#1)(2007-11#1)(2008-3#1)(2008-7#1)
simulation shows that the##3##4##(2007-11#1)(2011-1#1)(2013-7#1)
simulation shows that##8##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)(2011-1#1)(2013-7#1)
simulation shows##9##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)(2011-1#1)(2013-7#1)
simulation strategy##2##2##(2007-12#1)(2008-12#1)
simulation studies and##5##3##(2009-12#2)(2010-2#1)(2012-12#1)(2012-3#1)
simulation studies are##2##3##(2009-10#1)(2010-2#1)
simulation studies of##2##3##(2008-3#1)(2010-3#1)
simulation studies that##3##3##(2008-3#1)(2009-9#1)(2010-7#1)
simulation studies to##3##3##(1997-3#1)(2009-10#1)(2012-2#1)
simulation studies##36##2##(1990-10#1)(1992-12#1)(1992-8#1)(1993-5#1)(1997-3#1)(2006-10#1)(2006-2#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-8#1)(2009-10#2)(2009-12#3)(2009-2#1)(2009-9#1)(2010-2#3)(2010-3#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)
simulation study of the##3##4##(2006-10#1)(2008-2#1)(2012-2#1)
simulation study of##6##3##(1993-4#1)(2006-10#1)(2008-2#1)(2008-9#1)(2010-8#1)(2012-2#1)
simulation study that compares##2##4##(1995-8#1)(1997-3#1)
simulation study was undertaken##2##4##(2008-5#1)(2008-7#1)
simulation study was##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
simulation study##40##2##(1992-9#1)(1993-4#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-3#3)(2006-10#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-9#1)(2010-2#1)(2010-8#2)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#1)
simulation system##3##2##(2006-10#1)(2008-10#1)(2008-2#1)
simulation technique##3##2##(1997-1#1)(2006-10#1)(2008-2#1)
simulation techniques##5##2##(2006-10#1)(2007-11#1)(2008-4#1)(2008-7#1)(2011-1#1)
simulation technologies##2##2##(2008-11#2)
simulation that uses##2##3##(2006-12#1)(2008-10#1)
simulation that##8##2##(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2010-2#1)
simulation the##4##2##(1996-8#1)(2007-11#1)(2008-2#1)(2012-1#1)
simulation time of##2##3##(2006-12#1)(2010-2#1)
simulation time##3##2##(2006-12#1)(2010-2#1)(2012-2#1)
simulation to be##2##3##(2008-2#1)(2008-3#1)
simulation to##11##2##(1995-2#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-9#1)(2011-2#1)(2013-7#1)
simulation tool for##2##3##(2008-2#2)
simulation tool##5##2##(2005-5#1)(2008-2#3)(2008-3#1)
simulation tools##3##2##(2008-2#2)(2009-5#1)
simulation training##2##2##(2008-11#2)
simulation using a##5##3##(1992-6#1)(2007-12#1)(2008-3#1)(2009-12#1)(2011-2#1)
simulation using the##4##3##(1992-6#1)(2008-3#2)(2008-7#1)
simulation using##11##2##(1992-6#2)(2007-12#1)(2008-10#1)(2008-3#3)(2008-7#1)(2008-8#1)(2009-12#1)(2011-2#1)
simulation was carried out##2##4##(1993-8#1)(2006-10#1)
simulation was used to##2##4##(1995-1#1)(2008-3#1)
simulation was used##3##3##(1995-1#1)(2008-3#1)(2008-6#1)
simulation was##12##2##(1993-8#1)(1995-1#1)(2006-10#1)(2007-12#1)(2008-2#2)(2008-3#2)(2008-6#1)(2009-6#1)(2011-2#1)(2013-1#1)
simulation we##2##2##(2008-3#1)(2010-4#1)
simulation with experimental##2##3##(2007-4#1)(2008-3#1)
simulation with the##2##3##(1993-2#1)(2008-3#1)
simulation with##10##2##(1993-2#1)(2006-10#1)(2006-6#1)(2007-4#1)(2007-5#2)(2008-3#2)(2008-8#1)(2008-9#1)
simulation##880##1##(1990-10#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-8#2)(1991-1#1)(1991-11#2)(1991-12#5)(1991-2#3)(1991-4#2)(1991-5#1)(1991-6#1)(1992-1#2)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#3)(1992-8#2)(1992-9#2)(1993-11#4)(1993-2#3)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#2)(1994-11#1)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#3)(1994-7#3)(1994-8#3)(1995-1#3)(1995-10#1)(1995-2#6)(1995-3#1)(1995-4#3)(1995-5#2)(1995-6#4)(1995-7#1)(1995-8#4)(1995-9#2)(1996-12#3)(1996-3#1)(1996-5#1)(1996-7#5)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#5)(1997-4#6)(1997-6#2)(2005-11#3)(2005-4#1)(2005-5#1)(2006-10#28)(2006-11#3)(2006-12#7)(2006-2#3)(2006-4#2)(2006-5#3)(2006-6#14)(2007-11#17)(2007-12#34)(2007-3#1)(2007-4#1)(2007-5#14)(2007-6#3)(2007-7#3)(2007-8#6)(2007-9#6)(2008-1#1)(2008-10#51)(2008-11#23)(2008-12#4)(2008-2#117)(2008-3#126)(2008-4#6)(2008-5#6)(2008-6#9)(2008-7#13)(2008-8#21)(2008-9#12)(2009-10#5)(2009-11#3)(2009-12#6)(2009-2#2)(2009-3#3)(2009-4#4)(2009-5#8)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#5)(2010-10#1)(2010-12#6)(2010-2#15)(2010-3#4)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#5)(2010-8#13)(2010-9#4)(2011-1#14)(2011-12#3)(2011-2#13)(2012-1#9)(2012-12#5)(2012-2#13)(2012-3#28)(2013-1#18)(2013-7#10)(2013-8#8)
simulation)##2##1##(2008-11#1)(2008-2#1)
simulation-based approach##2##2##(2006-10#1)(2012-2#1)
simulation-based training##2##2##(2006-6#2)
simulation-based##10##1##(2006-10#1)(2006-6#2)(2008-6#1)(2009-10#1)(2009-5#1)(2010-8#1)(2012-2#2)(2013-8#1)
simulational##2##1##(2005-11#1)(2008-2#1)
simulations agree with experimental##2##4##(1993-11#1)(2008-2#1)
simulations agree##3##2##(1993-11#1)(2008-2#1)(2008-3#1)
simulations allow a comparison of##2##5##(2008-2#1)(2008-7#1)
simulations also show##2##3##(2008-2#1)(2008-3#1)
simulations also##4##2##(2006-10#1)(2008-2#1)(2008-3#2)
simulations and a sensitivity analysis##2##5##(2008-3#2)
simulations and experimental results##6##4##(2008-2#3)(2008-3#3)
simulations and experimental##9##3##(1995-8#1)(2008-2#4)(2008-3#3)(2009-9#1)
simulations and experiments##6##3##(2008-2#1)(2008-3#5)
simulations and field##2##3##(2008-3#2)
simulations and goniometric measurements##2##4##(2008-3#2)
simulations and predictions##2##3##(2009-12#1)(2013-1#1)
simulations and the##5##3##(2007-12#1)(2008-3#2)(2010-2#1)(2012-3#1)
simulations and##64##2##(1994-9#1)(1995-8#2)(1996-12#1)(2006-11#1)(2006-5#1)(2007-12#5)(2007-9#1)(2008-11#1)(2008-2#10)(2008-3#20)(2008-8#1)(2009-12#2)(2009-8#1)(2009-9#3)(2010-1#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-1#3)(2012-12#1)(2012-3#5)(2013-1#1)
simulations are able to##3##4##(1995-6#1)(2008-11#1)(2013-8#1)
simulations are also##2##3##(2008-2#2)
simulations are performed to##3##4##(2008-2#1)(2008-3#2)
simulations are performed##4##3##(2008-2#1)(2008-3#3)
simulations are presented##3##3##(2008-2#1)(2008-3#1)(2008-8#1)
simulations are used to##3##4##(1992-2#1)(2007-12#1)(2008-3#1)
simulations are used##5##3##(1992-2#1)(2006-2#1)(2007-12#1)(2008-3#2)
simulations are##34##2##(1992-2#1)(1992-3#1)(1993-11#1)(1993-4#1)(1995-6#1)(2006-10#3)(2006-2#1)(2007-12#3)(2007-3#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#6)(2008-3#7)(2008-8#1)(2011-1#1)(2013-8#2)
simulations based on the##4##4##(1992-6#1)(2007-12#1)(2008-2#2)
simulations based on##12##3##(1992-6#1)(2006-11#1)(2006-5#1)(2007-12#2)(2008-2#2)(2008-3#4)(2008-7#1)
simulations can be##3##3##(1995-6#1)(2008-12#1)(2008-8#1)
simulations carried out##3##3##(2008-2#2)(2008-3#1)
simulations confirm the##2##3##(2008-11#1)(2008-2#1)
simulations confirm##3##2##(2007-12#1)(2008-11#1)(2008-2#1)
simulations demonstrate that the##2##4##(2007-12#1)(2008-8#1)
simulations demonstrate that##3##3##(2007-12#1)(2008-3#1)(2008-8#1)
simulations demonstrate##5##2##(2007-11#1)(2007-12#1)(2008-3#1)(2008-8#1)(2010-12#1)
simulations for both##2##3##(2007-12#1)(2008-3#1)
simulations for##16##2##(1992-3#1)(1997-1#1)(2006-10#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-9#1)(2011-1#1)(2013-1#2)(2013-8#1)
simulations has been##2##3##(2008-10#1)(2008-12#1)
simulations have been conducted##2##4##(2006-6#1)(2012-3#1)
simulations have been##6##3##(2005-11#1)(2006-6#1)(2007-11#1)(2008-11#1)(2008-3#1)(2012-3#1)
simulations have##9##2##(1993-11#1)(2005-11#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-3#1)(2012-3#1)
simulations in the##3##3##(2006-10#1)(2007-9#1)(2008-2#1)
simulations in which the##2##4##(1994-11#1)(2010-2#1)
simulations in##17##2##(1991-11#1)(1994-11#1)(1996-7#1)(2006-10#2)(2007-11#1)(2007-9#1)(2008-2#3)(2008-3#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-2#1)(2011-1#1)
simulations including##3##2##(1992-1#1)(1992-6#1)(2008-12#1)
simulations indicate that the##4##4##(1994-2#1)(2006-2#1)(2008-3#1)(2008-4#1)
simulations indicate that##11##3##(1994-2#1)(1994-6#1)(2006-2#1)(2007-11#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2012-12#1)(2013-1#1)
simulations is##5##2##(1994-11#1)(2008-3#1)(2010-2#1)(2011-1#1)(2011-2#1)
simulations of a passive##2##4##(2008-2#1)(2010-9#1)
simulations of a##8##3##(1993-4#1)(2006-10#1)(2007-12#1)(2008-2#1)(2010-2#1)(2010-9#1)(2012-2#1)(2013-8#1)
simulations of alternative##2##3##(1993-12#1)(1996-1#1)
simulations of an##2##3##(1993-11#1)(2008-2#1)
simulations of biological##2##3##(2006-10#1)(2010-7#1)
simulations of light scattering##3##4##(2008-2#3)
simulations of nonlinear##2##3##(2007-12#1)(2008-2#1)
simulations of photon migration##2##4##(2008-2#2)
simulations of protein##4##3##(1995-3#1)(2006-10#2)(2010-2#1)
simulations of several##3##3##(2007-4#1)(2008-10#1)(2008-3#1)
simulations of the##38##3##(1990-2#1)(1990-8#1)(1991-4#1)(1991-9#1)(1992-2#1)(1992-7#1)(1992-9#1)(1994-7#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-8#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-2#5)(2008-3#8)(2008-5#1)(2009-4#1)(2012-1#1)
simulations of##131##2##(1990-10#1)(1990-2#1)(1990-8#1)(1991-11#1)(1991-2#2)(1991-4#1)(1991-9#1)(1992-2#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-4#1)(1993-5#1)(1994-7#1)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#1)(1995-8#1)(1996-1#1)(1996-7#1)(1996-8#1)(1997-6#1)(2005-11#4)(2006-10#7)(2006-12#1)(2006-2#1)(2007-11#3)(2007-12#7)(2007-4#2)(2007-5#1)(2007-9#3)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#24)(2008-3#18)(2008-5#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-2#4)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#1)
simulations on a##2##3##(2006-10#1)(2007-12#1)
simulations on the##2##3##(1990-8#1)(2006-11#1)
simulations on##7##2##(1990-8#1)(1995-6#1)(1996-4#1)(2006-10#1)(2006-11#1)(2007-12#1)(2008-2#1)
simulations performed on a##2##4##(2007-11#1)(2007-12#1)
simulations performed##3##2##(2007-11#2)(2007-12#1)
simulations predict##3##2##(2008-2#1)(2008-3#2)
simulations presented here##2##3##(2011-2#1)(2013-8#1)
simulations provide a##2##3##(1993-11#1)(2010-9#1)
simulations provide##3##2##(1993-11#1)(2008-12#1)(2010-9#1)
simulations reveal##2##2##(2007-12#1)(2008-2#1)
simulations revealed that##3##3##(2005-11#1)(2008-2#1)(2012-2#1)
simulations show a##3##3##(2006-10#1)(2006-11#1)(2008-3#1)
simulations show that the##8##4##(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#3)
simulations show that##22##3##(1993-2#1)(1995-11#1)(2007-12#4)(2008-10#1)(2008-11#1)(2008-2#7)(2008-3#5)(2008-8#1)(2010-2#1)
simulations show##31##2##(1993-2#1)(1995-11#1)(1997-2#1)(2006-10#1)(2006-11#1)(2007-12#6)(2008-10#1)(2008-11#2)(2008-2#7)(2008-3#8)(2008-8#1)(2010-2#1)
simulations showed that the##2##4##(2008-3#1)(2009-5#1)
simulations showed that##5##3##(2008-3#2)(2008-8#1)(2009-5#1)(2012-2#1)
simulations showed##7##2##(2008-3#2)(2008-8#1)(2009-5#1)(2010-2#1)(2012-1#1)(2012-2#1)
simulations suggest that the##3##4##(2007-12#2)(2008-8#1)
simulations suggest that##8##3##(2007-12#2)(2008-12#1)(2008-3#1)(2008-8#1)(2012-1#1)(2012-2#1)(2013-8#1)
simulations suggest##9##2##(2007-12#2)(2008-12#1)(2008-3#1)(2008-8#2)(2012-1#1)(2012-2#1)(2013-8#1)
simulations support##2##2##(2007-11#1)(2008-3#1)
simulations that a##2##3##(2007-11#1)(2007-12#1)
simulations that are##2##3##(1993-2#1)(2010-9#1)
simulations that demonstrate the##2##4##(2008-3#2)
simulations that show##2##3##(2008-3#1)(2008-4#1)
simulations that the##2##3##(2007-11#1)(2007-12#1)
simulations that##23##2##(1993-2#1)(1995-2#1)(2007-11#3)(2007-12#8)(2008-3#5)(2008-4#1)(2008-6#1)(2009-8#1)(2010-9#1)(2012-2#1)
simulations the##5##2##(2005-11#2)(2008-3#3)
simulations to compare##2##3##(1994-9#1)(2009-3#1)
simulations to investigate the##2##4##(2008-8#1)(2009-6#1)
simulations to predict##3##3##(2007-12#1)(2010-2#1)(2011-2#1)
simulations to the##2##3##(2005-11#1)(2008-3#1)
simulations to##25##2##(1993-4#1)(1994-9#1)(1995-2#1)(1995-8#1)(2005-11#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#4)(2008-6#1)(2008-8#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-2#2)(2011-2#2)(2011-3#1)
simulations using the##5##3##(2005-11#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-1#1)
simulations using##8##2##(2005-11#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-2#1)(2011-1#1)(2012-1#1)
simulations verify the##2##3##(2008-2#2)
simulations was##5##2##(1992-11#1)(2006-11#1)(2008-10#1)(2008-11#1)(2009-5#1)
simulations we##7##2##(1997-7#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#1)
simulations were carried out##3##4##(2008-10#1)(2008-3#1)(2009-6#1)
simulations were judged to be##2##5##(2008-11#2)
simulations were performed to##3##4##(2006-10#1)(2008-2#1)(2012-3#1)
simulations were performed##4##3##(2006-10#1)(2008-2#1)(2010-2#1)(2012-3#1)
simulations were run##4##3##(1991-12#1)(2006-10#1)(2008-3#1)(2010-2#1)
simulations were used to##3##4##(1997-2#1)(2005-11#1)(2008-10#1)
simulations were##26##2##(1991-12#1)(1992-12#1)(1993-11#1)(1995-6#1)(1995-7#1)(1997-2#1)(2005-11#1)(2006-10#2)(2006-12#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#4)(2009-6#1)(2010-2#2)(2010-7#1)(2012-3#1)
simulations with the##6##3##(1992-3#1)(1995-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-8#1)
simulations with##25##2##(1992-3#1)(1993-11#1)(1995-6#1)(1996-4#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-8#2)(2008-9#1)(2010-2#1)(2012-3#1)
simulations##793##1##(1990-10#5)(1990-2#1)(1990-8#3)(1991-11#2)(1991-12#1)(1991-2#4)(1991-4#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#3)(1992-6#3)(1992-7#1)(1992-9#1)(1993-11#12)(1993-12#1)(1993-2#2)(1993-4#3)(1993-5#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-10#2)(1995-11#2)(1995-2#4)(1995-3#4)(1995-4#1)(1995-5#5)(1995-6#7)(1995-7#1)(1995-8#7)(1996-1#1)(1996-12#2)(1996-4#2)(1996-6#1)(1996-7#3)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#2)(2005-11#19)(2006-10#21)(2006-11#10)(2006-12#4)(2006-2#3)(2006-4#1)(2006-5#4)(2006-6#1)(2007-10#2)(2007-11#24)(2007-12#73)(2007-3#2)(2007-4#4)(2007-5#2)(2007-9#18)(2008-1#4)(2008-10#23)(2008-11#17)(2008-12#10)(2008-2#100)(2008-3#133)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#7)(2008-8#20)(2008-9#9)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#9)(2009-6#3)(2009-7#2)(2009-8#5)(2009-9#4)(2010-1#2)(2010-11#1)(2010-12#5)(2010-2#20)(2010-3#4)(2010-4#1)(2010-5#2)(2010-7#3)(2010-8#1)(2010-9#4)(2011-1#12)(2011-2#6)(2011-3#1)(2012-1#8)(2012-12#8)(2012-2#11)(2012-3#11)(2013-1#19)(2013-8#11)
simulative##2##1##(2006-6#1)(2013-7#1)
simulator and##3##2##(2007-5#1)(2012-1#1)(2012-12#1)
simulator called##2##2##(2008-2#1)(2008-8#1)
simulator equipped with##2##3##(2008-11#1)(2008-3#1)
simulator for the##2##3##(1994-12#1)(2008-10#1)
simulator for##8##2##(1994-12#1)(2006-6#1)(2007-5#2)(2008-10#1)(2008-2#1)(2010-12#1)(2012-1#1)
simulator in##2##2##(2007-11#1)(2010-12#1)
simulator predicts the##2##3##(2008-2#2)
simulator training##3##2##(2011-2#2)(2012-2#1)
simulator with##2##2##(2008-10#1)(2012-1#1)
simulator##63##1##(1994-12#1)(1994-3#1)(1996-12#1)(2004-9#2)(2006-10#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-5#3)(2008-10#4)(2008-11#1)(2008-2#11)(2008-3#4)(2008-5#1)(2008-8#4)(2009-10#1)(2009-7#1)(2009-9#3)(2010-12#3)(2010-5#1)(2010-8#1)(2011-2#3)(2012-1#5)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)
simulators are##3##2##(2006-6#1)(2008-11#2)
simulators for##3##2##(2008-2#2)(2011-2#1)
simulators in##3##2##(2008-5#1)(2009-4#1)(2011-2#1)
simulators to##2##2##(2007-3#1)(2011-1#1)
simulators##35##1##(1996-12#2)(2006-10#9)(2006-6#4)(2007-3#1)(2007-5#2)(2008-11#2)(2008-2#3)(2008-5#1)(2009-4#1)(2009-5#1)(2011-1#2)(2011-2#5)(2012-2#1)(2012-3#1)
simultaneity##3##1##(2007-7#1)(2008-3#1)(2010-2#1)
simultaneous EEG and near infrared optical tomography##2##7##(2011-1#2)
simultaneous action of two##2##4##(2007-11#1)(2007-12#1)
simultaneous activation of PPARalpha##2##4##(2008-1#2)
simultaneous activation of##3##3##(1993-9#1)(2008-1#2)
simultaneous addition of##12##3##(1991-8#1)(1993-7#1)(1995-11#1)(1996-11#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-2#1)(2009-8#1)
simultaneous administration of the##2##4##(1991-1#1)(1992-5#1)
simultaneous administration of##9##3##(1990-10#1)(1991-1#1)(1991-3#1)(1991-5#1)(1992-5#1)(1992-6#1)(1994-5#1)(1995-5#1)(2008-4#1)
simultaneous administration##10##2##(1990-10#1)(1991-1#1)(1991-3#1)(1991-5#1)(1992-5#1)(1992-6#1)(1994-5#1)(1995-5#2)(2008-4#1)
simultaneous amplification##2##2##(2007-10#1)(2008-10#1)
simultaneous analysis of 11 opiates in hair samples##2##8##(2012-3#2)
simultaneous analysis of 11##3##4##(2008-12#1)(2012-3#2)
simultaneous analysis of several##2##4##(2008-10#1)(2008-4#1)
simultaneous analysis of the##2##4##(2008-10#1)(2012-2#1)
simultaneous analysis of three##2##4##(2008-10#2)
simultaneous analysis of##35##3##(1990-8#1)(1991-7#1)(1996-6#1)(2006-5#1)(2007-8#2)(2008-10#19)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#3)
simultaneous analysis##36##2##(1990-8#1)(1991-7#1)(1996-6#1)(2006-5#1)(2007-8#2)(2008-10#20)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#3)
simultaneous and quantitative##2##3##(2008-10#1)(2008-5#1)
simultaneous and##12##2##(1995-2#1)(1995-7#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)
simultaneous application of##2##3##(1997-5#1)(2008-3#1)
simultaneous assay##5##2##(1993-2#1)(1997-8#1)(2007-12#1)(2008-10#2)
simultaneous assessment of##6##3##(2008-12#1)(2008-4#1)(2008-9#2)(2012-12#1)(2013-1#1)
simultaneous atomic absorption spectrometry (SIMAAS)##2##5##(2008-10#2)
simultaneous atomic absorption spectrometry##3##4##(2008-10#3)
simultaneous binding##3##2##(1990-12#1)(1991-4#1)(1994-5#1)
simultaneous calculation of##2##3##(2008-2#1)(2008-3#1)
simultaneous changes in##3##3##(1991-9#1)(1995-3#1)(2013-1#1)
simultaneous changes of##2##3##(2008-3#1)(2012-1#1)
simultaneous changes##5##2##(1991-9#1)(1995-3#1)(2008-3#1)(2012-1#1)(2013-1#1)
simultaneous cochlear implantation in children##2##5##(2012-2#2)
simultaneous cochlear implantation in##4##4##(2008-9#2)(2012-2#2)
simultaneous cochlear##5##2##(2008-9#2)(2012-2#3)
simultaneous confidence intervals for##2##4##(1997-7#1)(2010-2#1)
simultaneous confidence intervals##3##3##(1997-7#1)(2010-2#2)
simultaneous confidence##5##2##(1997-7#1)(2009-5#1)(2010-11#1)(2010-2#2)
simultaneous control of##4##3##(2007-12#3)(2009-2#1)
simultaneous coordination##2##2##(2010-5#1)(2010-6#1)
simultaneous detection and##5##3##(2008-10#2)(2010-6#1)(2012-12#1)(2013-1#1)
simultaneous detection of multiple##3##4##(2007-12#1)(2008-2#1)(2008-9#1)
simultaneous detection of the##3##4##(2008-10#2)(2011-1#1)
simultaneous detection of two##3##4##(2007-12#1)(2008-4#1)(2013-8#1)
simultaneous detection of##32##3##(1994-2#1)(1994-6#1)(1996-8#1)(2006-8#1)(2007-12#3)(2008-10#14)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#2)(2010-11#1)(2011-1#1)(2013-8#2)
simultaneous detection##43##2##(1994-2#1)(1994-6#1)(1996-8#1)(2006-8#1)(2007-12#3)(2008-10#19)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#3)(2009-11#1)(2010-11#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
simultaneous determination method##2##3##(2008-10#2)
simultaneous determination of 19##2##4##(2008-10#2)
simultaneous determination of As##5##4##(2008-10#5)
simultaneous determination of Cu##2##4##(2005-4#1)(2008-10#1)
simultaneous determination of Fe(II)##5##4##(2008-10#5)
simultaneous determination of Fe(III) and Fe(II)##2##6##(2008-10#2)
simultaneous determination of GLY and AMPA in##2##7##(2008-10#1)(2011-1#1)
simultaneous determination of Pb(2+) and Cd(2+)##2##6##(2008-10#2)
simultaneous determination of V(V) and##2##5##(2008-10#2)
simultaneous determination of all##3##4##(2008-10#3)
simultaneous determination of ammonium##4##4##(2008-10#4)
simultaneous determination of arsenic##3##4##(2008-10#3)
simultaneous determination of both organic and inorganic anions in##2##9##(2008-10#2)
simultaneous determination of both##5##4##(2008-10#5)
simultaneous determination of caffeine##3##4##(2008-10#3)
simultaneous determination of catecholamines##2##4##(1990-8#1)(1996-11#1)
simultaneous determination of cobalt##2##4##(2008-10#2)
simultaneous determination of copper and iron##2##6##(2008-10#2)
simultaneous determination of copper and##3##5##(2008-10#3)
simultaneous determination of cyclosporine A##2##5##(2008-10#2)
simultaneous determination of direct and total##2##6##(2008-10#2)
simultaneous determination of five##3##4##(2005-4#1)(2008-5#2)
simultaneous determination of four##5##4##(2008-10#5)
simultaneous determination of heavy metals##2##5##(2008-10#1)(2009-6#1)
simultaneous determination of honokiol and magnolol in rat plasma##2##9##(2008-10#2)
simultaneous determination of iron and##3##5##(2008-10#3)
simultaneous determination of iron##4##4##(2008-10#4)
simultaneous determination of iron(III) and copper(II) and of iron(III) and palladium(II) based on##2##13##(2008-10#2)
simultaneous determination of iron(III) and##3##5##(2008-10#3)
simultaneous determination of mephenesin and diclofenac diethylamine##2##7##(2010-2#2)
simultaneous determination of nitrite and nitrate in##6##7##(2008-10#6)
simultaneous determination of nitrite and nitrate##9##6##(2008-10#9)
simultaneous determination of nitroaniline isomers##2##5##(2008-10#2)
simultaneous determination of nitroaniline##3##4##(2008-10#3)
simultaneous determination of organic##2##4##(2008-10#2)
simultaneous determination of oxidizable amino acids##2##6##(2008-10#2)
simultaneous determination of periodate-bromate and iodate-bromate##2##6##(2008-10#2)
simultaneous determination of selenium(IV) and##2##5##(2008-10#2)
simultaneous determination of seven##3##4##(2008-10#2)(2012-3#1)
simultaneous determination of some##4##4##(2008-10#4)
simultaneous determination of sulfamonomethoxine##3##4##(1996-6#2)(2008-10#1)
simultaneous determination of the compounds##2##5##(2008-10#2)
simultaneous determination of the##21##4##(1996-5#1)(1997-8#1)(2008-10#15)(2008-2#2)(2008-3#1)(2012-12#1)
simultaneous determination of these compounds##2##5##(2005-4#1)(2008-10#1)
simultaneous determination of these##5##4##(2005-4#1)(2008-10#4)
simultaneous determination of three##4##4##(2008-10#4)
simultaneous determination of trace##7##4##(2008-10#7)
simultaneous determination of two##4##4##(2005-4#1)(2008-10#3)
simultaneous determination of various##2##4##(1990-8#1)(1996-6#1)
simultaneous determination of##303##3##(1990-11#2)(1990-6#4)(1990-8#5)(1991-8#1)(1993-2#1)(1993-9#1)(1995-3#2)(1996-11#1)(1996-3#1)(1996-5#2)(1996-6#5)(1996-8#1)(1997-3#1)(1997-8#2)(2004-11#1)(2005-4#5)(2007-8#4)(2008-10#232)(2008-2#3)(2008-3#2)(2008-5#3)(2009-6#2)(2010-12#3)(2010-2#4)(2011-1#3)(2011-2#1)(2011-3#1)(2012-12#6)(2012-2#1)(2012-3#1)(2013-7#2)
simultaneous determination##310##2##(1990-11#2)(1990-6#4)(1990-8#5)(1991-8#1)(1993-2#1)(1993-9#1)(1995-3#2)(1996-11#1)(1996-3#1)(1996-5#2)(1996-6#5)(1996-8#1)(1997-3#1)(1997-8#2)(2004-11#1)(2005-4#5)(2007-8#4)(2008-10#239)(2008-2#3)(2008-3#2)(2008-5#3)(2009-6#2)(2010-12#3)(2010-2#4)(2011-1#3)(2011-2#1)(2011-3#1)(2012-12#6)(2012-2#1)(2012-3#1)(2013-7#2)
simultaneous determinations of##3##3##(2008-10#2)(2008-3#1)
simultaneous determinations##5##2##(2008-10#4)(2008-3#1)
simultaneous dilution##2##2##(2008-10#2)
simultaneous direct##4##2##(2006-10#1)(2008-10#2)(2008-5#1)
simultaneous electrochemical##3##2##(2008-10#2)(2010-2#1)
simultaneous elevation of##2##3##(1993-7#1)(2008-11#1)
simultaneous equations##3##2##(2007-7#1)(2008-3#1)(2010-5#1)
simultaneous estimation of frusemide and amiloride hydrochloride in##2##8##(2010-12#2)
simultaneous estimation of the##2##4##(2008-10#1)(2008-2#1)
simultaneous estimation of##10##3##(2006-10#1)(2008-10#2)(2008-2#1)(2010-12#2)(2010-2#2)(2010-3#1)(2013-7#1)
simultaneous estimation##11##2##(2006-10#1)(2008-10#3)(2008-2#1)(2010-12#2)(2010-2#2)(2010-3#1)(2013-7#1)
simultaneous evaluation of##4##3##(2007-1#1)(2007-5#1)(2008-2#1)(2008-5#1)
simultaneous evolution of##2##3##(2004-9#1)(2008-8#1)
simultaneous exposure of##2##3##(1992-2#1)(1993-8#1)
simultaneous exposure to##2##3##(1991-12#1)(2010-4#1)
simultaneous exposure##4##2##(1991-12#1)(1992-2#1)(1993-8#1)(2010-4#1)
simultaneous expression of##4##3##(1992-7#1)(1996-10#1)(2006-5#1)(2011-3#1)
simultaneous expression##5##2##(1992-7#1)(1996-10#1)(2006-5#1)(2008-1#1)(2011-3#1)
simultaneous extraction##2##2##(2008-10#2)
simultaneous first-order processes##2##3##(2005-11#2)
simultaneous flow injection##2##3##(2008-10#2)
simultaneous formation of##3##3##(1991-7#1)(2005-12#1)(2008-6#1)
simultaneous generation of##2##3##(2007-12#2)
simultaneous handling of##2##3##(2008-10#2)
simultaneous i##2##2##(1992-10#1)(1997-7#1)
simultaneous identification and enumeration of##2##5##(2007-12#1)(2008-9#1)
simultaneous identification and##5##3##(2007-12#1)(2008-10#1)(2008-5#2)(2008-9#1)
simultaneous imaging##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2009-11#1)
simultaneous in situ##2##3##(2007-8#1)(2008-2#1)
simultaneous in##3##2##(2007-8#1)(2008-10#1)(2008-2#1)
simultaneous increase##2##2##(2005-10#1)(2010-4#1)
simultaneous information##2##2##(2008-3#1)(2012-11#1)
simultaneous infusion of##2##3##(1992-10#1)(1993-12#1)
simultaneous intracavity##2##2##(2007-12#2)
simultaneous intravenous##2##2##(1993-9#1)(2010-11#1)
simultaneous kidney-pancreas##2##2##(2007-11#1)(2008-1#1)
simultaneous kinetic##2##2##(2008-10#2)
simultaneous manipulation##2##2##(2007-11#1)(2008-7#1)
simultaneous measurement of temperature and##4##5##(2007-11#2)(2007-12#1)(2008-3#1)
simultaneous measurement of temperature##5##4##(2007-11#2)(2007-12#2)(2008-3#1)
simultaneous measurement of the##8##4##(1992-12#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#2)
simultaneous measurement of##35##3##(1992-12#1)(1994-12#1)(1994-9#1)(1997-3#1)(1997-8#1)(2007-11#5)(2007-12#6)(2007-8#1)(2008-1#1)(2008-2#5)(2008-3#9)(2008-4#2)(2011-12#1)
simultaneous measurement##37##2##(1992-12#1)(1994-12#1)(1994-9#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-11#5)(2007-12#6)(2007-8#1)(2008-1#1)(2008-2#5)(2008-3#10)(2008-4#2)(2011-12#1)
simultaneous measurements of##9##3##(1995-8#1)(2007-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-7#1)
simultaneous measurements with lidar##2##4##(2008-2#2)
simultaneous measurements with##3##3##(2008-2#2)(2008-3#1)
simultaneous measurements##13##2##(1995-8#1)(2007-1#1)(2008-10#3)(2008-2#4)(2008-3#3)(2008-7#1)
simultaneous monitoring of the##3##4##(2006-5#1)(2007-8#1)(2008-3#1)
simultaneous monitoring of##6##3##(1996-12#1)(2006-5#1)(2007-8#1)(2008-10#2)(2008-3#1)
simultaneous monitoring##7##2##(1996-12#1)(2006-5#1)(2007-8#2)(2008-10#2)(2008-3#1)
simultaneous multielement determination of##2##4##(2008-10#2)
simultaneous multielement determination##3##3##(2008-10#3)
simultaneous multielement flame atomic absorption spectrometry##2##6##(2008-10#2)
simultaneous multielement##5##2##(2008-10#5)
simultaneous multiple injection##2##3##(2008-10#2)
simultaneous multiple##3##2##(2008-10#3)
simultaneous occurrence of##8##3##(1992-10#1)(1992-2#1)(1994-10#1)(2007-7#1)(2008-2#1)(2011-1#1)(2013-1#2)
simultaneous operation##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
simultaneous optical pattern##2##3##(2007-12#1)(2008-2#1)
simultaneous optical wavelength interchange##3##4##(2007-12#3)
simultaneous optical##6##2##(2007-12#4)(2008-2#1)(2008-3#1)
simultaneous optimization of##2##3##(2008-10#1)(2008-3#1)
simultaneous optimization##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
simultaneous or sequential##3##3##(2005-8#1)(2008-10#2)
simultaneous overexpression of##3##3##(1994-11#1)(2007-2#1)(2008-7#1)
simultaneous pancreas-kidney transplantation##2##3##(2006-10#2)
simultaneous performance of##2##3##(1991-9#1)(1994-3#1)
simultaneous preconcentration##2##2##(2008-10#2)
simultaneous presence of##16##3##(1991-12#1)(1991-8#1)(1992-4#1)(1994-5#1)(1995-1#2)(1996-5#1)(1996-7#1)(1997-2#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-5#2)(2012-2#1)
simultaneous presence##17##2##(1991-12#1)(1991-8#1)(1992-4#1)(1992-5#1)(1994-5#1)(1995-1#2)(1996-5#1)(1996-7#1)(1997-2#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-5#2)(2012-2#1)
simultaneous production of##3##3##(1992-1#1)(2008-3#1)(2008-5#1)
simultaneous quadriceps##2##2##(2009-4#1)(2011-2#1)
simultaneous quantification of##12##3##(1993-11#2)(1996-8#1)(2005-12#1)(2008-10#2)(2008-11#1)(2010-12#2)(2011-3#1)(2012-12#1)(2012-2#1)
simultaneous quantitation of##6##3##(1990-9#1)(1997-3#2)(2008-10#2)(2008-9#1)
simultaneous quantitative analysis of##2##4##(2008-10#1)(2010-2#1)
simultaneous quantitative##3##2##(2008-10#2)(2010-2#1)
simultaneous reconstruction of the##2##4##(2007-12#1)(2008-5#1)
simultaneous reconstruction of##3##3##(2007-12#1)(2008-2#1)(2008-5#1)
simultaneous recording of##2##3##(1991-8#1)(2008-3#1)
simultaneous recordings of##2##3##(1994-6#1)(2008-7#1)
simultaneous refractive-index and##2##3##(2007-11#1)(2008-2#1)
simultaneous release##2##2##(2007-8#1)(2008-10#1)
simultaneous replacement of##2##3##(1992-6#1)(1993-3#1)
simultaneous resection of the##2##4##(1992-6#1)(2007-11#1)
simultaneous resistance to##2##3##(2008-11#1)(2008-5#1)
simultaneous saccharification and cofermentation (SSCF)##3##5##(2008-5#2)(2008-6#1)
simultaneous saccharification and cofermentation##4##4##(2008-5#3)(2008-6#1)
simultaneous saccharification and fermentation (SSF)##3##5##(2008-6#2)(2013-1#1)
simultaneous saccharification and fermentation##9##4##(2008-5#1)(2008-6#6)(2013-1#2)
simultaneous saccharification and##13##3##(2008-5#4)(2008-6#7)(2013-1#2)
simultaneous saccharification##14##2##(2008-5#4)(2008-6#8)(2013-1#2)
simultaneous scores monitoring and residuals tracking (SMART)##2##7##(2008-10#2)
simultaneous screening##3##2##(1990-11#1)(1996-6#1)(2010-3#1)
simultaneous second-harmonic generation and##4##4##(2007-12#4)
simultaneous second-harmonic generation##5##3##(2007-12#5)
simultaneous secretion of##2##3##(1995-3#2)
simultaneous separation and determination of different##2##6##(2008-10#2)
simultaneous separation and determination of##4##5##(1991-8#1)(2008-10#3)
simultaneous separation and##9##3##(1991-8#1)(2008-10#6)(2012-11#2)
simultaneous separation of##7##3##(1990-8#1)(1997-3#2)(2008-10#4)
simultaneous separation##17##2##(1990-8#1)(1991-8#1)(1997-3#2)(2008-10#11)(2012-11#2)
simultaneous sequencing##2##2##(1995-7#1)(2008-3#1)
simultaneous spectrophotometric determination of copper(II) and nickel(II) in##2##8##(2008-10#2)
simultaneous spectrophotometric determination of trace amounts of##2##7##(2008-10#2)
simultaneous spectrophotometric determination of##19##4##(2008-10#19)
simultaneous spectrophotometric##20##2##(2008-10#20)
simultaneous staining##2##2##(1996-12#1)(2008-11#1)
simultaneous strain and temperature##2##4##(2007-12#1)(2008-3#1)
simultaneous sunphotometer##2##2##(2008-2#1)(2008-3#1)
simultaneous system##3##2##(2007-7#1)(2008-10#2)
simultaneous temperature and##4##3##(2006-12#1)(2007-11#1)(2008-2#2)
simultaneous thermal lens and beam deflection phenomena##2##7##(2008-3#2)
simultaneous thermal##3##2##(2008-3#2)(2011-2#1)
simultaneous to##2##2##(2008-12#2)
simultaneous treatment with##4##3##(1993-3#3)(2008-10#1)
simultaneous treatment##5##2##(1993-3#3)(1994-3#1)(2008-10#1)
simultaneous triple ENBD insertion##2##4##(2013-1#2)
simultaneous triple ENBD##3##3##(2013-1#3)
simultaneous triple##4##2##(2013-1#4)
simultaneous use of##8##3##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-8#1)
simultaneous utilization of##2##3##(2008-7#1)(2008-9#1)
simultaneous visualization of##3##3##(2008-4#1)(2008-7#1)(2011-2#1)
simultaneous visualization##4##2##(2008-4#1)(2008-7#1)(2009-11#1)(2011-2#1)
simultaneous with the##3##3##(1997-8#1)(2008-1#1)(2008-3#1)
simultaneous with##6##2##(1992-8#1)(1997-8#1)(2008-1#2)(2008-3#1)(2009-2#1)
simultaneous##1207##1##(1990-10#1)(1990-11#3)(1990-12#4)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#4)(1990-8#8)(1990-9#1)(1991-1#3)(1991-10#1)(1991-12#4)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#6)(1991-9#2)(1992-1#2)(1992-10#4)(1992-12#2)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#3)(1992-6#4)(1992-7#1)(1992-8#3)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#4)(1993-5#1)(1993-7#2)(1993-8#2)(1993-9#4)(1994-10#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#3)(1994-6#3)(1994-7#1)(1994-9#3)(1995-1#3)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#6)(1995-5#3)(1995-6#2)(1995-7#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#4)(1996-2#1)(1996-3#4)(1996-4#1)(1996-5#6)(1996-6#8)(1996-7#1)(1996-8#3)(1997-1#1)(1997-2#1)(1997-3#7)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#7)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-12#3)(2005-4#6)(2005-8#2)(2005-9#1)(2006-10#7)(2006-11#1)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#5)(2006-6#4)(2006-7#1)(2006-8#2)(2007-1#2)(2007-10#6)(2007-11#32)(2007-12#58)(2007-2#3)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#18)(2007-9#2)(2008-1#16)(2008-10#426)(2008-11#10)(2008-12#7)(2008-2#53)(2008-3#60)(2008-4#15)(2008-5#25)(2008-6#14)(2008-7#17)(2008-8#9)(2008-9#21)(2009-1#1)(2009-10#6)(2009-11#3)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#4)(2010-12#10)(2010-2#13)(2010-3#2)(2010-4#5)(2010-5#6)(2010-6#2)(2010-8#3)(2011-1#13)(2011-12#3)(2011-2#8)(2011-3#3)(2012-1#6)(2012-11#3)(2012-12#15)(2012-2#17)(2012-3#7)(2013-1#17)(2013-7#4)(2013-8#9)
simultaneously a##2##2##(2008-10#1)(2008-5#1)
simultaneously according to##2##3##(2007-8#1)(2008-10#1)
simultaneously accounts for the##2##4##(1991-7#1)(2010-2#1)
simultaneously acquired##5##2##(2007-12#2)(2008-1#1)(2008-3#1)(2011-1#1)
simultaneously administered vaccines##2##3##(1995-5#1)(2007-11#1)
simultaneously administered##3##2##(1994-5#1)(1995-5#1)(2007-11#1)
simultaneously affect##2##2##(1992-12#1)(2010-9#1)
simultaneously allows##2##2##(2008-10#1)(2008-4#1)
simultaneously amplified##3##2##(2007-11#1)(2008-10#2)
simultaneously amplifies##2##2##(2007-12#1)(2008-9#1)
simultaneously analysed##2##2##(1995-3#1)(2013-1#1)
simultaneously and in##2##3##(2007-12#1)(2008-10#1)
simultaneously and quantitatively##2##3##(2008-11#1)(2010-5#1)
simultaneously and##18##2##(1991-12#1)(1992-11#1)(1994-7#1)(1995-7#1)(2005-8#1)(2007-12#4)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2010-5#1)(2012-2#1)(2013-1#1)
simultaneously applied##2##2##(1996-12#1)(2012-1#1)
simultaneously applying##2##2##(1996-12#1)(2011-2#1)
simultaneously are##3##2##(2007-11#1)(2008-10#1)(2011-1#1)
simultaneously as a##3##3##(2007-11#1)(2008-3#1)(2009-12#1)
simultaneously as##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-12#1)
simultaneously at the##3##3##(2008-7#1)(2011-1#1)(2012-2#1)
simultaneously at##14##2##(1995-4#1)(2006-12#1)(2006-5#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-2#2)
simultaneously be##2##2##(2008-3#1)(2009-5#1)
simultaneously block##2##2##(1992-7#1)(2012-2#1)
simultaneously by the##2##3##(2008-10#2)
simultaneously by use of##5##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
simultaneously by using##2##3##(2007-9#1)(2008-10#1)
simultaneously by##26##2##(1993-4#1)(1993-8#1)(1994-2#2)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#8)(2008-2#1)(2008-3#3)(2008-4#2)(2008-7#1)(2009-5#1)(2011-2#1)
simultaneously compensated##2##2##(1992-11#1)(1995-3#1)
simultaneously decreasing the##2##3##(2007-8#1)(2008-3#1)
simultaneously demonstrate##2##2##(1995-12#1)(2005-8#1)
simultaneously detect##5##2##(2007-8#1)(2008-10#2)(2008-9#1)(2013-8#1)
simultaneously detected in the##2##4##(1994-7#1)(2008-10#1)
simultaneously detected in##3##3##(1994-7#1)(2008-10#1)(2008-4#1)
simultaneously detected##8##2##(1994-7#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-4#2)
simultaneously detects##3##2##(2008-2#1)(2012-3#1)(2013-1#1)
simultaneously determine##7##2##(1996-3#1)(1997-8#1)(2008-10#3)(2008-2#1)(2011-1#1)
simultaneously determined by##5##3##(2007-8#1)(2008-10#4)
simultaneously determined in##5##3##(2008-10#5)
simultaneously determined##15##2##(1993-2#1)(1996-8#1)(2007-8#1)(2008-10#11)(2008-2#1)
simultaneously determining##4##2##(1994-3#1)(2007-1#1)(2008-10#2)
simultaneously develop##2##2##(1994-2#1)(2008-8#1)
simultaneously employs##2##2##(2008-3#1)(2010-8#1)
simultaneously enhancing##2##2##(1994-12#1)(2012-12#1)
simultaneously estimates##2##2##(2008-2#1)(2008-3#1)
simultaneously evaluated##3##2##(1994-7#1)(2006-5#1)(2008-2#1)
simultaneously evaluating##2##2##(2007-12#1)(2010-1#1)
simultaneously examine##2##2##(1990-2#1)(2009-9#1)
simultaneously exposed to##3##3##(1995-12#1)(2005-9#1)(2009-9#1)
simultaneously express##2##2##(1996-12#2)
simultaneously extracted and##2##3##(1990-8#1)(2008-10#1)
simultaneously extracted##4##2##(1990-8#1)(2007-11#1)(2008-10#2)
simultaneously fitted to##2##3##(1997-2#1)(2008-3#1)
simultaneously fitting##2##2##(2008-2#1)(2008-3#1)
simultaneously for all the fractional##2##5##(2007-12#1)(2008-2#1)
simultaneously for##10##2##(1996-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#4)(2008-4#1)
simultaneously from both##2##3##(2008-2#1)(2008-3#1)
simultaneously from the same##2##4##(2007-12#1)(2008-3#1)
simultaneously from the##8##3##(1996-2#1)(1997-7#1)(2007-12#1)(2008-3#3)(2012-12#2)
simultaneously from##19##2##(1991-12#1)(1991-3#1)(1995-5#1)(1996-2#1)(1997-7#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#6)(2010-4#1)(2011-2#1)(2012-12#2)
simultaneously generated##2##2##(2007-12#2)
simultaneously generating##2##2##(2008-1#1)(2008-5#1)
simultaneously imaged##2##2##(2007-10#1)(2009-10#1)
simultaneously images##2##2##(2008-5#1)(2011-1#1)
simultaneously imaging##2##2##(2008-3#2)
simultaneously improves##2##2##(1996-8#1)(2010-12#1)
simultaneously in a single##2##4##(1994-12#1)(2006-6#1)
simultaneously in a##4##3##(1994-12#1)(2006-6#1)(2008-10#1)(2008-3#1)
simultaneously in all##2##3##(1997-7#1)(2007-7#1)
simultaneously in combined dosage form##3##5##(2010-2#1)(2010-3#1)(2010-5#1)
simultaneously in several##2##3##(2007-12#2)
simultaneously in the blood##2##4##(2008-5#1)(2009-2#1)
simultaneously in the same##6##4##(1994-10#1)(1995-5#1)(2008-10#2)(2008-9#1)(2012-2#1)
simultaneously in the##22##3##(1990-2#1)(1992-12#1)(1994-10#1)(1995-5#1)(1996-9#1)(2005-5#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#1)(2008-9#1)(2009-2#2)(2011-1#1)(2012-2#1)(2013-8#1)
simultaneously in two##2##3##(2007-12#2)
simultaneously in##52##2##(1990-2#1)(1992-12#1)(1994-10#1)(1994-12#1)(1995-5#1)(1995-6#1)(1996-8#1)(1996-9#1)(1997-7#1)(2005-10#1)(2005-5#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#5)(2007-7#1)(2007-8#2)(2008-10#6)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#1)(2008-9#1)(2009-12#1)(2009-2#2)(2009-6#2)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
simultaneously increased##4##2##(1996-6#1)(2008-8#1)(2009-4#1)(2009-6#1)
simultaneously infected##3##2##(2008-10#1)(2012-12#2)
simultaneously injected##2##2##(1994-2#1)(2008-10#1)
simultaneously into a##2##3##(2006-12#1)(2008-10#1)
simultaneously into##5##2##(2006-12#1)(2008-10#1)(2008-11#1)(2009-11#1)(2010-8#1)
simultaneously is##2##2##(2007-12#1)(2007-2#1)
simultaneously measure##5##2##(1994-2#1)(2007-12#1)(2008-3#1)(2008-9#2)
simultaneously measured##6##2##(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2011-2#2)
simultaneously minimize the##2##3##(2007-12#1)(2008-2#1)
simultaneously minimize##3##2##(2007-12#1)(2008-2#1)(2013-7#1)
simultaneously monitor##4##2##(1996-12#1)(1997-2#1)(2008-2#1)(2013-1#1)
simultaneously monitored##2##2##(2008-10#2)
simultaneously observed##7##2##(1995-9#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-8#1)
simultaneously obtained##3##2##(2008-10#2)(2008-8#1)
simultaneously on a##4##3##(2008-10#2)(2008-3#1)(2008-7#1)
simultaneously on the##3##3##(1996-1#1)(2008-10#1)(2008-4#1)
simultaneously on##11##2##(1996-1#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#1)(2011-2#1)
simultaneously or sequentially##2##3##(1992-5#1)(2008-7#1)
simultaneously or##3##2##(1992-5#1)(2005-11#1)(2008-7#1)
simultaneously over a##3##3##(2008-2#1)(2008-3#2)
simultaneously over the##2##3##(2007-12#1)(2011-1#1)
simultaneously over##7##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2011-1#1)
simultaneously performed##7##2##(1990-12#1)(1994-3#1)(2007-10#1)(2009-6#1)(2010-12#1)(2013-7#2)
simultaneously phase-matched##2##2##(2007-11#1)(2007-12#1)
simultaneously present in##3##3##(1994-5#1)(2007-8#1)(2008-10#1)
simultaneously present##6##2##(1994-5#1)(2005-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2010-8#1)
simultaneously presented with##2##3##(2009-11#1)(2013-8#1)
simultaneously rather than##2##3##(2007-12#1)(2012-3#1)
simultaneously recorded##14##2##(1991-11#1)(1992-1#1)(1995-11#2)(1997-6#1)(2006-8#1)(2007-10#1)(2007-12#3)(2008-2#2)(2008-3#1)(2010-8#1)
simultaneously several##2##2##(2006-10#1)(2008-7#1)
simultaneously the##12##2##(1995-5#1)(2007-12#3)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2011-12#1)
simultaneously to identify##2##3##(2008-9#1)(2012-3#1)
simultaneously to the same##2##4##(1994-12#1)(1994-2#1)
simultaneously to the##7##3##(1992-2#1)(1994-12#1)(1994-2#1)(1997-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
simultaneously to##19##2##(1992-2#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-7#1)(1997-7#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
simultaneously treated with##3##3##(1993-3#1)(2008-6#1)(2011-2#1)
simultaneously treated##4##2##(1993-3#1)(2006-6#1)(2008-6#1)(2011-2#1)
simultaneously under##2##2##(2006-6#1)(2008-7#1)
simultaneously using##5##2##(1997-5#1)(2007-6#1)(2008-10#2)(2008-3#1)
simultaneously with a##9##3##(1990-8#1)(1992-10#1)(1995-2#1)(1995-6#1)(2008-1#1)(2008-2#3)(2008-3#1)
simultaneously with an##2##3##(1990-12#1)(2008-10#1)
simultaneously with high##2##3##(2007-12#1)(2008-10#1)
simultaneously with one##2##3##(1990-2#1)(2007-11#1)
simultaneously with the##28##3##(1990-4#1)(1991-10#1)(1991-3#1)(1991-7#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-2#1)(1995-5#1)(1995-8#2)(1996-1#1)(2005-11#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#6)(2008-3#2)(2011-1#1)
simultaneously with##94##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-8#1)(1991-10#1)(1991-3#2)(1991-7#1)(1991-8#2)(1992-10#2)(1992-3#3)(1992-6#2)(1992-8#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-2#2)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#3)(1996-1#1)(1996-7#1)(1997-1#1)(1997-8#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#16)(2008-2#4)(2008-3#7)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#2)(2010-7#1)(2011-1#2)(2011-2#2)(2012-7#1)(2013-7#1)
simultaneously within##2##2##(2008-10#1)(2008-4#1)
simultaneously##971##1##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#3)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#2)(1990-8#6)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#4)(1991-5#1)(1991-7#4)(1991-8#3)(1991-9#3)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#5)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#2)(1994-10#2)(1994-12#7)(1994-2#9)(1994-3#4)(1994-4#1)(1994-5#5)(1994-6#1)(1994-7#3)(1994-9#1)(1995-1#3)(1995-11#4)(1995-12#3)(1995-2#3)(1995-3#6)(1995-4#1)(1995-5#8)(1995-6#2)(1995-7#2)(1995-8#5)(1995-9#2)(1996-1#4)(1996-11#1)(1996-12#6)(1996-2#3)(1996-3#3)(1996-5#3)(1996-6#2)(1996-7#2)(1996-8#4)(1996-9#2)(1997-1#2)(1997-2#7)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#3)(1997-8#3)(2004-11#4)(2005-1#1)(2005-10#2)(2005-11#7)(2005-5#1)(2005-8#3)(2005-9#1)(2006-10#7)(2006-11#1)(2006-12#4)(2006-3#1)(2006-4#3)(2006-5#7)(2006-6#6)(2006-7#3)(2006-8#2)(2006-9#1)(2007-1#5)(2007-10#6)(2007-11#25)(2007-12#65)(2007-2#3)(2007-5#2)(2007-6#1)(2007-7#6)(2007-8#13)(2007-9#4)(2008-1#7)(2008-10#142)(2008-11#15)(2008-12#3)(2008-2#63)(2008-3#80)(2008-4#19)(2008-5#12)(2008-6#7)(2008-7#19)(2008-8#12)(2008-9#19)(2009-10#3)(2009-11#2)(2009-12#5)(2009-2#5)(2009-3#1)(2009-4#5)(2009-5#5)(2009-6#4)(2009-7#2)(2009-8#4)(2009-9#2)(2010-1#2)(2010-12#9)(2010-2#5)(2010-3#2)(2010-4#4)(2010-5#2)(2010-6#2)(2010-7#4)(2010-8#6)(2010-9#1)(2011-1#17)(2011-12#1)(2011-2#17)(2012-1#5)(2012-11#2)(2012-12#13)(2012-2#15)(2012-3#8)(2012-7#1)(2013-1#10)(2013-7#6)(2013-8#9)
simvastatin 20 mg daily##2##4##(1997-2#1)(2011-12#1)
simvastatin 20##3##2##(1997-2#1)(2008-5#1)(2011-12#1)
simvastatin and##2##2##(2006-5#1)(2012-2#1)
simvastatin in patients with##2##4##(1994-2#1)(2012-2#1)
simvastatin in##3##2##(1994-2#1)(2008-12#1)(2012-2#1)
simvastatin is##3##2##(1991-1#1)(1991-6#1)(1997-6#1)
simvastatin significantly reduced##2##3##(2011-2#1)(2012-2#1)
simvastatin therapy##2##2##(2013-1#2)
simvastatin was##2##2##(1991-6#1)(2008-4#1)
simvastatin##52##1##(1991-1#3)(1991-12#2)(1991-6#5)(1993-9#1)(1994-2#1)(1997-2#1)(1997-5#1)(1997-6#3)(2006-10#1)(2006-5#3)(2007-11#1)(2008-12#5)(2008-3#2)(2008-4#8)(2008-5#1)(2008-7#2)(2009-5#1)(2011-12#1)(2011-2#3)(2012-2#4)(2013-1#3)
sin##4##1##(2006-2#1)(2008-3#1)(2009-2#1)(2012-2#1)
sinapic acid##4##2##(2004-8#1)(2008-5#1)(2013-1#2)
sinapine analogs##2##2##(2012-3#2)
sinapinic acid##2##2##(2004-8#1)(2008-10#1)
since (i)##3##2##(1990-2#1)(1992-6#1)(1995-6#1)
since 1 year and##2##4##(2013-1#1)(2013-7#1)
since 1 year##3##3##(2007-7#1)(2013-1#1)(2013-7#1)
since 1##5##2##(2007-7#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
since 1906##2##2##(2007-5#1)(2008-3#1)
since 1953##2##2##(2008-7#1)(2012-11#1)
since 1967##3##2##(1990-12#2)(1993-5#1)
since 1969##2##2##(1990-2#1)(1996-8#1)
since 1970 has##2##3##(1990-11#2)
since 1970##8##2##(1990-11#2)(1992-2#1)(1995-3#1)(2007-3#1)(2007-5#1)(2010-8#1)(2013-1#1)
since 1973##3##2##(1991-3#2)(1992-1#1)
since 1974##3##2##(2007-8#1)(2008-10#1)(2008-4#1)
since 1975##4##2##(1990-9#1)(1991-4#1)(1992-2#1)(1997-5#1)
since 1976##2##2##(1992-10#1)(2007-8#1)
since 1977##2##2##(1992-2#1)(1993-3#1)
since 1978##2##2##(1993-9#1)(2006-12#1)
since 1979##4##2##(1991-2#1)(1992-3#1)(1995-2#1)(1997-1#1)
since 1980##9##2##(1992-3#1)(1994-3#1)(1994-9#1)(1997-3#1)(2008-10#2)(2010-8#1)(2012-1#1)(2013-1#1)
since 1981##4##2##(1990-12#1)(1991-1#1)(1996-11#1)(2006-10#1)
since 1983##5##2##(1992-2#1)(1992-3#1)(1993-9#1)(2011-2#2)
since 1984##6##2##(1991-1#1)(1992-2#1)(1993-5#1)(2006-8#3)
since 1985##12##2##(1990-2#2)(1991-3#1)(1991-8#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-9#1)(1996-8#1)(1997-2#1)(1997-3#1)(2008-7#1)
since 1986##6##2##(1990-12#1)(1996-4#1)(2007-11#1)(2007-3#1)(2008-1#1)(2009-3#1)
since 1987##2##2##(1993-3#1)(1995-4#1)
since 1988##4##2##(1992-11#1)(1996-1#1)(1996-12#1)(2008-10#1)
since 1989##3##2##(2008-2#1)(2009-3#1)(2013-1#1)
since 1990##13##2##(1993-5#1)(1994-1#1)(1995-6#1)(1996-2#1)(1997-5#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-12#1)(2011-2#2)(2012-12#1)
since 1991##4##2##(2007-8#1)(2008-1#1)(2008-9#1)(2010-12#1)
since 1992 for##2##3##(2008-1#1)(2008-10#1)
since 1992##11##2##(1996-3#2)(2005-10#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)
since 1993##10##2##(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#3)
since 1994##5##2##(2006-2#1)(2008-1#1)(2009-4#1)(2010-7#1)(2012-3#1)
since 1995##3##2##(2006-11#1)(2007-4#1)(2008-9#1)
since 1996##7##2##(2005-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-12#1)
since 1997 with##2##3##(2006-3#1)(2008-2#1)
since 1997##7##2##(2005-7#1)(2006-3#1)(2007-2#1)(2008-10#1)(2008-12#2)(2008-2#1)
since 1998##8##2##(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-7#1)(2010-5#1)(2011-1#2)
since 1999##8##2##(2007-2#3)(2008-5#2)(2009-3#1)(2010-8#1)(2011-2#1)
since 2 years##3##3##(2007-11#1)(2007-7#1)(2012-2#1)
since 2000##10##2##(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2010-4#1)(2011-2#1)(2013-8#1)
since 2001##5##2##(2005-9#1)(2007-5#1)(2008-10#1)(2008-7#1)(2009-11#1)
since 2002##4##2##(2008-10#1)(2009-6#1)(2009-9#1)(2010-9#1)
since 2003##3##2##(2010-11#1)(2011-1#1)(2011-2#1)
since 2004##6##2##(2007-8#1)(2011-2#1)(2012-3#3)(2013-8#1)
since 2005##5##2##(2008-12#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
since 2006##5##2##(2008-12#1)(2011-2#2)(2011-3#1)(2013-1#1)
since 2007##4##2##(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
since 2008##2##2##(2012-3#1)(2013-7#1)
since 2012##2##2##(2013-8#2)
since 3 years##3##3##(2007-7#1)(2011-12#1)(2012-12#1)
since 3##4##2##(2007-7#1)(2007-8#1)(2011-12#1)(2012-12#1)
since 8##2##2##(1993-11#1)(2013-7#1)
since August##3##2##(1995-6#1)(1996-8#1)(2012-12#1)
since December##3##2##(1996-5#1)(2006-10#1)(2009-9#1)
since I##2##2##(2008-10#1)(2011-1#1)
since January##5##2##(1990-12#1)(1995-12#1)(2006-10#1)(2010-12#1)(2011-2#1)
since June##3##2##(1991-6#1)(2008-3#1)(2008-5#1)
since March##5##2##(1995-2#1)(2008-3#1)(2008-7#1)(2011-1#1)(2013-8#1)
since May##3##2##(1996-11#1)(2010-10#1)(2012-2#1)
since November##3##2##(2007-11#1)(2013-1#2)
since October##2##2##(1996-11#1)(2006-7#1)
since September##3##2##(1991-2#1)(1996-3#1)(2008-2#1)
since WIN##2##2##(1996-6#2)
since World War II##4##4##(1990-12#1)(2006-2#1)(2010-7#1)(2011-1#1)
since a large##2##3##(1996-12#1)(2011-11#1)
since a majority of VA and DoD patients receive a portion of their health care from the private sector##2##19##(2013-1#2)
since a##29##2##(1990-6#1)(1991-12#1)(1994-8#1)(1995-1#1)(1996-12#2)(1996-5#1)(1996-8#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-4#1)(2008-5#1)(2010-12#1)(2011-11#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
since about##2##2##(2007-3#1)(2008-10#1)
since after##2##2##(1991-12#1)(1994-10#1)
since all the##2##3##(2008-10#1)(2011-1#1)
since all##5##2##(1991-8#1)(1995-6#1)(2008-10#1)(2009-12#1)(2011-1#1)
since an##11##2##(1991-9#1)(1996-4#1)(1996-9#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-10#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-7#1)
since ancient times##5##3##(2008-10#1)(2008-5#1)(2008-9#1)(2012-11#1)(2013-1#1)
since animals##2##2##(1991-12#1)(1997-5#1)
since antiquity##3##2##(2006-12#2)(2011-2#1)
since at least two##2##4##(1997-5#1)(2011-2#1)
since at least##5##3##(1993-6#1)(1997-5#1)(2007-8#1)(2008-10#1)(2011-2#1)
since at##6##2##(1993-6#1)(1997-5#1)(2007-8#1)(2008-10#1)(2008-6#1)(2011-2#1)
since been##16##2##(1990-11#1)(1991-3#1)(1992-2#1)(1996-3#1)(2005-12#1)(2006-10#1)(2007-10#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-3#1)(2013-8#1)
since birth##15##2##(2007-5#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-12#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-3#1)(2010-6#2)(2013-7#2)
since both of##2##3##(1990-5#1)(2010-5#1)
since both##9##2##(1990-5#1)(1994-2#1)(1994-8#1)(1995-3#1)(1995-5#1)(2007-12#1)(2008-10#1)(2010-5#1)(2013-1#1)
since cell##2##2##(2005-12#1)(2009-6#1)
since childhood##8##2##(2005-12#1)(2007-2#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)
since day##2##2##(2009-2#1)(2011-12#1)
since diagnosis##6##2##(1993-9#1)(1996-2#1)(2008-9#2)(2011-2#1)(2013-1#1)
since disease##2##2##(1995-2#1)(2008-10#1)
since each##3##2##(1995-8#1)(1996-9#1)(2008-2#1)
since early childhood##5##3##(1995-4#1)(2006-8#1)(2007-7#2)(2008-9#1)
since early##11##2##(1993-2#1)(1994-10#1)(1995-4#1)(2006-8#1)(2007-11#1)(2007-7#2)(2008-4#1)(2008-9#1)(2010-8#1)(2012-2#1)
since environmental##2##2##(2008-7#1)(2010-11#1)
since even##2##2##(1997-3#1)(2005-8#1)
since evolved##2##2##(2008-10#1)(2011-1#1)
since for##2##2##(2007-10#1)(2008-9#1)
since he was##3##3##(1990-5#1)(2007-6#1)(2011-2#1)
since high##2##2##(1994-12#1)(2008-3#1)
since his##2##2##(2007-8#1)(2013-1#1)
since human##2##2##(2006-10#1)(2008-1#1)
since in the##3##3##(1990-9#1)(1992-9#1)(1995-11#1)
since in this##3##3##(1994-8#1)(2008-3#2)
since in##14##2##(1990-9#1)(1991-7#1)(1992-8#1)(1992-9#2)(1993-10#1)(1993-12#1)(1994-8#1)(1995-11#1)(1996-5#1)(2008-3#2)(2009-8#1)(2010-12#1)
since increased##2##2##(1996-11#1)(2006-10#1)
since inhibition##2##2##(1996-10#1)(2005-11#1)
since initial##2##2##(2008-3#1)(2013-8#1)
since it can also##2##4##(2008-8#1)(2012-12#1)
since it can be##5##4##(1992-2#1)(1994-9#1)(2008-3#1)(2013-1#1)(2013-8#1)
since it can##12##3##(1992-2#1)(1994-9#1)(1996-7#1)(1997-3#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2012-12#1)(2013-1#2)(2013-8#1)
since it could##2##3##(2009-5#1)(2013-1#1)
since it did not##2##4##(2008-6#1)(2009-6#1)
since it does not require##4##5##(2004-12#1)(2007-11#1)(2008-3#1)(2009-7#1)
since it does not##7##4##(1995-6#1)(2004-12#2)(2007-11#1)(2008-2#1)(2008-3#1)(2009-7#1)
since it has a##2##4##(1996-6#1)(2006-9#1)
since it has been##4##4##(2006-9#1)(2008-1#1)(2008-10#1)(2010-4#1)
since it has##9##3##(1990-10#1)(1996-6#1)(2006-9#2)(2008-1#1)(2008-10#1)(2008-8#1)(2010-4#1)(2013-1#1)
since it is a##3##4##(1997-8#1)(2007-7#1)(2010-7#1)
since it is an##2##4##(2006-10#1)(2007-2#1)
since it is known that##2##5##(1994-5#1)(2012-2#1)
since it is likely##2##4##(2007-11#1)(2008-4#1)
since it is the##4##4##(1991-10#1)(2006-10#1)(2008-8#1)(2008-9#1)
since it is##38##3##(1990-8#1)(1991-10#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-3#1)(1994-12#2)(1994-3#1)(1994-5#1)(1996-9#1)(1997-8#2)(2005-12#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-10#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
since it lacks##2##3##(1994-8#1)(2010-10#1)
since it may be##2##4##(2010-7#1)(2013-1#1)
since it may##9##3##(1995-5#1)(1996-9#1)(2004-4#1)(2007-5#1)(2008-5#2)(2010-7#1)(2010-9#1)(2013-1#1)
since it provides##2##3##(2008-10#2)
since it requires##2##3##(1990-4#1)(2008-10#1)
since it was first described##2##5##(1992-2#1)(2011-12#1)
since it was first##3##4##(1992-2#1)(2009-7#1)(2011-12#1)
since it was introduced##2##4##(2008-11#1)(2010-12#1)
since it was not accompanied by##2##6##(1992-8#1)(1994-12#1)
since it was not##3##4##(1992-8#1)(1994-12#1)(2006-12#1)
since it was reversed by##2##5##(1991-8#1)(1994-2#1)
since it was reversed##3##4##(1991-8#1)(1994-2#1)(1997-7#1)
since it was##25##3##(1991-8#1)(1992-2#1)(1992-8#1)(1992-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-7#1)(2010-12#1)(2011-12#1)
since it##153##2##(1990-10#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-3#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-2#2)(1992-8#1)(1992-9#2)(1993-3#2)(1993-8#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#2)(1995-6#3)(1996-6#1)(1996-7#1)(1996-9#3)(1997-1#2)(1997-3#2)(1997-7#1)(1997-8#4)(2004-12#2)(2004-4#1)(2005-12#1)(2006-10#3)(2006-12#3)(2006-2#1)(2006-9#3)(2007-11#3)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#13)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-5#3)(2009-6#2)(2009-7#2)(2010-10#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#3)(2010-9#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#2)
since its activity##2##3##(1991-2#1)(2008-5#1)
since its discovery##2##3##(2008-8#1)(2009-3#1)
since its first##5##3##(1990-9#1)(1995-12#1)(2008-10#1)(2011-1#1)(2012-12#1)
since its inception in##3##4##(1995-12#1)(2005-7#1)(2010-8#1)
since its inception##8##3##(1995-12#1)(1996-3#1)(2005-7#1)(2008-1#1)(2008-3#1)(2008-6#1)(2010-8#1)(2011-2#1)
since its introduction##2##3##(2010-2#1)(2013-7#1)
since its launch in##2##4##(2007-2#1)(2008-3#1)
since its##42##2##(1990-3#1)(1990-9#1)(1991-2#1)(1992-8#1)(1995-12#2)(1996-3#1)(1996-5#1)(1997-2#1)(2005-11#1)(2005-7#1)(2006-6#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#2)(2013-7#2)
since joining managed care panels##3##5##(2005-7#3)
since last##5##2##(2008-10#1)(2011-1#1)(2012-11#3)
since long##4##2##(2008-10#1)(2008-11#1)(2012-2#1)(2012-3#1)
since many of the##2##4##(1996-3#1)(2008-7#1)
since many of##3##3##(1994-2#1)(1996-3#1)(2008-7#1)
since many years##2##3##(1990-9#1)(1991-4#1)
since many##14##2##(1990-9#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-6#1)(1994-2#1)(1996-3#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#2)
since more##3##2##(1994-3#1)(2008-4#1)(2011-2#1)
since most of##2##3##(2008-10#1)(2008-4#1)
since most##9##2##(1992-2#1)(1996-3#1)(2005-11#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2012-3#1)(2013-1#1)
since neither##4##2##(1992-1#1)(1994-11#1)(1994-5#1)(1995-12#1)
since new##2##2##(1990-11#1)(2011-2#1)
since no other##4##3##(2007-7#1)(2009-2#1)(2009-6#1)(2012-12#1)
since no statistical differences were found after applying the paired t-test at the 95%##2##14##(2008-10#2)
since no##20##2##(1990-12#1)(1990-4#1)(1991-2#1)(1991-7#1)(1991-8#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-9#1)(1996-5#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-5#2)(2009-2#1)(2009-6#1)(2012-12#2)
since one##7##2##(1996-7#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#1)(2013-1#1)
since only patients##2##3##(1990-8#1)(1991-6#1)
since only the##2##3##(1994-6#1)(1996-10#1)
since only##10##2##(1990-4#2)(1990-8#1)(1991-6#2)(1994-6#1)(1996-10#1)(1996-8#1)(2006-7#1)(2013-8#1)
since other##3##2##(1996-7#1)(2006-5#1)(2011-2#1)
since oxidative##2##2##(1994-9#1)(2013-1#1)
since patients##2##2##(2006-2#1)(2006-9#1)
since recent##2##2##(2011-2#1)(2012-12#1)
since reduction of##2##3##(1995-2#1)(2008-11#1)
since remained##2##2##(1996-11#1)(2013-8#1)
since serum##2##2##(2011-1#1)(2011-12#1)
since several##4##2##(2005-11#1)(2012-12#1)(2013-1#2)
since she##2##2##(2010-9#1)(2011-2#1)
since significant##2##2##(1991-4#1)(1996-3#1)
since similar##3##2##(1990-8#1)(1995-1#1)(1995-8#1)
since six##2##2##(2011-12#1)(2013-1#1)
since some of the##2##4##(2005-10#1)(2011-1#1)
since some of##3##3##(1994-3#1)(2005-10#1)(2011-1#1)
since some##5##2##(1994-3#1)(2005-10#1)(2008-11#1)(2008-2#1)(2011-1#1)
since statistical estimation of models for such data is prone to over-fitting##2##12##(2013-1#2)
since such a##2##3##(1991-1#1)(1991-9#1)
since such##6##2##(1991-1#1)(1991-9#1)(1994-11#1)(1995-3#1)(1996-10#1)(2008-7#1)
since surgical##3##2##(2007-11#2)(2011-2#1)
since that time##5##3##(1996-3#1)(2005-8#1)(2007-11#1)(2008-1#1)(2008-12#1)
since that##7##2##(1994-10#1)(1996-3#1)(2005-8#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-3#1)
since the 1920s##2##3##(2008-1#1)(2009-10#1)
since the 1950s##2##3##(1994-6#1)(2008-10#1)
since the 1960s##2##3##(2010-10#1)(2010-5#1)
since the 1970s##5##3##(1994-12#1)(1996-2#1)(2008-10#3)
since the 1980s##2##3##(2006-10#1)(2008-5#1)
since the 1990s##5##3##(2010-12#1)(2010-8#1)(2013-8#3)
since the 19th century##2##4##(2007-12#1)(2008-8#1)
since the 19th##3##3##(2007-12#1)(2008-8#1)(2013-1#1)
since the WHO##2##3##(2006-12#2)
since the advent of##3##4##(2005-10#1)(2009-7#1)(2012-3#1)
since the age of##4##4##(2007-2#1)(2007-7#1)(2010-12#1)(2012-11#1)
since the apparent##2##3##(1990-11#1)(2008-10#1)
since the association##2##3##(1990-10#1)(2011-2#1)
since the availability of##3##4##(2006-7#1)(2006-8#1)(2008-5#1)
since the beginning of the 19th century##2##7##(2005-11#1)(2009-2#1)
since the beginning of the##8##5##(1990-3#1)(1991-6#1)(1992-5#1)(2005-11#1)(2008-1#1)(2008-9#1)(2009-2#2)
since the beginning of##12##4##(1990-3#1)(1991-6#1)(1992-2#1)(1992-5#1)(2005-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-2#2)
since the cloning##2##3##(2007-11#1)(2008-4#1)
since the discovery of##4##4##(1996-5#1)(2008-1#1)(2008-4#1)(2009-6#1)
since the discovery##5##3##(1996-5#1)(2008-1#1)(2008-4#1)(2009-6#1)(2010-3#1)
since the disease##2##3##(2007-9#1)(2008-10#1)
since the earliest##2##3##(1995-12#1)(2010-12#1)
since the early 1970s##5##4##(1995-5#1)(2005-7#1)(2007-11#1)(2007-12#1)(2013-8#1)
since the early 1980s and##2##5##(1997-6#1)(2005-7#1)
since the early 1980s##6##4##(1997-6#1)(2005-10#1)(2005-7#1)(2010-1#1)(2010-7#1)(2012-12#1)
since the early 1990s##3##4##(2008-10#1)(2012-1#1)(2013-1#1)
since the early##22##3##(1992-8#1)(1995-4#1)(1995-5#1)(1997-6#1)(2005-10#1)(2005-7#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-1#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
since the end of##4##4##(2007-11#1)(2009-2#1)(2011-2#1)(2012-11#1)
since the enzyme##2##3##(1990-12#1)(1993-8#1)
since the first##14##3##(1992-5#1)(1993-6#1)(1995-4#1)(1996-4#1)(1997-8#1)(2006-10#1)(2006-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2013-1#1)(2013-8#2)
since the founding of the##3##5##(1997-2#1)(2008-7#1)(2011-2#1)
since the identification of##2##4##(2008-8#1)(2011-1#1)
since the implementation of##2##4##(1990-12#1)(1992-2#1)
since the inception of the##3##5##(2007-10#1)(2007-8#1)(2011-2#1)
since the inception of##6##4##(1995-12#1)(2006-12#1)(2007-10#1)(2007-2#1)(2007-8#1)(2011-2#1)
since the incidence of##2##4##(1991-5#1)(1994-3#1)
since the incidence##3##3##(1991-5#1)(1994-3#1)(2008-9#1)
since the initial##4##3##(2006-5#1)(2008-10#1)(2008-2#1)(2012-2#1)
since the initiation of##2##4##(2007-12#1)(2007-7#1)
since the introduction of the##3##5##(1997-5#1)(2010-8#1)(2011-1#1)
since the introduction of##19##4##(1990-4#1)(1991-9#1)(1993-2#1)(1997-5#1)(2006-10#1)(2006-12#1)(2006-8#2)(2006-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)
since the introduction##20##3##(1990-4#1)(1991-9#1)(1993-2#1)(1997-5#1)(2006-10#2)(2006-12#1)(2006-8#2)(2006-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)
since the last##4##3##(1991-12#1)(2006-10#1)(2006-5#1)(2013-1#1)
since the late 1970s##2##4##(1995-3#1)(2008-4#1)
since the late 1990s##4##4##(2005-10#1)(2008-10#1)(2010-2#1)(2013-1#1)
since the late 19th century##2##5##(1993-12#1)(2013-7#1)
since the late##15##3##(1993-12#1)(1995-3#1)(2005-10#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-2#1)(2010-2#1)(2010-8#1)(2011-2#1)(2011-7#1)(2012-12#1)(2013-1#1)(2013-7#1)
since the latter is##2##4##(1990-3#1)(2008-10#1)
since the latter##6##3##(1990-3#1)(1992-4#1)(1995-1#1)(1996-12#1)(1997-7#1)(2008-10#1)
since the mid##2##3##(2008-7#1)(2013-7#1)
since the mid-1990s##3##3##(2006-7#1)(2011-12#1)(2012-3#1)
since the only##3##3##(1993-5#1)(1993-7#1)(2008-11#1)
since the onset of the##2##5##(1996-5#1)(2008-9#1)
since the original##3##3##(2008-11#1)(2008-12#1)(2012-3#1)
since the patient was##3##4##(2011-2#1)(2013-1#2)
since the presence of##2##4##(1995-3#1)(2006-10#1)
since the publication of the##2##5##(2004-1#1)(2011-1#1)
since the publication of##4##4##(2004-1#2)(2010-8#1)(2011-1#1)
since the relative##3##3##(1992-11#1)(1992-9#1)(1994-12#1)
since the remaining##2##3##(1994-5#1)(2011-2#1)
since the resulting##2##3##(1994-8#1)(2010-7#1)
since the results##2##3##(1994-2#1)(2008-11#1)
since the second##2##3##(1996-6#1)(2008-4#1)
since the seventeenth century##2##4##(2009-7#1)(2010-1#1)
since the start of the##3##5##(2007-2#1)(2007-3#1)(2012-12#1)
since the start of##5##4##(2004-2#1)(2005-1#1)(2007-2#1)(2007-3#1)(2012-12#1)
since the time##2##3##(1996-1#1)(2007-7#1)
since the two##2##3##(1991-8#1)(2008-3#1)
since the use of##2##4##(1997-3#1)(2008-6#1)
since the widespread use of##2##5##(2008-7#2)
since the widespread##3##3##(2008-7#2)(2010-12#1)
since the##481##2##(1990-1#1)(1990-10#2)(1990-11#6)(1990-12#4)(1990-2#2)(1990-3#6)(1990-4#1)(1990-8#2)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#4)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#2)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#3)(1992-9#3)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-4#1)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#4)(1995-2#2)(1995-3#3)(1995-4#3)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-4#1)(1996-5#4)(1996-6#4)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#2)(2004-1#2)(2004-12#1)(2004-2#1)(2004-4#1)(2005-1#1)(2005-10#4)(2005-11#4)(2005-7#2)(2005-8#1)(2005-9#2)(2006-10#16)(2006-11#1)(2006-12#7)(2006-2#1)(2006-5#2)(2006-6#2)(2006-7#3)(2006-8#6)(2006-9#1)(2007-10#3)(2007-11#10)(2007-12#5)(2007-2#5)(2007-3#1)(2007-4#1)(2007-5#3)(2007-7#4)(2007-8#8)(2007-9#2)(2008-1#8)(2008-10#37)(2008-11#7)(2008-12#3)(2008-2#6)(2008-3#8)(2008-4#8)(2008-5#9)(2008-6#5)(2008-7#8)(2008-8#5)(2008-9#5)(2009-10#2)(2009-2#4)(2009-3#3)(2009-4#5)(2009-6#4)(2009-7#2)(2009-8#3)(2010-1#3)(2010-10#3)(2010-12#7)(2010-2#3)(2010-3#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#6)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#17)(2011-7#1)(2012-1#2)(2012-11#2)(2012-12#7)(2012-2#6)(2012-3#8)(2013-1#8)(2013-7#4)(2013-8#8)
since their initial description##2##4##(2008-11#1)(2012-12#1)
since their introduction##3##3##(2007-11#1)(2007-12#1)(2009-4#1)
since their##20##2##(1993-1#1)(1994-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-5#2)(2012-12#2)(2012-3#1)
since then many##2##3##(2007-5#1)(2012-12#1)
since then##14##2##(1991-3#1)(1991-5#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-5#2)(2008-10#2)(2008-12#1)(2012-12#2)(2012-2#1)(2013-7#1)
since there are few##2##4##(1994-3#1)(2007-11#1)
since there are##7##3##(1994-3#1)(1995-5#1)(1997-8#1)(2006-2#1)(2007-11#1)(2011-2#1)(2012-2#1)
since there is an##3##4##(1995-7#1)(2006-6#1)(2010-2#1)
since there is##4##3##(1993-1#1)(1995-7#1)(2006-6#1)(2010-2#1)
since there was no##2##4##(1996-6#1)(2007-7#1)
since there was##4##3##(1990-11#1)(1996-6#1)(2007-1#1)(2007-7#1)
since there##16##2##(1990-11#1)(1993-1#1)(1994-3#1)(1995-5#1)(1995-7#1)(1996-6#1)(1997-8#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-10#1)(2010-2#1)(2011-2#1)(2012-2#1)
since these are##2##3##(2008-10#2)
since these cells##3##3##(1996-5#1)(2008-4#1)(2009-10#1)
since these compounds##2##3##(1996-8#1)(2008-10#1)
since these diseases have##2##4##(2011-2#1)(2012-2#1)
since these two##2##3##(2007-12#1)(2013-1#1)
since these variables##2##3##(1993-1#1)(2013-1#1)
since these##32##2##(1990-8#1)(1991-2#1)(1991-6#1)(1992-10#1)(1992-3#1)(1993-1#1)(1995-1#1)(1995-12#1)(1996-5#1)(1996-8#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
since they act##2##3##(1996-12#1)(2008-7#1)
since they are##14##3##(1991-8#1)(1994-11#1)(1994-9#1)(2004-4#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-6#1)(2009-2#1)(2011-1#2)(2012-3#1)
since they can be##2##4##(2004-9#1)(2009-7#1)
since they can##3##3##(2004-9#1)(2008-4#1)(2009-7#1)
since they do not##4##4##(1991-4#1)(1994-9#1)(1997-1#1)(2008-12#1)
since they exhibit##2##3##(2008-11#1)(2013-1#1)
since they have been##2##4##(1990-12#1)(2007-12#1)
since they have to correct the##2##6##(2008-2#2)
since they have to##3##4##(1997-6#1)(2008-2#2)
since they have##9##3##(1990-12#1)(1991-5#1)(1997-6#1)(2007-12#1)(2008-2#2)(2009-8#1)(2010-11#1)(2010-3#1)
since they may##4##3##(1990-5#1)(1992-1#1)(1992-6#1)(1997-6#1)
since they provide the##2##4##(1996-10#1)(2010-9#1)
since they provide##3##3##(1996-10#1)(2008-10#1)(2010-9#1)
since they were##6##3##(1995-1#1)(1995-3#1)(1996-11#1)(2007-3#1)(2007-9#1)(2008-11#1)
since they##79##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#2)(1994-11#1)(1994-3#2)(1994-4#1)(1994-9#2)(1995-1#1)(1995-3#1)(1996-10#1)(1996-11#1)(1996-12#1)(1997-1#2)(1997-6#2)(2004-4#1)(2004-9#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#2)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-3#1)(2013-1#1)
since this is a##2##4##(1994-3#1)(2007-11#1)
since this is##6##3##(1994-3#1)(1997-1#1)(2007-11#1)(2007-8#1)(2008-10#2)
since this may##2##3##(1996-6#1)(2007-3#1)
since this procedure##2##3##(1997-2#1)(2010-6#1)
since this technique##2##3##(1990-5#1)(2011-2#1)
since this was##2##3##(1997-4#1)(2008-10#1)
since this##42##2##(1990-5#1)(1990-7#1)(1991-10#1)(1991-5#1)(1992-5#1)(1993-3#1)(1993-7#2)(1994-3#1)(1995-2#1)(1995-9#1)(1996-4#1)(1996-6#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2005-10#1)(2005-6#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-6#1)(2011-1#1)(2011-2#3)(2013-1#1)
since those##2##2##(1992-7#1)(2011-2#1)
since trauma##2##2##(2008-7#1)(2010-7#1)
since two##2##2##(2008-5#1)(2013-8#1)
since under the##2##3##(1992-9#1)(2010-7#1)
since we##7##2##(1990-12#1)(1991-4#1)(1994-2#1)(1996-4#1)(1997-3#1)(2008-10#1)(2009-8#1)
since when the##2##3##(2008-7#1)(2009-2#1)
since##1934##1##(1990-1#1)(1990-10#5)(1990-11#19)(1990-12#17)(1990-2#6)(1990-3#8)(1990-4#7)(1990-5#9)(1990-6#3)(1990-7#6)(1990-8#10)(1990-9#10)(1991-1#3)(1991-10#4)(1991-11#2)(1991-12#13)(1991-2#8)(1991-3#9)(1991-4#6)(1991-5#7)(1991-6#11)(1991-7#4)(1991-8#9)(1991-9#5)(1992-1#4)(1992-10#7)(1992-11#5)(1992-12#4)(1992-2#14)(1992-3#13)(1992-4#4)(1992-5#6)(1992-6#8)(1992-7#2)(1992-8#11)(1992-9#10)(1993-1#4)(1993-10#2)(1993-11#6)(1993-12#7)(1993-2#6)(1993-3#8)(1993-5#4)(1993-6#5)(1993-7#4)(1993-8#3)(1993-9#7)(1994-1#2)(1994-10#5)(1994-11#3)(1994-12#10)(1994-2#7)(1994-3#16)(1994-4#2)(1994-5#7)(1994-6#8)(1994-8#15)(1994-9#10)(1995-1#13)(1995-10#3)(1995-11#2)(1995-12#14)(1995-2#10)(1995-3#12)(1995-4#6)(1995-5#7)(1995-6#11)(1995-7#2)(1995-8#9)(1995-9#3)(1996-1#4)(1996-10#6)(1996-11#9)(1996-12#7)(1996-2#5)(1996-3#10)(1996-4#7)(1996-5#12)(1996-6#15)(1996-7#8)(1996-8#12)(1996-9#7)(1997-1#9)(1997-2#10)(1997-3#9)(1997-4#6)(1997-5#8)(1997-6#8)(1997-7#7)(1997-8#9)(2004-1#2)(2004-12#5)(2004-2#1)(2004-4#3)(2004-7#1)(2004-9#1)(2005-1#1)(2005-10#7)(2005-11#9)(2005-12#4)(2005-6#1)(2005-7#8)(2005-8#4)(2005-9#4)(2006-1#3)(2006-10#34)(2006-11#4)(2006-12#15)(2006-2#8)(2006-3#1)(2006-5#4)(2006-6#8)(2006-7#8)(2006-8#14)(2006-9#6)(2007-1#2)(2007-10#8)(2007-11#32)(2007-12#19)(2007-2#18)(2007-3#9)(2007-4#5)(2007-5#14)(2007-6#2)(2007-7#25)(2007-8#28)(2007-9#4)(2008-1#33)(2008-10#135)(2008-11#25)(2008-12#16)(2008-2#25)(2008-3#28)(2008-4#38)(2008-5#41)(2008-6#18)(2008-7#36)(2008-8#21)(2008-9#23)(2009-10#4)(2009-11#1)(2009-12#5)(2009-2#12)(2009-3#10)(2009-4#10)(2009-5#4)(2009-6#11)(2009-7#7)(2009-8#14)(2009-9#6)(2010-1#6)(2010-10#10)(2010-11#6)(2010-12#22)(2010-2#6)(2010-3#11)(2010-4#4)(2010-5#11)(2010-6#4)(2010-7#11)(2010-8#15)(2010-9#7)(2011-1#31)(2011-11#1)(2011-12#7)(2011-2#65)(2011-3#4)(2011-7#1)(2012-1#4)(2012-11#11)(2012-12#26)(2012-2#25)(2012-3#25)(2013-1#59)(2013-7#17)(2013-8#29)
sincere##5##1##(1992-2#1)(1995-11#1)(2008-11#1)(2009-2#1)(2009-4#1)
sincerely##2##1##(2005-7#1)(2013-8#1)
sindbis##3##1##(1997-8#2)(2013-1#1)
sine and##2##2##(2007-12#1)(2008-3#1)
sine oculis##4##2##(2007-12#4)
sine qua non##3##3##(2006-12#1)(2007-4#1)(2008-1#1)
sine wave##7##2##(1991-1#1)(2006-12#3)(2007-1#1)(2011-2#2)
sine##25##1##(1991-1#1)(1993-2#1)(2004-4#1)(2006-10#2)(2006-12#4)(2007-1#1)(2007-12#6)(2007-4#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-3#2)(2011-2#2)
sinefungin##5##1##(1995-8#3)(2008-7#2)
sinensis and##2##2##(2010-4#1)(2013-8#1)
sinensis##32##1##(1993-3#2)(1997-8#1)(2005-11#2)(2007-1#3)(2007-6#1)(2008-10#2)(2008-6#2)(2008-7#3)(2008-8#2)(2010-4#5)(2011-12#4)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
sinensis)##9##1##(2008-10#7)(2010-4#1)(2012-12#1)
sinensis]##2##1##(2012-3#1)(2013-8#1)
sing##5##1##(1991-3#1)(1991-8#1)(2008-2#1)(2008-8#1)(2013-8#1)
singers##3##1##(2009-2#3)
singing males##2##2##(2008-8#2)
singing##7##1##(1990-5#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#1)
single African##2##2##(1994-3#2)
single BK(Ca)##2##2##(1996-12#2)
single Cys##4##2##(1994-11#1)(1994-5#2)(1995-6#1)
single DNA molecule##2##3##(2008-10#1)(2008-12#1)
single DNA molecules##3##3##(2006-10#1)(2006-2#1)(2008-9#1)
single DNA##10##2##(1993-11#1)(1995-6#1)(1995-8#1)(2006-10#1)(2006-2#1)(2008-10#2)(2008-12#1)(2008-9#2)
single G##4##2##(1990-5#1)(1990-8#1)(1991-7#2)
single GST-P##2##2##(1993-7#2)
single IV##2##2##(1996-9#1)(2012-2#1)
single P##4##2##(2008-10#4)
single QTL##3##2##(2008-10#2)(2012-3#1)
single RNA##5##2##(1991-8#1)(1996-10#1)(2007-12#1)(2008-7#1)(2009-3#1)
single T##3##2##(1990-12#1)(1991-12#1)(1994-3#1)
single U##2##2##(2008-10#1)(2011-2#1)
single academic##2##2##(2007-10#1)(2010-12#1)
single access retroperitoneoscopic adrenalectomy##2##4##(2012-12#2)
single access retroperitoneoscopic##4##3##(2012-12#4)
single access##5##2##(2012-12#4)(2012-2#1)
single administration of##9##3##(1990-5#1)(1990-7#1)(1991-2#1)(1995-12#1)(1995-3#1)(1997-7#1)(2007-7#1)(2010-12#1)(2012-2#1)
single administration##13##2##(1990-5#1)(1990-7#1)(1991-2#1)(1995-12#1)(1995-3#3)(1997-7#1)(2007-7#1)(2010-12#1)(2012-2#2)(2013-1#1)
single agent and in##3##4##(2006-6#1)(2009-8#1)(2013-8#1)
single agent in pretreated##2##4##(1991-6#1)(1994-8#1)
single agent in##5##3##(1991-6#2)(1994-8#2)(2008-5#1)
single agent or combination##2##4##(1993-5#1)(2010-4#1)
single agent##29##2##(1991-6#2)(1993-5#1)(1994-8#3)(2004-11#1)(2005-7#1)(2005-8#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-12#1)(2009-3#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-8#1)
single agents or##3##3##(2007-10#1)(2007-5#1)(2008-5#1)
single agents##8##2##(2007-10#1)(2007-5#1)(2008-10#1)(2008-5#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-6#1)
single alanine##2##2##(1992-6#1)(1996-7#1)
single amino acid change in the##2##6##(2008-10#1)(2012-3#1)
single amino acid change##4##4##(1995-2#1)(1997-2#1)(2008-10#1)(2012-3#1)
single amino acid mutations##2##4##(1997-2#1)(2008-10#1)
single amino acid of the##2##5##(1994-12#2)
single amino acid substitution in##5##5##(1990-11#1)(1992-12#1)(1994-9#1)(1995-8#1)(2008-10#1)
single amino acid substitution##12##4##(1990-11#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-12#1)(1994-9#2)(1995-8#1)(1996-7#1)(2008-10#1)(2008-8#1)
single amino acid substitutions in the##2##6##(1994-2#1)(1995-1#1)
single amino acid substitutions in##3##5##(1994-2#1)(1995-1#2)
single amino acid substitutions##7##4##(1994-2#2)(1994-5#1)(1995-1#2)(1996-8#1)(2007-11#1)
single amino acid##48##3##(1990-11#1)(1990-12#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-4#2)(1991-5#1)(1991-8#2)(1992-12#1)(1993-11#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-9#2)(1995-1#2)(1995-2#2)(1995-3#2)(1995-8#1)(1996-7#2)(1996-8#1)(1997-2#2)(1997-4#3)(1997-5#1)(2007-11#1)(2008-10#3)(2008-8#2)(2009-9#1)(2012-12#1)(2012-3#1)
single amino##49##2##(1990-11#1)(1990-12#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-4#2)(1991-5#1)(1991-8#2)(1992-12#1)(1993-11#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-9#2)(1995-1#2)(1995-2#2)(1995-3#2)(1995-8#1)(1996-7#2)(1996-8#1)(1997-2#2)(1997-4#3)(1997-5#1)(2007-11#1)(2008-10#4)(2008-8#2)(2009-9#1)(2012-12#1)(2012-3#1)
single amino-acid substitution in the##3##5##(1991-11#1)(1992-4#1)(1996-10#1)
single amygdaloid neurons##2##3##(1992-7#2)
single amygdaloid##3##2##(1992-7#3)
single analysis##6##2##(1990-8#1)(1994-9#1)(1997-3#1)(2008-10#1)(2009-11#1)(2012-12#1)
single analytical##3##2##(2007-12#1)(2012-12#1)(2012-2#1)
single ancestral##2##2##(2007-11#1)(2008-8#1)
single and combined##3##3##(1991-12#1)(1993-3#1)(2011-1#1)
single and double stranded##2##4##(1990-5#1)(2006-2#1)
single and double##9##3##(1990-5#1)(1990-7#1)(1991-9#1)(1995-1#1)(2006-2#1)(2007-1#1)(2007-12#1)(2008-2#1)(2013-8#1)
single and double-stranded##2##3##(1990-10#1)(1990-7#1)
single and dual##4##3##(1997-2#1)(2011-1#1)(2013-1#1)(2013-8#1)
single and mixed##5##3##(1996-12#1)(2008-10#1)(2008-12#1)(2013-1#1)(2013-8#1)
single and multiple turnover##2##4##(1994-9#1)(1996-7#1)
single and multiple##25##3##(1990-3#1)(1990-9#1)(1992-8#1)(1994-3#1)(1994-9#1)(1996-7#1)(1996-8#1)(1997-7#1)(2006-11#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-12#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-12#1)(2013-7#1)
single and repeated##4##3##(1994-2#1)(1997-8#1)(2012-1#1)(2013-1#1)
single and triple-helical strands of##2##5##(2011-1#2)
single and two##2##3##(1991-8#1)(2010-12#1)
single and##79##2##(1990-10#1)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-8#1)(1993-1#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-11#1)(2006-2#1)(2007-1#2)(2007-10#2)(2007-12#5)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2010-12#2)(2011-1#5)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#3)
single antibody-secreting cells##2##3##(2008-4#2)
single antigen##2##2##(2008-5#1)(2011-1#1)
single antimicrobial intervention##2##3##(2010-4#2)
single application of##10##3##(1990-6#1)(2006-5#1)(2007-3#1)(2008-10#6)(2013-1#1)
single application##14##2##(1990-6#1)(1992-4#1)(2006-5#1)(2007-3#1)(2008-10#8)(2008-4#1)(2013-1#1)
single approach is##2##3##(1994-12#1)(2008-7#1)
single approach to##3##3##(2007-8#1)(2008-4#1)(2013-8#1)
single approach##7##2##(1994-12#1)(2007-8#1)(2007-9#1)(2008-4#1)(2008-7#1)(2012-3#1)(2013-8#1)
single asparagine##2##2##(1992-6#1)(1995-4#1)
single assay##4##2##(1991-5#1)(1992-3#1)(2008-10#2)
single astrocytes##2##2##(1994-3#1)(1994-6#1)
single atoms##3##2##(1991-11#1)(2007-11#1)(2008-10#1)
single axon##2##2##(1991-3#1)(1995-6#1)
single bacterial##3##2##(1995-2#1)(2006-12#1)(2008-10#1)
single band in##4##3##(1990-11#1)(1993-2#1)(1996-5#1)(2008-10#1)
single band##37##2##(1990-11#2)(1990-2#2)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-7#2)(1992-8#2)(1993-2#2)(1993-3#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#2)(1996-10#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-10#1)(2008-10#2)
single base change##2##3##(1990-5#1)(1990-6#1)
single base deletion##4##3##(1992-8#3)(1997-4#1)
single base pair mutation##2##4##(2008-10#2)
single base pair##10##3##(1990-5#1)(1991-11#1)(1992-2#1)(1993-6#1)(2005-8#1)(2007-10#1)(2007-7#1)(2008-10#2)(2011-2#1)
single base substitution##3##3##(1992-4#1)(1993-3#1)(2008-1#1)
single base##25##2##(1990-5#2)(1990-6#1)(1991-11#1)(1991-12#1)(1992-2#1)(1992-4#1)(1992-8#3)(1993-3#1)(1993-6#1)(1997-4#1)(1997-7#1)(2004-1#1)(2005-8#1)(2006-6#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2011-2#1)
single base-pair transition##2##3##(1990-5#2)
single base-pair##4##2##(1990-5#2)(1995-5#1)(2008-5#1)
single bead string##3##3##(2008-10#3)
single bead##5##2##(2008-10#3)(2008-11#1)(2013-7#1)
single beam##7##2##(2006-12#1)(2007-12#1)(2008-2#4)(2008-3#1)
single best##2##2##(1992-2#1)(2006-5#1)
single biological##2##2##(2007-11#1)(2008-5#1)
single biomarkers##2##2##(1992-12#1)(2012-1#1)
single biomolecules##2##2##(2010-7#1)(2012-2#1)
single blind clinical trial##2##4##(2011-2#2)
single blind randomized##2##3##(2007-7#1)(2008-6#1)
single blind##7##2##(1996-8#1)(2007-7#1)(2008-5#1)(2008-6#1)(2011-2#2)(2012-2#1)
single blocks##4##2##(2006-7#1)(2006-8#3)
single body##2##2##(1996-2#1)(2007-12#1)
single bolus##4##2##(2004-12#1)(2007-11#2)(2007-7#1)
single brain metastases##2##3##(1992-4#1)(1993-10#1)
single brain metastasis##3##3##(1990-12#1)(2006-7#1)(2012-2#1)
single brain##7##2##(1990-12#1)(1992-4#1)(1993-10#1)(2006-7#1)(2008-4#2)(2012-2#1)
single breath-hold##2##2##(2006-10#1)(2010-6#1)
single broad##2##2##(1990-4#1)(1995-10#1)
single cable##2##2##(1995-7#1)(2007-2#1)
single cancer cells##2##3##(2008-11#1)(2009-12#1)
single cancer##3##2##(2008-11#1)(2009-12#1)(2010-12#1)
single capillary##2##2##(2007-8#1)(2008-4#1)
single carbon source##2##3##(2008-10#1)(2008-8#1)
single carbon##5##2##(2005-11#1)(2007-8#1)(2008-10#2)(2008-8#1)
single cardiac##2##2##(1991-9#1)(2011-2#1)
single case of##6##3##(1996-2#1)(2007-10#1)(2007-7#1)(2009-2#1)(2011-2#2)
single case studies##2##3##(2008-12#1)(2010-5#1)
single case study##7##3##(1991-4#2)(1993-9#1)(1995-1#1)(2007-6#1)(2008-9#1)(2013-1#1)
single case with##3##3##(2007-7#2)(2008-4#1)
single case##38##2##(1990-6#1)(1991-4#2)(1993-11#1)(1993-9#1)(1995-1#1)(1996-2#2)(2006-10#1)(2007-10#2)(2007-11#1)(2007-6#1)(2007-7#4)(2008-10#1)(2008-12#1)(2008-4#4)(2008-9#1)(2009-2#1)(2009-5#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#3)(2013-1#5)
single cause of##3##3##(1992-5#1)(1992-6#1)(1996-7#1)
single cause##6##2##(1992-5#1)(1992-6#1)(1996-7#2)(2007-7#1)(2008-11#1)
single cause-of-death analysis##2##3##(2006-12#2)
single cavity##2##2##(2006-10#1)(2007-12#1)
single cell analysis##2##3##(2007-12#1)(2009-12#1)
single cell gel electrophoresis##4##4##(1996-2#1)(1997-4#2)(2012-2#1)
single cell gel##5##3##(1996-2#1)(1997-4#2)(2012-2#1)(2013-1#1)
single cell level in##2##4##(1994-10#1)(2007-12#1)
single cell level##10##3##(1990-12#1)(1991-10#1)(1994-10#1)(1997-4#2)(2007-12#1)(2008-9#1)(2011-1#2)(2011-2#1)
single cell type##2##3##(1994-8#1)(1996-5#1)
single cell##62##2##(1990-12#2)(1991-10#1)(1992-12#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-8#3)(1995-1#1)(1995-2#1)(1996-2#2)(1996-5#1)(1997-4#5)(1997-7#1)(2005-11#1)(2006-2#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#1)(2008-11#6)(2008-2#2)(2008-4#6)(2008-5#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2010-12#1)(2011-1#3)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
single cells and##6##3##(1993-7#1)(1994-3#1)(1995-11#1)(2007-8#1)(2008-9#1)(2009-4#1)
single cells from##4##3##(1995-5#1)(2008-11#1)(2008-2#1)(2009-2#1)
single cells in##5##3##(1994-11#1)(1996-3#1)(2006-2#1)(2008-1#1)(2008-7#1)
single cells of##2##3##(1994-11#1)(2009-2#1)
single cells##47##2##(1990-11#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-8#1)(1993-3#1)(1993-7#1)(1994-11#2)(1994-3#2)(1994-6#1)(1995-11#1)(1995-12#1)(1995-5#2)(1996-3#1)(2006-12#1)(2006-2#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#5)(2008-5#1)(2008-7#7)(2008-9#2)(2009-12#2)(2009-2#2)(2009-4#1)(2011-1#1)(2012-11#1)
single center experience##10##3##(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2009-8#1)(2010-5#2)
single center study##3##3##(2008-1#1)(2010-12#1)(2012-2#1)
single center##23##2##(2007-4#1)(2007-7#4)(2007-8#2)(2008-1#2)(2008-3#1)(2008-4#1)(2008-5#2)(2009-2#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#2)(2012-2#1)(2013-1#2)(2013-7#1)
single centre experience##4##3##(2009-6#1)(2012-12#1)(2012-2#1)(2013-8#1)
single centre study##3##3##(1992-8#1)(2007-8#1)(2012-2#1)
single centre##10##2##(1992-8#1)(1993-2#1)(2007-7#1)(2007-8#1)(2008-7#1)(2009-6#1)(2012-12#1)(2012-2#2)(2013-8#1)
single cerebellar##2##2##(1990-7#1)(1995-7#1)
single chain Fv antibody fragment##2##5##(1994-11#1)(2008-8#1)
single chain T cell receptor##2##5##(1994-6#2)
single chain antibodies##6##3##(1994-9#4)(2008-10#2)
single chain antibody to vascular endothelial growth factor##2##8##(2008-8#2)
single chain antibody##6##3##(1992-6#2)(1997-2#1)(2008-8#3)
single chain insulin##6##3##(2008-9#6)
single chain polypeptide##3##3##(1990-11#1)(1990-6#1)(1995-3#1)
single chain##35##2##(1990-11#2)(1990-6#1)(1991-8#3)(1992-6#2)(1994-11#1)(1994-3#1)(1994-6#2)(1994-9#4)(1995-3#1)(1997-2#1)(2006-12#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#4)(2008-9#6)
single chains##2##2##(1991-7#1)(2005-11#1)
single chamber##2##2##(1990-12#1)(2006-9#1)
single channel conductance##5##3##(1991-2#1)(1992-7#1)(1994-12#1)(1994-3#1)(1996-2#1)
single channel currents##3##3##(1990-9#3)
single channel events##3##3##(1994-2#2)(1995-2#1)
single channel##30##2##(1990-9#4)(1991-2#1)(1992-7#1)(1992-9#1)(1994-12#1)(1994-2#2)(1994-3#2)(1995-2#1)(1996-2#2)(2005-4#1)(2007-12#2)(2007-3#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-8#2)(2009-8#1)(2011-3#2)(2012-3#1)
single channels##3##2##(1990-2#1)(1991-12#1)(1996-12#1)
single charge##2##2##(2009-10#1)(2011-2#1)
single chemical##5##2##(1993-11#1)(1994-11#1)(2008-10#1)(2008-3#1)(2008-7#1)
single chirality##2##2##(2010-12#2)
single circular bend##2##3##(2008-3#2)
single class of high affinity binding sites##2##7##(1993-3#1)(1994-2#1)
single class of high affinity##3##5##(1991-4#1)(1993-3#1)(1994-2#1)
single class of##22##3##(1990-2#1)(1990-7#3)(1991-4#3)(1991-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-2#2)(1995-10#1)(1995-5#1)(1996-5#1)(1996-9#1)(2008-2#1)(2008-9#1)
single class##25##2##(1990-2#2)(1990-7#3)(1991-4#3)(1991-5#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-2#2)(1995-10#1)(1995-5#1)(1996-5#1)(1996-9#1)(1997-5#1)(2008-2#1)(2008-9#1)
single clinical##5##2##(2008-11#1)(2008-6#1)(2009-10#3)
single clone##2##2##(1994-9#1)(1995-2#1)
single colonies##3##2##(1994-11#1)(2008-10#2)
single colony##4##2##(2005-11#1)(2008-11#1)(2008-2#1)(2008-9#1)
single column##2##2##(1997-2#1)(2008-10#1)
single complex##2##2##(1995-1#2)
single component analyses##2##3##(1993-11#2)
single component of the##2##4##(2008-2#1)(2008-3#1)
single component of##4##3##(1992-12#1)(2008-2#1)(2008-3#2)
single component##14##2##(1991-9#1)(1992-12#1)(1993-11#2)(1993-12#1)(1995-1#1)(2005-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2009-6#1)
single components in##2##3##(2008-10#2)
single components##5##2##(1996-4#1)(2008-10#3)(2011-2#1)
single compound##8##2##(2008-1#1)(2008-10#1)(2008-11#4)(2008-5#1)(2009-8#1)
single compounds##2##2##(1996-4#1)(2008-10#1)
single control##5##2##(2005-11#1)(2006-6#1)(2007-11#1)(2008-10#1)(2013-1#1)
single copy in the human genome and is##2##8##(1991-4#1)(1992-3#1)
single copy in the human genome##3##6##(1991-4#1)(1992-3#1)(1994-10#1)
single copy in the##6##4##(1991-4#1)(1992-11#1)(1992-3#1)(1994-10#1)(1995-8#1)(1997-4#1)
single copy in##7##3##(1991-4#1)(1992-11#1)(1992-3#1)(1994-10#1)(1995-8#1)(1997-4#1)(2010-10#1)
single copy of the gene##2##5##(1991-1#1)(1996-11#1)
single copy of the##8##4##(1991-1#1)(1991-7#1)(1992-6#1)(1993-3#1)(1994-12#1)(1996-11#1)(1997-2#2)
single copy of##14##3##(1990-7#1)(1991-1#1)(1991-7#1)(1992-6#1)(1993-3#2)(1994-12#1)(1996-11#1)(1997-2#4)(2008-11#1)(2008-8#1)
single copy##48##2##(1990-10#1)(1990-7#2)(1991-1#1)(1991-12#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1995-5#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-8#1)(1997-2#5)(1997-4#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#4)(2009-10#1)(2010-10#1)(2012-2#1)
single coronary artery##7##3##(1996-9#4)(2007-8#1)(2008-12#2)
single coronary##9##2##(1996-9#4)(2006-12#1)(2007-8#1)(2008-12#2)(2009-11#1)
single crown##3##2##(1990-5#1)(2013-1#2)
single crystal C60##2##3##(1992-3#1)(1995-2#1)
single crystal X-ray diffraction analysis##3##5##(2008-3#1)(2010-5#1)(2011-1#1)
single crystal X-ray diffraction##11##4##(2007-10#1)(2007-11#2)(2008-3#2)(2008-5#2)(2009-3#1)(2010-5#2)(2011-1#1)
single crystal X-ray##15##3##(2007-10#1)(2007-11#3)(2007-8#1)(2008-3#2)(2008-5#3)(2009-3#1)(2010-5#3)(2011-1#1)
single crystal and a##2##4##(1992-8#1)(2008-1#1)
single crystal measured##2##3##(1994-5#1)(2007-11#1)
single crystal of##11##3##(1992-1#1)(1997-7#3)(2006-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2013-1#2)
single crystal structure analysis##2##4##(2007-11#1)(2008-5#1)
single crystal with a##2##4##(2006-4#2)
single crystal##60##2##(1990-4#1)(1991-3#1)(1992-1#1)(1992-3#1)(1992-8#1)(1994-5#1)(1995-2#1)(1997-7#4)(2004-9#1)(2006-4#4)(2006-5#2)(2007-10#1)(2007-11#6)(2007-12#6)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#4)(2009-11#2)(2009-3#1)(2010-11#1)(2010-5#3)(2011-1#1)(2013-1#3)
single crystalline titanium dioxide##2##4##(2009-11#2)
single crystalline##11##2##(1991-3#1)(1997-4#1)(2006-4#1)(2007-9#2)(2009-11#4)(2009-2#1)(2011-1#1)
single crystals and##3##3##(1992-8#1)(2008-3#1)(2012-11#1)
single crystals as##2##3##(2006-4#1)(2008-3#1)
single crystals have##2##3##(2006-4#1)(2012-1#1)
single crystals implanted with##2##4##(2006-4#2)
single crystals of##7##3##(1990-5#1)(1991-5#1)(1996-2#1)(2008-10#2)(2012-2#2)
single crystals with different##2##4##(2007-12#1)(2008-3#1)
single crystals with##3##3##(2007-12#1)(2008-3#1)(2009-3#1)
single crystals##36##2##(1990-5#1)(1991-5#2)(1992-8#1)(1994-10#1)(1994-5#2)(1996-2#1)(1997-7#1)(2006-4#4)(2006-5#3)(2007-11#2)(2007-12#2)(2007-5#1)(2008-10#2)(2008-3#6)(2009-3#1)(2009-5#1)(2012-1#1)(2012-11#2)(2012-2#2)
single cycle##4##2##(1990-6#1)(1997-2#1)(1997-7#1)(2008-11#1)
single cysteine residue##2##3##(1994-11#1)(1995-2#1)
single cysteine##3##2##(1990-4#1)(1994-11#1)(1995-2#1)
single cystosorus isolates##2##3##(2008-10#2)
single cystosorus##3##2##(2008-10#3)
single daily dose##7##3##(1990-11#2)(1990-7#2)(1991-11#1)(2008-11#1)(2011-2#1)
single daily##9##2##(1990-11#2)(1990-7#2)(1991-11#2)(2007-7#1)(2008-11#1)(2011-2#1)
single data point##2##3##(2008-2#1)(2009-9#1)
single data##3##2##(1996-5#1)(2008-2#1)(2009-9#1)
single day##5##2##(1991-2#1)(2008-12#1)(2010-10#2)(2013-8#1)
single determinant of##2##3##(2005-12#1)(2008-11#1)
single determinant##3##2##(2005-12#1)(2008-11#1)(2010-7#1)
single device##5##2##(1992-10#2)(2006-10#1)(2011-2#1)(2011-7#1)
single diagnostic tool##2##3##(2008-3#1)(2010-9#1)
single diagnostic##3##2##(1993-5#1)(2008-3#1)(2010-9#1)
single difference##2##2##(2008-3#1)(2009-6#1)
single digit##2##2##(1995-12#1)(2006-3#1)
single digital micromirror##2##3##(2008-3#2)
single digital##3##2##(2008-3#3)
single digits were##2##3##(1995-12#2)
single digits##3##2##(1995-12#3)
single dimensionless##2##2##(2005-11#1)(2009-6#1)
single diode laser##2##3##(2006-12#1)(2011-1#1)
single diploid##2##2##(2008-10#1)(2012-3#1)
single disease##10##2##(2005-12#1)(2005-8#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-3#1)(2010-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
single displacement##2##2##(1991-7#1)(1994-3#1)
single dominant avirulence genes##2##4##(2008-10#2)
single dominant avirulence##3##3##(2008-10#3)
single dominant gene for##2##4##(2008-10#1)(2008-5#1)
single dominant gene##20##3##(2008-10#17)(2008-5#1)(2012-11#2)
single dominant##32##2##(2008-10#28)(2008-5#1)(2012-11#3)
single dose administration##2##3##(2005-8#1)(2008-5#1)
single dose and##2##3##(1993-2#1)(2007-11#1)
single dose of##53##3##(1990-6#2)(1990-9#1)(1991-2#1)(1991-8#1)(1992-12#2)(1992-5#1)(1993-1#1)(1993-2#3)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-11#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-5#3)(1997-7#2)(2005-7#1)(2005-8#1)(2006-11#1)(2006-2#1)(2006-8#1)(2007-11#3)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-4#1)(2008-5#1)(2008-8#2)(2010-1#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#1)
single dose##80##2##(1990-6#2)(1990-9#1)(1991-2#1)(1991-8#1)(1992-12#3)(1992-5#1)(1993-1#1)(1993-2#5)(1993-3#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-5#3)(1997-7#2)(2004-12#1)(2005-7#1)(2005-8#2)(2006-11#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#6)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#3)(2010-1#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)
single doses of##7##3##(1994-5#1)(1996-8#1)(2005-10#1)(2007-11#1)(2008-11#1)(2008-5#2)
single doses##9##2##(1994-5#1)(1996-8#1)(2004-12#1)(2005-10#1)(2005-7#1)(2007-11#1)(2008-11#1)(2008-5#2)
single droplet##2##2##(2007-12#1)(2008-2#1)
single drug##5##2##(1995-8#1)(2008-3#1)(2009-7#1)(2011-1#1)(2011-10#1)
single ectopic ureteric##2##3##(2008-10#2)
single ectopic ureters with hypoplastic bladder##3##6##(2008-10#3)
single ectopic##5##2##(2008-10#5)
single electrical##2##2##(2008-1#1)(2009-8#1)
single electron##3##2##(1995-6#1)(2008-2#1)(2009-12#1)
single element of the##2##4##(2008-9#1)(2009-4#1)
single element##5##2##(2008-10#2)(2008-9#1)(2009-4#1)(2009-5#1)
single emulsion##2##2##(2010-12#2)
single enantiomer##3##2##(1994-3#2)(2007-11#1)
single enantiomers##2##2##(1997-2#1)(2006-12#1)
single enzyme##3##2##(1991-2#1)(1993-2#1)(2008-10#1)
single episode of##3##3##(1991-12#1)(2011-2#1)(2013-8#1)
single episode##5##2##(1991-12#1)(1992-5#1)(2007-4#1)(2011-2#1)(2013-8#1)
single epithelial##2##2##(1992-2#1)(2007-12#1)
single epochs##2##2##(1996-6#2)
single equivalent##2##2##(1996-1#1)(2006-8#1)
single eukaryotic##2##2##(1995-9#1)(2009-12#1)
single event##3##2##(1997-3#1)(2007-10#1)(2008-2#1)
single excitation##5##2##(1996-7#1)(2007-12#1)(2008-9#1)(2010-5#1)(2011-1#1)
single exercise##2##2##(2008-7#1)(2010-9#1)
single exons##2##2##(1991-6#1)(1996-4#1)
single experimental##2##2##(2007-11#1)(2012-3#1)
single exponential##9##2##(1990-2#1)(1990-7#1)(1991-12#1)(1994-11#1)(1995-11#1)(1996-5#1)(1997-7#1)(2008-3#1)(2008-5#1)
single exposure##6##2##(2007-12#1)(2007-9#1)(2008-3#2)(2008-7#1)(2012-3#1)
single expression##2##2##(2008-5#1)(2009-6#1)
single extract of##2##3##(2008-10#2)
single extraction##10##2##(2007-8#2)(2008-10#8)
single factor that##2##3##(2008-3#1)(2011-1#1)
single factor##9##2##(2005-11#1)(2006-7#1)(2008-10#1)(2008-11#2)(2008-3#2)(2009-12#1)(2011-1#1)
single factors##2##2##(1990-9#1)(1993-1#1)
single family##4##2##(1991-10#1)(2007-7#1)(2011-2#1)(2012-12#1)
single feature##2##2##(2008-12#1)(2012-3#1)
single fiber optic sensor##2##4##(2008-10#2)
single fiber##14##2##(2007-12#3)(2008-10#3)(2008-2#4)(2008-3#4)
single fibres##2##2##(2008-5#1)(2010-5#1)
single fields##4##2##(2008-10#3)(2008-3#1)
single fluorescent##2##2##(1997-6#1)(2008-3#1)
single form of##4##3##(1990-12#1)(1990-6#1)(1991-5#1)(1995-12#1)
single form##5##2##(1990-12#1)(1990-6#1)(1991-5#1)(1994-11#1)(1995-12#1)
single formulation##2##2##(2007-9#1)(2008-10#1)
single fraction 8Gy##3##3##(2008-10#3)
single fraction##7##2##(1990-2#1)(1994-4#1)(2008-10#4)(2012-12#1)
single frequency and##2##3##(1991-5#1)(2007-12#1)
single frequency##7##2##(1991-5#2)(2007-12#2)(2008-10#1)(2008-2#2)
single gastric##2##2##(1990-5#1)(2011-1#1)
single gene by alternative splicing##3##5##(1991-4#1)(1993-7#1)(1996-7#1)
single gene by##4##3##(1991-4#1)(1993-7#1)(1996-2#1)(1996-7#1)
single gene control of##3##4##(2008-10#3)
single gene disorders##4##3##(1993-1#1)(1995-12#1)(2008-8#2)
single gene mutation##2##3##(1996-3#1)(2010-4#1)
single gene or##3##3##(2005-8#1)(2008-10#1)(2008-7#1)
single gene##68##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#1)(1993-1#1)(1993-2#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2005-8#2)(2006-1#2)(2008-10#17)(2008-4#1)(2008-7#3)(2008-8#3)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
single genes and##2##3##(2007-12#1)(2010-7#1)
single genes for##2##3##(2008-10#2)
single genes##10##2##(1993-9#1)(1996-6#1)(2007-12#1)(2008-10#3)(2008-6#1)(2008-8#1)(2010-7#1)(2012-12#1)
single genetic##5##2##(1990-8#1)(1991-11#1)(2006-12#1)(2008-7#1)(2010-4#1)
single genome##4##2##(2008-1#1)(2008-7#1)(2009-12#1)(2013-8#1)
single genotype stands##2##3##(2008-10#2)
single genotype##5##2##(2008-10#5)
single genotypes##2##2##(2008-10#1)(2008-12#1)
single genotypic infections##2##3##(2008-12#2)
single genotypic##3##2##(2008-12#3)
single glycerinated##2##2##(1991-12#2)
single graphene##2##2##(2008-7#1)(2009-11#1)
single group##3##2##(1991-4#1)(2007-11#1)(2008-5#1)
single habitat##2##2##(2008-8#1)(2008-9#1)
single hair##3##2##(1995-12#1)(2008-5#2)
single haplotype##2##2##(2008-10#2)
single helical##2##2##(1994-2#1)(1995-5#1)
single high dose of BUP##2##5##(2007-2#2)
single high##8##2##(1990-10#1)(1990-3#1)(1991-3#1)(1995-3#2)(2007-2#2)(2011-2#1)
single hippocampal##2##2##(1991-11#1)(1996-12#1)
single histidine residue##4##3##(1992-7#1)(1994-11#2)(1994-12#1)
single hologram##2##2##(2008-2#1)(2008-3#1)
single i##7##2##(1990-11#1)(1990-4#1)(1992-5#2)(1993-7#2)(2008-4#1)
single image##10##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-6#1)
single immunoreactive##2##2##(1990-10#1)(1993-7#1)
single implants inserted##2##3##(2013-1#2)
single implants##4##2##(2013-1#4)
single in##4##2##(2007-8#1)(2008-10#1)(2008-5#2)
single incision laparoscopic##3##3##(2012-12#3)
single incision##5##2##(2006-4#1)(2007-1#1)(2012-12#3)
single individual##4##2##(2008-10#2)(2008-3#1)(2013-1#1)
single individuals##5##2##(1994-6#1)(1997-2#1)(2008-10#1)(2009-5#1)(2011-2#1)
single infarct##2##2##(2007-10#2)
single infection with##2##3##(2008-10#1)(2011-2#1)
single infection##8##2##(2006-4#1)(2008-10#2)(2008-11#1)(2008-5#3)(2011-2#1)
single infections##6##2##(1997-6#1)(2007-7#1)(2008-10#3)(2008-8#1)
single injection and##2##3##(2008-10#2)
single injection of##13##3##(1991-2#1)(1991-3#2)(1993-7#1)(1995-11#1)(1995-2#1)(2004-10#1)(2006-5#1)(2008-10#2)(2008-8#1)(2012-2#1)(2013-1#1)
single injection##25##2##(1991-2#1)(1991-3#2)(1992-10#1)(1993-4#1)(1993-7#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1997-3#1)(2004-10#1)(2005-11#1)(2006-5#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
single input##2##2##(2007-11#1)(2008-2#1)
single institution experience##2##3##(2007-5#1)(2011-2#1)
single institution##12##2##(1993-6#1)(1994-4#1)(2006-11#1)(2007-5#1)(2007-8#2)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#2)(2013-1#1)
single institutional experience##2##3##(2008-11#1)(2011-1#1)
single institutional##5##2##(2006-12#1)(2008-11#1)(2010-12#2)(2011-1#1)
single institutions##4##2##(1996-12#1)(2008-6#2)(2011-2#1)
single instrument##2##2##(1997-8#1)(2008-10#1)
single interaction##3##2##(2008-10#1)(2012-12#2)
single internal##2##2##(1992-9#1)(2008-9#1)
single interphase##2##2##(2008-4#2)
single intervention##2##2##(2008-3#1)(2013-8#1)
single intradermal##3##2##(1997-8#2)(2008-9#1)
single intraperitoneal administration of##2##4##(1992-6#1)(2012-2#1)
single intraperitoneal injection##7##3##(1990-4#1)(1991-3#1)(1992-12#1)(1993-7#1)(1994-5#1)(2008-10#1)(2012-1#1)
single intraperitoneal##14##2##(1990-4#1)(1991-3#1)(1992-12#1)(1992-6#1)(1993-7#1)(1994-5#2)(1994-6#1)(1994-8#1)(2008-10#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-2#1)
single intravenous administration of##2##4##(2007-11#1)(2012-3#1)
single intravenous administration##3##3##(2007-11#1)(2010-5#1)(2012-3#1)
single intravenous injection of##2##4##(1991-12#1)(1991-9#1)
single intravenous##10##2##(1991-12#1)(1991-9#1)(2007-11#2)(2007-2#1)(2008-3#1)(2009-4#1)(2010-5#1)(2011-1#1)(2012-3#1)
single ion##4##2##(1991-11#1)(2007-12#2)(2008-7#1)
single isolate##6##2##(2008-10#5)(2008-5#1)
single isotope enzymatic assay##2##4##(1992-7#2)
single item##2##2##(2007-12#1)(2012-3#1)
single joint##6##2##(1992-8#1)(2006-7#1)(2007-11#1)(2008-4#1)(2008-7#1)(2013-1#1)
single kick-out condition##2##3##(2008-2#2)
single kidney##2##2##(1997-3#1)(2007-9#1)
single known##2##2##(2009-9#1)(2012-12#1)
single large##9##2##(1990-2#1)(1993-12#1)(1993-7#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)
single laser flow##2##3##(1990-12#1)(2008-4#1)
single laser pulse##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
single laser##23##2##(1990-12#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-1#1)(2008-2#8)(2008-3#5)(2008-4#1)
single layer##10##2##(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#3)(2010-2#1)
single layers##3##2##(2008-2#2)(2008-3#1)
single left##4##2##(2007-8#1)(2008-1#1)(2013-1#1)(2013-2#1)
single leg##3##2##(2007-12#2)(2013-1#1)
single lens##3##2##(2007-12#1)(2008-3#2)
single lesion halo naevus##2##4##(2007-7#2)
single lesion##4##2##(2007-7#3)(2008-10#1)
single lesions##2##2##(2006-5#1)(2008-10#1)
single letters##2##2##(2008-4#2)
single ligation of cystic artery and duct (SLAD)##2##8##(2011-1#2)
single ligation of cystic artery and##3##6##(2011-1#3)
single line##8##2##(1990-10#1)(1990-5#1)(1995-12#1)(2008-10#4)(2008-3#1)
single lineage##2##2##(2008-10#1)(2008-6#1)
single linear##3##2##(2006-9#1)(2008-10#1)(2009-10#1)
single liquid##2##2##(1992-3#1)(2008-2#1)
single live##3##2##(2009-2#1)(2010-8#1)(2011-1#1)
single loci##2##2##(2008-12#1)(2013-1#1)
single locus##13##2##(1990-7#1)(1993-7#1)(1994-8#1)(1995-8#1)(1996-4#1)(1996-5#1)(2006-5#1)(2008-10#4)(2008-5#1)(2008-8#1)
single longitudinal mode with a##3##5##(2007-12#2)(2008-3#1)
single longitudinal mode##7##3##(2007-12#4)(2008-2#1)(2008-3#2)
single longitudinal##9##2##(1996-11#1)(2007-12#4)(2008-2#1)(2008-3#2)(2009-11#1)
single low##4##2##(1994-3#1)(1995-3#1)(1995-8#1)(2008-7#1)
single lumen tube##3##3##(2006-10#3)
single lumen##4##2##(2006-10#3)(2007-8#1)
single lung transplantation##2##3##(2007-8#1)(2011-3#1)
single lung##4##2##(2006-10#1)(2007-8#1)(2011-3#2)
single magnetic##2##2##(1992-3#1)(2010-8#1)
single major##11##2##(1990-8#1)(1992-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(2008-10#4)(2010-8#1)
single mandibular##3##2##(2013-1#3)
single marker##2##2##(2006-9#1)(2007-7#1)
single mass##3##2##(1990-5#1)(1992-1#1)(2010-6#1)
single mating##2##2##(1992-8#1)(2008-10#1)
single measure##6##2##(2008-8#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)
single measurements##3##2##(1990-8#2)(2010-4#1)
single mechanism##5##2##(1996-8#2)(2007-12#1)(2008-10#1)(2012-2#1)
single men##2##2##(2010-8#2)
single methionine##3##2##(1992-2#1)(1995-3#1)(1995-5#1)
single method##2##2##(2007-11#1)(2008-9#1)
single microaperture-per-channel##2##2##(2008-3#2)
single mirror##3##2##(2007-11#1)(2008-2#1)(2008-6#1)
single modality##6##2##(2006-10#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-6#1)(2011-1#1)
single mode and##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
single mode##10##2##(1990-8#1)(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#2)(2013-8#1)
single model##8##2##(1995-2#1)(1997-5#1)(2007-11#1)(2008-11#1)(2008-4#1)(2010-2#1)(2010-5#1)(2010-6#1)
single molecular##2##2##(2009-11#1)(2009-9#1)
single molecule as a##2##4##(2007-12#2)
single molecule detection##2##3##(2009-2#1)(2012-2#1)
single molecule force##2##3##(2009-12#1)(2009-9#1)
single molecule##34##2##(1992-3#1)(1996-7#1)(1997-6#1)(2006-2#2)(2006-9#1)(2007-12#4)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-9#2)(2010-2#2)(2010-5#3)(2010-6#1)(2010-7#4)(2011-1#1)(2012-2#1)(2012-3#1)
single molecules and##2##3##(2008-4#1)(2008-7#1)
single molecules on the##2##4##(2007-12#2)
single molecules on##3##3##(2007-12#2)(2009-4#1)
single molecules with##2##3##(2007-12#1)(2008-7#1)
single molecules##20##2##(2007-11#2)(2007-12#6)(2008-2#1)(2008-4#1)(2008-7#6)(2009-4#1)(2009-8#1)(2012-1#1)(2012-2#1)
single morning urine##2##3##(1996-12#2)
single most important factor in##2##5##(1990-8#1)(2011-1#1)
single most important factor##4##4##(1990-8#1)(2008-7#1)(2008-9#1)(2011-1#1)
single most important##10##3##(1990-8#1)(1994-7#1)(2007-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-1#2)(2013-1#1)
single most##19##2##(1990-8#1)(1991-12#1)(1993-12#1)(1994-7#1)(1995-10#1)(1996-12#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-7#1)(2011-1#2)(2013-1#1)
single mothers##6##2##(1994-3#1)(2007-2#3)(2009-11#1)(2013-8#1)
single mutant receptors##2##3##(1995-6#2)
single mutant##13##2##(1993-9#1)(1995-1#1)(1995-6#4)(1996-6#1)(1997-7#1)(2007-11#1)(2008-8#2)(2011-2#1)(2013-8#1)
single mutants##9##2##(1990-3#1)(1995-11#1)(1995-6#1)(1997-4#1)(2012-2#1)(2013-8#4)
single mutation in##2##3##(1995-10#1)(2009-8#1)
single mutation##7##2##(1990-5#1)(1995-1#1)(1995-10#1)(1997-3#1)(2008-11#1)(2008-3#1)(2009-8#1)
single mutations##4##2##(1990-5#1)(2008-10#2)(2009-11#1)
single nanoparticles##3##2##(2008-10#1)(2010-7#2)
single network##2##2##(2008-10#1)(2008-2#1)
single neuron##5##2##(1992-11#2)(1996-12#1)(2008-10#1)(2008-11#1)
single neurones##3##2##(1996-1#2)(1997-3#1)
single neurons and##2##3##(2007-8#1)(2008-11#1)
single neurons in the dorsal column nuclei##2##7##(1997-3#2)
single neurons in the dorsal column##3##6##(1997-1#1)(1997-3#2)
single neurons in the##4##4##(1995-11#1)(1997-1#1)(1997-3#2)
single neurons in##6##3##(1994-8#1)(1995-11#1)(1997-1#1)(1997-3#2)(1997-8#1)
single neurons##19##2##(1993-6#1)(1994-8#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-3#1)(1997-1#1)(1997-3#2)(1997-8#1)(2007-8#1)(2008-10#1)(2008-11#3)(2009-2#1)(2009-5#1)
single noble metal##2##3##(2008-10#1)(2010-4#1)
single normal##2##2##(2007-2#1)(2012-3#1)
single nucleolus##2##2##(2008-12#1)(2008-5#1)
single nucleotide polymorphism (SNP) markers##2##5##(2008-7#1)(2012-5#1)
single nucleotide polymorphism (SNP)##13##4##(2008-10#1)(2008-4#1)(2008-7#3)(2009-7#1)(2010-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#1)
single nucleotide polymorphism in##2##4##(2011-2#1)(2013-8#1)
single nucleotide polymorphism is a##2##5##(2008-1#1)(2011-2#1)
single nucleotide polymorphism##30##3##(2007-10#1)(2007-12#4)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#4)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-2#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
single nucleotide polymorphisms (SNP)##4##4##(2008-4#1)(2009-4#1)(2011-1#1)(2013-1#1)
single nucleotide polymorphisms (SNPs) and##4##5##(2005-8#1)(2006-12#1)(2008-10#1)(2013-1#1)
single nucleotide polymorphisms (SNPs) have been##2##6##(2009-4#1)(2012-1#1)
single nucleotide polymorphisms (SNPs) of the##3##6##(2008-11#1)(2009-8#1)(2011-1#1)
single nucleotide polymorphisms (SNPs) were##2##5##(2008-7#1)(2008-8#1)
single nucleotide polymorphisms (SNPs)##21##4##(2005-8#1)(2006-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#2)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#3)(2013-1#1)
single nucleotide polymorphisms and##4##4##(2005-8#1)(2008-7#1)(2010-6#1)(2013-8#1)
single nucleotide polymorphisms in##2##4##(2009-8#1)(2012-2#1)
single nucleotide polymorphisms of##4##4##(2008-10#1)(2011-1#2)(2012-12#1)
single nucleotide polymorphisms##43##3##(1997-9#1)(2005-8#2)(2006-12#1)(2007-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-4#3)(2009-8#3)(2009-9#1)(2010-12#1)(2010-2#1)(2010-6#2)(2011-1#4)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
single nucleotide substitution of##2##4##(1990-4#1)(1993-12#1)
single nucleotide substitution##5##3##(1990-4#1)(1993-12#1)(1995-8#1)(1996-6#1)(2008-2#1)
single nucleotide substitutions##2##3##(1993-12#1)(2010-12#1)
single nucleotide##100##2##(1990-12#1)(1990-4#2)(1991-12#1)(1991-4#1)(1992-9#1)(1993-12#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-4#2)(1996-6#1)(1997-1#1)(1997-9#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-12#4)(2007-3#1)(2007-6#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#6)(2008-8#3)(2009-4#4)(2009-5#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-6#2)(2011-1#6)(2011-2#5)(2012-1#3)(2012-12#3)(2012-2#4)(2012-3#3)(2012-5#1)(2013-1#4)(2013-7#1)(2013-8#2)
single open reading frame (ORF)##2##5##(1993-11#1)(1997-7#1)
single open reading frame##8##4##(1990-5#1)(1990-9#1)(1992-12#1)(1993-11#1)(1994-8#1)(1997-7#1)(2008-10#2)
single open##9##2##(1990-11#1)(1990-5#1)(1990-9#1)(1992-12#1)(1993-11#1)(1994-8#1)(1997-7#1)(2008-10#2)
single optical##8##2##(2007-12#5)(2008-2#1)(2008-3#2)
single or double##4##3##(1997-6#1)(2007-8#1)(2007-9#1)(2009-9#1)
single or dual##3##3##(2007-10#1)(2008-3#1)(2011-1#1)
single or few##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
single or in##2##3##(2008-12#1)(2008-8#1)
single or mixed##2##3##(2008-5#1)(2011-12#1)
single or multiple##14##3##(1992-7#1)(1994-2#2)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#2)(2008-10#1)(2008-11#1)(2009-3#1)(2011-1#2)(2012-1#1)
single or repeated##2##3##(2008-5#1)(2012-2#1)
single or##45##2##(1992-3#1)(1992-7#1)(1994-2#2)(1994-7#1)(1995-6#1)(1996-9#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#1)(2009-9#1)(2010-2#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)
single oral administration of##3##4##(2008-10#1)(2008-4#1)(2010-11#1)
single oral dose of##14##4##(1990-3#2)(1992-2#2)(1995-3#1)(1996-8#1)(2004-12#1)(2008-10#1)(2008-12#1)(2008-7#2)(2009-4#1)(2012-2#1)(2013-1#1)
single oral dose##19##3##(1990-3#2)(1992-2#2)(1995-3#1)(1996-8#1)(2004-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#3)(2009-4#1)(2012-2#1)(2013-1#1)
single oral##26##2##(1990-3#2)(1992-2#2)(1995-3#1)(1996-8#1)(2004-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#3)(2009-4#1)(2010-11#1)(2010-12#2)(2011-1#1)(2012-2#1)(2013-1#1)
single organ##3##2##(2008-9#1)(2009-9#1)(2010-12#1)
single origin for modern humans##2##5##(1994-3#1)(1996-4#1)
single origin for##3##3##(1994-3#1)(1996-4#1)(2009-6#1)
single origin##6##2##(1990-11#1)(1994-3#2)(1996-4#1)(2008-10#1)(2009-6#1)
single out##6##2##(1992-10#1)(1997-4#1)(2008-11#1)(2008-3#1)(2011-1#1)(2013-1#1)
single output##5##2##(2008-10#2)(2008-3#1)(2008-6#1)(2011-1#1)
single pair of##9##3##(2006-12#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-2#1)(2008-5#1)
single parameter##8##2##(1994-9#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-12#1)(2011-1#1)
single parasite##4##2##(1991-2#1)(2006-4#1)(2008-4#1)(2011-1#1)
single parent##2##2##(1994-4#1)(2008-4#1)
single particle analysis##3##3##(2008-10#3)
single particle##17##2##(1990-12#1)(1994-12#1)(2008-10#7)(2008-2#2)(2008-3#2)(2008-5#1)(2009-4#1)(2009-8#1)(2010-4#1)
single particles in##2##3##(1994-10#1)(2007-2#1)
single particles##10##2##(1994-10#1)(2007-2#1)(2007-3#3)(2008-10#2)(2008-3#1)(2008-5#1)(2013-7#1)
single pass of##3##3##(2006-6#1)(2008-10#1)(2008-2#1)
single pass##14##2##(1994-6#1)(1997-8#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)
single pathologist##2##2##(1992-12#1)(2007-8#1)
single pathway##3##2##(1990-12#1)(2009-8#1)(2012-3#1)
single patient at the##2##4##(1992-4#1)(1994-7#1)
single patient with##3##3##(1990-3#1)(2009-10#1)(2013-8#1)
single patient##18##2##(1990-12#1)(1990-3#1)(1992-4#1)(1993-4#1)(1994-7#1)(2006-12#1)(2007-1#1)(2007-7#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
single peak of##4##3##(1993-4#1)(1995-7#1)(2008-10#1)(2010-8#1)
single peak##19##2##(1990-10#2)(1990-8#1)(1991-6#1)(1993-12#1)(1993-4#1)(1995-1#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-6#1)(2006-10#1)(2008-10#3)(2008-3#1)(2008-8#1)(2010-8#1)(2013-8#1)
single peptides##2##2##(2007-11#1)(2008-4#1)
single phase##7##2##(1990-7#1)(1991-6#1)(1992-6#1)(1994-2#1)(2007-12#1)(2008-5#1)(2009-11#1)
single photon counting##8##3##(2006-10#1)(2007-11#1)(2011-1#6)
single photon emission computed tomographic (SPECT)##2##6##(1996-5#1)(2008-2#1)
single photon emission computed tomography (SPECT)##11##6##(1996-12#1)(1996-5#1)(1996-7#1)(2005-1#1)(2005-9#1)(2007-9#2)(2008-11#1)(2008-8#1)(2009-12#1)(2009-8#1)
single photon emission computed tomography in##2##6##(1994-1#1)(1996-5#1)
single photon emission computed tomography##20##5##(1994-1#1)(1995-5#1)(1996-12#1)(1996-5#2)(1996-7#1)(2005-1#1)(2005-9#1)(2006-10#1)(2007-10#2)(2007-9#3)(2008-11#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-12#1)
single photon emission computed##22##4##(1994-1#1)(1995-5#1)(1996-12#1)(1996-5#3)(1996-7#1)(2005-1#1)(2005-9#1)(2006-10#1)(2007-10#2)(2007-9#3)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-12#1)
single photon emission computerized tomography##2##5##(1995-4#1)(2008-12#1)
single photon emission tomography##4##4##(1992-10#1)(2005-8#1)(2006-10#1)(2008-2#1)
single photon emission##30##3##(1992-10#1)(1994-1#1)(1995-4#1)(1995-5#1)(1996-12#1)(1996-5#3)(1996-7#1)(2005-1#1)(2005-8#1)(2005-9#1)(2006-10#2)(2007-10#2)(2007-9#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-2#1)
single photon ionisation (SPI)-time-of-flight mass spectrometry (TOFMS)##2##7##(2007-8#2)
single photon##45##2##(1992-10#1)(1994-1#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#3)(1996-7#1)(1997-8#1)(2005-1#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#3)(2007-10#2)(2007-11#1)(2007-8#2)(2007-9#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-2#2)(2011-1#6)(2012-2#1)
single photons##2##2##(2007-12#1)(2007-9#1)
single plane##5##2##(1995-11#1)(2007-1#1)(2008-2#3)
single plants##4##2##(2008-10#2)(2008-5#1)(2011-12#1)
single plasmid##2##2##(2008-12#1)(2008-4#1)
single platform##2##2##(2008-9#1)(2012-2#1)
single point mutation##5##3##(1995-7#1)(2008-10#4)
single point mutations##5##3##(1995-3#3)(1997-6#1)(2013-8#1)
single point##23##2##(1990-9#1)(1992-12#1)(1995-12#1)(1995-3#3)(1995-7#1)(1997-6#1)(2008-10#9)(2008-2#3)(2008-6#1)(2009-4#1)(2013-8#1)
single polar##2##2##(2005-11#1)(2006-8#1)
single polypeptide chain##7##3##(1990-2#1)(1993-12#1)(1994-8#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-4#1)
single polypeptide##16##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#1)(1993-12#1)(1994-8#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-5#2)(2008-10#1)(2008-11#1)(2008-4#1)(2010-5#1)
single population of##4##3##(1990-8#1)(1992-9#1)(1996-2#1)(2007-9#1)
single population##7##2##(1990-8#1)(1992-9#1)(1996-2#1)(2007-9#1)(2008-10#2)(2011-2#1)
single pregnancies##2##2##(1993-1#1)(2011-2#1)
single primary##3##2##(2008-10#1)(2008-4#1)(2013-1#1)
single primer##3##2##(1993-12#1)(2008-8#2)
single protein##27##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-7#2)(1991-1#1)(1991-10#1)(1991-2#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-8#2)(1994-9#1)(1995-5#1)(1995-7#1)(1996-5#1)(2006-10#2)(2008-2#1)(2008-4#4)(2009-3#1)(2009-6#1)(2009-9#1)
single proteins##4##2##(1994-12#1)(1995-7#1)(2006-10#1)(2012-12#1)
single psychiatric occupational therapy##2##4##(2012-1#2)
single psychiatric##3##2##(2009-8#1)(2012-1#2)
single pulse##8##2##(1997-4#1)(2006-5#1)(2007-12#4)(2008-5#1)(2013-7#1)
single pulsed##4##2##(2007-12#1)(2008-10#1)(2008-9#2)
single pulses##2##2##(2007-12#1)(2008-3#1)
single pump beam##2##3##(2008-1#2)
single pump##6##2##(2007-11#1)(2007-12#3)(2008-1#2)
single pyramidal cells in the hippocampal CA1##2##7##(2008-11#2)
single pyramidal cells##4##3##(2008-11#4)
single quantum dots##3##3##(2007-11#1)(2007-12#1)(2010-2#1)
single quantum##5##2##(1992-12#1)(2007-11#1)(2007-12#2)(2010-2#1)
single radial immunodiffusion##3##3##(1993-2#1)(2006-2#1)(2007-2#1)
single radiolabeled##2##2##(1991-8#1)(1993-3#1)
single random##2##2##(2008-10#1)(2008-3#1)
single rare##3##2##(2008-10#1)(2012-3#2)
single rat##4##2##(1991-9#1)(1995-12#1)(1996-12#2)
single real-time##2##2##(2006-6#1)(2013-8#1)
single receptor##3##2##(1990-8#1)(1996-8#1)(1997-4#1)
single recessive gene##8##3##(2008-10#5)(2008-5#1)(2008-8#1)(2008-9#1)
single recessive##10##2##(2008-10#7)(2008-5#1)(2008-8#1)(2008-9#1)
single red blood##2##3##(1996-8#1)(2007-12#1)
single reference##2##2##(2008-10#1)(2008-3#1)
single registered diagnosis##2##3##(2006-8#2)
single resistance##5##2##(2008-10#5)
single response##4##2##(1997-7#2)(2008-10#2)
single restriction site##2##3##(2008-10#1)(2008-5#1)
single rovibrational##2##2##(2008-2#2)
single run##9##2##(1990-11#2)(1991-11#1)(1994-12#1)(1996-5#1)(2008-10#2)(2008-11#1)(2013-7#1)
single samples##2##2##(2008-10#2)
single scan##5##2##(2008-10#2)(2011-1#2)(2012-2#1)
single scattering##13##2##(2007-12#2)(2008-2#6)(2008-3#4)(2009-11#1)
single scoliosis##2##2##(2007-8#2)
single secretory##3##2##(1991-12#1)(1997-7#1)(2008-6#1)
single seed##6##2##(2008-10#2)(2008-11#1)(2008-9#2)(2009-10#1)
single sensor##2##2##(2006-6#1)(2007-11#1)
single sensory##4##2##(1996-12#1)(2007-12#1)(2009-5#1)(2010-11#1)
single separation##2##2##(2008-10#1)(2008-4#1)
single sequence##4##2##(2008-4#2)(2008-7#1)(2010-8#1)
single sequences##4##2##(1994-6#2)(2008-4#1)(2011-2#1)
single serum sample##2##3##(1991-11#1)(2008-4#1)
single serum##3##2##(1991-11#1)(1996-12#1)(2008-4#1)
single session of##3##3##(2008-10#1)(2008-7#1)(2013-7#1)
single session##5##2##(1993-6#1)(2008-10#1)(2008-7#1)(2012-1#1)(2013-7#1)
single set of##9##3##(1994-12#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2010-2#1)(2012-12#2)
single short##3##2##(1994-8#1)(2007-12#1)(2008-10#1)
single shot##6##2##(2007-12#3)(2008-3#1)(2009-4#1)(2010-7#1)
single side##2##2##(2007-8#1)(2013-8#1)
single site##20##2##(1990-8#1)(1990-9#1)(1991-7#1)(1995-11#1)(1995-8#2)(1996-2#1)(1996-5#1)(1996-6#1)(1997-4#2)(2006-4#2)(2006-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2012-12#1)
single sites##3##2##(1995-1#1)(2007-10#1)(2008-10#1)
single slice##2##2##(2006-4#1)(2008-7#1)
single social##3##2##(1997-3#1)(2010-10#1)(2010-2#1)
single sodium channels##2##3##(1991-9#1)(1994-12#1)
single sodium##3##2##(1991-11#1)(1991-9#1)(1994-12#1)
single sound##2##2##(2008-9#1)(2013-8#1)
single source##9##2##(1991-4#1)(1992-1#2)(1993-2#1)(1993-4#1)(2008-10#1)(2008-2#1)(2009-9#1)(2012-1#1)
single spatial##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
single species of##4##3##(1992-9#1)(1995-12#1)(1996-12#1)(2008-7#1)
single species##24##2##(1992-9#1)(1993-12#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-4#1)(2006-10#1)(2007-5#2)(2008-10#8)(2008-7#1)(2009-6#1)(2011-2#1)(2012-2#1)
single specific##3##2##(1990-11#1)(1994-6#1)(1995-3#1)
single specimen##3##2##(2007-12#1)(2010-8#1)(2013-8#1)
single spectral line##2##3##(2008-2#2)
single spectrum##5##2##(2005-8#1)(2007-12#2)(2008-4#2)
single sperm##2##2##(2007-12#1)(2008-9#1)
single spherical mirror systems##2##4##(2008-2#2)
single spherical mirror##3##3##(2008-2#3)
single spherical##5##2##(2008-2#4)(2008-3#1)
single spike##2##2##(1995-12#1)(2008-10#1)
single spot##5##2##(1996-2#1)(2007-12#1)(2007-8#2)(2008-3#1)
single stage technique##2##3##(2008-8#1)(2013-7#1)
single stage##9##2##(1992-2#1)(2007-8#2)(2008-2#1)(2008-6#1)(2008-8#1)(2011-12#1)(2011-2#1)(2013-7#1)
single stance##2##2##(2007-10#2)
single standard addition##2##3##(2008-10#2)
single standard##4##2##(2008-10#3)(2008-7#1)
single stem##2##2##(2008-10#1)(2011-2#1)
single step at##2##3##(1995-10#1)(2008-10#1)
single step##34##2##(1990-2#1)(1992-11#2)(1993-6#1)(1994-10#1)(1994-12#1)(1995-10#1)(1995-11#2)(1996-1#1)(1996-2#1)(1996-7#2)(1997-2#1)(1997-3#2)(1997-4#1)(2005-11#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-3#3)(2008-4#1)(2008-9#1)(2010-5#1)(2013-1#1)(2013-8#1)
single stimulus test and##2##4##(1991-1#2)
single strain##5##2##(2008-10#2)(2009-6#1)(2012-3#2)
single strand binding##2##3##(1994-12#2)
single strand breaks##4##3##(1990-4#1)(1993-12#1)(1995-10#1)(1996-5#1)
single strand conformational##2##3##(1996-6#1)(2008-12#1)
single strand##19##2##(1990-10#1)(1990-4#1)(1992-2#1)(1993-12#1)(1994-12#2)(1994-8#1)(1995-10#2)(1995-3#1)(1996-5#1)(1996-6#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-8#1)(2011-1#1)
single stranded DNA##6##3##(1994-11#1)(1996-11#1)(1997-1#1)(2008-10#2)(2009-3#1)
single stranded nucleic acids##2##4##(2008-10#1)(2008-3#1)
single stranded##14##2##(1991-7#2)(1994-11#1)(1994-3#1)(1996-11#1)(1997-1#1)(2006-10#1)(2008-10#4)(2008-3#1)(2009-3#1)(2011-2#1)
single strands##5##2##(1993-8#1)(1995-6#1)(2006-10#3)
single strategy##2##2##(2007-8#1)(2013-8#1)
single stroke##2##2##(2007-9#1)(2012-1#1)
single structural##3##2##(1990-11#1)(1996-12#1)(2006-12#1)
single structure##5##2##(1990-4#1)(1995-6#1)(2005-5#1)(2007-12#1)(2008-7#1)
single study##3##2##(2008-8#1)(2009-10#1)(2012-2#1)
single subcutaneous injection of##3##4##(1993-1#1)(1993-4#1)(2008-7#1)
single subject##7##2##(1997-2#1)(1997-8#4)(2013-1#1)(2013-8#1)
single subscales##2##2##(2011-1#2)
single substituted analogs##4##3##(1996-4#4)
single substitutions##2##2##(1991-2#1)(1993-3#1)
single substrate##4##2##(1991-5#1)(2008-3#3)
single subunit##3##2##(1991-12#1)(1992-8#1)(2011-1#1)
single surgeon experience##2##3##(2007-8#1)(2013-1#1)
single surgeon##4##2##(2007-8#1)(2008-9#1)(2013-1#2)
single surgical##3##2##(1994-8#1)(2008-11#1)(2012-2#1)
single system##3##2##(2005-11#1)(2008-8#1)(2012-2#1)
single target##3##2##(1993-11#1)(2008-2#1)(2008-3#1)
single telia##2##2##(2008-10#2)
single test in##2##3##(2008-6#1)(2008-8#1)
single test##6##2##(1997-6#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-12#1)(2012-2#1)
single therapy##2##2##(2006-3#1)(2007-12#1)
single thin##2##2##(2008-2#2)
single time##7##2##(1991-9#1)(1995-12#1)(1996-9#1)(2007-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
single to##3##2##(2006-12#1)(2008-3#1)(2011-1#1)
single tooth##5##2##(2007-12#3)(2011-12#1)(2012-3#1)
single topical application of##3##4##(1992-8#2)(1994-3#1)
single topical##4##2##(1992-8#2)(1994-3#1)(2009-8#1)
single training##2##2##(2008-2#1)(2013-8#1)
single transverse mode##6##3##(2007-12#1)(2008-2#1)(2008-3#4)
single treatment##9##2##(1994-10#1)(1995-12#1)(2005-8#1)(2007-12#1)(2008-12#1)(2010-5#1)(2010-9#1)(2011-12#1)(2012-2#1)
single treatments##4##2##(1994-10#1)(2008-10#1)(2013-1#2)
single trees##5##2##(2004-2#1)(2007-1#1)(2008-10#3)
single trial##4##2##(1994-2#2)(1996-12#1)(2008-4#1)
single trials##2##2##(1994-2#1)(2012-1#1)
single tropocollagen##2##2##(2009-7#2)
single tryptophan residue##8##3##(1990-7#1)(1991-2#2)(1991-7#1)(1992-12#1)(1992-6#1)(1996-7#1)(2005-11#1)
single tryptophan##14##2##(1990-7#1)(1991-2#2)(1991-5#1)(1991-7#1)(1992-12#1)(1992-6#1)(1993-9#1)(1994-8#1)(1995-1#1)(1995-5#1)(1996-7#1)(1997-7#1)(2005-11#1)
single tumor cells##3##3##(2011-2#2)(2012-12#1)
single tumor##4##2##(1994-12#1)(2011-2#2)(2012-12#1)
single turnover##9##2##(1990-7#1)(1994-11#2)(1994-12#1)(1994-9#1)(1995-1#1)(1995-11#1)(1997-3#1)(1997-4#1)
single two-dimensional synthetic##2##3##(2008-3#2)
single two-dimensional##5##2##(2007-11#2)(2008-2#1)(2008-3#2)
single type of##6##3##(1992-2#1)(1997-5#1)(2007-7#1)(2008-1#1)(2009-8#1)(2010-8#1)
single type##8##2##(1992-2#1)(1994-2#1)(1997-5#1)(2007-5#1)(2007-7#1)(2008-1#1)(2009-8#1)(2010-8#1)
single tyrosine residue##2##3##(1996-5#1)(2005-8#1)
single tyrosine##3##2##(1995-3#1)(1996-5#1)(2005-8#1)
single unique##2##2##(1991-2#1)(1997-7#1)
single unit activity##3##3##(1991-3#1)(1994-2#1)(2008-4#1)
single unit recording##2##3##(1994-8#1)(1996-10#1)
single unit responses##2##3##(1995-11#1)(1996-12#1)
single unit##11##2##(1991-3#1)(1994-2#1)(1994-8#1)(1995-11#1)(1996-10#1)(1996-12#2)(2007-7#1)(2008-10#1)(2008-4#1)(2012-3#1)
single units in##2##3##(1992-9#1)(2008-8#1)
single units##5##2##(1992-9#1)(1995-11#1)(1996-2#1)(2008-1#1)(2008-8#1)
single vaccination##2##2##(2008-5#2)
single variable##2##2##(2011-2#1)(2012-3#1)
single ventricle physiology##3##3##(2005-12#1)(2007-8#1)(2013-7#1)
single ventricle##13##2##(2005-12#1)(2007-8#4)(2008-9#4)(2009-4#2)(2012-1#1)(2013-7#1)
single versus multiple##5##3##(2008-10#3)(2011-1#1)(2012-3#1)
single versus##6##2##(2007-4#1)(2008-10#3)(2011-1#1)(2012-3#1)
single vesicle##2##2##(1997-7#1)(2012-2#1)
single vessel bypass grafting##2##4##(2006-10#1)(2007-8#1)
single vessel##8##2##(2006-10#2)(2007-8#3)(2008-3#2)(2013-8#1)
single virus##2##2##(1997-6#1)(2012-11#1)
single vision##4##2##(2007-4#3)(2008-7#1)
single wall carbon nanotubes##2##4##(2010-7#2)
single walled carbon nanotubes##2##4##(2010-3#1)(2010-8#1)
single walled carbon##3##3##(2010-3#1)(2010-8#2)
single wave of##2##3##(1995-11#1)(1996-5#1)
single wavelength modulation##2##3##(2008-10#2)
single wavelength##11##2##(2006-4#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2010-4#1)(2013-1#1)
single word##3##2##(2008-2#1)(2013-1#2)
single year##3##2##(1992-5#1)(2008-8#1)(2010-6#1)
single zoospore isolates##6##3##(2008-10#6)
single##4889##1##(1990-10#12)(1990-11#26)(1990-12#16)(1990-2#18)(1990-3#11)(1990-4#14)(1990-5#21)(1990-6#9)(1990-7#31)(1990-8#23)(1990-9#11)(1991-1#8)(1991-10#5)(1991-11#15)(1991-12#26)(1991-2#21)(1991-3#13)(1991-4#15)(1991-5#17)(1991-6#16)(1991-7#17)(1991-8#12)(1991-9#18)(1992-1#11)(1992-10#8)(1992-11#15)(1992-12#24)(1992-2#16)(1992-3#17)(1992-4#9)(1992-5#10)(1992-6#16)(1992-7#14)(1992-8#25)(1992-9#10)(1993-1#10)(1993-10#1)(1993-11#21)(1993-12#22)(1993-2#25)(1993-3#19)(1993-4#12)(1993-5#4)(1993-6#12)(1993-7#17)(1993-8#8)(1993-9#9)(1994-1#1)(1994-10#8)(1994-11#30)(1994-12#27)(1994-2#30)(1994-3#33)(1994-4#5)(1994-5#19)(1994-6#19)(1994-7#5)(1994-8#31)(1994-9#20)(1995-1#18)(1995-10#8)(1995-11#26)(1995-12#31)(1995-2#23)(1995-3#32)(1995-4#4)(1995-5#25)(1995-6#33)(1995-7#8)(1995-8#20)(1995-9#5)(1996-1#9)(1996-10#12)(1996-11#7)(1996-12#34)(1996-2#17)(1996-3#7)(1996-4#13)(1996-5#25)(1996-6#16)(1996-7#21)(1996-8#18)(1996-9#12)(1997-1#11)(1997-2#24)(1997-3#26)(1997-4#34)(1997-5#15)(1997-6#14)(1997-7#41)(1997-8#16)(1997-9#1)(2004-1#4)(2004-10#1)(2004-11#5)(2004-12#4)(2004-2#2)(2004-7#1)(2004-9#2)(2005-1#1)(2005-10#4)(2005-11#27)(2005-12#4)(2005-2#1)(2005-4#1)(2005-5#3)(2005-7#6)(2005-8#17)(2005-9#1)(2006-1#3)(2006-10#43)(2006-11#5)(2006-12#38)(2006-2#14)(2006-3#3)(2006-4#19)(2006-5#18)(2006-6#10)(2006-7#9)(2006-8#16)(2006-9#7)(2007-1#9)(2007-10#29)(2007-11#104)(2007-12#214)(2007-2#23)(2007-3#15)(2007-4#9)(2007-5#6)(2007-6#7)(2007-7#41)(2007-8#73)(2007-9#20)(2008-1#41)(2008-10#567)(2008-11#87)(2008-12#37)(2008-2#177)(2008-3#208)(2008-4#101)(2008-5#87)(2008-6#29)(2008-7#87)(2008-8#72)(2008-9#71)(2009-1#1)(2009-10#20)(2009-11#18)(2009-12#21)(2009-2#11)(2009-3#11)(2009-4#26)(2009-5#17)(2009-6#9)(2009-7#6)(2009-8#23)(2009-9#15)(2010-1#6)(2010-10#10)(2010-11#11)(2010-12#32)(2010-2#22)(2010-3#8)(2010-4#15)(2010-5#21)(2010-6#11)(2010-7#18)(2010-8#20)(2010-9#6)(2011-1#86)(2011-10#1)(2011-12#12)(2011-2#96)(2011-3#6)(2011-7#1)(2012-1#37)(2012-11#12)(2012-12#49)(2012-2#77)(2012-3#46)(2012-5#1)(2012-6#2)(2013-1#101)(2013-2#1)(2013-7#20)(2013-8#56)
single- and two-laser##2##3##(2008-2#2)
single- and##18##2##(1994-11#1)(2004-10#1)(2007-11#1)(2007-12#3)(2008-2#4)(2008-3#3)(2008-4#1)(2008-9#1)(2009-10#1)(2009-4#1)(2013-8#1)
single- or##16##2##(1996-9#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-8#1)
single-##42##1##(1994-11#1)(1995-2#1)(1996-9#1)(2004-10#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#6)(2008-3#8)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2010-5#1)(2013-8#2)
single-SNP##3##1##(2010-12#1)(2012-3#2)
single-aa##3##1##(1993-12#1)(1993-5#1)(1997-1#1)
single-agent activity in##2##3##(2005-10#1)(2006-10#1)
single-agent chemotherapy##3##2##(2008-6#2)(2009-3#1)
single-agent##13##1##(1997-5#1)(2005-10#1)(2006-10#1)(2007-10#1)(2008-6#3)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2012-1#1)(2013-1#1)
single-amino-acid##2##1##(1993-12#1)(2011-1#1)
single-arc RapidArc##2##2##(2013-1#2)
single-arc##3##1##(2013-1#3)
single-arm clinical trials##2##3##(1995-2#2)
single-arm##9##1##(1995-2#3)(2008-2#1)(2008-6#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
single-axial-mode##2##1##(2007-12#1)(2008-3#1)
single-band##9##1##(1993-11#1)(2008-2#3)(2008-3#5)
single-base mismatch in##2##3##(2008-10#2)
single-base mismatch##3##2##(1993-11#1)(2008-10#2)
single-base mismatches##2##2##(2008-10#1)(2008-4#1)
single-base resolution##3##2##(2008-2#1)(2012-3#2)
single-base##18##1##(1990-8#2)(1992-3#1)(1993-11#1)(1997-2#1)(2008-10#5)(2008-2#1)(2008-4#2)(2008-9#3)(2012-3#2)
single-beam gradient force##2##3##(2007-12#1)(2008-2#1)
single-beam gradient##3##2##(2005-11#1)(2007-12#1)(2008-2#1)
single-beam##11##1##(2005-11#1)(2007-12#2)(2008-2#6)(2008-3#2)
single-blind phase##2##2##(2008-6#2)
single-blind randomized##2##2##(2011-2#1)(2013-1#1)
single-blind study##3##2##(1990-6#1)(1991-4#1)(2010-8#1)
single-blind##15##1##(1990-3#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-4#1)(1993-5#1)(2008-6#2)(2008-8#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#2)
single-blinded##4##1##(2006-7#1)(2012-12#1)(2013-1#1)(2013-7#1)
single-bundle##3##1##(2009-7#1)(2013-1#1)(2013-7#1)
single-carbon metabolism##2##2##(1992-10#2)
single-case research##3##2##(2009-11#3)
single-case##8##1##(2008-4#1)(2009-11#3)(2009-5#1)(2013-1#2)(2013-8#1)
single-cell analysis##2##2##(1995-12#1)(2009-12#1)
single-cell gel electrophoresis assay##2##4##(1996-2#1)(1997-4#1)
single-cell gel electrophoresis##5##3##(1996-2#1)(1997-4#3)(2009-4#1)
single-cell level##9##2##(1990-12#1)(1993-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#2)(2011-2#1)
single-cell measurements##2##2##(1994-3#1)(2008-9#1)
single-cell reproduction##2##2##(2008-8#2)
single-cell suspension##3##2##(2008-11#2)(2008-9#1)
single-cell suspensions of##3##3##(2008-4#2)(2008-9#1)
single-cell suspensions##5##2##(2008-11#1)(2008-4#3)(2008-9#1)
single-cell##44##1##(1990-12#1)(1990-7#1)(1993-12#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-12#1)(1996-2#1)(1997-4#3)(2008-10#2)(2008-11#4)(2008-2#2)(2008-4#8)(2008-8#3)(2008-9#5)(2009-12#2)(2009-2#1)(2009-4#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-12#2)
single-celled organisms##2##2##(2012-2#1)(2013-8#1)
single-celled##5##1##(1995-2#1)(2008-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
single-center experience##6##2##(2007-12#3)(2007-8#1)(2008-11#1)(2011-2#1)
single-center##13##1##(2005-8#1)(2007-12#3)(2007-8#1)(2008-11#1)(2008-4#2)(2010-7#1)(2011-2#2)(2013-1#2)
single-centre study##2##2##(2007-8#1)(2011-2#1)
single-centre##7##1##(2007-5#1)(2007-8#1)(2008-11#1)(2010-12#1)(2011-2#2)(2012-2#1)
single-chain Fv##9##2##(1993-8#1)(1994-12#1)(1995-8#2)(2008-10#1)(2008-8#2)(2010-12#2)
single-chain antibodies (scFvs) against##2##4##(2008-10#2)
single-chain antibodies (scFvs)##3##3##(2008-10#2)(2008-4#1)
single-chain antibody fragment (scFv)##2##4##(2006-12#1)(2009-2#1)
single-chain antibody fragment##5##3##(1997-3#2)(1997-4#1)(2006-12#1)(2009-2#1)
single-chain antibody##12##2##(1993-8#1)(1994-8#1)(1997-2#1)(1997-3#2)(1997-4#1)(2006-12#1)(2008-4#1)(2008-8#2)(2009-2#1)(2009-8#1)
single-chain polypeptide##2##2##(1990-11#1)(1994-12#1)
single-chain precursor##4##2##(1992-10#1)(1992-12#2)(1996-2#1)
single-chain urokinase-type##2##2##(1990-11#1)(1992-12#1)
single-chain variable fragment antibodies (scFv) that bind##2##7##(2008-10#2)
single-chain variable fragment antibodies##3##4##(2008-10#3)
single-chain variable##4##2##(2008-10#4)
single-chain##61##1##(1990-11#2)(1990-12#1)(1991-2#1)(1991-7#1)(1991-8#3)(1992-10#1)(1992-12#4)(1992-2#1)(1992-6#1)(1992-8#1)(1993-8#2)(1994-12#2)(1994-6#1)(1994-8#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-2#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#1)(2004-8#1)(2006-12#1)(2008-10#8)(2008-4#2)(2008-5#3)(2008-8#7)(2009-2#1)(2009-8#1)(2010-12#2)(2011-1#1)
single-chamber##4##1##(2005-12#1)(2008-4#3)
single-channel activity of alamethicin##2##4##(1996-1#2)
single-channel activity##6##2##(1990-2#1)(1994-2#3)(1996-1#2)
single-channel and##2##2##(2007-11#1)(2008-4#1)
single-channel conductance##6##2##(1993-3#1)(1994-12#1)(1994-2#1)(1995-8#1)(1997-4#1)(2008-8#1)
single-channel currents##2##2##(1991-12#1)(1997-5#1)
single-channel data##2##2##(1992-11#1)(2007-12#1)
single-channel patch-clamp##2##2##(1995-12#1)(1995-6#1)
single-channel transmission##2##2##(2007-12#1)(2008-3#1)
single-channel##35##1##(1990-11#1)(1990-2#2)(1991-12#1)(1992-11#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-5#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-1#2)(1997-4#1)(1997-5#1)(1997-6#2)(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)
single-charged##6##1##(2008-10#6)
single-codon deletion##4##2##(1995-4#4)
single-color##3##1##(1997-6#1)(2008-1#1)(2008-4#1)
single-component##2##1##(2008-2#1)(2010-5#1)
single-copy DNA##3##2##(1994-12#1)(2008-10#2)
single-copy gene##17##2##(1991-5#1)(1991-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-4#1)(1996-6#1)(2008-4#1)(2008-7#1)(2008-8#1)
single-copy genes##4##2##(1991-5#1)(1997-4#1)(2008-10#1)(2008-4#1)
single-copy restriction fragment length polymorphism##2##5##(2008-10#2)
single-copy sequence##2##2##(1996-7#2)
single-copy##43##1##(1990-5#1)(1991-5#2)(1991-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-12#3)(1994-8#1)(1995-4#1)(1995-6#1)(1995-8#2)(1996-6#1)(1996-7#3)(1997-4#1)(2006-12#1)(2008-10#6)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-10#1)
single-core##2##1##(2010-2#1)(2012-2#1)
single-crystal X-ray diffraction##6##3##(1996-2#1)(1997-7#3)(2006-5#1)(2010-5#1)
single-crystal X-ray##12##2##(1996-2#1)(1997-2#2)(1997-7#3)(2005-7#1)(2006-12#1)(2006-5#1)(2010-2#1)(2010-5#2)
single-crystal diamond##2##2##(2006-4#2)
single-crystal diffraction##4##2##(1996-2#1)(2006-5#1)(2010-5#1)(2012-3#1)
single-crystal quartz##3##2##(2008-3#2)(2009-11#1)
single-crystal silver##2##2##(2006-12#1)(2008-2#1)
single-crystal structure##2##2##(1997-7#1)(2006-5#1)
single-crystal wafers##2##2##(2008-7#1)(2009-5#1)
single-crystal##53##1##(1992-12#1)(1992-7#1)(1996-2#3)(1997-2#2)(1997-7#6)(2005-7#1)(2006-12#2)(2006-4#8)(2006-5#3)(2007-12#8)(2008-1#1)(2008-2#4)(2008-3#4)(2008-7#1)(2009-11#1)(2009-5#1)(2010-2#1)(2010-5#4)(2012-3#1)
single-crystalline##8##1##(2006-12#1)(2006-5#1)(2008-3#1)(2010-12#1)(2010-4#2)(2010-7#2)
single-cycle electromagnetic pulses##3##3##(2007-12#3)
single-cycle pulses of terahertz##2##4##(2007-12#2)
single-cycle##10##1##(1997-7#1)(2007-12#9)
single-cysteine mutants##2##2##(1994-5#2)
single-digit arithmetic##5##2##(2009-1#5)
single-digit##7##1##(1994-12#2)(2009-1#5)
single-domain##4##1##(1993-12#1)(2007-11#1)(2007-12#1)(2008-2#1)
single-dose administration of##2##3##(1993-2#1)(2008-10#1)
single-dose administration##3##2##(1990-6#1)(1993-2#1)(2008-10#1)
single-dose therapy with##3##3##(1992-9#1)(1993-1#1)(2007-12#1)
single-dose therapy##4##2##(1991-12#1)(1992-9#1)(1993-1#1)(2007-12#1)
single-dose##24##1##(1990-6#2)(1991-12#1)(1992-9#2)(1993-1#3)(1993-2#1)(1994-9#1)(1995-5#1)(1997-5#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
single-drop microextraction (SDME)##4##3##(2008-10#4)
single-drop microextraction##6##2##(2008-10#6)
single-drop##10##1##(2008-10#9)(2008-3#1)
single-electron reduction##3##2##(1995-8#3)
single-electron tunneling##2##2##(1992-9#1)(1996-5#1)
single-electron##8##1##(1990-7#1)(1992-9#1)(1995-8#3)(1996-5#2)(2008-11#1)
single-electron-transferring##2##1##(1995-8#2)
single-element##3##1##(2007-11#1)(2008-2#1)(2008-3#1)
single-ended distributed##2##2##(2007-11#1)(2007-12#1)
single-ended##3##1##(2007-11#2)(2007-12#1)
single-enzyme##3##1##(2008-7#2)(2012-2#1)
single-family##2##1##(2008-10#1)(2008-5#1)
single-female-derived lines##2##2##(2008-10#2)
single-fiber pull-out test##2##3##(2005-11#2)
single-fiber##8##1##(2005-11#2)(2008-3#5)(2010-4#1)
single-field##2##1##(2008-2#2)
single-fraction##4##1##(2007-3#2)(2007-4#1)(2008-7#1)
single-frame##2##1##(2008-2#2)
single-frequency 532-nm##2##2##(2007-12#1)(2008-3#1)
single-frequency diode-pumped Q-switched Er##2##4##(2007-12#2)
single-frequency green laser##2##3##(2007-12#2)
single-frequency green output##2##3##(2008-3#2)
single-frequency green##4##2##(2007-12#2)(2008-3#2)
single-frequency idler wave##2##3##(2007-12#2)
single-frequency idler##4##2##(2007-11#1)(2007-12#3)
single-frequency laser##2##2##(2007-11#1)(2008-2#1)
single-frequency operation is##3##3##(2008-2#2)(2008-3#1)
single-frequency operation of##3##3##(2007-12#2)(2008-1#1)
single-frequency operation##10##2##(2007-11#2)(2007-12#3)(2008-1#1)(2008-2#3)(2008-3#1)
single-frequency oscillations on different transitions##2##5##(2007-12#2)
single-frequency radiation at##3##3##(2007-12#3)
single-frequency radiation##5##2##(2007-11#1)(2007-12#3)(2008-2#1)
single-frequency##69##1##(2007-11#7)(2007-12#30)(2008-1#6)(2008-2#14)(2008-3#12)
single-gene analyses##2##2##(2012-3#2)
single-gene association tests##2##3##(2012-3#2)
single-gene mutation##2##2##(2009-12#1)(2010-7#1)
single-gene##16##1##(1992-12#1)(2006-10#1)(2008-10#2)(2008-4#2)(2008-9#1)(2009-12#1)(2009-5#2)(2009-9#1)(2010-7#1)(2012-3#4)
single-genotype plots##4##2##(2008-10#4)
single-genotype##5##1##(2008-10#5)
single-grating##5##1##(2007-12#4)(2008-1#1)
single-group##4##1##(1993-1#1)(2007-2#1)(2010-7#1)(2013-1#1)
single-hTREK1-channel##2##1##(2012-2#2)
single-headed myosin II##4##3##(1995-8#4)
single-headed##6##1##(1995-8#4)(1996-11#2)
single-hospital##2##1##(1996-3#1)(1997-7#1)
single-image codebook##2##2##(2008-3#2)
single-image##4##1##(2008-2#1)(2008-3#3)
single-incision##4##1##(2006-4#1)(2011-2#2)(2012-12#1)
single-institution experience##3##2##(2008-3#1)(2008-5#1)(2012-2#1)
single-institution##7##1##(2007-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-3#1)(2011-2#1)(2012-2#1)
single-instruction multiple-data##2##2##(2008-2#1)(2008-3#1)
single-instruction##3##1##(2008-2#2)(2008-3#1)
single-instruction-multiple-data##2##1##(2008-3#2)
single-ion##4##1##(2007-12#1)(2008-10#1)(2010-7#1)(2012-2#1)
single-item##2##1##(2007-1#1)(2008-8#1)
single-joint strength##2##2##(2010-7#2)
single-joint##3##1##(2008-7#1)(2010-7#2)
single-knob tuning##2##2##(2008-2#2)
single-laser##7##1##(2008-2#2)(2008-3#1)(2008-4#2)(2008-9#2)
single-laser-shot##2##1##(2008-2#1)(2008-3#1)
single-layer viscous##2##2##(2009-10#2)
single-layer##15##1##(1997-4#1)(2007-12#2)(2008-2#5)(2008-3#2)(2009-10#2)(2009-11#1)(2009-7#1)(2010-4#1)
single-layered##3##1##(2007-12#1)(2008-3#1)(2011-1#1)
single-lens##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
single-level C-ADR with##2##3##(2012-12#2)
single-level C-ADR##4##2##(2012-12#4)
single-level##16##1##(2006-8#5)(2008-2#1)(2010-1#2)(2012-12#7)(2012-3#1)
single-line##3##1##(2008-10#2)(2008-3#1)
single-locus QTL mapping##2##3##(2012-3#2)
single-locus QTL##3##2##(2012-3#3)
single-locus##10##1##(2008-10#1)(2008-4#2)(2010-2#1)(2010-6#1)(2012-3#5)
single-longitudinal mode##2##2##(2008-2#1)(2008-3#1)
single-longitudinal##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
single-longitudinal- and##2##2##(2007-11#1)(2008-2#1)
single-longitudinal-mode (SLM)##3##2##(2007-12#2)(2008-3#1)
single-longitudinal-mode erbium-doped fiber laser##2##4##(2007-12#1)(2008-3#1)
single-longitudinal-mode erbium-doped fiber##3##3##(2007-12#1)(2008-3#2)
single-longitudinal-mode laser##2##2##(2007-12#1)(2008-2#1)
single-longitudinal-mode operation##2##2##(2007-11#1)(2008-2#1)
single-longitudinal-mode##15##1##(2007-11#1)(2007-12#8)(2008-2#3)(2008-3#3)
single-lung ventilation##4##2##(2006-10#4)
single-lung##5##1##(2006-10#4)(2012-1#1)
single-marker analysis using PLINK##2##4##(2012-3#2)
single-marker analysis##3##2##(2012-3#3)
single-marker##4##1##(2012-3#4)
single-masked##2##1##(2005-11#1)(2007-11#1)
single-minded gene##2##2##(1991-12#1)(1996-6#1)
single-minded##3##1##(1991-12#2)(1996-6#1)
single-modality##2##1##(2006-9#1)(2010-9#1)
single-mode Gaussian##2##2##(2008-2#2)
single-mode Nd##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
single-mode behavior##3##2##(2007-11#1)(2007-8#1)(2008-2#1)
single-mode cavity ringdown spectroscopy##2##4##(2008-3#2)
single-mode channel waveguide##2##3##(2007-12#1)(2008-2#1)
single-mode class B lasers##2##4##(2007-11#2)
single-mode continuous-wave##4##2##(2008-2#2)(2008-3#2)
single-mode core##2##2##(2007-11#1)(2007-12#1)
single-mode diode lasers##4##3##(2008-2#1)(2008-3#3)
single-mode diode##6##2##(2007-12#2)(2008-2#1)(2008-3#3)
single-mode emission##2##2##(2007-12#2)
single-mode fiber by##2##3##(2007-11#1)(2007-12#1)
single-mode fiber collimators##2##3##(2008-3#2)
single-mode fiber coupler##2##3##(2007-11#1)(2007-12#1)
single-mode fiber coupling##3##3##(2008-2#2)(2008-3#1)
single-mode fiber depolarizer##2##3##(2008-2#2)
single-mode fiber is##2##3##(2007-11#2)
single-mode fiber with a##3##4##(2007-12#1)(2008-2#2)
single-mode fiber with an##2##4##(2008-2#1)(2008-3#1)
single-mode fiber with##7##3##(2007-12#1)(2008-2#4)(2008-3#2)
single-mode fiber##54##2##(2007-11#10)(2007-12#18)(2008-1#1)(2008-2#14)(2008-3#11)
single-mode fiber-optic##2##2##(2008-2#2)
single-mode fibers are##2##3##(2007-11#1)(2007-12#1)
single-mode fibers by##2##3##(2007-12#1)(2008-1#1)
single-mode fibers with##2##3##(2007-12#1)(2008-2#1)
single-mode fibers##21##2##(2007-11#3)(2007-12#10)(2008-1#2)(2008-2#4)(2008-3#2)
single-mode gain margin##2##3##(2008-3#2)
single-mode laser diode##3##3##(2007-12#2)(2008-2#1)
single-mode laser##8##2##(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#1)
single-mode operation of a##2##4##(2008-3#2)
single-mode operation of##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
single-mode operation##13##2##(2007-11#1)(2007-12#6)(2008-2#3)(2008-3#3)
single-mode optical fiber by##3##4##(2008-1#1)(2008-2#2)
single-mode optical fiber with##3##4##(2007-12#2)(2008-1#1)
single-mode optical fiber##22##3##(2007-11#6)(2007-12#6)(2008-1#3)(2008-2#4)(2008-3#3)
single-mode optical fibers were##2##4##(2007-11#2)
single-mode optical fibers##11##3##(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#5)
single-mode optical##35##2##(2007-11#9)(2007-12#9)(2008-1#3)(2008-2#5)(2008-3#9)
single-mode or multimode##2##3##(2008-2#1)(2008-3#1)
single-mode output power##2##3##(2008-3#2)
single-mode output when##2##3##(2007-12#1)(2008-2#1)
single-mode output##7##2##(2007-12#2)(2008-2#3)(2008-3#2)
single-mode photonic crystal fiber##2##4##(2007-12#2)
single-mode polarization-maintaining##2##2##(2008-3#2)
single-mode quantum cascade##2##3##(2007-11#2)
single-mode regime##2##2##(2007-11#2)
single-mode slab waveguides##2##3##(2008-2#2)
single-mode tuning of##2##3##(2007-11#1)(2008-3#1)
single-mode tuning##4##2##(2007-11#2)(2008-2#1)(2008-3#1)
single-mode vertical-cavity surface-emitting laser with##2##5##(2007-12#2)
single-mode vertical-cavity surface-emitting laser##3##4##(2007-12#3)
single-mode waveguide##4##2##(2007-12#3)(2008-2#1)
single-mode waveguides##9##2##(2007-11#1)(2007-12#4)(2007-8#1)(2008-2#2)(2008-3#1)
single-mode##271##1##(2007-11#46)(2007-12#98)(2007-8#2)(2008-1#8)(2008-2#60)(2008-3#56)(2008-7#1)
single-molecule detection##3##2##(2008-2#2)(2012-2#1)
single-molecule fluorescence experiments##2##3##(2009-4#2)
single-molecule fluorescence##11##2##(2007-12#4)(2008-10#2)(2008-2#1)(2009-4#4)
single-molecule imaging of oxidation catalysis##2##5##(2008-7#2)
single-molecule imaging##3##2##(2008-7#2)(2010-2#1)
single-molecule studies##2##2##(2008-7#2)
single-molecule##35##1##(1997-6#1)(2007-11#1)(2007-12#4)(2008-10#3)(2008-2#3)(2008-7#6)(2009-4#5)(2009-9#1)(2010-10#1)(2010-2#2)(2010-7#1)(2011-12#1)(2012-1#1)(2012-2#4)(2013-8#1)
single-monitor method##3##2##(2010-9#3)
single-monitor##4##1##(2010-9#4)
single-neuron##4##1##(1990-7#1)(1994-2#1)(2008-4#1)(2009-8#1)
single-nucleotide polymorphism (SNP)##9##3##(2008-10#1)(2008-4#1)(2009-5#1)(2012-3#5)(2013-8#1)
single-nucleotide polymorphism##14##2##(2008-10#1)(2008-4#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-3#7)(2013-8#1)
single-nucleotide polymorphisms (SNPs) (minor allele frequency##2##6##(2012-3#2)
single-nucleotide polymorphisms (SNPs) in##3##4##(2012-3#3)
single-nucleotide polymorphisms (SNPs) that##2##4##(2012-3#2)
single-nucleotide polymorphisms (SNPs)##18##3##(2009-7#1)(2012-3#16)(2013-1#1)
single-nucleotide polymorphisms and##2##3##(2012-3#2)
single-nucleotide polymorphisms in##2##3##(2008-10#1)(2012-3#1)
single-nucleotide polymorphisms##40##2##(2007-8#2)(2008-10#1)(2008-4#1)(2009-7#1)(2012-3#32)(2013-1#2)(2013-8#1)
single-nucleotide##60##1##(1993-6#1)(1995-6#1)(2007-8#2)(2008-10#2)(2008-4#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-3#39)(2013-1#2)(2013-8#2)
single-order##5##1##(2007-12#1)(2008-2#1)(2008-3#3)
single-ovulating##2##1##(1994-7#1)(2008-3#1)
single-parent families##2##2##(2008-11#1)(2008-9#1)
single-parent##3##1##(2008-11#1)(2008-9#1)(2010-4#1)
single-particle detection##2##2##(2008-3#2)
single-particle tracking##2##2##(2009-4#1)(2011-1#1)
single-particle##10##1##(1991-12#1)(2008-2#2)(2008-3#3)(2008-7#1)(2009-4#1)(2011-1#1)(2012-1#1)
single-pass amplification##2##2##(2007-12#2)
single-pass and##2##2##(2007-12#1)(2008-3#1)
single-pass compression##2##2##(2008-2#2)
single-pass configuration##4##2##(2007-12#2)(2008-1#1)(2008-3#1)
single-pass cw##2##2##(2008-1#2)
single-pass frequency doubling##4##3##(2007-11#2)(2007-12#1)(2008-2#1)
single-pass pumping##2##2##(2007-12#1)(2008-2#1)
single-pass second-harmonic generation##2##3##(2007-12#2)
single-pass second-harmonic##3##2##(2007-12#3)
single-pass##42##1##(1997-2#1)(1997-4#1)(2007-11#3)(2007-12#17)(2008-1#4)(2008-2#6)(2008-3#8)(2011-3#2)
single-passage##2##1##(2008-5#2)
single-passband filters##2##2##(2007-12#2)
single-path##2##1##(2007-12#2)
single-payer##3##1##(1993-6#1)(1995-1#1)(1996-12#1)
single-peaked##2##1##(2007-11#1)(2007-12#1)
single-phase extraction##2##2##(2008-10#2)
single-phase solution##2##2##(2008-10#2)
single-phase##7##1##(1996-2#1)(2005-11#1)(2008-10#4)(2010-4#1)
single-photon and two-photon excitation##2##4##(2008-3#2)
single-photon and two-photon##3##3##(2008-3#3)
single-photon counting##5##2##(2007-11#1)(2008-3#4)
single-photon emission computed tomography (SPECT)##3##5##(2007-9#1)(2009-10#1)(2012-2#1)
single-photon emission computed tomography##8##4##(1995-5#1)(2006-10#1)(2007-9#2)(2009-10#1)(2012-2#3)
single-photon emission computed##10##3##(1995-5#1)(2006-10#1)(2007-9#3)(2009-10#1)(2012-2#3)(2013-7#1)
single-photon emission tomography##2##3##(1992-10#1)(2007-12#1)
single-photon emission##15##2##(1992-10#1)(1995-5#1)(2006-10#1)(2006-8#1)(2007-12#2)(2007-9#4)(2009-10#1)(2012-2#3)(2013-7#1)
single-photon excitation##2##2##(2008-3#2)
single-photon photolysis##2##2##(2008-4#2)
single-photon##37##1##(1992-10#1)(1995-5#1)(2006-10#1)(2006-8#1)(2007-11#3)(2007-12#6)(2007-9#4)(2008-2#3)(2008-3#10)(2008-4#2)(2009-10#1)(2012-2#3)(2013-7#1)
single-photon-counting##4##1##(2006-4#1)(2007-11#1)(2008-2#2)
single-point measurements##2##2##(2008-2#1)(2013-1#1)
single-point mutants##3##2##(1993-11#2)(2008-9#1)
single-point##17##1##(1991-5#1)(1993-11#3)(1993-8#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#2)(2008-9#2)(2011-1#2)(2013-1#1)
single-polarization operation of##2##3##(2007-12#2)
single-polarization operation##3##2##(2007-12#3)
single-polarization##4##1##(2007-12#3)(2008-2#1)
single-pool Kt/V##2##2##(2007-8#2)
single-port approach##2##2##(2007-8#2)
single-port##4##1##(2007-8#3)(2012-12#1)
single-projection##2##1##(2008-2#2)
single-pulse energy##2##2##(2008-3#2)
single-pulse##17##1##(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#9)
single-pump scheme##2##2##(2007-11#2)
single-pump##4##1##(1997-3#2)(2007-11#2)
single-resistance##2##1##(2008-10#2)
single-ring##2##1##(2007-11#1)(2010-2#1)
single-round##2##1##(2008-10#2)
single-scan##3##1##(2008-3#1)(2012-8#2)
single-scatter albedo was 0##3##4##(2008-3#3)
single-scatter##5##1##(2008-3#5)
single-scattering albedo and the##3##4##(2008-2#3)
single-scattering albedo and##4##3##(2008-2#4)
single-scattering albedo at##2##3##(2008-3#2)
single-scattering albedo of the hexagonal column##2##6##(2008-3#2)
single-scattering albedo of##4##3##(2008-3#4)
single-scattering albedo##20##2##(2008-2#7)(2008-3#13)
single-scattering##36##1##(2007-12#3)(2008-2#13)(2008-3#20)
single-seed descent##2##2##(2008-10#2)
single-session##3##1##(2011-12#1)(2013-1#1)(2013-7#1)
single-shelled oblate spheroid dielectric model##2##5##(1997-1#2)
single-shot autocorrelator##2##2##(2007-11#2)
single-shot geometry##2##2##(2007-12#2)
single-shot measurement of the##4##4##(2007-11#2)(2007-12#1)(2008-2#1)
single-shot measurement##5##2##(2007-11#2)(2007-12#2)(2008-2#1)
single-shot measurements of##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
single-shot measurements##7##2##(2007-12#3)(2008-2#1)(2008-3#3)
single-shot two-photon exposure##2##3##(2007-12#2)
single-shot##54##1##(2007-11#11)(2007-12#19)(2008-2#9)(2008-3#12)(2011-1#3)
single-side##2##1##(2012-2#2)
single-sideband modulation of##2##3##(2007-12#2)
single-sideband##6##1##(2007-12#3)(2008-3#3)
single-sided##2##1##(2008-2#2)
single-site mutants##2##2##(1997-2#1)(1997-7#1)
single-site mutations in the catalytic##2##5##(1990-8#2)
single-site mutations in##3##3##(1990-8#2)(2008-11#1)
single-site surgery##2##2##(2009-2#2)
single-site##15##1##(1990-8#2)(1991-7#1)(1994-11#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-7#1)(2008-11#1)(2008-3#1)(2009-2#2)(2012-12#2)(2012-2#1)
single-species##3##1##(2008-3#1)(2008-7#1)(2008-8#1)
single-spore isolates##3##2##(2008-10#3)
single-spore##4##1##(2008-10#4)
single-spot multianalyte##2##2##(2008-10#2)
single-stage bilateral##3##2##(2008-10#2)(2008-8#1)
single-stage ultrafast laser amplifier system##2##5##(2007-11#2)
single-stage##20##1##(2007-11#4)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-2#2)(2008-3#3)(2008-8#1)(2012-3#1)
single-step PCR##2##2##(1996-11#2)
single-step fabrication##2##2##(2007-11#1)(2008-2#1)
single-step phase modulation##2##3##(2008-3#2)
single-step procedure##4##2##(1991-11#2)(2005-12#1)(2008-10#1)
single-step##32##1##(1991-11#2)(1992-12#1)(1992-9#1)(1994-3#1)(1995-6#1)(1996-11#2)(1996-6#1)(1997-7#1)(2005-12#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-8#2)(2010-5#1)(2012-12#3)
single-strand (ss)##2##2##(1997-1#1)(2008-1#1)
single-strand DNA-binding protein ICP8##2##4##(1996-8#2)
single-strand DNA-binding protein##3##3##(1996-8#3)
single-strand RNA##2##2##(1995-12#1)(2006-10#1)
single-strand annealing##2##2##(1995-1#1)(2013-1#1)
single-strand breaks and##2##3##(1994-5#1)(1994-8#1)
single-strand breaks in##4##3##(1993-3#2)(1996-6#1)(1997-4#1)
single-strand breaks were##3##3##(1993-8#1)(2006-12#1)(2008-11#1)
single-strand breaks##22##2##(1992-3#1)(1993-3#4)(1993-8#1)(1994-5#1)(1994-8#4)(1995-6#2)(1996-2#1)(1996-6#1)(1997-4#3)(2006-12#1)(2008-11#2)(2008-3#1)
single-strand conformation polymorphism (SSCP) analysis##3##5##(1994-7#1)(2008-10#2)
single-strand conformation polymorphism (SSCP)##4##4##(1994-7#1)(2005-10#1)(2008-10#2)
single-strand conformation polymorphism analysis##2##4##(1992-8#1)(2011-2#1)
single-strand conformation polymorphism##13##3##(1990-11#1)(1990-12#1)(1992-8#1)(1994-7#1)(2005-10#1)(2007-12#3)(2008-10#4)(2011-2#1)
single-strand conformational polymorphism##4##3##(1997-4#1)(2008-10#2)(2008-4#1)
single-strand##54##1##(1990-11#1)(1990-12#1)(1990-4#1)(1992-3#1)(1992-8#1)(1993-3#4)(1993-7#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-7#2)(1994-8#4)(1995-1#1)(1995-12#1)(1995-6#3)(1996-2#1)(1996-6#1)(1996-8#3)(1997-1#1)(1997-4#4)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-12#3)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#1)(2011-2#1)(2013-1#1)
single-stranded (ss) DNA##3##3##(1993-4#1)(1997-2#1)(2008-2#1)
single-stranded (ss)##6##2##(1991-7#1)(1993-3#1)(1993-4#1)(1997-2#1)(2008-10#1)(2008-2#1)
single-stranded DNA (msDNA)##2##3##(1997-6#1)(2008-4#1)
single-stranded DNA (ssDNA)##6##3##(1993-3#1)(1994-12#1)(1995-2#1)(2008-10#1)(2008-7#1)(2012-3#1)
single-stranded DNA and RNA##2##4##(1992-12#1)(1994-8#1)
single-stranded DNA and##5##3##(1991-5#1)(1992-12#1)(1994-12#1)(1994-8#1)(2010-5#1)
single-stranded DNA binding ability##2##4##(1991-2#2)
single-stranded DNA binding protein##11##4##(1991-2#2)(1992-3#1)(1992-6#1)(1992-9#2)(1994-11#1)(1997-3#2)(1997-7#2)
single-stranded DNA binding##15##3##(1991-2#4)(1992-3#1)(1992-6#1)(1992-9#2)(1994-11#1)(1994-9#1)(1997-2#1)(1997-3#2)(1997-7#2)
single-stranded DNA or##2##3##(1990-3#1)(2008-4#1)
single-stranded DNA virus##3##3##(2006-2#1)(2008-10#1)(2008-9#1)
single-stranded DNA##60##2##(1990-2#1)(1990-3#1)(1990-5#2)(1991-2#4)(1991-3#1)(1991-5#2)(1992-12#1)(1992-3#1)(1992-6#2)(1992-9#2)(1993-3#3)(1994-11#1)(1994-12#6)(1994-8#1)(1994-9#1)(1995-2#2)(1995-6#1)(1996-7#4)(1997-2#1)(1997-3#3)(1997-6#2)(1997-7#3)(2006-12#1)(2006-2#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-4#2)(2008-7#1)(2008-9#1)(2010-5#1)(2012-3#2)
single-stranded DNA-binding protein##6##3##(1990-2#2)(1994-12#2)(1994-9#1)(2008-10#1)
single-stranded DNA-binding##7##2##(1990-2#2)(1994-12#2)(1994-9#1)(2008-10#1)(2010-10#1)
single-stranded DNAs##2##2##(1992-8#1)(2007-8#1)
single-stranded RNA molecules##2##3##(2008-10#1)(2011-2#1)
single-stranded RNA##13##2##(1992-12#1)(1992-8#1)(2008-10#5)(2008-4#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
single-stranded and double-stranded DNA##2##4##(2008-10#1)(2008-9#1)
single-stranded and double-stranded##3##3##(2008-10#1)(2008-9#2)
single-stranded and##7##2##(2008-10#2)(2008-4#2)(2008-9#2)(2009-3#1)
single-stranded binding##2##2##(1992-12#1)(1995-6#1)
single-stranded collagen fragments##2##3##(2011-1#2)
single-stranded collagen##4##2##(2011-1#4)
single-stranded conformational polymorphism##2##3##(1996-3#2)
single-stranded conformational##3##2##(1994-12#1)(1996-3#2)
single-stranded deoxyribonucleic acid##2##3##(2008-10#2)
single-stranded loops and##2##3##(1992-9#2)
single-stranded molecules##2##2##(1991-7#1)(2006-8#1)
single-stranded nucleic acid##4##3##(1994-9#1)(2007-8#1)(2008-10#1)(2008-9#1)
single-stranded nucleic acids##4##3##(1990-4#1)(1991-5#1)(2007-11#1)(2008-4#1)
single-stranded nucleic##8##2##(1990-4#1)(1991-5#1)(1994-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#1)
single-stranded nucleotides##2##2##(1993-1#2)
single-stranded oligodeoxyribonucleotides##3##2##(1990-4#1)(1991-7#1)(1992-2#1)
single-stranded oligonucleotide##3##2##(1992-9#1)(1995-5#1)(2008-5#1)
single-stranded oligonucleotides##4##2##(1993-8#1)(1994-11#1)(1996-5#2)
single-stranded polynucleotides##2##2##(1997-2#1)(2008-4#1)
single-stranded regions##3##2##(1990-4#1)(1992-9#1)(1996-5#1)
single-stranded viral RNA##2##3##(2008-10#1)(2010-7#1)
single-stranded##194##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#5)(1990-3#1)(1990-4#3)(1990-5#4)(1990-9#1)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#4)(1991-7#4)(1992-12#3)(1992-2#2)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#8)(1993-1#2)(1993-11#1)(1993-3#5)(1993-4#1)(1993-8#2)(1994-11#2)(1994-12#11)(1994-6#3)(1994-8#2)(1994-9#5)(1995-1#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#2)(1996-10#2)(1996-11#1)(1996-3#2)(1996-5#3)(1996-7#4)(1996-9#2)(1997-2#3)(1997-3#3)(1997-6#2)(1997-7#4)(2006-12#2)(2006-2#1)(2006-8#1)(2007-11#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#24)(2008-11#2)(2008-2#3)(2008-4#9)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#5)(2009-3#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-5#2)(2010-7#1)(2011-1#5)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
single-stripe##2##1##(2007-11#1)(2007-12#1)
single-subject experimental##3##2##(2007-4#1)(2007-7#1)(2011-2#1)
single-subject##8##1##(2006-10#2)(2007-4#1)(2007-7#1)(2009-12#1)(2009-9#1)(2011-2#2)
single-tailed##2##1##(2005-11#2)
single-tone##2##1##(2007-11#2)
single-tooth##5##1##(1996-3#1)(2013-1#4)
single-transmembrane##2##1##(1995-3#1)(2010-3#1)
single-transverse-mode##3##1##(2007-12#3)
single-tube##3##1##(2008-12#1)(2011-1#1)(2012-12#1)
single-turnover conditions##3##2##(1995-10#3)
single-turnover##8##1##(1993-11#1)(1995-1#1)(1995-10#4)(1996-7#1)(1997-4#1)
single-unit##5##1##(1991-5#1)(1995-1#1)(1995-12#2)(2008-1#1)
single-uredinial isolates##2##2##(2008-10#2)
single-uredinial##3##1##(2008-10#3)
single-use PCA pumps##2##3##(2007-2#2)
single-use patient-controlled analgesia##2##3##(2007-2#2)
single-use phosphorimetric##2##2##(2008-10#2)
single-use##10##1##(2007-2#4)(2008-10#4)(2011-2#1)(2012-3#1)
single-valued function##2##2##(2008-2#1)(2008-3#1)
single-vessel##2##1##(2007-8#2)
single-wall carbon nanotubes##5##3##(2007-11#1)(2008-10#2)(2008-12#1)(2009-6#1)
single-wall##6##1##(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2009-6#1)
single-walled carbon nanohorns##2##3##(2009-2#2)
single-walled carbon nanotube##5##3##(2008-10#1)(2008-7#4)
single-walled carbon nanotubes (SWNTs) are##3##5##(2008-7#1)(2009-11#1)(2010-7#1)
single-walled carbon nanotubes (SWNTs)##7##4##(2006-12#1)(2008-7#4)(2009-11#1)(2010-7#1)
single-walled carbon nanotubes with##2##4##(2010-2#1)(2010-7#1)
single-walled carbon nanotubes##23##3##(2006-12#2)(2007-2#1)(2008-10#4)(2008-3#1)(2008-7#9)(2009-11#2)(2010-2#1)(2010-7#2)(2013-1#1)
single-walled carbon##31##2##(2006-12#2)(2007-2#1)(2008-10#5)(2008-3#1)(2008-7#14)(2009-11#2)(2009-2#2)(2010-2#1)(2010-7#2)(2013-1#1)
single-walled nanotubes##3##2##(2008-7#3)
single-walled##39##1##(2006-12#2)(2007-12#2)(2007-2#1)(2008-10#5)(2008-3#1)(2008-7#19)(2009-11#2)(2009-2#2)(2010-11#1)(2010-2#1)(2010-7#2)(2013-1#1)
single-wavelength##5##1##(2006-5#1)(2007-11#2)(2008-2#2)
single-well potential##5##2##(2008-10#5)
single-well##7##1##(2007-12#2)(2008-10#5)
single-zoospore progeny##2##2##(2008-10#2)
single-zoospore##3##1##(2008-10#3)
singled out as##2##3##(2008-11#1)(2009-2#1)
singled out##8##2##(1991-4#1)(1994-6#1)(1996-12#1)(2006-10#1)(2007-12#1)(2007-5#1)(2008-11#1)(2009-2#1)
singlehood##2##1##(2011-2#2)
singles##4##1##(1991-2#1)(1992-6#1)(2006-8#1)(2008-3#1)
singlet and triplet##3##3##(1996-5#1)(2008-2#1)(2009-10#1)
singlet molecular oxygen##3##3##(1992-9#1)(2010-5#2)
singlet oxygen (1O2)##4##3##(1991-2#1)(2007-8#1)(2008-5#2)
singlet oxygen and superoxide##2##4##(2008-8#2)
singlet oxygen and##6##3##(1993-12#1)(2008-5#2)(2008-8#3)
singlet oxygen quencher##2##3##(2008-3#1)(2008-5#1)
singlet oxygen was##2##3##(2007-8#1)(2008-8#1)
singlet oxygen##49##2##(1990-1#1)(1990-11#3)(1991-2#3)(1991-9#2)(1992-12#2)(1992-7#1)(1993-12#1)(1994-10#1)(1994-12#1)(1996-7#1)(2006-12#1)(2007-11#3)(2007-8#4)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#11)(2008-8#6)(2009-4#1)(2010-4#1)(2012-11#1)
singlet states##3##2##(1997-7#1)(2008-10#1)(2012-1#1)
singlet##73##1##(1990-1#1)(1990-11#3)(1990-7#1)(1991-2#3)(1991-8#1)(1991-9#2)(1992-12#2)(1992-7#1)(1992-9#1)(1993-12#1)(1994-10#1)(1994-12#1)(1995-6#1)(1996-5#1)(1996-7#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-11#3)(2007-8#4)(2008-1#1)(2008-10#6)(2008-2#2)(2008-3#4)(2008-5#12)(2008-8#6)(2009-10#1)(2009-4#1)(2010-2#2)(2010-4#2)(2010-5#3)(2012-1#1)(2012-11#1)
singlet-singlet##3##1##(1993-11#1)(1993-12#1)(2008-3#1)
singlet-triplet##5##1##(1993-3#2)(1995-2#1)(2012-2#2)
singleton pregnancy##3##2##(2004-10#1)(2011-1#2)
singleton##22##1##(1992-10#1)(1992-12#2)(1993-10#1)(1994-6#1)(2004-10#1)(2006-2#1)(2007-11#2)(2008-12#1)(2008-2#1)(2009-2#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
singletons##3##1##(1995-6#1)(2008-11#1)(2011-2#1)
singling out##2##2##(2007-12#1)(2007-9#1)
singly and doubly protonated##3##4##(1996-7#3)
singly and doubly##4##3##(1996-7#3)(2013-8#1)
singly and in combination with##2##5##(1990-6#1)(2007-11#1)
singly and in combination##3##4##(1990-6#1)(2007-11#1)(2012-6#1)
singly and in##11##3##(1990-6#1)(1994-9#1)(1996-4#1)(2004-2#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2012-6#1)
singly and multiply##2##3##(1990-6#1)(2013-8#1)
singly and##22##2##(1990-6#2)(1994-9#2)(1995-10#1)(1996-4#1)(1996-7#3)(2004-2#1)(2004-4#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2012-6#1)(2013-8#2)
singly charged##4##2##(2006-3#1)(2008-1#1)(2009-12#2)
singly immunoprecipitated##2##2##(2008-2#2)
singly infected##2##2##(2008-10#1)(2013-8#1)
singly labeled##2##2##(1994-11#1)(2006-10#1)
singly occupied##2##2##(1996-2#2)
singly or in combination##3##4##(2007-11#1)(2008-5#1)(2012-12#1)
singly or in##10##3##(1995-4#1)(1996-5#1)(2006-8#2)(2007-11#1)(2008-5#3)(2010-1#1)(2012-12#1)
singly or##14##2##(1995-4#1)(1995-6#1)(1996-5#1)(2006-8#2)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#3)(2010-1#1)(2012-12#1)(2013-1#1)
singly phosphorylated##2##2##(1995-2#1)(2013-8#1)
singly protonated##5##2##(1996-7#4)(2010-5#1)
singly resonant OPO##5##3##(2007-11#3)(2007-12#2)
singly resonant optical parametric oscillator (SRO)##4##6##(2007-12#3)(2008-1#1)
singly resonant optical parametric oscillator based on periodically poled##2##9##(2007-12#2)
singly resonant optical parametric oscillator##12##5##(2007-11#1)(2007-12#9)(2008-1#1)(2008-3#1)
singly resonant optical parametric oscillators##3##5##(2007-12#2)(2008-3#1)
singly resonant optical parametric##15##4##(2007-11#1)(2007-12#11)(2008-1#1)(2008-3#2)
singly resonant##35##2##(2007-11#7)(2007-12#21)(2008-1#2)(2008-3#5)
singly scattered light##2##3##(2008-2#1)(2008-3#1)
singly scattered##3##2##(2008-2#2)(2008-3#1)
singly to##2##2##(1995-11#1)(2008-5#1)
singly##121##1##(1990-5#1)(1990-6#2)(1990-8#1)(1991-4#1)(1991-7#1)(1992-5#1)(1992-9#1)(1993-11#1)(1994-11#2)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-2#2)(1996-4#3)(1996-5#1)(1996-7#7)(2004-2#1)(2004-4#1)(2005-11#3)(2006-10#1)(2006-3#1)(2006-8#2)(2007-11#9)(2007-12#22)(2008-1#3)(2008-10#8)(2008-12#1)(2008-2#6)(2008-3#6)(2008-5#5)(2008-6#2)(2008-7#1)(2009-12#3)(2010-1#1)(2010-2#1)(2010-5#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-6#1)(2013-1#1)(2013-8#4)
singly-doped and doubly-doped##2##3##(2008-3#2)
singly-doped##3##1##(2008-3#3)
sings##2##1##(1997-6#1)(2005-12#1)
singular perturbation##4##2##(2006-10#1)(2007-9#1)(2008-2#1)(2011-1#1)
singular points of##2##3##(2007-11#1)(2008-3#1)
singular points##4##2##(1992-9#1)(2007-11#1)(2008-3#2)
singular spectra##4##2##(2010-8#4)
singular spectrum##2##2##(2008-2#1)(2010-8#1)
singular value decomposition (SVD) and##2##5##(1994-11#1)(2008-2#1)
singular value decomposition (SVD)##5##4##(1990-8#1)(1994-11#1)(2006-10#1)(2008-2#2)
singular value decomposition##14##3##(1990-8#1)(1994-11#1)(1994-9#1)(2006-10#1)(2007-12#1)(2008-10#5)(2008-2#3)(2010-10#1)
singular value##16##2##(1990-8#1)(1994-11#1)(1994-9#2)(2006-10#1)(2007-12#1)(2008-10#5)(2008-2#4)(2010-10#1)
singular values##4##2##(2008-2#3)(2008-3#1)
singular##62##1##(1990-8#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-3#1)(1994-9#2)(1997-5#1)(2004-8#2)(2006-10#2)(2007-11#2)(2007-12#2)(2007-9#1)(2008-10#7)(2008-11#1)(2008-2#13)(2008-3#5)(2008-7#2)(2009-10#1)(2009-7#1)(2010-10#1)(2010-7#1)(2010-8#5)(2011-1#4)(2011-2#2)(2013-1#1)(2013-8#1)
singular-value decomposition##5##2##(2008-2#1)(2008-3#4)
singularis##7##1##(2011-12#7)
singularities are##2##2##(2008-2#1)(2008-3#1)
singularities in the##2##3##(2007-11#1)(2012-1#1)
singularities in##4##2##(2007-11#2)(2008-1#1)(2012-1#1)
singularities##18##1##(2006-10#1)(2007-11#8)(2007-12#2)(2008-1#2)(2008-2#2)(2008-3#2)(2012-1#1)
singularity at the##2##3##(2005-11#1)(2008-3#1)
singularity at##3##2##(2005-11#1)(2008-2#1)(2008-3#1)
singularity in##2##2##(1995-7#1)(2008-3#1)
singularity##17##1##(1995-7#2)(2005-11#1)(2006-10#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#4)(2008-6#1)(2009-10#1)(2013-1#1)
singularly perturbed##2##2##(2013-8#2)
singularly##4##1##(2006-10#1)(2007-11#1)(2013-8#2)
sinica##5##1##(2008-10#4)(2008-5#1)
sinicola##4##1##(2011-12#4)
sinister##3##1##(2007-9#1)(2008-4#1)(2012-3#1)
sink for##6##2##(1992-1#1)(1992-6#1)(1997-4#1)(2008-10#1)(2008-11#2)
sink populations##3##2##(2013-1#3)
sink tissues##2##2##(1996-10#1)(2008-10#1)
sink##51##1##(1992-1#3)(1992-6#1)(1993-2#2)(1994-5#1)(1995-6#1)(1996-10#1)(1997-2#1)(1997-4#2)(2007-12#1)(2007-9#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#14)(2008-9#1)(2009-6#1)(2010-1#1)(2013-1#4)(2013-8#4)
sinking phytoplankton species##2##3##(2008-8#2)
sinking phytoplankton##4##2##(2008-8#4)
sinking##10##1##(2008-10#1)(2008-3#1)(2008-8#6)(2008-9#1)(2010-8#1)
sinks are##2##2##(2007-12#1)(2007-9#1)
sinks planted to##2##3##(2008-10#2)
sinks planted##4##2##(2008-10#4)
sinks to##2##2##(2008-10#1)(2008-9#1)
sinks##21##1##(1995-3#1)(2005-11#1)(2007-12#1)(2007-9#3)(2008-10#6)(2008-11#2)(2008-2#1)(2008-8#3)(2008-9#1)(2009-8#1)(2013-1#1)
sinoatrial blocks##4##2##(1996-3#4)
sinoatrial node##2##2##(2008-1#1)(2008-8#1)
sinoatrial##6##1##(1996-3#4)(2008-1#1)(2008-8#1)
sinogram##4##1##(2012-1#3)(2012-3#1)
sinomenine##3##1##(1994-8#2)(2008-12#1)
sinonasal epithelial cells##2##3##(2012-1#2)
sinonasal lymphoma##2##2##(2007-2#2)
sinonasal malignancies##3##2##(2008-3#1)(2011-1#1)(2012-1#1)
sinonasal symptoms following##2##3##(2011-2#2)
sinonasal symptoms##3##2##(2011-2#3)
sinonasal tract##5##2##(1993-6#1)(2009-1#1)(2010-7#3)
sinonasal undifferentiated carcinoma##3##3##(2008-3#2)(2010-7#1)
sinonasal##37##1##(1990-6#1)(1993-6#1)(2006-12#1)(2007-2#4)(2008-11#1)(2008-3#3)(2008-8#2)(2009-1#1)(2010-2#2)(2010-7#7)(2011-1#1)(2011-2#4)(2012-1#7)(2012-2#1)(2013-1#1)
sins##2##1##(1996-12#1)(2008-11#1)
sintered densities of the##2##4##(2004-9#2)
sintered##18##1##(1991-6#1)(1994-6#2)(2004-9#6)(2007-5#2)(2008-11#2)(2008-5#2)(2009-7#3)
sintering and##4##2##(1994-6#1)(2008-3#1)(2008-5#1)(2013-8#1)
sintering at##2##2##(2005-11#1)(2009-7#1)
sintering conditions##2##2##(2004-9#2)
sintering of##4##2##(2004-9#2)(2009-7#1)(2010-11#1)
sintering process##2##2##(2008-11#1)(2009-7#1)
sintering processes##2##2##(2006-12#1)(2008-3#1)
sintering temperature##2##2##(2004-9#2)
sintering temperatures##2##2##(2004-9#2)
sintering##29##1##(1994-6#2)(2004-9#9)(2005-11#2)(2006-12#2)(2008-11#1)(2008-3#4)(2008-5#3)(2009-7#3)(2010-11#1)(2013-8#2)
sinus access##2##2##(2012-1#2)
sinus and a##2##3##(2007-8#1)(2007-9#1)
sinus and skull base##3##4##(2007-5#2)(2013-1#1)
sinus and the##4##3##(1993-12#1)(1994-7#1)(1996-6#1)(2007-8#1)
sinus and##24##2##(1990-12#1)(1993-12#1)(1994-7#1)(1996-6#1)(1996-9#2)(1997-3#1)(1997-5#1)(2007-10#1)(2007-5#2)(2007-8#2)(2007-9#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-2#4)(2012-3#1)(2012-8#1)(2013-1#1)
sinus are##3##2##(2006-12#1)(2008-7#1)(2013-1#1)
sinus beats##2##2##(1996-6#2)
sinus blood##2##2##(1990-12#1)(1997-1#1)
sinus bradycardia##4##2##(1993-10#1)(1997-2#2)(2011-2#1)
sinus but##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
sinus can##2##2##(1996-9#1)(2005-5#1)
sinus conversion##2##2##(2007-8#2)
sinus disease##4##2##(2007-11#1)(2011-1#1)(2013-8#2)
sinus dural arteriovenous malformations##4##4##(2006-12#2)(2008-7#2)
sinus dural##5##2##(1996-9#1)(2006-12#2)(2008-7#2)
sinus during##2##2##(1993-12#1)(2013-8#1)
sinus fistula##2##2##(1995-6#1)(2007-8#1)
sinus floor augmentation##2##3##(2007-12#1)(2013-1#1)
sinus floor##4##2##(2007-12#2)(2008-11#1)(2013-1#1)
sinus gland##7##2##(1996-5#1)(2007-12#1)(2008-5#2)(2008-6#3)
sinus histiocytosis##2##2##(2011-1#1)(2012-12#1)
sinus in a##3##3##(1991-12#1)(2008-10#1)(2012-1#1)
sinus in an##3##3##(1994-7#1)(1996-6#1)(2013-7#1)
sinus in##10##2##(1991-12#1)(1994-7#1)(1996-6#1)(2005-10#1)(2007-10#2)(2008-10#1)(2008-5#1)(2012-1#1)(2013-7#1)
sinus involvement##2##2##(2006-4#1)(2008-7#1)
sinus is an##2##3##(1996-9#1)(2013-1#1)
sinus is##11##2##(1995-11#1)(1996-9#2)(2006-12#1)(2007-3#1)(2008-7#2)(2010-11#1)(2013-1#3)
sinus lift##3##2##(2007-12#1)(2010-5#2)
sinus mucocele##2##2##(2013-1#2)
sinus mucosa of##2##3##(2012-1#1)(2013-1#1)
sinus nerve##5##2##(1991-6#1)(1994-6#1)(1997-5#2)(1997-8#1)
sinus node artery##7##3##(2007-8#7)
sinus node disease##3##3##(1992-4#1)(1997-1#1)(2008-3#1)
sinus node##11##2##(1992-4#1)(1993-8#1)(1997-1#1)(2007-8#7)(2008-3#1)
sinus of Valsalva##12##3##(1997-5#3)(2007-8#3)(2009-10#3)(2010-5#1)(2010-9#1)(2011-2#1)
sinus of the##2##3##(2010-3#2)
sinus of##17##2##(1997-5#3)(2007-8#5)(2009-10#3)(2010-3#2)(2010-5#1)(2010-9#1)(2011-2#2)
sinus or paced rhythm##2##4##(2007-8#2)
sinus or##8##2##(2007-8#2)(2008-4#2)(2011-2#1)(2011-7#1)(2012-3#2)
sinus pressure##4##2##(1993-1#2)(2007-8#2)
sinus rhythm and##4##3##(1990-3#1)(1995-12#1)(2006-9#1)(2011-2#1)
sinus rhythm in patients with##2##5##(2010-6#1)(2011-2#1)
sinus rhythm in##3##3##(2008-7#1)(2010-6#1)(2011-2#1)
sinus rhythm showed##2##3##(2008-11#1)(2012-3#1)
sinus rhythm with##3##3##(1996-6#1)(1997-1#1)(2007-8#1)
sinus rhythm##46##2##(1990-3#1)(1990-9#1)(1994-3#1)(1995-12#2)(1995-4#1)(1996-4#1)(1996-6#1)(1997-1#3)(2006-10#1)(2006-9#1)(2007-7#1)(2007-8#7)(2007-9#3)(2008-1#2)(2008-11#2)(2008-7#2)(2009-10#1)(2010-12#3)(2010-2#1)(2010-6#2)(2011-2#6)(2012-3#2)(2013-1#1)
sinus showed##2##2##(2007-10#1)(2008-7#1)
sinus surgery##11##2##(2005-5#1)(2007-5#4)(2008-3#1)(2008-5#1)(2012-1#3)(2013-8#1)
sinus syndrome##8##2##(1990-12#2)(1993-10#2)(1997-1#2)(2007-8#1)(2010-12#1)
sinus system##2##2##(1996-9#1)(2011-2#1)
sinus tachycardia##2##2##(2010-12#1)(2011-2#1)
sinus that##3##2##(1996-9#1)(2008-2#1)(2008-3#1)
sinus thrombosis##21##2##(1997-3#1)(1997-6#2)(2007-10#2)(2007-9#9)(2008-7#5)(2012-12#1)(2012-3#1)
sinus to##2##2##(1993-9#1)(2006-5#1)
sinus tract##5##2##(2013-1#2)(2013-8#3)
sinus was performed##2##3##(2006-12#1)(2007-8#1)
sinus was##7##2##(1996-6#1)(1996-9#1)(1997-5#1)(2006-12#2)(2007-8#1)(2008-7#1)
sinus with detachable##2##3##(2006-12#2)
sinus with##7##2##(1993-7#1)(1996-9#1)(2006-12#2)(2008-7#2)(2013-1#1)
sinus##445##1##(1990-12#9)(1990-3#1)(1990-5#2)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-6#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-1#3)(1993-10#4)(1993-12#11)(1993-7#1)(1993-8#1)(1993-9#2)(1994-3#1)(1994-6#1)(1994-7#3)(1995-11#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-6#1)(1996-4#1)(1996-5#1)(1996-6#9)(1996-9#28)(1997-1#7)(1997-2#2)(1997-3#5)(1997-5#7)(1997-6#2)(1997-8#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-5#2)(2005-7#1)(2005-9#1)(2006-10#1)(2006-11#2)(2006-12#16)(2006-4#1)(2006-5#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#7)(2007-11#1)(2007-12#6)(2007-3#1)(2007-5#6)(2007-7#2)(2007-8#36)(2007-9#13)(2008-1#2)(2008-10#9)(2008-11#6)(2008-2#5)(2008-3#5)(2008-4#2)(2008-5#9)(2008-6#5)(2008-7#33)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#5)(2009-3#1)(2009-6#2)(2009-9#2)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#3)(2010-5#3)(2010-6#3)(2010-9#1)(2011-1#3)(2011-2#34)(2011-7#1)(2012-1#11)(2012-11#1)(2012-12#6)(2012-2#3)(2012-3#8)(2012-8#3)(2013-1#22)(2013-7#3)(2013-8#16)
sinuses and the##3##3##(2006-6#1)(2013-1#1)(2013-8#1)
sinuses and##8##2##(2005-5#1)(2006-6#1)(2007-2#1)(2007-7#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
sinuses are##3##2##(1996-9#2)(2005-10#1)
sinuses in##3##2##(1992-10#1)(2007-12#1)(2010-5#1)
sinuses were##2##2##(2007-8#1)(2008-7#1)
sinuses with##5##2##(1992-5#1)(2007-7#1)(2007-9#1)(2008-3#1)(2013-8#1)
sinuses##61##1##(1990-6#1)(1990-8#1)(1991-6#1)(1992-10#2)(1992-5#1)(1993-12#1)(1993-4#2)(1996-9#4)(2005-10#1)(2005-5#1)(2006-12#3)(2006-6#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-11#2)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#5)(2009-2#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#5)(2011-7#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
sinusitis and otitis##2##3##(2012-12#2)
sinusitis and##5##2##(1997-3#1)(2007-2#1)(2008-5#1)(2012-12#2)
sinusitis in pregnancy##2##3##(2012-8#2)
sinusitis in##9##2##(1991-6#1)(1993-5#2)(2008-5#1)(2010-12#1)(2011-1#2)(2012-8#2)
sinusitis is##3##2##(2011-1#1)(2013-1#2)
sinusitis was##3##2##(1993-5#1)(2008-5#1)(2011-2#1)
sinusitis##72##1##(1990-10#1)(1991-1#1)(1991-6#4)(1992-9#1)(1993-2#9)(1993-5#5)(1995-8#1)(1996-1#1)(1997-3#2)(1997-4#1)(2005-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-7#1)(2008-3#2)(2008-5#6)(2008-7#2)(2009-5#1)(2010-12#1)(2010-6#1)(2011-1#5)(2011-2#4)(2012-1#3)(2012-12#2)(2012-8#3)(2013-1#7)(2013-8#1)
sinusoid##9##1##(1991-5#1)(1996-12#1)(2006-12#1)(2007-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2012-12#1)
sinusoidal GSH##4##2##(1995-2#4)
sinusoidal and##6##2##(1990-12#1)(2008-2#3)(2008-3#1)(2012-1#1)
sinusoidal cells##2##2##(2006-10#1)(2009-3#1)
sinusoidal frequency modulation##2##3##(2008-2#1)(2008-3#1)
sinusoidal fringe##3##2##(2008-3#3)
sinusoidal function##2##2##(2008-3#2)
sinusoidal grating##4##2##(2008-2#2)(2008-3#2)
sinusoidal gratings##4##2##(1996-2#1)(2007-12#1)(2008-3#1)(2008-8#1)
sinusoidal phase modulation of the##2##5##(2007-11#1)(2008-2#1)
sinusoidal phase modulation##5##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#2)
sinusoidal phase##6##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)
sinusoidal phase-modulating interferometry##2##3##(2008-2#1)(2008-3#1)
sinusoidal phase-modulating##4##2##(2008-2#1)(2008-3#3)
sinusoidal signal##2##2##(2008-3#2)
sinusoidal transforms##2##2##(2008-2#2)
sinusoidal variation##2##2##(2007-12#1)(2008-2#1)
sinusoidal wavelength-scanning##2##2##(2008-3#2)
sinusoidal##95##1##(1990-12#2)(1990-3#1)(1991-12#2)(1992-6#1)(1992-9#1)(1995-2#5)(1996-11#1)(1996-2#1)(1996-5#3)(1996-8#1)(1996-9#1)(1997-5#1)(1997-7#1)(2006-1#1)(2006-10#4)(2006-8#1)(2007-11#4)(2007-12#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#17)(2008-3#30)(2008-4#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-7#1)(2012-1#1)(2013-1#1)
sinusoidally modulated laser diodes##2##4##(2008-3#2)
sinusoidally modulated##4##2##(1996-12#1)(2008-2#1)(2008-3#2)
sinusoidally with##2##2##(2007-12#1)(2008-3#1)
sinusoidally##10##1##(1995-12#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#5)
sinusoids##7##1##(1991-5#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)
sion##2##1##(2008-11#1)(2012-1#1)
siphon##4##1##(2006-8#1)(2008-10#1)(2008-5#2)
sir1 cells##3##2##(2008-8#3)
sir1##5##1##(1996-7#1)(2008-8#4)
sire and##2##2##(2005-7#1)(2013-8#1)
sire lines of Japanese Black cattle##2##6##(2012-2#2)
sire lines of##3##3##(2012-2#3)
sire##8##1##(2005-7#1)(2012-2#6)(2013-8#1)
sired by##5##2##(2005-7#1)(2008-8#1)(2010-8#2)(2012-1#1)
sired##9##1##(1990-6#1)(2005-7#1)(2008-8#1)(2010-2#3)(2010-8#2)(2012-1#1)
sires for##2##2##(2010-4#1)(2013-8#1)
sires from##2##2##(2012-2#1)(2013-8#1)
sires in##2##2##(2012-2#2)
sires##12##1##(2006-5#1)(2008-9#1)(2010-4#1)(2012-1#3)(2012-2#3)(2013-8#3)
siring success##2##2##(2008-8#1)(2008-9#1)
siring##3##1##(2008-8#1)(2008-9#2)
siro##4##1##(2011-2#4)
siroheme##3##1##(1993-8#3)
sirolimus (rapamycin)##2##2##(2007-11#2)
sirolimus and##3##2##(2007-11#2)(2010-5#1)
sirolimus eluting##2##2##(2008-11#1)(2009-12#1)
sirolimus##29##1##(2006-5#2)(2007-11#8)(2007-7#1)(2007-8#5)(2008-11#1)(2008-4#1)(2009-12#1)(2010-5#1)(2011-12#1)(2011-2#2)(2013-1#6)
sirolimus-eluting stent##3##2##(2008-11#1)(2008-12#1)(2010-5#1)
sirolimus-eluting stents##2##2##(2008-12#1)(2009-5#1)
sirolimus-eluting##7##1##(2008-11#2)(2008-12#2)(2009-5#2)(2010-5#1)
sirtuin##3##1##(2008-7#1)(2010-1#1)(2010-12#1)
sirtuins are##2##2##(2008-10#2)
sirtuins##5##1##(2008-10#5)
sisomicin##7##1##(2007-7#7)
sister and##2##2##(1995-10#1)(2008-1#1)
sister both##2##2##(1994-2#1)(1997-6#1)
sister chromatid exchange (SCE)##3##4##(1992-8#1)(2004-4#1)(2008-11#1)
sister chromatid exchange##8##3##(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#1)(2004-4#1)(2008-11#2)
sister chromatid exchanges (SCEs)##3##4##(1996-2#1)(1997-7#1)(2008-11#1)
sister chromatid exchanges and##2##4##(1993-12#1)(2008-11#1)
sister chromatid exchanges in human##2##5##(2008-11#2)
sister chromatid exchanges##9##3##(1992-6#1)(1993-12#1)(1996-2#1)(1997-7#2)(2008-11#4)
sister chromatid##19##2##(1992-6#3)(1992-8#1)(1992-9#1)(1993-12#2)(1996-2#1)(1997-7#2)(2004-4#1)(2008-11#6)(2008-7#1)(2012-2#1)
sister clades##2##2##(2008-8#2)
sister group of the##3##4##(2007-5#1)(2010-2#1)(2012-12#1)
sister group of##5##3##(2007-5#1)(2008-8#1)(2010-2#1)(2010-3#1)(2012-12#1)
sister group to##4##3##(2007-12#1)(2008-10#1)(2012-12#1)(2012-2#1)
sister group##11##2##(2007-12#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-8#2)(2010-2#1)(2010-3#1)(2012-12#2)(2012-2#1)
sister groups##2##2##(1992-12#1)(2008-10#1)
sister of##4##2##(1990-12#1)(1991-5#1)(2008-1#1)(2012-2#1)
sister relationship##2##2##(2008-6#1)(2009-5#1)
sister species##3##2##(1995-11#1)(2008-8#1)(2012-3#1)
sister taxa##3##2##(2008-10#2)(2009-2#1)
sister were##2##2##(2007-12#2)
sister who##2##2##(1996-6#1)(2011-2#1)
sister with##2##2##(1996-3#1)(1996-6#1)
sister##83##1##(1990-12#1)(1990-7#1)(1991-5#1)(1991-7#1)(1992-12#2)(1992-6#3)(1992-8#1)(1992-9#1)(1993-12#2)(1994-2#1)(1995-10#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1997-1#3)(1997-6#2)(1997-7#2)(2004-11#4)(2004-4#1)(2005-12#1)(2006-12#1)(2007-12#6)(2007-4#1)(2007-5#1)(2007-7#3)(2008-1#2)(2008-10#5)(2008-11#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-2#1)(2009-5#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)
sister's##2##1##(1996-5#1)(2012-1#1)
sister-chromatid exchange##2##2##(2008-8#1)(2012-2#1)
sisters and##3##2##(2004-8#1)(2008-12#2)
sisters had##3##2##(1996-5#1)(2007-10#1)(2008-1#1)
sisters were##2##2##(1992-12#1)(2011-2#1)
sisters with##5##2##(1997-5#1)(2004-11#2)(2008-9#1)(2011-2#1)
sisters##42##1##(1990-12#1)(1990-6#1)(1991-12#1)(1992-12#1)(1995-10#1)(1996-5#1)(1996-6#1)(1997-5#1)(2004-11#2)(2004-8#1)(2006-7#8)(2007-10#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-12#3)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#2)(2011-2#8)
sit at the##2##3##(2012-2#1)(2012-3#1)
sit at##3##2##(2006-10#1)(2012-2#1)(2012-3#1)
sit in a##2##3##(2010-4#1)(2011-7#1)
sit in the##2##3##(1995-3#1)(2006-8#1)
sit in##4##2##(1995-3#1)(2006-8#1)(2010-4#1)(2011-7#1)
sit without support##3##3##(1995-8#3)
sit##15##1##(1990-3#1)(1995-3#1)(1995-8#3)(2006-10#1)(2006-11#1)(2006-8#1)(2007-7#1)(2008-6#1)(2010-4#1)(2011-2#1)(2011-7#1)(2012-2#1)(2012-3#1)
sit-to-stand##4##1##(2012-1#4)
site (Asn##2##2##(1990-8#1)(1994-8#1)
site (Kd =##3##3##(1990-2#1)(1996-2#2)
site (Kd##5##2##(1990-2#1)(1990-3#1)(1994-5#1)(1996-2#2)
site (Ki##3##2##(1991-5#1)(1995-11#2)
site (RBS)##2##2##(1997-1#1)(2012-2#1)
site (STS) markers##8##3##(1996-10#1)(1996-12#2)(1997-4#2)(1997-8#1)(2008-10#2)
site (STS)##9##2##(1994-12#1)(1996-10#1)(1996-12#2)(1997-4#2)(1997-8#1)(2008-10#2)
site (attB)##2##2##(1993-12#1)(2007-12#1)
site (attP)##3##2##(1993-12#1)(1997-1#1)(2007-12#1)
site (center##3##2##(1992-11#3)
site (mean daily minimum##2##4##(2013-1#2)
site (the##3##2##(1991-6#1)(1995-5#1)(2008-2#1)
site -##2##2##(1990-12#1)(2010-9#1)
site 1##5##2##(1990-5#4)(2013-1#1)
site 2##6##2##(1990-5#3)(2008-8#3)
site 8 O-acetylated sialomucins##3##4##(1990-2#3)
site A##5##2##(1996-2#3)(2013-1#1)(2013-8#1)
site B##3##2##(1996-2#2)(2013-1#1)
site I##9##2##(1991-5#1)(1992-7#1)(1993-3#2)(1994-12#1)(1995-1#1)(1995-5#1)(2008-10#2)
site II##4##2##(2008-10#3)(2008-5#1)
site III##2##2##(1991-2#1)(1995-1#1)
site a##2##2##(1997-7#1)(2011-2#1)
site accessible to##2##3##(1991-11#1)(1992-7#1)
site after##6##2##(1990-4#1)(1990-6#2)(1991-7#1)(1994-9#1)(2011-2#1)
site agents are##2##3##(1995-5#2)
site agents##8##2##(1995-5#8)
site agonists##3##2##(1996-5#3)
site along the##2##3##(2006-3#1)(2008-8#1)
site amino acid residues##2##4##(1997-3#1)(2012-2#1)
site analysis of##4##3##(1994-12#1)(1996-4#1)(2008-4#1)(2008-8#1)
site analysis##5##2##(1994-12#1)(1996-4#1)(2008-4#1)(2008-5#1)(2008-8#1)
site and a potential##2##4##(1990-10#1)(1992-3#1)
site and a##12##3##(1990-10#1)(1991-8#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-6#1)(1995-1#1)(1996-4#1)(1997-4#1)(2007-6#1)(2007-9#1)(2008-2#1)
site and an##2##3##(1990-4#1)(1991-2#1)
site and for##2##3##(2009-10#1)(2013-8#1)
site and in##4##3##(1996-4#1)(2005-11#1)(2008-7#1)(2010-6#1)
site and is##3##3##(1990-5#1)(1994-8#1)(2008-8#1)
site and mode of##2##4##(1997-4#1)(1997-5#1)
site and multiple##2##3##(1990-9#1)(1996-4#1)
site and of##2##3##(1991-2#1)(1991-4#1)
site and regional##2##3##(1993-4#1)(2007-5#1)
site and size##2##3##(2007-10#1)(2008-6#1)
site and that the##2##4##(1992-10#1)(1994-12#1)
site and that##4##3##(1990-3#1)(1992-10#1)(1994-12#1)(1996-5#1)
site and the catalytic##2##4##(1993-3#1)(1994-10#1)
site and the##23##3##(1990-5#2)(1991-12#1)(1991-2#1)(1991-4#1)(1992-12#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-11#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-1#1)(2012-2#1)
site and then the##2##4##(1993-11#1)(1995-5#1)
site and then##3##3##(1991-7#1)(1993-11#1)(1995-5#1)
site and##175##2##(1990-10#2)(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#2)(1991-12#1)(1991-2#5)(1991-4#2)(1991-6#1)(1991-7#2)(1991-8#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#3)(1993-4#2)(1993-6#1)(1994-10#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#2)(1994-8#4)(1995-1#5)(1995-10#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-8#3)(1996-10#1)(1996-11#1)(1996-4#3)(1996-5#2)(1996-8#3)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#1)(2004-9#1)(2005-11#2)(2005-7#1)(2006-11#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-2#1)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#4)(2007-8#3)(2007-9#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#2)(2009-3#1)(2009-4#1)(2009-6#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#5)
site are discussed##2##3##(1990-4#1)(1995-8#1)
site are##20##2##(1990-4#1)(1990-6#1)(1991-4#1)(1991-8#1)(1992-11#1)(1992-2#1)(1994-9#1)(1995-5#1)(1995-8#2)(1996-7#1)(1997-1#1)(2005-10#1)(2006-12#1)(2006-3#1)(2007-12#2)(2008-6#1)(2008-8#1)(2011-2#1)
site areas##2##2##(2008-10#1)(2008-12#1)
site as a##4##3##(1992-12#1)(1995-11#1)(1995-6#1)(1997-7#1)
site as an##2##3##(1996-12#1)(2009-9#1)
site as the##3##3##(1990-5#1)(1991-8#1)(1996-12#1)
site as well as##2##4##(1992-3#1)(2007-7#1)
site as##21##2##(1990-5#3)(1990-9#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-4#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-12#2)(1997-7#1)(2003-11#1)(2007-7#1)(2008-10#1)(2008-9#1)(2009-9#1)
site associated with##4##3##(1991-3#1)(1991-9#1)(2005-7#1)(2005-8#1)
site at residues##2##3##(1994-8#1)(1994-9#1)
site at the##10##3##(1990-4#1)(1992-9#2)(1994-8#1)(1995-1#1)(1995-11#1)(2007-9#1)(2008-8#1)(2013-1#2)
site at which##3##3##(1991-3#1)(1992-3#1)(1992-9#1)
site at##34##2##(1990-4#1)(1990-7#1)(1991-3#2)(1991-4#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-9#3)(1994-12#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#2)(1996-2#1)(1996-4#1)(1996-5#1)(1997-4#3)(2007-9#1)(2008-10#2)(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#2)
site availability##5##2##(2008-11#2)(2008-4#1)(2009-8#1)(2012-2#1)
site available to##2##3##(1992-6#2)
site based on the##2##4##(2007-8#1)(2008-8#1)
site because of##2##3##(1994-9#1)(2006-7#1)
site between the##3##3##(1995-6#1)(2004-11#1)(2007-8#1)
site between##5##2##(1995-11#1)(1995-6#1)(2004-11#1)(2007-8#1)(2008-8#1)
site binding##2##2##(1990-7#1)(1997-2#1)
site binds##2##2##(1992-3#1)(1994-8#1)
site bleeding##3##2##(1997-8#1)(2007-8#1)(2011-2#1)
site but also##2##3##(2008-6#1)(2012-2#1)
site but##10##2##(1990-5#1)(1990-7#1)(1993-4#1)(1994-3#1)(1996-11#1)(1997-3#1)(1997-5#1)(2008-10#1)(2008-6#1)(2012-2#1)
site by the##2##3##(1995-3#1)(1995-6#1)
site by##19##2##(1990-7#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-6#1)(1993-7#1)(1994-12#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-4#1)(1997-1#1)(1997-6#1)(2008-10#4)(2010-4#1)(2013-8#1)
site can be detected##2##4##(1997-5#1)(2009-5#1)
site can be##7##3##(1997-2#1)(1997-5#1)(2006-9#1)(2007-11#2)(2007-2#1)(2009-5#1)
site can##13##2##(1992-3#1)(1995-1#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-5#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-4#1)(2009-5#1)
site changes##2##2##(2008-10#1)(2008-5#1)
site characterization of##2##3##(1991-12#1)(1994-12#1)
site characterization##5##2##(1991-12#1)(1994-12#1)(2008-10#3)
site closely##2##2##(1991-4#1)(1994-2#1)
site codon##4##2##(2006-11#4)
site complications but##3##3##(2011-2#2)(2013-1#1)
site complications##7##2##(2011-2#5)(2013-1#2)
site confirmed##2##2##(2008-10#1)(2008-5#1)
site conformation##2##2##(1990-5#1)(1995-3#1)
site contact##2##2##(1991-8#2)
site contained##2##2##(1992-11#1)(1995-12#1)
site containing##2##2##(1993-2#1)(1995-8#1)
site contains a##4##3##(1992-9#1)(1995-2#1)(2009-3#1)(2009-4#1)
site contains##6##2##(1992-9#1)(1994-3#1)(1995-2#1)(2008-4#1)(2009-3#1)(2009-4#1)
site cooperativity##3##2##(1997-2#2)(2012-2#1)
site corresponding to amino acid position##2##6##(1994-8#2)
site corresponding to##3##3##(1994-8#2)(1996-5#1)
site could be##2##3##(1992-11#1)(1997-6#1)
site could##5##2##(1990-5#1)(1992-11#1)(1997-6#1)(2008-11#1)(2008-9#1)
site defined##2##2##(1993-11#1)(2013-8#1)
site described##2##2##(1990-2#1)(2013-7#1)
site development##6##2##(2007-12#6)
site did not##5##3##(1993-7#1)(1994-10#1)(1994-5#1)(1995-2#1)(2008-4#1)
site dif##2##2##(1997-2#2)
site directed mutagenesis##7##3##(1990-2#1)(1990-3#1)(1992-12#1)(1992-4#1)(1992-9#1)(1994-3#1)(2008-1#1)
site directed##9##2##(1990-2#1)(1990-3#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-9#1)(1994-3#1)(2008-1#1)(2011-2#1)
site displayed##4##2##(1994-12#1)(1996-7#1)(2007-8#1)(2008-10#1)
site disrupts##2##2##(1994-12#1)(1994-8#1)
site distribution in##2##3##(2007-11#1)(2010-12#1)
site distribution##3##2##(2007-11#1)(2007-12#1)(2010-12#1)
site does not##4##3##(1993-7#1)(1994-11#1)(1996-5#1)(1997-4#1)
site duplex##2##2##(1993-11#2)
site during##3##2##(1995-3#1)(1996-7#1)(2008-10#1)
site effects##2##2##(1992-2#1)(2008-8#1)
site energies##2##2##(1991-6#1)(2008-3#1)
site environment is##2##3##(1995-11#1)(2008-3#1)
site environment##3##2##(1995-11#1)(2008-3#1)(2013-7#1)
site even##2##2##(1991-11#1)(1997-2#1)
site fidelity##2##2##(2010-4#2)
site flanked by##2##3##(1995-8#1)(1997-3#1)
site following##2##2##(1991-11#1)(1995-11#1)
site for a##4##3##(1993-8#1)(1995-11#1)(1997-6#1)(2008-10#1)
site for both##2##3##(1990-7#1)(1991-8#1)
site for intraosseous schwannoma##2##4##(2009-3#2)
site for the##37##3##(1990-12#1)(1990-5#2)(1990-7#2)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#2)(1992-8#3)(1993-12#1)(1993-3#3)(1993-9#1)(1994-11#2)(1994-8#1)(1994-9#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-10#1)(1997-7#1)(2008-10#2)(2008-4#1)(2009-8#1)(2010-5#1)(2010-7#1)(2012-2#1)
site for these##3##3##(1990-8#1)(1992-12#1)(1994-11#1)
site for two##2##3##(1994-11#1)(1997-4#1)
site for##165##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#6)(1990-6#1)(1990-7#4)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#3)(1991-6#2)(1991-7#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-4#3)(1992-5#1)(1992-7#1)(1992-8#4)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#2)(1994-11#4)(1994-12#2)(1994-2#3)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#4)(1995-5#1)(1995-6#4)(1995-8#3)(1996-10#1)(1996-2#1)(1996-4#1)(1996-5#2)(1997-3#1)(1997-4#5)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2005-7#1)(2006-10#3)(2007-12#1)(2007-4#1)(2007-7#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#2)(2009-8#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-2#3)(2013-7#1)
site formed by##2##3##(1995-11#1)(1995-8#1)
site found in the##2##4##(1995-11#1)(1997-5#1)
site from the##6##3##(1991-3#1)(1992-12#1)(1994-11#1)(1995-5#1)(2007-1#1)(2013-1#1)
site from##9##2##(1990-11#1)(1991-3#1)(1992-12#1)(1994-11#1)(1995-5#1)(1997-7#1)(2007-1#1)(2008-11#1)(2013-1#1)
site gastric cancer after##3##4##(2008-12#3)
site geometry##2##2##(1991-8#1)(1994-9#1)
site had##5##2##(1994-11#1)(2008-10#2)(2009-10#1)(2012-12#1)
site has been##8##3##(1991-3#1)(1991-4#1)(1992-7#1)(1994-12#1)(1995-2#1)(1997-7#1)(2005-8#1)(2013-8#1)
site has##12##2##(1991-12#1)(1991-3#1)(1991-4#2)(1992-7#1)(1994-12#1)(1995-2#1)(1997-1#1)(1997-7#1)(2005-8#1)(2013-1#1)(2013-8#1)
site have been##3##3##(1992-6#1)(1994-9#1)(1997-2#1)
site have##4##2##(1992-6#1)(1994-8#1)(1994-9#1)(1997-2#1)
site having##2##2##(1996-2#1)(1997-7#1)
site hemorrhage##2##2##(2007-9#1)(2012-12#1)
site identified##3##2##(1991-9#1)(1995-2#1)(2013-8#1)
site in T##2##3##(1994-11#2)
site in a##7##3##(1990-5#2)(1990-7#1)(1991-9#1)(1995-8#1)(2006-12#1)(2008-8#1)
site in each##2##3##(1990-5#1)(1994-11#1)
site in exon##3##3##(1991-4#1)(1995-10#1)(2008-4#1)
site in human pancreatic##2##4##(1992-2#1)(1995-11#1)
site in human##3##3##(1992-2#1)(1994-9#1)(1995-11#1)
site in northern##2##3##(2004-11#1)(2008-2#1)
site in one##2##3##(1995-10#1)(1995-8#1)
site in rat##2##3##(1990-2#1)(1994-2#1)
site in the intact##2##4##(1996-5#1)(1997-6#1)
site in the regulation of##2##5##(1990-8#1)(1991-12#1)
site in the same##2##4##(1996-2#1)(2007-12#1)
site in the##77##3##(1990-11#1)(1990-5#3)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#5)(1995-1#1)(1995-12#1)(1995-3#3)(1995-5#1)(1995-6#3)(1996-1#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-7#2)(1996-8#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-10#1)(2006-7#1)(2006-9#1)(2007-12#4)(2007-5#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-6#1)(2012-3#1)
site in vitro##2##3##(1991-12#1)(1996-3#1)
site in which##4##3##(1992-8#1)(1994-12#1)(1995-3#1)(1996-2#1)
site in##187##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#6)(1990-7#7)(1990-8#4)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#5)(1992-8#2)(1993-11#2)(1993-12#1)(1993-8#2)(1993-9#1)(1994-11#4)(1994-12#4)(1994-2#1)(1994-3#1)(1994-8#5)(1994-9#5)(1995-1#2)(1995-10#2)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#4)(1995-5#3)(1995-6#3)(1995-8#4)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#3)(1996-8#2)(1997-1#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(2004-10#1)(2004-11#2)(2004-4#1)(2006-12#3)(2006-7#2)(2006-9#1)(2007-12#4)(2007-5#1)(2007-8#2)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-8#3)(2008-9#2)(2009-2#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
site include##2##2##(1994-12#1)(2008-7#1)
site increases##2##2##(1996-11#1)(2010-12#1)
site indicated that##2##3##(1995-2#1)(1996-5#1)
site induced##2##2##(1993-12#1)(1994-5#1)
site infection##11##2##(2007-7#2)(2007-8#1)(2008-8#3)(2009-3#1)(2010-12#2)(2012-3#1)(2013-8#1)
site infections##25##2##(2006-6#3)(2007-8#1)(2008-10#4)(2009-3#2)(2010-2#1)(2010-8#2)(2012-11#8)(2012-3#3)(2013-1#1)
site interactions##3##2##(1990-10#1)(1996-8#1)(1997-2#1)
site into##2##2##(1994-5#1)(1995-6#1)
site involved in##2##3##(1994-8#1)(1995-10#1)
site is a##7##3##(1990-5#1)(1996-7#1)(1996-8#1)(2006-2#1)(2008-6#1)(2008-7#1)(2012-3#1)
site is also##2##3##(1991-11#1)(1995-6#1)
site is an##2##3##(1990-8#1)(1997-2#1)
site is at##2##3##(1991-3#1)(1994-9#1)
site is contained within a##2##5##(1995-2#1)(1995-5#1)
site is contained##3##3##(1995-11#1)(1995-2#1)(1995-5#1)
site is located in the##4##5##(1992-9#1)(1995-2#1)(2008-11#1)(2010-10#1)
site is located in##6##4##(1991-10#1)(1992-9#1)(1995-2#1)(1997-7#1)(2008-11#1)(2010-10#1)
site is located##11##3##(1990-7#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-9#1)(1993-8#1)(1995-2#1)(1997-7#1)(2008-11#1)(2010-10#1)
site is not##6##3##(1992-6#1)(1993-6#1)(1994-3#1)(1995-3#1)(2008-5#1)(2012-2#1)
site is presented##2##3##(2007-5#1)(2008-3#1)
site is required for##2##4##(1993-12#1)(1997-7#1)
site is responsible for the##2##5##(1990-5#2)
site is responsible for##3##4##(1990-5#2)(1992-12#1)
site is responsible##4##3##(1990-5#2)(1992-12#1)(2006-10#1)
site is the##4##3##(1991-3#1)(1997-1#1)(1997-4#1)(2007-7#1)
site is##104##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#5)(1990-7#2)(1990-8#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1992-12#2)(1992-3#1)(1992-5#3)(1992-6#1)(1992-9#1)(1993-12#2)(1993-4#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#4)(1995-8#2)(1996-11#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-7#3)(2005-10#1)(2006-10#2)(2006-2#1)(2006-3#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
site isolates##2##2##(2011-2#2)
site just upstream##2##3##(1993-9#1)(1995-8#1)
site just##3##2##(1993-9#1)(1995-8#2)
site leads to##2##3##(1990-5#1)(1992-8#1)
site lies##4##2##(1991-7#1)(1992-6#1)(1993-11#1)(2008-4#1)
site ligands were##2##3##(1995-11#2)
site ligands##7##2##(1991-12#1)(1995-11#4)(1995-12#1)(1995-5#1)
site located at##3##3##(2006-12#1)(2008-10#2)
site located in the##2##4##(1996-8#1)(2008-11#1)
site located in##3##3##(1996-8#1)(1997-7#1)(2008-11#1)
site located near##2##3##(1991-5#1)(2013-8#1)
site located within the##2##4##(1990-7#1)(1996-9#1)
site located##16##2##(1990-7#1)(1991-5#1)(1995-7#1)(1995-8#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2013-8#1)
site locations##2##2##(2006-10#1)(2012-12#1)
site loop##5##2##(1994-2#2)(1994-8#1)(1995-6#2)
site map##2##2##(2008-5#1)(2013-8#1)
site mapping##3##2##(1992-1#1)(1992-6#1)(2007-8#1)
site may be##10##3##(1990-3#1)(1991-1#1)(1991-3#1)(1994-12#1)(1995-2#2)(1995-5#1)(1996-8#1)(1997-3#1)(2011-12#1)
site may##16##2##(1990-3#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1994-12#1)(1995-2#2)(1995-5#1)(1996-5#1)(1996-8#1)(1997-3#1)(2005-7#1)(2010-11#1)(2011-12#1)(2011-2#1)
site metal##2##2##(1995-5#1)(2012-2#1)
site might##2##2##(1995-3#1)(1995-8#1)
site model##5##2##(1992-3#1)(1996-8#2)(2009-10#1)(2010-7#1)
site motif##4##2##(1993-11#1)(1993-4#1)(1994-12#1)(2013-1#1)
site mutants##2##2##(1992-3#1)(1992-9#1)
site mutation##4##2##(1997-7#1)(2005-6#1)(2008-12#1)(2008-8#1)
site mutations##5##2##(2005-10#1)(2009-3#2)(2009-5#1)(2012-2#1)
site near the##3##3##(1993-9#1)(1994-12#1)(1997-5#1)
site near##5##2##(1993-9#1)(1994-12#1)(1997-5#1)(2004-4#1)(2008-10#1)
site nor##2##2##(1995-1#1)(1997-2#1)
site observed##2##2##(1993-6#1)(1995-11#1)
site occupancy##2##2##(1995-2#1)(1995-5#1)
site of Bacillus stearothermophilus##2##4##(1995-2#1)(1996-8#1)
site of Bacillus##3##3##(1992-3#1)(1995-2#1)(1996-8#1)
site of DNA##4##3##(1990-5#1)(1991-8#1)(1994-9#1)(2008-1#1)
site of Escherichia coli##3##4##(1990-12#1)(1992-9#1)(1995-1#1)
site of S##2##3##(2008-12#1)(2011-2#1)
site of [3H]EHDA##2##3##(1992-1#2)
site of a##18##3##(1990-11#1)(1990-9#1)(1991-9#1)(1993-2#1)(1994-12#1)(1994-8#1)(1995-3#1)(1995-8#1)(2006-1#1)(2007-3#2)(2008-1#1)(2008-6#1)(2010-6#3)(2011-2#1)(2012-12#1)
site of access##2##3##(2007-7#1)(2008-11#1)
site of action for##3##4##(1994-2#1)(1996-1#1)(2011-1#1)
site of action of the##3##5##(1990-4#1)(1991-1#1)(1996-2#1)
site of action of##8##4##(1990-10#1)(1990-4#1)(1991-1#2)(1994-8#1)(1996-2#1)(2008-1#1)(2011-2#1)
site of action##22##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1991-1#2)(1991-2#1)(1991-6#2)(1994-2#1)(1994-8#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-6#1)(2004-3#1)(2006-8#1)(2008-1#1)(2008-10#1)(2011-1#1)(2011-2#1)
site of all##2##3##(1992-2#1)(2005-9#1)
site of an##10##3##(1990-9#1)(1992-3#1)(1995-3#1)(1996-1#1)(1996-7#1)(2006-4#1)(2008-7#1)(2012-2#1)(2013-1#2)
site of aortic##2##3##(2007-4#1)(2007-8#1)
site of application##43##3##(2007-7#1)(2008-10#1)(2008-9#41)
site of attachment##2##3##(1990-8#1)(2008-7#1)
site of bleeding##3##3##(1993-2#1)(2008-3#1)(2008-7#1)
site of bone##2##3##(1991-10#1)(2006-2#1)
site of cancer##4##3##(1997-8#1)(2007-11#2)(2008-5#1)
site of care##5##3##(2005-9#1)(2006-10#1)(2007-12#1)(2009-4#2)
site of ceruloplasmin##3##3##(1993-12#3)
site of cleavage of the signal peptide in##2##8##(1992-11#2)
site of cleavage##3##3##(1992-11#3)
site of covalent attachment of##2##5##(1992-6#1)(1994-5#1)
site of covalent binding of 1-nitroacridines##2##6##(1997-2#2)
site of covalent##4##3##(1992-6#1)(1994-5#1)(1997-2#2)
site of disease##4##3##(1990-9#1)(2006-10#1)(2008-6#1)(2012-2#1)
site of entry##2##3##(2008-11#1)(2011-1#1)
site of free radical##2##4##(1993-3#1)(2008-4#1)
site of human##4##3##(1990-12#1)(1990-4#1)(1993-6#1)(1994-11#1)
site of implantation##3##3##(2008-10#1)(2010-10#1)(2012-1#1)
site of infection and##2##4##(2008-10#1)(2011-1#1)
site of infection in##2##4##(1996-8#1)(2011-2#1)
site of infection##17##3##(1996-8#1)(1997-1#1)(2006-8#1)(2008-10#4)(2008-4#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#3)
site of injection##11##3##(1991-8#1)(1992-6#1)(1996-5#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-7#1)(2009-10#1)(2011-1#2)
site of injury##12##3##(1990-4#1)(1991-10#1)(1996-5#1)(2005-10#1)(2006-9#1)(2007-11#1)(2007-4#1)(2008-2#1)(2008-5#1)(2008-9#1)(2012-12#1)(2012-2#1)
site of insertion##3##3##(1996-9#1)(1997-4#1)(2006-10#1)
site of insulin resistance in Type 2##2##7##(2008-1#2)
site of integration##2##3##(1991-9#1)(2008-4#1)
site of interaction##4##3##(1993-3#1)(1994-3#1)(1996-8#1)(2012-1#1)
site of intron 5##2##4##(1993-4#2)
site of intron##3##3##(1993-4#2)(2011-1#1)
site of involvement##3##3##(2007-8#1)(2011-2#1)(2012-2#1)
site of itching and##2##4##(2008-1#2)
site of lesion##2##3##(1991-5#1)(2007-9#1)
site of long##3##3##(2007-11#1)(2007-7#2)
site of measurement##2##3##(1990-2#1)(2008-5#1)
site of metastases##5##3##(1991-10#2)(2007-11#1)(2008-3#1)(2008-7#1)
site of metastasis from##2##4##(1993-12#1)(2013-1#1)
site of metastasis##4##3##(1993-12#1)(2008-5#1)(2008-8#1)(2013-1#1)
site of metastatic disease##3##4##(2006-6#1)(2008-1#1)(2008-6#1)
site of metastatic##5##3##(1993-1#1)(2006-6#1)(2008-1#2)(2008-6#1)
site of mitochondrial##2##3##(1990-2#1)(1992-12#1)
site of nerve##2##3##(1991-3#1)(2012-2#1)
site of occurrence##2##3##(2007-5#2)
site of origin of##2##4##(2008-6#1)(2012-2#1)
site of origin##7##3##(1993-8#1)(2005-5#1)(2008-11#1)(2008-6#1)(2009-9#1)(2012-2#1)(2013-7#1)
site of phosphorylation##4##3##(1991-2#3)(1997-2#1)
site of plasminogen##2##3##(1990-12#1)(1997-2#1)
site of primary##2##3##(1990-11#1)(1991-6#1)
site of protein tyrosine##2##4##(1990-7#1)(1996-5#1)
site of protein##3##3##(1990-7#1)(1995-6#1)(1996-5#1)
site of rat liver##2##4##(1990-10#1)(1992-8#1)
site of rat##3##3##(1990-10#1)(1992-8#1)(1995-2#1)
site of recurrence##2##3##(1990-1#1)(2006-6#1)
site of reverse##2##3##(1991-10#2)
site of stimulation##7##3##(1991-11#1)(1992-12#2)(1994-2#1)(2011-1#3)
site of synthesis##2##3##(1990-12#1)(2008-1#1)
site of the E##2##4##(1991-4#1)(2008-8#1)
site of the NMDA receptor complex##4##6##(1991-9#2)(1996-1#1)(1996-2#1)
site of the NMDA receptor##9##5##(1990-2#2)(1991-9#2)(1996-1#2)(1996-2#2)(1997-2#1)
site of the NMDA##10##4##(1990-2#2)(1991-11#1)(1991-9#2)(1996-1#2)(1996-2#2)(1997-2#1)
site of the enzyme and##2##5##(1991-1#1)(1995-1#1)
site of the enzyme##22##4##(1990-9#1)(1991-1#2)(1991-2#1)(1991-5#2)(1992-11#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-4#1)(1994-5#1)(1994-8#2)(1995-1#1)(1996-10#1)(1997-6#1)(2008-4#1)(2008-5#1)(2009-9#1)
site of the human##3##4##(1990-12#1)(1994-5#1)(1995-6#1)
site of the lesion##3##4##(1991-1#1)(2007-12#1)(2007-9#1)
site of the mutation##3##4##(1990-12#1)(1993-8#1)(1994-11#1)
site of the protein##3##4##(1992-8#1)(1995-1#1)(2008-10#1)
site of the rat##2##4##(1996-11#1)(1997-2#1)
site of the reaction center##2##5##(1992-3#2)
site of the reaction##4##4##(1992-3#2)(1994-11#1)(2008-4#1)
site of the target##2##4##(2006-6#1)(2008-10#1)
site of the##186##3##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#3)(1991-11#3)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#3)(1991-7#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#4)(1992-9#1)(1993-11#3)(1993-3#3)(1993-4#1)(1993-7#1)(1993-8#2)(1993-9#2)(1994-11#7)(1994-12#1)(1994-2#1)(1994-5#5)(1994-8#3)(1994-9#2)(1995-1#3)(1995-11#1)(1995-2#3)(1995-3#3)(1995-5#4)(1995-6#2)(1995-8#1)(1996-1#3)(1996-10#1)(1996-11#2)(1996-2#2)(1996-5#3)(1996-7#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#3)(2005-11#1)(2005-9#2)(2006-12#1)(2006-3#1)(2006-6#2)(2007-10#1)(2007-12#5)(2007-6#2)(2007-8#2)(2007-9#3)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#6)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2009-9#1)(2010-12#2)(2010-4#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)
site of their##3##3##(1994-9#1)(1996-6#1)(2008-9#1)
site of these##3##3##(1990-12#1)(1996-5#1)(2006-3#1)
site of this##8##3##(1990-5#2)(1991-8#1)(1991-9#1)(1992-11#1)(1994-3#1)(1995-5#1)(2008-6#1)
site of thrombin##2##3##(1993-3#1)(1997-1#1)
site of transcription initiation##2##4##(1997-2#1)(1997-7#1)
site of transcription##3##3##(1991-5#1)(1997-2#1)(1997-7#1)
site of transplantation##2##3##(2008-8#1)(2012-12#1)
site of vascular##5##3##(2007-8#1)(2007-9#1)(2008-10#1)(2008-6#1)(2009-8#1)
site of##816##2##(1990-1#1)(1990-10#3)(1990-11#8)(1990-12#11)(1990-2#11)(1990-3#2)(1990-4#6)(1990-5#6)(1990-6#2)(1990-7#3)(1990-8#4)(1990-9#4)(1991-1#5)(1991-10#7)(1991-11#5)(1991-12#5)(1991-2#8)(1991-3#2)(1991-4#5)(1991-5#8)(1991-6#8)(1991-7#5)(1991-8#4)(1991-9#5)(1992-1#3)(1992-10#2)(1992-11#9)(1992-12#6)(1992-2#3)(1992-3#11)(1992-4#3)(1992-5#1)(1992-6#7)(1992-7#2)(1992-8#7)(1992-9#4)(1993-1#1)(1993-11#5)(1993-12#4)(1993-2#4)(1993-3#7)(1993-4#4)(1993-6#5)(1993-7#3)(1993-8#5)(1993-9#4)(1994-10#1)(1994-11#10)(1994-12#7)(1994-2#4)(1994-3#4)(1994-5#19)(1994-8#9)(1994-9#10)(1995-1#5)(1995-11#5)(1995-12#1)(1995-2#11)(1995-3#6)(1995-5#11)(1995-6#8)(1995-8#7)(1996-1#7)(1996-10#4)(1996-11#3)(1996-12#1)(1996-2#5)(1996-3#1)(1996-4#1)(1996-5#15)(1996-6#1)(1996-7#6)(1996-8#5)(1996-9#3)(1997-1#4)(1997-2#10)(1997-3#3)(1997-4#7)(1997-5#2)(1997-6#7)(1997-7#6)(1997-8#2)(2004-11#1)(2004-12#1)(2004-3#1)(2005-10#4)(2005-11#1)(2005-4#1)(2005-5#2)(2005-8#1)(2005-9#7)(2006-1#2)(2006-10#9)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#1)(2006-6#5)(2006-7#1)(2006-8#4)(2006-9#2)(2007-10#3)(2007-11#6)(2007-12#8)(2007-2#3)(2007-3#2)(2007-4#3)(2007-5#3)(2007-6#2)(2007-7#9)(2007-8#10)(2007-9#6)(2008-1#12)(2008-10#23)(2008-11#10)(2008-12#2)(2008-2#2)(2008-3#9)(2008-4#12)(2008-5#21)(2008-6#11)(2008-7#11)(2008-8#7)(2008-9#51)(2009-10#2)(2009-11#1)(2009-3#5)(2009-4#2)(2009-8#5)(2009-9#2)(2010-10#4)(2010-12#3)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#4)(2010-8#1)(2011-1#12)(2011-12#2)(2011-2#15)(2012-1#4)(2012-12#9)(2012-2#13)(2012-3#3)(2012-9#1)(2013-1#5)(2013-7#5)
site on a##2##3##(1995-11#1)(2008-7#1)
site on the NMDA##3##4##(1990-2#1)(1996-12#1)(1997-2#1)
site on the enzyme##3##4##(1991-5#1)(1995-5#1)(1996-5#1)
site on the##34##3##(1990-2#1)(1990-7#2)(1991-12#2)(1991-3#1)(1991-5#1)(1992-4#1)(1993-10#1)(1994-11#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-5#2)(1997-2#1)(1997-7#1)(2005-6#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-8#1)(2009-8#1)(2010-4#1)(2012-3#1)
site on tubulin##3##3##(1991-7#2)(1995-5#1)
site on##68##2##(1990-11#1)(1990-2#1)(1990-7#2)(1991-12#2)(1991-3#2)(1991-5#1)(1991-7#3)(1991-8#2)(1992-11#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-10#1)(1993-8#1)(1994-11#4)(1994-2#1)(1994-5#3)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#3)(1995-5#3)(1995-6#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#3)(1997-2#1)(1997-3#1)(1997-7#1)(2005-6#1)(2006-9#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-11#1)(2010-4#1)(2010-6#1)(2012-3#2)(2013-1#1)
site only##2##2##(1990-7#1)(2011-2#1)
site or##14##2##(1994-9#2)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(2004-4#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-2#2)(2010-8#1)
site outside the##2##3##(1991-7#1)(1995-8#1)
site outside##3##2##(1991-7#1)(1992-6#1)(1995-8#1)
site peptide##6##2##(1991-8#2)(1992-11#1)(1992-5#1)(1994-2#2)
site per##3##2##(1991-11#1)(1994-11#1)(1997-4#1)
site percolation##2##2##(2005-11#1)(2012-2#1)
site polymorphism##5##2##(2008-10#2)(2008-5#3)
site preference was##2##3##(1995-5#1)(1997-2#1)
site preference##3##2##(1990-7#1)(1995-5#1)(1997-2#1)
site preparation##3##2##(1990-12#1)(2007-12#1)(2008-10#1)
site present##2##2##(1992-6#1)(2008-4#1)
site preservation##2##2##(2007-12#2)
site prior to##2##3##(2008-6#1)(2009-10#1)
site producing##2##2##(1997-8#1)(2009-3#1)
site provides##2##2##(1994-8#1)(2008-2#1)
site reactions##4##2##(1996-8#1)(2008-8#3)
site recognized by the##2##4##(1990-10#1)(1990-11#1)
site recurrence after video-assisted thoracoscopic resection of chest wall schwannoma##2##10##(2007-8#2)
site region##5##2##(1990-2#1)(1993-5#1)(1994-6#1)(1994-8#1)(1997-3#1)
site remained##2##2##(1993-3#1)(2009-12#1)
site represents a##2##3##(1995-5#1)(2009-5#1)
site residue##3##2##(1993-11#1)(1993-6#1)(1994-6#1)
site residues are##3##3##(1992-8#1)(1994-9#1)(2012-2#1)
site residues in the##2##4##(1996-6#1)(2013-8#1)
site residues in##4##3##(1993-3#1)(1996-6#1)(2009-9#1)(2013-8#1)
site residues##25##2##(1990-3#1)(1991-9#1)(1992-11#2)(1992-8#1)(1992-9#1)(1993-3#1)(1994-11#2)(1994-9#2)(1995-11#1)(1995-2#1)(1996-6#1)(1996-7#2)(1997-4#2)(1997-7#1)(2007-6#1)(2009-9#1)(2012-2#3)(2013-8#1)
site resulting##2##2##(1991-9#1)(2008-11#1)
site results in##2##3##(1991-12#1)(1996-7#1)
site revealed##3##2##(1997-2#1)(2005-11#1)(2009-6#1)
site selection##7##2##(1991-12#1)(1991-6#1)(1995-8#1)(1997-4#1)(2006-5#1)(2008-12#1)(2008-8#1)
site selectivity##3##2##(1991-2#1)(1994-11#1)(1994-6#1)
site sequence##7##2##(1990-3#1)(1990-9#1)(1993-6#1)(1994-12#1)(1994-8#1)(2008-8#1)(2009-9#1)
site serine##9##2##(1991-2#2)(1991-4#1)(1992-12#1)(1992-6#2)(1994-8#2)(1995-3#1)
site showed##3##2##(1995-5#1)(2008-5#1)(2008-7#1)
site so that##2##3##(1992-7#1)(1995-3#1)
site specific##5##2##(1990-8#1)(1994-12#1)(1995-5#1)(2008-4#1)(2008-9#1)
site specifically##3##2##(1992-6#1)(2008-2#1)(2008-4#1)
site specificity of##2##3##(1990-12#1)(1990-7#1)
site specificity##5##2##(1990-12#1)(1990-7#1)(1992-5#1)(1994-10#1)(2006-10#1)
site structure##7##2##(1990-10#1)(1992-3#1)(1992-6#1)(1995-1#1)(1997-1#1)(2008-5#1)(2009-3#1)
site structures##3##2##(1991-2#1)(1992-8#1)(1995-5#1)
site than for##2##3##(1996-11#1)(1996-7#1)
site than##5##2##(1991-3#1)(1994-3#1)(1995-5#1)(1996-11#1)(1996-7#1)
site that had been##2##4##(2008-10#2)
site that had##3##3##(2008-10#2)(2013-1#1)
site that is##6##3##(1990-8#1)(1991-12#1)(1991-8#1)(1994-5#2)(2011-1#1)
site that may result in##2##5##(1995-10#1)(2011-2#1)
site that##30##2##(1990-8#1)(1991-12#1)(1991-6#1)(1991-8#1)(1993-8#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-10#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-4#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#3)
site the##2##2##(1993-11#1)(2011-12#1)
site therapy##2##2##(1992-2#1)(2011-12#1)
site through##3##2##(1991-10#1)(1991-12#1)(1996-7#1)
site throughout the##2##3##(1996-5#1)(2009-5#1)
site tissues##2##2##(2013-1#2)
site to be##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
site to block##2##3##(1994-8#1)(2009-7#1)
site to form##2##3##(1990-3#1)(2008-5#1)
site to the##6##3##(1990-7#1)(1992-6#1)(1996-8#1)(1997-1#1)(2008-3#1)(2012-1#1)
site to##43##2##(1990-10#1)(1990-3#1)(1990-7#2)(1991-1#1)(1991-11#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-6#2)(1993-7#1)(1994-5#2)(1994-8#1)(1995-10#1)(1995-5#1)(1995-6#1)(1996-8#1)(1997-1#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-7#1)(2009-9#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#3)
site toward##3##2##(2007-8#1)(2008-10#1)(2009-12#1)
site used to##2##3##(1994-11#1)(2008-4#1)
site used##3##2##(1994-11#1)(2006-6#1)(2008-4#1)
site using##3##2##(1994-8#1)(1996-2#1)(2011-12#1)
site variation##2##2##(2008-10#1)(2008-5#1)
site visits to##2##3##(1993-1#1)(2007-5#1)
site visits##3##2##(1993-1#1)(1995-12#1)(2007-5#1)
site was detected##2##3##(1992-6#1)(1994-5#1)
site was determined##2##3##(1991-9#1)(1996-7#1)
site was found to##2##4##(1990-10#1)(1996-5#1)
site was found##5##3##(1990-10#1)(1996-5#1)(1997-2#1)(1997-7#2)
site was identified and##2##4##(1992-12#1)(2007-8#1)
site was identified##8##3##(1991-7#2)(1992-12#1)(2005-5#1)(2006-12#1)(2007-8#1)(2008-8#1)(2013-8#1)
site was induced##2##3##(1995-1#1)(2007-7#1)
site was localized##2##3##(1994-11#1)(1995-6#1)
site was located##4##3##(1991-4#1)(1997-6#1)(2008-9#2)
site was mapped##3##3##(1994-8#1)(2009-7#1)(2011-2#1)
site was not##3##3##(1993-6#1)(1995-2#1)(2004-4#1)
site was##71##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-4#2)(1991-7#4)(1991-9#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-6#1)(1994-11#2)(1994-5#1)(1994-8#1)(1995-1#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#3)(2004-4#1)(2005-5#1)(2006-12#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-12#2)(2008-5#3)(2008-8#2)(2008-9#2)(2009-7#1)(2011-1#2)(2011-2#6)(2012-2#1)(2013-8#2)
site were found##2##3##(1991-6#1)(1995-5#1)
site were identified##2##3##(1991-10#1)(1996-4#1)
site were measured##3##3##(1993-11#1)(2008-10#1)(2008-9#1)
site were obtained##2##3##(1991-3#1)(2008-10#1)
site were studied##2##3##(2004-12#1)(2008-6#1)
site were used##2##3##(1995-2#1)(2008-10#1)
site were##35##2##(1990-3#1)(1990-6#1)(1991-10#1)(1991-3#1)(1991-6#2)(1993-11#1)(1994-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-4#1)(1997-4#1)(2004-12#2)(2006-12#1)(2007-11#1)(2007-3#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
site when##3##2##(1992-3#1)(1994-11#1)(1996-4#1)
site where it##2##3##(1996-8#1)(2007-12#1)
site where the##3##3##(1994-2#1)(2007-7#1)(2008-4#1)
site where##13##2##(1992-3#1)(1994-2#1)(1995-11#1)(1996-8#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-4#1)(2010-12#1)(2013-1#1)(2013-8#1)
site which is##4##3##(1991-1#1)(1992-1#1)(1995-3#1)(2010-12#1)
site which was##3##3##(1990-7#1)(1996-5#1)(1997-7#1)
site which##15##2##(1990-7#1)(1991-1#1)(1991-5#1)(1992-1#1)(1993-11#1)(1993-12#1)(1994-3#1)(1995-3#1)(1996-5#1)(1996-7#1)(1997-7#1)(2006-8#1)(2007-5#1)(2010-12#1)(2011-1#1)
site while##4##2##(1991-4#1)(1992-6#1)(1993-11#1)(2008-5#1)
site with a Ka of##2##5##(1995-5#2)
site with a##6##3##(1995-5#2)(1997-4#1)(1997-5#1)(2008-5#1)(2013-1#1)
site with an apparent##2##4##(1990-7#1)(1991-7#1)
site with an##4##3##(1990-7#1)(1991-7#1)(1992-7#1)(1994-5#1)
site with the##3##3##(1991-4#1)(1991-6#1)(2007-3#1)
site with two##2##3##(1993-11#1)(2011-2#1)
site with##42##2##(1990-2#1)(1990-5#2)(1990-7#1)(1991-4#3)(1991-5#2)(1991-6#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-11#2)(1994-5#1)(1995-11#2)(1995-2#1)(1995-5#4)(1997-2#1)(1997-4#1)(1997-5#1)(2006-7#1)(2007-1#2)(2007-2#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2011-2#1)(2013-1#2)
site within intron##2##3##(1993-9#1)(1995-5#1)
site within the##12##3##(1991-8#1)(1992-2#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-11#2)(1995-5#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-8#1)
site within##19##2##(1990-3#1)(1991-8#1)(1992-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-11#2)(1995-3#1)(1995-5#3)(1996-12#1)(1996-5#1)(1997-7#1)(2008-10#2)(2008-8#1)
site without##3##2##(1992-12#1)(1995-1#1)(2008-6#1)
site would##2##2##(1995-8#1)(2009-7#1)
site##3965##1##(1990-1#1)(1990-10#21)(1990-11#24)(1990-12#26)(1990-2#42)(1990-3#17)(1990-4#17)(1990-5#59)(1990-6#13)(1990-7#50)(1990-8#27)(1990-9#21)(1991-1#14)(1991-10#18)(1991-11#23)(1991-12#36)(1991-2#43)(1991-3#25)(1991-4#36)(1991-5#29)(1991-6#29)(1991-7#35)(1991-8#22)(1991-9#19)(1992-1#10)(1992-10#8)(1992-11#32)(1992-12#36)(1992-2#15)(1992-3#46)(1992-4#14)(1992-5#17)(1992-6#49)(1992-7#10)(1992-8#21)(1992-9#23)(1993-1#2)(1993-10#2)(1993-11#32)(1993-12#19)(1993-2#9)(1993-3#37)(1993-4#10)(1993-5#2)(1993-6#25)(1993-7#11)(1993-8#17)(1993-9#14)(1994-10#7)(1994-11#59)(1994-12#51)(1994-2#21)(1994-3#21)(1994-4#1)(1994-5#46)(1994-6#7)(1994-8#68)(1994-9#51)(1995-1#30)(1995-10#11)(1995-11#43)(1995-12#21)(1995-2#58)(1995-3#50)(1995-5#81)(1995-6#44)(1995-7#5)(1995-8#57)(1995-9#1)(1996-1#8)(1996-10#9)(1996-11#19)(1996-12#15)(1996-2#27)(1996-3#4)(1996-4#15)(1996-5#59)(1996-6#3)(1996-7#40)(1996-8#38)(1996-9#10)(1997-1#19)(1997-2#52)(1997-3#18)(1997-4#52)(1997-5#17)(1997-6#22)(1997-7#50)(1997-8#11)(2003-11#1)(2004-10#1)(2004-11#10)(2004-12#5)(2004-3#1)(2004-4#11)(2004-9#3)(2005-10#8)(2005-11#12)(2005-4#1)(2005-5#3)(2005-6#2)(2005-7#9)(2005-8#4)(2005-9#8)(2006-1#2)(2006-10#23)(2006-11#10)(2006-12#30)(2006-2#3)(2006-3#15)(2006-4#4)(2006-5#3)(2006-6#17)(2006-7#7)(2006-8#14)(2006-9#7)(2007-1#5)(2007-10#8)(2007-11#28)(2007-12#42)(2007-2#9)(2007-3#14)(2007-4#9)(2007-5#13)(2007-6#7)(2007-7#42)(2007-8#42)(2007-9#16)(2008-1#15)(2008-10#188)(2008-11#40)(2008-12#22)(2008-2#16)(2008-3#35)(2008-4#54)(2008-5#70)(2008-6#37)(2008-7#42)(2008-8#58)(2008-9#71)(2009-1#1)(2009-10#13)(2009-11#2)(2009-12#4)(2009-2#3)(2009-3#20)(2009-4#7)(2009-5#7)(2009-6#4)(2009-7#5)(2009-8#16)(2009-9#11)(2010-10#9)(2010-11#3)(2010-12#19)(2010-2#7)(2010-3#4)(2010-4#9)(2010-5#5)(2010-6#11)(2010-7#6)(2010-8#7)(2010-9#4)(2011-1#31)(2011-11#2)(2011-12#7)(2011-2#92)(2012-1#8)(2012-11#9)(2012-12#24)(2012-2#52)(2012-3#36)(2012-5#1)(2012-9#1)(2013-1#52)(2013-7#13)(2013-8#34)
site')##2##1##(1991-8#2)
site's##3##1##(2008-10#1)(2009-3#1)(2010-12#1)
site(s) in the##2##3##(1994-8#1)(2007-10#1)
site(s) in##3##2##(1994-8#1)(2007-10#1)(2008-5#1)
site(s) located##2##2##(1990-5#1)(1995-2#1)
site(s) of##5##2##(1991-2#1)(1993-3#1)(1994-8#1)(1995-5#1)(2008-10#1)
site(s) responsible for##2##3##(1990-7#1)(1991-9#1)
site(s)##31##1##(1990-5#1)(1990-7#1)(1991-2#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-8#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-5#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-10#1)(2012-2#1)
site) and##2##2##(1995-2#1)(2008-7#1)
site) of the##2##3##(1993-12#1)(1995-6#1)
site) of##3##2##(1993-12#1)(1995-2#1)(1995-6#1)
site) was##2##2##(1992-12#1)(1995-5#1)
site)##26##1##(1990-12#1)(1990-5#1)(1991-2#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-6#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-7#1)(1997-3#1)(1997-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#2)(2008-9#1)(2010-7#1)(2012-2#1)(2012-9#1)
site-binding model##2##2##(2005-11#1)(2008-10#1)
site-binding##3##1##(1994-5#1)(2005-11#1)(2008-10#1)
site-dependent##3##1##(1995-3#1)(2008-5#1)(2012-1#1)
site-directed antibodies##3##2##(1995-10#2)(1995-11#1)
site-directed inhibitors##2##2##(1996-8#1)(2008-5#1)
site-directed mutagenesis and##10##3##(1990-12#1)(1991-2#1)(1992-3#2)(1993-3#1)(1994-5#1)(1995-2#1)(1997-4#1)(2008-4#1)(2013-8#1)
site-directed mutagenesis as##3##3##(1990-5#1)(1994-8#1)(1994-9#1)
site-directed mutagenesis at##3##3##(1992-1#1)(1994-8#1)(2008-9#1)
site-directed mutagenesis combined with##2##4##(1995-8#1)(2010-5#1)
site-directed mutagenesis experiments##3##3##(1991-8#1)(1994-8#1)(1996-7#1)
site-directed mutagenesis in##3##3##(1990-5#1)(1995-2#1)(1995-8#1)
site-directed mutagenesis of the##7##4##(1990-5#1)(1990-6#1)(1992-6#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-10#1)
site-directed mutagenesis of this##2##4##(1992-11#1)(1995-5#1)
site-directed mutagenesis of##14##3##(1990-5#1)(1990-6#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#2)(1994-12#2)(1994-2#1)(1994-9#1)(1995-10#1)(1995-5#1)
site-directed mutagenesis on the##2##4##(1991-2#1)(1993-8#1)
site-directed mutagenesis studies##2##3##(1994-9#1)(2011-2#1)
site-directed mutagenesis to investigate the##3##5##(1990-7#1)(1994-9#1)(1995-5#1)
site-directed mutagenesis to##13##3##(1990-7#1)(1992-1#1)(1993-11#1)(1993-9#1)(1994-11#3)(1994-5#1)(1994-9#2)(1995-5#1)(1997-7#1)(2008-10#1)
site-directed mutagenesis using##4##3##(1990-11#2)(1990-5#1)(2008-10#1)
site-directed mutagenesis was##5##3##(1990-12#1)(1995-2#1)(1995-5#1)(2008-4#1)(2008-9#1)
site-directed mutagenesis we have##2##4##(1990-3#1)(1990-9#1)
site-directed mutagenesis##162##2##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#3)(1990-3#1)(1990-5#4)(1990-6#1)(1990-7#4)(1990-8#1)(1990-9#1)(1991-10#3)(1991-2#3)(1991-4#3)(1991-5#2)(1991-8#2)(1991-9#2)(1992-1#2)(1992-11#2)(1992-2#2)(1992-3#4)(1992-6#5)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#3)(1993-3#2)(1993-6#4)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#9)(1994-12#4)(1994-2#1)(1994-5#5)(1994-8#4)(1994-9#8)(1995-10#2)(1995-2#9)(1995-3#4)(1995-5#8)(1995-6#1)(1995-8#7)(1996-5#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#3)(2007-6#1)(2008-10#2)(2008-4#3)(2008-8#1)(2008-9#6)(2009-10#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-8#1)
site-directed mutants of##6##3##(1992-9#1)(1994-11#1)(1994-8#1)(1995-6#1)(1997-9#1)(2008-10#1)
site-directed mutants##11##2##(1992-9#1)(1994-11#1)(1994-8#2)(1995-2#2)(1995-6#2)(1997-2#1)(1997-9#1)(2008-10#1)
site-directed mutation of##2##3##(2008-8#2)
site-directed mutation##3##2##(1997-3#1)(2008-8#2)
site-directed mutations of##3##3##(1990-7#1)(1995-2#1)(1995-6#1)
site-directed mutations##5##2##(1990-7#1)(1991-5#1)(1995-2#2)(1995-6#1)
site-directed polyclonal antibodies##2##3##(1992-12#2)
site-directed##208##1##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#3)(1990-3#1)(1990-5#4)(1990-6#1)(1990-7#5)(1990-8#1)(1990-9#1)(1991-10#3)(1991-2#3)(1991-4#3)(1991-5#3)(1991-6#1)(1991-8#2)(1991-9#2)(1992-1#2)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#6)(1992-6#5)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#4)(1993-3#2)(1993-6#5)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#10)(1994-12#5)(1994-2#1)(1994-3#1)(1994-5#5)(1994-8#6)(1994-9#8)(1995-10#6)(1995-11#1)(1995-2#14)(1995-3#5)(1995-5#8)(1995-6#5)(1995-8#7)(1996-5#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#3)(1997-6#2)(1997-7#3)(1997-9#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-5#2)(2008-8#4)(2008-9#6)(2009-10#2)(2009-5#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-8#1)
site-independent telemedicine##2##2##(2008-8#2)
site-independent##4##1##(2008-8#4)
site-leucine-rich##2##1##(2008-10#1)(2012-11#1)
site-selective##3##1##(1991-6#1)(1997-7#1)(2006-12#1)
site-specific DNA##3##2##(1990-6#1)(1995-3#1)(1997-4#1)
site-specific TFs##2##2##(2008-9#2)
site-specific cancers##2##2##(2010-1#1)(2011-2#1)
site-specific cleavage##3##2##(1991-11#1)(1995-1#2)
site-specific endonuclease##2##2##(1994-5#1)(1995-1#1)
site-specific gene integration##2##3##(2006-12#2)
site-specific integration##4##2##(2006-12#3)(2008-5#1)
site-specific interaction##2##2##(1997-5#1)(2008-9#1)
site-specific mutagenesis##11##2##(1990-11#1)(1991-10#1)(1992-3#1)(1992-4#1)(1992-6#2)(1993-6#1)(1994-6#1)(1997-4#1)(2008-8#1)(2010-4#1)
site-specific mutant##3##2##(1995-10#1)(1995-3#1)(1997-4#1)
site-specific mutants##2##2##(1991-7#1)(1995-3#1)
site-specific mutation##3##2##(1993-6#1)(1997-6#1)(1997-7#1)
site-specific mutations of##2##3##(1991-8#1)(1992-3#1)
site-specific mutations##6##2##(1990-3#1)(1991-8#3)(1992-3#1)(2008-11#1)
site-specific recombinase##6##2##(1994-3#1)(1995-1#3)(1996-4#1)(2006-12#1)
site-specific recombinases##3##2##(1997-2#1)(2008-11#2)
site-specific recombination between##2##3##(1995-1#1)(2007-12#1)
site-specific recombination system##2##3##(1990-3#1)(1995-2#1)
site-specific recombination##16##2##(1990-3#1)(1995-1#2)(1995-2#1)(1996-4#1)(1997-2#2)(2006-12#2)(2007-12#2)(2008-2#1)(2008-4#1)(2008-8#1)(2011-12#1)(2012-2#1)
site-specific transcription##2##2##(1994-3#1)(2008-9#1)
site-specific##129##1##(1990-11#1)(1990-2#1)(1990-3#2)(1990-6#2)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#1)(1991-6#1)(1991-7#1)(1991-8#5)(1992-3#2)(1992-4#2)(1992-6#3)(1993-5#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1995-1#10)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#3)(1995-5#1)(1996-4#3)(1996-7#2)(1996-8#1)(1997-2#3)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-12#1)(2006-12#10)(2006-5#1)(2007-12#5)(2007-8#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-4#5)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#4)(2009-3#1)(2010-1#3)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#3)
site-specifically modified##4##2##(1996-11#1)(2008-4#2)(2010-7#1)
site-specifically##10##1##(1990-7#1)(1994-12#1)(1995-5#1)(1996-11#1)(2005-11#1)(2008-4#4)(2010-7#1)
site-to-site##2##1##(2007-11#1)(2007-12#1)
site-years##2##1##(2008-10#2)
sited in the##3##3##(1992-9#1)(1997-1#1)(2008-10#1)
sited##7##1##(1992-4#1)(1992-9#1)(1997-1#1)(2008-10#2)(2008-7#1)(2009-6#1)
siteof##2##1##(2008-11#1)(2009-8#1)
sites (D2##2##2##(1993-9#2)
sites (assessed by displacement of##2##5##(1995-12#2)
sites (e##4##2##(2008-10#1)(2008-4#1)(2012-2#1)(2012-3#1)
sites -##2##2##(2007-8#1)(2012-2#1)
sites I and II##5##4##(1994-8#1)(1995-1#1)(1996-7#3)
sites III and IV##4##4##(1994-8#2)(1995-1#2)
sites accessible to the##2##4##(1992-7#1)(2007-2#1)
sites accessible to##3##3##(1992-7#1)(2005-11#1)(2007-2#1)
sites across the##3##3##(2008-10#1)(2008-2#1)(2013-8#1)
sites across##5##2##(2008-10#1)(2008-2#1)(2011-12#1)(2011-2#1)(2013-8#1)
sites adjacent to##4##3##(1992-9#1)(1996-9#2)(2008-10#1)
sites after##4##2##(1992-6#2)(1994-11#1)(2008-9#1)
sites along the##6##3##(1992-9#1)(1994-9#1)(2007-3#1)(2008-10#1)(2012-3#2)
sites along##9##2##(1991-6#1)(1992-9#1)(1994-9#1)(2007-3#1)(2008-10#1)(2008-5#1)(2009-5#1)(2012-3#2)
sites also##7##2##(1991-10#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-9#1)(1994-3#1)
sites among##2##2##(2008-10#1)(2008-11#1)
sites and a##3##3##(1995-11#1)(1997-4#1)(2008-11#1)
sites and an##2##3##(2008-10#1)(2013-1#1)
sites and by##2##3##(1990-12#1)(2009-6#1)
sites and degree of##2##4##(1991-9#1)(1992-9#1)
sites and in##5##3##(1991-7#1)(2004-4#1)(2008-10#2)(2011-2#1)
sites and induce##2##3##(1992-1#1)(1996-6#1)
sites and one##2##3##(1990-6#1)(2008-3#1)
sites and putative##2##3##(1994-2#1)(1997-2#1)
sites and that##7##3##(1990-3#1)(1990-7#1)(1995-10#1)(1995-6#1)(1997-2#1)(2007-12#1)(2008-11#1)
sites and the##14##3##(1990-12#1)(1990-7#1)(1992-3#1)(1993-6#1)(1994-2#1)(1995-12#1)(1996-3#1)(1997-2#1)(2006-8#1)(2007-2#1)(2008-10#3)(2008-9#1)
sites and their##2##3##(1990-11#1)(1992-1#1)
sites and were##3##3##(1991-3#1)(2007-5#1)(2008-10#1)
sites and##153##2##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#3)(1991-1#1)(1991-2#1)(1991-3#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-11#1)(1992-3#4)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#3)(1993-11#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-6#3)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-10#4)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-7#1)(1996-1#2)(1996-10#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#4)(1997-4#1)(1997-6#1)(1997-8#1)(2004-11#1)(2004-12#1)(2004-3#1)(2004-4#1)(2005-8#1)(2006-10#2)(2006-2#2)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-3#2)(2007-5#3)(2007-6#1)(2007-8#1)(2008-10#15)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#4)(2013-8#1)
sites appear to be##2##4##(1990-2#1)(1991-4#1)
sites appear##3##2##(1990-2#1)(1991-4#1)(1996-2#1)
sites are being##2##3##(2007-12#1)(2007-7#1)
sites are bound##2##3##(1995-1#1)(2011-1#1)
sites are close to##2##4##(1994-12#1)(2011-1#1)
sites are conserved##2##3##(1992-12#1)(1997-9#1)
sites are discussed##2##3##(1993-6#1)(1995-2#1)
sites are exposed##3##3##(1990-3#1)(1990-5#1)(1991-11#1)
sites are found in the##2##5##(1992-4#1)(1993-11#1)
sites are found in##4##4##(1991-12#1)(1992-4#1)(1993-11#1)(2008-8#1)
sites are found##5##3##(1991-12#1)(1992-4#1)(1993-11#1)(1995-11#1)(2008-8#1)
sites are functional##2##3##(1997-2#1)(2008-5#1)
sites are highly##2##3##(1995-6#1)(2008-10#1)
sites are identified##3##3##(1994-11#1)(1995-10#1)(1995-6#1)
sites are likely##2##3##(1991-6#1)(1992-6#1)
sites are located in the##3##5##(1991-1#1)(1993-8#1)(2008-10#1)
sites are located within##2##4##(1996-7#1)(2009-4#1)
sites are located##5##3##(1991-1#1)(1993-8#1)(1996-7#1)(2008-10#1)(2009-4#1)
sites are more##2##3##(1992-2#1)(1994-11#1)
sites are not##3##3##(1993-3#1)(1995-3#1)(1997-4#1)
sites are of the##3##4##(1994-5#2)(1995-8#1)
sites are present in##3##4##(1991-10#1)(1994-11#1)(2008-11#1)
sites are present##10##3##(1991-10#1)(1993-9#1)(1994-10#1)(1994-11#1)(1995-10#1)(1995-3#1)(1995-7#1)(1997-4#1)(2008-11#1)(2008-7#1)
sites are presented##2##3##(1993-12#1)(2008-10#1)
sites are the##4##3##(2007-5#1)(2008-5#1)(2010-3#1)(2012-3#1)
sites are##128##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#2)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#3)(1992-4#3)(1992-6#1)(1992-9#2)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#5)(1994-12#3)(1994-5#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-2#1)(1995-3#2)(1995-6#3)(1995-7#1)(1995-8#3)(1996-1#1)(1996-3#1)(1996-4#3)(1996-7#5)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#2)(1997-7#2)(1997-9#1)(2004-11#1)(2004-12#1)(2007-12#2)(2007-5#1)(2007-7#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-3#2)(2010-9#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#4)(2012-3#2)
sites around##3##2##(2008-10#1)(2010-5#1)(2011-2#1)
sites as a##2##3##(1994-12#1)(2008-5#1)
sites as well##3##3##(1992-3#1)(1996-10#1)(2007-3#1)
sites as##11##2##(1991-11#1)(1991-9#1)(1992-3#1)(1994-12#1)(1995-8#1)(1996-10#1)(1997-2#1)(2007-3#1)(2007-5#1)(2008-5#1)(2009-11#1)
sites assigned##2##2##(1996-8#1)(2008-4#1)
sites associated with the##3##4##(1991-1#1)(1992-3#1)(2013-8#1)
sites at positions##2##3##(1994-11#1)(2011-1#1)
sites at residues##2##3##(2008-11#1)(2008-12#1)
sites at the##13##3##(1990-8#2)(1991-4#1)(1992-9#1)(1994-12#1)(1997-1#1)(1997-2#1)(2007-3#1)(2008-9#1)(2009-2#1)(2010-4#1)(2011-2#1)(2013-8#1)
sites at which##8##3##(1991-3#1)(1993-6#1)(1994-3#1)(1994-6#1)(1996-8#1)(2006-10#1)(2008-4#1)(2008-5#1)
sites at##41##2##(1990-2#1)(1990-8#2)(1991-11#1)(1991-3#1)(1991-4#1)(1991-5#2)(1992-12#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-8#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#2)(2006-10#1)(2007-3#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-9#1)(2009-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#2)
sites based on##3##3##(1990-10#1)(1991-3#1)(2008-4#1)
sites between##5##2##(1990-5#1)(1992-9#1)(1994-9#1)(1996-8#1)(2013-1#1)
sites bind##2##2##(1990-8#1)(1997-5#1)
sites both for##2##3##(1990-2#1)(2005-8#1)
sites but did not##2##4##(1995-10#1)(2008-10#1)
sites but##6##2##(1990-11#1)(1994-2#1)(1994-5#1)(1995-10#1)(1997-1#1)(2008-10#1)
sites by##19##2##(1990-12#1)(1991-5#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-6#1)(1997-5#1)(2005-11#1)(2006-12#1)(2006-3#1)(2008-10#2)(2008-9#1)(2010-12#1)(2011-2#1)
sites called##2##2##(2008-1#1)(2009-3#1)
sites can be##2##3##(1991-4#1)(2008-10#1)
sites can##7##2##(1991-4#1)(1993-9#1)(1995-6#1)(1996-10#1)(2008-10#1)(2008-9#1)(2011-2#1)
sites compared to##3##3##(1996-8#1)(2005-7#1)(2010-4#1)
sites compared##4##2##(1996-8#1)(2005-7#1)(2008-10#1)(2010-4#1)
sites conserved##2##2##(1992-12#1)(2013-1#1)
sites containing wild##2##3##(2008-10#2)
sites containing##4##2##(1995-8#1)(2004-10#1)(2008-10#2)
sites corresponding to the##2##4##(1994-11#1)(2008-10#1)
sites corresponding to##5##3##(1993-11#1)(1994-11#1)(1996-5#1)(2007-8#1)(2008-10#1)
sites could be##4##3##(1993-11#1)(1993-4#1)(1994-9#1)(2013-8#1)
sites covered##2##2##(2008-10#2)
sites decreases##2##2##(1990-5#1)(2013-8#1)
sites depending##2##2##(1996-10#1)(2008-10#1)
sites did not##5##3##(1992-7#1)(1995-7#1)(2007-2#1)(2011-12#1)(2013-1#1)
sites did##6##2##(1992-7#1)(1995-7#1)(2007-2#1)(2010-12#1)(2011-12#1)(2013-1#1)
sites differ##3##2##(1991-8#1)(1994-11#1)(2013-8#1)
sites distant from the##2##4##(1996-7#1)(2006-10#1)
sites distant from##4##3##(1996-7#1)(2006-10#1)(2008-10#1)(2012-11#1)
sites distant##5##2##(1996-7#1)(2006-10#1)(2008-10#1)(2012-11#1)(2013-7#1)
sites distributed along##2##3##(2008-1#1)(2013-7#1)
sites distributed##3##2##(1993-2#1)(2008-1#1)(2013-7#1)
sites do not##2##3##(1993-11#1)(1997-2#1)
sites dominated the##2##3##(1993-12#2)
sites due to the##2##4##(1990-12#1)(2009-5#1)
sites due to##4##3##(1990-12#1)(1994-12#1)(2009-5#1)(2011-2#1)
sites during##6##2##(2004-3#1)(2004-4#1)(2008-10#1)(2008-9#1)(2012-11#1)(2012-2#1)
sites excluding##2##2##(2008-10#1)(2011-2#1)
sites exhibit##2##2##(1991-6#1)(1993-9#1)
sites exhibited##4##2##(1993-12#1)(1994-9#1)(1995-10#1)(2008-3#1)
sites exhibiting##2##2##(2008-10#1)(2008-8#1)
sites following##4##2##(1991-11#1)(1991-5#1)(1993-5#1)(1997-2#1)
sites for 5-methyl-urapidil##3##3##(1995-12#3)
sites for ATP (Kd =##3##5##(1990-7#3)
sites for ATP##7##3##(1990-7#6)(1997-4#1)
sites for SH2##2##3##(1995-6#1)(1996-2#1)
sites for a##3##3##(1993-2#1)(1997-6#1)(2008-7#1)
sites for both##3##3##(1991-8#1)(1995-5#1)(2010-4#1)
sites for phosphorylation by##2##4##(1990-10#1)(1990-8#1)
sites for phosphorylation##3##3##(1990-10#1)(1990-8#1)(1995-3#1)
sites for protein##3##3##(1990-6#1)(1997-5#1)(1997-8#1)
sites for the##26##3##(1990-12#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-7#1)(1993-3#2)(1993-6#2)(1993-8#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-1#1)(1997-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2012-12#1)
sites for their##2##3##(1995-6#1)(1995-8#1)
sites for these##3##3##(1990-11#1)(1991-11#1)(1994-8#1)
sites for this##2##3##(1990-5#1)(2012-2#1)
sites for two##2##3##(1991-5#1)(1992-10#1)
sites for##235##2##(1990-1#1)(1990-10#1)(1990-11#4)(1990-12#4)(1990-2#2)(1990-3#4)(1990-4#1)(1990-5#5)(1990-6#2)(1990-7#8)(1990-8#7)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#9)(1991-6#2)(1991-7#5)(1991-8#4)(1991-9#3)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#3)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#2)(1993-3#8)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#3)(1994-11#2)(1994-12#3)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#5)(1994-9#5)(1995-1#2)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#3)(1995-5#5)(1995-6#4)(1995-7#1)(1995-8#5)(1996-10#1)(1996-2#3)(1996-3#1)(1996-7#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-12#1)(2005-10#1)(2005-11#1)(2006-12#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-4#6)(2008-6#1)(2008-7#3)(2008-8#2)(2009-2#1)(2009-6#1)(2009-8#2)(2010-2#3)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#2)(2013-1#2)
sites found##3##2##(1991-9#1)(2007-12#1)(2008-10#1)
sites from an##2##3##(1995-8#1)(1996-5#1)
sites from the##9##3##(1991-12#1)(1991-6#1)(1992-9#1)(1996-5#1)(1997-8#1)(2008-10#1)(2008-3#1)(2009-5#1)(2010-8#1)
sites from##21##2##(1990-5#1)(1990-8#1)(1991-12#1)(1991-6#1)(1992-9#1)(1993-11#1)(1995-8#1)(1996-4#1)(1996-5#2)(1997-8#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-8#1)(2012-6#1)
sites had##7##2##(1991-3#1)(1994-9#1)(1997-8#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
sites has been reported##2##4##(2011-12#1)(2012-2#1)
sites has been##4##3##(1994-12#1)(2005-9#1)(2011-12#1)(2012-2#1)
sites has##6##2##(1990-6#1)(1994-12#1)(2005-9#1)(2008-9#1)(2011-12#1)(2012-2#1)
sites have been identified##3##4##(1990-9#1)(1991-4#1)(1996-10#1)
sites have been##11##3##(1990-2#1)(1990-9#1)(1991-4#1)(1994-12#1)(1994-2#1)(1996-10#1)(1997-4#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-12#1)
sites have##17##2##(1990-2#1)(1990-9#1)(1991-4#1)(1992-3#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-10#1)(1997-1#1)(1997-4#1)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#1)(2010-12#1)
sites identified by##2##3##(2007-6#1)(2010-12#1)
sites identified##4##2##(1990-7#1)(1991-7#1)(2007-6#1)(2010-12#1)
sites in DNA##2##3##(2006-12#1)(2007-3#1)
sites in Florida and##2##4##(2004-2#1)(2011-2#1)
sites in Switzerland##2##3##(2008-10#1)(2008-2#1)
sites in Trinidad and##2##4##(2007-5#2)
sites in a##8##3##(1991-7#1)(1992-9#1)(1993-12#1)(1993-3#1)(1997-6#1)(2008-11#1)(2008-5#1)(2008-9#1)
sites in both##4##3##(1990-12#1)(1991-2#1)(1994-3#1)(2011-2#1)
sites in brain and peripheral tissues##2##6##(1992-6#1)(1994-3#1)
sites in cardiac##2##3##(1990-3#1)(1996-9#1)
sites in each of##2##4##(1995-1#1)(1996-8#1)
sites in each##5##3##(1991-5#1)(1993-2#1)(1995-1#1)(1995-3#1)(1996-8#1)
sites in four##2##3##(2007-12#1)(2008-10#1)
sites in guinea pig##2##4##(1991-1#1)(1994-3#1)
sites in human##3##3##(1995-7#1)(1997-4#1)(2008-11#1)
sites in individual##2##3##(1991-11#1)(2008-3#1)
sites in lambda##2##3##(1990-5#1)(1997-5#1)
sites in primary##2##3##(1990-7#1)(2008-4#1)
sites in proteins##6##3##(1993-3#1)(1993-6#2)(1994-9#2)(2008-4#1)
sites in rat brain##5##4##(1990-7#1)(1992-9#1)(1993-11#2)(1993-5#1)
sites in rat##14##3##(1990-6#1)(1990-7#2)(1991-5#2)(1992-6#1)(1992-9#1)(1993-11#3)(1993-5#1)(1994-11#1)(1997-1#1)(2008-11#1)
sites in significant##2##3##(2012-5#2)
sites in tandem##2##3##(1995-1#2)
sites in the Firth of Forth##2##6##(2004-4#2)
sites in the US##2##4##(2008-5#2)
sites in the United States##3##5##(2007-10#1)(2008-10#1)(2008-2#1)
sites in the absence of##4##5##(1991-1#1)(1995-3#2)(1997-5#1)
sites in the beta-subunit##2##4##(1994-6#2)
sites in the brain##2##4##(1993-11#1)(1997-8#1)
sites in the complex##2##4##(1996-11#1)(2008-10#1)
sites in the genome##4##4##(1993-12#1)(1997-3#1)(2008-10#1)(2009-3#1)
sites in the presence of##2##5##(1990-5#1)(1994-9#1)
sites in the rat##4##4##(1992-6#1)(1993-12#1)(1996-4#1)(1997-8#1)
sites in the three##2##4##(1994-9#1)(2008-10#1)
sites in the vector##2##4##(1991-7#1)(2008-10#1)
sites in the ventral tegmental area##2##6##(1993-6#2)
sites in the vicinity of a##2##6##(1991-5#1)(1996-4#1)
sites in the##142##3##(1990-11#1)(1990-2#2)(1990-4#1)(1990-5#3)(1990-7#2)(1991-1#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#3)(1992-1#1)(1992-11#3)(1992-6#3)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#3)(1993-7#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#3)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#1)(1997-8#2)(2004-4#2)(2005-8#1)(2006-12#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#1)(2007-5#2)(2007-8#2)(2008-10#13)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-3#1)(2009-5#2)(2009-8#1)(2010-6#1)(2011-3#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
sites in these##4##3##(1990-3#1)(1990-9#1)(1991-4#1)(1992-7#1)
sites in this region##3##4##(1991-3#1)(1994-11#1)(1996-5#1)
sites in this##9##3##(1991-3#1)(1992-7#1)(1994-11#1)(1995-3#1)(1996-5#1)(2008-11#1)(2008-4#1)(2010-8#1)(2011-1#1)
sites in various##2##3##(1990-5#1)(2012-2#1)
sites in vivo##5##3##(1990-9#1)(1991-10#1)(1994-11#1)(1996-7#1)(2012-3#1)
sites in which##2##3##(1996-9#1)(1997-2#1)
sites in##388##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#4)(1990-3#7)(1990-4#1)(1990-5#6)(1990-6#1)(1990-7#5)(1990-9#2)(1991-1#6)(1991-10#1)(1991-11#2)(1991-2#4)(1991-3#1)(1991-4#5)(1991-5#7)(1991-6#1)(1991-7#5)(1992-1#1)(1992-11#3)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#6)(1992-7#4)(1992-9#4)(1993-11#5)(1993-12#5)(1993-2#3)(1993-3#4)(1993-5#1)(1993-6#5)(1993-7#2)(1993-9#2)(1994-11#6)(1994-12#4)(1994-2#1)(1994-3#6)(1994-6#2)(1994-7#2)(1994-8#4)(1994-9#6)(1995-1#4)(1995-10#3)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#6)(1995-5#5)(1995-6#5)(1995-7#6)(1995-8#2)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#5)(1996-5#3)(1996-7#3)(1996-8#5)(1996-9#2)(1997-1#3)(1997-2#3)(1997-3#3)(1997-4#4)(1997-5#6)(1997-6#2)(1997-7#4)(1997-8#3)(2004-2#1)(2004-4#2)(2005-8#1)(2006-10#2)(2006-12#3)(2006-3#1)(2006-4#2)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#6)(2007-2#1)(2007-3#1)(2007-5#5)(2007-8#4)(2008-10#35)(2008-11#8)(2008-2#3)(2008-3#4)(2008-4#6)(2008-5#6)(2008-7#3)(2008-8#2)(2008-9#4)(2009-3#3)(2009-5#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#4)(2011-2#8)(2011-3#2)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#5)(2012-5#2)(2013-1#4)(2013-7#1)(2013-8#4)
sites include##4##2##(1996-12#1)(2006-9#1)(2009-3#1)(2013-1#1)
sites included##3##2##(1995-2#2)(2008-6#1)
sites including the##3##3##(1993-6#1)(1994-10#1)(2006-9#1)
sites including##8##2##(1991-2#1)(1993-6#1)(1994-10#1)(2006-9#1)(2007-8#1)(2008-12#1)(2008-4#1)(2010-4#1)
sites increased##2##2##(1997-6#1)(2005-11#1)
sites indicated that##2##3##(2008-10#1)(2008-8#1)
sites indicated##3##2##(2008-10#2)(2008-8#1)
sites indicates that##2##3##(1990-10#1)(1990-2#1)
sites indicates##3##2##(1990-10#1)(1990-2#1)(2007-6#1)
sites indicating##2##2##(1990-7#1)(1995-12#1)
sites induced##2##2##(1993-3#1)(2010-5#1)
sites into##4##2##(1990-3#1)(1994-11#2)(1994-12#1)
sites involved in##2##3##(2008-4#1)(2012-3#1)
sites involved##3##2##(2007-8#1)(2008-4#1)(2012-3#1)
sites is a##2##3##(1993-11#1)(1996-7#1)
sites is required for the##2##5##(1993-3#1)(1993-8#1)
sites is very important for##2##5##(1991-10#1)(1992-12#1)
sites is##33##2##(1990-5#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-12#2)(1992-9#1)(1993-11#1)(1993-3#2)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#3)(1995-8#1)(1996-7#1)(1997-6#1)(2008-10#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
sites lie in the##2##4##(1991-4#1)(1994-8#1)
sites lie in##3##3##(1991-4#1)(1994-8#1)(1997-5#1)
sites linked to a luciferase reporter gene##2##7##(1995-6#1)(1995-8#1)
sites located in##2##3##(2007-7#1)(2011-1#1)
sites located##9##2##(1991-2#1)(1991-6#1)(1993-12#1)(1993-3#1)(1994-12#1)(2004-4#2)(2007-7#1)(2011-1#1)
sites lost##2##2##(1992-3#1)(1997-1#1)
sites may be##5##3##(1991-1#1)(1992-8#1)(1996-4#1)(2007-3#1)(2013-7#1)
sites may occur##2##3##(1995-5#1)(2011-2#1)
sites may##13##2##(1990-10#1)(1990-12#1)(1991-1#1)(1992-8#1)(1994-11#1)(1995-5#1)(1996-4#1)(1996-7#1)(1997-7#1)(2007-3#1)(2008-1#1)(2011-2#1)(2013-7#1)
sites might##4##2##(1991-12#1)(2008-10#1)(2012-12#2)
sites more##2##2##(1991-3#1)(2013-8#1)
sites near the##3##3##(1995-10#1)(2006-1#1)(2009-7#1)
sites near##6##2##(1992-9#1)(1995-10#1)(2004-4#1)(2006-1#1)(2008-10#1)(2009-7#1)
sites not##4##2##(1996-11#1)(2008-1#1)(2008-8#1)(2013-7#1)
sites observed##2##2##(1992-9#1)(1993-3#1)
sites of DNA damage##3##4##(2008-8#1)(2012-12#1)(2013-1#1)
sites of DNA##4##3##(2008-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
sites of Kd##3##3##(1992-12#3)
sites of a##3##3##(1991-4#1)(1995-8#1)(1996-8#1)
sites of action of##2##4##(1994-5#1)(1997-4#1)
sites of action##13##3##(1990-5#1)(1993-3#1)(1994-5#1)(1995-3#1)(1996-4#1)(1997-4#1)(2006-10#2)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)
sites of acute##2##3##(1991-2#1)(2009-6#1)
sites of an##2##3##(2006-10#1)(2006-4#1)
sites of bacterial##2##3##(1992-2#1)(1992-3#1)
sites of both##4##3##(1993-8#1)(1997-2#1)(2008-10#1)(2010-12#1)
sites of cell##3##3##(1996-5#1)(1997-4#1)(2009-10#1)
sites of cleavage##2##3##(1990-11#1)(2013-8#1)
sites of disease##5##3##(1991-4#1)(1997-6#1)(2008-11#1)(2008-6#1)(2012-2#1)
sites of electron donation##2##4##(1990-5#2)
sites of four##2##3##(1990-12#1)(1991-2#1)
sites of high affinity##2##4##(1992-6#1)(1995-12#1)
sites of high##3##3##(1992-6#1)(1995-12#1)(2008-3#1)
sites of human##4##3##(1990-12#1)(1991-8#1)(1993-8#1)(2008-11#1)
sites of infection##4##3##(1991-8#1)(2008-10#1)(2013-1#2)
sites of inflammation##4##3##(1990-5#1)(1992-9#1)(2008-4#2)
sites of injury##3##3##(1991-10#1)(2006-10#1)(2009-6#1)
sites of interaction##5##3##(1990-11#1)(1992-6#1)(1994-8#1)(1996-10#1)(1996-5#1)
sites of interest##3##3##(2008-4#1)(2010-5#1)(2010-8#1)
sites of involvement##3##3##(2007-2#1)(2007-8#1)(2008-12#1)
sites of large##2##3##(1994-3#1)(1996-4#1)
sites of lesions##2##3##(1992-8#1)(2008-7#1)
sites of metastasis##3##3##(1994-8#1)(2006-6#1)(2006-9#1)
sites of origin##4##3##(1995-2#1)(2008-1#1)(2008-2#1)(2013-1#1)
sites of phosphorylation##5##3##(1993-6#1)(1995-10#1)(1995-8#1)(1997-7#1)(2008-4#1)
sites of potential pathogen##2##4##(2008-10#2)
sites of potential##5##3##(2008-10#5)
sites of protein methylation##2##4##(2008-4#2)
sites of proteins##3##3##(1993-11#1)(2008-8#1)(2011-2#1)
sites of proteolysis##2##3##(1991-2#2)
sites of recurrence##2##3##(2007-11#1)(2010-12#1)
sites of tau##2##3##(1995-12#2)
sites of the HA1 gene##2##5##(1994-8#2)
sites of the herpes simplex##2##5##(1994-3#1)(1995-3#1)
sites of the##58##3##(1990-12#2)(1990-3#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#2)(1993-3#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-10#2)(1996-12#1)(1997-1#1)(1997-2#5)(1997-6#2)(1997-7#1)(1997-8#1)(2005-10#1)(2006-1#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-9#1)(2008-10#6)(2008-4#2)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-9#2)(2010-12#1)(2011-1#1)(2012-2#1)
sites of these proteins##2##4##(1992-8#1)(2005-12#1)
sites of these##4##3##(1992-8#1)(1994-5#1)(2005-12#1)(2009-8#1)
sites of thrombosis##2##3##(2008-7#2)
sites of transcription initiation##2##4##(1992-4#1)(1997-8#1)
sites of transcription##3##3##(1991-7#1)(1992-4#1)(1997-8#1)
sites of two##3##3##(1994-2#1)(2008-8#1)(2012-11#1)
sites of vascular injury##3##4##(1992-12#1)(1994-11#1)(1994-5#1)
sites of##388##2##(1990-10#1)(1990-11#4)(1990-12#5)(1990-3#3)(1990-5#7)(1990-6#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#7)(1991-3#4)(1991-4#3)(1991-5#2)(1991-6#1)(1991-7#4)(1991-8#3)(1991-9#3)(1992-10#1)(1992-11#2)(1992-12#6)(1992-2#4)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#5)(1992-9#2)(1993-11#1)(1993-3#5)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#4)(1993-9#1)(1994-10#1)(1994-11#5)(1994-12#3)(1994-2#1)(1994-3#4)(1994-5#5)(1994-6#2)(1994-7#1)(1994-8#9)(1994-9#2)(1995-1#2)(1995-10#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#5)(1995-5#2)(1995-6#1)(1995-8#4)(1996-1#2)(1996-10#3)(1996-11#1)(1996-12#2)(1996-2#2)(1996-4#3)(1996-5#5)(1996-7#3)(1996-8#1)(1997-1#1)(1997-2#9)(1997-3#1)(1997-4#9)(1997-5#2)(1997-6#7)(1997-7#3)(1997-8#3)(1997-9#1)(2004-11#1)(2004-2#1)(2005-10#1)(2005-12#1)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#5)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-11#8)(2007-12#3)(2007-2#2)(2007-3#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#30)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#8)(2008-5#8)(2008-6#4)(2008-7#5)(2008-8#10)(2008-9#1)(2009-10#1)(2009-6#4)(2009-7#1)(2009-8#1)(2009-9#2)(2010-12#3)(2010-3#3)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-11#1)(2012-12#3)(2012-2#7)(2012-3#4)(2013-1#7)(2013-7#2)(2013-8#4)
sites often##2##2##(2007-2#1)(2011-2#1)
sites on DNA##2##3##(1991-5#1)(2008-5#1)
sites on MAP kinase##2##4##(1995-2#2)
sites on a##3##3##(1997-5#1)(2008-10#1)(2008-9#1)
sites on cells of the##2##5##(1991-1#1)(1993-7#1)
sites on the A##2##4##(1992-5#1)(1996-5#1)
sites on the cell surface##3##5##(1990-12#1)(1994-5#1)(2008-11#1)
sites on the enzyme##2##4##(1992-12#1)(1992-3#1)
sites on the##55##3##(1990-11#1)(1990-12#2)(1990-7#2)(1991-1#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-2#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-11#2)(1995-2#1)(1996-10#1)(1996-12#2)(1996-5#2)(1996-6#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#2)(2005-11#2)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-8#1)(2010-6#1)(2010-8#1)(2011-1#1)
sites on their##2##3##(1991-6#1)(2010-5#1)
sites on these##2##3##(1991-2#1)(1997-5#1)
sites on##128##2##(1990-11#1)(1990-12#3)(1990-3#1)(1990-5#3)(1990-7#5)(1991-1#3)(1991-2#2)(1991-3#3)(1991-4#1)(1991-5#4)(1991-6#1)(1991-7#2)(1991-8#3)(1992-11#1)(1992-12#3)(1992-3#2)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#4)(1994-8#2)(1994-9#2)(1995-11#2)(1995-2#4)(1995-5#1)(1995-8#2)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-5#3)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#3)(1997-6#2)(1997-7#1)(2005-11#5)(2005-8#1)(2006-1#1)(2006-10#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#3)(2008-8#3)(2008-9#1)(2009-3#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#3)(2012-12#1)(2012-2#1)(2013-1#1)
sites or##9##2##(1992-4#1)(1993-2#1)(1994-12#1)(1994-8#1)(1996-4#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-5#1)
sites other than the##2##4##(2006-11#1)(2013-1#1)
sites outside the##2##3##(1991-6#1)(2009-6#1)
sites over##3##2##(1997-6#1)(2008-10#1)(2012-12#1)
sites per cell##3##3##(1993-9#1)(2008-11#1)(2010-10#1)
sites per cell)##2##3##(1993-6#1)(1995-10#1)
sites per##15##2##(1990-12#1)(1992-3#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-10#1)(2005-11#1)(2008-11#1)(2008-4#1)(2010-10#1)(2013-8#1)
sites prediction##4##2##(2012-3#4)
sites present in##4##3##(1990-9#1)(1991-3#1)(1993-9#1)(1996-4#1)
sites present on##2##3##(1993-11#1)(1995-3#1)
sites present##6##2##(1990-9#1)(1991-3#1)(1993-11#1)(1993-9#1)(1995-3#1)(1996-4#1)
sites recognized by##2##3##(1991-2#1)(2008-4#1)
sites reduced##2##2##(1997-2#1)(2006-12#1)
sites related to##2##3##(1997-7#1)(2012-12#1)
sites remained##2##2##(1992-4#1)(2008-6#1)
sites remains##2##2##(1996-5#1)(2008-6#1)
sites represented##4##2##(1994-2#2)(2008-10#1)(2012-3#1)
sites responsible for the##2##4##(2008-10#2)
sites responsible for##4##3##(2005-11#1)(2008-10#2)(2011-1#1)
sites resulted in##5##3##(1993-8#1)(1996-4#1)(1997-4#1)(2007-8#1)(2012-2#1)
sites revealed that##2##3##(1996-7#1)(2008-8#1)
sites revealed##5##2##(1996-7#1)(2007-12#1)(2008-7#1)(2008-8#2)
sites seen##2##2##(1995-11#1)(1996-10#1)
sites separated by a##2##4##(1997-4#1)(2011-1#1)
sites show##4##2##(1992-8#1)(1994-3#1)(1994-9#2)
sites showed##5##2##(1993-2#1)(1995-3#1)(1997-7#1)(2008-4#1)(2008-5#1)
sites shows##2##2##(2010-11#1)(2012-12#1)
sites simultaneously##2##2##(1993-6#1)(2008-8#1)
sites situated##2##2##(1990-5#1)(2008-6#1)
sites studied##4##2##(2004-4#1)(2007-3#2)(2008-10#1)
sites such as the##3##4##(2006-8#1)(2009-3#2)
sites such as##7##3##(1994-11#1)(2006-8#1)(2008-1#1)(2008-5#1)(2009-3#2)(2011-2#1)
sites suggested##2##2##(1997-2#1)(2007-2#1)
sites suggests that##2##3##(1991-5#1)(1997-2#1)
sites suggests##3##2##(1991-5#1)(1996-2#1)(1997-2#1)
sites tested##2##2##(2007-12#1)(2012-3#1)
sites than##2##2##(1994-8#1)(2011-2#1)
sites that are##8##3##(1991-9#1)(1994-3#1)(1995-3#1)(1997-5#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-9#1)
sites that become##2##3##(1992-3#1)(2006-10#1)
sites that can##2##3##(2005-7#1)(2010-12#1)
sites that have##2##3##(1997-4#1)(2008-10#1)
sites that were##3##3##(1993-2#1)(1993-3#1)(2012-3#1)
sites that##50##2##(1991-2#1)(1991-4#1)(1991-9#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-4#1)(1997-5#1)(2005-7#1)(2006-10#2)(2007-12#2)(2007-2#8)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#3)(2008-8#1)(2008-9#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
sites throughout the United States##2##5##(1996-12#1)(2012-12#1)
sites throughout the##5##3##(1993-6#1)(1996-12#1)(2004-2#1)(2010-8#1)(2012-12#1)
sites throughout##8##2##(1993-6#1)(1994-9#1)(1996-12#1)(2004-2#1)(2008-10#2)(2010-8#1)(2012-12#1)
sites to be##3##3##(1996-6#1)(2008-9#1)(2013-1#1)
sites to control##2##3##(2008-7#1)(2012-2#1)
sites to recruit##2##3##(2007-12#1)(2009-5#1)
sites to the##4##3##(1990-3#1)(1993-4#1)(1994-8#1)(1997-9#1)
sites to##41##2##(1990-3#1)(1991-1#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-4#1)(1992-5#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-12#2)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#2)(1995-5#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-5#1)(1997-9#1)(2005-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-5#1)(2010-3#1)(2012-2#1)(2013-1#1)
sites treated##3##2##(2007-1#1)(2008-5#1)(2011-2#1)
sites under##3##2##(1996-9#1)(1997-5#1)(2008-3#1)
sites used##3##2##(2008-10#1)(2008-4#1)(2013-7#1)
sites using the##3##3##(2008-4#1)(2008-5#1)(2008-9#1)
sites using##7##2##(1996-2#1)(1997-5#1)(2008-4#2)(2008-5#1)(2008-9#1)(2012-3#1)
sites varied##2##2##(1992-3#1)(2007-12#1)
sites via##2##2##(2010-2#1)(2011-1#1)
sites was 0##2##3##(2007-1#1)(2007-4#1)
sites was also##3##3##(1993-9#1)(1994-11#1)(2012-3#1)
sites was carried out##2##4##(1997-2#1)(2012-12#1)
sites was determined##2##3##(1995-5#1)(2006-4#1)
sites was found to##2##4##(1992-3#1)(2007-10#1)
sites was increased##3##3##(1995-6#1)(1997-2#1)(1997-7#1)
sites was not##2##3##(1990-7#1)(1996-11#1)
sites was observed##2##3##(1991-4#1)(2012-3#1)
sites was##56##2##(1990-5#5)(1990-7#1)(1991-4#1)(1991-9#1)(1992-3#2)(1993-9#2)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-4#2)(1996-5#1)(1997-2#4)(1997-7#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-4#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-6#1)(2010-12#1)(2011-1#2)(2012-12#1)(2012-3#2)
sites were accessible to##2##4##(1991-8#1)(1994-5#1)
sites were also##7##3##(1991-7#1)(1992-6#1)(1993-3#1)(1995-5#1)(1995-7#1)(2008-5#1)(2008-7#1)
sites were analyzed##4##3##(1993-12#1)(2008-10#1)(2008-5#1)(2009-4#1)
sites were collected##2##3##(2007-10#1)(2013-7#1)
sites were compared##2##3##(1995-7#1)(2008-10#1)
sites were detected##5##3##(1991-4#1)(1993-3#1)(1994-2#1)(1995-11#1)(2008-3#1)
sites were determined by##2##4##(1994-11#1)(1995-7#1)
sites were determined##5##3##(1990-2#1)(1994-11#1)(1994-8#1)(1995-7#1)(1997-4#1)
sites were found in##3##4##(1991-7#1)(1992-11#1)(1993-3#1)
sites were found##7##3##(1991-7#1)(1992-11#1)(1993-3#2)(1994-9#1)(1996-8#1)(2008-8#1)
sites were identified##10##3##(1991-7#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-5#1)(2008-11#2)(2009-6#1)
sites were localized##3##3##(1991-6#1)(1994-3#1)(1996-7#1)
sites were made##2##3##(1996-2#1)(2008-5#1)
sites were mapped##2##3##(1993-3#1)(1994-12#1)
sites were mutated##3##3##(1994-9#1)(1996-4#1)(1996-7#1)
sites were not##3##3##(1991-6#1)(1995-6#1)(1997-6#1)
sites were observed in the##2##5##(1994-12#1)(2008-5#1)
sites were observed##5##3##(1991-8#2)(1994-12#1)(2005-11#1)(2008-5#1)
sites were predicted##5##3##(1997-6#1)(2006-12#1)(2008-12#2)(2013-8#1)
sites were predominant##2##3##(1994-2#2)
sites were present##2##3##(1990-8#1)(1992-7#1)
sites were the##4##3##(2006-12#1)(2006-2#1)(2012-12#1)(2013-1#1)
sites were##143##2##(1990-2#1)(1990-4#2)(1990-7#2)(1990-8#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-7#3)(1991-8#3)(1992-11#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#3)(1992-7#1)(1992-9#1)(1993-12#2)(1993-3#5)(1993-5#1)(1993-9#1)(1994-11#2)(1994-12#6)(1994-2#5)(1994-3#4)(1994-5#1)(1994-8#3)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-5#2)(1995-6#1)(1995-7#4)(1995-8#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#3)(1996-8#3)(1997-2#2)(1997-4#1)(1997-5#2)(1997-6#4)(1997-8#1)(2005-11#2)(2005-9#1)(2006-12#2)(2006-2#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#4)(2008-11#4)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
sites when##3##2##(1996-1#1)(2008-10#2)
sites where disease pressure was##2##5##(2008-10#2)
sites where the##5##3##(1995-4#1)(1996-10#1)(2006-12#1)(2007-9#1)(2009-10#1)
sites where##30##2##(1991-7#1)(1992-12#2)(1992-4#1)(1994-12#1)(1995-11#1)(1995-4#1)(1996-10#1)(1997-3#1)(1997-8#1)(2006-12#2)(2007-8#1)(2007-9#2)(2008-10#6)(2008-11#1)(2008-4#2)(2008-5#1)(2009-10#1)(2010-12#2)(2011-1#1)(2012-11#1)
sites which are assumed to##2##5##(1991-2#1)(1996-2#1)
sites which are##7##3##(1990-8#1)(1991-2#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-7#1)
sites which can##2##3##(1997-4#1)(2007-9#1)
sites which contain##2##3##(1991-9#1)(1995-5#1)
sites which##20##2##(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-2#2)(1991-4#1)(1991-9#1)(1992-9#1)(1993-6#1)(1995-10#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-4#1)(2007-9#1)(2012-2#2)
sites while##2##2##(1994-11#1)(2012-1#1)
sites will##4##2##(1990-3#1)(2006-9#1)(2008-1#1)(2009-12#1)
sites with a##13##3##(1990-2#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-6#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-8#2)(2012-12#1)
sites with an##5##3##(1990-5#1)(1991-3#1)(1991-4#1)(1996-8#1)(2008-10#1)
sites with different##4##3##(1990-8#1)(1996-5#1)(2008-10#1)(2008-8#1)
sites with high##5##3##(1990-7#1)(1993-1#1)(2008-10#1)(2011-2#1)(2012-12#1)
sites with the##2##3##(1994-2#1)(1996-2#1)
sites with##66##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#5)(1990-8#2)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-8#3)(1996-10#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-8#2)(1997-7#1)(2004-4#1)(2007-3#1)(2007-5#1)(2008-10#7)(2008-11#1)(2008-5#3)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
sites within a##3##3##(1996-4#1)(1997-4#1)(2008-10#1)
sites within an##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
sites within the first##2##4##(1993-3#1)(1996-5#1)
sites within the##24##3##(1990-3#1)(1990-7#1)(1991-12#1)(1991-8#2)(1992-9#1)(1993-3#1)(1994-12#2)(1996-3#1)(1996-5#1)(1996-7#3)(1997-2#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
sites within##45##2##(1990-3#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-8#2)(1992-9#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-12#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#3)(1997-2#1)(1997-4#3)(1997-7#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-4#2)(2008-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
sites without##2##2##(1991-1#1)(2008-5#1)
sites would##2##2##(1992-7#1)(1993-11#1)
sites yielded##2##2##(2004-11#1)(2008-10#1)
sites##3730##1##(1990-1#1)(1990-10#12)(1990-11#21)(1990-12#25)(1990-2#24)(1990-3#39)(1990-4#7)(1990-5#47)(1990-6#8)(1990-7#51)(1990-8#25)(1990-9#9)(1991-1#23)(1991-10#8)(1991-11#18)(1991-12#18)(1991-2#38)(1991-3#31)(1991-4#36)(1991-5#41)(1991-6#23)(1991-7#30)(1991-8#24)(1991-9#20)(1992-1#8)(1992-10#4)(1992-11#11)(1992-12#31)(1992-2#13)(1992-3#43)(1992-4#18)(1992-5#11)(1992-6#38)(1992-7#18)(1992-8#16)(1992-9#29)(1993-1#3)(1993-10#2)(1993-11#30)(1993-12#32)(1993-2#19)(1993-3#58)(1993-4#5)(1993-5#7)(1993-6#47)(1993-7#6)(1993-8#22)(1993-9#24)(1994-1#2)(1994-10#4)(1994-11#57)(1994-12#59)(1994-2#27)(1994-3#24)(1994-4#2)(1994-5#20)(1994-6#15)(1994-7#8)(1994-8#57)(1994-9#46)(1995-1#26)(1995-10#29)(1995-11#21)(1995-12#32)(1995-2#25)(1995-3#37)(1995-4#2)(1995-5#28)(1995-6#38)(1995-7#20)(1995-8#40)(1996-1#14)(1996-10#23)(1996-11#10)(1996-12#20)(1996-2#27)(1996-3#9)(1996-4#27)(1996-5#32)(1996-6#5)(1996-7#35)(1996-8#26)(1996-9#12)(1997-1#17)(1997-2#49)(1997-3#10)(1997-4#42)(1997-5#36)(1997-6#27)(1997-7#25)(1997-8#17)(1997-9#3)(2004-10#4)(2004-11#8)(2004-12#4)(2004-2#5)(2004-3#2)(2004-4#21)(2005-10#4)(2005-11#18)(2005-12#1)(2005-4#2)(2005-5#1)(2005-7#7)(2005-8#8)(2005-9#2)(2006-1#3)(2006-10#25)(2006-11#2)(2006-12#19)(2006-2#5)(2006-3#4)(2006-4#5)(2006-5#1)(2006-6#3)(2006-8#17)(2006-9#6)(2007-1#6)(2007-10#10)(2007-11#22)(2007-12#33)(2007-2#30)(2007-3#22)(2007-4#3)(2007-5#22)(2007-6#5)(2007-7#13)(2007-8#22)(2007-9#12)(2008-1#17)(2008-10#274)(2008-11#51)(2008-12#16)(2008-2#14)(2008-3#17)(2008-4#66)(2008-5#84)(2008-6#26)(2008-7#31)(2008-8#55)(2008-9#27)(2009-10#7)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#13)(2009-4#4)(2009-5#10)(2009-6#9)(2009-7#2)(2009-8#10)(2009-9#4)(2010-1#1)(2010-10#2)(2010-11#8)(2010-12#21)(2010-2#8)(2010-3#8)(2010-4#13)(2010-5#8)(2010-6#7)(2010-7#4)(2010-8#16)(2010-9#3)(2011-1#36)(2011-12#6)(2011-2#71)(2011-3#3)(2012-1#7)(2012-11#9)(2012-12#42)(2012-2#46)(2012-3#39)(2012-5#2)(2012-6#1)(2013-1#41)(2013-7#22)(2013-8#27)
sites&quot##3##1##(1990-4#1)(1994-12#1)(2008-10#1)
sites'##2##1##(1991-3#1)(2005-7#1)
sites) was##2##2##(1991-5#1)(2010-11#1)
sites)##22##1##(1991-5#1)(1992-1#2)(1992-4#1)(1992-9#2)(1993-12#2)(1993-4#1)(1994-1#1)(1994-8#1)(1995-7#1)(1996-2#2)(1997-5#1)(2007-5#2)(2008-10#1)(2008-8#1)(2010-11#1)(2012-2#1)(2013-8#1)
sites/cell##8##1##(1991-4#2)(1993-12#1)(1994-8#1)(1995-8#1)(1997-5#2)(2008-4#1)
sites/cell)##3##1##(1994-8#1)(1996-11#1)(1996-5#1)
sitostanol##2##1##(2007-8#2)
sitosterol 3- O-beta-##2##3##(2007-1#2)
sitosterol and##3##2##(1991-5#1)(2006-10#1)(2007-1#1)
sitosterol##10##1##(1991-5#1)(2006-10#5)(2007-1#3)(2007-11#1)
sitosterolemia##2##1##(2009-4#2)
sits between##2##2##(1995-3#1)(1997-6#1)
sits##5##1##(1995-3#1)(1996-2#1)(1997-6#1)(2008-11#1)(2008-4#1)
sitting and##4##2##(1995-8#1)(2007-2#1)(2010-3#1)(2013-1#1)
sitting behavior of##3##3##(2007-7#3)
sitting height##2##2##(2011-2#2)
sitting in##2##2##(2008-10#1)(2008-8#1)
sitting on##2##2##(2008-10#1)(2008-11#1)
sitting or standing##2##3##(2012-1#2)
sitting position##15##2##(1992-11#2)(1993-10#2)(1993-7#1)(2007-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#4)(2013-8#1)
sitting positions##4##2##(1993-10#1)(2011-2#3)
sitting unsupported and##2##3##(1995-8#2)
sitting##74##1##(1991-7#1)(1991-8#1)(1992-10#1)(1992-11#3)(1993-10#4)(1993-7#1)(1995-8#4)(2006-10#1)(2006-8#2)(2007-11#1)(2007-2#2)(2007-7#6)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#2)(2009-4#1)(2009-6#2)(2009-7#1)(2010-3#3)(2010-9#3)(2011-1#3)(2011-2#7)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#5)(2013-1#8)(2013-8#2)
sittings##2##1##(1997-3#1)(2013-1#1)
situ RT-PCR##2##2##(1996-3#1)(2008-10#1)
situ Raman##3##2##(2007-12#1)(2008-10#1)(2010-11#1)
situ X-ray##2##2##(2006-12#1)(2007-5#1)
situ activity##4##2##(1991-2#3)(2008-10#1)
situ analysis of##11##3##(1995-1#1)(1997-8#1)(2006-12#2)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2013-8#1)
situ analysis##17##2##(1995-1#1)(1997-8#1)(2006-12#2)(2007-8#1)(2008-10#5)(2008-2#2)(2008-3#1)(2009-12#2)(2013-8#2)
situ and in##10##3##(1991-12#1)(1991-3#1)(1993-5#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
situ and##34##2##(1990-2#1)(1991-12#1)(1991-3#1)(1992-3#1)(1993-5#1)(1993-7#1)(1995-12#1)(1995-7#1)(1996-11#2)(1996-12#1)(2004-10#1)(2007-12#1)(2007-5#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2010-2#1)(2012-2#1)(2013-7#1)(2013-8#3)
situ by##21##2##(1992-11#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-6#1)(1997-6#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-2#2)(2010-7#1)(2013-8#1)
situ calibration##6##2##(2008-2#5)(2008-3#1)
situ combustion measurements##2##3##(2008-2#1)(2008-3#1)
situ combustion##3##2##(2008-2#1)(2008-3#2)
situ conditions##6##2##(2008-2#1)(2009-12#1)(2013-8#4)
situ conservation of##2##3##(2007-11#1)(2008-8#1)
situ conservation##5##2##(2007-11#1)(2008-8#3)(2013-7#1)
situ data##6##2##(2007-5#2)(2008-2#2)(2008-3#2)
situ detection of##6##3##(1993-12#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-9#1)(2010-5#1)
situ detection##8##2##(1993-12#1)(1995-1#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-9#2)(2010-5#1)
situ determination of##4##3##(2008-10#2)(2008-11#1)(2008-3#1)
situ end labelling##3##3##(1994-10#2)(2003-11#1)
situ end##7##2##(1994-10#2)(1995-3#1)(1996-10#1)(2003-11#1)(2008-7#2)
situ extraction##6##2##(1990-11#1)(1994-11#5)
situ extractive fermentation##4##3##(2013-7#4)
situ forming polymeric##3##3##(2004-1#1)(2010-5#2)
situ forming##4##2##(2004-1#1)(2007-12#1)(2010-5#2)
situ from##5##2##(1996-1#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-2#1)
situ gel##4##2##(2010-5#1)(2011-3#3)
situ generated##9##2##(1990-11#1)(2008-10#3)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)
situ generation of##6##3##(1992-11#2)(2008-10#2)(2010-2#1)(2011-2#1)
situ hybridisation##17##2##(1992-11#1)(1994-12#1)(1995-12#1)(1995-5#2)(1996-12#2)(1997-5#2)(1997-6#1)(2006-8#2)(2008-1#1)(2008-12#2)(2009-8#1)(2010-7#1)
situ hybridization (FISH)##31##3##(1993-12#1)(1994-6#1)(1995-4#1)(1996-3#1)(1997-1#1)(1997-2#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#5)(2008-9#2)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#1)
situ hybridization (ISH) for##2##4##(2008-4#1)(2010-7#1)
situ hybridization (ISH)##12##3##(1992-12#1)(1996-12#1)(1997-7#1)(2006-4#1)(2007-12#1)(2007-2#1)(2008-4#1)(2010-1#1)(2010-7#2)(2012-3#2)
situ hybridization after##2##3##(1996-12#1)(1996-9#1)
situ hybridization analysis##16##3##(1991-5#1)(1992-9#1)(1994-12#1)(1994-5#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-4#2)(2007-12#1)(2007-5#1)(2008-5#1)(2008-9#1)(2010-2#1)
situ hybridization and immunocytochemical techniques##2##5##(1991-12#1)(1997-3#1)
situ hybridization and immunocytochemistry to##2##5##(1997-4#1)(1997-7#1)
situ hybridization and immunocytochemistry##4##4##(1995-10#2)(1997-4#1)(1997-7#1)
situ hybridization and immunohistochemistry##4##4##(1991-8#1)(1995-2#1)(1996-4#1)(2006-10#1)
situ hybridization and##26##3##(1990-11#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-8#1)(1993-7#1)(1994-2#1)(1995-10#2)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)
situ hybridization combined with##3##4##(1992-8#1)(1995-12#1)(1997-1#1)
situ hybridization for##5##3##(1994-8#1)(2007-2#1)(2008-4#2)(2008-5#1)
situ hybridization histochemistry with##6##4##(1992-8#1)(1993-12#1)(1997-4#1)(1997-6#1)(1997-8#2)
situ hybridization histochemistry##28##3##(1990-5#1)(1990-7#2)(1990-8#1)(1991-3#1)(1992-6#1)(1992-8#3)(1993-12#1)(1994-11#1)(1994-2#1)(1995-11#2)(1995-2#1)(1996-12#3)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#2)(2004-11#2)
situ hybridization in##9##3##(1994-10#1)(1994-3#1)(1995-7#1)(1996-12#1)(1997-8#1)(2005-10#1)(2008-2#1)(2009-1#1)(2010-1#1)
situ hybridization indicated##4##3##(1993-8#1)(1993-9#1)(1996-4#1)(2006-12#1)
situ hybridization is##2##3##(1996-12#1)(2008-4#1)
situ hybridization of the##2##4##(1995-11#1)(1996-12#1)
situ hybridization of##15##3##(1993-12#1)(1994-3#1)(1995-11#1)(1996-12#3)(1997-7#1)(2005-10#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#2)(2010-3#1)
situ hybridization performed##2##3##(2008-8#1)(2010-3#1)
situ hybridization showed that##3##4##(1995-12#1)(1996-12#1)(1997-1#1)
situ hybridization showed##5##3##(1995-12#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-5#1)
situ hybridization studies##9##3##(1994-10#1)(1995-1#1)(1995-8#1)(1996-12#3)(2007-10#1)(2008-4#1)(2009-8#1)
situ hybridization study##3##3##(1994-2#1)(1996-12#1)(2009-8#1)
situ hybridization technique##7##3##(1994-2#1)(2007-5#1)(2008-11#1)(2008-8#1)(2010-12#1)(2011-1#1)(2013-8#1)
situ hybridization to##9##3##(1990-11#1)(1991-2#1)(1994-2#1)(1995-12#1)(1997-7#1)(2008-2#2)(2008-4#2)
situ hybridization using##9##3##(1990-12#1)(1991-5#1)(1993-5#1)(1994-9#1)(1996-12#2)(2008-10#1)(2008-2#1)(2008-5#1)
situ hybridization##322##2##(1990-11#3)(1990-12#2)(1990-5#1)(1990-7#3)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#3)(1991-8#1)(1992-11#1)(1992-12#2)(1992-6#2)(1992-7#1)(1992-8#6)(1992-9#1)(1993-12#4)(1993-5#2)(1993-7#3)(1993-8#1)(1993-9#3)(1994-10#2)(1994-11#1)(1994-12#2)(1994-2#6)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#3)(1995-10#2)(1995-11#6)(1995-12#7)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#2)(1995-8#5)(1996-1#1)(1996-10#2)(1996-12#26)(1996-2#4)(1996-3#1)(1996-4#3)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#6)(1997-2#4)(1997-3#2)(1997-4#7)(1997-5#1)(1997-6#2)(1997-7#6)(1997-8#5)(2004-11#2)(2005-10#2)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#2)(2007-12#7)(2007-2#3)(2007-5#3)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#5)(2008-2#5)(2008-4#20)(2008-5#12)(2008-6#2)(2008-7#1)(2008-8#12)(2008-9#17)(2009-1#1)(2009-5#2)(2009-7#1)(2009-8#3)(2010-1#3)(2010-12#3)(2010-2#1)(2010-3#4)(2010-7#3)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#4)(2013-1#2)(2013-8#2)
situ hybridization)##5##2##(2006-6#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-3#1)
situ hybridizations##3##2##(2008-11#2)(2009-12#1)
situ images of##2##3##(2007-11#2)
situ light-scattering measurements##2##3##(2008-3#2)
situ localization of##5##3##(1994-3#1)(1996-12#1)(1997-6#1)(2008-10#1)(2009-8#1)
situ measurement of##5##3##(1991-10#1)(2008-2#1)(2008-3#1)(2009-5#1)(2010-2#1)
situ measurement##8##2##(1991-10#1)(2008-2#1)(2008-3#4)(2009-5#1)(2010-2#1)
situ measurements of CO##2##4##(2008-2#1)(2008-3#1)
situ measurements of##16##3##(2008-10#1)(2008-2#5)(2008-3#9)(2008-6#1)
situ measurements##27##2##(2008-10#1)(2008-2#9)(2008-3#16)(2008-6#1)
situ monitoring of##11##3##(1993-6#1)(1996-8#1)(2008-10#1)(2008-2#1)(2008-3#4)(2010-2#3)
situ monitoring##15##2##(1991-5#1)(1993-6#1)(1996-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#4)(2010-2#3)
situ mutagenesis##2##2##(2008-6#2)
situ nick end labeling (TUNEL)##2##5##(2007-10#1)(2008-9#1)
situ nick end labeling##4##4##(2007-10#3)(2008-9#1)
situ nick##7##2##(2007-10#3)(2008-4#3)(2008-9#1)
situ observation of##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
situ prepared BiFE##2##3##(2008-10#2)
situ studies##4##2##(1992-12#1)(1994-3#1)(2007-5#1)(2008-8#1)
situ surface-enhanced Raman spectroscopy (SERS)##2##5##(2007-12#1)(2013-1#1)
situ surface-enhanced Raman spectroscopy##3##4##(2007-12#2)(2013-1#1)
situ synthesis of##4##3##(2005-11#1)(2008-4#3)
situ synthesis##7##2##(1996-5#1)(2005-11#1)(2008-4#4)(2010-4#1)
situ technique##2##2##(2008-11#1)(2008-3#1)
situ visualization of##2##3##(2006-12#1)(2008-2#1)
situ##1168##1##(1990-10#1)(1990-11#5)(1990-12#5)(1990-2#8)(1990-5#1)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#6)(1991-2#5)(1991-3#5)(1991-4#2)(1991-5#4)(1991-6#1)(1991-8#1)(1991-9#5)(1992-1#1)(1992-10#2)(1992-11#6)(1992-12#5)(1992-3#2)(1992-4#4)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#11)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#7)(1993-4#1)(1993-5#4)(1993-6#2)(1993-7#4)(1993-8#2)(1993-9#5)(1994-1#1)(1994-10#5)(1994-11#10)(1994-12#7)(1994-2#7)(1994-3#6)(1994-5#3)(1994-6#4)(1994-8#6)(1994-9#1)(1995-1#5)(1995-10#2)(1995-11#6)(1995-12#12)(1995-2#6)(1995-3#9)(1995-4#3)(1995-5#4)(1995-6#4)(1995-7#8)(1995-8#5)(1996-1#4)(1996-10#3)(1996-11#8)(1996-12#32)(1996-2#4)(1996-3#5)(1996-4#6)(1996-5#5)(1996-6#5)(1996-7#2)(1996-8#4)(1996-9#2)(1997-1#9)(1997-2#6)(1997-3#7)(1997-4#12)(1997-5#3)(1997-6#6)(1997-7#9)(1997-8#10)(2003-11#1)(2004-1#5)(2004-10#1)(2004-11#2)(2004-2#1)(2004-4#7)(2004-9#1)(2005-10#4)(2005-11#5)(2005-12#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#8)(2006-12#8)(2006-4#6)(2006-5#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#6)(2007-11#11)(2007-12#29)(2007-2#3)(2007-3#2)(2007-4#6)(2007-5#16)(2007-6#2)(2007-7#3)(2007-8#15)(2007-9#7)(2008-1#12)(2008-10#123)(2008-11#18)(2008-12#2)(2008-2#58)(2008-3#78)(2008-4#35)(2008-5#23)(2008-6#8)(2008-7#18)(2008-8#25)(2008-9#31)(2009-1#1)(2009-11#1)(2009-12#7)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#6)(2009-6#2)(2009-7#2)(2009-8#7)(2010-1#3)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#9)(2010-3#6)(2010-4#4)(2010-5#8)(2010-6#7)(2010-7#8)(2010-8#2)(2010-9#2)(2011-1#10)(2011-12#2)(2011-2#10)(2011-3#3)(2012-1#6)(2012-12#14)(2012-2#14)(2012-3#7)(2013-1#9)(2013-7#9)(2013-8#25)
situ) and##2##2##(1991-3#1)(2008-3#1)
situ)##7##1##(1991-3#1)(1991-4#1)(2008-10#1)(2008-3#2)(2008-5#1)(2012-12#1)
situated around##2##2##(1995-2#1)(2008-10#1)
situated at##5##2##(1993-10#1)(1995-11#1)(2007-11#1)(2008-10#1)(2008-6#1)
situated between the##2##3##(2006-12#1)(2008-7#1)
situated between##8##2##(1990-5#1)(1990-8#1)(1992-9#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-2#1)
situated close to the##2##4##(2011-1#1)(2012-2#1)
situated close##3##2##(2007-11#1)(2011-1#1)(2012-2#1)
situated downstream##2##2##(1990-11#1)(2009-6#1)
situated in Wardha River Valley##2##5##(2007-10#1)(2008-5#1)
situated in a##2##3##(1994-8#1)(2009-3#1)
situated in different##2##3##(2007-12#1)(2009-9#1)
situated in the northern part of##2##6##(1990-6#1)(2011-2#1)
situated in the##31##3##(1990-12#1)(1990-6#2)(1990-9#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-6#2)(1993-8#1)(1995-6#1)(1997-2#1)(1997-6#1)(1997-9#1)(2005-10#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-2#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-3#1)(2013-1#2)
situated in##53##2##(1990-12#1)(1990-6#2)(1990-9#1)(1991-3#1)(1991-5#1)(1991-6#2)(1992-10#1)(1992-6#2)(1993-8#1)(1994-8#1)(1995-6#1)(1996-11#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-9#1)(2005-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-8#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
situated near##3##2##(2006-3#1)(2011-2#2)
situated on the##4##3##(1990-3#1)(2006-1#1)(2008-3#1)(2012-3#1)
situated on##6##2##(1990-3#1)(1997-3#1)(2006-1#1)(2007-10#1)(2008-3#1)(2012-3#1)
situated ventrally##2##2##(2006-12#1)(2011-2#1)
situated within or close to##2##5##(1996-8#1)(2007-11#1)
situated within the##2##3##(2007-5#1)(2008-7#1)
situated within##5##2##(1996-8#1)(2007-11#1)(2007-5#1)(2008-12#1)(2008-7#1)
situated##126##1##(1990-11#1)(1990-12#1)(1990-3#2)(1990-5#1)(1990-6#3)(1990-8#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-6#2)(1992-10#1)(1992-6#2)(1992-9#1)(1993-10#1)(1993-7#1)(1993-8#1)(1994-2#1)(1994-8#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-7#2)(1996-8#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-9#1)(2005-10#2)(2006-1#1)(2006-12#5)(2006-2#1)(2006-3#1)(2006-5#1)(2007-10#2)(2007-11#7)(2007-12#4)(2007-2#2)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#4)(2008-6#2)(2008-7#3)(2008-9#1)(2009-3#1)(2009-6#2)(2009-7#1)(2009-9#2)(2010-12#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#3)
situating them##2##2##(2010-6#1)(2012-2#1)
situating##6##1##(2008-2#1)(2010-6#1)(2012-2#3)(2013-1#1)
situation (Experiment##2##2##(2012-1#2)
situation a##5##2##(1990-8#1)(2008-11#1)(2008-2#1)(2013-1#2)
situation analysis##3##2##(2010-5#1)(2012-12#1)(2013-1#1)
situation and in##3##3##(1993-1#1)(1996-1#1)(1996-9#1)
situation and the##2##3##(1990-12#1)(1995-4#1)
situation and to##2##3##(2008-5#1)(2013-7#1)
situation and##33##2##(1990-11#1)(1990-12#4)(1991-3#1)(1993-1#1)(1995-4#1)(1996-1#1)(1996-3#1)(1996-9#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-5#5)(2008-7#1)(2008-9#1)(2010-12#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#2)(2013-8#3)
situation as##5##2##(1995-5#1)(2006-10#1)(2007-8#1)(2009-5#2)
situation at##3##2##(2006-10#1)(2008-1#1)(2008-10#1)
situation by##4##2##(1994-8#1)(1997-3#1)(2008-2#1)(2012-3#1)
situation can be##4##3##(1990-12#1)(2007-2#1)(2009-11#1)(2010-4#1)
situation during##2##2##(1994-2#1)(2008-2#1)
situation for##13##2##(1991-5#1)(1993-3#1)(1994-12#2)(1995-6#1)(1997-5#1)(2008-12#1)(2008-2#2)(2010-9#1)(2011-2#1)(2011-7#1)(2013-8#1)
situation had##2##2##(2011-12#1)(2012-1#1)
situation has##5##2##(1997-6#1)(2008-10#1)(2008-3#2)(2011-2#1)
situation in Brazil##2##3##(1991-6#2)
situation in a##4##3##(1993-1#1)(2005-7#1)(2007-8#2)
situation in the##15##3##(1990-6#1)(1991-11#1)(1991-6#1)(1991-8#1)(1993-12#1)(1995-7#1)(1996-3#1)(2005-5#1)(2007-11#1)(2007-2#1)(2008-1#2)(2008-5#1)(2010-8#1)(2013-7#1)
situation in which a##3##4##(2008-4#1)(2008-5#1)(2008-9#1)
situation in which the##3##4##(2008-11#1)(2011-12#1)(2013-1#1)
situation in which##9##3##(1995-2#1)(1995-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-12#1)(2013-1#1)
situation in##73##2##(1990-6#1)(1991-11#1)(1991-5#1)(1991-6#3)(1991-8#2)(1992-2#1)(1992-5#2)(1993-1#1)(1993-12#1)(1993-2#1)(1994-6#1)(1995-2#1)(1995-7#1)(1995-8#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-4#1)(2005-5#1)(2005-7#1)(2006-10#3)(2006-2#1)(2006-4#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-8#1)(2011-12#2)(2011-2#2)(2012-12#2)(2013-1#2)(2013-7#1)
situation involving##2##2##(2005-10#1)(2008-2#1)
situation is different##3##3##(1996-2#1)(2006-7#1)(2007-9#1)
situation is more##2##3##(1996-2#1)(2009-7#1)
situation is observed##2##3##(2008-7#1)(2008-8#1)
situation is the##3##3##(1993-6#1)(1994-12#1)(2004-9#1)
situation is##37##2##(1990-8#1)(1992-9#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-2#2)(2004-9#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-7#1)(2011-2#1)(2012-2#1)
situation model##3##2##(2013-1#3)
situation of a##3##3##(1990-8#1)(2008-3#1)(2010-4#1)
situation of children##2##3##(1995-5#1)(2013-1#1)
situation of increased##2##3##(1996-9#1)(2008-7#1)
situation of the##9##3##(1990-8#1)(1993-3#1)(1994-2#1)(1996-11#1)(1996-9#1)(2011-1#1)(2011-2#1)(2012-2#2)
situation of those##2##3##(1996-9#1)(2006-10#1)
situation of##58##2##(1990-12#1)(1990-8#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-2#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-9#3)(2005-4#1)(2006-10#2)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-2#3)(2008-3#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-12#4)(2011-2#2)(2012-2#3)(2013-1#6)(2013-8#1)
situation or##3##2##(1994-4#1)(2008-7#1)(2011-2#1)
situation regarding##3##2##(2008-1#2)(2012-12#1)
situation should##2##2##(2008-10#1)(2008-8#1)
situation that is##2##3##(1995-3#1)(2008-8#1)
situation that##14##2##(1995-3#1)(2005-11#1)(2006-10#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-7#1)(2011-1#1)(2012-11#1)(2012-12#1)
situation the##6##2##(1990-6#1)(1995-5#1)(2007-9#1)(2008-10#1)(2008-3#2)
situation to##4##2##(1995-6#1)(2008-2#1)(2010-12#1)(2012-11#1)
situation today##2##2##(1995-9#2)
situation was found##2##3##(2008-11#1)(2012-12#1)
situation was##6##2##(1997-5#1)(2006-8#1)(2008-1#1)(2008-11#1)(2012-12#1)(2012-3#1)
situation we##2##2##(1992-2#1)(1992-4#1)
situation were##2##2##(1996-1#1)(1996-9#1)
situation when##4##2##(2008-10#1)(2008-2#1)(2008-8#1)(2009-5#1)
situation where the##7##3##(1993-6#1)(1997-6#1)(2005-11#1)(2008-4#1)(2010-12#1)(2010-2#1)(2013-7#1)
situation where##12##2##(1993-6#1)(1996-1#1)(1997-6#1)(2005-11#1)(2008-4#1)(2008-8#2)(2010-12#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
situation which##5##2##(1992-5#1)(1994-4#1)(1996-7#1)(2005-1#1)(2010-12#1)
situation will##3##2##(1992-6#1)(1993-11#1)(2007-3#1)
situation with##12##2##(1990-4#1)(1997-8#1)(2005-11#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-12#2)(2009-6#1)(2010-10#1)(2012-2#1)(2013-7#1)
situation##625##1##(1990-10#1)(1990-11#1)(1990-12#17)(1990-2#2)(1990-3#4)(1990-4#2)(1990-5#1)(1990-6#3)(1990-8#5)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#5)(1991-7#2)(1991-8#5)(1992-1#1)(1992-2#5)(1992-3#5)(1992-4#2)(1992-5#5)(1992-6#1)(1992-8#2)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#3)(1993-5#1)(1993-6#4)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-4#3)(1994-5#1)(1994-6#2)(1994-8#1)(1995-11#4)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#5)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#3)(1996-1#8)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#5)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#4)(1997-5#2)(1997-6#3)(1997-8#3)(2004-11#1)(2004-3#1)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#5)(2005-4#1)(2005-5#3)(2005-7#2)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#16)(2006-12#3)(2006-2#3)(2006-4#6)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#5)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#8)(2007-12#9)(2007-2#5)(2007-3#4)(2007-4#4)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#7)(2007-9#7)(2008-1#12)(2008-10#15)(2008-11#17)(2008-12#9)(2008-2#20)(2008-3#13)(2008-4#8)(2008-5#14)(2008-6#1)(2008-7#12)(2008-8#12)(2008-9#5)(2009-10#2)(2009-11#5)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#5)(2009-6#5)(2009-7#4)(2009-8#3)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#9)(2010-2#4)(2010-4#3)(2010-5#5)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#6)(2011-12#8)(2011-2#27)(2011-7#1)(2012-1#4)(2012-11#4)(2012-12#14)(2012-2#11)(2012-3#8)(2013-1#24)(2013-7#5)(2013-8#12)
situation)##2##1##(1996-1#2)
situation-specific##3##1##(2007-4#1)(2008-2#1)(2009-6#1)
situation]##2##1##(1992-11#1)(1996-10#1)
situational and##3##2##(1993-12#1)(1994-2#1)(2007-12#1)
situational context##2##2##(1994-2#1)(2009-7#1)
situational contexts##2##2##(2007-12#1)(2009-7#1)
situational factors##5##2##(1996-3#1)(2007-12#1)(2008-12#1)(2008-7#2)
situational##29##1##(1993-12#1)(1994-2#2)(1996-3#1)(1997-8#1)(2006-1#1)(2006-7#1)(2006-8#1)(2007-12#4)(2007-5#2)(2008-12#2)(2008-3#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-7#2)(2010-3#1)(2012-3#1)(2013-1#3)(2013-8#1)
situations and to##2##3##(2008-12#1)(2009-6#1)
situations and##29##2##(1990-6#1)(1992-9#1)(1994-5#1)(1995-3#1)(1995-5#1)(1995-6#1)(2004-3#1)(2006-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2009-10#1)(2009-6#1)(2010-11#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#2)(2013-1#3)
situations are discussed##2##3##(2008-2#1)(2009-4#1)
situations are##11##2##(1996-4#1)(2007-9#1)(2008-2#2)(2008-7#1)(2009-4#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
situations as well##3##3##(2008-5#1)(2013-1#2)
situations as##8##2##(1996-12#1)(2006-10#1)(2008-5#1)(2009-6#1)(2012-2#1)(2013-1#3)
situations at##2##2##(2008-11#1)(2008-3#1)
situations can be##2##3##(2008-11#1)(2008-3#1)
situations can##3##2##(2008-11#1)(2008-3#1)(2009-10#1)
situations commonly encountered in##2##4##(1993-9#1)(2006-12#1)
situations either##2##2##(2006-9#1)(2008-3#1)
situations exist##2##2##(1993-1#2)
situations has been##2##3##(1994-6#1)(2008-3#1)
situations in the hospital##2##4##(1991-1#1)(2011-1#1)
situations in the##4##3##(1990-9#1)(1991-1#1)(2009-4#1)(2011-1#1)
situations in which a##3##4##(1996-12#1)(2013-1#2)
situations in which the##7##4##(2006-3#1)(2006-7#1)(2006-8#1)(2007-12#1)(2008-3#1)(2011-1#1)(2013-1#1)
situations in which##30##3##(1993-10#1)(1996-12#1)(2004-11#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-3#4)(2008-4#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#4)
situations in##46##2##(1990-9#1)(1991-1#1)(1993-10#1)(1995-5#1)(1996-12#1)(2004-11#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-3#1)(2013-1#4)
situations include##2##2##(2008-9#1)(2010-3#1)
situations involving a##2##3##(1993-12#1)(1996-10#1)
situations involving##7##2##(1991-3#1)(1992-12#1)(1993-12#1)(1996-10#1)(1996-3#1)(2008-10#1)(2012-2#1)
situations is##5##2##(2005-9#1)(2006-10#1)(2007-12#1)(2008-3#2)
situations it##2##2##(1993-6#1)(2008-7#1)
situations like##3##2##(1992-9#1)(1995-12#1)(2012-2#1)
situations may##3##2##(1995-7#1)(2007-12#1)(2009-6#1)
situations of acute##2##3##(1993-5#1)(1996-1#1)
situations of clinical##2##3##(1993-8#1)(2008-1#1)
situations of##15##2##(1990-3#1)(1991-9#1)(1993-12#1)(1993-5#1)(1993-8#1)(1996-1#1)(2005-10#1)(2007-12#1)(2007-5#1)(2008-1#1)(2010-12#1)(2010-8#1)(2011-12#1)(2012-3#2)
situations only##2##2##(1997-6#1)(2009-4#1)
situations or##6##2##(1990-5#1)(1993-11#1)(2006-12#1)(2007-2#1)(2008-12#1)(2011-2#1)
situations related to##2##3##(1997-5#1)(2013-8#1)
situations should be##2##3##(2009-6#1)(2013-1#1)
situations should##3##2##(2009-6#2)(2013-1#1)
situations such as##11##3##(1990-5#1)(1994-5#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)
situations than##2##2##(2006-4#1)(2008-8#1)
situations that are##2##3##(2008-2#2)
situations that may##2##3##(1995-8#1)(2010-11#1)
situations that##21##2##(1990-6#1)(1995-8#1)(2005-7#1)(2006-10#1)(2006-3#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-2#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-4#1)(2011-2#3)(2012-12#1)
situations the##6##2##(1994-9#1)(1995-8#1)(2006-10#1)(2006-2#1)(2007-11#1)(2012-3#1)
situations this##2##2##(2005-10#1)(2011-2#1)
situations to##5##2##(1995-3#1)(2006-9#1)(2007-2#1)(2009-3#1)(2009-8#1)
situations was##2##2##(2007-12#1)(2010-11#1)
situations were##4##2##(1990-12#1)(1991-3#1)(2007-12#1)(2008-10#1)
situations when##6##2##(1990-5#1)(1992-11#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-9#1)
situations where a##4##3##(1993-8#1)(2008-10#1)(2010-7#1)(2012-12#1)
situations where no##4##3##(1995-11#1)(1996-6#1)(1997-6#1)(2012-12#1)
situations where the most probable##2##5##(2008-11#1)(2010-6#1)
situations where the##11##3##(1995-2#1)(1997-7#1)(2008-11#1)(2008-4#2)(2008-7#2)(2009-3#1)(2010-6#1)(2012-12#2)
situations where there##3##3##(2010-2#1)(2012-12#2)
situations where##47##2##(1991-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-11#2)(1995-2#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-12#1)(2006-4#1)(2007-11#3)(2008-10#3)(2008-11#2)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#3)(2009-11#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2012-12#6)
situations which##2##2##(1991-3#1)(2008-10#1)
situations with##8##2##(1991-12#1)(1992-2#1)(1993-9#1)(2008-10#1)(2008-12#2)(2008-9#1)(2009-8#1)
situations within##2##2##(2007-5#1)(2008-2#1)
situations##588##1##(1990-12#2)(1990-3#1)(1990-5#5)(1990-6#3)(1990-9#2)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#3)(1992-6#2)(1992-8#1)(1992-9#3)(1993-1#2)(1993-10#3)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#3)(1993-9#4)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#3)(1995-2#3)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#2)(1996-1#4)(1996-10#1)(1996-11#1)(1996-12#7)(1996-3#4)(1996-4#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#2)(2004-11#2)(2004-12#3)(2004-3#1)(2004-9#1)(2005-10#5)(2005-11#1)(2005-12#1)(2005-4#3)(2005-6#1)(2005-7#3)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#14)(2006-11#1)(2006-12#3)(2006-2#4)(2006-3#2)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#3)(2006-8#7)(2006-9#4)(2007-11#10)(2007-12#12)(2007-2#5)(2007-3#1)(2007-4#3)(2007-5#3)(2007-7#4)(2007-8#4)(2007-9#3)(2008-1#2)(2008-10#26)(2008-11#17)(2008-12#7)(2008-2#17)(2008-3#23)(2008-4#8)(2008-5#7)(2008-6#5)(2008-7#13)(2008-8#9)(2008-9#11)(2009-10#4)(2009-11#4)(2009-12#1)(2009-2#4)(2009-3#2)(2009-4#7)(2009-5#5)(2009-6#13)(2009-7#1)(2009-8#7)(2009-9#3)(2010-1#1)(2010-11#5)(2010-12#7)(2010-2#7)(2010-3#3)(2010-4#3)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#14)(2011-10#1)(2011-12#3)(2011-2#21)(2011-3#2)(2012-1#2)(2012-11#2)(2012-12#17)(2012-2#6)(2012-3#12)(2013-1#29)(2013-8#3)
situations)##3##1##(2004-3#1)(2008-3#1)(2010-1#1)
situations]##3##1##(1990-12#1)(1993-2#1)(1993-5#1)
situs inversus totalis##3##3##(1993-9#2)(2007-8#1)
situs inversus with##2##3##(2008-7#1)(2012-12#1)
situs inversus##11##2##(1993-9#2)(2007-8#1)(2008-7#2)(2009-8#3)(2012-12#3)
situs viscerum inversus totalis##2##4##(2007-3#1)(2012-12#1)
situs##17##1##(1993-9#2)(2006-6#1)(2007-3#1)(2007-8#3)(2008-11#1)(2008-7#2)(2009-8#3)(2012-12#4)
situs&lt##2##1##(2006-6#2)
sive non specificata)##2##3##(1990-12#2)
sivelestat##4##1##(2005-8#3)(2009-6#1)
six (20%)##2##2##(2011-2#2)
six (22%)##2##2##(1990-8#1)(2007-8#1)
six (3##2##2##(1990-3#1)(2008-1#1)
six (4##2##2##(2007-7#1)(2007-8#1)
six (9%)##2##2##(1994-6#1)(2008-10#1)
six 25##2##2##(2006-4#1)(2006-6#1)
six Cys residues##2##3##(1991-6#1)(1993-2#1)
six European##3##2##(1994-3#1)(2007-8#1)(2008-7#1)
six H1##2##2##(1996-4#1)(1997-1#1)
six Myb-binding sites##2##3##(1992-7#2)
six active##2##2##(2008-10#1)(2008-5#1)
six additional##8##2##(1991-2#1)(1992-7#1)(1993-12#1)(1994-9#1)(2008-10#2)(2008-6#1)(2009-8#1)
six alkaloids##2##2##(2008-10#1)(2011-3#1)
six amino acids of the##2##5##(2006-9#1)(2007-8#1)
six amino acids##5##3##(1992-8#1)(1994-6#2)(2006-9#1)(2007-8#1)
six amino##6##2##(1992-8#1)(1994-6#2)(1997-4#1)(2006-9#1)(2007-8#1)
six amplified fragment length polymorphism markers##2##6##(2008-10#2)
six analytes##2##2##(2008-10#1)(2008-3#1)
six and eight##2##3##(1995-11#1)(2005-8#1)
six and five##3##3##(1996-12#1)(2006-7#1)(2008-5#1)
six and four##2##3##(2008-10#1)(2012-1#1)
six and##16##2##(1990-4#1)(1992-9#1)(1995-11#1)(1996-12#1)(1997-1#1)(2005-8#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-5#2)(2009-4#1)(2012-1#1)
six animals##7##2##(1994-8#1)(1996-12#1)(1996-3#1)(1997-6#1)(2006-8#1)(2008-7#1)(2009-5#1)
six areas of##2##3##(2008-1#1)(2008-10#1)
six areas##6##2##(1991-12#1)(1993-3#1)(2008-1#2)(2008-10#1)(2011-2#1)
six articles##4##2##(2008-5#3)(2008-6#1)
six bands##2##2##(2005-4#1)(2010-12#1)
six biweekly##2##2##(2013-1#2)
six cadavers##3##2##(2005-9#1)(2008-6#2)
six care practice papers##9##4##(2007-2#7)(2008-6#2)
six care practices that promote##2##5##(2007-2#1)(2008-6#1)
six care practices##4##3##(2007-2#2)(2008-6#2)
six care##14##2##(2007-2#10)(2008-6#4)
six cases of##8##3##(1994-6#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-7#1)(2008-9#1)(2012-12#1)
six cases##35##2##(1990-3#1)(1991-11#1)(1992-2#1)(1993-3#1)(1994-3#1)(1994-4#1)(1994-6#2)(1995-3#1)(1997-3#2)(2005-9#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
six cell lines##4##3##(1990-4#3)(2013-1#1)
six children who had received##2##5##(2008-9#1)(2010-10#1)
six children##8##2##(1990-3#1)(1992-9#1)(1997-3#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-10#1)(2010-8#1)
six chronic##2##2##(1994-12#1)(2011-2#1)
six clades##2##2##(2008-10#1)(2012-11#1)
six classes##4##2##(2008-10#1)(2008-5#1)(2010-2#1)(2012-12#1)
six clinical isolates##2##3##(2008-5#2)
six clinical##4##2##(1992-1#1)(2007-10#1)(2008-5#2)
six clusters##3##2##(1991-5#1)(2005-11#1)(2008-5#1)
six combinations##2##2##(2008-5#1)(2008-8#1)
six common##3##2##(2006-10#1)(2008-10#2)
six compounds##3##2##(2008-10#1)(2008-9#1)(2013-7#1)
six consecutive##4##2##(1997-4#3)(2008-4#1)
six conserved##3##2##(1992-10#1)(1994-12#1)(2013-8#1)
six coordinate##2##2##(1991-4#1)(2010-5#1)
six core##2##2##(2008-1#1)(2013-1#1)
six countries##5##2##(1995-2#1)(2008-1#1)(2008-10#1)(2012-2#2)
six courses of##2##3##(2008-6#2)
six critical points of intervention##2##5##(1997-2#2)
six cultivars##2##2##(2008-10#2)
six cycles of##5##3##(1994-5#1)(2007-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
six cycles##7##2##(1994-5#1)(2006-12#1)(2007-8#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
six cysteines##5##2##(1990-5#1)(1990-9#1)(1992-1#1)(1993-3#2)
six cytologically##2##2##(1990-2#1)(2004-2#1)
six databases##2##2##(1992-12#1)(1996-12#1)
six day##5##2##(2007-9#1)(2008-3#1)(2008-7#1)(2009-10#1)(2012-2#1)
six days after the##2##4##(2007-12#1)(2012-3#1)
six days after##5##3##(1992-8#1)(1996-5#1)(2007-12#2)(2012-3#1)
six days later##2##3##(2006-4#1)(2013-8#1)
six days of##3##3##(1992-8#1)(1993-2#1)(2008-11#1)
six days##14##2##(1992-8#2)(1993-2#1)(1993-8#1)(1996-5#1)(2006-4#1)(2007-12#2)(2008-11#1)(2008-5#1)(2008-6#1)(2009-5#1)(2012-3#1)(2013-8#1)
six degrees of freedom (DoF)##3##5##(2006-6#3)
six degrees of freedom##5##4##(2006-6#3)(2007-5#1)(2008-2#1)
six degrees of##6##3##(2006-6#3)(2007-4#1)(2007-5#1)(2008-2#1)
six derivatives of##2##3##(1990-8#1)(2008-10#1)
six different amino##2##3##(1994-3#1)(1994-6#1)
six different commercial##2##3##(2008-10#2)
six different##38##2##(1990-4#2)(1991-5#1)(1991-6#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-4#1)(2004-7#1)(2006-5#1)(2007-3#1)(2008-10#8)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2011-2#1)(2013-8#1)
six dimensions of##2##3##(1992-3#1)(2010-3#1)
six dimensions##4##2##(1991-3#2)(1992-3#1)(2010-3#1)
six distinct##4##2##(1993-3#1)(1994-9#1)(2007-7#1)(2008-6#1)
six donors##3##2##(2008-11#1)(2011-12#1)(2012-2#1)
six doses##2##2##(2007-7#1)(2008-1#1)
six electron equivalents##2##3##(1995-3#2)
six elements##2##2##(1996-3#1)(2007-4#1)
six enzymes##2##2##(1994-3#1)(2008-7#1)
six examples##2##2##(1992-11#1)(2008-3#1)
six exons##2##2##(1991-6#2)
six experimental##3##2##(1990-8#1)(2008-7#1)(2010-8#1)
six female tigers (Panthera tigris)##2##5##(2009-4#2)
six females##2##2##(1990-2#1)(2009-12#1)
six focus##2##2##(2007-7#1)(2007-9#1)
six for##3##2##(1997-8#1)(2008-10#1)(2008-9#1)
six fresh frozen##2##3##(2008-9#2)
six genera##2##2##(2007-5#1)(2011-2#1)
six genes##3##2##(1996-10#1)(1996-6#1)(2012-3#1)
six genotypes##2##2##(2008-10#2)
six groups of##4##3##(1994-7#1)(2008-4#2)(2010-5#1)
six groups##8##2##(1994-7#1)(2008-11#1)(2008-4#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-11#1)
six had##8##2##(1990-5#1)(1995-12#1)(2006-6#1)(2007-1#1)(2007-3#1)(2007-7#1)(2008-4#1)(2011-2#1)
six healthy subjects##2##3##(1991-2#1)(2012-1#1)
six healthy volunteers##2##3##(1995-11#1)(2008-5#1)
six healthy##7##2##(1991-2#1)(1995-11#1)(2008-5#1)(2008-6#1)(2009-5#1)(2012-1#1)(2012-12#1)
six highly##2##2##(1997-8#1)(2009-5#1)
six histidine##2##2##(1992-7#1)(1993-4#1)
six hours after##2##3##(1991-6#1)(1995-5#1)
six hours of##3##3##(2007-10#1)(2007-2#1)(2007-7#1)
six hours##12##2##(1990-8#1)(1991-11#1)(1991-6#1)(1992-6#1)(1995-5#1)(2007-10#1)(2007-2#2)(2007-7#1)(2007-9#1)(2008-5#1)(2009-4#1)
six hr##2##2##(1991-10#1)(1994-5#1)
six human##11##2##(1990-4#1)(1991-2#2)(1991-6#1)(1992-8#1)(1993-11#1)(1995-7#1)(1996-3#1)(1997-4#1)(2006-12#1)(2009-12#1)
six hundred##2##2##(2006-10#1)(2008-4#1)
six in the##2##3##(2006-12#1)(2008-10#1)
six in##5##2##(2006-12#1)(2007-7#1)(2008-10#2)(2011-2#1)
six indigenous communities residing in the city of Cali##2##9##(2012-12#2)
six indigenous communities residing in##3##5##(2012-12#3)
six introns##5##2##(1991-9#1)(1994-8#1)(1995-8#1)(1996-7#1)(1997-2#1)
six isolated##2##2##(2006-8#1)(2013-7#1)
six isolates##5##2##(2008-10#4)(2008-5#1)
six key##7##2##(1993-12#1)(1994-2#1)(1995-3#1)(2006-5#1)(2007-10#1)(2010-4#1)(2012-2#1)
six known compounds##3##3##(2007-1#1)(2010-2#2)
six known##8##2##(2007-1#4)(2008-10#1)(2008-4#1)(2010-2#2)
six large##2##2##(1993-3#1)(2007-2#1)
six levels##2##2##(2009-6#1)(2010-7#1)
six locations##2##2##(2008-10#1)(2013-8#1)
six loci##2##2##(1996-12#2)
six main##2##2##(2004-1#1)(2007-8#1)
six major##6##2##(1995-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-10#1)(2010-8#1)
six male##2##2##(2007-4#1)(2008-7#1)
six malignancies##3##2##(2007-3#3)
six markers##2##2##(2007-5#1)(2008-4#1)
six media##5##2##(2005-6#1)(2008-12#4)
six members of the##2##4##(1994-2#1)(2008-7#1)
six men and##2##3##(1996-2#1)(2006-12#1)
six men##3##2##(1991-3#1)(1996-2#1)(2006-12#1)
six methods##2##2##(2008-10#2)
six million##2##2##(2006-10#1)(2008-3#1)
six mismatched##3##2##(1996-1#1)(2010-11#2)
six modified##2##2##(1992-1#1)(1995-2#1)
six month follow-up##2##3##(2005-12#1)(2012-12#1)
six month period##4##3##(1992-2#1)(1992-5#1)(2007-11#1)(2008-12#1)
six month##14##2##(1992-2#1)(1992-5#1)(1996-11#1)(2005-12#1)(2006-10#1)(2007-11#3)(2007-6#1)(2008-12#1)(2008-6#1)(2011-12#1)(2012-12#1)(2012-2#1)
six months after an##2##4##(2013-1#2)
six months after embolisation##2##4##(1997-3#2)
six months after surgery##2##4##(1993-3#2)
six months after the event##2##5##(1991-3#1)(2013-8#1)
six months after the onset of##2##6##(1992-11#1)(2007-3#1)
six months after the operation##3##5##(2006-4#1)(2013-1#2)
six months after the procedure##2##5##(2008-11#1)(2011-2#1)
six months after the##13##4##(1991-3#2)(1992-11#1)(2006-4#1)(2007-11#1)(2007-3#1)(2008-11#1)(2009-11#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
six months after##31##3##(1990-2#2)(1990-5#1)(1991-3#3)(1992-11#1)(1992-2#1)(1993-3#2)(1997-3#2)(2006-4#1)(2007-11#2)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2009-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#5)(2013-8#1)
six months and one year##2##5##(1991-11#1)(2009-10#1)
six months and##7##3##(1991-11#1)(1995-9#1)(2008-1#1)(2008-11#1)(2009-10#1)(2013-1#2)
six months as##2##3##(1995-9#1)(2006-7#1)
six months at -20 degreeC##3##5##(2013-7#3)
six months at -20##5##4##(1992-2#1)(2013-7#4)
six months at##6##3##(1992-2#1)(2007-8#1)(2013-7#4)
six months before##2##3##(2012-12#1)(2013-8#1)
six months follow-up##2##3##(1992-9#1)(2008-8#1)
six months for##2##3##(1991-11#1)(1996-1#1)
six months in##5##3##(1993-2#1)(1995-9#1)(1996-8#1)(2008-1#1)(2013-1#1)
six months later##3##3##(1992-11#1)(2006-8#1)(2013-8#1)
six months of age##8##4##(1991-11#1)(1991-6#1)(2006-10#1)(2007-9#2)(2008-1#1)(2008-10#1)(2010-11#1)
six months of treatment##5##4##(2008-5#1)(2010-4#2)(2011-1#1)(2013-1#1)
six months of##25##3##(1991-11#1)(1991-5#2)(1991-6#1)(1996-11#1)(2005-10#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-3#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-5#1)(2010-11#1)(2010-4#2)(2010-8#1)(2011-1#2)(2013-1#3)
six months or more##2##4##(2010-4#1)(2013-1#1)
six months or##4##3##(1990-5#1)(1991-11#1)(2010-4#1)(2013-1#1)
six months to##3##3##(1990-5#1)(2008-1#1)(2013-1#1)
six months with a##2##4##(1990-2#1)(1991-10#1)
six months with##3##3##(1990-2#1)(1991-10#1)(2008-12#1)
six months##190##2##(1990-12#2)(1990-2#3)(1990-5#6)(1990-6#1)(1991-10#4)(1991-11#5)(1991-12#1)(1991-2#1)(1991-3#4)(1991-5#2)(1991-6#2)(1992-10#1)(1992-11#3)(1992-2#2)(1992-9#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-9#2)(1995-9#3)(1996-1#1)(1996-11#2)(1996-8#1)(1997-3#3)(1997-4#1)(2004-3#1)(2004-9#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-4#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#6)(2007-2#1)(2007-3#3)(2007-7#6)(2007-8#2)(2007-9#5)(2008-1#8)(2008-10#2)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#6)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-4#7)(2010-8#1)(2011-1#8)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#16)(2013-7#4)(2013-8#6)
six months'##2##2##(1992-6#1)(2007-7#1)
six months)##2##2##(1990-5#1)(2006-10#1)
six more##3##2##(1997-8#1)(2008-10#2)
six multimember VCGs##2##3##(2008-10#2)
six multimember##3##2##(2008-10#3)
six new##10##2##(1990-4#1)(1991-8#1)(1993-8#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-5#1)(2009-12#1)(2012-3#1)(2013-1#1)
six normal##2##2##(1995-12#1)(1996-3#1)
six nuclear##3##2##(1991-2#1)(1996-5#1)(2012-1#1)
six nucleotides##3##2##(1995-2#1)(1997-4#1)(1997-5#1)
six of nine##2##3##(2006-9#1)(2008-10#1)
six of our##2##3##(2007-7#1)(2009-4#1)
six of the eight##2##4##(2011-2#1)(2013-8#1)
six of the proteins##2##4##(1990-12#1)(1990-9#1)
six of the seven##3##4##(1991-2#1)(1993-12#1)(2009-2#1)
six of the##19##3##(1990-12#1)(1990-9#1)(1991-2#1)(1991-7#1)(1993-12#1)(1994-5#1)(1996-9#1)(2004-4#1)(2006-4#1)(2006-8#1)(2008-10#2)(2008-11#2)(2008-7#1)(2009-10#1)(2009-2#1)(2011-2#1)(2013-8#1)
six of them had##2##4##(1997-4#1)(2011-2#1)
six of them##7##3##(1991-4#1)(1997-4#1)(2007-7#2)(2011-2#1)(2013-1#1)(2013-7#1)
six of these##7##3##(1995-5#1)(1996-3#1)(2006-8#1)(2006-9#1)(2007-2#1)(2008-10#1)(2008-7#1)
six of type##3##3##(2010-4#3)
six of which were##2##4##(1994-9#1)(2006-12#1)
six of which##3##3##(1993-5#1)(1994-9#1)(2006-12#1)
six of##55##2##(1990-12#1)(1990-9#1)(1991-2#2)(1991-4#1)(1991-7#1)(1991-8#1)(1993-12#1)(1993-5#1)(1994-5#1)(1994-9#1)(1995-5#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-4#1)(2004-4#1)(2006-12#1)(2006-4#1)(2006-8#4)(2006-9#2)(2007-2#2)(2007-7#3)(2008-10#7)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-2#1)(2009-4#1)(2010-4#3)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
six open reading frames##3##4##(1995-9#2)(2005-11#1)
six or more##4##3##(1990-4#1)(2008-2#1)(2008-6#1)(2011-2#1)
six or seven##2##3##(1990-5#1)(2006-12#1)
six or##8##2##(1990-4#1)(1990-5#1)(2004-9#1)(2006-12#1)(2006-6#1)(2008-2#1)(2008-6#1)(2011-2#1)
six orders of magnitude##3##4##(2007-12#1)(2007-8#1)(2008-10#1)
six orders##5##2##(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2013-7#1)
six organic##2##2##(2008-10#1)(2013-8#1)
six other members of the SCMV subgroup##2##7##(2008-10#2)
six other##9##2##(1996-4#1)(1996-6#1)(2008-10#4)(2011-2#2)(2012-12#1)
six out of ten##2##4##(1991-8#1)(2008-7#1)
six out of the##3##4##(1993-12#1)(1994-3#1)(2008-5#1)
six out of##11##3##(1991-8#1)(1991-9#1)(1993-12#1)(1993-6#1)(1994-3#1)(1994-8#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)
six oxygen atoms##2##3##(1997-7#1)(2010-2#1)
six pairs of primers##2##4##(2006-10#1)(2008-8#1)
six pairs of##4##3##(2006-10#1)(2006-11#1)(2008-10#1)(2008-8#1)
six parameters##2##2##(2007-12#1)(2009-8#1)
six participants##2##2##(2007-10#1)(2010-8#1)
six parts##2##2##(2007-8#1)(2008-5#1)
six patient##2##2##(1992-8#1)(1995-5#1)
six patients had##3##3##(1990-2#1)(1990-8#1)(2008-7#1)
six patients treated##2##3##(1991-3#1)(2008-10#1)
six patients who were##2##4##(1994-6#1)(2007-2#1)
six patients who##6##3##(1994-6#1)(2007-2#1)(2007-7#1)(2007-8#1)(2011-2#1)(2012-12#1)
six patients with##18##3##(1997-1#2)(2006-8#1)(2007-2#1)(2007-7#2)(2008-2#1)(2008-6#2)(2008-7#3)(2008-9#3)(2011-2#1)(2013-1#2)
six patients##73##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-3#2)(1991-5#1)(1992-2#1)(1994-6#1)(1995-1#2)(1995-11#1)(1996-12#1)(1996-4#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#1)(2006-11#2)(2006-12#1)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-12#1)(2007-2#3)(2007-7#4)(2007-8#6)(2008-1#4)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#6)(2008-9#5)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
six peptides##2##2##(1993-6#1)(1994-9#1)
six percent of the##3##4##(2008-10#1)(2008-5#1)(2013-1#1)
six percent of##5##3##(1995-1#1)(2008-1#1)(2008-10#1)(2008-5#1)(2013-1#1)
six percent##6##2##(1995-1#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2013-1#1)
six persons##2##2##(1991-11#1)(2010-10#1)
six plates##2##2##(2008-9#2)
six populations##2##2##(2008-10#2)
six possible##2##2##(1992-6#1)(2008-10#1)
six potential##4##2##(1993-3#1)(1994-12#1)(1997-7#1)(2006-7#1)
six previously##2##2##(1996-10#1)(1996-3#1)
six primary##4##2##(1990-12#1)(2007-12#1)(2013-8#2)
six proteins##5##2##(1991-2#2)(1994-9#1)(1995-5#1)(2010-12#1)
six proton##2##2##(1991-7#1)(2008-10#1)
six public##2##2##(1995-6#1)(2011-1#1)
six published##3##2##(2006-10#1)(2007-11#1)(2010-11#1)
six putative##3##2##(1997-7#1)(1997-9#1)(2008-10#1)
six pyrethroids##3##2##(2008-10#3)
six questions##2##2##(1996-8#1)(2006-10#1)
six races##2##2##(2008-10#2)
six rats##4##2##(1993-7#1)(1997-2#1)(2007-1#1)(2011-2#1)
six received##2##2##(1992-11#1)(2007-2#1)
six receptor-centered gene networks##2##4##(2013-1#2)
six regions##3##2##(1991-5#1)(2008-10#2)
six replicate##5##2##(2008-10#5)
six replicates##3##2##(2008-10#3)
six rounds##4##2##(1995-2#1)(1997-4#3)
six samples per##2##3##(2008-10#1)(2013-7#1)
six samples##8##2##(2008-10#7)(2013-7#1)
six scales##2##2##(2008-10#1)(2008-3#1)
six schools##2##2##(2006-5#1)(2009-10#1)
six sections##2##2##(2012-3#2)
six selected##3##2##(2008-10#2)(2011-1#1)
six series of six samples were analyzed along 5 months##2##10##(2008-10#2)
six series of##3##3##(2008-10#2)(2008-8#1)
six sessions##2##2##(2005-8#1)(2008-1#1)
six showed##2##2##(1993-5#1)(2008-6#1)
six sites##3##2##(2008-5#1)(2008-6#1)(2012-3#1)
six species have##2##3##(2006-10#1)(2007-5#1)
six species of##4##3##(2008-5#1)(2008-9#2)(2013-1#1)
six species##13##2##(1993-12#1)(2006-10#1)(2007-12#2)(2007-3#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#3)(2013-1#1)
six spectral##2##2##(2008-3#1)(2008-6#1)
six state-of-the-art##2##2##(2008-2#1)(2008-3#1)
six states in##2##3##(2008-10#1)(2012-3#1)
six states##7##2##(1995-12#1)(2005-4#1)(2008-10#3)(2012-2#1)(2012-3#1)
six steps##8##2##(1992-12#1)(1994-12#2)(1997-2#1)(2006-12#1)(2008-4#1)(2009-4#1)(2011-1#1)
six structural##4##2##(1994-5#1)(1995-3#1)(1995-4#1)(2008-10#1)
six students##2##2##(1997-2#1)(2008-11#1)
six studies##4##2##(1995-5#1)(1996-6#1)(2008-6#1)(2011-2#1)
six study##2##2##(2006-10#1)(2008-8#1)
six subfamilies##2##2##(1997-4#1)(2007-3#1)
six subjects were##2##3##(2008-7#2)
six subjects with##3##3##(1995-4#1)(2010-1#1)(2013-8#1)
six subjects##8##2##(1995-4#1)(1996-1#1)(2006-8#1)(2008-3#1)(2008-7#2)(2010-1#1)(2013-8#1)
six successive##2##2##(2008-10#2)
six such##2##2##(2007-8#1)(2008-9#1)
six times during##2##3##(1993-12#1)(2007-10#1)
six times higher than that##2##5##(2007-11#1)(2007-12#1)
six times higher##3##3##(1995-12#1)(2007-11#1)(2007-12#1)
six times more likely to##2##5##(2008-9#1)(2009-5#1)
six times more##4##3##(2005-11#1)(2008-1#1)(2008-9#1)(2009-5#1)
six times##23##2##(1993-1#1)(1993-10#1)(1993-12#1)(1994-8#1)(1995-12#1)(2005-11#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-8#1)
six to eight copies##2##4##(2008-10#2)
six to eight weeks##2##4##(2007-2#1)(2007-3#1)
six to eight##9##3##(1990-10#1)(1995-1#1)(2006-10#1)(2007-2#1)(2007-3#1)(2008-10#3)(2008-5#1)
six to##16##2##(1990-10#1)(1991-12#1)(1995-1#1)(1995-4#1)(1996-9#1)(2006-10#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#4)(2008-5#2)(2011-1#1)
six transmembrane segments##2##3##(1996-12#1)(1997-2#1)
six transmembrane##4##2##(1996-12#1)(1996-5#1)(1997-2#1)(2009-9#1)
six tryptophans##2##2##(1997-1#1)(1997-4#1)
six tumor cell lines##2##4##(1991-6#2)
six tumours##2##2##(2004-2#2)
six types of##5##3##(1994-9#1)(2006-4#1)(2008-10#1)(2011-2#1)(2013-8#1)
six types##6##2##(1994-9#1)(2006-4#1)(2008-10#1)(2011-2#1)(2012-1#1)(2013-8#1)
six variables##5##2##(1990-9#1)(1995-1#1)(2008-10#2)(2008-7#1)
six variants##3##2##(2008-10#2)(2010-2#1)
six villages##2##2##(2007-6#1)(2008-2#1)
six volunteers##5##2##(1992-3#1)(1994-6#1)(2007-7#1)(2008-5#1)(2008-9#1)
six water molecules##2##3##(2006-1#1)(2008-10#1)
six wavelengths##3##2##(2005-4#1)(2008-3#2)
six week##2##2##(2006-4#1)(2012-12#1)
six weeks after the##3##4##(1992-1#1)(1992-10#1)(2007-5#1)
six weeks after##6##3##(1992-1#1)(1992-10#1)(2007-12#1)(2007-5#1)(2008-7#1)(2011-2#1)
six weeks and three months##2##5##(1991-11#2)
six weeks and##6##3##(1990-5#1)(1990-6#1)(1991-11#2)(1991-6#1)(2006-10#1)
six weeks in##3##3##(1994-2#1)(2007-12#1)(2009-6#1)
six weeks later##4##3##(1995-9#1)(2008-10#1)(2008-5#1)(2012-8#1)
six weeks of age##4##4##(1997-5#1)(2008-10#1)(2009-4#1)(2012-2#1)
six weeks of##7##3##(1991-10#1)(1997-5#1)(2007-8#1)(2008-10#1)(2009-4#1)(2011-1#1)(2012-2#1)
six weeks##53##2##(1990-5#1)(1990-6#1)(1991-10#1)(1991-11#3)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-10#1)(1993-8#1)(1994-2#1)(1995-9#2)(1997-5#1)(2006-10#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#4)(2012-3#2)(2012-8#1)(2013-1#1)(2013-7#1)
six were also##2##3##(1991-2#2)
six were##20##2##(1991-2#2)(1991-6#1)(1993-8#1)(1996-9#1)(2006-11#1)(2006-7#1)(2007-1#2)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-5#1)(2010-4#1)(2010-5#1)
six with##6##2##(1993-5#1)(1994-6#1)(1995-6#1)(1996-2#1)(2006-8#1)(2008-3#1)
six women##2##2##(2006-8#1)(2010-7#1)
six year old##2##3##(2008-1#1)(2009-9#1)
six year##7##2##(1990-3#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-8#1)(2009-9#1)
six years in##2##3##(1992-2#1)(2008-7#1)
six years later##2##3##(1992-11#1)(2004-2#1)
six years of age##4##4##(1995-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
six years of operation##2##4##(2004-12#1)(2008-2#1)
six years of##9##3##(1991-2#1)(1995-2#1)(2004-12#1)(2008-1#1)(2008-2#1)(2009-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
six years old##2##3##(2012-2#1)(2013-8#1)
six years to##2##3##(2008-3#1)(2008-7#1)
six years with##2##3##(2007-7#1)(2007-8#1)
six years##42##2##(1991-2#2)(1992-11#1)(1992-2#1)(1993-1#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-8#1)(2004-12#1)(2004-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-10#1)(2009-2#3)(2011-1#3)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
six young##2##2##(1991-12#1)(1991-6#1)
six##1945##1##(1990-10#3)(1990-11#3)(1990-12#7)(1990-2#7)(1990-3#8)(1990-4#10)(1990-5#15)(1990-6#5)(1990-8#6)(1990-9#4)(1991-10#7)(1991-11#11)(1991-12#6)(1991-2#18)(1991-3#10)(1991-4#3)(1991-5#6)(1991-6#13)(1991-7#2)(1991-8#8)(1991-9#4)(1992-1#7)(1992-10#3)(1992-11#6)(1992-12#6)(1992-2#9)(1992-3#6)(1992-4#1)(1992-5#1)(1992-6#5)(1992-7#4)(1992-8#6)(1992-9#5)(1993-1#4)(1993-10#1)(1993-11#4)(1993-12#8)(1993-2#6)(1993-3#13)(1993-4#1)(1993-5#3)(1993-6#5)(1993-7#2)(1993-8#4)(1993-9#7)(1994-1#3)(1994-10#1)(1994-11#1)(1994-12#10)(1994-2#3)(1994-3#8)(1994-4#2)(1994-5#5)(1994-6#11)(1994-7#1)(1994-8#7)(1994-9#10)(1995-1#9)(1995-10#3)(1995-11#5)(1995-12#7)(1995-2#10)(1995-3#9)(1995-4#3)(1995-5#9)(1995-6#6)(1995-7#2)(1995-8#3)(1995-9#7)(1996-1#4)(1996-10#5)(1996-11#5)(1996-12#17)(1996-2#10)(1996-3#14)(1996-4#4)(1996-5#7)(1996-6#6)(1996-7#3)(1996-8#5)(1996-9#9)(1997-1#9)(1997-2#11)(1997-3#12)(1997-4#18)(1997-5#5)(1997-6#1)(1997-7#5)(1997-8#4)(1997-9#1)(2004-1#1)(2004-10#1)(2004-12#2)(2004-2#5)(2004-3#1)(2004-4#2)(2004-7#1)(2004-9#3)(2005-1#1)(2005-10#2)(2005-11#4)(2005-12#1)(2005-4#4)(2005-6#1)(2005-7#1)(2005-8#5)(2005-9#4)(2006-1#1)(2006-10#21)(2006-11#7)(2006-12#12)(2006-2#1)(2006-3#3)(2006-4#7)(2006-5#8)(2006-6#11)(2006-7#10)(2006-8#25)(2006-9#6)(2007-1#18)(2007-10#6)(2007-11#21)(2007-12#29)(2007-2#31)(2007-3#20)(2007-4#4)(2007-5#17)(2007-6#5)(2007-7#40)(2007-8#40)(2007-9#17)(2008-1#37)(2008-10#232)(2008-11#21)(2008-12#20)(2008-2#15)(2008-3#30)(2008-4#24)(2008-5#78)(2008-6#41)(2008-7#35)(2008-8#24)(2008-9#27)(2009-10#7)(2009-11#1)(2009-12#5)(2009-2#8)(2009-3#1)(2009-4#12)(2009-5#8)(2009-6#5)(2009-7#3)(2009-8#3)(2009-9#3)(2010-1#2)(2010-10#5)(2010-11#4)(2010-12#6)(2010-2#8)(2010-3#3)(2010-4#22)(2010-5#6)(2010-6#2)(2010-7#3)(2010-8#10)(2010-9#2)(2011-1#25)(2011-10#1)(2011-12#6)(2011-2#45)(2011-3#4)(2012-1#6)(2012-11#4)(2012-12#22)(2012-2#36)(2012-3#17)(2012-8#1)(2013-1#52)(2013-7#15)(2013-8#36)
six)##4##1##(2004-1#2)(2008-10#1)(2008-5#1)
six-##2##1##(2007-4#2)
six-arm##3##1##(2008-3#2)(2009-2#1)
six-axis##2##1##(2006-11#1)(2013-1#1)
six-carbon##2##1##(1993-6#1)(2008-10#1)
six-component##3##1##(2008-10#2)(2012-3#1)
six-coordinate carbide##2##2##(2010-5#2)
six-coordinate##4##1##(2007-11#1)(2010-5#3)
six-coordinated##2##1##(1992-1#1)(2007-11#1)
six-day##2##1##(2008-7#2)
six-dimensional##3##1##(2007-11#1)(2008-5#2)
six-eight##2##1##(2007-5#1)(2012-12#1)
six-fold##4##1##(1991-5#1)(1997-3#1)(2006-8#1)(2008-10#1)
six-hour##3##1##(1992-11#1)(1996-8#1)(2007-10#1)
six-membered ring##3##2##(2004-7#2)(2008-5#1)
six-membered##7##1##(1996-2#1)(1997-7#2)(2004-7#2)(2005-8#1)(2008-5#1)
six-month period##6##2##(1996-11#1)(1997-3#1)(2007-7#1)(2008-1#3)
six-month sampling##2##2##(2007-5#2)
six-month survival##2##2##(1994-12#2)
six-month trial##2##2##(1992-11#1)(2006-9#1)
six-month##24##1##(1991-12#1)(1992-11#1)(1992-2#1)(1994-12#2)(1995-9#1)(1996-11#1)(1997-3#1)(2006-10#1)(2006-8#1)(2006-9#2)(2007-5#3)(2007-7#1)(2008-1#3)(2008-4#1)(2008-5#1)(2008-6#1)(2010-9#1)(2012-2#1)
six-monthly##3##1##(1996-12#1)(2008-6#1)(2008-9#1)
six-months follow-up##2##2##(2007-8#2)
six-phase strategy##2##2##(1996-1#1)(1996-2#1)
six-point##2##1##(2010-6#1)(2013-1#1)
six-port valve##2##2##(2008-10#2)
six-port##5##1##(2008-10#5)
six-stage##4##1##(2008-5#2)(2013-1#2)
six-step##4##1##(1990-5#1)(1992-3#1)(2007-4#1)(2011-2#1)
six-wave mixing##2##2##(2007-12#2)
six-way valve##2##2##(2008-10#2)
six-week##7##1##(2006-10#1)(2008-3#1)(2008-9#1)(2010-8#1)(2010-9#1)(2012-1#1)(2013-1#1)
six-week-old##3##1##(2007-2#2)(2010-7#1)
six-year period##10##2##(1991-10#1)(1992-3#1)(1993-10#1)(1995-5#1)(1996-1#1)(2006-6#1)(2010-4#1)(2011-2#2)(2012-2#1)
six-year time period##2##3##(2007-8#1)(2011-2#1)
six-year time##3##2##(2007-8#1)(2011-2#2)
six-year##14##1##(1991-10#1)(1992-3#1)(1993-10#1)(1995-5#1)(1996-1#1)(2006-6#1)(2007-7#1)(2007-8#1)(2010-4#1)(2011-2#4)(2012-2#1)
six-year-old boy with##2##3##(1997-7#1)(2009-9#1)
six-year-old boy##3##2##(1997-7#1)(2008-11#1)(2009-9#1)
six-year-old##4##1##(1997-7#1)(2006-11#1)(2008-11#1)(2009-9#1)
sixfold higher##4##2##(1993-5#1)(2006-12#1)(2008-10#1)(2013-8#1)
sixfold in the##2##3##(1996-9#1)(2005-11#1)
sixfold##25##1##(1990-7#1)(1992-6#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-9#1)(1996-4#1)(1996-9#1)(2005-11#1)(2006-10#1)(2006-12#2)(2007-12#2)(2008-1#1)(2008-10#3)(2008-3#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-2#1)(2013-8#1)
sixteen of##2##2##(1993-2#1)(1996-2#1)
sixteen##38##1##(1990-2#1)(1991-5#1)(1991-6#1)(1993-12#1)(1993-2#1)(1993-7#1)(1995-1#1)(1996-2#1)(1996-5#1)(1997-2#1)(2005-4#2)(2006-10#1)(2006-11#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#2)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)
sixteenth century##3##2##(2008-11#1)(2012-2#1)(2013-8#1)
sixteenth##6##1##(1990-2#1)(2008-11#1)(2008-8#2)(2012-2#1)(2013-8#1)
sixteenth-century##7##1##(2007-5#1)(2008-11#4)(2008-2#1)(2012-2#1)
sixth case of##3##3##(1993-10#1)(2006-5#1)(2008-6#1)
sixth cycle##2##2##(2009-5#1)(2012-12#1)
sixth decade of life##4##4##(2005-10#1)(2007-9#1)(2009-5#1)(2012-12#1)
sixth decade##6##2##(1997-7#1)(2005-10#1)(2007-9#1)(2008-9#1)(2009-5#1)(2012-12#1)
sixth grade##2##2##(2006-10#1)(2011-1#1)
sixth ligand##3##2##(1997-4#1)(1997-7#1)(2008-10#1)
sixth month##4##2##(1990-6#1)(1993-3#1)(1997-8#2)
sixth nerve##2##2##(2011-2#1)(2012-3#1)
sixth of##2##2##(1990-2#1)(2011-2#1)
sixth through eighth##2##3##(2007-12#1)(2010-9#1)
sixth transmembrane##6##2##(1992-5#1)(1993-8#1)(1994-8#1)(1995-3#1)(1997-2#2)
sixth week##3##2##(2005-11#1)(2005-12#1)(2013-1#1)
sixth##96##1##(1990-12#1)(1990-2#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-5#1)(1993-10#1)(1993-11#1)(1993-3#2)(1993-6#3)(1993-8#1)(1994-10#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-5#3)(1997-7#2)(1997-8#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-12#4)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#2)(2010-1#1)(2010-10#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#4)
sixth-order##7##1##(2007-12#2)(2008-2#2)(2008-3#1)(2010-12#2)
sixties##11##1##(1990-9#1)(1992-10#1)(1992-8#1)(1993-8#1)(1997-8#1)(2007-6#1)(2007-8#1)(2008-6#1)(2011-2#1)(2012-2#2)
sixty (65%)##2##2##(1997-3#2)
sixty five##2##2##(2007-11#1)(2012-12#1)
sixty patients##4##2##(2006-9#1)(2007-9#1)(2011-2#2)
sixty seven##2##2##(1992-11#1)(2010-8#1)
sixty years##2##2##(1990-10#1)(2008-5#1)
sixty##35##1##(1990-10#1)(1990-12#1)(1991-12#1)(1992-10#1)(1992-11#1)(1997-3#2)(2006-9#2)(2007-10#1)(2007-11#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-5#1)(2009-4#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#2)
sixty-five##5##1##(1991-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-1#1)
sixty-four##4##1##(2006-10#1)(2008-10#1)(2008-5#1)(2013-1#1)
sixty-nine##4##1##(2005-10#2)(2006-4#1)(2007-6#1)
sixty-seven##5##1##(1991-9#1)(1992-10#1)(1996-3#1)(2007-10#1)(2010-10#1)
sixty-six patients##2##2##(2007-10#1)(2009-10#1)
sixty-six##4##1##(2007-1#1)(2007-10#1)(2008-12#1)(2009-10#1)
sixty-three##5##1##(1991-7#1)(2004-10#1)(2007-4#1)(2012-2#1)(2013-1#1)
sixty-two##6##1##(1991-2#1)(1996-10#1)(2004-12#1)(2007-8#2)(2011-2#1)
six weeks##2##1##(2011-1#2)
sizable##15##1##(1990-5#1)(1991-7#1)(1992-12#1)(1993-10#1)(1995-2#1)(1996-11#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#2)(2009-9#1)(2011-2#1)
size &gt##3##2##(2008-10#1)(2008-6#2)
size &lt##4##2##(2008-10#2)(2008-2#1)(2012-2#1)
size ( approximately##2##3##(2007-12#1)(2008-10#1)
size (&gt##4##2##(2008-9#1)(2012-2#2)(2013-8#1)
size (&lt##3##2##(2007-7#1)(2008-4#1)(2010-4#1)
size (8##3##2##(1993-9#1)(2006-2#1)(2008-10#1)
size (ES)##2##2##(2009-9#1)(2012-12#1)
size (Ne)##2##2##(1996-8#1)(2008-8#1)
size (P = 0##2##4##(1996-3#1)(2008-6#1)
size (approximately##2##2##(1995-2#1)(2007-10#1)
size (at##2##2##(1994-10#1)(2008-5#1)
size (diameter)##2##2##(2008-10#1)(2008-11#1)
size (n =##2##3##(1995-3#1)(2011-1#1)
size (p##2##2##(1990-6#1)(2008-12#1)
size (typically##2##2##(2008-1#1)(2008-10#1)
size 10##2##2##(2008-2#1)(2008-3#1)
size 2##2##2##(1996-6#1)(2011-2#1)
size 5##4##2##(1993-1#1)(1996-6#1)(2012-12#2)
size 50##2##2##(1996-9#1)(2009-12#1)
size =##2##2##(2008-12#1)(2008-9#1)
size N##2##2##(2008-10#1)(2008-8#1)
size VLDL##4##2##(1993-8#4)
size a##4##2##(1993-12#1)(2007-8#1)(2012-12#1)(2012-3#1)
size affected##2##2##(2008-10#1)(2009-8#1)
size after##7##2##(1990-4#1)(1994-4#1)(2005-10#1)(2006-12#1)(2008-1#1)(2010-7#1)(2012-12#1)
size alone##2##2##(2008-10#1)(2012-3#1)
size among##3##2##(1991-8#1)(1993-9#1)(2008-8#1)
size analysis of##2##3##(2004-9#1)(2008-3#1)
size analysis##10##2##(2004-12#1)(2004-9#1)(2005-11#2)(2008-10#2)(2008-12#1)(2008-3#1)(2012-12#1)(2013-8#1)
size and a##5##3##(1996-12#1)(2008-10#1)(2008-3#2)(2013-1#1)
size and aa sequence##2##4##(1993-3#1)(1995-2#1)
size and age at settlement##2##5##(2007-5#2)
size and age##4##3##(2006-8#1)(2007-5#2)(2008-8#1)
size and an##2##3##(2009-8#1)(2012-2#1)
size and area##2##3##(2008-10#1)(2012-2#1)
size and both##2##3##(2008-8#2)
size and branching##2##3##(1994-11#1)(2007-12#1)
size and by##2##3##(1995-11#1)(2008-8#1)
size and cell##2##3##(2008-11#1)(2008-8#1)
size and character##2##3##(1991-11#1)(1995-5#1)
size and charge density##2##4##(2005-11#1)(2008-10#1)
size and charge distribution##2##4##(1997-2#1)(2008-10#1)
size and charge##6##3##(1992-8#1)(1993-9#1)(1997-2#1)(2005-11#1)(2008-10#2)
size and complexity##3##3##(2005-11#1)(2005-8#1)(2011-2#1)
size and composition##3##3##(2009-8#2)(2010-2#1)
size and compression##2##3##(2007-8#1)(2008-2#1)
size and concentration of##2##4##(1995-3#1)(2008-10#1)
size and concentration##9##3##(1992-8#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-3#4)(2011-2#1)
size and connectivity##2##3##(2008-8#1)(2010-4#1)
size and cover##2##3##(2008-5#2)
size and density of##2##4##(2008-1#1)(2008-5#1)
size and density##7##3##(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#2)
size and diversity of##2##4##(1995-7#1)(2007-12#1)
size and diversity##3##3##(1995-7#1)(2005-7#1)(2007-12#1)
size and expression level##2##4##(1997-8#1)(2008-10#1)
size and flexibility##2##3##(1993-4#2)
size and function##2##3##(2007-8#2)
size and gene##2##3##(1997-2#1)(2007-11#1)
size and grade##2##3##(2007-10#1)(2011-1#1)
size and greater##2##3##(1991-2#1)(2011-2#1)
size and initial##2##3##(2008-10#1)(2008-11#1)
size and intensity##3##3##(1993-12#2)(2008-9#1)
size and is##2##3##(1994-11#1)(2006-9#1)
size and link density##2##4##(2008-5#2)
size and location of the##3##5##(1995-2#1)(1995-3#1)(2011-2#1)
size and location of##4##4##(1995-2#1)(1995-3#1)(2007-10#1)(2011-2#1)
size and location##5##3##(1995-2#1)(1995-3#1)(2007-10#1)(2010-12#1)(2011-2#1)
size and low##2##3##(2007-10#1)(2009-8#1)
size and magnetization##2##3##(2012-11#2)
size and mass##4##3##(2007-12#1)(2012-12#2)(2013-8#1)
size and mature height##2##4##(2008-9#2)
size and morphology of the##2##5##(2006-12#1)(2013-7#1)
size and morphology of##4##4##(2006-12#1)(2008-5#1)(2010-12#1)(2013-7#1)
size and morphology##12##3##(1994-4#2)(2005-11#1)(2006-12#1)(2007-11#1)(2007-2#1)(2008-5#1)(2010-12#1)(2011-12#1)(2012-11#2)(2013-7#1)
size and number of##14##4##(1996-6#1)(1997-7#1)(2005-8#1)(2007-12#3)(2008-10#4)(2008-2#1)(2008-7#1)(2008-8#1)(2010-12#1)
size and number##19##3##(1991-5#1)(1996-6#1)(1997-7#1)(2005-8#1)(2007-12#3)(2008-10#5)(2008-2#2)(2008-7#1)(2008-8#2)(2010-12#1)(2010-8#1)
size and optical##2##3##(2008-2#1)(2008-3#1)
size and orientation##7##3##(1992-2#1)(1996-1#1)(2011-1#1)(2013-1#4)
size and particle##2##3##(2005-11#1)(2008-10#1)
size and polydispersity##2##3##(1994-12#1)(2008-5#1)
size and position of the##2##5##(2007-12#1)(2008-2#1)
size and position##3##3##(2007-12#1)(2008-2#2)
size and power##5##3##(1994-2#1)(1994-9#1)(1997-3#2)(2007-7#1)
size and purity of##2##4##(2009-5#2)
size and quality of##2##4##(1993-3#1)(2012-2#1)
size and quality##3##3##(1990-3#1)(1993-3#1)(2012-2#1)
size and rate##2##3##(2008-7#1)(2011-2#1)
size and refractive index##2##4##(2008-2#1)(2008-3#1)
size and rotation##2##3##(2008-2#2)
size and sample##3##3##(2008-10#2)(2010-4#1)
size and sequence##4##3##(1995-1#1)(2008-2#1)(2008-7#1)(2008-9#1)
size and sex were##2##4##(2007-3#1)(2008-8#1)
size and sex##4##3##(2007-3#1)(2008-5#2)(2008-8#1)
size and shape is##2##4##(2008-10#1)(2008-3#1)
size and shape of the##10##5##(1993-10#1)(2005-11#3)(2006-10#1)(2007-12#1)(2008-2#1)(2008-5#1)(2010-12#1)(2013-8#1)
size and shape of##20##4##(1992-6#1)(1993-10#1)(1995-5#1)(2005-10#1)(2005-11#3)(2006-10#2)(2006-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#2)(2010-12#2)(2013-8#1)
size and shape selectivity##2##4##(2008-10#1)(2009-2#1)
size and shape##44##3##(1990-7#1)(1991-11#1)(1992-6#1)(1993-10#1)(1993-9#1)(1994-8#1)(1995-5#1)(2005-10#1)(2005-11#3)(2006-10#2)(2006-11#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#1)(2009-2#2)(2009-4#1)(2010-12#3)(2010-7#1)(2010-8#1)(2013-1#1)(2013-7#3)(2013-8#2)
size and short##2##3##(2011-2#1)(2012-11#1)
size and size distributions##2##4##(2007-10#1)(2007-9#1)
size and size##3##3##(2007-10#1)(2007-5#1)(2007-9#1)
size and specific##2##3##(2004-9#1)(2008-7#1)
size and strength##3##3##(2007-12#1)(2008-5#1)(2009-12#1)
size and structural##2##3##(2004-9#1)(2013-8#1)
size and structure##4##3##(1990-5#1)(1997-6#1)(2008-10#1)(2008-4#1)
size and surface##3##3##(2006-5#1)(2007-8#1)(2009-2#1)
size and that##4##3##(2008-3#1)(2008-8#2)(2008-9#1)
size and the location of the##2##6##(2007-3#1)(2013-8#1)
size and the shape of##2##5##(2008-3#2)
size and the shape##3##4##(2008-3#3)
size and the size distribution of the particles##2##8##(2005-11#1)(2008-10#1)
size and the size##3##4##(2005-11#1)(2007-12#1)(2008-10#1)
size and the use of##2##5##(1993-1#1)(2008-10#1)
size and the##46##3##(1993-1#1)(1994-11#1)(1995-11#1)(1995-9#1)(1996-3#2)(1996-6#2)(2005-11#4)(2006-1#1)(2007-11#4)(2007-12#4)(2007-3#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#8)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2011-2#3)(2013-8#1)
size and to##2##3##(2007-12#1)(2012-11#1)
size and type##3##3##(1994-2#1)(1996-1#1)(2010-8#1)
size and volume##3##3##(1991-9#1)(2008-4#1)(2009-11#1)
size and was##2##3##(2009-7#1)(2011-1#1)
size and weight##6##3##(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-5#1)
size and zeta potential##2##4##(2012-2#1)(2012-3#1)
size and##569##2##(1990-10#1)(1990-12#3)(1990-3#1)(1990-5#1)(1990-7#2)(1991-11#3)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#3)(1992-3#1)(1992-5#3)(1992-6#1)(1992-7#2)(1992-8#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-4#4)(1993-6#2)(1993-9#3)(1994-11#3)(1994-12#3)(1994-2#5)(1994-3#3)(1994-4#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-2#4)(1995-3#3)(1995-4#1)(1995-5#7)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-3#3)(1996-6#6)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#2)(2004-1#2)(2004-11#1)(2004-2#1)(2004-9#3)(2005-10#2)(2005-11#19)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-5#2)(2006-8#1)(2006-9#1)(2007-1#3)(2007-10#5)(2007-11#11)(2007-12#27)(2007-2#1)(2007-3#4)(2007-5#4)(2007-6#1)(2007-7#2)(2007-8#8)(2007-9#5)(2008-1#4)(2008-10#54)(2008-11#4)(2008-12#2)(2008-2#23)(2008-3#28)(2008-4#9)(2008-5#18)(2008-7#8)(2008-8#25)(2008-9#13)(2009-10#4)(2009-11#2)(2009-12#2)(2009-2#7)(2009-4#1)(2009-5#3)(2009-7#2)(2009-8#6)(2010-1#1)(2010-11#1)(2010-12#9)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#2)(2010-7#1)(2010-8#10)(2010-9#1)(2011-1#5)(2011-12#3)(2011-2#21)(2012-1#2)(2012-11#6)(2012-12#7)(2012-2#8)(2012-3#7)(2013-1#13)(2013-7#5)(2013-8#9)
size are##11##2##(1992-4#1)(1996-12#1)(1996-3#1)(2005-11#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#2)(2012-2#1)
size as a##4##3##(2008-11#1)(2008-7#1)(2008-9#1)(2011-1#1)
size as the##4##3##(1992-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
size as well as in##3##5##(2008-8#1)(2013-1#2)
size as well as##4##4##(2008-8#1)(2009-10#1)(2013-1#2)
size as##20##2##(1992-12#1)(1992-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
size associated with##2##3##(1995-6#1)(2009-4#1)
size asymmetric##2##2##(2008-8#2)
size asymmetry of competition##3##4##(2008-8#3)
size asymmetry##5##2##(2008-8#5)
size at maturity and##6##4##(2008-9#4)(2010-8#2)
size at maturity##9##3##(2008-8#2)(2008-9#5)(2010-8#2)
size at the##4##3##(2007-12#1)(2008-1#1)(2008-2#2)
size at##28##2##(1997-4#2)(2006-5#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#5)(2008-9#6)(2010-8#2)(2012-3#1)(2013-8#1)
size based on the##2##4##(2007-9#1)(2012-2#1)
size based on##4##3##(1990-9#1)(1995-9#1)(2007-9#1)(2012-2#1)
size based##6##2##(1990-9#1)(1995-9#1)(2007-9#1)(2008-10#2)(2012-2#1)
size before##3##2##(1996-3#1)(1996-6#1)(2008-7#1)
size below which##2##3##(2008-10#2)
size below##4##2##(2008-10#2)(2008-8#2)
size between##5##2##(1993-9#1)(1995-6#1)(2006-5#1)(2006-6#1)(2011-1#1)
size bias in##2##3##(2008-8#2)
size bias##4##2##(2008-8#4)
size but##12##2##(1993-11#1)(1993-12#1)(1996-2#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-10#1)(2012-3#2)(2013-7#1)
size by an##2##3##(2008-3#1)(2008-7#1)
size by##17##2##(1991-8#1)(1993-11#1)(1994-10#1)(1996-9#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-8#1)(2011-2#1)(2012-12#2)(2012-2#3)
size calculation##6##2##(1992-6#1)(1993-8#2)(1994-4#1)(2007-7#1)(2013-1#1)
size calculations for##3##3##(2007-8#1)(2012-3#2)
size calculations##10##2##(1992-6#1)(2007-10#1)(2007-8#1)(2008-8#1)(2010-1#1)(2012-3#5)
size can be##4##3##(2006-5#1)(2007-12#1)(2008-10#1)(2008-2#1)
size can##9##2##(1992-10#1)(1993-6#1)(2006-5#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
size change##2##2##(2008-7#1)(2013-8#1)
size characteristics of##2##3##(1992-12#1)(1992-3#1)
size characteristics##3##2##(1992-12#1)(1992-3#1)(2008-3#1)
size characterization of##2##3##(2004-9#2)
size characterization##4##2##(2004-9#2)(2007-8#2)
size characterized##2##2##(2007-8#2)
size class##2##2##(2007-5#1)(2008-8#1)
size classes of##2##3##(1992-4#1)(1996-12#1)
size classes##12##2##(1992-4#1)(1992-6#1)(1993-11#1)(1996-12#2)(2008-10#3)(2010-8#2)(2013-7#2)
size compared to##2##3##(2005-9#1)(2008-3#1)
size compared##3##2##(2005-9#1)(2008-3#1)(2013-1#1)
size considerations##3##2##(1994-6#1)(2013-1#2)
size constraints##2##2##(2008-1#1)(2010-10#1)
size control##3##2##(2005-11#1)(2006-2#1)(2010-12#1)
size could##3##2##(1995-3#1)(2004-9#1)(2008-10#1)
size data##2##2##(2005-11#1)(2008-10#1)
size decreased##2##2##(2008-8#1)(2012-3#1)
size decreases with##3##3##(2008-2#1)(2008-4#1)(2008-8#1)
size dependence of##2##3##(2006-4#1)(2008-3#1)
size dependence##3##2##(2006-4#1)(2008-10#1)(2008-3#1)
size dependent##6##2##(1990-12#1)(1991-10#1)(1991-2#1)(1996-8#1)(1997-1#1)(2008-3#1)
size depending on##2##3##(1995-8#1)(1996-12#1)
size depends on##2##3##(1995-3#1)(2008-2#1)
size determination for##3##3##(1992-2#1)(1994-2#1)(1994-6#1)
size determination in stratified##2##4##(1992-2#1)(1995-9#1)
size determination##9##2##(1992-2#2)(1994-2#1)(1994-6#1)(1995-9#1)(2008-10#1)(2008-3#1)(2010-2#1)(2012-3#1)
size determined by##2##3##(2005-10#1)(2007-10#1)
size determined##3##2##(2005-10#1)(2007-10#2)
size did not##3##3##(1995-8#1)(2007-10#1)(2007-5#1)
size differences##3##2##(2007-12#1)(2008-8#1)(2012-12#1)
size dimorphism##2##2##(1990-4#1)(2008-8#1)
size discrepancies##2##2##(2010-2#2)
size disparity##2##2##(2007-8#1)(2010-8#1)
size distribution and##14##3##(1996-12#1)(2008-10#3)(2008-2#3)(2008-3#3)(2009-2#1)(2012-11#2)(2013-1#1)
size distribution are##2##3##(2005-11#1)(2013-1#1)
size distribution as##2##3##(2007-12#1)(2008-7#1)
size distribution at##3##3##(1995-3#1)(2005-11#1)(2008-5#1)
size distribution for##2##3##(2009-11#1)(2012-3#1)
size distribution from##5##3##(2005-11#2)(2008-2#2)(2008-3#1)
size distribution function##2##3##(2005-11#1)(2008-3#1)
size distribution in the##2##4##(2008-9#1)(2013-8#1)
size distribution is##5##3##(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)
size distribution of a##2##4##(2005-11#1)(2008-7#1)
size distribution of the##8##4##(1992-2#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2013-8#1)
size distribution of##30##3##(1991-12#1)(1992-2#1)(1995-2#1)(1996-7#1)(1997-8#1)(2005-11#9)(2006-10#1)(2006-12#1)(2008-10#1)(2008-2#5)(2008-3#4)(2008-5#1)(2008-7#1)(2009-5#1)(2013-8#1)
size distribution were##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
size distribution##134##2##(1990-3#1)(1991-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-8#1)(2004-9#1)(2005-11#22)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-2#24)(2008-3#20)(2008-5#6)(2008-7#5)(2008-8#1)(2008-9#4)(2009-11#3)(2009-2#2)(2009-5#1)(2010-12#1)(2010-5#1)(2011-2#4)(2012-11#3)(2012-3#1)(2013-1#3)(2013-8#2)
size distributions are presented##2##4##(2008-10#1)(2008-3#1)
size distributions are##3##3##(1994-12#1)(2008-10#1)(2008-3#1)
size distributions of circular##2##4##(2005-11#2)
size distributions of the##3##4##(2005-11#2)(2008-3#1)
size distributions of##12##3##(1992-3#1)(1997-2#1)(2005-11#5)(2007-10#1)(2008-2#3)(2008-3#1)
size distributions were##2##3##(2005-11#1)(2008-3#1)
size distributions##47##2##(1992-3#1)(1994-12#1)(1997-2#1)(2004-9#1)(2005-11#7)(2007-10#1)(2007-9#1)(2008-10#1)(2008-2#10)(2008-3#18)(2008-9#3)(2009-11#1)(2009-3#1)
size does not##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
size does##4##2##(1992-6#1)(2007-12#1)(2008-10#1)(2008-3#1)
size due to##4##3##(2008-10#1)(2008-11#1)(2013-1#2)
size during the##6##3##(2007-5#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-8#1)
size during##10##2##(1995-9#1)(1996-9#1)(2004-11#1)(2007-5#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-11#1)(2010-8#1)
size effect on##2##3##(2005-11#1)(2007-6#1)
size effect##6##2##(2005-11#3)(2007-6#1)(2008-10#1)(2010-7#1)
size effects in##2##3##(1993-5#1)(2008-1#1)
size effects##8##2##(1993-5#1)(2005-11#2)(2008-1#1)(2008-3#1)(2008-8#3)
size equivalent to the##2##4##(2010-4#1)(2012-2#1)
size estimate of##2##3##(1990-8#1)(2010-4#1)
size estimate##3##2##(1990-8#1)(1994-9#1)(2010-4#1)
size estimates##3##2##(1992-2#1)(1996-6#1)(2007-12#1)
size estimation##3##2##(1994-4#1)(2007-12#1)(2013-7#1)
size evolution##3##2##(2012-3#3)
size exclusion chromatography (SEC) with##2##5##(2008-10#2)
size exclusion chromatography (SEC)##5##4##(2006-10#1)(2007-8#1)(2008-10#3)
size exclusion chromatography and##4##4##(1992-1#1)(1992-4#1)(1997-7#1)(2008-10#1)
size exclusion chromatography with##2##4##(2008-10#2)
size exclusion chromatography##23##3##(1990-2#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-4#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-10#7)(2008-3#1)(2011-2#1)(2012-12#1)
size exclusion column##2##3##(1994-12#1)(1994-9#1)
size exclusion##31##2##(1990-2#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-4#1)(1992-6#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-11#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-10#10)(2008-3#1)(2010-12#1)(2011-2#1)(2012-12#1)
size following##3##2##(1991-4#1)(1992-9#1)(2012-2#1)
size for a##6##3##(1995-9#1)(1996-12#1)(1996-8#1)(2006-10#1)(2008-8#1)(2011-1#1)
size for each##5##3##(1993-9#1)(1995-9#1)(2013-1#3)
size for the##3##3##(1996-3#1)(2007-8#1)(2009-11#1)
size for##41##2##(1991-11#1)(1993-9#1)(1994-6#2)(1994-9#1)(1995-3#1)(1995-8#1)(1995-9#2)(1996-12#1)(1996-3#1)(1996-8#1)(2004-9#1)(2006-10#1)(2006-3#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-2#3)(2008-3#2)(2008-8#3)(2009-11#3)(2011-1#1)(2012-12#1)(2013-1#5)(2013-8#1)
size formulae which##2##3##(1994-4#1)(1995-8#1)
size formulae##6##2##(1994-4#1)(1995-8#2)(2012-3#3)
size fraction of##2##3##(1991-11#1)(1993-9#1)
size fraction##5##2##(1991-11#1)(1993-9#1)(2008-12#2)(2012-2#1)
size fractionated##4##2##(1992-3#1)(1993-9#1)(1995-12#1)(2008-10#1)
size fractionation of##5##3##(1994-3#1)(2008-10#4)
size fractionation##7##2##(1994-3#1)(2008-10#5)(2008-2#1)
size fractions##3##2##(2005-11#1)(2008-10#1)(2008-12#1)
size frequency distribution##2##3##(2008-5#2)
size frequency##3##2##(2008-5#2)(2010-8#1)
size from 1##2##3##(1995-5#1)(2012-3#1)
size from 2 to##3##4##(1991-11#1)(1997-8#1)(2007-12#1)
size from 4##2##3##(1991-5#1)(2008-10#1)
size from##32##2##(1990-12#2)(1991-11#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-8#1)(1993-11#1)(1995-5#1)(1995-8#2)(1996-4#1)(1997-8#1)(2004-9#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-8#1)(2009-4#1)(2011-2#1)(2012-2#1)(2012-3#2)
size greater than##2##3##(1992-5#1)(2011-2#1)
size had no##2##3##(2008-11#1)(2010-9#1)
size had##5##2##(2008-10#1)(2008-11#1)(2008-8#1)(2010-9#1)(2013-8#1)
size has been##5##3##(1991-11#1)(1995-4#1)(2007-11#1)(2011-2#1)(2012-12#1)
size has##7##2##(1991-11#1)(1995-4#1)(2005-11#1)(2007-11#1)(2008-8#1)(2011-2#1)(2012-12#1)
size have been##2##3##(2008-10#1)(2009-5#1)
size have##5##2##(1995-1#1)(2008-10#1)(2008-9#1)(2009-5#1)(2012-12#1)
size heterogeneity##4##2##(1990-5#1)(1991-2#1)(2008-10#1)(2008-9#1)
size in a##6##3##(1990-8#1)(1995-7#1)(1996-9#1)(2008-12#1)(2008-7#2)
size in an##2##3##(2012-2#1)(2012-3#1)
size in children##2##3##(2011-1#1)(2012-12#1)
size in determining##2##3##(2006-5#1)(2008-10#1)
size in patients with##2##4##(2007-3#1)(2012-2#1)
size in relation to##2##4##(2008-3#1)(2013-7#1)
size in the range##2##4##(2005-11#1)(2011-2#1)
size in the##17##3##(1993-9#1)(1995-5#1)(1995-6#1)(1996-3#1)(1997-5#1)(2005-11#1)(2006-7#1)(2007-2#1)(2008-10#2)(2008-5#2)(2008-9#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-2#1)
size in this##2##3##(1994-11#1)(2008-3#1)
size in##93##2##(1990-8#1)(1991-11#1)(1991-5#2)(1992-12#1)(1992-3#2)(1992-9#1)(1993-9#1)(1994-11#3)(1995-10#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#2)(1996-2#1)(1996-3#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-5#1)(2005-10#1)(2005-11#2)(2006-5#1)(2006-7#1)(2007-10#1)(2007-2#2)(2007-3#3)(2007-8#1)(2008-1#3)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#3)(2008-7#3)(2008-8#6)(2008-9#8)(2009-1#1)(2009-5#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-7#1)
size increase##6##2##(1995-9#2)(2005-11#1)(2008-8#2)(2008-9#1)
size increased##6##2##(1991-11#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-7#1)
size increases##7##2##(1997-2#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-8#1)(2013-8#1)
size index##3##2##(2004-4#1)(2009-11#1)(2010-5#1)
size information##4##2##(1993-9#1)(2007-11#1)(2007-12#1)(2011-2#1)
size is 6##2##3##(2009-8#1)(2011-2#1)
size is a##2##3##(2008-7#1)(2008-8#1)
size is an##2##3##(2006-12#1)(2007-7#1)
size is determined##2##3##(2008-10#1)(2008-8#1)
size is generally##2##3##(2008-10#1)(2009-4#1)
size is more closely related to host size##2##8##(2008-9#2)
size is much##2##3##(2008-3#1)(2012-3#1)
size is not##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
size is possible##2##3##(2008-5#1)(2008-8#1)
size is small##4##3##(2008-7#1)(2008-8#1)(2012-1#1)(2012-2#1)
size is the##4##3##(1995-8#1)(2008-10#1)(2008-11#2)
size is##81##2##(1994-11#1)(1995-8#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-5#1)(2004-9#1)(2005-11#2)(2006-12#1)(2006-9#1)(2007-11#2)(2007-7#3)(2008-10#4)(2008-11#3)(2008-2#5)(2008-3#6)(2008-5#3)(2008-7#2)(2008-8#13)(2008-9#5)(2009-11#2)(2009-4#2)(2009-8#2)(2010-7#2)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#4)(2013-7#1)(2013-8#2)
size larger than##4##3##(1996-4#1)(2008-2#1)(2008-8#1)(2013-1#1)
size less than##5##3##(1996-6#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-11#1)
size limit in##2##3##(2007-12#1)(2008-7#1)
size limit##5##2##(1991-5#1)(2007-12#1)(2008-1#1)(2008-7#1)(2013-7#1)
size may be##5##3##(1995-5#1)(1996-9#1)(2007-12#1)(2008-7#1)(2008-8#1)
size may##9##2##(1995-5#1)(1996-9#1)(2007-12#1)(2007-9#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-1#1)
size measured##2##2##(1996-3#1)(2008-3#1)
size measurement##2##2##(1991-9#2)
size measurements of##2##3##(1991-9#1)(2011-2#1)
size measurements##5##2##(1991-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
size might##2##2##(2006-7#1)(2008-3#1)
size needed##3##2##(2012-11#1)(2013-1#2)
size observed##3##2##(1992-12#1)(1993-4#1)(2013-7#1)
size obtained from##2##3##(2008-10#1)(2008-2#1)
size obtained with the##2##4##(1995-6#1)(2012-12#1)
size obtained with##3##3##(1995-6#1)(2007-7#1)(2012-12#1)
size obtained##6##2##(1995-6#1)(2007-7#1)(2008-10#2)(2008-2#1)(2012-12#1)
size occurred##2##2##(1992-3#1)(2008-10#1)
size occurs##2##2##(2008-5#1)(2008-8#1)
size of 0##4##3##(2006-5#1)(2008-10#1)(2008-2#1)(2008-3#1)
size of 1##10##3##(1990-6#1)(1992-6#2)(1995-3#1)(1995-4#1)(1996-6#1)(2008-2#1)(2008-8#1)(2009-2#1)(2011-2#1)
size of 10 microm##2##4##(2005-11#1)(2009-4#1)
size of 10##3##3##(2005-11#1)(2007-11#1)(2009-4#1)
size of 100##4##3##(2006-10#1)(2007-12#1)(2008-3#1)(2013-8#1)
size of 12##2##3##(2007-12#1)(2011-12#1)
size of 2##4##3##(1996-6#2)(2008-10#1)(2009-4#1)
size of 20##2##3##(1993-12#1)(2008-5#1)
size of 3##10##3##(1992-12#1)(1992-5#1)(1994-9#1)(1996-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-1#1)(2013-8#2)
size of 30##3##3##(2008-5#1)(2010-12#1)(2013-1#1)
size of 4##4##3##(1991-3#2)(1994-11#1)(1995-4#1)
size of 8##2##3##(1997-4#1)(2008-3#1)
size of DNA fragments##2##4##(1991-9#1)(2008-4#1)
size of P##3##3##(2008-10#3)
size of PSD-95 clusters##2##4##(2012-3#2)
size of a##25##3##(1992-5#1)(1992-6#1)(1994-11#2)(1994-3#2)(1995-5#1)(2005-11#1)(2006-10#1)(2007-12#3)(2007-4#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-8#2)(2009-9#1)(2010-3#1)(2012-2#1)(2013-1#1)(2013-7#1)
size of about##3##3##(1997-2#1)(2008-5#1)(2008-8#1)
size of all##2##3##(1991-10#1)(2008-7#1)
size of an##2##3##(1992-3#1)(1994-11#1)
size of approximately##6##3##(1993-3#1)(1993-6#1)(2007-11#1)(2008-3#1)(2008-8#1)(2008-9#1)
size of both##4##3##(1996-5#1)(2008-3#1)(2008-9#1)(2011-2#1)
size of cells##2##3##(2008-10#1)(2008-11#1)
size of colonies##2##3##(1995-2#1)(1995-6#1)
size of crown##2##3##(2008-10#1)(2013-7#1)
size of detectable populations of##2##5##(2008-10#2)
size of detectable populations##3##4##(2008-10#3)
size of different##2##3##(2005-10#1)(2008-10#1)
size of fragments##2##3##(1991-12#1)(1993-2#1)
size of germinal##2##3##(1995-2#1)(2008-10#1)
size of hospital##3##3##(1997-3#1)(2007-12#1)(2011-2#1)
size of infarction##2##3##(2007-9#2)
size of less than##3##4##(2008-3#1)(2008-5#1)(2011-12#1)
size of more than##2##4##(2008-7#1)(2008-8#1)
size of one of the##4##5##(1994-3#1)(1995-10#1)(2007-12#2)
size of one##5##3##(1994-3#1)(1995-10#1)(2007-12#2)(2008-5#1)
size of our##2##3##(2007-12#1)(2008-8#1)
size of pancreas##2##3##(2012-3#2)
size of particles and##2##4##(2005-11#1)(2008-2#1)
size of particles was##2##4##(2005-11#1)(2008-5#1)
size of particles##6##3##(2005-11#2)(2006-2#1)(2007-12#1)(2008-2#1)(2008-5#1)
size of protein##3##3##(1990-8#1)(1995-5#1)(2009-6#1)
size of setae##2##3##(2007-12#1)(2008-4#1)
size of such##4##3##(1990-12#1)(2005-11#1)(2008-3#1)(2010-5#1)
size of the Golgi##2##4##(1993-12#2)
size of the aneurysm##2##4##(2010-12#1)(2013-8#1)
size of the areas##2##4##(1996-4#1)(2010-9#1)
size of the cells##3##4##(2004-11#1)(2008-11#1)(2012-1#1)
size of the cloned##2##4##(1994-12#1)(2008-8#1)
size of the field##2##4##(2008-10#1)(2008-2#1)
size of the gene##2##4##(1993-2#1)(1993-4#1)
size of the genome##2##4##(2008-5#1)(2010-3#1)
size of the hospital##5##4##(2007-12#5)
size of the inoculum##2##4##(1991-11#1)(2008-5#1)
size of the lesion was##2##5##(1995-10#1)(2007-11#1)
size of the lesion##7##4##(1995-10#1)(2007-11#1)(2007-7#2)(2008-5#2)(2013-8#1)
size of the lesions##2##4##(1995-4#1)(2007-8#1)
size of the major##2##4##(1992-1#1)(1993-12#1)
size of the mass##3##4##(2005-5#1)(2006-10#1)(2011-1#1)
size of the meeting##3##4##(2005-9#1)(2008-7#1)(2010-11#1)
size of the nanoparticles##3##4##(2010-1#1)(2010-2#2)
size of the nutrient foramen was##2##6##(2013-8#2)
size of the nutrient foramen##3##5##(2013-8#3)
size of the optical##2##4##(2007-12#1)(2013-8#1)
size of the order of##3##5##(1996-4#1)(2007-11#1)(2008-2#1)
size of the orifice##2##4##(1995-11#1)(2013-1#1)
size of the particles##4##4##(2005-11#2)(2008-10#1)(2012-11#1)
size of the patient##2##4##(1996-6#1)(2004-2#1)
size of the polar headgroup of##2##6##(1990-11#1)(2008-10#1)
size of the population##2##4##(1993-8#1)(2013-7#1)
size of the primary tumor##2##5##(1995-10#1)(2007-5#1)
size of the primary##4##4##(1995-10#2)(1995-6#1)(2007-5#1)
size of the probe##2##4##(2008-2#2)
size of the referred pain area##2##6##(2010-9#2)
size of the source##4##4##(2006-4#1)(2006-5#1)(2008-10#1)(2008-11#1)
size of the system and##2##5##(2007-6#1)(2008-10#1)
size of the tumor##5##4##(1991-10#1)(2009-2#1)(2009-3#1)(2010-3#1)(2010-9#1)
size of the tumour##3##4##(1990-4#1)(2012-12#2)
size of the two##2##4##(1990-7#1)(1996-8#1)
size of the##424##3##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#3)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#3)(1993-11#2)(1993-12#3)(1993-2#5)(1993-3#3)(1993-4#3)(1993-5#1)(1993-6#3)(1993-8#2)(1994-11#2)(1994-12#3)(1994-6#1)(1994-8#1)(1994-9#3)(1995-10#4)(1995-11#5)(1995-2#3)(1995-3#1)(1995-4#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#4)(1996-3#5)(1996-4#2)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#2)(2004-2#1)(2004-9#3)(2005-10#2)(2005-11#18)(2005-5#2)(2005-9#1)(2006-1#2)(2006-10#3)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#2)(2006-9#1)(2007-1#2)(2007-10#4)(2007-11#6)(2007-12#13)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#3)(2008-1#7)(2008-10#31)(2008-11#5)(2008-12#1)(2008-2#24)(2008-3#16)(2008-4#5)(2008-5#21)(2008-6#4)(2008-7#6)(2008-8#8)(2008-9#5)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#4)(2010-3#2)(2010-4#3)(2010-5#2)(2010-7#1)(2010-8#4)(2010-9#4)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#9)(2012-2#5)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#8)
size of their##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
size of these##10##3##(1994-12#1)(1994-2#1)(1995-3#1)(1996-1#1)(1997-3#1)(2006-10#1)(2008-3#1)(2008-9#1)(2009-3#1)(2010-5#1)
size of this##8##3##(1990-12#1)(1991-2#1)(1993-4#1)(1995-2#1)(2008-6#1)(2008-8#1)(2010-2#1)(2010-4#1)
size of tumors##2##3##(1993-7#1)(2009-8#1)
size of tumour and##2##4##(1990-4#1)(1991-4#1)
size of tumour##5##3##(1990-4#1)(1991-4#1)(1992-2#1)(2008-6#2)
size of visual##2##3##(1994-3#1)(1996-2#1)
size of which##3##3##(1991-2#1)(1996-1#1)(2006-12#1)
size of##840##2##(1990-10#2)(1990-11#3)(1990-12#7)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#3)(1990-7#4)(1990-8#1)(1991-1#3)(1991-10#3)(1991-11#3)(1991-12#3)(1991-2#2)(1991-3#4)(1991-4#3)(1991-5#2)(1991-6#3)(1991-7#2)(1991-8#3)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#3)(1992-5#2)(1992-6#4)(1992-8#1)(1992-9#4)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#4)(1993-2#6)(1993-3#4)(1993-4#4)(1993-5#1)(1993-6#4)(1993-7#1)(1993-8#3)(1994-11#9)(1994-12#6)(1994-2#2)(1994-3#6)(1994-6#1)(1994-8#3)(1994-9#7)(1995-1#2)(1995-10#6)(1995-11#6)(1995-2#7)(1995-3#5)(1995-4#4)(1995-5#4)(1995-6#2)(1995-8#2)(1995-9#2)(1996-1#5)(1996-10#3)(1996-12#7)(1996-2#5)(1996-3#5)(1996-4#2)(1996-5#2)(1996-6#6)(1996-7#5)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#9)(1997-3#5)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#4)(1997-9#1)(2004-11#4)(2004-2#1)(2004-9#7)(2005-10#4)(2005-11#27)(2005-5#2)(2005-9#1)(2006-1#2)(2006-10#10)(2006-12#6)(2006-2#2)(2006-4#1)(2006-5#6)(2006-8#1)(2006-9#1)(2007-1#3)(2007-10#4)(2007-11#12)(2007-12#27)(2007-2#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#6)(2007-9#7)(2008-1#8)(2008-10#70)(2008-11#7)(2008-12#2)(2008-2#40)(2008-3#34)(2008-4#11)(2008-5#36)(2008-6#11)(2008-7#14)(2008-8#23)(2008-9#12)(2009-10#3)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#2)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#3)(2010-10#1)(2010-11#3)(2010-12#10)(2010-2#10)(2010-3#6)(2010-4#5)(2010-5#4)(2010-7#1)(2010-8#9)(2010-9#4)(2011-1#8)(2011-12#3)(2011-2#13)(2012-1#3)(2012-11#3)(2012-12#10)(2012-2#7)(2012-3#6)(2012-5#1)(2013-1#14)(2013-7#9)(2013-8#16)
size often##2##2##(1997-3#1)(2008-8#1)
size on computed tomography##2##4##(2007-10#1)(2007-9#1)
size on laser##2##3##(2008-2#1)(2008-3#1)
size on the##11##3##(1993-1#1)(1996-5#1)(2006-5#1)(2008-2#1)(2008-3#1)(2008-8#2)(2009-2#2)(2010-5#1)(2013-8#1)
size on##40##2##(1991-9#1)(1993-1#1)(1995-11#1)(1996-5#1)(1997-4#1)(2005-11#1)(2006-2#1)(2006-5#1)(2007-10#2)(2007-6#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-2#4)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-2#2)(2010-5#1)(2012-3#1)(2013-8#3)
size ones##2##2##(2008-5#1)(2011-1#1)
size only##2##2##(2004-9#1)(2007-12#1)
size or age##2##3##(2006-11#1)(2008-8#1)
size or lymph node##2##4##(1996-3#1)(2011-2#1)
size or number##3##3##(2006-6#1)(2007-7#1)(2008-10#1)
size or sex##2##3##(2007-12#1)(2008-8#1)
size or the##2##3##(1997-4#1)(2008-3#1)
size or##34##2##(1993-8#1)(1995-1#1)(1995-5#1)(1996-3#1)(1996-8#2)(1997-4#1)(2005-11#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-1#1)(2007-12#2)(2007-7#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-8#4)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
size over##2##2##(2007-10#1)(2008-6#1)
size parameter of 20##3##4##(2008-3#3)
size parameter of##7##3##(2008-2#3)(2008-3#4)
size parameter##16##2##(2008-2#7)(2008-3#9)
size parameters of##2##3##(2008-2#1)(2008-3#1)
size parameters up to##2##4##(2008-2#1)(2008-3#1)
size parameters##15##2##(2007-11#1)(2008-2#4)(2008-3#10)
size particles##2##2##(2008-5#1)(2013-8#1)
size perception##2##2##(1996-1#1)(2013-8#1)
size phenotype##2##2##(2008-3#2)
size polydispersity##4##2##(2007-12#1)(2008-10#1)(2013-8#2)
size polymorphism##3##2##(1991-10#1)(1993-2#1)(2008-10#1)
size preferences and##3##3##(2006-7#1)(2007-12#2)
size produced##4##2##(1996-9#3)(2012-5#1)
size range between##2##3##(2008-3#1)(2013-7#1)
size range from##2##3##(2007-5#1)(2008-3#1)
size range of the##2##4##(1993-9#1)(2008-5#1)
size range of##16##3##(1991-10#1)(1993-3#1)(1993-8#1)(1993-9#1)(1995-3#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-5#3)(2008-7#1)(2010-12#1)(2010-9#1)
size range were##2##3##(2007-8#1)(2008-10#1)
size range##34##2##(1991-10#1)(1991-8#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-3#1)(1997-3#1)(1997-5#2)(2004-12#1)(2007-5#1)(2007-8#3)(2008-10#2)(2008-3#4)(2008-5#3)(2008-7#4)(2008-9#1)(2009-3#1)(2010-12#1)(2010-9#1)(2012-3#1)(2013-7#1)
size ranged from##4##3##(1991-9#1)(1993-8#1)(2006-6#1)(2007-3#1)
size ranged##6##2##(1991-9#1)(1993-8#1)(2006-6#1)(2007-3#1)(2008-5#1)(2010-2#1)
size ranges from##2##3##(2006-10#1)(2010-2#1)
size ranges##8##2##(1997-2#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-2#1)
size ranging from##3##3##(2006-2#1)(2008-10#1)(2010-1#1)
size ratings##2##2##(2007-12#2)
size ratio##3##2##(2008-2#1)(2008-9#1)(2011-2#1)
size ratios##5##2##(2008-11#2)(2008-3#3)
size re-estimation##3##2##(2012-2#3)
size reduction##11##2##(2006-2#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#3)(2012-3#1)(2013-1#3)
size relative to##2##3##(2007-12#1)(2010-2#1)
size required for##4##3##(1992-2#1)(1993-1#1)(1994-6#1)(2008-10#1)
size required##7##2##(1992-2#1)(1992-9#1)(1993-1#1)(1994-6#2)(1995-9#1)(2008-10#1)
size requirement##3##2##(1996-9#1)(2008-3#1)(2008-8#1)
size requirements##4##2##(1990-7#1)(1993-1#2)(2008-9#1)
size selected##2##2##(1996-7#1)(2008-10#1)
size selection##2##2##(2006-12#2)
size separation##4##2##(1994-6#1)(2008-10#1)(2008-6#1)(2012-11#1)
size should##2##2##(2008-10#1)(2013-7#1)
size showed##2##2##(1997-2#1)(2008-7#1)
size similar to##3##3##(1992-11#1)(1994-9#1)(2006-10#1)
size smaller than##3##3##(2008-10#2)(2008-5#1)
size spectrum##2##2##(2008-2#1)(2013-8#1)
size standards##3##2##(1991-9#1)(2008-4#2)
size structure##5##2##(2008-5#2)(2013-8#3)
size structuring##2##2##(2008-8#2)
size than the##3##3##(1991-10#1)(1996-2#1)(2008-2#1)
size than##6##2##(1991-10#1)(1996-2#1)(2004-2#1)(2007-12#1)(2008-2#1)(2008-5#1)
size that is##3##3##(1997-4#1)(2008-3#1)(2008-4#1)
size that was##2##3##(1994-6#1)(2008-10#1)
size that would##4##3##(2007-11#1)(2010-2#3)
size that##19##2##(1994-5#1)(1994-6#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#2)(2010-2#4)(2010-6#1)
size the##2##2##(1996-8#1)(2005-11#1)
size they##2##2##(1993-4#1)(2007-12#1)
size through##3##2##(2006-10#1)(2007-12#1)(2008-8#1)
size to achieve##2##3##(2008-10#1)(2011-2#1)
size to avoid bleeding and thrombosis##3##6##(2008-11#3)
size to be##3##3##(1997-2#1)(2008-3#1)(2008-8#1)
size to the##5##3##(1992-10#1)(1995-2#1)(1997-6#1)(2008-10#1)(2008-5#1)
size to those of##3##4##(2005-11#1)(2008-10#1)(2008-8#1)
size to those##6##3##(1995-8#1)(2005-11#1)(2007-9#1)(2008-10#2)(2008-8#1)
size to##37##2##(1990-9#1)(1992-10#1)(1993-12#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-6#1)(2005-11#1)(2006-6#1)(2007-12#3)(2007-9#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-7#1)(2011-2#1)
size under##2##2##(2008-8#1)(2012-2#1)
size using##3##2##(2009-8#1)(2011-2#1)(2012-3#1)
size variable##3##2##(2011-2#3)
size variants##2##2##(1995-11#2)
size variation and##3##3##(2008-10#1)(2008-7#1)(2009-5#1)
size variation in##3##3##(2008-8#2)(2013-1#1)
size variation within##2##3##(2008-8#2)
size variation##14##2##(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#8)(2009-5#1)(2010-5#1)(2013-1#1)
size was 1##3##3##(1990-12#1)(2008-10#1)(2008-3#1)
size was 10##2##3##(2007-3#1)(2007-6#1)
size was 2##2##3##(2007-3#1)(2012-3#1)
size was 7##2##3##(2006-12#1)(2012-2#1)
size was approximately##3##3##(2007-11#1)(2013-1#2)
size was around##2##3##(1990-7#1)(1992-4#1)
size was calculated using##2##4##(2008-11#1)(2012-12#1)
size was calculated##5##3##(2007-12#1)(2008-10#2)(2008-11#1)(2012-12#1)
size was determined##2##3##(2008-10#1)(2008-7#1)
size was greater##2##3##(2008-10#1)(2008-5#1)
size was larger##3##3##(2008-7#1)(2011-2#1)(2013-7#1)
size was measured##2##3##(2010-12#1)(2013-8#1)
size was not##3##3##(1992-2#1)(1993-8#1)(2008-10#1)
size was observed##2##3##(1992-3#1)(1996-8#1)
size was reduced##2##3##(1996-9#1)(2008-10#1)
size was significantly greater in##2##5##(2004-2#1)(2008-10#1)
size was significantly##3##3##(1993-11#1)(2004-2#1)(2008-10#1)
size was small##3##3##(2006-7#1)(2008-7#1)(2012-2#1)
size was the##2##3##(1995-5#1)(2008-11#1)
size was##91##2##(1990-12#1)(1990-7#1)(1991-1#1)(1991-7#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-7#1)(1993-11#1)(1993-8#1)(1994-5#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(2004-11#1)(2004-2#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#2)(2006-7#1)(2007-11#1)(2007-12#3)(2007-3#2)(2007-6#1)(2007-9#1)(2008-10#17)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#4)(2009-2#2)(2009-3#1)(2010-12#2)(2010-3#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
size were also studied##2##4##(2007-10#1)(2008-6#1)
size were measured##2##3##(2008-10#1)(2010-2#1)
size were more##2##3##(2007-12#1)(2009-10#1)
size were used##2##3##(2007-11#1)(2013-7#1)
size were##27##2##(1992-4#1)(1994-3#2)(1996-7#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-8#1)(2008-10#5)(2008-5#2)(2008-6#1)(2009-10#1)(2010-10#1)(2010-2#1)(2010-7#1)(2012-3#1)(2013-7#2)
size when the##2##3##(2006-12#1)(2008-2#1)
size when##8##2##(1992-9#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-10#1)
size while the##2##3##(2008-9#1)(2012-2#1)
size while##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
size will be##2##3##(1996-2#1)(2008-3#1)
size will##5##2##(1996-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#1)
size with a##4##3##(2007-10#1)(2007-12#1)(2008-1#1)(2008-2#1)
size with the##2##3##(2005-10#1)(2008-10#1)
size with time##2##3##(2005-11#1)(2009-8#1)
size with##26##2##(1990-12#1)(1991-8#1)(1994-6#1)(1996-2#1)(1996-3#1)(1997-5#1)(2005-10#1)(2005-11#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-5#1)(2012-2#1)(2012-5#1)
size within##5##2##(1993-6#1)(2008-4#1)(2008-8#2)(2012-2#1)
size without##2##2##(2006-1#1)(2008-7#1)
size ≥50 mm##2##2##(2011-2#2)
size##4154##1##(1990-10#5)(1990-11#6)(1990-12#20)(1990-2#7)(1990-3#8)(1990-4#4)(1990-5#4)(1990-6#6)(1990-7#9)(1990-8#7)(1990-9#2)(1991-1#6)(1991-10#9)(1991-11#15)(1991-12#10)(1991-2#7)(1991-3#6)(1991-4#7)(1991-5#13)(1991-6#11)(1991-7#7)(1991-8#10)(1991-9#13)(1992-1#3)(1992-10#5)(1992-11#5)(1992-12#10)(1992-2#14)(1992-3#17)(1992-4#6)(1992-5#9)(1992-6#15)(1992-7#5)(1992-8#7)(1992-9#13)(1993-1#9)(1993-10#3)(1993-11#11)(1993-12#12)(1993-2#14)(1993-3#8)(1993-4#12)(1993-5#7)(1993-6#9)(1993-7#1)(1993-8#15)(1993-9#17)(1994-10#4)(1994-11#19)(1994-12#12)(1994-2#11)(1994-3#14)(1994-4#6)(1994-5#9)(1994-6#13)(1994-8#8)(1994-9#17)(1995-1#8)(1995-10#10)(1995-11#12)(1995-12#5)(1995-2#18)(1995-3#19)(1995-4#10)(1995-5#24)(1995-6#11)(1995-7#2)(1995-8#16)(1995-9#13)(1996-1#13)(1996-10#6)(1996-11#2)(1996-12#19)(1996-2#17)(1996-3#25)(1996-4#13)(1996-5#7)(1996-6#24)(1996-7#13)(1996-8#16)(1996-9#15)(1997-1#7)(1997-2#31)(1997-3#14)(1997-4#11)(1997-5#6)(1997-6#9)(1997-7#7)(1997-8#16)(1997-9#1)(2004-1#3)(2004-11#10)(2004-12#3)(2004-2#7)(2004-3#1)(2004-4#1)(2004-9#26)(2005-1#2)(2005-10#13)(2005-11#124)(2005-5#2)(2005-7#3)(2005-8#4)(2005-9#2)(2006-1#5)(2006-10#27)(2006-11#6)(2006-12#23)(2006-2#17)(2006-3#4)(2006-4#7)(2006-5#21)(2006-6#7)(2006-7#7)(2006-8#3)(2006-9#5)(2007-1#11)(2007-10#28)(2007-11#47)(2007-12#138)(2007-2#5)(2007-3#19)(2007-4#6)(2007-5#17)(2007-6#7)(2007-7#20)(2007-8#50)(2007-9#31)(2008-1#32)(2008-10#387)(2008-11#55)(2008-12#23)(2008-2#203)(2008-3#232)(2008-4#52)(2008-5#142)(2008-6#36)(2008-7#84)(2008-8#199)(2008-9#114)(2009-1#2)(2009-10#16)(2009-11#18)(2009-12#15)(2009-2#23)(2009-3#8)(2009-4#14)(2009-5#19)(2009-6#3)(2009-7#5)(2009-8#21)(2009-9#7)(2010-1#10)(2010-10#7)(2010-11#6)(2010-12#37)(2010-2#39)(2010-3#9)(2010-4#17)(2010-5#15)(2010-6#7)(2010-7#15)(2010-8#42)(2010-9#11)(2011-1#38)(2011-12#19)(2011-2#96)(2012-1#18)(2012-11#17)(2012-12#54)(2012-2#66)(2012-3#64)(2012-5#4)(2012-9#2)(2013-1#84)(2013-7#36)(2013-8#67)
size'##2##1##(1996-7#1)(2008-10#1)
size) and the##2##3##(2008-9#1)(2011-2#1)
size) and##8##2##(2005-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-12#1)
size) in##3##2##(1996-6#1)(2005-11#1)(2008-11#1)
size) of##2##2##(1993-12#1)(1997-4#1)
size) was##2##2##(2005-10#1)(2008-10#1)
size) were##3##2##(1994-12#1)(1996-5#1)(2008-5#1)
size) with##3##2##(2006-9#1)(2008-10#1)(2010-3#1)
size)##42##1##(1993-12#1)(1993-9#1)(1994-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-11#3)(2006-9#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-6#2)(2008-8#4)(2008-9#3)(2009-6#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#3)(2013-7#2)
size-abundance relationships among##3##3##(2008-9#3)
size-asymmetric##3##1##(2008-8#3)
size-based separation##2##2##(2008-4#1)(2008-7#1)
size-based##5##1##(1997-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)
size-controlled##3##1##(2010-12#2)(2010-4#1)
size-dependent optical properties##2##3##(2008-10#1)(2008-7#1)
size-dependent##13##1##(1991-10#1)(1996-8#1)(2005-11#2)(2008-10#2)(2008-7#2)(2008-8#2)(2009-11#1)(2009-2#1)(2010-8#1)
size-exclusion (SE) chromatography##2##3##(2008-4#2)
size-exclusion and##3##2##(1991-9#1)(1993-11#1)(2008-10#1)
size-exclusion chromatography (SEC) on##2##4##(1991-3#1)(1996-8#1)
size-exclusion chromatography (SEC)##7##3##(1991-3#1)(1996-5#1)(1996-8#1)(2004-4#1)(2008-10#1)(2008-5#1)(2008-8#1)
size-exclusion chromatography to##2##3##(2008-4#1)(2008-5#1)
size-exclusion chromatography##33##2##(1990-12#1)(1991-3#1)(1991-5#2)(1992-12#1)(1992-2#1)(1992-9#3)(1993-11#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#1)(1996-5#2)(1996-8#2)(1997-2#1)(1997-8#1)(2004-4#1)(2005-11#1)(2008-10#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)
size-exclusion##46##1##(1990-12#1)(1990-8#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-9#3)(1993-11#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#1)(1995-6#1)(1996-5#2)(1996-8#2)(1997-2#2)(1997-6#1)(1997-8#1)(2004-4#1)(2005-11#1)(2008-10#4)(2008-4#6)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)
size-fractionated by##2##2##(1994-8#1)(1995-8#1)
size-fractionated cDNA libraries##2##3##(1997-2#1)(1997-4#1)
size-fractionated##7##1##(1990-11#1)(1994-8#1)(1995-8#1)(1997-2#1)(1997-4#1)(2008-10#2)
size-independent##3##1##(2007-12#1)(2008-10#1)(2008-2#1)
size-matched##2##1##(2006-3#1)(2010-8#1)
size-related##6##1##(1996-12#1)(2008-8#1)(2009-5#1)(2010-8#3)
size-selected##4##1##(1992-8#1)(2006-12#2)(2008-2#1)
size-selective##3##1##(2005-11#1)(2008-1#1)(2008-5#1)
size-sieving polymer solution##2##3##(1997-5#2)
size-specific##3##1##(2007-9#2)(2008-11#1)
size/BMR##2##1##(2008-8#2)
sizeable##7##1##(1993-7#1)(1995-11#1)(1996-3#1)(2006-10#1)(2010-12#1)(2011-1#1)(2012-2#1)
sized DNA##3##2##(1991-8#2)(2006-2#1)
sized and##2##2##(2007-9#1)(2008-10#1)
sized objects##2##2##(2008-7#1)(2009-4#1)
sized particles##2##2##(2008-10#2)
sized species##3##2##(2007-3#1)(2008-10#1)(2012-2#1)
sized##78##1##(1990-12#1)(1990-3#1)(1990-8#2)(1991-10#1)(1991-7#1)(1991-8#2)(1992-10#1)(1992-3#1)(1992-9#1)(1993-6#1)(1994-11#1)(1995-8#1)(1996-12#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#2)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#5)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#2)(2010-2#1)(2011-1#2)(2011-12#2)(2011-2#2)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#1)
sizer##4##1##(1993-2#2)(2005-11#1)(2008-3#1)
sizes and ages##2##3##(2006-11#1)(2007-4#1)
sizes and different##2##3##(2005-11#1)(2008-5#1)
sizes and in##3##3##(2007-3#1)(2008-9#1)(2010-8#1)
sizes and morphologies##2##3##(1990-4#1)(1997-3#1)
sizes and numbers of##2##4##(1997-6#1)(2007-12#1)
sizes and of##2##3##(2009-2#1)(2010-8#1)
sizes and shapes##5##3##(2006-4#1)(2007-12#1)(2008-10#2)(2009-4#1)
sizes and the##5##3##(2004-9#1)(2008-3#1)(2009-12#1)(2011-2#1)(2013-7#1)
sizes and##80##2##(1990-4#1)(1992-2#1)(1993-1#2)(1993-4#1)(1995-1#1)(1995-4#1)(1996-1#1)(1996-12#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#2)(2004-9#1)(2005-11#1)(2006-11#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-10#9)(2008-2#1)(2008-3#7)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-2#3)(2009-4#2)(2009-7#1)(2010-6#1)(2010-8#3)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
sizes are often##2##3##(2008-4#1)(2008-8#1)
sizes are##15##2##(1991-11#1)(1993-4#1)(1993-9#1)(1994-5#1)(1994-6#1)(1996-8#1)(1997-8#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-3#2)
sizes as a##2##3##(2005-11#1)(2008-8#1)
sizes as small as##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
sizes as well as the##2##5##(2006-2#1)(2008-8#1)
sizes as##9##2##(2005-11#1)(2006-2#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-8#2)(2010-12#1)
sizes at##3##2##(2007-4#1)(2008-3#1)(2012-3#1)
sizes based on##2##3##(1995-9#1)(2008-2#1)
sizes below##4##2##(2007-11#1)(2007-3#1)(2008-1#1)(2008-8#1)
sizes between##3##2##(1994-12#1)(2008-10#1)(2010-6#1)
sizes both##2##2##(1995-8#1)(2007-12#1)
sizes by electron microscopy##2##4##(1997-3#1)(2008-3#1)
sizes by##3##2##(1997-3#1)(2008-3#2)
sizes can be##3##3##(1995-5#1)(2008-2#1)(2009-5#1)
sizes can##5##2##(1995-5#1)(1996-1#1)(2008-2#1)(2009-5#1)(2012-3#1)
sizes compared with##3##3##(2008-10#1)(2012-12#2)
sizes for##17##2##(1991-9#1)(1994-6#2)(1995-12#1)(2005-11#1)(2006-8#1)(2008-10#1)(2008-3#2)(2010-8#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-1#3)
sizes from##5##2##(1993-3#1)(1997-4#1)(2008-2#1)(2008-4#1)(2009-5#1)
sizes have##2##2##(2006-5#1)(2008-10#1)
sizes in the##8##3##(1991-10#1)(1993-3#1)(2004-9#1)(2006-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-2#1)
sizes in this##2##3##(2008-10#1)(2008-9#1)
sizes in##30##2##(1990-5#1)(1990-8#1)(1991-10#1)(1992-9#1)(1993-3#1)(2004-9#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#2)
sizes increased##5##2##(2007-5#1)(2008-11#1)(2008-3#1)(2011-12#1)(2011-2#1)
sizes is##3##2##(1993-9#1)(2008-12#1)(2008-2#1)
sizes larger than##2##3##(2008-10#1)(2011-2#1)
sizes less than##2##3##(1993-2#1)(2011-2#1)
sizes limit##2##2##(2008-2#1)(2008-9#1)
sizes obtained##2##2##(2005-10#1)(2005-11#1)
sizes of 0##4##3##(2008-10#2)(2008-12#1)(2008-6#1)
sizes of 1##2##3##(1990-11#1)(2008-6#1)
sizes of Eh252##2##3##(2008-10#2)
sizes of the##36##3##(1991-9#1)(1993-3#1)(1993-5#1)(1993-9#1)(2005-11#4)(2006-10#1)(2006-12#1)(2007-11#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#8)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-11#1)(2010-7#2)(2011-2#1)(2013-8#2)
sizes of these##3##3##(2008-10#3)
sizes of##111##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-9#2)(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-5#1)(1993-9#1)(1994-11#1)(1994-6#1)(1996-4#1)(1997-2#2)(2004-11#1)(2004-9#1)(2005-11#5)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#3)(2007-11#2)(2007-12#4)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#29)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#2)(2009-1#1)(2009-11#1)(2009-8#1)(2010-4#2)(2010-7#3)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#2)
sizes on the##2##3##(2009-2#1)(2012-3#1)
sizes on##7##2##(2006-3#1)(2008-10#1)(2008-5#2)(2009-2#1)(2010-12#1)(2012-3#1)
sizes or##3##2##(2008-3#1)(2008-7#1)(2008-8#1)
sizes ranged from##2##3##(2008-10#1)(2011-1#1)
sizes ranging from##4##3##(1992-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
sizes similar to##2##3##(2005-11#1)(2008-8#1)
sizes smaller than##2##3##(2005-11#1)(2008-3#1)
sizes tested##6##2##(2008-10#5)(2013-7#1)
sizes than##2##2##(2008-2#1)(2008-3#1)
sizes that were##2##3##(2007-7#1)(2008-10#1)
sizes that##6##2##(1996-8#2)(2007-7#1)(2008-10#1)(2008-2#1)(2011-2#1)
sizes to##3##2##(2006-9#1)(2007-12#1)(2009-7#1)
sizes up to##6##3##(1990-4#1)(1997-2#1)(2008-10#2)(2008-7#1)(2013-7#1)
sizes was##6##2##(1991-9#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-7#1)(2011-1#1)
sizes were detected##2##3##(1995-8#1)(2009-4#1)
sizes were obtained##3##3##(2008-10#2)(2008-3#1)
sizes were##32##2##(1991-6#1)(1992-7#1)(1995-8#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#2)(2009-2#1)(2009-4#1)(2009-7#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-1#3)(2013-8#2)
sizes when##2##2##(2007-12#1)(2008-11#1)
sizes with##2##2##(2008-1#1)(2008-3#1)
sizes##633##1##(1990-11#1)(1990-12#1)(1990-2#7)(1990-4#3)(1990-5#1)(1990-7#1)(1990-8#2)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#5)(1992-2#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#4)(1993-2#2)(1993-3#3)(1993-4#4)(1993-5#1)(1993-9#4)(1994-11#2)(1994-12#2)(1994-5#1)(1994-6#6)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-1#3)(1996-12#1)(1996-3#2)(1996-4#3)(1996-6#2)(1996-7#1)(1996-8#4)(1997-2#6)(1997-3#2)(1997-4#3)(1997-6#4)(1997-7#1)(1997-8#2)(2004-11#1)(2004-9#3)(2005-10#2)(2005-11#16)(2006-10#2)(2006-11#3)(2006-12#2)(2006-2#4)(2006-3#4)(2006-4#2)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#7)(2007-12#25)(2007-3#5)(2007-4#2)(2007-5#3)(2007-6#5)(2007-7#4)(2007-8#9)(2007-9#4)(2008-1#3)(2008-10#87)(2008-11#8)(2008-12#3)(2008-2#26)(2008-3#38)(2008-4#10)(2008-5#14)(2008-6#5)(2008-7#17)(2008-8#23)(2008-9#12)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#5)(2009-3#1)(2009-4#6)(2009-5#3)(2009-7#8)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#4)(2010-3#1)(2010-4#3)(2010-6#3)(2010-7#4)(2010-8#7)(2010-9#2)(2011-1#6)(2011-12#2)(2011-2#21)(2012-1#7)(2012-11#4)(2012-12#7)(2012-2#11)(2012-3#15)(2013-1#10)(2013-7#4)(2013-8#11)
sizes)##3##1##(2008-10#2)(2013-8#1)
sizing and the##2##3##(2005-10#1)(2008-10#1)
sizing and##4##2##(2005-10#1)(2008-10#1)(2008-3#1)(2010-5#1)
sizing in##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
sizing large particles##2##3##(2008-2#2)
sizing of##4##2##(2008-2#2)(2008-3#1)(2010-8#1)
sizing systems##2##2##(1992-3#2)
sizing##58##1##(1992-3#3)(1995-3#2)(1996-6#1)(1997-4#1)(2005-10#5)(2007-12#1)(2008-10#1)(2008-2#20)(2008-3#18)(2010-5#2)(2010-8#1)(2011-2#3)
sizzled encodes a secreted protein with both Wnt and BMP inhibitor activities##2##12##(2012-12#2)
sizzled function and secreted factor network dynamics##2##7##(2012-12#2)
sizzled##14##1##(2012-12#14)
siècle##3##1##(1995-1#1)(2009-4#1)(2011-2#1)
sk##2##1##(1991-4#1)(1992-8#1)
skate Leucoraja##2##2##(2010-8#2)
skate species##2##2##(2009-4#2)
skate##15##1##(2008-11#1)(2008-4#1)(2009-4#6)(2010-8#7)
skaters##5##1##(2006-8#5)
skates##3##1##(2009-4#2)(2010-8#1)
skating##4##1##(2006-8#3)(2008-9#1)
skatole##6##1##(2006-10#1)(2010-4#5)
skeletal Ca##2##2##(1997-4#2)
skeletal Class III patients##4##4##(2010-2#4)
skeletal Class III##8##3##(2009-7#1)(2010-2#6)(2013-1#1)
skeletal Class##9##2##(2009-7#1)(2010-2#6)(2012-12#1)(2013-1#1)
skeletal abnormalities##7##2##(1992-6#1)(1997-3#1)(1997-4#1)(2008-3#1)(2011-1#2)(2012-2#1)
skeletal abnormality##2##2##(2007-7#1)(2012-3#1)
skeletal actin [alpha]##2##3##(1990-5#2)
skeletal actin##3##2##(1990-5#3)
skeletal and cardiac muscle development##2##5##(2010-7#2)
skeletal and cardiac muscle##5##4##(1991-3#1)(1997-8#1)(2010-7#2)(2012-3#1)
skeletal and cardiac muscles##5##4##(1992-2#1)(1994-9#1)(1997-2#1)(2012-3#2)
skeletal and cardiac##10##3##(1991-3#1)(1992-2#1)(1994-9#1)(1997-2#1)(1997-8#1)(2010-7#2)(2012-3#3)
skeletal and dental##2##3##(2008-5#2)
skeletal and dentoalveolar changes##2##4##(2012-12#2)
skeletal and heart muscle##2##4##(1990-2#1)(1995-3#1)
skeletal and soft tissue##2##4##(1991-2#1)(2011-2#1)
skeletal and##26##2##(1990-10#1)(1990-2#1)(1991-2#1)(1991-3#1)(1992-2#1)(1994-9#1)(1995-3#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-4#1)(2008-5#2)(2009-7#1)(2010-3#1)(2010-7#2)(2011-2#1)(2012-12#2)(2012-3#4)(2013-1#1)(2013-8#1)
skeletal anomalies were##2##3##(1993-12#2)
skeletal anomalies##5##2##(1993-12#3)(1997-1#1)(2007-2#1)
skeletal bone##2##2##(1994-7#1)(2012-2#1)
skeletal bones##2##2##(2008-12#1)(2011-1#1)
skeletal changes##7##2##(1996-12#3)(2009-7#1)(2009-9#1)(2011-1#1)(2012-12#1)
skeletal characteristics##2##2##(1992-12#1)(1993-11#1)
skeletal complications and##3##3##(2007-11#1)(2008-7#2)
skeletal complications in patients with##2##5##(2008-7#2)
skeletal complications##10##2##(2007-11#3)(2008-7#7)
skeletal data##2##2##(2008-10#1)(2012-12#1)
skeletal defects##7##2##(1993-12#1)(1993-4#1)(1995-3#1)(2004-9#1)(2009-7#1)(2010-6#2)
skeletal deformities##3##2##(2007-12#1)(2012-2#1)(2013-8#1)
skeletal demineralization observed##2##3##(1997-4#2)
skeletal demineralization##4##2##(1997-4#3)(2008-6#1)
skeletal development and##3##3##(1996-2#1)(2008-11#1)(2012-2#1)
skeletal development##6##2##(1996-2#1)(2008-11#2)(2012-12#2)(2012-2#1)
skeletal discrepancy##3##2##(2007-12#2)(2012-2#1)
skeletal disease##4##2##(2007-11#2)(2011-1#1)(2012-2#1)
skeletal dysplasia was##2##3##(2011-1#2)
skeletal dysplasia##11##2##(1996-12#1)(1996-3#2)(2008-11#1)(2009-9#1)(2011-1#6)
skeletal dysplasias##2##2##(1996-12#1)(2010-3#1)
skeletal effects##3##2##(2008-5#1)(2009-7#1)(2013-1#1)
skeletal elements##5##2##(1993-12#3)(2012-12#2)
skeletal fluorosis##6##2##(2007-10#1)(2008-8#3)(2012-1#2)
skeletal fractures##3##2##(2007-8#1)(2008-8#2)
skeletal growth##4##2##(2007-12#1)(2008-4#1)(2008-7#2)
skeletal hyperostosis##4##2##(2005-9#1)(2006-10#1)(2007-8#1)(2008-1#1)
skeletal integrity##5##2##(1997-4#1)(2007-7#1)(2009-4#1)(2010-2#1)(2010-9#1)
skeletal malformations##3##2##(1993-3#2)(2008-7#1)
skeletal maturation##5##2##(1992-5#1)(2006-1#2)(2008-1#1)(2012-12#1)
skeletal maturity##5##2##(2006-11#1)(2007-12#1)(2007-8#1)(2008-6#2)
skeletal metabolism##2##2##(2008-1#1)(2012-2#1)
skeletal metastases from soft tissue sarcomas##4##6##(2008-6#4)
skeletal metastases from##5##3##(2007-11#1)(2008-6#4)
skeletal metastases in##2##3##(2008-7#1)(2013-1#1)
skeletal metastases##19##2##(1994-7#1)(2007-11#4)(2008-1#2)(2008-6#5)(2008-7#3)(2009-8#2)(2011-2#1)(2013-1#1)
skeletal muscle &gt##2##3##(1994-9#1)(1997-2#1)
skeletal muscle actin##6##3##(1990-7#1)(1991-7#1)(1994-8#1)(1995-1#1)(1997-1#2)
skeletal muscle alpha##3##3##(1990-12#1)(1994-9#1)(1995-2#1)
skeletal muscle and heart##2##4##(1990-11#1)(1993-2#1)
skeletal muscle and kidney##4##4##(1990-11#1)(1992-4#2)(1996-7#1)
skeletal muscle and testis##2##4##(1994-11#1)(1997-8#1)
skeletal muscle and##30##3##(1990-11#3)(1990-2#1)(1990-8#1)(1991-6#1)(1992-11#1)(1992-4#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-12#1)(1996-4#1)(1996-7#1)(1997-8#1)(2008-1#2)(2008-3#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-3#1)
skeletal muscle are##6##3##(1991-2#1)(1994-8#1)(1997-2#1)(2008-3#1)(2009-3#1)(2010-9#1)
skeletal muscle by##7##3##(1992-6#1)(1992-7#1)(1995-2#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)
skeletal muscle cDNA library##4##4##(1993-11#1)(1994-12#1)(1994-9#1)(1996-10#1)
skeletal muscle cell##2##3##(1992-2#1)(1993-4#1)
skeletal muscle cells##10##3##(1994-5#1)(1995-1#1)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#2)(2010-10#2)
skeletal muscle differentiation##3##3##(1991-6#1)(1994-11#1)(2013-1#1)
skeletal muscle during##3##3##(1991-2#2)(2008-10#1)
skeletal muscle fatigue##3##3##(1993-11#3)
skeletal muscle fiber##5##3##(1991-12#2)(1991-6#1)(1993-5#1)(1996-3#1)
skeletal muscle fibers##6##3##(1991-12#1)(1994-12#1)(1994-6#1)(1997-2#1)(2009-8#1)(2010-1#1)
skeletal muscle from##4##3##(1990-8#1)(1995-1#1)(1995-2#2)
skeletal muscle functions##2##3##(1991-5#1)(1997-7#1)
skeletal muscle glucose##3##3##(1990-8#1)(1997-7#1)(2008-1#1)
skeletal muscle growth##2##3##(2008-5#1)(2012-12#1)
skeletal muscle in response to##2##5##(1990-2#1)(1997-6#1)
skeletal muscle in##8##3##(1990-2#1)(1993-2#1)(1994-2#1)(1997-6#1)(1997-7#1)(2007-6#1)(2008-1#1)(2012-12#1)
skeletal muscle insulin resistance in##2##5##(2008-1#1)(2008-3#1)
skeletal muscle insulin resistance##3##4##(2008-1#1)(2008-3#1)(2010-10#1)
skeletal muscle is a##3##4##(2008-1#2)(2011-1#1)
skeletal muscle is##17##3##(1990-8#1)(1991-9#1)(1993-2#1)(1995-3#1)(1997-2#1)(1997-3#1)(2006-10#1)(2008-1#8)(2009-3#1)(2011-1#1)
skeletal muscle lineage##3##3##(1992-5#2)(2008-3#1)
skeletal muscle myosin##3##3##(1992-12#1)(1993-12#1)(1993-9#1)
skeletal muscle nebulin##2##3##(2008-6#2)
skeletal muscle of the##2##4##(1994-4#1)(2013-1#1)
skeletal muscle of##8##3##(1990-10#1)(1991-4#1)(1992-1#1)(1992-12#1)(1992-7#1)(1994-4#1)(2008-8#1)(2013-1#1)
skeletal muscle phosphorylase##2##3##(1991-1#1)(1994-12#1)
skeletal muscle sarcolemma##2##3##(1991-9#1)(1993-4#1)
skeletal muscle sarcoplasmic reticulum##4##4##(1991-8#1)(1992-6#1)(1992-7#1)(2008-8#1)
skeletal muscle sodium channel gene##3##5##(1991-12#1)(1992-3#2)
skeletal muscle sodium##4##3##(1991-12#1)(1992-3#2)(1994-3#1)
skeletal muscle that##3##3##(2008-11#1)(2008-5#1)(2012-1#1)
skeletal muscle tissue##9##3##(1991-5#1)(2007-11#1)(2008-10#1)(2008-2#4)(2009-10#1)(2012-3#1)
skeletal muscle to##4##3##(1991-12#1)(1991-6#1)(1995-8#1)(2010-2#1)
skeletal muscle toxicity##2##3##(2005-7#1)(2008-7#1)
skeletal muscle triads##2##3##(1992-1#2)
skeletal muscle was##5##3##(1994-2#1)(1995-11#1)(2008-3#1)(2012-12#1)(2013-1#1)
skeletal muscle were##2##3##(1991-10#1)(2008-8#1)
skeletal muscle##398##2##(1990-10#2)(1990-11#6)(1990-12#2)(1990-2#3)(1990-5#4)(1990-7#1)(1990-8#5)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#8)(1991-2#6)(1991-3#2)(1991-4#2)(1991-5#4)(1991-6#9)(1991-7#3)(1991-8#2)(1991-9#6)(1992-1#4)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#4)(1992-7#4)(1992-8#5)(1992-9#1)(1993-11#10)(1993-12#12)(1993-2#4)(1993-3#2)(1993-4#4)(1993-5#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#5)(1994-12#10)(1994-2#6)(1994-3#3)(1994-4#1)(1994-5#4)(1994-6#3)(1994-8#4)(1994-9#7)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#10)(1995-3#3)(1995-5#3)(1995-6#1)(1995-8#2)(1995-9#3)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#5)(1996-4#2)(1996-5#1)(1996-7#2)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#1)(1997-4#1)(1997-6#6)(1997-7#8)(1997-8#1)(2004-4#1)(2005-1#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-9#1)(2007-11#2)(2007-6#1)(2008-1#25)(2008-10#3)(2008-11#8)(2008-12#1)(2008-2#4)(2008-3#10)(2008-4#3)(2008-5#7)(2008-6#5)(2008-7#3)(2008-8#7)(2008-9#7)(2009-10#2)(2009-12#2)(2009-3#4)(2009-5#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#4)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#3)(2012-1#3)(2012-12#5)(2012-3#5)(2012-7#1)(2013-1#5)(2013-8#4)
skeletal muscle)##2##2##(1994-12#1)(2012-12#1)
skeletal muscle-specific##4##2##(1993-12#1)(1995-2#2)(2008-8#1)
skeletal muscles are##2##3##(2008-1#1)(2008-10#1)
skeletal muscles in##3##3##(1993-5#1)(1996-5#1)(2012-1#1)
skeletal muscles of##6##3##(1991-9#1)(1994-9#1)(1995-8#1)(2008-11#1)(2008-7#1)(2010-12#1)
skeletal muscles under##2##3##(1995-2#1)(2008-3#1)
skeletal muscles were##2##3##(1993-11#2)
skeletal muscles##43##2##(1990-11#1)(1990-8#1)(1991-10#1)(1991-6#3)(1991-9#1)(1992-2#1)(1993-11#2)(1993-5#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-9#2)(1995-12#1)(1995-2#5)(1995-8#2)(1996-5#1)(1997-6#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-12#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#3)
skeletal myoblasts##6##2##(1990-12#1)(1993-12#1)(1995-3#2)(2008-1#1)(2009-9#1)
skeletal myopathy##3##2##(1995-1#1)(2008-7#2)
skeletal myosin##2##2##(1991-2#1)(1995-6#1)
skeletal myotubes##3##2##(1995-3#3)
skeletal pain##2##2##(1996-2#1)(2011-1#1)
skeletal remains##3##2##(1991-11#1)(1995-6#1)(2010-9#1)
skeletal sarcoplasmic reticulum (SR)##2##4##(1991-7#1)(1994-12#1)
skeletal sites##2##2##(2008-9#1)(2009-3#1)
skeletal stabilization##2##2##(2009-9#1)(2013-8#1)
skeletal status##2##2##(1997-4#1)(2013-8#1)
skeletal structures##2##2##(2007-12#1)(2009-3#1)
skeletal survey##4##2##(2010-9#1)(2011-1#3)
skeletal system##8##2##(2007-11#3)(2007-3#1)(2007-8#3)(2008-5#1)
skeletal tissues##3##2##(1990-11#1)(1994-12#1)(1997-5#1)
skeletal troponin C##2##3##(1991-4#2)
skeletal troponin##5##2##(1991-4#2)(1994-3#1)(2008-7#2)
skeletal##771##1##(1990-10#3)(1990-11#9)(1990-12#3)(1990-2#4)(1990-5#7)(1990-7#1)(1990-8#6)(1990-9#1)(1991-1#1)(1991-10#3)(1991-11#4)(1991-12#8)(1991-2#8)(1991-3#4)(1991-4#4)(1991-5#4)(1991-6#13)(1991-7#4)(1991-8#2)(1991-9#7)(1992-1#4)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#2)(1992-4#2)(1992-5#3)(1992-6#6)(1992-7#5)(1992-8#5)(1992-9#1)(1993-11#14)(1993-12#21)(1993-2#4)(1993-3#4)(1993-4#5)(1993-5#2)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#7)(1994-12#13)(1994-2#8)(1994-3#7)(1994-4#1)(1994-5#5)(1994-6#3)(1994-7#3)(1994-8#4)(1994-9#10)(1995-1#5)(1995-11#2)(1995-12#2)(1995-2#17)(1995-3#10)(1995-5#3)(1995-6#4)(1995-8#4)(1995-9#3)(1996-10#1)(1996-12#6)(1996-2#4)(1996-3#8)(1996-4#2)(1996-5#2)(1996-7#3)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#6)(1997-3#3)(1997-4#12)(1997-5#1)(1997-6#7)(1997-7#8)(1997-8#2)(2004-11#1)(2004-4#1)(2004-9#1)(2005-1#1)(2005-7#2)(2005-9#1)(2006-1#2)(2006-10#6)(2006-11#3)(2006-4#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#21)(2007-12#10)(2007-2#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#4)(2007-8#8)(2008-1#36)(2008-10#5)(2008-11#12)(2008-12#3)(2008-2#6)(2008-3#12)(2008-4#5)(2008-5#13)(2008-6#14)(2008-7#23)(2008-8#13)(2008-9#9)(2009-10#2)(2009-12#3)(2009-3#8)(2009-4#2)(2009-5#3)(2009-7#5)(2009-8#4)(2009-9#7)(2010-1#1)(2010-10#5)(2010-12#4)(2010-2#11)(2010-3#5)(2010-4#4)(2010-6#4)(2010-7#3)(2010-8#2)(2010-9#5)(2011-1#23)(2011-12#1)(2011-2#8)(2012-1#8)(2012-12#20)(2012-2#8)(2012-3#10)(2012-7#1)(2013-1#13)(2013-8#11)
skeletal-related events (SREs)##2##3##(2008-7#2)
skeletal-related events##3##2##(2008-7#2)(2013-7#1)
skeletally immature##9##2##(2006-10#1)(2008-6#1)(2009-3#1)(2010-3#1)(2013-1#5)
skeletally mature##4##2##(2006-10#1)(2009-3#1)(2010-3#1)(2012-12#1)
skeletally##13##1##(2006-10#2)(2008-6#1)(2009-3#2)(2010-3#2)(2012-12#1)(2013-1#5)
skeletogenic##3##1##(1993-12#1)(2012-12#2)
skeleton and##8##2##(1991-11#1)(1993-11#1)(1996-9#1)(2008-1#1)(2012-12#1)(2012-2#3)
skeleton are##2##2##(2007-12#1)(2009-2#1)
skeleton for the synthesis of##2##5##(2008-5#2)
skeleton for##3##2##(2008-5#2)(2013-1#1)
skeleton is a##2##3##(2007-11#1)(2007-12#1)
skeleton is##6##2##(1993-11#1)(1996-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2011-2#1)
skeleton of##9##2##(1991-5#1)(1992-5#1)(2007-2#2)(2007-5#1)(2008-8#3)(2013-1#1)
skeleton transform##4##2##(2008-2#4)
skeleton were##2##2##(1990-8#1)(2006-12#1)
skeleton with##3##2##(1997-2#2)(2011-12#1)
skeleton##138##1##(1990-2#1)(1990-3#3)(1990-8#1)(1991-11#1)(1991-3#1)(1991-5#3)(1991-7#2)(1992-4#1)(1992-5#1)(1993-11#5)(1993-3#1)(1993-4#1)(1994-12#2)(1994-7#1)(1994-9#1)(1995-11#1)(1995-7#1)(1996-5#3)(1996-6#1)(1996-8#2)(1996-9#2)(1997-2#3)(2006-10#1)(2006-12#3)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#2)(2007-1#2)(2007-10#1)(2007-11#6)(2007-12#7)(2007-2#2)(2007-5#1)(2007-7#1)(2007-9#4)(2008-1#7)(2008-10#3)(2008-11#1)(2008-2#7)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#10)(2009-10#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-3#1)(2010-6#4)(2010-8#1)(2011-12#1)(2011-2#5)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#4)
skeleton-muscle##2##1##(2007-12#2)
skeletonisation##2##1##(1996-9#1)(2007-8#1)
skeletonised internal mammary##3##3##(2005-12#1)(2007-8#2)
skeletonised##4##1##(2005-12#2)(2007-8#2)
skeletonization##5##1##(2007-8#2)(2008-2#1)(2008-7#1)(2010-8#1)
skeletonized IMA##2##2##(2007-8#2)
skeletonized arterial graft##2##3##(2007-8#2)
skeletonized arterial##3##2##(2007-8#3)
skeletonized fashion##2##2##(2007-8#1)(2010-8#1)
skeletonized##11##1##(2007-8#10)(2010-8#1)
skeletons of volumetric models##3##4##(2008-5#3)
skeletons of##4##2##(2008-5#3)(2010-6#1)
skeletons with##3##2##(2008-2#1)(2008-5#2)
skeletons##26##1##(1990-3#1)(1993-12#1)(1995-2#1)(1995-6#1)(2006-7#1)(2007-11#2)(2007-3#1)(2007-7#1)(2008-10#1)(2008-2#5)(2008-5#6)(2009-3#1)(2010-6#2)(2011-1#1)(2012-3#1)
skeptical of##2##2##(1990-10#1)(2007-4#1)
skeptical##5##1##(1990-10#1)(2007-4#1)(2007-9#2)(2009-11#1)
skepticism to##2##2##(2007-12#1)(2011-2#1)
skepticism##11##1##(1991-12#1)(1995-2#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-4#1)(2009-1#1)(2009-10#1)(2009-3#1)(2011-2#2)
skeptics##2##1##(1991-2#1)(2006-7#1)
skerries##2##1##(2008-3#2)
sketch a##2##2##(2009-3#1)(2013-8#1)
sketch of##2##2##(2008-8#1)(2010-10#1)
sketch##11##1##(1992-1#1)(1993-3#1)(2006-4#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
sketches##2##1##(2009-10#1)(2010-11#1)
sketchy##2##1##(1993-3#1)(2013-8#1)
skew foot deformity in a patient with##2##7##(2012-3#2)
skew foot deformity##3##3##(2012-3#3)
skew in##5##2##(2008-8#3)(2008-9#2)
skew model##2##2##(2008-8#1)(2010-2#1)
skew models##6##2##(2008-8#3)(2008-9#1)(2010-2#2)
skew or##2##2##(2008-8#1)(2008-9#1)
skew was associated with##2##4##(2008-9#2)
skew##48##1##(1995-4#1)(1995-8#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#2)(2008-8#20)(2008-9#7)(2009-12#1)(2010-2#4)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#3)
skewed to the##2##3##(1993-12#1)(1996-5#1)
skewed to##3##2##(1993-12#1)(1996-5#1)(2007-8#1)
skewed toward##3##2##(2008-10#3)
skewed##22##1##(1993-1#1)(1993-12#1)(1995-11#1)(1996-5#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-9#1)(2011-1#2)(2012-3#1)(2013-1#2)
skewing of##3##2##(2005-10#1)(2008-10#1)(2008-11#1)
skewing##8##1##(2005-10#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#3)(2012-1#1)
skewness of##2##2##(1993-5#1)(2008-10#1)
skewness##5##1##(1993-5#1)(2007-3#1)(2008-10#2)(2008-3#1)
skews##3##1##(2008-8#2)(2009-9#1)
ski##2##1##(2008-11#1)(2012-2#1)
skies##6##1##(2008-1#1)(2008-2#2)(2008-3#3)
skiing##7##1##(1992-6#1)(2007-12#1)(2009-5#1)(2012-2#2)(2013-1#2)
skill acquisition##4##2##(1994-2#1)(2008-11#1)(2011-1#2)
skill and##14##2##(1990-12#1)(1997-1#1)(2005-8#1)(2006-10#2)(2006-8#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-2#1)
skill development##8##2##(1993-2#1)(1994-2#1)(2010-3#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-7#1)
skill for##6##2##(1992-2#1)(1997-3#1)(2006-10#1)(2008-11#2)(2008-12#1)
skill in the##2##3##(2005-8#1)(2006-5#1)
skill in##7##2##(1992-11#1)(1995-12#1)(2004-10#1)(2005-8#1)(2006-5#1)(2008-11#2)
skill is##2##2##(2007-8#1)(2008-11#1)
skill learning##7##2##(2006-10#1)(2007-8#3)(2009-6#1)(2012-1#1)(2012-2#1)
skill level##4##2##(1996-12#1)(2007-11#1)(2008-11#1)(2009-2#1)
skill levels##4##2##(2006-10#2)(2011-2#2)
skill mix##5##2##(1990-12#1)(1995-2#1)(1997-2#2)(2013-8#1)
skill of##9##2##(2005-12#1)(2006-10#1)(2007-11#1)(2008-11#4)(2009-6#1)(2010-4#1)
skill or##2##2##(1992-11#1)(2008-11#1)
skill performance##5##2##(2012-2#1)(2013-7#4)
skill set##5##2##(2007-12#4)(2012-3#1)
skill sets##2##2##(1996-2#1)(2007-4#1)
skill that##6##2##(1995-1#1)(2008-11#1)(2008-12#2)(2009-8#1)(2013-1#1)
skill training programs##2##3##(2004-8#1)(2006-9#1)
skill training##5##2##(2004-8#1)(2006-6#1)(2006-9#1)(2010-1#1)(2013-7#1)
skill##167##1##(1990-12#6)(1990-3#1)(1991-3#2)(1992-11#3)(1992-2#2)(1993-2#1)(1994-12#1)(1994-2#2)(1995-1#1)(1995-12#2)(1995-2#2)(1996-1#4)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(2004-10#2)(2004-8#1)(2005-12#1)(2005-8#2)(2006-10#11)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#2)(2006-9#2)(2007-10#1)(2007-11#3)(2007-12#7)(2007-4#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#17)(2008-12#5)(2008-3#1)(2008-7#1)(2008-8#2)(2009-11#2)(2009-2#2)(2009-4#1)(2009-6#2)(2009-8#2)(2010-1#1)(2010-12#2)(2010-2#2)(2010-3#4)(2010-4#2)(2010-8#1)(2011-1#2)(2011-2#6)(2011-7#1)(2012-1#4)(2012-12#6)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#8)(2013-8#1)
skill-building##2##1##(2008-11#1)(2009-9#1)
skilled and experienced##2##3##(2008-4#2)
skilled and##9##2##(1992-12#1)(1995-5#1)(1997-3#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-4#2)(2012-2#1)
skilled attendance at delivery##2##4##(2011-1#2)
skilled attendance##4##2##(2010-12#1)(2011-1#3)
skilled birth attendance##2##3##(2010-12#1)(2011-1#1)
skilled care and##2##3##(1997-4#1)(2008-3#1)
skilled in##2##2##(1990-10#1)(2006-8#1)
skilled movements##2##2##(1991-1#1)(1992-11#1)
skilled nursing facilities##6##3##(1990-12#1)(1991-2#1)(1992-2#1)(2006-1#1)(2012-12#1)(2012-3#1)
skilled nursing facility (SNF) benefit##2##5##(1990-12#1)(1994-2#1)
skilled nursing facility (SNF)##4##4##(1990-12#1)(1994-12#1)(1994-2#1)(1995-3#1)
skilled nursing facility benefit##3##4##(1990-12#1)(1992-1#1)(1994-2#1)
skilled nursing facility services##3##4##(1991-1#1)(1992-1#2)
skilled nursing facility##13##3##(1990-12#2)(1991-1#2)(1992-1#3)(1994-12#1)(1994-2#2)(1995-3#2)(2010-6#1)
skilled nursing##24##2##(1990-12#4)(1991-1#2)(1991-2#1)(1992-1#3)(1992-2#1)(1994-12#2)(1994-2#3)(1995-3#2)(2006-1#1)(2006-7#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-3#1)
skilled performance##2##2##(2005-9#2)
skilled reaching##3##2##(1992-10#1)(1992-9#1)(1994-3#1)
skilled resuscitation##4##2##(1994-6#4)
skilled use of##2##3##(2007-10#1)(2008-12#1)
skilled##84##1##(1990-10#1)(1990-12#4)(1991-1#3)(1991-2#1)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-9#2)(1994-12#2)(1994-2#3)(1994-3#2)(1994-6#4)(1995-3#2)(1995-5#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-9#2)(2006-1#1)(2006-10#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-6#1)(2011-1#7)(2011-12#1)(2012-12#1)(2012-2#2)(2012-3#1)
skillful##9##1##(1991-2#1)(1994-6#1)(1995-7#1)(1997-1#1)(2006-6#1)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)
skillfully##3##1##(1996-12#1)(2010-5#1)(2012-1#1)
skills acquired##2##2##(2007-2#1)(2010-3#1)
skills acquisition##4##2##(2008-11#2)(2010-3#1)(2011-2#1)
skills after##2##2##(2010-3#1)(2012-1#1)
skills among##3##2##(1995-6#1)(1995-9#1)(2009-4#1)
skills and abilities##2##3##(1993-1#1)(2008-12#1)
skills and attitudes##3##3##(2008-11#1)(2008-7#1)(2012-2#1)
skills and autistic##2##3##(2009-4#1)(2013-1#1)
skills and confidence##2##3##(2008-11#1)(2008-12#1)
skills and experience##2##3##(1992-3#1)(2012-2#1)
skills and improve##2##3##(1992-11#1)(2006-8#1)
skills and information##2##3##(2008-7#2)
skills and knowledge of##3##4##(2008-10#1)(2008-3#1)(2011-2#1)
skills and knowledge##6##3##(1995-4#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
skills and methods##2##3##(1993-10#1)(2013-1#1)
skills and the##6##3##(1992-3#1)(1993-2#1)(1995-6#1)(2006-10#1)(2008-11#1)(2011-2#1)
skills and##90##2##(1992-11#1)(1992-12#1)(1992-3#3)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#3)(1994-3#1)(1995-1#1)(1995-10#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#1)(2005-10#2)(2006-10#3)(2006-2#1)(2006-8#1)(2007-10#1)(2007-3#2)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#13)(2008-12#6)(2008-2#2)(2008-3#1)(2008-7#3)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-6#1)(2011-1#2)(2011-2#8)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
skills are required to##2##4##(2006-12#1)(2011-2#1)
skills are required##3##3##(2006-12#1)(2006-6#1)(2011-2#1)
skills are the##2##3##(2008-11#1)(2012-3#1)
skills are##18##2##(1993-12#1)(1996-1#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-1#1)(2008-11#2)(2008-12#1)(2009-10#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)
skills as a##3##3##(2007-6#1)(2008-11#1)(2009-10#1)
skills as well as##3##4##(1992-12#1)(2007-6#1)(2012-2#1)
skills as well##4##3##(1991-4#1)(1992-12#1)(2007-6#1)(2012-2#1)
skills as##11##2##(1991-4#1)(1992-12#1)(1995-12#1)(1995-3#1)(2007-6#2)(2008-11#3)(2009-10#1)(2012-2#1)
skills at##4##2##(1993-12#1)(2008-11#1)(2008-12#1)(2008-5#1)
skills between##3##2##(2008-11#2)(2013-7#1)
skills by##4##2##(2008-11#2)(2008-12#1)(2013-7#1)
skills can##3##2##(1997-4#1)(2011-12#1)(2012-3#1)
skills compared##2##2##(2005-10#1)(2010-1#1)
skills course##3##2##(2008-11#1)(2010-3#1)(2013-1#1)
skills did not##2##3##(2007-9#1)(2011-2#1)
skills enhanced##2##2##(1995-3#1)(2008-2#1)
skills explained##2##2##(2009-5#2)
skills for people who will##2##5##(1994-1#2)
skills for##22##2##(1990-12#1)(1992-1#1)(1992-12#1)(1994-1#2)(1997-3#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-3#1)(2008-1#1)(2008-12#4)(2008-9#1)(2009-4#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-12#1)
skills from the##3##3##(1996-3#1)(2007-12#1)(2013-7#1)
skills from##6##2##(1992-6#1)(1996-3#1)(2006-6#1)(2007-12#1)(2013-1#1)(2013-7#1)
skills groups for people aged 6 to 21 with autism spectrum disorders##3##12##(2013-7#3)
skills had##2##2##(1995-6#1)(2009-12#1)
skills has been##2##3##(2006-10#1)(2012-3#1)
skills have been##3##3##(1997-3#1)(2007-1#1)(2012-3#1)
skills have##4##2##(1997-3#1)(2007-1#1)(2012-2#1)(2012-3#1)
skills in a##2##3##(2008-10#1)(2012-2#1)
skills in caring for##2##4##(2007-10#1)(2013-8#1)
skills in managing##2##3##(2008-7#1)(2013-7#1)
skills in order##2##3##(2007-6#1)(2008-11#1)
skills in standard and non-standard entry diploma students##2##8##(2008-11#2)
skills in the##8##3##(1994-8#1)(2005-8#1)(2008-11#1)(2008-12#1)(2009-6#1)(2010-2#1)(2011-2#1)(2012-1#1)
skills in their##3##3##(2005-12#1)(2008-11#1)(2012-12#1)
skills in##72##2##(1993-12#2)(1994-8#1)(1995-1#2)(1995-3#1)(1995-4#1)(1996-2#1)(1997-3#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-9#3)(2007-1#1)(2007-10#2)(2007-12#3)(2007-6#3)(2007-8#1)(2007-9#3)(2008-10#1)(2008-11#11)(2008-12#5)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-1#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
skills into##3##2##(2006-10#1)(2008-11#1)(2008-12#1)
skills involved##2##2##(2007-3#1)(2012-1#1)
skills is considered##2##3##(2008-11#1)(2008-7#1)
skills is##5##2##(1995-5#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-7#1)
skills laboratories##2##2##(2006-6#2)
skills may be##4##3##(1992-6#1)(2006-10#1)(2008-11#1)(2010-5#1)
skills may##6##2##(1992-6#1)(2006-10#1)(2007-8#1)(2008-11#1)(2010-5#1)(2011-2#1)
skills must##2##2##(1994-3#1)(2005-5#1)
skills necessary to##3##3##(1993-2#1)(2008-1#1)(2008-5#1)
skills necessary##4##2##(1993-2#1)(2007-4#1)(2008-1#1)(2008-5#1)
skills needed by##3##3##(1995-2#1)(2005-12#1)(2012-12#1)
skills needed for##3##3##(1993-12#1)(2008-12#1)(2012-3#1)
skills needed to##3##3##(2006-5#1)(2010-5#1)(2012-12#1)
skills needed##9##2##(1993-12#1)(1995-2#1)(2005-12#1)(2006-5#1)(2008-12#1)(2010-5#1)(2012-12#2)(2012-3#1)
skills of a##6##3##(1990-12#1)(2006-10#1)(2007-11#1)(2008-6#1)(2008-9#2)
skills of children with cochlear implants##2##6##(2008-9#2)
skills of children with##3##4##(2008-9#2)(2009-2#1)
skills of the##7##3##(1991-8#1)(1993-5#1)(2007-4#1)(2008-11#1)(2008-2#1)(2009-8#1)(2010-11#1)
skills of##56##2##(1990-12#1)(1991-12#1)(1991-8#1)(1992-3#1)(1993-5#1)(1994-2#1)(1996-12#1)(1996-3#2)(1997-4#1)(2004-12#1)(2004-7#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-3#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-11#5)(2008-12#1)(2008-2#2)(2008-6#1)(2008-9#7)(2009-2#1)(2009-4#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)
skills on##3##2##(2008-4#1)(2010-3#1)(2012-3#1)
skills or##2##2##(1994-2#1)(2012-3#1)
skills remained within##2##3##(1997-5#1)(2008-6#1)
skills required for##4##3##(1991-1#1)(2008-11#1)(2008-2#1)(2009-12#1)
skills required to##4##3##(1990-12#1)(1996-2#1)(2007-12#1)(2013-8#1)
skills required##9##2##(1990-12#1)(1991-1#1)(1996-2#1)(2004-3#1)(2007-12#1)(2008-11#1)(2008-2#1)(2009-12#1)(2013-8#1)
skills should be##4##3##(1992-6#1)(2006-10#1)(2008-10#1)(2008-4#1)
skills should##5##2##(1992-6#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-8#1)
skills such as##2##3##(1992-1#1)(2008-11#1)
skills taught in##2##3##(2004-10#1)(2012-2#1)
skills than##2##2##(2009-4#1)(2013-7#1)
skills that are##2##3##(2008-11#1)(2012-12#1)
skills that could##2##3##(2008-11#1)(2008-2#1)
skills that have##2##3##(2007-6#1)(2008-1#1)
skills that were##3##3##(2007-12#1)(2007-4#1)(2007-6#1)
skills that##14##2##(1990-12#1)(1992-2#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#3)(2008-1#2)(2008-11#2)(2008-2#1)(2012-12#1)
skills through##2##2##(1990-12#1)(2006-6#1)
skills to a##2##3##(2008-11#2)
skills to manage##2##3##(1994-2#1)(2010-2#1)
skills to provide##3##3##(2008-11#1)(2010-1#1)(2011-1#1)
skills to##28##2##(1990-11#1)(1993-1#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-3#1)(1997-3#1)(2004-12#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#5)(2008-4#2)(2009-5#1)(2010-1#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-3#1)(2013-8#1)
skills training approaches##2##3##(2005-7#2)
skills training course##2##3##(2010-3#2)
skills training for##5##3##(2005-6#1)(2005-7#1)(2010-3#1)(2011-1#1)(2013-8#1)
skills training may##2##3##(2005-7#1)(2013-1#1)
skills training to##2##3##(2008-11#1)(2013-1#1)
skills training##29##2##(1996-2#1)(1997-2#3)(2005-6#1)(2005-7#9)(2007-7#2)(2008-11#1)(2010-3#3)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#2)(2013-8#2)
skills using##2##2##(2008-6#1)(2008-9#1)
skills was found##2##3##(2005-10#1)(2009-10#1)
skills was##6##2##(1994-3#1)(1995-6#1)(2005-10#1)(2009-10#1)(2012-2#2)
skills were found##2##3##(2007-9#1)(2009-12#1)
skills were##10##2##(2005-10#1)(2006-10#1)(2007-9#1)(2008-11#1)(2008-12#3)(2008-6#1)(2008-9#1)(2009-12#1)
skills which##2##2##(1994-2#1)(2012-2#1)
skills with##5##2##(2006-7#1)(2009-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
skills within the##2##3##(2007-8#1)(2012-3#1)
skills would##2##2##(2006-10#1)(2012-3#1)
skills##799##1##(1990-11#1)(1990-12#9)(1991-1#2)(1991-12#2)(1991-4#1)(1991-8#1)(1992-1#3)(1992-11#1)(1992-12#4)(1992-2#5)(1992-3#5)(1992-6#4)(1993-1#5)(1993-10#1)(1993-11#1)(1993-12#8)(1993-2#3)(1993-3#3)(1993-5#1)(1993-6#2)(1994-1#3)(1994-12#6)(1994-2#8)(1994-3#5)(1994-8#1)(1995-1#8)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#6)(1995-4#3)(1995-5#1)(1995-6#7)(1995-9#1)(1996-1#5)(1996-12#2)(1996-2#5)(1996-3#9)(1997-1#1)(1997-2#5)(1997-3#5)(1997-4#3)(1997-5#1)(1997-8#1)(2004-10#2)(2004-11#1)(2004-12#2)(2004-3#1)(2004-7#1)(2005-10#8)(2005-11#1)(2005-12#2)(2005-4#1)(2005-5#2)(2005-6#1)(2005-7#9)(2005-8#1)(2006-1#1)(2006-10#33)(2006-12#3)(2006-2#6)(2006-3#4)(2006-5#2)(2006-6#13)(2006-7#4)(2006-8#6)(2006-9#3)(2007-1#6)(2007-10#6)(2007-11#1)(2007-12#17)(2007-2#2)(2007-3#7)(2007-4#5)(2007-5#5)(2007-6#8)(2007-7#6)(2007-8#10)(2007-9#12)(2008-1#9)(2008-10#4)(2008-11#80)(2008-12#43)(2008-2#7)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#5)(2008-7#8)(2008-8#6)(2008-9#22)(2009-1#5)(2009-10#7)(2009-11#1)(2009-12#6)(2009-2#3)(2009-3#2)(2009-4#14)(2009-5#7)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#5)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#4)(2010-3#13)(2010-4#3)(2010-5#4)(2010-6#3)(2010-7#1)(2010-8#2)(2010-9#5)(2011-1#12)(2011-12#2)(2011-2#32)(2012-1#19)(2012-11#2)(2012-12#14)(2012-2#17)(2012-3#29)(2013-1#20)(2013-7#11)(2013-8#10)
skills)##6##1##(1995-8#1)(2005-5#1)(2005-7#1)(2006-3#1)(2006-6#1)(2011-1#1)
skills-based##5##1##(1997-7#1)(2008-11#1)(2008-6#2)(2012-2#1)
skills?##4##1##(1992-2#1)(2007-12#1)(2008-11#1)(2009-11#1)
skills]##2##1##(1992-6#1)(2009-5#1)
skim milk##10##2##(1991-9#1)(2006-5#1)(2008-10#1)(2010-2#6)(2013-1#1)
skim##12##1##(1991-9#1)(2006-5#1)(2008-10#1)(2010-2#6)(2013-1#3)
skimmed milk and##2##3##(2008-5#2)
skimmed milk##9##2##(2005-11#1)(2008-10#1)(2008-5#7)
skimmed##12##1##(2005-11#1)(2008-10#1)(2008-11#1)(2008-5#8)(2013-1#1)
skimmer interface and ion attachment mass spectrometry##2##7##(2008-10#2)
skimmer interface and##3##3##(2008-10#3)
skimmer interface##6##2##(2008-10#6)
skimmer##8##1##(2008-10#8)
skimming##4##1##(1994-3#1)(2011-1#1)(2013-1#2)
skimping##2##1##(1993-1#2)
skin -##4##2##(2006-11#1)(2008-5#1)(2012-3#2)
skin Raman##2##2##(2012-12#2)
skin abscess in a HIV-infected patient##2##6##(2006-8#2)
skin abscesses in##2##3##(2012-2#2)
skin abscesses##5##2##(2007-2#1)(2011-2#1)(2012-2#3)
skin absorption##3##2##(2008-5#1)(2009-6#2)
skin according to##2##3##(2008-5#2)
skin after##4##2##(2008-5#3)(2012-3#1)
skin against##4##2##(2008-5#3)(2009-6#1)
skin ageing##10##2##(2008-5#10)
skin aging##20##2##(2007-12#2)(2008-5#12)(2009-4#1)(2009-9#2)(2011-2#2)(2013-1#1)
skin ailments##6##2##(2006-12#2)(2007-8#1)(2008-4#1)(2008-5#1)(2010-12#1)
skin and 10 with type V skin were subjected to graded incremental doses of##2##14##(2007-7#1)(2007-8#1)
skin and a##5##3##(1996-5#1)(2008-5#2)(2010-8#1)(2013-8#1)
skin and eye##2##3##(2006-10#1)(2010-7#1)
skin and hair##3##3##(2008-5#1)(2008-9#1)(2012-11#1)
skin and into##2##3##(1994-9#1)(1995-12#1)
skin and its##3##3##(2006-4#1)(2008-5#1)(2009-3#1)
skin and joint##2##3##(1992-6#1)(2008-1#1)
skin and lung##3##3##(2007-11#1)(2008-10#1)(2013-1#1)
skin and measuring##2##3##(2008-5#2)
skin and mucous membranes##3##4##(2010-1#1)(2012-12#1)(2013-8#1)
skin and mucous##4##3##(2007-8#1)(2010-1#1)(2012-12#1)(2013-8#1)
skin and muscle##3##3##(1992-9#2)(2006-10#1)
skin and nervous system##2##4##(1991-9#1)(1995-8#1)
skin and on##2##3##(2008-3#1)(2008-5#1)
skin and oral##2##3##(2008-3#1)(2011-2#1)
skin and peripheral blood##3##4##(2012-2#3)
skin and skin structure infections##3##5##(2008-3#3)
skin and soft tissue infection##4##5##(2005-8#1)(2011-2#1)(2012-12#2)
skin and soft tissue infections in##2##6##(2008-10#1)(2009-4#1)
skin and soft tissue infections##10##5##(2005-7#2)(2007-12#1)(2008-10#1)(2008-3#2)(2009-4#2)(2010-11#1)(2010-12#1)
skin and soft tissue##17##4##(2005-7#2)(2005-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-8#2)(2009-4#2)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#2)
skin and soft tissues##2##4##(1992-10#1)(2006-10#1)
skin and soft##19##3##(1992-10#1)(2005-7#2)(2005-8#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-8#2)(2009-4#2)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#2)
skin and soft-tissue infections##2##4##(1992-6#1)(2008-3#1)
skin and subcutaneous tissue##3##4##(2009-2#1)(2011-12#1)(2013-1#1)
skin and subcutaneous##5##3##(2005-7#1)(2009-2#1)(2011-12#1)(2013-1#1)(2013-8#1)
skin and the nervous system##4##5##(2006-12#1)(2008-5#3)
skin and the##19##3##(1991-8#1)(1994-6#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-7#2)(2008-10#1)(2008-5#6)(2009-9#2)(2011-3#2)(2013-1#1)
skin and to##2##3##(2006-12#1)(2008-5#1)
skin and underlying##3##3##(1992-2#1)(2008-2#1)(2009-4#1)
skin and veins##3##3##(1995-12#3)
skin and##196##2##(1990-3#2)(1990-7#1)(1991-11#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-2#1)(1992-6#3)(1992-8#1)(1992-9#4)(1993-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#5)(1995-2#2)(1995-8#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#1)(2004-12#1)(2005-11#2)(2005-12#1)(2005-7#3)(2005-8#1)(2006-10#7)(2006-11#1)(2006-12#3)(2006-4#1)(2006-8#2)(2007-10#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-4#2)(2007-7#5)(2007-8#3)(2008-1#4)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#10)(2008-5#38)(2008-6#1)(2008-8#3)(2008-9#3)(2009-2#1)(2009-3#1)(2009-4#4)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-7#2)(2010-8#2)(2010-9#4)(2011-1#1)(2011-12#1)(2011-2#6)(2011-3#2)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#5)
skin appendages##2##2##(1990-12#1)(2010-5#1)
skin application##3##2##(1994-3#1)(2011-2#1)(2012-12#1)
skin are##11##2##(1992-2#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-5#5)(2010-5#1)
skin area##4##2##(1996-6#1)(2008-11#1)(2008-5#1)(2010-12#1)
skin areas##7##2##(1995-5#1)(1996-6#1)(2008-5#4)(2010-8#1)
skin as a##3##3##(1993-3#1)(2008-5#1)(2010-2#1)
skin as an##2##3##(2009-6#1)(2010-9#1)
skin as well as##2##4##(2008-10#1)(2012-2#1)
skin as##8##2##(1993-3#1)(2008-10#1)(2008-5#1)(2009-6#1)(2010-2#1)(2010-9#1)(2012-2#2)
skin associated with##3##3##(1991-8#1)(2005-11#1)(2007-7#1)
skin at the##6##3##(1992-6#1)(2008-9#5)
skin at##7##2##(1992-6#1)(2008-3#1)(2008-9#5)
skin atrophy##4##2##(1995-5#1)(2007-11#2)(2010-8#1)
skin barrier and##2##3##(2005-11#1)(2010-7#1)
skin barrier function##4##3##(2008-5#4)
skin barrier##15##2##(1994-8#1)(2005-11#1)(2008-5#10)(2010-3#1)(2010-7#1)(2012-2#1)
skin before and after##3##4##(2007-11#1)(2008-10#2)
skin biology##3##2##(2008-5#3)
skin biopsies of##2##3##(1992-12#1)(2008-5#1)
skin biopsies taken from##2##4##(2007-2#1)(2010-5#1)
skin biopsies were##2##3##(1996-11#1)(2006-4#1)
skin biopsies##19##2##(1991-5#1)(1992-12#1)(1996-11#1)(1997-1#1)(1997-5#1)(2006-4#1)(2007-12#1)(2007-2#3)(2007-8#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2010-5#1)(2012-2#1)
skin biopsy from the##2##4##(2006-4#1)(2007-7#1)
skin biopsy revealed##2##3##(1990-9#1)(1992-5#1)
skin biopsy samples##2##3##(1993-7#2)
skin biopsy showed##4##3##(2005-11#1)(2007-7#1)(2008-7#1)(2010-6#1)
skin biopsy was##3##3##(2007-11#1)(2013-1#1)(2013-8#1)
skin biopsy##23##2##(1990-9#1)(1992-2#1)(1992-5#1)(1993-7#2)(2005-11#1)(2006-10#1)(2006-4#2)(2007-11#1)(2007-2#1)(2007-7#2)(2007-9#1)(2008-2#1)(2008-7#1)(2010-6#2)(2011-2#1)(2012-1#2)(2013-1#1)(2013-8#1)
skin blood flow##6##3##(1992-3#2)(1994-4#3)(2007-12#1)
skin blood##9##2##(1992-3#2)(1994-4#5)(2007-12#1)(2008-5#1)
skin but also##2##3##(2008-5#1)(2012-12#1)
skin but##9##2##(1991-6#1)(1992-6#1)(2008-5#2)(2010-3#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
skin by##14##2##(1992-7#1)(1994-3#1)(1994-9#1)(1995-9#1)(1996-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#3)(2009-6#1)(2011-2#1)(2013-1#1)
skin can be##2##3##(1994-8#1)(2009-5#1)
skin can##8##2##(1993-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-9#1)
skin cancer and##2##3##(1994-5#1)(2012-3#1)
skin cancer development##2##3##(2007-11#1)(2010-9#1)
skin cancer has been##2##4##(2007-12#1)(2008-8#1)
skin cancer in organ transplant recipients##4##6##(1991-11#1)(2007-11#3)
skin cancer in##9##3##(1991-11#1)(1993-8#1)(2007-11#5)(2007-4#1)(2008-8#1)
skin cancer is##6##3##(2007-11#1)(2007-12#2)(2008-12#1)(2011-2#2)
skin cancer later in life##2##5##(1991-6#1)(2006-12#1)
skin cancer prevention##3##3##(2005-11#1)(2007-12#1)(2008-4#1)
skin cancer##64##2##(1990-2#1)(1991-11#1)(1991-6#3)(1993-8#1)(1994-5#1)(1994-7#1)(1996-6#1)(2005-11#1)(2006-12#2)(2007-11#8)(2007-12#12)(2007-4#2)(2008-12#2)(2008-4#2)(2008-8#2)(2009-4#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#4)(2011-2#6)(2012-12#2)(2012-3#4)(2013-1#1)(2013-7#1)
skin cancers and##4##3##(1992-6#1)(2007-11#1)(2007-12#1)(2011-2#1)
skin cancers in##2##3##(2010-8#1)(2012-3#1)
skin cancers##29##2##(1992-6#1)(1995-5#1)(2006-12#1)(2007-11#5)(2007-12#3)(2008-12#2)(2008-4#1)(2008-5#1)(2010-8#3)(2011-2#2)(2011-3#1)(2012-12#2)(2012-3#3)(2013-1#2)(2013-7#1)
skin carcinogenesis in##2##3##(1990-11#1)(1993-9#1)
skin carcinogenesis##12##2##(1990-11#1)(1990-5#1)(1990-6#2)(1993-9#2)(1994-6#2)(2006-12#2)(2009-3#1)(2012-12#1)
skin care formulation##2##3##(2008-5#2)
skin care product##2##3##(2008-5#2)
skin care products##3##3##(2006-12#1)(2008-5#1)(2008-8#1)
skin care##19##2##(2006-12#1)(2006-5#1)(2007-12#2)(2008-5#13)(2008-8#1)(2013-8#1)
skin caused by##2##3##(2007-7#1)(2008-5#1)
skin cells##15##2##(2006-12#3)(2008-4#2)(2008-5#6)(2008-9#1)(2012-3#3)
skin changes in##2##3##(2011-2#1)(2013-8#1)
skin changes##11##2##(2005-1#1)(2005-11#1)(2006-12#1)(2007-7#1)(2007-8#1)(2010-6#1)(2011-2#2)(2013-8#3)
skin characteristics##2##2##(2008-5#2)
skin chronic##2##2##(2012-3#2)
skin closure##2##2##(2009-3#1)(2012-12#1)
skin color##5##2##(2008-5#3)(2008-6#1)(2011-2#1)
skin coloration##3##2##(2008-5#1)(2008-6#2)
skin colors##2##2##(1995-6#1)(2008-5#1)
skin colour and##2##3##(1996-7#1)(2008-5#1)
skin colour##11##2##(1991-6#1)(1993-5#1)(1996-7#3)(2008-5#6)
skin commensal##2##2##(2010-3#1)(2010-4#1)
skin compared with##3##3##(2008-5#3)
skin compared##4##2##(1994-4#1)(2008-5#3)
skin compatibility of##4##3##(2008-10#1)(2008-5#3)
skin compatibility##7##2##(2008-10#2)(2008-5#5)
skin condition##15##2##(2007-7#3)(2008-12#1)(2008-5#6)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)
skin conditions##13##2##(2006-12#1)(2007-7#5)(2008-1#1)(2008-5#4)(2012-11#1)(2013-8#1)
skin conductance level##2##3##(2008-7#2)
skin conductance##4##2##(1996-6#1)(2008-7#3)
skin contact##4##2##(1991-4#1)(1994-6#1)(2008-4#1)(2008-5#1)
skin contactor##3##2##(1991-11#3)
skin contamination##2##2##(1994-9#1)(2006-10#1)
skin cream##2##2##(2008-5#2)
skin cultures##3##2##(2006-7#1)(2008-5#1)(2010-5#1)
skin damage caused by##3##4##(2006-12#1)(2008-5#1)(2011-2#1)
skin damage##8##2##(1995-11#1)(2006-12#1)(2008-5#4)(2009-9#1)(2011-2#1)
skin defect##2##2##(1991-8#1)(2012-3#1)
skin defects##6##2##(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-9#1)(2011-2#1)
skin delivery##2##2##(2008-5#1)(2012-2#1)
skin density##2##2##(2008-5#2)
skin depth##3##2##(2008-2#1)(2008-3#2)
skin disease in which##2##4##(1991-11#1)(2012-12#1)
skin disease in##3##3##(1991-11#1)(2007-2#1)(2012-12#1)
skin disease which##2##3##(1997-8#1)(2008-5#1)
skin disease##25##2##(1991-11#1)(1992-10#1)(1995-1#1)(1996-4#1)(1997-8#1)(2005-11#1)(2006-10#2)(2007-12#1)(2007-2#2)(2007-7#2)(2007-9#1)(2008-2#1)(2008-5#2)(2008-6#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
skin diseases and##2##3##(2006-10#1)(2006-12#1)
skin diseases has##2##3##(2006-10#1)(2007-2#1)
skin diseases in##2##3##(2007-12#1)(2007-3#1)
skin diseases with##2##3##(2005-11#1)(2006-6#1)
skin diseases##44##2##(1991-6#1)(1992-6#1)(1994-3#1)(1994-8#1)(1995-11#1)(1996-11#1)(2005-11#3)(2006-10#4)(2006-12#2)(2006-2#2)(2006-6#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#6)(2007-8#2)(2008-12#2)(2008-5#2)(2010-7#1)(2011-1#2)(2011-2#5)
skin disorder that##2##3##(2005-11#1)(2008-10#1)
skin disorder##11##2##(1990-12#1)(2005-11#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-5#3)(2010-8#1)(2013-7#1)(2013-8#1)
skin disorders and##2##3##(2006-12#1)(2008-5#1)
skin disorders in##5##3##(2006-4#2)(2007-7#1)(2011-2#2)
skin disorders such as##2##4##(2006-12#1)(2008-3#1)
skin disorders##22##2##(1992-10#2)(2006-12#2)(2006-4#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#2)(2008-8#1)(2010-3#1)(2011-2#3)(2013-1#1)
skin doses##2##2##(2007-10#2)
skin dryness##4##2##(2008-5#4)
skin due to##2##3##(2008-6#1)(2008-7#1)
skin during##4##2##(1997-8#1)(2007-11#1)(2008-3#1)(2008-5#1)
skin effects##4##2##(2008-10#1)(2008-5#3)
skin elasticity is##2##3##(2008-5#2)
skin elasticity##5##2##(2008-5#5)
skin electron##2##2##(1993-9#1)(1995-9#1)
skin equivalent model##6##3##(2008-5#6)
skin equivalent##9##2##(2004-12#1)(2008-5#8)
skin equivalents##3##2##(2008-5#3)
skin erosions##2##2##(1994-11#1)(1995-4#1)
skin eruption##4##2##(2007-12#1)(2008-8#1)(2012-3#1)(2013-7#1)
skin eruptions were##2##3##(2006-8#1)(2007-7#1)
skin eruptions##3##2##(1990-9#1)(2006-8#1)(2007-7#1)
skin erythema##2##2##(2008-5#1)(2012-1#1)
skin erythemal response##2##3##(2008-5#2)
skin excision##2##2##(2007-12#1)(2010-11#1)
skin exposure to##3##3##(1994-6#1)(2008-5#2)
skin fibroblast and##2##3##(1995-3#1)(2012-3#1)
skin fibroblast cells##2##3##(2008-11#1)(2008-9#1)
skin fibroblast##12##2##(1990-3#1)(1991-2#1)(1991-3#1)(1994-3#1)(1995-3#2)(1996-5#1)(2008-11#1)(2008-2#1)(2008-9#2)(2012-3#1)
skin fibroblasts and the##2##4##(2008-5#2)
skin fibroblasts and##10##3##(1991-12#1)(1993-12#1)(1994-6#1)(1995-3#1)(1996-3#1)(2008-5#3)(2008-8#1)(2009-8#1)
skin fibroblasts but##2##3##(1990-11#1)(1996-11#1)
skin fibroblasts by##2##3##(1992-1#1)(1994-3#1)
skin fibroblasts from patients with##2##5##(1991-3#1)(1995-4#1)
skin fibroblasts from patients##3##4##(1991-3#1)(1995-4#1)(1997-1#1)
skin fibroblasts from##12##3##(1990-3#1)(1991-3#1)(1991-5#1)(1993-3#1)(1993-8#1)(1995-12#1)(1995-4#1)(1995-8#1)(1996-7#2)(1997-1#1)(2007-3#1)
skin fibroblasts in culture##2##4##(1993-9#1)(1994-6#1)
skin fibroblasts in##3##3##(1993-9#1)(1994-6#1)(2007-3#1)
skin fibroblasts of patients##2##4##(1990-11#1)(2005-8#1)
skin fibroblasts of##3##3##(1990-11#1)(1995-4#1)(2005-8#1)
skin fibroblasts treated with##2##4##(1994-11#1)(1994-2#1)
skin fibroblasts##93##2##(1990-11#3)(1990-2#4)(1990-3#3)(1991-12#2)(1991-3#5)(1991-5#3)(1991-9#1)(1992-1#1)(1992-4#3)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#1)(1993-9#6)(1994-11#1)(1994-2#1)(1994-3#4)(1994-6#4)(1995-10#1)(1995-12#1)(1995-3#2)(1995-4#3)(1995-5#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-7#2)(1997-1#3)(1997-3#1)(2005-8#1)(2007-3#2)(2008-11#1)(2008-2#2)(2008-5#14)(2008-7#2)(2008-8#3)(2009-8#1)
skin fiducials##2##2##(2006-12#2)
skin flap in##2##3##(2008-9#1)(2013-8#1)
skin flap##6##2##(1994-7#1)(2008-5#1)(2008-9#1)(2009-9#1)(2013-7#1)(2013-8#1)
skin flaps##3##2##(2008-9#1)(2009-5#1)(2009-7#1)
skin flora##2##2##(1994-11#1)(2007-7#1)
skin fold thickness (r = -0##2##6##(2012-2#2)
skin fold thickness##4##3##(2006-12#1)(2012-2#3)
skin fold##6##2##(1995-9#1)(1996-12#1)(2006-12#1)(2012-2#3)
skin folds##3##2##(1992-4#1)(2008-5#1)(2009-5#1)
skin following##2##2##(1992-2#1)(2008-10#1)
skin for##5##2##(2006-5#1)(2007-7#1)(2008-5#3)
skin from the##4##3##(2005-7#1)(2006-12#1)(2008-10#1)(2008-5#1)
skin from##9##2##(2005-7#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-5#3)(2011-2#1)(2012-12#1)
skin function##3##2##(2008-5#2)(2008-9#1)
skin functions##2##2##(2008-5#1)(2010-3#1)
skin graft and##2##3##(2005-7#1)(2012-3#1)
skin graft was##2##3##(1995-2#1)(2007-7#1)
skin graft##22##2##(1990-4#1)(1991-12#1)(1995-2#1)(2005-7#1)(2007-7#3)(2007-8#1)(2008-8#1)(2008-9#4)(2009-1#1)(2009-6#1)(2012-3#2)(2013-1#4)(2013-8#1)
skin grafting##8##2##(1991-4#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2013-8#3)
skin grafts and##2##3##(2006-4#1)(2012-2#1)
skin grafts##18##2##(1991-12#2)(1995-2#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-4#1)(2009-1#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#2)
skin haemorrhages##2##2##(1990-8#1)(1995-3#1)
skin has an##2##3##(2008-5#1)(2009-4#1)
skin has been##3##3##(2008-5#3)
skin has##6##2##(1992-9#1)(2008-5#4)(2009-4#1)
skin have##2##2##(2008-5#2)
skin health and beauty##2##4##(2010-9#2)
skin health and##3##3##(2010-9#3)
skin health##6##2##(2008-5#1)(2010-9#4)(2012-3#1)
skin homeostasis##4##2##(2006-12#1)(2008-5#1)(2008-9#1)(2010-9#1)
skin hydration and##6##3##(2008-5#6)
skin hydration state##2##3##(2008-5#2)
skin hydration were##2##3##(2008-10#1)(2008-5#1)
skin hydration##24##2##(2008-10#1)(2008-5#20)(2009-4#1)(2010-8#2)
skin hyperpigmentation##3##2##(2013-7#3)
skin impedance at##2##3##(2008-10#2)
skin impedance##7##2##(2008-10#6)(2013-1#1)
skin improvement##5##2##(2008-5#5)
skin in terms of##2##4##(2008-5#2)
skin in the##6##3##(1996-12#1)(2008-5#5)
skin in vivo##9##3##(1990-11#1)(2007-12#1)(2008-3#1)(2008-5#5)(2012-3#1)
skin in##41##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-5#1)(1992-8#1)(1993-3#1)(1995-11#1)(1996-12#2)(2007-12#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#17)(2009-10#1)(2011-12#1)(2011-3#1)(2012-1#1)(2012-3#1)(2013-8#1)
skin incision##8##2##(1991-12#1)(2005-5#1)(2006-12#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2009-5#1)
skin incisions##5##2##(2006-9#1)(2007-8#3)(2008-9#1)
skin infection to##2##3##(1995-2#1)(2008-9#1)
skin infection were##2##3##(1992-2#1)(2008-12#1)
skin infection##11##2##(1991-3#1)(1992-2#1)(1995-2#1)(1997-3#1)(2008-12#3)(2008-5#1)(2008-7#1)(2008-9#2)
skin infections##4##2##(1991-6#1)(2008-5#1)(2011-2#1)(2013-1#1)
skin inflammation##6##2##(1992-11#1)(1996-6#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-5#1)
skin injury##2##2##(2008-5#1)(2010-8#1)
skin integrity##3##2##(1995-3#1)(2011-2#1)(2012-3#1)
skin invasion##3##2##(1996-10#1)(2009-5#2)
skin involvement##7##2##(1996-11#1)(2006-10#2)(2007-3#2)(2007-7#1)(2013-1#1)
skin irritation and##2##3##(2008-10#1)(2012-12#1)
skin irritation potential##3##3##(2009-6#1)(2012-12#2)
skin irritation##16##2##(2008-10#3)(2008-5#8)(2009-6#1)(2012-12#4)
skin is a##8##3##(1990-4#1)(2007-5#1)(2007-7#1)(2008-5#2)(2008-9#1)(2010-7#1)(2011-2#1)
skin is also exposed to##2##5##(2008-8#1)(2011-2#1)
skin is also##3##3##(2007-8#1)(2008-8#1)(2011-2#1)
skin is described##2##3##(2008-3#2)
skin is the##5##3##(1992-6#1)(2006-12#1)(2008-5#2)(2010-7#1)
skin is##56##2##(1990-4#1)(1992-3#1)(1992-6#2)(1992-9#2)(1994-5#1)(1997-5#1)(2006-12#2)(2006-7#2)(2007-5#1)(2007-7#2)(2007-8#2)(2008-3#2)(2008-4#1)(2008-5#21)(2008-8#1)(2008-9#2)(2009-6#1)(2010-7#2)(2011-12#1)(2011-2#4)(2013-1#3)(2013-8#1)
skin island##2##2##(1990-4#1)(2008-6#1)
skin keratinocytes##3##2##(1997-4#2)(2008-7#1)
skin layer##5##2##(2005-11#4)(2008-3#1)
skin layers##9##2##(2008-10#1)(2008-11#5)(2008-5#2)(2010-12#1)
skin lesion of##3##3##(1994-4#1)(2006-10#1)(2011-2#1)
skin lesion##13##2##(1994-4#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-7#1)(2008-9#1)(2010-6#1)(2011-2#3)(2012-2#1)(2013-8#1)
skin lesions and##6##3##(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2013-1#1)(2013-8#1)
skin lesions are##3##3##(1997-8#1)(2007-12#1)(2012-3#1)
skin lesions at the site of application##4##7##(2008-9#4)
skin lesions at the site of##5##6##(1992-6#1)(2008-9#4)
skin lesions from##2##3##(1992-2#1)(1996-11#1)
skin lesions had##3##3##(1991-4#1)(2007-8#1)(2013-8#1)
skin lesions in the##2##4##(2011-1#1)(2011-2#1)
skin lesions in##5##3##(2006-4#1)(2011-1#1)(2011-2#2)(2012-3#1)
skin lesions that##2##3##(2006-10#1)(2010-8#1)
skin lesions when##3##3##(2007-8#1)(2011-1#2)
skin lesions with##2##3##(1993-12#1)(2009-4#1)
skin lesions##95##2##(1990-3#3)(1990-6#1)(1991-4#3)(1991-6#1)(1992-10#2)(1992-2#2)(1992-6#1)(1993-1#1)(1993-12#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-6#1)(1997-5#1)(1997-6#2)(1997-8#1)(2005-11#1)(2006-10#3)(2006-4#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#11)(2008-10#3)(2008-5#1)(2008-9#5)(2009-4#2)(2010-12#2)(2010-6#5)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#6)(2012-2#3)(2012-3#5)(2013-1#2)(2013-8#3)
skin lightening##3##2##(2007-2#1)(2008-5#2)
skin lipids##4##2##(2008-5#4)
skin loss##2##2##(2007-8#1)(2013-8#1)
skin lotion##6##2##(2008-5#6)
skin markers can be##2##4##(2013-1#2)
skin markers for##2##3##(2011-2#1)(2013-1#1)
skin markers##6##2##(2011-2#1)(2013-1#5)
skin may##2##2##(2008-5#1)(2012-2#1)
skin measurements##2##2##(2007-12#2)
skin melanoma and##6##3##(1991-9#1)(1995-5#4)(1997-2#1)
skin melanoma in the##2##4##(1994-12#1)(2009-2#1)
skin melanoma in##4##3##(1994-12#1)(1994-8#1)(2009-2#1)(2011-2#1)
skin melanoma##13##2##(1991-9#1)(1994-12#1)(1994-8#1)(1995-5#5)(1997-2#1)(2009-2#1)(2010-5#1)(2011-2#1)(2013-8#1)
skin metastases##4##2##(1991-6#2)(1996-6#1)(2008-6#1)
skin metastasis##3##2##(1996-6#1)(2010-9#1)(2011-2#1)
skin microflora##4##2##(2008-5#1)(2012-3#3)
skin microrelief##3##2##(2008-5#3)
skin model##16##2##(1992-7#1)(2005-11#1)(2008-5#6)(2008-6#2)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#3)
skin moisture and##2##3##(2008-5#2)
skin moisture##3##2##(2008-5#3)
skin moisturisation##4##2##(2008-5#4)
skin moisturization##3##2##(2008-5#3)
skin moisturizing##2##2##(2008-5#2)
skin necrosis and sloughing##3##4##(1991-8#3)
skin necrosis##16##2##(1990-8#1)(1991-8#3)(1995-4#2)(2007-11#1)(2008-9#1)(2009-1#1)(2010-2#2)(2011-2#3)(2013-1#2)
skin nodules##4##2##(1997-6#2)(2007-12#1)(2007-8#1)
skin of an operator##2##4##(2008-5#2)
skin of both##2##3##(2006-6#1)(2007-7#1)
skin of colour##4##3##(2008-5#4)
skin of female##3##3##(1990-7#1)(1992-2#1)(2010-8#1)
skin of male##2##3##(1995-2#1)(2008-8#1)
skin of the##22##3##(1990-6#1)(1992-11#2)(1992-3#1)(1992-9#1)(1994-4#1)(1994-5#1)(1996-1#1)(2005-7#1)(2006-8#1)(2008-12#1)(2008-5#6)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-7#1)
skin of##82##2##(1990-2#1)(1990-6#1)(1990-7#2)(1992-11#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-8#3)(1992-9#1)(1993-3#1)(1994-11#2)(1994-3#1)(1994-4#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-2#1)(1996-1#1)(2005-10#1)(2005-7#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-7#4)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#18)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2010-5#2)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
skin often##4##2##(2008-5#2)(2012-12#2)
skin on the##2##3##(1995-11#1)(2008-5#1)
skin or muscle##2##3##(1993-11#1)(2008-4#1)
skin or##21##2##(1992-6#1)(1993-11#1)(1995-3#1)(1996-1#2)(2005-11#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#4)(2011-2#2)
skin over time##2##3##(2008-10#1)(2008-5#1)
skin over##3##2##(2008-10#1)(2008-5#2)
skin overlying fat##2##3##(2008-2#1)(2008-3#1)
skin overlying##4##2##(2008-2#1)(2008-3#2)(2010-11#1)
skin pH and skin hydration##2##5##(2008-5#2)
skin pH##5##2##(2008-5#5)
skin paddle##4##2##(2006-3#2)(2008-1#1)(2008-4#1)
skin papules##2##2##(2013-8#2)
skin parameters##5##2##(2008-5#4)(2009-9#1)
skin penetration and##3##3##(2006-10#1)(2008-3#1)(2008-5#1)
skin penetration of the##2##4##(2008-3#1)(2008-5#1)
skin penetration of##3##3##(2008-3#2)(2008-5#1)
skin penetration##11##2##(2006-10#1)(2007-2#1)(2008-3#3)(2008-5#4)(2010-7#1)(2013-1#1)
skin permeation##6##2##(2007-2#1)(2008-5#4)(2010-12#1)
skin phenotype##2##2##(2005-11#1)(2008-5#1)
skin photoprotection##2##2##(2008-5#2)
skin photoreceptors##2##2##(1993-3#2)
skin phototype##3##2##(2008-5#2)(2011-2#1)
skin physiology##10##2##(1997-8#1)(2008-5#8)(2009-8#1)
skin pigmentation were##3##3##(1997-6#2)(2008-9#1)
skin pigmentation##14##2##(1997-3#1)(1997-6#2)(2006-12#1)(2008-5#4)(2008-9#3)(2009-5#2)(2013-7#1)
skin preparation##2##2##(2007-12#1)(2007-7#1)
skin prick test (SPT)##3##4##(2007-2#1)(2008-10#1)(2012-3#1)
skin prick test##6##3##(2007-2#4)(2008-10#1)(2012-3#1)
skin prick testing##5##3##(1996-8#1)(2006-8#1)(2007-2#1)(2012-12#1)(2013-1#1)
skin prick tests##6##3##(1992-9#1)(1993-5#1)(2006-10#1)(2007-9#1)(2008-10#1)(2012-3#1)
skin prick##20##2##(1992-9#1)(1993-5#1)(1996-8#1)(1997-6#1)(2006-10#2)(2006-8#1)(2007-2#6)(2007-9#1)(2008-10#2)(2012-12#1)(2012-3#2)(2013-1#1)
skin problems##6##2##(1994-11#1)(2007-11#2)(2007-7#1)(2008-5#1)(2009-12#1)
skin properties##2##2##(2008-5#2)
skin protection##3##2##(2008-5#2)(2009-6#1)
skin rash and##4##3##(2010-12#1)(2010-4#1)(2012-2#1)(2013-8#1)
skin rash##21##2##(1997-8#1)(2006-10#2)(2006-4#4)(2007-2#1)(2007-8#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
skin rashes##5##2##(1997-1#1)(2006-10#1)(2007-11#1)(2008-3#1)(2010-8#1)
skin reaction to##2##3##(1994-1#1)(2006-8#1)
skin reaction was##2##3##(1992-12#1)(2008-5#1)
skin reaction##9##2##(1992-12#1)(1994-1#1)(2006-8#1)(2008-5#4)(2010-6#1)(2013-1#1)
skin reactions at##2##3##(2006-2#1)(2008-11#1)
skin reactions##13##2##(1992-8#1)(1996-11#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-12#1)
skin reactivity to weeds##2##4##(2007-2#2)
skin reactivity to##4##3##(2007-2#3)(2011-2#1)
skin reactivity##5##2##(1991-5#1)(2007-2#3)(2011-2#1)
skin recurrences##2##2##(1991-12#2)
skin regions##3##2##(2008-5#1)(2009-4#1)(2013-7#1)
skin rejuvenation##2##2##(2006-12#1)(2010-8#1)
skin response to##2##3##(2008-5#2)
skin response##5##2##(2008-5#3)(2012-3#2)
skin resurfacing##4##2##(2007-12#3)(2010-11#1)
skin retraction##2##2##(2006-4#1)(2008-10#1)
skin revealed##2##2##(1996-7#1)(2005-11#1)
skin sample##2##2##(2008-5#1)(2013-7#1)
skin samples were##2##3##(2008-5#2)
skin samples##11##2##(1996-11#1)(1996-7#1)(2007-7#1)(2008-5#3)(2009-4#2)(2011-2#1)(2013-7#2)
skin scaliness##2##2##(2008-5#2)
skin sections##3##2##(2012-12#1)(2012-3#2)
skin segmentation##2##2##(2008-6#2)
skin self-examination##2##2##(2013-1#2)
skin sensitivity##3##2##(2008-5#3)
skin sensitization##8##2##(1997-2#1)(2007-8#2)(2008-10#1)(2008-5#3)(2009-2#1)
skin sensitizing potency of##4##4##(2008-5#4)
skin sensitizing potency##5##3##(2008-5#5)
skin sites##5##2##(2008-5#4)(2010-12#1)
skin smoothness##3##2##(2008-5#3)
skin specimens##3##2##(2007-9#1)(2008-5#1)(2012-1#1)
skin squamous cell carcinomas##2##4##(1994-6#2)
skin stained##2##2##(1995-8#1)(2012-3#1)
skin structure and##4##3##(2008-5#2)(2010-8#1)(2011-2#1)
skin structure##7##2##(2008-3#3)(2008-5#2)(2010-8#1)(2011-2#1)
skin substitutes##10##2##(2005-7#2)(2006-10#1)(2006-9#6)(2012-12#1)
skin surface cellular morphology##2##4##(2008-5#2)
skin surface is##2##3##(2008-5#2)
skin surface lipids##2##3##(2008-5#1)(2010-5#1)
skin surface morphology##2##3##(2008-5#2)
skin surface pH and##2##4##(2008-5#2)
skin surface pH are##3##4##(2008-5#3)
skin surface pH is on average##3##6##(2008-5#3)
skin surface pH##18##3##(2008-5#17)(2013-1#1)
skin surface temperature##2##3##(2007-7#1)(2008-5#1)
skin surface##68##2##(2005-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#58)(2008-9#1)(2010-5#1)(2010-8#1)(2013-1#1)(2013-7#1)
skin swabs##2##2##(1996-12#1)(2006-8#1)
skin symptoms##2##2##(1991-2#1)(1996-1#1)
skin syndrome##3##2##(2005-11#1)(2007-7#2)
skin temperature was##2##3##(2007-4#1)(2008-5#1)
skin temperature##14##2##(1990-6#1)(1997-7#2)(2007-4#3)(2008-3#1)(2008-5#2)(2011-1#5)
skin temperatures##4##2##(1992-3#1)(2007-4#3)
skin test and##4##3##(2005-8#1)(2008-5#1)(2008-7#2)
skin test conversion##3##3##(2007-2#3)
skin test in##3##3##(2007-7#1)(2012-12#1)(2012-3#1)
skin test was positive##2##4##(1997-4#1)(2007-7#1)
skin test was##3##3##(1997-4#1)(2007-7#1)(2013-1#1)
skin test##28##2##(1990-6#1)(1995-12#1)(1997-4#1)(2005-8#3)(2007-10#1)(2007-2#3)(2007-4#1)(2007-7#2)(2008-10#1)(2008-5#1)(2008-7#4)(2010-4#1)(2010-5#1)(2011-1#1)(2011-11#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
skin testing and##2##3##(1990-12#1)(2006-8#1)
skin testing##9##2##(1990-12#1)(1996-3#2)(2005-8#1)(2006-2#1)(2006-8#1)(2007-2#1)(2013-1#2)
skin tests were performed##2##4##(2007-2#1)(2011-1#1)
skin tests##15##2##(1990-3#1)(1991-11#1)(1991-4#1)(1992-5#1)(1994-6#2)(1996-11#1)(2007-2#3)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
skin texture##2##2##(2008-2#1)(2009-6#1)
skin that##8##2##(2007-7#2)(2008-5#2)(2011-2#1)(2012-12#2)(2012-3#1)
skin thickness##6##2##(2007-7#1)(2008-5#5)
skin tissue phantom##2##3##(2008-3#2)
skin tissue##15##2##(1992-9#1)(1995-11#1)(2007-8#1)(2008-3#6)(2008-6#2)(2008-9#1)(2009-11#1)(2011-2#1)(2013-8#1)
skin tissues##3##2##(1992-9#1)(2008-5#2)
skin to UV##2##3##(2008-5#2)
skin to the##3##3##(2007-8#1)(2008-3#1)(2008-5#1)
skin to##17##2##(2006-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#10)(2010-8#1)(2011-2#1)(2012-3#1)
skin tone bias##2##3##(2008-11#2)
skin tone##5##2##(2008-11#5)
skin toxicity##5##2##(2004-1#1)(2008-5#1)(2008-6#2)(2008-8#1)
skin treated with##3##3##(1992-8#1)(2008-5#1)(2012-12#1)
skin treatment##2##2##(2006-12#1)(2008-5#1)
skin tumor promotion in##3##4##(1992-8#2)(1996-11#1)
skin tumor promotion##4##3##(1992-8#2)(1993-8#1)(1996-11#1)
skin tumor##10##2##(1990-6#1)(1992-8#2)(1993-3#1)(1993-8#1)(1993-9#1)(1996-11#1)(2005-11#1)(2007-11#1)(2008-10#1)
skin tumorigenesis##4##2##(1990-6#1)(1992-2#1)(1992-8#1)(1993-12#1)
skin tumors in##2##3##(1990-5#1)(1992-8#1)
skin tumors were##2##3##(1991-6#1)(1992-7#1)
skin tumors##14##2##(1990-5#1)(1991-6#1)(1992-7#6)(1992-8#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-6#1)(2011-2#1)
skin tumour##4##2##(1992-2#1)(2008-5#2)(2013-1#1)
skin tumours##9##2##(1992-2#1)(1997-4#1)(1997-6#1)(2005-11#2)(2006-12#1)(2008-8#1)(2011-2#1)(2012-2#1)
skin type##12##2##(2007-7#1)(2008-4#1)(2008-5#7)(2010-8#2)(2011-2#1)
skin types##16##2##(2007-7#1)(2008-5#12)(2010-12#1)(2010-8#1)(2011-2#1)
skin ulceration and##2##3##(1996-11#1)(2006-9#1)
skin ulceration##4##2##(1996-11#2)(1996-3#1)(2006-9#1)
skin ulcers##5##2##(1992-10#1)(1993-2#1)(2007-8#1)(2011-1#2)
skin under##2##2##(2007-12#1)(2008-5#1)
skin using the##2##3##(2008-5#1)(2009-4#1)
skin using##7##2##(2008-5#4)(2008-6#1)(2009-4#1)(2012-2#1)
skin was analyzed##2##3##(2008-5#1)(2012-3#1)
skin was investigated##2##3##(2008-10#1)(2008-11#1)
skin was observed##2##3##(2008-5#1)(2011-3#1)
skin was##30##2##(1990-9#1)(1994-4#1)(1996-5#2)(2004-12#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#11)(2011-3#2)(2012-1#1)(2012-3#1)(2012-8#1)(2013-1#1)
skin water##2##2##(2008-3#1)(2008-5#1)
skin were investigated##2##3##(1996-5#1)(2008-5#1)
skin were##20##2##(1991-6#1)(1995-10#1)(1996-5#1)(2004-12#1)(2005-11#1)(2006-9#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-5#6)(2008-6#2)
skin when##2##2##(2008-5#1)(2010-3#1)
skin which##5##2##(1990-5#1)(2007-8#1)(2008-5#1)(2008-9#1)(2010-12#1)
skin whitening agents##2##3##(2008-5#2)
skin whitening##6##2##(2008-5#6)
skin with a scar##3##4##(2009-9#3)
skin with a##5##3##(2008-6#1)(2009-9#3)(2012-2#1)
skin with pH values##2##4##(2008-5#2)
skin with##26##2##(1992-2#1)(1992-7#1)(1992-8#2)(2006-12#1)(2006-3#1)(2007-12#1)(2007-7#1)(2008-5#7)(2008-6#1)(2008-9#1)(2009-9#3)(2010-12#1)(2010-3#1)(2012-11#1)(2012-2#2)(2013-8#1)
skin without##2##2##(2005-10#1)(2009-2#1)
skin wound##2##2##(2012-12#1)(2012-3#1)
skin wounds##4##2##(1996-7#1)(2008-4#1)(2012-2#1)(2012-3#1)
skin wrinkling and sagging##2##4##(2008-5#1)(2010-8#1)
skin wrinkling##3##2##(2008-5#2)(2010-8#1)
skin##3144##1##(1990-11#7)(1990-12#4)(1990-2#8)(1990-3#12)(1990-4#6)(1990-5#3)(1990-6#9)(1990-7#5)(1990-8#5)(1990-9#4)(1991-10#4)(1991-11#8)(1991-12#10)(1991-2#5)(1991-3#9)(1991-4#9)(1991-5#8)(1991-6#18)(1991-7#1)(1991-8#9)(1991-9#10)(1992-1#1)(1992-10#8)(1992-11#5)(1992-12#3)(1992-2#17)(1992-3#7)(1992-4#5)(1992-5#3)(1992-6#16)(1992-7#10)(1992-8#23)(1992-9#16)(1993-1#1)(1993-11#3)(1993-12#6)(1993-2#1)(1993-3#10)(1993-5#5)(1993-6#1)(1993-7#2)(1993-8#3)(1993-9#12)(1994-1#1)(1994-10#1)(1994-11#6)(1994-12#2)(1994-2#3)(1994-3#15)(1994-4#10)(1994-5#5)(1994-6#16)(1994-7#3)(1994-8#5)(1994-9#6)(1995-1#5)(1995-10#3)(1995-11#8)(1995-12#9)(1995-2#12)(1995-3#11)(1995-4#7)(1995-5#10)(1995-6#3)(1995-8#5)(1995-9#4)(1996-1#4)(1996-10#2)(1996-11#14)(1996-12#9)(1996-2#1)(1996-3#9)(1996-4#2)(1996-5#5)(1996-6#17)(1996-7#8)(1996-8#3)(1997-1#6)(1997-2#6)(1997-3#11)(1997-4#5)(1997-5#8)(1997-6#13)(1997-7#4)(1997-8#12)(2004-1#1)(2004-11#1)(2004-12#7)(2005-1#1)(2005-10#4)(2005-11#34)(2005-12#1)(2005-5#1)(2005-7#8)(2005-8#6)(2006-10#36)(2006-11#3)(2006-12#57)(2006-2#4)(2006-3#5)(2006-4#15)(2006-5#6)(2006-6#4)(2006-7#6)(2006-8#15)(2006-9#12)(2007-1#1)(2007-10#11)(2007-11#47)(2007-12#58)(2007-2#39)(2007-3#6)(2007-4#12)(2007-5#5)(2007-7#96)(2007-8#62)(2007-9#6)(2008-1#9)(2008-10#61)(2008-11#29)(2008-12#19)(2008-2#13)(2008-3#52)(2008-4#29)(2008-5#899)(2008-6#25)(2008-7#23)(2008-8#30)(2008-9#60)(2009-1#4)(2009-10#3)(2009-11#3)(2009-12#1)(2009-2#6)(2009-3#5)(2009-4#19)(2009-5#13)(2009-6#14)(2009-7#1)(2009-8#6)(2009-9#12)(2010-1#1)(2010-10#1)(2010-11#5)(2010-12#27)(2010-2#4)(2010-3#18)(2010-4#4)(2010-5#18)(2010-6#19)(2010-7#17)(2010-8#34)(2010-9#27)(2011-1#27)(2011-11#2)(2011-12#10)(2011-2#112)(2011-3#10)(2012-1#12)(2012-11#3)(2012-12#48)(2012-2#53)(2012-3#62)(2012-8#1)(2013-1#61)(2013-7#20)(2013-8#41)
skin&quot##4##1##(2005-11#1)(2008-10#1)(2008-5#1)(2010-5#1)
skin's##5##1##(2008-5#4)(2010-9#1)
skin)##11##1##(1990-9#1)(1993-3#1)(2008-5#3)(2008-6#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-1#2)
skin- and##4##2##(2006-12#4)
skin-associated##3##1##(1991-2#1)(2008-10#1)(2012-2#1)
skin-care##2##1##(2008-5#2)
skin-colored##2##1##(2005-11#1)(2007-7#1)
skin-contact thermometer##2##2##(2010-5#2)
skin-derived micro-organ##2##2##(2012-2#2)
skin-derived##6##1##(2008-9#1)(2010-7#2)(2012-12#1)(2012-2#2)
skin-lightening##4##1##(2006-12#1)(2008-5#3)
skin-prick tests##2##2##(2006-10#2)
skin-prick##4##1##(2006-10#2)(2013-1#2)
skin-resident bacteria##2##2##(2008-5#2)
skin-to-skin contact and##3##3##(2008-6#2)(2011-2#1)
skin-to-skin contact for##2##3##(2006-9#1)(2011-2#1)
skin-to-skin contact##16##2##(2006-9#4)(2008-6#3)(2008-9#1)(2010-5#1)(2011-2#7)
skin-to-skin##17##1##(2006-9#4)(2007-2#1)(2008-6#3)(2008-9#1)(2010-5#1)(2011-2#7)
skin-whitening agent##3##2##(2008-5#1)(2012-12#1)(2013-1#1)
skin-whitening cosmetic##4##2##(2008-5#1)(2012-12#3)
skin-whitening##8##1##(2008-5#3)(2012-12#4)(2013-1#1)
skin]##6##1##(2005-11#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
skinfold measurements##5##2##(1997-7#1)(2007-6#3)(2009-11#1)
skinfold thickness##6##2##(2007-9#6)
skinfold##11##1##(1997-7#1)(2007-6#3)(2007-9#6)(2009-11#1)
skinfolds and percent body fat##2##5##(2007-6#2)
skink##2##1##(2013-1#2)
skinks##2##1##(2010-3#2)
skinned fibers##2##2##(1994-12#1)(1995-2#1)
skinned muscle fibres##2##3##(1991-10#2)
skinned muscle##3##2##(1991-10#2)(1994-11#1)
skinned##12##1##(1991-10#2)(1991-12#1)(1993-3#2)(1994-11#1)(1994-12#1)(1995-2#1)(1995-5#2)(1997-2#2)
skinning##4##1##(1997-5#3)(2008-4#1)
skins and##2##2##(1997-4#1)(2010-8#1)
skins of##4##2##(1992-7#1)(2008-10#1)(2008-8#1)(2011-3#1)
skins were##2##2##(1997-4#1)(2011-12#1)
skins##12##1##(1992-7#1)(1997-4#2)(2006-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-3#1)
skip##2##1##(2007-12#1)(2010-8#1)
skipped frame##2##2##(2008-2#2)
skipped##7##1##(1992-1#1)(1993-8#2)(2008-1#1)(2008-2#3)
skipping the##3##2##(1993-6#1)(1993-8#2)
skipping##14##1##(1992-1#2)(1992-5#1)(1993-6#2)(1993-8#4)(1996-7#1)(1997-7#1)(2008-2#1)(2011-2#1)(2013-1#1)
skull and brain##2##3##(2007-4#1)(2008-3#1)
skull and the brain##3##4##(2006-11#2)(2010-5#1)
skull and the##4##3##(2006-11#2)(2007-4#1)(2010-5#1)
skull and##16##2##(1994-3#1)(1995-6#1)(2006-11#2)(2007-1#1)(2007-11#1)(2007-4#2)(2008-3#1)(2009-6#1)(2010-12#3)(2010-5#1)(2012-12#1)(2012-2#1)
skull base and##8##3##(2006-12#4)(2007-1#1)(2007-12#1)(2011-2#1)(2012-2#1)
skull base are##3##3##(2006-12#1)(2008-7#1)(2011-2#1)
skull base chordomas##4##3##(2006-6#4)
skull base defects##5##3##(2005-5#2)(2006-12#3)
skull base fracture##2##3##(2008-9#1)(2011-2#1)
skull base in##3##3##(2008-1#2)(2011-2#1)
skull base lesions##5##3##(2005-5#1)(2006-12#2)(2011-2#1)(2013-1#1)
skull base malignancies##2##3##(2011-2#2)
skull base model##3##3##(2011-2#3)
skull base procedures##4##3##(2005-5#1)(2006-12#3)
skull base surgery with##2##4##(2007-5#1)(2011-2#1)
skull base surgery##16##3##(2006-12#2)(2006-6#1)(2007-5#2)(2009-5#2)(2011-2#8)(2012-3#1)
skull base tumors##9##3##(2005-5#3)(2006-12#2)(2006-6#2)(2011-2#1)(2012-3#1)
skull base##114##2##(1996-12#1)(2005-5#12)(2005-9#2)(2006-12#34)(2006-6#13)(2007-1#1)(2007-12#1)(2007-5#2)(2008-1#4)(2008-7#4)(2008-9#1)(2009-5#2)(2011-1#1)(2011-2#30)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
skull bone##2##2##(2008-8#1)(2013-8#1)
skull fracture##10##2##(1992-6#1)(2006-11#3)(2007-4#1)(2008-11#1)(2008-12#1)(2008-7#1)(2013-1#2)
skull from##2##2##(1990-3#1)(2009-6#1)
skull in##4##2##(1995-6#2)(2011-1#1)(2012-12#1)
skull metastasis from HCC##2##4##(2010-12#2)
skull metastasis from##3##3##(2007-12#1)(2010-12#2)
skull metastasis##4##2##(2007-12#2)(2010-12#2)
skull morphology##2##2##(1995-6#1)(2008-7#1)
skull rotation##3##2##(2007-1#3)
skull thickness##7##2##(2007-11#1)(2007-4#6)
skull vault##4##2##(2006-11#1)(2009-3#1)(2013-8#2)
skull was##3##2##(1995-6#2)(2007-4#1)
skull##264##1##(1990-3#3)(1990-7#1)(1991-11#1)(1991-3#1)(1992-6#2)(1993-10#3)(1993-2#2)(1994-2#1)(1994-3#2)(1995-6#10)(1996-12#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#1)(2005-5#12)(2005-9#2)(2006-11#12)(2006-12#37)(2006-5#1)(2006-6#14)(2006-7#3)(2006-9#1)(2007-1#11)(2007-11#5)(2007-12#5)(2007-4#18)(2007-5#2)(2007-6#2)(2008-1#4)(2008-11#3)(2008-12#1)(2008-3#3)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#2)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#3)(2010-12#6)(2010-3#1)(2010-5#1)(2011-1#5)(2011-2#34)(2012-1#1)(2012-12#7)(2012-2#4)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#3)
skull-base surgery##6##2##(2008-9#1)(2009-2#2)(2012-1#3)
skull-base##8##1##(2008-9#1)(2009-2#2)(2011-2#1)(2012-1#4)
skull-image superimposition##2##2##(1995-6#2)
skulls were##2##2##(2007-4#1)(2013-1#1)
skulls##12##1##(1995-6#1)(1995-9#1)(2006-12#1)(2007-12#1)(2007-4#3)(2008-4#1)(2011-2#1)(2013-1#3)
sky and##2##2##(2007-9#1)(2008-3#1)
sky at##3##2##(2007-12#1)(2007-8#2)
sky conditions##2##2##(2007-12#1)(2008-3#1)
sky optical phenomena##3##3##(2008-2#3)
sky radiance over##2##3##(2008-2#2)
sky radiance##11##2##(2008-2#6)(2008-3#5)
sky##59##1##(1993-3#1)(1994-10#1)(2006-10#1)(2007-12#5)(2007-7#1)(2007-8#3)(2007-9#2)(2008-2#27)(2008-3#17)(2012-2#1)
skylight in##2##2##(2008-3#2)
skylight polarization is##2##3##(2008-2#2)
skylight polarization##7##2##(2008-2#7)
skylight##21##1##(2007-12#1)(2008-2#12)(2008-3#8)
skyrocketing##3##1##(1996-12#1)(2009-7#1)(2010-7#1)
sl##2##1##(1994-12#1)(2008-5#1)
slab PC##2##2##(2007-11#2)
slab Ti##2##2##(2008-3#2)
slab and##5##2##(2008-2#2)(2008-3#2)(2013-8#1)
slab at the##2##3##(2007-12#1)(2013-8#1)
slab gel##4##2##(2008-2#2)(2008-4#2)
slab is##9##2##(1995-6#2)(2007-12#1)(2008-3#6)
slab laser with a##2##4##(2007-12#1)(2008-3#1)
slab laser##5##2##(2007-11#1)(2007-12#1)(2008-3#3)
slab lasers##3##2##(2007-11#2)(2008-2#1)
slab of a##2##3##(2008-2#1)(2008-3#1)
slab of##3##2##(2008-2#1)(2008-3#1)(2009-5#1)
slab optical waveguide (SOWG)##3##4##(2008-10#3)
slab optical waveguide spectroscopy##2##4##(2008-10#2)
slab optical waveguide##6##3##(2008-10#6)
slab structure##2##2##(2007-11#1)(2008-2#1)
slab waveguide##11##2##(2007-11#3)(2007-12#5)(2008-2#3)
slab waveguides are##2##3##(2007-11#2)
slab waveguides##11##2##(2007-11#2)(2007-12#6)(2008-2#2)(2008-3#1)
slab with##4##2##(2008-3#4)
slab##112##1##(1992-3#1)(1995-6#4)(2005-11#1)(2006-2#1)(2007-11#17)(2007-12#20)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#18)(2008-3#34)(2008-4#3)(2009-5#1)(2009-9#1)(2013-8#3)
slab)##2##1##(2007-11#1)(2008-2#1)
slabs of##4##2##(1997-7#1)(2008-2#1)(2008-3#1)(2013-8#1)
slabs with##2##2##(1996-2#1)(2008-3#1)
slabs##25##1##(1993-4#1)(1996-2#1)(1997-7#1)(2007-11#3)(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#5)(2008-3#4)(2008-7#2)(2013-8#4)
slack##5##1##(1996-9#2)(2006-8#1)(2008-11#2)
slag filters##3##2##(2013-1#3)
slag samples##3##2##(2008-10#3)
slag##17##1##(2005-11#2)(2008-10#11)(2013-1#4)
slags##2##1##(2008-10#1)(2013-1#1)
slalom chromatography##4##2##(2008-10#4)
slant angle to##2##3##(2007-11#1)(2008-2#1)
slant angle##3##2##(2007-11#1)(2008-2#2)
slant of##2##2##(1996-3#1)(2004-3#1)
slant##10##1##(1993-6#1)(1996-3#1)(2004-3#1)(2005-8#1)(2007-11#1)(2008-2#5)
slanted volume holographic gratings##2##4##(2008-3#2)
slanted##7##1##(2007-11#1)(2007-12#2)(2008-3#3)(2011-1#1)
slanted-fringe volume grating##2##3##(2007-12#1)(2008-2#1)
slanted-fringe volume##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
slants##2##1##(2007-7#1)(2007-8#1)
slash and burn##2##3##(2010-7#2)
slash and loblolly pine##2##4##(2008-10#2)
slash and loblolly##3##3##(2008-10#3)
slash and##5##2##(2008-10#3)(2010-7#2)
slash##12##1##(1994-10#1)(1995-10#1)(2004-9#1)(2005-9#1)(2008-10#6)(2010-7#2)
slashing##3##1##(1992-2#1)(1995-10#1)(2007-8#1)
slate##3##1##(2007-7#1)(2010-6#1)(2011-2#1)
slaughter age##3##2##(2010-4#3)
slaughter and##2##2##(1990-3#1)(2007-6#1)
slaughter at##2##2##(2008-3#1)(2010-4#1)
slaughter line##3##2##(1997-4#1)(1997-5#1)(2010-4#1)
slaughter weight and breed##2##4##(2010-4#2)
slaughter weight##5##2##(2010-4#5)
slaughter##51##1##(1990-3#3)(1993-2#2)(1994-7#2)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#2)(2005-5#1)(2005-7#4)(2006-5#1)(2007-6#1)(2008-12#1)(2008-3#2)(2008-5#1)(2010-4#21)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#4)
slaughtered at 14months of age##2##5##(2010-4#2)
slaughtered at##13##2##(1994-7#1)(1996-12#1)(2010-4#8)(2011-1#1)(2012-2#1)(2013-1#1)
slaughtered for the##2##3##(2007-2#1)(2011-1#1)
slaughtered in##3##2##(1994-7#1)(2011-2#1)(2013-8#1)
slaughtered pigs in##2##3##(2011-2#2)
slaughtered pigs##4##2##(1991-8#1)(2010-4#1)(2011-2#2)
slaughtered when##2##2##(2010-4#2)
slaughtered##40##1##(1991-8#1)(1994-7#2)(1996-12#2)(1996-3#1)(1997-5#1)(2006-5#2)(2006-8#1)(2007-2#1)(2008-12#3)(2008-9#1)(2010-2#1)(2010-4#13)(2011-1#4)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#2)
slaughterhouse wastewater##4##2##(2007-6#4)
slaughterhouse##13##1##(1994-7#1)(2007-6#4)(2008-12#2)(2010-4#4)(2013-1#2)
slaughterhouses##3##1##(2008-12#1)(2009-3#1)(2010-4#1)
slaughtering##4##1##(1990-9#1)(1994-5#1)(1997-4#1)(2010-4#1)
slave laser##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
slave lasers##2##2##(2007-12#1)(2008-3#1)
slave model of autobiographical memory##2##5##(2008-2#2)
slave trade##2##2##(2008-10#1)(2008-8#1)
slave##20##1##(1991-3#1)(1992-1#1)(2006-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-7#3)(2008-8#3)
slavery##4##1##(2008-7#3)(2008-8#1)
slaves##5##1##(2008-8#2)(2009-4#3)
sled environment##2##2##(2006-11#1)(2007-4#1)
sled impact##2##2##(2007-1#2)
sled test##4##2##(2006-11#2)(2007-1#2)
sled tests were conducted##2##4##(2006-11#2)
sled tests were performed##2##4##(2006-11#1)(2007-4#1)
sled tests were##5##3##(2006-11#4)(2007-4#1)
sled tests##18##2##(2006-11#12)(2007-4#6)
sled##35##1##(2006-11#20)(2007-1#4)(2007-4#11)
sledge##2##1##(2008-4#1)(2008-5#1)
sleep (NREMS)##2##2##(1991-9#1)(1995-6#1)
sleep (SWS)##2##2##(1990-7#1)(1996-1#1)
sleep EEG##11##2##(1994-11#2)(2004-11#1)(2009-8#3)(2010-8#5)
sleep abnormalities##3##2##(1996-3#1)(1997-6#1)(2006-7#1)
sleep after##3##2##(1995-12#1)(1996-1#1)(2012-12#1)
sleep and arousal##2##3##(1990-7#1)(1994-3#1)
sleep and health##2##3##(2011-2#1)(2012-1#1)
sleep and its##5##3##(1996-1#1)(2008-12#1)(2008-7#1)(2009-8#1)(2010-3#1)
sleep and mood##3##3##(1996-7#2)(2007-6#1)
sleep and obesity##2##3##(2013-1#2)
sleep and sleep##4##3##(1994-8#1)(2007-8#1)(2008-12#1)(2008-6#1)
sleep and the##2##3##(1993-2#1)(2007-8#1)
sleep and wake##2##3##(1993-11#1)(1994-2#1)
sleep and wakefulness##2##3##(1992-1#1)(1993-11#1)
sleep and waking##2##3##(1990-11#1)(1991-5#1)
sleep and##72##2##(1990-11#1)(1990-3#1)(1990-7#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-8#1)(1993-11#4)(1993-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-6#1)(1996-1#5)(1996-3#1)(1996-6#2)(1996-7#2)(1996-9#1)(2006-1#2)(2006-10#2)(2007-1#1)(2007-6#2)(2007-8#2)(2008-11#3)(2008-12#3)(2008-2#1)(2008-6#1)(2008-7#2)(2009-11#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#2)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#4)(2013-7#1)
sleep apnea (OSA) and##2##4##(2009-9#1)(2010-5#1)
sleep apnea (OSA)##8##3##(2006-10#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-5#1)(2011-1#2)(2012-2#1)
sleep apnea and##7##3##(2006-10#3)(2007-6#1)(2010-5#1)(2010-9#2)
sleep apnea syndrome##11##3##(2005-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-6#1)(2010-5#3)(2013-1#1)(2013-8#1)
sleep apnea##63##2##(1992-5#1)(1993-5#1)(2005-10#1)(2006-10#9)(2006-12#1)(2007-11#1)(2007-12#11)(2007-2#2)(2007-3#1)(2007-6#6)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-9#2)(2010-5#5)(2010-9#2)(2011-1#3)(2012-1#1)(2012-2#4)(2013-1#3)(2013-7#4)(2013-8#1)
sleep apnoe##2##2##(1993-5#1)(1997-4#1)
sleep apnoea syndrome##4##3##(2007-1#1)(2010-6#2)(2012-2#1)
sleep apnoea##13##2##(1992-11#1)(1997-8#1)(2005-11#1)(2007-1#3)(2008-7#1)(2008-9#1)(2009-10#1)(2010-6#2)(2012-2#1)(2013-1#1)
sleep architecture##3##2##(1996-1#2)(2007-6#1)
sleep are##3##2##(1994-4#1)(2007-6#1)(2009-8#1)
sleep as##2##2##(2004-11#1)(2006-10#1)
sleep at##3##2##(1990-5#1)(2007-6#1)(2010-7#1)
sleep behavior##3##2##(2007-6#1)(2008-11#1)(2013-8#1)
sleep breathing##2##2##(2011-1#1)(2011-2#1)
sleep by##2##2##(1992-1#1)(1994-8#1)
sleep compared to##2##3##(1994-12#1)(1994-4#1)
sleep complaints##4##2##(2007-6#3)(2012-12#1)
sleep continuity##2##2##(1994-8#1)(1996-1#1)
sleep cycle##3##2##(1991-1#1)(2004-11#2)
sleep data##2##2##(1996-1#1)(2006-7#1)
sleep deficits##3##2##(1992-1#2)(1996-3#1)
sleep deprivation in##2##3##(1991-10#1)(1996-9#1)
sleep deprivation##25##2##(1991-10#3)(1991-6#3)(1995-12#1)(1996-1#5)(1996-9#3)(1997-6#1)(2006-10#1)(2007-2#1)(2008-4#1)(2011-12#1)(2011-2#4)(2013-1#1)
sleep diaries##2##2##(2012-12#2)
sleep diary##4##2##(2008-10#1)(2012-11#1)(2012-12#1)(2013-1#1)
sleep difficulty##2##2##(2006-10#2)
sleep disordered breathing##7##3##(2005-11#1)(2006-10#2)(2007-12#1)(2007-6#1)(2008-9#1)(2010-2#1)
sleep disorders and increased body weight##2##6##(2013-1#2)
sleep disorders and##3##3##(2008-8#1)(2013-1#2)
sleep disorders are##5##3##(2007-10#1)(2007-2#1)(2007-6#1)(2008-8#1)(2013-7#1)
sleep disorders in##2##3##(2008-11#1)(2013-8#1)
sleep disorders such as##2##4##(2013-7#2)
sleep disorders##27##2##(1993-2#1)(1993-5#1)(1997-6#1)(2005-7#1)(2007-10#1)(2007-2#2)(2007-6#4)(2007-8#1)(2008-11#2)(2008-8#4)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#3)(2013-8#1)
sleep disorders]##2##2##(1997-6#2)
sleep disruption##5##2##(2007-6#2)(2009-2#1)(2012-12#1)(2013-1#1)
sleep disturbance is##2##3##(2008-3#1)(2010-12#1)
sleep disturbance##13##2##(1990-6#1)(1993-5#1)(2004-3#1)(2006-8#1)(2008-3#1)(2009-7#2)(2010-12#3)(2011-1#1)(2011-2#2)
sleep disturbances have##2##3##(2006-10#1)(2008-7#1)
sleep disturbances in##7##3##(2006-10#3)(2006-7#1)(2008-7#1)(2009-9#1)(2011-2#1)
sleep disturbances##25##2##(2004-7#1)(2006-10#10)(2006-7#1)(2008-11#1)(2008-7#3)(2009-3#1)(2009-7#1)(2009-9#1)(2011-2#2)(2012-1#1)(2012-3#2)(2013-8#1)
sleep does##2##2##(1997-7#1)(2011-2#1)
sleep duration and##3##3##(1996-7#2)(2009-7#1)
sleep duration was##2##3##(1996-7#1)(2011-2#1)
sleep duration##14##2##(1995-12#4)(1996-7#3)(2009-7#1)(2011-2#5)(2012-12#1)
sleep during##5##2##(1991-1#1)(2007-2#1)(2008-5#1)(2008-9#1)(2012-1#1)
sleep effect##2##2##(1991-1#1)(2007-6#1)
sleep efficiency##4##2##(2007-6#1)(2011-2#1)(2012-3#2)
sleep electroencephalogram (EEG)##2##3##(1997-3#1)(2009-8#1)
sleep electroencephalogram##4##2##(1997-3#1)(2004-11#2)(2009-8#1)
sleep episodes##2##2##(1993-2#1)(1996-1#1)
sleep fragmentation##3##2##(1994-2#1)(2010-5#1)(2012-3#1)
sleep gradually##2##2##(1992-3#2)
sleep habits##4##2##(2007-2#3)(2013-1#1)
sleep hours and##2##3##(2006-10#1)(2010-8#1)
sleep in a##2##3##(2012-12#1)(2013-1#1)
sleep in schizophrenia##2##3##(1996-1#1)(1996-3#1)
sleep in the mood disorders##2##5##(2010-12#2)
sleep in the##8##3##(1992-8#1)(1994-4#1)(1994-8#1)(2007-6#1)(2008-11#1)(2010-12#2)(2011-1#1)
sleep in##21##2##(1992-1#1)(1992-8#1)(1993-12#1)(1994-4#1)(1994-8#1)(1996-1#2)(1996-3#1)(1997-3#1)(1997-7#1)(2007-1#1)(2007-11#1)(2007-6#1)(2008-11#1)(2010-12#3)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
sleep increased##2##2##(1992-3#1)(2008-7#1)
sleep inertia##4##2##(2013-7#4)
sleep is##4##2##(2007-1#1)(2007-6#1)(2008-12#1)(2008-8#1)
sleep latency##11##2##(2004-11#2)(2004-3#2)(2007-6#2)(2008-4#2)(2011-2#1)(2012-12#2)
sleep loss##12##2##(1995-12#2)(2008-12#3)(2008-6#2)(2013-1#5)
sleep may##2##2##(1995-6#1)(1997-3#1)
sleep medicine##5##2##(2007-6#2)(2008-9#2)(2011-1#1)
sleep onset time##2##3##(1990-5#2)
sleep onset##6##2##(1990-5#3)(1990-7#1)(1996-7#1)(2010-7#1)
sleep or##4##2##(2007-2#1)(2009-2#1)(2010-7#1)(2012-12#1)
sleep paralysis##2##2##(2007-2#1)(2013-7#1)
sleep parameters##3##2##(1996-7#1)(2012-12#2)
sleep pattern##3##2##(2006-10#1)(2008-12#1)(2008-7#1)
sleep patterns and##2##3##(2006-10#1)(2008-7#1)
sleep patterns##8##2##(1991-1#1)(1997-5#2)(2005-9#1)(2006-10#1)(2008-7#1)(2009-8#1)(2012-12#1)
sleep position##3##2##(2008-9#1)(2011-1#2)
sleep problems##10##2##(1993-5#1)(1997-3#1)(2007-2#2)(2008-11#1)(2008-9#1)(2013-1#3)(2013-7#1)
sleep quality in##2##3##(2012-12#1)(2013-7#1)
sleep quality##7##2##(2009-11#1)(2009-3#3)(2012-12#2)(2013-7#1)
sleep related##2##2##(1997-4#1)(2007-12#1)
sleep resulted from##2##3##(2007-1#2)
sleep spindles and##2##3##(2009-8#2)
sleep spindles##3##2##(2009-8#3)
sleep stage##4##2##(2004-11#1)(2009-8#2)(2010-8#1)
sleep stages##9##2##(1990-11#1)(1997-4#1)(2006-10#1)(2010-8#6)
sleep states##4##2##(1994-4#1)(2006-10#1)(2009-8#2)
sleep studies##4##2##(2006-10#3)(2007-12#1)
sleep study##3##2##(2006-10#2)(2007-12#1)
sleep time and##2##3##(1994-8#1)(2012-12#1)
sleep time##9##2##(1992-1#2)(1992-8#1)(1994-8#1)(2008-12#1)(2010-7#1)(2012-12#3)
sleep troubles##4##2##(2013-1#4)
sleep using##2##2##(2007-1#1)(2012-12#1)
sleep was##4##2##(1992-3#1)(1996-7#1)(2012-12#2)
sleep were analyzed##2##3##(1995-6#1)(2007-4#1)
sleep were##5##2##(1992-10#1)(1995-6#1)(1996-1#1)(2007-4#1)(2011-10#1)
sleep without##2##2##(1992-1#1)(2004-3#1)
sleep##756##1##(1990-11#4)(1990-3#1)(1990-5#6)(1990-6#1)(1990-7#9)(1991-1#4)(1991-10#3)(1991-5#4)(1991-6#4)(1991-8#1)(1991-9#4)(1992-1#25)(1992-10#4)(1992-11#2)(1992-3#6)(1992-5#1)(1992-8#4)(1993-1#1)(1993-10#1)(1993-11#4)(1993-12#3)(1993-2#5)(1993-3#1)(1993-5#5)(1994-11#2)(1994-12#4)(1994-2#3)(1994-3#1)(1994-4#6)(1994-8#10)(1995-12#10)(1995-6#5)(1996-1#33)(1996-3#5)(1996-6#6)(1996-7#11)(1996-8#3)(1996-9#5)(1997-2#1)(1997-3#7)(1997-4#10)(1997-5#2)(1997-6#6)(1997-7#5)(1997-8#1)(2004-11#13)(2004-3#4)(2004-7#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-9#2)(2006-1#2)(2006-10#46)(2006-11#1)(2006-12#1)(2006-7#3)(2006-8#2)(2007-1#16)(2007-10#1)(2007-11#2)(2007-12#16)(2007-2#14)(2007-3#1)(2007-4#1)(2007-6#40)(2007-8#4)(2007-9#3)(2008-10#3)(2008-11#13)(2008-12#12)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#3)(2008-6#4)(2008-7#14)(2008-8#10)(2008-9#13)(2009-10#2)(2009-11#2)(2009-2#2)(2009-3#5)(2009-4#1)(2009-5#1)(2009-7#5)(2009-8#17)(2009-9#4)(2010-12#8)(2010-2#1)(2010-3#2)(2010-5#7)(2010-6#5)(2010-7#8)(2010-8#15)(2010-9#2)(2011-1#13)(2011-10#1)(2011-12#1)(2011-2#23)(2012-1#6)(2012-11#1)(2012-12#38)(2012-2#15)(2012-3#10)(2013-1#37)(2013-7#16)(2013-8#10)
sleep)##2##1##(1996-3#1)(2012-12#1)
sleep-deprived##5##1##(1996-9#5)
sleep-disordered breathing and##2##3##(2007-1#1)(2007-6#1)
sleep-disordered breathing##3##2##(2007-1#1)(2007-12#1)(2007-6#1)
sleep-inducing peptide (DSIP) and##2##4##(1990-2#2)
sleep-inducing peptide (DSIP)##3##3##(1990-2#2)(1990-5#1)
sleep-inducing##4##1##(1990-2#2)(1990-5#2)
sleep-related breathing##5##2##(2006-10#2)(2007-12#3)
sleep-related neurogenic tachypnea##2##3##(2007-6#2)
sleep-related##12##1##(1993-10#1)(2006-10#2)(2007-1#1)(2007-12#3)(2007-6#2)(2010-3#1)(2012-1#1)(2012-12#1)
sleep-wake cycle of##2##3##(1994-2#1)(2006-7#1)
sleep-wake cycle##6##2##(1994-2#3)(2006-7#2)(2007-1#1)
sleep-wake cycles##2##2##(1996-1#1)(2006-7#1)
sleep-wake regulation##3##2##(1994-12#1)(2007-1#1)(2009-2#1)
sleep-wake rhythm in the rat##2##5##(1992-3#2)
sleep-wake##17##1##(1991-1#1)(1992-3#2)(1994-12#1)(1994-2#4)(1996-1#1)(2006-1#1)(2006-7#3)(2007-1#2)(2009-2#1)(2012-1#1)
sleep-wakefulness##2##1##(1995-6#1)(2006-10#1)
sleep/wake##2##1##(1997-6#1)(2008-6#1)
sleepers##5##1##(2007-2#1)(2012-1#1)(2012-11#1)(2012-12#2)
sleepiness and##5##2##(1991-5#1)(2006-11#1)(2010-7#3)
sleepiness##23##1##(1991-5#1)(2004-11#1)(2006-11#1)(2007-1#1)(2007-2#2)(2008-7#1)(2008-8#3)(2010-7#7)(2011-2#1)(2012-12#5)
sleeping and##4##2##(1994-2#1)(2007-11#1)(2012-2#2)
sleeping in##2##2##(1992-4#1)(2008-4#1)
sleeping on##2##2##(2011-1#1)(2011-2#1)
sleeping pills##2##2##(1993-10#1)(2005-11#1)
sleeping position##13##2##(1991-2#1)(1992-11#4)(1992-4#4)(2007-1#3)(2008-1#1)
sleeping positions and other possible risk factors##2##7##(1992-11#2)
sleeping positions at the age of one##2##7##(1992-11#2)
sleeping positions##9##2##(1992-11#9)
sleeping problems##2##2##(2011-2#1)(2012-2#1)
sleeping prone##2##2##(1992-4#1)(2011-1#1)
sleeping sickness and##2##3##(2008-3#1)(2010-1#1)
sleeping sickness##22##2##(1994-2#2)(1994-6#1)(2006-10#1)(2007-6#1)(2008-2#10)(2008-3#2)(2008-5#1)(2010-1#4)
sleeping time in##2##3##(1996-4#1)(2008-12#1)
sleeping time was examined in##2##5##(1993-7#1)(1996-4#1)
sleeping time##13##2##(1990-10#1)(1993-7#2)(1995-12#2)(1996-4#5)(2008-12#1)(2008-4#2)
sleeping under##2##2##(2007-2#1)(2008-4#1)
sleeping with##2##2##(2007-4#1)(2007-6#1)
sleeping##94##1##(1990-10#1)(1990-2#1)(1991-2#1)(1991-5#1)(1992-11#13)(1992-4#7)(1993-10#1)(1993-5#2)(1993-7#2)(1994-12#1)(1994-2#3)(1994-6#1)(1995-12#2)(1996-4#6)(1996-8#2)(2004-4#1)(2005-11#1)(2005-6#1)(2006-10#1)(2007-1#3)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#2)(2008-1#2)(2008-11#1)(2008-12#2)(2008-2#10)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#1)(2009-4#1)(2009-9#1)(2010-1#4)(2010-6#1)(2011-1#2)(2011-2#2)(2012-2#3)
sleepy driving##4##2##(2012-12#4)
sleepy##6##1##(2007-3#1)(2012-12#5)
sleeve gastrectomy (LSG)##3##3##(2013-1#3)
sleeve gastrectomy##5##2##(2013-1#5)
sleeve of##2##2##(2006-12#1)(2008-11#1)
sleeve pneumonectomy##3##2##(2007-8#3)
sleeve resection##5##2##(2007-8#1)(2008-5#1)(2009-2#1)(2012-12#2)
sleeve resections##2##2##(2007-8#2)
sleeve##35##1##(1991-12#2)(2006-11#1)(2006-12#9)(2007-12#1)(2007-8#7)(2008-11#2)(2008-5#2)(2009-2#2)(2010-4#1)(2012-1#1)(2012-12#2)(2013-1#5)
sleeve&quot##3##1##(2007-10#1)(2007-7#2)
slender##9##1##(1996-8#1)(2006-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-8#1)(2011-1#1)(2013-7#1)
slender&quot##2##1##(2007-12#1)(2009-8#1)
slept in##2##2##(1990-2#2)
slept##6##1##(1990-2#2)(1997-4#1)(2006-8#1)(2007-9#1)(2012-1#1)
slice culture##5##2##(1995-9#1)(2007-3#3)(2008-11#1)
slice cultures from##3##3##(2008-11#3)
slice cultures##11##2##(1995-9#1)(1996-1#1)(1996-6#2)(2006-11#2)(2008-11#5)
slice from##2##2##(1995-11#1)(2005-10#1)
slice in##3##2##(1994-10#1)(1996-2#1)(2005-10#1)
slice of##5##2##(1991-2#1)(1996-7#1)(2007-12#1)(2008-10#1)(2009-4#1)
slice preparation of the retina##2##5##(2008-8#2)
slice preparation##18##2##(1991-8#2)(1992-1#2)(1994-2#2)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-11#1)(2008-4#3)(2008-7#1)(2008-8#2)
slice preparations##7##2##(1992-8#1)(1995-3#1)(2008-11#2)(2008-4#2)(2008-7#1)
slice shear##2##2##(2010-4#2)
slice thickness##3##2##(1995-5#1)(1997-8#1)(2012-12#1)
slice was##4##2##(1996-1#1)(2008-6#1)(2008-8#1)(2013-1#1)
slice##123##1##(1990-2#2)(1990-4#1)(1991-2#1)(1991-8#2)(1991-9#2)(1992-1#2)(1992-8#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#6)(1994-3#2)(1994-8#1)(1995-11#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#5)(1996-1#4)(1996-2#5)(1996-3#1)(1996-6#3)(1996-7#1)(1997-1#1)(1997-2#1)(1997-8#3)(2005-10#8)(2006-11#2)(2006-4#2)(2007-11#1)(2007-12#2)(2007-3#3)(2007-8#1)(2008-10#1)(2008-11#20)(2008-2#1)(2008-3#1)(2008-4#8)(2008-6#2)(2008-7#5)(2008-8#4)(2009-4#1)(2010-4#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
sliced and##2##2##(2008-11#1)(2008-3#1)
sliced dry fermented sausage##2##4##(2013-1#2)
sliced dry fermented##3##3##(2013-1#3)
sliced inverse regression##3##3##(2012-3#3)
sliced##17##1##(1991-1#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#3)(2010-1#1)(2010-4#2)(2012-3#3)(2013-1#3)(2013-8#1)
slicer##2##1##(1993-3#1)(2008-8#1)
slices after##3##2##(1990-7#1)(1995-11#1)(2008-2#1)
slices and the##2##3##(1992-3#1)(1995-5#1)
slices and##13##2##(1990-3#1)(1990-7#2)(1992-3#1)(1993-9#1)(1994-6#1)(1995-5#1)(2006-4#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)
slices are##4##2##(1994-11#1)(2008-11#1)(2008-7#1)(2013-8#1)
slices as##2##2##(1994-11#1)(2008-7#1)
slices but##2##2##(1996-4#1)(1997-4#1)
slices by##4##2##(1991-11#1)(1993-6#1)(1994-5#1)(1996-1#1)
slices containing the##2##3##(1996-1#1)(2008-7#1)
slices containing##3##2##(1995-12#1)(1996-1#1)(2008-7#1)
slices during##4##2##(1993-12#1)(1993-4#1)(1994-12#1)(1996-5#1)
slices evoked##2##2##(1994-2#1)(1996-11#1)
slices exposed to strongly hyperosmotic media##2##6##(1992-5#2)
slices exposed to##4##3##(1992-5#2)(1993-4#1)(1995-11#1)
slices from the##3##3##(1995-12#2)(2008-3#1)
slices from##17##2##(1995-11#2)(1995-12#4)(1995-2#1)(1996-1#1)(1996-5#1)(1997-5#1)(1997-7#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-3#1)(2013-8#1)
slices in a##2##3##(1991-12#1)(1994-8#1)
slices in vitro##3##3##(1990-7#1)(1993-12#1)(1994-12#1)
slices in##8##2##(1990-7#1)(1991-12#1)(1993-12#2)(1994-12#1)(1994-8#1)(1997-8#1)(2010-8#1)
slices incubated with##2##3##(1992-5#1)(1996-6#1)
slices incubated##5##2##(1991-10#1)(1992-5#1)(1995-11#1)(1996-6#1)(2008-6#1)
slices obtained from phenobarbitone-induced##2##4##(1996-4#2)
slices obtained from##7##3##(1992-7#1)(1995-12#2)(1996-4#4)
slices obtained##8##2##(1992-7#1)(1994-11#1)(1995-12#2)(1996-4#4)
slices of rat hippocampus##2##4##(1990-7#1)(1991-6#1)
slices of rat##5##3##(1990-7#2)(1991-6#1)(1994-12#1)(1996-7#1)
slices of the##5##3##(1992-9#2)(1995-12#1)(1996-6#1)(1996-7#1)
slices of##27##2##(1990-10#1)(1990-7#2)(1991-6#2)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-2#1)(1994-12#1)(1995-12#5)(1996-5#2)(1996-6#1)(1996-7#2)(2007-3#1)(2008-2#1)(2008-3#1)(2008-4#1)(2013-8#1)
slices prepared from PND##2##4##(1996-5#2)
slices prepared from the##2##4##(1996-9#1)(1997-2#1)
slices prepared from##5##3##(1996-5#3)(1996-9#1)(1997-2#1)
slices showed##2##2##(1993-3#1)(2011-3#1)
slices that##3##2##(1990-4#2)(1996-7#1)
slices to##9##2##(1992-1#1)(1992-8#1)(1993-4#1)(1994-6#1)(1996-3#1)(1996-9#1)(1997-2#1)(2008-7#1)(2011-3#1)
slices was investigated##2##3##(1992-3#1)(1996-5#1)
slices was##11##2##(1990-5#1)(1991-9#1)(1992-3#1)(1992-9#1)(1994-5#1)(1995-12#2)(1996-1#1)(1996-5#1)(1997-1#1)(1997-2#1)
slices were exposed to##3##4##(1992-9#1)(1993-4#1)(1996-9#1)
slices were##15##2##(1991-9#1)(1992-9#1)(1993-3#2)(1993-4#1)(1994-2#1)(1995-3#1)(1996-1#1)(1996-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-12#1)(2012-3#1)
slices with##13##2##(1990-10#1)(1990-7#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-8#2)(1994-3#1)(1996-1#1)(1996-4#1)(1996-7#1)(1997-2#1)(2008-7#1)
slices without##2##2##(2007-12#1)(2008-10#1)
slices##323##1##(1990-10#3)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#1)(1990-7#14)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-9#4)(1992-1#3)(1992-12#1)(1992-3#5)(1992-5#3)(1992-7#7)(1992-8#7)(1992-9#8)(1993-12#4)(1993-2#2)(1993-3#4)(1993-4#5)(1993-5#1)(1993-6#1)(1993-9#2)(1994-11#3)(1994-12#4)(1994-2#9)(1994-3#6)(1994-5#3)(1994-6#3)(1994-8#4)(1995-11#5)(1995-12#24)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#1)(1995-7#1)(1996-1#11)(1996-11#2)(1996-2#1)(1996-3#3)(1996-4#8)(1996-5#15)(1996-6#4)(1996-7#4)(1996-8#2)(1996-9#6)(1997-1#3)(1997-2#8)(1997-3#1)(1997-4#3)(1997-5#10)(1997-7#1)(1997-8#5)(2004-11#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-3#2)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#5)(2008-12#1)(2008-2#8)(2008-3#2)(2008-4#10)(2008-5#2)(2008-6#1)(2008-7#9)(2008-8#2)(2009-12#2)(2009-9#2)(2010-3#1)(2010-8#1)(2011-1#2)(2011-3#2)(2011-7#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
slicing of a##2##3##(2007-12#1)(2012-2#1)
slicing##11##1##(1993-11#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#2)(2008-8#1)(2012-2#2)
slide agglutination##3##2##(2006-10#2)(2008-5#1)
slide along the##3##3##(1993-3#1)(2009-11#1)(2009-4#1)
slide along##4##2##(1993-3#1)(2007-8#1)(2009-11#1)(2009-4#1)
slide and##5##2##(2006-5#1)(2007-7#1)(2008-11#1)(2008-9#2)
slide by##2##2##(2006-10#1)(2007-12#1)
slide culture##2##2##(2007-7#1)(2009-8#1)
slide glass##3##2##(1991-5#2)(2007-11#1)
slide glasses##2##2##(1991-5#1)(2008-12#1)
slide sets##2##2##(2011-2#2)
slide was##3##2##(2005-8#1)(2008-10#2)
slide##64##1##(1990-12#1)(1991-5#3)(1993-3#1)(1993-8#1)(1994-3#1)(1994-4#1)(1996-6#2)(2005-10#2)(2005-11#1)(2005-8#1)(2006-10#5)(2006-11#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#4)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
slide-mounted##3##1##(1993-9#1)(2008-2#1)(2008-4#1)
slider##14##1##(2007-1#1)(2007-12#2)(2007-3#1)(2007-7#2)(2008-2#3)(2008-3#4)(2009-3#1)
sliders##4##1##(2008-2#4)
slides and##4##2##(1990-12#1)(2005-10#1)(2006-12#1)(2006-5#1)
slides are##4##2##(2008-1#1)(2008-11#3)
slides by##2##2##(2008-10#1)(2008-4#1)
slides for##3##2##(2005-12#1)(2008-4#1)(2008-9#1)
slides from##4##2##(2005-12#1)(2006-2#1)(2006-7#1)(2008-9#1)
slides in##2##2##(2007-9#1)(2008-5#1)
slides is##2##2##(2008-10#1)(2008-2#1)
slides of made up##2##4##(2008-5#2)
slides of the##2##3##(2004-1#1)(2006-7#1)
slides of##10##2##(1991-3#1)(2004-1#1)(2006-7#2)(2007-5#1)(2008-5#2)(2010-3#1)(2011-12#1)(2011-2#1)
slides prepared##2##2##(2005-8#1)(2008-9#1)
slides to##2##2##(2008-11#1)(2008-2#1)
slides was##3##2##(2007-5#1)(2008-10#2)
slides washed with##2##3##(2006-2#2)
slides were##7##2##(1991-3#1)(2007-2#1)(2007-9#1)(2008-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
slides with##5##2##(2008-10#1)(2008-4#2)(2011-2#2)
slides##100##1##(1990-12#1)(1991-3#2)(1991-5#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-12#1)(2004-1#1)(2005-10#1)(2005-12#2)(2005-8#2)(2006-10#1)(2006-12#1)(2006-2#3)(2006-5#2)(2006-7#6)(2007-2#2)(2007-5#6)(2007-6#1)(2007-9#2)(2008-1#2)(2008-10#8)(2008-11#7)(2008-12#1)(2008-2#2)(2008-4#14)(2008-5#7)(2008-8#1)(2008-9#3)(2009-12#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#5)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
sliding and##3##2##(2009-7#1)(2010-11#1)(2012-12#1)
sliding filters##2##2##(2007-12#1)(2008-1#1)
sliding in##3##2##(1995-2#1)(1995-5#1)(2010-10#1)
sliding movement##3##2##(1994-8#1)(2006-10#2)
sliding of the##2##3##(1990-9#1)(2007-8#1)
sliding of##5##2##(1990-9#1)(1991-2#1)(1995-3#1)(2007-11#1)(2007-8#1)
sliding velocity of##2##3##(2005-11#2)
sliding velocity##10##2##(1993-9#1)(1996-4#1)(2005-11#5)(2006-10#3)
sliding##63##1##(1990-9#1)(1991-2#2)(1993-3#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-5#2)(1996-4#7)(2005-10#1)(2005-11#5)(2006-10#6)(2006-11#3)(2007-11#1)(2007-12#4)(2007-8#2)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-10#2)(2010-11#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-3#1)(2013-1#1)
sliding-frequency guiding filters##2##3##(2007-12#2)
sliding-frequency##5##1##(2007-12#4)(2008-1#1)
slight amounts of##2##3##(1996-6#1)(2007-12#1)
slight and##2##2##(1990-2#1)(1996-2#1)
slight but significant##5##3##(1991-4#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-3#1)
slight but##10##2##(1991-4#1)(1992-7#1)(1994-5#1)(1995-8#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-8#1)(2012-3#1)
slight change in##4##3##(1991-2#1)(1996-5#1)(1997-7#1)(2008-3#1)
slight changes in##4##3##(1991-7#1)(2006-12#1)(2008-1#1)(2008-5#1)
slight changes##7##2##(1991-7#1)(1997-3#1)(2006-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-6#1)
slight decrease in the##7##4##(1990-11#1)(1990-4#1)(1992-10#1)(1993-11#1)(1994-12#1)(1996-7#1)(2008-6#1)
slight decrease in##15##3##(1990-11#1)(1990-4#1)(1991-6#1)(1992-10#1)(1992-11#1)(1993-11#1)(1994-12#1)(1994-8#1)(1996-10#2)(1996-7#1)(2008-10#1)(2008-12#1)(2008-6#1)(2011-2#1)
slight decrease of the##2##4##(2008-10#1)(2008-7#1)
slight decrease##18##2##(1990-11#1)(1990-4#1)(1991-6#1)(1992-10#1)(1992-11#1)(1993-11#1)(1994-12#1)(1994-8#1)(1996-10#2)(1996-7#1)(2006-7#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#1)
slight difference between##2##3##(2003-11#1)(2008-10#1)
slight difference in##2##3##(2012-2#1)(2013-8#1)
slight difference##6##2##(2003-11#1)(2007-4#1)(2007-6#1)(2008-10#1)(2012-2#1)(2013-8#1)
slight differences in the##2##4##(2007-2#1)(2008-5#1)
slight differences##7##2##(1991-2#1)(1991-7#1)(1996-2#1)(2007-2#1)(2008-10#1)(2008-5#1)(2011-12#1)
slight effect on the##3##4##(1990-7#1)(1991-2#2)
slight effect##7##2##(1990-7#1)(1991-2#2)(1992-11#1)(1995-1#1)(2008-11#1)(2008-4#1)
slight excess##2##2##(1996-3#1)(2008-10#1)
slight hemiparesis##3##2##(1991-6#1)(1993-8#1)(2008-7#1)
slight improvement in##4##3##(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)
slight improvement##5##2##(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-6#1)
slight increase in##26##3##(1990-5#1)(1991-10#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#1)(1994-10#1)(1994-3#1)(1995-4#1)(1996-1#1)(1996-7#1)(1997-2#1)(1997-3#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-5#1)(2012-2#1)(2013-1#2)
slight increase##35##2##(1990-5#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#1)(1993-8#1)(1994-10#1)(1994-3#1)(1995-4#1)(1996-1#1)(1996-7#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-8#1)(2009-9#1)(2010-5#1)(2011-12#1)(2012-2#1)(2013-1#2)
slight increases in##3##3##(1990-12#1)(2007-10#1)(2010-7#1)
slight increases were##2##3##(2007-9#1)(2008-10#1)
slight increases##5##2##(1990-12#1)(2007-10#1)(2007-9#1)(2008-10#1)(2010-7#1)
slight inflammatory##2##2##(1990-12#1)(2006-4#1)
slight inhibition of##3##3##(1995-3#1)(1996-10#1)(2008-5#1)
slight inhibition##4##2##(1995-3#1)(1996-10#1)(2007-1#1)(2008-5#1)
slight interference##2##2##(2008-10#2)
slight limitation of##3##3##(2007-7#2)(2010-9#1)
slight loss of##3##3##(1996-5#1)(2007-11#2)
slight loss##4##2##(1996-5#1)(1997-4#1)(2007-11#2)
slight male preponderance##2##3##(1996-9#1)(2011-2#1)
slight modifications##4##2##(1995-8#1)(1996-3#1)(2007-1#1)(2008-5#1)
slight mononuclear##2##2##(1997-8#1)(2008-5#1)
slight morphological##2##2##(2012-3#1)(2013-7#1)
slight or moderate##2##3##(2008-5#1)(2008-7#1)
slight or##4##2##(2008-10#2)(2008-5#1)(2008-7#1)
slight pain##3##2##(1991-12#1)(1993-5#1)(2005-12#1)
slight reduction in##2##3##(2008-10#1)(2008-9#1)
slight reduction##5##2##(1992-8#1)(1993-12#1)(1997-2#1)(2008-10#1)(2008-9#1)
slight stimulation of##2##3##(1990-3#1)(1994-9#1)
slight to moderately##2##3##(1993-9#1)(2006-2#1)
slight to##4##2##(1993-9#1)(2006-2#1)(2008-10#1)(2009-12#1)
slight trend towards##2##3##(1995-9#1)(2011-2#1)
slight trend##5##2##(1995-9#1)(2008-10#1)(2008-6#1)(2011-2#1)(2013-1#1)
slight variations in##3##3##(2004-4#1)(2008-10#1)(2008-3#1)
slight##333##1##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#6)(1991-4#3)(1991-5#2)(1991-6#4)(1991-7#3)(1991-8#1)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-7#1)(1993-8#3)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#3)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-5#3)(1996-6#3)(1996-7#2)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#1)(2003-11#1)(2004-4#1)(2005-11#2)(2005-12#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#2)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#10)(2007-12#5)(2007-2#5)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#9)(2007-9#1)(2008-1#3)(2008-10#37)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#5)(2008-5#11)(2008-6#4)(2008-7#8)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#4)(2009-9#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#2)(2011-2#4)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#4)(2012-7#1)(2013-1#8)(2013-7#1)(2013-8#4)
slightest##3##1##(1990-9#1)(2008-11#1)(2013-1#1)
slightly above the##2##3##(1993-2#1)(2008-11#1)
slightly above##3##2##(1993-2#1)(1997-6#1)(2008-11#1)
slightly acid##2##2##(2007-3#1)(2008-10#1)
slightly acidic conditions##2##3##(1994-3#1)(2008-10#1)
slightly acidic pH##2##3##(1997-6#1)(1997-8#1)
slightly acidic##13##2##(1994-3#1)(1997-6#1)(1997-8#1)(2008-10#4)(2008-5#4)(2011-12#1)(2011-2#1)
slightly activated##2##2##(1991-5#1)(1994-3#1)
slightly active##2##2##(1997-2#1)(2008-5#1)
slightly affected by the##2##4##(2005-11#1)(2008-3#1)
slightly affected by##5##3##(1993-6#1)(1995-8#1)(1996-8#1)(2005-11#1)(2008-3#1)
slightly affected##8##2##(1993-6#1)(1995-7#1)(1995-8#1)(1996-5#1)(1996-8#1)(2005-11#1)(2008-10#1)(2008-3#1)
slightly affects the##2##3##(1992-3#1)(1996-3#1)
slightly affects##4##2##(1992-3#1)(1996-3#1)(2006-7#1)(2012-1#1)
slightly asynchronous##2##2##(2008-5#1)(2008-7#1)
slightly basic##2##2##(2007-3#1)(2008-10#1)
slightly before##2##2##(1990-9#1)(2007-7#1)
slightly below the##3##3##(1995-11#1)(2007-12#1)(2008-11#1)
slightly below##4##2##(1995-11#1)(2007-11#1)(2007-12#1)(2008-11#1)
slightly better for##2##3##(2008-10#1)(2008-11#1)
slightly better than for##2##4##(2006-11#1)(2008-10#1)
slightly better than##7##3##(1994-9#1)(1996-9#1)(2006-11#1)(2006-8#1)(2008-10#1)(2008-6#1)(2008-9#1)
slightly better##19##2##(1992-12#1)(1994-9#1)(1996-8#1)(1996-9#1)(2006-11#1)(2006-8#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-6#1)(2008-9#1)(2010-4#1)(2011-2#1)(2013-1#1)
slightly but significantly decreases the##2##5##(2007-8#1)(2007-9#1)
slightly but significantly##7##3##(1991-6#1)(1992-1#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)
slightly but the##2##3##(1990-4#1)(1995-6#1)
slightly but##12##2##(1990-4#1)(1990-7#1)(1991-6#1)(1992-1#1)(1993-6#1)(1995-12#1)(1995-6#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)
slightly by##5##2##(1990-9#1)(1991-2#1)(1991-4#1)(1995-7#1)(1997-6#1)
slightly changed##5##2##(1995-2#1)(1995-7#1)(2008-10#1)(2008-5#1)(2010-12#1)
slightly decreased the##2##3##(1993-4#1)(2008-11#1)
slightly decreased##17##2##(1990-11#1)(1991-12#1)(1993-2#1)(1993-4#1)(1993-9#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-1#1)(1997-2#1)(1997-6#1)(2005-11#1)(2007-10#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-1#1)
slightly decreases##2##2##(1992-6#1)(1997-4#1)
slightly degraded##3##2##(1990-5#1)(2007-8#1)(2008-2#1)
slightly dependent on the##2##4##(2005-11#1)(2008-10#1)
slightly dependent on##3##3##(1990-3#1)(2005-11#1)(2008-10#1)
slightly different from that##2##4##(1992-1#1)(2008-10#1)
slightly different from those of##2##5##(1991-2#1)(2008-10#1)
slightly different from##7##3##(1991-2#1)(1992-1#1)(1996-6#1)(2006-5#1)(2008-10#2)(2008-11#1)
slightly different proteins##2##3##(1993-3#1)(2006-10#1)
slightly different##32##2##(1991-2#1)(1991-8#1)(1992-1#1)(1992-5#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-5#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-7#1)(2010-8#1)(2012-12#1)
slightly distorted##3##2##(1996-7#1)(2008-3#2)
slightly elevated in##4##3##(1990-2#1)(1990-9#1)(1993-11#1)(2012-12#1)
slightly elevated##15##2##(1990-2#2)(1990-9#1)(1991-2#2)(1993-11#1)(1995-3#1)(2004-10#1)(2006-10#1)(2006-4#1)(2008-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
slightly enhanced##4##2##(1992-12#1)(1995-11#1)(2008-5#1)(2009-4#1)
slightly enlarged##3##2##(1992-5#1)(2007-3#1)(2008-7#1)
slightly favored##3##2##(1997-2#1)(2006-11#1)(2009-11#1)
slightly from the##2##3##(2008-10#1)(2008-3#1)
slightly from those reported##3##4##(2007-2#1)(2008-1#1)(2010-4#1)
slightly from those##4##3##(2007-2#1)(2008-1#1)(2008-10#1)(2010-4#1)
slightly from##8##2##(1992-10#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-4#1)
slightly greater in##4##3##(1994-9#1)(1997-6#1)(2009-4#1)(2009-9#1)
slightly greater than the##2##4##(1996-2#1)(2008-10#1)
slightly greater than##4##3##(1992-3#1)(1996-2#1)(2008-10#1)(2008-7#1)
slightly greater##12##2##(1992-3#1)(1994-9#1)(1996-2#1)(1996-3#1)(1997-6#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-4#1)(2009-9#1)(2010-10#1)
slightly higher and##2##3##(1992-12#1)(1997-6#1)
slightly higher for##3##3##(2005-11#1)(2013-1#2)
slightly higher in the##5##4##(1992-9#1)(2008-11#1)(2011-2#1)(2012-1#1)(2012-2#1)
slightly higher in##14##3##(1992-9#1)(1994-4#1)(1995-1#1)(1997-8#1)(2007-2#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
slightly higher than that of##3##5##(2007-7#1)(2010-8#1)(2013-1#1)
slightly higher than that##6##4##(1994-12#1)(2007-11#1)(2007-7#1)(2008-11#1)(2010-8#1)(2013-1#1)
slightly higher than the##6##4##(1993-6#1)(1995-11#1)(1995-2#1)(1996-8#1)(2008-2#1)(2012-1#1)
slightly higher than those##7##4##(1991-8#1)(1994-8#1)(1995-3#1)(1995-5#1)(2008-10#2)(2008-6#1)
slightly higher than##28##3##(1991-8#1)(1992-2#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-8#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#1)(2009-6#1)(2010-3#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-1#1)
slightly higher##92##2##(1990-12#1)(1990-3#1)(1990-6#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-9#1)(1993-2#2)(1993-5#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#2)(1996-10#1)(1996-8#1)(1997-2#1)(1997-6#2)(1997-8#1)(2004-2#1)(2005-11#4)(2006-2#2)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2009-6#1)(2010-12#2)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#7)
slightly impaired##3##2##(1993-11#1)(1993-12#1)(1995-5#1)
slightly improved##12##2##(1991-8#1)(1995-9#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2009-5#1)(2009-8#1)(2011-1#1)(2013-1#2)
slightly in favour of##2##4##(1994-5#1)(2008-6#1)
slightly in##11##2##(1992-6#1)(1994-5#1)(1995-3#1)(1996-7#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2010-4#1)
slightly increase the##2##3##(2010-12#1)(2012-3#1)
slightly increase##3##2##(2010-12#1)(2012-12#1)(2012-3#1)
slightly increased in the##6##4##(1994-12#1)(1994-8#1)(2006-12#1)(2006-8#1)(2008-10#1)(2013-1#1)
slightly increased in##9##3##(1990-11#1)(1993-12#1)(1994-12#1)(1994-8#1)(2006-12#1)(2006-8#1)(2008-10#1)(2011-1#1)(2013-1#1)
slightly increased risk##2##3##(1990-7#1)(1994-2#1)
slightly increased the##5##3##(1990-10#1)(1991-10#1)(1993-4#1)(2008-5#1)(2013-8#1)
slightly increased##43##2##(1990-10#1)(1990-11#2)(1990-4#1)(1990-7#1)(1991-10#3)(1991-2#1)(1992-1#1)(1992-11#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-7#1)(1997-5#1)(2005-7#1)(2006-12#1)(2006-8#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2009-7#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
slightly increases the##2##3##(1994-11#1)(2007-12#1)
slightly increasing##2##2##(1992-11#1)(2008-10#1)
slightly inhibited by##3##3##(1990-10#1)(1996-2#1)(2008-5#1)
slightly inhibited the growth of##2##5##(1992-9#1)(2010-4#1)
slightly inhibited the##4##3##(1991-4#1)(1991-9#1)(1992-9#1)(2010-4#1)
slightly inhibited##13##2##(1990-10#1)(1990-11#1)(1991-1#1)(1991-4#1)(1991-9#1)(1992-9#1)(1993-9#1)(1995-11#1)(1996-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-4#1)
slightly inhomogeneous##2##2##(2008-2#2)
slightly irregular##2##2##(1996-6#1)(2013-1#1)
slightly larger and##2##3##(2005-11#1)(2008-7#1)
slightly larger than that##2##4##(2006-10#1)(2007-12#1)
slightly larger than the##4##4##(2006-8#1)(2008-2#1)(2008-3#1)(2013-7#1)
slightly larger than##8##3##(2006-10#1)(2006-8#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-7#1)
slightly larger##16##2##(1994-11#1)(1995-3#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-8#2)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2012-3#1)(2013-7#1)
slightly less active than##2##4##(1995-2#1)(2008-5#1)
slightly less active##3##3##(1992-3#1)(1995-2#1)(2008-5#1)
slightly less potent##2##3##(1995-1#1)(1997-8#1)
slightly less than 3##2##4##(2008-3#1)(2011-2#1)
slightly less than##5##3##(1993-3#1)(2008-3#3)(2011-2#1)
slightly less toxic than##2##4##(1992-1#1)(1994-5#1)
slightly less##26##2##(1991-1#1)(1991-4#1)(1992-1#1)(1992-3#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-2#2)(1995-3#1)(1997-1#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-5#3)(2008-9#1)(2009-2#1)(2011-2#1)
slightly longer than##2##3##(1992-7#1)(2008-5#1)
slightly longer##8##2##(1992-7#2)(1997-3#1)(1997-5#1)(2007-12#1)(2008-3#1)(2008-5#1)(2012-11#1)
slightly lower in##5##3##(1990-3#1)(1991-10#1)(1994-2#1)(1996-12#1)(2008-3#1)
slightly lower molecular mass##2##4##(1990-12#1)(1993-11#1)
slightly lower than that (6##2##5##(1992-6#1)(2006-10#1)
slightly lower than that of##8##5##(1991-5#1)(1992-6#1)(1996-3#2)(2007-12#1)(2008-11#1)(2010-8#1)(2013-1#1)
slightly lower than that##11##4##(1991-5#1)(1992-6#2)(1996-3#2)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-8#1)(2013-1#1)
slightly lower than those##2##4##(1995-5#1)(2008-10#1)
slightly lower than##17##3##(1990-2#1)(1991-5#1)(1992-6#2)(1995-5#1)(1996-3#2)(1997-8#1)(2006-10#2)(2007-12#1)(2008-10#2)(2008-11#1)(2009-9#1)(2010-8#1)(2013-1#1)
slightly lower##44##2##(1990-12#1)(1990-2#2)(1990-3#1)(1991-10#1)(1991-5#1)(1992-6#2)(1993-11#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-5#1)(1996-12#1)(1996-3#2)(1996-7#1)(1997-4#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-12#2)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
slightly modified##7##2##(1990-3#1)(1993-11#1)(1994-6#1)(2007-8#1)(2008-11#1)(2008-7#1)(2008-8#1)
slightly more active##2##3##(1990-3#1)(1990-7#1)
slightly more common##2##3##(1991-11#1)(2008-10#1)
slightly more effective than##7##4##(1990-12#1)(1993-12#1)(2008-10#2)(2008-11#1)(2008-5#2)
slightly more effective##9##3##(1990-12#1)(1993-12#1)(1994-3#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-5#2)
slightly more frequent in women##2##5##(1992-5#1)(2013-8#1)
slightly more frequent in##4##4##(1990-2#1)(1992-5#1)(1995-10#1)(2013-8#1)
slightly more frequent##6##3##(1990-1#1)(1990-2#1)(1992-5#1)(1995-10#1)(2011-11#1)(2013-8#1)
slightly more potent than##3##4##(1993-4#1)(1994-11#1)(2007-10#1)
slightly more potent##4##3##(1993-4#1)(1994-11#1)(1997-8#1)(2007-10#1)
slightly more sensitive##4##3##(1990-12#1)(1991-6#1)(2008-3#1)(2008-4#1)
slightly more stable##2##3##(1996-2#1)(2007-11#1)
slightly more susceptible##2##3##(1990-4#1)(2008-5#1)
slightly more than half##2##4##(2009-7#1)(2010-11#1)
slightly more than one##2##4##(1992-5#1)(2009-9#1)
slightly more than##6##3##(1992-5#1)(2007-7#1)(2009-7#1)(2009-9#1)(2010-11#1)(2011-1#1)
slightly more##60##2##(1990-1#1)(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#2)(1990-7#1)(1991-11#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-5#2)(1992-6#1)(1992-7#1)(1993-12#1)(1993-4#1)(1994-11#1)(1994-3#1)(1995-10#1)(1995-11#1)(1995-5#2)(1996-2#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#1)(2008-9#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#1)(2011-1#1)(2011-11#1)(2012-5#1)(2013-1#1)(2013-8#1)
slightly negative##2##2##(2005-11#1)(2007-7#1)
slightly nonspherical##2##2##(2007-11#1)(2008-2#1)
slightly older##3##2##(1991-11#1)(2008-10#1)(2010-3#1)
slightly on the##2##3##(1993-6#1)(2008-3#1)
slightly on##4##2##(1993-6#1)(2007-12#1)(2008-3#2)
slightly or##3##2##(1995-1#1)(1996-7#1)(2008-10#1)
slightly over time##2##3##(2007-12#1)(2008-2#1)
slightly over##6##2##(1992-10#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-2#1)
slightly overestimated##2##2##(2011-12#1)(2012-12#1)
slightly raised##2##2##(1996-9#1)(2008-10#1)
slightly reduced in##2##3##(1993-12#1)(2007-11#1)
slightly reduced the##2##3##(1994-5#1)(2008-5#1)
slightly reduced##17##2##(1991-7#1)(1993-12#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-6#1)(1997-4#1)(1997-5#1)(2004-9#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)
slightly rough##2##2##(2007-12#2)
slightly shifted##4##2##(2008-1#1)(2008-10#3)
slightly shorter than that##2##4##(1991-3#1)(2010-5#1)
slightly shorter##3##2##(1991-3#1)(2008-8#1)(2010-5#1)
slightly slower in##2##3##(1994-11#1)(1994-2#1)
slightly slower##5##2##(1990-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(2007-8#1)
slightly smaller than the##3##4##(1990-12#1)(2007-12#1)(2008-5#1)
slightly smaller than##6##3##(1990-12#1)(1992-3#1)(2007-12#1)(2008-5#1)(2012-2#1)(2012-3#1)
slightly smaller##10##2##(1990-12#1)(1992-2#1)(1992-3#1)(1993-4#1)(1994-8#1)(2006-10#1)(2007-12#1)(2008-5#1)(2012-2#1)(2012-3#1)
slightly soluble##2##2##(2008-10#2)
slightly stimulated##4##2##(1992-11#1)(1996-5#1)(2008-11#2)
slightly stronger##3##2##(1991-5#1)(2010-2#1)(2010-5#1)
slightly superior to##2##3##(1996-9#1)(2008-1#1)
slightly suppressed by##2##3##(2008-11#1)(2013-8#1)
slightly the##6##2##(1990-8#1)(1996-2#1)(2007-11#1)(2008-10#2)(2011-12#1)
slightly tilted##2##2##(2008-2#1)(2008-5#1)
slightly to##6##2##(1990-7#1)(1991-9#1)(1992-6#1)(1995-1#1)(2008-3#1)(2008-4#1)
slightly weaker##2##2##(1994-8#1)(2008-10#1)
slightly with##8##2##(1993-12#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)
slightly younger##2##2##(2007-10#1)(2010-7#1)
slightly##823##1##(1990-1#1)(1990-10#3)(1990-11#4)(1990-12#8)(1990-2#7)(1990-3#9)(1990-4#5)(1990-5#2)(1990-6#1)(1990-7#4)(1990-8#1)(1990-9#3)(1991-1#3)(1991-10#4)(1991-11#3)(1991-12#4)(1991-2#8)(1991-3#1)(1991-4#7)(1991-5#5)(1991-6#2)(1991-7#3)(1991-8#3)(1991-9#5)(1992-1#7)(1992-10#2)(1992-11#4)(1992-12#7)(1992-2#2)(1992-3#4)(1992-4#2)(1992-5#4)(1992-6#9)(1992-7#4)(1992-8#1)(1992-9#4)(1993-1#1)(1993-11#4)(1993-12#6)(1993-2#5)(1993-3#3)(1993-4#4)(1993-5#1)(1993-6#7)(1993-8#2)(1993-9#4)(1994-11#7)(1994-12#3)(1994-2#5)(1994-3#6)(1994-4#1)(1994-5#5)(1994-6#1)(1994-8#6)(1994-9#6)(1995-1#5)(1995-10#1)(1995-11#8)(1995-12#2)(1995-2#8)(1995-3#7)(1995-5#10)(1995-6#3)(1995-7#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#5)(1996-3#6)(1996-4#1)(1996-5#4)(1996-6#3)(1996-7#5)(1996-8#3)(1996-9#4)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#3)(1997-5#5)(1997-6#7)(1997-7#3)(1997-8#7)(2004-10#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#12)(2005-7#2)(2006-10#8)(2006-11#4)(2006-12#3)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#4)(2006-7#1)(2006-8#5)(2007-10#3)(2007-11#15)(2007-12#24)(2007-2#2)(2007-3#3)(2007-4#2)(2007-6#2)(2007-7#8)(2007-8#10)(2007-9#3)(2008-1#5)(2008-10#79)(2008-11#22)(2008-12#4)(2008-2#24)(2008-3#25)(2008-4#11)(2008-5#33)(2008-6#7)(2008-7#13)(2008-8#8)(2008-9#7)(2009-10#2)(2009-11#2)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#4)(2010-10#4)(2010-11#2)(2010-12#7)(2010-2#3)(2010-3#6)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#6)(2011-11#1)(2011-12#3)(2011-2#11)(2012-1#5)(2012-11#1)(2012-12#8)(2012-2#4)(2012-3#6)(2012-5#2)(2013-1#16)(2013-7#1)(2013-8#4)
slim##8##1##(1990-9#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-12#1)(2007-8#1)(2012-2#2)
slim-tube##2##1##(2005-11#2)
slime coating##2##2##(2005-11#2)
slime mold Dictyostelium discoideum##3##4##(1995-3#2)(1996-7#1)
slime mold##7##2##(1991-9#1)(1992-12#1)(1995-3#2)(1995-6#1)(1996-7#1)(2008-3#1)
slime molds##3##2##(1993-2#1)(2008-8#2)
slime producing##2##2##(1997-6#1)(2006-10#1)
slime production##2##2##(1991-3#2)
slime##26##1##(1991-3#3)(1991-9#1)(1992-11#1)(1992-12#1)(1993-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-7#1)(1997-6#1)(2005-11#2)(2006-10#1)(2008-10#2)(2008-3#2)(2008-8#2)(2011-1#1)(2012-2#3)
slime-producing##2##1##(1991-3#2)
slimming##4##1##(1990-4#1)(1992-6#1)(2008-5#2)
slimness##3##1##(1990-9#1)(2006-7#1)(2007-12#1)
sling and##4##2##(1993-12#1)(2006-9#2)(2007-8#1)
sling was##2##2##(2007-8#1)(2012-2#1)
sling##17##1##(1993-12#4)(2006-9#6)(2007-10#1)(2007-8#2)(2009-8#1)(2011-12#1)(2012-1#1)(2012-2#1)
slingshot##3##1##(2008-1#3)
slip and##2##2##(1990-11#1)(1996-4#1)
slip in the##2##3##(1990-8#1)(1994-8#1)
slip in##5##2##(1990-8#1)(1992-3#1)(1994-8#1)(2007-11#2)
slip of the##4##3##(2005-11#1)(2008-8#1)(2008-9#2)
slip on the San Andreas fault##2##6##(1990-11#1)(1991-3#1)
slip on the##4##3##(1990-11#1)(1991-3#1)(1996-4#2)
slip on##6##2##(1990-11#1)(1990-8#1)(1991-3#1)(1996-4#3)
slip velocity##2##2##(2005-11#1)(2008-6#1)
slip was##2##2##(2007-11#1)(2008-3#1)
slip weakening##2##2##(1996-4#2)
slip##53##1##(1990-11#2)(1990-8#3)(1991-3#1)(1992-3#1)(1994-8#1)(1996-4#23)(2004-9#1)(2005-11#5)(2007-11#3)(2007-12#2)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-1#1)(2010-6#1)(2011-1#1)(2012-2#1)
slippage and##2##2##(2007-8#1)(2013-1#1)
slippage of##2##2##(2007-8#1)(2008-3#1)
slippage##7##1##(2007-7#2)(2007-8#2)(2008-3#1)(2013-1#2)
slipped capital femoral epiphysis (SCFE)##2##5##(2007-8#1)(2008-8#1)
slipped capital femoral epiphysis##4##4##(2007-8#1)(2008-7#1)(2008-8#2)
slipped femoral##2##2##(2008-8#1)(2013-8#1)
slipped##10##1##(1995-9#1)(2005-11#1)(2007-8#1)(2008-7#1)(2008-8#3)(2011-1#1)(2013-8#2)
slippery##4##1##(1992-10#1)(1994-6#1)(2008-5#2)
slipping##8##1##(1990-2#1)(1992-5#1)(1996-9#1)(2006-6#3)(2007-10#1)(2008-11#1)
slips and##2##2##(1990-12#1)(2011-1#1)
slips in##2##2##(1990-8#1)(1996-4#1)
slips##10##1##(1990-12#1)(1990-8#1)(1994-5#1)(1995-4#1)(1996-4#1)(2006-6#1)(2007-12#1)(2008-3#1)(2011-1#1)(2013-1#1)
slit and##3##2##(2007-12#1)(2008-2#2)
slit diaphragm##3##2##(2007-7#3)
slit effect##3##2##(2007-12#2)(2008-3#1)
slit for##2##2##(2006-4#1)(2008-2#1)
slit function##2##2##(2008-3#2)
slit in the collecting##2##4##(2008-2#2)
slit in##3##2##(2008-2#2)(2008-3#1)
slit is##6##2##(2006-4#1)(2007-1#1)(2008-2#3)(2008-3#1)
slit lamp examination and##2##4##(2012-2#1)(2013-1#1)
slit lamp##4##2##(2008-9#1)(2012-2#1)(2013-1#2)
slit was made##2##3##(2008-4#2)
slit was##3##2##(2008-1#1)(2008-4#2)
slit width##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
slit widths##2##2##(2008-3#2)
slit##75##1##(2006-4#6)(2007-1#1)(2007-11#2)(2007-12#10)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#18)(2008-3#20)(2008-4#3)(2008-9#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
slit-coupled intensity##2##2##(2008-2#2)
slit-lamp##3##1##(2006-8#1)(2008-3#1)(2009-8#1)
slit-scan confocal##2##2##(2008-2#2)
slit-scan##3##1##(2007-12#1)(2008-2#2)
slits are##2##2##(2006-4#1)(2008-2#1)
slits is proposed##2##3##(2008-2#1)(2008-3#1)
slits##15##1##(1995-11#1)(1995-12#1)(2006-4#2)(2008-11#1)(2008-2#3)(2008-3#5)(2008-7#1)(2008-8#1)
slogans##2##1##(2008-9#2)
slooffiae##2##1##(2007-7#1)(2008-5#1)
slope 1##2##2##(1990-11#1)(1997-5#1)
slope =##2##2##(2008-10#2)
slope T/C ratio##2##3##(2009-4#2)
slope T/C ratios##2##3##(2009-4#2)
slope T/C##4##2##(2009-4#4)
slope analysis##2##2##(2008-10#2)
slope and correlation##2##3##(1995-4#2)
slope and intercept for##2##4##(2008-10#2)
slope and intercept were 0##2##5##(2008-10#2)
slope and intercept were##4##4##(2008-10#3)(2011-2#1)
slope and intercept##9##3##(2008-10#7)(2011-2#1)(2013-8#1)
slope and##24##2##(1991-8#1)(1993-12#1)(1993-2#2)(1995-4#2)(1996-12#1)(1997-5#1)(2008-10#10)(2008-4#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
slope area##2##2##(2010-8#2)
slope at##3##2##(1995-3#1)(2007-12#1)(2008-10#1)
slope between##4##2##(2010-8#2)(2011-2#1)(2013-1#1)
slope changes##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
slope conductance##2##2##(1992-8#2)
slope data##2##2##(2007-12#1)(2008-3#1)
slope distribution##3##2##(2008-3#3)
slope efficiencies of##3##3##(2007-11#1)(2007-12#2)
slope efficiencies##7##2##(2007-11#1)(2007-12#4)(2008-2#2)
slope efficiency and##2##3##(2007-12#1)(2008-2#1)
slope efficiency as##2##3##(2007-12#1)(2008-1#1)
slope efficiency at##2##3##(2007-12#1)(2008-2#1)
slope efficiency increased by##2##4##(2008-3#2)
slope efficiency increased##3##3##(2008-2#1)(2008-3#2)
slope efficiency is##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
slope efficiency of 26%##2##4##(2008-1#1)(2008-2#1)
slope efficiency of 32%##2##4##(2007-12#2)
slope efficiency of 52%##2##4##(2007-12#2)
slope efficiency of 55%##2##4##(2007-11#1)(2008-2#1)
slope efficiency of##39##3##(2007-11#9)(2007-12#15)(2008-1#1)(2008-2#11)(2008-3#3)
slope efficiency was##3##3##(2007-11#1)(2007-12#2)
slope efficiency with respect to the##2##6##(2007-11#1)(2007-12#1)
slope efficiency with respect to##3##5##(2007-11#1)(2007-12#1)(2008-2#1)
slope efficiency##68##2##(2007-11#13)(2007-12#26)(2008-1#3)(2008-2#19)(2008-3#7)
slope equal to##2##3##(2008-10#1)(2008-9#1)
slope facet##2##2##(2008-3#2)
slope for##5##2##(1991-8#1)(1992-3#1)(1995-5#2)(2008-10#1)
slope from the##3##3##(2007-5#1)(2008-10#2)
slope greater than##2##3##(1990-11#1)(2008-10#1)
slope in the##6##3##(1990-9#1)(1993-2#1)(1997-5#1)(2007-5#1)(2008-3#2)
slope in##8##2##(1990-9#1)(1993-2#1)(1997-5#1)(2007-5#1)(2008-10#1)(2008-3#3)
slope indicated##2##2##(2008-10#1)(2013-8#1)
slope is obtained##3##3##(1990-7#1)(2008-10#1)(2008-2#1)
slope is##7##2##(1990-7#1)(1995-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)
slope method and##3##3##(2005-11#1)(2008-2#1)(2008-3#1)
slope method##8##2##(2005-11#2)(2008-2#2)(2008-3#4)
slope of -55##2##3##(2008-10#2)
slope of -59##2##3##(2008-10#2)
slope of 0##6##3##(2008-10#5)(2008-2#1)
slope of 19##4##3##(2008-10#4)
slope of 28##4##3##(2008-10#4)
slope of 29 mV##3##4##(2008-10#3)
slope of 29##12##3##(2008-10#12)
slope of 30##2##3##(2008-10#2)
slope of 30+/-1 mV per decade##2##6##(2008-10#2)
slope of 56##4##3##(2008-10#4)
slope of 57##2##3##(2008-10#2)
slope of calibration##2##3##(2007-8#1)(2008-10#1)
slope of the electrode##3##4##(2008-10#3)
slope of the field EPSP##2##5##(1996-5#1)(1997-5#1)
slope of the field##3##4##(1995-3#1)(1996-5#1)(1997-5#1)
slope of the line##2##4##(1997-2#1)(2008-3#1)
slope of the linear portion##3##5##(2008-10#3)
slope of the linear##4##4##(1990-11#1)(2008-10#3)
slope of the regression line##2##5##(1993-7#1)(2006-7#1)
slope of the response##2##4##(1997-2#1)(2008-10#1)
slope of the survival curve##2##5##(1995-3#2)
slope of the##70##3##(1990-10#1)(1990-11#1)(1992-8#1)(1993-12#1)(1993-7#1)(1995-3#3)(1996-5#1)(1997-2#2)(1997-5#2)(2004-12#1)(2005-11#3)(2006-7#1)(2007-12#2)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#24)(2008-2#5)(2008-3#9)(2008-8#4)(2008-9#1)(2009-12#2)(2009-5#1)
slope of this##4##3##(1991-5#1)(1993-12#1)(2007-11#1)(2011-1#1)
slope of##186##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-8#1)(1993-12#2)(1993-7#1)(1994-12#1)(1994-8#1)(1995-3#3)(1995-6#1)(1996-2#2)(1996-5#1)(1997-2#2)(1997-5#3)(2004-12#1)(2005-11#4)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#110)(2008-2#8)(2008-3#10)(2008-4#1)(2008-5#2)(2008-8#4)(2008-9#1)(2009-12#2)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
slope or##3##2##(1994-9#1)(2007-12#1)(2008-10#1)
slope over a##2##3##(2007-11#1)(2008-10#1)
slope structure-correlation coefficient##2##3##(2007-12#2)
slope to##2##2##(2007-12#1)(2008-3#1)
slope was##6##2##(1995-8#1)(2007-10#1)(2008-10#4)
slope were##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
slope##454##1##(1990-10#1)(1990-11#4)(1990-3#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-2#1)(1991-5#2)(1991-8#3)(1992-10#1)(1992-3#1)(1992-8#3)(1993-12#3)(1993-2#4)(1993-7#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-3#6)(1995-4#5)(1995-5#2)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#3)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-5#9)(2004-12#1)(2005-11#6)(2006-10#2)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#19)(2007-12#47)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#165)(2008-11#1)(2008-12#1)(2008-2#43)(2008-3#38)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#8)(2008-9#2)(2009-12#2)(2009-4#4)(2009-5#1)(2009-6#1)(2009-8#2)(2010-8#5)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#7)
slope/bias correction##2##2##(2007-12#1)(2008-10#1)
sloped##5##1##(2008-2#4)(2010-2#1)
slopes 0##2##2##(2008-10#2)
slopes and##9##2##(1997-5#1)(2007-12#1)(2008-10#2)(2012-1#3)(2013-1#1)(2013-7#1)
slopes are##2##2##(2005-7#1)(2008-10#1)
slopes can be##2##3##(2007-12#1)(2012-1#1)
slopes for the##3##3##(1991-12#1)(1996-6#1)(2013-1#1)
slopes for##4##2##(1991-12#1)(1996-6#1)(2008-10#1)(2013-1#1)
slopes from##2##2##(1992-8#1)(2008-10#1)
slopes in##2##2##(2008-10#1)(2008-3#1)
slopes measured##2##2##(2008-10#1)(2008-2#1)
slopes of the Andes##2##4##(2008-10#1)(2008-8#1)
slopes of the##19##3##(1990-11#1)(1991-7#1)(1996-5#1)(2006-10#1)(2007-12#1)(2007-8#2)(2008-10#7)(2008-2#3)(2008-8#1)(2012-3#1)
slopes of##40##2##(1990-11#1)(1990-8#1)(1991-7#1)(1993-12#1)(1994-8#1)(1996-5#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-10#14)(2008-12#1)(2008-2#3)(2008-3#1)(2008-8#4)(2008-9#1)(2010-8#1)(2012-12#1)(2012-3#1)
slopes to##3##2##(1993-6#2)(2008-2#1)
slopes were not significantly##2##4##(2008-10#2)
slopes were##7##2##(1990-7#1)(2008-10#5)(2012-1#1)
slopes##115##1##(1990-10#1)(1990-11#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-7#2)(1992-12#1)(1992-8#1)(1993-12#1)(1993-6#2)(1994-8#1)(1995-3#1)(1996-12#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-12#5)(2007-5#1)(2007-8#4)(2008-10#33)(2008-12#1)(2008-2#8)(2008-3#6)(2008-5#1)(2008-8#5)(2008-9#5)(2009-6#1)(2010-8#1)(2011-12#2)(2012-1#8)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#3)(2013-8#2)
slopes)##2##1##(2004-9#1)(2008-8#1)
sloping##2##1##(2008-5#1)(2010-11#1)
sloppy##2##1##(1996-5#1)(2008-9#1)
slot blot assay to determine the infectious titer of the purified HDAd##2##12##(2008-2#1)(2008-4#1)
slot blot hybridization##4##3##(1994-12#1)(1995-7#1)(2008-2#2)
slot blot##9##2##(1990-11#1)(1991-3#1)(1994-12#1)(1994-8#1)(1995-7#1)(2008-2#3)(2008-4#1)
slot of##2##2##(1996-2#1)(2007-8#1)
slot or##5##2##(1996-2#1)(2008-2#1)(2008-4#3)
slot##22##1##(1990-11#2)(1990-2#1)(1991-3#1)(1994-12#1)(1994-8#1)(1995-7#1)(1996-2#2)(2007-8#2)(2007-9#1)(2008-2#5)(2008-4#4)(2012-1#1)
slot-blot hybridization of RNA samples##3##5##(2008-2#1)(2008-4#2)
slot-blot hybridization##6##2##(1991-5#1)(2008-2#1)(2008-4#4)
slot-blot##7##1##(1991-5#1)(1995-5#1)(2008-2#1)(2008-4#4)
slots##5##1##(1992-9#1)(1996-3#2)(2007-12#1)(2007-8#1)
slotted##3##1##(2005-10#1)(2006-3#1)(2012-3#1)
slough off##2##2##(2006-7#1)(2008-10#1)
slough##5##1##(1992-10#1)(2006-7#1)(2008-10#2)(2010-11#1)
sloughed##3##1##(2008-10#3)
sloughing of##3##2##(1991-8#1)(2007-9#1)(2011-2#1)
sloughing##7##1##(1991-8#4)(2007-3#1)(2007-9#1)(2011-2#1)
slovaca##8##1##(1995-12#3)(2009-2#5)
slow (t1/2##2##2##(1991-5#1)(1991-7#1)
slow K(+)##2##2##(2008-8#2)
slow MHC isoforms##2##3##(1997-6#2)
slow accumulation of##3##3##(1990-2#1)(1994-12#1)(1996-10#1)
slow acetylator phenotypes##2##3##(1996-3#2)
slow acetylator##3##2##(1996-3#2)(2010-2#1)
slow acquisition##2##2##(1992-8#1)(1993-5#1)
slow and at##2##3##(1990-12#1)(1997-1#1)
slow and fast##6##3##(1996-8#1)(1997-2#1)(2005-11#1)(2007-12#1)(2008-4#1)(2011-2#1)
slow and the##3##3##(1995-1#1)(2004-9#1)(2007-12#1)
slow and##38##2##(1990-12#1)(1990-7#1)(1991-9#1)(1993-12#1)(1993-6#1)(1994-2#2)(1995-1#1)(1995-10#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-9#1)(2005-11#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-2#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
slow annealing of the##2##4##(1995-1#2)
slow axis##2##2##(2007-11#1)(2007-12#1)
slow binding##2##2##(1992-5#1)(2006-6#1)
slow but##3##2##(1991-2#1)(1994-5#1)(2008-3#1)
slow channel##2##2##(2013-1#2)
slow compared##2##2##(2005-9#1)(2007-11#1)
slow component##3##2##(1992-3#1)(2005-11#1)(2008-3#1)
slow components##3##2##(1996-1#1)(2008-3#2)
slow conduction##2##2##(2006-9#1)(2010-8#1)
slow conformational##2##2##(1995-2#1)(1997-5#1)
slow conversion##2##2##(1991-7#1)(1997-2#1)
slow cooling##6##2##(1996-8#1)(1997-1#1)(2005-11#1)(2007-11#1)(2008-3#1)(2008-7#1)
slow deterioration##2##2##(1993-2#1)(2010-10#1)
slow disease progression##2##3##(2007-10#1)(2007-11#1)
slow disease##3##2##(2007-10#1)(2007-11#1)(2008-10#1)
slow dissociation of the##3##4##(1992-4#1)(1993-11#1)(1994-9#1)
slow dissociation of##4##3##(1992-4#1)(1993-11#1)(1994-9#1)(2008-4#1)
slow dissociation##5##2##(1992-4#1)(1993-11#1)(1994-9#1)(1995-1#1)(2008-4#1)
slow down the process of##2##5##(2008-12#1)(2008-9#1)
slow down the##10##3##(2006-4#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#2)(2009-5#1)(2011-2#1)
slow down##16##2##(1991-12#1)(2006-4#1)(2007-3#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#3)(2009-5#1)(2011-1#1)(2011-2#1)
slow energy transfer from##2##4##(1997-4#2)
slow evolution##3##2##(1991-9#1)(2007-11#1)(2008-10#1)
slow exchange##2##2##(1992-10#1)(1993-11#1)
slow flow##3##2##(1996-9#1)(2008-7#1)(2013-8#1)
slow folding##2##2##(1992-3#1)(1992-6#1)
slow freezing##3##2##(2006-5#2)(2012-3#1)
slow growing and##5##3##(2008-10#1)(2008-6#1)(2008-7#1)(2013-7#1)(2013-8#1)
slow growing##13##2##(1994-11#1)(1997-4#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-3#1)(2013-7#1)(2013-8#1)
slow growth and##2##3##(1993-3#1)(2008-8#1)
slow growth in##3##3##(1992-12#1)(1997-3#1)(2007-12#1)
slow growth phenotype##4##3##(2006-11#1)(2010-2#3)
slow growth rates##2##3##(1991-11#1)(1994-11#1)
slow growth##18##2##(1991-11#1)(1992-12#1)(1993-3#1)(1994-11#1)(1996-4#1)(1997-2#1)(1997-3#1)(2006-11#1)(2007-12#1)(2008-8#1)(2010-12#1)(2010-2#3)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
slow in coming##2##3##(1996-1#1)(2008-8#1)
slow in##10##2##(1991-10#1)(1991-12#1)(1995-9#1)(1996-1#1)(1997-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-11#1)(2013-1#1)
slow increase in##2##3##(2012-12#1)(2013-8#1)
slow increase of the##2##4##(1997-7#1)(2008-11#1)
slow increase##5##2##(1997-7#1)(2008-11#1)(2009-8#1)(2012-12#1)(2013-8#1)
slow inward current##6##3##(1990-7#1)(1991-11#1)(1991-2#1)(1991-9#1)(1994-2#2)
slow its##2##2##(1995-9#1)(2012-12#1)
slow kinetics##2##2##(1995-11#1)(2008-10#1)
slow learning##2##2##(1993-12#1)(1993-7#1)
slow loss of the##2##4##(1993-5#1)(2008-10#1)
slow membrane##2##2##(1993-12#1)(1997-4#1)
slow mobility##2##2##(1990-10#1)(1995-3#1)
slow molecular##2##2##(2008-1#1)(2012-1#1)
slow muscle##3##2##(1991-12#2)(1997-6#1)
slow on the##2##3##(1994-5#1)(1995-10#1)
slow onset of##3##3##(1996-9#1)(2008-11#1)(2012-2#1)
slow onset##6##2##(1991-4#1)(1994-9#1)(1995-12#1)(1996-9#1)(2008-11#1)(2012-2#1)
slow or reverse##2##3##(2006-2#1)(2009-8#1)
slow or##6##2##(1993-7#1)(2006-2#1)(2006-4#1)(2007-12#1)(2008-7#1)(2009-8#1)
slow oscillations##2##2##(2008-1#1)(2009-8#1)
slow phase##8##2##(1990-5#1)(1991-12#1)(1992-6#1)(1995-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)
slow phases##2##2##(1994-8#1)(2009-8#1)
slow potential shift##2##3##(1996-5#2)
slow process##10##2##(1990-3#1)(1991-12#1)(1992-3#1)(1993-11#1)(1994-12#1)(1995-3#1)(2008-1#1)(2008-10#1)(2009-8#1)(2012-2#1)
slow processes##2##2##(1990-5#1)(2009-8#1)
slow progression and##2##3##(2004-11#1)(2007-12#1)
slow progression##5##2##(2004-11#1)(2007-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
slow rate of##7##3##(1992-4#1)(1997-1#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)
slow rate##13##2##(1992-4#1)(1993-8#1)(1997-1#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#3)(2012-3#1)
slow rates##4##2##(2008-8#3)(2008-9#1)
slow reaction##6##2##(1990-2#1)(1991-2#2)(2008-10#2)(2008-5#1)
slow recovery of##2##3##(1992-5#1)(2008-5#1)
slow recovery##5##2##(1992-5#1)(2006-10#1)(2006-4#1)(2008-3#1)(2008-5#1)
slow relaxation##2##2##(1995-1#1)(1997-7#1)
slow release of##5##3##(1991-7#1)(1994-11#1)(1994-12#1)(2010-1#1)(2011-2#1)
slow release##10##2##(1991-7#2)(1993-4#1)(1994-11#1)(1994-12#1)(1996-12#1)(2004-9#1)(2010-1#1)(2010-5#1)(2011-2#1)
slow religation to##2##3##(1996-6#2)
slow response##2##2##(2007-7#1)(2008-2#1)
slow rusting resistance to leaf rust##2##6##(2008-10#2)
slow saccades##2##2##(2013-1#2)
slow skeletal muscles##4##3##(1994-3#2)(1995-2#2)
slow skeletal##5##2##(1994-3#2)(1995-2#2)(1997-6#1)
slow speed##2##2##(2008-10#1)(2013-1#1)
slow step##2##2##(1990-3#1)(2008-10#1)
slow steps in##2##3##(1992-6#1)(2006-12#1)
slow steps##3##2##(1992-6#1)(1994-8#1)(2006-12#1)
slow the growth of##3##4##(1992-2#1)(1993-12#1)(2012-2#1)
slow the growth##4##3##(1992-2#2)(1993-12#1)(2012-2#1)
slow the progression of the##2##5##(2008-1#1)(2011-2#1)
slow the progression of##15##4##(1993-12#2)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-11#1)(2009-11#1)(2011-2#1)(2012-12#2)(2013-8#3)
slow the rate of##3##4##(2005-7#1)(2007-7#1)(2008-10#1)
slow the##30##2##(1992-2#2)(1993-12#3)(1996-4#1)(1996-9#1)(1997-4#1)(2004-12#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-11#1)(2009-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#3)
slow to adopt##2##3##(2007-11#1)(2008-11#1)
slow to respond to##2##4##(2006-10#1)(2009-4#1)
slow to##20##2##(1990-2#1)(1991-11#1)(1993-5#1)(1993-9#1)(1997-2#1)(2004-11#1)(2006-1#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-11#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-4#1)(2012-3#1)(2013-1#1)
slow transport##2##2##(2007-8#2)
slow turnover##3##2##(1996-11#1)(2008-7#1)(2009-6#1)
slow wave activity during##2##4##(1992-9#1)(1996-1#1)
slow wave activity##5##3##(1991-2#1)(1992-9#1)(1996-1#2)(2008-7#1)
slow wave and##2##3##(1992-10#1)(1996-1#1)
slow wave for the##3##4##(2006-5#3)
slow wave in response to the infrequent##2##7##(2006-5#2)
slow wave sleep##6##3##(1990-11#1)(1990-7#1)(1996-1#1)(1996-3#2)(2004-11#1)
slow wave##22##2##(1990-11#1)(1990-7#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-9#2)(1993-11#1)(1996-1#4)(1996-3#2)(2004-11#1)(2006-5#5)(2008-7#1)(2012-12#1)
slow waves in the##2##4##(2006-5#1)(2007-1#1)
slow waves##6##2##(1991-9#1)(2006-5#1)(2007-1#1)(2009-8#1)(2011-1#1)(2013-7#1)
slow##667##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#4)(1990-3#3)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#5)(1990-8#1)(1990-9#1)(1991-10#2)(1991-11#3)(1991-12#10)(1991-2#5)(1991-3#4)(1991-4#2)(1991-5#1)(1991-7#7)(1991-8#1)(1991-9#8)(1992-1#1)(1992-10#7)(1992-12#3)(1992-2#3)(1992-3#4)(1992-4#3)(1992-5#3)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#5)(1993-10#1)(1993-11#5)(1993-12#8)(1993-2#7)(1993-3#4)(1993-4#2)(1993-5#3)(1993-6#1)(1993-7#2)(1993-8#4)(1993-9#3)(1994-10#1)(1994-11#7)(1994-12#4)(1994-2#5)(1994-3#5)(1994-5#4)(1994-6#1)(1994-8#4)(1994-9#5)(1995-1#7)(1995-10#2)(1995-11#5)(1995-12#5)(1995-2#4)(1995-3#3)(1995-5#1)(1995-7#1)(1995-8#6)(1995-9#2)(1996-1#8)(1996-10#1)(1996-11#1)(1996-12#5)(1996-3#4)(1996-4#2)(1996-5#3)(1996-6#2)(1996-7#3)(1996-8#5)(1996-9#4)(1997-1#6)(1997-2#7)(1997-3#1)(1997-4#9)(1997-5#3)(1997-6#6)(1997-7#7)(1997-8#1)(2004-1#1)(2004-11#4)(2004-12#1)(2004-9#3)(2005-10#1)(2005-11#10)(2005-7#2)(2005-8#1)(2005-9#1)(2006-1#3)(2006-10#7)(2006-11#2)(2006-12#2)(2006-2#1)(2006-4#4)(2006-5#10)(2006-6#2)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#13)(2007-12#15)(2007-3#2)(2007-5#2)(2007-7#7)(2007-8#5)(2007-9#2)(2008-1#7)(2008-10#46)(2008-11#10)(2008-12#3)(2008-2#5)(2008-3#20)(2008-4#6)(2008-5#10)(2008-6#5)(2008-7#15)(2008-8#9)(2008-9#17)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#4)(2009-6#2)(2009-8#8)(2009-9#2)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#4)(2010-3#3)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#4)(2011-1#7)(2011-12#1)(2011-2#8)(2012-1#2)(2012-11#1)(2012-12#8)(2012-2#7)(2012-3#6)(2013-1#12)(2013-7#2)(2013-8#9)
slow&quot##3##1##(1993-11#1)(1996-6#1)(2007-12#1)
slow)##3##1##(1994-3#1)(2008-2#1)(2008-8#1)
slow- and##3##2##(1993-11#1)(1994-9#1)(2007-12#1)
slow-##4##1##(1993-11#1)(1994-9#2)(2007-12#1)
slow-binding##3##1##(1992-3#1)(1994-6#1)(2012-12#1)
slow-canker-growth (SCG)##2##2##(2008-10#2)
slow-down##2##1##(1990-2#1)(1995-12#1)
slow-growing benign##2##2##(2010-3#1)(2012-12#1)
slow-growing tumors##2##2##(1997-8#1)(2005-5#1)
slow-growing##19##1##(1991-12#1)(1993-9#1)(1997-8#1)(2005-5#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-9#2)(2010-12#1)(2010-3#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
slow-grown##2##1##(1996-12#2)
slow-onset potentiation##3##2##(1995-12#3)
slow-onset##5##1##(1995-12#3)(2010-4#1)(2012-1#1)
slow-release##10##1##(1991-2#1)(1991-3#1)(1992-5#1)(1994-6#1)(1996-12#1)(2004-9#1)(2006-7#1)(2007-2#1)(2008-11#1)(2008-8#1)
slow-rusting resistance to leaf rust in wheat##2##7##(2008-10#2)
slow-rusting resistance to leaf rust##3##5##(2008-10#3)
slow-rusting resistance##5##2##(2008-10#5)
slow-rusting##6##1##(2008-10#6)
slow-spreading ridges##4##2##(1992-7#4)
slow-twitch muscles of the##2##4##(1993-12#2)
slow-twitch muscles##3##2##(1993-12#2)(1996-10#1)
slow-twitch##13##1##(1991-6#7)(1993-12#3)(1995-9#1)(1996-10#1)(1996-2#1)
slow-wave activity##4##2##(1992-12#1)(1994-8#1)(1997-3#1)(2006-8#1)
slow-wave sleep##6##2##(1992-8#2)(1994-2#1)(1996-1#1)(2012-12#1)(2012-3#1)
slow-wave##11##1##(1992-12#1)(1992-8#2)(1994-2#1)(1994-8#1)(1996-1#1)(1997-3#1)(2006-8#1)(2008-11#1)(2012-12#1)(2012-3#1)
slowdown of##2##2##(2007-12#2)
slowdown##5##1##(2007-12#2)(2008-12#1)(2012-1#1)(2013-8#1)
slowed by the##3##3##(1991-8#1)(2009-5#1)(2010-3#1)
slowed by##5##2##(1991-8#1)(1993-2#1)(2008-1#1)(2009-5#1)(2010-3#1)
slowed down the##5##3##(1991-5#1)(1997-2#1)(2004-9#1)(2008-11#1)(2008-5#1)
slowed down##13##2##(1991-2#1)(1991-5#1)(1992-3#1)(1997-2#1)(1997-7#1)(2004-9#1)(2008-11#2)(2008-5#1)(2010-1#1)(2011-12#1)(2012-2#2)
slowed in##2##2##(2011-2#1)(2013-1#1)
slowed the##6##2##(1993-2#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-7#1)
slowed##62##1##(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-12#2)(1992-3#1)(1992-6#1)(1993-2#2)(1994-10#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-2#3)(1997-5#1)(1997-7#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-2#1)(2006-5#1)(2007-11#3)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-3#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
slower and less accurate than the##2##6##(2009-4#2)
slower and less accurate##4##4##(2007-12#1)(2009-4#2)(2010-2#1)
slower and less##5##3##(1996-9#1)(2007-12#1)(2009-4#2)(2010-2#1)
slower and more##4##3##(1996-11#1)(2008-10#1)(2008-4#1)(2010-5#1)
slower and##14##2##(1993-8#1)(1994-5#1)(1996-11#1)(1996-9#1)(2004-9#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-4#2)(2010-2#1)(2010-5#1)
slower at##4##2##(1991-9#1)(1993-6#1)(1994-11#1)(2006-10#1)
slower compared to##2##3##(2005-11#1)(2012-12#1)
slower compared##3##2##(2005-11#1)(2008-10#1)(2012-12#1)
slower decline##2##2##(1990-10#1)(2013-1#1)
slower decrease##3##2##(1994-7#1)(2008-7#2)
slower dissociation##2##2##(1997-4#1)(2008-10#1)
slower growth rate##2##3##(1994-12#1)(2008-10#1)
slower growth##4##2##(1994-12#1)(1996-10#1)(2008-10#1)(2008-5#1)
slower in the presence of##2##5##(1994-12#1)(2008-10#1)
slower in the##4##3##(1994-11#1)(1994-12#1)(1995-12#1)(2008-10#1)
slower in##19##2##(1990-11#1)(1991-2#1)(1992-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-7#1)(2008-10#4)(2008-11#1)(2008-4#1)(2009-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
slower learning##2##2##(1993-12#1)(2008-9#1)
slower migratory rate##2##3##(1997-8#2)
slower on##3##2##(1994-2#1)(2008-10#1)(2008-4#1)
slower phase##3##2##(1992-10#1)(1993-9#1)(2007-4#1)
slower population##2##2##(1990-3#1)(1993-3#1)
slower rate of##8##3##(1990-3#1)(1991-2#1)(1993-12#1)(1994-11#1)(1995-11#1)(2005-9#1)(2006-10#1)(2010-8#1)
slower rate than that between##2##5##(1990-12#2)
slower rate than the##2##4##(1990-2#1)(1991-10#1)
slower rate than##5##3##(1990-12#2)(1990-2#1)(1991-10#1)(1995-2#1)
slower rate##17##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1991-10#1)(1991-2#1)(1992-8#1)(1993-12#1)(1994-11#1)(1995-11#1)(1995-2#1)(2005-7#1)(2005-9#1)(2006-10#1)(2007-7#1)(2010-8#1)
slower rates##7##2##(1990-3#1)(1991-7#1)(1991-8#1)(1992-2#1)(2008-6#1)(2008-8#1)(2012-12#1)
slower recovery in the##2##4##(2007-8#1)(2008-5#1)
slower recovery##3##2##(2007-8#1)(2008-5#1)(2012-1#1)
slower release##2##2##(2004-11#2)
slower responses##2##2##(2008-2#1)(2011-1#1)
slower than controls##2##3##(2008-7#1)(2009-1#1)
slower than for##2##3##(1995-6#1)(2010-2#1)
slower than in the##2##4##(1994-2#1)(2008-8#1)
slower than in##4##3##(1991-10#1)(1994-2#1)(2006-10#1)(2008-8#1)
slower than that in##2##4##(2008-10#1)(2008-4#1)
slower than that of the##2##5##(1990-7#1)(1996-6#1)
slower than that of##5##4##(1990-5#1)(1990-7#1)(1996-6#1)(2007-11#1)(2008-10#1)
slower than that##13##3##(1990-5#1)(1990-7#2)(1994-3#1)(1996-6#1)(2005-11#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-4#1)(2011-2#1)
slower than the rate of##2##5##(1993-11#1)(2008-10#1)
slower than the##18##3##(1990-3#1)(1990-5#1)(1991-1#1)(1992-6#2)(1992-9#1)(1993-11#1)(1994-12#1)(2006-12#1)(2006-9#1)(2008-10#5)(2008-7#1)(2010-10#1)(2010-8#1)
slower than those##3##3##(1997-7#1)(2008-9#1)(2012-12#1)
slower than##50##2##(1990-3#1)(1990-5#2)(1990-7#2)(1991-1#1)(1991-10#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-4#1)(1996-6#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#2)(2008-10#8)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-8#1)
slower to##7##2##(1993-6#1)(1995-12#1)(2008-10#1)(2008-4#1)(2009-8#1)(2012-2#1)(2012-3#1)
slower with##3##2##(1990-9#1)(1995-8#1)(2008-10#1)
slower##249##1##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#6)(1990-5#3)(1990-7#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#2)(1991-4#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-10#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#3)(1993-3#1)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-9#5)(1997-4#3)(1997-5#1)(1997-7#2)(1997-8#2)(2004-11#3)(2004-4#1)(2004-9#1)(2005-11#7)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-3#1)(2006-4#1)(2006-9#1)(2007-11#5)(2007-12#5)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#24)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#6)(2008-5#2)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#3)(2009-1#2)(2009-10#2)(2009-2#1)(2009-4#3)(2009-8#4)(2010-10#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#4)(2013-1#4)(2013-8#2)
slower)##2##1##(2008-10#2)
slowest##20##1##(1990-7#1)(1992-4#1)(1993-11#1)(1993-12#1)(1994-9#1)(1995-3#1)(1995-4#1)(1997-1#1)(1997-3#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-1#1)(2010-8#1)(2011-2#1)(2013-8#1)
slowing and##2##2##(2007-9#1)(2008-9#1)
slowing down of the##5##4##(1994-3#1)(2006-2#1)(2008-10#2)(2012-2#1)
slowing down of##6##3##(1994-3#1)(2006-2#1)(2007-12#1)(2008-10#2)(2012-2#1)
slowing down the##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
slowing down##14##2##(1994-3#1)(1997-8#1)(2006-2#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-12#1)(2011-2#3)(2012-2#1)(2013-1#1)
slowing effect##2##2##(2004-12#1)(2012-12#1)
slowing in##5##2##(1991-2#1)(1995-3#1)(1997-2#1)(2008-7#1)(2012-2#1)
slowing of the##7##3##(1990-11#1)(1991-11#1)(1991-12#1)(2006-9#1)(2007-12#1)(2008-11#1)(2012-3#1)
slowing of##21##2##(1990-11#1)(1991-11#2)(1991-12#2)(1991-7#1)(1993-6#1)(1994-12#1)(1994-3#1)(1996-3#2)(1996-9#1)(2006-11#1)(2006-9#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#2)(2012-2#1)(2012-3#1)
slowing related to##2##3##(2009-4#2)
slowing the growth##2##3##(1992-2#1)(2012-12#1)
slowing the progression of myopia##2##5##(2012-12#2)
slowing the##13##2##(1991-12#1)(1992-2#1)(1995-3#1)(1996-11#1)(2007-7#1)(2007-8#2)(2008-10#2)(2011-2#1)(2012-12#3)
slowing was##3##2##(1991-12#1)(1993-2#1)(2009-4#1)
slowing##89##1##(1990-11#1)(1990-3#4)(1991-11#2)(1991-12#4)(1991-2#1)(1991-7#2)(1992-2#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#2)(1995-3#2)(1995-5#1)(1996-11#1)(1996-3#2)(1996-8#1)(1996-9#2)(1997-2#1)(1997-8#1)(2004-12#1)(2005-11#1)(2006-11#1)(2006-2#1)(2006-9#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-4#3)(2009-8#2)(2011-2#4)(2012-1#1)(2012-12#7)(2012-2#3)(2012-3#2)(2013-1#1)
slowly (t1/2##2##2##(1990-2#1)(1995-6#1)
slowly after##2##2##(1994-5#1)(2008-5#1)
slowly and were##2##3##(1990-4#1)(1995-5#1)
slowly and##11##2##(1990-4#1)(1991-2#1)(1991-8#1)(1993-2#1)(1993-7#1)(1995-3#1)(1995-5#1)(2004-9#1)(2007-8#1)(2008-10#1)(2011-2#1)
slowly as##2##2##(2007-11#1)(2008-10#1)
slowly at##3##2##(1995-5#1)(2008-4#1)(2010-8#1)
slowly but##4##2##(2006-10#1)(2006-6#1)(2008-10#2)
slowly by##3##2##(1990-7#1)(1991-2#1)(2009-10#1)
slowly compared##2##2##(1995-3#1)(2005-11#1)
slowly decreasing##2##2##(1995-3#1)(2011-1#1)
slowly digested##3##2##(1991-11#1)(2006-10#2)
slowly during##2##2##(1997-4#1)(2008-10#1)
slowly evolving##2##2##(1995-8#1)(2007-12#1)
slowly exchanging##3##2##(1990-9#1)(1991-11#1)(1995-1#1)
slowly gaining##2##2##(2006-2#1)(2009-10#1)
slowly growing soft tissue##2##4##(2008-5#1)(2012-12#1)
slowly growing##9##2##(1992-4#1)(1993-5#1)(1997-2#1)(2006-10#1)(2008-10#1)(2008-5#1)(2011-2#2)(2012-12#1)
slowly hydrolyzable analogue of GTP)##2##5##(1997-7#2)
slowly hydrolyzed##3##2##(1992-11#1)(1992-6#1)(2008-4#1)
slowly in the absence##2##4##(1990-3#1)(1990-7#1)
slowly in the##7##3##(1990-3#1)(1990-7#1)(1996-12#1)(2005-12#1)(2007-8#1)(2008-10#2)
slowly in##14##2##(1990-3#1)(1990-7#1)(1992-3#1)(1994-5#1)(1996-12#1)(2005-12#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-4#1)(2013-7#1)
slowly increased##4##2##(1990-8#1)(2008-10#2)(2008-12#1)
slowly increasing##5##2##(1994-4#1)(1996-2#1)(1996-4#2)(1997-6#1)
slowly migrating species##2##3##(1993-12#2)
slowly migrating##4##2##(1993-12#2)(1995-3#1)(1997-7#1)
slowly moving##2##2##(1994-7#1)(2007-12#1)
slowly on the NMR time scale##2##6##(1990-5#1)(1991-2#1)
slowly on the##3##3##(1990-5#1)(1991-2#1)(2008-10#1)
slowly on##6##2##(1990-5#1)(1991-11#1)(1991-2#1)(2008-10#2)(2008-9#1)
slowly over a##2##3##(1991-2#1)(2010-8#1)
slowly over the##3##3##(1991-2#1)(2006-4#1)(2008-11#1)
slowly over##6##2##(1991-2#2)(2006-4#1)(2008-11#1)(2008-2#1)(2010-8#1)
slowly progressive CES##2##3##(2012-3#2)
slowly progressive ataxia##2##3##(1991-2#1)(2006-11#1)
slowly progressive##19##2##(1990-9#1)(1991-2#1)(1993-10#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-7#1)(2010-2#1)(2012-3#3)(2013-1#2)
slowly released##2##2##(1992-3#1)(2009-7#1)
slowly through##2##2##(1994-8#1)(2004-9#1)
slowly to the##2##3##(1991-6#1)(2008-3#1)
slowly to##8##2##(1991-5#1)(1991-6#1)(1994-8#1)(2007-12#2)(2008-11#1)(2008-3#1)(2011-12#1)
slowly until##2##2##(2008-11#1)(2011-2#1)
slowly varying##8##2##(1996-6#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#2)
slowly with the##5##3##(1995-2#1)(2004-9#1)(2008-3#2)(2012-1#1)
slowly with##11##2##(1994-12#1)(1995-10#1)(1995-2#1)(2004-9#1)(2005-11#1)(2006-10#1)(2008-3#3)(2008-8#1)(2012-1#1)
slowly##291##1##(1990-1#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#2)(1990-8#1)(1990-9#2)(1991-11#3)(1991-12#1)(1991-2#7)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#1)(1992-3#4)(1992-4#1)(1992-6#1)(1992-9#3)(1993-10#1)(1993-12#2)(1993-2#3)(1993-3#2)(1993-5#3)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-4#1)(1994-5#3)(1994-7#2)(1994-8#4)(1995-1#3)(1995-10#1)(1995-11#3)(1995-2#1)(1995-3#5)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-6#2)(1997-7#5)(1997-8#1)(2004-9#3)(2005-10#1)(2005-11#5)(2005-12#2)(2005-7#1)(2006-1#1)(2006-10#8)(2006-11#4)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-11#7)(2007-12#7)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#5)(2008-1#1)(2008-10#20)(2008-11#7)(2008-12#2)(2008-2#7)(2008-3#11)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#3)(2009-10#2)(2009-11#2)(2009-12#1)(2009-4#2)(2009-7#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-3#4)(2013-1#5)(2013-7#1)
slowness in##2##2##(1991-12#1)(2006-3#1)
slowness##4##1##(1991-12#1)(2006-3#1)(2007-10#1)(2012-12#1)
slows down the##4##3##(2008-10#1)(2008-4#1)(2011-1#1)(2012-1#1)
slows down##7##2##(2007-2#1)(2008-10#2)(2008-4#1)(2011-1#1)(2011-12#1)(2012-1#1)
slows the##6##2##(1993-6#1)(2007-11#1)(2008-5#1)(2008-8#1)(2009-6#1)(2012-2#1)
slows##25##1##(1990-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1996-7#1)(1996-8#1)(2007-11#1)(2007-2#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-6#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-8#1)
slpA signals##2##2##(1997-2#2)
slpA##4##1##(1997-2#4)
sludge and##7##2##(2004-4#2)(2008-12#1)(2008-6#1)(2010-12#1)(2012-12#2)
sludge are##2##2##(1993-5#1)(2005-11#1)
sludge as##3##2##(2007-10#1)(2008-5#1)(2012-12#1)
sludge can##2##2##(1997-4#1)(2012-12#1)
sludge during##2##2##(1992-6#1)(1997-4#1)
sludge floc##2##2##(2005-11#2)
sludge flocs##11##2##(2005-11#10)(2013-1#1)
sludge had##2##2##(2004-4#2)
sludge in##6##2##(1992-6#1)(1997-4#3)(2004-4#1)(2008-5#1)
sludge is##3##2##(2007-10#2)(2008-10#1)
sludge or##2##2##(2007-12#1)(2010-12#1)
sludge samples were##2##3##(2005-11#1)(2012-12#1)
sludge samples##7##2##(2005-11#5)(2012-12#2)
sludge studies##2##2##(2008-10#1)(2010-5#1)
sludge that##2##2##(2004-4#1)(2008-6#1)
sludge treatment##2##2##(1997-4#1)(2008-11#1)
sludge used##2##2##(2006-8#1)(2008-12#1)
sludge was##3##2##(2008-12#1)(2008-5#1)(2012-3#1)
sludge were##2##2##(2008-6#2)
sludge##128##1##(1992-2#1)(1992-6#2)(1992-7#1)(1993-5#1)(1997-4#14)(2004-4#11)(2005-11#19)(2006-8#2)(2007-10#5)(2007-12#2)(2008-1#2)(2008-10#15)(2008-11#4)(2008-12#14)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#4)(2008-7#1)(2008-9#1)(2009-6#1)(2010-12#2)(2010-5#2)(2011-2#4)(2012-12#6)(2012-3#3)(2013-1#4)
sludge)##2##1##(1991-7#1)(1992-7#1)
sludge-derived fertilizer##2##2##(2005-11#2)
sludges and##3##2##(2005-11#1)(2008-11#2)
sludges from##2##2##(2008-10#1)(2008-5#1)
sludges##19##1##(1992-6#1)(2005-11#1)(2007-6#1)(2008-10#8)(2008-11#3)(2008-5#4)(2008-6#1)
sludges)##2##1##(2004-4#1)(2008-11#1)
slug##7##1##(1993-6#3)(2008-10#1)(2008-6#2)(2008-7#1)
sluggish##6##1##(1990-7#1)(1992-5#1)(1993-7#1)(2008-10#1)(2008-4#1)(2012-2#1)
slugs##2##1##(1995-8#1)(2008-10#1)
sluicing##2##1##(2007-3#2)
slum communities##2##2##(1991-6#1)(2012-3#1)
slum of Delhi##3##3##(2008-7#1)(2008-8#1)(2011-12#1)
slum of##5##2##(2008-7#1)(2008-8#1)(2009-10#1)(2011-12#1)(2012-2#1)
slum##13##1##(1991-6#1)(2007-7#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-12#2)(2012-2#3)(2012-3#3)
slump in##2##2##(1992-11#1)(1995-10#1)
slump test##3##2##(2008-12#3)
slump##8##1##(1992-11#1)(1992-6#1)(1995-10#1)(2008-12#4)(2011-2#1)
slums##6##1##(2009-10#1)(2011-1#2)(2012-3#3)
slurried in##2##2##(2008-10#2)
slurried##5##1##(2008-10#5)
slurries (2%##2##2##(2008-10#2)
slurries and##2##2##(2008-10#2)
slurries of##6##2##(1995-1#1)(2006-8#1)(2008-10#4)
slurries were prepared by##3##4##(2008-10#3)
slurries were##8##2##(2004-9#1)(2008-10#7)
slurries with TTCP/DCPA molar##2##4##(2004-9#2)
slurries with##3##2##(2004-9#3)
slurries##39##1##(1995-1#1)(2004-9#4)(2005-11#1)(2006-8#6)(2008-10#22)(2008-11#1)(2008-5#4)
slurry analysis##3##2##(2008-10#3)
slurry and##3##2##(2008-10#3)
slurry formation##3##2##(2008-10#3)
slurry from##2##2##(2006-8#1)(2009-11#1)
slurry preparation##4##2##(2008-10#4)
slurry prepared##2##2##(2005-4#1)(2008-6#1)
slurry sample introduction##2##3##(2008-10#2)
slurry sample##3##2##(2008-10#3)
slurry samples##6##2##(2008-10#6)
slurry sampling ETAAS##3##3##(2008-10#3)
slurry sampling and##3##3##(2005-4#1)(2008-10#2)
slurry sampling electrothermal atomic absorption spectrometry##2##6##(2008-10#2)
slurry sampling electrothermal atomic absorption##3##5##(2008-10#3)
slurry sampling electrothermal vaporisation##2##4##(2008-10#2)
slurry sampling electrothermal##6##3##(2008-10#6)
slurry sampling with##2##3##(2005-4#2)
slurry sampling##30##2##(2005-4#3)(2008-10#27)
slurry technique##3##2##(2008-10#3)
slurry was##7##2##(2008-10#5)(2008-3#1)(2012-12#1)
slurry##94##1##(2004-9#1)(2005-4#4)(2006-8#1)(2008-1#1)(2008-10#73)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2009-11#1)(2012-12#1)(2013-1#1)
sm1 carcinoma##2##2##(2008-5#2)
sm1##3##1##(2008-5#3)
smad proteins##5##2##(2005-8#5)
smad##6##1##(2005-8#6)
small (&lt##15##2##(1995-11#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-8#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-12#1)(2012-3#1)(2013-1#1)
small (0##2##2##(2007-11#1)(2008-10#1)
small (1##2##2##(1991-11#1)(2008-3#1)
small (6##2##2##(1992-10#1)(1994-2#1)
small (about##3##2##(1997-6#1)(2007-3#1)(2010-8#1)
small (approximately##3##2##(1997-6#1)(2008-3#1)(2011-1#1)
small (diameter##2##2##(2007-12#1)(2009-10#1)
small (less than##2##3##(1990-10#1)(1991-6#1)
small 5'##2##2##(1993-2#1)(1995-2#1)
small 62-bp unit##2##3##(1995-1#2)
small DNA fragments##2##3##(1995-2#1)(2008-4#1)
small DNA##6##2##(1995-2#1)(2008-10#2)(2008-4#1)(2008-7#1)(2012-2#1)
small G protein Rac##2##4##(2011-1#2)
small G protein##5##3##(1991-5#1)(1992-1#1)(1993-12#1)(2011-1#2)
small G##6##2##(1991-5#1)(1992-1#2)(1993-12#1)(2011-1#2)
small GTP binding proteins##4##4##(1996-5#1)(1997-4#2)(2008-1#1)
small GTP binding##6##3##(1996-5#1)(1997-4#4)(2008-1#1)
small GTP-binding protein##10##3##(1991-12#1)(1992-11#1)(1992-5#1)(1993-6#1)(1994-11#1)(1994-12#3)(1994-9#1)(1997-6#1)
small GTP-binding proteins by##2##4##(1992-3#1)(1995-8#1)
small GTP-binding proteins##18##3##(1991-1#1)(1991-10#1)(1991-8#1)(1992-1#2)(1992-3#1)(1993-6#3)(1994-11#1)(1994-12#2)(1994-6#1)(1994-9#1)(1995-6#1)(1995-8#1)(1997-1#1)(2008-6#1)
small GTP-binding##29##2##(1991-1#1)(1991-10#1)(1991-12#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-3#1)(1992-5#1)(1993-6#4)(1994-11#2)(1994-12#5)(1994-6#1)(1994-9#2)(1995-6#1)(1995-8#1)(1996-4#1)(1997-1#1)(1997-6#1)(2008-6#1)
small GTPase##6##2##(1997-6#1)(2006-10#2)(2008-7#1)(2011-2#2)
small GTPases and##2##3##(1997-7#1)(2008-11#1)
small GTPases of the##2##4##(1993-8#1)(2008-11#1)
small GTPases##16##2##(1993-6#1)(1993-8#1)(1995-6#1)(1996-2#1)(1997-7#1)(2005-7#1)(2006-8#1)(2008-1#1)(2008-11#2)(2008-7#2)(2009-10#1)(2009-8#1)(2011-2#1)(2012-2#1)
small LDL##2##2##(2008-3#1)(2012-2#1)
small Maf family protein##3##4##(1995-3#2)(1996-2#1)
small Maf family##4##3##(1995-3#3)(1996-2#1)
small N##2##2##(2007-3#1)(2008-2#1)
small PG##3##2##(1997-8#3)
small PGs##2##2##(1997-8#2)
small PTTH##2##2##(1995-11#2)
small PTTH-stimulated ecdysteroid secretion##2##4##(1995-11#2)
small QTL##2##2##(2012-11#2)
small RNA and##2##3##(2008-10#1)(2010-5#1)
small RNA##11##2##(1993-9#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-8#1)(2009-3#2)(2010-5#1)(2013-8#1)
small RNAs can be##2##4##(1994-12#1)(2008-9#1)
small RNAs from##2##3##(2008-9#2)
small RNAs that##4##3##(2009-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
small RNAs##27##2##(1991-2#2)(1994-12#1)(2007-10#1)(2008-1#1)(2008-2#3)(2008-4#3)(2008-9#8)(2009-3#3)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
small Reynolds numbers##2##3##(2005-11#1)(2008-2#1)
small aberrations##2##2##(2008-3#2)
small absorbers##2##2##(2007-11#1)(2008-3#1)
small active##2##2##(1993-3#1)(2008-2#1)
small adult##2##2##(2006-11#1)(2007-4#1)
small air##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
small airways##5##2##(1991-4#1)(2005-8#2)(2010-10#1)(2012-12#1)
small amino acid##3##3##(1993-6#1)(1997-1#1)(2007-10#1)
small amino acids##2##3##(1993-6#1)(1996-8#1)
small amino##5##2##(1993-6#2)(1996-8#1)(1997-1#1)(2007-10#1)
small amount of absorption of##2##5##(2008-2#1)(2008-3#1)
small amount of the##5##4##(1990-1#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-6#1)
small amount of##64##3##(1990-1#1)(1990-11#1)(1990-7#1)(1991-1#1)(1991-4#1)(1991-9#1)(1992-8#1)(1993-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#1)(2004-11#1)(2005-10#1)(2005-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#1)(2009-11#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
small amount##67##2##(1990-1#1)(1990-11#1)(1990-7#1)(1991-1#1)(1991-4#1)(1991-9#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-5#1)(1994-8#2)(1995-2#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#1)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#1)(2009-11#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
small amounts of a##3##4##(2008-10#1)(2010-4#2)
small amounts of blood can be obtained with little ill effect on the animal##2##14##(2008-4#2)
small amounts of blood##5##4##(1990-11#1)(2008-11#1)(2008-4#3)
small amounts of human##2##4##(1990-4#1)(1992-7#1)
small amounts of ionic##2##4##(2005-11#2)
small amounts of the##5##4##(1990-5#1)(1993-3#1)(1995-11#1)(2007-11#1)(2008-10#1)
small amounts of##70##3##(1990-11#1)(1990-2#2)(1990-4#1)(1990-5#2)(1991-10#1)(1991-9#1)(1992-11#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-12#3)(1995-11#1)(1995-2#1)(1996-5#2)(1996-9#1)(1997-8#1)(2005-10#1)(2005-11#4)(2006-10#3)(2006-4#1)(2007-11#1)(2007-12#2)(2008-10#14)(2008-11#2)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#2)(2012-1#1)(2012-2#3)(2013-8#1)
small amounts##81##2##(1990-11#1)(1990-2#2)(1990-4#1)(1990-5#2)(1991-10#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-12#3)(1994-2#1)(1995-10#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-5#2)(1996-9#1)(1997-4#1)(1997-8#1)(2005-10#2)(2005-11#4)(2005-7#1)(2006-10#3)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#2)(2008-10#14)(2008-11#3)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-4#2)(2012-1#1)(2012-2#3)(2013-8#1)
small amplitude##8##2##(1990-2#1)(1993-12#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)
small analyte##3##2##(2008-4#1)(2008-7#2)
small analytes##2##2##(2008-10#2)
small and a##3##3##(2006-10#1)(2008-10#1)(2011-1#1)
small and asymptomatic##2##3##(2013-1#1)(2013-8#1)
small and in##2##3##(2006-12#1)(2007-12#1)
small and isolated patches##2##4##(2008-9#2)
small and isolated##3##3##(1996-12#1)(2008-9#2)
small and large bowel##2##4##(2008-4#1)(2008-7#1)
small and large intestines##4##4##(1995-5#1)(2007-4#1)(2008-5#1)(2008-7#1)
small and large populations##2##4##(1996-2#1)(1996-6#1)
small and large subunits##3##4##(1990-11#2)(2005-10#1)
small and large##26##3##(1990-11#2)(1990-5#1)(1992-10#1)(1993-12#1)(1994-11#1)(1994-3#1)(1995-5#1)(1996-2#1)(1996-6#1)(1997-5#1)(2005-10#1)(2007-4#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
small and median enterprises##3##4##(2007-4#3)
small and medium size##2##4##(1994-6#1)(2012-12#1)
small and medium##9##3##(1994-6#1)(1996-12#1)(1997-3#1)(2006-10#2)(2006-12#1)(2008-10#1)(2011-1#1)(2012-12#1)
small and medium-sized##2##3##(1997-8#2)
small and non-significant##2##3##(1997-4#1)(2008-4#1)
small and not##3##3##(1991-5#1)(1994-2#1)(2006-9#1)
small and the##7##3##(1991-9#1)(1995-9#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-6#1)(2012-3#1)
small and there##2##3##(2008-10#1)(2010-12#1)
small and transient##3##3##(1994-5#1)(2007-8#1)(2011-10#1)
small and##116##2##(1990-11#2)(1990-5#2)(1991-12#1)(1991-5#1)(1991-9#1)(1992-10#2)(1992-3#1)(1992-8#1)(1993-10#1)(1993-12#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-8#3)(2005-10#2)(2005-11#1)(2006-10#3)(2006-12#3)(2006-3#1)(2006-6#1)(2006-9#2)(2007-11#1)(2007-12#3)(2007-2#2)(2007-4#4)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#9)(2008-11#2)(2008-3#4)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-3#1)(2010-11#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-10#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#2)
small angle X-ray scattering##3##4##(2005-11#1)(2006-10#1)(2008-11#1)
small angle X-ray##4##3##(2005-11#1)(2006-10#1)(2008-11#1)(2008-5#1)
small angle neutron scattering (SANS)##2##5##(2005-11#1)(2008-10#1)
small angle neutron scattering and##2##5##(2008-10#1)(2008-5#1)
small angle neutron scattering##4##4##(2005-11#1)(2008-10#2)(2008-5#1)
small angle##18##2##(1992-9#1)(2005-11#2)(2006-10#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2009-6#1)
small angles##9##2##(1992-7#1)(2007-12#1)(2008-2#3)(2008-3#4)
small angular##5##2##(2006-4#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-12#1)
small animal imaging##6##3##(2007-12#1)(2009-8#1)(2011-1#3)(2012-12#1)
small animal model system##2##4##(2008-11#2)
small animal model##5##3##(1994-12#1)(2006-10#1)(2007-8#1)(2008-11#2)
small animal models of##2##4##(2008-5#1)(2012-12#1)
small animal##23##2##(1994-12#1)(1996-12#2)(2006-10#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-5#1)(2009-8#2)(2010-2#3)(2011-1#3)(2012-12#6)
small animals using##2##3##(2011-1#2)
small animals##14##2##(1990-12#1)(1991-11#1)(2007-12#2)(2010-12#1)(2010-2#2)(2010-7#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-2#1)
small antral follicles##3##3##(2008-8#2)(2008-9#1)
small apertures##3##2##(2007-11#2)(2008-2#1)
small applied##2##2##(2007-11#1)(2008-10#1)
small aqueous pore##3##3##(1990-2#3)
small are##2##2##(2008-2#1)(2013-8#1)
small area variation##2##3##(2008-7#2)
small area##16##2##(1990-8#1)(1991-7#1)(1991-8#1)(1993-2#1)(1994-8#1)(2005-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#3)(2011-2#1)(2013-7#1)
small areas of##3##3##(2008-10#2)(2008-2#1)
small areas##9##2##(1990-8#1)(1995-12#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)
small aromatic molecules##2##3##(2010-11#2)
small arteries and##3##3##(1996-8#1)(2007-10#1)(2007-9#1)
small arteries##5##2##(1996-8#1)(2007-10#1)(2007-9#2)(2009-1#1)
small artery disease##2##3##(2007-10#2)
small artery##11##2##(1994-3#1)(2005-11#1)(2007-10#5)(2009-1#2)(2012-2#1)(2013-8#1)
small artificial##2##2##(2010-8#2)
small as##54##2##(1991-12#1)(1991-2#1)(1993-7#1)(1997-5#1)(1997-6#1)(2005-11#1)(2006-12#1)(2007-11#3)(2007-12#5)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#10)(2008-3#16)(2008-5#2)(2009-12#1)(2010-11#1)(2010-12#1)(2011-1#1)
small astatic##2##2##(2008-5#2)
small at##3##2##(2007-12#1)(2008-2#1)(2008-7#1)
small average##3##2##(2007-11#2)(2009-2#1)
small babies##2##2##(1990-3#1)(2010-12#1)
small basic##4##2##(1991-5#1)(1992-12#1)(1993-6#1)(1995-4#1)
small beam##4##2##(2008-3#4)
small bend##2##2##(2008-2#1)(2008-3#1)
small benefit##3##2##(1991-7#1)(1997-8#1)(2007-8#1)
small biases##2##2##(1997-3#1)(2010-2#1)
small biological networks##2##3##(2008-11#1)(2010-10#1)
small biological samples##3##3##(1997-3#2)(2008-1#1)
small biological##7##2##(1997-3#2)(2008-1#1)(2008-11#1)(2008-8#1)(2010-10#2)
small biopharmaceutical companies and##2##4##(2005-9#2)
small biopsy##3##2##(1993-5#1)(2008-1#1)(2011-2#1)
small blood vessels##3##3##(2007-9#1)(2008-12#1)(2009-11#1)
small blood##5##2##(2007-7#1)(2007-9#1)(2008-12#1)(2008-3#1)(2009-11#1)
small blue copper##2##3##(1993-11#2)
small bore##2##2##(2008-2#1)(2012-1#1)
small bowel biopsy##2##3##(1991-3#1)(2005-12#1)
small bowel capsule endoscopy##3##4##(2011-2#3)
small bowel disease##5##3##(1995-12#1)(2006-10#3)(2010-12#1)
small bowel diseases##2##3##(2006-10#1)(2011-2#1)
small bowel disorders##3##3##(2012-2#3)
small bowel enteroscopy##2##3##(2006-10#2)
small bowel following##2##3##(2005-12#1)(2011-2#1)
small bowel involvement##2##3##(1995-10#1)(2010-12#1)
small bowel juice##2##3##(1990-12#2)
small bowel lesions##2##3##(2010-12#2)
small bowel loop##2##3##(2007-3#1)(2008-3#1)
small bowel obstruction is##2##4##(2006-10#1)(2008-3#1)
small bowel obstruction##16##3##(2006-10#1)(2006-6#2)(2007-8#2)(2008-12#2)(2008-3#2)(2009-6#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-1#2)
small bowel receiving &gt##2##4##(2008-6#1)(2013-1#1)
small bowel resection##4##3##(1992-5#2)(2008-10#1)(2010-12#1)
small bowel transplantation as##2##4##(2004-11#1)(2006-10#1)
small bowel transplantation##7##3##(2004-11#1)(2006-10#4)(2008-11#2)
small bowel was##2##3##(2006-2#1)(2010-12#1)
small bowel##145##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-8#1)(1991-12#1)(1991-3#2)(1991-6#1)(1991-9#3)(1992-5#4)(1992-9#1)(1993-10#2)(1993-8#1)(1995-10#1)(1995-12#2)(1996-8#1)(1997-3#1)(1997-8#3)(2004-11#1)(2005-10#2)(2005-12#3)(2006-10#18)(2006-2#3)(2006-4#1)(2006-6#2)(2006-8#1)(2007-3#1)(2007-5#1)(2007-8#4)(2008-10#2)(2008-11#2)(2008-12#3)(2008-3#3)(2008-6#4)(2008-7#1)(2008-8#1)(2009-1#1)(2009-2#2)(2009-4#3)(2009-6#1)(2009-7#2)(2009-8#1)(2010-12#20)(2010-2#1)(2011-2#11)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#4)(2013-1#5)(2013-8#2)
small boxes##3##2##(1995-3#3)
small brains##2##2##(2008-3#1)(2012-3#1)
small breast##4##2##(1994-12#1)(1996-6#1)(2012-2#1)(2013-1#1)
small business##2##2##(1991-12#1)(2007-4#1)
small but significant increases in##3##5##(1990-3#1)(1993-12#1)(2008-10#1)
small but significant##25##3##(1990-3#1)(1990-4#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-2#1)(1995-11#1)(1995-8#1)(1997-3#1)(1997-5#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#2)(2008-9#1)
small but statistically significant##5##4##(1992-2#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-2#1)
small but statistically##7##3##(1992-2#1)(1995-12#1)(2007-8#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-2#1)
small but##48##2##(1990-3#1)(1990-4#1)(1990-6#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-2#1)(1995-11#1)(1995-12#2)(1995-8#1)(1996-10#1)(1996-5#2)(1997-1#1)(1997-3#1)(1997-5#2)(2004-2#1)(2005-10#1)(2005-9#1)(2006-10#2)(2006-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-2#1)(2010-4#1)
small caliber##2##2##(1992-1#1)(2004-9#1)
small capacity##2##2##(1991-2#1)(2007-3#1)
small carnivores##2##2##(2008-5#2)
small case series of##2##4##(2008-8#1)(2013-1#1)
small case series##4##3##(2006-2#1)(2008-8#1)(2010-5#1)(2013-1#1)
small case##5##2##(2006-2#1)(2008-11#1)(2008-8#1)(2010-5#1)(2013-1#1)
small cations##2##2##(2005-9#1)(2006-2#1)
small cell and non-small cell lung cancer cells##2##8##(1994-3#2)
small cell and non-small cell lung##3##6##(1994-3#2)(1997-4#1)
small cell carcinoma and##2##4##(1991-6#1)(2009-5#1)
small cell carcinoma of the bladder##2##6##(1992-12#2)
small cell carcinoma of the gallbladder##3##6##(2009-3#3)
small cell carcinoma of the lung##3##6##(1990-12#1)(1995-9#1)(2007-11#1)
small cell carcinoma of the##11##5##(1990-12#1)(1992-12#2)(1995-9#1)(1997-5#1)(2007-11#1)(2007-7#1)(2009-3#3)(2009-8#1)
small cell carcinoma or##2##4##(2009-1#1)(2012-3#1)
small cell carcinoma was##2##4##(2007-8#1)(2009-3#1)
small cell carcinoma##25##3##(1990-10#1)(1990-12#1)(1991-6#1)(1992-12#2)(1992-4#1)(1995-9#1)(1997-5#1)(2007-11#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2009-1#2)(2009-3#5)(2009-5#1)(2009-8#2)(2012-3#1)
small cell carcinomas##3##3##(1990-10#1)(2009-5#1)(2011-2#1)
small cell lung cancer (SCLC)##2##5##(1992-10#1)(2013-8#1)
small cell lung cancer cells##3##5##(1993-12#1)(1994-3#1)(1994-9#1)
small cell lung cancer patients##3##5##(1991-12#3)
small cell lung cancer##33##4##(1990-2#1)(1991-12#5)(1991-6#1)(1992-10#2)(1993-12#1)(1993-2#1)(1994-10#1)(1994-3#1)(1994-4#2)(1994-9#1)(1995-8#1)(1996-1#2)(1996-2#1)(2006-6#1)(2007-4#1)(2008-10#2)(2008-5#1)(2009-1#2)(2009-5#1)(2010-8#2)(2012-2#1)(2013-8#2)
small cell lung carcinoma (SCLC)##2##5##(1994-3#1)(2012-2#1)
small cell lung carcinoma cell line##3##6##(1992-3#1)(1994-8#1)(1996-12#1)
small cell lung carcinoma##11##4##(1990-12#1)(1992-3#1)(1994-10#1)(1994-3#2)(1994-8#2)(1996-12#2)(2012-2#2)
small cell lung##47##3##(1990-12#1)(1990-2#1)(1991-12#5)(1991-6#1)(1992-10#2)(1992-3#2)(1993-12#1)(1993-2#1)(1994-10#2)(1994-3#3)(1994-4#2)(1994-8#2)(1994-9#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#1)(2006-6#2)(2007-4#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-1#2)(2009-5#1)(2010-8#2)(2012-2#3)(2013-8#2)
small cell##88##2##(1990-10#3)(1990-12#2)(1990-2#1)(1991-12#5)(1991-6#2)(1992-10#2)(1992-12#2)(1992-3#2)(1992-4#1)(1993-12#1)(1993-2#1)(1994-10#2)(1994-3#5)(1994-4#2)(1994-8#2)(1994-9#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#2)(1996-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-6#2)(2007-11#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#2)(2009-1#4)(2009-3#5)(2009-5#4)(2009-8#2)(2010-8#3)(2011-2#2)(2012-2#3)(2012-3#2)(2013-8#2)
small cells with##2##3##(2008-11#1)(2008-6#1)
small cells##6##2##(1991-6#1)(1992-8#1)(1995-5#1)(1995-7#1)(2008-11#1)(2008-6#1)
small change in the##5##4##(1992-2#1)(1994-8#1)(2007-11#1)(2008-3#2)
small change in##7##3##(1992-2#1)(1994-8#1)(2007-11#3)(2008-3#2)
small changes in the##12##4##(1994-12#1)(1995-5#1)(2005-11#1)(2006-4#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-8#1)(2010-7#1)(2013-1#1)
small changes in##24##3##(1990-12#1)(1994-12#1)(1995-5#1)(1996-7#1)(2004-9#1)(2005-11#1)(2006-12#1)(2006-4#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-8#3)(2009-11#1)(2010-7#1)(2012-1#1)(2013-1#1)
small changes##28##2##(1990-12#1)(1992-1#1)(1994-12#1)(1995-5#1)(1996-7#1)(2004-9#1)(2005-11#1)(2005-3#1)(2006-12#1)(2006-4#1)(2008-2#2)(2008-3#6)(2008-4#2)(2008-8#3)(2009-11#1)(2010-7#1)(2012-1#1)(2013-1#2)
small channel##3##2##(1991-12#1)(1992-12#1)(1992-7#1)
small chemicals##2##2##(1995-2#1)(2007-8#1)
small children treated##2##3##(1992-4#1)(1996-11#1)
small children with##4##3##(2008-1#1)(2008-10#1)(2009-4#1)(2013-1#1)
small children##22##2##(1990-11#1)(1991-10#1)(1991-8#1)(1992-4#1)(1993-1#1)(1993-5#1)(1994-2#1)(1996-11#1)(1996-3#1)(2006-10#2)(2007-11#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-9#1)(2009-4#1)(2012-12#2)(2013-1#1)(2013-7#1)
small chromosomes##3##2##(2008-10#1)(2008-8#2)
small circular##2##2##(2008-10#1)(2008-2#1)
small clinic##2##2##(2006-4#2)
small clinical trials##2##3##(1993-12#1)(2007-4#1)
small clinical##3##2##(1993-12#1)(2007-4#1)(2008-5#1)
small closed##2##2##(2004-11#1)(2008-10#1)
small clumps##2##2##(1992-2#1)(2008-4#1)
small cluster of##2##3##(2006-2#1)(2007-8#1)
small clusters of##4##3##(1990-3#1)(1991-9#1)(1996-5#1)(2007-12#1)
small cohort##2##2##(2008-11#1)(2010-4#1)
small collagen##3##2##(2011-1#2)(2013-1#1)
small colorectal polyps##2##3##(2008-5#2)
small communities##6##2##(1994-11#1)(2008-1#1)(2008-10#1)(2010-9#2)(2012-2#1)
small companies##2##2##(1995-6#1)(2007-12#1)
small compared to##5##3##(1996-4#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-8#1)
small compared with that##2##4##(1991-10#1)(1995-11#1)
small compared with##8##3##(1991-10#1)(1995-11#1)(1995-3#1)(2007-11#1)(2008-10#2)(2008-3#2)
small compared##13##2##(1991-10#1)(1995-11#1)(1995-3#1)(1996-4#1)(2005-11#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-8#1)
small concentration##2##2##(2008-10#2)
small concentrations of##3##3##(1990-4#1)(1993-5#1)(1994-11#1)
small concentrations##5##2##(1990-4#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-11#1)
small conductance##2##2##(1996-8#1)(1997-5#1)
small conformational##2##2##(1992-12#1)(1995-11#1)
small contact angles##2##3##(2005-11#2)
small core##2##2##(2007-12#2)
small coronary arteries##2##3##(1996-12#2)
small coronary##3##2##(1996-12#2)(2008-5#1)
small cortical##2##2##(2006-3#1)(2007-10#1)
small country##4##2##(1996-6#1)(2008-1#1)(2008-8#1)(2011-1#1)
small crystal##2##2##(2006-12#1)(2008-3#1)
small currents##2##2##(1992-9#1)(2008-2#1)
small cysts##3##2##(1993-5#1)(2010-6#1)(2011-1#1)
small cytoplasmic RNA##2##3##(1994-3#1)(1996-5#1)
small decrease in##10##3##(1990-5#1)(1997-1#1)(1997-7#1)(2007-12#1)(2007-2#1)(2007-9#2)(2008-10#1)(2008-7#1)(2012-1#1)
small decrease##15##2##(1990-5#1)(1992-3#1)(1992-9#1)(1997-1#1)(1997-7#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-9#2)(2008-10#2)(2008-7#1)(2010-9#1)(2012-1#1)
small decreases in the##2##4##(1990-3#1)(1990-7#1)
small decreases in##4##3##(1990-3#1)(1990-7#1)(1992-9#1)(1997-4#1)
small deformation##4##2##(2005-11#2)(2007-11#1)(2008-8#1)
small deformations##6##2##(2005-11#3)(2008-2#1)(2008-3#2)
small degree of##3##3##(1991-6#1)(2005-12#1)(2008-1#1)
small degree##5##2##(1990-6#1)(1991-6#1)(1992-10#1)(2005-12#1)(2008-1#1)
small deletion in##2##3##(1990-5#1)(2012-11#1)
small deletion##5##2##(1990-5#1)(1993-8#1)(2008-4#1)(2008-9#1)(2012-11#1)
small dense LDL##4##3##(2005-7#1)(2008-1#1)(2008-3#2)
small dense##8##2##(1997-2#1)(2005-7#1)(2008-1#1)(2008-3#4)(2011-1#1)
small dependence on##2##3##(1993-8#1)(1997-6#1)
small diameter afferents##2##3##(1993-4#2)
small diameter##10##2##(1993-4#3)(2006-12#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-11#1)
small difference between##2##3##(2007-3#1)(2010-2#1)
small difference in##5##3##(1995-11#1)(2005-11#1)(2007-12#1)(2012-3#1)(2013-8#1)
small difference##9##2##(1995-11#1)(2005-11#2)(2007-1#1)(2007-12#1)(2007-3#1)(2010-2#1)(2012-3#1)(2013-8#1)
small differences between the##2##4##(2006-12#1)(2008-11#1)
small differences between##4##3##(2006-12#1)(2008-11#2)(2011-2#1)
small differences in##7##3##(1991-8#1)(1993-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)
small differences that are##2##4##(2006-10#1)(2007-11#1)
small differences##16##2##(1991-8#1)(1992-8#1)(1993-2#1)(1994-8#1)(1996-2#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
small dimension##2##2##(2007-12#1)(2012-1#1)
small dimensions##3##2##(1990-10#1)(2008-10#2)
small dispersal rates##2##3##(2008-8#2)
small displacement##2##2##(2008-2#2)
small distances##8##2##(1990-8#1)(2007-11#3)(2007-12#2)(2008-3#2)
small domain##2##2##(2008-3#1)(2009-7#1)
small domains##3##2##(1997-6#1)(2006-10#1)(2008-10#1)
small doses and##2##3##(1990-5#1)(2011-1#1)
small doses of##9##3##(1990-6#1)(1991-11#1)(1991-3#1)(1993-12#1)(1997-7#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-7#1)
small doses##14##2##(1990-5#1)(1990-6#1)(1991-11#1)(1991-3#1)(1993-12#2)(1996-1#1)(1997-7#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#1)(2011-1#1)
small droplets of##2##3##(2006-5#1)(2008-10#1)
small droplets##6##2##(1994-12#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-2#2)
small drops##4##2##(2005-11#4)
small dsRNA##2##2##(2008-10#2)
small duct##2##2##(2006-10#2)
small effect of##2##3##(1997-8#1)(2008-9#1)
small effect on the##2##4##(1993-9#1)(2005-1#1)
small effect on##7##3##(1990-2#1)(1993-9#1)(1995-3#2)(2005-1#1)(2008-8#1)(2009-10#1)
small effect##17##2##(1990-2#1)(1991-5#1)(1993-9#1)(1995-3#2)(1996-5#1)(1997-8#1)(2005-1#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-10#2)(2010-4#1)(2012-11#1)(2013-1#1)
small effective##4##2##(1995-11#1)(2006-6#1)(2007-12#2)
small effects##6##2##(1991-12#1)(1991-5#1)(1996-8#1)(1997-4#1)(2007-9#1)(2008-10#1)
small electric##3##2##(1991-11#1)(2008-2#1)(2011-2#1)
small employers##2##2##(1994-3#2)
small energetic contribution##2##3##(2005-11#2)
small enough to fit in##2##5##(1994-2#1)(2008-2#1)
small enough to##10##3##(1994-1#1)(1994-2#1)(1997-6#1)(2007-5#1)(2008-10#1)(2008-2#3)(2008-3#2)
small enough##15##2##(1994-1#1)(1994-2#1)(1997-6#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#4)(2008-3#2)(2010-7#1)
small error##3##2##(2007-12#1)(2008-3#2)
small excitatory##2##2##(1992-8#1)(1997-4#1)
small experimental animals##2##3##(1990-12#1)(2008-11#1)
small experimental##3##2##(1990-12#1)(2008-11#1)(2013-1#1)
small exploratory##2##2##(2008-11#1)(2010-2#1)
small extent##6##2##(1991-9#1)(1995-3#1)(1996-1#1)(2006-12#1)(2007-1#1)(2008-10#1)
small factories##2##2##(1994-6#1)(1994-9#1)
small families##2##2##(1990-6#1)(2010-7#1)
small family##2##2##(1994-7#1)(2008-8#1)
small features##2##2##(2007-11#1)(2007-12#1)
small female##7##2##(2006-11#6)(2007-4#1)
small females##2##2##(2006-11#1)(2007-4#1)
small fiber##3##2##(2008-3#1)(2010-1#1)(2012-3#1)
small fibers##2##2##(1997-5#1)(2010-1#1)
small field sizes##2##3##(2008-3#2)
small field##5##2##(1994-9#1)(2008-2#1)(2008-3#2)(2011-1#1)
small fish##2##2##(2010-8#1)(2013-7#1)
small focal##3##2##(1991-9#1)(2011-1#1)(2012-2#1)
small foci of##2##3##(2008-11#1)(2011-2#1)
small follicles of the##3##4##(2011-1#3)
small for gestational age (SGA)##7##5##(1992-7#1)(1994-3#1)(1994-4#1)(2007-5#1)(2011-1#2)(2013-1#1)
small for gestational age##11##4##(1990-12#1)(1992-7#1)(1994-3#1)(1994-4#1)(1994-6#1)(2007-5#1)(2007-9#1)(2008-4#1)(2011-1#2)(2013-1#1)
small for the##3##3##(2006-3#1)(2008-3#2)
small for their##2##3##(1991-12#1)(1993-1#1)
small for##20##2##(1990-12#1)(1991-12#1)(1991-5#1)(1992-7#1)(1993-1#1)(1994-3#1)(1994-4#1)(1994-6#1)(2006-3#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-2#1)(2008-3#3)(2008-4#1)(2011-1#2)(2013-1#1)
small forces##2##2##(2008-2#1)(2012-12#1)
small forest##2##2##(1997-4#1)(2008-5#1)
small fraction of the##9##4##(1992-11#1)(1992-6#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-11#1)(2010-8#1)(2013-1#1)
small fraction of##23##3##(1991-12#1)(1991-5#1)(1992-11#1)(1992-6#1)(1994-5#1)(1995-11#1)(1997-6#1)(2005-12#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2010-11#2)(2010-5#1)(2010-8#1)(2013-1#1)
small fraction##26##2##(1991-12#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-6#1)(1994-5#1)(1995-11#1)(1997-6#1)(2005-12#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#2)(2010-11#2)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
small fractions of##2##3##(1990-3#1)(1994-9#1)
small fragment##3##2##(1993-3#1)(2008-8#1)(2012-3#1)
small fruit##2##2##(2008-10#2)
small genetic##2##2##(2008-10#2)
small genomes##2##2##(2009-5#1)(2012-11#1)
small genomic##3##2##(2008-9#1)(2009-7#1)(2013-1#1)
small geographic areas##2##3##(2008-10#1)(2012-1#1)
small geographic##3##2##(2008-10#1)(2011-12#1)(2012-1#1)
small geographical##3##2##(2008-10#2)(2012-3#1)
small glass columns##2##3##(1991-8#1)(2008-10#1)
small globular##3##2##(1995-1#1)(1995-5#1)(2008-8#1)
small gold##2##2##(2009-3#1)(2010-4#1)
small grains##7##2##(2004-9#1)(2008-10#5)(2008-9#1)
small grazing##3##2##(2007-11#2)(2008-2#1)
small group discussion##2##3##(2005-10#1)(2013-8#1)
small group of patients##5##4##(1996-2#1)(2005-10#1)(2005-11#1)(2005-8#1)(2010-8#1)
small group of##17##3##(1990-2#1)(1995-12#1)(1996-2#1)(2005-10#1)(2005-11#1)(2005-8#1)(2007-9#2)(2008-10#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-10#1)(2010-12#1)(2010-8#1)(2013-1#2)
small group process##2##3##(2008-12#2)
small group##28##2##(1990-2#1)(1994-12#1)(1995-12#1)(1996-2#1)(2004-10#1)(2005-10#2)(2005-11#1)(2005-8#1)(2006-12#1)(2007-2#1)(2007-9#2)(2008-10#2)(2008-12#2)(2008-7#1)(2008-8#1)(2009-2#1)(2010-10#1)(2010-12#1)(2010-8#1)(2012-3#1)(2013-1#2)(2013-8#2)
small groups of##8##3##(1995-3#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-11#1)(2012-1#1)
small groups##21##2##(1991-11#1)(1992-3#1)(1994-4#1)(1995-3#1)(1996-5#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-11#1)(2012-1#1)
small hairpin RNA##4##3##(2013-1#4)
small hairpin##5##2##(2010-11#1)(2013-1#4)
small health##2##2##(1996-1#1)(2006-8#1)
small heat capacity changes##2##4##(1997-2#2)
small heat capacity##3##3##(1997-2#3)
small heat shock protein##4##4##(1992-1#1)(1992-11#1)(1997-6#1)(2013-1#1)
small heat shock proteins##5##4##(1992-11#1)(1992-5#1)(1992-9#1)(1996-10#1)(2008-7#1)
small heat shock##9##3##(1992-1#1)(1992-11#2)(1992-5#1)(1992-9#1)(1996-10#1)(1997-6#1)(2008-7#1)(2013-1#1)
small heat##13##2##(1992-1#1)(1992-11#2)(1992-5#1)(1992-9#1)(1996-10#1)(1997-2#3)(1997-6#1)(2008-7#1)(2013-1#2)
small heat-shock protein##5##3##(1993-6#3)(1996-10#1)(2009-8#1)
small hepatocellular##3##2##(1993-3#1)(2005-8#1)(2013-1#1)
small hole##4##2##(1997-3#1)(2007-8#2)(2013-7#1)
small holes##2##2##(2005-10#1)(2008-11#1)
small hollow##2##2##(2010-4#2)
small hospitals##8##2##(1991-12#1)(1991-6#1)(1994-2#4)(2008-4#1)(2008-8#1)
small hydrophilic##2##2##(1993-3#1)(2006-3#1)
small hydrophobic##8##2##(1990-7#1)(1991-4#1)(1992-11#1)(1992-9#1)(1993-6#1)(1994-10#1)(1994-9#1)(2008-10#1)
small impact on##2##3##(1996-11#1)(2012-12#1)
small impact##3##2##(1991-3#1)(1996-11#1)(2012-12#1)
small in comparison with the##3##5##(2008-3#1)(2008-7#1)(2010-4#1)
small in comparison##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2010-4#1)
small in number##3##3##(1990-6#1)(1997-5#1)(2008-10#1)
small in size##2##3##(1991-12#1)(2010-7#1)
small in##19##2##(1990-12#1)(1990-6#1)(1991-12#1)(1993-8#1)(1996-9#1)(1997-5#1)(1997-8#1)(2005-11#1)(2008-10#3)(2008-3#1)(2008-7#3)(2010-4#1)(2010-7#1)(2010-8#1)(2012-1#1)
small incision lenticule extraction##2##4##(2013-8#2)
small incision##9##2##(1996-8#1)(2006-3#2)(2006-6#2)(2008-11#1)(2009-3#1)(2013-8#2)
small incisions##3##2##(2006-8#1)(2008-9#1)(2009-10#1)
small inclination misalignment##2##3##(2008-3#2)
small inclination##9##2##(2008-3#9)
small inclined angle##2##3##(2008-3#2)
small inclusions##2##2##(2008-2#2)
small increase in the##8##4##(1991-10#1)(1992-6#1)(1992-8#1)(1995-1#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-3#1)
small increase in##22##3##(1990-12#1)(1991-10#1)(1992-6#1)(1992-8#1)(1993-6#1)(1995-1#2)(1996-5#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-10#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#1)(2009-9#1)(2010-2#1)(2012-1#1)
small increase##27##2##(1990-12#1)(1990-5#1)(1991-10#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-6#1)(1995-1#2)(1996-5#1)(1997-5#2)(1997-7#1)(1997-8#1)(2005-10#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-2#1)(2012-1#1)
small increases in##3##3##(1990-4#1)(1995-7#1)(1997-4#1)
small increases##4##2##(1990-4#1)(1991-12#1)(1995-7#1)(1997-4#1)
small increments##2##2##(2003-11#1)(2008-10#1)
small individuals##2##2##(2007-3#1)(2008-8#1)
small inducible##2##2##(1994-9#2)
small infants##2##2##(2006-10#1)(2010-12#1)
small influence##3##2##(1993-8#1)(2008-4#1)(2008-5#1)
small inhomogeneities##2##2##(2008-2#2)
small insertion loss##2##3##(2008-1#1)(2008-2#1)
small insertion##3##2##(1991-2#1)(2008-1#1)(2008-2#1)
small insertions or deletions##2##4##(1991-11#1)(2012-12#1)
small insertions or##3##3##(1991-11#1)(2011-1#1)(2012-12#1)
small interference RNA##2##3##(2006-12#1)(2013-8#1)
small interference##4##2##(2006-12#1)(2008-10#2)(2013-8#1)
small interfering RNA (siRNA)##3##4##(2009-3#1)(2010-2#1)(2012-3#1)
small interfering RNA##5##3##(2007-11#1)(2009-3#1)(2010-2#1)(2010-5#1)(2012-3#1)
small interfering RNAs (siRNAs)##5##4##(2008-10#1)(2008-2#1)(2008-4#1)(2011-2#1)(2012-2#1)
small interfering RNAs##7##3##(2008-10#2)(2008-2#1)(2008-4#1)(2011-2#1)(2012-1#1)(2012-2#1)
small interfering##12##2##(2007-11#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-3#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
small internal##4##2##(2007-12#2)(2008-3#2)
small intestinal NET##3##3##(2013-1#3)
small intestinal bacterial##2##3##(2010-6#1)(2013-1#1)
small intestinal brush border membranes##2##5##(1990-11#1)(1996-3#1)
small intestinal brush border##4##4##(1990-11#1)(1990-2#2)(1996-3#1)
small intestinal enterocytes##3##3##(1990-11#3)
small intestinal mucosa##5##3##(1990-2#1)(2006-10#3)(2007-9#1)
small intestinal resection in rats##2##5##(2008-4#2)
small intestinal resection##3##3##(2008-4#3)
small intestinal submucosa (SIS)##2##4##(2006-9#1)(2008-5#1)
small intestinal##58##2##(1990-11#4)(1990-12#1)(1990-2#4)(1990-8#2)(1991-9#1)(1992-6#1)(1994-3#1)(1994-9#1)(1996-3#1)(1996-6#1)(1997-3#1)(2004-11#1)(2006-10#14)(2006-8#1)(2006-9#1)(2007-2#1)(2007-9#2)(2008-11#1)(2008-4#4)(2008-5#3)(2009-4#1)(2009-5#1)(2010-6#1)(2012-2#3)(2013-1#6)
small intestine and colon##4##4##(1991-12#1)(1992-12#1)(2011-2#1)(2012-2#1)
small intestine and##15##3##(1991-12#1)(1992-12#2)(1994-5#1)(1995-3#1)(1997-6#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-12#2)(2012-2#1)
small intestine are regulated both##2##5##(1992-11#2)
small intestine are##5##3##(1992-11#2)(2006-10#1)(2008-5#1)(2009-2#1)
small intestine during##2##3##(1991-9#1)(1996-11#1)
small intestine in##7##3##(1990-11#1)(1991-9#1)(1992-11#1)(1996-11#1)(2007-2#1)(2007-8#1)(2012-2#1)
small intestine is##6##3##(1993-8#1)(1994-3#1)(2006-10#3)(2006-2#1)
small intestine metastases##2##3##(1995-12#2)
small intestine of##13##3##(1991-12#1)(1992-11#1)(1993-8#1)(1994-11#1)(1996-4#1)(1997-2#1)(2006-10#1)(2008-4#1)(2008-5#1)(2012-2#3)(2013-1#1)
small intestine using##2##3##(1990-12#1)(1993-10#1)
small intestine was##4##3##(1991-12#1)(1994-3#1)(2011-12#1)(2012-12#1)
small intestine with##3##3##(1990-11#1)(1997-2#1)(2008-5#1)
small intestine##188##2##(1990-11#6)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-12#5)(1991-4#1)(1991-5#2)(1991-9#4)(1992-11#12)(1992-12#2)(1992-5#2)(1992-6#3)(1993-1#1)(1993-10#2)(1993-6#1)(1993-8#2)(1994-11#5)(1994-12#1)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-3#4)(1996-11#5)(1996-2#3)(1996-4#1)(1996-6#1)(1997-2#3)(1997-3#2)(1997-5#2)(1997-6#2)(1997-8#1)(2004-11#3)(2005-10#1)(2005-11#1)(2006-10#22)(2006-2#3)(2006-8#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#5)(2008-5#7)(2008-8#4)(2009-1#1)(2009-2#7)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-12#2)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#5)(2013-1#6)(2013-7#1)(2013-8#1)
small intestines##7##2##(1993-11#1)(1993-9#3)(1997-3#1)(2007-3#1)(2013-1#1)
small introns##4##2##(1991-8#2)(1992-12#1)(1993-3#1)
small inverse##2##2##(2008-4#1)(2012-2#1)
small island countries##5##3##(2008-1#5)
small island##8##2##(1996-6#1)(2008-1#6)(2012-12#1)
small isolated##2##2##(1996-12#1)(2008-1#1)
small joints##3##2##(2006-10#1)(2007-12#1)(2010-5#1)
small labeled##3##2##(2012-2#1)(2013-1#2)
small laser##2##2##(2007-8#1)(2008-3#1)
small lateral##3##2##(2008-12#2)(2008-3#1)
small lesions##10##2##(1997-3#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
small levels##2##2##(2007-12#1)(2008-10#1)
small liberal arts##2##3##(2005-12#2)
small ligands to##2##3##(1996-7#1)(2007-8#1)
small ligands##3##2##(1990-8#1)(1996-7#1)(2007-8#1)
small lipid##2##2##(1995-3#1)(2008-7#1)
small local##6##2##(1991-2#1)(2007-12#1)(2008-2#2)(2008-3#2)
small loop##2##2##(1991-2#1)(1996-8#1)
small loss##2##2##(2008-7#1)(2013-1#1)
small lung vessels##2##3##(1991-8#2)
small lymphocytes and##3##3##(1991-8#1)(1997-6#2)
small lymphocytes##7##2##(1991-8#1)(1997-6#4)(2005-7#1)(2009-2#1)
small lymphoid##2##2##(1997-6#1)(2009-8#1)
small males##2##2##(2009-9#1)(2012-3#1)
small mammals##7##2##(1991-11#1)(1995-8#1)(1996-6#1)(2008-11#1)(2009-12#1)(2012-2#2)
small marks##2##2##(2007-11#1)(2008-3#1)
small mean##2##2##(2006-9#1)(2008-3#1)
small membrane vesicles##2##3##(1994-12#1)(2008-1#1)
small membrane##3##2##(1992-9#1)(1994-12#1)(2008-1#1)
small metal##3##2##(1992-8#1)(1993-4#1)(2008-9#1)
small model##2##2##(1993-11#1)(2008-11#1)
small molecular compounds##2##3##(2009-12#1)(2011-3#1)
small molecular weight##7##3##(1990-2#1)(1990-7#1)(1993-7#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)
small molecular##13##2##(1990-2#1)(1990-7#1)(1993-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-2#1)(2011-3#1)(2012-1#2)
small molecule inhibitors have##2##4##(2008-5#1)(2011-2#1)
small molecule inhibitors of the##2##5##(1997-6#1)(2005-6#1)
small molecule inhibitors of##5##4##(1997-6#1)(2005-6#1)(2005-7#1)(2008-1#1)(2010-3#1)
small molecule inhibitors##11##3##(1997-6#1)(2005-6#1)(2005-7#1)(2008-1#2)(2008-4#1)(2008-5#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-2#1)
small molecule solvents##4##3##(2005-12#4)
small molecule surfactants##2##3##(2005-11#2)
small molecule##59##2##(1992-8#1)(1994-2#1)(1994-9#1)(1997-6#1)(2005-11#2)(2005-12#5)(2005-6#1)(2005-7#1)(2005-9#2)(2007-2#1)(2007-3#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#5)(2008-5#2)(2009-2#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-3#3)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-12#5)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
small molecules against##2##3##(2010-7#1)(2013-8#1)
small molecules and##5##3##(1996-11#1)(2007-8#1)(2008-7#1)(2012-11#2)
small molecules as##3##3##(2009-7#1)(2013-1#2)
small molecules for##3##3##(1996-8#1)(2008-4#1)(2011-2#1)
small molecules from##2##3##(2008-4#1)(2013-8#1)
small molecules have been##2##4##(1992-9#1)(2008-7#1)
small molecules have##3##3##(1992-9#1)(2008-7#1)(2008-9#1)
small molecules in the##3##4##(1990-11#1)(2008-8#1)(2010-11#1)
small molecules in##5##3##(1990-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-11#1)
small molecules such as##2##4##(1992-12#1)(1994-2#1)
small molecules that bind to##2##5##(1993-3#1)(2007-8#1)
small molecules that bind##3##4##(1993-3#1)(2007-8#1)(2008-4#1)
small molecules that##7##3##(1993-3#1)(2007-8#1)(2008-4#1)(2009-4#1)(2009-7#1)(2009-9#1)(2012-3#1)
small molecules through##2##3##(1996-11#1)(2008-4#1)
small molecules to##5##3##(2007-8#1)(2008-4#1)(2010-12#1)(2010-5#1)(2011-2#1)
small molecules with##2##3##(2008-10#1)(2010-2#1)
small molecules##78##2##(1990-11#1)(1990-12#1)(1992-12#1)(1992-9#1)(1993-3#1)(1993-7#1)(1994-2#1)(1996-11#3)(1996-8#1)(2006-12#1)(2007-12#1)(2007-8#7)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#8)(2008-7#2)(2008-8#3)(2008-9#1)(2009-4#1)(2009-7#4)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-5#1)(2010-7#3)(2011-1#1)(2011-2#6)(2011-3#1)(2012-1#2)(2012-11#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
small multiples##3##2##(1995-2#1)(2013-1#2)
small municipalities##2##2##(1994-11#2)
small network of##2##3##(2008-2#1)(2013-7#1)
small neurons##6##2##(1991-3#1)(1995-6#1)(1996-12#2)(1996-6#2)
small neutral amino##2##3##(1994-5#2)
small nodules##2##2##(2008-1#1)(2008-5#1)
small non-coding RNAs that##2##4##(2008-11#1)(2010-7#1)
small non-coding RNAs##5##3##(2008-1#1)(2008-11#1)(2010-12#2)(2010-7#1)
small normal##2##2##(2008-10#1)(2008-5#1)
small novel##2##2##(1993-8#1)(2009-8#1)
small nuclear RNA (snRNA)##3##4##(1996-4#2)(2006-12#1)
small nuclear RNA gene##3##4##(1993-9#2)(1996-3#1)
small nuclear RNA##10##3##(1990-5#1)(1993-8#1)(1993-9#2)(1994-8#2)(1996-3#1)(1996-4#2)(2006-12#1)
small nuclear ribonucleoprotein particle (snRNP)##2##5##(1994-8#1)(2007-12#1)
small nuclear ribonucleoprotein particle##3##4##(1993-8#1)(1994-8#1)(2007-12#1)
small nuclear ribonucleoprotein##4##3##(1991-6#1)(1993-8#1)(1994-8#1)(2007-12#1)
small nuclear##20##2##(1990-5#1)(1991-12#1)(1991-6#1)(1993-8#2)(1993-9#2)(1994-8#3)(1995-6#1)(1996-3#2)(1996-4#2)(1996-9#1)(1997-3#1)(2006-12#1)(2007-12#1)(2008-10#1)
small nucleolar##3##2##(1997-7#1)(1997-8#1)(2008-11#1)
small number of cases##6##4##(1994-9#1)(2008-6#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
small number of children##2##4##(2006-10#1)(2008-5#1)
small number of genes##4##4##(1997-7#1)(2007-11#1)(2008-7#1)(2008-9#1)
small number of molecules##2##4##(1991-2#2)
small number of patients with##4##5##(2007-11#1)(2007-7#1)(2009-3#1)(2011-2#1)
small number of patients##20##4##(1991-9#1)(1994-6#1)(1996-12#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-5#2)(2011-2#1)(2013-8#1)
small number of potential##2##4##(2006-12#1)(2008-11#1)
small number of reported cases##2##5##(2008-11#1)(2008-6#1)
small number of samples##2##4##(2008-10#1)(2008-11#1)
small number of subjects##3##4##(1991-6#1)(1995-5#1)(2012-3#1)
small number of the##2##4##(1993-5#1)(2012-1#1)
small number of##146##3##(1990-2#1)(1990-5#1)(1990-9#1)(1991-2#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-7#2)(1992-8#2)(1992-9#2)(1993-3#1)(1993-5#2)(1993-6#2)(1993-7#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-3#1)(1995-5#3)(1996-12#2)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#6)(2007-12#3)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-5#2)(2009-8#1)(2010-1#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#7)(2013-8#2)
small number##160##2##(1990-2#1)(1990-5#1)(1990-9#1)(1991-2#2)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-7#2)(1992-8#2)(1992-9#2)(1993-3#2)(1993-5#2)(1993-6#2)(1993-7#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-3#1)(1995-5#5)(1996-12#2)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#6)(2007-12#3)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#6)(2008-11#6)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-5#2)(2009-8#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#2)
small numbers and##2##3##(1994-6#1)(2007-8#1)
small numbers of cells##3##4##(2008-11#2)(2008-4#1)
small numbers of patients##7##4##(2007-11#1)(2007-5#2)(2007-8#1)(2008-1#1)(2008-12#1)(2008-9#1)
small numbers of##26##3##(1991-12#1)(1992-7#1)(1993-12#1)(1993-7#1)(1994-5#1)(1995-9#1)(2005-7#1)(2007-11#2)(2007-5#2)(2007-8#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#3)(2008-7#1)(2008-9#1)(2010-4#1)(2010-8#1)(2012-2#1)
small numbers##32##2##(1991-12#2)(1992-7#1)(1993-12#1)(1993-7#1)(1994-5#1)(1994-6#1)(1995-9#1)(2005-7#1)(2007-11#2)(2007-5#2)(2007-8#2)(2008-1#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)
small object##2##2##(1992-9#1)(2008-7#1)
small objects##6##2##(1995-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2011-2#1)
small on##2##2##(1997-6#1)(2012-1#1)
small open reading frames##2##4##(1993-12#1)(1994-3#1)
small open reading##3##3##(1993-12#1)(1994-3#1)(2008-9#1)
small open##4##2##(1993-12#1)(1994-3#1)(2008-9#1)(2013-7#1)
small optical##3##2##(2007-12#1)(2008-3#2)
small or absent##2##3##(1997-7#1)(2011-1#1)
small or large##6##3##(1992-11#1)(1994-11#1)(2005-11#1)(2007-1#1)(2008-9#1)(2011-2#1)
small or medium-sized##2##3##(1993-9#1)(2008-2#1)
small or moderate##3##3##(1995-9#1)(2008-8#1)(2010-2#1)
small or##26##2##(1990-1#1)(1991-4#1)(1991-8#1)(1992-11#1)(1993-8#1)(1993-9#2)(1994-11#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-7#1)(2004-11#1)(2005-11#1)(2006-11#1)(2007-1#1)(2007-11#1)(2008-2#2)(2008-8#1)(2008-9#2)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
small organic molecules and##2##4##(1994-2#1)(2010-2#1)
small organic molecules##12##3##(1992-8#1)(1994-2#1)(1996-5#1)(1997-6#2)(2008-11#1)(2008-9#2)(2009-11#2)(2010-11#1)(2010-2#1)
small out-of-plane##2##2##(2007-12#1)(2008-3#1)
small pancreatic##2##2##(1990-12#1)(1991-9#1)
small parameter##5##2##(2011-1#5)
small part of the##9##4##(1991-6#1)(1991-9#1)(1993-6#1)(1994-12#1)(1996-6#1)(2008-3#1)(2010-12#1)(2010-5#1)(2010-9#1)
small part of##11##3##(1991-6#1)(1991-9#1)(1993-6#1)(1994-12#1)(1996-6#1)(1997-6#1)(2006-10#1)(2008-3#1)(2010-12#1)(2010-5#1)(2010-9#1)
small part##12##2##(1991-6#1)(1991-9#1)(1993-6#1)(1994-12#1)(1996-6#1)(1997-6#1)(2006-10#1)(2008-3#1)(2010-12#1)(2010-5#1)(2010-9#1)(2012-3#1)
small particle size and##2##4##(2005-11#1)(2013-8#1)
small particle size##5##3##(1997-2#1)(2005-11#1)(2008-5#2)(2013-8#1)
small particle##7##2##(1997-2#1)(2005-11#1)(2008-2#1)(2008-5#2)(2013-8#2)
small particles in##2##3##(2008-3#2)
small particles##16##2##(1991-12#1)(1995-8#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)
small patch##2##2##(1990-12#1)(2008-5#1)
small pelvis##3##2##(2007-11#1)(2009-2#1)(2012-3#1)
small peptide##5##2##(1990-5#1)(1990-7#1)(1994-2#1)(1994-3#1)(2008-1#1)
small peptides and beta-lactam antibiotics##2##5##(1990-11#2)
small peptides and##6##3##(1990-11#3)(1990-12#1)(1994-8#1)(2008-5#1)
small peptides##20##2##(1990-11#6)(1990-12#1)(1991-2#1)(1991-5#1)(1993-11#1)(1994-8#1)(2007-1#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
small percent of##3##3##(2008-5#1)(2012-12#1)(2012-2#1)
small percent##4##2##(1990-2#1)(2008-5#1)(2012-12#1)(2012-2#1)
small percentage of patients##6##4##(2006-10#1)(2006-6#2)(2007-11#1)(2007-12#1)(2011-2#1)
small percentage of the##6##4##(1991-3#1)(1992-11#1)(1993-3#1)(2006-11#1)(2007-5#1)(2012-2#1)
small percentage of##25##3##(1991-3#1)(1992-11#1)(1992-12#1)(1993-3#1)(2006-10#1)(2006-11#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#2)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
small percentage##30##2##(1990-3#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-3#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#2)(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#2)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
small peripheral lung##2##3##(2007-8#1)(2008-1#1)
small peripheral##9##2##(1990-2#1)(1992-8#1)(2007-5#1)(2007-8#3)(2008-1#2)(2011-2#1)
small perturbation##6##2##(2007-11#1)(2007-12#2)(2008-3#2)(2008-4#1)
small perturbations to the##2##4##(1993-7#1)(2006-12#1)
small perturbations##3##2##(1993-7#1)(2006-12#1)(2008-2#1)
small phase##4##2##(2004-1#1)(2007-12#1)(2008-3#1)(2008-5#1)
small piece of##2##3##(1992-3#1)(2008-12#1)
small pieces##3##2##(1990-12#1)(2008-11#1)(2008-8#1)
small pilot study##2##3##(2006-10#1)(2007-12#1)
small pilot##4##2##(2006-10#1)(2007-12#1)(2008-7#1)(2012-12#1)
small pleural effusion##2##3##(2008-6#1)(2010-12#1)
small pool of##2##3##(1994-12#1)(2009-5#1)
small population and##2##3##(2008-1#1)(2008-12#1)
small population of##7##3##(1991-12#1)(1993-6#1)(1995-1#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-7#1)
small population##18##2##(1991-12#1)(1993-6#1)(1995-1#1)(1996-12#2)(1997-2#1)(1997-4#1)(1997-5#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#2)
small populations of neurons##2##4##(1992-5#1)(2010-12#1)
small populations of##5##3##(1991-8#1)(1992-5#1)(2008-1#1)(2010-12#1)(2013-1#1)
small populations##12##2##(1990-11#1)(1991-8#1)(1992-5#1)(1995-8#1)(1996-6#1)(2008-1#1)(2008-9#3)(2010-12#1)(2011-1#1)(2013-1#1)
small pores##2##2##(2005-11#1)(2012-2#1)
small portion of the##8##4##(1991-10#1)(1991-6#1)(1992-3#1)(1994-11#1)(2008-10#1)(2008-3#1)(2009-5#1)(2011-1#1)
small portion of##13##3##(1991-10#1)(1991-6#1)(1992-3#1)(1994-11#1)(1996-12#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-4#2)(2009-5#1)(2010-3#1)(2011-1#1)
small portion##14##2##(1991-10#1)(1991-6#1)(1992-3#1)(1994-11#1)(1996-12#1)(2007-10#1)(2008-10#2)(2008-3#1)(2008-4#2)(2009-5#1)(2010-3#1)(2011-1#1)
small portions##2##2##(1990-4#1)(2008-11#1)
small prey##2##2##(1991-11#1)(2012-12#1)
small primary##2##2##(1990-4#1)(2007-9#1)
small probe##2##2##(2007-9#1)(2008-3#1)
small proportion of cases##2##4##(1991-11#1)(1996-5#1)
small proportion of patients##7##4##(1991-4#1)(1991-5#1)(2007-7#1)(2008-7#1)(2009-11#1)(2010-12#1)(2011-2#1)
small proportion of the##14##4##(1991-12#1)(1994-8#1)(1995-12#1)(1995-2#1)(2004-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
small proportion of##38##3##(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-5#2)(1996-6#1)(1997-1#1)(2004-1#1)(2006-5#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#2)
small proportion##42##2##(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-5#2)(1996-6#1)(1997-1#1)(2004-1#1)(2006-5#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2009-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#2)
small protein##7##2##(1992-4#1)(2006-10#1)(2008-7#1)(2009-10#1)(2010-8#1)(2011-1#2)
small proteins##8##2##(1991-3#1)(1994-5#1)(2006-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)
small quantities of##13##3##(1991-11#1)(1994-3#1)(1995-2#1)(2006-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#1)(2009-10#1)
small quantities##20##2##(1991-11#1)(1994-3#1)(1995-2#1)(2004-2#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-9#1)(2009-10#1)(2010-5#1)
small quantity of##3##3##(1992-9#1)(1996-1#1)(2008-10#1)
small radial diameters##2##3##(2011-2#2)
small radial##3##2##(2011-2#3)
small radii of##2##3##(2005-11#1)(2010-2#1)
small range of##3##3##(2006-6#1)(2008-10#1)(2009-5#1)
small range##4##2##(2005-11#1)(2006-6#1)(2008-10#1)(2009-5#1)
small reaction##2##2##(2008-10#2)
small recurrent carcinomas##2##3##(1991-4#2)
small red##2##2##(1991-2#1)(2006-12#1)
small region of the##3##4##(1990-5#1)(2007-9#1)(2008-2#1)
small region of##5##3##(1990-5#1)(1993-9#1)(1997-5#1)(2007-9#1)(2008-2#1)
small region##10##2##(1990-5#1)(1993-8#1)(1993-9#1)(1995-11#2)(1997-5#1)(2005-11#1)(2007-12#1)(2007-9#1)(2008-2#1)
small regions of##2##3##(1990-12#1)(2007-10#1)
small regions##4##2##(1990-12#1)(2007-10#1)(2007-9#1)(2013-1#1)
small regulatory RNAs##2##3##(2008-2#1)(2010-7#1)
small relative to that of##2##5##(2008-2#1)(2011-12#1)
small relative to the##2##4##(1992-5#1)(2005-11#1)
small relative to##5##3##(1992-5#1)(2005-11#1)(2008-2#1)(2008-8#1)(2011-12#1)
small relative##7##2##(1992-5#1)(2005-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-8#1)(2011-12#1)
small remote islands##4##3##(2013-8#4)
small renal##2##2##(2008-6#1)(2009-5#1)
small residual##2##2##(1993-2#1)(2007-12#1)
small ribosomal subunit##6##3##(1994-12#1)(1997-4#1)(2006-12#1)(2009-11#1)(2009-9#2)
small right##2##2##(2007-12#1)(2011-2#1)
small rodents##3##2##(1991-3#1)(2006-10#1)(2008-10#1)
small role in the##2##4##(2009-6#1)(2009-9#1)
small role in##5##3##(2008-8#1)(2008-9#1)(2009-6#1)(2009-9#1)(2011-1#1)
small rotation angles##3##3##(2008-2#1)(2008-3#2)
small round cell tumor (DSRCT)##2##5##(2008-10#1)(2008-6#1)
small round cell tumor##3##4##(2008-10#2)(2008-6#1)
small round cell##4##3##(2008-10#2)(2008-12#1)(2008-6#1)
small round structured viruses##2##4##(2006-10#2)
small round structured##3##3##(1996-3#1)(2006-10#2)
small round##12##2##(1990-3#1)(1996-3#1)(2006-10#2)(2007-12#1)(2008-10#2)(2008-12#1)(2008-6#1)(2009-5#1)(2010-12#1)(2010-6#1)
small ruminant strains##2##3##(1991-8#2)
small ruminant##3##2##(1991-8#3)
small ruminants##3##2##(1991-8#1)(1997-7#1)(2013-1#1)
small rural hospitals##5##3##(1990-12#1)(1991-1#1)(1992-2#1)(1996-3#1)(2008-11#1)
small rural##7##2##(1990-12#1)(1991-1#1)(1992-2#1)(1994-11#1)(1996-3#1)(2008-11#1)(2010-5#1)
small sample properties##2##3##(1993-9#1)(2010-8#1)
small sample size and##5##4##(1996-12#1)(2008-11#1)(2009-8#1)(2011-2#1)(2013-1#1)
small sample size##21##3##(1996-12#2)(1997-2#1)(2005-10#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2011-2#2)(2012-12#1)(2013-1#3)
small sample sizes##17##3##(1997-6#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-4#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
small sample volumes and##2##4##(1990-6#1)(2008-10#1)
small sample volumes##3##3##(1990-6#1)(2008-10#1)(2011-2#1)
small sample##56##2##(1990-6#1)(1993-9#1)(1994-6#1)(1996-12#2)(1997-2#1)(1997-5#1)(1997-6#1)(2005-10#1)(2006-10#2)(2007-2#1)(2007-4#1)(2007-8#3)(2007-9#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#3)(2009-10#1)(2009-4#2)(2009-8#1)(2010-11#1)(2010-2#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
small samples and##2##3##(2007-12#1)(2008-10#1)
small samples##12##2##(2006-12#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-4#2)(2009-2#1)(2012-2#1)
small scale##18##2##(1991-11#1)(1996-4#1)(2005-11#1)(2008-11#6)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-5#1)(2010-8#2)(2011-2#1)
small scales##5##2##(2008-8#1)(2010-8#4)
small secondary##3##2##(1994-8#1)(1995-10#1)(2008-7#1)
small sections##3##2##(2008-10#1)(2011-1#1)(2011-12#1)
small segment of##2##3##(2007-8#1)(2008-10#1)
small segment##3##2##(1992-9#1)(2007-8#1)(2008-10#1)
small segments of##3##3##(1994-12#1)(1996-8#1)(2010-8#1)
small segments##5##2##(1990-6#1)(1994-12#1)(1996-8#1)(2008-10#1)(2010-8#1)
small separation##2##2##(1990-4#1)(2008-3#1)
small series of##3##3##(1996-9#1)(2009-10#1)(2011-2#1)
small series##11##2##(1993-3#1)(1996-9#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-8#1)(2009-10#1)(2011-2#2)(2012-12#1)
small set of##5##3##(2008-10#2)(2008-2#1)(2008-6#1)(2013-1#1)
small sets of##2##3##(2008-7#1)(2008-9#1)
small share of##2##3##(1994-1#1)(1996-1#1)
small shears##2##2##(2008-3#2)
small shift##3##2##(1995-3#1)(1997-4#1)(2008-10#1)
small shocks##2##2##(1996-4#2)
small signal##7##2##(2007-11#1)(2008-1#3)(2008-2#1)(2008-3#1)(2010-5#1)
small significant##2##2##(1996-12#1)(2012-11#1)
small simulators##2##2##(2006-10#2)
small size and weight and##2##5##(2007-11#1)(2008-10#1)
small size and##7##3##(1993-4#1)(1994-2#1)(2006-12#1)(2007-11#1)(2007-3#1)(2008-10#1)(2009-8#1)
small size of the##7##4##(1991-5#1)(1992-12#1)(2007-12#1)(2008-12#1)(2009-3#1)(2010-11#1)(2010-2#1)
small size of these##2##4##(2006-10#1)(2008-9#1)
small size of##15##3##(1991-5#1)(1992-12#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-12#1)
small size##51##2##(1991-5#1)(1992-12#1)(1993-4#3)(1993-8#3)(1994-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
small sized##5##2##(1992-10#1)(2008-1#1)(2011-1#1)(2012-2#1)(2013-8#1)
small sizes##2##2##(2006-2#1)(2009-8#1)
small skin##3##2##(1991-12#1)(2008-3#1)(2008-4#1)
small smooth##2##2##(2008-5#1)(2010-1#1)
small solid##2##2##(2008-3#1)(2012-12#1)
small solute clearance##2##3##(2007-8#2)
small solvated##2##2##(2006-3#1)(2007-12#1)
small source##2##2##(2006-5#1)(2010-3#1)
small source-detector separations##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
small source-detector##6##2##(2007-12#2)(2008-2#1)(2008-3#3)
small spatial extent of##2##4##(2008-2#1)(2008-3#1)
small spatial extent##3##3##(2008-2#2)(2008-3#1)
small spatial##8##2##(2006-10#1)(2007-9#1)(2008-2#2)(2008-3#1)(2008-9#1)(2010-6#1)(2010-8#1)
small specialized##2##2##(1994-6#1)(1994-8#1)
small species##2##2##(2008-5#2)
small spectral##2##2##(2008-3#2)
small spot##4##2##(2007-12#1)(2008-3#2)(2009-5#1)
small stable##2##2##(1995-10#1)(2006-8#1)
small strain##3##2##(2005-10#1)(2005-11#1)(2007-4#1)
small strains##2##2##(2007-1#1)(2008-7#1)
small structural changes##2##3##(1991-12#1)(2008-3#1)
small structures##3##2##(1993-5#1)(2007-9#1)(2008-10#1)
small studies of##2##3##(2008-6#1)(2008-7#1)
small studies##6##2##(1995-12#1)(2006-7#1)(2008-6#2)(2008-7#1)(2013-8#1)
small study##8##2##(1990-1#1)(1990-11#1)(1990-2#1)(1992-2#1)(2007-10#1)(2008-11#2)(2009-8#1)
small sub-group of##2##3##(1992-1#1)(1995-11#1)
small subset of all##2##4##(2008-6#1)(2010-2#1)
small subset of these##2##4##(1996-5#1)(2006-5#1)
small subset of##20##3##(1992-6#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-5#1)(1997-1#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-2#1)(2007-9#1)(2008-6#2)(2010-2#1)(2012-1#1)(2012-12#1)
small subset##21##2##(1992-6#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-5#1)(1997-1#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-2#1)(2007-9#2)(2008-6#2)(2010-2#1)(2012-1#1)(2012-12#1)
small subunit genes##2##3##(1990-9#1)(2006-12#1)
small subunit of##8##3##(1990-4#1)(1992-3#1)(1993-12#1)(1994-12#1)(1994-5#1)(1994-8#1)(2009-10#1)(2011-1#1)
small subunit rDNA##2##3##(2008-10#1)(2010-10#1)
small subunit ribosomal##2##3##(1993-11#1)(2008-10#1)
small subunit##32##2##(1990-11#1)(1990-4#1)(1990-6#3)(1990-9#2)(1991-5#1)(1992-3#1)(1993-11#1)(1993-12#2)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(2005-7#1)(2006-12#3)(2006-8#1)(2008-10#5)(2008-8#1)(2009-10#1)(2010-10#1)(2011-1#2)(2013-8#1)
small subunits##6##2##(1991-5#2)(1992-11#1)(1997-6#1)(2009-11#1)(2013-8#1)
small surface area##3##3##(1990-8#1)(2008-2#1)(2008-3#1)
small surface##6##2##(1990-8#1)(2007-12#1)(2008-2#1)(2008-3#2)(2010-4#1)
small survey##3##2##(2008-10#1)(2012-12#2)
small swarms##2##2##(2013-8#2)
small synthetic substrates##3##3##(1993-3#2)(1995-7#1)
small synthetic##6##2##(1993-3#2)(1995-2#1)(1995-7#1)(2005-8#1)(2008-10#1)
small systems##3##2##(2008-9#1)(2009-5#1)(2012-1#1)
small t-antigen##4##2##(1996-9#4)
small tattoo removal##2##3##(1992-10#2)
small telescopes##2##2##(2007-9#2)
small temperature##3##2##(2008-2#2)(2012-2#1)
small testicular##2##2##(2006-10#1)(2013-8#1)
small that##2##2##(1993-10#1)(2008-2#1)
small thorax##2##2##(1996-3#1)(2010-4#1)
small tidal##2##2##(1996-2#1)(2006-10#1)
small time##3##2##(2008-1#2)(2008-3#1)
small tissue samples##2##3##(2005-8#1)(2008-10#1)
small tissue##4##2##(1997-3#1)(2005-8#1)(2008-10#2)
small to allow##2##3##(1996-9#1)(2008-3#1)
small to be##7##3##(1990-8#1)(1990-9#1)(1991-3#2)(2007-9#1)(2008-3#1)(2011-2#1)
small to large numbers of##2##5##(1997-8#1)(2008-4#1)
small to large##7##3##(1990-12#1)(1992-5#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-5#1)
small to moderate##3##3##(1995-9#1)(2010-5#1)(2012-2#1)
small to##36##2##(1990-12#1)(1990-8#2)(1990-9#1)(1991-2#1)(1991-3#2)(1991-7#1)(1992-5#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-9#1)(1996-9#1)(1997-8#1)(2004-11#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-5#1)(2010-5#1)(2011-2#3)(2012-2#1)(2012-3#1)
small town##2##2##(1995-11#1)(2011-2#1)
small transient##3##2##(1991-5#1)(1992-3#1)(1995-3#1)
small trial##3##2##(2007-11#3)
small trials have##2##3##(2008-3#1)(2013-8#1)
small trials##6##2##(1993-12#2)(2007-12#1)(2008-3#1)(2013-8#2)
small tumor##4##2##(1997-7#1)(2008-6#1)(2010-12#1)(2011-2#1)
small tumors##6##2##(1992-3#1)(1992-7#2)(1992-8#1)(2006-12#1)(2007-8#1)
small tyrosine##2##2##(1997-5#1)(2008-1#1)
small ubiquitin-like##2##2##(2008-4#1)(2011-1#1)
small unilamellar liposomes##2##3##(1990-2#1)(1993-8#1)
small unilamellar vesicles (SUV)##3##4##(1991-9#1)(1997-1#1)(2008-10#1)
small unilamellar vesicles and##2##4##(1991-9#1)(1994-11#1)
small unilamellar vesicles of##3##4##(1990-4#1)(1994-11#1)(2009-12#1)
small unilamellar vesicles##18##3##(1990-2#4)(1990-4#1)(1991-10#1)(1991-9#2)(1994-11#2)(1994-5#1)(1995-8#1)(1997-1#1)(1997-7#1)(2006-10#1)(2008-10#2)(2009-12#1)
small unilamellar##23##2##(1990-2#5)(1990-4#1)(1991-10#1)(1991-9#2)(1992-3#2)(1993-8#1)(1994-11#2)(1994-5#1)(1995-8#1)(1996-7#1)(1997-1#1)(1997-7#1)(2006-10#1)(2008-10#2)(2009-12#1)
small user##2##2##(2008-7#2)
small vacuoles##2##2##(2009-12#1)(2013-1#1)
small values of the##3##4##(1990-8#1)(2005-11#1)(2008-2#1)
small values of##9##3##(1990-8#1)(1992-9#1)(2005-11#1)(2008-2#4)(2008-3#1)(2013-8#1)
small variation in##2##3##(1996-9#1)(2008-9#1)
small variation of the##3##4##(2007-12#2)(2008-2#1)
small variation##6##2##(1990-8#1)(1996-9#1)(2007-12#2)(2008-2#1)(2008-9#1)
small variations in the##4##4##(1991-9#1)(1994-12#1)(2008-2#2)
small variations in##8##3##(1991-9#1)(1994-12#1)(1994-3#1)(1995-5#1)(2005-7#1)(2008-2#2)(2013-8#1)
small variations of the##2##4##(2007-12#1)(2008-2#1)
small variations##10##2##(1991-9#1)(1994-12#1)(1994-3#1)(1995-5#1)(2005-7#1)(2007-12#1)(2008-2#3)(2013-8#1)
small versus large##2##3##(1993-6#1)(2011-12#1)
small vesicles##8##2##(1990-9#1)(1991-9#1)(1992-12#1)(1995-7#1)(2007-12#2)(2007-9#1)(2010-4#1)
small vessel disease##7##3##(2007-10#3)(2007-9#1)(2008-8#2)(2009-10#1)
small vessel##16##2##(1994-3#1)(1997-8#2)(2007-10#3)(2007-2#1)(2007-9#1)(2008-10#1)(2008-8#2)(2009-10#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
small vessels##16##2##(1993-10#1)(1994-8#1)(2004-1#1)(2005-11#1)(2005-8#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-6#1)(2010-8#1)(2012-1#1)(2013-1#1)(2013-8#1)
small vibration amplitudes of a rough surface##2##7##(2008-3#2)
small villages##2##2##(2009-8#1)(2011-1#1)
small volume of##20##3##(1993-2#1)(2006-7#1)(2007-2#1)(2008-10#13)(2008-11#1)(2008-4#1)(2008-8#1)(2011-1#1)
small volume##30##2##(1993-2#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#17)(2008-11#2)(2008-2#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-7#1)(2011-1#1)
small volumes of##8##3##(1996-11#1)(1996-12#1)(2005-8#1)(2008-10#4)(2008-9#1)
small volumes##19##2##(1992-1#1)(1996-1#1)(1996-11#1)(1996-12#1)(2005-8#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#2)(2009-7#2)(2011-1#1)
small water droplets##3##3##(2007-11#1)(2008-2#1)(2011-1#1)
small water##4##2##(2007-11#1)(2008-2#2)(2011-1#1)
small with##2##2##(2009-7#1)(2009-8#1)
small wounds##2##2##(2010-3#1)(2012-3#1)
small##4670##1##(1990-1#3)(1990-10#6)(1990-11#32)(1990-12#29)(1990-2#27)(1990-3#15)(1990-4#9)(1990-5#22)(1990-6#16)(1990-7#12)(1990-8#21)(1990-9#12)(1991-1#7)(1991-10#9)(1991-11#18)(1991-12#37)(1991-2#17)(1991-3#11)(1991-4#11)(1991-5#19)(1991-6#18)(1991-7#10)(1991-8#20)(1991-9#27)(1992-1#10)(1992-10#13)(1992-11#27)(1992-12#18)(1992-2#9)(1992-3#18)(1992-4#5)(1992-5#19)(1992-6#9)(1992-7#13)(1992-8#16)(1992-9#22)(1993-1#6)(1993-10#7)(1993-11#15)(1993-12#20)(1993-2#9)(1993-3#17)(1993-4#10)(1993-5#10)(1993-6#26)(1993-7#9)(1993-8#23)(1993-9#16)(1994-1#4)(1994-10#5)(1994-11#21)(1994-12#33)(1994-2#21)(1994-3#23)(1994-4#6)(1994-5#12)(1994-6#10)(1994-7#2)(1994-8#25)(1994-9#21)(1995-1#9)(1995-10#5)(1995-11#30)(1995-12#19)(1995-2#15)(1995-3#26)(1995-4#3)(1995-5#16)(1995-6#7)(1995-7#5)(1995-8#12)(1995-9#5)(1996-1#10)(1996-10#6)(1996-11#17)(1996-12#34)(1996-2#14)(1996-3#17)(1996-4#14)(1996-5#20)(1996-6#17)(1996-7#8)(1996-8#15)(1996-9#15)(1997-1#10)(1997-2#15)(1997-3#23)(1997-4#21)(1997-5#20)(1997-6#30)(1997-7#12)(1997-8#27)(2003-11#1)(2004-1#4)(2004-10#1)(2004-11#11)(2004-2#2)(2004-4#1)(2004-9#5)(2005-1#1)(2005-10#20)(2005-11#73)(2005-12#13)(2005-3#1)(2005-5#1)(2005-6#2)(2005-7#11)(2005-8#13)(2005-9#9)(2006-10#107)(2006-11#15)(2006-12#40)(2006-2#18)(2006-3#9)(2006-4#10)(2006-5#9)(2006-6#17)(2006-7#4)(2006-8#20)(2006-9#6)(2007-1#12)(2007-10#27)(2007-11#73)(2007-12#124)(2007-2#18)(2007-3#15)(2007-4#16)(2007-5#16)(2007-6#4)(2007-7#17)(2007-8#62)(2007-9#49)(2008-1#61)(2008-10#322)(2008-11#103)(2008-12#29)(2008-2#159)(2008-3#229)(2008-4#94)(2008-5#92)(2008-6#43)(2008-7#94)(2008-8#79)(2008-9#77)(2009-1#11)(2009-10#18)(2009-11#17)(2009-12#11)(2009-2#26)(2009-3#19)(2009-4#13)(2009-5#22)(2009-6#5)(2009-7#16)(2009-8#25)(2009-9#10)(2010-1#7)(2010-10#7)(2010-11#18)(2010-12#60)(2010-2#32)(2010-3#12)(2010-4#20)(2010-5#24)(2010-6#12)(2010-7#17)(2010-8#38)(2010-9#12)(2011-1#67)(2011-10#1)(2011-12#8)(2011-2#89)(2011-3#2)(2012-1#35)(2012-11#13)(2012-12#46)(2012-2#71)(2012-3#40)(2013-1#91)(2013-7#21)(2013-8#60)
small)##2##1##(1990-7#1)(2008-7#1)
small- and medium-sized##2##3##(1993-6#1)(2006-10#1)
small- and##6##2##(1993-6#1)(2006-10#1)(2008-5#1)(2008-9#2)(2010-3#1)
small- f -number lenses##2##4##(2007-12#2)
small- to##2##2##(2008-2#1)(2008-4#1)
small-##11##1##(1993-6#1)(2006-10#1)(2007-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#3)(2010-3#1)
small-RNA##2##1##(2008-9#2)
small-airway diseases##2##2##(2005-8#2)
small-amplitude##3##1##(2008-2#2)(2011-1#1)
small-angle X-ray scattering (SAXS)##4##4##(2005-11#1)(2006-10#1)(2008-10#2)
small-angle X-ray scattering##11##3##(1996-11#1)(2005-11#3)(2006-10#2)(2006-12#1)(2006-5#1)(2008-10#3)
small-angle X-ray##13##2##(1996-11#1)(2005-11#3)(2006-10#2)(2006-12#1)(2006-5#1)(2008-10#3)(2008-5#1)(2010-4#1)
small-angle approximation to##2##3##(2008-3#2)
small-angle approximation##8##2##(2008-2#3)(2008-3#5)
small-angle measurement##5##2##(2008-2#1)(2008-3#4)
small-angle measurements##2##2##(2008-3#2)
small-angle neutron scattering##3##3##(2008-2#1)(2009-10#1)(2009-12#1)
small-angle scattering is##2##3##(2008-2#1)(2008-3#1)
small-angle scattering##13##2##(1995-8#1)(2005-11#1)(2006-5#1)(2007-12#1)(2008-2#3)(2008-3#3)(2010-2#2)(2011-2#1)
small-angle x-ray scattering##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
small-angle##58##1##(1995-8#1)(1996-11#1)(2005-11#4)(2006-10#2)(2006-12#1)(2006-5#4)(2007-12#2)(2008-10#3)(2008-2#13)(2008-3#18)(2008-5#2)(2009-10#1)(2009-12#1)(2010-2#2)(2010-4#1)(2011-2#1)(2012-1#1)
small-animal imaging##3##2##(2009-8#1)(2012-2#2)
small-animal##6##1##(2008-4#1)(2009-10#1)(2009-8#1)(2012-2#2)(2013-1#1)
small-artery disease with##2##3##(2007-10#2)
small-artery##3##1##(2007-10#3)
small-bore##6##1##(2007-12#2)(2007-7#1)(2008-2#3)
small-bowel atresia##3##2##(2008-9#3)
small-bowel##14##1##(1990-6#1)(1993-9#1)(1995-1#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#5)(2012-1#1)(2013-1#1)
small-breasted patients##2##2##(2013-1#2)
small-breasted##3##1##(2013-1#3)
small-caliber##3##1##(2010-6#1)(2011-3#2)
small-cell carcinoma cells##4##3##(1991-10#4)
small-cell carcinoma of the##3##4##(1992-12#1)(1994-11#1)(2007-6#1)
small-cell carcinoma##12##2##(1991-10#4)(1992-12#1)(1994-11#1)(1997-1#1)(2007-6#5)
small-cell gastrointestinal carcinoma lines##2##4##(1993-7#2)
small-cell gastrointestinal carcinoma##5##3##(1993-7#5)
small-cell lung cancer (SCLC)##5##4##(1992-9#2)(1993-7#1)(2004-1#1)(2005-11#1)
small-cell lung cancer cell line##2##5##(1997-1#1)(2010-12#1)
small-cell lung cancer##30##3##(1992-9#2)(1993-7#2)(1994-11#1)(1996-8#2)(1997-1#1)(2004-1#12)(2005-11#2)(2007-8#1)(2008-3#1)(2008-7#3)(2010-12#3)
small-cell lung carcinoma##5##3##(1993-7#1)(1996-12#2)(1997-8#1)(2006-6#1)
small-cell lung##36##2##(1992-9#2)(1993-7#3)(1994-11#1)(1996-12#2)(1996-8#2)(1997-1#1)(1997-7#1)(1997-8#1)(2004-1#12)(2005-11#2)(2006-6#1)(2007-8#1)(2008-3#1)(2008-7#3)(2010-12#3)
small-cell##57##1##(1991-10#4)(1992-12#1)(1992-9#2)(1993-3#1)(1993-7#8)(1994-11#2)(1996-12#2)(1996-8#2)(1997-1#2)(1997-7#1)(1997-8#1)(2004-1#12)(2005-11#2)(2006-6#1)(2007-6#5)(2007-8#1)(2008-3#2)(2008-7#3)(2010-12#3)(2012-12#2)
small-conductance##4##1##(1997-5#3)(2008-6#1)
small-diameter##13##1##(1990-7#1)(1991-2#2)(1991-8#1)(1996-3#1)(1996-8#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-3#2)(2010-1#1)(2013-1#1)
small-event complexity##2##2##(1996-4#2)
small-f-number##2##1##(2007-12#2)
small-fiber neuropathy##2##2##(2013-1#2)
small-fiber##3##1##(2008-9#1)(2013-1#2)
small-field##2##1##(2008-2#1)(2008-3#1)
small-group discussions##2##2##(2011-2#2)
small-group##7##1##(1996-12#1)(1996-4#1)(2010-9#1)(2011-2#3)(2013-1#1)
small-intestinal##2##1##(1996-1#1)(2006-10#1)
small-intestine##2##1##(1992-2#1)(1994-3#1)
small-molecule and##2##2##(2008-12#1)(2008-4#1)
small-molecule crystallography##2##2##(2006-4#2)
small-molecule##22##1##(1996-7#1)(1997-3#1)(1997-4#1)(2004-12#1)(2005-7#2)(2006-4#3)(2007-8#1)(2008-1#2)(2008-12#1)(2008-3#1)(2008-4#2)(2010-11#2)(2010-12#2)(2010-4#1)(2013-1#1)
small-particle##2##1##(1996-1#1)(2008-2#1)
small-period##2##1##(2008-2#1)(2008-7#1)
small-plot##2##1##(2011-2#2)
small-sample##3##1##(2012-2#3)
small-scale disturbance##2##2##(1994-3#2)
small-scale experiments##2##2##(2008-11#1)(2008-3#1)
small-scale studies##3##2##(2008-7#1)(2011-1#1)(2013-1#1)
small-scale##47##1##(1994-3#2)(1994-8#2)(1995-6#1)(2006-11#1)(2006-4#1)(2007-12#3)(2008-1#2)(2008-10#5)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-10#1)(2011-1#2)(2011-2#2)(2013-1#3)(2013-7#1)
small-signal gain of##3##3##(2007-12#2)(2008-2#1)
small-signal gain##7##2##(2007-12#3)(2008-2#3)(2008-3#1)
small-signal gains##2##2##(2007-11#1)(2008-3#1)
small-signal##19##1##(2007-11#2)(2007-12#7)(2008-2#6)(2008-3#4)
small-size##3##1##(1990-5#1)(2008-10#1)(2008-6#1)
small-sized##7##1##(1994-10#1)(2007-11#1)(2008-10#2)(2008-5#1)(2012-2#1)(2013-1#1)
small-solute##3##1##(2007-12#2)(2011-2#1)
small-spored Alternaria##3##2##(2008-10#3)
small-vessel##5##1##(2006-10#1)(2007-10#2)(2007-8#1)(2010-6#1)
small-volume##5##1##(2007-12#1)(2008-3#2)(2008-4#1)(2009-9#1)
small-world##4##1##(2008-11#4)
smaller (p &lt##2##3##(2008-3#1)(2011-2#1)
smaller DNA##2##2##(1993-11#1)(1993-3#1)
smaller adult##2##2##(2008-8#1)(2010-2#1)
smaller aggregates##2##2##(1994-11#1)(2005-11#1)
smaller amount##2##2##(2008-2#1)(2010-2#1)
smaller amounts of##4##3##(1990-2#1)(1996-5#1)(2007-10#1)(2008-2#1)
smaller amounts##6##2##(1990-2#1)(1992-9#1)(1996-5#1)(1997-1#1)(2007-10#1)(2008-2#1)
smaller amplitude##2##2##(1991-1#1)(1994-2#1)
smaller and more##4##3##(1996-2#1)(2006-10#1)(2008-4#1)(2013-7#1)
smaller and##31##2##(1990-7#1)(1991-2#1)(1992-7#1)(1993-2#1)(1994-2#1)(1995-3#1)(1996-2#2)(1997-6#1)(2005-11#1)(2006-10#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-7#1)(2013-8#2)
smaller at##3##2##(1996-8#1)(2007-5#1)(2008-6#1)
smaller brains##2##2##(1996-5#1)(2012-3#1)
smaller breeds##2##2##(1996-12#2)
smaller but##8##2##(1991-5#1)(1994-2#1)(1994-5#1)(2007-9#1)(2008-10#1)(2008-4#1)(2009-3#1)(2011-2#1)
smaller cells##2##2##(1995-5#1)(1996-8#1)
smaller changes##4##2##(1994-5#1)(1994-6#1)(2007-5#1)(2012-3#1)
smaller colonies##2##2##(2008-9#1)(2010-8#1)
smaller companies##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
smaller compared##2##2##(2008-3#1)(2012-12#1)
smaller cysts##2##2##(2008-9#1)(2012-3#1)
smaller decrease##2##2##(1990-3#1)(2008-5#1)
smaller diameters##2##2##(2006-5#1)(2010-8#1)
smaller difference between##2##3##(2008-10#1)(2011-1#1)
smaller difference##3##2##(2007-12#1)(2008-10#1)(2011-1#1)
smaller differences##2##2##(2007-6#1)(2008-7#1)
smaller doses##2##2##(1990-3#1)(2006-10#1)
smaller effect##2##2##(1996-5#1)(2006-3#1)
smaller effects##2##2##(2008-10#1)(2012-2#1)
smaller field of view##2##4##(2008-2#1)(2008-3#1)
smaller for##6##2##(1991-9#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2012-3#1)
smaller form of##2##3##(1990-3#1)(1995-12#1)
smaller fragment##2##2##(1997-5#1)(2008-8#1)
smaller fragments##3##2##(1995-3#1)(1996-8#2)
smaller genomes##3##2##(2008-8#2)(2010-12#1)
smaller geographic areas##2##3##(1994-3#1)(2008-10#1)
smaller geographic##3##2##(1994-3#1)(1994-6#1)(2008-10#1)
smaller groups##3##2##(1990-11#1)(2007-3#1)(2008-9#1)
smaller head circumference##2##3##(2008-11#1)(2008-12#1)
smaller hospitals##7##2##(1990-11#1)(1990-12#2)(1992-6#1)(1993-6#1)(2006-10#1)(2006-6#1)
smaller in animals exposed to##2##5##(1990-5#2)
smaller in magnitude##2##3##(1993-3#1)(2008-3#1)
smaller in size##3##3##(2008-5#2)(2013-1#1)
smaller in the##13##3##(1991-4#1)(1992-3#1)(1993-5#1)(1994-11#1)(1994-2#1)(1996-2#1)(1996-7#1)(2004-11#1)(2004-4#1)(2008-7#1)(2010-1#1)(2010-12#1)(2012-2#1)
smaller in##41##2##(1990-5#2)(1990-8#1)(1991-11#1)(1991-12#1)(1991-4#1)(1992-3#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-12#3)(1996-2#1)(1996-7#1)(1997-2#1)(2004-11#1)(2004-4#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
smaller incisions##2##2##(2007-5#1)(2010-7#1)
smaller increases in the##2##4##(2008-2#1)(2010-6#1)
smaller increases in##6##3##(1993-3#1)(1994-12#1)(2005-11#1)(2008-12#1)(2008-2#1)(2010-6#1)
smaller lesions##4##2##(1997-3#1)(2008-10#2)(2009-2#1)
smaller loss##2##2##(2008-3#1)(2008-5#1)
smaller mRNA species##2##3##(1990-11#1)(1992-12#1)
smaller magnitude##2##2##(1991-11#1)(2011-1#1)
smaller mean##4##2##(2007-5#1)(2009-10#1)(2010-4#1)(2013-8#1)
smaller molecular##3##2##(1995-3#1)(2005-11#1)(2008-10#1)
smaller molecule##2##2##(1990-11#1)(1991-11#1)
smaller molecules##3##2##(2008-10#1)(2008-4#1)(2008-5#1)
smaller number of##10##3##(1993-12#1)(1994-2#1)(1995-10#1)(2005-9#1)(2006-1#1)(2008-10#1)(2008-3#1)(2011-2#2)(2012-2#1)
smaller number##11##2##(1993-12#1)(1994-2#1)(1995-10#1)(2005-9#1)(2006-1#1)(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#2)(2012-2#1)
smaller numbers of##2##3##(1996-5#1)(1997-3#1)
smaller numbers##5##2##(1990-12#1)(1991-12#1)(1996-5#1)(1997-3#1)(2008-4#1)
smaller of the two##2##4##(1991-7#2)
smaller on the##2##3##(2007-10#1)(2007-12#1)
smaller ones##5##2##(1993-9#1)(1994-12#1)(1995-12#1)(2007-12#1)(2008-10#1)
smaller part of the##2##4##(1995-3#1)(1995-7#1)
smaller particles##3##2##(1997-2#1)(2008-10#1)(2010-4#1)
smaller peaks##2##2##(2008-10#1)(2009-11#1)
smaller population##2##2##(1996-5#1)(1997-2#1)
smaller pore##2##2##(2008-5#1)(2008-7#1)
smaller propagule size##2##3##(2008-8#2)
smaller proportion of the##2##4##(1994-3#1)(2008-10#1)
smaller proportion of##4##3##(1993-9#1)(1994-3#1)(1995-5#1)(2008-10#1)
smaller protein##6##2##(1991-10#1)(1993-12#1)(1997-5#2)(2006-10#1)(2008-9#1)
smaller quantities##2##2##(2007-11#1)(2008-5#1)
smaller reduction in##2##3##(1994-8#1)(2008-10#1)
smaller reduction##3##2##(1991-8#1)(1994-8#1)(2008-10#1)
smaller sample volumes##4##3##(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)
smaller sample##7##2##(2008-10#3)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#1)
smaller segments##2##2##(2008-10#1)(2008-5#1)
smaller size##8##2##(1991-2#1)(1992-6#1)(1993-2#1)(1994-12#1)(2008-7#1)(2008-9#1)(2010-6#1)(2010-8#1)
smaller sized mRNAs##2##3##(1990-8#2)
smaller sized##3##2##(1990-8#2)(2008-10#1)
smaller species##4##2##(1991-4#1)(2008-8#1)(2008-9#2)
smaller studies##2##2##(1995-10#1)(2008-8#1)
smaller subgroup of##2##3##(2006-6#1)(2013-1#1)
smaller test##2##2##(1995-2#1)(2008-10#1)
smaller than 0##6##3##(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2013-1#1)
smaller than 1##5##3##(2007-12#1)(2008-10#3)(2008-2#1)
smaller than 10 mm##3##4##(2008-1#1)(2008-7#1)(2013-8#1)
smaller than 10##5##3##(2005-11#1)(2008-1#1)(2008-7#2)(2013-8#1)
smaller than 2 cm##2##4##(1995-4#1)(2008-5#1)
smaller than 2##3##3##(1995-4#1)(2008-10#1)(2008-5#1)
smaller than 3##2##3##(2008-10#1)(2008-3#1)
smaller than 5 mm##4##4##(2008-10#1)(2008-5#2)(2008-8#1)
smaller than 5##6##3##(2008-1#1)(2008-10#1)(2008-5#2)(2008-8#1)(2010-12#1)
smaller than a##4##3##(2005-11#1)(2008-3#1)(2008-9#1)(2011-1#1)
smaller than approximately##2##3##(2008-3#2)
smaller than at pH##2##4##(2008-10#2)
smaller than both##2##3##(2005-11#1)(2008-7#1)
smaller than for##3##3##(1993-8#1)(1996-12#1)(2008-11#1)
smaller than half of the##2##5##(2008-3#2)
smaller than half##3##3##(2008-2#1)(2008-3#2)
smaller than in the##5##4##(2006-6#1)(2008-2#1)(2008-5#1)(2009-6#1)(2013-8#1)
smaller than in##11##3##(1990-4#1)(1994-9#1)(1995-12#1)(2006-12#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-6#1)(2013-8#1)
smaller than its##3##3##(1992-12#1)(2008-2#2)
smaller than normal)##2##3##(1996-3#1)(2011-2#1)
smaller than one##2##3##(1997-1#1)(2008-10#1)
smaller than predicted##2##3##(2007-11#1)(2007-12#1)
smaller than that between##2##4##(2008-10#1)(2011-1#1)
smaller than that for a##3##5##(1997-4#1)(2008-2#1)(2008-3#1)
smaller than that for##6##4##(1997-4#1)(2006-7#1)(2008-2#2)(2008-3#1)(2012-2#1)
smaller than that in the##5##5##(2012-12#2)(2012-2#3)
smaller than that in##10##4##(1993-7#1)(1993-8#1)(1995-10#1)(2007-8#1)(2008-10#1)(2012-12#2)(2012-2#3)
smaller than that observed with##2##5##(1990-3#1)(1992-12#1)
smaller than that observed##3##4##(1990-3#1)(1992-12#1)(2008-2#1)
smaller than that obtained##2##4##(2008-10#2)
smaller than that of a##2##5##(1992-3#1)(2008-2#1)
smaller than that of the##7##5##(1995-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-6#1)
smaller than that of##18##4##(1992-3#1)(1995-6#1)(1996-5#1)(2004-11#1)(2005-11#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#2)(2008-6#1)(2010-6#1)(2012-2#1)
smaller than that##45##3##(1990-3#1)(1992-12#1)(1992-3#2)(1993-7#1)(1993-8#1)(1994-3#1)(1995-10#1)(1995-11#1)(1995-6#1)(1996-5#1)(1997-4#1)(2004-11#1)(2005-11#1)(2006-7#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#7)(2008-3#3)(2008-6#1)(2010-6#1)(2011-1#1)(2012-12#2)(2012-2#5)
smaller than the center wavelength of##2##6##(2007-11#2)
smaller than the control##2##4##(1990-12#1)(2010-12#1)
smaller than the extension of the##2##6##(2013-7#2)
smaller than the ligand##2##4##(2008-10#2)
smaller than the##52##3##(1990-12#1)(1990-7#1)(1992-10#1)(1994-8#2)(1995-6#1)(1996-2#1)(2004-4#1)(2005-11#1)(2006-5#1)(2007-11#2)(2007-12#7)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-2#5)(2008-3#6)(2008-5#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#3)(2013-8#1)
smaller than those in##4##4##(1990-1#1)(1994-9#1)(2008-7#1)(2013-1#1)
smaller than those of the##2##5##(2005-11#1)(2008-8#1)
smaller than those of##9##4##(1994-11#1)(1994-5#1)(2005-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2010-2#1)
smaller than those##22##3##(1990-1#1)(1992-9#1)(1994-11#1)(1994-5#1)(1994-9#1)(2005-11#2)(2007-3#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
smaller than##248##2##(1990-1#1)(1990-11#1)(1990-12#1)(1990-3#2)(1990-4#1)(1990-7#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-7#2)(1993-8#3)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-7#1)(2004-11#1)(2004-4#1)(2005-11#9)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#7)(2007-12#12)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#5)(2008-1#5)(2008-10#33)(2008-11#3)(2008-12#1)(2008-2#20)(2008-3#22)(2008-4#2)(2008-5#9)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-12#3)(2010-2#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#3)(2013-7#3)(2013-8#3)
smaller the##6##2##(1993-3#1)(2005-11#1)(2007-4#1)(2008-3#1)(2008-5#1)(2011-2#1)
smaller tumors##2##2##(2008-5#1)(2009-5#1)
smaller tumour##2##2##(1996-11#1)(2007-11#1)
smaller units were caring for##2##5##(2011-2#2)
smaller units##6##2##(1990-7#1)(2011-2#3)(2012-3#2)
smaller values in##2##3##(1997-2#1)(2007-9#1)
smaller values##4##2##(1997-2#1)(2007-9#1)(2008-12#1)(2008-6#1)
smaller volumes##2##2##(2008-10#1)(2009-7#1)
smaller voxel##2##2##(2008-7#2)
smaller when the##2##3##(2004-8#1)(2008-11#1)
smaller when##5##2##(1997-8#1)(2004-8#1)(2008-11#1)(2008-3#1)(2013-8#1)
smaller with##5##2##(1995-6#1)(2006-12#1)(2009-3#1)(2011-12#1)(2012-2#1)
smaller##957##1##(1990-1#1)(1990-11#5)(1990-12#11)(1990-2#4)(1990-3#6)(1990-4#1)(1990-5#6)(1990-7#4)(1990-8#4)(1991-1#2)(1991-10#2)(1991-11#3)(1991-12#4)(1991-2#2)(1991-3#1)(1991-4#4)(1991-5#4)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#4)(1992-1#2)(1992-10#2)(1992-12#5)(1992-2#1)(1992-3#4)(1992-4#3)(1992-5#1)(1992-6#3)(1992-7#3)(1992-9#4)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#5)(1993-4#3)(1993-5#1)(1993-6#3)(1993-7#4)(1993-8#5)(1993-9#3)(1994-10#1)(1994-11#4)(1994-12#5)(1994-2#6)(1994-3#6)(1994-4#1)(1994-5#5)(1994-6#2)(1994-8#9)(1994-9#5)(1995-1#3)(1995-10#4)(1995-11#4)(1995-12#7)(1995-2#4)(1995-3#9)(1995-4#2)(1995-5#5)(1995-6#5)(1995-7#1)(1995-8#3)(1996-1#2)(1996-11#4)(1996-12#3)(1996-2#7)(1996-3#4)(1996-4#1)(1996-5#8)(1996-6#2)(1996-7#2)(1996-8#4)(1997-1#4)(1997-2#7)(1997-3#6)(1997-4#2)(1997-5#7)(1997-6#4)(1997-7#3)(1997-8#3)(2004-1#2)(2004-11#4)(2004-4#2)(2004-8#1)(2005-10#4)(2005-11#22)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#8)(2006-11#3)(2006-12#4)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#4)(2006-7#3)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#13)(2007-12#30)(2007-3#2)(2007-4#4)(2007-5#5)(2007-6#2)(2007-7#6)(2007-8#9)(2007-9#12)(2008-1#9)(2008-10#93)(2008-11#11)(2008-12#4)(2008-2#42)(2008-3#48)(2008-4#14)(2008-5#29)(2008-6#7)(2008-7#24)(2008-8#16)(2008-9#17)(2009-10#7)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#4)(2009-4#2)(2009-5#4)(2009-6#4)(2009-7#3)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#6)(2010-4#4)(2010-6#4)(2010-7#2)(2010-8#11)(2010-9#1)(2011-1#9)(2011-12#4)(2011-2#17)(2011-3#1)(2012-1#2)(2012-12#14)(2012-2#21)(2012-3#15)(2013-1#10)(2013-7#7)(2013-8#16)
smaller-diameter##2##1##(1996-8#1)(2013-7#1)
smallest among##2##2##(1992-9#1)(2008-8#1)
smallest chromosome##3##2##(1996-9#1)(2008-10#2)
smallest electron storage ring##2##4##(2006-5#2)
smallest in##3##2##(1993-5#1)(1996-5#1)(2010-4#1)
smallest particles##2##2##(1997-2#1)(2005-8#1)
smallest spatial##3##2##(2008-10#2)(2008-2#1)
smallest unit##2##2##(1990-11#1)(1995-8#1)
smallest volume##2##2##(2008-7#1)(2009-7#1)
smallest##117##1##(1990-11#1)(1990-7#2)(1991-7#2)(1991-9#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-3#2)(1993-5#1)(1993-6#1)(1994-9#1)(1995-8#2)(1996-12#2)(1996-2#2)(1996-5#1)(1996-8#1)(1996-9#3)(1997-2#2)(2005-11#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-5#3)(2007-11#1)(2007-12#9)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#3)(2008-10#13)(2008-11#4)(2008-2#4)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-2#1)(2009-6#1)(2009-7#2)(2010-11#1)(2010-2#2)(2010-4#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-11#2)(2012-12#1)(2012-2#2)(2013-1#2)
smallpox and##2##2##(1993-3#1)(1996-12#1)
smallpox epidemic##3##2##(1993-6#1)(2007-12#2)
smallpox eradication##3##2##(1993-3#2)(1994-3#1)
smallpox vaccine##2##2##(2008-1#1)(2008-5#1)
smallpox##24##1##(1993-12#1)(1993-3#3)(1993-6#5)(1994-3#2)(1994-9#1)(1996-12#1)(2005-7#1)(2006-12#1)(2006-7#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-5#1)(2009-9#1)(2010-8#1)(2011-2#1)
smaragdinae##3##1##(2011-2#3)
smart cannula was##2##3##(2007-8#2)
smart cannula##5##2##(2007-8#5)
smart hydrogels##2##2##(2010-2#1)(2013-7#1)
smart illumination##3##2##(2007-12#3)
smart materials that##2##3##(2009-7#1)(2011-1#1)
smart materials##4##2##(2008-7#1)(2009-7#1)(2010-2#1)(2011-1#1)
smart pixel##3##2##(2008-3#3)
smart pixels##4##2##(2008-2#3)(2008-3#1)
smart##55##1##(1990-9#1)(1994-1#2)(1994-3#1)(1996-3#2)(1997-1#1)(2004-5#1)(2006-2#1)(2006-5#1)(2007-11#2)(2007-12#5)(2007-8#5)(2007-9#1)(2008-2#4)(2008-3#5)(2008-7#1)(2008-8#3)(2009-3#3)(2009-7#2)(2010-12#1)(2010-2#3)(2011-1#2)(2011-2#1)(2012-11#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#2)
smart&quot##4##1##(2007-10#1)(2009-11#1)(2010-2#1)(2010-4#1)
smart-pixel array##8##2##(2008-2#5)(2008-3#3)
smart-pixel arrays##2##2##(2008-2#1)(2008-3#1)
smart-pixel devices##2##2##(2008-2#2)
smart-pixel technology##2##2##(2008-3#2)
smart-pixel##18##1##(2007-12#1)(2008-2#11)(2008-3#6)
smart-structure applications##2##2##(2007-11#1)(2007-12#1)
smarter##2##1##(1995-12#1)(2008-9#1)
smcR mutant exhibited##2##3##(2007-12#2)
smcR mutant##3##2##(2007-12#3)
smcR##6##1##(2007-12#6)
smco7 mutant##5##2##(1997-4#5)
smco7##7##1##(1997-4#7)
smear and##7##2##(1990-6#1)(2006-10#1)(2007-3#2)(2007-7#1)(2008-1#1)(2012-2#1)
smear for##3##2##(1991-4#1)(1992-3#1)(2007-8#1)
smear from##3##2##(2006-10#1)(2007-12#1)(2012-2#1)
smear images##3##2##(2008-3#3)
smear in##2##2##(2006-10#1)(2011-2#1)
smear is a##2##3##(2007-8#1)(2011-2#1)
smear is##6##2##(1992-3#1)(2007-8#1)(2011-2#4)
smear layer##2##2##(1991-2#1)(2010-6#1)
smear method##2##2##(2006-4#1)(2011-1#1)
smear negative##2##2##(2007-7#1)(2007-8#1)
smear of##5##2##(1996-12#1)(2007-2#1)(2008-3#1)(2008-5#1)(2011-2#1)
smear positive##2##2##(2007-7#2)
smear positivity among the new cases##2##6##(2007-7#2)
smear positivity##3##2##(2007-7#2)(2012-2#1)
smear preparation##4##2##(2007-6#1)(2008-1#1)(2012-1#2)
smear results##3##2##(1991-6#1)(2006-10#2)
smear screening##9##2##(2006-10#2)(2008-3#1)(2011-2#6)
smear showed##2##2##(2007-7#1)(2013-8#1)
smear slides##3##2##(2008-2#1)(2011-2#2)
smear was##5##2##(2006-10#1)(2006-6#1)(2007-7#1)(2008-10#1)(2012-2#1)
smear within##2##2##(1992-8#1)(2011-2#1)
smear##142##1##(1990-3#1)(1990-6#1)(1990-8#3)(1991-2#1)(1991-4#1)(1991-6#4)(1992-1#2)(1992-3#4)(1992-5#2)(1992-8#3)(1995-3#1)(1996-12#3)(1996-3#1)(2004-10#1)(2005-9#1)(2006-10#24)(2006-4#1)(2006-6#1)(2007-12#2)(2007-2#2)(2007-3#4)(2007-6#1)(2007-7#11)(2007-8#5)(2008-1#3)(2008-10#1)(2008-2#4)(2008-3#5)(2008-5#1)(2008-7#1)(2010-6#1)(2011-1#1)(2011-2#28)(2012-1#4)(2012-2#6)(2012-3#2)(2013-1#4)(2013-8#1)
smear-positive PTB cases##2##3##(2013-8#2)
smear-positive pulmonary tuberculosis##4##3##(2013-1#3)(2013-8#1)
smear-positive pulmonary##5##2##(2005-9#1)(2013-1#3)(2013-8#1)
smear-positive##9##1##(1991-11#1)(2005-9#2)(2013-1#3)(2013-8#3)
smeared out##2##2##(2005-11#1)(2008-1#1)
smeared##5##1##(2005-11#1)(2006-5#1)(2008-1#1)(2008-2#1)(2013-8#1)
smearing##3##1##(2005-11#1)(2008-2#1)(2008-3#1)
smears and##18##2##(1990-10#1)(1990-12#1)(1990-6#1)(1992-1#1)(1992-10#1)(1992-3#1)(1997-7#3)(2004-10#1)(2006-10#2)(2007-7#2)(2008-9#1)(2009-8#1)(2012-1#1)(2013-8#1)
smears are##2##2##(1997-7#1)(2006-10#1)
smears at the##2##3##(1992-3#1)(2006-9#1)
smears from##3##2##(1991-11#1)(2007-2#1)(2008-3#1)
smears in##5##2##(2005-12#1)(2006-10#2)(2007-8#1)(2008-7#1)
smears of##6##2##(1996-12#1)(2006-10#2)(2008-1#1)(2008-7#1)(2010-5#1)
smears taken##2##2##(1996-12#2)
smears were positive for##2##4##(2007-2#1)(2008-4#1)
smears were##10##2##(1990-6#1)(1992-3#1)(1996-12#1)(2006-10#2)(2007-2#1)(2008-2#2)(2008-4#1)(2013-8#1)
smears##95##1##(1990-10#3)(1990-12#2)(1990-6#5)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1992-1#1)(1992-10#1)(1992-3#3)(1992-8#1)(1996-12#6)(1997-7#7)(2004-10#1)(2005-12#1)(2005-8#1)(2006-10#19)(2006-9#1)(2007-12#1)(2007-2#3)(2007-7#4)(2007-8#5)(2008-1#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-7#4)(2008-9#1)(2009-8#1)(2010-5#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#3)
smears)##2##1##(1990-12#1)(2011-1#1)
smectic A(*)##2##2##(2007-11#1)(2008-1#1)
smectic##7##1##(1992-1#2)(1993-7#1)(2007-11#3)(2008-1#1)
smectite##6##1##(1994-8#1)(2005-11#3)(2008-10#2)
smectites intercalated with##2##3##(2005-11#2)
smectites##4##1##(2005-11#4)
smegmatis and M##2##3##(2008-7#2)
smegmatis and##4##2##(1997-4#1)(2006-9#1)(2008-7#2)
smegmatis##12##1##(1996-10#2)(1997-1#2)(1997-4#1)(2006-9#1)(2008-7#4)(2010-12#2)
smell and##3##2##(1995-5#1)(2007-9#2)
smell of##3##2##(1995-6#1)(2008-2#1)(2009-6#1)
smell##29##1##(1992-5#1)(1993-6#1)(1995-5#2)(1995-6#1)(2006-12#1)(2006-2#1)(2007-8#1)(2007-9#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#8)
smelling##3##1##(2006-2#1)(2007-12#1)(2007-7#1)
smells##4##1##(1990-8#1)(1997-2#1)(2012-2#2)
smelt antifreeze##2##2##(1992-5#2)
smelt##4##1##(1992-5#3)(2010-8#1)
smelter plant##2##2##(2009-6#1)(2012-1#1)
smelter##18##1##(1992-3#1)(1995-11#3)(1996-3#5)(2004-4#5)(2008-11#1)(2009-6#2)(2012-1#1)
smelters##5##1##(1992-3#1)(2004-4#1)(2007-9#1)(2008-10#1)(2008-3#1)
smelting##4##1##(1997-6#1)(2008-10#3)
smg GDS and rho GDI##2##5##(1992-1#2)
smg GDS and rho##3##4##(1992-1#2)(1992-5#1)
smg GDS##4##2##(1992-1#3)(1992-5#1)
smg p25A GDI was##2##4##(1991-1#2)
smg p25A GDI##6##3##(1991-1#6)
smg p25A##12##2##(1991-1#11)(1992-1#1)
smg##17##1##(1991-1#11)(1992-1#5)(1992-5#1)
smile##8##1##(2007-8#1)(2008-7#1)(2012-2#1)(2012-3#5)
smiles and eyebrow raises##3##4##(2010-3#3)
smiles and##4##2##(2004-3#1)(2010-3#3)
smiles##6##1##(2004-3#1)(2010-3#4)(2012-3#1)
smo##2##1##(1997-4#2)
smoke and those##2##3##(1994-2#1)(2008-1#1)
smoke and##14##2##(1993-2#1)(1993-8#1)(1994-2#1)(1996-12#1)(1996-3#1)(2007-2#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-5#1)(2010-7#1)(2011-2#1)
smoke are##2##2##(2007-1#1)(2008-11#1)
smoke by##5##2##(2007-8#1)(2011-1#3)(2013-8#1)
smoke can##2##2##(1991-4#1)(2006-9#1)
smoke caused##3##2##(2008-5#3)
smoke components##3##2##(2007-8#1)(2013-1#2)
smoke control##3##2##(1996-12#3)
smoke during pregnancy##3##3##(1991-11#1)(2007-2#1)(2012-1#1)
smoke from##3##2##(1996-12#2)(2007-8#1)
smoke generating##2##2##(2007-11#2)
smoke in##7##2##(1991-12#1)(1991-4#1)(1993-8#1)(1996-12#1)(2005-10#1)(2007-2#1)(2008-11#1)
smoke inhalation##2##2##(2008-8#2)
smoke is##4##2##(1991-12#1)(1992-9#1)(1996-12#2)
smoke may##3##2##(2006-2#1)(2006-9#1)(2009-5#1)
smoke more##2##2##(1992-8#2)
smoke on##7##2##(1991-4#2)(1991-9#1)(2008-5#2)(2011-12#1)(2012-12#1)
smoke or##3##2##(1991-12#1)(1993-6#1)(1993-8#1)
smoke production##2##2##(1993-12#1)(1996-12#1)
smoke stimulates##2##2##(2006-9#2)
smoke to##2##2##(1994-7#1)(1996-3#1)
smoke toxicity testing##2##3##(1996-12#2)
smoke toxicity##5##2##(1996-12#5)
smoke was##2##2##(2008-5#1)(2011-1#1)
smoke while##2##2##(1991-11#1)(2010-5#1)
smoke##187##1##(1990-9#1)(1991-11#4)(1991-12#3)(1991-3#1)(1991-4#5)(1991-9#3)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#5)(1992-9#3)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#2)(1993-8#5)(1994-2#2)(1994-3#2)(1994-7#2)(1995-6#1)(1996-12#30)(1996-3#2)(1996-6#1)(1997-1#1)(2005-10#2)(2005-8#1)(2006-10#2)(2006-2#2)(2006-7#1)(2006-9#5)(2007-1#1)(2007-11#4)(2007-2#4)(2007-5#2)(2007-8#8)(2008-1#4)(2008-10#2)(2008-11#8)(2008-2#1)(2008-3#2)(2008-5#12)(2008-7#1)(2008-8#5)(2009-11#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-2#3)(2010-3#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#8)(2011-12#4)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
smoke)##2##1##(1992-4#1)(2008-3#1)
smoke-exposed##2##1##(1993-8#1)(2007-2#1)
smoke-free environment##3##2##(1990-6#1)(1993-5#1)(2011-2#1)
smoke-free##10##1##(1990-6#1)(1991-5#3)(1993-5#1)(1993-6#1)(1995-6#2)(1996-12#1)(2011-2#1)
smoke-induced damage##2##2##(2008-8#2)
smoke-induced##5##1##(1991-9#1)(2008-5#1)(2008-8#3)
smoke?##2##1##(2010-9#1)(2011-2#1)
smoked and##2##2##(1991-1#1)(2011-1#1)
smoked cigarettes##3##2##(1996-8#1)(2007-2#1)(2008-3#1)
smoked daily##4##2##(2005-10#1)(2011-1#1)(2013-1#2)
smoked for##2##2##(2006-12#1)(2012-12#1)
smoked in##2##2##(2007-12#1)(2011-2#1)
smoked more##2##2##(1991-11#1)(1993-11#1)
smoked tobacco##2##2##(1990-10#1)(2008-9#1)
smoked##50##1##(1990-10#1)(1990-12#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-11#3)(1991-5#1)(1991-8#1)(1993-11#1)(1994-5#1)(1994-6#1)(1996-6#1)(1996-8#1)(1997-4#2)(2005-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-9#1)(2011-1#2)(2011-2#5)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
smokeless powders##2##2##(2008-10#2)
smokeless tobacco use##2##3##(2008-4#2)
smokeless tobacco users##2##3##(2006-2#1)(2008-4#1)
smokeless tobacco using patients enrolled)##2##5##(2008-4#2)
smokeless tobacco##12##2##(1991-8#3)(1993-4#1)(2006-2#1)(2008-4#7)
smokeless##15##1##(1991-8#3)(1993-4#1)(1993-5#1)(2006-2#1)(2008-10#2)(2008-4#7)
smoker (n =##2##3##(2008-12#2)
smoker##26##1##(1991-4#1)(1994-6#1)(1995-3#1)(1996-1#1)(1996-3#1)(2006-10#1)(2006-9#1)(2008-10#2)(2008-12#4)(2008-4#1)(2008-6#1)(2010-2#2)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-3#1)(2013-1#2)
smoker)##2##1##(2006-8#1)(2010-7#1)
smokers (&gt##2##2##(1994-6#1)(1995-6#1)
smokers (N =##3##3##(2007-12#2)(2012-3#1)
smokers and non-smokers and##2##4##(1996-9#1)(2008-10#1)
smokers and non-smokers in a##2##5##(2010-2#1)(2010-3#1)
smokers and non-smokers in##3##4##(2010-2#1)(2010-3#1)(2011-2#1)
smokers and non-smokers##18##3##(1990-10#2)(1990-12#1)(1993-2#1)(1993-5#1)(1996-9#1)(1997-2#1)(2008-10#1)(2008-12#3)(2008-7#1)(2009-6#2)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#1)
smokers and nonsmokers##3##3##(2008-10#2)(2009-5#1)
smokers and##38##2##(1990-10#3)(1990-12#1)(1992-4#1)(1993-2#1)(1993-5#1)(1996-9#1)(1997-2#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-12#5)(2008-4#1)(2008-7#2)(2009-2#1)(2009-5#2)(2009-6#2)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#1)(2013-1#3)(2013-4#1)
smokers are##5##2##(1996-3#1)(1996-9#1)(2008-12#1)(2011-2#2)
smokers before##2##2##(2010-2#2)
smokers by##3##2##(1993-8#3)
smokers can##2##2##(1991-4#1)(2012-1#1)
smokers compared to##3##3##(2009-5#1)(2010-9#1)(2013-1#1)
smokers compared##6##2##(2009-5#4)(2010-9#1)(2013-1#1)
smokers comprised##2##2##(1994-6#1)(2012-2#1)
smokers continue to##2##3##(2010-2#1)(2013-1#1)
smokers had##6##2##(1991-8#1)(2006-2#1)(2008-10#1)(2008-12#1)(2010-7#1)(2013-4#1)
smokers in the##3##3##(1991-5#1)(2008-10#1)(2010-11#1)
smokers in##11##2##(1991-5#1)(1994-5#2)(2008-10#1)(2008-12#1)(2009-5#2)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
smokers increased##2##2##(1991-8#1)(1993-2#1)
smokers of##4##2##(1991-4#1)(1991-9#1)(2007-3#1)(2011-2#1)
smokers or ex-smokers##2##3##(1991-3#2)
smokers or##3##2##(1991-3#2)(2008-4#1)
smokers reported##2##2##(1993-10#1)(2010-3#1)
smokers showed##2##2##(2008-12#1)(2010-2#1)
smokers than among the##2##4##(1991-8#1)(2006-12#1)
smokers than non-smokers##4##3##(1992-9#1)(2008-10#2)(2010-2#1)
smokers than##9##2##(1991-8#1)(1992-9#1)(1995-6#1)(2006-12#1)(2008-10#2)(2009-5#2)(2010-2#1)
smokers to quit##2##3##(2012-1#1)(2012-2#1)
smokers to##3##2##(1996-2#1)(2012-1#1)(2012-2#1)
smokers using##2##2##(2009-7#1)(2010-11#1)
smokers versus##2##2##(2012-1#1)(2013-4#1)
smokers was##8##2##(1990-5#1)(1991-10#1)(1994-5#2)(2009-5#3)(2011-2#1)
smokers were significantly more##2##4##(2006-2#1)(2010-3#1)
smokers were significantly##3##3##(2006-2#1)(2010-11#1)(2010-3#1)
smokers were##9##2##(1993-9#1)(1994-6#2)(2006-2#1)(2010-11#1)(2010-3#1)(2012-2#1)(2013-1#2)
smokers who##5##2##(1997-4#1)(2012-1#1)(2013-1#3)
smokers with schizophrenia##3##3##(2009-9#3)
smokers with##12##2##(1992-9#2)(2005-8#1)(2006-2#1)(2008-5#1)(2008-6#1)(2009-9#3)(2010-2#1)(2010-5#1)(2013-1#1)
smokers##297##1##(1990-10#6)(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-9#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#2)(1991-4#6)(1991-5#1)(1991-8#5)(1991-9#4)(1992-2#1)(1992-4#3)(1992-9#6)(1993-1#2)(1993-10#3)(1993-11#1)(1993-2#5)(1993-5#2)(1993-6#2)(1993-8#3)(1993-9#1)(1994-11#1)(1994-5#4)(1994-6#8)(1995-12#1)(1995-6#3)(1996-2#1)(1996-3#7)(1996-8#2)(1996-9#2)(1997-2#4)(1997-4#1)(2004-1#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-2#10)(2006-7#1)(2006-9#1)(2007-11#3)(2007-12#9)(2007-3#3)(2007-7#3)(2007-8#1)(2008-10#15)(2008-11#2)(2008-12#11)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#3)(2009-2#1)(2009-5#18)(2009-6#2)(2009-7#2)(2009-9#4)(2010-11#5)(2010-2#12)(2010-3#4)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#15)(2012-1#4)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#6)(2013-1#19)(2013-4#5)(2013-8#5)
smokers'##6##1##(1990-10#1)(1993-8#1)(1995-6#1)(2008-11#1)(2010-2#1)(2011-2#1)
smokers)##4##1##(1991-8#2)(1992-4#1)(2009-12#1)
smoking (19%)##2##2##(2007-12#1)(2007-9#1)
smoking (OR = 2##3##4##(2011-1#1)(2012-1#2)
smoking (OR =##6##3##(2011-1#1)(2012-1#2)(2013-1#3)
smoking (OR##7##2##(2010-4#1)(2011-1#1)(2012-1#2)(2013-1#3)
smoking (p##2##2##(1991-12#1)(2008-8#1)
smoking abstinence at##2##3##(2009-2#1)(2013-1#1)
smoking abstinence##6##2##(2009-2#1)(2010-11#3)(2010-4#1)(2013-1#1)
smoking after##2##2##(2012-1#1)(2012-2#1)
smoking among the##2##3##(2011-2#1)(2012-1#1)
smoking among##16##2##(1990-9#1)(1991-11#3)(1991-4#1)(1991-9#1)(2006-2#1)(2007-3#1)(2009-5#1)(2009-7#1)(2011-2#2)(2012-1#2)(2013-1#2)
smoking and a##2##3##(2009-5#1)(2012-1#1)
smoking and alcohol drinking##2##4##(1991-9#1)(2005-11#1)
smoking and alcohol use##2##4##(2008-8#1)(2011-1#1)
smoking and alcohol##7##3##(1991-9#2)(2005-11#1)(2008-8#1)(2011-1#1)(2013-1#2)
smoking and coronary atherosclerosis##2##4##(2013-4#2)
smoking and employment##2##3##(2004-10#2)
smoking and ethnicity##2##3##(2008-1#1)(2013-8#1)
smoking and excessive alcohol intake##2##5##(2011-1#2)
smoking and hypertension##2##3##(1997-8#1)(2008-3#1)
smoking and its##3##3##(2009-5#1)(2013-1#2)
smoking and low##2##3##(2011-1#2)
smoking and lung cancer##5##4##(1996-3#1)(2012-2#1)(2013-1#3)
smoking and other##2##3##(1992-8#1)(2011-1#1)
smoking and the risk of##2##5##(2008-12#1)(2011-2#1)
smoking and the##7##3##(1995-6#1)(2006-8#1)(2007-9#1)(2008-12#1)(2009-5#1)(2011-1#1)(2011-2#1)
smoking and##94##2##(1990-12#1)(1991-11#1)(1991-5#2)(1991-8#1)(1991-9#5)(1992-6#1)(1992-8#1)(1993-9#1)(1994-6#3)(1995-6#2)(1996-3#2)(1997-8#1)(2004-10#3)(2005-11#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-9#1)(2008-1#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-8#2)(2009-5#6)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#11)(2011-12#1)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#3)(2013-1#10)(2013-4#4)(2013-7#1)(2013-8#1)
smoking are##9##2##(1994-6#1)(2005-8#1)(2006-8#1)(2007-6#1)(2008-7#1)(2011-2#2)(2012-11#1)(2013-8#1)
smoking as a##4##3##(1990-2#1)(1996-6#1)(2011-2#1)(2012-11#1)
smoking as##7##2##(1990-2#1)(1996-6#1)(2006-8#1)(2008-8#2)(2011-2#1)(2012-11#1)
smoking at Wave 1 were##2##5##(2013-8#2)
smoking at age##3##3##(1997-3#1)(2010-3#2)
smoking at home##2##3##(1993-10#1)(2012-1#1)
smoking at##11##2##(1991-11#1)(1991-9#1)(1993-10#1)(1997-3#1)(1997-4#1)(2010-11#1)(2010-3#2)(2012-1#1)(2013-8#2)
smoking behavior and##2##3##(2008-8#1)(2013-1#1)
smoking behavior##12##2##(1991-1#1)(2007-11#2)(2008-8#3)(2009-12#1)(2009-9#1)(2010-2#1)(2010-9#1)(2012-12#1)(2013-1#1)
smoking behaviour##6##2##(1990-9#1)(1995-6#1)(1995-8#1)(2010-12#1)(2010-3#2)
smoking between the##2##3##(1990-2#1)(2011-2#1)
smoking by doctors##2##3##(2008-10#2)
smoking by mother during subjects' childhood##2##6##(2011-2#2)
smoking by##4##2##(2008-10#2)(2011-2#2)
smoking can be##2##3##(2006-5#1)(2008-10#1)
smoking cannabis##2##2##(1991-8#1)(2006-7#1)
smoking caused##2##2##(1996-3#1)(2011-2#1)
smoking causes##2##2##(1992-6#1)(2005-10#1)
smoking cessation among##4##3##(1994-7#1)(2007-12#2)(2010-4#1)
smoking cessation and##7##3##(1991-4#1)(2006-12#1)(2007-12#1)(2008-7#1)(2010-2#1)(2013-1#2)
smoking cessation education##4##3##(2012-3#4)
smoking cessation for##2##3##(2009-7#1)(2010-2#1)
smoking cessation in##9##3##(2007-12#1)(2008-6#1)(2009-7#2)(2010-2#2)(2011-1#1)(2011-2#1)(2012-2#1)
smoking cessation intervention##2##3##(2007-12#1)(2008-8#1)
smoking cessation interventions##5##3##(2009-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
smoking cessation may##2##3##(2007-12#1)(2010-4#1)
smoking cessation programs##3##3##(1991-12#1)(2008-8#2)
smoking cessation rate##2##3##(1991-11#1)(2008-11#1)
smoking cessation rates##4##3##(2007-12#2)(2008-11#2)
smoking cessation training##2##3##(2011-2#2)
smoking cessation treatment##2##3##(2009-7#1)(2012-1#1)
smoking cessation trial##2##3##(2007-12#2)
smoking cessation##104##2##(1990-12#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-4#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-7#1)(1995-3#1)(1997-4#2)(2005-12#1)(2005-9#1)(2006-12#2)(2007-12#11)(2007-9#1)(2008-11#4)(2008-6#1)(2008-7#2)(2008-8#6)(2009-11#1)(2009-4#1)(2009-7#6)(2010-2#11)(2010-4#3)(2011-1#2)(2011-12#1)(2011-2#8)(2012-1#6)(2012-2#3)(2012-3#9)(2013-1#12)
smoking cognitions##4##2##(2012-12#4)
smoking compared to##2##3##(1997-4#1)(2006-10#1)
smoking crack##2##2##(2008-5#2)
smoking does##2##2##(1995-6#1)(2004-10#1)
smoking during pregnancy##8##3##(1991-11#1)(1992-7#1)(1995-6#1)(1997-7#2)(2006-10#1)(2012-1#1)(2012-2#1)
smoking during##10##2##(1991-11#2)(1992-7#1)(1994-6#1)(1995-6#1)(1997-7#2)(2006-10#1)(2012-1#1)(2012-2#1)
smoking epidemic##2##2##(1994-5#1)(1997-8#1)
smoking exposure##2##2##(2011-1#1)(2012-1#1)
smoking for##5##2##(1995-6#2)(2006-12#1)(2006-8#1)(2012-12#1)
smoking habit##17##2##(1991-12#1)(1993-6#1)(1994-4#1)(1995-3#1)(1996-12#1)(2006-8#1)(2007-10#2)(2007-3#1)(2008-1#1)(2008-12#1)(2009-5#1)(2010-5#3)(2011-1#1)(2011-2#1)
smoking habits among##4##3##(1993-10#1)(1994-5#1)(1995-6#1)(2011-1#1)
smoking habits and physical activity##2##5##(2006-9#2)
smoking habits and##6##3##(1990-9#1)(1993-4#1)(2006-9#2)(2008-8#1)(2012-1#1)
smoking habits in##4##3##(1993-2#1)(1994-5#1)(1995-6#1)(2006-8#1)
smoking habits of##3##3##(1994-6#1)(2009-5#2)
smoking habits was carried out##2##5##(1993-6#1)(1994-6#1)
smoking habits##46##2##(1990-10#2)(1990-12#1)(1990-2#4)(1990-9#1)(1991-10#1)(1991-11#1)(1992-8#1)(1993-10#2)(1993-2#1)(1993-4#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-5#2)(1994-6#4)(1995-6#3)(1996-3#1)(1996-6#1)(1996-7#1)(2006-10#1)(2006-8#2)(2006-9#3)(2008-8#1)(2009-5#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
smoking has##4##2##(1994-5#1)(2006-10#1)(2007-1#1)(2008-12#1)
smoking histories##2##2##(1991-12#1)(1992-6#1)
smoking history##6##2##(1993-1#1)(1996-3#2)(2009-4#1)(2009-5#1)(2013-1#1)
smoking in pregnancy##6##3##(1992-11#1)(1995-6#3)(2007-1#1)(2010-6#1)
smoking in public places##2##4##(1991-5#1)(1996-1#1)
smoking in public##3##3##(1991-5#1)(1996-1#1)(2012-1#1)
smoking in the##6##3##(1991-5#1)(1993-5#1)(2008-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
smoking in##33##2##(1990-6#1)(1991-10#1)(1991-3#2)(1991-5#2)(1991-9#2)(1992-11#1)(1993-5#1)(1995-6#3)(1996-1#1)(1996-8#1)(2006-1#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-7#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
smoking index##2##2##(2008-7#1)(2011-2#1)
smoking induces##2##2##(1990-5#1)(2012-2#1)
smoking initiation##9##2##(2008-8#3)(2010-11#1)(2010-2#2)(2012-12#3)
smoking is a major##2##4##(2005-10#1)(2011-12#1)
smoking is a##5##3##(2005-10#1)(2011-1#1)(2011-12#1)(2013-1#1)(2013-4#1)
smoking is associated with a##2##5##(2008-4#1)(2011-2#1)
smoking is associated with##4##4##(2007-10#1)(2008-12#1)(2008-4#1)(2011-2#1)
smoking is the##2##3##(2010-9#1)(2011-2#1)
smoking is##23##2##(1991-4#1)(1992-3#1)(1994-6#1)(2005-10#1)(2005-8#1)(2007-10#1)(2007-3#1)(2008-12#1)(2008-4#1)(2008-8#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#2)(2013-1#3)(2013-4#1)
smoking maintenance##2##2##(2010-2#2)
smoking mothers##8##2##(1990-5#2)(1991-11#2)(1991-4#1)(2007-2#3)
smoking norms and##2##3##(2010-2#1)(2013-1#1)
smoking of##4##2##(1991-1#1)(1992-8#1)(2007-8#1)(2008-4#1)
smoking on the risk##2##4##(1993-8#1)(2007-2#1)
smoking on the##5##3##(1993-8#1)(2005-9#1)(2007-2#2)(2012-3#1)
smoking on##26##2##(1990-6#1)(1990-9#1)(1992-3#1)(1992-9#1)(1993-8#1)(1995-6#1)(1996-3#1)(2005-9#1)(2006-11#2)(2007-10#1)(2007-2#4)(2008-10#2)(2008-12#1)(2008-4#2)(2009-11#2)(2009-12#1)(2012-3#2)(2013-8#1)
smoking or##6##2##(1990-9#1)(1993-2#1)(2008-7#1)(2009-5#1)(2010-8#1)(2013-8#1)
smoking over time##2##3##(2008-8#2)
smoking prevalence in##2##3##(2006-8#2)
smoking prevalence##14##2##(1994-6#3)(1996-3#3)(2005-10#1)(2006-8#3)(2008-7#1)(2008-8#1)(2011-2#2)
smoking prevention program##3##3##(2008-8#2)(2009-5#1)
smoking prevention##6##2##(1996-3#2)(2008-8#3)(2009-5#1)
smoking rate of##2##3##(1996-7#1)(2009-5#1)
smoking rate##5##2##(1996-7#1)(2007-12#1)(2007-7#1)(2008-2#1)(2009-5#1)
smoking rates and##3##3##(2007-12#1)(2011-2#1)(2013-1#1)
smoking rates##6##2##(2006-5#1)(2007-11#1)(2007-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
smoking related causes##2##3##(2006-8#2)
smoking related##5##2##(1997-7#1)(2006-8#3)(2010-2#1)
smoking significantly##2##2##(2008-8#1)(2012-1#1)
smoking status and##3##3##(2007-12#1)(2011-2#1)(2013-1#1)
smoking status of##6##3##(2005-9#1)(2008-12#1)(2009-5#4)
smoking status##36##2##(1990-5#1)(1995-8#1)(2005-9#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-8#1)(2009-5#5)(2010-12#2)(2010-3#3)(2010-4#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-3#4)(2013-1#3)
smoking to##2##2##(1992-2#1)(2012-12#1)
smoking was less##2##3##(1994-6#1)(2007-11#1)
smoking was the##2##3##(1991-8#1)(1997-2#1)
smoking was##25##2##(1990-5#1)(1991-8#1)(1991-9#2)(1992-10#1)(1994-6#1)(1996-3#1)(1997-2#1)(1997-4#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-2#2)(2011-2#3)(2012-1#2)(2013-1#2)
smoking were associated with##3##4##(1990-10#1)(1995-12#1)(2008-5#1)
smoking were the##2##3##(2007-10#1)(2012-2#1)
smoking were##16##2##(1990-10#1)(1993-7#1)(1995-12#1)(1996-3#1)(2006-8#1)(2007-10#1)(2008-5#1)(2009-5#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-9#1)(2012-1#1)(2012-2#1)(2013-8#1)
smoking while##2##2##(1993-2#1)(2007-2#1)
smoking##954##1##(1990-10#4)(1990-12#7)(1990-2#6)(1990-5#7)(1990-6#7)(1990-9#7)(1991-1#4)(1991-10#3)(1991-11#12)(1991-12#9)(1991-2#1)(1991-3#2)(1991-4#5)(1991-5#6)(1991-6#1)(1991-8#5)(1991-9#22)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#3)(1992-9#3)(1993-1#1)(1993-10#4)(1993-11#1)(1993-12#2)(1993-2#5)(1993-4#1)(1993-5#2)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#3)(1994-11#2)(1994-2#2)(1994-3#1)(1994-4#1)(1994-5#6)(1994-6#18)(1994-7#2)(1995-12#4)(1995-3#2)(1995-6#16)(1995-8#2)(1996-1#2)(1996-12#2)(1996-3#18)(1996-6#2)(1996-7#3)(1996-8#3)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#6)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#2)(2004-10#4)(2005-10#7)(2005-11#3)(2005-12#1)(2005-8#4)(2005-9#3)(2006-1#1)(2006-10#8)(2006-11#8)(2006-12#4)(2006-2#12)(2006-5#2)(2006-7#7)(2006-8#17)(2006-9#4)(2007-1#3)(2007-10#10)(2007-11#6)(2007-12#19)(2007-2#14)(2007-3#15)(2007-6#3)(2007-7#5)(2007-8#7)(2007-9#8)(2008-1#9)(2008-10#14)(2008-11#10)(2008-12#9)(2008-2#2)(2008-3#6)(2008-4#9)(2008-5#5)(2008-6#5)(2008-7#15)(2008-8#41)(2009-11#3)(2009-12#3)(2009-2#1)(2009-4#5)(2009-5#24)(2009-6#1)(2009-7#10)(2009-9#6)(2010-10#2)(2010-11#7)(2010-12#9)(2010-2#32)(2010-3#13)(2010-4#7)(2010-5#7)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#24)(2011-12#5)(2011-2#51)(2012-1#32)(2012-11#2)(2012-12#17)(2012-2#15)(2012-3#15)(2013-1#72)(2013-4#6)(2013-7#2)(2013-8#14)
smoking)##3##1##(1991-8#2)(2008-5#1)
smoking-cessation##2##1##(1991-10#1)(2010-4#1)
smoking-induced##2##1##(1992-3#1)(2011-2#1)
smoking-negative samples##2##2##(2010-4#2)
smoking-related TP53 mutation##2##3##(2011-2#2)
smoking-related##5##1##(2005-8#2)(2011-2#2)(2013-1#1)
smoking?##4##1##(2006-10#1)(2007-2#1)(2011-2#1)(2013-1#1)
smoking]##6##1##(1991-4#1)(1995-12#1)(1996-3#2)(2008-10#1)(2013-8#1)
smooth and the##3##3##(2007-12#1)(2008-7#1)(2011-2#1)
smooth and##17##2##(1995-4#1)(2004-9#1)(2006-4#2)(2007-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
smooth as##3##2##(1995-12#1)(1996-1#1)(2008-10#1)
smooth but##2##2##(2007-12#2)
smooth endoplasmic reticulum and##2##4##(2007-12#2)
smooth endoplasmic reticulum##5##3##(2006-5#1)(2007-12#3)(2008-5#1)
smooth endoplasmic##6##2##(2006-5#1)(2007-12#3)(2008-5#1)(2009-2#1)
smooth fibers##4##2##(1994-5#4)
smooth induction##2##2##(2007-9#1)(2012-2#1)
smooth muscle (VSM) cells##2##4##(1993-8#1)(1997-7#1)
smooth muscle actin and##3##4##(2008-11#1)(2008-7#1)(2010-12#1)
smooth muscle actin##16##3##(1994-12#1)(1997-2#1)(2007-6#2)(2008-11#2)(2008-6#1)(2008-7#1)(2009-5#1)(2009-7#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
smooth muscle alpha-actin##2##3##(1995-3#1)(1997-4#1)
smooth muscle and endothelial cells##3##5##(1995-3#3)
smooth muscle and nonmuscle##2##4##(1996-4#2)
smooth muscle and##18##3##(1990-8#1)(1991-12#1)(1991-8#1)(1992-3#1)(1992-4#1)(1995-12#1)(1995-3#3)(1995-5#1)(1996-4#2)(1997-4#2)(1997-7#1)(2005-8#1)(2008-7#1)(2011-2#1)
smooth muscle are##3##3##(1990-4#1)(1994-8#1)(2010-1#1)
smooth muscle by a##2##4##(1991-1#1)(1993-3#1)
smooth muscle by##6##3##(1990-7#1)(1990-8#1)(1991-1#1)(1993-3#1)(1993-6#1)(1994-11#1)
smooth muscle calponin##3##3##(1990-9#2)(2008-6#1)
smooth muscle cell (SMC)##4##4##(1991-10#1)(1993-11#1)(1995-3#2)
smooth muscle cell growth and##2##5##(1992-8#1)(1996-9#1)
smooth muscle cell growth##3##4##(1992-8#1)(1994-12#1)(1996-9#1)
smooth muscle cell proliferation and##2##5##(2008-10#1)(2008-11#1)
smooth muscle cell proliferation##9##4##(1990-7#2)(1992-4#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)
smooth muscle cell##37##3##(1990-7#2)(1991-10#1)(1991-9#1)(1992-4#3)(1992-8#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-8#1)(1995-12#2)(1995-3#3)(1996-9#1)(1997-2#1)(1997-5#2)(2006-2#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-7#1)(2008-9#1)(2010-12#1)(2012-12#2)
smooth muscle cells (SMC)##5##4##(1994-11#1)(1995-2#1)(1996-8#1)(2008-4#2)
smooth muscle cells (SMCs)##2##4##(1993-8#1)(2012-12#1)
smooth muscle cells and fibroblasts##5##5##(1990-2#2)(1991-4#1)(1997-1#1)(1997-2#1)
smooth muscle cells and human##2##5##(1990-7#1)(1997-2#1)
smooth muscle cells and##14##4##(1990-2#2)(1990-7#1)(1991-4#1)(1994-9#1)(1995-2#1)(1997-1#1)(1997-2#2)(2003-11#1)(2006-6#1)(2008-1#1)(2008-9#1)(2010-12#1)
smooth muscle cells are##3##4##(1990-12#1)(1995-3#1)(2009-7#1)
smooth muscle cells by##3##4##(1990-9#1)(1994-9#1)(1997-2#1)
smooth muscle cells during the##2##5##(1992-4#1)(1994-12#1)
smooth muscle cells from guinea pig bladder##2##7##(1996-12#2)
smooth muscle cells from rat##3##5##(1990-2#1)(1990-9#1)(1993-4#1)
smooth muscle cells from##13##4##(1990-2#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-6#1)(1993-4#1)(1994-11#1)(1994-3#1)(1995-11#1)(1996-12#2)(1997-2#1)(2008-4#1)
smooth muscle cells in culture##3##5##(1991-10#2)(1997-3#1)
smooth muscle cells in the media##2##6##(1995-12#1)(2009-1#1)
smooth muscle cells in the##3##5##(1993-2#1)(1995-12#1)(2009-1#1)
smooth muscle cells in##9##4##(1991-10#2)(1993-2#1)(1995-1#1)(1995-12#1)(1997-3#1)(2008-5#1)(2008-7#1)(2009-1#1)
smooth muscle cells is##4##4##(1990-12#1)(1990-8#1)(1992-9#1)(2008-4#1)
smooth muscle cells isolated from##2##5##(1992-12#1)(1992-6#1)
smooth muscle cells of##4##4##(1991-11#1)(1993-12#1)(1997-8#1)(2009-4#1)
smooth muscle cells or##2##4##(1992-3#1)(1997-2#1)
smooth muscle cells stimulated##2##4##(1990-7#1)(1995-2#1)
smooth muscle cells to##4##4##(1990-12#1)(1993-8#1)(1995-11#1)(1996-10#1)
smooth muscle cells was studied##2##5##(1990-5#1)(1990-7#1)
smooth muscle cells was##7##4##(1990-5#1)(1990-7#1)(1994-11#1)(1994-9#2)(1995-3#1)(2008-11#1)
smooth muscle cells were studied##3##5##(1991-2#1)(1992-8#1)(1996-8#1)
smooth muscle cells were##6##4##(1990-8#2)(1990-9#1)(1991-2#1)(1992-8#1)(1996-8#1)
smooth muscle cells with##3##4##(1991-7#1)(1994-11#1)(1996-8#1)
smooth muscle cells##244##3##(1990-10#2)(1990-11#2)(1990-12#5)(1990-2#4)(1990-5#1)(1990-7#9)(1990-8#5)(1990-9#3)(1991-10#6)(1991-11#1)(1991-12#3)(1991-2#5)(1991-4#1)(1991-5#1)(1991-7#5)(1991-9#2)(1992-12#5)(1992-2#2)(1992-3#3)(1992-4#1)(1992-6#5)(1992-8#4)(1992-9#3)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#4)(1993-4#2)(1993-8#2)(1994-11#7)(1994-12#2)(1994-3#1)(1994-6#2)(1994-8#3)(1994-9#9)(1995-1#1)(1995-11#7)(1995-12#5)(1995-2#9)(1995-3#8)(1995-6#1)(1996-10#3)(1996-12#3)(1996-2#3)(1996-3#1)(1996-5#3)(1996-6#2)(1996-8#7)(1997-1#2)(1997-2#9)(1997-3#2)(1997-4#1)(1997-5#5)(1997-7#2)(1997-8#1)(2003-11#2)(2005-1#1)(2006-10#1)(2006-5#1)(2006-6#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#6)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#1)(2009-2#1)(2009-4#2)(2009-7#1)(2010-12#4)(2010-2#1)(2011-1#1)(2011-12#1)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-8#1)
smooth muscle cells)##3##3##(1995-2#1)(2006-5#1)(2008-1#1)
smooth muscle cells]##3##3##(2008-8#1)(2010-12#1)(2011-2#1)
smooth muscle contractile##3##3##(1991-12#1)(1995-5#1)(1996-8#1)
smooth muscle contraction in##2##4##(1990-12#1)(1991-12#1)
smooth muscle contraction##10##3##(1990-12#1)(1990-3#1)(1990-9#1)(1991-12#2)(1991-2#1)(1992-5#1)(1993-3#1)(1994-8#1)(1997-7#1)
smooth muscle endothelin-converting enzyme##2##4##(1995-1#2)
smooth muscle fibers##2##3##(1997-1#1)(2010-1#1)
smooth muscle fibres##3##3##(1995-5#1)(2007-8#1)(2008-10#1)
smooth muscle from##2##3##(1990-4#1)(1995-5#1)
smooth muscle has been##2##4##(1995-1#1)(1995-12#1)
smooth muscle in##7##3##(1990-10#2)(1991-8#1)(1997-5#1)(2008-4#2)(2010-5#1)
smooth muscle is not##2##4##(1994-8#1)(2009-5#1)
smooth muscle is##4##3##(1994-8#1)(1995-8#1)(2009-5#2)
smooth muscle membranes##2##3##(1990-7#2)
smooth muscle mitochondria##3##3##(2008-8#3)
smooth muscle myosin light chain kinase##11##6##(1990-4#2)(1990-8#2)(1991-2#2)(1992-5#2)(1992-9#1)(1993-8#2)
smooth muscle myosin light chain##13##5##(1990-4#3)(1990-8#3)(1991-2#2)(1992-5#2)(1992-9#1)(1993-8#2)
smooth muscle myosin light chains##2##5##(1991-2#1)(1992-5#1)
smooth muscle myosin light##15##4##(1990-4#3)(1990-8#3)(1991-2#3)(1992-5#3)(1992-9#1)(1993-8#2)
smooth muscle myosin##17##3##(1990-4#3)(1990-8#3)(1991-2#3)(1991-5#1)(1992-5#3)(1992-9#1)(1993-8#2)(1995-1#1)
smooth muscle neoplasms##2##3##(2010-9#1)(2012-2#1)
smooth muscle of the##4##4##(1990-4#1)(1991-5#1)(1997-4#1)(2004-12#1)
smooth muscle of##13##3##(1990-4#1)(1991-5#1)(1993-8#2)(1994-9#1)(1997-4#1)(2004-12#1)(2008-4#3)(2012-3#3)
smooth muscle preparation of##2##4##(1991-5#1)(1993-11#1)
smooth muscle proliferation##2##3##(1995-12#1)(2008-3#1)
smooth muscle relaxant##4##3##(1990-11#1)(1992-9#1)(1997-4#1)(2007-2#1)
smooth muscle relaxation##9##3##(1990-5#1)(1990-7#2)(1991-9#1)(1992-6#2)(1993-6#1)(2005-11#1)(2010-2#1)
smooth muscle tissue##2##3##(1994-11#1)(1996-5#1)
smooth muscle tone##2##3##(1990-5#1)(1992-8#1)
smooth muscle tumor##2##3##(1990-10#1)(1994-6#1)
smooth muscle was##3##3##(1991-3#1)(1997-7#1)(2008-4#1)
smooth muscle were##2##3##(1991-5#1)(2010-3#1)
smooth muscle##565##2##(1990-10#5)(1990-11#5)(1990-12#8)(1990-2#4)(1990-3#3)(1990-4#6)(1990-5#3)(1990-7#21)(1990-8#11)(1990-9#6)(1991-1#4)(1991-10#7)(1991-11#1)(1991-12#7)(1991-2#11)(1991-3#2)(1991-4#1)(1991-5#5)(1991-6#2)(1991-7#5)(1991-8#4)(1991-9#5)(1992-11#1)(1992-12#7)(1992-2#2)(1992-3#4)(1992-4#6)(1992-5#9)(1992-6#9)(1992-7#1)(1992-8#7)(1992-9#10)(1993-10#1)(1993-11#4)(1993-12#3)(1993-2#2)(1993-3#10)(1993-4#2)(1993-6#3)(1993-8#8)(1993-9#1)(1994-11#11)(1994-12#4)(1994-3#1)(1994-6#5)(1994-8#11)(1994-9#11)(1995-1#7)(1995-11#8)(1995-12#13)(1995-2#10)(1995-3#17)(1995-5#4)(1995-6#3)(1995-8#1)(1996-1#2)(1996-10#4)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#1)(1996-4#3)(1996-5#7)(1996-6#2)(1996-7#1)(1996-8#9)(1996-9#1)(1997-1#5)(1997-2#11)(1997-3#3)(1997-4#10)(1997-5#10)(1997-6#4)(1997-7#6)(1997-8#2)(2003-11#2)(2004-12#1)(2005-1#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-2#3)(2006-5#2)(2006-6#2)(2007-10#1)(2007-11#2)(2007-2#1)(2007-6#3)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#6)(2008-11#10)(2008-12#1)(2008-3#2)(2008-4#13)(2008-5#6)(2008-6#4)(2008-7#6)(2008-8#9)(2008-9#3)(2009-1#1)(2009-2#2)(2009-4#2)(2009-5#5)(2009-7#2)(2010-1#2)(2010-12#10)(2010-2#2)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#12)(2012-2#4)(2012-3#4)(2013-1#2)(2013-8#2)
smooth muscle-specific##2##2##(2008-6#1)(2009-2#1)
smooth muscles of the aorta##2##5##(1991-11#2)
smooth muscles of the##5##4##(1991-11#2)(1994-5#1)(2006-6#1)(2008-8#1)
smooth muscles##17##2##(1991-1#1)(1991-11#2)(1992-4#2)(1994-5#1)(1995-12#2)(1996-3#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-1#1)(2006-6#1)(2008-8#1)(2009-5#1)(2012-1#1)
smooth or##5##2##(2008-2#1)(2008-3#2)(2011-2#1)(2013-8#1)
smooth phase##3##2##(2007-12#1)(2008-2#2)
smooth pursuit and##2##3##(1996-1#1)(1996-8#1)
smooth pursuit eye tracking##2##4##(1996-8#1)(1997-8#1)
smooth pursuit eye##3##3##(1996-1#1)(1996-8#1)(1997-8#1)
smooth pursuit##12##2##(1993-2#3)(1996-1#2)(1996-8#2)(1997-8#1)(2008-11#1)(2008-7#1)(2009-8#2)
smooth septate junctions##4##3##(2008-7#4)
smooth surface##14##2##(1990-9#1)(1994-7#1)(2004-9#1)(2005-11#2)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-1#1)(2010-5#1)(2011-2#1)
smooth surfaced##2##2##(1993-6#1)(2008-7#1)
smooth surfaces##3##2##(1990-9#1)(1997-2#1)(2005-11#1)
smooth the##5##2##(1994-6#1)(2005-11#1)(2006-12#1)(2008-10#1)(2011-2#1)
smooth to##2##2##(2004-9#1)(2008-2#1)
smooth tongue sole##2##3##(2013-8#2)
smooth transition##3##2##(2005-10#1)(2008-6#1)(2013-1#1)
smooth tuning of the##3##4##(2007-11#1)(2007-12#2)
smooth tuning##4##2##(2007-11#1)(2007-12#3)
smooth variation of##2##3##(2008-2#1)(2008-5#1)
smooth variation##3##2##(1994-4#1)(2008-2#1)(2008-5#1)
smooth##822##1##(1990-10#5)(1990-11#5)(1990-12#8)(1990-2#4)(1990-3#4)(1990-4#7)(1990-5#3)(1990-7#23)(1990-8#11)(1990-9#9)(1991-1#5)(1991-10#7)(1991-11#3)(1991-12#7)(1991-2#11)(1991-3#3)(1991-4#1)(1991-5#5)(1991-6#2)(1991-7#5)(1991-8#4)(1991-9#5)(1992-11#1)(1992-12#7)(1992-2#2)(1992-3#4)(1992-4#8)(1992-5#9)(1992-6#9)(1992-7#3)(1992-8#7)(1992-9#10)(1993-10#1)(1993-11#4)(1993-12#4)(1993-2#7)(1993-3#10)(1993-4#2)(1993-6#5)(1993-7#2)(1993-8#8)(1993-9#2)(1994-11#11)(1994-12#4)(1994-3#1)(1994-4#1)(1994-5#5)(1994-6#6)(1994-7#1)(1994-8#11)(1994-9#11)(1995-1#7)(1995-11#8)(1995-12#16)(1995-2#10)(1995-3#17)(1995-4#1)(1995-5#4)(1995-6#3)(1995-8#1)(1996-1#6)(1996-10#4)(1996-11#1)(1996-12#5)(1996-2#3)(1996-3#2)(1996-4#5)(1996-5#7)(1996-6#2)(1996-7#1)(1996-8#11)(1996-9#1)(1997-1#5)(1997-2#14)(1997-3#3)(1997-4#11)(1997-5#10)(1997-6#4)(1997-7#7)(1997-8#3)(2003-11#2)(2004-12#1)(2004-9#3)(2005-1#2)(2005-10#1)(2005-11#9)(2005-7#1)(2005-8#2)(2006-10#3)(2006-12#1)(2006-2#3)(2006-3#1)(2006-4#4)(2006-5#3)(2006-6#3)(2006-7#1)(2006-8#1)(2007-10#3)(2007-11#4)(2007-12#22)(2007-2#1)(2007-4#1)(2007-6#3)(2007-7#1)(2007-8#8)(2007-9#3)(2008-1#6)(2008-10#15)(2008-11#12)(2008-12#1)(2008-2#16)(2008-3#16)(2008-4#16)(2008-5#16)(2008-6#14)(2008-7#17)(2008-8#15)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#4)(2009-4#3)(2009-5#6)(2009-7#4)(2009-8#3)(2010-1#5)(2010-11#1)(2010-12#11)(2010-2#2)(2010-3#1)(2010-5#3)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#6)(2011-12#2)(2011-2#8)(2011-3#1)(2012-1#5)(2012-12#17)(2012-2#11)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#7)
smooth-muscle##3##1##(1995-8#2)(2007-6#1)
smooth-surfaced##3##1##(2008-5#1)(2009-7#1)(2013-8#1)
smoothed##7##1##(1995-2#1)(2006-10#1)(2008-10#1)(2008-2#2)(2008-8#1)(2009-12#1)
smoother##17##1##(1993-12#1)(1993-3#1)(1996-5#1)(2004-9#1)(2006-5#2)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#1)
smoothing algorithms##2##2##(2008-6#2)
smoothing and##4##2##(2007-11#2)(2007-12#1)(2008-2#1)
smoothing based on##2##3##(2008-10#1)(2008-2#1)
smoothing factor gamma##2##3##(2008-2#2)
smoothing in##3##2##(2007-11#1)(2008-3#1)(2009-7#1)
smoothing is performed##2##3##(2008-2#2)
smoothing is##4##2##(2007-9#1)(2008-2#2)(2008-8#1)
smoothing of##3##2##(2007-11#1)(2008-3#1)(2008-5#1)
smoothing parameter for##2##3##(2009-10#2)
smoothing parameter##6##2##(1997-6#1)(2009-10#4)(2010-5#1)
smoothing procedure##2##2##(2007-9#1)(2008-3#1)
smoothing technologies##3##2##(2007-12#3)
smoothing term##2##2##(2008-2#1)(2011-2#1)
smoothing that##2##2##(2007-12#1)(2008-6#1)
smoothing the##3##2##(1996-12#1)(2008-2#2)
smoothing##80##1##(1990-8#1)(1994-11#1)(1996-12#1)(1997-3#1)(1997-6#3)(2005-11#1)(2007-11#5)(2007-12#7)(2007-9#5)(2008-10#3)(2008-2#15)(2008-3#8)(2008-5#1)(2008-6#8)(2008-7#1)(2008-8#1)(2009-10#6)(2009-12#2)(2009-7#3)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#3)
smoothly converted to##2##3##(2005-11#1)(2012-3#1)
smoothly converted##3##2##(2005-11#1)(2007-11#1)(2012-3#1)
smoothly in##2##2##(1996-12#1)(2005-8#1)
smoothly over##2##2##(2008-2#1)(2008-3#1)
smoothly to##2##2##(2007-8#1)(2008-5#1)
smoothly tunable##2##2##(2008-2#2)
smoothly with##2##2##(2008-7#1)(2010-4#1)
smoothly##34##1##(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#1)(2004-9#1)(2005-11#1)(2005-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-2#5)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#1)(2010-1#1)(2010-3#1)(2010-4#2)(2010-6#1)(2012-3#2)(2013-8#1)
smoothness and##7##2##(1992-9#1)(2006-12#1)(2008-3#1)(2008-5#2)(2008-6#2)
smoothness of##6##2##(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2009-4#1)(2010-6#1)
smoothness##23##1##(1992-9#1)(2006-12#2)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#4)(2008-6#3)(2009-4#1)(2010-6#1)(2011-2#2)(2012-1#2)
smothering##2##1##(1996-5#2)
smouldering##2##1##(1996-12#1)(2007-11#1)
smut fungi##5##2##(2008-10#3)(2013-7#2)
smut##17##1##(2008-10#11)(2008-8#1)(2009-8#1)(2013-7#4)
smuts##8##1##(2008-10#1)(2013-7#7)
sn-1##12##1##(1990-2#1)(1990-7#2)(1991-4#1)(1992-8#1)(1993-3#1)(1995-1#1)(1995-8#1)(1996-9#1)(2004-8#1)(2012-1#1)(2012-2#1)
sn-2 of##2##2##(1994-12#1)(2013-1#1)
sn-2##11##1##(1990-2#2)(1990-7#1)(1991-11#2)(1991-4#1)(1994-12#2)(2012-1#1)(2012-2#1)(2013-1#1)
sn-3##2##1##(1991-2#1)(2012-1#1)
sn-glycerol-3-phosphate##3##1##(1990-5#1)(1995-6#1)(2008-5#1)
snRNA##15##1##(1991-12#4)(1995-6#1)(1996-4#4)(2006-12#2)(2008-1#1)(2008-2#1)(2008-9#1)(2013-8#1)
snRNAs##2##1##(1995-6#1)(2007-12#1)
snRNP##9##1##(1991-6#1)(1993-6#1)(1993-8#1)(1995-6#2)(1997-9#1)(2007-12#2)(2013-8#1)
snRNP-specific##3##1##(1991-6#3)
snRNPs were##2##2##(1993-8#1)(1994-8#1)
snRNPs##9##1##(1990-11#1)(1993-8#3)(1994-8#1)(1995-6#3)(2013-8#1)
snack##3##1##(2008-3#1)(2009-2#1)(2010-10#1)
snacks and cookies##2##3##(2008-10#2)
snacks and##3##2##(2008-10#3)
snacks##10##1##(2006-12#3)(2007-10#1)(2008-10#3)(2011-1#1)(2012-1#2)
snail Lymnaea acuminata##2##3##(2010-11#2)
snail Lymnaea##3##2##(1991-11#1)(2010-11#2)
snail and oyster samples##2##4##(1997-4#2)
snail and parasite##2##3##(2008-4#1)(2008-8#1)
snail and##8##2##(1997-4#3)(2007-12#1)(2008-12#2)(2008-4#1)(2008-8#1)
snail areas##2##2##(2012-3#2)
snail control##4##2##(2006-10#1)(2011-12#1)(2012-3#2)
snail habitats in##2##3##(2008-8#1)(2013-7#1)
snail habitats##4##2##(2008-8#3)(2013-7#1)
snail of##2##2##(2006-10#1)(2008-8#1)
snail populations##2##2##(2006-10#1)(2008-5#1)
snail species##3##2##(2008-8#3)
snail surveillance is##2##3##(2012-3#2)
snail vectors##2##2##(1993-6#1)(1994-6#1)
snail##81##1##(1990-7#1)(1991-11#1)(1991-5#1)(1991-7#2)(1993-11#1)(1993-6#2)(1994-3#1)(1994-6#2)(1995-5#2)(1996-5#1)(1997-1#2)(1997-4#5)(2006-10#4)(2006-12#1)(2006-8#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#5)(2008-12#5)(2008-4#3)(2008-5#4)(2008-7#1)(2008-8#14)(2009-8#1)(2010-11#2)(2011-1#2)(2011-12#3)(2011-2#1)(2012-3#9)(2013-7#1)
snails Helix##2##2##(2008-12#2)
snails and infected##2##3##(2011-12#1)(2012-3#1)
snails and##6##2##(2007-7#1)(2010-4#1)(2011-12#2)(2012-3#2)
snails in##2##2##(2008-5#1)(2012-3#1)
snails under##2##2##(1994-6#1)(2008-12#1)
snails were##4##2##(2008-11#1)(2008-12#1)(2011-12#1)(2012-3#1)
snails with##2##2##(2008-4#1)(2012-2#1)
snails##55##1##(1990-7#2)(1994-11#1)(1994-3#1)(1994-6#1)(1997-1#2)(1997-6#1)(2005-8#1)(2006-10#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-11#4)(2008-12#10)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2010-4#3)(2011-12#5)(2011-2#2)(2012-2#1)(2012-3#7)(2013-8#1)
snails/0##4##1##(2011-12#4)
snake and##2##2##(2008-8#1)(2012-2#1)
snake bite##5##2##(2006-2#1)(2007-1#1)(2009-6#1)(2009-7#1)(2012-2#1)
snake bites##4##2##(2006-2#1)(2009-6#3)
snake envenomation##3##2##(2006-4#3)
snake muscle fructose-1##3##3##(2008-9#3)
snake species##3##2##(1994-12#2)(2009-5#1)
snake venom in##2##3##(2008-5#1)(2013-7#1)
snake venom protein##3##3##(1993-3#1)(1996-2#2)
snake venom##22##2##(1992-12#1)(1992-3#2)(1992-5#1)(1993-3#3)(1994-12#1)(1994-3#2)(1995-5#1)(1996-2#2)(1997-2#1)(2008-5#6)(2011-2#1)(2013-7#1)
snake venoms##4##2##(1994-5#1)(1996-2#1)(2008-8#1)(2011-2#1)
snake##96##1##(1991-4#1)(1991-6#1)(1991-8#1)(1992-12#3)(1992-3#2)(1992-5#1)(1992-8#1)(1993-3#3)(1994-12#3)(1994-3#2)(1994-5#2)(1995-1#1)(1995-12#1)(1995-5#2)(1996-12#2)(1996-2#3)(1997-2#1)(2006-2#2)(2006-4#7)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#3)(2007-7#1)(2008-12#1)(2008-5#9)(2008-7#1)(2008-8#6)(2008-9#4)(2009-5#1)(2009-6#4)(2009-7#1)(2010-3#8)(2010-8#1)(2011-2#3)(2012-2#7)(2013-1#1)(2013-7#1)
snake-based segmentation method##2##3##(2007-12#2)
snake-based segmentation##4##2##(2007-11#1)(2007-12#3)
snake-based##6##1##(2007-11#1)(2007-12#5)
snake-bite##2##1##(1991-8#1)(2008-4#1)
snakebite##9##1##(2005-8#1)(2009-6#4)(2012-2#4)
snakebites in##2##2##(2005-8#1)(2009-6#1)
snakebites##7##1##(2005-8#1)(2007-6#1)(2009-6#4)(2012-2#1)
snakes and##4##2##(2008-8#1)(2010-3#1)(2012-2#1)(2013-7#1)
snakes as##2##2##(2010-3#1)(2012-2#1)
snakes based on##2##3##(1996-12#1)(2008-6#1)
snakes fed##2##2##(1996-12#2)
snakes##33##1##(1991-8#1)(1996-12#7)(2005-8#1)(2007-12#1)(2007-2#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-5#1)(2009-9#1)(2010-3#6)(2010-8#1)(2012-2#5)(2013-7#1)
snap and dry bean##2##4##(2008-10#2)
snap bean and##2##3##(2006-3#1)(2008-10#1)
snap bean##12##2##(2006-3#1)(2008-10#11)
snap##18##1##(1996-2#1)(2006-3#1)(2008-10#15)(2012-3#1)
snapper Lutjanus##2##2##(2007-3#1)(2010-8#1)
snapper##8##1##(2007-3#4)(2008-10#1)(2010-8#3)
snapping hip##3##2##(2006-10#2)(2008-8#1)
snapping##7##1##(2006-10#4)(2008-8#1)(2009-10#2)
snapshot of the##8##3##(1993-6#1)(2006-12#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-3#1)
snapshot of##11##2##(1993-6#1)(2006-12#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
snapshot##19##1##(1992-2#1)(1993-6#1)(1997-6#1)(2006-12#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#1)(2008-3#4)(2008-6#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
snapshots of##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
snapshots##4##1##(2008-1#1)(2008-2#1)(2008-3#1)(2009-10#1)
snare resection##3##2##(1991-4#1)(2006-10#1)(2006-6#1)
snare##9##1##(1991-4#1)(2006-10#1)(2006-6#2)(2007-9#1)(2008-5#2)(2013-8#2)
sneak##2##1##(2010-8#1)(2012-3#1)
sneaking behaviour##2##2##(2010-8#2)
sneaking##4##1##(2010-8#4)
sneezing and##4##2##(2006-10#1)(2007-2#1)(2007-9#1)(2008-5#1)
sneezing cats##2##2##(1995-7#2)
sneezing##18##1##(1995-7#3)(2006-10#1)(2007-1#1)(2007-2#2)(2007-9#1)(2008-3#2)(2008-5#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
sniffing##12##1##(1991-11#1)(1992-8#2)(1993-9#1)(1995-12#1)(1997-2#1)(2007-7#4)(2008-10#1)(2012-1#1)
snoRNA gene##4##2##(2008-8#4)
snoRNA genes##3##2##(1997-7#1)(2008-8#2)
snoRNA##11##1##(1997-7#1)(1997-8#1)(2008-8#8)(2010-11#1)
snoRNAs in##2##2##(1997-7#2)
snoRNAs##6##1##(1997-7#4)(2008-1#1)(2008-8#1)
snook##5##1##(2013-7#5)
snoring and obstructive sleep apnea##3##5##(2005-10#1)(2006-12#1)(2007-6#1)
snoring and##8##2##(2005-10#1)(2006-12#1)(2007-12#3)(2007-6#1)(2009-1#1)(2009-10#1)
snoring in##2##2##(2009-1#1)(2011-2#1)
snoring##21##1##(1993-5#1)(2005-10#1)(2006-12#1)(2007-1#2)(2007-12#3)(2007-2#1)(2007-6#2)(2008-9#1)(2009-1#4)(2009-10#1)(2009-4#1)(2011-2#1)(2013-8#2)
snorkelers##2##1##(2011-2#2)
snorkeling##2##1##(2007-5#1)(2012-2#1)
snorted cocaine##2##2##(2013-8#2)
snout length##2##2##(2008-5#1)(2013-7#1)
snout skin of##2##3##(2010-8#2)
snout##13##1##(1992-9#2)(1993-2#1)(2007-9#1)(2008-5#3)(2010-8#4)(2013-7#2)
snout-vent##2##1##(2008-5#1)(2009-4#1)
snow albedo##2##2##(2008-3#2)
snow and lake water samples##2##5##(2008-10#2)
snow and##3##2##(2008-10#3)
snow cover by##2##3##(2008-10#1)(2008-3#1)
snow cover period##4##3##(2013-8#4)
snow cover##14##2##(2008-10#4)(2008-3#4)(2013-8#6)
snow molds##6##2##(2008-10#6)
snow##46##1##(1993-3#3)(2008-10#18)(2008-2#2)(2008-3#13)(2011-2#1)(2012-6#1)(2013-8#8)
snow-covered ground##2##2##(2008-2#1)(2008-3#1)
snow-covered##3##1##(2008-2#1)(2008-3#2)
snow-field site##2##2##(2008-3#2)
snowball sampling##2##2##(2011-1#1)(2013-8#1)
snowball##4##1##(2007-9#1)(2008-4#1)(2011-1#1)(2013-8#1)
snuff among young people in 2 municipalities in Nordland]##2##9##(1991-8#2)
snuff##9##1##(1991-6#1)(1991-8#2)(2008-4#5)(2009-4#1)
snus initiators##2##2##(2012-12#2)
snus##10##1##(2012-12#10)
so a good##2##3##(2009-10#1)(2011-2#1)
so a##16##2##(1990-8#1)(1996-3#1)(1997-5#1)(2004-1#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-10#1)(2010-10#1)(2010-3#1)(2011-2#2)
so after##2##2##(2007-11#1)(2012-12#1)
so an##3##2##(1992-10#1)(2007-12#1)(2008-10#1)
so and what##2##3##(1992-11#1)(1996-3#1)
so and##7##2##(1990-2#1)(1992-11#1)(1996-3#1)(2007-12#1)(2008-5#1)(2012-11#1)(2012-12#1)
so are the##3##3##(1994-11#1)(1997-8#1)(2008-3#1)
so are##9##2##(1991-12#1)(1994-11#1)(1997-8#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-3#1)(2011-1#1)(2013-8#1)
so as not to##6##4##(1992-6#2)(1997-8#1)(2008-12#1)(2008-2#1)(2012-12#1)
so as to achieve the##2##5##(1990-3#1)(2007-12#1)
so as to achieve##3##4##(1990-3#2)(2007-12#1)
so as to allow for the##2##6##(2009-7#1)(2011-2#1)
so as to allow##3##4##(2009-7#1)(2011-2#1)(2012-1#1)
so as to avoid##5##4##(1996-11#1)(2008-3#1)(2009-6#1)(2010-7#1)(2013-8#1)
so as to be able to##2##6##(1994-6#1)(2006-5#1)
so as to be##3##4##(1994-6#1)(2006-5#1)(2010-10#1)
so as to better##2##4##(2008-12#1)(2013-8#1)
so as to compensate for the##2##6##(2008-1#1)(2010-8#1)
so as to guide##2##4##(1993-10#1)(2007-10#1)
so as to have##3##4##(2006-6#1)(2008-12#1)(2010-8#1)
so as to improve the##2##5##(2008-3#1)(2008-5#1)
so as to improve##3##4##(2008-3#1)(2008-5#1)(2009-10#1)
so as to incorporate##2##4##(1997-6#1)(2008-5#1)
so as to increase the##2##5##(1997-1#1)(2013-8#1)
so as to increase##3##4##(1997-1#1)(2008-10#1)(2013-8#1)
so as to inhibit the##2##5##(1990-4#1)(1990-9#1)
so as to inhibit##3##4##(1990-4#1)(1990-9#1)(1992-5#1)
so as to maintain##2##4##(2010-4#1)(2011-2#1)
so as to maximize##2##4##(2008-9#1)(2011-1#1)
so as to minimize the##2##5##(2008-2#1)(2013-8#1)
so as to minimize##3##4##(2008-2#1)(2012-11#1)(2013-8#1)
so as to optimize##3##4##(2005-11#1)(2008-10#1)(2008-3#1)
so as to place the AP site toward a target nucleobase##2##11##(2007-8#1)(2008-10#1)
so as to preserve##2##4##(2007-7#1)(2010-1#1)
so as to prevent##6##4##(1990-5#1)(2006-3#1)(2008-1#1)(2008-3#1)(2011-12#1)(2013-7#1)
so as to provide##5##4##(1995-3#1)(2006-11#1)(2007-12#1)(2011-1#1)(2012-3#1)
so as to reduce##4##4##(2005-8#1)(2007-1#1)(2007-10#1)(2009-10#1)
so as to suppress the##2##5##(2006-4#1)(2008-10#1)
so as to##125##3##(1990-11#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-5#1)(1992-9#1)(1993-10#1)(1993-3#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-7#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#2)(2005-4#1)(2005-8#2)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#7)(2008-12#5)(2008-2#6)(2008-3#5)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#3)(2009-6#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#1)(2013-7#2)(2013-8#5)
so as##134##2##(1990-11#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-10#1)(1993-3#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-7#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-11#2)(2005-4#1)(2005-8#2)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#3)(2007-2#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#7)(2008-12#6)(2008-2#7)(2008-3#5)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#3)(2009-6#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#5)(2012-6#1)(2013-1#1)(2013-7#2)(2013-8#5)
so at 12 months##2##4##(2012-2#2)
so at the##4##3##(2007-10#1)(2008-5#1)(2008-9#1)(2010-8#1)
so at##8##2##(2007-10#1)(2007-12#1)(2008-5#2)(2008-9#1)(2010-8#1)(2012-2#2)
so be##3##2##(1993-3#1)(2005-7#1)(2013-7#1)
so because##2##2##(2006-10#1)(2008-3#1)
so by##9##2##(1991-7#1)(1992-8#1)(2006-8#1)(2007-6#1)(2008-11#1)(2008-3#1)(2009-2#1)(2009-6#1)(2011-1#1)
so called &quot##10##3##(1990-3#1)(2006-10#1)(2007-3#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-4#1)(2011-3#1)(2012-1#1)(2013-1#1)
so called##42##2##(1990-3#1)(1990-5#1)(1991-12#1)(1991-5#1)(1992-5#1)(1993-3#1)(1993-8#1)(1993-9#1)(1995-3#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-3#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
so can##3##2##(2008-2#1)(2010-4#1)(2011-2#1)
so clear##3##2##(2007-11#1)(2008-4#1)(2008-9#1)
so clearly##3##2##(1991-12#1)(2007-11#1)(2013-1#1)
so common to##2##3##(2007-12#1)(2009-3#1)
so common##4##2##(2006-10#1)(2007-12#1)(2009-3#1)(2011-2#1)
so complete##2##2##(1990-12#1)(1997-1#1)
so created##2##2##(2008-11#1)(2011-2#1)
so did##2##2##(1997-3#1)(2008-8#1)
so different##4##2##(1996-1#2)(2007-4#2)
so difficult##3##2##(1997-9#1)(2006-10#1)(2007-4#1)
so distant##2##2##(1997-2#1)(2006-9#1)
so does the##5##3##(1994-1#1)(1995-2#1)(1996-1#1)(2008-10#1)(2013-7#1)
so does##8##2##(1994-1#1)(1994-9#1)(1995-2#1)(1996-1#1)(2006-10#1)(2008-10#1)(2012-3#1)(2013-7#1)
so doing##12##2##(1991-2#1)(2006-5#1)(2006-7#1)(2008-12#2)(2008-3#1)(2008-8#1)(2009-8#1)(2009-9#1)(2012-2#3)
so during##2##2##(2012-1#1)(2013-8#1)
so each##2##2##(2008-5#1)(2008-8#1)
so exclusively##2##2##(2008-12#1)(2012-2#1)
so far and##7##3##(1991-4#1)(1995-6#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#1)
so far are reviewed##2##4##(1991-5#1)(2010-11#1)
so far are##3##3##(1991-5#1)(2008-7#1)(2010-11#1)
so far as it##2##4##(1996-11#1)(2005-8#1)
so far as##7##3##(1990-10#1)(1990-9#1)(1991-2#1)(1996-11#1)(1997-6#1)(2005-8#1)(2009-8#1)
so far available##2##3##(1994-9#1)(2010-11#1)
so far been described##2##4##(1990-12#1)(1992-8#1)
so far been reported##4##4##(1990-11#1)(1992-2#1)(1993-5#1)(2007-2#1)
so far been##27##3##(1990-11#1)(1990-12#2)(1991-12#1)(1991-6#1)(1992-2#1)(1992-8#1)(1993-10#1)(1993-2#1)(1993-5#1)(1994-9#1)(1995-2#1)(1996-5#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-11#1)(2009-5#1)(2009-8#1)(2009-9#1)(2011-2#1)(2013-8#1)
so far characterized##3##3##(1990-12#1)(1992-8#1)(1996-11#1)
so far contain##2##3##(1996-5#1)(2008-7#1)
so far described##2##3##(1996-12#1)(2009-4#1)
so far developed##2##3##(1993-3#1)(2008-10#1)
so far examined##2##3##(2006-12#1)(2013-7#1)
so far for##3##3##(1994-4#1)(1996-10#1)(2007-8#1)
so far has##4##3##(2007-12#2)(2008-12#1)(2009-3#1)
so far have been##2##4##(1995-3#1)(2013-8#1)
so far have not##2##4##(1994-6#1)(1996-12#1)
so far have##11##3##(1994-4#1)(1994-6#1)(1995-3#1)(1996-12#1)(2005-7#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-10#1)(2012-2#1)(2013-8#1)
so far identified##4##3##(1992-7#1)(1996-7#1)(2011-1#1)(2012-2#1)
so far in the literature##5##5##(2006-4#1)(2008-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
so far in the##10##4##(2005-1#1)(2006-4#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
so far in##16##3##(1990-1#1)(1991-11#1)(1997-6#1)(2005-1#1)(2006-4#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
so far include##2##3##(2005-7#1)(2008-11#1)
so far investigated##2##3##(2008-12#1)(2011-1#1)
so far is##4##3##(1996-12#1)(2006-2#1)(2008-7#1)(2013-8#1)
so far it is##2##4##(1995-3#1)(2006-11#1)
so far little##2##3##(1996-9#1)(2009-7#1)
so far no##4##3##(1990-2#1)(1992-10#1)(2007-2#1)(2011-2#1)
so far none##2##3##(2008-9#1)(2010-12#1)
so far not been##2##4##(1996-5#1)(2010-3#1)
so far not##7##3##(1991-11#1)(1993-5#1)(1996-5#1)(2007-1#1)(2008-10#1)(2010-3#1)(2011-2#1)
so far of##2##3##(2006-10#1)(2012-1#1)
so far only##6##3##(1990-11#1)(1997-6#1)(2008-7#1)(2012-12#2)(2012-3#1)
so far proposed##2##3##(1996-11#1)(2008-8#1)
so far reported##5##3##(1990-3#1)(1995-10#1)(1996-10#1)(2006-10#1)(2008-1#1)
so far studied##2##3##(2008-10#1)(2012-2#1)
so far tested##2##3##(2008-7#1)(2009-4#1)
so far the##4##3##(1990-5#1)(1994-9#1)(2006-2#1)(2008-10#1)
so far there##3##3##(1997-8#1)(2010-5#1)(2013-8#1)
so far this##2##3##(1993-11#1)(2007-9#1)
so far to##6##3##(2006-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-7#1)(2012-1#1)
so far unknown##4##3##(1990-7#1)(1992-8#1)(1994-6#1)(1997-2#1)
so far with##4##3##(2006-8#2)(2010-12#1)(2011-2#1)
so far##313##2##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#3)(1991-10#1)(1991-11#5)(1991-12#4)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-2#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#3)(1993-10#1)(1993-11#4)(1993-2#1)(1993-3#1)(1993-5#3)(1993-6#1)(1993-8#2)(1993-9#2)(1994-2#2)(1994-3#1)(1994-4#3)(1994-6#2)(1994-9#5)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#1)(1996-10#2)(1996-11#3)(1996-12#3)(1996-3#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-4#2)(1997-6#5)(1997-7#2)(1997-8#3)(2004-9#1)(2005-1#1)(2005-11#1)(2005-7#2)(2005-8#3)(2006-10#8)(2006-11#1)(2006-12#5)(2006-2#4)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#8)(2007-2#3)(2007-3#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#6)(2008-10#14)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#8)(2008-6#3)(2008-7#13)(2008-8#3)(2008-9#3)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#6)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#10)(2012-1#2)(2012-12#6)(2012-2#7)(2012-3#2)(2013-1#8)(2013-7#2)(2013-8#8)
so far?##2##2##(2006-12#1)(2010-12#1)
so fast##6##2##(2006-10#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-3#1)
so few##2##2##(1996-3#1)(2008-9#1)
so for##6##2##(1991-5#1)(1996-6#1)(1997-5#1)(2008-10#1)(2010-8#1)(2012-2#1)
so frequent##2##2##(1993-8#1)(2008-1#1)
so frequently##3##2##(2006-10#2)(2007-7#1)
so from##2##2##(1990-7#1)(2007-6#1)
so good##3##2##(2007-8#1)(2008-10#1)(2013-1#1)
so great##4##2##(1992-9#1)(2007-9#2)(2010-10#1)
so has##4##2##(1991-2#1)(1994-9#1)(2006-12#1)(2012-10#1)
so high that##3##3##(2008-10#2)(2008-8#1)
so high##4##2##(2008-10#2)(2008-5#1)(2008-8#1)
so if the##2##3##(2007-12#1)(2008-7#1)
so if##3##2##(2007-12#1)(2008-7#1)(2012-12#1)
so important in##2##3##(2008-5#1)(2008-8#1)
so important##6##2##(1990-11#1)(1991-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-2#1)
so in others##2##3##(2006-12#1)(2008-10#1)
so in the##12##3##(1993-9#1)(1994-2#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
so in this##4##3##(1996-12#1)(2007-7#1)(2008-10#1)(2008-5#1)
so in##41##2##(1990-12#1)(1991-3#1)(1991-6#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-2#1)(1996-10#1)(1996-12#1)(1996-9#1)(1997-1#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-7#2)(2008-10#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
so is the##4##3##(2008-10#1)(2008-7#1)(2008-8#1)(2012-11#1)
so is##11##2##(1991-9#1)(1993-11#1)(2005-11#1)(2005-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-11#1)(2012-11#1)(2012-2#1)(2013-1#1)
so it can be##3##4##(2008-10#1)(2008-2#1)(2008-5#1)
so it can##4##3##(2008-10#2)(2008-2#1)(2008-5#1)
so it has##2##3##(1997-8#1)(2008-8#1)
so it is important to decode enough to obtain a good average##2##12##(2012-12#2)
so it is important to##5##5##(2008-5#1)(2011-2#1)(2012-12#2)(2013-8#1)
so it is important##6##4##(2008-2#1)(2008-5#1)(2011-2#1)(2012-12#2)(2013-8#1)
so it is not##2##4##(2008-1#1)(2009-10#1)
so it is##21##3##(1990-10#1)(1994-9#1)(1995-12#1)(1995-3#1)(2006-10#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#1)
so it may be##2##4##(1991-9#1)(2010-8#1)
so it may##4##3##(1991-9#1)(2010-8#1)(2010-9#1)(2013-1#1)
so it was##4##3##(1996-4#1)(2008-10#1)(2008-11#1)(2012-2#1)
so it would be##2##4##(2005-4#1)(2008-11#1)
so it##48##2##(1990-10#1)(1991-9#1)(1992-3#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-4#1)(1997-5#1)(1997-8#2)(2005-4#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-10#1)(2010-11#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
so its##4##2##(2006-2#1)(2007-7#1)(2008-1#1)(2008-2#1)
so large as to##2##4##(1994-2#1)(2012-2#1)
so large##6##2##(1991-9#1)(1994-11#1)(1994-2#1)(1997-1#1)(2006-12#1)(2012-2#1)
so limited##2##2##(1990-4#1)(2013-1#1)
so little##4##2##(1995-6#1)(1995-9#1)(2010-12#1)(2012-3#1)
so long as##5##3##(1992-3#1)(1993-8#1)(2006-10#1)(2008-1#1)(2008-4#1)
so long to##2##3##(2007-9#1)(2008-10#1)
so long##7##2##(1992-3#1)(1993-8#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#1)
so low that##4##3##(1990-4#1)(2007-12#1)(2007-2#1)(2008-3#1)
so low##6##2##(1990-4#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-3#1)(2008-5#1)
so many different##2##3##(1993-3#1)(2008-10#1)
so many##22##2##(1992-2#3)(1993-1#2)(1993-3#1)(1994-12#2)(1997-3#1)(2005-9#1)(2006-2#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-8#1)(2011-1#2)(2012-12#1)(2012-2#1)
so may##3##2##(2008-7#1)(2008-9#1)(2010-10#1)
so more quickly##2##3##(2008-11#1)(2008-9#1)
so more##3##2##(2008-11#1)(2008-9#1)(2009-6#1)
so most##2##2##(2008-11#1)(2012-3#1)
so much on##2##3##(2006-6#1)(2007-4#1)
so much so that##3##4##(1993-3#1)(2008-7#1)(2010-5#1)
so much##22##2##(1991-6#1)(1993-3#2)(1995-11#1)(1995-12#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-5#1)(2006-12#1)(2006-6#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2013-1#1)
so no##2##2##(1990-6#1)(2008-11#1)
so obtained can be used for##3##6##(2008-2#1)(2008-3#1)(2009-8#1)
so obtained can##4##3##(2007-9#1)(2008-2#1)(2008-3#1)(2009-8#1)
so obtained##11##2##(1991-5#1)(1997-1#1)(2005-11#1)(2007-9#2)(2008-10#3)(2008-2#1)(2008-3#1)(2009-8#1)
so obvious that##3##3##(2007-4#1)(2009-9#1)(2010-12#1)
so obvious##4##2##(2007-4#1)(2009-9#1)(2010-12#1)(2013-8#1)
so often##3##2##(2006-10#1)(2008-2#1)(2010-7#1)
so on##32##2##(1992-1#1)(1992-10#1)(1993-11#1)(1996-6#1)(1997-8#1)(2005-12#1)(2005-3#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-3#1)(2011-4#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
so rapid##2##2##(2010-12#1)(2012-12#1)
so rapidly that##3##3##(1996-1#1)(2007-2#1)(2011-2#1)
so rapidly##5##2##(1996-1#1)(2007-2#1)(2008-1#1)(2008-9#1)(2011-2#1)
so severe as to##2##4##(1990-5#1)(2007-5#1)
so severe that##5##3##(2006-10#1)(2008-4#1)(2008-7#1)(2013-1#2)
so severe##7##2##(1990-5#1)(2006-10#1)(2007-5#1)(2008-4#1)(2008-7#1)(2013-1#2)
so she##3##2##(2009-2#1)(2010-12#1)(2011-2#1)
so should be##2##3##(1993-7#1)(2011-2#1)
so significant##4##2##(2005-11#1)(2007-7#1)(2008-10#2)
so slow that##3##3##(1995-8#1)(2006-5#1)(2007-12#1)
so small##4##2##(1993-10#1)(1997-5#1)(2007-8#1)(2008-7#1)
so strong##2##2##(1992-4#1)(2008-11#1)
so strongly##4##2##(2006-10#1)(2008-10#1)(2008-8#2)
so successful in##2##3##(2008-10#1)(2010-7#1)
so than##5##2##(2006-10#1)(2008-10#1)(2009-11#1)(2011-1#1)(2013-1#1)
so that a##25##3##(1991-8#1)(1992-2#1)(1992-5#1)(1993-1#1)(1994-12#1)(1996-5#1)(1997-3#1)(2008-10#5)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-3#1)(2011-2#1)
so that after##2##3##(1992-8#1)(2007-12#1)
so that all the##2##4##(1996-5#1)(2012-3#1)
so that all##8##3##(1996-5#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-12#1)(2012-3#1)
so that alternative##2##3##(1997-2#1)(2010-5#1)
so that an##5##3##(1995-2#1)(2008-2#1)(2008-3#2)(2011-1#1)
so that any##2##3##(1995-5#1)(2006-9#1)
so that appropriate##6##3##(1993-6#1)(2004-2#1)(2005-9#1)(2006-2#1)(2008-3#1)(2008-4#1)
so that at##3##3##(1993-5#1)(1994-2#1)(2008-7#1)
so that both##6##3##(1994-6#1)(1996-3#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)
so that by##3##3##(2007-12#2)(2008-10#1)
so that clinical##3##3##(1995-3#1)(2005-10#1)(2009-2#1)
so that different##2##3##(2008-10#1)(2008-3#1)
so that each##2##3##(1991-12#1)(2011-1#1)
so that even##2##3##(1994-3#1)(2005-8#1)
so that evidence-based##2##3##(2007-2#1)(2008-11#1)
so that in##7##3##(1990-6#1)(1992-9#1)(1996-3#1)(2005-11#1)(2008-10#1)(2008-11#2)
so that it becomes##2##4##(2008-10#1)(2008-11#1)
so that it can be used##3##6##(2008-10#1)(2008-2#1)(2008-3#1)
so that it can be##8##5##(1990-9#1)(1995-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-6#1)
so that it can##10##4##(1990-9#1)(1995-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-6#2)(2013-8#1)
so that it does not##2##5##(1992-4#1)(1995-1#1)
so that it is##8##4##(1991-4#1)(1995-3#1)(2008-10#1)(2008-5#2)(2008-8#2)(2011-2#1)
so that it will##2##4##(2012-11#1)(2012-12#1)
so that it##40##3##(1990-3#1)(1990-9#1)(1991-4#1)(1991-8#1)(1992-4#1)(1993-11#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#1)(2006-8#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-7#1)(2010-3#1)(2010-6#2)(2011-2#1)(2012-11#1)(2012-12#2)(2013-8#1)
so that its##2##3##(2006-3#1)(2011-2#1)
so that long-term##2##3##(1992-11#1)(2008-11#1)
so that more##6##3##(1997-1#1)(2009-11#1)(2010-7#1)(2012-2#2)(2013-8#1)
so that no##7##3##(1992-7#1)(1995-8#1)(2008-1#1)(2008-11#1)(2008-2#2)(2011-2#1)
so that one##3##3##(1994-12#1)(1995-3#1)(1996-7#1)
so that only##3##3##(1992-6#1)(1993-6#1)(2008-3#1)
so that our##2##3##(1996-4#1)(2007-12#1)
so that patients##2##3##(1996-12#1)(2007-9#1)
so that possible##2##3##(1990-9#1)(1992-11#1)
so that potential##2##3##(1991-12#1)(2007-3#1)
so that provide##2##3##(2008-3#1)(2013-8#1)
so that quantitative##2##3##(2008-10#2)
so that researchers##2##3##(2008-4#1)(2008-7#1)
so that six##2##3##(1991-8#1)(1994-9#1)
so that some##2##3##(1994-2#1)(2008-10#1)
so that such##2##3##(2008-5#1)(2012-1#1)
so that targeted##3##3##(2006-10#1)(2013-1#2)
so that the appropriate##2##4##(1994-12#1)(2007-12#1)
so that the distance##2##4##(1994-8#1)(1997-3#1)
so that the individual##3##4##(2008-3#1)(2010-2#1)(2011-1#1)
so that the lesions##2##4##(1990-5#1)(1993-11#1)
so that the model##2##4##(1996-4#1)(2008-11#1)
so that the number of##5##5##(1993-12#1)(1995-8#1)(2008-10#1)(2008-2#1)(2012-2#1)
so that the rate##2##4##(1991-2#1)(1994-12#1)
so that the surgeon##2##4##(2007-5#1)(2011-2#1)
so that the system##2##4##(2005-5#1)(2008-3#1)
so that the##142##3##(1990-2#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#2)(1994-1#1)(1994-11#1)(1994-12#3)(1994-5#1)(1994-6#4)(1994-8#2)(1994-9#2)(1995-12#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#1)(2005-10#1)(2005-12#1)(2005-5#1)(2006-10#3)(2006-3#2)(2007-1#2)(2007-11#4)(2007-12#4)(2007-4#1)(2007-5#1)(2007-8#2)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#11)(2008-3#13)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-11#1)(2009-3#1)(2009-6#1)(2010-1#1)(2010-2#3)(2010-5#1)(2011-1#2)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
so that their##17##3##(1991-12#1)(1996-11#1)(1996-2#1)(2006-10#1)(2006-3#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-2#3)(2010-3#1)(2012-2#1)(2013-8#3)
so that there is##5##4##(1995-1#1)(2005-5#1)(2008-12#1)(2008-4#1)(2011-1#1)
so that these##4##3##(1992-11#1)(2008-10#1)(2008-5#1)(2008-7#1)
so that they are more##2##5##(1994-5#1)(2008-5#1)
so that they are##4##4##(1994-5#2)(2008-5#1)(2010-4#1)
so that they become##3##4##(1992-5#1)(2008-7#1)(2010-4#1)
so that they can be##6##5##(1994-3#1)(1997-3#1)(2008-9#2)(2009-9#1)(2011-2#1)
so that they can##14##4##(1991-7#1)(1994-3#1)(1995-5#1)(1997-3#1)(2006-4#1)(2007-1#1)(2007-2#1)(2008-9#3)(2009-9#1)(2011-1#1)(2011-2#1)(2012-1#1)
so that they may##3##4##(2007-2#1)(2008-8#1)(2012-12#1)
so that they were##2##4##(2008-10#2)
so that they will be more##2##6##(1997-3#1)(1997-7#1)
so that they will be##4##5##(1997-3#1)(1997-7#1)(2004-3#1)(2007-3#1)
so that they##39##3##(1991-10#1)(1991-7#1)(1992-4#1)(1992-5#1)(1994-3#1)(1994-5#2)(1995-5#1)(1997-3#2)(1997-7#1)(2004-3#1)(2006-11#1)(2006-4#1)(2007-1#1)(2007-12#1)(2007-2#2)(2007-3#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-9#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
so that this##4##3##(1990-6#1)(1992-3#1)(1993-8#1)(2008-2#1)
so that those##2##3##(2008-7#1)(2010-2#1)
so that total##2##3##(1995-1#1)(2012-2#1)
so that treatment##2##3##(1991-4#1)(2009-9#1)
so that we can##3##4##(1992-5#1)(2011-2#1)(2013-8#1)
so that we##5##3##(1992-5#1)(1997-2#1)(2008-3#1)(2011-2#1)(2013-8#1)
so that##577##2##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#3)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#3)(1991-1#1)(1991-10#2)(1991-12#4)(1991-2#1)(1991-4#2)(1991-5#1)(1991-6#3)(1991-7#3)(1991-8#4)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#3)(1992-4#2)(1992-5#3)(1992-6#4)(1992-7#2)(1992-8#2)(1992-9#3)(1993-1#2)(1993-10#2)(1993-11#4)(1993-12#4)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#7)(1994-2#3)(1994-3#4)(1994-4#1)(1994-5#3)(1994-6#7)(1994-8#2)(1994-9#3)(1995-1#5)(1995-12#3)(1995-2#4)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#4)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#6)(1996-2#3)(1996-3#4)(1996-4#2)(1996-5#3)(1996-7#2)(1996-9#1)(1997-1#5)(1997-2#4)(1997-3#4)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#4)(2004-2#1)(2004-3#1)(2004-9#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-4#1)(2005-5#2)(2005-7#1)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#7)(2006-11#2)(2006-2#1)(2006-3#4)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#3)(2006-8#1)(2006-9#3)(2007-1#3)(2007-11#10)(2007-12#13)(2007-2#4)(2007-3#2)(2007-4#2)(2007-5#2)(2007-7#1)(2007-8#6)(2007-9#2)(2008-1#7)(2008-10#43)(2008-11#13)(2008-12#3)(2008-2#32)(2008-3#30)(2008-4#11)(2008-5#12)(2008-6#3)(2008-7#16)(2008-8#11)(2008-9#9)(2009-11#2)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#2)(2010-1#1)(2010-12#4)(2010-2#5)(2010-3#3)(2010-4#2)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#8)(2011-2#13)(2011-3#1)(2012-1#6)(2012-11#2)(2012-12#8)(2012-2#9)(2012-3#5)(2012-4#1)(2013-1#6)(2013-8#9)
so thatthe##2##2##(2008-11#2)
so the treatment##3##3##(2006-12#1)(2008-3#1)(2008-7#1)
so the##75##2##(1991-12#3)(1991-4#1)(1991-8#1)(1992-12#1)(1993-1#2)(1993-10#1)(1993-2#1)(1994-12#1)(1995-1#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-2#1)(2005-11#2)(2005-5#1)(2006-1#1)(2006-12#1)(2007-12#5)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#6)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
so their analysis may require microdissection##2##6##(2008-2#1)(2008-4#1)
so their##5##2##(1990-10#1)(1995-2#1)(2008-2#1)(2008-4#2)
so there is##3##3##(1994-8#1)(2012-2#1)(2013-7#1)
so there##4##2##(1994-8#1)(2007-8#1)(2012-2#1)(2013-7#1)
so these##4##2##(2004-12#1)(2007-11#1)(2008-10#1)(2010-5#1)
so they are##5##3##(1992-3#1)(1994-4#1)(2007-9#1)(2008-4#1)(2013-8#1)
so they can be##4##4##(2006-8#1)(2008-10#1)(2008-4#1)(2008-8#1)
so they can##9##3##(1990-5#1)(2006-8#1)(2006-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
so they##20##2##(1990-5#1)(1992-3#1)(1994-4#1)(1995-11#1)(1997-2#1)(2006-8#1)(2006-9#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#3)(2008-7#1)(2008-8#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-8#1)
so this##9##2##(1996-1#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-4#1)(2008-9#1)(2009-6#1)(2009-8#1)(2011-2#1)
so through##2##2##(1994-6#1)(1996-2#1)
so tightly##2##2##(2007-8#1)(2009-3#1)
so to##11##2##(1990-12#1)(1991-2#1)(1992-5#1)(1993-3#1)(1994-2#1)(1997-6#1)(2005-10#1)(2008-10#1)(2008-12#1)(2008-6#1)(2010-10#1)
so too have##2##3##(1996-1#1)(2008-7#1)
so too##8##2##(1996-1#2)(2008-7#3)(2012-1#2)(2013-1#1)
so used##2##2##(2010-11#1)(2013-7#1)
so vulnerable to##2##3##(2009-10#1)(2012-2#1)
so was##9##2##(1991-4#1)(2007-10#1)(2007-3#1)(2008-10#1)(2008-9#2)(2009-5#1)(2011-1#1)(2012-2#1)
so we conclude that##2##4##(2007-8#1)(2008-8#1)
so we decided to##2##4##(2007-8#1)(2013-7#1)
so we##20##2##(1993-11#1)(1997-8#1)(2007-12#2)(2007-3#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-2#2)(2008-7#1)(2008-8#1)(2009-2#2)(2009-6#1)(2010-7#1)(2011-2#1)(2013-7#1)
so well##3##2##(1991-6#1)(2008-11#1)(2008-2#1)
so were the##2##3##(2010-12#1)(2013-8#1)
so were##3##2##(2008-6#1)(2010-12#1)(2013-8#1)
so when##8##2##(1990-6#1)(1995-11#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-6#1)
so will##3##2##(2007-12#1)(2008-6#1)(2008-9#1)
so with a##2##3##(1991-6#1)(2007-11#1)
so with the##2##3##(2007-10#1)(2008-11#1)
so with##8##2##(1991-6#1)(1996-9#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-4#1)(2013-1#1)
so without##3##2##(1992-1#1)(1994-3#1)(2009-10#1)
so would be##4##3##(2008-10#1)(2008-7#1)(2013-1#2)
so##2105##1##(1990-1#1)(1990-10#5)(1990-11#9)(1990-12#11)(1990-2#4)(1990-3#9)(1990-4#3)(1990-5#13)(1990-6#5)(1990-7#5)(1990-8#3)(1990-9#7)(1991-1#2)(1991-10#3)(1991-11#11)(1991-12#18)(1991-2#7)(1991-3#3)(1991-4#5)(1991-5#6)(1991-6#9)(1991-7#4)(1991-8#8)(1991-9#8)(1992-1#3)(1992-10#5)(1992-11#4)(1992-12#3)(1992-2#9)(1992-3#8)(1992-4#6)(1992-5#8)(1992-6#10)(1992-7#3)(1992-8#6)(1992-9#7)(1993-1#6)(1993-10#6)(1993-11#12)(1993-12#6)(1993-2#4)(1993-3#10)(1993-4#1)(1993-5#5)(1993-6#3)(1993-7#3)(1993-8#6)(1993-9#6)(1994-1#3)(1994-11#4)(1994-12#15)(1994-2#9)(1994-3#9)(1994-4#5)(1994-5#4)(1994-6#12)(1994-8#3)(1994-9#12)(1995-1#6)(1995-10#2)(1995-11#5)(1995-12#9)(1995-2#11)(1995-3#9)(1995-4#2)(1995-5#5)(1995-6#5)(1995-7#3)(1995-8#6)(1995-9#4)(1996-1#9)(1996-10#3)(1996-11#5)(1996-12#12)(1996-2#9)(1996-3#10)(1996-4#4)(1996-5#7)(1996-6#2)(1996-7#3)(1996-8#4)(1996-9#4)(1997-1#12)(1997-2#10)(1997-3#7)(1997-4#3)(1997-5#7)(1997-6#11)(1997-7#8)(1997-8#19)(1997-9#1)(2003-11#1)(2004-1#1)(2004-12#1)(2004-2#2)(2004-3#2)(2004-9#3)(2005-1#1)(2005-10#7)(2005-11#13)(2005-12#3)(2005-3#1)(2005-4#3)(2005-5#5)(2005-7#6)(2005-8#9)(2005-9#3)(2006-1#3)(2006-10#38)(2006-11#5)(2006-12#17)(2006-2#12)(2006-3#5)(2006-4#6)(2006-5#7)(2006-6#9)(2006-7#8)(2006-8#8)(2006-9#10)(2007-1#8)(2007-10#7)(2007-11#28)(2007-12#51)(2007-2#18)(2007-3#9)(2007-4#11)(2007-5#6)(2007-6#7)(2007-7#17)(2007-8#26)(2007-9#19)(2008-1#30)(2008-10#143)(2008-11#46)(2008-12#20)(2008-2#69)(2008-3#56)(2008-4#32)(2008-5#44)(2008-6#21)(2008-7#62)(2008-8#44)(2008-9#38)(2009-1#3)(2009-10#17)(2009-11#4)(2009-12#3)(2009-2#11)(2009-3#7)(2009-4#7)(2009-5#5)(2009-6#9)(2009-7#6)(2009-8#10)(2009-9#9)(2010-1#5)(2010-10#7)(2010-11#6)(2010-12#20)(2010-2#6)(2010-3#9)(2010-4#7)(2010-5#8)(2010-6#5)(2010-7#10)(2010-8#16)(2010-9#7)(2011-1#30)(2011-12#3)(2011-2#61)(2011-3#3)(2011-4#1)(2012-1#13)(2012-10#1)(2012-11#5)(2012-12#36)(2012-2#43)(2012-3#26)(2012-4#1)(2012-6#1)(2012-7#1)(2013-1#39)(2013-7#10)(2013-8#41)
so-Gal4##3##1##(2007-12#3)
so-called &quot##31##2##(1990-1#1)(1990-6#1)(1990-8#3)(1991-2#1)(1991-3#2)(1993-3#2)(1993-6#1)(1994-8#2)(1995-3#1)(2005-11#1)(2006-4#1)(2006-5#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-12#1)(2010-12#2)(2011-2#2)(2012-1#1)
so-called DNA##3##2##(1995-5#1)(2005-11#1)(2010-8#1)
so-called cystic hypersecretory##2##3##(1996-6#2)
so-called fusiform##2##2##(2007-8#1)(2008-10#1)
so-called hairy length##2##3##(2008-7#2)
so-called hybrid##2##2##(2007-4#1)(2008-10#1)
so-called individual##2##2##(2008-2#1)(2008-5#1)
so-called natural##2##2##(2008-3#1)(2008-5#1)
so-called nerve endings##2##3##(1990-11#2)
so-called nerve##3##2##(1990-11#2)(2007-12#1)
so-called second-generation##2##2##(2006-5#1)(2008-10#1)
so-called##268##1##(1990-1#1)(1990-11#3)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#3)(1990-8#4)(1991-2#1)(1991-3#2)(1991-4#1)(1992-1#1)(1992-2#1)(1992-3#2)(1992-5#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#4)(1993-5#1)(1993-6#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#3)(1994-8#2)(1995-11#1)(1995-12#3)(1995-3#2)(1995-5#2)(1995-6#2)(1995-7#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-6#3)(1996-7#1)(1997-3#1)(1997-6#2)(1997-7#2)(1997-8#1)(2003-11#1)(2005-10#1)(2005-11#6)(2005-8#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#6)(2006-3#1)(2006-4#2)(2006-5#4)(2006-6#2)(2006-7#1)(2006-8#5)(2007-10#1)(2007-11#6)(2007-12#11)(2007-4#2)(2007-8#3)(2007-9#4)(2008-1#3)(2008-10#15)(2008-11#8)(2008-12#2)(2008-2#14)(2008-3#6)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#7)(2009-11#3)(2009-12#1)(2009-2#3)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#4)(2010-1#2)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#5)(2012-1#2)(2012-12#4)(2012-2#8)(2012-3#2)(2012-5#1)(2013-8#1)
so?##2##1##(2011-1#1)(2012-3#1)
soak##2##1##(1995-10#1)(2008-10#1)
soaked in a##4##3##(1994-8#1)(2008-10#3)
soaked in##13##2##(1992-7#1)(1993-7#1)(1993-8#1)(1994-8#1)(1997-3#1)(2008-10#3)(2008-5#2)(2010-2#2)(2011-2#1)
soaked with##2##2##(2007-8#1)(2008-10#1)
soaked##25##1##(1992-7#1)(1993-7#1)(1993-8#1)(1994-8#1)(1997-3#1)(2006-4#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-5#3)(2010-2#2)(2010-8#1)(2011-2#2)(2012-3#1)
soaking in aqueous ammonia##2##4##(2008-5#2)
soaking in##6##2##(2006-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2010-8#1)
soaking period##6##2##(2006-7#6)
soaking periods##2##2##(2006-7#1)(2008-10#1)
soaking##23##1##(2006-11#1)(2006-7#8)(2008-10#4)(2008-12#1)(2008-2#2)(2008-5#3)(2010-4#1)(2010-8#2)(2013-1#1)
soap and water##4##3##(2005-8#1)(2007-12#1)(2007-2#1)(2008-5#1)
soap and##7##2##(2005-8#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-5#1)(2011-1#1)
soap##25##1##(1996-6#2)(2005-11#1)(2005-8#1)(2007-12#2)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-5#4)(2009-5#1)(2011-1#1)(2012-12#1)(2012-3#1)
soapnut##5##1##(2009-3#5)
soaps and##3##2##(1990-2#1)(2008-5#2)
soaps##13##1##(1990-2#1)(2005-11#1)(2006-12#1)(2007-8#3)(2008-10#2)(2008-5#5)
soaps/cleansers available in the Indian market##2##6##(2007-8#2)
soapy##2##1##(1990-3#1)(2008-5#1)
soar##2##1##(1991-9#1)(1996-8#1)
sobatum##3##1##(2011-2#3)
sober##4##1##(1995-6#1)(2013-7#2)(2013-8#1)
sobriety##2##1##(2008-5#1)(2010-2#1)
soc##3##1##(1990-3#2)(2011-12#1)
soccer is the##2##3##(2013-1#2)
soccer is##3##2##(1996-6#1)(2013-1#2)
soccer player##5##2##(2006-10#2)(2008-9#1)(2011-2#2)
soccer players and##3##3##(1996-6#1)(2011-2#1)(2013-1#1)
soccer players were##2##3##(2008-5#1)(2013-1#1)
soccer players##17##2##(1996-6#1)(2008-5#4)(2010-3#1)(2011-2#2)(2013-1#7)(2013-7#2)
soccer##40##1##(1996-6#7)(2006-10#2)(2008-5#4)(2008-9#1)(2009-4#1)(2010-1#1)(2010-3#1)(2011-2#5)(2012-3#1)(2013-1#12)(2013-7#5)
sociability behaviors##3##2##(2011-12#3)
sociability##11##1##(2004-11#1)(2006-5#1)(2006-7#3)(2008-1#1)(2008-5#1)(2011-12#3)(2011-2#1)
sociable##2##1##(2006-7#1)(2008-11#1)
social Hymenoptera##3##2##(2008-8#3)
social ability##2##2##(2006-8#1)(2011-1#1)
social acceptance##2##2##(2010-4#1)(2013-8#1)
social action in##2##3##(1996-1#1)(2009-11#1)
social action##3##2##(1996-1#1)(2008-5#1)(2009-11#1)
social activities##9##2##(1996-3#1)(1997-5#2)(2004-11#1)(2007-8#1)(2008-6#1)(2010-11#1)(2011-12#1)(2012-12#1)
social actors##2##2##(2010-1#1)(2013-1#1)
social adaptation##4##2##(2008-6#1)(2012-1#1)(2012-2#2)
social adjustment##4##2##(1990-2#1)(1990-5#1)(1991-11#1)(1996-1#1)
social agents##3##2##(2008-5#1)(2009-4#1)(2012-12#1)
social analysis##2##2##(1994-6#1)(2006-10#1)
social and academic##6##3##(1993-1#1)(2008-12#4)(2009-9#1)
social and behavioral##3##3##(1996-2#1)(1996-4#1)(2008-12#1)
social and casualty problems##2##4##(2005-10#2)
social and communication##3##3##(2008-6#1)(2011-12#1)(2012-2#1)
social and communicative impairments##2##4##(2006-2#2)
social and cultural context##4##4##(2005-7#1)(2006-2#1)(2008-9#1)(2010-8#1)
social and cultural factors that##2##5##(2006-9#1)(2008-1#1)
social and cultural factors##4##4##(2006-9#1)(2007-1#1)(2008-1#1)(2009-3#1)
social and cultural norms##2##4##(2006-10#1)(2007-3#1)
social and cultural##20##3##(1990-3#1)(1993-11#1)(2005-7#1)(2006-10#1)(2006-2#2)(2006-9#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-2#1)(2011-7#1)(2012-3#1)
social and demographic characteristics##2##4##(2006-1#1)(2007-11#1)
social and demographic factors##2##4##(2007-7#1)(2013-1#1)
social and demographic##6##3##(2006-1#1)(2007-11#1)(2007-7#1)(2008-9#1)(2010-2#1)(2013-1#1)
social and ecological factors##3##4##(1992-11#1)(2008-2#2)
social and ecological##4##3##(1992-11#1)(2008-2#2)(2013-8#1)
social and economic consequences##2##4##(2008-5#1)(2010-2#1)
social and economic development##5##4##(1991-3#1)(1994-9#1)(2008-11#1)(2009-7#2)
social and economic factors##3##4##(1996-9#1)(2006-10#1)(2011-1#1)
social and economic impact##3##4##(1996-3#1)(2008-7#1)(2011-2#1)
social and economic##35##3##(1991-3#2)(1992-12#1)(1994-9#1)(1995-4#1)(1996-1#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-3#1)(2006-10#3)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#2)(2010-12#1)(2010-2#2)(2010-8#1)(2011-1#2)(2011-2#3)(2013-1#2)
social and economical practice opportunity benefits associated with our rural location##2##11##(1994-1#2)
social and emotional problems##2##4##(2006-3#1)(2013-8#1)
social and emotional##8##3##(2005-11#1)(2006-3#1)(2008-11#1)(2008-2#1)(2009-10#1)(2009-4#1)(2011-2#1)(2013-8#1)
social and environmental factors##4##4##(2008-11#1)(2011-2#1)(2012-1#1)(2012-3#1)
social and environmental##5##3##(2008-11#2)(2011-2#1)(2012-1#1)(2012-3#1)
social and ethical##2##3##(2005-7#1)(2008-1#1)
social and financial##4##3##(1996-12#1)(1997-8#1)(2006-10#1)(2007-7#1)
social and health##4##3##(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
social and historical##2##3##(2008-2#1)(2010-7#1)
social and legal aspects##2##4##(2011-2#2)
social and legal##3##3##(1997-8#1)(2011-2#2)
social and medical##5##3##(1991-1#1)(1994-4#1)(2007-2#1)(2012-11#1)(2013-1#1)
social and non-social behaviours##2##4##(1994-6#2)
social and non-social##3##3##(1994-6#3)
social and nonsocial##2##3##(2008-11#1)(2009-8#1)
social and occupational functioning##2##4##(2012-12#1)(2013-8#1)
social and past-temporal##2##3##(2009-5#2)
social and personal##2##3##(1995-5#1)(2009-7#1)
social and physical##4##3##(2011-2#1)(2012-1#1)(2012-2#2)
social and political order##2##4##(2009-4#1)(2013-1#1)
social and political##11##3##(1991-12#1)(1991-6#1)(1993-11#1)(1997-2#1)(2005-11#1)(2008-11#1)(2008-2#2)(2009-4#1)(2010-12#1)(2013-1#1)
social and professional##4##3##(2007-11#1)(2009-10#1)(2012-12#1)(2013-1#1)
social and psychological##6##3##(1992-5#1)(1994-3#1)(2006-12#1)(2007-12#1)(2008-4#1)(2008-5#1)
social and recreational activities##2##4##(2011-2#2)
social and##187##2##(1990-3#1)(1991-1#1)(1991-12#1)(1991-3#2)(1991-6#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#1)(1993-1#1)(1993-11#2)(1994-1#2)(1994-3#1)(1994-4#1)(1994-6#3)(1994-9#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#2)(2005-10#2)(2005-11#2)(2005-7#2)(2006-1#1)(2006-10#5)(2006-12#1)(2006-2#6)(2006-3#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#9)(2008-12#6)(2008-2#7)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#1)(2008-9#5)(2009-10#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#3)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#4)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-12#2)(2011-2#15)(2011-7#1)(2012-1#4)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#7)(2013-8#3)
social and/or legal##2##3##(2011-2#2)
social and/or##3##2##(2011-2#3)
social animals##4##2##(2006-7#2)(2008-9#1)(2009-8#1)
social anxiety disorder##9##3##(2008-6#1)(2011-1#1)(2011-2#4)(2013-1#2)(2013-8#1)
social anxiety symptoms##3##3##(2004-11#2)(2008-2#1)
social anxiety##27##2##(2004-11#4)(2004-3#3)(2008-11#1)(2008-2#7)(2008-6#1)(2009-11#2)(2011-1#1)(2011-2#4)(2013-1#2)(2013-8#2)
social approach##2##2##(2009-4#1)(2012-3#1)
social aspect##2##2##(1994-12#1)(1996-4#1)
social aspects of##4##3##(1993-11#1)(1996-11#1)(2007-10#1)(2012-12#1)
social aspects##8##2##(1990-12#1)(1993-11#1)(1996-11#1)(2007-10#1)(2011-1#1)(2011-2#1)(2012-12#2)
social attributes##3##2##(2008-12#1)(2009-4#1)(2013-1#1)
social audit process##2##3##(2012-3#2)
social audit##13##2##(2012-3#13)
social audits##12##2##(2012-3#12)
social avoidance##2##2##(2006-12#1)(2008-6#1)
social awareness of##2##3##(2007-10#1)(2008-12#1)
social awareness##3##2##(2007-10#1)(2008-12#1)(2013-1#1)
social behavior in##5##3##(1992-6#1)(2006-7#1)(2008-8#1)(2009-4#1)(2012-12#1)
social behavior is##3##3##(2008-10#2)(2008-8#1)
social behavior##39##2##(1992-12#5)(1992-6#1)(1995-12#2)(2006-12#1)(2006-2#1)(2006-7#2)(2008-10#5)(2008-11#4)(2008-8#6)(2008-9#1)(2009-4#1)(2009-9#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-9#1)(2012-12#3)(2012-3#1)
social behavioral##2##2##(2007-10#1)(2012-2#1)
social behaviors in##2##3##(2007-2#1)(2009-4#1)
social behaviors##4##2##(2007-2#1)(2008-10#1)(2009-4#2)
social behaviour##6##2##(1991-11#1)(1991-5#1)(1994-6#2)(2008-11#1)(2010-10#1)
social benefits to##2##3##(2008-9#1)(2010-7#1)
social benefits##3##2##(2008-9#1)(2010-7#1)(2013-1#1)
social bonds##2##2##(2009-7#2)
social capital and##3##3##(2009-9#1)(2010-2#1)(2010-5#1)
social capital through##2##3##(2009-2#1)(2012-12#1)
social capital##21##2##(2008-2#1)(2008-7#3)(2009-2#1)(2009-7#2)(2009-9#1)(2010-2#6)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-3#1)
social care##21##2##(1992-11#1)(1992-2#1)(1992-5#1)(1995-11#1)(1996-8#1)(2006-8#1)(2007-8#1)(2008-11#8)(2008-12#3)(2008-5#1)(2012-11#1)(2013-8#1)
social categories##2##2##(2012-1#1)(2013-7#1)
social category conjunctions##2##3##(2012-1#2)
social category##5##2##(1995-10#2)(1996-12#1)(2012-1#2)
social challenges##2##2##(2009-4#1)(2012-12#1)
social change##6##2##(2007-12#1)(2008-1#3)(2008-12#1)(2010-12#1)
social changes##2##2##(2004-3#1)(2007-7#1)
social class or##2##3##(1997-2#1)(2007-2#1)
social class##19##2##(1991-3#1)(1992-8#4)(1994-2#1)(1996-9#1)(1997-2#3)(1997-3#1)(2005-10#1)(2007-1#1)(2007-2#1)(2008-9#4)(2010-8#1)
social classes##10##2##(1990-12#1)(1991-9#3)(1997-2#3)(2008-9#2)(2012-1#1)
social climate##3##2##(2007-10#1)(2008-7#1)(2009-7#1)
social cognition and##4##3##(2008-1#1)(2008-11#1)(2012-1#1)(2013-1#1)
social cognition in##2##3##(2012-1#1)(2012-12#1)
social cognition##13##2##(2008-1#1)(2008-11#6)(2009-9#1)(2010-12#1)(2012-1#2)(2012-12#1)(2013-1#1)
social cognitive theory##3##3##(2006-4#1)(2010-3#1)(2010-9#1)
social cognitive##11##2##(2006-4#1)(2008-11#2)(2008-5#1)(2009-4#1)(2010-3#2)(2010-9#1)(2012-12#1)(2013-1#2)
social cohesion##6##2##(2008-7#1)(2009-7#2)(2009-9#1)(2010-4#1)(2012-1#1)
social communication##4##2##(1995-5#1)(2005-5#1)(2009-10#1)(2013-8#1)
social comparison tendencies##3##3##(2007-12#3)
social comparison##9##2##(2006-7#1)(2007-12#7)(2012-2#1)
social comparisons were##2##3##(2006-7#1)(2007-12#1)
social comparisons with##3##3##(2007-12#3)
social comparisons##8##2##(2006-7#1)(2007-12#7)
social competence and self-regulation##2##4##(2008-12#2)
social competence and##4##3##(2008-12#2)(2010-11#2)
social competence##12##2##(1996-1#1)(2006-3#1)(2008-11#1)(2008-12#3)(2008-9#1)(2009-12#1)(2009-9#1)(2010-11#3)
social complexity##3##2##(2009-8#3)
social concerns##3##2##(2008-12#1)(2009-9#1)(2011-1#1)
social condition##4##2##(1991-6#1)(2007-11#1)(2012-1#2)
social conditions##6##2##(1994-6#1)(1995-11#1)(2007-12#2)(2008-8#1)(2010-12#1)
social connectedness##2##2##(2013-1#2)
social consequences of##4##3##(2006-9#1)(2008-3#1)(2012-2#1)(2013-1#1)
social consequences##10##2##(1990-3#1)(1991-12#1)(1995-6#1)(2006-9#1)(2008-3#1)(2009-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
social construction of##6##3##(1991-6#1)(1993-8#1)(2008-7#1)(2009-4#1)(2012-12#1)(2013-7#1)
social contact with##3##3##(1997-1#1)(1997-2#1)(2008-4#1)
social contact##8##2##(1997-1#1)(1997-2#1)(2006-2#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-1#1)
social contacts##4##2##(1996-11#1)(2007-1#1)(2010-2#1)(2011-2#1)
social context in which##2##4##(1992-1#1)(2009-10#1)
social context of##8##3##(1993-1#1)(2006-2#2)(2007-3#2)(2008-11#1)(2010-8#1)(2011-1#1)
social context on##2##3##(2006-10#1)(2010-8#1)
social context##27##2##(1992-1#1)(1993-1#1)(2004-3#1)(2006-1#1)(2006-10#1)(2006-2#2)(2007-3#2)(2008-11#2)(2008-2#1)(2008-7#1)(2009-10#2)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#3)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
social contexts##6##2##(2006-3#1)(2008-4#1)(2010-4#1)(2011-1#1)(2012-11#1)(2013-1#1)
social contract&quot##2##2##(1995-1#1)(2008-9#1)
social contracts##2##2##(2008-9#2)
social control##13##2##(1996-1#1)(2006-7#1)(2008-2#1)(2009-7#3)(2009-9#1)(2010-12#2)(2010-7#1)(2011-2#3)
social coping##2##2##(1995-1#1)(2006-12#1)
social cost##2##2##(2010-11#1)(2010-5#1)
social costs##6##2##(1991-6#1)(2007-8#1)(2008-11#1)(2008-5#1)(2012-11#1)(2012-12#1)
social data##3##2##(1990-10#1)(2007-1#1)(2010-2#1)
social defeat##2##2##(1997-3#2)
social demand##2##2##(2005-3#1)(2007-3#1)
social deprivation##2##2##(1993-10#1)(1997-8#1)
social desirability##4##2##(1990-6#1)(2006-1#1)(2007-12#1)(2013-1#1)
social determinants of health##5##4##(2008-2#1)(2011-1#1)(2011-2#1)(2013-1#2)
social determinants of##10##3##(2007-2#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#2)
social determinants##13##2##(2007-2#1)(2008-2#2)(2008-3#1)(2008-9#1)(2010-12#1)(2011-1#3)(2011-2#2)(2013-1#2)
social development and##5##3##(2008-8#1)(2009-4#1)(2009-9#2)(2012-2#1)
social development##13##2##(1995-12#1)(2007-11#1)(2008-8#1)(2009-10#2)(2009-4#1)(2009-9#4)(2011-2#1)(2012-12#1)(2012-2#1)
social dilemmas##2##2##(2008-4#1)(2012-3#1)
social disadvantage##2##2##(2012-1#1)(2012-2#1)
social distance between##2##3##(2006-4#1)(2010-4#1)
social distance##3##2##(2006-4#1)(2010-4#1)(2011-2#1)
social dominance is##2##3##(2008-8#2)
social dominance##9##2##(1995-8#1)(1997-6#1)(2008-11#1)(2008-8#5)(2010-1#1)
social drinkers##2##2##(2008-2#1)(2009-5#1)
social dysfunction##2##2##(2006-9#1)(2008-2#1)
social effects of the##2##4##(1992-2#1)(2009-10#1)
social effects##5##2##(1992-2#1)(2005-10#1)(2008-8#2)(2009-10#1)
social engineering##2##2##(2007-4#2)
social environment and##2##3##(2006-2#1)(2010-2#1)
social environment of the##3##4##(1995-12#1)(2007-3#1)(2009-6#1)
social environment of##7##3##(1995-12#1)(2006-8#1)(2007-3#1)(2008-11#3)(2009-6#1)
social environment that##2##3##(2006-4#1)(2009-6#1)
social environment##21##2##(1995-12#1)(2005-9#1)(2006-2#1)(2006-4#2)(2006-8#1)(2007-3#1)(2008-10#3)(2008-11#3)(2008-6#1)(2009-6#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#2)
social environments##5##2##(2008-1#1)(2008-9#1)(2009-5#1)(2009-8#1)(2012-12#1)
social ethic##2##2##(1992-2#1)(1992-3#1)
social events and##2##3##(2010-2#2)
social events##6##2##(2010-11#1)(2010-2#2)(2010-4#1)(2011-12#1)(2012-2#1)
social evolution and##2##3##(2008-8#1)(2010-4#1)
social evolution in##2##3##(2008-8#2)
social evolution##10##2##(2008-8#5)(2010-4#1)(2012-3#4)
social exclusion##5##2##(2007-12#1)(2008-9#1)(2009-6#1)(2012-3#2)
social exclusion&quot##2##2##(2013-1#2)
social experiences##5##2##(1993-1#1)(2008-11#1)(2009-12#1)(2012-2#2)
social fabric##2##2##(1997-5#1)(2008-11#1)
social factors and##2##3##(2008-1#1)(2008-4#1)
social factors in stuttering##2##4##(2008-2#2)
social factors in##4##3##(1991-6#1)(2008-2#2)(2008-7#1)
social factors may play##2##4##(2007-3#1)(2008-11#1)
social factors such as religion##2##5##(2009-6#2)
social factors such as##3##4##(2009-6#2)(2009-7#1)
social factors##24##2##(1991-6#1)(1992-12#1)(1993-8#1)(1995-9#1)(2006-8#1)(2007-3#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-2#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-6#2)(2009-7#3)(2011-2#1)(2012-12#1)
social field narratives##2##3##(2012-12#2)
social field##3##2##(2012-12#2)(2012-3#1)
social function in##3##3##(2013-1#3)
social function##12##2##(1997-8#1)(2005-10#1)(2006-10#1)(2007-10#1)(2008-11#1)(2009-5#1)(2013-1#5)(2013-8#1)
social functioning and##4##3##(1992-5#1)(1996-1#1)(2007-11#1)(2011-12#1)
social functioning in##4##3##(1996-1#1)(1997-8#1)(2005-10#1)(2012-1#1)
social functioning of patients##2##4##(2007-12#1)(2013-1#1)
social functioning of##7##3##(1996-1#1)(1997-8#1)(2005-10#1)(2007-1#1)(2007-12#1)(2011-2#1)(2013-1#1)
social functioning was##2##3##(1997-8#2)
social functioning##33##2##(1992-5#2)(1995-5#1)(1996-1#5)(1997-8#4)(2005-10#2)(2005-6#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#1)(2008-6#1)(2008-8#1)(2009-10#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
social grants##2##2##(2007-7#2)
social group##8##2##(1993-9#1)(1996-6#1)(2008-3#2)(2008-9#1)(2009-3#1)(2009-7#1)(2013-8#1)
social grouping##2##2##(2008-5#1)(2009-4#1)
social groups and##2##3##(2008-3#1)(2012-2#1)
social groups##18##2##(1990-12#1)(1992-12#1)(1993-1#1)(1993-5#1)(1994-4#1)(2007-11#1)(2008-11#1)(2008-3#3)(2008-8#2)(2010-4#2)(2011-1#1)(2012-2#1)(2013-1#2)
social health insurance##2##3##(2008-7#1)(2010-8#1)
social health maintenance organization##3##4##(1991-3#1)(1992-1#1)(1997-1#1)
social health maintenance##4##3##(1991-3#2)(1992-1#1)(1997-1#1)
social health##7##2##(1991-3#2)(1992-1#1)(1997-1#1)(2007-10#1)(2008-7#1)(2010-8#1)
social hierarchy##3##2##(1992-12#1)(2008-11#2)
social history of##2##3##(1997-3#1)(2008-10#1)
social history##9##2##(1997-3#1)(2005-12#1)(2006-8#1)(2008-10#2)(2013-1#4)
social identities##3##2##(2008-10#1)(2009-4#1)(2012-3#1)
social identity performance can##2##4##(2008-5#2)
social identity performance##3##3##(2008-5#3)
social identity##8##2##(2006-7#1)(2008-10#1)(2008-5#5)(2012-3#1)
social impact of##4##3##(2005-10#1)(2009-10#1)(2009-5#1)(2012-1#1)
social impact##8##2##(2005-10#1)(2007-10#1)(2008-11#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-12#1)(2012-1#1)
social implications##2##2##(2006-11#1)(2007-7#1)
social importance##3##2##(1991-5#1)(2006-12#1)(2010-1#1)
social inclusion##2##2##(2008-9#1)(2011-2#1)
social indicator research##2##3##(2011-1#2)
social indicators##2##2##(2007-10#2)
social inequalities and##2##3##(2008-9#1)(2012-3#1)
social inequalities in##3##3##(1994-4#1)(1996-5#1)(2011-1#1)
social inequalities##6##2##(1994-4#1)(1996-5#1)(2008-9#2)(2011-1#1)(2012-3#1)
social influence and##3##3##(2008-5#1)(2008-6#1)(2012-2#1)
social influence##8##2##(2006-3#1)(2008-5#4)(2008-6#1)(2010-2#1)(2012-2#1)
social influences##6##2##(2006-2#1)(2008-8#1)(2009-12#1)(2009-7#1)(2012-12#1)(2012-2#1)
social information##2##2##(2007-8#1)(2008-11#1)
social insect colonies##3##3##(2008-10#1)(2008-8#2)
social insect##4##2##(2008-10#1)(2008-6#1)(2008-8#2)
social insects##7##2##(2006-5#1)(2008-8#5)(2008-9#1)
social institution##2##2##(1995-2#1)(2008-8#1)
social institutions##6##2##(2006-2#1)(2006-4#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)
social insurance##10##2##(1995-5#3)(1996-12#1)(1996-8#1)(1997-8#1)(2006-8#2)(2008-1#1)(2013-8#1)
social integration##5##2##(2007-7#1)(2008-2#2)(2010-2#1)(2012-3#1)
social intelligence##4##2##(2009-8#1)(2010-1#3)
social interaction and##3##3##(1993-3#1)(1996-11#1)(2005-7#1)
social interaction##28##2##(1993-3#1)(1995-3#1)(1996-11#1)(1996-2#1)(2004-11#1)(2005-7#1)(2007-12#1)(2007-6#1)(2008-11#2)(2008-4#2)(2009-4#1)(2010-12#1)(2011-2#6)(2012-1#1)(2012-2#4)(2012-3#3)
social interactions and##4##3##(2007-3#1)(2010-4#2)(2011-2#1)
social interactions between##2##3##(1996-1#1)(2012-2#1)
social interactions in##2##3##(2010-4#1)(2010-8#1)
social interactions##37##2##(1996-1#1)(1996-2#1)(2007-3#2)(2008-11#5)(2008-12#1)(2008-6#1)(2008-8#4)(2009-10#1)(2009-12#1)(2010-10#1)(2010-2#3)(2010-4#6)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
social investigation##2##2##(1993-2#1)(1995-4#1)
social involvement##2##2##(2008-6#1)(2010-4#1)
social isolation and##3##3##(1994-12#1)(2006-1#1)(2012-2#1)
social isolation##14##2##(1991-2#1)(1994-12#1)(2006-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2009-5#1)(2011-2#1)(2012-12#2)(2012-2#2)
social issues##5##2##(2007-4#2)(2008-12#2)(2008-4#1)
social justice##8##2##(1990-12#1)(2006-3#1)(2006-7#2)(2008-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
social knowledge##2##2##(2008-12#1)(2010-9#1)
social leaders##2##2##(2007-7#1)(2013-1#1)
social learning##7##2##(1994-2#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-4#1)(2009-7#1)
social life and##2##3##(1997-3#1)(2007-7#1)
social life##13##2##(1991-6#1)(1992-1#1)(1997-3#1)(2006-11#1)(2007-7#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-4#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-1#1)
social marketing and##2##3##(2006-10#1)(2007-10#1)
social marketing techniques##2##3##(1997-3#2)
social marketing##6##2##(1997-3#2)(2006-10#1)(2007-10#1)(2012-1#1)(2012-3#1)
social meanings and##2##3##(2007-12#2)
social media in##4##3##(2013-1#4)
social media technologies##2##3##(2012-2#2)
social media to##2##3##(2012-2#2)
social media##13##2##(2012-2#4)(2013-1#9)
social memory/recognition##3##2##(1994-3#3)
social needs##2##2##(2007-7#1)(2010-3#1)
social network structure##2##3##(2008-5#1)(2012-3#1)
social network##18##2##(1991-12#1)(1995-1#1)(2005-10#1)(2006-10#2)(2008-5#1)(2010-1#2)(2010-10#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
social networking##5##2##(2010-3#1)(2011-2#1)(2012-2#2)(2012-3#1)
social networks and relationships##2##4##(2008-5#1)(2011-2#1)
social networks and##6##3##(2008-5#1)(2009-12#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-12#1)
social networks##16##2##(2007-7#1)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
social norm##5##2##(2007-12#2)(2008-11#1)(2012-12#2)
social norms that##2##3##(2012-12#1)(2013-7#1)
social norms##11##2##(1993-3#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-2#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
social or##9##2##(1991-4#1)(2004-3#1)(2008-12#1)(2008-2#1)(2008-6#2)(2009-6#1)(2011-2#1)(2013-8#1)
social order##2##2##(1992-12#1)(2013-1#1)
social organization in##2##3##(2008-11#1)(2012-2#1)
social organization##9##2##(1991-11#1)(1992-12#1)(2006-4#1)(2007-12#1)(2008-11#1)(2008-9#1)(2010-1#1)(2012-2#2)
social origins##2##2##(2006-7#1)(2013-1#1)
social outcome following paediatric traumatic brain injury##2##7##(2009-10#2)
social outcome##6##2##(2009-10#6)
social outcomes##3##2##(2005-10#2)(2010-2#1)
social participation and work performance##2##5##(2011-2#2)
social participation and##3##3##(2009-5#1)(2011-2#2)
social participation in##2##3##(2008-12#1)(2008-9#1)
social participation##8##2##(2008-12#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-2#1)(2011-2#2)(2013-8#1)
social partners##3##2##(2008-8#1)(2012-3#2)
social perception##4##2##(2008-11#2)(2013-8#2)
social phenomenon##2##2##(1995-5#1)(2009-4#1)
social phenotypes##4##2##(2008-11#3)(2009-4#1)
social phobia (GSP)##2##3##(2006-6#1)(2010-2#1)
social phobia and##3##3##(2006-6#1)(2008-4#2)
social phobia has##2##3##(2006-6#1)(2008-4#1)
social phobia is##3##3##(2005-9#3)
social phobia subtypes##3##3##(2006-6#1)(2008-4#1)(2010-2#1)
social phobia##51##2##(1996-1#2)(2004-11#1)(2005-9#5)(2006-12#1)(2006-6#6)(2007-7#2)(2007-9#2)(2008-1#1)(2008-2#1)(2008-4#18)(2010-2#6)(2012-12#1)(2012-2#2)(2013-1#3)
social phobias and panic disorders##2##5##(2005-9#2)
social play##2##2##(2008-4#2)
social policy to##2##3##(1997-2#1)(2013-1#1)
social policy##9##2##(1996-12#1)(1997-2#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-1#1)(2013-1#1)
social practice##2##2##(2012-3#2)
social pressure##2##2##(2007-7#1)(2010-3#1)
social prestige##2##2##(1991-6#1)(2009-4#1)
social problem##7##2##(2006-10#1)(2007-11#2)(2007-8#1)(2008-11#1)(2009-10#1)(2010-12#1)
social problem-solving skills and##2##4##(2009-10#1)(2010-6#1)
social problem-solving skills##5##3##(2006-3#1)(2009-10#3)(2010-6#1)
social problem-solving##6##2##(2006-3#1)(2008-11#1)(2009-10#3)(2010-6#1)
social problems of##2##3##(2005-1#1)(2008-1#1)
social problems such as##2##4##(1996-11#1)(2013-1#1)
social problems##17##2##(1990-11#1)(1996-11#1)(1996-7#1)(2005-1#1)(2005-10#2)(2006-7#2)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
social process##3##2##(2006-3#1)(2007-11#1)(2008-12#1)
social programs##2##2##(1994-2#1)(1997-2#1)
social proximity##3##2##(2009-4#3)
social psychiatric##2##2##(2006-9#2)
social psychological##3##2##(2006-10#1)(2008-5#1)(2008-9#1)
social psychology##8##2##(2007-11#1)(2007-12#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-9#1)
social rank##3##2##(1993-9#1)(2008-11#2)
social reasons##2##2##(1996-2#1)(2006-2#1)
social reciprocity##2##2##(2008-11#1)(2012-11#1)
social recognition in##2##3##(1993-2#1)(2008-11#1)
social recognition##7##2##(1993-2#4)(2008-11#2)(2008-4#1)
social recovery##2##2##(2006-9#1)(2008-4#1)
social reform##2##2##(2006-10#1)(2011-2#1)
social rehabilitation##2##2##(1994-5#1)(2012-11#1)
social reintegration of##2##3##(1992-1#1)(1994-5#1)
social relations##8##2##(1994-8#1)(1995-3#2)(2005-2#1)(2006-2#2)(2009-9#1)(2011-2#1)
social relationships and##3##3##(2008-1#1)(2008-9#1)(2011-2#1)
social relationships in##3##3##(2008-5#2)(2009-4#1)
social relationships##14##2##(2005-7#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-5#3)(2008-9#1)(2009-4#1)(2010-1#1)(2011-2#3)
social representation of the##2##4##(1994-3#1)(2011-2#1)
social representation of##4##3##(1994-3#2)(2008-9#1)(2011-2#1)
social representation##9##2##(1994-3#2)(2008-9#1)(2011-2#4)(2012-3#1)(2013-7#1)
social representations of the##2##4##(2011-2#1)(2012-12#1)
social representations of##4##3##(2007-7#1)(2011-2#1)(2012-12#2)
social representations##6##2##(1993-3#1)(2007-7#1)(2011-2#1)(2012-12#2)(2012-3#1)
social research##6##2##(1994-3#1)(1997-1#1)(2005-7#1)(2006-10#1)(2007-7#1)(2011-1#1)
social resources##5##2##(1994-6#1)(2006-1#2)(2007-12#1)(2011-2#1)
social responses##3##2##(2008-11#3)
social responsibility of the##2##4##(1991-6#1)(2008-10#1)
social responsibility##6##2##(1991-6#1)(1995-12#1)(2008-10#1)(2012-11#1)(2012-3#1)(2013-1#1)
social rights##4##2##(1993-3#1)(2007-10#1)(2008-9#1)(2010-9#1)
social risk factors##2##3##(1993-3#2)
social risk##3##2##(1993-3#3)
social roles##9##2##(2005-10#1)(2006-7#5)(2008-5#2)(2012-12#1)
social science and##2##3##(2010-2#2)
social science research on##2##4##(2009-4#1)(2013-7#1)
social science research##5##3##(1995-2#1)(2005-8#1)(2008-12#1)(2009-4#1)(2013-7#1)
social science surveys##5##3##(2010-2#5)
social science##20##2##(1993-5#1)(1995-2#1)(1996-3#1)(2005-8#1)(2006-7#1)(2007-7#1)(2008-12#1)(2008-2#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-2#7)(2013-7#1)
social science) to understand technology adoption##2##6##(2013-1#2)
social sciences##19##2##(1996-6#1)(2006-7#3)(2007-5#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#3)(2009-10#1)(2009-4#2)(2010-11#1)(2011-2#1)(2012-2#3)
social scientific##2##2##(2007-3#1)(2013-1#1)
social scientists##7##2##(1994-3#1)(1994-6#1)(2006-7#3)(2009-4#1)(2010-4#1)
social security##9##2##(1995-5#5)(2007-7#1)(2008-9#1)(2011-1#1)(2012-12#1)
social selection##6##2##(2008-8#2)(2012-3#4)
social self##2##2##(2007-2#1)(2012-11#1)
social service organizations##2##3##(1991-12#2)
social service##9##2##(1991-12#2)(1994-2#2)(1995-3#1)(1996-3#1)(1997-6#1)(2008-3#1)(2011-2#1)
social services for##2##3##(1996-4#1)(2005-1#1)
social services with##2##3##(1996-12#1)(2011-2#1)
social services##33##2##(1991-12#1)(1991-3#1)(1992-1#2)(1992-11#1)(1992-12#1)(1994-1#2)(1994-12#1)(1994-6#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-3#4)(1996-4#1)(2005-1#1)(2008-1#2)(2008-11#2)(2008-2#2)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)
social setting##2##2##(2006-3#1)(2013-1#1)
social signals##2##2##(2007-8#1)(2008-11#1)
social situation##3##2##(1995-5#1)(2008-11#1)(2013-1#1)
social situations and##2##3##(2006-2#1)(2008-6#1)
social situations##7##2##(2004-11#1)(2006-2#1)(2006-6#1)(2008-6#2)(2010-2#1)(2010-4#1)
social skill##5##2##(1996-1#4)(2009-8#1)
social skills and##2##3##(2008-2#1)(2011-2#1)
social skills##15##2##(1997-2#1)(2004-11#1)(2006-3#1)(2007-1#1)(2008-11#2)(2008-12#1)(2008-2#1)(2009-12#1)(2009-7#1)(2010-5#1)(2011-2#1)(2013-1#3)
social spacing##2##2##(2010-8#2)
social species##6##2##(2007-12#1)(2008-6#1)(2008-8#2)(2008-9#2)
social spending##5##2##(2008-9#2)(2013-1#3)
social spider##3##2##(2008-9#3)
social status and##4##3##(1991-12#1)(1997-2#1)(2008-11#1)(2010-8#1)
social status in##3##3##(2008-12#1)(2009-11#1)(2010-8#1)
social status##23##2##(1991-12#4)(1994-6#1)(1995-4#1)(1997-2#1)(2006-7#1)(2008-11#2)(2008-12#2)(2008-8#1)(2009-11#1)(2009-3#1)(2009-9#2)(2010-8#4)(2011-2#1)(2012-12#1)
social stigmatization and##2##3##(1997-6#1)(2007-12#1)
social strategies##2##2##(2006-7#2)
social stress##4##2##(1997-3#1)(2008-8#1)(2010-8#1)(2011-1#1)
social structure and##6##3##(2007-1#1)(2008-12#1)(2008-5#1)(2008-9#1)(2013-1#2)
social structure##10##2##(1997-8#1)(2007-1#1)(2008-12#3)(2008-5#1)(2008-9#2)(2013-1#2)
social structures in##2##3##(1995-6#1)(2012-12#1)
social structures##5##2##(1995-6#1)(2007-7#1)(2008-1#1)(2012-12#1)(2012-2#1)
social support and##20##3##(1992-3#3)(1996-3#1)(2005-10#1)(2006-9#1)(2007-10#1)(2009-7#4)(2009-9#1)(2010-1#2)(2010-10#1)(2010-3#2)(2012-1#1)(2013-8#2)
social support are##2##3##(2010-10#2)
social support for##7##3##(1995-1#1)(2007-12#1)(2008-6#1)(2010-10#1)(2010-11#1)(2011-2#2)
social support from##8##3##(1992-3#1)(2006-3#1)(2006-4#2)(2008-12#1)(2009-7#3)
social support in##7##3##(1992-3#2)(2006-4#2)(2009-7#1)(2009-8#1)(2010-7#1)
social support interventions##2##3##(2007-1#2)
social support networks of##2##4##(1992-3#2)
social support networks##5##3##(1992-3#2)(2008-3#1)(2009-5#1)(2012-12#1)
social support satisfaction##2##3##(2006-4#2)
social support to##2##3##(1996-2#1)(2005-10#1)
social support with##3##3##(2009-10#1)(2009-7#1)(2012-2#1)
social support##131##2##(1990-10#1)(1991-1#1)(1992-1#3)(1992-12#1)(1992-2#2)(1992-3#13)(1993-1#1)(1993-10#1)(1995-1#1)(1995-2#2)(1995-5#1)(1996-1#1)(1996-2#4)(1996-3#4)(2005-10#7)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#8)(2006-5#1)(2006-9#1)(2007-1#4)(2007-10#4)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-9#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-6#3)(2009-10#2)(2009-5#5)(2009-7#12)(2009-8#1)(2009-9#5)(2010-1#3)(2010-10#5)(2010-11#1)(2010-12#1)(2010-3#2)(2010-7#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#2)
social supports##2##2##(2008-3#1)(2011-1#1)
social surveys##12##2##(2008-5#1)(2010-1#2)(2010-2#9)
social system##2##2##(2006-5#1)(2007-1#1)
social systems##7##2##(2007-1#1)(2008-8#1)(2010-5#1)(2012-2#4)
social terms##2##2##(2006-7#1)(2008-5#1)
social threat##2##2##(2008-4#1)(2012-2#1)
social ties##10##2##(2009-7#1)(2011-2#7)(2012-12#1)(2013-1#1)
social unit##2##2##(2008-1#1)(2008-7#1)
social validity##3##2##(1993-1#1)(2009-11#2)
social value##2##2##(1992-8#1)(1995-2#1)
social variables##3##2##(2006-12#1)(2008-7#1)(2012-2#1)
social violence##2##2##(1993-3#1)(2013-1#1)
social vulnerability##3##2##(2010-4#1)(2011-2#1)(2012-12#1)
social welfare and##3##3##(2008-11#1)(2008-9#1)(2012-11#1)
social welfare services##2##3##(1990-5#1)(2008-9#1)
social welfare system##2##3##(1994-1#1)(2008-9#1)
social welfare##14##2##(1990-4#1)(1990-5#1)(1994-1#1)(1995-3#1)(2008-11#1)(2008-9#6)(2011-2#1)(2012-11#1)(2013-8#1)
social withdrawal were##2##3##(1993-9#1)(2012-2#1)
social withdrawal##6##2##(1993-9#1)(1996-1#1)(2005-7#1)(2008-6#1)(2012-1#1)(2012-2#1)
social work and##2##3##(2007-9#1)(2008-1#1)
social work consultation##2##3##(1992-12#2)
social work practice##6##3##(2007-9#2)(2008-3#3)(2010-2#1)
social work##35##2##(1991-12#1)(1992-12#2)(1994-6#2)(1996-1#1)(2007-9#11)(2008-1#1)(2008-12#1)(2008-3#4)(2009-12#1)(2009-4#1)(2010-10#2)(2010-2#2)(2010-3#1)(2012-12#3)(2012-2#1)(2013-1#1)
social worker##9##2##(1991-6#1)(1993-12#1)(1995-11#1)(1996-1#1)(2006-4#2)(2006-8#1)(2012-3#1)(2013-1#1)
social workers and##7##3##(1994-3#1)(1994-8#1)(2004-10#1)(2007-9#1)(2008-1#1)(2010-2#1)(2013-1#1)
social workers are##2##3##(2008-3#1)(2010-2#1)
social workers as##2##3##(2007-9#1)(2008-2#1)
social workers in##4##3##(2007-9#1)(2010-2#3)
social workers with##2##3##(2007-9#2)
social workers##33##2##(1994-3#1)(1994-8#1)(1995-11#1)(2004-10#1)(2005-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#9)(2008-1#1)(2008-2#1)(2008-3#1)(2010-11#1)(2010-2#9)(2010-7#1)(2012-3#1)(2013-1#1)
social workers'##4##2##(2006-4#1)(2007-9#3)
social world##6##2##(1994-6#1)(2008-11#1)(2008-5#2)(2008-6#1)(2009-3#1)
social##2368##1##(1990-10#4)(1990-11#1)(1990-12#6)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#1)(1990-9#1)(1991-1#2)(1991-11#3)(1991-12#11)(1991-2#3)(1991-3#6)(1991-4#1)(1991-5#2)(1991-6#12)(1991-8#2)(1991-9#4)(1992-1#11)(1992-11#3)(1992-12#17)(1992-2#5)(1992-3#21)(1992-4#1)(1992-5#4)(1992-6#1)(1992-8#7)(1993-1#6)(1993-10#2)(1993-11#3)(1993-12#1)(1993-2#7)(1993-3#13)(1993-5#3)(1993-6#1)(1993-8#2)(1993-9#5)(1994-1#5)(1994-11#2)(1994-12#8)(1994-2#6)(1994-3#10)(1994-4#5)(1994-5#3)(1994-6#16)(1994-8#2)(1994-9#2)(1995-1#6)(1995-10#2)(1995-11#6)(1995-12#7)(1995-2#5)(1995-3#9)(1995-4#6)(1995-5#16)(1995-6#2)(1995-8#4)(1995-9#1)(1996-1#25)(1996-11#6)(1996-12#12)(1996-2#8)(1996-3#15)(1996-4#4)(1996-5#1)(1996-6#3)(1996-7#1)(1996-8#5)(1996-9#3)(1997-1#4)(1997-2#16)(1997-3#12)(1997-5#5)(1997-6#4)(1997-8#11)(2004-10#1)(2004-11#9)(2004-12#3)(2004-3#8)(2005-1#2)(2005-10#26)(2005-11#3)(2005-12#1)(2005-2#1)(2005-3#1)(2005-5#1)(2005-6#2)(2005-7#7)(2005-8#1)(2005-9#8)(2006-1#6)(2006-10#19)(2006-11#2)(2006-12#10)(2006-2#19)(2006-3#13)(2006-4#19)(2006-5#3)(2006-6#10)(2006-7#38)(2006-8#14)(2006-9#12)(2007-1#14)(2007-10#25)(2007-11#17)(2007-12#50)(2007-2#9)(2007-3#13)(2007-4#6)(2007-5#2)(2007-6#2)(2007-7#35)(2007-8#11)(2007-9#31)(2008-1#31)(2008-10#23)(2008-11#104)(2008-12#51)(2008-2#47)(2008-3#18)(2008-4#39)(2008-5#47)(2008-6#27)(2008-7#25)(2008-8#61)(2008-9#69)(2009-10#31)(2009-11#8)(2009-12#9)(2009-2#2)(2009-3#4)(2009-4#41)(2009-5#17)(2009-6#10)(2009-7#43)(2009-8#13)(2009-9#24)(2010-1#18)(2010-10#15)(2010-11#13)(2010-12#25)(2010-2#64)(2010-3#10)(2010-4#25)(2010-5#6)(2010-6#5)(2010-7#11)(2010-8#17)(2010-9#6)(2011-1#30)(2011-12#7)(2011-2#106)(2011-7#1)(2012-1#32)(2012-11#11)(2012-12#60)(2012-2#61)(2012-3#72)(2013-1#103)(2013-7#5)(2013-8#30)
social-cognitive processing##2##2##(2008-11#2)
social-cognitive##6##1##(2007-12#1)(2008-11#3)(2008-5#1)(2012-12#1)
social-economic##2##1##(1991-6#1)(2006-5#1)
social-emotional growth fostering##2##3##(1990-12#2)
social-emotional##3##1##(1990-12#2)(1992-3#1)
social-psychiatric##2##1##(2007-1#1)(2009-2#1)
social/health maintenance organization (S/HMO)##2##4##(1995-2#1)(1997-1#1)
social/health maintenance organization##3##3##(1995-2#2)(1997-1#1)
social/health maintenance##4##2##(1993-12#1)(1995-2#2)(1997-1#1)
socialising##2##1##(2010-10#1)(2012-3#1)
sociality##12##1##(2008-8#9)(2013-1#3)
socialization and##7##2##(2008-12#1)(2009-7#5)(2010-10#1)
socialization in##2##2##(2007-4#1)(2012-12#1)
socialization of##4##2##(1991-3#1)(1992-6#1)(2010-10#1)(2011-1#1)
socialization process##2##2##(2008-5#1)(2010-10#1)
socialization##33##1##(1991-3#1)(1992-6#1)(2006-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-5#1)(2009-12#1)(2009-7#9)(2009-9#2)(2010-10#6)(2011-1#1)(2011-2#1)(2012-12#4)(2012-3#1)
socializing##2##1##(1991-3#1)(2007-3#1)
socially and##2##2##(2007-6#1)(2010-1#1)
socially anxious##2##2##(2008-4#1)(2009-11#1)
socially appropriate##2##2##(2009-11#1)(2012-12#1)
socially constructed##2##2##(2010-7#1)(2013-1#1)
socially desirable##2##2##(2007-12#1)(2008-1#1)
socially disadvantaged populations##2##3##(2011-2#2)
socially disadvantaged##4##2##(2010-12#1)(2011-2#2)(2012-1#1)
socially isolated##2##2##(2008-12#1)(2012-11#1)
socially marginalized groups in##2##4##(2012-11#2)
socially marginalized groups##4##3##(2012-11#4)
socially marginalized##6##2##(1993-6#1)(2012-11#4)(2012-12#1)
socially rejected##2##2##(2007-12#1)(2013-1#1)
socially relevant information##2##3##(1993-2#1)(2008-11#1)
socially relevant##5##2##(1993-2#1)(2006-6#2)(2007-8#1)(2008-11#1)
socially vulnerable##2##2##(2008-11#1)(2012-11#1)
socially##68##1##(1991-2#2)(1993-2#1)(1993-6#1)(1994-2#2)(1995-1#1)(1995-11#1)(1995-5#2)(2004-11#1)(2006-6#2)(2007-12#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#6)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-11#2)(2009-12#1)(2009-6#1)(2009-7#2)(2010-1#2)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-1#2)(2012-11#6)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
societal and##4##2##(1995-12#1)(2006-12#1)(2007-12#1)(2008-3#1)
societal attitudes##3##2##(1996-7#1)(2006-4#1)(2007-7#1)
societal benefit##3##2##(2007-12#1)(2007-9#1)(2008-8#1)
societal costs##3##2##(2006-12#1)(2008-12#1)(2011-1#1)
societal expectations##2##2##(2006-9#1)(2010-10#1)
societal factors##2##2##(2008-3#1)(2012-2#1)
societal impacts##2##2##(2007-12#1)(2010-12#1)
societal implications##2##2##(2009-4#1)(2010-12#1)
societal norms##2##2##(2006-12#1)(2010-2#1)
societal perspective##6##2##(1990-12#1)(2006-12#3)(2008-7#1)(2013-1#1)
societal perspectives##2##2##(2006-12#1)(2013-1#1)
societal pressure to##2##3##(2007-12#1)(2007-5#1)
societal pressure##3##2##(2007-12#1)(2007-5#1)(2008-1#1)
societal racism and oppression##2##4##(2004-12#2)
societal##71##1##(1990-12#1)(1995-12#1)(1996-3#1)(1996-7#1)(1997-1#1)(2004-12#2)(2006-12#7)(2006-4#2)(2006-9#3)(2007-12#11)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-12#2)(2008-3#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-10#2)(2010-12#2)(2010-2#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
societies and##6##2##(1996-1#1)(2006-9#1)(2007-4#1)(2009-12#1)(2009-4#1)(2012-1#1)
societies are##2##2##(2006-10#1)(2010-11#1)
societies can be##3##3##(2009-2#1)(2012-1#2)
societies for##2##2##(2008-7#1)(2013-8#1)
societies have##2##2##(2009-6#1)(2010-11#1)
societies in##2##2##(1991-10#1)(2008-11#1)
societies is##3##2##(2008-10#1)(2009-12#1)(2010-12#1)
societies may##2##2##(2011-1#1)(2012-2#1)
societies of##4##2##(2008-9#1)(2012-11#2)(2012-2#1)
societies such as##2##3##(2007-4#1)(2007-8#1)
societies to##4##2##(2006-7#1)(2007-12#1)(2007-4#1)(2010-12#1)
societies##119##1##(1991-10#2)(1991-4#1)(1992-1#1)(1992-10#1)(1992-12#1)(1993-1#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-9#1)(1997-7#1)(2005-10#3)(2006-1#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#2)(2007-12#1)(2007-2#1)(2007-4#7)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#5)(2008-9#1)(2009-12#3)(2009-2#4)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#4)(2011-3#1)(2011-4#1)(2012-1#3)(2012-11#2)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#2)
society and how##2##3##(2009-3#1)(2010-8#1)
society and the##12##3##(1992-6#1)(1995-10#1)(2006-10#2)(2006-7#1)(2007-11#1)(2007-8#1)(2008-12#2)(2010-1#1)(2010-4#1)(2012-2#1)
society and##34##2##(1992-12#1)(1992-6#1)(1994-6#1)(1995-10#1)(1995-5#1)(2004-12#1)(2006-10#2)(2006-7#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#3)(2009-3#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-8#1)(2010-9#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#2)
society as a whole##7##4##(1994-3#1)(1995-5#1)(2006-9#1)(2007-12#1)(2008-1#2)(2010-1#1)
society as a##8##3##(1994-3#1)(1995-5#1)(2006-9#1)(2007-12#1)(2008-1#2)(2010-1#1)(2012-1#1)
society as##11##2##(1994-3#1)(1995-5#1)(2006-9#1)(2007-12#1)(2008-1#2)(2008-12#1)(2008-7#1)(2009-6#1)(2010-1#1)(2012-1#1)
society at large##3##3##(1993-12#1)(2008-7#1)(2012-2#1)
society at##4##2##(1993-12#1)(2006-10#1)(2008-7#1)(2012-2#1)
society by##2##2##(2008-11#1)(2008-8#1)
society can##2##2##(1993-9#1)(2004-12#1)
society for##8##2##(2006-10#2)(2006-9#2)(2008-11#1)(2009-9#2)(2013-8#1)
society has changed##2##3##(2006-10#1)(2011-2#1)
society has##5##2##(1991-6#1)(2006-10#1)(2006-12#1)(2011-2#1)(2013-1#1)
society held##2##2##(1990-12#1)(2008-5#1)
society in the 18th century]##2##5##(2008-8#2)
society in the##5##3##(2008-11#1)(2008-8#3)(2012-2#1)
society in##11##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#3)(2008-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
society is##9##2##(1990-12#1)(1996-8#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#1)
society may##2##2##(1990-12#1)(2008-1#1)
society of the##2##3##(2007-2#1)(2008-2#1)
society of##27##2##(1992-5#1)(1994-2#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-11#6)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-8#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-8#1)
society or##2##2##(2005-10#1)(2012-2#1)
society places##2##2##(1992-8#1)(2007-3#1)
society that are##2##3##(1990-9#1)(2007-7#1)
society that##6##2##(1990-9#1)(1993-1#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-9#1)
society the##2##2##(2006-12#1)(2011-2#1)
society to##6##2##(1991-3#1)(1992-3#1)(1992-4#1)(2007-7#1)(2008-8#1)(2008-9#1)
society was formed with##2##4##(2005-6#1)(2008-7#1)
society was##5##2##(2005-6#1)(2007-7#1)(2008-7#1)(2010-9#1)(2013-1#1)
society with##3##2##(1991-3#1)(2007-10#1)(2013-1#1)
society##402##1##(1990-12#4)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#3)(1991-3#3)(1991-6#4)(1991-9#1)(1992-10#1)(1992-12#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-1#3)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#3)(1993-6#2)(1993-9#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-10#1)(1995-11#3)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-2#1)(1996-8#2)(1997-2#3)(1997-4#1)(1997-6#2)(2004-10#1)(2004-12#4)(2004-3#1)(2005-10#2)(2005-11#3)(2005-12#1)(2005-6#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#11)(2006-11#8)(2006-12#7)(2006-2#1)(2006-5#2)(2006-7#4)(2006-9#4)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#4)(2007-2#4)(2007-3#3)(2007-4#2)(2007-5#1)(2007-7#7)(2007-8#5)(2007-9#1)(2008-1#13)(2008-10#31)(2008-11#7)(2008-12#8)(2008-2#4)(2008-3#7)(2008-4#2)(2008-5#10)(2008-6#2)(2008-7#17)(2008-8#10)(2008-9#13)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#5)(2009-5#3)(2009-6#1)(2009-7#2)(2009-9#4)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#7)(2011-2#14)(2011-3#2)(2012-1#5)(2012-12#3)(2012-2#13)(2012-3#6)(2013-1#10)(2013-7#4)(2013-8#7)
society's##10##1##(1990-12#1)(1992-1#1)(1993-12#1)(1995-12#1)(2005-7#1)(2006-10#1)(2008-8#2)(2012-2#2)
society]##4##1##(1990-5#1)(1993-3#1)(1996-6#1)(2011-1#1)
socio demographic##2##2##(2009-5#1)(2011-2#1)
socio##3##1##(2009-5#1)(2011-2#1)(2013-1#1)
socio-cognitive dimensions##2##2##(2008-6#2)
socio-cognitive##3##1##(2008-6#3)
socio-cultural and##5##2##(2007-7#1)(2008-11#1)(2008-12#1)(2012-3#2)
socio-cultural factors##5##2##(2007-12#2)(2007-2#1)(2007-7#1)(2012-12#1)
socio-cultural##20##1##(1991-6#1)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2009-4#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#3)
socio-demographic and clinical data##2##4##(2010-8#1)(2012-12#1)
socio-demographic and clinical##3##3##(2008-6#1)(2010-8#1)(2012-12#1)
socio-demographic and##6##2##(2006-2#1)(2006-9#1)(2008-6#1)(2010-8#1)(2012-12#1)(2013-1#1)
socio-demographic characteristics and##4##3##(2007-3#1)(2009-4#1)(2009-7#1)(2011-2#1)
socio-demographic characteristics of the##2##4##(2008-7#1)(2010-12#1)
socio-demographic characteristics of##3##3##(2008-7#1)(2008-8#1)(2010-12#1)
socio-demographic characteristics##10##2##(2007-12#1)(2007-3#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
socio-demographic correlates of##2##3##(2006-8#1)(2009-4#1)
socio-demographic correlates##3##2##(2006-8#1)(2009-4#2)
socio-demographic factors##9##2##(1992-4#1)(2007-6#1)(2008-8#1)(2009-12#1)(2011-2#1)(2013-1#4)
socio-demographic variables##8##2##(2008-9#1)(2009-7#1)(2010-6#1)(2011-1#1)(2012-12#2)(2013-1#2)
socio-demographic##51##1##(1992-4#2)(1994-3#1)(2006-2#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-12#2)(2007-3#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#3)(2009-7#2)(2010-12#1)(2010-6#2)(2010-8#2)(2011-1#3)(2011-2#3)(2012-12#4)(2012-3#2)(2013-1#10)
socio-demographics##4##1##(2011-11#1)(2012-2#2)(2012-3#1)
socio-ecological##3##1##(1997-4#1)(2009-4#1)(2012-12#1)
socio-economic and behavioural factors on##3##5##(2010-6#2)(2012-12#1)
socio-economic and demographic##4##3##(1993-3#1)(2007-7#2)(2013-8#1)
socio-economic and##13##2##(1993-3#1)(2007-6#1)(2007-7#3)(2008-10#1)(2010-6#2)(2011-12#1)(2012-12#2)(2012-2#1)(2013-8#1)
socio-economic background##2##2##(2011-12#1)(2013-1#1)
socio-economic conditions##4##2##(2006-2#1)(2007-7#1)(2010-4#1)(2013-1#1)
socio-economic crisis##2##2##(2012-2#2)
socio-economic development##6##2##(2006-10#1)(2007-12#2)(2010-9#1)(2012-1#1)(2013-7#1)
socio-economic factors##4##2##(2008-12#1)(2009-4#1)(2010-4#1)(2012-12#1)
socio-economic groups##2##2##(2007-7#1)(2011-2#1)
socio-economic impact##2##2##(1990-10#1)(2007-7#1)
socio-economic level##2##2##(2008-1#1)(2009-10#1)
socio-economic situations##2##2##(1996-12#1)(2008-7#1)
socio-economic status of##2##3##(2007-6#1)(2008-1#1)
socio-economic status##21##2##(1991-5#1)(1992-2#1)(1995-6#1)(2006-1#1)(2007-6#2)(2007-7#1)(2008-1#1)(2008-7#1)(2010-11#1)(2010-6#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
socio-economic vulnerabilities including##2##3##(2011-12#2)
socio-economic vulnerabilities##3##2##(2011-12#3)
socio-economic##99##1##(1990-10#1)(1991-11#2)(1991-5#1)(1992-2#2)(1993-3#1)(1995-6#1)(1996-12#1)(2006-1#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-6#4)(2007-7#9)(2008-1#3)(2008-10#1)(2008-12#4)(2008-3#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#2)(2010-11#4)(2010-4#2)(2010-6#4)(2010-9#1)(2011-1#2)(2011-12#6)(2011-2#5)(2012-1#1)(2012-12#8)(2012-2#6)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#1)
socio-economical model##2##2##(1994-1#2)
socio-economical##3##1##(1990-12#1)(1994-1#2)
socio-economically distinct populations##2##3##(2007-12#2)
socio-economically##3##1##(1992-12#1)(2007-12#2)
socio-emotional##3##1##(2008-11#1)(2009-11#1)(2009-9#1)
socio-environmental##4##1##(2008-9#2)(2012-2#1)(2013-8#1)
socio-normative judgments##2##2##(2008-11#2)
socio-normative##4##1##(2008-11#4)
socio-occupational and health insurance##2##4##(2013-1#2)
socio-occupational##3##1##(2013-1#3)
socio-political##6##1##(2008-11#2)(2008-4#1)(2009-7#1)(2012-12#1)(2012-2#1)
socio-professional##5##1##(2008-2#4)(2009-7#1)
socio-spatial##2##1##(2008-11#1)(2011-1#1)
sociobiological##2##1##(2006-7#2)
sociobiology##5##1##(2006-7#1)(2010-4#4)
sociocultural and##2##2##(2009-10#1)(2011-1#1)
sociocultural context##3##2##(2006-4#1)(2007-10#1)(2008-11#1)
sociocultural factors##6##2##(1997-7#1)(2006-9#1)(2007-12#2)(2008-4#1)(2010-12#1)
sociocultural influences##2##2##(2007-12#2)
sociocultural theory##2##2##(2006-7#1)(2007-12#1)
sociocultural##32##1##(1991-8#1)(1997-7#1)(2006-10#1)(2006-4#1)(2006-7#4)(2006-9#1)(2007-10#1)(2007-12#13)(2007-3#1)(2008-11#1)(2008-4#1)(2009-10#1)(2010-12#1)(2011-1#2)(2012-3#1)(2013-1#1)
sociodemographic and clinical characteristics##2##4##(1995-10#1)(2008-3#1)
sociodemographic and clinical##3##3##(1995-10#1)(2008-3#1)(2013-1#1)
sociodemographic and psychosocial##2##3##(2011-2#2)
sociodemographic and##11##2##(1995-10#1)(2005-10#1)(2007-6#1)(2008-3#1)(2009-5#1)(2011-2#4)(2012-12#1)(2013-1#1)
sociodemographic characteristics and##2##3##(1994-1#1)(2011-1#1)
sociodemographic characteristics of##3##3##(2007-2#1)(2011-2#1)(2012-3#1)
sociodemographic characteristics##11##2##(1994-1#1)(2007-2#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#2)
sociodemographic correlates##2##2##(2010-12#1)(2013-8#1)
sociodemographic factors and##2##3##(2006-4#1)(2011-2#1)
sociodemographic factors##9##2##(1997-4#1)(2006-4#1)(2011-2#3)(2012-2#2)(2013-1#2)
sociodemographic patterns##2##2##(2006-2#1)(2011-2#1)
sociodemographic profile##2##2##(2008-3#1)(2013-1#1)
sociodemographic variables##3##2##(2006-10#1)(2012-12#1)(2013-7#1)
sociodemographic##54##1##(1994-1#1)(1995-10#1)(1997-4#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-8#2)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-3#2)(2008-5#1)(2009-11#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-6#1)(2011-1#2)(2011-2#13)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#2)
socioecological##4##1##(2008-2#1)(2008-8#1)(2009-5#2)
socioeconomic and cultural##2##3##(2007-2#1)(2009-5#1)
socioeconomic and demographic factors##3##4##(2012-12#1)(2013-1#2)
socioeconomic and demographic##5##3##(1992-12#1)(2007-2#1)(2012-12#1)(2013-1#2)
socioeconomic and##14##2##(1992-12#1)(1996-3#1)(1997-3#1)(2006-2#1)(2007-2#2)(2008-1#1)(2009-5#2)(2012-12#1)(2013-1#3)(2013-8#1)
socioeconomic background##3##2##(1994-6#1)(2006-7#1)(2007-9#1)
socioeconomic backgrounds##4##2##(2007-9#1)(2009-5#1)(2009-7#1)(2010-8#1)
socioeconomic burden##4##2##(2008-3#1)(2010-10#1)(2012-12#1)(2012-2#1)
socioeconomic change##4##2##(1991-12#1)(2008-12#3)
socioeconomic characteristics##3##2##(2005-10#2)(2007-10#1)
socioeconomic class##3##2##(1996-3#1)(2009-6#1)(2011-2#1)
socioeconomic classes##2##2##(2008-10#1)(2013-7#1)
socioeconomic condition##2##2##(2013-1#2)
socioeconomic conditions##4##2##(1994-6#1)(1997-5#1)(2006-10#1)(2007-7#1)
socioeconomic deprivation##2##2##(2004-10#1)(2012-3#1)
socioeconomic determinants##2##2##(2010-2#1)(2012-3#1)
socioeconomic disparities##2##2##(2006-10#1)(2010-12#1)
socioeconomic factors##7##2##(2005-6#1)(2006-9#1)(2007-11#1)(2007-7#1)(2011-2#1)(2012-12#2)
socioeconomic group##3##2##(1990-2#1)(2007-7#2)
socioeconomic groups##7##2##(1995-1#1)(2005-10#1)(2006-4#1)(2008-1#1)(2008-10#1)(2009-5#1)(2011-1#1)
socioeconomic impact of##3##3##(1996-2#1)(2008-5#1)(2008-6#1)
socioeconomic impact##6##2##(1996-2#1)(2006-10#1)(2007-3#1)(2007-5#1)(2008-5#1)(2008-6#1)
socioeconomic level##4##2##(1997-5#1)(2012-2#2)(2013-8#1)
socioeconomic status (SES)##5##3##(2009-9#1)(2011-1#2)(2012-12#1)(2012-2#1)
socioeconomic status and health##3##4##(2006-10#2)(2010-2#1)
socioeconomic status and##17##3##(1993-3#1)(2004-11#1)(2006-10#3)(2006-7#1)(2007-12#2)(2008-4#1)(2009-11#1)(2010-11#1)(2010-2#2)(2010-3#1)(2011-1#2)(2013-1#1)
socioeconomic status in##2##3##(2006-1#1)(2013-8#1)
socioeconomic status of##3##3##(2006-10#1)(2008-4#1)(2010-8#1)
socioeconomic status##73##2##(1990-2#1)(1991-2#1)(1991-6#1)(1991-8#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-6#2)(2004-11#2)(2006-1#2)(2006-10#5)(2006-7#1)(2006-9#2)(2007-10#1)(2007-12#3)(2007-9#1)(2008-1#2)(2008-4#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#7)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#3)
socioeconomic status)##3##2##(2004-11#1)(2010-1#1)(2012-1#1)
socioeconomic strata##9##2##(2006-10#1)(2006-4#1)(2008-1#1)(2009-12#1)(2010-11#1)(2013-1#4)
socioeconomic##212##1##(1990-2#2)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#2)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-2#2)(1994-6#4)(1995-1#1)(1996-12#1)(1996-2#1)(1996-3#3)(1997-3#1)(1997-5#2)(2004-10#1)(2004-11#3)(2005-10#6)(2005-11#1)(2005-6#1)(2006-1#2)(2006-10#12)(2006-2#1)(2006-4#2)(2006-7#2)(2006-8#1)(2006-9#3)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#5)(2007-9#3)(2008-1#7)(2008-10#2)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-5#6)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#5)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#10)(2012-1#2)(2012-12#7)(2012-2#9)(2012-3#3)(2013-1#18)(2013-7#2)(2013-8#6)
socioeconomical##2##1##(1994-6#1)(2006-10#1)
socioeconomically disadvantaged##3##2##(1992-4#1)(1995-2#1)(2013-8#1)
socioeconomically##5##1##(1992-4#1)(1995-2#1)(2010-12#1)(2013-1#1)(2013-8#1)
socioeconomics##3##1##(2005-10#1)(2007-2#1)(2011-2#1)
socioeducational##2##1##(2008-1#2)
sociological literature##2##2##(2008-10#1)(2009-3#1)
sociological##23##1##(1991-9#1)(1993-3#1)(1994-7#1)(1996-9#1)(2006-7#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#3)(2009-3#1)(2009-7#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
sociologist##2##1##(1991-6#1)(2009-4#1)
sociologists##6##1##(2008-12#6)
sociology and##4##2##(1996-1#1)(2005-12#1)(2008-12#1)(2008-5#1)
sociology of##8##2##(2008-12#2)(2009-4#1)(2012-11#5)
sociology##17##1##(1993-2#1)(1996-1#1)(2005-12#1)(2008-12#4)(2008-2#1)(2008-5#1)(2009-10#1)(2009-4#1)(2010-7#1)(2012-11#5)
sociometric popularity##2##2##(2010-1#2)
sociometric##4##1##(2010-1#2)(2013-1#2)
sociopolitical##4##1##(1993-2#1)(1997-3#1)(2010-7#1)(2011-1#1)
sociosexual behavior##2##2##(1997-5#1)(2009-8#1)
sociosexual experience##6##2##(1997-5#6)
sociosexual##9##1##(1995-5#1)(1997-5#7)(2009-8#1)
sociotechnical systems theory and##2##4##(1993-12#2)
sociotechnical systems##3##2##(1993-12#2)(2010-8#1)
sociotechnical##5##1##(1993-12#2)(2010-8#1)(2013-1#2)
socket alignment##3##2##(2008-6#2)(2013-1#1)
socket septum##2##2##(2005-10#2)
socket##24##1##(2005-10#2)(2007-10#6)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#4)(2008-7#2)(2009-5#1)(2010-11#1)(2013-1#3)(2013-7#1)
sockets##6##1##(2007-10#1)(2007-11#1)(2008-4#1)(2008-7#3)
sockeye salmon##4##2##(2008-5#1)(2010-8#1)(2012-3#2)
sockeye##5##1##(2008-5#2)(2010-8#1)(2012-3#2)
socks##5##1##(2007-4#4)(2013-1#1)
socotrana##2##1##(2008-10#2)
sod-2 was##2##2##(1996-6#2)
sod1Delta##2##1##(1997-6#2)
soda lime##3##2##(2006-10#2)(2008-10#1)
soda##9##1##(2005-11#1)(2006-10#2)(2008-10#6)
soda-lime glass##4##2##(2007-11#1)(2008-3#1)(2010-1#2)
soda-lime##6##1##(2007-11#1)(2008-2#2)(2008-3#1)(2010-1#2)
sodalites##7##1##(2008-10#7)
sodefrin##4##1##(2008-6#4)
sodic tolerance was##2##3##(2012-11#2)
sodic tolerance##3##2##(2012-11#3)
sodic##10##1##(2007-10#3)(2012-11#7)
sodium (Na(+))##4##2##(2008-10#1)(2008-3#1)(2010-7#1)(2012-2#1)
sodium (Na)##3##2##(1995-8#1)(2004-4#1)(2009-4#1)
sodium (Na+)##3##2##(2008-7#1)(2009-6#2)
sodium 1##2##2##(2008-10#2)
sodium L-ascorbate##2##2##(1992-3#2)
sodium acetate and##3##3##(2006-10#1)(2008-10#2)
sodium acetate buffer (pH##3##4##(1990-8#2)(2008-10#1)
sodium acetate buffer##6##3##(1990-8#2)(1996-8#1)(2008-10#3)
sodium acetate concentration##3##3##(1993-12#1)(2006-10#2)
sodium acetate in##2##3##(1996-6#1)(2007-11#1)
sodium acetate solutions at##2##4##(2005-11#1)(2006-10#1)
sodium acetate solutions##4##3##(2005-11#1)(2006-10#3)
sodium acetate was##2##3##(2005-11#1)(2005-12#1)
sodium acetate##36##2##(1990-8#2)(1990-9#1)(1991-7#1)(1993-12#1)(1993-2#1)(1996-6#1)(1996-8#1)(1997-4#1)(2005-11#3)(2005-12#3)(2006-10#9)(2007-11#1)(2008-10#8)(2008-5#1)(2012-2#1)(2013-7#1)
sodium acetate-acetic acid buffer##2##4##(2008-10#2)
sodium acetate-acetic##3##2##(2008-10#2)(2009-10#1)
sodium alginate##15##2##(1992-8#1)(2004-8#1)(2005-11#1)(2008-5#1)(2008-6#1)(2010-12#1)(2010-2#2)(2010-5#4)(2010-9#1)(2011-1#1)(2011-2#1)
sodium aluminosilicate glass##3##3##(1992-1#1)(2007-12#2)
sodium aluminosilicate##4##2##(1992-1#1)(2007-12#3)
sodium and calcium##3##3##(1996-1#1)(2005-8#1)(2010-12#1)
sodium and chloride##2##3##(2006-10#1)(2013-7#1)
sodium and glucose##3##3##(1994-6#3)
sodium and potassium concentrations##2##4##(1995-8#1)(2007-1#1)
sodium and potassium picrates##4##4##(2008-10#4)
sodium and potassium sensing##2##4##(2008-10#2)
sodium and potassium##20##3##(1990-3#1)(1991-3#1)(1995-8#1)(2007-1#2)(2007-10#1)(2008-10#11)(2008-4#1)(2008-5#1)(2012-2#1)
sodium and sulfate##2##3##(2008-10#1)(2008-6#1)
sodium and water retention##3##4##(1997-7#3)
sodium and water##6##3##(1997-7#3)(2008-1#2)(2013-8#1)
sodium and##63##2##(1990-3#1)(1990-5#1)(1990-6#1)(1991-3#1)(1993-2#3)(1994-6#3)(1995-8#1)(1996-1#1)(1996-10#1)(1997-7#3)(2005-8#1)(2006-10#1)(2006-4#1)(2007-1#2)(2007-10#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#17)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-12#1)(2010-2#4)(2010-3#2)(2010-5#1)(2010-8#1)(2012-2#2)(2013-1#1)(2013-7#2)(2013-8#1)
sodium antimony gluconate##2##3##(2007-7#2)
sodium arsenate##2##2##(1997-4#1)(2010-11#1)
sodium arsenite##5##2##(1990-2#1)(1992-4#1)(1994-11#1)(1995-11#1)(2009-10#1)
sodium as a##2##3##(1995-12#1)(2013-1#1)
sodium as##3##2##(1995-12#1)(2010-5#1)(2013-1#1)
sodium ascorbate##6##2##(1991-10#1)(1997-4#3)(2008-11#1)(2009-9#1)
sodium at##3##2##(1996-10#1)(2008-10#2)
sodium atom##5##2##(1996-2#5)
sodium atoms##7##2##(1995-11#1)(1996-2#3)(2007-11#1)(2007-12#2)
sodium azide and##5##3##(1994-3#1)(1996-8#1)(2007-10#1)(2008-12#1)(2008-8#1)
sodium azide##31##2##(1990-1#1)(1990-11#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-6#1)(1993-4#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-8#1)(1996-8#1)(1997-6#1)(1997-7#1)(2005-11#1)(2007-10#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#2)
sodium balance##2##2##(2008-1#2)
sodium benzoate and##2##3##(2008-6#1)(2008-8#1)
sodium benzoate##9##2##(2005-4#2)(2008-10#1)(2008-6#1)(2008-8#3)(2012-2#2)
sodium bicarbonate and##4##3##(2008-10#1)(2010-3#3)
sodium bicarbonate##12##2##(1990-9#1)(1991-1#1)(2006-2#1)(2006-4#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-6#1)(2010-3#4)
sodium bis(2-ethylhexyl)sulfosuccinate##4##2##(1990-5#1)(2005-11#2)(2006-12#1)
sodium bisulfite##2##2##(2007-10#1)(2009-3#1)
sodium borate glasses##2##3##(2007-12#2)
sodium borate##8##2##(1990-3#3)(1992-2#1)(2007-12#2)(2008-10#2)
sodium borohydride and##2##3##(1991-12#1)(2008-10#1)
sodium borohydride flow##2##3##(2008-10#2)
sodium borohydride reduction##3##3##(2008-10#2)(2010-6#1)
sodium borohydride##22##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-12#1)(1995-11#1)(1995-2#1)(1995-8#1)(2008-10#9)(2008-5#2)(2010-4#2)(2010-6#1)(2013-8#1)
sodium bromate in##4##3##(2008-9#4)
sodium bromate##16##2##(2008-10#1)(2008-9#14)(2012-12#1)
sodium bromide##3##2##(1991-5#1)(1994-5#1)(2008-9#1)
sodium butyrate and##2##3##(1992-1#1)(1992-2#1)
sodium butyrate in##2##3##(1990-6#1)(1992-1#1)
sodium butyrate##24##2##(1990-12#1)(1990-6#1)(1992-1#4)(1992-2#2)(1992-3#2)(1993-9#2)(1996-7#1)(1997-7#2)(2008-11#5)(2008-5#1)(2012-3#1)(2013-7#2)
sodium by##2##2##(2008-10#1)(2010-4#1)
sodium cacodylate buffer solutions (pH##2##5##(2007-8#1)(2008-10#1)
sodium can##2##2##(1993-4#1)(2013-1#1)
sodium carbonate##5##2##(1990-11#1)(2008-10#3)(2009-6#1)
sodium carbonate-sodium bicarbonate##4##3##(2005-12#4)
sodium caseinate and whey protein##2##5##(2005-11#2)
sodium caseinate##4##2##(2005-11#4)
sodium caseinates##2##2##(2010-4#2)
sodium channel activity##2##3##(1995-3#1)(2013-1#1)
sodium channel alpha-subunit mRNAs##2##4##(1996-12#2)
sodium channel blockade##3##3##(1995-12#2)(2008-12#1)
sodium channel blocker##4##3##(1990-9#1)(2009-3#1)(2012-3#1)(2013-1#1)
sodium channel blockers##4##3##(1996-5#1)(2008-8#1)(2012-3#2)
sodium channel gene in##2##4##(1992-3#1)(1994-3#1)
sodium channel gene##8##3##(1991-12#1)(1992-3#2)(1994-3#5)
sodium channel in the##2##4##(1995-9#1)(1997-3#1)
sodium channel in##3##3##(1994-9#1)(1995-9#1)(1997-3#1)
sodium channel mRNA##2##3##(1996-12#2)
sodium channel mRNAs##2##3##(1996-12#2)
sodium channel protein##2##3##(1991-12#1)(1995-8#1)
sodium channel##80##2##(1990-9#1)(1991-12#2)(1991-9#1)(1992-3#3)(1992-9#1)(1994-11#1)(1994-12#2)(1994-3#7)(1994-9#9)(1995-12#3)(1995-3#2)(1995-8#2)(1995-9#3)(1996-12#9)(1996-5#2)(1997-3#3)(2006-10#1)(2008-12#3)(2008-5#1)(2008-7#2)(2008-8#5)(2009-10#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#2)(2012-3#4)(2013-1#3)(2013-7#1)
sodium channel-binding##2##2##(1994-9#2)
sodium channels are##3##3##(1995-3#1)(2008-8#1)(2012-3#1)
sodium channels displayed##2##3##(1994-3#2)
sodium channels from##3##3##(1991-9#1)(1994-3#1)(1995-9#1)
sodium channels has##2##3##(1992-11#1)(2006-10#1)
sodium channels have been##2##4##(1991-9#1)(2012-3#1)
sodium channels in##6##3##(1992-2#1)(1994-12#1)(1995-3#2)(1995-8#2)
sodium channels of##2##3##(1992-9#1)(1994-3#1)
sodium channels##37##2##(1991-9#2)(1992-11#1)(1992-2#1)(1992-9#1)(1994-12#1)(1994-3#5)(1995-3#5)(1995-8#2)(1995-9#1)(2005-8#1)(2006-10#4)(2006-12#4)(2008-5#1)(2008-8#5)(2012-3#3)
sodium chloride (NaCl)##8##3##(1990-9#1)(1992-3#1)(2004-4#1)(2005-11#2)(2007-3#2)(2008-5#1)
sodium chloride (pH##2##3##(1992-10#1)(2012-12#1)
sodium chloride aerosol##3##3##(1996-3#2)(2008-2#1)
sodium chloride and##3##3##(1994-8#1)(1997-2#1)(1997-6#1)
sodium chloride at##4##3##(2008-10#2)(2008-2#1)(2008-4#1)
sodium chloride concentration##5##3##(2008-10#4)(2011-2#1)
sodium chloride in##4##3##(1990-8#1)(2008-10#2)(2011-2#1)
sodium chloride is##2##3##(2008-10#1)(2010-4#1)
sodium chloride on##4##3##(1990-8#2)(2005-11#1)(2008-12#1)
sodium chloride solution##3##3##(1997-2#1)(2008-10#1)(2008-3#1)
sodium chloride solutions##2##3##(2005-11#2)
sodium chloride stress##2##3##(2012-2#2)
sodium chloride was##2##3##(2008-10#2)
sodium chloride##84##2##(1990-5#1)(1990-6#1)(1990-8#4)(1990-9#1)(1991-12#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-3#1)(1993-12#3)(1994-5#2)(1994-8#1)(1996-3#3)(1996-7#1)(1997-2#2)(1997-6#1)(2004-4#2)(2005-11#5)(2005-4#1)(2007-3#3)(2007-8#1)(2008-10#21)(2008-12#5)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#3)(2010-4#3)(2011-2#3)(2012-12#1)(2012-2#3)
sodium chloride)##3##2##(2006-10#2)(2008-10#1)
sodium chlorite##6##2##(2008-5#3)(2010-4#3)
sodium cholate (SC)##2##3##(2008-10#2)
sodium cholate##10##2##(1990-2#1)(1991-3#1)(1992-6#1)(1993-11#1)(1994-9#3)(2005-11#1)(2008-10#2)
sodium citrate 40 mg/mL (4%)##3##5##(2010-3#3)
sodium citrate and##4##3##(1997-4#1)(2008-10#1)(2010-3#2)
sodium citrate concentrations##2##3##(2010-3#2)
sodium citrate##24##2##(1990-12#1)(1993-3#1)(1994-9#1)(1997-4#1)(2007-7#1)(2008-10#5)(2010-3#11)(2011-2#2)(2012-2#1)
sodium concentration##11##2##(1990-11#2)(1991-9#1)(1992-11#1)(1994-3#1)(1995-8#1)(1996-12#1)(2008-2#1)(2008-5#1)(2010-1#2)
sodium concentrations##2##2##(1991-9#1)(2012-12#1)
sodium content of processed##2##4##(2013-1#2)
sodium content of##4##3##(2010-4#1)(2013-1#3)
sodium content##8##2##(1994-3#1)(2007-8#1)(2008-10#1)(2010-4#2)(2013-1#3)
sodium current##2##2##(1992-11#1)(2004-11#1)
sodium currents##4##2##(1995-12#1)(1995-8#1)(1996-12#1)(2008-11#1)
sodium cyanide##2##2##(1991-9#1)(2008-5#1)
sodium cyanoborohydride##4##2##(1992-5#2)(1994-8#1)(1995-1#1)
sodium cyclamate##4##2##(2008-10#2)(2011-1#2)
sodium deoxycholate##13##2##(1990-7#1)(1991-2#1)(1992-9#1)(1993-8#1)(1994-12#1)(1997-7#1)(2008-10#3)(2010-12#1)(2011-2#3)
sodium depletion##4##2##(1993-12#3)(1995-9#1)
sodium di-2-ethylhexylsulfosuccinate##2##2##(1992-8#2)
sodium dichloroisocyanurate##2##2##(2008-10#2)
sodium diethyldithiocarbamate##8##2##(2008-10#6)(2009-6#2)
sodium dihydrogen phosphate##3##3##(1996-5#1)(2012-12#1)(2012-3#1)
sodium dihydrogen##4##2##(1996-5#1)(2011-1#1)(2012-12#1)(2012-3#1)
sodium dithionite##3##2##(1993-11#1)(1994-8#1)(1997-7#1)
sodium dodecyl sulfate (SDS) are##2##5##(2004-9#1)(2005-11#1)
sodium dodecyl sulfate (SDS) by##2##5##(2005-11#1)(2008-4#1)
sodium dodecyl sulfate (SDS) in the##2##6##(2005-11#1)(2008-10#1)
sodium dodecyl sulfate (SDS) micellar##2##5##(2008-10#2)
sodium dodecyl sulfate (SDS) micelles##2##5##(1994-11#1)(2008-10#1)
sodium dodecyl sulfate (SDS) or##2##5##(2005-11#1)(2008-10#1)
sodium dodecyl sulfate (SDS)##37##4##(1990-11#1)(1994-11#1)(1994-9#2)(1995-5#1)(1996-5#1)(2004-9#1)(2005-11#8)(2006-8#1)(2007-8#2)(2008-10#14)(2008-2#1)(2008-4#2)(2012-2#1)(2013-1#1)
sodium dodecyl sulfate and##6##4##(1990-7#1)(1992-1#1)(1993-7#1)(1995-5#1)(1996-12#1)(2008-10#1)
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)##4##7##(1991-1#1)(1991-9#1)(2009-4#1)(2012-2#1)
sodium dodecyl sulfate polyacrylamide gel electrophoresis##10##6##(1990-10#1)(1991-1#1)(1991-12#1)(1991-9#1)(2008-10#2)(2008-2#1)(2009-4#1)(2011-12#1)(2012-2#1)
sodium dodecyl sulfate to##3##4##(1991-3#1)(1997-3#1)(2008-10#1)
sodium dodecyl sulfate##88##3##(1990-10#1)(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-7#2)(1991-9#2)(1992-1#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-7#1)(1994-11#1)(1994-9#2)(1995-5#2)(1996-11#1)(1996-12#1)(1996-5#4)(1997-3#1)(1997-6#1)(2004-9#1)(2005-11#11)(2006-8#1)(2007-1#1)(2007-8#2)(2008-1#1)(2008-10#25)(2008-11#1)(2008-2#2)(2008-4#2)(2009-4#1)(2010-11#1)(2011-12#1)(2012-2#2)(2013-1#1)
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)##4##6##(1991-5#1)(1992-11#1)(1992-12#1)(1996-12#1)
sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis##2##6##(1990-8#1)(2008-10#1)
sodium dodecyl sulfate-polyacrylamide gel electrophoresis and##3##6##(1990-11#1)(2008-11#1)(2008-5#1)
sodium dodecyl sulfate-polyacrylamide gel electrophoresis of##5##6##(1994-9#1)(2008-10#4)
sodium dodecyl sulfate-polyacrylamide gel electrophoresis with##2##6##(1990-6#1)(1992-6#1)
sodium dodecyl sulfate-polyacrylamide gel electrophoresis##34##5##(1990-10#2)(1990-11#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-5#2)(1991-8#1)(1992-11#1)(1992-12#2)(1992-6#3)(1993-3#1)(1994-9#2)(1996-12#1)(2006-3#2)(2008-10#11)(2008-11#1)(2008-5#1)
sodium dodecyl sulfate-polyacrylamide##35##3##(1990-10#2)(1990-11#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-5#2)(1991-8#1)(1992-11#1)(1992-12#2)(1992-6#3)(1993-3#1)(1994-9#2)(1996-12#1)(2006-3#2)(2008-10#11)(2008-11#1)(2008-5#1)
sodium dodecyl sulfate-polyacrylamide-gel electrophoresis##3##4##(1990-10#1)(1990-5#1)(1997-4#1)
sodium dodecyl sulphate (SDS) and##4##5##(1994-9#1)(2008-10#2)(2008-5#1)
sodium dodecyl sulphate (SDS)##5##4##(1994-9#1)(2008-10#3)(2008-5#1)
sodium dodecyl sulphate and sodium##2##5##(1992-2#1)(2008-5#1)
sodium dodecyl sulphate polyacrylamide gel electrophoresis##4##6##(1990-6#1)(1990-8#2)(1991-11#1)
sodium dodecyl sulphate polyacrylamide##5##4##(1990-6#1)(1990-8#2)(1991-11#1)(1993-9#1)
sodium dodecyl sulphate##21##3##(1990-6#1)(1990-7#1)(1990-8#2)(1991-11#1)(1992-2#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-9#1)(1995-7#1)(1996-5#1)(2008-10#6)(2008-5#2)
sodium dodecyl sulphate-polyacrylamide gel electrophoresis##7##5##(1991-11#3)(1991-3#1)(1992-2#1)(1994-2#1)(2008-10#1)
sodium dodecyl##163##2##(1990-10#4)(1990-11#3)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#2)(1990-7#3)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#4)(1991-12#3)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#1)(1992-6#4)(1992-7#1)(1992-8#1)(1993-2#1)(1993-3#2)(1993-7#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-9#5)(1995-5#2)(1995-7#1)(1996-11#1)(1996-12#2)(1996-5#6)(1997-3#1)(1997-4#1)(1997-6#1)(2004-9#1)(2005-11#12)(2006-3#2)(2006-8#1)(2007-1#1)(2007-8#2)(2008-1#1)(2008-10#47)(2008-11#3)(2008-2#2)(2008-4#2)(2008-5#3)(2009-4#1)(2010-11#1)(2011-12#1)(2012-2#2)(2013-1#1)
sodium dodecylbenzene##2##2##(2008-10#1)(2008-5#1)
sodium dodecylsulfate (SDS) and##3##4##(2005-8#1)(2008-10#2)
sodium dodecylsulfate (SDS) in##2##4##(2008-10#2)
sodium dodecylsulfate (SDS)##11##3##(2005-11#2)(2005-8#1)(2008-10#7)(2013-8#1)
sodium dodecylsulfate##20##2##(1990-4#1)(1991-12#1)(2005-11#3)(2005-8#2)(2008-10#11)(2008-5#1)(2013-8#1)
sodium dodecylsulphate as##2##3##(2008-10#1)(2010-2#1)
sodium dodecylsulphate##4##2##(1992-9#1)(2008-10#1)(2010-2#2)
sodium efflux##4##2##(1990-11#1)(1992-12#3)
sodium excretion##3##2##(1997-7#1)(2007-8#1)(2011-2#1)
sodium ferric gluconate and iron sucrose have been##2##8##(2005-10#2)
sodium ferric gluconate##3##3##(2005-10#3)
sodium fluorescein##2##2##(1993-4#1)(2005-11#1)
sodium fluoride (NaF)##5##3##(1993-7#1)(2008-10#3)(2013-1#1)
sodium fluoride and##2##3##(2008-10#1)(2012-2#1)
sodium fluoride in##2##3##(1996-2#1)(2008-12#1)
sodium fluoride pollution##2##3##(2008-12#2)
sodium fluoride was##2##3##(1995-12#1)(2008-10#1)
sodium fluoride##41##2##(1990-2#2)(1990-7#1)(1991-11#2)(1992-11#4)(1993-11#3)(1993-7#1)(1995-12#4)(1995-3#1)(1996-2#1)(2004-11#1)(2008-10#6)(2008-11#1)(2008-12#4)(2008-3#1)(2010-3#1)(2011-2#6)(2012-2#1)(2013-1#1)
sodium for##3##2##(1993-11#1)(1997-4#1)(2005-6#1)
sodium formate##5##2##(1991-7#3)(1995-3#1)(2007-9#1)
sodium from##2##2##(1995-6#1)(2013-8#1)
sodium glutamate##2##2##(1995-3#1)(2008-10#1)
sodium has##3##2##(2009-8#2)(2013-1#1)
sodium hexadecane-sulfonate##2##2##(2008-10#2)
sodium hyaluronan##3##2##(2011-2#3)
sodium hyaluronate##3##2##(2006-10#1)(2008-10#1)(2010-11#1)
sodium hydrogen##2##2##(1990-2#1)(2008-10#1)
sodium hydroxide and sodium acetate as##2##6##(2005-12#2)
sodium hydroxide and sodium##3##4##(2005-12#2)(2008-10#1)
sodium hydroxide and##12##3##(2005-12#2)(2007-10#1)(2008-10#7)(2013-1#2)
sodium hydroxide in the##2##4##(2008-10#1)(2008-5#1)
sodium hydroxide in##5##3##(2005-11#1)(2008-10#2)(2008-5#1)(2009-5#1)
sodium hydroxide solution##5##3##(2008-10#5)
sodium hydroxide##48##2##(1991-4#2)(1991-7#1)(1994-9#1)(2005-11#2)(2005-12#3)(2005-7#1)(2007-10#1)(2007-8#1)(2008-10#26)(2008-3#1)(2008-5#2)(2008-6#1)(2009-5#1)(2010-12#1)(2010-2#1)(2013-1#3)
sodium hydroxide)##2##2##(1990-8#1)(1991-11#1)
sodium hypochlorite (NaOCl)##2##3##(2013-1#2)
sodium hypochlorite and##4##3##(1991-2#1)(2007-8#1)(2008-10#2)
sodium hypochlorite solution##5##3##(2008-10#3)(2008-5#2)
sodium hypochlorite##17##2##(1991-2#1)(2006-10#1)(2007-8#1)(2008-10#7)(2008-5#2)(2009-2#1)(2010-12#1)(2013-1#3)
sodium in the##5##3##(1991-1#1)(1997-1#1)(2005-12#1)(2008-10#1)(2008-3#1)
sodium in##20##2##(1991-1#1)(1994-3#1)(1995-4#1)(1997-1#2)(2005-10#2)(2005-12#1)(2007-7#1)(2008-10#10)(2008-3#1)
sodium increased##2##2##(1991-1#1)(2009-12#1)
sodium influx##2##2##(1992-12#2)
sodium intake and##3##3##(2011-1#2)(2013-1#1)
sodium intake in the##3##4##(2011-1#1)(2011-2#1)(2013-1#1)
sodium intake in##4##3##(2011-1#1)(2011-2#1)(2013-1#2)
sodium intake is##4##3##(1997-4#1)(2013-1#3)
sodium intake when injected##2##4##(1997-4#2)
sodium intake##23##2##(1997-4#4)(2006-11#1)(2007-9#5)(2008-7#1)(2011-1#4)(2011-2#1)(2013-1#7)
sodium iodide##5##2##(1996-11#1)(2007-10#1)(2007-8#1)(2008-10#2)
sodium ion concentration##3##3##(1992-7#1)(2006-3#1)(2008-10#1)
sodium ion##14##2##(1990-11#1)(1992-3#2)(1992-7#1)(1993-3#1)(2006-12#1)(2006-3#1)(2008-10#7)
sodium ionophore##2##2##(2005-8#1)(2008-10#1)
sodium ions are##2##3##(1991-8#1)(1992-3#1)
sodium ions##12##2##(1990-3#2)(1991-8#3)(1992-3#3)(2006-2#1)(2008-10#3)
sodium is##3##2##(1992-4#1)(1994-6#1)(2008-10#1)
sodium lactate and##2##3##(2007-3#1)(2009-2#1)
sodium lactate##7##2##(1996-2#1)(2007-3#2)(2008-4#2)(2009-2#1)(2013-8#1)
sodium lauryl ether sulfate##2##4##(2008-10#1)(2008-5#1)
sodium lauryl ether sulphate##3##4##(2008-5#3)
sodium lauryl ether##5##3##(2008-10#1)(2008-5#4)
sodium lauryl sulfate##2##3##(1996-5#1)(2008-10#1)
sodium lauryl sulphate##3##3##(2008-5#2)(2010-3#1)
sodium lauryl##11##2##(1996-5#2)(2008-10#2)(2008-5#6)(2010-3#1)
sodium level##3##2##(2007-11#1)(2010-6#1)(2013-8#1)
sodium levels##2##2##(2006-4#1)(2009-10#1)
sodium metabisulfite##3##2##(2008-10#3)
sodium metaperiodate##2##2##(2008-10#2)
sodium metasilicate##4##2##(2008-10#1)(2010-4#3)
sodium methoxide in##2##3##(1996-8#1)(2005-8#1)
sodium methoxide##3##2##(1996-8#1)(2005-8#1)(2009-10#1)
sodium molybdate##5##2##(1990-2#1)(1993-8#1)(2008-10#3)
sodium motive##2##2##(2006-8#2)
sodium myristate##2##2##(2005-11#2)
sodium n-vanadate##3##2##(2008-8#3)
sodium nitrate in##2##3##(2008-10#2)
sodium nitrate##7##2##(2008-10#6)(2008-2#1)
sodium nitrilotriacetate##2##2##(2008-10#2)
sodium nitrite in##2##3##(1991-10#1)(2008-10#1)
sodium nitrite##9##2##(1990-5#2)(1991-10#4)(1991-7#1)(2008-10#2)
sodium nitroprusside (SNP)##11##3##(1994-2#1)(1995-11#1)(1995-5#1)(1997-6#2)(2007-1#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-4#1)
sodium nitroprusside was not different##2##5##(2004-12#1)(2012-3#1)
sodium nitroprusside##32##2##(1990-12#1)(1991-9#1)(1993-3#1)(1993-9#1)(1994-2#2)(1995-11#1)(1995-5#1)(1995-8#3)(1996-1#1)(1997-6#3)(2004-12#1)(2007-1#1)(2007-11#1)(2007-8#1)(2007-9#3)(2008-10#3)(2008-11#3)(2008-4#1)(2012-3#1)(2013-7#2)
sodium or potassium##2##3##(2008-10#2)
sodium or##4##2##(1990-5#1)(1993-8#1)(2008-10#2)
sodium orthovanadate##6##2##(1994-11#1)(1994-9#1)(1995-1#1)(1995-5#1)(1997-7#1)(2008-10#1)
sodium oxalate##3##2##(2008-10#3)
sodium oxybate##2##2##(2008-8#2)
sodium pentanesulphonate##3##2##(2008-10#3)
sodium pentobarbital##2##2##(2008-4#2)
sodium percarbonate##3##2##(2007-11#1)(2008-10#2)
sodium perchlorate solutions##2##3##(2008-10#2)
sodium perchlorate##7##2##(1994-8#1)(1996-8#1)(2008-10#5)
sodium periodate##5##2##(1992-3#1)(1996-12#1)(2006-8#1)(2007-11#1)(2007-7#1)
sodium phenolate complexes##3##3##(1996-2#3)
sodium phosphate buffer (pH##4##4##(1992-1#1)(1995-6#1)(2008-10#1)(2010-4#1)
sodium phosphate buffer##8##3##(1992-1#1)(1995-6#1)(2004-9#1)(2008-10#3)(2010-2#1)(2010-4#1)
sodium phosphate##24##2##(1990-4#1)(1991-1#1)(1992-1#1)(1992-3#1)(1993-3#1)(1995-6#1)(1996-2#1)(1997-2#1)(2004-9#1)(2008-10#6)(2008-5#1)(2009-8#1)(2010-2#3)(2010-4#1)(2011-2#3)
sodium piperacillin##2##2##(1990-2#2)
sodium polyacrylate##3##2##(2005-11#2)(2008-10#1)
sodium polypectate##2##2##(2008-10#2)
sodium polystyrenesulfonate (NaPSS)##2##3##(2008-10#2)
sodium potassium##3##2##(1995-8#1)(2007-8#1)(2008-10#1)
sodium pump activity in##2##4##(2008-4#2)
sodium pump rate constant##3##4##(1991-1#3)
sodium pump##14##2##(1990-11#1)(1991-1#3)(1992-11#3)(1996-1#2)(2008-4#2)(2008-7#1)(2008-9#1)(2010-1#1)
sodium pumps##4##2##(1990-8#1)(1992-11#1)(2008-11#1)(2008-5#1)
sodium pyruvate##3##2##(1991-8#3)
sodium reabsorption##3##2##(1992-2#1)(1992-7#1)(2012-12#1)
sodium reduction##4##2##(2011-1#1)(2013-1#3)
sodium retention##7##2##(1994-2#1)(1995-5#1)(1997-7#1)(2006-10#3)(2008-7#1)
sodium saccharin##4##2##(1992-11#1)(1995-11#1)(2011-1#2)
sodium salicylate##4##2##(1991-3#1)(1997-3#1)(2008-10#2)
sodium salt glycosylation of##2##4##(1997-2#2)
sodium salt##25##2##(1990-6#1)(1993-4#1)(1993-8#2)(1995-11#2)(1995-3#1)(1996-11#1)(1997-2#3)(2007-10#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#2)(2010-3#1)(2012-11#1)(2013-1#3)
sodium salts of##2##3##(2008-10#1)(2008-11#1)
sodium salts##8##2##(1994-5#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-5#2)(2012-7#1)
sodium selenate##2##2##(2008-6#1)(2008-7#1)
sodium selenite and##3##3##(1992-8#1)(1995-11#1)(2008-10#1)
sodium selenite##13##2##(1992-4#1)(1992-8#1)(1995-1#1)(1995-11#1)(1996-2#1)(2007-7#1)(2008-10#2)(2008-7#1)(2010-11#1)(2011-1#3)
sodium signal##2##2##(1994-3#2)
sodium silicate##2##2##(2010-2#2)
sodium starch glycolate##2##3##(2010-3#2)
sodium stibogluconate##3##2##(2005-8#1)(2005-9#1)(2007-7#1)
sodium sulfacetamide 10%-sulfur 5% emollient foam##3##6##(2010-8#3)
sodium sulfacetamide 10%-sulfur 5%##4##4##(2010-8#4)
sodium sulfide in##2##3##(2008-10#1)(2013-1#1)
sodium sulfide or sodium##2##4##(1997-6#1)(2008-5#1)
sodium sulfide##7##2##(1997-6#1)(2008-10#3)(2008-5#2)(2013-1#1)
sodium sulfite as##2##3##(2008-10#2)
sodium sulfite##7##2##(2008-10#7)
sodium sulphate##8##2##(1990-8#1)(2005-11#1)(2007-3#1)(2008-10#5)
sodium tartrate##4##2##(2008-10#4)
sodium taurocholate##2##2##(1993-9#1)(2005-11#1)
sodium tetrahydroborate solution##2##3##(2007-12#1)(2008-10#1)
sodium tetrahydroborate##11##2##(1992-2#1)(2007-12#1)(2008-10#9)
sodium tetrahydroborate(III)##2##2##(2008-10#2)
sodium tetrakis (4-fluorophenyl) borate##2##4##(2008-10#2)
sodium tetraphenyl borate (NaTPB) as##2##5##(2008-10#2)
sodium tetraphenyl borate##4##3##(2008-10#4)
sodium tetraphenylborate (NaTPB) as##4##4##(2008-10#4)
sodium tetraphenylborate (NaTPB)##5##3##(2008-10#5)
sodium tetraphenylborate##10##2##(2008-10#10)
sodium thiocyanate in##2##3##(2008-10#2)
sodium thiocyanate##3##2##(2008-10#3)
sodium thiomalate##5##2##(1994-5#2)(1995-3#2)(2008-5#1)
sodium thiosulfate alone##3##3##(1990-4#3)
sodium thiosulfate##9##2##(1990-4#6)(1997-6#1)(2007-8#1)(2008-10#1)
sodium to##3##2##(1990-7#1)(2007-12#1)(2008-10#1)
sodium transport in##3##3##(1992-2#2)(2008-7#1)
sodium transport##7##2##(1992-12#1)(1992-2#2)(1992-6#1)(1994-6#1)(1995-8#1)(2008-7#1)
sodium tripolyphosphate##2##2##(1997-4#1)(2008-10#1)
sodium valproate (VPA)##3##3##(1991-3#1)(1995-7#1)(2007-11#1)
sodium valproate overdose##3##3##(2006-4#3)
sodium valproate##15##2##(1991-3#1)(1995-12#4)(1995-7#1)(2006-4#6)(2007-11#1)(2008-3#1)(2008-6#1)
sodium vanadate##2##2##(1990-7#1)(1995-2#1)
sodium was##5##2##(1991-1#1)(2004-10#1)(2008-10#2)(2012-12#1)
sodium were##2##2##(1992-7#1)(2007-6#1)
sodium with##2##2##(1997-5#1)(2008-1#1)
sodium##1759##1##(1990-1#1)(1990-10#5)(1990-11#13)(1990-12#5)(1990-2#11)(1990-3#11)(1990-4#8)(1990-5#8)(1990-6#6)(1990-7#12)(1990-8#16)(1990-9#8)(1991-1#16)(1991-10#5)(1991-11#8)(1991-12#11)(1991-2#4)(1991-3#7)(1991-4#4)(1991-5#4)(1991-6#1)(1991-7#9)(1991-8#9)(1991-9#10)(1992-1#8)(1992-10#1)(1992-11#18)(1992-12#9)(1992-2#13)(1992-3#16)(1992-4#4)(1992-5#2)(1992-6#7)(1992-7#4)(1992-8#9)(1992-9#5)(1993-11#7)(1993-12#9)(1993-2#6)(1993-3#6)(1993-4#8)(1993-7#2)(1993-8#6)(1993-9#7)(1994-11#4)(1994-12#5)(1994-2#4)(1994-3#22)(1994-5#8)(1994-6#6)(1994-8#5)(1994-9#26)(1995-1#3)(1995-10#2)(1995-11#9)(1995-12#14)(1995-2#3)(1995-3#13)(1995-4#1)(1995-5#5)(1995-6#3)(1995-7#3)(1995-8#15)(1995-9#7)(1996-1#4)(1996-10#2)(1996-11#3)(1996-12#15)(1996-2#16)(1996-3#3)(1996-5#12)(1996-6#1)(1996-7#4)(1996-8#4)(1996-9#2)(1997-1#6)(1997-2#9)(1997-3#5)(1997-4#15)(1997-5#1)(1997-6#9)(1997-7#11)(2004-10#2)(2004-11#2)(2004-12#4)(2004-4#3)(2004-8#1)(2004-9#2)(2005-10#5)(2005-11#49)(2005-12#11)(2005-4#3)(2005-6#1)(2005-7#1)(2005-8#9)(2005-9#1)(2006-1#1)(2006-10#23)(2006-11#1)(2006-12#6)(2006-2#2)(2006-3#4)(2006-4#9)(2006-5#1)(2006-8#6)(2007-1#4)(2007-10#9)(2007-11#13)(2007-12#13)(2007-2#1)(2007-3#6)(2007-5#1)(2007-6#2)(2007-7#11)(2007-8#15)(2007-9#11)(2008-1#12)(2008-10#424)(2008-11#22)(2008-12#17)(2008-2#7)(2008-3#17)(2008-4#17)(2008-5#55)(2008-6#7)(2008-7#10)(2008-8#20)(2008-9#21)(2009-10#5)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#7)(2009-7#1)(2009-8#8)(2009-9#2)(2010-1#3)(2010-11#5)(2010-12#7)(2010-2#16)(2010-3#22)(2010-4#21)(2010-5#7)(2010-6#2)(2010-7#1)(2010-8#10)(2010-9#1)(2011-1#18)(2011-12#1)(2011-2#28)(2011-3#2)(2012-11#1)(2012-12#10)(2012-2#18)(2012-3#10)(2012-7#1)(2013-1#38)(2013-7#10)(2013-8#11)
sodium)##10##1##(1990-9#1)(1991-3#1)(1996-5#1)(2007-11#1)(2008-10#3)(2008-5#1)(2010-7#1)(2013-1#1)
sodium-##3##1##(1990-8#1)(2006-8#1)(2008-10#1)
sodium-binding benzofuran##2##2##(1992-7#1)(1994-8#1)
sodium-dependent and##3##2##(1991-3#1)(1992-3#2)
sodium-dependent high-affinity choline##2##3##(1993-9#1)(1994-3#1)
sodium-dependent phosphate##4##2##(1991-9#1)(1994-3#2)(2008-4#1)
sodium-dependent transport##2##2##(1994-9#1)(1995-11#1)
sodium-dependent##28##1##(1990-3#2)(1990-4#1)(1991-3#3)(1991-8#1)(1991-9#2)(1992-3#2)(1993-3#1)(1993-9#1)(1994-3#7)(1994-8#1)(1994-9#1)(1995-11#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-9#1)
sodium-depleted rats##3##2##(1994-10#1)(1997-4#2)
sodium-depleted##4##1##(1991-5#1)(1994-10#1)(1997-4#2)
sodium-free##2##1##(1990-3#1)(1992-3#1)
sodium-independent##4##1##(1992-8#1)(1994-12#1)(1994-3#1)(2005-12#1)
sodium-lithium counter-transport activity##5##3##(1992-6#5)
sodium-selective electrodes##3##2##(2008-10#3)
sodium-selective ionophore##2##2##(1992-8#1)(2008-10#1)
sodium-selective##5##1##(1992-8#1)(2008-10#4)
sodium/low potassium diet##2##3##(2008-7#2)
sodiumindependent##2##1##(2008-11#2)
soft X-ray##9##2##(2006-4#4)(2006-5#1)(2007-12#1)(2008-7#1)(2012-1#1)(2012-2#1)
soft agar and##4##3##(1992-11#1)(1992-2#1)(2008-11#1)(2008-8#1)
soft agar##16##2##(1990-5#1)(1991-12#2)(1991-5#1)(1991-8#1)(1992-11#2)(1992-2#1)(1995-2#1)(1997-1#2)(2008-11#3)(2008-8#2)
soft agarose##4##2##(1991-2#1)(1994-5#1)(1995-5#2)
soft and hard tissue##2##4##(2007-12#2)
soft and hard tissues##3##4##(1990-10#1)(2008-5#2)
soft and hard##8##3##(1990-10#1)(2006-5#1)(2007-12#2)(2008-5#2)(2008-7#1)(2011-2#1)
soft and two##2##3##(2006-7#1)(2012-1#1)
soft and##17##2##(1990-10#1)(1991-2#2)(2006-5#1)(2006-7#1)(2007-12#2)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
soft biological##3##2##(2006-6#1)(2008-2#1)(2012-2#1)
soft bottoms from##2##3##(2008-5#2)
soft bottoms##4##2##(2007-5#1)(2008-5#3)
soft cervical##2##2##(2008-12#1)(2009-5#1)
soft contact and adhesion##2##4##(2011-1#2)
soft contact lens wear##2##4##(2005-11#1)(2008-4#1)
soft contact lens wearers##2##4##(2005-11#1)(2008-4#1)
soft contact lens##5##3##(2005-11#3)(2008-4#2)
soft contact lenses##5##3##(1993-11#1)(2005-11#3)(2012-12#1)
soft contact##12##2##(1993-11#1)(2005-11#6)(2008-4#2)(2011-1#2)(2012-12#1)
soft dough stage##2##3##(2008-10#2)
soft dough##3##2##(2008-10#3)
soft drink powders##2##3##(2008-10#2)
soft drink sample##2##3##(2008-10#2)
soft drink samples##2##3##(2008-10#2)
soft drink##9##2##(2008-10#9)
soft drinks##15##2##(2008-10#15)
soft gel##6##2##(1991-5#1)(1995-2#1)(1996-8#1)(1997-2#1)(2008-5#1)(2010-3#1)
soft hydrated tissues##2##3##(2008-7#2)
soft ice cream##3##3##(2011-2#3)
soft independent modeling of class analogy (SIMCA)##2##7##(2008-10#1)(2013-8#1)
soft independent modeling of class##3##5##(2008-10#2)(2013-8#1)
soft independent modelling of class analogy (SIMCA)##2##7##(2008-10#2)
soft independent modelling of class analogy##4##6##(2008-10#4)
soft independent##7##2##(2008-10#6)(2013-8#1)
soft ionization##4##2##(2008-10#1)(2010-7#1)(2013-7#2)
soft law&quot##3##2##(2006-3#3)
soft lithography and##3##3##(2007-5#1)(2008-11#1)(2008-7#1)
soft lithography##8##2##(2007-5#1)(2007-9#1)(2008-11#2)(2008-3#1)(2008-7#2)(2010-9#1)
soft materials##2##2##(2009-7#2)
soft matter cell model##2##4##(2011-1#2)
soft matter model##2##3##(2011-1#2)
soft matter##5##2##(1995-10#1)(2011-1#4)
soft metal##2##2##(2007-9#1)(2008-10#1)
soft modeling##2##2##(2008-10#2)
soft or##2##2##(2007-4#1)(2009-2#1)
soft palate is##2##3##(1991-2#1)(1991-3#1)
soft palate##15##2##(1990-6#1)(1991-2#1)(1991-3#1)(1996-3#1)(2006-6#1)(2008-3#1)(2009-8#2)(2010-5#2)(2011-2#1)(2012-12#4)
soft part sarcoma of the##2##5##(1990-2#1)(2013-7#1)
soft part sarcoma##4##3##(1990-2#2)(2013-7#2)
soft particle##2##2##(2005-11#2)
soft particles##2##2##(2005-11#2)
soft polymer matrix##2##3##(2005-11#2)
soft red winter wheat##3##4##(2008-10#1)(2008-5#2)
soft rot##5##2##(2008-10#5)
soft sediment##3##2##(2006-6#3)
soft sensors##2##2##(2013-1#2)
soft spherical##2##2##(2008-3#2)
soft tick strains##2##3##(2008-12#2)
soft tissue and bone##5##4##(2008-11#1)(2010-6#1)(2013-1#2)(2013-8#1)
soft tissue and bony##2##4##(2005-10#1)(2013-8#1)
soft tissue and muscles##2##4##(2013-1#2)
soft tissue and patellar tendon##2##5##(2008-1#2)
soft tissue and##22##3##(2005-10#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-8#2)(2008-1#2)(2008-11#1)(2008-12#2)(2008-6#1)(2009-10#1)(2010-6#1)(2011-12#1)(2012-2#1)(2013-1#4)(2013-8#2)
soft tissue as##2##3##(2007-7#1)(2009-7#1)
soft tissue augmentation##5##3##(2005-11#2)(2006-12#1)(2007-7#1)(2010-11#1)
soft tissue balance##3##3##(2007-5#2)(2007-7#1)
soft tissue by##4##3##(2008-10#2)(2009-4#1)(2012-2#1)
soft tissue contrast and##2##4##(2008-8#1)(2009-10#1)
soft tissue contrast##6##3##(2007-4#1)(2007-6#1)(2008-1#1)(2008-8#1)(2009-10#1)(2010-12#1)
soft tissue cover##3##3##(2008-12#2)(2008-9#1)
soft tissue coverage##6##3##(2008-2#3)(2008-6#1)(2013-8#2)
soft tissue damage##3##3##(1992-2#1)(2007-11#1)(2010-3#1)
soft tissue defect was reconstructed##2##5##(2008-1#1)(2011-2#1)
soft tissue defect##9##3##(2008-1#2)(2008-12#1)(2008-9#2)(2010-9#2)(2011-2#1)(2012-12#1)
soft tissue defects of the##2##5##(2008-3#1)(2011-2#1)
soft tissue defects of##3##4##(2006-3#1)(2008-3#1)(2011-2#1)
soft tissue defects##8##3##(2006-3#1)(2007-8#1)(2008-3#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-12#2)
soft tissue density##2##3##(2006-4#2)
soft tissue dissection##2##3##(2011-2#1)(2012-2#1)
soft tissue envelope##2##3##(2008-8#2)
soft tissue grafts##3##3##(1996-8#1)(2013-1#2)
soft tissue healing##3##3##(2009-8#2)(2011-12#1)
soft tissue health##2##3##(2008-4#1)(2013-1#1)
soft tissue imaging##2##3##(2008-10#1)(2008-7#1)
soft tissue in the##3##4##(2008-2#1)(2008-3#1)(2008-6#1)
soft tissue in##4##3##(2008-2#1)(2008-3#1)(2008-6#1)(2009-4#1)
soft tissue infection in##2##4##(2006-10#1)(2011-2#1)
soft tissue infection##11##3##(2005-8#1)(2006-10#1)(2006-4#2)(2007-7#1)(2008-9#1)(2011-2#3)(2012-12#2)
soft tissue infections and##2##4##(2005-7#1)(2008-10#1)
soft tissue infections##24##3##(1995-5#1)(2005-7#2)(2006-10#2)(2006-4#2)(2007-12#2)(2008-10#2)(2008-3#2)(2009-3#2)(2009-4#3)(2010-11#1)(2010-12#1)(2013-1#4)
soft tissue inflammation of##2##4##(2008-12#2)
soft tissue injuries##4##3##(1990-12#1)(1994-2#1)(2007-4#1)(2009-5#1)
soft tissue injury##4##3##(2006-11#1)(2007-8#1)(2009-3#1)(2010-3#1)
soft tissue is##2##3##(2006-6#1)(2008-11#1)
soft tissue lesions of the##3##5##(2007-11#1)(2012-2#2)
soft tissue lesions##8##3##(1995-3#1)(2007-11#1)(2008-6#1)(2011-12#1)(2012-2#3)(2013-1#1)
soft tissue limb sarcoma##3##4##(2006-6#3)
soft tissue management##2##3##(2007-12#1)(2011-12#1)
soft tissue mass##9##3##(1993-10#1)(2008-12#1)(2009-3#1)(2009-9#1)(2011-1#2)(2012-12#2)(2013-8#1)
soft tissue masses##2##3##(2007-12#1)(2013-1#1)
soft tissue necrosis##2##3##(2008-6#2)
soft tissue neoplasms##2##3##(2012-2#1)(2013-7#1)
soft tissue or bone##2##4##(2009-9#1)(2013-8#1)
soft tissue or##3##3##(2009-3#1)(2009-9#1)(2013-8#1)
soft tissue reconstruction##3##3##(2010-11#1)(2012-2#1)(2012-8#1)
soft tissue release##3##3##(2007-7#1)(2010-7#1)(2013-1#1)
soft tissue repair##2##3##(2008-8#1)(2010-11#1)
soft tissue sarcoma (STS)##9##4##(2008-6#9)
soft tissue sarcoma and##3##4##(2008-6#2)(2009-3#1)
soft tissue sarcoma in##3##4##(2008-6#2)(2008-7#1)
soft tissue sarcoma of the extremities##3##6##(2008-6#3)
soft tissue sarcoma of the##8##5##(1992-12#1)(2008-6#7)
soft tissue sarcoma of##10##4##(1992-12#1)(2008-6#8)(2012-12#1)
soft tissue sarcoma specimens##2##4##(2008-6#2)
soft tissue sarcoma##59##3##(1990-10#2)(1992-12#1)(1994-7#1)(1995-4#1)(2006-6#1)(2007-2#1)(2008-6#45)(2008-7#1)(2009-3#1)(2010-3#1)(2012-12#4)
soft tissue sarcomas and##2##4##(2008-6#2)
soft tissue sarcomas are##3##4##(2008-6#3)
soft tissue sarcomas in adults##2##5##(1992-12#1)(2008-6#1)
soft tissue sarcomas in##3##4##(1992-12#1)(2008-6#2)
soft tissue sarcomas is##3##4##(1992-12#1)(2006-6#1)(2008-6#1)
soft tissue sarcomas of the##3##5##(1993-9#1)(2007-4#1)(2013-7#1)
soft tissue sarcomas##54##3##(1992-12#3)(1993-9#1)(2006-6#3)(2007-2#1)(2007-4#1)(2008-6#41)(2009-3#1)(2011-2#1)(2012-12#1)(2013-7#1)
soft tissue swelling##2##3##(2008-5#1)(2013-1#1)
soft tissue trauma##2##3##(2007-8#1)(2009-4#1)
soft tissue treatment##2##3##(2009-6#1)(2013-8#1)
soft tissue tumor##4##3##(1991-10#1)(2006-10#1)(2010-11#1)(2012-2#1)
soft tissue tumors in##2##4##(1994-10#1)(2011-2#1)
soft tissue tumors##6##3##(1994-10#1)(1994-6#1)(2007-8#1)(2011-2#2)(2012-12#1)
soft tissue tumour##3##3##(2008-6#2)(2013-7#1)
soft tissue tumours##10##3##(2007-10#1)(2008-6#5)(2008-7#1)(2012-2#3)
soft tissue using##3##3##(2006-6#1)(2010-3#1)(2012-2#1)
soft tissue##465##2##(1990-10#3)(1990-12#1)(1990-6#1)(1991-10#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-12#4)(1992-2#3)(1993-10#2)(1993-9#1)(1994-10#1)(1994-2#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-11#1)(1996-5#4)(1996-8#1)(1997-4#1)(1997-6#1)(2004-3#1)(2004-9#3)(2005-10#1)(2005-11#2)(2005-7#2)(2005-8#1)(2006-10#11)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#6)(2006-6#10)(2006-9#1)(2007-10#1)(2007-11#7)(2007-12#9)(2007-2#3)(2007-4#4)(2007-5#3)(2007-6#1)(2007-7#6)(2007-8#10)(2008-1#5)(2008-10#7)(2008-11#2)(2008-12#15)(2008-2#6)(2008-3#4)(2008-4#7)(2008-5#3)(2008-6#102)(2008-7#8)(2008-8#7)(2008-9#9)(2009-10#3)(2009-3#13)(2009-4#10)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#3)(2010-11#7)(2010-12#5)(2010-2#2)(2010-3#4)(2010-4#1)(2010-6#5)(2010-7#1)(2010-9#3)(2011-1#4)(2011-12#7)(2011-2#11)(2012-11#4)(2012-12#19)(2012-2#20)(2012-8#1)(2013-1#23)(2013-7#7)(2013-8#9)
soft tissues and##8##3##(2007-4#1)(2008-6#1)(2008-8#1)(2009-4#1)(2012-2#2)(2013-1#2)
soft tissues for##2##3##(2007-5#1)(2008-9#1)
soft tissues in the##4##4##(2008-2#1)(2008-6#1)(2011-2#1)(2012-2#1)
soft tissues in##10##3##(1994-10#1)(2007-11#1)(2007-5#1)(2008-12#1)(2008-2#1)(2008-6#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
soft tissues of the##11##4##(1992-10#1)(2007-11#1)(2007-7#1)(2008-12#2)(2008-5#1)(2009-5#1)(2010-6#1)(2010-9#1)(2012-12#1)(2013-7#1)
soft tissues of##12##3##(1992-10#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-12#2)(2008-5#1)(2009-5#1)(2010-6#1)(2010-9#1)(2012-12#1)(2013-7#1)
soft tissues on##2##3##(2007-1#1)(2009-6#1)
soft tissues when##2##3##(2007-6#1)(2013-1#1)
soft tissues##83##2##(1990-10#1)(1992-10#1)(1994-10#1)(1995-3#1)(2004-9#1)(2006-10#2)(2006-8#1)(2007-1#2)(2007-11#5)(2007-12#3)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#1)(2008-10#1)(2008-12#5)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#4)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#4)(2013-1#6)(2013-7#2)
soft tube##2##2##(2007-8#2)
soft water##2##2##(2006-2#1)(2008-10#1)
soft x rays##3##3##(2007-12#2)(2008-2#1)
soft x##4##2##(2007-12#2)(2008-2#2)
soft x-ray laser##2##3##(1990-3#2)
soft x-ray##5##2##(1990-3#4)(2008-2#1)
soft x-rays##2##2##(2007-12#2)
soft##863##1##(1990-10#5)(1990-12#1)(1990-2#2)(1990-3#4)(1990-5#1)(1990-6#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#7)(1991-3#1)(1991-5#2)(1991-8#2)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#4)(1992-2#5)(1993-1#1)(1993-10#2)(1993-11#2)(1993-5#1)(1993-9#1)(1994-10#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-10#1)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#4)(1996-11#1)(1996-3#1)(1996-5#4)(1996-8#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2004-3#2)(2004-4#1)(2004-9#5)(2005-10#1)(2005-11#16)(2005-7#2)(2005-8#1)(2006-10#14)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#5)(2006-4#10)(2006-5#2)(2006-6#15)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#13)(2007-12#26)(2007-2#6)(2007-3#1)(2007-4#11)(2007-5#8)(2007-6#3)(2007-7#8)(2007-8#14)(2007-9#4)(2008-1#6)(2008-10#61)(2008-11#8)(2008-12#25)(2008-2#19)(2008-3#17)(2008-4#11)(2008-5#14)(2008-6#107)(2008-7#19)(2008-8#10)(2008-9#17)(2009-10#3)(2009-11#4)(2009-2#1)(2009-3#15)(2009-4#13)(2009-5#3)(2009-6#4)(2009-7#4)(2009-8#4)(2009-9#7)(2010-11#8)(2010-12#7)(2010-2#4)(2010-3#9)(2010-4#5)(2010-5#4)(2010-6#7)(2010-7#2)(2010-8#2)(2010-9#6)(2011-1#16)(2011-12#8)(2011-2#19)(2012-1#4)(2012-11#4)(2012-12#32)(2012-2#29)(2012-3#1)(2012-8#1)(2013-1#35)(2013-7#15)(2013-8#12)
soft&quot##4##1##(1990-4#1)(1991-3#1)(2008-4#1)(2009-5#1)
soft-agar culture##5##2##(1991-5#3)(1992-9#2)
soft-agar##6##1##(1991-5#3)(1992-9#2)(1995-2#1)
soft-tissue coverage##3##2##(2008-4#1)(2008-9#2)
soft-tissue defects##5##2##(2006-3#1)(2007-8#1)(2008-9#1)(2009-9#2)
soft-tissue infections##3##2##(1992-6#1)(2006-8#1)(2008-3#1)
soft-tissue injuries##2##2##(2007-4#1)(2009-3#1)
soft-tissue loss##2##2##(2006-3#1)(2008-9#1)
soft-tissue osteoma##2##2##(2012-12#2)
soft-tissue reconstruction##3##2##(2008-9#1)(2010-12#1)(2010-3#1)
soft-tissue sarcoma who##2##3##(1991-8#1)(2008-6#1)
soft-tissue sarcoma##11##2##(1991-8#1)(2008-6#8)(2008-7#1)(2009-3#1)
soft-tissue sarcomas##6##2##(2008-6#3)(2009-3#2)(2011-2#1)
soft-tissue thickening##2##2##(2011-2#1)(2013-7#1)
soft-tissue tumors##2##2##(2007-8#1)(2012-2#1)
soft-tissue tumours##3##2##(2008-6#2)(2012-2#1)
soft-tissue##70##1##(1991-8#1)(1992-2#1)(1992-6#1)(1994-6#1)(1996-5#1)(2006-3#3)(2006-8#3)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#14)(2008-7#4)(2008-9#6)(2009-3#6)(2009-9#3)(2010-12#1)(2010-3#2)(2011-2#2)(2012-11#3)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#1)
soft-ware##2##1##(2007-7#2)
soft-water acclimation##3##2##(2008-10#3)
soft-water##5##1##(2008-10#4)(2009-8#1)
soft-water-acclimated fish had##2##3##(2008-10#2)
soft-x-ray laser##5##2##(2007-12#5)
soft-x-ray lasers##2##2##(2007-12#1)(2008-3#1)
soft-x-ray performance##2##2##(2007-11#2)
soft-x-ray reflectivity measurements##2##3##(2008-2#2)
soft-x-ray synchrotron radiation##2##3##(2008-2#1)(2008-3#1)
soft-x-ray##39##1##(1991-12#1)(2007-11#3)(2007-12#11)(2008-2#15)(2008-3#9)
softened##5##1##(2005-11#2)(2006-2#1)(2007-3#1)(2008-9#1)
softeners##3##1##(2006-12#1)(2008-7#1)(2011-2#1)
softening and##2##2##(1990-12#1)(1993-5#1)
softening during##2##2##(2008-10#1)(2010-4#1)
softening for##3##2##(2007-1#1)(2007-4#2)
softening or##2##2##(2009-5#1)(2010-4#1)
softening##20##1##(1990-12#1)(1993-5#1)(2006-2#1)(2007-1#1)(2007-4#3)(2007-5#1)(2007-8#1)(2008-10#2)(2008-2#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-4#2)(2011-2#2)
softer and##2##2##(1990-4#1)(2008-5#1)
softer##11##1##(1990-4#1)(1994-8#1)(2005-11#1)(2006-6#1)(2007-12#1)(2008-5#4)(2008-8#1)(2008-9#1)
softgel##4##1##(2007-8#4)
softly##2##1##(2007-11#1)(2010-12#1)
softness of the##2##3##(2007-12#2)
softness of##3##2##(2005-11#1)(2007-12#2)
softness##8##1##(2005-11#2)(2007-12#2)(2007-5#1)(2010-4#2)(2013-1#1)
software and hardware##4##3##(1994-3#1)(2008-7#1)(2009-10#1)(2012-2#1)
software and the##3##3##(2008-10#1)(2010-12#1)(2013-8#1)
software and##25##2##(1991-2#1)(1993-3#1)(1994-3#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
software application##2##2##(1996-12#1)(2008-3#1)
software applications##3##2##(2007-12#1)(2008-7#1)(2009-12#1)
software architecture##2##2##(2006-2#1)(2006-5#1)
software are discussed##2##3##(2007-11#1)(2008-4#1)
software are##5##2##(2007-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)
software based on##4##3##(2007-8#1)(2008-2#2)(2012-3#1)
software by##3##2##(2008-12#1)(2008-4#1)(2008-5#1)
software can##3##2##(1993-6#1)(2007-10#1)(2011-2#1)
software compensation##3##2##(2008-9#3)
software correlator##2##2##(2008-3#2)
software design##3##2##(2009-12#1)(2013-1#2)
software designed##2##2##(2007-9#1)(2012-3#1)
software developed in##2##3##(2008-10#2)
software developed##6##2##(2007-3#1)(2007-8#1)(2008-10#3)(2011-2#1)
software developers##2##2##(2006-10#1)(2008-7#1)
software development##6##2##(2007-11#1)(2008-11#1)(2011-2#1)(2013-1#3)
software engineering##5##2##(2012-1#1)(2013-1#4)
software for 3D reconstruction##2##4##(2009-1#1)(2012-2#1)
software for automated##2##3##(2006-5#1)(2012-1#1)
software for the##5##3##(2008-10#3)(2008-2#1)(2008-5#1)
software for##28##2##(1992-9#1)(1994-2#1)(1996-7#1)(1997-4#1)(1997-8#1)(2006-5#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#2)(2009-1#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#2)
software has been##2##3##(2008-3#1)(2008-5#1)
software has made##2##3##(2006-6#1)(2008-7#1)
software has##8##2##(1991-2#1)(2006-6#1)(2007-7#1)(2008-3#2)(2008-5#1)(2008-7#1)(2011-2#1)
software have been##2##3##(2010-7#1)(2013-1#1)
software implementation##4##2##(2007-11#1)(2007-4#1)(2008-2#2)
software in a##3##3##(1992-3#1)(2008-7#1)(2012-1#1)
software in##12##2##(1992-3#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-7#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
software infrastructure for##3##3##(2006-10#2)(2008-4#1)
software is also##2##3##(2008-4#1)(2011-2#1)
software is available for##2##4##(1997-2#1)(2008-10#1)
software is available##5##3##(1997-2#1)(2008-10#1)(2008-7#1)(2011-2#2)
software is##25##2##(1993-3#1)(1996-12#3)(1997-2#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#4)(2008-7#3)(2009-10#1)(2011-2#4)(2012-3#1)(2013-1#1)
software method##2##2##(2008-9#1)(2012-1#1)
software of##3##2##(2007-5#1)(2010-8#1)(2011-2#1)
software package for##6##3##(1996-12#1)(2006-5#2)(2007-7#1)(2008-4#1)(2011-1#1)
software package to##2##3##(2007-8#1)(2011-1#1)
software package##24##2##(1991-3#1)(1992-12#1)(1992-2#1)(1993-9#1)(1996-12#2)(2006-11#1)(2006-5#2)(2007-1#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-4#3)(2008-9#1)(2010-8#1)(2011-1#2)(2012-3#1)
software packages##7##2##(1992-12#1)(1992-2#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-2#1)
software permits##2##2##(1991-12#1)(2008-10#1)
software platform to support##2##4##(1994-2#1)(1994-3#1)
software product##2##2##(1997-2#1)(2008-10#1)
software program based on graph theory##2##6##(1995-6#2)
software program##14##2##(1992-2#1)(1995-6#3)(1996-2#1)(2007-7#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
software programs##3##2##(2008-4#1)(2008-9#1)(2009-3#1)
software requirements##2##2##(1994-2#1)(2008-4#1)
software solution##2##2##(2007-6#1)(2008-4#1)
software suite##2##2##(2008-4#1)(2011-1#1)
software suites##2##2##(2008-7#1)(2012-3#1)
software that allows##2##3##(2008-11#1)(2008-4#1)
software that can##2##3##(1991-12#1)(2008-4#1)
software that is##2##3##(1992-12#1)(2011-1#1)
software that##13##2##(1991-12#1)(1992-12#1)(1993-12#1)(1994-2#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
software to obtain##2##3##(2012-12#1)(2012-3#1)
software to produce##2##3##(1992-9#1)(2013-7#1)
software to##21##2##(1992-3#1)(1992-9#1)(1996-1#1)(1996-12#2)(2008-10#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-2#1)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-7#1)
software tool for##3##3##(2008-4#1)(2013-1#2)
software tool##6##2##(2007-5#1)(2008-2#1)(2008-4#1)(2012-3#1)(2013-1#2)
software tools for##3##3##(2010-11#1)(2011-3#1)(2012-2#1)
software tools##12##2##(1996-12#1)(2006-10#1)(2006-6#1)(2007-1#1)(2008-4#2)(2009-12#1)(2010-10#1)(2010-11#1)(2011-3#1)(2012-2#1)(2013-1#1)
software used in##2##3##(2008-10#1)(2012-2#1)
software used##4##2##(2006-11#1)(2006-5#1)(2008-10#1)(2012-2#1)
software vendors##3##2##(1994-2#1)(2005-12#1)(2011-2#1)
software version##3##2##(2008-4#1)(2011-2#2)
software was developed##2##3##(2007-11#1)(2007-5#1)
software was used for##5##4##(2008-10#3)(2008-5#1)(2012-12#1)
software was used in order to##2##6##(2008-10#1)(2008-12#1)
software was used to##4##4##(2007-3#1)(2008-1#1)(2008-10#1)(2008-2#1)
software was used##11##3##(2007-3#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-5#1)(2012-12#1)
software was written##2##3##(2008-10#2)
software was##21##2##(1992-10#1)(1996-12#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-5#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2012-12#1)
software we##2##2##(2009-2#1)(2010-9#1)
software were##2##2##(2008-10#1)(2010-9#1)
software which##3##2##(1992-10#1)(2006-5#1)(2011-3#1)
software with##2##2##(2007-3#1)(2008-9#1)
software written in##4##3##(2008-10#3)(2010-5#1)
software##584##1##(1990-12#1)(1991-1#1)(1991-12#3)(1991-2#3)(1991-3#1)(1992-10#3)(1992-12#5)(1992-2#4)(1992-3#2)(1992-9#2)(1993-1#1)(1993-12#4)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-2#8)(1994-3#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#6)(1996-1#1)(1996-12#12)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#1)(2004-3#1)(2005-11#4)(2005-12#1)(2005-4#1)(2005-5#1)(2006-10#6)(2006-11#2)(2006-12#1)(2006-2#1)(2006-5#7)(2006-6#5)(2007-1#2)(2007-10#5)(2007-11#9)(2007-12#7)(2007-2#1)(2007-3#3)(2007-4#7)(2007-5#9)(2007-6#2)(2007-7#10)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#62)(2008-11#17)(2008-12#6)(2008-2#27)(2008-3#23)(2008-4#31)(2008-5#14)(2008-6#2)(2008-7#24)(2008-8#1)(2008-9#12)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#5)(2009-2#2)(2009-3#5)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#5)(2010-9#5)(2011-1#17)(2011-2#29)(2011-3#2)(2011-7#1)(2012-1#8)(2012-12#7)(2012-2#10)(2012-3#15)(2013-1#36)(2013-7#1)(2013-8#10)
software)##3##1##(2007-10#1)(2007-7#1)(2008-10#1)
software-based##5##1##(1994-1#1)(2006-12#1)(2008-4#2)(2008-6#1)
software-controlled##2##1##(2007-8#1)(2008-10#1)
softwood species##2##2##(2008-10#1)(2009-3#1)
softwood##3##1##(2008-10#1)(2008-6#1)(2009-3#1)
softwoods##3##1##(2005-10#1)(2008-10#1)(2008-6#1)
soil (P &lt##3##3##(2008-10#2)(2008-6#1)
soil (pH##2##2##(2008-10#2)
soil 2##2##2##(2008-10#1)(2008-11#1)
soil CO2 efflux##3##3##(2011-12#3)
soil CO2##4##2##(2011-12#4)
soil GHG fluxes##4##3##(2012-2#4)
soil GHG##5##2##(2012-2#5)
soil ROC content##3##3##(2013-8#3)
soil ROC##7##2##(2013-8#7)
soil acidification##2##2##(2008-10#2)
soil after##3##2##(2006-5#1)(2008-10#2)
soil amended with##5##3##(2008-10#3)(2008-5#1)(2009-3#1)
soil amendment##2##2##(2008-10#2)
soil and a##2##3##(2008-10#2)
soil and airborne##2##3##(2008-10#1)(2008-11#1)
soil and fruit##2##3##(2008-10#2)
soil and groundwater##3##3##(2004-4#1)(2008-10#1)(2008-2#1)
soil and infected##2##3##(2008-10#2)
soil and marine##2##3##(2008-10#1)(2011-2#1)
soil and on##3##3##(2008-10#3)
soil and plant processes##2##4##(1990-9#2)
soil and plant##6##3##(1990-9#2)(2008-10#3)(2008-11#1)
soil and root##2##3##(2008-10#2)
soil and sediment certified##2##4##(2008-10#2)
soil and sediment samples##7##4##(2008-10#7)
soil and sediment##16##3##(2008-10#16)
soil and the##6##3##(2007-12#1)(2008-10#4)(2008-2#1)
soil and vegetation cover##2##4##(2008-12#2)
soil and vegetation##4##3##(2008-10#1)(2008-12#2)(2008-9#1)
soil and water##9##3##(2005-12#1)(2008-10#4)(2008-11#2)(2008-9#1)(2013-8#1)
soil and##116##2##(1990-9#3)(1993-11#1)(1997-4#1)(2004-2#1)(2004-4#1)(2005-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#80)(2008-11#6)(2008-12#3)(2008-2#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)(2011-2#1)(2012-2#1)(2012-9#1)(2013-1#2)(2013-8#1)
soil animals##4##2##(2004-4#4)
soil applications of##2##3##(2008-10#1)(2008-12#1)
soil applications##3##2##(2008-10#2)(2008-12#1)
soil are##5##2##(1993-9#1)(2006-10#1)(2008-10#2)(2008-2#1)
soil around the##2##3##(2009-3#1)(2011-2#1)
soil around##3##2##(2008-10#1)(2009-3#1)(2011-2#1)
soil arthropod community##6##3##(2013-8#6)
soil arthropod##7##2##(2013-8#7)
soil as a##3##3##(1993-8#1)(2004-4#1)(2008-10#1)
soil as well as##2##4##(2008-10#2)
soil as##8##2##(1993-8#1)(2004-4#1)(2008-10#6)
soil at 5##2##3##(2008-10#2)
soil at the end of##2##5##(2008-10#2)
soil at the##3##3##(2008-10#3)
soil at##19##2##(2006-3#1)(2008-10#15)(2008-4#1)(2008-5#2)
soil attributes##3##2##(2012-2#3)
soil available##5##2##(2008-10#1)(2013-8#4)
soil bacteria##8##2##(1996-5#1)(1997-4#1)(2006-3#1)(2008-10#1)(2009-3#1)(2012-12#1)(2012-3#1)(2013-8#1)
soil bacterial##2##2##(2013-7#2)
soil bacterium##5##2##(1991-11#1)(2008-11#2)(2011-1#1)(2011-2#1)
soil block##4##2##(2008-10#4)
soil bulk density##7##3##(2008-12#3)(2013-7#1)(2013-8#3)
soil but##4##2##(2008-10#3)(2008-12#1)
soil by##16##2##(2004-4#1)(2005-12#1)(2008-10#10)(2008-11#1)(2008-4#1)(2011-2#1)(2012-12#1)
soil can##3##2##(2008-10#1)(2008-11#1)(2010-5#1)
soil carbon##3##2##(2006-5#1)(2013-7#1)(2013-8#1)
soil caused##3##2##(2008-10#3)
soil characteristics##5##2##(2008-10#2)(2010-12#1)(2012-2#1)(2013-8#1)
soil chemical properties and microbial##2##5##(2006-5#1)(2013-8#1)
soil chemical properties and##3##4##(2006-5#1)(2008-10#1)(2013-8#1)
soil chemical##7##2##(2006-5#2)(2008-10#4)(2013-8#1)
soil classification##2##2##(2008-1#1)(2012-12#1)
soil columns and##2##3##(2004-4#1)(2008-10#1)
soil columns##5##2##(2004-4#4)(2008-10#1)
soil compared with##3##3##(2008-10#3)
soil compartment##2##2##(2008-10#1)(2008-11#1)
soil composition##2##2##(2008-10#1)(2008-4#1)
soil compounds##3##2##(2010-3#3)
soil concentrations##4##2##(2005-11#2)(2008-12#1)(2008-5#1)
soil conditioners##2##2##(2008-10#2)
soil conditions##4##2##(2007-10#1)(2008-10#3)
soil conservation function##2##3##(2013-8#2)
soil containing##4##2##(2006-3#1)(2008-10#2)(2008-11#1)
soil contaminated with##2##3##(2005-12#1)(2006-12#1)
soil contaminated##3##2##(2005-12#1)(2006-12#1)(2008-11#1)
soil contamination and##2##3##(2008-10#1)(2011-1#1)
soil contamination with##2##3##(2008-4#1)(2011-1#1)
soil contamination##8##2##(1995-11#1)(1996-3#1)(2004-4#1)(2007-8#1)(2008-10#1)(2008-4#1)(2011-1#2)
soil copper##4##2##(2004-4#4)
soil core samples##2##3##(2011-1#2)
soil core##3##2##(2008-10#1)(2011-1#2)
soil cores##4##2##(2008-10#2)(2008-5#1)(2013-7#1)
soil could##2##2##(2008-10#1)(2008-6#1)
soil depth##4##2##(2008-10#2)(2013-8#2)
soil depths##2##2##(2008-10#1)(2008-12#1)
soil developed from##2##3##(2013-8#2)
soil disinfestation##2##2##(2008-10#2)
soil drought##6##2##(2012-5#2)(2012-6#3)(2012-8#1)
soil during root mineralisation##2##4##(2010-5#2)
soil during##5##2##(2008-10#2)(2008-2#1)(2010-5#2)
soil ecology##2##2##(2006-5#1)(2008-11#1)
soil ecosystem##3##2##(2006-5#1)(2008-11#1)(2011-12#1)
soil environment##2##2##(2005-12#1)(2008-10#1)
soil environments##2##2##(2008-10#1)(2011-12#1)
soil erosion##5##2##(2007-8#2)(2011-12#3)
soil exposed to##3##3##(2005-12#2)(2008-10#1)
soil extract containing##2##3##(2008-10#2)
soil extract##3##2##(2008-10#3)
soil extracts and##3##3##(1996-5#1)(2008-10#2)
soil extracts using a##2##4##(2008-10#2)
soil extracts using##4##3##(2008-10#4)
soil extracts was##3##3##(2007-8#1)(2008-10#2)
soil extracts were##2##3##(2008-10#2)
soil extracts##31##2##(1996-5#1)(2007-8#1)(2008-10#27)(2008-12#1)(2011-12#1)
soil factors##3##2##(2008-10#3)
soil fertility##9##2##(2006-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-7#1)(2013-7#2)(2013-8#2)
soil for##2##2##(2006-9#1)(2008-10#1)
soil formation##2##2##(2008-12#2)
soil fractions##3##2##(2008-10#3)
soil from a##2##3##(2008-10#1)(2008-5#1)
soil from the##7##3##(2008-10#4)(2008-11#1)(2008-5#2)
soil from##22##2##(1990-9#1)(2006-3#1)(2007-10#1)(2007-7#1)(2008-10#12)(2008-11#1)(2008-5#4)(2009-3#1)
soil fulvic acid##3##3##(2008-10#3)
soil fumigant##2##2##(2008-10#2)
soil fumigants##3##2##(2008-10#3)
soil fungi##5##2##(2008-10#3)(2013-8#2)
soil had significantly##3##3##(2008-10#3)
soil had##8##2##(2008-10#8)
soil having##2##2##(2008-10#1)(2008-2#1)
soil heat flux##2##3##(2013-8#2)
soil humic##2##2##(2005-4#1)(2008-10#1)
soil in a##2##3##(2008-10#2)
soil in the##6##3##(2008-10#4)(2008-4#1)(2013-8#1)
soil in##27##2##(1996-3#1)(2004-4#1)(2008-10#15)(2008-4#1)(2008-5#3)(2011-1#1)(2011-2#3)(2012-11#1)(2013-8#1)
soil infestation##4##2##(2008-10#4)
soil infested with T##2##4##(2008-10#2)
soil infested with##7##3##(2008-10#7)
soil ingestion##5##2##(1996-8#1)(2008-7#4)
soil inoculum##2##2##(2008-10#2)
soil into##2##2##(2008-4#2)
soil is an attractive##2##4##(2008-5#1)(2008-7#1)
soil is##15##2##(1990-9#1)(1992-12#1)(1992-6#1)(2004-4#3)(2006-10#1)(2006-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)
soil isolates##2##2##(2008-10#2)
soil layer##3##2##(2008-10#2)(2013-8#1)
soil layers##6##2##(2008-10#4)(2009-3#1)(2013-8#1)
soil leachates##3##2##(2008-10#3)
soil lead##2##2##(1995-11#1)(2012-12#1)
soil management##4##2##(2008-10#1)(2008-5#1)(2010-7#1)(2011-12#1)
soil material##2##2##(2008-11#2)
soil matric potential##2##3##(2008-10#2)
soil matrices##2##2##(2008-10#2)
soil may##5##2##(2004-4#3)(2006-3#1)(2008-10#1)
soil microbes were##2##3##(2008-10#1)(2008-11#1)
soil microbes##7##2##(2008-10#3)(2008-11#3)(2013-8#1)
soil microbial activity##2##3##(2006-5#1)(2008-10#1)
soil microbial communities and##2##4##(2008-10#2)
soil microbial communities##4##3##(2008-10#4)
soil microbial community structure##2##4##(2008-10#2)
soil microbial community##8##3##(2008-10#8)
soil microbial##22##2##(1990-9#1)(2004-4#1)(2006-12#2)(2006-5#1)(2008-10#17)
soil microcosm experiments##3##3##(2008-10#3)
soil microflora##6##2##(2008-10#6)
soil mixtures##3##2##(2008-10#2)(2008-2#1)
soil moisture and temperature##4##4##(2008-10#4)
soil moisture and##9##3##(2008-10#6)(2008-9#1)(2012-7#1)(2013-8#1)
soil moisture content##9##3##(2008-10#1)(2008-12#1)(2012-7#2)(2013-7#1)(2013-8#4)
soil moisture regime##2##3##(2011-1#1)(2013-8#1)
soil moisture##34##2##(1995-3#1)(2008-10#16)(2008-12#1)(2008-9#1)(2011-1#3)(2011-12#2)(2012-7#3)(2013-7#1)(2013-8#6)
soil moisture)##4##2##(2008-10#4)
soil moistures##4##2##(2011-12#4)
soil monitoring##2##2##(2007-8#1)(2009-3#1)
soil nitrogen##2##2##(2006-12#1)(2008-5#1)
soil nutrients and##2##3##(2008-5#1)(2013-8#1)
soil nutrients##3##2##(2008-5#2)(2013-8#1)
soil of the##2##3##(2008-10#1)(2008-5#1)
soil of##19##2##(1996-7#1)(2005-11#1)(2008-10#6)(2008-2#1)(2008-5#3)(2008-7#1)(2010-3#1)(2012-2#1)(2013-8#4)
soil on the##3##3##(1993-2#1)(2008-10#1)(2010-12#1)
soil on##6##2##(1993-2#1)(2008-10#3)(2008-11#1)(2010-12#1)
soil or##11##2##(2005-9#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-6#1)(2012-1#1)(2012-2#1)
soil organic carbon content##3##4##(2013-8#3)
soil organic carbon##14##3##(2008-12#5)(2013-8#9)
soil organic matter and available nitrogen and##2##7##(2013-8#2)
soil organic matter and##3##4##(2008-12#1)(2013-8#2)
soil organic matter##8##3##(2006-3#1)(2008-10#2)(2008-12#1)(2011-12#1)(2013-8#3)
soil organic##29##2##(2005-4#2)(2006-3#1)(2008-10#5)(2008-12#7)(2011-12#1)(2013-8#13)
soil organisms##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
soil pH and soil##2##4##(2013-8#2)
soil pH and the soil organic carbon and available phosphorus contents##2##11##(2013-8#2)
soil pH and##6##3##(2006-12#1)(2008-10#1)(2013-8#4)
soil pH on##2##3##(2004-4#2)
soil pH##25##2##(1995-3#1)(2004-4#3)(2006-12#1)(2007-10#2)(2008-10#10)(2008-12#1)(2010-5#1)(2012-11#1)(2012-6#1)(2013-8#4)
soil parameters##3##2##(2008-10#1)(2008-2#1)(2013-7#1)
soil particles##5##2##(1992-6#3)(2008-10#2)
soil pasteurization##2##2##(2008-10#2)
soil pathogen##2##2##(2010-10#1)(2013-8#1)
soil physical and chemical properties##3##5##(2013-8#3)
soil physical##5##2##(2008-12#2)(2013-8#3)
soil pollution##2##2##(2008-10#1)(2008-11#1)
soil population##2##2##(2008-10#2)
soil populations of Pythium spp##2##5##(2008-10#2)
soil populations of##6##3##(2008-10#6)
soil populations##12##2##(2008-10#12)
soil prior to##2##3##(2008-10#2)
soil processes##2##2##(2005-11#1)(2006-5#1)
soil profiles##2##2##(1996-3#1)(2008-12#1)
soil properties and##4##3##(2008-10#2)(2008-12#2)
soil properties in##2##3##(2008-10#2)
soil properties##9##2##(2008-10#5)(2008-12#2)(2010-5#1)(2012-2#1)
soil quality##4##2##(2006-12#1)(2007-10#1)(2008-12#1)(2008-5#1)
soil ranged##2##2##(2008-10#1)(2013-8#1)
soil reduced the##2##3##(2008-10#2)
soil reference materials##3##3##(2008-10#3)
soil respiration##7##2##(2004-4#1)(2008-11#2)(2011-12#4)
soil sample in##2##3##(2008-10#1)(2011-1#1)
soil sample with##2##3##(2008-10#2)
soil sample##10##2##(2006-9#1)(2008-10#8)(2011-1#1)
soil samples by##6##3##(2008-10#6)
soil samples collected from the##2##5##(2008-10#1)(2011-12#1)
soil samples collected from##9##4##(2005-11#1)(2008-10#7)(2011-12#1)
soil samples collected##11##3##(2005-11#1)(2006-12#1)(2008-10#8)(2011-12#1)
soil samples from an intensive horticulture area##2##7##(2008-10#2)
soil samples from##6##3##(2008-10#4)(2011-1#1)(2011-12#1)
soil samples of##4##3##(2005-11#1)(2008-10#1)(2008-11#2)
soil samples taken from an##2##5##(2008-10#2)
soil samples that##4##3##(2008-10#4)
soil samples using##2##3##(2008-10#2)
soil samples was developed##2##4##(2008-10#2)
soil samples was##4##3##(2008-10#3)(2008-5#1)
soil samples were collected from##3##5##(2007-10#1)(2008-12#1)(2013-8#1)
soil samples were collected##4##4##(2007-10#1)(2008-10#1)(2008-12#1)(2013-8#1)
soil samples were##14##3##(2007-10#2)(2008-10#8)(2008-12#1)(2011-1#1)(2013-7#1)(2013-8#1)
soil samples with##6##3##(1994-3#1)(2007-8#1)(2008-10#3)(2012-2#1)
soil samples##113##2##(1994-3#1)(1996-3#1)(2005-11#3)(2006-10#2)(2006-12#3)(2007-10#2)(2007-8#3)(2008-10#76)(2008-11#4)(2008-12#1)(2008-5#5)(2008-6#1)(2008-8#1)(2009-3#1)(2011-1#2)(2011-12#3)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
soil solarization##4##2##(2008-10#4)
soil solution##10##2##(1992-3#2)(2008-10#7)(2008-11#1)
soil solutions##4##2##(2005-11#1)(2007-8#1)(2008-10#2)
soil spiked##2##2##(2008-10#1)(2011-12#1)
soil surface of##2##3##(2008-10#2)
soil surface temperature##2##3##(2011-1#2)
soil surface##21##2##(2008-10#12)(2008-11#1)(2008-6#3)(2010-5#2)(2011-1#2)(2011-12#1)
soil suspensions##2##2##(2008-10#2)
soil temperature and##4##3##(2008-10#4)
soil temperature##12##2##(2008-10#9)(2011-12#2)(2013-7#1)
soil temperatures##5##2##(2008-10#5)
soil texture and##2##3##(2004-4#1)(2008-10#1)
soil texture##9##2##(2004-4#1)(2008-10#8)
soil than in##3##3##(2008-10#3)
soil than##5##2##(2008-10#4)(2008-11#1)
soil that was##3##3##(2008-10#2)(2009-3#1)
soil that##7##2##(1990-9#1)(2008-10#4)(2009-3#2)
soil to plants##2##3##(1992-3#1)(2004-4#1)
soil to the##2##3##(2004-2#1)(2008-10#1)
soil to##17##2##(1992-3#1)(1994-9#1)(2004-2#1)(2004-4#1)(2008-10#12)(2012-12#1)
soil total nitrogen##3##3##(2013-8#3)
soil total phosphorus##2##3##(2013-8#2)
soil total##5##2##(2013-8#5)
soil transplant experiment##2##3##(2008-9#2)
soil treatments and##2##3##(2008-10#2)
soil treatments##10##2##(2004-4#1)(2008-10#8)(2009-8#1)
soil type and##2##3##(2004-4#1)(2009-3#1)
soil type##15##2##(2004-4#3)(2005-10#1)(2008-10#4)(2009-3#2)(2012-6#1)(2012-9#4)
soil types and##3##3##(2004-4#1)(2008-10#1)(2012-2#1)
soil types of##2##3##(2008-10#1)(2012-9#1)
soil types##14##2##(1993-8#1)(2004-4#1)(2005-10#2)(2008-10#3)(2009-3#3)(2012-2#1)(2012-5#1)(2012-9#2)
soil using##7##2##(2007-12#1)(2008-10#4)(2011-1#1)(2011-12#1)
soil was added to 9##2##5##(2009-3#2)
soil was added to##3##4##(2008-10#1)(2009-3#2)
soil was inoculated with##2##4##(2008-10#2)
soil was investigated##2##3##(2008-10#1)(2008-5#1)
soil was subjected to##2##4##(2006-3#1)(2008-10#1)
soil was##43##2##(1994-8#1)(2004-4#2)(2006-3#1)(2008-10#26)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#1)(2009-3#3)(2010-3#1)(2011-1#1)(2012-12#1)(2013-8#1)
soil water content##3##3##(2008-7#1)(2012-8#2)
soil water infiltration##2##3##(2008-12#2)
soil water potential##2##3##(2008-10#2)
soil water##16##2##(2007-3#1)(2008-10#3)(2008-12#2)(2008-7#1)(2008-8#1)(2012-5#1)(2012-6#1)(2012-8#2)(2013-7#1)(2013-8#3)
soil were analysed##2##3##(2004-4#1)(2008-10#1)
soil were not##2##3##(2008-10#2)
soil were##23##2##(2004-4#1)(2005-11#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-5#1)(2011-1#2)(2013-7#1)(2013-8#1)
soil with##20##2##(2006-3#1)(2007-11#1)(2007-12#1)(2008-10#14)(2008-12#1)(2008-6#1)(2010-5#1)
soil within##2##2##(2008-10#1)(2008-11#1)
soil without##3##2##(2008-10#1)(2010-5#2)
soil##1731##1##(1990-9#11)(1991-11#1)(1991-7#1)(1992-12#3)(1992-3#8)(1992-6#6)(1993-11#1)(1993-2#1)(1993-5#1)(1993-7#1)(1993-8#4)(1993-9#3)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-3#4)(1996-3#6)(1996-5#2)(1996-7#1)(1996-8#1)(1997-4#3)(2004-2#6)(2004-4#50)(2005-10#3)(2005-11#13)(2005-12#6)(2005-4#4)(2005-9#1)(2006-10#4)(2006-12#13)(2006-3#12)(2006-4#1)(2006-5#10)(2006-9#4)(2007-1#3)(2007-10#13)(2007-11#3)(2007-12#6)(2007-3#4)(2007-7#7)(2007-8#14)(2008-1#2)(2008-10#916)(2008-11#68)(2008-12#45)(2008-2#12)(2008-3#1)(2008-4#14)(2008-5#43)(2008-6#17)(2008-7#12)(2008-8#3)(2008-9#11)(2009-3#22)(2009-4#1)(2009-7#1)(2009-8#3)(2010-10#2)(2010-11#1)(2010-12#4)(2010-3#8)(2010-5#15)(2010-7#3)(2010-8#1)(2011-1#23)(2011-12#45)(2011-2#14)(2012-1#2)(2012-11#2)(2012-12#7)(2012-2#22)(2012-3#3)(2012-5#4)(2012-6#10)(2012-7#3)(2012-8#3)(2012-9#8)(2013-1#4)(2013-7#23)(2013-8#113)
soil&quot##4##1##(2007-4#3)(2012-12#1)
soil) and##2##2##(2008-12#1)(2008-8#1)
soil) by##2##2##(2007-8#1)(2008-10#1)
soil)##17##1##(2007-8#1)(2008-10#14)(2008-12#1)(2008-8#1)
soil-borne##3##1##(2006-12#1)(2008-8#1)(2012-3#1)
soil-dwelling insects and insects##2##4##(2009-6#2)
soil-plant##2##1##(1992-3#2)
soil-to-solvent ratios##2##2##(2008-10#2)
soil-transmitted##5##1##(1994-11#2)(2007-7#1)(2008-7#1)(2011-12#1)
soil]##3##1##(2011-12#1)(2013-8#2)
soilborne disease of##3##3##(2008-10#2)(2010-3#1)
soilborne disease##6##2##(2008-10#5)(2010-3#1)
soilborne diseases##4##2##(2008-10#4)
soilborne fungal pathogens##3##3##(2008-10#3)
soilborne fungus##5##2##(2008-10#5)
soilborne pathogen##6##2##(2008-10#6)
soilborne pathogens under##2##3##(2008-10#2)
soilborne pathogens##15##2##(2008-10#15)
soilborne pests in fresh market vegetable production systems##2##8##(2008-10#2)
soilborne pests##4##2##(2008-10#4)
soilborne plant pathogen##2##3##(2008-10#2)
soilborne plant pathogens##7##3##(2008-10#7)
soilborne plant##10##2##(2008-10#10)
soilborne##72##1##(2007-7#1)(2008-10#70)(2010-3#1)
soiled equine bedding substrate##2##4##(2011-12#2)
soiled##8##1##(1990-8#2)(1996-12#1)(1997-5#2)(2005-11#1)(2011-12#2)
soiling of the##2##3##(1994-4#1)(1997-5#1)
soiling##8##1##(1990-3#1)(1991-8#1)(1994-4#1)(1997-5#2)(2008-3#1)(2011-2#1)(2012-12#1)
soilless container##2##2##(2008-10#2)
soilless potting##2##2##(2008-10#2)
soilless##9##1##(2008-10#9)
soils after##2##2##(2008-10#2)
soils amended with##6##3##(2008-10#6)
soils and have##2##3##(2005-11#1)(2008-10#1)
soils and sediments are##2##4##(2007-8#1)(2008-10#1)
soils and sediments##7##3##(2007-8#1)(2008-10#6)
soils and the##3##3##(2008-10#2)(2008-11#1)
soils and vegetation##2##3##(2008-10#2)
soils and wastes##2##3##(2008-10#2)
soils and##43##2##(1996-3#1)(2005-11#1)(2005-4#2)(2007-3#1)(2007-8#1)(2008-10#33)(2008-11#1)(2008-5#1)(2012-2#1)(2013-8#1)
soils are a##3##3##(2008-11#2)(2012-2#1)
soils are##9##2##(2004-4#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2012-11#1)(2012-2#1)(2013-7#1)
soils at##4##2##(2008-10#1)(2008-6#1)(2011-12#2)
soils by##9##2##(1993-9#1)(2006-12#1)(2008-10#6)(2008-12#1)
soils can##2##2##(2004-2#1)(2008-10#1)
soils collected from##2##3##(2006-3#1)(2008-10#1)
soils collected##3##2##(2006-3#1)(2008-10#2)
soils contained##2##2##(2008-10#1)(2008-5#1)
soils containing the##2##3##(2008-10#2)
soils contaminated with##4##3##(2004-4#1)(2008-10#1)(2008-6#2)
soils developed from##2##3##(2013-8#2)
soils eaten by chimpanzees of the Mahale Mountains and Gombe##2##10##(2004-2#2)
soils eaten by##3##3##(2004-2#3)
soils exhibited##2##2##(2008-10#2)
soils from the##2##3##(2004-2#1)(2008-10#1)
soils from##17##2##(1993-9#2)(2004-2#2)(2008-10#11)(2009-3#1)(2013-7#1)
soils had higher##2##3##(2013-7#1)(2013-8#1)
soils had##4##2##(2008-10#2)(2013-7#1)(2013-8#1)
soils in a##2##3##(2008-10#2)
soils in the##4##3##(1996-8#1)(2008-12#1)(2012-6#1)(2013-8#1)
soils in which##5##3##(2008-10#5)
soils in##21##2##(1996-8#1)(2004-2#1)(2004-4#1)(2008-10#14)(2008-12#1)(2009-8#1)(2012-6#1)(2013-8#1)
soils infested with##5##3##(2008-10#5)
soils is##4##2##(2008-10#3)(2012-12#1)
soils may be##2##3##(2008-10#1)(2008-11#1)
soils may##3##2##(2006-12#1)(2008-10#1)(2008-11#1)
soils of##7##2##(2006-9#1)(2008-10#1)(2008-12#2)(2009-8#1)(2013-8#2)
soils on the##3##3##(2008-10#1)(2008-12#2)
soils or##2##2##(2006-12#1)(2008-10#1)
soils over##3##2##(2008-10#3)
soils prior to planting##2##4##(2008-10#2)
soils prior to##3##3##(2008-10#3)
soils resulted in##2##3##(2006-3#1)(2008-10#1)
soils sampled##2##2##(2008-10#1)(2008-5#1)
soils tested##3##2##(2006-3#1)(2008-10#2)
soils than in##2##3##(2010-12#2)
soils the##2##2##(1992-3#1)(2005-11#1)
soils to##3##2##(2006-3#1)(2008-10#2)
soils under##2##2##(2008-10#2)
soils using##2##2##(2005-11#1)(2008-10#1)
soils was investigated##2##3##(2005-11#1)(2008-10#1)
soils was##8##2##(2005-11#1)(2008-10#7)
soils were collected##2##3##(2006-12#1)(2008-10#1)
soils were infested with##2##4##(2008-10#2)
soils were infested##3##3##(2008-10#3)
soils were##16##2##(1996-7#1)(2005-4#1)(2006-12#1)(2008-10#11)(2013-7#1)(2013-8#1)
soils with different##3##3##(2008-10#2)(2011-12#1)
soils with##21##2##(1995-3#1)(2004-4#1)(2007-8#1)(2008-10#13)(2011-1#1)(2011-12#2)(2012-2#1)(2012-6#1)
soils##446##1##(1991-11#1)(1992-3#3)(1993-8#1)(1993-9#3)(1995-3#1)(1996-3#1)(1996-7#2)(1996-8#1)(2004-2#8)(2004-4#8)(2005-10#1)(2005-11#7)(2005-4#3)(2006-12#18)(2006-3#8)(2006-9#1)(2007-10#2)(2007-3#1)(2007-8#4)(2008-10#279)(2008-11#8)(2008-12#11)(2008-2#3)(2008-5#8)(2008-6#7)(2008-7#1)(2008-9#3)(2009-3#3)(2009-8#3)(2010-12#6)(2010-5#4)(2010-7#1)(2011-1#1)(2011-12#7)(2012-11#1)(2012-12#1)(2012-2#3)(2012-6#3)(2013-7#8)(2013-8#11)
soils)##4##1##(2004-4#1)(2008-10#1)(2009-8#1)(2012-6#1)
soit##3##1##(2008-5#1)(2011-2#1)(2012-2#1)
soja Sieb##3##2##(2012-11#3)
soja##8##1##(2008-5#1)(2012-11#7)
sojae and##3##2##(2008-10#2)(2012-11#1)
sojae f##4##2##(1997-6#4)
sojae from##2##2##(2008-10#2)
sojae in soil##2##3##(2008-10#2)
sojae in the##3##3##(2008-10#2)(2012-11#1)
sojae in##9##2##(2008-10#8)(2012-11#1)
sojae is##3##2##(2008-10#3)
sojae isolates were##2##3##(2008-10#2)
sojae isolates##4##2##(2008-10#4)
sojae was##4##2##(2008-10#4)
sojae were##2##2##(2008-10#2)
sojae##47##1##(1997-6#4)(2008-10#40)(2012-11#3)
sojourn##2##1##(1994-3#1)(2011-1#1)
sol is##2##2##(2008-10#2)
sol solution##4##2##(2005-11#3)(2008-10#1)
sol was##3##2##(2005-11#1)(2008-10#2)
sol##27##1##(2005-11#12)(2008-10#11)(2008-2#1)(2008-8#2)(2010-5#1)
sol-gel and self-assembly##3##3##(2008-10#3)
sol-gel and##5##2##(2007-8#1)(2008-10#3)(2010-7#1)
sol-gel carbon composite##2##3##(2008-10#2)
sol-gel carbon##3##2##(2008-10#3)
sol-gel chemistry##2##2##(2008-10#1)(2010-7#1)
sol-gel coating##2##2##(2008-10#2)
sol-gel derived##4##2##(2008-10#4)
sol-gel film with##2##3##(2008-10#2)
sol-gel film##11##2##(2007-9#1)(2008-10#10)
sol-gel films##3##2##(2007-8#1)(2008-10#2)
sol-gel glass##5##2##(2007-11#1)(2008-10#4)
sol-gel layer with##2##3##(2008-10#2)
sol-gel layer##3##2##(2007-8#1)(2008-10#2)
sol-gel material##2##2##(2008-10#2)
sol-gel matrix##5##2##(2007-8#1)(2008-10#4)
sol-gel membranes##2##2##(2008-10#2)
sol-gel method and characterized by##2##5##(2008-10#2)
sol-gel method and##3##3##(2008-10#3)
sol-gel method##12##2##(2008-10#9)(2009-8#1)(2010-1#2)
sol-gel prepared##2##2##(2010-1#2)
sol-gel process##5##2##(2008-10#2)(2008-3#1)(2008-5#1)(2009-7#1)
sol-gel processing##5##2##(2006-12#1)(2007-8#2)(2008-10#1)(2009-3#1)
sol-gel solution##2##2##(2010-4#2)
sol-gel synthesis of##2##3##(2007-9#1)(2008-10#1)
sol-gel technique is##2##3##(2008-10#2)
sol-gel technique was##2##3##(2005-12#1)(2008-10#1)
sol-gel technique##10##2##(2004-9#1)(2005-12#1)(2008-10#8)
sol-gel techniques##2##2##(2008-10#1)(2010-4#1)
sol-gel transition##7##2##(2005-11#4)(2008-2#2)(2011-1#1)
sol-gel was##3##2##(2008-10#3)
sol-gel##130##1##(2004-9#3)(2005-11#5)(2005-12#1)(2006-12#1)(2007-11#1)(2007-8#9)(2007-9#2)(2008-10#84)(2008-2#2)(2008-3#1)(2008-5#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#4)(2010-12#1)(2010-4#6)(2010-5#1)(2010-7#2)(2011-1#1)(2012-2#2)
sol-gel-imprinted##2##1##(2008-10#2)
sol-gels##3##1##(2008-10#1)(2010-7#2)
solanacearum 1609##3##2##(2008-10#3)
solanacearum and##2##2##(2008-10#2)
solanacearum biovar 2##3##3##(2008-10#3)
solanacearum cells##4##2##(2008-10#4)
solanacearum growth##2##2##(2008-10#2)
solanacearum is##4##2##(2008-10#4)
solanacearum population##3##2##(2008-10#3)
solanacearum race 3##2##3##(2008-10#2)
solanacearum race##3##2##(2008-10#3)
solanacearum strains from ginger in Hawaii##2##6##(2008-10#2)
solanacearum strains from##3##3##(2008-10#3)
solanacearum strains##7##2##(2008-10#7)
solanacearum##73##1##(2008-10#73)
solanaceous crops##2##2##(2008-10#1)(2008-6#1)
solanaceous hosts##2##2##(2008-10#2)
solanaceous species##4##2##(1996-8#2)(2008-10#2)
solanaceous##10##1##(1996-8#2)(2008-10#7)(2008-6#1)
solanesyl##2##1##(1993-4#2)
solani AG-3##4##2##(2008-10#3)(2008-12#1)
solani AG-4##2##2##(2008-10#2)
solani AG-5##3##2##(2008-10#3)
solani AG1-1A##2##2##(2008-10#2)
solani AGs##2##2##(2008-10#2)
solani anastomosis group##8##3##(2008-10#8)
solani and BNR##2##3##(2008-12#2)
solani and##13##2##(2006-12#1)(2008-10#8)(2008-12#4)
solani at##2##2##(2008-10#2)
solani by##5##2##(2008-10#5)
solani cutinase##2##2##(2008-7#2)
solani f##27##2##(2008-10#27)
solani from##3##2##(2008-10#3)
solani in##9##2##(2008-10#9)
solani is##2##2##(2008-10#2)
solani isolates from coffee##2##4##(2008-10#2)
solani isolates from##4##3##(2008-10#4)
solani isolates##5##2##(2008-10#5)
solani on soybean##2##3##(2008-10#2)
solani on the surface of##2##5##(2008-10#2)
solani on##8##2##(2008-10#8)
solani only##2##2##(2008-10#2)
solani or##3##2##(2008-10#3)
solani pisi##3##2##(1995-3#1)(2008-7#2)
solani resulted in##2##3##(2008-10#2)
solani showed##2##2##(2008-10#2)
solani to##2##2##(2008-10#2)
solani was##5##2##(2008-10#5)
solani were##7##2##(2008-10#7)
solani##217##1##(1992-8#1)(1995-3#1)(2005-11#1)(2006-12#1)(2007-7#1)(2008-10#198)(2008-12#6)(2008-5#1)(2008-7#4)(2010-10#3)
solani)##4##1##(2008-10#2)(2012-11#2)
solar UV irradiation##2##3##(2006-12#1)(2008-5#1)
solar UV radiation##4##3##(1992-6#1)(2006-3#1)(2008-10#1)(2013-8#1)
solar UV##10##2##(1992-6#1)(2006-12#1)(2006-3#1)(2008-10#1)(2008-2#1)(2008-5#2)(2010-9#1)(2011-2#1)(2013-8#1)
solar UV-B##2##2##(1991-5#2)
solar UV-radiation##2##2##(2010-9#2)
solar UVB radiation##2##3##(2006-12#1)(2008-10#1)
solar UVB##6##2##(2006-12#2)(2008-10#1)(2010-7#2)(2012-3#1)
solar absorptance is##2##3##(2008-3#2)
solar absorptance##7##2##(2008-2#1)(2008-3#6)
solar absorption##3##2##(2008-3#3)
solar and##6##2##(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)(2010-9#1)
solar angle##3##2##(2008-2#1)(2008-3#2)
solar aureole##3##2##(2008-2#1)(2008-3#2)
solar background##7##2##(1996-5#1)(2008-2#1)(2008-3#5)
solar cells and##3##3##(2008-2#1)(2008-7#1)(2009-11#1)
solar cells by##2##3##(2010-4#1)(2011-2#1)
solar cells##12##2##(2008-10#1)(2008-2#1)(2008-7#1)(2009-11#1)(2010-4#6)(2011-2#2)
solar concentrator for##2##3##(2008-2#2)
solar disk##2##2##(2008-2#1)(2008-3#1)
solar elevation##4##2##(2008-2#1)(2008-3#3)
solar elevations##2##2##(2008-3#2)
solar energy##6##2##(2008-3#1)(2008-8#1)(2008-9#1)(2009-2#1)(2011-1#2)
solar exposure was##2##3##(2008-5#2)
solar exposure##7##2##(2008-5#6)(2011-2#1)
solar irradiance##13##2##(1990-8#1)(2008-10#1)(2008-2#7)(2008-3#2)(2008-7#2)
solar light##6##2##(1995-5#1)(2008-10#1)(2008-3#1)(2008-8#2)(2011-12#1)
solar measurements##3##2##(2008-3#3)
solar nebula##2##2##(1996-5#2)
solar neutrino##2##2##(1992-11#1)(1992-9#1)
solar occultation##5##2##(2008-2#4)(2008-3#1)
solar polarimetry##3##2##(2008-3#3)
solar radiance##2##2##(2008-3#2)
solar radiation and cancer mortality##2##5##(2010-1#2)
solar radiation and##4##3##(2008-10#1)(2008-2#1)(2010-1#2)
solar radiation in##2##3##(1990-9#1)(2008-2#1)
solar radiation on##6##3##(2006-3#2)(2008-10#1)(2008-2#1)(2010-1#2)
solar radiation##40##2##(1990-9#1)(1991-3#1)(1992-2#1)(1992-7#1)(2006-12#1)(2006-3#3)(2007-8#1)(2008-10#8)(2008-11#3)(2008-2#4)(2008-3#6)(2008-5#2)(2010-1#7)(2011-2#1)
solar radiative##2##2##(2008-2#1)(2008-3#1)
solar simulator##4##2##(1994-3#1)(2008-10#1)(2008-11#1)(2008-3#1)
solar spectra##4##2##(2008-3#4)
solar spectral irradiance##3##3##(2008-2#1)(2008-3#2)
solar spectral##4##2##(2008-2#1)(2008-3#3)
solar spectrum##6##2##(2008-11#1)(2008-2#3)(2008-3#2)
solar system##7##2##(1996-5#1)(2007-8#1)(2007-9#5)
solar transmittance##2##2##(2008-3#2)
solar ultraviolet##8##2##(2006-12#2)(2008-2#3)(2010-7#1)(2011-2#2)
solar ultraviolet-B (UVB)##2##3##(2008-11#1)(2010-7#1)
solar ultraviolet-B##4##2##(2008-11#1)(2010-7#3)
solar zenith angle and##3##4##(2008-3#3)
solar zenith angle##10##3##(2008-2#4)(2008-3#6)
solar zenith angles as##2##4##(2008-2#1)(2008-3#1)
solar zenith angles##9##3##(2008-2#5)(2008-3#4)
solar zenith##19##2##(2008-2#9)(2008-3#10)
solar##291##1##(1990-8#2)(1990-9#1)(1991-3#1)(1991-5#2)(1992-11#1)(1992-2#1)(1992-6#2)(1992-7#1)(1992-9#1)(1994-3#1)(1995-10#1)(1995-5#1)(1996-5#10)(1997-5#1)(2006-12#7)(2006-3#4)(2007-11#2)(2007-12#2)(2007-3#2)(2007-7#1)(2007-8#3)(2007-9#6)(2008-10#17)(2008-11#6)(2008-2#56)(2008-3#91)(2008-4#1)(2008-5#12)(2008-7#5)(2008-8#3)(2008-9#1)(2009-11#1)(2009-2#1)(2010-1#7)(2010-12#4)(2010-4#7)(2010-7#6)(2010-9#5)(2011-1#2)(2011-12#1)(2011-2#9)(2012-3#1)(2013-8#2)
solar-UV##2##1##(2008-2#2)
solar-blind Raman lidars##2##3##(2007-12#1)(2008-3#1)
solar-blind##3##1##(2007-12#2)(2008-3#1)
solar-imaging spectroscopy##2##2##(2008-3#2)
solar-selective##2##1##(2008-3#2)
solarization and##2##2##(2008-10#2)
solarization for##2##2##(2008-10#2)
solarization in the field##2##4##(2008-10#1)(2009-3#1)
solarization of##3##2##(2008-10#2)(2008-2#1)
solarization was##2##2##(2008-10#2)
solarization##25##1##(2008-10#19)(2008-2#3)(2009-3#3)
solasodine glycosides##4##2##(2008-11#4)
sold as##2##2##(2007-8#1)(2008-5#1)
sold by##2##2##(2007-6#1)(2008-3#1)
sold in Chandigarh##2##3##(2007-8#2)
sold in the##3##3##(2007-1#1)(2007-3#1)(2009-4#1)
sold in##13##2##(1996-3#1)(2006-5#1)(2007-1#1)(2007-3#2)(2007-4#1)(2007-7#2)(2007-8#3)(2009-4#1)(2010-2#1)
sold on##2##2##(1991-9#1)(2012-12#1)
sold##31##1##(1990-6#1)(1991-9#1)(1992-10#1)(1996-2#1)(1996-3#2)(2006-5#1)(2007-1#1)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2009-10#1)(2009-4#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-8#1)
solder##5##1##(2008-2#1)(2008-3#4)
soldering##5##1##(1991-4#1)(2008-2#1)(2008-3#3)
soldier##10##1##(2007-10#1)(2007-12#1)(2008-7#1)(2011-12#7)
soldiers and##3##2##(2007-12#1)(2007-8#2)
soldiers in##3##2##(1992-4#1)(1993-2#1)(2007-12#1)
soldiers##25##1##(1990-12#1)(1992-4#1)(1993-2#2)(1995-6#1)(2007-12#5)(2007-7#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#2)(2011-2#1)(2012-12#3)(2012-2#2)
sole carbohydrate source##2##3##(2008-10#2)
sole carbon and energy source##2##5##(2006-3#1)(2006-8#1)
sole carbon source and##3##4##(2008-10#1)(2008-4#1)(2011-1#1)
sole carbon source##19##3##(1997-6#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-6#5)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
sole carbon##22##2##(1997-6#1)(2005-11#1)(2006-3#1)(2006-8#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-6#5)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
sole energy##2##2##(1990-12#1)(1990-5#1)
sole factor##4##2##(1994-11#1)(2007-11#1)(2008-10#1)(2012-2#1)
sole possibility##2##2##(1990-3#1)(1991-5#1)
sole presenting symptom##2##3##(2006-9#1)(2007-2#1)
sole reason##2##2##(1997-5#1)(2006-10#1)
sole source of carbon and energy##2##6##(1994-12#1)(2006-3#1)
sole source of carbon##4##4##(1991-8#1)(1994-12#1)(2006-3#1)(2008-7#1)
sole source of##13##3##(1991-12#1)(1991-8#1)(1994-12#1)(1994-3#1)(1995-6#1)(2004-11#2)(2006-3#2)(2008-10#2)(2008-6#1)(2008-7#1)
sole species##2##2##(2011-2#2)
sole##168##1##(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#2)(1990-9#1)(1991-12#4)(1991-5#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#3)(1995-8#2)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2004-10#1)(2004-11#3)(2004-3#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-3#3)(2006-8#1)(2006-9#1)(2007-11#3)(2007-2#1)(2007-4#2)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#21)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#7)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#2)(2010-2#1)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#10)(2011-3#1)(2012-11#1)(2012-2#4)(2012-3#1)(2013-8#4)
solely as a##2##3##(1997-8#1)(2008-9#1)
solely by the##8##3##(1991-4#1)(2007-12#1)(2007-4#2)(2008-10#1)(2008-2#2)(2009-3#1)
solely by##23##2##(1991-4#1)(1992-1#1)(1993-2#1)(1994-8#1)(1996-4#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-12#2)(2007-4#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-8#1)(2009-3#1)(2012-2#1)(2013-8#1)
solely depend on##2##3##(1996-2#1)(2008-7#1)
solely dependent on##2##3##(2008-10#1)(2009-3#1)
solely derived from##2##3##(2006-8#1)(2008-10#1)
solely due to the##2##4##(1994-12#1)(2012-2#1)
solely due to##5##3##(1993-3#1)(1994-12#1)(1996-12#1)(2007-10#1)(2012-2#1)
solely from the##7##3##(1991-8#1)(1994-8#1)(2007-11#1)(2007-12#1)(2008-3#2)(2013-1#1)
solely from##21##2##(1991-8#1)(1994-2#1)(1994-8#1)(2006-10#3)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#4)(2008-3#4)(2011-2#1)(2013-1#3)
solely in the##5##3##(1990-6#1)(1995-4#1)(1995-8#1)(1997-5#1)(2008-10#1)
solely in##11##2##(1990-6#1)(1990-7#1)(1995-3#1)(1995-4#1)(1995-8#1)(1997-5#1)(2008-10#3)(2008-11#1)(2009-12#1)
solely of##2##2##(2008-10#1)(2013-8#1)
solely on the basis of##6##5##(1992-8#1)(1995-4#1)(1995-6#1)(1996-4#1)(2006-7#1)(2008-9#1)
solely on the##15##3##(1992-8#2)(1995-4#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-4#1)(2006-10#2)(2006-7#1)(2008-3#1)(2008-8#1)(2008-9#2)(2010-2#1)
solely on##43##2##(1991-10#1)(1991-5#1)(1992-12#1)(1992-8#2)(1994-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-4#1)(1995-6#2)(1995-8#1)(1996-2#1)(1996-4#1)(1997-3#1)(1997-7#1)(2006-10#4)(2006-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2010-2#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
solely responsible for the##3##4##(1994-9#1)(1997-9#1)(2008-5#1)
solely responsible for##4##3##(1991-2#1)(1994-9#1)(1997-9#1)(2008-5#1)
solely the##6##2##(1996-5#1)(2008-2#1)(2008-7#1)(2013-1#3)
solely through##2##2##(2008-3#1)(2012-3#1)
solely to##13##2##(1990-9#1)(1992-9#1)(1993-1#1)(1994-8#1)(1995-12#1)(1995-8#2)(1997-4#1)(2005-7#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-7#1)
solely under##2##2##(1991-4#1)(2008-7#1)
solely with##2##2##(1997-2#1)(2008-7#1)
solely##191##1##(1990-12#1)(1990-3#2)(1990-6#1)(1990-7#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#3)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#2)(1995-6#2)(1995-8#4)(1996-11#1)(1996-12#1)(1996-2#3)(1996-4#2)(1996-5#1)(1996-8#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#3)(1997-7#2)(1997-8#2)(1997-9#1)(2005-11#1)(2005-7#1)(2006-10#8)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#15)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#6)(2008-5#2)(2008-6#3)(2008-7#8)(2008-8#5)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#10)(2013-7#1)(2013-8#2)
solenoid actuated##2##2##(2008-10#2)
solenoid micro-pumps##2##2##(2008-10#2)
solenoid valve was##2##3##(2008-10#2)
solenoid valve##4##2##(2007-12#1)(2007-8#1)(2008-10#2)
solenoid valves and##3##3##(2008-10#3)
solenoid valves assembled to##3##4##(2008-10#3)
solenoid valves controlled by##2##4##(2008-10#1)(2008-11#1)
solenoid valves for##2##3##(2008-10#2)
solenoid valves##16##2##(2007-10#1)(2008-10#14)(2008-11#1)
solenoid##28##1##(1991-1#1)(2007-10#3)(2007-12#1)(2007-8#1)(2008-10#21)(2008-11#1)
solenopsis##3##1##(2011-12#3)
soles and##4##2##(1997-3#1)(2007-7#2)(2008-5#1)
soles of the feet##2##4##(1996-3#1)(2012-3#1)
soles##9##1##(1996-3#1)(1997-3#1)(2007-7#2)(2007-8#1)(2008-5#1)(2008-9#1)(2010-6#1)(2012-3#1)
soleus H-reflex##3##2##(1993-12#2)(2013-1#1)
soleus and##4##2##(1993-12#1)(1993-7#1)(2008-6#1)(2013-8#1)
soleus motor##2##2##(1993-12#1)(1993-9#1)
soleus muscle##9##2##(1991-12#1)(1992-8#2)(1993-7#1)(1993-9#1)(1995-12#1)(1995-9#1)(2009-9#1)(2012-7#1)
soleus muscles##4##2##(1991-1#1)(1991-2#1)(1995-12#1)(2012-7#1)
soleus##37##1##(1990-4#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#2)(1992-8#2)(1993-12#6)(1993-7#3)(1993-9#2)(1995-12#4)(1995-9#1)(1996-10#1)(1996-8#5)(2008-6#1)(2009-9#1)(2010-12#1)(2012-7#2)(2013-1#1)(2013-8#1)
solfataricus##12##1##(1990-9#3)(1994-2#1)(1994-9#2)(1995-2#5)(2008-9#1)
solgel fiber##2##2##(2007-11#2)
solgel glasses##3##2##(2008-3#3)
solgel material##2##2##(2007-12#2)
solgel silica lasers##2##3##(2008-3#2)
solgel silica##4##2##(2008-2#1)(2008-3#3)
solgel waveguide##2##2##(2008-3#2)
solgel##25##1##(2007-11#3)(2007-12#4)(2008-1#2)(2008-2#6)(2008-3#10)
solgel-derived##4##1##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
solicit feedback##2##2##(2007-12#1)(2010-7#1)
solicit##6##1##(1992-12#1)(1995-3#1)(2006-8#1)(2007-12#1)(2008-3#1)(2010-7#1)
solicitation##3##1##(1993-12#1)(2010-12#1)(2012-3#1)
solicitations##2##1##(2008-7#1)(2012-12#1)
solicited a##2##2##(1995-12#1)(1996-2#1)
solicited##12##1##(1995-1#3)(1995-12#1)(1996-1#1)(1996-2#1)(2004-3#2)(2006-10#1)(2006-5#1)(2008-5#1)(2012-12#1)
soliciting##4##1##(1990-12#1)(1996-3#1)(2008-1#1)(2008-8#1)
solid 3He##2##2##(1990-12#1)(1993-8#1)
solid C60##3##2##(1991-9#1)(1992-6#1)(2005-4#1)
solid K(2)CO(3)##2##2##(2008-3#1)(2008-5#1)
solid Sarcoma 180##2##3##(1992-7#1)(2008-5#1)
solid abdominal organs##2##3##(2006-11#2)
solid abdominal##3##2##(2006-11#2)(2008-7#1)
solid acid catalysts##2##3##(2007-11#1)(2010-12#1)
solid acid##6##2##(2007-11#1)(2008-10#2)(2008-5#1)(2010-12#2)
solid adsorbents##2##2##(2008-10#2)
solid amalgam electrode##3##3##(2008-10#3)
solid amalgam##5##2##(2008-10#5)
solid and fluid##2##3##(1990-4#1)(2008-10#1)
solid and liquid media##2##4##(2008-10#1)(2011-12#1)
solid and liquid phases##2##4##(2008-2#1)(2008-5#1)
solid and liquid##12##3##(2007-8#1)(2008-10#4)(2008-2#2)(2008-5#2)(2010-12#1)(2010-2#1)(2011-12#1)
solid and the##5##3##(2005-11#3)(2008-10#1)(2010-4#1)
solid and water##3##3##(2007-8#1)(2008-10#2)
solid and##39##2##(1990-4#1)(2005-11#3)(2005-6#1)(2005-7#1)(2006-10#1)(2007-3#1)(2007-8#2)(2008-1#2)(2008-10#9)(2008-12#1)(2008-2#4)(2008-5#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2011-12#3)(2012-2#1)(2013-1#2)
solid angle of the##2##4##(2007-12#1)(2008-2#1)
solid angle of##5##3##(2007-12#2)(2008-2#2)(2008-3#1)
solid angle##10##2##(2006-2#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#3)
solid angles##2##2##(2008-3#2)
solid arthrodesis from##2##3##(2008-8#2)
solid arthrodesis##3##2##(2006-8#1)(2008-8#2)
solid bone fusion##2##3##(2006-8#1)(2008-9#1)
solid bony union##2##3##(1993-8#1)(2008-6#1)
solid bony##4##2##(1993-8#2)(2007-12#1)(2008-6#1)
solid by##3##2##(2007-12#2)(2008-10#1)
solid cancers##2##2##(1993-8#1)(2013-1#1)
solid carbon##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
solid catalysts and##2##3##(2008-1#1)(2008-5#1)
solid complexes##3##2##(2005-4#1)(2008-5#2)
solid concentration##2##2##(2008-5#1)(2011-2#1)
solid contact electrodes##4##3##(2008-10#4)
solid contact sensor for the determination of doxycycline hydrochloride##2##9##(2008-10#2)
solid contact were##2##3##(2008-10#2)
solid contact##11##2##(2008-10#11)
solid crystals##2##2##(2008-2#1)(2008-5#1)
solid data##2##2##(1990-8#1)(1996-1#1)
solid diet and##2##3##(2007-9#2)
solid diet##3##2##(1994-6#1)(2007-9#2)
solid dispersion##5##2##(2011-1#2)(2012-2#3)
solid dispersions##3##2##(2012-2#3)
solid dosage forms##2##3##(2005-10#1)(2008-10#1)
solid dosage##3##2##(2005-10#2)(2008-10#1)
solid earnings##2##2##(1990-7#1)(1995-11#1)
solid electrodes##3##2##(2008-10#3)
solid evidence for##2##3##(2006-8#1)(2009-4#1)
solid evidence##5##2##(2006-2#1)(2006-8#1)(2007-12#1)(2007-4#1)(2009-4#1)
solid explosive##2##2##(2008-10#2)
solid fermentation##3##2##(2008-10#3)
solid food##6##2##(1990-6#2)(2007-7#3)(2011-1#1)
solid foods##5##2##(2007-7#4)(2008-10#1)
solid fraction##2##2##(2008-5#2)
solid fusion##6##2##(2006-8#3)(2008-11#1)(2012-3#2)
solid immersion lens (SIL)##5##4##(2007-12#1)(2008-3#4)
solid immersion lens##13##3##(2007-12#4)(2008-3#9)
solid immersion##14##2##(2007-11#1)(2007-12#4)(2008-3#9)
solid in##3##2##(2005-11#1)(2008-10#1)(2011-2#1)
solid iodine##2##2##(2008-10#2)
solid knowledge##2##2##(2008-10#1)(2010-12#1)
solid lipid nanoparticle##2##3##(2008-5#2)
solid lipid nanoparticles##4##3##(2008-5#2)(2010-1#1)(2012-2#1)
solid lipid##7##2##(1990-4#1)(2008-5#4)(2010-1#1)(2012-2#1)
solid liver##2##2##(2008-3#2)
solid malignancies##2##2##(2005-11#1)(2010-4#1)
solid mass is##3##3##(2008-10#3)
solid mass##10##2##(2008-10#7)(2008-5#1)(2009-8#1)(2012-2#1)
solid masses##2##2##(1990-10#1)(2007-5#1)
solid material##2##2##(2008-10#2)
solid materials##4##2##(2008-10#3)(2008-5#1)
solid matrices##6##2##(1992-11#1)(2008-10#3)(2008-7#1)(2008-9#1)
solid matrix##9##2##(1991-10#1)(2006-6#1)(2007-9#2)(2008-10#4)(2008-2#1)
solid matter##2##2##(2007-10#1)(2008-11#1)
solid media containing##2##3##(1997-4#1)(2005-11#1)
solid media##16##2##(1994-6#1)(1994-8#1)(1997-4#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-9#3)(2010-12#1)(2011-12#2)(2013-7#1)
solid medium previously inoculated with##2##5##(2009-6#1)(2011-1#1)
solid medium##7##2##(1993-9#1)(1994-6#1)(1997-2#1)(2007-1#1)(2008-7#1)(2009-6#1)(2011-1#1)
solid mercury##2##2##(2008-10#2)
solid microspheres##2##2##(2010-4#2)
solid mixture##3##2##(2008-10#3)
solid nodules##2##2##(2012-12#1)(2013-1#1)
solid or liquid media##4##4##(1991-11#1)(2008-10#3)
solid or liquid particles##2##4##(1992-3#2)
solid or liquid##6##3##(1991-11#1)(1992-3#2)(2008-10#3)
solid or##9##2##(1991-11#1)(1992-3#2)(2008-10#4)(2008-9#1)(2010-4#1)
solid organ transplantation##18##3##(1995-2#1)(2006-10#2)(2007-11#10)(2007-12#1)(2008-1#2)(2008-6#1)(2012-3#1)
solid organ transplants##3##3##(2005-7#1)(2010-12#1)(2010-8#1)
solid organ##28##2##(1995-2#1)(2005-7#1)(2006-10#4)(2007-11#12)(2007-12#2)(2008-1#2)(2008-10#1)(2008-6#1)(2009-6#1)(2010-12#1)(2010-8#1)(2012-3#1)
solid organs##9##2##(2006-11#2)(2007-11#1)(2007-12#2)(2007-4#1)(2008-1#1)(2011-2#1)(2013-8#1)
solid pancreatic hamartoma##2##3##(2013-1#2)
solid pancreatic hamartomas##3##3##(2013-1#3)
solid pancreatic##5##2##(2013-1#5)
solid particles##3##2##(1990-12#1)(1996-3#1)(2008-10#1)
solid petrolatum##2##2##(2008-5#2)
solid phantoms##2##2##(2007-10#1)(2008-2#1)
solid phase and##4##3##(1990-12#1)(1993-3#1)(1997-3#1)(2008-10#1)
solid phase assay##3##3##(1991-1#1)(1993-9#1)(2008-7#1)
solid phase assays##2##3##(1993-3#1)(2011-1#1)
solid phase binding##2##3##(1993-2#1)(1994-3#1)
solid phase degradation of l-ascorbic acid##4##6##(2008-10#4)
solid phase domains##2##3##(1990-4#2)
solid phase extractant for##2##4##(2008-10#2)
solid phase extractant##5##3##(2008-10#4)(2008-3#1)
solid phase extraction (SPE) and##4##5##(2008-10#3)(2008-11#1)
solid phase extraction (SPE) cartridges##2##5##(2008-10#2)
solid phase extraction (SPE) method##3##5##(2007-8#1)(2008-10#2)
solid phase extraction (SPE) procedure was##2##6##(2008-10#2)
solid phase extraction (SPE) procedure##5##5##(2007-8#1)(2008-10#4)
solid phase extraction (SPE) systems##2##5##(2008-10#2)
solid phase extraction (SPE)##40##4##(2007-8#4)(2008-10#31)(2008-11#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-8#1)
solid phase extraction and##6##4##(1990-9#1)(2008-10#5)
solid phase extraction cartridge##2##4##(2008-10#1)(2012-12#1)
solid phase extraction cartridges##2##4##(2008-10#2)
solid phase extraction column##2##4##(2009-8#1)(2012-12#1)
solid phase extraction followed by##2##5##(2008-10#2)
solid phase extraction method##2##4##(2007-8#1)(2008-10#1)
solid phase extraction of##8##4##(2008-10#8)
solid phase extraction procedure##3##4##(2008-10#3)
solid phase extraction system##2##4##(2008-10#2)
solid phase extraction systems##2##4##(2007-8#1)(2008-10#1)
solid phase extraction using##3##4##(2008-10#3)
solid phase extraction with##2##4##(2008-10#2)
solid phase extraction##107##3##(1990-9#1)(1993-11#1)(1996-3#1)(2005-11#1)(2007-8#10)(2008-10#82)(2008-11#1)(2009-10#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-12#3)(2013-1#1)(2013-7#1)(2013-8#1)
solid phase extractive preconcentration and separation of##2##7##(2008-10#2)
solid phase extractive preconcentration of##3##5##(2008-10#3)
solid phase extractive preconcentration##6##4##(2008-10#6)
solid phase extractor for##3##4##(2008-10#3)
solid phase extractor##4##3##(2008-10#4)
solid phase immunoassay##2##3##(1993-4#2)
solid phase lipid##2##3##(1990-4#2)
solid phase micro extraction##3##4##(2008-10#2)(2009-3#1)
solid phase micro-extraction##4##3##(1996-12#1)(2008-10#3)
solid phase microextraction (HSSPME)##2##4##(2008-10#2)
solid phase microextraction (SPME) and##2##5##(2007-8#1)(2008-10#1)
solid phase microextraction (SPME) fiber##2##5##(2007-8#1)(2012-1#1)
solid phase microextraction (SPME) to##2##5##(2008-10#2)
solid phase microextraction (SPME)##10##4##(2007-8#2)(2008-10#7)(2012-1#1)
solid phase microextraction coupled##2##4##(2008-10#2)
solid phase microextraction technique (SPME)##2##5##(2007-8#1)(2008-3#1)
solid phase microextraction##28##3##(2007-11#1)(2007-8#7)(2008-10#17)(2008-3#1)(2011-12#1)(2012-1#1)
solid phase microextraction-gas chromatography##2##4##(2007-8#1)(2010-4#1)
solid phase microextraction-gas##4##3##(2007-8#1)(2008-10#2)(2010-4#1)
solid phase protein A##2##4##(1996-12#2)
solid phase spectrophotometric##3##3##(2008-10#3)
solid phase spectrophotometry##3##3##(2008-10#3)
solid phase synthesis of##2##4##(1996-7#1)(2007-10#1)
solid phase synthesis##3##3##(1996-7#1)(2007-10#1)(2008-10#1)
solid phase##274##2##(1990-12#4)(1990-2#1)(1990-4#4)(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-2#2)(1993-3#3)(1993-4#2)(1993-9#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-12#3)(1996-3#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#2)(2005-11#2)(2006-12#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-8#19)(2008-10#169)(2008-11#2)(2008-3#3)(2008-4#4)(2008-5#4)(2008-7#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#3)(2013-1#2)(2013-7#1)(2013-8#3)
solid phases##5##2##(1994-6#1)(1994-9#1)(2004-9#1)(2008-5#1)(2013-1#1)
solid polymer##2##2##(1991-11#1)(2008-10#1)
solid propellants##2##2##(2008-10#2)
solid pseudopapillary##2##2##(2008-3#1)(2013-8#1)
solid residue##2##2##(2007-10#1)(2008-5#1)
solid sample by##2##3##(2007-8#1)(2008-10#1)
solid sample##13##2##(2005-4#1)(2007-8#1)(2008-10#9)(2008-3#1)(2013-7#1)
solid samples and##4##3##(2008-10#4)
solid samples by##2##3##(2008-10#2)
solid samples has##2##3##(2008-10#2)
solid samples using the##2##4##(2008-10#2)
solid samples was##4##3##(2008-1#1)(2008-10#3)
solid samples were##2##3##(2008-10#2)
solid samples##30##2##(2007-8#2)(2008-1#2)(2008-10#25)(2012-1#1)
solid sampling electrothermal atomic absorption spectrometry##2##6##(2008-10#2)
solid sampling##7##2##(2008-10#7)
solid sampling-graphite furnace atomic absorption spectrometry##2##6##(2007-8#1)(2008-10#1)
solid sensing zone##2##3##(2008-10#2)
solid sensing##3##2##(2008-10#3)
solid solution##11##2##(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-5#2)(2010-7#1)(2012-2#1)
solid sorbents##5##2##(2007-8#2)(2008-10#3)
solid spheres##4##2##(2005-11#4)
solid state (13)C NMR##3##4##(2008-10#3)
solid state 13C##2##3##(1995-3#1)(2013-8#1)
solid state NMR##5##3##(1994-9#1)(1995-10#3)(2005-11#1)
solid state and in solution##4##5##(2007-10#1)(2008-4#1)(2011-2#2)
solid state and in##5##4##(2007-10#1)(2008-3#1)(2008-4#1)(2011-2#2)
solid state and##8##3##(1992-2#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2011-2#2)
solid state bioprocessing of##2##4##(1997-2#2)
solid state bioprocessing##3##3##(1997-2#3)
solid state fermentation##5##3##(2008-5#5)
solid state reaction at room temperature##2##6##(2005-11#2)
solid state reaction at##3##4##(2005-11#2)(2010-7#1)
solid state reaction##4##3##(2005-11#2)(2008-10#1)(2010-7#1)
solid state structures##3##3##(1996-2#3)
solid state##65##2##(1991-11#1)(1992-2#1)(1993-3#1)(1994-9#1)(1995-10#3)(1995-3#1)(1996-2#5)(1997-2#4)(1997-4#1)(1997-7#2)(2004-12#2)(2005-11#3)(2005-4#2)(2007-10#3)(2007-11#1)(2007-9#1)(2008-10#9)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#1)(2010-12#1)(2010-5#5)(2010-7#1)(2011-2#3)(2013-8#2)
solid substrate inoculum##2##3##(2008-10#2)
solid substrate room temperature phosphorescence (SS-RTP)##2##6##(2008-10#2)
solid substrate room temperature phosphorescence##3##5##(2008-10#3)
solid substrate##18##2##(1992-11#1)(1997-2#1)(2005-11#2)(2008-10#11)(2008-2#1)(2008-5#1)(2008-7#1)
solid substrate-room temperature phosphorimetry##2##4##(2008-10#2)
solid substrates##11##2##(1994-11#1)(2005-11#1)(2007-8#2)(2008-10#3)(2008-4#1)(2008-7#1)(2009-6#1)(2010-4#1)
solid support and##5##3##(1994-6#1)(2008-10#2)(2008-4#2)
solid support is##4##3##(2008-10#2)(2012-11#2)
solid support of##3##3##(1994-11#1)(2008-10#2)
solid support surface##3##3##(1993-3#1)(2006-5#1)(2013-8#1)
solid support was##3##3##(2007-10#1)(2008-10#2)
solid support##55##2##(1991-7#1)(1993-12#1)(1993-3#1)(1994-11#2)(1994-6#1)(2006-5#1)(2007-10#1)(2008-10#26)(2008-2#1)(2008-4#10)(2008-5#1)(2008-6#1)(2009-12#1)(2012-11#6)(2013-8#1)
solid supports for##2##3##(2008-10#1)(2008-12#1)
solid supports##10##2##(1995-7#1)(1997-3#1)(1997-4#2)(2008-10#4)(2008-12#1)(2013-8#1)
solid surface fluorescence##2##3##(2008-10#2)
solid surface fluorescence-based sensing##2##4##(2008-10#2)
solid surface is##2##3##(2008-10#2)
solid surface##15##2##(2005-11#3)(2008-10#8)(2008-11#1)(2008-7#1)(2009-4#1)(2012-2#1)
solid surfaces for##2##3##(2008-10#1)(2009-11#1)
solid surfaces##9##2##(1990-7#1)(1994-6#2)(2005-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-11#1)(2010-7#1)
solid system with##2##3##(2010-12#2)
solid targets##3##2##(1992-12#1)(2007-11#1)(2008-1#1)
solid tissues##3##2##(2007-12#1)(2008-2#2)
solid to##3##2##(1990-4#1)(1996-4#1)(2013-1#1)
solid tubular carcinoma##2##3##(1995-4#2)
solid tubular##5##2##(1995-4#5)
solid tumor cell lines##2##4##(2008-5#1)(2012-12#1)
solid tumor cells##3##3##(1990-12#1)(1993-12#1)(2008-11#1)
solid tumor##19##2##(1990-12#1)(1992-12#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-9#1)(2006-9#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-5#1)(2010-7#1)(2012-12#2)(2012-2#1)
solid tumors and##14##3##(1994-4#1)(2007-7#1)(2008-1#2)(2008-3#1)(2008-4#1)(2008-7#4)(2009-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
solid tumors are##2##3##(1991-7#1)(2008-11#1)
solid tumors by##3##3##(2008-9#1)(2011-2#1)(2012-12#1)
solid tumors have been##2##4##(2006-6#1)(2008-5#1)
solid tumors have##4##3##(2006-6#2)(2008-5#1)(2010-11#1)
solid tumors in##2##3##(1990-2#1)(1996-7#1)
solid tumors is##2##3##(1991-9#1)(2008-7#1)
solid tumors with##3##3##(1991-10#1)(2008-7#2)
solid tumors##93##2##(1990-2#3)(1991-10#3)(1991-7#1)(1991-9#2)(1992-10#2)(1992-4#1)(1992-9#1)(1993-12#1)(1994-4#1)(1994-9#1)(1996-10#1)(1996-7#1)(2005-6#1)(2005-8#1)(2006-11#3)(2006-5#1)(2006-6#7)(2006-9#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#23)(2008-9#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-11#2)(2012-12#4)(2013-1#4)(2013-8#1)
solid tumour##6##2##(2006-10#1)(2008-1#1)(2008-11#1)(2008-7#2)(2013-8#1)
solid tumours in##3##3##(1992-6#1)(2006-6#1)(2010-9#1)
solid tumours##19##2##(1992-6#1)(1993-9#2)(1994-10#3)(1997-4#1)(2006-6#2)(2007-11#2)(2007-7#1)(2007-9#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-9#1)(2013-7#1)
solid variant of##3##3##(2007-6#1)(2012-2#2)
solid variant##4##2##(2007-6#2)(2012-2#2)
solid waste disposal##3##3##(2008-12#2)(2008-6#1)
solid waste##15##2##(2008-10#4)(2008-12#4)(2008-6#2)(2009-6#4)(2012-12#1)
solid wastes##4##2##(1997-4#1)(2008-10#1)(2008-5#2)
solid wood##2##2##(2006-12#1)(2008-10#1)
solid##1321##1##(1990-10#3)(1990-12#8)(1990-2#5)(1990-3#1)(1990-4#8)(1990-6#3)(1990-7#4)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#4)(1991-11#4)(1991-12#1)(1991-2#1)(1991-5#2)(1991-7#2)(1991-9#5)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#7)(1993-4#2)(1993-6#2)(1993-8#6)(1993-9#7)(1994-10#3)(1994-11#3)(1994-12#1)(1994-3#2)(1994-4#1)(1994-6#7)(1994-7#1)(1994-8#3)(1994-9#4)(1995-1#3)(1995-10#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-4#5)(1995-6#2)(1995-7#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#7)(1996-3#3)(1996-4#1)(1996-7#2)(1997-1#1)(1997-2#8)(1997-3#3)(1997-4#8)(1997-7#4)(2004-12#3)(2004-8#1)(2004-9#2)(2005-10#5)(2005-11#37)(2005-4#7)(2005-6#2)(2005-7#3)(2005-8#3)(2005-9#1)(2006-1#2)(2006-10#7)(2006-11#8)(2006-12#4)(2006-2#2)(2006-3#1)(2006-5#2)(2006-6#11)(2006-7#1)(2006-8#6)(2006-9#2)(2007-1#4)(2007-10#8)(2007-11#26)(2007-12#26)(2007-2#1)(2007-3#1)(2007-4#5)(2007-5#1)(2007-6#3)(2007-7#11)(2007-8#30)(2007-9#10)(2008-1#18)(2008-10#429)(2008-11#16)(2008-12#10)(2008-2#29)(2008-3#37)(2008-4#25)(2008-5#58)(2008-6#8)(2008-7#39)(2008-8#4)(2008-9#13)(2009-10#1)(2009-11#3)(2009-12#4)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#7)(2009-8#4)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#16)(2010-2#1)(2010-3#2)(2010-4#8)(2010-5#8)(2010-6#1)(2010-7#5)(2010-8#1)(2010-9#3)(2011-1#9)(2011-12#6)(2011-2#14)(2012-1#4)(2012-11#8)(2012-12#12)(2012-2#21)(2012-3#4)(2013-1#31)(2013-7#4)(2013-8#16)
solid&quot##4##1##(1992-3#1)(1994-5#2)(2008-10#1)
solid-contact##4##1##(2008-10#4)
solid-fluid##2##1##(2007-2#1)(2008-3#1)
solid-like##2##1##(1991-11#1)(2006-7#1)
solid-liquid extraction of##2##3##(2008-10#2)
solid-liquid extraction##12##2##(2008-10#12)
solid-liquid interface##5##2##(2005-11#4)(2008-7#1)
solid-liquid transition of the PDTS##2##5##(2005-11#2)
solid-liquid transition##3##2##(2005-11#3)
solid-liquid##28##1##(2005-11#8)(2006-3#1)(2008-10#16)(2008-7#1)(2012-1#1)(2013-1#1)
solid-matrix luminescence##3##2##(2008-10#3)
solid-matrix phosphorescence##2##2##(2008-10#2)
solid-matrix##7##1##(2007-8#1)(2008-10#6)
solid-organ transplant##2##2##(2006-10#1)(2007-11#1)
solid-organ##3##1##(2006-10#2)(2007-11#1)
solid-phase PbO(2)##2##2##(2008-10#2)
solid-phase and##4##2##(1992-6#1)(1993-11#1)(1996-1#2)
solid-phase assay##5##2##(1990-12#1)(1991-7#1)(1992-8#1)(1994-9#1)(2008-1#1)
solid-phase assembly##2##2##(2008-4#1)(2010-12#1)
solid-phase enzyme-linked##2##2##(1992-1#1)(1992-8#1)
solid-phase extraction (SPE) and##3##4##(2008-10#1)(2010-9#1)(2012-12#1)
solid-phase extraction (SPE) on##2##4##(1997-8#1)(2008-10#1)
solid-phase extraction (SPE) using##2##4##(2008-10#2)
solid-phase extraction (SPE)##24##3##(1996-6#1)(1996-8#1)(1997-2#1)(1997-8#2)(2007-8#1)(2008-10#15)(2010-9#2)(2012-12#1)
solid-phase extraction and gas chromatography-mass spectrometry##2##6##(2008-10#2)
solid-phase extraction and gas chromatography-mass##3##5##(2008-10#3)
solid-phase extraction and##24##3##(1992-1#1)(1992-11#1)(1992-2#3)(1993-2#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-8#1)(2008-10#10)(2008-11#1)
solid-phase extraction by##2##3##(2008-10#2)
solid-phase extraction cartridges##3##3##(1992-2#1)(1996-8#1)(2008-10#1)
solid-phase extraction coupled##2##3##(1996-11#1)(2008-10#1)
solid-phase extraction device##2##3##(1997-2#2)
solid-phase extraction followed by liquid##2##5##(2008-10#1)(2010-4#1)
solid-phase extraction method##3##3##(1992-1#1)(2007-8#1)(2008-10#1)
solid-phase extraction of the##2##4##(2008-10#2)
solid-phase extraction of##10##3##(1997-2#1)(2007-5#1)(2008-10#7)(2008-4#1)
solid-phase extraction support##2##3##(2008-10#2)
solid-phase extraction system##2##3##(2008-10#2)
solid-phase extraction technique##4##3##(1990-9#1)(1992-11#1)(2008-10#1)(2013-8#1)
solid-phase extraction using a##2##4##(1996-5#1)(2007-8#1)
solid-phase extraction using##8##3##(1990-9#1)(1996-5#1)(1996-8#1)(2007-8#1)(2008-10#4)
solid-phase extraction was##3##3##(1996-11#1)(2008-10#2)
solid-phase extraction with a##3##4##(1992-7#1)(1997-3#1)(2008-10#1)
solid-phase extraction with##7##3##(1992-2#1)(1992-7#1)(1997-3#1)(2008-10#4)
solid-phase extraction##137##2##(1990-6#3)(1990-9#2)(1991-8#2)(1992-1#2)(1992-11#4)(1992-2#6)(1992-7#1)(1993-2#3)(1996-11#3)(1996-3#2)(1996-5#3)(1996-6#3)(1996-8#4)(1997-2#9)(1997-3#8)(1997-8#3)(2007-5#1)(2007-8#4)(2008-10#64)(2008-11#1)(2008-4#1)(2008-5#2)(2010-4#1)(2010-9#2)(2012-12#1)(2013-7#1)(2013-8#1)
solid-phase extractions##2##2##(1997-2#1)(2007-12#1)
solid-phase immunoassay##2##2##(1990-12#1)(1990-8#1)
solid-phase immunoassays##2##2##(1994-9#2)
solid-phase method##4##2##(1994-6#1)(1995-6#1)(1996-8#1)(2008-9#1)
solid-phase methods##2##2##(1992-6#1)(2005-8#1)
solid-phase microextraction (HS-SPME) for the##2##5##(2007-8#1)(2008-10#1)
solid-phase microextraction (HS-SPME)##8##3##(2007-8#3)(2008-10#4)(2012-1#1)
solid-phase microextraction (SPME) fiber##2##4##(2008-10#2)
solid-phase microextraction (SPME) with##2##4##(2008-10#2)
solid-phase microextraction (SPME)##15##3##(2008-10#15)
solid-phase microextraction and gas##2##4##(2007-8#1)(2008-10#1)
solid-phase microextraction and##4##3##(2007-8#1)(2008-10#3)
solid-phase microextraction coupled with gas##2##5##(2007-8#1)(2008-10#1)
solid-phase microextraction coupled with high-performance liquid chromatography##2##7##(2008-10#2)
solid-phase microextraction coupled with##4##4##(2007-8#1)(2008-10#3)
solid-phase microextraction coupled##5##3##(2007-8#1)(2008-10#4)
solid-phase microextraction using calix[4]arene fiber##2##5##(2008-10#2)
solid-phase microextraction with##2##3##(2008-10#2)
solid-phase microextraction##53##2##(1997-2#1)(2007-8#5)(2008-10#44)(2012-1#2)(2012-12#1)
solid-phase organic synthesis##2##3##(1997-4#2)
solid-phase organic##3##2##(1997-3#1)(1997-4#2)
solid-phase peptide synthesis##4##3##(1992-5#1)(2008-2#1)(2008-4#2)
solid-phase procedures##2##2##(1991-3#1)(1995-1#1)
solid-phase reactants are##2##3##(2008-4#2)
solid-phase reactants##3##2##(2008-4#3)
solid-phase reactor##2##2##(2008-10#2)
solid-phase reagents##2##2##(2008-10#1)(2008-4#1)
solid-phase spectrofluorimetry##2##2##(2008-10#2)
solid-phase spectrophotometric##2##2##(2008-10#2)
solid-phase spectrophotometry##3##2##(2008-10#3)
solid-phase synthesis and##3##3##(1993-11#1)(2006-12#1)(2008-4#1)
solid-phase synthesis of malondiamides##2##4##(2007-11#2)
solid-phase synthesis of oligosaccharides##2##4##(1997-4#2)
solid-phase synthesis of##13##3##(1991-10#1)(1997-3#1)(1997-4#2)(2006-12#1)(2007-11#2)(2008-4#6)
solid-phase synthesis##23##2##(1991-10#1)(1993-11#1)(1997-3#1)(1997-4#5)(2005-8#1)(2006-12#4)(2007-11#2)(2008-4#8)
solid-phase techniques##3##2##(1992-3#1)(2008-2#1)(2008-4#1)
solid-phase technology##2##2##(1992-6#1)(2008-4#1)
solid-phase##338##1##(1990-10#1)(1990-12#3)(1990-4#1)(1990-6#3)(1990-8#1)(1990-9#2)(1991-10#1)(1991-3#1)(1991-7#1)(1991-8#3)(1992-1#3)(1992-11#4)(1992-2#7)(1992-3#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#2)(1993-11#2)(1993-2#3)(1993-4#1)(1994-12#2)(1994-6#4)(1994-9#4)(1995-1#2)(1995-2#1)(1995-6#2)(1995-8#1)(1996-1#2)(1996-11#3)(1996-3#2)(1996-5#3)(1996-6#4)(1996-8#6)(1997-2#11)(1997-3#12)(1997-4#8)(1997-8#3)(2005-8#2)(2006-12#6)(2007-11#4)(2007-12#2)(2007-5#1)(2007-6#1)(2007-8#12)(2008-1#3)(2008-10#142)(2008-11#1)(2008-2#6)(2008-4#26)(2008-5#2)(2008-9#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-9#2)(2012-1#2)(2012-12#4)(2012-2#1)(2013-7#1)(2013-8#1)
solid-pseudopapillary##2##1##(2010-12#2)
solid-solid##3##1##(1992-2#1)(2006-12#1)(2007-11#1)
solid-state NMR and##2##3##(2005-11#1)(2010-7#1)
solid-state NMR spectroscopy##7##3##(2005-11#1)(2010-12#1)(2010-7#1)(2012-2#4)
solid-state NMR##15##2##(1991-11#2)(1995-10#1)(2005-11#2)(2010-12#1)(2010-4#1)(2010-7#2)(2011-1#2)(2012-2#4)
solid-state and##5##2##(2007-12#1)(2008-10#2)(2008-7#1)(2012-2#1)
solid-state contact##3##2##(2008-10#3)
solid-state detector##3##2##(2006-4#1)(2006-5#1)(2008-2#1)
solid-state device##2##2##(2008-7#1)(2012-2#1)
solid-state dye laser##4##3##(2008-2#2)(2008-3#2)
solid-state dye lasers##5##3##(2008-2#2)(2008-3#3)
solid-state dye##10##2##(2007-12#1)(2008-2#4)(2008-3#5)
solid-state electrochemiluminescence##2##2##(2008-10#2)
solid-state electrodes##3##2##(2008-10#3)
solid-state fermentation##2##2##(2011-2#2)
solid-state gain medium##3##3##(2007-11#1)(2008-2#2)
solid-state laser is##2##3##(2007-11#1)(2007-12#1)
solid-state laser with a##3##4##(2007-12#1)(2008-3#2)
solid-state laser##27##2##(2007-11#7)(2007-12#11)(2008-2#3)(2008-3#6)
solid-state lasers based on##3##4##(2007-12#2)(2008-3#1)
solid-state lasers is##2##3##(2007-12#1)(2007-8#1)
solid-state lasers with##3##3##(2007-11#2)(2008-2#1)
solid-state lasers##22##2##(2007-11#6)(2007-12#7)(2007-8#1)(2008-2#3)(2008-3#4)(2013-1#1)
solid-state nanopore##3##2##(2008-7#3)
solid-state nanopores##2##2##(2008-7#2)
solid-state saturable##3##2##(2008-2#1)(2008-3#2)
solid-state##173##1##(1991-11#2)(1991-4#1)(1991-6#1)(1992-1#1)(1992-2#1)(1995-10#2)(1996-2#1)(2005-11#2)(2006-12#3)(2006-4#2)(2006-5#1)(2007-11#14)(2007-12#31)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#24)(2008-2#24)(2008-3#25)(2008-7#9)(2008-9#1)(2009-10#1)(2010-12#2)(2010-4#2)(2010-5#3)(2010-7#2)(2011-1#2)(2011-2#2)(2012-2#7)(2013-1#2)
solid-support assisted on-line derivatization##2##4##(2008-10#2)
solid-support assisted##3##2##(2008-10#3)
solid-surface fluorescence##2##2##(2008-10#2)
solid-surface##4##1##(2008-10#4)
solid-to-liquid ratio##2##2##(2008-5#2)
solid-to-liquid##3##1##(2005-11#1)(2008-5#2)
solid/liquid##3##1##(2004-9#1)(2005-11#1)(2008-7#1)
solidarity and##3##2##(1997-8#1)(2008-7#1)(2009-9#1)
solidarity##19##1##(1992-11#1)(1997-8#6)(2006-2#1)(2006-4#1)(2007-8#1)(2008-12#1)(2008-7#3)(2009-10#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
solidification of##2##2##(2008-2#1)(2011-1#1)
solidification##7##1##(1993-5#1)(2008-2#1)(2008-5#1)(2010-8#1)(2011-1#1)(2011-12#2)
solidified in a##2##3##(2008-10#1)(2010-2#1)
solidified wastes##2##2##(2008-10#2)
solidified with##3##2##(2006-3#2)(2007-11#1)
solidified##9##1##(2006-3#2)(2007-11#1)(2008-10#3)(2008-5#1)(2010-2#1)(2011-1#1)
solidify##4##1##(2009-4#1)(2010-8#1)(2013-1#2)
solidifying##4##1##(1991-2#1)(2008-12#1)(2008-5#2)
solidity##3##1##(1990-3#1)(2008-5#1)(2012-1#1)
solidphase##2##1##(2008-7#1)(2012-12#1)
solids and liquids##2##3##(2008-3#2)
solids and##9##2##(1995-10#1)(2004-4#1)(2008-10#2)(2008-2#1)(2008-3#2)(2011-2#1)(2012-2#1)
solids content##8##2##(2007-11#4)(2008-5#2)(2009-6#1)(2011-2#1)
solids has##2##2##(2005-11#1)(2008-10#1)
solids have been##3##3##(2005-11#1)(2008-10#2)
solids in the##2##3##(2007-5#1)(2008-10#1)
solids such as##3##3##(2008-1#1)(2008-10#1)(2008-2#1)
solids that##2##2##(2005-11#1)(2008-10#1)
solids##108##1##(1991-6#1)(1992-6#1)(1993-4#1)(1994-12#1)(1995-10#1)(1995-11#1)(1997-2#1)(2004-4#1)(2005-11#11)(2006-8#1)(2007-10#3)(2007-11#6)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#4)(2008-10#25)(2008-12#1)(2008-2#6)(2008-3#2)(2008-5#11)(2008-6#1)(2009-2#1)(2009-6#3)(2010-12#1)(2010-5#2)(2011-2#4)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#1)
solids) and##2##2##(2008-5#2)
solids)##5##1##(2008-5#5)
solidus##3##1##(2004-9#1)(2010-8#2)
solitarily##3##1##(2008-8#1)(2008-9#1)(2010-7#1)
solitary RCC metastasis to the head of pancreas##2##8##(2008-3#2)
solitary RCC##3##2##(2006-9#1)(2008-3#2)
solitary acoustic tumors and##2##4##(2006-11#2)
solitary and##5##2##(1997-1#1)(2007-11#1)(2008-9#1)(2012-3#1)(2013-7#1)
solitary beams##3##2##(2007-12#3)
solitary bees##2##2##(2008-7#1)(2011-12#1)
solitary bone##3##2##(2007-7#1)(2008-6#1)(2013-1#1)
solitary brain metastasis##3##3##(2006-7#1)(2008-6#2)
solitary brain##5##2##(2005-1#2)(2006-7#1)(2008-6#2)
solitary cells##2##2##(1994-6#1)(2008-10#1)
solitary complex in vitro##2##4##(1992-9#2)
solitary complex##3##2##(1992-9#3)
solitary costal exostosis##2##3##(2007-8#2)
solitary cutaneous infantile myofibroma##2##4##(2007-10#2)
solitary cutaneous##3##2##(2007-10#2)(2007-7#1)
solitary cysts##2##2##(2007-1#1)(2013-1#1)
solitary extramedullary plasmacytoma##2##3##(2009-3#2)
solitary fibrous tumor##3##3##(2007-8#3)
solitary fibrous tumour in the retroperitoneum##2##6##(2012-3#2)
solitary fibrous tumour of the pleura##2##6##(2010-3#1)(2011-1#1)
solitary fibrous tumour of the##3##5##(2004-2#1)(2010-3#1)(2011-1#1)
solitary fibrous tumour of##4##4##(2004-2#1)(2010-3#1)(2011-1#2)
solitary fibrous tumour##6##3##(2004-2#1)(2010-3#1)(2011-1#2)(2012-3#2)
solitary fibrous tumours##2##3##(2004-2#2)
solitary fibrous##11##2##(2004-2#3)(2007-8#3)(2010-3#1)(2011-1#2)(2012-3#2)
solitary foragers##2##2##(2008-9#2)
solitary infantile myofibroma##2##3##(2011-1#1)(2012-2#1)
solitary kidney in##2##3##(2012-12#1)(2012-2#1)
solitary kidney##6##2##(2006-7#1)(2012-12#3)(2012-2#2)
solitary lesion##3##2##(1993-10#1)(2007-8#1)(2013-7#1)
solitary lesions##2##2##(2013-1#1)(2013-8#1)
solitary metastases of##2##3##(1990-8#1)(2007-11#1)
solitary metastases##5##2##(1990-8#1)(1992-12#1)(2006-10#1)(2007-11#1)(2008-10#1)
solitary metastasis##2##2##(1990-8#1)(2005-1#1)
solitary nodule##2##2##(2007-8#1)(2012-3#1)
solitary nodules##2##2##(2012-3#2)
solitary nonparasitic cyst of the##2##5##(1991-3#2)
solitary or multiple##3##3##(2007-7#1)(2008-6#1)(2010-3#1)
solitary pancreas transplantation##2##3##(2007-11#2)
solitary plasmacytoma##3##2##(2009-3#1)(2012-12#2)
solitary pulmonary nodule##3##3##(2007-8#2)(2008-1#1)
solitary pulmonary##5##2##(1991-3#1)(2007-8#3)(2008-1#1)
solitary solid##2##2##(1993-6#1)(2013-1#1)
solitary species##2##2##(2008-6#1)(2008-9#1)
solitary thyroid nodule##2##3##(1992-9#1)(2006-1#1)
solitary tract nucleus##3##3##(1991-11#1)(1994-6#1)(1996-8#1)
solitary tract##19##2##(1991-11#5)(1992-8#2)(1992-9#1)(1993-12#2)(1993-2#1)(1994-10#1)(1994-6#1)(1995-5#2)(1996-5#1)(1996-8#1)(1997-8#1)(2013-1#1)
solitary tumors##4##2##(1992-11#1)(2006-11#3)
solitary wasps and bees##4##4##(2008-6#4)
solitary waves can##2##3##(2007-12#1)(2008-1#1)
solitary waves in a##3##4##(2007-12#2)(2008-1#1)
solitary waves in quadratic##2##4##(2007-12#2)
solitary waves in the##2##4##(2007-12#2)
solitary waves in##9##3##(2007-12#8)(2008-1#1)
solitary waves is##2##3##(2007-12#1)(2008-1#1)
solitary waves that##2##3##(2007-12#2)
solitary waves##25##2##(2007-11#1)(2007-12#18)(2008-1#6)
solitary##232##1##(1990-11#1)(1990-12#1)(1990-8#3)(1990-9#1)(1991-11#5)(1991-3#4)(1991-9#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#2)(1992-9#5)(1993-10#2)(1993-12#2)(1993-2#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-6#3)(1995-1#1)(1995-11#1)(1995-4#1)(1995-5#2)(1996-1#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-5#1)(1997-8#1)(2004-2#3)(2005-1#3)(2005-12#4)(2006-1#2)(2006-10#1)(2006-11#6)(2006-7#3)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#24)(2007-7#6)(2007-8#11)(2007-9#1)(2008-1#8)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#12)(2008-7#3)(2008-8#1)(2008-9#7)(2009-3#6)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#2)(2010-6#3)(2010-8#1)(2011-1#5)(2011-12#2)(2011-2#6)(2012-1#1)(2012-12#11)(2012-2#5)(2012-3#6)(2013-1#9)(2013-7#4)(2013-8#1)
solitary-wave##3##1##(2007-12#1)(2008-1#2)
soliton and##6##2##(2007-11#1)(2007-12#3)(2008-1#2)
soliton at##2##2##(2007-12#2)
soliton beams in Kerr media##2##5##(2007-12#2)
soliton can be##3##3##(2007-12#3)
soliton collisions##4##2##(2007-11#2)(2007-12#2)
soliton compressor##2##2##(2007-12#2)
soliton control##2##2##(2007-12#2)
soliton dynamics##2##2##(2007-12#1)(2008-1#1)
soliton energy is##2##3##(2007-12#1)(2008-1#1)
soliton energy##5##2##(2007-12#2)(2008-1#3)
soliton existence##2##2##(2007-12#2)
soliton fiber laser##4##3##(2007-11#1)(2007-12#3)
soliton fiber##5##2##(2007-11#1)(2007-12#4)
soliton formation##6##2##(2007-11#1)(2007-12#4)(2008-1#1)
soliton generation and##2##3##(2007-11#1)(2007-12#1)
soliton generation by##2##3##(2007-12#1)(2008-1#1)
soliton generation##8##2##(2007-11#3)(2007-12#4)(2008-1#1)
soliton in a##5##3##(2007-11#1)(2007-12#4)
soliton in##8##2##(2007-11#2)(2007-12#6)
soliton induces a##2##3##(2007-11#1)(2008-3#1)
soliton interaction in##2##3##(2007-12#2)
soliton interaction##3##2##(2007-12#3)
soliton interactions in##2##3##(2007-11#1)(2007-12#1)
soliton interactions##4##2##(2007-11#1)(2007-12#3)
soliton is##3##2##(2007-11#1)(2007-12#2)
soliton laser##2##2##(2007-12#2)
soliton lasers##2##2##(2007-12#2)
soliton mode locking##2##3##(2007-11#1)(2007-12#1)
soliton pairs in##3##3##(2007-11#1)(2007-12#2)
soliton pairs##4##2##(2007-11#1)(2007-12#3)
soliton pixels##2##2##(2007-11#2)
soliton propagation in##3##3##(2007-12#2)(2008-1#1)
soliton propagation##9##2##(2007-12#6)(2008-1#1)(2008-2#1)(2008-3#1)
soliton pulse##5##2##(2007-11#4)(2007-12#1)
soliton pulses##5##2##(2007-11#3)(2007-12#2)
soliton self-frequency shift by##2##4##(2007-11#2)
soliton self-frequency shift##4##3##(2007-11#4)
soliton solutions##4##2##(2007-12#4)
soliton switching in a##2##4##(2008-3#2)
soliton system##9##2##(2007-11#1)(2007-12#7)(2008-1#1)
soliton systems##8##2##(2007-11#4)(2007-12#3)(2008-1#1)
soliton that##2##2##(2007-12#2)
soliton to##2##2##(2007-12#1)(2008-1#1)
soliton train##2##2##(2007-11#1)(2007-12#1)
soliton transmission in##2##3##(2007-12#2)
soliton transmission over##2##3##(2007-12#2)
soliton transmission system##3##3##(2007-11#1)(2007-12#2)
soliton transmission systems##3##3##(2007-12#2)(2008-1#1)
soliton transmission with##2##3##(2007-11#1)(2007-12#1)
soliton transmission##17##2##(2007-11#3)(2007-12#11)(2008-1#3)
soliton with##3##2##(2007-11#1)(2007-12#2)
soliton##238##1##(1992-11#1)(2007-11#53)(2007-12#151)(2008-1#25)(2008-2#2)(2008-3#6)
soliton-induced waveguides##7##2##(2007-11#1)(2007-12#5)(2008-1#1)
soliton-induced##8##1##(2007-11#2)(2007-12#5)(2008-1#1)
soliton-transmission systems##2##2##(2007-12#1)(2008-2#1)
solitonic gluons##3##2##(2007-12#3)
solitonlike pulses##4##2##(2007-11#1)(2007-12#3)
solitons along##2##2##(2007-11#1)(2007-12#1)
solitons and show that the##2##5##(2007-12#2)
solitons and the##2##3##(2007-11#1)(2007-12#1)
solitons and##17##2##(1991-12#1)(2007-11#5)(2007-12#11)
solitons are observed##4##3##(2007-11#1)(2007-12#3)
solitons are##15##2##(2007-11#5)(2007-12#10)
solitons can be##2##3##(2007-12#2)
solitons can##5##2##(2007-11#1)(2007-12#4)
solitons do##2##2##(2007-12#2)
solitons excited##3##2##(2007-12#2)(2008-1#1)
solitons exist in##3##3##(2007-11#1)(2007-12#2)
solitons exist##5##2##(2007-11#2)(2007-12#3)
solitons exists##2##2##(2007-12#1)(2008-1#1)
solitons for##5##2##(2007-12#5)
solitons formed##2##2##(2007-12#1)(2008-1#1)
solitons from##2##2##(2007-11#1)(2007-12#1)
solitons in LiNbO(3)##2##3##(2007-12#1)(2008-2#1)
solitons in a bulk##3##4##(2007-12#3)
solitons in a planar##2##4##(2007-12#2)
solitons in a quadratic nonlinear##2##5##(2007-12#2)
solitons in a quadratic##3##4##(2007-12#3)
solitons in a system with##2##5##(2007-12#2)
solitons in a##19##3##(2007-11#3)(2007-12#16)
solitons in centrosymmetric##3##3##(2007-12#2)(2008-1#1)
solitons in fiber lines with##2##5##(2007-12#2)
solitons in photorefractive##5##3##(2007-11#1)(2007-12#3)(2008-1#1)
solitons in quadratic media##2##4##(2007-12#1)(2008-1#1)
solitons in quadratic##3##3##(2007-12#2)(2008-1#1)
solitons in the normal dispersion regime##2##6##(2007-12#2)
solitons in the##6##3##(2007-11#1)(2007-12#5)
solitons in##74##2##(2007-11#11)(2007-12#54)(2008-1#5)(2008-2#3)(2008-3#1)
solitons is##6##2##(2007-11#1)(2007-12#3)(2008-1#1)(2008-3#1)
solitons of different##2##3##(2007-12#2)
solitons of##4##2##(2007-11#1)(2007-12#3)
solitons resulting from##2##3##(2007-12#2)
solitons that##2##2##(2007-11#1)(2007-12#1)
solitons were##2##2##(2007-11#1)(2008-1#1)
solitons with a##3##3##(2007-11#1)(2008-1#1)(2008-3#1)
solitons with##15##2##(2007-11#3)(2007-12#8)(2008-1#2)(2008-3#2)
solitons##271##1##(1991-12#1)(1994-2#1)(2007-11#48)(2007-12#192)(2008-1#21)(2008-2#4)(2008-3#4)
solium##9##1##(1991-8#2)(1995-12#1)(2005-8#3)(2011-2#3)
solo##4##1##(1991-1#1)(2005-7#1)(2012-1#1)(2012-2#1)
solo-surgery##2##1##(2007-8#2)
sols##5##1##(2005-11#2)(2007-11#1)(2008-10#1)(2010-4#1)
solstitialis##2##1##(2008-10#2)
solubilisates##2##1##(1990-11#1)(1990-12#1)
solubilisation of##2##2##(1990-2#1)(2006-8#1)
solubilisation##6##1##(1990-2#1)(2006-8#1)(2008-10#2)(2008-5#1)(2010-4#1)
solubilised##3##1##(1991-2#1)(1993-4#1)(2005-7#1)
solubilities and##2##2##(2008-10#2)
solubilities##10##1##(1994-9#1)(2005-11#1)(2008-10#7)(2008-5#1)
solubility and dissolution rate of celecoxib##2##6##(2008-5#2)
solubility and dissolution rate of##3##5##(2008-10#1)(2008-5#2)
solubility and dissolution##4##3##(2008-10#1)(2008-5#2)(2010-12#1)
solubility and high##2##3##(2010-12#1)(2010-4#1)
solubility and##24##2##(1991-2#1)(1995-3#1)(1996-7#2)(2004-12#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-10#5)(2008-4#1)(2008-5#3)(2010-12#3)(2010-4#1)(2010-5#1)(2012-12#1)(2013-1#1)
solubility constant##2##2##(2008-10#2)
solubility data##2##2##(2008-10#1)(2010-3#1)
solubility enhancement##2##2##(2010-2#1)(2012-2#1)
solubility in molten##2##3##(2008-10#2)
solubility in the##5##3##(1991-12#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-11#1)
solubility in water and##2##4##(2005-11#1)(2008-10#1)
solubility in water##9##3##(2005-11#1)(2008-10#5)(2008-5#1)(2008-9#1)(2009-12#1)
solubility in##22##2##(1991-12#1)(1993-8#1)(2005-11#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#1)(2010-4#1)(2010-5#1)
solubility is##4##2##(1990-4#1)(1991-12#1)(2008-10#1)(2010-12#1)
solubility of Cholesterol##2##3##(2009-7#2)
solubility of furosemide##2##3##(2012-2#2)
solubility of such##2##3##(1996-11#1)(2008-10#1)
solubility of the##11##3##(1990-11#1)(1990-4#1)(2007-11#1)(2008-10#6)(2008-5#1)(2013-1#1)
solubility of toluene##3##3##(2008-10#3)
solubility of##61##2##(1990-11#1)(1990-4#1)(1992-12#1)(1994-8#1)(1995-2#1)(1996-11#1)(2005-11#3)(2006-10#4)(2007-11#1)(2007-8#2)(2008-10#23)(2008-11#1)(2008-4#1)(2008-5#6)(2009-7#2)(2010-2#2)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#1)(2012-2#4)(2013-1#1)
solubility on##3##2##(2005-11#1)(2008-10#2)
solubility or##2##2##(1995-1#1)(1997-1#1)
solubility parameter##4##2##(2005-11#1)(2008-10#3)
solubility parameters##5##2##(2008-10#5)
solubility product of##3##3##(2005-11#1)(2007-8#1)(2008-10#1)
solubility product##5##2##(2005-11#1)(2007-8#1)(2008-10#2)(2010-4#1)
solubility properties##3##2##(1997-2#1)(2006-12#1)(2008-10#1)
solubility was##5##2##(2008-11#1)(2010-2#1)(2010-5#1)(2012-2#2)
solubility were##2##2##(2009-4#1)(2010-4#1)
solubility##242##1##(1990-11#1)(1990-4#4)(1991-12#2)(1991-2#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-8#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#3)(1995-5#1)(1996-11#1)(1996-7#2)(1997-1#4)(1997-2#1)(2004-12#1)(2005-11#20)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#7)(2006-12#3)(2006-5#1)(2007-11#4)(2007-8#3)(2008-1#1)(2008-10#72)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#20)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#2)(2010-12#10)(2010-2#6)(2010-3#1)(2010-4#7)(2010-5#5)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#8)(2013-1#8)(2013-8#3)
solubility)##2##1##(2008-10#1)(2008-5#1)
solubilization and##6##2##(1991-4#1)(1996-8#1)(2008-11#1)(2008-4#1)(2008-5#2)
solubilization from##2##2##(2006-10#1)(2008-4#1)
solubilization in##7##2##(1991-10#1)(1994-5#1)(1995-1#1)(2008-10#2)(2008-11#1)(2013-1#1)
solubilization is##4##2##(1990-3#2)(1994-12#1)(2008-4#1)
solubilization of a##2##3##(1990-4#2)
solubilization of the protein##3##4##(2008-2#1)(2008-4#2)
solubilization of the##9##3##(1990-2#1)(1991-3#1)(2005-8#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)
solubilization of##30##2##(1990-2#1)(1990-3#1)(1990-4#2)(1991-3#1)(1992-5#1)(1994-12#1)(1994-5#1)(1994-6#1)(2005-11#2)(2005-8#1)(2006-12#2)(2008-1#1)(2008-10#4)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#1)(2013-1#4)
solubilization process##2##2##(1992-6#1)(2005-11#1)
solubilization site##2##2##(2005-11#2)
solubilization were##2##2##(2005-11#2)
solubilization with##5##2##(1990-11#1)(1991-3#1)(2005-11#1)(2008-10#1)(2008-4#1)
solubilization##107##1##(1990-11#3)(1990-2#2)(1990-3#5)(1990-4#2)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-3#2)(1991-4#1)(1991-8#1)(1992-12#2)(1992-5#1)(1992-6#2)(1993-12#1)(1994-12#3)(1994-5#2)(1994-6#2)(1995-1#1)(1996-8#1)(1997-1#1)(1997-4#1)(2005-11#15)(2005-4#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-3#1)(2008-1#1)(2008-10#9)(2008-11#6)(2008-2#2)(2008-4#12)(2008-5#5)(2008-7#1)(2010-2#2)(2012-2#2)(2013-1#7)
solubilize and##3##2##(1995-1#1)(2005-11#1)(2012-2#1)
solubilize the##4##2##(1990-7#1)(1992-12#1)(2005-11#1)(2008-4#1)
solubilize##16##1##(1990-7#1)(1991-8#1)(1992-12#1)(1993-5#1)(1994-9#1)(1995-1#1)(1996-5#1)(2005-11#3)(2008-10#1)(2008-4#1)(2009-10#2)(2012-2#1)(2013-1#1)
solubilized and partially purified##2##4##(1991-9#1)(1994-11#1)
solubilized and partially##3##3##(1991-9#1)(1993-3#1)(1994-11#1)
solubilized and##8##2##(1990-12#1)(1990-8#1)(1991-9#1)(1993-3#1)(1993-5#1)(1994-11#1)(2008-10#1)(2008-11#1)
solubilized at##2##2##(1990-3#1)(2008-10#1)
solubilized brush border##3##3##(1990-11#3)
solubilized by the##2##3##(1990-7#1)(1990-8#1)
solubilized by##10##2##(1990-2#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-8#1)(1992-1#1)(1996-4#1)(1996-6#1)(1997-7#1)(2006-3#1)
solubilized enzyme##3##2##(1990-5#2)(1994-8#1)
solubilized from rat brain and Swiss 3T3 cells##2##8##(1990-5#2)
solubilized from the##4##3##(1990-7#1)(1994-12#1)(1994-8#1)(2008-5#1)
solubilized from##13##2##(1990-2#1)(1990-5#3)(1990-7#1)(1991-2#1)(1991-9#1)(1994-11#1)(1994-12#2)(1994-8#1)(1996-12#1)(2008-5#1)
solubilized in the##2##3##(1997-6#1)(2008-10#1)
solubilized in these##2##3##(2005-11#1)(2008-10#1)
solubilized in##11##2##(1990-2#2)(1992-6#1)(1995-11#1)(1997-6#1)(2005-11#1)(2008-10#3)(2009-6#1)(2010-1#1)
solubilized into##2##2##(1994-11#1)(2008-10#1)
solubilized membrane proteins##2##3##(1991-4#1)(2008-1#1)
solubilized membrane##5##2##(1990-2#1)(1991-4#1)(1991-5#2)(2008-1#1)
solubilized membranes##3##2##(1990-2#1)(1990-5#1)(1994-11#1)
solubilized proteins are separated according to their isoelectric point (pI) by isoelectric focusing##2##13##(2008-2#1)(2008-4#1)
solubilized proteins##3##2##(1994-11#1)(2008-2#1)(2008-4#1)
solubilized receptor##2##2##(1990-5#1)(1990-7#1)
solubilized tonoplast proteins##2##3##(2008-11#2)
solubilized with Triton X-100##2##4##(1990-7#1)(1992-6#1)
solubilized with##12##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-7#2)(1991-5#1)(1992-4#1)(1992-6#1)(1994-11#1)(1994-12#1)(2008-10#2)
solubilized##125##1##(1990-10#1)(1990-11#6)(1990-12#1)(1990-2#8)(1990-3#2)(1990-5#8)(1990-7#7)(1990-8#2)(1991-10#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#3)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#2)(1992-5#2)(1992-6#4)(1993-11#2)(1993-3#2)(1993-5#1)(1994-11#7)(1994-12#6)(1994-3#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-6#1)(1996-12#2)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-6#2)(1997-7#1)(2005-11#1)(2006-12#1)(2006-3#1)(2006-8#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-4#4)(2008-5#2)(2008-6#2)(2009-6#2)(2010-1#1)(2010-4#2)(2013-1#2)
solubilizes##3##1##(1990-9#1)(1994-12#1)(2010-11#1)
solubilizing agent for##2##3##(2010-5#1)(2013-1#1)
solubilizing agents##2##2##(1992-7#1)(2010-2#1)
solubilizing the##2##2##(2008-10#1)(2008-11#1)
solubilizing##14##1##(1992-7#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#3)(2010-2#1)(2010-5#1)(2013-1#1)(2013-7#2)
soluble A beta##6##3##(1993-12#1)(1994-11#1)(1994-12#2)(1995-12#1)(1996-5#1)
soluble APP##2##2##(1990-3#2)
soluble B7-H3##2##2##(2011-12#2)
soluble CD4##3##2##(1992-4#1)(1994-8#1)(2005-7#1)
soluble Cr##3##2##(2008-10#3)
soluble FMN phosphatase##2##3##(1992-12#2)
soluble ICAM-1##3##2##(1992-6#2)(1995-5#1)
soluble IL-2##2##2##(1990-2#1)(1997-8#1)
soluble IL-6 receptor##4##3##(1995-7#1)(1997-7#2)(2008-4#1)
soluble Mn (IV)-formaldehyde-indomethacin##2##3##(2008-10#2)
soluble P-glycoprotein is##2##3##(1994-8#2)
soluble P-glycoprotein##5##2##(1994-8#5)
soluble TNF receptors (sTNF-Rs)##2##4##(2008-4#2)
soluble TNF##3##2##(2007-11#1)(2008-4#2)
soluble TNFalpha receptors##2##3##(2007-11#2)
soluble activity##2##2##(1991-8#1)(1992-12#1)
soluble adhesion molecules##2##3##(2009-4#1)(2009-7#1)
soluble aminopeptidases##4##2##(1990-2#1)(1992-4#3)
soluble and abundant (yield =##2##5##(1992-7#2)
soluble and exchangeable cations and##2##5##(2011-2#2)
soluble and exchangeable##4##3##(2007-10#1)(2011-2#3)
soluble and immobilized##2##3##(1990-11#1)(2008-5#1)
soluble and insoluble##7##3##(1996-1#1)(1997-4#1)(2008-10#3)(2008-4#1)(2011-2#1)
soluble and membrane fractions##2##4##(1994-3#1)(1997-1#1)
soluble and membrane##3##3##(1994-3#1)(1997-1#1)(2008-4#1)
soluble and membrane-associated##2##3##(1995-1#2)
soluble and membrane-bound proteins##2##4##(2008-4#1)(2011-2#1)
soluble and membrane-bound##6##3##(1991-7#1)(1994-2#1)(2008-4#3)(2011-2#1)
soluble and microsomal b5##2##4##(1992-6#2)
soluble and microsomal##4##3##(1992-6#4)
soluble and particulate##2##3##(1995-3#1)(2008-4#1)
soluble and##57##2##(1990-11#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-6#4)(1992-7#3)(1993-12#1)(1993-6#1)(1994-11#2)(1994-2#2)(1994-3#1)(1995-1#3)(1995-2#1)(1995-3#2)(1995-5#1)(1996-1#1)(1997-1#1)(1997-4#1)(2005-11#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-4#7)(2008-5#1)(2008-8#1)(2009-7#1)(2010-2#1)(2010-4#1)(2011-2#5)(2012-1#1)(2012-12#3)
soluble antigens##6##2##(1997-9#1)(2008-11#3)(2008-4#1)(2008-9#1)
soluble cGMP-insensitive type IV##2##4##(1990-2#2)
soluble carbohydrate##2##2##(2008-10#1)(2013-7#1)
soluble chemicals##2##2##(2008-11#1)(2008-7#1)
soluble complexes##3##2##(2008-10#3)
soluble components##4##2##(2008-10#3)(2008-9#1)
soluble compounds##4##2##(2008-3#1)(2008-5#3)
soluble cytochrome b5##2##3##(1992-6#1)(1993-6#1)
soluble cytokines##3##2##(2008-9#2)(2009-8#1)
soluble drugs##3##2##(2008-5#1)(2010-12#1)(2011-2#1)
soluble endopeptidase 22##2##3##(1993-2#2)
soluble enzyme##5##2##(1991-1#1)(1994-5#1)(1995-8#1)(1997-2#1)(2008-5#1)
soluble even##2##2##(2008-10#2)
soluble extract of##2##3##(1990-5#1)(1992-9#1)
soluble extract##7##2##(1990-2#2)(1990-5#1)(1990-8#1)(1992-1#1)(1992-9#1)(1994-12#1)
soluble extracts from##3##3##(1990-7#1)(1994-8#1)(2008-10#1)
soluble extracts##6##2##(1990-7#2)(1992-4#1)(1994-8#1)(1995-3#1)(2008-10#1)
soluble factors on##2##3##(2008-4#1)(2012-12#1)
soluble factors which##3##3##(1996-1#1)(2007-11#1)(2008-5#1)
soluble factors##19##2##(1996-1#1)(1996-11#1)(1997-7#1)(2005-10#1)(2006-2#1)(2007-11#1)(2008-4#2)(2008-5#2)(2008-9#2)(2009-12#1)(2009-3#1)(2012-12#2)(2012-4#1)(2013-1#1)(2013-8#1)
soluble fiber##2##2##(2004-11#2)
soluble film##3##2##(2011-2#3)
soluble form of RGP##2##4##(1995-2#2)
soluble form of furin##3##4##(1992-12#3)
soluble form of the extracellular domain of##2##7##(1992-7#1)(1994-8#1)
soluble form of the##8##4##(1992-11#1)(1992-7#1)(1993-8#1)(1994-8#2)(1997-2#1)(1997-7#2)
soluble form of##17##3##(1990-3#1)(1992-11#1)(1992-12#3)(1992-7#1)(1993-8#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-2#2)(1997-2#1)(1997-7#2)(2008-8#1)
soluble form was##2##3##(1992-5#1)(1995-2#1)
soluble form##34##2##(1990-11#1)(1990-3#1)(1990-5#1)(1992-11#1)(1992-12#3)(1992-5#4)(1992-6#1)(1992-7#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#4)(1995-1#1)(1995-2#3)(1996-7#1)(1997-2#1)(1997-7#2)(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#2)
soluble forms in##2##3##(2009-4#1)(2010-5#1)
soluble forms of##4##3##(1990-3#1)(1992-6#1)(1994-11#1)(1995-12#1)
soluble forms##9##2##(1990-3#1)(1992-6#1)(1994-11#1)(1995-10#1)(1995-12#1)(1996-8#1)(2008-10#1)(2009-4#1)(2010-5#1)
soluble fraction and##2##3##(1990-11#1)(1990-2#1)
soluble fraction of bovine##2##4##(1990-6#1)(1994-3#1)
soluble fraction of##14##3##(1990-6#4)(1991-7#1)(1991-9#1)(1992-6#1)(1992-9#1)(1994-3#1)(1995-10#1)(1996-12#1)(1996-5#1)(1997-5#1)(1997-8#1)
soluble fraction##27##2##(1990-11#1)(1990-2#2)(1990-6#4)(1990-7#2)(1991-7#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-12#3)(1994-3#1)(1994-5#2)(1995-10#1)(1996-12#1)(1996-5#1)(1997-5#1)(1997-8#1)(2008-10#1)(2009-10#1)
soluble fractions##7##2##(1990-11#3)(1993-11#1)(1995-7#1)(1997-2#1)(2005-8#1)
soluble fragment of##2##3##(1990-11#1)(1990-2#1)
soluble fragments of##2##3##(1991-9#1)(2013-8#1)
soluble glucan##2##2##(1990-9#1)(1991-9#1)
soluble glucose oxidase##2##3##(2008-10#2)
soluble guanylate cyclase (sGC) activity##2##5##(1996-6#1)(2007-9#1)
soluble guanylate cyclase (sGC)##4##4##(1996-6#1)(1997-2#1)(2007-9#1)(2008-4#1)
soluble guanylate cyclase##11##3##(1990-8#2)(1991-9#1)(1993-6#1)(1996-6#1)(1997-2#2)(2007-9#2)(2008-4#1)(2008-6#1)
soluble guanylyl cyclase##7##3##(1996-6#5)(2008-8#2)
soluble guanylyl##9##2##(1996-6#5)(2008-8#2)(2009-10#2)
soluble human##4##2##(1990-5#1)(1995-12#1)(2008-11#2)
soluble in a##2##3##(2008-10#2)
soluble in aqueous##2##3##(1990-7#1)(2008-10#1)
soluble in the##10##3##(1991-5#1)(1997-7#1)(1997-8#1)(2004-8#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-9#1)
soluble in water than##2##4##(1991-12#2)
soluble in water##10##3##(1991-12#3)(1994-3#1)(2008-10#2)(2008-5#2)(2010-2#1)(2010-3#1)
soluble in##37##2##(1990-7#1)(1990-9#1)(1991-12#3)(1991-5#2)(1994-3#1)(1996-1#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-8#1)(2007-6#1)(2008-10#11)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-3#1)
soluble inorganic##2##2##(1991-12#1)(2008-10#1)
soluble insulin##2##2##(1991-8#2)
soluble interleukin-2 receptor##2##3##(1990-6#1)(2009-4#1)
soluble interleukin-2##3##2##(1990-2#1)(1990-6#1)(2009-4#1)
soluble interleukin-6 receptor##3##3##(1994-2#1)(1996-11#2)
soluble intracellular##2##2##(2005-11#1)(2012-12#1)
soluble leptin receptor##2##3##(2006-6#1)(2006-9#1)
soluble ligands##3##2##(2008-10#1)(2008-4#1)(2008-5#1)
soluble magnesium##2##2##(2008-10#2)
soluble manganese(IV)##2##2##(2008-10#2)
soluble mediators##2##2##(1990-9#1)(1995-2#1)
soluble methane monooxygenase##3##3##(1995-10#1)(1997-4#1)(2009-3#1)
soluble mouse##2##2##(1991-12#1)(1993-8#1)
soluble or##9##2##(1990-4#1)(1994-6#1)(1994-9#1)(1995-2#1)(2008-4#5)
soluble organic##2##2##(2008-10#1)(2013-8#1)
soluble oxalate##2##2##(2012-2#2)
soluble peptide##2##2##(1993-4#1)(1996-6#1)
soluble phenolic compounds##4##3##(2008-10#4)
soluble phenolics##5##2##(2004-4#5)
soluble polymer##4##2##(2008-10#3)(2008-6#1)
soluble product##2##2##(2008-10#1)(2008-5#1)
soluble protein in the##3##4##(1994-5#1)(1995-2#1)(2013-1#1)
soluble protein in##8##3##(1992-11#1)(1993-9#1)(1994-5#1)(1995-2#1)(1995-8#1)(2006-12#1)(2007-8#1)(2013-1#1)
soluble protein of##2##3##(1993-12#1)(2008-11#1)
soluble protein##32##2##(1990-12#1)(1990-5#3)(1992-11#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-8#2)(1997-4#1)(2006-11#1)(2006-12#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-4#1)(2012-9#1)(2013-1#1)
soluble proteins and##2##3##(1995-12#1)(2008-6#1)
soluble proteins from##3##3##(1994-3#1)(2008-4#2)
soluble proteins##29##2##(1992-12#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-2#1)(1997-1#1)(1997-4#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#9)(2008-5#1)(2008-6#2)(2010-4#1)(2012-1#1)
soluble receptor##4##2##(1994-2#1)(1994-8#1)(1997-7#1)(1997-8#1)
soluble receptors##2##2##(2004-12#1)(2008-4#1)
soluble recombinant##5##2##(1992-4#1)(1995-11#1)(1996-2#2)(2013-8#1)
soluble salts##2##2##(1990-5#1)(2008-10#1)
soluble solids##4##2##(2008-10#1)(2011-2#1)(2012-2#2)
soluble species of##2##3##(2008-10#2)
soluble starch##8##2##(1994-2#1)(2006-12#1)(2008-5#2)(2008-6#1)(2008-9#1)(2013-8#2)
soluble substrates##2##2##(2006-8#1)(2008-7#1)
soluble sugar##3##2##(2007-3#2)(2008-12#1)
soluble sugars contents##2##3##(2007-3#1)(2008-5#1)
soluble sugars was##2##3##(2008-12#2)
soluble sugars##8##2##(2007-3#1)(2008-12#3)(2008-5#3)(2008-9#1)
soluble thrombomodulin (sTM)##2##3##(2007-10#1)(2008-9#1)
soluble thrombomodulin##3##2##(2007-10#2)(2008-9#1)
soluble to##3##2##(1994-12#1)(1996-1#1)(2007-11#1)
soluble tumor necrosis##2##3##(2006-10#1)(2009-3#1)
soluble type##2##2##(1993-3#1)(2008-11#1)
soluble##800##1##(1990-10#1)(1990-11#10)(1990-12#3)(1990-2#11)(1990-3#7)(1990-4#3)(1990-5#9)(1990-6#5)(1990-7#7)(1990-8#3)(1990-9#3)(1991-1#2)(1991-10#1)(1991-12#7)(1991-2#5)(1991-5#3)(1991-7#2)(1991-8#5)(1991-9#6)(1992-1#1)(1992-11#5)(1992-12#11)(1992-3#4)(1992-4#8)(1992-5#5)(1992-6#15)(1992-7#10)(1992-8#4)(1992-9#2)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#6)(1993-4#3)(1993-5#1)(1993-6#6)(1993-8#3)(1993-9#3)(1994-11#7)(1994-12#8)(1994-2#8)(1994-3#9)(1994-5#8)(1994-6#5)(1994-8#20)(1994-9#2)(1995-1#7)(1995-10#4)(1995-11#2)(1995-12#6)(1995-2#15)(1995-3#13)(1995-5#5)(1995-6#1)(1995-7#2)(1995-8#5)(1996-1#4)(1996-11#3)(1996-12#2)(1996-2#6)(1996-5#4)(1996-6#8)(1996-7#2)(1996-8#5)(1996-9#3)(1997-1#4)(1997-2#5)(1997-3#2)(1997-4#6)(1997-5#1)(1997-6#4)(1997-7#14)(1997-8#9)(1997-9#1)(2004-11#2)(2004-12#1)(2004-4#6)(2004-8#1)(2005-10#1)(2005-11#7)(2005-7#2)(2005-8#5)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#5)(2006-2#1)(2006-4#1)(2006-6#3)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#9)(2007-11#6)(2007-12#1)(2007-3#3)(2007-5#1)(2007-6#1)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#96)(2008-11#23)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#45)(2008-5#32)(2008-6#6)(2008-7#8)(2008-8#8)(2008-9#13)(2009-10#3)(2009-12#3)(2009-2#2)(2009-3#6)(2009-4#3)(2009-6#3)(2009-7#2)(2009-8#2)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#5)(2010-5#3)(2010-9#1)(2011-1#1)(2011-12#3)(2011-2#13)(2012-1#2)(2012-12#7)(2012-2#6)(2012-4#1)(2012-9#1)(2013-1#7)(2013-7#1)(2013-8#8)
solubles##5##1##(2007-1#1)(2008-12#1)(2008-5#3)
solublized##2##1##(2008-10#1)(2008-11#1)
soluflazine##2##1##(1994-8#2)
solute and##12##2##(1990-8#1)(1994-6#1)(2005-11#1)(2006-10#3)(2008-10#4)(2008-7#1)(2011-2#1)
solute are##2##2##(1996-5#1)(2006-10#1)
solute atoms##3##2##(2006-10#1)(2010-2#1)(2012-2#1)
solute clearance##6##2##(2007-8#6)
solute clearances##2##2##(2011-2#2)
solute concentration##2##2##(1997-7#1)(2005-11#1)
solute concentrations##2##2##(2005-12#1)(2007-9#1)
solute dielectric##2##2##(2008-4#1)(2013-1#1)
solute distribution##3##2##(2008-7#1)(2011-2#2)
solute in##6##2##(2006-10#2)(2008-10#3)(2008-7#1)
solute is##7##2##(2005-11#1)(2006-10#2)(2008-10#2)(2008-3#1)(2013-1#1)
solute molecules##3##2##(2005-11#2)(2008-2#1)
solute on the##2##3##(2008-10#1)(2010-2#1)
solute particles##2##2##(2008-7#2)
solute potential##2##2##(2006-10#1)(2008-10#1)
solute retention and##2##3##(2008-10#2)
solute size##2##2##(2005-11#1)(2006-10#1)
solute surface area##2##3##(1995-8#1)(2010-2#1)
solute to##3##2##(1992-2#1)(2008-12#1)(2008-4#1)
solute transport##4##2##(1990-3#1)(2006-10#1)(2007-9#1)(2011-2#1)
solute was##4##2##(1991-4#1)(2006-10#1)(2008-10#1)(2009-5#1)
solute with##2##2##(2005-12#1)(2006-10#1)
solute##136##1##(1990-3#2)(1990-8#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-11#2)(1994-6#1)(1994-9#1)(1995-8#1)(1996-5#3)(1997-7#2)(2005-11#10)(2005-12#2)(2006-10#28)(2006-5#1)(2007-12#2)(2007-8#6)(2007-9#2)(2008-10#26)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#6)(2009-10#1)(2009-12#1)(2009-5#2)(2010-2#5)(2011-2#7)(2012-12#1)(2012-2#2)(2012-7#1)(2013-1#4)
solute-solute##2##1##(2008-10#1)(2010-2#1)
solute-solvent interactions##3##2##(2008-10#3)
solute-solvent##8##1##(2006-10#2)(2008-10#4)(2010-2#2)
solute-water attractive interactions##2##3##(2006-10#2)
solute-water##3##1##(2005-11#1)(2006-10#2)
solutes and the##3##3##(2005-11#1)(2007-8#1)(2012-12#1)
solutes and##9##2##(2005-11#1)(2007-8#1)(2008-10#2)(2008-7#1)(2011-2#2)(2012-12#2)
solutes are##2##2##(2008-10#2)
solutes from##3##2##(1993-6#1)(2008-10#2)
solutes in##8##2##(1991-2#1)(1993-11#2)(1996-5#1)(1997-8#1)(2008-10#1)(2012-12#1)(2012-7#1)
solutes on##2##2##(2008-10#2)
solutes such as##4##3##(1996-5#1)(2006-10#1)(2008-4#1)(2011-2#1)
solutes that##2##2##(2006-10#1)(2008-7#1)
solutes was##2##2##(1996-5#1)(2008-10#1)
solutes were separated in parallel##2##5##(2008-10#2)
solutes were##4##2##(1993-2#1)(2008-10#3)
solutes with##2##2##(2008-10#1)(2011-1#1)
solutes##91##1##(1990-12#1)(1990-5#2)(1991-2#1)(1992-1#1)(1993-11#4)(1993-2#2)(1993-6#1)(1994-6#1)(1994-9#1)(1995-5#1)(1996-5#7)(1996-7#1)(1996-8#1)(1997-2#1)(1997-7#2)(1997-8#2)(2005-11#1)(2005-12#2)(2005-8#1)(2006-10#5)(2007-8#1)(2008-10#23)(2008-12#1)(2008-4#3)(2008-7#4)(2009-8#1)(2010-2#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#7)(2012-2#2)(2012-7#2)(2013-1#1)
solution (0##10##2##(1992-3#1)(1994-11#1)(1996-6#1)(2006-1#2)(2008-10#5)
solution (1##5##2##(1991-12#1)(2008-10#2)(2008-5#1)(2010-4#1)
solution (100##2##2##(2008-10#1)(2008-7#1)
solution (2##6##2##(2005-11#1)(2007-11#1)(2008-10#3)(2008-5#1)
solution (31)P-NMR##2##2##(2008-10#2)
solution (4##2##2##(2005-12#1)(2011-2#1)
solution (5##3##2##(2008-10#2)(2013-8#1)
solution (NaNO(3) 0##2##3##(2008-10#2)
solution (containing##2##2##(2008-10#1)(2012-12#1)
solution (in##2##2##(1993-8#1)(2008-10#1)
solution (pH 12)##2##3##(2008-10#2)
solution (pH 2)##3##3##(2007-8#1)(2008-10#2)
solution (pH 4##9##3##(2008-10#6)(2008-3#1)(2009-3#1)(2012-12#1)
solution (pH 7##5##3##(2008-10#4)(2012-12#1)
solution (pH 8##2##3##(2008-10#1)(2008-11#1)
solution (pH##34##2##(2006-12#1)(2007-8#1)(2008-10#26)(2008-11#1)(2008-3#1)(2009-3#1)(2012-12#3)
solution (since##2##2##(2008-8#2)
solution 0##2##2##(2008-10#2)
solution NMR structure of##2##4##(1996-8#1)(2008-9#1)
solution NMR##5##2##(1991-11#1)(1995-6#1)(1996-8#1)(2007-8#1)(2008-9#1)
solution a##2##2##(1993-4#1)(2008-10#1)
solution acidity##6##2##(2008-10#6)
solution adjusted to pH##3##4##(2008-10#3)
solution after each##2##3##(2008-10#2)
solution after##15##2##(1991-12#1)(1994-8#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-4#1)(2009-7#1)(2012-12#1)(2013-8#1)
solution alone##2##2##(2008-10#1)(2008-5#1)
solution also##3##2##(1993-7#1)(2008-10#1)(2008-5#1)
solution and a##7##3##(1990-10#1)(2007-8#1)(2008-10#5)
solution and at##2##3##(2008-10#1)(2008-12#1)
solution and crystal structures##2##4##(1991-2#1)(1992-8#1)
solution and crystal##3##3##(1991-2#1)(1992-8#2)
solution and crystalline##2##3##(1990-5#1)(2011-1#1)
solution and for##4##3##(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)
solution and in##21##3##(1990-2#1)(1991-9#1)(1993-6#2)(1994-2#1)(1995-10#1)(1996-6#1)(1997-4#1)(1997-7#1)(2004-12#1)(2006-10#1)(2006-2#2)(2006-8#1)(2008-10#6)(2009-9#1)
solution and its##2##3##(2007-12#1)(2008-10#1)
solution and liquid##2##3##(1995-6#1)(2008-5#1)
solution and solid##2##3##(2006-1#1)(2008-10#1)
solution and subsequently##2##3##(2008-10#2)
solution and that the##2##4##(1991-6#1)(2010-4#1)
solution and the##26##3##(1990-12#1)(1993-3#1)(1996-11#1)(2004-12#1)(2005-11#1)(2006-10#1)(2007-8#1)(2008-10#15)(2008-2#1)(2008-3#1)(2008-9#1)(2010-4#1)
solution and then##2##3##(2008-10#2)
solution and to##5##3##(2007-12#1)(2008-10#3)(2008-5#1)
solution and was##3##3##(2006-10#1)(2008-10#2)
solution and were##3##3##(2007-9#1)(2008-10#1)(2008-12#1)
solution and##197##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#2)(1991-2#1)(1991-3#2)(1991-6#1)(1991-9#2)(1992-12#1)(1992-7#1)(1992-8#3)(1993-3#1)(1993-6#2)(1993-9#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-6#2)(1997-2#2)(1997-3#1)(1997-4#3)(1997-7#1)(2004-12#2)(2005-11#6)(2005-4#1)(2006-1#1)(2006-10#3)(2006-2#2)(2006-8#1)(2007-10#1)(2007-12#2)(2007-8#7)(2007-9#1)(2008-10#96)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#4)(2008-9#3)(2009-3#2)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2011-1#2)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#2)
solution appeared##2##2##(2008-2#1)(2008-5#1)
solution are 0##3##3##(1996-11#1)(2005-11#1)(2008-10#1)
solution are described##4##3##(2007-12#1)(2008-10#1)(2008-2#2)
solution are##20##2##(1990-8#1)(1991-8#1)(1992-5#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-8#1)(2005-11#2)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-4#1)
solution as a titrant##2##4##(2008-10#2)
solution as a##11##3##(1990-7#1)(1994-6#1)(2008-10#7)(2008-3#1)(2009-11#1)
solution as eluent##2##3##(2008-10#2)
solution as mobile phase##2##4##(2008-10#2)
solution as the##3##3##(2008-10#2)(2008-5#1)
solution as well as the##3##5##(1993-11#1)(2005-11#1)(2008-5#1)
solution as well as##6##4##(1993-11#1)(1996-7#1)(2005-11#2)(2008-5#2)
solution as##39##2##(1990-7#1)(1993-11#1)(1994-6#1)(1994-9#2)(1996-7#1)(2005-11#3)(2006-8#1)(2007-10#1)(2007-8#1)(2008-10#19)(2008-3#1)(2008-5#3)(2008-9#1)(2009-11#1)(2010-4#1)(2013-7#1)
solution at 4##2##3##(2008-10#2)
solution at a flow-rate of##2##5##(2008-10#2)
solution at a##9##3##(2007-8#1)(2008-10#8)
solution at an##2##3##(2008-10#2)
solution at concentrations##2##3##(1995-8#1)(2005-11#1)
solution at different##3##3##(1996-4#1)(2008-10#2)
solution at high##2##3##(2008-5#1)(2008-8#1)
solution at pH 3##3##4##(2008-10#3)
solution at pH 5##2##4##(2008-10#2)
solution at pH 6##3##4##(2008-10#3)
solution at pH 7##3##4##(2008-10#3)
solution at pH 8##3##4##(2008-10#3)
solution at pH##19##3##(2005-11#1)(2008-10#17)(2010-5#1)
solution at room temperature##2##4##(2007-12#1)(2010-4#1)
solution at the##3##3##(1990-3#1)(1994-3#1)(2008-10#1)
solution at##71##2##(1990-3#1)(1991-2#1)(1991-6#1)(1992-9#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-2#3)(1996-4#1)(1997-7#1)(2004-2#1)(2005-11#4)(2007-12#1)(2007-8#1)(2008-10#40)(2008-3#1)(2008-5#3)(2008-8#1)(2009-12#1)(2009-6#1)(2010-4#1)(2010-5#1)(2012-2#1)
solution based on the##3##4##(2007-11#1)(2008-1#1)(2011-1#1)
solution based on##7##3##(2007-11#1)(2008-1#1)(2008-2#1)(2008-6#1)(2011-1#1)(2011-3#1)(2013-1#1)
solution because of##2##3##(1996-9#1)(2008-10#1)
solution before##2##2##(2007-8#1)(2011-2#1)
solution behavior of##2##3##(1996-11#1)(2010-4#1)
solution between##2##2##(2008-10#2)
solution binding##2##2##(1992-6#1)(2008-10#1)
solution by means of##4##4##(2006-12#1)(2008-10#3)
solution by the##2##3##(2008-10#2)
solution by using##2##3##(2008-10#2)
solution by##36##2##(1990-1#1)(1990-2#1)(1991-3#1)(1991-5#1)(1994-5#1)(1995-5#1)(1997-1#1)(1997-2#1)(2005-11#2)(2005-4#2)(2006-12#2)(2007-8#1)(2008-10#17)(2008-2#1)(2008-5#1)(2009-9#1)(2012-3#1)
solution calorimetry##6##2##(2008-10#5)(2008-5#1)
solution can be##15##3##(1991-3#1)(1992-9#1)(1995-4#1)(2007-6#1)(2007-8#2)(2008-10#5)(2008-2#4)
solution can##23##2##(1991-3#1)(1992-9#1)(1995-4#1)(1996-1#1)(2007-6#1)(2007-8#2)(2008-10#8)(2008-2#4)(2008-5#1)(2008-6#1)(2010-5#1)(2013-8#1)
solution carrier##2##2##(2008-10#2)
solution casting##3##2##(2008-10#2)(2008-5#1)
solution caused a##2##3##(2006-7#1)(2008-10#1)
solution caused##4##2##(1991-1#1)(2006-7#1)(2008-10#1)(2008-8#1)
solution causes##2##2##(1994-9#1)(2008-10#1)
solution chemistry##2##2##(1993-12#1)(2008-5#1)
solution composed of##3##3##(2004-11#1)(2007-8#1)(2008-10#1)
solution composition##3##2##(2005-11#1)(2008-10#2)
solution concentration and##2##3##(2008-10#1)(2008-5#1)
solution concentration##9##2##(2005-11#2)(2008-10#3)(2008-5#2)(2009-7#1)(2011-2#1)
solution concentrations##2##2##(2005-11#1)(2008-5#1)
solution condition##2##2##(2005-11#1)(2008-4#1)
solution conditions##8##2##(1991-4#1)(1993-3#1)(1997-2#2)(2005-11#1)(2008-10#2)(2010-4#1)
solution conformation of D-gluco-dihydroacarbose##2##4##(2005-7#2)
solution conformation of a synthetic peptide##2##6##(1991-2#2)
solution conformation of the##3##4##(1991-12#1)(1991-8#1)(1996-7#1)
solution conformation of##14##3##(1991-12#1)(1991-2#2)(1991-7#1)(1991-8#1)(1992-1#1)(1994-11#2)(1995-10#1)(1996-11#1)(1996-7#1)(2005-7#3)
solution conformation##19##2##(1991-12#1)(1991-2#2)(1991-7#2)(1991-8#1)(1992-1#1)(1994-11#2)(1994-9#1)(1995-10#1)(1995-3#1)(1996-11#1)(1996-7#1)(2005-7#3)(2008-6#1)(2008-9#1)
solution conformations of##2##3##(1995-10#1)(1996-11#1)
solution conformations##4##2##(1994-11#1)(1995-10#1)(1996-11#1)(2008-9#1)
solution containing 0##12##3##(2007-8#1)(2008-10#9)(2008-12#1)(2011-12#1)
solution containing 1##4##3##(2007-9#1)(2008-10#2)(2008-8#1)
solution containing 100##2##3##(1995-8#1)(2008-10#1)
solution containing 2##4##3##(1991-1#1)(2008-10#3)
solution containing 7##2##3##(2008-10#2)
solution containing a##4##3##(2005-11#1)(2008-10#3)
solution containing both##2##3##(2008-10#2)
solution containing calcium##2##3##(1990-4#1)(2008-5#1)
solution containing different##3##3##(2008-10#1)(2010-8#1)(2011-12#1)
solution containing polyethylene glycol##2##4##(1990-6#1)(1991-12#1)
solution containing the##6##3##(1991-9#1)(2008-10#3)(2008-4#1)(2008-5#1)
solution containing various##2##3##(2008-10#1)(2008-12#1)
solution containing##118##2##(1990-10#1)(1990-4#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-9#1)(1993-9#1)(1995-8#1)(1996-11#1)(1997-3#2)(1997-6#1)(2004-11#1)(2004-4#1)(2004-8#1)(2005-11#2)(2005-4#1)(2006-10#1)(2007-11#1)(2007-8#3)(2007-9#1)(2008-10#73)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#2)(2008-9#1)(2009-11#2)(2009-12#1)(2010-5#1)(2010-8#1)(2011-12#2)(2011-2#1)(2012-12#1)(2013-1#1)
solution could be##4##3##(1997-2#1)(2008-10#2)(2013-1#1)
solution could##5##2##(1997-2#1)(2008-10#2)(2008-2#1)(2013-1#1)
solution culture##3##2##(2008-8#1)(2008-9#1)(2013-8#1)
solution decreased##2##2##(1996-2#1)(2008-10#1)
solution depends on##2##3##(1997-2#1)(2011-2#1)
solution developed##2##2##(2008-2#1)(2009-9#1)
solution diffusion##2##2##(1995-12#1)(2005-11#1)
solution does not##6##3##(1990-12#1)(1996-3#1)(2005-11#1)(2008-10#1)(2008-2#1)(2009-8#1)
solution drop##3##2##(2005-11#1)(2007-10#2)
solution during the##5##3##(1996-4#1)(2008-10#1)(2008-2#1)(2009-12#1)(2013-1#1)
solution during##7##2##(1996-4#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-12#1)(2013-1#1)
solution embedded with##3##3##(2007-12#3)
solution equilibria of##3##3##(2008-10#3)
solution exchange##2##2##(1994-2#1)(2012-2#1)
solution exhibits##2##2##(2007-12#1)(2009-6#1)
solution flows##2##2##(2007-8#1)(2008-10#1)
solution followed by##5##3##(2007-7#1)(2008-10#2)(2008-11#1)(2010-7#1)
solution following##2##2##(2008-10#1)(2010-2#1)
solution for a##6##3##(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-8#1)
solution for an##2##3##(1993-8#1)(1994-1#1)
solution for light scattering by nonspherical##2##6##(2008-3#2)
solution for light scattering by##3##5##(2008-3#3)
solution for parenteral nutrition##2##4##(2012-2#2)
solution for the problem of##2##5##(2006-6#1)(2007-12#1)
solution for the##31##3##(1991-9#1)(1993-11#1)(1997-3#1)(2005-11#2)(2006-6#2)(2007-1#1)(2007-11#1)(2007-12#5)(2008-10#5)(2008-2#4)(2008-3#2)(2008-5#1)(2008-6#1)(2009-7#1)(2011-7#1)(2012-12#2)
solution for transient propagation of electromagnetic waves through a medium##5##10##(2007-12#5)
solution for##127##2##(1990-3#1)(1990-8#1)(1991-9#1)(1992-9#2)(1993-11#1)(1993-8#1)(1994-1#1)(1995-2#1)(1996-3#1)(1997-3#1)(2004-12#1)(2004-9#2)(2005-11#6)(2006-12#1)(2006-3#1)(2006-6#4)(2006-8#1)(2007-1#1)(2007-11#4)(2007-12#12)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-2#12)(2008-3#14)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2011-7#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
solution form##2##2##(1991-11#1)(2010-12#1)
solution from the##6##3##(2005-11#1)(2007-8#1)(2008-10#3)(2008-3#1)
solution from##15##2##(1993-11#1)(2005-11#1)(2006-4#1)(2007-8#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-6#1)
solution gave a mean absorbance of 0##3##7##(2008-10#3)
solution gave a mean##4##4##(2008-10#4)
solution gave a##6##3##(2008-10#6)
solution generated##2##2##(2008-10#2)
solution given##2##2##(2006-10#1)(2008-3#1)
solution growth technique##2##3##(2005-11#1)(2013-1#1)
solution had##6##2##(1995-12#1)(1996-2#1)(2008-10#4)
solution has been carried out##2##5##(2008-10#2)
solution has been described##2##4##(2008-10#2)
solution has been determined##2##4##(1991-7#1)(2008-10#1)
solution has been developed##2##4##(1991-8#1)(2008-3#1)
solution has been investigated##5##4##(2005-11#1)(2006-12#1)(2008-10#2)(2008-5#1)
solution has been studied##3##4##(2005-11#1)(2005-4#2)
solution has been##22##3##(1990-10#1)(1991-7#1)(1991-8#1)(1992-2#1)(2004-9#1)(2005-11#2)(2005-4#2)(2006-12#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-5#1)(2010-5#1)
solution has##28##2##(1990-10#1)(1991-7#2)(1991-8#1)(1992-2#1)(2004-9#1)(2005-11#3)(2005-4#2)(2006-10#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-2#2)(2008-3#1)(2008-5#1)(2010-5#1)
solution have been determined by##2##5##(2007-11#1)(2008-5#1)
solution have been determined##3##4##(2007-11#1)(2008-10#1)(2008-5#1)
solution have been investigated using##2##5##(2005-11#2)
solution have been studied by##3##5##(1990-9#1)(2007-9#1)(2008-10#1)
solution have been##12##3##(1990-9#1)(1995-6#1)(2005-11#2)(2006-1#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-5#1)(2010-5#1)
solution have##13##2##(1990-9#1)(1995-6#1)(2005-11#2)(2006-1#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-5#1)(2010-5#1)
solution hybridisation-RNase protection assay##3##4##(1996-12#3)
solution hybridisation-RNase protection##4##3##(1996-12#4)
solution hybridization assay##3##3##(1991-9#3)
solution hybridization in the##2##4##(1995-3#1)(2008-4#1)
solution hybridization##10##2##(1991-9#4)(1995-10#1)(1995-3#1)(1995-8#1)(1997-8#1)(2008-10#1)(2008-4#1)
solution in 0##2##3##(1990-6#1)(2008-10#1)
solution in 1##2##3##(2008-9#1)(2010-1#1)
solution in a##17##3##(1997-4#1)(2007-11#1)(2007-8#2)(2008-10#9)(2008-3#1)(2009-9#1)(2011-2#2)
solution in both##2##3##(1993-12#1)(2004-9#1)
solution in order to##4##4##(2007-10#1)(2008-10#3)
solution in the presence of##7##5##(1991-4#1)(1995-11#1)(1996-2#1)(2007-11#1)(2008-10#3)
solution in the range##2##4##(2008-10#2)
solution in the##28##3##(1991-1#1)(1991-4#1)(1991-9#1)(1994-9#1)(1995-11#1)(1995-3#2)(1996-2#1)(2004-4#1)(2004-8#1)(2005-11#3)(2007-10#1)(2007-11#2)(2007-12#2)(2008-10#9)(2010-4#1)
solution in water##2##3##(1993-2#1)(2008-10#1)
solution in which the##3##4##(2007-12#1)(2008-10#1)(2008-8#1)
solution in which##4##3##(1992-9#1)(2007-12#1)(2008-10#1)(2008-8#1)
solution in##100##2##(1990-6#1)(1991-1#1)(1991-11#1)(1991-4#1)(1991-9#2)(1992-9#1)(1993-12#1)(1993-2#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-3#2)(1995-6#1)(1996-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-4#1)(2004-8#1)(2004-9#1)(2005-11#4)(2006-7#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-7#1)(2007-8#3)(2007-9#2)(2008-10#40)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#3)
solution including##2##2##(2008-10#2)
solution increased##2##2##(1990-5#1)(2008-11#1)
solution injected##3##2##(2008-12#1)(2008-5#1)(2012-1#1)
solution instead of##2##3##(2008-10#1)(2008-11#1)
solution interface##4##2##(2005-11#3)(2008-10#1)
solution into a##4##3##(2005-11#1)(2008-10#3)
solution into the##6##3##(1990-7#1)(2008-10#4)(2008-5#1)
solution into##12##2##(1990-7#1)(1994-2#1)(2005-11#1)(2008-10#8)(2008-5#1)
solution intraperitoneally##2##2##(1991-8#1)(2006-9#1)
solution ionic strength##2##3##(2005-11#1)(2008-5#1)
solution is added to##2##4##(2008-10#2)
solution is also##3##3##(2008-10#1)(2008-2#2)
solution is derived##2##3##(2007-11#1)(2008-2#1)
solution is determined##2##3##(2008-10#2)
solution is injected into##3##4##(2008-10#3)
solution is known##2##3##(1994-9#1)(2008-2#1)
solution is mixed##2##3##(2008-10#2)
solution is needed##2##3##(2008-10#1)(2008-11#1)
solution is obtained##3##3##(2007-12#3)
solution is presented##4##3##(2008-10#1)(2008-3#3)
solution is proposed##2##3##(2008-10#1)(2008-2#1)
solution is required##2##3##(2008-10#2)
solution is to##3##3##(1994-3#1)(2010-12#1)(2011-2#1)
solution is used to##3##4##(2008-1#1)(2008-10#1)(2008-2#1)
solution is used##5##3##(2008-1#1)(2008-10#3)(2008-2#1)
solution is##113##2##(1991-8#1)(1992-9#1)(1993-3#1)(1994-3#1)(1994-9#1)(1996-12#1)(1997-2#1)(1997-7#1)(2005-11#2)(2005-4#1)(2006-10#3)(2006-2#1)(2006-5#1)(2007-11#2)(2007-12#9)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#44)(2008-11#2)(2008-2#13)(2008-3#5)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2010-12#3)(2010-2#1)(2011-2#4)
solution leaving##3##2##(2006-10#1)(2008-10#2)
solution led to##3##3##(1996-12#1)(1997-7#1)(2013-1#1)
solution maintained##2##2##(2007-8#1)(2010-3#1)
solution matrix##2##2##(2008-10#1)(2008-8#1)
solution may be##4##3##(1992-3#1)(2005-10#1)(2007-8#1)(2008-3#1)
solution may##6##2##(1992-3#1)(2005-10#1)(2007-8#1)(2008-3#1)(2010-7#1)(2013-1#1)
solution measurements##2##2##(1993-8#1)(2008-10#1)
solution method##4##2##(2008-3#1)(2009-2#1)(2013-8#2)
solution model##3##2##(1994-12#1)(2005-11#2)
solution must be##2##3##(2008-10#2)
solution nuclear magnetic resonance##2##4##(1995-6#1)(2012-1#1)
solution obtained by##3##3##(1991-5#1)(2008-10#1)(2011-2#1)
solution obtained##4##2##(1991-5#1)(2008-10#2)(2011-2#1)
solution of 0##9##3##(2008-10#9)
solution of 1##2##3##(2005-11#1)(2008-6#1)
solution of 2##5##3##(1992-1#1)(2008-10#4)
solution of Rhodamine##2##3##(2008-2#1)(2008-3#1)
solution of a##19##3##(1991-5#1)(1995-2#2)(1997-6#1)(2006-10#1)(2008-10#3)(2008-2#5)(2008-3#2)(2008-7#2)(2009-10#1)(2009-11#1)
solution of an inverse##2##4##(2007-11#1)(2008-3#1)
solution of light scattering##3##4##(2008-3#3)
solution of metal complexes##2##4##(2008-3#2)
solution of metal##3##3##(2008-10#1)(2008-3#2)
solution of pH 8##2##4##(2008-10#2)
solution of pH##7##3##(2005-4#1)(2008-10#6)
solution of potassium phosphate dibasic (pH 7##2##7##(2008-10#2)
solution of potassium##3##3##(2007-7#1)(2008-10#2)
solution of sodium##4##3##(2008-10#3)(2012-3#1)
solution of the complex##2##4##(2008-10#1)(2008-2#1)
solution of the diffusion equation is##2##6##(2007-12#1)(2008-2#1)
solution of the diffusion equation##6##5##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)
solution of the diffusion##7##4##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#1)
solution of the radiative transfer equation##2##6##(2008-2#2)
solution of the reagent##2##4##(2008-10#2)
solution of the two-frequency lidar inversion##2##6##(2008-3#2)
solution of the##75##3##(1991-11#1)(1991-12#2)(1991-9#1)(1992-9#1)(1993-3#1)(1997-2#1)(2005-11#1)(2006-10#1)(2007-11#3)(2007-12#8)(2008-1#1)(2008-10#13)(2008-11#1)(2008-2#15)(2008-3#12)(2008-5#2)(2008-7#2)(2008-9#1)(2009-2#1)(2010-10#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)
solution of these##3##3##(2007-8#2)(2008-10#1)
solution of this##2##3##(2009-4#1)(2011-1#1)
solution of##306##2##(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-2#2)(1995-3#1)(1996-2#4)(1996-6#1)(1996-8#5)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#2)(2004-9#2)(2005-11#8)(2005-12#1)(2005-4#1)(2006-10#5)(2006-2#1)(2006-4#1)(2006-6#1)(2007-11#10)(2007-12#10)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#93)(2008-11#4)(2008-12#1)(2008-2#29)(2008-3#28)(2008-4#3)(2008-5#9)(2008-6#2)(2008-7#6)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-7#3)(2010-8#1)(2011-1#5)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#3)
solution on a##3##3##(2005-11#1)(2007-8#1)(2013-1#1)
solution on the##17##3##(1994-3#1)(2005-11#5)(2006-9#2)(2008-10#8)(2013-8#1)
solution on##36##2##(1994-3#1)(2004-9#2)(2005-11#10)(2006-9#2)(2007-8#1)(2008-10#11)(2008-11#2)(2008-2#1)(2010-7#1)(2012-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
solution only##3##2##(2006-12#1)(2008-10#1)(2008-12#1)
solution onto##4##2##(2005-11#1)(2008-10#2)(2008-11#1)
solution or the##3##3##(1993-4#1)(2008-10#2)
solution or##22##2##(1990-2#1)(1990-5#1)(1990-8#1)(1993-12#2)(1993-4#1)(1994-9#1)(1997-7#1)(2007-11#1)(2008-10#10)(2008-2#1)(2008-4#1)(2009-12#1)
solution orientation##2##2##(2011-2#2)
solution over a##2##3##(1994-3#1)(2008-10#1)
solution over the##2##3##(2006-10#1)(2008-10#1)
solution over##6##2##(1994-3#1)(2005-11#1)(2006-10#1)(2006-7#1)(2008-10#2)
solution pH and##5##3##(2005-11#1)(2008-10#3)(2008-6#1)
solution pH for##2##3##(2005-11#1)(2008-10#1)
solution pH on the##3##4##(2008-10#2)(2008-5#1)
solution pH##42##2##(1995-2#1)(1995-3#1)(2005-11#5)(2006-12#1)(2007-8#2)(2008-1#1)(2008-10#27)(2008-4#1)(2008-5#2)(2008-6#1)
solution phase sensing##2##3##(2008-10#2)
solution phase##13##2##(1996-6#1)(2005-11#1)(2007-8#1)(2008-10#8)(2008-5#1)(2010-5#1)
solution precipitation##2##2##(2009-11#2)
solution preparation##2##2##(2008-10#1)(2008-9#1)
solution prepared##2##2##(2008-10#1)(2008-5#1)
solution prior to##3##3##(1994-3#1)(1996-2#1)(2010-5#1)
solution procedure##3##2##(1990-7#1)(1992-6#1)(2009-10#1)
solution produced##2##2##(2008-10#1)(2008-5#1)
solution properties of##5##3##(1991-7#1)(1996-4#1)(2005-11#3)
solution properties##7##2##(1991-7#1)(1996-4#1)(2005-11#4)(2011-2#1)
solution provides##4##2##(1997-5#1)(2008-10#2)(2008-3#1)
solution ranged from##2##3##(2008-10#2)
solution reacted##2##2##(2005-4#1)(2008-10#1)
solution reaction##2##2##(1995-10#1)(2005-4#1)
solution resulted in##3##3##(1994-6#1)(1996-4#1)(2007-8#1)
solution results in##4##3##(1990-2#1)(1996-5#1)(2009-6#1)(2010-5#1)
solution route##2##2##(2009-2#1)(2010-4#1)
solution samples##12##2##(2007-8#1)(2008-10#11)
solution set of##3##3##(2008-8#3)
solution should be##3##3##(2008-10#1)(2008-2#1)(2013-1#1)
solution showed that##2##3##(2008-10#1)(2008-5#1)
solution showed##5##2##(2008-10#2)(2008-5#1)(2009-3#1)(2010-3#1)
solution shows##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2010-5#1)
solution significantly##3##2##(2005-11#1)(2006-3#1)(2009-8#1)
solution species##2##2##(2007-8#1)(2008-10#1)
solution spectroscopy##2##2##(2010-5#2)
solution stability##3##2##(2008-10#1)(2010-12#1)(2010-2#1)
solution state##2##2##(2006-1#1)(2012-2#1)
solution strongly##2##2##(2005-11#1)(2008-10#1)
solution structure is##2##3##(1994-5#1)(1996-11#1)
solution structure of a##4##4##(1992-4#1)(1995-1#1)(1995-8#1)(1996-6#1)
solution structure of an##3##4##(1994-11#1)(1994-8#1)(1996-11#1)
solution structure of the (-)-cis-anti-[BP]dG##3##5##(1996-7#3)
solution structure of the N-terminal receiver domain of##2##8##(1995-1#2)
solution structure of the complexes##2##5##(2008-3#1)(2010-5#1)
solution structure of the##22##4##(1994-11#2)(1994-12#1)(1994-9#1)(1995-1#6)(1995-2#1)(1996-6#2)(1996-7#5)(1997-2#1)(1997-7#1)(2008-3#1)(2010-5#1)
solution structure of##40##3##(1991-11#1)(1992-4#1)(1994-11#3)(1994-12#1)(1994-5#5)(1994-8#1)(1994-9#1)(1995-1#7)(1995-10#2)(1995-2#2)(1995-3#1)(1995-8#1)(1996-11#1)(1996-6#3)(1996-7#5)(1997-2#1)(1997-7#1)(2008-3#1)(2010-5#1)(2011-2#1)
solution structure##50##2##(1991-11#1)(1991-4#2)(1992-4#1)(1994-11#3)(1994-12#1)(1994-5#8)(1994-8#1)(1994-9#1)(1995-1#7)(1995-10#2)(1995-2#2)(1995-3#1)(1995-8#1)(1996-11#2)(1996-6#3)(1996-7#5)(1997-2#1)(1997-7#1)(2006-12#1)(2008-3#2)(2009-7#2)(2010-5#1)(2011-2#1)
solution structures of 1-methoxyallenyllithium##2##4##(2010-6#2)
solution structures of the##2##4##(1996-5#1)(1996-7#1)
solution structures of##5##3##(1996-5#1)(1996-7#1)(2010-6#2)(2012-2#1)
solution structures##6##2##(1996-11#1)(1996-5#1)(1996-7#1)(2010-6#2)(2012-2#1)
solution studied##2##2##(2006-10#1)(2008-10#1)
solution studies##2##2##(1993-8#1)(1997-1#1)
solution such##2##2##(2009-4#1)(2010-12#1)
solution temperature##6##2##(2005-11#1)(2008-10#3)(2013-8#2)
solution than##2##2##(2008-10#2)
solution that can##3##3##(2006-10#1)(2008-2#1)(2009-12#1)
solution that contained##3##3##(2008-10#2)(2008-6#1)
solution that##25##2##(1991-7#1)(1992-12#1)(1995-1#1)(1996-5#1)(1996-8#1)(2006-10#1)(2006-12#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-6#1)(2009-12#1)(2009-6#1)(2010-8#1)(2013-1#2)
solution the##8##2##(1992-2#1)(1994-8#1)(2006-4#1)(2007-12#1)(2008-10#3)(2008-4#1)
solution through the##4##3##(2007-8#1)(2008-10#3)
solution through##7##2##(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)
solution to a##6##3##(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-6#1)(2010-3#1)
solution to achieve##2##3##(2008-10#1)(2011-1#1)
solution to an##2##3##(2008-10#2)
solution to enhance the##2##4##(2007-12#1)(2008-10#1)
solution to facilitate##3##3##(2008-10#1)(2013-1#2)
solution to form a##2##4##(2008-10#1)(2008-4#1)
solution to form the##2##4##(1994-12#1)(2008-10#1)
solution to form##6##3##(1994-12#1)(1997-7#1)(2008-10#3)(2008-4#1)
solution to give##2##3##(2008-10#2)
solution to increase##2##3##(2008-10#1)(2008-2#1)
solution to problems##2##3##(1993-6#1)(1994-6#1)
solution to simulate the##2##4##(2008-3#1)(2009-4#1)
solution to the current##3##4##(2008-1#1)(2008-11#1)(2011-1#1)
solution to the problem of##8##5##(1990-12#1)(1990-6#1)(1991-9#1)(1994-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)
solution to the problem##15##4##(1990-12#1)(1990-6#1)(1991-9#1)(1994-8#1)(1994-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-9#1)(2012-12#1)
solution to the##50##3##(1990-12#1)(1990-5#1)(1990-6#1)(1991-4#1)(1991-9#1)(1994-8#1)(1994-9#1)(2005-11#2)(2007-12#4)(2007-7#2)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#10)(2008-3#3)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)
solution to their problem##2##4##(2007-11#1)(2009-6#1)
solution to these problems##2##4##(2008-8#1)(2008-9#1)
solution to these##3##3##(2008-6#1)(2008-8#1)(2008-9#1)
solution to this problem##9##4##(1990-11#1)(1991-5#1)(2004-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-2#1)(2008-3#1)(2012-2#1)
solution to this##19##3##(1990-11#1)(1991-5#1)(1992-5#1)(1993-2#1)(2004-4#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-8#1)(2012-1#1)(2012-2#1)
solution to##152##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-6#3)(1994-8#2)(1994-9#1)(1995-1#1)(1996-4#1)(1997-1#1)(1997-5#1)(1997-7#2)(2004-4#1)(2005-10#1)(2005-11#2)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#7)(2007-2#2)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#27)(2008-11#5)(2008-12#1)(2008-2#19)(2008-3#7)(2008-4#2)(2008-5#3)(2008-6#8)(2008-7#1)(2008-8#2)(2008-9#3)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
solution under##8##2##(1995-2#1)(2008-10#5)(2008-2#2)
solution upon##3##2##(2008-10#3)
solution used for##4##3##(2005-11#1)(2008-10#1)(2008-3#1)(2009-9#1)
solution used in##3##3##(2008-10#3)
solution used##10##2##(2005-11#1)(2007-11#1)(2008-10#6)(2008-3#1)(2009-9#1)
solution using a##5##3##(1992-8#1)(2008-10#1)(2008-11#1)(2008-2#2)
solution using the##3##3##(1996-12#1)(2008-4#1)(2010-3#1)
solution using##23##2##(1992-8#1)(1993-3#2)(1994-2#1)(1996-12#1)(1997-4#1)(2006-12#1)(2006-5#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-2#1)(2010-11#1)(2010-3#1)
solution volume of##3##3##(2008-10#2)(2008-5#1)
solution volume##5##2##(2005-11#1)(2008-10#3)(2008-5#1)
solution was 0##6##3##(2007-8#1)(2008-10#5)
solution was added##2##3##(2007-8#1)(2008-10#1)
solution was adjusted to##2##4##(1990-8#1)(2008-10#1)
solution was administered##2##3##(2006-12#1)(2013-1#1)
solution was also observed##2##4##(2005-11#1)(2008-10#1)
solution was also##4##3##(2005-11#1)(2008-10#2)(2008-5#1)
solution was analyzed##2##3##(2008-10#1)(2011-3#1)
solution was applied##2##3##(2005-12#1)(2007-8#1)
solution was carried out##2##4##(2008-10#2)
solution was carried##3##3##(2008-10#3)
solution was changed##2##3##(1990-5#1)(2008-10#1)
solution was determined by##2##4##(2006-4#1)(2008-10#1)
solution was determined##3##3##(2006-4#1)(2008-10#2)
solution was directly##3##3##(2008-10#3)
solution was employed##2##3##(2008-10#1)(2010-5#1)
solution was evaluated##2##3##(2008-10#2)
solution was found to be##4##5##(2005-11#2)(2008-10#1)(2012-2#1)
solution was found to##5##4##(2004-9#1)(2005-11#2)(2008-10#1)(2012-2#1)
solution was found##6##3##(2004-9#1)(2005-11#2)(2008-10#1)(2008-9#1)(2012-2#1)
solution was heated##2##3##(2008-10#2)
solution was injected and##2##4##(2008-10#1)(2012-1#1)
solution was injected in to##2##5##(2008-10#2)
solution was injected into the##3##5##(2008-10#3)
solution was injected into##4##4##(2008-10#3)(2008-9#1)
solution was injected##12##3##(2008-10#10)(2008-9#1)(2012-1#1)
solution was investigated##7##3##(1991-3#1)(1991-8#1)(1996-5#1)(2005-11#3)(2008-10#1)
solution was linear##2##3##(2008-10#2)
solution was measured##5##3##(2004-12#1)(2008-10#3)(2013-1#1)
solution was mixed##2##3##(2004-1#1)(2008-2#1)
solution was monitored##2##3##(2008-10#1)(2011-12#1)
solution was observed for##2##4##(2005-11#1)(2008-10#1)
solution was observed##3##3##(2005-11#1)(2007-8#1)(2008-10#1)
solution was obtained##3##3##(2008-10#3)
solution was passed through##2##4##(2008-10#2)
solution was performed by##2##4##(2008-10#2)
solution was performed##3##3##(2008-10#3)
solution was perfused##2##3##(1990-12#1)(1994-8#1)
solution was reduced##2##3##(2010-7#1)(2012-2#1)
solution was studied using##2##4##(2006-10#1)(2008-10#1)
solution was studied##5##3##(2006-10#2)(2008-10#3)
solution was then##3##3##(2005-4#1)(2008-10#1)(2010-7#1)
solution was to##2##3##(1995-1#1)(2008-7#1)
solution was used as a##2##5##(2008-10#2)
solution was used as##5##4##(2008-10#5)
solution was used to##6##4##(2007-12#1)(2008-10#1)(2008-9#1)(2009-8#1)(2010-5#1)(2011-1#1)
solution was used##14##3##(2007-12#1)(2007-8#1)(2008-10#8)(2008-9#1)(2009-8#1)(2010-5#1)(2011-1#1)
solution was##184##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-8#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-4#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-7#1)(2004-1#1)(2004-12#1)(2004-9#3)(2005-11#8)(2005-12#1)(2005-4#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#6)(2008-10#101)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-3#1)(2012-1#2)(2012-2#2)(2013-1#2)(2013-7#1)
solution were carried out##2##4##(1991-5#1)(2008-10#1)
solution were determined##2##3##(2008-10#2)
solution were introduced##2##3##(2008-10#2)
solution were investigated##2##3##(2008-10#1)(2008-5#1)
solution were measured##2##3##(2008-10#1)(2008-3#1)
solution were obtained##3##3##(2008-10#3)
solution were performed##2##3##(2008-3#1)(2008-8#1)
solution were sequentially##3##3##(2007-8#1)(2008-10#2)
solution were studied by##2##4##(2005-4#1)(2008-10#1)
solution were studied##5##3##(2005-4#2)(2008-10#3)
solution were##52##2##(1991-5#1)(1996-2#1)(1996-4#2)(2005-11#2)(2005-4#4)(2007-8#1)(2007-9#1)(2008-10#32)(2008-11#1)(2008-3#2)(2008-5#2)(2008-8#1)(2010-5#1)(2012-12#1)
solution when the##2##3##(2008-3#1)(2012-12#1)
solution when##4##2##(2006-6#1)(2008-3#1)(2009-5#1)(2012-12#1)
solution which was##2##3##(2008-10#2)
solution which##7##2##(1992-3#1)(1997-8#1)(2008-10#4)(2008-5#1)
solution while##3##2##(2006-12#1)(2008-10#1)(2009-10#1)
solution will be##2##3##(2008-2#1)(2009-12#1)
solution will##3##2##(2008-10#1)(2008-2#1)(2009-12#1)
solution with a correlation coefficient of 0##3##7##(2008-10#3)
solution with a detection limit of##2##6##(2008-10#2)
solution with a detection limit##3##5##(2008-10#3)
solution with a pH##2##4##(2007-2#1)(2008-10#1)
solution with a##11##3##(2004-9#1)(2007-2#1)(2008-10#9)
solution with an##3##3##(1992-3#1)(2007-12#1)(2008-5#1)
solution with low##2##3##(2008-10#1)(2011-2#1)
solution with pH##2##3##(2008-10#2)
solution with the##9##3##(2005-4#1)(2008-10#5)(2008-2#2)(2008-5#1)
solution with##64##2##(1990-12#1)(1992-3#1)(1992-7#1)(1993-12#1)(1995-11#1)(2004-9#1)(2005-11#2)(2005-4#1)(2006-10#4)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#32)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#1)(2010-5#1)(2011-2#1)(2012-8#1)(2013-1#1)(2013-8#1)
solution within the##4##3##(1990-5#1)(2008-10#3)
solution without the##2##3##(1992-2#1)(2008-10#1)
solution without##5##2##(1992-2#1)(2008-10#3)(2008-12#1)
solution yielded##2##2##(1997-7#1)(2008-3#1)
solution yielding a##2##3##(2008-10#2)
solution##3830##1##(1990-1#1)(1990-10#7)(1990-11#5)(1990-12#8)(1990-2#9)(1990-3#3)(1990-4#4)(1990-5#12)(1990-6#6)(1990-7#6)(1990-8#7)(1990-9#2)(1991-1#4)(1991-11#6)(1991-12#6)(1991-2#12)(1991-3#7)(1991-4#10)(1991-5#12)(1991-6#5)(1991-7#9)(1991-8#13)(1991-9#18)(1992-1#5)(1992-10#1)(1992-11#2)(1992-12#5)(1992-2#5)(1992-3#8)(1992-4#6)(1992-5#4)(1992-6#8)(1992-7#5)(1992-8#8)(1992-9#10)(1993-1#2)(1993-11#7)(1993-12#7)(1993-2#4)(1993-3#9)(1993-4#6)(1993-6#14)(1993-7#1)(1993-8#8)(1993-9#3)(1994-1#3)(1994-11#12)(1994-12#7)(1994-2#6)(1994-3#14)(1994-5#16)(1994-6#9)(1994-8#13)(1994-9#14)(1995-1#16)(1995-10#9)(1995-11#6)(1995-12#7)(1995-2#11)(1995-3#11)(1995-4#5)(1995-5#6)(1995-6#10)(1995-7#4)(1995-8#7)(1996-1#2)(1996-10#1)(1996-11#11)(1996-12#14)(1996-2#30)(1996-3#5)(1996-4#7)(1996-5#6)(1996-6#14)(1996-7#12)(1996-8#9)(1996-9#3)(1997-1#11)(1997-2#18)(1997-3#7)(1997-4#11)(1997-5#6)(1997-6#5)(1997-7#16)(1997-8#10)(2004-1#1)(2004-11#2)(2004-12#7)(2004-2#1)(2004-4#3)(2004-8#2)(2004-9#24)(2005-10#2)(2005-11#161)(2005-12#3)(2005-4#28)(2005-7#7)(2006-1#5)(2006-10#46)(2006-12#28)(2006-2#6)(2006-3#2)(2006-4#6)(2006-5#6)(2006-6#11)(2006-7#6)(2006-8#3)(2006-9#7)(2007-1#4)(2007-10#11)(2007-11#46)(2007-12#71)(2007-2#5)(2007-3#3)(2007-4#2)(2007-5#2)(2007-6#4)(2007-7#15)(2007-8#82)(2007-9#21)(2008-1#13)(2008-10#1476)(2008-11#35)(2008-12#14)(2008-2#141)(2008-3#116)(2008-4#55)(2008-5#99)(2008-6#31)(2008-7#27)(2008-8#26)(2008-9#33)(2009-10#9)(2009-11#10)(2009-12#8)(2009-2#9)(2009-3#7)(2009-4#7)(2009-5#10)(2009-6#10)(2009-7#8)(2009-8#9)(2009-9#10)(2010-1#5)(2010-10#5)(2010-11#3)(2010-12#17)(2010-2#11)(2010-3#10)(2010-4#21)(2010-5#26)(2010-6#6)(2010-7#12)(2010-8#10)(2010-9#3)(2011-1#24)(2011-12#5)(2011-2#42)(2011-3#3)(2011-7#1)(2012-1#15)(2012-11#2)(2012-12#23)(2012-2#23)(2012-3#9)(2012-7#1)(2012-8#1)(2013-1#38)(2013-7#10)(2013-8#24)
solution&quot##2##1##(1995-5#1)(1996-2#1)
solution) and##4##2##(2008-10#2)(2008-3#2)
solution) were##3##2##(2008-10#2)(2008-5#1)
solution)##26##1##(1991-10#1)(1991-12#1)(1994-2#1)(2007-12#1)(2007-8#1)(2008-10#10)(2008-12#1)(2008-3#3)(2008-5#1)(2008-9#1)(2009-12#2)(2010-12#1)(2011-2#1)(2013-1#1)
solution- and##4##2##(1997-4#1)(2006-9#3)
solution-##5##1##(1997-4#1)(2006-9#4)
solution-based##2##1##(2012-2#2)
solution-binding##2##1##(1997-4#2)
solution-phase reaction work-up##2##3##(2008-10#2)
solution-phase synthesis of##4##3##(2007-11#1)(2007-12#1)(2008-4#1)(2009-7#1)
solution-phase##13##1##(1997-4#1)(2006-12#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#1)(2009-7#1)
solution-to-powder mass ratio##2##3##(2010-4#2)
solution-treated##3##1##(2006-9#2)(2012-2#1)
solution?##7##1##(1995-1#2)(1995-2#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-7#1)
solution]##4##1##(1997-5#1)(2005-4#2)(2008-4#1)
solutions (0##3##2##(2007-8#1)(2008-10#2)
solutions (i##2##2##(1991-3#2)
solutions (pH##5##2##(2005-11#1)(2007-8#1)(2008-10#2)(2010-5#1)
solutions after##4##2##(2008-10#3)(2011-3#1)
solutions and for##3##3##(2008-10#2)(2008-4#1)
solutions and in the##3##4##(2008-10#2)(2008-11#1)
solutions and in##11##3##(1990-8#1)(1996-6#1)(2008-10#7)(2008-11#1)(2008-8#1)
solutions and its##4##3##(2005-10#1)(2008-10#2)(2013-1#1)
solutions and natural##2##3##(2007-8#1)(2008-10#1)
solutions and the##12##3##(1995-2#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2009-6#1)
solutions and their##2##3##(1993-3#1)(2012-2#1)
solutions and to##2##3##(1997-2#1)(2008-10#1)
solutions and##95##2##(1990-5#1)(1990-8#1)(1991-5#1)(1992-4#1)(1993-3#1)(1995-2#1)(1995-8#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(2005-10#1)(2005-11#4)(2005-4#2)(2006-10#1)(2006-4#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#3)(2008-10#40)(2008-11#2)(2008-2#4)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
solutions are described##2##3##(1992-11#1)(2008-10#1)
solutions are discussed##2##3##(2008-1#1)(2011-1#1)
solutions are found for##3##4##(2007-12#2)(2008-3#1)
solutions are found##4##3##(2007-12#2)(2008-3#1)(2008-7#1)
solutions are given##2##3##(2005-11#1)(2008-2#1)
solutions are possible##2##3##(1994-9#1)(2008-3#1)
solutions are presented for the##2##5##(2008-2#2)
solutions are the##3##3##(1995-1#1)(2007-4#1)(2010-2#1)
solutions are##59##2##(1992-11#1)(1992-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1996-12#1)(2005-10#1)(2005-11#2)(2006-10#1)(2006-4#1)(2006-6#1)(2007-11#2)(2007-12#6)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#12)(2008-2#5)(2008-3#6)(2008-7#1)(2008-8#2)(2009-5#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
solutions as a function of##2##5##(2008-10#2)
solutions as the##2##3##(1991-8#1)(2008-10#1)
solutions as well##2##3##(2008-10#1)(2008-3#1)
solutions as##10##2##(1991-8#1)(2005-11#1)(2007-10#1)(2008-10#6)(2008-3#1)
solutions at a##2##3##(2006-10#1)(2008-10#1)
solutions at concentrations of##3##4##(1992-8#1)(2008-10#1)(2012-3#1)
solutions at different concentrations and##2##5##(2005-11#1)(2008-10#1)
solutions at different concentrations##6##4##(2005-11#4)(2008-10#1)(2008-5#1)
solutions at different##7##3##(2005-11#4)(2008-10#2)(2008-5#1)
solutions at pH##4##3##(1992-2#1)(2005-11#1)(2008-10#2)
solutions at room temperature##2##4##(2005-11#1)(2008-10#1)
solutions at the##3##3##(2008-10#1)(2009-10#1)(2010-4#1)
solutions at##40##2##(1991-7#1)(1992-2#1)(1992-8#1)(2005-11#8)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#1)(2008-10#15)(2008-11#1)(2008-5#2)(2008-6#2)(2009-10#1)(2009-2#1)(2010-4#1)(2012-3#1)
solutions based on the##2##4##(2008-3#1)(2008-7#1)
solutions based on##8##3##(2008-10#4)(2008-3#1)(2008-7#1)(2009-11#1)(2009-3#1)
solutions by##18##2##(1990-10#1)(1997-3#1)(2007-12#1)(2007-9#1)(2008-10#11)(2008-3#2)(2009-4#1)
solutions can be##12##3##(1993-2#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-9#1)(2008-1#1)(2008-10#2)(2008-6#1)(2011-2#1)
solutions can##13##2##(1993-2#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-6#1)(2011-2#1)
solutions cannot##2##2##(2005-11#1)(2008-10#1)
solutions contain##2##2##(2005-11#1)(2008-10#1)
solutions contained##2##2##(1991-9#1)(2008-10#1)
solutions containing 0##3##3##(1991-9#1)(2008-10#2)
solutions containing 1##2##3##(1996-2#1)(2008-10#1)
solutions containing 20##2##3##(2008-10#1)(2009-6#1)
solutions containing a##4##3##(1990-12#1)(2008-10#3)
solutions containing acetic##2##3##(2008-10#2)
solutions containing an##2##3##(2008-10#1)(2013-8#1)
solutions containing both##2##3##(2008-10#2)
solutions containing different##2##3##(2008-10#1)(2013-1#1)
solutions containing only##2##3##(2008-10#2)
solutions containing the##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
solutions containing up to##2##4##(2008-10#2)
solutions containing##66##2##(1990-12#1)(1991-8#1)(1991-9#2)(1992-8#1)(1993-6#1)(1993-8#1)(1996-2#2)(1996-5#1)(2005-11#1)(2008-10#46)(2008-2#1)(2008-5#2)(2008-8#1)(2009-6#1)(2011-2#2)(2013-1#1)(2013-8#1)
solutions could be##2##3##(2008-10#1)(2013-1#1)
solutions could##4##2##(1994-9#1)(2008-10#1)(2008-2#1)(2013-1#1)
solutions decreased##3##2##(1990-2#1)(1995-7#1)(2008-10#1)
solutions decreases##2##2##(2005-11#1)(2008-10#1)
solutions did not##3##3##(2008-10#2)(2011-2#1)
solutions due to##2##3##(2008-10#1)(2011-2#1)
solutions due##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
solutions during##2##2##(2005-11#1)(2009-6#1)
solutions exist for##2##3##(2008-2#1)(2012-1#1)
solutions exist##6##2##(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-12#1)(2012-1#1)
solutions for a##5##3##(2008-11#1)(2008-2#2)(2010-4#1)(2013-8#1)
solutions for all##2##3##(2008-10#1)(2013-8#1)
solutions for extraction##2##3##(2008-10#2)
solutions for the##12##3##(1996-9#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2009-3#1)(2009-4#1)(2013-8#1)
solutions for##71##2##(1993-2#1)(1993-4#1)(1995-2#1)(1996-12#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-6#1)(2005-11#4)(2006-10#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#6)(2008-4#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-4#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#6)
solutions from the##2##3##(2010-11#1)(2012-1#1)
solutions from##5##2##(2007-8#1)(2008-10#2)(2010-11#1)(2012-1#1)
solutions had##2##2##(1991-7#1)(2007-10#1)
solutions has been carried out##2##5##(2004-9#1)(2008-10#1)
solutions has been investigated##2##4##(2008-10#2)
solutions has been studied using##2##5##(2008-10#2)
solutions has been studied##5##4##(1996-2#1)(2005-11#2)(2008-10#2)
solutions has been##13##3##(1991-5#1)(1996-2#1)(2004-9#1)(2005-11#2)(2006-12#1)(2008-10#7)
solutions has##14##2##(1991-5#1)(1996-2#1)(2004-9#1)(2005-11#2)(2006-12#1)(2007-11#1)(2008-10#7)
solutions have been proposed##3##4##(2006-6#1)(2007-4#1)(2008-2#1)
solutions have been studied for##2##5##(2005-11#1)(2008-10#1)
solutions have been tried##2##4##(2007-11#1)(2009-6#1)
solutions have been##14##3##(2005-11#1)(2005-4#1)(2006-12#2)(2006-6#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
solutions have##23##2##(1994-11#1)(1996-9#1)(2005-11#2)(2005-4#1)(2006-12#2)(2006-6#1)(2007-11#1)(2007-4#1)(2008-10#4)(2008-12#2)(2008-2#1)(2009-11#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
solutions in the presence of##2##5##(2007-4#1)(2008-10#1)
solutions in the range##3##4##(2008-10#2)(2011-2#1)
solutions in the treatment of##2##5##(1994-2#1)(1997-3#1)
solutions in the##19##3##(1991-1#1)(1992-2#1)(1992-3#1)(1994-2#1)(1997-3#1)(2007-12#1)(2007-4#1)(2008-10#7)(2008-2#1)(2008-5#2)(2009-12#1)(2011-2#1)
solutions in view of##2##4##(2008-10#2)
solutions in vitro##2##3##(1995-1#2)
solutions in##55##2##(1990-3#1)(1991-1#1)(1992-2#1)(1992-3#1)(1994-2#1)(1995-1#2)(1995-4#1)(1997-3#1)(2005-11#2)(2006-10#1)(2006-3#1)(2006-5#1)(2007-12#1)(2007-4#2)(2008-10#21)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#2)(2009-12#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#2)
solutions include##2##2##(2007-11#1)(2007-5#1)
solutions including##3##2##(2008-10#3)
solutions increased the##2##3##(1995-5#1)(2008-10#1)
solutions increases##2##2##(1992-3#1)(2005-11#1)
solutions into a##2##3##(2008-10#2)
solutions into the##2##3##(2007-10#1)(2008-10#1)
solutions into##8##2##(2007-10#1)(2008-10#5)(2010-4#1)(2011-1#1)
solutions is described##2##3##(2008-10#2)
solutions is presented##2##3##(2007-9#1)(2008-10#1)
solutions is proposed##3##3##(2008-10#3)
solutions is##22##2##(1991-7#1)(1993-4#1)(1997-5#1)(1997-8#1)(2005-11#1)(2007-9#1)(2008-10#12)(2008-2#1)(2008-3#2)(2008-5#1)
solutions may be##3##3##(2007-2#1)(2008-3#1)(2009-8#1)
solutions may##6##2##(2007-12#2)(2007-2#1)(2008-3#1)(2009-8#1)(2010-4#1)
solutions need to be##2##4##(1995-1#1)(2008-2#1)
solutions needed for##2##3##(2008-10#1)(2008-9#1)
solutions obtained from the##2##4##(2008-10#1)(2008-3#1)
solutions obtained from##4##3##(2008-10#2)(2008-3#2)
solutions obtained##11##2##(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#3)
solutions of 0##4##3##(2006-10#1)(2008-10#3)
solutions of 1##3##3##(1995-7#1)(2008-10#1)(2008-6#1)
solutions of 10##2##3##(2008-10#2)
solutions of 2##2##3##(2008-10#2)
solutions of 5##2##3##(2008-10#2)
solutions of As(III)##2##3##(2008-10#2)
solutions of NaCl##4##3##(1992-3#1)(1995-5#1)(2006-10#2)
solutions of a##3##3##(2005-11#2)(2008-2#1)
solutions of anionic##2##3##(1996-11#1)(2008-7#1)
solutions of different##6##3##(1990-12#1)(1992-2#1)(2008-10#3)(2013-8#1)
solutions of higher##3##3##(1990-10#1)(2008-10#1)(2012-11#1)
solutions of increasing concentration##2##4##(1990-5#1)(2005-11#1)
solutions of ionic##2##3##(2005-11#1)(2008-10#1)
solutions of mixed salts##2##4##(2008-10#2)
solutions of pH 2##2##4##(1990-8#1)(2008-10#1)
solutions of pH##4##3##(1990-8#1)(2008-10#3)
solutions of sodium##4##3##(1997-4#1)(2008-10#2)(2009-2#1)
solutions of the complex##2##4##(2008-10#1)(2008-5#1)
solutions of the compounds##2##4##(2008-10#1)(2010-5#1)
solutions of the single molecule magnet Ni(4)##2##7##(2009-5#2)
solutions of the##37##3##(1992-8#1)(1993-5#1)(1995-2#1)(1997-7#2)(1997-8#1)(2005-11#2)(2005-4#1)(2006-10#1)(2006-12#1)(2007-11#3)(2007-12#3)(2008-10#10)(2008-2#4)(2008-4#1)(2008-5#1)(2009-5#3)(2010-5#1)
solutions of these##3##3##(1994-8#1)(2005-11#1)(2009-4#1)
solutions of urea##2##3##(1990-8#1)(1991-7#1)
solutions of various##5##3##(2008-10#4)(2008-5#1)
solutions of##220##2##(1990-10#1)(1990-12#3)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#3)(1991-10#2)(1991-5#3)(1991-7#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-5#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-5#1)(1995-7#1)(1996-11#2)(1996-2#1)(1997-4#2)(1997-7#5)(1997-8#1)(2005-11#22)(2005-4#1)(2005-8#1)(2006-10#6)(2006-12#4)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#7)(2007-8#2)(2007-9#1)(2008-10#83)(2008-2#9)(2008-3#6)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#4)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#3)(2009-6#1)(2010-1#1)(2010-2#2)(2010-4#2)(2010-5#2)(2011-1#1)(2012-11#2)(2013-8#2)
solutions on the##7##3##(2005-11#1)(2006-7#1)(2008-1#1)(2008-10#2)(2011-1#1)(2012-7#1)
solutions on##14##2##(1993-1#1)(2005-11#1)(2006-7#1)(2007-9#1)(2008-1#1)(2008-10#4)(2009-6#1)(2010-11#1)(2011-1#1)(2012-7#1)(2013-1#1)
solutions onto##5##2##(2005-11#1)(2008-10#2)(2008-3#1)(2008-4#1)
solutions or for##2##3##(2008-10#2)
solutions or##5##2##(1994-2#1)(2008-10#3)(2011-1#1)
solutions over##5##2##(2005-11#2)(2008-10#3)
solutions prepared in##3##3##(1992-11#2)(2008-10#1)
solutions prepared##4##2##(1992-11#3)(2008-10#1)
solutions previously##4##2##(2007-11#1)(2008-10#3)
solutions provide##2##2##(2005-11#1)(2009-2#1)
solutions provided##2##2##(1993-4#1)(2008-10#1)
solutions ranging##3##2##(1994-3#1)(2008-2#1)(2008-4#1)
solutions resulted in##3##3##(1994-6#1)(2008-10#2)
solutions resulting from##2##3##(2008-10#1)(2009-9#1)
solutions should be##3##3##(1996-9#2)(2013-1#1)
solutions should##4##2##(1996-9#3)(2013-1#1)
solutions show that##2##3##(2008-10#1)(2008-3#1)
solutions show##5##2##(2005-11#1)(2008-10#2)(2008-2#1)(2008-3#1)
solutions showed##3##2##(1990-7#1)(2008-10#2)
solutions shows##3##2##(2008-10#2)(2008-2#1)
solutions such as##3##3##(1996-2#1)(2006-2#1)(2011-12#1)
solutions that are##4##3##(2007-5#1)(2008-10#1)(2008-2#1)(2011-2#1)
solutions that became available##2##4##(2008-11#1)(2008-3#1)
solutions that can##3##3##(2008-4#1)(2008-5#1)(2011-2#1)
solutions that contain##2##3##(1997-7#1)(2005-11#1)
solutions that##28##2##(1997-7#1)(2005-11#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-10#6)(2008-11#2)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2009-10#1)(2010-7#1)(2011-2#2)(2013-1#3)
solutions through the##2##3##(2007-8#1)(2008-6#1)
solutions through##3##2##(2007-8#1)(2008-10#1)(2008-6#1)
solutions to be developed##2##4##(2012-2#1)(2012-3#1)
solutions to be##3##3##(2008-10#1)(2012-2#1)(2012-3#1)
solutions to common##2##3##(1992-1#1)(1994-12#1)
solutions to enhance##2##3##(2010-8#1)(2013-8#1)
solutions to problems##2##3##(1994-6#1)(2008-2#1)
solutions to the diffusion equation##2##5##(2008-3#2)
solutions to the problem of##3##5##(2005-8#1)(2008-2#1)(2009-7#1)
solutions to the##16##3##(1996-1#1)(1997-7#1)(2005-11#1)(2005-8#1)(2007-12#1)(2007-4#1)(2008-2#5)(2008-3#2)(2008-8#1)(2008-9#1)(2009-7#1)
solutions to their##3##3##(1996-12#1)(2007-10#1)(2008-7#1)
solutions to these##5##3##(1990-2#1)(2009-6#1)(2011-1#1)(2011-2#2)
solutions to this##4##3##(1997-3#1)(2006-2#1)(2007-9#1)(2008-3#1)
solutions to##85##2##(1990-2#1)(1992-1#2)(1994-12#1)(1994-6#3)(1995-3#2)(1996-1#1)(1996-12#1)(1996-3#3)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-11#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-12#3)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-2#8)(2008-3#4)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#2)(2009-7#1)(2010-1#2)(2010-11#3)(2010-8#2)(2011-1#3)(2011-2#2)(2012-10#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
solutions under##5##2##(2007-11#1)(2008-10#3)(2008-2#1)
solutions used in##2##3##(2008-10#1)(2012-2#1)
solutions using a##6##3##(1991-8#1)(2005-11#1)(2007-8#1)(2008-10#3)
solutions using the##2##3##(1997-3#1)(2008-10#1)
solutions using##20##2##(1991-8#1)(1994-3#1)(1997-3#1)(2005-11#3)(2007-8#1)(2008-10#10)(2008-2#1)(2008-5#1)(2012-2#1)
solutions via##2##2##(2008-10#1)(2009-6#1)
solutions was determined##2##3##(2008-10#2)
solutions was developed##3##3##(2008-10#3)
solutions was shown##2##3##(2005-11#1)(2008-10#1)
solutions was studied##5##3##(1995-6#1)(2008-10#3)(2008-6#1)
solutions was##32##2##(1990-2#1)(1993-1#1)(1995-3#1)(1995-6#1)(1996-1#1)(2005-11#4)(2007-8#1)(2008-10#19)(2008-5#1)(2008-6#1)(2009-2#1)
solutions were 0##2##3##(1990-8#1)(2008-10#1)
solutions were analysed##2##3##(2007-5#1)(2008-10#1)
solutions were determined##7##3##(1990-8#1)(2005-11#1)(2008-10#2)(2012-12#1)(2013-8#2)
solutions were in##2##3##(2004-9#1)(2007-8#1)
solutions were introduced##2##3##(2008-10#2)
solutions were measured##5##3##(1996-9#1)(2005-11#2)(2008-3#2)
solutions were mixed and##2##4##(2008-10#1)(2009-9#1)
solutions were observed##2##3##(2008-10#2)
solutions were studied##3##3##(2005-11#1)(2008-10#2)
solutions were used to##3##4##(2008-10#1)(2008-3#1)(2010-4#1)
solutions were used##5##3##(2008-10#2)(2008-3#1)(2010-4#1)(2011-2#1)
solutions were##70##2##(1990-11#1)(1990-8#3)(1991-12#1)(1991-5#1)(1992-11#1)(1995-12#1)(1996-5#1)(1996-9#1)(2004-9#1)(2005-11#4)(2005-12#2)(2006-12#1)(2007-10#1)(2007-5#1)(2007-8#2)(2008-10#35)(2008-3#3)(2009-6#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-8#2)
solutions when##6##2##(2005-11#1)(2005-8#1)(2007-12#1)(2008-10#1)(2009-5#1)(2011-1#1)
solutions which##4##2##(1994-3#1)(1997-1#1)(2008-10#1)(2008-7#1)
solutions while##2##2##(2004-9#1)(2009-12#1)
solutions will be##2##3##(1993-12#1)(2008-6#1)
solutions will##3##2##(1993-12#1)(2008-6#2)
solutions with a##2##3##(2008-10#1)(2013-8#1)
solutions with different##3##3##(2008-10#3)
solutions with low##3##3##(2008-10#2)(2011-2#1)
solutions with the##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-6#1)
solutions with##36##2##(1992-5#1)(1994-1#1)(1996-5#1)(2007-12#2)(2008-10#20)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#2)(2011-2#2)(2012-1#1)(2013-8#1)
solutions without##4##2##(1990-11#1)(2008-10#2)(2008-5#1)
solutions##1764##1##(1990-10#3)(1990-11#7)(1990-12#8)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#5)(1990-7#3)(1990-8#12)(1990-9#2)(1991-1#1)(1991-10#2)(1991-12#3)(1991-3#3)(1991-5#9)(1991-7#5)(1991-8#4)(1991-9#7)(1992-1#2)(1992-10#2)(1992-11#6)(1992-12#1)(1992-2#5)(1992-3#5)(1992-4#3)(1992-5#4)(1992-6#1)(1992-7#2)(1992-8#5)(1992-9#3)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#3)(1993-5#2)(1993-6#1)(1993-8#3)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#5)(1994-3#3)(1994-6#6)(1994-8#3)(1994-9#4)(1995-1#5)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#5)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#2)(1995-8#2)(1996-1#2)(1996-11#2)(1996-12#4)(1996-2#8)(1996-3#3)(1996-4#2)(1996-5#8)(1996-6#1)(1996-8#2)(1996-9#10)(1997-1#6)(1997-2#1)(1997-3#4)(1997-4#5)(1997-5#1)(1997-6#1)(1997-7#8)(1997-8#5)(2004-12#2)(2004-8#1)(2004-9#7)(2005-10#5)(2005-11#106)(2005-12#2)(2005-4#6)(2005-5#1)(2005-6#1)(2005-7#3)(2005-8#5)(2006-10#24)(2006-12#12)(2006-2#3)(2006-3#1)(2006-4#6)(2006-5#5)(2006-6#4)(2006-7#2)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#11)(2007-11#19)(2007-12#34)(2007-2#3)(2007-3#2)(2007-4#11)(2007-5#6)(2007-6#1)(2007-7#4)(2007-8#28)(2007-9#8)(2008-1#10)(2008-10#635)(2008-11#14)(2008-12#6)(2008-2#74)(2008-3#66)(2008-4#20)(2008-5#33)(2008-6#22)(2008-7#17)(2008-8#8)(2008-9#10)(2009-10#4)(2009-11#4)(2009-12#5)(2009-2#6)(2009-3#7)(2009-4#6)(2009-5#7)(2009-6#16)(2009-7#2)(2009-8#4)(2009-9#5)(2010-1#3)(2010-10#1)(2010-11#6)(2010-12#1)(2010-2#5)(2010-3#2)(2010-4#12)(2010-5#11)(2010-6#3)(2010-7#4)(2010-8#6)(2010-9#2)(2011-1#16)(2011-12#4)(2011-2#25)(2011-3#1)(2012-1#6)(2012-10#1)(2012-11#3)(2012-12#8)(2012-2#13)(2012-3#13)(2012-7#1)(2013-1#25)(2013-7#1)(2013-8#17)
solutions' to##2##2##(2007-11#1)(2008-10#1)
solutions) were##2##2##(2005-11#1)(2008-10#1)
solutions)##9##1##(2005-11#1)(2006-10#1)(2007-10#1)(2007-9#1)(2008-10#3)(2008-11#1)(2009-12#1)
solutions]##2##1##(2009-2#1)(2011-12#1)
solvable in##2##2##(2006-10#2)
solvable##3##1##(2006-10#2)(2008-2#1)
solvate)##2##1##(1996-2#2)
solvated by##2##2##(1994-11#1)(2008-10#1)
solvated##20##1##(1991-7#1)(1992-6#2)(1993-11#1)(1994-11#1)(1995-5#1)(2005-11#2)(2006-10#3)(2006-3#1)(2007-12#2)(2007-9#1)(2008-10#3)(2012-2#1)(2013-1#1)
solvating##11##1##(1992-9#1)(1995-2#2)(1996-5#2)(2008-10#5)(2012-11#1)
solvation and the##3##3##(2008-10#2)(2008-4#1)
solvation and##6##2##(1997-5#1)(2005-11#1)(2008-10#3)(2008-4#1)
solvation changes##2##2##(1997-7#2)
solvation energy##5##2##(2005-11#3)(2008-10#1)(2011-3#1)
solvation forces##2##2##(2006-10#2)
solvation free energy##8##3##(1994-11#3)(2006-10#4)(2010-2#1)
solvation free##9##2##(1994-11#3)(2006-10#4)(2010-2#1)(2012-2#1)
solvation in##6##2##(1990-8#3)(2006-10#1)(2008-5#2)
solvation is##2##2##(2009-12#1)(2010-7#1)
solvation model##4##2##(1995-1#1)(2006-10#1)(2009-3#1)(2009-5#1)
solvation of the##4##3##(1990-5#1)(1994-11#1)(1996-2#1)(2008-10#1)
solvation of##14##2##(1990-2#1)(1990-5#1)(1994-11#1)(1995-8#1)(1996-2#1)(1997-7#2)(2006-10#5)(2008-10#1)(2010-2#1)
solvation on##2##2##(1994-11#1)(2010-4#1)
solvation shell and##2##3##(1995-8#1)(2006-1#1)
solvation shell##7##2##(1995-8#1)(1997-7#1)(2006-1#3)(2006-3#2)
solvation##96##1##(1990-2#1)(1990-5#1)(1990-8#4)(1993-8#1)(1994-11#6)(1994-9#1)(1995-1#1)(1995-8#2)(1996-2#1)(1996-8#1)(1997-5#1)(1997-7#7)(2005-11#9)(2006-1#3)(2006-10#19)(2006-3#2)(2007-9#1)(2008-10#8)(2008-4#3)(2008-5#3)(2009-12#2)(2009-3#1)(2009-5#1)(2009-9#1)(2010-2#4)(2010-4#1)(2010-7#5)(2011-1#2)(2011-3#1)(2012-2#2)(2013-1#1)
solvatochromic##2##1##(2006-10#1)(2008-10#1)
solve a problem##2##3##(1994-12#1)(2009-12#1)
solve a##11##2##(1991-10#1)(1992-12#1)(1994-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-12#1)(2010-7#1)(2011-2#1)
solve both##2##2##(2008-9#1)(2012-2#1)
solve issues##2##2##(2007-10#1)(2010-3#1)
solve some##4##2##(2008-10#2)(2008-2#1)(2010-7#1)
solve the health care##2##4##(1990-12#1)(1991-2#1)
solve the inverse problem##2##4##(2007-12#1)(2008-2#1)
solve the problem of##6##4##(1992-9#1)(2008-10#2)(2008-3#3)
solve the problem##14##3##(1992-9#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#5)(2009-3#1)
solve the##58##2##(1990-12#1)(1991-2#1)(1991-4#1)(1992-9#3)(1994-6#1)(1997-3#1)(1997-8#1)(2005-7#1)(2007-11#1)(2007-12#3)(2007-2#1)(2008-10#8)(2008-2#7)(2008-3#11)(2008-6#2)(2008-7#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)
solve their##2##2##(1997-7#1)(2006-10#1)
solve these problems##6##3##(2006-2#1)(2006-6#1)(2008-10#2)(2008-5#1)(2010-12#1)
solve these##8##2##(2006-2#1)(2006-6#1)(2008-10#2)(2008-5#1)(2009-2#1)(2009-4#1)(2010-12#1)
solve this problem##17##3##(1997-1#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-10#1)(2010-11#1)(2010-2#1)(2013-1#1)(2013-8#1)
solve this##20##2##(1995-8#1)(1997-1#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-10#1)(2010-11#1)(2010-2#1)(2013-1#3)(2013-8#1)
solve##156##1##(1990-12#2)(1991-10#1)(1991-2#1)(1991-4#1)(1992-12#1)(1992-9#3)(1994-12#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-2#2)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#8)(2007-2#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#16)(2008-3#19)(2008-5#4)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#2)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#3)(2011-2#3)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#1)
solved analytically##5##2##(2005-11#1)(2006-6#1)(2008-10#1)(2008-2#2)
solved and refined##3##3##(1991-2#1)(1995-3#1)(1995-8#1)
solved and##5##2##(1991-2#1)(1995-3#1)(1995-8#1)(1997-2#1)(2007-11#1)
solved by X-ray##2##3##(1991-12#1)(1995-3#1)
solved by a##8##3##(1991-4#1)(1992-9#1)(1994-8#1)(1997-5#1)(2005-11#1)(2008-2#1)(2011-12#1)(2011-2#1)
solved by applying the##2##4##(1991-12#1)(2012-3#1)
solved by molecular replacement##2##4##(1992-4#1)(1996-2#1)
solved by multiple isomorphous replacement##2##5##(1990-7#1)(1992-8#1)
solved by multiple##3##3##(1990-7#1)(1992-8#1)(1993-6#1)
solved by single-crystal##2##3##(1996-2#1)(1997-7#1)
solved by the##4##3##(1992-12#1)(1995-11#1)(2008-2#1)(2008-3#1)
solved by use of the##2##5##(1991-9#1)(2008-3#1)
solved by use of##6##4##(1991-9#1)(2008-3#4)(2008-8#1)
solved by using##3##3##(2007-10#1)(2008-10#1)(2013-1#1)
solved by##49##2##(1990-7#1)(1991-12#2)(1991-4#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-9#1)(1996-2#2)(1997-3#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#5)(2008-8#1)(2008-9#1)(2010-1#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
solved crystal##3##2##(1992-12#1)(1996-11#1)(1997-9#1)
solved for each##2##3##(1990-8#1)(2005-11#1)
solved for##4##2##(1990-2#1)(1990-8#1)(2005-11#1)(2008-3#1)
solved in a##2##3##(1991-4#1)(2008-3#1)
solved in the##3##3##(2005-11#1)(2008-10#1)(2008-3#1)
solved in##8##2##(1991-4#1)(1996-3#1)(2005-11#2)(2008-10#1)(2008-2#1)(2008-3#2)
solved numerically##3##2##(2005-11#1)(2007-12#1)(2008-3#1)
solved structures##2##2##(1997-7#1)(2008-7#1)
solved the##8##2##(1992-11#1)(1995-6#1)(2008-10#2)(2008-2#1)(2010-1#2)(2011-2#1)
solved through##3##2##(2009-5#1)(2012-11#2)
solved to##5##2##(1995-2#1)(1997-2#1)(2008-3#1)(2010-10#1)(2011-1#1)
solved using a##2##3##(2007-9#1)(2009-12#1)
solved using the##2##3##(2008-7#1)(2009-6#1)
solved using##11##2##(1991-6#1)(1994-12#1)(2005-11#1)(2007-9#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-6#1)(2011-1#1)
solved with a##2##3##(2008-10#1)(2008-7#1)
solved with the##2##3##(2008-11#1)(2010-10#1)
solved with##11##2##(1996-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-12#1)(2010-10#1)(2011-3#1)(2012-1#1)(2013-8#1)
solved##173##1##(1990-2#2)(1990-7#2)(1990-8#1)(1991-12#2)(1991-2#2)(1991-4#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-8#2)(1992-9#2)(1993-3#1)(1993-6#3)(1994-11#1)(1994-12#3)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-2#2)(1996-3#2)(1996-8#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#3)(1997-8#1)(1997-9#1)(2005-11#8)(2006-3#1)(2006-5#2)(2006-6#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#10)(2008-11#3)(2008-2#11)(2008-3#14)(2008-5#1)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#2)(2009-5#1)(2009-6#1)(2010-1#4)(2010-10#2)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
solvent A##3##2##(1993-2#1)(1996-3#1)(2012-12#1)
solvent B at##2##3##(1996-8#2)
solvent B##9##2##(1993-2#1)(1996-3#1)(1996-8#5)(2008-10#1)(2012-12#1)
solvent H2O##2##2##(1990-5#1)(2008-4#1)
solvent access to##2##3##(1992-4#2)
solvent accessibility of##3##3##(1996-2#2)(2011-2#1)
solvent accessibility##7##2##(1996-2#3)(1997-1#1)(2008-4#1)(2010-7#1)(2011-2#1)
solvent addition##2##2##(1994-11#1)(2008-10#1)
solvent and analyzed by##2##4##(1990-12#1)(2012-12#1)
solvent and of##2##3##(1996-5#1)(2008-10#1)
solvent and the##10##3##(1996-11#1)(1996-2#1)(1996-5#1)(1997-1#1)(2008-10#5)(2009-9#1)
solvent and##44##2##(1990-12#1)(1992-7#1)(1996-11#1)(1996-2#1)(1996-5#2)(1997-1#2)(1997-7#1)(1997-8#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#20)(2008-4#1)(2008-8#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-9#1)(2012-12#2)(2012-2#1)
solvent are##6##2##(2007-12#1)(2008-10#4)(2010-4#1)
solvent as##3##2##(2006-10#1)(2008-10#2)
solvent at the##2##3##(2005-11#1)(2008-10#1)
solvent at##3##2##(2005-11#1)(2005-12#1)(2008-10#1)
solvent by##4##2##(1997-1#1)(2005-11#1)(2008-4#1)(2009-10#1)
solvent composition and##3##3##(2007-10#1)(2008-10#1)(2008-5#1)
solvent composition##10##2##(1994-9#1)(1995-4#1)(1997-1#1)(2007-10#1)(2008-10#4)(2008-5#1)(2009-3#1)
solvent concentration##5##2##(1997-7#1)(2007-1#1)(2008-10#1)(2008-4#1)(2008-7#1)
solvent conditions##7##2##(1991-4#1)(1997-4#1)(2006-10#5)
solvent consumption and##3##3##(2008-10#3)
solvent consumption was##2##3##(2008-10#1)(2011-1#1)
solvent consumption##14##2##(1996-5#1)(1996-7#1)(2008-10#10)(2011-1#2)
solvent containing##2##2##(1994-12#1)(2008-10#1)
solvent content##2##2##(1992-9#1)(2008-10#1)
solvent control##3##2##(1995-2#2)(2008-11#1)
solvent density##3##2##(2005-8#1)(2006-10#1)(2010-5#1)
solvent dependence of the##2##4##(1995-4#1)(2008-7#1)
solvent dependence of##3##3##(1995-4#1)(2008-7#1)(2009-9#1)
solvent dependence##6##2##(1995-4#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-9#2)
solvent dependent##2##2##(1996-2#1)(2008-10#1)
solvent deuterium##2##2##(1994-11#1)(2008-4#1)
solvent dielectric relaxation##2##3##(1994-8#2)
solvent dielectric##3##2##(1994-8#2)(2013-1#1)
solvent diffusion method##4##3##(2010-12#3)(2011-2#1)
solvent diffusion##5##2##(2010-1#1)(2010-12#3)(2011-2#1)
solvent dimethylsulfoxide##2##2##(1997-1#1)(2008-10#1)
solvent discrimination tritium isotope##2##4##(1995-10#2)
solvent effect on the##4##4##(1994-8#1)(2007-11#2)(2008-10#1)
solvent effect on##7##3##(1994-8#1)(1996-2#1)(2007-11#2)(2008-10#2)(2008-7#1)
solvent effect##8##2##(1994-8#1)(1996-2#1)(2005-4#1)(2007-11#2)(2008-10#2)(2008-7#1)
solvent effects on##2##3##(1996-2#1)(2008-10#1)
solvent effects##6##2##(1991-8#1)(1994-8#1)(1996-2#1)(2008-10#2)(2008-3#1)
solvent evaporation and cogrinding##2##4##(2011-1#2)
solvent evaporation technique##2##3##(2010-5#1)(2013-7#1)
solvent evaporation##9##2##(2005-11#1)(2007-12#1)(2010-5#1)(2010-7#1)(2011-1#2)(2012-2#1)(2013-1#1)(2013-7#1)
solvent exchange##5##2##(1996-2#2)(2008-10#2)(2013-7#1)
solvent exposed##2##2##(1991-4#1)(2006-10#1)
solvent extracted samples##3##3##(2010-8#3)
solvent extracted##4##2##(2008-10#1)(2010-8#3)
solvent extraction (ASE)##5##3##(2008-10#4)(2012-12#1)
solvent extraction and the##2##4##(1993-2#1)(2005-4#1)
solvent extraction and##10##3##(1992-3#1)(1993-2#1)(2005-4#1)(2008-10#7)
solvent extraction combined with solid-phase microextraction##2##6##(2008-10#2)
solvent extraction for##2##3##(2007-8#1)(2008-10#1)
solvent extraction in##2##3##(2008-10#1)(2008-7#1)
solvent extraction method and##2##4##(2008-10#2)
solvent extraction method##6##3##(2007-10#1)(2008-10#5)
solvent extraction of Pb(II)##2##4##(2008-10#2)
solvent extraction of##11##3##(2008-10#11)
solvent extraction or##2##3##(2008-10#2)
solvent extraction procedure##3##3##(2008-10#3)
solvent extraction separation of##2##4##(2008-10#2)
solvent extraction step##2##3##(2008-10#2)
solvent extraction techniques##2##3##(2008-10#2)
solvent extraction using##2##3##(2008-10#2)
solvent extraction##79##2##(1990-1#1)(1991-8#1)(1992-3#2)(1993-2#1)(1995-2#1)(2005-4#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#63)(2008-5#2)(2008-7#1)(2008-9#1)(2010-8#1)(2012-12#1)
solvent extracts of##2##3##(2008-10#1)(2013-8#1)
solvent extracts##3##2##(2008-10#1)(2010-7#1)(2013-8#1)
solvent flow rate##2##3##(2008-10#1)(2013-8#1)
solvent flow##3##2##(2008-10#2)(2013-8#1)
solvent followed by a##2##4##(1997-1#1)(2008-10#1)
solvent for a##2##3##(1993-2#1)(2008-10#1)
solvent for the##4##3##(2006-10#1)(2008-10#2)(2008-3#1)
solvent for##15##2##(1990-9#1)(1993-2#2)(2006-10#1)(2008-10#9)(2008-3#1)(2008-5#1)
solvent free##3##2##(2007-11#2)(2008-10#1)
solvent from##3##2##(2008-10#2)(2008-5#1)
solvent has been developed##2##4##(2008-10#2)
solvent has been##4##3##(2008-10#3)(2010-11#1)
solvent has##5##2##(2008-10#3)(2008-11#1)(2010-11#1)
solvent in the##4##3##(1997-4#1)(2008-10#1)(2008-9#1)(2012-11#1)
solvent in which##2##3##(2008-10#2)
solvent in##13##2##(1992-9#1)(1996-2#1)(1997-4#1)(2008-10#8)(2008-9#1)(2012-11#1)
solvent interactions##2##2##(1996-4#1)(2009-5#1)
solvent ionizing power##2##3##(2009-3#1)(2011-1#1)
solvent is##11##2##(1991-4#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#3)(2008-7#2)
solvent kinetic isotope effect##2##4##(1992-3#2)
solvent kinetic isotope effects of 0##2##6##(1992-3#2)
solvent kinetic isotope effects##4##4##(1991-9#1)(1992-3#3)
solvent kinetic isotope##6##3##(1991-9#1)(1992-3#5)
solvent media and##2##3##(2008-10#2)
solvent media##8##2##(2008-10#7)(2010-6#1)
solvent mediator##4##2##(2008-10#4)
solvent mediators##5##2##(2008-10#5)
solvent microextraction##6##2##(2008-10#6)
solvent mixture of##3##3##(2008-10#1)(2008-2#1)(2013-7#1)
solvent mixture##15##2##(1992-1#1)(1992-4#1)(1996-7#1)(2007-8#1)(2008-10#8)(2008-2#1)(2008-7#1)(2013-7#1)
solvent mixtures##9##2##(1993-6#2)(2005-11#1)(2008-10#5)(2008-5#1)
solvent molecules in the##2##4##(2007-12#1)(2008-10#1)
solvent molecules##17##2##(1991-4#1)(1995-3#2)(1996-2#1)(1996-4#1)(1997-7#1)(2006-10#5)(2007-12#1)(2008-10#4)(2010-7#1)
solvent nucleophilicity##2##2##(2009-3#1)(2011-1#1)
solvent of##8##2##(2005-4#1)(2007-11#1)(2008-10#4)(2008-2#1)(2010-12#1)
solvent on the##6##3##(2005-11#1)(2006-1#1)(2008-10#4)
solvent or##6##2##(1996-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#2)
solvent pH##2##2##(1992-2#1)(2008-10#1)
solvent per##2##2##(1995-10#1)(2008-10#1)
solvent perturbation##3##2##(1995-2#1)(2006-10#2)
solvent polarity and##2##3##(1990-2#1)(2010-2#1)
solvent polarity##5##2##(1990-2#1)(2008-10#2)(2010-2#1)(2010-5#1)
solvent polymeric membrane electrodes##2##4##(2008-10#2)
solvent polymeric membrane##4##3##(2008-10#4)
solvent polymeric membranes##3##3##(2008-10#3)
solvent polymeric##11##2##(2008-10#11)
solvent precipitation##3##2##(2008-10#3)
solvent properties of##3##3##(1996-2#1)(2010-5#1)(2012-2#1)
solvent properties##6##2##(1991-5#1)(1996-2#1)(1997-1#1)(2008-10#1)(2010-5#1)(2012-2#1)
solvent relaxation##5##2##(1997-1#1)(2013-1#4)
solvent stable##3##2##(2013-1#3)
solvent strength##2##2##(1990-9#2)
solvent structure and##2##3##(1993-8#1)(2006-10#1)
solvent structure##3##2##(1993-8#1)(2005-11#1)(2006-10#1)
solvent studies##2##2##(1997-4#1)(2010-2#1)
solvent sublation##3##2##(2008-10#3)
solvent system of##4##3##(1993-2#1)(2007-1#1)(2008-10#1)(2012-3#1)
solvent system##25##2##(1990-10#1)(1993-2#1)(1996-9#1)(1997-5#1)(2004-12#1)(2005-8#1)(2007-1#1)(2007-8#1)(2008-10#10)(2008-2#1)(2008-4#1)(2011-1#3)(2012-3#1)(2013-7#1)
solvent systems##11##2##(1997-7#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-6#2)(2010-2#1)(2011-1#1)
solvent that##2##2##(2007-12#1)(2008-10#1)
solvent through the##2##3##(2005-11#1)(2008-10#1)
solvent to##6##2##(1993-9#1)(1994-8#1)(1997-1#1)(2008-10#2)(2010-1#1)
solvent under##2##2##(1996-5#1)(2008-10#1)
solvent used##7##2##(1996-7#1)(1997-8#1)(2008-10#3)(2008-7#1)(2010-4#1)
solvent vapor##4##2##(2005-11#2)(2008-10#1)(2008-7#1)
solvent viscosity##4##2##(1991-7#1)(1995-11#2)(2005-11#1)
solvent volume and##2##3##(2008-10#2)
solvent volume surrounding##2##3##(2006-10#2)
solvent volume##10##2##(2006-10#2)(2007-8#1)(2008-10#7)
solvent was a mixture of##2##5##(1997-3#1)(2008-10#1)
solvent was optimized##2##3##(2008-10#2)
solvent was##19##2##(1990-4#1)(1990-8#1)(1992-1#1)(1996-9#1)(1997-3#2)(2007-11#1)(2007-8#1)(2008-10#10)(2009-9#1)
solvent water##6##2##(1992-4#1)(1993-11#1)(1994-8#3)(2009-8#1)
solvent were##3##2##(2008-10#3)
solvent which##3##2##(1995-1#1)(2004-12#1)(2009-6#1)
solvent with a##2##3##(2005-11#1)(2008-7#1)
solvent with##5##2##(2005-11#1)(2006-10#1)(2008-10#1)(2008-7#1)(2012-2#1)
solvent##869##1##(1990-1#1)(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#3)(1990-5#5)(1990-7#2)(1990-8#7)(1990-9#3)(1991-11#1)(1991-2#2)(1991-4#8)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#3)(1992-12#1)(1992-2#3)(1992-3#12)(1992-4#5)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-2#7)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#2)(1994-3#2)(1994-5#1)(1994-8#8)(1994-9#4)(1995-1#2)(1995-10#11)(1995-11#2)(1995-2#9)(1995-3#3)(1995-4#3)(1995-5#1)(1996-10#1)(1996-11#1)(1996-2#16)(1996-3#2)(1996-4#3)(1996-5#5)(1996-6#1)(1996-7#4)(1996-8#6)(1996-9#2)(1997-1#15)(1997-2#3)(1997-3#3)(1997-4#3)(1997-5#1)(1997-7#4)(1997-8#2)(2004-12#2)(2005-11#15)(2005-12#2)(2005-4#3)(2005-8#2)(2006-1#1)(2006-10#38)(2006-12#4)(2006-2#1)(2006-5#1)(2006-8#1)(2007-1#3)(2007-10#5)(2007-11#16)(2007-12#6)(2007-6#3)(2007-8#9)(2008-10#363)(2008-11#6)(2008-2#6)(2008-3#3)(2008-4#9)(2008-5#17)(2008-6#4)(2008-7#15)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#5)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#5)(2010-1#3)(2010-11#1)(2010-12#5)(2010-2#8)(2010-4#4)(2010-5#6)(2010-6#1)(2010-7#5)(2010-8#4)(2010-9#2)(2011-1#12)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#10)(2012-2#9)(2012-3#2)(2013-1#13)(2013-7#7)(2013-8#3)
solvent)##7##1##(1995-3#1)(2008-10#4)(2008-2#1)(2011-2#1)
solvent-accessible surface area##2##3##(1994-5#1)(1997-2#1)
solvent-accessible##5##1##(1994-11#1)(1994-5#2)(1995-2#1)(1997-2#1)
solvent-based##5##1##(2008-10#3)(2008-5#1)(2008-9#1)
solvent-cage##3##1##(1994-8#3)
solvent-dependent##5##1##(1993-9#1)(1995-3#1)(2008-10#1)(2009-11#1)(2009-9#1)
solvent-exposed loop##2##2##(1995-8#2)
solvent-exposed##12##1##(1990-10#1)(1990-2#1)(1993-11#1)(1995-5#1)(1995-8#2)(1997-2#2)(2005-7#1)(2006-10#1)(2008-7#1)(2013-1#1)
solvent-free oxidation of##2##3##(2007-11#2)
solvent-free##20##1##(1991-11#2)(2007-10#1)(2007-11#6)(2007-8#1)(2008-10#3)(2008-5#6)(2011-2#1)
solvent-mediated##2##1##(1995-4#1)(2006-10#1)
solvent-soluble conducting##2##2##(2008-10#2)
solvent/detergent mixture##2##2##(1992-2#2)
solvent/detergent##3##1##(1991-6#1)(1992-2#2)
solventless##8##1##(1990-9#1)(2007-10#1)(2007-11#2)(2008-10#2)(2008-5#1)(2012-3#1)
solvents (e##2##2##(1995-2#1)(2008-10#1)
solvents (including##2##2##(2008-10#1)(2012-12#1)
solvents (water##2##2##(1997-7#1)(2008-10#1)
solvents and in##2##3##(1992-12#1)(2008-11#1)
solvents and the##2##3##(2006-10#1)(2010-2#1)
solvents and##21##2##(1992-12#1)(1993-2#1)(1997-8#1)(2004-4#1)(2005-12#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#5)(2008-11#2)(2008-5#1)(2010-2#1)(2010-4#1)(2011-1#1)
solvents are##6##2##(1990-8#1)(1993-2#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-5#1)
solvents as##5##2##(2008-10#4)(2008-2#1)
solvents at##2##2##(1994-3#1)(2005-12#1)
solvents but not##2##3##(1990-7#1)(1995-2#1)
solvents but##3##2##(1990-7#1)(1995-2#1)(2010-4#1)
solvents compared with##2##3##(2008-10#2)
solvents for the##3##3##(1993-2#1)(2008-10#1)(2011-2#1)
solvents for##8##2##(1993-2#1)(1996-2#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
solvents have been##3##3##(2006-5#1)(2008-10#2)
solvents in the##3##3##(2007-6#1)(2008-10#2)
solvents in##8##2##(1996-5#1)(2007-6#1)(2008-10#3)(2012-12#3)
solvents is##5##2##(1995-2#1)(1997-1#1)(2005-11#1)(2008-10#1)(2008-2#1)
solvents like##2##2##(2008-10#1)(2010-5#1)
solvents of##4##2##(1994-8#1)(2005-12#1)(2008-10#2)
solvents on the##7##3##(1997-4#1)(2005-11#1)(2008-10#3)(2008-3#1)(2011-1#1)
solvents on##8##2##(1997-4#1)(2005-11#1)(2008-10#4)(2008-3#1)(2011-1#1)
solvents revealed##2##2##(2008-10#2)
solvents showed##2##2##(2007-11#1)(2008-10#1)
solvents such as n-hexane##2##4##(2008-10#2)
solvents such as##8##3##(1993-2#1)(2008-10#2)(2008-3#1)(2009-9#1)(2010-2#1)(2010-4#1)(2013-1#1)
solvents than##2##2##(1997-4#1)(2008-10#1)
solvents that absorb##3##3##(2007-8#1)(2008-3#2)
solvents that##7##2##(2007-8#2)(2008-3#3)(2008-7#1)(2009-11#1)
solvents to the##2##3##(1995-3#1)(2008-2#1)
solvents to##6##2##(1991-10#1)(1995-3#1)(2008-10#3)(2008-2#1)
solvents used##3##2##(1995-4#1)(2008-10#1)(2010-10#1)
solvents using##2##2##(1991-5#1)(2008-10#1)
solvents was##3##2##(2005-11#1)(2005-12#1)(2008-10#1)
solvents were used##2##3##(2008-10#2)
solvents were##13##2##(1991-1#1)(1991-8#1)(1996-2#1)(2007-6#1)(2007-8#1)(2008-10#6)(2008-3#1)(2012-2#1)
solvents with##5##2##(2008-10#1)(2008-2#1)(2008-4#1)(2009-10#1)(2011-1#1)
solvents##362##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-4#4)(1990-5#1)(1990-7#1)(1990-8#6)(1991-1#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-4#1)(1993-2#5)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#5)(1994-9#1)(1995-2#6)(1995-3#2)(1995-4#2)(1995-5#3)(1996-2#4)(1996-5#5)(1997-1#2)(1997-4#4)(1997-7#3)(1997-8#3)(2004-4#3)(2005-11#7)(2005-12#6)(2005-4#2)(2005-8#1)(2006-10#13)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#11)(2007-3#1)(2007-6#8)(2007-7#1)(2007-8#7)(2008-1#1)(2008-10#123)(2008-11#6)(2008-12#1)(2008-2#6)(2008-3#7)(2008-4#5)(2008-5#11)(2008-6#3)(2008-7#15)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#3)(2009-9#1)(2010-10#1)(2010-2#3)(2010-4#5)(2010-5#4)(2010-6#2)(2010-7#2)(2010-9#1)(2011-1#4)(2011-2#2)(2012-12#7)(2012-2#3)(2013-1#5)(2013-8#3)
solvents)##2##1##(1993-8#1)(2008-10#1)
solver is##3##2##(2005-11#1)(2008-2#1)(2009-11#1)
solver##9##1##(1992-2#1)(2005-11#1)(2006-2#1)(2008-2#1)(2008-3#1)(2008-6#2)(2009-11#2)
solves a##2##2##(2008-2#1)(2008-9#1)
solves the problem of##2##4##(1995-6#1)(2012-2#1)
solves the problem##4##3##(1995-6#1)(2006-12#1)(2008-2#1)(2012-2#1)
solves the##9##2##(1992-5#1)(1995-6#1)(2006-12#1)(2007-11#1)(2008-2#3)(2009-12#1)(2012-2#1)
solves two##2##2##(2008-2#1)(2008-3#1)
solves##15##1##(1992-5#1)(1995-6#1)(2006-12#1)(2007-11#1)(2007-5#1)(2008-2#5)(2008-3#1)(2008-9#1)(2009-12#1)(2012-1#1)(2012-2#1)
solving a##13##2##(1993-3#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-2#4)(2008-6#1)(2008-7#1)(2010-7#1)(2010-8#1)(2012-3#1)
solving and##7##2##(1994-2#1)(2007-3#2)(2008-11#1)(2008-6#1)(2010-10#1)(2011-2#1)
solving problems##4##2##(1990-4#1)(1994-2#1)(2008-10#1)(2008-8#1)
solving skills##2##2##(1993-3#1)(2008-11#1)
solving some##3##2##(2007-4#1)(2013-1#2)
solving the equations##2##3##(1996-12#1)(2008-7#1)
solving the health care problems##2##5##(1997-8#1)(2008-7#1)
solving the optimization problem##2##4##(2008-2#2)
solving the problem of##4##4##(2006-10#1)(2008-12#1)(2008-6#1)(2009-10#1)
solving the problem##6##3##(2006-10#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-6#1)(2009-10#1)
solving the radiative transfer equation##2##5##(2008-2#1)(2008-3#1)
solving the resulting##2##3##(2008-2#1)(2009-3#1)
solving the##39##2##(1996-12#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#9)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-7#1)(2012-1#1)
solving these##2##2##(2008-2#2)
solving this problem##3##3##(2008-7#1)(2009-3#1)(2013-1#1)
solving this##7##2##(2008-2#1)(2008-3#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
solving##139##1##(1990-4#1)(1990-9#1)(1991-2#1)(1992-1#2)(1992-2#1)(1992-3#1)(1993-11#1)(1993-3#3)(1993-5#1)(1994-12#1)(1994-2#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-7#1)(2005-10#1)(2005-12#2)(2006-10#1)(2006-2#2)(2006-4#1)(2006-5#2)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-3#2)(2007-4#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-12#4)(2008-2#23)(2008-3#4)(2008-4#1)(2008-6#5)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#2)(2010-8#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
solvolysis in##2##2##(1991-7#1)(2009-3#1)
solvolysis of##3##2##(2008-5#1)(2009-3#1)(2011-1#1)
solvolysis##10##1##(1991-7#1)(1993-4#1)(1995-1#1)(2008-5#2)(2009-3#3)(2011-1#2)
solvothermal##3##1##(2009-11#2)(2010-7#1)
soma and proximal dendrites##2##4##(1995-8#1)(1997-2#1)
soma and##4##2##(1995-8#1)(1997-2#1)(1997-7#1)(2008-11#1)
soma in##2##2##(1991-12#1)(2008-6#1)
soma of##3##2##(1990-7#1)(1991-10#1)(1995-12#1)
soma size##6##2##(1995-8#1)(1996-3#2)(1996-6#2)(2008-4#1)
soma##42##1##(1990-4#1)(1990-7#3)(1991-1#1)(1991-10#1)(1991-12#1)(1992-8#1)(1993-12#1)(1995-11#1)(1995-12#1)(1995-8#2)(1996-3#3)(1996-6#3)(1996-9#4)(1997-2#1)(1997-5#1)(1997-7#2)(2005-6#1)(2005-7#1)(2007-12#2)(2008-11#3)(2008-4#1)(2008-6#1)(2010-12#3)(2010-8#1)(2013-8#2)
somaclonal variation##2##2##(2007-1#1)(2008-12#1)
somal size##2##2##(1994-10#2)
somal##9##1##(1992-1#2)(1994-10#4)(1994-11#1)(1995-11#1)(2008-11#1)
somaliensis GS 1242##2##3##(2005-11#2)
soman intoxication##3##2##(1995-12#2)(1997-7#1)
soman poisoning##2##2##(1997-7#2)
soman##7##1##(1995-12#2)(1997-7#4)(2010-2#1)
somas in the##2##3##(1994-10#2)
somas##4##1##(1992-1#2)(1994-10#2)
somata and dendrites##2##3##(1996-3#1)(1997-3#1)
somata and proximal##2##3##(1993-12#2)
somata and##6##2##(1993-12#2)(1996-3#1)(1996-9#1)(1997-3#1)(2008-9#1)
somata are##3##2##(2007-12#3)
somata in the##2##3##(1995-12#1)(1996-4#1)
somata located##2##2##(2007-12#1)(2010-12#1)
somata of the##2##3##(1995-12#1)(2009-8#1)
somata of##5##2##(1992-11#1)(1993-12#1)(1995-12#1)(1996-4#1)(2009-8#1)
somata showed##2##2##(1995-12#2)
somata were##3##2##(1997-3#2)(2008-7#1)
somata##40##1##(1992-11#1)(1993-12#3)(1994-12#1)(1995-11#1)(1995-12#8)(1995-5#2)(1996-1#1)(1996-12#2)(1996-3#1)(1996-4#2)(1996-9#1)(1997-3#3)(1997-4#3)(2007-12#5)(2008-5#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-12#1)
somatic and autonomic##2##3##(2006-9#1)(2013-8#1)
somatic and dendritic##3##3##(1994-10#1)(1996-8#1)(2008-7#1)
somatic and germline##2##3##(2007-12#1)(2012-12#1)
somatic and##14##2##(1994-10#1)(1995-5#1)(1996-8#1)(1997-5#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
somatic anxiety##2##2##(1996-2#1)(2009-11#1)
somatic cell count##4##3##(1992-2#1)(1996-8#1)(2005-7#1)(2012-2#1)
somatic cell counts##2##3##(1993-2#1)(1996-3#1)
somatic cell division##2##3##(1991-8#1)(2008-9#1)
somatic cell gene targeting##4##4##(2008-2#4)
somatic cell hybrid##3##3##(1994-11#1)(1994-9#1)(1997-5#1)
somatic cell hybrids##4##3##(1991-6#2)(1991-9#1)(1997-9#1)
somatic cell lines##2##3##(1992-11#1)(2005-6#1)
somatic cell nuclear transfer (SCNT)##2##5##(2012-2#1)(2013-1#1)
somatic cell nuclear transfer##5##4##(2008-1#2)(2012-2#2)(2013-1#1)
somatic cell score##2##3##(2012-1#2)
somatic cell##37##2##(1991-6#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-9#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-5#1)(1997-9#1)(2005-6#1)(2005-7#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-2#4)(2008-7#1)(2008-9#3)(2009-10#1)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#1)
somatic cells and##5##3##(1994-11#1)(1994-8#1)(2008-5#1)(2009-10#2)
somatic cells from##2##3##(2007-12#1)(2012-12#1)
somatic cells of##3##3##(1994-11#2)(2007-12#1)
somatic cells to##3##3##(2006-6#1)(2010-7#1)(2012-12#1)
somatic cells##42##2##(1991-11#1)(1993-6#3)(1994-11#3)(1994-8#1)(1997-4#1)(2006-5#1)(2006-6#1)(2007-12#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#3)(2009-10#3)(2009-3#3)(2010-7#1)(2011-2#2)(2012-11#2)(2012-12#3)
somatic compatibility##2##2##(2008-10#2)
somatic complaints##10##2##(1995-12#1)(1996-2#1)(1997-3#2)(2004-10#1)(2008-10#1)(2008-2#1)(2008-7#2)(2009-8#1)
somatic differentiation##2##2##(1993-9#1)(2009-3#1)
somatic disease##2##2##(1990-10#1)(2004-4#1)
somatic diseases##3##2##(1993-5#1)(1995-9#1)(2011-1#1)
somatic diseases]##3##2##(1990-5#1)(1997-3#2)
somatic elements##4##2##(2007-4#3)(2008-9#1)
somatic embryo##4##2##(2008-9#3)(2009-8#1)
somatic embryogenesis##5##2##(2008-12#2)(2008-9#1)(2009-8#2)
somatic embryos##2##2##(2008-10#1)(2008-12#1)
somatic fields##3##2##(1992-2#3)
somatic gene conversion##3##3##(1990-11#3)
somatic gene therapy##9##3##(1993-2#2)(1993-9#1)(1994-5#1)(1995-6#1)(1995-8#1)(2006-10#1)(2008-5#1)(2008-8#1)
somatic gene##14##2##(1990-11#3)(1993-2#2)(1993-9#2)(1994-5#1)(1995-6#1)(1995-8#1)(2006-10#1)(2007-4#1)(2008-5#1)(2008-8#1)
somatic genetic##2##2##(2008-4#1)(2009-6#1)
somatic growth##3##2##(2009-4#1)(2012-2#1)(2013-1#1)
somatic health##3##2##(1996-6#2)(2011-2#1)
somatic hybrid##2##2##(2008-8#1)(2013-1#1)
somatic hybridization between##3##3##(2008-8#1)(2008-9#1)(2013-1#1)
somatic hybrids##3##2##(2008-5#1)(2008-9#1)(2013-1#1)
somatic hypermutation##3##2##(1995-8#1)(2009-10#1)(2012-1#1)
somatic illnesses##3##2##(1996-12#2)(1997-3#1)
somatic inactivation of##2##3##(1990-6#1)(2008-8#1)
somatic incompatibility types##3##3##(2008-10#3)
somatic index##2##2##(1990-12#1)(2004-4#1)
somatic input from##2##3##(1992-2#2)
somatic mosaicism##2##2##(1996-12#1)(2007-7#1)
somatic motor##5##2##(1991-11#2)(1996-12#1)(2008-4#2)
somatic muscle##5##2##(2008-4#2)(2012-12#3)
somatic mutation of the##3##4##(1994-11#1)(1996-11#1)(2008-4#1)
somatic mutation##6##2##(1992-12#1)(1994-11#1)(1996-11#1)(2008-4#1)(2008-8#1)(2013-8#1)
somatic mutations in the##2##4##(2007-4#1)(2010-5#1)
somatic mutations in##3##3##(2007-4#1)(2010-5#1)(2012-2#1)
somatic mutations##17##2##(1992-2#1)(1995-12#1)(2006-12#1)(2007-4#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-8#1)(2008-9#2)(2009-8#1)(2009-9#1)(2010-5#1)(2012-2#2)
somatic nucleus##2##2##(2008-9#2)
somatic pain##2##2##(2006-10#2)
somatic perception##2##2##(1994-2#2)
somatic profiles##2##2##(1997-2#2)
somatic sex##2##2##(2007-12#2)
somatic sexual differentiation##3##3##(2007-12#3)
somatic stem cells##3##3##(2008-1#1)(2008-11#1)(2011-1#1)
somatic stimuli were##2##3##(1991-8#1)(1992-2#1)
somatic stimuli##5##2##(1991-8#2)(1992-2#1)(1992-9#1)(2006-12#1)
somatic structures##3##2##(1991-8#2)(2008-9#1)
somatic symptoms of##3##3##(1995-5#1)(2007-4#1)(2011-12#1)
somatic symptoms were##2##3##(1990-2#1)(2004-10#1)
somatic symptoms##14##2##(1990-2#1)(1995-5#1)(1996-2#1)(2004-10#1)(2007-4#1)(2009-6#2)(2009-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
somatic tissues##7##2##(1990-8#1)(1992-11#1)(1993-2#2)(1994-9#1)(1996-11#1)(2007-12#1)
somatic treatment##2##2##(1994-8#1)(2009-9#1)
somatic treatments##2##2##(2008-4#1)(2008-7#1)
somatic##379##1##(1990-10#2)(1990-11#4)(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#5)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-6#2)(1991-8#6)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#8)(1992-4#1)(1992-9#1)(1993-12#2)(1993-2#5)(1993-5#1)(1993-6#3)(1993-9#3)(1994-10#1)(1994-11#5)(1994-12#4)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#6)(1994-9#3)(1995-11#1)(1995-12#2)(1995-3#4)(1995-5#4)(1995-6#2)(1995-8#4)(1995-9#2)(1996-11#2)(1996-12#6)(1996-2#3)(1996-3#1)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#2)(1997-2#3)(1997-3#5)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#4)(1997-9#1)(2004-10#4)(2004-3#2)(2004-4#3)(2005-6#2)(2005-7#2)(2006-10#3)(2006-12#2)(2006-3#1)(2006-5#1)(2006-6#4)(2006-7#2)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#16)(2007-4#7)(2007-7#1)(2008-1#3)(2008-10#10)(2008-11#8)(2008-12#3)(2008-2#8)(2008-3#1)(2008-4#12)(2008-5#6)(2008-7#7)(2008-8#14)(2008-9#25)(2009-10#6)(2009-11#1)(2009-2#1)(2009-3#5)(2009-4#1)(2009-6#3)(2009-8#5)(2009-9#3)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#5)(2012-11#3)(2012-12#14)(2012-2#13)(2012-3#1)(2013-1#10)(2013-8#3)
somatically##4##1##(2008-10#1)(2008-7#1)(2012-1#1)(2012-3#1)
somatization and##5##2##(1991-4#1)(2004-3#1)(2006-8#1)(2008-10#1)(2012-1#1)
somatization disorder and##2##3##(2006-8#2)
somatization disorder##10##2##(1995-6#1)(2006-8#8)(2011-12#1)
somatization disorders in##2##3##(1995-6#1)(2012-12#1)
somatization disorders##4##2##(1995-6#1)(2008-9#1)(2012-12#2)
somatization##36##1##(1991-4#5)(1995-1#1)(1995-6#3)(2004-12#2)(2004-3#1)(2006-8#15)(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#1)(2011-12#1)(2012-1#1)(2012-12#3)
somatodendritic 5-HT release##2##3##(2008-7#2)
somatodendritic##10##1##(1990-7#1)(1992-3#1)(1997-4#1)(1997-7#1)(2007-8#1)(2008-4#1)(2008-7#3)(2012-3#1)
somatoform disorder##5##2##(1990-12#1)(2006-8#2)(2011-1#1)(2011-12#1)
somatoform disorders##9##2##(1997-8#2)(2006-8#1)(2010-12#1)(2011-12#5)
somatoform##17##1##(1990-12#1)(1995-6#1)(1997-8#3)(2006-8#3)(2010-12#1)(2011-1#1)(2011-12#7)
somatogenic##5##1##(1991-12#1)(1992-6#3)(2005-11#1)
somatomedin C##2##2##(1992-11#1)(2006-1#1)
somatomedin##6##1##(1992-11#1)(1996-5#2)(2006-1#1)(2008-7#2)
somatometry##2##1##(1993-9#1)(1995-6#1)
somatosensory and motor##4##3##(1991-5#1)(1993-2#1)(1996-9#2)
somatosensory and motor-evoked##2##3##(2010-7#1)(2011-2#1)
somatosensory and##8##2##(1991-5#1)(1993-2#1)(1995-11#1)(1995-12#1)(1996-9#2)(2010-7#1)(2011-2#1)
somatosensory area##2##2##(1994-3#1)(1995-8#1)
somatosensory barrel cortex##4##3##(1997-6#1)(2007-8#2)(2008-1#1)
somatosensory cortex and##2##3##(1997-2#1)(2008-11#1)
somatosensory cortex of##2##3##(1990-7#1)(1995-11#1)
somatosensory cortex##27##2##(1990-4#1)(1990-7#1)(1991-11#2)(1991-3#1)(1992-7#1)(1993-12#1)(1994-3#2)(1995-11#4)(1995-12#4)(1996-1#2)(1996-2#1)(1996-7#1)(1997-2#1)(1997-3#1)(2008-11#2)(2008-5#1)(2011-2#1)
somatosensory cortical##2##2##(1995-12#1)(2007-12#1)
somatosensory evoked potential##2##3##(2007-9#1)(2011-2#1)
somatosensory evoked potentials and##2##4##(1991-10#1)(2007-9#1)
somatosensory evoked potentials##9##3##(1991-1#1)(1991-10#1)(1996-1#1)(2006-10#1)(2006-3#1)(2006-4#1)(2007-8#1)(2007-9#2)
somatosensory evoked##14##2##(1991-1#1)(1991-10#1)(1996-1#3)(2006-10#2)(2006-3#1)(2006-4#1)(2007-8#1)(2007-9#3)(2011-2#1)
somatosensory information##3##2##(1991-2#1)(1997-5#1)(2008-11#1)
somatosensory input from the##2##4##(1993-12#1)(1994-2#1)
somatosensory inputs##2##2##(1994-2#1)(1997-5#1)
somatosensory pain memory##2##3##(2006-10#2)
somatosensory projections##2##2##(1991-11#1)(1993-2#1)
somatosensory stimulation##4##2##(1991-3#2)(1993-2#1)(1993-6#1)
somatosensory systems##2##2##(1993-12#1)(1997-8#1)
somatosensory##90##1##(1990-4#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-11#3)(1991-2#1)(1991-3#4)(1991-5#1)(1992-2#1)(1992-7#1)(1993-12#4)(1993-2#3)(1993-6#1)(1994-2#2)(1994-3#3)(1994-8#1)(1995-11#6)(1995-12#7)(1995-8#1)(1996-1#5)(1996-2#1)(1996-7#1)(1996-8#2)(1996-9#2)(1997-2#1)(1997-3#1)(1997-5#3)(1997-6#1)(1997-8#1)(2006-10#4)(2006-12#1)(2006-3#1)(2006-4#1)(2007-12#1)(2007-8#3)(2007-9#4)(2008-1#1)(2008-11#3)(2008-5#6)(2010-7#1)(2011-2#3)
somatostatin (SOM)##2##2##(1995-2#1)(2008-4#1)
somatostatin (SRIF)##2##2##(1997-2#1)(2008-4#1)
somatostatin (SS)##4##2##(1995-5#1)(1996-11#1)(1996-5#1)(2011-2#1)
somatostatin analog##7##2##(1991-7#4)(1997-8#1)(2005-7#1)(2008-1#1)
somatostatin analogs##4##2##(1994-11#1)(2008-1#1)(2011-2#1)(2012-3#1)
somatostatin analogue RC-160##2##3##(1995-2#2)
somatostatin analogue octreotide##3##3##(1994-8#1)(1995-5#1)(2006-10#1)
somatostatin analogue##14##2##(1990-4#1)(1994-8#2)(1995-2#2)(1995-5#1)(2006-1#1)(2006-10#2)(2006-12#1)(2007-8#1)(2008-7#2)(2013-8#1)
somatostatin analogues##6##2##(2006-1#3)(2006-10#1)(2006-11#1)(2013-1#1)
somatostatin and##4##2##(1990-5#1)(1991-5#1)(1995-12#1)(1997-4#1)
somatostatin content##2##2##(1992-3#1)(1995-5#1)
somatostatin gene in##2##3##(1995-8#2)
somatostatin gene##6##2##(1995-8#5)(1996-10#1)
somatostatin in##6##2##(1992-3#1)(1994-11#1)(1994-8#1)(1995-9#1)(1997-2#2)
somatostatin or##5##2##(1993-1#1)(1995-9#2)(1997-4#1)(2007-11#1)
somatostatin receptor 2##3##3##(1994-2#3)
somatostatin receptor subtype##2##3##(1993-3#2)
somatostatin receptor subtypes##6##3##(1994-11#1)(1995-12#1)(1995-2#2)(1995-7#1)(2011-2#1)
somatostatin receptor##24##2##(1993-3#3)(1994-11#5)(1994-12#2)(1994-2#4)(1995-12#1)(1995-2#2)(1995-7#1)(1997-8#1)(2006-1#1)(2006-12#1)(2010-9#1)(2011-2#1)(2012-3#1)
somatostatin receptors##8##2##(1995-12#1)(1997-2#2)(2006-10#1)(2006-12#1)(2008-7#1)(2012-12#1)(2012-3#1)
somatostatin release in##3##3##(1990-3#1)(1996-11#2)
somatostatin secretion##3##2##(1992-6#1)(2006-10#2)
somatostatin was##2##2##(1992-6#1)(1997-4#1)
somatostatin##144##1##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-5#1)(1991-7#4)(1992-12#1)(1992-3#2)(1992-6#12)(1992-9#1)(1993-1#1)(1993-3#3)(1994-11#9)(1994-12#2)(1994-2#4)(1994-8#3)(1995-12#5)(1995-2#6)(1995-5#4)(1995-7#1)(1995-8#5)(1995-9#3)(1996-10#1)(1996-11#3)(1996-5#2)(1997-1#1)(1997-2#5)(1997-4#8)(1997-6#1)(1997-8#4)(2005-7#1)(2006-1#6)(2006-10#9)(2006-11#1)(2006-12#4)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-4#2)(2008-7#4)(2008-8#1)(2010-11#4)(2010-9#1)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#1)
somatostatin)##2##1##(1997-8#1)(2008-1#1)
somatostatin-14##5##1##(1994-11#1)(1994-8#1)(1995-2#2)(1997-8#1)
somatostatin-28##4##1##(1993-11#3)(1994-11#1)
somatostatine##2##1##(1991-5#2)
somatostatinergic##4##1##(1994-10#1)(1995-2#1)(1996-5#1)(1997-6#1)
somatosympathetic reflexes##2##2##(1993-12#2)
somatosympathetic##3##1##(1993-12#3)
somatotopic organization##2##2##(1993-9#1)(1997-3#1)
somatotopic##6##1##(1993-9#1)(1997-3#3)(2009-8#2)
somatotopically##2##1##(1994-5#1)(1997-3#1)
somatotopy##2##1##(1995-5#1)(1997-8#1)
somatotropes##4##1##(1992-6#3)(1994-9#1)
somatotroph responsiveness to##2##3##(2006-9#1)(2007-7#1)
somatotroph##4##1##(1992-6#1)(2006-9#1)(2007-7#2)
somatotrophs##5##1##(1992-6#1)(1994-8#1)(2008-5#3)
somatotropic axis##3##2##(2010-5#2)(2011-2#1)
somatotropic##5##1##(2008-1#1)(2008-7#1)(2010-5#2)(2011-2#1)
somatropin therapy##2##2##(2007-11#2)
somatropin treatment##2##2##(2007-11#2)
somatropin##19##1##(2007-11#19)
somatropin)##2##1##(2007-11#2)
somber##2##1##(2006-2#1)(2006-9#1)
some &quot##6##2##(1992-3#1)(1995-3#2)(2006-5#1)(2007-8#1)(2011-2#1)
some (particularly those describing the metabolic labeling of proteins or nucleic acids within cells) require amounts on the order of millicuries##2##21##(2008-4#1)(2008-9#1)
some 10% of##2##3##(1992-8#1)(2006-9#1)
some 12##2##2##(1991-11#1)(2008-9#1)
some 150##2##2##(1996-6#1)(2007-5#1)
some 2##3##2##(1991-4#1)(1995-12#1)(2013-7#1)
some 2-acetamido-2-deoxyaldono(1----4)lactones##2##2##(1990-5#2)
some 20##2##2##(1990-9#1)(2007-8#1)
some 3##5##2##(1995-11#1)(1995-3#1)(2008-5#1)(2010-3#1)(2013-1#1)
some 30##2##2##(1992-10#1)(1994-2#1)
some 40%##2##2##(1995-2#1)(2012-12#1)
some 43% of##2##3##(1996-12#1)(2006-6#1)
some 60##2##2##(2008-4#1)(2008-7#1)
some 70##2##2##(2008-11#2)
some 80%##2##2##(1994-9#1)(1997-6#1)
some Chinese##2##2##(2005-11#1)(2013-1#1)
some DNA##3##2##(2008-7#1)(2008-8#1)(2013-1#1)
some European##4##2##(1995-3#1)(2006-7#1)(2010-12#1)(2011-2#1)
some G##3##2##(1992-2#1)(1997-1#1)(2010-8#1)
some HAART##2##2##(2007-1#1)(2010-12#1)
some HIV-infected##2##2##(2004-9#2)
some Indian##2##2##(2008-4#1)(2011-2#1)
some New World##2##3##(2008-11#1)(2012-1#1)
some PHAs##2##2##(2007-1#2)
some Schiff bases and##2##4##(2006-9#1)(2008-10#1)
some Schiff bases##3##3##(2006-9#1)(2008-10#1)(2008-6#1)
some T##2##2##(1990-12#1)(2008-4#1)
some US##2##2##(2006-10#1)(2008-5#1)
some [corrected] metal ions by use of sulfide in the Belousov-Zhabotinskii##2##11##(2007-8#2)
some [corrected] metal ions##3##4##(2007-8#3)
some a##3##2##(2005-8#1)(2006-1#1)(2008-2#1)
some abnormalities##3##2##(2006-8#1)(2010-1#1)(2012-2#1)
some accessions##2##2##(2008-10#1)(2008-5#1)
some acid soils##2##3##(2008-10#2)
some actinomycetes##2##2##(2005-11#2)
some actions of##3##3##(1991-12#1)(1997-3#1)(2005-7#1)
some active##5##2##(1994-5#1)(2005-8#1)(2008-10#2)(2008-3#1)
some activity##3##2##(2006-8#1)(2008-6#2)
some additional##16##2##(1990-5#1)(1992-2#1)(2005-8#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-4#2)(2009-8#1)(2012-2#1)(2013-8#2)
some adjustments##2##2##(1990-6#1)(2010-8#1)
some adult##3##2##(1990-7#1)(2008-1#1)(2012-2#1)
some advanced##2##2##(1995-3#1)(2013-7#1)
some advantage##4##2##(2006-10#1)(2007-11#1)(2008-5#1)(2012-1#1)
some advantages and##3##3##(2008-10#1)(2009-2#1)(2012-1#1)
some advantages in##2##3##(2006-10#1)(2008-3#1)
some advantages over##6##3##(1993-3#1)(1995-1#1)(1996-5#1)(2005-7#1)(2006-8#1)(2008-10#1)
some advantages##16##2##(1993-3#1)(1995-1#1)(1996-5#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-10#6)(2008-3#1)(2009-2#1)(2012-1#1)
some adverse##3##2##(2007-3#1)(2008-10#1)(2008-8#1)
some agent##2##2##(2008-10#1)(2011-2#1)
some alcoholic##2##2##(2008-10#1)(2009-7#1)
some alkaline##2##2##(2008-10#2)
some alleles##2##2##(2012-2#1)(2012-3#1)
some allergens##2##2##(2007-11#1)(2011-1#1)
some also##3##2##(1992-1#2)(2008-4#1)
some alterations##2##2##(2006-6#1)(2008-1#1)
some alternative##4##2##(1990-9#1)(1993-4#1)(2008-10#1)(2009-12#1)
some amines##2##2##(2008-10#2)
some amino acid##2##3##(1996-10#1)(1997-2#1)
some amino acids and##2##4##(2008-10#1)(2009-10#1)
some amino acids##5##3##(1996-2#1)(2008-10#2)(2009-10#1)(2012-1#1)
some amino##7##2##(1996-10#1)(1996-2#1)(1997-2#1)(2008-10#2)(2009-10#1)(2012-1#1)
some amino-alcohols##2##2##(2008-10#2)
some amount of##4##3##(2007-10#1)(2007-12#1)(2007-8#1)(2012-2#1)
some analogues##2##2##(1994-8#1)(1995-7#1)
some analysts##2##2##(2007-9#1)(2008-10#1)
some analytes##2##2##(2008-10#2)
some analytical##6##2##(2008-10#6)
some and##3##2##(2007-10#1)(2007-7#1)(2009-10#1)
some animal protein sources##2##4##(2008-10#2)
some animal##5##2##(2006-10#1)(2007-11#1)(2008-10#2)(2013-1#1)
some animals were##2##3##(1994-9#1)(2008-12#1)
some animals##8##2##(1992-11#1)(1992-8#1)(1994-9#1)(1997-5#1)(2005-7#1)(2008-12#1)(2009-8#1)(2010-12#1)
some answers##4##2##(1992-12#1)(1997-2#1)(2005-7#1)(2012-2#1)
some antibodies##2##2##(2005-7#1)(2009-3#1)
some anticancer##2##2##(1992-9#1)(2006-12#1)
some antimicrobial##2##2##(2007-1#1)(2008-7#1)
some antioxidants##4##2##(1993-11#2)(1993-2#1)(2008-10#1)
some apparent##2##2##(1992-1#1)(2005-11#1)
some apparently##3##2##(2008-5#2)(2009-8#1)
some applications of##4##3##(2008-10#1)(2008-5#1)(2011-2#1)(2013-7#1)
some applications##13##2##(1992-9#1)(2007-4#1)(2007-5#1)(2008-10#4)(2008-2#1)(2008-4#2)(2008-5#1)(2011-2#1)(2013-7#1)
some are more##2##3##(2008-5#1)(2008-9#1)
some are##21##2##(1991-3#1)(1991-9#1)(1996-12#1)(1996-3#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-7#1)(2012-3#1)
some areas of##9##3##(1996-4#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-4#1)(2010-7#1)(2011-1#2)(2013-1#1)
some areas##29##2##(1991-11#1)(1991-9#1)(1993-3#1)(1994-2#1)(1994-3#1)(1996-4#2)(1997-3#1)(1997-7#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-9#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-9#1)(2009-4#1)(2010-4#1)(2010-7#1)(2011-1#2)(2013-1#1)
some aromatic amines##6##3##(1990-8#2)(2007-11#2)(2008-10#2)
some aromatic amino acids##2##4##(2008-10#2)
some aromatic##14##2##(1990-8#2)(2007-11#2)(2008-10#7)(2008-5#2)(2011-3#1)
some articles##3##2##(2009-8#1)(2013-1#2)
some as##8##2##(1990-6#2)(1995-3#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2012-1#1)
some aspect of##7##3##(1991-1#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-9#2)(2010-2#1)
some aspects of its##3##4##(2008-3#1)(2013-7#1)(2013-8#1)
some aspects of the##12##4##(1995-12#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2010-11#1)(2012-12#1)
some aspects of##52##3##(1990-7#1)(1992-7#1)(1994-12#1)(1995-12#3)(1996-11#2)(1997-5#1)(2006-10#3)(2006-6#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2009-10#2)(2010-1#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
some aspects related##2##3##(1996-5#1)(2009-4#1)
some aspects to be improved##2##5##(2008-4#1)(2012-12#1)
some aspects to be##3##4##(2008-4#1)(2009-10#1)(2012-12#1)
some aspects##63##2##(1990-7#1)(1992-7#1)(1994-12#1)(1995-12#3)(1996-11#2)(1996-5#1)(1997-5#1)(2006-10#3)(2006-6#1)(2006-7#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#3)(2009-2#1)(2009-4#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#4)(2012-3#1)(2013-7#2)(2013-8#1)
some assistance##3##2##(1991-12#1)(1994-1#1)(2007-2#1)
some associated##4##2##(1991-5#1)(2007-9#1)(2013-1#2)
some association##2##2##(2008-11#1)(2011-1#1)
some assumptions##2##2##(2007-11#1)(2008-10#1)
some assurance##2##2##(2005-7#1)(2008-5#1)
some at##2##2##(2008-10#1)(2011-2#1)
some attempts to##2##3##(2005-10#1)(2013-1#1)
some attempts##3##2##(2005-10#1)(2008-11#1)(2013-1#1)
some attention##2##2##(1991-1#1)(2012-3#1)
some atypical##2##2##(1996-11#1)(2008-5#1)
some authors have##6##3##(1990-5#1)(2005-2#1)(2006-9#1)(2007-9#1)(2009-3#1)(2013-1#1)
some authors to##2##3##(1993-6#1)(2012-2#1)
some authors##25##2##(1990-5#1)(1992-10#1)(1992-2#1)(1993-5#1)(1993-6#1)(1994-6#1)(1995-11#1)(2005-2#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-3#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
some autoimmune diseases##2##3##(2010-11#1)(2011-2#1)
some avian species##2##3##(1994-5#1)(2008-3#1)
some avian##4##2##(1994-5#1)(1997-6#1)(2008-3#1)(2008-5#1)
some background##3##2##(2006-10#1)(2006-2#1)(2010-8#1)
some bacteria##2##2##(1994-2#1)(2007-11#1)
some bacterial species##2##3##(1994-8#1)(2008-8#1)
some bacterial##9##2##(1994-8#1)(1996-6#1)(1996-7#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-5#1)(2010-4#1)(2010-7#1)
some bands##4##2##(1992-8#1)(1996-2#1)(2005-4#1)(2006-8#1)
some basic information about the##2##5##(2008-4#1)(2010-5#1)
some basic information about##3##4##(2008-1#1)(2008-4#1)(2010-5#1)
some basic principles of##2##4##(1994-5#1)(2004-10#1)
some basic principles##3##3##(1994-5#1)(2004-10#1)(2012-1#1)
some basic##23##2##(1990-3#1)(1990-8#1)(1991-12#1)(1992-12#1)(1994-5#1)(1995-3#1)(1996-3#1)(1996-5#1)(2004-10#1)(2005-12#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2012-1#1)(2013-1#1)
some behavioral##2##2##(1993-11#1)(1997-7#1)
some behavioural##2##2##(1991-3#1)(1995-12#1)
some being##2##2##(1992-3#1)(2007-7#1)
some beneficial effects##2##3##(2009-8#1)(2013-7#1)
some beneficial##4##2##(2007-9#1)(2008-10#1)(2009-8#1)(2013-7#1)
some benefit##5##2##(2006-10#1)(2008-5#1)(2008-8#1)(2010-12#1)(2013-8#1)
some benefits##5##2##(2007-11#1)(2008-11#1)(2011-1#1)(2012-3#1)(2013-7#1)
some biochemical parameters##6##3##(2007-1#2)(2008-12#1)(2008-4#1)(2008-7#1)(2011-12#1)
some biochemical##9##2##(2007-1#2)(2008-10#1)(2008-12#2)(2008-4#1)(2008-7#2)(2011-12#1)
some biologic##2##2##(1991-6#1)(1994-10#1)
some biological characteristics of##2##4##(2008-6#1)(2013-8#1)
some biological fluids##2##3##(2008-10#2)
some biological##14##2##(1991-12#1)(1992-6#1)(1994-3#1)(2008-10#6)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)(2013-8#1)
some biologically important##2##3##(2008-10#1)(2008-12#1)
some biologically##4##2##(2007-11#1)(2008-10#1)(2008-12#1)(2013-8#1)
some birds##3##2##(1997-2#1)(2006-5#1)(2008-5#1)
some blood##7##2##(1991-6#1)(1992-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2013-1#1)
some body##3##2##(1992-5#1)(2007-3#1)(2008-5#1)
some boys##2##2##(2007-12#1)(2008-10#1)
some brain regions##2##3##(1991-11#1)(1997-5#1)
some brain##7##2##(1991-11#1)(1992-8#1)(1997-5#1)(2007-11#1)(2008-1#1)(2011-1#2)
some but not all##7##4##(1994-12#1)(1997-4#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-6#1)(2010-7#1)
some but not##10##3##(1992-2#1)(1993-12#1)(1994-12#1)(1996-8#1)(1997-4#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-6#1)(2010-7#1)
some can##2##2##(2007-4#1)(2010-9#1)
some cancer##4##2##(1990-12#1)(1994-11#1)(2008-11#1)(2010-8#1)
some cancers and##2##3##(2008-5#1)(2013-8#1)
some cancers##17##2##(1992-7#1)(2005-10#2)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-4#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
some cardiovascular risk factors##2##4##(1993-12#1)(2008-7#1)
some cardiovascular##5##2##(1993-12#1)(1994-3#1)(1996-5#1)(2007-9#1)(2008-7#1)
some care##2##2##(2008-10#1)(2012-1#1)
some case##4##2##(1995-2#1)(2005-12#1)(2008-11#1)(2008-8#1)
some cases are##3##3##(2006-12#1)(2007-12#1)(2009-3#1)
some cases for##5##3##(1990-2#1)(1992-6#1)(2008-10#1)(2009-10#1)(2011-2#1)
some cases it can##2##4##(2007-1#1)(2010-5#1)
some cases it##6##3##(1994-11#1)(2007-1#1)(2007-3#1)(2008-11#1)(2009-6#1)(2010-5#1)
some cases might##2##3##(1994-12#1)(2008-4#1)
some cases of early##2##4##(1996-6#1)(1997-8#1)
some cases of idiopathic##2##4##(2006-10#2)
some cases of##21##3##(1991-12#1)(1991-9#1)(1995-11#1)(1996-6#1)(1997-6#1)(1997-8#1)(2006-10#2)(2006-12#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-8#1)(2011-1#1)(2012-12#2)(2012-3#1)
some cases the##10##3##(1991-2#1)(1991-8#1)(1992-2#1)(1994-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2010-4#1)
some cases with##2##3##(2008-8#1)(2009-8#1)
some cases##264##2##(1990-1#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#2)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#2)(1993-12#2)(1993-7#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-4#1)(1996-6#1)(1996-9#2)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-1#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#6)(2006-11#1)(2006-12#5)(2006-2#1)(2006-4#2)(2006-5#3)(2006-6#2)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#3)(2007-2#5)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#28)(2008-11#7)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#11)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#9)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-6#3)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#10)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#6)
some caution##3##2##(1992-5#1)(1993-11#1)(2008-1#1)
some caveats##2##2##(1992-1#1)(1996-1#1)
some cell lines##5##3##(1992-3#1)(2008-11#2)(2008-4#1)(2008-8#1)
some cell##10##2##(1991-5#1)(1992-3#1)(1996-12#1)(1997-6#1)(2007-2#1)(2008-11#2)(2008-4#1)(2008-8#1)(2011-2#1)
some cells in##2##3##(1992-6#1)(2008-8#1)
some cells##22##2##(1990-2#1)(1990-4#1)(1991-11#1)(1991-4#1)(1992-3#1)(1992-6#2)(1993-11#1)(1993-12#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-7#1)(1996-4#1)(1997-2#1)(1997-3#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)
some cellular immune parameters##2##4##(2007-1#2)
some cellular##8##2##(1991-5#1)(1994-6#1)(1996-9#1)(1997-3#1)(2007-1#2)(2008-8#1)(2012-12#1)
some centres##5##2##(1996-12#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-5#1)
some challenges##5##2##(2007-11#1)(2008-11#2)(2008-9#1)(2012-3#1)
some change##2##2##(2005-11#1)(2008-5#1)
some changes in##4##3##(1992-2#1)(1994-3#1)(2007-9#1)(2009-4#1)
some changes##7##2##(1992-2#1)(1994-3#1)(2006-9#1)(2007-9#1)(2009-4#1)(2011-1#1)(2013-8#1)
some characteristics of##8##3##(1990-11#1)(1997-3#1)(1997-5#1)(2008-2#1)(2008-8#1)(2010-3#1)(2011-1#1)(2013-1#1)
some characteristics##11##2##(1990-11#1)(1997-3#1)(1997-5#1)(2008-1#1)(2008-2#1)(2008-8#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#1)
some chemical##3##2##(1995-6#1)(2008-10#1)(2008-2#1)
some chemicals##2##2##(1993-12#1)(2008-8#1)
some children##5##2##(1996-3#1)(2007-11#1)(2008-1#1)(2008-12#1)(2013-8#1)
some chronic##4##2##(1996-1#1)(2006-11#1)(2007-4#1)(2007-8#1)
some circumstances and##2##3##(2006-3#1)(2008-10#1)
some circumstances##17##2##(1992-2#1)(1994-6#1)(1996-1#1)(1996-10#1)(1997-2#1)(2004-11#1)(2006-10#2)(2006-3#1)(2007-10#1)(2008-10#2)(2008-2#1)(2009-9#1)(2010-10#1)(2011-1#1)(2012-3#1)
some classes of##2##3##(1997-2#1)(2010-2#1)
some clear##2##2##(2008-10#1)(2008-4#1)
some clinical and##2##3##(2008-9#1)(2010-12#1)
some clinical applications##2##3##(2004-9#1)(2008-6#1)
some clinical characteristics of##2##4##(2006-11#1)(2012-12#1)
some clinical studies##2##3##(1990-8#1)(2009-8#1)
some clinical##31##2##(1990-8#1)(1991-4#1)(2004-9#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-9#1)(2008-1#3)(2008-10#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-12#3)(2012-2#2)
some clinically##2##2##(2008-11#1)(2013-8#1)
some clinics##2##2##(2007-2#1)(2008-11#1)
some clones##2##2##(1991-9#1)(2005-11#1)
some closely related##2##3##(1996-6#1)(2012-1#1)
some clues to##2##3##(2008-5#1)(2012-2#1)
some clues##5##2##(1991-6#1)(2007-12#1)(2008-5#1)(2009-8#1)(2012-2#1)
some cognitive##2##2##(1990-3#1)(2008-9#1)
some combination of these##2##4##(2007-11#1)(2008-6#1)
some combination of##10##3##(1992-1#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-6#2)(2009-9#1)(2010-11#1)(2010-2#1)
some combinations of##5##3##(1995-6#1)(2007-9#1)(2008-10#1)(2008-8#1)(2012-3#1)
some comments##3##2##(1990-12#1)(1991-2#1)(2007-5#1)
some commercial##7##2##(1996-3#1)(1997-1#1)(2007-5#1)(2008-10#3)(2010-8#1)
some common pharmaceutical species##2##4##(2008-10#2)
some common pitfalls in##2##4##(1995-2#1)(2009-3#1)
some common##26##2##(1991-6#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-6#1)(1995-12#1)(1995-2#1)(1997-3#1)(2005-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#5)(2008-2#2)(2008-4#1)(2008-9#1)(2009-3#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
some commonly used##10##3##(1992-2#1)(2006-8#1)(2007-7#1)(2008-4#2)(2008-9#2)(2009-8#1)(2011-1#1)(2013-1#1)
some commonly##12##2##(1992-2#1)(2006-8#1)(2007-7#1)(2008-4#3)(2008-9#2)(2009-8#1)(2009-9#1)(2011-1#1)(2013-1#1)
some complications##4##2##(2007-7#1)(2007-8#2)(2012-2#1)
some components in##2##3##(2007-12#1)(2008-10#1)
some components of the##6##4##(1993-5#1)(1996-12#2)(1996-8#1)(2006-12#1)(2008-10#1)
some components of##9##3##(1993-5#1)(1995-1#1)(1996-12#2)(1996-8#1)(2006-12#1)(2008-10#2)(2008-5#1)
some components##13##2##(1993-5#1)(1994-3#1)(1995-1#1)(1996-12#2)(1996-8#1)(2006-12#1)(2007-12#1)(2008-10#4)(2008-5#1)
some compounds with##2##3##(1995-3#1)(2006-10#1)
some compounds##6##2##(1992-3#1)(1994-12#1)(1995-3#1)(2006-10#1)(2007-6#1)(2008-10#1)
some concepts of##2##3##(1993-3#1)(2008-9#1)
some concern##2##2##(2008-10#1)(2012-2#1)
some concerns about##3##3##(2005-7#1)(2008-3#1)(2011-2#1)
some concerns##6##2##(2005-7#1)(2006-10#1)(2008-3#2)(2010-11#1)(2011-2#1)
some conditions of##2##3##(1991-5#1)(1995-12#1)
some conditions##12##2##(1990-2#1)(1991-5#1)(1992-3#1)(1994-6#1)(1995-12#1)(1996-10#1)(2007-10#1)(2008-10#1)(2008-9#1)(2009-8#1)(2010-4#1)(2010-5#1)
some conformational changes##2##3##(1992-4#1)(2008-5#1)
some confusion in##3##3##(1997-3#1)(2008-10#1)(2008-8#1)
some confusion##6##2##(1997-3#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)
some conserved##2##2##(1997-3#1)(2008-7#1)
some considerations about the##2##4##(2006-5#1)(2011-2#1)
some considerations on the##2##4##(1991-12#1)(1994-9#1)
some considerations on##3##3##(1991-12#1)(1994-9#1)(2013-1#1)
some considerations##8##2##(1990-2#1)(1991-12#1)(1994-9#1)(2006-5#1)(2008-7#1)(2010-11#1)(2011-2#1)(2013-1#1)
some constructs##2##2##(2007-11#1)(2010-11#1)
some control over##2##3##(1993-12#1)(2004-10#1)
some controversies##2##2##(1995-12#1)(2007-7#1)
some controversy##2##2##(1992-11#1)(2008-5#1)
some cooperative##2##2##(1993-11#1)(1995-12#1)
some correlation##2##2##(1997-7#1)(2005-11#1)
some cosmetic##2##2##(2008-5#2)
some cost##2##2##(2007-11#1)(2008-8#1)
some costs##2##2##(2008-11#1)(2012-3#1)
some countries of##2##3##(2007-2#1)(2008-1#1)
some countries##23##2##(1993-11#1)(1993-3#1)(1994-4#1)(1996-2#1)(2005-8#2)(2006-1#1)(2006-2#1)(2007-11#1)(2007-2#3)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#1)(2010-3#1)(2011-2#2)(2012-12#2)
some criteria##3##2##(1992-2#1)(2007-3#1)(2009-4#1)
some critical##9##2##(1991-3#1)(1994-11#1)(2005-11#1)(2007-1#1)(2007-6#1)(2008-1#1)(2008-11#2)(2012-3#1)
some cross-reactivity##2##2##(1991-4#1)(2008-10#1)
some current##5##2##(1996-3#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-8#1)
some currently##2##2##(1993-7#1)(2008-10#1)
some dark##2##2##(2007-7#1)(2008-2#1)
some data##7##2##(1991-12#1)(1994-12#1)(2005-11#1)(2006-10#1)(2008-10#1)(2009-8#1)(2012-12#1)
some decades##2##2##(2009-8#1)(2013-7#1)
some decrease in##2##3##(1990-5#1)(1994-3#1)
some decrease##3##2##(1990-5#1)(1994-3#1)(2009-8#1)
some degenerative changes##2##3##(2006-6#1)(2008-5#1)
some degradation##2##2##(2007-8#1)(2008-3#1)
some degree and##2##3##(2006-12#1)(2007-4#1)
some degree of recovery##2##4##(2008-10#1)(2008-7#1)
some degree of success##2##4##(2008-1#1)(2013-1#1)
some degree of##34##3##(1992-11#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-10#1)(1997-7#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-2#2)(2013-1#1)
some degree##51##2##(1992-11#1)(1992-2#1)(1993-12#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-10#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-12#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-4#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
some delay##2##2##(1992-2#1)(2007-11#1)
some derivatives##3##2##(2006-12#1)(2007-10#1)(2008-10#1)
some design##3##2##(2007-8#1)(2008-3#1)(2008-6#1)
some details##4##2##(1992-6#1)(2007-11#1)(2007-3#1)(2011-2#1)
some diagnostic##3##2##(1991-2#1)(1993-5#1)(2008-6#1)
some dietary##2##2##(2006-12#1)(2008-10#1)
some difference##2##2##(2008-10#1)(2011-2#1)
some differences between the##3##4##(1994-11#1)(2006-7#1)(2008-3#1)
some differences between##8##3##(1994-11#1)(2006-7#1)(2007-2#1)(2008-3#1)(2009-7#1)(2010-12#1)(2012-12#1)(2013-1#1)
some differences in the##7##4##(1992-7#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-5#1)(2012-3#2)
some differences in##16##3##(1991-6#1)(1991-7#1)(1992-7#1)(1993-3#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2011-12#1)(2012-3#2)(2013-7#1)
some differences##33##2##(1991-11#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-7#1)(1993-3#1)(1994-11#1)(1994-3#1)(2006-11#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#2)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-7#1)(2010-12#1)(2011-12#1)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
some different##3##2##(2005-11#1)(2008-10#1)(2010-10#1)
some difficult##2##2##(2009-12#1)(2009-6#1)
some difficulties##5##2##(1990-8#1)(2006-10#1)(2009-12#1)(2009-4#1)(2011-1#1)
some dipeptides##3##2##(2008-10#3)
some direct##3##2##(1994-5#1)(2008-5#1)(2008-9#1)
some disadvantages in##2##3##(2004-9#1)(2009-2#1)
some disadvantages of the##2##4##(2008-3#1)(2010-8#1)
some disadvantages##7##2##(2004-9#1)(2007-8#1)(2008-11#1)(2008-3#1)(2009-2#1)(2010-8#1)(2012-2#1)
some disagreement##3##2##(2008-11#1)(2008-2#1)(2013-1#1)
some discrete##2##2##(1993-11#1)(2008-10#1)
some discussion##2##2##(2006-10#1)(2012-1#1)
some diseases##11##2##(1992-8#1)(1993-2#1)(1997-7#1)(2007-1#1)(2008-11#1)(2008-2#1)(2008-4#2)(2010-4#1)(2013-1#2)
some distal##2##2##(1992-9#1)(2007-8#1)
some distance from the##4##4##(1997-5#1)(2008-4#2)(2013-1#1)
some distance##7##2##(1997-5#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-4#2)(2013-1#1)
some distinct##5##2##(1992-2#1)(1993-8#1)(2006-10#1)(2007-1#1)(2009-9#1)
some do not##2##3##(2005-10#1)(2007-12#1)
some doctors##3##2##(1994-7#1)(2007-1#1)(2012-11#1)
some dopaminergic##2##2##(1994-12#2)
some doubt##2##2##(1993-3#1)(2010-3#1)
some drawbacks##2##2##(2008-2#1)(2008-3#1)
some drug##6##2##(1990-5#1)(1996-12#1)(2006-6#1)(2008-10#1)(2011-3#2)
some drugs and##2##3##(2007-11#1)(2008-10#1)
some drugs##19##2##(1991-1#2)(1995-7#1)(1996-10#1)(1996-6#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#1)(2013-1#1)
some dyes##2##2##(2008-10#2)
some early##4##2##(1990-4#1)(1993-11#1)(1996-7#1)(2012-3#1)
some earthquakes##2##2##(1996-4#2)
some economical##2##2##(2006-10#1)(2007-5#1)
some effect on##3##3##(1996-2#1)(2007-6#1)(2011-1#1)
some effect##5##2##(1996-10#1)(1996-2#1)(2007-11#1)(2007-6#1)(2011-1#1)
some effects of##2##3##(1993-11#1)(2013-1#1)
some effects##3##2##(1993-11#1)(2012-2#1)(2013-1#1)
some efficacy in##3##3##(2007-11#2)(2012-1#1)
some efficacy##6##2##(2007-11#2)(2007-8#1)(2008-5#1)(2010-12#1)(2012-1#1)
some efficiency##2##2##(2008-3#1)(2008-7#1)
some empirical##4##2##(1993-1#1)(2008-11#1)(2008-6#1)(2012-2#1)
some encouraging##2##2##(1993-11#1)(2010-6#1)
some endocrine##2##2##(1990-2#1)(2008-10#1)
some environmental factors##2##3##(2008-10#1)(2010-12#1)
some environmental samples##2##3##(2008-10#2)
some environmental##8##2##(1990-6#1)(1993-8#1)(2006-10#1)(2008-10#3)(2010-12#1)(2013-7#1)
some enzymes of##2##3##(1993-1#1)(2007-11#1)
some enzymes##8##2##(1990-8#1)(1991-4#1)(1993-1#1)(1993-9#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-10#1)
some epidemiological##6##2##(1993-3#1)(2007-7#1)(2008-10#1)(2010-2#1)(2011-2#2)
some epileptic##2##2##(2007-11#1)(2008-7#1)
some errors##2##2##(2008-3#1)(2009-5#1)
some essential properties##2##3##(2008-2#1)(2008-6#1)
some essential##11##2##(1993-8#2)(2006-9#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2010-11#1)
some estrogens##2##2##(2005-3#1)(2008-10#1)
some ethical##2##2##(1994-2#1)(1997-8#1)
some ethnic groups##2##3##(2007-12#1)(2009-10#1)
some ethnic##3##2##(2007-12#1)(2009-10#1)(2009-9#1)
some eukaryotes##2##2##(2005-7#1)(2010-4#1)
some evidence for a##2##4##(2007-10#1)(2008-7#1)
some evidence for##7##3##(2006-10#1)(2007-10#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#1)
some evidence of a##3##4##(1992-2#1)(2007-9#1)(2011-1#1)
some evidence of the##2##4##(2008-5#1)(2013-1#1)
some evidence of##22##3##(1991-1#1)(1991-9#1)(1992-2#1)(1994-12#1)(1995-5#1)(1997-5#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-9#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
some evidence suggests that##2##4##(1993-6#1)(2010-2#1)
some evidence suggests##3##3##(1990-7#1)(1993-6#1)(2010-2#1)
some evidence that the##6##4##(1992-1#1)(1994-5#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-5#1)
some evidence that##22##3##(1990-12#1)(1990-2#1)(1992-1#1)(1993-1#1)(1994-5#1)(1996-2#1)(1996-6#1)(2003-11#1)(2005-8#2)(2006-10#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
some evidence to suggest that##5##5##(1994-3#1)(2006-7#1)(2008-3#1)(2009-3#1)(2013-1#1)
some evidence##65##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-1#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-5#1)(2003-11#1)(2005-8#2)(2006-10#3)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-6#1)(2007-8#1)(2007-9#2)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-6#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
some evidences##2##2##(1995-2#1)(2008-1#1)
some examples of such##3##4##(2012-2#1)(2013-1#2)
some examples of the##2##4##(2008-8#1)(2009-10#1)
some examples of##12##3##(2006-10#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-8#1)(2012-2#1)(2013-1#2)
some examples##17##2##(2006-10#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-4#2)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#2)
some exceptions##4##2##(2008-6#1)(2010-8#1)(2011-2#1)(2012-12#1)
some exhibit##2##2##(1995-8#1)(2008-4#1)
some existing##2##2##(2008-2#1)(2009-12#1)
some experience with##3##3##(2006-12#1)(2007-9#1)(2008-4#1)
some experience##7##2##(2006-12#1)(2006-6#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-11#1)
some experiences##3##2##(1995-4#1)(1996-12#1)(2010-2#1)
some experimental and##2##3##(2008-3#1)(2010-12#1)
some experimental results are shown##2##5##(2008-2#2)
some experimental results are##4##4##(2008-2#3)(2008-3#1)
some experimental results##7##3##(2006-10#1)(2008-2#3)(2008-3#3)
some experimental##21##2##(1990-2#1)(1997-6#1)(2006-10#2)(2007-12#1)(2007-9#1)(2008-10#4)(2008-2#3)(2008-3#4)(2008-8#1)(2009-3#1)(2010-12#2)
some experiments##11##2##(1994-8#1)(1996-10#1)(1997-4#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-5#1)
some experts##2##2##(2007-9#2)
some explanatory variables##2##3##(2008-10#2)
some expressed concern##2##3##(1990-2#1)(2008-8#1)
some extent##58##2##(1990-10#1)(1990-4#1)(1990-5#1)(1992-11#1)(1993-1#1)(1993-12#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-6#1)(2004-4#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-10#1)(2007-2#1)(2007-6#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-9#2)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
some external##2##2##(1996-5#1)(1997-7#1)
some factors associated with##3##4##(2008-10#1)(2011-2#1)(2012-1#1)
some factors controlling##2##3##(2007-5#1)(2008-10#1)
some factors##11##2##(2006-6#1)(2007-5#1)(2008-10#3)(2008-4#2)(2008-6#1)(2011-2#2)(2012-1#1)
some families##6##2##(1997-1#1)(1997-2#1)(2006-10#1)(2008-8#2)(2011-1#1)
some features of##5##3##(1990-8#1)(1991-10#1)(2006-6#1)(2008-10#1)(2009-2#1)
some features##8##2##(1990-8#1)(1991-10#1)(1992-2#1)(2006-6#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-2#1)
some field##2##2##(2007-12#1)(2008-10#1)
some findings##3##2##(1996-3#1)(1997-3#1)(1997-8#1)
some flowers##2##2##(2006-12#1)(2011-2#1)
some form of national##2##4##(2008-11#1)(2009-3#1)
some form of physical##2##4##(2005-8#1)(2008-10#1)
some form of##34##3##(1990-12#1)(1991-3#1)(1992-12#1)(1993-2#1)(1994-1#1)(1996-6#1)(1996-7#1)(1997-3#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-3#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#2)(2011-12#1)(2012-11#1)(2012-3#2)(2013-1#1)
some form##36##2##(1990-12#1)(1991-3#1)(1992-12#1)(1993-2#1)(1994-1#1)(1995-1#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-3#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-3#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#2)(2011-12#1)(2012-11#1)(2012-3#2)(2013-1#1)
some formal##2##2##(2008-7#1)(2012-3#1)
some forms of cancer##2##4##(1994-12#1)(2012-1#1)
some forms of##18##3##(1991-11#1)(1991-12#1)(1994-12#1)(1995-12#2)(1995-7#1)(1996-11#1)(1996-6#1)(2005-9#1)(2006-10#1)(2006-7#1)(2006-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-1#1)
some forms##19##2##(1991-11#1)(1991-12#1)(1994-12#1)(1995-12#2)(1995-7#1)(1996-11#1)(1996-6#2)(2005-9#1)(2006-10#1)(2006-7#1)(2006-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-1#1)
some formulations##2##2##(1993-11#1)(2010-4#1)
some fragments##4##2##(1993-7#1)(1994-2#1)(1995-11#1)(2010-5#1)
some function##2##2##(1993-6#1)(1993-9#1)
some functional##9##2##(1996-10#1)(1996-7#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-8#1)
some functions of the##2##4##(1991-12#1)(2008-2#1)
some fundamental##4##2##(1994-11#1)(2007-12#1)(2008-12#1)(2008-7#1)
some fungal##2##2##(2008-10#1)(2012-2#1)
some further##4##2##(1991-5#1)(1992-2#1)(2006-10#1)(2008-8#1)
some future##5##2##(1991-6#1)(2008-1#1)(2008-3#1)(2010-12#1)(2010-7#1)
some gaps##3##2##(2006-9#2)(2008-2#1)
some gastrointestinal##2##2##(2006-10#1)(2006-6#1)
some genera##2##2##(2013-7#2)
some general guidelines for##2##4##(1993-12#1)(2008-9#1)
some general##11##2##(1991-2#1)(1993-10#1)(1993-12#1)(1996-6#1)(1996-7#1)(1997-6#1)(2006-10#1)(2008-1#1)(2008-9#1)(2009-4#1)(2010-5#1)
some genes of##2##3##(2011-2#1)(2012-12#1)
some genes##11##2##(1995-6#1)(2005-11#1)(2006-4#1)(2007-12#1)(2009-10#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
some genetic and##3##3##(1995-6#1)(1996-8#1)(2010-4#1)
some genetic##8##2##(1994-11#1)(1995-11#1)(1995-6#1)(1996-8#1)(1997-8#1)(2006-10#1)(2008-10#1)(2010-4#1)
some geometric##2##2##(2005-11#1)(2008-3#1)
some good##3##2##(1992-3#1)(2008-9#1)(2012-3#1)
some groups of##6##3##(2006-7#1)(2007-12#2)(2007-8#1)(2010-4#2)
some groups##13##2##(1991-12#1)(2006-7#2)(2007-12#2)(2007-8#1)(2008-10#1)(2008-7#1)(2009-5#1)(2010-4#2)(2010-7#2)
some growth##2##2##(2008-12#1)(2010-8#1)
some guidance##3##2##(1993-1#1)(2006-10#1)(2007-8#1)
some hair##2##2##(1994-10#1)(2010-12#1)
some halophile organisms##2##3##(2006-10#2)
some hard and soft metals##2##5##(2008-10#2)
some have a##2##3##(1993-9#1)(2011-3#1)
some have been##5##3##(2005-8#1)(2006-12#1)(2010-12#1)(2010-5#1)(2011-3#1)
some have##15##2##(1991-9#1)(1993-9#1)(1996-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-3#2)
some health care##2##3##(1997-1#1)(2009-6#1)
some health##6##2##(1997-1#1)(1997-8#1)(2008-10#2)(2009-6#1)(2012-1#1)
some heavy metal ions##3##4##(2008-10#3)
some heavy metals##6##3##(2007-10#1)(2008-10#2)(2008-4#1)(2010-11#1)(2010-12#1)
some heavy##9##2##(2007-10#1)(2008-10#5)(2008-4#1)(2010-11#1)(2010-12#1)
some heteropoly##3##2##(2008-10#3)
some higher##4##2##(1995-8#1)(2007-1#1)(2008-8#1)(2010-4#1)
some highlights##2##2##(1997-7#1)(2008-11#1)
some hope##2##2##(1997-5#1)(2008-1#1)
some hospital##3##2##(1991-2#1)(2011-1#1)(2012-2#1)
some hospitals##6##2##(1991-4#1)(1993-12#1)(1997-8#1)(2007-9#1)(2008-10#1)(2013-7#1)
some host##2##2##(2008-10#2)
some human##10##2##(1992-11#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-10#1)(1995-3#1)(2008-5#1)(2008-7#1)(2013-8#2)
some ideas for##2##3##(1992-2#1)(2008-4#1)
some ideas on##2##3##(1995-2#1)(2009-10#1)
some ideas##8##2##(1992-2#1)(1995-2#1)(2006-10#1)(2006-5#1)(2008-4#1)(2009-10#1)(2011-3#1)(2012-1#1)
some illustrative examples##2##3##(1994-2#1)(2005-8#1)
some immune##2##2##(1993-6#1)(2013-1#1)
some impact##2##2##(2007-4#1)(2012-2#1)
some implications for##3##3##(2006-8#1)(2009-4#1)(2011-1#1)
some implications of the##2##4##(1991-1#1)(2007-9#1)
some implications of##4##3##(1991-1#1)(2007-9#1)(2008-11#1)(2009-6#1)
some implications##7##2##(1991-1#1)(2006-8#1)(2007-9#1)(2008-11#1)(2009-4#1)(2009-6#1)(2011-1#1)
some important biological##2##3##(2008-8#1)(2009-8#1)
some important differences##3##3##(1994-5#1)(2007-1#1)(2009-12#1)
some important factors##3##3##(2008-10#1)(2012-11#1)(2012-3#1)
some important questions##2##3##(1993-12#1)(2013-7#1)
some important##42##2##(1991-12#1)(1992-1#1)(1992-3#1)(1992-7#2)(1993-12#1)(1994-5#1)(1994-8#1)(1996-4#1)(2005-11#1)(2006-12#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
some improvement in##2##3##(1990-8#1)(2006-8#1)
some improvement##5##2##(1990-8#1)(2005-10#1)(2006-8#1)(2007-9#1)(2008-7#1)
some improvements##7##2##(1991-9#1)(1993-12#1)(2006-3#1)(2008-3#2)(2010-2#1)(2012-3#1)
some in vitro##4##3##(2006-10#1)(2008-10#2)(2008-4#1)
some in##8##2##(2006-10#1)(2006-3#1)(2008-10#2)(2008-4#1)(2009-10#1)(2010-3#1)(2012-12#1)
some inconsistencies##2##2##(1995-12#1)(2008-10#1)
some inconsistency in##2##3##(2008-3#1)(2012-12#1)
some inconsistency##3##2##(2008-3#2)(2012-12#1)
some increase in##2##3##(1990-6#1)(2012-2#1)
some increase of##2##3##(2008-3#1)(2010-7#1)
some increase##4##2##(1990-6#1)(2008-3#1)(2010-7#1)(2012-2#1)
some indication of##2##3##(1990-10#1)(2008-9#1)
some indication##3##2##(1990-10#1)(2008-9#2)
some indications##4##2##(2007-5#1)(2007-8#1)(2008-5#2)
some indicators##4##2##(1994-9#1)(2008-9#1)(2012-1#1)(2012-12#1)
some individual##9##2##(1992-12#1)(1993-12#1)(1995-9#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-5#1)(2011-12#1)
some individuals##25##2##(1990-11#1)(1991-8#1)(1992-11#1)(1995-6#1)(1996-5#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-3#3)(2010-5#1)(2012-11#1)(2012-2#1)(2013-1#2)
some industrial waste waters##2##4##(2008-10#2)
some industrial##4##2##(2008-10#3)(2008-3#1)
some infectious diseases##3##3##(2005-7#1)(2007-11#1)(2013-7#1)
some inflammatory diseases##2##3##(2008-10#1)(2013-1#1)
some inflammatory##6##2##(2007-8#1)(2008-10#1)(2011-2#1)(2012-2#2)(2013-1#1)
some influence on the##2##4##(1992-6#1)(2007-10#1)
some information on##2##3##(1991-12#1)(2005-11#1)
some information##6##2##(1990-8#1)(1991-12#1)(1992-12#1)(1997-3#1)(2005-11#1)(2006-10#1)
some inhibitors##2##2##(1995-8#1)(2013-7#1)
some initial##3##2##(2008-7#1)(2010-2#1)(2010-7#1)
some innovative##3##2##(1996-8#1)(2008-11#1)(2008-3#1)
some inorganic##3##2##(2007-10#1)(2008-10#2)
some insects##4##2##(1990-5#1)(2008-10#1)(2008-6#1)(2009-8#1)
some insight into the##5##4##(1992-1#1)(1993-12#1)(1997-5#1)(2006-10#1)(2008-9#1)
some insight into##9##3##(1992-1#1)(1993-12#1)(1997-5#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-9#2)(2012-2#1)
some insight##10##2##(1992-1#1)(1993-12#1)(1997-5#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-9#2)(2009-4#1)(2012-2#1)
some insights into the##5##4##(1992-9#1)(2006-10#1)(2008-7#1)(2010-12#1)(2011-1#1)
some insights##9##2##(1992-9#1)(2006-10#1)(2007-3#1)(2008-7#1)(2010-12#1)(2011-1#1)(2013-1#3)
some instances the##3##3##(1997-5#1)(2006-6#1)(2008-2#1)
some instances##34##2##(1990-11#1)(1993-12#1)(1995-12#1)(1995-3#1)(1996-7#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-5#1)(2006-10#2)(2006-2#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-7#2)(2008-9#2)(2010-12#1)(2011-1#1)(2012-11#2)
some instrumental parameters##2##3##(2008-10#2)
some instrumental##4##2##(2008-10#4)
some insulin##2##2##(1995-8#1)(2010-11#1)
some interaction##2##2##(2005-11#1)(2008-7#1)
some interesting##15##2##(1991-3#1)(1996-4#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-10#1)(2007-9#1)(2008-2#1)(2008-5#1)(2010-11#1)(2010-7#1)(2012-11#1)(2013-1#1)
some internal##3##2##(1993-12#1)(2008-5#1)(2008-9#1)
some international##2##2##(2008-10#2)
some interventions##2##2##(2007-2#1)(2013-1#1)
some intracellular##2##2##(1994-5#1)(1995-11#1)
some intrinsic##2##2##(2008-7#1)(2011-1#1)
some invasive##3##2##(2008-10#1)(2012-12#2)
some investigators##4##2##(1993-11#1)(1994-3#1)(1996-9#1)(2008-8#1)
some involvement##2##2##(2010-8#1)(2011-1#1)
some ions##5##2##(2008-10#5)
some isoforms##2##2##(1993-3#1)(1997-6#1)
some isolated##3##2##(2007-8#1)(2009-2#1)(2010-9#1)
some isolates of V##2##4##(2008-10#2)
some isolates of##3##3##(2008-10#3)
some isolates##13##2##(1997-3#1)(2008-10#10)(2008-3#1)(2012-12#1)
some issues about the##2##4##(2008-1#1)(2009-10#1)
some issues and##2##3##(1996-5#1)(2008-9#1)
some issues of##2##3##(2006-5#1)(2013-8#1)
some issues regarding##2##3##(2008-7#1)(2012-2#1)
some issues##11##2##(1990-12#1)(1996-5#1)(2006-5#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-10#1)(2012-2#2)(2013-8#1)
some items##2##2##(2008-4#1)(2013-7#1)
some journals##2##2##(2007-4#1)(2009-11#1)
some key issues##2##3##(2008-12#1)(2012-2#1)
some key lessons##3##3##(1995-12#1)(2008-12#2)
some key##19##2##(1991-2#1)(1992-3#1)(1994-3#1)(1995-12#1)(1995-3#1)(1997-1#1)(2006-2#1)(2007-12#1)(2008-12#4)(2008-5#1)(2008-7#1)(2010-10#1)(2012-12#2)(2012-2#1)(2013-1#1)
some kind of##17##3##(1991-12#1)(1993-3#1)(1997-3#1)(2005-11#1)(2006-10#3)(2007-3#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-8#1)(2009-2#1)(2009-5#1)(2009-9#1)(2013-8#1)
some kinds of##6##3##(1991-10#1)(1991-8#1)(1993-2#1)(1996-6#1)(2005-6#1)(2008-8#1)
some knowledge##4##2##(2006-6#1)(2009-10#1)(2012-2#1)(2012-3#1)
some lanthanide metal ions##2##4##(2008-10#2)
some large##5##2##(1991-11#1)(1991-3#1)(1991-4#1)(2006-7#1)(2008-10#1)
some lead##2##2##(2008-10#1)(2012-3#1)
some leads##2##2##(2008-2#1)(2009-4#1)
some length##3##2##(1991-4#1)(2010-12#1)(2012-2#1)
some lesions##5##2##(1997-3#1)(2006-1#1)(2007-3#1)(2007-7#1)(2010-12#1)
some level of##9##3##(2005-11#1)(2006-1#1)(2008-10#1)(2008-4#2)(2008-9#1)(2010-8#2)(2011-2#1)
some level##10##2##(2005-11#1)(2006-1#1)(2008-10#1)(2008-4#3)(2008-9#1)(2010-8#2)(2011-2#1)
some ligands##3##2##(1996-7#1)(2010-11#1)(2012-2#1)
some light into##2##3##(2012-12#1)(2012-2#1)
some light on the##6##4##(1993-12#1)(2006-10#2)(2008-10#1)(2008-11#1)(2008-8#1)
some light on##11##3##(1993-12#1)(2006-10#2)(2006-8#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#2)(2012-2#1)
some light##14##2##(1993-12#1)(2006-10#2)(2006-8#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#2)(2011-2#1)(2012-12#1)(2012-2#2)
some limitations##11##2##(1990-3#1)(1994-12#1)(2004-4#1)(2008-11#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
some limited##3##2##(1991-12#1)(2006-3#1)(2009-3#1)
some limiting value##2##3##(2007-12#1)(2007-4#1)
some linear##2##2##(2007-11#1)(2010-2#1)
some lines##5##2##(2008-10#3)(2008-5#1)(2008-9#1)
some literature##2##2##(2008-10#1)(2008-6#1)
some liver##2##2##(1990-2#1)(2010-12#1)
some local##4##2##(1990-3#1)(2008-10#1)(2008-12#1)(2013-7#1)
some locations##4##2##(2008-10#3)(2008-4#1)
some long-term##2##2##(1993-12#1)(2008-11#1)
some loss of##5##3##(2008-10#3)(2008-3#1)(2008-5#1)
some loss##7##2##(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#2)
some maize##2##2##(2008-10#1)(2008-5#1)
some major##6##2##(1996-2#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)
some malignancies##4##2##(2010-12#1)(2012-12#2)(2012-2#1)
some malignant tumors##3##3##(1993-6#1)(2008-3#1)(2010-1#1)
some malignant##4##2##(1993-6#1)(2008-3#1)(2010-1#1)(2011-2#1)
some mammals##2##2##(2010-12#1)(2012-2#1)
some managers##2##2##(1993-2#1)(2008-11#1)
some manifestations of##2##3##(1992-12#1)(2006-10#1)
some markers##4##2##(1990-4#1)(2007-7#1)(2008-5#1)(2009-2#1)
some materials##4##2##(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)
some may##3##2##(2006-10#1)(2007-2#1)(2008-7#1)
some measure of##7##3##(1993-3#1)(1995-5#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)
some measure##8##2##(1993-3#1)(1995-5#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2010-9#1)
some measurement##2##2##(2007-11#1)(2008-3#1)
some measures##6##2##(1996-3#1)(2007-12#1)(2008-11#1)(2008-9#1)(2010-10#1)(2010-8#1)
some mechanism to##2##3##(1992-5#1)(1994-9#1)
some mechanisms##5##2##(1993-3#1)(2006-10#1)(2008-2#1)(2008-7#1)(2008-8#1)
some medications##4##2##(2006-10#1)(2009-4#1)(2010-8#1)(2012-12#1)
some medicines##2##2##(1997-6#1)(2007-9#1)
some members of the##4##4##(1994-3#1)(1994-9#1)(1997-3#1)(2009-8#1)
some members##6##2##(1993-3#1)(1994-3#1)(1994-9#1)(1997-3#1)(2009-10#1)(2009-8#1)
some metabolic##2##2##(2008-2#1)(2008-9#1)
some metabolites##2##2##(2008-10#1)(2012-1#1)
some metal ions and##4##4##(2008-10#4)
some metal ions##12##3##(2008-10#12)
some metal##13##2##(2008-10#12)(2008-3#1)
some metallocenes##2##2##(2007-11#2)
some metals##9##2##(2004-4#1)(2007-11#1)(2008-10#6)(2008-12#1)
some methodologic##2##2##(1994-6#1)(2008-7#1)
some methodological##3##2##(1993-6#1)(2008-10#1)(2008-8#1)
some methods for##2##3##(1995-8#1)(2008-11#1)
some methods of##3##3##(1994-9#1)(2008-10#1)(2011-2#1)
some methods##6##2##(1994-9#1)(1995-8#1)(2008-10#1)(2008-11#1)(2011-2#2)
some microanatomical##2##2##(1994-6#2)
some might##2##2##(1991-6#2)
some migration##2##2##(2008-8#1)(2008-9#1)
some mild##2##2##(2007-2#1)(2012-1#1)
some minor##6##2##(1990-7#1)(1995-2#1)(2006-9#1)(2008-2#1)(2008-5#1)(2011-1#1)
some model##4##2##(1990-12#1)(2008-7#1)(2010-2#1)(2011-1#1)
some models##4##2##(1995-8#1)(1996-4#1)(2008-10#1)(2008-3#1)
some modest##3##2##(1990-4#1)(2008-8#1)(2012-1#1)
some modifications in##2##3##(2007-2#1)(2012-12#1)
some modifications of the##2##4##(1990-9#1)(2005-8#1)
some modifications of##3##3##(1990-9#1)(2005-8#1)(2008-10#1)
some modifications##7##2##(1990-9#1)(2005-8#1)(2006-3#1)(2007-2#1)(2008-10#1)(2009-4#1)(2012-12#1)
some modified##2##2##(1996-11#1)(1997-2#1)
some molecular##2##2##(1991-9#1)(2013-8#1)
some molecules##4##2##(2005-7#1)(2008-1#1)(2008-10#1)(2008-4#1)
some months##4##2##(1991-11#1)(1994-4#1)(1994-6#1)(2008-2#1)
some more##5##2##(2006-10#1)(2007-11#1)(2007-6#1)(2007-7#1)(2009-4#1)
some morphological##4##2##(1990-11#1)(2007-7#1)(2008-10#1)(2008-2#1)
some morphologically##3##2##(1997-4#1)(2011-2#1)(2013-7#1)
some motion##2##2##(2007-1#1)(2012-1#1)
some motor##2##2##(1994-2#1)(2010-6#1)
some multiple##2##2##(1995-1#1)(2008-9#1)
some murine##2##2##(1994-9#1)(1997-8#1)
some native##2##2##(1991-12#1)(2008-10#1)
some natural compounds##2##3##(2011-3#2)
some natural##8##2##(2008-10#4)(2008-3#1)(2011-3#2)(2012-2#1)
some ncRNAs##2##2##(2012-3#2)
some neural##3##2##(1995-12#1)(2008-11#1)(2011-1#1)
some neurological diseases##2##3##(2007-11#1)(2013-7#1)
some neurological##3##2##(2007-11#1)(2013-7#2)
some neurons##12##2##(1990-7#1)(1992-9#1)(1994-10#1)(1995-11#1)(1996-12#1)(1996-3#1)(1996-9#2)(2007-9#1)(2008-8#1)(2009-10#2)
some neuropsychological##3##2##(2004-11#1)(2005-11#1)(2007-10#1)
some neurotransmitter receptors##2##3##(2008-1#1)(2008-7#1)
some new##38##2##(1990-11#1)(1991-9#1)(1994-8#1)(1996-6#1)(1997-2#1)(2005-11#1)(2006-10#2)(2007-11#9)(2007-9#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-11#1)(2011-1#1)(2012-1#1)(2012-11#3)(2012-3#1)
some newly##2##2##(1996-5#1)(2008-12#1)
some normal##6##2##(1991-12#1)(1991-5#1)(1994-6#1)(1995-2#1)(2005-7#1)(2010-11#1)
some normally situated pyramidal cells had##2##6##(1996-3#2)
some notable##2##2##(1992-12#1)(1994-10#1)
some novel approaches##3##3##(2005-8#1)(2007-8#1)(2013-1#1)
some novel##16##2##(1990-11#1)(1996-5#1)(2005-11#1)(2005-8#1)(2006-9#1)(2007-11#5)(2007-8#1)(2008-1#2)(2008-5#1)(2012-2#1)(2013-1#1)
some nuclear proteins##3##3##(1994-9#2)(2008-9#1)
some nucleotides##2##2##(1995-11#1)(2008-9#1)
some objects##2##2##(2005-4#1)(2011-2#1)
some observations on##2##3##(1992-6#1)(2012-1#1)
some observations##8##2##(1991-9#1)(1992-6#1)(1992-7#1)(1996-1#1)(1997-3#1)(2006-12#1)(2008-10#1)(2012-1#1)
some occasions##2##2##(2006-6#1)(2008-5#1)
some of its##27##3##(1990-12#1)(1991-7#1)(1991-9#1)(1992-2#1)(1993-12#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-5#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-8#2)(2012-3#1)(2013-8#1)
some of our current##2##4##(1996-2#1)(2007-5#1)
some of our##8##3##(1994-6#1)(1995-11#1)(1996-2#1)(2004-2#1)(2006-6#1)(2007-5#1)(2008-12#1)(2012-2#1)
some of the abnormalities##2##4##(1992-5#1)(2006-5#1)
some of the actions of##4##5##(1991-4#1)(1991-5#1)(1993-11#1)(1994-10#1)
some of the additional##2##4##(1993-5#1)(2005-10#1)
some of the advances##4##4##(2006-10#1)(2006-8#1)(2008-11#1)(2010-11#1)
some of the advantages##2##4##(1993-2#1)(2007-12#1)
some of the adverse##2##4##(2008-7#1)(2013-1#1)
some of the answers##2##4##(1990-5#1)(1994-1#1)
some of the anti-inflammatory actions of##2##6##(1993-4#2)
some of the areas##3##4##(1991-2#1)(2007-10#1)(2008-7#1)
some of the barriers to##2##5##(1997-2#1)(2012-2#1)
some of the barriers##3##4##(1994-1#1)(1997-2#1)(2012-2#1)
some of the bases##2##4##(1995-1#1)(2006-12#1)
some of the basic##5##4##(1995-7#1)(2007-5#1)(2008-4#2)(2008-6#1)
some of the benefit##2##4##(2010-7#1)(2012-2#1)
some of the best##2##4##(2007-4#1)(2008-11#1)
some of the biological activities##2##5##(1992-6#1)(1995-3#1)
some of the biological##4##4##(1991-10#1)(1992-6#1)(1995-3#1)(2008-5#1)
some of the cases##3##4##(1990-12#1)(2006-8#1)(2010-12#1)
some of the causes##4##4##(1991-6#1)(1996-2#1)(2007-11#1)(2009-4#1)
some of the challenges and##2##5##(1996-2#1)(2008-1#1)
some of the challenges of##2##5##(2006-5#1)(2008-11#1)
some of the challenges##7##4##(1996-2#1)(2006-5#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-2#1)
some of the characteristic##2##4##(2008-11#1)(2009-12#1)
some of the characteristics of##2##5##(1990-11#1)(2008-8#1)
some of the clinical##6##4##(1996-3#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-6#1)(2011-1#1)
some of the cognitive deficits##2##5##(1995-11#1)(2008-11#1)
some of the common##7##4##(2005-8#1)(2007-7#1)(2008-4#3)(2008-7#1)(2009-3#1)
some of the complications of##2##5##(2006-10#1)(2011-2#1)
some of the complications##3##4##(2006-10#1)(2008-6#1)(2011-2#1)
some of the compounds##5##4##(1993-11#1)(1994-8#1)(1997-2#1)(2008-10#1)(2008-5#1)
some of the core##3##4##(2007-12#1)(2007-4#1)(2009-8#1)
some of the critical##3##4##(1992-12#1)(2008-8#1)(2011-2#1)
some of the current issues##2##5##(2006-10#1)(2009-4#1)
some of the current##11##4##(2004-12#1)(2006-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#2)(2012-3#1)(2013-7#1)
some of the data##4##4##(2008-12#1)(2008-2#1)(2008-5#1)(2010-4#1)
some of the diagnostic##3##4##(1992-8#1)(1997-2#1)(2008-1#1)
some of the different##2##4##(2006-10#1)(2010-12#1)
some of the difficulties##6##4##(1990-10#2)(2006-10#1)(2007-2#1)(2008-7#1)(2008-9#1)
some of the diseases##2##4##(2008-10#2)
some of the early##3##4##(1996-4#1)(2008-11#1)(2011-2#1)
some of the effects of##3##5##(1996-4#1)(2008-3#1)(2009-12#1)
some of the effects##5##4##(1994-6#1)(1996-4#1)(2008-3#1)(2009-12#1)(2012-3#1)
some of the emerging##2##4##(1997-2#1)(1997-5#1)
some of the ethical##2##4##(2007-7#1)(2013-8#1)
some of the existing##4##4##(2006-10#1)(2008-3#1)(2008-5#1)(2009-1#1)
some of the factors involved##2##5##(1992-9#1)(2009-5#1)
some of the factors that##3##5##(1997-1#1)(2008-1#1)(2008-4#1)
some of the factors which##2##5##(1990-12#1)(1992-6#1)
some of the factors##11##4##(1990-12#1)(1991-3#1)(1992-6#1)(1992-9#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-5#1)(2009-5#1)
some of the features##3##4##(1994-1#1)(1996-3#1)(2004-9#1)
some of the first##3##4##(1991-12#1)(2008-10#1)(2008-9#1)
some of the following heavy##2##5##(2007-10#1)(2008-10#1)
some of the following##3##4##(1995-12#1)(2007-10#1)(2008-10#1)
some of the functions of##3##5##(2004-3#1)(2007-8#1)(2008-1#1)
some of the fundamental##2##4##(1996-8#1)(2008-5#1)
some of the future directions for##2##6##(1994-2#1)(2012-2#1)
some of the future##3##4##(1994-2#1)(2008-2#1)(2012-2#1)
some of the gaps##3##4##(1997-1#1)(2006-10#1)(2012-12#1)
some of the genes##2##4##(2008-10#1)(2008-9#1)
some of the groups##4##4##(1992-3#1)(1995-6#1)(2008-11#2)
some of the health##3##4##(1994-3#1)(2007-6#1)(2010-3#1)
some of the highest##5##4##(2006-4#1)(2007-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
some of the highlights of##2##5##(2007-11#1)(2009-3#1)
some of the historical##2##4##(1995-1#1)(2010-2#1)
some of the human##2##4##(1996-10#1)(2006-12#1)
some of the immune##2##4##(2007-11#1)(2008-7#1)
some of the impacts of##2##5##(1993-1#1)(2008-1#1)
some of the important factors##3##5##(2007-12#1)(2007-9#1)(2009-2#1)
some of the important##10##4##(1992-3#1)(2005-10#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-4#1)(2009-2#1)(2009-7#1)(2010-7#1)(2013-8#1)
some of the inherent##2##4##(2008-11#1)(2008-12#1)
some of the issues involved in##2##6##(1991-12#2)
some of the issues that##4##5##(1991-3#1)(2008-12#1)(2008-4#2)
some of the issues##17##4##(1991-12#2)(1991-3#1)(1992-3#1)(1993-11#1)(2005-11#1)(2006-9#1)(2008-11#1)(2008-12#1)(2008-4#2)(2009-4#1)(2009-6#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
some of the key studies##2##5##(2008-1#1)(2008-7#1)
some of the key##15##4##(1992-1#1)(1992-12#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-5#1)(2010-6#1)(2012-2#1)(2013-1#1)
some of the latest##3##4##(2006-10#1)(2009-10#1)(2012-1#1)
some of the legal considerations##2##5##(1991-12#1)(2012-2#1)
some of the legal##5##4##(1991-12#1)(1992-3#1)(2007-7#1)(2008-11#1)(2012-2#1)
some of the limitations and##2##5##(2008-10#2)
some of the limitations of##3##5##(2008-10#1)(2008-5#1)(2010-6#1)
some of the limitations##8##4##(2008-1#1)(2008-10#3)(2008-5#1)(2010-6#1)(2013-1#2)
some of the main##10##4##(1991-6#1)(2005-10#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)
some of the major problems##2##5##(1997-2#1)(2008-12#1)
some of the major##11##4##(1997-2#1)(2005-7#1)(2005-9#1)(2006-10#3)(2007-10#1)(2008-11#1)(2008-12#1)(2010-7#1)(2011-2#1)
some of the many##4##4##(2006-10#3)(2007-6#1)
some of the mechanisms underlying##2##5##(1993-8#1)(2008-1#1)
some of the mechanisms##4##4##(1993-8#1)(2004-11#1)(2007-8#1)(2008-1#1)
some of the methods used##2##5##(2008-11#1)(2008-4#1)
some of the methods##4##4##(2008-10#1)(2008-11#1)(2008-4#1)(2009-9#1)
some of the models##2##4##(2008-2#1)(2009-3#1)
some of the molecular##3##4##(2008-7#2)(2010-5#1)
some of the more common##6##5##(2006-10#1)(2008-1#1)(2008-9#2)(2009-9#1)(2012-2#1)
some of the more commonly used##3##6##(2007-7#1)(2008-4#2)
some of the more frequent##2##5##(2005-11#1)(2006-1#1)
some of the more recent##3##5##(1990-4#1)(2005-10#1)(2008-1#1)
some of the more##25##4##(1990-12#1)(1990-4#1)(1994-10#1)(1995-9#1)(1996-3#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#2)(2007-11#1)(2007-7#1)(2008-1#3)(2008-11#1)(2008-12#1)(2008-4#2)(2008-9#2)(2009-5#1)(2009-9#1)(2010-12#1)(2012-2#1)
some of the most common##7##5##(1991-4#1)(2005-8#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-10#1)
some of the most commonly used##2##6##(2008-4#2)
some of the most commonly##3##5##(2006-8#1)(2008-4#2)
some of the most current##2##5##(2005-8#1)(2008-12#1)
some of the most frequent##3##5##(2011-2#1)(2013-1#2)
some of the most frequently##2##5##(2004-5#1)(2010-6#1)
some of the most important##9##5##(1995-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-10#1)(2010-12#1)(2013-1#1)
some of the most interesting##2##5##(2007-5#1)(2011-2#1)
some of the most primitive##2##5##(2007-8#1)(2009-12#1)
some of the most recent findings##2##6##(2008-5#1)(2009-2#1)
some of the most recent##5##5##(2006-10#1)(2008-5#2)(2009-2#1)(2009-7#1)
some of the most##54##4##(1991-4#1)(1995-1#1)(2004-5#1)(2005-8#2)(2006-10#2)(2006-2#1)(2006-8#2)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#3)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-6#2)(2010-7#2)(2011-2#2)(2012-2#1)(2013-1#3)
some of the natural##3##4##(2007-3#1)(2008-7#1)(2009-1#1)
some of the neurons##3##4##(1994-2#1)(1995-6#1)(2007-9#1)
some of the new##6##4##(1994-8#1)(1995-10#1)(1996-5#1)(2006-10#1)(2007-9#1)(2012-2#1)
some of the newer##2##4##(2006-10#1)(2009-9#1)
some of the newly identified##2##5##(1996-6#1)(2006-10#1)
some of the newly##3##4##(1996-6#1)(2006-10#1)(2010-11#1)
some of the novel##2##4##(1996-8#1)(2004-4#1)
some of the observed##4##4##(2008-10#1)(2008-3#1)(2008-8#1)(2012-1#1)
some of the obstacles to##2##5##(2007-4#1)(2007-5#1)
some of the obstacles##4##4##(1993-2#1)(1995-3#1)(2007-4#1)(2007-5#1)
some of the open##2##4##(1992-9#1)(1995-11#1)
some of the options##2##4##(2007-4#1)(2009-5#1)
some of the other##5##4##(2006-12#1)(2007-2#1)(2008-7#1)(2008-9#1)(2010-3#1)
some of the participating##2##4##(2008-11#1)(2008-12#1)
some of the patients##2##4##(2006-6#1)(2007-2#1)
some of the pharmacological##2##4##(1994-3#2)
some of the philosophical##3##4##(2006-9#1)(2008-4#1)(2008-7#1)
some of the pitfalls##2##4##(1993-2#1)(2008-8#1)
some of the populations##2##4##(2007-6#1)(2012-1#1)
some of the possible##4##4##(1991-11#1)(2006-2#1)(2008-4#1)(2008-7#1)
some of the potential##6##4##(1993-7#1)(1994-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2011-1#1)
some of the practical##3##4##(1995-3#1)(2008-8#1)(2013-1#1)
some of the preparations##2##4##(1996-7#1)(2008-5#1)
some of the presentations##2##4##(2005-7#1)(2008-10#1)
some of the previously##5##4##(1991-11#1)(1995-7#1)(1996-8#1)(2012-12#2)
some of the problems associated with##2##6##(2005-5#1)(2006-5#1)
some of the problems of##2##5##(1994-8#1)(2008-11#1)
some of the problems that##4##5##(1990-12#1)(1993-3#1)(1995-11#1)(2008-1#1)
some of the problems##13##4##(1990-12#1)(1992-12#1)(1993-3#1)(1994-4#1)(1994-8#1)(1995-11#1)(2005-5#1)(2005-7#1)(2006-5#1)(2008-1#1)(2008-11#1)(2008-4#1)(2012-1#1)
some of the progress##2##4##(2006-12#1)(2010-12#1)
some of the promising##2##4##(2008-3#1)(2009-10#1)
some of the properties of##3##5##(1991-11#1)(2008-10#1)(2008-7#1)
some of the questions##3##4##(2004-12#1)(2008-2#1)(2008-7#1)
some of the real##2##4##(1997-7#1)(2008-3#1)
some of the reasons for the##3##6##(1996-2#1)(2013-1#2)
some of the reasons why##3##5##(2009-11#1)(2009-6#1)(2012-2#1)
some of the reasons##7##4##(1994-3#1)(1996-2#1)(2009-11#1)(2009-6#1)(2012-2#1)(2013-1#2)
some of the recent advances##2##5##(2008-7#1)(2013-1#1)
some of the recent developments in##3##6##(1993-6#1)(2008-10#1)(2011-1#1)
some of the recent developments##4##5##(1993-6#1)(2008-10#1)(2010-5#1)(2011-1#1)
some of the recent findings##2##5##(2006-10#1)(2010-3#1)
some of the recent literature##2##5##(2006-10#2)
some of the recent##16##4##(1993-6#1)(2006-10#5)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-7#2)(2010-3#1)(2010-5#1)(2011-1#1)(2013-1#1)
some of the recently##2##4##(1992-4#1)(1995-3#1)
some of the relevant##3##4##(1992-1#1)(2008-5#1)(2008-7#1)
some of the residues##2##4##(1994-5#1)(1997-7#1)
some of the resources available##2##5##(2008-4#2)
some of the responses##2##4##(1991-3#1)(2007-12#1)
some of the risk of##2##5##(1993-7#1)(2008-3#1)
some of the same##6##4##(1993-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2012-3#1)
some of the sequelae##2##4##(2006-9#1)(2007-11#1)
some of the sites##2##4##(1992-2#1)(2007-2#1)
some of the species##3##4##(2007-11#2)(2013-7#1)
some of the specific##3##4##(2006-10#1)(2009-10#1)(2012-11#1)
some of the steps##3##4##(1993-2#1)(2007-4#1)(2009-8#1)
some of the strategies##3##4##(1991-12#1)(1992-1#1)(2006-10#1)
some of the strengths##2##4##(1991-1#1)(2008-7#1)
some of the studies##2##4##(1990-6#1)(2008-7#1)
some of the symptoms##3##4##(2006-6#1)(2008-11#1)(2009-11#1)
some of the techniques##2##4##(2008-1#1)(2008-9#1)
some of the theoretical##2##4##(1991-12#1)(2006-10#1)
some of the unique##4##4##(1991-1#1)(2006-5#1)(2008-11#2)
some of the##895##3##(1990-10#2)(1990-11#3)(1990-12#7)(1990-2#1)(1990-4#3)(1990-5#4)(1990-6#2)(1990-7#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#4)(1991-12#9)(1991-2#3)(1991-3#4)(1991-4#2)(1991-5#1)(1991-6#2)(1991-9#1)(1992-1#3)(1992-12#6)(1992-2#2)(1992-3#7)(1992-4#4)(1992-5#1)(1992-6#2)(1992-8#3)(1992-9#2)(1993-1#4)(1993-11#4)(1993-12#4)(1993-2#9)(1993-3#3)(1993-4#2)(1993-5#2)(1993-6#3)(1993-7#3)(1993-8#1)(1993-9#1)(1994-1#5)(1994-10#3)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#4)(1994-4#1)(1994-5#2)(1994-6#1)(1994-8#5)(1994-9#4)(1995-1#8)(1995-10#3)(1995-11#3)(1995-12#7)(1995-2#1)(1995-3#5)(1995-4#2)(1995-6#2)(1995-7#2)(1995-8#2)(1995-9#3)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#4)(1996-2#6)(1996-3#4)(1996-4#2)(1996-5#4)(1996-6#3)(1996-7#2)(1996-8#4)(1996-9#1)(1997-1#5)(1997-2#8)(1997-3#2)(1997-4#1)(1997-5#2)(1997-7#6)(1997-8#2)(2004-11#1)(2004-12#2)(2004-3#1)(2004-4#1)(2004-5#1)(2004-7#1)(2004-9#3)(2005-10#8)(2005-11#5)(2005-5#1)(2005-7#4)(2005-8#5)(2005-9#2)(2006-1#1)(2006-10#39)(2006-11#2)(2006-12#6)(2006-2#6)(2006-4#3)(2006-5#6)(2006-6#5)(2006-8#6)(2006-9#3)(2007-1#2)(2007-10#4)(2007-11#16)(2007-12#12)(2007-2#5)(2007-3#2)(2007-4#12)(2007-5#6)(2007-6#4)(2007-7#7)(2007-8#10)(2007-9#7)(2008-1#24)(2008-10#43)(2008-11#32)(2008-12#16)(2008-2#13)(2008-3#15)(2008-4#31)(2008-5#23)(2008-6#4)(2008-7#38)(2008-8#13)(2008-9#12)(2009-1#2)(2009-10#7)(2009-11#2)(2009-12#7)(2009-2#3)(2009-3#6)(2009-4#5)(2009-5#4)(2009-6#4)(2009-7#2)(2009-8#3)(2009-9#4)(2010-10#1)(2010-11#3)(2010-12#11)(2010-2#5)(2010-3#4)(2010-4#1)(2010-5#3)(2010-6#5)(2010-7#7)(2010-8#3)(2011-1#4)(2011-12#1)(2011-2#18)(2012-1#4)(2012-11#1)(2012-12#10)(2012-2#16)(2012-3#9)(2012-7#1)(2013-1#20)(2013-7#2)(2013-8#5)
some of their##26##3##(1990-2#1)(1991-12#1)(1991-2#1)(1991-3#1)(1995-1#1)(1996-8#1)(1997-3#1)(1997-8#1)(2005-4#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2010-12#2)(2013-8#1)
some of them are not##2##5##(1996-4#1)(2007-3#1)
some of them are##4##4##(1996-4#1)(2007-3#1)(2012-12#1)(2012-2#1)
some of them have##3##4##(2007-11#1)(2007-7#1)(2008-8#1)
some of them may##2##4##(2011-1#1)(2013-1#1)
some of them showing activities comparable to ketoconazole##2##8##(2008-5#2)
some of them showing##3##4##(2008-5#3)
some of them were##5##4##(2007-11#1)(2008-7#1)(2011-1#2)(2012-1#1)
some of them##55##3##(1990-12#1)(1994-2#1)(1994-3#2)(1996-2#1)(1996-3#1)(1996-4#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#4)(2008-7#4)(2008-8#2)(2009-2#1)(2010-10#1)(2010-12#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)
some of these activities##2##4##(1995-10#1)(2006-10#1)
some of these agents##3##4##(1994-6#1)(2008-5#1)(2009-1#1)
some of these are##4##4##(1996-3#1)(2006-10#1)(2009-12#1)(2013-1#1)
some of these cases##2##4##(2007-11#1)(2013-1#1)
some of these compounds##3##4##(1990-3#1)(2006-12#1)(2008-5#1)
some of these conditions##4##4##(1991-8#1)(2006-2#1)(2008-4#1)(2008-7#1)
some of these developments and the##2##6##(2006-10#1)(2011-1#1)
some of these diseases##3##4##(1997-8#1)(2008-1#1)(2012-12#1)
some of these drugs have##2##5##(1997-2#1)(2006-10#1)
some of these effects##3##4##(1993-12#1)(1993-7#1)(2005-12#1)
some of these isolates##2##4##(2008-10#1)(2010-4#1)
some of these issues and##3##5##(2007-2#1)(2008-1#1)(2009-2#1)
some of these issues##8##4##(1990-6#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-7#1)(2009-2#1)(2010-9#1)
some of these patients##4##4##(1996-6#1)(2007-11#2)(2012-1#1)
some of these peptides##2##4##(1994-10#1)(2006-10#1)
some of these populations##2##4##(2008-10#1)(2009-10#1)
some of these problems##3##4##(2004-2#1)(2008-10#1)(2008-11#1)
some of these products##2##4##(2008-10#2)
some of these##150##3##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-11#2)(1991-5#1)(1991-8#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-2#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#8)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#5)(2007-12#4)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-4#2)(2010-8#1)(2010-9#3)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
some of this##8##3##(1990-2#1)(1991-12#1)(1992-11#1)(1993-12#1)(1995-4#1)(2008-5#1)(2008-8#1)(2013-1#1)
some of those##12##3##(1991-3#2)(1992-12#1)(1997-1#1)(2006-3#1)(2007-8#1)(2008-1#1)(2008-5#1)(2009-8#1)(2013-1#2)(2013-8#1)
some of which are currently##2##5##(2008-12#1)(2008-5#1)
some of which are more likely to be##2##8##(1991-7#2)
some of which are not##3##5##(1991-12#1)(1995-1#1)(2012-1#1)
some of which are used##2##5##(2008-11#1)(2010-7#1)
some of which are##27##4##(1991-12#1)(1991-7#2)(1992-10#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-12#1)(1995-1#1)(1996-8#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
some of which can be##3##5##(1993-9#1)(2008-2#1)(2012-3#1)
some of which have been##2##5##(1997-5#1)(2008-10#1)
some of which have##7##4##(1990-4#1)(1995-1#1)(1995-6#1)(1997-5#1)(2004-7#1)(2008-10#1)(2012-1#1)
some of which is##2##4##(2009-5#1)(2012-12#1)
some of which may be##3##5##(1996-5#1)(2006-10#1)(2009-4#1)
some of which may##7##4##(1996-5#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-8#1)(2009-4#1)(2009-7#1)
some of which result##2##4##(1994-11#1)(2011-1#1)
some of which were##5##4##(2005-12#1)(2007-11#1)(2008-5#1)(2009-4#1)(2013-1#1)
some of which##75##3##(1990-4#1)(1991-12#1)(1991-7#2)(1991-8#1)(1992-10#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-9#2)(1994-11#2)(1994-12#1)(1995-1#2)(1995-6#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-4#2)(1997-5#1)(1997-7#1)(2004-7#1)(2005-12#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#1)(2009-12#1)(2009-4#2)(2009-5#2)(2009-7#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-3#1)(2013-1#2)
some of whom are##2##4##(2006-5#1)(2007-11#1)
some of whom##5##3##(1991-4#1)(1991-8#1)(2006-5#1)(2007-11#1)(2007-6#1)
some of##1291##2##(1990-10#3)(1990-11#4)(1990-12#9)(1990-2#3)(1990-3#1)(1990-4#4)(1990-5#5)(1990-6#3)(1990-7#3)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#6)(1991-12#13)(1991-2#4)(1991-3#8)(1991-4#3)(1991-5#3)(1991-6#2)(1991-7#3)(1991-8#3)(1991-9#2)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#7)(1992-2#3)(1992-3#8)(1992-4#4)(1992-5#1)(1992-6#3)(1992-8#3)(1992-9#2)(1993-1#4)(1993-10#1)(1993-11#6)(1993-12#7)(1993-2#9)(1993-3#4)(1993-4#3)(1993-5#3)(1993-6#3)(1993-7#4)(1993-8#1)(1993-9#4)(1994-1#5)(1994-10#4)(1994-11#3)(1994-12#7)(1994-2#6)(1994-3#8)(1994-4#1)(1994-5#2)(1994-6#3)(1994-8#5)(1994-9#5)(1995-1#13)(1995-10#4)(1995-11#4)(1995-12#7)(1995-2#1)(1995-3#6)(1995-4#3)(1995-5#1)(1995-6#4)(1995-7#2)(1995-8#3)(1995-9#3)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#5)(1996-2#8)(1996-3#8)(1996-4#3)(1996-5#6)(1996-6#4)(1996-7#2)(1996-8#7)(1996-9#1)(1997-1#6)(1997-2#10)(1997-3#3)(1997-4#4)(1997-5#4)(1997-6#1)(1997-7#9)(1997-8#5)(2004-11#1)(2004-12#2)(2004-2#2)(2004-3#1)(2004-4#1)(2004-5#1)(2004-7#2)(2004-9#3)(2005-10#8)(2005-11#6)(2005-12#2)(2005-4#1)(2005-5#1)(2005-7#5)(2005-8#8)(2005-9#2)(2006-1#1)(2006-10#51)(2006-11#2)(2006-12#7)(2006-2#8)(2006-3#1)(2006-4#4)(2006-5#9)(2006-6#7)(2006-7#1)(2006-8#9)(2006-9#5)(2007-1#3)(2007-10#6)(2007-11#28)(2007-12#20)(2007-2#7)(2007-3#3)(2007-4#12)(2007-5#7)(2007-6#6)(2007-7#10)(2007-8#13)(2007-9#9)(2008-1#29)(2008-10#70)(2008-11#41)(2008-12#23)(2008-2#19)(2008-3#20)(2008-4#40)(2008-5#43)(2008-6#6)(2008-7#52)(2008-8#20)(2008-9#15)(2009-1#3)(2009-10#10)(2009-11#2)(2009-12#9)(2009-2#6)(2009-3#8)(2009-4#7)(2009-5#7)(2009-6#4)(2009-7#3)(2009-8#5)(2009-9#5)(2010-10#2)(2010-11#5)(2010-12#16)(2010-2#5)(2010-3#5)(2010-4#3)(2010-5#4)(2010-6#5)(2010-7#8)(2010-8#7)(2010-9#3)(2011-1#12)(2011-12#2)(2011-2#22)(2012-1#9)(2012-11#1)(2012-12#15)(2012-2#23)(2012-3#16)(2012-7#1)(2013-1#31)(2013-7#2)(2013-8#10)
some older##2##2##(1996-2#1)(2013-1#1)
some operons##2##2##(2008-8#2)
some or all of their##2##5##(1990-12#1)(2006-12#1)
some or all of##5##4##(1990-12#1)(1995-1#1)(1996-5#1)(2006-12#1)(2007-12#1)
some or all##8##3##(1990-12#2)(1995-1#1)(1996-5#1)(2006-12#1)(2007-12#1)(2008-10#1)(2011-1#1)
some or##9##2##(1990-12#2)(1995-1#1)(1996-5#1)(2006-12#1)(2007-12#1)(2007-6#1)(2008-10#1)(2011-1#1)
some organic compounds of##2##4##(2008-10#1)(2011-2#1)
some organic compounds##3##3##(2008-10#2)(2011-2#1)
some organic solvents##2##3##(1995-3#1)(2008-10#1)
some organic##11##2##(1990-9#1)(1995-3#1)(2008-10#8)(2011-2#1)
some organisms##4##2##(1997-3#1)(2008-3#2)(2012-3#1)
some organizational aspects##2##3##(1990-11#1)(2012-12#1)
some original##2##2##(2006-2#1)(2013-8#1)
some other properties##3##3##(2007-11#1)(2008-11#2)
some other##76##2##(1990-2#1)(1990-4#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-11#1)(1994-2#1)(1995-1#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-5#1)(1997-8#2)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-6#1)(2006-7#2)(2006-8#2)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#3)
some others##5##2##(1992-11#1)(1995-3#1)(2007-8#1)(2008-10#1)(2011-2#1)
some overall##2##2##(2008-10#1)(2010-9#1)
some overlap between##2##3##(2005-8#1)(2006-12#1)
some parallels##2##2##(2008-6#1)(2012-2#1)
some parameter##2##2##(2008-2#1)(2008-8#1)
some parameters of##4##3##(2008-12#1)(2009-5#2)(2012-1#1)
some parameters such as##2##4##(2008-10#2)
some parameters##14##2##(1996-9#1)(1997-1#2)(1997-8#1)(2008-10#3)(2008-12#1)(2008-5#1)(2009-5#2)(2010-3#1)(2012-1#1)(2013-8#1)
some parasites##3##2##(1997-3#1)(2007-9#1)(2008-5#1)
some part of the##2##4##(2005-8#1)(2008-12#1)
some part##6##2##(2005-8#1)(2006-6#1)(2007-4#1)(2008-12#2)(2010-12#1)
some partial##3##2##(1993-7#1)(2006-11#1)(2006-6#1)
some participants##4##2##(1990-11#1)(2009-7#2)(2013-1#1)
some particular##4##2##(2008-10#1)(2008-2#1)(2008-9#1)(2013-1#1)
some parts of the##7##4##(1994-11#1)(1996-11#1)(1997-6#1)(2007-12#1)(2008-11#1)(2010-12#1)(2012-2#1)
some parts of##11##3##(1994-11#1)(1996-11#1)(1997-6#1)(2006-11#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-11#1)(2010-12#1)(2012-2#1)
some parts##12##2##(1994-11#1)(1996-11#1)(1997-6#1)(2006-11#2)(2006-2#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-11#1)(2010-12#1)(2012-2#1)
some past##2##2##(2006-10#1)(2008-8#1)
some pathogenic##2##2##(1994-12#1)(2007-9#1)
some pathogens##3##2##(2005-11#1)(2008-10#1)(2012-12#1)
some pathological##2##2##(2008-1#1)(2010-12#1)
some pathophysiological##2##2##(2007-9#1)(2008-7#1)
some patients are##2##3##(2008-7#1)(2011-2#1)
some patients may##5##3##(2006-10#1)(2008-10#1)(2008-7#1)(2010-11#1)(2012-12#1)
some patients never##2##3##(2006-10#1)(2008-8#1)
some patients on intervention units with access to the electronic toolkit fell##2##12##(2013-1#2)
some patients suffering from##2##4##(1994-2#1)(2012-12#1)
some patients the##2##3##(1992-8#1)(2011-2#1)
some patients who##3##3##(1992-3#1)(2007-11#1)(2010-3#1)
some patients will##2##3##(2006-5#1)(2011-1#1)
some patients with acute##3##4##(2007-11#1)(2007-9#1)(2010-12#1)
some patients with refractory##2##4##(2007-11#1)(2013-1#1)
some patients with##34##3##(1990-4#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-11#2)(1994-3#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-10#1)(2006-10#3)(2006-6#1)(2006-7#1)(2007-11#5)(2007-9#2)(2008-1#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
some patients##134##2##(1990-3#1)(1990-4#1)(1991-1#2)(1991-2#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-11#3)(1994-2#1)(1994-3#1)(1995-12#1)(1995-9#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#2)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#1)(2004-10#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#3)(2006-10#12)(2006-12#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#12)(2007-3#1)(2007-4#1)(2007-7#4)(2007-8#2)(2007-9#4)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
some patterns##2##2##(1990-12#1)(2013-1#1)
some peculiarities of##2##3##(2008-2#1)(2008-3#1)
some peculiarities##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
some people are##2##3##(2006-12#1)(2008-2#1)
some people develop##2##3##(1994-4#1)(1996-2#1)
some people##12##2##(1993-3#1)(1993-9#1)(1994-4#1)(1996-2#1)(1997-6#1)(2006-12#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-12#1)(2013-8#1)
some peptides##4##2##(1991-3#1)(2005-11#1)(2007-11#1)(2010-10#1)
some peripheral##2##2##(1992-6#1)(1995-12#1)
some persistent##3##2##(1994-3#1)(1996-3#1)(2008-7#1)
some perspective on the##2##4##(2008-4#1)(2009-4#1)
some perspectives##2##2##(2012-12#1)(2012-2#1)
some pesticides##2##2##(1997-8#1)(2010-9#1)
some pharmaceutical formulations##3##3##(2008-10#2)(2011-1#1)
some pharmaceutical preparations##2##3##(2006-6#1)(2008-11#1)
some pharmaceutical products##3##3##(2007-2#2)(2008-10#1)
some pharmaceutical##11##2##(2006-6#1)(2007-2#2)(2008-10#6)(2008-11#1)(2011-1#1)
some pharmacological##3##2##(1992-10#1)(2008-4#1)(2008-5#1)
some phenotypic##2##2##(1996-11#1)(2012-3#1)
some physical properties##2##3##(1995-8#1)(2006-10#1)
some physical##9##2##(1992-6#1)(1995-8#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)
some physicians##4##2##(1993-1#1)(1995-8#1)(2008-4#1)(2013-7#1)
some physicochemical conditions##2##3##(2013-7#2)
some physicochemical##5##2##(2004-8#1)(2007-11#1)(2009-3#1)(2013-7#2)
some physiological growth parameters##2##4##(2008-12#2)
some physiological parameters##2##3##(2008-12#2)
some physiological##9##2##(1996-6#1)(1997-4#1)(2008-12#5)(2008-7#1)(2012-2#1)
some pigments##2##2##(2008-10#2)
some plant growth##2##3##(2008-10#1)(2013-1#1)
some plant##5##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2013-1#1)
some plants##8##2##(2006-12#1)(2008-10#5)(2011-12#1)(2013-1#1)
some point in##5##3##(2007-11#1)(2007-3#1)(2008-9#1)(2009-5#1)(2013-1#1)
some point##11##2##(1990-11#1)(1991-12#1)(2006-11#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-9#1)(2009-5#2)(2013-1#2)
some points##3##2##(2007-8#1)(2008-7#1)(2009-5#1)
some polymeric##3##2##(2008-10#1)(2008-11#2)
some populations##7##2##(1996-3#1)(2006-10#1)(2008-1#1)(2010-11#2)(2011-2#1)(2012-1#1)
some positions##2##2##(1995-9#1)(2008-3#1)
some positive##4##2##(1991-4#1)(2008-1#1)(2010-2#1)(2013-1#1)
some possible applications##2##3##(2006-4#1)(2008-2#1)
some possible##10##2##(1990-12#1)(1992-12#1)(1994-3#1)(2006-4#1)(2007-1#1)(2008-2#2)(2008-3#1)(2008-6#1)(2009-8#1)
some potential for##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
some potential##14##2##(1994-8#1)(2005-8#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-1#1)
some potentially##2##2##(2006-12#1)(2006-5#1)
some power##2##2##(2006-5#1)(2011-2#1)
some practical advice##2##3##(1992-12#1)(2008-1#1)
some practical considerations##2##3##(1994-6#1)(1995-5#1)
some practical guidance##2##3##(2007-7#1)(2013-8#1)
some practical##14##2##(1992-12#1)(1992-5#1)(1993-2#1)(1994-6#1)(1995-1#1)(1995-5#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-11#1)(2009-2#1)(2013-1#1)(2013-8#2)
some practitioners##2##2##(2007-11#1)(2008-5#1)
some precautions##2##2##(2006-9#1)(2011-2#1)
some precious##2##2##(2006-12#1)(2008-10#1)
some preliminary data##2##3##(1995-12#1)(2011-2#1)
some preliminary results##3##3##(1996-4#1)(2008-2#1)(2009-3#1)
some preliminary##8##2##(1995-12#1)(1996-4#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-3#1)(2011-2#1)(2012-2#1)
some preparations##3##2##(1991-7#1)(1993-9#1)(2008-4#1)
some prepubertal children with idiopathic growth hormone deficiency##2##8##(2007-11#2)
some previous reports##3##3##(1991-3#1)(1991-8#1)(2006-10#1)
some previous studies##2##3##(2008-11#1)(2008-9#1)
some previous##9##2##(1991-3#1)(1991-8#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#2)(2012-1#1)
some previously##8##2##(1994-11#1)(1997-5#1)(2006-9#1)(2007-11#2)(2007-9#1)(2008-2#1)(2013-1#1)
some primary##4##2##(2006-6#1)(2007-11#1)(2007-2#1)(2009-5#1)
some primates##2##2##(2010-4#1)(2011-2#1)
some prior##3##2##(1991-12#1)(2008-10#1)(2008-8#1)
some problem##2##2##(1992-8#1)(1997-2#1)
some problems and##2##3##(1992-3#1)(2007-4#1)
some problems in##7##3##(2008-10#2)(2010-12#2)(2011-12#1)(2013-1#2)
some problems with##4##3##(2006-11#1)(2007-5#1)(2007-6#2)
some problems##17##2##(1991-10#1)(1992-11#1)(1992-3#1)(2006-11#1)(2007-4#1)(2007-5#1)(2007-6#2)(2008-10#2)(2008-4#1)(2010-12#2)(2011-12#1)(2012-2#1)(2013-1#2)
some procedures##5##2##(1991-10#1)(1992-6#1)(1997-7#1)(2006-2#1)(2009-8#1)
some processes##2##2##(1993-4#1)(2010-4#1)
some products##5##2##(1995-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
some progress has been made##2##5##(2006-10#1)(2011-1#1)
some promise in##3##3##(2010-12#1)(2010-7#1)(2012-3#1)
some promise##8##2##(1994-3#1)(2005-7#1)(2009-4#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
some promising##6##2##(1991-10#1)(1992-3#1)(2008-5#1)(2011-3#1)(2012-2#2)
some proof that the##2##4##(1996-12#1)(2008-9#1)
some properties of the##4##4##(1991-5#1)(2007-11#1)(2008-11#1)(2008-2#1)
some properties of##8##3##(1990-7#1)(1991-5#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)
some properties with##2##3##(1990-7#1)(1996-2#1)
some properties##15##2##(1990-6#1)(1990-7#2)(1991-5#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
some protection against##4##3##(1996-4#1)(1997-6#1)(2006-12#1)(2010-8#1)
some protective##3##2##(1992-12#1)(1993-5#1)(2010-2#1)
some protein##7##2##(1996-8#1)(2007-6#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2010-2#1)
some proteins involved in##2##4##(1995-6#1)(2007-6#1)
some proteins##9##2##(1993-11#1)(1995-6#1)(2007-6#1)(2007-8#1)(2008-10#3)(2009-9#1)(2013-1#1)
some protocols##2##2##(2008-4#1)(2008-6#1)
some psychiatric disorders##3##3##(1995-11#1)(2008-4#1)(2008-5#1)
some psychiatric##6##2##(1995-11#1)(1996-5#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#1)
some psychological##4##2##(2008-11#1)(2008-12#1)(2010-8#1)(2011-2#1)
some public##2##2##(2007-2#1)(2012-12#1)
some publications##2##2##(2006-6#1)(2007-8#1)
some published##2##2##(2009-2#1)(2009-6#1)
some purposes##2##2##(1997-8#1)(2008-1#1)
some putative##4##2##(1993-7#1)(1996-9#1)(2008-7#1)(2009-10#1)
some pyramidal cells##2##3##(1996-3#1)(1997-3#1)
some qualitative##2##2##(2008-2#1)(2008-8#1)
some questions##8##2##(1992-2#1)(1993-6#1)(2004-10#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-5#1)(2013-1#1)
some rare cases##3##3##(1990-1#1)(1993-3#1)(2008-9#1)
some rare##4##2##(1990-1#1)(1993-3#1)(2006-6#1)(2008-9#1)
some rays##2##2##(1990-6#1)(1995-3#1)
some reactions##2##2##(2007-11#1)(2008-11#1)
some real cases##2##3##(2008-10#1)(2008-2#1)
some real##4##2##(2008-10#1)(2008-2#2)(2012-12#1)
some recent advances##2##3##(2009-12#1)(2011-2#1)
some recent developments##4##3##(1991-2#1)(2008-10#1)(2009-10#1)(2011-2#1)
some recent results##2##3##(2008-10#2)
some recent##31##2##(1991-12#1)(1991-2#1)(1996-6#1)(1997-3#1)(2004-3#1)(2005-8#1)(2005-9#1)(2006-11#1)(2006-6#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-6#1)(2008-8#2)(2009-10#2)(2009-11#1)(2009-12#1)(2010-7#1)(2011-2#3)(2012-2#1)
some recently synthesized##4##3##(2008-10#4)
some recommendations for##3##3##(1994-6#1)(2007-12#1)(2008-11#1)
some recommendations##5##2##(1994-6#1)(1997-4#1)(2007-12#2)(2008-11#1)
some recovery of##3##3##(1992-10#1)(1997-5#1)(2008-9#1)
some reduction in##2##3##(1991-8#1)(2008-6#1)
some regions of the##2##4##(1994-2#1)(2009-12#1)
some regions of##3##3##(1994-2#1)(2007-7#1)(2009-12#1)
some regions##7##2##(1990-5#1)(1994-2#1)(2007-7#1)(2008-2#1)(2008-8#1)(2009-12#1)(2011-2#1)
some related##5##2##(1993-6#1)(1995-4#1)(1997-2#1)(2008-10#1)(2010-7#1)
some relation to##2##3##(1992-8#1)(2008-7#1)
some relationship between the##2##4##(1993-8#1)(1994-3#1)
some relationships##2##2##(1997-6#1)(2008-12#1)
some relative##2##2##(2008-2#1)(2008-3#1)
some relevant##6##2##(1996-3#1)(1997-1#1)(2006-2#1)(2008-11#1)(2009-2#1)(2012-2#1)
some relief from##2##3##(2008-5#1)(2011-3#1)
some relief##4##2##(2006-12#1)(2008-11#1)(2008-5#1)(2011-3#1)
some remaining##3##2##(1993-3#1)(1995-5#1)(1997-4#1)
some remarks##2##2##(2007-8#1)(2008-2#1)
some renal corpuscles##2##3##(2008-8#2)
some renal##4##2##(2008-12#1)(2008-8#2)(2011-2#1)
some reported##4##2##(1991-8#1)(1993-2#1)(2008-5#1)(2011-1#1)
some reports##9##2##(1993-3#1)(1997-8#1)(2005-3#1)(2008-1#1)(2008-7#1)(2009-2#1)(2010-12#1)(2010-3#1)(2013-1#1)
some representative examples##2##3##(1997-6#1)(2006-12#1)
some representative##6##2##(1997-6#1)(2006-12#1)(2007-11#1)(2008-3#2)(2008-8#1)
some reproductive characteristics of##2##4##(2008-5#2)
some require##3##2##(1996-2#1)(2008-7#1)(2009-11#1)
some research##5##2##(1991-2#1)(2008-5#1)(2010-11#1)(2010-7#1)(2013-8#1)
some researchers have##2##3##(1996-11#1)(2012-12#1)
some researchers to##2##3##(1995-1#1)(2010-5#1)
some researchers##7##2##(1995-1#1)(1996-11#1)(2007-8#1)(2010-5#1)(2011-12#1)(2012-12#1)(2012-2#1)
some residual##8##2##(1993-2#1)(1995-8#1)(1996-11#1)(2006-6#1)(2007-3#1)(2008-11#1)(2012-12#2)
some residues##3##2##(1990-12#1)(1990-9#1)(2008-9#1)
some resistance to##2##3##(1996-7#1)(2008-12#1)
some resistant##2##2##(2008-10#2)
some respects##4##2##(2006-5#1)(2006-9#1)(2008-3#1)(2010-8#1)
some results of##5##3##(2006-6#1)(2008-10#1)(2009-8#1)(2013-1#2)
some results##10##2##(1996-5#1)(1997-6#1)(2006-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2013-1#2)
some risk factors##4##3##(2007-11#1)(2008-1#1)(2011-11#1)(2013-8#1)
some risk##9##2##(1995-11#1)(2006-12#1)(2007-11#1)(2008-1#1)(2009-4#1)(2010-2#1)(2011-11#1)(2012-12#1)(2013-8#1)
some risks##2##2##(2007-11#1)(2008-5#1)
some role in the##4##4##(2006-4#1)(2007-12#1)(2008-7#1)(2012-12#1)
some role in##8##3##(1990-7#1)(1993-7#1)(2006-4#1)(2007-12#1)(2008-7#2)(2008-8#1)(2012-12#1)
some role##9##2##(1990-7#1)(1993-7#1)(2006-4#1)(2007-12#1)(2007-2#1)(2008-7#2)(2008-8#1)(2012-12#1)
some roles##2##2##(1992-12#1)(1994-3#1)
some rural areas##2##3##(1991-6#1)(2013-1#1)
some rural##4##2##(1991-6#1)(1993-6#1)(2012-1#1)(2013-1#1)
some samples with##3##3##(2007-8#1)(2008-10#2)
some samples##14##2##(1993-1#1)(1994-2#1)(2007-8#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2011-2#1)
some scatter##2##2##(1992-6#1)(2008-2#1)
some schizophrenic##2##2##(1995-11#1)(2007-8#1)
some scientific##3##2##(1994-8#1)(2010-12#1)(2013-8#1)
some scientists##2##2##(2007-9#1)(2008-10#1)
some secondary##2##2##(1994-9#1)(2010-8#1)
some sections##2##2##(2006-10#1)(2008-3#1)
some seeds##2##2##(2008-5#1)(2013-1#1)
some selected##12##2##(2006-4#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-5#2)(2009-7#1)(2011-12#1)(2011-2#2)(2012-2#1)
some selective##2##2##(2007-4#1)(2013-1#1)
some selectivity##3##2##(2005-8#1)(2008-10#1)(2008-5#1)
some sense##5##2##(1991-10#1)(2006-12#1)(2008-2#1)(2010-2#1)(2011-12#1)
some sensory##2##2##(1996-3#1)(2011-2#1)
some sequence##4##2##(1994-2#1)(1995-8#1)(2008-10#1)(2008-8#1)
some sequences##2##2##(1995-4#1)(1997-3#1)
some series##2##2##(2010-12#1)(2011-2#1)
some serious##2##2##(1995-1#1)(2005-7#1)
some serotypes not included in##2##5##(2012-12#2)
some short##2##2##(2011-3#1)(2013-1#1)
some shortcomings of##2##3##(2012-3#1)(2013-1#1)
some shortcomings##4##2##(1996-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
some showed##2##2##(1990-5#1)(2010-1#1)
some showing##2##2##(2005-8#1)(2006-10#1)
some side effects in##2##4##(1996-5#1)(2008-10#1)
some side##3##2##(1996-5#1)(2006-11#1)(2008-10#1)
some side-effects##2##2##(1991-4#1)(2008-5#1)
some significant differences##5##3##(1994-5#1)(1995-2#1)(1997-5#1)(2008-6#1)(2011-1#1)
some significant##10##2##(1994-5#1)(1995-2#2)(1995-6#1)(1997-5#1)(2007-5#1)(2008-6#1)(2011-1#2)(2012-12#1)
some similar##2##2##(2007-4#1)(2008-10#1)
some similarities to known genes##3##5##(1995-8#1)(1996-10#1)(1996-2#1)
some similarities to the##2##4##(1992-12#1)(1997-7#1)
some similarities to##6##3##(1992-12#1)(1993-8#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-7#1)
some similarities##9##2##(1991-1#1)(1992-12#1)(1993-8#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-7#1)(2008-10#1)(2011-1#1)
some similarity with##2##3##(1997-7#1)(2008-5#1)
some similarity##3##2##(1992-8#1)(1997-7#1)(2008-5#1)
some simple models##2##3##(1996-1#1)(2008-8#1)
some simple##10##2##(1995-12#1)(1995-5#1)(1996-1#2)(1996-2#1)(1997-4#1)(2008-2#1)(2008-3#2)(2008-8#1)
some sites##2##2##(1993-3#1)(1994-2#1)
some situations in which the##2##5##(2006-8#1)(2013-1#1)
some situations##17##2##(1991-12#1)(1993-6#1)(1997-6#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
some skin##3##2##(1992-6#1)(2012-12#1)(2013-1#1)
some small##9##2##(1990-6#1)(1991-8#1)(1993-12#1)(1994-6#1)(1997-6#1)(2007-8#1)(2008-4#1)(2008-8#1)(2008-9#1)
some smaller##2##2##(1995-2#1)(2008-11#1)
some social##2##2##(2009-7#2)
some soils##2##2##(2008-10#2)
some solid##4##2##(1992-9#1)(2006-6#1)(2008-12#1)(2012-12#1)
some solutions##3##2##(2006-9#1)(2009-4#1)(2013-8#1)
some sort of##5##3##(1996-9#1)(2008-1#1)(2008-3#2)(2012-12#1)
some sort##6##2##(1996-9#1)(2008-1#1)(2008-10#1)(2008-3#2)(2012-12#1)
some special##6##2##(2006-10#1)(2006-6#1)(2008-5#2)(2010-2#1)(2012-3#1)
some specialized##2##2##(2006-8#1)(2008-9#1)
some species are##2##3##(1990-7#1)(2009-6#1)
some species of##14##3##(1991-11#1)(1993-9#1)(1995-3#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-8#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-7#1)
some species##30##2##(1990-7#1)(1991-11#1)(1993-9#1)(1995-12#1)(1995-3#2)(2004-4#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#3)(2009-6#1)(2009-9#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-7#1)
some specific activities##2##3##(2008-4#1)(2008-9#1)
some specific problems##2##3##(2006-9#2)
some specific sequence of the##2##5##(1992-11#1)(1993-12#1)
some specific##32##2##(1990-6#1)(1992-10#1)(1992-11#1)(1993-12#1)(1994-2#1)(1995-11#1)(1995-9#1)(1996-12#1)(1996-6#1)(2005-7#1)(2006-7#1)(2006-9#2)(2007-11#1)(2007-3#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-2#2)
some specificity##3##2##(1994-2#1)(1994-8#1)(1995-12#1)
some stage##4##2##(2005-7#1)(2006-10#1)(2007-3#1)(2007-8#1)
some standard##9##2##(2008-10#3)(2008-2#2)(2008-4#1)(2013-1#3)
some states##4##2##(1993-12#1)(1993-2#1)(1993-3#1)(2007-11#1)
some steps##3##2##(1992-12#1)(1994-8#1)(2011-2#1)
some still##3##2##(1991-7#1)(2006-10#1)(2008-11#1)
some stimuli##2##2##(2004-11#1)(2012-12#1)
some strains of##9##3##(1991-12#1)(1994-11#1)(1995-1#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)
some strains##18##2##(1991-12#1)(1991-3#1)(1994-11#1)(1995-1#1)(1995-8#1)(2006-5#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2012-3#1)
some strategic##2##2##(1992-8#1)(1993-2#1)
some strategies##3##2##(1991-1#1)(2008-10#1)(2009-4#1)
some striking##2##2##(1996-4#1)(1996-6#1)
some structural similarities to##2##4##(2008-8#1)(2009-4#1)
some structural##9##2##(1994-12#1)(1995-3#1)(2006-10#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-7#1)(2012-2#1)
some structures##2##2##(1996-1#1)(2007-4#1)
some students##2##2##(2008-11#1)(2012-3#1)
some studies have demonstrated that##2##5##(2006-10#1)(2011-1#1)
some studies have##7##3##(1990-5#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#1)(2011-1#1)
some studies indicate that##4##4##(1997-7#1)(2006-10#1)(2011-2#1)(2013-1#1)
some studies may##2##3##(2008-1#1)(2012-2#1)
some studies suggest that##2##4##(2006-9#1)(2009-12#1)
some studies##31##2##(1990-5#1)(1991-10#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-10#2)(2006-12#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#3)(2009-12#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-2#3)(2013-1#1)
some subjects##8##2##(1990-3#1)(1991-8#1)(1993-5#1)(1994-3#1)(1995-5#1)(2005-11#1)(2006-8#1)(2009-4#1)
some substrates##3##2##(1995-1#1)(2008-10#1)(2010-2#1)
some success in##7##3##(1993-2#1)(2008-1#2)(2008-11#1)(2008-8#1)(2012-12#2)
some success##12##2##(1991-9#1)(1993-2#1)(2005-10#1)(2008-1#2)(2008-11#1)(2008-8#1)(2009-5#1)(2010-6#1)(2012-12#2)(2012-3#1)
some such##4##2##(1996-4#1)(2013-1#2)(2013-8#1)
some suggestions for##4##3##(1991-2#1)(2006-11#1)(2007-7#1)(2008-5#1)
some suggestions##9##2##(1991-2#1)(1992-9#1)(1994-6#1)(2004-10#1)(2006-11#1)(2007-7#1)(2008-1#1)(2008-5#1)(2012-3#1)
some support for the##4##4##(1991-12#1)(2007-1#1)(2011-1#2)
some support for##7##3##(1991-12#1)(2007-1#1)(2009-10#1)(2010-4#1)(2011-1#2)(2013-1#1)
some support to the##2##4##(1997-8#1)(2007-1#1)
some support##9##2##(1991-12#1)(1997-8#1)(2007-1#2)(2009-10#1)(2010-4#1)(2011-1#2)(2013-1#1)
some supporting##2##2##(1995-5#1)(2010-7#1)
some surfactants##2##2##(2008-10#2)
some surgical##4##2##(2006-6#1)(2008-4#1)(2009-7#1)(2010-12#1)
some symptoms of##2##3##(1993-1#1)(2012-12#1)
some symptoms##5##2##(1992-10#1)(1993-1#1)(2008-6#1)(2011-2#1)(2012-12#1)
some synthetic mixtures##3##3##(2008-10#3)
some synthetic##5##2##(2008-10#5)
some systems##4##2##(1990-12#2)(2008-10#1)(2013-8#1)
some taxonomic##2##2##(2008-6#1)(2011-2#1)
some technical##3##2##(1994-6#1)(1996-3#1)(2006-8#1)
some ten years ago##2##4##(1990-6#1)(2007-1#1)
some ten##4##2##(1990-6#1)(1997-4#1)(2007-1#1)(2007-12#1)
some tens of##2##3##(2008-3#1)(2008-7#1)
some tens##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
some test##3##2##(1993-9#1)(2006-8#1)(2008-2#1)
some tests##3##2##(2007-9#1)(2008-10#1)(2008-11#1)
some that##4##2##(1995-2#1)(2006-11#1)(2006-6#1)(2007-4#1)
some theoretical##5##2##(1990-12#1)(1993-10#1)(1994-6#1)(2008-10#1)(2008-4#1)
some theories##2##2##(1994-12#1)(2008-12#1)
some therapeutic##3##2##(1991-12#1)(2006-11#1)(2008-12#1)
some thoughts on##3##3##(2008-6#1)(2010-11#1)(2011-1#1)
some thoughts##5##2##(2008-2#1)(2008-6#1)(2010-11#2)(2011-1#1)
some time after##3##3##(1997-3#1)(2008-10#1)(2011-2#1)
some time and##2##3##(1995-9#1)(1996-11#1)
some time during their##2##4##(2007-7#1)(2008-5#1)
some time during##3##3##(2007-11#1)(2007-7#1)(2008-5#1)
some time in##3##3##(1992-3#1)(1997-1#1)(2010-1#1)
some time to##5##3##(1995-12#1)(2004-10#1)(2006-10#1)(2007-8#1)(2009-6#1)
some time##49##2##(1990-5#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-4#1)(1995-12#1)(1995-9#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-3#1)(2004-10#1)(2005-10#1)(2005-7#1)(2006-10#2)(2007-11#3)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-6#1)(2010-1#1)(2010-10#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)
some tissue structures that are not perceptible##2##7##(2007-12#1)(2008-3#1)
some tissue##3##2##(2007-12#1)(2008-3#1)(2008-7#1)
some tissues of##2##3##(2008-12#2)
some tissues##5##2##(1992-9#1)(1995-10#1)(1996-12#1)(2008-12#2)
some to##3##2##(1997-3#1)(2007-2#1)(2011-2#1)
some tools##2##2##(2010-11#1)(2012-3#1)
some topological##2##2##(2007-11#1)(2008-7#1)
some trace elements##4##3##(2008-10#3)(2010-12#1)
some transcriptional##2##2##(1996-4#1)(2008-9#1)
some transition metal ions##3##4##(2008-10#3)
some transition metals##3##3##(2008-10#3)
some transition##8##2##(1996-7#1)(2008-10#7)
some treatment##2##2##(2005-7#1)(2008-7#1)
some treatments##3##2##(2008-12#1)(2008-5#1)(2008-8#1)
some trophic##2##2##(2008-1#1)(2008-5#1)
some tumor cell lines were##2##5##(1991-2#1)(1995-3#1)
some tumor cell lines##3##4##(1991-2#1)(1995-3#1)(2008-8#1)
some tumor cells##2##3##(1990-10#1)(1995-3#1)
some tumor##11##2##(1990-10#1)(1991-2#1)(1992-2#1)(1995-3#2)(1996-4#1)(2007-11#2)(2007-9#1)(2008-8#1)(2013-1#1)
some tumors and##2##3##(1991-12#1)(1993-8#1)
some tumors##9##2##(1991-12#1)(1993-7#1)(1993-8#1)(1996-4#2)(2007-2#1)(2008-9#1)(2010-3#1)(2012-12#1)
some type of##12##3##(1991-4#1)(1992-12#1)(1993-10#1)(2005-5#1)(2006-10#1)(2007-1#1)(2008-10#2)(2008-12#1)(2009-8#1)(2009-9#1)(2013-1#1)
some types of samples##2##4##(2008-10#2)
some types of##23##3##(1990-4#1)(1994-3#1)(1995-8#1)(2007-11#2)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-2#1)(2011-2#1)(2011-3#1)
some types##24##2##(1990-4#1)(1994-3#1)(1995-8#1)(2007-11#2)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-2#1)(2011-2#2)(2011-3#1)
some typical##8##2##(1995-6#1)(1996-5#1)(2007-11#2)(2008-10#2)(2009-10#1)(2012-12#1)
some uncertainties##2##2##(1995-1#1)(2008-10#1)
some uncertainty##3##2##(1996-11#1)(2007-11#1)(2008-10#1)
some understanding of the##2##4##(1992-1#1)(2008-9#1)
some unexpected##4##2##(1993-11#1)(2005-11#1)(2008-8#1)(2010-8#1)
some unique##4##2##(1990-5#1)(2007-4#1)(2008-10#1)(2009-8#1)
some unresolved##3##2##(1996-1#1)(2011-3#1)(2013-7#1)
some unusual##4##2##(2007-7#1)(2008-10#1)(2008-11#1)(2009-2#1)
some urban##2##2##(1992-6#1)(2008-1#1)
some useful##6##2##(1994-3#1)(1997-3#1)(1997-4#1)(2008-11#1)(2009-10#1)(2012-3#1)
some users##2##2##(1991-3#1)(2009-5#1)
some utility in the##2##4##(2008-5#1)(2011-2#1)
some vaccines##2##2##(2006-10#1)(2013-1#1)
some valuable##4##2##(2008-5#1)(2009-10#1)(2012-1#1)(2013-8#1)
some variability##3##2##(1997-6#1)(2008-9#2)
some variables##4##2##(2008-10#1)(2008-8#1)(2011-1#1)(2012-12#1)
some variation in##4##3##(1996-1#1)(2009-4#2)(2011-2#1)
some variation was##2##3##(1997-7#1)(2008-10#1)
some variation##8##2##(1996-1#1)(1997-7#1)(2008-10#2)(2009-4#2)(2011-1#1)(2011-2#1)
some variations in the##2##4##(1994-7#1)(2008-3#1)
some variations in##4##3##(1994-3#1)(1994-7#1)(2008-3#1)(2008-7#1)
some variations##7##2##(1994-3#1)(1994-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
some vascular##2##2##(2008-6#1)(2010-12#1)
some very interesting##2##3##(2012-2#2)
some very small##2##3##(2008-10#1)(2011-1#1)
some very##8##2##(1991-1#1)(1993-12#1)(2007-9#1)(2008-10#1)(2011-1#1)(2012-2#2)(2013-8#1)
some viral##2##2##(1997-4#1)(2008-11#1)
some viruses##5##2##(2008-10#1)(2008-11#2)(2010-1#1)(2013-8#1)
some visual##2##2##(1993-12#1)(2011-2#1)
some volunteers##2##2##(2008-9#1)(2010-4#1)
some water##2##2##(1997-1#1)(2008-10#1)
some way to##2##3##(1994-6#1)(2008-8#1)
some way##11##2##(1990-4#1)(1991-6#1)(1994-6#1)(1994-8#1)(2007-9#1)(2008-11#1)(2008-8#1)(2009-3#1)(2009-7#1)(2009-9#1)(2011-2#1)
some ways##6##2##(1990-6#1)(1991-2#1)(1997-8#1)(2007-4#1)(2012-12#1)(2012-3#1)
some weeks##5##2##(1991-3#1)(1991-8#1)(1994-4#1)(1996-9#1)(1997-6#1)
some weight##2##2##(1992-8#1)(2010-1#1)
some well known##3##3##(1996-1#1)(2008-10#1)(2009-5#1)
some well##4##2##(1996-1#1)(2008-10#2)(2009-5#1)
some well-known##3##2##(1993-3#1)(2008-2#1)(2009-2#1)
some were even##2##3##(2008-3#1)(2008-9#1)
some were found##2##3##(1995-11#1)(2010-10#1)
some were not##2##3##(1994-12#1)(1997-2#1)
some were##11##2##(1990-10#1)(1994-12#1)(1995-11#2)(1995-4#1)(1997-2#1)(1997-3#1)(2008-3#1)(2008-9#1)(2010-10#1)(2011-1#1)
some western##2##2##(2006-2#1)(2007-10#1)
some what##3##2##(1990-5#1)(2007-8#1)(2008-8#1)
some who are##2##3##(2008-12#1)(2009-10#1)
some who##5##2##(2007-2#2)(2008-12#1)(2009-10#1)(2012-12#1)
some with##5##2##(2006-8#1)(2007-11#1)(2008-11#1)(2009-2#1)(2013-1#1)
some women with##2##3##(2007-1#1)(2010-10#1)
some women##8##2##(1990-6#1)(1994-9#1)(2007-1#1)(2007-3#1)(2007-9#1)(2010-10#1)(2010-12#1)(2010-2#1)
some work##2##2##(2007-4#1)(2007-8#1)
some would##2##2##(2008-10#1)(2008-2#1)
some years after##2##3##(2006-6#1)(2011-2#1)
some years later##2##3##(1997-5#1)(2007-11#1)
some years##11##2##(1993-10#1)(1996-2#1)(1997-5#1)(2006-6#1)(2007-11#1)(2008-10#4)(2008-3#1)(2011-2#1)
some young##2##2##(2006-7#1)(2009-5#1)
some##7315##1##(1990-1#4)(1990-10#9)(1990-11#20)(1990-12#31)(1990-2#18)(1990-3#14)(1990-4#22)(1990-5#26)(1990-6#19)(1990-7#18)(1990-8#18)(1990-9#8)(1991-1#16)(1991-10#10)(1991-11#27)(1991-12#51)(1991-2#24)(1991-3#22)(1991-4#20)(1991-5#15)(1991-6#14)(1991-7#9)(1991-8#17)(1991-9#16)(1992-1#16)(1992-10#12)(1992-11#18)(1992-12#27)(1992-2#28)(1992-3#35)(1992-4#8)(1992-5#9)(1992-6#25)(1992-7#13)(1992-8#20)(1992-9#21)(1993-1#16)(1993-10#8)(1993-11#28)(1993-12#47)(1993-2#29)(1993-3#30)(1993-4#9)(1993-5#12)(1993-6#19)(1993-7#14)(1993-8#17)(1993-9#16)(1994-1#10)(1994-10#14)(1994-11#22)(1994-12#28)(1994-2#31)(1994-3#33)(1994-4#7)(1994-5#12)(1994-6#30)(1994-7#2)(1994-8#22)(1994-9#26)(1995-1#36)(1995-10#8)(1995-11#26)(1995-12#41)(1995-2#23)(1995-3#38)(1995-4#9)(1995-5#17)(1995-6#25)(1995-7#8)(1995-8#21)(1995-9#12)(1996-1#17)(1996-10#18)(1996-11#17)(1996-12#33)(1996-2#31)(1996-3#36)(1996-4#26)(1996-5#35)(1996-6#27)(1996-7#16)(1996-8#21)(1996-9#22)(1997-1#20)(1997-2#30)(1997-3#46)(1997-4#27)(1997-5#21)(1997-6#25)(1997-7#33)(1997-8#31)(1997-9#2)(2003-11#2)(2004-1#1)(2004-10#6)(2004-11#8)(2004-12#4)(2004-2#2)(2004-3#2)(2004-4#11)(2004-5#2)(2004-7#3)(2004-8#1)(2004-9#9)(2005-1#3)(2005-10#23)(2005-11#47)(2005-12#6)(2005-2#1)(2005-3#3)(2005-4#7)(2005-5#2)(2005-6#1)(2005-7#34)(2005-8#46)(2005-9#12)(2006-1#6)(2006-10#198)(2006-11#18)(2006-12#53)(2006-2#28)(2006-3#10)(2006-4#17)(2006-5#33)(2006-6#50)(2006-7#22)(2006-8#45)(2006-9#35)(2007-1#30)(2007-10#27)(2007-11#182)(2007-12#94)(2007-2#51)(2007-3#27)(2007-4#44)(2007-5#25)(2007-6#28)(2007-7#50)(2007-8#81)(2007-9#66)(2008-1#103)(2008-10#758)(2008-11#170)(2008-12#108)(2008-2#134)(2008-3#145)(2008-4#157)(2008-5#219)(2008-6#62)(2008-7#165)(2008-8#144)(2008-9#128)(2009-1#5)(2009-10#46)(2009-11#8)(2009-12#28)(2009-2#28)(2009-3#26)(2009-4#46)(2009-5#34)(2009-6#22)(2009-7#15)(2009-8#43)(2009-9#27)(2010-1#14)(2010-10#20)(2010-11#35)(2010-12#77)(2010-2#36)(2010-3#25)(2010-4#22)(2010-5#21)(2010-6#13)(2010-7#34)(2010-8#43)(2010-9#14)(2011-1#76)(2011-11#1)(2011-12#17)(2011-2#158)(2011-3#15)(2012-1#54)(2012-11#19)(2012-12#114)(2012-2#118)(2012-3#80)(2012-7#2)(2013-1#155)(2013-7#43)(2013-8#72)
some)##2##1##(2007-4#1)(2008-2#1)
someday##3##1##(1994-5#1)(2007-6#1)(2013-1#1)
somehow##3##1##(1990-5#1)(1995-11#1)(2008-10#1)
someone else##4##2##(1996-3#1)(2008-11#1)(2010-11#1)(2012-12#1)
someone has##2##2##(2005-9#1)(2006-10#1)
someone other than##2##3##(2010-8#1)(2013-8#1)
someone who drew an##2##4##(2012-1#2)
someone who is##2##3##(2007-7#1)(2008-1#1)
someone who##8##2##(2007-7#1)(2008-1#1)(2008-3#1)(2008-6#1)(2009-6#1)(2012-1#3)
someone##31##1##(1990-4#1)(1994-2#1)(1995-9#1)(1996-11#1)(1996-3#1)(2005-9#2)(2006-10#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#2)(2009-6#2)(2010-10#1)(2010-11#1)(2010-8#2)(2012-1#3)(2012-11#1)(2012-12#1)(2013-1#2)(2013-8#2)
something is##2##2##(1996-6#1)(2011-2#1)
something of##3##2##(1995-6#1)(2008-4#1)(2013-1#1)
something that was##2##3##(2007-10#1)(2008-12#1)
something that##5##2##(1996-2#1)(2007-10#1)(2007-3#1)(2008-12#1)(2008-5#1)
something to##3##2##(1996-11#1)(1997-2#1)(2008-7#1)
something##39##1##(1991-1#1)(1991-3#1)(1992-6#1)(1993-10#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-3#1)(2005-9#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-2#1)(2007-3#2)(2007-9#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-2#2)(2010-5#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)
sometime during the##2##3##(2007-2#1)(2008-10#1)
sometime during##3##2##(2006-8#1)(2007-2#1)(2008-10#1)
sometime##8##1##(1990-3#1)(1991-8#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-10#1)(2013-1#1)
sometimes a##4##2##(1997-3#1)(2007-11#1)(2008-7#1)(2012-12#1)
sometimes accompanied by##3##3##(1997-3#1)(2007-7#1)(2008-3#1)
sometimes also##4##2##(1997-4#1)(1997-8#1)(2005-8#1)(2011-2#1)
sometimes are##2##2##(2005-8#1)(2008-3#1)
sometimes as##2##2##(1994-12#1)(2006-2#1)
sometimes associated with##7##3##(1992-7#1)(2006-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2013-1#1)
sometimes be difficult##3##3##(1993-11#1)(2013-1#2)
sometimes be observed##3##3##(2006-10#1)(2007-2#1)(2013-1#1)
sometimes be##23##2##(1991-11#1)(1993-11#1)(1993-9#1)(1994-12#1)(1995-3#1)(1997-3#1)(2006-10#2)(2006-6#1)(2007-2#1)(2008-1#1)(2008-10#2)(2009-6#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#4)
sometimes been##3##2##(2008-3#1)(2008-7#1)(2008-8#1)
sometimes called##2##2##(2004-11#1)(2008-5#1)
sometimes combined with##2##3##(2007-11#1)(2011-1#1)
sometimes complex##2##2##(1997-7#1)(2005-8#1)
sometimes conflicting##2##2##(2008-4#1)(2009-5#1)
sometimes contradictory##3##2##(1996-12#1)(2012-2#2)
sometimes death##3##2##(2007-8#2)(2007-9#1)
sometimes delayed##2##2##(2006-10#1)(2007-12#1)
sometimes even in##2##3##(1991-3#1)(2012-1#1)
sometimes even the##2##3##(1994-1#1)(2005-8#1)
sometimes even##13##2##(1991-3#1)(1993-9#1)(1994-1#1)(1996-11#1)(2005-8#1)(2005-9#1)(2007-2#1)(2008-2#1)(2009-6#1)(2012-1#1)(2013-1#3)
sometimes fatal##5##2##(1997-4#1)(2004-11#1)(2006-5#1)(2008-11#1)(2012-2#1)
sometimes followed by##2##3##(2007-3#1)(2010-8#1)
sometimes for##3##2##(2007-7#2)(2007-9#1)
sometimes found in##3##3##(1995-1#1)(2007-3#1)(2007-8#1)
sometimes found##4##2##(1995-1#1)(2004-4#1)(2007-3#1)(2007-8#1)
sometimes from##2##2##(1997-4#1)(2008-10#1)
sometimes in the##4##3##(2007-7#1)(2010-1#1)(2012-12#2)
sometimes in##7##2##(1995-12#1)(2007-7#1)(2010-1#1)(2010-2#1)(2011-2#1)(2012-12#2)
sometimes it is##3##3##(1990-3#1)(1990-5#1)(2012-3#1)
sometimes it##4##2##(1990-3#1)(1990-5#1)(2006-12#1)(2012-3#1)
sometimes leads to##2##3##(2007-2#1)(2011-12#1)
sometimes led to##2##3##(2008-7#1)(2012-2#1)
sometimes limited##3##2##(1994-1#1)(2007-9#1)(2010-12#1)
sometimes present##2##2##(2010-3#1)(2010-9#1)
sometimes refer##2##2##(1994-2#1)(2007-2#1)
sometimes referred to as##5##4##(2006-10#1)(2007-11#1)(2007-4#1)(2008-10#1)(2011-2#1)
sometimes serious##2##2##(2009-6#1)(2012-2#1)
sometimes severely##2##2##(2008-10#2)
sometimes subtle##4##2##(1991-12#1)(2006-5#1)(2007-6#1)(2011-1#1)
sometimes termed##2##2##(2006-8#1)(2012-2#1)
sometimes the epidermis instructs the amnioserosa##2##6##(2012-12#2)
sometimes the##12##2##(1991-6#1)(1994-6#1)(2006-10#1)(2007-6#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-4#1)(2012-12#2)
sometimes this##2##2##(2012-2#2)
sometimes treated##2##2##(2008-8#1)(2008-9#1)
sometimes uses##2##2##(2007-5#1)(2008-2#1)
sometimes very##2##2##(2007-9#1)(2011-2#1)
sometimes were##2##2##(2008-10#2)
sometimes with##7##2##(1993-10#1)(1996-9#1)(2007-7#1)(2008-8#1)(2009-10#1)(2012-1#1)(2012-2#1)
sometimes within##2##2##(2011-12#1)(2011-2#1)
sometimes yielded##2##2##(1995-8#1)(1997-5#1)
sometimes##402##1##(1990-3#3)(1990-4#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-3#4)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#3)(1994-1#3)(1994-12#5)(1994-2#2)(1994-6#2)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#4)(1996-2#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-4#3)(1997-5#3)(1997-7#3)(1997-8#2)(2004-11#2)(2004-4#1)(2005-11#1)(2005-2#1)(2005-3#1)(2005-7#2)(2005-8#4)(2005-9#3)(2006-1#1)(2006-10#9)(2006-11#1)(2006-12#4)(2006-2#2)(2006-4#1)(2006-5#2)(2006-6#2)(2006-8#5)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#9)(2007-12#4)(2007-2#7)(2007-3#5)(2007-4#1)(2007-5#2)(2007-6#4)(2007-7#7)(2007-8#6)(2007-9#7)(2008-1#6)(2008-10#28)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#6)(2008-4#5)(2008-5#15)(2008-6#1)(2008-7#14)(2008-8#10)(2008-9#5)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#6)(2009-7#1)(2009-8#2)(2010-1#2)(2010-10#1)(2010-12#5)(2010-2#2)(2010-3#2)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-12#3)(2011-2#18)(2012-1#7)(2012-11#2)(2012-12#7)(2012-2#16)(2012-3#5)(2013-1#20)
somewhat better##2##2##(1994-11#1)(2008-6#1)
somewhat between##3##2##(2006-10#1)(2007-12#1)(2013-1#1)
somewhat controversial##2##2##(2006-9#1)(2009-3#1)
somewhat different from##2##3##(1994-9#1)(1995-6#1)
somewhat different than##2##3##(1997-1#1)(2008-2#1)
somewhat different##15##2##(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-6#1)(1997-1#1)(2006-8#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-5#1)(2010-6#1)(2013-1#1)
somewhat from that##2##3##(1991-5#1)(1995-12#1)
somewhat from##3##2##(1991-5#1)(1995-12#1)(2008-3#1)
somewhat greater##6##2##(1992-5#1)(1994-11#1)(1996-4#1)(2007-11#1)(2008-10#1)(2013-7#1)
somewhat higher than that of##2##5##(2007-11#1)(2008-10#1)
somewhat higher than that##3##4##(2007-11#1)(2008-10#1)(2008-2#1)
somewhat higher##10##2##(1994-11#1)(1996-8#1)(1996-9#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-1#1)
somewhat increased##2##2##(1992-11#1)(1993-10#1)
somewhat larger##4##2##(1991-6#1)(2005-11#1)(2008-1#1)(2008-10#1)
somewhat less than##2##3##(2005-10#1)(2008-2#1)
somewhat less##20##2##(1990-11#1)(1990-5#1)(1991-10#1)(1992-9#1)(1995-12#1)(1996-10#1)(1997-5#1)(1997-6#1)(2005-10#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#2)(2010-2#1)(2010-5#1)(2011-2#1)(2012-2#1)
somewhat limited##5##2##(2005-11#1)(2007-9#1)(2008-10#1)(2008-3#1)(2010-9#1)
somewhat lower than the##2##4##(1991-4#1)(2008-5#1)
somewhat lower than##4##3##(1990-4#1)(1991-4#1)(2008-10#1)(2008-5#1)
somewhat lower##12##2##(1990-4#1)(1991-1#1)(1991-4#1)(1994-8#1)(1995-9#1)(1997-8#1)(2006-4#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)
somewhat more##16##2##(1991-1#1)(1993-3#1)(1995-12#1)(1995-3#1)(1997-6#2)(1997-8#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-1#1)(2013-8#1)
somewhat neglected##2##2##(1994-4#1)(2006-12#1)
somewhat reduced##4##2##(1993-6#1)(1995-10#1)(1997-2#1)(2008-11#1)
somewhat similar##2##2##(1990-6#1)(2012-2#1)
somewhat smaller##3##2##(1991-7#1)(1992-6#1)(2013-8#1)
somewhat stronger##2##2##(1990-5#1)(2006-7#1)
somewhat surprisingly##2##2##(2008-1#1)(2009-4#1)
somewhat with##3##2##(1993-2#1)(2008-2#1)(2008-9#1)
somewhat##210##1##(1990-11#2)(1990-12#1)(1990-4#1)(1990-5#3)(1990-6#1)(1991-1#2)(1991-10#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-10#2)(1992-11#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-11#4)(1994-12#2)(1994-3#2)(1994-4#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#3)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-4#1)(1996-5#3)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#2)(1997-6#5)(1997-8#3)(2004-11#1)(2005-10#1)(2005-11#4)(2006-10#4)(2006-11#1)(2006-12#2)(2006-4#3)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#4)(2007-2#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#3)(2008-10#17)(2008-11#5)(2008-12#1)(2008-2#9)(2008-3#6)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#2)(2009-3#1)(2009-4#3)(2009-5#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#1)(2012-5#1)(2013-1#3)(2013-7#3)(2013-8#3)
somewhere between##2##2##(2006-6#1)(2008-10#1)
somewhere else##2##2##(2007-9#1)(2008-6#1)
somewhere in the##2##3##(1994-5#1)(1996-11#1)
somewhere within##2##2##(2008-7#1)(2008-8#1)
somewhere##12##1##(1994-5#1)(1996-11#1)(2005-9#1)(2006-6#1)(2007-9#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-11#1)(2012-2#1)
somite pairs)##2##2##(1995-1#2)
somite##8##1##(1993-12#1)(1994-12#3)(1995-1#2)(1996-4#1)(2006-11#1)
somites##9##1##(1994-12#4)(1995-1#2)(1995-8#1)(1996-5#1)(2006-11#1)
somitic mesoderm##3##2##(1994-12#2)(1997-4#1)
somnolence##6##1##(1991-2#1)(1994-3#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)
son and##3##2##(1996-12#1)(2008-12#2)
son of##3##2##(1994-12#1)(2006-12#1)(2007-10#1)
son preference##2##2##(1994-7#1)(2006-12#1)
son was##2##2##(2008-7#2)
son##34##1##(1992-3#1)(1994-12#2)(1994-7#1)(1995-6#1)(1996-12#4)(2004-12#1)(2006-12#6)(2007-10#1)(2007-2#1)(2008-12#4)(2008-5#1)(2008-7#3)(2009-4#1)(2010-2#1)(2012-1#1)(2012-2#2)(2013-1#3)
sonar##3##1##(2008-3#1)(2009-8#2)
sondes##2##1##(2008-2#1)(2008-3#1)
song rate##4##2##(2008-9#4)
song sparrows##4##2##(2008-8#2)(2008-9#2)
song system##4##2##(1990-4#1)(1996-7#2)(2009-2#1)
song was highly##2##3##(2008-9#2)
song##37##1##(1990-4#1)(1996-3#1)(1996-7#3)(1997-2#4)(2007-10#1)(2007-2#1)(2007-4#1)(2007-6#2)(2008-8#8)(2008-9#9)(2009-2#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-3#1)
songbird##3##1##(2008-9#1)(2009-2#1)(2013-1#1)
songbirds##12##1##(1990-4#2)(1995-3#1)(2008-5#1)(2008-8#1)(2008-9#6)(2010-2#1)
songs of C##2##3##(2008-8#2)
songs of##3##2##(2008-8#3)
songs##17##1##(1994-3#1)(2006-5#1)(2007-6#3)(2008-8#11)(2011-2#1)
sonic hedgehog##6##2##(1993-12#1)(1996-12#2)(2008-11#1)(2009-4#1)(2013-1#1)
sonic##8##1##(1993-12#1)(1996-12#2)(2008-11#1)(2008-3#1)(2009-4#1)(2013-1#2)
sonicate##4##1##(1990-9#1)(1991-5#2)(2008-10#1)
sonicated in##2##2##(2008-10#2)
sonicated liposomes##2##2##(1991-8#1)(1996-1#1)
sonicated vesicles##2##2##(1992-3#1)(1994-11#1)
sonicated##23##1##(1990-2#1)(1990-9#1)(1991-8#3)(1992-3#1)(1993-3#1)(1994-11#2)(1994-5#3)(1994-6#1)(1996-1#1)(2006-8#1)(2008-10#5)(2008-11#2)(2013-1#1)
sonicates##4##1##(1990-11#1)(1990-9#1)(1991-5#1)(1992-8#1)
sonicating##2##1##(2008-10#2)
sonication amplitude##3##2##(2008-10#3)
sonication and##6##2##(1993-12#1)(2007-8#1)(2008-10#4)
sonication for##2##2##(2008-10#2)
sonication in##2##2##(2008-10#2)
sonication step##2##2##(1992-9#1)(2008-10#1)
sonication time and##2##3##(2008-10#2)
sonication time##13##2##(2008-10#13)
sonication were##3##2##(2008-10#2)(2011-2#1)
sonication##62##1##(1990-11#1)(1991-3#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-6#1)(1996-6#1)(2005-11#1)(2005-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#43)(2008-11#1)(2008-5#2)(2008-6#1)(2011-12#1)(2011-2#1)(2012-12#1)
sonication-assisted##2##1##(2008-10#2)
sonicator##2##1##(2011-12#2)
sonnei in##2##2##(1996-3#1)(2008-9#1)
sonnei strain##2##2##(2008-9#2)
sonnei##11##1##(1996-3#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-9#4)(2010-9#2)(2012-2#1)
sonochemical##2##1##(2005-11#1)(2010-7#1)
sonoelastography##2##1##(2010-12#1)(2013-1#1)
sonoelectrochemical##2##1##(2007-8#1)(2008-10#1)
sonogel-carbon electrode is##2##3##(2008-10#2)
sonogel-carbon electrode##4##2##(2008-10#4)
sonogram trace##2##2##(2007-11#2)
sonogram##7##1##(2007-11#6)(2007-12#1)
sonographic and##3##2##(1990-8#1)(2007-7#1)(2011-12#1)
sonographic appearances##2##2##(2008-4#2)
sonographic criteria##2##2##(2008-1#1)(2012-2#1)
sonographic evaluation##4##2##(2007-11#1)(2008-5#1)(2010-12#1)(2012-2#1)
sonographic examinations##2##2##(2007-11#1)(2007-7#1)
sonographic findings##5##2##(1991-8#1)(2011-8#1)(2012-2#1)(2013-1#2)
sonographic studies##2##2##(1994-9#1)(2008-1#1)
sonographic##34##1##(1990-8#1)(1991-8#1)(1992-5#1)(1993-5#1)(1994-9#1)(2006-4#1)(2007-11#3)(2007-2#1)(2007-7#3)(2008-1#3)(2008-4#2)(2008-5#1)(2008-8#1)(2010-12#3)(2010-8#1)(2011-12#1)(2011-8#1)(2012-2#6)(2013-1#2)
sonographically##5##1##(1990-9#1)(1991-11#1)(1993-5#1)(1995-4#1)(2009-4#1)
sonography and MR##2##3##(1997-8#1)(2008-1#1)
sonography and a CT##2##4##(1990-6#1)(1992-5#1)
sonography and##14##2##(1990-6#1)(1991-3#1)(1992-5#2)(1997-8#2)(2006-10#1)(2007-3#1)(2008-1#1)(2008-4#1)(2008-7#2)(2011-2#1)(2012-1#1)
sonography are##2##2##(1990-9#1)(1995-6#1)
sonography as a##3##3##(1990-6#1)(1990-9#1)(2008-8#1)
sonography as##4##2##(1990-6#1)(1990-9#1)(2005-10#1)(2008-8#1)
sonography for##2##2##(2008-9#1)(2011-2#1)
sonography in the##6##3##(1994-3#1)(2007-9#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-7#1)
sonography in##15##2##(1990-9#1)(1991-12#1)(1991-3#1)(1994-3#1)(1997-8#1)(2006-10#1)(2007-8#1)(2007-9#2)(2010-12#1)(2011-2#3)(2013-1#1)(2013-7#1)
sonography is a##3##3##(1992-5#1)(2007-9#1)(2012-12#1)
sonography is##8##2##(1992-5#1)(2006-10#1)(2007-10#1)(2007-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
sonography of the##4##3##(1991-6#1)(1995-6#1)(2007-9#2)
sonography of##9##2##(1991-6#1)(1993-6#1)(1995-6#1)(2007-9#4)(2013-1#2)
sonography or##2##2##(1990-12#1)(2010-5#1)
sonography permits##2##2##(1992-5#1)(1993-6#1)
sonography revealed##3##2##(2012-12#1)(2013-1#2)
sonography showed a##2##3##(1992-5#1)(2005-11#1)
sonography study##2##2##(2012-1#1)(2013-1#1)
sonography was performed##3##3##(2007-10#1)(2012-12#1)(2013-1#1)
sonography was##4##2##(2007-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
sonography##123##1##(1990-10#2)(1990-12#1)(1990-6#2)(1990-7#2)(1990-9#5)(1991-11#1)(1991-12#1)(1991-3#2)(1991-6#1)(1992-12#2)(1992-5#5)(1993-5#1)(1993-6#3)(1994-3#1)(1995-4#1)(1995-6#2)(1995-9#1)(1996-6#1)(1997-8#8)(2005-1#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#7)(2006-6#1)(2007-10#5)(2007-3#4)(2007-8#2)(2007-9#13)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#3)(2010-12#2)(2010-5#2)(2011-1#1)(2011-2#10)(2012-1#3)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
sonolinear sweep voltammetry##2##3##(2008-10#2)
sonoluminescence##5##1##(1994-2#2)(1995-7#1)(2008-2#2)
sonorensis and M##2##3##(2010-2#2)
sonorensis##6##1##(2010-2#6)
sonothrombolysis##2##1##(2013-1#2)
sons and##2##2##(1996-3#1)(1997-3#1)
sons of##2##2##(2011-1#1)(2012-3#1)
sons or##2##2##(1995-1#2)
sons that they##2##3##(2008-8#2)
sons##19##1##(1993-1#1)(1995-1#2)(1996-3#1)(1996-6#1)(1997-3#1)(2006-12#1)(2006-4#1)(2008-12#1)(2008-7#1)(2008-8#3)(2010-2#3)(2011-1#1)(2012-3#2)
sont decrits##3##2##(2008-5#3)
sont des tumeurs##2##3##(2012-2#1)(2013-1#1)
sont des##6##2##(2008-5#2)(2011-2#1)(2012-2#1)(2013-1#2)
sont les##2##2##(2011-2#1)(2012-2#1)
sont##25##1##(2008-11#1)(2008-5#8)(2011-2#5)(2012-2#4)(2013-1#7)
soon after birth##5##3##(1993-12#1)(1995-12#1)(1997-6#1)(2006-9#1)(2009-12#1)
soon after discharge##2##3##(1993-7#2)
soon after partial##2##3##(1991-5#1)(1994-2#1)
soon after presentation##2##3##(2007-11#1)(2008-1#1)
soon after the insult##2##4##(1996-5#1)(2008-7#1)
soon after the onset of##3##5##(2007-10#1)(2008-1#1)(2008-5#1)
soon after the##17##3##(1993-2#1)(1996-5#1)(1996-6#1)(2006-4#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#4)(2013-1#3)
soon after their##3##3##(2008-7#1)(2011-2#1)(2012-12#1)
soon after##64##2##(1991-11#1)(1991-12#1)(1991-5#3)(1991-9#1)(1993-12#1)(1993-2#1)(1993-7#3)(1994-2#1)(1995-12#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-6#1)(2004-9#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-12#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#1)
soon as the##14##3##(1990-9#1)(1992-1#1)(1992-5#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-4#1)(2009-8#1)(2010-6#1)(2011-1#1)
soon as we##2##3##(2008-4#1)(2012-8#1)
soon as##69##2##(1990-1#1)(1990-5#1)(1990-9#2)(1991-12#3)(1991-6#1)(1992-1#1)(1992-3#2)(1992-5#1)(1993-10#1)(1994-3#1)(1994-4#1)(1995-9#1)(1996-1#1)(1997-1#1)(1997-3#1)(2006-10#3)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-10#1)(2012-2#1)(2012-8#1)(2013-1#3)(2013-8#2)
soon be used for##2##4##(2008-3#1)(2012-2#1)
soon be##15##2##(1994-2#1)(2006-10#1)(2006-6#2)(2007-11#1)(2007-4#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-7#1)(2009-6#1)(2012-1#1)(2012-2#1)(2012-3#1)
soon become##2##2##(2008-10#1)(2011-2#1)
soon followed by##2##3##(2006-10#1)(2008-7#1)
soon may have##2##3##(1992-2#1)(1993-6#1)
soon may##4##2##(1991-4#1)(1992-2#1)(1993-6#1)(2007-9#1)
soon thereafter##2##2##(1990-12#1)(1993-6#1)
soon to##4##2##(2006-5#1)(2008-7#1)(2009-4#1)(2011-2#1)
soon##216##1##(1990-1#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#4)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-7#3)(1994-2#3)(1994-3#1)(1994-4#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-12#1)(2004-9#1)(2005-7#1)(2005-8#2)(2006-10#7)(2006-12#2)(2006-4#1)(2006-5#2)(2006-6#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#8)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#3)(2007-7#3)(2007-8#4)(2007-9#4)(2008-1#5)(2008-10#14)(2008-11#6)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#13)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-4#3)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#6)(2012-1#2)(2012-10#1)(2012-12#2)(2012-2#3)(2012-3#3)(2012-8#1)(2013-1#6)(2013-8#3)
sooner after##2##2##(2007-9#1)(2012-12#1)
sooner in the##2##3##(2007-8#1)(2008-10#1)
sooner or later##2##3##(1990-5#1)(1993-5#1)
sooner than##5##2##(1991-8#1)(2006-6#1)(2008-10#1)(2008-9#2)
sooner##19##1##(1990-5#1)(1991-8#1)(1992-3#1)(1993-5#1)(1993-7#1)(1996-9#1)(2005-7#1)(2006-6#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-9#2)(2012-12#2)(2012-3#1)(2013-8#1)
soot and##2##2##(2007-8#1)(2008-3#1)
soot concentration##2##2##(2008-3#2)
soot diagnostic##2##2##(2008-3#2)
soot distribution##4##2##(2008-2#1)(2008-3#3)
soot in the##2##3##(2008-3#2)
soot in##4##2##(2008-3#4)
soot particles##4##2##(2006-12#2)(2008-2#2)
soot volume fraction and##2##4##(2008-3#2)
soot volume fraction##6##3##(2008-2#3)(2008-3#3)
soot volume##7##2##(2008-2#4)(2008-3#3)
soot with##2##2##(2008-10#1)(2008-3#1)
soot##71##1##(1994-7#1)(2006-12#7)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#3)(2008-2#20)(2008-3#29)(2011-2#2)
sooting flames##3##2##(2007-12#2)(2008-3#1)
sooting##8##1##(2006-12#2)(2007-12#3)(2008-2#2)(2008-3#1)
sooty##5##1##(1995-2#1)(2008-10#3)(2008-3#1)
sophisticated and expensive##2##3##(2007-5#1)(2013-8#1)
sophisticated and##9##2##(2007-5#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-8#1)(2013-1#1)(2013-8#1)
sophisticated approach##3##2##(2006-10#1)(2007-2#1)(2013-1#1)
sophisticated as##2##2##(1995-7#1)(2007-11#1)
sophisticated data##3##2##(1995-12#1)(2008-4#1)(2011-2#1)
sophisticated equipment and expertise##2##4##(2008-4#1)(2010-12#1)
sophisticated equipment##4##2##(2006-2#1)(2008-10#1)(2008-4#1)(2010-12#1)
sophisticated experimental##2##2##(2008-11#1)(2012-2#1)
sophisticated genetic##2##2##(2008-2#1)(2011-2#1)
sophisticated imaging methods##2##3##(2007-5#1)(2007-7#1)
sophisticated imaging##3##2##(2007-5#1)(2007-7#1)(2013-1#1)
sophisticated in##2##2##(2007-12#1)(2008-11#1)
sophisticated information systems##2##3##(1997-2#1)(2008-10#1)
sophisticated mechanisms to##3##3##(2007-12#1)(2011-10#1)(2012-1#1)
sophisticated mechanisms##4##2##(2007-12#1)(2011-1#1)(2011-10#1)(2012-1#1)
sophisticated models##2##2##(2007-8#2)
sophisticated molecular##3##2##(2008-10#1)(2010-12#1)(2011-1#1)
sophisticated processes##2##2##(1997-6#1)(2010-12#1)
sophisticated techniques##5##2##(1994-12#1)(2006-11#1)(2008-11#1)(2008-5#1)(2008-8#1)
sophisticated technological##2##2##(2008-11#1)(2009-5#1)
sophisticated technology##5##2##(1990-12#1)(1994-12#1)(1996-1#1)(2006-11#1)(2011-2#1)
sophisticated tools##2##2##(2008-7#1)(2008-8#1)
sophisticated##154##1##(1990-12#1)(1991-12#2)(1991-2#1)(1991-3#2)(1992-3#3)(1993-1#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#3)(1994-2#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-7#1)(1996-1#2)(1996-12#2)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#1)(2004-9#2)(2006-10#4)(2006-11#2)(2006-2#1)(2006-5#1)(2006-6#3)(2006-9#2)(2007-11#4)(2007-12#4)(2007-2#1)(2007-4#2)(2007-5#3)(2007-7#1)(2007-8#2)(2007-9#5)(2008-1#1)(2008-10#7)(2008-11#7)(2008-2#4)(2008-3#5)(2008-4#4)(2008-5#2)(2008-7#7)(2008-8#2)(2008-9#4)(2009-10#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-12#3)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-10#1)(2011-12#1)(2011-2#7)(2012-1#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#1)
sophistication and complexity##3##3##(2006-8#1)(2009-10#2)
sophistication of##4##2##(2004-10#1)(2005-12#1)(2008-11#1)(2010-6#1)
sophistication##14##1##(1995-2#1)(1996-2#2)(1997-4#1)(2004-10#1)(2005-12#1)(2006-10#1)(2006-8#1)(2008-11#1)(2008-7#1)(2009-10#2)(2010-12#1)(2010-6#1)
sophomore##2##1##(2008-12#2)
sophoridine##2##1##(2008-10#2)
sophorose##2##1##(2005-12#1)(2008-11#1)
sorafenib and##3##2##(2008-6#1)(2009-11#1)(2010-12#1)
sorafenib##24##1##(2008-3#2)(2008-5#1)(2008-6#2)(2008-8#2)(2009-11#4)(2009-3#1)(2010-12#2)(2011-1#1)(2011-2#1)(2013-8#8)
sorbate##4##1##(1996-5#1)(2008-10#1)(2010-2#1)(2010-4#1)
sorbed on the##5##3##(2007-8#1)(2008-10#4)
sorbed on##9##2##(2005-11#1)(2007-8#1)(2008-10#7)
sorbed onto activated##2##3##(2008-10#2)
sorbed onto the resin##2##4##(2008-10#2)
sorbed onto the##3##3##(2008-10#3)
sorbed onto##8##2##(2008-10#8)
sorbed##37##1##(2005-11#4)(2006-12#1)(2007-8#1)(2008-10#31)
sorbent and##4##2##(2008-10#4)
sorbent column##2##2##(2008-10#2)
sorbent extraction preconcentration system##2##4##(2008-10#2)
sorbent extraction preconcentration##4##3##(2008-10#4)
sorbent extraction##8##2##(2008-10#8)
sorbent for the##2##3##(2008-10#2)
sorbent for##10##2##(2005-11#1)(2008-10#9)
sorbent has been developed for##2##5##(2008-10#2)
sorbent has been developed##4##4##(2008-10#4)
sorbent has##5##2##(2008-10#5)
sorbent is##2##2##(2008-10#2)
sorbent material##6##2##(2007-8#3)(2008-10#3)
sorbent phase##2##2##(2008-10#2)
sorbent tube for##2##3##(2008-10#2)
sorbent was##8##2##(2008-10#8)
sorbent with##2##2##(2008-10#1)(2009-8#1)
sorbent##109##1##(1991-8#1)(1993-2#1)(1996-8#2)(1997-2#1)(2005-11#1)(2007-10#1)(2007-8#5)(2008-10#94)(2008-5#1)(2009-8#1)(2013-8#1)
sorbent)##2##1##(1996-8#1)(2008-10#1)
sorbents for##6##2##(2007-8#1)(2008-10#5)
sorbents in##2##2##(1996-11#1)(2008-10#1)
sorbents##29##1##(1992-2#1)(1996-11#1)(1996-8#5)(2005-11#1)(2007-8#3)(2008-10#16)(2009-2#1)(2009-3#1)
sorbic acid and##3##3##(1990-10#1)(2007-8#1)(2010-2#1)
sorbic acid##13##2##(1990-10#1)(1996-5#1)(2007-8#1)(2008-10#6)(2010-2#1)(2011-2#3)
sorbic##14##1##(1990-10#1)(1996-5#1)(2007-8#1)(2008-10#6)(2010-2#1)(2011-2#4)
sorbicillactone A##2##2##(2008-5#2)
sorbicillactone##3##1##(2008-5#3)
sorbing solids##5##2##(2008-10#5)
sorbing##8##1##(2008-10#7)(2008-11#1)
sorbinil##5##1##(1994-8#5)
sorbitan acrylate##5##2##(2008-5#5)
sorbitan##11##1##(1994-9#1)(2008-5#8)(2009-11#1)(2010-1#1)
sorbitol and##5##2##(1996-2#1)(2008-12#1)(2008-6#2)(2011-1#1)
sorbitol dehydrogenase (SDH)##2##3##(1996-12#1)(2008-11#1)
sorbitol dehydrogenase##6##2##(1996-12#1)(1996-2#3)(2008-11#1)(2008-8#1)
sorbitol instead of##2##3##(1991-5#1)(2012-7#1)
sorbitol or##2##2##(1994-8#1)(2008-11#1)
sorbitol release##5##2##(1990-7#5)
sorbitol were##2##2##(2008-6#1)(2008-8#1)
sorbitol##40##1##(1990-7#6)(1991-1#1)(1991-5#4)(1992-7#1)(1994-11#1)(1994-8#1)(1994-9#1)(1996-12#1)(1996-2#5)(1997-2#1)(2005-7#2)(2006-4#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-6#5)(2008-8#2)(2011-1#1)(2012-2#1)(2012-7#1)
sorcery##2##1##(1993-11#1)(2008-4#1)
sordida and T##2##3##(2004-11#2)
sordida##4##1##(2004-11#4)
sore throat and##3##3##(1992-6#1)(2008-1#1)(2012-12#1)
sore throat##10##2##(1992-6#1)(1995-11#1)(1996-9#1)(2006-10#1)(2007-7#1)(2008-1#1)(2012-12#1)(2012-2#2)(2013-7#1)
sore throats##2##2##(1990-4#1)(2008-10#1)
sore##21##1##(1990-4#1)(1992-6#1)(1995-11#1)(1996-1#2)(1996-9#1)(2006-10#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-8#1)(2012-12#1)(2012-2#3)(2013-7#1)
sorely needed##2##2##(2008-10#1)(2008-11#1)
soreness##6##1##(2005-10#2)(2006-3#2)(2007-11#1)(2011-2#1)
sores##11##1##(1990-6#1)(1996-1#2)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-5#1)(2012-2#1)
sorghi and##2##2##(2008-10#2)
sorghi##14##1##(2008-10#14)
sorghum and millet##3##3##(2008-10#3)
sorghum and##5##2##(1995-8#1)(2008-10#3)(2008-7#1)
sorghum ergot##3##2##(2008-10#3)
sorghum mosaic virus##3##3##(2008-10#2)(2008-9#1)
sorghum pathogen##3##2##(2008-10#3)
sorghum was##2##2##(2008-10#2)
sorghum##49##1##(1990-6#1)(1995-8#1)(2008-10#35)(2008-7#3)(2008-9#4)(2009-10#4)(2009-8#1)
sorokiniana conidia on##2##3##(2008-10#2)
sorokiniana conidia##3##2##(2008-10#3)
sorokiniana on##2##2##(2008-10#2)
sorokiniana##27##1##(2007-7#1)(2008-10#25)(2013-1#1)
sorption and preconcentration for the off-line determination of##2##8##(2008-10#2)
sorption and recovery of##2##4##(2008-10#2)
sorption and solubility##3##3##(2013-1#2)(2013-8#1)
sorption and the##2##3##(2005-11#1)(2008-10#1)
sorption and##12##2##(2005-11#1)(2008-10#7)(2008-5#1)(2013-1#2)(2013-8#1)
sorption by##2##2##(2005-11#1)(2008-10#1)
sorption capacities##4##2##(2005-11#1)(2008-10#2)(2010-12#1)
sorption capacity of the impregnated resin##2##6##(2008-10#2)
sorption capacity of the##10##4##(2008-10#10)
sorption capacity of##16##3##(2007-8#1)(2008-10#15)
sorption capacity values##2##3##(2008-10#2)
sorption capacity was##2##3##(2008-10#2)
sorption capacity##31##2##(2007-8#1)(2008-10#30)
sorption characteristics##2##2##(2008-10#1)(2010-4#1)
sorption conditions##2##2##(2008-10#2)
sorption data##5##2##(2005-11#1)(2008-10#4)
sorption efficiency##3##2##(1997-1#1)(2008-10#2)
sorption equilibria##3##2##(2008-10#3)
sorption in##2##2##(2005-11#1)(2008-10#1)
sorption is##3##2##(2008-10#3)
sorption isotherms were##2##3##(2005-11#1)(2008-6#1)
sorption isotherms##8##2##(2005-11#1)(2008-10#1)(2008-6#3)(2010-4#3)
sorption kinetics##4##2##(2008-10#4)
sorption mechanism##4##2##(2005-11#1)(2008-10#3)
sorption mechanisms##2##2##(1997-1#1)(2008-10#1)
sorption of Hg(II)##2##3##(2008-10#2)
sorption of Pb(II)##2##3##(2008-10#2)
sorption of Pd(II)##2##3##(2007-8#2)
sorption of benzene to##2##4##(2005-11#2)
sorption of benzene##3##3##(2005-11#3)
sorption of metal ions##3##4##(2005-11#1)(2008-10#2)
sorption of metal##4##3##(2005-11#1)(2008-10#3)
sorption of nitrogen##2##3##(2005-11#2)
sorption of silver ions onto PUF##2##6##(2008-10#2)
sorption of silver##3##3##(2008-10#3)
sorption of the##6##3##(2007-8#1)(2008-10#4)(2008-2#1)
sorption of uranium(VI)##2##3##(2008-10#2)
sorption of##62##2##(2005-11#10)(2007-8#3)(2008-10#48)(2008-2#1)
sorption on a##6##3##(2008-10#6)
sorption on activated carbon##2##4##(2008-10#2)
sorption on octadecyl silica membrane disks modified with##2##8##(2008-10#2)
sorption on##16##2##(2005-11#4)(2008-10#12)
sorption onto the##2##3##(2004-4#1)(2007-8#1)
sorption onto##7##2##(2004-4#1)(2007-8#1)(2008-10#5)
sorption preconcentration##5##2##(2008-10#5)
sorption properties of the##2##4##(2007-8#1)(2008-10#1)
sorption properties of##4##3##(2005-11#1)(2007-8#1)(2008-10#2)
sorption properties##6##2##(2005-11#1)(2007-8#1)(2008-10#4)
sorption rate##2##2##(2008-10#2)
sorption sites##2##2##(2005-11#2)
sorption was##3##2##(2008-10#3)
sorption were##3##2##(2005-11#1)(2008-10#1)(2010-4#1)
sorption with##5##2##(2008-10#5)
sorption##264##1##(1991-8#1)(1993-2#1)(1997-1#2)(2004-4#1)(2005-11#34)(2007-8#7)(2008-10#193)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#5)(2008-8#1)(2009-2#1)(2010-12#1)(2010-3#1)(2010-4#6)(2010-7#1)(2013-1#2)(2013-8#3)
sorption-spectroscopic##3##1##(2008-10#3)
sorptive capacity of##2##3##(2005-11#1)(2007-5#1)
sorptive##11##1##(2005-11#4)(2007-5#1)(2008-10#6)
sorrow##4##1##(1993-11#1)(2009-9#3)
sort cells##2##2##(2008-6#1)(2011-2#1)
sort of##17##2##(1990-7#1)(1992-3#1)(1996-8#1)(1996-9#1)(2006-7#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-7#2)(2010-9#1)(2012-12#1)(2012-3#1)
sort##46##1##(1990-10#1)(1990-12#1)(1990-7#1)(1991-1#1)(1991-12#1)(1992-3#1)(1995-3#1)(1996-12#1)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#1)(2005-8#1)(2006-2#1)(2006-6#1)(2006-7#1)(2007-11#2)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#2)(2008-7#2)(2008-9#1)(2010-9#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)
sorted by##5##2##(1996-12#1)(2005-7#1)(2006-2#1)(2006-8#1)(2008-7#1)
sorted chromosomes##2##2##(2008-9#2)
sorted from##2##2##(2008-10#1)(2008-11#1)
sorted into the regulated##2##4##(1990-5#1)(1992-12#1)
sorted into the##3##3##(1990-12#1)(1990-5#1)(1992-12#1)
sorted into##10##2##(1990-11#1)(1990-12#1)(1990-5#1)(1992-12#2)(1992-3#1)(2007-10#1)(2008-10#1)(2008-9#1)(2012-3#1)
sorted out##3##2##(1994-2#1)(2008-4#1)(2011-2#1)
sorted to##2##2##(1990-5#1)(1991-1#1)
sorted with##2##2##(1996-12#1)(2008-10#1)
sorted##40##1##(1990-11#1)(1990-12#1)(1990-5#2)(1991-1#2)(1992-11#1)(1992-12#2)(1992-3#1)(1994-2#1)(1995-8#1)(1996-12#2)(2005-7#1)(2006-2#1)(2006-8#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#3)(2011-2#6)(2012-12#1)(2012-3#1)(2013-7#1)
sorters##3##1##(2008-9#2)(2011-2#1)
sorting algorithm##2##2##(2008-2#2)
sorting and patterning of##4##4##(2012-11#4)
sorting and##21##2##(1995-11#1)(1996-8#1)(1996-9#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#1)(2010-6#1)(2011-2#1)(2012-11#4)(2012-3#1)
sorting are##2##2##(1996-5#1)(2010-6#1)
sorting block box##2##3##(2012-1#2)
sorting by##3##2##(2010-6#1)(2012-3#2)
sorting defect##3##2##(1990-5#3)
sorting experiments##3##2##(1997-4#1)(2011-2#2)
sorting for##3##2##(1996-12#1)(2008-4#1)(2010-6#1)
sorting in the##2##3##(1993-6#1)(1997-6#1)
sorting in##6##2##(1992-3#1)(1993-6#2)(1993-9#1)(1997-6#1)(2008-5#1)
sorting into##2##2##(2008-4#1)(2010-2#1)
sorting is##3##2##(1991-1#1)(2009-10#1)(2011-2#1)
sorting nexin 27##2##3##(2008-8#2)
sorting nexin AtSNX2b##2##3##(2009-10#2)
sorting nexin##4##2##(2008-8#2)(2009-10#2)
sorting of ancestral##2##3##(2006-5#1)(2010-6#1)
sorting of particles##2##3##(2008-6#1)(2011-2#1)
sorting of the##2##3##(1995-8#1)(2012-2#1)
sorting of##35##2##(1991-1#1)(1992-3#1)(1995-8#2)(1996-4#1)(1996-5#2)(1997-1#1)(1997-6#1)(2006-5#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#6)(2009-2#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
sorting out##2##2##(2008-7#2)
sorting system##3##2##(2008-2#1)(2008-8#1)(2008-9#1)
sorting task##3##2##(2012-1#1)(2012-2#2)
sorting the data##2##3##(1992-11#2)
sorting the##4##2##(1992-11#2)(2005-11#1)(2008-9#1)
sorting to the##2##3##(1993-6#1)(1996-4#1)
sorting to##5##2##(1993-6#1)(1996-4#1)(2008-9#1)(2012-12#2)
sorting using the##2##3##(2008-4#1)(2008-9#1)
sorting using##3##2##(1992-9#1)(2008-4#1)(2008-9#1)
sorting yield##2##2##(2011-2#2)
sorting##187##1##(1990-5#4)(1991-1#3)(1992-11#2)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#5)(1993-9#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#4)(1996-5#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#3)(2005-11#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-6#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#4)(2008-2#6)(2008-3#1)(2008-4#10)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#22)(2009-10#7)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-6#8)(2011-1#2)(2011-2#19)(2012-1#4)(2012-11#4)(2012-12#9)(2012-2#5)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#2)
sortings##2##1##(2008-1#1)(2008-2#1)
sorts for##2##2##(2004-12#1)(2009-10#1)
sorts of##11##2##(1996-9#1)(1997-8#2)(2005-11#1)(2005-4#1)(2007-12#2)(2008-5#1)(2010-9#1)(2012-12#2)
sorts the##2##2##(2007-12#1)(2008-10#1)
sorts##22##1##(1990-12#1)(1990-6#1)(1996-6#1)(1996-9#1)(1997-8#3)(2004-12#1)(2005-11#1)(2005-4#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-2#1)(2010-9#1)(2012-12#2)
sotalol##7##1##(1992-3#1)(1993-2#2)(1995-6#1)(2006-9#1)(2008-10#1)(2010-8#1)
sought a##2##2##(2007-10#1)(2007-2#1)
sought advice##2##2##(1990-4#1)(2008-10#1)
sought after##3##2##(1991-1#1)(1995-3#1)(2009-4#1)
sought an##2##2##(1993-8#1)(2008-9#1)
sought and##5##2##(1991-11#1)(1994-1#1)(2006-7#1)(2008-3#1)(2013-1#1)
sought between##3##2##(1990-10#1)(1992-6#1)(2006-10#1)
sought by##4##2##(1994-8#1)(2007-8#1)(2008-7#1)(2009-6#1)
sought for##8##2##(1990-10#1)(1990-3#1)(1995-2#1)(1996-5#1)(2009-5#1)(2011-12#1)(2011-2#1)(2012-12#1)
sought from##6##2##(1992-2#1)(2006-6#1)(2007-12#1)(2007-8#1)(2010-8#1)(2012-12#1)
sought help##2##2##(1990-8#1)(2006-8#1)
sought if##2##2##(1993-12#1)(2007-12#1)
sought in##9##2##(1992-6#1)(1995-2#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
sought included##2##2##(2007-7#1)(2011-11#1)
sought medical advice for##3##4##(2007-7#3)
sought medical advice##4##3##(2007-7#3)(2013-1#1)
sought medical##7##2##(1992-2#1)(1994-9#1)(2006-12#1)(2007-7#3)(2013-1#1)
sought out##2##2##(2007-2#1)(2012-3#1)
sought solutions to##2##3##(2011-2#1)(2012-2#1)
sought the##2##2##(1993-9#1)(2011-2#1)
sought to address this##2##4##(2008-7#1)(2008-9#1)
sought to address##3##3##(2008-7#2)(2008-9#1)
sought to assess the##2##4##(2011-2#1)(2012-3#1)
sought to capture##2##3##(2008-11#1)(2012-11#1)
sought to compare##3##3##(1997-5#1)(2007-8#1)(2008-10#1)
sought to create##3##3##(2011-2#1)(2013-1#2)
sought to describe a##2##4##(2012-1#1)(2012-3#1)
sought to describe##3##3##(2012-1#1)(2012-3#2)
sought to determine if##12##4##(1990-11#1)(1990-3#1)(1992-11#1)(1992-5#1)(1993-6#1)(1994-2#1)(1996-10#1)(2006-12#1)(2008-10#1)(2010-11#1)(2012-2#2)
sought to determine the effects of##2##6##(1994-11#1)(2007-12#1)
sought to determine the role of##2##6##(1997-8#1)(2008-7#1)
sought to determine the##20##4##(1993-12#1)(1994-11#1)(1997-7#1)(1997-8#1)(2007-10#3)(2007-12#1)(2007-9#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
sought to determine whether the##4##5##(1993-11#1)(1997-7#1)(2008-11#1)(2012-3#1)
sought to determine whether##11##4##(1991-2#1)(1993-11#1)(1993-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-3#1)
sought to determine which##2##4##(2010-9#1)(2013-1#1)
sought to determine##49##3##(1990-11#1)(1990-3#1)(1991-2#1)(1992-11#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-2#1)(1996-10#1)(1997-7#2)(1997-8#1)(2006-12#1)(2007-10#3)(2007-12#1)(2007-8#1)(2007-9#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
sought to develop a##2##4##(2007-10#1)(2013-1#1)
sought to develop##5##3##(2007-10#2)(2008-12#1)(2013-1#2)
sought to document##2##3##(2007-9#1)(2009-7#1)
sought to evaluate the##6##4##(2006-8#1)(2007-10#1)(2007-8#1)(2010-1#1)(2011-2#1)(2012-3#1)
sought to evaluate whether##2##4##(2009-4#1)(2012-12#1)
sought to evaluate##9##3##(2005-11#1)(2006-8#1)(2007-10#1)(2007-8#1)(2009-4#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
sought to examine the##6##4##(1996-9#1)(2007-11#1)(2009-10#1)(2011-1#1)(2012-2#2)
sought to examine##8##3##(1996-9#1)(2007-11#1)(2008-6#1)(2009-10#1)(2010-8#1)(2011-1#1)(2012-2#2)
sought to explore##3##3##(1993-12#1)(2008-11#1)(2010-10#1)
sought to extend##2##3##(2006-4#1)(2008-10#1)
sought to identify and##2##4##(2005-12#1)(2008-9#1)
sought to identify factors that##2##5##(2007-10#1)(2013-1#1)
sought to identify the gene##2##5##(1997-4#1)(2008-9#1)
sought to identify the##4##4##(1997-4#1)(2008-9#1)(2010-10#1)(2011-2#1)
sought to identify##17##3##(1991-12#1)(1995-3#1)(1997-4#1)(2005-12#2)(2007-10#3)(2008-10#1)(2008-9#2)(2009-4#1)(2010-10#1)(2011-1#1)(2011-2#2)(2013-1#1)
sought to investigate whether##2##4##(2008-5#1)(2013-1#1)
sought to investigate##5##3##(2006-12#1)(2008-11#1)(2008-5#1)(2012-3#1)(2013-1#1)
sought to promote##2##3##(2008-3#1)(2012-2#1)
sought to provide##2##3##(1996-12#1)(2008-5#1)
sought to study##2##3##(2007-8#1)(2013-1#1)
sought to test the hypothesis that##2##6##(1994-6#1)(2008-7#1)
sought to test the##3##4##(1994-6#1)(2007-10#1)(2008-7#1)
sought to##164##2##(1990-11#1)(1990-12#1)(1990-3#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2005-11#1)(2005-12#2)(2006-10#1)(2006-12#2)(2006-4#1)(2006-8#1)(2007-10#10)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#6)(2007-9#5)(2008-10#5)(2008-11#9)(2008-12#1)(2008-3#3)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#3)(2009-10#3)(2009-12#1)(2009-4#3)(2009-5#1)(2009-7#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#8)(2013-1#11)(2013-8#3)
sought treatment at a##2##4##(2009-9#1)(2011-1#1)
sought treatment at##3##3##(2006-12#1)(2009-9#1)(2011-1#1)
sought treatment for##2##3##(2006-12#2)
sought treatment##7##2##(1991-8#1)(2006-12#3)(2007-2#1)(2009-9#1)(2011-1#1)
sought##290##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-3#2)(1990-4#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-11#2)(1992-12#2)(1992-2#3)(1992-5#1)(1992-6#2)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2005-10#2)(2005-11#3)(2005-12#2)(2005-8#1)(2006-10#5)(2006-12#6)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#12)(2007-11#2)(2007-12#3)(2007-2#9)(2007-3#1)(2007-7#4)(2007-8#8)(2007-9#5)(2008-1#4)(2008-10#6)(2008-11#11)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#7)(2008-8#6)(2008-9#4)(2009-10#3)(2009-12#1)(2009-4#4)(2009-5#3)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#3)(2010-8#3)(2010-9#2)(2011-1#4)(2011-11#1)(2011-12#1)(2011-2#14)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#6)(2012-3#11)(2013-1#17)(2013-8#4)
sought-after##2##1##(2008-11#1)(2008-2#1)
soul##11##1##(2004-8#1)(2006-12#3)(2007-2#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2013-8#1)
sound and##10##2##(1991-1#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-9#1)(2009-5#1)(2012-3#2)
sound arguments##2##2##(2012-2#2)
sound can##2##2##(2008-11#1)(2012-2#1)
sound clinical##2##2##(2008-12#1)(2010-10#1)
sound condition##2##2##(2013-8#2)
sound condition)##2##2##(2013-8#2)
sound cues##3##2##(2007-2#1)(2012-2#2)
sound decisions##2##2##(1993-3#1)(2010-1#1)
sound evidence##6##2##(1993-12#2)(1996-12#1)(2006-10#1)(2010-12#1)(2010-5#1)
sound in##3##2##(1994-10#1)(2008-8#1)(2008-9#1)
sound intensity##6##2##(1993-9#1)(1994-8#1)(2008-8#1)(2008-9#3)
sound is##5##2##(2007-12#1)(2008-3#2)(2008-8#1)(2012-3#1)
sound localization##3##2##(2008-9#2)(2012-2#1)
sound measurement##2##2##(2008-2#1)(2012-2#1)
sound method##2##2##(2008-10#1)(2010-11#1)
sound of a##2##3##(2008-2#1)(2012-11#1)
sound of##4##2##(2007-5#1)(2008-2#1)(2010-2#1)(2012-11#1)
sound on fishes##2##3##(2010-8#2)
sound on##3##2##(2010-8#2)(2012-2#1)
sound perception##2##2##(2008-9#2)
sound pressure##4##2##(1995-12#1)(2008-3#1)(2010-2#2)
sound production##2##2##(1992-2#1)(2007-12#1)
sound scientific##2##2##(2009-11#1)(2010-5#1)
sound source segregation##2##3##(2009-5#2)
sound source##3##2##(2008-2#1)(2009-5#2)
sound speed and##2##3##(2007-12#1)(2008-3#1)
sound speed measurements##2##3##(2007-12#1)(2008-3#1)
sound speed##9##2##(1996-5#1)(2007-12#2)(2008-2#4)(2008-3#2)
sound stimuli##5##2##(1991-5#3)(2008-9#1)(2012-2#1)
sound strategies##2##2##(2008-7#1)(2009-4#1)
sound stress##4##2##(1992-3#4)
sound to##2##2##(2009-2#1)(2012-1#1)
sound transmission##2##2##(2006-1#1)(2007-9#1)
sound velocity##4##2##(2006-10#1)(2008-2#3)
sound wave##5##2##(2008-10#1)(2008-2#3)(2008-3#1)
sound waves##2##2##(2007-12#1)(2008-10#1)
sound when##2##2##(2007-12#1)(2008-9#1)
sound with##3##2##(2008-4#1)(2008-9#1)(2012-1#1)
sound##245##1##(1990-11#1)(1990-2#1)(1991-1#1)(1991-5#3)(1992-1#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#6)(1993-12#2)(1993-2#1)(1993-3#1)(1993-9#2)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#3)(1995-5#5)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-6#1)(2005-10#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-12#2)(2006-2#1)(2007-11#1)(2007-12#10)(2007-2#1)(2007-5#2)(2007-6#1)(2007-9#1)(2008-10#7)(2008-11#5)(2008-12#5)(2008-2#21)(2008-3#11)(2008-4#5)(2008-5#1)(2008-7#3)(2008-8#8)(2008-9#20)(2009-11#1)(2009-2#2)(2009-4#1)(2009-5#3)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#5)(2010-5#3)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#4)(2011-2#5)(2011-8#1)(2012-1#4)(2012-11#2)(2012-12#1)(2012-2#17)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#14)
sound)##2##1##(1995-11#1)(2010-8#1)
sound-induced seizures##5##2##(1995-12#1)(1997-5#4)
sound-induced##6##1##(1995-12#1)(1997-5#4)(2007-9#1)
sounded##5##1##(2008-3#3)(2009-10#2)
sounder##10##1##(1996-8#1)(2008-2#4)(2008-3#5)
sounding board##3##2##(1992-2#1)(2010-4#1)(2012-3#1)
sounding rocket##6##2##(2008-3#6)
sounding##26##1##(1990-12#1)(1992-2#1)(2008-2#4)(2008-3#15)(2008-8#1)(2008-9#2)(2010-4#1)(2012-3#1)
soundings##2##1##(2008-2#1)(2008-3#1)
soundness of the##3##3##(1993-3#1)(1996-12#1)(2007-12#1)
soundness##4##1##(1991-6#1)(1993-3#1)(1996-12#1)(2007-12#1)
sounds and associated behaviours##2##4##(2010-8#2)
sounds and##4##2##(1993-12#1)(2009-4#1)(2010-8#2)
sounds by##3##2##(1997-7#1)(2008-11#2)
sounds in a##2##3##(1993-12#1)(2008-11#1)
sounds in##10##2##(1993-12#2)(1993-9#1)(1997-1#1)(2008-11#1)(2008-9#2)(2010-8#1)(2012-1#1)(2012-12#1)
sounds of##3##2##(1997-7#1)(2008-11#1)(2008-4#1)
sounds on##3##2##(2010-8#1)(2011-2#1)(2012-2#1)
sounds or##2##2##(2009-9#1)(2012-1#1)
sounds was##2##2##(1993-12#1)(2008-9#1)
sounds with##2##2##(2012-1#1)(2013-1#1)
sounds##69##1##(1993-12#7)(1993-9#1)(1995-11#2)(1997-1#1)(1997-2#1)(1997-7#4)(2005-12#1)(2006-10#2)(2007-9#1)(2008-10#1)(2008-11#5)(2008-4#3)(2008-6#1)(2008-9#7)(2009-2#1)(2009-4#1)(2009-9#2)(2010-2#1)(2010-8#6)(2011-1#2)(2011-12#2)(2011-2#1)(2012-1#5)(2012-12#2)(2012-2#6)(2013-1#1)(2013-8#2)
sound–object##2##1##(2012-1#2)
soup##8##1##(2008-4#5)(2011-1#2)(2012-1#1)
soups##2##1##(1991-5#1)(1992-5#1)
sour orange##7##2##(2008-10#7)
sour##14##1##(1996-1#2)(2008-10#9)(2008-8#1)(2008-9#1)(2013-1#1)
source analysis##5##2##(1992-8#1)(1997-7#1)(2008-11#2)(2008-3#1)
source and a##12##3##(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-2#1)(2008-4#1)
source and an##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
source and as##2##3##(2008-10#1)(2008-2#1)
source and channel coding##3##4##(2008-2#3)
source and culture##2##3##(2008-11#1)(2008-5#1)
source and detector##7##3##(2007-12#1)(2008-2#2)(2008-3#3)(2009-5#1)
source and is##5##3##(1990-12#1)(1993-6#1)(1996-1#1)(2007-10#1)(2008-2#1)
source and sink##2##3##(1996-10#1)(2007-12#1)
source and the detector##2##4##(2007-12#1)(2008-3#1)
source and the##20##3##(2005-4#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-10#5)(2008-3#5)(2008-8#1)(2010-2#1)(2012-2#1)
source and##106##2##(1990-12#1)(1993-6#1)(1994-3#1)(1995-1#1)(1996-1#1)(1996-10#1)(1996-3#1)(2005-4#2)(2005-8#1)(2006-3#1)(2006-5#2)(2007-10#4)(2007-11#4)(2007-12#9)(2007-3#1)(2007-9#1)(2008-10#21)(2008-11#1)(2008-12#2)(2008-2#13)(2008-3#15)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2010-2#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)
source are necessary##2##3##(2008-3#2)
source are##11##2##(2008-2#5)(2008-3#5)(2009-9#1)
source area##3##2##(1996-4#1)(2006-10#1)(2008-10#1)
source areas##2##2##(2008-10#2)
source as##2##2##(1993-4#1)(2006-4#1)
source at 3##2##3##(2007-12#1)(2008-2#1)
source at the##2##3##(2006-4#1)(2008-10#1)
source at##10##2##(2006-4#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#1)
source based on a##6##4##(2007-12#3)(2008-3#3)
source based on##16##3##(2007-11#3)(2007-12#9)(2008-3#3)(2011-1#1)
source based##17##2##(2007-11#3)(2007-12#9)(2008-10#1)(2008-3#3)(2011-1#1)
source by##8##2##(2006-5#1)(2006-8#1)(2007-11#1)(2008-10#3)(2008-6#1)(2011-2#1)
source can be used##2##4##(2007-12#1)(2008-2#1)
source can be##5##3##(2007-12#1)(2008-2#2)(2010-1#1)(2013-8#1)
source can##6##2##(2007-12#1)(2008-10#1)(2008-2#2)(2010-1#1)(2013-8#1)
source code for##2##3##(2010-5#1)(2012-3#1)
source code##7##2##(1996-2#1)(2007-4#2)(2008-10#1)(2008-4#1)(2010-5#1)(2012-3#1)
source coding##2##2##(1995-9#1)(2008-2#1)
source control##3##2##(2011-2#3)
source could##2##2##(2007-12#1)(2008-3#1)
source crater##2##2##(1993-7#1)(1997-5#1)
source data for##2##3##(2008-1#1)(2008-3#1)
source data##4##2##(2006-2#1)(2008-1#1)(2008-3#1)(2010-11#1)
source distance##2##2##(2008-2#2)
source during the##2##3##(2008-10#1)(2008-6#1)
source emitting##2##2##(2007-12#1)(2008-3#1)
source for a##6##3##(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#2)(2010-2#1)
source for all##2##3##(1993-12#1)(2008-4#1)
source for both##2##3##(1991-5#1)(2010-5#1)
source for coherent laser radar##2##5##(2007-12#2)
source for functional##2##3##(2008-7#1)(2010-2#1)
source for fungicidal preparations against##2##5##(2008-10#2)
source for genetic##2##3##(2008-5#1)(2012-2#1)
source for growth##2##3##(2007-12#1)(2011-2#1)
source for harvesting##2##3##(2007-1#1)(2011-12#1)
source for new##2##3##(2008-10#1)(2011-12#1)
source for optical##2##3##(2007-11#1)(2007-12#1)
source for secondary##2##3##(1993-9#1)(2008-10#1)
source for the generation of##2##5##(2007-12#1)(2008-1#1)
source for the treatment of##2##5##(2008-10#1)(2008-8#1)
source for the##21##3##(1991-12#1)(1994-8#1)(2004-8#1)(2006-4#1)(2006-7#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-12#1)(2013-1#1)
source for##132##2##(1990-10#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-8#2)(1992-2#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-6#1)(2004-8#1)(2006-4#2)(2006-7#1)(2007-1#1)(2007-11#9)(2007-12#11)(2007-2#1)(2007-3#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#17)(2008-11#4)(2008-12#1)(2008-2#8)(2008-3#5)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-3#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2011-1#4)(2011-12#2)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-9#1)(2013-1#5)(2013-8#1)
source from##3##2##(2007-12#1)(2008-2#1)(2011-1#1)
source generated##3##2##(2007-12#2)(2008-3#1)
source generates##2##2##(2007-12#2)
source habitats##2##2##(2008-8#1)(2010-6#1)
source has##2##2##(2007-11#1)(2008-8#1)
source having##2##2##(2007-12#1)(2008-3#1)
source in a##11##3##(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#4)(2008-3#1)(2008-7#1)
source in combination with a##2##5##(2007-12#1)(2008-2#1)
source in the##20##3##(1993-9#1)(1995-1#1)(1995-8#1)(1996-4#1)(2007-11#1)(2007-12#3)(2007-8#2)(2008-10#1)(2008-3#5)(2008-5#1)(2008-6#1)(2012-12#1)(2013-1#1)
source in##47##2##(1993-5#1)(1993-9#1)(1995-1#1)(1995-8#1)(1996-4#1)(2005-8#1)(2006-12#1)(2007-11#5)(2007-12#5)(2007-4#1)(2007-8#3)(2008-10#4)(2008-2#9)(2008-3#7)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2012-12#1)(2013-1#1)
source is a##3##3##(2007-12#1)(2008-11#1)(2008-3#1)
source is also##3##3##(2007-12#2)(2008-2#1)
source is an##2##3##(2007-12#1)(2008-2#1)
source is demonstrated##2##3##(2007-12#1)(2008-1#1)
source is described##3##3##(2007-12#1)(2007-9#1)(2008-10#1)
source is located##2##3##(2008-3#2)
source is not##3##3##(2006-10#1)(2008-3#1)(2011-2#1)
source is used to##2##4##(2007-11#1)(2008-3#1)
source is used##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
source is##60##2##(1990-12#1)(1994-11#1)(2005-10#1)(2006-10#2)(2007-11#6)(2007-12#11)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#8)(2008-3#18)(2011-12#1)(2011-2#1)(2012-3#1)(2013-7#1)
source leaves##2##2##(2009-8#2)
source localization##2##2##(2004-11#1)(2008-11#1)
source located##2##2##(2008-3#2)
source material##4##2##(1990-11#1)(2008-3#1)(2008-4#1)(2008-7#1)
source may be##2##3##(2008-3#2)
source model##4##2##(2007-3#3)(2008-3#1)
source modulation##2##2##(2007-12#1)(2008-2#1)
source near##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
source of C##2##3##(1990-3#1)(2010-3#1)
source of DNA##2##3##(1991-11#1)(1995-11#1)
source of MSCs for##2##4##(2009-10#1)(2012-12#1)
source of MSCs##3##3##(2009-10#1)(2012-12#2)
source of NO##4##3##(1992-8#1)(1996-1#1)(1997-6#1)(2005-10#1)
source of a##8##3##(1994-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2010-9#1)(2013-1#1)
source of advice on##2##4##(2007-12#1)(2011-1#1)
source of advice##3##3##(2007-12#1)(2011-1#1)(2012-3#1)
source of animal protein consumed##2##5##(2013-7#2)
source of antigen for##3##4##(2008-4#2)(2011-1#1)
source of antimicrobials##2##3##(2012-12#2)
source of asbestos exposure##2##4##(1991-12#2)
source of asbestos##3##3##(1991-12#2)(2010-9#1)
source of atmospheric##3##3##(1992-6#1)(1995-3#1)(2013-7#1)
source of bacterial##2##3##(1997-3#1)(2012-2#1)
source of biomass##2##3##(2008-5#2)
source of bleeding##2##3##(2006-6#1)(2010-3#1)
source of both##3##3##(1994-3#1)(2008-4#1)(2011-1#1)
source of carbon and energy##3##5##(1994-12#1)(2006-3#1)(2011-2#1)
source of carbon##8##3##(1991-8#1)(1994-12#1)(2005-8#1)(2006-3#1)(2006-5#1)(2008-10#1)(2008-7#1)(2011-2#1)
source of cells for##3##4##(2008-9#1)(2012-12#1)(2013-1#1)
source of cells##5##3##(1995-12#1)(2008-5#1)(2008-9#1)(2012-12#1)(2013-1#1)
source of circulating##2##3##(2008-1#1)(2008-4#1)
source of contamination##2##3##(2007-2#1)(2010-4#1)
source of data on the##2##5##(1995-2#1)(2007-3#1)
source of data##5##3##(1995-2#1)(2007-3#1)(2008-4#1)(2013-1#2)
source of dietary##7##3##(2006-12#1)(2006-4#1)(2007-1#1)(2008-12#1)(2008-4#1)(2012-2#1)(2013-1#1)
source of drinking water##3##4##(2008-5#1)(2011-2#1)(2013-1#1)
source of drinking##4##3##(2007-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
source of energy and##2##4##(2006-3#1)(2012-12#1)
source of energy##10##3##(1995-1#1)(1997-6#1)(2006-3#1)(2007-2#1)(2008-4#1)(2008-6#3)(2011-2#1)(2012-12#1)
source of environmental##3##3##(1995-11#1)(2008-5#1)(2008-7#1)
source of enzyme##2##3##(1990-5#1)(1992-4#1)
source of error in##2##4##(2008-10#1)(2008-3#1)
source of error##5##3##(2006-5#1)(2008-10#2)(2008-3#2)
source of errors##2##3##(2008-2#1)(2008-3#1)
source of estrogens##2##3##(2012-2#1)(2013-1#1)
source of fear and##2##4##(1990-12#1)(2011-2#1)
source of febrile illness##2##4##(2006-2#2)
source of fish##2##3##(1992-8#1)(2007-5#1)
source of fluorescence##2##3##(2008-2#1)(2008-4#1)
source of fluoride##3##3##(1993-11#1)(2007-10#1)(2008-5#1)
source of free##3##3##(1994-9#1)(2008-5#1)(2009-9#1)
source of functional##2##3##(2012-2#1)(2013-1#1)
source of funding##4##3##(1992-1#1)(2007-4#1)(2007-6#1)(2008-7#1)
source of gender differences in##2##5##(2008-12#2)
source of health##4##3##(2008-10#3)(2012-12#1)
source of hematopoietic stem cells##2##5##(2007-8#1)(2008-1#1)
source of human##2##3##(2008-8#1)(2011-2#1)
source of hydrocarbons##2##3##(1992-3#1)(2007-9#1)
source of infected##2##3##(2008-10#2)
source of infection for##2##4##(1991-7#1)(2013-1#1)
source of infection is##2##4##(2007-12#1)(2011-12#1)
source of infection of##2##4##(1997-3#1)(2011-12#1)
source of infection##19##3##(1991-7#1)(1993-12#1)(1994-4#1)(1996-3#1)(1997-1#1)(1997-3#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-12#1)(2008-6#1)(2008-9#1)(2011-12#4)(2011-2#1)(2013-1#1)
source of information and##2##4##(1993-2#1)(2006-2#1)
source of information for##3##4##(2007-5#1)(2012-3#1)(2013-1#1)
source of information to##3##4##(2006-3#2)(2006-8#1)
source of information##15##3##(1993-2#1)(1995-12#1)(2006-10#1)(2006-2#1)(2006-3#2)(2006-8#1)(2007-5#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
source of injury##2##3##(2008-12#2)
source of inoculum and##2##4##(2008-10#2)
source of inoculum for##3##4##(2008-10#3)
source of inoculum##9##3##(2006-8#1)(2008-10#8)
source of islet##2##3##(2008-1#1)(2008-4#1)
source of knowledge##3##3##(2012-11#2)(2013-1#1)
source of lead exposure##2##4##(1991-11#1)(1993-6#1)
source of lead##4##3##(1991-11#1)(1993-6#2)(2007-6#1)
source of light##4##3##(1993-3#2)(2008-2#1)(2008-3#1)
source of low back##3##4##(2006-8#3)
source of major##2##3##(2006-8#1)(2012-2#1)
source of many##3##3##(2008-4#3)
source of medical##3##3##(2012-2#1)(2013-1#2)
source of medication##2##3##(2007-7#1)(2008-7#1)
source of microbial##2##3##(2008-5#1)(2012-2#1)
source of morbidity and mortality##4##5##(2006-10#1)(2006-6#1)(2007-6#1)(2010-6#1)
source of morbidity##5##3##(2006-10#1)(2006-6#1)(2007-6#1)(2010-6#1)(2012-3#1)
source of natural##2##3##(2010-7#1)(2013-8#1)
source of new##4##3##(2006-10#1)(2008-10#1)(2008-11#1)(2010-7#1)
source of nitrogen##2##3##(1994-3#1)(2008-5#1)
source of noise in##3##4##(2006-10#1)(2007-12#1)(2010-10#1)
source of noise##4##3##(2006-10#1)(2007-12#1)(2008-3#1)(2010-10#1)
source of nutrition##2##3##(1991-3#1)(2008-10#1)
source of organic carbon##2##4##(2008-10#2)
source of organs##2##3##(1991-2#1)(2007-11#1)
source of pain##5##3##(2006-8#1)(2007-11#2)(2013-1#1)(2013-7#1)
source of polyphenol oxidase##2##4##(2008-10#2)
source of potential##3##3##(2006-2#1)(2008-10#1)(2008-4#1)
source of primary inoculum##6##4##(2008-10#5)(2008-12#1)
source of primary##8##3##(2008-10#5)(2008-12#1)(2008-8#1)(2010-3#1)
source of progestin did not##2##5##(2008-12#2)
source of progestin##3##3##(2008-12#3)
source of protein##3##3##(1997-4#1)(2008-8#1)(2013-7#1)
source of radiation to##2##4##(2006-8#1)(2008-2#1)
source of radiation##3##3##(2006-8#1)(2008-2#2)
source of radical generation##2##4##(1994-9#2)
source of reactive oxygen species##2##5##(2006-2#1)(2011-1#1)
source of recurrent##2##3##(1994-5#1)(2011-2#1)
source of resistance##9##3##(2008-10#6)(2009-3#3)
source of secondary##2##3##(1994-3#1)(2007-7#1)
source of significance##2##3##(2011-1#2)
source of some##2##3##(2006-4#1)(2013-8#1)
source of stem cells##4##4##(2006-10#1)(2006-7#1)(2008-1#1)(2008-9#1)
source of stem rust resistance in oat breeding##2##8##(2008-10#2)
source of stem##6##3##(2006-10#1)(2006-7#1)(2008-1#1)(2008-10#2)(2008-9#1)
source of stress##3##3##(2007-8#1)(2008-11#1)(2012-1#1)
source of superoxide##2##3##(1995-3#1)(2008-1#1)
source of the infection##3##4##(2007-12#1)(2007-4#1)(2007-7#1)
source of the##49##3##(1991-12#2)(1991-2#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-9#1)(1994-12#1)(1994-2#1)(1995-1#2)(1995-11#2)(1995-5#1)(1995-8#1)(1995-9#1)(1996-4#1)(1996-5#2)(1997-1#1)(1997-4#1)(1997-5#1)(2006-2#1)(2006-8#1)(2007-12#2)(2007-3#1)(2007-4#2)(2007-7#2)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
source of these differences##2##4##(1990-5#1)(1993-11#1)
source of these##4##3##(1990-5#1)(1993-11#1)(2007-7#1)(2008-10#1)
source of this factor##2##4##(1991-8#1)(2009-3#1)
source of this##10##3##(1991-11#1)(1991-8#1)(1991-9#1)(1992-8#1)(1993-9#1)(2008-12#2)(2008-7#1)(2008-8#1)(2009-3#1)
source of variability##2##3##(2008-10#1)(2008-3#1)
source of variation in##4##4##(2006-5#2)(2009-2#1)(2010-4#1)
source of variation##6##3##(2006-5#2)(2008-10#2)(2009-2#1)(2010-4#1)
source of##727##2##(1990-1#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#3)(1990-5#2)(1990-7#1)(1990-8#3)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#4)(1991-2#2)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#4)(1992-11#1)(1992-12#3)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#4)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#2)(1993-8#4)(1993-9#4)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#4)(1994-4#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#6)(1995-1#6)(1995-11#5)(1995-12#4)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#3)(1996-11#1)(1996-3#3)(1996-4#1)(1996-5#5)(1996-7#2)(1997-1#6)(1997-2#1)(1997-3#4)(1997-4#3)(1997-5#2)(1997-6#2)(1997-8#1)(2004-1#1)(2004-11#3)(2004-4#1)(2004-5#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-3#1)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#13)(2006-11#2)(2006-12#4)(2006-2#7)(2006-3#6)(2006-4#2)(2006-5#6)(2006-6#4)(2006-7#2)(2006-8#14)(2007-1#3)(2007-10#5)(2007-11#5)(2007-12#16)(2007-2#6)(2007-3#3)(2007-4#3)(2007-5#5)(2007-6#8)(2007-7#8)(2007-8#8)(2007-9#1)(2008-1#12)(2008-10#74)(2008-11#16)(2008-12#20)(2008-2#11)(2008-3#17)(2008-4#23)(2008-5#22)(2008-6#9)(2008-7#12)(2008-8#9)(2008-9#8)(2009-10#1)(2009-2#1)(2009-3#8)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#3)(2010-1#3)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#3)(2010-3#4)(2010-4#6)(2010-5#1)(2010-6#4)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#10)(2011-12#4)(2011-2#14)(2012-1#12)(2012-11#6)(2012-12#15)(2012-2#15)(2012-3#6)(2013-1#36)(2013-7#7)(2013-8#9)
source on a##2##3##(2008-2#1)(2008-3#1)
source on the##4##3##(2004-11#2)(2006-6#1)(2007-3#1)
source on##9##2##(2004-11#2)(2006-5#1)(2006-6#1)(2007-3#1)(2008-12#1)(2008-2#1)(2008-3#1)(2010-10#1)
source operating##3##2##(2007-12#2)(2008-1#1)
source or##7##2##(1992-1#2)(1995-2#1)(2006-12#1)(2008-10#1)(2008-6#1)(2010-11#1)
source phase##3##2##(2008-10#3)
source plant##4##2##(2008-10#4)
source plants 21##2##3##(2008-10#2)
source plants displaying##2##3##(2008-10#2)
source plants##12##2##(2008-10#12)
source population##5##2##(1996-7#1)(2008-10#3)(2013-1#1)
source populations in##3##3##(1995-3#1)(2008-10#1)(2008-8#1)
source power##2##2##(2007-12#1)(2011-1#1)
source produces##2##2##(2008-3#2)
source reduction and##2##3##(2008-12#1)(2013-8#1)
source reduction##3##2##(2008-12#2)(2013-8#1)
source remained##2##2##(2007-9#1)(2008-10#1)
source size is##2##3##(2008-3#2)
source size##5##2##(2008-2#3)(2008-3#2)
source software##3##2##(2010-2#1)(2011-1#2)
source spectra##2##2##(2007-11#2)
source strength##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
source such as a##2##4##(2008-1#1)(2008-2#1)
source such as##3##3##(2008-1#1)(2008-2#2)
source such##4##2##(2008-1#1)(2008-2#3)
source terms##2##2##(2008-3#2)
source than##4##2##(2004-4#1)(2008-10#3)
source that is##5##3##(1994-11#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-3#1)
source that was##4##3##(2007-12#1)(2008-3#3)
source that##15##2##(1994-11#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#6)(2008-4#1)
source through##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
source tissue##3##2##(1991-8#1)(2008-10#2)
source to a##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
source to achieve##2##3##(2008-3#1)(2008-5#1)
source to the##5##3##(2007-12#2)(2008-10#1)(2008-2#1)(2010-9#1)
source to##32##2##(2006-4#1)(2006-6#1)(2007-12#5)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#4)(2008-3#4)(2008-5#1)(2008-7#1)(2009-3#1)(2010-11#1)(2010-5#1)(2010-9#1)(2012-2#2)(2012-3#1)(2013-1#2)
source used was##2##3##(2008-10#1)(2008-3#1)
source used##6##2##(1995-9#1)(1996-4#1)(2007-4#1)(2008-10#1)(2008-3#2)
source using##2##2##(2007-11#1)(2007-12#1)
source was a##6##3##(2007-1#1)(2007-12#3)(2008-3#1)(2008-5#1)
source was investigated##2##3##(2008-10#1)(2008-6#1)
source was used##4##3##(2008-3#1)(2010-4#1)(2011-3#2)
source was##34##2##(1994-4#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#5)(2008-10#5)(2008-2#3)(2008-3#3)(2008-5#2)(2008-6#1)(2008-9#1)(2010-4#2)(2011-2#2)(2011-3#2)(2012-12#1)(2013-1#2)
source water##2##2##(2008-9#1)(2011-12#1)
source wavelength##2##2##(2008-2#1)(2011-7#1)
source were compared##2##3##(2008-3#2)
source were##10##2##(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-6#1)
source when##3##2##(1992-1#1)(2006-6#1)(2008-10#1)
source which##2##2##(2008-10#1)(2012-2#1)
source while##2##2##(2006-9#1)(2008-10#1)
source will##2##2##(2007-11#1)(2008-11#1)
source with a##8##3##(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#3)
source with##21##2##(2007-11#2)(2007-12#7)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#5)(2009-4#1)(2012-11#1)(2012-12#1)(2013-7#1)
source within the##2##3##(2007-12#1)(2008-8#1)
source without##2##2##(2008-7#1)(2011-2#1)
source##2089##1##(1990-1#1)(1990-10#2)(1990-11#1)(1990-12#7)(1990-2#2)(1990-3#2)(1990-4#3)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#5)(1991-1#3)(1991-10#2)(1991-11#4)(1991-12#5)(1991-2#2)(1991-3#5)(1991-4#2)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#5)(1991-9#5)(1992-1#8)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#4)(1992-8#5)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#4)(1993-2#4)(1993-3#6)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#2)(1993-8#5)(1993-9#9)(1994-11#3)(1994-12#5)(1994-2#2)(1994-3#6)(1994-4#2)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#3)(1994-9#8)(1995-1#8)(1995-11#5)(1995-12#5)(1995-2#5)(1995-3#7)(1995-4#1)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#7)(1995-9#4)(1996-1#5)(1996-10#1)(1996-11#2)(1996-2#2)(1996-3#6)(1996-4#6)(1996-5#6)(1996-7#3)(1996-8#1)(1997-1#7)(1997-2#4)(1997-3#4)(1997-4#4)(1997-5#3)(1997-6#3)(1997-7#2)(1997-8#1)(2004-1#1)(2004-11#12)(2004-4#3)(2004-5#1)(2004-8#1)(2005-10#2)(2005-11#4)(2005-12#1)(2005-3#1)(2005-4#3)(2005-7#2)(2005-8#5)(2005-9#1)(2006-10#19)(2006-11#3)(2006-12#8)(2006-2#8)(2006-3#7)(2006-4#11)(2006-5#22)(2006-6#9)(2006-7#3)(2006-8#21)(2006-9#1)(2007-1#5)(2007-10#13)(2007-11#77)(2007-12#168)(2007-2#8)(2007-3#11)(2007-4#8)(2007-5#7)(2007-6#9)(2007-7#10)(2007-8#18)(2007-9#9)(2008-1#32)(2008-10#271)(2008-11#40)(2008-12#31)(2008-2#144)(2008-3#218)(2008-4#34)(2008-5#43)(2008-6#34)(2008-7#29)(2008-8#19)(2008-9#20)(2009-10#1)(2009-11#3)(2009-12#3)(2009-2#5)(2009-3#11)(2009-4#6)(2009-5#9)(2009-6#5)(2009-8#4)(2009-9#5)(2010-1#5)(2010-10#4)(2010-11#5)(2010-12#7)(2010-2#11)(2010-3#5)(2010-4#10)(2010-5#8)(2010-6#5)(2010-7#5)(2010-8#6)(2010-9#4)(2011-1#28)(2011-12#10)(2011-2#36)(2011-3#3)(2011-7#1)(2012-1#17)(2012-11#11)(2012-12#30)(2012-2#28)(2012-3#14)(2012-9#1)(2013-1#62)(2013-7#17)(2013-8#18)
source(s)##2##1##(1996-12#1)(1996-7#1)
source) were##2##2##(2006-8#1)(2008-10#1)
source)##9##1##(1995-2#2)(2006-8#2)(2008-10#1)(2008-3#1)(2008-4#1)(2010-2#1)(2011-2#1)
source-channel coding for motion-compensated DCT-based##2##5##(2008-2#2)
source-channel decoding##2##2##(2008-2#2)
source-channel##4##1##(2008-2#4)
source-detector configurations##2##2##(2008-3#2)
source-detector distance##2##2##(2008-2#1)(2008-3#1)
source-detector distances##2##2##(2008-2#1)(2008-3#1)
source-detector separation##3##2##(2008-3#3)
source-detector separations and##2##3##(2007-12#1)(2008-3#1)
source-detector separations##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
source-detector##18##1##(2007-12#2)(2008-2#3)(2008-3#10)(2011-1#3)
source-sink dynamics##4##2##(2008-8#4)
source-sink##11##1##(2008-8#9)(2008-9#2)
sourced from the##2##3##(2009-4#1)(2011-2#1)
sourced from##6##2##(2006-12#1)(2008-5#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
sourced##9##1##(2006-12#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
sources (e##6##2##(1990-4#1)(2008-10#1)(2008-4#3)(2008-5#1)
sources allows##2##2##(1991-3#1)(2008-7#1)
sources also##2##2##(1991-6#1)(2012-3#1)
sources and a##2##3##(1991-7#1)(2010-2#1)
sources and consequences of##2##4##(2006-3#1)(2008-4#1)
sources and detectors##2##3##(2008-3#2)
sources and has##2##3##(1994-9#1)(2008-10#1)
sources and is##2##3##(1992-6#1)(2008-11#1)
sources and methods##2##3##(1991-2#1)(2013-1#1)
sources and sinks##5##3##(2007-12#1)(2008-11#2)(2008-8#1)(2008-9#1)
sources and targets##2##3##(1992-9#1)(2008-10#1)
sources and the##2##3##(2004-11#1)(2012-2#1)
sources and to##6##3##(1996-8#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-5#1)
sources and with##2##3##(1994-3#1)(2008-2#1)
sources and##89##2##(1991-2#1)(1991-7#1)(1992-6#1)(1992-9#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-8#1)(1997-8#1)(2004-11#1)(2006-3#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-12#7)(2007-2#2)(2007-8#4)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#10)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-11#2)(2010-2#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#3)(2012-2#4)(2013-1#3)(2013-8#1)
sources appear to be##2##4##(1990-11#1)(1993-9#1)
sources appear##3##2##(1990-11#1)(1993-9#1)(1995-9#1)
sources are being##2##3##(2008-3#1)(2012-3#1)
sources are derived##2##3##(2008-2#2)
sources are used##3##3##(1995-12#1)(2008-10#1)(2008-3#1)
sources are##35##2##(1993-4#1)(1995-12#1)(1996-3#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#4)(2008-3#11)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)
sources as##6##2##(1996-6#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
sources at##7##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#1)
sources available##2##2##(2006-9#1)(2008-10#1)
sources based on##2##3##(2007-12#1)(2012-2#1)
sources by a##2##3##(1991-5#1)(2008-2#1)
sources by##3##2##(1991-5#1)(2008-2#2)
sources can be##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
sources can##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-9#1)
sources could be##2##3##(2008-5#1)(2008-6#1)
sources could##3##2##(2008-10#1)(2008-5#1)(2008-6#1)
sources for biomedical##2##3##(1993-3#1)(2010-1#1)
sources for the production of bioplastics by##2##7##(2008-6#2)
sources for the##6##3##(2008-1#1)(2008-4#1)(2008-6#3)(2008-9#1)
sources for##42##2##(1993-3#1)(1993-4#1)(1995-2#1)(1996-1#1)(1996-3#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#3)(2008-9#4)(2009-10#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-12#1)(2012-12#1)(2013-1#2)
sources from##5##2##(1990-11#1)(1993-2#1)(1997-6#1)(2008-10#1)(2010-1#1)
sources has been##2##3##(1996-2#1)(2008-3#1)
sources has##6##2##(1996-2#1)(2006-4#1)(2007-9#1)(2008-2#1)(2008-3#1)(2012-12#1)
sources have been##3##3##(1992-6#1)(2008-10#1)(2008-3#1)
sources have##10##2##(1992-6#1)(1995-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)
sources in an##2##3##(2008-7#1)(2012-12#1)
sources in both##2##3##(1990-6#1)(2008-2#1)
sources in the##20##3##(1991-9#1)(1996-3#1)(1997-1#1)(1997-2#1)(2005-7#2)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#2)(2009-9#1)(2011-7#1)(2012-3#1)(2013-8#1)
sources in##42##2##(1990-6#1)(1991-9#1)(1992-3#1)(1993-7#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(2004-4#1)(2005-7#2)(2007-11#2)(2007-12#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#3)(2008-3#6)(2008-5#3)(2008-7#2)(2009-9#1)(2010-10#1)(2010-7#1)(2011-7#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
sources include##5##2##(2006-8#1)(2007-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
sources included##4##2##(1993-6#1)(1997-3#1)(2005-9#1)(2008-12#1)
sources including##9##2##(1993-9#1)(1995-3#1)(2007-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-8#1)(2013-8#1)
sources is presented##4##3##(2007-12#1)(2008-10#1)(2008-3#2)
sources is##13##2##(1991-12#1)(1991-8#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)(2009-8#1)(2010-12#1)(2012-12#1)(2013-8#1)
sources like##2##2##(2008-2#1)(2008-6#1)
sources located##3##2##(2007-12#1)(2008-3#2)
sources may also##2##3##(1991-4#1)(2007-9#1)
sources may##4##2##(1991-4#1)(2007-8#1)(2007-9#1)(2008-7#1)
sources of a##2##3##(2008-11#1)(2011-1#1)
sources of advice##2##3##(2004-10#1)(2012-3#1)
sources of antioxidant and##2##4##(2008-4#2)
sources of bias##4##3##(1992-6#1)(2008-10#2)(2013-8#1)
sources of cadmium##2##3##(1993-9#1)(2009-5#1)
sources of cells for##2##4##(2008-1#1)(2008-11#1)
sources of contamination##5##3##(1994-3#1)(1996-3#1)(2006-5#1)(2008-10#1)(2012-2#1)
sources of data##7##3##(1990-12#2)(2008-1#2)(2008-7#1)(2011-3#1)(2012-3#1)
sources of dietary##3##3##(2004-11#1)(2011-2#1)(2012-2#1)
sources of diverted##2##3##(2012-1#2)
sources of drinking water##3##4##(2008-4#2)(2011-1#1)
sources of error are##2##4##(1991-12#1)(2008-3#1)
sources of error in the##2##5##(2008-2#1)(2008-3#1)
sources of error in##3##4##(2005-11#1)(2008-2#1)(2008-3#1)
sources of error##11##3##(1991-12#1)(1991-8#1)(2005-11#1)(2007-12#1)(2008-2#2)(2008-3#3)(2008-8#1)(2009-5#1)
sources of errors##3##3##(2006-10#1)(2008-10#1)(2008-3#1)
sources of exposure##3##3##(2004-4#1)(2008-3#1)(2013-1#1)
sources of funding##7##3##(1993-2#2)(1994-2#1)(1995-3#1)(1997-1#1)(1997-2#1)(1997-3#1)
sources of health care##2##4##(2008-3#1)(2009-5#1)
sources of health information##4##4##(2012-3#1)(2013-1#2)(2013-7#1)
sources of health##7##3##(2008-3#1)(2009-5#1)(2012-3#2)(2013-1#2)(2013-7#1)
sources of heterogeneity##2##3##(2008-12#1)(2008-8#1)
sources of human##2##3##(2008-4#1)(2010-12#1)
sources of income##2##3##(1995-5#1)(2012-12#1)
sources of infection in##3##4##(2007-7#1)(2012-3#2)
sources of infection##7##3##(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-3#2)(2013-1#1)
sources of information about##4##4##(1996-11#1)(2007-9#1)(2008-1#1)(2008-2#1)
sources of information are##2##4##(1995-12#1)(2011-2#1)
sources of information available##3##4##(1995-3#1)(2008-11#1)(2013-7#1)
sources of information##21##3##(1990-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1997-3#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-7#1)(2008-9#1)(2009-4#2)(2009-7#1)(2011-1#1)(2011-2#1)(2013-7#1)
sources of inoculum and##2##4##(2008-10#2)
sources of inoculum for##3##4##(2008-10#3)
sources of inoculum##11##3##(2008-10#11)
sources of input##2##3##(1991-3#1)(2008-9#1)
sources of interictal epileptiform activities##2##5##(2004-11#2)
sources of lead in house##2##5##(1993-9#2)
sources of lead in##3##4##(1993-9#2)(1997-4#1)
sources of lead##4##3##(1993-6#1)(1993-9#2)(1997-4#1)
sources of leaf rust resistance##2##5##(2008-10#2)
sources of measurement error##2##4##(2008-3#2)
sources of new##3##3##(2007-3#1)(2013-1#2)
sources of noise##3##3##(2008-2#1)(2008-3#1)(2008-4#1)
sources of nutrients##2##3##(2008-8#1)(2009-2#1)
sources of nutrition##2##3##(1991-3#2)
sources of pain##2##3##(2006-8#1)(2008-11#1)
sources of patient education##2##4##(1991-3#1)(2006-9#1)
sources of perceived##2##3##(2010-1#2)
sources of pollution##4##3##(2007-10#1)(2007-5#2)(2009-6#1)
sources of potential##2##3##(2008-12#1)(2011-2#1)
sources of primary inoculum##2##4##(2008-10#2)
sources of proteins##3##3##(2006-10#1)(2008-5#2)
sources of resistance and##2##4##(2008-10#2)
sources of resistance to##3##4##(2008-10#3)
sources of resistance##8##3##(2008-10#7)(2011-2#1)
sources of stem cells##5##4##(2007-8#1)(2008-1#1)(2012-12#3)
sources of stress##2##3##(2007-2#1)(2012-3#1)
sources of support##4##3##(2007-7#1)(2009-7#1)(2010-1#1)(2010-10#1)
sources of systematic##2##3##(2008-3#2)
sources of the##10##3##(1990-5#1)(1990-8#1)(1992-3#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-9#1)(2012-3#1)
sources of these##2##3##(1996-1#1)(2009-11#1)
sources of uncertainty##5##3##(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)
sources of variability##8##3##(1994-8#2)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-3#1)
sources of variation in the##2##5##(2008-7#1)(2010-8#1)
sources of variation in##3##4##(2008-10#1)(2008-7#1)(2010-8#1)
sources of variation##6##3##(1992-6#1)(2008-10#1)(2008-7#2)(2010-8#1)(2011-2#1)
sources of vitamin D##2##4##(2010-7#1)(2012-3#1)
sources of water##8##3##(2007-10#1)(2008-10#1)(2012-3#3)(2013-8#3)
sources of##399##2##(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#4)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#2)(1992-6#3)(1993-12#1)(1993-2#3)(1993-6#2)(1993-8#1)(1993-9#4)(1994-2#1)(1994-3#2)(1994-8#2)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(2004-10#1)(2004-11#6)(2004-12#1)(2004-4#1)(2005-10#1)(2005-11#2)(2006-10#4)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#4)(2007-3#1)(2007-4#2)(2007-5#5)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#10)(2008-10#51)(2008-11#8)(2008-12#6)(2008-2#6)(2008-3#20)(2008-4#14)(2008-5#10)(2008-7#7)(2008-8#7)(2008-9#7)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#5)(2009-6#1)(2009-7#3)(2009-9#3)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#4)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#3)(2011-12#1)(2011-2#11)(2011-3#3)(2012-1#6)(2012-11#2)(2012-12#8)(2012-2#9)(2012-3#13)(2013-1#17)(2013-7#2)(2013-8#6)
sources offer a##2##3##(1996-1#1)(2010-9#1)
sources on growth##2##3##(2008-12#1)(2008-5#1)
sources on the##4##3##(2008-10#1)(2011-8#1)(2012-3#2)
sources on##8##2##(2008-10#2)(2008-12#1)(2008-5#1)(2011-1#1)(2011-8#1)(2012-3#2)
sources or##6##2##(1990-3#1)(1991-3#1)(2006-12#1)(2007-5#1)(2008-10#1)(2009-8#1)
sources previously##2##2##(2008-10#2)
sources should be##2##3##(2012-3#1)(2013-1#1)
sources show that##2##3##(2009-4#1)(2009-7#1)
sources so that##2##3##(2008-2#2)
sources such as##13##3##(1996-3#1)(1997-3#1)(2004-4#1)(2006-4#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#1)
sources that##4##2##(2008-3#1)(2011-1#1)(2012-12#1)(2013-1#1)
sources to identify##2##3##(2010-11#1)(2011-8#1)
sources to the##5##3##(1997-7#1)(2007-10#1)(2008-10#1)(2008-2#1)(2012-1#1)
sources to##26##2##(1991-11#1)(1991-3#1)(1992-1#1)(1993-4#1)(1995-1#1)(1997-5#1)(1997-7#1)(2005-12#1)(2006-3#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-2#1)(2010-11#2)(2011-2#2)(2011-8#1)(2012-1#1)
sources used to##2##3##(1991-2#1)(2010-11#1)
sources used##5##2##(1991-2#1)(2008-2#1)(2008-3#1)(2010-11#1)(2012-12#1)
sources using##2##2##(1995-12#1)(2010-4#1)
sources was studied##3##3##(2004-11#1)(2008-10#1)(2008-5#1)
sources was##10##2##(1994-10#1)(2004-11#1)(2008-10#3)(2008-5#1)(2012-2#1)(2013-1#3)
sources were determined##3##3##(2008-10#2)(2008-8#1)
sources were used##5##3##(1995-1#1)(1996-2#1)(2011-2#1)(2013-1#2)
sources were##27##2##(1991-5#1)(1992-1#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-5#1)(2004-11#1)(2004-4#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-8#1)(2010-2#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
sources when##2##2##(2008-10#1)(2008-2#1)
sources which are##2##3##(1995-9#1)(2007-8#1)
sources which##5##2##(1990-12#1)(1992-1#1)(1995-9#1)(2007-8#1)(2010-5#1)
sources will##2##2##(2006-7#1)(2012-2#1)
sources with a##2##3##(2007-11#1)(2008-2#1)
sources with##11##2##(1991-8#1)(1992-3#1)(1995-12#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-4#1)
sources within the##2##3##(1996-2#1)(2008-10#1)
sources##1295##1##(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#2)(1990-6#3)(1990-8#3)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#6)(1991-2#4)(1991-3#9)(1991-4#1)(1991-5#4)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#2)(1992-1#5)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#8)(1992-4#4)(1992-5#2)(1992-6#8)(1992-7#4)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#8)(1993-3#2)(1993-4#3)(1993-6#3)(1993-7#1)(1993-8#3)(1993-9#6)(1994-10#2)(1994-12#1)(1994-2#2)(1994-3#4)(1994-5#3)(1994-8#2)(1994-9#3)(1995-1#6)(1995-12#6)(1995-2#4)(1995-3#8)(1995-4#3)(1995-5#3)(1995-6#1)(1995-8#2)(1995-9#5)(1996-1#4)(1996-11#4)(1996-12#4)(1996-2#8)(1996-3#6)(1996-4#1)(1996-5#2)(1996-6#4)(1996-7#3)(1996-8#2)(1996-9#2)(1997-1#6)(1997-2#3)(1997-3#7)(1997-4#5)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#1)(2004-10#2)(2004-11#11)(2004-12#1)(2004-4#5)(2005-10#1)(2005-11#4)(2005-12#1)(2005-7#4)(2005-8#2)(2005-9#1)(2006-10#9)(2006-12#4)(2006-3#6)(2006-4#14)(2006-5#11)(2006-6#1)(2006-7#4)(2006-8#6)(2006-9#7)(2007-1#6)(2007-10#5)(2007-11#18)(2007-12#42)(2007-2#8)(2007-3#3)(2007-4#4)(2007-5#14)(2007-7#3)(2007-8#23)(2007-9#8)(2008-1#19)(2008-10#146)(2008-11#31)(2008-12#11)(2008-2#59)(2008-3#97)(2008-4#31)(2008-5#36)(2008-6#9)(2008-7#30)(2008-8#14)(2008-9#24)(2009-10#6)(2009-11#4)(2009-12#2)(2009-2#6)(2009-3#3)(2009-4#4)(2009-5#7)(2009-6#1)(2009-7#5)(2009-8#3)(2009-9#6)(2010-1#5)(2010-10#2)(2010-11#7)(2010-12#5)(2010-2#10)(2010-4#4)(2010-5#8)(2010-6#2)(2010-7#3)(2010-8#4)(2010-9#7)(2011-1#17)(2011-12#3)(2011-2#28)(2011-3#4)(2011-7#2)(2011-8#2)(2012-1#12)(2012-11#5)(2012-12#23)(2012-2#23)(2012-3#25)(2013-1#44)(2013-7#5)(2013-8#18)
sources)##8##1##(1992-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2010-10#1)(2013-1#1)
sourcing of##2##2##(2008-11#1)(2009-7#1)
sourcing##5##1##(2006-12#1)(2008-11#2)(2009-7#1)(2011-1#1)
soursop (guanábana)##3##2##(2012-12#3)
sous##5##1##(2012-2#4)(2013-1#1)
south Asia##2##2##(1994-3#1)(2007-10#1)
south India##16##2##(1992-11#1)(2007-7#3)(2007-8#3)(2008-3#1)(2010-10#1)(2010-9#1)(2012-2#1)(2012-3#5)
south Indian population##2##3##(2012-2#1)(2012-3#1)
south London##3##2##(1996-8#3)
south and##2##2##(1991-4#1)(2008-10#1)
south east Nigeria##2##3##(2007-3#1)(2013-1#1)
south east##4##2##(2007-3#1)(2010-3#1)(2013-1#2)
south eastern##2##2##(2008-10#1)(2013-7#1)
south of Cap Rhir##2##4##(2013-1#2)
south of the##9##3##(2007-2#1)(2007-9#1)(2008-10#3)(2008-2#1)(2009-5#1)(2012-12#1)(2012-2#1)
south of##28##2##(1990-12#2)(1992-9#1)(2004-4#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-10#9)(2008-2#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-8#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
south than in##2##3##(2008-10#2)
south than##3##2##(2007-5#1)(2008-10#2)
south to##4##2##(2008-10#2)(2008-9#1)(2012-3#1)
south west##2##2##(1995-9#1)(2012-12#1)
south western Nigeria##2##3##(2010-3#1)(2010-8#1)
south western##4##2##(2005-9#1)(2006-9#1)(2010-3#1)(2010-8#1)
south zone##2##2##(2011-2#2)
south##107##1##(1990-12#2)(1991-11#1)(1991-4#1)(1992-11#1)(1992-8#1)(1992-9#1)(1994-3#2)(1995-9#1)(1996-3#1)(1996-8#3)(2004-4#2)(2005-9#1)(2006-2#1)(2006-4#1)(2006-9#2)(2007-1#1)(2007-10#4)(2007-2#1)(2007-3#1)(2007-5#4)(2007-7#6)(2007-8#3)(2007-9#3)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#2)(2010-10#1)(2010-3#2)(2010-8#2)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#7)(2013-1#5)(2013-7#4)(2013-8#2)
south-central##4##1##(2007-3#1)(2008-10#3)
south-east of##2##2##(2012-11#1)(2012-2#1)
south-east##7##1##(2007-3#3)(2010-8#1)(2012-11#1)(2012-2#1)(2013-1#1)
south-eastern##9##1##(1994-5#1)(2006-2#1)(2007-3#2)(2008-8#2)(2010-8#2)(2013-1#1)
south-west##5##1##(1991-5#1)(1993-8#1)(2010-3#1)(2010-8#1)(2011-2#1)
south-western Nigeria##7##2##(2007-1#1)(2007-3#2)(2013-8#4)
south-western##14##1##(1997-4#1)(2007-1#1)(2007-3#2)(2008-12#1)(2008-4#1)(2010-3#2)(2010-8#2)(2013-8#4)
southeast Asia##5##2##(1991-9#1)(1994-9#1)(2006-10#1)(2006-11#1)(2008-6#1)
southeast of##3##2##(2006-12#1)(2008-12#1)(2012-2#1)
southeast##29##1##(1991-11#1)(1991-3#1)(1991-9#2)(1994-9#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-2#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-4#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#1)
southeastern Brazil##7##2##(2007-3#2)(2008-5#2)(2008-6#3)
southeastern Nigeria##7##2##(2008-2#2)(2008-4#3)(2011-2#1)(2012-3#1)
southeastern Spain##3##2##(2007-7#1)(2008-10#2)
southeastern USA##4##2##(2006-6#1)(2007-7#2)(2012-11#1)
southeastern United States has##2##4##(2008-10#1)(2012-1#1)
southeastern United States##22##3##(1992-8#1)(1993-1#1)(1994-1#1)(2007-12#1)(2008-10#9)(2008-4#1)(2008-5#1)(2011-2#5)(2012-1#2)
southeastern state##2##2##(1996-12#1)(1996-2#1)
southeastern##66##1##(1992-8#1)(1993-1#1)(1994-1#1)(1995-2#1)(1996-12#1)(1996-2#1)(2006-4#2)(2006-6#1)(2007-12#1)(2007-3#4)(2007-7#3)(2008-1#1)(2008-10#14)(2008-12#1)(2008-2#2)(2008-4#4)(2008-5#6)(2008-6#4)(2008-8#1)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#7)(2012-1#2)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
southern Africa##13##2##(1994-6#1)(1995-7#1)(2006-4#1)(2007-7#3)(2008-10#1)(2009-2#1)(2010-1#2)(2011-2#1)(2012-3#1)(2013-1#1)
southern African##4##2##(1994-6#3)(1997-6#1)
southern Arizona##5##2##(2008-10#1)(2008-9#1)(2009-8#2)(2011-2#1)
southern Asia##2##2##(2006-10#1)(2009-11#1)
southern California##11##2##(1996-4#2)(2008-10#5)(2009-4#1)(2011-2#1)(2012-1#2)
southern Californian soil##2##3##(2008-10#2)
southern Cameroon##2##2##(2011-12#2)
southern Chile##2##2##(2007-5#1)(2007-8#1)
southern China##8##2##(1991-6#1)(2008-10#1)(2011-1#3)(2013-1#2)(2013-7#1)
southern Egypt##2##2##(1994-9#1)(2008-10#1)
southern Europe##3##2##(2010-1#1)(2011-2#2)
southern Florida##2##2##(2004-11#1)(2008-10#1)
southern Germany##3##2##(1994-3#1)(2008-10#1)(2008-8#1)
southern India##11##2##(1995-7#1)(2007-7#1)(2008-10#1)(2012-3#6)(2013-1#2)
southern Iran##2##2##(2009-7#1)(2013-8#1)
southern Italy##7##2##(1996-3#1)(1996-4#1)(1997-5#1)(2008-4#1)(2008-7#1)(2008-8#2)
southern Mexico##2##2##(2004-11#2)
southern New Jersey##2##3##(1997-3#1)(2008-10#1)
southern New##3##2##(1997-3#1)(2008-10#2)
southern Nigeria##3##2##(2007-12#1)(2011-11#1)(2013-7#1)
southern Oman (0##2##3##(2012-12#2)
southern Ontario##2##2##(1992-6#1)(1994-3#1)
southern Somalia##4##2##(2011-2#4)
southern Spain##9##2##(2008-10#9)
southern Sudan##3##2##(2005-9#2)(2008-4#1)
southern Taiwan##4##2##(2008-10#1)(2010-8#1)(2013-8#2)
southern Tanzania##2##2##(2005-8#2)
southern United States##2##3##(2008-10#1)(2008-11#1)
southern and northern##4##3##(2008-8#3)(2013-1#1)
southern and##10##2##(2008-10#3)(2008-11#1)(2008-8#3)(2010-2#1)(2011-12#1)(2013-1#1)
southern blight##4##2##(2008-10#4)
southern corn##2##2##(2008-10#2)
southern division meeting##8##3##(2008-11#8)
southern hemisphere##2##2##(2009-2#1)(2009-5#1)
southern ocean islands##3##3##(2008-8#1)(2008-9#2)
southern ocean##4##2##(1991-3#1)(2008-8#1)(2008-9#2)
southern parts of##3##3##(2007-1#1)(2012-11#1)(2013-7#1)
southern parts##4##2##(1997-6#1)(2007-1#1)(2012-11#1)(2013-7#1)
southern##295##1##(1990-6#1)(1991-12#2)(1991-3#1)(1991-6#3)(1991-7#1)(1992-6#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-3#2)(1994-6#4)(1994-9#2)(1995-6#1)(1995-7#2)(1995-8#2)(1996-12#2)(1996-3#1)(1996-4#5)(1996-8#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-8#1)(2004-11#3)(2005-5#1)(2005-8#6)(2005-9#2)(2006-10#3)(2006-2#1)(2006-4#4)(2006-8#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-2#3)(2007-3#2)(2007-5#3)(2007-6#2)(2007-7#4)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#59)(2008-11#10)(2008-3#3)(2008-4#4)(2008-5#7)(2008-7#1)(2008-8#12)(2008-9#3)(2009-11#1)(2009-2#2)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#3)(2010-1#4)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-8#13)(2010-9#1)(2011-1#4)(2011-11#1)(2011-12#3)(2011-2#18)(2012-1#3)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#11)(2013-1#16)(2013-7#4)(2013-8#10)
southernmost##7##1##(1992-4#1)(1992-8#1)(2007-5#2)(2008-2#1)(2008-5#1)(2009-8#1)
southward##3##1##(2008-10#2)(2010-1#1)
southwest France##2##2##(2008-10#2)
southwest of##4##2##(2007-2#1)(2008-12#1)(2008-9#1)(2010-5#1)
southwest##25##1##(1997-6#2)(2004-4#2)(2007-10#1)(2007-2#1)(2007-3#2)(2007-5#1)(2008-10#8)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-5#1)(2011-12#1)(2012-2#1)
southwestern Nigeria##2##2##(2007-3#1)(2011-1#1)
southwestern Ontario##3##2##(1996-12#1)(1997-3#1)(2008-10#1)
southwestern##35##1##(1990-8#3)(1991-10#1)(1992-1#1)(1992-7#1)(1993-5#1)(1993-7#1)(1994-3#1)(1996-12#1)(1997-3#1)(2004-11#1)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#8)(2008-12#1)(2008-9#1)(2009-10#1)(2010-11#1)(2011-1#1)(2011-12#2)(2012-3#1)
souvent##5##1##(2011-2#3)(2012-2#1)(2013-1#1)
sovereignty##2##1##(2008-2#2)
sovra-molecular complex between the##2##4##(1992-4#2)
sow and##2##2##(2005-11#1)(2010-4#1)
sow##7##1##(1990-9#1)(2005-11#2)(2006-8#2)(2010-4#1)(2013-8#1)
sowing and##3##2##(2008-10#2)(2008-12#1)
sowing date##11##2##(2008-10#9)(2013-8#2)
sowing dates##2##2##(2013-8#2)
sowing distances##7##2##(2008-12#7)
sowing##41##1##(1992-3#1)(2006-12#1)(2008-10#14)(2008-12#13)(2008-5#1)(2012-11#1)(2013-8#10)
sowing)##3##1##(2013-8#3)
sowings##3##1##(2008-10#2)(2012-7#1)
sown in early##2##3##(2012-2#1)(2013-8#1)
sown in##3##2##(2008-10#1)(2012-2#1)(2013-8#1)
sown with##3##2##(2008-10#1)(2008-12#2)
sown##10##1##(2008-10#4)(2008-12#2)(2012-2#1)(2013-8#3)
sows and##5##2##(1992-12#3)(2006-5#1)(2010-2#1)
sows by##2##2##(2006-5#2)
sows fed the##4##3##(2010-2#4)
sows fed##5##2##(2010-2#5)
sows were##6##2##(1990-3#2)(2010-2#4)
sows with##2##2##(1992-12#1)(2006-5#1)
sows##46##1##(1990-3#2)(1991-11#1)(1992-12#14)(2006-5#8)(2008-8#3)(2010-2#15)(2012-1#2)(2013-1#1)
soxhlet extraction##4##2##(2008-10#3)(2011-12#1)
soxhlet##5##1##(2007-3#1)(2008-10#3)(2011-12#1)
soy and tabasco##2##3##(1997-3#2)
soy and##3##2##(1997-3#2)(2008-10#1)
soy bean##3##2##(1991-10#1)(1993-8#1)(2008-10#1)
soy flour##2##2##(2008-5#2)
soy hydrolysate##4##2##(2008-11#4)
soy isoflavones##2##2##(2008-10#2)
soy products##2##2##(2007-2#1)(2008-7#1)
soy protein##5##2##(1996-3#1)(2008-7#1)(2010-12#1)(2010-4#1)(2012-2#1)
soy sauce and hot-pepper paste##2##5##(2010-4#2)
soy sauce and##4##3##(2008-10#1)(2010-4#2)(2011-1#1)
soy sauce##11##2##(1996-2#4)(2008-10#1)(2010-4#3)(2011-1#2)(2012-11#1)
soy##46##1##(1991-10#1)(1993-8#1)(1996-2#4)(1996-3#1)(1996-8#1)(1997-3#2)(2006-8#1)(2007-2#1)(2008-10#6)(2008-11#5)(2008-2#1)(2008-5#2)(2008-7#3)(2010-1#2)(2010-12#1)(2010-4#4)(2011-1#3)(2012-11#1)(2012-2#2)(2013-1#4)
soya bean##4##2##(1990-3#2)(2008-5#1)(2012-12#1)
soya beans##2##2##(2008-3#2)
soya biopeptide##3##2##(2008-5#3)
soya peptide##2##2##(2008-5#2)
soya##24##1##(1990-3#2)(1993-12#2)(1997-2#1)(2008-10#3)(2008-3#2)(2008-5#7)(2008-8#1)(2012-12#5)(2013-8#1)
soya-based##2##1##(1991-9#2)
soybean (Glycine max (L##6##4##(2012-11#6)
soybean (Glycine max L##4##4##(1990-5#1)(1997-6#1)(2008-12#1)(2012-2#1)
soybean (Glycine max##11##3##(1990-5#1)(1997-6#1)(2008-12#1)(2012-11#7)(2012-2#1)
soybean (Glycine max) plants##2##4##(2008-10#2)
soybean (Glycine max)##15##3##(1990-7#1)(1991-12#1)(2008-10#6)(2008-11#1)(2012-11#2)(2012-2#2)(2013-1#2)
soybean (Glycine soja Sieb##2##4##(2012-11#2)
soybean (Glycine##29##2##(1990-5#1)(1990-7#1)(1991-12#1)(1997-6#1)(2008-10#6)(2008-11#1)(2008-12#1)(2010-11#1)(2012-11#11)(2012-2#3)(2013-1#2)
soybean (diet##2##2##(2008-12#2)
soybean Bowman-Birk inhibitor##2##3##(1996-12#2)
soybean PC##3##2##(1995-8#2)(2005-11#1)
soybean Sclerotinia stem rot (SSR)##2##5##(2008-10#2)
soybean [Glycine max (L##2##4##(2011-2#1)(2012-11#1)
soybean accessions##3##2##(2012-11#3)
soybean after##3##2##(2008-10#2)(2013-1#1)
soybean agglutinin##4##2##(1995-11#4)
soybean and the##3##3##(2008-10#2)(2008-12#1)
soybean and##21##2##(1994-2#1)(1995-3#1)(2008-10#10)(2008-11#1)(2008-12#1)(2011-2#1)(2012-11#4)(2013-1#2)
soybean asolecithin##3##2##(1990-11#3)
soybean by##3##2##(2008-10#3)
soybean cultivar response to S##2##5##(2008-10#2)
soybean cultivar##4##2##(2008-10#3)(2012-11#1)
soybean cultivars##13##2##(2008-10#4)(2012-11#9)
soybean cv##2##2##(2008-10#1)(2012-11#1)
soybean cvs##2##2##(2008-10#2)
soybean cyst nematode##5##3##(2008-10#2)(2009-3#2)(2012-11#1)
soybean domestication##2##2##(2012-11#2)
soybean dwarf##2##2##(2008-10#2)
soybean fields in##4##3##(2008-10#4)
soybean fields##8##2##(2008-10#7)(2013-7#1)
soybean genome database##2##3##(2012-11#2)
soybean genome is##2##3##(2010-10#1)(2012-11#1)
soybean genome sequence##2##3##(2012-11#2)
soybean genome##14##2##(1995-3#1)(2006-12#1)(2010-10#1)(2012-11#11)
soybean genotypes carrying##2##3##(2008-10#2)
soybean genotypes##4##2##(2008-10#3)(2009-3#1)
soybean germplasm##3##2##(2012-11#3)
soybean has been##3##3##(2008-10#1)(2012-11#2)
soybean hull flour##4##3##(2012-2#4)
soybean hull##5##2##(2008-10#1)(2012-2#4)
soybean hypocotyls##4##2##(1997-6#3)(2008-10#1)
soybean in the##2##3##(2008-10#1)(2012-11#1)
soybean is##4##2##(2008-10#2)(2011-2#1)(2012-11#1)
soybean landraces##3##2##(2012-11#3)
soybean leaves and##2##3##(1995-3#1)(2008-10#1)
soybean leaves##3##2##(1995-3#1)(2008-10#2)
soybean lecithin##2##2##(2005-10#1)(2008-11#1)
soybean lipoxygenase L-1##4##3##(1992-7#2)(1993-6#2)
soybean lipoxygenase##8##2##(1990-7#1)(1992-7#2)(1993-6#3)(2006-1#1)(2008-6#1)
soybean meal##4##2##(2012-2#4)
soybean nodules##2##2##(1995-3#1)(1997-6#1)
soybean oil with##3##3##(2004-8#1)(2008-5#1)(2008-6#1)
soybean oil##31##2##(2004-11#1)(2004-8#6)(2007-8#8)(2008-10#5)(2008-5#7)(2008-6#2)(2012-11#1)(2012-2#1)
soybean peptone##3##2##(2008-5#3)
soybean peroxygenase##2##2##(1990-12#2)
soybean plants in##2##3##(2008-10#2)
soybean plants were##2##3##(2008-10#2)
soybean plants##14##2##(2008-10#12)(2010-11#1)(2012-11#1)
soybean production##4##2##(2008-10#3)(2012-11#1)
soybean resulted in##3##3##(2006-12#1)(2008-10#2)
soybean resulted##4##2##(2006-12#1)(2008-10#2)(2008-12#1)
soybean roots##4##2##(2008-10#3)(2009-3#1)
soybean rust epidemics##2##3##(2008-10#2)
soybean rust##22##2##(2008-10#22)
soybean seed oil##2##3##(2012-11#2)
soybean seed##8##2##(2006-12#2)(2008-10#3)(2012-11#3)
soybean seedlings##6##2##(1993-8#1)(2008-10#3)(2008-8#2)
soybean seeds##4##2##(1990-11#1)(2006-12#1)(2008-10#1)(2012-11#1)
soybean sites and##2##3##(2013-1#2)
soybean sites##3##2##(2013-1#3)
soybean stem##5##2##(2008-10#5)
soybean stems and##3##3##(2008-10#1)(2011-2#2)
soybean stems##6##2##(2008-10#4)(2011-2#2)
soybean tissue##4##2##(2008-10#4)
soybean transformation##3##2##(2012-11#3)
soybean trypsin inhibitor and aprotinin##2##5##(1991-8#1)(1992-8#1)
soybean trypsin inhibitor and##3##4##(1991-8#1)(1992-8#1)(1995-7#1)
soybean trypsin inhibitor##8##3##(1990-12#1)(1991-2#1)(1991-8#1)(1992-8#1)(1994-6#1)(1995-5#1)(1995-7#1)(1996-11#1)
soybean varieties##5##2##(2008-12#1)(2008-8#1)(2009-3#2)(2011-2#1)
soybean variety##3##2##(2008-12#2)(2011-2#1)
soybean was domesticated from##2##4##(2012-11#2)
soybean was##3##2##(2008-10#1)(2012-11#2)
soybean were##2##2##(2008-10#2)
soybean##490##1##(1990-11#5)(1990-12#4)(1990-2#1)(1990-5#3)(1990-7#3)(1991-10#1)(1991-12#2)(1991-2#2)(1991-8#3)(1992-1#1)(1992-7#2)(1992-8#3)(1993-12#1)(1993-6#3)(1993-8#2)(1994-2#2)(1994-6#1)(1994-9#1)(1995-10#2)(1995-11#4)(1995-3#5)(1995-5#1)(1995-7#1)(1995-8#2)(1996-11#1)(1996-12#2)(1997-6#8)(1997-7#1)(2004-11#1)(2004-8#6)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-12#7)(2007-11#1)(2007-2#1)(2007-8#8)(2008-10#184)(2008-11#4)(2008-12#13)(2008-5#10)(2008-6#3)(2008-7#6)(2008-8#6)(2009-10#1)(2009-12#1)(2009-3#6)(2010-10#2)(2010-11#2)(2010-3#1)(2011-10#1)(2011-2#13)(2012-11#112)(2012-2#18)(2013-1#11)(2013-7#1)
soybean-nodulating bacteria##2##2##(2013-1#2)
soybean-producing##2##1##(2008-10#1)(2012-11#1)
soybeans and##2##2##(2007-2#1)(2012-11#1)
soybeans in##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
soybeans##28##1##(2006-12#2)(2007-2#1)(2008-10#10)(2008-7#1)(2009-10#1)(2011-2#3)(2012-11#8)(2013-1#2)
sp PCC 7120##2##3##(2008-8#1)(2013-8#1)
sp and##3##2##(2007-2#2)(2008-3#1)
sp##923##1##(1990-1#2)(1990-12#1)(1990-4#1)(1990-9#1)(1991-12#3)(1991-5#2)(1991-6#1)(1991-8#3)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#3)(1992-7#2)(1993-3#2)(1993-4#2)(1993-7#1)(1994-11#3)(1994-12#5)(1994-3#3)(1994-5#2)(1994-8#1)(1995-1#2)(1995-12#2)(1995-2#6)(1995-3#3)(1995-4#1)(1995-6#4)(1995-8#2)(1996-12#3)(1996-5#1)(1996-6#5)(1996-7#8)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#1)(1997-4#2)(1997-6#17)(1997-7#2)(2005-11#15)(2005-12#2)(2005-7#6)(2006-10#5)(2006-12#4)(2006-3#6)(2006-5#2)(2006-8#20)(2007-1#1)(2007-11#2)(2007-12#4)(2007-2#5)(2007-3#12)(2007-5#5)(2007-6#1)(2007-7#5)(2007-9#3)(2008-10#414)(2008-11#2)(2008-12#23)(2008-3#5)(2008-4#29)(2008-5#53)(2008-6#24)(2008-7#7)(2008-8#7)(2008-9#5)(2009-10#4)(2009-2#4)(2009-3#3)(2009-4#4)(2009-6#14)(2009-9#1)(2010-10#3)(2010-3#2)(2010-4#11)(2010-8#3)(2011-1#17)(2011-12#1)(2011-2#16)(2012-1#1)(2012-12#2)(2012-2#22)(2012-3#5)(2013-1#6)(2013-7#13)(2013-8#15)
sp(3)##2##1##(2009-3#1)(2010-12#1)
sp3-hybridized##2##1##(2007-11#2)
spa therapy with Politzer##2##4##(2008-4#2)
spa therapy with##3##3##(2008-4#3)
spa therapy##5##2##(2008-4#5)
spa##13##1##(1991-11#1)(1992-11#1)(1994-3#2)(1997-1#2)(2006-12#1)(2008-4#5)(2008-7#1)
space Green's function##2##3##(1992-9#1)(2011-1#1)
space acquisition##3##2##(2008-8#2)(2008-9#1)
space after##3##2##(1993-10#1)(2007-10#1)(2007-8#1)
space analysis of##2##3##(2005-9#1)(2009-8#1)
space analysis##4##2##(2005-9#1)(2007-12#1)(2008-5#1)(2009-8#1)
space and a##3##3##(2007-12#1)(2008-2#1)(2013-8#1)
space and are##4##3##(1994-3#2)(2007-1#1)(2008-2#1)
space and frequency##2##3##(2007-11#1)(2008-2#1)
space and in##3##3##(1992-2#1)(2008-3#1)(2008-4#1)
space and is##2##3##(2008-1#1)(2013-1#1)
space and the##8##3##(2008-1#2)(2008-2#1)(2008-3#1)(2008-7#1)(2012-12#1)(2013-8#2)
space and time##30##3##(1995-8#1)(1995-9#1)(2006-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#2)(2009-9#1)(2010-5#1)(2010-8#1)(2013-1#5)(2013-8#1)
space and##107##2##(1991-12#1)(1992-11#1)(1992-2#1)(1993-6#1)(1993-9#3)(1994-11#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-4#1)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#4)(2008-1#4)(2008-10#4)(2008-12#1)(2008-2#11)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#5)(2009-6#1)(2009-8#3)(2009-9#1)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#3)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#8)(2013-8#5)
space applications##2##2##(2008-2#1)(2008-3#1)
space are the##2##3##(2006-8#1)(2008-3#1)
space are##9##2##(1993-10#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#2)(2008-11#1)(2008-3#2)
space as##4##2##(1991-12#1)(2006-10#1)(2008-7#1)(2013-8#1)
space at the##2##3##(1993-10#1)(2008-5#1)
space at##6##2##(1993-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-3#2)
space available##4##2##(1991-1#1)(2008-9#1)(2010-2#1)(2011-2#1)
space between the##5##3##(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-12#1)
space between##8##2##(1995-4#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)
space but also##2##3##(2007-12#1)(2012-2#1)
space but##3##2##(2007-12#1)(2008-1#1)(2012-2#1)
space by##8##2##(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#2)
space can##5##2##(1995-7#1)(1996-8#1)(2007-11#1)(2008-11#1)(2013-1#1)
space code-division multiple access##2##4##(2008-2#2)
space code-division##3##2##(2008-2#3)
space curve##2##2##(2008-2#2)
space curves##3##2##(2008-2#3)
space domain##4##2##(2004-3#1)(2008-2#3)
space due to##4##3##(2005-9#1)(2006-12#1)(2006-3#1)(2009-2#1)
space during##5##2##(1990-2#1)(1993-9#1)(2005-11#1)(2009-6#1)(2012-2#1)
space environment##2##2##(2008-3#2)
space exploration##4##2##(2012-3#4)
space flight##2##2##(1996-12#1)(2007-12#1)
space for the##6##3##(2006-12#1)(2007-12#1)(2007-5#1)(2008-2#1)(2008-8#1)(2010-8#1)
space for##17##2##(1991-6#1)(1996-2#1)(2006-12#1)(2007-12#1)(2007-5#1)(2008-11#2)(2008-2#4)(2008-8#1)(2008-9#1)(2010-4#2)(2010-8#1)(2012-3#1)
space from##3##2##(2008-4#1)(2009-8#2)
space geometry##2##2##(2007-12#1)(2008-10#1)
space group C2 with##2##4##(1990-8#1)(1991-12#1)
space group C2##3##3##(1990-8#1)(1991-12#1)(1992-8#1)
space group C2/c##3##3##(1996-2#3)
space group P&amp##7##3##(1996-2#5)(1997-7#2)
space group P-1##4##3##(2007-11#2)(2008-5#2)
space group P1##2##3##(1995-3#1)(1996-2#1)
space group P2(1) and##2##4##(2007-11#1)(2008-8#1)
space group P2(1) with cell dimensions a##2##7##(1994-9#2)
space group P2(1) with##3##4##(1991-12#1)(1994-9#2)
space group P2(1)##5##3##(1991-12#1)(1994-9#2)(2007-11#1)(2008-8#1)
space group P2(1)/a##2##3##(1997-7#2)
space group P2(1)/c (No##2##4##(1996-2#1)(2007-11#1)
space group P2(1)/c with a =##4##6##(1996-2#1)(2007-10#1)(2007-11#1)(2008-4#1)
space group P2(1)/c##12##3##(1996-2#6)(1997-7#1)(2007-10#1)(2007-11#3)(2008-4#1)
space group P2(1)/n (Z =##2##5##(1996-2#2)
space group P2(1)/n with a =##2##6##(1997-7#2)
space group P2(1)/n with##3##4##(1996-2#1)(1997-7#2)
space group P2(1)/n##8##3##(1996-2#4)(1996-5#1)(1997-7#2)(2007-10#1)
space group P2(1)2(1)2(1) with a =##4##6##(1996-2#4)
space group P2(1)2(1)2(1) with unit cell dimensions##2##7##(1991-12#1)(1991-4#1)
space group P2(1)2(1)2(1) with##6##4##(1991-12#1)(1991-4#1)(1996-2#4)
space group P2(1)2(1)2(1)##12##3##(1991-12#1)(1991-4#1)(1994-9#2)(1996-2#6)(1997-6#1)(2009-3#1)
space group P6(1)##3##3##(1992-8#1)(1995-2#1)(2008-9#1)
space group Pbca##2##3##(1996-2#1)(2008-5#1)
space group of##4##3##(2007-12#1)(2008-8#1)(2011-1#1)(2013-1#1)
space group##102##2##(1990-8#2)(1991-12#3)(1991-4#1)(1991-7#2)(1992-11#1)(1992-12#2)(1992-8#3)(1993-8#2)(1994-9#5)(1995-11#1)(1995-2#1)(1995-3#1)(1996-2#30)(1996-5#1)(1996-6#1)(1996-9#1)(1997-6#1)(1997-7#12)(2007-10#3)(2007-11#10)(2007-12#1)(2008-4#2)(2008-5#4)(2008-8#3)(2008-9#3)(2009-3#2)(2010-10#1)(2011-1#1)(2012-11#1)(2013-1#1)
space groups##2##2##(1997-7#1)(2005-7#1)
space has been##2##3##(2007-11#1)(2008-10#1)
space in a##3##3##(2006-6#1)(2010-1#1)(2012-12#1)
space in the##5##3##(1990-5#1)(1992-7#1)(1995-1#1)(2007-11#1)(2008-10#1)
space in##25##2##(1990-5#1)(1991-2#1)(1992-7#1)(1995-1#1)(1997-6#1)(1997-8#1)(2004-3#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-1#1)(2010-12#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
space infrared##2##2##(2008-3#2)
space inside##2##2##(2007-11#1)(2008-11#1)
space instrument##3##2##(2008-2#1)(2008-3#2)
space into the##3##3##(2006-5#1)(2008-3#1)(2008-8#1)
space into##4##2##(2006-5#1)(2008-11#1)(2008-3#1)(2008-8#1)
space is the##2##3##(1997-3#1)(2006-7#1)
space is##25##2##(1991-2#1)(1992-11#1)(1994-12#1)(1997-3#1)(1997-6#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-11#4)(2007-7#1)(2008-10#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-2#1)(2012-12#1)(2012-2#1)
space may be##2##3##(1995-5#1)(1997-8#1)
space may##3##2##(1995-5#1)(1997-8#1)(2008-4#1)
space missions##2##2##(2007-11#1)(2008-3#1)
space model##6##2##(2008-2#1)(2008-8#1)(2013-1#4)
space models##7##2##(2008-11#6)(2008-2#1)
space occupying lesion##3##3##(1993-12#1)(2011-2#1)(2012-2#1)
space occupying##4##2##(1993-12#1)(2008-3#1)(2011-2#1)(2012-2#1)
space of a##3##3##(2006-11#1)(2008-5#1)(2012-11#1)
space of the##25##3##(1990-12#1)(1993-9#1)(1994-12#1)(1997-6#1)(2007-10#2)(2007-12#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#4)(2009-7#1)(2010-7#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#2)
space of##55##2##(1990-12#1)(1990-6#1)(1990-7#1)(1991-6#1)(1992-11#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-5#1)(1996-8#1)(1997-3#1)(1997-6#2)(1997-8#1)(2005-11#1)(2006-10#3)(2006-11#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-12#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#1)(2008-8#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-7#1)(2011-12#1)(2012-1#2)(2012-11#1)(2012-2#1)(2013-1#2)(2013-8#2)
space offers an##2##3##(2008-4#1)(2008-9#1)
space on##3##2##(1991-12#1)(2008-7#1)(2011-1#1)
space or##4##2##(2008-3#1)(2008-4#1)(2008-6#1)(2012-3#1)
space other than##2##3##(2008-8#1)(2011-2#1)
space perception##3##2##(1996-4#1)(2008-2#2)
space program##3##2##(1993-7#1)(2007-9#2)
space repellents##2##2##(2011-2#2)
space representation##2##2##(1997-1#1)(2012-1#1)
space requirements##3##2##(2004-9#1)(2006-6#2)
space shuttle##2##2##(1994-2#1)(2008-2#1)
space spanned by the interferences##2##5##(2011-1#2)
space structure of##6##3##(2006-12#1)(2008-8#5)
space structure##7##2##(2005-11#1)(2006-12#1)(2008-8#5)
space telescope##8##2##(1990-3#1)(2008-2#4)(2008-3#3)
space that is##2##3##(2007-12#1)(2011-1#1)
space that##10##2##(1994-3#1)(1997-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-7#1)(2011-1#1)(2012-3#1)
space the##2##2##(2008-2#1)(2008-9#1)
space through the##2##3##(2008-2#1)(2009-8#1)
space time conversion##2##3##(2007-12#1)(2008-1#1)
space to##16##2##(1995-11#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-9#1)(2009-7#1)(2009-9#1)(2013-1#2)(2013-8#1)
space under##2##2##(2007-7#1)(2013-7#1)
space use of##2##3##(2008-8#1)(2008-9#1)
space use patterns##2##3##(2008-8#1)(2008-9#1)
space use##6##2##(2008-8#3)(2008-9#2)(2012-2#1)
space using##2##2##(1993-11#1)(2009-10#1)
space vehicle##3##2##(2007-11#1)(2008-2#2)
space was found##2##3##(2007-5#1)(2008-10#1)
space was##10##2##(1996-5#1)(2007-5#3)(2008-10#2)(2008-3#1)(2008-8#2)(2009-7#1)
space were##3##2##(1993-4#1)(2006-12#1)(2008-3#1)
space where##6##2##(1991-2#1)(2006-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2011-2#1)
space which##2##2##(2008-1#1)(2008-2#1)
space whose##2##2##(2009-6#1)(2011-2#1)
space with a##2##3##(2008-7#1)(2012-1#1)
space with an##3##3##(1997-7#1)(2008-10#1)(2008-2#1)
space with the##4##3##(1996-12#1)(2008-2#1)(2008-3#1)(2012-1#1)
space with##18##2##(1994-11#1)(1994-2#1)(1996-12#1)(1997-7#1)(2006-5#2)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-7#1)(2010-11#1)(2012-1#3)(2013-7#1)
space within the##2##3##(2007-12#1)(2012-2#1)
space within##3##2##(2007-12#1)(2008-6#1)(2012-2#1)
space without##2##2##(2008-10#1)(2008-7#1)
space##1110##1##(1990-11#2)(1990-12#2)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#8)(1991-2#9)(1991-4#1)(1991-6#2)(1991-7#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#5)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#4)(1992-9#1)(1993-10#5)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#7)(1994-1#1)(1994-11#6)(1994-12#3)(1994-2#6)(1994-3#3)(1994-6#3)(1994-8#5)(1994-9#6)(1995-1#2)(1995-11#4)(1995-12#3)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#3)(1995-7#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#32)(1996-4#5)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#8)(1997-4#1)(1997-6#10)(1997-7#19)(1997-8#11)(2004-3#7)(2004-9#1)(2005-1#1)(2005-11#7)(2005-7#1)(2005-8#3)(2005-9#2)(2006-10#12)(2006-11#1)(2006-12#18)(2006-2#2)(2006-3#8)(2006-4#5)(2006-5#10)(2006-6#6)(2006-7#2)(2006-8#6)(2006-9#1)(2007-1#1)(2007-10#7)(2007-11#37)(2007-12#37)(2007-3#3)(2007-4#7)(2007-5#7)(2007-6#3)(2007-7#9)(2007-8#11)(2007-9#12)(2008-1#21)(2008-10#29)(2008-11#27)(2008-12#6)(2008-2#89)(2008-3#69)(2008-4#22)(2008-5#14)(2008-6#11)(2008-7#24)(2008-8#50)(2008-9#33)(2009-10#7)(2009-11#5)(2009-2#2)(2009-3#5)(2009-5#3)(2009-6#6)(2009-7#3)(2009-8#11)(2009-9#7)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#4)(2010-2#4)(2010-3#1)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#9)(2010-8#2)(2011-1#14)(2011-12#2)(2011-2#21)(2011-7#1)(2012-1#16)(2012-11#3)(2012-12#9)(2012-2#26)(2012-3#21)(2013-1#24)(2013-7#2)(2013-8#15)
space&quot##2##1##(1990-12#1)(2012-2#1)
space)##12##1##(1996-12#1)(1996-5#1)(2007-11#1)(2007-7#2)(2008-2#3)(2008-5#1)(2010-10#1)(2012-12#2)
space-bandwidth product of the spatial light modulators##2##7##(2008-2#2)
space-bandwidth product of the##4##4##(2008-2#4)
space-bandwidth product##11##2##(2007-12#1)(2008-2#5)(2008-3#5)
space-bandwidth##12##1##(2007-12#1)(2008-2#5)(2008-3#6)
space-based lidar##3##2##(2008-2#2)(2008-3#1)
space-based##12##1##(1996-5#1)(2007-12#1)(2008-2#4)(2008-3#6)
space-charge field##11##2##(2007-11#3)(2007-12#6)(2008-2#1)(2008-3#1)
space-charge fields##2##2##(2007-12#2)
space-charge region of##2##3##(2007-12#1)(2012-2#1)
space-charge region##3##2##(2007-12#2)(2012-2#1)
space-charge wave##2##2##(2008-1#2)
space-charge##21##1##(2007-11#3)(2007-12#12)(2008-1#2)(2008-2#1)(2008-3#1)(2012-2#2)
space-charge-field##3##1##(2007-11#2)(2007-12#1)
space-consuming##2##1##(1994-11#1)(2012-12#1)
space-dependent rate equation##3##3##(2008-3#3)
space-filling curve##2##2##(2008-6#2)
space-filling##4##1##(2005-11#2)(2008-6#2)
space-invariant and space-variant##3##3##(2008-3#3)
space-invariant##7##1##(2008-1#1)(2008-2#1)(2008-3#5)
space-occupying lesion in the##3##4##(1990-3#1)(2008-6#1)(2012-12#1)
space-occupying lesion##5##2##(1990-3#1)(2008-1#1)(2008-4#1)(2008-6#1)(2012-12#1)
space-occupying lesions##2##2##(1990-9#1)(1991-3#1)
space-occupying##14##1##(1990-3#1)(1990-9#1)(1991-3#1)(2006-7#2)(2008-1#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2012-12#1)(2013-7#1)
space-time analogies##2##2##(2007-12#2)
space-time clustering##3##2##(2008-6#3)
space-time coupling caused##2##3##(2008-3#2)
space-time coupling##6##2##(2007-11#3)(2007-12#1)(2008-3#2)
space-time##30##1##(1996-4#1)(1997-8#2)(2007-11#4)(2007-12#7)(2007-9#1)(2008-2#2)(2008-3#5)(2008-6#3)(2008-8#1)(2009-2#1)(2009-3#3)
space-variant operations##3##2##(2008-3#3)
space-variant optical##3##2##(2008-2#2)(2008-3#1)
space-variant subwavelength dielectric grating##2##4##(2007-11#2)
space-variant subwavelength dielectric##3##3##(2007-11#3)
space-variant subwavelength##4##2##(2007-11#3)(2007-12#1)
space-variant##28##1##(2007-11#10)(2007-12#7)(2008-2#5)(2008-3#6)
spaceborne lidar##3##2##(2008-3#3)
spaceborne sensors##2##2##(2008-3#2)
spaceborne##28##1##(2007-12#2)(2008-2#7)(2008-3#19)
spacecraft with##2##2##(2008-3#2)
spacecraft##17##1##(1991-8#1)(1995-3#1)(2007-12#1)(2007-9#2)(2008-2#1)(2008-3#10)(2012-3#1)
spaced and##2##2##(2007-3#1)(2008-5#1)
spaced by 4 base pairs in##2##6##(1994-12#2)
spaced by##6##2##(1994-12#2)(1995-3#1)(1996-5#1)(2005-8#1)(2008-3#1)
spaced locations##2##2##(2006-3#1)(2007-12#1)
spaced polyps and##2##3##(2009-8#2)
spaced samples##2##2##(2008-3#2)
spaced wavelengths##3##2##(2007-12#1)(2008-2#1)(2011-1#1)
spaced##74##1##(1990-5#1)(1992-2#3)(1992-4#1)(1994-11#1)(1994-12#3)(1995-3#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#1)(2005-8#1)(2006-12#1)(2006-3#1)(2007-11#5)(2007-12#10)(2007-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#12)(2008-3#9)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-11#1)(2009-8#2)(2010-6#1)(2011-1#1)(2012-11#1)(2012-3#1)(2013-1#1)
spaceflight##10##1##(1991-2#2)(2008-3#1)(2009-7#3)(2012-12#1)(2012-3#3)
spacer and##3##2##(2008-10#2)(2010-6#1)
spacer are##2##2##(2005-11#1)(2010-9#1)
spacer arm##2##2##(1994-11#1)(2008-4#1)
spacer arm)##2##2##(1994-11#2)
spacer between the##3##3##(1997-1#1)(1997-3#1)(2008-1#1)
spacer between##6##2##(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#2)(2010-10#1)
spacer boxA of##2##3##(1997-1#2)
spacer boxA##6##2##(1997-1#6)
spacer devices##3##2##(2004-12#3)
spacer from##2##2##(1995-6#1)(2008-10#1)
spacer in##3##2##(2008-10#2)(2008-8#1)
spacer layer##5##2##(2008-3#3)(2009-11#2)
spacer layers##3##2##(2008-2#1)(2008-3#2)
spacer length##7##2##(2005-11#4)(2008-5#1)(2013-1#2)
spacer models##2##2##(2009-3#2)
spacer of the##4##3##(2007-12#1)(2008-10#3)
spacer of##6##2##(2005-7#1)(2007-12#1)(2008-10#4)
spacer rDNA##3##2##(2008-10#2)(2010-10#1)
spacer region between the##2##4##(1991-6#1)(2008-10#1)
spacer region between##3##3##(1991-6#1)(2008-10#2)
spacer region of the##3##4##(1993-5#1)(2008-10#2)
spacer region of##5##3##(1993-5#1)(2008-10#4)
spacer region were##3##3##(2008-10#3)
spacer region##30##2##(1991-6#1)(1993-5#1)(2008-10#26)(2008-9#1)(2011-2#1)
spacer regions of##5##3##(2008-10#5)
spacer regions##10##2##(1993-9#1)(1994-12#1)(2008-10#8)
spacer sequence analysis and##2##4##(2008-9#1)(2010-10#1)
spacer sequence analysis##3##3##(2008-8#1)(2008-9#1)(2010-10#1)
spacer sequences##5##2##(2008-10#2)(2008-7#1)(2011-12#2)
spacer unit##2##2##(1991-6#1)(2008-10#1)
spacer was##2##2##(2008-5#1)(2008-8#1)
spacer##253##1##(1990-7#1)(1991-12#3)(1991-6#2)(1992-9#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-9#2)(1995-6#2)(1995-8#5)(1996-1#3)(1996-2#3)(1997-1#8)(1997-3#1)(1997-4#1)(1997-7#1)(2004-12#4)(2005-11#16)(2005-7#1)(2005-9#1)(2006-3#1)(2006-7#1)(2007-11#3)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#123)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#3)(2008-5#4)(2008-6#5)(2008-7#1)(2008-8#6)(2008-9#3)(2009-11#2)(2009-3#2)(2009-4#2)(2010-10#4)(2010-5#3)(2010-6#1)(2010-9#1)(2011-1#1)(2011-12#3)(2011-2#2)(2013-1#3)
spacers and##3##2##(2008-3#1)(2010-5#1)(2011-2#1)
spacers are##3##2##(2008-2#1)(2008-8#2)
spacers in##4##2##(1997-2#1)(2008-10#1)(2008-2#1)(2008-6#1)
spacers with##2##2##(2007-11#1)(2008-8#1)
spacers##33##1##(1992-3#2)(1993-9#2)(1995-1#1)(1995-8#1)(1997-2#1)(2004-12#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#2)(2008-8#5)(2009-3#1)(2009-4#1)(2010-5#1)(2011-2#1)(2013-1#1)
spaces and the##3##3##(2008-8#1)(2009-7#1)(2012-3#1)
spaces and##9##2##(1996-1#1)(2006-5#1)(2008-10#3)(2008-2#1)(2008-8#1)(2009-7#1)(2012-3#1)
spaces are##2##2##(2007-12#1)(2013-8#1)
spaces as##2##2##(2010-6#1)(2010-9#1)
spaces between##6##2##(2007-5#1)(2008-5#4)(2010-3#1)
spaces for##2##2##(2009-5#1)(2012-12#1)
spaces from##2##2##(2008-11#1)(2009-5#1)
spaces in##3##2##(2007-7#1)(2008-5#1)(2008-7#1)
spaces is##3##2##(2007-11#1)(2008-3#1)(2010-3#1)
spaces of the##10##3##(1997-3#1)(1997-6#1)(2006-5#1)(2007-11#2)(2008-10#4)(2010-3#1)
spaces of##18##2##(1990-3#1)(1990-4#1)(1997-3#1)(1997-6#1)(2006-5#1)(2007-11#2)(2007-9#1)(2008-10#6)(2009-6#1)(2010-3#1)(2011-2#1)(2012-12#1)
spaces was##2##2##(1995-12#1)(1996-12#1)
spaces were##2##2##(2008-7#1)(2012-1#1)
spaces##125##1##(1990-3#1)(1990-4#1)(1991-4#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-4#1)(1995-11#1)(1995-12#1)(1996-1#2)(1996-12#1)(1996-3#1)(1997-3#1)(1997-6#2)(2005-11#1)(2005-8#1)(2006-10#1)(2006-5#4)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#1)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#10)(2008-8#1)(2009-2#1)(2009-5#5)(2009-6#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-3#3)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#3)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
spacetime##2##1##(1992-9#1)(1995-10#1)
spacial##2##1##(1997-1#1)(2008-10#1)
spacing and##22##2##(1990-4#1)(1992-4#1)(1995-5#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-7#2)(2008-1#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#2)(2009-2#1)(2011-1#1)(2011-2#1)
spacing as##2##2##(2008-2#1)(2012-2#1)
spacing because the##2##3##(1992-4#1)(2008-2#1)
spacing between the##8##3##(1991-11#1)(1994-11#1)(2007-11#1)(2007-12#1)(2008-3#4)
spacing between##14##2##(1990-9#1)(1991-11#1)(1993-12#1)(1994-11#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#6)(2010-4#1)
spacing effect in visual search##2##5##(2008-1#2)
spacing for##3##2##(2008-1#2)(2010-4#1)
spacing in the##2##3##(2010-8#1)(2012-2#1)
spacing in##6##2##(1992-3#1)(2007-12#1)(2008-1#1)(2010-8#1)(2012-12#1)(2012-2#1)
spacing increases##2##2##(2007-11#1)(2008-3#1)
spacing is varied##3##3##(2007-12#2)(2008-3#1)
spacing is##11##2##(1992-6#1)(2007-12#2)(2008-1#3)(2008-2#2)(2008-3#3)
spacing of 100 km##2##4##(2007-12#2)
spacing of 2##2##3##(1995-8#1)(2008-3#1)
spacing of all possible stopbands##2##5##(2008-3#2)
spacing of the##11##3##(1990-4#1)(1992-7#1)(1993-3#1)(1994-8#1)(2007-12#3)(2008-2#2)(2008-3#2)
spacing of##33##2##(1990-4#1)(1992-7#1)(1993-3#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-8#2)(1996-2#1)(2005-11#1)(2005-4#1)(2007-12#6)(2008-2#4)(2008-3#11)(2008-9#1)
spacing on the##6##3##(2008-12#2)(2008-3#3)(2012-2#1)
spacing on##9##2##(1990-4#1)(2008-1#2)(2008-12#2)(2008-3#3)(2012-2#1)
spacing or##2##2##(1995-2#2)
spacing to##6##2##(1994-11#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)
spacing was##4##2##(1995-1#1)(2007-12#1)(2008-1#1)(2008-3#1)
spacing were##3##2##(2006-4#1)(2007-7#1)(2008-3#1)
spacing##202##1##(1990-2#1)(1990-4#3)(1990-9#1)(1991-11#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-4#4)(1992-6#1)(1992-7#1)(1993-12#1)(1993-3#1)(1994-11#2)(1994-8#1)(1995-1#2)(1995-2#3)(1995-5#1)(1995-8#2)(1995-9#1)(1996-2#4)(1997-5#1)(2005-11#2)(2005-4#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#2)(2007-11#10)(2007-12#23)(2007-7#3)(2008-1#24)(2008-11#3)(2008-12#9)(2008-2#17)(2008-3#38)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#3)(2009-2#3)(2010-4#2)(2010-8#2)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#7)
spacings between##2##2##(2008-2#2)
spacings of the##2##3##(2008-2#1)(2010-11#1)
spacings of##6##2##(1997-7#1)(2007-5#1)(2008-2#2)(2008-5#1)(2010-11#1)
spacings##14##1##(1992-8#1)(1997-7#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-2#5)(2008-3#2)(2008-5#1)(2010-11#1)
spalt##3##1##(2006-7#2)(2008-9#1)
spalt-electroporated neural crest cells##2##4##(2006-7#2)
span a##2##2##(2005-8#1)(2009-10#1)
span and the##2##3##(2005-1#1)(2008-1#1)
span and##15##2##(1992-12#1)(1996-9#1)(2005-1#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
span as##2##2##(1994-6#1)(2006-6#1)
span at##2##2##(1994-11#1)(1994-3#1)
span between##2##2##(1990-11#1)(2007-12#1)
span in the##2##3##(2007-11#1)(2009-9#1)
span in##9##2##(1991-8#1)(1994-5#1)(1995-5#1)(1996-6#1)(2007-11#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-8#1)
span is a##3##3##(1995-6#1)(1996-3#1)(2008-1#1)
span is##5##2##(1992-2#1)(1995-6#1)(1996-3#1)(2008-1#1)(2008-10#1)
span of the##12##3##(1991-12#1)(1991-4#1)(1991-5#1)(1993-8#1)(2006-10#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-7#1)(2011-1#1)
span of##48##2##(1990-3#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-5#1)(1993-11#1)(1993-8#3)(1994-12#1)(1995-2#1)(1995-6#1)(1996-3#1)(1996-9#2)(1997-3#1)(1997-4#2)(2004-11#1)(2006-10#1)(2006-6#1)(2007-12#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#5)(2008-7#4)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
span study##2##2##(1994-6#1)(2008-9#1)
span the range of##2##4##(1996-2#1)(2008-10#1)
span the##17##2##(1991-9#1)(1993-4#1)(1993-8#1)(1995-8#1)(1996-2#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-8#1)(2010-7#1)(2012-3#1)
span to##3##2##(1997-2#1)(2006-6#1)(2009-6#1)
span was##6##2##(1990-3#1)(1995-6#1)(2007-12#1)(2008-1#1)(2008-9#1)(2013-7#1)
span##214##1##(1990-11#1)(1990-3#6)(1990-4#1)(1991-12#1)(1991-2#1)(1991-4#3)(1991-5#3)(1991-6#1)(1991-8#3)(1991-9#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-5#2)(1992-7#1)(1993-11#1)(1993-4#2)(1993-6#1)(1993-8#4)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#5)(1994-6#7)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#5)(1995-8#1)(1996-10#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-9#4)(1997-2#1)(1997-3#1)(1997-4#3)(2004-11#1)(2005-1#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-6#3)(2007-11#3)(2007-12#10)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#6)(2008-10#12)(2008-11#7)(2008-12#1)(2008-2#5)(2008-3#15)(2008-4#2)(2008-5#1)(2008-7#6)(2008-8#7)(2008-9#7)(2009-10#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#3)
spanish##2##1##(2008-5#1)(2011-1#1)
spanned approximately##2##2##(1997-7#1)(2013-8#1)
spanned by the##4##3##(1995-1#1)(2006-4#1)(2011-1#2)
spanned by##6##2##(1995-1#1)(1997-6#1)(2006-4#1)(2008-3#1)(2011-1#2)
spanned##18##1##(1991-10#1)(1992-11#1)(1992-12#1)(1992-7#1)(1994-8#1)(1995-1#1)(1995-5#1)(1995-6#1)(1997-1#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-4#1)(2008-10#1)(2008-3#1)(2011-1#2)(2013-8#1)
spanning a wide range of##2##5##(2007-5#1)(2008-9#1)
spanning a##5##2##(1990-5#1)(1996-4#1)(2007-5#1)(2008-3#1)(2008-9#1)
spanning an##2##2##(1990-6#1)(1997-4#1)
spanning approx##2##2##(1991-6#1)(1996-7#1)
spanning approximately##3##2##(1996-8#1)(2008-10#1)(2008-5#1)
spanning domains##2##2##(1996-5#1)(2008-11#1)
spanning from##7##2##(1992-3#1)(2006-12#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-4#1)(2013-1#1)
spanning more than##3##3##(1995-5#1)(1997-7#1)(2007-12#1)
spanning several##4##2##(1994-5#1)(2008-12#1)(2008-2#1)(2009-11#1)
spanning the##32##2##(1990-11#1)(1990-8#1)(1992-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-10#1)(1995-6#2)(1995-8#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-5#2)(2006-11#1)(2006-12#2)(2006-6#1)(2007-11#1)(2007-3#1)(2008-10#6)(2008-5#1)(2010-5#1)(2011-1#1)
spanning two##2##2##(2007-12#1)(2009-6#1)
spanning##113##1##(1990-11#2)(1990-12#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#3)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#2)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-10#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#2)(1997-3#1)(1997-4#3)(1997-5#3)(1997-7#1)(2006-11#1)(2006-12#3)(2006-6#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#3)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-5#1)(2011-1#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
spans a##3##2##(1993-3#1)(1997-8#1)(2009-4#1)
spans about##2##2##(1991-5#1)(2008-5#1)
spans approximately##3##2##(1992-7#1)(1994-11#1)(1996-2#1)
spans both##2##2##(1991-2#1)(2005-11#1)
spans more than##2##3##(1993-12#1)(1997-8#1)
spans of##2##2##(2007-12#1)(2011-2#1)
spans the##4##2##(1991-5#2)(2008-12#1)(2008-5#1)
spans##49##1##(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#3)(1992-12#1)(1992-7#1)(1993-12#2)(1993-2#1)(1993-3#2)(1994-11#1)(1995-6#1)(1996-2#1)(1996-5#2)(1996-6#2)(1997-8#3)(2005-11#1)(2006-12#1)(2007-12#3)(2007-8#1)(2008-1#2)(2008-12#2)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-11#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#2)
spantide##4##1##(1993-12#1)(1994-2#2)(2011-2#1)
spare the##7##2##(1994-2#1)(1997-3#1)(2007-11#1)(2008-10#1)(2009-5#1)(2010-12#1)(2012-3#1)
spare##17##1##(1991-4#1)(1993-12#1)(1994-2#1)(1994-6#1)(1995-1#1)(1997-3#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-12#1)(2012-3#1)
spared a thoracotomy##2##3##(2005-2#1)(2007-6#1)
spared area of the##3##4##(2008-4#3)
spared by##2##2##(1995-8#1)(2005-8#1)
spared from##5##2##(1992-3#1)(2011-2#1)(2012-12#1)(2013-1#2)
spared in##4##2##(1991-4#1)(1992-10#1)(1995-3#1)(2009-10#1)
spared the##3##2##(1990-9#1)(1994-7#1)(2006-5#1)
spared##40##1##(1990-2#1)(1990-9#1)(1991-4#1)(1992-10#1)(1992-3#1)(1993-10#1)(1993-3#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-9#1)(2005-2#1)(2005-8#2)(2006-10#1)(2006-5#1)(2006-7#1)(2007-6#1)(2008-4#4)(2008-9#1)(2009-10#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-6#1)(2011-1#3)(2011-2#1)(2012-12#1)(2013-1#3)
spares the##3##2##(2009-5#2)(2010-8#1)
spares##10##1##(1996-5#1)(2007-1#1)(2007-3#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-5#3)(2010-8#1)
sparfloxacin##9##1##(2005-7#1)(2006-10#1)(2007-11#1)(2007-7#2)(2008-11#1)(2008-7#2)(2010-5#1)
sparganosis mansoni##2##2##(2011-12#2)
sparge##2##1##(2008-10#1)(2008-11#1)
sparged##2##1##(1994-3#1)(2008-6#1)
sparging##3##1##(1994-3#2)(2008-11#1)
sparing effect##2##2##(2005-11#1)(2008-7#1)
sparing in##3##2##(2006-6#1)(2007-8#1)(2010-3#1)
sparing of brain##2##3##(2008-11#2)
sparing of the##4##3##(1991-1#1)(2008-5#1)(2008-9#1)(2009-10#1)
sparing of##19##2##(1991-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-9#1)(1996-5#1)(2007-11#1)(2007-4#1)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)
sparing surgery##5##2##(1990-12#1)(2006-6#1)(2007-7#1)(2009-4#1)(2011-1#1)
sparing the##9##2##(1990-6#1)(1993-12#1)(1994-2#2)(2006-10#1)(2007-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
sparing treatment##2##2##(2008-6#1)(2012-3#1)
sparing##69##1##(1990-12#1)(1990-6#1)(1991-1#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-12#2)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1996-5#1)(1996-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#2)(2007-1#1)(2007-11#1)(2007-4#2)(2007-7#2)(2007-8#3)(2008-10#2)(2008-11#3)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#5)(2008-9#1)(2009-10#1)(2009-4#2)(2009-5#2)(2010-3#1)(2011-1#4)(2012-2#3)(2012-3#2)(2013-1#3)
sparingly soluble and insoluble Cr(VI) from##2##6##(2008-10#2)
sparingly soluble##8##2##(1996-8#1)(2005-11#1)(2008-10#5)(2010-2#1)
sparingly##11##1##(1996-8#1)(2005-11#1)(2008-10#7)(2010-12#1)(2010-2#1)
spark ablation vessel##3##3##(2008-10#3)
spark ablation##7##2##(2008-10#7)
spark gap##2##2##(2007-9#2)
spark ignition##2##2##(2007-10#2)
spark source##3##2##(2008-10#3)
spark##29##1##(2004-9#1)(2005-4#1)(2006-12#4)(2007-10#2)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#14)(2008-7#1)
spark-ignition##2##1##(2008-2#2)
sparked an##2##2##(1995-1#1)(1997-1#1)
sparked by the##2##3##(2006-10#1)(2011-2#1)
sparked renewed interest in##2##4##(2005-7#1)(2008-7#1)
sparked the##2##2##(2004-5#1)(2009-4#1)
sparked##21##1##(1993-12#1)(1994-11#1)(1995-1#1)(1997-1#1)(2004-5#1)(2005-7#1)(2006-1#1)(2006-10#2)(2007-9#1)(2008-4#1)(2008-7#2)(2009-3#2)(2009-4#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#1)
sparking##3##1##(2008-11#1)(2010-12#1)(2012-1#1)
sparkling wines##4##2##(2008-10#4)
sparkling##5##1##(2008-10#5)
sparks##7##1##(1995-5#1)(1996-3#1)(2008-1#4)(2009-10#1)
sparring##2##1##(1993-8#1)(2008-7#1)
sparrows (Melospiza##4##2##(2008-8#1)(2008-9#2)(2010-2#1)
sparrows (Passer##4##2##(2008-5#3)(2013-8#1)
sparrows##14##1##(2008-5#5)(2008-8#2)(2008-9#2)(2010-2#2)(2013-8#3)
sparse and##6##2##(1993-12#1)(2005-10#1)(2006-10#1)(2007-2#1)(2008-11#1)(2009-1#1)
sparse data##5##2##(1997-6#1)(2006-7#1)(2008-2#1)(2008-5#1)(2012-2#1)
sparse genotypes##2##2##(2012-1#2)
sparse in##3##2##(2013-1#2)(2013-7#1)
sparse matrix approximation method##2##4##(2008-3#2)
sparse matrix##4##2##(2008-3#3)(2010-2#1)
sparse networks##2##2##(2008-5#1)(2012-3#1)
sparse representation##4##2##(2006-4#2)(2008-2#1)(2010-7#1)
sparse sampling##3##2##(2008-2#1)(2011-2#1)(2012-3#1)
sparse##92##1##(1990-3#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-9#1)(1994-1#1)(1996-1#1)(1996-5#1)(1997-6#1)(1997-8#2)(2004-11#1)(2004-2#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-4#2)(2006-7#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-9#2)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#4)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-5#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#5)(2012-1#7)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#4)(2013-7#1)
sparse-data pages##2##2##(2008-3#2)
sparsely ionizing radiation##2##3##(2008-7#2)
sparsely ionizing##3##2##(2008-7#3)
sparsely##14##1##(1991-1#1)(1991-9#1)(1994-8#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#3)(2009-6#1)(2012-12#2)(2012-3#1)
sparseness of##2##2##(2008-10#1)(2008-11#1)
sparser##3##1##(2008-6#1)(2010-1#1)(2013-8#1)
sparsity##5##1##(1995-5#1)(2008-2#1)(2008-3#3)
sparsomycin##4##1##(1992-6#1)(1993-4#2)(2006-12#1)
sparteine##3##1##(1996-3#2)(2004-2#1)
spas have##2##2##(1997-1#1)(2006-12#1)
spas##4##1##(1997-1#1)(2006-12#1)(2008-7#1)(2013-1#1)
spasm after##2##2##(2009-10#1)(2012-3#1)
spasm and##6##2##(1992-6#2)(2006-12#1)(2008-7#2)(2011-2#1)
spasm during##2##2##(2011-2#1)(2012-2#1)
spasm in the##2##3##(1991-9#1)(2007-8#1)
spasm in##5##2##(1991-9#1)(2007-8#1)(2008-7#2)(2012-2#1)
spasm is##4##2##(2006-12#2)(2007-8#2)
spasm##73##1##(1991-3#1)(1991-9#1)(1992-6#3)(1993-12#8)(1994-11#1)(1995-3#3)(2005-1#1)(2005-12#1)(2006-11#1)(2006-12#6)(2006-5#1)(2006-8#3)(2007-8#11)(2008-1#1)(2008-10#1)(2008-12#2)(2008-7#9)(2009-10#2)(2009-12#1)(2009-9#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#8)(2012-2#2)(2012-3#1)
spasmodic torticollis##4##2##(1990-10#2)(1992-8#1)(2008-2#1)
spasmodic##10##1##(1990-10#3)(1991-8#1)(1992-8#1)(1993-11#1)(1996-2#3)(2008-2#1)
spasmogenic##3##1##(1996-3#1)(2007-1#2)
spasmolytic##3##1##(1990-12#2)(2011-2#1)
spasms and##4##2##(1991-3#1)(1992-5#1)(2009-11#1)(2011-2#1)
spasms##19##1##(1990-12#1)(1990-8#1)(1990-9#1)(1991-3#1)(1992-5#1)(1994-4#1)(2006-12#1)(2008-12#1)(2009-11#5)(2009-3#1)(2011-1#2)(2011-2#2)(2012-12#1)
spastic attacks##2##2##(2007-8#2)
spastic cerebral palsy##2##3##(2006-10#1)(2009-9#1)
spastic foot drop##2##3##(2009-11#2)
spastic paralysis##2##2##(2004-11#1)(2008-5#1)
spastic paraparesis##7##2##(1991-11#1)(2006-10#1)(2007-10#1)(2008-7#1)(2012-12#3)
spastic paraplegia##3##2##(2007-7#1)(2011-2#2)
spastic quadriplegic cerebral palsy##2##4##(2005-10#1)(2009-3#1)
spastic##42##1##(1991-11#1)(1992-2#1)(1992-8#2)(1995-6#1)(1996-2#2)(1996-9#1)(1997-5#1)(1997-6#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-3#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-7#2)(2007-8#3)(2008-5#1)(2008-7#1)(2009-11#2)(2009-3#1)(2009-9#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#1)
spasticity and pain##3##3##(2006-12#1)(2006-8#1)(2009-9#1)
spasticity and##10##2##(1997-5#1)(2006-12#1)(2006-8#1)(2007-7#1)(2009-3#1)(2009-9#1)(2011-2#1)(2012-1#3)
spasticity in##8##2##(1997-5#1)(2006-10#2)(2006-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2012-1#1)
spasticity is##3##2##(2006-12#1)(2009-4#1)(2012-1#1)
spasticity or##2##2##(2006-10#1)(2011-2#1)
spasticity##51##1##(1997-5#3)(2006-10#6)(2006-12#4)(2006-4#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-7#8)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-9#2)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-1#11)(2012-11#1)
spat##9##1##(1995-3#1)(2007-5#5)(2008-5#2)(2010-11#1)
spataceum##2##1##(2012-2#2)
spatial Fourier transform##2##3##(2008-2#2)
spatial abilities##4##2##(1993-2#1)(1996-1#1)(2008-11#2)
spatial ability##5##2##(1994-8#1)(2008-11#3)(2008-7#1)
spatial adaptation##3##2##(2013-8#3)
spatial aggregation of##2##3##(2007-6#1)(2008-10#1)
spatial aggregation##7##2##(2007-6#1)(2008-10#4)(2008-8#2)
spatial allocation##3##2##(2013-8#3)
spatial analysis by distance indices (SADIE)##3##6##(2008-10#3)
spatial analysis by distance indices##4##5##(2008-10#4)
spatial analysis of##3##3##(2007-7#1)(2008-3#1)(2008-4#1)
spatial analysis##12##2##(2007-7#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-8#4)
spatial and a##2##3##(1992-10#1)(2007-12#1)
spatial and angular correlations in beams of any state of spatial coherence##2##12##(2007-11#2)
spatial and angular##4##3##(2007-11#2)(2008-2#2)
spatial and contextual learning##2##4##(1993-12#2)
spatial and contextual##3##3##(1993-12#2)(2011-2#1)
spatial and scale-space##3##3##(2008-2#3)
spatial and spectral data##3##4##(2008-2#2)(2008-3#1)
spatial and spectral##10##3##(2007-12#3)(2008-2#3)(2008-3#4)
spatial and temporal changes in##3##5##(2008-11#1)(2010-4#1)(2013-7#1)
spatial and temporal characteristics of##2##5##(2007-12#1)(2008-1#1)
spatial and temporal characteristics##4##4##(2007-12#1)(2008-1#1)(2008-8#2)
spatial and temporal control##2##4##(1994-11#1)(2008-11#1)
spatial and temporal distribution of##4##5##(2007-11#1)(2007-5#1)(2007-6#1)(2008-5#1)
spatial and temporal distribution##5##4##(2007-11#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-5#1)
spatial and temporal dynamics##2##4##(2008-9#1)(2009-8#1)
spatial and temporal expression of the##2##6##(1996-3#1)(1996-6#1)
spatial and temporal expression of##4##5##(1991-12#1)(1996-3#1)(1996-6#1)(2008-4#1)
spatial and temporal expression pattern of##2##6##(2006-12#1)(2008-5#1)
spatial and temporal expression pattern##5##5##(2006-12#2)(2008-5#1)(2012-12#2)
spatial and temporal expression##9##4##(1991-12#1)(1996-3#1)(1996-6#1)(2006-12#2)(2008-4#1)(2008-5#1)(2012-12#2)
spatial and temporal information##2##4##(2008-2#1)(2008-3#1)
spatial and temporal patterns of the##2##6##(2008-7#2)
spatial and temporal patterns of##5##5##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)
spatial and temporal patterns##8##4##(2003-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#3)
spatial and temporal resolution and##2##5##(2006-4#1)(2008-12#1)
spatial and temporal resolution in##3##5##(2008-11#1)(2011-2#1)(2013-8#1)
spatial and temporal resolution of##2##5##(2010-9#1)(2011-2#1)
spatial and temporal resolution##15##4##(1991-2#1)(2006-4#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-1#1)(2013-8#2)
spatial and temporal resolutions##3##4##(2007-5#1)(2008-10#2)
spatial and temporal scales##4##4##(2006-7#1)(2007-9#1)(2008-9#1)(2013-1#1)
spatial and temporal stochastic variability##2##5##(1991-6#2)
spatial and temporal variability##2##4##(2008-10#1)(2009-12#1)
spatial and temporal variations in##2##5##(2011-12#2)
spatial and temporal variations##5##4##(2006-6#1)(2006-7#1)(2008-5#1)(2011-12#2)
spatial and temporal walk-off##2##4##(2007-12#2)
spatial and temporal##109##3##(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#2)(1992-9#1)(1994-11#1)(1994-6#1)(1996-3#1)(1996-6#1)(1997-2#1)(2003-11#1)(2005-11#1)(2006-12#2)(2006-4#1)(2006-6#1)(2006-7#2)(2007-11#2)(2007-12#7)(2007-5#2)(2007-6#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#5)(2008-12#1)(2008-2#9)(2008-3#5)(2008-4#1)(2008-5#5)(2008-7#3)(2008-8#4)(2008-9#3)(2009-11#1)(2009-12#2)(2009-3#1)(2009-5#2)(2009-8#2)(2010-12#1)(2010-4#1)(2010-9#1)(2011-11#1)(2011-12#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#4)(2013-1#2)(2013-7#2)(2013-8#3)
spatial and the temporal##7##4##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#1)
spatial and the##8##3##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#2)
spatial and vertical##2##3##(2007-5#2)
spatial and##168##2##(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#2)(1992-10#1)(1992-3#1)(1992-9#1)(1993-12#3)(1993-5#1)(1994-11#1)(1994-2#3)(1994-6#1)(1994-8#1)(1996-3#1)(1996-6#1)(1997-2#1)(2003-11#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-6#1)(2006-7#2)(2007-11#5)(2007-12#14)(2007-5#5)(2007-6#1)(2007-9#2)(2008-1#2)(2008-10#8)(2008-11#7)(2008-12#1)(2008-2#24)(2008-3#11)(2008-4#1)(2008-5#5)(2008-7#3)(2008-8#4)(2008-9#4)(2009-11#1)(2009-12#2)(2009-3#2)(2009-5#2)(2009-8#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-11#1)(2011-12#2)(2011-2#5)(2012-1#3)(2012-12#2)(2012-2#4)(2013-1#2)(2013-7#2)(2013-8#4)
spatial and/or temporal##2##3##(2008-2#2)
spatial architecture##2##2##(2008-8#2)
spatial arrangement of the##4##4##(1995-11#1)(2008-3#2)(2013-7#1)
spatial arrangement of##14##3##(1993-8#1)(1994-9#1)(1995-11#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-3#2)(2008-5#1)(2010-10#1)(2013-1#1)(2013-7#2)
spatial arrangement##21##2##(1993-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1996-8#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-9#2)(2008-10#3)(2008-3#2)(2008-5#1)(2008-9#1)(2010-10#1)(2013-1#1)(2013-7#2)
spatial arrangements##2##2##(1996-7#1)(2008-11#1)
spatial aspects of disease incidence data##2##6##(2008-10#2)
spatial assimilation##2##2##(2011-2#2)
spatial attention##8##2##(1994-3#1)(1995-5#2)(2008-1#1)(2008-11#1)(2008-4#2)(2010-5#1)
spatial autocorrelation in##2##3##(1994-5#1)(2008-8#1)
spatial autocorrelation##15##2##(1994-5#1)(2008-10#7)(2008-2#1)(2008-7#1)(2008-8#2)(2009-11#1)(2011-1#1)(2013-7#1)
spatial beam profile##5##3##(2007-12#1)(2008-3#4)
spatial beam quality##2##3##(2007-12#2)
spatial beam##7##2##(2007-12#3)(2008-3#4)
spatial carrier frequency##2##3##(2008-2#1)(2008-3#1)
spatial carrier##6##2##(2008-2#4)(2008-3#2)
spatial characteristics of##2##3##(2007-12#1)(2011-1#1)
spatial characteristics##5##2##(1993-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2011-1#1)
spatial characterization of the##2##4##(2007-3#1)(2009-8#1)
spatial clustering##2##2##(2008-10#1)(2008-6#1)
spatial clusters##2##2##(1995-4#1)(2010-2#1)
spatial coherence and##6##3##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#1)
spatial coherence in##2##3##(2008-2#1)(2008-3#1)
spatial coherence is not##2##4##(2007-12#2)
spatial coherence is##3##3##(2007-12#2)(2008-3#1)
spatial coherence of light influenced by turbulence##2##7##(2008-3#2)
spatial coherence of light##4##4##(2008-1#1)(2008-3#3)
spatial coherence of the##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
spatial coherence of##12##3##(2007-12#2)(2008-1#1)(2008-2#4)(2008-3#5)
spatial coherence##39##2##(2007-11#6)(2007-12#9)(2008-1#1)(2008-2#8)(2008-3#15)
spatial component##2##2##(1993-5#1)(1995-5#1)
spatial configuration of the##2##4##(2008-2#2)
spatial configuration of##3##3##(2007-7#1)(2008-2#2)
spatial configuration##5##2##(2007-7#1)(2008-2#2)(2010-12#1)(2011-12#1)
spatial conformation of the##3##4##(1990-4#1)(2008-8#2)
spatial conformation of##4##3##(1990-4#1)(1997-3#1)(2008-8#2)
spatial conformation##5##2##(1990-4#1)(1997-3#1)(2008-8#3)
spatial control of##3##3##(2006-2#1)(2007-12#1)(2010-4#1)
spatial control over##3##3##(2008-7#1)(2010-9#2)
spatial control##7##2##(2006-2#1)(2007-12#1)(2008-7#1)(2010-4#1)(2010-9#3)
spatial coordinate##5##2##(2005-12#1)(2007-11#1)(2008-10#2)(2008-3#1)
spatial coordinates##4##2##(1997-8#1)(2008-2#1)(2008-3#1)(2008-4#1)
spatial correlation##12##2##(2007-12#1)(2007-5#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-8#3)(2013-8#1)
spatial correlations in##2##3##(1994-8#1)(1995-10#1)
spatial correlations##5##2##(1994-8#3)(1995-10#1)(2008-3#1)
spatial correlator##2##2##(2008-3#2)
spatial covariance##2##2##(2008-8#2)
spatial cueing##3##2##(2008-1#3)
spatial cues##3##2##(1996-6#1)(2008-8#1)(2010-1#1)
spatial data sets##3##3##(1997-6#1)(2009-9#2)
spatial data##5##2##(1997-6#1)(2008-10#1)(2008-8#1)(2009-9#2)
spatial deficits##3##2##(1992-9#1)(1994-3#1)(1995-12#1)
spatial degrees of freedom##2##4##(2007-5#1)(2008-2#1)
spatial delayed alternation##7##3##(1991-1#5)(1991-2#1)(1994-8#1)
spatial delayed##10##2##(1991-1#5)(1991-2#2)(1993-3#1)(1994-8#1)(1995-12#1)
spatial dependence##10##2##(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#1)(2009-12#2)(2009-7#1)
spatial dependence)##2##2##(2008-10#2)
spatial dependency##2##2##(2008-10#1)(2008-3#1)
spatial detail##2##2##(2007-12#1)(2008-3#1)
spatial differences in##2##3##(2004-4#1)(2007-3#1)
spatial differences##5##2##(2004-4#1)(2007-3#1)(2007-5#1)(2008-5#1)(2012-3#1)
spatial dimension##2##2##(2007-9#1)(2013-8#1)
spatial dimensions##7##2##(1996-8#1)(2007-11#1)(2008-10#1)(2008-3#3)(2009-10#1)
spatial directions##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
spatial dispersion##2##2##(2008-2#1)(2008-3#1)
spatial displacement##2##2##(2007-11#1)(2007-12#1)
spatial distortions and##2##3##(2007-12#2)
spatial distribution and##5##3##(2007-12#2)(2008-10#1)(2008-8#2)
spatial distribution characteristics of##2##4##(2008-10#1)(2013-8#1)
spatial distribution during##2##3##(2008-3#1)(2008-8#1)
spatial distribution in##3##3##(1991-6#1)(2008-2#1)(2008-5#1)
spatial distribution of the optical##3##5##(2007-12#1)(2008-2#2)
spatial distribution of the quantum dots##2##6##(1995-3#1)(2007-11#1)
spatial distribution of the##23##4##(1995-3#1)(2007-11#1)(2007-12#4)(2007-3#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-5#2)(2008-8#1)(2009-10#2)(2009-4#1)(2010-8#1)(2011-1#1)(2013-8#1)
spatial distribution of##79##3##(1990-5#1)(1990-7#1)(1994-2#1)(1994-9#1)(1995-3#1)(1996-6#1)(1997-4#1)(1997-6#1)(2004-11#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#7)(2007-3#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#8)(2008-3#6)(2008-5#3)(2008-8#5)(2009-10#4)(2009-4#1)(2009-5#1)(2010-4#1)(2010-8#3)(2011-1#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-7#4)(2013-8#2)
spatial distribution##117##2##(1990-5#1)(1990-7#2)(1991-6#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-6#1)(1997-4#1)(1997-6#1)(2004-11#2)(2006-10#1)(2006-11#1)(2006-12#2)(2007-10#1)(2007-11#3)(2007-12#10)(2007-3#3)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-2#11)(2008-3#10)(2008-5#6)(2008-8#11)(2009-10#5)(2009-4#1)(2009-5#1)(2010-4#1)(2010-8#3)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-7#5)(2013-8#5)
spatial distributions of##5##3##(2006-12#1)(2007-5#1)(2008-10#1)(2008-2#2)
spatial distributions##7##2##(2006-12#1)(2007-5#1)(2008-10#2)(2008-2#2)(2008-3#1)
spatial domain##9##2##(2007-12#2)(2008-2#5)(2008-3#2)
spatial dynamics of the##2##4##(2008-10#2)
spatial dynamics of##8##3##(1995-5#1)(2008-10#6)(2011-2#1)
spatial dynamics##12##2##(1995-5#1)(2007-9#1)(2008-10#6)(2008-8#2)(2009-2#1)(2011-2#1)
spatial encoding##2##2##(2007-12#1)(2013-8#1)
spatial environment##4##2##(2008-11#1)(2008-4#1)(2008-7#1)(2013-8#1)
spatial error##2##2##(2009-12#1)(2012-2#1)
spatial expression of##5##3##(1995-3#1)(1995-8#1)(1997-8#1)(2008-10#1)(2012-2#1)
spatial expression##7##2##(1993-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1997-8#1)(2008-10#1)(2012-2#1)
spatial extent of##7##3##(1993-7#1)(1996-5#1)(2008-2#2)(2008-3#1)(2009-4#2)
spatial extent##11##2##(1993-7#1)(1995-12#1)(1996-5#1)(2007-5#2)(2008-2#3)(2008-3#1)(2009-4#2)
spatial filter is##2##3##(2007-11#1)(2008-2#1)
spatial filter values##2##3##(1997-8#2)
spatial filter##14##2##(1997-8#2)(2007-11#2)(2007-12#4)(2008-2#4)(2008-3#2)
spatial filtering and##2##3##(2007-12#1)(2008-3#1)
spatial filtering by##2##3##(2008-1#2)
spatial filtering in##2##3##(2007-12#1)(2008-3#1)
spatial filtering is##2##3##(2008-2#2)
spatial filtering of##2##3##(2007-12#1)(2008-2#1)
spatial filtering##21##2##(2007-12#4)(2008-1#3)(2008-2#9)(2008-3#5)
spatial filters##3##2##(2008-2#2)(2008-3#1)
spatial frame##3##2##(2009-9#1)(2012-2#2)
spatial frequencies in##2##3##(2008-3#2)
spatial frequencies that##2##3##(2007-11#1)(2008-2#1)
spatial frequencies##21##2##(1996-12#1)(2007-11#2)(2007-12#2)(2008-2#7)(2008-3#7)(2008-7#1)(2011-1#1)
spatial frequency and the##2##4##(2008-3#2)
spatial frequency and##4##3##(2007-12#1)(2008-3#3)
spatial frequency content of##2##4##(1994-8#1)(1995-8#1)
spatial frequency of the##4##4##(2007-12#2)(2008-2#1)(2008-3#1)
spatial frequency of##9##3##(2007-12#3)(2008-2#2)(2008-3#2)(2008-8#1)(2009-10#1)
spatial frequency to##2##3##(2008-2#1)(2008-8#1)
spatial frequency##36##2##(1994-2#2)(1994-8#1)(1995-8#2)(1996-12#1)(1997-8#1)(2007-12#6)(2008-2#11)(2008-3#8)(2008-8#2)(2009-10#2)
spatial functions##2##2##(1990-3#1)(1992-9#1)
spatial gain##2##2##(2007-12#1)(2008-1#1)
spatial gradients##3##2##(2007-5#1)(2008-10#1)(2009-7#1)
spatial heterodyne##4##2##(2007-11#2)(2013-8#2)
spatial heterogeneity in##5##3##(1991-12#1)(2008-10#2)(2008-8#1)(2008-9#1)
spatial heterogeneity of##6##3##(1996-2#1)(2008-10#4)(2012-1#1)
spatial heterogeneity##18##2##(1991-12#1)(1996-2#1)(2008-10#6)(2008-3#2)(2008-8#4)(2008-9#2)(2010-7#1)(2012-1#1)
spatial hierarchy##6##2##(2008-10#6)
spatial hole burning is##2##4##(2008-3#2)
spatial hole burning##10##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#6)
spatial image of##2##3##(2008-3#2)
spatial image##5##2##(2008-3#4)(2008-6#1)
spatial imaging##2##2##(2007-11#2)
spatial impulse response of##2##4##(2007-12#1)(2008-3#1)
spatial information from##2##3##(2007-6#1)(2008-3#1)
spatial information on##3##3##(2008-11#1)(2008-3#1)(2012-12#1)
spatial information##19##2##(1992-8#1)(1995-12#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#4)(2008-6#2)(2008-7#1)(2008-9#1)(2012-12#1)
spatial integration##2##2##(2008-2#1)(2012-2#1)
spatial intensity##2##2##(2008-3#1)(2010-11#1)
spatial interactions##4##2##(2008-2#1)(2009-8#2)(2011-1#1)
spatial interpolation##4##2##(2007-5#1)(2008-3#1)(2012-2#2)
spatial issues##2##2##(2008-8#2)
spatial lag##2##2##(2008-10#1)(2009-12#1)
spatial layout##2##2##(1997-8#1)(2008-2#1)
spatial learning ability##2##3##(1994-3#1)(1997-5#1)
spatial learning and memory##3##4##(1994-8#1)(2011-2#1)(2012-2#1)
spatial learning and##6##3##(1991-7#1)(1992-10#1)(1993-7#1)(1994-8#1)(2011-2#1)(2012-2#1)
spatial learning by##3##3##(1993-12#1)(1994-3#1)(2012-2#1)
spatial learning deficit##6##3##(1991-7#1)(1993-12#4)(1997-5#1)
spatial learning deficits##3##3##(1993-11#1)(1993-3#1)(1997-5#1)
spatial learning following##3##3##(1996-5#1)(1997-5#2)
spatial learning impairment##2##3##(1991-7#1)(1993-11#1)
spatial learning in the##4##4##(1993-12#2)(1994-8#1)(2008-9#1)
spatial learning in##8##3##(1993-12#2)(1993-2#1)(1993-3#1)(1994-8#1)(2008-9#3)
spatial learning task##3##3##(1993-2#2)(1996-6#1)
spatial learning##57##2##(1991-7#4)(1992-10#1)(1993-11#4)(1993-12#14)(1993-2#4)(1993-3#3)(1993-7#2)(1994-3#2)(1994-8#3)(1996-2#2)(1996-5#2)(1996-6#2)(1997-5#5)(2008-7#1)(2008-9#4)(2011-2#1)(2012-2#2)(2013-8#1)
spatial light modulator (SLM)##11##4##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#5)
spatial light modulator are##2##4##(2007-12#1)(2008-2#1)
spatial light modulator for##5##4##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)
spatial light modulator in the##3##5##(2007-12#2)(2008-2#1)
spatial light modulator in##4##4##(2007-12#3)(2008-2#1)
spatial light modulator is##2##4##(2007-12#1)(2008-3#1)
spatial light modulator operating##2##4##(2007-12#1)(2008-2#1)
spatial light modulator that uses electroabsorption##2##6##(2008-2#2)
spatial light modulator that uses##3##5##(2008-2#3)
spatial light modulator that##4##4##(2008-2#3)(2008-3#1)
spatial light modulator##79##3##(2007-11#6)(2007-12#18)(2008-1#2)(2008-2#24)(2008-3#29)
spatial light modulators (SLM's)##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
spatial light modulators and##2##4##(2007-12#1)(2008-2#1)
spatial light modulators are##2##4##(2008-2#1)(2008-3#1)
spatial light modulators in a##3##5##(2008-2#3)
spatial light modulators in##4##4##(2007-12#1)(2008-2#3)
spatial light modulators to##2##4##(2007-12#1)(2008-3#1)
spatial light modulators##41##3##(2007-12#11)(2008-1#1)(2008-2#18)(2008-3#11)
spatial light##122##2##(2007-11#7)(2007-12#29)(2008-1#3)(2008-2#43)(2008-3#40)
spatial light-scattering##2##2##(2008-3#2)
spatial localization##6##2##(1990-11#1)(1995-2#1)(1996-11#2)(2007-9#1)(2008-3#1)
spatial location of the##2##4##(1996-9#1)(2010-4#1)
spatial location of##3##3##(1996-9#1)(2008-3#1)(2010-4#1)
spatial location##16##2##(1990-7#1)(1994-3#3)(1995-12#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-7#1)
spatial locations##3##2##(1993-9#1)(2009-8#1)(2009-9#1)
spatial mapping of##2##3##(2007-12#1)(2008-2#1)
spatial mapping##3##2##(2007-12#1)(2008-2#2)
spatial maps##2##2##(2008-3#1)(2011-2#1)
spatial memory deficits##3##3##(1997-2#2)(2013-1#1)
spatial memory function##3##3##(1993-12#3)
spatial memory in##4##3##(1993-2#1)(1993-5#1)(1994-11#1)(1996-3#1)
spatial memory task##2##3##(1993-5#1)(2008-7#1)
spatial memory tasks##2##3##(1993-12#1)(2011-2#1)
spatial memory##41##2##(1993-12#5)(1993-2#3)(1993-5#4)(1994-11#2)(1994-2#1)(1994-8#3)(1995-11#1)(1995-12#1)(1996-3#1)(1997-2#3)(1997-4#1)(2008-11#1)(2008-4#3)(2008-7#6)(2008-9#1)(2009-11#2)(2011-2#2)(2013-1#1)
spatial mismatch##5##2##(2009-9#4)(2012-12#1)
spatial mode##9##2##(2007-11#2)(2007-12#6)(2008-3#1)
spatial model##2##2##(2008-8#2)
spatial modelling##2##2##(2009-9#1)(2010-10#1)
spatial models##6##2##(2008-4#2)(2008-8#3)(2009-9#1)
spatial modes of lasers##2##4##(2008-3#2)
spatial modes##5##2##(2007-12#2)(2008-3#3)
spatial modulation of##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
spatial modulation##5##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
spatial movements##3##2##(2009-8#2)(2012-1#1)
spatial navigation and##2##3##(1993-12#1)(1994-5#1)
spatial navigation##7##2##(1992-3#1)(1993-12#1)(1994-10#1)(1994-3#1)(1994-5#2)(2008-11#1)
spatial nonuniformity##2##2##(2008-2#2)
spatial optical##3##2##(2007-11#2)(2007-12#1)
spatial or temporal##2##3##(2008-9#1)(2009-10#1)
spatial or##4##2##(1994-2#1)(2008-9#1)(2009-10#1)(2009-3#1)
spatial order##2##2##(1992-6#1)(2008-7#1)
spatial organisation##3##2##(2010-10#3)
spatial organization and##3##3##(1994-7#1)(2007-12#1)(2008-9#1)
spatial organization of##6##3##(1991-2#1)(1994-3#1)(2008-1#1)(2008-7#1)(2009-5#2)
spatial organization##14##2##(1991-2#1)(1994-3#1)(1994-7#1)(1995-6#1)(1996-2#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-5#2)(2010-9#1)(2011-1#1)
spatial orientation and##2##3##(2008-2#1)(2008-7#1)
spatial orientation##4##2##(1995-5#1)(2006-2#1)(2008-2#1)(2008-7#1)
spatial oscillation##2##2##(2006-4#2)
spatial parallel link mechanism and a##2##6##(2012-1#2)
spatial pattern formation##2##3##(2007-9#1)(2008-11#1)
spatial pattern of disease##2##4##(2008-10#1)(2008-8#1)
spatial pattern of spore deposition##2##5##(2008-10#2)
spatial pattern of##19##3##(1994-5#1)(2006-10#1)(2007-12#1)(2008-10#13)(2008-8#3)
spatial pattern##35##2##(1994-5#2)(1995-6#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#18)(2008-11#1)(2008-8#10)
spatial patterns at##2##3##(2008-10#1)(2008-8#1)
spatial patterns of ACC##2##4##(2008-10#2)
spatial patterns of##22##3##(1996-12#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#13)(2008-2#1)(2008-3#1)(2010-2#1)
spatial patterns##37##2##(1991-6#1)(1993-8#1)(1996-12#1)(2006-5#1)(2007-10#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#16)(2008-2#1)(2008-3#1)(2008-8#5)(2008-9#1)(2010-2#1)(2011-2#1)(2013-7#1)(2013-8#1)
spatial performance##2##2##(1994-8#1)(2008-3#1)
spatial period##2##2##(2008-3#2)
spatial phase modulation##2##3##(2007-12#2)
spatial phase##11##2##(1991-12#1)(2007-11#1)(2007-12#4)(2008-3#5)
spatial point##5##2##(2008-10#1)(2008-2#1)(2010-11#2)(2013-8#1)
spatial population structure##2##3##(2008-8#2)
spatial population##3##2##(2008-8#3)
spatial position##9##2##(1993-12#1)(1993-9#1)(1997-2#1)(2006-6#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-3#2)
spatial positions of##2##3##(2008-1#1)(2012-2#1)
spatial positions##3##2##(2008-1#1)(2008-3#1)(2012-2#1)
spatial power##2##2##(2008-3#1)(2010-7#1)
spatial precision##2##2##(2009-4#1)(2012-2#1)
spatial prediction##4##2##(1997-6#1)(2007-5#2)(2008-8#1)
spatial prior##2##2##(2011-1#2)
spatial problems##2##2##(1991-2#1)(2008-8#1)
spatial processes##5##2##(1993-5#1)(2008-10#1)(2008-8#1)(2009-12#2)
spatial processing in rodents##2##4##(1992-9#1)(1994-3#1)
spatial processing##5##2##(1992-9#2)(1994-3#3)
spatial profile of##3##3##(2006-12#1)(2008-3#1)(2008-4#1)
spatial profile##9##2##(2005-11#1)(2006-12#1)(2007-12#2)(2008-2#3)(2008-3#1)(2008-4#1)
spatial profiles##4##2##(2007-12#3)(2008-2#1)
spatial properties of##4##3##(1992-9#1)(2008-10#1)(2008-2#1)(2009-6#1)
spatial proximity##4##2##(1992-8#1)(1994-9#1)(2008-7#2)
spatial quality##2##2##(2007-11#1)(2007-12#1)
spatial reasoning##2##2##(2008-11#2)
spatial recognition memory##2##3##(1992-10#1)(1994-3#1)
spatial recognition##5##2##(1992-10#3)(1993-5#1)(1994-3#1)
spatial redistribution of surface water##2##5##(2008-8#2)
spatial redistribution of##5##3##(1995-6#1)(1996-9#1)(2007-12#1)(2008-8#2)
spatial redistribution##6##2##(1995-6#1)(1996-9#1)(2007-12#1)(2008-8#3)
spatial reference memory##4##3##(1993-12#2)(2013-1#2)
spatial reference##5##2##(1993-12#2)(2012-3#1)(2013-1#2)
spatial region##4##2##(2007-8#1)(2008-3#1)(2008-8#1)(2013-8#1)
spatial registration##2##2##(2005-12#1)(2009-4#1)
spatial relations##6##2##(1997-1#1)(2008-1#1)(2008-2#2)(2013-1#2)
spatial relationship of##3##3##(1993-3#1)(2008-10#1)(2008-4#1)
spatial relationship##5##2##(1993-3#1)(1996-11#1)(2007-8#1)(2008-10#1)(2008-4#1)
spatial relationships among##3##3##(1996-5#1)(2007-5#1)(2008-9#1)
spatial relationships between##2##3##(1997-8#1)(2008-9#1)
spatial relationships of##2##3##(1997-3#1)(2012-2#1)
spatial relationships##9##2##(1996-5#1)(1997-3#1)(1997-8#1)(2007-5#1)(2008-10#1)(2008-9#2)(2011-7#1)(2012-2#1)
spatial release from masking##2##4##(2009-5#2)
spatial representation##3##2##(1995-5#1)(2009-8#1)(2013-8#1)
spatial representations##2##2##(1995-12#1)(2009-8#1)
spatial resolution along the##2##4##(2007-12#1)(2008-7#1)
spatial resolution and contrast##2##4##(2006-4#1)(2012-2#1)
spatial resolution and reproducibility##2##4##(2009-1#1)(2009-4#1)
spatial resolution and temporal resolution##2##5##(2007-12#1)(2008-6#1)
spatial resolution and##21##3##(1994-2#1)(2006-4#1)(2006-5#1)(2006-6#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-4#1)(2010-12#1)(2012-12#1)(2012-2#1)
spatial resolution at##3##3##(2008-3#2)(2009-5#1)
spatial resolution better than##2##4##(2008-3#1)(2008-7#1)
spatial resolution by##3##3##(1994-2#1)(2007-11#1)(2008-2#1)
spatial resolution for##2##3##(2008-10#1)(2008-3#1)
spatial resolution in optical diffusion tomography##2##6##(2008-3#2)
spatial resolution in##11##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#4)(2008-7#1)(2012-12#2)
spatial resolution is the##2##4##(2012-12#2)
spatial resolution is##9##3##(2005-9#1)(2006-5#1)(2007-12#3)(2008-2#1)(2008-7#1)(2012-12#2)
spatial resolution of 0##2##4##(2008-2#1)(2008-3#1)
spatial resolution of a##3##4##(2007-12#1)(2008-2#1)(2008-9#1)
spatial resolution of better than 100##2##6##(2007-12#1)(2008-2#1)
spatial resolution of the##12##4##(1991-2#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#3)
spatial resolution of##45##3##(1991-2#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#9)(2008-1#1)(2008-10#1)(2008-2#11)(2008-3#12)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#1)
spatial resolution that##3##3##(2008-10#2)(2008-3#1)
spatial resolution to##2##3##(2007-12#1)(2012-2#1)
spatial resolution was##3##3##(2006-5#1)(2007-12#1)(2008-2#1)
spatial resolution were##2##3##(2007-12#1)(2008-3#1)
spatial resolution with##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
spatial resolution##190##2##(1991-2#1)(1992-7#1)(1994-2#2)(1994-5#1)(1995-11#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#4)(2006-6#2)(2007-11#6)(2007-12#27)(2007-8#1)(2008-1#4)(2008-10#6)(2008-2#36)(2008-3#40)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#9)(2008-8#4)(2008-9#2)(2009-1#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-9#2)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#4)(2013-8#1)
spatial response is##2##3##(2008-2#1)(2008-3#1)
spatial response##6##2##(2008-2#5)(2008-3#1)
spatial responsivity##2##2##(2008-2#1)(2008-3#1)
spatial reversal##2##2##(1993-3#2)
spatial sampling##5##2##(2008-2#2)(2008-3#1)(2010-2#2)
spatial scale is essential##2##4##(2008-10#1)(2009-2#1)
spatial scale of the##2##4##(2008-8#2)
spatial scale of##5##3##(2008-2#1)(2008-8#4)
spatial scale##21##2##(2008-10#4)(2008-2#1)(2008-8#7)(2009-2#1)(2010-6#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-7#3)(2013-8#1)
spatial scale)##3##2##(2013-7#3)
spatial scales to##2##3##(2007-9#1)(2008-10#1)
spatial scales##31##2##(2007-11#1)(2007-9#1)(2008-10#8)(2008-3#2)(2008-8#6)(2008-9#4)(2009-12#1)(2009-2#3)(2010-8#1)(2012-12#1)(2013-1#1)(2013-7#2)
spatial segregation of the sexes may be##2##7##(2008-9#2)
spatial segregation of the sexes##3##5##(2008-9#3)
spatial segregation of##5##3##(2008-9#3)(2010-10#1)(2013-8#1)
spatial selectivity of##2##3##(2008-2#1)(2008-7#1)
spatial separation of the spectral components##2##6##(2007-11#1)(2007-12#1)
spatial separation of the##4##4##(2007-11#1)(2007-12#3)
spatial separation of##6##3##(2007-11#1)(2007-12#3)(2008-10#1)(2008-3#1)
spatial separation##10##2##(1991-2#1)(2007-11#1)(2007-12#4)(2008-10#2)(2008-3#1)(2009-9#1)
spatial shaping of##2##3##(2007-11#1)(2008-2#1)
spatial shearing##2##2##(2007-11#2)
spatial signal##3##2##(2008-3#3)
spatial smoothing##2##2##(2009-7#2)
spatial solitary waves##4##3##(2007-12#3)(2008-1#1)
spatial soliton generation##2##3##(2007-11#1)(2008-1#1)
spatial soliton##12##2##(2007-11#5)(2007-12#6)(2008-1#1)
spatial solitons and##3##3##(2007-11#1)(2007-12#2)
spatial solitons are observed in##2##5##(2007-12#2)
spatial solitons are##3##3##(2007-12#3)
spatial solitons in AlGaAs slab waveguides##2##6##(2007-12#2)
spatial solitons in a##3##4##(2007-12#3)
spatial solitons in bulk nematic liquid crystals##2##7##(2007-12#2)
spatial solitons in photorefractive##3##4##(2007-12#2)(2008-1#1)
spatial solitons in##21##3##(2007-11#2)(2007-12#15)(2008-1#3)(2008-2#1)
spatial solitons is##2##3##(2008-1#1)(2008-3#1)
spatial solitons##50##2##(2007-11#7)(2007-12#31)(2008-1#10)(2008-2#1)(2008-3#1)
spatial specificity##2##2##(1994-3#1)(2007-12#1)
spatial spread of##6##3##(2008-10#5)(2011-3#1)
spatial spread##7##2##(2008-10#5)(2008-9#1)(2011-3#1)
spatial statistics of##4##3##(2008-10#1)(2008-3#3)
spatial statistics##10##2##(2008-10#1)(2008-3#3)(2008-8#3)(2009-3#1)(2012-1#1)(2013-1#1)
spatial stochastic simulation model##2##4##(1991-12#2)
spatial stochastic##3##2##(1991-12#2)(1995-5#1)
spatial structure and##3##3##(2008-10#1)(2008-11#1)(2009-8#1)
spatial structure in##2##3##(1995-4#1)(2008-10#1)
spatial structure of the##5##4##(1992-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#1)
spatial structure of##13##3##(1992-9#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-8#4)(2009-2#1)(2013-1#1)
spatial structure##24##2##(1990-5#1)(1992-9#1)(1995-4#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-8#8)(2009-2#2)(2009-8#1)(2013-1#1)
spatial structures of##2##3##(2008-1#1)(2008-3#1)
spatial structures##6##2##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#1)
spatial task##7##2##(1991-1#1)(1993-4#1)(1994-8#4)(1996-5#1)
spatial tasks##4##2##(1993-9#1)(1994-3#1)(2008-11#1)(2012-2#1)
spatial temperature##2##2##(2008-3#1)(2011-2#1)
spatial template##2##2##(2007-12#1)(2008-2#1)
spatial terms##2##2##(2009-7#2)
spatial transfer functions##2##3##(2008-2#2)
spatial trends##2##2##(2008-10#1)(2011-2#1)
spatial uniformity##6##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#3)
spatial variability in the secretion at##2##6##(1991-6#2)
spatial variability in##5##3##(1991-6#2)(2010-2#1)(2010-8#2)
spatial variability of##6##3##(2007-11#1)(2008-2#2)(2009-11#2)(2010-8#1)
spatial variability##14##2##(1991-6#2)(2007-11#1)(2008-10#1)(2008-2#2)(2009-11#2)(2010-2#2)(2010-8#3)(2011-2#1)
spatial variance in fitness##2##4##(2008-8#2)
spatial variance##3##2##(2008-8#2)(2009-5#1)
spatial variation in habitat quality##2##5##(2008-8#2)
spatial variation in the##2##4##(2008-2#1)(2012-3#1)
spatial variation in##9##3##(2008-2#1)(2008-8#4)(2010-8#2)(2012-3#1)(2013-7#1)
spatial variation of the##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
spatial variation of##7##3##(2006-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-8#1)(2011-2#1)
spatial variation##22##2##(1992-6#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-8#4)(2009-8#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
spatial variations in##3##3##(2007-12#1)(2007-9#1)(2011-12#1)
spatial variations##5##2##(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2011-12#1)
spatial vector solitons##2##3##(2007-11#2)
spatial vector##3##2##(2007-11#3)
spatial walk-off polarizing film##2##4##(2007-12#2)
spatial water-maze##2##2##(1994-8#2)
spatial win-stay lose-shift task##2##4##(1991-1#2)
spatial working memory task##5##4##(1994-8#3)(1997-8#2)
spatial working memory##12##3##(1992-11#1)(1993-12#1)(1994-5#1)(1994-8#4)(1997-8#2)(2008-11#2)(2009-7#1)
spatial working##13##2##(1992-11#1)(1993-12#1)(1994-5#1)(1994-8#4)(1997-8#2)(2008-11#3)(2009-7#1)
spatial##2132##1##(1990-10#2)(1990-11#2)(1990-3#2)(1990-4#1)(1990-5#2)(1990-7#3)(1990-8#1)(1991-1#8)(1991-11#3)(1991-12#5)(1991-2#8)(1991-5#1)(1991-6#6)(1991-7#4)(1992-10#5)(1992-11#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#8)(1993-11#5)(1993-12#27)(1993-2#11)(1993-3#9)(1993-4#1)(1993-5#12)(1993-6#1)(1993-7#3)(1993-8#2)(1993-9#4)(1994-10#1)(1994-11#3)(1994-2#11)(1994-3#17)(1994-5#7)(1994-6#3)(1994-7#1)(1994-8#24)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#9)(1995-2#2)(1995-3#2)(1995-4#2)(1995-5#7)(1995-6#3)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#5)(1996-2#6)(1996-3#3)(1996-5#6)(1996-6#5)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#2)(1997-4#4)(1997-5#5)(1997-6#4)(1997-8#11)(2003-11#1)(2004-11#2)(2004-4#1)(2004-9#1)(2005-11#3)(2005-12#2)(2005-8#1)(2005-9#1)(2006-10#8)(2006-11#1)(2006-12#8)(2006-2#3)(2006-4#4)(2006-5#5)(2006-6#5)(2006-7#3)(2007-10#3)(2007-11#96)(2007-12#230)(2007-3#6)(2007-5#22)(2007-6#3)(2007-7#2)(2007-8#8)(2007-9#14)(2008-1#41)(2008-10#170)(2008-11#36)(2008-12#1)(2008-2#266)(2008-3#263)(2008-4#20)(2008-5#17)(2008-6#6)(2008-7#38)(2008-8#128)(2008-9#31)(2009-1#2)(2009-10#17)(2009-11#7)(2009-12#10)(2009-2#7)(2009-3#4)(2009-4#7)(2009-5#12)(2009-6#2)(2009-7#9)(2009-8#19)(2009-9#21)(2010-1#2)(2010-10#6)(2010-11#7)(2010-12#7)(2010-2#9)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#6)(2010-8#11)(2010-9#9)(2011-1#18)(2011-11#1)(2011-12#6)(2011-2#27)(2011-3#2)(2011-7#1)(2012-1#13)(2012-11#1)(2012-12#14)(2012-2#24)(2012-3#4)(2013-1#13)(2013-7#22)(2013-8#36)
spatial&quot##2##1##(1993-5#2)
spatial-domain##2##1##(2007-12#1)(2008-3#1)
spatial-filtering method##3##2##(2008-2#2)(2008-3#1)
spatial-filtering##8##1##(2008-2#5)(2008-3#3)
spatial-frequency##12##1##(2007-12#5)(2008-1#1)(2008-2#4)(2008-3#2)
spatial-learning##2##1##(1993-5#1)(2008-7#1)
spatial-mode##2##1##(2007-12#1)(2008-3#1)
spatial-only##2##1##(2008-2#2)
spatial-response##2##1##(2008-3#2)
spatial-soliton##4##1##(2007-12#1)(2008-3#3)
spatial-spectral##3##1##(2007-12#2)(2008-2#1)
spatial-temporal converters##3##2##(2008-2#1)(2008-3#2)
spatial-temporal##7##1##(1995-12#1)(2006-7#1)(2007-12#1)(2008-2#1)(2008-3#2)(2011-1#1)
spatially adaptive##3##2##(2008-2#2)(2009-9#1)
spatially aggregated within##2##3##(2008-10#2)
spatially aggregated##5##2##(1995-4#1)(2008-10#4)
spatially and spectrally##3##3##(2007-12#2)(2008-2#1)
spatially and temporally regulated##5##4##(1994-2#1)(2009-3#2)(2009-8#1)(2011-2#1)
spatially and temporally##20##3##(1991-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-3#2)(2009-4#1)(2009-8#1)(2010-3#1)(2011-2#2)
spatially and##27##2##(1991-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(2006-10#1)(2007-12#4)(2007-5#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-5#1)(2008-9#2)(2009-3#2)(2009-4#1)(2009-8#1)(2010-3#1)(2011-2#2)
spatially autocorrelated##4##2##(2008-10#1)(2008-8#1)(2010-2#2)
spatially by##4##2##(1994-9#1)(2008-2#2)(2013-7#1)
spatially characterized##3##2##(2008-2#1)(2008-5#2)
spatially coherent light##2##3##(2007-12#1)(2008-3#1)
spatially coherent##5##2##(2007-11#1)(2007-12#3)(2008-3#1)
spatially complex##2##2##(2007-12#1)(2008-8#1)
spatially confined##3##2##(2005-11#1)(2007-12#1)(2008-3#1)
spatially continuous##2##2##(2008-8#2)
spatially correlated##11##2##(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#4)(2008-9#2)
spatially dependent##2##2##(2008-2#1)(2009-9#1)
spatially discrete##3##2##(1996-9#1)(2008-8#2)
spatially distant##2##2##(2010-3#1)(2012-2#1)
spatially distinct##5##2##(1993-12#1)(1997-7#1)(2007-12#2)(2008-4#1)
spatially distributed##4##2##(1990-3#1)(1995-11#1)(2007-12#1)(2008-3#1)
spatially encrypted signal##3##3##(2008-3#3)
spatially explicit model##2##3##(2008-10#1)(2008-8#1)
spatially explicit models##4##3##(2008-8#1)(2008-9#3)
spatially explicit##15##2##(2006-5#1)(2008-10#2)(2008-8#7)(2008-9#4)(2013-8#1)
spatially extended##6##2##(1995-12#1)(2007-12#1)(2012-1#1)(2013-8#3)
spatially filtered##4##2##(2006-12#1)(2007-12#1)(2008-3#2)
spatially heterogeneous##8##2##(1991-12#1)(2006-10#1)(2007-4#1)(2008-10#3)(2008-8#1)(2013-1#1)
spatially homogeneous##9##2##(2006-10#1)(2007-12#1)(2007-6#1)(2008-8#6)
spatially in##2##2##(2008-10#1)(2008-2#1)
spatially incoherent light##5##3##(2007-11#2)(2007-12#1)(2008-1#1)(2008-3#1)
spatially incoherent signals##2##3##(2008-3#2)
spatially incoherent source##2##3##(2007-12#2)
spatially incoherent sources##2##3##(2007-12#2)
spatially incoherent##20##2##(2007-11#4)(2007-12#7)(2008-1#1)(2008-2#1)(2008-3#7)
spatially independent##2##2##(2008-8#1)(2009-12#1)
spatially integrated##2##2##(2011-2#2)
spatially local information##2##3##(2012-3#2)
spatially localized##8##2##(2007-12#3)(2008-1#1)(2008-3#1)(2009-4#1)(2012-2#1)(2013-1#1)
spatially modulated light##2##3##(2007-12#1)(2011-1#1)
spatially modulated##6##2##(2007-11#1)(2007-12#2)(2008-2#1)(2011-1#1)(2012-2#1)
spatially multiplexed##7##2##(2007-11#1)(2008-2#5)(2008-3#1)
spatially nonhomogeneous##2##2##(2007-12#1)(2008-2#1)
spatially nonoverlapping white##2##3##(2008-2#2)
spatially nonoverlapping##3##2##(2008-2#3)
spatially nonuniform nonlinear coefficients##2##4##(2007-11#2)
spatially nonuniform##3##2##(2007-11#2)(2008-2#1)
spatially organized in##2##3##(1996-7#1)(2007-11#1)
spatially organized##5##2##(1995-11#1)(1996-3#1)(1996-7#1)(2007-10#1)(2007-11#1)
spatially periodic##4##2##(1992-9#1)(2007-12#2)(2008-2#1)
spatially realistic metapopulation model##4##4##(2008-8#3)(2008-9#1)
spatially resolved diffuse reflectance##2##4##(2008-2#1)(2008-3#1)
spatially resolved diffuse##3##3##(2008-2#2)(2008-3#1)
spatially resolved light##2##3##(2008-2#2)
spatially resolved measurements of the##3##5##(2007-12#1)(2008-3#2)
spatially resolved measurements##4##3##(2007-12#1)(2008-3#2)(2013-8#1)
spatially resolved optical##2##3##(2006-2#1)(2008-3#1)
spatially resolved phase##2##3##(2007-12#2)
spatially resolved probe##2##3##(2008-3#2)
spatially resolved reflectance##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
spatially resolved spectroscopy##2##3##(1997-6#2)
spatially resolved##52##2##(1997-6#3)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2007-11#3)(2007-12#8)(2008-1#1)(2008-10#1)(2008-2#13)(2008-3#15)(2008-5#1)(2012-2#1)(2013-8#1)
spatially resolving##2##2##(2008-3#1)(2008-7#1)
spatially restricted epileptiform activity##2##4##(1996-5#2)
spatially restricted##3##2##(1995-8#1)(1996-5#2)
spatially segregated##3##2##(2008-10#1)(2008-9#2)
spatially selective##3##2##(2007-11#1)(2008-3#2)
spatially separate##3##2##(1990-7#1)(2007-12#1)(2008-1#1)
spatially separated from##3##3##(2008-3#1)(2009-5#2)
spatially separated##13##2##(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2009-5#2)(2009-6#1)(2009-9#1)(2012-2#1)
spatially structured##5##2##(1991-8#1)(2008-8#3)(2008-9#1)
spatially uniform##7##2##(2007-12#2)(2008-2#2)(2008-3#2)(2008-9#1)
spatially variable pest management##2##4##(2008-10#2)
spatially variable##6##2##(2008-10#2)(2008-3#1)(2008-8#2)(2009-8#1)
spatially varying##8##2##(1995-11#1)(2008-2#1)(2008-3#2)(2008-9#1)(2011-1#2)(2013-1#1)
spatially##398##1##(1990-3#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-4#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#3)(1995-12#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-6#3)(1997-7#1)(2005-11#2)(2006-10#5)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#20)(2007-12#54)(2007-4#1)(2007-5#3)(2007-6#1)(2007-9#1)(2008-1#5)(2008-10#29)(2008-11#5)(2008-2#53)(2008-3#48)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#42)(2008-9#14)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#6)(2009-9#3)(2010-1#1)(2010-10#1)(2010-2#2)(2010-3#2)(2010-4#3)(2010-7#1)(2010-9#2)(2011-1#3)(2011-2#4)(2012-1#3)(2012-2#6)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#7)
spatially-resolved##2##1##(1997-6#1)(2008-10#1)
spatio-temporal dynamics##3##2##(2008-10#2)(2008-2#1)
spatio-temporal expression patterns##2##3##(2005-10#1)(2009-5#1)
spatio-temporal organization##2##2##(1995-6#1)(2011-2#1)
spatio-temporal pattern##2##2##(2007-12#1)(2013-8#1)
spatio-temporal patterns of##2##3##(1994-10#1)(1997-3#1)
spatio-temporal patterns##3##2##(1994-10#1)(1997-3#1)(2008-5#1)
spatio-temporal##30##1##(1992-12#1)(1994-10#1)(1995-12#1)(1995-6#1)(1996-5#1)(1997-3#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-4#1)(2008-5#1)(2009-12#1)(2009-5#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#2)
spatio-temporally##2##1##(1992-12#1)(2009-12#1)
spatiotemporal analysis of##2##3##(2008-10#1)(2008-3#1)
spatiotemporal analysis##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
spatiotemporal characteristics of the##2##4##(2007-11#1)(2007-12#1)
spatiotemporal control##2##2##(2008-4#1)(2011-2#1)
spatiotemporal correlations##2##2##(2008-7#1)(2011-1#1)
spatiotemporal data##2##2##(1995-5#1)(2009-9#1)
spatiotemporal digital holography##2##3##(2007-12#2)
spatiotemporal dynamics of##4##3##(2008-10#2)(2008-11#2)
spatiotemporal expression##2##2##(1996-12#1)(2008-7#1)
spatiotemporal maps##2##2##(2008-10#2)
spatiotemporal parameters##2##2##(2013-7#2)
spatiotemporal pattern##2##2##(2007-9#1)(2008-9#1)
spatiotemporal patterns of activity##2##4##(1990-5#1)(2009-8#1)
spatiotemporal patterns of##3##3##(1990-5#1)(2009-8#1)(2013-1#1)
spatiotemporal patterns##7##2##(1990-5#1)(1996-2#1)(2006-10#1)(2008-11#1)(2009-8#1)(2013-1#2)
spatiotemporal profiles of##2##3##(2007-12#1)(2010-2#1)
spatiotemporal resolution##4##2##(1991-2#1)(1994-3#1)(2008-2#1)(2009-7#1)
spatiotemporal variation in##2##3##(2008-8#2)
spatiotemporal variation##3##2##(2008-8#3)
spatiotemporal##95##1##(1990-5#1)(1991-2#2)(1994-3#1)(1995-12#2)(1995-5#1)(1996-12#1)(1996-2#1)(2006-10#1)(2007-11#5)(2007-12#10)(2007-2#1)(2007-9#1)(2008-10#10)(2008-11#8)(2008-2#4)(2008-3#8)(2008-4#2)(2008-7#2)(2008-8#7)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#3)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#2)(2013-8#1)
spatiotemporally##5##1##(2007-11#1)(2007-8#1)(2008-4#1)(2008-5#1)(2012-12#1)
spatter##3##1##(2010-5#1)(2011-1#2)
spatula##10##1##(2006-6#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-2#6)
spatula-cyto brush##2##2##(2011-2#2)
spatula-cytobrush##3##1##(2011-2#3)
spawn##5##1##(1994-9#1)(2006-12#1)(2006-4#1)(2007-5#1)(2008-8#1)
spawned by##2##2##(1995-1#1)(2006-4#1)
spawned in##2##2##(2007-3#2)
spawned##15##1##(1993-7#1)(1995-1#1)(1996-3#1)(2006-4#1)(2007-3#4)(2007-5#3)(2008-1#1)(2008-5#2)(2010-8#1)
spawners##3##1##(2008-8#2)(2010-8#1)
spawning and##5##2##(2008-12#1)(2008-4#1)(2010-8#3)
spawning habitat##2##2##(2010-8#2)
spawning in##3##2##(2008-4#1)(2010-8#2)
spawning number##3##2##(2010-8#3)
spawning of the##3##3##(2007-3#2)(2008-12#1)
spawning of##5##2##(1991-8#1)(2007-3#2)(2008-11#1)(2008-12#1)
spawning period##3##2##(2007-3#1)(2010-8#1)(2013-7#1)
spawning rhythm##2##2##(2010-8#2)
spawning rhythms##3##2##(2010-8#3)
spawning season from##2##3##(2008-12#1)(2010-8#1)
spawning season##5##2##(2007-3#1)(2008-12#1)(2008-7#1)(2010-8#2)
spawning was observed in##2##4##(2010-8#2)
spawning was##3##2##(2007-3#1)(2010-8#2)
spawning with##2##2##(2010-8#2)
spawning##68##1##(1991-8#1)(2007-3#8)(2007-5#1)(2007-9#1)(2008-11#1)(2008-12#7)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2010-8#40)(2013-1#1)(2013-7#1)
spawnings##7##1##(2008-5#1)(2010-8#6)
spawns##2##1##(1993-7#1)(2008-5#1)
spayed##2##1##(2012-2#1)(2013-1#1)
speA gene##2##2##(1992-2#2)
speA##3##1##(1992-2#3)
speC gene##3##2##(1994-12#3)
speak English##4##2##(1996-2#1)(2005-10#1)(2008-4#1)(2011-1#1)
speak for##2##2##(1996-3#1)(2010-5#1)
speak of a##2##3##(1996-3#1)(2012-1#1)
speak of##5##2##(1996-3#1)(2007-10#1)(2010-9#2)(2012-1#1)
speak to the importance of##2##5##(2007-12#1)(2012-12#1)
speak to the##5##3##(2007-12#1)(2008-11#1)(2009-4#1)(2010-7#1)(2012-12#1)
speak to##6##2##(1993-12#1)(2007-12#1)(2008-11#1)(2009-4#1)(2010-7#1)(2012-12#1)
speak##32##1##(1991-2#1)(1993-12#1)(1995-3#1)(1996-2#1)(1996-3#2)(2005-10#2)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-11#1)(2009-4#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-8#1)
speaker and##2##2##(2008-2#1)(2010-12#1)
speaker from prosody##2##3##(2009-10#2)
speaker from##3##2##(2009-10#2)(2011-1#1)
speaker sounded##2##2##(2009-10#2)
speaker##27##1##(1993-9#1)(2007-2#1)(2007-7#1)(2008-11#2)(2008-2#4)(2008-3#1)(2008-4#1)(2009-10#6)(2009-9#1)(2010-12#2)(2010-5#1)(2011-1#2)(2012-2#1)(2013-8#3)
speaker's voice##2##2##(1995-12#1)(2008-2#1)
speaker's##9##1##(1995-12#1)(2008-11#1)(2008-2#1)(2008-5#2)(2009-10#2)(2009-5#1)(2011-1#1)
speakers and##6##2##(2005-7#1)(2006-7#1)(2008-11#1)(2008-2#2)(2009-10#1)
speakers are##2##2##(2007-8#1)(2008-2#1)
speakers discussed##2##2##(2005-7#1)(2005-8#1)
speakers for the##2##3##(1995-12#1)(2007-11#1)
speakers for##3##2##(1995-12#1)(2005-7#1)(2007-11#1)
speakers of##6##2##(2008-2#1)(2009-10#2)(2010-12#1)(2013-8#2)
speakers to##3##2##(2008-2#3)
speakers were##3##2##(1995-12#1)(2008-5#1)(2013-8#1)
speakers who learned##2##3##(2009-10#2)
speakers who stammer##6##3##(2008-2#3)(2008-4#3)
speakers who stutter##6##3##(2008-2#5)(2008-4#1)
speakers who##15##2##(2008-2#8)(2008-4#5)(2009-10#2)
speakers with aphasia##2##3##(2007-7#2)
speakers##90##1##(1995-1#1)(1995-12#2)(1995-6#1)(1996-3#1)(1997-4#1)(2004-12#1)(2005-7#3)(2005-8#3)(2005-9#3)(2006-11#2)(2006-12#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-7#3)(2007-8#2)(2008-11#1)(2008-2#20)(2008-4#7)(2008-5#3)(2008-7#1)(2009-10#13)(2009-4#1)(2009-9#1)(2010-11#4)(2010-12#1)(2010-5#2)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#3)
speakers'##4##1##(1995-1#1)(2008-11#1)(2011-1#1)(2013-8#1)
speaking and##3##2##(2010-7#2)(2011-7#1)
speaking of##2##2##(1992-5#1)(2007-3#1)
speaking the##5##2##(1991-7#1)(2008-10#1)(2009-4#1)(2011-2#1)(2012-2#1)
speaking##47##1##(1990-5#1)(1991-6#1)(1991-7#1)(1992-2#1)(1992-5#1)(1996-5#1)(2006-10#1)(2006-8#1)(2007-2#3)(2007-3#2)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#3)(2008-2#2)(2008-5#2)(2008-7#2)(2009-11#1)(2009-3#1)(2009-4#2)(2010-7#2)(2011-1#2)(2011-2#2)(2011-7#1)(2012-12#2)(2012-2#2)(2013-1#4)(2013-7#1)
speaking)##2##1##(2010-12#1)(2012-12#1)
speaks for##2##2##(1991-6#1)(1993-1#1)
speaks of##2##2##(2011-2#1)(2012-3#1)
speaks to##2##2##(2008-6#1)(2012-3#1)
speaks##8##1##(1991-6#1)(1992-11#1)(1993-1#1)(2008-6#1)(2011-2#2)(2012-3#2)
spear grass##3##2##(2006-8#3)
spearheaded##2##1##(1994-9#1)(2008-5#1)
special QA##4##2##(2013-1#4)
special alignment##2##2##(2008-3#2)
special application##2##2##(1994-5#1)(2008-10#1)
special attention in##3##3##(1995-12#1)(2007-10#1)(2011-1#1)
special attention is given to##3##5##(2005-11#1)(2008-3#1)(2010-10#1)
special attention is paid to##2##5##(1992-1#1)(2006-7#1)
special attention is paid##3##4##(1992-1#1)(2006-10#1)(2006-7#1)
special attention is##7##3##(1992-1#1)(1992-2#1)(2005-11#1)(2006-10#1)(2006-7#1)(2008-3#1)(2010-10#1)
special attention should be paid to the##2##7##(2007-2#1)(2012-2#1)
special attention should be paid to##6##6##(1990-2#1)(1991-11#1)(2005-11#1)(2007-2#1)(2008-5#1)(2012-2#1)
special attention should be##7##4##(1990-2#1)(1991-11#1)(2005-11#1)(2007-2#1)(2008-5#1)(2011-2#1)(2012-2#1)
special attention to the##13##4##(1993-12#1)(1993-6#1)(1996-8#1)(2005-11#1)(2006-7#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-4#1)(2013-1#1)(2013-7#1)(2013-8#1)
special attention to##33##3##(1990-6#1)(1991-5#1)(1993-12#1)(1993-3#1)(1993-6#1)(1995-12#1)(1996-6#1)(1996-8#1)(1997-2#1)(2005-11#2)(2006-2#1)(2006-7#2)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-4#2)(2011-3#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
special attention was##2##3##(2007-11#1)(2009-5#1)
special attention##67##2##(1990-2#1)(1990-4#1)(1990-6#1)(1991-11#1)(1991-5#1)(1992-1#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1995-12#2)(1996-6#1)(1996-8#1)(1997-2#1)(2005-11#4)(2006-10#1)(2006-2#1)(2006-6#1)(2006-7#4)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#3)(2008-8#1)(2009-5#1)(2010-10#1)(2010-4#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
special care in##3##3##(2006-10#1)(2008-11#1)(2011-1#1)
special care is##2##3##(2008-3#1)(2010-3#1)
special care nursery##2##3##(1993-3#2)
special care to##2##3##(2007-12#1)(2008-10#1)
special care##19##2##(1991-4#1)(1993-3#2)(1994-3#1)(1997-8#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-3#1)(2011-1#1)(2011-2#2)
special case in which##2##4##(2006-10#1)(2008-3#1)
special case of the##6##4##(2006-10#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
special case of##19##3##(1994-6#1)(2006-10#1)(2006-3#1)(2007-11#2)(2008-10#3)(2008-2#4)(2008-3#3)(2008-8#3)(2008-9#1)
special case##36##2##(1992-6#1)(1994-6#2)(2006-10#2)(2006-3#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-2#5)(2008-3#4)(2008-8#8)(2008-9#1)(2010-4#1)(2012-3#1)(2013-1#1)
special cases and##2##3##(2005-11#1)(2008-2#1)
special cases of the##2##4##(2008-10#1)(2008-2#1)
special cases of##6##3##(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-1#1)
special cases##21##2##(1993-6#1)(1996-9#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#3)(2008-7#1)(2008-8#1)(2010-1#1)(2012-2#2)
special category##2##2##(2006-6#1)(2011-2#1)
special challenges for the##2##4##(2006-5#1)(2009-9#1)
special challenges for##3##3##(1996-12#1)(2006-5#1)(2009-9#1)
special challenges##6##2##(1996-12#1)(2006-10#1)(2006-4#1)(2006-5#1)(2009-9#1)(2011-2#1)
special characteristics and##2##3##(2008-6#1)(2011-2#1)
special characteristics of##3##3##(2008-11#1)(2010-12#1)(2012-12#1)
special characteristics##5##2##(2008-11#1)(2008-6#1)(2010-12#1)(2011-2#1)(2012-12#1)
special circumstances##7##2##(2005-11#1)(2006-11#1)(2007-11#1)(2008-12#1)(2008-5#1)(2009-8#1)(2011-12#1)
special clinics##2##2##(1995-2#2)
special concern##3##2##(2008-11#1)(2010-2#1)(2011-1#1)
special condition##2##2##(2007-6#1)(2008-3#1)
special conditions##3##2##(1996-2#1)(2007-9#1)(2008-11#1)
special consideration##8##2##(1990-6#1)(1993-3#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-6#1)(2011-2#1)(2013-8#1)
special considerations in Asia##2##4##(2012-3#2)
special considerations in##4##3##(2007-12#1)(2010-6#1)(2012-3#2)
special considerations##9##2##(2007-12#1)(2008-4#1)(2010-6#1)(2010-8#1)(2011-12#1)(2012-12#1)(2012-3#2)(2013-1#1)
special criteria##3##2##(1990-6#1)(1990-7#1)(2010-3#1)
special diet##5##2##(1990-5#3)(2006-12#1)(2013-1#1)
special dietary habits##2##3##(2008-5#2)
special dietary##3##2##(2008-10#1)(2008-5#2)
special edition##2##2##(1997-1#1)(2008-12#1)
special education##8##2##(1993-1#1)(2006-7#1)(2008-11#1)(2008-12#1)(2009-6#1)(2010-12#1)(2010-2#1)(2011-2#1)
special efforts##2##2##(1991-3#1)(2008-3#1)
special emphasis is placed##2##4##(1995-4#1)(2007-8#1)
special emphasis on the##23##4##(1991-2#1)(1993-3#1)(1995-7#1)(1997-1#1)(2006-10#2)(2006-12#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-10#1)(2009-2#1)(2010-7#2)(2012-2#1)(2013-1#1)
special emphasis on##62##3##(1990-11#1)(1990-2#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-6#1)(1993-11#2)(1993-3#1)(1994-12#1)(1994-5#1)(1995-7#2)(1996-12#1)(1997-1#1)(2006-10#3)(2006-12#1)(2006-7#3)(2006-8#1)(2007-10#1)(2007-11#2)(2007-2#2)(2007-3#1)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-2#1)(2010-1#1)(2010-7#2)(2011-2#2)(2012-11#1)(2012-2#2)(2013-1#2)
special emphasis was##2##3##(2008-7#1)(2013-1#1)
special emphasis##69##2##(1990-11#1)(1990-2#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-6#1)(1993-11#2)(1993-3#1)(1994-12#1)(1994-5#1)(1995-4#1)(1995-7#2)(1996-12#1)(1997-1#1)(2006-10#3)(2006-12#1)(2006-7#3)(2006-8#1)(2007-10#1)(2007-11#2)(2007-2#3)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-10#1)(2009-2#1)(2010-1#1)(2010-7#2)(2011-2#2)(2012-11#1)(2012-2#2)(2013-1#3)
special events##2##2##(1990-12#1)(1996-3#1)
special experiences##2##2##(2012-2#2)
special feature of##5##3##(1991-8#1)(1994-3#1)(1997-8#1)(2008-2#1)(2012-2#1)
special features of the##3##4##(2008-10#3)
special features of##5##3##(1994-3#1)(2008-10#3)(2008-12#1)
special features##9##2##(1991-1#1)(1994-3#1)(1994-9#1)(2008-10#4)(2008-12#1)(2009-2#1)
special focus on##14##3##(1990-6#1)(1992-4#1)(1997-6#1)(2003-11#1)(2007-2#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-7#1)(2010-12#1)(2010-3#1)(2011-2#2)
special focus##16##2##(1990-6#1)(1992-4#1)(1994-3#2)(1997-6#1)(2003-11#1)(2007-2#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-7#1)(2010-12#1)(2010-3#1)(2011-2#2)
special form##5##2##(1992-3#1)(1996-2#1)(2007-8#1)(2008-10#1)(2012-12#1)
special forms##2##2##(1995-4#1)(2010-11#1)
special health care needs##22##4##(1991-12#1)(1991-3#1)(1993-1#1)(1993-12#1)(1995-1#1)(1995-12#4)(1995-3#2)(1997-2#2)(2005-9#1)(2007-9#1)(2008-11#1)(2008-5#1)(2010-11#2)(2011-1#1)(2013-1#2)
special health##25##2##(1991-12#1)(1991-3#1)(1992-2#1)(1993-1#1)(1993-12#1)(1994-3#1)(1995-1#1)(1995-12#4)(1995-3#2)(1996-12#1)(1997-2#2)(2005-9#1)(2007-9#1)(2008-11#1)(2008-5#1)(2010-11#2)(2011-1#1)(2013-1#2)
special importance in##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
special importance of##4##3##(1990-7#1)(1993-4#1)(2006-10#1)(2013-1#1)
special importance##8##2##(1990-7#1)(1993-4#1)(1994-3#1)(2006-10#1)(2008-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
special indications##5##2##(1991-11#1)(2006-10#1)(2009-8#1)(2011-2#1)(2012-2#1)
special individual##2##2##(2005-7#1)(2010-7#1)
special informed consent##2##3##(2009-2#2)
special instrumentation##2##2##(1996-7#1)(2009-4#1)
special interest because of##3##4##(1997-3#1)(2011-2#2)
special interest because##4##3##(1997-3#1)(2011-2#3)
special interest for##7##3##(2007-11#1)(2008-10#2)(2011-2#3)(2013-8#1)
special interest groups##3##3##(1996-11#1)(1996-3#1)(2008-5#1)
special interest in##5##3##(2007-11#1)(2007-2#1)(2011-1#2)(2013-1#1)
special interest##40##2##(1990-6#1)(1990-9#1)(1991-11#1)(1991-3#1)(1995-2#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-3#1)(2005-7#1)(2005-8#1)(2006-12#1)(2006-2#1)(2007-11#2)(2007-2#2)(2007-3#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2011-1#2)(2011-2#8)(2013-1#1)(2013-8#1)
special issue devoted to##2##4##(1990-12#1)(2008-4#1)
special issue in##2##3##(2009-4#1)(2010-2#1)
special issue of the Journal##2##5##(1994-3#1)(2007-2#1)
special issue of the##3##4##(1994-3#1)(2007-2#1)(2013-1#1)
special issue of##11##3##(1994-3#1)(2006-2#1)(2007-2#1)(2008-12#1)(2008-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
special issue on##2##3##(2008-8#1)(2013-1#1)
special issue##33##2##(1990-12#1)(1993-6#1)(1994-3#1)(2006-2#1)(2007-2#1)(2008-12#2)(2008-2#3)(2008-4#2)(2008-8#2)(2009-2#1)(2009-4#7)(2009-8#1)(2009-9#1)(2010-2#2)(2010-4#1)(2011-1#2)(2012-12#1)(2013-1#2)(2013-8#1)
special issues for##2##3##(2007-9#1)(2008-12#1)
special issues##7##2##(2005-7#1)(2007-7#1)(2007-9#1)(2008-12#1)(2009-9#1)(2010-2#1)(2010-5#1)
special kind of##3##3##(1991-4#1)(2008-2#1)(2010-12#1)
special learning disabilities##2##3##(2009-8#2)
special list health journals##3##4##(1991-12#3)
special measures##2##2##(1991-11#1)(1997-8#1)
special mention##4##2##(2006-10#1)(2008-8#1)(2013-1#2)
special needs and##5##3##(1991-3#1)(1996-3#1)(2008-5#1)(2012-3#2)
special needs of##8##3##(1991-2#1)(1991-4#1)(1997-2#1)(1997-8#1)(2007-8#1)(2012-12#2)(2013-1#1)
special needs##34##2##(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1994-3#1)(1995-1#2)(1996-11#1)(1996-3#1)(1997-2#3)(1997-8#1)(2005-11#1)(2005-12#3)(2007-8#1)(2008-12#2)(2008-2#1)(2008-5#1)(2009-11#1)(2009-12#1)(2010-7#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#1)
special needs&quot##2##2##(1990-12#1)(2008-5#1)
special optical##3##2##(2008-2#1)(2008-3#1)(2008-5#1)
special orthopedic##2##2##(2008-12#1)(2011-2#1)
special perioperative##2##2##(2007-8#2)
special population groups##2##3##(2005-7#2)
special population##7##2##(1996-3#1)(2005-7#2)(2008-2#1)(2008-6#1)(2008-8#1)(2013-1#1)
special populations##8##2##(1996-2#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-3#1)(2011-1#1)(2013-7#2)
special position##2##2##(1995-11#1)(2010-3#1)
special precautions must be taken##2##5##(1992-3#1)(2009-6#1)
special precautions##7##2##(1992-10#1)(1992-2#1)(1992-3#1)(2007-2#1)(2008-4#1)(2009-6#1)(2010-4#1)
special preparation##3##2##(1997-2#1)(2007-11#1)(2008-4#1)
special probe##2##2##(2008-9#2)
special problem##3##2##(1990-8#1)(1993-3#1)(1994-8#1)
special procedures##2##2##(1995-3#1)(2010-12#1)
special program##2##2##(2006-8#1)(2008-10#1)
special properties##5##2##(2007-12#1)(2008-2#2)(2008-3#1)(2009-8#1)
special protection##2##2##(2007-1#1)(2009-6#1)
special quadrature scheme##2##3##(2008-3#2)
special reactor##2##2##(2008-11#2)
special reagent##2##2##(2008-10#2)
special reference to##45##3##(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-6#3)(1995-1#1)(1995-11#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-5#1)(2004-4#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
special reference##46##2##(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-6#3)(1995-1#1)(1995-11#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-5#1)(2004-4#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-5#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
special regard to the##7##4##(1991-6#1)(1994-5#1)(1996-6#1)(2008-10#2)(2010-2#1)(2013-8#1)
special regard to##9##3##(1991-6#1)(1994-5#1)(1996-6#1)(2007-11#2)(2008-10#2)(2010-2#1)(2013-8#1)
special relationship##3##2##(1996-11#1)(2005-3#1)(2011-1#1)
special relativity effects##2##3##(2008-3#2)
special relativity##4##2##(2008-3#3)(2009-3#1)
special report##3##2##(1994-12#1)(1995-1#1)(2008-8#1)
special requirements##3##2##(2007-12#1)(2009-3#1)(2013-1#1)
special responsibility##2##2##(2005-7#1)(2006-10#1)
special role##5##2##(1990-11#1)(1990-3#1)(1991-6#1)(2006-10#1)(2009-12#1)
special section of##6##3##(2008-7#5)(2011-2#1)
special section##10##2##(2008-7#5)(2009-10#1)(2011-2#2)(2012-2#2)
special situations##5##2##(1992-9#1)(1997-6#1)(2007-12#1)(2010-12#1)(2010-5#1)
special skills##2##2##(2007-6#1)(2008-7#1)
special software##2##2##(2006-6#1)(2013-8#1)
special staining##2##2##(2007-7#1)(2008-5#1)
special structure of the##2##4##(1992-6#1)(2012-3#1)
special structure##6##2##(1992-6#1)(2008-10#1)(2012-3#2)(2013-7#1)(2013-8#1)
special surgical##2##2##(1996-12#2)
special teachers##2##2##(1993-6#2)
special test##3##2##(2008-2#2)(2013-1#1)
special tests are##2##3##(2008-12#2)
special three-peak-wavelength LED source##2##4##(2008-2#2)
special three-peak-wavelength LED##3##3##(2008-2#3)
special training##3##2##(1990-3#1)(1992-11#1)(2006-6#1)
special treatment##6##2##(1992-12#1)(1995-2#2)(2005-7#1)(2011-2#2)
special type of##2##3##(1991-10#1)(1992-4#1)
special type##4##2##(1991-10#1)(1992-4#1)(2007-5#2)
special way within##2##3##(1991-4#2)
special way##4##2##(1991-4#2)(1997-6#1)(2008-10#1)
special##1024##1##(1990-11#3)(1990-12#3)(1990-2#4)(1990-3#2)(1990-4#2)(1990-5#7)(1990-6#7)(1990-7#3)(1990-8#4)(1990-9#3)(1991-1#2)(1991-10#3)(1991-11#5)(1991-12#6)(1991-2#3)(1991-3#7)(1991-4#7)(1991-5#3)(1991-6#6)(1991-7#1)(1991-8#3)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#2)(1992-2#5)(1992-3#4)(1992-4#3)(1992-6#5)(1992-7#1)(1992-9#2)(1993-1#2)(1993-10#3)(1993-11#3)(1993-12#5)(1993-2#4)(1993-3#8)(1993-4#2)(1993-5#2)(1993-6#5)(1993-8#4)(1993-9#1)(1994-12#2)(1994-2#3)(1994-3#9)(1994-5#3)(1994-6#7)(1994-8#2)(1994-9#1)(1995-1#7)(1995-10#3)(1995-11#3)(1995-12#11)(1995-2#8)(1995-3#5)(1995-4#3)(1995-5#1)(1995-6#2)(1995-7#3)(1995-8#3)(1996-1#2)(1996-11#4)(1996-12#5)(1996-2#5)(1996-3#7)(1996-5#1)(1996-6#4)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#3)(1997-2#9)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#3)(1997-8#5)(2003-11#1)(2004-4#1)(2004-9#2)(2005-11#11)(2005-12#4)(2005-3#1)(2005-5#1)(2005-7#7)(2005-8#2)(2005-9#1)(2006-10#15)(2006-11#1)(2006-12#4)(2006-2#3)(2006-3#3)(2006-4#3)(2006-5#5)(2006-6#7)(2006-7#9)(2006-8#3)(2007-1#4)(2007-10#3)(2007-11#22)(2007-12#24)(2007-2#11)(2007-3#3)(2007-4#2)(2007-5#6)(2007-6#3)(2007-7#10)(2007-8#16)(2007-9#10)(2008-1#6)(2008-10#62)(2008-11#19)(2008-12#16)(2008-2#42)(2008-3#31)(2008-4#12)(2008-5#25)(2008-6#7)(2008-7#20)(2008-8#20)(2008-9#11)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#8)(2009-3#4)(2009-4#10)(2009-5#4)(2009-6#5)(2009-7#2)(2009-8#8)(2009-9#3)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#11)(2010-2#8)(2010-3#4)(2010-4#8)(2010-5#3)(2010-6#1)(2010-7#4)(2010-8#5)(2010-9#1)(2011-1#10)(2011-12#3)(2011-2#40)(2011-3#1)(2011-7#1)(2012-1#2)(2012-11#1)(2012-12#19)(2012-2#20)(2012-3#14)(2013-1#33)(2013-7#6)(2013-8#14)
special-needs children##2##2##(1994-3#2)
special-needs##3##1##(1994-3#3)
special-purpose fibers##2##2##(2010-8#2)
special-purpose##5##1##(1994-8#1)(2006-7#1)(2010-8#3)
specialisation in##3##2##(1993-2#1)(1994-12#1)(1994-3#1)
specialisation##6##1##(1993-2#2)(1994-12#1)(1994-3#1)(1997-8#1)(2012-3#1)
specialised computer##2##2##(2006-10#1)(2006-6#1)
specialised##26##1##(1992-9#1)(1993-11#2)(1994-9#1)(1995-5#1)(1995-9#1)(1996-6#1)(2005-12#1)(2005-5#1)(2006-10#1)(2006-2#3)(2006-6#1)(2007-11#1)(2007-12#2)(2007-2#2)(2008-11#2)(2008-5#1)(2009-3#1)(2011-2#1)(2011-3#1)(2013-1#1)
specialising in##3##2##(1991-11#1)(2008-1#1)(2011-1#1)
specialism and##2##2##(1990-12#1)(2013-8#1)
specialism##5##1##(1990-12#1)(1994-6#1)(2005-8#1)(2010-1#1)(2013-8#1)
specialist and##7##2##(1990-12#1)(1990-8#1)(1996-11#1)(2006-8#1)(2008-8#1)(2009-4#1)(2009-8#1)
specialist care##3##2##(2006-12#1)(2009-4#1)(2010-8#1)
specialist center##4##2##(2008-3#4)
specialist centre##4##2##(2008-6#4)
specialist centres##4##2##(1994-11#1)(2006-10#1)(2008-6#1)(2009-8#1)
specialist clinics##3##2##(1993-2#1)(1994-11#1)(2009-10#1)
specialist doctors##4##2##(1993-6#1)(2006-10#3)
specialist education in##2##3##(2010-10#2)
specialist education##5##2##(1992-11#1)(2010-10#4)
specialist health##3##2##(1993-6#2)(2008-1#1)
specialist hospital##3##2##(2008-1#1)(2011-2#1)(2012-2#1)
specialist in endocrinology##2##3##(2013-1#2)
specialist in##15##2##(1991-7#1)(1992-2#1)(1993-2#1)(1993-5#2)(1995-6#1)(1996-9#1)(2007-11#1)(2008-11#1)(2008-8#1)(2010-12#1)(2010-9#2)(2013-1#2)
specialist is##3##2##(1990-6#1)(1993-5#1)(2007-6#1)
specialist medical##2##2##(2008-7#1)(2012-3#1)
specialist mental health##2##3##(2010-5#1)(2011-1#1)
specialist nurses##3##2##(2005-11#1)(2008-7#1)(2011-2#1)
specialist opinion##2##2##(2010-9#1)(2011-2#1)
specialist or##4##2##(1992-3#1)(1992-5#1)(2010-2#1)(2010-9#1)
specialist parasitoid##2##2##(2007-12#1)(2008-8#1)
specialist physicians##2##2##(2009-4#1)(2010-8#1)
specialist practice##3##2##(2006-10#1)(2008-11#2)
specialist referral##2##2##(2008-1#1)(2009-11#1)
specialist services##5##2##(1991-6#1)(1993-12#1)(1993-8#1)(1996-2#1)(2009-4#1)
specialist should be##2##3##(1990-10#1)(2010-11#1)
specialist the##2##2##(1991-2#1)(2008-8#1)
specialist to##3##2##(1993-12#2)(2008-6#1)
specialist training##4##2##(1991-3#1)(1992-9#1)(1993-2#1)(1993-6#1)
specialist##186##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-6#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#2)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-5#2)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#4)(1993-5#3)(1993-6#4)(1993-8#1)(1994-11#2)(1994-12#2)(1995-12#1)(1995-3#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-7#1)(1997-8#3)(2004-2#3)(2004-3#1)(2005-11#1)(2006-10#5)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#3)(2007-12#4)(2007-6#1)(2007-7#2)(2008-1#4)(2008-11#7)(2008-3#5)(2008-6#7)(2008-7#7)(2008-8#9)(2008-9#2)(2009-10#1)(2009-11#3)(2009-4#8)(2009-5#1)(2009-6#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#4)(2010-9#4)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#8)(2013-8#4)
specialist's##2##1##(1992-12#1)(1995-4#1)
specialist]##2##1##(1991-12#1)(1993-5#1)
specialistic##3##1##(2007-11#2)(2009-2#1)
specialists across##2##2##(2007-1#1)(2008-8#1)
specialists and the##2##3##(2008-7#1)(2011-2#1)
specialists and##8##2##(1993-6#1)(2006-9#1)(2008-5#1)(2008-7#1)(2011-2#2)(2011-3#1)(2012-2#1)
specialists as consultants in##2##4##(1996-12#2)
specialists as##3##2##(1996-12#2)(2008-7#1)
specialists at##2##2##(1994-3#1)(2007-3#1)
specialists can##2##2##(1992-12#1)(1997-1#1)
specialists for##2##2##(2005-11#1)(2008-8#1)
specialists from##3##2##(2007-11#1)(2008-5#1)(2011-12#1)
specialists in Hygiene and Preventive##2##5##(2007-1#2)
specialists in internal medicine##3##4##(1990-6#2)(1993-6#1)
specialists in the##6##3##(1990-6#1)(2005-7#1)(2007-11#1)(2008-12#1)(2009-4#1)(2011-1#1)
specialists in##35##2##(1990-10#1)(1990-6#3)(1991-11#1)(1991-12#1)(1991-2#1)(1993-2#1)(1993-6#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-5#1)(1996-9#1)(1997-8#1)(2004-10#1)(2005-7#1)(2006-4#1)(2007-1#2)(2007-11#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
specialists is a##2##3##(1991-2#1)(2012-12#1)
specialists is##6##2##(1991-2#1)(2006-10#1)(2008-7#1)(2009-2#1)(2010-12#1)(2012-12#1)
specialists may be##3##3##(1993-3#1)(2005-8#1)(2008-4#1)
specialists should be##2##3##(1990-12#1)(2013-1#1)
specialists should##4##2##(1990-10#1)(1990-12#1)(1993-2#1)(2013-1#1)
specialists to assess##3##3##(1993-2#1)(2013-1#2)
specialists to##9##2##(1993-2#1)(1996-2#1)(2006-2#1)(2007-8#1)(2008-5#1)(2011-1#1)(2012-3#1)(2013-1#2)
specialists were##4##2##(2007-1#1)(2012-2#1)(2013-1#2)
specialists with##2##2##(2008-8#1)(2013-7#1)
specialists working in##3##3##(2008-4#1)(2013-1#2)
specialists##162##1##(1990-10#4)(1990-12#2)(1990-6#3)(1991-11#1)(1991-12#1)(1991-2#3)(1991-6#1)(1992-12#1)(1992-4#1)(1993-2#5)(1993-3#2)(1993-6#3)(1994-1#2)(1994-10#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-4#1)(1996-1#2)(1996-12#3)(1996-2#2)(1996-5#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-8#1)(2004-10#2)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#3)(2006-12#2)(2006-2#2)(2006-4#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#4)(2007-10#1)(2007-11#4)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#5)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#4)(2008-4#4)(2008-5#3)(2008-7#5)(2008-8#6)(2008-9#3)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#2)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#3)(2011-3#1)(2012-11#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#12)(2013-7#1)(2013-8#2)
specialists'##4##1##(1995-11#1)(1996-1#1)(1997-4#1)(2008-7#1)
specialists]##2##1##(1993-9#1)(1994-11#1)
specialities##10##1##(1990-10#1)(1996-1#1)(2006-10#2)(2006-6#2)(2008-11#2)(2009-4#1)(2012-12#1)
speciality in##3##2##(1990-2#1)(2009-4#1)(2012-2#1)
speciality##15##1##(1990-2#1)(1996-1#1)(2006-10#1)(2006-4#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-11#1)(2010-7#1)(2012-2#2)(2013-1#1)
specialization (such as##2##3##(2008-8#2)
specialization and##14##2##(1990-10#1)(1993-5#1)(1993-6#1)(2008-10#1)(2008-4#1)(2008-8#7)(2011-1#1)(2013-8#1)
specialization in the##2##3##(1993-12#1)(2008-10#1)
specialization in##12##2##(1993-12#1)(1993-2#1)(2007-12#1)(2008-10#4)(2008-6#1)(2008-8#2)(2008-9#1)(2012-3#1)
specialization interests##2##2##(2013-1#2)
specialization is##5##2##(1995-5#1)(2006-6#1)(2008-5#1)(2008-8#2)
specialization of brain regions##2##4##(2008-11#1)(2011-12#1)
specialization of function##4##3##(2011-1#1)(2011-12#3)
specialization of the##2##3##(1996-12#1)(2008-10#1)
specialization of##19##2##(1992-5#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#3)(2008-9#1)(2011-1#1)(2011-12#6)(2012-12#1)(2012-2#1)(2012-3#1)
specialization on##3##2##(2005-11#1)(2008-9#1)(2013-1#1)
specialization to##3##2##(2007-12#1)(2008-10#2)
specialization within the##2##3##(2008-10#1)(2008-12#1)
specialization##110##1##(1990-10#2)(1991-9#1)(1992-11#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-5#3)(1993-6#1)(1994-12#2)(1995-12#2)(1995-5#1)(1996-12#1)(2005-11#1)(2006-6#1)(2007-12#3)(2008-10#18)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#25)(2008-9#7)(2009-10#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-12#7)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
specializations in the##3##3##(2007-12#3)
specializations in##4##2##(1996-4#1)(2007-12#3)
specializations of##3##2##(2008-7#1)(2010-2#1)(2012-1#1)
specializations on##2##2##(1991-3#1)(2008-9#1)
specializations##20##1##(1991-3#2)(1992-1#1)(1993-12#1)(1995-6#1)(1996-4#2)(2007-12#5)(2008-7#1)(2008-9#3)(2009-10#1)(2010-2#1)(2012-1#1)(2013-8#1)
specialize in##3##2##(2007-8#1)(2008-11#1)(2011-2#1)
specialize##8##1##(2007-11#1)(2007-8#1)(2008-11#1)(2008-9#2)(2009-6#1)(2010-10#1)(2011-2#1)
specialized and##5##2##(2005-9#1)(2008-11#1)(2008-2#1)(2009-8#1)(2011-2#1)
specialized antigen-presenting cells##2##3##(2008-4#1)(2010-5#1)
specialized bacterial##2##2##(2007-12#1)(2013-1#1)
specialized care##5##2##(1992-12#1)(1993-12#1)(2009-5#1)(2011-12#1)(2013-1#1)
specialized cells that##3##3##(2008-1#1)(2008-4#1)(2009-8#1)
specialized cells##10##2##(1994-2#1)(1994-3#1)(2006-7#1)(2008-1#1)(2008-2#1)(2008-4#2)(2009-4#1)(2009-5#1)(2009-8#1)
specialized centers##7##2##(2006-10#1)(2006-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-5#1)
specialized centres##5##2##(1990-6#1)(1991-11#1)(1992-6#2)(2007-11#1)
specialized chromatin##2##2##(1994-5#1)(1995-2#1)
specialized clinics##5##2##(1995-11#1)(2008-2#4)
specialized columnar epithelium##2##3##(1991-5#2)
specialized database##2##2##(1995-1#1)(2012-11#1)
specialized equipment and##2##3##(2008-11#1)(2008-9#1)
specialized equipment##6##2##(2008-11#1)(2008-4#2)(2008-9#1)(2010-4#1)(2013-8#1)
specialized expertise##2##2##(2008-11#1)(2012-11#1)
specialized feeding##2##2##(2008-10#2)
specialized for##12##2##(1995-1#1)(2007-12#3)(2007-5#1)(2008-11#4)(2008-7#1)(2009-2#1)(2012-3#1)
specialized form##2##2##(2008-10#1)(2012-2#1)
specialized functions##3##2##(2012-2#1)(2013-1#2)
specialized geriatric##2##2##(1990-5#1)(1991-2#1)
specialized health care##4##3##(1993-1#1)(2008-11#2)(2010-7#1)
specialized health##7##2##(1992-9#1)(1993-1#1)(2008-11#2)(2010-7#1)(2013-1#2)
specialized home care team##2##4##(1993-3#2)
specialized hospital##2##2##(1996-9#1)(2007-8#1)
specialized host races##2##3##(2008-9#2)
specialized host##3##2##(1993-12#1)(2008-9#2)
specialized in the##3##3##(1995-12#1)(2008-7#1)(2011-2#1)
specialized in##11##2##(1990-11#1)(1992-9#1)(1995-12#1)(2006-12#1)(2007-9#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#2)
specialized infection##3##2##(2008-10#3)
specialized information##4##2##(1995-1#3)(1996-2#1)
specialized intensive care##2##3##(2006-10#1)(2009-6#1)
specialized journals##2##2##(1993-6#1)(2009-4#1)
specialized knowledge##3##2##(1991-12#1)(1993-12#1)(2008-11#1)
specialized laboratories##3##2##(2011-2#1)(2013-1#2)
specialized laboratory##2##2##(1990-6#1)(2007-7#1)
specialized medicine##2##2##(1992-9#1)(1997-3#1)
specialized membrane##3##2##(1993-9#1)(1997-7#1)(2008-4#1)
specialized metabolism##2##2##(2011-2#2)
specialized metabolites##3##2##(2011-2#3)
specialized methods##3##2##(2006-6#1)(2007-12#1)(2008-1#1)
specialized nature##2##2##(2008-1#1)(2008-4#1)
specialized nutrition support##2##3##(2005-10#2)
specialized on different##2##3##(2008-10#1)(2008-8#1)
specialized on##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
specialized opioid management clinics##2##4##(2006-12#2)
specialized program##2##2##(1991-1#1)(2006-9#1)
specialized psychiatric##2##2##(2008-2#2)
specialized receptors##2##2##(2009-8#1)(2012-1#1)
specialized regions##3##2##(1996-5#1)(2008-1#2)
specialized retinal##3##2##(1990-3#1)(2008-5#1)(2011-2#1)
specialized services for##2##3##(1996-1#1)(1997-1#1)
specialized services##11##2##(1993-2#2)(1996-1#3)(1996-2#1)(1997-1#1)(1997-3#2)(2008-7#1)(2008-9#1)
specialized software##2##2##(1997-2#1)(2008-9#1)
specialized structures##4##2##(1990-5#1)(2006-2#1)(2008-11#2)
specialized techniques##2##2##(2005-8#1)(2011-2#1)
specialized tests##2##2##(2008-12#1)(2013-1#1)
specialized to##5##2##(2008-1#1)(2008-10#3)(2013-1#1)
specialized training##5##2##(1990-6#1)(1994-12#1)(1996-11#1)(2005-8#1)(2010-8#1)
specialized treatment##3##2##(2006-7#1)(2009-10#1)(2013-1#1)
specialized type of##2##3##(2008-4#1)(2008-7#1)
specialized units##6##2##(1990-10#1)(1994-8#2)(1995-11#1)(2006-10#1)(2008-11#1)
specialized##353##1##(1990-10#1)(1990-11#2)(1990-3#2)(1990-5#2)(1990-6#3)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-5#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-6#2)(1992-9#5)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#2)(1995-1#5)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-7#1)(1996-1#4)(1996-11#2)(1996-2#4)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#2)(1997-6#1)(1997-7#1)(2005-10#2)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#4)(2006-12#3)(2006-2#1)(2006-3#2)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#3)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#14)(2007-2#2)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#8)(2008-10#17)(2008-11#16)(2008-12#1)(2008-2#10)(2008-3#1)(2008-4#12)(2008-5#5)(2008-6#2)(2008-7#12)(2008-8#4)(2008-9#13)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#1)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#4)(2011-2#16)(2012-1#2)(2012-11#3)(2012-12#2)(2012-2#6)(2012-3#6)(2013-1#16)(2013-8#2)
specializes in##2##2##(2006-10#1)(2008-5#1)
specializing in##7##2##(1992-8#1)(1994-3#1)(1996-1#1)(2005-2#1)(2006-5#1)(2008-12#1)(2008-6#1)
specializing on the##2##3##(2008-9#2)
specializing on##3##2##(2008-8#1)(2008-9#2)
specializing##12##1##(1992-8#1)(1994-3#1)(1996-1#1)(2005-2#1)(2006-5#1)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-8#1)(2011-2#1)
specially adapted##4##2##(1996-4#1)(2008-10#1)(2008-3#1)(2010-2#1)
specially constructed##6##2##(1991-11#1)(1991-4#1)(1992-11#1)(2004-10#1)(2008-2#1)(2008-9#1)
specially designed and##2##3##(2007-11#1)(2008-2#1)
specially designed for##3##3##(1992-10#1)(2008-10#1)(2008-5#1)
specially designed instruments##2##3##(2006-3#1)(2006-6#1)
specially designed lens##2##3##(2007-12#1)(2008-3#1)
specially designed to##3##3##(2008-10#2)(2008-5#1)
specially designed##51##2##(1991-11#1)(1992-10#2)(1993-2#1)(1994-12#1)(1995-8#1)(2005-12#1)(2006-3#2)(2006-6#2)(2007-11#4)(2007-12#5)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#4)(2008-7#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-3#1)(2010-8#1)(2012-12#1)
specially developed##5##2##(1993-10#1)(2007-10#1)(2007-12#1)(2008-2#1)(2008-3#1)
specially during##2##2##(2009-7#1)(2012-2#1)
specially in the##3##3##(2008-10#1)(2008-11#1)(2009-9#1)
specially in##8##2##(1991-9#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-9#1)(2011-1#2)
specially modified##3##2##(1994-5#1)(1997-6#1)(2008-5#1)
specially on##2##2##(2007-11#1)(2008-12#1)
specially prepared##4##2##(2007-3#1)(2008-10#1)(2008-2#1)(2008-4#1)
specially selected##2##2##(2008-10#1)(2008-2#1)
specially suited for##3##3##(2007-12#1)(2008-11#1)(2008-3#1)
specially the##2##2##(2007-10#1)(2008-11#1)
specially to##2##2##(2009-9#1)(2011-2#1)
specially trained##5##2##(1993-3#1)(1994-4#1)(2006-10#1)(2007-11#1)(2013-8#1)
specially##136##1##(1990-8#1)(1991-11#2)(1991-4#1)(1991-9#1)(1992-10#2)(1992-11#1)(1993-10#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-4#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-4#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-10#2)(2005-11#2)(2005-12#1)(2006-1#1)(2006-10#1)(2006-3#2)(2006-6#2)(2007-10#2)(2007-11#8)(2007-12#7)(2007-2#1)(2007-3#3)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#20)(2008-11#5)(2008-12#1)(2008-2#8)(2008-3#8)(2008-4#2)(2008-5#8)(2008-7#3)(2008-8#1)(2008-9#3)(2009-2#2)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2013-8#1)
specialties and subspecialties##2##3##(1991-6#1)(1995-1#1)
specialties and##12##2##(1991-11#2)(1991-6#1)(1992-4#2)(1993-6#1)(1994-1#2)(1995-1#1)(1995-3#1)(2013-1#2)
specialties are##2##2##(1993-12#1)(2007-12#1)
specialties such as##2##3##(1997-2#1)(2006-6#1)
specialties that##2##2##(2008-2#1)(2013-1#1)
specialties were##2##2##(2007-9#1)(2009-7#1)
specialties##68##1##(1990-2#1)(1991-11#2)(1991-6#5)(1992-11#1)(1992-12#2)(1992-4#2)(1993-12#1)(1993-3#1)(1993-6#2)(1994-1#2)(1994-12#3)(1995-1#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-2#1)(2006-12#1)(2006-6#2)(2006-7#1)(2006-8#3)(2007-11#3)(2007-12#1)(2007-4#5)(2007-9#1)(2008-10#2)(2008-2#2)(2008-7#1)(2008-9#2)(2009-11#1)(2009-7#1)(2010-2#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-2#1)(2012-3#2)(2013-1#3)
specialty and the##2##3##(1993-6#1)(2007-8#1)
specialty and##9##2##(1993-6#2)(1994-12#1)(1996-12#1)(2006-10#1)(2007-4#1)(2007-8#2)(2010-12#1)
specialty area##3##2##(1997-4#1)(2007-2#1)(2011-1#1)
specialty boards##5##2##(1994-12#1)(2008-4#4)
specialty care services##2##3##(1990-12#1)(1997-2#1)
specialty care##5##2##(1990-12#1)(1997-1#1)(1997-2#1)(2007-6#1)(2008-9#1)
specialty choices##2##2##(2007-4#2)
specialty clinics##2##2##(2006-10#1)(2007-10#1)
specialty group##2##2##(1993-1#1)(1994-12#1)
specialty health##2##2##(1993-2#1)(1994-3#1)
specialty hospitals##2##2##(1991-4#1)(2005-8#1)
specialty in##9##2##(1993-1#1)(1997-8#1)(2006-10#1)(2007-4#1)(2007-7#1)(2008-9#1)(2012-2#3)
specialty ingredients##2##2##(2010-7#2)
specialty of##9##2##(1995-9#2)(2006-10#1)(2007-12#1)(2007-4#4)(2012-2#1)
specialty physician##4##2##(1994-1#2)(1997-1#1)(2009-9#1)
specialty physicians in##2##3##(1994-12#1)(1997-1#1)
specialty practice##3##2##(1992-3#1)(1995-4#1)(2007-12#1)
specialty referral##2##2##(2006-8#1)(2007-12#1)
specialty services##3##2##(1991-2#1)(1994-3#1)(2009-12#1)
specialty societies##3##2##(2007-4#2)(2008-4#1)
specialty that##2##2##(2007-12#1)(2010-8#1)
specialty will be##2##3##(2006-10#1)(2008-2#1)
specialty with##3##2##(2006-7#1)(2007-6#1)(2009-9#1)
specialty##151##1##(1990-12#2)(1991-2#1)(1991-4#1)(1991-6#4)(1992-11#1)(1992-3#3)(1993-1#2)(1993-12#1)(1993-2#1)(1993-6#2)(1994-1#6)(1994-12#5)(1994-3#4)(1995-12#1)(1995-3#1)(1995-4#1)(1995-9#2)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#1)(1997-1#3)(1997-2#2)(1997-4#2)(1997-8#1)(2005-1#1)(2005-6#1)(2005-8#1)(2005-9#2)(2006-10#8)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-12#6)(2007-2#1)(2007-4#19)(2007-6#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#12)(2008-6#1)(2008-9#3)(2009-10#1)(2009-12#2)(2009-9#2)(2010-10#2)(2010-12#2)(2010-3#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#5)(2013-1#2)
specialty-specific##2##1##(1991-1#1)(2006-8#1)
specialty?##3##1##(2005-4#1)(2006-11#1)(2007-7#1)
specialty]##5##1##(1991-6#1)(1996-5#1)(1996-9#1)(1997-1#1)(2007-9#1)
speciate##6##1##(1994-6#1)(2006-5#1)(2007-7#1)(2007-8#1)(2008-10#2)
speciated and##2##2##(2008-6#1)(2008-7#1)
speciated simultaneously##2##2##(2008-10#2)
speciated##10##1##(1995-11#1)(1996-4#1)(2008-10#4)(2008-6#1)(2008-7#2)(2010-6#1)
speciation analysis by##2##3##(2008-10#1)(2009-6#1)
speciation analysis in##4##3##(2008-10#4)
speciation analysis is##2##3##(2008-10#2)
speciation analysis of inorganic##2##4##(2008-3#1)(2009-6#1)
speciation analysis of iron in##2##5##(2008-10#2)
speciation analysis of this element##2##5##(2008-10#2)
speciation analysis of##12##3##(2005-4#1)(2008-10#8)(2008-3#1)(2009-6#1)(2010-11#1)
speciation analysis##27##2##(2005-4#1)(2008-10#22)(2008-3#1)(2009-6#2)(2010-11#1)
speciation and determination##3##3##(2008-10#3)
speciation and preconcentration##2##3##(2008-10#2)
speciation and##17##2##(2008-10#11)(2008-3#1)(2008-9#1)(2010-3#1)(2010-5#1)(2012-11#1)(2013-7#1)
speciation approaches##3##2##(2008-10#2)(2008-3#1)
speciation are##2##2##(2008-10#1)(2008-8#1)
speciation as a function of##2##5##(2008-10#2)
speciation as a##3##3##(2008-10#2)(2008-8#1)
speciation based on##2##3##(2008-10#1)(2010-3#1)
speciation by##9##2##(2008-10#8)(2008-9#1)
speciation calculations##3##2##(1996-8#1)(2008-10#2)
speciation continuum##3##2##(2010-8#1)(2013-1#2)
speciation data##4##2##(1996-8#2)(2007-8#1)(2008-10#1)
speciation event##2##2##(2006-3#1)(2012-3#1)
speciation events##2##2##(2008-8#2)
speciation for##3##2##(1996-6#1)(2008-10#1)(2010-2#1)
speciation has##2##2##(2008-10#1)(2013-1#1)
speciation in angiosperms##2##3##(2009-2#2)
speciation in aqueous solutions##2##4##(2008-10#2)
speciation in biological##2##3##(2006-12#1)(2008-10#1)
speciation in environmental samples##4##4##(2008-10#4)
speciation in environmental##6##3##(2008-10#6)
speciation in phylogenesis##2##3##(2010-3#2)
speciation in water by##2##4##(2008-10#2)
speciation in water##3##3##(2008-10#3)
speciation in##40##2##(1994-6#1)(1996-6#2)(1996-8#1)(2006-12#1)(2006-5#1)(2008-10#29)(2009-2#2)(2010-3#2)(2010-8#1)
speciation information##2##2##(2008-10#1)(2008-3#1)
speciation is##4##2##(2006-5#1)(2008-10#1)(2008-8#1)(2009-2#1)
speciation measurements##3##2##(2008-10#2)(2010-2#1)
speciation method##4##2##(2008-10#4)
speciation methods##2##2##(2008-10#2)
speciation models##2##2##(1996-6#1)(2008-10#1)
speciation of As(III) and As(V)##3##5##(2008-10#3)
speciation of Cr(III) and Cr(VI)##2##5##(2008-10#2)
speciation of Cr(VI)##2##3##(2008-10#2)
speciation of Fe(II) and Fe(III)##2##5##(2008-10#2)
speciation of arsenic in environmental and biological samples##2##8##(2008-10#2)
speciation of arsenic in##7##4##(2008-10#7)
speciation of arsenic##14##3##(2008-10#14)
speciation of chromium in##7##4##(2008-10#7)
speciation of chromium##13##3##(2008-10#13)
speciation of different forms using##2##5##(2008-10#2)
speciation of inorganic##8##3##(2008-10#7)(2008-3#1)
speciation of iron##2##3##(2008-10#2)
speciation of mercury##2##3##(2008-10#2)
speciation of selenium in##2##4##(2008-10#2)
speciation of selenium##3##3##(2008-10#3)
speciation of the##3##3##(1996-8#1)(2008-10#2)
speciation of this group##2##4##(2008-10#1)(2008-9#1)
speciation of##102##2##(1996-8#1)(2005-11#1)(2007-8#1)(2008-10#94)(2008-3#1)(2008-5#1)(2008-9#2)(2013-1#1)
speciation on##3##2##(1996-6#1)(2008-10#1)(2010-5#1)
speciation or##3##2##(2008-10#1)(2008-8#1)(2013-8#1)
speciation scheme##2##2##(2008-10#2)
speciation studies##5##2##(2007-8#1)(2008-10#4)
speciation study in##2##3##(2008-10#2)
speciation study of##2##3##(2008-10#2)
speciation study##4##2##(2008-10#4)
speciation was assessed by performing multiple analyses of the spiked samples##2##11##(2008-10#2)
speciation was##9##2##(2008-10#7)(2010-11#1)(2013-1#1)
speciation without the##2##3##(2006-5#1)(2008-10#1)
speciation##375##1##(1992-4#1)(1994-6#1)(1996-3#1)(1996-6#9)(1996-8#9)(2005-11#1)(2005-4#1)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#3)(2007-8#6)(2008-1#1)(2008-10#249)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#20)(2008-9#9)(2009-2#5)(2009-6#2)(2010-11#4)(2010-2#3)(2010-3#5)(2010-5#2)(2010-6#4)(2010-8#5)(2012-11#1)(2012-3#4)(2013-1#9)(2013-7#3)(2013-8#1)
specie of##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
specie##14##1##(2007-10#1)(2007-3#1)(2008-10#2)(2008-4#1)(2008-5#2)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#3)(2013-1#1)
species (0##2##2##(1990-3#1)(1990-5#1)
species (14##2##2##(2006-10#1)(2007-3#1)
species (2##2##2##(1991-7#1)(2012-3#1)
species (3##3##2##(1995-3#1)(2011-1#1)(2011-12#1)
species (A beta##2##3##(1994-12#1)(1997-5#1)
species (A##4##2##(1994-12#1)(1997-5#1)(1997-6#1)(2008-10#1)
species (C##2##2##(2013-7#2)
species (Diptera##2##2##(2007-12#1)(2011-2#1)
species (F##2##2##(2008-10#1)(2010-2#1)
species (G##2##2##(2010-3#1)(2010-8#1)
species (H##4##2##(2006-2#1)(2007-1#1)(2009-9#2)
species (Q##4##2##(2012-5#3)(2012-6#1)
species (e##3##2##(2008-10#1)(2009-6#1)(2012-3#1)
species (human##2##2##(1995-2#1)(1996-10#1)
species (i##5##2##(2008-10#2)(2010-5#1)(2012-9#1)(2013-1#1)
species (including##3##2##(1991-2#1)(2007-12#1)(2008-7#1)
species (n =##2##3##(2008-10#1)(2008-5#1)
species (the##3##2##(2007-5#1)(2008-10#1)(2012-3#1)
species -##3##2##(2007-12#1)(2011-12#1)(2012-11#1)
species A##2##2##(2004-11#1)(2008-5#1)
species B##3##2##(2008-10#3)
species C##4##2##(2008-10#3)(2008-5#1)
species E##2##2##(2004-11#1)(2008-5#1)
species Lycopersicon##2##2##(2006-12#1)(2008-10#1)
species M##2##2##(2007-3#1)(2008-10#1)
species MLH(-1)##2##2##(2008-3#2)
species P##6##2##(2006-8#2)(2008-10#1)(2008-12#1)(2008-7#1)(2013-1#1)
species S##2##2##(2011-12#1)(2011-2#1)
species X##2##2##(2008-10#2)
species able to##2##3##(2008-10#1)(2013-7#1)
species abundance distribution##2##3##(2008-8#2)
species abundance distributions##3##3##(2008-8#3)
species abundance##12##2##(2007-3#1)(2008-5#1)(2008-8#8)(2010-2#1)(2013-7#1)
species abundances##3##2##(2008-5#1)(2008-8#1)(2011-2#1)
species according to##2##3##(2008-10#1)(2008-8#1)
species account for##2##3##(1990-4#1)(2007-5#1)
species accounted for##2##3##(2007-5#1)(2011-2#1)
species across##2##2##(2009-8#1)(2011-1#1)
species after a##2##3##(2008-10#1)(2012-12#1)
species after##8##2##(1995-2#1)(2004-11#1)(2005-7#1)(2008-10#3)(2012-12#1)(2013-1#1)
species alone##2##2##(2007-4#1)(2010-10#1)
species also##5##2##(1995-12#1)(2008-10#2)(2008-9#1)(2011-2#1)
species although##2##2##(1992-1#1)(2007-5#1)
species analysed##2##2##(2006-12#1)(2008-10#1)
species analysis##6##2##(2008-10#5)(2013-7#1)
species analyzed##4##2##(1990-5#1)(1991-8#1)(1997-6#1)(2006-10#1)
species and a##9##3##(1991-9#1)(1996-2#1)(2006-12#1)(2008-8#1)(2009-2#1)(2010-4#1)(2011-2#1)(2011-3#1)(2013-8#1)
species and also##3##3##(1994-12#1)(2006-8#1)(2012-12#1)
species and an##2##3##(2006-2#1)(2008-10#1)
species and are##2##3##(1995-11#1)(2004-4#1)
species and at##2##3##(2007-3#1)(2008-10#1)
species and between##4##3##(2007-3#1)(2008-10#1)(2008-9#1)(2009-5#1)
species and by the##2##4##(2007-1#1)(2008-8#1)
species and can##2##3##(2008-10#1)(2008-11#1)
species and could##2##3##(2008-10#1)(2010-3#1)
species and ecological##2##3##(2008-10#1)(2012-1#1)
species and environmental##2##3##(2007-3#1)(2008-10#1)
species and for##2##3##(2008-8#1)(2010-8#1)
species and human##2##3##(1991-6#1)(2006-12#1)
species and in some##2##4##(2008-8#1)(2010-3#1)
species and in##4##3##(2007-12#1)(2008-8#1)(2010-3#1)(2013-1#1)
species and its##4##3##(2008-10#1)(2010-12#1)(2011-1#1)(2013-8#1)
species and may##2##3##(2008-8#1)(2011-12#1)
species and one##4##3##(2007-3#1)(2007-9#1)(2008-10#1)(2013-1#1)
species and other morphologically##2##4##(2008-10#1)(2011-2#1)
species and other##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
species and oxidation##2##3##(1996-2#1)(2012-2#1)
species and several##3##3##(2006-5#1)(2007-3#1)(2010-3#1)
species and shows##2##3##(1997-7#1)(2008-10#1)
species and six##3##3##(2006-8#1)(2007-5#1)(2013-8#1)
species and strain##2##3##(1995-2#1)(2008-3#1)
species and strains##4##3##(1997-2#1)(2006-2#1)(2008-10#1)(2008-5#1)
species and subsequently##2##3##(2008-2#1)(2010-2#1)
species and subspecies##4##3##(2008-10#1)(2008-12#1)(2012-2#2)
species and that##3##3##(1997-2#1)(2008-10#1)(2008-8#1)
species and the##30##3##(1991-12#1)(1991-8#1)(1993-9#1)(1995-3#1)(1996-11#1)(1996-2#1)(2005-11#1)(2006-8#2)(2006-9#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
species and their hybrids##2##4##(2008-10#1)(2008-9#1)
species and their##10##3##(1995-10#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-9#1)(2011-1#1)(2012-2#1)
species and this##3##3##(1993-3#1)(1997-9#1)(2010-3#1)
species and to##7##3##(2006-10#1)(2007-1#1)(2007-2#1)(2008-3#1)(2008-8#1)(2009-2#1)(2010-3#1)
species and two##5##3##(1993-12#1)(2005-7#1)(2008-10#1)(2008-5#1)(2011-2#1)
species and was##3##3##(2006-9#1)(2008-10#1)(2009-3#1)
species and were##2##3##(2008-10#1)(2008-7#1)
species and with##2##3##(2010-10#1)(2010-4#1)
species and##315##2##(1990-12#1)(1990-5#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-12#2)(1992-5#2)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-9#3)(1995-10#1)(1995-11#3)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-2#3)(1997-2#3)(1997-3#1)(1997-7#2)(1997-9#1)(2004-2#1)(2004-4#2)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#3)(2006-2#2)(2006-5#2)(2006-8#6)(2006-9#3)(2007-1#3)(2007-12#2)(2007-2#2)(2007-3#10)(2007-5#6)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#67)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#11)(2008-6#1)(2008-7#8)(2008-8#15)(2008-9#6)(2009-2#4)(2009-3#2)(2009-4#1)(2009-5#4)(2009-8#2)(2009-9#1)(2010-10#2)(2010-12#2)(2010-2#4)(2010-3#5)(2010-4#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#4)(2011-2#9)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#6)(2012-3#5)(2012-6#2)(2013-1#7)(2013-7#2)(2013-8#6)
species appeared##3##2##(1997-1#1)(2006-8#1)(2008-10#1)
species appears to be##2##4##(1992-1#1)(2008-5#1)
species appears##3##2##(1992-1#1)(2008-4#1)(2008-5#1)
species are able to##5##4##(2006-8#2)(2008-9#2)(2012-2#1)
species are abundant##2##3##(2007-5#1)(2008-5#1)
species are also##5##3##(1993-3#1)(2008-5#2)(2010-7#1)(2010-8#1)
species are available##2##3##(2007-5#1)(2011-2#1)
species are capable of##2##4##(1990-6#1)(2010-10#1)
species are collected##2##3##(2007-5#2)
species are considered##2##3##(2008-5#1)(2013-1#1)
species are currently##2##3##(1995-8#1)(2007-6#1)
species are determined by##2##4##(2008-10#2)
species are determined##3##3##(2008-10#3)
species are discussed##5##3##(2006-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-8#1)
species are endemic to##2##4##(2007-3#1)(2008-11#1)
species are extremely##2##3##(2012-12#2)
species are formed##3##3##(2008-10#3)
species are found in##2##4##(2007-5#1)(2011-2#1)
species are found##3##3##(2007-5#1)(2008-10#1)(2011-2#1)
species are illustrated##2##3##(2012-2#1)(2013-8#1)
species are known##3##3##(2008-5#1)(2008-9#1)(2012-5#1)
species are new records for the##2##6##(2007-5#1)(2008-5#1)
species are new records for##3##5##(2007-3#1)(2007-5#1)(2008-5#1)
species are new reports for##2##5##(2008-5#2)
species are new##5##3##(2007-3#1)(2007-5#1)(2008-5#3)
species are not##5##3##(2004-11#1)(2008-8#2)(2010-4#1)(2013-1#1)
species are of##2##3##(1997-4#1)(2007-3#1)
species are often##2##3##(2008-10#1)(2008-12#1)
species are present in the##3##5##(2008-10#2)(2008-5#1)
species are present in##6##4##(1992-11#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-5#1)
species are present##9##3##(1992-11#1)(1997-4#1)(2006-10#1)(2008-1#2)(2008-10#3)(2008-5#1)
species are reported for the##2##5##(2008-5#2)
species are reported##4##3##(2008-10#1)(2008-5#3)
species are responsible for##2##4##(1990-8#1)(2008-2#1)
species are separated##4##3##(2008-10#2)(2008-4#1)(2008-6#1)
species are similar##2##3##(1997-4#1)(2008-10#1)
species are synthesized with##2##4##(2009-5#2)
species are the same##2##4##(2008-4#1)(2008-8#1)
species are the##5##3##(2007-5#1)(2008-1#1)(2008-4#1)(2008-8#1)(2009-8#1)
species are unable to##2##4##(2008-4#1)(2013-1#1)
species are very similar##2##4##(1995-11#1)(2008-7#1)
species are very##6##3##(1995-11#1)(1996-2#1)(2004-4#1)(2008-10#2)(2008-7#1)
species are well##2##3##(2007-8#1)(2008-11#1)
species are widely##2##3##(2007-3#1)(2011-12#1)
species are widespread##2##3##(2005-8#1)(2007-3#1)
species are##197##2##(1990-10#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-9#2)(1992-11#1)(1992-6#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-4#3)(2004-11#1)(2004-4#2)(2005-8#1)(2006-10#2)(2006-8#3)(2007-1#1)(2007-10#2)(2007-12#5)(2007-3#9)(2007-5#7)(2007-6#1)(2007-8#1)(2008-1#6)(2008-10#32)(2008-11#3)(2008-12#5)(2008-2#1)(2008-3#2)(2008-4#6)(2008-5#21)(2008-6#1)(2008-7#3)(2008-8#12)(2008-9#8)(2009-10#1)(2009-5#3)(2009-6#2)(2009-8#2)(2009-9#1)(2010-10#2)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#6)(2012-11#1)(2012-12#2)(2012-2#4)(2012-5#1)(2013-1#6)(2013-7#3)(2013-8#1)
species arise##2##2##(1997-7#1)(2008-1#1)
species arrived##2##2##(2007-3#1)(2009-2#1)
species as a function##2##4##(2008-10#2)
species as a##3##3##(2007-3#1)(2008-10#2)
species as well as the##3##5##(1995-2#1)(2008-10#2)
species as well as to##3##5##(1997-7#1)(2008-10#1)(2008-4#1)
species as well as##12##4##(1993-8#1)(1995-2#1)(1997-7#1)(2006-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2010-7#1)
species as##37##2##(1992-7#1)(1993-11#1)(1993-8#1)(1995-2#1)(1997-2#1)(1997-7#2)(2004-11#1)(2004-4#1)(2006-12#2)(2007-3#2)(2007-6#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#2)(2009-2#1)(2010-7#1)(2011-12#1)(2011-2#2)
species associated to##3##3##(2007-3#1)(2010-10#2)
species associated with##8##3##(1991-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-3#1)(2010-9#1)(2011-2#1)
species associated##11##2##(1991-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-10#2)(2010-3#1)(2010-9#1)(2011-2#1)
species at a##4##3##(2008-8#1)(2008-9#2)(2011-2#1)
species at pH##2##3##(1992-2#1)(2008-10#1)
species at the##4##3##(2005-7#1)(2008-10#2)(2008-7#1)
species at two##2##3##(2012-3#2)
species at##25##2##(1992-2#1)(1995-8#2)(1996-4#1)(1997-5#1)(2005-5#1)(2005-7#1)(2008-10#9)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2010-2#1)(2011-2#1)(2012-3#2)
species attacking rodents were##2##4##(2011-1#2)
species barrier##3##2##(1993-1#1)(2006-10#2)
species barriers##2##2##(1992-1#1)(2013-1#1)
species based on##5##3##(2005-7#1)(2008-10#3)(2008-5#1)
species because of##2##3##(2008-8#1)(2009-8#1)
species because##5##2##(2006-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-8#1)
species becoming##2##2##(2008-8#2)
species being##5##2##(1992-1#1)(2004-4#1)(2007-1#1)(2008-10#1)(2011-1#1)
species belong to##2##3##(2008-8#1)(2011-2#1)
species belonged to##2##3##(2010-10#1)(2011-2#1)
species belonging to the genus##2##5##(2008-10#1)(2008-5#1)
species belonging to the##7##4##(1994-12#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-5#1)
species belonging to two##2##4##(2008-10#1)(2012-2#1)
species belonging to##21##3##(1994-12#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#2)
species between##3##2##(1993-3#1)(2013-1#1)(2013-8#1)
species both##2##2##(1997-1#1)(2008-10#1)
species bound##2##2##(1991-3#1)(1997-2#1)
species boundaries##5##2##(2008-7#1)(2010-6#1)(2012-3#1)(2013-1#1)(2013-7#1)
species but not##4##3##(2007-1#1)(2008-10#1)(2008-9#1)(2010-11#1)
species but remain##2##3##(2008-10#2)
species but##15##2##(1994-12#1)(1995-6#1)(1997-6#1)(2007-1#1)(2007-12#1)(2008-10#3)(2008-8#2)(2008-9#2)(2009-2#1)(2010-11#1)(2010-8#1)
species by employing##2##3##(2008-7#1)(2012-2#1)
species by the##3##3##(1993-9#1)(1997-1#1)(2008-10#1)
species by##47##2##(1990-9#2)(1992-2#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-2#1)(1996-11#2)(1996-12#1)(1996-8#1)(1997-1#1)(2004-4#1)(2006-10#1)(2007-1#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-3#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2012-2#2)
species can be distinguished##2##4##(2007-3#1)(2008-10#1)
species can be##19##3##(1991-9#1)(2007-12#2)(2007-2#1)(2007-3#1)(2008-10#5)(2008-5#3)(2008-8#2)(2008-9#1)(2009-2#1)(2011-2#1)(2013-1#1)
species can##32##2##(1991-9#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-9#1)(2008-10#7)(2008-12#1)(2008-5#3)(2008-8#4)(2008-9#2)(2009-2#1)(2009-8#1)(2010-2#1)(2010-5#1)(2011-12#1)(2011-2#2)(2013-1#2)
species cannot be##3##3##(1990-8#1)(2004-11#1)(2008-6#1)
species cannot##4##2##(1990-8#1)(2004-11#1)(2008-6#1)(2008-8#1)
species capable of##2##3##(2008-10#2)
species captured##2##2##(2008-10#1)(2008-5#1)
species cause##4##2##(1992-6#1)(2008-10#1)(2011-12#1)(2013-8#1)
species causing##4##2##(2008-10#3)(2008-5#1)
species closely related to##2##4##(2008-10#1)(2011-12#1)
species cluster##3##2##(1994-12#1)(2008-2#1)(2008-5#1)
species coexistence##3##2##(2008-8#2)(2008-9#1)
species collected from##2##3##(2008-10#1)(2011-1#1)
species collected in##3##3##(2007-3#1)(2008-10#1)(2008-8#1)
species collected##5##2##(2007-3#1)(2008-10#2)(2008-8#1)(2011-1#1)
species common##2##2##(2008-10#1)(2008-5#1)
species compete##2##2##(2008-10#1)(2008-8#1)
species competing##2##2##(2007-9#1)(2008-9#1)
species complementary##2##2##(1994-10#2)
species complex are the##2##4##(1990-6#1)(2012-11#1)
species complex was##2##3##(2008-10#1)(2010-10#1)
species complex##19##2##(1990-6#1)(1993-11#1)(2008-10#6)(2008-12#1)(2009-9#2)(2010-10#2)(2011-2#2)(2012-11#3)(2013-1#1)
species complexes##2##2##(1996-3#1)(2008-10#1)
species composed of##2##3##(1996-2#2)
species composition and##8##3##(2004-4#1)(2008-5#2)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
species composition in the##2##4##(2013-7#1)(2013-8#1)
species composition of##10##3##(1990-2#2)(1995-8#1)(1997-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-2#1)(2011-1#1)
species composition##36##2##(1990-2#4)(1992-1#1)(1995-8#1)(1997-1#1)(2004-11#1)(2004-4#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-8#1)(2008-9#3)(2009-2#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#2)(2013-7#5)(2013-8#2)
species comprising##2##2##(2007-8#1)(2011-1#1)
species concentration##2##2##(2008-2#1)(2008-3#1)
species concentrations in##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
species concentrations##4##2##(2006-10#1)(2007-12#1)(2008-10#1)(2008-3#1)
species concept in##3##3##(2008-10#3)
species concept##5##2##(2007-3#1)(2008-10#4)
species concepts##4##2##(2008-1#1)(2008-10#1)(2008-8#1)(2010-3#1)
species conservation##4##2##(2006-7#3)(2013-7#1)
species contain the##2##3##(1991-8#1)(1994-3#1)
species contain##8##2##(1991-2#1)(1991-8#1)(1994-3#1)(1995-12#1)(2006-12#2)(2008-5#2)
species contained##3##2##(1991-10#1)(1992-4#1)(2008-10#1)
species containing##7##2##(1990-2#1)(1991-10#1)(1992-4#1)(1993-2#1)(1995-8#1)(1996-2#1)(2005-11#1)
species correlations##2##2##(1997-4#2)
species could be##5##3##(1993-8#1)(2008-10#3)(2011-2#1)
species could##13##2##(1993-8#1)(1994-12#1)(1994-6#1)(2006-10#1)(2007-2#1)(2008-10#4)(2008-12#1)(2008-5#1)(2011-12#1)(2011-2#1)
species decreased##4##2##(1991-11#2)(2007-7#1)(2008-4#1)
species delimitation based##2##3##(2012-3#1)(2013-7#1)
species delimitation in##2##3##(2008-1#1)(2012-3#1)
species delimitation##6##2##(2008-1#1)(2012-3#3)(2013-1#1)(2013-7#1)
species delineation##2##2##(2008-10#1)(2010-6#1)
species demonstrated##2##2##(1996-1#1)(1996-6#1)
species dependent##3##2##(1992-1#1)(2008-10#2)
species depends on##2##3##(2007-12#1)(2008-7#1)
species described in##3##3##(2006-8#1)(2007-3#1)(2013-7#1)
species described##5##2##(2006-4#1)(2006-8#1)(2007-3#1)(2008-10#1)(2013-7#1)
species designation##2##2##(2008-5#1)(2012-3#1)
species detected in##2##3##(2008-10#1)(2010-11#1)
species detected##6##2##(2008-10#3)(2010-11#1)(2013-1#1)(2013-7#1)
species detection##5##2##(2008-10#2)(2008-2#2)(2008-3#1)
species determination in##3##3##(2007-8#1)(2008-10#2)
species determination##5##2##(2007-8#1)(2008-10#4)
species did not##3##3##(1991-7#1)(2008-10#2)
species differ##4##2##(2006-10#1)(2008-8#2)(2009-8#1)
species differed##3##2##(1996-8#1)(2010-2#1)(2011-12#1)
species difference in##4##3##(1990-7#1)(1996-4#2)(2008-7#1)
species difference##8##2##(1990-7#1)(1996-4#2)(1996-5#1)(1997-7#1)(2008-4#1)(2008-7#1)(2008-8#1)
species differences in the##2##4##(1990-6#1)(2006-10#1)
species differences in##8##3##(1990-6#1)(1995-12#1)(1995-2#1)(1997-3#2)(2006-10#1)(2007-12#1)(2008-9#1)
species differences##16##2##(1990-6#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-7#1)(1997-3#2)(2005-8#1)(2006-10#1)(2007-12#1)(2008-8#1)(2008-9#1)(2012-2#1)
species differentiation##5##2##(2006-10#1)(2008-10#3)(2008-4#1)
species differing in##2##3##(1990-3#1)(2012-6#1)
species differs from##2##3##(2007-3#1)(2008-4#1)
species discovery##2##2##(2010-6#2)
species display##4##2##(2007-12#2)(2008-3#1)(2009-9#1)
species distributed in##2##3##(2007-3#1)(2010-3#1)
species distributed##3##2##(2007-3#1)(2010-3#1)(2013-7#1)
species distribution in##2##3##(1990-8#1)(2008-10#1)
species distribution##8##2##(1990-8#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-5#3)(2013-7#1)
species divergence##4##2##(2010-6#2)(2012-3#2)
species diversification##4##2##(1996-4#1)(2008-8#1)(2010-3#2)
species diversity and##4##3##(2008-5#2)(2008-8#1)(2008-9#1)
species diversity in##5##3##(2004-2#1)(2008-8#2)(2009-2#1)(2012-3#1)
species diversity of fruit flies##2##5##(2013-8#2)
species diversity of##3##3##(2012-3#1)(2013-8#2)
species diversity##27##2##(2004-2#1)(2007-5#1)(2008-5#6)(2008-8#6)(2008-9#4)(2009-2#1)(2010-3#1)(2012-2#1)(2012-3#3)(2013-7#1)(2013-8#2)
species do not##4##3##(1997-3#1)(2008-1#1)(2008-8#1)(2011-2#1)
species does not##3##3##(1993-2#1)(2007-3#1)(2013-8#1)
species dominance in##3##3##(2013-8#3)
species dominance was##2##3##(2011-2#1)(2013-8#1)
species dominance##6##2##(2011-2#1)(2012-2#1)(2013-8#4)
species dominant under##2##3##(2008-8#2)
species due to##3##3##(1996-8#1)(2008-1#1)(2008-10#1)
species during the##4##3##(2008-10#2)(2008-5#1)(2010-12#1)
species during##7##2##(1996-11#1)(2008-10#3)(2008-5#2)(2010-12#1)
species each##2##2##(2008-5#2)
species endemic to##3##3##(2008-5#2)(2013-7#1)
species endemic##4##2##(2007-3#1)(2008-5#2)(2013-7#1)
species evaluated##3##2##(2008-10#1)(2008-5#1)(2009-4#1)
species evolved##3##2##(1995-6#1)(2008-10#2)
species examined##13##2##(1990-4#1)(1990-5#1)(1993-12#1)(1993-2#1)(1996-5#2)(2008-10#3)(2008-5#2)(2008-7#1)(2009-5#1)
species except##2##2##(2008-10#2)
species exhibit##5##2##(1994-8#1)(2008-8#2)(2008-9#1)(2010-8#1)
species exhibited an##2##3##(2008-10#1)(2010-8#1)
species exhibited##7##2##(1993-12#1)(1997-2#1)(2008-10#2)(2008-8#1)(2010-3#1)(2010-8#1)
species exhibiting##3##2##(1995-5#1)(2010-2#1)(2010-8#1)
species exhibits a##2##3##(2008-5#1)(2013-7#1)
species exhibits##3##2##(2008-5#1)(2008-9#1)(2013-7#1)
species exist##3##2##(1995-11#1)(2008-10#1)(2008-5#1)
species existing in##2##3##(2008-10#2)
species existing##3##2##(1992-2#1)(2008-10#2)
species exposed to##2##3##(2007-5#1)(2008-8#1)
species extinctions##2##2##(2008-8#2)
species fell##2##2##(2008-5#1)(2010-6#1)
species followed by##2##3##(2008-10#1)(2008-2#1)
species following##2##2##(1993-11#1)(1996-7#1)
species for the first##2##4##(2007-8#1)(2008-12#1)
species for the##8##3##(2007-8#1)(2008-10#2)(2008-12#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
species for which##5##3##(1991-8#1)(1993-12#1)(1994-7#1)(2008-5#1)(2008-8#1)
species for##44##2##(1990-2#1)(1991-8#1)(1992-6#1)(1993-12#1)(1994-7#1)(1995-2#2)(1996-2#1)(2005-11#1)(2007-1#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-12#1)(2008-5#5)(2008-6#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
species formed by##5##3##(1993-12#1)(2007-12#1)(2008-10#2)(2008-3#1)
species formed during##3##3##(1992-8#1)(1995-1#1)(2008-10#1)
species formed in##3##3##(1994-9#1)(2008-10#2)
species formed##23##2##(1992-8#1)(1993-12#1)(1994-9#1)(1995-1#1)(2006-12#1)(2007-12#1)(2008-10#12)(2008-3#1)(2008-5#1)(2008-6#1)(2009-9#1)(2011-2#1)
species found in##8##3##(1992-6#1)(2008-12#1)(2008-5#2)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)
species found##15##2##(1992-6#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#2)
species from a##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
species from different families##2##4##(2006-12#1)(2008-12#1)
species from different##4##3##(2006-12#1)(2008-10#1)(2008-12#1)(2013-1#1)
species from five##2##3##(2011-2#1)(2012-3#1)
species from liver##2##3##(2007-8#2)
species from the##21##3##(1997-2#1)(2006-6#1)(2007-6#1)(2008-10#4)(2008-5#7)(2008-8#1)(2009-2#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-7#1)
species from##90##2##(1990-8#1)(1991-9#1)(1992-5#1)(1992-9#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-2#1)(2006-12#2)(2006-6#1)(2007-3#6)(2007-6#1)(2007-8#4)(2008-10#18)(2008-11#2)(2008-12#2)(2008-5#14)(2008-6#1)(2008-8#4)(2008-9#2)(2009-2#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#3)(2012-9#1)(2013-1#4)(2013-7#5)(2013-8#2)
species generally##2##2##(2008-5#1)(2012-5#1)
species generated by##5##3##(1990-2#1)(1993-11#1)(2005-8#1)(2008-4#1)(2010-11#1)
species generation##3##2##(2007-12#1)(2008-4#1)(2009-12#1)
species group by##2##3##(2013-7#2)
species group##6##2##(2006-8#1)(2008-5#2)(2013-7#3)
species grouped##2##2##(2008-10#1)(2013-7#1)
species groups##6##2##(2006-2#1)(2006-4#1)(2007-3#1)(2008-6#1)(2010-4#2)
species growing in the##3##4##(2007-1#1)(2008-10#1)(2008-9#1)
species growing in##7##3##(2006-12#1)(2007-1#3)(2008-10#1)(2008-9#1)(2012-5#1)
species growing##9##2##(2004-4#1)(2006-12#1)(2007-1#3)(2008-10#1)(2008-9#1)(2012-5#1)(2012-6#1)
species grown in##2##3##(2006-8#1)(2008-10#1)
species had a##3##3##(1993-8#1)(1996-1#1)(2008-8#1)
species had the##2##3##(2007-8#1)(2008-12#1)
species had##12##2##(1993-8#1)(1996-1#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#2)(2013-7#1)
species harbor##2##2##(2005-12#1)(2012-3#1)
species has a##7##3##(1991-8#1)(1992-10#1)(2007-3#1)(2007-5#1)(2008-5#1)(2008-8#1)(2010-8#1)
species has been developed##2##4##(1990-9#1)(2008-5#1)
species has been reported##2##4##(2007-11#1)(2012-2#1)
species has been##16##3##(1990-9#1)(1994-12#1)(1995-8#1)(2004-11#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-3#1)(2010-8#1)(2012-2#2)
species has##40##2##(1990-9#1)(1991-8#1)(1992-10#1)(1994-12#1)(1995-8#1)(2004-11#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#2)(2007-9#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#5)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-2#2)(2013-8#1)
species have a##5##3##(1993-6#1)(2007-12#1)(2008-12#1)(2008-5#1)(2011-12#1)
species have become##2##3##(2012-3#1)(2013-7#1)
species have been determined##2##4##(2008-10#2)
species have been found in##2##5##(2006-8#1)(2008-10#1)
species have been found##3##4##(2006-8#1)(2007-5#1)(2008-10#1)
species have been identified##3##4##(2006-10#1)(2007-5#1)(2008-5#1)
species have been previously reported##2##5##(2008-5#1)(2011-12#1)
species have been recorded##2##4##(2007-3#1)(2007-5#1)
species have been used##2##4##(2008-10#1)(2011-1#1)
species have been##42##3##(1994-6#2)(1995-7#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-4#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-12#3)(2007-3#1)(2007-5#3)(2007-7#1)(2008-10#11)(2008-5#2)(2009-5#1)(2009-6#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-1#2)
species have not been##2##4##(1992-5#1)(2007-2#1)
species have not##3##3##(1992-5#1)(2004-11#1)(2007-2#1)
species have the##2##3##(1996-12#1)(2009-2#1)
species have##84##2##(1992-5#1)(1993-6#1)(1994-6#2)(1995-12#1)(1995-7#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-8#1)(1997-4#1)(2004-11#1)(2004-4#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-8#2)(2007-12#6)(2007-2#1)(2007-3#2)(2007-5#6)(2007-7#1)(2008-10#15)(2008-12#2)(2008-5#3)(2008-8#2)(2008-9#3)(2009-2#1)(2009-5#1)(2009-6#1)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
species histories##2##2##(2010-6#2)
species identification and Halal authentication##2##5##(2010-4#2)
species identification and##7##3##(2008-3#1)(2008-9#1)(2010-4#3)(2011-1#1)(2011-2#1)
species identification of##3##3##(2009-5#1)(2010-4#1)(2012-12#1)
species identification was##2##3##(2007-12#1)(2007-8#1)
species identification##20##2##(1996-12#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-9#2)(2009-5#2)(2010-3#1)(2010-4#5)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
species identifications##3##2##(2007-5#1)(2008-9#1)(2010-4#1)
species identified in##2##3##(2008-10#1)(2011-2#1)
species identified##7##2##(1996-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#1)(2011-2#1)
species if##2##2##(2008-9#1)(2012-1#1)
species in a single##2##4##(2008-10#2)
species in a##22##3##(1991-8#1)(1994-2#1)(2006-12#1)(2008-10#8)(2008-12#1)(2008-3#2)(2008-8#5)(2008-9#1)(2009-3#1)(2012-3#1)
species in aqueous solution##2##4##(2008-10#1)(2008-3#1)
species in aqueous##4##3##(2008-10#3)(2008-3#1)
species in both##4##3##(1996-2#1)(2008-8#1)(2008-9#1)(2013-8#1)
species in brain##2##3##(1994-11#1)(1996-5#1)
species in deep##2##3##(2008-10#1)(2008-8#1)
species in different##3##3##(2008-3#1)(2008-8#1)(2013-1#1)
species in each of##2##4##(1991-5#1)(2008-10#1)
species in each##3##3##(1991-5#1)(2008-10#1)(2008-2#1)
species in environmental samples##2##4##(2008-10#2)
species in environmental##5##3##(2008-10#5)
species in equilibrium##2##3##(2005-11#1)(2008-10#1)
species in fish##2##3##(2008-10#2)
species in human##4##3##(2008-10#2)(2009-11#1)(2010-12#1)
species in natural waters##4##4##(2004-4#1)(2008-10#3)
species in natural##6##3##(2004-4#1)(2008-10#5)
species in normal##2##3##(1996-1#1)(2008-5#1)
species in order to##2##4##(1994-3#1)(2011-2#1)
species in plant##2##3##(2007-9#1)(2008-10#1)
species in regard to##2##4##(2008-6#1)(2011-2#1)
species in response to drought##2##5##(2012-8#2)
species in river##2##3##(2008-10#2)
species in situ##2##3##(2006-4#1)(2012-12#1)
species in six##2##3##(2008-10#2)
species in soils##2##3##(2007-8#1)(2010-5#1)
species in solution##4##3##(2008-10#3)(2008-5#1)
species in spiked##2##3##(2008-10#2)
species in terms of##2##4##(2008-7#1)(2009-5#1)
species in the Caribbean##2##4##(1996-6#1)(2007-5#1)
species in the Gulf of##2##5##(2007-5#1)(2013-7#1)
species in the USA##2##4##(2006-12#1)(2008-7#1)
species in the family##3##4##(2008-10#2)(2008-7#1)
species in the genera##2##4##(2008-10#2)
species in the genus Tospovirus##2##5##(2008-10#2)
species in the genus##12##4##(2007-12#1)(2008-10#7)(2008-8#1)(2011-12#1)(2011-2#2)
species in the membrane##2##4##(1990-12#1)(2008-10#1)
species in the sample##3##4##(2007-8#2)(2008-10#1)
species in the system##5##4##(1995-2#3)(2008-11#1)(2008-5#1)
species in the whole##2##4##(1990-2#1)(2008-4#1)
species in the##132##3##(1990-12#1)(1990-2#1)(1990-5#3)(1990-8#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-6#1)(1994-3#2)(1995-2#3)(1995-3#1)(1996-5#2)(1996-6#2)(1997-2#1)(1997-4#1)(1997-5#1)(2005-11#2)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#5)(2007-3#2)(2007-5#3)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#29)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#11)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-8#2)(2010-9#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#1)(2013-7#7)
species in these##4##3##(2007-3#1)(2008-5#1)(2008-8#2)
species in this genus##2##4##(2005-11#1)(2008-10#1)
species in this##9##3##(1992-6#1)(2005-11#1)(2008-10#3)(2008-5#1)(2009-10#1)(2011-2#1)(2012-5#1)
species in tropical##2##3##(2008-8#1)(2013-7#1)
species in two##2##3##(2008-10#1)(2008-5#1)
species in urine samples##2##4##(2008-10#1)(2008-3#1)
species in various##3##3##(2007-5#1)(2008-2#2)
species in vitro##2##3##(1995-1#1)(2006-11#1)
species in water samples##3##4##(2008-10#3)
species in water##5##3##(2008-10#5)
species in which the##3##4##(2008-4#1)(2008-5#1)(2013-1#1)
species in which##11##3##(1996-4#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#4)(2011-12#1)(2013-1#1)
species in##401##2##(1990-12#1)(1990-2#1)(1990-5#3)(1990-8#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#3)(1991-9#2)(1992-12#1)(1992-3#1)(1992-6#5)(1993-11#1)(1993-12#1)(1994-11#2)(1994-2#1)(1994-3#4)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#3)(1995-3#1)(1995-8#2)(1996-1#1)(1996-2#1)(1996-4#1)(1996-5#3)(1996-6#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-4#3)(2005-11#5)(2005-8#1)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#7)(2007-3#7)(2007-5#4)(2007-8#8)(2007-9#3)(2008-1#1)(2008-10#121)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#6)(2008-5#26)(2008-6#5)(2008-7#5)(2008-8#27)(2008-9#5)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#2)(2009-8#4)(2010-10#4)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#3)(2010-5#2)(2010-8#4)(2010-9#1)(2011-1#1)(2011-12#3)(2011-2#11)(2012-1#1)(2012-11#3)(2012-12#6)(2012-2#3)(2012-3#2)(2012-5#1)(2012-8#2)(2013-1#5)(2013-7#10)(2013-8#3)
species include##4##2##(2007-12#1)(2008-1#1)(2008-12#1)(2012-3#1)
species included##5##2##(2006-8#1)(2007-5#2)(2008-5#2)
species including B##2##3##(1997-2#1)(2006-8#1)
species including##20##2##(1990-9#1)(1992-11#1)(1997-2#1)(2004-2#1)(2006-8#1)(2007-8#1)(2008-10#8)(2008-2#1)(2008-5#1)(2008-8#1)(2010-1#1)(2011-1#1)(2012-2#1)
species increased with##2##3##(1992-1#1)(2007-8#1)
species increased##3##2##(1992-1#1)(2007-8#1)(2011-2#1)
species indicate the##2##3##(1990-9#1)(2009-5#1)
species indicated##3##2##(1990-11#1)(1993-12#1)(2008-9#1)
species indicates that##3##3##(1993-12#1)(1993-6#1)(2006-11#1)
species indicates##4##2##(1993-12#1)(1993-6#1)(2006-11#1)(2008-10#1)
species infected with##2##3##(2008-10#1)(2012-3#1)
species infecting##3##2##(2008-10#3)
species infection##5##2##(1996-6#1)(2006-10#1)(2006-2#2)(2009-4#1)
species inhabiting##4##2##(2007-3#1)(2008-8#1)(2011-2#1)(2012-12#1)
species integrity##2##2##(1994-3#1)(2008-10#1)
species interactions in##2##3##(2008-9#2)
species interactions##11##2##(2008-8#2)(2008-9#8)(2010-2#1)
species into the##2##3##(1994-3#1)(2008-10#1)
species into##8##2##(1994-3#1)(2006-8#1)(2008-10#5)(2008-5#1)
species investigated##5##2##(1993-7#1)(2008-10#1)(2008-11#1)(2010-4#1)(2012-5#1)
species involved in the##4##4##(1993-6#1)(1994-11#1)(2008-10#1)(2011-1#1)
species involved in##5##3##(1993-6#1)(1994-11#1)(2008-10#1)(2008-5#1)(2011-1#1)
species involved##13##2##(1993-6#1)(1994-11#1)(2006-8#1)(2008-10#5)(2008-3#1)(2008-5#2)(2011-1#1)(2012-2#1)
species is a##12##3##(1993-11#1)(1994-3#1)(2007-3#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-8#1)(2011-2#4)
species is also##3##3##(2008-10#2)(2008-5#1)
species is an##3##3##(2006-10#1)(2008-10#1)(2013-1#1)
species is characterized by a##4##5##(2006-12#1)(2008-5#1)(2008-8#1)(2011-2#1)
species is characterized by the##3##5##(2008-3#1)(2008-5#2)
species is characterized by##8##4##(2006-12#1)(2008-3#1)(2008-5#3)(2008-8#1)(2009-3#1)(2011-2#1)
species is discussed##4##3##(2007-12#1)(2008-10#1)(2010-10#1)(2010-12#1)
species is important##2##3##(2006-8#1)(2008-5#1)
species is less##2##3##(1994-5#1)(2011-2#1)
species is not##6##3##(1996-1#1)(1997-2#1)(2007-3#1)(2008-10#1)(2008-5#1)(2012-3#1)
species is now##2##3##(2008-10#1)(2008-12#1)
species is observed##2##3##(1994-2#1)(2008-8#1)
species is of interest because##3##5##(2011-2#3)
species is of interest##4##4##(2011-2#4)
species is of##5##3##(2008-11#1)(2011-2#4)
species is possible by##2##4##(2008-10#2)
species is presented##4##3##(2008-10#1)(2008-5#1)(2013-7#2)
species is regulated##2##3##(2006-12#1)(2009-8#1)
species is related to##2##4##(2007-3#1)(2008-5#1)
species is retained##2##3##(1996-9#1)(2010-3#1)
species is the##8##3##(1990-12#1)(1994-3#1)(1994-6#1)(2007-12#1)(2008-10#3)(2013-1#1)
species is##166##2##(1990-11#2)(1990-12#1)(1990-3#1)(1991-7#3)(1991-9#1)(1993-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-1#2)(1996-2#1)(1996-9#1)(1997-2#2)(1997-4#1)(2004-11#1)(2006-10#2)(2006-12#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#10)(2007-5#5)(2007-6#2)(2007-7#1)(2007-9#1)(2008-10#40)(2008-11#2)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#20)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#4)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#11)(2012-1#2)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#2)(2013-7#4)
species isolated from cases of##3##5##(2007-7#2)(2008-7#1)
species isolated from the##2##4##(2006-8#1)(2011-2#1)
species isolated from##10##3##(1996-3#1)(2006-8#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-2#1)
species isolated in##2##3##(2008-10#1)(2008-5#1)
species isolated##16##2##(1993-8#1)(1996-3#1)(2006-8#1)(2007-7#4)(2007-8#2)(2008-10#2)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-2#1)
species known to be##5##4##(1990-11#1)(1995-1#1)(2008-8#1)(2012-3#1)(2012-6#1)
species known to##6##3##(1990-11#1)(1995-1#1)(2008-8#2)(2012-3#1)(2012-6#1)
species known##7##2##(1990-11#1)(1995-1#1)(2004-4#1)(2008-8#2)(2012-3#1)(2012-6#1)
species lacking##4##2##(1994-8#1)(1995-12#1)(1996-10#1)(2008-11#1)
species leading to##2##3##(1992-12#1)(1995-5#1)
species level by##2##3##(2008-10#1)(2011-2#1)
species level using##2##3##(2007-7#1)(2008-10#1)
species level##20##2##(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-5#4)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#4)(2012-6#1)
species life history##2##3##(2008-8#2)
species life##4##2##(1995-6#1)(2008-5#1)(2008-8#2)
species like##5##2##(1995-8#1)(2006-12#2)(2008-12#1)(2012-12#1)
species likely##2##2##(2007-8#1)(2009-2#1)
species list##5##2##(2007-3#2)(2007-5#2)(2013-1#1)
species living in different##2##4##(2007-12#1)(2007-3#1)
species longevity##3##2##(2009-5#3)
species mate##3##2##(2008-8#1)(2008-9#2)
species may be responsible for##2##5##(2008-3#1)(2009-11#1)
species may be##15##3##(1995-5#1)(2006-10#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-8#2)(2011-12#1)(2012-3#1)
species may have been##2##4##(2008-10#2)
species may have##3##3##(2007-11#1)(2008-10#2)
species may##36##2##(1990-7#1)(1992-8#1)(1993-6#1)(1995-11#1)(1995-12#1)(1995-5#1)(2005-9#2)(2006-10#1)(2007-11#1)(2007-3#1)(2008-10#7)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#3)(2011-12#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
species might have##3##3##(2008-3#1)(2008-7#1)(2009-8#1)
species mixtures##2##2##(2008-10#2)
species most commonly##2##3##(2007-8#1)(2008-11#1)
species most##6##2##(2006-10#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-4#2)
species native to##2##3##(2008-10#1)(2008-8#1)
species nesting##2##2##(2008-6#1)(2008-9#1)
species no##2##2##(2004-4#1)(2006-7#1)
species not##5##2##(1990-10#1)(2008-10#2)(2008-9#1)(2009-8#1)
species number##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
species observed##3##2##(1991-12#1)(2008-3#2)
species obtained##4##2##(2007-3#1)(2008-10#1)(2009-3#1)(2012-2#1)
species occupying##2##2##(1990-11#1)(2013-1#1)
species occur in the##3##4##(2007-3#2)(2013-7#1)
species occur in##5##3##(1992-9#1)(2007-3#2)(2009-2#1)(2013-7#1)
species occur##11##2##(1992-9#1)(2004-4#2)(2007-3#3)(2008-1#1)(2008-10#1)(2008-5#1)(2009-2#1)(2013-7#1)
species occurred##2##2##(2008-4#1)(2008-5#1)
species occurring in##2##3##(2008-5#1)(2013-1#1)
species occurs##3##2##(2007-5#1)(2008-8#1)(2011-2#1)
species of &quot##2##3##(2011-2#2)
species of 1##2##3##(1991-9#1)(1992-12#1)
species of Antipatharia##2##3##(2007-5#2)
species of Aspergillus##3##3##(1993-12#1)(1994-3#1)(2007-7#1)
species of Cryptocercus##2##3##(2007-12#2)
species of Drosophila##4##3##(1993-12#1)(2008-10#1)(2008-8#1)(2012-3#1)
species of Euglena##2##3##(2007-3#2)
species of Fusarium##2##3##(2008-10#2)
species of Gemella##2##3##(2007-12#2)
species of Gracilaria##2##3##(2008-11#2)
species of Hyphessobrycon from the Pacific Coast of Colombia##2##9##(2013-7#2)
species of Hyphessobrycon##3##3##(2013-7#3)
species of Hypocrea##2##3##(2008-10#2)
species of IFN##2##3##(2008-4#2)
species of Lamiaceae##2##3##(2007-3#2)
species of Mentha##2##3##(2013-1#2)
species of Neotibilis Grazia &amp##2##5##(2008-6#2)
species of Nicotiana##2##3##(2008-10#2)
species of Old World##2##4##(1995-11#1)(2013-1#1)
species of Phytophthora##9##3##(2008-10#9)
species of Shigella##2##3##(2006-10#1)(2008-10#1)
species of Solanum##2##3##(2008-7#2)
species of Trichoderma##2##3##(2008-10#2)
species of a##3##3##(1994-9#1)(1997-3#1)(2007-3#1)
species of animals##3##3##(1990-12#1)(1993-11#1)(2009-5#1)
species of approximately##4##3##(1997-6#1)(2008-10#3)
species of bacteria##5##3##(1992-7#1)(1994-3#1)(2006-6#1)(2008-9#1)(2011-2#1)
species of bats##3##3##(1994-11#2)(2013-1#1)
species of birds##9##3##(1997-3#1)(1997-4#1)(1997-6#1)(2006-5#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-5#1)
species of bitterling##2##3##(2010-8#2)
species of both##2##3##(2007-11#1)(2008-10#1)
species of cerebroside sulfate##2##4##(1993-8#2)
species of copper(II)##2##3##(2008-10#2)
species of cyanobacteria##2##3##(1996-12#1)(2008-10#1)
species of different genera##2##4##(2008-5#1)(2011-12#1)
species of different##5##3##(1990-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-12#1)
species of digeneans##2##3##(2007-3#2)
species of each##2##3##(1992-6#1)(1997-4#1)
species of echinoderms (one##2##4##(2007-5#2)
species of echinoderms##3##3##(2007-5#3)
species of economic##2##3##(2008-5#1)(2009-10#1)
species of ectoparasites were##2##4##(2012-12#1)(2012-2#1)
species of enterococci##2##3##(2007-8#2)
species of fish from##2##4##(2008-11#1)(2013-1#1)
species of fish were##2##4##(1991-7#1)(2013-7#1)
species of fish##12##3##(1991-7#2)(1996-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
species of fishes##6##3##(2007-11#2)(2007-3#3)(2008-5#1)
species of forest##2##3##(1995-3#1)(2008-9#1)
species of fresh##2##3##(2008-5#1)(2010-4#1)
species of freshwater##3##3##(2007-3#1)(2008-11#1)(2008-5#1)
species of frugivorous bats##2##4##(2008-5#2)
species of fungi##4##3##(2007-11#1)(2008-10#2)(2008-5#1)
species of gelatinase/type IV collagenase##2##5##(1991-12#2)
species of hosts##2##3##(2011-2#1)(2012-2#1)
species of insect##3##3##(1991-10#1)(2008-5#1)(2011-2#1)
species of interest##6##3##(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2009-5#1)
species of mRNAs##2##3##(1992-8#1)(1997-2#1)
species of mammals##2##3##(2008-5#1)(2009-5#1)
species of mealybug##2##3##(2008-10#1)(2011-12#1)
species of mice##2##3##(1992-5#1)(2008-10#1)
species of mosquitoes##3##3##(2005-8#1)(2008-7#1)(2008-8#1)
species of parasites##2##3##(2011-2#1)(2013-1#1)
species of parasitoids##2##3##(2010-2#1)(2011-12#1)
species of pathogenic fungi##3##4##(2008-10#2)(2008-5#1)
species of pathogenic##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
species of pathogens##2##3##(2008-10#2)
species of penguins##2##3##(1993-9#1)(2008-5#1)
species of phosphatidylcholine (PC)##2##4##(1993-8#1)(1994-12#1)
species of phosphatidylcholine##3##3##(1992-2#1)(1993-8#1)(1994-12#1)
species of plants##5##3##(2008-10#3)(2008-5#1)(2008-6#1)
species of plasma##3##3##(1994-12#2)(1995-8#1)
species of poikilothermic vertebrates##2##4##(2008-7#2)
species of primate##2##3##(1990-12#2)
species of primates##3##3##(1991-11#1)(1991-8#1)(1992-11#1)
species of reptiles##2##3##(1992-8#1)(2010-3#1)
species of rodent##2##3##(1990-12#1)(2011-1#1)
species of rodents##2##3##(1995-5#1)(2011-1#1)
species of sand flies##2##4##(2013-1#2)
species of seaweed##2##3##(2007-8#1)(2011-12#1)
species of serogroup IV##2##4##(2008-10#2)
species of similar density##2##4##(2005-10#2)
species of similar##4##3##(1994-6#1)(2005-10#2)(2008-8#1)
species of skate (Rajidae)##2##4##(2010-8#2)
species of tRNA genes##2##4##(1995-8#1)(2008-9#1)
species of teleosts##2##3##(2007-3#1)(2010-2#1)
species of the Paramecium aurelia complex##3##6##(2008-12#3)
species of the family##5##4##(2008-10#2)(2008-4#1)(2010-2#1)(2011-2#1)
species of the genera##2##4##(1997-4#1)(2008-5#1)
species of the genus Squatina##2##5##(2008-5#2)
species of the genus##56##4##(1997-2#1)(2005-11#1)(2007-2#1)(2007-3#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#1)(2009-5#1)(2010-8#2)(2011-2#26)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
species of the obscura group##2##5##(2013-1#2)
species of the order##2##4##(2008-5#1)(2008-8#1)
species of the rotifer##2##4##(2012-2#2)
species of the same##2##4##(1996-12#1)(2007-3#1)
species of the##113##3##(1990-9#1)(1991-4#1)(1992-11#1)(1992-2#1)(1994-6#1)(1996-12#1)(1997-2#2)(1997-4#1)(2004-11#1)(2005-11#1)(2007-1#1)(2007-12#2)(2007-2#1)(2007-3#4)(2007-5#1)(2007-9#1)(2008-10#14)(2008-11#1)(2008-12#5)(2008-4#2)(2008-5#12)(2008-6#6)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-8#2)(2011-2#30)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
species of these##2##3##(1992-4#1)(1995-12#1)
species of this genus##4##4##(2008-5#2)(2008-9#1)(2013-1#1)
species of this##8##3##(2007-3#1)(2008-10#2)(2008-5#2)(2008-9#1)(2013-1#1)(2013-8#1)
species of ungulates##2##3##(2008-5#1)(2008-8#1)
species of vertebrates have been studied for helminths in Costa Rica (31 species of fishes##2##15##(2007-3#2)
species of vertebrates##4##3##(1993-2#1)(2007-3#3)
species of wild##3##3##(2007-2#1)(2008-12#1)(2013-7#1)
species of##738##2##(1990-10#1)(1990-11#1)(1990-12#5)(1990-2#2)(1990-3#2)(1990-4#2)(1990-7#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#7)(1991-8#3)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#5)(1992-2#2)(1992-3#1)(1992-4#4)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#4)(1992-9#3)(1993-11#3)(1993-12#3)(1993-2#1)(1993-6#1)(1993-8#4)(1993-9#2)(1994-11#4)(1994-12#3)(1994-3#5)(1994-6#4)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#4)(1996-1#2)(1996-11#2)(1996-12#2)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#6)(1997-6#2)(2004-11#2)(2005-10#2)(2005-11#4)(2005-8#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#4)(2007-1#5)(2007-10#2)(2007-11#5)(2007-12#21)(2007-2#6)(2007-3#35)(2007-5#13)(2007-7#4)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#115)(2008-11#11)(2008-12#16)(2008-2#3)(2008-3#6)(2008-4#14)(2008-5#73)(2008-6#14)(2008-7#12)(2008-8#19)(2008-9#16)(2009-10#1)(2009-11#1)(2009-2#3)(2009-4#1)(2009-5#5)(2009-8#5)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#5)(2010-3#5)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#12)(2011-1#4)(2011-12#5)(2011-2#49)(2012-1#1)(2012-11#3)(2012-12#3)(2012-2#10)(2012-3#4)(2013-1#20)(2013-7#14)(2013-8#7)
species often##2##2##(2007-6#1)(2008-10#1)
species on a##2##3##(1991-12#1)(2013-8#1)
species on the basis of##2##5##(2007-1#1)(2008-10#1)
species on the##8##3##(1996-5#1)(2007-1#1)(2008-10#6)
species on##38##2##(1991-12#1)(1996-5#1)(2005-11#2)(2006-12#1)(2007-1#1)(2007-12#1)(2008-10#17)(2008-5#1)(2008-8#2)(2009-4#4)(2011-1#1)(2012-1#1)(2012-2#1)(2012-6#2)(2013-7#1)(2013-8#1)
species only##5##2##(1990-10#1)(2008-10#2)(2008-5#1)(2008-8#1)
species or a##2##3##(2008-8#1)(2008-9#1)
species or by##2##3##(2008-10#1)(2008-7#1)
species or genera##2##3##(2008-10#2)
species or genotypes##3##3##(2005-11#2)(2007-12#1)
species or subspecies##2##3##(2008-10#1)(2008-4#1)
species or##29##2##(1991-3#1)(1992-5#1)(1994-12#1)(1997-4#1)(2005-11#2)(2006-4#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#9)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#1)
species originating from##2##3##(1990-4#1)(2012-9#1)
species other than##7##3##(1991-1#1)(1996-7#1)(2005-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
species over a##3##3##(2008-10#2)(2008-3#1)
species over##5##2##(2008-10#3)(2008-3#1)(2008-8#1)
species pairs##4##2##(2008-2#1)(2008-7#1)(2009-2#1)(2013-7#1)
species per##2##2##(2007-8#1)(2009-5#1)
species persistence##2##2##(2008-8#1)(2013-8#1)
species play##2##2##(2008-10#1)(2009-6#1)
species possess##2##2##(2008-9#1)(2012-3#1)
species predominate##2##2##(2008-10#1)(2010-11#1)
species presence##2##2##(2008-5#1)(2008-8#1)
species present in the##5##4##(1990-4#1)(1997-2#1)(2007-8#1)(2008-10#1)(2013-1#1)
species present in these samples##2##5##(2008-10#2)
species present in these##3##4##(1990-2#1)(2008-10#2)
species present in##13##3##(1990-2#1)(1990-4#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-5#1)(2013-1#1)
species present##21##2##(1990-2#1)(1990-4#1)(1997-2#1)(2004-4#1)(2005-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-4#1)(2008-5#1)(2010-12#1)(2013-1#1)
species presented##3##2##(2007-3#1)(2007-6#1)(2013-7#1)
species produced##5##2##(1992-1#1)(1995-5#1)(1995-8#1)(2007-9#1)(2008-5#1)
species production##8##2##(1991-9#1)(2008-1#2)(2010-12#2)(2010-4#1)(2010-7#1)(2011-1#1)
species provide##2##2##(2008-8#2)
species provided##2##2##(2008-10#1)(2008-5#1)
species provides##2##2##(2008-10#1)(2008-7#1)
species ranged from##2##3##(2008-10#1)(2008-12#1)
species ranging from##2##3##(1993-3#1)(2008-10#1)
species rather than##3##3##(1995-8#1)(2008-8#1)(2009-8#1)
species ratios##2##2##(2004-11#1)(2008-10#1)
species recorded##2##2##(2007-3#1)(2011-2#1)
species recovered from##2##3##(2010-3#1)(2011-1#1)
species remain##2##2##(2008-10#1)(2008-7#1)
species remains##2##2##(1990-10#1)(1993-9#1)
species reported##5##2##(2007-5#1)(2007-7#1)(2008-10#1)(2008-5#2)
species represent##2##2##(2008-10#1)(2013-1#1)
species representing##4##2##(2007-12#1)(2008-10#1)(2008-9#1)(2010-3#1)
species represents##3##2##(1990-7#1)(2007-5#1)(2011-2#1)
species requires##2##2##(2008-10#1)(2013-8#1)
species residing##2##2##(2008-8#1)(2013-1#1)
species responded to##2##3##(2008-7#1)(2008-8#1)
species responded##3##2##(2008-7#1)(2008-8#2)
species responsible for##4##3##(1991-10#1)(1991-7#1)(2010-11#1)(2011-2#1)
species responsible##5##2##(1991-10#1)(1991-7#1)(2010-11#1)(2011-2#1)(2012-2#1)
species result in##2##3##(2006-1#1)(2008-10#1)
species results from##2##3##(1997-7#1)(2008-9#1)
species results##3##2##(1990-8#1)(1997-7#1)(2008-9#1)
species retained on##2##3##(2008-10#2)
species retained##3##2##(2008-10#2)(2008-3#1)
species reveal that##2##3##(1991-7#1)(2008-10#1)
species reveal##3##2##(1991-7#1)(2008-10#1)(2011-1#1)
species revealed that##3##3##(1997-7#1)(2008-8#1)(2008-9#1)
species revealed##6##2##(1991-4#1)(1997-7#1)(2008-10#1)(2008-8#1)(2008-9#1)(2013-7#1)
species reveals a##2##3##(2008-5#1)(2009-5#1)
species reveals##3##2##(2008-5#1)(2009-5#1)(2009-7#1)
species richness along##2##3##(2008-8#2)
species richness and abundance##5##4##(2007-3#1)(2008-5#1)(2013-7#3)
species richness and diversity##3##4##(2008-5#3)
species richness and plant functional group richness had##2##8##(2008-8#2)
species richness and plant functional group richness##3##7##(2008-8#3)
species richness and plant functional group##4##6##(2008-8#4)
species richness and plant functional##5##5##(2008-8#4)(2008-9#1)
species richness and##20##3##(2007-3#1)(2007-5#1)(2008-5#5)(2008-8#5)(2008-9#2)(2012-12#1)(2013-1#1)(2013-7#4)
species richness at##2##3##(2007-5#1)(2008-8#1)
species richness is##5##3##(2008-8#4)(2008-9#1)
species richness of Asteroidea##2##4##(2007-5#2)
species richness of##9##3##(1994-3#1)(2007-12#1)(2007-3#1)(2007-5#3)(2008-8#1)(2008-9#2)
species richness on##2##3##(2008-8#2)
species richness was##5##3##(2007-5#1)(2008-5#1)(2008-9#1)(2012-2#1)(2013-7#1)
species richness##86##2##(1994-3#4)(2007-12#1)(2007-3#2)(2007-5#9)(2008-5#10)(2008-8#31)(2008-9#14)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#11)
species sampled##2##2##(2008-10#2)
species separation##3##2##(2008-10#3)
species share the same##2##4##(1994-6#1)(2008-1#1)
species share##3##2##(1994-6#1)(2008-1#1)(2008-8#1)
species should be considered##2##4##(2009-4#1)(2010-11#1)
species should be##3##3##(2009-4#1)(2010-11#1)(2012-12#1)
species show a##2##3##(2008-12#1)(2012-5#1)
species show##7##2##(1991-11#1)(1993-12#1)(2008-10#1)(2008-12#2)(2011-2#1)(2012-5#1)
species showed a##2##3##(2012-5#1)(2013-1#1)
species showed distinct##2##3##(2008-10#1)(2008-8#1)
species showed significant##2##3##(1995-8#1)(2008-5#1)
species showed that##8##3##(1990-11#1)(1992-3#1)(2007-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-8#1)(2013-8#1)
species showed##27##2##(1990-11#1)(1992-3#1)(1993-12#1)(1995-6#1)(1995-8#1)(1997-4#1)(2004-4#1)(2005-9#1)(2007-6#2)(2007-7#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-4#1)(2010-8#1)(2012-5#1)(2013-1#1)(2013-8#1)
species shows that##2##3##(2007-5#1)(2008-3#1)
species shows##8##2##(2007-5#1)(2008-10#2)(2008-3#1)(2008-8#2)(2009-2#1)(2010-2#1)
species since##2##2##(1996-8#1)(2008-10#1)
species so far##3##3##(2006-10#1)(2008-10#1)(2013-7#1)
species so##4##2##(2006-10#2)(2008-10#1)(2013-7#1)
species specific primer-probe##2##3##(2010-4#2)
species specific##17##2##(1990-10#1)(1990-6#1)(1990-7#1)(1991-2#1)(1992-8#1)(1995-11#1)(1997-3#1)(1997-5#1)(2004-4#1)(2007-11#1)(2008-10#3)(2010-4#2)(2012-12#1)(2012-3#1)
species specificity of##4##3##(1997-5#1)(2008-10#2)(2012-2#1)
species specificity##15##2##(1991-3#1)(1991-4#1)(1992-2#1)(1997-5#1)(2008-1#2)(2008-10#4)(2008-12#2)(2008-7#1)(2009-8#1)(2012-2#1)
species studied are##2##3##(2012-5#1)(2013-7#1)
species studied were##2##3##(2008-10#1)(2013-8#1)
species studied##19##2##(1990-2#1)(1990-5#1)(1994-8#1)(2004-11#1)(2007-11#2)(2007-12#1)(2007-3#1)(2008-10#2)(2008-5#2)(2008-8#1)(2010-12#1)(2010-5#1)(2012-5#1)(2013-1#1)(2013-7#1)(2013-8#1)
species such as ascorbic acid##2##5##(2008-10#2)
species such as birds##2##4##(2006-10#1)(2009-5#1)
species such as human##2##4##(1990-12#1)(1992-10#1)
species such as the##3##4##(1994-11#1)(1997-2#1)(1997-8#1)
species such as##34##3##(1990-10#1)(1990-12#1)(1992-10#1)(1992-12#1)(1993-9#1)(1994-11#1)(1995-3#1)(1997-2#1)(1997-8#1)(2006-10#1)(2007-11#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-4#1)(2010-5#1)(2011-12#2)
species suggest that##4##3##(1993-2#1)(2008-10#1)(2008-9#1)(2011-2#1)
species suggest##5##2##(1993-2#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#1)
species suggests that##5##3##(1993-11#1)(1996-5#1)(2008-9#1)(2010-3#1)(2010-8#1)
species suggests##6##2##(1993-11#1)(1996-5#1)(2008-9#1)(2010-3#1)(2010-8#1)(2013-7#1)
species support the##2##3##(2009-5#1)(2011-2#1)
species survival##2##2##(1997-9#1)(2013-1#1)
species tend to be##2##4##(2008-1#1)(2008-10#1)
species tend to##3##3##(2008-1#1)(2008-10#1)(2010-2#1)
species tested and##2##3##(2006-8#1)(2008-10#1)
species tested were##3##3##(2008-10#2)(2008-6#1)
species tested##24##2##(1990-12#1)(1992-7#1)(1993-11#1)(2004-4#1)(2006-8#6)(2007-11#1)(2007-6#1)(2008-10#8)(2008-12#1)(2008-5#1)(2008-6#1)(2011-2#1)
species than##5##2##(1990-8#1)(2008-10#2)(2008-5#1)(2008-9#1)
species that are associated with##2##5##(2006-8#1)(2008-8#1)
species that are##22##3##(1992-10#1)(1995-1#2)(2006-8#1)(2007-9#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2010-2#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-7#1)
species that belong to##2##4##(2008-10#1)(2008-3#1)
species that can##4##3##(1996-5#1)(2008-3#1)(2008-7#1)(2011-2#1)
species that cause##3##3##(2005-7#1)(2008-10#1)(2011-12#1)
species that causes##2##3##(2008-10#2)
species that exhibit##3##3##(2008-8#1)(2008-9#1)(2009-5#1)
species that have been##3##4##(1994-3#1)(2008-10#1)(2013-7#1)
species that have##9##3##(1994-3#1)(2005-10#1)(2007-7#2)(2008-10#1)(2008-8#1)(2010-6#1)(2010-8#1)(2013-7#1)
species that inhabit##2##3##(2007-3#1)(2013-1#1)
species that is##3##3##(1995-10#1)(2008-10#1)(2008-7#1)
species that may##3##3##(2006-4#1)(2011-1#1)(2013-7#1)
species that occur##2##3##(2007-12#1)(2008-8#1)
species that probably##2##3##(1993-3#1)(2008-6#1)
species that produce##2##3##(1997-4#1)(2008-10#1)
species that provide##2##3##(2008-10#1)(2008-6#1)
species that vary in##2##4##(2008-12#1)(2008-8#1)
species that was##3##3##(1992-10#2)(1992-6#1)
species that were##4##3##(2008-10#1)(2008-4#1)(2010-1#1)(2012-2#1)
species that##130##2##(1991-6#1)(1992-10#3)(1992-12#1)(1992-6#1)(1992-7#1)(1993-3#2)(1994-3#2)(1995-1#2)(1995-10#1)(1996-11#1)(1996-5#2)(1997-4#1)(1997-8#1)(2005-10#1)(2005-7#1)(2005-9#1)(2006-12#1)(2006-4#2)(2006-5#1)(2006-8#1)(2007-12#1)(2007-3#5)(2007-5#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-10#18)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#7)(2008-6#4)(2008-7#4)(2008-8#18)(2008-9#4)(2009-10#1)(2009-4#1)(2009-5#2)(2009-8#3)(2010-1#1)(2010-2#2)(2010-3#2)(2010-6#3)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#5)
species the##11##2##(1993-2#1)(1994-12#1)(1995-11#1)(1995-12#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#1)
species through a##2##3##(1995-2#1)(1997-2#1)
species through##6##2##(1991-3#1)(1995-2#1)(1997-2#1)(2005-11#1)(2008-8#1)(2008-9#1)
species throughout##2##2##(1994-6#1)(2013-8#1)
species to avoid##2##3##(2008-5#1)(2009-8#1)
species to be located##2##4##(1992-8#1)(2008-1#1)
species to be##12##3##(1990-2#1)(1992-8#1)(1993-12#1)(1996-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-5#1)
species to neighbors##2##3##(2008-8#2)
species to possess##2##3##(1993-3#1)(2010-3#1)
species to regenerate##2##3##(2008-5#1)(2008-8#1)
species to the##7##3##(1992-6#1)(2005-11#1)(2008-10#1)(2008-8#2)(2013-1#1)(2013-8#1)
species to##85##2##(1990-2#2)(1990-3#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-12#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(2004-2#1)(2004-4#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-5#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-8#11)(2008-9#4)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#4)(2012-6#1)(2013-1#1)(2013-8#1)
species tree (i##2##3##(2010-6#2)
species tree inference from##2##4##(2010-6#1)(2012-3#1)
species tree inference##3##3##(2010-6#1)(2012-3#2)
species tree##10##2##(2010-6#6)(2012-3#4)
species tree)##3##2##(2010-6#2)(2012-3#1)
species trees and##2##3##(2010-6#1)(2012-3#1)
species trees that##2##3##(2010-6#2)
species trees##9##2##(2008-4#1)(2010-6#6)(2012-3#2)
species under the##2##3##(2008-10#1)(2009-8#1)
species under##7##2##(1992-1#1)(1993-9#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-4#1)(2009-8#1)
species undergoing##3##2##(1991-10#1)(2008-7#1)(2009-8#1)
species use##3##2##(2007-3#1)(2008-8#1)(2012-2#1)
species used for##3##3##(2010-11#2)(2010-5#1)
species used in##2##3##(2006-8#1)(2010-11#1)
species used##9##2##(2006-2#1)(2006-8#1)(2008-10#2)(2008-11#1)(2010-11#3)(2010-5#1)
species using HPLC##2##3##(1997-1#1)(2008-10#1)
species using a##4##3##(1990-8#1)(2004-11#1)(2008-10#1)(2009-5#1)
species using##23##2##(1990-8#1)(1994-11#1)(1997-1#1)(1997-4#1)(2004-11#1)(2007-1#1)(2007-6#1)(2008-10#9)(2008-5#1)(2009-5#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#2)
species usually##4##2##(1996-12#1)(2008-10#1)(2008-4#1)(2008-8#1)
species values##2##2##(1997-4#2)
species variability##3##2##(1992-9#1)(1993-3#1)(1994-5#1)
species variation##3##2##(1995-11#1)(2005-7#1)(2010-1#1)
species varied##2##2##(1991-1#1)(2008-10#1)
species varies##2##2##(1991-9#1)(1992-12#1)
species via##3##2##(1996-2#1)(2008-10#1)(2012-2#1)
species was achieved##2##3##(2008-10#1)(2012-2#1)
species was also##2##3##(1992-12#1)(1994-12#1)
species was being described##2##4##(2013-7#2)
species was being##3##3##(2013-7#3)
species was carried out using##2##5##(2008-5#1)(2010-3#1)
species was carried out##3##4##(2008-10#1)(2008-5#1)(2010-3#1)
species was demonstrated##2##3##(2008-10#2)
species was detected##3##3##(2008-10#1)(2010-11#1)(2013-1#1)
species was determined##2##3##(2008-10#2)
species was estimated##3##3##(1993-4#1)(2008-10#2)
species was first##4##3##(2008-5#1)(2011-1#1)(2011-2#2)
species was found in##3##4##(1992-6#1)(2006-10#1)(2007-5#1)
species was found to##3##4##(2007-12#1)(2008-12#1)(2011-2#1)
species was found##7##3##(1992-6#1)(2006-10#1)(2007-12#1)(2007-5#1)(2008-12#1)(2011-2#1)(2012-12#1)
species was not##5##3##(1990-8#1)(2004-4#1)(2008-10#1)(2012-12#1)(2012-2#1)
species was observed##4##3##(2008-10#2)(2008-5#1)(2008-6#1)
species was performed##3##3##(1996-12#1)(2008-10#2)
species was present in##2##4##(2008-10#1)(2008-5#1)
species was present##4##3##(1992-9#1)(2008-10#1)(2008-5#2)
species was reduced##2##3##(2007-6#1)(2008-10#1)
species was studied##3##3##(2008-10#2)(2008-12#1)
species was suggested##2##3##(1994-3#1)(2005-4#1)
species was the##7##3##(1991-3#1)(2006-8#1)(2007-5#1)(2008-10#2)(2008-5#1)(2011-1#1)
species was##131##2##(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-2#2)(1991-3#1)(1991-7#1)(1992-10#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#1)(1994-12#1)(1994-3#1)(1994-8#1)(1996-12#1)(1997-2#1)(2004-4#1)(2005-11#1)(2005-4#1)(2006-10#2)(2006-8#1)(2007-12#1)(2007-3#2)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#43)(2008-12#3)(2008-2#1)(2008-5#10)(2008-6#1)(2008-7#3)(2008-8#5)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#3)(2012-5#1)(2012-6#1)(2013-1#3)(2013-7#4)(2013-8#1)
species we##4##2##(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)
species were able to##2##4##(2006-5#1)(2006-8#1)
species were analyzed##2##3##(2008-10#1)(2008-11#1)
species were as follows##2##4##(2007-3#1)(2012-12#1)
species were assessed for##2##4##(1997-2#1)(2008-10#1)
species were carried out##2##4##(2007-8#1)(2013-8#1)
species were carried##3##3##(2007-8#1)(2008-5#1)(2013-8#1)
species were chosen##3##3##(2007-12#1)(2007-6#1)(2008-10#1)
species were classified##2##3##(2007-3#1)(2008-5#1)
species were collected from##3##4##(2008-10#1)(2011-1#2)
species were collected##5##3##(2008-10#1)(2008-5#1)(2008-6#1)(2011-1#2)
species were detected##5##3##(1993-11#1)(1994-9#1)(2005-12#1)(2008-10#1)(2012-2#1)
species were determined by##2##4##(2008-10#2)
species were determined in##2##4##(2008-10#2)
species were determined##7##3##(2007-3#1)(2008-10#6)
species were estimated##2##3##(1991-9#1)(2008-10#1)
species were evaluated##3##3##(2008-10#1)(2009-10#1)(2012-2#1)
species were examined##2##3##(2008-10#1)(2011-12#1)
species were found in the##2##5##(2007-5#1)(2012-12#1)
species were found in##5##4##(2007-5#1)(2008-5#1)(2009-10#1)(2012-12#1)(2012-2#1)
species were found to be##4##5##(2008-10#3)(2013-7#1)
species were found to##7##4##(2008-10#4)(2008-4#1)(2009-2#1)(2013-7#1)
species were found##20##3##(1997-1#1)(2007-5#1)(2008-10#5)(2008-4#1)(2008-5#4)(2009-10#1)(2009-2#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#2)
species were grown in##2##4##(2006-8#1)(2008-5#1)
species were identified by##3##4##(2006-10#1)(2008-12#1)(2012-12#1)
species were identified from##2##4##(2007-3#1)(2008-5#1)
species were identified##15##3##(1996-2#1)(2006-10#1)(2007-3#2)(2008-10#2)(2008-12#1)(2008-5#3)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)
species were investigated by##2##4##(1990-8#1)(1994-3#1)
species were investigated##3##3##(1990-8#1)(1994-3#1)(2008-10#1)
species were isolated from##3##4##(2008-10#1)(2008-5#2)
species were isolated##4##3##(2008-10#2)(2008-5#2)
species were located##2##3##(1993-9#1)(2008-10#1)
species were measured##2##3##(2008-10#2)
species were more##5##3##(2008-10#1)(2008-11#1)(2008-8#1)(2011-1#1)(2013-7#1)
species were not##6##3##(1992-6#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-12#1)
species were observed##6##3##(1991-7#1)(2007-7#1)(2008-10#2)(2008-12#1)(2012-6#1)
species were obtained##3##3##(2007-3#1)(2008-5#2)
species were placed in##2##4##(2008-10#2)
species were placed##3##3##(2008-10#2)(2008-8#1)
species were present in##3##4##(1994-2#1)(2008-5#1)(2012-2#1)
species were present##4##3##(1994-2#1)(2006-2#1)(2008-5#1)(2012-2#1)
species were recorded##9##3##(2007-12#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-5#3)(2011-1#1)(2013-1#1)
species were recovered from##2##4##(2008-10#1)(2011-2#1)
species were recovered##3##3##(2007-3#1)(2008-10#1)(2011-2#1)
species were reduced##2##3##(2008-10#1)(2012-6#1)
species were relatively##2##3##(2007-8#1)(2008-6#1)
species were separated from##2##4##(2008-10#2)
species were separated##6##3##(1990-9#1)(1992-2#1)(2008-10#4)
species were shown to##2##4##(2008-10#2)
species were studied and##2##4##(2008-10#1)(2008-5#1)
species were studied by##2##4##(2008-10#1)(2008-12#1)
species were studied##6##3##(2007-10#1)(2008-10#3)(2008-12#1)(2008-5#1)
species were susceptible to##2##4##(2011-1#1)(2012-2#1)
species were synthesized from##2##4##(1997-8#1)(2008-11#1)
species were tested and in##2##5##(2008-8#2)
species were tested and##3##4##(2007-5#1)(2008-8#2)
species were tested for##2##4##(2008-10#2)
species were tested##5##3##(2007-5#1)(2008-10#2)(2008-8#2)
species were the##3##3##(2007-3#2)(2010-8#1)
species were used##2##3##(2008-10#1)(2008-8#1)
species were very##2##3##(2008-10#1)(2012-8#1)
species were##257##2##(1990-8#1)(1990-9#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#2)(1994-9#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-11#1)(2004-4#1)(2005-12#1)(2006-10#1)(2006-2#1)(2006-5#2)(2006-8#6)(2007-10#1)(2007-12#3)(2007-2#1)(2007-3#17)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#4)(2008-10#68)(2008-11#3)(2008-12#8)(2008-4#1)(2008-5#32)(2008-6#3)(2008-8#7)(2008-9#2)(2009-10#2)(2009-2#1)(2009-5#2)(2009-7#1)(2009-8#3)(2010-12#1)(2010-8#1)(2011-1#7)(2011-12#2)(2011-2#9)(2011-3#1)(2012-12#3)(2012-2#11)(2012-6#2)(2012-8#1)(2012-9#1)(2013-1#3)(2013-7#11)(2013-8#1)
species when##10##2##(1992-1#1)(2004-4#1)(2006-8#1)(2008-10#3)(2008-5#1)(2008-8#1)(2011-1#1)(2011-12#1)
species where##2##2##(2008-10#1)(2008-8#1)
species which are##4##3##(1992-9#1)(2007-11#1)(2008-5#1)(2011-2#1)
species which can be##2##4##(2008-10#1)(2009-5#1)
species which is##2##3##(1996-2#1)(2011-2#1)
species which migrate at a molecular weight consistent with that reported for##2##12##(1994-2#2)
species which were##2##3##(2008-10#2)
species which##24##2##(1990-7#1)(1991-2#1)(1992-3#1)(1992-9#1)(1993-11#1)(1994-2#2)(1994-3#1)(1995-3#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-5#1)(2009-5#1)(2010-2#1)(2010-4#1)(2011-12#2)(2011-2#2)(2013-7#1)
species whose##2##2##(2008-10#1)(2008-8#1)
species widely distributed##3##3##(1994-6#1)(2008-10#1)(2013-7#1)
species widely##4##2##(1994-6#1)(2008-10#1)(2010-2#1)(2013-7#1)
species will##7##2##(1996-10#1)(2006-12#1)(2007-8#1)(2008-9#1)(2011-2#1)(2013-1#2)
species with a high##2##4##(2007-3#1)(2008-7#1)
species with a large##2##4##(2008-9#1)(2013-7#1)
species with a##17##3##(1991-11#1)(1991-9#1)(1993-9#1)(1994-8#1)(1995-5#1)(1997-7#1)(2006-8#2)(2007-3#2)(2008-10#1)(2008-7#1)(2008-9#1)(2009-12#1)(2013-7#3)
species with alterations in##2##4##(1993-12#2)
species with an asexual morph##2##5##(2013-7#2)
species with an##4##3##(2007-5#1)(2008-10#1)(2013-7#2)
species with contrasting##2##3##(2008-5#1)(2008-9#1)
species with different##3##3##(1996-9#1)(2008-8#2)
species with high##3##3##(2008-8#1)(2010-5#1)(2011-1#1)
species with longer##2##3##(2008-9#1)(2009-5#1)
species with low##2##3##(2008-9#2)
species with no##2##3##(2008-10#1)(2010-5#1)
species with short##2##3##(2008-5#1)(2009-12#1)
species with similar##2##3##(2008-10#1)(2013-1#1)
species with the highest##2##4##(2008-10#2)
species with the##8##3##(1995-4#1)(2007-3#1)(2008-10#4)(2008-5#1)(2013-7#1)
species with##117##2##(1990-3#1)(1990-5#1)(1991-11#1)(1991-9#2)(1992-6#1)(1993-12#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-4#1)(1995-5#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#1)(2005-8#1)(2006-8#2)(2007-1#1)(2007-12#1)(2007-3#5)(2007-5#1)(2007-8#1)(2008-10#18)(2008-11#2)(2008-3#1)(2008-5#8)(2008-7#2)(2008-8#8)(2008-9#7)(2009-12#2)(2009-5#4)(2010-2#2)(2010-3#3)(2010-5#2)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#6)(2013-7#7)(2013-8#1)
species within a##4##3##(2008-8#2)(2009-5#1)(2010-2#1)
species within each##2##3##(2008-8#1)(2010-7#1)
species within the families##2##4##(2007-3#1)(2008-10#1)
species within the family##3##4##(2005-12#1)(2008-10#2)
species within the##18##3##(1997-6#1)(2005-12#1)(2006-8#1)(2007-3#2)(2008-10#6)(2008-5#2)(2010-2#1)(2010-3#1)(2011-2#2)(2012-1#1)
species within this##3##3##(2006-5#1)(2010-10#1)(2013-7#1)
species within##29##2##(1997-6#1)(2005-12#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-3#2)(2008-10#6)(2008-5#2)(2008-8#3)(2009-5#1)(2010-10#2)(2010-2#2)(2010-3#1)(2010-7#1)(2011-2#2)(2012-1#1)(2013-7#1)
species without defined importance to eucalyptus##2##6##(2008-5#2)
species without##5##2##(2008-10#3)(2008-5#2)
species would##2##2##(2006-8#1)(2011-12#1)
species##7347##1##(1990-10#11)(1990-11#14)(1990-12#12)(1990-2#18)(1990-3#12)(1990-4#9)(1990-5#16)(1990-6#7)(1990-7#13)(1990-8#19)(1990-9#13)(1991-1#7)(1991-10#9)(1991-11#10)(1991-12#16)(1991-2#10)(1991-3#10)(1991-4#11)(1991-5#8)(1991-6#8)(1991-7#20)(1991-8#18)(1991-9#30)(1992-1#22)(1992-10#11)(1992-11#10)(1992-12#25)(1992-2#8)(1992-3#8)(1992-4#9)(1992-5#9)(1992-6#26)(1992-7#13)(1992-8#14)(1992-9#12)(1993-1#1)(1993-11#20)(1993-12#28)(1993-2#14)(1993-3#11)(1993-4#5)(1993-5#2)(1993-6#10)(1993-7#1)(1993-8#16)(1993-9#13)(1994-10#5)(1994-11#22)(1994-12#25)(1994-2#11)(1994-3#39)(1994-5#8)(1994-6#21)(1994-7#1)(1994-8#21)(1994-9#19)(1995-1#17)(1995-10#5)(1995-11#24)(1995-12#15)(1995-2#25)(1995-3#10)(1995-4#2)(1995-5#14)(1995-6#12)(1995-7#3)(1995-8#27)(1996-1#8)(1996-10#7)(1996-11#13)(1996-12#20)(1996-2#25)(1996-3#3)(1996-4#9)(1996-5#18)(1996-6#16)(1996-7#6)(1996-8#12)(1996-9#8)(1997-1#13)(1997-2#43)(1997-3#14)(1997-4#40)(1997-5#7)(1997-6#15)(1997-7#14)(1997-8#9)(1997-9#2)(2004-11#26)(2004-2#11)(2004-4#35)(2005-10#12)(2005-11#28)(2005-12#4)(2005-4#3)(2005-5#1)(2005-6#1)(2005-7#14)(2005-8#15)(2005-9#8)(2006-1#1)(2006-10#49)(2006-11#4)(2006-12#45)(2006-2#12)(2006-3#3)(2006-4#12)(2006-5#17)(2006-6#4)(2006-7#9)(2006-8#86)(2006-9#4)(2007-1#48)(2007-10#12)(2007-11#26)(2007-12#138)(2007-2#26)(2007-3#200)(2007-4#5)(2007-5#100)(2007-6#28)(2007-7#35)(2007-8#66)(2007-9#25)(2008-1#46)(2008-10#1448)(2008-11#76)(2008-12#88)(2008-2#40)(2008-3#80)(2008-4#93)(2008-5#525)(2008-6#52)(2008-7#126)(2008-8#404)(2008-9#215)(2009-10#17)(2009-11#4)(2009-12#12)(2009-2#33)(2009-3#18)(2009-4#26)(2009-5#57)(2009-6#12)(2009-7#5)(2009-8#74)(2009-9#12)(2010-1#6)(2010-10#30)(2010-11#19)(2010-12#40)(2010-2#44)(2010-3#64)(2010-4#38)(2010-5#22)(2010-6#40)(2010-7#14)(2010-8#73)(2010-9#7)(2011-1#64)(2011-10#2)(2011-12#71)(2011-2#239)(2011-3#6)(2012-1#24)(2012-11#17)(2012-12#61)(2012-2#142)(2012-3#88)(2012-5#20)(2012-6#17)(2012-7#1)(2012-8#5)(2012-9#10)(2013-1#131)(2013-7#181)(2013-8#78)
species' range##4##2##(2008-10#1)(2008-9#1)(2009-2#1)(2013-1#1)
species' ranges##2##2##(2008-8#2)
species' responses to disturbance##4##4##(2008-8#4)
species'##28##1##(1992-8#1)(1996-8#1)(2006-12#2)(2007-4#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#12)(2008-9#4)(2009-2#1)(2009-8#1)(2010-8#1)(2013-1#1)
species) and##5##2##(2004-11#1)(2007-11#1)(2007-5#1)(2012-2#1)(2013-7#1)
species) are##3##2##(2008-5#1)(2010-3#1)(2010-8#1)
species) for##2##2##(2008-7#1)(2009-5#1)
species) were##4##2##(2007-2#1)(2008-10#1)(2011-2#1)(2012-2#1)
species)##52##1##(1991-4#1)(1993-4#1)(1994-5#1)(1996-8#1)(1997-2#1)(2004-11#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-5#5)(2008-10#6)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2009-3#1)(2009-5#1)(2010-3#1)(2010-6#2)(2010-8#1)(2011-12#1)(2011-2#3)(2012-2#3)(2012-5#1)(2012-9#2)(2013-7#2)(2013-8#1)
species- and##2##2##(1990-8#1)(2012-5#1)
species-area##5##1##(2008-8#4)(2008-9#1)
species-dependent##4##1##(1991-2#1)(1993-3#2)(2008-1#1)
species-group##3##1##(2008-10#2)(2013-1#1)
species-groups##4##1##(2008-10#4)
species-level##3##1##(2008-7#2)(2010-4#1)
species-rich##8##1##(1994-3#1)(2008-11#1)(2008-8#1)(2010-6#3)(2011-12#1)(2013-1#1)
species-specific characteristic##2##2##(2008-10#1)(2009-5#1)
species-specific database##2##2##(2008-4#2)
species-specific differences in##3##3##(2010-4#1)(2011-10#1)(2011-12#1)
species-specific differences##6##2##(1991-1#1)(2007-12#1)(2008-10#1)(2010-4#1)(2011-10#1)(2011-12#1)
species-specific markers##2##2##(2010-4#2)
species-specific polymerase chain reaction (PCR)##2##5##(2008-10#2)
species-specific primer pair##3##3##(2008-10#3)
species-specific primer##5##2##(1995-12#1)(2008-10#3)(2011-2#1)
species-specific primers and TaqMan probes##2##5##(2008-10#2)
species-specific primers and##3##3##(2008-10#3)
species-specific primers for##3##3##(2005-9#1)(2008-10#1)(2008-12#1)
species-specific primers##15##2##(2005-9#1)(2008-10#12)(2008-12#1)(2010-4#1)
species-specific probes##2##2##(1994-12#1)(2012-2#1)
species-specific##95##1##(1991-1#1)(1991-3#1)(1992-1#1)(1992-11#1)(1993-2#1)(1994-12#1)(1994-5#2)(1994-6#1)(1995-12#3)(1995-5#1)(1996-12#1)(1997-5#3)(2005-9#1)(2007-1#1)(2007-12#4)(2008-10#33)(2008-12#2)(2008-3#1)(2008-4#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#4)(2009-8#1)(2010-2#2)(2010-4#5)(2011-10#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#2)(2012-8#1)(2013-7#1)(2013-8#1)
species-specificity##3##1##(1996-4#1)(1997-3#1)(2008-6#1)
species-tree##4##1##(2010-6#4)
species-typical##3##1##(1991-1#1)(2008-4#1)(2009-12#1)
species?##4##1##(1995-6#1)(1997-5#1)(2006-10#1)(2008-11#1)
specifiable factors##2##2##(2006-12#2)
specifiable##3##1##(2006-12#2)(2008-1#1)
specific &quot##3##2##(1994-2#1)(1996-8#1)(2012-3#1)
specific 1H##3##2##(2009-7#3)
specific AFC##2##2##(1992-8#1)(2008-10#1)
specific AT receptors##2##3##(1993-8#2)
specific ATP-binding with##2##3##(1996-9#2)
specific B cell##2##3##(2008-4#1)(2011-2#1)
specific B##3##2##(1992-7#1)(2008-4#1)(2011-2#1)
specific BCR-ABL##3##2##(1996-2#3)
specific CAT activity##2##3##(2008-7#2)
specific DNA binding##8##3##(1990-11#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-8#2)(1996-10#1)(2005-8#1)
specific DNA fragment##2##3##(2008-10#1)(2008-8#1)
specific DNA probe##2##3##(1991-2#1)(1993-9#1)
specific DNA probes##3##3##(2008-10#1)(2008-5#2)
specific DNA recognition##3##3##(1991-4#2)(1993-11#1)
specific DNA sequence##3##3##(1995-8#1)(1997-2#1)(2008-8#1)
specific DNA sequences in a##2##5##(2006-12#1)(2007-2#1)
specific DNA sequences in##3##4##(2006-12#1)(2007-2#1)(2012-3#1)
specific DNA sequences##9##3##(1991-11#1)(1991-4#1)(1993-9#1)(1994-8#1)(1997-1#1)(2006-10#1)(2006-12#1)(2007-2#1)(2012-3#1)
specific DNA site##2##3##(1993-3#1)(1997-5#1)
specific DNA target sequences##2##4##(1997-6#1)(2009-2#1)
specific DNA##42##2##(1990-11#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-4#3)(1993-11#1)(1993-3#1)(1993-9#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-8#3)(1996-10#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#3)(2008-8#2)(2009-2#1)(2012-3#1)(2013-1#1)
specific DNA-binding proteins##2##3##(1991-4#2)
specific DNA-binding##3##2##(1990-5#1)(1991-4#2)
specific ERK1/2 pathway##2##3##(2012-3#2)
specific G-protein-coupled##2##2##(1996-5#1)(2005-7#1)
specific HLA##2##2##(1990-11#1)(2013-1#1)
specific HPLC method##2##3##(1997-8#1)(2006-8#1)
specific IgA##5##2##(1992-8#1)(1993-5#1)(2008-11#3)
specific IgE antibody##2##3##(1994-6#1)(2008-10#1)
specific IgE in##3##3##(1990-12#2)(2008-10#1)
specific IgE##14##2##(1990-12#3)(1990-3#1)(1992-8#1)(1993-5#2)(1994-6#1)(2006-8#2)(2008-10#3)(2013-1#1)
specific IgG antibody to##2##4##(1992-8#2)
specific IgG antibody##3##3##(1992-8#3)
specific IgG##10##2##(1992-8#5)(1994-5#1)(1995-11#1)(2008-4#1)(2012-12#1)(2013-1#1)
specific IgG1##2##2##(1995-11#1)(2006-10#1)
specific IgM##4##2##(2007-2#1)(2007-8#1)(2008-10#1)(2008-5#1)
specific Low-density lipoprotein##2##3##(1990-2#2)
specific MHC##2##2##(2008-4#1)(2010-8#1)
specific MR##2##2##(2007-11#1)(2013-1#1)
specific MRI##3##2##(2008-3#1)(2008-6#1)(2012-2#1)
specific N-glycosylation##2##2##(2010-12#1)(2013-1#1)
specific NADPH##2##2##(1990-2#1)(1994-8#1)
specific P450##3##2##(1990-10#1)(1994-6#1)(1996-11#1)
specific PAF##2##2##(1991-12#1)(1991-5#1)
specific PCR amplification product##2##4##(2006-8#2)
specific PCR assays##2##3##(2008-10#1)(2010-10#1)
specific PCR product was##2##4##(1992-3#1)(2008-5#1)
specific PCR##17##2##(1992-3#1)(1993-7#1)(1996-8#1)(1997-3#1)(2005-11#1)(2006-8#3)(2007-10#1)(2007-11#2)(2008-10#4)(2008-5#1)(2010-10#1)
specific PDE##2##2##(1996-6#1)(2008-3#1)
specific PKC##3##2##(1993-3#1)(1995-7#1)(1996-9#1)
specific RIA##2##2##(1992-7#1)(1995-10#1)
specific RNA##2##2##(2008-10#1)(2013-1#1)
specific STAT##2##2##(1996-5#2)
specific T cell##4##3##(1990-12#1)(2005-12#1)(2008-1#1)(2008-4#1)
specific T##6##2##(1990-12#1)(2005-12#1)(2007-11#1)(2008-1#1)(2008-4#2)
specific [3H]5-HT##2##2##(1994-2#2)
specific absorbance##3##2##(1990-3#2)(2007-12#1)
specific absorption of##2##3##(2008-2#1)(2008-5#1)
specific absorption##5##2##(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)
specific acceptor##2##2##(1992-2#1)(1992-3#1)
specific accumulation##3##2##(1994-8#1)(1995-8#1)(2007-1#1)
specific action of##2##3##(1993-5#1)(2007-7#1)
specific action##6##2##(1992-8#1)(1993-5#1)(2007-7#1)(2008-10#1)(2008-4#1)(2011-2#1)
specific actions##4##2##(1994-1#1)(1995-2#1)(1996-11#1)(2007-1#1)
specific activation##2##2##(1994-3#2)
specific active##2##2##(1991-7#1)(2008-5#1)
specific activities found in##2##4##(1991-1#1)(1992-6#1)
specific activities in##3##3##(1992-3#1)(1993-9#1)(1994-3#1)
specific activities of key enzymes##2##5##(2005-11#2)
specific activities of##11##3##(1990-2#1)(1991-12#1)(1991-2#1)(1992-1#1)(1993-9#1)(1994-11#1)(1997-6#1)(2005-11#2)(2005-8#2)
specific activities that##2##3##(1993-3#1)(1994-2#1)
specific activities were##3##3##(1991-1#1)(1991-12#1)(2008-5#1)
specific activities##41##2##(1990-2#1)(1991-1#3)(1991-12#2)(1991-2#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-2#2)(1994-3#3)(1995-11#1)(1995-8#2)(1996-10#1)(1996-8#3)(1997-2#1)(1997-6#1)(2005-11#2)(2005-8#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#2)(2011-2#1)
specific activity and##10##3##(1990-4#1)(1991-5#1)(1993-8#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-9#1)(2008-5#2)
specific activity in the##3##4##(1995-12#1)(1997-4#1)(2008-7#1)
specific activity in##6##3##(1991-9#1)(1995-12#1)(1995-3#1)(1997-4#2)(2008-7#1)
specific activity of brain##2##4##(1994-8#1)(2008-7#1)
specific activity of the purified enzyme was##2##7##(1990-2#1)(1997-6#1)
specific activity of the##14##4##(1990-2#1)(1990-4#1)(1991-2#1)(1991-8#1)(1993-11#1)(1994-6#1)(1994-8#1)(1996-8#1)(1997-6#1)(2006-10#1)(2008-10#3)(2008-4#1)
specific activity of##61##3##(1990-12#1)(1990-2#1)(1990-4#2)(1990-7#2)(1990-8#2)(1991-12#3)(1991-2#1)(1991-7#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-9#1)(1993-11#4)(1993-3#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-5#2)(1994-6#2)(1994-8#3)(1995-1#2)(1995-12#1)(1995-3#2)(1995-6#1)(1996-4#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-6#2)(2004-11#1)(2006-10#1)(2008-10#3)(2008-4#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-4#1)
specific activity was##5##3##(1994-2#1)(1995-4#1)(1997-4#1)(1997-6#1)(2008-7#1)
specific activity when compared##2##4##(1994-9#1)(1995-5#1)
specific activity##123##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#2)(1990-4#3)(1990-7#2)(1990-8#2)(1991-12#3)(1991-2#2)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#4)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#3)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#4)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#2)(1995-1#3)(1995-12#3)(1995-2#1)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-4#2)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#6)(1997-6#3)(1997-7#1)(2004-11#3)(2006-10#1)(2006-3#1)(2006-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-1#1)
specific acupuncture##2##2##(2013-1#1)(2013-7#1)
specific acute##2##2##(2008-5#1)(2008-7#1)
specific adenine##2##2##(1994-12#1)(1995-8#1)
specific adhesion molecules##2##3##(1992-4#1)(1995-2#1)
specific adhesion##8##2##(1990-2#1)(1991-3#1)(1992-4#1)(1992-9#1)(1995-2#1)(1996-10#1)(1996-12#1)(2005-11#1)
specific admission##2##2##(1995-3#1)(1997-3#1)
specific adsorption of##7##3##(2005-11#3)(2006-12#1)(2008-10#2)(2009-3#1)
specific adsorption##10##2##(2005-11#5)(2006-12#1)(2008-10#3)(2009-3#1)
specific advantages##2##2##(2009-10#1)(2012-2#1)
specific affinity##6##2##(1990-11#1)(1991-11#1)(1991-3#1)(2006-12#1)(2008-9#1)(2010-1#1)
specific agent##2##2##(1997-7#1)(2007-11#1)
specific agonist##3##2##(1996-2#1)(1997-7#1)(2006-12#1)
specific agonists##3##2##(1996-5#1)(2008-4#1)(2011-2#1)
specific aim of##3##3##(1995-1#1)(2006-5#1)(2008-7#1)
specific aim##5##2##(1995-1#1)(1995-6#2)(2006-5#1)(2008-7#1)
specific aims##2##2##(2010-10#1)(2010-9#1)
specific alpha##2##2##(1993-5#1)(1995-12#1)
specific alteration of##2##3##(1990-9#1)(2013-1#1)
specific alteration##3##2##(1990-9#1)(2007-7#1)(2013-1#1)
specific alterations in##4##3##(1995-5#1)(2008-1#1)(2010-1#1)(2013-1#1)
specific alterations##7##2##(1995-5#1)(1995-8#1)(2007-12#1)(2008-1#1)(2009-2#1)(2010-1#1)(2013-1#1)
specific amino acid acceptor activities##2##5##(1991-10#2)
specific amino acid acceptor##3##4##(1991-10#3)
specific amino acid residues of##2##5##(1993-6#1)(1994-9#1)
specific amino acid residues##5##4##(1990-7#1)(1992-7#1)(1993-6#1)(1994-9#1)(2010-5#1)
specific amino acid sequence##2##4##(1991-9#1)(1997-4#1)
specific amino acid substitutions##2##4##(2008-8#1)(2009-8#1)
specific amino acid##14##3##(1990-7#1)(1991-10#4)(1991-9#1)(1992-7#1)(1993-6#2)(1994-9#1)(1997-4#1)(2008-8#1)(2009-8#1)(2010-5#1)
specific amino acids##4##3##(1993-6#1)(1994-8#1)(1995-3#1)(1995-5#1)
specific amino##18##2##(1990-7#1)(1991-10#4)(1991-9#1)(1992-7#1)(1993-6#3)(1994-8#1)(1994-9#1)(1995-3#1)(1995-5#1)(1997-4#1)(2008-8#1)(2009-8#1)(2010-5#1)
specific amplification of the##2##4##(1993-11#1)(2008-10#1)
specific amplification of##5##3##(1990-3#1)(1993-11#1)(1993-5#1)(2008-10#2)
specific amplification##7##2##(1990-3#1)(1993-11#1)(1993-5#1)(1997-7#1)(2008-10#3)
specific amplified ribosomal-DNA restriction analysis##3##5##(2006-5#3)
specific amplified##4##2##(2006-5#4)
specific analysis##2##2##(2008-9#2)
specific anatomic##2##2##(2010-12#1)(2010-8#1)
specific anatomical##2##2##(2007-11#1)(2007-7#1)
specific and diverse##2##3##(2007-11#1)(2008-10#1)
specific and effective##2##3##(1991-5#1)(1997-2#1)
specific and efficient##2##3##(2008-4#1)(2010-12#1)
specific and general symptoms##2##4##(2008-4#2)
specific and general##4##3##(2008-4#2)(2008-7#1)(2010-7#1)
specific and high##2##3##(1992-5#1)(1995-12#1)
specific and irreversible##3##3##(1990-2#1)(2008-11#1)(2008-4#1)
specific and non-specific##9##3##(1991-7#1)(1992-1#1)(1994-6#1)(1994-9#1)(1997-5#1)(2005-11#1)(2005-8#1)(2007-11#1)(2008-10#1)
specific and not##3##3##(1990-4#1)(1995-11#1)(2008-5#1)
specific and reliable##2##3##(2006-8#1)(2008-8#1)
specific and reproducible##2##3##(1991-9#1)(1993-9#1)
specific and selective##2##3##(1996-12#1)(2008-10#1)
specific and sensitive##17##3##(1990-11#1)(1990-7#1)(1991-11#1)(1993-11#1)(1994-12#1)(1997-3#1)(2005-11#1)(2007-11#1)(2007-2#1)(2008-10#4)(2008-4#1)(2010-3#1)(2010-4#1)(2013-8#1)
specific and showed##2##3##(1994-8#1)(2008-10#1)
specific and shows##2##3##(1996-12#1)(1997-2#1)
specific and stable##2##3##(2008-4#1)(2011-3#1)
specific and strong##2##3##(2008-8#1)(2009-2#1)
specific and unique##3##3##(1990-12#1)(1995-1#1)(2007-5#1)
specific and##135##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-4#2)(1991-5#3)(1991-7#1)(1991-9#1)(1992-1#1)(1992-5#2)(1992-6#1)(1993-11#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-6#2)(1994-8#2)(1994-9#3)(1995-1#3)(1995-11#1)(1995-12#1)(1995-8#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-5#2)(1996-7#2)(1996-9#1)(1997-2#2)(1997-3#1)(1997-5#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-8#1)(2007-11#3)(2007-12#4)(2007-2#3)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-4#7)(2008-5#2)(2008-7#2)(2008-8#3)(2009-2#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
specific angiotensin II (Ang##2##4##(2007-1#2)
specific anion##2##2##(1994-8#1)(2005-11#1)
specific antagonist for##2##3##(1992-8#1)(1994-9#1)
specific antagonist##10##2##(1991-12#2)(1992-8#1)(1993-11#1)(1994-8#1)(1994-9#1)(1995-3#1)(2008-4#1)(2008-7#2)
specific antagonists##4##2##(1992-5#1)(1993-10#1)(1993-6#1)(2008-10#1)
specific anti-Eimeria##2##2##(1992-8#2)
specific antiarrhythmic##2##2##(1991-9#1)(2008-10#1)
specific antibiotic therapy##3##3##(2007-8#2)(2012-3#1)
specific antibodies against##9##3##(1994-2#1)(1995-11#1)(1997-7#1)(1997-9#1)(2005-11#1)(2005-8#1)(2008-4#1)(2008-7#1)(2011-1#1)
specific antibodies and##2##3##(1997-8#1)(2008-1#1)
specific antibodies by##2##3##(2007-12#1)(2008-10#1)
specific antibodies for##2##3##(1994-12#1)(2010-12#1)
specific antibodies of##2##3##(1990-12#1)(2013-7#1)
specific antibodies raised against##3##4##(1990-7#1)(1992-3#1)(2008-6#1)
specific antibodies to##5##3##(1991-9#1)(1992-8#1)(1994-12#1)(1996-5#1)(2007-7#1)
specific antibodies were##2##3##(1990-8#1)(1994-5#1)
specific antibodies##50##2##(1990-1#1)(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-7#1)(1992-8#2)(1993-8#1)(1994-12#4)(1994-2#1)(1994-5#1)(1995-11#1)(1996-11#1)(1996-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2005-11#1)(2005-8#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#3)(2008-6#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-12#2)(2012-7#1)(2013-7#1)
specific antibody against##4##3##(1992-7#1)(1992-8#1)(1994-9#1)(2012-2#1)
specific antibody binding##2##3##(1991-10#1)(1995-6#1)
specific antibody production##3##3##(2008-11#1)(2008-5#1)(2012-2#1)
specific antibody raised against##2##4##(1992-11#1)(1992-12#1)
specific antibody response##2##3##(1992-7#1)(2007-12#1)
specific antibody responses##2##3##(1990-4#1)(2008-10#1)
specific antibody to this##2##4##(1992-8#1)(2008-9#1)
specific antibody to##5##3##(1990-9#1)(1991-1#1)(1992-8#1)(1995-12#1)(2008-9#1)
specific antibody was##3##3##(1996-12#1)(1996-6#1)(2008-10#1)
specific antibody##50##2##(1990-12#1)(1990-4#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#2)(1992-11#1)(1992-12#1)(1992-7#2)(1992-8#4)(1993-8#1)(1994-9#1)(1995-12#1)(1995-6#1)(1995-7#1)(1996-12#2)(1996-6#2)(1997-1#1)(1997-5#1)(2004-9#1)(2007-12#1)(2008-10#3)(2008-11#5)(2008-2#1)(2008-4#4)(2008-5#1)(2008-8#1)(2008-9#2)(2010-9#1)(2012-2#2)
specific anticancer##2##2##(2007-5#1)(2008-11#1)
specific antigen (PSA)##7##3##(1994-12#1)(2007-11#1)(2007-3#1)(2008-12#1)(2009-2#1)(2010-5#1)(2011-2#1)
specific antigen and##2##3##(2006-8#1)(2008-9#1)
specific antigen##26##2##(1992-6#1)(1992-7#1)(1994-12#2)(1994-8#1)(1995-1#1)(1995-12#1)(1995-4#1)(2006-8#1)(2007-11#1)(2007-3#2)(2008-1#1)(2008-12#1)(2008-4#3)(2008-6#1)(2008-9#1)(2009-2#2)(2010-5#1)(2011-2#1)(2012-1#1)(2013-8#2)
specific antigenic##2##2##(2007-8#1)(2008-9#1)
specific antigens in##2##3##(2006-10#1)(2008-4#1)
specific antigens##13##2##(1990-4#1)(1991-5#1)(1996-6#1)(2006-10#2)(2006-6#1)(2007-11#1)(2008-2#1)(2008-4#4)(2012-2#1)
specific antioxidant defense systems##2##4##(2010-4#2)
specific antisense##2##2##(1995-8#1)(2011-2#1)
specific antisera##7##2##(1990-6#1)(1996-3#2)(1997-4#1)(2007-8#1)(2008-10#1)(2008-5#1)
specific antiserum##6##2##(1990-7#1)(1991-9#1)(1994-6#1)(1995-12#1)(1995-7#1)(2006-10#1)
specific antitumor agents##2##3##(1992-3#1)(1996-8#1)
specific antitumor immunity##2##3##(1996-10#2)
specific antitumor##4##2##(1992-3#1)(1996-10#2)(1996-8#1)
specific apoptosis##2##2##(2008-9#1)(2009-8#1)
specific application##6##2##(1997-2#1)(2007-11#1)(2008-10#1)(2008-4#2)(2010-8#1)
specific applications##9##2##(2005-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-11#1)
specific approach for##2##3##(2008-11#1)(2012-2#1)
specific approach to##4##3##(2005-8#1)(2008-1#1)(2008-10#1)(2008-9#1)
specific approach##8##2##(2005-8#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-3#1)(2012-2#1)
specific area##2##2##(1994-2#1)(2008-10#1)
specific areas of the body##2##5##(2007-11#1)(2012-12#1)
specific areas of the##3##4##(2007-11#1)(2008-11#1)(2012-12#1)
specific areas of##10##3##(1990-7#1)(1991-12#1)(1996-12#1)(1997-5#1)(2006-10#1)(2007-11#1)(2008-11#1)(2009-10#1)(2011-2#1)(2012-12#1)
specific areas##12##2##(1990-7#1)(1991-12#1)(1996-12#1)(1997-5#1)(2005-10#1)(2006-10#2)(2007-11#1)(2008-11#1)(2009-10#1)(2011-2#1)(2012-12#1)
specific aromatic##2##2##(1994-8#1)(2008-7#1)
specific arrangement##2##2##(1990-11#1)(2008-3#1)
specific as##3##2##(1992-10#1)(2008-4#1)(2008-5#1)
specific aspect of##2##3##(1995-11#1)(2008-7#1)
specific aspect##4##2##(1995-11#1)(2006-6#2)(2008-7#1)
specific aspects of face processing##2##5##(2009-4#2)
specific aspects of the##5##4##(1992-2#2)(1997-8#1)(2008-8#1)(2010-4#1)
specific aspects of##20##3##(1991-3#1)(1992-2#2)(1995-5#1)(1996-6#1)(1996-7#1)(1997-5#1)(1997-8#1)(2007-8#1)(2008-11#1)(2008-8#1)(2009-10#1)(2009-4#2)(2009-7#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-9#1)
specific aspects##22##2##(1991-3#1)(1992-2#2)(1995-5#1)(1996-6#1)(1996-7#1)(1997-5#1)(1997-8#1)(2007-8#1)(2008-11#1)(2008-8#2)(2009-10#1)(2009-3#1)(2009-4#2)(2009-7#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-9#1)
specific assay for##4##3##(1990-2#1)(1990-4#1)(1997-3#1)(1997-8#1)
specific assay##8##2##(1990-2#1)(1990-4#1)(1990-9#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-8#1)(2008-2#1)
specific assays##4##2##(2007-11#1)(2008-4#1)(2008-9#1)(2010-3#1)
specific association of##3##3##(1991-12#1)(1994-8#1)(2006-12#1)
specific association with##2##3##(1994-8#1)(1995-12#1)
specific association##6##2##(1991-12#1)(1993-8#1)(1994-8#2)(1995-12#1)(2006-12#1)
specific associations between##2##3##(2010-7#2)
specific associations##4##2##(1994-8#1)(2010-7#2)(2011-1#1)
specific attachment##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
specific attention to##2##3##(1994-3#1)(2008-2#1)
specific attention##3##2##(1994-3#1)(2008-2#1)(2008-8#1)
specific bacteria and##2##3##(2008-5#1)(2008-9#1)
specific bacteria##3##2##(2004-4#1)(2008-5#1)(2008-9#1)
specific bacterial##5##2##(2006-10#1)(2006-2#2)(2008-10#1)(2011-1#1)
specific band##4##2##(2008-4#1)(2008-8#1)(2010-3#1)(2013-1#1)
specific bands##2##2##(1994-8#1)(1997-6#1)
specific base pairs##2##3##(1993-3#1)(1996-7#1)
specific behavior##5##2##(1990-6#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-12#1)
specific behavioral##3##2##(1993-12#1)(2008-4#2)
specific behaviors that##4##3##(2006-4#1)(2007-12#1)(2010-11#1)(2011-2#1)
specific behaviors##10##2##(1997-6#1)(2006-4#1)(2007-12#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#1)
specific behaviours##3##2##(1996-3#1)(2006-10#1)(2012-2#1)
specific beneficial##2##2##(2008-10#1)(2012-2#1)
specific benefits##2##2##(2006-10#1)(2011-1#1)
specific binding activity was##2##4##(1994-8#1)(1995-3#1)
specific binding activity##3##3##(1994-8#1)(1995-3#1)(1997-2#1)
specific binding affinities##2##3##(2008-1#1)(2008-4#1)
specific binding and high affinity##2##5##(1992-4#1)(1997-5#1)
specific binding capacity of##2##4##(1990-11#1)(1993-3#1)
specific binding for##2##3##(1991-8#1)(1995-5#1)
specific binding in##4##3##(1993-6#1)(1995-12#2)(2012-12#1)
specific binding of biotinylated##2##4##(1990-11#1)(1996-5#1)
specific binding of the transcription factor c-Ets1 to##2##8##(1993-12#2)
specific binding of the##3##4##(1992-11#1)(1993-12#2)
specific binding of##39##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-7#1)(1991-1#2)(1991-2#1)(1991-4#2)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-12#3)(1993-8#1)(1994-10#1)(1994-12#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-2#2)(1996-5#4)(2008-11#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-7#1)
specific binding site##4##3##(1990-8#1)(1994-6#1)(1995-11#1)(1996-8#1)
specific binding sites for [3H]-staurosporine on##2##6##(1990-8#2)
specific binding sites for##14##4##(1990-1#1)(1990-11#1)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#2)(1992-12#1)(1992-7#1)(1993-5#1)(1993-7#1)(1995-6#1)(2008-4#1)
specific binding sites in##4##4##(1990-5#2)(1992-7#1)(1997-1#1)
specific binding sites on##2##4##(1990-5#1)(1992-12#1)
specific binding sites##26##3##(1990-1#1)(1990-11#1)(1990-3#2)(1990-5#4)(1990-7#1)(1990-8#2)(1991-4#1)(1992-12#2)(1992-7#3)(1993-5#1)(1993-7#1)(1993-8#2)(1995-6#1)(1996-3#1)(1997-1#1)(2006-1#1)(2008-4#1)
specific binding to##11##3##(1991-5#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-7#1)(1997-2#1)(2008-10#1)(2009-7#1)(2012-12#1)
specific binding was observed##2##4##(1995-12#1)(2008-10#1)
specific binding with##3##3##(1993-12#1)(1997-1#1)(2007-8#1)
specific binding##118##2##(1990-1#1)(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#4)(1990-3#4)(1990-5#4)(1990-7#2)(1990-8#3)(1991-1#2)(1991-12#1)(1991-2#1)(1991-4#3)(1991-5#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#3)(1992-8#1)(1993-12#4)(1993-3#1)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#3)(1994-10#1)(1994-12#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#3)(1995-11#3)(1995-12#7)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#1)(1996-2#2)(1996-3#1)(1996-5#4)(1996-8#1)(1997-1#2)(1997-2#2)(1997-5#2)(2006-1#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-7#1)(2012-12#2)
specific bioassay and##2##3##(1992-2#1)(2008-10#1)
specific bioassay##4##2##(1990-12#1)(1991-8#1)(1992-2#1)(2008-10#1)
specific biochemical##5##2##(1994-11#1)(1994-6#1)(1995-2#1)(2007-11#1)(2011-2#1)
specific biological activity##4##3##(1990-12#2)(1990-8#1)(2011-2#1)
specific biological##13##2##(1990-12#2)(1990-8#1)(2006-11#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-12#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)
specific biomarkers##3##2##(2008-10#1)(2010-5#1)(2011-12#1)
specific blockade##2##2##(2007-7#1)(2012-3#1)
specific blocker of##2##3##(1996-11#1)(1997-5#1)
specific blocking##2##2##(1990-12#1)(1994-12#1)
specific body##2##2##(2007-12#2)
specific bone##2##2##(1992-5#1)(2007-5#1)
specific brain areas##3##3##(1991-3#1)(1997-2#1)(1997-5#1)
specific brain region##2##3##(2008-11#1)(2008-7#1)
specific brain regions##11##3##(1994-10#1)(1994-2#1)(1994-5#1)(1994-6#1)(1996-3#1)(1997-5#2)(2008-4#3)(2011-2#1)
specific brain##22##2##(1991-3#1)(1993-8#1)(1994-10#1)(1994-2#2)(1994-5#1)(1994-6#1)(1996-3#1)(1997-2#1)(1997-5#3)(2006-10#1)(2008-11#1)(2008-12#1)(2008-4#3)(2008-7#1)(2009-6#1)(2009-7#1)(2011-2#1)
specific burden##3##2##(2009-11#1)(2010-12#2)
specific but##3##2##(1990-11#1)(1997-1#1)(2005-8#1)
specific cDNA by##2##3##(1992-11#1)(1993-9#1)
specific cDNA clones##2##3##(1996-10#1)(2008-11#1)
specific cDNA##7##2##(1990-2#1)(1992-11#1)(1993-9#1)(1996-10#1)(1997-6#1)(2008-11#2)
specific cDNAs##2##2##(1993-8#1)(1994-12#1)
specific cancer##2##2##(2007-3#1)(2009-5#1)
specific capacitance##3##2##(1997-1#2)(2010-4#1)
specific capacity##3##2##(2008-10#3)
specific carbohydrate##2##2##(1990-5#1)(2007-12#1)
specific carcinogens##2##2##(1991-11#1)(1992-3#1)
specific cardiac##2##2##(2007-8#2)
specific case##11##2##(2004-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#1)
specific cases##5##2##(2005-8#1)(2009-11#1)(2013-1#1)(2013-8#2)
specific categories of##2##3##(1993-1#1)(2009-8#1)
specific categories##4##2##(1992-8#1)(1993-1#1)(2009-8#1)(2011-12#1)
specific causal##2##2##(2008-11#1)(2011-2#1)
specific cause of##4##3##(1992-2#1)(2004-10#1)(2008-7#1)(2009-3#1)
specific cause##8##2##(1992-2#1)(1997-2#1)(2004-10#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-7#1)(2009-3#1)
specific causes of##3##3##(2004-11#1)(2009-2#1)(2010-4#1)
specific causes##5##2##(2004-11#1)(2009-2#1)(2009-3#1)(2010-4#1)(2010-9#1)
specific cell fates##2##3##(2007-8#1)(2009-12#1)
specific cell surface receptors##5##4##(1990-2#2)(1991-3#1)(1994-10#1)(2008-7#1)
specific cell surface##8##3##(1990-2#2)(1991-3#1)(1992-8#1)(1994-10#1)(2005-7#1)(2006-6#1)(2008-7#1)
specific cell types from##2##4##(2008-4#1)(2009-3#1)
specific cell types in##2##4##(1994-11#1)(1996-6#1)
specific cell types##10##3##(1994-11#1)(1996-6#1)(1997-4#1)(2007-12#1)(2008-11#1)(2008-4#3)(2009-3#1)(2013-7#1)
specific cell##30##2##(1990-2#2)(1991-12#1)(1991-3#1)(1992-8#1)(1992-9#1)(1994-10#1)(1994-11#1)(1994-3#1)(1996-6#1)(1996-8#1)(1997-4#1)(2005-7#1)(2006-6#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-11#3)(2008-4#3)(2008-7#2)(2008-9#1)(2009-12#1)(2009-3#1)(2013-7#1)
specific cells in##2##3##(2008-7#1)(2013-8#1)
specific cells of##2##3##(2010-5#1)(2013-7#1)
specific cells##7##2##(1992-5#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-5#1)(2013-7#1)(2013-8#1)
specific cellular adhesion##2##3##(1991-5#1)(1992-9#1)
specific cellular expression##2##3##(2013-8#2)
specific cellular##19##2##(1990-3#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-9#1)(1995-3#1)(1996-2#1)(1996-4#1)(1997-6#1)(2004-11#1)(2007-11#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-8#2)
specific cerebral##2##2##(1994-2#1)(1997-6#1)
specific changes at##2##3##(1995-5#1)(2008-2#1)
specific changes in the##5##4##(2007-6#1)(2008-10#2)(2008-3#1)(2010-12#1)
specific changes in##8##3##(1994-6#1)(1996-1#1)(2007-6#1)(2008-10#2)(2008-3#1)(2010-12#1)(2010-2#1)
specific changes##12##2##(1994-6#1)(1995-5#1)(1996-1#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-2#1)
specific channel##4##2##(1994-12#1)(2007-11#1)(2008-8#1)(2010-12#1)
specific characteristics and##5##3##(1991-3#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-1#1)
specific characteristics of##8##3##(1990-11#1)(2006-10#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-8#1)
specific characteristics##23##2##(1990-11#1)(1990-4#1)(1991-3#1)(1993-12#1)(1995-6#1)(2006-10#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#2)(2013-8#2)
specific chemical##9##2##(1990-7#1)(1991-3#1)(1993-11#1)(2006-8#1)(2008-10#1)(2009-2#1)(2010-12#1)(2010-7#1)(2012-1#1)
specific chemicals##2##2##(2008-10#1)(2008-5#1)
specific chemistry##3##2##(2005-11#1)(2012-11#2)
specific chest##2##2##(2010-9#1)(2013-1#1)
specific chromosomes##2##2##(2008-7#1)(2009-12#1)
specific chronic diseases##2##3##(1994-5#1)(2012-2#1)
specific chronic##4##2##(1994-5#1)(2006-12#1)(2010-2#1)(2012-2#1)
specific circumstances##5##2##(2006-12#1)(2008-2#2)(2008-4#1)(2011-1#1)
specific claims##2##2##(2010-2#1)(2013-8#1)
specific class of##3##3##(1994-12#1)(2008-10#1)(2012-1#1)
specific classes of##3##3##(2006-9#1)(2008-10#2)
specific cleavage of##4##3##(1991-9#2)(2006-12#1)(2008-9#1)
specific cleavage reaction##2##3##(1994-2#1)(1995-2#1)
specific cleavage##10##2##(1990-9#1)(1991-9#2)(1993-9#1)(1994-2#1)(1995-2#1)(2006-12#1)(2006-2#1)(2008-9#2)
specific clinical and##3##3##(1996-1#1)(2007-7#1)(2008-12#1)
specific clinical situation##3##3##(1997-3#1)(2008-2#1)(2010-12#1)
specific clinical situations##4##3##(1997-4#1)(2007-9#1)(2008-6#1)(2008-8#1)
specific clinical##25##2##(1996-1#1)(1997-3#1)(1997-4#1)(2006-4#1)(2006-8#2)(2006-9#1)(2007-5#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-4#1)(2012-12#1)(2013-1#2)
specific cognitive##2##2##(2006-3#1)(2013-8#1)
specific combination##2##2##(1993-12#1)(2008-5#1)
specific combinations of##4##3##(1994-9#1)(1995-5#1)(2008-10#1)(2008-3#1)
specific community##2##2##(1992-1#1)(2012-2#1)
specific compartmentalization of##2##3##(1997-6#2)
specific complex##2##2##(1994-9#1)(2008-11#1)
specific complexes between##2##3##(2008-7#2)
specific complexes##7##2##(1990-5#1)(1991-12#1)(1992-5#1)(1996-5#1)(1997-5#1)(2008-7#2)
specific complications and##2##3##(1995-8#1)(2007-12#1)
specific complications of##2##3##(2005-8#1)(2013-1#1)
specific complications##6##2##(1995-8#1)(2005-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2013-1#1)
specific components of the##7##4##(2005-8#1)(2006-10#1)(2008-4#1)(2009-10#1)(2009-4#2)(2009-7#1)
specific components of##9##3##(2005-11#1)(2005-8#1)(2006-10#1)(2007-6#1)(2008-4#1)(2009-10#1)(2009-4#2)(2009-7#1)
specific components##10##2##(2005-11#1)(2005-8#1)(2006-10#1)(2007-6#1)(2008-4#1)(2009-10#1)(2009-4#2)(2009-7#1)(2010-12#1)
specific compounds##8##2##(2007-8#1)(2007-9#2)(2008-10#2)(2008-11#1)(2008-2#1)(2010-2#1)
specific computational rules##2##3##(1991-8#2)
specific computer##2##2##(1996-2#1)(2008-12#1)
specific condition##3##2##(2006-10#1)(2007-11#1)(2013-1#1)
specific conditions##17##2##(1995-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(2006-12#1)(2006-8#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
specific conductance##2##2##(2005-11#1)(2008-10#1)
specific conductivity##10##2##(1997-7#1)(2005-11#2)(2008-10#3)(2008-5#1)(2012-2#3)
specific configurations of##3##3##(1997-2#1)(2007-12#1)(2008-11#1)
specific considerations##2##2##(2008-4#1)(2010-12#1)
specific content of##2##3##(1995-3#1)(2007-8#1)
specific content##3##2##(1995-3#1)(2007-8#1)(2011-2#1)
specific contents##2##2##(1993-3#1)(2012-3#1)
specific context of the##2##4##(2008-2#1)(2013-8#1)
specific context##5##2##(2008-2#1)(2008-7#1)(2013-1#2)(2013-8#1)
specific contexts##4##2##(2007-12#1)(2008-12#1)(2008-2#1)(2013-8#1)
specific contraceptive##2##2##(2013-1#2)
specific contribution of##4##3##(1996-3#1)(2008-11#1)(2013-1#2)
specific conversion##3##2##(1991-10#1)(1995-3#1)(2008-6#1)
specific core##2##2##(1996-4#1)(2008-11#1)
specific correlates##2##2##(2007-8#1)(2011-1#1)
specific criteria##4##2##(1991-2#1)(1995-11#1)(2011-7#1)(2012-1#1)
specific critical##2##2##(1996-5#1)(2008-5#1)
specific cultural##2##2##(2012-12#1)(2013-8#1)
specific culture##2##2##(1997-4#1)(2012-12#1)
specific cycle##2##2##(1992-3#1)(2007-8#1)
specific cyclin##2##2##(1997-6#1)(2004-11#1)
specific cysteine##2##2##(1994-9#1)(2008-4#1)
specific cytochrome##2##2##(1993-11#1)(1993-4#1)
specific cytokine##7##2##(1991-12#1)(1992-11#1)(2006-10#2)(2012-2#1)(2013-1#2)
specific cytotoxic T##2##3##(2007-11#1)(2008-8#1)
specific cytotoxic##3##2##(2007-11#1)(2008-4#1)(2008-8#1)
specific data##3##2##(2008-11#1)(2010-8#1)(2012-2#1)
specific death##2##2##(1996-3#1)(2006-10#1)
specific defect##2##2##(1992-4#1)(1995-1#1)
specific defects##2##2##(2007-11#1)(2012-12#1)
specific defence##2##2##(2005-11#2)
specific deficits in##3##3##(1991-8#1)(1995-11#1)(1996-7#1)
specific deficits##4##2##(1991-8#1)(1995-11#1)(1996-7#1)(2013-1#1)
specific degradation of the##2##4##(2008-5#1)(2011-2#1)
specific degradation of##4##3##(1994-6#1)(2008-5#1)(2011-2#1)(2012-3#1)
specific degradation##7##2##(1990-12#1)(1994-12#1)(1994-6#1)(2008-5#1)(2011-2#1)(2012-3#2)
specific deletion##2##2##(1991-12#1)(1996-12#1)
specific density##2##2##(2008-10#1)(2008-5#1)
specific design##4##2##(2008-3#3)(2013-1#1)
specific detection and##2##3##(2007-8#1)(2008-10#1)
specific detection of P##3##4##(2008-10#3)
specific detection of the##5##4##(1990-11#1)(1992-2#1)(2008-10#2)(2010-10#1)
specific detection of##19##3##(1990-11#1)(1992-2#1)(1995-2#1)(2007-8#2)(2008-10#8)(2010-10#1)(2010-12#1)(2010-5#1)(2010-9#1)(2013-7#1)(2013-8#1)
specific detection##25##2##(1990-11#1)(1991-2#1)(1992-2#1)(1995-2#1)(2007-8#3)(2008-10#10)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-9#1)(2013-7#1)(2013-8#2)
specific determinants##3##2##(1990-3#1)(1996-5#1)(2007-3#1)
specific determination of hydrogen peroxide##2##5##(2008-10#2)
specific determination of l-ascorbic acid##2##5##(2008-10#2)
specific determination of##7##3##(2007-3#1)(2007-8#1)(2008-10#5)
specific developmental##7##2##(2004-10#1)(2008-7#1)(2008-9#2)(2009-10#1)(2011-2#1)(2012-1#1)
specific diagnoses were##2##3##(1990-3#1)(1994-3#1)
specific diagnoses##4##2##(1990-3#1)(1991-9#1)(1994-3#1)(2008-10#1)
specific diagnosis is##2##3##(1993-5#1)(2005-8#1)
specific diagnosis of##3##3##(2007-12#1)(2010-12#1)(2013-8#1)
specific diagnosis##12##2##(1990-3#1)(1993-5#1)(1996-6#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-6#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-8#1)
specific diagnostic criteria##2##3##(2008-12#1)(2011-2#1)
specific diagnostic procedures##3##3##(2008-1#1)(2008-10#1)(2008-4#1)
specific diagnostic test##3##3##(1990-4#1)(2008-7#1)(2011-1#1)
specific diagnostic tests##2##3##(2006-9#1)(2012-1#1)
specific diagnostic##19##2##(1990-4#1)(1991-2#1)(1996-7#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-8#1)
specific dietary##2##2##(1990-8#1)(2008-10#1)
specific differences in##3##3##(1995-11#1)(2008-11#1)(2008-8#1)
specific differences##5##2##(1995-11#1)(1995-3#1)(2008-11#1)(2008-8#1)(2013-1#1)
specific difficulties##2##2##(2008-2#1)(2008-5#1)
specific dimensions##3##2##(2009-7#1)(2013-1#2)
specific direction##3##2##(1996-2#1)(2008-11#1)(2008-4#1)
specific directions##2##2##(2007-11#1)(2009-5#1)
specific disease processes##2##3##(2007-12#1)(2012-2#1)
specific disease##8##2##(1995-5#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-2#1)
specific diseases of##2##3##(2008-4#1)(2008-8#1)
specific diseases##9##2##(1993-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
specific domain##2##2##(1995-3#1)(2008-11#1)
specific domains of the##4##4##(1992-12#1)(1992-3#1)(1994-9#1)(2007-8#1)
specific domains of##6##3##(1992-12#1)(1992-3#1)(1994-9#1)(1995-3#1)(2007-8#1)(2009-8#1)
specific domains##9##2##(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-9#1)(1995-3#1)(2007-8#1)(2009-8#1)(2011-1#1)
specific dose-dependent##2##2##(1995-2#1)(2008-2#1)
specific downstream##2##2##(1996-2#1)(2009-8#1)
specific drug delivery##2##3##(2008-11#2)
specific drug##8##2##(1993-9#1)(2007-11#1)(2008-11#3)(2011-3#1)(2012-2#1)(2013-8#1)
specific drugs##3##2##(2008-1#1)(2010-10#1)(2010-6#1)
specific duties##2##2##(1992-1#1)(2008-11#1)
specific effect of##4##3##(1991-7#1)(1996-3#1)(2008-4#1)(2012-2#1)
specific effect on##3##3##(1990-2#1)(1996-5#1)(2008-5#1)
specific effect##7##2##(1990-2#1)(1991-7#1)(1996-3#1)(1996-5#1)(2008-4#1)(2008-5#1)(2012-2#1)
specific effects of##5##3##(1990-12#1)(2005-11#1)(2006-9#1)(2008-1#1)(2012-1#1)
specific effects on##3##3##(1994-11#1)(1997-1#1)(2007-2#1)
specific effects##12##2##(1990-12#1)(1991-8#1)(1993-9#1)(1994-11#1)(1997-1#1)(2005-11#1)(2005-8#1)(2006-9#1)(2007-2#1)(2008-1#1)(2008-11#1)(2012-1#1)
specific electrical##2##2##(2008-10#1)(2012-2#1)
specific elements of couples##2##4##(2012-2#2)
specific elements of the##2##4##(2009-5#1)(2010-1#1)
specific elements of##5##3##(1996-5#1)(2009-5#1)(2010-1#1)(2012-2#2)
specific elements##9##2##(1995-4#1)(1996-5#1)(2005-10#1)(2006-4#1)(2007-5#1)(2009-5#1)(2010-1#1)(2012-2#2)
specific emphasis on the##2##4##(1994-1#1)(2012-12#1)
specific emphasis##3##2##(1994-1#1)(1995-11#1)(2012-12#1)
specific energy dissipation rate##9##4##(2008-7#9)
specific energy dissipation rates##2##4##(2008-7#2)
specific energy dissipation##12##3##(2008-7#12)
specific energy##13##2##(1990-11#1)(2008-7#12)
specific enhancement of##2##3##(1994-6#1)(1997-8#1)
specific enolase (NSE) in##2##4##(1990-2#1)(1990-6#1)
specific enolase (NSE)##6##3##(1990-10#2)(1990-2#1)(1990-6#1)(1990-8#2)
specific enolase##13##2##(1990-10#2)(1990-11#2)(1990-2#3)(1990-6#1)(1990-8#2)(1997-7#1)(2010-12#1)(2012-2#1)
specific enough to##2##3##(2007-4#1)(2010-1#1)
specific entity##4##2##(1996-12#1)(2005-11#1)(2006-10#1)(2006-9#1)
specific environmental##9##2##(1990-7#1)(1994-3#1)(1995-9#1)(2007-7#1)(2008-10#1)(2008-11#2)(2010-8#1)(2011-1#1)
specific enzymatic activity##2##3##(1995-6#1)(2008-11#1)
specific enzymatic##7##2##(1990-2#1)(1995-6#1)(1996-7#1)(1997-7#1)(2006-5#1)(2008-11#1)(2011-1#1)
specific enzyme##12##2##(1990-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1994-11#2)(1994-12#1)(1994-3#1)(2004-11#1)(2008-4#1)(2008-7#1)(2008-8#1)
specific enzymes##9##2##(1990-4#1)(1992-2#1)(2007-12#1)(2007-9#1)(2008-4#1)(2008-5#2)(2012-1#1)(2013-8#1)
specific epitope##2##2##(2008-11#1)(2008-8#1)
specific etiology##3##2##(1990-5#1)(1991-2#1)(2011-2#1)
specific events##3##2##(1994-12#1)(1996-4#1)(2007-6#1)
specific example of##4##3##(1996-3#1)(2007-12#1)(2008-10#1)(2011-2#1)
specific example##8##2##(1994-6#1)(1996-3#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-4#1)(2011-2#1)
specific examples from##2##3##(1994-12#1)(2007-11#1)
specific examples of##4##3##(1990-6#1)(2008-4#3)
specific examples##16##2##(1990-6#1)(1990-8#1)(1992-2#1)(1994-12#1)(2007-11#1)(2008-1#1)(2008-4#4)(2008-8#1)(2009-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)
specific exercise##3##2##(2008-12#3)
specific expectations of##2##3##(2013-1#2)
specific experimental conditions##2##3##(1996-2#2)
specific experimental##3##2##(1996-12#1)(1996-2#2)
specific experiments##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
specific expertise##2##2##(2007-4#1)(2010-11#1)
specific exposures##2##2##(1991-7#1)(1992-4#1)
specific expression and##2##3##(2008-11#1)(2012-3#1)
specific expression in##2##3##(1991-5#1)(2008-9#1)
specific expression of HOX##2##4##(1992-3#2)
specific expression of the##4##4##(1991-12#1)(1993-9#1)(1995-2#1)(1997-6#1)
specific expression of this##2##4##(1992-12#1)(1994-6#1)
specific expression of##11##3##(1991-12#1)(1992-12#1)(1992-3#2)(1993-9#1)(1994-11#1)(1994-6#1)(1995-10#1)(1995-2#1)(1997-6#1)(2008-11#1)
specific expression##26##2##(1991-12#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-11#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-2#1)(1996-3#1)(1997-6#1)(2008-11#3)(2008-8#2)(2008-9#1)(2011-2#1)(2012-12#2)(2012-3#1)
specific extracellular matrix##2##3##(1991-5#1)(2008-5#1)
specific extraction##2##2##(2008-10#2)
specific factors##9##2##(1992-7#1)(2007-10#1)(2007-2#1)(2008-11#2)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)
specific fashion##2##2##(1996-4#1)(2012-3#1)
specific fatty acids##2##3##(1996-6#2)
specific fatty##3##2##(1994-2#1)(1996-6#2)
specific features of the metabolic syndrome##2##6##(2008-3#2)
specific features of the##5##4##(2008-10#2)(2008-3#3)
specific features of##15##3##(1991-10#1)(1993-10#1)(2008-10#3)(2008-3#4)(2008-4#1)(2008-6#1)(2008-9#1)(2010-12#1)(2012-2#1)(2012-3#1)
specific features that##4##3##(2007-11#1)(2007-12#1)(2008-11#1)(2010-8#1)
specific features##26##2##(1991-10#1)(1993-10#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-6#1)(2008-9#1)(2009-10#1)(2010-12#2)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
specific findings##3##2##(2007-10#1)(2013-1#2)
specific fluorescence##2##2##(1997-4#1)(2008-9#1)
specific focus on the##3##4##(2007-8#1)(2008-10#1)(2008-6#1)
specific focus on##7##3##(2006-2#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-6#1)(2011-2#1)(2013-1#1)
specific focus##9##2##(2006-2#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
specific food##3##2##(1993-9#1)(2011-2#1)(2012-1#1)
specific for 2##2##3##(1991-9#1)(2008-10#1)
specific for Na(+)##2##3##(2008-5#2)
specific for P##5##3##(2008-10#5)
specific for PKA##2##3##(1992-6#1)(1995-2#1)
specific for S##2##3##(1992-7#1)(2008-10#1)
specific for a particular##2##4##(1993-11#1)(1994-8#1)
specific for a##13##3##(1990-12#1)(1991-12#1)(1992-9#1)(1993-11#2)(1994-8#1)(1995-3#1)(1995-6#1)(2006-10#1)(2008-10#1)(2008-4#2)(2009-2#1)
specific for all##2##3##(1995-12#1)(2008-10#1)
specific for an##2##3##(1994-2#1)(2008-4#1)
specific for conserved##2##3##(1993-12#1)(2012-3#1)
specific for each of the##2##5##(1991-5#1)(2008-10#1)
specific for each##10##3##(1991-4#1)(1991-5#1)(2007-12#1)(2008-10#5)(2008-4#1)(2008-5#1)
specific for either##4##3##(2008-10#2)(2013-8#2)
specific for glycoprotein IIb-IIIa##2##4##(1990-5#2)
specific for human##6##3##(1990-7#1)(1991-6#1)(1997-6#1)(2008-4#2)(2008-7#1)
specific for individual##3##3##(1993-9#1)(2008-10#2)
specific for murine##2##3##(1991-5#1)(1995-2#1)
specific for protein##3##3##(1990-4#1)(1996-4#1)(2008-4#1)
specific for the alpha##2##4##(1995-11#1)(1995-3#1)
specific for the detection of##2##5##(2008-10#1)(2013-8#1)
specific for the highly##2##4##(1992-2#1)(2008-10#1)
specific for the respective##2##4##(1990-12#1)(1996-11#1)
specific for the##86##3##(1990-10#1)(1990-12#2)(1990-4#1)(1990-8#1)(1991-4#1)(1991-5#1)(1992-2#3)(1992-3#2)(1992-6#2)(1992-8#1)(1993-12#1)(1993-8#1)(1994-11#3)(1994-3#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#3)(1996-1#1)(1996-10#2)(1996-11#2)(1996-2#1)(1996-5#1)(2004-1#1)(2006-3#2)(2006-8#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#4)(2009-4#1)(2009-6#1)(2010-11#1)(2010-2#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#3)
specific for these##3##3##(1991-12#1)(1995-12#1)(2008-10#1)
specific for this##3##3##(1994-11#1)(2008-10#1)(2011-1#1)
specific for various##2##3##(1995-3#1)(2007-2#1)
specific for##355##2##(1990-10#1)(1990-11#1)(1990-12#8)(1990-2#2)(1990-4#3)(1990-5#4)(1990-7#6)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-3#1)(1991-4#3)(1991-5#4)(1991-6#3)(1991-8#5)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#3)(1992-3#4)(1992-4#1)(1992-6#4)(1992-7#4)(1992-8#3)(1992-9#3)(1993-11#5)(1993-12#4)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#4)(1994-10#1)(1994-11#6)(1994-12#4)(1994-2#5)(1994-3#2)(1994-6#2)(1994-8#3)(1994-9#5)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#7)(1995-2#8)(1995-3#9)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#4)(1996-1#1)(1996-10#3)(1996-11#5)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#6)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#3)(1997-8#1)(2004-1#1)(2005-8#1)(2006-10#3)(2006-3#2)(2006-4#1)(2006-6#1)(2006-8#4)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-7#2)(2008-1#2)(2008-10#45)(2008-11#12)(2008-12#1)(2008-3#1)(2008-4#16)(2008-5#9)(2008-7#6)(2008-8#3)(2009-10#1)(2009-11#2)(2009-2#2)(2009-3#1)(2009-4#2)(2009-6#1)(2009-9#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#3)(2010-5#1)(2011-1#3)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#7)
specific force##2##2##(2008-3#2)
specific form of##3##3##(1994-12#1)(2008-11#1)(2008-3#1)
specific forms##2##2##(1990-5#1)(1993-12#1)
specific fragments##3##2##(1991-2#1)(2007-1#1)(2013-8#1)
specific frequencies##2##2##(2011-2#1)(2012-12#1)
specific frequency##2##2##(1993-2#1)(2010-8#1)
specific function of##2##3##(1992-3#1)(1992-5#1)
specific function##7##2##(1991-6#1)(1992-3#1)(1992-5#1)(1993-6#1)(1994-6#1)(1997-4#1)(2008-8#1)
specific functional exercise##2##3##(2007-10#1)(2012-1#1)
specific functional##12##2##(1992-5#1)(1994-5#1)(1996-2#1)(1997-5#1)(1997-7#1)(2007-10#2)(2008-7#1)(2008-8#2)(2011-2#1)(2012-1#1)
specific functions of the##4##4##(1994-6#1)(1996-8#1)(2009-5#1)(2009-6#1)
specific functions of##6##3##(1992-9#1)(1994-6#1)(1996-8#1)(2008-11#1)(2009-5#1)(2009-6#1)
specific functions##13##2##(1992-9#1)(1994-6#1)(1994-8#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-8#1)(2008-11#2)(2009-5#2)(2009-6#1)
specific gas##2##2##(2006-6#1)(2007-12#1)
specific gene expression##3##3##(1992-2#1)(1996-11#1)(1997-4#1)
specific gene in##3##3##(1997-1#1)(2008-8#2)
specific gene regulation##2##3##(1994-2#1)(1995-11#1)
specific gene sequences##2##3##(1997-4#1)(2008-10#1)
specific gene silencing in mammalian cells##2##6##(2008-2#1)(2009-3#1)
specific gene##24##2##(1990-3#1)(1991-4#1)(1992-2#1)(1994-2#1)(1995-11#2)(1995-8#1)(1996-11#1)(1997-1#1)(1997-4#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-3#1)(2012-2#2)
specific genes are expressed##2##4##(2008-10#1)(2012-2#1)
specific genes are##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
specific genes in##3##3##(2006-6#1)(2009-8#1)(2013-8#1)
specific genes##37##2##(1990-11#1)(1991-12#1)(1991-5#2)(1992-8#1)(1993-11#1)(1993-2#1)(1994-3#1)(1996-12#1)(1996-4#1)(2006-10#3)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#3)(2008-7#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#3)
specific genetic background##3##3##(2007-10#2)(2008-7#1)
specific genetic causes##2##3##(2006-10#1)(2012-11#1)
specific genetic factors##2##3##(2007-10#1)(2007-9#1)
specific genetic mutations##2##3##(2008-8#1)(2009-12#1)
specific genetic##22##2##(1996-5#1)(1997-4#2)(2005-6#1)(2006-10#2)(2007-10#3)(2007-8#1)(2007-9#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#1)
specific genome##2##2##(2008-10#1)(2008-7#1)
specific genomic regions##4##3##(2008-1#1)(2008-10#1)(2008-2#1)(2011-2#1)
specific genomic##7##2##(1997-1#1)(2008-1#2)(2008-10#1)(2008-2#2)(2011-2#1)
specific geographical##2##2##(2008-10#1)(2012-5#1)
specific geometry##2##2##(2008-3#2)
specific germline##2##2##(2006-12#2)
specific glucose consumption rate##3##4##(2008-11#3)
specific glucose consumption##4##3##(2008-11#4)
specific glucose uptake rate##5##4##(1994-5#5)
specific glucose uptake##6##3##(1994-5#6)
specific glucose##12##2##(1994-5#6)(2008-11#4)(2008-7#2)
specific glycosaminoglycan##2##2##(1990-3#1)(1991-8#1)
specific goals##5##2##(1994-3#1)(1995-5#1)(2006-10#1)(2012-12#2)
specific gravity and##2##3##(1991-1#1)(2007-1#1)
specific gravity##7##2##(1991-1#2)(1994-2#1)(1995-6#1)(2007-1#2)(2007-3#1)
specific group of patients##2##4##(2006-1#1)(2008-7#1)
specific group of##4##3##(1993-2#1)(2006-1#1)(2006-8#1)(2008-7#1)
specific group##5##2##(1993-2#1)(2006-1#1)(2006-8#1)(2007-12#1)(2008-7#1)
specific groups##5##2##(1992-1#1)(1993-3#1)(2006-12#1)(2006-2#1)(2009-4#1)
specific growth and##3##3##(1993-9#1)(2008-11#1)(2008-7#1)
specific growth conditions##2##3##(2008-9#1)(2010-11#1)
specific growth factor##3##3##(1993-9#1)(2008-9#1)(2012-11#1)
specific growth rate (mu)##2##4##(2008-11#2)
specific growth rate and##5##4##(1994-2#1)(1996-2#1)(2005-11#1)(2008-11#2)
specific growth rate of 0##6##5##(1994-2#1)(2008-11#3)(2008-6#1)(2011-2#1)
specific growth rate of##13##4##(1994-2#1)(1995-9#1)(2006-8#1)(2008-11#4)(2008-6#1)(2008-7#3)(2010-11#1)(2011-2#1)
specific growth rate remained##2##4##(1994-5#1)(2008-11#1)
specific growth rate was##4##4##(1996-2#1)(2008-11#1)(2010-11#1)(2013-1#1)
specific growth rate##48##3##(1994-2#2)(1994-3#2)(1994-5#1)(1995-9#2)(1996-2#4)(2005-11#1)(2006-8#1)(2007-3#1)(2008-10#1)(2008-11#14)(2008-6#1)(2008-7#11)(2008-9#1)(2010-11#2)(2010-8#1)(2011-2#1)(2013-1#2)
specific growth rates of##2##4##(2006-8#1)(2008-11#1)
specific growth rates##7##3##(1994-2#1)(2006-8#1)(2008-11#4)(2008-7#1)
specific growth##66##2##(1991-6#1)(1993-9#2)(1994-2#3)(1994-3#2)(1994-5#1)(1995-9#2)(1996-2#4)(2005-11#1)(2006-8#2)(2007-3#1)(2008-10#1)(2008-11#21)(2008-6#1)(2008-7#13)(2008-9#3)(2010-11#3)(2010-8#1)(2011-2#1)(2012-11#1)(2013-1#2)
specific guidelines for##2##3##(2009-8#1)(2011-2#1)
specific guidelines##4##2##(2008-11#1)(2008-12#1)(2009-8#1)(2011-2#1)
specific hMab productivity in##2##4##(2008-11#2)
specific hMab productivity##3##3##(2008-11#3)
specific health and##2##3##(1995-3#1)(2008-1#1)
specific health care##2##3##(2008-8#1)(2010-10#1)
specific health##10##2##(1994-6#1)(1995-3#1)(2006-12#1)(2008-1#2)(2008-7#1)(2008-8#1)(2010-10#1)(2010-4#1)(2012-12#1)
specific heat##3##2##(1992-3#1)(1993-12#1)(2008-3#1)
specific high affinity##3##3##(1990-2#1)(1991-2#1)(1996-11#1)
specific high-affinity##2##2##(1990-7#1)(1994-10#1)
specific hippocampal##2##2##(1991-2#1)(2008-4#1)
specific histologic##3##2##(1993-8#1)(2004-11#1)(2009-12#1)
specific histological##2##2##(2012-12#1)(2013-1#1)
specific hormonal changes##2##3##(1993-5#1)(2006-5#1)
specific hormonal##3##2##(1993-5#1)(1994-3#1)(2006-5#1)
specific hospital##2##2##(1994-12#1)(2008-11#1)
specific host##4##2##(2006-10#1)(2008-10#2)(2011-12#1)
specific human monoclonal##2##3##(2008-11#2)
specific human##7##2##(2006-7#1)(2008-11#5)(2008-8#1)
specific hybridization with##2##3##(1995-2#1)(2008-9#1)
specific hybridization##5##2##(1995-2#1)(1996-7#1)(2008-4#1)(2008-5#1)(2008-9#1)
specific hyperfine##2##2##(2007-12#2)
specific identification of##4##3##(1992-2#1)(1996-12#1)(2007-7#1)(2012-12#1)
specific identification##6##2##(1992-2#1)(1996-12#1)(2007-7#1)(2008-10#1)(2008-9#1)(2012-12#1)
specific imaging##5##2##(2007-11#1)(2007-4#2)(2010-6#1)(2011-1#1)
specific immune response##4##3##(1992-1#2)(2008-5#1)(2008-9#1)
specific immune responses following##2##4##(2008-4#2)
specific immune responses##8##3##(1990-4#1)(2008-10#1)(2008-4#2)(2008-9#1)(2009-9#1)(2010-7#1)(2012-1#1)
specific immune system##2##3##(2008-10#1)(2011-1#1)
specific immune##20##2##(1990-4#1)(1992-1#2)(1992-12#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-9#2)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)
specific immunity##3##2##(1991-12#1)(2009-8#1)(2011-2#1)
specific immunoassay##3##2##(2008-10#2)(2010-12#1)
specific immunological##6##2##(1996-12#2)(2005-11#2)(2006-8#1)(2013-1#1)
specific in the##5##3##(1997-1#1)(2007-9#1)(2009-8#1)(2009-9#1)(2011-2#1)
specific in vitro##3##3##(1991-12#1)(2013-1#2)
specific in vivo##2##3##(1994-12#1)(1994-9#1)
specific in##26##2##(1990-12#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-2#1)(1994-12#1)(1994-9#1)(1996-7#1)(1997-1#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#4)(2009-8#2)(2009-9#1)(2011-2#1)(2013-1#2)
specific incidence##3##2##(2006-8#2)(2008-3#1)
specific incorporation of the##2##4##(1992-3#1)(2008-4#1)
specific incorporation of##5##3##(1992-3#1)(1994-5#1)(2007-8#1)(2008-4#2)
specific increase##2##2##(1995-8#1)(1997-7#1)
specific indication##3##2##(1990-6#1)(1996-9#1)(1997-5#1)
specific indications##6##2##(1996-9#1)(1997-6#1)(2006-3#1)(2007-8#2)(2010-6#1)
specific indicator##3##2##(1995-12#1)(2008-7#1)(2011-1#1)
specific indicators##2##2##(2007-4#1)(2008-11#1)
specific individual##2##2##(1996-11#1)(2008-6#1)
specific induction of##2##3##(2008-10#1)(2008-3#1)
specific induction##3##2##(1994-12#1)(2008-10#1)(2008-3#1)
specific infection##2##2##(1990-6#1)(2006-2#1)
specific infections##2##2##(2009-5#1)(2011-1#1)
specific information about the##3##4##(2008-4#1)(2008-9#1)(2012-1#1)
specific information about##4##3##(2008-4#1)(2008-9#1)(2009-9#1)(2012-1#1)
specific information concerning##2##3##(1992-11#1)(1995-3#1)
specific information##16##2##(1992-11#1)(1995-3#1)(1996-12#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-8#1)(2009-9#1)(2012-1#1)(2013-1#2)
specific inhibition of the##2##4##(1994-9#1)(2008-3#1)
specific inhibition of##4##3##(1994-9#1)(1995-5#1)(2005-7#1)(2008-3#1)
specific inhibition##9##2##(1992-11#1)(1994-9#1)(1995-5#1)(2005-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2013-1#1)
specific inhibitor of Ca2+/calmodulin-dependent protein kinase II##2##7##(1991-12#1)(1992-11#1)
specific inhibitor of protein kinase C##3##6##(1990-10#1)(1990-11#1)(1997-7#1)
specific inhibitor of protein serine/threonine##2##5##(1994-11#1)(1997-6#1)
specific inhibitor of protein##7##4##(1990-10#1)(1990-11#1)(1994-11#1)(1994-2#1)(1995-8#1)(1997-6#1)(1997-7#1)
specific inhibitor of the##7##4##(1992-11#1)(1992-12#1)(1993-3#1)(1994-6#1)(1996-2#1)(1996-5#1)(2008-3#1)
specific inhibitor of##45##3##(1990-10#1)(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-7#1)(1992-11#4)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-11#3)(1994-2#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#3)(1997-6#1)(1997-7#1)(2005-9#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-5#1)(2009-10#1)(2010-11#1)
specific inhibitor##52##2##(1990-10#1)(1990-11#3)(1990-2#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-7#2)(1991-8#1)(1992-11#4)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-11#3)(1994-2#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#3)(1997-6#1)(1997-7#1)(2003-11#1)(2005-9#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-3#3)(2008-5#1)(2009-10#1)(2009-6#1)(2010-11#1)
specific inhibitors of the##4##4##(1992-6#1)(1995-3#1)(1996-2#1)(2006-10#1)
specific inhibitors of##14##3##(1991-2#1)(1991-3#1)(1992-6#1)(1993-3#1)(1993-9#1)(1995-2#1)(1995-3#2)(1996-2#1)(2006-10#1)(2007-5#1)(2008-5#1)(2008-9#1)(2013-1#1)
specific inhibitors##29##2##(1991-2#1)(1991-3#1)(1992-6#1)(1993-3#1)(1993-9#1)(1995-2#1)(1995-3#2)(1995-7#1)(1996-2#2)(1996-5#1)(1996-6#1)(2005-8#1)(2006-10#4)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-3#1)(2012-2#2)(2013-1#1)
specific inhibitory systems##2##3##(1992-7#1)(2007-8#1)
specific inhibitory##4##2##(1990-2#1)(1992-7#1)(1993-3#1)(2007-8#1)
specific initiatives##2##2##(1992-1#1)(1992-12#1)
specific injuries##2##2##(2006-3#1)(2013-1#1)
specific input##4##2##(2007-7#1)(2008-11#1)(2008-3#2)
specific interaction between the##3##4##(1995-10#1)(1996-9#1)(1997-4#1)
specific interaction between##9##3##(1991-8#1)(1992-3#1)(1995-10#1)(1996-8#1)(1996-9#1)(1997-4#1)(2008-10#2)(2011-1#1)
specific interaction of guanidine hydrochloride with##2##6##(1993-3#1)(1993-6#1)
specific interaction of the##3##4##(1991-6#1)(1993-2#1)(2008-10#1)
specific interaction of##10##3##(1991-6#1)(1992-5#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#2)(1996-5#1)(2008-10#1)(2008-3#1)
specific interaction with the##2##4##(1994-8#1)(1996-4#1)
specific interaction with##6##3##(1994-8#1)(1994-9#1)(1996-4#1)(1997-4#1)(2008-10#1)(2008-7#1)
specific interaction##30##2##(1990-5#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-5#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-8#1)(1994-9#1)(1995-10#1)(1996-4#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-4#2)(2008-10#5)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#1)
specific interactions between host and##2##5##(2008-10#1)(2008-12#1)
specific interactions between the##5##4##(1992-12#1)(1993-2#1)(2005-11#1)(2008-3#1)(2009-3#1)
specific interactions between##10##3##(1992-12#1)(1993-2#1)(1995-3#1)(2005-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-3#1)(2013-1#1)
specific interactions of##2##3##(1995-5#1)(1996-12#1)
specific interactions with##3##3##(1993-6#1)(1995-8#1)(2008-5#1)
specific interactions##17##2##(1992-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(2005-11#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-3#1)(2013-1#1)
specific interest##3##2##(2008-11#1)(2009-4#1)(2012-2#1)
specific intervals##2##2##(2007-9#1)(2008-5#1)
specific intervention strategies##2##3##(2006-10#2)
specific intervention##6##2##(2006-10#2)(2007-9#1)(2011-2#2)(2013-8#1)
specific interventions##7##2##(1993-12#1)(1995-6#1)(2006-7#1)(2007-9#1)(2008-11#1)(2008-2#1)(2012-12#1)
specific intracellular##8##2##(1993-2#1)(1995-11#1)(2006-2#1)(2009-2#1)(2010-10#1)(2010-9#1)(2011-1#1)(2012-2#1)
specific intrathecal##2##2##(1991-7#1)(1992-11#1)
specific intrinsic##2##2##(2004-1#1)(2011-2#1)
specific investigations for##2##3##(2007-7#1)(2013-8#1)
specific investigations##3##2##(2007-7#1)(2012-3#1)(2013-8#1)
specific ion channels##2##3##(2007-12#1)(2009-3#1)
specific ion interaction##2##3##(2008-10#2)
specific ion##5##2##(1991-11#1)(2007-12#1)(2008-10#2)(2009-3#1)
specific isolates##2##2##(2008-10#2)
specific issue##3##2##(2008-11#1)(2008-5#1)(2008-9#1)
specific issues related to##3##4##(2009-7#1)(2012-3#1)(2013-1#1)
specific issues##10##2##(2006-10#1)(2006-8#1)(2007-8#1)(2008-9#1)(2009-7#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#2)
specific kappa-opioid##2##2##(1996-12#1)(2009-12#1)
specific killing of##2##3##(1997-4#1)(2008-1#1)
specific kinase##2##2##(1995-10#1)(1997-2#1)
specific knowledge about##2##3##(2009-4#1)(2010-12#1)
specific knowledge##6##2##(2006-10#2)(2007-12#1)(2008-11#1)(2009-4#1)(2010-12#1)
specific labeling of##7##3##(1991-12#1)(1991-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1996-12#1)(2012-3#1)
specific labeling##11##2##(1991-12#1)(1991-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1994-8#2)(1995-7#1)(1996-12#1)(2008-7#1)(2012-3#1)
specific labelling of the##3##4##(1993-9#1)(2009-8#2)
specific laboratory##3##2##(2010-4#1)(2011-2#1)(2012-2#1)
specific language impairment (SLI)##5##4##(2009-1#2)(2009-8#1)(2012-3#2)
specific language##6##2##(1992-1#1)(2009-1#2)(2009-8#1)(2012-3#2)
specific leaf area##4##3##(2008-5#1)(2008-8#1)(2012-5#1)(2013-7#1)
specific leaf mass##2##3##(2007-3#1)(2008-12#1)
specific leaf##9##2##(2007-3#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#1)(2012-5#1)(2013-7#1)
specific learning disability##3##3##(2012-12#2)(2013-1#1)
specific learning##4##2##(2008-11#1)(2012-12#2)(2013-1#1)
specific lectins##2##2##(1995-2#2)
specific lesion##2##2##(1992-8#1)(1997-1#1)
specific lesions##2##2##(2008-12#1)(2010-2#1)
specific level of##2##3##(2006-5#1)(2009-5#1)
specific life##3##2##(1993-11#1)(2007-6#1)(2013-8#1)
specific ligand of##2##3##(1995-8#1)(2008-9#1)
specific ligand##7##2##(1990-5#1)(1995-8#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-1#1)
specific ligands##5##2##(1990-8#1)(1993-11#1)(2005-9#1)(2007-11#1)(2008-4#1)
specific limitations##2##2##(2008-7#1)(2009-10#1)
specific limited##2##2##(1990-11#1)(1997-2#1)
specific lipid##3##2##(1994-11#1)(2009-2#1)(2010-5#1)
specific loading##2##2##(2008-6#1)(2011-1#1)
specific local interaction##2##3##(1997-4#2)
specific local##6##2##(1994-1#1)(1995-5#1)(1995-9#1)(1997-4#2)(2013-1#1)
specific localization##3##2##(1990-12#1)(1996-12#1)(1997-6#1)
specific location##8##2##(1995-5#1)(2006-11#1)(2007-12#1)(2007-7#1)(2008-8#1)(2009-9#1)(2011-2#1)(2012-2#1)
specific locations##9##2##(1997-4#1)(2008-10#2)(2008-5#1)(2008-7#2)(2010-4#1)(2011-1#1)(2012-2#1)
specific loci##3##2##(1994-3#1)(2005-10#1)(2010-2#1)
specific locus##3##2##(1995-10#1)(1995-2#1)(1997-3#1)
specific loss##2##2##(2007-12#1)(2008-7#1)
specific lung##2##2##(1994-2#1)(2008-7#1)
specific lysine##3##2##(2008-4#1)(2008-9#1)(2012-3#1)
specific mRNA of##2##3##(1990-8#1)(1991-5#1)
specific mRNA##10##2##(1990-12#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-8#1)(1994-12#1)(1997-1#1)(2006-12#1)(2008-8#1)
specific magnetic field##2##3##(1997-1#2)
specific mammalian##2##2##(1994-10#1)(2008-11#1)
specific management strategies##2##3##(2006-10#1)(2013-8#1)
specific manner and##2##3##(1993-6#1)(1993-8#1)
specific manner in##3##3##(1990-11#1)(1993-8#1)(1995-10#1)
specific manner##27##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-12#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-8#1)(1995-10#1)(1996-12#1)(1996-2#2)(1996-4#1)(1997-1#1)(1997-4#1)(1997-7#1)(2005-7#1)(2006-9#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-3#1)(2010-7#1)
specific marker for##8##3##(1990-4#1)(1991-4#1)(1995-11#1)(1996-12#1)(1997-7#1)(2007-8#1)(2008-12#1)(2008-5#1)
specific marker of myocardial##2##4##(1990-12#1)(2006-6#1)
specific marker of##9##3##(1990-10#1)(1990-12#1)(1994-8#1)(1995-12#1)(2006-6#1)(2007-10#1)(2008-4#1)(2012-1#2)
specific marker##22##2##(1990-10#1)(1990-12#1)(1990-4#1)(1991-4#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-11#3)(1995-12#1)(1996-12#1)(1997-7#1)(2006-6#1)(2007-10#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-1#2)
specific markers for##4##3##(2008-10#1)(2008-9#2)(2012-11#1)
specific markers of##3##3##(1995-2#1)(2008-4#1)(2010-9#1)
specific markers##12##2##(1995-2#1)(1996-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#2)(2010-9#1)(2011-2#2)(2012-11#1)(2013-8#1)
specific material##2##2##(1992-7#1)(2004-9#1)
specific materials##2##2##(1994-3#1)(1995-6#1)
specific measurement##3##2##(1996-3#1)(2008-5#1)(2013-1#1)
specific measures of##2##3##(2007-12#1)(2008-6#1)
specific measures##3##2##(1995-12#1)(2007-12#1)(2008-6#1)
specific mechanism for##2##3##(2010-5#1)(2012-11#1)
specific mechanism of action##2##4##(1995-5#1)(2007-9#1)
specific mechanism of##4##3##(1992-9#1)(1995-5#1)(2007-9#1)(2008-10#1)
specific mechanism##6##2##(1992-9#1)(1995-5#1)(2007-9#1)(2008-10#1)(2010-5#1)(2012-11#1)
specific mechanisms of##3##3##(1992-11#1)(2008-10#1)(2010-8#1)
specific mechanisms##12##2##(1992-11#1)(1992-6#1)(1995-1#1)(2006-10#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-2#1)(2009-4#1)(2010-8#1)
specific medical conditions##2##3##(2008-11#1)(2013-7#1)
specific medical##8##2##(1995-4#1)(2005-11#1)(2008-11#1)(2008-2#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-7#1)
specific medication##2##2##(2008-12#1)(2008-4#1)
specific membrane components##2##3##(2007-5#1)(2009-8#1)
specific membrane markers##2##3##(2013-1#2)
specific membrane##15##2##(1990-9#1)(1991-2#1)(1991-4#1)(1993-4#1)(1996-1#1)(1997-1#2)(2007-11#2)(2007-5#1)(2007-8#1)(2008-8#1)(2009-8#1)(2013-1#2)
specific memory##4##2##(1991-6#1)(2009-8#3)
specific mental health##2##3##(2008-8#1)(2009-5#1)
specific mention of##2##3##(1992-11#1)(2012-11#1)
specific messages##2##2##(1993-7#1)(2008-2#1)
specific metabolic##4##2##(1992-7#1)(1994-8#1)(2005-8#1)(2006-9#1)
specific metabolism##2##2##(1995-3#1)(2009-5#1)
specific methanogenic activity##2##3##(2006-8#1)(2011-2#1)
specific method for the determination of##2##6##(2008-10#2)
specific method for the##3##4##(2008-10#3)
specific method for##11##3##(1990-1#1)(1992-4#2)(2006-8#1)(2008-10#6)(2011-3#1)
specific method##18##2##(1990-1#1)(1992-4#2)(1996-3#1)(2006-8#1)(2007-8#1)(2008-10#7)(2008-5#1)(2011-3#1)(2012-2#1)(2013-1#2)
specific methodology##3##2##(2008-10#1)(2009-7#1)(2013-8#1)
specific methods of##2##3##(2008-3#1)(2013-8#1)
specific methods##6##2##(2007-12#1)(2008-10#1)(2008-3#2)(2011-2#1)(2013-8#1)
specific miRNA##2##2##(2011-1#1)(2011-2#1)
specific microbe##3##2##(2007-1#1)(2011-2#2)
specific micronutrients##2##2##(2006-10#1)(2008-2#1)
specific mind-body##2##2##(2010-12#2)
specific modality##2##2##(2010-3#1)(2013-1#1)
specific model##3##2##(1993-1#1)(1993-6#1)(2007-12#1)
specific models##5##2##(1993-9#1)(1996-3#1)(2004-10#1)(2010-5#1)(2012-2#1)
specific modification##2##2##(1990-3#1)(2008-11#1)
specific modifications##4##2##(2007-12#1)(2008-4#1)(2010-12#1)(2011-1#1)
specific molecular##14##2##(1994-11#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-4#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
specific molecule##2##2##(1993-9#1)(2008-9#1)
specific molecules in##3##3##(2008-3#1)(2008-4#1)(2008-9#1)
specific molecules##11##2##(2007-12#1)(2008-1#2)(2008-3#2)(2008-4#3)(2008-9#1)(2010-12#1)(2012-1#1)
specific monoclonal antibodies##12##3##(1990-11#1)(1992-8#1)(1992-9#1)(1993-4#1)(1993-9#1)(1994-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-9#1)(2012-3#1)
specific monoclonal antibody production##4##4##(2008-11#4)
specific monoclonal antibody##13##3##(1990-10#1)(1990-11#1)(1991-10#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-10#1)(2006-8#1)(2008-10#1)(2008-11#4)
specific monoclonal##27##2##(1990-10#1)(1990-11#2)(1991-10#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-2#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-11#5)(2008-8#1)(2008-9#1)(2009-9#1)(2010-4#1)(2012-3#1)
specific morphological##3##2##(1994-11#1)(1994-3#1)(2008-9#1)
specific motor##2##2##(1994-8#1)(2012-2#1)
specific multiple##3##2##(1993-9#1)(2008-10#1)(2009-3#1)
specific mutants##3##2##(1990-7#1)(1990-8#2)
specific mutations in the##4##4##(1994-8#1)(1997-5#1)(2011-1#1)(2012-2#1)
specific mutations##11##2##(1992-1#1)(1994-8#1)(1997-5#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-3#1)(2010-12#1)(2011-1#1)(2012-2#1)
specific nature and##2##3##(1994-8#1)(2006-5#1)
specific nature of the##4##4##(1990-5#1)(1996-5#1)(2007-12#1)(2008-2#1)
specific nature of##7##3##(1990-5#1)(1996-5#2)(2007-12#1)(2007-7#1)(2008-2#1)(2010-2#1)
specific nature##11##2##(1990-5#1)(1994-8#1)(1996-5#2)(2006-2#1)(2006-5#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-2#1)(2010-2#1)
specific needs and##2##3##(2010-6#1)(2012-1#1)
specific needs for##2##3##(1992-6#1)(2008-10#1)
specific needs##18##2##(1992-2#1)(1992-6#1)(1995-1#1)(1996-3#1)(2006-2#2)(2007-10#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-6#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)
specific neural##8##2##(1996-4#1)(1996-5#1)(1996-6#1)(2007-2#1)(2008-12#1)(2008-3#1)(2008-4#1)(2013-7#1)
specific neuronal pathways##2##3##(2007-12#1)(2010-12#1)
specific neuronal populations##4##3##(1991-12#1)(1996-12#2)(1996-3#1)
specific neuronal##10##2##(1991-12#1)(1992-7#1)(1995-11#1)(1995-5#1)(1996-12#2)(1996-3#1)(2007-12#1)(2010-12#1)(2010-9#1)
specific neurons##4##2##(1992-3#1)(1994-5#1)(2007-12#1)(2008-8#1)
specific neurotransmitter##2##2##(1993-11#1)(2008-1#1)
specific nodes##2##2##(2008-11#1)(2013-7#1)
specific nor##2##2##(1991-9#1)(2008-9#1)
specific nuclear##6##2##(1991-12#1)(1992-5#1)(1995-2#1)(1997-6#1)(2008-8#1)(2012-2#1)
specific nuclease##2##2##(1991-7#1)(1997-7#1)
specific nucleic acid##4##3##(1990-11#1)(2007-2#1)(2008-2#2)
specific nucleotide sequence##2##3##(1995-8#2)
specific nucleotide##4##2##(1993-11#1)(1995-8#2)(2008-10#1)
specific nutrient##4##2##(1991-11#1)(2007-12#2)(2008-7#1)
specific nutrients##7##2##(1991-11#1)(1995-6#1)(2006-10#1)(2006-2#2)(2007-12#1)(2012-1#1)
specific nutritional deficiencies##2##3##(2008-4#1)(2012-2#1)
specific nutritional##4##2##(1993-12#1)(2008-4#1)(2012-2#2)
specific objective of##2##3##(2008-5#1)(2010-7#1)
specific objective##3##2##(1993-11#1)(2008-5#1)(2010-7#1)
specific objectives##2##2##(1991-10#1)(2012-2#1)
specific objects##2##2##(2008-11#1)(2008-7#1)
specific of the##2##3##(1990-12#1)(1992-12#1)
specific of##9##2##(1990-12#1)(1991-8#1)(1992-12#2)(1992-6#1)(1992-8#1)(1994-5#1)(2007-9#1)(2009-2#1)
specific oligonucleotide primers##3##3##(1991-10#1)(2008-10#2)
specific oligonucleotide probe##3##3##(1995-1#1)(1996-2#1)(1997-8#1)
specific oligonucleotide probes##3##3##(1990-7#1)(1991-1#1)(1991-9#1)
specific oligonucleotide##13##2##(1990-7#1)(1991-1#1)(1991-10#1)(1991-9#1)(1995-1#1)(1996-11#1)(1996-2#1)(1997-8#3)(2008-10#3)
specific oligonucleotides##3##2##(1991-5#1)(1992-11#1)(1996-7#1)
specific only##2##2##(1991-8#1)(2009-3#1)
specific optical##3##2##(2007-12#1)(2008-2#2)
specific or non-specific##2##3##(2006-10#1)(2010-6#1)
specific or not##2##3##(2007-12#1)(2008-10#1)
specific or##9##2##(1992-4#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-7#1)(2010-6#1)
specific organ##4##2##(1995-8#1)(1996-12#1)(2008-5#1)(2012-1#1)
specific organic##3##2##(1990-3#1)(1995-9#1)(2008-10#1)
specific orientation##2##2##(1995-11#1)(2010-3#1)
specific outcome##3##2##(1997-8#1)(2007-8#1)(2010-5#1)
specific oxygen uptake rate##2##4##(1995-1#1)(2008-11#1)
specific oxygen uptake##4##3##(1995-1#2)(2008-11#2)
specific oxygen##5##2##(1995-1#2)(2008-11#2)(2010-4#1)
specific pH values##2##3##(2007-8#1)(2008-10#1)
specific pH##4##2##(2005-11#1)(2007-8#1)(2008-10#1)(2008-4#1)
specific parameter##2##2##(1993-5#1)(2006-5#1)
specific parameters##6##2##(1990-10#1)(1990-3#1)(1991-5#1)(2006-8#1)(2007-12#1)(2008-10#1)
specific parasite##2##2##(2006-10#1)(2011-2#1)
specific parasitism##2##2##(2008-10#2)
specific parts of##3##3##(2008-11#1)(2008-5#2)
specific pathogen free hens##2##4##(1991-11#2)
specific pathogen free##4##3##(1991-11#2)(1991-6#1)(2008-5#1)
specific pathogen##6##2##(1991-11#2)(1991-6#1)(2008-10#1)(2008-5#1)(2011-2#1)
specific pathogen-free (SPF)##3##3##(1992-5#1)(2008-5#2)
specific pathogen-free chickens##3##3##(2008-5#3)
specific pathogen-free##8##2##(1992-10#1)(1992-5#1)(1997-6#1)(2008-5#5)
specific pathogenic##3##2##(2005-8#1)(2008-7#1)(2010-1#1)
specific pathogens##2##2##(2007-11#1)(2010-6#1)
specific pathological##4##2##(2006-12#1)(2006-5#1)(2007-6#1)(2008-10#1)
specific pathophysiological##2##2##(2006-12#1)(2008-4#1)
specific pathway for the##2##4##(1994-8#1)(2011-2#1)
specific pathway for##3##3##(1994-8#1)(2011-2#2)
specific pathway##6##2##(1990-4#1)(1994-8#1)(2008-1#1)(2008-7#1)(2011-2#2)
specific pathways##4##2##(2008-11#1)(2009-7#2)(2012-12#1)
specific patient##7##2##(1996-3#1)(2006-1#2)(2006-6#1)(2010-6#1)(2010-8#1)(2012-2#1)
specific patients##9##2##(1990-12#1)(2005-7#2)(2007-11#1)(2008-7#1)(2010-8#1)(2012-10#1)(2013-1#2)
specific pattern of##3##3##(1993-6#1)(2009-1#1)(2011-2#1)
specific pattern##5##2##(1993-6#1)(2008-2#1)(2008-3#1)(2009-1#1)(2011-2#1)
specific patterns of gene##2##4##(2008-7#1)(2008-8#1)
specific patterns of regional loss##2##5##(2008-11#1)(2009-4#1)
specific patterns of##9##3##(1995-11#2)(1996-12#1)(1997-8#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-2#1)
specific patterns##12##2##(1995-11#2)(1996-12#1)(1996-2#1)(1997-8#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-2#1)(2012-1#1)(2013-1#1)
specific peptide residues##2##3##(1990-10#1)(2008-4#1)
specific peptide##9##2##(1990-10#1)(1990-4#1)(1993-11#1)(1994-10#1)(1995-3#1)(1996-5#1)(1997-3#1)(2008-4#2)
specific peptides derived from cardiac myosin##2##6##(2008-4#2)
specific peptides##4##2##(1991-5#1)(1994-12#1)(2008-4#2)
specific performance##4##2##(1993-2#1)(2009-6#2)(2012-3#1)
specific perfusion rates##4##3##(2008-11#4)
specific perfusion##5##2##(2008-11#5)
specific personality##3##2##(2008-6#1)(2009-10#1)(2013-7#1)
specific phage##2##2##(1990-5#1)(1995-5#1)
specific phages##2##2##(2011-12#1)(2013-1#1)
specific pharmacological##3##2##(1991-2#1)(1991-4#1)(1996-10#1)
specific phases of##2##3##(2009-5#1)(2012-2#1)
specific phenotypic##2##2##(1997-6#1)(2011-2#1)
specific phobia##2##2##(2010-2#2)
specific phosphoprotein##3##2##(1994-9#1)(2008-2#1)(2008-4#1)
specific phosphorylation##3##2##(1990-8#2)(1995-10#1)
specific phosphotyrosine##2##2##(1994-9#1)(1996-5#1)
specific physical examination##2##3##(2006-12#1)(2006-8#1)
specific physical##8##2##(1997-1#1)(2006-12#1)(2006-8#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
specific physiological##7##2##(1995-6#1)(2008-7#1)(2008-8#1)(2010-2#2)(2011-2#1)(2012-2#1)
specific place##2##2##(1994-6#1)(2013-8#1)
specific places##2##2##(2007-5#1)(2008-10#1)
specific plasma membrane##2##3##(2008-4#1)(2009-8#1)
specific point mutations##2##3##(1997-4#1)(1997-6#1)
specific points in##3##3##(1992-1#1)(1995-6#1)(2008-11#1)
specific points##6##2##(1992-1#1)(1992-9#1)(1995-6#1)(2007-7#1)(2008-11#1)(2009-1#1)
specific polyclonal antibodies##5##3##(1994-3#1)(1995-12#2)(1997-5#1)(2008-10#1)
specific polyclonal antibody was##2##4##(1990-6#1)(2008-10#1)
specific polyclonal antibody##3##3##(1990-6#1)(1992-11#1)(2008-10#1)
specific polyclonal##11##2##(1990-11#2)(1990-6#1)(1992-11#1)(1994-3#1)(1995-12#2)(1997-5#1)(2008-10#3)
specific polymerase chain reaction##6##4##(1992-12#1)(1996-11#1)(2008-10#4)
specific polymorphic##2##2##(1990-5#1)(1995-2#1)
specific population of##3##3##(1990-7#1)(1995-12#1)(2008-7#1)
specific population##10##2##(1990-7#1)(1995-12#1)(2006-10#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#2)
specific populations##3##2##(1991-12#1)(1992-1#1)(2013-8#1)
specific position##3##2##(1990-3#1)(1991-7#1)(1997-4#1)
specific positions##5##2##(1995-7#1)(2007-12#1)(2007-6#1)(2009-8#1)(2013-1#1)
specific power##3##2##(1992-2#1)(2008-3#1)(2008-6#1)
specific practice##2##2##(2008-11#1)(2011-2#1)
specific predictions##4##2##(2008-11#1)(2008-8#2)(2008-9#1)
specific pregnancy##2##2##(1990-5#1)(2013-7#1)
specific preparation##2##2##(2008-3#1)(2011-2#1)
specific prescriptions##2##2##(1991-1#1)(1995-6#1)
specific primary and##2##3##(2008-11#1)(2008-4#1)
specific primary##5##2##(1995-2#1)(2008-11#3)(2008-4#1)
specific primer sets##2##3##(2008-10#2)
specific primer##7##2##(1990-3#1)(2008-10#4)(2009-3#1)(2011-1#1)
specific primers and##3##3##(2008-10#2)(2012-12#1)
specific primers designed##2##3##(2008-10#1)(2013-8#1)
specific primers for the##2##4##(2008-10#1)(2008-5#1)
specific primers for##7##3##(1994-11#1)(1996-2#1)(2006-4#1)(2008-10#2)(2008-5#1)(2008-7#1)
specific primers was##2##3##(2007-2#1)(2008-12#1)
specific primers were designed##2##4##(2008-10#1)(2013-8#1)
specific primers were##4##3##(2008-10#3)(2013-8#1)
specific primers##33##2##(1992-9#1)(1994-11#1)(1996-2#1)(1997-8#1)(2005-11#1)(2006-4#1)(2007-2#1)(2007-3#1)(2008-10#12)(2008-12#2)(2008-5#1)(2008-7#1)(2011-2#2)(2012-12#3)(2013-1#1)(2013-8#3)
specific probe for##7##3##(1990-12#1)(1991-12#1)(1991-9#1)(1994-8#1)(2008-8#2)(2008-9#1)
specific probe##18##2##(1990-12#1)(1991-12#1)(1991-9#1)(1992-12#2)(1994-11#1)(1994-5#1)(1994-8#1)(1996-5#1)(1997-1#2)(1997-2#1)(2007-2#1)(2008-10#1)(2008-8#2)(2008-9#1)(2013-8#1)
specific probes##9##2##(1990-7#1)(1991-5#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1997-7#1)(2008-5#1)(2013-8#1)
specific problem##4##2##(1994-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
specific problems of##2##3##(2006-1#1)(2008-5#1)
specific problems with##2##3##(2006-10#1)(2009-4#1)
specific problems##15##2##(1994-2#1)(2006-1#1)(2006-10#2)(2006-9#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-11#1)(2012-12#1)
specific procedures##6##2##(1993-2#1)(1995-8#1)(2006-10#1)(2009-5#1)(2010-12#1)(2012-12#1)
specific process##5##2##(1991-1#1)(1996-11#1)(2008-8#2)(2010-2#1)
specific product##3##2##(1992-8#1)(2007-4#1)(2008-5#1)
specific production rate##3##3##(2008-11#2)(2011-2#1)
specific production##7##2##(2007-11#1)(2008-10#1)(2008-11#4)(2011-2#1)
specific productivity of##8##3##(2008-11#5)(2008-6#2)(2008-7#1)
specific productivity##17##2##(2008-11#13)(2008-6#2)(2008-7#2)
specific products##3##2##(2007-8#1)(2008-7#1)(2012-3#1)
specific profile##2##2##(2006-10#1)(2010-7#1)
specific programming##2##2##(1996-5#1)(2013-8#1)
specific promoter in##2##3##(2008-11#1)(2008-9#1)
specific promoter##6##2##(1991-8#1)(1992-11#1)(2008-11#3)(2008-9#1)
specific properties##5##2##(1992-3#1)(1993-4#1)(1994-4#1)(2008-10#1)(2008-7#1)
specific protease##5##2##(1993-12#1)(1994-8#1)(1995-3#1)(2008-9#1)(2012-3#1)
specific protection##2##2##(1990-5#1)(2013-1#1)
specific protein binding assay##2##4##(1990-10#1)(1992-6#1)
specific protein binding to##2##4##(1992-11#2)
specific protein binding##4##3##(1990-10#1)(1992-11#2)(1992-6#1)
specific protein kinase C##3##4##(1990-9#1)(1991-9#1)(2008-11#1)
specific protein kinase##7##3##(1990-9#1)(1991-7#1)(1991-9#1)(1992-6#1)(1993-6#1)(1994-3#1)(2008-11#1)
specific protein of##2##3##(1992-9#1)(1996-12#1)
specific protein##39##2##(1990-10#1)(1990-11#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-7#1)(1991-9#3)(1992-11#3)(1992-12#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-4#1)(2005-10#1)(2006-10#1)(2008-11#2)(2008-2#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)
specific protein-protein interactions##2##3##(2008-4#1)(2009-9#1)
specific protein-protein##3##2##(2008-2#1)(2008-4#1)(2009-9#1)
specific proteins in##4##3##(1990-6#1)(1993-11#1)(2008-1#1)(2010-11#1)
specific proteins that##2##3##(2010-11#2)
specific proteins##34##2##(1990-6#2)(1990-9#1)(1991-6#1)(1992-4#1)(1993-11#1)(1994-6#1)(1996-12#2)(1997-1#1)(1997-6#1)(2006-10#1)(2006-9#1)(2007-2#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-2#2)(2008-4#2)(2009-12#1)(2009-3#1)(2010-11#3)(2010-12#1)(2012-2#1)
specific proteolytic activity##2##3##(1992-5#1)(1994-6#1)
specific proteolytic##3##2##(1992-5#1)(1994-6#1)(1994-8#1)
specific protocols for##3##3##(2008-1#1)(2008-4#2)
specific protocols##5##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)
specific protonation of##2##3##(1995-10#2)
specific psychiatric##4##2##(1991-2#1)(1994-2#1)(2006-4#1)(2009-4#1)
specific pulmonary##2##2##(1996-2#1)(2007-12#1)
specific purpose##4##2##(2005-11#1)(2010-11#1)(2013-1#2)
specific purposes##2##2##(1994-1#1)(2012-1#1)
specific quality of##2##3##(2012-2#1)(2013-1#1)
specific questions are##3##3##(1993-4#1)(1996-3#1)(2012-2#1)
specific questions##9##2##(1990-12#1)(1993-4#1)(1996-3#2)(2006-10#1)(2010-6#1)(2012-12#1)(2012-2#2)
specific radioactivity of the##2##4##(1995-10#1)(1995-6#1)
specific radioactivity of##4##3##(1991-3#1)(1995-10#2)(1995-6#1)
specific radioactivity##9##2##(1990-12#4)(1991-3#1)(1993-4#1)(1995-10#2)(1995-6#1)
specific radiographic##2##2##(2006-10#1)(2013-8#1)
specific radioimmunoassay##2##2##(1996-2#1)(1996-9#1)
specific radioimmunoassays##2##2##(1990-11#1)(1992-8#1)
specific rat##3##2##(1992-12#1)(1995-11#2)
specific rate##5##2##(2006-12#2)(2007-11#1)(2008-11#1)(2009-3#1)
specific rates of##5##3##(2006-12#1)(2008-11#3)(2011-1#1)
specific rates##8##2##(2006-12#1)(2008-11#4)(2011-1#1)(2011-2#1)(2013-1#1)
specific reaction##2##2##(2008-10#1)(2008-5#1)
specific reactivity##2##2##(1990-12#1)(1992-8#1)
specific reading##3##2##(2004-10#3)
specific reagent##3##2##(1990-5#1)(1994-5#1)(2008-10#1)
specific reagents##5##2##(1990-2#1)(2008-10#1)(2008-4#1)(2008-9#2)
specific receptor for##2##3##(1992-11#1)(1995-10#1)
specific receptor in##2##3##(1993-12#1)(2010-12#1)
specific receptor on##3##3##(1990-7#1)(1994-11#1)(1994-6#1)
specific receptor##24##2##(1990-12#1)(1990-5#1)(1990-7#2)(1991-2#1)(1992-11#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-10#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-7#1)(2004-12#1)(2005-7#1)(2006-12#1)(2008-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#1)
specific receptors are##2##3##(1997-4#1)(2008-4#1)
specific receptors on the##3##4##(1991-12#1)(2008-4#1)(2010-10#1)
specific receptors on##5##3##(1991-12#1)(1994-8#1)(2008-4#1)(2010-10#1)(2013-7#1)
specific receptors##24##2##(1990-4#1)(1990-7#1)(1991-12#1)(1994-3#2)(1994-6#2)(1994-8#1)(1996-5#1)(1997-4#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-8#3)(2010-10#1)(2013-7#1)
specific recognition of the##3##4##(1991-9#1)(1995-3#1)(2008-10#1)
specific recognition of##11##3##(1990-2#1)(1991-9#1)(1995-3#2)(1996-5#2)(1997-4#1)(2006-12#1)(2008-10#3)
specific recognition##17##2##(1990-2#1)(1991-2#1)(1991-9#1)(1994-9#2)(1995-3#2)(1996-5#2)(1997-4#1)(2006-12#1)(2007-11#1)(2008-10#4)(2008-4#1)
specific recombinant##3##2##(2008-11#2)(2013-8#1)
specific recommendations for##3##3##(1993-7#1)(2008-5#1)(2009-11#1)
specific recommendations##10##2##(1990-6#1)(1993-7#1)(2007-2#1)(2008-12#1)(2008-5#1)(2009-11#1)(2009-4#1)(2010-2#1)(2010-6#1)(2011-2#1)
specific reference to the##4##4##(1993-10#1)(2006-11#1)(2008-10#1)(2008-2#1)
specific reference to##8##3##(1991-3#1)(1992-12#1)(1993-1#1)(1993-10#1)(2006-11#1)(2008-10#1)(2008-2#1)(2011-1#1)
specific reference##9##2##(1991-3#1)(1992-12#1)(1993-1#1)(1993-10#1)(2006-11#1)(2007-11#1)(2008-10#1)(2008-2#1)(2011-1#1)
specific region of##4##3##(1994-11#1)(2007-5#1)(2007-7#1)(2011-2#1)
specific region##10##2##(1990-10#1)(1993-3#1)(1993-9#1)(1994-11#1)(1996-1#1)(2007-5#1)(2007-7#1)(2008-4#1)(2011-2#1)(2013-8#1)
specific regional##2##2##(2006-8#1)(2011-2#1)
specific regions of interest##2##4##(2008-6#1)(2012-1#1)
specific regions of the genome##2##5##(2008-4#1)(2008-9#1)
specific regions of the##6##4##(1993-6#1)(1995-1#1)(1995-3#1)(1996-12#1)(2008-4#1)(2008-9#1)
specific regions of##10##3##(1993-6#1)(1995-1#1)(1995-3#2)(1995-5#1)(1996-12#1)(2008-4#1)(2008-6#1)(2008-9#1)(2012-1#1)
specific regions##14##2##(1992-6#1)(1993-6#1)(1995-1#1)(1995-3#2)(1995-5#1)(1996-12#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-1#1)
specific regulation of##2##3##(1992-6#1)(2009-12#1)
specific regulation##5##2##(1992-6#1)(1995-8#1)(2009-12#1)(2012-12#2)
specific regulators##3##2##(1990-6#1)(2008-1#1)(2008-7#1)
specific regulatory##7##2##(1993-3#1)(1994-10#1)(1994-8#1)(1995-11#1)(1997-6#1)(2008-2#1)(2012-1#1)
specific rehabilitation##3##2##(2008-8#1)(2009-9#1)(2011-1#1)
specific relationship##3##2##(2006-7#1)(2007-12#1)(2008-10#1)
specific relationships between fibre##2##4##(2010-4#2)
specific relationships between##3##3##(2010-4#2)(2010-7#1)
specific relationships##5##2##(2007-12#1)(2010-4#2)(2010-7#2)
specific release of##3##3##(1995-11#1)(2008-4#1)(2009-3#1)
specific repair##2##2##(2008-11#1)(2008-9#1)
specific requirement for the##2##4##(1990-5#1)(1994-3#1)
specific requirement for##3##3##(1990-5#1)(1994-12#1)(1994-3#1)
specific requirements and##2##3##(2008-9#1)(2013-8#1)
specific requirements##8##2##(1991-12#1)(1991-4#1)(1992-11#1)(1995-5#1)(2006-10#1)(2008-4#1)(2008-9#1)(2013-8#1)
specific research##8##2##(1996-1#1)(1996-2#1)(2008-1#1)(2008-4#1)(2008-7#1)(2012-2#2)(2012-3#1)
specific residues in the##2##4##(1995-8#1)(1996-7#1)
specific residues in##3##3##(1995-8#1)(1996-7#1)(1997-7#1)
specific residues##6##2##(1990-8#1)(1991-2#1)(1995-3#1)(1995-8#1)(1996-7#1)(1997-7#1)
specific resistance##6##2##(2008-10#6)
specific response of##2##3##(1995-8#1)(2008-10#1)
specific response to##3##3##(2006-10#1)(2007-2#1)(2008-7#1)
specific response##11##2##(1990-5#1)(1992-10#1)(1995-8#1)(2005-11#1)(2006-10#2)(2007-2#1)(2008-10#1)(2008-7#1)(2010-4#1)(2011-1#1)
specific responses##5##2##(1992-8#1)(1995-12#2)(2007-12#1)(2008-11#1)
specific results##2##2##(1992-6#1)(2008-3#1)
specific retention of the##2##4##(1992-5#1)(1993-12#1)
specific richness##4##2##(2007-3#1)(2008-5#3)
specific risk factors and##2##4##(2008-1#2)
specific risk factors##9##3##(2006-10#1)(2007-1#1)(2008-1#3)(2008-9#1)(2009-8#1)(2013-1#2)
specific risk##13##2##(1996-12#1)(1997-8#1)(2006-10#1)(2007-1#1)(2008-1#3)(2008-3#1)(2008-9#1)(2009-10#1)(2009-8#1)(2013-1#2)
specific role for this##3##4##(1991-1#1)(1991-6#1)(1996-2#1)
specific role for##7##3##(1991-1#1)(1991-6#1)(1996-2#1)(1997-4#1)(2006-5#1)(2010-2#1)(2011-2#1)
specific role in##4##3##(1997-2#1)(2008-11#1)(2008-6#1)(2008-8#1)
specific role of##11##3##(1990-11#1)(1991-9#1)(1993-6#2)(1996-2#2)(2006-10#1)(2008-1#1)(2008-11#1)(2008-7#1)(2012-2#1)
specific role##29##2##(1990-11#1)(1991-1#1)(1991-6#1)(1991-9#1)(1993-6#2)(1996-2#3)(1997-2#1)(1997-4#1)(2006-10#1)(2006-5#1)(2007-10#1)(2008-1#1)(2008-11#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
specific roles for##2##3##(1992-12#1)(2013-8#1)
specific roles in##4##3##(1992-12#1)(1995-2#1)(2008-11#1)(2008-4#1)
specific roles of##6##3##(1993-8#1)(1996-2#1)(2006-2#1)(2008-4#1)(2009-6#1)(2009-9#1)
specific roles##17##2##(1991-4#1)(1992-12#2)(1993-8#1)(1995-2#1)(1996-2#1)(2006-2#1)(2007-10#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-8#1)(2009-6#1)(2009-9#1)(2013-8#1)
specific rotation##4##2##(2007-8#1)(2008-10#2)(2008-3#1)
specific routes##2##2##(2006-4#1)(2008-7#1)
specific sample##2##2##(1990-8#1)(2008-10#1)
specific scoring##2##2##(2008-11#2)
specific screening##2##2##(1994-2#1)(2008-3#1)
specific search##2##2##(1993-1#1)(2008-7#1)
specific secretory##2##2##(1990-5#1)(2013-1#1)
specific selection criteria##2##3##(2006-10#1)(2011-11#1)
specific selection##3##2##(2006-10#1)(2008-2#1)(2011-11#1)
specific semantic##3##2##(1991-2#1)(2013-1#2)
specific sensitivity##3##2##(1991-7#1)(2008-11#1)(2011-2#1)
specific sensory##4##2##(1996-3#1)(2007-12#2)(2012-1#1)
specific sequence of the##3##4##(1992-11#1)(1993-12#1)(1996-8#1)
specific sequence##10##2##(1992-11#1)(1993-12#1)(1996-8#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-9#1)(2010-1#1)(2013-8#1)
specific sequences##4##2##(1991-5#1)(1995-4#1)(1995-8#1)(2008-4#1)
specific serine##3##2##(1995-10#1)(1996-9#1)(2008-8#1)
specific serum##4##2##(1991-10#1)(1996-2#1)(2010-12#1)(2011-1#1)
specific service##2##2##(1997-3#1)(2011-2#1)
specific services and##2##3##(1990-12#1)(2007-2#1)
specific services##5##2##(1990-12#1)(1995-12#1)(2007-2#1)(2010-2#2)
specific sets of##3##3##(1990-5#1)(1995-2#1)(2009-12#1)
specific siRNA##3##2##(2008-4#1)(2009-3#1)(2010-12#1)
specific signal##5##2##(1994-9#1)(1997-6#1)(2007-12#1)(2008-9#1)(2010-4#1)
specific signaling events##2##3##(2006-9#1)(2011-2#1)
specific signaling pathways##2##3##(2009-3#1)(2009-8#1)
specific signaling##6##2##(2006-9#1)(2008-11#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-2#1)
specific signalling##2##2##(2008-7#1)(2011-2#1)
specific signals##2##2##(2009-12#2)
specific signatures##2##2##(2012-2#1)(2012-3#1)
specific since it##2##3##(1991-8#1)(2008-6#1)
specific since the##2##3##(1991-10#1)(1993-11#1)
specific since##7##2##(1991-10#1)(1991-7#1)(1991-8#1)(1993-11#1)(2008-4#1)(2008-6#1)(2013-1#1)
specific site##6##2##(1991-8#1)(1991-9#1)(1992-2#1)(1994-8#1)(2011-2#1)(2013-8#1)
specific sites in the##2##4##(1995-11#1)(2009-3#1)
specific sites in##4##3##(1994-12#1)(1995-11#1)(2009-3#1)(2010-8#1)
specific sites of##4##3##(1991-11#1)(1991-2#1)(2011-1#1)(2012-2#1)
specific sites on the##2##4##(1991-8#1)(2010-8#1)
specific sites on##5##3##(1991-8#1)(1997-7#1)(2010-8#2)(2013-1#1)
specific sites##21##2##(1991-11#1)(1991-2#1)(1991-8#1)(1993-11#1)(1994-12#2)(1995-11#1)(1996-2#1)(1996-7#1)(1997-4#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-4#1)(2009-3#1)(2010-8#3)(2011-1#1)(2012-2#1)(2013-1#1)
specific situation##5##2##(1990-3#1)(2006-2#1)(2009-11#1)(2010-12#1)(2011-2#1)
specific situations##11##2##(2006-12#1)(2006-7#1)(2006-8#5)(2007-2#1)(2007-5#1)(2008-12#1)(2012-12#1)
specific skeletal##2##2##(2008-9#1)(2011-1#1)
specific skills##4##2##(1993-10#1)(2004-10#1)(2011-2#1)(2012-12#1)
specific sleep##2##2##(2007-2#1)(2010-8#1)
specific social##5##2##(2008-12#1)(2010-2#1)(2010-8#1)(2012-11#1)(2013-1#1)
specific soluble antigen##2##3##(2008-11#2)
specific somatic##2##2##(2008-4#1)(2008-9#1)
specific spatial##2##2##(2008-7#1)(2013-8#1)
specific species##3##2##(2008-11#1)(2011-1#1)(2013-7#1)
specific spectral##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
specific stages of##5##3##(2006-12#1)(2007-12#1)(2010-12#1)(2012-2#2)
specific stages##8##2##(2006-12#1)(2007-12#1)(2008-6#1)(2010-12#2)(2010-5#1)(2012-2#2)
specific statistical##2##2##(2008-10#1)(2008-6#1)
specific status##3##2##(2004-11#2)(2013-7#1)
specific stem##2##2##(2008-10#1)(2008-11#1)
specific steps in##2##3##(2011-3#1)(2013-1#1)
specific steps##9##2##(1992-2#1)(1995-6#1)(2006-6#1)(2007-4#1)(2008-11#1)(2008-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
specific strain##2##2##(2008-10#1)(2008-11#1)
specific strains of##3##3##(2006-10#1)(2008-10#2)
specific strains##5##2##(2006-10#2)(2006-6#1)(2008-10#2)
specific strategies##4##2##(2007-10#1)(2008-7#1)(2010-12#1)(2013-1#1)
specific stressors##2##2##(2006-3#1)(2009-3#1)
specific structural features##3##3##(1992-9#1)(1995-3#1)(2008-5#1)
specific structural##9##2##(1992-9#1)(1994-5#2)(1995-3#1)(1997-6#1)(2007-12#1)(2008-5#1)(2009-12#1)(2012-3#1)
specific structure##4##2##(1995-5#1)(1997-4#1)(2008-10#1)(2012-2#1)
specific structures##2##2##(2008-7#1)(2010-4#1)
specific studies##4##2##(2012-12#2)(2013-1#2)
specific subgroups of##3##3##(2005-10#1)(2006-10#1)(2011-1#1)
specific subgroups##5##2##(1997-2#1)(2005-10#1)(2006-10#1)(2011-1#2)
specific subject##2##2##(2012-1#1)(2013-1#1)
specific subsets of##2##3##(2008-2#1)(2008-7#1)
specific subsets##3##2##(2008-2#1)(2008-7#1)(2011-12#1)
specific substrate##7##2##(1991-10#1)(1992-4#1)(1993-11#1)(1996-5#1)(1996-7#1)(2008-6#1)(2010-12#1)
specific substrates##6##2##(2006-6#1)(2008-1#1)(2008-2#1)(2008-9#1)(2010-12#1)(2012-12#1)
specific subtypes of##6##3##(1994-5#1)(1997-3#1)(2007-2#1)(2008-3#1)(2008-5#1)(2008-8#1)
specific subtypes##8##2##(1994-5#1)(1997-3#1)(2007-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#2)
specific sugar##3##2##(1994-6#2)(2011-1#1)
specific suppression of##2##3##(1991-12#2)
specific surface area (SSA)##2##4##(2004-9#1)(2013-1#1)
specific surface area and the##2##5##(2008-5#1)(2010-4#1)
specific surface area and##6##4##(2005-11#4)(2008-5#1)(2010-4#1)
specific surface area of the##5##5##(1996-8#1)(2004-9#1)(2005-11#3)
specific surface area was synthesized##2##5##(2008-10#2)
specific surface area was##3##4##(2008-10#2)(2013-8#1)
specific surface area##26##3##(1990-8#1)(1993-12#1)(1996-2#1)(1996-8#1)(2004-9#2)(2005-11#12)(2008-10#2)(2008-5#1)(2010-4#2)(2013-1#1)(2013-8#2)
specific surface areas##4##3##(1990-8#1)(2004-9#1)(2005-11#1)(2008-10#1)
specific surface marker##2##3##(1995-5#1)(2011-2#1)
specific surface of the##2##4##(2005-12#1)(2005-4#1)
specific surface of##3##3##(2005-12#1)(2005-4#1)(2007-9#1)
specific surface##44##2##(1990-8#2)(1993-12#1)(1995-5#1)(1996-2#1)(1996-8#1)(2004-9#4)(2005-11#13)(2005-12#1)(2005-4#1)(2007-9#1)(2008-10#4)(2008-5#2)(2009-11#1)(2009-7#1)(2010-4#2)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#4)
specific surgical##3##2##(2006-6#1)(2007-5#1)(2007-8#1)
specific symptoms and##2##3##(2008-9#1)(2010-12#1)
specific symptoms of##3##3##(1996-4#1)(2006-7#1)(2008-4#1)
specific symptoms that##2##3##(2007-11#2)
specific symptoms##12##2##(1996-4#1)(1997-2#1)(2006-3#1)(2006-7#1)(2007-11#2)(2008-4#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-1#1)(2013-1#1)
specific syndromes##2##2##(2006-10#1)(2008-2#1)
specific tRNA##2##2##(1995-12#1)(1997-2#1)
specific target cells##2##3##(2008-4#2)
specific target##15##2##(1993-5#1)(1995-3#1)(1996-4#2)(1997-5#1)(2006-2#1)(2007-2#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2012-2#1)
specific targeting of##3##3##(1995-12#1)(1997-7#1)(2012-3#1)
specific targeting##6##2##(1992-7#1)(1994-8#1)(1995-12#1)(1997-7#1)(2011-2#1)(2012-3#1)
specific targets##5##2##(2006-10#1)(2008-3#1)(2009-9#1)(2012-3#1)(2013-8#1)
specific task##7##2##(1992-8#1)(2006-10#1)(2008-4#1)(2008-7#1)(2013-1#2)(2013-7#1)
specific tasks##6##2##(1995-11#1)(1996-1#1)(2007-9#2)(2008-10#1)(2009-5#1)
specific technique##4##2##(1990-7#1)(2007-10#1)(2007-2#1)(2008-10#1)
specific techniques##4##2##(2004-11#1)(2007-6#1)(2007-8#1)(2009-2#1)
specific temporal##4##2##(2008-11#3)(2012-1#1)
specific test for the##2##4##(2007-11#1)(2011-2#1)
specific test of##2##3##(1996-3#1)(2007-9#1)
specific test##6##2##(1996-3#1)(2007-11#2)(2007-9#1)(2008-2#1)(2011-2#1)
specific tests##5##2##(1993-2#1)(2007-6#1)(2007-7#1)(2008-4#1)(2008-5#1)
specific than the##5##3##(1993-4#1)(1994-3#1)(1995-1#1)(2010-5#2)
specific than##10##2##(1990-2#1)(1993-4#1)(1994-3#1)(1995-1#1)(1995-12#1)(1997-1#1)(2008-3#1)(2009-10#1)(2010-5#2)
specific therapeutic##6##2##(1990-4#1)(2006-10#1)(2007-11#1)(2008-10#1)(2011-2#1)(2012-3#1)
specific therapies to##2##3##(2009-1#1)(2010-7#1)
specific therapies##7##2##(2006-4#2)(2008-2#1)(2009-1#1)(2009-4#1)(2010-12#1)(2010-7#1)
specific therapy and##2##3##(1990-7#1)(2008-4#1)
specific therapy for##3##3##(1990-2#1)(2008-10#1)(2011-12#1)
specific therapy##13##2##(1990-2#1)(1990-7#1)(1992-11#1)(2006-7#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-4#3)(2010-1#1)(2010-10#1)(2011-12#1)
specific thioredoxins##2##2##(1990-12#1)(2009-10#1)
specific thrombin inhibitor##3##3##(1991-9#1)(2007-10#1)(2007-11#1)
specific thromboxane##2##2##(1990-11#2)
specific time points##2##3##(2010-4#2)
specific time##10##2##(1991-8#1)(1995-9#1)(1996-3#1)(1997-4#1)(2006-11#1)(2007-9#1)(2008-10#2)(2010-4#2)
specific times##3##2##(1997-6#1)(2006-12#1)(2007-12#1)
specific tissue##3##2##(1995-6#1)(2008-10#1)(2010-1#1)
specific tissues##7##2##(1993-12#1)(1993-3#1)(1994-11#1)(1994-5#1)(2008-11#1)(2010-5#1)(2011-2#1)
specific to A##3##3##(2007-1#3)
specific to DRB1*0406##2##3##(1997-8#2)
specific to V##3##3##(2008-10#2)(2009-8#1)
specific to a##5##3##(1994-12#1)(1995-3#1)(2007-12#1)(2008-10#1)(2011-2#1)
specific to an##2##3##(1992-8#1)(2008-10#1)
specific to each##3##3##(2008-8#1)(2011-2#1)(2012-3#1)
specific to human##2##3##(1996-6#1)(1997-8#1)
specific to pregnancy##2##3##(2007-9#2)
specific to the particular##2##4##(1995-8#1)(2008-10#1)
specific to the##60##3##(1990-11#1)(1990-7#1)(1991-10#1)(1991-3#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-6#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-7#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-4#1)(1997-8#2)(2004-12#1)(2005-11#1)(2006-12#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
specific to these##2##3##(1996-7#1)(2007-12#1)
specific to this application are##2##5##(2007-3#1)(2009-11#1)
specific to this##8##3##(1997-6#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-11#1)
specific to##210##2##(1990-11#2)(1990-2#1)(1990-4#1)(1990-7#2)(1990-8#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-11#2)(1993-2#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-3#3)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#2)(1995-6#1)(1995-7#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#2)(1997-6#4)(1997-7#1)(1997-8#7)(2004-12#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-1#3)(2007-10#2)(2007-11#5)(2007-12#8)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#26)(2008-11#5)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#6)(2008-7#6)(2008-8#3)(2008-9#2)(2009-10#3)(2009-11#2)(2009-2#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-4#3)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#4)
specific tools for##2##3##(1994-4#1)(2013-1#1)
specific tools##4##2##(1992-4#1)(1994-4#1)(1996-1#1)(2013-1#1)
specific toxic##2##2##(1996-12#1)(2004-4#1)
specific toxicity##2##2##(1991-9#1)(1996-11#1)
specific training##7##2##(1991-12#1)(2006-3#1)(2006-6#1)(2006-7#1)(2011-2#1)(2012-1#1)(2012-12#1)
specific traits##2##2##(2008-8#1)(2008-9#1)
specific transcription factor##4##3##(1992-2#1)(1995-2#1)(1996-8#1)(2008-11#1)
specific transcription factors##3##3##(1993-2#1)(1993-3#1)(2007-12#1)
specific transcription##9##2##(1992-2#1)(1993-2#1)(1993-3#1)(1993-9#1)(1995-2#1)(1996-8#2)(2007-12#1)(2008-11#1)
specific transcriptional##3##2##(1995-3#1)(2008-7#1)(2012-12#1)
specific transcripts##3##2##(1991-7#1)(1996-2#2)
specific transgene##2##2##(2008-11#1)(2009-10#1)
specific transient##2##2##(1990-8#1)(2008-9#1)
specific transport##6##2##(1995-8#1)(2006-10#2)(2009-4#1)(2010-9#1)(2012-11#1)
specific transporters##2##2##(1994-10#1)(2013-8#1)
specific treatment and##2##3##(2007-2#1)(2011-2#1)
specific treatment for##7##3##(1994-9#1)(1996-11#1)(2005-7#1)(2007-7#1)(2008-6#1)(2013-1#2)
specific treatment guidelines##2##3##(2011-1#1)(2011-2#1)
specific treatment of##6##3##(1993-11#1)(2008-1#1)(2008-8#1)(2009-1#1)(2009-3#1)(2011-2#1)
specific treatment strategies##2##3##(1996-9#1)(2007-5#1)
specific treatment##48##2##(1990-5#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-9#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-2#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-8#2)(2007-10#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-3#2)(2009-4#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#3)(2013-1#2)
specific treatments##6##2##(1995-12#1)(2006-10#1)(2008-9#1)(2009-4#1)(2010-12#1)(2013-1#1)
specific tumor##4##2##(2008-10#1)(2008-5#1)(2008-7#1)(2010-2#1)
specific tumors##2##2##(2007-11#1)(2008-1#1)
specific type of##12##3##(1990-8#1)(1992-2#1)(1993-9#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-4#1)(2013-7#1)
specific type##14##2##(1990-8#1)(1991-5#1)(1992-2#1)(1993-9#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-4#1)(2011-1#1)(2013-7#1)
specific types of##12##3##(1991-6#1)(1995-5#1)(2005-7#1)(2006-1#2)(2007-4#1)(2007-8#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#1)
specific tyrosine kinase##2##3##(2008-1#1)(2010-5#1)
specific tyrosine##4##2##(1995-3#1)(2008-1#1)(2008-5#1)(2010-5#1)
specific tyrosine-phosphorylated peptides##3##3##(2008-1#2)(2008-4#1)
specific uptake##3##2##(1990-8#1)(1996-5#2)
specific use in##2##3##(1994-1#1)(1996-8#1)
specific use of##3##3##(2008-1#1)(2012-12#2)
specific use##5##2##(1994-1#1)(1996-8#1)(2008-1#1)(2012-12#2)
specific uses##2##2##(1991-12#1)(2008-6#1)
specific vaccination##2##2##(2012-12#2)
specific value for##2##3##(1993-2#1)(1995-9#1)
specific values##5##2##(1993-5#1)(2008-3#1)(2008-7#1)(2013-1#2)
specific viral##2##2##(1991-11#1)(2008-8#1)
specific virulence on##2##3##(2008-10#2)
specific virulence##7##2##(2008-10#6)(2012-12#1)
specific virus##2##2##(2008-11#1)(2012-11#1)
specific volume##5##2##(2006-10#1)(2008-10#3)(2009-7#1)
specific volumes of##2##3##(2006-10#1)(2008-10#1)
specific walking##2##2##(2010-2#1)(2012-1#1)
specific warnings##2##2##(2013-1#2)
specific way##3##2##(1997-7#1)(2008-12#1)(2009-2#1)
specific ways##4##2##(1996-1#1)(2008-10#2)(2008-11#1)
specific wheat cultivars##2##3##(2008-10#2)
specific with regard to##2##4##(2007-3#1)(2009-6#1)
specific with respect to##2##4##(1992-3#1)(1995-1#1)
specific with##5##2##(1992-3#1)(1995-1#1)(2007-3#1)(2009-6#1)(2012-3#1)
specific yeast artificial chromosome##2##4##(1996-8#1)(2008-5#1)
specific##6714##1##(1990-1#3)(1990-10#20)(1990-11#49)(1990-12#51)(1990-2#42)(1990-3#24)(1990-4#23)(1990-5#36)(1990-6#17)(1990-7#44)(1990-8#29)(1990-9#10)(1991-1#16)(1991-10#21)(1991-11#18)(1991-12#47)(1991-2#38)(1991-3#18)(1991-4#25)(1991-5#31)(1991-6#20)(1991-7#16)(1991-8#30)(1991-9#32)(1992-1#19)(1992-10#6)(1992-11#33)(1992-12#32)(1992-2#35)(1992-3#33)(1992-4#12)(1992-5#23)(1992-6#36)(1992-7#27)(1992-8#46)(1992-9#27)(1993-1#11)(1993-10#5)(1993-11#38)(1993-12#32)(1993-2#19)(1993-3#27)(1993-4#10)(1993-5#17)(1993-6#33)(1993-7#9)(1993-8#33)(1993-9#39)(1994-1#8)(1994-10#15)(1994-11#46)(1994-12#50)(1994-2#43)(1994-3#44)(1994-4#2)(1994-5#31)(1994-6#40)(1994-7#1)(1994-8#61)(1994-9#38)(1995-1#35)(1995-10#23)(1995-11#44)(1995-12#48)(1995-2#42)(1995-3#59)(1995-4#8)(1995-5#32)(1995-6#29)(1995-7#12)(1995-8#44)(1995-9#11)(1996-1#12)(1996-10#15)(1996-11#24)(1996-12#46)(1996-2#50)(1996-3#34)(1996-4#24)(1996-5#59)(1996-6#18)(1996-7#21)(1996-8#24)(1996-9#23)(1997-1#33)(1997-2#32)(1997-3#18)(1997-4#54)(1997-5#21)(1997-6#44)(1997-7#31)(1997-8#32)(1997-9#1)(2003-11#1)(2004-1#2)(2004-10#8)(2004-11#12)(2004-12#5)(2004-2#1)(2004-3#2)(2004-4#4)(2004-9#7)(2005-10#10)(2005-11#54)(2005-12#4)(2005-4#3)(2005-5#1)(2005-6#2)(2005-7#19)(2005-8#24)(2005-9#3)(2006-1#9)(2006-10#111)(2006-11#7)(2006-12#41)(2006-2#22)(2006-3#13)(2006-4#12)(2006-5#17)(2006-6#18)(2006-7#10)(2006-8#51)(2006-9#14)(2007-1#16)(2007-10#25)(2007-11#74)(2007-12#101)(2007-2#37)(2007-3#15)(2007-4#16)(2007-5#20)(2007-6#21)(2007-7#33)(2007-8#63)(2007-9#25)(2008-1#79)(2008-10#458)(2008-11#272)(2008-12#37)(2008-2#93)(2008-3#90)(2008-4#194)(2008-5#123)(2008-6#46)(2008-7#164)(2008-8#102)(2008-9#98)(2009-1#7)(2009-10#28)(2009-11#13)(2009-12#16)(2009-2#18)(2009-3#32)(2009-4#35)(2009-5#26)(2009-6#18)(2009-7#20)(2009-8#39)(2009-9#19)(2010-1#11)(2010-10#13)(2010-11#25)(2010-12#58)(2010-2#33)(2010-3#13)(2010-4#40)(2010-5#24)(2010-6#22)(2010-7#17)(2010-8#30)(2010-9#14)(2011-1#69)(2011-10#1)(2011-11#1)(2011-12#10)(2011-2#151)(2011-3#7)(2011-7#1)(2011-9#1)(2012-1#39)(2012-10#1)(2012-11#15)(2012-12#84)(2012-2#119)(2012-3#53)(2012-5#2)(2012-7#2)(2012-8#1)(2013-1#145)(2013-7#28)(2013-8#80)
specific&quot##6##1##(1997-5#2)(2008-11#1)(2010-3#1)(2013-1#2)
specific)##2##1##(1996-8#1)(2012-3#1)
specific-PCR##2##1##(2008-10#1)(2011-2#1)
specific-pathogen-free (SPF)##3##2##(2008-5#1)(2013-8#2)
specific-pathogen-free chickens##4##2##(1997-6#1)(2008-5#2)(2013-8#1)
specific-pathogen-free chicks were##2##3##(2013-8#2)
specific-pathogen-free chicks##4##2##(2008-5#2)(2013-8#2)
specific-pathogen-free##11##1##(1997-6#1)(2008-5#5)(2013-8#5)
specifically a##4##2##(1994-11#1)(1994-12#1)(1995-12#1)(2006-10#1)
specifically activates##2##2##(1990-11#1)(2013-1#1)
specifically adapted##2##2##(1993-2#1)(2008-4#1)
specifically address the##2##3##(2008-11#1)(2008-4#1)
specifically address##4##2##(2006-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
specifically addressing the##2##3##(2007-6#1)(2011-2#1)
specifically addressing##3##2##(2007-6#1)(2011-2#1)(2013-1#1)
specifically affect the##4##3##(1993-8#1)(1995-8#1)(2008-11#1)(2008-7#1)
specifically affect##8##2##(1993-8#1)(1995-6#1)(1995-8#1)(1996-5#1)(2006-12#1)(2008-11#1)(2008-7#1)(2010-8#1)
specifically against##2##2##(1996-12#1)(2012-3#1)
specifically aimed at this##2##4##(2008-12#1)(2009-9#1)
specifically amplified a##2##3##(2008-10#1)(2011-2#1)
specifically amplified##4##2##(1993-12#1)(2008-10#2)(2011-2#1)
specifically an##2##2##(1990-8#1)(1994-8#1)
specifically and directly##2##3##(1992-8#1)(2010-1#1)
specifically and reversibly##2##3##(1996-5#1)(1997-2#1)
specifically and selectively##2##3##(2007-1#1)(2008-10#1)
specifically and stably##2##3##(1994-8#2)
specifically and##19##2##(1991-3#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-8#2)(1994-8#2)(1996-11#1)(1996-5#1)(1997-2#1)(1997-5#1)(2007-1#2)(2008-10#1)(2010-1#1)(2010-11#1)
specifically antagonized by##2##3##(1992-8#1)(1993-11#1)
specifically as it##2##3##(2008-1#1)(2013-8#1)
specifically as##3##2##(2008-1#1)(2013-8#2)
specifically ask if##2##3##(2007-11#1)(2008-9#1)
specifically assess##2##2##(2007-12#1)(2007-7#1)
specifically associated with##6##3##(1990-8#1)(1995-12#1)(2006-9#1)(2007-8#1)(2011-2#1)(2013-8#1)
specifically associated##10##2##(1990-8#1)(1995-12#1)(2006-9#1)(2007-8#1)(2008-2#2)(2008-4#2)(2011-2#1)(2013-8#1)
specifically at the##4##3##(1991-5#1)(2008-5#2)(2013-8#1)
specifically at##7##2##(1990-12#1)(1991-5#1)(1995-1#1)(2006-10#1)(2008-5#2)(2013-8#1)
specifically attached to##2##3##(1993-9#1)(2008-2#1)
specifically be##2##2##(2006-10#1)(2008-10#1)
specifically between##3##2##(1995-8#1)(2008-8#1)(2011-1#1)
specifically bind and##2##3##(1994-8#1)(1996-8#1)
specifically bind the##3##3##(1993-6#1)(1997-1#1)(2008-10#1)
specifically bind to the##6##4##(1992-6#1)(1994-9#2)(1997-1#1)(2008-7#1)(2012-12#1)
specifically bind to##11##3##(1990-10#1)(1992-12#1)(1992-6#1)(1992-8#1)(1994-9#2)(1997-1#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-2#1)
specifically bind##23##2##(1990-10#1)(1990-7#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-8#2)(1994-9#2)(1995-10#1)(1996-8#2)(1997-1#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#1)
specifically binds BMP-2 and BMP-4##2##5##(1994-12#2)
specifically binds to the##5##4##(1990-12#1)(1990-2#2)(1991-3#1)(1994-6#1)
specifically binds to##18##3##(1990-12#1)(1990-2#2)(1990-7#1)(1991-3#1)(1991-5#1)(1991-8#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-9#1)
specifically binds##32##2##(1990-12#2)(1990-2#2)(1990-7#1)(1991-3#2)(1991-5#2)(1991-8#1)(1992-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-5#1)(1995-6#1)(1997-1#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)
specifically blocked by##4##3##(1994-5#1)(1995-6#1)(1997-7#1)(2012-12#1)
specifically blocked##5##2##(1994-5#1)(1994-6#1)(1995-6#1)(1997-7#1)(2012-12#1)
specifically blocks##2##2##(1991-7#1)(1996-7#1)
specifically bound by##2##3##(1990-11#1)(1995-8#1)
specifically bound to a##2##4##(1993-3#1)(1994-6#1)
specifically bound to the##5##4##(1991-9#1)(1992-4#1)(1993-6#1)(2008-11#1)(2008-8#1)
specifically bound to##12##3##(1991-9#1)(1992-12#1)(1992-4#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-6#1)(1996-3#1)(1996-8#1)(2008-11#1)(2008-8#2)
specifically bound##22##2##(1990-11#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-9#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-3#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-8#2)
specifically by the##2##3##(1990-2#1)(1991-10#1)
specifically by##14##2##(1990-11#1)(1990-2#1)(1990-3#1)(1991-10#1)(1991-9#1)(1993-3#1)(1993-6#1)(1995-6#1)(1996-12#1)(1996-8#1)(2008-10#1)(2008-12#1)(2008-5#2)
specifically cleave##2##2##(1993-9#1)(2008-8#1)
specifically cleaved##4##2##(1991-5#1)(1992-11#1)(1994-8#1)(1994-9#1)
specifically competed for##2##3##(1993-6#1)(1994-9#1)
specifically competed##3##2##(1993-6#1)(1994-9#1)(1996-12#1)
specifically cytotoxic##3##2##(1995-2#1)(1995-3#1)(2008-9#1)
specifically decreases in##2##3##(1991-12#1)(1994-12#1)
specifically deoxygenated at position C-3##2##5##(1996-4#2)
specifically dependent on the##2##4##(1994-9#1)(2006-10#1)
specifically described##3##2##(2006-8#1)(2008-4#2)
specifically designed for the##9##4##(1991-1#1)(1992-1#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-2#1)(2012-3#1)
specifically designed for this##2##4##(1993-12#1)(2007-1#1)
specifically designed for use##3##4##(2007-11#1)(2008-3#1)(2008-4#1)
specifically designed for##21##3##(1991-1#1)(1992-1#1)(1993-12#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-6#1)(2009-2#1)(2010-9#1)(2012-3#1)
specifically designed to allow##2##4##(2008-4#1)(2008-5#1)
specifically designed to compare##2##4##(2006-10#1)(2007-1#1)
specifically designed to measure##2##4##(1996-12#1)(2006-9#1)
specifically designed to##22##3##(1995-2#1)(1996-1#1)(1996-12#1)(1997-1#1)(2005-11#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-1#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-11#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
specifically designed##53##2##(1990-3#1)(1991-1#1)(1992-1#1)(1993-12#1)(1995-2#1)(1995-4#1)(1996-1#1)(1996-12#1)(1997-1#1)(2005-11#1)(2006-10#2)(2006-6#1)(2006-7#2)(2006-9#1)(2007-1#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#6)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#1)(2009-2#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
specifically detect##5##2##(2008-10#3)(2008-4#1)(2011-2#1)
specifically detected by##2##3##(2008-10#1)(2008-6#1)
specifically detected in##2##3##(1994-3#1)(2008-4#1)
specifically detected the##2##3##(1992-6#1)(2008-10#1)
specifically detected##11##2##(1992-6#1)(1993-3#1)(1993-9#1)(1994-3#1)(1996-7#1)(2008-10#4)(2008-4#1)(2008-6#1)
specifically developed for##4##3##(1996-3#1)(2008-10#1)(2008-3#1)(2008-4#1)
specifically developed to##2##3##(2008-3#1)(2011-1#1)
specifically developed##9##2##(1996-3#1)(2008-10#1)(2008-3#2)(2008-4#1)(2009-10#1)(2010-3#1)(2011-1#1)(2012-1#1)
specifically devoted to##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
specifically directed against##3##3##(1996-5#1)(2008-6#1)(2009-2#1)
specifically directed##6##2##(1991-5#1)(1996-5#1)(2007-7#1)(2008-6#1)(2009-2#1)(2010-2#1)
specifically eliminated##2##2##(1994-3#1)(1994-8#1)
specifically evaluated##3##2##(1997-4#1)(2006-2#1)(2008-3#1)
specifically examined##3##2##(2006-9#1)(2008-11#2)
specifically expressed during##2##3##(1994-3#1)(2008-8#1)
specifically expressed in a##3##4##(1996-10#1)(2007-12#1)(2008-7#1)
specifically expressed in testis##2##4##(1995-6#1)(2008-8#1)
specifically expressed in the##4##4##(1992-9#1)(2008-11#1)(2008-8#1)(2011-1#1)
specifically expressed in##25##3##(1990-8#1)(1991-5#1)(1992-5#1)(1992-9#1)(1993-6#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-5#1)(2007-12#1)(2008-11#4)(2008-7#2)(2008-8#4)(2008-9#1)(2009-8#1)(2010-7#1)(2011-1#1)(2012-12#1)
specifically expressed##31##2##(1990-8#1)(1990-9#1)(1991-5#2)(1991-9#1)(1992-5#1)(1992-9#1)(1993-6#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-5#1)(2007-12#1)(2008-11#4)(2008-7#2)(2008-8#5)(2008-9#2)(2009-8#1)(2010-7#1)(2011-1#1)(2012-12#1)
specifically focusing on##2##3##(2010-4#1)(2012-12#1)
specifically for the##8##3##(1992-4#1)(2004-10#1)(2007-6#1)(2008-3#1)(2008-5#1)(2013-1#3)
specifically for these##2##3##(2008-4#1)(2011-1#1)
specifically for use##2##3##(2008-11#1)(2008-5#1)
specifically for##49##2##(1990-11#1)(1992-1#1)(1992-4#1)(1994-11#1)(1995-6#1)(1996-1#1)(1997-2#2)(2004-10#1)(2005-7#1)(2007-12#2)(2007-5#1)(2007-6#2)(2008-10#3)(2008-11#4)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#2)(2009-11#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)
specifically from the##2##3##(2008-10#1)(2013-1#1)
specifically from##9##2##(1995-2#1)(1995-3#1)(2008-10#4)(2008-3#1)(2009-9#1)(2013-1#1)
specifically how##2##2##(2006-10#1)(2011-12#1)
specifically hydrolyze##3##2##(1990-12#1)(1993-7#1)(2012-2#1)
specifically in relation to##2##4##(1991-1#1)(1996-9#1)
specifically in relation##3##3##(1991-1#1)(1996-9#1)(2008-2#1)
specifically in the liver##2##4##(1994-12#1)(1995-1#1)
specifically in the testis##2##4##(1993-12#1)(1995-6#1)
specifically in the##23##3##(1990-11#1)(1990-12#2)(1991-10#1)(1992-7#1)(1993-12#2)(1994-10#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-2#1)(2006-10#1)(2007-12#2)(2008-11#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-12#1)
specifically in##64##2##(1990-11#4)(1990-12#2)(1990-8#1)(1991-1#1)(1991-10#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-12#2)(1993-6#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-2#1)(1996-4#1)(1996-9#1)(2006-10#1)(2007-10#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#2)(2013-8#1)
specifically increased##2##2##(1991-5#1)(1996-2#1)
specifically increases cytosolic##2##3##(1993-8#1)(1994-6#1)
specifically increases##3##2##(1993-8#1)(1994-3#1)(1994-6#1)
specifically indicated##2##2##(2008-5#1)(2012-2#1)
specifically induced by wounding##2##4##(1997-2#2)
specifically induced by##3##3##(1997-2#2)(2008-10#1)
specifically induced during##2##3##(1991-8#1)(1995-1#1)
specifically induced##7##2##(1991-8#1)(1995-1#2)(1997-2#2)(1997-6#1)(2008-10#1)
specifically inhibit##5##2##(1991-7#1)(1993-3#1)(1996-4#1)(2008-8#1)(2009-12#1)
specifically inhibited by the##2##4##(1990-12#1)(2006-12#1)
specifically inhibited by##4##3##(1990-12#1)(1991-7#1)(1995-6#1)(2006-12#1)
specifically inhibited the##3##3##(1990-9#1)(1992-3#1)(1992-7#1)
specifically inhibited##14##2##(1990-12#1)(1990-9#1)(1991-11#1)(1991-7#1)(1992-3#2)(1992-5#1)(1992-7#1)(1992-8#1)(1994-9#1)(1995-6#1)(1996-5#1)(2006-12#1)(2008-10#1)
specifically inhibits##5##2##(1992-11#1)(1992-7#1)(1993-4#1)(1996-2#1)(2011-1#1)
specifically interact with the##2##4##(1991-2#1)(2009-6#1)
specifically interact with##7##3##(1991-2#1)(1992-11#1)(1994-12#1)(1995-8#1)(1996-8#1)(1997-7#1)(2009-6#1)
specifically interacts with the##3##4##(1991-3#1)(1994-2#1)(1995-6#1)
specifically interacts with##5##3##(1991-3#1)(1991-8#1)(1994-2#1)(1995-6#1)(1997-4#1)
specifically into##4##2##(1993-12#1)(1994-3#1)(1995-8#1)(2008-5#1)
specifically involved in the##2##4##(1990-9#1)(2009-10#1)
specifically involved in##4##3##(1990-9#1)(1992-9#1)(2009-10#1)(2009-8#1)
specifically labeled##6##2##(1991-3#1)(1992-12#1)(1992-8#1)(1994-2#1)(2008-10#1)(2009-5#1)
specifically large public health surveys##2##5##(2013-1#2)
specifically linked to##2##3##(1997-3#1)(2011-1#1)
specifically localized in##2##3##(1993-6#1)(2013-8#1)
specifically localized##3##2##(1993-6#1)(1997-4#1)(2013-8#1)
specifically located##2##2##(2010-9#1)(2013-8#1)
specifically modifies##2##2##(1994-12#1)(2007-12#1)
specifically modulate##2##2##(1995-6#1)(2012-2#1)
specifically of##2##2##(2008-1#1)(2010-1#1)
specifically on the##11##3##(1991-12#2)(1994-12#1)(1996-8#1)(2007-11#1)(2007-5#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-7#1)(2013-1#1)
specifically on##20##2##(1990-11#1)(1991-12#2)(1993-3#1)(1994-12#1)(1996-5#1)(1996-8#1)(2005-7#1)(2007-11#1)(2007-5#1)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-11#1)(2010-3#1)(2010-7#1)(2011-1#1)(2013-1#1)
specifically phosphorylated##2##2##(1992-11#1)(2009-6#1)
specifically present in##2##3##(2007-12#1)(2008-12#1)
specifically present##3##2##(1992-7#1)(2007-12#1)(2008-12#1)
specifically prevented by##2##3##(1992-5#1)(1994-3#1)
specifically prevents the##2##3##(1990-11#1)(1994-8#1)
specifically reacted with##4##3##(1991-2#1)(1995-11#1)(1997-4#1)(2008-10#1)
specifically recognize##10##2##(1992-11#1)(1992-8#1)(1994-6#1)(1995-1#1)(1995-2#2)(1996-5#1)(2008-10#2)(2009-5#1)
specifically recognized a single##2##4##(1991-9#1)(1995-6#1)
specifically recognized a##3##3##(1991-9#1)(1995-6#1)(2008-11#1)
specifically recognized by the##2##4##(1990-12#1)(2006-12#1)
specifically recognized by##6##3##(1990-12#1)(1992-2#1)(1994-8#1)(2006-12#1)(2008-4#1)(2012-3#1)
specifically recognized the##4##3##(1990-5#1)(1992-7#1)(1995-8#1)(1996-2#1)
specifically recognized##21##2##(1990-12#1)(1990-5#1)(1991-9#1)(1992-2#1)(1992-7#1)(1993-12#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-4#1)(2005-12#1)(2006-12#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#2)(2012-3#1)
specifically recognizes##4##2##(1990-10#1)(1991-3#1)(1994-8#1)(1995-5#1)
specifically recognizing the##3##3##(1994-3#1)(1996-8#1)(2008-7#1)
specifically reduced##3##2##(1991-2#1)(1992-12#1)(2008-10#1)
specifically regulate##2##2##(1991-9#1)(2009-8#1)
specifically related to the##2##4##(1990-2#1)(2008-11#1)
specifically related to##7##3##(1990-2#1)(1992-3#1)(1995-8#1)(1996-6#1)(2005-11#1)(2008-11#1)(2009-11#1)
specifically released##2##2##(1990-9#1)(2006-10#1)
specifically removes##3##2##(1992-9#1)(1993-12#1)(1996-8#1)
specifically repressed##2##2##(1993-9#1)(1996-11#1)
specifically requires##2##2##(1994-12#1)(1995-8#1)
specifically restricted##2##2##(1992-4#1)(1995-11#1)
specifically sensitive to the##2##4##(1991-5#1)(1993-1#1)
specifically sensitive to##3##3##(1991-5#1)(1991-8#1)(1993-1#1)
specifically stimulate##2##2##(1992-8#1)(2007-11#1)
specifically stimulated##4##2##(1993-1#1)(1994-12#1)(1994-8#1)(2008-11#1)
specifically studied##2##2##(1996-6#1)(2008-8#1)
specifically suppress##2##2##(1990-6#1)(1994-12#1)
specifically suppressed##3##2##(1991-12#1)(1992-4#1)(1994-6#1)
specifically synthesized##4##2##(1990-9#1)(1993-3#1)(2008-3#1)(2009-10#1)
specifically tailored to##2##3##(1992-6#1)(2012-3#1)
specifically tailored##3##2##(1992-6#1)(2008-1#1)(2012-3#1)
specifically target the##4##3##(2008-12#1)(2008-4#1)(2010-2#1)(2010-4#1)
specifically target##10##2##(2008-1#2)(2008-12#1)(2008-4#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2013-1#1)
specifically targeted by##2##3##(1990-4#1)(2006-10#1)
specifically targeted to##3##3##(1995-12#1)(2005-7#1)(2007-1#1)
specifically targeted##7##2##(1990-4#1)(1990-6#1)(1995-12#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-1#1)
specifically targeting the##3##3##(2010-6#1)(2010-7#1)(2012-3#1)
specifically targeting##6##2##(2005-8#1)(2006-10#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-3#1)
specifically targets##3##2##(1994-9#1)(2004-11#1)(2012-2#1)
specifically the Resnik method##2##4##(2013-1#2)
specifically the role of##2##4##(1990-12#1)(2008-12#1)
specifically the use of##2##4##(2005-12#1)(2012-12#1)
specifically the##32##2##(1990-12#1)(1991-3#2)(1992-1#1)(1992-11#1)(1992-12#1)(1993-1#1)(1994-8#1)(1994-9#1)(1996-5#1)(2005-12#1)(2006-8#2)(2007-1#1)(2007-9#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#1)(2009-11#1)(2009-4#1)(2010-10#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
specifically those##2##2##(2006-10#1)(2008-7#1)
specifically through the##3##3##(1997-7#1)(2008-10#1)(2008-7#1)
specifically to a##5##3##(1990-6#1)(1990-8#1)(1992-6#1)(1995-5#1)(1995-6#1)
specifically to address##3##3##(1995-6#1)(2008-11#1)(2012-2#1)
specifically to target##2##3##(2009-12#1)(2012-12#1)
specifically to the##26##3##(1990-6#1)(1990-9#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-5#1)(1992-8#1)(1994-12#1)(1994-3#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-12#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-9#1)(2010-10#1)(2010-11#1)(2011-1#1)(2012-12#1)(2013-7#1)
specifically to##94##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-6#2)(1990-8#1)(1990-9#2)(1991-10#2)(1991-12#2)(1991-3#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-12#2)(1992-4#1)(1992-5#3)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#2)(1994-3#4)(1995-11#1)(1995-2#2)(1995-3#4)(1995-5#1)(1995-6#4)(1995-8#2)(1996-12#1)(1997-8#2)(2005-11#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-6#1)(2011-1#3)(2011-2#1)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#1)(2013-7#1)
specifically trained##2##2##(1994-12#1)(2008-4#1)
specifically transcribed in##2##3##(1993-11#1)(1994-2#1)
specifically under##2##2##(2008-8#1)(2012-1#1)
specifically upregulated##2##2##(2008-11#1)(2010-12#1)
specifically where##2##2##(1992-6#1)(2012-3#1)
specifically whether##2##2##(2007-7#1)(2008-4#1)
specifically with a##6##3##(1991-12#1)(1994-11#1)(1994-8#1)(1996-8#1)(2006-10#1)(2007-8#1)
specifically with regard to##2##4##(2006-10#1)(2010-11#1)
specifically with the##9##3##(1990-7#1)(1992-8#1)(1993-2#1)(1993-6#1)(1995-6#1)(1996-10#1)(2008-10#1)(2008-4#1)(2008-5#1)
specifically with##40##2##(1990-7#1)(1991-12#1)(1991-3#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-4#1)(1996-8#2)(1997-6#1)(2005-10#1)(2006-10#3)(2007-12#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#2)(2008-9#1)(2010-11#1)(2011-2#1)(2012-3#1)
specifically##1222##1##(1990-10#4)(1990-11#14)(1990-12#12)(1990-2#8)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#4)(1990-7#5)(1990-8#6)(1990-9#7)(1991-1#2)(1991-10#5)(1991-11#2)(1991-12#8)(1991-2#4)(1991-3#12)(1991-4#3)(1991-5#12)(1991-6#1)(1991-7#4)(1991-8#7)(1991-9#8)(1992-1#3)(1992-10#2)(1992-11#7)(1992-12#12)(1992-2#3)(1992-3#5)(1992-4#7)(1992-5#9)(1992-6#6)(1992-7#5)(1992-8#10)(1992-9#7)(1993-1#3)(1993-10#1)(1993-11#6)(1993-12#11)(1993-2#2)(1993-3#9)(1993-4#1)(1993-5#1)(1993-6#9)(1993-7#2)(1993-8#6)(1993-9#5)(1994-10#2)(1994-11#6)(1994-12#17)(1994-2#9)(1994-3#13)(1994-5#1)(1994-6#9)(1994-8#19)(1994-9#16)(1995-1#8)(1995-10#1)(1995-11#6)(1995-12#8)(1995-2#16)(1995-3#13)(1995-4#1)(1995-5#4)(1995-6#19)(1995-8#12)(1996-1#3)(1996-10#3)(1996-11#4)(1996-12#6)(1996-2#5)(1996-3#5)(1996-4#7)(1996-5#16)(1996-6#4)(1996-7#5)(1996-8#12)(1996-9#2)(1997-1#6)(1997-2#8)(1997-3#2)(1997-4#8)(1997-5#2)(1997-6#4)(1997-7#5)(1997-8#4)(2004-10#1)(2004-11#1)(2004-12#2)(2005-10#1)(2005-11#5)(2005-12#2)(2005-7#7)(2005-8#2)(2006-1#1)(2006-10#20)(2006-11#1)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#1)(2006-7#4)(2006-8#7)(2006-9#5)(2007-1#6)(2007-10#2)(2007-11#11)(2007-12#17)(2007-2#2)(2007-4#1)(2007-5#3)(2007-6#3)(2007-7#4)(2007-8#6)(2007-9#2)(2008-1#13)(2008-10#57)(2008-11#37)(2008-12#9)(2008-2#16)(2008-3#22)(2008-4#37)(2008-5#29)(2008-6#8)(2008-7#20)(2008-8#19)(2008-9#22)(2009-10#7)(2009-11#7)(2009-12#4)(2009-2#2)(2009-3#1)(2009-4#6)(2009-5#2)(2009-6#4)(2009-7#2)(2009-8#9)(2009-9#5)(2010-1#3)(2010-10#6)(2010-11#8)(2010-12#4)(2010-2#3)(2010-3#3)(2010-4#7)(2010-5#3)(2010-6#4)(2010-7#5)(2010-8#6)(2010-9#3)(2011-1#18)(2011-12#4)(2011-2#25)(2012-1#7)(2012-12#21)(2012-2#25)(2012-3#10)(2012-6#1)(2013-1#21)(2013-7#1)(2013-8#11)
specification and##13##2##(1991-3#1)(1994-12#1)(1995-4#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-1#1)
specification for##5##2##(2007-11#1)(2007-4#2)(2010-8#1)(2013-1#1)
specification in Drosophila##3##3##(1994-9#1)(2007-12#2)
specification in##5##2##(1994-9#1)(2007-12#2)(2009-4#1)(2010-9#1)
specification is##6##2##(1992-2#1)(1994-3#1)(2009-3#1)(2010-2#1)(2013-1#1)(2013-8#1)
specification of a##2##3##(1990-12#1)(2008-7#1)
specification of neuronal##2##3##(1991-3#1)(1996-3#1)
specification of the##19##3##(1992-3#1)(1993-6#1)(1994-9#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-4#1)(1997-8#1)(2005-10#1)(2005-11#1)(2007-8#1)(2008-2#1)(2008-7#1)(2009-2#1)(2009-8#2)(2010-5#1)(2013-1#1)
specification of##46##2##(1990-11#1)(1990-12#1)(1991-1#1)(1991-3#1)(1992-3#1)(1993-6#1)(1994-3#2)(1994-9#1)(1995-2#2)(1995-6#2)(1995-8#1)(1996-3#1)(1996-4#1)(1997-8#1)(2005-10#1)(2005-11#1)(2007-12#3)(2007-4#1)(2007-8#2)(2008-1#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-10#2)(2009-2#1)(2009-8#2)(2010-5#1)(2012-1#1)(2012-2#1)(2013-1#2)
specification##122##1##(1990-11#1)(1990-12#1)(1990-6#1)(1991-1#1)(1991-3#2)(1992-2#2)(1992-3#1)(1993-6#1)(1994-12#1)(1994-3#6)(1994-9#2)(1995-2#2)(1995-4#1)(1995-6#2)(1995-8#1)(1996-3#2)(1996-4#1)(1996-9#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-6#2)(2006-8#1)(2007-11#1)(2007-12#10)(2007-4#4)(2007-5#1)(2007-8#2)(2008-1#3)(2008-10#2)(2008-2#5)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#3)(2009-2#1)(2009-3#2)(2009-4#2)(2009-8#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#2)(2010-9#2)(2011-2#2)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#14)(2013-8#1)
specifications and##9##2##(2006-11#1)(2008-1#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-1#4)
specifications are##5##2##(1993-3#1)(2008-10#1)(2008-2#2)(2008-3#1)
specifications can be##2##3##(2008-2#1)(2011-2#1)
specifications for a##3##3##(1997-6#1)(2008-2#1)(2008-3#1)
specifications for##11##2##(1993-9#1)(1994-1#1)(1997-6#1)(2004-9#1)(2006-5#1)(2008-1#1)(2008-2#2)(2008-3#3)
specifications of a##3##3##(2007-12#2)(2008-2#1)
specifications of the##4##3##(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#1)
specifications of##11##2##(2006-10#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#1)
specifications such as##2##3##(2008-3#1)(2010-4#1)
specifications that##3##2##(1993-2#1)(2008-4#1)(2012-2#1)
specifications##73##1##(1990-12#1)(1991-1#1)(1992-2#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-3#1)(1997-6#1)(2004-9#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-6#1)(2007-12#3)(2007-4#3)(2007-8#1)(2008-1#3)(2008-10#7)(2008-2#12)(2008-3#10)(2008-4#3)(2008-8#1)(2009-11#1)(2009-12#1)(2010-4#4)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#4)
specificities among##2##2##(1991-4#1)(2009-5#1)
specificities and##10##2##(1991-12#1)(1992-12#1)(1993-6#1)(1994-2#1)(2004-4#1)(2006-12#1)(2008-3#1)(2010-3#1)(2011-1#1)(2011-2#1)
specificities for##5##2##(1992-2#1)(1994-12#1)(1995-7#1)(1996-5#1)(2006-12#1)
specificities from##2##2##(2006-12#1)(2009-9#1)
specificities in the##2##3##(2006-12#1)(2007-7#1)
specificities in##8##2##(1990-11#1)(1991-4#1)(1992-2#1)(2006-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)
specificities of human##3##3##(1991-4#1)(1993-6#2)
specificities of the##8##3##(1993-3#1)(1993-6#2)(1994-12#2)(1994-8#1)(2007-2#1)(2008-4#1)
specificities of these##4##3##(1993-6#1)(1994-11#1)(2007-11#1)(2008-4#1)
specificities of##35##2##(1990-12#1)(1990-7#1)(1991-12#2)(1991-2#1)(1991-4#1)(1993-3#1)(1993-4#1)(1993-6#5)(1994-11#1)(1994-12#4)(1994-8#2)(1995-1#1)(1995-8#1)(1997-2#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2010-4#1)(2011-12#1)(2011-2#3)
specificities that##2##2##(2008-2#1)(2009-4#1)
specificities towards##2##2##(2008-10#1)(2012-2#1)
specificities##113##1##(1990-11#1)(1990-12#1)(1990-4#2)(1990-7#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-4#3)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#6)(1993-8#1)(1994-11#1)(1994-12#7)(1994-2#1)(1994-3#2)(1994-6#2)(1994-8#4)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-7#2)(2004-4#1)(2006-12#5)(2007-11#2)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#1)(2008-6#1)(2008-9#2)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-3#2)(2010-4#1)(2011-1#4)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
specificity (0##2##2##(2006-10#1)(2012-3#1)
specificity (i##2##2##(1993-11#1)(2005-12#1)
specificity 0##3##2##(1991-12#1)(2011-2#2)
specificity 68%##2##2##(2008-4#1)(2009-4#1)
specificity 84%##3##2##(1990-2#2)(2009-4#1)
specificity 91##2##2##(1997-4#1)(2011-2#1)
specificity 93##2##2##(2008-5#1)(2011-1#1)
specificity 94##2##2##(1993-10#1)(2011-2#1)
specificity 95%)##2##2##(1997-8#2)
specificity 98%##2##2##(2009-2#2)
specificity =##2##2##(2008-12#1)(2009-4#1)
specificity against##4##2##(1992-11#1)(1993-7#1)(1997-7#1)(2008-10#1)
specificity among##3##2##(1993-7#1)(2009-5#1)(2013-1#1)
specificity and Youden's index were 0##2##6##(2010-12#2)
specificity and Youden's index were##3##5##(2010-12#3)
specificity and a##2##3##(1992-1#1)(1994-7#1)
specificity and accuracy of##4##4##(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
specificity and accuracy##5##3##(2007-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
specificity and activity##2##3##(1996-7#1)(1997-4#1)
specificity and affinity##2##3##(1994-2#1)(1996-5#1)
specificity and diagnostic accuracy##2##4##(1995-11#1)(2005-1#1)
specificity and efficacy##2##3##(2008-1#1)(2009-8#1)
specificity and efficiency of##2##4##(2009-4#1)(2012-3#1)
specificity and high##2##3##(1997-3#1)(2010-12#1)
specificity and is##2##3##(2008-12#1)(2011-1#1)
specificity and mechanism##2##3##(1992-11#1)(1997-7#1)
specificity and positive predictive value##2##5##(2007-3#1)(2008-11#1)
specificity and positive predictive##3##4##(2004-2#1)(2007-3#1)(2008-11#1)
specificity and positive##4##3##(1996-8#1)(2004-2#1)(2007-3#1)(2008-11#1)
specificity and predictive value##2##4##(1991-12#1)(2007-12#1)
specificity and predictive##3##3##(1991-12#1)(2007-12#2)
specificity and recovery##2##3##(1993-1#1)(2008-10#1)
specificity and reproducibility of the##2##5##(2008-4#1)(2013-8#1)
specificity and selectivity##2##3##(1997-5#1)(2010-10#1)
specificity and sensitivity for##4##4##(1996-1#1)(1997-6#1)(2006-10#1)(2008-10#1)
specificity and sensitivity of##5##4##(1997-3#1)(2008-10#2)(2008-11#1)(2013-7#1)
specificity and sensitivity##16##3##(1996-1#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-10#2)(2008-10#5)(2008-11#1)(2008-4#1)(2008-6#1)(2013-7#1)
specificity and the##7##3##(1990-3#1)(1991-8#1)(1993-10#1)(1993-6#1)(1993-8#1)(2008-10#1)(2013-1#1)
specificity and##140##2##(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-3#3)(1991-4#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-5#2)(1992-6#1)(1993-1#1)(1993-10#2)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-2#3)(1994-3#2)(1994-5#2)(1994-7#1)(1994-9#1)(1995-11#1)(1995-2#3)(1995-7#1)(1996-1#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#2)(2004-2#1)(2005-1#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-8#2)(2007-10#2)(2007-11#2)(2007-12#4)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-4#6)(2008-5#4)(2008-6#2)(2008-7#2)(2008-9#1)(2009-1#1)(2009-2#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#7)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
specificity are##6##2##(1991-9#1)(1992-10#1)(1995-1#1)(2008-4#1)(2009-2#1)(2009-4#1)
specificity as the##2##3##(1994-12#1)(2006-12#1)
specificity as well as##4##4##(1990-10#1)(1991-9#1)(2008-4#1)(2010-4#1)
specificity as##10##2##(1990-10#1)(1991-12#1)(1991-9#1)(1994-12#1)(1995-1#1)(1997-4#1)(2006-12#1)(2008-4#1)(2009-9#1)(2010-4#1)
specificity at the##3##3##(1994-9#1)(1997-2#1)(2008-12#1)
specificity at##4##2##(1994-9#1)(1996-12#1)(1997-2#1)(2008-12#1)
specificity between##6##2##(1991-4#1)(1993-3#1)(1993-9#1)(1995-3#1)(1995-5#1)(1996-5#1)
specificity but##4##2##(1991-4#1)(1992-4#1)(2005-7#1)(2012-3#1)
specificity by##11##2##(1990-7#1)(1991-2#1)(1992-7#1)(1995-5#1)(1997-4#2)(1997-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)
specificity compared to##2##3##(1992-8#1)(2006-10#1)
specificity constant for the##2##4##(1992-3#1)(1994-9#1)
specificity constant##3##2##(1992-3#1)(1994-9#1)(1996-7#1)
specificity constants##2##2##(1994-8#1)(1995-10#1)
specificity could##2##2##(1995-2#1)(2008-10#1)
specificity determinant##2##2##(1991-3#1)(1995-2#1)
specificity determinants##5##2##(1990-12#1)(1990-7#1)(1997-2#1)(2008-10#1)(2008-4#1)
specificity differences##2##2##(2005-12#1)(2008-3#1)
specificity different from##2##3##(1992-9#1)(1994-9#1)
specificity during##2##2##(2008-6#1)(2012-2#1)
specificity for DNA##2##3##(2008-11#2)
specificity for a##3##3##(1990-11#1)(1992-12#1)(2012-3#1)
specificity for aspartate##2##3##(1995-6#1)(2008-4#1)
specificity for different##2##3##(1992-8#1)(2010-2#1)
specificity for insulin##2##3##(1994-12#2)
specificity for the diagnosis of##4##5##(2005-8#2)(2008-3#1)(2011-2#1)
specificity for the##22##3##(1990-7#1)(1990-9#1)(1991-3#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-9#1)(1997-2#1)(1997-4#1)(2005-8#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
specificity for##106##2##(1990-11#2)(1990-3#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#4)(1992-9#1)(1993-12#1)(1993-6#2)(1993-9#3)(1994-11#2)(1994-12#5)(1994-2#4)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-3#3)(1995-6#2)(1995-8#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#4)(2005-8#2)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#3)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-3#2)(2008-4#4)(2008-5#4)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#4)(2012-3#4)(2013-1#2)(2013-8#1)
specificity from##4##2##(1992-11#1)(1994-5#1)(1997-2#1)(1997-7#1)
specificity have been##3##3##(1994-6#1)(2007-8#1)(2008-3#1)
specificity have##4##2##(1994-6#1)(2007-8#1)(2008-3#1)(2009-9#1)
specificity in the##15##3##(1991-10#2)(1992-12#1)(1992-9#1)(1993-6#1)(1996-8#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-6#1)(2011-2#2)(2012-12#1)
specificity in these##3##3##(1996-9#1)(1997-4#1)(2006-2#1)
specificity in##53##2##(1990-12#1)(1991-10#3)(1991-11#1)(1991-4#1)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-5#1)(1996-8#1)(1996-9#2)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2009-9#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
specificity is achieved##2##3##(2006-10#1)(2010-5#1)
specificity is determined by##2##4##(1995-2#1)(2011-1#1)
specificity is determined##3##3##(1991-5#1)(1995-2#1)(2011-1#1)
specificity is##15##2##(1990-2#1)(1991-5#1)(1991-8#1)(1992-12#1)(1993-2#1)(1994-9#1)(1995-2#2)(1996-9#1)(1997-2#1)(1997-5#1)(2006-10#1)(2008-5#1)(2010-5#1)(2011-1#1)
specificity may##3##2##(1992-11#1)(1992-4#1)(2008-8#1)
specificity observed##3##2##(1997-5#1)(2008-10#1)(2009-8#1)
specificity obtained##2##2##(2005-12#1)(2008-10#1)
specificity of 100% and##2##4##(1997-3#1)(2007-7#1)
specificity of 100%##3##3##(1997-3#1)(2007-7#1)(2007-8#1)
specificity of 78%##2##3##(1993-2#1)(2006-2#1)
specificity of 85##2##3##(2011-1#1)(2013-8#1)
specificity of 90% and##2##4##(1993-8#1)(2008-5#1)
specificity of 90%##3##3##(1993-8#1)(2005-8#1)(2008-5#1)
specificity of 92##2##3##(2005-12#1)(2007-12#1)
specificity of 95%##3##3##(1997-8#1)(2006-2#1)(2013-1#1)
specificity of 96##3##3##(1990-9#1)(2007-12#1)(2007-8#1)
specificity of 97%##4##3##(1993-1#1)(1993-12#1)(2006-10#1)(2006-2#1)
specificity of 98##3##3##(1992-4#1)(2012-2#1)(2012-3#1)
specificity of 99##2##3##(1992-6#1)(1996-11#1)
specificity of D-dimer##2##3##(1992-3#1)(2011-2#1)
specificity of NotI##3##3##(1990-3#3)
specificity of PSA##2##3##(2008-9#1)(2012-12#1)
specificity of a new##2##4##(1995-7#1)(2008-10#1)
specificity of a##11##3##(1991-9#1)(1992-9#1)(1994-12#1)(1995-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-10#1)(2012-3#1)(2013-1#1)
specificity of action of##2##4##(1990-11#1)(1991-3#1)
specificity of action##4##3##(1990-11#1)(1990-12#1)(1991-3#1)(1992-5#1)
specificity of bacterial##2##3##(1991-9#1)(2008-8#1)
specificity of beta##2##3##(1991-5#1)(1992-2#1)
specificity of binding##5##3##(1990-5#1)(1994-12#1)(1995-2#1)(1997-4#1)(2008-4#1)
specificity of both##3##3##(1990-2#1)(1991-5#1)(2005-10#1)
specificity of cleavage##2##3##(1992-7#1)(1996-7#1)
specificity of cytochrome##2##3##(1992-9#1)(1993-4#1)
specificity of each##3##3##(1992-1#1)(1996-5#1)(2008-10#1)
specificity of expression##2##3##(1990-9#1)(1992-11#1)
specificity of gene##2##3##(1990-10#1)(2007-11#1)
specificity of human##5##3##(1991-7#1)(1993-6#1)(1994-11#1)(1994-3#1)(2012-12#1)
specificity of interaction##2##3##(1995-3#1)(2008-9#1)
specificity of protein##2##3##(1995-1#1)(1996-9#1)
specificity of t-PA for plasminogen##2##5##(1995-3#2)
specificity of t-PA##3##3##(1995-3#3)
specificity of the TDX system##2##5##(1993-8#2)
specificity of the antibody##4##4##(1991-1#1)(1997-5#1)(2007-11#1)(2008-5#1)
specificity of the assay##4##4##(1995-3#1)(1997-2#1)(1997-4#1)(2008-10#1)
specificity of the enzyme is##2##5##(1992-3#1)(1994-9#1)
specificity of the enzyme##3##4##(1990-10#1)(1992-3#1)(1994-9#1)
specificity of the immobilized##2##4##(2008-10#1)(2008-7#1)
specificity of the insulin receptor##2##5##(1994-12#2)
specificity of the method##2##4##(1990-9#1)(2010-12#1)
specificity of the receptor##2##4##(1990-11#1)(1993-9#1)
specificity of the screening##2##4##(1997-2#1)(2007-7#1)
specificity of the test was##2##5##(1996-12#1)(2012-2#1)
specificity of the test##3##4##(1990-4#1)(1996-12#1)(2012-2#1)
specificity of the##146##3##(1990-10#2)(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#2)(1990-7#4)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-9#2)(1992-3#2)(1992-4#2)(1992-6#2)(1992-8#3)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#2)(1994-9#5)(1995-2#1)(1995-3#2)(1995-5#2)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-2#5)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(2005-1#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-4#2)(2008-5#5)(2008-7#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#5)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#5)(2013-8#1)
specificity of these##6##3##(1992-3#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)
specificity of this effect##2##4##(1990-10#1)(1997-2#1)
specificity of this##20##3##(1990-10#2)(1990-9#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-5#1)(1993-4#1)(1994-2#1)(1994-5#1)(1994-9#1)(1996-10#1)(1996-3#1)(1996-5#1)(1997-2#1)(2007-2#1)(2008-10#2)(2008-11#1)(2013-1#1)
specificity of three##2##3##(1990-12#1)(1992-8#1)
specificity of trypsin##2##3##(1990-8#1)(1992-12#1)
specificity of##469##2##(1990-10#5)(1990-11#4)(1990-12#3)(1990-2#2)(1990-3#5)(1990-4#1)(1990-5#5)(1990-6#3)(1990-7#5)(1990-8#2)(1990-9#4)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#3)(1991-2#3)(1991-3#4)(1991-4#2)(1991-5#3)(1991-7#2)(1991-9#5)(1992-1#2)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#8)(1992-4#3)(1992-5#3)(1992-6#3)(1992-7#4)(1992-8#6)(1992-9#3)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#4)(1993-8#3)(1993-9#4)(1994-11#2)(1994-12#6)(1994-2#4)(1994-3#3)(1994-5#2)(1994-6#3)(1994-8#2)(1994-9#11)(1995-1#4)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#10)(1995-4#2)(1995-5#4)(1995-6#2)(1995-7#1)(1995-8#2)(1996-10#1)(1996-11#3)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#6)(1996-7#2)(1996-8#3)(1996-9#3)(1997-2#7)(1997-3#5)(1997-4#5)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#2)(2004-1#2)(2004-4#1)(2005-1#1)(2005-10#4)(2005-12#5)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#9)(2006-12#2)(2006-2#4)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#4)(2007-2#4)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#6)(2007-8#7)(2008-1#2)(2008-10#30)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#9)(2008-5#10)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#2)(2009-10#4)(2009-12#1)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#3)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#6)(2011-1#10)(2011-12#1)(2011-2#11)(2012-1#2)(2012-12#4)(2012-2#9)(2012-3#5)(2013-1#9)(2013-7#2)(2013-8#3)
specificity on the##2##3##(1992-2#1)(2012-2#1)
specificity on##7##2##(1992-2#1)(2006-10#1)(2006-12#1)(2008-10#3)(2012-2#1)
specificity or##3##2##(2004-9#1)(2008-10#1)(2013-8#1)
specificity pocket is##2##3##(1994-8#1)(1995-3#1)
specificity pocket##3##2##(1994-8#1)(1995-3#1)(2008-4#1)
specificity protein 1##2##3##(2013-1#2)
specificity protein##4##2##(1996-5#2)(2013-1#2)
specificity remains##2##2##(2008-11#1)(2012-2#1)
specificity requirements##3##2##(1994-8#2)(2007-11#1)
specificity site##2##2##(1994-11#1)(1997-1#1)
specificity studies##4##2##(1990-11#1)(1994-12#1)(1996-2#1)(2004-8#1)
specificity than the##2##3##(1992-12#1)(2006-10#1)
specificity than##4##2##(1992-12#1)(2006-10#2)(2008-10#1)
specificity that##2##2##(1992-11#1)(2011-1#1)
specificity to a##3##3##(1994-8#1)(2008-4#1)(2008-8#1)
specificity to glucocorticoids##2##3##(1995-10#2)
specificity to the##8##3##(1991-9#1)(1994-12#1)(1997-3#1)(1997-4#1)(2007-2#1)(2008-10#1)(2008-4#1)(2011-2#1)
specificity to##29##2##(1990-2#1)(1991-8#1)(1991-9#2)(1992-6#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-10#2)(1995-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#1)(2006-5#1)(2006-8#1)(2007-2#1)(2008-10#2)(2008-4#3)(2008-8#1)(2011-2#2)(2013-1#1)
specificity toward##4##2##(1991-4#1)(1992-9#1)(1995-3#1)(2008-10#1)
specificity towards##7##2##(1990-12#1)(1993-2#1)(1994-2#1)(1994-5#1)(1996-3#1)(1997-6#1)(2012-3#1)
specificity using a##2##3##(2006-5#1)(2008-8#1)
specificity using##3##2##(2006-5#1)(2007-8#1)(2008-8#1)
specificity values##3##2##(1995-2#1)(2009-7#1)(2010-8#1)
specificity was 100%##2##3##(2007-11#1)(2011-2#1)
specificity was 93##2##3##(1993-1#1)(2007-6#1)
specificity was observed##2##3##(1991-5#1)(2007-12#1)
specificity was##40##2##(1991-5#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-12#5)(1996-9#1)(1997-3#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-8#2)(2009-4#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-7#1)
specificity were##9##2##(1990-6#1)(1991-9#1)(1994-12#1)(2008-10#1)(2008-5#1)(2011-1#2)(2013-1#2)
specificity which##3##2##(1992-11#1)(1995-10#1)(1996-9#1)
specificity with##5##2##(1997-3#2)(2006-8#1)(2011-1#1)(2012-12#1)
specificity would##2##2##(1990-4#1)(2012-12#1)
specificity##1494##1##(1990-1#1)(1990-10#8)(1990-11#9)(1990-12#9)(1990-2#9)(1990-3#8)(1990-4#3)(1990-5#9)(1990-6#5)(1990-7#13)(1990-8#2)(1990-9#5)(1991-1#4)(1991-10#6)(1991-11#7)(1991-12#9)(1991-2#8)(1991-3#9)(1991-4#15)(1991-5#7)(1991-6#2)(1991-7#4)(1991-8#4)(1991-9#15)(1992-1#5)(1992-10#3)(1992-11#13)(1992-12#8)(1992-2#7)(1992-3#14)(1992-4#7)(1992-5#8)(1992-6#7)(1992-7#8)(1992-8#13)(1992-9#7)(1993-1#4)(1993-10#4)(1993-11#3)(1993-12#5)(1993-2#7)(1993-3#7)(1993-4#2)(1993-5#2)(1993-6#11)(1993-7#3)(1993-8#9)(1993-9#11)(1994-10#1)(1994-11#8)(1994-12#19)(1994-2#13)(1994-3#7)(1994-5#9)(1994-6#8)(1994-7#1)(1994-8#9)(1994-9#20)(1995-1#10)(1995-10#5)(1995-11#4)(1995-12#6)(1995-2#16)(1995-3#18)(1995-4#2)(1995-5#6)(1995-6#6)(1995-7#2)(1995-8#8)(1996-1#1)(1996-10#1)(1996-11#5)(1996-12#8)(1996-2#4)(1996-3#4)(1996-4#1)(1996-5#14)(1996-7#5)(1996-8#7)(1996-9#15)(1997-1#4)(1997-2#22)(1997-3#16)(1997-4#27)(1997-5#9)(1997-6#10)(1997-7#7)(1997-8#7)(2004-1#3)(2004-2#1)(2004-3#1)(2004-4#1)(2004-8#1)(2004-9#1)(2005-1#2)(2005-10#6)(2005-12#9)(2005-7#3)(2005-8#6)(2005-9#1)(2006-1#2)(2006-10#38)(2006-11#1)(2006-12#8)(2006-2#7)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#3)(2006-7#3)(2006-8#10)(2006-9#2)(2007-1#2)(2007-10#7)(2007-11#20)(2007-12#11)(2007-2#8)(2007-3#5)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#11)(2007-8#22)(2007-9#6)(2008-1#10)(2008-10#110)(2008-11#19)(2008-12#7)(2008-2#6)(2008-3#10)(2008-4#47)(2008-5#29)(2008-6#8)(2008-7#21)(2008-8#14)(2008-9#12)(2009-1#3)(2009-10#5)(2009-11#1)(2009-12#1)(2009-2#5)(2009-3#1)(2009-4#11)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#8)(2009-9#6)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#16)(2010-2#8)(2010-3#3)(2010-4#4)(2010-5#5)(2010-6#2)(2010-7#6)(2010-8#9)(2011-1#30)(2011-12#2)(2011-2#45)(2012-1#5)(2012-12#22)(2012-2#28)(2012-3#20)(2013-1#33)(2013-7#6)(2013-8#9)
specificity&quot##2##1##(2006-10#1)(2012-12#1)
specificity) and##2##2##(1991-12#1)(2011-2#1)
specificity)##4##1##(1991-12#2)(2008-10#1)(2011-2#1)
specificity-conferring residues##2##2##(1996-11#2)
specificity?##4##1##(1992-11#1)(1994-6#1)(2008-12#1)(2009-5#1)
specifics of##10##2##(1996-2#1)(2005-10#1)(2006-7#1)(2007-12#1)(2007-9#2)(2008-4#1)(2010-12#1)(2010-4#1)(2011-1#1)
specifics##12##1##(1996-2#1)(2005-10#1)(2006-7#1)(2007-12#1)(2007-9#2)(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-1#1)
specified a##4##2##(1997-1#1)(1997-2#1)(2008-10#1)(2013-1#1)
specified and##3##2##(1996-9#1)(2007-7#1)(2009-7#1)
specified as a function of##2##5##(2008-11#1)(2008-2#1)
specified as endothelial NOS (eNOS)##2##5##(2009-10#2)
specified as##6##2##(1993-5#1)(1997-8#1)(2008-11#1)(2008-2#1)(2009-10#2)
specified by a##7##3##(1992-2#1)(1992-3#1)(1994-11#1)(1995-6#1)(2008-10#1)(2012-3#1)(2013-1#1)
specified by the##8##3##(1990-9#2)(1996-7#1)(1996-8#1)(2007-4#1)(2008-1#1)(2008-10#1)(2011-2#1)
specified by##20##2##(1990-9#2)(1991-5#1)(1992-2#1)(1992-3#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-6#1)(1996-7#1)(1996-8#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
specified conditions##4##2##(1997-6#1)(2008-10#2)(2011-1#1)
specified for a##2##3##(2007-7#1)(2010-11#1)
specified for##6##2##(1991-12#1)(1992-6#1)(2007-7#1)(2008-10#1)(2010-11#1)(2013-1#1)
specified in the##7##3##(1991-4#1)(2006-8#1)(2008-3#2)(2010-12#1)(2011-2#1)(2012-12#1)
specified in##9##2##(1991-4#1)(1996-9#1)(2006-8#1)(2008-3#2)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)
specified intervals##2##2##(1996-4#1)(2007-10#1)
specified precision##2##2##(1993-1#1)(2008-2#1)
specified requirements##2##2##(1994-12#1)(2007-4#1)
specified that##2##2##(1997-4#1)(2006-5#1)
specified the##2##2##(2008-10#1)(2009-4#1)
specified time intervals##2##3##(2008-12#1)(2008-6#1)
specified time##5##2##(2007-1#1)(2008-10#1)(2008-12#2)(2008-6#1)
specified treatment##2##2##(1991-8#1)(2008-10#1)
specified using##3##2##(1995-12#1)(2008-2#2)
specified value##2##2##(1996-1#1)(2007-12#1)
specified##201##1##(1990-2#1)(1990-3#1)(1990-4#2)(1990-9#3)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#1)(1996-11#2)(1996-12#3)(1996-4#2)(1996-7#2)(1996-8#5)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-8#1)(2005-5#2)(2005-8#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#2)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#5)(2008-12#3)(2008-2#16)(2008-3#11)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#4)(2009-10#3)(2009-12#2)(2009-4#1)(2009-5#3)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#8)(2013-8#1)
specifies a##2##2##(1990-9#1)(1995-8#1)
specifies that##2##2##(2006-12#1)(2011-2#1)
specifies the##11##2##(1990-2#1)(1991-1#1)(1991-9#1)(1993-9#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-9#1)(2011-2#1)
specifies##37##1##(1990-11#2)(1990-2#1)(1990-9#3)(1991-1#1)(1991-4#1)(1991-9#1)(1993-11#2)(1993-9#3)(1995-8#1)(1996-8#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-9#2)(2011-2#2)(2012-12#2)
specifities of##2##2##(2006-6#1)(2011-1#1)
specifity but##2##2##(1997-7#1)(2007-2#1)
specifity##5##1##(1997-7#1)(2007-2#1)(2007-7#1)(2008-10#1)(2011-2#1)
specify a##10##2##(1994-5#2)(1995-6#1)(2007-2#1)(2008-10#1)(2008-7#1)(2009-5#1)(2011-1#1)(2013-1#2)
specify cell fates##2##3##(2007-12#1)(2009-6#1)
specify how##2##2##(1991-7#1)(2009-3#1)
specify the level of##2##4##(1992-12#1)(2008-7#1)
specify the relationship between##2##4##(1997-1#1)(2010-11#1)
specify the##32##2##(1992-12#1)(1994-12#1)(1995-2#1)(1996-4#1)(1996-7#1)(1997-1#1)(2005-11#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-10#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#2)(2009-10#2)(2010-11#1)(2010-12#1)(2011-1#2)(2013-1#1)(2013-8#1)
specify##75##1##(1990-8#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-3#1)(1994-12#1)(1994-4#1)(1994-5#2)(1995-1#1)(1995-2#1)(1995-6#2)(1996-4#1)(1996-7#1)(1997-1#1)(1997-8#1)(2004-9#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#5)(2008-2#4)(2008-3#3)(2008-4#1)(2008-7#3)(2009-10#3)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2011-1#3)(2012-1#1)(2012-12#1)(2013-1#5)(2013-8#1)
specifying a##3##2##(1996-10#1)(2008-3#1)(2013-8#1)
specifying an##3##2##(1990-9#1)(1997-6#1)(2011-12#1)
specifying and##2##2##(1991-1#1)(2007-12#1)
specifying that##2##2##(1990-4#1)(2007-8#1)
specifying the##18##2##(1990-1#1)(1990-4#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-3#1)(1997-2#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-8#1)(2011-2#2)
specifying##45##1##(1990-1#1)(1990-4#2)(1990-9#2)(1991-1#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-9#2)(1993-2#1)(1993-6#1)(1994-12#1)(1994-3#2)(1995-2#1)(1995-8#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-10#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#2)(2013-8#1)
specimen and the##2##3##(2006-11#2)
specimen and##13##2##(1990-9#1)(1993-12#2)(1997-1#2)(1997-8#1)(2006-11#2)(2006-8#1)(2008-11#1)(2008-4#1)(2011-2#1)(2013-7#1)
specimen at a##2##3##(2008-2#1)(2012-2#1)
specimen by##3##2##(2005-12#1)(2007-8#1)(2012-12#1)
specimen collection for##2##3##(1991-9#1)(2010-6#1)
specimen collection methods##2##3##(2006-10#1)(2010-2#1)
specimen collection##8##2##(1991-9#1)(2006-10#1)(2007-8#1)(2008-5#1)(2009-5#1)(2010-2#1)(2010-6#2)
specimen consisted##2##2##(2008-5#2)
specimen for##4##2##(2006-8#1)(2007-12#1)(2008-9#1)(2009-8#1)
specimen from the##4##3##(1993-9#1)(2007-12#2)(2010-6#1)
specimen from##7##2##(1993-9#1)(2007-12#2)(2008-10#1)(2008-5#1)(2010-6#1)(2010-8#1)
specimen has##2##2##(2008-1#1)(2010-4#1)
specimen in rectal##2##3##(2008-10#2)
specimen in##5##2##(2008-10#2)(2008-3#1)(2008-8#1)(2012-2#1)
specimen is##8##2##(1995-8#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-1#1)
specimen may##2##2##(2004-2#1)(2006-10#1)
specimen movement##2##2##(2011-1#2)
specimen obtained from the##3##4##(2006-4#1)(2007-10#1)(2013-8#1)
specimen obtained##5##2##(2006-4#1)(2007-10#1)(2007-12#1)(2008-1#1)(2013-8#1)
specimen of a##3##3##(1994-4#1)(2006-5#1)(2011-1#1)
specimen of an##3##3##(2006-1#1)(2006-5#1)(2010-4#1)
specimen of primary##2##3##(1991-9#1)(2011-2#1)
specimen of the##5##3##(2005-1#1)(2007-3#1)(2008-10#2)(2008-5#1)
specimen of##18##2##(1991-9#1)(1992-2#1)(1994-4#1)(1995-3#1)(2005-1#1)(2006-1#1)(2006-5#2)(2007-3#1)(2008-10#2)(2008-5#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)
specimen on##2##2##(2007-12#1)(2009-4#1)
specimen radiography##2##2##(2004-2#2)
specimen removal##2##2##(1996-1#1)(2004-9#1)
specimen request##2##2##(1993-12#2)
specimen resected from the##2##4##(2007-12#1)(2007-8#1)
specimen revealed a##2##3##(1991-9#1)(2008-11#1)
specimen revealed##12##2##(1991-9#1)(1992-4#1)(1996-6#1)(2005-12#1)(2006-4#1)(2007-2#1)(2007-8#1)(2008-11#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
specimen showed a##2##3##(2008-5#1)(2009-5#1)
specimen showed##9##2##(2007-7#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-5#2)(2009-8#1)(2010-9#1)(2011-2#1)
specimen surface and##2##3##(2012-2#1)(2013-8#1)
specimen surface##3##2##(2012-2#2)(2013-8#1)
specimen that can##2##3##(2008-5#1)(2009-4#1)
specimen that##3##2##(2008-5#1)(2009-4#1)(2011-1#1)
specimen type##2##2##(2007-12#2)
specimen using##2##2##(2009-8#1)(2011-1#1)
specimen volume##3##2##(2009-7#3)
specimen was subjected to##4##4##(1995-2#1)(2007-4#2)(2013-8#1)
specimen was##26##2##(1991-12#1)(1992-6#1)(1995-2#2)(1995-4#1)(2004-9#1)(2006-11#1)(2006-8#1)(2007-12#1)(2007-4#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-11#1)(2010-2#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#1)
specimen were##9##2##(1991-1#1)(1997-1#1)(1997-8#1)(2006-4#1)(2008-11#1)(2010-2#1)(2011-1#1)(2011-12#1)(2012-3#1)
specimen with##5##2##(1995-2#1)(2008-2#1)(2008-7#2)(2012-2#1)
specimen##296##1##(1990-10#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-6#1)(1991-9#5)(1992-2#1)(1992-4#1)(1992-6#1)(1992-8#2)(1993-12#4)(1993-9#1)(1994-4#1)(1994-9#1)(1995-2#3)(1995-3#2)(1995-4#2)(1995-8#1)(1996-1#1)(1996-6#2)(1996-7#1)(1997-1#6)(1997-8#2)(2004-2#3)(2004-9#2)(2005-1#1)(2005-12#3)(2006-1#1)(2006-10#7)(2006-11#3)(2006-4#7)(2006-5#2)(2006-7#1)(2006-8#5)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#16)(2007-2#2)(2007-3#2)(2007-4#5)(2007-7#1)(2007-8#9)(2007-9#2)(2008-1#3)(2008-10#15)(2008-11#4)(2008-12#3)(2008-2#8)(2008-3#9)(2008-4#6)(2008-5#13)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-11#1)(2009-3#2)(2009-4#3)(2009-5#3)(2009-7#12)(2009-8#3)(2010-11#2)(2010-12#2)(2010-2#4)(2010-4#3)(2010-6#5)(2010-8#5)(2010-9#2)(2011-1#12)(2011-12#1)(2011-2#13)(2012-1#1)(2012-12#6)(2012-2#6)(2012-3#2)(2013-1#8)(2013-7#3)(2013-8#8)
specimen)##2##1##(1995-2#1)(2007-8#1)
specimen-specific pelvic FE##2##3##(2013-1#2)
specimen-specific##3##1##(2013-1#3)
specimens (mean##2##2##(1995-12#1)(2012-1#1)
specimens after##3##2##(2006-8#1)(2011-1#1)(2011-2#1)
specimens analyzed##3##2##(1991-9#1)(2007-12#1)(2008-5#1)
specimens and a##2##3##(2006-11#1)(2011-2#1)
specimens and in the##2##4##(2009-3#1)(2012-3#1)
specimens and the##2##3##(1991-9#1)(1993-3#1)
specimens and their##2##3##(1994-2#1)(2012-2#1)
specimens and##28##2##(1991-10#1)(1991-9#2)(1992-12#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-2#1)(1996-6#1)(2005-12#1)(2006-10#1)(2006-11#2)(2006-4#1)(2007-12#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-3#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-7#1)
specimens are available##2##3##(1995-9#1)(2011-2#1)
specimens are##11##2##(1990-2#1)(1991-6#1)(1992-6#1)(1995-9#1)(2007-12#1)(2008-1#1)(2008-6#1)(2009-7#1)(2011-1#1)(2011-2#2)
specimens as well as##2##4##(1995-8#1)(2008-4#1)
specimens as##6##2##(1993-11#1)(1995-8#1)(2004-9#1)(2006-2#1)(2008-2#1)(2008-4#1)
specimens at the##2##3##(2008-11#1)(2008-12#1)
specimens at##8##2##(1993-8#1)(1994-5#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2010-4#1)(2011-2#1)
specimens but also##2##3##(1992-10#1)(2008-3#1)
specimens but##3##2##(1990-11#1)(1992-10#1)(2008-3#1)
specimens by PCR and##2##4##(1993-12#1)(1997-3#1)
specimens by##16##2##(1993-12#1)(1996-8#1)(1997-3#1)(1997-7#1)(2006-12#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-4#1)(2011-2#1)
specimens can be##5##3##(1997-4#1)(2008-9#2)(2009-5#1)(2011-1#1)
specimens caught##2##2##(2013-7#2)
specimens collected at hours##2##4##(2007-8#2)
specimens collected at##4##3##(2007-8#4)
specimens collected from##5##3##(1996-8#1)(2007-8#2)(2008-3#1)(2010-4#1)
specimens collected in##2##3##(2007-3#1)(2013-7#1)
specimens collected via##2##3##(2011-1#2)
specimens collected##16##2##(1996-8#1)(2007-12#1)(2007-3#1)(2007-8#6)(2008-3#1)(2008-5#1)(2008-6#1)(2010-4#1)(2011-1#2)(2013-7#1)
specimens confirmed##3##2##(2005-12#1)(2008-3#1)(2012-2#1)
specimens could##2##2##(2007-10#1)(2008-5#1)
specimens demonstrated##5##2##(1993-11#1)(2008-1#1)(2008-6#1)(2008-8#1)(2013-1#1)
specimens disclosed##2##2##(1992-11#1)(2008-1#1)
specimens during##4##2##(1995-2#1)(2008-3#1)(2009-4#1)(2010-8#1)
specimens ex vivo##2##3##(2007-11#1)(2008-6#1)
specimens examined##5##2##(1994-8#1)(2004-1#1)(2008-5#2)(2008-6#1)
specimens exhibited##3##2##(2007-8#1)(2008-8#1)(2013-1#1)
specimens expressed the alpha##2##4##(1991-9#2)
specimens expressed the##4##3##(1991-9#3)(2007-6#1)
specimens expressed##5##2##(1991-9#3)(2007-6#2)
specimens failed##2##2##(2007-1#1)(2013-8#1)
specimens for##18##2##(1992-4#1)(1993-7#1)(1993-8#1)(1996-11#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-12#1)(2006-7#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-9#1)(2010-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
specimens from 24 patients##2##4##(2007-8#1)(2012-3#1)
specimens from Brazil##2##3##(2007-3#1)(2008-5#1)
specimens from normal##2##3##(1992-9#1)(1995-4#1)
specimens from patients in##2##4##(2007-12#1)(2008-5#1)
specimens from patients with##3##4##(2012-1#3)
specimens from patients##7##3##(2006-8#1)(2007-12#1)(2008-5#1)(2009-11#1)(2012-1#3)
specimens from the##8##3##(1990-7#1)(1991-9#1)(2007-9#1)(2008-12#1)(2008-5#1)(2010-12#1)(2010-4#1)(2013-7#1)
specimens from##74##2##(1990-7#2)(1990-9#1)(1991-4#1)(1991-9#2)(1992-2#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-4#1)(1995-9#1)(1996-12#3)(1996-6#1)(1997-3#1)(1997-4#1)(2005-10#1)(2006-11#3)(2006-8#2)(2007-12#1)(2007-2#2)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#1)(2008-9#1)(2009-11#1)(2009-8#2)(2010-12#2)(2010-4#1)(2011-1#2)(2011-2#1)(2012-1#3)(2012-3#2)(2012-9#1)(2013-7#1)(2013-8#2)
specimens had##3##2##(2007-1#1)(2007-11#1)(2008-9#1)
specimens has##2##2##(2010-5#1)(2011-2#1)
specimens have been##3##3##(2008-1#1)(2009-9#1)(2011-3#1)
specimens have##4##2##(2007-8#1)(2008-1#1)(2009-9#1)(2011-3#1)
specimens in a##2##3##(1992-11#1)(2008-3#1)
specimens in order to##2##4##(1996-4#1)(2010-12#1)
specimens in the##2##3##(2006-11#1)(2007-4#1)
specimens in this##2##3##(1990-10#1)(2007-2#1)
specimens in##17##2##(1990-10#1)(1992-11#1)(1996-4#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#2)(2008-3#1)(2008-5#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-2#1)
specimens increased##2##2##(2011-2#1)(2012-2#1)
specimens is##2##2##(1994-3#1)(2010-5#1)
specimens isolated from##2##3##(2008-10#1)(2012-2#1)
specimens may be##2##3##(1994-6#2)
specimens obtained at the##2##4##(1997-8#1)(2010-12#1)
specimens obtained at##3##3##(1994-7#1)(1997-8#1)(2010-12#1)
specimens obtained from the##2##4##(1993-1#1)(2012-1#1)
specimens obtained from##11##3##(1993-1#2)(1994-3#1)(1997-8#1)(2004-9#1)(2006-11#1)(2006-12#1)(2006-8#1)(2012-1#1)(2012-3#1)(2013-7#1)
specimens obtained##19##2##(1990-6#1)(1992-7#1)(1993-1#3)(1994-3#1)(1994-7#1)(1997-8#2)(2004-9#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-12#1)(2010-1#1)(2010-12#1)(2012-1#1)(2012-3#1)(2013-7#1)
specimens of C##2##3##(2008-10#1)(2008-6#1)
specimens of O##2##3##(2008-10#1)(2008-5#1)
specimens of Pimelodus##2##3##(2008-12#2)
specimens of all##2##3##(2010-3#1)(2010-9#1)
specimens of patients##2##3##(2008-12#1)(2010-11#1)
specimens of the same species##2##5##(1996-12#2)
specimens of the##15##3##(1991-10#1)(1994-6#1)(1996-12#2)(1996-5#1)(2007-5#3)(2008-10#1)(2008-11#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
specimens of##70##2##(1991-10#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-3#1)(1993-9#1)(1994-6#3)(1995-10#2)(1995-11#1)(1995-8#1)(1996-10#1)(1996-12#2)(1996-5#1)(2004-1#1)(2005-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#2)(2007-5#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-3#1)(2008-5#4)(2008-6#2)(2008-9#1)(2010-1#2)(2010-11#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
specimens on##3##2##(2008-10#1)(2008-7#1)(2010-8#1)
specimens prepared from##2##3##(2008-1#1)(2008-10#1)
specimens received##2##2##(2008-12#1)(2012-3#1)
specimens revealed that##2##3##(1991-2#1)(2007-8#1)
specimens revealed##10##2##(1991-11#1)(1991-2#1)(2007-8#1)(2008-1#3)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#1)
specimens should##2##2##(1996-12#1)(2007-12#1)
specimens showed that##2##3##(1991-7#1)(2008-5#1)
specimens showed##8##2##(1991-7#1)(1995-2#1)(2007-8#1)(2008-5#2)(2011-2#1)(2012-1#1)(2012-2#1)
specimens submitted##2##2##(2008-9#1)(2011-1#1)
specimens sustained##2##2##(2007-1#2)
specimens taken##2##2##(1990-9#1)(2007-7#1)
specimens tested##3##2##(1993-8#1)(2004-9#1)(2008-1#1)
specimens that can be##2##4##(2008-2#1)(2008-9#1)
specimens that##5##2##(1993-1#1)(1993-12#1)(1994-3#1)(2008-2#1)(2008-9#1)
specimens the##2##2##(2007-4#1)(2009-7#1)
specimens to the##2##3##(1994-3#1)(2007-5#1)
specimens to##8##2##(1994-3#1)(2006-10#2)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2010-4#1)
specimens using##6##2##(2007-10#1)(2008-12#1)(2008-5#1)(2012-2#2)(2012-3#1)
specimens was not##2##3##(2007-9#1)(2009-7#1)
specimens was##13##2##(1990-7#1)(1993-7#1)(1994-6#1)(1994-9#1)(1995-2#1)(2004-9#1)(2006-8#1)(2007-6#1)(2007-9#1)(2008-12#1)(2008-7#1)(2009-7#1)(2013-8#1)
specimens were analyzed and##2##4##(2013-7#2)
specimens were analyzed##6##3##(1991-2#1)(2007-7#1)(2013-1#1)(2013-7#3)
specimens were collected and##2##4##(2010-9#1)(2011-2#1)
specimens were collected from##7##4##(1991-7#1)(2006-8#1)(2007-2#1)(2007-6#1)(2008-12#1)(2010-12#1)(2011-2#1)
specimens were collected##14##3##(1991-7#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-6#1)(2008-12#1)(2008-5#2)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)
specimens were divided into##2##4##(2010-2#1)(2011-1#1)
specimens were divided##3##3##(2010-2#1)(2011-1#1)(2013-1#1)
specimens were identified##2##3##(2008-5#1)(2011-2#1)
specimens were immersed in##2##4##(2008-10#1)(2013-8#1)
specimens were loaded##4##3##(2006-9#1)(2008-12#1)(2011-2#1)(2013-8#1)
specimens were obtained and##2##4##(1991-8#1)(1997-8#1)
specimens were obtained from##5##4##(1992-5#1)(2007-12#1)(2008-12#1)(2012-2#1)(2013-1#1)
specimens were obtained##8##3##(1991-8#1)(1992-5#1)(1997-8#1)(2007-12#1)(2008-12#1)(2012-2#1)(2013-1#2)
specimens were placed##2##3##(2004-9#1)(2007-4#1)
specimens were prepared##3##3##(2008-12#1)(2009-3#1)(2011-2#1)
specimens were processed for##2##4##(2007-7#2)
specimens were processed##4##3##(2007-7#2)(2007-8#1)(2008-5#1)
specimens were randomly##2##3##(2013-1#2)
specimens were resistant to##2##4##(2012-2#2)
specimens were stored for 24 hours##2##6##(2006-8#1)(2010-2#1)
specimens were stored##3##3##(2006-8#1)(2008-12#1)(2010-2#1)
specimens were subjected to##4##4##(2007-7#1)(2008-5#1)(2013-1#2)
specimens were taken##3##3##(2008-5#2)(2013-7#1)
specimens were tested in##3##4##(2008-12#1)(2012-2#1)(2013-8#1)
specimens were tested##8##3##(2006-11#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-12#1)(2011-1#1)(2012-2#1)(2013-8#1)
specimens were then##2##3##(2008-3#1)(2009-7#1)
specimens were used for##4##4##(1993-9#2)(2008-8#2)
specimens were used##7##3##(1993-9#2)(1994-12#1)(2008-12#1)(2008-8#2)(2013-1#1)
specimens were##122##2##(1990-2#1)(1990-7#1)(1991-2#1)(1991-7#1)(1991-8#2)(1992-5#1)(1993-9#2)(1994-12#1)(1996-12#3)(1997-8#1)(2004-9#2)(2006-11#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-12#1)(2007-2#2)(2007-3#3)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#4)(2007-9#2)(2008-10#3)(2008-12#8)(2008-3#1)(2008-5#11)(2008-6#1)(2008-7#2)(2008-8#3)(2009-3#3)(2009-7#2)(2009-8#1)(2010-12#2)(2010-2#4)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#6)(2012-12#1)(2012-2#6)(2013-1#11)(2013-7#4)(2013-8#4)
specimens which##3##2##(1991-9#2)(1996-7#1)
specimens with the##3##3##(1990-12#1)(2008-6#1)(2013-1#1)
specimens with##17##2##(1990-12#1)(1995-2#2)(1997-1#1)(2004-9#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-6#1)(2009-8#2)(2010-4#1)(2012-2#1)(2013-1#1)
specimens##886##1##(1990-1#1)(1990-10#4)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#3)(1990-7#5)(1990-9#2)(1991-10#2)(1991-11#3)(1991-12#3)(1991-2#3)(1991-4#1)(1991-6#1)(1991-7#3)(1991-8#3)(1991-9#20)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#4)(1992-9#1)(1993-1#6)(1993-11#4)(1993-12#5)(1993-2#1)(1993-3#1)(1993-7#2)(1993-8#6)(1993-9#3)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#7)(1994-5#1)(1994-6#9)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#7)(1995-3#2)(1995-4#1)(1995-5#2)(1995-8#2)(1995-9#5)(1996-10#1)(1996-11#1)(1996-12#13)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#3)(1996-7#4)(1996-8#3)(1997-1#3)(1997-2#2)(1997-3#3)(1997-4#2)(1997-7#2)(1997-8#5)(2004-1#4)(2004-11#2)(2004-9#7)(2005-10#1)(2005-12#2)(2005-8#2)(2006-10#10)(2006-11#14)(2006-12#4)(2006-2#3)(2006-4#2)(2006-7#1)(2006-8#14)(2006-9#1)(2007-1#9)(2007-10#4)(2007-11#9)(2007-12#20)(2007-2#11)(2007-3#10)(2007-4#14)(2007-5#13)(2007-6#6)(2007-7#12)(2007-8#34)(2007-9#9)(2008-1#15)(2008-10#31)(2008-11#5)(2008-12#29)(2008-2#9)(2008-3#19)(2008-4#13)(2008-5#43)(2008-6#12)(2008-7#10)(2008-8#9)(2008-9#22)(2009-10#1)(2009-11#3)(2009-3#4)(2009-4#5)(2009-5#1)(2009-7#11)(2009-8#8)(2009-9#1)(2010-1#4)(2010-10#2)(2010-11#2)(2010-12#8)(2010-2#10)(2010-3#4)(2010-4#11)(2010-5#3)(2010-7#1)(2010-8#10)(2010-9#4)(2011-1#17)(2011-2#29)(2011-3#1)(2012-1#8)(2012-12#7)(2012-2#19)(2012-3#9)(2012-7#1)(2012-9#1)(2013-1#25)(2013-7#15)(2013-8#21)
specimens) in##2##2##(2008-12#1)(2008-6#1)
specimens)##7##1##(2007-8#2)(2008-12#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-2#1)
speciosa extract##2##2##(2008-5#1)(2010-3#1)
speciosa##16##1##(2007-1#2)(2008-12#1)(2008-5#4)(2010-3#5)(2010-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
speciose##2##1##(2008-9#1)(2013-7#1)
speck of tomato##2##3##(2008-10#2)
speck of##3##2##(2008-10#2)(2011-1#1)
speck##13##1##(2008-10#12)(2011-1#1)
speckle and##4##2##(2007-12#1)(2008-3#3)
speckle as##2##2##(2007-12#1)(2008-3#1)
speckle contrast analysis##2##3##(2013-1#2)
speckle contrast##4##2##(2008-3#2)(2013-1#2)
speckle correlation method##3##3##(2008-3#2)(2008-5#1)
speckle correlation##7##2##(2008-3#6)(2008-5#1)
speckle decorrelation##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
speckle effects in##2##3##(2008-2#1)(2008-3#1)
speckle field with##2##3##(2007-12#1)(2008-2#1)
speckle field##8##2##(2007-12#4)(2008-2#2)(2008-3#2)
speckle fields##6##2##(2008-2#3)(2008-3#3)
speckle images##2##2##(2007-11#1)(2008-2#1)
speckle imaging##7##2##(2007-12#4)(2008-3#1)(2013-1#2)
speckle in##2##2##(2007-12#2)
speckle intensity##6##2##(2007-12#1)(2008-2#4)(2008-3#1)
speckle interference patterns##2##3##(2008-2#2)
speckle interferometer##6##2##(2007-11#1)(2008-2#2)(2008-3#3)
speckle interferometric##3##2##(2008-2#3)
speckle interferometry##13##2##(2007-12#2)(2008-1#1)(2008-2#5)(2008-3#5)
speckle is##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
speckle modulation##3##2##(2007-11#1)(2007-12#2)
speckle noise##9##2##(2007-12#1)(2008-2#5)(2008-3#3)
speckle pattern fluctuations##2##3##(2007-11#2)
speckle pattern interferometer##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
speckle pattern interferometry (ESPI)##3##4##(2008-2#2)(2009-7#1)
speckle pattern interferometry##17##3##(2007-12#1)(2008-2#9)(2008-3#5)(2008-8#1)(2009-7#1)
speckle pattern##39##2##(2007-11#3)(2007-12#7)(2008-2#17)(2008-3#9)(2008-8#1)(2009-7#1)(2013-1#1)
speckle patterns scattered##2##3##(2008-2#1)(2008-3#1)
speckle patterns##12##2##(2007-12#2)(2008-2#6)(2008-3#4)
speckle photography and##2##3##(2008-2#1)(2008-3#1)
speckle photography technique##2##3##(2007-11#1)(2008-3#1)
speckle photography##17##2##(2007-11#2)(2008-2#1)(2008-3#14)
speckle reducing anisotropic diffusion##2##4##(2008-2#2)
speckle reduction##5##2##(2007-12#1)(2008-2#1)(2008-3#1)(2010-2#2)
speckle removal##2##2##(2008-2#1)(2008-3#1)
speckle signal##3##2##(2008-3#3)
speckle signals##2##2##(2008-3#2)
speckle size##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
speckle statistics in##2##3##(2008-2#1)(2008-3#1)
speckle statistics##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
speckle tracking##2##2##(2010-5#2)
speckle velocimeter with two self-mixing laser diodes##2##7##(2008-3#2)
speckle velocimeter with##3##3##(2008-3#3)
speckle velocimeter##6##2##(2008-3#6)
speckle##246##1##(2006-5#1)(2007-11#11)(2007-12#39)(2008-1#4)(2008-2#82)(2008-3#94)(2008-5#1)(2008-8#1)(2009-7#1)(2010-11#1)(2010-2#2)(2010-5#2)(2013-1#7)
speckle-field-based##2##1##(2007-11#2)
speckle-free##2##1##(2007-12#1)(2008-3#1)
speckle-pattern illumination##2##2##(2008-2#2)
speckle-pattern interferometry##17##2##(2007-12#1)(2008-2#6)(2008-3#10)
speckle-pattern##21##1##(2007-12#1)(2008-2#8)(2008-3#12)
speckle-tracking echocardiography##3##2##(2009-10#1)(2011-2#2)
speckled images##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
speckled leaf blotch##6##3##(2008-10#6)
speckled speckles##2##2##(2008-3#2)
speckled##18##1##(1995-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#6)(2008-2#2)(2008-3#4)(2012-12#1)
speckles and##2##2##(2007-12#1)(2008-2#1)
speckles are##3##2##(2007-12#2)(2008-2#1)
speckles in the##3##3##(2008-2#2)(2008-3#1)
speckles in##5##2##(2008-2#4)(2008-3#1)
speckles##23##1##(2007-12#6)(2008-2#12)(2008-3#4)(2013-1#1)
speckling##2##1##(2008-3#2)
specks&quot##3##1##(2005-11#3)
spectabilis##2##1##(2010-3#2)
spectacle corrected visual##2##3##(2011-2#1)(2012-3#1)
spectacle independence##2##2##(2011-2#2)
spectacle##5##1##(2011-2#3)(2012-12#1)(2012-3#1)
spectacles##2##1##(1993-11#1)(2011-2#1)
spectacular in##2##2##(1995-9#1)(2008-8#1)
spectacular progress##2##2##(2007-12#1)(2010-7#1)
spectacular##21##1##(1991-2#1)(1991-6#1)(1992-5#1)(1995-9#1)(1996-1#1)(1996-9#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-4#2)(2010-7#1)(2011-12#1)(2011-2#1)
spectators##3##1##(1996-3#2)(2012-2#1)
specter of##2##2##(1995-12#1)(2006-10#1)
specter##3##1##(1995-12#1)(2006-10#1)(2013-1#1)
spectinomycin##3##1##(1997-2#1)(2006-11#1)(2008-4#1)
spectra CWT-zero##2##2##(2008-10#2)
spectra after##2##2##(2008-1#1)(2013-8#1)
spectra allowed the##2##3##(1992-3#1)(1997-7#1)
spectra along##2##2##(2008-10#1)(2008-6#1)
spectra and a##2##3##(2008-10#2)
spectra and electrochemical properties of##2##5##(1996-5#1)(2008-8#1)
spectra and elemental analysis##2##4##(2007-11#1)(2008-5#1)
spectra and the##10##3##(1990-10#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#1)(2010-9#1)
spectra and their##7##3##(1996-7#1)(2005-4#1)(2008-10#5)
spectra and##91##2##(1990-10#1)(1990-2#1)(1990-6#1)(1991-10#1)(1991-7#1)(1992-1#1)(1992-2#1)(1993-11#1)(1993-4#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-5#2)(1996-7#1)(1997-7#2)(2005-11#1)(2005-4#5)(2005-7#1)(2006-10#3)(2006-4#1)(2007-1#1)(2007-11#4)(2007-12#6)(2007-9#1)(2008-1#1)(2008-10#21)(2008-11#1)(2008-2#7)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-2#1)(2009-9#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-8#1)
spectra are assigned to##2##4##(1997-7#2)
spectra are compared with##2##4##(1990-12#1)(2008-2#1)
spectra are compared##3##3##(1990-12#1)(1994-9#1)(2008-2#1)
spectra are in good agreement##2##5##(2008-2#1)(2008-3#1)
spectra are measured at##2##4##(2008-10#1)(2008-3#1)
spectra are obtained for##2##4##(1995-10#1)(2008-4#1)
spectra are obtained in##2##4##(2008-10#1)(2012-8#1)
spectra are obtained##6##3##(1995-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2012-8#1)
spectra are presented##2##3##(2008-10#1)(2008-2#1)
spectra are recorded##4##3##(1997-2#1)(2007-12#1)(2008-3#1)(2012-2#1)
spectra are reported for##2##4##(1994-12#1)(2006-4#1)
spectra are reported##3##3##(1994-12#1)(2006-4#1)(2008-5#1)
spectra are to##2##3##(1991-4#1)(2007-11#1)
spectra are used to##3##4##(2006-3#1)(2008-2#1)(2008-3#1)
spectra are used##4##3##(2006-3#1)(2008-2#1)(2008-3#2)
spectra are##56##2##(1990-12#1)(1991-4#1)(1992-2#1)(1994-12#1)(1994-9#2)(1995-10#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-7#2)(2005-4#1)(2006-3#1)(2006-4#2)(2006-5#2)(2007-11#2)(2007-12#6)(2008-10#10)(2008-2#5)(2008-3#6)(2008-4#2)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-8#1)
spectra as a function of the##2##6##(2008-2#1)(2008-3#1)
spectra as a##5##3##(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)
spectra as well as##5##4##(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)(2011-2#1)
spectra as##17##2##(2005-11#1)(2008-10#7)(2008-2#3)(2008-3#3)(2008-6#1)(2011-1#1)(2011-2#1)
spectra associated with##2##3##(2008-3#1)(2011-1#1)
spectra at##13##2##(1991-7#1)(1993-6#1)(1993-8#1)(1996-2#1)(1996-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)
spectra before##2##2##(2006-5#1)(2008-2#1)
spectra between##9##2##(1990-12#1)(1994-11#1)(2005-11#1)(2006-5#1)(2007-12#1)(2008-10#3)(2008-3#1)
spectra but##3##2##(1995-8#1)(2007-8#1)(2008-10#1)
spectra by a##3##3##(2008-3#3)
spectra by use of the##2##5##(2007-12#2)
spectra by use of##6##4##(2007-12#3)(2008-3#3)
spectra by using a##2##4##(2008-2#1)(2008-3#1)
spectra by using##3##3##(2008-2#1)(2008-3#2)
spectra by##21##2##(1996-8#1)(2005-11#1)(2005-4#1)(2007-12#3)(2008-10#2)(2008-2#2)(2008-3#11)
spectra calculated##2##2##(1992-12#1)(2011-1#1)
spectra can be obtained##2##4##(2007-11#1)(2008-3#1)
spectra can be##6##3##(2007-11#2)(2008-10#1)(2008-3#2)(2010-12#1)
spectra can##7##2##(2007-11#2)(2008-10#2)(2008-3#2)(2010-12#1)
spectra change##2##2##(2008-3#1)(2013-7#1)
spectra characteristic for##2##3##(1993-3#1)(2013-7#1)
spectra clearly##2##2##(1993-6#1)(2008-10#1)
spectra collected##4##2##(2005-4#1)(2006-12#1)(2006-4#1)(2008-10#1)
spectra confirmed the##2##3##(1997-2#1)(2008-10#1)
spectra confirmed##3##2##(1994-12#1)(1997-2#1)(2008-10#1)
spectra demonstrated##2##2##(2007-12#1)(2008-10#1)
spectra derivative##6##2##(2008-10#6)
spectra derived##2##2##(2008-10#1)(2008-2#1)
spectra did not##2##3##(1993-8#1)(1997-8#1)
spectra directly##2##2##(2007-11#1)(2008-10#1)
spectra do not##2##3##(2008-3#1)(2008-5#1)
spectra do##3##2##(2007-11#1)(2008-3#1)(2008-5#1)
spectra due to##3##3##(2008-10#2)(2012-2#1)
spectra during the##2##3##(1996-12#1)(2007-12#1)
spectra exhibit##2##2##(1997-7#1)(2007-1#1)
spectra first##2##2##(2008-10#1)(2013-8#1)
spectra for a##2##3##(2008-10#1)(2008-2#1)
spectra for each##2##3##(2008-10#1)(2010-8#1)
spectra for the##8##3##(1995-2#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2010-11#1)
spectra for this##2##3##(1990-7#1)(2013-7#1)
spectra for##31##2##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1995-2#1)(1997-2#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#7)(2008-2#5)(2008-3#4)(2008-5#1)(2010-11#1)(2010-8#1)(2013-7#2)
spectra from a##5##3##(1990-8#1)(2008-1#1)(2008-2#2)(2008-8#1)
spectra from such##2##3##(2008-1#1)(2008-2#1)
spectra from the##3##3##(1992-4#1)(2007-12#1)(2008-2#1)
spectra from various##2##3##(2008-10#1)(2008-5#1)
spectra from##32##2##(1990-8#1)(1991-10#1)(1992-2#1)(1992-4#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-12#6)(2008-1#4)(2008-10#2)(2008-2#8)(2008-3#2)(2008-5#1)(2008-8#1)(2013-1#1)
spectra generated##2##2##(2007-11#1)(2008-10#1)
spectra give a##2##3##(2006-4#1)(2008-3#1)
spectra has been##3##3##(2006-5#1)(2008-10#2)
spectra have been measured##2##4##(2007-12#2)
spectra have been obtained##2##4##(1991-7#1)(2005-4#1)
spectra have been##6##3##(1990-8#1)(1991-7#1)(2005-4#1)(2007-12#2)(2008-10#1)
spectra have enabled##2##3##(2006-10#1)(2008-10#1)
spectra have shown##2##3##(1992-8#1)(2008-5#1)
spectra have##11##2##(1990-8#1)(1991-7#1)(1992-8#1)(2005-4#1)(2006-10#1)(2006-12#1)(2007-12#2)(2008-10#2)(2008-5#1)
spectra in a##2##3##(1995-10#1)(2008-3#1)
spectra in order to##2##4##(2006-12#1)(2007-11#1)
spectra in the presence of##2##5##(1992-6#1)(1997-4#1)
spectra in the visible##2##4##(2008-10#1)(2008-2#1)
spectra in the wavelength##2##4##(2008-3#2)
spectra in the##23##3##(1992-6#1)(1992-8#1)(1993-3#1)(1994-11#1)(1997-4#1)(2007-12#3)(2008-10#5)(2008-2#3)(2008-3#5)(2008-5#1)(2010-7#1)
spectra in##42##2##(1992-6#1)(1992-8#1)(1993-3#1)(1994-11#1)(1995-10#1)(1996-7#1)(1997-4#1)(2005-4#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-11#3)(2007-12#4)(2007-5#1)(2008-10#6)(2008-2#4)(2008-3#10)(2008-5#1)(2010-6#1)(2010-7#1)
spectra indicate a##2##3##(1996-2#1)(2010-12#1)
spectra indicate that##7##3##(1991-11#1)(1993-6#3)(1995-1#1)(2007-11#1)(2008-10#1)
spectra indicate##10##2##(1990-10#1)(1991-11#1)(1993-6#3)(1995-1#1)(1996-2#1)(2007-11#1)(2008-10#1)(2010-12#1)
spectra indicated that the##2##4##(1997-7#1)(2008-10#1)
spectra indicated that##5##3##(1990-8#1)(1997-7#1)(2008-10#1)(2008-5#1)(2013-8#1)
spectra indicated##8##2##(1990-8#1)(1992-6#1)(1997-4#1)(1997-7#1)(2008-10#2)(2008-5#1)(2013-8#1)
spectra into##2##2##(2008-10#1)(2008-7#1)
spectra is based on##2##4##(1995-5#1)(2008-10#1)
spectra is demonstrated##2##3##(2008-10#1)(2008-3#1)
spectra is presented##3##3##(1994-3#1)(2007-8#1)(2008-3#1)
spectra is##28##2##(1994-3#1)(1995-5#1)(2006-12#1)(2006-3#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#4)(2008-3#7)(2008-4#1)(2008-5#1)(2008-9#1)(2010-2#1)
spectra library##2##2##(2007-8#1)(2010-2#1)
spectra measured in##2##3##(2008-3#1)(2010-5#1)
spectra measured##5##2##(2006-12#1)(2008-3#3)(2010-5#1)
spectra must be##2##3##(2008-2#2)
spectra obtained by##2##3##(2007-8#1)(2008-10#1)
spectra obtained from the##2##4##(2008-2#1)(2008-3#1)
spectra obtained from##7##3##(1995-11#1)(2008-10#1)(2008-2#3)(2008-3#1)(2010-5#1)
spectra obtained over a##2##4##(1990-3#1)(2008-10#1)
spectra obtained were##2##3##(2010-5#1)(2013-7#1)
spectra obtained with##5##3##(1990-7#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-3#1)
spectra obtained##29##2##(1990-3#1)(1990-5#1)(1990-7#1)(1994-5#1)(1995-11#1)(1997-4#1)(2006-12#1)(2007-11#2)(2007-8#1)(2008-10#7)(2008-2#4)(2008-3#3)(2008-4#1)(2010-5#3)(2013-7#1)
spectra of 12##2##3##(2008-10#2)
spectra of 5##2##3##(2006-12#1)(2007-1#1)
spectra of HA##3##3##(2008-10#1)(2013-8#2)
spectra of a##12##3##(1991-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-9#1)(2011-1#1)
spectra of alpha##4##3##(2005-4#4)
spectra of ammonia##2##3##(2007-12#2)
spectra of aqueous dispersions of##2##5##(1991-4#1)(1992-1#1)
spectra of aqueous##7##3##(1991-4#1)(1992-1#1)(2005-4#1)(2008-10#2)(2008-3#1)(2012-1#1)
spectra of biological##4##3##(1995-12#1)(2008-10#1)(2011-1#2)
spectra of both##4##3##(1992-2#1)(1995-10#1)(2005-11#1)(2008-10#1)
spectra of calcified human heart-valve##2##5##(2008-3#2)
spectra of calcified##3##3##(2008-3#3)
spectra of chitosan##2##3##(2005-4#2)
spectra of complexes##2##3##(1996-7#1)(2010-5#1)
spectra of different##3##3##(2008-10#1)(2009-6#1)(2010-5#1)
spectra of faceted diamonds##2##4##(2007-11#1)(2007-8#1)
spectra of human sera##2##4##(2008-3#2)
spectra of human##5##3##(1992-9#1)(2008-3#4)
spectra of individual##3##3##(2008-10#2)(2009-9#1)
spectra of liquid water in the##2##6##(2007-11#2)
spectra of methane##2##3##(2007-12#1)(2008-3#1)
spectra of mixtures##3##3##(2008-10#3)
spectra of molecular##2##3##(1996-2#1)(2012-2#1)
spectra of n-component solid mixtures##2##5##(2008-10#2)
spectra of nitric oxide##2##4##(2008-2#2)
spectra of oligosaccharides in##2##4##(1996-4#2)
spectra of perchloric acid extracts##3##5##(1990-5#1)(1991-1#2)
spectra of phenol and##2##4##(2005-4#2)
spectra of pure chlorophenols##2##4##(2008-10#2)
spectra of pure##3##3##(2008-10#3)
spectra of reduced##2##3##(1991-4#1)(1993-11#1)
spectra of selected##3##3##(2007-11#1)(2008-6#1)(2013-8#1)
spectra of several##2##3##(1991-11#1)(2005-4#1)
spectra of single##2##3##(2008-9#1)(2010-7#1)
spectra of six##2##3##(2008-10#2)
spectra of some##4##3##(1992-3#1)(2006-4#1)(2007-11#1)(2008-10#1)
spectra of the analytes##2##4##(2008-10#2)
spectra of the complex##2##4##(1994-11#1)(2008-10#1)
spectra of the complexes##3##4##(1992-9#1)(2008-10#2)
spectra of the drug##2##4##(2008-10#1)(2010-4#1)
spectra of the enzyme##2##4##(1993-9#1)(1995-1#1)
spectra of the individual##2##4##(1994-11#1)(2008-10#1)
spectra of the metal##2##4##(2008-10#1)(2008-4#1)
spectra of the native##2##4##(1993-9#1)(2008-8#1)
spectra of the protein##2##4##(1997-7#1)(2009-3#1)
spectra of the stars alpha and rho Leonis##2##8##(2008-2#1)(2008-3#1)
spectra of the two##3##4##(1991-6#1)(2006-12#1)(2011-2#1)
spectra of the wild-type##2##4##(1995-11#1)(1997-4#1)
spectra of the##132##3##(1990-12#1)(1990-2#2)(1990-5#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#6)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-3#1)(1995-5#2)(1996-2#1)(1997-1#1)(1997-4#2)(1997-7#3)(1997-8#1)(2004-4#1)(2005-11#6)(2005-4#1)(2006-12#2)(2006-3#1)(2006-7#2)(2007-11#5)(2007-12#7)(2007-8#3)(2008-10#25)(2008-2#9)(2008-3#9)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-3#1)(2010-4#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#3)
spectra of their##3##3##(2007-8#1)(2008-10#2)
spectra of these compounds##3##4##(2008-10#3)
spectra of these##10##3##(2005-4#1)(2007-12#1)(2008-10#6)(2008-3#1)(2009-10#1)
spectra of thin##2##3##(2008-1#1)(2008-2#1)
spectra of this##2##3##(1994-2#1)(1995-2#1)
spectra of turbid media##2##4##(2008-3#2)
spectra of two##3##3##(1992-2#1)(2005-4#1)(2007-11#1)
spectra of undoped##2##3##(2005-4#2)
spectra of various##3##3##(1997-8#1)(2006-12#1)(2011-1#1)
spectra of##490##2##(1990-10#1)(1990-12#3)(1990-2#4)(1990-3#2)(1990-5#3)(1991-1#2)(1991-11#1)(1991-3#1)(1991-4#4)(1991-5#3)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#3)(1992-12#1)(1992-2#4)(1992-3#3)(1992-4#1)(1992-6#2)(1992-8#5)(1992-9#2)(1993-11#3)(1993-3#1)(1993-5#1)(1993-6#4)(1993-8#1)(1993-9#2)(1994-11#10)(1994-2#1)(1994-3#3)(1994-5#3)(1994-8#2)(1994-9#1)(1995-1#3)(1995-10#4)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#4)(1995-7#1)(1996-1#1)(1996-11#1)(1996-2#6)(1996-4#2)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#3)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#8)(1997-8#3)(2004-4#1)(2005-10#2)(2005-11#7)(2005-4#29)(2006-12#9)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#2)(2007-1#2)(2007-11#16)(2007-12#22)(2007-5#1)(2007-8#7)(2008-1#6)(2008-10#92)(2008-11#1)(2008-12#1)(2008-2#21)(2008-3#48)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#11)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#3)(2009-9#2)(2010-12#2)(2010-4#3)(2010-5#8)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#6)(2011-2#6)(2012-1#3)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#14)
spectra on the##4##3##(2006-5#1)(2007-12#1)(2008-10#2)
spectra on##7##2##(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#1)
spectra or##4##2##(2006-5#1)(2007-12#1)(2008-7#1)(2010-11#1)
spectra over##2##2##(2008-10#1)(2008-3#1)
spectra produced##3##2##(2008-10#1)(2008-6#1)(2008-8#1)
spectra provide##2##2##(2008-5#1)(2010-4#1)
spectra provided##3##2##(2007-12#1)(2008-10#1)(2008-6#1)
spectra recorded at##3##3##(2008-10#1)(2008-3#1)(2010-12#1)
spectra recorded by##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
spectra recorded from##2##3##(2007-12#1)(2008-7#1)
spectra recorded##14##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#5)(2008-7#1)(2010-12#1)
spectra reveal that the##2##4##(2008-10#1)(2010-4#1)
spectra reveal that##4##3##(1994-8#1)(2006-6#1)(2008-10#1)(2010-4#1)
spectra reveal the##3##3##(2005-11#1)(2008-10#1)(2008-3#1)
spectra reveal##10##2##(1994-8#2)(1995-11#1)(1996-7#1)(2005-11#1)(2006-6#1)(2008-10#2)(2008-3#1)(2010-4#1)
spectra revealed that the##2##4##(1997-4#1)(2005-11#1)
spectra revealed that##4##3##(1992-5#1)(1997-4#1)(2005-11#1)(2010-4#1)
spectra revealed the##3##3##(2007-11#1)(2008-3#2)
spectra revealed##12##2##(1992-5#2)(1992-6#1)(1994-3#1)(1997-4#1)(2005-11#1)(2007-11#1)(2008-10#2)(2008-3#2)(2010-4#1)
spectra show that the##8##4##(2005-11#1)(2005-4#1)(2006-12#1)(2007-1#1)(2007-12#2)(2008-10#1)(2008-8#1)
spectra show that##12##3##(1990-12#1)(1994-3#1)(2005-11#1)(2005-4#1)(2006-12#1)(2007-1#1)(2007-12#2)(2008-10#2)(2008-8#1)(2009-6#1)
spectra show##19##2##(1990-12#1)(1990-3#1)(1994-3#1)(1995-11#1)(1996-2#1)(2005-11#1)(2005-4#1)(2006-12#1)(2007-1#1)(2007-12#3)(2008-10#3)(2008-8#1)(2009-2#1)(2009-6#1)(2011-2#1)
spectra showed that the##2##4##(1994-11#1)(2007-12#1)
spectra showed that##6##3##(1993-4#1)(1994-11#1)(1995-3#1)(2007-12#1)(2013-8#2)
spectra showed the presence of##2##5##(2006-8#1)(2008-10#1)
spectra showed the##6##3##(1995-5#1)(2006-8#1)(2008-10#2)(2008-5#1)(2012-2#1)
spectra showed##22##2##(1990-2#1)(1993-4#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-10#1)(1995-3#1)(1995-5#1)(2006-8#1)(2007-12#1)(2008-10#3)(2008-5#2)(2010-7#1)(2012-2#1)(2013-7#1)(2013-8#2)
spectra shows that the##2##4##(1995-5#1)(2007-12#1)
spectra shows that##4##3##(1994-5#1)(1995-5#1)(2007-12#1)(2008-2#1)
spectra similar to##3##3##(1993-12#1)(1994-12#1)(2010-5#1)
spectra study##3##2##(1997-1#1)(2005-4#1)(2013-8#1)
spectra suggest that the##2##4##(2008-10#1)(2008-5#1)
spectra suggest that##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
spectra suggest##6##2##(1990-7#1)(1992-8#1)(1996-2#1)(2008-10#1)(2008-5#1)(2008-8#1)
spectra taken##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
spectra that are##3##3##(1994-9#1)(2007-12#1)(2008-3#1)
spectra that cover##2##3##(2008-3#2)
spectra that##14##2##(1994-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#4)(2012-2#1)
spectra the##2##2##(1992-9#1)(2008-10#1)
spectra to a##2##3##(2008-2#1)(2011-1#1)
spectra to be##3##3##(2008-10#1)(2008-3#2)
spectra to the##3##3##(2008-2#1)(2008-3#2)
spectra to those of##2##4##(1990-12#1)(2007-11#1)
spectra to##19##2##(1990-12#1)(1993-6#2)(1994-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#7)(2008-7#1)(2011-1#1)
spectra typical##2##2##(1992-9#1)(2008-11#1)
spectra under##2##2##(2005-11#1)(2008-2#1)
spectra using##6##2##(2008-10#3)(2008-4#1)(2010-4#2)
spectra was##6##2##(2008-10#4)(2008-6#1)(2013-1#1)
spectra were acquired by accumulating##2##5##(2007-8#1)(2008-10#1)
spectra were acquired##4##3##(2007-8#1)(2008-10#1)(2008-2#1)(2008-6#1)
spectra were analysed by principal component analysis (PCA) and the relevant principal components (PCs) were used for constructing multivariate Shewhart##2##20##(2008-10#2)
spectra were analysed##3##3##(2008-10#3)
spectra were analyzed by##2##4##(2006-12#1)(2008-3#1)
spectra were analyzed##4##3##(2005-4#1)(2006-12#1)(2008-10#1)(2008-3#1)
spectra were collected from##3##4##(1990-5#1)(2007-11#1)(2008-3#1)
spectra were collected##8##3##(1990-5#1)(1995-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2013-8#1)
spectra were compared to those##2##5##(1994-8#1)(2007-11#1)
spectra were compared##3##3##(1994-8#1)(2005-4#1)(2007-11#1)
spectra were examined##2##3##(1997-1#1)(2008-10#1)
spectra were found to be##2##5##(1996-8#1)(2008-10#1)
spectra were generated##3##3##(2008-2#1)(2012-12#2)
spectra were measured for##3##4##(1996-5#1)(2005-11#1)(2008-2#1)
spectra were measured##9##3##(1990-2#1)(1990-5#1)(1996-5#1)(2005-11#1)(2006-5#1)(2007-11#1)(2008-2#3)
spectra were observed for##2##4##(1996-11#1)(2007-11#1)
spectra were observed##6##3##(1996-11#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)
spectra were obtained for##3##4##(1990-10#1)(1994-11#1)(1997-8#1)
spectra were obtained##9##3##(1990-10#1)(1990-7#1)(1994-11#1)(1995-10#1)(1997-8#1)(2006-10#1)(2008-10#2)(2008-2#1)
spectra were recorded at various##2##5##(2008-10#2)
spectra were recorded for##2##4##(2008-10#2)
spectra were recorded##8##3##(2007-11#1)(2008-10#7)
spectra were used to##4##4##(2005-11#2)(2008-10#1)(2008-6#1)
spectra were used##6##3##(2005-11#2)(2008-10#1)(2008-3#1)(2008-6#1)(2011-1#1)
spectra were##94##2##(1990-10#1)(1990-2#1)(1990-5#2)(1990-7#1)(1992-1#1)(1992-8#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#2)(1995-8#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-4#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#4)(2005-4#5)(2006-10#1)(2006-12#2)(2006-5#1)(2007-11#6)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#24)(2008-2#9)(2008-3#6)(2008-6#2)(2011-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
spectra when##2##2##(1997-4#1)(2006-12#1)
spectra which##3##2##(1994-3#1)(1997-1#1)(2008-2#1)
spectra with a##7##3##(1993-2#1)(1997-1#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-2#2)
spectra with an##2##3##(2006-12#1)(2008-3#1)
spectra with high##2##3##(1996-5#1)(2005-4#1)
spectra with the##6##3##(1994-5#1)(2008-1#1)(2010-4#1)(2010-5#1)(2013-1#1)(2013-8#1)
spectra with those of##2##4##(1990-5#1)(2008-10#1)
spectra with those##3##3##(1990-5#1)(2007-3#1)(2008-10#1)
spectra with##32##2##(1990-3#1)(1990-5#1)(1991-2#1)(1993-2#1)(1994-5#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-7#1)(2005-4#1)(2006-12#1)(2006-5#2)(2007-11#1)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-3#2)(2010-4#1)(2010-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
spectra without##4##2##(1995-2#1)(2008-10#2)(2008-3#1)
spectra yielded##2##2##(1991-7#1)(1996-7#1)
spectra##1749##1##(1990-10#6)(1990-11#1)(1990-12#12)(1990-2#8)(1990-3#8)(1990-4#1)(1990-5#11)(1990-6#1)(1990-7#6)(1990-8#5)(1990-9#1)(1991-1#2)(1991-10#3)(1991-11#3)(1991-2#2)(1991-3#1)(1991-4#9)(1991-5#4)(1991-6#1)(1991-7#8)(1991-8#1)(1991-9#2)(1992-1#5)(1992-10#1)(1992-12#4)(1992-2#8)(1992-3#7)(1992-4#2)(1992-5#2)(1992-6#5)(1992-8#9)(1992-9#8)(1993-11#5)(1993-12#2)(1993-2#1)(1993-3#4)(1993-4#4)(1993-5#1)(1993-6#11)(1993-8#3)(1993-9#2)(1994-11#14)(1994-12#3)(1994-2#4)(1994-3#9)(1994-5#9)(1994-8#7)(1994-9#6)(1995-1#6)(1995-10#10)(1995-11#7)(1995-12#1)(1995-2#6)(1995-3#5)(1995-4#1)(1995-5#8)(1995-6#4)(1995-7#1)(1995-8#5)(1996-1#3)(1996-11#3)(1996-12#1)(1996-2#15)(1996-4#2)(1996-5#7)(1996-6#2)(1996-7#7)(1996-8#4)(1996-9#4)(1997-1#11)(1997-2#4)(1997-3#2)(1997-4#13)(1997-6#3)(1997-7#21)(1997-8#5)(2004-4#1)(2005-10#3)(2005-11#29)(2005-4#54)(2005-7#1)(2006-1#1)(2006-10#7)(2006-12#24)(2006-3#3)(2006-4#9)(2006-5#15)(2006-6#2)(2006-7#2)(2006-8#2)(2007-1#8)(2007-10#2)(2007-11#77)(2007-12#103)(2007-3#1)(2007-5#3)(2007-8#23)(2007-9#1)(2008-1#21)(2008-10#354)(2008-11#8)(2008-12#4)(2008-2#131)(2008-3#186)(2008-4#20)(2008-5#32)(2008-6#13)(2008-7#12)(2008-8#8)(2008-9#13)(2009-1#1)(2009-10#3)(2009-2#3)(2009-3#3)(2009-4#2)(2009-6#3)(2009-8#4)(2009-9#3)(2010-11#2)(2010-12#7)(2010-2#3)(2010-4#14)(2010-5#20)(2010-6#2)(2010-7#6)(2010-8#5)(2010-9#1)(2011-1#15)(2011-2#13)(2012-1#5)(2012-12#5)(2012-2#9)(2012-3#3)(2012-8#2)(2013-1#8)(2013-7#9)(2013-8#32)
spectra)##8##1##(2008-10#7)(2008-3#1)
spectral CT##2##2##(2012-12#2)
spectral EEG activity##2##3##(1996-12#2)
spectral EEG characteristics of##3##4##(2008-7#3)
spectral EEG##6##2##(1996-12#3)(2008-7#3)
spectral absorption data##2##3##(2008-10#1)(2008-3#1)
spectral absorption##6##2##(2008-10#1)(2008-3#5)
spectral acquisition of##3##3##(2007-11#2)(2007-8#1)
spectral acquisition##4##2##(2007-11#3)(2007-8#1)
spectral amplitude##4##2##(1997-1#1)(2007-12#2)(2008-3#1)
spectral amplitudes##2##2##(2008-3#2)
spectral analyses of##2##3##(1995-10#1)(1996-9#1)
spectral analyses##7##2##(1990-12#1)(1995-10#1)(1996-9#1)(2006-12#1)(2007-11#1)(2008-11#1)(2009-3#1)
spectral analysis and##3##3##(2008-4#1)(2008-7#1)(2012-2#1)
spectral analysis in##4##3##(1991-12#1)(2007-12#1)(2008-7#1)(2013-7#1)
spectral analysis is##2##3##(2008-10#1)(2011-2#1)
spectral analysis of the##4##4##(1991-8#1)(1992-8#1)(1997-3#1)(2008-2#1)
spectral analysis of##17##3##(1990-5#1)(1991-10#1)(1991-4#1)(1991-8#1)(1992-8#1)(1994-7#1)(1997-3#1)(2007-12#2)(2008-2#3)(2008-3#2)(2009-9#1)(2012-2#1)(2013-1#1)
spectral analysis was##2##3##(1995-2#1)(1996-5#1)
spectral analysis with##2##3##(2008-2#2)
spectral analysis##56##2##(1990-5#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-8#3)(1992-8#1)(1993-9#1)(1994-7#1)(1995-2#1)(1996-4#1)(1996-5#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-1#3)(2007-11#2)(2007-12#5)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#3)(2008-4#1)(2008-7#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#1)(2013-7#1)
spectral and analytical data##6##4##(2008-5#6)
spectral and chemical evidence##2##4##(2007-1#1)(2008-4#1)
spectral and chemical##3##3##(2007-1#2)(2008-4#1)
spectral and kinetic##2##3##(1992-2#1)(2005-11#1)
spectral and photophysical properties##2##4##(2007-8#2)
spectral and polarization##2##3##(2007-12#1)(2008-3#1)
spectral and spatial resolution##5##4##(2007-12#1)(2008-2#2)(2008-3#2)
spectral and spatial##11##3##(2007-12#2)(2008-2#3)(2008-3#6)
spectral and spectro-temporal features##2##4##(2008-3#2)
spectral and temporal##3##3##(2007-12#2)(2008-3#1)
spectral and##42##2##(1991-4#1)(1992-2#1)(1994-3#1)(1996-2#1)(2005-11#1)(2007-1#2)(2007-12#5)(2007-8#2)(2008-10#2)(2008-2#3)(2008-3#13)(2008-4#1)(2008-5#6)(2008-6#1)(2009-9#1)(2010-3#1)
spectral angle##4##2##(2007-12#1)(2013-8#3)
spectral artifacts##6##2##(1996-5#1)(2008-2#5)
spectral assignment of##2##3##(2007-1#1)(2009-7#1)
spectral asymmetry of TEA CO2 laser pulses##2##7##(2008-3#2)
spectral atmospheric transmission and##2##4##(2008-2#2)
spectral band##12##2##(2008-10#1)(2008-2#1)(2008-3#7)(2008-7#2)(2012-2#1)
spectral bandpass##2##2##(2007-11#1)(2008-10#1)
spectral bands are##2##3##(2006-12#1)(2008-10#1)
spectral bands by##2##3##(2006-12#1)(2008-3#1)
spectral bands of##2##3##(2008-10#2)
spectral bands##15##2##(1991-4#1)(2006-12#2)(2007-12#1)(2008-10#3)(2008-3#5)(2008-7#1)(2010-11#1)(2010-5#1)
spectral bandwidth and##3##3##(2006-5#1)(2007-11#1)(2008-2#1)
spectral bandwidth at##2##3##(2007-11#1)(2007-12#1)
spectral bandwidth calibration##2##3##(2008-3#2)
spectral bandwidth of the##2##4##(2008-2#1)(2008-3#1)
spectral bandwidth of##7##3##(2007-11#1)(2008-1#1)(2008-2#2)(2008-3#3)
spectral bandwidth standard##3##3##(2008-3#3)
spectral bandwidth##29##2##(2006-5#1)(2007-11#4)(2007-12#6)(2008-1#1)(2008-2#5)(2008-3#12)
spectral bandwidths##7##2##(2007-12#4)(2008-3#3)
spectral basis model##2##3##(2008-4#2)
spectral basis##4##2##(2008-4#4)
spectral behavior of##5##3##(2005-11#1)(2007-12#2)(2008-10#1)(2008-3#1)
spectral behavior##10##2##(1990-2#1)(2005-11#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)
spectral behaviors##2##2##(2007-11#1)(2007-12#1)
spectral bleaching was also observed##2##5##(2005-11#2)
spectral bleaching##3##2##(2005-11#3)
spectral broadening is##3##3##(2007-12#3)
spectral broadening##9##2##(2007-11#5)(2007-12#4)
spectral calibration accuracy##2##3##(2008-2#2)
spectral calibration##7##2##(2008-2#5)(2008-3#2)
spectral change##4##2##(1990-2#1)(1995-2#1)(1997-2#1)(2010-5#1)
spectral changes and##3##3##(1990-3#1)(1995-8#1)(2006-10#1)
spectral changes are##2##3##(1990-3#1)(2005-11#1)
spectral changes observed##2##3##(1992-4#1)(2008-10#1)
spectral changes of##2##3##(1994-2#1)(2009-3#1)
spectral changes were##2##3##(1992-6#1)(1995-5#1)
spectral changes##26##2##(1990-3#2)(1991-9#1)(1992-3#1)(1992-4#1)(1992-6#2)(1994-2#1)(1995-10#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-7#1)(2005-11#2)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-3#1)(2010-12#1)
spectral channel response functions of##2##5##(2008-2#1)(2008-3#1)
spectral channel##3##2##(2008-2#2)(2008-3#1)
spectral characteristics and##4##3##(2007-11#1)(2008-3#2)(2009-4#1)
spectral characteristics of the##6##4##(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)
spectral characteristics of##15##3##(1990-2#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#4)(2013-8#2)
spectral characteristics##36##2##(1990-2#1)(1991-12#1)(1991-4#1)(2006-12#1)(2007-11#5)(2007-12#3)(2008-10#3)(2008-12#1)(2008-2#6)(2008-3#7)(2008-4#1)(2008-6#1)(2008-9#2)(2009-4#1)(2013-8#2)
spectral characterization of##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
spectral classification library##2##3##(2013-8#2)
spectral classification##6##2##(2013-8#6)
spectral coherence##4##2##(2007-1#1)(2007-12#3)
spectral collapse##2##2##(2007-12#2)
spectral component##3##2##(1997-7#1)(2008-1#2)
spectral components##9##2##(1990-8#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#1)(2010-5#1)
spectral compression##2##2##(2007-12#2)
spectral cone types##2##3##(2007-5#2)
spectral context##2##2##(2006-2#2)
spectral continuum##2##2##(2007-12#1)(2008-3#1)
spectral contributions##2##2##(1994-9#1)(2006-12#1)
spectral correction##3##2##(2008-10#3)
spectral coverage##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
spectral curves##3##2##(2005-4#1)(2008-2#1)(2008-3#1)
spectral data (IR##3##3##(2006-9#1)(2007-11#1)(2008-6#1)
spectral data and##5##3##(2007-1#1)(2007-11#1)(2007-8#1)(2008-3#1)(2012-12#1)
spectral data are##3##3##(2007-1#1)(2008-10#1)(2008-5#1)
spectral data obtained##3##3##(2007-11#1)(2008-10#2)
spectral data sets##2##3##(2008-10#2)
spectral data to##2##3##(1992-1#1)(2008-10#1)
spectral data##86##2##(1990-11#1)(1991-1#1)(1991-10#1)(1992-1#1)(1993-11#1)(1994-11#1)(1995-7#1)(1996-10#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-1#8)(2007-10#1)(2007-11#6)(2007-8#2)(2008-10#21)(2008-11#2)(2008-2#3)(2008-3#5)(2008-5#10)(2008-6#1)(2009-2#1)(2009-8#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-8#1)
spectral decay##2##2##(2009-12#2)
spectral deconvolution##4##2##(2008-10#3)(2011-2#1)
spectral density for##2##3##(2008-2#1)(2008-3#1)
spectral density is##2##3##(2007-12#2)
spectral density of a##2##4##(2007-12#2)
spectral density of the##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
spectral density of##8##3##(2007-11#1)(2007-12#5)(2008-3#2)
spectral density##25##2##(2006-7#1)(2007-11#2)(2007-12#7)(2008-2#4)(2008-3#7)(2010-8#2)(2012-1#1)(2012-2#1)
spectral dependence of the##2##4##(2007-11#1)(2008-2#1)
spectral dependences of the##2##4##(2008-3#2)
spectral dependences##3##2##(2008-3#3)
spectral detection##3##2##(2007-12#1)(2010-4#2)
spectral differences between##2##3##(2008-10#1)(2009-1#1)
spectral diffusion##3##2##(2008-2#3)
spectral dimension##2##2##(2007-11#1)(2013-8#1)
spectral discrimination##6##2##(2007-11#2)(2007-12#2)(2008-2#2)
spectral dispersion##9##2##(2007-11#3)(2008-2#1)(2008-3#5)
spectral distortions##2##2##(2008-10#1)(2010-5#1)
spectral distribution of the Raman-scattering##2##5##(2008-2#2)
spectral distribution of the##7##4##(2007-11#1)(2008-2#5)(2008-3#1)
spectral distribution of##10##3##(2007-11#1)(2008-2#6)(2008-3#3)
spectral distribution##14##2##(2007-11#1)(2008-10#1)(2008-2#7)(2008-3#5)
spectral diversity technique##2##3##(2008-3#2)
spectral domain optical coherence tomography##4##5##(2009-4#1)(2011-1#2)(2012-12#1)
spectral domain##18##2##(2007-11#1)(2007-12#3)(2008-2#4)(2008-3#3)(2009-4#2)(2011-1#3)(2012-12#1)(2013-8#1)
spectral domains##2##2##(2006-10#1)(2007-12#1)
spectral effects##3##2##(1994-11#1)(2007-12#1)(2008-2#1)
spectral emission##2##2##(2008-10#1)(2008-2#1)
spectral equilibration##2##2##(1996-7#2)
spectral estimation##3##2##(2008-3#1)(2009-3#1)(2010-4#1)
spectral evidence##6##2##(1992-1#1)(1994-3#1)(2007-1#4)
spectral evolution of##2##3##(1997-5#1)(2007-11#1)
spectral evolution##3##2##(1997-5#1)(2007-11#2)
spectral extinction and backscatter##2##4##(2008-3#2)
spectral extinction measurements##2##3##(2008-3#2)
spectral extinction##11##2##(2008-3#11)
spectral feature##5##2##(1992-3#1)(2008-10#1)(2008-3#3)
spectral features and##2##3##(1994-5#1)(2008-3#1)
spectral features of the##6##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2010-11#1)
spectral features of##9##3##(1995-10#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#2)(2010-11#1)
spectral features##28##2##(1991-4#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-10#1)(2006-12#1)(2007-11#3)(2007-12#1)(2008-10#7)(2008-2#5)(2008-3#3)(2008-7#1)(2010-11#2)
spectral filter##5##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
spectral filtering and##2##3##(2007-12#1)(2008-2#1)
spectral filtering of##2##3##(2007-12#1)(2008-3#1)
spectral filtering##12##2##(2007-11#4)(2007-12#5)(2008-2#2)(2008-3#1)
spectral filters that##2##3##(2007-12#1)(2008-6#1)
spectral filters##8##2##(2007-11#2)(2007-12#2)(2008-6#1)(2013-1#3)
spectral fluctuations##2##2##(2007-12#2)
spectral fluorescence##3##2##(2008-2#3)
spectral focusing##2##2##(2008-3#2)
spectral forms of Chl d##2##5##(1997-6#2)
spectral forms##3##2##(1992-8#1)(1997-6#2)
spectral frequency##4##2##(1992-9#1)(2007-11#1)(2008-2#2)
spectral gain##2##2##(2007-12#1)(2008-1#1)
spectral grating##4##2##(2007-12#4)
spectral hole burning (PSHB)##2##4##(2007-12#2)
spectral hole burning is##2##4##(2007-12#2)
spectral hole burning##13##3##(2007-11#2)(2007-12#11)
spectral hole##14##2##(2007-11#2)(2007-12#12)
spectral hole-burning##6##2##(2007-11#2)(2007-12#2)(2008-3#2)
spectral holography##6##2##(2007-12#1)(2008-2#1)(2008-3#4)
spectral identity##2##2##(2007-12#2)
spectral image data##2##3##(2007-12#2)
spectral image of the##2##4##(2008-2#1)(2008-5#1)
spectral image##6##2##(2007-12#3)(2008-2#1)(2008-3#1)(2008-5#1)
spectral imager operates based on##2##5##(2013-8#2)
spectral imager##6##2##(2008-2#1)(2008-3#1)(2013-8#4)
spectral images##10##2##(2008-2#2)(2008-3#1)(2013-8#7)
spectral imaging##10##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)(2009-4#2)(2011-1#2)
spectral information in the##2##4##(2007-8#1)(2008-3#1)
spectral information in##5##3##(2007-12#1)(2007-8#1)(2008-3#3)
spectral information##16##2##(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#5)(2008-9#1)(2012-1#1)
spectral intensities##4##2##(2007-11#2)(2009-8#1)(2013-8#1)
spectral intensity##6##2##(2007-11#3)(2008-2#1)(2013-8#2)
spectral interference##11##2##(2005-4#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2011-1#1)
spectral interferences from##3##3##(2005-4#1)(2006-12#1)(2008-10#1)
spectral interferences of##2##3##(2008-10#2)
spectral interferences##15##2##(2005-4#1)(2006-12#1)(2008-10#11)(2011-1#2)
spectral interfering elements##2##3##(2008-10#2)
spectral interferometry and##2##3##(2007-11#1)(2007-12#1)
spectral interferometry##12##2##(2007-11#5)(2007-12#7)
spectral interval##5##2##(2007-12#2)(2008-3#3)
spectral intervals##6##2##(2007-12#2)(2008-2#2)(2008-3#2)
spectral inversion and##2##3##(2007-12#1)(2008-3#1)
spectral inversion##4##2##(2007-12#3)(2008-3#1)
spectral investigations##2##2##(2007-11#2)
spectral irradiance measurements##2##3##(2008-2#1)(2008-3#1)
spectral irradiance scale##2##3##(2008-2#2)
spectral irradiance##14##2##(1992-2#1)(2008-2#8)(2008-3#5)
spectral karyotyping##2##2##(2008-1#2)
spectral leakage##2##2##(2008-3#2)
spectral library##4##2##(2008-10#1)(2010-5#1)(2011-2#1)(2012-12#1)
spectral line and##2##3##(2008-3#1)(2013-8#1)
spectral line is##2##3##(2008-2#2)
spectral line shape##2##3##(2007-12#1)(2008-3#1)
spectral line##16##2##(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#2)(2013-8#8)
spectral line-shape##2##2##(2007-11#1)(2008-2#1)
spectral lines and##2##3##(2005-4#1)(2011-1#1)
spectral lines##12##2##(2005-4#1)(2007-12#3)(2008-3#4)(2011-1#1)(2011-2#1)(2013-8#2)
spectral linewidth of##2##3##(2008-3#2)
spectral linewidth##5##2##(2007-12#2)(2008-3#3)
spectral measurement##5##2##(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)
spectral measurements of##5##3##(2007-11#1)(2007-12#2)(2008-2#1)(2012-12#1)
spectral measurements##12##2##(2007-11#2)(2007-12#3)(2007-9#1)(2008-11#1)(2008-2#2)(2008-3#2)(2012-12#1)
spectral method for the determination of trace##2##7##(2008-10#2)
spectral method for##3##3##(2008-10#3)
spectral method##7##2##(2005-4#1)(2008-10#4)(2008-2#1)(2012-2#1)
spectral method]##2##2##(2005-4#1)(2013-8#1)
spectral methods##4##2##(1994-11#1)(2006-12#1)(2007-1#2)
spectral model##2##2##(2008-2#2)
spectral models for##2##3##(2007-12#1)(2008-2#1)
spectral narrowing##2##2##(2007-11#1)(2007-12#1)
spectral nonflatness##2##2##(2008-2#2)
spectral optical##3##2##(2007-11#2)(2008-3#1)
spectral output##2##2##(2007-11#1)(2008-10#1)
spectral overlap was##3##3##(2008-10#3)
spectral overlap##13##2##(1994-11#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-2#1)
spectral overlapping of##2##3##(2008-10#2)
spectral overlapping##7##2##(2008-10#6)(2010-5#1)
spectral parameters##7##2##(1991-2#1)(2005-4#1)(2008-10#2)(2008-2#1)(2008-7#1)(2013-8#1)
spectral patterns##2##2##(2008-3#1)(2009-9#1)
spectral peak##4##2##(2007-12#1)(2008-10#1)(2008-8#1)(2010-6#1)
spectral peaks##4##2##(2008-10#1)(2008-2#1)(2009-6#1)(2010-6#1)
spectral performance##3##2##(2008-2#1)(2008-3#2)
spectral phase and##2##3##(2007-12#2)
spectral phase conjugation##2##3##(2007-12#2)
spectral phase interferometry for direct electric field reconstruction##2##8##(2007-11#1)(2007-12#1)
spectral phase interferometry for direct electric-field reconstruction (SPIDER)##3##8##(2007-12#3)
spectral phase interferometry for direct electric-field reconstruction##9##7##(2007-12#9)
spectral phase interferometry for direct##11##5##(2007-11#1)(2007-12#10)
spectral phase of##3##3##(2007-12#1)(2008-3#1)(2012-11#1)
spectral phase##24##2##(2007-11#2)(2007-12#20)(2008-3#1)(2012-11#1)
spectral polarization optical imaging##2##4##(2007-12#2)
spectral power and##2##3##(1995-3#1)(2008-3#1)
spectral power##9##2##(1991-1#1)(1992-7#1)(1993-9#1)(1995-3#2)(1997-1#1)(2008-2#1)(2008-3#2)
spectral profile of##2##3##(2007-11#1)(2008-10#1)
spectral profile##4##2##(2007-11#1)(2008-1#2)(2008-10#1)
spectral profiles of##2##3##(2008-10#1)(2009-1#1)
spectral profiles##10##2##(1992-12#1)(2007-11#1)(2008-10#5)(2008-3#1)(2009-1#1)(2009-12#1)
spectral properties and##5##3##(1990-7#1)(1992-2#1)(1995-10#1)(2008-2#1)(2008-5#1)
spectral properties have##2##3##(1990-7#1)(1992-1#1)
spectral properties of the##8##4##(1991-7#1)(1992-1#1)(2005-4#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
spectral properties of these##2##4##(2007-11#1)(2008-10#1)
spectral properties of##22##3##(1991-7#1)(1992-1#1)(1994-11#1)(1996-2#1)(2005-4#2)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#5)(2008-4#1)(2008-7#1)(2012-2#1)(2013-1#1)
spectral properties that##2##3##(1995-10#1)(1995-8#1)
spectral properties was##2##3##(1990-12#1)(1991-3#1)
spectral properties were evaluated##2##4##(2008-10#2)
spectral properties##53##2##(1990-12#1)(1990-7#3)(1991-3#2)(1991-7#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-7#1)(1993-2#1)(1994-11#1)(1995-10#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(2005-4#3)(2006-12#2)(2007-11#1)(2007-8#1)(2008-1#3)(2008-10#6)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#2)
spectral purity of##2##3##(2008-2#1)(2008-3#1)
spectral purity##10##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#4)(2008-3#2)
spectral quality##2##2##(2007-8#1)(2012-12#1)
spectral radiance##9##2##(2008-2#5)(2008-3#4)
spectral radiances##2##2##(2008-2#1)(2008-3#1)
spectral range and##5##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)
spectral range from the ultraviolet##2##5##(2007-11#1)(2008-3#1)
spectral range from##13##3##(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#3)(2010-4#1)(2013-7#1)
spectral range in##3##3##(2007-11#1)(2008-1#1)(2008-2#1)
spectral range is##5##3##(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)
spectral range of the##6##4##(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#1)
spectral range of##19##3##(2007-11#3)(2007-12#7)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-5#1)
spectral range was##2##3##(2008-10#1)(2008-3#1)
spectral range with##6##3##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)
spectral range##120##2##(2006-12#1)(2006-5#1)(2007-11#14)(2007-12#26)(2008-1#4)(2008-10#9)(2008-2#24)(2008-3#36)(2008-5#1)(2009-12#1)(2010-4#1)(2013-7#1)(2013-8#1)
spectral ranges##6##2##(1996-4#1)(2007-11#1)(2008-2#2)(2008-3#1)(2009-12#1)
spectral reflectance and##2##3##(2008-2#1)(2009-11#1)
spectral reflectance##15##2##(2008-10#1)(2008-12#2)(2008-2#5)(2008-3#3)(2008-5#2)(2009-11#1)(2013-8#1)
spectral reflectances##2##2##(2007-5#1)(2008-3#1)
spectral reflectivity##3##2##(2007-12#1)(2008-2#2)
spectral region and number of factors##2##6##(2008-10#2)
spectral region and##3##3##(2008-10#2)(2008-2#1)
spectral region are##2##3##(2008-3#2)
spectral region because of##2##4##(2008-2#1)(2008-3#1)
spectral region between##2##3##(2008-2#2)
spectral region for##2##3##(1994-8#1)(2008-2#1)
spectral region from 49##2##4##(2008-3#2)
spectral region from##6##3##(2007-12#1)(2008-2#2)(2008-3#3)
spectral region near##5##3##(2007-11#1)(2007-12#2)(2008-3#2)
spectral region was##2##3##(2007-12#1)(2007-8#1)
spectral region where##3##3##(2007-12#1)(2007-8#1)(2008-3#1)
spectral region##75##2##(1991-5#1)(1992-6#1)(1994-8#1)(2006-5#1)(2007-11#2)(2007-12#11)(2007-8#3)(2008-1#1)(2008-10#3)(2008-2#16)(2008-3#34)(2009-12#1)
spectral regions are##2##3##(2008-3#2)
spectral regions with##3##3##(2008-3#2)(2008-6#1)
spectral regions##23##2##(2007-12#2)(2008-10#2)(2008-2#4)(2008-3#13)(2008-6#1)(2013-7#1)
spectral representation of##2##3##(2007-11#1)(2008-3#1)
spectral representation##3##2##(2007-11#1)(2008-3#1)(2008-9#1)
spectral requirements##2##2##(2008-3#2)
spectral resolution and##6##3##(2007-12#3)(2008-1#1)(2008-2#2)
spectral resolution for##2##3##(2008-2#1)(2008-3#1)
spectral resolution in the##3##4##(2007-11#1)(2007-12#2)
spectral resolution is##3##3##(2007-12#1)(2008-3#2)
spectral resolution of 0##2##4##(2008-2#2)
spectral resolution of approximately##2##4##(2008-2#1)(2008-3#1)
spectral resolution of the##2##4##(2007-12#1)(2008-3#1)
spectral resolution of##10##3##(1991-5#1)(2007-12#4)(2008-2#3)(2008-3#2)
spectral resolution over a##2##4##(2007-12#2)
spectral resolution was##3##3##(2007-12#1)(2008-3#2)
spectral resolution##60##2##(1991-5#1)(1997-5#1)(2007-11#2)(2007-12#17)(2008-1#1)(2008-2#16)(2008-3#18)(2008-9#1)(2009-4#1)(2012-2#1)(2013-8#1)
spectral resolutions of##2##3##(2008-2#1)(2008-3#1)
spectral response linewidth##2##3##(2008-3#2)
spectral response of the##5##4##(2007-12#1)(2008-2#2)(2008-3#2)
spectral response of##10##3##(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#3)
spectral response was##2##3##(2006-7#1)(2007-12#1)
spectral response##28##2##(2006-7#1)(2007-11#1)(2007-12#8)(2008-10#1)(2008-2#5)(2008-3#12)
spectral responses of##2##3##(2007-11#1)(2008-10#1)
spectral responses##6##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
spectral responsivity of##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
spectral responsivity##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
spectral sampling##2##2##(2008-3#2)
spectral scan##2##2##(1992-1#1)(2008-3#1)
spectral scanning##2##2##(2005-4#1)(2007-12#1)
spectral sculpting##2##2##(2007-11#2)
spectral selectivities##3##2##(2008-2#3)
spectral sensitivity of##2##3##(2007-12#2)
spectral sensitivity##8##2##(1992-2#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-8#2)
spectral separation##4##2##(2008-2#2)(2009-10#1)(2012-1#1)
spectral shape of##5##3##(2007-12#1)(2008-2#3)(2008-3#1)
spectral shape##11##2##(1994-6#1)(2007-12#2)(2008-2#3)(2008-3#5)
spectral shapes##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
spectral shaping of##2##3##(2007-12#2)
spectral shaping##5##2##(2007-11#2)(2007-12#2)(2008-3#1)
spectral shift of the##3##4##(1992-12#1)(2008-2#2)
spectral shift##6##2##(1992-12#1)(2005-11#1)(2008-2#4)
spectral shifts and##2##3##(2008-10#1)(2009-2#1)
spectral shifts of##2##3##(2008-11#1)(2009-6#1)
spectral shifts##12##2##(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2009-2#1)(2009-6#2)(2010-12#1)
spectral signature##2##2##(2008-2#1)(2010-5#1)
spectral signatures of##2##3##(2007-8#1)(2008-3#1)
spectral signatures##4##2##(2007-11#1)(2007-8#1)(2008-3#2)
spectral simulation##2##2##(2005-4#1)(2011-2#1)
spectral spacing of##3##3##(2008-3#3)
spectral spacing##4##2##(2008-3#4)
spectral structure##3##2##(2008-2#1)(2008-3#2)
spectral studies confirm the##2##4##(2008-5#2)
spectral studies##14##2##(2005-4#1)(2008-10#2)(2008-3#1)(2008-5#10)
spectral subtraction##3##2##(2008-9#2)(2013-7#1)
spectral titration##2##2##(1994-8#1)(2008-10#1)
spectral transmission factor of liquids##2##5##(2008-2#2)
spectral transmission factor##4##3##(2008-2#2)(2008-3#2)
spectral transmission function and optical thickness##2##6##(2008-2#2)
spectral transmission##10##2##(2008-2#5)(2008-3#3)(2008-5#2)
spectral transmittance and##3##3##(2008-2#2)(2008-3#1)
spectral transmittance##4##2##(2008-2#2)(2008-3#1)(2008-5#1)
spectral tuning in a continuous-wave##2##5##(2007-12#2)
spectral tuning##4##2##(2007-12#3)(2008-2#1)
spectral types##3##2##(1991-2#1)(2008-2#2)
spectral variance##2##2##(1995-12#1)(2008-10#1)
spectral variation##5##2##(1990-3#1)(2008-2#3)(2008-3#1)
spectral variations of##2##3##(2008-2#2)
spectral variations##4##2##(2008-2#3)(2012-1#1)
spectral width and##3##3##(2007-11#2)(2007-12#1)
spectral width of the##6##4##(2007-12#3)(2008-2#1)(2008-3#2)
spectral width of##7##3##(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#2)
spectral width##13##2##(2007-11#2)(2007-12#6)(2008-1#1)(2008-2#1)(2008-3#2)(2012-8#1)
spectral window##5##2##(2008-10#1)(2008-2#2)(2008-3#1)(2012-12#1)
spectral##1790##1##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#4)(1990-5#1)(1990-7#4)(1990-8#1)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#7)(1991-5#2)(1991-7#1)(1991-8#5)(1991-9#1)(1992-1#5)(1992-12#3)(1992-2#4)(1992-3#2)(1992-4#1)(1992-6#3)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#5)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#3)(1994-9#2)(1995-1#2)(1995-10#5)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#3)(1995-5#3)(1995-7#1)(1995-8#2)(1996-10#1)(1996-12#3)(1996-2#2)(1996-4#2)(1996-5#2)(1996-7#3)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#3)(1997-7#2)(1997-8#1)(2004-4#1)(2004-9#1)(2005-11#8)(2005-4#19)(2005-7#1)(2006-10#7)(2006-11#1)(2006-12#12)(2006-2#4)(2006-5#4)(2006-7#2)(2006-9#1)(2007-1#22)(2007-10#1)(2007-11#140)(2007-12#274)(2007-5#3)(2007-8#16)(2007-9#1)(2008-1#25)(2008-10#158)(2008-11#7)(2008-12#4)(2008-2#289)(2008-3#383)(2008-4#9)(2008-5#37)(2008-6#5)(2008-7#13)(2008-8#3)(2008-9#9)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#6)(2009-2#3)(2009-3#3)(2009-4#8)(2009-6#4)(2009-7#2)(2009-8#4)(2009-9#4)(2010-11#5)(2010-12#6)(2010-2#2)(2010-3#1)(2010-4#8)(2010-5#14)(2010-6#2)(2010-8#2)(2011-1#12)(2011-2#12)(2011-3#1)(2012-1#4)(2012-11#2)(2012-12#10)(2012-2#9)(2012-7#1)(2012-8#1)(2013-1#9)(2013-7#4)(2013-8#46)
spectral-curvature algorithms##2##2##(2008-3#2)
spectral-domain OCT in the diagnosis and management of##2##8##(2011-7#2)
spectral-domain OCT##8##2##(2011-7#6)(2012-12#1)(2013-1#1)
spectral-domain##13##1##(2007-12#1)(2008-3#2)(2011-7#8)(2012-12#1)(2013-1#1)
spectrally and##2##2##(1992-8#1)(2008-3#1)
spectrally broadened by self-phase modulation##2##5##(2008-2#2)
spectrally broadened##4##2##(2007-12#1)(2008-2#3)
spectrally continuous##2##2##(2008-3#2)
spectrally decomposed##3##2##(2007-12#3)
spectrally disperse##2##2##(2007-12#1)(2008-2#1)
spectrally distinct##5##2##(2007-12#1)(2008-2#2)(2008-4#1)(2008-9#1)
spectrally encoded confocal scanning laser##2##5##(2011-1#2)
spectrally encoded##5##2##(2007-11#1)(2008-2#2)(2011-1#2)
spectrally narrow##2##2##(2007-12#1)(2008-2#1)
spectrally pure##3##2##(1990-11#1)(2008-1#1)(2008-2#1)
spectrally resolved fluorescence##3##3##(2008-12#1)(2008-2#1)(2008-3#1)
spectrally resolved two-beam coupling##2##4##(2007-12#2)
spectrally resolved##18##2##(2007-11#2)(2007-12#5)(2008-12#1)(2008-2#5)(2008-3#3)(2008-8#1)(2011-1#1)
spectrally similar##3##2##(1996-7#2)(2013-1#1)
spectrally uniform##2##2##(2008-3#2)
spectrally##86##1##(1990-11#1)(1992-8#1)(1995-3#1)(1995-5#1)(1996-7#2)(1997-7#1)(2007-11#8)(2007-12#24)(2008-1#2)(2008-12#1)(2008-2#22)(2008-3#13)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2011-1#3)(2013-1#1)
spectre##2##1##(1991-6#1)(2013-1#1)
spectrin and##2##2##(1990-5#1)(1996-12#1)
spectrin is##2##2##(1990-5#2)
spectrin structure##3##2##(1990-3#2)(1993-4#1)
spectrin##34##1##(1990-3#7)(1990-5#4)(1991-4#5)(1991-5#1)(1993-11#2)(1993-3#1)(1993-4#5)(1996-12#2)(1997-6#4)(1997-8#1)(2007-10#1)(2008-10#1)
spectrin-actin##5##1##(1990-3#5)
spectroanalytical##2##1##(2008-10#2)
spectrochemical analysis of##2##3##(1996-3#1)(2007-12#1)
spectrochemical analysis##4##2##(1996-3#1)(2007-12#1)(2010-2#2)
spectrochemical##7##1##(1996-3#1)(1997-7#1)(2007-12#1)(2008-10#1)(2010-2#3)
spectroelectrochemical cell##3##2##(2008-10#3)
spectroelectrochemical characterization of##2##3##(2008-10#2)
spectroelectrochemical flow cell##2##3##(2007-8#2)
spectroelectrochemical##16##1##(1994-12#1)(2007-8#3)(2008-10#11)(2010-2#1)
spectroelectrochemistry##4##1##(2007-12#1)(2008-10#2)(2009-9#1)
spectrofluorimeter##9##1##(1995-3#1)(2008-10#7)(2008-4#1)
spectrofluorimetric detection##3##2##(1992-2#1)(2008-10#2)
spectrofluorimetric determination of acetylsalicylic acid##2##5##(2008-10#2)
spectrofluorimetric determination of the##2##4##(2008-10#2)
spectrofluorimetric determination of trace amounts of##2##6##(2008-10#2)
spectrofluorimetric determination of trace##5##4##(2008-10#5)
spectrofluorimetric determination of##26##3##(2008-10#25)(2008-3#1)
spectrofluorimetric determination##27##2##(2008-10#26)(2008-3#1)
spectrofluorimetric method for the determination of##10##6##(2007-8#1)(2008-10#9)
spectrofluorimetric method for the##12##4##(2007-8#1)(2008-10#11)
spectrofluorimetric method for##14##3##(2007-8#1)(2008-10#13)
spectrofluorimetric method##23##2##(2007-8#2)(2008-10#21)
spectrofluorimetric system is##2##3##(2008-10#2)
spectrofluorimetric##62##1##(1992-2#1)(2007-8#2)(2008-10#58)(2008-3#1)
spectrofluorimetrically in##2##2##(1991-9#1)(2008-10#1)
spectrofluorimetrically##6##1##(1991-9#1)(1992-4#1)(2008-10#4)
spectrofluorimetry and##2##2##(2005-11#1)(2008-10#1)
spectrofluorimetry of ultra trace##2##4##(2008-10#2)
spectrofluorimetry of##3##2##(2008-10#3)
spectrofluorimetry##28##1##(1990-8#2)(2005-11#2)(2008-10#23)(2008-11#1)
spectrofluorometer or a filter fluorometer##2##5##(2008-1#1)(2008-2#1)
spectrofluorometer##10##1##(1995-3#1)(2008-1#1)(2008-10#7)(2008-2#1)
spectrofluorometric method##3##2##(1992-7#1)(2005-4#1)(2008-10#1)
spectrofluorometric##10##1##(1992-7#2)(2005-4#2)(2008-10#4)(2008-11#2)
spectrofluorometry##3##1##(2005-4#2)(2008-10#1)
spectrogram of##2##2##(2007-11#1)(2009-3#1)
spectrogram##8##1##(2007-11#1)(2007-12#2)(2008-2#1)(2009-3#2)(2013-7#1)(2013-8#1)
spectrograms and##2##2##(2008-10#1)(2008-9#1)
spectrograms##6##1##(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-9#1)
spectrograph and a##2##3##(2007-12#1)(2008-10#1)
spectrograph and##4##2##(2007-12#2)(2008-10#2)
spectrograph for##2##2##(2008-2#1)(2008-3#1)
spectrograph is designed##2##3##(2008-2#1)(2008-3#1)
spectrograph is##3##2##(2008-2#2)(2008-3#1)
spectrograph with a##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
spectrograph with##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
spectrograph##36##1##(2006-12#3)(2007-1#2)(2007-12#4)(2008-10#3)(2008-2#9)(2008-3#15)
spectrographic analysis##2##2##(2005-4#2)
spectrographic##6##1##(1993-11#1)(2005-4#3)(2012-12#2)
spectrographs##10##1##(2008-2#2)(2008-3#8)
spectrometer (EDS)##2##2##(2005-11#1)(2008-5#1)
spectrometer (FTS)##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
spectrometer (ICP-MS)##5##2##(2007-8#1)(2008-10#4)
spectrometer after##2##2##(2007-12#1)(2008-10#1)
spectrometer and the##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
spectrometer and##14##2##(1992-3#1)(1993-4#1)(2006-12#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#2)
spectrometer are##4##2##(2008-10#1)(2008-3#3)
spectrometer based on measuring the periodicity of Talbot self-images##2##9##(2007-12#2)
spectrometer based on##13##3##(2006-12#1)(2007-11#2)(2007-12#4)(2008-10#1)(2008-2#2)(2008-3#1)(2013-8#2)
spectrometer by using##2##3##(2008-2#2)
spectrometer by##6##2##(1995-10#1)(2008-10#1)(2008-2#3)(2008-3#1)
spectrometer capable of##2##3##(2008-3#2)
spectrometer coupled to a##2##4##(2009-4#1)(2010-9#1)
spectrometer designed to##2##3##(2008-2#1)(2008-3#1)
spectrometer devoted to the in situ##2##6##(2008-3#2)
spectrometer equipped with a##4##4##(2008-10#2)(2008-5#1)(2009-2#1)
spectrometer equipped with##6##3##(2008-10#3)(2008-5#1)(2009-2#1)(2011-3#1)
spectrometer equipped##7##2##(2008-10#3)(2008-12#1)(2008-5#1)(2009-2#1)(2011-3#1)
spectrometer for dual wavelength##2##4##(2007-12#2)
spectrometer for the##4##3##(1996-5#1)(2006-12#1)(2008-3#1)(2010-6#1)
spectrometer for##26##2##(1996-5#1)(2006-12#1)(2007-12#3)(2007-8#1)(2008-10#6)(2008-2#4)(2008-3#8)(2008-4#1)(2010-6#1)
spectrometer has been used##2##4##(2008-10#1)(2008-2#1)
spectrometer has been##6##3##(2006-4#1)(2007-11#1)(2008-10#3)(2008-2#1)
spectrometer in##8##2##(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2009-10#1)(2011-1#1)
spectrometer is demonstrated by##2##4##(2007-12#1)(2008-3#1)
spectrometer is described##2##3##(2005-4#1)(2008-10#1)
spectrometer is presented##2##3##(2008-10#1)(2008-3#1)
spectrometer is proposed##2##3##(2007-12#1)(2013-8#1)
spectrometer is used##2##3##(2008-10#2)
spectrometer is##19##2##(2005-4#1)(2007-12#2)(2008-10#5)(2008-2#3)(2008-3#5)(2010-7#1)(2013-8#2)
spectrometer may be##2##3##(2008-3#2)
spectrometer operated##2##2##(2008-3#1)(2012-12#1)
spectrometer operating##3##2##(2007-12#1)(2007-8#1)(2008-3#1)
spectrometer position##2##2##(2007-12#2)
spectrometer systems##3##2##(2008-10#2)(2008-2#1)
spectrometer that was##2##3##(2008-3#2)
spectrometer that##7##2##(2008-1#1)(2008-2#2)(2008-3#4)
spectrometer to yield##2##3##(2007-12#1)(2008-2#1)
spectrometer to##5##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
spectrometer using a##2##3##(1997-3#1)(2008-3#1)
spectrometer using##3##2##(1997-3#1)(2008-2#1)(2008-3#1)
spectrometer was calibrated##2##3##(2008-10#1)(2008-3#1)
spectrometer was used to##3##4##(2007-12#1)(2008-2#1)(2010-9#1)
spectrometer was used##4##3##(2005-4#1)(2007-12#1)(2008-2#1)(2010-9#1)
spectrometer was##17##2##(1990-9#1)(1992-1#1)(2005-4#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#2)(2010-9#1)(2011-1#1)
spectrometer which is##2##3##(2007-8#1)(2008-10#1)
spectrometer with a##9##3##(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#2)
spectrometer with the##2##3##(2008-3#2)
spectrometer with##22##2##(2007-12#1)(2008-10#9)(2008-2#3)(2008-3#8)(2013-8#1)
spectrometer##408##1##(1990-9#1)(1991-8#1)(1992-1#2)(1992-3#2)(1993-4#1)(1993-9#1)(1994-5#1)(1995-10#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-11#3)(2005-4#8)(2006-1#1)(2006-12#5)(2006-4#1)(2007-11#7)(2007-12#34)(2007-2#1)(2007-8#11)(2008-1#4)(2008-10#122)(2008-11#1)(2008-12#1)(2008-2#63)(2008-3#90)(2008-4#5)(2008-5#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-9#2)(2011-1#2)(2011-3#1)(2012-12#1)(2013-7#2)(2013-8#12)
spectrometer's##5##1##(2008-10#2)(2008-3#3)
spectrometer-detector parameters##3##2##(2007-12#3)
spectrometer]##6##1##(2005-4#3)(2013-8#3)
spectrometers Coronal Diagnostic Spectrometer (CDS) and Solar Ultraviolet Measurements of Emitted Radiation (SUMER)##2##13##(2008-3#2)
spectrometers are##2##2##(2008-10#1)(2013-8#1)
spectrometers can be##2##3##(2008-3#1)(2008-4#1)
spectrometers for##4##2##(2007-12#1)(2008-10#2)(2008-3#1)
spectrometers has been##2##3##(2008-2#1)(2008-3#1)
spectrometers is##3##2##(2008-10#2)(2008-3#1)
spectrometers to##3##2##(2008-1#1)(2008-3#2)
spectrometers with##4##2##(2008-2#2)(2008-3#1)(2008-6#1)
spectrometers##57##1##(2007-12#3)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-2#8)(2008-3#23)(2008-4#1)(2008-6#1)(2008-7#1)(2010-4#1)(2010-7#2)(2011-2#2)(2013-8#3)
spectrometric analyses##3##2##(2007-1#1)(2012-12#2)
spectrometric analysis of##9##3##(1990-1#1)(1990-2#1)(1991-8#1)(1992-9#1)(1995-5#1)(2008-10#2)(2008-5#1)(2011-12#1)
spectrometric analysis##14##2##(1990-1#1)(1990-2#1)(1990-7#1)(1991-8#1)(1992-9#1)(1995-5#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2011-12#1)
spectrometric assay##3##2##(1996-6#1)(1997-1#1)(2010-4#1)
spectrometric data##4##2##(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)
spectrometric detection has been developed##3##5##(2008-10#3)
spectrometric detection in the##3##4##(2008-10#3)
spectrometric detection##30##2##(1996-6#1)(2007-8#1)(2008-10#23)(2008-4#1)(2008-5#2)(2010-4#1)(2012-1#1)
spectrometric detector##3##2##(2008-10#3)
spectrometric determination of trace##2##4##(2008-10#2)
spectrometric determination of##32##3##(1990-9#1)(1992-1#1)(1992-7#1)(2007-12#1)(2008-10#28)
spectrometric determination##34##2##(1990-9#1)(1992-1#1)(1992-7#1)(2007-12#1)(2008-10#30)
spectrometric determinations##5##2##(2008-10#5)
spectrometric identification of##2##3##(2005-8#1)(2008-10#1)
spectrometric identification##5##2##(2005-8#1)(2008-10#3)(2008-4#1)
spectrometric measurements##4##2##(1992-8#1)(2008-10#2)(2010-11#1)
spectrometric method for the determination of##3##6##(1996-6#1)(2005-4#1)(2008-10#1)
spectrometric method for the##4##4##(1996-6#1)(2005-4#1)(2007-8#1)(2008-10#1)
spectrometric method##13##2##(1996-6#1)(2005-4#1)(2007-8#1)(2008-10#8)(2011-1#1)(2012-12#1)
spectrometric methods for the##2##4##(2008-10#1)(2008-7#1)
spectrometric methods##6##2##(1992-12#1)(2008-10#2)(2008-7#1)(2013-1#2)
spectrometric microtitration set up##2##4##(2008-10#2)
spectrometric microtitration##4##2##(2008-10#4)
spectrometric procedure##5##2##(2008-10#5)
spectrometric system##3##2##(2008-10#2)(2008-2#1)
spectrometric techniques is##3##3##(2008-10#2)(2008-3#1)
spectrometric techniques##9##2##(2007-1#1)(2008-10#6)(2008-3#1)(2008-7#1)
spectrometric##190##1##(1990-1#1)(1990-2#1)(1990-7#2)(1990-9#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-2#2)(1993-8#1)(1995-5#1)(1996-3#1)(1996-6#3)(1996-9#1)(1997-1#1)(1997-3#2)(2005-4#1)(2005-8#1)(2007-1#2)(2007-12#1)(2007-8#5)(2008-10#119)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#2)(2010-11#1)(2010-4#3)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-12#4)(2013-1#3)
spectrometrically##2##1##(2008-10#2)
spectrometry (ESI-MS)##15##2##(1996-10#1)(1996-5#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-6#1)(2009-10#1)(2011-1#3)
spectrometry (FAAS##2##2##(2008-10#2)
spectrometry (GC##4##2##(2008-10#4)
spectrometry (GC-MS) in##2##3##(2007-8#1)(2008-10#1)
spectrometry (GC-MS) with##2##3##(2005-12#1)(2013-7#1)
spectrometry (GC-MS)##40##2##(1990-5#1)(1992-1#1)(1992-5#1)(1992-7#1)(1993-12#1)(1995-2#1)(1996-6#1)(1996-8#1)(2005-12#1)(2007-1#1)(2007-8#4)(2008-10#19)(2008-4#1)(2008-5#1)(2010-5#1)(2011-1#1)(2012-1#2)(2013-7#1)
spectrometry (GC/MS)##7##2##(1995-11#1)(2008-10#4)(2011-1#1)(2013-1#1)
spectrometry (ICP-MS) and##3##3##(2008-10#3)
spectrometry (ICP-MS) was##2##3##(2007-8#1)(2008-10#1)
spectrometry (ICP-MS)##38##2##(2007-8#1)(2008-10#34)(2010-11#1)(2013-8#2)
spectrometry (ICP/MS)##3##2##(1996-7#2)(2008-10#1)
spectrometry (LA-ICP-MS)##5##2##(2008-10#3)(2010-11#2)
spectrometry (LC-ESI-MS)##4##2##(2007-8#1)(2008-10#1)(2010-4#2)
spectrometry (LC-MS)##5##2##(2008-10#2)(2010-4#1)(2011-1#1)(2012-1#1)
spectrometry (LC/MS)##2##2##(2007-8#1)(2008-10#1)
spectrometry (LOQ=0##2##2##(2008-10#2)
spectrometry (MS) and##3##3##(1997-2#1)(2008-10#1)(2011-2#1)
spectrometry (MS)##16##2##(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-4#2)(2008-8#1)(2009-3#1)(2010-1#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-8#2)
spectrometry (MS)-based##2##2##(2008-9#1)(2013-8#1)
spectrometry after pre-concentration##2##3##(2008-10#1)(2009-6#1)
spectrometry after preconcentration##2##3##(2008-10#1)(2013-8#1)
spectrometry after##26##2##(1992-1#1)(1992-2#1)(1992-3#1)(1995-12#1)(1997-8#1)(2008-10#19)(2009-6#1)(2013-8#1)
spectrometry analysis of##5##3##(1993-11#1)(2008-7#1)(2009-10#1)(2011-1#1)(2013-1#1)
spectrometry analysis was##2##3##(1996-5#1)(2009-6#1)
spectrometry analysis##19##2##(1992-8#1)(1993-11#1)(1993-9#1)(1994-12#1)(1996-5#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#2)(2009-6#1)(2010-6#1)(2011-1#1)(2013-1#2)(2013-8#1)
spectrometry and cyclic voltammetry##2##4##(2008-10#2)
spectrometry and inductively coupled plasma##2##5##(2008-10#2)
spectrometry and its##2##3##(2008-10#1)(2013-8#1)
spectrometry and liquid##2##3##(1990-8#1)(2007-1#1)
spectrometry and nuclear magnetic resonance spectroscopy##2##6##(1990-10#1)(1990-3#1)
spectrometry and temperature-constrained cascade correlation networks##2##6##(2008-10#2)
spectrometry and the##4##3##(1997-3#1)(2008-10#2)(2009-3#1)
spectrometry and##75##2##(1990-1#1)(1990-10#1)(1990-3#2)(1990-8#1)(1991-2#1)(1991-8#1)(1992-4#2)(1994-11#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-8#1)(1997-2#2)(1997-3#1)(2005-11#1)(2006-12#2)(2007-1#2)(2007-11#1)(2007-8#1)(2008-10#25)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#1)(2010-2#1)(2010-5#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-8#4)
spectrometry as a##6##3##(1996-8#1)(1997-2#1)(2008-10#2)(2008-2#1)(2011-2#1)
spectrometry as an alternative##2##4##(2008-10#2)
spectrometry as an##4##3##(2008-10#3)(2012-1#1)
spectrometry as##18##2##(1993-12#1)(1995-2#1)(1996-8#1)(1997-2#1)(1997-3#1)(2008-10#9)(2008-2#1)(2008-9#1)(2011-2#1)(2012-1#1)
spectrometry at##7##2##(1990-5#1)(2008-10#4)(2008-5#2)
spectrometry can be used##2##4##(2008-10#2)
spectrometry can be##4##3##(2007-11#1)(2008-10#2)(2008-4#1)
spectrometry coupled with##4##3##(2008-10#3)(2008-6#1)
spectrometry data##10##2##(2007-11#1)(2007-8#1)(2008-7#2)(2009-11#1)(2010-2#1)(2011-1#1)(2012-1#2)(2013-1#1)
spectrometry detection##19##2##(2007-10#1)(2007-8#2)(2008-10#14)(2010-5#1)(2013-1#1)
spectrometry determination of Malathion in pesticide##2##6##(2008-10#2)
spectrometry determination of##7##3##(2008-10#7)
spectrometry determination##9##2##(2008-10#9)
spectrometry for determination of##2##4##(2008-10#2)
spectrometry for on-line##2##3##(2006-12#1)(2008-10#1)
spectrometry for quantitative##2##3##(2008-10#2)
spectrometry for the determination of##5##5##(2008-1#1)(2008-10#4)
spectrometry for the##20##3##(1996-8#1)(2007-8#3)(2008-1#1)(2008-10#13)(2008-4#1)(2010-9#1)
spectrometry for trace##2##3##(2008-10#2)
spectrometry for##42##2##(1995-4#1)(1996-8#1)(1997-4#1)(2006-12#1)(2007-12#1)(2007-8#6)(2008-1#1)(2008-10#27)(2008-3#1)(2008-4#1)(2010-9#1)
spectrometry has become##2##3##(2008-10#2)
spectrometry has been##9##3##(1990-12#1)(1997-2#1)(2006-10#1)(2008-10#6)
spectrometry has##14##2##(1990-12#1)(1997-2#1)(2006-10#1)(2008-10#9)(2009-4#1)(2009-5#1)
spectrometry in terms of##3##4##(2008-3#2)(2010-7#1)
spectrometry in the##4##3##(1996-6#1)(2006-10#1)(2008-10#2)
spectrometry in##36##2##(1990-6#1)(1992-3#1)(1993-12#1)(1994-10#2)(1994-2#1)(1994-7#1)(1996-6#1)(1996-8#1)(2006-10#1)(2007-8#3)(2008-10#16)(2008-3#2)(2010-4#1)(2010-5#1)(2010-7#2)(2013-1#1)
spectrometry is described##10##3##(1992-3#1)(1996-3#1)(2008-10#7)(2008-11#1)
spectrometry is presented##3##3##(2007-8#1)(2008-10#2)
spectrometry is used for##2##4##(2008-10#2)
spectrometry is##29##2##(1992-3#1)(1996-3#1)(2006-12#1)(2007-8#3)(2008-10#19)(2008-11#1)(2008-4#1)(2008-9#1)(2011-1#1)
spectrometry measurement##2##2##(1996-5#1)(2008-10#1)
spectrometry method for##3##3##(2008-10#3)
spectrometry method was developed for the##2##6##(2008-10#1)(2011-1#1)
spectrometry method was developed##3##4##(2008-10#2)(2011-1#1)
spectrometry method##10##2##(2007-10#1)(2008-10#7)(2011-1#1)(2013-7#1)
spectrometry methods##3##2##(2008-10#2)(2010-5#1)
spectrometry of the##3##3##(1990-7#1)(1990-8#1)(1993-11#1)
spectrometry of##22##2##(1990-7#1)(1990-8#1)(1990-9#1)(1992-2#2)(1992-6#1)(1993-11#1)(1994-3#1)(1995-4#2)(1996-12#1)(1997-3#1)(1997-7#1)(2007-3#1)(2008-10#6)(2008-9#1)(2010-7#1)
spectrometry on##5##2##(1996-6#1)(2006-12#1)(2010-5#1)(2011-1#1)(2013-7#1)
spectrometry provides##3##2##(2006-12#1)(2008-5#1)(2010-8#1)
spectrometry results##2##2##(2008-10#2)
spectrometry revealed that the##2##4##(2007-5#1)(2008-10#1)
spectrometry revealed that##3##3##(2007-5#1)(2008-10#1)(2009-8#1)
spectrometry system##4##2##(1997-2#1)(1997-5#1)(2007-8#1)(2008-10#1)
spectrometry technique is##2##3##(2008-10#1)(2008-3#1)
spectrometry technique##8##2##(1992-6#1)(2004-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)
spectrometry techniques##3##2##(2008-10#3)
spectrometry technology##2##2##(2007-12#1)(2007-8#1)
spectrometry that##2##2##(2008-3#2)
spectrometry to determine the##2##4##(1993-2#1)(2008-8#1)
spectrometry to determine##3##3##(1993-2#1)(2008-10#1)(2008-8#1)
spectrometry to study##2##3##(1996-3#1)(1996-8#1)
spectrometry to##18##2##(1991-2#1)(1993-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(2008-10#3)(2008-4#1)(2008-7#2)(2008-8#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)
spectrometry using a##8##3##(1996-3#1)(2007-8#1)(2008-10#5)(2008-4#1)
spectrometry using solid##2##3##(2008-10#2)
spectrometry using the##2##3##(2008-10#2)
spectrometry using##35##2##(1990-9#1)(1996-3#1)(1997-3#1)(2005-4#1)(2007-8#1)(2008-10#24)(2008-3#1)(2008-4#1)(2008-5#2)(2010-12#1)(2010-5#1)
spectrometry was applied##4##3##(1992-2#1)(2008-10#2)(2011-3#1)
spectrometry was developed##2##3##(2008-10#1)(2010-12#1)
spectrometry was employed to##2##4##(2008-2#1)(2012-12#1)
spectrometry was employed##3##3##(2008-10#1)(2008-2#1)(2012-12#1)
spectrometry was used for the##3##5##(2008-10#3)
spectrometry was used for##5##4##(2008-10#5)
spectrometry was used to##6##4##(1997-1#1)(1997-3#1)(2008-10#4)
spectrometry was used##13##3##(1997-1#1)(1997-3#1)(2008-10#11)
spectrometry was##28##2##(1992-2#1)(1993-11#1)(1997-1#1)(1997-3#1)(2005-4#1)(2008-10#19)(2008-2#1)(2010-12#1)(2011-3#1)(2012-12#1)
spectrometry were used to##3##4##(1991-8#1)(1997-7#1)(2010-11#1)
spectrometry were used##4##3##(1991-8#1)(1997-7#1)(2008-10#1)(2010-11#1)
spectrometry were##10##2##(1991-8#1)(1997-7#2)(2008-10#6)(2010-11#1)
spectrometry with a##3##3##(2008-10#3)
spectrometry with both##2##3##(2008-10#2)
spectrometry with high performance liquid chromatography for the analysis of##2##10##(2008-10#2)
spectrometry with the##2##3##(1994-2#1)(2009-6#1)
spectrometry with##47##2##(1990-6#1)(1990-9#1)(1992-1#1)(1994-2#1)(1996-8#1)(2006-12#3)(2007-5#1)(2007-8#1)(2008-10#29)(2008-2#1)(2008-3#1)(2008-7#1)(2009-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-7#1)
spectrometry without##2##2##(1994-5#1)(2008-10#1)
spectrometry##1827##1##(1990-1#2)(1990-10#3)(1990-11#1)(1990-12#3)(1990-3#5)(1990-5#4)(1990-6#2)(1990-7#4)(1990-8#8)(1990-9#4)(1991-10#1)(1991-12#2)(1991-2#5)(1991-3#2)(1991-5#3)(1991-8#3)(1992-1#6)(1992-11#1)(1992-12#1)(1992-2#6)(1992-3#9)(1992-4#3)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#4)(1993-11#5)(1993-12#7)(1993-2#6)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#4)(1994-10#3)(1994-11#1)(1994-12#7)(1994-2#2)(1994-3#7)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#1)(1995-1#4)(1995-11#5)(1995-12#3)(1995-2#2)(1995-3#2)(1995-4#5)(1995-5#3)(1995-6#3)(1995-7#3)(1996-1#1)(1996-10#1)(1996-12#2)(1996-3#6)(1996-4#1)(1996-5#7)(1996-6#4)(1996-7#4)(1996-8#23)(1996-9#2)(1997-1#5)(1997-2#11)(1997-3#12)(1997-4#5)(1997-5#3)(1997-7#4)(1997-8#5)(2004-12#1)(2004-2#1)(2004-4#1)(2004-9#3)(2005-11#2)(2005-12#2)(2005-4#16)(2005-8#1)(2006-10#3)(2006-12#20)(2006-3#1)(2006-7#1)(2006-8#1)(2007-1#10)(2007-10#3)(2007-11#4)(2007-12#9)(2007-2#1)(2007-3#2)(2007-5#3)(2007-8#62)(2008-1#4)(2008-10#1067)(2008-11#12)(2008-2#13)(2008-3#21)(2008-4#31)(2008-5#16)(2008-6#5)(2008-7#18)(2008-8#8)(2008-9#4)(2009-10#6)(2009-11#1)(2009-12#5)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#7)(2009-8#1)(2010-1#3)(2010-11#9)(2010-12#2)(2010-2#5)(2010-4#9)(2010-5#18)(2010-6#3)(2010-7#13)(2010-8#2)(2010-9#4)(2011-1#28)(2011-12#2)(2011-2#13)(2011-3#1)(2012-1#8)(2012-12#17)(2012-2#7)(2012-3#8)(2013-1#12)(2013-7#9)(2013-8#17)
spectrometry)##9##1##(2007-8#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-7#2)
spectrometry-based approaches##2##2##(2009-5#2)
spectrometry-based techniques##2##2##(2009-4#1)(2010-5#1)
spectrometry-based##18##1##(2007-3#1)(2008-1#1)(2008-10#2)(2008-4#2)(2009-4#2)(2009-5#2)(2010-11#2)(2010-5#4)(2010-7#2)
spectrometry-selected ion monitoring##2##3##(1997-8#1)(2008-10#1)
spectrometry]##37##1##(2005-12#2)(2005-4#12)(2011-1#7)(2012-12#4)(2012-3#3)(2013-1#1)(2013-7#2)(2013-8#6)
spectrophotometer and##4##2##(2005-4#1)(2008-10#2)(2008-3#1)
spectrophotometer as detector##2##3##(2008-10#2)
spectrophotometer assay##4##2##(2008-10#3)(2009-5#1)
spectrophotometer at##3##2##(1994-3#1)(2008-10#2)
spectrophotometer for##3##2##(2008-10#3)
spectrophotometer in##3##2##(1997-4#1)(2005-4#1)(2008-2#1)
spectrophotometer is used to##2##4##(2008-3#1)(2008-4#1)
spectrophotometer is##3##2##(2008-3#2)(2008-4#1)
spectrophotometer over##2##2##(2008-2#1)(2012-2#1)
spectrophotometer to##2##2##(2008-10#2)
spectrophotometer was##2##2##(2008-10#2)
spectrophotometer with##4##2##(2008-10#2)(2008-3#2)
spectrophotometer without##2##2##(2005-4#1)(2008-10#1)
spectrophotometer##83##1##(1994-3#1)(1997-4#1)(2005-4#5)(2006-12#1)(2007-3#2)(2007-8#1)(2008-10#44)(2008-2#5)(2008-3#9)(2008-4#2)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
spectrophotometeric##2##1##(2008-10#2)
spectrophotometerically##2##1##(2008-10#2)
spectrophotometers##6##1##(2008-2#3)(2008-3#2)(2008-5#1)
spectrophotometic method##2##2##(2005-4#1)(2008-10#1)
spectrophotometic##3##1##(2005-4#2)(2008-10#1)
spectrophotometric FI system with a column##2##6##(2008-10#2)
spectrophotometric FI##3##2##(2008-10#3)
spectrophotometric analyses##4##2##(1991-7#1)(2008-10#2)(2008-5#1)
spectrophotometric analysis of##3##3##(2008-10#3)
spectrophotometric analysis##6##2##(1995-3#1)(2005-8#1)(2008-10#4)
spectrophotometric and electrochemical##2##3##(1991-3#1)(2010-2#1)
spectrophotometric and inductively coupled plasma atomic emission##2##7##(2008-10#2)
spectrophotometric and spectrofluorimetric analysis##2##4##(2008-10#2)
spectrophotometric and spectrofluorimetric determination of##2##5##(2008-10#2)
spectrophotometric and spectrofluorimetric##4##3##(2008-10#4)
spectrophotometric and##26##2##(1991-3#2)(1995-1#1)(2006-12#1)(2008-1#1)(2008-10#18)(2008-2#1)(2010-2#1)(2011-1#1)
spectrophotometric assay for the##2##4##(1991-3#1)(2008-10#1)
spectrophotometric assay for##3##3##(1991-3#1)(1994-10#1)(2008-10#1)
spectrophotometric assay of##3##3##(2007-8#1)(2008-10#2)
spectrophotometric assay##9##2##(1991-3#1)(1994-10#1)(2007-8#2)(2008-10#5)
spectrophotometric assays##2##2##(2008-10#2)
spectrophotometric data in##3##3##(2008-10#3)
spectrophotometric data##15##2##(1993-8#1)(2006-10#1)(2008-10#11)(2008-3#1)(2011-1#1)
spectrophotometric detection at##4##3##(2007-8#1)(2008-10#3)
spectrophotometric detection has been developed for the##2##7##(2008-10#2)
spectrophotometric detection in##2##3##(2008-10#2)
spectrophotometric detection is proposed##2##4##(2008-10#2)
spectrophotometric detection is##3##3##(2008-10#3)
spectrophotometric detection of##3##3##(2008-10#3)
spectrophotometric detection was##4##3##(1996-5#1)(2008-10#3)
spectrophotometric detection##39##2##(1996-5#1)(2007-8#1)(2008-10#37)
spectrophotometric determination method##3##3##(2005-4#1)(2008-10#2)
spectrophotometric determination of Fe and Ni##2##6##(2008-10#2)
spectrophotometric determination of Fe##3##4##(2008-10#3)
spectrophotometric determination of Fe(II) and Fe(III)##2##6##(2008-10#2)
spectrophotometric determination of ascorbic acid based on##2##7##(2008-10#2)
spectrophotometric determination of ascorbic acid##5##5##(2008-10#5)
spectrophotometric determination of boron in##4##5##(2008-10#4)
spectrophotometric determination of boron##5##4##(2008-10#5)
spectrophotometric determination of calcium using murexide##2##6##(2008-10#2)
spectrophotometric determination of calcium##3##4##(2008-10#3)
spectrophotometric determination of captopril##2##4##(2008-10#2)
spectrophotometric determination of chromium (VI) with diphenylcarbazide##2##7##(2008-10#2)
spectrophotometric determination of chromium##3##4##(2008-10#3)
spectrophotometric determination of chromium(VI) in##2##5##(2008-10#2)
spectrophotometric determination of chromium(VI)##3##4##(2008-10#3)
spectrophotometric determination of cobalt##3##4##(2008-10#3)
spectrophotometric determination of cobalt(II)##2##4##(2008-10#2)
spectrophotometric determination of copper and iron##2##6##(2008-10#2)
spectrophotometric determination of copper##5##4##(2005-4#1)(2008-10#4)
spectrophotometric determination of copper(II) in##2##5##(2008-10#2)
spectrophotometric determination of copper(II)##6##4##(2008-10#6)
spectrophotometric determination of europium##2##4##(2008-10#2)
spectrophotometric determination of free chlorine##2##5##(2008-10#2)
spectrophotometric determination of hydrazine##2##4##(2008-10#2)
spectrophotometric determination of hydrosoluble vitamins##2##5##(2008-10#2)
spectrophotometric determination of iron##3##4##(2007-8#1)(2008-10#2)
spectrophotometric determination of manganese##4##4##(2008-10#4)
spectrophotometric determination of molybdenum in##2##5##(2008-10#2)
spectrophotometric determination of molybdenum##3##4##(2008-10#3)
spectrophotometric determination of nickel in##3##5##(2008-10#3)
spectrophotometric determination of nickel##7##4##(2008-10#7)
spectrophotometric determination of nitrite##4##4##(2008-10#4)
spectrophotometric determination of the##4##4##(2008-10#4)
spectrophotometric determination of total##4##4##(2008-10#4)
spectrophotometric determination of trace amount of##2##6##(2008-10#2)
spectrophotometric determination of trace amounts of copper##2##7##(2008-10#2)
spectrophotometric determination of trace amounts of##7##6##(2008-10#7)
spectrophotometric determination of trace##14##4##(2005-4#1)(2008-10#13)
spectrophotometric determination of tungsten##3##4##(2008-10#3)
spectrophotometric determination of vanillin##3##4##(2008-10#3)
spectrophotometric determination of zinc in##2##5##(2008-10#2)
spectrophotometric determination of zinc##3##4##(2008-10#3)
spectrophotometric determination of##213##3##(1990-12#1)(2005-4#3)(2007-10#2)(2007-8#3)(2008-10#201)(2009-8#1)(2010-5#1)(2011-2#1)
spectrophotometric determination##225##2##(1990-12#1)(2005-4#4)(2007-10#2)(2007-8#3)(2008-10#212)(2009-8#1)(2010-5#1)(2011-2#1)
spectrophotometric determinations of##3##3##(2008-10#3)
spectrophotometric determinations##4##2##(2008-10#4)
spectrophotometric enzyme##2##2##(1995-7#1)(2008-5#1)
spectrophotometric estimation of##2##3##(2008-10#1)(2010-5#1)
spectrophotometric estimation##3##2##(2008-10#2)(2010-5#1)
spectrophotometric evaluation##2##2##(1992-1#1)(2009-8#1)
spectrophotometric flow injection##3##3##(2008-10#3)
spectrophotometric flow-injection method is##2##4##(2008-10#2)
spectrophotometric flow-injection##3##2##(2008-10#3)
spectrophotometric measurement of the##2##4##(2008-10#1)(2008-4#1)
spectrophotometric measurement of##4##3##(2008-10#1)(2008-3#1)(2008-4#1)(2010-5#1)
spectrophotometric measurement##8##2##(2008-10#5)(2008-3#1)(2008-4#1)(2010-5#1)
spectrophotometric measurements in##3##3##(1994-3#1)(2008-10#2)
spectrophotometric measurements##15##2##(1994-3#1)(2008-10#7)(2008-2#5)(2008-5#2)
spectrophotometric method and##3##3##(2006-12#1)(2008-10#2)
spectrophotometric method at##2##3##(2008-10#1)(2013-8#1)
spectrophotometric method based on the##2##5##(2008-10#2)
spectrophotometric method based on##5##4##(2008-10#5)
spectrophotometric method for determination of acidity constants##2##7##(2008-10#2)
spectrophotometric method for determination of##8##5##(2008-10#7)(2011-2#1)
spectrophotometric method for determining##2##4##(2008-10#1)(2013-8#1)
spectrophotometric method for measuring##2##4##(1994-6#1)(2008-10#1)
spectrophotometric method for simultaneous determination of##2##6##(2007-8#1)(2008-10#1)
spectrophotometric method for the analysis of##2##6##(2008-10#2)
spectrophotometric method for the determination of hydrogen peroxide##2##8##(2008-10#2)
spectrophotometric method for the determination of trace##3##7##(2008-10#3)
spectrophotometric method for the determination of##23##6##(2008-10#23)
spectrophotometric method for the simultaneous##2##5##(2008-10#2)
spectrophotometric method for the##32##4##(2008-10#32)
spectrophotometric method for##57##3##(1990-6#1)(1994-6#1)(2007-8#3)(2008-10#49)(2008-5#1)(2011-2#1)(2013-8#1)
spectrophotometric method has been developed for the determination of##5##9##(2008-10#5)
spectrophotometric method has been developed for the##9##7##(2008-10#9)
spectrophotometric method has been developed for##10##6##(2008-10#9)(2010-2#1)
spectrophotometric method has been developed##12##5##(2008-10#10)(2010-2#2)
spectrophotometric method in the##2##4##(2008-10#2)
spectrophotometric method in##4##3##(2005-4#1)(2008-10#3)
spectrophotometric method is described for the determination of trace amounts of##2##11##(2008-10#2)
spectrophotometric method is described for the determination of##4##8##(2008-10#4)
spectrophotometric method is described for##5##5##(2008-10#5)
spectrophotometric method is proposed for the determination of##4##8##(2008-10#4)
spectrophotometric method is proposed for the simultaneous determination of##2##9##(2008-10#2)
spectrophotometric method is proposed for the##7##6##(2008-10#7)
spectrophotometric method is##14##3##(2008-10#14)
spectrophotometric method of the##2##4##(2005-4#1)(2008-10#1)
spectrophotometric method of##5##3##(2005-4#2)(2008-10#2)(2008-5#1)
spectrophotometric method to##3##3##(1994-10#1)(2008-10#2)
spectrophotometric method using##3##3##(2008-10#3)
spectrophotometric method was developed for the determination of##2##8##(2008-10#2)
spectrophotometric method was developed for##3##5##(2008-10#2)(2010-12#1)
spectrophotometric method was proposed for the determination of##2##8##(2008-10#2)
spectrophotometric method was proposed for##3##5##(2008-10#3)
spectrophotometric method was##11##3##(2008-10#10)(2010-12#1)
spectrophotometric method##166##2##(1990-6#1)(1990-8#2)(1991-2#1)(1991-9#1)(1994-10#1)(1994-6#1)(1996-12#1)(2005-4#4)(2006-12#1)(2007-8#4)(2008-10#137)(2008-5#3)(2010-12#1)(2010-2#2)(2010-5#1)(2011-2#2)(2013-8#3)
spectrophotometric methodology##2##2##(2008-10#2)
spectrophotometric methods are described for the##2##6##(2008-10#2)
spectrophotometric methods are described##3##4##(2008-10#3)
spectrophotometric methods are##5##3##(1996-12#1)(2008-10#3)(2010-2#1)
spectrophotometric methods for the assay of##2##6##(2008-10#1)(2011-1#1)
spectrophotometric methods for the determination of##3##6##(2008-10#3)
spectrophotometric methods for the##5##4##(2008-10#4)(2011-1#1)
spectrophotometric methods##27##2##(1996-12#1)(2008-10#20)(2010-2#2)(2010-7#1)(2010-8#1)(2011-1#1)(2012-11#1)
spectrophotometric monitoring of the##3##4##(2008-10#3)
spectrophotometric monitoring of##4##3##(2008-10#4)
spectrophotometric monitoring##5##2##(2008-10#5)
spectrophotometric multicomponent analysis of##2##4##(2008-10#2)
spectrophotometric procedure and##2##3##(2008-10#2)
spectrophotometric procedure for DNA assay##2##5##(2008-10#2)
spectrophotometric procedure for##5##3##(2008-10#5)
spectrophotometric procedure is proposed for the determination of##2##8##(2008-10#2)
spectrophotometric procedure is proposed for##3##5##(2008-10#3)
spectrophotometric procedure##17##2##(1993-12#1)(1993-9#1)(2008-10#15)
spectrophotometric procedures##2##2##(2008-10#2)
spectrophotometric reaction##2##2##(2008-10#2)
spectrophotometric reagent##4##2##(2008-10#4)
spectrophotometric reference method##4##3##(2008-10#4)
spectrophotometric studies##3##2##(2008-10#3)
spectrophotometric study on##2##3##(2008-10#2)
spectrophotometric study##6##2##(2005-4#1)(2006-10#1)(2008-10#4)
spectrophotometric system##2##2##(2008-10#2)
spectrophotometric technique for the##2##4##(1990-2#1)(2008-10#1)
spectrophotometric technique##4##2##(1990-2#1)(1995-1#1)(2008-10#2)
spectrophotometric titration method##2##3##(1995-2#1)(2008-10#1)
spectrophotometric titration##3##2##(1995-2#1)(2008-10#1)(2011-2#1)
spectrophotometric##671##1##(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#2)(1991-2#1)(1991-3#3)(1991-7#1)(1991-9#1)(1992-1#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-3#1)(1994-6#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-7#1)(1996-12#2)(1996-5#1)(2005-4#9)(2005-8#1)(2006-10#2)(2006-12#2)(2007-10#2)(2007-11#1)(2007-2#2)(2007-8#13)(2008-1#1)(2008-10#562)(2008-2#7)(2008-3#4)(2008-4#1)(2008-5#7)(2008-6#1)(2009-8#2)(2010-12#1)(2010-2#5)(2010-5#4)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#4)(2012-11#1)(2013-8#4)
spectrophotometrically and##2##2##(2008-10#2)
spectrophotometrically as##5##2##(1991-12#1)(2008-10#4)
spectrophotometrically at##24##2##(1993-12#1)(2007-8#1)(2008-10#20)(2008-3#1)(2010-2#1)
spectrophotometrically by using##2##3##(2008-10#1)(2013-8#1)
spectrophotometrically by##18##2##(2007-8#1)(2008-10#13)(2008-3#2)(2008-5#1)(2013-8#1)
spectrophotometrically in aqueous##2##3##(2008-10#2)
spectrophotometrically using##4##2##(2008-10#3)(2012-2#1)
spectrophotometrically with##3##2##(2008-10#3)
spectrophotometrically##94##1##(1991-12#1)(1992-1#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1996-9#1)(2005-11#1)(2007-6#1)(2007-8#3)(2008-10#72)(2008-3#3)(2008-4#1)(2008-5#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
spectrophotometry after##4##2##(2004-12#1)(2006-12#1)(2008-10#2)
spectrophotometry and by##2##3##(2008-10#2)
spectrophotometry and flame atomic absorption spectrometry##2##6##(2008-10#2)
spectrophotometry and multivariate calibration##2##4##(2008-10#2)
spectrophotometry and the##2##3##(2005-4#1)(2008-10#1)
spectrophotometry and##28##2##(1991-8#1)(1993-1#1)(1995-2#1)(2005-4#1)(2008-10#20)(2008-2#1)(2008-4#1)(2008-5#1)(2012-11#1)
spectrophotometry at##4##2##(1992-8#1)(1994-11#1)(2008-10#2)
spectrophotometry for determination of##2##4##(2008-10#2)
spectrophotometry for##10##2##(2008-10#8)(2008-2#1)(2009-5#1)
spectrophotometry has been developed##2##4##(2008-10#2)
spectrophotometry has been##4##3##(1991-10#1)(2008-10#3)
spectrophotometry has the advantage of high sensitivity than normal##2##9##(2008-10#2)
spectrophotometry has##7##2##(1991-10#1)(2008-10#5)(2010-4#1)
spectrophotometry in##4##2##(2008-10#4)
spectrophotometry is##8##2##(2005-4#1)(2008-10#5)(2008-9#1)(2010-5#1)
spectrophotometry of##5##2##(1990-9#1)(2005-4#1)(2008-10#3)
spectrophotometry or##2##2##(2008-10#2)
spectrophotometry showed##2##2##(2008-5#1)(2013-1#1)
spectrophotometry using##5##2##(2008-10#5)
spectrophotometry was used to determine##2##5##(1997-4#1)(2008-10#1)
spectrophotometry was used to##4##4##(1997-4#1)(2008-10#2)(2012-3#1)
spectrophotometry was used##6##3##(1997-4#1)(2008-10#4)(2012-3#1)
spectrophotometry was##10##2##(1990-6#1)(1997-4#1)(2005-4#2)(2008-10#5)(2012-3#1)
spectrophotometry were##2##2##(2008-10#2)
spectrophotometry with flow injection##2##4##(2008-10#2)
spectrophotometry with##9##2##(2008-10#9)
spectrophotometry##230##1##(1990-10#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-7#2)(1991-8#1)(1992-8#1)(1993-1#1)(1993-2#1)(1994-11#1)(1995-2#1)(1996-3#1)(1997-4#2)(2004-12#2)(2004-4#1)(2004-9#1)(2005-11#1)(2005-4#11)(2006-10#3)(2006-12#3)(2006-5#1)(2007-10#1)(2008-1#1)(2008-10#167)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-4#1)(2010-5#3)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#2)(2013-7#1)
spectrophotometry]##7##1##(2005-4#7)
spectropolarimeter##3##1##(2005-4#1)(2008-3#2)
spectropolarimetric imager##2##2##(2008-3#2)
spectropolarimetric##6##1##(1994-5#1)(2008-10#1)(2008-3#4)
spectroradiometer for the##2##3##(2008-2#2)
spectroradiometer for##3##2##(2008-2#3)
spectroradiometer was##2##2##(2008-2#1)(2008-3#1)
spectroradiometer##21##1##(2008-2#8)(2008-3#13)
spectroradiometers that##2##2##(2008-2#2)
spectroradiometers##8##1##(2008-2#4)(2008-3#4)
spectroradiometry##2##1##(2008-3#2)
spectroscope##2##1##(2007-12#1)(2008-11#1)
spectroscopic analyses##7##2##(1991-10#1)(1992-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#2)
spectroscopic analysis and##2##3##(2008-10#1)(2013-1#1)
spectroscopic analysis as##2##3##(2007-1#1)(2008-10#1)
spectroscopic analysis of the##2##4##(1990-7#1)(1992-9#1)
spectroscopic analysis of##6##3##(1990-5#1)(1990-7#1)(1992-9#1)(1994-3#1)(2006-2#1)(2009-1#1)
spectroscopic analysis##25##2##(1990-5#1)(1990-7#2)(1992-9#1)(1994-3#1)(1995-3#1)(1997-4#2)(2006-12#2)(2006-2#1)(2007-1#4)(2007-8#1)(2008-10#5)(2008-3#1)(2009-1#1)(2010-6#1)(2013-1#1)
spectroscopic and biochemical##2##3##(1991-8#1)(2008-3#1)
spectroscopic and chemical methods##2##4##(1994-3#1)(2007-1#1)
spectroscopic and chemical##6##3##(1994-3#1)(1994-8#1)(1997-7#1)(2007-1#2)(2008-4#1)
spectroscopic and electrochemical methods##2##4##(1996-2#1)(2010-7#1)
spectroscopic and electrochemical##3##3##(1996-2#1)(2008-5#1)(2010-7#1)
spectroscopic and medicinal##2##3##(2008-3#2)
spectroscopic and##31##2##(1991-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1996-2#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-1#2)(2007-12#1)(2008-10#4)(2008-3#5)(2008-4#2)(2008-5#3)(2009-2#1)(2010-5#2)(2010-7#1)(2012-12#1)
spectroscopic applications##5##2##(2007-11#1)(2007-12#2)(2008-2#2)
spectroscopic approach##2##2##(1993-3#1)(2008-5#1)
spectroscopic changes##3##2##(1991-8#1)(1994-6#1)(2009-10#1)
spectroscopic characterization of a##3##4##(1991-1#1)(1992-9#1)(2010-6#1)
spectroscopic characterization of the##3##4##(1992-3#1)(1996-7#1)(2008-3#1)
spectroscopic characterization of##13##3##(1991-1#1)(1992-3#1)(1992-9#1)(1996-7#1)(1997-8#1)(2005-4#1)(2007-11#1)(2008-10#1)(2008-3#2)(2010-6#1)(2010-8#2)
spectroscopic characterization##17##2##(1991-1#1)(1992-3#1)(1992-9#1)(1995-5#1)(1996-7#1)(1997-8#1)(2005-4#1)(2007-10#1)(2007-11#2)(2008-10#1)(2008-3#2)(2010-6#1)(2010-8#3)
spectroscopic cytology##2##2##(2010-5#2)
spectroscopic data and##2##3##(1990-7#1)(2007-11#1)
spectroscopic data illustrate##2##3##(1990-9#1)(1995-6#1)
spectroscopic data##34##2##(1990-2#1)(1990-7#1)(1990-9#1)(1991-7#2)(1993-6#1)(1995-6#2)(1996-10#1)(1996-11#1)(1997-7#1)(2006-10#1)(2006-12#2)(2007-1#4)(2007-10#1)(2007-11#5)(2008-10#4)(2008-3#1)(2009-10#1)(2009-3#1)(2011-2#1)(2013-1#2)
spectroscopic detection of##2##3##(2008-10#1)(2008-3#1)
spectroscopic detection##6##2##(2008-10#5)(2008-3#1)
spectroscopic determination of##4##3##(2008-10#3)(2012-2#1)
spectroscopic differences##4##2##(1997-8#1)(2009-4#1)(2010-2#2)
spectroscopic ellipsometer##6##2##(2008-2#2)(2008-3#4)
spectroscopic ellipsometry (SE)##2##3##(2008-2#1)(2008-3#1)
spectroscopic ellipsometry##17##2##(2007-11#1)(2007-9#1)(2008-2#8)(2008-3#7)
spectroscopic evidence for##2##3##(1991-5#1)(1995-5#1)
spectroscopic evidence##4##2##(1991-5#1)(1992-9#1)(1995-5#1)(2007-1#1)
spectroscopic experiment##2##2##(1996-8#1)(2008-3#1)
spectroscopic experiments##5##2##(2006-10#1)(2007-12#1)(2009-3#1)(2010-2#2)
spectroscopic features##4##2##(1993-6#1)(2006-10#1)(2008-10#1)(2008-2#1)
spectroscopic gas##3##2##(2007-12#2)(2008-3#1)
spectroscopic imaging of the##2##4##(1997-5#2)
spectroscopic imaging of##3##3##(1997-5#2)(2007-12#1)
spectroscopic imaging##10##2##(1996-3#1)(1997-3#1)(1997-5#3)(2006-8#1)(2007-12#2)(2010-12#1)(2010-4#1)
spectroscopic information##4##2##(1990-7#1)(2006-12#1)(2007-12#1)(2008-2#1)
spectroscopic investigation of##2##3##(2007-12#1)(2008-10#1)
spectroscopic investigation##5##2##(2006-12#2)(2007-12#1)(2008-10#1)(2008-5#1)
spectroscopic investigations##2##2##(2006-12#1)(2007-10#1)
spectroscopic means##4##2##(1994-12#1)(2007-1#1)(2007-11#2)
spectroscopic measurement of##3##3##(1992-1#1)(1992-7#1)(2007-12#1)
spectroscopic measurements in the##2##4##(2008-3#2)
spectroscopic measurements of##5##3##(1995-5#1)(2007-11#1)(2008-2#1)(2010-4#1)(2013-8#1)
spectroscopic measurements to##2##3##(2007-12#1)(2008-5#1)
spectroscopic measurements##21##2##(1992-12#1)(1994-8#1)(1995-5#1)(1997-6#1)(2005-11#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#4)(2008-3#3)(2008-5#1)(2010-4#1)(2013-8#1)
spectroscopic method for##3##3##(1992-7#1)(2008-10#2)
spectroscopic method to##3##3##(2008-10#2)(2008-5#1)
spectroscopic method was##2##3##(2008-10#2)
spectroscopic method##11##2##(1992-7#1)(2008-10#9)(2008-5#1)
spectroscopic methods and##4##3##(2006-12#1)(2007-1#2)(2008-3#1)
spectroscopic methods have been##2##4##(2007-12#1)(2009-2#1)
spectroscopic methods including##4##3##(1996-2#1)(2007-1#3)
spectroscopic methods##37##2##(1991-7#1)(1996-2#1)(1996-5#1)(2006-12#4)(2007-1#13)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#3)(2008-4#1)(2009-2#1)(2010-5#1)(2011-2#1)(2012-11#1)
spectroscopic parameters of##2##3##(2007-11#1)(2008-2#1)
spectroscopic parameters##6##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)
spectroscopic probe##6##2##(1992-8#1)(1995-8#1)(2007-12#1)(2008-10#1)(2010-4#1)(2011-1#1)
spectroscopic probes##4##2##(1991-2#2)(2008-10#1)(2008-12#1)
spectroscopic properties and##4##3##(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#1)
spectroscopic properties of the##6##4##(1996-2#1)(1997-2#1)(2006-12#1)(2008-10#2)(2009-10#1)
spectroscopic properties of##10##3##(1991-3#1)(1994-12#1)(1996-2#1)(1997-2#1)(2006-12#1)(2007-11#2)(2008-10#2)(2009-10#1)
spectroscopic properties##23##2##(1990-3#1)(1991-3#1)(1991-7#1)(1994-11#1)(1994-12#1)(1996-2#1)(1997-2#1)(1997-6#1)(2006-12#2)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-3#2)(2008-5#2)(2009-10#1)
spectroscopic resolution##2##2##(1994-8#1)(2008-7#1)
spectroscopic results indicate##3##3##(1993-3#1)(1994-6#1)(2008-3#1)
spectroscopic results##4##2##(1993-3#1)(1994-6#1)(2008-10#1)(2008-3#1)
spectroscopic studies of the##3##4##(1990-7#1)(1995-10#1)(2008-5#1)
spectroscopic studies of##9##3##(1990-7#1)(1992-3#1)(1995-10#1)(2007-10#1)(2008-10#1)(2008-5#1)(2010-11#1)(2012-12#1)(2013-1#1)
spectroscopic studies on##3##3##(1993-6#1)(1994-12#1)(2008-10#1)
spectroscopic studies##19##2##(1990-3#1)(1990-7#1)(1992-3#1)(1993-6#1)(1994-12#1)(1995-10#1)(1995-6#1)(2005-4#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-11#1)(2010-4#1)(2012-12#1)(2013-1#1)
spectroscopic study of the##4##4##(1990-2#1)(1994-9#1)(2007-11#1)(2008-3#1)
spectroscopic study of##11##3##(1990-2#1)(1991-5#1)(1994-9#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#2)(2010-4#1)
spectroscopic study##21##2##(1990-2#1)(1990-3#1)(1991-5#1)(1993-4#1)(1994-8#1)(1994-9#1)(1996-11#1)(1996-2#1)(2006-12#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-4#1)(2011-12#1)
spectroscopic system##2##2##(2006-12#1)(2007-2#1)
spectroscopic technique##6##2##(2007-12#2)(2008-10#1)(2008-2#2)(2013-8#1)
spectroscopic techniques and##2##3##(1997-2#1)(2007-11#1)
spectroscopic techniques can be used##2##5##(1997-8#1)(2008-10#1)
spectroscopic techniques##31##2##(1993-3#1)(1994-3#1)(1995-8#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-8#2)(2008-10#8)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-5#4)(2012-1#1)
spectroscopic titrations##2##2##(2008-5#1)(2011-1#1)
spectroscopic units##3##2##(2008-10#3)
spectroscopic##487##1##(1990-10#1)(1990-2#2)(1990-3#3)(1990-5#1)(1990-7#5)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#3)(1991-3#1)(1991-5#2)(1991-7#4)(1991-8#3)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#3)(1992-7#2)(1992-8#2)(1992-9#4)(1993-11#1)(1993-3#4)(1993-4#1)(1993-6#3)(1994-11#1)(1994-12#4)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#4)(1994-9#2)(1995-10#3)(1995-3#1)(1995-5#3)(1995-6#3)(1995-8#3)(1996-10#1)(1996-11#2)(1996-2#5)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#4)(1997-6#2)(1997-7#2)(1997-8#3)(2005-11#1)(2005-4#2)(2006-10#5)(2006-12#19)(2006-2#1)(2006-8#1)(2007-1#26)(2007-10#6)(2007-11#23)(2007-12#22)(2007-2#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#82)(2008-11#1)(2008-12#1)(2008-2#32)(2008-3#52)(2008-4#7)(2008-5#16)(2008-7#6)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#3)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#3)(2010-11#2)(2010-12#1)(2010-2#4)(2010-4#5)(2010-5#10)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#5)(2011-12#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#4)(2013-7#2)(2013-8#2)
spectroscopical##2##1##(2008-10#2)
spectroscopically and##3##2##(1992-6#1)(2005-11#1)(2006-12#1)
spectroscopically##19##1##(1992-1#1)(1992-3#1)(1992-6#1)(1992-8#1)(1994-11#1)(1994-5#1)(1995-2#1)(2005-11#1)(2006-12#3)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2012-2#1)
spectroscopies and##2##2##(1992-3#1)(1995-11#1)
spectroscopies have been used to##2##5##(2006-10#1)(2008-10#1)
spectroscopies to##2##2##(1993-11#1)(2010-4#1)
spectroscopies##31##1##(1991-2#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-11#1)(1996-2#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-5#3)(2008-6#1)(2009-4#1)(2010-4#1)(2010-7#2)
spectroscopy (CRDS)##2##2##(2008-2#1)(2010-7#1)
spectroscopy (EDS)##3##2##(2008-10#1)(2008-11#2)
spectroscopy (FTIR) and##3##3##(2008-10#3)
spectroscopy (FTIR)##18##2##(1991-3#1)(2004-9#1)(2005-12#1)(2008-10#7)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#2)(2013-8#2)
spectroscopy (IR)##2##2##(2008-10#1)(2009-8#1)
spectroscopy (IRRAS)##2##2##(2005-11#1)(2006-5#1)
spectroscopy (IS)##2##2##(2005-11#1)(2008-2#1)
spectroscopy (LIBS)##5##2##(2006-12#2)(2008-10#2)(2013-8#1)
spectroscopy (MRS)##6##2##(2007-11#1)(2007-12#1)(2007-9#1)(2008-7#1)(2009-4#1)(2011-1#1)
spectroscopy (NIRS) technology together with a remote reflectance fibre-optic probe##2##10##(2008-10#2)
spectroscopy (NIRS) was##2##3##(2008-10#2)
spectroscopy (NIRS)##13##2##(1997-6#1)(2007-9#2)(2008-10#8)(2008-3#1)(2011-12#1)
spectroscopy (TRNOESY) studies of##3##4##(1993-11#1)(1994-11#2)
spectroscopy (TRNOESY)##4##2##(1993-11#2)(1994-11#2)
spectroscopy (XPS)##22##2##(2004-9#3)(2005-11#7)(2005-4#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-5#1)(2009-7#1)(2010-8#1)(2013-8#1)
spectroscopy after##3##2##(1996-2#1)(2008-10#1)(2008-7#1)
spectroscopy allows##3##2##(1997-6#1)(2008-2#1)(2010-12#1)
spectroscopy analysis##4##2##(2006-10#1)(2008-10#1)(2008-6#1)(2010-9#1)
spectroscopy and HPLC##2##3##(1991-7#1)(2008-10#1)
spectroscopy and X-ray diffraction##3##4##(1991-2#1)(2008-10#1)(2012-2#1)
spectroscopy and X-ray photoelectron spectroscopy##2##5##(2008-10#2)
spectroscopy and X-ray##9##3##(1991-2#1)(1994-3#1)(1996-5#1)(2008-10#3)(2010-1#1)(2010-12#1)(2012-2#1)
spectroscopy and a##3##3##(1994-12#1)(2007-11#1)(2008-10#1)
spectroscopy and atomic force microscopy##2##5##(2005-11#1)(2008-6#1)
spectroscopy and atomic force##3##4##(2005-11#1)(2008-10#1)(2008-6#1)
spectroscopy and atomic##4##3##(1990-7#1)(2005-11#1)(2008-10#1)(2008-6#1)
spectroscopy and chemical##2##3##(1992-3#1)(2008-7#1)
spectroscopy and chemometrics##4##3##(2007-12#2)(2010-2#1)(2012-11#1)
spectroscopy and cyclic voltammetry##2##4##(2008-10#1)(2013-7#1)
spectroscopy and differential scanning##2##4##(1990-3#1)(2008-5#1)
spectroscopy and electron##3##3##(1997-7#1)(2008-5#2)
spectroscopy and elemental##2##3##(2008-10#1)(2010-5#1)
spectroscopy and ellipsometry##2##3##(2005-11#1)(2008-2#1)
spectroscopy and fast atom bombardment mass spectrometry##2##7##(1991-3#1)(1994-3#1)
spectroscopy and fast##3##3##(1991-3#1)(1994-3#1)(2008-2#1)
spectroscopy and fluorescence##2##3##(1992-7#1)(2010-9#1)
spectroscopy and gel##2##3##(2009-2#1)(2012-11#1)
spectroscopy and imaging##3##3##(1993-3#1)(2006-12#1)(2008-11#1)
spectroscopy and in vitro antitumor activity of##2##7##(2008-5#2)
spectroscopy and in##6##3##(2006-12#1)(2007-11#1)(2008-5#2)(2010-7#1)(2012-2#1)
spectroscopy and it##2##3##(2008-10#1)(2010-12#1)
spectroscopy and its##4##3##(1990-2#1)(2006-12#1)(2007-12#1)(2012-2#1)
spectroscopy and mass spectrometry##5##4##(1990-3#1)(2008-4#1)(2010-5#2)(2011-1#1)
spectroscopy and molecular modeling##2##4##(1990-10#1)(1992-4#1)
spectroscopy and molecular##3##3##(1990-10#1)(1992-4#1)(1994-11#1)
spectroscopy and multivariate calibration##5##4##(2008-10#5)
spectroscopy and multivariate control charts##3##5##(2008-10#3)
spectroscopy and multivariate##11##3##(2006-11#1)(2008-10#9)(2013-8#1)
spectroscopy and other##2##3##(1996-11#1)(2008-4#1)
spectroscopy and scanning electron microscopy##2##5##(2007-9#1)(2008-10#1)
spectroscopy and the##8##3##(1992-1#1)(1994-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#3)
spectroscopy and transmission electron microscopy (TEM)##2##6##(2010-7#1)(2013-8#1)
spectroscopy and##174##2##(1990-1#1)(1990-10#1)(1990-2#1)(1990-3#2)(1990-7#2)(1991-2#2)(1991-3#1)(1991-7#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-11#1)(1993-3#1)(1994-11#3)(1994-12#1)(1994-3#4)(1995-2#1)(1995-6#1)(1996-11#1)(1996-2#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-5#1)(1997-6#2)(1997-7#1)(2005-11#6)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-4#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#4)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#39)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#14)(2008-6#1)(2008-7#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-1#2)(2010-12#3)(2010-2#3)(2010-4#2)(2010-5#7)(2010-7#2)(2010-9#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-11#2)(2012-2#4)(2013-7#1)(2013-8#4)
spectroscopy applications##2##2##(2005-4#1)(2007-12#1)
spectroscopy applied to the##2##4##(2006-12#1)(2008-10#1)
spectroscopy applied to##3##3##(1997-6#1)(2006-12#1)(2008-10#1)
spectroscopy are demonstrated##2##3##(2007-12#1)(2008-3#1)
spectroscopy are discussed##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
spectroscopy are used##2##3##(2005-11#1)(2006-12#1)
spectroscopy are##12##2##(1990-7#1)(2005-11#1)(2006-12#2)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#2)(2008-4#1)(2010-11#1)
spectroscopy as a tool for##3##5##(2006-4#1)(2008-4#1)(2010-11#1)
spectroscopy as a##10##3##(1990-10#1)(1995-10#1)(2006-10#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-12#1)(2010-11#1)
spectroscopy as an##2##3##(2008-10#1)(2010-4#1)
spectroscopy as##16##2##(1990-10#2)(1995-10#1)(2006-10#1)(2006-4#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-4#1)(2009-12#1)(2010-11#1)(2010-4#2)
spectroscopy at the##3##3##(1996-5#1)(2006-4#1)(2008-10#1)
spectroscopy at##22##2##(1990-9#1)(1991-2#1)(1993-11#1)(1993-6#1)(1996-2#1)(1996-5#1)(2006-10#1)(2006-4#1)(2007-3#1)(2008-10#4)(2008-3#6)(2008-5#1)(2011-1#1)(2013-7#1)
spectroscopy by use of##3##4##(2008-3#3)
spectroscopy by##4##2##(2008-3#4)
spectroscopy can be applied##2##4##(2006-12#1)(2008-10#1)
spectroscopy can be used for##2##5##(2008-2#1)(2010-7#1)
spectroscopy can be used##4##4##(1997-6#1)(2008-2#1)(2008-3#1)(2010-7#1)
spectroscopy can be##6##3##(1997-6#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-7#1)
spectroscopy can##9##2##(1994-6#1)(1996-7#1)(1997-6#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-7#1)
spectroscopy combined with hybrid distance##2##5##(1991-4#1)(1994-5#1)
spectroscopy combined with##6##3##(1991-4#1)(1994-5#1)(1995-5#1)(2007-12#1)(2008-6#1)(2013-8#1)
spectroscopy coupled to multivariate##2##4##(2008-10#2)
spectroscopy coupled to##3##3##(2008-10#3)
spectroscopy coupled##4##2##(2008-10#4)
spectroscopy data##2##2##(2005-11#1)(2006-5#1)
spectroscopy detects##2##2##(1995-11#1)(2010-5#1)
spectroscopy determinations##2##2##(2008-10#2)
spectroscopy experiment##4##2##(2007-11#1)(2008-1#1)(2008-3#2)
spectroscopy experiments##3##2##(1997-1#1)(2006-5#1)(2008-10#1)
spectroscopy for in situ##3##4##(2008-10#3)
spectroscopy for in##4##3##(2008-10#3)(2011-1#1)
spectroscopy for quantitative##2##3##(2007-11#1)(2008-3#1)
spectroscopy for the##14##3##(1995-7#1)(2006-12#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#1)(2010-4#2)(2012-12#2)
spectroscopy for##40##2##(1995-2#1)(1995-7#1)(2006-12#1)(2006-3#1)(2006-4#1)(2007-11#3)(2007-8#1)(2008-10#10)(2008-2#4)(2008-3#6)(2008-4#1)(2009-2#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-12#4)
spectroscopy from##3##2##(1992-8#1)(2007-11#1)(2008-3#1)
spectroscopy gives##2##2##(2008-3#1)(2008-5#1)
spectroscopy has a##2##3##(1997-6#1)(2008-11#1)
spectroscopy has been applied in##2##5##(1996-9#1)(2013-8#1)
spectroscopy has been applied to the##2##6##(2008-10#1)(2008-2#1)
spectroscopy has been applied##5##4##(1996-9#1)(2006-12#1)(2008-10#1)(2008-2#1)(2013-8#1)
spectroscopy has been employed to##2##5##(1993-8#1)(1994-5#1)
spectroscopy has been employed##3##4##(1993-8#1)(1994-5#1)(2007-8#1)
spectroscopy has been used to investigate the##3##7##(1990-8#1)(1994-5#1)(1995-11#1)
spectroscopy has been used to monitor the##2##7##(1991-7#1)(1992-3#1)
spectroscopy has been used to study##3##6##(1991-12#1)(1994-8#1)(2007-11#1)
spectroscopy has been used to##13##5##(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-7#1)(1992-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(2007-11#1)(2008-7#1)(2010-4#1)(2010-5#1)
spectroscopy has been##29##3##(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-7#1)(1992-3#1)(1993-8#1)(1994-5#2)(1994-8#1)(1995-11#1)(1996-9#1)(2005-4#1)(2006-12#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2009-9#1)(2010-4#2)(2010-5#1)(2013-7#1)(2013-8#1)
spectroscopy has##39##2##(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-7#1)(1992-3#1)(1992-9#1)(1993-8#1)(1994-5#2)(1994-8#1)(1995-11#1)(1996-9#1)(1997-6#2)(2005-4#1)(2006-12#1)(2007-11#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-9#1)(2010-4#2)(2010-5#1)(2013-7#2)(2013-8#2)
spectroscopy have been##5##3##(1992-3#1)(2008-10#2)(2008-3#1)(2008-7#1)
spectroscopy have##7##2##(1992-3#1)(1997-6#1)(2008-10#2)(2008-3#2)(2008-7#1)
spectroscopy in a##6##3##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)
spectroscopy in aqueous##4##3##(1993-6#3)(2008-5#1)
spectroscopy in combination with##7##4##(1991-2#1)(1993-3#1)(2008-10#1)(2008-6#1)(2009-5#2)(2012-11#1)
spectroscopy in order to##3##4##(2008-10#2)(2008-5#1)
spectroscopy in patients with##2##4##(2006-8#1)(2008-7#1)
spectroscopy in the visible##2##4##(1990-3#1)(2007-11#1)
spectroscopy in the##17##3##(1990-3#2)(1993-8#2)(1995-1#1)(1997-6#3)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)
spectroscopy in turbid media##2##4##(2008-3#2)
spectroscopy in vivo##2##3##(1990-5#1)(1996-5#1)
spectroscopy in##78##2##(1990-3#2)(1990-5#2)(1990-9#1)(1991-2#1)(1993-3#1)(1993-6#3)(1993-8#2)(1995-1#1)(1996-10#1)(1996-2#1)(1996-5#1)(1997-5#1)(1997-6#5)(2004-9#2)(2006-12#3)(2006-8#1)(2006-9#1)(2007-11#5)(2007-12#5)(2008-10#16)(2008-11#1)(2008-2#4)(2008-3#7)(2008-5#2)(2008-6#1)(2008-7#1)(2009-5#2)(2010-5#1)(2010-7#1)(2011-1#1)(2012-11#1)(2012-12#1)
spectroscopy indicated that the##2##4##(1997-1#1)(2008-10#1)
spectroscopy indicated that##4##3##(1997-1#1)(2006-7#1)(2008-10#1)(2013-8#1)
spectroscopy indicated##5##2##(1997-1#1)(2006-7#1)(2008-10#2)(2013-8#1)
spectroscopy is a##4##3##(1997-6#1)(2007-11#1)(2008-3#1)(2010-12#1)
spectroscopy is also##2##3##(2007-11#1)(2007-12#1)
spectroscopy is an important tool##2##5##(2008-4#1)(2010-12#1)
spectroscopy is an##3##3##(2008-2#1)(2008-4#1)(2010-12#1)
spectroscopy is applied to##2##4##(2008-2#1)(2008-3#1)
spectroscopy is demonstrated##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
spectroscopy is introduced##2##3##(2007-12#1)(2008-3#1)
spectroscopy is presented##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
spectroscopy is used to study##2##5##(2008-10#1)(2008-3#1)
spectroscopy is used to##6##4##(1995-2#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
spectroscopy is used##7##3##(1995-2#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
spectroscopy is##46##2##(1995-2#1)(1997-6#5)(2006-6#1)(2007-11#3)(2007-12#3)(2007-8#2)(2008-1#1)(2008-10#7)(2008-2#7)(2008-3#7)(2008-4#1)(2009-2#1)(2009-4#1)(2010-12#2)(2010-5#1)(2011-1#1)(2013-7#1)(2013-8#1)
spectroscopy may##4##2##(1992-2#1)(2006-12#2)(2008-10#1)
spectroscopy measurements of##5##3##(1997-6#1)(2007-11#1)(2007-12#1)(2008-3#1)(2011-1#1)
spectroscopy measurements##16##2##(1997-6#4)(2005-11#2)(2007-11#1)(2007-12#1)(2008-3#2)(2009-12#1)(2010-12#1)(2010-4#2)(2011-1#1)(2012-2#1)
spectroscopy method for##2##3##(2008-10#1)(2008-3#1)
spectroscopy method##3##2##(2008-10#2)(2008-3#1)
spectroscopy methods##3##2##(2008-10#2)(2008-9#1)
spectroscopy of an##3##3##(1992-7#1)(1995-2#1)(2008-2#1)
spectroscopy of anisotropic surfaces and films##2##6##(2007-12#2)
spectroscopy of biological##2##3##(2007-12#1)(2010-5#1)
spectroscopy of human##4##3##(2007-11#1)(2008-3#2)(2009-5#1)
spectroscopy of the polysaccharide##2##4##(1991-12#1)(1991-7#1)
spectroscopy of the skin##2##4##(2008-5#2)
spectroscopy of the##28##3##(1990-7#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-9#2)(1994-10#2)(1995-1#1)(1995-12#1)(1997-3#1)(1997-4#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#1)(2009-2#1)(2009-5#1)(2010-11#1)(2010-5#1)
spectroscopy of##116##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-12#3)(1991-3#1)(1991-6#1)(1991-7#2)(1991-9#4)(1992-11#1)(1992-3#2)(1992-6#1)(1992-7#1)(1993-11#1)(1993-3#2)(1993-6#1)(1994-10#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-12#1)(1995-2#2)(1995-7#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#2)(2004-9#1)(2005-11#1)(2005-4#2)(2006-10#2)(2006-4#1)(2007-1#1)(2007-11#8)(2007-12#7)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#6)(2008-3#15)(2008-4#2)(2008-5#3)(2008-7#2)(2009-2#2)(2009-5#2)(2010-11#1)(2010-2#2)(2010-4#1)(2010-5#3)(2011-1#1)(2012-2#1)(2013-8#1)
spectroscopy on##6##2##(1992-1#1)(1994-11#1)(1997-6#1)(2008-2#1)(2008-3#1)(2010-4#1)
spectroscopy or##6##2##(1990-5#1)(1994-5#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-4#1)
spectroscopy provide evidence for the##2##5##(2005-11#1)(2008-10#1)
spectroscopy provides a##3##3##(1997-6#1)(2005-11#1)(2010-11#1)
spectroscopy provides##6##2##(1995-11#1)(1997-6#1)(2005-11#1)(2008-3#1)(2009-1#1)(2010-11#1)
spectroscopy revealed that the##2##4##(1993-9#1)(2005-11#1)
spectroscopy revealed that##4##3##(1993-9#1)(1994-11#1)(2005-11#1)(2013-7#1)
spectroscopy revealed the presence of##3##5##(1994-5#1)(2007-1#1)(2010-8#1)
spectroscopy revealed the##4##3##(1991-12#1)(1994-5#1)(2007-1#1)(2010-8#1)
spectroscopy revealed##11##2##(1990-2#1)(1991-12#1)(1993-9#1)(1994-11#1)(1994-5#1)(2005-11#1)(2007-1#1)(2010-8#3)(2013-7#1)
spectroscopy reveals##3##2##(1992-6#1)(1995-10#1)(2012-2#1)
spectroscopy show##3##2##(1994-9#1)(1997-7#1)(2013-8#1)
spectroscopy showed that##4##3##(1990-4#2)(1997-4#1)(1997-7#1)
spectroscopy showed##5##2##(1990-4#2)(1997-4#1)(1997-7#1)(2008-11#1)
spectroscopy signal##4##2##(1997-6#1)(2006-12#1)(2008-2#1)(2008-3#1)
spectroscopy studies of##2##3##(1994-12#1)(2008-10#1)
spectroscopy studies##7##2##(1991-9#1)(1993-11#1)(1994-12#1)(2008-10#1)(2008-3#2)(2008-5#1)
spectroscopy study of the##2##4##(2008-10#1)(2013-8#1)
spectroscopy study of##5##3##(1991-2#1)(1992-11#1)(2008-10#1)(2012-12#1)(2013-8#1)
spectroscopy study##10##2##(1991-2#1)(1992-11#1)(1992-6#1)(1992-9#1)(1997-6#1)(1997-7#1)(2007-9#1)(2008-10#1)(2012-12#1)(2013-8#1)
spectroscopy system##6##2##(2007-12#2)(2008-2#1)(2013-8#3)
spectroscopy technique for##2##3##(2007-12#1)(2009-9#1)
spectroscopy technique to##2##3##(2008-1#1)(2008-2#1)
spectroscopy technique##13##2##(2005-4#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#2)(2009-9#1)(2013-8#1)
spectroscopy techniques were##2##3##(1990-2#1)(2008-3#1)
spectroscopy techniques##13##2##(1990-2#1)(2007-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2010-12#1)(2012-12#1)
spectroscopy that##4##2##(1994-11#1)(1994-5#1)(2007-11#1)(2007-12#1)
spectroscopy the##4##2##(1991-8#1)(1996-2#1)(2008-10#2)
spectroscopy to be##2##3##(1997-8#1)(2008-10#1)
spectroscopy to determine the##5##4##(1993-11#1)(2008-2#1)(2008-5#1)(2010-4#1)(2010-9#1)
spectroscopy to determine##6##3##(1993-11#1)(2008-2#1)(2008-5#1)(2009-12#1)(2010-4#1)(2010-9#1)
spectroscopy to investigate the##2##4##(1993-11#1)(2010-4#1)
spectroscopy to investigate##4##3##(1993-11#1)(2008-5#1)(2009-4#1)(2010-4#1)
spectroscopy to measure##4##3##(1993-9#1)(2005-11#1)(2006-4#1)(2008-3#1)
spectroscopy to predict##3##3##(2010-4#3)
spectroscopy to study the##2##4##(1990-12#1)(1997-7#1)
spectroscopy to study##4##3##(1990-12#1)(1994-11#1)(1997-7#1)(2012-2#1)
spectroscopy to the##5##3##(2008-10#2)(2008-2#1)(2013-8#2)
spectroscopy to##52##2##(1990-10#1)(1990-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1993-11#2)(1993-9#1)(1994-11#1)(1994-2#1)(1996-8#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-12#2)(2006-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-8#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-4#6)(2010-9#1)(2012-2#1)(2013-7#1)(2013-8#2)
spectroscopy under##2##2##(2010-5#1)(2012-2#1)
spectroscopy using a##4##3##(2007-11#2)(2008-1#1)(2008-10#1)
spectroscopy using an##3##3##(1997-1#1)(2008-10#1)(2010-4#1)
spectroscopy using quantum-cascade##2##3##(2007-12#2)
spectroscopy using##20##2##(1990-11#1)(1994-11#1)(1994-5#1)(1996-7#1)(1997-1#1)(2007-11#2)(2007-12#4)(2008-1#2)(2008-10#3)(2008-2#1)(2008-3#1)(2010-4#1)(2010-5#1)
spectroscopy verified##2##2##(2006-5#1)(2013-1#1)
spectroscopy was applied to##3##4##(1996-2#1)(1997-1#1)(2010-4#1)
spectroscopy was employed to##2##4##(1990-10#1)(2007-12#1)
spectroscopy was used to characterize##2##5##(2006-12#1)(2008-10#1)
spectroscopy was used to determine the##2##6##(1992-7#1)(2007-8#1)
spectroscopy was used to investigate the##5##6##(1992-9#1)(1995-10#1)(2008-10#2)(2008-8#1)
spectroscopy was used to investigate##7##5##(1991-4#1)(1992-9#1)(1995-10#1)(2008-10#2)(2008-8#1)(2010-5#1)
spectroscopy was used to study the##2##6##(1990-2#2)
spectroscopy was used to study##3##5##(1990-2#2)(1994-11#1)
spectroscopy was used to##22##4##(1990-2#2)(1991-10#1)(1991-4#2)(1992-7#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-10#1)(1996-2#1)(2006-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2010-5#1)
spectroscopy was used##23##3##(1990-2#2)(1991-10#1)(1991-4#2)(1992-7#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-10#1)(1996-2#1)(2006-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2010-5#1)(2013-8#1)
spectroscopy was##38##2##(1990-10#1)(1990-2#2)(1991-10#1)(1991-4#2)(1992-7#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-10#1)(1996-2#2)(1997-1#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-4#2)(2010-5#1)(2013-8#2)
spectroscopy were used to##4##4##(2005-11#1)(2006-3#1)(2008-10#2)
spectroscopy were##7##2##(2005-11#1)(2006-3#1)(2006-8#1)(2008-10#3)(2008-3#1)
spectroscopy with a 1##2##4##(2008-2#1)(2008-3#1)
spectroscopy with a continuous-wave##2##4##(2007-12#1)(2008-2#1)
spectroscopy with a##14##3##(1996-7#1)(2007-12#3)(2008-10#2)(2008-2#6)(2008-3#2)
spectroscopy with the##4##3##(1997-4#1)(2008-2#2)(2008-5#1)
spectroscopy with##41##2##(1991-8#1)(1996-7#1)(1997-4#1)(2004-2#1)(2007-11#2)(2007-12#9)(2007-8#2)(2008-1#1)(2008-10#3)(2008-2#10)(2008-3#7)(2008-5#1)(2013-8#2)
spectroscopy without##3##2##(2007-12#2)(2008-10#1)
spectroscopy##1981##1##(1990-1#1)(1990-10#7)(1990-11#3)(1990-12#4)(1990-2#11)(1990-3#11)(1990-4#5)(1990-5#11)(1990-6#1)(1990-7#8)(1990-8#3)(1990-9#5)(1991-1#2)(1991-10#1)(1991-12#7)(1991-2#12)(1991-3#5)(1991-4#6)(1991-5#7)(1991-6#3)(1991-7#13)(1991-8#4)(1991-9#12)(1992-1#3)(1992-11#5)(1992-12#6)(1992-2#5)(1992-3#12)(1992-4#5)(1992-5#1)(1992-6#6)(1992-7#6)(1992-8#3)(1992-9#10)(1993-11#15)(1993-2#1)(1993-3#9)(1993-4#2)(1993-6#8)(1993-8#6)(1993-9#3)(1994-10#2)(1994-11#15)(1994-12#9)(1994-2#3)(1994-3#5)(1994-4#1)(1994-5#9)(1994-6#7)(1994-8#6)(1994-9#7)(1995-1#12)(1995-10#4)(1995-11#7)(1995-12#1)(1995-2#13)(1995-3#1)(1995-4#2)(1995-5#6)(1995-6#2)(1995-7#2)(1995-8#4)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#15)(1996-3#2)(1996-4#1)(1996-5#6)(1996-6#3)(1996-7#6)(1996-8#3)(1996-9#3)(1997-1#8)(1997-2#1)(1997-3#3)(1997-4#7)(1997-5#3)(1997-6#42)(1997-7#9)(1997-8#2)(2004-12#1)(2004-2#2)(2004-9#8)(2005-11#57)(2005-12#2)(2005-4#12)(2005-7#3)(2005-8#1)(2006-10#19)(2006-11#2)(2006-12#51)(2006-2#1)(2006-3#2)(2006-4#9)(2006-5#8)(2006-6#2)(2006-7#4)(2006-8#2)(2006-9#1)(2007-1#10)(2007-10#5)(2007-11#72)(2007-12#95)(2007-3#5)(2007-5#7)(2007-8#28)(2007-9#11)(2008-1#13)(2008-10#357)(2008-11#15)(2008-2#118)(2008-3#135)(2008-4#18)(2008-5#62)(2008-6#4)(2008-7#15)(2008-8#8)(2008-9#4)(2009-1#2)(2009-10#3)(2009-11#2)(2009-12#7)(2009-2#12)(2009-3#6)(2009-4#3)(2009-5#6)(2009-6#1)(2009-7#5)(2009-8#3)(2009-9#10)(2010-1#3)(2010-11#9)(2010-12#15)(2010-2#7)(2010-4#42)(2010-5#27)(2010-7#17)(2010-8#5)(2010-9#4)(2011-1#18)(2011-12#3)(2011-2#15)(2012-1#7)(2012-11#3)(2012-12#10)(2012-2#16)(2013-1#11)(2013-7#14)(2013-8#42)
spectroscopy) and##2##2##(2004-9#1)(2008-5#1)
spectroscopy) to##2##2##(2008-3#2)
spectroscopy)##15##1##(1993-4#1)(2004-4#1)(2004-9#1)(2005-11#1)(2006-7#1)(2008-10#1)(2008-3#3)(2008-5#2)(2010-2#1)(2010-3#2)(2010-7#1)
spectroscopy]##3##1##(2013-8#3)
spectrotemporal##2##1##(2007-12#1)(2008-2#1)
spectrum (340-640 nm) of##2##4##(2008-2#2)
spectrum -lactamase##3##2##(2007-7#3)
spectrum agrees##2##2##(1995-1#1)(2008-3#1)
spectrum also##2##2##(2007-11#1)(2008-3#1)
spectrum analysis of##2##3##(1991-12#1)(2008-10#1)
spectrum analysis##9##2##(1991-12#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-3#2)(2009-5#1)(2009-8#1)(2013-8#1)
spectrum analyzer##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
spectrum and a##4##3##(2005-4#1)(2007-12#1)(2008-1#1)(2008-3#1)
spectrum and can be##2##4##(1993-6#1)(2007-12#1)
spectrum and mode of action##2##5##(2008-6#2)
spectrum and the##8##3##(1997-4#1)(2005-4#1)(2005-7#1)(2008-1#1)(2008-3#2)(2008-8#1)(2008-9#1)
spectrum and to##2##3##(1991-8#1)(2010-11#1)
spectrum and##55##2##(1990-12#1)(1990-8#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-6#1)(1993-6#1)(1996-12#1)(1997-4#1)(2005-1#2)(2005-4#5)(2005-7#1)(2007-11#3)(2007-12#7)(2008-1#2)(2008-10#2)(2008-2#2)(2008-3#8)(2008-5#2)(2008-6#3)(2008-8#1)(2008-9#2)(2010-11#2)(2011-2#1)(2012-1#1)(2013-8#2)
spectrum antibiotics##6##2##(1994-11#1)(2005-7#1)(2008-5#2)(2010-5#1)(2012-2#1)
spectrum appears##2##2##(1996-1#1)(2008-10#1)
spectrum are assigned##2##3##(1990-4#1)(1995-10#1)
spectrum are##15##2##(1990-4#1)(1995-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#5)(2009-12#1)(2009-4#1)(2013-8#1)
spectrum as a##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
spectrum as well as##3##4##(2008-3#1)(2008-4#1)(2008-5#1)
spectrum as##10##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)
spectrum associated with##3##3##(1995-11#2)(1997-7#1)
spectrum at a##2##3##(2007-11#1)(2008-3#1)
spectrum at##9##2##(1991-2#1)(2007-11#2)(2008-10#3)(2008-3#3)
spectrum beta lactamase (ESBL)##2##4##(2007-7#2)
spectrum beta##4##2##(2007-7#2)(2008-3#1)(2012-2#1)
spectrum between##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
spectrum by##11##2##(1990-5#1)(1992-3#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#3)(2008-4#1)
spectrum can be##2##3##(2008-10#1)(2013-8#1)
spectrum can##5##2##(2008-10#1)(2013-1#2)(2013-8#2)
spectrum cephalosporins##3##2##(2007-7#2)(2009-2#1)
spectrum change##4##2##(2008-10#1)(2008-2#1)(2008-4#1)(2013-8#1)
spectrum characteristic of##2##3##(1993-6#1)(1995-5#1)
spectrum concept##3##2##(2008-1#1)(2012-2#2)
spectrum corresponding to##2##3##(1991-5#1)(2008-3#1)
spectrum could##4##2##(1992-11#1)(2007-12#1)(2008-8#1)(2013-8#1)
spectrum covers wavelengths##2##3##(2007-11#1)(2007-12#1)
spectrum disorder##22##2##(2005-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-10#1)(2009-4#4)(2010-11#1)(2010-2#1)(2010-4#2)(2011-12#1)(2012-12#1)(2013-1#3)(2013-7#2)(2013-8#1)
spectrum disorders (ASD)##9##3##(2009-4#2)(2010-12#1)(2010-2#1)(2012-2#2)(2013-1#1)(2013-7#2)
spectrum disorders (ASDs)##2##3##(2009-4#1)(2012-2#1)
spectrum disorders##46##2##(2008-11#3)(2008-6#2)(2009-10#1)(2009-2#1)(2009-4#8)(2010-12#2)(2010-2#1)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#11)(2013-1#2)(2013-7#3)
spectrum displays four peaks##2##4##(2008-8#2)
spectrum displays##5##2##(1993-11#1)(2008-10#1)(2008-2#1)(2008-8#2)
spectrum distribution function##2##3##(2008-2#1)(2013-8#1)
spectrum during##2##2##(1997-4#1)(2008-2#1)
spectrum exhibits##3##2##(1990-3#1)(1996-9#1)(2008-2#1)
spectrum for the##2##3##(2006-10#1)(2008-2#1)
spectrum for##18##2##(1991-1#1)(1992-5#2)(1993-8#1)(1995-5#1)(1995-8#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-2#6)(2010-5#1)(2011-1#1)
spectrum from a##6##3##(1992-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-9#1)(2010-5#1)
spectrum from the##3##3##(1992-3#1)(2007-12#1)(2008-3#1)
spectrum from##23##2##(1992-11#1)(1992-3#1)(1992-8#1)(1993-8#1)(2004-12#1)(2005-9#1)(2007-12#6)(2008-2#1)(2008-3#5)(2008-8#1)(2009-4#1)(2009-9#1)(2010-5#1)(2011-1#1)
spectrum has##4##2##(2007-11#1)(2007-12#2)(2008-11#1)
spectrum in the visible##3##4##(1993-11#1)(1995-1#1)(2007-12#1)
spectrum in the##13##3##(1993-11#2)(1993-3#1)(1993-9#1)(1995-1#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2011-1#1)
spectrum in##33##2##(1993-11#3)(1993-3#1)(1993-9#1)(1994-11#2)(1995-1#1)(1997-4#2)(1997-7#1)(2005-1#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-8#1)(2011-1#1)(2013-7#1)
spectrum including the##2##3##(2007-4#1)(2008-3#1)
spectrum inhibitors are##2##3##(2008-1#2)
spectrum is a##2##3##(1997-7#1)(2008-1#1)
spectrum is acquired by##2##4##(2008-10#1)(2008-3#1)
spectrum is acquired in##2##4##(2008-10#1)(2008-3#1)
spectrum is acquired##4##3##(2008-10#2)(2008-3#2)
spectrum is compared with##2##4##(2008-1#1)(2008-3#1)
spectrum is measured##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
spectrum is presented##4##3##(1992-2#1)(2007-11#1)(2008-10#1)(2008-2#1)
spectrum is used##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
spectrum is##58##2##(1992-12#1)(1992-2#1)(1992-8#1)(1993-2#1)(1994-6#1)(1995-1#1)(1997-3#1)(1997-7#1)(2005-4#1)(2006-10#1)(2007-11#5)(2007-12#10)(2008-1#2)(2008-10#8)(2008-11#1)(2008-2#9)(2008-3#12)(2010-7#1)
spectrum may##2##2##(2008-3#1)(2012-2#1)
spectrum measured##3##2##(2006-4#1)(2008-3#2)
spectrum method##2##2##(2007-12#1)(2008-2#1)
spectrum obtained by a##2##4##(2008-2#2)
spectrum obtained by##3##3##(2008-2#3)
spectrum obtained##6##2##(1990-5#1)(2005-11#1)(2008-2#3)(2009-8#1)
spectrum of HCAII##2##3##(1994-11#2)
spectrum of a fiber optical parametric amplifier##2##7##(2007-11#2)
spectrum of a single##2##4##(2008-10#1)(2010-7#1)
spectrum of a##31##3##(1990-3#1)(1991-1#1)(1992-1#1)(1992-3#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-1#1)(1996-9#1)(2007-11#4)(2007-12#8)(2008-1#2)(2008-10#4)(2008-2#1)(2008-3#2)(2010-7#1)
spectrum of abnormalities##2##3##(1990-6#1)(2012-2#1)
spectrum of acetylene##2##3##(1992-9#1)(2008-2#1)
spectrum of action##6##3##(1990-5#1)(1994-6#1)(2006-6#1)(2008-8#1)(2010-6#1)(2013-8#1)
spectrum of activities##3##3##(2008-5#1)(2011-2#1)(2013-7#1)
spectrum of activity and##5##4##(1996-8#1)(2008-10#2)(2008-5#1)(2012-3#1)
spectrum of activity##17##3##(1992-2#1)(1996-8#1)(2005-7#1)(2005-8#1)(2008-1#1)(2008-10#4)(2008-5#4)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
spectrum of acute##3##3##(1991-7#1)(1992-9#1)(2008-1#1)
spectrum of adverse effects##2##4##(1996-7#1)(2007-11#1)
spectrum of an extreme-ultraviolet##2##4##(2007-11#2)
spectrum of an##9##3##(2007-11#3)(2008-2#1)(2008-3#4)(2013-7#1)
spectrum of antibacterial activity##3##4##(1996-8#1)(2005-8#1)(2008-3#1)
spectrum of antibiotics##3##3##(2008-10#1)(2010-12#1)(2011-2#1)
spectrum of antimicrobial activity##3##4##(1991-12#1)(1994-11#1)(2006-10#1)
spectrum of biological and##2##4##(2007-2#1)(2008-10#1)
spectrum of biological##5##3##(1990-4#1)(1994-6#1)(2007-2#1)(2008-10#1)(2010-4#1)
spectrum of both##2##3##(2008-10#1)(2012-2#1)
spectrum of clinical manifestations##3##4##(2006-10#2)(2013-1#1)
spectrum of clinical##9##3##(1996-12#1)(2006-10#2)(2006-2#1)(2008-11#1)(2008-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
spectrum of congenital##3##3##(2007-9#1)(2008-11#1)(2008-8#1)
spectrum of differential##2##3##(1993-8#1)(2008-12#1)
spectrum of disease severity##2##4##(2010-11#1)(2012-2#1)
spectrum of disease##7##3##(1991-12#1)(2006-10#3)(2010-11#1)(2011-2#1)(2012-2#1)
spectrum of diseases##3##3##(2005-12#1)(2010-11#1)(2012-2#1)
spectrum of disorders##3##3##(2005-12#1)(2010-10#1)(2012-2#1)
spectrum of each##5##3##(1994-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
spectrum of free##3##3##(2008-10#2)(2008-5#1)
spectrum of genetic##2##3##(2010-11#1)(2012-3#1)
spectrum of human carbonic anhydrase II##2##6##(1994-11#2)
spectrum of human##5##3##(1991-9#1)(1994-11#2)(2006-10#1)(2010-7#1)
spectrum of illness##3##3##(2008-5#1)(2011-2#2)
spectrum of indications##2##3##(1993-3#1)(2010-12#1)
spectrum of infection##3##3##(2006-10#1)(2008-7#2)
spectrum of its##2##3##(2005-12#1)(2007-12#1)
spectrum of light transmitted through turbid##2##6##(2008-3#2)
spectrum of light##4##3##(2007-12#1)(2008-3#3)
spectrum of liquid water##4##4##(2008-2#1)(2008-3#3)
spectrum of mutations##2##3##(1990-3#1)(1995-9#1)
spectrum of native##2##3##(1993-11#1)(2008-10#1)
spectrum of neurological##2##3##(2008-8#1)(2010-9#1)
spectrum of patients##2##3##(1997-1#1)(2007-8#1)
spectrum of physical##2##3##(1992-2#1)(2011-2#1)
spectrum of physiological##3##3##(1995-5#1)(2011-2#1)(2013-8#1)
spectrum of plane waves##2##4##(2008-3#2)
spectrum of plasma##2##3##(2012-1#1)(2013-8#1)
spectrum of possible##3##3##(2008-10#1)(2008-7#1)(2010-3#1)
spectrum of potential##3##3##(2007-12#1)(2008-11#1)(2010-5#1)
spectrum of products##2##3##(2008-5#1)(2008-6#1)
spectrum of pure##5##3##(2008-2#3)(2008-3#2)
spectrum of reduced##3##3##(1991-2#1)(1991-7#1)(1993-11#1)
spectrum of resistance to##2##4##(2008-10#1)(2011-2#1)
spectrum of resistance##3##3##(2008-10#2)(2011-2#1)
spectrum of respiratory##2##3##(2007-2#1)(2008-4#1)
spectrum of samples##2##3##(2008-3#1)(2008-5#1)
spectrum of symptoms##3##3##(2008-7#2)(2009-6#1)
spectrum of the adduct##2##4##(1995-2#1)(1996-7#1)
spectrum of the complex##2##4##(1990-4#1)(2008-4#1)
spectrum of the peptide##2##4##(1992-3#1)(1992-9#1)
spectrum of the product##2##4##(1990-8#1)(2008-10#1)
spectrum of the sample##2##4##(2005-4#1)(2008-10#1)
spectrum of the##88##3##(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-7#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-2#2)(1995-3#1)(1995-5#2)(1996-12#1)(1996-2#1)(1996-7#1)(1997-4#2)(1997-7#1)(2005-4#2)(2006-10#1)(2006-6#1)(2007-11#2)(2007-12#7)(2007-8#3)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#8)(2008-3#9)(2008-4#1)(2008-5#1)(2008-8#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-7#1)
spectrum of therapeutic##3##3##(1990-6#1)(2005-7#1)(2011-1#1)
spectrum of these##5##3##(1996-12#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-2#1)
spectrum of this##3##3##(1996-2#1)(2006-10#2)
spectrum of three##2##3##(1991-9#1)(2012-2#1)
spectrum of##599##2##(1990-12#1)(1990-2#5)(1990-3#3)(1990-4#4)(1990-5#3)(1990-6#2)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#5)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#1)(1992-9#4)(1993-11#4)(1993-2#2)(1993-3#4)(1993-8#5)(1993-9#2)(1994-11#6)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#5)(1994-6#4)(1994-8#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#3)(1995-5#4)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#4)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#5)(1997-8#3)(2004-3#1)(2005-1#2)(2005-11#2)(2005-12#4)(2005-4#7)(2005-7#3)(2005-8#5)(2006-1#1)(2006-10#21)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#5)(2006-7#3)(2006-8#3)(2006-9#1)(2007-10#2)(2007-11#17)(2007-12#31)(2007-2#4)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#10)(2007-9#2)(2008-1#13)(2008-10#40)(2008-11#9)(2008-12#4)(2008-2#24)(2008-3#40)(2008-4#9)(2008-5#20)(2008-6#2)(2008-7#14)(2008-8#14)(2008-9#4)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#4)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#5)(2011-2#15)(2011-3#1)(2012-1#4)(2012-11#2)(2012-12#7)(2012-2#16)(2012-3#6)(2013-1#11)(2013-7#4)(2013-8#9)
spectrum or##3##2##(2008-3#1)(2010-7#2)
spectrum peak##2##2##(2008-3#1)(2008-5#1)
spectrum phase##3##2##(2008-3#2)(2013-8#1)
spectrum profile##2##2##(2005-4#1)(2010-10#1)
spectrum ranging from##3##3##(1995-1#1)(2007-11#1)(2008-5#1)
spectrum rather than##2##3##(1996-3#1)(2008-3#1)
spectrum resolution of the##2##4##(2013-8#2)
spectrum resolution##4##2##(2013-8#4)
spectrum showed a##3##3##(1994-8#1)(2008-3#2)
spectrum shows##4##2##(1992-3#1)(1996-7#1)(2007-11#1)(2008-10#1)
spectrum similar to that of##2##5##(1993-3#1)(1994-8#1)
spectrum that is##3##3##(2008-2#1)(2008-3#1)(2011-2#1)
spectrum that was##2##3##(1994-11#1)(1997-7#1)
spectrum that##14##2##(1991-2#1)(1994-11#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2010-5#1)(2011-2#1)
spectrum they##2##2##(1995-10#1)(2008-1#1)
spectrum to a##2##3##(2008-3#1)(2012-12#1)
spectrum to##8##2##(1991-2#1)(1995-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2011-2#1)(2012-12#1)
spectrum typical of##2##3##(1990-12#1)(2008-10#1)
spectrum using##3##2##(2008-10#1)(2010-8#1)(2012-1#1)
spectrum was observed##2##3##(1996-12#1)(2007-12#1)
spectrum was obtained##2##3##(1997-6#1)(2006-12#1)
spectrum was used to##3##4##(2007-12#1)(2008-10#1)(2012-3#1)
spectrum was##22##2##(1991-7#1)(1994-8#1)(1995-11#1)(1996-12#1)(1997-6#1)(2006-12#1)(2007-11#2)(2007-12#4)(2008-10#6)(2008-2#1)(2012-3#1)(2013-8#2)
spectrum were##6##2##(1994-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2013-8#1)
spectrum when the##2##3##(2007-11#1)(2008-10#1)
spectrum when##3##2##(1991-2#1)(2007-11#1)(2008-10#1)
spectrum which##3##2##(1996-2#1)(2010-11#1)(2010-5#1)
spectrum with a maximum at##2##5##(1993-6#1)(2008-10#1)
spectrum with a##6##3##(1993-6#1)(2007-12#3)(2008-10#1)(2009-10#1)
spectrum with the##4##3##(2005-4#1)(2008-3#1)(2011-1#1)(2013-8#1)
spectrum with##18##2##(1990-8#1)(1993-6#1)(2005-11#1)(2005-4#2)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-3#2)(2009-10#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
spectrum without##2##2##(1992-4#1)(2007-11#1)
spectrum##1570##1##(1990-10#1)(1990-12#6)(1990-2#5)(1990-3#11)(1990-4#7)(1990-5#8)(1990-6#2)(1990-7#3)(1990-8#6)(1991-1#3)(1991-12#4)(1991-2#11)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#8)(1991-8#4)(1991-9#4)(1992-1#1)(1992-11#4)(1992-12#3)(1992-2#4)(1992-3#10)(1992-4#4)(1992-5#4)(1992-6#4)(1992-7#4)(1992-8#3)(1992-9#4)(1993-11#11)(1993-2#3)(1993-3#6)(1993-4#1)(1993-6#6)(1993-8#10)(1993-9#3)(1994-10#2)(1994-11#11)(1994-12#2)(1994-2#2)(1994-3#4)(1994-5#8)(1994-6#6)(1994-7#1)(1994-8#9)(1994-9#1)(1995-1#6)(1995-10#4)(1995-11#6)(1995-12#3)(1995-2#3)(1995-3#3)(1995-4#1)(1995-5#7)(1995-6#1)(1995-8#2)(1995-9#2)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#8)(1996-2#6)(1996-3#2)(1996-7#4)(1996-8#3)(1996-9#2)(1997-1#4)(1997-2#3)(1997-3#5)(1997-4#11)(1997-5#1)(1997-6#3)(1997-7#9)(1997-8#4)(2004-12#2)(2004-3#2)(2005-1#6)(2005-11#6)(2005-12#4)(2005-4#23)(2005-7#7)(2005-8#9)(2005-9#1)(2006-1#1)(2006-10#29)(2006-12#6)(2006-2#1)(2006-4#3)(2006-5#2)(2006-6#7)(2006-7#4)(2006-8#4)(2006-9#1)(2007-10#3)(2007-11#68)(2007-12#125)(2007-2#5)(2007-3#3)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#16)(2007-8#16)(2007-9#3)(2008-1#31)(2008-10#110)(2008-11#25)(2008-12#4)(2008-2#112)(2008-3#174)(2008-4#23)(2008-5#36)(2008-6#9)(2008-7#20)(2008-8#22)(2008-9#8)(2009-10#3)(2009-12#3)(2009-2#4)(2009-3#1)(2009-4#16)(2009-5#3)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#8)(2010-12#7)(2010-2#3)(2010-3#2)(2010-4#4)(2010-5#10)(2010-6#1)(2010-7#7)(2010-8#4)(2010-9#2)(2011-1#13)(2011-12#2)(2011-2#39)(2011-3#1)(2012-1#9)(2012-11#4)(2012-12#18)(2012-2#41)(2012-3#8)(2013-1#20)(2013-7#12)(2013-8#49)
spectrum&quot##3##1##(1990-5#1)(2012-2#2)
spectrum)##3##1##(1995-1#1)(2007-11#1)(2008-10#1)
spectrum]##4##1##(1995-11#1)(2005-4#2)(2010-6#1)
specular and##2##2##(2008-2#2)
specular component##2##2##(2008-2#1)(2008-3#1)
specular direction##5##2##(2007-11#3)(2008-3#2)
specular microscope##2##2##(2011-2#2)
specular reflectance and##2##3##(2008-2#2)
specular reflectance was also##2##4##(2008-2#2)
specular reflectance##7##2##(2008-2#6)(2008-4#1)
specular reflection and##2##3##(2008-3#2)
specular reflection##8##2##(2005-11#1)(2006-7#1)(2008-2#1)(2008-3#4)(2010-4#1)
specular reflections##2##2##(2008-2#1)(2008-3#1)
specular##40##1##(2005-11#1)(2006-5#1)(2006-7#1)(2007-11#4)(2007-9#1)(2008-2#16)(2008-3#12)(2008-4#1)(2010-4#1)(2011-2#2)
specularities##4##1##(1991-2#2)(2008-2#1)(2008-6#1)
speculate about how##2##3##(1993-5#1)(2008-10#1)
speculate about their##2##3##(1996-4#1)(2006-10#1)
speculate about##8##2##(1993-5#1)(1996-3#1)(1996-4#1)(2006-10#1)(2006-5#1)(2008-10#1)(2011-2#1)(2012-2#1)
speculate as to the##2##4##(2006-10#1)(2007-11#1)
speculate on the possible##3##4##(2007-12#1)(2008-11#1)(2010-3#1)
speculate on the potential##2##4##(2006-10#1)(2012-12#1)
speculate on the##14##3##(1990-8#1)(1991-6#1)(1995-4#1)(1996-3#1)(1997-6#1)(2006-1#1)(2006-10#1)(2007-12#1)(2008-11#1)(2009-5#1)(2010-11#1)(2010-3#1)(2012-12#1)(2012-3#1)
speculate on##21##2##(1990-8#1)(1991-6#1)(1994-1#1)(1994-2#1)(1995-4#1)(1996-3#1)(1997-6#1)(2006-1#1)(2006-10#1)(2006-4#1)(2007-12#1)(2008-11#3)(2008-3#1)(2009-5#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
speculate that an##2##3##(1990-4#1)(1995-12#1)
speculate that both##2##3##(2006-10#1)(2008-7#1)
speculate that the##11##3##(1990-11#1)(1992-12#1)(1992-3#1)(1994-2#1)(1994-5#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-4#1)(2012-1#1)
speculate that these##3##3##(1992-5#1)(2008-10#1)(2008-7#1)
speculate that this##7##3##(1994-12#1)(1996-7#1)(2005-11#1)(2008-1#1)(2008-11#1)(2010-2#1)(2012-3#1)
speculate that##51##2##(1990-11#1)(1990-4#1)(1990-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-7#1)(1997-2#1)(1997-3#1)(2005-11#3)(2006-10#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
speculate the##2##2##(1995-7#1)(2011-2#1)
speculate##91##1##(1990-11#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-5#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#2)(1994-5#1)(1995-1#1)(1995-12#1)(1995-4#1)(1995-7#1)(1995-8#1)(1996-3#2)(1996-4#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2005-11#3)(2005-7#1)(2006-1#1)(2006-10#4)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
speculated that a##3##3##(1994-6#1)(2008-9#1)(2009-6#1)
speculated that the##8##3##(1993-2#1)(1996-2#1)(1997-8#1)(2006-1#1)(2008-10#1)(2008-3#1)(2010-2#1)(2012-1#1)
speculated that this##6##3##(1990-7#1)(1991-9#1)(1992-3#1)(1995-6#1)(2008-2#2)
speculated that##43##2##(1990-11#1)(1990-7#1)(1991-9#2)(1992-3#2)(1993-2#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-1#2)(2006-10#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)
speculated to be the##3##4##(2008-3#1)(2008-5#1)(2012-2#1)
speculated to be##6##3##(1997-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-8#1)(2012-2#1)
speculated to##8##2##(1997-1#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-10#1)(2012-2#1)
speculated##56##1##(1990-11#1)(1990-7#1)(1991-9#2)(1992-3#2)(1993-2#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#2)(2005-11#1)(2006-1#2)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)
speculates on the future##2##4##(2005-7#1)(2012-2#1)
speculates on the##4##3##(2005-7#1)(2006-8#1)(2008-9#1)(2012-2#1)
speculates on##5##2##(1993-3#1)(2005-7#1)(2006-8#1)(2008-9#1)(2012-2#1)
speculation that##10##2##(1992-11#1)(1993-12#2)(1994-6#1)(1996-1#1)(1996-12#1)(1997-5#1)(2007-9#1)(2008-4#1)(2013-8#1)
speculation##20##1##(1991-8#1)(1992-11#1)(1993-12#2)(1993-5#1)(1994-6#1)(1996-1#1)(1996-12#2)(1997-5#1)(1997-8#1)(2007-9#1)(2008-11#1)(2008-4#2)(2009-8#1)(2009-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
speculations about##3##2##(1992-3#1)(1996-9#1)(2012-2#1)
speculations##7##1##(1992-3#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-12#1)(2012-2#1)
speculative and##2##2##(2008-11#1)(2012-2#1)
speculative model##2##2##(1995-11#1)(2009-8#1)
speculative##22##1##(1990-11#1)(1992-2#1)(1995-11#1)(2006-10#2)(2006-11#1)(2006-2#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-3#1)(2009-8#1)(2010-5#1)(2012-2#1)(2013-1#3)(2013-7#1)
speculum##2##1##(2007-7#1)(2013-8#1)
speech and compared##2##3##(2007-10#1)(2010-2#1)
speech and language disorder##2##4##(1995-1#2)
speech and language disturbances##4##4##(2007-8#4)
speech and language##14##3##(1995-1#3)(2007-8#5)(2008-9#3)(2011-1#1)(2011-2#1)(2012-3#1)
speech and phonological awareness##2##4##(2011-1#2)
speech and swallowing##3##3##(2008-10#2)(2012-2#1)
speech and##35##2##(1993-9#1)(1995-1#3)(2006-3#1)(2007-10#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-10#2)(2008-9#4)(2009-2#1)(2010-12#1)(2010-2#1)(2011-1#7)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#1)
speech are##2##2##(2007-10#1)(2007-7#1)
speech at##3##2##(1994-1#1)(2008-2#1)(2010-2#1)
speech control##2##2##(2008-2#2)
speech development##2##2##(1995-10#1)(2007-3#1)
speech discrimination##3##2##(2008-9#1)(2012-2#1)(2013-1#1)
speech disturbance##3##2##(2007-10#2)(2009-3#1)
speech enhancement##3##2##(2007-11#2)(2008-2#1)
speech for the##2##3##(2006-4#1)(2012-12#1)
speech for##3##2##(2006-4#1)(2008-2#1)(2012-12#1)
speech in##8##2##(2006-3#1)(2007-10#1)(2008-11#1)(2009-10#1)(2009-5#1)(2011-1#3)
speech intelligibility##2##2##(2008-9#2)
speech is##3##2##(2008-4#1)(2011-12#1)(2012-2#1)
speech language pathologists##2##3##(2007-10#1)(2012-2#1)
speech of##9##2##(2007-9#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-10#2)(2011-2#1)(2012-12#1)(2013-8#1)
speech on##2##2##(2011-1#1)(2012-12#1)
speech or##2##2##(2007-12#1)(2009-5#1)
speech perception and production##2##4##(2008-11#1)(2008-4#1)
speech perception and##3##3##(2008-11#1)(2008-4#1)(2008-9#1)
speech perception in adult##2##4##(2008-9#2)
speech perception in##3##3##(2008-9#2)(2012-2#1)
speech perception performance in##3##4##(2008-9#1)(2012-2#2)
speech perception performance##7##3##(2008-9#5)(2012-2#2)
speech perception scores##2##3##(2008-9#2)
speech perception##31##2##(2008-11#2)(2008-4#1)(2008-9#20)(2009-2#1)(2009-9#1)(2010-12#1)(2012-2#5)
speech performance##2##2##(2008-9#2)
speech problems##2##2##(2011-2#1)(2012-2#1)
speech processing##4##2##(1993-9#1)(2006-2#1)(2008-9#2)
speech processor##13##2##(2007-3#1)(2008-9#12)
speech processors##2##2##(2008-9#2)
speech production and##2##3##(2008-9#1)(2012-12#1)
speech production##11##2##(2007-10#1)(2008-4#1)(2008-9#6)(2011-1#2)(2012-12#1)
speech rate##5##2##(2008-2#1)(2008-4#1)(2009-11#3)
speech recognition for##2##3##(2007-7#1)(2008-9#1)
speech recognition in noise##2##4##(2008-9#2)
speech recognition in##4##3##(2007-7#1)(2008-9#3)
speech recognition system##2##3##(2004-9#2)
speech recognition##22##2##(2004-9#4)(2007-12#1)(2007-7#5)(2008-2#3)(2008-9#9)
speech segregation##2##2##(2008-2#2)
speech signal##4##2##(2007-7#1)(2008-2#1)(2009-2#1)(2010-2#1)
speech sounds##5##2##(1993-9#1)(2008-9#3)(2012-1#1)
speech than##2##2##(2007-11#1)(2009-10#1)
speech that##3##2##(2007-1#1)(2009-5#1)(2012-3#1)
speech therapy##4##2##(1995-1#1)(2007-10#1)(2009-7#1)(2011-2#1)
speech to##2##2##(2011-1#1)(2013-8#1)
speech was##4##2##(2007-3#1)(2007-7#1)(2009-2#1)(2011-1#1)
speech##335##1##(1990-12#1)(1990-3#1)(1990-5#1)(1991-11#4)(1991-3#1)(1992-2#1)(1993-9#3)(1994-1#3)(1994-12#1)(1994-3#1)(1995-1#4)(1995-10#1)(1995-11#2)(1995-12#1)(1996-12#1)(1997-8#1)(2004-3#1)(2004-9#4)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#2)(2006-3#7)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#13)(2007-11#6)(2007-12#5)(2007-2#1)(2007-3#3)(2007-7#12)(2007-8#5)(2007-9#2)(2008-10#8)(2008-11#4)(2008-2#22)(2008-4#10)(2008-9#80)(2009-10#12)(2009-11#3)(2009-2#5)(2009-3#1)(2009-5#3)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#7)(2010-4#1)(2010-8#1)(2011-1#27)(2011-12#1)(2011-2#5)(2012-1#6)(2012-12#8)(2012-2#16)(2012-3#4)(2013-1#3)(2013-8#5)
speech-coding##2##1##(2008-9#2)
speech-language##2##1##(2007-9#1)(2011-1#1)
speech-perception performance in##3##3##(2008-9#3)
speech-perception performance##4##2##(2008-9#4)
speech-processing##4##1##(2008-9#3)(2009-2#1)
speech-production##2##1##(2008-9#2)
speech-recognition performance##2##2##(2008-9#2)
speech-recognition technology##3##2##(2007-12#3)
speech-recognition##6##1##(2007-12#3)(2008-9#3)
speeches were##2##2##(2008-9#1)(2012-12#1)
speeches##8##1##(1997-2#1)(2006-7#1)(2008-9#1)(2010-10#1)(2011-2#2)(2012-1#1)(2012-12#1)
speed (0##2##2##(2007-10#1)(2008-10#1)
speed adaptation controller##3##3##(2012-1#3)
speed and accuracy of##4##4##(2004-10#1)(2008-11#1)(2008-3#2)
speed and accuracy##11##3##(1996-3#1)(2004-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2009-12#1)(2011-2#1)(2013-1#2)
speed and direction##4##3##(2007-12#1)(2008-10#1)(2008-5#1)(2010-5#1)
speed and ease of##2##4##(2006-10#1)(2009-9#1)
speed and ease##4##3##(2006-10#1)(2008-11#1)(2009-9#1)(2011-2#1)
speed and is##2##3##(2008-10#1)(2011-1#1)
speed and memory##2##3##(2008-2#1)(2008-3#1)
speed and precision##3##3##(2008-2#1)(2010-2#1)(2010-3#1)
speed and resolution##3##3##(2008-7#1)(2008-9#1)(2011-7#1)
speed and simplicity makes##2##4##(2005-4#1)(2009-4#1)
speed and simplicity##4##3##(2005-4#1)(2007-12#1)(2008-11#1)(2009-4#1)
speed and the##5##3##(1992-6#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-9#1)
speed and time##6##3##(2008-10#1)(2008-5#5)
speed and##87##2##(1990-5#1)(1991-12#1)(1992-6#1)(1993-6#1)(1995-6#1)(1996-12#1)(1996-3#2)(1996-6#1)(1997-5#1)(2004-10#1)(2005-4#1)(2005-7#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#3)(2008-10#7)(2008-11#4)(2008-2#5)(2008-3#9)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2011-1#2)(2011-2#3)(2011-7#1)(2012-1#3)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
speed are##2##2##(1995-10#1)(1997-2#1)
speed as well##2##3##(1994-3#1)(2010-8#1)
speed at which##2##3##(2007-8#1)(2012-1#1)
speed at##3##2##(2007-8#1)(2008-3#1)(2012-1#1)
speed because##2##2##(2007-12#1)(2008-2#1)
speed change (r(2)##2##3##(2007-1#2)
speed change of##3##3##(2007-1#1)(2007-4#2)
speed change##9##2##(2007-1#7)(2007-4#2)
speed decreases##4##2##(2007-11#1)(2009-6#3)
speed during##4##2##(2008-7#1)(2010-8#1)(2012-12#2)
speed for##3##2##(2008-10#1)(2008-8#1)(2010-8#1)
speed from##2##2##(1992-6#1)(2008-2#1)
speed in a##2##3##(1994-8#1)(2008-3#1)
speed in the##7##3##(1993-12#1)(2007-12#1)(2008-12#2)(2008-2#2)(2010-8#1)
speed in##21##2##(1993-12#1)(1994-8#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-7#1)(2010-2#1)(2010-8#3)(2011-2#1)(2012-1#1)(2013-1#2)
speed increases##2##2##(2008-2#1)(2008-3#1)
speed is not##3##3##(2007-10#1)(2008-2#1)(2013-8#1)
speed is required##2##3##(2008-3#2)
speed is##13##2##(1990-4#1)(1995-2#1)(2006-4#1)(2007-10#1)(2007-12#1)(2008-2#2)(2008-3#4)(2009-11#1)(2013-8#1)
speed limit##2##2##(2012-1#1)(2013-1#1)
speed measured##2##2##(2007-12#1)(2012-1#1)
speed of 0##4##3##(2006-8#1)(2008-12#1)(2012-1#1)(2013-1#1)
speed of 2##2##3##(2008-3#1)(2010-12#1)
speed of 5##3##3##(2007-4#1)(2008-12#1)(2008-3#1)
speed of about##2##3##(2008-10#1)(2008-6#1)
speed of analysis##4##3##(2006-12#1)(2008-10#2)(2008-9#1)
speed of convergence##2##3##(2008-2#2)
speed of germination##2##3##(2004-2#1)(2008-10#1)
speed of light##2##3##(2007-9#1)(2008-2#1)
speed of post mortem##2##4##(1996-9#2)
speed of propagation of the##2##5##(2007-11#1)(2008-1#1)
speed of propagation of##4##4##(2007-11#1)(2008-1#1)(2008-5#2)
speed of sound##8##3##(2008-2#3)(2008-3#5)
speed of the##23##3##(1990-12#1)(1993-8#2)(1994-2#1)(1995-8#1)(1997-5#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-2#4)(2008-3#1)(2008-6#1)(2008-9#1)(2009-6#1)(2011-2#2)(2012-1#1)(2012-2#1)
speed of transmission##2##3##(2006-6#1)(2008-9#1)
speed of##135##2##(1990-12#1)(1990-3#1)(1992-10#1)(1992-2#2)(1993-12#3)(1993-2#1)(1993-8#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-6#2)(1995-8#1)(1996-9#2)(1997-5#1)(1997-7#1)(2004-10#2)(2004-2#2)(2004-4#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#6)(2007-12#5)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#12)(2008-12#3)(2008-2#16)(2008-3#15)(2008-4#1)(2008-5#5)(2008-6#2)(2008-8#1)(2008-9#4)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-3#2)(2010-8#2)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#4)(2013-1#3)
speed on##3##2##(1994-8#1)(2008-1#1)(2008-7#1)
speed over the##2##3##(2008-2#2)
speed the##2##2##(1990-4#1)(2010-7#1)
speed to##7##2##(1991-3#1)(1992-6#1)(1997-6#1)(2008-10#1)(2009-4#1)(2010-2#1)(2012-1#1)
speed up the search##2##4##(2008-2#1)(2010-2#1)
speed up the##10##3##(1997-2#1)(2006-2#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#1)(2010-2#1)
speed up##20##2##(1990-11#1)(1992-8#1)(1994-9#1)(1997-2#1)(2006-2#2)(2007-2#1)(2008-10#4)(2008-2#2)(2008-3#5)(2008-7#1)(2010-2#1)
speed varies with##2##3##(2008-1#1)(2010-8#1)
speed was observed##2##3##(2004-11#1)(2008-10#1)
speed was##7##2##(2004-11#1)(2008-10#2)(2008-3#1)(2011-1#1)(2013-1#2)
speed were##5##2##(2008-12#2)(2008-2#1)(2008-3#1)(2011-2#1)
speed with##9##2##(1991-10#1)(1993-2#1)(2007-12#1)(2007-9#1)(2008-3#1)(2008-5#1)(2010-12#1)(2012-12#1)(2013-7#1)
speed##616##1##(1990-11#3)(1990-12#1)(1990-3#3)(1990-4#2)(1990-5#1)(1990-6#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#2)(1991-5#1)(1992-10#1)(1992-2#2)(1992-3#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#10)(1993-2#2)(1993-6#1)(1993-8#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#8)(1994-9#1)(1995-1#4)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#4)(1995-8#1)(1996-12#2)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#4)(1997-1#1)(1997-2#3)(1997-4#2)(1997-5#3)(1997-6#3)(1997-7#1)(2004-10#3)(2004-11#1)(2004-2#2)(2004-4#1)(2005-11#2)(2005-12#1)(2005-4#1)(2005-7#1)(2006-10#4)(2006-11#6)(2006-12#2)(2006-2#2)(2006-4#1)(2006-6#3)(2006-8#1)(2006-9#2)(2007-1#10)(2007-10#11)(2007-11#14)(2007-12#21)(2007-2#2)(2007-3#1)(2007-4#6)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#11)(2008-1#13)(2008-10#54)(2008-11#8)(2008-12#7)(2008-2#55)(2008-3#57)(2008-4#12)(2008-5#17)(2008-6#7)(2008-7#11)(2008-8#9)(2008-9#7)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-4#2)(2009-5#1)(2009-6#5)(2009-7#2)(2009-9#2)(2010-1#2)(2010-10#2)(2010-12#3)(2010-2#9)(2010-3#5)(2010-4#1)(2010-5#4)(2010-7#1)(2010-8#13)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#15)(2011-7#2)(2012-1#20)(2012-11#1)(2012-12#10)(2012-2#7)(2012-3#1)(2013-1#20)(2013-7#1)(2013-8#4)
speed&quot##3##1##(2007-9#1)(2008-5#1)(2009-1#1)
speed-up##2##1##(2009-5#1)(2012-12#1)
speeded up##3##2##(1997-2#1)(2005-10#1)(2007-1#1)
speeded##5##1##(1997-2#1)(2005-10#1)(2007-1#1)(2009-10#1)(2009-4#1)
speeding up the##2##3##(2010-7#1)(2013-1#1)
speeding##5##1##(2005-11#1)(2005-7#1)(2010-7#1)(2013-1#2)
speeds and high##2##3##(2007-11#1)(2012-1#1)
speeds and##8##2##(1990-4#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2012-1#1)
speeds are##2##2##(1996-12#1)(2008-4#1)
speeds for##3##2##(1996-9#1)(2008-2#1)(2009-2#1)
speeds in##2##2##(2007-12#1)(2012-12#1)
speeds of 0##2##3##(2007-10#1)(2008-11#1)
speeds of the##3##3##(1996-12#1)(2008-1#1)(2009-5#1)
speeds of##13##2##(1993-9#1)(1996-12#1)(1996-9#1)(2007-10#2)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-5#1)(2012-1#1)
speeds revealed differences from##2##4##(1997-2#2)
speeds up the##4##3##(1993-6#1)(2006-12#1)(2007-5#1)(2008-3#1)
speeds up##5##2##(1993-6#1)(2006-12#1)(2007-5#1)(2008-3#1)(2012-2#1)
speeds when##2##2##(2012-12#2)
speeds##92##1##(1990-4#2)(1992-12#1)(1993-6#1)(1993-7#2)(1993-9#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-12#2)(1996-9#5)(1997-2#3)(1997-8#1)(2006-11#2)(2006-12#1)(2007-1#1)(2007-10#8)(2007-11#2)(2007-12#3)(2007-4#4)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-2#6)(2008-3#11)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-5#2)(2010-5#1)(2011-2#1)(2012-1#5)(2012-12#4)(2012-2#1)(2013-1#2)
speedup of##3##2##(2008-2#2)(2012-12#1)
speedup##9##1##(2007-9#2)(2008-2#2)(2008-6#1)(2012-12#1)(2012-2#3)
speedups##2##1##(2010-2#1)(2012-2#1)
speedy and accurate##2##3##(2008-3#1)(2010-8#1)
speedy and##3##2##(2007-8#1)(2008-3#1)(2010-8#1)
speedy##13##1##(1996-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2010-6#1)(2010-7#1)(2010-8#1)(2012-12#1)(2013-1#1)
spell##5##1##(2008-10#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-4#1)
spelled##2##1##(2008-12#1)(2009-7#1)
spelling and decoding abilities##2##4##(2012-12#2)
spelling and punctuation##2##3##(2012-1#2)
spelling and##4##2##(2012-1#2)(2012-12#2)
spelling correction##2##2##(2007-12#2)
spelling errors##2##2##(2012-3#2)
spelling of##3##2##(2008-4#1)(2009-7#2)
spelling out##2##2##(2008-2#1)(2008-9#1)
spelling performance##3##2##(2009-7#3)
spelling##36##1##(1990-8#1)(2007-12#2)(2007-9#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#2)(2009-2#3)(2009-7#11)(2011-1#2)(2012-1#2)(2012-12#2)(2012-3#2)(2013-1#2)
spelling)##2##1##(1996-7#1)(2012-3#1)
spellings##2##1##(2009-7#1)(2012-3#1)
spells and##2##2##(1990-8#1)(1991-6#1)
spells of##2##2##(2008-9#1)(2012-3#1)
spells##6##1##(1990-8#1)(1991-6#1)(2004-3#1)(2006-11#1)(2008-9#1)(2012-3#1)
spelt##3##1##(2006-8#2)(2008-10#1)
speltoides##9##1##(2008-10#9)
spend a##2##2##(1996-12#1)(2011-2#1)
spend compared to##2##3##(2009-4#2)
spend less##3##2##(1992-3#1)(1992-5#1)(2008-2#1)
spend more time in##2##4##(2008-7#1)(2012-2#1)
spend more time##10##3##(1993-1#1)(1996-9#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-2#2)(2013-8#1)
spend more##12##2##(1993-1#1)(1994-2#1)(1996-9#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-2#2)(2013-7#1)(2013-8#1)
spend on##4##2##(1990-2#2)(1995-6#1)(2009-4#1)
spend the##3##2##(2007-3#1)(2007-9#1)(2008-7#1)
spend their##2##2##(1997-1#1)(2009-10#1)
spend##59##1##(1990-2#2)(1991-2#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-1#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-9#1)(1997-1#1)(2005-7#1)(2005-8#1)(2006-7#1)(2007-3#1)(2007-9#3)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#5)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#5)(2011-2#4)(2012-2#2)(2013-7#1)(2013-8#2)
spend-down##2##1##(1994-2#2)
spenders in##2##2##(2010-2#2)
spending and service use##2##4##(2010-2#2)
spending and##9##2##(1992-3#1)(1993-3#1)(1995-1#1)(1996-1#1)(2008-11#1)(2010-2#2)(2010-5#1)(2012-3#1)
spending between##2##2##(1997-3#1)(2010-8#1)
spending bill##2##2##(1996-5#1)(2007-9#1)
spending by state##2##3##(1995-12#1)(1997-3#1)
spending by##5##2##(1992-3#1)(1994-1#2)(1995-12#1)(1997-3#1)
spending continues to##2##3##(1990-12#1)(1995-3#1)
spending for##8##2##(1990-12#1)(1991-2#3)(1995-3#1)(1997-1#2)(1997-3#1)
spending growth##2##2##(1993-1#1)(1996-2#1)
spending in Brazil##2##3##(2008-9#2)
spending in the##2##3##(1992-12#1)(1995-3#1)
spending in##7##2##(1992-12#1)(1995-3#1)(2008-10#1)(2008-9#2)(2013-1#2)
spending increasing amounts of##2##4##(1994-2#1)(2012-1#1)
spending is##3##2##(1990-12#1)(2012-3#1)(2013-8#1)
spending more time##5##3##(2008-11#1)(2009-8#1)(2010-2#1)(2011-1#1)(2012-12#1)
spending more##6##2##(1991-3#1)(2008-11#1)(2009-8#1)(2010-2#1)(2011-1#1)(2012-12#1)
spending on health##2##3##(1992-2#1)(1996-8#1)
spending on##6##2##(1991-12#1)(1992-2#1)(1996-8#1)(2007-8#1)(2010-5#2)
spending per capita##2##3##(1994-1#1)(2008-7#1)
spending per##3##2##(1994-1#1)(1996-3#1)(2008-7#1)
spending the##3##2##(1990-8#1)(1995-12#1)(2012-2#1)
spending time##4##2##(1991-2#2)(2009-9#1)(2010-2#1)
spending to##3##2##(1995-3#1)(1996-1#1)(2010-11#1)
spending##151##1##(1990-12#3)(1990-8#1)(1991-12#2)(1991-2#6)(1991-3#2)(1991-4#1)(1992-11#1)(1992-12#2)(1992-2#7)(1992-3#5)(1993-1#1)(1993-2#1)(1993-3#3)(1994-1#9)(1994-10#1)(1994-12#1)(1994-2#3)(1994-3#1)(1995-1#5)(1995-12#4)(1995-2#2)(1995-3#4)(1995-6#1)(1996-1#2)(1996-2#4)(1996-3#2)(1996-5#2)(1996-8#1)(1997-1#3)(1997-2#4)(1997-3#6)(2005-9#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#1)(2008-11#10)(2008-4#1)(2008-7#2)(2008-9#3)(2009-8#1)(2009-9#1)(2010-11#7)(2010-2#5)(2010-5#4)(2010-8#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#1)
spends##6##1##(1990-2#1)(1990-5#1)(1991-2#2)(1996-3#1)(2007-4#1)
spent CAPD fluids by##2##4##(2008-10#2)
spent CAPD fluids##4##3##(2008-10#4)
spent CAPD##5##2##(2008-10#5)
spent a##3##2##(1991-12#1)(1993-7#1)(2004-1#1)
spent an##2##2##(2008-5#1)(2008-7#1)
spent as##2##2##(2005-11#1)(2006-8#1)
spent at##2##2##(1992-4#1)(1996-8#1)
spent between##2##2##(2006-2#1)(2007-2#1)
spent by photons inside a##2##5##(2007-12#2)
spent by##4##2##(1995-4#1)(2007-12#2)(2008-2#1)
spent each year on##2##4##(2007-9#1)(2010-3#1)
spent in hospital##2##3##(2007-11#1)(2013-1#1)
spent in the##7##3##(1992-8#1)(1993-2#1)(1995-5#1)(1996-10#1)(2008-9#1)(2011-2#2)
spent in##29##2##(1990-5#1)(1992-8#1)(1993-2#1)(1995-5#1)(1996-1#1)(1996-10#2)(1997-4#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-7#1)(2011-1#1)(2011-2#5)(2013-1#4)
spent ion exchange##2##3##(2008-10#2)
spent less##2##2##(1993-6#1)(2008-5#1)
spent male and female buffalo meat##2##6##(2010-4#2)
spent male and##3##3##(2010-4#3)
spent male##4##2##(2010-4#4)
spent medium was##3##3##(1994-5#1)(2008-11#2)
spent medium##6##2##(1994-5#2)(1995-1#1)(2008-11#3)
spent more time in##3##4##(2009-7#3)
spent more time##12##3##(1994-2#1)(2008-5#1)(2009-11#1)(2009-7#4)(2009-9#2)(2010-2#1)(2010-4#1)(2012-3#1)
spent more##13##2##(1994-2#1)(2006-8#1)(2008-5#1)(2009-11#1)(2009-7#4)(2009-9#2)(2010-2#1)(2010-4#1)(2012-3#1)
spent much##2##2##(2007-8#1)(2008-11#1)
spent on the##5##3##(1992-4#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-5#1)
spent on##27##2##(1990-2#1)(1992-2#1)(1992-4#1)(1993-12#1)(1993-3#1)(1993-9#2)(1994-12#1)(1995-11#2)(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#1)(2005-7#1)(2006-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-4#1)(2010-12#1)(2011-2#1)(2013-1#3)
spent pot liners##2##3##(2009-6#2)
spent pot##3##2##(2009-6#3)
spent their##2##2##(2008-12#1)(2011-2#1)
spent to##3##2##(1997-3#1)(2006-8#1)(2008-8#1)
spent with##2##2##(2007-1#1)(2010-8#1)
spent##197##1##(1990-2#1)(1990-3#2)(1990-5#1)(1991-12#2)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-12#2)(1994-2#1)(1994-5#4)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#3)(1995-4#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-10#2)(1996-11#1)(1996-2#3)(1996-3#1)(1996-8#1)(1997-2#4)(1997-3#3)(1997-4#1)(2004-1#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-5#1)(2006-8#5)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#2)(2009-6#4)(2009-7#5)(2009-9#3)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#6)(2010-8#5)(2011-1#1)(2011-2#10)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#11)(2013-7#1)
spent-sulfidic caustic##3##2##(2008-6#3)
sperm DNA is##3##3##(1990-11#1)(1993-6#1)(2008-9#1)
sperm DNA##20##2##(1990-11#2)(1993-6#1)(1997-1#1)(2008-10#12)(2008-3#1)(2008-4#1)(2008-9#2)
sperm abnormalities##4##2##(2008-3#4)
sperm acrosome reaction##5##3##(1992-8#1)(2006-5#1)(2008-4#1)(2008-8#2)
sperm acrosome##8##2##(1992-8#1)(1995-6#1)(2006-5#1)(2008-4#1)(2008-8#4)
sperm allocation##4##2##(2013-1#4)
sperm and microbes##2##3##(1996-9#2)
sperm and oocyte##3##3##(2012-12#3)
sperm and##18##2##(1992-7#1)(1995-6#1)(1996-9#3)(1997-4#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-12#3)(2012-2#2)
sperm antigen##2##2##(1997-4#1)(2008-8#1)
sperm are##8##2##(1992-1#1)(1992-8#2)(1994-8#1)(2005-7#1)(2007-12#1)(2008-8#2)
sperm binding to ZP and##2##5##(2013-1#2)
sperm binding to##3##3##(1995-6#1)(2013-1#2)
sperm binding##5##2##(1995-6#2)(2006-5#1)(2013-1#2)
sperm bundles in the duplex##2##5##(2008-5#2)
sperm bundles##4##2##(2007-12#1)(2008-5#3)
sperm by a##3##3##(1997-6#1)(1997-8#1)(2008-4#1)
sperm by##4##2##(1990-9#1)(1997-6#1)(1997-8#1)(2008-4#1)
sperm can be##2##3##(2006-5#1)(2007-12#1)
sperm can##5##2##(1994-5#1)(1994-8#1)(2006-5#1)(2007-12#2)
sperm cell##8##2##(1993-6#1)(2006-5#2)(2007-12#4)(2008-12#1)
sperm cells and##2##3##(2008-12#2)
sperm cells for##2##3##(2006-10#1)(2006-5#1)
sperm cells from##2##3##(1997-4#1)(2010-4#1)
sperm cells in##2##3##(2007-12#1)(2008-12#1)
sperm cells of##2##3##(2007-12#1)(2008-8#1)
sperm cells were##5##3##(1997-4#1)(2008-12#4)
sperm cells##28##2##(1993-6#3)(1994-5#1)(1997-4#2)(1997-6#3)(2006-10#1)(2006-5#1)(2007-12#3)(2008-12#9)(2008-8#1)(2009-8#1)(2010-4#1)(2012-2#1)(2013-8#1)
sperm chromatin condensation##4##3##(2012-3#1)(2013-8#3)
sperm chromatin##12##2##(1990-7#1)(1992-1#1)(1992-5#3)(2009-5#1)(2012-2#1)(2012-3#1)(2013-8#4)
sperm competition##12##2##(2006-5#2)(2008-6#1)(2008-8#4)(2009-6#2)(2013-1#3)
sperm concentration and##2##3##(2008-7#1)(2008-8#1)
sperm concentration##7##2##(2006-5#1)(2008-5#1)(2008-7#2)(2008-8#1)(2013-8#2)
sperm count and motility##5##4##(2008-10#2)(2008-5#1)(2010-4#1)(2011-2#1)
sperm count and##9##3##(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2010-4#1)(2011-2#2)(2012-12#1)
sperm count##11##2##(2008-10#2)(2008-4#1)(2008-5#2)(2008-6#1)(2010-4#1)(2011-2#3)(2012-12#1)
sperm counts##5##2##(2008-5#2)(2008-6#2)(2009-5#1)
sperm cryopreservation##2##2##(2010-7#1)(2012-3#1)
sperm decondensation##2##2##(1992-5#2)
sperm density##6##2##(2008-3#2)(2008-5#4)
sperm development##3##2##(1991-5#1)(2012-2#2)
sperm flagella##5##2##(1991-2#2)(1995-6#1)(2007-12#1)(2007-9#1)
sperm flagellum##2##2##(2007-9#1)(2008-7#1)
sperm from the##2##3##(1993-7#1)(2008-6#1)
sperm from##10##2##(1993-7#1)(1995-11#1)(1996-11#1)(1997-4#1)(1997-6#1)(2007-12#2)(2008-6#1)(2012-12#2)
sperm function in vitro##3##4##(2006-5#2)(2009-6#1)
sperm function##4##2##(2006-5#2)(2009-6#2)
sperm functions##2##2##(2009-6#1)(2013-8#1)
sperm head length##2##3##(2010-8#2)
sperm head shape abnormality test##2##5##(1992-5#2)
sperm head shape abnormality##4##4##(1992-5#4)
sperm head##13##2##(1992-5#4)(1994-8#1)(2006-5#1)(2008-10#1)(2008-4#1)(2009-5#1)(2010-8#2)(2011-2#1)(2012-2#1)
sperm in the##2##3##(1997-4#1)(2008-6#1)
sperm in##8##2##(1994-5#1)(1997-4#1)(1997-5#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)
sperm injection (ICSI)##6##3##(2006-10#1)(2006-2#1)(2009-6#1)(2010-12#1)(2012-12#1)(2012-3#1)
sperm injection##12##2##(2006-10#5)(2006-2#1)(2009-5#1)(2009-6#1)(2010-12#1)(2012-12#1)(2012-3#2)
sperm insemination##2##2##(1996-9#1)(2012-3#1)
sperm investment##4##2##(2009-6#4)
sperm is##2##2##(1994-8#1)(2009-2#1)
sperm limitation and polyspermy##2##4##(2008-8#2)
sperm limitation##4##2##(2008-8#4)
sperm mGC##2##2##(2008-5#2)
sperm maturation and##2##3##(1997-6#1)(2011-1#1)
sperm maturation##4##2##(1997-6#2)(2011-1#2)
sperm may acquire new membrane-bound##2##5##(1997-6#1)(1997-8#1)
sperm may##3##2##(1990-10#1)(1997-6#1)(1997-8#1)
sperm membrane integrity##2##3##(2006-5#2)
sperm morphology##9##2##(2008-12#1)(2008-3#1)(2008-5#4)(2008-7#1)(2009-6#1)(2013-8#1)
sperm morphometry##2##2##(2010-8#2)
sperm motility and##4##3##(1993-9#1)(2007-11#1)(2010-4#1)(2013-8#1)
sperm motility as well as##2##5##(2006-5#1)(2008-3#1)
sperm motility was##2##3##(1992-7#1)(2006-5#1)
sperm motility##27##2##(1992-7#3)(1993-9#2)(1996-5#1)(2006-5#4)(2007-11#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-5#4)(2008-7#3)(2009-5#1)(2009-6#1)(2010-4#1)(2010-8#1)(2012-12#1)(2013-8#1)
sperm movement##6##2##(2007-12#1)(2008-12#1)(2008-5#4)
sperm nuclear matrix##4##3##(1990-11#4)
sperm nuclear##5##2##(1990-11#5)
sperm nuclei##3##2##(1990-9#1)(1992-1#1)(2007-9#1)
sperm nucleus##3##2##(2008-7#1)(2009-5#1)(2012-2#1)
sperm of##5##2##(1994-12#1)(1997-5#1)(2007-12#1)(2008-4#1)(2008-8#1)
sperm parameters##6##2##(2008-12#3)(2010-8#1)(2012-2#2)
sperm penetration##5##2##(2006-5#3)(2013-1#2)
sperm precedence##5##2##(2008-5#1)(2008-8#2)(2012-12#2)
sperm production##7##2##(1992-12#2)(1994-8#1)(2008-5#2)(2009-10#1)(2012-2#1)
sperm protein##5##2##(1994-3#1)(2007-12#2)(2007-8#1)(2012-3#1)
sperm quality and##3##3##(2008-12#1)(2009-10#1)(2011-1#1)
sperm quality##12##2##(1992-12#4)(1996-6#1)(2006-5#1)(2008-12#1)(2009-10#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
sperm release##3##2##(2008-5#1)(2008-8#1)(2009-10#1)
sperm retrieval##2##2##(2011-2#1)(2012-12#1)
sperm storage and##2##3##(2007-12#2)
sperm storage organs##5##3##(2007-12#5)
sperm storage##10##2##(2007-12#8)(2008-6#1)(2008-7#1)
sperm stored##4##2##(2008-8#2)(2012-12#2)
sperm surface##2##2##(1995-5#1)(1995-6#1)
sperm tail##3##2##(1994-12#1)(2007-9#1)(2008-7#1)
sperm that##2##2##(2007-8#1)(2008-9#1)
sperm to##4##2##(2008-5#1)(2008-8#1)(2009-2#1)(2013-1#1)
sperm transfer and storage##2##4##(2007-12#2)
sperm transfer##3##2##(1995-2#1)(2007-12#2)
sperm ultrastructure of##2##3##(2008-7#2)
sperm velocity and sperm longevity##2##5##(2010-8#2)
sperm velocity##3##2##(2010-8#3)
sperm viability and##4##3##(2006-5#1)(2008-12#1)(2009-5#1)(2009-6#1)
sperm viability in##2##3##(2006-5#1)(2010-8#1)
sperm viability##10##2##(2006-5#2)(2008-12#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-8#4)
sperm was##8##2##(1992-7#1)(1994-12#1)(1997-4#1)(2008-4#1)(2008-5#2)(2009-5#1)(2012-1#1)
sperm were alive##2##3##(2008-12#2)
sperm were##8##2##(1992-7#1)(2006-5#1)(2007-5#1)(2008-12#4)(2008-4#1)
sperm whale myoglobin##6##3##(1993-11#1)(1993-3#2)(1993-6#2)(1994-5#1)
sperm whale##10##2##(1993-11#1)(1993-3#2)(1993-6#3)(1994-5#2)(1995-2#1)(1995-3#1)
sperm when stimulated with##2##4##(2008-8#2)
sperm##608##1##(1990-10#4)(1990-11#10)(1990-12#1)(1990-2#4)(1990-5#1)(1990-7#3)(1990-8#1)(1990-9#4)(1991-11#2)(1991-2#3)(1991-5#1)(1991-8#5)(1992-1#3)(1992-12#6)(1992-5#9)(1992-7#8)(1992-8#6)(1993-11#1)(1993-3#2)(1993-6#8)(1993-7#2)(1993-9#2)(1994-12#5)(1994-3#2)(1994-5#5)(1994-6#3)(1994-8#9)(1995-10#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#12)(1996-11#1)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#6)(1997-1#1)(1997-4#9)(1997-5#2)(1997-6#11)(1997-8#4)(2005-7#1)(2006-10#8)(2006-2#1)(2006-5#36)(2007-11#3)(2007-12#41)(2007-3#2)(2007-5#1)(2007-8#4)(2007-9#8)(2008-10#15)(2008-11#1)(2008-12#30)(2008-3#15)(2008-4#15)(2008-5#38)(2008-6#10)(2008-7#17)(2008-8#37)(2008-9#9)(2009-10#4)(2009-2#3)(2009-3#1)(2009-5#8)(2009-6#16)(2009-8#1)(2010-12#1)(2010-4#3)(2010-7#3)(2010-8#20)(2011-1#6)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#19)(2012-2#21)(2012-3#7)(2013-1#16)(2013-8#11)
sperm)##3##1##(1997-8#1)(2006-5#1)(2008-8#1)
sperm-ZP interactions##3##2##(2013-1#3)
sperm-egg membrane fusion##2##3##(2008-8#2)
sperm-egg membrane##3##2##(1994-3#1)(2008-8#2)
sperm-egg##8##1##(1994-3#1)(1995-10#1)(1995-6#1)(2008-6#1)(2008-8#4)
sperm-oocyte adhesion##3##2##(2012-2#3)
sperm-oocyte fusion as##2##3##(2012-12#2)
sperm-oocyte##8##1##(1995-6#1)(2006-5#1)(2012-12#3)(2012-2#3)
sperm-specific##3##1##(1992-5#1)(1997-4#1)(2012-2#1)
sperm-zona pellucida binding##3##3##(2006-5#3)
sperm-zona pellucida##5##2##(1997-4#1)(2006-5#3)(2013-1#1)
spermatheca and##3##2##(2007-12#1)(2008-6#1)(2009-3#1)
spermatheca is##3##2##(2007-12#1)(2012-12#2)
spermatheca##22##1##(2007-12#2)(2008-5#1)(2008-6#5)(2008-8#1)(2009-3#1)(2012-12#12)
spermathecae and##2##2##(2007-12#2)
spermathecae##12##1##(2007-12#5)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#2)
spermathecal ducts##4##2##(2007-12#2)(2008-8#2)
spermathecal sperm##3##2##(2008-8#3)
spermathecal##11##1##(2007-12#3)(2008-5#3)(2008-8#5)
spermatia##2##1##(2008-10#2)
spermatic cord torsion##5##3##(2006-10#2)(2008-10#3)
spermatic cord##12##2##(2006-10#2)(2006-7#1)(2007-7#1)(2008-10#4)(2008-6#4)
spermatic cysts##2##2##(2007-3#2)
spermatic##27##1##(1990-9#2)(1994-5#1)(2006-10#3)(2006-2#1)(2006-7#1)(2007-3#2)(2007-5#1)(2007-7#1)(2008-10#4)(2008-5#1)(2008-6#4)(2008-7#4)(2009-5#1)(2012-2#1)
spermatid differentiation##3##2##(2008-7#2)(2012-12#1)
spermatid nuclei##4##2##(1991-9#1)(2012-12#2)(2012-2#1)
spermatid##18##1##(1991-9#2)(1996-8#1)(2008-7#4)(2009-12#1)(2012-12#3)(2012-2#7)
spermatids and spermatozoa##4##3##(1996-8#1)(2008-5#1)(2008-7#1)(2012-2#1)
spermatids and##6##2##(1991-2#1)(1996-8#1)(2008-5#1)(2008-7#2)(2012-2#1)
spermatids of##3##2##(1992-7#2)(2007-12#1)
spermatids that##2##2##(2008-7#1)(2012-2#1)
spermatids which##2##2##(2006-5#1)(2012-2#1)
spermatids##45##1##(1990-11#1)(1990-9#1)(1991-2#2)(1991-9#1)(1992-12#1)(1992-5#2)(1992-7#2)(1993-7#1)(1994-11#1)(1996-8#1)(2006-5#4)(2007-12#2)(2008-1#1)(2008-3#1)(2008-5#2)(2008-7#5)(2008-9#1)(2009-10#4)(2012-12#4)(2012-2#6)(2013-1#1)(2013-8#1)
spermatids) and##2##2##(2007-9#1)(2012-12#1)
spermatids)##3##1##(2006-5#1)(2007-9#1)(2012-12#1)
spermatocidal##2##1##(1990-10#1)(1990-11#1)
spermatocystes##2##1##(2008-12#2)
spermatocyte##7##1##(2008-7#1)(2009-10#3)(2011-2#1)(2012-12#1)(2012-2#1)
spermatocytes and##10##2##(1992-5#1)(1993-7#1)(2008-3#1)(2009-10#2)(2010-5#1)(2012-12#2)(2012-2#2)
spermatocytes by##2##2##(2008-5#1)(2012-2#1)
spermatocytes of##2##2##(2006-5#1)(2009-7#1)
spermatocytes were##3##2##(2006-5#1)(2008-4#1)(2008-5#1)
spermatocytes##44##1##(1990-10#1)(1990-11#2)(1992-2#1)(1992-5#1)(1993-7#1)(2006-5#6)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#2)(2009-10#3)(2009-7#1)(2010-5#2)(2012-12#4)(2012-2#11)(2013-1#1)
spermatocytogenesis##2##1##(2006-5#2)
spermatodesm##2##1##(2008-7#2)
spermatodesms##5##1##(2008-7#5)
spermatogenesis and in##3##3##(1990-8#1)(2008-8#1)(2012-2#1)
spermatogenesis and male fertility##2##4##(2009-10#1)(2012-2#1)
spermatogenesis and spermiogenesis##2##3##(1992-3#1)(2011-1#1)
spermatogenesis and to##2##3##(2006-5#1)(2009-10#1)
spermatogenesis and##18##2##(1990-8#1)(1992-3#1)(1995-8#1)(2006-5#1)(2007-12#3)(2007-9#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#2)(2011-1#1)(2012-2#4)
spermatogenesis are##6##2##(1992-3#1)(2009-10#1)(2010-5#1)(2012-2#3)
spermatogenesis by##4##2##(2008-4#1)(2010-11#1)(2012-2#2)
spermatogenesis during the##2##3##(2007-12#1)(2008-7#1)
spermatogenesis in the##5##3##(1996-8#1)(2006-5#1)(2010-5#1)(2012-2#1)(2013-7#1)
spermatogenesis in##9##2##(1996-8#1)(2006-5#1)(2009-7#1)(2010-5#1)(2012-2#4)(2013-7#1)
spermatogenesis or##2##2##(1992-12#1)(2010-12#1)
spermatogenesis which##2##2##(2006-5#1)(2008-3#1)
spermatogenesis##141##1##(1990-8#3)(1992-12#4)(1992-3#2)(1992-5#1)(1993-12#2)(1993-7#2)(1995-11#2)(1995-8#1)(1996-2#1)(1996-8#1)(1997-1#1)(2006-5#8)(2007-12#9)(2007-3#1)(2007-9#3)(2008-10#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#7)(2008-8#1)(2008-9#1)(2009-10#18)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#4)(2011-1#1)(2012-1#1)(2012-12#4)(2012-2#44)(2012-3#1)(2013-7#1)(2013-8#4)
spermatogenic cells and atresia of developing oocytes##2##7##(2012-2#2)
spermatogenic cells##12##2##(1990-11#3)(1992-7#1)(2008-5#3)(2009-10#1)(2012-2#4)
spermatogenic cycle##2##2##(2006-5#1)(2007-9#1)
spermatogenic##29##1##(1990-11#3)(1992-7#1)(2006-5#1)(2007-9#1)(2008-10#1)(2008-4#3)(2008-5#4)(2008-9#1)(2009-10#3)(2012-2#11)
spermatogonia and Sertoli cells##2##4##(2007-9#1)(2009-10#1)
spermatogonia and##7##2##(2007-9#1)(2008-5#2)(2008-9#1)(2009-10#1)(2013-1#1)(2013-7#1)
spermatogonia##26##1##(2007-9#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-10#5)(2009-7#1)(2010-5#2)(2012-2#9)(2013-1#2)(2013-7#1)
spermatogonial and spermatocyte##2##3##(2009-10#1)(2011-2#1)
spermatogonial stem cell##2##3##(2012-2#2)
spermatogonial stem cells##2##3##(2009-10#1)(2012-2#1)
spermatogonial stem##4##2##(2009-10#1)(2012-2#3)
spermatogonial##13##1##(2008-7#2)(2009-10#2)(2011-2#1)(2012-2#8)
spermatological##2##1##(2008-7#2)
spermatology##3##1##(2007-12#2)(2008-7#1)
spermatophore weight##2##2##(2008-5#2)
spermatophore were##2##2##(2008-5#2)
spermatophore##8##1##(2008-5#6)(2008-7#2)
spermatophores##3##1##(2008-5#3)
spermatozoa after##3##2##(2006-5#2)(2008-8#1)
spermatozoa against##2##2##(2006-5#1)(2013-8#1)
spermatozoa and fertility in mating trials and biochemical parameters of reproductive organs##3##12##(2008-3#1)(2008-5#2)
spermatozoa and fertility in mating##5##5##(2008-3#1)(2008-5#4)
spermatozoa and that##2##3##(2006-5#1)(2013-8#1)
spermatozoa and##13##2##(1996-8#1)(1997-8#1)(2006-5#3)(2008-3#1)(2008-5#4)(2008-8#1)(2010-8#1)(2013-8#1)
spermatozoa are##5##2##(2006-5#2)(2007-12#1)(2010-7#1)(2012-2#1)
spermatozoa by the##2##3##(2006-5#1)(2013-8#1)
spermatozoa by##3##2##(1993-9#1)(2006-5#1)(2013-8#1)
spermatozoa could be##3##3##(1993-11#1)(2006-5#1)(2012-12#1)
spermatozoa during the##2##3##(1995-10#1)(2007-9#1)
spermatozoa during their transit##2##4##(1996-8#1)(2008-7#1)
spermatozoa during##7##2##(1995-10#1)(1996-8#1)(2007-12#1)(2007-9#1)(2008-7#1)(2011-1#2)
spermatozoa from 3 different##2##4##(2006-5#1)(2011-1#1)
spermatozoa from##6##2##(2006-5#2)(2007-12#1)(2008-12#1)(2011-1#1)(2013-1#1)
spermatozoa in vitro##3##3##(1993-11#2)(2008-8#1)
spermatozoa in##8##2##(1993-11#2)(1993-9#1)(1994-5#1)(1996-5#1)(2006-5#1)(2008-8#1)(2010-2#1)
spermatozoa is##2##2##(2007-12#1)(2008-6#1)
spermatozoa obtained##2##2##(1996-9#1)(2011-2#1)
spermatozoa of all the species##3##5##(2007-12#2)(2008-7#1)
spermatozoa of the rove beetle Aleochara bilineata##2##7##(2008-7#2)
spermatozoa of the rove beetle Aleochara##3##6##(2007-12#1)(2008-7#2)
spermatozoa of the##6##3##(2007-12#1)(2008-7#4)(2010-8#1)
spermatozoa of##17##2##(2007-12#5)(2008-7#8)(2008-8#1)(2010-8#1)(2011-12#1)(2013-8#1)
spermatozoa on##2##2##(2009-4#1)(2012-3#1)
spermatozoa retrieval##2##2##(2011-2#1)(2012-12#1)
spermatozoa stored in the##3##4##(2008-7#3)
spermatozoa that##2##2##(2006-5#1)(2008-7#1)
spermatozoa to##4##2##(2006-5#1)(2011-1#1)(2013-1#2)
spermatozoa using##2##2##(2006-5#2)
spermatozoa were incubated##2##3##(2010-8#2)
spermatozoa were##12##2##(1995-6#1)(2006-5#2)(2007-9#1)(2008-12#1)(2008-8#2)(2010-7#1)(2010-8#2)(2012-12#1)(2013-8#1)
spermatozoa with##3##2##(2007-9#1)(2008-8#1)(2011-1#1)
spermatozoa##209##1##(1991-2#1)(1991-6#1)(1992-4#1)(1993-11#5)(1993-7#2)(1993-9#2)(1994-2#1)(1994-5#2)(1995-10#2)(1995-6#2)(1996-5#1)(1996-8#3)(1996-9#1)(1997-8#1)(2006-5#52)(2007-12#14)(2007-9#3)(2008-10#1)(2008-12#3)(2008-3#1)(2008-4#4)(2008-5#8)(2008-6#1)(2008-7#25)(2008-8#10)(2009-10#3)(2009-4#1)(2010-2#1)(2010-5#1)(2010-7#4)(2010-8#6)(2011-1#7)(2011-12#4)(2011-2#6)(2012-12#6)(2012-2#6)(2012-3#5)(2013-1#6)(2013-8#6)
spermatozoal function##2##2##(2011-1#2)
spermatozoal##8##1##(2006-5#2)(2008-7#1)(2008-9#1)(2010-4#1)(2011-1#3)
spermatozoan production is##2##3##(2006-5#2)
spermatozoan production##3##2##(2006-5#3)
spermatozoon of##2##2##(1990-10#1)(2008-7#1)
spermatozoon##12##1##(1990-10#3)(2006-5#1)(2007-12#2)(2008-7#4)(2008-8#2)
spermiation and BTB restructuring##2##4##(2012-2#2)
spermiation and##4##2##(2007-3#1)(2012-2#3)
spermiation##12##1##(2007-3#2)(2012-2#10)
spermidine (Spd)##2##2##(1997-8#1)(2010-12#1)
spermidine and putrescine##2##3##(1996-12#1)(2008-8#1)
spermidine and spermine##8##3##(1991-7#1)(1992-11#1)(1996-7#1)(2008-10#2)(2008-8#1)(2009-8#1)(2010-4#1)
spermidine and spermine)##2##3##(1991-5#1)(2009-8#1)
spermidine and##16##2##(1991-5#1)(1991-7#1)(1992-11#1)(1996-12#1)(1996-7#1)(2008-10#4)(2008-8#2)(2009-6#2)(2009-8#2)(2010-4#1)
spermidine as##2##2##(1995-2#1)(2009-8#1)
spermidine importer##2##2##(2009-6#2)
spermidine synthase##2##2##(2009-8#1)(2013-8#1)
spermidine was##3##2##(1991-10#1)(1995-2#2)
spermidine##55##1##(1990-10#3)(1990-4#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-9#3)(1993-12#1)(1995-2#4)(1995-3#1)(1996-10#1)(1996-12#1)(1996-7#2)(1997-6#1)(1997-8#1)(2005-11#1)(2006-10#2)(2007-8#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-8#4)(2009-6#4)(2009-8#4)(2010-12#1)(2010-4#2)(2013-8#2)
spermidine/spermine N1-acetyltransferase (SSAT)##2##3##(1992-10#1)(1995-2#1)
spermidine/spermine N1-acetyltransferase##7##2##(1991-9#2)(1992-10#2)(1994-12#1)(1995-2#2)
spermine (Spm)##2##2##(1997-8#1)(2010-12#1)
spermine analogue N1##2##3##(1990-10#1)(1991-7#1)
spermine and other polyamines##2##4##(1991-4#1)(1993-12#1)
spermine and##7##2##(1990-7#1)(1991-10#1)(1991-4#1)(1991-5#1)(1993-12#2)(1995-2#1)
spermine in the##3##3##(1990-10#1)(1990-3#2)
spermine in##4##2##(1990-10#1)(1990-3#3)
spermine to##3##2##(1990-10#1)(1992-4#1)(1996-2#1)
spermine uptake##2##2##(1994-8#2)
spermine was##2##2##(1994-8#1)(2008-10#1)
spermine##78##1##(1990-10#4)(1990-3#6)(1990-7#4)(1991-10#1)(1991-12#1)(1991-4#1)(1991-5#3)(1991-7#3)(1991-8#1)(1992-11#5)(1992-12#1)(1992-4#1)(1993-12#3)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-7#1)(1994-8#5)(1995-2#1)(1996-12#1)(1996-2#3)(1996-7#1)(1997-4#2)(1997-6#1)(1997-8#1)(2007-8#2)(2008-10#5)(2008-8#10)(2009-8#4)(2010-12#1)(2010-4#2)
spermine)##6##1##(1991-5#1)(1994-9#1)(1996-7#2)(2008-10#1)(2009-8#1)
spermiogenesis and spermiation##3##3##(2012-2#3)
spermiogenesis and##6##2##(2007-12#2)(2012-2#4)
spermiogenesis in two##2##3##(2007-12#1)(2008-7#1)
spermiogenesis in##4##2##(2007-12#1)(2008-7#2)(2012-12#1)
spermiogenesis##33##1##(1990-11#1)(1991-9#1)(1992-3#1)(1992-7#1)(2006-5#1)(2007-12#6)(2008-7#4)(2008-9#1)(2011-1#1)(2012-12#6)(2012-2#10)
spermiograms##4##1##(2006-10#4)
spermogonia##4##1##(2008-10#4)
sperms are##2##2##(2007-12#1)(2008-8#1)
sperms##16##1##(1994-6#1)(2007-12#2)(2008-8#2)(2008-9#3)(2009-5#4)(2009-6#2)(2012-2#1)(2013-8#1)
spf mice##5##2##(1992-4#5)
spf##6##1##(1992-4#6)
sph-SiON is stable##2##3##(2013-8#2)
sph-SiON##4##1##(2013-8#4)
sphaericus 2362 in##2##3##(2004-11#2)
sphaericus against##2##2##(2004-11#2)
sphaericus in##2##2##(1996-7#1)(2004-11#1)
sphaericus was##2##2##(2004-11#1)(2008-6#1)
sphaericus##18##1##(1994-6#2)(1996-7#2)(2004-11#8)(2008-10#1)(2008-6#5)
sphaeroides reaction##2##2##(1992-6#1)(1993-11#1)
sphaeroides were##2##2##(1993-11#1)(2008-8#1)
sphaeroides##25##1##(1991-3#1)(1991-4#1)(1992-6#2)(1993-11#4)(1995-2#1)(1995-8#1)(2005-11#1)(2007-12#3)(2008-10#2)(2008-8#4)(2008-9#2)(2010-2#3)
sphagnum peat mix##2##3##(2008-10#2)
sphagnum peat##4##2##(2008-10#4)
spheno-clival region##3##2##(2011-2#3)
sphenoid bone##3##2##(2006-12#1)(2007-6#1)(2008-10#1)
sphenoid ridge##2##2##(2008-7#2)
sphenoid sinus and##2##3##(2011-2#1)(2012-3#1)
sphenoid sinus##12##2##(1990-9#1)(1993-12#1)(2005-9#1)(2008-7#3)(2011-2#3)(2012-3#3)
sphenoid##27##1##(1990-9#1)(1993-12#1)(2005-9#1)(2006-12#4)(2007-6#3)(2007-7#1)(2008-10#3)(2008-7#5)(2011-2#4)(2012-3#3)(2013-1#1)
sphenoidal##3##1##(1991-11#1)(1993-5#1)(2006-12#1)
sphenopalatine ganglion block##4##3##(2006-7#3)(2012-1#1)
sphenopalatine ganglion##6##2##(2006-11#1)(2006-7#4)(2012-1#1)
sphenopalatine##13##1##(2006-11#3)(2006-7#5)(2008-8#1)(2009-10#3)(2012-1#1)
sphenoparietal sinus##4##2##(1996-9#4)
sphere and##6##2##(1991-7#1)(2007-12#1)(2008-2#3)(2008-3#1)
sphere complex##2##2##(1991-7#2)
sphere complexes##2##2##(1991-7#1)(2008-5#1)
sphere for##2##2##(2007-12#1)(2008-3#1)
sphere in an##2##3##(2007-12#1)(2008-3#1)
sphere in the##2##3##(1996-8#1)(2008-3#1)
sphere in##5##2##(1996-8#1)(2007-12#1)(2008-2#1)(2008-3#2)
sphere into a##2##3##(1996-8#1)(2008-2#1)
sphere of the##5##3##(1993-6#1)(1996-7#1)(1997-7#1)(2008-10#1)(2010-5#1)
sphere of##16##2##(1990-7#1)(1991-6#1)(1993-6#1)(1994-11#1)(1996-2#1)(1996-7#1)(1997-7#1)(2006-9#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-2#1)(2009-4#1)(2010-5#1)
sphere radius##2##2##(2007-12#1)(2008-2#1)
sphere size##2##2##(2008-3#2)
sphere suspensions##3##2##(2007-12#1)(2008-3#2)
sphere template##2##2##(2010-4#2)
sphere##139##1##(1990-12#1)(1990-3#1)(1990-7#1)(1991-6#3)(1991-7#4)(1991-8#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-2#2)(1995-11#1)(1996-2#2)(1996-7#1)(1996-8#2)(1997-7#1)(2005-11#6)(2006-12#1)(2006-3#1)(2006-9#1)(2007-11#2)(2007-12#15)(2007-8#1)(2008-10#3)(2008-2#26)(2008-3#29)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-2#1)(2009-4#3)(2009-7#2)(2010-12#1)(2010-2#1)(2010-4#6)(2010-5#1)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
sphere's##2##1##(2006-12#1)(2013-1#1)
spheres and##16##2##(2005-11#1)(2007-11#1)(2007-12#1)(2008-2#5)(2008-3#5)(2008-7#1)(2010-7#1)(2012-12#1)
spheres are##5##2##(1997-7#1)(2007-11#1)(2008-3#2)(2012-11#1)
spheres can##2##2##(2008-2#1)(2008-3#1)
spheres coated with##2##3##(2005-11#2)
spheres containing##3##2##(2008-11#2)(2008-3#1)
spheres in the##2##3##(2008-2#2)
spheres in water##2##3##(2005-11#1)(2007-11#1)
spheres in##10##2##(2005-11#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#2)
spheres is##3##2##(2005-11#1)(2008-2#1)(2008-3#1)
spheres of##11##2##(2005-11#3)(2006-4#1)(2008-11#2)(2008-3#1)(2008-7#1)(2010-5#2)(2011-2#1)
spheres that##5##2##(2005-11#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
spheres to##2##2##(2010-4#1)(2012-11#1)
spheres upon a silicon##2##4##(2007-12#2)
spheres was##2##2##(1994-2#2)
spheres were##2##2##(2008-4#1)(2009-4#1)
spheres with a##2##3##(2008-3#2)
spheres with the##2##3##(2008-3#2)
spheres with##11##2##(1994-8#1)(2007-8#1)(2008-2#3)(2008-3#6)
spheres##174##1##(1990-12#1)(1990-2#2)(1994-12#1)(1994-2#5)(1994-8#1)(1995-5#2)(1997-7#1)(2005-11#19)(2006-2#3)(2006-4#2)(2006-7#1)(2007-11#8)(2007-12#13)(2007-8#4)(2007-9#1)(2008-11#7)(2008-2#31)(2008-3#49)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-11#1)(2009-4#2)(2010-12#1)(2010-4#6)(2010-5#2)(2010-7#1)(2011-2#2)(2012-11#2)(2012-12#1)
spheres)##2##1##(2007-12#2)
spheric##3##1##(2006-6#1)(2008-2#1)(2008-5#1)
spherical aberration and coma##2##4##(2007-12#1)(2008-3#1)
spherical aberration and##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
spherical aberration is##4##3##(2005-11#1)(2007-12#2)(2008-2#1)
spherical aberration of the##3##4##(2008-2#2)(2008-3#1)
spherical aberration of##6##3##(2007-12#1)(2008-2#3)(2008-3#2)
spherical aberration on the##2##4##(2008-2#1)(2008-3#1)
spherical aberration on##5##3##(2008-2#2)(2008-3#2)(2009-4#1)
spherical aberration##49##2##(2005-11#2)(2007-12#7)(2008-2#17)(2008-3#19)(2009-4#3)(2009-5#1)
spherical aberrations##5##2##(2008-2#3)(2008-3#2)
spherical aggregates##2##2##(1993-7#1)(2008-11#1)
spherical and aspheric##2##3##(2005-11#2)
spherical and cylindrical##5##3##(2005-11#2)(2007-12#1)(2007-9#1)(2008-2#1)
spherical and linear contact distributions and K-functions##2##7##(2008-2#2)
spherical and toroidal##2##3##(2008-2#1)(2008-3#1)
spherical and##22##2##(1990-3#1)(1991-9#1)(2005-11#4)(2006-12#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-2#8)(2008-3#2)(2010-4#1)
spherical beads##2##2##(2008-11#1)(2013-1#1)
spherical bioparticle##3##2##(2008-6#1)(2008-7#2)
spherical cavity##3##2##(2005-11#1)(2007-12#1)(2008-1#1)
spherical ceramic##2##2##(2010-11#2)
spherical colloidal##3##2##(2005-11#3)
spherical coordinates##2##2##(2008-2#1)(2008-3#1)
spherical counterparts##2##2##(2008-7#1)(2012-11#1)
spherical drop##2##2##(2008-10#2)
spherical end##2##2##(2008-10#2)
spherical holographic gratings in a modified##2##6##(2008-3#2)
spherical holographic gratings##5##3##(2008-2#2)(2008-3#3)
spherical illumination##4##2##(2008-2#4)
spherical in shape##4##3##(2005-11#1)(2008-2#1)(2008-5#1)(2010-1#1)
spherical inhomogeneity##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
spherical interference##3##2##(2008-3#3)
spherical macroporous epoxy-dicyandiamide chelating resin##2##5##(2008-10#2)
spherical micelles in##2##3##(1994-2#1)(2008-10#1)
spherical micelles##5##2##(1994-2#1)(2008-10#3)(2008-12#1)
spherical microcavities##3##2##(2007-12#3)
spherical microparticles##2##2##(2007-11#2)
spherical mirror##12##2##(2007-12#2)(2008-2#4)(2008-3#6)
spherical mirrors are##3##3##(2008-2#1)(2008-3#2)
spherical mirrors##8##2##(2008-2#2)(2008-3#6)
spherical morphology##2##2##(1993-12#1)(2013-1#1)
spherical multicellular aggregates (spheroids)##2##4##(2008-11#2)
spherical object##3##2##(2008-2#1)(2008-3#1)(2009-12#1)
spherical or##6##2##(1997-8#1)(2005-11#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-2#1)
spherical particle##10##2##(2008-2#5)(2008-3#4)(2011-2#1)
spherical particles in##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
spherical particles of##4##3##(2005-11#2)(2006-8#1)(2008-3#1)
spherical particles with##2##3##(2008-3#1)(2008-7#1)
spherical particles##19##2##(2005-11#5)(2006-8#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#6)(2008-7#2)
spherical precipitates with an average radius of##2##7##(2009-5#2)
spherical primary##3##2##(2008-3#3)
spherical shape and##2##3##(2007-8#1)(2010-12#1)
spherical shape##9##2##(2005-11#2)(2007-8#1)(2008-10#1)(2008-2#2)(2009-5#1)(2010-12#1)(2011-2#1)
spherical shell##2##2##(2007-9#1)(2010-4#1)
spherical silica particles##6##3##(2005-11#5)(2008-5#1)
spherical silica##7##2##(2005-11#5)(2008-5#1)(2010-4#1)
spherical structure of##2##3##(2005-11#1)(2010-12#1)
spherical structure##3##2##(2005-11#2)(2010-12#1)
spherical surface##8##2##(1993-4#1)(2008-2#1)(2008-3#5)(2008-7#1)
spherical surfaces and##3##3##(2008-2#1)(2008-3#2)
spherical surfaces##5##2##(2008-2#1)(2008-3#4)
spherical symmetry##2##2##(2008-3#2)
spherical variable-line-spaced grating##2##3##(2008-3#2)
spherical variable-line-spaced##3##2##(2008-3#3)
spherical varied-line-space##3##2##(2008-2#1)(2008-3#2)
spherical vesicles##4##2##(1990-2#2)(1997-2#1)(2008-10#1)
spherical virus##5##2##(2008-10#4)(2013-8#1)
spherical wave##6##2##(2007-12#2)(2008-2#1)(2008-3#3)
spherical waves##3##2##(2007-12#3)
spherical##388##1##(1990-2#2)(1990-3#1)(1990-5#1)(1990-8#3)(1991-11#1)(1991-9#1)(1992-12#2)(1992-5#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-7#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-8#1)(2005-11#38)(2006-10#1)(2006-12#3)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#7)(2007-12#33)(2007-3#1)(2007-5#1)(2007-8#2)(2007-9#4)(2008-1#3)(2008-10#19)(2008-11#5)(2008-12#2)(2008-2#76)(2008-3#101)(2008-5#2)(2008-6#1)(2008-7#8)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#5)(2009-5#4)(2009-7#2)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-4#3)(2010-9#1)(2011-1#1)(2011-2#6)(2012-11#6)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#4)
spherical-grating monochromators##2##2##(2006-4#1)(2008-3#1)
sphericality##2##1##(1994-4#2)
spherically curved##2##2##(2008-2#2)
spherically symmetric##3##2##(2008-2#1)(2008-3#1)(2008-5#1)
spherically##9##1##(2008-11#1)(2008-2#5)(2008-3#2)(2008-5#1)
sphericity##12##1##(2007-12#2)(2008-2#6)(2008-3#1)(2009-4#2)(2010-5#1)
sphering##3##1##(2008-2#3)
spherochromatism##3##1##(2008-3#3)
spheroid assay##2##2##(2013-1#2)
spheroid culture##4##2##(2008-11#4)
spheroid cultures##2##2##(2008-11#2)
spheroid formation##2##2##(2008-11#1)(2012-12#1)
spheroid with##2##2##(2008-3#1)(2012-11#1)
spheroid##36##1##(1995-1#3)(1997-1#2)(2005-11#1)(2007-3#1)(2007-9#1)(2008-11#11)(2008-2#4)(2008-3#4)(2010-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2013-1#3)
spheroidal coordinates##4##2##(2007-12#1)(2008-2#3)
spheroidal particle##2##2##(2008-2#1)(2008-3#1)
spheroidal particles##4##2##(2008-2#3)(2008-3#1)
spheroidal shape##2##2##(2008-2#2)
spheroidal##19##1##(1992-8#1)(2007-11#2)(2007-12#1)(2008-2#11)(2008-3#3)(2008-7#1)
spheroidene##2##1##(2010-2#2)
spheroids and##5##2##(1994-11#1)(1997-4#1)(2007-12#1)(2008-11#1)(2012-2#1)
spheroids are##2##2##(2008-11#1)(2008-3#1)
spheroids disaggregated after 1 week##2##5##(1992-9#2)
spheroids disaggregated##4##2##(1992-9#4)
spheroids formed##2##2##(2008-11#2)
spheroids of##3##2##(1995-12#1)(2008-11#1)(2008-2#1)
spheroids on a##2##3##(2008-11#2)
spheroids were##3##2##(1995-1#1)(2008-11#2)
spheroids with##5##2##(2008-3#5)
spheroids##66##1##(1991-6#1)(1992-9#6)(1994-11#1)(1995-1#3)(1995-12#2)(1997-4#3)(2006-12#1)(2007-12#2)(2007-9#1)(2008-11#22)(2008-2#2)(2008-3#8)(2008-5#1)(2011-2#3)(2012-11#1)(2012-12#5)(2012-2#4)
spheroplasts##8##1##(1990-8#1)(1992-7#3)(2008-4#2)(2009-8#1)(2012-2#1)
spherule recovered from##2##3##(2008-10#2)
spherules found##2##2##(1991-3#2)
spherules##7##1##(1991-3#5)(1991-9#2)
spherulites##2##1##(2005-11#2)
sphincter and##3##2##(1990-3#1)(1993-12#1)(2013-8#1)
sphincter apparatus##2##2##(2008-8#2)
sphincter dysfunction##4##2##(2006-2#2)(2007-5#1)(2012-12#1)
sphincter mechanism##2##2##(1996-11#2)
sphincter of Oddi and##2##4##(2006-6#1)(2008-3#1)
sphincter of Oddi dysfunction##2##4##(2006-2#1)(2007-5#1)
sphincter of Oddi##6##3##(2006-2#1)(2006-6#2)(2007-5#1)(2008-3#1)(2010-12#1)
sphincter preserving##3##2##(2007-4#1)(2008-8#2)
sphincter##76##1##(1990-3#1)(1990-9#1)(1992-10#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-2#1)(1994-4#1)(1995-5#2)(1996-11#2)(1996-9#1)(2005-1#1)(2006-10#5)(2006-2#4)(2006-6#2)(2006-9#3)(2007-12#1)(2007-4#1)(2007-5#2)(2008-10#3)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#4)(2010-12#2)(2010-6#1)(2011-1#3)(2011-2#18)(2012-12#1)(2012-3#4)(2013-8#4)
sphincterectomy##2##1##(1990-3#1)(1991-10#1)
sphincteroplasty##6##1##(1995-4#3)(2007-5#1)(2008-3#1)(2011-1#1)
sphincterotome##2##1##(2009-8#1)(2010-12#1)
sphincterotomy should be##2##3##(2007-5#1)(2013-1#1)
sphincterotomy was##2##2##(2007-8#2)
sphincterotomy##23##1##(1990-2#1)(1990-3#4)(1991-3#1)(1993-2#1)(1993-5#1)(2006-2#3)(2007-3#1)(2007-5#1)(2007-8#4)(2008-5#2)(2010-12#1)(2011-2#2)(2013-1#1)
sphincters##2##1##(1990-6#1)(2006-2#1)
sphinganine##7##1##(1992-1#2)(1992-11#3)(2008-10#1)(2008-5#1)
sphingoid bases##2##2##(2008-5#2)
sphingoid##7##1##(1990-5#1)(1990-7#1)(1992-11#1)(1996-3#2)(2008-5#2)
sphingolipid metabolism in##2##3##(2008-5#1)(2009-9#1)
sphingolipid metabolism##4##2##(2008-5#2)(2009-9#2)
sphingolipid metabolite##3##2##(2005-7#2)(2009-10#1)
sphingolipid##22##1##(1991-4#1)(1993-9#1)(1994-12#1)(1995-1#1)(1995-8#1)(1997-3#1)(1997-7#1)(2005-7#2)(2008-10#1)(2008-5#4)(2008-8#4)(2009-10#1)(2009-9#2)(2010-5#1)
sphingolipids##11##1##(1992-11#2)(1994-12#1)(1994-6#1)(1996-11#1)(1996-3#2)(1997-7#1)(2008-5#2)(2009-12#1)
sphingomyelin (SM)##2##2##(1990-5#1)(1994-12#1)
sphingomyelin (SPM)##2##2##(2008-10#1)(2012-2#1)
sphingomyelin and##3##2##(1992-6#1)(1997-1#1)(1997-8#1)
sphingomyelin##42##1##(1990-5#1)(1991-9#1)(1992-10#1)(1992-6#1)(1992-9#1)(1993-3#2)(1993-8#1)(1993-9#3)(1994-12#3)(1994-3#2)(1994-5#3)(1995-12#2)(1995-6#2)(1995-8#1)(1996-2#1)(1996-8#2)(1997-1#1)(1997-6#1)(1997-7#4)(1997-8#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-5#2)(2008-7#1)(2012-2#2)
sphingomyelin/cholesterol##2##1##(1997-7#2)
sphingomyelinase activity##3##2##(1992-6#1)(1996-5#2)
sphingomyelinase and##3##2##(1996-5#1)(2009-9#1)(2013-1#1)
sphingomyelinase##20##1##(1991-9#2)(1992-6#3)(1995-12#2)(1995-6#1)(1996-5#7)(2008-6#1)(2008-8#1)(2009-9#1)(2013-1#2)
sphingomyeline##3##1##(2012-2#1)(2013-1#2)
sphingosine 1-phosphate##3##2##(2010-7#3)
sphingosine and ceramide##3##3##(1992-3#3)
sphingosine and##9##2##(1990-10#1)(1990-11#1)(1992-11#1)(1992-3#3)(1992-6#1)(1997-5#1)(2008-5#1)
sphingosine as a##2##3##(1990-10#2)
sphingosine inhibited##2##2##(1990-10#2)
sphingosine is a##2##3##(1992-6#1)(2010-7#1)
sphingosine is##3##2##(1992-11#1)(1992-6#1)(2010-7#1)
sphingosine levels were##2##3##(1992-8#1)(1994-3#1)
sphingosine levels##3##2##(1992-8#1)(1994-3#2)
sphingosine on##2##2##(1990-10#1)(1994-3#1)
sphingosine or##2##2##(1990-10#1)(2010-7#1)
sphingosine production##3##2##(1994-3#3)
sphingosine treatment##2##2##(1994-3#2)
sphingosine was##3##2##(1992-3#1)(2010-7#2)
sphingosine##60##1##(1990-10#9)(1990-11#1)(1990-8#1)(1990-9#2)(1991-5#1)(1991-9#1)(1992-11#2)(1992-3#4)(1992-6#4)(1992-8#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-3#12)(1995-2#1)(1996-3#2)(1997-5#3)(2006-12#2)(2008-5#1)(2009-10#1)(2009-9#2)(2010-7#7)
sphingosine)##2##1##(2008-5#2)
sphingosine-1-phospate##2##1##(2008-5#1)(2009-9#1)
sphingosine-1-phosphate##4##1##(1997-6#1)(2009-10#1)(2009-9#2)
sphingosine-dependent##2##1##(1994-3#2)
sphingosines##2##1##(1990-5#2)
sphingosyl##2##1##(1990-5#1)(1993-9#1)
sphygmomanometer##10##1##(1990-8#1)(1991-3#1)(1992-6#1)(1993-8#2)(2007-10#1)(2008-1#1)(2008-11#1)(2008-4#1)(2012-12#1)
spi gene in##2##3##(1997-7#2)
spi gene##3##2##(1997-7#3)
spica cast##2##2##(2006-9#1)(2008-9#1)
spica##6##1##(2006-9#1)(2008-9#3)(2010-3#1)(2013-7#1)
spicata##6##1##(1990-8#1)(2008-10#1)(2008-9#2)(2012-12#2)
spice consumption##2##2##(2011-2#2)
spice##17##1##(1990-12#1)(2007-3#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)
spices and##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
spices##18##1##(1997-4#1)(2008-10#2)(2008-11#5)(2008-4#1)(2009-11#1)(2011-2#7)(2013-1#1)
spicifera##5##1##(2008-10#1)(2008-11#3)(2008-5#1)
spiculatus##2##1##(2007-11#2)
spicules in##2##2##(2008-1#1)(2008-4#1)
spicules##6##1##(1992-3#1)(2007-12#3)(2008-1#1)(2008-4#1)
spider Misumenops pallidus##2##3##(2008-5#2)
spider Nephila clavipes##4##3##(2006-12#4)
spider and##2##2##(1993-11#1)(2008-9#1)
spider bite##3##2##(2010-8#3)
spider dragline silk##4##3##(1995-8#2)(2008-7#1)(2012-2#1)
spider envenomation##2##2##(2007-12#1)(2010-8#1)
spider mite Tetranychus urticae##2##4##(2007-6#1)(2008-8#1)
spider mite##6##2##(2007-6#2)(2008-12#1)(2008-8#2)(2011-2#1)
spider mite-induced##2##2##(2007-6#2)
spider mites##3##2##(2007-6#2)(2008-12#1)
spider monkey##3##2##(2008-5#1)(2011-2#2)
spider silk proteins##2##3##(1995-8#1)(2008-7#1)
spider silk##3##2##(1995-8#1)(2008-7#2)
spider##88##1##(1990-5#2)(1993-11#2)(1993-7#1)(1995-8#5)(1996-11#2)(1996-2#1)(2006-12#10)(2006-2#1)(2007-12#16)(2007-6#7)(2008-10#1)(2008-12#2)(2008-5#5)(2008-7#4)(2008-8#2)(2008-9#5)(2009-4#2)(2009-6#2)(2009-9#3)(2010-12#1)(2010-8#6)(2011-2#3)(2012-2#2)(2012-3#2)(2013-8#1)
spiders are##2##2##(2006-12#1)(2009-9#1)
spiders##21##1##(2006-12#1)(2007-12#5)(2007-3#1)(2007-9#2)(2008-5#1)(2008-9#2)(2009-9#3)(2012-2#2)(2012-3#4)
spiders)##2##1##(2008-9#2)
spigot##2##1##(2007-12#2)
spike activity##8##2##(1990-7#2)(1995-12#1)(1996-2#1)(2006-8#1)(2008-11#3)
spike amplitude##8##2##(1996-5#1)(1996-8#1)(1997-5#2)(1997-7#3)(2008-7#1)
spike and a##2##3##(2007-12#1)(2008-8#1)
spike and##4##2##(1990-2#1)(2007-12#1)(2008-8#1)(2012-2#1)
spike burst##2##2##(1993-2#1)(2012-1#1)
spike bursts in the##2##4##(1997-2#1)(2012-1#1)
spike by##2##2##(2006-10#1)(2008-10#1)
spike characteristics##2##2##(2008-10#2)
spike component##2##2##(1990-7#2)
spike discharge##3##2##(1993-2#1)(1995-7#1)(1996-12#1)
spike discharges in##2##3##(1993-12#1)(1996-6#1)
spike firing##3##2##(1991-3#1)(1993-12#1)(1996-2#1)
spike frequency##4##2##(1994-2#1)(1997-8#1)(2007-12#1)(2008-8#1)
spike gene##5##2##(1997-3#5)
spike in##6##2##(1991-12#2)(1997-3#1)(2008-8#1)(2009-4#1)(2011-2#1)
spike of##4##2##(1993-9#1)(1994-6#1)(2008-7#2)
spike protein##3##2##(1997-3#1)(2008-5#2)
spike rate##4##2##(1995-7#1)(1996-1#2)(2008-11#1)
spike recoveries##2##2##(2008-10#1)(2013-8#1)
spike recovery##4##2##(1995-12#1)(2008-10#3)
spike responses##2##2##(1992-8#2)
spike timing##8##2##(1995-12#3)(2008-11#2)(2008-6#2)(2009-8#1)
spike train##11##2##(1991-6#2)(1996-12#1)(2008-1#1)(2008-11#3)(2009-8#3)(2013-8#1)
spike trains with##2##3##(1996-12#1)(2013-8#1)
spike trains##15##2##(1995-12#2)(1996-12#2)(2008-11#5)(2009-8#3)(2012-2#1)(2013-8#2)
spike was##5##2##(1990-7#1)(2006-10#1)(2008-10#2)(2008-3#1)
spike wave##2##2##(1990-3#1)(1992-3#1)
spike which##2##2##(1990-7#1)(1995-12#1)
spike##205##1##(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#15)(1991-12#3)(1991-3#2)(1991-6#4)(1991-8#1)(1992-3#4)(1992-8#2)(1993-12#3)(1993-2#3)(1993-9#3)(1994-2#1)(1994-6#1)(1995-12#11)(1995-7#2)(1996-1#2)(1996-10#2)(1996-12#5)(1996-2#2)(1996-5#1)(1996-6#4)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#10)(1997-5#7)(1997-6#1)(1997-7#3)(1997-8#1)(2006-10#3)(2006-8#1)(2007-12#3)(2007-8#2)(2008-1#2)(2008-10#25)(2008-11#21)(2008-12#3)(2008-2#1)(2008-3#3)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#1)(2009-12#1)(2009-4#2)(2009-7#1)(2009-8#8)(2011-2#1)(2012-1#2)(2012-2#5)(2012-3#1)(2013-7#1)(2013-8#6)
spike) and##2##2##(2008-10#2)
spike)##3##1##(2008-10#3)
spike-burst##3##1##(2008-11#3)
spike-like gold-silver alloy nanoparticles##2##4##(2007-8#2)
spike-like##5##1##(1997-1#1)(2007-8#3)(2008-10#1)
spike-wave discharges##4##2##(1993-7#4)
spike-wave##6##1##(1990-5#2)(1993-7#4)
spiked and unspiked##2##3##(2008-10#2)
spiked and##6##2##(2008-10#5)(2011-12#1)
spiked artificial##2##2##(2008-10#2)
spiked at##4##2##(1997-8#1)(2008-10#2)(2011-2#1)
spiked biological##2##2##(1996-8#1)(2008-10#1)
spiked blood from healthy volunteers (n =##2##7##(1992-8#2)
spiked commercial##2##2##(2007-8#1)(2008-10#1)
spiked environmental samples##2##3##(2008-10#1)(2011-1#1)
spiked food samples##2##3##(2007-8#1)(2011-1#1)
spiked human urine and serum##2##5##(2008-10#2)
spiked human urine and##4##4##(2008-10#4)
spiked human urine##7##3##(2008-10#6)(2010-5#1)
spiked human##12##2##(1995-3#1)(2008-10#10)(2010-5#1)
spiked in a##2##3##(2008-10#2)
spiked in the##2##3##(2007-8#1)(2008-1#1)
spiked in##8##2##(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)(2012-12#1)
spiked into##4##2##(2008-10#3)(2011-2#1)
spiked levels of 0##2##4##(2011-1#1)(2012-12#1)
spiked levels of##4##3##(2011-1#1)(2012-12#2)(2013-8#1)
spiked levels##6##2##(2011-1#3)(2012-12#2)(2013-8#1)
spiked matrices and##2##3##(2008-10#2)
spiked matrices##3##2##(2008-10#3)
spiked natural water samples##3##4##(2007-8#1)(2008-10#2)
spiked natural water##4##3##(2007-8#1)(2008-10#3)
spiked natural##6##2##(2007-8#1)(2008-10#5)
spiked oil samples##2##3##(2007-8#1)(2008-10#1)
spiked on the surface of the##2##6##(2008-10#2)
spiked plasma samples##4##3##(2008-10#4)
spiked recoveries of##3##3##(2008-10#1)(2011-1#1)(2012-12#1)
spiked recoveries##6##2##(2007-8#1)(2008-10#2)(2011-1#1)(2012-12#2)
spiked river##5##2##(2007-8#1)(2008-10#4)
spiked sample##2##2##(2008-10#1)(2008-9#1)
spiked samples are in##2##4##(2008-10#2)
spiked samples are##3##3##(2008-10#3)
spiked samples of##3##3##(2008-10#3)
spiked samples ranged##3##3##(2007-8#1)(2008-10#1)(2011-1#1)
spiked samples were over##2##4##(2008-10#2)
spiked samples were##8##3##(2008-10#8)
spiked samples##39##2##(1997-3#2)(2007-8#1)(2008-10#34)(2008-7#1)(2011-1#1)
spiked seawater samples##2##3##(2008-10#2)
spiked serum##2##2##(2008-10#2)
spiked soil##2##2##(2008-10#1)(2008-12#1)
spiked tap water##2##3##(2008-10#2)
spiked tap##4##2##(2008-10#4)
spiked to##3##2##(2008-10#3)
spiked urine samples##4##3##(1995-2#1)(2008-10#3)
spiked urine##7##2##(1995-2#1)(1996-5#1)(2008-10#5)
spiked vegetable##2##2##(2008-10#2)
spiked water and##3##3##(2008-10#3)
spiked water samples##10##3##(2007-8#1)(2008-10#9)
spiked water##15##2##(2007-8#1)(2008-10#14)
spiked with 1##2##3##(2008-10#2)
spiked with 10##2##3##(2008-10#2)
spiked with Au##2##3##(2008-10#2)
spiked with Hg(II)##2##3##(2008-10#2)
spiked with a mixture of##2##5##(2008-10#2)
spiked with a##5##3##(1996-8#2)(2008-10#3)
spiked with different concentrations of##3##5##(2007-8#1)(2008-10#2)
spiked with different##6##3##(2007-8#1)(2008-10#5)
spiked with known amounts of##4##5##(2008-10#4)
spiked with known##8##3##(2008-10#7)(2012-3#1)
spiked with the##5##3##(2007-8#1)(2008-10#3)(2012-1#1)
spiked with##84##2##(1990-12#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-10#1)(1996-6#1)(1996-8#2)(2004-4#1)(2005-12#1)(2006-3#1)(2007-8#4)(2008-10#59)(2008-11#1)(2008-2#1)(2008-5#1)(2009-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-3#1)
spiked##316##1##(1990-12#1)(1991-8#1)(1992-8#8)(1993-2#1)(1993-9#1)(1994-10#1)(1995-2#1)(1995-3#1)(1996-5#1)(1996-6#1)(1996-8#3)(1997-2#1)(1997-3#2)(1997-8#1)(2004-4#1)(2005-12#1)(2006-12#1)(2006-3#1)(2007-1#1)(2007-8#16)(2008-1#1)(2008-10#234)(2008-11#1)(2008-12#2)(2008-2#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-5#2)(2011-1#8)(2011-12#3)(2011-2#2)(2012-1#1)(2012-12#6)(2012-3#1)(2013-8#1)
spiked)##2##1##(2008-10#2)
spikelet differentiation in rice##2##4##(2008-9#2)
spikelet differentiation##4##2##(2008-9#4)
spikelet##18##1##(2006-9#2)(2007-3#2)(2008-10#4)(2008-12#1)(2008-5#1)(2008-8#4)(2008-9#4)
spikelets per##3##2##(2008-10#2)(2013-8#1)
spikelets##14##1##(2006-9#2)(2008-10#10)(2008-9#1)(2013-8#1)
spikenard##3##1##(2008-4#3)
spikes added to the##2##4##(2008-10#2)
spikes and waves##2##3##(1996-1#2)
spikes and##7##2##(1992-1#2)(1996-1#2)(1996-5#1)(1996-9#1)(2009-8#1)
spikes are##2##2##(2008-4#1)(2009-8#1)
spikes at##2##2##(2004-11#1)(2008-10#1)
spikes can##3##2##(2008-10#1)(2008-11#2)
spikes for##2##2##(1996-6#1)(2008-10#1)
spikes in the##4##3##(1990-4#1)(2007-8#1)(2008-10#1)(2008-3#1)
spikes in##11##2##(1990-4#1)(1994-10#2)(1995-2#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
spikes of##5##2##(1994-2#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-10#1)
spikes or##2##2##(1994-6#1)(2009-5#1)
spikes over##2##2##(1990-3#1)(2004-11#1)
spikes that##2##2##(2008-10#1)(2008-11#1)
spikes were localized in the medio-basal temporal lobe with##2##9##(2004-11#2)
spikes were##10##2##(1990-7#1)(1995-12#2)(1996-1#1)(2004-11#2)(2008-10#3)(2008-3#1)
spikes##95##1##(1990-3#1)(1990-4#3)(1990-7#2)(1991-5#1)(1991-6#1)(1992-1#2)(1992-3#1)(1992-7#1)(1993-2#1)(1994-10#2)(1994-2#1)(1994-3#2)(1994-6#1)(1995-12#2)(1995-2#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#4)(1996-9#1)(1997-2#2)(1997-5#3)(1997-7#1)(1997-8#1)(2004-11#6)(2006-4#3)(2007-12#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#21)(2008-11#5)(2008-2#2)(2008-3#3)(2008-4#1)(2008-8#1)(2009-5#1)(2009-8#5)(2010-8#1)(2012-4#1)
spikes) and##2##2##(2004-11#1)(2008-10#1)
spikes)##6##1##(2004-11#2)(2006-8#1)(2008-10#3)
spiking activity in##2##3##(2009-8#1)(2013-8#1)
spiking activity##6##2##(1991-3#2)(2009-8#3)(2013-8#1)
spiking and##5##2##(2008-10#4)(2008-2#1)
spiking fever##2##2##(1995-11#1)(2011-2#1)
spiking is##2##2##(2006-10#1)(2013-8#1)
spiking level##2##2##(2008-10#2)
spiking levels##5##2##(1991-8#1)(2007-8#2)(2009-3#1)(2011-1#1)
spiking neural networks##2##3##(2008-2#2)
spiking neuron models##2##3##(2008-11#2)
spiking neuron##4##2##(2008-11#3)(2013-7#1)
spiking neurons##3##2##(1991-6#1)(2008-11#1)(2008-2#1)
spiking procedure##3##2##(2008-10#3)
spiking with##4##2##(2008-10#2)(2009-5#1)(2013-7#1)
spiking##71##1##(1990-11#3)(1990-7#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1993-2#1)(1995-11#1)(2006-10#3)(2006-12#1)(2007-8#2)(2008-10#25)(2008-11#6)(2008-2#7)(2008-7#2)(2009-3#1)(2009-5#1)(2009-8#3)(2011-1#1)(2011-2#2)(2012-2#1)(2013-7#2)(2013-8#2)
spiky##2##1##(2008-1#1)(2008-2#1)
spill to##2##2##(1997-4#1)(2006-5#1)
spill##14##1##(1997-4#4)(2006-5#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2009-7#1)(2013-1#1)
spillage##6##1##(1994-9#1)(2006-12#3)(2008-11#1)(2008-2#1)
spilled on##2##2##(2008-10#1)(2008-4#1)
spilled##5##1##(2006-6#1)(2008-10#2)(2008-4#1)(2012-2#1)
spillover effects##4##2##(2009-4#1)(2009-8#3)
spillover of##2##2##(1997-8#1)(2008-4#1)
spillover##13##1##(1997-7#1)(1997-8#3)(2005-10#1)(2008-4#1)(2009-4#1)(2009-8#3)(2010-2#2)(2010-7#1)
spillovers##2##1##(1997-1#2)
spills##6##1##(2004-4#1)(2006-2#1)(2008-11#3)(2013-1#1)
spin angular momentum##2##3##(2007-12#1)(2008-7#1)
spin axis##2##2##(2008-2#2)
spin blockade##4##2##(2012-2#4)
spin canting##3##2##(1996-2#1)(2010-5#2)
spin coating and##2##3##(2008-2#1)(2010-4#1)
spin coating method##2##3##(2008-10#2)
spin coating##6##2##(2008-10#4)(2008-2#1)(2010-4#1)
spin component##2##2##(2006-5#1)(2008-10#1)
spin coupling##3##2##(1990-3#1)(1992-9#1)(1993-11#1)
spin delocalization from##2##3##(2007-11#1)(2010-7#1)
spin delocalization##4##2##(2007-11#2)(2010-7#2)
spin density wave##2##3##(2012-2#2)
spin density##9##2##(1993-8#1)(1994-5#2)(1996-2#1)(2007-11#2)(2009-10#1)(2012-2#2)
spin diffusion##3##2##(1990-5#1)(1995-2#1)(1997-4#1)
spin echo##6##2##(1993-11#1)(2005-11#1)(2007-9#1)(2008-1#1)(2008-3#1)(2011-2#1)
spin echoes##2##2##(2008-1#2)
spin equilibrium##2##2##(1991-2#2)
spin excitations in##2##3##(2012-2#2)
spin excitations##3##2##(2012-2#3)
spin filter perfusion##2##3##(2008-11#2)
spin filter##4##2##(2008-10#1)(2008-11#3)
spin filters##2##2##(2008-2#2)
spin finish##2##2##(2010-8#2)
spin fluctuations in##3##3##(1991-12#1)(2006-7#2)
spin fluctuations##7##2##(1991-12#1)(1995-2#1)(2006-7#3)(2008-7#1)(2012-2#1)
spin form##3##2##(1990-5#1)(1996-5#1)(2007-3#1)
spin gap##2##2##(1992-9#1)(1993-3#1)
spin label##10##2##(1990-12#1)(1991-10#1)(1993-8#1)(1994-11#3)(1995-10#1)(1996-2#1)(2006-10#2)
spin labeled##2##2##(1992-8#1)(1995-10#1)
spin labeling##5##2##(1994-11#1)(1995-10#1)(2009-10#1)(2011-1#2)
spin labels##14##2##(1990-2#1)(1990-8#1)(1993-8#4)(1994-11#1)(1995-8#2)(1996-2#1)(2006-10#1)(2010-9#3)
spin of##3##2##(1997-7#1)(2007-9#1)(2008-5#1)
spin probe method##2##3##(2005-11#1)(2008-4#1)
spin probe##7##2##(2005-11#2)(2006-10#1)(2008-10#3)(2008-4#1)
spin profiles##5##2##(2007-11#2)(2007-12#3)
spin relaxation##4##2##(1993-8#1)(2008-7#3)
spin resonance (ESR) spectra##2##4##(1990-5#1)(1995-10#1)
spin resonance (ESR)##12##3##(1990-5#1)(1993-7#1)(1995-10#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#1)
spin resonance##32##2##(1990-5#1)(1990-7#1)(1991-6#1)(1992-11#1)(1992-3#1)(1993-7#1)(1994-12#1)(1994-8#1)(1995-10#3)(1996-1#1)(1996-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#10)(2008-5#1)(2008-8#2)(2008-9#1)(2010-4#1)
spin state##3##2##(2008-7#1)(2010-5#1)(2012-12#1)
spin states##5##2##(2009-3#1)(2009-5#1)(2010-5#1)(2012-2#2)
spin systems and##3##3##(1992-9#1)(1995-5#1)(2008-8#1)
spin systems##7##2##(1990-3#1)(1991-7#1)(1992-3#1)(1992-9#1)(1995-5#1)(2008-8#1)(2009-3#1)
spin trap##4##2##(1990-12#1)(1993-3#2)(1994-9#1)
spin trapping agent##2##3##(1993-3#1)(1997-8#1)
spin trapping of##3##3##(1991-9#1)(1993-9#2)
spin trapping with##2##3##(1994-12#1)(2008-5#1)
spin trapping##12##2##(1991-9#1)(1993-3#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-9#1)(1995-1#2)(1997-8#1)(2008-10#1)(2008-5#1)
spin valve##3##2##(2008-10#1)(2008-7#2)
spin##269##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#7)(1990-7#2)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-4#1)(1991-6#1)(1991-7#2)(1991-9#2)(1992-11#2)(1992-12#1)(1992-3#4)(1992-8#1)(1992-9#3)(1993-11#2)(1993-3#5)(1993-7#1)(1993-8#7)(1993-9#2)(1994-11#7)(1994-12#3)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#7)(1995-11#1)(1995-2#2)(1995-5#1)(1995-7#2)(1995-8#2)(1996-1#1)(1996-2#5)(1996-5#2)(1997-4#1)(1997-7#1)(1997-8#1)(2003-11#1)(2005-11#3)(2006-1#1)(2006-10#5)(2006-12#1)(2006-5#1)(2006-7#3)(2007-11#18)(2007-12#5)(2007-3#6)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#5)(2008-10#25)(2008-11#3)(2008-2#9)(2008-3#1)(2008-4#3)(2008-5#5)(2008-7#14)(2008-8#3)(2008-9#2)(2009-10#2)(2009-3#4)(2009-5#3)(2009-6#1)(2010-4#3)(2010-5#7)(2010-7#3)(2010-8#4)(2010-9#3)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#13)
spin-Peierls system##2##2##(1995-2#2)
spin-allowed##2##1##(1997-7#2)
spin-coated films##2##2##(2008-10#2)
spin-coated onto the##2##3##(2008-2#1)(2009-11#1)
spin-coated##7##1##(2008-10#4)(2008-2#1)(2009-11#1)(2010-4#1)
spin-coating##3##1##(2008-10#1)(2009-2#1)(2010-8#1)
spin-coupled##2##1##(1992-3#1)(1992-9#1)
spin-dependent##5##1##(1992-9#1)(2006-4#3)(2008-7#1)
spin-echo NMR##2##2##(1992-5#2)
spin-echo sequence##2##2##(1995-8#1)(2008-10#1)
spin-echo##13##1##(1992-3#1)(1992-5#2)(1995-8#1)(1997-8#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-3#2)(2007-12#1)(2008-10#1)(2010-4#1)
spin-exchange interaction##2##2##(1991-9#1)(2005-11#1)
spin-flip processes##2##2##(2007-12#1)(2008-1#1)
spin-flip##4##1##(2007-12#2)(2008-1#1)(2012-2#1)
spin-forbidden##4##1##(1993-3#1)(1997-7#3)
spin-label##2##1##(1992-3#1)(1997-1#1)
spin-labeled phospholipids##4##2##(1990-2#3)(1993-3#1)
spin-labeled##17##1##(1990-2#4)(1990-3#1)(1990-5#1)(1992-11#1)(1992-3#1)(1993-3#3)(1994-5#3)(1997-7#1)(2005-11#1)(2006-10#1)
spin-lattice relaxation time##4##3##(1994-11#1)(2008-10#2)(2008-9#1)
spin-lattice relaxation times (T1)##2##4##(1991-5#1)(1996-7#1)
spin-lattice relaxation times##3##3##(1991-5#1)(1995-11#1)(1996-7#1)
spin-lattice relaxation##11##2##(1991-5#1)(1991-7#1)(1994-11#1)(1995-11#1)(1996-7#1)(2005-11#1)(2008-10#3)(2008-9#1)(2010-8#1)
spin-orbit mixing##2##2##(1997-7#2)
spin-orbit##4##1##(1993-2#1)(1997-7#3)
spin-polarized##5##1##(1995-2#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#1)
spin-redirection phase##4##2##(2007-11#1)(2007-12#3)
spin-spin##3##1##(1996-7#1)(1997-7#1)(2007-11#1)
spin-trap##4##1##(1990-12#1)(1991-2#1)(2008-8#1)(2010-7#1)
spin-trapping technique combined with electron paramagnetic resonance (EPR) spectroscopy##2##9##(1993-9#1)(1994-5#1)
spin-trapping##9##1##(1990-12#1)(1993-9#1)(1994-2#1)(1994-5#2)(1995-5#1)(1996-2#1)(2008-5#1)(2008-8#1)
spin-traps##2##1##(1993-6#2)
spina bifida and##3##3##(1990-9#1)(1996-6#1)(2012-2#1)
spina bifida occulta##2##3##(1997-1#1)(2008-7#1)
spina bifida##16##2##(1990-9#1)(1996-6#1)(1997-1#1)(1997-3#1)(2006-10#2)(2007-3#1)(2007-7#3)(2008-10#1)(2008-7#1)(2009-7#2)(2010-12#1)(2012-2#1)
spina##17##1##(1990-9#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-3#1)(2006-10#2)(2007-3#1)(2007-7#3)(2008-10#1)(2008-7#1)(2009-7#2)(2010-12#1)(2012-2#1)
spinach (Spinacia oleracea) tissue##2##4##(2008-10#2)
spinach (Spinacia oleracea)##3##3##(1994-9#1)(2008-10#2)
spinach CA##4##2##(1994-11#4)
spinach and##4##2##(1995-11#1)(2008-10#3)
spinach anti-22 kDa antibodies##2##4##(1994-12#2)
spinach chloroplast##3##2##(1991-3#1)(1991-8#1)(1992-4#1)
spinach chloroplasts##6##2##(1992-3#1)(1995-2#1)(1996-7#1)(2005-10#2)(2008-4#1)
spinach ferredoxin##3##2##(1990-7#2)(1995-6#1)
spinach ferredoxin-NADP+##2##2##(1993-6#2)
spinach leaves##4##2##(1990-5#1)(1994-11#2)(2008-10#1)
spinach thylakoid##2##2##(1992-4#1)(1995-8#1)
spinach tissue homogenate##2##3##(2008-10#2)
spinach##78##1##(1990-5#2)(1990-7#2)(1990-8#1)(1991-3#1)(1991-8#2)(1991-9#1)(1992-11#2)(1992-12#2)(1992-3#3)(1992-4#2)(1993-6#2)(1994-10#1)(1994-11#9)(1994-12#4)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-6#3)(1995-8#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-7#1)(2005-10#2)(2007-10#1)(2008-10#19)(2008-4#2)(2008-9#4)(2011-1#1)(2012-2#1)
spinaciae in##2##2##(2008-10#2)
spinaciae##4##1##(2008-10#4)
spinal 5HT3##2##2##(1995-7#2)
spinal AVMs##2##2##(2008-7#2)
spinal ROM##2##2##(2011-12#2)
spinal accessory nerve##2##3##(2008-7#1)(2008-9#1)
spinal adenosine##2##2##(1991-1#1)(1996-11#1)
spinal anaesthesia for caesarean section##3##5##(2006-10#1)(2009-7#1)(2012-2#1)
spinal anaesthesia##22##2##(1991-12#2)(1992-11#2)(1993-10#1)(1993-4#2)(2006-10#6)(2006-6#1)(2009-7#1)(2011-1#1)(2011-12#5)(2012-2#1)
spinal and epidural##2##3##(2006-10#1)(2008-7#1)
spinal and rib##2##3##(2007-11#2)
spinal and##16##2##(1992-1#2)(1992-12#1)(1995-12#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-8#1)(2006-1#1)(2006-10#1)(2006-4#1)(2007-11#3)(2007-8#1)(2008-7#1)
spinal anesthesia for cesarean##2##4##(2012-12#2)
spinal anesthesia for##3##3##(2011-2#1)(2012-12#2)
spinal anesthesia in the##2##4##(2006-10#1)(2012-12#1)
spinal anesthesia in##7##3##(2006-10#1)(2007-12#1)(2007-7#1)(2012-12#1)(2012-3#3)
spinal anesthesia is a##2##4##(2013-7#2)
spinal anesthesia is##3##3##(2013-7#3)
spinal anesthesia with isobaric bypivacain##2##5##(2012-3#2)
spinal anesthesia with##5##3##(2006-12#1)(2006-7#1)(2012-12#1)(2012-3#2)
spinal anesthesia##35##2##(1996-12#1)(2006-10#2)(2006-12#3)(2006-7#1)(2007-12#1)(2007-7#3)(2010-6#1)(2011-2#3)(2012-12#4)(2012-3#8)(2013-7#8)
spinal anesthesia]##2##2##(1991-12#1)(1992-11#1)
spinal angiomas##2##2##(2007-11#2)
spinal antinociception mediated##2##3##(1994-10#2)
spinal antinociception##5##2##(1991-1#1)(1994-10#3)(1996-2#1)
spinal arteriovenous malformation (AVM)##3##4##(1991-3#1)(2008-7#1)(2013-1#1)
spinal arteriovenous malformation##4##3##(1991-3#1)(2008-7#2)(2013-1#1)
spinal arteriovenous malformations##4##3##(2008-7#3)(2011-2#1)
spinal arteriovenous##10##2##(1991-3#1)(1995-11#1)(2006-6#1)(2008-7#5)(2011-2#1)(2013-1#1)
spinal artery aneurysm##3##3##(2013-8#3)
spinal artery##6##2##(2007-9#1)(2013-8#5)
spinal arthrodesis##3##2##(2007-1#1)(2009-4#1)(2012-3#1)
spinal axis##4##2##(1997-6#1)(2006-10#1)(2007-8#1)(2008-12#1)
spinal bone mineral density##3##4##(1993-11#1)(2005-3#1)(2012-2#1)
spinal bone mineral##4##3##(1993-11#2)(2005-3#1)(2012-2#1)
spinal bone##5##2##(1993-11#2)(2005-3#1)(2007-11#1)(2012-2#1)
spinal cGMP##2##2##(1996-8#2)
spinal canal and intervertebral##2##4##(2007-11#1)(2007-7#1)
spinal canal and##5##3##(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)
spinal canal endoscopy##5##3##(2006-8#5)
spinal canal involvement##3##3##(2007-8#3)
spinal canal is a##2##4##(2006-7#1)(2009-4#1)
spinal canal is##3##3##(2006-7#1)(2008-7#1)(2009-4#1)
spinal canal stenosis##4##3##(2006-5#2)(2006-7#1)(2008-12#1)
spinal canal##45##2##(1991-8#2)(1992-11#1)(2006-10#1)(2006-12#1)(2006-5#3)(2006-7#2)(2006-8#10)(2007-11#3)(2007-7#1)(2007-8#11)(2008-1#1)(2008-12#2)(2008-7#2)(2009-3#1)(2009-4#3)(2011-2#1)
spinal cats##5##2##(1990-4#5)
spinal column and##2##3##(2006-2#1)(2008-11#1)
spinal column##12##2##(1995-5#1)(1997-8#1)(2006-2#2)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-6#1)
spinal compression##2##2##(1991-8#1)(2011-2#1)
spinal conditions##2##2##(2008-8#2)
spinal cord after##4##3##(1991-6#1)(1993-12#1)(1994-4#1)(2011-2#1)
spinal cord and RT##2##4##(1990-11#2)
spinal cord and brainstem##2##4##(1992-7#1)(1996-11#1)
spinal cord and dorsal root ganglia##3##6##(1991-10#1)(1994-2#2)
spinal cord and dorsal##4##4##(1991-10#1)(1994-2#2)(1996-9#1)
spinal cord and in the##2##5##(1995-5#1)(2013-7#1)
spinal cord and in##3##4##(1990-7#1)(1995-5#1)(2013-7#1)
spinal cord and telencephalon##2##4##(1996-5#2)
spinal cord and##47##3##(1990-11#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-7#2)(1992-8#1)(1994-2#2)(1994-8#2)(1995-11#1)(1995-12#2)(1995-5#1)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#2)(1996-9#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#2)(2008-7#2)(2009-3#1)(2009-4#1)(2012-2#1)(2013-7#1)(2013-8#1)
spinal cord are##2##3##(2008-5#1)(2011-2#1)
spinal cord arteriovenous malformations (SCAVMs)##2##5##(1995-11#1)(1997-6#1)
spinal cord but not in##2##5##(1996-12#1)(1997-2#1)
spinal cord but##3##3##(1996-12#1)(1997-2#1)(2008-5#1)
spinal cord by##7##3##(1992-8#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-7#1)(2008-7#1)(2012-1#1)
spinal cord can##2##3##(1993-11#1)(2006-10#1)
spinal cord cells##2##3##(1993-5#2)
spinal cord circuitry in the##2##5##(1995-6#2)
spinal cord compression and##3##4##(1990-6#1)(2007-11#2)
spinal cord compression in patients with##2##6##(1996-9#1)(2007-11#1)
spinal cord compression in pregnancy##2##5##(2008-7#2)
spinal cord compression in##5##4##(1996-1#1)(1996-9#1)(2007-11#1)(2008-7#2)
spinal cord compression is##3##4##(1996-9#1)(2007-11#2)
spinal cord compression##50##3##(1990-6#1)(1991-9#2)(1992-12#4)(1993-11#1)(1993-4#1)(1993-9#1)(1996-1#1)(1996-9#5)(2006-2#2)(2006-8#1)(2007-11#12)(2007-5#1)(2007-7#1)(2008-10#1)(2008-6#4)(2008-7#10)(2009-3#1)(2012-3#1)
spinal cord contusion##2##3##(2009-12#2)
spinal cord dorsal horn##4##4##(1993-12#1)(1994-8#1)(2008-4#1)(2008-5#1)
spinal cord dysfunction##3##3##(1991-6#1)(2007-7#1)(2013-8#1)
spinal cord following lesions of the##2##6##(1996-9#2)
spinal cord following peripheral nerve##2##5##(1994-10#1)(1995-7#1)
spinal cord following##6##3##(1993-12#1)(1994-10#1)(1995-7#2)(1996-9#2)
spinal cord from##4##3##(1991-11#1)(1993-4#1)(1996-12#1)(2006-8#1)
spinal cord herniation##2##3##(2006-8#2)
spinal cord immediately after##2##4##(1992-9#1)(1995-3#1)
spinal cord in the##3##4##(1992-3#1)(2008-1#1)(2008-5#1)
spinal cord in##17##3##(1990-5#1)(1992-3#1)(1992-6#1)(1992-9#1)(1994-2#2)(1995-12#1)(1995-3#1)(1996-5#1)(1996-9#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-8#1)
spinal cord injured (SCI)##2##4##(2012-1#2)
spinal cord injured patients##2##4##(1996-9#1)(2012-12#1)
spinal cord injured rats##2##4##(2011-2#2)
spinal cord injured##8##3##(1996-9#1)(2005-3#1)(2011-2#2)(2012-1#2)(2012-12#1)(2013-1#1)
spinal cord injuries##15##3##(1990-8#1)(1991-6#3)(1992-6#2)(2007-10#1)(2007-11#2)(2007-8#1)(2008-11#1)(2008-5#2)(2008-8#1)(2012-2#1)
spinal cord injuries]##5##3##(1991-6#1)(1993-2#1)(1995-9#2)(1996-9#1)
spinal cord injury (SCI) in##2##5##(2008-12#1)(2008-2#1)
spinal cord injury (SCI)##11##4##(2008-12#1)(2008-2#1)(2008-7#1)(2009-12#1)(2010-2#1)(2010-8#2)(2012-1#3)(2013-1#1)
spinal cord injury (class##2##4##(2011-2#2)
spinal cord injury and##3##4##(2004-12#1)(2008-7#1)(2009-4#1)
spinal cord injury are##2##4##(1993-12#1)(2007-11#1)
spinal cord injury in##5##4##(1995-11#1)(1996-1#1)(2007-11#2)(2008-5#1)
spinal cord injury##75##3##(1991-12#1)(1993-12#2)(1993-2#1)(1995-11#2)(1995-9#1)(1996-1#1)(1996-11#1)(2004-12#1)(2005-11#1)(2005-3#1)(2006-10#3)(2006-3#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#2)(2007-7#8)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#4)(2008-9#2)(2009-12#1)(2009-4#1)(2010-12#1)(2010-2#2)(2010-8#2)(2011-2#2)(2012-1#9)(2012-2#1)(2013-1#5)
spinal cord is##7##3##(1991-9#1)(1992-11#1)(2006-8#1)(2007-12#1)(2008-4#1)(2008-5#1)(2011-1#1)
spinal cord ischemia##3##3##(2007-8#1)(2010-8#2)
spinal cord lesion##5##3##(1995-11#1)(1995-9#1)(2007-11#2)(2013-8#1)
spinal cord lesion]##2##3##(1997-8#1)(2013-8#1)
spinal cord lesions in##2##4##(1993-6#1)(1997-4#1)
spinal cord lesions##3##3##(1993-6#1)(1997-4#1)(2012-12#1)
spinal cord metastases##2##3##(2006-12#1)(2006-2#1)
spinal cord neurons were##2##4##(1996-12#1)(1996-4#1)
spinal cord neurons##8##3##(1990-7#1)(1991-9#2)(1996-12#1)(1996-4#1)(1997-1#2)(2008-11#1)
spinal cord of adult##2##4##(1993-12#1)(1995-3#1)
spinal cord of the rat##3##5##(1991-1#1)(1991-6#1)(2008-11#1)
spinal cord of the##10##4##(1991-1#1)(1991-6#1)(1993-12#1)(1995-5#1)(1996-11#1)(1996-5#1)(1997-2#1)(2006-11#1)(2008-11#1)(2008-5#1)
spinal cord of##26##3##(1990-5#1)(1991-1#1)(1991-5#1)(1991-6#2)(1992-9#1)(1993-12#2)(1995-3#1)(1995-5#1)(1996-11#3)(1996-5#1)(1996-6#1)(1997-2#4)(1997-3#1)(2006-11#1)(2006-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-1#1)
spinal cord or##4##3##(2007-11#1)(2008-1#1)(2008-11#1)(2008-7#1)
spinal cord segments##2##3##(1992-9#1)(1996-5#1)
spinal cord slices##2##3##(1992-8#1)(1995-12#1)
spinal cord stimulation (SCS)##2##4##(1997-2#1)(2006-12#1)
spinal cord stimulation in##2##4##(1991-2#1)(1997-2#1)
spinal cord stimulation is##2##4##(1991-2#1)(2013-1#1)
spinal cord stimulation##17##3##(1991-2#2)(1997-2#3)(2006-10#1)(2006-12#2)(2006-8#6)(2010-7#1)(2013-1#2)
spinal cord stimulator##3##3##(2006-7#3)
spinal cord synaptosomes##5##3##(1993-4#2)(1996-2#3)
spinal cord that##3##3##(1994-5#1)(1995-5#1)(2012-1#1)
spinal cord the##2##3##(1990-7#1)(1996-5#1)
spinal cord to##3##3##(1996-12#1)(1996-9#1)(2006-8#1)
spinal cord trauma##3##3##(1993-12#1)(2006-10#1)(2007-10#1)
spinal cord tumor##3##3##(2006-12#1)(2007-2#1)(2008-12#1)
spinal cord tumors##2##3##(2006-12#2)
spinal cord using##3##3##(1991-5#1)(1993-11#1)(1993-5#1)
spinal cord was##13##3##(1991-5#1)(1992-8#2)(1992-9#1)(1994-10#1)(1996-5#1)(1997-8#1)(2007-2#2)(2007-6#1)(2008-5#3)
spinal cord were##7##3##(1991-5#1)(1993-12#1)(1995-3#1)(1995-7#1)(1996-4#1)(2006-5#1)(2006-8#1)
spinal cord which##2##3##(1995-3#1)(2012-3#1)
spinal cord while##3##3##(1990-4#1)(1992-9#1)(1997-8#1)
spinal cord with##4##3##(1995-11#1)(2006-6#1)(2006-8#1)(2008-5#1)
spinal cord##710##2##(1990-11#3)(1990-2#1)(1990-4#2)(1990-5#6)(1990-6#3)(1990-7#10)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#4)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#16)(1991-6#15)(1991-8#1)(1991-9#8)(1992-1#2)(1992-10#2)(1992-11#1)(1992-12#5)(1992-3#1)(1992-6#4)(1992-7#5)(1992-8#11)(1992-9#7)(1993-11#5)(1993-12#13)(1993-2#4)(1993-4#7)(1993-5#3)(1993-6#1)(1993-7#3)(1993-9#2)(1994-10#3)(1994-11#3)(1994-2#9)(1994-3#1)(1994-4#2)(1994-5#4)(1994-8#5)(1994-9#3)(1995-1#1)(1995-11#14)(1995-12#10)(1995-3#10)(1995-4#1)(1995-5#7)(1995-6#2)(1995-7#13)(1995-9#5)(1996-1#3)(1996-11#8)(1996-12#14)(1996-2#7)(1996-3#1)(1996-4#2)(1996-5#14)(1996-6#3)(1996-7#2)(1996-8#3)(1996-9#14)(1997-1#3)(1997-2#11)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#6)(2004-12#1)(2005-11#1)(2005-3#2)(2005-9#1)(2006-10#14)(2006-11#3)(2006-12#14)(2006-2#8)(2006-3#1)(2006-5#7)(2006-6#3)(2006-7#6)(2006-8#23)(2006-9#1)(2007-1#5)(2007-10#8)(2007-11#42)(2007-12#6)(2007-2#4)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#10)(2007-8#3)(2008-1#5)(2008-10#2)(2008-11#9)(2008-12#5)(2008-2#3)(2008-3#1)(2008-4#8)(2008-5#20)(2008-6#5)(2008-7#39)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#2)(2009-4#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#6)(2010-2#2)(2010-5#3)(2010-7#1)(2010-8#5)(2011-1#3)(2011-2#8)(2012-1#18)(2012-12#4)(2012-2#4)(2012-3#6)(2013-1#11)(2013-7#2)(2013-8#9)
spinal cords of##3##3##(1995-12#1)(1996-9#1)(2012-1#1)
spinal cords was##2##3##(1990-5#1)(1997-8#1)
spinal cords##15##2##(1990-5#1)(1991-9#1)(1995-12#1)(1995-3#1)(1996-6#1)(1996-9#2)(1997-8#5)(2008-11#1)(2008-2#1)(2012-1#1)
spinal curvature##7##2##(2007-8#3)(2008-11#1)(2008-12#3)
spinal decompression##2##2##(2006-8#1)(2007-11#1)
spinal decompressive surgery##3##3##(2006-5#3)
spinal deformities##6##2##(2007-8#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-12#1)(2012-2#1)
spinal deformity may##2##3##(2006-5#2)
spinal deformity##12##2##(2006-5#3)(2006-8#2)(2007-8#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-3#2)
spinal disease##6##2##(2006-2#5)(2012-12#1)
spinal diseases##2##2##(1990-12#1)(1992-10#1)
spinal disorders##4##2##(2006-8#1)(2007-1#1)(2007-7#1)(2008-8#1)
spinal dorsal horn neurons##2##4##(1994-2#2)
spinal dorsal horn##8##3##(1991-9#1)(1992-6#1)(1994-2#3)(1994-5#1)(1997-2#2)
spinal dural arteriovenous fistula##2##4##(2006-6#1)(2008-7#1)
spinal dural arteriovenous##3##3##(2006-6#1)(2008-7#2)
spinal dural##4##2##(1991-3#1)(2006-6#1)(2008-7#2)
spinal dysraphism##3##2##(2012-2#1)(2013-1#2)
spinal endoscopic adhesiolysis##3##3##(2006-8#3)
spinal endoscopy and##2##3##(2006-8#2)
spinal endoscopy##4##2##(2006-7#1)(2006-8#3)
spinal epidural abscess##3##3##(2007-2#1)(2009-5#1)(2012-3#1)
spinal epidural haematoma##3##3##(2008-7#3)
spinal epidural hematoma##3##3##(2007-3#1)(2008-7#2)
spinal epidural##17##2##(1992-12#2)(2006-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-7#6)(2009-5#1)(2010-7#1)(2011-2#1)(2012-3#1)
spinal field##2##2##(2007-10#2)
spinal fixation##2##2##(2008-8#1)(2012-3#1)
spinal flexion##2##2##(1993-3#1)(2007-4#1)
spinal fluid##10##2##(1990-3#1)(1990-8#1)(1994-2#1)(1997-3#1)(2006-11#1)(2006-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2013-8#1)
spinal fracture##2##2##(2008-1#1)(2012-12#1)
spinal fractures##6##2##(2007-11#2)(2007-8#1)(2008-1#1)(2012-12#2)
spinal fusion and##4##3##(2006-7#1)(2007-7#1)(2008-6#1)(2012-3#1)
spinal fusion in##2##3##(2007-1#1)(2008-8#1)
spinal fusion is##2##3##(2006-8#1)(2008-8#1)
spinal fusion surgery##5##3##(2012-3#1)(2013-1#4)
spinal fusion with##3##3##(2008-8#3)
spinal fusion##35##2##(2005-2#3)(2006-7#1)(2006-8#2)(2007-1#3)(2007-7#3)(2008-6#1)(2008-8#6)(2009-3#2)(2012-12#1)(2012-3#7)(2013-1#4)(2013-7#2)
spinal fusions##4##2##(2006-7#1)(2007-1#3)
spinal ganglion neurons##5##3##(2007-9#2)(2008-7#3)
spinal ganglion##6##2##(1996-6#1)(2007-9#2)(2008-7#3)
spinal glial##2##2##(2008-7#2)
spinal implants##2##2##(2007-7#1)(2009-3#1)
spinal inclination angle (r = -0##2##4##(2011-12#2)
spinal injections##3##2##(2006-7#3)
spinal injures##3##2##(2007-8#3)
spinal injuries and##2##3##(2007-11#2)
spinal injuries##5##2##(2007-11#2)(2008-10#1)(2009-4#1)(2012-12#1)
spinal injury and##2##3##(2007-11#1)(2011-2#1)
spinal injury##12##2##(2007-11#2)(2009-4#1)(2009-5#1)(2011-2#5)(2012-2#3)
spinal instability and##2##3##(2007-11#1)(2012-12#1)
spinal instability##10##2##(2006-5#1)(2006-8#2)(2007-11#4)(2008-11#1)(2008-7#1)(2012-12#1)
spinal instrumentation##5##2##(2006-8#2)(2007-2#1)(2008-8#2)
spinal interneurons##2##2##(1995-11#1)(1997-3#1)
spinal interventionalists##2##2##(2006-8#2)
spinal involvement##2##2##(2007-11#2)
spinal ischaemia##2##2##(2012-1#2)
spinal lesions##5##2##(2006-2#2)(2007-11#1)(2007-8#1)(2012-3#1)
spinal level##4##2##(1990-2#1)(1991-3#1)(1996-1#1)(2007-4#1)
spinal levels##3##2##(2006-11#1)(2006-12#1)(2008-8#1)
spinal manipulation##3##2##(2007-6#1)(2008-12#1)(2010-7#1)
spinal manipulative therapy##5##3##(2007-11#3)(2013-1#2)
spinal manipulative##6##2##(2007-11#4)(2013-1#2)
spinal metastases##20##2##(1994-10#1)(2006-2#7)(2007-11#10)(2008-7#2)
spinal metastasis of Ewing's sarcoma##2##5##(2007-3#2)
spinal metastasis##6##2##(1994-7#1)(2006-2#1)(2007-3#2)(2008-7#2)
spinal metastatic disease##3##3##(2006-2#2)(2006-8#1)
spinal metastatic tumors##2##3##(2007-11#2)
spinal metastatic##6##2##(2006-2#2)(2006-8#1)(2007-11#3)
spinal microglia##2##2##(2008-4#2)
spinal mobility##3##2##(2011-12#3)
spinal motoneuron##2##2##(1991-5#1)(1995-1#1)
spinal motoneurons##5##2##(1991-3#1)(1994-5#1)(1995-1#1)(1995-5#1)(1997-7#1)
spinal motor neurons##3##3##(2008-7#2)(2012-12#1)
spinal motor##7##2##(1992-8#2)(1996-1#1)(1997-7#1)(2008-7#2)(2012-12#1)
spinal muscular atrophy (SMA)##2##4##(2007-11#1)(2013-1#1)
spinal muscular atrophy##8##3##(1993-11#1)(1996-12#1)(2007-11#1)(2007-7#1)(2010-12#1)(2012-2#1)(2013-1#2)
spinal muscular##9##2##(1993-11#1)(1996-12#1)(2007-11#1)(2007-7#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
spinal needle##2##2##(2012-3#2)
spinal neoplasms##4##2##(2006-8#1)(2007-11#2)(2011-2#1)
spinal nerve ligation##2##3##(2008-1#1)(2008-4#1)
spinal nerve roots##4##3##(2006-10#1)(2006-12#2)(2013-1#1)
spinal nerve##13##2##(1993-11#1)(1996-12#2)(2006-10#1)(2006-12#3)(2006-7#1)(2008-1#1)(2008-4#1)(2011-2#1)(2013-1#2)
spinal nerves##9##2##(1993-4#1)(1994-2#2)(1995-8#2)(2006-12#1)(2008-7#2)(2011-2#1)
spinal neurons and##2##3##(1994-5#1)(2005-11#1)
spinal neurons##9##2##(1991-8#1)(1992-1#1)(1992-8#2)(1994-10#1)(1994-5#1)(1995-11#1)(1996-12#1)(2005-11#1)
spinal nociceptive##4##2##(1990-2#2)(1991-5#1)(1996-12#1)
spinal nucleus of the bulbocavernosus (SNB)##4##6##(1992-7#1)(1994-5#1)(1995-5#1)(1996-9#1)
spinal nucleus##6##2##(1991-9#1)(1992-7#1)(1994-5#1)(1995-5#1)(1996-5#1)(1996-9#1)
spinal opioid binding sites##2##4##(1995-7#2)
spinal opioid##3##2##(1994-10#1)(1995-7#2)
spinal or##3##2##(1992-11#1)(2006-10#1)(2009-5#1)
spinal orthoses##3##2##(2007-8#3)
spinal overload syndrome##3##3##(2007-7#3)
spinal pain and related disorders##3##5##(2008-12#3)
spinal pain and related##5##4##(2008-12#5)
spinal pain and##7##3##(2006-8#2)(2008-12#5)
spinal pain of##2##3##(2006-7#2)
spinal pain syndromes##5##3##(2006-8#1)(2007-11#2)(2008-12#1)(2009-5#1)
spinal pain##33##2##(2006-12#2)(2006-7#4)(2006-8#13)(2007-11#2)(2007-7#3)(2007-8#1)(2008-12#6)(2009-5#2)
spinal pathways##2##2##(1992-9#1)(1996-9#1)
spinal presynaptic inhibition##2##3##(1995-12#2)
spinal projections##3##2##(1994-2#3)
spinal puncture##2##2##(1991-6#1)(1995-11#1)
spinal rats##2##2##(1993-7#1)(2005-8#1)
spinal reconstruction##4##2##(2006-8#1)(2007-8#1)(2008-7#2)
spinal reflex##4##2##(1996-1#2)(1997-7#1)(2005-8#1)
spinal regions##2##2##(2006-7#1)(2008-12#1)
spinal release of##2##3##(1993-7#1)(2009-3#1)
spinal release##4##2##(1993-7#1)(2009-11#1)(2009-3#2)
spinal roots##8##2##(1990-2#1)(1995-3#1)(2007-11#1)(2008-4#3)(2008-9#2)
spinal sagittal balance##3##3##(2011-12#3)
spinal segment##2##2##(1991-9#1)(2007-11#1)
spinal segments##4##2##(1993-12#1)(1993-9#1)(2008-7#1)(2008-9#1)
spinal stability##8##2##(2006-2#1)(2007-11#4)(2010-12#2)(2013-7#1)
spinal stabilization##4##2##(2007-11#2)(2007-7#2)
spinal stenosis##17##2##(1996-12#1)(2006-7#3)(2006-8#2)(2007-8#1)(2008-11#1)(2008-8#1)(2009-3#2)(2012-12#4)(2012-2#1)(2013-1#1)
spinal structures##3##2##(2006-8#2)(2007-11#1)
spinal subarachnoid space##6##3##(1995-7#2)(1996-8#1)(2006-5#2)(2008-12#1)
spinal subarachnoid##8##2##(1995-7#2)(1996-8#1)(2006-5#4)(2008-12#1)
spinal subdural haematoma##4##3##(2008-7#4)
spinal subdural hematoma##2##3##(2012-12#2)
spinal subdural##7##2##(2008-7#4)(2012-12#3)
spinal surgery##18##2##(1994-7#1)(2006-2#1)(2007-1#2)(2007-11#1)(2007-8#3)(2008-8#4)(2010-10#2)(2011-1#1)(2012-12#1)(2012-3#2)
spinal syringomyelia##3##2##(2006-5#3)
spinal tract of##3##3##(1996-5#3)
spinal trauma##4##2##(2006-5#1)(2007-11#2)(2012-12#1)
spinal trigeminal nuclei##2##3##(1991-11#1)(1996-9#1)
spinal trigeminal nucleus##9##3##(1990-4#2)(1994-2#1)(1994-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(2012-2#1)
spinal trigeminal##13##2##(1990-4#2)(1991-11#1)(1994-2#2)(1994-6#1)(1995-5#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-5#1)(2012-2#1)
spinal tumors##6##2##(2006-10#2)(2006-2#3)(2012-2#1)
spinal##1644##1##(1990-11#4)(1990-12#2)(1990-2#5)(1990-3#1)(1990-4#10)(1990-5#7)(1990-6#3)(1990-7#12)(1990-8#2)(1990-9#2)(1991-1#4)(1991-10#5)(1991-11#3)(1991-12#4)(1991-2#3)(1991-3#6)(1991-5#23)(1991-6#16)(1991-8#6)(1991-9#12)(1992-1#5)(1992-10#5)(1992-11#6)(1992-12#8)(1992-3#1)(1992-6#5)(1992-7#8)(1992-8#17)(1992-9#8)(1993-10#2)(1993-11#11)(1993-12#14)(1993-2#4)(1993-3#1)(1993-4#11)(1993-5#3)(1993-6#1)(1993-7#7)(1993-9#3)(1994-10#12)(1994-11#3)(1994-2#23)(1994-3#1)(1994-4#2)(1994-5#8)(1994-6#2)(1994-7#3)(1994-8#5)(1994-9#3)(1995-1#3)(1995-11#22)(1995-12#16)(1995-3#13)(1995-4#1)(1995-5#12)(1995-6#2)(1995-7#22)(1995-8#2)(1995-9#5)(1996-1#8)(1996-10#3)(1996-11#9)(1996-12#25)(1996-2#8)(1996-3#3)(1996-4#2)(1996-5#22)(1996-6#5)(1996-7#2)(1996-8#8)(1996-9#20)(1997-1#5)(1997-2#13)(1997-3#7)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#8)(1997-8#20)(2004-12#1)(2005-11#2)(2005-2#4)(2005-3#3)(2005-8#4)(2005-9#2)(2006-1#1)(2006-10#37)(2006-11#12)(2006-12#26)(2006-2#35)(2006-3#1)(2006-4#1)(2006-5#25)(2006-6#8)(2006-7#30)(2006-8#82)(2006-9#1)(2007-1#18)(2007-10#11)(2007-11#116)(2007-12#10)(2007-2#6)(2007-3#5)(2007-4#5)(2007-5#1)(2007-6#3)(2007-7#41)(2007-8#42)(2007-9#3)(2008-1#12)(2008-10#4)(2008-11#18)(2008-12#22)(2008-2#4)(2008-3#2)(2008-4#16)(2008-5#20)(2008-6#7)(2008-7#90)(2008-8#22)(2008-9#9)(2009-10#1)(2009-11#2)(2009-12#4)(2009-3#13)(2009-4#9)(2009-5#8)(2009-6#2)(2009-7#2)(2009-8#1)(2010-10#3)(2010-12#16)(2010-2#2)(2010-3#1)(2010-5#3)(2010-6#1)(2010-7#4)(2010-8#6)(2011-1#5)(2011-12#17)(2011-2#32)(2012-1#21)(2012-12#30)(2012-2#23)(2012-3#31)(2013-1#30)(2013-7#13)(2013-8#18)
spinal-epidural##3##1##(2006-10#3)
spinal-pelvic sagittal##2##2##(2013-8#2)
spinalized##5##1##(1990-4#1)(1992-8#1)(1995-12#1)(1996-1#1)(1997-7#1)
spinally##3##1##(1992-12#1)(1992-3#1)(1995-11#1)
spindle activity in##2##3##(1991-12#1)(1992-10#1)
spindle activity##3##2##(1991-12#1)(1992-10#2)
spindle afferents in the##2##4##(1990-4#2)
spindle afferents##5##2##(1990-4#5)
spindle and##5##2##(1995-6#1)(2008-8#1)(2009-5#2)(2010-5#1)
spindle assembly##3##2##(1997-3#1)(2007-12#1)(2011-1#1)
spindle cell carcinoma and apocrine carcinoma##2##6##(2008-10#2)
spindle cell carcinoma##5##3##(2008-10#5)
spindle cell lipoma##2##3##(1990-12#2)
spindle cell neoplasm##3##3##(2007-6#1)(2010-12#1)(2011-2#1)
spindle cell nodules##3##3##(2008-11#3)
spindle cell sarcoma##3##3##(2008-6#2)(2011-2#1)
spindle cell tumours##2##3##(2008-6#1)(2013-8#1)
spindle cell##26##2##(1990-12#3)(1991-8#1)(2007-6#2)(2008-10#6)(2008-11#3)(2008-6#4)(2009-11#1)(2010-12#2)(2011-2#3)(2013-8#1)
spindle cells arranged in##2##4##(2007-2#1)(2007-7#1)
spindle cells were##2##3##(2013-1#1)(2013-8#1)
spindle cells##21##2##(1990-12#1)(1996-9#1)(2007-2#3)(2007-7#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-12#2)(2010-6#3)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
spindle checkpoint and##2##3##(2008-8#2)
spindle checkpoint##3##2##(2008-8#3)
spindle in##3##2##(2007-12#1)(2009-3#1)(2011-2#1)
spindle pole##7##2##(1990-6#3)(1991-5#1)(1997-6#2)(2010-5#1)
spindle poles##3##2##(1997-6#1)(2009-10#1)(2011-2#1)
spindle shape##2##2##(1995-5#1)(2010-7#1)
spindle shaped##3##2##(1995-5#1)(2008-10#1)(2008-11#1)
spindle streak mosaic virus (WSSMV)##3##5##(2008-10#2)(2008-8#1)
spindle streak mosaic##4##3##(2008-10#3)(2008-8#1)
spindle##133##1##(1990-11#1)(1990-12#4)(1990-4#5)(1990-6#3)(1990-7#2)(1991-12#2)(1991-5#1)(1991-8#1)(1992-10#3)(1994-8#1)(1995-5#2)(1995-6#1)(1996-9#1)(1997-3#1)(1997-6#4)(2007-12#4)(2007-2#3)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-2#3)(2008-6#5)(2008-7#1)(2008-8#9)(2008-9#2)(2009-10#5)(2009-11#1)(2009-3#1)(2009-5#3)(2009-7#1)(2010-12#4)(2010-5#2)(2010-6#3)(2010-7#1)(2011-1#1)(2011-2#7)(2012-12#16)(2012-2#2)(2013-1#5)(2013-8#3)
spindle-cell##3##1##(2008-6#1)(2012-3#2)
spindle-shaped cells with##2##3##(2007-9#1)(2009-3#1)
spindle-shaped cells##7##2##(1990-5#1)(1991-8#1)(1994-6#1)(1996-3#1)(2007-12#1)(2007-9#1)(2009-3#1)
spindle-shaped##14##1##(1990-5#1)(1991-8#1)(1993-12#1)(1994-6#1)(1996-3#1)(2007-12#1)(2007-9#1)(2008-5#1)(2008-6#2)(2009-3#1)(2009-5#1)(2011-2#1)(2012-12#1)
spindled##3##1##(2004-2#1)(2008-11#1)(2010-12#1)
spindles and##3##2##(1997-3#1)(2009-8#2)
spindles in the##2##3##(1992-9#1)(2009-8#1)
spindles in##4##2##(1990-7#1)(1992-9#2)(2009-8#1)
spindles##31##1##(1990-7#2)(1991-9#1)(1992-3#4)(1992-8#1)(1992-9#7)(1996-12#2)(1996-9#2)(1997-3#1)(2008-8#1)(2009-10#1)(2009-8#3)(2011-12#1)(2011-2#1)(2012-12#4)
spine -##3##2##(2007-11#1)(2007-7#1)(2007-8#1)
spine after surgical##2##3##(2007-11#1)(2007-7#1)
spine after##5##2##(2007-11#2)(2007-7#3)
spine and can##2##3##(2008-1#1)(2012-2#1)
spine and femur##3##3##(1991-11#1)(2011-2#2)
spine and hip##5##3##(1994-8#1)(2006-10#2)(2008-3#1)(2008-8#1)
spine and pelvis##2##3##(2007-11#1)(2010-1#1)
spine and proximal femur##2##4##(2011-2#2)
spine and spinal cord##4##4##(2007-11#3)(2011-2#1)
spine and the##5##3##(2007-11#2)(2007-8#1)(2008-8#1)(2012-2#1)
spine and##58##2##(1991-11#2)(1993-11#2)(1993-12#1)(1994-8#1)(1995-11#1)(1997-3#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-9#1)(2007-1#3)(2007-11#11)(2007-4#3)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-3#2)(2008-8#3)(2009-3#1)(2009-5#1)(2010-1#1)(2010-5#1)(2010-9#1)(2011-12#1)(2011-2#5)(2012-2#4)
spine are the##2##3##(1997-4#1)(2007-11#1)
spine are##16##2##(1990-12#1)(1997-4#2)(2006-2#2)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-6#2)(2008-6#1)(2008-9#1)(2011-2#1)
spine as well as##2##4##(2008-7#1)(2009-4#1)
spine at the##2##3##(2007-11#1)(2011-2#1)
spine at##4##2##(2007-11#2)(2008-8#1)(2011-2#1)
spine bone##2##2##(2007-4#1)(2010-1#1)
spine can be##3##3##(2006-8#2)(2008-6#1)
spine can##4##2##(2006-8#2)(2008-1#1)(2008-6#1)
spine color##2##2##(2008-4#2)
spine correction##2##2##(2007-8#2)
spine could##2##2##(2008-11#1)(2010-8#1)
spine curvature##2##2##(2007-1#1)(2008-12#1)
spine curve##6##2##(2007-8#6)
spine density of##2##3##(1997-5#2)
spine density##4##2##(1994-10#2)(1997-5#2)
spine disorders##2##2##(2007-11#2)
spine dynamics##2##2##(2012-2#2)
spine for##2##2##(2008-7#1)(2012-3#1)
spine fracture##2##2##(2007-7#1)(2011-2#1)
spine fractures##3##2##(2007-11#2)(2009-8#1)
spine from##3##2##(2007-1#1)(2007-4#1)(2008-11#1)
spine fusion##5##2##(2008-8#2)(2011-1#1)(2012-12#1)(2012-3#1)
spine geometry in##2##3##(2007-1#2)
spine geometry##3##2##(2007-1#3)
spine has been##2##3##(2006-8#1)(2007-11#1)
spine has##4##2##(2006-11#1)(2006-8#2)(2007-11#1)
spine have##3##2##(2006-8#1)(2007-11#1)(2012-3#1)
spine in a group of##2##5##(1990-12#1)(2006-10#1)
spine in a##4##3##(1990-12#1)(2006-10#1)(2008-12#1)(2011-2#1)
spine in patients##2##3##(2005-12#1)(2006-10#1)
spine in the##6##3##(2007-11#3)(2007-7#1)(2012-1#2)
spine in##28##2##(1990-12#1)(1991-11#1)(2005-12#1)(2006-10#3)(2006-11#1)(2006-9#1)(2007-11#5)(2007-7#3)(2007-8#1)(2008-12#1)(2008-4#1)(2009-10#1)(2009-3#1)(2010-8#1)(2011-2#3)(2012-1#2)(2012-2#1)
spine injuries##5##2##(2006-10#1)(2007-11#2)(2007-6#1)(2009-5#1)
spine injury##8##2##(2006-10#4)(2006-11#1)(2006-8#1)(2011-2#2)
spine instability and##2##3##(2007-11#1)(2009-3#1)
spine instability##5##2##(2006-10#1)(2007-11#1)(2009-3#3)
spine is a rare##2##4##(2011-2#2)
spine is a##4##3##(2005-2#1)(2006-3#1)(2011-2#2)
spine is##15##2##(1992-1#1)(2005-2#1)(2006-11#1)(2006-3#1)(2006-7#1)(2006-8#2)(2007-11#2)(2007-7#2)(2008-8#1)(2009-3#1)(2011-2#2)
spine metastasis##2##2##(2011-2#1)(2012-2#1)
spine metastatic tumours##2##3##(2007-11#2)
spine morphologies##2##2##(2008-11#2)
spine motion##4##2##(2007-4#3)(2012-2#1)
spine movement##2##2##(2007-11#1)(2013-1#1)
spine not##2##2##(2007-7#1)(2013-1#1)
spine of##5##2##(1991-6#1)(1995-8#1)(2006-11#1)(2007-11#1)(2007-12#1)
spine on##2##2##(2007-7#1)(2011-2#1)
spine or##7##2##(2006-10#1)(2007-11#1)(2007-6#1)(2008-4#1)(2009-5#1)(2010-8#1)(2012-12#1)
spine radiographs##3##2##(2006-11#2)(2010-10#1)
spine radiography##2##2##(2007-7#1)(2008-3#1)
spine revealed a##3##3##(2009-3#1)(2010-12#1)(2012-2#1)
spine revealed##7##2##(2006-10#1)(2007-11#1)(2009-3#2)(2010-12#1)(2012-12#1)(2012-2#1)
spine scoliosis##2##2##(2007-8#2)
spine segments##3##2##(2007-7#1)(2008-8#2)
spine stabilisation##2##2##(2006-4#1)(2007-8#1)
spine stabilization##2##2##(2007-11#2)
spine surgeons##5##2##(2007-10#2)(2009-3#1)(2011-2#1)(2012-12#1)
spine surgeries##2##2##(2006-7#1)(2011-2#1)
spine surgery##31##2##(1997-4#1)(2006-7#2)(2006-8#3)(2007-11#1)(2007-8#2)(2008-7#4)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#8)(2012-2#3)(2012-3#4)
spine synostosis##2##2##(2013-1#2)
spine than in the##2##4##(1996-6#1)(2007-1#1)
spine than##3##2##(1996-6#1)(2006-7#1)(2007-1#1)
spine that##3##2##(2006-11#2)(2008-8#1)
spine to the##2##3##(2007-4#1)(2008-6#1)
spine to##4##2##(2006-11#1)(2007-4#1)(2008-6#1)(2009-1#1)
spine trauma in children and adults##2##6##(2007-11#2)
spine trauma in##3##3##(2007-11#3)
spine trauma##8##2##(2006-8#1)(2007-11#7)
spine using##2##2##(2007-11#1)(2010-3#1)
spine was##14##2##(1993-12#1)(2006-11#1)(2006-7#1)(2007-1#2)(2007-11#2)(2007-4#1)(2007-8#1)(2008-6#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-2#1)
spine were##5##2##(2006-10#1)(2007-1#1)(2007-11#1)(2007-8#2)
spine which##2##2##(2006-7#1)(2007-4#1)
spine with##7##2##(1993-1#1)(2006-7#1)(2007-11#2)(2007-6#1)(2009-3#1)(2012-12#1)
spine##712##1##(1990-12#4)(1990-6#2)(1991-11#4)(1991-6#3)(1992-1#1)(1992-10#1)(1992-3#1)(1993-1#1)(1993-11#3)(1993-12#3)(1994-10#2)(1994-8#1)(1995-11#1)(1995-6#1)(1995-7#2)(1995-8#4)(1996-11#1)(1996-6#1)(1997-3#1)(1997-4#3)(1997-5#3)(2005-12#1)(2005-2#2)(2006-1#2)(2006-10#23)(2006-11#25)(2006-12#2)(2006-2#6)(2006-3#2)(2006-4#3)(2006-5#1)(2006-6#3)(2006-7#16)(2006-8#44)(2006-9#4)(2007-1#26)(2007-10#3)(2007-11#126)(2007-12#5)(2007-3#3)(2007-4#33)(2007-5#1)(2007-6#10)(2007-7#31)(2007-8#40)(2007-9#1)(2008-1#11)(2008-11#9)(2008-12#13)(2008-2#1)(2008-3#3)(2008-4#10)(2008-6#4)(2008-7#10)(2008-8#16)(2008-9#2)(2009-1#2)(2009-10#1)(2009-2#4)(2009-3#15)(2009-4#4)(2009-5#5)(2009-8#2)(2009-9#3)(2010-1#3)(2010-10#1)(2010-12#9)(2010-3#5)(2010-5#1)(2010-6#1)(2010-8#5)(2010-9#1)(2011-1#4)(2011-12#10)(2011-2#28)(2012-1#4)(2012-12#23)(2012-2#22)(2012-3#11)(2013-1#10)(2013-7#1)(2013-8#2)
spine)##3##1##(2007-11#1)(2008-4#1)(2011-1#1)
spine]##7##1##(1992-1#1)(1992-10#1)(1992-9#1)(2007-8#1)(2008-1#1)(2008-6#1)(2011-1#1)
spinel##4##1##(2008-10#1)(2008-3#1)(2010-4#2)
spinel-type manganese oxide##2##3##(2008-10#2)
spinel-type##4##1##(2008-10#4)
spinels##2##1##(1991-3#2)
spines and##6##2##(1995-7#1)(2006-11#1)(2007-1#1)(2007-12#2)(2008-5#1)
spines are##4##2##(1995-8#1)(2008-11#2)(2012-2#1)
spines in the##2##3##(1995-8#1)(2008-11#1)
spines in##5##2##(1995-8#2)(1997-7#1)(2008-11#1)(2009-8#1)
spines of Purkinje##2##3##(1996-2#1)(1996-4#1)
spines of##7##2##(1995-6#1)(1995-8#1)(1996-2#1)(1996-4#1)(2007-4#1)(2008-5#1)(2012-2#1)
spines on the##4##3##(2007-12#2)(2008-4#1)(2013-7#1)
spines on##6##2##(1995-6#1)(1997-5#1)(2007-12#2)(2008-4#1)(2013-7#1)
spines or##3##2##(1991-9#1)(1995-7#1)(2008-11#1)
spines was##2##2##(1995-7#1)(2007-2#1)
spines were##4##2##(2007-3#1)(2008-8#3)
spines with##2##2##(2006-8#1)(2007-12#1)
spines##88##1##(1991-9#1)(1995-11#2)(1995-12#1)(1995-6#5)(1995-7#8)(1995-8#6)(1996-2#5)(1996-4#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-7#2)(2006-11#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#10)(2007-2#1)(2007-3#3)(2007-4#1)(2008-11#10)(2008-4#2)(2008-5#5)(2008-6#2)(2008-8#6)(2009-8#1)(2010-8#1)(2012-2#3)(2012-3#1)(2013-7#1)
spinfilter##8##1##(2008-11#8)
spinner bottle##2##2##(2008-11#2)
spinner culture##4##2##(1994-11#1)(2008-11#3)
spinner flask to##2##3##(2008-11#2)
spinner flask##10##2##(1996-11#1)(2008-11#9)
spinner flasks##3##2##(2008-11#2)(2008-7#1)
spinner##25##1##(1994-11#2)(1996-11#1)(2008-11#19)(2008-3#1)(2008-7#1)(2008-9#1)
spinning NMR##3##2##(1991-7#2)(2006-12#1)
spinning disc##2##2##(2008-9#1)(2010-11#1)
spinning nuclear magnetic resonance spectroscopy##2##5##(2008-10#1)(2013-8#1)
spinning nuclear magnetic resonance##3##4##(2008-10#2)(2013-8#1)
spinning nuclear magnetic##5##3##(2008-1#2)(2008-10#2)(2013-8#1)
spinning rates##3##2##(2008-10#3)
spinning##38##1##(1990-3#1)(1990-4#1)(1991-7#2)(1996-1#1)(2005-11#5)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-1#2)(2010-11#1)(2010-4#1)(2012-2#2)(2013-8#2)
spinocellular##2##1##(1991-3#1)(2008-8#1)
spinocerebellar ataxia in South Africa##2##5##(1997-5#2)
spinocerebellar ataxia type 8 (SCA8)##2##5##(2006-11#1)(2008-8#1)
spinocerebellar ataxia type##4##3##(1997-5#1)(1997-8#1)(2006-11#1)(2008-8#1)
spinocerebellar ataxia##10##2##(1997-5#3)(1997-8#1)(2006-11#1)(2007-2#1)(2007-7#1)(2008-8#1)(2011-12#1)(2013-1#1)
spinocerebellar ataxias (SCAs)##2##3##(2008-6#1)(2008-7#1)
spinocerebellar ataxias##6##2##(2008-11#1)(2008-6#4)(2008-7#1)
spinocerebellar axons##2##2##(1996-5#2)
spinocerebellar tract##2##2##(1996-5#1)(1996-8#1)
spinocerebellar##25##1##(1991-3#2)(1991-8#2)(1996-5#3)(1996-8#1)(1997-5#3)(1997-8#1)(2005-8#1)(2006-11#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-6#4)(2008-7#1)(2008-8#1)(2011-12#1)(2013-1#1)
spinodal decomposition##5##2##(1992-9#1)(1993-8#1)(1995-11#1)(1995-7#1)(2005-11#1)
spinodal demixing##2##2##(2006-10#2)
spinodal##7##1##(1992-9#1)(1993-8#1)(1995-11#1)(1995-7#1)(2005-11#1)(2006-10#2)
spinohypothalamic tract##2##2##(1996-9#2)
spinopelvic parameters##2##2##(2013-8#2)
spinosa##2##1##(2004-11#2)
spinosad##2##1##(2011-2#2)
spinosum##4##1##(2005-9#3)(2008-10#1)
spinosus##4##1##(2008-4#3)(2011-2#1)
spinothalamic tract##4##2##(1991-8#1)(1992-2#1)(1992-5#1)(1996-7#1)
spinothalamic##6##1##(1991-8#2)(1992-2#1)(1992-5#1)(1996-7#1)(2007-3#1)
spinous process##4##2##(2006-6#1)(2007-4#1)(2009-3#1)(2011-2#1)
spinous processes of##2##3##(2007-11#1)(2009-3#1)
spinous processes##7##2##(2007-1#1)(2007-11#2)(2007-5#2)(2009-3#1)(2013-1#1)
spinous##12##1##(2006-6#1)(2007-1#1)(2007-11#2)(2007-4#1)(2007-5#2)(2008-5#1)(2009-3#2)(2011-2#1)(2013-1#1)
spins on##2##2##(1995-8#1)(2008-7#1)
spins with##3##2##(2008-7#3)
spins##16##1##(1995-8#1)(2006-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#10)(2012-2#1)
spinulosa##2##1##(2008-10#1)(2011-1#1)
spiny mice##2##2##(2010-11#2)
spiny mouse)##3##2##(2010-11#3)
spiny neurons (MSNs) that##2##4##(2008-11#1)(2013-8#1)
spiny neurons##6##2##(2008-1#1)(2008-11#2)(2008-4#1)(2013-8#2)
spiny##20##1##(1995-12#1)(2007-12#3)(2007-3#1)(2008-1#1)(2008-11#5)(2008-4#1)(2010-11#5)(2010-3#1)(2013-8#2)
spiperone and##2##2##(1993-11#1)(1997-6#1)
spiperone binding sites##3##3##(1997-6#3)
spiperone plus propranolol##2##3##(1993-11#2)
spiperone##14##1##(1993-11#3)(1995-7#1)(1996-1#1)(1996-12#1)(1997-6#7)(1997-7#1)
spiracles and##2##2##(1995-12#1)(2007-12#1)
spiracles##4##1##(1995-12#1)(2007-12#2)(2008-5#1)
spiradenoma##4##1##(2007-7#4)
spiradoline##2##1##(1997-8#2)
spiraecola##2##1##(2008-10#2)
spiral CT angiography##2##3##(1997-8#1)(2007-8#1)
spiral CT for##2##3##(2005-10#1)(2005-8#1)
spiral CT technology##2##3##(2005-8#2)
spiral CT##19##2##(1997-6#1)(1997-8#1)(2005-10#5)(2005-12#1)(2005-8#3)(2006-4#1)(2007-10#1)(2007-8#2)(2008-3#1)(2008-5#1)(2012-2#2)
spiral and##2##2##(1994-2#1)(1995-5#1)
spiral arteries##2##2##(1994-9#1)(2012-3#1)
spiral cell##3##2##(2008-10#3)
spiral computed tomographic##2##3##(2008-7#1)(2013-8#1)
spiral computed tomography in the evaluation of##2##7##(1995-2#1)(2013-7#1)
spiral computed tomography##9##3##(1995-2#1)(2006-6#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2013-7#2)
spiral computed##11##2##(1995-2#1)(2006-6#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2013-7#2)(2013-8#1)
spiral ganglion cell##2##3##(1996-3#1)(2011-2#1)
spiral ganglion neurons##3##3##(1995-12#3)
spiral ganglion##7##2##(1995-12#3)(1996-3#1)(2008-9#2)(2011-2#1)
spiral optical##2##2##(2008-2#2)
spiral shape##2##2##(2007-12#2)
spiral waves and##2##3##(1995-8#1)(1997-3#1)
spiral waves##6##2##(1992-3#1)(1995-10#1)(1995-8#1)(1997-3#2)(2007-12#1)
spiral##96##1##(1990-3#1)(1991-11#1)(1992-3#1)(1992-7#2)(1994-2#1)(1994-9#1)(1995-10#1)(1995-12#4)(1995-2#1)(1995-5#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-3#2)(1997-3#3)(1997-6#1)(1997-8#1)(2005-10#5)(2005-12#1)(2005-8#3)(2006-2#1)(2006-4#1)(2006-6#2)(2007-10#1)(2007-11#2)(2007-12#6)(2007-8#3)(2008-10#10)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-6#1)(2010-10#2)(2010-5#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
spiral&quot##3##1##(2011-2#3)
spiral-shaped##2##1##(2006-8#1)(2007-12#1)
spiralin##4##1##(2008-10#4)
spiraling costs##2##2##(2007-9#1)(2009-4#1)
spiraling##5##1##(2007-12#3)(2007-9#1)(2009-4#1)
spiralis (T1)##2##2##(1996-12#2)
spiralis##6##1##(1990-12#1)(1992-11#1)(1996-12#2)(2007-12#2)
spiralling##2##1##(2009-11#1)(2009-5#1)
spirally##3##1##(1991-3#1)(1996-2#1)(2011-2#1)
spiramycin##5##1##(1990-9#1)(2008-10#2)(2008-5#2)
spirit and##2##2##(2009-8#1)(2010-7#1)
spirit of##13##2##(1992-12#1)(1993-5#1)(1994-11#1)(1996-1#1)(1997-8#1)(2006-7#1)(2006-8#2)(2007-6#1)(2008-2#2)(2009-10#1)(2012-2#1)
spirit or##3##2##(2007-10#1)(2009-10#1)(2012-3#1)
spirit to##2##2##(1994-11#1)(1995-2#1)
spirit##43##1##(1992-12#1)(1993-5#1)(1994-11#2)(1995-2#2)(1996-1#1)(1996-3#1)(1997-3#1)(1997-8#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#1)(2007-3#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-12#2)(2008-2#4)(2009-10#5)(2009-5#1)(2009-8#1)(2010-7#1)(2012-2#2)(2012-3#2)(2013-1#2)
spirits##10##1##(1992-1#2)(1993-9#1)(1996-3#1)(2005-12#1)(2007-10#1)(2008-10#3)(2009-7#1)
spiritual and religious involvement##2##4##(2009-7#2)
spiritual and religious##6##3##(2006-4#2)(2008-4#2)(2009-7#2)
spiritual and##10##2##(2006-4#2)(2008-1#1)(2008-4#3)(2008-7#1)(2009-7#2)(2013-8#1)
spiritual aspect of##2##3##(2007-2#1)(2008-1#1)
spiritual belief##3##2##(2009-7#1)(2010-2#2)
spiritual care in Hong Kong##4##5##(2010-11#4)
spiritual care in##7##3##(2008-4#1)(2009-11#1)(2010-11#5)
spiritual care##18##2##(1990-5#1)(2008-4#2)(2009-11#2)(2010-11#8)(2010-2#2)(2011-1#3)
spiritual education session##2##3##(2011-1#2)
spiritual experience##3##2##(2009-11#2)(2010-2#1)
spiritual experiences##6##2##(2009-11#2)(2013-1#4)
spiritual journey##2##2##(1994-1#1)(2008-12#1)
spiritual needs##7##2##(1990-10#1)(1993-2#1)(2008-11#3)(2011-1#2)
spiritual practices##2##2##(2008-4#1)(2010-2#1)
spiritual support##2##2##(2011-2#1)(2013-1#1)
spiritual techniques##2##2##(2010-2#2)
spiritual themes##2##2##(2008-4#2)
spiritual well-being##4##2##(2006-7#3)(2008-4#1)
spiritual##110##1##(1990-10#1)(1990-12#1)(1990-5#1)(1993-2#1)(1993-8#1)(1994-1#1)(1995-5#2)(1995-7#3)(1997-2#1)(2004-3#1)(2004-8#2)(2006-4#2)(2006-7#4)(2007-12#1)(2007-2#3)(2007-5#2)(2007-8#1)(2008-1#4)(2008-11#3)(2008-12#5)(2008-4#11)(2008-7#1)(2008-8#1)(2009-11#7)(2009-4#1)(2009-7#5)(2010-11#8)(2010-2#12)(2010-8#1)(2011-1#8)(2011-2#2)(2013-1#7)(2013-8#6)
spirituality and spiritual care in Hong Kong##2##7##(2010-11#2)
spirituality and spiritual##4##3##(2010-11#2)(2013-1#2)
spirituality and##13##2##(1991-6#1)(2008-12#1)(2008-4#2)(2010-11#2)(2010-2#1)(2011-1#1)(2013-1#5)
spirituality as a tool for recovery##2##6##(2008-4#2)
spirituality as a##3##3##(2008-12#1)(2008-4#2)
spirituality has##2##2##(2008-4#1)(2013-1#1)
spirituality in nursing##4##3##(2008-4#4)
spirituality in##14##2##(2006-4#1)(2008-12#2)(2008-4#8)(2008-7#1)(2013-1#1)(2013-8#1)
spirituality to##3##2##(1997-2#1)(2009-11#1)(2010-8#1)
spirituality##68##1##(1991-6#1)(1994-1#1)(1997-2#2)(2004-12#1)(2006-3#1)(2006-4#1)(2007-2#2)(2008-11#3)(2008-12#7)(2008-4#23)(2008-7#1)(2009-11#1)(2009-5#1)(2010-10#1)(2010-11#3)(2010-2#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#13)(2013-8#2)
spirituality&quot##2##1##(2013-1#2)
spiritually based##3##2##(2008-4#1)(2010-10#2)
spiritually##5##1##(2008-4#1)(2009-11#1)(2010-10#2)(2010-2#1)
spirituous beverages##4##2##(2008-10#4)
spirituous##5##1##(2008-10#5)
spiro compounds##2##2##(2007-11#1)(2008-11#1)
spiro heterocycles##2##2##(2007-11#2)
spiro##10##1##(1996-5#1)(2007-11#5)(2008-10#2)(2008-11#1)(2011-1#1)
spirobenzylisoquinoline##2##1##(2008-11#2)
spirochaetes##2##1##(2006-8#1)(2008-5#1)
spirochetal##4##1##(1993-5#1)(2008-9#2)(2011-2#1)
spirochete Borrelia burgdorferi##2##3##(1993-9#1)(2010-6#1)
spirochete Treponema##2##2##(2008-9#1)(2009-10#1)
spirochete of the##2##3##(2007-2#1)(2011-2#1)
spirochete was##2##2##(1996-2#1)(1997-4#1)
spirochete##17##1##(1990-2#1)(1993-5#1)(1993-9#1)(1995-5#1)(1996-2#2)(1997-4#1)(2007-2#1)(2008-9#4)(2009-10#1)(2010-6#2)(2010-7#1)(2011-2#1)
spirochetes##17##1##(1990-2#2)(1997-4#6)(2004-11#1)(2006-5#1)(2006-8#2)(2008-9#3)(2011-2#2)
spirochetosis is##2##2##(2006-8#2)
spirochetosis##7##1##(2006-8#6)(2006-9#1)
spirodioxanyl oligosaccharides##2##2##(1992-12#2)
spirodioxanyl##3##1##(1992-12#3)
spiroergometric##2##1##(2005-1#2)
spiroergometry##4##1##(2005-1#4)
spiroforme##5##1##(1991-8#5)
spirometer##4##1##(2007-10#1)(2009-11#1)(2012-2#1)(2012-3#1)
spirometric and##2##2##(1997-3#1)(2006-10#1)
spirometric parameters##3##2##(2008-1#2)(2008-7#1)
spirometric pulmonary function test##2##4##(2010-8#2)
spirometric values were##2##3##(1990-9#1)(2006-10#1)
spirometric values##3##2##(1990-9#1)(2006-10#1)(2012-12#1)
spirometric variables##2##2##(2007-8#2)
spirometric##20##1##(1990-9#2)(1997-3#1)(2006-10#2)(2006-5#2)(2007-8#2)(2008-1#2)(2008-7#1)(2009-6#1)(2010-8#3)(2011-2#3)(2012-12#1)
spirometry and##5##2##(1990-9#1)(1996-1#1)(2005-11#1)(2006-10#1)(2007-2#1)
spirometry in the primary care##3##5##(2006-5#3)
spirometry in##6##2##(2006-5#4)(2008-1#2)
spirometry interpretation##4##2##(2005-10#4)
spirometry is##3##2##(2006-5#3)
spirometry parameters##2##2##(2007-8#2)
spirometry##51##1##(1990-9#1)(1991-4#1)(1996-1#2)(2005-10#9)(2005-11#1)(2006-10#2)(2006-5#13)(2006-8#1)(2007-2#2)(2007-8#2)(2008-1#3)(2008-12#1)(2008-3#1)(2008-7#2)(2009-3#1)(2009-6#1)(2010-2#2)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
spiromustine##2##1##(2008-4#2)
spironolactone and##4##2##(2007-1#1)(2008-10#2)(2009-8#1)
spironolactone in##2##2##(2007-8#1)(2008-10#1)
spironolactone##25##1##(2004-12#2)(2005-10#1)(2005-7#2)(2007-1#1)(2007-8#6)(2008-10#7)(2008-5#2)(2009-8#1)(2012-12#3)
spiroplas-mas##2##1##(2008-10#2)
spiroplasma membrane##2##2##(2008-10#2)
spiroplasma##11##1##(2008-10#11)
spiroplasmas to##2##2##(2008-10#2)
spiroplasmas with##2##2##(2008-10#2)
spiroplasmas##7##1##(2006-10#1)(2008-10#6)
spiropyran in##2##2##(2008-10#1)(2008-3#1)
spiroxatrine##2##1##(1995-12#2)
spite of a significant##3##4##(1990-5#1)(1992-2#1)(2008-1#1)
spite of a##21##3##(1990-5#1)(1991-4#1)(1991-8#1)(1992-2#1)(1992-3#1)(1993-4#1)(1993-5#1)(1994-6#1)(1997-5#1)(2006-10#1)(2006-8#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-7#1)(2010-10#1)(2012-12#1)
spite of all##3##3##(1994-3#1)(1994-7#1)(2007-11#1)
spite of an##4##3##(1995-11#1)(2006-10#1)(2007-8#1)(2009-3#1)
spite of having##4##3##(1992-10#1)(2008-7#1)(2009-4#1)(2009-6#1)
spite of high##5##3##(1995-10#1)(1996-12#1)(2008-10#1)(2008-4#1)(2008-8#1)
spite of its prevalence##2##4##(2008-6#1)(2013-8#1)
spite of its##19##3##(1992-9#1)(1994-6#1)(1995-12#1)(1995-3#2)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2009-6#1)(2010-7#1)(2013-1#1)(2013-7#1)(2013-8#1)
spite of large##3##3##(1996-7#1)(2007-8#1)(2008-10#1)
spite of long##2##3##(2007-2#1)(2008-7#1)
spite of many##5##3##(1996-9#1)(2006-10#1)(2008-10#2)(2008-8#1)
spite of numerous##2##3##(1992-12#1)(1993-2#1)
spite of remarkable##2##3##(2008-1#1)(2008-12#1)
spite of some##4##3##(1995-12#1)(2004-11#1)(2008-3#1)(2012-2#1)
spite of that##2##3##(2006-11#1)(2006-8#1)
spite of the absence of##3##5##(1991-2#1)(2008-3#1)(2009-2#1)
spite of the fact that##16##5##(1991-10#1)(1991-2#1)(1991-4#1)(1993-5#1)(1994-5#1)(1995-5#1)(2004-9#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-2#1)(2009-8#1)(2010-7#1)(2011-1#1)
spite of the high##2##4##(2007-1#1)(2010-4#1)
spite of the many##2##4##(2007-11#1)(2008-5#1)
spite of the small##2##4##(1994-3#1)(2009-3#1)
spite of the##104##3##(1990-10#1)(1990-2#2)(1990-5#1)(1991-10#1)(1991-2#3)(1991-4#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1994-3#1)(1994-5#1)(1995-5#2)(1996-10#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-4#1)(2004-12#1)(2004-4#1)(2004-9#1)(2005-11#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#4)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#2)(2009-3#1)(2009-8#1)(2010-11#1)(2010-4#2)(2010-7#1)(2011-1#3)(2011-2#2)(2012-12#3)(2012-2#3)(2013-1#2)(2013-8#1)
spite of their##13##3##(1991-9#1)(1994-5#1)(1996-4#1)(1996-5#1)(1997-4#1)(2005-8#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-12#1)
spite of this##16##3##(1991-12#1)(1991-2#1)(1992-10#1)(1994-6#1)(1995-2#1)(1995-6#1)(1997-2#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-12#1)(2011-1#1)(2013-1#2)
spite of##299##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#4)(1991-4#3)(1991-8#3)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-9#3)(1993-1#1)(1993-10#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#2)(1994-12#1)(1994-3#2)(1994-4#1)(1994-5#3)(1994-6#3)(1994-7#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#1)(1995-7#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-5#2)(1997-7#1)(2004-11#1)(2004-12#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-8#2)(2006-10#7)(2006-11#2)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#5)(2006-9#1)(2007-1#1)(2007-11#8)(2007-12#1)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#7)(2007-8#10)(2007-9#1)(2008-1#3)(2008-10#29)(2008-11#7)(2008-12#6)(2008-2#5)(2008-3#6)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#7)(2008-8#5)(2008-9#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#9)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#3)
spite##300##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#4)(1991-4#3)(1991-8#3)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-9#3)(1993-1#1)(1993-10#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#2)(1994-12#1)(1994-3#2)(1994-4#1)(1994-5#3)(1994-6#3)(1994-7#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#1)(1995-7#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-5#2)(1997-7#1)(2004-11#1)(2004-12#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-8#2)(2006-10#7)(2006-11#2)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#5)(2006-9#1)(2007-1#1)(2007-11#8)(2007-12#1)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#7)(2007-8#10)(2007-9#1)(2008-1#3)(2008-10#29)(2008-11#7)(2008-12#6)(2008-2#5)(2008-3#6)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#7)(2008-8#5)(2008-9#2)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#9)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#3)
spitting##4##1##(1997-5#1)(2006-2#1)(2011-1#2)
splanchnic nerve stimulation##2##3##(1997-5#2)
splanchnic nerve##3##2##(1997-5#3)
splanchnic nerves##3##2##(1997-8#1)(2006-12#1)(2006-8#1)
splanchnic##14##1##(1991-8#1)(1996-3#2)(1997-5#3)(1997-7#1)(1997-8#1)(2006-12#1)(2006-8#2)(2008-12#1)(2008-6#1)(2012-2#1)
splash dispersal of three##2##4##(2008-10#2)
splash dispersal of##5##3##(2008-10#5)
splash dispersal##13##2##(2008-10#13)
splash in##2##2##(2008-10#2)
splash##22##1##(2008-10#22)
splash-dispersed##2##1##(2008-10#2)
splashed rain intensity and##2##4##(2008-10#2)
splashed rain##5##2##(2008-10#5)
splashed##7##1##(2007-9#1)(2008-10#6)
splashing##5##1##(2008-10#5)
splay##2##1##(1996-1#2)
spleen &gt##2##2##(1994-11#1)(1994-9#1)
spleen T##2##2##(1992-8#1)(2008-5#1)
spleen and a##2##3##(1994-11#1)(2010-12#1)
spleen and bone marrow##2##4##(1991-9#1)(2008-5#1)
spleen and bone##3##3##(1991-9#1)(1995-11#1)(2008-5#1)
spleen and brain##2##3##(1990-4#1)(1993-2#1)
spleen and kidney##2##3##(1994-5#1)(2009-5#1)
spleen and kidneys##2##3##(1993-5#1)(2012-3#1)
spleen and liver##9##3##(1994-5#1)(2006-10#1)(2008-10#2)(2008-5#3)(2008-6#1)(2008-7#1)
spleen and lungs##2##3##(2013-1#2)
spleen and lymph node##3##4##(2008-4#3)
spleen and lymph nodes##3##4##(1994-3#1)(2008-10#1)(2008-4#1)
spleen and lymph##6##3##(1994-3#1)(2008-10#1)(2008-4#4)
spleen and pronephros was##3##4##(1997-3#3)
spleen and pronephros##6##3##(1997-3#6)
spleen and testis##3##3##(2008-8#2)(2009-2#1)
spleen and thymus after##2##4##(2008-10#1)(2013-8#1)
spleen and thymus##5##3##(1990-2#1)(2008-10#1)(2012-1#1)(2013-8#2)
spleen and##74##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#2)(1990-7#1)(1991-4#1)(1991-9#1)(1992-10#1)(1993-2#1)(1993-4#2)(1993-5#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-3#6)(1997-6#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-6#1)(2007-2#1)(2008-10#7)(2008-4#6)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#2)(2013-8#2)
spleen are##4##2##(2006-11#1)(2008-4#1)(2008-9#2)
spleen as well as in the remnant##2##7##(1992-7#2)
spleen as well as##4##4##(1992-7#2)(2008-4#2)
spleen as##5##2##(1992-7#2)(2008-4#2)(2013-8#1)
spleen by##3##2##(2007-2#1)(2008-4#1)(2010-12#1)
spleen cell numbers##2##3##(1991-12#1)(1995-2#1)
spleen cell##5##2##(1991-12#3)(1995-2#1)(2008-4#1)
spleen cells and##3##3##(1991-12#1)(2008-4#2)
spleen cells from diabetic##2##4##(1994-3#1)(1996-10#1)
spleen cells from##8##3##(1991-12#1)(1991-9#1)(1992-7#1)(1994-3#1)(1995-2#1)(1995-9#1)(1996-10#1)(2007-2#1)
spleen cells stimulated with LPS-A##4##5##(2006-8#4)
spleen cells stimulated with##5##4##(2006-8#5)
spleen cells to produce NO##2##5##(2006-8#2)
spleen cells to produce##3##4##(2006-8#3)
spleen cells to##4##3##(2006-8#3)(2007-11#1)
spleen cells were##2##3##(1995-2#1)(2007-2#1)
spleen cells with##2##3##(1990-2#1)(1996-12#1)
spleen cells##43##2##(1990-2#1)(1991-12#3)(1991-9#1)(1992-7#4)(1994-2#1)(1994-3#2)(1995-2#3)(1995-6#1)(1995-7#1)(1995-9#6)(1996-10#1)(1996-11#1)(1996-12#1)(2006-8#9)(2007-11#1)(2007-2#2)(2008-11#1)(2008-4#3)(2008-7#1)
spleen due to##2##3##(2008-11#1)(2010-1#1)
spleen ferritin##2##2##(1996-2#1)(2012-1#1)
spleen in the left##2##4##(1990-5#1)(2012-2#1)
spleen in the##3##3##(1990-5#1)(1992-3#1)(2012-2#1)
spleen in##8##2##(1990-5#1)(1992-2#1)(1992-3#1)(1992-7#1)(1995-2#1)(2008-10#1)(2010-8#1)(2012-2#1)
spleen is a##2##3##(1990-9#1)(2008-11#1)
spleen is##3##2##(1990-9#1)(1992-12#1)(2008-11#1)
spleen mass##2##2##(2008-9#2)
spleen of##8##2##(1992-7#1)(1995-10#1)(1995-2#2)(2006-7#1)(2008-5#1)(2008-9#1)(2012-2#1)
spleen or thymus##3##3##(2008-10#1)(2008-4#2)
spleen or##7##2##(1992-8#2)(1996-12#1)(2008-10#1)(2008-4#3)
spleen preserving resections##2##3##(2008-9#2)
spleen re-plantation##2##2##(2009-2#2)
spleen samples from##2##3##(2013-8#2)
spleen size in##3##3##(2007-3#2)(2012-12#1)
spleen to##4##2##(1992-8#1)(1994-2#1)(1995-2#1)(2008-11#1)
spleen trauma##4##2##(2008-9#4)
spleen tyrosine protein##2##3##(1990-12#2)
spleen was##5##2##(1991-11#1)(1995-2#1)(2006-1#2)(2008-9#1)
spleen weight##6##2##(1991-6#1)(1996-12#2)(2008-10#1)(2013-8#2)
spleen were significantly decreased##2##4##(1995-12#1)(2008-4#1)
spleen were significantly##3##3##(1993-3#1)(1995-12#1)(2008-4#1)
spleen were##10##2##(1992-3#1)(1993-3#1)(1995-12#1)(1995-2#1)(2006-7#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-7#1)
spleen with##3##2##(1992-5#1)(1993-9#1)(2008-6#1)
spleen##450##1##(1990-10#1)(1990-11#3)(1990-12#7)(1990-2#4)(1990-3#4)(1990-4#8)(1990-5#5)(1990-7#5)(1990-9#7)(1991-10#1)(1991-11#1)(1991-12#8)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#7)(1991-8#2)(1991-9#5)(1992-10#2)(1992-11#4)(1992-12#1)(1992-2#2)(1992-3#4)(1992-5#3)(1992-6#3)(1992-7#9)(1992-8#4)(1992-9#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#2)(1993-5#2)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#3)(1994-11#5)(1994-12#2)(1994-2#3)(1994-3#6)(1994-5#3)(1994-8#2)(1994-9#3)(1995-1#1)(1995-10#3)(1995-11#2)(1995-12#8)(1995-2#12)(1995-3#3)(1995-5#1)(1995-6#2)(1995-7#1)(1995-9#7)(1996-10#5)(1996-11#3)(1996-12#7)(1996-2#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#8)(1997-4#2)(1997-6#2)(1997-8#2)(1997-9#1)(2004-2#1)(2005-10#3)(2005-7#1)(2006-1#6)(2006-10#2)(2006-11#2)(2006-12#1)(2006-4#2)(2006-6#6)(2006-7#2)(2006-8#9)(2007-11#2)(2007-2#9)(2007-3#4)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#21)(2008-11#9)(2008-4#24)(2008-5#20)(2008-6#5)(2008-7#9)(2008-8#6)(2008-9#17)(2009-2#4)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#8)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-12#3)(2011-2#1)(2012-1#4)(2012-12#2)(2012-2#10)(2012-3#2)(2013-1#4)(2013-8#11)
spleen)##4##1##(1994-11#1)(1995-12#1)(2008-9#1)(2009-8#1)
spleen]##4##1##(1992-10#1)(1994-9#1)(2008-9#1)(2009-5#1)
spleens and peripheral blood##2##4##(1994-2#1)(2013-8#1)
spleens and##5##2##(1990-7#2)(1994-2#1)(2006-2#1)(2013-8#1)
spleens from##2##2##(2008-11#1)(2013-8#1)
spleens of immunized##2##3##(1995-2#1)(2008-4#1)
spleens of##10##2##(1994-2#1)(1995-2#2)(2008-10#2)(2008-4#1)(2008-5#1)(2013-8#3)
spleens##36##1##(1990-12#1)(1990-7#5)(1992-7#1)(1993-11#1)(1994-2#3)(1994-3#1)(1994-6#1)(1995-2#2)(1995-9#1)(1996-12#1)(1997-6#1)(2006-2#2)(2008-10#3)(2008-11#2)(2008-4#2)(2008-5#1)(2010-12#1)(2013-8#7)
splendens##6##1##(2008-5#2)(2008-8#1)(2009-12#2)(2012-2#1)
splendid##2##1##(2007-8#1)(2008-1#1)
splendida##3##1##(2007-3#2)(2013-7#1)
splenectomized individuals##2##2##(1994-9#2)
splenectomized patient with systemic lupus erythematosus##2##6##(2006-10#2)
splenectomized patients##6##2##(1990-9#2)(1994-9#2)(2005-10#1)(2009-4#1)
splenectomized##17##1##(1990-9#2)(1991-5#1)(1994-9#8)(2005-10#1)(2006-10#2)(2008-4#1)(2009-4#1)(2012-3#1)
splenectomy and##6##2##(1997-8#1)(2007-3#1)(2010-1#1)(2010-12#1)(2011-2#1)(2013-8#1)
splenectomy for##2##2##(1992-10#1)(2007-5#1)
splenectomy in##3##2##(2007-12#1)(2007-2#1)(2012-3#1)
splenectomy is##4##2##(2007-2#2)(2008-9#2)
splenectomy using a linear stapler##2##5##(1992-3#2)
splenectomy was beneficial##2##3##(2007-2#2)
splenectomy was##3##2##(1992-5#1)(2007-2#2)
splenectomy with##3##2##(2012-12#2)(2012-2#1)
splenectomy##59##1##(1990-9#1)(1992-10#2)(1992-3#2)(1992-5#1)(1993-10#1)(1994-9#3)(1997-8#1)(2006-1#1)(2006-2#1)(2007-12#3)(2007-2#8)(2007-3#2)(2007-5#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-2#2)(2010-1#2)(2010-12#2)(2010-6#1)(2011-12#1)(2011-2#5)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#3)
splenic B##3##2##(1992-7#2)(1995-12#1)
splenic CD4 T cells##3##4##(2008-11#3)
splenic DCs##3##2##(2008-11#3)
splenic T cells##2##3##(1993-12#1)(2008-5#1)
splenic T-cells##2##2##(2008-10#2)
splenic T-lymphocytes##4##2##(2008-10#3)(2008-7#1)
splenic abscess##4##2##(1991-5#1)(2006-2#1)(2007-2#2)
splenic and##2##2##(2008-10#1)(2008-4#1)
splenic artery aneurysm##5##3##(2007-1#1)(2011-2#4)
splenic artery##16##2##(1990-10#1)(1990-3#1)(1993-10#3)(2006-2#2)(2006-6#1)(2007-1#1)(2008-7#1)(2011-2#5)(2012-2#1)
splenic cellularity##2##2##(2008-10#2)
splenic culture for Leishmania##4##4##(2008-7#4)
splenic cyst##7##2##(1993-5#1)(1997-8#5)(2007-12#1)
splenic cysts##2##2##(1993-5#1)(2008-7#1)
splenic dendritic cells##2##3##(2007-2#1)(2008-11#1)
splenic explants from young##2##4##(2010-12#2)
splenic flexure##6##2##(1993-9#1)(2006-6#1)(2008-12#2)(2013-8#2)
splenic hematoma##3##2##(2011-2#3)
splenic infarction##2##2##(2007-2#1)(2009-6#1)
splenic injury##3##2##(1991-6#1)(2007-4#2)
splenic involvement##3##2##(2006-1#2)(2013-1#1)
splenic lymphocyte##2##2##(2008-10#1)(2012-3#1)
splenic lymphocytes##5##2##(1991-12#1)(1992-8#2)(2008-10#1)(2008-4#1)
splenic macrophages##7##2##(1991-6#1)(1995-10#1)(2006-8#3)(2008-10#2)
splenic mass##3##2##(2012-2#3)
splenic metastasis of##2##3##(1992-2#1)(2011-2#1)
splenic metastasis##7##2##(1992-2#1)(1993-9#2)(2007-8#2)(2011-2#2)
splenic remnant##2##2##(1992-3#1)(2007-2#1)
splenic rupture in##5##3##(1992-2#2)(1992-5#1)(1993-9#1)(2011-2#1)
splenic rupture##13##2##(1992-2#4)(1992-5#1)(1993-9#1)(2007-4#3)(2007-5#1)(2011-12#1)(2011-2#2)
splenic sequestration crisis##3##3##(2007-2#3)
splenic sequestration##5##2##(2007-2#3)(2013-1#2)
splenic tRNAs from##2##3##(1991-10#2)
splenic tRNAs were##2##3##(1991-10#2)
splenic tRNAs##4##2##(1991-10#4)
splenic tumor##2##2##(2011-2#2)
splenic##191##1##(1990-10#1)(1990-3#1)(1991-10#4)(1991-12#1)(1991-5#1)(1991-6#3)(1992-10#4)(1992-11#1)(1992-2#6)(1992-3#2)(1992-5#2)(1992-7#2)(1992-8#3)(1993-10#3)(1993-12#4)(1993-5#2)(1993-9#5)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#1)(1996-10#1)(1997-3#3)(1997-8#5)(2005-10#1)(2006-1#2)(2006-2#3)(2006-6#5)(2006-8#3)(2007-1#1)(2007-12#1)(2007-2#10)(2007-3#2)(2007-4#5)(2007-5#2)(2007-8#3)(2007-9#1)(2008-10#16)(2008-11#9)(2008-12#2)(2008-4#3)(2008-5#2)(2008-7#11)(2008-9#1)(2009-6#1)(2009-9#1)(2010-12#8)(2011-1#1)(2011-12#1)(2011-2#18)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#5)(2013-8#4)
splenium##2##1##(2010-12#2)
splenius##2##1##(2006-12#1)(2010-9#1)
splenocyte proliferation##5##2##(1991-3#1)(2008-10#4)
splenocyte subsets##2##2##(2008-10#1)(2011-2#1)
splenocyte##23##1##(1991-12#1)(1991-3#1)(1993-11#1)(1993-12#1)(1996-12#1)(1997-4#2)(2008-10#10)(2008-11#1)(2008-4#2)(2011-2#1)(2012-1#1)(2013-8#1)
splenocytes as##2##2##(1995-2#1)(2008-10#1)
splenocytes coupled with##2##3##(1991-12#2)
splenocytes from BALB/c##2##3##(1991-12#1)(2012-1#1)
splenocytes from toxic action of benzene and aflatoxin B1##2##9##(2004-12#2)
splenocytes from##8##2##(1991-12#2)(1995-2#1)(1996-12#1)(2004-12#2)(2008-10#1)(2012-1#1)
splenocytes immunized with##2##3##(2008-11#2)
splenocytes of##2##2##(1990-2#1)(2008-8#1)
splenocytes or##2##2##(1991-3#1)(2008-10#1)
splenocytes to##3##2##(1991-1#1)(1991-12#1)(1992-8#1)
splenocytes was##4##2##(1995-12#1)(1995-2#1)(2008-10#2)
splenocytes were##5##2##(1991-12#1)(1997-4#1)(2007-2#1)(2008-10#1)(2008-5#1)
splenocytes with##3##2##(1991-1#1)(2008-11#2)
splenocytes##68##1##(1990-2#1)(1990-5#1)(1991-1#3)(1991-12#10)(1991-3#2)(1991-8#2)(1991-9#1)(1992-11#1)(1992-7#3)(1992-8#4)(1993-12#1)(1995-12#1)(1995-2#3)(1996-12#2)(1997-4#1)(2004-12#3)(2006-8#2)(2007-2#3)(2008-10#8)(2008-11#6)(2008-5#4)(2008-8#1)(2008-9#1)(2010-12#1)(2012-1#2)(2013-1#1)
splenomegaly and##9##2##(1992-11#1)(2005-8#1)(2006-10#1)(2006-4#1)(2007-12#1)(2008-10#2)(2008-7#1)(2011-2#1)
splenomegaly in##5##2##(2007-2#1)(2007-3#2)(2008-10#1)(2011-1#1)
splenomegaly was##3##2##(2008-5#1)(2011-2#1)(2012-2#1)
splenomegaly##35##1##(1990-6#1)(1992-11#1)(1994-11#1)(1996-4#1)(2005-8#1)(2006-10#2)(2006-4#1)(2006-6#1)(2007-12#3)(2007-2#1)(2007-3#5)(2007-4#1)(2008-10#3)(2008-5#1)(2008-7#2)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-8#1)
splenorrhaphy##2##1##(2008-9#2)
splice acceptor site##8##3##(1990-6#2)(1993-11#1)(1993-5#1)(1995-12#2)(1997-7#1)(2012-12#1)
splice acceptor##9##2##(1990-6#2)(1993-11#1)(1993-5#1)(1995-12#2)(1997-5#1)(1997-7#1)(2012-12#1)
splice consensus deletion##2##3##(1990-11#2)
splice donor site of##2##4##(2007-2#1)(2011-1#1)
splice donor##4##2##(1993-5#1)(1994-11#1)(2007-2#1)(2011-1#1)
splice forms of##2##3##(1994-12#1)(1994-9#1)
splice forms##4##2##(1994-12#2)(1994-9#1)(1996-12#1)
splice junction sequences##3##3##(1992-6#1)(1994-12#1)(1995-2#1)
splice junction##10##2##(1991-2#3)(1991-9#1)(1992-6#1)(1992-7#1)(1994-12#1)(1995-2#1)(1996-5#1)(2008-4#1)
splice junctions##6##2##(1991-12#1)(1991-9#3)(1995-8#1)(1996-7#1)
splice mutation##3##2##(1990-12#1)(2008-4#1)(2010-4#1)
splice products##2##2##(1991-6#1)(1992-3#1)
splice sequence##2##2##(1990-2#2)
splice signals##2##2##(1994-8#2)
splice site in##2##3##(1994-9#1)(2008-8#1)
splice site variants##2##3##(2011-1#2)
splice site##24##2##(1990-11#1)(1991-11#1)(1991-5#2)(1993-6#1)(1993-8#1)(1994-8#3)(1994-9#1)(1995-12#2)(1996-9#4)(1997-7#2)(2008-8#2)(2009-10#1)(2009-5#1)(2011-1#2)
splice sites and##2##3##(1990-6#1)(1992-1#1)
splice sites for##2##3##(1995-8#2)
splice sites##9##2##(1990-6#1)(1992-1#2)(1992-6#1)(1993-6#1)(1995-8#3)(2008-4#1)
splice variant of the##3##4##(1992-2#1)(1995-1#1)(1996-11#1)
splice variant of##12##3##(1992-2#2)(1992-7#1)(1995-1#1)(1996-11#1)(1996-5#1)(1997-1#1)(1997-7#1)(2008-8#1)(2009-4#3)
splice variant##21##2##(1992-2#2)(1992-7#1)(1994-12#1)(1995-1#1)(1996-11#2)(1996-12#1)(1996-5#1)(1997-1#1)(1997-7#5)(2008-3#1)(2008-8#2)(2009-4#3)
splice variants in##2##3##(2012-2#2)
splice variants of##2##3##(1994-12#1)(2008-4#1)
splice variants were##2##3##(1994-8#1)(2011-2#1)
splice variants##12##2##(1992-10#1)(1994-12#1)(1994-8#1)(1996-12#1)(2008-4#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-8#1)
splice##121##1##(1990-11#3)(1990-12#1)(1990-2#2)(1990-6#3)(1991-11#1)(1991-12#1)(1991-2#3)(1991-5#3)(1991-6#1)(1991-9#4)(1992-1#2)(1992-10#1)(1992-2#2)(1992-3#1)(1992-6#2)(1992-7#2)(1993-11#1)(1993-4#1)(1993-5#3)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#6)(1994-8#6)(1994-9#2)(1995-1#1)(1995-12#4)(1995-2#1)(1995-8#4)(1996-11#2)(1996-12#4)(1996-5#3)(1996-7#1)(1996-9#4)(1997-1#1)(1997-5#1)(1997-7#8)(2007-11#1)(2007-2#1)(2008-3#1)(2008-4#5)(2008-8#5)(2009-10#2)(2009-4#3)(2009-5#1)(2009-9#1)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#3)(2013-8#1)
splice-isoform of CIITA##2##3##(2011-1#2)
splice-site##8##1##(1990-11#1)(1993-6#5)(1997-7#1)(2010-1#1)
spliced RNA##3##2##(1990-6#1)(1991-9#2)
spliced at the##2##3##(1993-12#1)(1995-8#1)
spliced exon##5##2##(1991-11#1)(1992-4#1)(1992-5#2)(1994-8#1)
spliced form##2##2##(1997-4#1)(2008-6#1)
spliced in a##2##3##(1991-6#2)
spliced in##3##2##(1991-6#2)(1997-5#1)
spliced mRNA##6##2##(1990-7#2)(1993-6#1)(1994-12#1)(1997-7#1)(2012-2#1)
spliced mRNAs##2##2##(1993-6#1)(2012-2#1)
spliced out in##2##3##(1993-8#1)(1995-12#1)
spliced out##3##2##(1993-8#1)(1995-12#1)(1997-4#1)
spliced to the##2##3##(1990-8#1)(1996-9#1)
spliced to##4##2##(1990-8#1)(1994-12#1)(1996-5#1)(1996-9#1)
spliced transcript of##2##3##(1994-12#1)(1997-2#1)
spliced transcript##3##2##(1994-12#1)(1996-5#1)(1997-2#1)
spliced transcripts##9##2##(1991-9#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-9#1)(1997-8#1)
spliced variants of##2##3##(1992-7#1)(1994-8#1)
spliced variants##3##2##(1992-7#1)(1994-8#1)(1997-2#1)
spliced viral transcripts##2##3##(1994-8#1)(2011-3#1)
spliced viral##3##2##(1994-8#1)(1996-4#1)(2011-3#1)
spliced with the##2##3##(1997-4#1)(2008-8#1)
spliced##101##1##(1990-12#1)(1990-6#2)(1990-7#3)(1990-8#2)(1991-10#1)(1991-11#1)(1991-6#2)(1991-7#1)(1991-9#3)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#1)(1993-12#2)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#8)(1994-2#1)(1994-3#5)(1994-8#4)(1994-9#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#3)(1996-4#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-2#3)(1997-4#6)(1997-5#1)(1997-7#4)(1997-8#1)(2004-2#1)(2006-11#1)(2007-11#2)(2007-12#3)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2011-3#1)(2012-2#3)
spliceosomal introns##3##2##(1995-8#2)(2009-5#1)
spliceosomal##4##1##(1990-11#1)(1995-8#2)(2009-5#1)
spliceosome##5##1##(1995-6#2)(2008-2#3)
spliceosomes##4##1##(1991-6#1)(1995-6#1)(2008-2#1)(2013-8#1)
splices##2##1##(1995-6#1)(2008-2#1)
splicing and##19##2##(1990-6#1)(1990-8#1)(1992-4#1)(1993-2#1)(1993-6#1)(1994-5#1)(1994-8#1)(1996-2#1)(1997-7#1)(2007-12#2)(2008-11#1)(2008-4#2)(2008-7#2)(2009-2#1)(2009-7#1)(2012-12#1)
splicing at the##2##3##(1992-5#1)(1993-4#1)
splicing at##5##2##(1991-7#1)(1992-5#1)(1993-4#1)(1993-9#1)(1995-6#1)
splicing between##2##2##(1992-5#1)(2008-12#1)
splicing but##2##2##(1995-6#1)(2007-11#1)
splicing by##9##2##(1991-2#1)(1991-5#1)(1991-9#3)(1992-5#1)(1992-6#1)(1993-12#1)(1997-4#1)
splicing event##4##2##(1991-10#1)(1994-12#1)(1996-5#1)(2007-6#1)
splicing events##7##2##(1992-6#1)(1993-8#1)(1997-5#1)(2008-4#1)(2010-11#1)(2010-12#2)
splicing factor##7##2##(1993-8#1)(1995-6#2)(1997-4#1)(2011-1#3)
splicing factors##4##2##(1992-12#1)(2007-12#1)(2009-10#1)(2009-2#1)
splicing generates##2##2##(1992-4#1)(1997-4#1)
splicing gives rise to##2##4##(1990-2#1)(1994-3#1)
splicing in C##2##3##(2007-12#2)
splicing in the##4##3##(1990-7#1)(1991-7#1)(1992-6#1)(2008-12#1)
splicing in##14##2##(1990-7#1)(1991-6#2)(1991-7#1)(1992-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1996-5#1)(2007-12#2)(2008-12#1)(2008-2#1)(2010-11#1)
splicing is a##3##3##(1993-12#1)(1995-8#1)(2007-12#1)
splicing is##6##2##(1991-6#1)(1993-12#1)(1993-8#1)(1995-8#2)(2007-12#1)
splicing isoform##2##2##(1997-2#2)
splicing machinery from##2##3##(1992-1#1)(2009-10#1)
splicing may play##2##3##(1996-10#1)(1996-7#1)
splicing may##4##2##(1994-9#1)(1996-10#1)(1996-7#1)(1997-4#1)
splicing mechanism##2##2##(1993-6#1)(1996-10#1)
splicing occurs##3##2##(1995-1#1)(1995-6#1)(1997-4#1)
splicing of RNA##3##3##(1991-4#1)(1993-12#1)(1993-8#1)
splicing of a##9##3##(1990-5#1)(1991-5#1)(1993-11#1)(1993-5#1)(1994-6#1)(1994-9#2)(1996-5#1)(2008-8#1)
splicing of exon##5##3##(1990-7#1)(1991-12#1)(1991-6#1)(1992-5#1)(1996-5#1)
splicing of five exons##2##4##(1993-6#1)(1997-4#1)
splicing of group I introns##2##5##(1995-1#1)(1995-6#1)
splicing of its##2##3##(1991-5#1)(1996-5#1)
splicing of pre-mRNA##2##3##(1991-9#2)
splicing of purified precursor##2##4##(1993-12#2)
splicing of the##17##3##(1990-11#1)(1990-5#2)(1991-1#1)(1991-5#1)(1992-5#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#2)(1994-3#1)(1995-3#1)(1996-10#1)(2008-7#1)
splicing of##65##2##(1990-11#1)(1990-12#2)(1990-5#3)(1990-6#1)(1990-7#1)(1991-1#2)(1991-12#1)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-5#2)(1993-11#1)(1993-12#3)(1993-5#2)(1993-6#2)(1993-8#4)(1993-9#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-10#1)(1996-4#1)(1996-5#4)(1997-4#1)(1997-5#1)(2008-4#2)(2008-7#1)(2008-8#1)(2012-2#2)
splicing or##2##2##(1993-12#1)(2008-9#1)
splicing out of exon##2##4##(1994-8#1)(1995-12#1)
splicing pattern##2##2##(1991-6#1)(2008-8#1)
splicing process and##2##3##(1991-9#1)(1993-11#1)
splicing process##4##2##(1991-9#2)(1993-11#1)(1996-7#1)
splicing product##2##2##(1995-8#1)(1996-7#1)
splicing reaction##2##2##(1990-6#1)(1991-9#1)
splicing site##4##2##(1993-6#1)(1993-9#2)(2007-6#1)
splicing that##3##2##(1995-2#1)(2007-12#1)(2010-12#1)
splicing variants of##2##3##(1995-3#1)(1996-7#1)
splicing was##4##2##(1992-12#2)(1993-12#1)(2012-2#1)
splicing were##2##2##(1992-5#2)
splicing##331##1##(1990-11#3)(1990-12#3)(1990-2#2)(1990-5#3)(1990-6#5)(1990-7#2)(1990-8#1)(1991-1#4)(1991-10#1)(1991-12#1)(1991-2#5)(1991-4#2)(1991-5#4)(1991-6#9)(1991-7#5)(1991-9#9)(1992-1#5)(1992-10#1)(1992-12#7)(1992-4#3)(1992-5#10)(1992-6#5)(1992-7#2)(1993-11#2)(1993-12#9)(1993-2#1)(1993-4#2)(1993-5#4)(1993-6#8)(1993-7#1)(1993-8#10)(1993-9#8)(1994-11#1)(1994-12#6)(1994-2#4)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#5)(1995-1#9)(1995-12#3)(1995-2#2)(1995-3#4)(1995-5#1)(1995-6#12)(1995-8#5)(1996-10#4)(1996-11#1)(1996-2#2)(1996-4#2)(1996-5#9)(1996-7#7)(1997-2#4)(1997-4#11)(1997-5#2)(1997-7#3)(2007-11#3)(2007-12#13)(2007-6#4)(2007-8#1)(2008-11#1)(2008-12#2)(2008-2#3)(2008-4#8)(2008-7#6)(2008-8#7)(2008-9#3)(2009-10#4)(2009-2#3)(2009-5#1)(2009-7#1)(2010-1#1)(2010-11#4)(2010-12#6)(2010-7#1)(2011-1#6)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#4)(2013-8#1)
splicing]##4##1##(2010-11#4)
spline approximation##2##2##(1996-1#1)(2008-2#1)
spline functions##5##2##(1994-5#3)(2006-12#1)(2007-1#1)
spline interpolation##2##2##(2008-3#1)(2010-12#1)
spline wavelet##4##2##(2008-10#4)
spline##25##1##(1993-1#1)(1994-5#3)(1995-9#2)(1996-1#1)(1997-6#2)(2006-12#1)(2007-1#1)(2008-10#5)(2008-2#1)(2008-3#3)(2008-6#1)(2009-3#1)(2010-12#1)(2012-1#1)(2012-12#1)
spline-based Cox regression##4##3##(2013-1#4)
spline-based##6##1##(2013-1#6)
splines and##2##2##(1997-6#2)
splines##8##1##(1997-6#2)(2008-11#1)(2008-6#4)(2012-1#1)
splint bone##3##2##(1991-6#3)
splint therapy##2##2##(2012-2#2)
splint##34##1##(1991-6#4)(2006-8#2)(2007-11#4)(2007-3#1)(2007-7#1)(2007-8#3)(2008-10#5)(2008-3#2)(2009-3#5)(2010-6#3)(2011-12#1)(2012-12#1)(2012-2#2)
splinted##2##1##(2006-3#1)(2008-4#1)
splinting of the##2##3##(1993-11#1)(1997-4#1)
splinting##8##1##(1993-11#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-5#2)
splints in##3##2##(2007-11#1)(2008-10#2)
splints##12##1##(2006-10#2)(2007-11#2)(2008-10#3)(2008-11#2)(2008-7#1)(2010-6#2)
split CFTR##2##2##(2011-3#2)
split and##3##2##(2007-10#1)(2007-12#2)
split angle##3##2##(2007-12#3)
split between##5##2##(1990-12#1)(1993-6#1)(2007-12#1)(2013-8#2)
split by a##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
split by##8##2##(1995-11#1)(1995-6#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-3#1)
split common fixed point problem##2##5##(2011-2#2)
split decomposition##2##2##(2008-4#1)(2008-5#1)
split from##2##2##(2008-6#1)(2009-10#1)
split in##4##2##(1995-8#1)(2007-12#1)(2011-1#1)(2011-10#1)
split influenza##2##2##(2009-5#1)(2010-1#1)
split into three##3##3##(1996-6#1)(2008-10#1)(2008-7#1)
split into two beams##2##4##(2007-12#2)
split into two##13##3##(1994-10#1)(1994-9#1)(2007-12#3)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)(2013-8#1)
split into##34##2##(1992-11#1)(1992-8#1)(1993-12#1)(1994-10#1)(1994-2#1)(1994-9#1)(1995-6#1)(1995-9#1)(1996-6#1)(1996-8#1)(1997-6#1)(2005-11#1)(2007-11#1)(2007-12#5)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-12#1)(2010-4#1)(2013-8#2)
split liver##2##2##(2008-12#1)(2010-6#1)
split of the##5##3##(1991-8#1)(1995-3#1)(1996-11#1)(2010-5#1)(2010-7#1)
split of##13##2##(1991-8#1)(1992-10#1)(1994-6#1)(1995-11#1)(1995-3#1)(1996-11#1)(2007-12#2)(2007-2#1)(2008-1#1)(2009-10#1)(2010-5#1)(2010-7#1)
split on##2##2##(1996-2#1)(2010-2#1)
split or##2##2##(1993-2#1)(1995-5#1)
split plot ANOVA##2##3##(2007-11#1)(2012-12#1)
split plot##5##2##(2007-11#1)(2008-12#3)(2012-12#1)
split rice spikelet##3##3##(2008-8#3)
split root##2##2##(2008-10#2)
split score##2##2##(1997-5#2)
split skin graft##4##3##(1990-4#1)(2007-7#3)
split skin##9##2##(1990-4#1)(2007-7#7)(2008-2#1)
split the##6##2##(1996-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-2#1)
split to##3##2##(2008-5#1)(2009-12#1)(2010-11#1)
split virus##2##2##(2007-11#2)
split window##2##2##(2013-8#2)
split with##2##2##(1997-2#1)(2007-11#1)
split##193##1##(1990-12#2)(1990-4#1)(1990-5#2)(1991-11#1)(1991-8#2)(1992-10#2)(1992-11#2)(1992-8#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#3)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#4)(1997-6#2)(1997-8#2)(2005-11#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#20)(2007-2#1)(2007-7#12)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#3)(2008-12#7)(2008-2#5)(2008-3#7)(2008-4#7)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#6)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-10#1)(2011-2#3)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-8#7)
split-face##2##1##(2008-5#2)
split-fovea processing##2##2##(2009-2#2)
split-half##2##1##(1996-8#1)(2007-12#1)
split-mouth##6##1##(2011-12#1)(2012-12#1)(2013-1#4)
split-plot##2##1##(2008-10#1)(2008-12#1)
split-root tests##2##2##(2008-10#2)
split-root##3##1##(2008-10#3)
split-sample##2##1##(2007-12#1)(2008-10#1)
split-signal##3##1##(2009-8#3)
split-step reconstruction technique##3##3##(2008-3#3)
split-step##8##1##(2007-11#1)(2007-12#2)(2008-3#5)
split-thickness skin graft##3##3##(2007-8#1)(2008-8#1)(2008-9#1)
split-thickness##4##1##(2007-8#1)(2008-11#1)(2008-8#1)(2008-9#1)
splitless##3##1##(2008-10#1)(2013-1#2)
splits into##2##2##(2007-11#1)(2012-2#1)
splits##15##1##(1990-11#1)(1990-5#1)(1994-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-5#2)(2008-3#1)(2008-4#3)(2008-5#1)(2010-4#1)(2012-2#1)
splitter at##2##2##(2007-11#1)(2007-12#1)
splitter based on##2##3##(2007-12#1)(2008-2#1)
splitter for##5##2##(2007-12#1)(2008-2#4)
splitter layer##2##2##(2008-2#2)
splitter operating at##2##3##(2007-11#1)(2008-3#1)
splitter was##2##2##(2008-2#1)(2008-3#1)
splitter##73##1##(2007-11#5)(2007-12#11)(2008-1#2)(2008-10#1)(2008-2#33)(2008-3#21)
splitters are##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
splitters##20##1##(2007-12#6)(2008-2#6)(2008-3#8)
splitting and focusing##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
splitting and##11##2##(2006-5#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#7)
splitting angle##2##2##(2007-11#1)(2008-3#1)
splitting by##3##2##(1997-8#1)(2007-11#1)(2010-5#1)
splitting in##6##2##(1990-7#1)(1992-1#2)(1994-5#1)(2007-12#1)(2012-7#1)
splitting is##2##2##(2007-12#1)(2008-2#1)
splitting of the##14##3##(1990-2#1)(1992-1#1)(1995-1#1)(1996-2#1)(1997-7#2)(2006-5#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-5#1)(2013-7#1)
splitting of##25##2##(1990-2#1)(1990-5#1)(1992-1#1)(1992-8#1)(1994-10#1)(1995-1#1)(1996-2#1)(1997-7#2)(1997-8#1)(2006-5#1)(2007-12#4)(2007-8#1)(2008-10#2)(2008-2#3)(2008-5#2)(2012-2#1)(2013-7#1)
splitting on the##3##3##(1992-1#1)(1994-5#2)
splitting parameters##2##2##(1993-11#1)(1996-7#1)
splitting ratio##3##2##(2007-12#1)(2008-2#2)
splitting the##4##2##(1995-6#1)(2008-2#1)(2008-3#1)(2012-2#1)
splitting was##3##2##(1992-1#1)(1992-8#1)(1997-7#1)
splitting##114##1##(1990-2#2)(1990-3#1)(1990-5#2)(1990-7#1)(1991-4#1)(1992-1#7)(1992-8#3)(1993-11#1)(1994-10#1)(1994-12#1)(1994-5#4)(1995-1#1)(1995-6#1)(1996-2#1)(1996-7#1)(1997-7#6)(1997-8#2)(2005-4#1)(2006-11#1)(2006-2#1)(2006-5#2)(2007-11#7)(2007-12#13)(2007-8#2)(2008-10#6)(2008-2#15)(2008-3#11)(2008-5#3)(2008-8#1)(2009-2#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-7#2)(2012-2#5)(2012-3#1)(2012-7#1)(2013-7#1)(2013-8#1)
splitting&quot##2##1##(2008-8#1)(2009-11#1)
splittings (approximately##2##2##(1991-4#2)
splittings##8##1##(1990-7#1)(1991-4#2)(1994-5#1)(1996-5#1)(2009-3#2)(2009-5#1)
splénectomie##2##1##(2011-2#2)
splénique##5##1##(2011-2#4)(2012-2#1)
spn-E mutation##2##2##(2006-12#2)
spn-E##3##1##(2006-12#3)
spoIIID gene##2##2##(1995-2#2)
spoIIID##6##1##(1995-2#6)
spoOA##3##1##(1997-4#3)
spoil the##2##2##(2008-7#1)(2010-12#1)
spoil##3##1##(2008-7#1)(2009-9#1)(2010-12#1)
spoilage and##5##2##(1997-4#1)(2011-2#3)(2012-12#1)
spoilage in##2##2##(2007-12#1)(2008-10#1)
spoilage microorganisms##3##2##(2008-10#2)(2012-2#1)
spoilage##28##1##(1997-4#4)(2007-12#1)(2008-1#1)(2008-10#9)(2008-7#1)(2011-2#10)(2012-12#1)(2012-2#1)
spoiled##6##1##(1997-8#4)(2008-10#1)(2010-4#1)
spoke Arabic##2##2##(2008-1#2)
spoke at the##2##3##(1992-3#1)(1993-12#1)
spoke channels##4##2##(2007-12#2)(2008-7#2)
spoke##22##1##(1990-6#1)(1992-3#1)(1992-8#2)(1993-12#2)(1996-1#1)(2007-12#2)(2008-1#2)(2008-10#1)(2008-7#2)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
spoken in the##2##3##(2013-8#2)
spoken in##3##2##(2013-1#1)(2013-8#2)
spoken language##3##2##(2006-2#1)(2008-9#1)(2009-10#1)
spoken languages##2##2##(2008-9#1)(2012-1#1)
spoken word production##2##3##(2008-9#2)
spoken word recognition in Spanish##2##5##(2008-11#2)
spoken word recognition##3##3##(2008-11#3)
spoken word##6##2##(2008-11#3)(2008-9#2)(2012-2#1)
spoken words##2##2##(2009-10#1)(2012-2#1)
spoken##30##1##(1993-9#1)(1995-12#1)(1996-3#1)(2006-2#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#2)(2008-8#1)(2008-9#5)(2009-10#2)(2009-11#1)(2011-2#1)(2012-1#2)(2012-2#2)(2013-1#1)(2013-8#2)
spokes##2##1##(2007-11#2)
spokesman##4##1##(1995-6#3)(1996-8#1)
spokespersons##2##1##(1997-3#2)
spoligotyping##2##1##(2011-2#1)(2012-12#1)
spondarthritides##6##1##(1990-6#6)
spondylarthropathy##2##1##(1990-6#1)(2007-12#1)
spondylectomy##3##1##(2006-8#2)(2013-7#1)
spondylitis (AS)##6##2##(2006-10#2)(2008-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
spondylitis in##3##2##(2005-12#1)(2006-10#1)(2008-12#1)
spondylitis is##4##2##(1990-6#1)(1993-1#1)(2007-11#1)(2012-2#1)
spondylitis##67##1##(1990-6#5)(1993-1#2)(1996-1#1)(2005-12#1)(2006-10#16)(2007-10#3)(2007-11#7)(2007-6#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2009-5#1)(2010-12#4)(2010-4#1)(2010-5#1)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
spondylitis]##3##1##(1993-11#1)(1994-3#1)(2013-8#1)
spondyloarthritis##5##1##(2010-12#1)(2012-12#3)(2012-3#1)
spondyloarthropathies##7##1##(1990-11#2)(2006-10#2)(2008-9#1)(2011-2#2)
spondyloarthropathy##9##1##(2005-8#1)(2006-10#6)(2008-7#1)(2012-3#1)
spondyloarthropaties##2##1##(2009-2#2)
spondylodesis using##2##2##(2007-11#1)(2007-8#1)
spondylodesis was##3##2##(2007-11#3)
spondylodesis with##3##2##(2007-7#1)(2007-8#2)
spondylodesis##29##1##(2007-11#13)(2007-7#11)(2007-8#5)
spondylodesis]##2##1##(2007-7#2)
spondylodiscitis in##2##2##(2006-10#1)(2013-1#1)
spondylodiscitis is##2##2##(2006-10#1)(2006-7#1)
spondylodiscitis##15##1##(1996-8#1)(2006-10#6)(2006-7#2)(2007-7#1)(2007-8#1)(2008-7#1)(2012-3#2)(2013-1#1)
spondylolistesis##3##1##(2007-11#3)
spondylolisthesis in the##2##3##(2006-8#1)(2007-6#1)
spondylolisthesis in##3##2##(2006-8#1)(2007-6#1)(2007-7#1)
spondylolisthesis is##3##2##(2006-8#1)(2007-11#1)(2007-6#1)
spondylolisthesis was##2##2##(2007-6#1)(2007-7#1)
spondylolisthesis who underwent posterior##2##4##(2006-8#1)(2008-11#1)
spondylolisthesis##36##1##(1992-1#1)(1996-6#1)(2006-3#1)(2006-8#4)(2007-11#11)(2007-6#4)(2007-7#8)(2007-8#1)(2008-11#1)(2008-7#1)(2012-12#2)(2013-8#1)
spondylolysis in##2##2##(1996-6#1)(2009-3#1)
spondylolysis of the##2##3##(2009-3#2)
spondylolysis of##3##2##(2009-3#3)
spondylolysis using computed tomography##2##4##(2007-7#2)
spondylolysis##17##1##(1996-6#2)(2006-3#1)(2007-11#1)(2007-7#7)(2009-3#6)
spondylosis grade##2##2##(2010-10#2)
spondylosis##12##1##(2006-10#1)(2006-8#1)(2007-11#4)(2007-8#2)(2010-10#3)(2013-1#1)
sponge Lissodendoryx (Acanthodoryx) fibrosa##2##4##(2010-6#2)
sponge and##2##2##(2008-9#1)(2009-11#1)
sponge reparative tissue##4##3##(2006-9#4)
sponge species##2##2##(2011-2#1)(2012-2#1)
sponge to##2##2##(1990-2#1)(2012-12#1)
sponge##46##1##(1990-2#1)(1990-8#1)(1994-3#1)(2004-9#2)(2006-5#2)(2006-6#1)(2006-9#4)(2007-1#3)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#2)(2008-10#1)(2008-5#8)(2008-9#1)(2009-11#1)(2010-6#2)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#2)(2013-8#1)
sponge-derived##2##1##(2008-5#1)(2009-3#1)
sponge-like mycelial mass was##2##4##(2008-10#2)
sponge-like mycelial mass##3##3##(2008-10#3)
sponges inoculated with##2##3##(2006-9#2)
sponges to##2##2##(2010-7#1)(2012-2#1)
sponges was##3##2##(1994-3#2)(2004-9#1)
sponges were##3##2##(1994-3#1)(2004-9#1)(2006-9#1)
sponges##45##1##(1994-3#4)(1994-8#1)(2004-9#7)(2006-9#13)(2008-4#1)(2008-5#5)(2010-12#1)(2010-7#2)(2011-2#5)(2012-1#1)(2012-2#4)(2012-3#1)
spongiform encephalopathies##6##2##(1996-5#1)(2006-10#1)(2008-11#1)(2008-4#1)(2009-5#1)(2010-12#1)
spongiform encephalopathy##26##2##(1990-3#1)(1990-9#1)(1992-5#1)(1996-3#8)(1997-3#1)(1997-7#2)(1997-8#1)(2005-5#1)(2007-9#2)(2008-11#1)(2008-5#1)(2010-4#2)(2011-2#4)
spongiform##37##1##(1990-3#1)(1990-9#1)(1992-5#1)(1993-2#1)(1996-3#8)(1996-5#1)(1997-3#1)(1997-7#2)(1997-8#1)(2005-10#1)(2005-5#1)(2006-10#1)(2007-9#2)(2008-11#3)(2008-4#1)(2008-5#2)(2009-5#1)(2010-12#2)(2010-4#2)(2011-2#4)
spongiosa##5##1##(2009-3#5)
spongiosis##3##1##(2007-7#1)(2007-8#1)(2011-2#1)
spongy##10##1##(2005-10#2)(2006-10#1)(2008-10#2)(2008-2#1)(2009-2#1)(2010-8#1)(2012-12#1)(2012-2#1)
sponsor##18##1##(1991-12#1)(1991-2#1)(1991-3#1)(1994-1#2)(1995-5#1)(2006-10#8)(2006-2#1)(2007-4#1)(2008-1#1)(2008-6#1)
sponsored a##3##2##(1993-9#1)(2013-1#2)
sponsored by a##2##3##(1994-1#1)(2012-12#1)
sponsored by the National Heart##2##5##(1991-10#1)(2008-3#1)
sponsored by the National##6##4##(1991-10#1)(1996-4#1)(2005-8#1)(2007-6#1)(2008-3#1)(2008-7#1)
sponsored by the Thomas Jefferson Program in Public Policy at the College of William and Mary##2##16##(1990-12#2)
sponsored by the##16##3##(1990-12#2)(1990-2#1)(1991-10#1)(1996-4#1)(1997-2#2)(1997-8#1)(2005-8#1)(2006-11#1)(2007-6#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)
sponsored by##29##2##(1990-12#2)(1990-2#1)(1991-10#1)(1992-3#1)(1994-1#1)(1994-3#1)(1996-4#1)(1997-2#2)(1997-8#1)(2005-12#1)(2005-8#2)(2006-11#2)(2007-6#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-11#1)(2009-6#1)(2012-12#1)
sponsored##40##1##(1990-12#2)(1990-2#1)(1991-10#1)(1991-3#1)(1992-3#1)(1993-9#1)(1994-1#1)(1994-3#1)(1996-4#1)(1997-2#2)(1997-8#1)(2005-12#1)(2005-8#2)(2006-11#2)(2007-4#1)(2007-6#2)(2007-8#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-10#1)(2009-11#1)(2009-6#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
sponsoring##6##1##(1992-2#1)(1993-1#1)(2005-8#1)(2007-4#1)(2008-11#1)(2013-1#1)
sponsors##10##1##(1992-1#1)(1993-1#1)(2006-3#1)(2006-6#1)(2007-4#2)(2008-11#1)(2009-6#1)(2012-2#1)(2013-8#1)
sponsorship of##4##2##(1995-3#1)(2005-12#1)(2007-1#1)(2008-7#1)
sponsorship to##3##2##(2008-12#3)
sponsorship##14##1##(1992-3#1)(1995-12#1)(1995-3#1)(2005-12#1)(2007-1#1)(2008-12#4)(2008-7#3)(2012-2#2)
sponsorships##2##1##(2008-12#2)
spontaneous Brillouin backscattered light##4##4##(2008-3#4)
spontaneous Brillouin scattering##4##3##(2007-11#2)(2007-12#2)
spontaneous Brillouin##8##2##(2007-11#2)(2007-12#2)(2008-3#4)
spontaneous EPSPs##2##2##(1992-8#2)
spontaneous HBeAg seroconversion##2##3##(2012-1#2)
spontaneous HCV clearance##3##3##(2012-2#3)
spontaneous Raman##4##2##(2006-5#1)(2008-2#2)(2008-3#1)
spontaneous abortion rate##3##3##(1994-3#1)(2008-10#2)
spontaneous abortion##15##2##(1991-2#1)(1991-3#1)(1991-8#1)(1992-2#1)(1992-6#1)(1993-10#1)(1994-3#2)(2007-1#1)(2007-2#1)(2008-10#2)(2010-12#2)(2012-2#1)
spontaneous abortions and##4##3##(1997-4#1)(2008-11#1)(2011-1#1)(2013-1#1)
spontaneous abortions##6##2##(1991-7#1)(1997-4#1)(2008-11#1)(2011-1#1)(2013-1#2)
spontaneous action##2##2##(1994-2#1)(1996-3#1)
spontaneous activities of##2##3##(1992-8#1)(1994-12#1)
spontaneous activities##3##2##(1992-8#2)(1994-12#1)
spontaneous activity and##4##3##(1993-11#1)(1995-7#1)(2008-8#1)(2012-1#1)
spontaneous activity in the absence of##2##6##(1996-2#1)(2013-8#1)
spontaneous activity in the##3##4##(1996-2#1)(2008-11#1)(2013-8#1)
spontaneous activity in##7##3##(1991-8#1)(1992-9#1)(1996-2#1)(2008-11#2)(2013-8#2)
spontaneous activity of##7##3##(1993-4#3)(1993-5#1)(1994-10#1)(1995-3#1)(1997-7#1)
spontaneous activity##37##2##(1991-8#3)(1992-7#1)(1992-9#1)(1993-11#1)(1993-4#3)(1993-5#1)(1994-10#2)(1995-3#1)(1995-6#1)(1995-7#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-7#1)(2007-12#1)(2008-11#6)(2008-8#1)(2009-3#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#5)
spontaneous alternation##5##2##(1993-3#1)(1994-5#2)(1994-8#1)(2012-2#1)
spontaneous and cytokine-dependent##2##3##(2006-6#2)
spontaneous and evoked##2##3##(1990-3#1)(1995-7#1)
spontaneous and induced##4##3##(1994-3#1)(1994-6#1)(2008-7#1)(2013-1#1)
spontaneous and intentional trait inferences##2##5##(2008-11#2)
spontaneous and intentional##3##3##(2008-11#3)
spontaneous and radiation-induced##2##3##(1997-4#1)(2008-7#1)
spontaneous and stimulated##2##3##(1991-11#1)(2007-12#1)
spontaneous and##29##2##(1990-3#1)(1990-4#1)(1991-11#2)(1991-6#1)(1991-9#1)(1992-12#1)(1992-6#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-5#1)(1995-7#1)(1997-4#1)(2006-6#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-11#3)(2008-6#1)(2008-7#2)(2009-4#1)(2010-12#1)(2012-12#1)(2013-1#1)
spontaneous apoptosis was##2##3##(1993-9#1)(2008-8#1)
spontaneous apoptosis##5##2##(1993-9#1)(1997-4#1)(2007-1#1)(2008-8#2)
spontaneous as well as##3##4##(1997-7#1)(2008-4#1)(2010-7#1)
spontaneous asymptomatic urinoma##2##3##(2008-10#2)
spontaneous attention in##2##3##(2009-4#2)
spontaneous attention##3##2##(2009-4#3)
spontaneous autoimmune diseases##2##3##(2006-5#1)(2008-4#1)
spontaneous autoimmune##4##2##(1997-4#1)(2006-5#1)(2008-10#1)(2008-4#1)
spontaneous bacterial peritonitis and##3##4##(2006-8#1)(2011-2#2)
spontaneous bacterial peritonitis##8##3##(2006-8#1)(2009-8#1)(2011-2#2)(2013-1#4)
spontaneous bacterial##9##2##(2006-8#2)(2009-8#1)(2011-2#2)(2013-1#4)
spontaneous beating##2##2##(2008-11#1)(2008-4#1)
spontaneous behavior##2##2##(2011-2#2)
spontaneous bladder contractions##2##3##(1995-12#2)
spontaneous bloody##2##2##(1990-11#2)
spontaneous breathing##3##2##(1996-2#1)(1997-4#1)(2008-2#1)
spontaneous calcium oscillations##2##3##(1994-11#2)
spontaneous calcium##4##2##(1994-11#2)(2008-11#1)(2008-4#1)
spontaneous cancer##2##2##(2008-7#1)(2011-2#1)
spontaneous cerebrospinal fluid##2##3##(2011-2#1)(2012-1#1)
spontaneous chloride-channel activity##2##3##(1995-11#2)
spontaneous chromosomal aberrations were##2##4##(2007-6#2)
spontaneous chromosomal aberrations##4##3##(2007-6#3)(2008-8#1)
spontaneous circulation##7##2##(1990-12#1)(1993-8#1)(2006-10#2)(2007-3#3)
spontaneous clearance of HCV##2##4##(2012-2#2)
spontaneous clearance of##4##3##(2012-2#4)
spontaneous cleavage##3##2##(1993-3#3)
spontaneous closure##3##2##(2007-8#1)(2008-4#1)(2012-12#1)
spontaneous contractions##3##2##(1991-10#2)(2010-3#1)
spontaneous conversion##2##2##(1990-6#1)(2010-5#1)
spontaneous course of##3##3##(1991-10#2)(1992-8#1)
spontaneous course##4##2##(1991-10#2)(1992-8#1)(1994-4#1)
spontaneous curvature##6##2##(1996-1#5)(2005-11#1)
spontaneous cytoplasmic##2##2##(1994-2#1)(1996-7#1)
spontaneous delivery##3##2##(1991-6#1)(1992-1#1)(1993-10#1)
spontaneous differentiation##3##2##(1990-5#1)(1991-11#1)(2008-9#1)
spontaneous discharge##4##2##(1993-7#2)(1994-12#1)(1995-7#1)
spontaneous echo contrast##4##3##(1997-1#4)
spontaneous electrical activity of pyramidal cells##2##6##(1991-5#2)
spontaneous electrorotation of##2##3##(2005-11#2)
spontaneous emission (ASE) in##2##4##(2007-12#1)(2008-2#1)
spontaneous emission (ASE)##6##3##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)
spontaneous emission from##7##3##(2007-11#2)(2007-12#2)(2008-1#1)(2008-2#1)(2008-7#1)
spontaneous emission in a##2##4##(2007-11#2)
spontaneous emission in the##2##4##(2008-2#1)(2008-3#1)
spontaneous emission in##4##3##(2007-11#2)(2008-2#1)(2008-3#1)
spontaneous emission into##2##3##(2005-4#1)(2007-12#1)
spontaneous emission is##4##3##(2007-12#2)(2008-2#2)
spontaneous emission of##3##3##(2007-11#1)(2008-1#1)(2008-2#1)
spontaneous emission rates##4##3##(2007-11#4)
spontaneous emission to##2##3##(2007-12#2)
spontaneous emission##54##2##(1993-5#1)(2005-4#1)(2007-11#12)(2007-12#22)(2008-1#3)(2008-2#8)(2008-3#5)(2008-7#2)
spontaneous emulsion##2##2##(2008-5#2)
spontaneous episodes of##2##3##(2012-3#2)
spontaneous evolution of##3##3##(1996-9#1)(1997-8#1)(2008-7#1)
spontaneous firing in##2##3##(1997-8#1)(2008-6#1)
spontaneous firing of##2##3##(1997-8#1)(2013-1#1)
spontaneous firing rate of##2##4##(1990-11#1)(1997-8#1)
spontaneous firing rate##5##3##(1990-11#1)(1997-8#4)
spontaneous firing##14##2##(1990-11#1)(1991-11#1)(1996-10#1)(1997-8#6)(2008-6#4)(2013-1#1)
spontaneous for##2##2##(2010-2#2)
spontaneous formation of##3##3##(1990-5#1)(2007-12#2)
spontaneous frequency##3##2##(2008-7#3)
spontaneous generation##2##2##(2007-12#1)(2010-7#1)
spontaneous haemothorax##4##2##(2007-8#1)(2011-2#2)(2013-7#1)
spontaneous healing##4##2##(1991-12#1)(2006-6#1)(2007-7#1)(2007-8#1)
spontaneous hexagon formation##2##3##(2007-12#2)
spontaneous hyperplastic foci##3##3##(2013-1#3)
spontaneous hypertensive##4##2##(1990-7#1)(1996-3#2)(2011-1#1)
spontaneous immortalization of##2##3##(1994-12#2)
spontaneous improvement##3##2##(1993-5#1)(2008-7#1)(2009-2#1)
spontaneous inferences##2##2##(2008-11#2)
spontaneous intracerebral hemorrhage##2##3##(2007-10#1)(2008-8#1)
spontaneous inward##2##2##(1997-5#1)(2009-12#1)
spontaneous locomotion##3##2##(1993-3#1)(2004-11#1)(2011-2#1)
spontaneous locomotor activity##4##3##(1990-2#1)(1993-6#1)(2008-6#1)(2012-1#1)
spontaneous lung##3##2##(1990-8#1)(2008-11#1)(2013-1#1)
spontaneous mechanical activity##2##3##(1993-11#2)
spontaneous metastasis of##4##3##(1991-9#1)(2008-8#3)
spontaneous metastasis##6##2##(1991-3#1)(1991-9#2)(2008-8#3)
spontaneous metastasis&quot##2##2##(1990-6#1)(2008-1#1)
spontaneous model##2##2##(2007-5#1)(2009-3#1)
spontaneous motor activity##8##3##(1994-10#1)(1994-2#1)(1995-12#1)(1996-10#2)(2008-12#2)(2012-1#1)
spontaneous motor##9##2##(1994-10#1)(1994-2#1)(1995-12#1)(1996-10#2)(2008-12#2)(2008-4#1)(2012-1#1)
spontaneous movement##2##2##(1995-5#1)(2010-3#1)
spontaneous movements##2##2##(2007-3#1)(2011-12#1)
spontaneous mutation##3##2##(1991-1#1)(1996-4#1)(2007-11#1)
spontaneous mutations##2##2##(1991-9#1)(2007-12#1)
spontaneous neural activity##2##3##(2009-3#1)(2013-8#1)
spontaneous neural differentiation##2##3##(1996-4#2)
spontaneous neural##5##2##(1996-4#2)(2009-3#2)(2013-8#1)
spontaneous nucleation of##2##3##(2007-11#1)(2007-12#1)
spontaneous onset##3##2##(2006-2#2)(2009-4#1)
spontaneous or evoked##2##3##(1995-7#1)(2010-12#1)
spontaneous or induced abortion##3##4##(1991-7#3)
spontaneous or induced##5##3##(1990-9#1)(1991-7#3)(2007-9#1)
spontaneous or radiation-induced##2##3##(2008-7#2)
spontaneous or##19##2##(1990-2#1)(1990-9#1)(1991-5#1)(1991-7#3)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#1)(1995-7#1)(1997-5#1)(2007-9#1)(2008-11#1)(2008-7#2)(2010-12#1)(2012-1#1)(2012-12#1)
spontaneous oral dyskinesia##2##3##(1991-8#2)
spontaneous oscillations##5##2##(1992-12#1)(1994-11#2)(1997-1#2)
spontaneous pain##5##2##(1990-10#1)(1993-11#1)(2006-7#1)(2008-6#1)(2008-9#1)
spontaneous parametric downconversion##5##3##(2007-11#1)(2007-12#3)(2008-3#1)
spontaneous perforation of the##3##4##(1993-8#1)(2011-2#1)(2013-1#1)
spontaneous platelet aggregation in##3##4##(1990-5#1)(1991-11#2)
spontaneous platelet aggregation##5##3##(1990-5#2)(1991-11#3)
spontaneous pneumothorax (PSP)##2##3##(2007-8#1)(2008-10#1)
spontaneous pneumothorax and##2##3##(1990-12#1)(2007-8#1)
spontaneous pneumothorax as##2##3##(2007-8#1)(2008-1#1)
spontaneous pneumothorax in##2##3##(2007-8#1)(2008-7#1)
spontaneous pneumothorax is##2##3##(2007-8#2)
spontaneous pneumothorax##37##2##(1990-12#1)(1991-6#2)(2006-10#4)(2007-8#17)(2008-1#1)(2008-10#1)(2008-7#8)(2009-6#1)(2010-8#1)(2012-11#1)
spontaneous pneumothorax]##2##2##(2008-1#1)(2008-10#1)
spontaneous polarization##5##2##(2008-2#3)(2008-3#2)
spontaneous polymerization##2##2##(1994-8#1)(1995-6#1)
spontaneous populations##2##2##(2011-12#2)
spontaneous pregnancy with invasive mole##2##5##(2012-2#2)
spontaneous pregnancy##4##2##(1997-5#1)(2012-2#2)(2013-7#1)
spontaneous pushing in upright or gravity-neutral positions##2##7##(2008-6#2)
spontaneous rearrangement##2##2##(2008-10#2)
spontaneous recovery of##3##3##(1995-5#1)(2013-7#2)
spontaneous recovery##9##2##(1991-4#1)(1995-12#1)(1995-5#1)(1996-6#1)(1997-2#1)(2006-2#1)(2013-7#3)
spontaneous recurrence of methamphetamine##3##4##(1996-10#2)(1996-7#1)
spontaneous recurrence of##4##3##(1996-10#2)(1996-7#2)
spontaneous recurrent seizures##2##3##(2008-3#1)(2009-8#1)
spontaneous recurrent##3##2##(2007-8#1)(2008-3#1)(2009-8#1)
spontaneous refolding##2##2##(1995-10#1)(1997-7#1)
spontaneous regeneration##3##2##(2007-11#3)
spontaneous regression of the##2##4##(1991-12#1)(1993-7#1)
spontaneous regression of##6##3##(1991-12#1)(1993-7#1)(1996-4#1)(2006-8#1)(2008-1#2)
spontaneous regression##12##2##(1991-12#1)(1993-7#1)(1996-4#1)(2006-10#1)(2006-8#1)(2007-8#2)(2008-1#2)(2010-8#1)(2010-9#1)(2012-2#1)
spontaneous release of##3##3##(1994-9#1)(1997-2#2)
spontaneous release##5##2##(1994-9#1)(1997-2#2)(2007-9#1)(2008-11#1)
spontaneous remission of##3##3##(2006-10#1)(2010-2#1)(2013-7#1)
spontaneous remission##6##2##(1993-2#2)(2006-10#1)(2008-10#1)(2010-2#1)(2013-7#1)
spontaneous reporting##4##2##(1991-10#1)(2008-8#3)
spontaneous reports##3##2##(1990-9#1)(1996-11#1)(2008-11#1)
spontaneous resolution of vesicoureteral reflux##2##5##(2012-11#2)
spontaneous resolution of##3##3##(2005-7#1)(2012-11#2)
spontaneous resolution##10##2##(1991-4#1)(2005-7#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-12#2)(2012-11#3)
spontaneous respiration##2##2##(1991-10#1)(1996-1#1)
spontaneous rhythmic contractions of the##2##5##(1991-5#1)(1997-4#1)
spontaneous rupture of the intestine and large vessels##2##8##(1990-2#2)
spontaneous rupture of the spleen##2##5##(1993-9#1)(2011-12#1)
spontaneous rupture of the##7##4##(1990-2#3)(1990-6#1)(1993-9#1)(2007-8#1)(2011-12#1)
spontaneous rupture of##8##3##(1990-2#3)(1990-6#1)(1993-9#1)(2007-8#1)(2011-12#1)(2013-7#1)
spontaneous rupture##13##2##(1990-2#3)(1990-6#1)(1993-9#1)(1996-6#1)(2006-10#1)(2006-9#1)(2007-8#1)(2008-4#1)(2010-9#1)(2011-12#1)(2013-7#1)
spontaneous seizures##3##2##(1994-2#1)(2008-4#1)(2009-8#1)
spontaneous speech##5##2##(1993-9#1)(2008-10#1)(2008-4#1)(2011-1#1)(2012-12#1)
spontaneous splenic rupture in##3##4##(1992-2#1)(1993-9#1)(2011-2#1)
spontaneous splenic rupture##6##3##(1992-2#2)(1993-9#1)(2007-4#1)(2007-5#1)(2011-2#1)
spontaneous synaptic##2##2##(2008-11#1)(2010-4#1)
spontaneous theta rhythm in##3##4##(1993-9#3)
spontaneous theta##4##2##(1993-9#4)
spontaneous transfer##7##2##(1991-11#1)(1991-2#2)(1992-3#3)(1992-6#1)
spontaneous transitions between##2##3##(1995-1#1)(2008-11#1)
spontaneous uterine##2##2##(2008-4#1)(2011-1#1)
spontaneous vaginal delivery rates##2##4##(2004-10#2)
spontaneous vaginal delivery##4##3##(1993-4#1)(2004-10#2)(2011-1#1)
spontaneous vaginal##5##2##(1993-4#1)(2004-10#2)(2011-1#1)(2013-1#1)
spontaneous ventilation##4##2##(2006-10#1)(2006-4#1)(2008-8#1)(2009-6#1)
spontaneous ventricular fibrillation##3##3##(1995-3#1)(2005-1#2)
spontaneous ventricular##4##2##(1995-3#1)(2005-1#3)
spontaneous yawning##2##2##(1990-10#1)(1993-9#1)
spontaneous##919##1##(1990-10#4)(1990-11#8)(1990-12#2)(1990-2#9)(1990-3#2)(1990-4#3)(1990-5#9)(1990-6#4)(1990-7#2)(1990-8#1)(1990-9#3)(1991-1#1)(1991-10#7)(1991-11#10)(1991-12#2)(1991-2#4)(1991-3#3)(1991-4#4)(1991-5#4)(1991-6#4)(1991-7#4)(1991-8#6)(1991-9#6)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#4)(1992-3#5)(1992-5#2)(1992-6#3)(1992-7#5)(1992-8#5)(1992-9#5)(1993-1#1)(1993-10#4)(1993-11#7)(1993-12#4)(1993-2#4)(1993-3#6)(1993-4#4)(1993-5#6)(1993-6#1)(1993-7#3)(1993-8#2)(1993-9#13)(1994-10#3)(1994-11#5)(1994-12#5)(1994-2#8)(1994-3#6)(1994-4#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#6)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#4)(1995-12#9)(1995-3#4)(1995-5#3)(1995-6#5)(1995-7#7)(1995-8#3)(1996-1#7)(1996-10#5)(1996-11#3)(1996-2#4)(1996-3#4)(1996-4#5)(1996-5#3)(1996-6#3)(1996-7#5)(1996-8#2)(1996-9#4)(1997-1#7)(1997-2#4)(1997-3#1)(1997-4#7)(1997-5#4)(1997-6#2)(1997-7#8)(1997-8#7)(2004-10#2)(2004-11#1)(2005-1#3)(2005-10#2)(2005-11#5)(2005-4#1)(2005-7#1)(2005-9#1)(2006-10#11)(2006-11#3)(2006-12#1)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#3)(2006-7#1)(2006-8#7)(2006-9#3)(2007-1#2)(2007-10#4)(2007-11#24)(2007-12#42)(2007-2#1)(2007-3#7)(2007-4#2)(2007-5#2)(2007-6#4)(2007-7#6)(2007-8#33)(2007-9#4)(2008-1#12)(2008-10#31)(2008-11#28)(2008-12#4)(2008-2#16)(2008-3#15)(2008-4#21)(2008-5#6)(2008-6#12)(2008-7#39)(2008-8#17)(2008-9#5)(2009-10#2)(2009-12#1)(2009-2#3)(2009-3#4)(2009-4#5)(2009-5#3)(2009-6#3)(2009-8#4)(2009-9#2)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#4)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#11)(2011-12#6)(2011-2#20)(2012-1#12)(2012-11#4)(2012-12#12)(2012-2#19)(2012-3#5)(2013-1#22)(2013-7#8)(2013-8#7)
spontaneous&quot##5##1##(1990-8#2)(1991-9#1)(1994-7#1)(2008-11#1)
spontaneous-emission##6##1##(2007-11#4)(2007-12#1)(2008-1#1)
spontaneously active##10##2##(1991-6#1)(1991-8#1)(1992-9#1)(1993-12#1)(1995-3#1)(1996-3#1)(1996-6#1)(2008-11#3)
spontaneously after##6##2##(1995-5#1)(2005-11#1)(2006-10#1)(2007-8#2)(2008-7#1)
spontaneously and##8##2##(1990-2#1)(1994-7#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-3#1)(2007-12#1)(2008-11#1)
spontaneously beating##2##2##(1994-11#1)(2009-3#1)
spontaneously breathing##5##2##(1994-10#1)(1995-7#1)(1996-5#1)(2007-9#1)(2012-3#1)
spontaneously but##2##2##(1992-10#1)(1994-9#1)
spontaneously cleared##2##2##(2012-11#1)(2012-2#1)
spontaneously cured##2##2##(2006-6#1)(2007-8#1)
spontaneously detach##2##2##(2011-2#2)
spontaneously develop uterine LMS##2##4##(2011-1#1)(2012-2#1)
spontaneously develop##9##2##(1993-2#1)(2008-10#2)(2008-4#4)(2011-1#1)(2012-2#1)
spontaneously developed##5##2##(1990-11#1)(1995-7#1)(1997-3#2)(2012-2#1)
spontaneously diabetic##3##2##(1994-12#2)(2008-4#1)
spontaneously epileptic rats##2##3##(1991-9#2)
spontaneously form##4##2##(1990-2#1)(2008-1#3)
spontaneously from##4##2##(1990-4#1)(1991-10#1)(2008-4#1)(2009-10#1)
spontaneously generated##2##2##(1996-3#1)(2008-5#1)
spontaneously hypertensive rat##9##3##(1990-7#2)(1991-12#1)(1992-9#2)(1993-2#2)(1994-8#1)(1997-2#1)
spontaneously hypertensive rats (SHR) and##5##5##(1990-3#1)(1990-7#1)(1991-6#1)(1997-6#1)(2009-4#1)
spontaneously hypertensive rats (SHR)##11##4##(1990-2#1)(1990-3#1)(1990-7#1)(1991-2#1)(1991-6#1)(1994-2#1)(1997-5#1)(1997-6#1)(2009-4#1)(2010-2#1)(2011-1#1)
spontaneously hypertensive rats (SHRSP)##2##4##(1991-6#1)(1995-12#1)
spontaneously hypertensive rats and##2##4##(1990-3#1)(1991-5#1)
spontaneously hypertensive rats were subjected to##2##6##(1995-3#1)(1997-2#1)
spontaneously hypertensive rats##37##3##(1990-2#2)(1990-3#2)(1990-7#1)(1991-2#2)(1991-5#1)(1991-6#3)(1992-7#2)(1993-3#1)(1994-2#2)(1995-11#2)(1995-12#4)(1995-3#1)(1997-2#1)(1997-5#2)(1997-6#2)(2008-5#1)(2009-4#1)(2010-12#2)(2010-2#1)(2011-1#3)(2012-1#1)
spontaneously hypertensive##54##2##(1990-2#2)(1990-3#2)(1990-7#3)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#3)(1992-3#2)(1992-7#2)(1992-9#2)(1993-2#2)(1993-3#1)(1994-2#2)(1994-8#1)(1995-11#2)(1995-12#4)(1995-3#1)(1996-5#1)(1997-2#2)(1997-5#2)(1997-6#2)(2008-3#1)(2008-5#1)(2009-4#1)(2009-9#1)(2010-12#2)(2010-2#1)(2011-1#3)(2012-1#2)(2012-12#1)(2013-8#1)
spontaneously immortalized HaCaT cell line##2##5##(1992-9#1)(2008-11#1)
spontaneously immortalized mouse##2##3##(1994-12#1)(1997-7#1)
spontaneously immortalized##6##2##(1990-10#1)(1992-9#1)(1994-12#2)(1997-7#1)(2008-11#1)
spontaneously in the##4##3##(1990-7#1)(1996-8#1)(1997-5#1)(2013-8#1)
spontaneously in##15##2##(1990-7#1)(1992-9#2)(1994-5#1)(1994-6#1)(1995-2#1)(1996-8#1)(1997-5#1)(1997-7#1)(2008-10#2)(2008-4#2)(2009-4#1)(2013-8#1)
spontaneously occurring##5##2##(1994-11#1)(1995-8#1)(1996-12#1)(2009-2#1)(2010-3#1)
spontaneously or after##3##3##(1990-2#1)(2006-10#1)(2009-3#1)
spontaneously or##7##2##(1990-2#1)(1997-2#1)(2006-10#1)(2008-10#1)(2009-3#1)(2009-8#1)(2011-2#1)
spontaneously resolved##4##2##(1993-9#1)(2007-8#1)(2008-10#1)(2008-7#1)
spontaneously secrete antibody##2##3##(1996-11#2)
spontaneously through##3##2##(2008-7#2)(2011-2#1)
spontaneously to##2##2##(2008-6#1)(2013-7#1)
spontaneously transformed rat-liver##2##3##(1992-9#2)
spontaneously transformed##4##2##(1991-2#1)(1992-9#2)(2008-11#1)
spontaneously with##3##2##(2005-9#1)(2007-12#1)(2009-11#1)
spontaneously without##2##2##(1997-4#1)(2011-1#1)
spontaneously##284##1##(1990-10#1)(1990-11#1)(1990-2#7)(1990-3#2)(1990-4#1)(1990-5#3)(1990-7#4)(1991-10#1)(1991-12#1)(1991-2#3)(1991-5#1)(1991-6#6)(1991-8#1)(1991-9#2)(1992-10#1)(1992-3#3)(1992-7#3)(1992-8#1)(1992-9#8)(1993-12#3)(1993-2#3)(1993-3#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#5)(1994-2#2)(1994-3#2)(1994-5#4)(1994-6#2)(1994-7#2)(1994-8#2)(1994-9#1)(1995-11#3)(1995-12#5)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#1)(1995-7#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#1)(1996-3#4)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#2)(1997-5#3)(1997-6#4)(1997-7#4)(2005-11#3)(2005-9#3)(2006-10#3)(2006-2#2)(2006-4#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#5)(2007-5#2)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#3)(2008-10#10)(2008-11#13)(2008-3#1)(2008-4#10)(2008-5#2)(2008-6#2)(2008-7#13)(2008-8#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#4)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-3#3)(2010-6#1)(2010-8#1)(2011-1#8)(2011-12#1)(2011-2#5)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#7)(2012-3#1)(2013-7#1)(2013-8#3)
spoonful##2##1##(1993-9#2)
sporadic AD and##2##3##(1994-12#1)(1997-1#1)
sporadic AD##9##2##(1994-12#1)(1994-8#3)(1996-5#2)(1997-1#1)(1997-5#1)(2013-1#1)
sporadic ALS##3##2##(2012-2#1)(2013-8#2)
sporadic Alzheimer's disease (AD)##2##4##(1994-12#1)(1995-12#1)
sporadic Alzheimer's disease##4##3##(1992-12#1)(1992-3#1)(1994-12#1)(1995-12#1)
sporadic Alzheimer's##5##2##(1992-12#1)(1992-3#1)(1994-12#1)(1995-12#1)(2010-11#1)
sporadic CLL##2##2##(2009-10#1)(2010-12#1)
sporadic CRC##2##2##(2010-12#1)(2012-2#1)
sporadic PD##6##2##(2008-11#5)(2008-7#1)
sporadic Parkinson's disease##3##3##(2008-11#2)(2008-7#1)
sporadic RCC##2##2##(2008-6#2)
sporadic and familial##3##3##(1991-8#1)(1997-1#1)(2007-7#1)
sporadic and hereditary forms of amyotrophic sclerosis are paralleled by the components of a reactive nature that involve the aggregation of proteins and conformational misfolding on the one hand and a powerful oxidative degradation that overwhelms the proteasome clearance mechanisms##2##40##(2013-1#2)
sporadic and hereditary##3##3##(2008-11#1)(2013-1#2)
sporadic and##14##2##(1991-8#1)(1993-8#1)(1997-1#1)(2004-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2009-12#1)(2013-1#4)
sporadic breast cancer##5##3##(1994-6#1)(1995-12#1)(2004-2#2)(2007-11#1)
sporadic breast##6##2##(1994-6#1)(1995-12#1)(1996-11#1)(2004-2#2)(2007-11#1)
sporadic cancer##2##2##(2007-4#1)(2011-2#1)
sporadic cases is##2##3##(1996-3#1)(2008-12#1)
sporadic cases of##3##3##(1992-3#1)(2008-7#2)
sporadic cases or##2##3##(2007-12#1)(2007-2#1)
sporadic cases##17##2##(1992-3#2)(1996-3#2)(2005-8#1)(2006-10#1)(2007-12#1)(2007-2#3)(2007-7#1)(2008-12#2)(2008-7#2)(2011-2#2)
sporadic colon cancer patients##2##4##(1990-5#1)(2007-4#1)
sporadic colorectal cancer##4##3##(1990-5#1)(1992-3#1)(2010-12#1)(2012-2#1)
sporadic congenital##2##2##(1996-12#1)(2008-4#1)
sporadic form of##3##3##(1997-3#1)(2012-1#2)
sporadic form##4##2##(1997-3#1)(2008-7#1)(2012-1#2)
sporadic forms##3##2##(1993-10#1)(2007-10#1)(2008-7#1)
sporadic in the##2##3##(2011-2#1)(2012-12#1)
sporadic in##3##2##(1993-12#1)(2011-2#1)(2012-12#1)
sporadic medullary thyroid carcinoma##3##4##(2008-1#3)
sporadic paraganglioma##2##2##(2012-2#1)(2013-1#1)
sporadic reports of##2##3##(1993-10#1)(1993-3#1)
sporadic tumors##2##2##(2011-2#1)(2013-8#1)
sporadic##172##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#1)(1991-10#1)(1991-5#1)(1991-8#2)(1992-12#1)(1992-3#4)(1992-9#1)(1993-10#2)(1993-12#1)(1993-3#2)(1993-5#1)(1993-8#1)(1994-12#2)(1994-4#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#1)(1995-12#2)(1995-2#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#2)(1997-1#2)(1997-3#1)(1997-5#2)(2004-12#1)(2004-2#2)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-4#1)(2007-10#3)(2007-11#2)(2007-12#3)(2007-2#3)(2007-4#2)(2007-7#5)(2007-8#1)(2008-1#4)(2008-10#7)(2008-11#12)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#7)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-8#1)(2010-11#1)(2010-12#5)(2010-2#1)(2011-1#3)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#6)
sporadic&quot##2##1##(1991-6#1)(1995-9#1)
sporadically and##2##2##(2007-11#1)(2008-10#1)
sporadically in the##2##3##(1992-3#1)(1997-4#1)
sporadically in##4##2##(1992-3#1)(1995-6#1)(1997-4#1)(2008-1#1)
sporadically or as part of##2##5##(2007-5#1)(2012-3#1)
sporadically or as##3##3##(2007-5#1)(2008-7#1)(2012-3#1)
sporadically reported##2##2##(2007-2#1)(2008-8#1)
sporadically##25##1##(1992-3#1)(1995-6#1)(1997-1#1)(1997-4#1)(2006-4#1)(2007-11#1)(2007-2#3)(2007-5#1)(2008-1#2)(2008-10#3)(2008-5#1)(2008-7#3)(2008-8#2)(2010-2#1)(2010-3#1)(2012-11#1)(2012-3#1)
sporamin##4##1##(2008-6#4)
sporangia and mycelia##3##3##(2008-10#3)
sporangia and zoospores of P##2##5##(2008-10#2)
sporangia and zoospores of##3##4##(2008-10#3)
sporangia and zoospores##7##3##(2008-10#7)
sporangia and##13##2##(2008-10#13)
sporangia of##6##2##(2008-10#6)
sporangia on##2##2##(2008-10#2)
sporangia or##2##2##(2008-10#2)
sporangia production##3##2##(2008-10#3)
sporangia released##2##2##(2008-10#2)
sporangia was##3##2##(2008-10#3)
sporangia were##2##2##(2008-10#2)
sporangia##64##1##(2007-7#1)(2008-10#62)(2010-3#1)
sporangiiferum##2##1##(2008-10#2)
sporangiophores and sporangia##2##3##(2008-10#2)
sporangiophores##5##1##(2008-10#5)
sporangiospores##3##1##(2008-10#1)(2008-5#1)(2008-8#1)
sporangium##2##1##(2007-7#1)(2008-10#1)
spore adhesion##5##2##(2008-10#5)
spore and##2##2##(2008-10#1)(2008-3#1)
spore attachment##3##2##(2008-10#3)
spore bearers##2##2##(2007-7#1)(2007-8#1)
spore cell##3##2##(1993-6#3)
spore coat##3##2##(2008-10#3)
spore concentration##5##2##(2008-10#2)(2008-5#1)(2011-1#2)
spore concentrations##7##2##(2008-10#1)(2008-5#2)(2010-5#1)(2011-1#3)
spore densities##2##2##(2008-10#2)
spore density on##2##3##(2008-10#2)
spore density##5##2##(2008-10#5)
spore deposition of G##2##4##(2008-10#2)
spore deposition of##3##3##(2008-10#3)
spore deposition##11##2##(2008-10#11)
spore dispersal gradient##4##3##(2008-10#4)
spore dispersal##10##2##(2008-10#10)
spore efficacy on##2##3##(2008-10#2)
spore efficacy##5##2##(2008-10#5)
spore flux density was##2##4##(2008-10#2)
spore flux density##4##3##(2008-10#4)
spore formation##5##2##(1991-11#1)(2008-8#1)(2010-2#2)(2012-2#1)
spore germination and germ tube growth of##2##7##(2008-10#2)
spore germination and germ tube##3##5##(2008-10#3)
spore germination and outgrowth##3##4##(2011-2#3)
spore germination and##10##3##(1997-6#1)(2008-10#6)(2011-2#3)
spore germination fluid##2##3##(2008-10#2)
spore germination frequency##2##3##(2008-10#2)
spore germination in Dictyostelium##2##4##(1994-5#2)
spore germination in##7##3##(1994-5#3)(2008-10#3)(2011-2#1)
spore germination##36##2##(1994-5#4)(1997-6#1)(1997-7#1)(2008-10#22)(2011-2#7)(2013-1#1)
spore maturation##2##2##(2008-10#1)(2012-2#1)
spore morphology##2##2##(2008-10#2)
spore movement##2##2##(2008-10#2)
spore outgrowth##2##2##(2011-2#2)
spore pigment##3##2##(2008-8#3)
spore precipitator in##2##3##(2008-10#2)
spore precipitator##4##2##(2008-10#4)
spore production per lesion##2##4##(2008-10#2)
spore production per##3##3##(2008-10#3)
spore production was##2##3##(2008-10#2)
spore production##17##2##(1991-11#1)(2008-10#13)(2010-10#2)(2012-3#1)
spore release of##3##3##(2008-10#3)
spore release##11##2##(2008-10#11)
spore samplers##3##2##(2008-10#3)
spore size##3##2##(2008-10#1)(2008-12#2)
spore suspension and irrigation water samples##2##6##(2008-10#2)
spore suspension##9##2##(2008-10#8)(2008-5#1)
spore suspensions##2##2##(2008-10#2)
spore traps##5##2##(2008-10#4)(2010-5#1)
spore types##3##2##(2008-10#3)
spore##237##1##(1991-11#2)(1992-6#2)(1993-6#4)(1994-5#5)(1995-3#1)(1995-6#1)(1996-8#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#1)(2007-7#2)(2007-8#1)(2008-10#156)(2008-12#2)(2008-3#4)(2008-5#6)(2008-8#6)(2010-1#1)(2010-10#2)(2010-2#2)(2010-5#2)(2011-1#5)(2011-2#23)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
spore-crystal preparations##2##2##(2007-6#2)
spore-crystal##3##1##(2007-6#3)
spore-forming bacteria and##3##3##(2011-2#3)
spore-forming bacteria##8##2##(2011-2#8)
spore-forming##14##1##(2006-10#1)(2006-8#2)(2011-2#11)
sporelings##2##1##(2008-10#1)(2010-4#1)
spores and the##2##3##(2011-2#2)
spores and##19##2##(2006-8#2)(2007-12#2)(2008-10#4)(2008-5#3)(2008-8#1)(2009-2#1)(2010-2#1)(2011-2#3)(2012-11#2)
spores are##7##2##(2006-8#1)(2007-3#1)(2008-10#2)(2008-5#2)(2008-8#1)
spores by##4##2##(2006-3#1)(2008-5#1)(2011-2#2)
spores can be##2##3##(2008-10#2)
spores can##3##2##(2008-10#2)(2011-2#1)
spores deposited##2##2##(2008-10#2)
spores dispersed##2##2##(2008-10#2)
spores from a##3##3##(2008-10#2)(2011-1#1)
spores from##6##2##(2007-5#1)(2008-10#4)(2011-1#1)
spores has been##2##3##(2011-2#2)
spores have##2##2##(2010-5#1)(2011-2#1)
spores in the##3##3##(2007-12#1)(2008-3#1)(2008-5#1)
spores in##8##2##(1997-4#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2011-2#1)
spores into##2##2##(2008-10#1)(2011-1#1)
spores is##4##2##(2008-10#3)(2010-1#1)
spores m(-3) day(-1)) was##2##4##(2010-5#2)
spores m(-3)##4##2##(2008-5#2)(2010-5#2)
spores of A##2##3##(2008-10#2)
spores of G##2##3##(2008-10#2)
spores of the##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
spores of##20##2##(1997-4#1)(2006-8#1)(2008-10#9)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#5)
spores on##4##2##(1994-6#1)(2006-8#1)(2008-10#2)
spores per m 3##2##4##(2007-3#2)
spores per m3##2##3##(2007-3#2)
spores per##9##2##(2007-3#4)(2008-10#5)
spores present##2##2##(2006-8#1)(2011-2#1)
spores produced at##2##3##(2011-2#2)
spores produced##4##2##(1990-6#1)(2008-10#1)(2011-2#2)
spores showed##2##2##(2008-5#1)(2010-3#1)
spores survived##2##2##(2006-8#1)(2008-10#1)
spores that##2##2##(2006-8#1)(2008-10#1)
spores to##2##2##(2010-1#1)(2011-2#1)
spores was##4##2##(2008-10#3)(2008-5#1)
spores were##18##2##(1997-3#1)(2006-8#1)(2007-3#1)(2008-10#10)(2010-5#4)(2011-2#1)
spores with##5##2##(2008-10#1)(2010-10#2)(2013-7#2)
spores within##2##2##(2005-9#1)(2011-2#1)
spores##225##1##(1990-6#1)(1991-5#1)(1993-6#2)(1994-5#1)(1994-6#1)(1994-9#1)(1997-3#1)(1997-4#3)(1997-6#1)(2005-9#1)(2006-3#1)(2006-8#9)(2007-12#3)(2007-3#8)(2007-5#1)(2007-7#2)(2008-10#94)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#18)(2008-8#7)(2008-9#2)(2009-2#1)(2009-8#1)(2010-1#3)(2010-10#4)(2010-2#1)(2010-3#1)(2010-5#8)(2011-1#5)(2011-2#31)(2012-11#2)(2013-1#1)(2013-7#2)
spores)##3##1##(1992-8#1)(2008-10#1)(2013-7#1)
sporidesmin intoxication##2##2##(2005-7#2)
sporidesmin##3##1##(2005-7#3)
sporidesmin-induced##2##1##(2005-7#2)
sporidia##5##1##(2008-10#5)
sporocyst##2##1##(2011-1#2)
sporocysts of S##2##3##(1996-12#2)
sporocysts of##4##2##(1996-12#3)(2011-1#1)
sporocysts##5##1##(1996-12#4)(2011-1#1)
sporogenesis##2##1##(2009-12#2)
sporogenic##2##1##(2006-8#1)(2008-10#1)
sporopollenin##6##1##(1991-9#1)(2011-2#5)
sporotrichioides enzyme##2##2##(1995-2#2)
sporotrichioides##5##1##(1995-2#2)(2007-7#1)(2008-10#1)(2010-10#1)
sporotrichosis##10##1##(2007-7#8)(2007-8#2)
sporozoan plastid##2##2##(2007-12#2)
sporozoan##4##1##(2007-12#3)(2011-12#1)
sporozoites##8##1##(1991-5#1)(1992-8#1)(1996-12#1)(1997-4#1)(2004-11#1)(2005-8#1)(2008-2#1)(2008-3#1)
sport activity##2##2##(1996-6#1)(2009-9#1)
sport and##6##2##(1993-3#1)(2005-12#1)(2006-6#1)(2007-3#1)(2010-7#1)(2011-2#1)
sport for##2##2##(1993-3#1)(2013-7#1)
sport in##2##2##(1995-8#1)(2008-10#1)
sport injury##2##2##(2010-9#1)(2012-1#1)
sport involves##2##2##(2006-8#1)(2010-11#1)
sport magazines##8##2##(2007-12#8)
sport orientation##3##2##(2009-7#3)
sport participation##4##2##(2009-7#1)(2010-1#1)(2010-7#2)
sport performance##3##2##(2008-5#2)(2009-1#1)
sport##93##1##(1993-3#4)(1995-6#1)(1995-8#1)(1996-6#1)(1996-9#1)(2005-12#1)(2006-11#1)(2006-6#4)(2006-8#2)(2007-11#3)(2007-12#8)(2007-3#3)(2007-8#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#4)(2008-6#1)(2008-9#1)(2009-1#2)(2009-10#1)(2009-11#3)(2009-3#1)(2009-5#3)(2009-7#8)(2009-9#4)(2010-1#1)(2010-11#2)(2010-4#2)(2010-7#4)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#3)(2013-7#7)
sport-related concussion##3##2##(2010-1#3)
sport-specific##3##1##(2009-1#1)(2012-2#1)(2013-1#1)
sport?##2##1##(2006-4#1)(2009-11#1)
sporting activities##3##2##(1990-9#1)(1996-11#1)(2006-11#1)
sporting activity in##2##3##(2008-8#1)(2009-5#1)
sporting activity##3##2##(2008-8#1)(2009-5#1)(2013-1#1)
sporting##10##1##(1990-9#1)(1991-3#1)(1993-3#1)(1996-11#1)(2005-10#1)(2006-11#1)(2008-8#1)(2009-5#1)(2013-1#2)
sports activities and##2##3##(1995-9#1)(2008-11#1)
sports activities##6##2##(1995-9#2)(2006-9#1)(2008-11#1)(2008-9#1)(2012-2#1)
sports activity and##2##3##(2008-9#1)(2013-1#1)
sports activity##5##2##(2008-9#2)(2011-2#1)(2013-1#2)
sports and##16##2##(1995-5#1)(1997-3#1)(2006-6#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2009-3#2)(2009-6#1)(2009-7#2)(2012-2#1)(2013-1#2)(2013-7#1)
sports are##3##2##(1995-8#1)(1996-3#1)(1996-6#1)
sports background##2##2##(2007-11#2)
sports drinks##2##2##(2011-2#1)(2012-6#1)
sports in##2##2##(1996-6#1)(2007-11#1)
sports injuries and illnesses##2##4##(1993-3#2)
sports injuries##9##2##(1993-3#2)(1996-3#2)(2010-1#2)(2012-2#2)(2013-1#1)
sports injury##2##2##(1993-3#1)(2007-6#1)
sports medicine##8##2##(1993-3#2)(1994-3#2)(1994-7#1)(1995-8#1)(2007-8#1)(2013-1#1)
sports nutrition##3##2##(2008-5#3)
sports or##2##2##(2010-4#1)(2012-12#1)
sports participation##4##2##(2007-7#1)(2009-7#1)(2010-7#1)(2013-7#1)
sports performance##6##2##(2008-5#6)
sports research in##2##3##(2013-7#2)
sports##128##1##(1990-9#1)(1991-6#2)(1991-9#1)(1993-3#7)(1994-3#2)(1994-7#1)(1995-10#1)(1995-5#1)(1995-6#1)(1995-8#4)(1995-9#3)(1996-3#3)(1996-6#4)(1996-9#1)(1997-3#1)(2006-10#1)(2006-6#2)(2006-7#1)(2006-9#1)(2007-11#8)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-5#9)(2008-6#1)(2008-7#1)(2008-9#3)(2009-3#2)(2009-5#3)(2009-6#1)(2009-7#5)(2010-1#3)(2010-11#1)(2010-4#3)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#4)(2012-2#10)(2012-3#1)(2012-6#1)(2013-1#10)(2013-7#6)
sports]##3##1##(1992-4#1)(1995-8#1)(2005-11#1)
sportsmen##8##1##(1990-3#1)(1995-6#2)(1996-3#1)(2007-11#1)(2011-2#1)(2013-1#2)
sporulate##7##1##(1990-10#1)(1991-8#1)(1995-9#1)(2008-10#3)(2012-3#1)
sporulated##6##1##(1997-3#1)(2008-10#4)(2011-2#1)
sporulates##2##1##(2008-10#2)
sporulating cells##2##2##(1990-10#1)(1997-4#1)
sporulating colonies##2##2##(2008-10#1)(2008-8#1)
sporulating lesions on##2##3##(2008-10#2)
sporulating lesions##6##2##(2008-10#6)
sporulating surface area##2##3##(2008-10#2)
sporulating surface##3##2##(2008-10#3)
sporulating##23##1##(1990-10#1)(1997-3#1)(1997-4#1)(2008-10#16)(2008-7#1)(2008-8#2)(2013-7#1)
sporulation ability##3##2##(1995-2#1)(2008-10#2)
sporulation and##7##2##(1993-3#1)(2008-10#4)(2011-2#2)
sporulation capacity on##2##3##(2008-10#2)
sporulation capacity##6##2##(2008-10#6)
sporulation curve##5##2##(2008-10#5)
sporulation from##2##2##(2008-10#2)
sporulation gene##2##2##(1990-10#1)(1995-9#1)
sporulation in##8##2##(1995-6#1)(1995-9#1)(2006-8#1)(2008-10#4)(2008-8#1)
sporulation medium##2##2##(1997-3#1)(2011-2#1)
sporulation occurred##2##2##(2008-10#2)
sporulation of B##2##3##(2008-10#2)
sporulation of the##6##3##(2008-10#5)(2008-6#1)
sporulation of##14##2##(2005-11#1)(2008-10#12)(2008-6#1)
sporulation on necrotic##2##3##(2008-10#2)
sporulation on##6##2##(2008-10#6)
sporulation per lesion##2##3##(2008-10#2)
sporulation per##3##2##(2008-10#3)
sporulation rate##5##2##(2008-10#5)
sporulation was observed##2##3##(2008-10#2)
sporulation was##9##2##(2008-10#9)
sporulation##132##1##(1990-10#2)(1990-11#2)(1990-12#1)(1990-5#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-2#2)(1995-6#5)(1995-9#4)(1997-3#1)(2005-11#3)(2006-8#1)(2008-10#95)(2008-6#3)(2008-8#1)(2011-2#5)(2012-2#3)
sporulation)##2##1##(2005-11#1)(2008-10#1)
sporulation-specific##2##1##(1995-6#1)(2012-2#1)
spot analysis##3##2##(1997-6#1)(2011-1#1)(2013-1#1)
spot and Stagonospora blotch##2##4##(2008-10#2)
spot and the##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
spot and##18##2##(2008-10#10)(2008-2#3)(2008-3#2)(2008-7#1)(2013-1#2)
spot are##2##2##(2008-10#1)(2008-3#1)
spot arrays##6##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
spot as##4##2##(2007-11#1)(2008-10#2)(2008-3#1)
spot at##2##2##(2008-2#1)(2008-3#1)
spot blotch disease##2##3##(2008-10#2)
spot blotch resistance##3##3##(2008-10#3)
spot blotch##7##2##(2008-10#7)
spot by##6##2##(2005-4#1)(2007-11#1)(2008-10#3)(2013-8#1)
spot caused by##3##3##(2008-10#3)
spot development##6##2##(2008-10#6)
spot diameter##6##2##(2007-12#3)(2008-2#2)(2008-3#1)
spot diameters##2##2##(2007-11#1)(2008-3#1)
spot disease of##2##3##(2008-10#2)
spot disease on##2##3##(2008-10#2)
spot disease##12##2##(2008-10#11)(2010-3#1)
spot epidemics##6##2##(2008-10#6)
spot from##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
spot has##3##2##(2007-11#1)(2008-10#2)
spot in each##2##3##(2007-12#1)(2008-4#1)
spot in the##2##3##(2007-11#2)
spot in##16##2##(1994-12#1)(2007-11#2)(2007-12#1)(2007-7#3)(2008-10#6)(2008-2#1)(2008-4#1)(2011-2#1)
spot incidence##3##2##(2008-10#3)
spot intensities##3##2##(1992-9#1)(2006-5#2)
spot is##13##2##(2004-2#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#1)
spot lesion formation##4##3##(2006-3#1)(2009-7#3)
spot lesion##5##2##(2006-3#1)(2009-7#4)
spot lesions on##3##3##(2008-10#3)
spot lesions##7##2##(2008-10#6)(2009-7#1)
spot of the##2##3##(2008-2#1)(2008-3#1)
spot of wheat##5##3##(2008-10#5)
spot of##42##2##(2008-10#36)(2008-2#1)(2008-3#2)(2008-9#1)(2010-12#1)(2012-2#1)
spot on the##7##3##(1995-2#1)(1996-11#1)(1996-4#1)(2007-1#1)(2008-3#1)(2010-12#1)(2013-7#1)
spot on##25##2##(1995-2#1)(1996-11#1)(1996-4#1)(2004-2#2)(2007-1#1)(2008-10#13)(2008-3#2)(2008-5#1)(2008-9#1)(2010-12#1)(2013-7#1)
spot pathogen##5##2##(2008-10#5)
spot produced by a##2##4##(2007-11#1)(2008-3#1)
spot produced by##3##3##(2007-11#1)(2008-3#2)
spot recording##2##2##(2008-3#2)
spot resistance##8##2##(2008-10#8)
spot sample##2##2##(2012-2#1)(2013-1#1)
spot samples##4##2##(1991-6#1)(1992-4#2)(2013-1#1)
spot scanning##2##2##(2010-9#2)
spot severity##6##2##(2008-10#6)
spot size and##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
spot size at the##2##4##(2007-12#1)(2008-2#1)
spot size for##3##3##(2008-10#2)(2008-3#1)
spot size on##3##3##(2006-5#1)(2008-2#2)
spot size##37##2##(2006-5#3)(2007-11#2)(2007-12#4)(2008-10#4)(2008-2#8)(2008-3#11)(2008-9#3)(2010-1#1)(2012-2#1)
spot sizes and##2##3##(2008-2#1)(2008-3#1)
spot sizes##8##2##(2006-5#1)(2007-12#1)(2008-2#1)(2008-3#5)
spot symptoms##3##2##(2008-10#3)
spot test analysis##2##3##(2008-10#2)
spot test##8##2##(2007-7#1)(2008-10#6)(2012-2#1)
spot that##3##2##(1996-1#1)(2007-11#1)(2008-2#1)
spot to##2##2##(2008-10#1)(2010-4#1)
spot urinary protein/creatinine and##2##4##(2008-5#2)
spot urinary protein/creatinine##4##3##(2008-5#4)
spot urinary protein/osmolality##2##3##(2008-5#2)
spot urinary##9##2##(2007-3#3)(2008-5#6)
spot urine sample##3##3##(1996-3#1)(2011-1#1)(2012-2#1)
spot urine##9##2##(1996-3#1)(1997-3#1)(2007-3#1)(2008-5#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#1)
spot virus and##2##3##(2008-10#2)
spot virus##29##2##(2008-10#29)
spot was##4##2##(2007-12#1)(2008-10#2)(2008-11#1)
spot welding##2##2##(1996-1#1)(2008-2#1)
spot were##3##2##(2008-10#2)(2008-3#1)
spot with a##2##3##(1996-2#1)(2008-10#1)
spot with##6##2##(1990-11#1)(1993-11#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-3#1)
spot##534##1##(1990-11#1)(1991-10#1)(1991-6#2)(1992-4#3)(1992-8#1)(1992-9#1)(1993-11#2)(1994-12#1)(1995-2#1)(1995-8#1)(1996-1#2)(1996-11#2)(1996-2#1)(1996-3#1)(1996-4#1)(1997-3#2)(1997-6#1)(2004-2#3)(2005-4#2)(2006-12#1)(2006-3#1)(2006-4#3)(2006-5#9)(2007-1#1)(2007-11#14)(2007-12#28)(2007-3#5)(2007-7#4)(2007-8#3)(2008-1#1)(2008-10#274)(2008-11#2)(2008-2#31)(2008-3#54)(2008-4#5)(2008-5#9)(2008-7#3)(2008-8#1)(2008-9#5)(2009-5#1)(2009-7#5)(2009-8#1)(2010-1#2)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-9#2)(2011-1#10)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#8)(2013-7#3)(2013-8#3)
spot) patterns##2##2##(2008-2#2)
spot)##9##1##(1991-5#2)(2008-10#5)(2008-2#2)
spot-array generator for a modulator-based free-space optical##2##7##(2008-2#1)(2008-3#1)
spot-array generator for a##3##4##(2008-2#2)(2008-3#1)
spot-array generator##4##2##(2008-2#2)(2008-3#2)
spot-array##6##1##(2007-11#1)(2008-2#3)(2008-3#2)
spot-resistant##2##1##(2008-10#2)
spot-size and numerical-aperture conversion##2##4##(2007-12#2)
spot-size mismatch##2##2##(2008-3#2)
spot-size##7##1##(2007-11#1)(2007-12#3)(2008-3#3)
spotlight on##3##2##(2008-11#1)(2010-5#1)(2012-2#1)
spotlight##14##1##(1995-2#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-3#1)(2007-10#1)(2008-11#1)(2008-2#3)(2008-7#1)(2009-7#1)(2010-5#1)(2012-2#1)
spots and##8##2##(1994-12#1)(1996-12#1)(2006-4#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-10#1)(2010-3#1)
spots are##4##2##(2006-5#1)(2007-12#1)(2011-2#1)(2012-3#1)
spots as##2##2##(2005-8#1)(2008-10#1)
spots based on a##2##4##(2006-4#1)(2008-4#1)
spots for##7##2##(2007-2#1)(2008-1#1)(2008-10#2)(2009-10#1)(2012-11#1)(2012-12#1)
spots from##2##2##(2008-3#1)(2008-5#1)
spots in the##3##3##(1997-6#1)(2008-3#1)(2008-7#1)
spots in##12##2##(1997-6#1)(2006-4#1)(2006-5#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
spots is##3##2##(2008-2#1)(2008-3#1)(2010-5#1)
spots of##8##2##(1992-1#1)(1994-2#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
spots on the##7##3##(1997-4#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2011-3#1)
spots on##17##2##(1991-8#1)(1992-4#1)(1995-7#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-3#2)(2008-4#1)(2008-9#1)(2009-6#1)(2010-3#1)(2011-3#1)
spots or##4##2##(1991-8#1)(2008-10#2)(2008-5#1)
spots representing##2##2##(1992-1#1)(2008-10#1)
spots that are##2##3##(2007-12#2)
spots that##3##2##(1997-2#1)(2007-12#2)
spots to##3##2##(1997-6#1)(2007-12#1)(2008-3#1)
spots was developed##2##3##(1992-7#1)(2010-9#1)
spots was##9##2##(1992-7#1)(1997-6#1)(2008-10#1)(2008-3#1)(2010-2#1)(2010-9#1)(2012-2#1)(2013-8#2)
spots were analyzed##2##3##(2005-8#1)(2007-3#1)
spots were observed##3##3##(1997-3#1)(1997-6#1)(2008-10#1)
spots were##17##2##(1991-6#2)(1992-4#1)(1996-8#1)(1997-3#1)(1997-6#1)(2005-8#1)(2007-3#1)(2008-10#3)(2009-4#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2012-2#1)
spots with##4##2##(2007-11#1)(2008-2#1)(2008-5#1)(2009-6#1)
spots##211##1##(1990-11#1)(1990-5#1)(1991-10#2)(1991-2#2)(1991-6#2)(1991-8#2)(1992-1#3)(1992-12#1)(1992-4#3)(1992-6#1)(1992-7#4)(1993-11#1)(1993-9#1)(1994-12#1)(1994-2#4)(1995-7#1)(1996-12#2)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#5)(2004-4#1)(2005-12#1)(2005-8#3)(2006-10#2)(2006-12#1)(2006-4#3)(2006-5#10)(2007-10#1)(2007-11#3)(2007-12#14)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#38)(2008-2#10)(2008-3#14)(2008-4#3)(2008-5#7)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#1)(2009-6#3)(2010-11#4)(2010-12#5)(2010-2#4)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
spotted fever group Rickettsiae##2##4##(1991-8#2)
spotted fever group##4##3##(1991-8#2)(1995-12#1)(2006-2#1)
spotted fever##8##2##(1991-8#2)(1995-12#1)(2006-2#1)(2008-4#1)(2009-2#1)(2013-8#2)
spotted on##3##2##(1997-1#1)(2008-2#1)(2008-3#1)
spotted onto a##3##3##(2008-10#1)(2008-4#1)(2012-3#1)
spotted shrimp##2##2##(2006-12#2)
spotted snapper##2##2##(2007-3#2)
spotted wilt tospovirus (TSWV)##3##4##(2008-10#3)
spotted wilt virus (TSWV)##16##4##(2008-10#16)
spotted wilt virus##31##3##(2008-10#31)
spotted wilt##35##2##(2008-10#35)
spotted##72##1##(1991-8#2)(1994-12#1)(1995-12#1)(1997-1#1)(2006-12#2)(2006-2#1)(2006-8#2)(2007-12#1)(2007-2#1)(2007-3#3)(2007-5#2)(2007-9#1)(2008-10#39)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#4)(2009-2#1)(2009-5#1)(2012-3#3)(2013-8#2)
spotting in##2##2##(1996-4#1)(2008-10#1)
spotting of##2##2##(2009-6#1)(2011-1#1)
spotting##24##1##(1992-2#1)(1994-12#4)(1996-4#2)(2006-10#1)(2007-8#1)(2008-10#4)(2009-6#1)(2010-4#1)(2011-1#1)(2013-1#8)
spotty##4##1##(1990-5#1)(1992-5#1)(1995-4#1)(2008-7#1)
spousal age difference##4##3##(2007-7#3)(2012-11#1)
spousal evaluation##3##2##(2007-12#3)
spousal##16##1##(1992-6#1)(1996-3#1)(2007-12#6)(2007-7#3)(2008-7#1)(2008-8#1)(2011-2#1)(2012-11#2)
spouse and##6##2##(1993-12#1)(2006-8#1)(2007-7#1)(2008-1#1)(2009-5#1)(2012-3#1)
spouse or##5##2##(2007-2#1)(2007-7#1)(2009-5#1)(2010-8#1)(2011-2#1)
spouse undermining##3##2##(2006-9#3)
spouse##38##1##(1990-2#1)(1991-10#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-11#1)(1997-3#2)(2006-5#1)(2006-8#1)(2006-9#7)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#1)(2009-5#2)(2010-12#1)(2010-4#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#1)(2012-3#1)
spouses and##2##2##(1993-4#1)(2012-12#1)
spouses in##4##2##(2008-10#1)(2012-12#3)
spouses of IDUs##2##3##(2012-1#2)
spouses of##7##2##(1994-7#1)(2008-7#1)(2010-8#1)(2012-1#4)
spouses##32##1##(1991-4#1)(1993-4#2)(1994-7#1)(1997-5#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-4#2)(2010-8#2)(2011-2#2)(2012-1#6)(2012-12#7)(2013-8#1)
spouses'##2##1##(2011-2#2)
spout was##2##2##(1990-7#2)
spout##12##1##(1990-7#9)(2008-4#2)(2013-1#1)
spp and##10##2##(1990-9#1)(2006-10#1)(2008-10#1)(2008-5#1)(2009-9#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
spp in##2##2##(2008-5#1)(2011-2#1)
spp isolated from##5##3##(1990-3#1)(1991-11#1)(2007-7#3)
spp##884##1##(1990-3#1)(1990-6#4)(1990-9#3)(1991-11#1)(1992-2#2)(1993-4#1)(1994-3#1)(1994-8#2)(1995-7#1)(1996-12#4)(1996-6#1)(1997-3#1)(1997-4#1)(1997-6#3)(2004-11#1)(2005-12#1)(2005-7#4)(2005-8#2)(2005-9#17)(2006-10#7)(2006-12#3)(2006-3#6)(2006-8#17)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#12)(2007-3#3)(2007-5#1)(2007-6#7)(2007-7#45)(2007-8#1)(2007-9#4)(2008-10#430)(2008-11#1)(2008-12#4)(2008-2#8)(2008-3#6)(2008-4#8)(2008-5#75)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#2)(2009-12#4)(2009-2#3)(2009-3#4)(2009-4#1)(2009-6#1)(2009-8#7)(2009-9#9)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#18)(2010-6#2)(2010-8#3)(2011-1#12)(2011-10#1)(2011-12#7)(2011-2#34)(2012-11#3)(2012-12#18)(2012-2#15)(2012-3#3)(2012-5#4)(2013-1#17)(2013-7#4)(2013-8#4)
spp)##3##1##(2005-7#1)(2008-4#1)(2013-1#1)
sprague-dawley rats##3##2##(2007-1#1)(2008-10#1)(2012-1#1)
sprain##14##1##(2006-12#1)(2007-11#3)(2007-7#2)(2008-12#2)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#3)
sprained##2##1##(1990-6#1)(2009-1#1)
sprains and##2##2##(2013-1#2)
sprains##6##1##(1992-2#2)(2013-1#4)
spraint##2##1##(1993-9#2)
spray against##2##2##(2008-10#1)(2008-7#1)
spray and##7##2##(2007-1#1)(2007-11#1)(2008-10#5)
spray applications##3##2##(2008-10#2)(2011-12#1)
spray by##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
spray catch##4##2##(2008-2#4)
spray dried##3##2##(2010-12#2)(2010-4#1)
spray drying##5##2##(2004-12#1)(2005-11#1)(2008-10#2)(2008-5#1)
spray formulation##2##2##(2008-2#1)(2008-5#1)
spray inoculation##4##2##(2008-10#3)(2008-9#1)
spray ionization##3##2##(2008-10#2)(2012-12#1)
spray is##5##2##(2007-2#1)(2008-10#1)(2008-2#2)(2008-3#1)
spray of validamycin##2##3##(2008-10#2)
spray of##7##2##(1996-2#1)(2006-12#1)(2007-2#1)(2008-10#4)
spray or##2##2##(2008-10#2)
spray pyrolysis##2##2##(2008-11#2)
spray reagent for the##2##4##(2008-10#1)(2008-5#1)
spray reagent for##3##3##(2008-10#2)(2008-5#1)
spray should##2##2##(2008-10#2)
spray to##3##2##(1992-2#1)(2006-4#1)(2008-10#1)
spray versus##2##2##(1996-9#1)(2007-2#1)
spray##145##1##(1991-12#1)(1992-12#1)(1992-2#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(2004-12#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-12#2)(2006-3#1)(2006-4#2)(2007-1#4)(2007-10#1)(2007-11#2)(2007-2#10)(2008-10#57)(2008-11#4)(2008-2#14)(2008-3#9)(2008-5#7)(2008-7#2)(2008-9#1)(2009-11#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-4#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
spray-dried##5##1##(2007-1#2)(2008-10#1)(2008-5#1)(2010-12#1)
spray-drying##8##1##(2004-12#2)(2004-9#1)(2007-1#1)(2008-5#2)(2010-4#2)
spray-inoculated onto##3##2##(2008-10#3)
sprayed and##2##2##(2008-10#2)
sprayed for##2##2##(1997-1#1)(2008-3#1)
sprayed houses##2##2##(2005-8#2)
sprayed in##3##2##(2008-10#3)
sprayed on##4##2##(2008-10#4)
sprayed with a##3##3##(2008-10#3)
sprayed with the##3##3##(2008-10#3)
sprayed with##18##2##(2005-8#1)(2008-10#14)(2008-7#1)(2008-8#1)(2011-2#1)
sprayed##42##1##(1997-1#1)(2004-12#1)(2005-8#4)(2008-10#30)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#2)
spraying and##2##2##(2008-10#1)(2009-4#1)
spraying in##2##2##(2005-8#1)(2006-4#1)
spraying of##4##2##(1997-7#1)(2006-10#1)(2011-2#1)(2013-8#1)
spraying the##3##2##(1991-8#1)(2008-10#1)(2008-9#1)
spraying was##2##2##(2009-4#1)(2013-7#1)
spraying##36##1##(1991-8#1)(1997-7#1)(2004-9#1)(2005-8#1)(2006-10#1)(2006-4#3)(2008-10#11)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#3)(2010-9#1)(2011-12#1)(2011-2#4)(2013-7#1)(2013-8#2)
sprayings##2##1##(2005-8#1)(2008-10#1)
sprays are##4##2##(2007-2#3)(2008-3#1)
sprays is##2##2##(2008-10#2)
sprays of the##2##3##(2008-10#2)
sprays of##4##2##(1996-2#1)(2007-8#1)(2008-10#2)
sprays with##4##2##(2008-10#4)
sprays##36##1##(1996-2#1)(1997-8#1)(2006-4#1)(2007-1#1)(2007-2#4)(2007-8#1)(2008-10#19)(2008-3#5)(2008-5#1)(2011-12#1)(2011-2#1)
spread across the##2##3##(2010-6#1)(2011-12#1)
spread across##4##2##(2008-10#1)(2008-11#1)(2010-6#1)(2011-12#1)
spread all over the##2##4##(1996-6#1)(2008-10#1)
spread along##3##2##(2008-1#1)(2008-9#1)(2012-3#1)
spread among##4##2##(2007-12#1)(2008-10#1)(2011-2#1)(2012-1#1)
spread and the##3##3##(2008-8#1)(2010-9#1)(2011-2#1)
spread and##33##2##(1991-12#1)(1991-6#1)(1993-2#1)(1996-5#1)(1997-6#1)(2005-11#1)(2006-10#2)(2006-4#1)(2006-5#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-2#1)(2010-8#1)(2010-9#1)(2011-2#2)(2013-1#1)
spread are discussed##2##3##(1990-6#1)(2008-10#1)
spread are##3##2##(1990-6#1)(1994-7#1)(2008-10#1)
spread as##5##2##(1996-11#1)(1996-8#1)(2008-10#1)(2008-9#1)(2012-2#1)
spread at a##2##3##(2008-3#1)(2013-1#1)
spread at##4##2##(1995-8#1)(2008-3#1)(2008-8#1)(2013-1#1)
spread beyond##2##2##(2008-7#1)(2010-7#1)
spread by##10##2##(1992-10#1)(1992-6#1)(1994-4#1)(2008-10#4)(2008-5#2)(2010-10#1)
spread from a##2##3##(2008-10#1)(2008-6#1)
spread from cell to cell##2##5##(2008-9#1)(2013-8#1)
spread from the##3##3##(2008-10#1)(2008-4#1)(2011-2#1)
spread from##16##2##(1997-6#1)(2007-2#1)(2008-10#4)(2008-4#1)(2008-6#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
spread function with time dispersion##2##5##(2008-2#2)
spread function##10##2##(2006-4#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-6#1)(2009-4#1)(2011-1#2)
spread has##2##2##(2008-10#1)(2008-12#1)
spread in a##2##3##(2006-7#1)(2012-12#1)
spread in the##9##3##(1992-9#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-10#2)(2012-1#1)(2012-3#1)(2013-1#1)
spread in##37##2##(1990-4#1)(1991-12#2)(1991-8#2)(1992-8#1)(1992-9#1)(1996-10#1)(1996-5#1)(2005-8#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#10)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
spread into##6##2##(2007-1#1)(2008-10#3)(2008-7#1)(2013-1#1)
spread is##9##2##(1990-3#1)(1992-8#1)(1992-9#1)(2006-9#1)(2007-8#1)(2008-9#1)(2010-12#1)(2012-2#1)(2013-8#1)
spread laterally##2##2##(1997-3#1)(2008-10#1)
spread may##2##2##(2008-1#1)(2012-2#1)
spread more slowly than##2##4##(2007-7#1)(2008-10#1)
spread more slowly##3##3##(2007-7#1)(2008-10#1)(2008-7#1)
spread occurred##2##2##(2008-10#1)(2008-9#1)
spread occurs##2##2##(2007-9#1)(2008-10#1)
spread of AIDS and other sexually transmitted diseases##2##8##(1993-6#1)(1993-9#1)
spread of AIDS##10##3##(1990-6#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-3#1)(1996-6#1)(1997-6#3)
spread of HIV in##2##4##(1996-11#1)(2010-12#1)
spread of HIV##17##3##(1996-11#3)(1996-6#1)(1997-5#2)(1997-6#3)(2007-7#1)(2008-1#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-3#1)
spread of P##4##3##(2008-10#4)
spread of SMV strain G-5##2##5##(2008-10#2)
spread of SMV strain##3##4##(2008-10#3)
spread of SMV##5##3##(2008-10#5)
spread of TSWV##3##3##(2008-10#3)
spread of a##4##3##(2008-10#1)(2008-9#2)(2011-2#1)
spread of activity##3##3##(1990-3#1)(1991-3#2)
spread of an##4##3##(1997-3#1)(2008-10#1)(2013-1#2)
spread of antibiotic resistance##2##4##(2007-6#1)(2012-2#1)
spread of antimicrobial resistance in bacteria##2##6##(2010-4#2)
spread of blueberry shock ilarvirus##2##5##(2008-10#2)
spread of breast cancer##3##4##(1993-9#2)(2009-2#1)
spread of carcinoma##2##3##(1990-8#1)(1995-11#1)
spread of disease from##2##4##(2008-10#1)(2010-3#1)
spread of disease##17##3##(1992-11#1)(2006-5#1)(2008-1#1)(2008-10#10)(2008-2#1)(2008-8#1)(2010-3#1)(2013-8#1)
spread of esophageal##2##3##(2006-10#1)(2009-3#1)
spread of hepatitis##2##3##(2007-12#1)(2007-3#1)
spread of infection through##2##4##(2009-6#1)(2012-12#1)
spread of infection##13##3##(1991-6#1)(1994-10#1)(1995-8#1)(2007-6#1)(2007-7#1)(2009-6#1)(2010-12#1)(2010-3#2)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
spread of infectious diseases##5##4##(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
spread of infectious##6##3##(1996-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
spread of new##2##3##(2007-12#1)(2008-4#1)
spread of plant diseases##2##4##(2008-10#2)
spread of plant##3##3##(2007-9#1)(2008-10#2)
spread of pollutants in##2##4##(2008-5#2)
spread of resistance to##3##4##(2005-7#1)(2005-8#1)(2005-9#1)
spread of resistance##5##3##(1997-6#1)(2005-7#1)(2005-8#2)(2005-9#1)
spread of resistant strains##2##4##(2012-2#1)(2013-8#1)
spread of resistant##4##3##(1995-5#1)(2008-10#1)(2012-2#1)(2013-8#1)
spread of soybean mosaic virus##2##5##(2008-10#2)
spread of soybean##3##3##(2008-10#3)
spread of the disease from##2##5##(2008-10#1)(2010-4#1)
spread of the disease##12##4##(1993-3#1)(2007-7#2)(2008-10#5)(2009-2#1)(2010-4#1)(2010-8#1)(2011-2#1)
spread of the fungus##2##4##(2008-10#2)
spread of the infection##3##4##(2011-1#1)(2011-2#2)
spread of the pathogen##4##4##(2008-10#4)
spread of the tumor##2##4##(2008-8#1)(2009-2#1)
spread of the virus##6##4##(1992-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2012-12#1)
spread of the##53##3##(1990-6#1)(1990-9#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-6#1)(1996-1#1)(1997-8#1)(2005-12#2)(2006-10#1)(2006-5#1)(2006-7#1)(2007-12#2)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#16)(2008-2#1)(2008-8#2)(2009-2#2)(2009-8#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)
spread of these##6##3##(1997-3#1)(2005-9#1)(2008-3#1)(2008-9#1)(2009-12#1)(2013-1#1)
spread of this disease##3##4##(1995-1#1)(2007-7#1)(2008-12#1)
spread of this##8##3##(1994-7#1)(1995-1#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-3#1)
spread of tuberculosis in##2##4##(2009-7#1)(2010-12#1)
spread of tuberculosis##3##3##(2009-7#1)(2010-12#1)(2011-2#1)
spread of tumor cells##3##4##(1992-7#1)(1993-10#1)(2010-3#1)
spread of tumor##4##3##(1992-7#1)(1993-10#1)(2006-12#1)(2010-3#1)
spread of##344##2##(1990-11#3)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#3)(1990-8#1)(1990-9#1)(1991-3#2)(1991-6#2)(1992-11#1)(1992-12#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-10#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#3)(1994-10#2)(1994-2#1)(1994-3#2)(1994-6#1)(1994-7#2)(1995-1#1)(1995-11#1)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#2)(1996-3#1)(1996-6#2)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#7)(1997-8#1)(2005-12#2)(2005-7#2)(2005-8#6)(2005-9#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#2)(2006-5#2)(2006-6#2)(2006-7#2)(2007-11#1)(2007-12#8)(2007-2#1)(2007-3#1)(2007-6#3)(2007-7#9)(2007-8#1)(2007-9#2)(2008-1#8)(2008-10#94)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#10)(2008-9#5)(2009-12#1)(2009-2#5)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#4)(2010-2#1)(2010-3#5)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#7)(2011-2#13)(2011-3#1)(2012-11#2)(2012-12#3)(2012-2#7)(2012-3#4)(2013-1#11)(2013-8#4)
spread on a##2##3##(1994-6#1)(1996-11#1)
spread on##8##2##(1993-9#1)(1994-6#1)(1996-11#1)(2008-10#2)(2008-8#1)(2008-9#1)(2012-2#1)
spread or##3##2##(2007-12#1)(2008-10#1)(2009-6#1)
spread out in the##2##4##(2009-10#1)(2012-3#1)
spread out over##2##3##(1990-11#1)(1991-11#1)
spread out##7##2##(1990-11#1)(1991-11#1)(2007-12#1)(2007-3#1)(2008-11#1)(2009-10#1)(2012-3#1)
spread over a##6##3##(1991-4#1)(1993-4#1)(1994-6#1)(2005-7#1)(2007-10#1)(2008-11#1)
spread over all the##2##4##(1990-5#1)(2008-10#1)
spread over the##3##3##(1996-5#1)(2008-10#1)(2010-4#1)
spread over##18##2##(1990-5#1)(1991-4#1)(1992-1#1)(1993-4#1)(1994-3#1)(1994-6#1)(1996-5#1)(2005-7#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2010-4#1)(2013-8#1)
spread rapidly in##3##3##(1994-4#1)(1997-6#1)(2010-12#1)
spread rapidly##9##2##(1990-3#1)(1990-5#1)(1990-6#1)(1994-4#1)(1996-11#1)(1997-6#1)(2005-10#1)(2008-11#1)(2010-12#1)
spread rate##3##2##(2008-8#2)(2011-2#1)
spread rates##2##2##(2008-8#2)
spread systemically##2##2##(2008-10#2)
spread the word##4##3##(1993-1#1)(1993-2#1)(1993-3#1)(2008-4#1)
spread the##11##2##(1990-7#1)(1993-1#1)(1993-2#1)(1993-3#1)(1997-6#1)(2006-10#2)(2007-7#1)(2008-4#1)(2010-12#2)
spread through##4##2##(1992-5#1)(2008-10#2)(2013-8#1)
spread throughout the##4##3##(1995-1#1)(2008-10#2)(2011-2#1)
spread throughout##5##2##(1995-1#1)(2008-10#3)(2011-2#1)
spread to a##2##3##(2008-8#2)
spread to adjacent##2##3##(1990-3#1)(2008-10#1)
spread to other parts of Malaysia##3##6##(2008-12#1)(2011-1#2)
spread to other##6##3##(2007-9#1)(2008-12#2)(2008-9#1)(2011-1#2)
spread to the##11##3##(1990-4#1)(1991-10#1)(1992-10#2)(2006-12#1)(2007-12#1)(2008-10#2)(2008-5#2)(2011-2#1)
spread to##46##2##(1990-3#2)(1990-4#1)(1991-10#1)(1991-6#2)(1992-10#2)(1994-12#1)(1995-1#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-5#3)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#1)(2010-12#1)(2011-1#4)(2011-2#1)(2013-8#1)
spread very rapidly among##2##4##(1996-11#1)(2008-3#1)
spread via##2##2##(2008-12#1)(2011-1#1)
spread was possible##2##3##(2008-10#2)
spread was##10##2##(1990-4#1)(1990-8#1)(1995-5#1)(2005-8#1)(2008-10#4)(2009-2#1)(2010-9#1)
spread well##2##2##(2008-11#1)(2008-5#1)
spread were##2##2##(1990-4#1)(2008-10#1)
spread when##2##2##(2008-10#1)(2008-8#1)
spread widely##2##2##(2007-7#1)(2011-2#1)
spread with##4##2##(2007-12#1)(2008-10#2)(2008-8#1)
spread within the##5##3##(2008-1#1)(2008-10#3)(2008-6#1)
spread within##8##2##(2008-1#1)(2008-10#6)(2008-6#1)
spread worldwide##2##2##(2007-7#1)(2011-2#1)
spread##839##1##(1990-11#4)(1990-12#1)(1990-2#2)(1990-3#6)(1990-4#5)(1990-5#3)(1990-6#6)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#2)(1991-4#1)(1991-6#7)(1991-7#2)(1991-8#3)(1992-1#1)(1992-10#3)(1992-11#1)(1992-12#1)(1992-2#2)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-10#1)(1993-2#2)(1993-3#3)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#5)(1994-10#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-4#2)(1994-6#3)(1994-7#3)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#1)(1995-5#2)(1995-6#2)(1995-8#3)(1995-9#2)(1996-1#2)(1996-10#1)(1996-11#8)(1996-12#3)(1996-3#2)(1996-5#5)(1996-6#3)(1996-8#1)(1997-3#4)(1997-4#2)(1997-5#2)(1997-6#11)(1997-8#3)(2004-11#1)(2005-10#1)(2005-11#3)(2005-12#2)(2005-4#1)(2005-7#3)(2005-8#10)(2005-9#2)(2006-10#10)(2006-11#1)(2006-12#2)(2006-2#2)(2006-4#4)(2006-5#4)(2006-6#4)(2006-7#6)(2006-8#3)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#20)(2007-2#3)(2007-3#4)(2007-5#1)(2007-6#5)(2007-7#17)(2007-8#6)(2007-9#5)(2008-1#23)(2008-10#215)(2008-11#8)(2008-12#8)(2008-2#7)(2008-3#11)(2008-4#5)(2008-5#19)(2008-6#8)(2008-7#9)(2008-8#28)(2008-9#19)(2009-10#1)(2009-12#1)(2009-2#8)(2009-3#4)(2009-4#1)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#2)(2010-10#4)(2010-12#11)(2010-2#1)(2010-3#6)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#7)(2010-9#2)(2011-1#17)(2011-12#3)(2011-2#26)(2011-3#1)(2012-1#3)(2012-11#2)(2012-12#7)(2012-2#13)(2012-3#7)(2013-1#19)(2013-7#1)(2013-8#15)
spread)##3##1##(2004-12#1)(2006-10#1)(2012-2#1)
spreadability##2##1##(2010-2#1)(2012-12#1)
spreader##2##1##(2007-12#1)(2012-2#1)
spreaders##3##1##(2008-2#1)(2012-2#2)
spreading a##3##2##(1995-12#1)(2008-2#1)(2008-9#1)
spreading activity##2##2##(1990-7#1)(1995-2#1)
spreading and infiltration of the##2##5##(2005-11#2)
spreading and infiltration of##3##4##(2005-11#3)
spreading and infiltration##4##3##(2005-11#4)
spreading and##14##2##(1990-7#2)(1996-5#2)(2005-11#5)(2006-9#1)(2008-3#2)(2008-5#1)(2008-9#1)
spreading broadly##2##2##(2007-12#1)(2008-11#1)
spreading center##2##2##(1994-7#2)
spreading cortical depression##2##3##(2004-12#2)
spreading depression##17##2##(1990-2#2)(1993-12#2)(1993-7#4)(1996-5#3)(2007-10#2)(2007-12#2)(2007-9#1)(2010-12#1)
spreading epidemic##2##2##(1997-2#1)(2008-2#1)
spreading from the##2##3##(2012-3#2)
spreading from##5##2##(2006-6#1)(2008-6#1)(2009-3#1)(2012-3#2)
spreading in the##4##3##(1992-9#1)(2008-2#1)(2008-7#1)(2009-6#1)
spreading in##12##2##(1992-12#1)(1992-9#1)(1995-9#1)(2007-1#2)(2007-12#1)(2008-2#1)(2008-7#1)(2008-8#2)(2009-6#1)(2012-1#1)
spreading is##3##2##(1991-5#1)(2005-11#2)
spreading limb melanoma##2##3##(2006-6#2)
spreading of the pulse in##2##5##(2007-12#2)
spreading of the##13##3##(1991-3#1)(1995-1#1)(1997-3#1)(2005-11#2)(2007-12#3)(2008-2#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-1#1)
spreading of##33##2##(1990-12#2)(1991-3#1)(1993-3#1)(1993-9#1)(1994-6#1)(1995-1#2)(1996-5#1)(1997-3#1)(1997-4#1)(2005-11#7)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-4#1)(2011-1#1)(2012-2#1)
spreading on##3##2##(1996-5#1)(2005-11#1)(2006-5#1)
spreading over a##2##3##(2005-11#1)(2008-10#1)
spreading over##3##2##(2005-11#1)(2008-10#1)(2009-6#1)
spreading panicle was##2##3##(2009-10#2)
spreading panicle##6##2##(2009-10#6)
spreading process##3##2##(2005-11#3)
spreading rapidly##2##2##(1990-3#1)(2008-10#1)
spreading rate##2##2##(2008-11#1)(2009-6#1)
spreading the##2##2##(2008-5#1)(2012-3#1)
spreading through##2##2##(2008-7#1)(2008-8#1)
spreading to the##4##3##(2008-3#2)(2009-3#1)(2011-2#1)
spreading to##6##2##(1992-7#1)(2006-7#1)(2008-3#2)(2009-3#1)(2011-2#1)
spreading vitiligo##2##2##(2007-7#1)(2010-6#1)
spreading was##3##2##(1994-6#1)(2005-11#1)(2012-11#1)
spreading with##2##2##(2009-10#1)(2012-12#1)
spreading##214##1##(1990-12#3)(1990-2#4)(1990-3#2)(1990-7#6)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#2)(1992-12#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-7#4)(1993-9#2)(1994-6#3)(1994-7#2)(1995-1#3)(1995-12#1)(1995-2#1)(1995-9#1)(1996-5#10)(1997-2#1)(1997-3#1)(1997-4#1)(2004-12#2)(2004-9#1)(2005-10#1)(2005-11#25)(2006-10#1)(2006-11#1)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#3)(2007-12#9)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#7)(2008-5#9)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#4)(2009-10#8)(2009-12#1)(2009-3#3)(2009-6#4)(2009-7#1)(2010-12#2)(2010-4#2)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#5)(2012-5#1)(2013-1#1)(2013-8#1)
spreads by##2##2##(1997-6#1)(2007-9#1)
spreads epidemically##2##2##(2008-10#2)
spreads from##2##2##(2008-10#1)(2008-4#1)
spreads in##2##2##(2008-11#1)(2010-12#1)
spreads through##2##2##(2008-7#1)(2009-3#1)
spreads to the##4##3##(1990-4#1)(1991-6#1)(2008-10#1)(2009-8#1)
spreads to##6##2##(1990-4#1)(1991-6#1)(2004-9#1)(2008-10#1)(2008-9#1)(2009-8#1)
spreads##31##1##(1990-4#1)(1991-6#2)(1996-4#1)(1997-6#1)(2004-9#1)(2006-11#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-12#1)(2012-2#3)
spreadsheet programs##2##2##(1997-8#2)
spreadsheet##11##1##(1992-12#1)(1992-8#1)(1993-1#1)(1997-8#3)(2006-6#1)(2008-11#2)(2011-2#1)(2013-1#1)
spreadsheets##2##1##(2008-10#1)(2008-4#1)
spring (May) and##2##3##(2011-12#1)(2013-8#1)
spring (May)##3##2##(2008-10#1)(2011-12#1)(2013-8#1)
spring 1990##2##2##(1992-10#1)(2008-10#1)
spring 1997##2##2##(2004-4#1)(2005-7#1)
spring 1999##2##2##(2008-10#2)
spring 2001##2##2##(2006-10#1)(2008-10#1)
spring and autumn##6##3##(2004-4#1)(2008-10#1)(2008-5#1)(2010-8#1)(2011-2#1)(2013-1#1)
spring and early summer##3##4##(2008-10#2)(2011-2#1)
spring and fall##5##3##(2007-2#1)(2008-10#4)
spring and summer season##2##4##(2012-3#2)
spring and summer##7##3##(2006-5#1)(2008-5#1)(2008-9#1)(2011-2#2)(2012-3#2)
spring and the##3##3##(2005-11#1)(2008-10#2)
spring and winter barley##2##4##(2008-10#2)
spring and winter wheat##2##4##(2008-10#2)
spring and winter##5##3##(2008-10#4)(2008-12#1)
spring and##35##2##(2004-4#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-2#1)(2007-9#1)(2008-10#15)(2008-12#1)(2008-5#2)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#4)(2012-3#2)(2013-1#1)(2013-8#1)
spring are##2##2##(2008-5#1)(2012-1#1)
spring barley cv##2##3##(2008-10#2)
spring barley##9##2##(2008-10#4)(2008-12#5)
spring cotton and fall corn every year##2##7##(2008-10#2)
spring cotton and fall corn##3##5##(2008-10#3)
spring crop##2##2##(2008-10#2)
spring from##2##2##(2006-12#1)(2012-12#1)
spring in the##3##3##(1994-3#2)(2006-6#1)
spring in##10##2##(1994-3#2)(2006-6#1)(2008-10#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-1#1)(2012-12#1)
spring infections##4##2##(2008-10#4)
spring is##3##2##(2008-12#2)(2008-6#1)
spring of 2003##3##3##(2007-2#1)(2008-11#2)
spring of the##2##3##(2007-8#1)(2008-10#1)
spring of##35##2##(1992-4#1)(1993-5#1)(1994-12#1)(1996-12#1)(1996-2#1)(2004-11#2)(2005-7#1)(2006-12#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#1)(2010-12#1)(2010-8#1)(2011-2#1)(2011-9#1)(2012-1#1)(2012-12#2)(2012-3#1)
spring or##2##2##(2004-11#1)(2011-12#1)
spring samples##2##2##(2008-10#1)(2011-2#1)
spring season##4##2##(2008-10#3)(2012-3#1)
spring systems##3##2##(2012-2#3)
spring was##2##2##(2008-10#1)(2013-8#1)
spring water##9##2##(1991-11#1)(2007-8#1)(2008-10#7)
spring wheat cultivars##4##3##(2008-10#4)
spring wheat##13##2##(2006-12#1)(2008-10#12)
spring##253##1##(1990-8#1)(1991-11#1)(1992-10#1)(1992-4#1)(1993-5#1)(1994-12#1)(1994-3#3)(1995-2#1)(1995-3#1)(1995-4#1)(1996-12#2)(1996-2#1)(1996-8#2)(2004-11#3)(2004-4#2)(2005-11#3)(2005-7#2)(2006-10#2)(2006-12#5)(2006-5#1)(2006-6#2)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-3#1)(2007-5#2)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#94)(2008-11#4)(2008-12#13)(2008-2#2)(2008-3#1)(2008-5#8)(2008-6#1)(2008-8#2)(2008-9#1)(2009-4#2)(2009-8#1)(2010-12#4)(2010-8#6)(2011-1#1)(2011-12#4)(2011-2#12)(2011-9#1)(2012-1#11)(2012-12#5)(2012-2#6)(2012-3#8)(2013-1#2)(2013-7#1)(2013-8#9)
spring)##4##1##(2008-10#1)(2008-12#1)(2011-12#1)(2012-1#1)
spring-dashpots##2##1##(2007-4#2)
spring-summer##2##1##(2008-7#2)
spring/summer##2##1##(2010-7#1)(2013-1#1)
springboard for##3##2##(2007-7#1)(2013-1#1)(2013-8#1)
springiness##2##1##(2011-2#2)
springs associated with the##2##4##(1990-8#2)
springs in##3##2##(1994-3#2)(2012-2#1)
springs##17##1##(1990-12#1)(1990-8#2)(1994-3#4)(2007-12#1)(2007-8#1)(2008-6#1)(2009-7#3)(2011-2#2)(2012-1#1)(2012-2#1)
springtails and##2##2##(2008-5#2)
sprinkler irrigation##2##2##(2008-10#2)
sprinklers##5##1##(2007-8#2)(2008-10#3)
sprinkling##3##1##(2008-10#2)(2012-1#1)
sprint##4##1##(2008-5#1)(2011-2#1)(2012-1#2)
sprinters##3##1##(2011-2#3)
sprout and##2##2##(1991-3#1)(2008-7#1)
sprout formation##3##2##(1991-4#3)
sprout in the##2##3##(1992-7#1)(1997-3#1)
sprout##13##1##(1990-2#1)(1991-3#1)(1991-4#3)(1992-7#2)(1997-3#3)(1997-5#1)(2008-11#1)(2008-7#1)
sprouted##4##1##(1997-3#1)(2008-5#1)(2013-8#2)
sprouting and##6##2##(1991-1#1)(1991-3#1)(1996-12#1)(2005-7#1)(2005-9#1)(2008-7#1)
sprouting in the##4##3##(1996-9#1)(2008-9#3)
sprouting in##6##2##(1996-9#1)(2008-9#5)
sprouting is##3##2##(1993-12#1)(1997-3#1)(2007-3#1)
sprouting of the##2##3##(1995-7#1)(1997-3#1)
sprouting of##11##2##(1991-1#1)(1992-7#1)(1993-12#3)(1995-7#1)(1996-9#1)(1997-3#1)(2008-5#2)(2009-6#1)
sprouting was##2##2##(1997-3#2)
sprouting##42##1##(1990-7#1)(1991-1#2)(1991-3#1)(1992-7#1)(1993-12#4)(1995-7#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-9#3)(1997-3#4)(1997-5#7)(2005-7#1)(2005-9#1)(2006-12#1)(2007-3#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-9#5)(2009-6#1)(2011-2#1)
sprouts and##3##2##(2007-3#1)(2008-10#2)
sprouts##13##1##(1997-2#1)(1997-5#1)(2007-1#2)(2007-3#3)(2008-10#3)(2008-11#2)(2008-5#1)
spruce (Picea##4##2##(2004-4#1)(2008-10#2)(2012-2#1)
spruce seedlings##4##2##(2008-10#4)
spruce wood##5##2##(2008-10#1)(2012-2#1)(2013-1#3)
spruce##36##1##(1996-3#1)(2004-4#4)(2005-10#2)(2008-10#15)(2008-5#6)(2011-12#3)(2012-2#2)(2013-1#3)
sprue##5##1##(2006-10#1)(2010-6#2)(2012-2#2)
spt4 and spt6##2##3##(1996-7#2)
spt4##3##1##(1996-7#3)
spt6##3##1##(1996-7#3)
spumigena##3##1##(2006-3#3)
spun and unspun fibers##3##4##(2007-12#3)
spun fiber##2##2##(2007-11#1)(2007-12#1)
spun fibers##6##2##(2007-11#6)
spun out of##2##3##(2008-8#1)(2012-3#1)
spun##20##1##(1990-12#1)(1992-8#1)(1993-7#1)(2007-11#8)(2007-12#6)(2008-8#2)(2012-3#1)
spur##14##1##(1990-11#1)(1992-2#1)(1997-2#1)(2005-10#2)(2006-12#1)(2007-1#2)(2007-10#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
spurious contrast##2##2##(2006-5#2)
spurious evidence for##2##3##(1997-5#2)
spurious evidence##3##2##(1997-5#3)
spurious##30##1##(1996-11#1)(1996-6#1)(1997-5#3)(1997-6#1)(1997-7#1)(2006-4#1)(2006-5#2)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#5)(2008-7#1)(2009-11#1)(2009-8#2)(2010-2#1)(2010-9#1)(2012-1#1)
spuriously##5##1##(1992-11#1)(1992-12#1)(1992-7#1)(1993-1#1)(1993-12#1)
spurred by##2##2##(2007-4#1)(2013-8#1)
spurred the development of##4##4##(2008-4#1)(2008-6#1)(2010-12#1)(2012-2#1)
spurred the##6##2##(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-12#1)(2012-2#1)
spurred##16##1##(1990-8#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-7#1)(2013-8#1)
spurs##6##1##(1995-1#1)(2004-9#1)(2005-3#1)(2008-10#1)(2008-8#1)(2010-10#1)
spurt##5##1##(1996-5#1)(2007-9#1)(2008-10#1)(2010-3#2)
spurts in##2##2##(1997-1#2)
sputter deposition of##2##3##(2008-2#2)
sputter deposition##4##2##(2007-5#2)(2008-2#2)
sputter##12##1##(2007-5#2)(2007-8#2)(2008-2#5)(2008-3#1)(2009-10#2)
sputter-deposited##3##1##(2008-2#3)
sputtered##15##1##(1992-9#1)(2007-11#1)(2008-10#1)(2008-12#2)(2008-2#4)(2008-3#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-4#1)
sputtering and##2##2##(2007-11#1)(2008-3#1)
sputtering for##2##2##(2007-11#1)(2008-2#1)
sputtering from##2##2##(2008-3#1)(2012-1#1)
sputtering of a##2##3##(2007-12#1)(2009-5#1)
sputtering of##3##2##(2007-12#1)(2008-3#1)(2009-5#1)
sputtering on##2##2##(1991-3#1)(2008-3#1)
sputtering system##2##2##(2008-2#1)(2008-5#1)
sputtering techniques##3##2##(2008-3#2)(2012-2#1)
sputtering##43##1##(1990-7#1)(1991-3#3)(2007-11#2)(2007-12#4)(2007-8#1)(2008-10#1)(2008-2#11)(2008-3#11)(2008-5#4)(2009-5#2)(2012-1#2)(2012-2#1)
sputum analysis##2##2##(2008-3#2)
sputum and##4##2##(2008-5#1)(2008-7#1)(2011-2#1)(2013-8#1)
sputum are##2##2##(2005-11#1)(2007-11#1)
sputum culture##3##2##(2007-2#1)(2013-1#2)
sputum examination##2##2##(2012-1#1)(2013-1#1)
sputum from##5##2##(1997-1#2)(2007-11#1)(2007-7#1)(2012-2#1)
sputum in##4##2##(2007-8#1)(2008-1#1)(2008-5#1)(2013-1#1)
sputum inflammatory cells##2##3##(2010-2#2)
sputum samples for##2##3##(2007-8#1)(2013-1#1)
sputum samples##5##2##(1991-12#1)(2007-8#1)(2008-1#1)(2008-3#1)(2013-1#1)
sputum smear##2##2##(2005-9#1)(2007-8#1)
sputum smear-positive pulmonary tuberculosis##2##4##(2013-1#1)(2013-8#1)
sputum smear-positive##3##2##(2005-9#1)(2013-1#1)(2013-8#1)
sputum was##3##2##(1997-1#1)(2010-2#1)(2012-2#1)
sputum##86##1##(1991-11#1)(1991-12#3)(1991-7#1)(1992-5#1)(1997-1#8)(2005-11#1)(2005-8#1)(2005-9#2)(2007-11#2)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#3)(2008-1#6)(2008-11#1)(2008-3#8)(2008-5#8)(2008-7#1)(2008-8#3)(2009-1#4)(2010-10#1)(2010-2#4)(2010-3#1)(2010-5#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#8)(2013-8#3)
squad##2##1##(1996-3#1)(2006-3#1)
squads##3##1##(1996-3#3)
squalane in##2##2##(1991-5#1)(2008-10#1)
squalane##5##1##(1991-5#2)(2008-10#3)
squalene 2##2##2##(1994-3#2)
squalene and squalene##2##3##(1994-3#1)(2010-5#1)
squalene and##3##2##(1994-3#1)(2010-3#1)(2010-5#1)
squalene derivatives##2##2##(1994-3#2)
squalene epoxidase##2##2##(1992-5#2)
squalene from##2##2##(2008-10#1)(2008-5#1)
squalene hydroperoxide##2##2##(2008-5#2)
squalene monohydroperoxide##3##2##(2008-5#2)(2010-5#1)
squalene peroxidation during##2##3##(2008-5#2)
squalene peroxidation##4##2##(2008-5#4)
squalene synthase##4##2##(1994-9#2)(1995-2#1)(2005-7#1)
squalene##38##1##(1992-5#4)(1992-8#1)(1994-3#7)(1994-9#2)(1995-2#1)(1995-5#1)(2005-7#1)(2008-10#2)(2008-5#12)(2010-12#1)(2010-3#2)(2010-5#4)
squalida##5##1##(2008-5#5)
squamate##3##1##(2010-3#3)
squamometry index##2##2##(2008-5#2)
squamometry tests##2##2##(2008-5#2)
squamometry##12##1##(2008-5#12)
squamosa leaf extract##2##3##(2008-11#2)
squamosa##6##1##(2008-10#1)(2008-11#4)(2008-8#1)
squamosissimus##3##1##(2008-7#3)
squamous and##3##2##(1996-9#2)(2009-6#1)
squamous carcinoma and##2##3##(1992-8#1)(2008-5#1)
squamous carcinoma cell line##3##4##(1990-11#1)(1991-9#1)(2007-3#1)
squamous carcinoma cell lines##2##4##(1991-3#1)(2007-3#1)
squamous carcinoma cell##5##3##(1990-11#1)(1991-3#1)(1991-9#1)(2007-3#2)
squamous carcinoma cells##7##3##(1991-10#1)(1991-3#1)(1992-9#3)(1997-1#1)(2007-11#1)
squamous carcinoma##17##2##(1990-11#1)(1991-10#1)(1991-3#2)(1991-9#1)(1992-8#1)(1992-9#3)(1997-1#1)(2007-11#2)(2007-3#2)(2008-5#1)(2010-12#1)(2010-7#1)
squamous cell cancer##2##3##(2010-5#1)(2010-8#1)
squamous cell cancers##2##3##(1997-7#1)(2006-10#1)
squamous cell carcinoma (OSCC)##4##4##(2010-12#1)(2011-1#1)(2013-1#2)
squamous cell carcinoma (SCC)##5##4##(2006-11#1)(2007-8#1)(2009-10#1)(2012-12#1)(2012-3#1)
squamous cell carcinoma and adenocarcinoma##2##5##(1993-5#1)(2011-2#1)
squamous cell carcinoma and the##3##5##(1993-8#1)(2012-2#1)(2012-3#1)
squamous cell carcinoma and##14##4##(1991-8#2)(1993-5#1)(1993-8#1)(1994-6#1)(1996-4#1)(2008-12#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
squamous cell carcinoma arising in##2##5##(2012-12#1)(2013-8#1)
squamous cell carcinoma arising##3##4##(2010-7#1)(2012-12#1)(2013-8#1)
squamous cell carcinoma associated with##2##5##(2012-3#2)
squamous cell carcinoma cell line##3##5##(2009-9#1)(2010-7#1)(2012-2#1)
squamous cell carcinoma cell lines (SCL-1) against the hazardous effects of##2##11##(2010-7#2)
squamous cell carcinoma cell lines (SCL-1)##3##6##(2010-7#3)
squamous cell carcinoma cell lines##4##5##(2008-2#1)(2010-7#3)
squamous cell carcinoma cell##7##4##(2008-2#1)(2009-9#1)(2010-7#4)(2012-2#1)
squamous cell carcinoma cells##2##4##(1997-1#1)(2012-12#1)
squamous cell carcinoma in a##3##5##(2007-2#3)
squamous cell carcinoma in the##5##5##(2010-5#1)(2010-7#2)(2011-2#1)(2012-1#1)
squamous cell carcinoma in##12##4##(2005-11#1)(2007-11#1)(2007-2#3)(2010-5#2)(2010-7#2)(2011-2#1)(2012-1#1)(2013-1#1)
squamous cell carcinoma is##2##4##(2011-12#1)(2012-3#1)
squamous cell carcinoma of head and neck (SCCHN)##2##8##(2012-12#2)
squamous cell carcinoma of nasopharynx##2##5##(2011-12#2)
squamous cell carcinoma of pulmonary origin##2##6##(2011-2#2)
squamous cell carcinoma of the appendix##2##6##(1993-12#2)
squamous cell carcinoma of the cervix##2##6##(1996-12#1)(2013-7#1)
squamous cell carcinoma of the esophagus##7##6##(1993-8#1)(1994-4#1)(2010-12#1)(2013-8#4)
squamous cell carcinoma of the head and neck (SCCHN)##3##9##(1991-10#1)(2005-7#1)(2007-11#1)
squamous cell carcinoma of the head and neck##7##8##(1990-6#1)(1991-10#1)(1993-4#1)(1993-8#1)(1993-9#1)(2005-7#1)(2007-11#1)
squamous cell carcinoma of the oral cavity##2##7##(1991-6#1)(2012-2#1)
squamous cell carcinoma of the uterine cervix##2##7##(1994-4#1)(2008-4#1)
squamous cell carcinoma of the uterine##3##6##(1994-4#2)(2008-4#1)
squamous cell carcinoma of the vulva##3##6##(1992-3#1)(2005-11#1)(2007-8#1)
squamous cell carcinoma of the##41##5##(1990-6#1)(1991-10#1)(1991-6#1)(1992-3#1)(1993-12#2)(1993-4#2)(1993-8#3)(1993-9#2)(1994-4#3)(1996-12#1)(2005-11#2)(2005-7#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-4#1)(2009-5#3)(2009-8#1)(2010-12#1)(2010-7#2)(2010-9#1)(2011-1#1)(2012-2#3)(2013-7#1)(2013-8#4)
squamous cell carcinoma of##51##4##(1990-6#1)(1991-10#1)(1991-6#1)(1992-3#1)(1993-12#2)(1993-4#2)(1993-8#3)(1993-9#2)(1994-4#3)(1996-12#1)(2005-11#2)(2005-7#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-4#1)(2009-5#5)(2009-8#1)(2010-12#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-12#3)(2011-2#2)(2012-12#2)(2012-2#3)(2013-7#1)(2013-8#4)
squamous cell carcinoma patients##3##4##(2007-11#1)(2010-4#2)
squamous cell carcinoma that##2##4##(2008-9#1)(2012-12#1)
squamous cell carcinoma was##4##4##(2006-10#1)(2007-8#1)(2012-3#2)
squamous cell carcinoma with##4##4##(2007-11#1)(2008-5#2)(2010-8#1)
squamous cell carcinoma##205##3##(1990-10#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-6#2)(1991-8#2)(1992-3#1)(1992-4#1)(1992-8#2)(1993-12#2)(1993-4#2)(1993-5#1)(1993-8#4)(1993-9#3)(1994-4#3)(1994-6#5)(1996-11#1)(1996-12#1)(1996-4#1)(1997-1#2)(1997-3#1)(2004-3#1)(2005-11#6)(2005-7#1)(2006-10#3)(2006-11#1)(2006-12#3)(2007-1#1)(2007-11#9)(2007-12#3)(2007-2#6)(2007-3#1)(2007-6#3)(2007-7#5)(2007-8#8)(2008-1#1)(2008-12#2)(2008-2#2)(2008-4#2)(2008-5#4)(2008-9#3)(2009-10#2)(2009-5#7)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#4)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#13)(2010-8#7)(2010-9#2)(2011-1#3)(2011-12#5)(2011-2#8)(2012-1#1)(2012-12#8)(2012-2#5)(2012-3#8)(2013-1#7)(2013-7#2)(2013-8#10)
squamous cell carcinoma]##3##3##(2012-2#1)(2012-3#1)(2013-1#1)
squamous cell carcinomas (SCC)##2##4##(2011-2#2)
squamous cell carcinomas and##2##4##(1992-3#1)(2010-7#1)
squamous cell carcinomas has##2##4##(1997-3#1)(2005-11#1)
squamous cell carcinomas of the##5##5##(1991-8#1)(1992-2#1)(2011-2#1)(2012-3#2)
squamous cell carcinomas of##7##4##(1991-8#1)(1992-2#2)(1994-4#1)(2011-2#1)(2012-3#2)
squamous cell carcinomas on##2##4##(1994-4#1)(2007-11#1)
squamous cell carcinomas##42##3##(1990-10#1)(1991-11#1)(1991-8#1)(1992-2#2)(1992-3#2)(1993-9#1)(1994-4#2)(1994-6#4)(1997-3#2)(2005-11#2)(2007-11#2)(2007-2#1)(2008-4#2)(2008-5#1)(2008-9#2)(2009-9#2)(2010-7#4)(2010-8#1)(2011-1#1)(2011-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
squamous cell lung cancer##5##4##(2012-12#2)(2012-2#3)
squamous cell lung##7##3##(1997-7#1)(2012-12#2)(2012-2#4)
squamous cell papilloma of the forestomach in##3##7##(2008-9#3)
squamous cell papilloma of the##4##5##(2008-9#4)
squamous cell papilloma##9##3##(2008-9#9)
squamous cell papillomas at##2##4##(2008-9#2)
squamous cell papillomas of the##2##5##(2008-9#2)
squamous cell papillomas##4##3##(2008-9#4)
squamous cell##288##2##(1990-10#2)(1990-5#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-6#2)(1991-8#3)(1992-2#3)(1992-3#3)(1992-4#1)(1992-8#2)(1993-12#2)(1993-4#2)(1993-5#2)(1993-8#4)(1993-9#4)(1994-4#5)(1994-6#9)(1996-11#1)(1996-12#1)(1996-4#1)(1997-1#2)(1997-3#3)(1997-7#2)(2004-3#1)(2005-11#9)(2005-7#1)(2006-10#4)(2006-11#1)(2006-12#3)(2007-1#1)(2007-10#1)(2007-11#11)(2007-12#3)(2007-2#7)(2007-3#1)(2007-4#1)(2007-6#3)(2007-7#5)(2007-8#9)(2008-1#2)(2008-11#1)(2008-12#2)(2008-2#2)(2008-4#4)(2008-5#5)(2008-9#18)(2009-10#2)(2009-5#8)(2009-6#1)(2009-8#1)(2009-9#3)(2010-12#5)(2010-4#2)(2010-5#5)(2010-6#2)(2010-7#17)(2010-8#9)(2010-9#2)(2011-1#5)(2011-12#6)(2011-2#11)(2012-1#1)(2012-12#10)(2012-2#10)(2012-3#12)(2013-1#9)(2013-7#3)(2013-8#11)
squamous cells of##5##3##(1997-5#1)(1997-7#1)(2006-10#2)(2007-12#1)
squamous cells##9##2##(1997-5#1)(1997-7#1)(2006-10#3)(2007-12#1)(2007-2#1)(2008-11#1)(2010-12#1)
squamous differentiation##4##2##(1993-11#2)(2011-2#1)(2013-7#1)
squamous epithelia##2##2##(1991-11#1)(2012-12#1)
squamous epithelium of the##2##4##(1995-8#1)(2009-3#1)
squamous epithelium##7##2##(1990-6#1)(1995-8#1)(2007-6#1)(2009-3#2)(2011-12#1)(2013-1#1)
squamous intraepithelial lesion##3##3##(2006-10#3)
squamous intraepithelial lesions and##2##4##(2006-10#1)(2009-1#1)
squamous intraepithelial lesions in##2##4##(2006-10#2)
squamous intraepithelial lesions of##2##4##(1994-1#1)(2012-1#1)
squamous intraepithelial lesions##16##3##(1994-1#1)(1994-12#1)(2006-10#8)(2009-1#1)(2010-5#4)(2012-1#1)
squamous intraepithelial neoplasia##2##3##(1992-9#1)(2009-8#1)
squamous intraepithelial##22##2##(1992-9#1)(1994-1#1)(1994-12#1)(2006-10#11)(2008-11#1)(2009-1#1)(2009-8#1)(2010-5#4)(2012-1#1)
squamous lesions##3##2##(1994-1#2)(2007-7#1)
squamous metaplasia##4##2##(1991-2#1)(1994-9#1)(2007-9#1)(2008-1#1)
squamous##373##1##(1990-10#2)(1990-11#1)(1990-5#1)(1990-6#3)(1991-10#2)(1991-11#2)(1991-2#2)(1991-3#2)(1991-6#2)(1991-8#3)(1991-9#1)(1992-2#3)(1992-3#3)(1992-4#1)(1992-8#3)(1992-9#4)(1993-11#2)(1993-12#2)(1993-4#2)(1993-5#2)(1993-8#5)(1993-9#4)(1994-1#3)(1994-12#3)(1994-4#5)(1994-6#9)(1994-9#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-9#2)(1997-1#3)(1997-3#3)(1997-5#1)(1997-7#3)(2004-3#1)(2005-11#9)(2005-7#1)(2006-10#19)(2006-11#1)(2006-12#3)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#13)(2007-12#4)(2007-2#8)(2007-3#3)(2007-4#2)(2007-6#4)(2007-7#6)(2007-8#9)(2007-9#1)(2008-1#3)(2008-11#3)(2008-12#2)(2008-2#3)(2008-4#4)(2008-5#6)(2008-9#18)(2009-1#1)(2009-10#2)(2009-3#2)(2009-5#8)(2009-6#2)(2009-8#3)(2009-9#3)(2010-12#8)(2010-4#2)(2010-5#9)(2010-6#2)(2010-7#18)(2010-8#10)(2010-9#2)(2011-1#5)(2011-12#7)(2011-2#13)(2012-1#2)(2012-12#11)(2012-2#10)(2012-3#12)(2013-1#10)(2013-7#4)(2013-8#11)
squamous-cell carcinoma of##2##3##(1990-8#1)(1991-9#1)
squamous-cell carcinoma##10##2##(1990-8#1)(1991-12#1)(1991-9#2)(1992-10#1)(1993-9#3)(2007-11#1)(2012-12#1)
squamous-cell carcinomas##5##2##(1991-5#2)(1992-12#1)(1992-9#1)(1993-9#1)
squamous-cell##17##1##(1990-8#1)(1991-12#1)(1991-5#2)(1991-9#2)(1992-10#1)(1992-12#1)(1992-9#2)(1993-9#5)(2007-11#1)(2012-12#1)
squamulosa##3##1##(2013-7#3)
squaraine##3##1##(2007-8#1)(2008-10#2)
squaraines##2##1##(2007-8#2)
square analysis##4##2##(2006-5#1)(2008-10#1)(2008-12#1)(2008-8#1)
square and##9##2##(1991-3#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#3)(2012-2#1)
square area##3##2##(2012-12#3)
square array##4##2##(1994-11#2)(2008-3#2)
square beam##3##2##(2008-2#3)
square capillaries##3##2##(2007-8#3)
square centimeter##14##2##(1991-5#1)(1993-2#1)(2007-12#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#1)
square error of prediction##7##4##(2008-10#7)
square error of##14##3##(2008-1#1)(2008-10#10)(2008-6#1)(2010-5#1)(2012-12#1)
square error##22##2##(2008-1#1)(2008-10#11)(2008-2#2)(2008-6#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)
square fit##3##2##(1997-2#1)(2008-10#1)(2012-2#1)
square foot##3##2##(1991-2#1)(1992-2#1)(2012-2#1)
square grid##5##2##(2008-10#1)(2008-2#2)(2008-3#2)
square kilometers##2##2##(2007-9#2)
square lattice##3##2##(1991-4#1)(2007-12#2)
square law##2##2##(2007-11#1)(2008-3#1)
square matrices##2##2##(1997-8#1)(2008-2#1)
square meter##11##2##(1991-11#4)(1995-8#1)(2007-11#1)(2008-10#4)(2008-5#1)
square miles##3##2##(2008-1#2)(2013-1#1)
square of the correlation##2##4##(1995-6#1)(2008-10#1)
square of the##20##3##(1990-7#1)(1995-6#1)(2005-11#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#7)(2012-11#1)
square of##23##2##(1990-7#1)(1995-6#1)(2005-11#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#8)(2012-11#1)(2012-3#1)
square planar geometry##6##3##(2008-3#2)(2008-5#4)
square planar##8##2##(2008-3#2)(2008-5#6)
square pyramidal coordination##3##3##(1994-9#1)(2008-10#1)(2008-5#1)
square pyramidal with##2##3##(1997-7#1)(2010-2#1)
square pyramidal##6##2##(1994-9#1)(1997-7#1)(2008-10#1)(2008-5#2)(2010-2#1)
square regression##4##2##(2008-10#1)(2012-12#1)(2013-8#2)
square root of the Allan variance##2##6##(2007-12#1)(2008-2#1)
square root of the##12##4##(1993-10#1)(1994-9#1)(2007-12#3)(2007-2#1)(2008-10#2)(2008-2#2)(2008-3#1)(2013-7#1)
square root of time##4##4##(2005-11#1)(2006-1#1)(2006-6#1)(2008-5#1)
square root of##22##3##(1993-10#1)(1993-8#1)(1994-9#1)(2005-11#1)(2006-1#1)(2006-6#1)(2007-12#4)(2007-2#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#2)(2008-8#1)(2008-9#1)(2013-7#1)
square root##24##2##(1993-10#1)(1993-8#1)(1994-9#1)(2005-11#1)(2006-1#1)(2006-11#1)(2006-6#1)(2007-12#5)(2007-2#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#2)(2008-8#1)(2008-9#1)(2013-7#1)
square wave adsorptive stripping voltammetry##7##5##(2008-10#7)
square wave adsorptive stripping##8##4##(2008-10#8)
square wave and##2##3##(2008-10#2)
square wave anodic stripping voltammetry##4##5##(2008-10#4)
square wave cathodic stripping voltammetry (SWCSV)##2##6##(2008-10#2)
square wave cathodic stripping voltammetry##4##5##(2008-10#4)
square wave gratings##2##3##(1992-7#1)(1994-2#1)
square wave pattern##2##3##(2011-2#2)
square wave voltammetric##12##3##(2007-8#1)(2008-10#11)
square wave voltammetry (SWV) with##2##5##(2008-10#2)
square wave voltammetry (SWV)##6##4##(2008-10#6)
square wave voltammetry and##2##4##(2007-8#1)(2008-10#1)
square wave voltammetry was##2##4##(2008-10#1)(2008-8#1)
square wave voltammetry with##2##4##(2008-10#2)
square wave voltammetry##27##3##(2007-8#1)(2008-10#24)(2008-8#2)
square wave##72##2##(1992-7#1)(1994-2#1)(2006-1#1)(2007-12#2)(2007-8#2)(2008-10#61)(2008-8#2)(2011-2#2)
square##341##1##(1990-3#2)(1990-7#1)(1990-8#2)(1991-11#4)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-2#2)(1992-4#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#3)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#2)(1995-1#2)(1995-12#1)(1995-6#1)(1995-8#1)(1995-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-11#7)(2006-1#2)(2006-10#3)(2006-11#1)(2006-12#2)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#6)(2007-12#14)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#8)(2007-9#4)(2008-1#4)(2008-10#106)(2008-12#2)(2008-2#22)(2008-3#31)(2008-5#12)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#2)(2009-2#1)(2009-4#2)(2009-5#2)(2009-7#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#11)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#5)(2013-7#1)(2013-8#6)
square)##4##1##(2007-12#1)(2008-2#1)(2008-7#1)(2011-2#1)
square-law##6##1##(2007-11#2)(2007-12#1)(2008-2#3)
square-planar geometry##3##2##(1997-7#1)(2008-5#1)(2010-5#1)
square-planar##7##1##(1996-8#1)(1997-7#1)(2007-11#1)(2008-5#2)(2010-5#2)
square-pulse##2##1##(2007-12#2)
square-root##6##1##(2007-12#2)(2008-2#1)(2008-3#2)(2010-8#1)
square-shaped##5##1##(2007-12#2)(2008-2#2)(2008-3#1)
square-wave (SW)##4##2##(2008-10#4)
square-wave adsorptive cathodic stripping voltammetric procedure was##2##7##(2008-10#2)
square-wave adsorptive cathodic stripping##3##4##(2008-10#3)
square-wave adsorptive stripping##2##3##(2008-10#2)
square-wave adsorptive##5##2##(2008-10#5)
square-wave and adsorptive stripping square-wave##2##5##(2008-10#2)
square-wave and##4##2##(2008-10#4)
square-wave anodic stripping voltammetry##8##4##(2008-10#8)
square-wave anodic##9##2##(2008-10#9)
square-wave stripping voltammetry (SWSV)##2##4##(2008-10#2)
square-wave stripping voltammetry##4##3##(2008-10#4)
square-wave techniques##2##2##(2008-10#2)
square-wave voltammetric (SWV) method##2##4##(2008-10#2)
square-wave voltammetric scan##3##3##(2008-10#3)
square-wave voltammetric##8##2##(1997-1#1)(2008-10#7)
square-wave voltammetry##8##2##(2008-10#8)
square-wave was 2##2##3##(2008-10#2)
square-wave##55##1##(1997-1#1)(2007-11#1)(2007-12#2)(2008-10#49)(2008-3#2)
squared error##11##2##(1995-4#1)(2006-10#2)(2008-10#3)(2008-2#3)(2008-7#1)(2009-10#1)
squared multiple correlation##2##3##(2007-10#1)(2008-12#1)
squared##27##1##(1995-4#1)(1995-9#1)(2006-10#2)(2007-10#1)(2007-12#3)(2008-10#4)(2008-12#1)(2008-2#6)(2008-3#2)(2008-7#2)(2009-10#1)(2011-1#1)(2011-3#1)(2012-3#1)
squared-grating deflectograms##2##2##(2008-3#2)
squarelike##2##1##(2007-12#2)
squares and##7##2##(1994-5#1)(2008-10#3)(2009-2#1)(2010-4#1)(2012-1#1)
squares method##7##2##(2007-12#1)(2007-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-2#1)
squares of##6##2##(1995-12#1)(2007-11#1)(2007-5#1)(2008-6#1)(2008-8#1)(2013-1#1)
squares regression analysis##4##3##(1993-12#1)(2008-10#2)(2008-11#1)
squares regression##33##2##(1993-12#1)(2005-4#1)(2007-11#2)(2007-4#1)(2008-10#22)(2008-11#2)(2008-3#1)(2010-4#1)(2011-2#1)(2012-2#1)
squares##210##1##(1990-3#1)(1992-6#3)(1993-12#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#3)(1996-1#1)(1997-2#1)(1997-6#1)(2005-4#1)(2007-11#5)(2007-12#3)(2007-4#1)(2007-5#1)(2007-8#5)(2008-10#120)(2008-11#3)(2008-2#8)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#4)(2008-8#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2010-2#3)(2010-4#2)(2010-5#1)(2011-1#7)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
squaring and##2##2##(2008-3#1)(2012-2#1)
squaring##3##1##(2008-3#2)(2012-2#1)
squarylium dye##2##2##(2008-10#2)
squarylium##3##1##(2007-11#1)(2008-10#2)
squash and melon plants##2##4##(2008-10#2)
squash and##4##2##(2008-10#4)
squash leaf curl virus##2##4##(2008-10#2)
squash leaf curl##3##3##(2008-10#3)
squash plants##2##2##(2008-10#2)
squash##22##1##(2008-10#21)(2008-5#1)
squash-leaf nitrate reductase##2##3##(2006-10#2)
squat##7##1##(1995-2#1)(2008-5#2)(2010-12#1)(2011-2#3)
squatting height##2##2##(2008-6#2)
squatting postures##3##2##(2008-6#3)
squatting##14##1##(2008-6#12)(2010-9#1)(2012-2#1)
squeeze##8##1##(1990-4#1)(1991-11#1)(1992-2#1)(1992-3#1)(1993-9#1)(1994-8#1)(1995-10#1)(2008-7#1)
squeezed##7##1##(1993-5#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-2#1)(2011-1#1)
squeezing and gravitational##2##3##(2009-6#2)
squeezing and##4##2##(2007-12#1)(2009-6#3)
squeezing by##3##2##(2007-12#2)(2008-1#1)
squeezing in the##2##3##(2007-12#2)
squeezing in##4##2##(2007-11#1)(2007-12#3)
squeezing of##4##2##(2007-11#1)(2007-12#3)
squeezing##22##1##(1995-10#1)(2007-11#3)(2007-12#10)(2008-1#4)(2008-12#1)(2009-6#3)
squeezing-out&quot##2##1##(1993-3#2)
squelching##2##1##(1995-3#1)(1995-6#1)
squid axons##3##2##(1990-11#1)(1990-4#1)(1992-9#1)
squid giant axon##5##3##(1990-11#1)(1990-4#1)(1992-9#1)(2012-12#2)
squid giant axons##3##3##(1990-4#1)(1997-4#2)
squid giant##8##2##(1990-11#1)(1990-4#2)(1992-9#1)(1997-4#2)(2012-12#2)
squid mutant##2##2##(1994-3#2)
squid ovaries##2##2##(1994-3#2)
squid##35##1##(1990-11#2)(1990-4#3)(1992-9#2)(1994-3#9)(1995-5#4)(1995-8#2)(1997-4#2)(2008-12#3)(2008-7#2)(2010-9#2)(2012-12#2)(2013-1#1)(2013-8#1)
squint##2##1##(2007-1#1)(2008-7#1)
squint-free##2##1##(2008-2#2)
squirrel monkey##8##2##(1991-12#2)(1991-5#2)(1995-11#3)(2008-7#1)
squirrel monkeys (Saimiri sciureus)##2##4##(1996-4#1)(1997-5#1)
squirrel monkeys##18##2##(1991-1#2)(1991-11#1)(1991-2#1)(1992-12#2)(1995-11#3)(1996-4#1)(1997-5#4)(2008-4#1)(2010-2#2)(2012-3#1)
squirrel##46##1##(1990-5#3)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#2)(1992-12#2)(1994-5#1)(1995-11#6)(1996-4#1)(1997-5#4)(1997-8#1)(2007-8#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#9)(2010-2#2)(2010-6#1)(2012-3#1)
squirrel)##2##1##(1992-12#1)(2011-2#1)
squirrels##11##1##(1995-12#3)(2008-5#3)(2008-8#2)(2010-6#3)
sr##5##1##(1992-11#1)(2006-2#1)(2007-11#1)(2008-2#1)(2008-3#1)
sr(-1) for the##3##3##(2008-3#3)
sr(-1)##11##1##(2008-2#4)(2008-3#7)
sr)##2##1##(2007-11#1)(2008-2#1)
src PTKs##2##2##(1992-9#2)
src family##7##2##(1990-11#1)(1990-12#2)(1991-11#1)(1991-5#1)(1992-9#1)(1994-3#1)
src kinase##3##2##(1994-6#3)
src transformation-associated##2##2##(1994-9#2)
src##26##1##(1990-11#1)(1990-12#3)(1990-8#1)(1991-11#1)(1991-5#1)(1992-11#1)(1992-5#2)(1992-9#3)(1993-6#1)(1993-9#1)(1994-3#1)(1994-6#6)(1994-8#1)(1994-9#2)(1996-2#1)
src-family##3##1##(1990-7#1)(1993-3#2)
src-oncogene##2##1##(1990-7#2)
src-related tyrosine##2##2##(1992-5#1)(1992-9#1)
src-related##5##1##(1992-11#2)(1992-5#1)(1992-9#1)(1994-12#1)
srebf1a##5##1##(2012-2#5)
sribBP##6##1##(1994-9#6)
srs-1 gene##3##2##(2008-8#3)
srs-1##6##1##(2008-8#6)
ss phagemid DNA##2##3##(1991-7#2)
ss##7##1##(1991-7#2)(1997-1#1)(2007-11#3)(2011-2#1)
ss-DNA probe##2##2##(2008-10#2)
ss-DNA to##2##2##(1997-2#1)(2006-12#1)
ss-DNA##10##1##(1997-2#4)(2006-12#3)(2008-10#3)
ss-casein##2##1##(2008-5#2)
ss-thalassemia##2##1##(2007-2#2)
ss2-microglobulin##6##1##(2007-3#6)
ssCRE-BP##5##1##(1996-10#5)
ssDNA and dsDNA##2##3##(2008-10#2)
ssDNA and##3##2##(1995-2#1)(2008-10#2)
ssDNA phages##2##2##(2012-2#2)
ssDNA to##2##2##(1996-7#1)(2008-4#1)
ssDNA##38##1##(1990-10#1)(1991-5#9)(1993-3#2)(1994-12#1)(1995-2#1)(1995-8#1)(1996-7#2)(2008-10#11)(2008-4#2)(2008-7#1)(2012-2#4)(2012-3#3)
ssRNA##6##1##(1991-5#1)(1996-9#3)(2008-10#2)
ssa##3##1##(2006-12#3)
ssb1##2##1##(1992-12#2)
ssh7a and ssh7b##2##3##(2008-9#2)
ssp##36##1##(1997-2#2)(2004-4#3)(2006-12#1)(2007-1#1)(2007-2#1)(2008-11#2)(2008-5#5)(2008-9#7)(2009-10#3)(2011-1#5)(2011-12#1)(2011-2#4)(2012-2#1)
sspA mutation##2##2##(1994-5#2)
sspA##4##1##(1994-5#4)
sst##2##1##(2006-1#2)
sst1##2##1##(1995-12#2)
sst2##3##1##(1994-12#1)(2006-10#1)(2008-1#1)
st##9##1##(1995-12#7)(1997-1#1)(2006-9#1)
stab agar##2##2##(2008-2#1)(2008-9#1)
stab wounds were##2##3##(1990-7#2)
stab wounds##10##2##(1990-2#2)(1990-7#3)(2007-3#1)(2007-8#2)(2011-2#2)
stab##14##1##(1990-2#2)(1990-7#3)(2005-9#1)(2007-3#1)(2007-8#2)(2008-2#1)(2008-9#1)(2011-2#3)
stabbed organs##2##2##(1996-6#2)
stabbing##5##1##(1996-9#4)(2008-4#1)
stabile fixation##2##2##(2007-11#2)
stabile##6##1##(1990-4#1)(1993-3#1)(1997-8#1)(2006-6#1)(2007-11#2)
stabilisation in##2##2##(2005-1#1)(2008-10#1)
stabilisation of IL-2 receptor alpha subunit mRNA by##2##8##(1991-2#2)
stabilisation of the##7##3##(1991-5#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-5#1)
stabilisation of##19##2##(1991-2#3)(1991-5#1)(1995-2#1)(1997-5#1)(2006-10#1)(2007-11#4)(2007-8#2)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-1#1)(2012-2#1)
stabilisation was performed##2##3##(2007-7#1)(2008-6#1)
stabilisation was##5##2##(2007-11#2)(2007-7#1)(2008-4#1)(2008-6#1)
stabilisation with##4##2##(2007-11#1)(2007-8#2)(2008-7#1)
stabilisation##57##1##(1991-2#3)(1991-5#1)(1995-2#1)(1997-5#1)(2005-1#1)(2006-10#1)(2006-4#1)(2006-6#2)(2007-11#17)(2007-12#1)(2007-7#1)(2007-8#7)(2007-9#2)(2008-10#6)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
stabilise IL-2R alpha mRNA##2##4##(1991-2#2)
stabilise the##3##2##(1991-6#1)(2007-8#2)
stabilise##9##1##(1991-2#2)(1991-6#1)(1997-1#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-4#1)
stabilised by##5##2##(1995-3#1)(1997-7#1)(2007-11#1)(2008-5#1)(2011-2#1)
stabilised with##2##2##(2007-11#1)(2012-2#1)
stabilised##17##1##(1990-11#1)(1991-5#1)(1994-4#1)(1995-3#1)(1997-4#1)(1997-7#1)(2007-11#4)(2007-7#1)(2008-10#1)(2008-5#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
stabiliser##6##1##(2006-6#2)(2008-10#3)(2013-7#1)
stabilisers##5##1##(2007-11#3)(2008-4#1)(2008-8#1)
stabilises##3##1##(1990-5#1)(2010-5#1)(2010-7#1)
stabilising##8##1##(1992-9#1)(1997-7#1)(2006-12#2)(2008-10#1)(2012-1#1)(2012-2#1)(2013-1#1)
stabilities and##3##2##(2008-10#2)(2008-5#1)
stabilities for##3##2##(1995-6#1)(2006-3#1)(2008-9#1)
stabilities in##2##2##(1994-3#1)(2009-3#1)
stabilities of the##4##3##(1993-11#1)(2006-2#1)(2007-10#1)(2008-4#1)
stabilities of##16##2##(1992-1#1)(1993-11#1)(1993-3#1)(1994-11#1)(1995-8#1)(1997-2#1)(2006-2#1)(2007-10#1)(2008-10#2)(2008-3#1)(2008-4#2)(2010-5#1)(2011-1#1)(2012-12#1)
stabilities were##3##2##(2006-12#1)(2008-10#1)(2010-5#1)
stabilities##48##1##(1990-12#2)(1990-6#1)(1991-3#1)(1991-4#1)(1992-1#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-4#1)(1997-2#1)(2006-12#2)(2006-2#1)(2006-3#1)(2007-10#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-5#2)(2011-1#1)(2012-12#1)(2012-3#3)
stability (at##3##2##(2008-10#1)(2010-2#1)(2010-3#1)
stability (up to##3##3##(2007-8#1)(2008-10#2)
stability after##2##2##(2008-6#1)(2008-8#1)
stability against##10##2##(1996-6#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#2)
stability analysis is##2##3##(2005-11#1)(2013-8#1)
stability analysis of the##2##4##(1997-1#1)(2008-9#1)
stability analysis of##4##3##(1992-3#1)(1997-1#1)(2008-3#1)(2008-9#1)
stability analysis that##2##3##(2007-9#1)(2008-2#1)
stability analysis##13##2##(1992-3#1)(1997-1#1)(2005-11#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2013-8#1)
stability and a##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2011-2#1)
stability and ability to##3##4##(1994-12#1)(2008-10#1)(2011-2#1)
stability and activity##4##3##(2012-11#4)
stability and biocompatibility##2##3##(2004-9#1)(2008-5#1)
stability and change in##3##4##(2006-3#1)(2006-9#1)(2008-5#1)
stability and change##4##3##(2006-3#1)(2006-9#1)(2008-10#1)(2008-5#1)
stability and control##2##3##(2007-12#1)(2007-6#1)
stability and energy##2##3##(1992-11#1)(2008-6#1)
stability and for##2##3##(2008-10#1)(2012-2#1)
stability and function##2##3##(1994-11#1)(2009-7#1)
stability and functionality##2##3##(2007-8#1)(2009-11#1)
stability and high##2##3##(1993-4#1)(2008-10#1)
stability and in##2##3##(1995-8#1)(1996-8#1)
stability and its##2##3##(2008-10#1)(2008-5#1)
stability and long-life##2##3##(2008-10#2)
stability and low##2##3##(2007-12#1)(2010-4#1)
stability and lower##2##3##(2008-10#1)(2009-3#1)
stability and no##2##3##(2008-10#1)(2008-7#1)
stability and postoperative##2##3##(2010-7#2)
stability and recovery##3##3##(1992-8#2)(2012-2#1)
stability and reproducibility of the##5##5##(2006-5#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-8#1)
stability and reproducibility of##7##4##(2006-5#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-8#1)(2009-9#1)
stability and reproducibility##18##3##(2006-5#2)(2008-10#11)(2008-12#1)(2008-2#1)(2008-8#1)(2009-9#1)(2013-8#1)
stability and selectivity##2##3##(2008-10#2)
stability and specificity##2##3##(1997-4#1)(2008-4#1)
stability and structure of DNA##2##5##(1995-5#2)
stability and structure of##5##4##(1991-8#1)(1994-8#1)(1995-5#2)(2007-11#1)
stability and the repeatability of##2##5##(2005-12#1)(2008-3#1)
stability and the##12##3##(1991-1#1)(1993-11#1)(1994-3#1)(1997-8#1)(2005-10#1)(2005-12#1)(2008-10#3)(2008-3#1)(2009-3#1)(2011-2#1)
stability and their##2##3##(2008-8#1)(2012-12#1)
stability and to##2##3##(2008-10#1)(2008-5#1)
stability and##226##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-8#1)(1991-1#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#2)(1994-8#5)(1995-1#1)(1995-3#1)(1995-4#1)(1995-5#3)(1995-8#1)(1996-5#1)(1996-6#2)(1996-8#1)(1997-3#1)(1997-4#1)(1997-8#2)(2004-9#3)(2005-10#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-9#1)(2007-11#5)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#45)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#7)(2008-5#12)(2008-6#3)(2008-7#6)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-4#4)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#6)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#6)
stability appears to be##2##4##(1997-2#1)(2005-11#1)
stability are discussed##2##3##(1990-8#1)(1994-6#1)
stability are##13##2##(1990-8#1)(1991-6#1)(1994-6#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-2#1)(2008-8#2)(2011-1#1)(2012-1#1)(2012-2#1)
stability as well as##3##4##(2008-10#1)(2009-12#1)(2011-2#1)
stability as##7##2##(1991-1#1)(2005-11#1)(2007-11#1)(2008-10#2)(2009-12#1)(2011-2#1)
stability at high temperatures##2##4##(1994-12#1)(1994-6#1)
stability at higher##2##3##(1990-11#1)(1995-2#1)
stability at the##4##3##(1995-8#1)(2008-11#1)(2008-4#1)(2008-8#1)
stability at##18##2##(1990-11#1)(1990-5#1)(1993-4#1)(1994-12#2)(1994-6#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-5#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-3#1)(2010-5#1)(2011-2#1)
stability because of the##2##4##(2008-10#2)
stability between##3##2##(2006-2#1)(2008-10#1)(2008-8#1)
stability but##4##2##(1994-8#1)(2008-4#1)(2008-5#1)(2012-2#1)
stability by##15##2##(1990-5#1)(1990-8#1)(1993-3#1)(1995-4#1)(2004-9#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-8#1)(2010-4#1)(2010-6#1)(2011-2#1)
stability can be##2##3##(2008-10#1)(2008-5#1)
stability compared to##2##3##(1995-8#1)(2010-4#1)
stability compared##3##2##(1995-8#1)(2008-10#1)(2010-4#1)
stability constant for the##2##4##(2006-6#1)(2008-10#1)
stability constant for##4##3##(2006-6#1)(2008-10#3)
stability constant of##8##3##(2006-6#1)(2008-10#7)
stability constant values##2##3##(2008-10#2)
stability constant##24##2##(2005-4#1)(2006-6#2)(2008-10#20)(2008-3#1)
stability constants (logK) were##2##4##(2008-10#2)
stability constants and##3##3##(2008-10#1)(2008-3#1)(2010-5#1)
stability constants are##2##3##(2008-10#2)
stability constants determination##2##3##(2008-10#2)
stability constants for metal-ligand complexes##2##5##(2008-10#2)
stability constants for the##3##4##(2008-10#2)(2008-5#1)
stability constants for##11##3##(2006-6#1)(2008-10#9)(2008-5#1)
stability constants of Fe(II)##2##4##(2008-10#2)
stability constants of complexes##3##4##(2008-10#3)
stability constants of praseodymium carbonate complexes##2##6##(2008-10#2)
stability constants of the complexes formed##2##6##(1996-2#1)(2008-10#1)
stability constants of the complexes##3##5##(1996-2#1)(2008-10#2)
stability constants of the##20##4##(1996-2#1)(1996-8#1)(2008-10#15)(2008-3#1)(2008-5#2)
stability constants of##40##3##(1992-9#1)(1996-2#1)(1996-8#1)(2008-10#34)(2008-3#1)(2008-5#2)
stability constants were##2##3##(2008-10#2)
stability constants with##2##3##(1996-8#1)(2008-10#1)
stability constants##94##2##(1992-9#1)(1996-2#1)(1996-8#3)(2006-6#1)(2008-10#78)(2008-3#2)(2008-5#6)(2010-5#1)(2010-6#1)
stability control##2##2##(2008-1#1)(2010-11#1)
stability could be##3##3##(1994-12#1)(1996-3#1)(2004-9#1)
stability criteria##4##2##(2007-12#2)(2008-2#1)(2010-4#1)
stability depends on##2##3##(1991-7#1)(2012-3#1)
stability domain##2##2##(1992-10#1)(2007-11#1)
stability due to##2##3##(1991-7#1)(2008-10#1)
stability during##8##2##(1990-10#1)(1996-5#1)(2006-10#1)(2008-10#1)(2008-5#1)(2009-7#1)(2011-12#1)(2011-2#1)
stability even##2##2##(2008-10#1)(2011-1#1)
stability for a##2##3##(2008-10#1)(2008-3#1)
stability for at least 3 months##2##6##(2008-10#2)
stability for at least##4##4##(1992-5#1)(2008-10#3)
stability for the##3##3##(2006-8#1)(2008-10#2)
stability for up to##2##4##(2008-10#2)
stability for##23##2##(1992-5#1)(2006-8#1)(2007-11#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
stability from the##2##3##(1992-5#1)(2008-3#1)
stability from##3##2##(1992-5#1)(2008-3#1)(2010-4#1)
stability has been##4##3##(1996-3#1)(2008-10#2)(2008-2#1)
stability have##3##2##(1994-12#1)(2008-10#1)(2009-4#1)
stability in aqueous##4##3##(1996-6#1)(2008-10#2)(2008-5#1)
stability in blood##2##3##(1990-11#1)(2008-1#1)
stability in patients##2##3##(2008-1#1)(2012-2#1)
stability in the##13##3##(1992-12#1)(1994-12#1)(1996-9#1)(2004-12#1)(2006-4#1)(2006-9#1)(2008-10#1)(2008-3#2)(2008-5#2)(2010-10#1)(2010-4#1)
stability in vivo##2##3##(1997-1#1)(2012-12#1)
stability in##73##2##(1990-11#2)(1990-2#1)(1990-9#1)(1991-4#1)(1992-12#1)(1992-2#1)(1993-12#2)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-6#2)(1996-9#1)(1997-1#1)(2004-12#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-9#1)(2007-9#1)(2008-1#3)(2008-10#6)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#2)(2009-1#1)(2009-12#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
stability indicating##10##2##(2008-10#5)(2010-12#3)(2011-1#1)(2011-2#1)
stability is achieved##3##3##(1995-1#1)(2005-7#1)(2007-8#1)
stability is better than##2##4##(2008-2#1)(2008-3#1)
stability is one of the##2##5##(2006-10#1)(2008-5#1)
stability is##35##2##(1991-1#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-1#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-3#2)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#6)(2008-2#3)(2008-3#2)(2008-5#3)(2008-8#2)(2009-8#2)(2013-8#2)
stability level##2##2##(2008-3#2)
stability may##2##2##(2008-5#1)(2011-1#1)
stability mutants##2##2##(2005-11#1)(2007-11#1)
stability observed##3##2##(1992-6#1)(2009-9#1)(2012-2#1)
stability occurred##2##2##(2007-12#1)(2007-8#1)
stability of 1##2##3##(2008-10#1)(2009-4#1)
stability of DNA##6##3##(1995-8#1)(1996-4#2)(2005-11#1)(2006-12#2)
stability of a model##2##4##(1993-11#1)(1995-8#1)
stability of a##29##3##(1990-4#1)(1991-1#1)(1991-4#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-9#1)(1995-8#1)(2005-11#1)(2006-7#1)(2007-12#5)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#3)(2008-9#1)(2009-9#2)(2012-2#1)(2013-8#1)
stability of adriamycin##2##3##(2008-10#2)
stability of all##2##3##(1990-11#1)(2010-4#1)
stability of an##3##3##(1992-6#1)(2007-8#1)(2009-3#1)
stability of both##3##3##(1995-6#1)(2009-9#1)(2013-7#1)
stability of complexes formed between##2##5##(2008-10#1)(2008-4#1)
stability of complexes formed##3##4##(2008-10#2)(2008-4#1)
stability of complexes##4##3##(2008-10#2)(2008-4#1)(2012-2#1)
stability of composites##3##3##(2008-5#2)(2013-1#1)
stability of different##4##3##(1996-12#1)(2008-10#1)(2010-4#2)
stability of each##2##3##(1995-1#1)(2008-8#1)
stability of equilibria##2##3##(1993-8#1)(2008-10#1)
stability of factor##2##3##(1990-11#1)(2008-11#1)
stability of gentamicin and sodium citrate##2##6##(2010-3#2)
stability of human##3##3##(1996-1#1)(2012-1#1)(2013-1#1)
stability of its##3##3##(1997-5#1)(2008-11#1)(2008-2#1)
stability of liposomes##2##3##(1994-3#1)(1996-1#1)
stability of microtubules##2##3##(1994-2#1)(1997-4#1)
stability of mutant##2##3##(1995-1#1)(2013-1#1)
stability of pGP1 was##2##4##(1995-8#2)
stability of protein##4##3##(1991-6#1)(1997-4#1)(2008-11#1)(2008-5#1)
stability of real##2##3##(1995-2#1)(2008-10#1)
stability of recombinant##4##3##(1994-11#1)(1994-3#1)(2008-5#1)(2011-2#1)
stability of self-representations##2##3##(2008-9#2)
stability of sleep##2##3##(1992-1#1)(1996-1#1)
stability of spatial##2##3##(2007-5#1)(2008-1#1)
stability of such##6##3##(1992-2#1)(2005-11#1)(2008-1#1)(2008-5#2)(2010-12#1)
stability of the PB##3##4##(2008-10#3)
stability of the aggregate##2##4##(2006-10#1)(2008-10#1)
stability of the algorithm##2##4##(2008-3#1)(2012-2#1)
stability of the complex##6##4##(1995-1#1)(1996-8#1)(2008-10#3)(2010-5#1)
stability of the complexes##2##4##(1996-2#1)(2006-10#1)
stability of the duplex##3##4##(1990-5#1)(1994-8#1)(2006-12#1)
stability of the electrode##3##4##(2008-10#3)
stability of the enzyme##4##4##(1992-2#1)(1996-12#1)(1997-6#1)(2008-6#1)
stability of the film##2##4##(2008-10#2)
stability of the films and the##2##6##(2008-10#2)
stability of the free##2##4##(2007-11#1)(2008-6#1)
stability of the helix##2##4##(1990-8#1)(1992-6#1)
stability of the interferometer##2##4##(2008-2#1)(2008-3#1)
stability of the joint##3##4##(2005-7#1)(2006-3#1)(2007-8#1)
stability of the monolayer##2##4##(2007-9#1)(2008-10#1)
stability of the mutant##3##4##(1993-11#1)(1995-1#2)
stability of the product##2##4##(1995-5#1)(2008-10#1)
stability of the protein is##2##5##(1993-11#1)(1996-5#1)
stability of the protein##8##4##(1992-4#1)(1993-11#1)(1994-5#1)(1995-10#1)(1996-5#1)(1997-2#2)(2008-5#1)
stability of the recombinant##2##4##(1994-2#1)(2008-5#1)
stability of the resulting##2##4##(2008-10#1)(2008-2#1)
stability of the sensor##4##4##(2007-8#2)(2008-10#1)(2008-3#1)
stability of the shoulder##2##4##(2007-11#1)(2007-7#1)
stability of the solutions##2##4##(2008-10#1)(2012-12#1)
stability of the spine##3##4##(2006-8#1)(2008-1#2)
stability of the system is##2##5##(2008-11#1)(2008-8#1)
stability of the system##6##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-11#1)
stability of the three##2##4##(1990-12#1)(1992-2#1)
stability of the##289##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#2)(1991-11#2)(1991-2#1)(1991-3#1)(1991-4#3)(1991-7#1)(1991-9#3)(1992-2#3)(1992-4#1)(1992-6#6)(1993-11#5)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-5#2)(1994-8#2)(1994-9#2)(1995-1#4)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#3)(1997-6#2)(1997-7#1)(2005-11#8)(2005-7#2)(2005-8#1)(2006-10#3)(2006-12#5)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#7)(2007-12#7)(2007-7#1)(2007-8#10)(2007-9#1)(2008-1#4)(2008-10#55)(2008-11#4)(2008-12#1)(2008-2#13)(2008-3#9)(2008-4#5)(2008-5#10)(2008-6#3)(2008-7#2)(2008-8#4)(2008-9#3)(2009-3#3)(2009-5#1)(2009-8#2)(2009-9#3)(2010-1#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
stability of their##3##3##(2007-2#1)(2008-10#1)(2011-2#1)
stability of these complexes##3##4##(1997-4#1)(2007-10#1)(2008-10#1)
stability of these##24##3##(1991-12#1)(1992-7#1)(1993-4#1)(1995-2#1)(1997-4#1)(2007-10#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#1)(2013-8#1)
stability of thioredoxin##2##3##(1991-7#1)(2008-4#1)
stability of this system##2##4##(2007-12#1)(2008-2#1)
stability of this##15##3##(1991-5#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-10#1)(1996-5#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-12#1)
stability of transgene##2##3##(2008-12#1)(2008-5#1)
stability of various##2##3##(1992-5#1)(2010-3#1)
stability of vesicles##2##3##(1990-2#1)(2013-7#1)
stability of vitamin##2##3##(2008-5#2)
stability of##728##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#3)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#3)(1990-8#4)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#9)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#4)(1992-1#3)(1992-11#1)(1992-12#4)(1992-2#5)(1992-3#2)(1992-4#3)(1992-5#1)(1992-6#8)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#6)(1993-12#1)(1993-2#1)(1993-3#6)(1993-4#4)(1993-6#5)(1993-8#3)(1993-9#3)(1994-11#5)(1994-12#5)(1994-2#3)(1994-3#5)(1994-5#3)(1994-8#4)(1994-9#4)(1995-1#9)(1995-10#2)(1995-11#4)(1995-12#1)(1995-2#8)(1995-3#1)(1995-5#7)(1995-6#3)(1995-8#9)(1996-1#5)(1996-12#2)(1996-2#3)(1996-4#4)(1996-5#7)(1996-6#2)(1996-7#2)(1996-8#4)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#6)(1997-5#1)(1997-6#5)(1997-7#1)(1997-8#2)(2004-12#1)(2004-8#1)(2004-9#4)(2005-11#23)(2005-7#2)(2005-8#1)(2006-10#4)(2006-12#11)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#18)(2007-12#22)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#12)(2007-9#2)(2008-1#6)(2008-10#112)(2008-11#14)(2008-12#5)(2008-2#23)(2008-3#20)(2008-4#9)(2008-5#30)(2008-6#7)(2008-7#9)(2008-8#17)(2008-9#11)(2009-12#2)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#6)(2009-9#6)(2010-1#3)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#4)(2010-4#13)(2010-5#4)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#10)(2012-1#4)(2012-12#5)(2012-2#10)(2012-3#4)(2012-6#1)(2012-7#2)(2013-1#10)(2013-7#3)(2013-8#7)
stability on##6##2##(2008-11#1)(2008-12#2)(2009-4#1)(2010-12#1)(2013-1#1)
stability or the##2##3##(1993-11#1)(2007-5#1)
stability or##10##2##(1990-11#1)(1990-3#1)(1991-11#1)(1993-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#1)(2009-10#1)(2012-8#1)
stability over a##3##3##(2008-10#1)(2008-2#1)(2013-1#1)
stability over time##2##3##(2008-10#1)(2011-2#1)
stability over##8##2##(2008-10#4)(2008-2#1)(2011-2#1)(2012-1#1)(2013-1#1)
stability problems##2##2##(2006-2#1)(2008-10#1)
stability profile##2##2##(2006-12#1)(2007-11#1)
stability properties##2##2##(2007-12#1)(2008-3#1)
stability range##4##2##(2005-11#1)(2007-12#1)(2008-3#1)(2012-1#1)
stability results##2##2##(2007-8#1)(2008-3#1)
stability showed that##2##3##(2008-5#1)(2011-1#1)
stability similar to##2##3##(1995-1#1)(2007-12#1)
stability so that##2##3##(2007-12#1)(2008-10#1)
stability studies at##2##3##(2008-5#2)
stability studies of the##3##4##(1996-6#1)(2008-10#1)(2008-5#1)
stability studies of##4##3##(1996-6#1)(2008-10#1)(2008-5#1)(2010-4#1)
stability studies##21##2##(1993-11#1)(1996-6#1)(2006-10#1)(2007-8#1)(2008-10#5)(2008-5#4)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#1)(2012-12#1)
stability study##3##2##(2008-5#2)(2010-3#1)
stability testing##3##2##(2005-11#1)(2008-5#1)(2011-1#1)
stability tests##8##2##(1996-6#1)(2005-11#1)(2008-10#2)(2008-5#2)(2008-6#1)(2012-12#1)
stability than the##5##3##(1994-2#1)(1994-5#1)(1997-4#2)(2009-3#1)
stability than##10##2##(1994-2#1)(1994-5#1)(1996-8#1)(1997-4#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-3#1)
stability that##3##2##(1990-8#1)(1992-6#1)(2008-3#1)
stability through##4##2##(2007-12#1)(2008-8#1)(2012-2#2)
stability to a##2##3##(1991-7#1)(1994-2#1)
stability to the##5##3##(1997-4#1)(2009-8#1)(2011-2#1)(2012-1#1)(2013-8#1)
stability to##23##2##(1991-7#2)(1992-6#1)(1992-9#1)(1994-11#1)(1994-2#1)(1994-9#1)(1997-4#1)(2005-11#1)(2006-7#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
stability toward##3##2##(1993-11#1)(1995-1#1)(2005-11#1)
stability towards##3##2##(1990-12#1)(2006-12#1)(2008-10#1)
stability training##2##2##(2008-12#1)(2009-1#1)
stability under##7##2##(1992-12#1)(2006-10#1)(2008-2#1)(2008-4#1)(2008-5#3)
stability upon##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
stability using##3##2##(2005-11#1)(2008-10#1)(2008-4#1)
stability was found##4##3##(1994-3#1)(2008-10#1)(2008-5#2)
stability was observed##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
stability was obtained in##2##4##(1990-11#1)(1997-1#1)
stability was obtained##3##3##(1990-11#1)(1993-4#1)(1997-1#1)
stability was reduced##2##3##(2007-8#1)(2008-5#1)
stability was##32##2##(1990-11#1)(1993-4#1)(1994-3#1)(1997-1#1)(2004-9#1)(2005-11#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#2)(2008-5#9)(2008-9#1)(2011-2#1)(2012-11#1)
stability were##12##2##(1990-2#1)(1990-8#1)(1995-8#1)(2005-11#1)(2008-10#6)(2008-6#1)(2008-7#1)
stability when stored##2##3##(2006-12#1)(2008-5#1)
stability when##5##2##(2006-12#1)(2008-10#2)(2008-4#1)(2008-5#1)
stability which measures##2##3##(1991-6#1)(2013-8#1)
stability which##4##2##(1991-6#1)(1992-5#1)(1994-11#1)(2013-8#1)
stability while##2##2##(2006-3#1)(2008-10#1)
stability will##3##2##(2008-9#1)(2009-7#1)(2013-8#1)
stability with##9##2##(1990-11#1)(1997-5#1)(2006-10#1)(2008-5#1)(2008-6#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)
stability without##3##2##(1993-7#1)(2007-2#1)(2013-7#1)
stability##2050##1##(1990-10#3)(1990-11#11)(1990-12#5)(1990-2#6)(1990-3#2)(1990-4#1)(1990-5#7)(1990-6#1)(1990-7#3)(1990-8#10)(1990-9#3)(1991-1#6)(1991-11#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#12)(1991-5#1)(1991-6#4)(1991-7#11)(1991-8#4)(1991-9#5)(1992-1#4)(1992-10#1)(1992-11#4)(1992-12#7)(1992-2#6)(1992-3#4)(1992-4#3)(1992-5#7)(1992-6#15)(1992-7#2)(1992-8#4)(1992-9#4)(1993-11#12)(1993-12#5)(1993-2#2)(1993-3#11)(1993-4#7)(1993-6#8)(1993-7#1)(1993-8#3)(1993-9#5)(1994-11#10)(1994-12#18)(1994-2#10)(1994-3#11)(1994-5#6)(1994-6#2)(1994-8#15)(1994-9#10)(1995-1#15)(1995-10#3)(1995-11#4)(1995-12#1)(1995-2#15)(1995-3#4)(1995-4#3)(1995-5#11)(1995-6#4)(1995-8#22)(1996-1#6)(1996-11#1)(1996-12#2)(1996-2#8)(1996-3#2)(1996-4#5)(1996-5#11)(1996-6#9)(1996-7#4)(1996-8#9)(1996-9#1)(1997-1#6)(1997-2#6)(1997-3#4)(1997-4#13)(1997-5#4)(1997-6#11)(1997-7#2)(1997-8#5)(2004-12#2)(2004-8#1)(2004-9#10)(2005-10#2)(2005-11#46)(2005-12#1)(2005-4#2)(2005-7#4)(2005-8#2)(2006-10#19)(2006-12#22)(2006-2#6)(2006-3#11)(2006-4#2)(2006-5#6)(2006-6#5)(2006-7#3)(2006-8#3)(2006-9#4)(2007-1#3)(2007-10#4)(2007-11#52)(2007-12#51)(2007-2#4)(2007-4#2)(2007-5#2)(2007-6#5)(2007-7#8)(2007-8#33)(2007-9#5)(2008-1#13)(2008-10#411)(2008-11#32)(2008-12#12)(2008-2#62)(2008-3#53)(2008-4#31)(2008-5#112)(2008-6#19)(2008-7#28)(2008-8#43)(2008-9#33)(2009-1#4)(2009-10#2)(2009-11#4)(2009-12#4)(2009-2#1)(2009-3#10)(2009-4#5)(2009-5#1)(2009-6#2)(2009-7#5)(2009-8#14)(2009-9#11)(2010-1#7)(2010-10#2)(2010-11#4)(2010-12#20)(2010-2#8)(2010-3#10)(2010-4#33)(2010-5#8)(2010-6#6)(2010-7#8)(2010-8#2)(2010-9#5)(2011-1#19)(2011-12#4)(2011-2#35)(2012-1#13)(2012-11#13)(2012-12#16)(2012-2#32)(2012-3#11)(2012-6#1)(2012-7#2)(2012-8#1)(2012-9#1)(2013-1#34)(2013-7#10)(2013-8#24)
stability)##4##1##(1992-12#2)(2008-12#1)(2008-2#1)
stability-diversity relationships##2##2##(2008-9#2)
stability-diversity##3##1##(2008-9#3)
stability-indicating HPLC##3##2##(2010-2#1)(2010-3#1)(2011-1#1)
stability-indicating capability##2##2##(2012-12#1)(2013-7#1)
stability-indicating high-performance thin-layer##2##3##(2007-8#1)(2008-10#1)
stability-indicating method##3##2##(2007-8#1)(2008-10#1)(2013-7#1)
stability-indicating##22##1##(2004-12#1)(2007-8#2)(2008-10#2)(2010-12#1)(2010-2#4)(2010-3#1)(2011-1#2)(2012-12#5)(2013-7#4)
stability?##2##1##(2008-9#1)(2010-1#1)
stability]##2##1##(2012-3#1)(2013-1#1)
stabilization against##3##2##(1997-7#1)(2007-12#1)(2008-3#1)
stabilization and destabilization##2##3##(1990-8#2)
stabilization and##25##2##(1990-8#2)(1992-6#1)(1995-5#1)(2005-11#1)(2006-2#1)(2007-11#2)(2007-8#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-6#1)(2009-2#1)(2009-8#1)(2010-1#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
stabilization are##2##2##(2005-10#1)(2006-10#1)
stabilization at the##2##3##(1992-1#1)(1995-10#1)
stabilization at##4##2##(1992-1#1)(1992-8#1)(1995-10#1)(1995-5#1)
stabilization by means of##4##4##(2007-12#1)(2007-7#1)(2008-3#2)
stabilization by##18##2##(1990-12#1)(1990-2#1)(1991-2#1)(1994-5#1)(1997-2#1)(2007-11#4)(2007-12#2)(2007-7#1)(2008-1#1)(2008-3#2)(2008-6#1)(2008-9#1)(2013-1#1)
stabilization effect##4##2##(1994-11#3)(2008-10#1)
stabilization energy##2##2##(1993-3#1)(2013-1#1)
stabilization for##3##2##(1992-3#1)(2008-3#1)(2010-2#1)
stabilization has been##2##3##(2006-3#1)(2009-8#1)
stabilization in the treatment of##2##5##(2007-7#1)(2007-8#1)
stabilization in the##5##3##(1991-2#1)(1997-4#1)(2007-7#1)(2007-8#1)(2008-3#1)
stabilization in##10##2##(1991-2#1)(1997-4#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-3#1)(2013-8#1)
stabilization is a##3##3##(2006-12#1)(2007-7#2)
stabilization is##10##2##(2006-10#1)(2006-12#1)(2007-12#1)(2007-7#3)(2008-10#1)(2008-3#2)(2009-9#1)
stabilization mechanism##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
stabilization method##3##2##(1993-3#1)(2005-11#1)(2007-12#1)
stabilization of a higher-order mode-locked##2##5##(2007-11#2)
stabilization of a##15##3##(1993-3#1)(2007-11#2)(2007-12#8)(2008-2#1)(2008-3#1)(2009-11#1)(2010-6#1)
stabilization of an##3##3##(1992-3#1)(2007-12#1)(2008-3#1)
stabilization of fractures##2##3##(1992-3#1)(2010-9#1)
stabilization of infrequently used##2##4##(1994-8#2)
stabilization of microtubules##2##3##(1997-4#1)(2009-8#1)
stabilization of neural circuitry##2##4##(1994-8#2)
stabilization of tellurium in##3##4##(2008-10#3)
stabilization of the active##2##4##(1993-3#1)(1995-5#1)
stabilization of the mRNA##2##4##(1991-2#1)(1994-9#1)
stabilization of the spine##2##4##(2007-11#1)(2008-1#1)
stabilization of the##62##3##(1990-8#1)(1991-12#1)(1991-2#2)(1991-6#1)(1991-7#1)(1992-3#1)(1992-5#2)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-5#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-11#4)(2007-12#2)(2007-7#2)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)
stabilization of this##2##3##(1991-5#1)(1994-11#1)
stabilization of unstable##2##3##(2007-1#1)(2007-8#1)
stabilization of##170##2##(1990-7#1)(1990-8#2)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-5#2)(1992-6#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1994-11#3)(1994-12#3)(1994-5#1)(1994-8#5)(1994-9#4)(1995-10#1)(1995-11#2)(1995-2#1)(1995-5#4)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#2)(2005-11#3)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#2)(2007-11#11)(2007-12#13)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#10)(2008-11#2)(2008-2#4)(2008-3#6)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-11#1)(2009-3#1)(2009-8#3)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-7#1)
stabilization or##2##2##(2004-3#1)(2007-6#1)
stabilization system##4##2##(2008-2#3)(2009-9#1)
stabilization time##3##2##(2007-8#2)(2008-12#1)
stabilization via a##2##3##(1990-2#1)(2005-11#1)
stabilization was done##3##3##(2007-11#3)
stabilization was##5##2##(2007-11#4)(2009-3#1)
stabilization were##3##2##(2005-11#1)(2008-10#1)(2013-1#1)
stabilization with##7##2##(2007-11#1)(2007-7#1)(2007-8#2)(2012-2#2)(2013-1#1)
stabilization##387##1##(1990-12#1)(1990-2#3)(1990-7#1)(1990-8#4)(1991-12#1)(1991-2#4)(1991-4#1)(1991-5#3)(1991-6#3)(1991-7#1)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#5)(1992-5#2)(1992-6#3)(1992-8#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#5)(1994-11#7)(1994-12#3)(1994-5#2)(1994-8#6)(1994-9#4)(1995-10#3)(1995-11#2)(1995-2#2)(1995-4#1)(1995-5#7)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-7#2)(1996-8#1)(1997-2#4)(1997-3#1)(1997-4#3)(1997-7#1)(2004-3#1)(2004-9#1)(2005-10#2)(2005-11#7)(2006-10#8)(2006-12#3)(2006-2#3)(2006-3#1)(2006-4#1)(2006-6#2)(2006-8#4)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#35)(2007-12#25)(2007-2#1)(2007-6#1)(2007-7#14)(2007-8#16)(2007-9#2)(2008-1#6)(2008-10#19)(2008-11#2)(2008-12#7)(2008-2#11)(2008-3#18)(2008-4#4)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#4)(2008-9#5)(2009-11#1)(2009-2#1)(2009-3#4)(2009-6#2)(2009-7#1)(2009-8#5)(2009-9#3)(2010-1#2)(2010-11#3)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-1#2)(2012-12#5)(2012-2#6)(2012-3#6)(2013-1#8)(2013-7#2)(2013-8#2)
stabilization)##2##1##(2007-8#2)
stabilizations##2##1##(2007-11#1)(2013-1#1)
stabilize DNA methylation##2##3##(2007-11#2)
stabilize DNA##4##2##(1995-5#2)(2007-11#2)
stabilize a##4##2##(1992-6#1)(1995-10#1)(1995-11#1)(2008-3#1)
stabilize emulsions##2##2##(2005-11#1)(2008-5#1)
stabilize its##2##2##(1993-3#1)(2010-4#1)
stabilize or##3##2##(1991-5#1)(1994-1#1)(1995-8#1)
stabilize the cooperative amplification in##2##5##(1997-6#1)(2006-10#1)
stabilize the disease##2##3##(2006-6#1)(2008-4#1)
stabilize the native state##2##4##(1990-9#1)(1995-1#1)
stabilize the##54##2##(1990-12#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-7#1)(1995-1#2)(1996-9#1)(1997-2#1)(1997-6#1)(2004-11#1)(2005-11#3)(2005-8#1)(2006-10#2)(2006-12#2)(2006-3#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#4)(2010-12#1)(2010-8#1)(2012-3#1)(2013-8#1)
stabilize this##2##2##(2011-2#1)(2011-3#1)
stabilize##135##1##(1990-12#1)(1990-2#1)(1990-8#3)(1990-9#1)(1991-10#1)(1991-2#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-11#2)(1993-3#2)(1993-5#1)(1993-6#1)(1994-1#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-1#3)(1995-10#3)(1995-11#1)(1995-5#2)(1995-8#2)(1996-11#1)(1996-2#1)(1996-5#2)(1996-9#1)(1997-2#2)(1997-6#2)(2004-11#1)(2004-12#1)(2005-11#6)(2005-8#2)(2006-10#2)(2006-12#2)(2006-3#1)(2006-4#1)(2006-6#1)(2007-11#4)(2007-12#2)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#6)(2008-8#8)(2008-9#2)(2009-12#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#2)
stabilized and##9##2##(1992-3#2)(1992-6#1)(1997-1#1)(2005-11#1)(2007-12#1)(2007-7#1)(2008-1#2)
stabilized at a##3##3##(1994-2#1)(2006-6#1)(2013-1#1)
stabilized at##9##2##(1992-6#1)(1992-7#1)(1993-2#1)(1994-2#1)(2006-6#1)(2007-6#1)(2008-10#1)(2008-4#1)(2013-1#1)
stabilized by a network of##2##5##(1991-7#1)(1994-8#1)
stabilized by a##12##3##(1991-6#1)(1991-7#1)(1993-6#1)(1994-8#1)(1996-2#1)(2005-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2011-2#1)(2012-12#1)
stabilized by an##2##3##(2007-12#1)(2008-1#1)
stabilized by the C-terminal##2##4##(1995-5#1)(2013-8#1)
stabilized by the interaction##2##4##(1995-5#1)(2008-4#1)
stabilized by the presence of##2##5##(1997-4#1)(1997-5#1)
stabilized by the##14##3##(1991-3#1)(1994-11#1)(1995-1#1)(1995-5#2)(1996-8#1)(1997-4#1)(1997-5#1)(2008-10#1)(2008-3#1)(2008-4#2)(2012-2#1)(2013-8#1)
stabilized by two##3##3##(1991-12#1)(1997-2#1)(2010-5#1)
stabilized by##90##2##(1990-5#2)(1990-8#1)(1991-12#2)(1991-3#1)(1991-4#2)(1991-6#1)(1991-7#4)(1991-9#1)(1992-10#1)(1992-4#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-5#2)(1995-6#3)(1996-11#2)(1996-2#2)(1996-6#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-8#1)(2005-11#11)(2005-9#1)(2006-12#2)(2007-10#2)(2007-12#4)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-8#1)(2009-2#2)(2009-3#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#2)
stabilized for##2##2##(1992-2#1)(1995-3#1)
stabilized in a##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
stabilized in the presence of##3##5##(1994-11#1)(1995-3#1)(2008-4#1)
stabilized in the##6##3##(1994-11#1)(1995-3#1)(2008-2#1)(2008-4#1)(2009-12#1)(2012-12#1)
stabilized in##14##2##(1994-11#1)(1994-9#1)(1995-3#1)(1996-6#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-12#2)(2012-12#1)
stabilized laser##2##2##(2007-11#1)(2008-3#1)
stabilized liposomes##9##2##(1995-2#1)(2006-10#2)(2008-5#6)
stabilized microtubules##2##2##(1993-8#1)(2012-4#1)
stabilized on##3##2##(2007-12#1)(2008-3#1)(2010-12#1)
stabilized percutaneously##2##2##(2008-4#1)(2013-1#1)
stabilized phosphate##2##2##(2008-10#2)
stabilized the##11##2##(1990-5#1)(1992-5#1)(1992-6#1)(1995-1#1)(1995-11#1)(1995-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-4#1)
stabilized through##2##2##(2007-12#1)(2008-10#1)
stabilized to a##3##3##(2007-12#3)
stabilized to the same##2##4##(1995-4#1)(2011-1#1)
stabilized to##11##2##(1995-4#1)(2007-12#6)(2008-2#1)(2008-3#2)(2011-1#1)
stabilized using##3##2##(2006-7#1)(2007-8#1)(2010-2#1)
stabilized while##2##2##(2008-3#1)(2011-2#1)
stabilized with a cervical plate##2##5##(2009-10#2)
stabilized with##14##2##(1992-6#1)(1995-2#1)(2005-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2009-10#2)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
stabilized within##2##2##(2008-10#1)(2012-3#1)
stabilized##272##1##(1990-10#1)(1990-5#3)(1990-7#1)(1990-8#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#5)(1991-9#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#4)(1995-1#3)(1995-11#1)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#4)(1995-6#3)(1996-11#2)(1996-12#1)(1996-2#3)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-10#2)(2005-11#19)(2005-9#1)(2006-10#3)(2006-12#2)(2006-3#1)(2006-6#1)(2006-7#1)(2007-10#2)(2007-11#6)(2007-12#20)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#4)(2008-1#5)(2008-10#20)(2008-11#1)(2008-2#8)(2008-3#12)(2008-4#8)(2008-5#8)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#1)(2009-9#2)(2010-1#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#3)(2010-7#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#2)(2012-4#1)(2013-1#5)(2013-8#2)
stabilizer is##3##2##(2007-11#2)(2012-2#1)
stabilizer of the##2##3##(1994-8#1)(2008-9#1)
stabilizer of##3##2##(1994-8#1)(2008-7#1)(2008-9#1)
stabilizer was##2##2##(2007-8#1)(2008-10#1)
stabilizer##24##1##(1992-6#1)(1992-7#1)(1993-11#1)(1994-8#1)(2006-6#1)(2007-11#3)(2007-8#2)(2008-10#3)(2008-2#2)(2008-5#1)(2008-7#1)(2008-9#2)(2010-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
stabilizers and##5##2##(2004-4#1)(2005-7#1)(2006-9#1)(2008-1#1)(2010-8#1)
stabilizers for##3##2##(2008-10#2)(2012-2#1)
stabilizers in the##2##3##(2007-11#1)(2008-10#1)
stabilizers in##3##2##(2007-11#1)(2008-10#2)
stabilizers of the##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
stabilizers of##4##2##(2008-10#1)(2008-8#1)(2009-8#1)(2011-2#1)
stabilizers##46##1##(1992-11#2)(2004-4#1)(2005-10#1)(2005-6#1)(2005-7#2)(2006-9#1)(2007-11#6)(2007-7#1)(2007-8#11)(2008-1#2)(2008-10#6)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-8#1)(2010-8#2)(2011-2#1)(2012-2#2)
stabilizes a##2##2##(1990-11#1)(1994-12#1)
stabilizes aFGF##2##2##(1993-6#2)
stabilizes and##4##2##(1991-2#1)(1996-2#1)(1997-2#1)(2011-2#1)
stabilizes the##17##2##(1990-5#1)(1991-10#1)(1991-7#2)(1992-6#1)(1993-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1996-11#1)(1996-5#2)(1997-6#1)(2005-11#1)(2008-1#1)(2008-10#2)
stabilizes##52##1##(1990-11#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-7#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-6#3)(1994-12#2)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#2)(1996-7#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-11#2)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-9#2)(2009-2#1)(2009-6#1)(2010-11#1)(2011-2#2)(2012-12#1)(2013-8#1)
stabilizing action##2##2##(1993-11#1)(1995-8#1)
stabilizing agent##4##2##(2005-10#1)(2005-11#1)(2008-9#1)(2010-4#1)
stabilizing and destabilizing##3##3##(1995-5#1)(1997-4#1)(1997-7#1)
stabilizing and##8##2##(1994-9#1)(1995-5#1)(1997-4#1)(1997-7#1)(2005-11#1)(2007-11#1)(2008-9#1)(2012-1#1)
stabilizing apparatus##2##2##(2006-10#2)
stabilizing device##2##2##(2007-8#2)
stabilizing drug##2##2##(2008-6#1)(2011-2#1)
stabilizing effect of the##2##4##(1993-8#1)(1996-11#1)
stabilizing effect of##7##3##(1990-5#1)(1992-1#1)(1993-8#1)(1995-2#1)(1996-11#1)(1997-2#1)(2008-1#1)
stabilizing effect##10##2##(1990-5#1)(1992-1#1)(1993-8#1)(1995-2#1)(1996-11#1)(1997-2#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-4#1)
stabilizing effects of bezafibrate on coronary plaques##2##7##(2008-5#2)
stabilizing effects of##3##3##(2007-11#1)(2008-5#2)
stabilizing effects##5##2##(1991-2#1)(2007-11#1)(2008-5#2)(2010-12#1)
stabilizing for##2##2##(1990-2#1)(2009-7#1)
stabilizing in##2##2##(1991-11#1)(2011-12#1)
stabilizing influence##3##2##(2005-11#3)
stabilizing interactions##2##2##(1992-3#1)(1997-5#1)
stabilizing its##2##2##(1990-7#1)(2008-4#1)
stabilizing material##3##2##(2007-11#3)
stabilizing or destabilizing influences##2##4##(2008-8#1)(2008-9#1)
stabilizing or##3##2##(2006-10#1)(2008-8#1)(2008-9#1)
stabilizing role##2##2##(1995-6#1)(2005-11#1)
stabilizing secondary##2##2##(1993-11#1)(1995-7#1)
stabilizing selection on##3##3##(2008-8#1)(2008-9#1)(2013-1#1)
stabilizing selection##15##2##(2007-3#1)(2008-10#1)(2008-8#9)(2008-9#3)(2013-1#1)
stabilizing the membrane##2##3##(2007-12#1)(2013-8#1)
stabilizing the native##2##3##(1993-11#1)(2008-4#1)
stabilizing the##24##2##(1993-11#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-2#1)(1995-3#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-9#1)(2010-4#1)(2010-7#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
stabilizing their##2##2##(1991-6#1)(2007-10#1)
stabilizing##152##1##(1990-2#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-2#2)(1991-6#1)(1991-7#2)(1992-1#1)(1992-3#1)(1992-6#2)(1993-11#4)(1993-6#2)(1993-8#2)(1994-12#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#4)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-4#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#2)(2005-10#1)(2005-11#9)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#13)(2008-9#10)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-7#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
stabilometric tests##2##2##(2011-1#2)
stabilometric##3##1##(2011-1#3)
stable (II##2##2##(2012-3#2)
stable 1##4##2##(1993-11#1)(1996-2#1)(2008-10#1)(2008-5#1)
stable 100% control##3##3##(2012-2#3)
stable BC1F4 line (denominated##2##4##(2008-10#2)
stable Chinese hamster ovary##2##4##(2008-11#2)
stable DNA##2##2##(1995-1#1)(2008-4#1)
stable HbA1C##2##2##(1990-6#2)
stable QTLs for the##2##4##(2012-11#2)
stable RNA##3##2##(1995-10#2)(1996-2#1)
stable across##2##2##(2006-12#1)(2007-10#1)
stable after##8##2##(1997-7#1)(2007-11#1)(2008-11#1)(2008-5#2)(2008-8#1)(2010-12#1)(2012-12#1)
stable against##2##2##(2007-12#1)(2008-10#1)
stable along##2##2##(1990-5#1)(2007-5#1)
stable amperometric response##2##3##(2007-8#1)(2008-10#1)
stable amperometric##3##2##(2007-8#1)(2008-10#2)
stable analogue of##3##3##(1990-12#1)(1995-5#1)(1997-7#1)
stable analogues##2##2##(1997-7#1)(2008-4#1)
stable and can be##3##4##(2008-11#1)(2008-4#1)(2010-4#1)
stable and dynamic motion##2##4##(2010-8#2)
stable and highly productive##3##4##(2008-11#3)
stable and homogeneous##3##3##(2008-10#2)(2008-4#1)
stable and reliable##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
stable and reproducible##4##3##(1992-7#1)(2008-10#3)
stable and sensitive to##2##4##(1991-9#1)(2008-10#1)
stable and sensitive##4##3##(1991-9#1)(2007-8#2)(2008-10#1)
stable and showed##2##3##(2008-10#2)
stable and specific##2##3##(1993-4#1)(1994-8#1)
stable and the##3##3##(2007-1#1)(2008-10#1)(2013-8#1)
stable and unstable##8##3##(2006-6#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#1)(2012-3#1)(2013-7#1)
stable and##112##2##(1990-2#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-9#1)(1992-7#1)(1993-11#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-8#3)(1995-4#1)(1996-5#2)(1997-1#1)(1997-7#1)(2005-4#1)(2006-10#1)(2006-6#1)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#2)(2007-7#2)(2007-8#8)(2008-10#20)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#2)(2008-8#4)(2009-3#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-2#3)(2012-3#2)(2012-4#1)(2013-1#2)(2013-7#1)(2013-8#3)
stable angina or acute myocardial infarction##2##6##(2008-5#1)(2012-11#1)
stable angina patients##2##3##(2005-8#1)(2012-2#1)
stable angina pectoris##6##3##(1993-12#2)(2005-8#1)(2006-6#1)(2008-10#2)
stable angina##38##2##(1993-12#2)(1996-6#1)(1997-8#1)(2005-8#4)(2006-6#1)(2007-9#8)(2008-1#5)(2008-10#4)(2008-3#2)(2008-4#1)(2008-5#2)(2009-12#1)(2010-12#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#2)
stable as an##2##3##(2006-10#1)(2006-3#1)
stable as the##3##3##(1995-5#1)(2008-2#1)(2008-3#1)
stable as##6##2##(1995-5#1)(2005-11#1)(2006-10#1)(2006-3#1)(2008-2#1)(2008-3#1)
stable association of##3##3##(1991-5#1)(1996-6#1)(2008-9#1)
stable association##4##2##(1991-5#1)(1994-9#1)(1996-6#1)(2008-9#1)
stable at 4 degrees C for##3##6##(1991-3#1)(1991-5#1)(2008-11#1)
stable at 4 degrees C##5##5##(1991-12#1)(1991-3#1)(1991-5#1)(2008-11#1)(2009-4#1)
stable at around##3##3##(1993-3#1)(1995-5#1)(2008-7#1)
stable at least##3##3##(1991-8#1)(2008-10#1)(2011-1#1)
stable at pH 5##2##4##(1997-8#1)(2008-11#1)
stable at room temperature and##2##5##(2007-11#1)(2007-12#1)
stable at room temperature##4##4##(2007-11#1)(2007-12#2)(2008-10#1)
stable at##36##2##(1991-12#2)(1991-3#1)(1991-5#1)(1991-8#1)(1992-7#1)(1993-3#1)(1994-6#1)(1995-5#1)(1997-1#1)(1997-3#2)(1997-8#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-10#5)(2008-11#3)(2008-5#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-4#1)(2010-9#1)(2011-1#2)(2012-3#1)
stable average##2##2##(2007-12#1)(2010-12#1)
stable baseline##3##2##(1993-4#1)(2007-7#1)(2008-10#1)
stable between##4##2##(1994-9#1)(2007-7#1)(2008-10#1)(2008-5#1)
stable biosensor for##2##3##(2008-10#2)
stable body weight##3##3##(2008-1#1)(2008-3#2)
stable bound##2##2##(2007-11#1)(2007-12#1)
stable bright##2##2##(2007-12#1)(2008-1#1)
stable but##4##2##(1991-8#1)(1995-1#1)(1997-6#1)(2008-4#1)
stable butyrate derivatives##2##3##(1991-5#2)
stable by##2##2##(2008-10#1)(2010-5#1)
stable carbon isotope##3##3##(2006-5#1)(2008-10#2)
stable carbon##5##2##(2006-5#2)(2008-10#2)(2012-9#1)
stable cardiac##2##2##(1995-2#1)(2007-8#1)
stable cavity##2##2##(2007-12#2)
stable cell line##5##3##(1990-7#2)(1993-3#1)(2008-2#2)
stable cell lines##11##3##(1995-2#1)(1997-4#1)(2005-8#1)(2008-1#1)(2008-11#3)(2008-2#2)(2008-7#1)(2009-6#1)
stable cell##19##2##(1990-7#2)(1993-3#1)(1994-5#1)(1995-2#1)(1997-4#1)(2005-8#1)(2008-1#1)(2008-11#3)(2008-2#5)(2008-7#1)(2008-8#1)(2009-6#1)
stable cells##2##2##(1995-1#1)(2013-7#1)
stable chelating resin was##2##4##(2008-10#2)
stable chelating resin##3##3##(2008-10#3)
stable chronic##3##2##(1997-1#1)(2008-10#1)(2012-3#1)
stable clones##2##2##(1994-5#1)(1995-4#1)
stable coating##2##2##(2008-10#1)(2008-3#1)
stable community##2##2##(1992-12#1)(2006-8#1)
stable complex in##2##3##(1992-3#1)(1996-5#1)
stable complex of##3##3##(1991-6#1)(2005-11#1)(2008-4#1)
stable complex with the##2##4##(1997-6#1)(2008-8#1)
stable complex with##6##3##(1997-6#1)(2008-10#2)(2008-8#1)(2010-12#1)(2013-8#1)
stable complex##22##2##(1990-12#1)(1990-6#1)(1991-6#4)(1992-3#1)(1994-8#1)(1996-5#1)(1997-1#1)(1997-6#1)(2005-11#2)(2006-10#1)(2008-10#4)(2008-4#1)(2008-8#1)(2010-12#1)(2013-8#1)
stable complexes with DNA##2##4##(1995-5#1)(2011-2#1)
stable complexes with##16##3##(1990-2#1)(1991-6#1)(1992-4#1)(1994-3#1)(1994-8#1)(1995-5#1)(2007-8#1)(2008-10#5)(2008-3#1)(2009-4#1)(2010-11#1)(2011-2#1)
stable complexes##24##2##(1990-12#2)(1990-2#1)(1991-6#1)(1992-4#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-6#2)(1997-4#1)(2006-10#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-4#1)(2009-4#1)(2010-11#1)(2011-2#1)
stable conditions##3##2##(1997-8#1)(2008-11#1)(2008-5#1)
stable conformation##4##2##(1990-7#1)(1993-11#1)(1993-9#1)(2012-2#1)
stable continuous##2##2##(2007-12#1)(2008-10#1)
stable core##4##2##(2008-3#2)(2009-2#1)(2012-12#1)
stable coronary artery disease##2##4##(2008-7#1)(2009-4#1)
stable coronary##3##2##(2008-5#1)(2008-7#1)(2009-4#1)
stable cruciform##2##2##(1994-11#2)
stable cyclic##2##2##(1994-2#1)(2008-10#1)
stable cylindrical##2##2##(2008-3#2)
stable diffraction-limited##2##2##(2007-11#1)(2007-12#1)
stable dimeric##2##2##(1993-11#1)(2008-10#1)
stable dioxin-responsive cell line##2##4##(2008-11#2)
stable disease (SD)##4##3##(1990-10#1)(1990-2#1)(2007-11#1)(2007-6#1)
stable disease and 9##2##4##(1992-12#1)(1992-4#1)
stable disease and the##2##4##(2008-10#1)(2008-6#1)
stable disease and##8##3##(1991-10#1)(1991-6#1)(1992-12#1)(1992-4#1)(2006-6#1)(2008-10#1)(2008-6#2)
stable disease in##4##3##(1992-12#1)(2006-6#1)(2008-6#2)
stable disease or##2##3##(1991-8#1)(2006-12#1)
stable disease##37##2##(1990-10#1)(1990-2#3)(1991-10#2)(1991-12#1)(1991-6#1)(1991-8#1)(1992-12#3)(1992-4#1)(1993-8#1)(1994-8#1)(2006-11#1)(2006-12#4)(2006-6#3)(2007-11#2)(2007-6#1)(2008-10#1)(2008-6#9)(2011-2#1)
stable diseases##2##2##(1991-2#1)(1992-8#1)
stable dispersion-managed##2##2##(2007-11#1)(2007-12#1)
stable dose##2##2##(2007-2#1)(2011-1#1)
stable drug##2##2##(1992-8#1)(2013-1#1)
stable duplexes with##2##3##(1991-8#1)(2008-4#1)
stable duplexes##3##2##(1991-8#1)(2008-4#2)
stable during the##5##3##(1997-8#1)(2006-12#1)(2008-12#1)(2011-2#1)(2012-1#1)
stable during##14##2##(1992-8#1)(1994-11#1)(1995-4#1)(1996-1#1)(1997-8#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
stable electrode##2##2##(2008-10#1)(2010-4#1)
stable enough to be transported##2##5##(1994-9#2)
stable enough to be##4##4##(1994-9#2)(2008-10#1)(2013-8#1)
stable enough to##5##3##(1994-9#2)(2007-11#1)(2008-10#1)(2013-8#1)
stable enterotoxins##2##2##(1991-9#1)(1992-6#1)
stable environment##5##2##(1997-7#1)(2008-4#2)(2011-2#1)(2013-7#1)
stable enzyme##3##2##(1992-3#1)(1994-11#1)(2008-10#1)
stable enzyme-inhibitor##2##2##(1992-3#1)(1993-8#1)
stable equilibria##5##2##(1995-3#1)(2008-8#4)
stable equilibrium##8##2##(1993-9#1)(2006-10#1)(2008-8#4)(2008-9#1)(2012-2#1)
stable even after##2##3##(2007-1#1)(2008-10#1)
stable even##6##2##(1996-8#1)(2007-1#1)(2008-10#1)(2009-4#1)(2010-7#1)(2013-8#1)
stable expression in##4##3##(1992-9#1)(1994-3#1)(1997-5#1)(2006-12#1)
stable expression of the##2##4##(1993-9#1)(2006-12#1)
stable expression of##7##3##(1993-9#1)(1997-4#1)(2006-12#1)(2008-11#3)(2009-4#1)
stable expression##11##2##(1992-9#1)(1993-9#1)(1994-3#1)(1997-4#1)(1997-5#1)(2006-12#2)(2008-11#3)(2009-4#1)
stable fixation of##2##3##(2007-11#1)(2012-2#1)
stable fixation##4##2##(2006-2#1)(2007-11#1)(2010-3#1)(2012-2#1)
stable flow##3##2##(2008-10#3)
stable fly hosts##2##3##(2011-12#2)
stable fly##13##2##(2011-12#4)(2011-2#5)(2012-12#4)
stable folding##3##2##(1990-7#1)(1992-6#1)(1997-6#1)
stable for 2##2##3##(2006-10#1)(2008-10#1)
stable for 24 h##4##4##(2008-10#3)(2008-7#1)
stable for 3##3##3##(2008-10#2)(2010-4#1)
stable for a##5##3##(1996-5#1)(2005-7#1)(2007-7#1)(2008-10#1)(2010-2#1)
stable for at least 2##2##5##(2008-10#2)
stable for at least 24h##2##5##(2008-10#2)
stable for at least 6##2##5##(1991-8#1)(2008-8#1)
stable for at least one##3##5##(1993-8#1)(2007-8#1)(2008-7#1)
stable for at least two months##2##6##(2008-10#1)(2008-6#1)
stable for at least##15##4##(1991-8#1)(1993-2#1)(1993-8#1)(1996-7#1)(2007-8#1)(2008-10#7)(2008-6#1)(2008-7#1)(2008-8#1)
stable for more than 2##2##5##(2008-10#1)(2008-11#1)
stable for more than##7##4##(1996-8#1)(2008-10#5)(2008-11#1)
stable for multiple##2##3##(2007-8#1)(2008-11#1)
stable for one##2##3##(1993-2#1)(1997-6#1)
stable for over##3##3##(1990-11#1)(1993-9#1)(2008-10#1)
stable for several hours##3##4##(1990-6#1)(2005-11#1)(2007-11#1)
stable for several months##2##4##(2005-11#1)(2008-2#1)
stable for several##7##3##(1990-6#1)(1996-9#1)(1997-8#1)(2005-11#2)(2007-11#1)(2008-2#1)
stable for the##2##3##(2008-7#1)(2008-9#1)
stable for##76##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-8#1)(1992-9#1)(1993-2#3)(1993-8#1)(1993-9#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-6#1)(1997-8#1)(2005-11#2)(2005-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-10#28)(2008-11#2)(2008-2#2)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-2#1)(2010-4#1)(2012-1#1)(2012-3#1)(2013-8#1)
stable form of##3##3##(1994-2#1)(1996-7#1)(2008-7#1)
stable form##6##2##(1994-11#1)(1994-2#1)(1995-5#1)(1996-7#1)(2007-12#1)(2008-7#1)
stable free##2##2##(1992-12#2)
stable from##3##2##(1990-12#1)(2008-2#1)(2008-7#1)
stable geometric isomers of carotenoids is needed to understand if a relationship between stereochemistry and biological function exists##2##18##(2010-2#2)
stable ground##2##2##(1991-4#2)
stable growth##2##2##(1995-1#1)(2008-11#1)
stable haemodynamic##2##2##(2004-10#1)(2006-10#1)
stable haemodynamics##2##2##(2007-9#1)(2010-7#1)
stable heart##2##2##(1995-2#1)(2010-3#1)
stable hemodynamic##2##2##(2006-12#1)(2012-3#1)
stable host##2##2##(2008-8#1)(2010-4#1)
stable in a##2##3##(1997-2#1)(2008-5#1)
stable in all##3##3##(1993-4#1)(2006-12#1)(2007-7#1)
stable in an##2##3##(2006-11#1)(2008-5#1)
stable in common##2##3##(1994-3#1)(2008-10#1)
stable in human##2##3##(1990-2#1)(1992-2#1)
stable in its##2##3##(1990-4#1)(1997-1#1)
stable in the absence of##2##5##(1990-2#1)(1997-4#1)
stable in the case##2##4##(2007-7#1)(2013-8#1)
stable in the pH##2##4##(1990-4#1)(2008-5#1)
stable in the presence of##3##5##(1991-4#1)(2008-10#2)
stable in the##23##3##(1990-2#1)(1990-4#2)(1991-4#1)(1992-1#1)(1992-6#1)(1997-4#1)(1997-7#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2010-5#1)(2013-1#2)(2013-8#1)
stable in their##2##3##(1991-2#1)(1995-2#1)
stable in##77##2##(1990-2#2)(1990-3#1)(1990-4#5)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-6#2)(1993-12#1)(1993-4#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#2)(1995-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#1)(2004-9#1)(2005-11#1)(2006-11#1)(2006-12#1)(2006-5#1)(2007-12#2)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#2)(2008-4#1)(2008-5#5)(2010-4#1)(2010-5#1)(2011-2#4)(2012-1#1)(2012-11#1)(2013-1#3)(2013-8#1)
stable inclusion complex##2##3##(2007-11#1)(2008-10#1)
stable incorporation of the##2##4##(1994-9#1)(2008-4#1)
stable integration of the##2##4##(1992-5#1)(2008-11#1)
stable integration of##4##3##(1992-5#1)(1995-5#1)(2006-12#1)(2008-11#1)
stable integration##5##2##(1992-5#1)(1995-5#1)(2006-12#2)(2008-11#1)
stable interferometer##2##2##(2007-12#2)
stable intermediate##3##2##(1991-2#1)(1995-5#1)(2008-10#1)
stable intermediates##3##2##(1991-4#1)(1997-6#1)(2007-6#1)
stable intramedullary##4##2##(2009-3#1)(2011-12#1)(2011-2#2)
stable introduction of##2##3##(1991-8#1)(1995-2#1)
stable ion pairs##2##3##(2005-11#1)(2008-10#1)
stable isotope data##2##3##(2013-1#2)
stable isotope dilution##3##3##(1990-10#1)(1990-11#1)(1991-5#1)
stable isotope labeling##3##3##(2008-8#1)(2009-5#1)(2010-5#1)
stable isotope of##2##3##(1990-5#1)(2011-2#1)
stable isotope tagging of epitopes (SITE)##2##6##(2008-4#2)
stable isotope##25##2##(1990-10#1)(1990-11#1)(1990-5#1)(1991-5#1)(1997-3#1)(2006-5#1)(2008-4#3)(2008-6#2)(2008-8#1)(2009-5#1)(2010-5#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#4)(2013-8#1)
stable isotope-labeled##2##2##(1990-12#1)(2008-4#1)
stable isotopes in##3##3##(2013-8#3)
stable isotopes##8##2##(2010-8#3)(2013-8#5)
stable karyotype##2##2##(1996-2#1)(2008-12#1)
stable kidney##2##2##(1995-12#1)(2008-1#1)
stable laser##2##2##(2007-11#1)(2008-2#1)
stable level of##2##3##(1992-11#1)(2007-11#1)
stable level##4##2##(1991-9#1)(1992-11#1)(2007-11#1)(2008-11#1)
stable levels of##2##3##(1993-12#1)(1994-2#1)
stable levels##3##2##(1993-12#1)(1994-2#1)(1994-3#1)
stable lines##5##2##(1995-6#1)(2008-1#1)(2008-2#1)(2008-4#1)(2011-2#1)
stable local##3##2##(1995-4#1)(2007-5#1)(2008-10#1)
stable maintenance##3##2##(1990-9#1)(2006-12#2)
stable mammalian cell lines##2##4##(2008-11#1)(2012-2#1)
stable measure##2##2##(2008-1#1)(2008-12#1)
stable measurements##2##2##(2008-10#1)(2008-3#1)
stable membrane##2##2##(1991-9#1)(1996-3#1)
stable metabolite of##3##3##(1991-5#1)(1991-8#1)(2008-10#1)
stable nitroxide radical##3##3##(1996-5#1)(2008-8#1)(2010-9#1)
stable on##6##2##(1993-9#1)(2007-9#1)(2008-10#2)(2008-2#1)(2010-5#1)
stable ones##4##2##(1996-9#1)(1997-7#1)(2009-5#1)(2013-8#1)
stable only if##2##3##(2008-8#2)
stable only##5##2##(1994-2#1)(1997-4#1)(2008-8#3)
stable operation of the##2##4##(2007-12#1)(2008-6#1)
stable operation##7##2##(2007-11#2)(2007-12#1)(2008-3#2)(2008-6#1)(2013-7#1)
stable optical##8##2##(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#2)(2011-2#1)
stable or responsive disease##2##4##(2004-1#2)
stable or##10##2##(1991-12#1)(1994-8#1)(1995-12#1)(1996-4#1)(1997-6#1)(2004-1#2)(2009-10#1)(2012-4#1)(2013-8#1)
stable organic##3##2##(2007-11#1)(2008-10#2)
stable output##3##2##(2007-11#1)(2007-12#1)(2013-7#1)
stable over 14 years##3##4##(2012-12#3)
stable over a 2-week period##2##5##(2007-12#1)(2009-11#1)
stable over a wide pH range##2##6##(2008-10#2)
stable over a wide##4##4##(2007-12#1)(2008-10#2)(2008-8#1)
stable over a##9##3##(2006-10#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-8#1)(2009-11#1)
stable over long periods##2##4##(2008-10#1)(2008-11#1)
stable over the##3##3##(1996-2#1)(2008-10#1)(2013-1#1)
stable over time##3##3##(1997-2#1)(2008-1#1)(2008-10#1)
stable over##30##2##(1996-2#1)(1997-2#2)(2006-10#1)(2007-12#4)(2008-1#1)(2008-10#9)(2008-11#2)(2008-5#1)(2008-8#1)(2009-11#1)(2010-7#1)(2012-12#5)(2013-1#1)
stable patients with##4##3##(2007-8#1)(2008-10#1)(2008-9#2)
stable patients##10##2##(1993-2#1)(2007-8#3)(2008-10#1)(2008-9#2)(2011-2#2)(2013-8#1)
stable personality characteristics##2##3##(2008-11#2)
stable phase##3##2##(2008-6#1)(2012-2#2)
stable plasma concentrations of##2##4##(1990-12#1)(2008-8#1)
stable population##5##2##(2008-11#1)(2008-9#4)
stable process##2##2##(2008-11#1)(2009-6#1)
stable protein##4##2##(1993-6#2)(1996-6#1)(2009-8#1)
stable region##2##2##(1993-11#1)(2008-8#1)
stable renal function##4##3##(2007-8#1)(2008-1#1)(2013-1#2)
stable renal##6##2##(2007-8#1)(2008-1#3)(2013-1#2)
stable resonator##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
stable resonators##5##2##(2007-11#1)(2008-2#3)(2008-3#1)
stable response##4##2##(2008-10#4)
stable results##2##2##(1993-1#1)(2007-8#1)
stable secondary##2##2##(2008-10#1)(2011-2#1)
stable semiquinone##2##2##(1994-8#1)(1995-5#1)
stable serum##2##2##(1993-6#1)(1993-7#1)
stable sexual##2##2##(2007-12#1)(2008-10#1)
stable simple##2##2##(2008-5#2)
stable single##2##2##(2007-12#1)(2012-2#1)
stable social##2##2##(1995-11#1)(2008-3#1)
stable solitons##2##2##(2007-12#2)
stable solution##4##2##(2005-11#1)(2007-11#2)(2008-2#1)
stable species with##2##3##(2008-10#2)
stable stage##2##2##(1992-1#1)(2013-8#1)
stable state##4##2##(2007-7#1)(2008-9#1)(2013-7#2)
stable states##2##2##(1995-5#1)(2007-9#1)
stable stationary states##2##3##(1990-3#2)
stable steady state##2##3##(2006-10#2)
stable steady states##3##3##(1992-7#1)(1997-1#1)(2006-10#1)
stable steady##5##2##(1992-7#1)(1997-1#1)(2006-10#3)
stable steroidic nitroxyl radicals##2##4##(1997-8#2)
stable strategies##3##2##(2006-10#2)(2008-9#1)
stable structure##3##2##(1992-4#1)(2006-7#1)(2008-3#1)
stable structures##3##2##(1992-12#1)(1995-6#1)(1996-9#1)
stable ternary##2##2##(1995-1#1)(2008-10#1)
stable than in the##2##4##(1991-2#1)(1992-11#1)
stable than the corresponding##2##4##(1997-4#1)(2008-5#1)
stable than the##24##3##(1990-2#1)(1994-10#1)(1994-3#1)(1996-2#1)(1997-2#1)(1997-4#2)(1997-6#1)(2006-12#2)(2006-2#3)(2006-4#1)(2007-11#1)(2008-10#2)(2008-5#3)(2009-10#1)(2009-8#1)(2011-1#1)(2012-1#1)
stable than wild-type##3##3##(1991-2#1)(1991-8#1)(1997-6#1)
stable than##55##2##(1990-2#1)(1991-2#2)(1991-4#1)(1991-7#2)(1991-8#1)(1992-11#2)(1992-9#1)(1993-2#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-6#2)(1995-3#2)(1995-5#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-4#2)(1997-6#2)(2005-11#1)(2006-12#3)(2006-2#3)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-5#8)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-8#1)(2011-1#1)(2012-1#2)
stable thereafter##2##2##(1993-11#1)(2006-11#1)
stable through##3##2##(1994-9#1)(2008-10#1)(2008-11#1)
stable throughout the##5##3##(1994-6#1)(1995-2#1)(2008-8#1)(2009-8#1)(2012-1#1)
stable throughout##9##2##(1994-6#1)(1995-2#1)(2007-8#1)(2007-9#2)(2008-8#1)(2009-8#1)(2010-12#1)(2012-1#1)
stable to heat##3##3##(1990-2#1)(1994-2#1)(2008-10#1)
stable to hydrolysis##2##3##(1991-5#1)(2008-5#1)
stable to neutral##2##3##(1996-8#1)(2010-12#1)
stable to within##2##3##(2008-2#1)(2011-1#1)
stable to##28##2##(1990-2#1)(1991-5#1)(1992-8#1)(1994-2#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-8#1)(2005-11#3)(2005-12#1)(2005-8#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-1#2)(2013-8#1)
stable toward##3##2##(1991-4#1)(1995-5#1)(2008-10#1)
stable towards##5##2##(1990-12#1)(2006-12#3)(2008-5#1)
stable transfectants##7##2##(1994-3#1)(1994-8#2)(2008-11#2)(2008-2#1)(2008-4#1)
stable transfected##3##2##(1994-3#1)(2005-8#1)(2008-4#1)
stable transfection of##4##3##(1992-2#1)(1992-7#1)(1997-1#1)(2008-4#1)
stable transfection##9##2##(1992-2#1)(1992-7#1)(1997-1#1)(1997-4#1)(2008-11#2)(2008-2#1)(2008-4#1)(2010-4#1)
stable transfections##5##2##(1994-5#1)(2008-1#1)(2008-2#1)(2008-4#2)
stable transformants##5##2##(1993-12#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#1)
stable transformation and##3##3##(2008-1#1)(2008-2#1)(2008-4#1)
stable transformation##8##2##(2008-1#2)(2008-2#2)(2008-4#2)(2010-5#1)(2012-2#1)
stable transgenic##4##2##(2006-12#1)(2008-10#1)(2008-8#1)(2012-3#1)
stable under these conditions##2##4##(1992-11#1)(2007-11#1)
stable under##11##2##(1992-11#1)(1995-1#1)(1995-6#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-9#1)
stable up to##8##3##(1992-8#1)(1994-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-8#1)
stable value##2##2##(2007-11#1)(2008-5#1)
stable vitiligo##2##2##(2007-7#2)
stable walking##2##2##(2007-12#1)(2012-1#1)
stable weight##2##2##(2007-7#1)(2008-3#1)
stable when##5##2##(1997-1#1)(2008-9#1)(2010-2#1)(2013-8#2)
stable with no##3##3##(2006-11#1)(2011-2#1)(2012-2#1)
stable with respect to##4##4##(1996-2#2)(2008-2#1)(2008-3#1)
stable with##16##2##(1992-12#1)(1993-12#1)(1996-2#2)(2006-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-2#1)
stable within##4##2##(2007-12#1)(2008-2#1)(2008-8#1)(2009-1#1)
stable xenon##2##2##(2007-9#1)(2008-7#1)
stable##2021##1##(1990-10#3)(1990-11#5)(1990-12#14)(1990-2#16)(1990-3#6)(1990-4#8)(1990-5#8)(1990-6#5)(1990-7#7)(1990-8#2)(1990-9#5)(1991-10#3)(1991-11#3)(1991-12#10)(1991-2#14)(1991-3#3)(1991-4#10)(1991-5#10)(1991-6#9)(1991-7#8)(1991-8#11)(1991-9#6)(1992-1#2)(1992-10#1)(1992-11#4)(1992-12#15)(1992-2#3)(1992-3#6)(1992-4#6)(1992-5#1)(1992-6#7)(1992-7#9)(1992-8#7)(1992-9#6)(1993-1#2)(1993-10#1)(1993-11#9)(1993-12#8)(1993-2#6)(1993-3#9)(1993-4#4)(1993-5#2)(1993-6#6)(1993-7#2)(1993-8#4)(1993-9#8)(1994-10#3)(1994-11#12)(1994-12#3)(1994-2#12)(1994-3#7)(1994-4#1)(1994-5#8)(1994-6#7)(1994-8#15)(1994-9#16)(1995-1#8)(1995-10#4)(1995-11#2)(1995-12#4)(1995-2#11)(1995-3#8)(1995-4#7)(1995-5#20)(1995-6#5)(1995-8#5)(1995-9#1)(1996-1#1)(1996-11#4)(1996-12#2)(1996-2#12)(1996-3#2)(1996-4#6)(1996-5#7)(1996-6#5)(1996-7#5)(1996-8#6)(1996-9#8)(1997-1#13)(1997-2#8)(1997-3#4)(1997-4#14)(1997-5#4)(1997-6#12)(1997-7#10)(1997-8#9)(2004-1#2)(2004-10#1)(2004-11#1)(2004-4#1)(2004-9#3)(2005-1#2)(2005-10#2)(2005-11#24)(2005-12#1)(2005-4#5)(2005-6#1)(2005-7#4)(2005-8#9)(2006-10#24)(2006-11#5)(2006-12#27)(2006-2#6)(2006-3#1)(2006-4#6)(2006-5#6)(2006-6#9)(2006-7#2)(2006-8#6)(2007-1#4)(2007-10#5)(2007-11#55)(2007-12#80)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#5)(2007-6#4)(2007-7#22)(2007-8#35)(2007-9#24)(2008-1#32)(2008-10#232)(2008-11#60)(2008-12#6)(2008-2#61)(2008-3#47)(2008-4#47)(2008-5#60)(2008-6#23)(2008-7#27)(2008-8#51)(2008-9#38)(2009-1#2)(2009-10#3)(2009-11#5)(2009-12#4)(2009-2#2)(2009-3#11)(2009-4#7)(2009-5#4)(2009-6#4)(2009-7#5)(2009-8#4)(2009-9#6)(2010-1#3)(2010-10#2)(2010-11#4)(2010-12#16)(2010-2#8)(2010-3#3)(2010-4#13)(2010-5#11)(2010-6#2)(2010-7#9)(2010-8#7)(2010-9#3)(2011-1#13)(2011-12#6)(2011-2#35)(2011-3#1)(2012-1#10)(2012-11#5)(2012-12#20)(2012-2#30)(2012-3#18)(2012-4#3)(2012-9#1)(2013-1#35)(2013-7#16)(2013-8#34)
stable&quot##2##1##(2005-11#1)(2008-7#1)
stable-cavity##2##1##(2007-12#2)
stables##3##1##(2008-6#1)(2010-4#2)
stably and##4##2##(1994-3#1)(1994-8#1)(2008-11#1)(2008-8#1)
stably associated with##2##3##(1993-12#1)(1995-3#1)
stably coexist##3##2##(2008-8#3)
stably express##6##2##(1993-9#1)(2006-12#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-9#1)
stably expressed in CHO cells##2##5##(1994-9#1)(2008-4#1)
stably expressed in Chinese hamster ovary cells##4##7##(1990-12#1)(1995-12#1)(1996-10#1)(1996-5#1)
stably expressed in##8##3##(1990-12#1)(1991-7#1)(1994-12#1)(1994-9#1)(1995-12#1)(1996-10#1)(1996-5#1)(2008-4#1)
stably expressed##14##2##(1990-12#1)(1991-7#1)(1992-9#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-10#1)(1996-11#1)(1996-5#1)(2006-12#1)(2008-11#2)(2008-4#1)
stably expressing the##3##3##(1995-11#1)(1995-12#1)(2008-8#1)
stably expressing##10##2##(1992-11#1)(1992-8#1)(1995-11#1)(1995-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#1)(2013-1#1)
stably folded##3##2##(1991-7#1)(1994-2#2)
stably in the##3##3##(1994-12#1)(1996-9#1)(2007-8#1)
stably in##6##2##(1990-3#1)(1993-9#1)(1994-12#1)(1996-9#1)(2007-8#1)(2008-9#1)
stably inherited##3##2##(1990-8#1)(2006-12#1)(2008-8#1)
stably integrate##3##2##(1990-9#1)(2008-2#1)(2008-4#1)
stably integrated into the##3##4##(1991-7#1)(1991-8#1)(2008-9#1)
stably integrated into##5##3##(1991-7#1)(1991-8#1)(1993-4#1)(2007-6#1)(2008-9#1)
stably integrated##7##2##(1991-7#1)(1991-8#1)(1993-4#1)(2007-6#1)(2008-2#1)(2008-4#1)(2008-9#1)
stably maintained in##4##3##(1991-9#1)(1993-9#1)(1994-3#1)(2012-12#1)
stably maintained over##2##3##(1991-8#1)(2008-7#1)
stably maintained##8##2##(1991-8#1)(1991-9#1)(1993-9#1)(1994-3#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)
stably transfected CHO cell lines##2##5##(1992-9#1)(2008-11#1)
stably transfected by##2##3##(2008-9#2)
stably transfected cell lines##4##4##(1994-2#1)(2008-1#1)(2008-2#2)
stably transfected into##4##3##(1993-4#1)(1997-2#1)(2008-4#1)(2008-8#1)
stably transfected to##2##3##(1995-2#1)(2012-12#1)
stably transfected with a##3##4##(1994-5#1)(1995-2#1)(1996-9#1)
stably transfected with the##2##4##(2008-11#1)(2013-1#1)
stably transfected with##16##3##(1992-9#2)(1994-12#1)(1994-5#1)(1995-2#2)(1996-11#1)(1996-5#2)(1996-9#2)(1997-1#1)(2008-11#2)(2012-3#1)(2013-1#1)
stably transfected##38##2##(1991-8#1)(1992-9#3)(1993-4#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-2#3)(1995-8#1)(1996-11#1)(1996-4#1)(1996-5#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-11#5)(2008-2#2)(2008-4#1)(2008-8#1)(2008-9#2)(2010-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
stably transformed with##2##3##(1993-2#1)(2008-10#1)
stably transformed##8##2##(1990-9#1)(1991-7#1)(1992-3#1)(1993-2#2)(2006-11#1)(2008-10#1)(2008-11#1)
stably##160##1##(1990-12#1)(1990-3#2)(1990-8#1)(1990-9#2)(1991-12#1)(1991-3#1)(1991-7#5)(1991-8#3)(1991-9#1)(1992-11#1)(1992-3#1)(1992-8#1)(1992-9#4)(1993-11#1)(1993-12#1)(1993-2#2)(1993-4#2)(1993-9#3)(1994-11#2)(1994-12#3)(1994-2#4)(1994-3#2)(1994-5#1)(1994-8#4)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-8#1)(1996-10#1)(1996-11#2)(1996-4#1)(1996-5#5)(1996-9#3)(1997-1#1)(1997-2#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-11#1)(2006-12#4)(2007-11#1)(2007-12#1)(2007-6#2)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#13)(2008-2#7)(2008-4#9)(2008-5#2)(2008-7#1)(2008-8#9)(2008-9#9)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
stachyose##8##1##(1996-4#1)(2008-10#6)(2010-2#1)
stack and##3##2##(2007-12#1)(2007-8#1)(2012-2#1)
stack as a##2##3##(2007-12#1)(2008-3#1)
stack heights##3##2##(2004-4#3)
stack of##9##2##(2007-11#1)(2007-12#2)(2008-3#5)(2008-5#1)
stack structure##2##2##(1996-2#1)(2007-12#1)
stack to##2##2##(1990-7#1)(2007-12#1)
stack with##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)
stack##48##1##(1990-7#1)(1993-1#1)(1995-2#1)(1996-2#1)(2004-4#3)(2007-11#1)(2007-12#8)(2007-8#1)(2008-10#1)(2008-2#6)(2008-3#14)(2008-4#1)(2008-5#4)(2008-7#1)(2011-12#1)(2012-2#3)
stacked alternately##4##2##(2007-11#1)(2007-12#1)(2010-5#2)
stacked around##2##2##(2008-7#2)
stacked cisternae##2##2##(1994-9#1)(2008-7#1)
stacked layers##2##2##(1997-2#1)(2007-11#1)
stacked phased coil array##2##4##(2013-7#2)
stacked stems##2##2##(2008-10#2)
stacked##45##1##(1991-2#1)(1991-5#1)(1993-8#1)(1994-5#1)(1994-9#1)(1995-10#1)(1996-5#1)(1997-2#1)(1997-5#1)(2005-11#1)(2006-10#2)(2007-11#2)(2007-12#1)(2008-10#6)(2008-2#3)(2008-3#7)(2008-4#3)(2008-5#1)(2008-7#4)(2010-5#2)(2012-11#1)(2012-2#1)(2013-7#2)
stacking action##2##2##(2008-10#2)
stacking and hydrogen-bonding interactions##2##4##(2007-8#1)(2010-5#1)
stacking and##6##2##(1994-8#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-5#1)(2012-12#1)
stacking at the##4##3##(1990-7#1)(1991-7#1)(1994-9#2)
stacking faults##3##2##(1991-11#1)(2006-5#1)(2009-7#1)
stacking in DNA and RNA##2##5##(1990-8#2)
stacking in DNA##3##3##(1990-8#2)(1993-8#1)
stacking in the##2##3##(2006-10#2)
stacking in##6##2##(1990-8#2)(1991-5#1)(1993-8#1)(2006-10#2)
stacking interactions with##2##3##(1990-2#1)(1997-7#1)
stacking interactions##9##2##(1990-2#1)(1994-8#1)(1997-7#1)(2006-12#1)(2007-10#3)(2008-8#1)(2009-6#1)
stacking is##3##2##(1993-11#1)(2008-10#1)(2008-3#1)
stacking of the##3##3##(1994-8#1)(1997-4#1)(2010-7#1)
stacking of##7##2##(1990-8#1)(1994-8#1)(1996-5#1)(1997-4#1)(2008-10#1)(2008-3#1)(2010-7#1)
stacking procedure##2##2##(1994-12#2)
stacking##89##1##(1990-2#1)(1990-7#1)(1990-8#3)(1991-11#1)(1991-2#1)(1991-5#4)(1991-7#2)(1993-11#4)(1993-8#2)(1994-12#2)(1994-8#3)(1994-9#2)(1996-5#2)(1997-4#1)(1997-7#1)(2005-11#2)(2006-10#5)(2006-12#1)(2006-5#1)(2007-10#4)(2007-11#2)(2007-8#3)(2008-10#12)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#2)(2008-8#3)(2009-11#1)(2009-12#1)(2009-6#3)(2009-7#1)(2010-5#1)(2010-7#1)(2012-12#5)(2013-7#1)
stacks by##2##2##(2008-3#2)
stacks in##2##2##(2004-4#1)(2008-3#1)
stacks of##9##2##(2005-11#1)(2007-12#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-10#1)(2009-8#1)
stacks##32##1##(1994-8#1)(1995-1#1)(1996-7#1)(2004-4#2)(2005-11#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#13)(2008-5#1)(2008-7#3)(2009-10#1)(2009-8#1)(2011-1#1)
stackup effects in free-space optical interconnects##2##6##(2008-3#2)
stadiation##2##1##(2006-2#1)(2013-1#1)
stadium of##2##2##(2007-9#1)(2011-3#1)
stadium##5##1##(1992-8#1)(2007-12#2)(2007-9#1)(2011-3#1)
staff (11##2##2##(2007-7#2)
staff about the##2##3##(1991-12#1)(2008-11#1)
staff about##4##2##(1991-12#1)(1995-12#1)(2008-11#1)(2011-2#1)
staff after##2##2##(2008-12#1)(2012-1#1)
staff and administrators##3##3##(1996-12#1)(2013-1#2)
staff and hospital##3##3##(1991-12#1)(1993-2#1)(1994-1#1)
staff and improved##2##3##(1992-2#1)(2006-1#1)
staff and managers##2##3##(1994-3#1)(1996-3#1)
staff and may##3##3##(2008-12#1)(2009-12#1)(2013-1#1)
staff and others##2##3##(1991-3#1)(2007-12#1)
staff and patients##5##3##(1992-3#1)(1993-2#2)(2006-6#1)(2011-2#1)
staff and students##3##3##(2007-1#1)(2008-12#2)
staff and the##5##3##(1992-12#1)(1996-2#1)(1997-3#1)(2008-11#2)
staff and to##2##3##(1991-2#1)(2007-2#1)
staff and##81##2##(1991-12#2)(1991-2#3)(1991-3#1)(1992-12#1)(1992-2#3)(1992-3#1)(1993-1#2)(1993-2#3)(1993-3#1)(1993-7#1)(1994-1#2)(1994-2#2)(1994-3#3)(1994-6#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#4)(1997-1#1)(1997-3#1)(2004-8#1)(2005-5#1)(2006-1#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-11#2)(2008-12#6)(2008-6#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-2#2)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-11#1)(2012-3#2)(2013-1#4)(2013-8#2)
staff appointment and##2##3##(1991-12#1)(1994-3#1)
staff are##11##2##(1991-11#1)(1993-2#1)(1995-3#1)(1996-12#2)(1997-5#1)(2006-1#1)(2007-9#1)(2009-3#1)(2012-12#1)(2012-2#1)
staff as##5##2##(1991-3#1)(1994-3#1)(2007-10#1)(2007-9#1)(2012-1#1)
staff at all##2##3##(2008-11#1)(2010-3#1)
staff at the##4##3##(1991-4#1)(2007-9#1)(2008-4#1)(2009-7#1)
staff at##14##2##(1991-4#1)(1992-2#1)(1993-12#2)(1995-8#1)(2007-9#1)(2008-11#2)(2008-4#1)(2009-7#1)(2010-3#1)(2010-8#1)(2010-9#1)(2012-1#1)
staff attitudes to patients##2##4##(2007-3#1)(2011-2#1)
staff attitudes to##3##3##(2007-3#1)(2007-9#1)(2011-2#1)
staff attitudes##7##2##(1992-1#1)(2007-3#1)(2007-9#1)(2011-2#4)
staff awareness and##2##3##(2009-6#1)(2013-8#1)
staff awareness##3##2##(2009-6#1)(2013-8#2)
staff behaviour##2##2##(2011-12#1)(2012-3#1)
staff by##3##2##(1994-3#1)(2008-7#1)(2010-12#1)
staff bylaws##4##2##(1991-2#3)(1991-3#1)
staff can##5##2##(1991-12#1)(1992-2#1)(1994-2#1)(2008-6#1)(2011-2#1)
staff communication##2##2##(2011-2#2)
staff competency##2##2##(1996-2#1)(2004-4#1)
staff credentialing and##2##3##(1992-2#1)(1993-1#1)
staff credentialing##7##2##(1992-2#1)(1993-1#1)(1993-12#3)(1994-3#1)(1997-2#1)
staff development##13##2##(1993-12#2)(1994-1#3)(1996-2#1)(2007-5#1)(2008-11#2)(2008-9#1)(2010-9#1)(2012-1#2)
staff during##4##2##(1992-10#1)(2007-12#1)(2008-6#1)(2011-2#1)
staff education on##2##3##(2007-3#1)(2010-9#1)
staff education##8##2##(1994-2#1)(1997-1#1)(2007-3#2)(2010-8#1)(2010-9#1)(2011-2#2)
staff engagement##5##2##(2011-2#5)
staff for##7##2##(1991-11#1)(1993-3#1)(1996-1#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-11#1)
staff from the##2##3##(1995-3#1)(2007-5#1)
staff from##11##2##(1991-10#1)(1994-1#1)(1995-3#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-2#1)(2010-4#1)(2012-3#1)(2013-7#1)
staff had##3##2##(2008-11#2)(2010-10#1)
staff has##2##2##(1995-1#1)(2010-11#1)
staff hours per##2##3##(2007-8#2)
staff in a##3##3##(2008-11#1)(2010-10#1)(2010-5#1)
staff in the##10##3##(1991-9#1)(1994-3#1)(1994-6#1)(1995-3#1)(1996-2#1)(2008-11#1)(2008-8#1)(2010-8#1)(2012-2#1)(2013-1#1)
staff in##45##2##(1991-12#1)(1991-9#1)(1992-2#1)(1993-1#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-7#1)(1995-2#2)(1995-3#1)(1996-2#1)(1997-1#1)(1997-6#1)(2006-5#1)(2006-6#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-11#4)(2008-7#1)(2008-8#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#1)
staff incentive program##2##3##(1992-3#2)
staff involved in##3##3##(1992-3#1)(2006-8#1)(2012-2#1)
staff is##10##2##(1991-1#1)(1991-2#1)(1994-1#1)(1994-2#2)(2004-12#1)(2005-5#1)(2008-11#1)(2008-12#1)(2009-4#1)
staff may be##3##3##(1991-12#1)(1995-2#1)(2007-8#1)
staff may##5##2##(1991-12#1)(1995-2#1)(2007-8#1)(2009-8#1)(2012-3#1)
staff meetings##3##2##(2004-4#1)(2013-1#2)
staff members and##2##3##(2005-5#1)(2010-12#1)
staff members can##2##3##(1996-1#1)(2008-9#1)
staff members from##2##3##(2007-2#1)(2009-9#1)
staff members in##3##3##(1995-1#1)(2007-2#1)(2010-10#1)
staff members regarding the##2##4##(1991-12#1)(1994-12#1)
staff members were##2##3##(1991-5#1)(1994-7#1)
staff members who##3##3##(1995-1#1)(1995-3#1)(2010-11#1)
staff members##34##2##(1991-12#1)(1991-5#1)(1991-7#1)(1993-1#2)(1994-12#1)(1994-7#2)(1995-1#2)(1995-3#2)(1996-1#1)(2005-5#1)(2007-11#1)(2007-2#3)(2007-4#3)(2008-9#2)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#2)
staff members'##8##2##(2007-5#2)(2008-11#1)(2010-10#5)
staff membership##2##2##(1992-2#2)
staff morale and##2##3##(1997-3#1)(2007-7#1)
staff morale##5##2##(1993-2#1)(1997-3#2)(2007-7#2)
staff must be##3##3##(1992-2#1)(2006-8#2)
staff must##4##2##(1991-12#1)(1992-2#1)(2006-8#2)
staff need##2##2##(1997-5#1)(2011-2#1)
staff needs##3##2##(1995-3#1)(2012-3#1)(2013-1#1)
staff numbers##2##2##(2008-12#1)(2012-12#1)
staff nurse##4##2##(2006-1#1)(2010-11#1)(2013-8#2)
staff nurses##4##2##(1991-2#1)(2012-11#3)
staff of the##9##3##(1991-12#1)(1994-7#1)(1995-1#1)(1996-1#1)(2007-2#1)(2007-7#1)(2008-8#1)(2010-4#1)(2011-2#1)
staff of##13##2##(1991-12#1)(1991-2#1)(1991-4#1)(1994-7#1)(1995-1#1)(1996-1#1)(2005-5#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-8#1)(2010-4#1)(2011-2#1)
staff on##3##2##(1990-12#1)(1996-12#1)(2008-12#1)
staff or##3##2##(1991-9#1)(1993-1#1)(1997-2#1)
staff participated in##2##3##(2007-5#1)(2008-12#1)
staff participation##2##2##(1993-1#1)(2008-10#1)
staff physicians##2##2##(1991-4#1)(1992-12#1)
staff privileges##6##2##(1991-12#1)(1992-12#1)(1993-1#2)(1993-3#1)(1994-1#1)
staff provided##2##2##(2010-11#1)(2010-8#1)
staff recruitment##2##2##(1996-1#1)(2007-12#1)
staff reductions##2##2##(1993-1#1)(1996-12#1)
staff regarding the##2##3##(2007-11#1)(2010-3#1)
staff regarding##4##2##(2007-11#1)(2010-10#1)(2010-3#1)(2012-3#1)
staff relations##2##2##(1990-12#1)(2008-8#1)
staff relationship##2##2##(1994-1#1)(1994-2#1)
staff resources##2##2##(1995-1#1)(2008-4#1)
staff responsibilities in##2##3##(1991-12#1)(1992-2#1)
staff satisfaction##3##2##(1992-1#1)(1992-3#1)(2004-4#1)
staff scheduling##4##2##(1994-2#4)
staff should be##2##3##(2006-8#1)(2012-3#1)
staff should##3##2##(1994-4#1)(2006-8#1)(2012-3#1)
staff support##6##2##(1991-12#1)(2006-1#1)(2007-4#1)(2008-11#1)(2008-9#1)(2010-2#1)
staff that##4##2##(2007-9#1)(2008-10#1)(2008-4#1)(2011-2#1)
staff the##2##2##(2007-3#1)(2012-2#1)
staff through##2##2##(2008-3#1)(2013-8#1)
staff throughout##2##2##(1994-12#1)(1997-3#1)
staff time##5##2##(1992-12#1)(1992-2#1)(1995-3#2)(2013-8#1)
staff to care for##2##4##(2008-7#1)(2012-2#1)
staff to help##2##3##(1992-9#1)(2007-5#1)
staff to##24##2##(1991-10#1)(1991-11#1)(1992-3#1)(1992-9#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-1#1)(2004-12#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-7#2)(2010-9#1)(2011-2#2)(2012-2#1)
staff towards##2##2##(2007-11#1)(2007-9#1)
staff training and##3##3##(2007-3#1)(2008-12#1)(2008-6#1)
staff training##7##2##(1991-12#1)(2007-3#1)(2007-9#1)(2008-12#1)(2008-6#1)(2010-8#1)(2012-12#1)
staff use##2##2##(1993-12#1)(2010-10#1)
staff utilization##3##2##(1994-1#1)(1994-2#1)(1994-3#1)
staff was##9##2##(1990-2#1)(1994-7#1)(1995-2#1)(2004-8#1)(2008-8#2)(2009-4#1)(2013-1#2)
staff were the##2##3##(2010-10#1)(2011-2#1)
staff were##6##2##(1994-12#1)(2008-12#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-12#1)
staff when##2##2##(2011-2#1)(2013-1#1)
staff while##2##2##(1995-3#2)
staff who are##2##3##(1990-4#1)(2008-11#1)
staff who##9##2##(1990-4#1)(2005-5#1)(2008-1#1)(2008-11#4)(2010-8#1)(2013-8#1)
staff will be##2##3##(2005-11#1)(2008-11#1)
staff will##3##2##(1994-1#1)(2005-11#1)(2008-11#1)
staff with the##2##3##(2010-3#1)(2013-8#1)
staff with##6##2##(1990-2#1)(1991-12#1)(1992-3#1)(2010-3#1)(2011-1#1)(2013-8#1)
staff within##2##2##(1995-2#1)(2012-12#1)
staff without##2##2##(1992-11#1)(2011-11#1)
staff working at##2##3##(2009-7#2)
staff working in##3##3##(1997-5#1)(2012-2#2)
staff working##5##2##(1997-5#1)(2009-7#2)(2012-2#2)
staff would##2##2##(2007-6#1)(2013-8#1)
staff##864##1##(1990-12#5)(1990-2#2)(1990-3#1)(1990-4#2)(1991-1#5)(1991-10#3)(1991-11#3)(1991-12#20)(1991-2#10)(1991-3#5)(1991-4#4)(1991-5#2)(1991-7#1)(1991-9#6)(1992-1#6)(1992-10#1)(1992-11#1)(1992-12#6)(1992-2#16)(1992-3#8)(1992-8#1)(1992-9#1)(1993-1#18)(1993-12#13)(1993-2#8)(1993-3#7)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-1#21)(1994-12#8)(1994-2#21)(1994-3#14)(1994-4#1)(1994-6#2)(1994-7#5)(1995-1#7)(1995-12#3)(1995-2#11)(1995-3#19)(1995-8#2)(1995-9#1)(1996-1#14)(1996-12#13)(1996-2#8)(1996-3#11)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#6)(1997-2#7)(1997-3#7)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#2)(2004-4#4)(2004-8#4)(2005-11#2)(2005-12#3)(2005-5#8)(2005-7#3)(2006-1#4)(2006-10#1)(2006-3#1)(2006-5#3)(2006-6#4)(2006-8#5)(2007-1#1)(2007-10#3)(2007-11#9)(2007-12#6)(2007-2#15)(2007-3#8)(2007-4#9)(2007-5#12)(2007-6#2)(2007-7#14)(2007-8#9)(2007-9#12)(2008-1#7)(2008-10#7)(2008-11#37)(2008-12#21)(2008-2#1)(2008-3#2)(2008-4#5)(2008-6#6)(2008-7#6)(2008-8#9)(2008-9#7)(2009-10#3)(2009-11#1)(2009-12#1)(2009-3#3)(2009-4#5)(2009-6#1)(2009-7#8)(2009-8#1)(2009-9#1)(2010-10#19)(2010-11#6)(2010-12#6)(2010-2#5)(2010-3#3)(2010-4#3)(2010-5#7)(2010-7#4)(2010-8#12)(2010-9#9)(2011-1#14)(2011-11#1)(2011-12#5)(2011-2#44)(2012-1#10)(2012-11#6)(2012-12#12)(2012-2#12)(2012-3#18)(2013-1#19)(2013-7#2)(2013-8#20)
staff's##5##1##(1993-12#1)(1993-2#1)(1993-3#1)(2007-12#1)(2010-10#1)
staff)##5##1##(1990-3#1)(2008-1#1)(2013-1#3)
staff- and group-model HMOs##2##4##(1994-1#2)
staff-led behavioral management##2##3##(2008-3#2)
staff?##5##1##(1991-3#1)(1993-3#1)(1994-12#1)(2011-2#1)(2013-8#1)
staff]##4##1##(1991-6#1)(1992-8#1)(1994-3#1)(1994-5#1)
staffed by##4##2##(1997-8#1)(2008-3#1)(2010-10#1)(2012-12#1)
staffed with##2##2##(1994-8#1)(2007-3#1)
staffed##8##1##(1990-5#1)(1994-8#1)(1997-8#1)(2007-3#1)(2008-3#2)(2010-10#1)(2012-12#1)
staffing and scheduling##2##3##(2012-3#2)
staffing and##11##2##(1993-12#1)(1994-12#1)(1996-1#2)(1996-11#1)(1997-2#1)(2006-2#1)(2009-4#1)(2012-3#2)(2013-8#1)
staffing in##3##2##(1990-3#1)(1994-3#1)(1996-11#1)
staffing levels in##2##3##(2008-11#1)(2008-7#1)
staffing levels##7##2##(1996-1#1)(2006-10#1)(2006-2#2)(2008-11#1)(2008-7#1)(2012-2#1)
staffing patterns##5##2##(1991-12#1)(1993-1#3)(1996-3#1)
staffing practices##2##2##(2012-3#2)
staffing##67##1##(1990-12#1)(1990-2#1)(1990-3#1)(1991-1#3)(1991-12#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-8#2)(1993-1#4)(1993-12#1)(1993-3#2)(1994-1#1)(1994-12#1)(1994-3#1)(1996-1#3)(1996-11#2)(1996-2#1)(1996-3#3)(1997-2#1)(1997-3#1)(2006-10#1)(2006-2#3)(2007-10#1)(2008-10#1)(2008-11#5)(2008-2#1)(2008-3#2)(2008-7#1)(2009-4#1)(2009-6#1)(2011-1#2)(2011-2#2)(2012-2#3)(2012-3#6)(2013-8#4)
staffs of##2##2##(2005-10#1)(2006-7#1)
staffs##18##1##(1991-12#1)(1991-2#3)(1992-1#2)(1992-2#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-3#1)(1997-2#1)(2005-10#1)(2006-7#1)
stage (P &lt##2##3##(2008-6#1)(2009-11#1)
stage (P = 0##4##4##(2008-6#2)(2013-1#2)
stage (P##6##2##(2008-6#3)(2009-11#1)(2013-1#2)
stage (in##2##2##(1993-5#1)(2008-10#1)
stage (lesions in the mucosa##2##5##(2013-1#2)
stage (lesions##3##2##(2013-1#3)
stage (n =##2##3##(1990-5#2)
stage (p &lt##2##3##(1997-8#1)(2006-10#1)
stage (p = 0##3##4##(2008-12#1)(2011-2#2)
stage (p##6##2##(1991-7#1)(1997-8#1)(2006-10#1)(2008-12#1)(2011-2#2)
stage 0##2##2##(1995-4#1)(2006-3#1)
stage 1 and##2##3##(2008-8#2)
stage 1 or##3##3##(1996-9#1)(2008-8#1)(2009-3#1)
stage 1 patients##2##3##(2008-6#1)(2008-8#1)
stage 1##18##2##(1996-9#1)(2006-3#1)(2007-2#1)(2007-9#2)(2008-6#2)(2008-8#5)(2009-10#1)(2009-3#1)(2012-3#4)
stage 2 SWS was##2##4##(1992-1#2)
stage 2 SWS##3##3##(1992-1#3)
stage 2 or 3##2##4##(2011-2#1)(2012-12#1)
stage 2 or##4##3##(1991-9#1)(2007-5#1)(2011-2#1)(2012-12#1)
stage 2 patients##2##3##(2008-8#2)
stage 2##28##2##(1990-6#1)(1991-4#1)(1991-9#1)(1992-1#5)(1996-9#1)(2004-11#1)(2006-10#3)(2006-3#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-8#5)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#2)
stage 3 and##2##3##(1996-3#1)(2012-2#1)
stage 3##11##2##(1991-4#1)(1996-3#1)(2008-10#1)(2009-3#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
stage 4 cancer##2##3##(2009-10#2)
stage 4 of disease was##2##5##(2011-2#2)
stage 4##11##2##(1991-4#1)(1995-2#1)(1995-8#1)(1996-3#1)(2009-10#2)(2011-2#5)
stage 5##6##2##(1993-2#1)(1996-12#1)(2007-8#1)(2008-10#1)(2010-4#1)(2012-3#1)
stage 52##3##2##(1994-9#3)
stage 6 oocytes##3##3##(1995-2#3)
stage A##5##2##(1993-10#1)(2006-6#1)(2006-8#1)(2007-3#2)
stage B##7##2##(2006-8#3)(2007-3#1)(2008-10#1)(2008-5#1)(2011-2#1)
stage C and##3##3##(1992-8#1)(2006-8#1)(2007-3#1)
stage D##4##2##(1992-8#1)(2006-8#1)(2007-3#1)(2011-2#1)
stage Drosophila##4##2##(2008-11#4)
stage HER2-positive##2##2##(2008-5#2)
stage I &amp##2##3##(1993-4#1)(2007-11#1)
stage I NSCLC##3##3##(2007-8#3)
stage I and II##3##4##(2007-8#2)(2012-3#1)
stage I and stage II##3##5##(2011-2#1)(2013-8#2)
stage I and##10##3##(1991-12#1)(1995-12#1)(2007-8#2)(2011-2#3)(2012-3#1)(2013-8#2)
stage I but##2##3##(1991-10#1)(1991-12#1)
stage I endometrial##2##3##(1993-12#1)(2013-1#1)
stage I lung cancer##2##4##(1990-2#2)
stage I or II##2##4##(1997-6#1)(2006-10#1)
stage I pulmonary##2##3##(2007-8#1)(2008-5#1)
stage I was##2##3##(2007-8#2)
stage I##71##2##(1990-10#1)(1990-2#3)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-8#1)(1992-2#2)(1993-11#1)(1993-12#1)(1993-4#1)(1994-10#1)(1994-12#1)(1994-4#2)(1995-10#2)(1995-12#1)(1996-2#2)(1996-7#1)(1997-2#1)(1997-6#1)(2004-1#1)(2006-10#3)(2006-12#2)(2006-6#2)(2006-9#1)(2007-11#1)(2007-8#16)(2008-10#1)(2008-5#1)(2008-7#2)(2009-2#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
stage I-II##3##2##(2007-8#1)(2009-12#2)
stage I/II##2##2##(1993-1#1)(2004-1#1)
stage IA##4##2##(2004-1#1)(2007-8#2)(2008-1#1)
stage IB##4##2##(1993-8#1)(1994-4#2)(2008-11#1)
stage IB)##3##2##(2012-12#2)(2013-7#1)
stage IB1 cervical##2##3##(2007-10#1)(2007-8#1)
stage II and III empyema##2##5##(2012-2#2)
stage II and III##5##4##(2007-4#1)(2008-5#1)(2012-1#1)(2012-2#2)
stage II and##9##3##(1994-7#1)(2007-4#1)(2008-5#1)(2009-3#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)
stage II breast cancer##2##4##(1997-7#1)(2011-2#1)
stage II breast##4##3##(1993-7#1)(1997-7#1)(2011-1#1)(2011-2#1)
stage II cases##3##3##(1991-4#1)(1991-7#2)
stage II colon##2##3##(2008-4#1)(2012-1#1)
stage II included tumors##2##4##(2007-8#2)
stage II or IIIa patients##2##5##(1993-11#2)
stage II or##4##3##(1993-11#2)(2005-8#1)(2013-7#1)
stage II to stage III##2##5##(2007-3#1)(2008-7#1)
stage II to##3##3##(2007-11#1)(2007-3#1)(2008-7#1)
stage II##59##2##(1990-6#1)(1990-9#1)(1991-4#4)(1991-7#2)(1992-2#1)(1993-11#2)(1993-7#1)(1994-12#2)(1994-6#1)(1994-7#1)(1996-7#1)(1997-7#4)(2004-1#1)(2005-8#1)(2006-10#3)(2006-6#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-8#7)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#3)(2009-3#2)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#3)(2013-7#1)(2013-8#2)
stage II)##2##2##(1991-7#1)(2008-8#1)
stage IIA##2##2##(2011-1#1)(2013-1#1)
stage III NSCLC##2##3##(2008-10#1)(2012-3#1)
stage III and IV##2##4##(1997-3#1)(2008-12#1)
stage III and above##2##4##(2011-2#2)
stage III and##6##3##(1990-6#1)(1997-3#1)(1997-7#1)(2008-12#1)(2011-2#2)
stage III disease##2##3##(2005-11#1)(2009-3#1)
stage III non small cell lung cancer##2##7##(1993-2#1)(2008-10#1)
stage III or IV##5##4##(1992-9#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-4#1)
stage III patients##2##3##(1991-4#1)(2006-6#1)
stage III##49##2##(1990-6#1)(1990-9#2)(1991-11#1)(1991-4#1)(1991-8#2)(1992-9#1)(1993-2#1)(1994-7#1)(1994-8#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#2)(2005-11#1)(2006-10#1)(2006-6#2)(2007-11#3)(2007-3#1)(2007-8#4)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-3#2)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)
stage III)##2##2##(1991-4#1)(2008-10#1)
stage III-IV##3##2##(1990-6#2)(2012-1#1)
stage IIIA##4##2##(1992-12#1)(1992-6#1)(2004-1#1)(2008-10#1)
stage IIIA-IIIB non-small-cell lung cancer##2##5##(1992-12#2)
stage IIIA-N2 non-small cell lung cancer##2##6##(2007-8#2)
stage IIIA-N2##3##2##(2007-8#3)
stage IIIB##2##2##(2004-1#1)(2010-6#1)
stage IIIC##6##2##(1995-12#1)(2011-2#5)
stage IIIb##2##2##(2004-1#2)
stage IIa##4##2##(2007-8#2)(2008-8#2)
stage IIb##6##2##(2007-11#1)(2007-8#3)(2008-8#2)
stage IV and##3##3##(1991-8#1)(2008-1#1)(2011-2#1)
stage IV breast cancer##3##4##(2011-12#2)(2013-8#1)
stage IV disease##2##3##(2009-3#1)(2011-1#1)
stage IV ovarian cancer##2##4##(1990-6#1)(2013-7#1)
stage IV ovarian carcinoma treated with##2##6##(1990-6#2)
stage IV ovarian##4##3##(1990-6#3)(2013-7#1)
stage IV patients##2##3##(1997-7#1)(2011-12#1)
stage IV##41##2##(1990-6#4)(1990-9#1)(1991-11#1)(1991-8#1)(1994-4#1)(1995-12#1)(1997-7#3)(2004-1#1)(2006-3#1)(2006-7#1)(2007-8#2)(2008-1#3)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#2)(2009-8#1)(2010-12#1)(2011-1#1)(2011-12#3)(2011-2#3)(2012-1#1)(2012-2#2)(2013-7#2)(2013-8#1)
stage Ia##2##2##(1991-2#1)(2007-8#1)
stage T1 urothelial carcinoma of the bladder##2##7##(2013-1#2)
stage T1##5##2##(1990-2#1)(2006-9#1)(2013-1#3)
stage TNM##2##2##(2007-7#1)(2011-2#1)
stage V##6##2##(2006-10#2)(2011-1#2)(2012-2#2)
stage VI##3##2##(1991-9#1)(1992-11#1)(2012-2#1)
stage according to the##2##4##(2007-8#1)(2013-7#1)
stage according to##4##3##(2007-8#1)(2008-10#1)(2011-2#1)(2013-7#1)
stage after##4##2##(1993-11#1)(1996-4#1)(2007-5#1)(2010-12#1)
stage along##2##2##(2004-12#1)(2011-12#1)
stage and a##6##3##(1992-3#1)(1994-3#1)(2008-10#1)(2008-12#2)(2008-2#1)
stage and can##3##3##(1996-11#1)(2008-2#1)(2009-11#1)
stage and grade##2##3##(2008-3#1)(2013-8#1)
stage and increased##2##3##(2007-10#1)(2008-10#1)
stage and may##2##3##(1997-6#1)(2008-11#1)
stage and the expression##2##4##(1997-8#1)(2008-5#1)
stage and the other##2##4##(2008-1#1)(2008-9#1)
stage and the##13##3##(1993-2#1)(1995-11#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-8#2)
stage and##96##2##(1990-12#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-9#1)(1997-1#1)(1997-5#2)(1997-6#2)(1997-8#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-7#1)(2007-10#2)(2007-12#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#2)(2008-5#4)(2008-6#4)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-12#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
stage appeared##2##2##(1993-2#1)(2007-3#1)
stage are##6##2##(1995-1#1)(2008-3#1)(2008-8#2)(2012-2#1)(2012-3#1)
stage as##3##2##(2006-6#1)(2010-12#1)(2011-1#1)
stage at diagnosis##4##3##(1990-12#3)(2012-3#1)
stage at presentation##3##3##(2008-6#1)(2011-2#1)(2013-1#1)
stage at the time of##3##5##(1991-10#1)(1993-3#1)(1995-2#1)
stage at which the##2##4##(1997-3#1)(2008-10#1)
stage at which##6##3##(1990-8#1)(1995-8#1)(1997-3#1)(2008-10#3)
stage at##24##2##(1990-12#3)(1990-8#1)(1991-10#1)(1993-3#1)(1995-2#1)(1995-8#1)(1997-3#1)(2006-10#1)(2006-5#1)(2007-5#1)(2008-10#6)(2008-6#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
stage before##3##2##(1993-10#1)(1996-6#1)(2012-12#1)
stage between##2##2##(2008-5#1)(2009-10#1)
stage breast cancer##8##3##(1994-8#1)(1995-9#1)(2004-1#2)(2008-4#1)(2013-1#3)
stage breast##10##2##(1994-8#1)(1995-9#1)(1996-6#1)(2004-1#2)(2007-10#1)(2008-4#1)(2013-1#3)
stage but was##2##3##(1991-8#1)(1994-3#1)
stage but##4##2##(1991-8#1)(1994-3#1)(1995-11#1)(2010-8#1)
stage by##8##2##(1997-1#1)(2005-1#1)(2007-11#1)(2008-12#1)(2008-8#1)(2009-4#1)(2011-2#1)(2013-8#1)
stage c)##2##2##(2008-7#2)
stage can be##2##3##(2009-9#1)(2012-1#1)
stage can##4##2##(2007-5#1)(2009-9#1)(2012-1#2)
stage cancer##3##2##(2007-9#1)(2011-1#1)(2013-1#1)
stage changes##2##2##(1993-1#1)(1994-2#1)
stage chronic renal failure##2##4##(1991-11#1)(2008-1#1)
stage chronic renal##3##3##(1991-11#1)(2008-1#1)(2008-10#1)
stage data##2##2##(2008-10#1)(2008-4#1)
stage decreased##3##2##(1990-3#1)(2007-10#1)(2008-4#1)
stage did not##3##3##(2008-12#1)(2008-5#1)(2011-12#1)
stage disease and##3##3##(2006-10#1)(2011-2#1)(2012-12#1)
stage disease##6##2##(2006-10#2)(2008-5#1)(2010-12#1)(2011-2#1)(2012-12#1)
stage distribution##5##2##(1994-8#1)(2004-2#1)(2008-8#1)(2012-12#1)(2013-1#1)
stage due to##3##3##(2006-11#1)(2008-10#1)(2009-5#1)
stage during##3##2##(1990-11#1)(2010-12#1)(2012-3#1)
stage embryo##3##2##(2008-5#2)(2008-9#1)
stage embryos##6##2##(2006-5#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-11#1)
stage following##3##2##(1994-12#1)(2008-10#1)(2013-1#1)
stage for the##7##3##(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
stage for##25##2##(1990-9#1)(1994-4#1)(1995-12#1)(1996-2#1)(1997-2#1)(2006-2#1)(2007-12#2)(2007-5#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
stage from##3##2##(2008-10#1)(2013-7#2)
stage grouping##2##2##(2011-2#2)
stage has##3##2##(1991-8#1)(1997-7#1)(2005-11#1)
stage have been##2##3##(2008-1#1)(2009-10#1)
stage in a##3##3##(2006-5#1)(2008-10#1)(2009-8#1)
stage in all##2##3##(1993-7#1)(2011-12#1)
stage in patients with##2##4##(2007-11#1)(2012-12#1)
stage in the##25##3##(1991-1#1)(1991-10#1)(1992-7#1)(1994-11#1)(1997-5#1)(2007-1#1)(2007-11#3)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-7#2)(2008-8#2)(2011-1#1)(2011-12#1)(2012-1#1)
stage in##61##2##(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-9#1)(1992-7#1)(1993-4#1)(1993-7#1)(1993-9#1)(1994-11#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-8#1)(1997-5#1)(2004-1#1)(2006-10#1)(2006-5#2)(2007-1#1)(2007-11#4)(2007-2#1)(2007-3#3)(2007-7#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#2)(2008-7#2)(2008-8#2)(2009-8#2)(2011-1#1)(2011-12#2)(2011-2#4)(2012-1#1)(2012-12#1)
stage involves##3##2##(2012-12#2)(2012-3#1)
stage involving##2##2##(1992-4#2)
stage is a##2##3##(1992-1#1)(2011-2#1)
stage is the##2##3##(2008-10#1)(2013-1#1)
stage is to##2##3##(2007-8#1)(2008-2#1)
stage is##22##2##(1990-8#1)(1992-1#2)(1997-2#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-9#1)(2010-12#2)(2010-7#1)(2010-9#1)(2011-2#1)(2013-1#2)
stage larvae##3##2##(2007-5#1)(2008-8#1)(2011-1#1)
stage lung cancer##3##3##(2007-4#1)(2008-5#2)
stage lung##5##2##(2006-10#1)(2007-4#1)(2008-5#2)(2010-8#1)
stage malaria parasites##4##3##(2008-4#2)(2012-2#2)
stage malaria##5##2##(2008-4#3)(2012-2#2)
stage management##4##2##(2013-1#2)(2013-8#2)
stage melanoma##3##2##(1997-7#1)(2007-11#1)(2009-4#1)
stage migration##4##2##(2008-6#1)(2008-8#1)(2011-2#2)
stage models##4##2##(2008-4#1)(2011-12#3)
stage of DR##2##3##(2008-1#1)(2010-8#1)
stage of HIV infection##2##4##(1990-10#1)(2008-1#1)
stage of P##2##3##(2010-4#1)(2011-2#1)
stage of Parkinson's disease##4##4##(2008-7#1)(2012-1#3)
stage of Streptomyces ansochromogenes##2##4##(2005-11#1)(2008-8#1)
stage of a three-stage##2##4##(1994-2#1)(2007-8#1)
stage of a##7##3##(1994-2#1)(1995-8#1)(2007-8#1)(2008-10#2)(2008-2#1)(2012-2#1)
stage of advanced CHF##2##4##(2009-10#2)
stage of an##4##3##(2008-10#1)(2008-11#1)(2008-2#2)
stage of cancer##3##3##(1996-7#1)(2007-11#1)(2011-2#1)
stage of cell##3##3##(1992-9#1)(2008-9#1)(2012-2#1)
stage of cerebral##4##3##(2007-10#3)(2008-9#1)
stage of change##2##3##(2008-11#1)(2013-1#1)
stage of clinical##5##3##(2005-7#1)(2006-2#1)(2006-7#1)(2007-11#1)(2010-12#1)
stage of development of##4##4##(1996-8#1)(2007-11#1)(2008-10#1)(2012-2#1)
stage of development##27##3##(1991-1#1)(1991-11#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-6#1)(1997-7#1)(2005-7#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-8#1)(2010-2#1)(2010-3#1)(2010-4#1)(2012-2#2)
stage of disease and##3##4##(1991-4#1)(1993-11#1)(1995-5#1)
stage of disease##15##3##(1990-12#1)(1991-4#1)(1991-5#1)(1993-11#1)(1995-5#1)(2004-11#1)(2005-1#1)(2005-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-11#1)(2011-2#2)(2013-1#1)
stage of dyspnea##5##3##(1996-6#5)
stage of embryogenesis##2##3##(1990-11#1)(1992-9#1)
stage of evolution##3##3##(1996-1#1)(2008-1#1)(2008-5#1)
stage of exercise##2##3##(2008-10#1)(2013-1#1)
stage of flower##2##3##(1997-8#1)(2008-8#1)
stage of follicle##2##3##(2008-7#1)(2011-1#1)
stage of fruit development##2##4##(2008-10#1)(2008-9#1)
stage of human##2##3##(1991-4#1)(1996-9#1)
stage of hypertension and serum##2##5##(2007-7#2)
stage of hypertension and##4##4##(2007-7#3)(2011-2#1)
stage of illness##2##3##(1995-5#1)(2009-6#1)
stage of infection##8##3##(1994-6#1)(1997-6#1)(2007-8#1)(2008-10#2)(2008-5#2)(2012-2#1)
stage of kernel development##2##4##(2008-10#2)
stage of labour##6##3##(1992-1#3)(1993-4#2)(2013-8#1)
stage of lag##2##3##(2011-2#2)
stage of life and##2##4##(1993-12#1)(2013-8#1)
stage of life##6##3##(1992-5#1)(1993-12#1)(2005-3#1)(2010-1#2)(2013-8#1)
stage of mycosis fungoides##2##4##(2007-8#2)
stage of organ##2##3##(2008-7#1)(2008-9#1)
stage of reed canarygrass##2##4##(2008-5#2)
stage of reed canarygrass--100 degrees C##2##6##(2008-5#2)
stage of reed##4##3##(2008-5#4)
stage of renal failure##2##4##(1990-4#2)
stage of retinopathy##2##3##(1995-9#1)(2007-2#1)
stage of severe##2##3##(2013-1#1)(2013-8#1)
stage of spreading##2##3##(2005-11#2)
stage of terminal respiration##3##4##(1996-6#3)
stage of the cell cycle##2##5##(1995-8#1)(2008-10#1)
stage of the disease and##5##5##(1991-6#1)(1995-9#1)(2005-11#1)(2008-3#1)(2009-8#1)
stage of the disease at##2##5##(1995-8#1)(2007-2#1)
stage of the disease##33##4##(1990-10#1)(1990-2#1)(1990-6#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-8#1)(1993-2#1)(1995-2#1)(1995-8#1)(1995-9#1)(2005-11#1)(2006-6#1)(2007-11#3)(2007-2#1)(2007-5#1)(2007-7#2)(2008-10#2)(2008-3#1)(2008-6#2)(2008-7#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
stage of the experiment##3##4##(2008-5#1)(2009-2#2)
stage of the illness##2##4##(2007-11#1)(2012-3#1)
stage of the infection##2##4##(1990-6#1)(2008-10#1)
stage of the luteal phase##2##5##(1990-8#1)(1994-9#1)
stage of the program##2##4##(1991-12#2)
stage of the##119##3##(1990-10#1)(1990-2#1)(1990-6#2)(1990-8#2)(1991-10#1)(1991-12#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#2)(1993-11#3)(1993-2#3)(1993-7#1)(1994-2#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-4#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-7#1)(1997-6#1)(2005-11#2)(2005-8#1)(2006-5#2)(2006-6#1)(2006-9#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-5#2)(2007-7#2)(2007-8#1)(2008-10#11)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#1)(2008-5#7)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#4)(2009-2#2)(2009-5#2)(2009-8#1)(2010-3#1)(2010-8#3)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
stage of their##5##3##(2006-10#1)(2008-7#1)(2010-12#1)(2012-3#1)(2013-8#1)
stage of this##7##3##(1991-2#1)(2004-12#1)(2008-10#2)(2008-5#1)(2010-12#1)(2013-1#1)
stage of treatment##2##3##(2012-3#2)
stage of weaning##2##3##(2013-1#2)
stage of##486##2##(1990-10#2)(1990-11#3)(1990-12#3)(1990-2#2)(1990-4#2)(1990-6#3)(1990-8#4)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#4)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#4)(1992-12#3)(1992-2#2)(1992-5#4)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#6)(1993-12#2)(1993-2#4)(1993-4#2)(1993-7#1)(1994-11#2)(1994-12#1)(1994-2#4)(1994-3#3)(1994-4#3)(1994-5#1)(1994-6#6)(1994-8#1)(1994-9#3)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-5#4)(1995-6#2)(1995-8#6)(1995-9#2)(1996-1#2)(1996-2#1)(1996-3#3)(1996-5#1)(1996-6#9)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-3#2)(1997-6#5)(1997-7#1)(1997-8#3)(2004-11#2)(2004-12#1)(2005-1#1)(2005-10#2)(2005-11#7)(2005-3#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#5)(2006-6#2)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#8)(2007-12#5)(2007-2#2)(2007-5#2)(2007-7#7)(2007-8#7)(2007-9#5)(2008-1#3)(2008-10#45)(2008-11#10)(2008-12#6)(2008-2#9)(2008-3#2)(2008-4#7)(2008-5#19)(2008-6#5)(2008-7#13)(2008-8#9)(2008-9#12)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#3)(2010-10#2)(2010-12#7)(2010-2#4)(2010-3#5)(2010-4#3)(2010-6#1)(2010-8#6)(2010-9#1)(2011-1#3)(2011-11#1)(2011-2#16)(2012-1#5)(2012-12#6)(2012-2#8)(2012-3#5)(2012-8#1)(2013-1#17)(2013-7#1)(2013-8#9)
stage on##2##2##(2005-8#1)(2008-6#1)
stage or the##2##3##(2008-10#1)(2008-5#1)
stage or##5##2##(1991-6#1)(2008-10#2)(2008-5#1)(2008-8#1)
stage pancreatic##2##2##(1992-4#1)(2006-10#1)
stage prostate##2##2##(2007-11#1)(2008-7#1)
stage ranged from##3##3##(2008-10#1)(2011-12#1)(2011-2#1)
stage renal disease (ESRD)##15##4##(1991-3#1)(1995-1#1)(1995-12#2)(1996-2#1)(1997-1#1)(2006-5#2)(2007-7#4)(2008-1#1)(2008-4#1)(2012-2#1)
stage renal disease and##3##4##(2010-11#1)(2011-2#1)(2013-1#1)
stage renal disease in##2##4##(2008-1#1)(2010-4#1)
stage renal disease patients##2##4##(2008-1#1)(2010-7#1)
stage renal disease##33##3##(1991-3#2)(1995-1#1)(1995-12#2)(1996-2#1)(1997-1#2)(2006-10#1)(2006-5#2)(2007-7#7)(2008-1#5)(2008-4#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-2#1)(2013-1#1)
stage renal failure in##3##4##(2008-1#2)(2008-4#1)
stage renal failure##7##3##(1997-8#2)(2008-1#3)(2008-4#1)(2009-8#1)
stage renal##41##2##(1991-3#2)(1995-1#1)(1995-12#2)(1996-2#1)(1997-1#2)(1997-8#2)(2006-10#1)(2006-5#2)(2007-7#7)(2008-1#8)(2008-4#2)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-2#1)(2013-1#1)
stage repair##2##2##(2007-8#1)(2009-10#1)
stage should##2##2##(1995-2#1)(2012-2#1)
stage significantly##3##2##(1994-11#1)(2008-10#1)(2012-1#1)
stage specific embryonic##2##3##(2008-11#2)
stage specific##6##2##(1992-3#1)(1993-2#1)(2008-11#2)(2008-9#1)(2009-10#1)
stage specificity##2##2##(1992-3#1)(1995-2#1)
stage structure##4##2##(2008-8#4)
stage surgical##2##2##(2006-6#1)(2008-9#1)
stage than in##2##3##(1991-6#1)(1997-2#1)
stage than##5##2##(1991-6#1)(1994-7#1)(1997-2#1)(2008-4#1)(2012-1#1)
stage that##6##2##(1995-11#1)(2006-5#1)(2007-12#1)(2011-1#1)(2011-3#1)(2012-1#1)
stage the##8##2##(1990-3#1)(1995-8#1)(1996-8#1)(2008-10#1)(2008-9#1)(2009-5#1)(2009-6#1)(2012-12#1)
stage there##2##2##(1991-9#1)(2012-3#1)
stage through the##2##3##(1996-9#1)(2009-7#1)
stage through##5##2##(1996-9#1)(2007-10#1)(2008-10#1)(2008-8#1)(2009-7#1)
stage to a##2##3##(1992-6#1)(2006-10#1)
stage to the##3##3##(2007-3#1)(2008-5#1)(2011-2#1)
stage to##20##2##(1992-6#1)(1994-1#1)(2006-10#1)(2007-3#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-5#2)(2009-11#1)(2009-9#2)(2011-2#2)
stage tumours##2##2##(2011-2#2)
stage using a##2##3##(1993-9#1)(2011-2#1)
stage using##3##2##(1993-9#1)(2008-12#1)(2011-2#1)
stage was T1 in 21##2##5##(1991-8#1)(2008-6#1)
stage was higher (P &lt##2##5##(2006-5#2)
stage was not##2##3##(2007-12#1)(2008-10#1)
stage was significantly##2##3##(2006-5#1)(2011-12#1)
stage was##36##2##(1991-8#1)(1994-11#1)(1996-9#1)(2006-5#3)(2007-12#2)(2007-3#1)(2007-5#4)(2008-10#7)(2008-12#3)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-12#1)(2011-2#2)(2012-2#2)
stage we##3##2##(1994-2#1)(2012-12#2)
stage were more afraid##2##4##(2006-10#2)
stage were more##3##3##(1990-12#1)(2006-10#2)
stage were##8##2##(1990-12#1)(1990-3#1)(1991-12#1)(1995-8#1)(2006-10#2)(2008-1#1)(2008-10#1)
stage when the##2##3##(2008-11#1)(2008-6#1)
stage when##5##2##(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-7#1)
stage where the##2##3##(1992-4#1)(1995-8#1)
stage where##3##2##(1992-4#1)(1995-8#1)(1996-1#1)
stage which##2##2##(1994-6#1)(2008-11#1)
stage with##6##2##(1997-3#1)(2007-8#1)(2008-3#1)(2009-9#1)(2011-11#1)(2012-12#1)
stage without##3##2##(1992-2#1)(1994-2#1)(2006-5#1)
stage##2223##1##(1990-10#4)(1990-11#4)(1990-12#12)(1990-2#6)(1990-3#7)(1990-4#2)(1990-5#8)(1990-6#17)(1990-7#2)(1990-8#12)(1990-9#12)(1991-1#3)(1991-10#5)(1991-11#5)(1991-12#8)(1991-2#5)(1991-3#4)(1991-4#13)(1991-5#2)(1991-6#5)(1991-7#4)(1991-8#13)(1991-9#17)(1992-1#12)(1992-10#1)(1992-11#3)(1992-12#7)(1992-2#8)(1992-3#4)(1992-4#4)(1992-5#6)(1992-6#5)(1992-7#2)(1992-8#7)(1992-9#4)(1993-1#4)(1993-10#3)(1993-11#11)(1993-12#8)(1993-2#12)(1993-3#4)(1993-4#5)(1993-5#1)(1993-6#1)(1993-7#7)(1993-8#2)(1993-9#5)(1994-1#1)(1994-10#4)(1994-11#5)(1994-12#5)(1994-2#9)(1994-3#8)(1994-4#10)(1994-5#1)(1994-6#10)(1994-7#4)(1994-8#6)(1994-9#11)(1995-1#7)(1995-10#2)(1995-11#6)(1995-12#9)(1995-2#13)(1995-3#2)(1995-4#7)(1995-5#9)(1995-6#4)(1995-8#17)(1995-9#7)(1996-1#3)(1996-10#2)(1996-11#3)(1996-12#3)(1996-2#7)(1996-3#5)(1996-4#4)(1996-5#3)(1996-6#14)(1996-7#7)(1996-8#5)(1996-9#8)(1997-1#5)(1997-2#7)(1997-3#7)(1997-4#5)(1997-5#5)(1997-6#13)(1997-7#18)(1997-8#10)(2004-1#14)(2004-10#1)(2004-11#6)(2004-12#2)(2004-2#1)(2005-1#3)(2005-10#3)(2005-11#14)(2005-3#1)(2005-7#4)(2005-8#7)(2005-9#1)(2006-1#3)(2006-10#44)(2006-11#2)(2006-12#8)(2006-2#2)(2006-3#8)(2006-4#1)(2006-5#21)(2006-6#15)(2006-7#6)(2006-8#10)(2006-9#4)(2007-1#3)(2007-10#19)(2007-11#27)(2007-12#36)(2007-2#7)(2007-3#17)(2007-4#5)(2007-5#12)(2007-6#2)(2007-7#22)(2007-8#73)(2007-9#15)(2008-1#26)(2008-10#187)(2008-11#42)(2008-12#35)(2008-2#35)(2008-3#13)(2008-4#32)(2008-5#72)(2008-6#37)(2008-7#38)(2008-8#65)(2008-9#32)(2009-10#13)(2009-11#5)(2009-12#6)(2009-2#5)(2009-3#13)(2009-4#4)(2009-5#14)(2009-6#4)(2009-7#5)(2009-8#10)(2009-9#10)(2010-1#5)(2010-10#6)(2010-11#6)(2010-12#25)(2010-2#8)(2010-3#7)(2010-4#7)(2010-5#3)(2010-6#5)(2010-7#4)(2010-8#14)(2010-9#4)(2011-1#27)(2011-11#4)(2011-12#19)(2011-2#103)(2011-3#1)(2012-1#23)(2012-12#32)(2012-2#42)(2012-3#38)(2012-8#1)(2013-1#72)(2013-7#12)(2013-8#46)
stage) and##4##2##(1991-6#1)(1992-12#1)(2008-10#2)
stage)##16##1##(1990-6#1)(1991-6#3)(1992-12#1)(2008-10#6)(2008-6#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-1#1)
stage-I##2##1##(1990-12#1)(1993-9#1)
stage-III##2##1##(1990-12#1)(2011-2#1)
stage-IV disease in##4##3##(2012-12#4)
stage-IV##5##1##(1990-12#1)(2012-12#4)
stage-dependent##5##1##(1990-12#1)(1992-11#1)(2007-12#1)(2012-2#2)
stage-related##4##1##(1992-3#1)(2006-1#1)(2008-8#1)(2008-9#1)
stage-specific manner##2##2##(1995-12#1)(2008-8#1)
stage-specific##16##1##(1992-11#1)(1994-12#2)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(2006-10#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-6#1)(2009-7#1)(2012-2#1)
stage-structured populations##2##2##(2012-2#2)
stage-structured##5##1##(2007-9#1)(2008-8#2)(2012-2#2)
stage]##3##1##(2008-1#1)(2013-1#1)(2013-7#1)
staged 4##2##2##(1995-8#2)
staged according to##3##3##(1990-8#1)(2008-6#1)(2012-3#1)
staged and##3##2##(1990-10#1)(2006-8#1)(2008-7#1)
staged approach##2##2##(2009-5#1)(2010-11#1)
staged based on the##2##4##(2007-12#1)(2011-2#1)
staged operation##2##2##(2008-10#1)(2008-7#1)
staged operations##2##2##(2008-7#2)
staged surgery##3##2##(2008-7#3)
staged therapy##2##2##(2012-3#2)
staged with##2##2##(1992-6#1)(2012-2#1)
staged##62##1##(1990-10#2)(1990-8#1)(1992-6#1)(1993-12#1)(1995-8#2)(1996-3#1)(1997-3#3)(2005-11#1)(2006-10#2)(2006-12#1)(2006-7#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-4#2)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-6#4)(2008-7#7)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#2)(2009-5#1)(2010-11#1)(2010-6#2)(2011-2#5)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
stages 2##2##2##(2008-10#1)(2008-11#1)
stages 3 to 4 chronic kidney disease##2##7##(2007-8#2)
stages 3##3##2##(2007-8#2)(2011-2#1)
stages I and II##3##4##(1993-9#1)(2007-6#1)(2007-8#1)
stages I and##5##3##(1990-8#1)(1993-9#1)(2007-6#1)(2007-8#1)(2008-1#1)
stages I##9##2##(1990-8#1)(1993-9#1)(1997-4#1)(2006-12#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-5#1)
stages II and##2##3##(1990-8#1)(2011-2#1)
stages II##3##2##(1990-8#1)(2011-2#2)
stages III and IV)##2##4##(1991-8#1)(2005-12#1)
stages III##4##2##(1991-8#1)(2005-12#1)(2008-5#1)(2011-2#1)
stages along the##2##3##(1997-4#1)(2005-9#1)
stages and in##3##3##(1993-6#1)(1995-2#1)(1997-7#1)
stages and that##2##3##(2006-1#1)(2008-5#1)
stages and the##7##3##(2007-3#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-6#1)
stages and was##2##3##(2004-11#1)(2008-10#1)
stages and with##2##3##(2008-10#1)(2011-2#1)
stages and##52##2##(1992-1#1)(1992-12#1)(1993-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-3#1)(1997-7#1)(2004-11#1)(2006-1#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#2)(2008-10#10)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
stages are##9##2##(1995-1#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-12#2)
stages as##3##2##(2007-11#1)(2008-10#1)(2010-8#1)
stages at##2##2##(2008-9#1)(2010-12#1)
stages based on##2##3##(2008-6#1)(2010-8#1)
stages before##2##2##(1996-3#1)(2008-10#1)
stages by##8##2##(1992-11#1)(1993-6#1)(2007-1#1)(2007-4#1)(2008-11#1)(2010-8#1)(2011-2#1)(2012-2#1)
stages can be##2##3##(2008-11#1)(2008-4#1)
stages can##4##2##(2007-4#1)(2008-11#1)(2008-4#1)(2011-3#1)
stages during##9##2##(1990-3#1)(1994-11#1)(2008-10#1)(2008-5#1)(2009-2#1)(2011-12#1)(2011-2#1)(2012-12#2)
stages for##4##2##(1993-6#1)(2006-4#1)(2008-4#1)(2010-8#1)
stages from##4##2##(1995-11#1)(2004-8#1)(2008-10#2)
stages in an##2##3##(1991-9#1)(2010-8#1)
stages in the development of##3##5##(1996-5#1)(2007-11#1)(2010-8#1)
stages in the life cycles of these pathogens##2##8##(2008-10#2)
stages in the##18##3##(1990-8#1)(1991-2#1)(1996-5#1)(2005-7#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-2#1)
stages in which##2##3##(1994-9#1)(2007-12#1)
stages in##38##2##(1990-11#1)(1990-8#1)(1991-2#1)(1991-9#1)(1994-10#1)(1994-11#1)(1994-9#1)(1996-12#1)(1996-5#1)(1996-6#1)(2005-7#1)(2007-11#2)(2007-12#4)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#2)(2010-2#1)(2010-8#2)(2011-2#2)(2012-12#1)
stages including##2##2##(2008-10#1)(2013-1#1)
stages increased##2##2##(2008-10#1)(2008-9#1)
stages involved in##2##3##(1996-2#1)(2012-1#1)
stages is##3##2##(2006-8#1)(2008-5#1)(2010-8#1)
stages leading to##2##3##(1995-8#1)(2012-12#1)
stages may##2##2##(1992-8#1)(2008-8#1)
stages of Alzheimer's disease##2##4##(1992-12#1)(1992-8#1)
stages of Alzheimer's##4##3##(1992-12#2)(1992-8#1)(2005-6#1)
stages of BPD##2##3##(2009-8#2)
stages of C##3##3##(2007-6#2)(2011-2#1)
stages of DNA replication##2##4##(1996-8#1)(2009-2#1)
stages of Drosophila##3##3##(1995-3#1)(2008-8#2)
stages of HCV infection##2##4##(2009-9#1)(2011-2#1)
stages of Myxozoan parasites of oligochaetes##2##6##(2008-4#2)
stages of Plasmodium falciparum##2##4##(1992-7#1)(2010-12#1)
stages of Plasmodium##6##3##(1992-7#1)(2006-10#3)(2010-12#1)(2010-2#1)
stages of a##5##3##(1994-3#1)(1995-5#1)(1997-2#1)(2004-11#1)(2005-8#1)
stages of adult##2##3##(2007-12#1)(2012-3#1)
stages of atherosclerosis##3##3##(2007-10#1)(2008-4#2)
stages of biofilm formation##4##4##(2008-9#1)(2011-11#1)(2013-8#2)
stages of both##2##3##(2008-10#1)(2008-9#1)
stages of cancer##2##3##(1990-5#1)(2013-1#1)
stages of cell death##2##4##(2008-11#1)(2008-9#1)
stages of cell division##2##4##(1997-4#1)(2012-12#1)
stages of cell##5##3##(1997-4#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-12#1)
stages of cervical##3##3##(2009-2#1)(2010-12#2)
stages of change##2##3##(2008-12#1)(2008-4#1)
stages of chronic##2##3##(1996-1#1)(1996-12#1)
stages of clinical##3##3##(2008-1#1)(2008-5#1)(2012-3#1)
stages of colonization##2##3##(2008-10#1)(2008-8#1)
stages of colorectal##2##3##(1991-9#1)(2009-9#1)
stages of data##3##3##(1994-2#1)(2008-4#1)(2008-7#1)
stages of development and##5##4##(1995-11#1)(2005-8#1)(2006-10#1)(2009-3#1)(2011-2#1)
stages of development ranging from##2##5##(1991-7#1)(2008-10#1)
stages of development##43##3##(1990-5#1)(1991-11#1)(1991-7#1)(1992-6#1)(1993-2#1)(1994-12#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-6#2)(2005-10#1)(2005-8#2)(2006-10#2)(2007-12#1)(2007-3#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2009-3#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
stages of diabetic nephropathy##2##4##(1990-4#1)(1997-8#1)
stages of diabetic##3##3##(1990-4#1)(1997-8#2)
stages of differentiation##3##3##(1991-8#1)(2006-10#1)(2008-9#1)
stages of disease development##2##4##(2008-10#2)
stages of disease##8##3##(1990-4#1)(1995-12#1)(2008-10#2)(2008-8#1)(2009-10#1)(2010-12#1)(2012-12#1)
stages of drug development##2##4##(1996-3#1)(2006-11#1)
stages of embryogenesis as##2##4##(1993-5#1)(1995-2#1)
stages of embryogenesis##6##3##(1990-8#1)(1993-5#1)(1994-3#1)(1995-2#1)(1997-5#1)(2013-1#1)
stages of embryonic development##4##4##(2007-12#2)(2008-11#1)(2012-3#1)
stages of embryos##2##3##(1992-12#1)(1997-8#1)
stages of epidemics##2##3##(2008-10#2)
stages of follicular atresia##2##4##(2008-7#2)
stages of gastric##2##3##(2010-12#1)(2011-2#1)
stages of germ##4##3##(2008-7#1)(2009-10#2)(2009-3#1)
stages of growth##7##3##(1990-7#1)(1995-4#1)(2005-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2010-7#1)
stages of healing##2##3##(2004-9#1)(2008-7#1)
stages of human##2##3##(1997-8#1)(2010-8#1)
stages of implementation##2##3##(1995-3#2)
stages of infection##9##3##(2008-10#4)(2008-2#1)(2008-7#1)(2010-6#1)(2011-10#1)(2013-8#1)
stages of lag##2##3##(2011-2#2)
stages of learning##2##3##(1993-9#1)(2013-1#1)
stages of life##8##3##(1997-7#1)(2007-12#1)(2007-3#1)(2008-10#1)(2009-2#1)(2009-5#1)(2013-1#1)(2013-7#1)
stages of mammalian##2##3##(2008-10#1)(2008-9#1)
stages of memory##2##3##(1993-11#1)(1996-1#1)
stages of oogenesis##4##3##(1994-3#1)(2007-12#3)
stages of ovarian cancer##2##4##(2011-2#2)
stages of physical activity##3##4##(2013-1#3)
stages of plant development##4##4##(2008-10#4)
stages of pregnancy and##2##4##(2008-11#1)(2008-9#1)
stages of pregnancy##5##3##(1995-12#1)(2008-11#1)(2008-9#1)(2009-3#1)(2010-10#1)
stages of processing##2##3##(2005-5#1)(2008-11#1)
stages of rehabilitation##2##3##(2007-11#1)(2007-8#1)
stages of reward##2##3##(2013-8#2)
stages of seed development##2##4##(1994-3#1)(2008-12#1)
stages of several##2##3##(1995-7#1)(2006-6#1)
stages of sexual##2##3##(2008-5#2)
stages of spermatogenesis##5##3##(1996-8#1)(2007-9#1)(2008-8#1)(2012-2#2)
stages of spermatogenic cells##2##4##(1990-11#1)(2008-5#1)
stages of squamous-cell##2##3##(1992-9#1)(1993-9#1)
stages of the disease were studied##2##6##(2008-5#1)(2008-7#1)
stages of the disease##16##4##(1990-11#1)(2006-10#1)(2006-11#1)(2006-6#2)(2007-11#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#2)(2010-2#1)(2012-1#1)
stages of the epithelial##2##4##(2005-11#1)(2009-10#1)
stages of the illness##3##4##(2006-6#1)(2008-9#1)(2013-7#1)
stages of the life cycle##3##5##(1995-2#1)(2008-12#1)(2008-4#1)
stages of the life##4##4##(1995-2#1)(1996-11#1)(2008-12#1)(2008-4#1)
stages of the operation##3##4##(2006-12#1)(2006-5#1)(2007-5#1)
stages of the parasite##4##4##(1992-7#1)(1997-6#1)(2008-5#1)(2010-2#1)
stages of the process##3##4##(2007-7#1)(2008-10#1)(2008-2#1)
stages of the##102##3##(1990-11#1)(1990-12#1)(1990-8#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-7#1)(1993-1#1)(1993-9#2)(1994-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-4#1)(1997-6#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-11#2)(2006-12#2)(2006-5#3)(2006-6#3)(2007-10#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#2)(2009-2#1)(2010-12#1)(2010-2#2)(2010-7#1)(2011-1#1)(2011-2#3)(2011-3#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
stages of their##5##3##(2008-5#1)(2009-10#1)(2009-8#1)(2012-2#1)(2013-8#1)
stages of this##3##3##(1996-4#1)(2012-12#1)(2012-2#1)
stages of training##2##3##(1993-3#1)(2006-10#1)
stages of treatment##7##3##(1991-11#1)(1995-2#1)(1997-4#1)(2007-10#1)(2008-4#2)(2012-3#1)
stages of tumor##4##3##(1993-4#1)(1993-8#1)(2009-6#1)(2012-2#1)
stages of visual processing##2##4##(1995-11#1)(1997-8#1)
stages of##621##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#1)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#3)(1991-11#2)(1991-12#3)(1991-4#3)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#4)(1992-1#4)(1992-12#4)(1992-3#3)(1992-4#1)(1992-6#3)(1992-7#2)(1992-8#1)(1992-9#5)(1993-1#3)(1993-11#6)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#6)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#5)(1994-8#2)(1994-9#3)(1995-1#2)(1995-11#5)(1995-12#5)(1995-2#3)(1995-3#4)(1995-4#2)(1995-5#1)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#4)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#2)(1996-8#2)(1997-2#3)(1997-4#4)(1997-5#1)(1997-6#8)(1997-7#1)(1997-8#8)(2004-11#3)(2004-3#1)(2004-9#3)(2005-10#1)(2005-11#2)(2005-12#2)(2005-5#1)(2005-6#1)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#19)(2006-11#5)(2006-12#5)(2006-5#4)(2006-6#5)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#9)(2007-12#19)(2007-2#1)(2007-3#3)(2007-4#2)(2007-5#1)(2007-6#3)(2007-7#5)(2007-8#7)(2007-9#1)(2008-1#6)(2008-10#54)(2008-11#9)(2008-12#13)(2008-2#7)(2008-3#5)(2008-4#16)(2008-5#17)(2008-6#2)(2008-7#18)(2008-8#12)(2008-9#9)(2009-10#8)(2009-2#6)(2009-3#5)(2009-4#1)(2009-5#4)(2009-6#2)(2009-8#10)(2009-9#2)(2010-10#3)(2010-11#1)(2010-12#9)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#7)(2010-9#1)(2011-1#5)(2011-10#1)(2011-11#1)(2011-12#2)(2011-2#20)(2011-3#3)(2012-1#5)(2012-11#1)(2012-12#9)(2012-2#14)(2012-3#7)(2012-7#1)(2013-1#16)(2013-7#2)(2013-8#10)
stages on##3##2##(2008-10#2)(2011-1#1)
stages or##7##2##(1996-11#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
stages ranging from##2##3##(2007-2#1)(2008-10#1)
stages tested##2##2##(2008-6#1)(2012-2#1)
stages that##3##2##(1994-12#1)(2006-12#1)(2010-12#1)
stages the##2##2##(1993-7#1)(2008-11#1)
stages to##10##2##(2006-2#1)(2007-3#1)(2008-1#1)(2008-3#1)(2008-5#1)(2009-2#1)(2011-2#1)(2012-12#2)(2012-8#1)
stages was significantly##2##3##(2008-10#1)(2011-12#1)
stages was##11##2##(1993-10#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2011-12#1)(2011-2#1)(2012-12#2)
stages were examined##2##3##(1997-4#1)(2011-2#1)
stages were identified##2##3##(2008-5#1)(2012-12#1)
stages were observed in##2##4##(2008-5#1)(2011-2#1)
stages were##15##2##(1997-4#1)(2006-7#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-6#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)
stages with a##3##3##(2008-10#2)(2011-2#1)
stages with the##2##3##(2008-12#1)(2012-2#1)
stages with##6##2##(2008-10#3)(2008-12#1)(2011-2#1)(2012-2#1)
stages within the##2##3##(2006-3#1)(2008-4#1)
stages##1276##1##(1990-10#3)(1990-11#4)(1990-12#1)(1990-2#3)(1990-3#2)(1990-4#2)(1990-5#7)(1990-6#1)(1990-7#1)(1990-8#7)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#1)(1991-4#4)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#3)(1991-9#5)(1992-1#5)(1992-10#1)(1992-11#1)(1992-12#7)(1992-2#1)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#3)(1992-7#3)(1992-8#3)(1992-9#5)(1993-1#3)(1993-10#1)(1993-11#6)(1993-12#1)(1993-2#3)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#5)(1993-7#2)(1993-8#2)(1993-9#9)(1994-10#3)(1994-11#3)(1994-12#6)(1994-2#4)(1994-3#6)(1994-5#2)(1994-8#3)(1994-9#6)(1995-1#6)(1995-11#9)(1995-12#6)(1995-2#4)(1995-3#5)(1995-4#2)(1995-5#5)(1995-6#2)(1995-7#1)(1995-8#5)(1995-9#2)(1996-1#4)(1996-10#1)(1996-11#4)(1996-12#5)(1996-2#7)(1996-3#5)(1996-4#2)(1996-5#2)(1996-6#5)(1996-7#2)(1996-8#2)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#11)(1997-5#2)(1997-6#9)(1997-7#3)(1997-8#11)(2004-1#1)(2004-11#6)(2004-3#1)(2004-8#1)(2004-9#3)(2005-10#2)(2005-11#6)(2005-12#3)(2005-5#3)(2005-6#1)(2005-7#2)(2005-8#3)(2005-9#1)(2006-1#2)(2006-10#28)(2006-11#6)(2006-12#10)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#7)(2006-6#6)(2006-7#2)(2006-8#5)(2006-9#4)(2007-1#2)(2007-10#4)(2007-11#16)(2007-12#35)(2007-2#3)(2007-3#18)(2007-4#5)(2007-5#5)(2007-6#6)(2007-7#12)(2007-8#18)(2007-9#5)(2008-1#14)(2008-10#133)(2008-11#25)(2008-12#25)(2008-2#12)(2008-3#14)(2008-4#32)(2008-5#40)(2008-6#14)(2008-7#29)(2008-8#26)(2008-9#16)(2009-1#1)(2009-10#14)(2009-12#2)(2009-2#11)(2009-3#8)(2009-4#2)(2009-5#5)(2009-6#4)(2009-7#1)(2009-8#12)(2009-9#5)(2010-1#1)(2010-10#6)(2010-11#3)(2010-12#22)(2010-2#7)(2010-3#1)(2010-4#3)(2010-5#4)(2010-6#4)(2010-7#4)(2010-8#24)(2010-9#2)(2011-1#14)(2011-10#1)(2011-11#1)(2011-12#6)(2011-2#64)(2011-3#5)(2012-1#6)(2012-11#3)(2012-12#28)(2012-2#29)(2012-3#13)(2012-7#1)(2012-8#1)(2013-1#27)(2013-7#2)(2013-8#24)
stages)##3##1##(2008-10#1)(2008-11#1)(2011-2#1)
stages]##2##1##(2008-7#1)(2011-2#1)
staggered double-strand breaks##2##3##(1991-5#1)(2013-1#1)
staggered##10##1##(1991-5#2)(1995-8#1)(1997-7#2)(2007-11#2)(2008-8#1)(2009-12#1)(2013-1#1)
staggering##5##1##(1991-12#1)(1994-9#1)(1996-2#1)(2008-2#1)(2008-5#1)
staghorn calculi##3##2##(1990-12#2)(2007-7#1)
staghorn stone##2##2##(2007-7#1)(2008-10#1)
staghorn##7##1##(1990-12#2)(2007-7#3)(2008-10#1)(2013-1#1)
staging and follow-up of##2##4##(2008-2#1)(2012-11#1)
staging and follow-up##4##3##(2008-1#1)(2008-2#1)(2008-6#1)(2012-11#1)
staging and monitoring##2##3##(2008-2#1)(2010-3#1)
staging and risk##2##3##(1995-1#1)(2011-2#1)
staging and the##2##3##(2010-3#1)(2011-2#1)
staging and treatment##3##3##(1993-9#1)(1995-11#1)(2006-9#1)
staging and##35##2##(1990-3#1)(1990-9#3)(1993-5#1)(1993-9#1)(1995-1#1)(1995-11#1)(2006-10#1)(2006-8#1)(2006-9#1)(2008-1#2)(2008-10#1)(2008-2#3)(2008-3#1)(2008-6#4)(2009-4#1)(2010-3#5)(2010-7#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#1)
staging for##5##2##(2004-1#1)(2005-5#1)(2006-10#1)(2012-2#1)(2012-3#1)
staging in patients with##2##4##(2007-9#1)(2009-5#1)
staging in##6##2##(1991-9#1)(2007-9#1)(2008-5#2)(2009-5#1)(2011-1#1)
staging is##6##2##(2006-10#2)(2007-4#1)(2007-8#1)(2008-2#1)(2012-12#1)
staging method in##2##3##(1990-9#2)
staging methods##2##2##(1990-6#1)(2006-10#1)
staging of esophageal cancer##2##4##(1993-5#1)(2012-12#1)
staging of fibrosis##3##3##(2006-6#3)
staging of malignancy##2##3##(2006-10#1)(2008-2#1)
staging of pancreatic cancer##2##4##(2006-10#1)(2009-5#1)
staging of pancreatic##6##3##(1993-5#1)(2006-10#1)(2008-1#2)(2009-5#1)(2010-12#1)
staging of patients with##3##4##(2007-4#2)(2007-6#1)
staging of patients##4##3##(2007-11#1)(2007-4#2)(2007-6#1)
staging of rectal##2##3##(1990-9#1)(2013-1#1)
staging of the##6##3##(2004-1#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-4#1)(2012-12#1)
staging of##51##2##(1990-9#1)(1992-9#1)(1993-5#2)(1996-4#1)(2004-1#1)(2006-10#5)(2006-6#4)(2006-8#1)(2007-11#3)(2007-12#1)(2007-4#4)(2007-6#2)(2007-8#1)(2008-1#3)(2008-2#4)(2008-3#2)(2008-8#1)(2008-9#3)(2009-5#1)(2010-12#2)(2010-8#1)(2012-12#3)(2012-2#3)(2013-1#1)
staging or##2##2##(2006-9#1)(2013-1#1)
staging procedure##5##2##(1990-12#1)(1994-12#1)(1997-8#1)(2008-1#1)(2010-7#1)
staging system and##3##3##(2011-2#3)
staging system for##5##3##(1995-9#1)(2005-10#1)(2007-8#1)(2008-9#1)(2010-12#1)
staging system of##2##3##(2008-9#1)(2009-3#1)
staging system##27##2##(1990-8#1)(1994-6#1)(1995-9#1)(2005-10#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-4#3)(2007-8#2)(2008-12#1)(2008-6#1)(2008-9#3)(2009-3#1)(2010-12#2)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#1)
staging systems##9##2##(2006-10#1)(2007-8#1)(2008-9#1)(2011-2#2)(2013-8#4)
staging the##5##2##(1994-2#1)(2004-1#1)(2007-12#1)(2007-5#1)(2010-8#1)
staging to##3##2##(2010-2#1)(2010-5#1)(2011-1#1)
staging was##2##2##(2008-10#2)
staging were##2##2##(2005-5#1)(2012-3#1)
staging with##2##2##(1992-4#1)(2006-11#1)
staging##261##1##(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#1)(1990-8#1)(1990-9#12)(1991-1#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-4#1)(1992-9#1)(1993-11#1)(1993-5#8)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-9#1)(1996-4#1)(1997-8#1)(2004-1#4)(2005-10#1)(2005-5#4)(2006-10#21)(2006-11#1)(2006-6#6)(2006-8#2)(2006-9#5)(2007-1#1)(2007-11#5)(2007-12#3)(2007-3#3)(2007-4#12)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#10)(2007-9#1)(2008-1#9)(2008-10#5)(2008-12#1)(2008-2#11)(2008-3#4)(2008-5#5)(2008-6#6)(2008-7#4)(2008-8#3)(2008-9#11)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#1)(2010-12#9)(2010-2#3)(2010-3#8)(2010-5#1)(2010-7#5)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#9)(2012-11#1)(2012-12#6)(2012-2#6)(2012-3#3)(2013-1#5)(2013-8#6)
staging]##2##1##(2008-4#1)(2013-7#1)
stagnant##11##1##(1992-1#1)(1993-10#1)(2005-11#2)(2006-7#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-5#1)(2009-6#1)
stagnation in##3##2##(2008-2#1)(2008-8#1)(2012-1#1)
stagnation point##4##2##(1994-5#1)(2008-3#3)
stagnation##13##1##(1992-1#1)(1994-5#1)(1997-7#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2010-12#1)(2012-1#1)(2012-11#1)(2013-1#1)
stagonospora##2##1##(2008-10#2)
stags##3##1##(1993-2#1)(2005-7#2)
stain and##9##2##(1992-2#1)(1995-12#1)(2007-7#2)(2009-6#1)(2009-8#1)(2010-5#1)(2012-2#1)(2012-3#1)
stain cells##3##2##(1997-2#1)(2008-11#1)(2008-9#1)
stain for the##2##3##(2006-2#1)(2007-11#1)
stain for##5##2##(1991-1#1)(1994-2#1)(1995-12#1)(2006-2#1)(2007-11#1)
stain in the diagnosis of##2##5##(2006-10#1)(2007-1#1)
stain in##4##2##(2006-10#1)(2007-1#1)(2007-8#1)(2012-12#1)
stain is##3##2##(1996-3#1)(2012-2#2)
stain method to##2##3##(2008-8#1)(2012-2#1)
stain of the##2##3##(2007-3#1)(2011-2#1)
stain of##3##2##(2007-3#1)(2011-2#2)
stain on##2##2##(1990-3#1)(1996-3#1)
stain positive##2##2##(1991-4#1)(2008-7#1)
stain removal##2##2##(2011-2#2)
stain showed##4##2##(2006-5#1)(2008-3#2)(2008-7#1)
stain solution##2##2##(2008-9#1)(2012-8#1)
stain the##4##2##(1991-12#1)(1992-8#1)(1996-4#1)(2013-7#1)
stain to##2##2##(1995-12#1)(2007-8#1)
stain was used##2##3##(1996-1#1)(2006-4#1)
stain was##10##2##(1992-2#1)(1996-1#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)
stain were##2##2##(1997-2#1)(2012-3#1)
stain with##3##2##(1991-12#1)(1992-2#1)(1997-2#1)
stain##137##1##(1990-2#1)(1990-3#3)(1991-1#2)(1991-12#2)(1991-4#1)(1991-5#1)(1992-2#3)(1992-6#1)(1992-8#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#4)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-3#2)(1996-4#1)(1997-2#3)(1997-6#1)(2004-4#2)(2006-10#5)(2006-2#6)(2006-4#2)(2006-5#3)(2007-1#1)(2007-11#2)(2007-12#4)(2007-3#2)(2007-5#1)(2007-7#8)(2007-8#5)(2008-1#2)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#6)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#7)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#7)(2012-12#2)(2012-2#4)(2012-3#3)(2012-8#1)(2013-7#2)(2013-8#1)
stain)##6##1##(1993-5#1)(1994-5#1)(1995-7#1)(2008-5#1)(2010-2#2)
stainability##2##1##(1995-12#1)(2008-5#1)
stained LEA rat hepatocytes only##2##5##(1993-12#2)
stained a##3##2##(1991-7#1)(1993-9#1)(2012-2#1)
stained according##2##2##(1990-12#1)(2010-2#1)
stained after##3##2##(2006-3#1)(2008-2#1)(2008-7#1)
stained and the##3##3##(2008-5#3)
stained and##8##2##(1990-2#1)(1990-4#1)(2008-11#1)(2008-5#3)(2008-9#1)(2011-3#1)
stained as##3##2##(1992-3#1)(1994-11#1)(2006-3#1)
stained blood##2##2##(2007-2#1)(2012-2#1)
stained by antibody to##2##4##(1992-12#1)(2007-9#1)
stained by the##5##3##(1991-9#1)(1997-2#1)(2007-12#1)(2008-10#2)
stained by these##2##3##(1991-7#1)(2008-9#1)
stained by##24##2##(1990-3#1)(1990-6#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-2#1)(2006-5#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-7#1)(2008-9#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#1)
stained cell##2##2##(1996-6#1)(2012-1#1)
stained cells##7##2##(1990-10#1)(1994-12#1)(2007-3#1)(2008-9#2)(2013-1#1)(2013-8#1)
stained for the presence of##2##5##(1992-6#1)(2007-11#1)
stained for the##5##3##(1992-6#1)(1995-9#1)(2007-11#1)(2007-8#1)(2008-6#1)
stained for##21##2##(1992-12#1)(1992-6#1)(1992-8#3)(1993-12#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-9#1)(1996-9#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)
stained gels##5##2##(2008-2#1)(2008-4#4)
stained heavily##2##2##(1996-6#1)(2008-8#1)
stained immunohistochemically##3##2##(2004-2#1)(2008-5#1)(2009-2#1)
stained in the##2##3##(1996-5#1)(2008-11#1)
stained in##7##2##(1996-5#1)(2007-12#1)(2008-11#1)(2008-12#2)(2008-5#2)
stained intensely##2##2##(1990-7#1)(1996-3#1)
stained neurons in the##2##4##(1994-5#2)
stained neurons in##3##3##(1994-5#3)
stained neurons##6##2##(1992-8#1)(1994-5#5)
stained nuclei##2##2##(1996-2#1)(2008-11#1)
stained positive for##5##3##(1995-1#1)(1997-8#1)(2008-4#2)(2012-3#1)
stained positive##7##2##(1993-11#1)(1995-1#1)(1997-8#1)(2007-8#1)(2008-4#2)(2012-3#1)
stained positively for##4##3##(1996-10#1)(1996-11#1)(2008-7#1)(2013-8#1)
stained positively##6##2##(1996-10#1)(1996-11#1)(1996-12#1)(2008-7#1)(2012-1#1)(2013-8#1)
stained sections##5##2##(1993-7#2)(2007-5#1)(2008-11#1)(2009-11#1)
stained slides##2##2##(2007-2#1)(2011-11#1)
stained smear##3##2##(2007-2#1)(2007-7#2)
stained smears##3##2##(2006-10#1)(2007-8#2)
stained the cells##2##3##(1997-2#1)(2008-5#1)
stained the##8##2##(1991-7#1)(1993-12#1)(1997-2#1)(2005-12#1)(2007-2#1)(2008-10#1)(2008-5#1)(2010-1#1)
stained to##2##2##(2007-3#1)(2008-2#1)
stained with Coomassie brilliant blue##2##5##(2008-4#1)(2009-6#1)
stained with Coomassie##3##3##(1993-8#1)(2008-4#1)(2009-6#1)
stained with DAPI##2##3##(2007-12#1)(2009-5#1)
stained with Evans blue##3##4##(2012-2#3)
stained with Giemsa's stain showed##2##5##(2008-3#2)
stained with Giemsa's stain##3##4##(2007-7#1)(2008-3#2)
stained with a##5##3##(1994-2#1)(1996-3#1)(1997-6#1)(2005-12#1)(2013-8#1)
stained with an##2##3##(1990-12#1)(1995-11#1)
stained with antibodies##2##3##(1993-9#1)(2008-11#1)
stained with any of the##2##5##(1992-7#1)(2007-12#1)
stained with both##2##3##(1992-8#1)(2008-5#1)
stained with haematoxylin and eosin##2##5##(2007-8#1)(2013-8#1)
stained with hematoxylin and eosin##3##5##(2009-2#1)(2011-2#1)(2013-1#1)
stained with monoclonal antibodies##2##4##(2008-10#1)(2008-7#1)
stained with monoclonal##3##3##(1997-8#1)(2008-10#1)(2008-7#1)
stained with one##2##3##(1990-12#1)(2008-5#1)
stained with the vital dye##2##5##(1995-8#1)(2008-9#1)
stained with the##12##3##(1991-12#1)(1991-5#1)(1994-2#1)(1995-8#1)(1996-5#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2013-8#1)
stained with toluidine blue##2##4##(1992-12#1)(2010-2#1)
stained with##92##2##(1990-12#2)(1991-1#2)(1991-11#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-7#1)(1992-8#2)(1993-12#1)(1993-4#2)(1993-8#1)(1993-9#1)(1994-2#2)(1994-5#1)(1995-11#1)(1995-12#1)(1995-8#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-5#1)(1997-6#2)(1997-8#1)(2004-1#1)(2005-12#2)(2006-5#2)(2007-12#5)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#2)(2009-2#2)(2009-5#1)(2009-6#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#4)(2013-1#2)(2013-7#2)(2013-8#4)
stained##323##1##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#4)(1991-1#2)(1991-11#2)(1991-12#3)(1991-4#1)(1991-5#2)(1991-7#6)(1991-9#2)(1992-11#1)(1992-12#3)(1992-3#3)(1992-6#2)(1992-7#2)(1992-8#6)(1993-11#1)(1993-12#8)(1993-4#2)(1993-7#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-5#8)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#4)(1996-4#2)(1996-5#3)(1996-6#4)(1996-9#1)(1997-1#1)(1997-2#5)(1997-5#1)(1997-6#6)(1997-8#2)(2004-1#1)(2004-2#1)(2005-11#1)(2005-12#3)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#2)(2006-5#4)(2007-10#1)(2007-11#1)(2007-12#10)(2007-2#5)(2007-3#2)(2007-5#1)(2007-7#6)(2007-8#8)(2007-9#2)(2008-10#11)(2008-11#9)(2008-12#3)(2008-2#7)(2008-3#4)(2008-4#11)(2008-5#13)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#9)(2009-11#1)(2009-2#3)(2009-5#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-12#2)(2010-2#6)(2010-7#1)(2011-1#3)(2011-11#1)(2011-12#1)(2011-2#9)(2011-3#1)(2012-1#6)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#3)(2013-7#3)(2013-8#6)
staining (e##2##2##(2006-6#1)(2008-4#1)
staining (n =##2##3##(2007-10#1)(2007-5#1)
staining IHC##2##2##(1997-8#1)(2013-8#1)
staining after##4##2##(2008-10#1)(2008-11#1)(2010-6#1)(2012-12#1)
staining agents##2##2##(2009-6#1)(2010-2#1)
staining and DNA##2##3##(2008-8#1)(2009-4#1)
staining and confocal##2##3##(2007-12#1)(2011-2#1)
staining and flow cytometry##2##4##(2008-10#2)
staining and the##2##3##(2008-7#1)(2013-8#1)
staining and##52##2##(1990-10#2)(1990-12#2)(1991-11#1)(1991-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-4#1)(2006-8#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-11#3)(2008-12#3)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#1)(2009-4#2)(2010-6#2)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-8#2)
staining are also##2##3##(2008-4#1)(2008-9#1)
staining are##3##2##(1993-12#1)(2008-4#1)(2008-9#1)
staining around##2##2##(1991-7#1)(2008-5#1)
staining as##3##2##(1994-5#1)(1995-7#1)(2006-12#1)
staining assay##2##2##(2008-10#1)(2008-2#1)
staining at##5##2##(1992-6#1)(1995-12#1)(1995-2#1)(2012-12#2)
staining cells##6##2##(1992-1#1)(1995-2#1)(2008-11#1)(2008-4#1)(2008-9#2)
staining confirmed the##2##3##(1992-6#1)(1995-6#1)
staining confirmed##3##2##(1992-6#1)(1995-6#1)(2008-5#1)
staining data##2##2##(1992-8#1)(2013-1#1)
staining for EMA##2##3##(1996-3#1)(2012-12#1)
staining for the##2##3##(1992-8#1)(2009-8#1)
staining for##47##2##(1990-4#1)(1990-7#1)(1991-3#1)(1992-12#3)(1992-8#1)(1993-9#1)(1995-12#3)(1995-2#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-3#2)(1997-6#1)(1997-7#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#4)(2013-8#1)
staining in both telomeres##2##4##(2008-12#2)
staining in the##12##3##(1990-7#1)(1991-7#1)(1992-7#1)(1992-8#1)(1994-10#1)(1994-12#1)(1994-5#2)(1994-6#1)(2007-3#1)(2012-3#1)(2013-1#1)
staining in##30##2##(1990-7#1)(1991-1#1)(1991-7#1)(1992-7#1)(1992-8#1)(1993-12#1)(1994-10#1)(1994-12#1)(1994-5#2)(1994-6#1)(1995-10#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(2005-11#1)(2007-3#1)(2008-10#1)(2008-12#2)(2008-4#2)(2008-8#1)(2008-9#1)(2011-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
staining increased##3##2##(1995-10#1)(1997-6#1)(2008-7#1)
staining indicated that##4##3##(1993-4#1)(2008-4#1)(2008-8#1)(2011-1#1)
staining intensity of##2##3##(1991-11#1)(1994-2#1)
staining intensity to##2##3##(1991-5#1)(2011-2#1)
staining intensity##11##2##(1990-12#1)(1991-11#1)(1991-5#2)(1992-6#1)(1994-2#1)(1994-3#1)(1996-2#1)(2009-4#1)(2011-2#2)
staining is a##2##3##(2008-2#1)(2008-9#1)
staining is##14##2##(1991-7#1)(1995-5#3)(1997-8#1)(2006-3#1)(2008-2#1)(2008-5#1)(2008-9#4)(2012-1#1)(2012-2#1)
staining method##13##2##(1991-10#1)(1996-5#1)(1997-2#1)(2007-12#1)(2007-8#2)(2008-11#1)(2008-2#1)(2008-4#3)(2012-2#2)
staining methods and##2##3##(1996-5#1)(2006-5#1)
staining methods##8##2##(1996-5#1)(1997-3#1)(2006-5#2)(2007-12#1)(2008-11#1)(2008-2#1)(2013-8#1)
staining observed##3##2##(1996-9#1)(2005-9#1)(2010-2#1)
staining of DNA and##2##4##(2008-11#1)(2008-9#1)
staining of a##2##3##(1991-7#1)(2013-8#1)
staining of cell##2##3##(2008-4#1)(2008-9#1)
staining of cells##5##3##(1990-12#1)(1997-6#1)(2008-4#2)(2008-9#1)
staining of frozen sections##2##4##(1991-9#1)(2010-8#1)
staining of frozen##3##3##(1990-7#1)(1991-9#1)(2010-8#1)
staining of the cells##2##4##(1991-10#1)(1991-2#1)
staining of the device##2##4##(2010-7#2)
staining of the##17##3##(1991-10#1)(1991-2#2)(1991-5#1)(1992-1#1)(1992-3#1)(1993-12#1)(1995-11#1)(1996-12#1)(1997-2#1)(2008-4#2)(2008-9#1)(2010-7#2)(2011-2#1)(2012-7#1)
staining of tissue sections##2##4##(2008-4#2)
staining of##100##2##(1990-11#2)(1990-12#1)(1990-7#2)(1991-10#2)(1991-11#2)(1991-2#4)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-3#2)(1992-8#1)(1993-12#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-7#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#2)(1996-3#1)(1996-9#2)(1997-2#2)(1997-6#1)(1997-8#1)(2005-9#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-11#5)(2008-12#3)(2008-2#2)(2008-4#14)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#8)(2010-2#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-11#2)(2012-12#2)(2012-2#1)(2012-7#1)(2013-8#1)
staining on the##2##3##(1991-9#1)(2011-1#1)
staining on##8##2##(1990-12#1)(1991-9#1)(1995-4#1)(2007-10#1)(2007-6#1)(2008-8#1)(2011-1#2)
staining or##10##2##(1990-8#1)(1996-3#1)(1997-4#1)(2008-11#1)(2008-2#2)(2008-4#3)(2013-8#1)
staining pattern##8##2##(1994-9#1)(1996-5#1)(1996-6#1)(2007-12#1)(2008-10#1)(2009-7#1)(2010-7#1)(2012-1#1)
staining patterns##6##2##(1991-6#1)(1991-7#2)(1993-12#1)(1994-9#1)(1996-6#1)
staining positively for##3##3##(1991-9#1)(2005-9#1)(2008-4#1)
staining procedure##3##2##(2007-8#1)(2008-11#1)(2008-9#1)
staining procedures for##3##3##(1991-10#1)(2008-9#2)
staining procedures##10##2##(1991-10#1)(2008-2#2)(2008-4#3)(2008-9#3)(2012-2#1)
staining protocol##6##2##(2008-4#1)(2008-9#3)(2012-12#2)
staining reaction##4##2##(1994-12#1)(1997-7#1)(2008-4#1)(2008-9#1)
staining reagents##2##2##(2008-4#1)(2013-8#1)
staining results##2##2##(2009-8#1)(2010-2#1)
staining revealed that##4##3##(1997-5#1)(2006-8#1)(2008-12#1)(2008-8#1)
staining revealed##7##2##(1997-5#1)(2006-12#1)(2006-8#1)(2007-7#1)(2008-12#1)(2008-8#1)(2010-5#1)
staining showed that##2##3##(2008-10#1)(2010-12#1)
staining solution##2##2##(2008-9#1)(2013-8#1)
staining technique and##2##3##(2007-8#1)(2008-5#1)
staining technique##8##2##(1991-6#1)(1993-7#1)(2004-1#1)(2005-8#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-9#1)
staining techniques##6##2##(1990-4#1)(1992-8#1)(2007-7#1)(2008-1#1)(2009-5#1)(2011-2#1)
staining tests##2##2##(1992-8#2)
staining that##3##2##(1997-2#1)(2006-2#1)(2008-9#1)
staining the##3##2##(1997-2#1)(2008-10#1)(2008-11#1)
staining to##7##2##(1991-2#1)(1993-9#1)(2006-5#1)(2008-4#3)(2008-8#1)
staining using##3##2##(1995-3#1)(1997-2#1)(2008-2#1)
staining was confined to##2##4##(1995-12#1)(1995-8#1)
staining was evaluated##2##3##(2005-11#1)(2008-11#1)
staining was not##2##3##(1992-7#1)(1996-5#1)
staining was observed at##2##4##(1990-10#1)(2007-12#1)
staining was observed in##2##4##(1991-7#1)(1991-9#1)
staining was observed##4##3##(1990-10#1)(1991-7#1)(1991-9#1)(2007-12#1)
staining was performed##3##3##(2008-5#1)(2009-2#1)(2011-2#1)
staining was positive for##2##4##(2007-7#1)(2008-1#1)
staining was present in##2##4##(1992-11#1)(1992-7#1)
staining was present##3##3##(1992-11#1)(1992-7#1)(2006-11#1)
staining was seen in the##2##5##(1992-11#1)(1997-2#1)
staining was seen in##3##4##(1992-11#1)(1995-8#1)(1997-2#1)
staining was seen##4##3##(1992-11#1)(1995-8#1)(1997-2#2)
staining was used to##4##4##(1992-8#1)(1994-5#1)(2008-5#1)(2011-2#1)
staining was##45##2##(1990-10#1)(1990-5#1)(1991-10#2)(1991-2#1)(1991-7#1)(1991-9#4)(1992-11#2)(1992-7#2)(1992-8#2)(1993-11#1)(1993-12#1)(1994-5#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-8#2)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-8#1)(2005-11#1)(2006-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#2)(2009-2#1)(2011-2#2)(2013-8#1)
staining were used to##2##4##(1992-1#1)(2007-10#1)
staining were##8##2##(1992-1#1)(1992-7#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-6#1)(2010-7#1)(2011-2#1)
staining which##2##2##(1995-3#1)(1996-12#1)
staining with 4'##2##3##(2008-10#1)(2008-11#1)
staining with a second fluorochrome (propidium iodide) after incubation of effector and target cells##2##14##(1990-12#2)
staining with a##7##3##(1990-12#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#1)
staining with ethidium bromide##2##4##(1990-7#1)(2006-8#1)
staining with fluorescein##2##3##(1996-1#1)(2008-10#1)
staining with the##2##3##(1990-4#1)(1995-8#1)
staining with##56##2##(1990-12#2)(1990-4#2)(1990-7#1)(1993-12#1)(1993-7#1)(1994-2#3)(1994-9#1)(1995-8#1)(1996-1#1)(1996-12#1)(1997-2#2)(1997-8#1)(2005-10#2)(2006-8#2)(2007-12#2)(2007-2#1)(2008-10#3)(2008-11#5)(2008-4#8)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#1)(2009-4#1)(2010-12#1)(2011-2#1)(2013-8#2)
staining##806##1##(1990-10#3)(1990-11#3)(1990-12#10)(1990-3#1)(1990-4#4)(1990-5#1)(1990-7#7)(1990-8#2)(1991-1#1)(1991-10#8)(1991-11#5)(1991-2#7)(1991-3#2)(1991-5#3)(1991-6#2)(1991-7#9)(1991-9#7)(1992-1#3)(1992-10#1)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#4)(1992-5#1)(1992-6#5)(1992-7#4)(1992-8#11)(1993-11#1)(1993-12#9)(1993-3#2)(1993-4#1)(1993-7#3)(1993-8#1)(1993-9#4)(1994-10#2)(1994-11#1)(1994-12#4)(1994-2#8)(1994-3#1)(1994-5#4)(1994-6#3)(1994-7#2)(1994-9#3)(1995-10#3)(1995-11#1)(1995-12#9)(1995-2#10)(1995-3#2)(1995-4#3)(1995-5#5)(1995-6#5)(1995-7#1)(1995-8#5)(1996-1#2)(1996-12#9)(1996-2#3)(1996-3#5)(1996-5#4)(1996-6#2)(1996-7#1)(1996-9#6)(1997-1#1)(1997-2#12)(1997-3#5)(1997-4#4)(1997-5#1)(1997-6#5)(1997-7#3)(1997-8#6)(2004-1#1)(2005-10#2)(2005-11#11)(2005-8#5)(2005-9#4)(2006-10#1)(2006-11#1)(2006-12#4)(2006-2#2)(2006-3#2)(2006-4#2)(2006-5#4)(2006-6#1)(2006-8#7)(2007-10#3)(2007-11#1)(2007-12#13)(2007-2#3)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#9)(2007-8#12)(2007-9#1)(2008-1#5)(2008-10#29)(2008-11#40)(2008-12#15)(2008-2#17)(2008-3#1)(2008-4#72)(2008-5#23)(2008-6#2)(2008-7#12)(2008-8#20)(2008-9#52)(2009-10#2)(2009-12#3)(2009-2#1)(2009-4#6)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2010-1#2)(2010-10#1)(2010-12#6)(2010-2#7)(2010-3#4)(2010-5#2)(2010-6#4)(2010-7#9)(2010-8#3)(2010-9#1)(2011-1#9)(2011-12#1)(2011-2#18)(2012-1#2)(2012-11#2)(2012-12#15)(2012-2#14)(2012-3#4)(2012-7#2)(2013-1#9)(2013-7#1)(2013-8#17)
staining)##4##1##(1990-4#1)(2008-10#1)(2008-11#1)(2012-1#1)
stainings of##2##2##(1993-12#1)(1996-3#1)
stainings##8##1##(1990-12#1)(1993-12#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-8#1)(2007-12#1)(2007-8#1)
stainless steel (SS)##3##3##(2004-9#1)(2010-4#1)(2013-8#1)
stainless steel and titanium##2##4##(2008-3#1)(2008-5#1)
stainless steel and##3##3##(2008-3#1)(2008-5#1)(2008-7#1)
stainless steel housing##2##3##(2008-7#2)
stainless steel plates##2##3##(2012-12#2)
stainless steel welding fume##2##4##(2008-10#2)
stainless steel welding##3##3##(2008-10#3)
stainless steel wire##5##3##(2007-8#2)(2008-10#1)(2009-3#1)(2012-1#1)
stainless steel##58##2##(1992-1#1)(2004-9#1)(2005-11#1)(2005-4#1)(2006-3#1)(2007-12#1)(2007-8#2)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#3)(2009-3#1)(2010-4#2)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#4)(2013-1#5)(2013-7#1)(2013-8#5)
stainless steel)##2##2##(2011-2#1)(2013-1#1)
stainless##64##1##(1992-1#1)(2004-9#2)(2005-11#1)(2005-4#1)(2006-3#1)(2007-12#2)(2007-8#2)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-3#1)(2010-4#2)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#5)(2013-1#6)(2013-7#1)(2013-8#5)
stainless-steel cone pinhole##2##3##(2008-3#2)
stainless-steel##8##1##(1992-8#1)(2007-12#1)(2008-2#1)(2008-3#3)(2008-6#2)
stains all##3##2##(2007-12#3)
stains and##6##2##(1990-7#1)(2006-2#1)(2008-5#1)(2008-9#2)(2013-1#1)
stains is##3##2##(1996-12#2)(2008-4#1)
stains of##2##2##(1996-11#1)(2006-8#1)
stains only##3##2##(1991-1#1)(2007-12#2)
stains revealed##3##2##(2008-5#1)(2008-7#1)(2012-2#1)
stains showed##2##2##(2009-1#1)(2012-2#1)
stains used##3##2##(2008-4#1)(2008-9#1)(2012-2#1)
stains was##2##2##(2008-12#1)(2013-1#1)
stains were##4##2##(1992-2#1)(2008-4#1)(2008-9#1)(2009-8#1)
stains with##2##2##(1990-7#1)(1996-12#1)
stains##79##1##(1990-7#4)(1991-1#2)(1992-2#1)(1992-3#1)(1993-6#1)(1995-7#1)(1996-11#2)(1996-12#4)(1996-7#1)(1997-3#1)(1997-5#1)(2004-1#1)(2005-11#1)(2006-2#3)(2006-8#1)(2007-12#7)(2007-6#1)(2007-8#1)(2008-11#4)(2008-12#2)(2008-4#7)(2008-5#2)(2008-7#1)(2008-9#7)(2009-1#1)(2009-8#1)(2010-5#1)(2010-8#2)(2011-2#5)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
stair climbing and##2##3##(2007-11#1)(2012-1#1)
stair climbing##5##2##(1991-9#1)(2007-11#1)(2012-1#2)(2013-1#1)
stair##9##1##(1991-9#1)(2007-11#1)(2007-2#1)(2012-1#3)(2013-1#3)
staircase effect##2##2##(2008-2#2)
staircase procedure##3##2##(1990-11#3)
staircase##12##1##(1990-11#4)(2007-10#1)(2007-12#2)(2008-2#3)(2012-2#1)(2013-1#1)
staircase&quot##2##1##(1996-5#1)(2006-4#1)
stairs##7##1##(2006-12#3)(2008-7#2)(2008-9#1)(2013-1#1)
stake in##5##2##(1990-4#1)(1993-5#1)(2008-5#1)(2009-10#1)(2012-1#1)
stake##12##1##(1990-4#1)(1992-4#1)(1993-5#1)(1995-2#1)(2005-9#1)(2007-4#1)(2008-5#1)(2009-10#1)(2009-12#1)(2010-8#1)(2012-1#1)(2013-8#1)
stakeholder alignment##3##2##(2013-1#3)
stakeholder analysis##3##2##(1995-1#3)
stakeholder communities##3##2##(2007-12#1)(2012-3#2)
stakeholder group participation##2##3##(1996-12#2)
stakeholder group##3##2##(1995-1#1)(1996-12#2)
stakeholder groups##7##2##(1995-1#1)(1996-12#2)(2004-10#1)(2012-11#1)(2012-2#1)(2012-3#1)
stakeholder input##2##2##(2008-7#1)(2009-4#1)
stakeholder involvement##2##2##(2010-8#1)(2013-7#1)
stakeholder management##3##2##(1991-3#1)(1993-3#1)(2008-1#1)
stakeholder##39##1##(1991-3#2)(1992-1#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-1#5)(1996-12#4)(2004-10#1)(2005-8#1)(2007-12#1)(2007-5#1)(2008-1#2)(2008-10#1)(2008-7#1)(2009-4#2)(2010-8#2)(2012-11#1)(2012-2#1)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#1)
stakeholders and##10##2##(1996-3#2)(1997-1#1)(2007-6#1)(2008-12#1)(2008-7#2)(2010-7#1)(2011-1#1)(2013-1#1)
stakeholders as##2##2##(2008-2#1)(2008-8#1)
stakeholders from##4##2##(1993-12#1)(2008-10#1)(2008-12#1)(2013-8#1)
stakeholders in the##5##3##(2006-1#1)(2008-1#1)(2008-10#1)(2008-12#1)(2011-2#1)
stakeholders in##18##2##(1993-1#1)(2006-1#1)(2007-4#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
stakeholders involved##3##2##(1991-12#1)(1992-1#1)(1997-2#1)
stakeholders to##4##2##(2008-11#1)(2009-4#1)(2011-2#1)(2012-12#1)
stakeholders was##3##2##(2008-11#1)(2010-3#1)(2012-3#1)
stakeholders who##2##2##(2005-8#1)(2013-8#1)
stakeholders##100##1##(1991-1#1)(1991-12#1)(1991-3#1)(1992-1#1)(1993-1#1)(1993-12#2)(1994-1#1)(1994-12#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-3#2)(1997-1#1)(1997-2#1)(2005-8#1)(2006-1#1)(2007-12#2)(2007-4#2)(2007-6#1)(2007-7#1)(2008-1#3)(2008-10#4)(2008-11#4)(2008-12#5)(2008-2#3)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#1)(2009-4#1)(2010-2#1)(2010-3#1)(2010-7#2)(2010-8#2)(2011-1#5)(2011-2#5)(2012-11#1)(2012-12#9)(2012-2#1)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#6)
stakeholders'##5##1##(1994-1#1)(1995-3#1)(2006-7#1)(2008-11#1)(2012-3#1)
stakes of##2##2##(2008-2#2)
stakes##8##1##(1993-12#1)(1995-1#1)(2007-3#1)(2008-12#1)(2008-2#4)
stalk and##3##2##(1995-5#1)(2008-8#1)(2011-2#1)
stalk cell##2##2##(1993-6#2)
stalk cells##3##2##(1993-6#2)(2008-8#1)
stalk complex##3##2##(1994-9#3)
stalk in the##3##3##(2010-5#1)(2011-2#2)
stalk is##2##2##(1995-5#1)(1997-3#1)
stalk of##7##2##(1995-6#1)(2010-12#5)(2010-2#1)
stalk pieces##3##2##(2008-10#3)
stalk was##3##2##(1997-8#1)(2011-2#2)
stalk##58##1##(1992-7#1)(1993-6#5)(1994-9#5)(1995-5#3)(1995-6#1)(1997-3#5)(1997-8#2)(2006-1#1)(2008-10#7)(2008-11#1)(2008-8#3)(2009-9#2)(2010-10#1)(2010-12#5)(2010-2#1)(2010-5#3)(2011-12#1)(2011-2#7)(2013-8#4)
stalk-cut broadleaf cigar wrapper tobacco##2##5##(2009-3#2)
stalk-sectioned rats##2##2##(1995-12#2)
stalker##2##1##(2009-9#2)
stalking##2##1##(2009-9#2)
stalks and##2##2##(2008-6#1)(2009-3#1)
stalks##17##1##(2004-2#1)(2007-12#1)(2008-10#6)(2008-5#4)(2008-6#1)(2009-3#1)(2011-12#3)
stall##6##1##(1991-9#1)(1994-9#1)(1997-3#1)(1997-4#1)(2007-11#1)(2011-2#1)
stalled at##2##2##(1994-8#1)(2009-9#1)
stalled by nucleotide omission##3##4##(1994-9#3)
stalled by##5##2##(1994-9#3)(1996-8#1)(2008-9#1)
stalled in##4##2##(1995-2#1)(1997-1#1)(2008-4#1)(2012-12#1)
stalled replication forks##3##3##(2008-8#2)(2011-2#1)
stalled##23##1##(1991-9#1)(1993-3#1)(1994-8#1)(1994-9#4)(1995-2#1)(1996-8#3)(1997-1#1)(1997-5#1)(2006-11#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-9#1)(2011-2#1)(2012-12#2)(2012-3#1)
stallii##5##1##(2004-2#5)
stalling##2##1##(2011-2#2)
stallion semen##4##2##(2006-5#4)
stallion##13##1##(2006-5#12)(2012-2#1)
stallions and##2##2##(2006-5#1)(2007-2#1)
stallions was##3##2##(2006-5#1)(2012-3#2)
stallions##13##1##(2006-5#10)(2007-2#1)(2012-3#2)
stalls##3##1##(1991-1#1)(1991-7#1)(1996-11#1)
stamen##5##1##(2008-8#1)(2009-8#4)
stamens and##2##2##(2008-8#2)
stamens##7##1##(2007-3#4)(2008-8#2)(2009-8#1)
stamina##3##1##(1996-4#1)(2007-6#1)(2007-8#1)
staminate ear tip##3##3##(2012-3#3)
staminate ear tips##2##3##(2012-3#2)
staminate ear##5##2##(2012-3#5)
staminate##10##1##(2008-5#1)(2012-3#9)
stammering##3##1##(2008-2#2)(2008-4#1)
stamp##11##1##(2007-6#1)(2007-9#1)(2008-10#1)(2008-3#1)(2009-2#5)(2010-4#1)(2010-8#1)
stamped##4##1##(2007-11#1)(2008-8#1)(2013-1#2)
stamping element is##2##3##(2008-3#2)
stamping of multilayer##2##3##(2008-3#2)
stamping process##3##2##(2006-5#3)
stamping##8##1##(1993-9#1)(2006-5#3)(2008-3#4)
stamping-out##2##1##(2007-6#2)
stamps##3##1##(2009-2#1)(2010-4#2)
stance during rapid leg flexion##2##5##(1993-9#2)
stance during##3##2##(1993-9#2)(2012-1#1)
stance of##2##2##(2006-3#1)(2007-8#1)
stance on##4##2##(2006-6#1)(2008-11#1)(2008-12#2)
stance phase##4##2##(2007-10#1)(2012-1#1)(2013-1#2)
stance was##2##2##(1994-9#1)(2007-10#1)
stance##38##1##(1991-12#1)(1992-1#1)(1993-3#2)(1993-9#3)(1994-1#3)(1994-9#1)(1996-3#1)(2005-7#1)(2006-3#2)(2006-6#1)(2007-10#4)(2007-12#1)(2007-8#2)(2008-11#2)(2008-12#3)(2008-7#1)(2009-10#1)(2010-12#1)(2010-9#1)(2012-1#3)(2012-11#1)(2013-1#2)
stances##2##1##(2005-7#1)(2008-7#1)
stanchions and handrails in buses##2##5##(2008-6#2)
stanchions and handrails##3##3##(2008-6#3)
stanchions##4##1##(2008-6#4)
stand against the##2##3##(2008-7#1)(2012-3#1)
stand against##4##2##(1990-6#1)(1991-2#1)(2008-7#1)(2012-3#1)
stand age##6##2##(2008-10#1)(2013-8#5)
stand alone##4##2##(2007-10#2)(2007-9#1)(2008-10#1)
stand and##4##2##(2008-10#2)(2008-5#1)(2009-11#1)
stand as##3##2##(2009-10#1)(2009-7#1)(2013-8#1)
stand density##6##2##(2013-8#6)
stand establishment##2##2##(2008-10#1)(2008-12#1)
stand for the##3##3##(1995-6#1)(2007-8#1)(2012-2#1)
stand for##10##2##(1995-6#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-6#1)(2009-7#1)(2012-2#1)
stand in the way##2##4##(2009-1#1)(2011-2#1)
stand in the##4##3##(1990-2#1)(2007-8#1)(2009-1#1)(2011-2#1)
stand in##8##2##(1990-2#1)(1993-12#1)(1993-7#1)(2006-8#1)(2007-8#1)(2008-11#1)(2009-1#1)(2011-2#1)
stand on##3##2##(1994-12#1)(2006-10#1)(2009-2#1)
stand or##2##2##(2008-10#1)(2011-12#1)
stand out##7##2##(1990-5#1)(1993-2#1)(1995-3#1)(2007-2#1)(2008-10#1)(2010-8#1)(2012-1#1)
stand point##2##2##(2008-6#1)(2010-10#1)
stand to##2##2##(2007-9#1)(2010-4#1)
stand up##6##2##(1995-9#1)(2006-10#1)(2007-8#1)(2008-5#1)(2010-5#1)(2012-12#1)
stand##108##1##(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-12#1)(1995-3#1)(1995-6#2)(1995-9#2)(1996-3#2)(1996-6#1)(1997-8#1)(2006-10#3)(2006-12#1)(2006-7#1)(2006-8#3)(2007-10#2)(2007-12#1)(2007-2#2)(2007-4#1)(2007-6#2)(2007-8#3)(2007-9#2)(2008-10#21)(2008-11#1)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#2)(2010-10#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#17)
stand-alone near-field optical microscope combined with force detection##2##8##(2008-2#2)
stand-alone##25##1##(1993-2#1)(2007-12#4)(2007-8#1)(2008-11#1)(2008-2#5)(2008-3#1)(2008-4#4)(2008-9#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
stand-by therapy##3##2##(1993-8#3)
stand-by treatment##2##2##(2006-4#1)(2007-2#1)
stand-by##5##1##(1993-8#3)(2006-4#1)(2007-2#1)
stand-off detection and##2##3##(2008-3#2)
stand-off##3##1##(2008-2#1)(2008-3#2)
stand?##7##1##(1996-3#1)(2005-8#1)(2006-10#1)(2007-3#1)(2008-10#1)(2008-7#1)(2012-12#1)
standalone##6##1##(1992-4#1)(2010-12#1)(2010-8#1)(2011-1#1)(2013-1#2)
standard &quot##4##2##(1991-7#1)(2007-3#1)(2008-8#1)(2011-2#1)
standard (i##2##2##(1990-6#1)(1993-12#1)
standard 10##2##2##(1991-12#1)(2004-9#1)
standard 12-lead ECG##2##3##(2007-5#1)(2009-4#1)
standard 12-lead electrocardiogram##2##3##(2006-8#1)(2007-5#1)
standard 12-lead##4##2##(2006-8#1)(2007-5#2)(2009-4#1)
standard 2##3##2##(1992-9#1)(1994-6#1)(2009-3#1)
standard CMOS##2##2##(2008-2#1)(2011-1#1)
standard CT##2##2##(1995-11#1)(2007-11#1)
standard DNA markers for##2##4##(2007-6#1)(2011-12#1)
standard DNA##6##2##(2007-6#1)(2008-10#2)(2008-2#1)(2011-12#1)(2012-2#1)
standard ELISA##4##2##(1992-8#1)(2007-2#1)(2009-3#1)(2010-7#1)
standard EN##2##2##(2005-5#1)(2006-6#1)
standard EVAR##2##2##(2012-2#2)
standard GDx VCC##2##3##(2010-8#2)
standard HPLC method##2##3##(2008-10#1)(2008-3#1)
standard LPA using PBMC##2##4##(2011-2#2)
standard LPA using##3##3##(2011-2#3)
standard LPA##4##2##(2011-2#4)
standard Michelson interferometer##2##3##(2007-12#1)(2008-2#1)
standard Michelson##3##2##(2007-12#2)(2008-2#1)
standard OCT##3##2##(2007-12#2)(2008-3#1)
standard PCR##5##2##(1993-12#1)(1996-4#1)(2008-10#1)(2013-8#2)
standard Papanicolaou smear##2##3##(1992-1#2)
standard Q-TWiST method##2##3##(1993-5#2)
standard SVM##5##2##(2008-2#5)
standard SeaWiFS##2##2##(2008-3#2)
standard VAS##4##2##(2009-3#4)
standard acid##2##2##(2008-10#2)
standard addition and H-point##2##4##(2007-8#1)(2008-10#1)
standard addition and##6##3##(2007-8#1)(2008-10#5)
standard addition approach##2##3##(2008-10#2)
standard addition calibration##6##3##(2008-10#6)
standard addition in##3##3##(2007-8#1)(2008-10#2)
standard addition method and##5##4##(2008-10#4)(2010-2#1)
standard addition method for##2##4##(2008-10#2)
standard addition method or##2##4##(2008-10#2)
standard addition method to##2##4##(2008-10#2)
standard addition method was##3##4##(2008-10#3)
standard addition method were##2##4##(2008-10#2)
standard addition method##60##3##(1992-1#1)(2007-8#3)(2008-10#55)(2010-2#1)
standard addition methodology##5##3##(2008-10#5)
standard addition of##2##3##(2006-12#1)(2008-10#1)
standard addition technique was##2##4##(2008-10#2)
standard addition technique##14##3##(1991-12#1)(1996-7#1)(2007-8#1)(2008-10#10)(2010-4#1)
standard addition##124##2##(1990-8#1)(1991-12#1)(1992-1#1)(1996-7#1)(2006-12#2)(2007-10#2)(2007-8#7)(2008-10#105)(2010-2#1)(2010-4#1)(2012-11#1)(2013-8#1)
standard additions and##2##3##(2007-8#1)(2008-10#1)
standard additions method was##2##4##(2008-10#2)
standard additions method##17##3##(2008-10#17)
standard additions methods##3##3##(2008-10#3)
standard additions##35##2##(2007-8#2)(2008-10#33)
standard against which##3##3##(2009-6#1)(2013-1#2)
standard agar##2##2##(2006-8#1)(2008-11#1)
standard alloy##2##2##(2008-10#2)
standard alloys and environmental samples##5##5##(2008-10#5)
standard alloys and##8##3##(2008-10#8)
standard alloys##12##2##(2008-10#12)
standard amino##5##2##(2006-10#1)(2006-7#2)(2007-8#1)(2008-4#1)
standard anatomical##3##2##(2006-3#2)(2008-7#1)
standard and a##3##3##(1990-12#1)(1995-5#1)(2008-5#1)
standard and deviant##2##3##(1995-5#1)(2013-8#1)
standard and novel##2##3##(2005-7#1)(2010-10#1)
standard and the##5##3##(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#1)(2013-8#1)
standard and##66##2##(1990-12#1)(1990-6#1)(1991-5#1)(1992-2#1)(1992-4#1)(1992-7#1)(1993-12#1)(1994-3#1)(1995-5#2)(1995-6#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-8#1)(2005-7#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#15)(2008-11#3)(2008-2#2)(2008-5#1)(2008-7#3)(2009-2#2)(2009-5#1)(2010-10#1)(2011-1#3)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#3)
standard anesthetic##2##2##(2006-12#1)(2007-2#1)
standard antibiotic##2##2##(2008-1#1)(2011-2#1)
standard application##2##2##(1990-12#1)(2008-11#1)
standard approach in##5##3##(2005-10#1)(2007-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
standard approach to the##2##4##(2007-8#1)(2012-3#1)
standard approach to##4##3##(1994-1#1)(2007-8#1)(2008-11#1)(2012-3#1)
standard approach##17##2##(1990-6#1)(1994-1#1)(1997-8#1)(2005-10#1)(2006-6#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-8#2)(2009-4#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
standard approaches##6##2##(1993-4#1)(2009-12#1)(2009-3#1)(2010-3#1)(2010-6#1)(2013-1#1)
standard aqueous##2##2##(1996-2#1)(2008-10#1)
standard are##5##2##(1996-8#1)(2006-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
standard as##2##2##(1990-11#1)(2008-10#1)
standard assay##5##2##(1990-3#1)(1991-2#1)(1992-11#1)(1992-4#1)(2008-12#1)
standard assays for##2##3##(1995-1#1)(2008-11#1)
standard assays##3##2##(1995-1#1)(1996-5#1)(2008-11#1)
standard assessments##2##2##(2007-10#1)(2009-1#1)
standard at##5##2##(2006-10#2)(2007-12#1)(2008-10#2)
standard atmospheric##2##2##(2008-2#1)(2008-3#1)
standard automated perimetry##3##3##(2007-6#3)
standard automated##4##2##(2007-6#3)(2008-4#1)
standard bacteriological##5##2##(2008-12#3)(2012-2#1)(2012-3#1)
standard base solution##2##3##(2008-10#2)
standard base##5##2##(2008-10#2)(2010-2#3)
standard beam description##2##3##(2008-2#2)
standard belt##2##2##(2006-11#1)(2007-4#1)
standard benefits##2##2##(1994-12#1)(1997-3#1)
standard biochemical tests##3##3##(2007-7#2)(2013-8#1)
standard biochemical##6##2##(1990-7#1)(2007-7#2)(2008-4#1)(2011-2#1)(2013-8#1)
standard by##2##2##(2008-3#1)(2011-1#1)
standard calibrated##2##2##(2008-10#1)(2008-3#1)
standard calibration technique##2##3##(2008-10#2)
standard calibration##4##2##(2008-10#4)
standard care##7##2##(2008-3#1)(2008-4#1)(2010-4#3)(2012-2#2)
standard cell culture##2##3##(1993-12#1)(2008-11#1)
standard cell##4##2##(1993-12#1)(2008-11#1)(2011-1#1)(2011-2#1)
standard cell-based##2##2##(2008-3#2)
standard challenge##2##2##(2008-5#2)
standard chemical##3##2##(1994-12#1)(2008-10#1)(2008-3#1)
standard chemotherapeutic##2##2##(2007-10#1)(2008-11#1)
standard chemotherapy##8##2##(2005-1#1)(2005-11#1)(2005-6#1)(2008-6#3)(2010-12#1)(2013-1#1)
standard chest##3##2##(1991-12#1)(2007-7#2)
standard chi-square##2##2##(1994-6#1)(2012-3#1)
standard cleavage##2##2##(1996-11#1)(2011-2#1)
standard clinical##8##2##(1994-3#1)(2007-10#1)(2007-9#2)(2008-10#1)(2009-10#1)(2011-1#1)(2013-8#1)
standard coals##2##2##(2008-10#2)
standard colorimetric##2##2##(2008-10#2)
standard combination##2##2##(2007-11#1)(2008-7#1)
standard commercial##4##2##(2007-11#1)(2008-10#2)(2008-2#1)
standard comparison##2##2##(1996-7#1)(2010-5#1)
standard compound##4##2##(2007-8#1)(2008-10#2)(2008-3#1)
standard compounds##5##2##(2008-10#3)(2008-5#1)(2013-8#1)
standard computer##2##2##(2006-10#1)(2008-3#1)
standard conditions##13##2##(1993-12#1)(1995-1#1)(1995-8#1)(1996-7#1)(1997-2#1)(2006-12#2)(2007-10#1)(2007-12#1)(2007-6#1)(2008-11#1)(2008-7#1)(2012-12#1)
standard control##2##2##(1991-1#1)(1992-2#1)
standard correction##2##2##(1996-6#1)(2005-4#1)
standard course of##2##3##(1993-2#1)(2013-7#1)
standard criteria for##2##3##(2006-9#1)(2008-5#1)
standard criteria##5##2##(2006-9#1)(2007-2#1)(2008-5#1)(2010-11#1)(2011-1#1)
standard culture medium##2##3##(1994-9#1)(2004-9#1)
standard culture techniques##2##3##(1993-2#1)(2013-8#1)
standard culture##7##2##(1993-2#1)(1994-9#1)(2004-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
standard curve method##3##3##(2008-2#1)(2011-2#2)
standard curve was linear##2##4##(1997-8#1)(2008-10#1)
standard curve was obtained##2##4##(1992-2#1)(2012-12#1)
standard curve was##6##3##(1992-2#1)(1997-8#1)(2008-10#3)(2012-12#1)
standard curve##25##2##(1990-4#1)(1992-2#1)(1994-2#1)(1995-1#1)(1996-12#1)(1997-8#1)(2005-12#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#3)(2008-6#1)(2010-11#1)(2010-8#1)(2011-2#3)(2012-12#1)
standard curves and##2##3##(2008-4#1)(2008-5#1)
standard curves were linear##3##4##(1990-12#2)(1996-8#1)
standard curves were##4##3##(1990-12#2)(1996-8#1)(2008-10#1)
standard curves##14##2##(1990-12#2)(1993-11#1)(1995-12#1)(1996-6#1)(1996-8#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2012-3#1)
standard cytotoxic agents##2##3##(2008-5#1)(2008-8#1)
standard data##6##2##(2008-2#1)(2008-8#1)(2013-1#4)
standard definition of##2##3##(2008-7#1)(2009-5#1)
standard derivative##2##2##(2008-10#2)
standard derivatives##2##2##(2008-10#2)
standard deviation &lt##3##3##(2008-10#2)(2008-3#1)
standard deviation (R##87##3##(2007-8#4)(2008-10#82)(2008-3#1)
standard deviation (S##5##3##(2008-10#5)
standard deviation (SD)##4##3##(2008-5#1)(2009-11#1)(2009-5#1)(2012-5#1)
standard deviation (n=10)##6##3##(2008-10#6)
standard deviation (n=6) was##2##4##(2008-10#2)
standard deviation (n=6)##3##3##(2008-10#3)
standard deviation =##2##3##(2008-10#2)
standard deviation about##2##3##(2008-10#1)(2008-2#1)
standard deviation and the##2##4##(2008-10#1)(2013-1#1)
standard deviation and##7##3##(2007-12#1)(2008-10#4)(2008-5#1)(2013-1#1)
standard deviation being##3##3##(2007-8#1)(2008-10#2)
standard deviation between##5##3##(2008-10#3)(2008-2#1)(2013-8#1)
standard deviation for the##10##4##(1993-1#1)(2008-10#9)
standard deviation for##45##3##(1993-1#1)(1997-8#1)(2008-10#42)(2010-9#1)
standard deviation from##3##3##(1995-8#1)(2008-10#1)(2012-2#1)
standard deviation in the##7##4##(2007-8#1)(2008-10#2)(2008-3#4)
standard deviation in##12##3##(1992-3#1)(2007-8#1)(2008-10#5)(2008-3#4)(2010-5#1)
standard deviation is 0##2##4##(2008-10#2)
standard deviation is##27##3##(1993-5#1)(2005-4#4)(2008-10#21)(2008-2#1)
standard deviation less than##2##4##(2008-10#2)
standard deviation of +/-##2##4##(2007-5#1)(2008-10#1)
standard deviation of +/-0##4##4##(2008-10#4)
standard deviation of 0##12##4##(2006-5#1)(2008-10#9)(2008-3#1)(2009-2#1)
standard deviation of 10##2##4##(2008-10#2)
standard deviation of 2##18##4##(2007-10#1)(2007-5#1)(2008-10#16)
standard deviation of 5##5##4##(1997-8#1)(2008-10#3)(2011-1#1)
standard deviation of less than##9##5##(2008-10#8)(2008-2#1)
standard deviation of the blank signal##2##6##(2008-10#2)
standard deviation of the blank##10##5##(2007-8#1)(2008-10#9)
standard deviation of the mean##2##5##(2008-3#2)
standard deviation of the method was##2##6##(2008-10#2)
standard deviation of the method##4##5##(2008-10#4)
standard deviation of the proposed method calculated from##2##8##(2008-10#2)
standard deviation of the proposed method##3##6##(2008-10#3)
standard deviation of the proposed##5##5##(2008-10#5)
standard deviation of the##51##4##(1994-11#1)(2007-11#1)(2007-8#1)(2008-10#33)(2008-2#4)(2008-3#9)(2012-12#2)
standard deviation of three independent##2##5##(2008-10#2)
standard deviation of three##4##4##(2008-10#4)
standard deviation of##182##3##(1994-11#1)(1994-9#1)(1996-8#1)(1997-8#1)(2005-4#2)(2006-5#1)(2007-10#1)(2007-11#1)(2007-5#2)(2007-8#2)(2008-10#146)(2008-2#6)(2008-3#11)(2009-2#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
standard deviation score (SDS)##2##4##(2011-1#2)
standard deviation was 0##4##4##(2008-10#3)(2012-12#1)
standard deviation was 2%##2##4##(1992-2#1)(2008-10#1)
standard deviation was 3##5##4##(2008-10#5)
standard deviation was 5##3##4##(2008-10#3)
standard deviation was##48##3##(1990-8#1)(1992-2#1)(2005-4#1)(2007-8#1)(2008-10#43)(2012-12#1)
standard deviation were##7##3##(2007-5#2)(2008-1#1)(2008-10#3)(2008-5#1)
standard deviation with##2##3##(2008-3#1)(2008-5#1)
standard deviation##607##2##(1990-8#1)(1990-9#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-5#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-8#1)(1997-8#2)(2004-12#1)(2005-3#1)(2005-4#10)(2005-5#1)(2006-11#2)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-5#4)(2007-8#14)(2008-1#2)(2008-10#469)(2008-11#1)(2008-2#13)(2008-3#20)(2008-5#4)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-12#3)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#4)(2011-2#3)(2011-3#1)(2012-12#4)(2012-2#4)(2012-5#1)(2013-1#6)(2013-8#5)
standard deviation) is##2##3##(2007-10#1)(2013-1#1)
standard deviation)##20##2##(1996-8#1)(2007-10#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
standard deviations (R##22##3##(1996-8#2)(2007-8#1)(2008-10#19)
standard deviations (SD)##2##3##(1991-5#1)(2011-1#1)
standard deviations and##2##3##(2008-10#1)(2013-8#1)
standard deviations between##4##3##(2008-10#1)(2008-5#1)(2009-8#1)(2012-12#1)
standard deviations for acetochlor and oxyfluorfen##2##6##(2005-12#2)
standard deviations for the##4##4##(1996-5#1)(2007-9#1)(2008-10#2)
standard deviations for##30##3##(1996-5#1)(1996-6#1)(2005-12#2)(2007-8#2)(2007-9#1)(2008-10#20)(2008-5#1)(2013-1#2)
standard deviations from##3##3##(2008-8#2)(2012-12#1)
standard deviations of the results##3##5##(2008-10#2)(2008-5#1)
standard deviations of the##16##4##(2005-4#1)(2007-8#1)(2008-10#11)(2008-12#1)(2008-4#1)(2008-5#1)
standard deviations of##47##3##(1992-1#2)(1993-6#2)(1993-9#1)(2005-4#3)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#32)(2008-12#1)(2008-4#1)(2008-5#1)(2013-1#1)
standard deviations were 0##2##4##(2008-10#2)
standard deviations were less than 3##3##6##(2005-4#1)(2008-10#1)(2013-7#1)
standard deviations were less than##4##5##(2005-4#1)(2008-10#2)(2013-7#1)
standard deviations were lower than##3##5##(2008-10#3)
standard deviations were##33##3##(1992-2#1)(2005-4#1)(2007-8#1)(2008-10#22)(2011-1#2)(2011-2#3)(2012-12#1)(2013-1#1)(2013-7#1)
standard deviations##211##2##(1990-12#1)(1991-5#1)(1992-1#2)(1992-2#1)(1993-6#2)(1993-9#1)(1994-9#1)(1996-5#2)(1996-6#1)(1996-8#2)(1997-2#1)(2004-1#1)(2005-12#4)(2005-4#6)(2007-10#1)(2007-12#1)(2007-8#6)(2007-9#2)(2008-10#126)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-8#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-5#1)(2011-1#10)(2011-2#3)(2012-1#1)(2012-12#11)(2013-1#5)(2013-7#1)(2013-8#3)
standard diagnostic##5##2##(2005-9#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)
standard diet##5##2##(1991-2#1)(1994-11#1)(1995-8#1)(2008-7#1)(2010-12#1)
standard dietary##2##2##(1992-3#1)(2010-10#1)
standard dosage##3##2##(1994-2#1)(2011-2#1)(2012-1#1)
standard dose and##2##3##(2006-12#1)(2007-12#1)
standard dose##10##2##(1990-6#1)(1994-6#1)(1995-12#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-6#1)(2008-7#1)(2009-10#1)
standard doses of##3##3##(2008-8#1)(2009-5#1)(2010-3#1)
standard doses##5##2##(1997-3#1)(2008-3#1)(2008-8#1)(2009-5#1)(2010-3#1)
standard drink##4##2##(2009-7#4)
standard drinks##3##2##(2009-7#3)
standard drug##9##2##(2004-2#1)(2006-10#2)(2006-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-2#1)
standard dural##2##2##(2012-3#1)(2013-8#1)
standard electrocardiograms##2##2##(1997-8#1)(2008-7#1)
standard electrode##2##2##(2008-10#1)(2008-9#1)
standard electrophysiology##2##2##(2008-11#2)
standard enthalpy and entropy of micellization##2##6##(2005-11#2)
standard enthalpy##4##2##(1993-3#2)(2005-11#2)
standard error (R##4##3##(2008-10#4)
standard error for##3##3##(2008-10#2)(2008-3#1)
standard error of estimate##2##4##(2007-11#1)(2008-10#1)
standard error of prediction##4##4##(2006-12#1)(2008-10#2)(2013-8#1)
standard error of the mean##3##5##(2011-2#1)(2012-12#2)
standard error of##21##3##(1997-8#1)(2006-12#2)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
standard error was##2##3##(2008-10#2)
standard error##36##2##(1997-3#1)(1997-8#1)(2006-12#2)(2007-10#1)(2007-11#2)(2007-2#1)(2007-8#1)(2008-10#17)(2008-2#1)(2008-3#2)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
standard errors are##2##3##(1993-9#1)(2008-3#1)
standard errors for##2##3##(1993-9#1)(1995-4#1)
standard errors of MLE##2##4##(2008-7#2)
standard errors of prediction##2##4##(2008-10#2)
standard errors of the##2##4##(2008-10#2)
standard errors of##7##3##(2008-10#5)(2008-7#2)
standard errors##20##2##(1993-9#3)(1995-4#1)(1995-9#1)(1996-1#1)(1996-7#1)(1997-4#1)(2008-10#6)(2008-3#1)(2008-7#2)(2008-8#1)(2010-2#1)(2012-3#1)
standard ethanol##2##2##(1997-7#1)(2008-9#1)
standard ethanolic deodorant##2##3##(2008-5#2)
standard fiber by##3##3##(2007-12#3)
standard fiber##10##2##(2007-12#9)(2008-3#1)
standard fibers with##2##3##(2007-12#2)
standard fibers##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
standard first-line chemotherapy##3##3##(2005-8#1)(2010-12#2)
standard first-line##7##2##(2005-8#1)(2006-11#1)(2006-2#1)(2010-10#1)(2010-12#2)(2013-1#1)
standard fixation##2##2##(1993-12#1)(2012-2#1)
standard for HMW/u-PA##3##3##(1990-11#3)
standard for electronic##2##3##(2004-9#1)(2008-11#1)
standard for evaluating##4##3##(2007-2#1)(2008-5#1)(2013-1#2)
standard for the diagnosis of##6##5##(2005-8#1)(2006-2#1)(2008-11#1)(2010-4#1)(2011-2#1)(2013-8#1)
standard for the diagnosis##8##4##(2005-8#1)(2006-2#1)(2008-11#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
standard for the##23##3##(1990-10#1)(1991-8#1)(2004-1#1)(2005-8#1)(2006-2#2)(2007-4#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-12#2)(2013-8#1)
standard for therapy##2##3##(2005-9#1)(2007-8#1)
standard for treating##2##3##(2007-10#1)(2008-3#1)
standard for##118##2##(1990-10#1)(1990-11#5)(1990-6#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-8#2)(1991-9#1)(1993-5#1)(1994-3#2)(1995-2#2)(1995-6#1)(1996-12#4)(1996-2#1)(1996-9#1)(1997-2#1)(1997-8#2)(2004-1#1)(2004-9#1)(2005-10#2)(2005-5#1)(2005-8#1)(2005-9#1)(2006-10#5)(2006-2#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-5#2)(2007-7#2)(2007-8#4)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#3)(2009-5#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#2)(2011-12#2)(2011-2#4)(2012-1#2)(2012-12#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
standard form of##2##3##(2005-11#1)(2007-7#1)
standard form##4##2##(2005-11#1)(2007-2#1)(2007-7#1)(2008-5#1)
standard format for##4##3##(2006-10#1)(2008-7#1)(2013-1#2)
standard format##6##2##(2006-10#1)(2006-6#1)(2008-7#2)(2013-1#2)
standard formula##3##2##(2008-4#1)(2012-1#2)
standard formulation and##2##3##(2005-1#1)(2006-1#1)
standard formulation##3##2##(1993-10#1)(2005-1#1)(2006-1#1)
standard free energy of adsorption##3##5##(2005-11#3)
standard free energy of##5##4##(1992-9#1)(2005-11#4)
standard free energy##7##3##(1992-9#1)(2005-11#5)(2008-10#1)
standard free##9##2##(1992-9#1)(2005-11#5)(2008-10#2)(2011-1#1)
standard from##4##2##(1996-8#2)(2008-10#2)
standard genetic##2##2##(1993-11#1)(1996-5#1)
standard growth##4##2##(1992-12#1)(2006-12#1)(2009-8#1)(2012-3#1)
standard guidelines for##2##3##(2007-8#1)(2010-8#1)
standard has##3##2##(1994-3#1)(2004-9#1)(2006-9#1)
standard have been##2##3##(1996-6#1)(2008-5#1)
standard health##2##2##(1997-3#1)(2008-1#1)
standard heparin##7##2##(1990-12#2)(1994-4#1)(1996-2#1)(1996-5#1)(2007-7#1)(2007-8#1)
standard histologic##2##2##(2006-2#1)(2008-7#1)
standard histological procedures##2##3##(1997-8#1)(2013-8#1)
standard histological##3##2##(1997-8#1)(2007-12#1)(2013-8#1)
standard image##3##2##(2008-2#2)(2008-3#1)
standard imaging##2##2##(2008-10#1)(2008-3#1)
standard immunohistochemical##2##2##(1996-4#1)(2010-2#1)
standard immunosuppressive##2##2##(2007-11#1)(2012-3#1)
standard in the##6##3##(1997-3#1)(2006-8#1)(2007-8#1)(2011-2#1)(2012-12#2)
standard in treatment##2##3##(1995-5#1)(2006-12#1)
standard in vitro##3##3##(2008-4#1)(2008-5#1)(2009-12#1)
standard in##29##2##(1995-5#1)(1997-3#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-8#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-4#1)(2008-5#1)(2009-10#1)(2009-12#1)(2011-2#3)(2011-3#1)(2012-11#1)(2012-12#3)(2013-1#3)
standard infection control##2##3##(2007-7#1)(2008-1#1)
standard information##3##2##(2005-5#1)(2013-1#2)
standard input function for##3##4##(2008-2#3)
standard input function##8##3##(2008-2#8)
standard instrument##2##2##(2007-1#1)(2007-12#1)
standard instruments##2##2##(2006-6#1)(2008-10#1)
standard interferon##4##2##(2006-10#1)(2009-8#1)(2010-11#1)(2011-12#1)
standard interview##3##2##(2008-12#2)(2011-2#1)
standard intravenous##2##2##(1996-8#1)(2012-12#1)
standard investigation##3##2##(1993-8#1)(2008-10#1)(2009-5#1)
standard iodine solution##2##3##(2008-10#2)
standard is the##3##3##(1990-6#1)(2006-2#1)(2013-8#1)
standard is##15##2##(1990-6#2)(1996-5#1)(1997-8#1)(2006-2#1)(2006-6#2)(2008-10#2)(2009-2#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#2)
standard kidney##2##2##(2007-8#2)
standard laboratory##13##2##(1992-11#1)(1993-6#1)(1996-12#1)(2007-3#1)(2007-5#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2009-5#1)
standard lamp##3##2##(2008-2#1)(2008-3#2)
standard lamps##2##2##(2008-2#2)
standard language##3##2##(2007-4#1)(2010-9#1)(2012-1#1)
standard laparoscopic##4##2##(2006-9#1)(2008-10#2)(2013-7#1)
standard least squares##2##3##(2010-2#2)
standard least-squares##3##2##(2008-3#3)
standard length (L(S))##4##3##(2010-8#4)
standard length of##2##3##(2010-8#2)
standard length##10##2##(2008-5#1)(2010-8#7)(2013-7#2)
standard light##2##2##(2008-5#2)
standard linear correlation##2##3##(2008-3#2)
standard linear##4##2##(2008-2#1)(2008-3#2)(2011-1#1)
standard linkage analysis##2##3##(1996-5#1)(2012-3#1)
standard liquid##3##2##(1994-5#1)(2008-4#1)(2008-9#1)
standard local##2##2##(2006-8#1)(2009-3#1)
standard logistic regression##4##3##(1993-6#1)(1994-5#2)(1996-2#1)
standard management##4##2##(2006-12#1)(2012-12#1)(2013-1#2)
standard market formula##2##3##(2008-5#2)
standard market##3##2##(2008-5#3)
standard material##3##2##(2008-10#3)
standard materials##3##2##(2008-10#3)
standard maternity care##3##3##(2010-9#1)(2013-1#2)
standard maximum likelihood##3##3##(1994-5#1)(1994-8#1)(2008-10#1)
standard means##3##2##(1992-10#1)(1995-12#1)(2008-1#1)
standard measurements##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
standard measures##2##2##(2008-7#1)(2009-4#1)
standard medical therapy##3##3##(2008-2#1)(2009-10#1)(2013-1#1)
standard medical treatment##2##3##(2007-1#1)(2008-4#1)
standard medical##11##2##(2006-10#1)(2006-8#1)(2007-1#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-10#1)(2011-1#2)(2012-2#1)(2013-1#1)
standard metal##4##2##(2007-5#1)(2008-10#2)(2008-7#1)
standard method and##3##3##(2008-10#2)(2011-2#1)
standard method for the##4##4##(1995-2#1)(2006-10#1)(2007-8#1)(2008-4#1)
standard method for##10##3##(1995-2#1)(1997-4#1)(2006-10#1)(2007-8#1)(2008-3#2)(2008-4#2)(2010-12#1)(2010-3#1)
standard method in##4##3##(1996-3#1)(2006-10#1)(2008-10#1)(2010-12#1)
standard method of treatment##2##4##(2007-8#1)(2013-1#1)
standard method of##6##3##(1991-11#1)(2007-8#1)(2008-3#1)(2009-6#1)(2011-2#1)(2013-1#1)
standard method to##3##3##(2011-2#1)(2013-1#2)
standard method used##2##3##(2008-10#1)(2012-2#1)
standard method##58##2##(1991-11#1)(1992-12#1)(1993-3#1)(1995-2#1)(1996-3#1)(1997-4#1)(2005-12#1)(2005-3#1)(2006-10#2)(2007-8#4)(2008-10#19)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2009-6#1)(2010-12#2)(2010-3#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#2)
standard methodology for##3##3##(1992-12#1)(1996-6#1)(2008-10#1)
standard methodology##8##2##(1992-12#1)(1994-9#1)(1996-6#1)(2008-10#1)(2008-11#1)(2009-6#1)(2012-12#1)(2012-3#1)
standard methods and##3##3##(1994-3#1)(2007-10#1)(2008-10#1)
standard methods are##2##3##(2010-12#2)
standard methods for##6##3##(1994-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-11#1)(2010-8#1)
standard methods of analysis##3##4##(1992-1#1)(1994-9#1)(2008-10#1)
standard methods of evaluation##2##4##(1997-6#1)(2006-10#1)
standard methods of##9##3##(1992-1#1)(1994-9#1)(1997-6#1)(2006-10#1)(2006-12#1)(2008-10#2)(2008-4#1)(2011-2#1)
standard methods to##3##3##(2006-12#1)(2008-3#1)(2013-7#1)
standard methods##51##2##(1992-1#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-3#2)(1994-9#1)(1997-6#2)(2006-10#1)(2006-12#2)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-3#4)(2008-4#3)(2008-5#1)(2009-11#1)(2009-5#2)(2010-12#4)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-7#2)
standard microbiological procedures##3##3##(2007-2#1)(2008-5#1)(2012-3#1)
standard microbiological##5##2##(2007-2#1)(2008-5#1)(2011-1#2)(2012-3#1)
standard mixture##2##2##(2008-10#1)(2010-12#1)
standard mixtures of##3##3##(2008-10#3)
standard mixtures##7##2##(2008-10#7)
standard model of##2##3##(1992-5#1)(2006-7#1)
standard model##4##2##(1992-5#1)(1996-5#1)(2006-7#1)(2009-5#1)
standard multidish##2##2##(2008-11#2)
standard national ED data set##2##5##(2007-7#2)
standard national##3##2##(2007-7#3)
standard neurosurgical##3##2##(2007-10#1)(2007-7#1)(2012-2#1)
standard of &quot##2##3##(2005-11#1)(2009-8#1)
standard of care (SOC)##2##4##(2008-7#1)(2012-12#1)
standard of care and##4##4##(1993-2#1)(2010-12#1)(2012-11#1)(2012-3#1)
standard of care for metastatic##2##5##(2006-10#1)(2008-5#1)
standard of care for patients with##5##6##(2008-1#1)(2008-6#2)(2009-11#1)(2009-12#1)
standard of care for##21##4##(1993-12#1)(2004-1#1)(2005-3#2)(2006-10#1)(2006-11#1)(2007-10#4)(2007-12#1)(2008-1#1)(2008-5#1)(2008-6#2)(2009-11#1)(2009-12#2)(2011-2#1)(2012-2#1)(2013-7#1)
standard of care in the management of##2##7##(2006-10#1)(2010-12#1)
standard of care in the##5##5##(2006-10#2)(2007-11#1)(2009-3#1)(2010-12#1)
standard of care in##13##4##(2006-10#3)(2006-12#1)(2006-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-3#2)(2010-12#2)(2012-3#1)
standard of care##76##3##(1990-11#1)(1991-12#1)(1993-12#1)(1993-2#1)(1993-5#1)(1995-9#1)(2004-1#1)(2005-10#1)(2005-3#3)(2006-10#8)(2006-11#1)(2006-12#1)(2006-3#1)(2006-8#2)(2007-10#6)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-3#3)(2008-5#1)(2008-6#3)(2008-7#1)(2009-11#1)(2009-12#2)(2009-3#3)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#6)(2010-5#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#2)
standard of care&quot##4##3##(2010-3#1)(2012-12#2)(2012-3#1)
standard of health care##3##4##(1990-11#1)(2006-2#1)(2007-3#1)
standard of living##2##3##(2008-11#1)(2012-3#1)
standard of practice##5##3##(1992-9#1)(2007-10#1)(2007-4#1)(2007-8#1)(2008-8#1)
standard of society##2##3##(1995-5#2)
standard of the##4##3##(2007-8#1)(2008-11#1)(2009-4#1)(2011-2#1)
standard of treatment##4##3##(2006-10#2)(2007-12#1)(2008-6#1)
standard of##136##2##(1990-11#4)(1991-10#1)(1991-12#1)(1992-3#2)(1992-9#1)(1993-12#1)(1993-2#2)(1993-5#1)(1994-4#1)(1995-3#1)(1995-5#2)(1995-9#2)(1996-3#1)(1997-8#1)(2004-1#2)(2005-10#1)(2005-11#1)(2005-3#3)(2006-10#12)(2006-11#1)(2006-12#1)(2006-2#2)(2006-3#1)(2006-8#2)(2007-10#7)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#2)(2009-3#4)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-12#7)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#8)(2013-1#3)(2013-7#2)(2013-8#1)
standard on the##3##3##(1993-2#1)(2008-10#1)(2008-3#1)
standard on##5##2##(1993-2#1)(2008-10#2)(2008-3#1)(2011-2#1)
standard one##3##2##(1991-1#1)(1995-9#1)(2011-1#1)
standard operating procedures (SOPs)##2##4##(2007-7#1)(2010-3#1)
standard operating procedures are##2##4##(2005-12#1)(2008-3#1)
standard operating procedures##6##3##(2005-12#1)(2007-7#1)(2008-3#1)(2010-11#1)(2010-3#1)(2011-2#1)
standard operating##11##2##(2005-12#1)(2007-12#1)(2007-7#1)(2008-3#1)(2009-12#1)(2010-11#1)(2010-3#1)(2011-2#2)(2012-12#2)
standard operation procedure##2##3##(2008-10#2)
standard operation##3##2##(2006-10#1)(2008-10#2)
standard optical fiber##2##3##(2007-12#2)
standard optical##7##2##(2007-11#1)(2007-12#4)(2007-8#1)(2008-3#1)
standard or a##2##3##(2006-12#1)(2007-11#1)
standard or##12##2##(1990-11#1)(1996-12#1)(2004-3#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#4)(2009-8#1)
standard oral glucose tolerance test (OGTT)##2##6##(2011-1#1)(2011-2#1)
standard oral##3##2##(2008-11#1)(2011-1#1)(2011-2#1)
standard osmolality##2##2##(2008-11#2)
standard paradigm##2##2##(2008-7#1)(2011-2#1)
standard pathway##2##2##(2011-2#1)(2012-3#1)
standard pellet diet##3##3##(2013-1#3)
standard perfusion##2##2##(2008-11#2)
standard peritoneal permeability analysis##3##4##(2011-2#3)
standard permutation procedure##2##3##(2012-3#2)
standard phase##2##2##(2005-8#1)(2008-2#1)
standard phase-sensitive detection##2##3##(2008-3#2)
standard phase-sensitive##3##2##(2008-2#1)(2008-3#2)
standard photolithography##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
standard populations##2##2##(2011-1#1)(2013-1#1)
standard potential##2##2##(2008-10#1)(2008-8#1)
standard practice##5##2##(2007-8#1)(2008-10#1)(2008-11#1)(2009-11#1)(2013-1#1)
standard practices##2##2##(2010-5#1)(2013-7#1)
standard precautions among##2##3##(2012-1#2)
standard precautions##6##2##(2012-1#5)(2012-3#1)
standard preparation##5##2##(1992-9#1)(1993-10#1)(2008-4#1)(2008-7#1)(2012-1#1)
standard procedure for the##2##4##(1997-5#1)(2007-8#1)
standard procedure for##4##3##(1997-5#1)(2007-8#1)(2008-10#1)(2008-11#1)
standard procedure to##3##3##(1997-2#1)(2008-10#1)(2008-7#1)
standard procedure##23##2##(1992-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(2007-11#4)(2007-6#1)(2007-8#3)(2008-10#4)(2008-11#3)(2008-12#1)(2008-7#1)(2011-12#1)(2012-3#1)
standard procedures and optimization##3##4##(2008-2#1)(2008-4#1)(2008-9#1)
standard procedures and##4##3##(2008-2#1)(2008-4#1)(2008-9#1)(2010-8#1)
standard procedures to##2##3##(1990-11#1)(2011-2#1)
standard procedures##21##2##(1990-11#1)(1990-12#1)(1991-11#1)(1991-2#1)(1995-5#1)(2007-8#2)(2008-10#2)(2008-2#2)(2008-4#1)(2008-5#2)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#3)
standard program##3##2##(2007-11#2)(2007-7#1)
standard protein##3##2##(1990-12#1)(1990-7#1)(2008-11#1)
standard proteins##3##2##(1996-8#1)(2008-10#1)(2012-12#1)
standard protocol and##2##3##(1991-7#1)(2011-12#1)
standard protocol##17##2##(1991-7#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-8#1)(2006-5#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
standard protocols for##2##3##(2008-11#1)(2012-12#1)
standard protocols##8##2##(2007-2#1)(2008-11#1)(2008-8#1)(2009-4#1)(2011-1#1)(2012-12#1)(2013-1#2)
standard purification##2##2##(1995-3#1)(2007-6#1)
standard questionnaire##5##2##(1990-10#1)(2007-2#1)(2007-3#1)(2008-7#1)(2009-5#1)
standard random effects##2##3##(1996-3#1)(1997-4#1)
standard rate##3##2##(2008-10#2)(2009-2#1)
standard recommendations##2##2##(2010-12#1)(2012-12#1)
standard recommended##2##2##(1994-3#1)(2010-8#1)
standard recovery##3##2##(2013-1#1)(2013-8#2)
standard reference material and##4##4##(2007-8#1)(2008-10#3)
standard reference material##20##3##(2007-8#1)(2008-10#19)
standard reference materials and##6##4##(2007-8#2)(2008-10#4)
standard reference materials were##2##4##(2005-4#1)(2008-10#1)
standard reference materials##34##3##(2005-4#1)(2007-8#2)(2008-10#31)
standard reference serum##2##3##(2011-2#2)
standard reference##67##2##(2005-4#1)(2007-8#3)(2008-1#1)(2008-10#57)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#2)
standard regarding##2##2##(2012-2#2)
standard regimen of##2##3##(2008-7#1)(2010-12#1)
standard regimen##5##2##(2006-10#1)(2008-7#2)(2010-12#2)
standard regimens##3##2##(1996-11#1)(2008-5#1)(2013-1#1)
standard regression models##2##3##(1994-6#2)
standard regression##3##2##(1994-6#2)(2012-12#1)
standard resection##2##2##(1990-2#2)
standard results##2##2##(2008-9#1)(2012-2#1)
standard sample and##3##3##(2005-4#1)(2008-10#2)
standard sample##8##2##(1992-8#1)(2005-4#3)(2008-10#3)(2008-7#1)
standard samples of##2##3##(2008-10#2)
standard samples##18##2##(1997-3#1)(2005-4#5)(2008-10#10)(2013-1#1)(2013-8#1)
standard scale##2##2##(2008-8#1)(2011-2#1)
standard scientific##2##2##(2006-12#1)(2009-11#1)
standard scoring##4##2##(1997-8#1)(2007-12#3)
standard screening##4##2##(1990-8#1)(2008-10#1)(2008-11#1)(2010-1#1)
standard series##4##2##(2007-7#3)(2012-2#1)
standard serum##2##2##(1993-9#1)(1995-2#1)
standard set of##5##3##(2008-10#1)(2008-4#1)(2012-2#1)(2013-1#2)
standard set##6##2##(2008-10#1)(2008-4#1)(2012-2#2)(2013-1#2)
standard setting##7##2##(1996-2#1)(2011-2#2)(2012-2#4)
standard short##2##2##(2008-10#1)(2008-9#1)
standard should be##2##3##(2005-11#1)(2006-10#1)
standard should##3##2##(2005-11#1)(2006-10#1)(2006-4#1)
standard simulation##2##2##(2008-12#1)(2011-1#1)
standard single-mode fiber##5##3##(2007-11#3)(2007-12#2)
standard single-mode##6##2##(2007-11#3)(2007-12#3)
standard slurries were##3##3##(2008-10#3)
standard slurries##4##2##(2008-10#4)
standard software##2##2##(2008-12#1)(2012-3#1)
standard solution and in##2##4##(2008-10#2)
standard solution and##6##3##(2007-8#1)(2008-10#5)
standard solution containing##5##3##(2008-10#5)
standard solution in##2##3##(1990-6#1)(2008-10#1)
standard solution of##6##3##(2007-12#1)(2008-10#5)
standard solution was##4##3##(1991-3#1)(2008-10#3)
standard solution##45##2##(1990-6#1)(1991-3#1)(1997-8#1)(2005-4#1)(2007-12#1)(2007-8#3)(2008-10#36)(2008-8#1)
standard solutions and##2##3##(2008-10#2)
standard solutions containing##3##3##(2008-10#3)
standard solutions in##2##3##(2008-10#2)
standard solutions of##8##3##(2007-8#1)(2008-10#6)(2012-11#1)
standard solutions was##3##3##(1996-1#1)(2008-10#2)
standard solutions were##4##3##(2008-10#4)
standard solutions##45##2##(1996-1#1)(2004-9#1)(2007-8#2)(2008-1#1)(2008-10#38)(2008-2#1)(2012-11#1)
standard spectrophotometric procedure##2##3##(2008-10#2)
standard spectrophotometric##3##2##(2008-10#3)
standard statistical methods##2##3##(1994-6#1)(2007-2#1)
standard statistical##6##2##(1990-6#1)(1994-6#1)(1997-2#1)(2007-2#1)(2008-7#1)(2011-1#1)
standard stimuli##2##2##(2008-8#2)
standard strains##4##2##(2007-7#1)(2008-10#1)(2008-12#1)(2011-1#1)
standard surgical resection##2##3##(2009-4#2)
standard surgical##8##2##(2006-11#1)(2006-5#1)(2007-8#1)(2008-7#1)(2009-4#2)(2009-5#1)(2011-2#1)
standard suturing techniques##2##3##(2006-6#2)
standard synthetic##2##2##(1992-7#1)(2007-3#1)
standard technique##9##2##(2006-3#1)(2007-7#2)(2008-2#1)(2008-3#1)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
standard techniques##10##2##(1991-2#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-2#1)(2008-4#1)(2010-7#1)(2011-2#1)
standard telecom fiber##4##3##(2007-11#2)(2007-12#2)
standard telecommunication fiber##2##3##(2007-11#1)(2008-2#1)
standard ten##2##2##(2013-1#2)
standard test for##2##3##(2011-2#1)(2012-3#1)
standard test##16##2##(1993-9#1)(2004-9#2)(2006-10#1)(2008-12#1)(2010-1#1)(2011-2#7)(2012-3#1)(2013-1#2)
standard testing procedures##2##3##(2008-12#1)(2008-5#1)
standard tests##2##2##(2012-2#1)(2013-1#1)
standard that is##2##3##(2008-7#1)(2011-2#1)
standard that##5##2##(1991-3#1)(1992-2#1)(2007-12#1)(2008-7#1)(2011-2#1)
standard therapeutic##2##2##(2005-9#1)(2012-3#1)
standard therapies have failed##2##4##(2006-8#1)(2007-11#1)
standard therapies##7##2##(2006-8#1)(2007-11#1)(2008-7#1)(2010-12#1)(2010-4#1)(2012-12#2)
standard therapy for metastatic##2##4##(1991-4#1)(2012-1#1)
standard therapy for##9##3##(1991-12#1)(1991-4#1)(1994-12#1)(1995-12#1)(1997-8#1)(2005-8#1)(2010-8#1)(2011-2#1)(2012-1#1)
standard therapy in##2##3##(2007-11#1)(2013-7#1)
standard therapy of##2##3##(1994-7#1)(2013-7#1)
standard therapy##30##2##(1991-12#1)(1991-4#1)(1991-9#2)(1992-10#1)(1994-11#1)(1994-12#1)(1994-7#1)(1995-12#1)(1995-2#1)(1997-8#2)(2004-1#1)(2005-8#1)(2006-10#2)(2007-11#1)(2007-2#1)(2009-4#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2013-1#1)(2013-7#2)
standard thoracotomy##2##2##(2008-5#1)(2010-8#1)
standard tissue culture plasticware##2##4##(2008-11#2)
standard tissue##3##2##(2008-11#2)(2008-4#1)
standard to##18##2##(1991-5#1)(1995-10#1)(2008-1#1)(2008-10#8)(2008-9#1)(2009-10#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#2)
standard tones##3##2##(1996-1#3)
standard transformed Gibbs##2##3##(1996-11#2)
standard treatment for##26##3##(1997-5#1)(2004-3#1)(2005-1#1)(2006-10#1)(2006-6#2)(2007-10#1)(2007-11#2)(2007-8#1)(2008-3#1)(2008-5#1)(2008-6#2)(2009-6#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
standard treatment is##4##3##(1990-2#1)(1995-9#1)(1997-5#1)(2008-5#1)
standard treatment of##2##3##(1993-5#1)(1997-3#1)
standard treatment with##3##3##(2004-9#1)(2005-8#1)(2013-1#1)
standard treatment##57##2##(1990-2#1)(1991-8#1)(1993-5#1)(1995-9#1)(1997-3#1)(1997-5#2)(2004-3#1)(2004-9#1)(2005-1#1)(2005-8#1)(2006-10#1)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#5)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2009-3#1)(2009-6#2)(2010-12#2)(2010-8#1)(2010-9#1)(2011-2#6)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#3)
standard treatments##6##2##(2006-8#1)(2008-3#1)(2008-7#1)(2013-1#3)
standard triple##2##2##(2007-11#1)(2012-1#1)
standard tube agglutination##3##3##(2005-12#1)(2005-9#1)(2007-2#1)
standard tube##5##2##(1993-9#2)(2005-12#1)(2005-9#1)(2007-2#1)
standard two-dimensional##3##2##(1992-12#1)(2008-2#1)(2008-9#1)
standard type##2##2##(1992-2#1)(2009-2#1)
standard ultrasonography##2##2##(1993-10#2)
standard uncertainty of##7##3##(2008-2#5)(2008-3#2)
standard uncertainty##8##2##(2008-2#5)(2008-3#3)
standard values##5##2##(2007-10#1)(2008-1#1)(2008-10#2)(2008-5#1)
standard versus##2##2##(2007-2#1)(2007-7#1)
standard visual##4##2##(2007-6#1)(2008-1#1)(2009-3#1)(2012-11#1)
standard was prepared##2##3##(1994-2#1)(2008-5#1)
standard was##21##2##(1990-6#1)(1991-2#1)(1991-8#1)(1992-12#1)(1993-2#1)(1994-2#1)(1996-3#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-3#1)(2008-5#1)(2010-12#1)(2012-12#1)
standard weight for##3##3##(1996-3#1)(2006-2#2)
standard weight##4##2##(1996-3#1)(2006-2#2)(2008-10#1)
standard were##10##2##(1990-12#1)(1990-5#1)(1992-2#1)(1992-8#1)(1996-5#1)(1997-8#1)(2005-12#1)(2008-10#3)
standard wheat##2##2##(2008-10#1)(2010-8#1)
standard with a##2##3##(2008-10#1)(2008-6#1)
standard with##8##2##(1997-8#1)(2007-5#1)(2008-10#2)(2008-6#1)(2009-6#1)(2011-1#1)(2012-12#1)
standard wound care##4##3##(2011-2#3)(2013-1#1)
standard wound##5##2##(2011-2#4)(2013-1#1)
standard x-ray##2##2##(1992-11#1)(2007-11#1)
standard##4129##1##(1990-10#4)(1990-11#19)(1990-12#18)(1990-2#6)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#17)(1990-7#5)(1990-8#5)(1990-9#4)(1991-1#5)(1991-10#3)(1991-11#5)(1991-12#13)(1991-2#7)(1991-3#4)(1991-4#1)(1991-5#6)(1991-6#2)(1991-7#2)(1991-8#7)(1991-9#3)(1992-1#7)(1992-10#6)(1992-11#4)(1992-12#9)(1992-2#18)(1992-3#4)(1992-4#5)(1992-5#5)(1992-6#3)(1992-7#3)(1992-8#7)(1992-9#5)(1993-1#2)(1993-10#5)(1993-11#2)(1993-12#9)(1993-2#16)(1993-3#4)(1993-4#1)(1993-5#8)(1993-6#6)(1993-8#2)(1993-9#8)(1994-1#3)(1994-10#2)(1994-11#4)(1994-12#5)(1994-2#6)(1994-3#10)(1994-4#3)(1994-5#4)(1994-6#7)(1994-7#2)(1994-8#5)(1994-9#9)(1995-1#5)(1995-10#2)(1995-11#1)(1995-12#8)(1995-2#11)(1995-3#2)(1995-4#1)(1995-5#8)(1995-6#4)(1995-7#2)(1995-8#5)(1995-9#5)(1996-1#9)(1996-11#11)(1996-12#13)(1996-2#10)(1996-3#8)(1996-4#3)(1996-5#15)(1996-6#10)(1996-7#5)(1996-8#20)(1996-9#7)(1997-1#3)(1997-2#10)(1997-3#19)(1997-4#7)(1997-5#4)(1997-6#5)(1997-7#3)(1997-8#30)(2004-1#5)(2004-11#1)(2004-12#2)(2004-2#1)(2004-3#3)(2004-9#9)(2005-1#3)(2005-10#7)(2005-11#21)(2005-12#12)(2005-3#5)(2005-4#29)(2005-5#4)(2005-6#1)(2005-7#2)(2005-8#8)(2005-9#4)(2006-1#1)(2006-10#50)(2006-11#12)(2006-12#20)(2006-2#14)(2006-3#5)(2006-4#5)(2006-5#9)(2006-6#18)(2006-7#9)(2006-8#22)(2006-9#8)(2007-1#10)(2007-10#29)(2007-11#66)(2007-12#90)(2007-2#25)(2007-3#7)(2007-4#10)(2007-5#13)(2007-6#10)(2007-7#44)(2007-8#106)(2007-9#12)(2008-1#30)(2008-10#1292)(2008-11#67)(2008-12#32)(2008-2#139)(2008-3#139)(2008-4#54)(2008-5#78)(2008-6#23)(2008-7#58)(2008-8#28)(2008-9#29)(2009-1#2)(2009-10#11)(2009-11#7)(2009-12#6)(2009-2#12)(2009-3#18)(2009-4#13)(2009-5#15)(2009-6#7)(2009-7#9)(2009-8#9)(2009-9#2)(2010-1#5)(2010-10#3)(2010-11#8)(2010-12#40)(2010-2#14)(2010-3#10)(2010-4#14)(2010-5#17)(2010-6#2)(2010-7#10)(2010-8#34)(2010-9#11)(2011-1#60)(2011-12#11)(2011-2#113)(2011-3#4)(2011-7#1)(2012-1#31)(2012-11#9)(2012-12#68)(2012-2#48)(2012-3#49)(2012-5#1)(2013-1#121)(2013-7#19)(2013-8#48)
standard&quot##29##1##(1992-3#1)(1993-2#1)(1995-5#1)(2006-2#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-8#2)(2008-10#3)(2008-5#4)(2009-3#2)(2009-7#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-4#1)
standard) and##2##2##(1992-8#1)(1996-5#1)
standard) was##2##2##(2005-3#1)(2008-10#1)
standard) were##2##2##(1995-2#1)(2006-12#1)
standard)##19##1##(1990-4#1)(1990-5#1)(1990-8#1)(1992-8#1)(1995-2#1)(1996-5#1)(1996-6#1)(1996-8#2)(2005-3#1)(2006-12#1)(2007-1#1)(2008-10#4)(2008-2#1)(2008-4#1)(2011-3#1)
standard-dose chemotherapy##3##2##(2006-11#1)(2008-7#2)
standard-dose##6##1##(2006-11#2)(2006-8#1)(2008-7#2)(2012-2#1)
standard-of-care##2##1##(2008-7#1)(2013-1#1)
standard/sample##2##1##(2008-10#2)
standard?##4##1##(1992-3#1)(2006-9#1)(2007-7#1)(2008-10#1)
standardisation of the##2##3##(1991-2#1)(2010-4#1)
standardisation of##5##2##(1991-2#1)(1992-3#1)(2008-10#1)(2008-6#1)(2010-4#1)
standardisation##14##1##(1990-3#1)(1991-2#1)(1992-3#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2010-4#2)(2012-12#1)(2012-3#1)
standardised Nordic Questionnaire was used##2##5##(2006-10#2)
standardised intraoperative ultrasound examination of the aorta and proximal coronary arteries##3##11##(2007-8#3)
standardised methods##2##2##(2008-10#1)(2008-11#1)
standardised protocol##4##2##(1992-8#2)(2009-8#2)
standardised##56##1##(1990-3#1)(1991-2#1)(1992-8#2)(1993-12#1)(1993-2#2)(1993-7#1)(1995-4#1)(2005-11#1)(2006-10#2)(2006-6#2)(2007-11#4)(2007-12#1)(2007-5#1)(2007-8#3)(2008-10#5)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-8#3)(2010-4#2)(2010-6#1)(2010-9#1)(2011-1#2)(2012-12#4)(2012-2#2)(2013-7#1)(2013-8#1)
standardising the##2##2##(1993-7#1)(2005-5#1)
standardising##3##1##(1993-7#1)(2005-5#1)(2007-12#1)
standardization and validation of##2##4##(2008-10#1)(2008-5#1)
standardization and##10##2##(2005-8#1)(2006-11#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-4#1)(2011-1#1)(2013-1#2)
standardization efforts##2##2##(1994-12#1)(2008-7#1)
standardization evaluation system##2##3##(2012-3#2)
standardization evaluation##3##2##(2012-3#3)
standardization for##5##2##(1990-9#1)(1996-12#1)(2008-10#2)(2012-3#1)
standardization in##6##2##(1990-12#1)(1993-1#1)(2006-8#1)(2007-4#1)(2008-9#1)(2010-12#1)
standardization is##2##2##(2006-10#1)(2008-11#1)
standardization method##2##2##(2008-10#1)(2011-1#1)
standardization methods##3##2##(2008-10#1)(2008-9#1)(2011-1#1)
standardization of diagnostic and##2##4##(1992-9#1)(2007-7#1)
standardization of diagnostic##3##3##(1992-9#1)(2007-7#1)(2012-3#1)
standardization of methodology##2##3##(1990-11#1)(1991-12#1)
standardization of the##10##3##(1992-5#1)(1996-2#1)(2006-6#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
standardization of##43##2##(1990-11#2)(1990-7#1)(1991-12#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-6#1)(1996-2#2)(1996-3#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-11#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
standardization procedure##3##2##(2004-12#1)(2008-10#1)(2012-3#1)
standardization process##2##2##(2008-10#2)
standardization was##2##2##(2008-3#1)(2012-12#1)
standardization##128##1##(1990-11#2)(1990-12#1)(1990-7#1)(1990-9#1)(1991-12#1)(1992-4#2)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-7#1)(1996-12#3)(1996-2#2)(1996-3#3)(1996-8#1)(1997-7#1)(1997-8#2)(2004-12#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#26)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#2)(2009-11#1)(2009-4#2)(2009-6#1)(2010-12#1)(2011-1#6)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#10)(2013-1#9)(2013-7#1)(2013-8#3)
standardize and##4##2##(2007-10#1)(2008-10#1)(2008-9#1)(2013-1#1)
standardize our##2##2##(2008-3#2)
standardize the##10##2##(1990-4#1)(1997-3#1)(2005-8#1)(2007-10#1)(2007-7#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-2#1)
standardize##31##1##(1990-4#2)(1992-4#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-3#1)(2005-8#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-7#3)(2008-9#2)(2010-4#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
standardized and validated##2##3##(2006-12#1)(2013-1#1)
standardized and##9##2##(1993-1#1)(1993-11#1)(2006-12#1)(2007-12#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
standardized approach for##3##3##(2008-8#1)(2013-1#2)
standardized approach to##2##3##(2009-4#2)
standardized approach##5##2##(2008-8#1)(2009-4#2)(2013-1#2)
standardized area under DII progress curve##2##6##(2008-10#2)
standardized area under DII progress##3##5##(2008-10#3)
standardized area under##4##3##(2008-10#4)
standardized as##2##2##(1993-8#1)(2008-9#1)
standardized assay##2##2##(2010-1#1)(2011-2#1)
standardized assessment##2##2##(2006-8#1)(2008-7#1)
standardized by##3##2##(2008-10#2)(2008-3#1)
standardized case##3##2##(2006-2#1)(2008-1#2)
standardized conditions##4##2##(1991-12#1)(1992-1#1)(2008-10#1)(2009-3#1)
standardized data##5##2##(1993-2#1)(1996-12#1)(2008-11#1)(2010-8#1)(2012-1#1)
standardized evaluation of##3##3##(2006-7#1)(2007-12#1)(2008-5#1)
standardized evaluation##4##2##(2006-7#1)(2007-12#1)(2008-5#1)(2008-7#1)
standardized for the##4##3##(1993-11#1)(2012-12#3)
standardized for##6##2##(1993-11#1)(1995-1#1)(2008-5#1)(2012-12#3)
standardized hospital##2##2##(1991-11#1)(2011-2#1)
standardized in##4##2##(1992-4#1)(2008-5#1)(2009-9#1)(2010-8#1)
standardized incidence ratio (SIR)##2##4##(1993-9#2)
standardized incidence##4##2##(1993-2#1)(1993-9#2)(2006-8#1)
standardized information on##3##3##(2006-8#1)(2012-11#2)
standardized instruments##2##2##(2010-12#1)(2012-2#1)
standardized mean differences##2##3##(2013-1#1)(2013-8#1)
standardized mean square##2##3##(2012-2#2)
standardized mean##4##2##(2012-2#2)(2013-1#1)(2013-8#1)
standardized measures of##3##3##(1996-2#1)(2007-12#1)(2010-12#1)
standardized methods##3##2##(1995-5#1)(2006-2#1)(2013-1#1)
standardized mortality or morbidity##2##4##(2008-7#2)
standardized mortality ratio##3##3##(1993-10#1)(1995-2#1)(2006-10#1)
standardized mortality##5##2##(1993-10#1)(1995-2#1)(2006-10#1)(2008-7#2)
standardized nomenclature and##2##3##(2008-4#1)(2013-7#1)
standardized or##2##2##(1992-3#1)(2011-2#1)
standardized parameters##2##2##(1992-2#1)(1994-5#1)
standardized patients##2##2##(1994-2#1)(2012-3#1)
standardized procedure##5##2##(1995-2#1)(2007-8#1)(2008-12#1)(2008-4#1)(2012-3#1)
standardized procedures##2##2##(2006-5#1)(2006-6#1)
standardized protocol for##4##3##(1990-12#1)(1997-1#1)(2008-11#1)(2008-3#1)
standardized protocol##5##2##(1990-12#1)(1997-1#2)(2008-11#1)(2008-3#1)
standardized protocols##3##2##(1997-8#1)(2008-3#1)(2013-8#1)
standardized questionnaire##12##2##(1993-5#1)(1993-6#1)(1994-12#1)(1996-11#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-8#2)
standardized rates##2##2##(2008-7#1)(2013-1#1)
standardized risk##2##2##(1996-12#1)(2006-8#1)
standardized scores##2##2##(2008-4#2)
standardized screening of##2##3##(1997-1#1)(2007-12#1)
standardized terminology##5##2##(2006-10#1)(2013-1#4)
standardized test scores##2##3##(2008-12#1)(2009-7#1)
standardized test##4##2##(2008-12#2)(2008-5#1)(2009-7#1)
standardized tests##5##2##(2007-4#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
standardized to##6##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2011-2#1)
standardized tool##2##2##(2008-6#1)(2013-1#1)
standardized using##2##2##(1996-9#1)(2010-3#1)
standardized##379##1##(1990-12#3)(1990-3#1)(1990-8#1)(1991-11#2)(1991-12#2)(1991-3#1)(1991-7#1)(1992-1#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-1#2)(1993-10#2)(1993-11#2)(1993-12#2)(1993-2#4)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#3)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#4)(1996-7#2)(1996-9#1)(1997-1#4)(1997-5#1)(1997-8#1)(2004-12#2)(2005-10#1)(2005-11#1)(2005-8#3)(2006-10#8)(2006-12#3)(2006-2#3)(2006-3#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#8)(2007-10#3)(2007-12#5)(2007-2#3)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#4)(2008-10#27)(2008-11#13)(2008-12#7)(2008-3#12)(2008-4#7)(2008-5#16)(2008-6#3)(2008-7#10)(2008-8#8)(2008-9#5)(2009-11#3)(2009-12#1)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#3)(2010-6#1)(2010-7#1)(2010-8#8)(2011-1#10)(2011-2#20)(2012-1#4)(2012-11#2)(2012-12#8)(2012-2#6)(2012-3#7)(2012-4#1)(2013-1#33)(2013-7#2)(2013-8#7)
standardizing the##6##2##(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)(2010-9#1)
standardizing##22##1##(1996-12#1)(1996-3#1)(1997-3#1)(2004-9#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-2#1)(2010-9#1)(2013-1#6)
standardless FP method##2##3##(2008-10#2)
standards across the##2##3##(2010-8#1)(2011-1#1)
standards across##3##2##(2005-7#1)(2010-8#1)(2011-1#1)
standards and a##2##3##(2008-12#1)(2011-2#1)
standards and from##2##3##(1992-11#1)(2008-10#1)
standards and guidelines for##2##4##(2005-8#1)(2012-12#1)
standards and recommendations##2##3##(1994-12#1)(2010-9#1)
standards and requirements##2##3##(2007-8#1)(2012-3#1)
standards and samples were##2##4##(2006-12#1)(2008-10#1)
standards and samples##3##3##(2006-12#1)(2008-10#2)
standards and the##4##3##(1995-2#1)(2006-8#1)(2008-10#1)(2010-9#1)
standards and to##2##3##(2007-3#1)(2008-10#1)
standards and##67##2##(1992-11#3)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-2#3)(1996-1#1)(1996-3#1)(1996-9#1)(2005-8#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-12#3)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#14)(2008-11#2)(2008-12#1)(2009-4#1)(2009-9#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#4)(2012-12#1)(2012-3#3)(2013-1#5)(2013-7#1)
standards are##17##2##(1992-3#2)(1993-12#1)(1993-3#1)(1996-8#1)(1997-1#1)(1997-8#1)(2004-12#3)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2010-11#1)(2011-2#1)(2012-12#1)
standards as##5##2##(1993-12#1)(1995-3#1)(2006-11#1)(2008-10#1)(2009-4#1)
standards at##3##2##(2008-10#1)(2010-8#1)(2012-2#1)
standards based on##2##3##(1992-3#1)(1997-8#1)
standards by##3##2##(1997-8#1)(2007-12#1)(2008-11#1)
standards can be##4##3##(2008-10#2)(2008-11#1)(2012-3#1)
standards can##6##2##(2006-5#1)(2008-10#2)(2008-11#1)(2012-12#1)(2012-3#1)
standards composed of##2##3##(2008-10#1)(2009-5#1)
standards containing 0##2##3##(1992-4#1)(2008-10#1)
standards containing##4##2##(1992-4#1)(2007-8#1)(2008-10#2)
standards could##2##2##(2008-10#1)(2013-8#1)
standards development organizations##2##3##(2006-8#1)(2013-1#1)
standards for a##2##3##(1992-12#1)(2008-3#1)
standards for clinical##2##3##(1992-3#1)(2007-9#1)
standards for comparability##2##3##(2010-12#1)(2013-1#1)
standards for data##3##3##(2008-7#3)
standards for each##2##3##(2008-1#1)(2008-10#1)
standards for health##2##3##(1996-2#1)(2006-8#1)
standards for patient handling##2##4##(1997-7#2)
standards for patient##4##3##(1997-7#2)(2009-4#1)(2012-2#1)
standards for prevention and##2##4##(2007-11#2)
standards for quality##2##3##(1991-12#1)(1991-2#1)
standards for the##14##3##(1991-10#1)(1995-12#1)(1996-9#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2010-5#1)(2010-8#1)(2012-12#2)(2012-2#1)
standards for##104##2##(1990-11#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1994-3#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-9#1)(1997-7#3)(2004-12#1)(2005-11#1)(2005-5#1)(2005-8#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#4)(2008-9#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#9)(2013-7#1)
standards from##6##2##(2008-3#1)(2008-4#1)(2011-2#1)(2013-1#3)
standards has##3##2##(2007-2#1)(2007-8#1)(2008-11#1)
standards have been##5##3##(1996-1#1)(2012-11#1)(2012-3#1)(2013-1#2)
standards have##6##2##(1996-1#1)(2011-1#1)(2012-11#1)(2012-3#1)(2013-1#2)
standards imposed by##2##3##(2009-4#1)(2012-2#1)
standards in papers published in##2##5##(2013-1#2)
standards in reversed-phase##3##3##(1990-8#2)(1993-11#1)
standards in the field##2##4##(2008-2#1)(2011-2#1)
standards in the##12##3##(1990-11#1)(1991-7#1)(1996-6#1)(2005-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-6#1)(2010-11#1)(2011-2#1)
standards in##41##2##(1990-11#2)(1990-8#2)(1991-7#2)(1993-11#1)(1996-2#1)(1996-6#1)(1996-8#2)(1996-9#1)(2004-12#1)(2005-10#1)(2006-2#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-4#1)(2008-7#2)(2009-2#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-5#1)(2011-2#1)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#4)
standards is##9##2##(1993-12#1)(1994-3#1)(2004-12#1)(2006-5#1)(2008-10#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
standards may be##2##3##(1995-2#1)(2005-5#1)
standards may##4##2##(1995-2#1)(2005-5#1)(2007-11#1)(2008-3#1)
standards must##2##2##(2008-4#1)(2011-2#1)
standards needed##2##2##(2008-10#1)(2008-9#1)
standards of beauty were##2##4##(2007-12#1)(2008-5#1)
standards of beauty##4##3##(2007-12#3)(2008-5#1)
standards of care and##3##4##(1991-1#1)(2006-5#1)(2008-3#1)
standards of care during##2##4##(2013-1#2)
standards of care for##4##4##(2005-10#1)(2008-3#1)(2010-4#1)(2013-1#1)
standards of care##30##3##(1990-12#1)(1991-1#1)(1991-3#1)(1994-3#1)(2004-10#1)(2005-10#1)(2006-5#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-3#5)(2008-5#1)(2010-4#2)(2011-1#1)(2012-2#4)(2013-1#3)(2013-8#4)
standards of health##2##3##(2007-2#1)(2008-1#1)
standards of practice##6##3##(2006-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-12#1)
standards of quality##4##3##(1996-12#2)(2007-3#1)(2009-7#1)
standards of the##4##3##(1991-8#1)(1993-2#1)(2008-7#1)(2011-2#1)
standards of##97##2##(1990-12#2)(1991-1#1)(1991-3#2)(1991-8#2)(1992-2#1)(1992-9#1)(1993-2#1)(1994-3#3)(1995-3#1)(1995-7#1)(1996-11#1)(1996-12#2)(1996-6#1)(1997-8#1)(2004-10#1)(2005-10#1)(2005-5#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#2)(2007-3#2)(2007-4#2)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#5)(2008-4#2)(2008-5#2)(2008-7#4)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-4#2)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#4)(2013-1#4)(2013-8#4)
standards on the##2##3##(2007-10#1)(2008-6#1)
standards on##9##2##(1991-2#1)(1992-12#1)(2004-12#1)(2004-5#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)
standards or##7##2##(1996-12#1)(2006-12#1)(2007-10#1)(2007-3#1)(2008-7#1)(2009-9#1)(2010-8#1)
standards prepared in##2##3##(2007-8#1)(2008-10#1)
standards regarding##2##2##(2007-12#1)(2011-2#1)
standards set by the##2##4##(1991-2#1)(2007-10#1)
standards set by##3##3##(1991-2#1)(2007-10#1)(2011-1#1)
standards should##2##2##(2008-5#1)(2012-12#1)
standards solutions##2##2##(2007-10#1)(2008-10#1)
standards such as##4##3##(2008-11#1)(2008-2#2)(2012-3#1)
standards that are##4##3##(2004-12#1)(2005-7#1)(2007-11#1)(2013-1#1)
standards that##10##2##(1994-3#1)(2004-12#2)(2005-7#1)(2006-5#1)(2007-11#1)(2007-9#1)(2009-6#1)(2013-1#1)(2013-8#1)
standards to a##2##3##(1996-8#1)(2008-10#1)
standards to support the##2##4##(2007-12#1)(2013-1#1)
standards to##16##2##(1991-10#1)(1995-6#1)(1996-8#1)(1997-8#2)(2005-7#1)(2007-12#1)(2008-10#4)(2008-3#1)(2011-2#1)(2013-1#3)
standards used##3##2##(2008-3#1)(2013-1#2)
standards was##7##2##(1991-2#1)(1995-7#1)(1996-5#1)(1997-7#1)(2008-10#2)(2011-1#1)
standards well##2##2##(2008-10#2)
standards were not##2##3##(1992-4#1)(2008-10#1)
standards were used by##2##4##(1991-2#2)
standards were used for quantification##2##5##(2008-10#1)(2008-7#1)
standards were used##6##3##(1991-2#2)(1995-7#1)(2008-10#2)(2008-7#1)
standards were##25##2##(1991-2#2)(1992-4#1)(1995-7#1)(1996-12#1)(2004-9#1)(2006-12#1)(2008-10#11)(2008-3#1)(2008-7#1)(2010-10#1)(2011-2#1)(2013-1#3)
standards which##5##2##(1991-2#1)(2007-8#1)(2008-11#1)(2009-6#1)(2013-1#1)
standards will##5##2##(1993-2#1)(1995-1#1)(2005-8#1)(2008-3#1)(2013-8#1)
standards with##2##2##(1996-12#1)(2008-10#1)
standards##813##1##(1990-10#1)(1990-11#3)(1990-12#4)(1990-3#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#2)(1991-12#3)(1991-2#8)(1991-3#4)(1991-4#2)(1991-5#1)(1991-7#2)(1991-8#2)(1991-9#1)(1992-11#3)(1992-12#3)(1992-2#3)(1992-3#7)(1992-4#3)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#13)(1993-2#7)(1993-3#4)(1994-12#3)(1994-3#14)(1994-5#1)(1995-1#1)(1995-10#1)(1995-12#4)(1995-2#8)(1995-3#2)(1995-6#2)(1995-7#3)(1995-8#1)(1996-1#4)(1996-11#1)(1996-12#9)(1996-2#4)(1996-3#5)(1996-5#2)(1996-6#4)(1996-8#9)(1996-9#5)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#7)(1997-8#11)(2004-10#1)(2004-12#12)(2004-3#2)(2004-4#2)(2004-5#1)(2004-9#1)(2005-10#2)(2005-11#1)(2005-4#2)(2005-5#5)(2005-7#4)(2005-8#3)(2006-10#5)(2006-11#1)(2006-12#5)(2006-2#2)(2006-4#1)(2006-5#12)(2006-7#2)(2006-8#6)(2007-1#3)(2007-10#6)(2007-11#8)(2007-12#23)(2007-2#3)(2007-3#5)(2007-4#11)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#15)(2007-9#7)(2008-1#10)(2008-10#122)(2008-11#20)(2008-12#9)(2008-2#12)(2008-3#15)(2008-4#15)(2008-5#7)(2008-6#4)(2008-7#19)(2008-8#1)(2008-9#7)(2009-10#1)(2009-2#4)(2009-3#3)(2009-4#5)(2009-5#1)(2009-6#9)(2009-7#2)(2009-8#1)(2009-9#5)(2010-1#1)(2010-10#2)(2010-11#5)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#5)(2010-5#5)(2010-7#2)(2010-8#7)(2010-9#3)(2011-1#12)(2011-2#30)(2011-7#1)(2012-1#1)(2012-11#2)(2012-12#11)(2012-2#14)(2012-3#14)(2013-1#56)(2013-7#3)(2013-8#9)
standards&quot##2##1##(1996-1#1)(2010-2#1)
standards)##4##1##(1991-5#1)(2008-10#2)(2011-2#1)
standards?##3##1##(2004-12#3)
standart##2##1##(2008-10#1)(2009-8#1)
standby##5##1##(2006-11#1)(2007-2#4)
stander##2##1##(2006-10#2)
standing and walking##3##3##(2006-8#2)(2007-10#1)
standing and##11##2##(1995-10#1)(2004-2#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-9#1)(2008-10#1)(2008-7#2)(2012-2#1)
standing controller for a powered##2##5##(2012-1#2)
standing estrus##5##2##(2006-5#4)(2013-1#1)
standing genetic variation##2##3##(2008-10#1)(2010-8#1)
standing height changes##2##3##(2010-3#2)
standing height gains##2##3##(2010-3#2)
standing height##4##2##(2010-3#4)
standing horses##2##2##(2013-8#2)
standing in a##2##3##(2009-3#1)(2010-9#1)
standing in##7##2##(1992-3#1)(2006-10#1)(2008-10#1)(2009-3#1)(2010-9#1)(2013-1#2)
standing litter of##2##3##(2005-12#2)
standing litter##4##2##(2005-12#4)
standing on the seesaw##2##4##(1991-4#2)
standing on the##5##3##(1991-4#4)(2008-6#1)
standing on##7##2##(1991-4#5)(2008-6#1)(2012-1#1)
standing orders##2##2##(2006-1#1)(2007-12#1)
standing position##3##2##(1990-6#1)(1997-4#1)(2007-8#1)
standing posture##3##2##(1991-4#1)(1995-12#1)(2007-4#1)
standing spore crop was##2##4##(2008-10#2)
standing spore crop##3##3##(2008-10#3)
standing surface plasmon##3##3##(2007-12#3)
standing trees and##2##3##(2008-10#1)(2008-5#1)
standing up and##2##3##(2007-11#1)(2007-9#1)
standing up##5##2##(2006-9#1)(2007-11#1)(2007-3#1)(2007-9#2)
standing variation##3##2##(2013-1#3)
standing wave is##2##3##(2007-12#2)
standing wave##9##2##(1992-8#1)(2006-4#1)(2007-11#1)(2007-12#4)(2008-1#2)
standing waves in the##2##4##(2008-2#1)(2008-3#1)
standing waves##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
standing with##2##2##(1992-3#1)(2007-4#1)
standing##171##1##(1990-12#1)(1990-6#1)(1991-3#1)(1991-4#7)(1991-9#1)(1992-10#1)(1992-3#2)(1992-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-6#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-4#1)(1997-7#1)(2004-2#5)(2004-4#1)(2005-12#4)(2005-6#1)(2006-1#2)(2006-10#3)(2006-12#1)(2006-4#1)(2006-5#4)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#12)(2007-2#1)(2007-3#1)(2007-4#5)(2007-5#1)(2007-7#4)(2007-8#2)(2007-9#7)(2008-1#2)(2008-10#10)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2009-11#2)(2009-3#2)(2009-4#1)(2010-10#2)(2010-12#4)(2010-3#6)(2010-8#1)(2010-9#2)(2011-2#1)(2012-1#7)(2012-12#1)(2012-2#5)(2013-1#15)(2013-8#3)
standing-wave trapping##2##2##(2007-12#2)
standing-wave##11##1##(2007-11#1)(2007-12#6)(2008-2#3)(2008-3#1)
standoff##4##1##(2008-2#2)(2008-3#2)
standpoint of##23##2##(1991-9#1)(1995-12#1)(1996-12#1)(2006-10#3)(2006-6#1)(2007-1#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#3)(2010-7#1)(2010-8#2)(2011-2#1)(2012-2#1)
standpoint##47##1##(1990-2#1)(1991-6#2)(1991-9#1)(1993-2#1)(1994-12#1)(1994-7#1)(1995-12#1)(1996-12#1)(2005-5#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-12#1)(2008-10#4)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-11#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-2#1)(2013-7#1)
standpoints of##2##2##(1996-2#1)(2006-11#1)
standpoints##9##1##(1996-2#1)(2005-11#1)(2006-11#1)(2006-8#1)(2007-11#1)(2008-5#1)(2008-9#1)(2010-3#1)(2010-4#1)
stands and##8##2##(2008-10#8)
stands as the##2##3##(2008-10#1)(2012-2#1)
stands as##4##2##(1995-3#1)(2007-12#1)(2008-10#1)(2012-2#1)
stands at##3##2##(1993-7#1)(2013-8#2)
stands for a##2##3##(2010-9#1)(2013-8#1)
stands for the##3##3##(1990-11#1)(2006-12#1)(2013-8#1)
stands for##14##2##(1990-11#1)(1991-12#1)(1991-2#1)(2006-12#1)(2008-10#4)(2008-2#2)(2010-9#1)(2012-3#1)(2013-8#2)
stands in contrast to##2##4##(2006-7#1)(2007-12#1)
stands in southern##2##3##(2008-10#2)
stands in stark contrast##2##4##(1996-12#1)(2011-1#1)
stands in##11##2##(1994-3#1)(1996-12#1)(2006-10#1)(2006-7#1)(2007-12#1)(2008-10#3)(2010-8#1)(2011-1#2)
stands of##8##2##(2007-3#1)(2008-10#5)(2008-12#2)
stands out##4##2##(1991-9#1)(2006-12#1)(2008-1#1)(2011-1#1)
stands that##2##2##(1995-3#1)(2008-9#1)
stands with##4##2##(2008-10#4)
stands##81##1##(1990-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1993-7#1)(1994-3#1)(1995-3#2)(1995-8#2)(1996-12#1)(2004-2#1)(2006-10#2)(2006-12#2)(2006-7#1)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#39)(2008-12#2)(2008-2#2)(2008-7#1)(2008-9#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#4)
stands/m2##2##1##(2006-12#2)
standstill##3##1##(1993-6#1)(1997-5#1)(2006-4#1)
stanford##3##1##(1992-1#1)(2006-5#1)(2012-2#1)
stanniocalcin was##2##2##(1996-11#2)
stanniocalcin##7##1##(1996-11#7)
stannous chloride##5##2##(2008-10#5)
stannous##7##1##(1994-9#1)(2007-10#1)(2008-10#5)
stannous-containing sodium fluoride dentifrice##6##4##(2011-2#6)
stapedius##6##1##(2008-9#6)
stapes vibration##2##2##(2007-5#2)
stapes##5##1##(2007-5#4)(2008-9#1)
staphylocoagulase##3##1##(2010-6#3)
staphylococcal enterotoxin B##4##3##(1994-8#1)(2007-8#2)(2008-10#1)
staphylococcal enterotoxin##5##2##(1993-3#1)(1994-8#1)(2007-8#2)(2008-10#1)
staphylococcal infections##7##2##(1990-10#1)(1991-7#2)(1993-5#1)(2005-8#2)(2008-11#1)
staphylococcal nuclease##15##2##(1990-2#3)(1991-7#2)(1992-6#3)(1994-8#2)(1994-9#2)(1995-4#2)(1997-2#1)
staphylococcal plasmids##6##2##(1991-9#1)(1995-8#1)(2012-3#4)
staphylococcal protein A (SpA)##2##4##(1992-7#1)(1995-1#1)
staphylococcal protein A##9##3##(1990-12#1)(1992-7#3)(1994-12#1)(1994-6#1)(1995-1#1)(1996-7#1)(2008-10#1)
staphylococcal protein##10##2##(1990-12#1)(1992-7#3)(1994-12#1)(1994-6#1)(1995-1#1)(1996-7#1)(2006-10#1)(2008-10#1)
staphylococcal##59##1##(1990-10#1)(1990-12#1)(1990-2#3)(1991-7#4)(1991-9#1)(1992-6#3)(1992-7#3)(1993-3#1)(1993-5#1)(1994-12#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#1)(1995-12#1)(1995-4#2)(1995-8#1)(1996-7#1)(1997-2#2)(2005-11#1)(2005-12#1)(2005-8#2)(2006-10#2)(2007-2#1)(2007-8#3)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-6#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#4)
staphylococci (CoNS)##2##2##(2011-2#1)(2012-12#1)
staphylococci and##6##2##(1997-3#1)(2005-8#1)(2006-8#1)(2007-12#2)(2007-7#1)
staphylococci are##2##2##(1991-7#1)(2008-5#1)
staphylococci have##2##2##(2006-10#1)(2006-11#1)
staphylococci isolated##2##2##(2008-7#1)(2012-3#1)
staphylococci##50##1##(1990-6#1)(1991-4#1)(1991-7#4)(1996-12#1)(1996-4#1)(1996-8#1)(1997-3#1)(1997-6#2)(2005-7#1)(2005-8#4)(2006-10#5)(2006-11#3)(2006-6#1)(2006-8#3)(2007-12#2)(2007-7#2)(2007-8#2)(2008-5#2)(2008-7#4)(2010-12#1)(2010-4#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)
staphylococcus aureus##4##2##(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
staphylococcus##11##1##(1991-3#1)(2005-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-4#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#2)
staphylokinase##8##1##(1993-12#1)(2012-2#7)
staphyloma##2##1##(1996-5#1)(2006-12#1)
staple crop production in southeastern Botswana##2##6##(2006-4#2)
staple crop production##4##3##(2006-4#4)
staple crop##7##2##(1991-11#1)(2006-4#6)
staple food##4##2##(1991-11#2)(2006-12#1)(2009-10#1)
staple foods##3##2##(2008-1#1)(2012-12#2)
staple##21##1##(1990-6#1)(1991-11#3)(1991-12#2)(2006-12#1)(2006-4#7)(2008-1#1)(2008-9#1)(2009-10#1)(2009-12#1)(2012-1#1)(2012-12#2)
stapled procedure for##2##3##(2006-6#2)
stapled procedure##3##2##(2006-6#3)
stapled resection##2##2##(2007-8#1)(2007-9#1)
stapled side-to-side anastomosis##2##3##(2013-1#2)
stapled side-to-side##3##2##(2013-1#3)
stapled##20##1##(1990-4#1)(2006-6#5)(2007-8#3)(2007-9#1)(2008-11#1)(2009-2#2)(2013-1#7)
stapler and##2##2##(1995-3#1)(2010-8#1)
stapler in##2##2##(1990-4#1)(1992-9#1)
stapler is##2##2##(1990-4#1)(2010-8#1)
stapler##20##1##(1990-4#3)(1990-6#1)(1992-3#2)(1992-9#2)(1995-1#1)(1995-3#1)(2006-6#4)(2007-8#1)(2010-8#4)(2011-12#1)
stapler]##2##1##(1990-6#1)(1992-3#1)
staplers and##2##2##(1990-4#1)(2007-8#1)
staplers from##3##2##(1990-4#1)(2010-8#2)
staplers##10##1##(1990-4#5)(1995-1#1)(2006-5#1)(2007-8#1)(2010-8#2)
staples in##2##2##(2011-2#2)
staples##8##1##(1995-1#1)(2010-2#1)(2011-2#4)(2012-11#1)(2012-2#1)
stapling device##6##2##(1993-10#2)(1993-12#1)(1995-3#1)(1996-2#2)
stapling technique##3##2##(1990-6#1)(1991-12#1)(2010-1#1)
stapling##16##1##(1990-6#1)(1991-12#1)(1993-10#2)(1993-12#1)(1995-3#2)(1996-2#2)(2006-6#1)(2007-8#4)(2010-1#1)(2013-1#1)
star actually##2##2##(1996-5#1)(2007-8#1)
star coupler##3##2##(2008-2#3)
star##60##1##(1990-9#1)(1991-8#1)(1992-11#3)(1994-2#1)(1994-8#1)(1995-9#1)(1996-5#1)(2004-11#1)(2007-11#1)(2007-12#7)(2007-2#1)(2007-5#3)(2007-8#5)(2007-9#4)(2008-2#18)(2008-3#10)(2013-8#1)
star&quot##2##1##(1994-8#1)(2004-12#1)
star)##2##1##(2011-2#2)
star-forming regions##2##2##(2007-9#1)(2010-12#1)
star-like##2##1##(1996-11#1)(2011-2#1)
star-shaped##2##1##(2008-2#1)(2009-2#1)
starch (HES)##2##2##(2011-12#1)(2012-1#1)
starch 4##4##2##(2008-5#4)
starch accumulation##2##2##(2008-10#2)
starch acetate##2##2##(2010-4#2)
starch and##9##2##(1990-12#1)(1990-7#1)(2004-8#1)(2008-10#1)(2008-5#2)(2009-12#1)(2013-7#1)(2013-8#1)
starch as##2##2##(2006-5#1)(2008-10#1)
starch at##2##2##(2008-7#1)(2008-8#1)
starch branching enzyme IIb##2##4##(2006-12#2)
starch branching enzyme##3##3##(2006-12#3)
starch breakdown##2##2##(2008-9#2)
starch by##3##2##(1991-9#1)(2008-6#1)(2008-7#1)
starch components##2##2##(1997-4#1)(2004-8#1)
starch concentrations##2##2##(2008-10#1)(2008-9#1)
starch content##2##2##(2006-11#1)(2008-10#1)
starch degradation##3##2##(2008-11#1)(2008-8#1)(2009-8#1)
starch granule##2##2##(2006-11#1)(2006-12#1)
starch granules##10##2##(2006-11#2)(2006-12#3)(2008-1#1)(2008-9#1)(2009-10#1)(2009-8#1)(2013-8#1)
starch hydrolysis##4##2##(2008-10#2)(2008-6#1)(2008-9#1)
starch in##9##2##(2006-12#2)(2008-10#2)(2008-5#2)(2008-8#2)(2010-8#1)
starch metabolism##3##2##(2008-10#1)(2009-5#1)(2009-6#1)
starch microgels##2##2##(2005-11#2)
starch of##2##2##(2006-12#1)(2008-5#1)
starch synthesis##3##2##(2009-6#3)
starch through##2##2##(1994-2#1)(2008-6#1)
starch to##4##2##(1990-12#1)(2006-10#1)(2007-11#1)(2008-10#1)
starch was##2##2##(2008-5#1)(2008-6#1)
starch with##6##2##(1991-12#1)(1991-5#1)(1991-7#1)(2006-12#1)(2008-10#1)(2010-8#1)
starch##184##1##(1990-12#2)(1990-7#1)(1991-12#5)(1991-5#4)(1991-7#2)(1991-9#1)(1992-8#1)(1993-6#2)(1994-2#2)(1995-5#1)(1995-6#2)(1996-6#2)(1997-4#1)(1997-5#2)(2004-11#2)(2004-8#4)(2005-11#5)(2006-10#2)(2006-11#8)(2006-12#16)(2006-5#2)(2006-8#1)(2006-9#1)(2007-11#2)(2008-1#1)(2008-10#21)(2008-11#1)(2008-5#26)(2008-6#14)(2008-7#4)(2008-8#5)(2008-9#6)(2009-10#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#5)(2009-8#2)(2010-3#3)(2010-4#3)(2010-8#3)(2011-12#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#6)
starch)##2##1##(1993-9#1)(2006-5#1)
starch-based nanospheres by##2##3##(2010-4#2)
starch-based##4##1##(2005-11#1)(2008-10#1)(2010-4#2)
starch-binding domain##4##2##(1993-5#1)(1996-4#1)(2006-12#2)
starch-binding##5##1##(1993-5#2)(1996-4#1)(2006-12#2)
starch-degrading##2##1##(1994-2#1)(1997-2#1)
starches and##2##2##(2006-5#1)(2012-1#1)
starches that##2##2##(2006-10#2)
starches##10##1##(2006-10#4)(2006-11#1)(2006-12#1)(2006-5#1)(2007-11#1)(2012-1#2)
starchy endosperm##3##2##(1995-6#1)(2006-12#2)
starchy##9##1##(1991-11#1)(1991-5#1)(1995-6#1)(2006-12#2)(2008-6#3)(2012-1#1)
stare##2##1##(2007-9#1)(2008-4#1)
starfish Allostichaster capensis##2##3##(2007-5#2)
starfish##18##1##(1991-10#3)(1992-8#3)(1994-8#2)(1997-6#1)(2007-5#5)(2008-4#3)(2008-9#1)
staring##3##1##(2008-2#1)(2008-3#2)
stark contrast##7##2##(1991-11#1)(1996-12#1)(2009-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
starlight nulling##2##2##(2008-3#2)
starlings##5##1##(2008-3#1)(2008-8#2)(2008-9#2)
stars and##2##2##(1996-5#1)(2007-8#1)
stars are##6##2##(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-2#1)(2013-8#1)
stars in##5##2##(1991-12#1)(1992-1#2)(2007-5#1)(2007-9#1)
stars##47##1##(1990-3#1)(1991-1#1)(1991-12#1)(1991-6#1)(1992-1#2)(1996-3#1)(1996-5#1)(2006-7#2)(2007-11#1)(2007-12#4)(2007-5#5)(2007-8#4)(2007-9#11)(2008-11#1)(2008-2#2)(2008-3#4)(2011-2#1)(2012-2#1)(2013-8#3)
stars&quot##2##1##(1991-3#1)(2012-3#1)
start an##5##2##(1993-7#1)(1993-9#1)(2007-6#1)(2007-8#1)(2011-2#1)
start and##9##2##(1991-3#1)(2005-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-6#1)(2012-12#1)(2013-8#1)
start antiretroviral##2##2##(2010-4#1)(2011-1#1)
start at the level of the##2##6##(2010-9#2)
start at the##3##3##(2007-12#1)(2010-9#2)
start at##7##2##(1990-2#1)(1995-12#1)(2007-12#2)(2010-9#2)(2011-12#1)
start by reviewing##2##3##(2010-2#1)(2012-2#1)
start by##7##2##(2008-2#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#1)
start codon and##3##3##(1990-9#1)(1992-3#1)(1993-5#1)
start codon for cat-86##2##4##(1990-9#2)
start codon for the##2##4##(1990-3#1)(2011-1#1)
start codon for##5##3##(1990-3#1)(1990-9#3)(2011-1#1)
start codon in##3##3##(1990-5#1)(1990-9#2)
start codon of the##7##4##(1990-10#1)(1990-3#1)(1996-10#1)(2006-8#1)(2008-10#1)(2008-8#1)(2009-5#1)
start codon of##8##3##(1990-10#1)(1990-3#1)(1993-11#1)(1996-10#1)(2006-8#1)(2008-10#1)(2008-8#1)(2009-5#1)
start codon to##3##3##(1990-9#2)(1991-6#1)
start codon##51##2##(1990-10#1)(1990-11#1)(1990-3#4)(1990-5#1)(1990-9#14)(1991-6#3)(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-11#3)(1993-4#1)(1993-5#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-10#1)(1997-4#4)(1997-7#1)(2005-11#1)(2006-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-1#1)
start codons##4##2##(1990-3#1)(1993-11#1)(1993-12#1)(1997-4#1)
start comparing##2##2##(1995-11#1)(2012-2#1)
start from##4##2##(1992-6#1)(2008-11#1)(2008-9#1)(2013-1#1)
start in life##4##3##(2005-9#1)(2007-2#1)(2008-11#1)(2010-5#1)
start in##9##2##(1993-2#1)(2005-9#1)(2006-2#1)(2007-2#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-5#1)
start of rehabilitation##2##3##(1995-5#1)(2007-10#1)
start of surgery##2##3##(1992-11#1)(2007-7#1)
start of the study and##4##5##(1992-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
start of the study##11##4##(1992-5#1)(1994-7#1)(2004-3#1)(2008-5#2)(2010-11#1)(2010-3#1)(2012-2#2)(2013-1#1)(2013-8#1)
start of the##55##3##(1990-12#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-5#1)(1993-2#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-7#1)(1996-10#1)(1997-1#1)(2004-3#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-8#2)(2010-11#1)(2010-3#2)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#2)
start of therapy##4##3##(1993-7#1)(2005-7#1)(2007-7#1)(2008-1#1)
start of translation##2##3##(1992-12#1)(1995-8#1)
start of treatment##15##3##(1990-2#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-4#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-12#4)
start of##158##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#3)(1992-1#1)(1992-11#1)(1992-12#2)(1992-5#2)(1992-9#2)(1993-1#1)(1993-10#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-7#2)(1993-8#1)(1994-12#2)(1994-3#3)(1994-4#2)(1994-6#2)(1994-7#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#3)(1997-2#1)(1997-3#1)(2004-2#1)(2004-3#1)(2004-9#1)(2005-1#1)(2005-5#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#2)(2006-5#1)(2006-8#2)(2007-10#2)(2007-12#3)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#7)(2008-1#3)(2008-10#8)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#5)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#3)
start or##3##2##(1993-12#1)(1995-3#1)(2009-8#1)
start performance##3##2##(2011-2#3)
start point (tsp)##19##3##(1991-12#1)(1991-6#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#3)(1995-2#1)(1995-8#1)(1996-8#1)(1997-2#1)
start point at##2##3##(1990-3#1)(1993-5#1)
start point##42##2##(1990-11#2)(1990-3#1)(1990-5#3)(1990-9#1)(1991-12#2)(1991-5#1)(1991-6#3)(1991-9#2)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#1)(1993-9#2)(1994-12#3)(1995-2#1)(1995-4#1)(1995-8#2)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)
start points##10##2##(1990-10#1)(1990-11#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1993-2#1)(1993-6#1)(1993-7#1)
start position##5##2##(1991-1#1)(1993-12#1)(2008-6#3)
start signals##3##2##(1990-5#1)(1994-9#1)(2010-5#1)
start site and##2##3##(1992-10#1)(1996-8#1)
start site for##2##3##(1990-3#1)(1995-11#1)
start site is##3##3##(1995-6#1)(1997-7#1)(2008-7#1)
start site of the human##2##5##(1994-5#1)(1995-6#1)
start site of the##6##4##(1992-8#1)(1994-5#1)(1995-6#1)(1997-2#1)(1997-5#1)(2006-12#1)
start site of##11##3##(1991-5#1)(1992-3#1)(1992-8#1)(1994-5#1)(1995-6#1)(1996-7#1)(1997-2#1)(1997-5#1)(2006-12#1)(2008-9#2)
start site was##7##3##(1991-7#2)(1994-11#1)(1994-8#1)(1997-2#1)(1997-6#1)(2008-9#1)
start site##60##2##(1990-3#1)(1990-5#1)(1991-11#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#2)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-11#2)(1995-2#2)(1995-3#3)(1995-6#3)(1995-8#1)(1996-12#1)(1996-4#1)(1996-7#1)(1996-8#4)(1997-2#4)(1997-5#4)(1997-6#1)(1997-7#1)(1997-8#1)(2006-12#2)(2008-11#1)(2008-7#1)(2008-9#3)
start site)##2##2##(1991-2#1)(2012-2#1)
start sites and##2##3##(1990-11#1)(1994-11#1)
start sites for##4##3##(1992-4#1)(1992-9#1)(1995-5#1)(1997-1#1)
start sites in exon 1##2##5##(1991-4#2)
start sites in exon##3##4##(1991-4#3)
start sites in##5##3##(1991-4#4)(1996-5#1)
start sites of##2##3##(1991-7#1)(1997-2#1)
start sites##20##2##(1990-11#1)(1991-4#4)(1991-7#1)(1992-4#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-11#3)(1995-5#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(2008-4#2)
start smoking##2##2##(1990-2#2)
start the program##2##3##(2008-6#1)(2008-9#1)
start the##10##2##(1996-1#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-9#1)(2010-12#1)(2013-1#1)
start their##4##2##(2007-5#1)(2008-5#1)(2009-12#1)(2011-2#1)
start this##2##2##(1990-4#1)(1992-9#1)
start to be##3##3##(2008-5#1)(2008-7#1)(2011-2#1)
start to end##2##3##(2008-10#1)(2012-1#1)
start to##17##2##(1996-1#1)(1996-3#1)(2006-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#2)
start up##3##2##(1992-1#1)(2008-10#1)(2008-6#1)
start with a##6##3##(2007-11#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-8#1)(2013-8#1)
start with an##3##3##(1993-1#1)(1993-3#1)(2005-10#1)
start with the##3##3##(1990-2#1)(1994-12#1)(2008-2#1)
start with##16##2##(1990-2#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-12#1)(1996-2#1)(2005-10#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-6#1)(2010-8#1)(2013-8#1)
start##574##1##(1990-10#2)(1990-11#8)(1990-12#1)(1990-2#6)(1990-3#9)(1990-4#2)(1990-5#7)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#16)(1991-1#1)(1991-11#3)(1991-12#3)(1991-2#4)(1991-3#5)(1991-4#6)(1991-5#6)(1991-6#9)(1991-7#4)(1991-8#1)(1991-9#4)(1992-1#4)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#5)(1993-1#2)(1993-10#1)(1993-11#6)(1993-12#11)(1993-2#5)(1993-3#6)(1993-4#2)(1993-5#6)(1993-6#4)(1993-7#4)(1993-8#3)(1993-9#3)(1994-11#5)(1994-12#7)(1994-2#1)(1994-3#5)(1994-4#2)(1994-5#1)(1994-6#2)(1994-7#2)(1994-8#4)(1994-9#4)(1995-10#1)(1995-11#3)(1995-12#6)(1995-2#3)(1995-3#4)(1995-4#3)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#5)(1996-1#4)(1996-10#2)(1996-12#2)(1996-2#2)(1996-3#4)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#3)(1996-8#7)(1997-1#4)(1997-2#10)(1997-3#2)(1997-4#6)(1997-5#4)(1997-6#4)(1997-7#3)(1997-8#1)(2004-10#1)(2004-2#1)(2004-3#1)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#4)(2005-5#1)(2005-7#1)(2005-8#3)(2005-9#2)(2006-10#4)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#4)(2007-1#1)(2007-10#3)(2007-11#8)(2007-12#7)(2007-2#4)(2007-3#2)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#11)(2007-8#10)(2007-9#6)(2008-1#7)(2008-10#14)(2008-11#8)(2008-12#4)(2008-2#3)(2008-3#7)(2008-4#7)(2008-5#6)(2008-6#6)(2008-7#5)(2008-8#6)(2008-9#10)(2009-1#1)(2009-10#1)(2009-12#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#5)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#4)(2010-6#2)(2010-8#1)(2010-9#4)(2011-1#6)(2011-12#1)(2011-2#17)(2011-3#1)(2012-1#3)(2012-12#9)(2012-2#7)(2012-3#1)(2012-8#1)(2013-1#7)(2013-7#1)(2013-8#5)
start-site##2##1##(1991-9#1)(1993-3#1)
start-up companies##2##2##(2005-7#1)(2008-5#1)
start-up was##2##2##(1991-3#1)(2006-8#1)
start-up##15##1##(1991-12#1)(1991-3#4)(1992-9#1)(1997-2#1)(2005-7#1)(2006-8#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)
start/stop##2##1##(2011-1#2)
start?##3##1##(2007-9#1)(2009-4#1)(2010-12#1)
started ART##2##2##(2010-8#2)
started after##5##2##(1993-7#2)(2006-8#1)(2008-10#2)
started an##2##2##(2006-10#1)(2010-9#1)
started and##7##2##(1990-8#1)(1991-11#1)(1993-12#1)(2007-2#1)(2008-12#1)(2011-1#1)(2012-3#1)
started as a##2##3##(2011-2#1)(2012-1#1)
started as##3##2##(2007-9#1)(2011-2#1)(2012-1#1)
started at the##6##3##(2007-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-8#1)
started at##12##2##(1991-6#1)(1993-11#1)(2006-10#1)(2007-11#2)(2007-3#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-8#1)
started attacking the##2##3##(1990-5#1)(2006-10#1)
started before the##2##3##(1990-6#1)(2013-1#1)
started before##7##2##(1990-10#1)(1990-6#1)(1991-6#1)(1993-7#1)(2007-8#1)(2013-1#2)
started by##7##2##(1990-3#1)(1990-6#1)(2005-11#1)(2006-1#1)(2007-12#1)(2007-6#1)(2008-5#1)
started early##3##2##(1996-6#1)(2006-9#1)(2009-7#1)
started from the##2##3##(2010-2#1)(2012-1#1)
started from##6##2##(1991-7#1)(1992-9#1)(2007-11#1)(2008-11#1)(2010-2#1)(2012-1#1)
started having##2##2##(2010-12#2)
started immediately after the##2##4##(2008-5#2)
started immediately after##5##3##(2006-3#1)(2008-10#1)(2008-5#2)(2008-7#1)
started immediately##6##2##(2006-3#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-11#1)
started in 1999##2##3##(2008-8#1)(2011-2#1)
started in February##2##3##(2004-10#1)(2013-8#1)
started in the##7##3##(1992-10#1)(1994-5#1)(1996-2#1)(2006-5#1)(2007-11#1)(2011-7#1)(2013-8#1)
started in##35##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1992-10#1)(1992-11#1)(1992-5#1)(1993-6#1)(1994-5#1)(1996-2#1)(1996-6#1)(2004-10#1)(2006-4#2)(2006-5#1)(2007-11#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#4)(2011-7#1)(2012-12#2)(2013-7#1)(2013-8#2)
started on a##2##3##(2005-11#1)(2008-7#1)
started on the##3##3##(1992-10#1)(1993-1#1)(2007-11#1)
started on##34##2##(1992-10#1)(1993-1#1)(2005-11#1)(2006-10#3)(2006-11#1)(2006-7#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-3#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
started out##4##2##(2008-7#1)(2009-8#1)(2012-2#2)
started sexual##3##2##(2007-3#1)(2013-8#2)
started the##7##2##(1996-4#1)(2005-9#1)(2009-2#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-3#1)
started to appear##2##3##(2007-7#1)(2007-8#1)
started to be##8##3##(1992-3#1)(2007-12#1)(2008-11#2)(2009-4#1)(2010-8#1)(2012-1#1)(2012-2#1)
started to decline##3##3##(1997-2#1)(2006-10#1)(2012-3#1)
started to decrease##5##3##(1996-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
started to develop##4##3##(1992-11#1)(1995-6#1)(2008-5#1)(2009-8#1)
started to express##2##3##(1993-11#1)(1997-8#1)
started to increase with##2##4##(1995-3#1)(2012-2#1)
started to increase##8##3##(1994-6#1)(1995-3#5)(2010-8#1)(2012-2#1)
started to receive##2##3##(1994-1#1)(2006-8#1)
started to use the##2##4##(1992-4#1)(2010-12#1)
started to##68##2##(1990-9#1)(1992-11#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-4#1)(1994-1#1)(1994-12#1)(1994-6#1)(1995-3#5)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-8#2)(2007-12#2)(2007-7#2)(2007-8#2)(2008-10#4)(2008-11#6)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-8#2)(2010-12#1)(2010-4#1)(2010-8#2)(2010-9#2)(2011-3#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#2)
started treatment##3##2##(1993-9#1)(1997-6#1)(2011-2#1)
started up##2##2##(2007-9#1)(2011-2#1)
started using a##2##3##(2011-1#1)(2011-2#1)
started using##3##2##(2007-2#1)(2011-1#1)(2011-2#1)
started when##2##2##(1994-7#1)(1997-6#1)
started with a##4##3##(1991-6#1)(1996-3#1)(2012-2#1)(2013-8#1)
started with the##2##3##(1991-2#1)(2007-4#1)
started with##21##2##(1990-11#1)(1991-2#2)(1991-6#1)(1995-2#2)(1996-3#1)(2006-4#1)(2007-3#1)(2007-4#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
started within 24 h##2##4##(2011-2#2)
started within 24##3##3##(2011-2#3)
started within##5##2##(1992-2#1)(2007-9#1)(2011-2#3)
started working in##2##3##(2006-4#1)(2012-12#1)
started##387##1##(1990-10#3)(1990-11#3)(1990-2#1)(1990-3#3)(1990-5#2)(1990-6#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-11#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#3)(1993-9#1)(1994-1#2)(1994-12#1)(1994-4#2)(1994-5#1)(1994-6#1)(1994-7#1)(1995-12#1)(1995-2#2)(1995-3#6)(1995-5#3)(1995-6#2)(1996-12#3)(1996-2#3)(1996-3#1)(1996-4#1)(1996-6#4)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#3)(1997-7#1)(1997-8#1)(2004-10#1)(2004-9#1)(2005-1#1)(2005-11#2)(2005-8#1)(2005-9#2)(2006-1#3)(2006-10#13)(2006-11#2)(2006-12#1)(2006-3#2)(2006-4#6)(2006-5#1)(2006-7#2)(2006-8#5)(2006-9#2)(2007-10#4)(2007-11#6)(2007-12#5)(2007-2#4)(2007-3#3)(2007-4#1)(2007-5#3)(2007-6#3)(2007-7#11)(2007-8#9)(2007-9#5)(2008-1#4)(2008-10#15)(2008-11#8)(2008-12#5)(2008-2#1)(2008-3#4)(2008-4#5)(2008-5#7)(2008-6#3)(2008-7#8)(2008-8#5)(2008-9#2)(2009-11#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#3)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#8)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#4)(2010-9#3)(2011-1#6)(2011-2#21)(2011-3#1)(2011-7#1)(2012-1#3)(2012-12#6)(2012-2#11)(2012-3#4)(2013-1#11)(2013-7#5)(2013-8#13)
starter culture##3##2##(2007-12#1)(2010-4#1)(2012-1#1)
starter cultures##3##2##(2010-4#1)(2011-2#1)(2012-1#1)
starter##11##1##(2007-12#2)(2008-3#1)(2008-7#3)(2010-4#2)(2011-2#1)(2012-1#2)
starters##4##1##(2008-12#1)(2008-7#1)(2010-7#1)(2011-2#1)
starting 1##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
starting 2 weeks##2##3##(2008-10#1)(2010-10#1)
starting 2##3##2##(2008-10#1)(2008-7#1)(2010-10#1)
starting 6 h after##2##4##(2008-10#1)(2012-11#1)
starting ART##2##2##(2009-3#1)(2010-8#1)
starting HAART##2##2##(2008-5#1)(2010-6#1)
starting a##4##2##(2006-10#1)(2008-2#1)(2008-3#1)(2008-4#1)
starting after##2##2##(1990-7#1)(2012-2#1)
starting and##3##2##(2008-10#3)
starting at 1##2##3##(1995-12#1)(2013-8#1)
starting at a##4##3##(1993-2#1)(1993-6#1)(2008-3#1)(2011-2#1)
starting at age##2##3##(1997-5#1)(2011-1#1)
starting at nucleotide##2##3##(1997-3#1)(1997-7#1)
starting at the age of##3##5##(2006-8#1)(2007-7#1)(2008-5#1)
starting at the##9##3##(1990-4#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#2)(2009-10#1)(2013-7#1)
starting at##41##2##(1990-3#1)(1990-4#1)(1991-6#1)(1992-11#1)(1993-2#1)(1993-6#1)(1994-5#2)(1994-7#1)(1995-12#2)(1996-5#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-7#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-3#2)(2008-5#2)(2008-6#1)(2009-10#1)(2009-2#1)(2010-10#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#1)
starting compound for the##2##4##(2007-1#1)(2008-11#1)
starting compound for##3##3##(2007-1#1)(2008-11#1)(2008-5#1)
starting concentrations of##2##3##(1997-3#1)(2012-2#1)
starting concentrations##3##2##(1994-5#1)(1997-3#1)(2012-2#1)
starting dosage##2##2##(2005-7#1)(2007-2#1)
starting dose of##4##3##(2008-6#1)(2008-7#2)(2013-1#1)
starting dose##7##2##(1992-10#1)(2007-11#1)(2008-6#1)(2008-7#2)(2013-1#2)
starting doses##2##2##(2008-7#1)(2013-1#1)
starting early in##2##3##(2006-12#1)(2012-2#1)
starting epoetin-alpha##2##2##(2007-11#2)
starting from 12##2##3##(2008-7#1)(2011-1#1)
starting from 3 months##2##4##(1992-5#1)(2008-4#1)
starting from 3##3##3##(1992-5#1)(1994-12#1)(2008-4#1)
starting from a##9##3##(1995-11#1)(2007-12#1)(2007-8#1)(2008-2#2)(2008-4#1)(2010-12#2)(2013-1#1)
starting from an##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
starting from its##2##3##(2006-9#1)(2011-2#1)
starting from room temperature##2##4##(2007-12#2)
starting from the first##2##4##(2007-12#1)(2012-1#1)
starting from the##24##3##(1990-2#1)(1992-10#1)(1992-2#1)(1995-2#2)(1995-6#1)(1996-2#1)(1996-5#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-2#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-2#1)
starting from##82##2##(1990-11#1)(1990-2#1)(1990-8#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-6#2)(1993-12#1)(1994-12#1)(1995-11#1)(1995-2#2)(1995-6#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-7#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#10)(2007-12#6)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#7)(2008-5#1)(2008-7#2)(2009-2#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
starting hemodialysis##4##2##(1991-11#1)(2007-7#2)(2012-3#1)
starting in 1997##2##3##(1994-12#1)(2013-7#1)
starting in infancy##2##3##(2006-2#1)(2010-12#1)
starting in the##6##3##(1993-8#1)(1995-11#1)(1996-3#1)(2009-2#1)(2009-7#1)(2012-3#1)
starting in##25##2##(1990-9#1)(1991-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-11#1)(1996-3#1)(2004-11#1)(2006-2#1)(2006-4#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-7#1)(2010-12#1)(2010-8#2)(2011-1#1)(2012-2#3)(2012-3#1)(2013-7#1)
starting material and##4##3##(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)
starting material for the##3##4##(1997-2#1)(2007-11#1)(2008-9#1)
starting material for##7##3##(1997-2#1)(2007-1#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)
starting material##30##2##(1990-12#1)(1996-5#1)(1997-2#2)(1997-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-4#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-9#2)(2009-7#1)(2010-12#1)(2010-2#2)
starting materials and##2##3##(2008-8#1)(2009-10#1)
starting materials for the synthesis of##2##6##(2007-11#1)(2008-11#1)
starting materials for the##3##4##(2007-11#1)(2008-11#1)(2008-5#1)
starting materials for##4##3##(2007-11#1)(2007-9#1)(2008-11#1)(2008-5#1)
starting materials##23##2##(2004-9#2)(2005-11#1)(2006-12#2)(2007-11#5)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-7#1)(2012-3#1)
starting model##3##2##(1993-8#1)(1995-11#1)(1995-3#1)
starting molar##3##2##(2008-10#3)
starting on day 2##2##4##(1992-8#1)(2010-7#1)
starting on day##3##3##(1992-8#1)(2010-4#1)(2010-7#1)
starting on the##2##3##(2007-12#1)(2007-8#1)
starting on##7##2##(1991-2#1)(1992-8#1)(2007-12#1)(2007-8#1)(2008-5#1)(2010-4#1)(2010-7#1)
starting or##2##2##(2007-2#1)(2008-6#1)
starting point for further##3##4##(2006-12#1)(2008-12#1)(2013-1#1)
starting point for the development of##3##6##(2006-12#1)(2010-5#1)(2013-1#1)
starting point for the##11##4##(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
starting point for understanding the##2##5##(1992-12#1)(1994-2#1)
starting point for##38##3##(1992-12#1)(1992-3#1)(1994-2#1)(1994-9#2)(1996-12#1)(2005-11#1)(2005-8#1)(2006-12#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
starting point is##2##3##(1994-12#1)(2008-11#1)
starting point of##3##3##(1990-10#1)(1993-10#1)(2009-10#1)
starting point on the##2##4##(1996-3#1)(2007-3#1)
starting point to##2##3##(2008-10#1)(2012-2#1)
starting point##62##2##(1990-10#1)(1992-12#1)(1992-3#1)(1993-10#1)(1994-12#1)(1994-2#1)(1994-9#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(2005-11#1)(2005-8#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-7#1)(2007-3#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)
starting points for##4##3##(1997-8#1)(2005-8#1)(2008-4#1)(2008-8#1)
starting points##6##2##(1991-7#1)(1997-8#1)(2005-8#1)(2008-4#1)(2008-7#1)(2008-8#1)
starting systemic##2##2##(2005-11#1)(2007-7#1)
starting the treatment##3##3##(1990-8#1)(1992-4#1)(2011-2#1)
starting the##17##2##(1990-8#1)(1992-12#1)(1992-4#1)(1993-6#1)(1997-8#1)(2006-11#1)(2006-5#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2010-8#1)(2011-2#1)
starting time of##2##3##(2008-10#2)
starting time##5##2##(2008-10#2)(2010-8#2)(2011-2#1)
starting to be##2##3##(2011-1#1)(2011-2#1)
starting to##9##2##(1991-3#1)(1994-3#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
starting treatment and##2##3##(2008-10#1)(2013-8#1)
starting treatment with##3##3##(1993-2#1)(2011-2#1)(2012-3#1)
starting treatment##12##2##(1990-6#1)(1991-9#1)(1993-2#1)(1996-12#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
starting values for##4##3##(1991-7#1)(2008-10#1)(2008-2#2)
starting values##6##2##(1991-7#1)(1993-8#1)(2008-10#1)(2008-2#3)
starting with a##6##3##(1995-9#1)(2008-10#1)(2008-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
starting with aspergilloma and later with chronic necrotizing pulmonary aspergillosis##2##10##(2012-11#2)
starting with the first##2##4##(2004-3#1)(2008-10#1)
starting with the##10##3##(1992-7#1)(1995-8#1)(1996-7#1)(2004-3#1)(2007-3#1)(2008-10#1)(2008-9#1)(2010-4#2)(2011-1#1)
starting with##38##2##(1990-1#1)(1992-7#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-8#1)(1995-9#1)(1996-7#1)(2004-3#1)(2007-11#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#4)(2008-6#1)(2008-9#2)(2010-1#1)(2010-2#1)(2010-4#2)(2011-1#2)(2011-2#2)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
starting##530##1##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#3)(1992-11#2)(1992-12#2)(1992-2#4)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#2)(1994-4#1)(1994-5#3)(1994-6#1)(1994-7#1)(1994-9#2)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#3)(1996-5#5)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#5)(2004-11#1)(2004-3#1)(2004-9#2)(2005-10#1)(2005-11#5)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#7)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#6)(2006-9#1)(2007-1#3)(2007-10#6)(2007-11#23)(2007-12#11)(2007-2#2)(2007-3#3)(2007-4#3)(2007-7#10)(2007-8#6)(2007-9#1)(2008-1#6)(2008-10#46)(2008-11#12)(2008-12#3)(2008-2#17)(2008-3#8)(2008-4#18)(2008-5#13)(2008-6#5)(2008-7#14)(2008-8#8)(2008-9#7)(2009-10#4)(2009-2#4)(2009-3#2)(2009-4#1)(2009-7#4)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#6)(2010-2#3)(2010-4#6)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#8)(2011-1#13)(2011-2#14)(2012-1#2)(2012-11#3)(2012-12#6)(2012-2#12)(2012-3#8)(2013-1#14)(2013-7#3)(2013-8#3)
startle and##2##2##(2008-11#1)(2008-4#1)
startle in mice##3##3##(2008-4#3)
startle reaction##2##2##(1991-12#1)(2005-10#1)
startle response of##2##3##(1991-11#1)(1996-2#1)
startle response to##3##3##(1991-11#1)(2008-11#1)(2008-4#1)
startle response##17##2##(1991-1#3)(1991-11#6)(1996-2#2)(1996-5#1)(2008-11#2)(2008-4#3)
startle responses##3##2##(1996-2#2)(2008-4#1)
startle##54##1##(1991-1#6)(1991-11#11)(1991-12#1)(1996-2#5)(1996-5#2)(2005-10#1)(2008-11#11)(2008-4#16)(2009-4#1)
startling##3##1##(2007-9#1)(2010-2#1)(2012-12#1)
starts at##4##2##(1990-9#1)(1992-3#1)(1992-6#1)(2011-1#1)
starts by##4##2##(1997-1#1)(2011-1#1)(2012-2#1)(2012-3#1)
starts from a##2##3##(2006-12#1)(2008-3#1)
starts from the##2##3##(2008-7#1)(2009-10#1)
starts from##4##2##(2006-12#1)(2008-3#1)(2008-7#1)(2009-10#1)
starts in the##3##3##(1994-11#1)(2008-10#1)(2013-8#1)
starts in##7##2##(1990-4#1)(1994-11#1)(2008-10#1)(2008-4#1)(2009-10#1)(2011-2#1)(2013-8#1)
starts out##2##2##(1994-5#1)(2011-12#1)
starts the##2##2##(2008-10#2)
starts to##12##2##(1994-11#1)(1994-3#1)(1997-6#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)(2009-2#1)(2012-12#1)
starts with a##7##3##(1990-9#1)(1991-2#1)(1991-8#1)(2007-7#1)(2009-7#1)(2010-10#1)(2011-2#1)
starts with an##3##3##(1992-9#1)(2006-7#1)(2011-12#1)
starts with the##6##3##(1995-5#1)(2007-11#1)(2007-4#1)(2008-7#1)(2010-11#1)(2012-2#1)
starts with##26##2##(1990-9#1)(1991-2#1)(1991-8#1)(1992-9#1)(1994-1#1)(1995-1#1)(1995-2#1)(1995-5#1)(2006-7#1)(2007-11#2)(2007-4#1)(2007-7#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)
starts##85##1##(1990-4#1)(1990-7#1)(1990-9#3)(1991-11#2)(1991-2#1)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-1#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-6#1)(2005-7#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-2#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2011-1#3)(2011-12#2)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
startup##5##1##(2008-11#4)(2010-8#1)
startups##2##1##(2007-2#1)(2008-11#1)
starvation and##5##2##(1990-11#1)(1995-2#1)(1995-6#1)(1996-1#1)(2008-4#1)
starvation conditions##2##2##(1996-5#1)(2012-12#1)
starvation in##5##2##(1991-11#1)(2008-7#2)(2013-1#2)
starvation of the##3##3##(1993-6#1)(1997-6#1)(2009-8#1)
starvation of##9##2##(1993-6#1)(1997-6#1)(2007-12#2)(2008-9#3)(2009-8#1)(2013-1#1)
starvation on the##2##3##(1996-8#1)(2008-11#1)
starvation on##3##2##(1996-8#2)(2008-11#1)
starvation period##2##2##(2008-6#1)(2008-7#1)
starvation resistance in##3##3##(2008-6#3)
starvation resistance##5##2##(2008-6#5)
starvation to##2##2##(1991-2#1)(1994-11#1)
starvation was##2##2##(2008-7#2)
starvation##104##1##(1990-11#3)(1990-2#1)(1990-7#1)(1991-11#2)(1991-2#2)(1992-3#1)(1992-7#1)(1993-6#2)(1993-9#1)(1994-11#2)(1994-5#1)(1995-1#2)(1995-2#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-10#2)(1996-2#1)(1996-4#1)(1996-5#1)(1996-8#3)(1997-6#2)(2005-8#2)(2007-11#1)(2007-12#4)(2008-10#1)(2008-11#7)(2008-12#2)(2008-4#5)(2008-6#7)(2008-7#12)(2008-8#1)(2008-9#4)(2009-3#2)(2009-8#2)(2010-10#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#5)(2013-1#8)
starved for##3##2##(1995-8#2)(2007-9#1)
starved semi-batch##2##2##(2007-11#2)
starved yeast cells##2##3##(1994-8#2)
starved##17##1##(1991-2#1)(1991-8#1)(1993-12#1)(1994-11#1)(1994-8#2)(1995-12#1)(1995-3#1)(1995-8#2)(2007-11#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
starving##5##1##(2008-5#1)(2009-8#1)(2011-2#1)(2012-1#2)
stasis and rupture##2##3##(1991-9#2)
stasis and##6##2##(1991-9#2)(2008-11#1)(2008-5#1)(2010-6#1)(2012-2#1)
stasis in the##2##3##(1992-5#1)(1994-3#1)
stasis in##3##2##(1992-5#1)(1994-3#1)(2013-1#1)
stasis of##2##2##(1995-5#1)(2012-3#1)
stasis ulcers often recur as a result of continuing venous insufficiency##2##11##(2013-1#2)
stasis ulcers##12##2##(2005-7#1)(2008-5#1)(2013-1#10)
stasis##38##1##(1991-9#3)(1992-5#1)(1994-3#2)(1995-5#1)(1996-3#1)(2005-7#1)(2006-2#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-2#1)(2009-8#1)(2010-6#3)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#13)(2013-8#2)
stat strategy##2##2##(2005-12#2)
stat##9##1##(1990-2#1)(1992-1#1)(1993-1#1)(1996-5#1)(2005-12#2)(2006-4#1)(2013-1#2)
state &quot##2##2##(2007-9#1)(2008-11#1)
state (or##2##2##(1991-2#1)(2007-9#1)
state 1##3##2##(1994-5#1)(2006-10#1)(2010-8#1)
state 2##2##2##(1994-5#1)(2010-8#1)
state 3 respiration##4##3##(1990-2#1)(1994-12#2)(2004-12#1)
state 3##12##2##(1990-2#1)(1990-8#2)(1994-12#2)(1996-9#1)(2004-12#1)(2005-11#2)(2005-8#2)(2010-8#1)
state 4 and state##2##4##(1990-8#1)(1996-9#1)
state 4 and##3##3##(1990-8#1)(1996-9#2)
state 4 respiration##2##3##(1990-2#1)(2005-8#1)
state 4##8##2##(1990-2#1)(1990-8#2)(1996-9#2)(2005-8#2)(2010-8#1)
state I##7##2##(1992-2#3)(1996-3#1)(2006-10#3)
state III respiration rates##2##4##(1994-8#2)
state III respiration##4##3##(1994-8#4)
state III##6##2##(1994-8#5)(2006-12#1)
state III/DNP##3##2##(1994-8#3)
state Medicaid programs##2##3##(1995-12#1)(1997-2#1)
state Medicaid##3##2##(1995-12#1)(1995-3#1)(1997-2#1)
state abortion restrictions##2##3##(1994-2#2)
state abortion##3##2##(1994-2#2)(1996-6#1)
state accompanying##2##2##(2007-11#1)(2008-10#1)
state according##2##2##(2008-10#1)(2011-1#1)
state activities##2##2##(1997-3#1)(1997-7#1)
state after##3##2##(1994-11#1)(2008-6#1)(2008-7#1)
state agencies##9##2##(1997-1#1)(1997-2#1)(1997-3#1)(2005-7#2)(2006-11#1)(2006-12#1)(2007-8#1)(2008-10#1)
state also##2##2##(1993-2#1)(2008-2#1)
state analog##2##2##(1991-5#2)
state analysis##2##2##(1994-3#1)(2005-4#1)
state and a##4##3##(1993-2#1)(2006-10#1)(2007-12#1)(2008-5#1)
state and after##2##3##(2008-10#1)(2008-8#1)
state and by##2##3##(2007-12#2)
state and can##2##3##(2008-2#1)(2008-3#1)
state and federal##10##3##(1994-3#1)(1995-1#1)(1995-2#1)(1996-1#2)(1997-3#1)(2007-4#1)(2008-2#1)(2010-9#1)(2013-8#1)
state and future##4##3##(2007-4#1)(2010-3#1)(2011-2#1)(2012-11#1)
state and in the##2##4##(1991-9#1)(2008-2#1)
state and in##9##3##(1991-9#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#2)
state and its##5##3##(1995-3#1)(1996-11#1)(2005-1#1)(2009-8#1)(2013-1#1)
state and local governments##3##4##(1992-3#1)(1993-2#1)(1995-1#1)
state and local health departments##2##5##(1991-8#1)(1997-3#1)
state and local health##4##4##(1991-8#1)(1996-3#1)(1997-3#1)(2011-9#1)
state and local public health##6##5##(1995-12#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(2007-11#1)
state and local##25##3##(1991-8#1)(1992-3#1)(1993-2#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#2)(1997-2#3)(1997-3#1)(2007-11#1)(2008-11#1)(2008-6#1)(2011-9#3)(2013-1#4)
state and national##3##3##(1992-1#1)(1997-3#1)(2011-1#1)
state and of##5##3##(1997-2#1)(2006-4#1)(2007-6#1)(2010-5#1)(2012-12#1)
state and on##4##3##(1990-3#1)(1990-8#1)(1992-2#1)(1996-3#1)
state and that##5##3##(1991-7#1)(1994-3#1)(1995-1#1)(2007-9#1)(2008-1#1)
state and the##16##3##(1993-9#1)(1996-1#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-5#1)(2005-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-9#1)(2012-12#1)(2013-1#1)
state and to##2##3##(1991-4#1)(1992-8#1)
state and##207##2##(1990-11#1)(1990-2#1)(1990-3#4)(1990-6#1)(1990-8#1)(1991-4#3)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-2#1)(1992-3#2)(1992-8#2)(1993-12#1)(1993-2#3)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-3#2)(1994-9#1)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#4)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#3)(1996-6#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#6)(1997-3#3)(1997-4#2)(1997-5#1)(2005-1#1)(2005-11#3)(2005-12#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-4#3)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#6)(2007-4#3)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#9)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-9#2)(2011-1#1)(2011-2#5)(2011-9#3)(2012-11#2)(2012-12#2)(2012-3#3)(2013-1#9)(2013-8#3)
state anxiety level##7##3##(1990-8#7)
state anxiety##15##2##(1990-8#11)(1995-12#1)(1996-8#1)(2010-6#2)
state are presented##2##3##(1997-7#1)(2006-1#1)
state are##14##2##(1990-5#1)(1991-2#1)(1994-2#1)(1996-2#2)(1997-7#3)(2005-10#1)(2006-1#1)(2007-11#1)(2008-7#1)(2008-8#1)(2009-12#1)
state as the##2##3##(1995-6#1)(2012-12#1)
state as well as the##3##5##(1997-2#1)(1997-7#1)(2005-7#1)
state as well as##6##4##(1997-2#1)(1997-7#1)(2005-7#1)(2008-3#1)(2008-5#1)(2011-2#1)
state as##14##2##(1993-2#1)(1995-6#1)(1997-2#1)(1997-7#1)(2005-7#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
state associated with a##2##4##(1991-3#1)(2011-2#1)
state associated with##4##3##(1991-3#1)(2010-12#1)(2011-2#1)(2012-3#1)
state at pH##4##3##(1990-8#2)(1993-8#2)
state at##14##2##(1990-7#1)(1990-8#2)(1993-8#2)(1994-8#1)(1995-12#1)(1996-5#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
state attorneys general##2##3##(2008-11#2)
state becomes##3##2##(1997-4#1)(2008-10#2)
state behavior of##2##3##(2005-11#1)(2008-11#1)
state between##2##2##(1996-5#1)(2008-7#1)
state body satisfaction##2##3##(2007-12#2)
state body##3##2##(2007-12#3)
state breast cancer##2##3##(1997-1#1)(2007-12#1)
state but##3##2##(1992-5#1)(1993-4#1)(2013-7#1)
state by the##4##3##(2007-12#1)(2008-1#2)(2011-2#1)
state by##24##2##(1990-11#1)(1991-7#1)(1993-5#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-8#1)(1996-8#1)(1997-4#1)(2005-4#1)(2007-10#1)(2007-12#3)(2008-1#2)(2008-10#1)(2008-4#1)(2009-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
state can be##7##3##(1990-2#1)(1997-2#1)(1997-6#1)(2005-11#1)(2008-7#1)(2009-6#1)(2011-1#1)
state can##9##2##(1990-2#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#1)(2008-7#1)(2009-6#1)(2011-1#1)
state changes in##2##3##(2007-9#2)
state changes##4##2##(2007-9#2)(2013-1#2)
state characterized by the##2##4##(2006-10#2)
state conditions##4##2##(1990-2#1)(2008-1#1)(2008-10#2)
state containing##2##2##(1992-6#1)(2006-10#1)
state contributions##2##2##(2010-12#1)(2013-8#1)
state control##2##2##(2005-5#1)(2006-4#1)
state death##2##2##(2007-10#1)(2008-6#1)
state dependent##2##2##(1993-3#1)(2009-7#1)
state distributions##2##2##(1990-12#1)(1995-5#1)
state does not##3##3##(1993-3#1)(1996-12#1)(1996-3#1)
state due to##5##3##(1996-3#1)(2007-9#1)(2008-1#1)(2013-1#2)
state during##8##2##(1990-12#1)(1992-6#1)(1993-2#1)(1994-9#2)(2010-12#1)(2011-2#1)(2012-3#1)
state energy##6##2##(1991-8#1)(2009-12#2)(2009-9#1)(2010-2#2)
state enzyme##3##2##(1994-9#1)(1997-7#2)
state estimation problems for##2##4##(2009-12#2)
state evaluations##2##2##(1993-2#1)(1997-3#1)
state evoked by the##2##4##(2013-8#2)
state examination (MMSE)##4##3##(2006-4#1)(2008-7#2)(2013-8#1)
state examination##5##2##(2006-4#1)(2007-3#1)(2008-7#2)(2013-8#1)
state exists##3##2##(2010-5#1)(2012-12#1)(2013-8#1)
state featured##2##2##(2008-2#2)
state fluorescence##4##2##(1994-8#1)(1995-3#1)(2008-10#2)
state following##3##2##(1990-11#1)(1991-2#1)(1993-2#1)
state for its##2##3##(1995-4#1)(2007-11#1)
state for##23##2##(1990-2#1)(1990-8#1)(1991-5#1)(1991-6#1)(1991-7#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#2)(1995-4#1)(1996-11#2)(1996-7#2)(1997-3#1)(1997-6#1)(2007-11#1)(2008-11#1)(2009-5#1)(2011-1#1)
state free##2##2##(2010-8#1)(2011-2#1)
state from which##2##3##(2007-9#2)
state from##7##2##(1991-4#1)(2007-9#2)(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#1)
state funding##2##2##(1990-12#1)(1995-2#1)
state government and##2##3##(1994-12#1)(2012-3#1)
state government##4##2##(1994-12#1)(1997-1#1)(1997-3#1)(2012-3#1)
state governments and##3##3##(1996-1#1)(2006-8#1)(2007-4#1)
state governments##8##2##(1993-2#1)(1995-1#1)(1995-2#1)(1996-1#1)(1997-3#1)(2006-8#1)(2007-4#2)
state had##2##2##(1991-6#1)(2011-2#1)
state has been##3##3##(1996-6#1)(2008-6#1)(2012-12#1)
state has##5##2##(1995-5#1)(1996-6#1)(2008-6#1)(2009-9#1)(2012-12#1)
state have been##4##3##(1991-11#1)(2008-10#2)(2013-1#1)
state have##5##2##(1991-11#1)(1995-1#1)(2008-10#2)(2013-1#1)
state health agencies to##3##4##(1997-1#3)
state health agencies##5##3##(1995-12#1)(1997-1#4)
state health agency##3##3##(1996-2#1)(1997-1#1)(1997-2#1)
state health department##2##3##(1995-12#1)(2007-11#1)
state health departments reported##3##4##(1991-11#1)(1992-1#1)(1992-5#1)
state health departments##7##3##(1991-11#1)(1992-1#1)(1992-5#1)(1994-2#1)(1996-3#1)(1997-2#1)(1997-3#1)
state health reform##2##3##(1994-2#1)(1997-3#1)
state health services commissions##3##4##(1996-12#1)(1997-2#2)
state health##30##2##(1991-11#1)(1991-12#1)(1992-1#1)(1992-5#1)(1994-2#2)(1995-12#2)(1995-2#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#5)(1997-2#4)(1997-3#3)(2007-11#1)(2013-8#1)
state hospital association##3##3##(1991-4#2)(2008-11#1)
state hospital##6##2##(1991-4#2)(1992-6#1)(1996-3#1)(1996-9#1)(2008-11#1)
state hospitals##4##2##(1992-8#1)(1995-1#1)(2008-12#1)(2011-7#1)
state in a##4##3##(1995-10#1)(2007-11#1)(2008-3#1)(2009-10#1)
state in an##2##3##(1995-12#1)(1997-4#1)
state in homogeneous##2##3##(2013-7#2)
state in solution##3##3##(1991-5#1)(2006-10#1)(2011-1#1)
state in the absence of##2##5##(2006-10#1)(2008-4#1)
state in the presence of##4##5##(1993-6#2)(1996-5#1)(2008-5#1)
state in the##28##3##(1991-9#1)(1992-7#1)(1993-6#2)(1993-9#1)(1994-10#1)(1995-9#1)(1996-3#1)(1996-5#3)(1997-2#2)(2005-3#1)(2005-4#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#2)(2009-3#1)(2010-5#1)(2011-2#1)(2013-1#1)
state in vivo##3##3##(1995-12#1)(1997-6#1)(2008-9#1)
state in which they##2##4##(1995-11#1)(2012-2#1)
state in which##6##3##(1991-11#1)(1995-11#1)(1995-12#1)(1996-11#1)(2011-1#1)(2012-2#1)
state in##100##2##(1990-3#2)(1991-11#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-7#1)(1993-2#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-5#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-5#3)(1996-8#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(2005-1#1)(2005-3#1)(2005-4#1)(2006-10#2)(2006-2#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-1#3)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#1)
state inactivation##2##2##(1993-12#1)(2008-8#1)
state induced by##2##3##(1990-10#1)(2009-4#1)
state into##3##2##(2006-9#1)(2007-12#1)(2013-7#1)
state is a##4##3##(2007-9#1)(2008-1#1)(2011-2#2)
state is at##2##3##(2007-12#1)(2008-7#1)
state is controlled by##2##4##(2006-10#1)(2007-12#1)
state is found##2##3##(2006-10#1)(2011-1#1)
state is known##2##3##(2007-7#1)(2008-10#1)
state is more robust than the##2##6##(2013-7#2)
state is not##3##3##(1994-5#1)(1996-1#1)(2007-7#1)
state is##62##2##(1990-8#2)(1991-10#1)(1991-2#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-1#1)(1996-11#1)(1996-8#1)(1997-4#2)(1997-5#1)(1997-7#1)(2005-10#1)(2005-4#1)(2006-10#2)(2006-7#1)(2007-11#1)(2007-12#4)(2007-7#3)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-7#2)
state it##2##2##(2008-11#1)(2012-1#1)
state itself##3##2##(1993-9#1)(2007-12#1)(2008-1#1)
state known as##2##3##(2008-5#1)(2008-9#1)
state law##6##2##(1991-10#1)(1995-9#1)(1996-2#1)(1996-5#1)(1997-7#1)(2008-4#1)
state laws##4##2##(1991-2#1)(2006-8#1)(2010-2#2)
state leading to##2##3##(1991-9#1)(1992-1#1)
state legislation##4##2##(2008-11#4)
state legislative##2##2##(1990-11#1)(2007-3#1)
state legislators##2##2##(2008-11#2)
state legislatures##4##2##(2007-4#1)(2008-12#1)(2008-4#1)(2012-2#1)
state level##9##2##(1994-12#3)(1994-6#1)(1996-5#1)(2005-12#1)(2008-6#1)(2008-8#2)
state levels were associated with##2##5##(2007-12#2)
state levels were##3##3##(1992-3#1)(2007-12#2)
state levels##18##2##(1990-3#1)(1991-12#2)(1991-5#1)(1992-3#1)(1992-8#1)(1993-12#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-3#1)(1997-2#1)(2007-12#2)(2008-11#1)(2012-12#1)(2013-8#1)
state licensure and##2##3##(1992-1#1)(2013-1#1)
state management##3##2##(1996-3#1)(2008-1#2)
state marker##4##2##(1990-10#3)(1996-7#1)
state may##8##2##(1992-8#2)(1994-3#1)(1996-5#1)(2006-10#1)(2006-11#1)(2008-11#1)(2008-9#1)
state mental health##3##3##(1993-1#1)(1995-2#2)
state mental##5##2##(1993-1#1)(1995-2#3)(1996-9#1)
state model##2##2##(1996-12#1)(2010-8#1)
state name##2##2##(1990-11#2)
state near##4##2##(1997-7#1)(2008-2#3)
state nursing##2##2##(1996-3#1)(2012-3#1)
state observed##2##2##(1995-5#1)(1997-7#1)
state of Bahia##4##3##(1993-3#1)(2008-8#1)(2009-10#2)
state of Espírito Santo##2##4##(1993-3#1)(2007-5#1)
state of Espírito##3##3##(1993-3#1)(2007-5#2)
state of Goiás##2##3##(2008-10#1)(2011-2#1)
state of SecA##2##3##(1997-7#2)
state of São Paulo##7##4##(1996-12#1)(2006-5#1)(2006-8#2)(2008-10#2)(2011-2#1)
state of Tamil Nadu##4##4##(2007-10#1)(2007-6#1)(2011-1#1)(2012-3#1)
state of a sphingomyeline cycle and##2##6##(2013-1#2)
state of a##21##3##(1991-9#1)(1993-11#1)(1994-9#1)(1996-2#1)(2006-10#1)(2006-6#1)(2007-11#3)(2007-12#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-9#1)(2010-2#2)(2013-1#2)
state of academic cancer surgery in the UK##2##8##(2009-4#2)
state of activation##3##3##(1995-1#1)(2006-11#1)(2008-9#1)
state of adrenal##2##3##(1994-2#1)(2006-10#1)
state of adult##2##3##(1996-3#1)(2008-8#1)
state of affairs##6##3##(1991-1#1)(2007-6#1)(2008-11#1)(2009-5#1)(2011-2#1)(2013-1#1)
state of aggregation of##3##4##(1994-5#2)(2005-11#1)
state of alcoholization##2##3##(1991-12#1)(1996-8#1)
state of an##3##3##(1996-4#1)(2007-12#1)(2008-3#1)
state of art and##2##4##(1993-2#1)(2006-6#1)
state of art##4##3##(1993-2#1)(2006-6#1)(2008-11#1)(2013-1#1)
state of both##2##3##(1993-4#1)(2013-1#1)
state of cells##3##3##(1990-2#1)(2008-5#1)(2012-2#1)
state of clinical##2##3##(2007-7#1)(2010-2#1)
state of consciousness##2##3##(1993-8#1)(2010-6#1)
state of conservation##2##3##(2008-2#1)(2008-4#1)
state of cytochrome##2##3##(1994-8#1)(1997-6#1)
state of differentiation##3##3##(1990-5#1)(1992-3#1)(2008-11#1)
state of diphenyloctatetraene##2##3##(2006-4#2)
state of glutathione and membrane proteins##2##6##(1995-1#2)
state of glutathione and##3##4##(1994-6#1)(1995-1#2)
state of health##9##3##(1992-3#1)(1993-11#1)(1994-4#1)(1994-9#1)(1997-1#1)(2006-10#1)(2011-2#1)(2013-1#2)
state of increased##2##3##(1990-3#1)(2011-1#1)
state of insulin resistance and##2##5##(2007-8#1)(2011-1#1)
state of insulin resistance##4##4##(1996-5#1)(2007-8#2)(2011-1#1)
state of internal Ca2+ stores##2##5##(1995-3#2)
state of internal Ca2+##3##4##(1995-3#3)
state of ionization##2##3##(2006-10#2)
state of its##2##3##(1992-8#1)(2009-11#1)
state of knowledge and##3##4##(2006-10#1)(2007-11#1)(2010-5#1)
state of knowledge of the##2##5##(2007-12#1)(2008-10#1)
state of knowledge of##3##4##(2007-12#1)(2008-10#1)(2010-3#1)
state of knowledge on the##3##5##(1990-8#1)(1995-11#1)(2007-11#1)
state of knowledge on##4##4##(1990-8#1)(1995-11#1)(2007-11#1)(2012-2#1)
state of knowledge##25##3##(1990-8#1)(1991-3#1)(1995-11#1)(2005-8#1)(2006-10#1)(2007-11#5)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-6#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-5#1)(2012-2#2)(2012-3#1)(2013-7#1)
state of management of##2##4##(2008-1#1)(2008-5#1)
state of medical##2##3##(2007-6#1)(2012-2#1)
state of membrane##2##3##(1992-5#1)(1995-1#1)
state of mind##3##3##(1993-8#1)(1994-2#1)(2013-1#1)
state of our knowledge##2##4##(2007-8#1)(2009-2#1)
state of our##3##3##(2007-8#2)(2009-2#1)
state of oxidative stress##3##4##(2008-5#2)(2011-1#1)
state of play##2##3##(2012-12#1)(2013-8#1)
state of polarization between##2##4##(2008-2#2)
state of polarization of##7##4##(2007-12#2)(2008-2#4)(2008-3#1)
state of polarization##26##3##(2007-11#1)(2007-12#8)(2008-2#10)(2008-3#7)
state of protein##4##3##(1995-4#1)(2008-7#1)(2010-12#1)(2010-9#1)
state of rebalance##2##3##(2013-1#2)
state of rhodopsin##2##3##(1994-9#1)(2006-3#1)
state of some##2##3##(1991-12#1)(1993-11#1)
state of staphylococcal nuclease##3##4##(1992-6#1)(1994-9#1)(1995-4#1)
state of stress##2##3##(1996-4#1)(2008-4#1)
state of the alpha##3##4##(1990-7#2)(1991-7#1)
state of the animal##5##4##(1992-10#1)(1994-10#2)(1996-2#1)(2007-12#1)
state of the art and science##3##6##(2006-8#2)(2013-1#1)
state of the art and##7##5##(1993-3#1)(1994-6#1)(2006-8#2)(2007-5#1)(2012-12#1)(2013-1#1)
state of the art for##3##5##(1994-6#1)(1995-2#1)(2008-4#1)
state of the art in the##2##6##(2006-10#1)(2009-12#1)
state of the art in##12##5##(2004-2#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-8#1)(2010-9#2)
state of the art of##7##5##(1991-4#1)(1993-3#1)(2007-8#1)(2008-5#1)(2009-12#1)(2012-2#1)(2012-3#1)
state of the art technology##2##5##(2007-8#1)(2009-4#1)
state of the art##65##4##(1991-12#1)(1991-4#1)(1991-9#1)(1993-3#3)(1994-6#2)(1994-8#1)(1995-2#1)(1995-5#2)(2004-2#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-6#2)(2006-8#3)(2006-9#1)(2007-12#2)(2007-5#1)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-12#2)(2009-4#1)(2009-5#1)(2010-12#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-12#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#1)
state of the art&quot##2##4##(2008-2#1)(2011-12#1)
state of the art]##3##4##(1990-4#1)(1996-11#1)(2013-8#1)
state of the cell##4##4##(1993-8#1)(1995-9#1)(2008-7#1)(2012-3#1)
state of the enzyme##5##4##(1990-2#1)(1990-8#1)(1994-3#1)(1997-1#1)(1997-2#1)
state of the laser##2##4##(2007-12#1)(2008-2#1)
state of the lipid##2##4##(1991-5#2)
state of the literature##2##4##(2008-5#1)(2009-7#1)
state of the molecule##2##4##(1990-8#1)(1995-1#1)
state of the patient and##2##5##(1990-10#1)(2006-5#1)
state of the patient##7##4##(1990-10#1)(1993-5#1)(1995-12#1)(2006-10#1)(2006-5#1)(2009-7#1)(2013-7#1)
state of the protein##3##4##(1991-2#1)(1991-5#1)(1996-7#1)
state of the receptor##2##4##(1990-2#1)(1994-3#1)
state of the science of##2##5##(2007-9#1)(2009-5#1)
state of the science##5##4##(1992-3#1)(2007-9#1)(2009-5#2)(2010-9#1)
state of the sigmoid colon##2##5##(2011-11#2)
state of the system##2##4##(1992-6#1)(2008-8#1)
state of the##239##3##(1990-10#1)(1990-12#1)(1990-2#4)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#5)(1991-1#4)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-7#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-12#1)(1993-3#3)(1993-5#1)(1993-8#1)(1994-10#3)(1994-11#2)(1994-12#2)(1994-3#2)(1994-6#3)(1994-8#3)(1994-9#2)(1995-1#2)(1995-10#1)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#1)(1995-9#2)(1996-11#3)(1996-2#4)(1996-4#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-7#3)(2004-2#1)(2005-1#1)(2005-11#2)(2005-8#1)(2006-10#5)(2006-12#2)(2006-5#3)(2006-6#4)(2006-7#2)(2006-8#3)(2006-9#1)(2007-12#8)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#3)(2008-1#3)(2008-10#14)(2008-11#5)(2008-2#4)(2008-3#7)(2008-4#3)(2008-5#6)(2008-7#6)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#4)(2009-7#2)(2009-9#1)(2010-12#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#3)(2010-9#3)(2011-11#2)(2011-12#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
state of these##3##3##(1990-12#1)(1997-6#1)(2005-11#1)
state of this##3##3##(1994-3#1)(1995-6#1)(2006-6#1)
state of well-being##3##3##(2006-8#1)(2008-2#1)(2011-2#1)
state of young##3##3##(2006-8#1)(2011-1#2)
state of##788##2##(1990-10#2)(1990-12#3)(1990-2#8)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#8)(1991-1#6)(1991-11#2)(1991-12#8)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#4)(1991-6#1)(1991-7#5)(1991-9#4)(1992-10#1)(1992-11#2)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#3)(1992-9#3)(1993-11#4)(1993-12#2)(1993-2#4)(1993-3#6)(1993-4#2)(1993-5#2)(1993-6#4)(1993-8#8)(1994-10#4)(1994-11#3)(1994-12#4)(1994-2#4)(1994-3#6)(1994-4#1)(1994-5#3)(1994-6#6)(1994-8#5)(1994-9#9)(1995-1#9)(1995-10#3)(1995-11#3)(1995-12#5)(1995-2#2)(1995-3#6)(1995-4#3)(1995-5#3)(1995-6#5)(1995-7#1)(1995-8#1)(1995-9#2)(1996-10#2)(1996-11#8)(1996-12#3)(1996-2#6)(1996-3#1)(1996-4#4)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#8)(1997-4#2)(1997-6#4)(1997-7#7)(1997-8#1)(2003-11#1)(2004-2#1)(2004-3#1)(2004-8#1)(2005-1#2)(2005-11#7)(2005-4#2)(2005-7#3)(2005-8#5)(2005-9#1)(2006-10#21)(2006-11#1)(2006-12#2)(2006-3#2)(2006-4#2)(2006-5#5)(2006-6#9)(2006-7#3)(2006-8#8)(2006-9#1)(2007-10#4)(2007-11#15)(2007-12#29)(2007-3#2)(2007-4#4)(2007-5#5)(2007-6#3)(2007-7#4)(2007-8#13)(2007-9#4)(2008-1#15)(2008-10#43)(2008-11#13)(2008-12#2)(2008-2#22)(2008-3#23)(2008-4#12)(2008-5#17)(2008-6#5)(2008-7#10)(2008-8#10)(2008-9#6)(2009-10#6)(2009-11#1)(2009-12#3)(2009-2#2)(2009-4#5)(2009-5#6)(2009-6#1)(2009-7#5)(2009-8#2)(2009-9#2)(2010-11#3)(2010-12#10)(2010-2#6)(2010-3#1)(2010-4#2)(2010-5#5)(2010-6#4)(2010-7#4)(2010-8#5)(2010-9#5)(2011-1#11)(2011-11#2)(2011-12#5)(2011-2#21)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#7)(2012-2#12)(2012-3#11)(2013-1#20)(2013-7#2)(2013-8#14)
state officials##2##2##(1992-3#1)(1996-12#1)
state on the##4##3##(1990-8#1)(1995-2#1)(2004-9#1)(2006-4#1)
state on##10##2##(1990-8#1)(1994-9#1)(1995-10#1)(1995-2#1)(2004-9#2)(2006-4#1)(2008-2#1)(2008-7#1)(2012-2#1)
state or local##3##3##(1995-2#1)(2011-9#1)(2012-1#1)
state or##14##2##(1990-9#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-3#1)(2008-11#1)(2008-2#1)(2011-9#1)(2012-1#1)(2013-1#3)(2013-8#1)
state over##2##2##(1991-4#1)(1993-3#1)
state policy##2##2##(2008-12#1)(2013-1#1)
state population##3##2##(2008-8#1)(2013-1#2)
state present##2##2##(1991-10#1)(1994-6#1)
state progresses##2##2##(1994-3#1)(2008-2#1)
state public health##4##3##(1995-2#2)(1997-3#1)(2008-1#1)
state public##5##2##(1995-2#2)(1997-3#1)(2008-1#1)(2012-3#1)
state reaction##5##2##(1991-7#1)(2005-11#2)(2008-10#1)(2010-7#1)
state regulation##3##2##(1995-2#1)(2010-2#2)
state regulations and##2##3##(2008-3#1)(2013-1#1)
state regulations##4##2##(1995-2#2)(2008-3#1)(2013-1#1)
state regulatory##2##2##(1996-1#1)(2011-1#1)
state response##2##2##(1997-3#1)(2008-10#1)
state restrictions on##3##3##(1994-2#3)
state resulting##2##2##(1991-9#1)(1996-3#1)
state space models in##2##4##(2008-11#2)
state space models##5##3##(2008-11#5)
state space##15##2##(2008-11#9)(2008-2#3)(2008-8#1)(2008-9#2)
state spaces##2##2##(2008-2#2)
state specific##2##2##(2007-6#1)(2009-6#1)
state structure##3##2##(1990-8#1)(1992-9#1)(2008-4#1)
state such as##2##3##(2006-8#1)(2013-7#1)
state than in the##3##4##(1997-2#1)(2008-10#1)(2013-1#1)
state than the##2##3##(1996-10#1)(2008-8#1)
state than##8##2##(1994-8#1)(1996-10#1)(1996-6#1)(1997-2#1)(2005-11#1)(2008-10#1)(2008-8#1)(2013-1#1)
state that can##2##3##(2007-11#1)(2008-12#1)
state that is##6##3##(1991-7#1)(1994-8#1)(1996-4#1)(2007-12#1)(2010-8#1)(2013-8#1)
state that the##5##3##(1997-3#1)(2006-12#1)(2007-11#1)(2007-8#1)(2011-1#1)
state that they have##2##4##(2008-1#1)(2012-2#1)
state that they##5##3##(1993-2#2)(2006-10#1)(2008-1#1)(2012-2#1)
state that##41##2##(1990-2#1)(1991-5#1)(1991-7#1)(1993-2#3)(1994-1#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-9#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-1#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
state the##3##2##(1994-3#1)(1995-11#1)(2011-2#1)
state through a##2##3##(1995-3#1)(2008-4#1)
state through##4##2##(1991-8#1)(1995-3#1)(2008-4#1)(2012-12#1)
state thus##2##2##(1991-7#1)(2010-8#1)
state to a##3##3##(1996-6#1)(2007-12#1)(2008-3#1)
state to an##2##3##(2008-10#1)(2010-6#1)
state to another##2##3##(2007-12#1)(2008-10#1)
state to be##3##3##(1996-11#1)(2008-2#1)(2008-6#1)
state to the##2##3##(1995-4#1)(2008-11#1)
state to##33##2##(1991-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1995-12#1)(1995-4#1)(1995-8#1)(1996-11#1)(1996-6#1)(1996-8#1)(1997-4#2)(1997-8#1)(2006-8#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#2)(2013-1#1)
state transition##4##2##(1990-9#1)(1993-5#1)(1996-5#1)(2008-2#1)
state under both##2##3##(1995-7#1)(2008-11#1)
state under##5##2##(1994-9#1)(1995-7#1)(1996-11#1)(1997-2#1)(2008-11#1)
state upon##4##2##(1995-10#1)(1996-6#1)(1997-7#1)(2008-10#1)
state using##2##2##(2008-10#1)(2010-6#1)
state variable##2##2##(1995-6#1)(2008-10#1)
state variables are##2##3##(2008-11#1)(2013-1#1)
state variables##11##2##(2008-11#5)(2008-2#4)(2009-12#1)(2013-1#1)
state versus##3##2##(1992-6#1)(1997-8#1)(2012-1#1)
state via##4##2##(1993-3#1)(1994-12#1)(2007-12#1)(2008-5#1)
state was achieved##2##3##(1991-12#1)(2008-10#1)
state was also##2##3##(1992-9#1)(2008-10#1)
state was not##2##3##(1993-12#1)(2006-7#1)
state was reached##2##3##(1993-4#1)(2010-6#1)
state was##35##2##(1991-12#1)(1991-6#1)(1992-5#1)(1992-7#1)(1992-9#3)(1993-12#2)(1993-2#1)(1993-4#1)(1994-12#1)(1994-6#1)(1995-8#1)(1995-9#1)(1996-8#1)(1997-8#2)(2004-12#1)(2006-7#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-7#1)
state were##10##2##(1990-12#1)(1991-9#1)(2004-12#1)(2005-11#1)(2006-8#1)(2007-7#1)(2007-9#1)(2008-3#1)(2008-7#1)(2011-2#1)
state when##3##2##(1996-8#1)(2007-6#1)(2008-9#1)
state where##2##2##(1995-2#1)(2008-9#1)
state which##8##2##(1992-6#1)(1993-12#1)(1995-8#1)(1996-11#1)(2007-12#1)(2008-9#1)(2011-1#1)(2012-2#1)
state with a##4##3##(1995-5#1)(2007-2#1)(2008-3#1)(2008-7#1)
state with high##2##3##(2007-11#1)(2008-11#1)
state with the##4##3##(1991-7#1)(1995-10#1)(2008-3#1)(2009-8#1)
state with##26##2##(1990-2#1)(1991-3#1)(1991-7#1)(1995-1#2)(1995-10#1)(1995-5#1)(2005-10#1)(2006-4#1)(2007-11#2)(2007-2#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-7#3)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
state within the##2##3##(1994-12#1)(2008-4#1)
state without##3##2##(1995-2#1)(2010-8#1)(2012-2#1)
state##2951##1##(1990-10#7)(1990-11#10)(1990-12#17)(1990-2#21)(1990-3#17)(1990-4#3)(1990-5#11)(1990-6#4)(1990-7#13)(1990-8#39)(1990-9#6)(1991-1#8)(1991-10#3)(1991-11#7)(1991-12#15)(1991-2#15)(1991-3#10)(1991-4#12)(1991-5#14)(1991-6#6)(1991-7#18)(1991-8#8)(1991-9#12)(1992-1#9)(1992-10#1)(1992-11#3)(1992-12#2)(1992-2#12)(1992-3#9)(1992-4#2)(1992-5#5)(1992-6#11)(1992-7#4)(1992-8#15)(1992-9#11)(1993-1#2)(1993-11#15)(1993-12#15)(1993-2#23)(1993-3#13)(1993-4#7)(1993-5#5)(1993-6#9)(1993-8#13)(1993-9#7)(1994-1#1)(1994-10#8)(1994-11#21)(1994-12#21)(1994-2#21)(1994-3#18)(1994-4#2)(1994-5#9)(1994-6#10)(1994-8#25)(1994-9#25)(1995-1#27)(1995-10#19)(1995-11#7)(1995-12#22)(1995-2#29)(1995-3#23)(1995-4#12)(1995-5#13)(1995-6#12)(1995-7#3)(1995-8#9)(1995-9#8)(1996-1#17)(1996-10#4)(1996-11#23)(1996-12#15)(1996-2#25)(1996-3#26)(1996-4#8)(1996-5#17)(1996-6#13)(1996-7#8)(1996-8#16)(1996-9#12)(1997-1#19)(1997-2#40)(1997-3#23)(1997-4#29)(1997-5#5)(1997-6#16)(1997-7#34)(1997-8#11)(2003-11#1)(2004-11#3)(2004-12#4)(2004-2#1)(2004-3#1)(2004-8#1)(2004-9#4)(2005-1#4)(2005-10#14)(2005-11#25)(2005-12#2)(2005-3#1)(2005-4#10)(2005-5#2)(2005-7#8)(2005-8#9)(2005-9#1)(2006-1#2)(2006-10#54)(2006-11#4)(2006-12#7)(2006-2#8)(2006-3#5)(2006-4#11)(2006-5#8)(2006-6#9)(2006-7#7)(2006-8#16)(2006-9#6)(2007-1#7)(2007-10#12)(2007-11#42)(2007-12#85)(2007-2#3)(2007-3#7)(2007-4#12)(2007-5#6)(2007-6#13)(2007-7#14)(2007-8#25)(2007-9#22)(2008-1#53)(2008-10#165)(2008-11#80)(2008-12#10)(2008-2#76)(2008-3#60)(2008-4#34)(2008-5#53)(2008-6#17)(2008-7#59)(2008-8#37)(2008-9#32)(2009-1#1)(2009-10#13)(2009-11#7)(2009-12#19)(2009-2#5)(2009-3#3)(2009-4#10)(2009-5#13)(2009-6#11)(2009-7#12)(2009-8#12)(2009-9#11)(2010-1#4)(2010-10#3)(2010-11#4)(2010-12#27)(2010-2#27)(2010-3#3)(2010-4#7)(2010-5#20)(2010-6#18)(2010-7#8)(2010-8#20)(2010-9#8)(2011-1#39)(2011-11#2)(2011-12#7)(2011-2#64)(2011-3#1)(2011-7#2)(2011-9#5)(2012-1#11)(2012-11#5)(2012-12#30)(2012-2#43)(2012-3#29)(2013-1#66)(2013-7#14)(2013-8#40)
state&quot##3##1##(1995-3#1)(2008-9#2)
state's##22##1##(1990-2#1)(1991-8#1)(1992-6#4)(1992-8#1)(1993-6#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-4#1)(2007-5#1)(2007-9#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#2)
state) of##2##2##(1990-4#1)(2010-5#1)
state)##18##1##(1990-4#1)(1995-1#1)(1995-3#1)(1995-4#1)(1996-12#1)(1997-2#1)(2006-8#3)(2007-10#1)(2007-6#2)(2008-10#1)(2010-10#2)(2010-5#1)(2012-12#1)(2013-1#1)
state-by-state##3##1##(1994-12#1)(1995-2#1)(1995-3#1)
state-dependent##9##1##(1991-8#1)(1996-4#2)(2008-1#2)(2008-8#3)(2010-8#1)
state-level data##3##2##(2011-1#2)(2013-1#1)
state-level##5##1##(2008-8#1)(2011-1#3)(2013-1#1)
state-of-the art##2##2##(2009-5#1)(2010-3#1)
state-of-the-art CTC technique##2##3##(2012-2#2)
state-of-the-art and##2##2##(2006-6#1)(2008-10#1)
state-of-the-art methods##3##2##(2007-5#1)(2009-7#1)(2012-2#1)
state-of-the-art of##5##2##(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-7#1)
state-of-the-art techniques##2##2##(2008-2#1)(2008-4#1)
state-of-the-art technology##3##2##(2005-12#1)(2008-8#1)(2010-5#1)
state-of-the-art##70##1##(1991-1#1)(1992-11#1)(1992-2#1)(1995-7#1)(1996-1#1)(1997-8#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#10)(2008-3#5)(2008-4#4)(2008-7#1)(2008-8#3)(2008-9#2)(2009-5#3)(2009-7#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#3)(2010-7#1)(2010-9#2)(2011-1#1)(2011-7#1)(2012-12#1)(2012-2#4)(2013-8#1)
state-operated##3##1##(1992-3#1)(1996-12#1)(2007-11#1)
state-run##3##1##(1991-1#1)(2008-9#1)(2012-3#1)
state-specific##2##1##(2008-2#2)
state-wide##3##1##(1996-2#1)(2007-9#1)(2008-8#1)
state?##3##1##(1991-12#1)(1996-12#1)(2008-8#1)
state]##7##1##(1994-4#1)(1996-11#1)(2006-5#1)(2006-6#1)(2008-8#1)(2010-4#1)(2013-1#1)
stated as##5##2##(1990-4#1)(1992-6#1)(2006-10#1)(2006-8#1)(2007-2#1)
stated by the##2##3##(1991-2#1)(2010-5#1)
stated by##7##2##(1991-2#1)(1991-6#2)(1992-2#1)(2008-7#1)(2009-8#1)(2010-5#1)
stated for##2##2##(1997-4#1)(1997-7#1)
stated in the##6##3##(1992-7#1)(1995-2#1)(2005-7#3)(2006-12#1)
stated in##16##2##(1992-7#1)(1995-2#1)(2005-7#3)(2006-12#1)(2006-8#1)(2007-11#3)(2007-4#1)(2007-7#1)(2013-1#4)
stated that the##13##3##(1990-11#1)(1992-11#1)(1993-3#1)(1995-6#2)(1996-9#1)(1997-8#1)(2005-7#1)(2007-11#1)(2008-11#1)(2008-5#1)(2009-4#1)(2011-2#1)
stated that their##3##3##(1996-1#1)(2010-6#1)(2013-1#1)
stated that there is##2##4##(2008-3#1)(2010-10#1)
stated that there##3##3##(1996-6#1)(2008-3#1)(2010-10#1)
stated that they had##3##4##(2008-11#1)(2011-2#2)
stated that they would##3##4##(1991-2#1)(2007-2#2)
stated that they##9##3##(1991-2#1)(1991-3#1)(2007-2#2)(2008-11#1)(2009-4#1)(2011-2#2)(2012-2#1)
stated that##61##2##(1990-11#1)(1991-2#2)(1991-3#1)(1992-11#2)(1993-3#1)(1993-6#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-1#2)(1996-11#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-5#1)(1997-8#1)(2005-7#3)(2006-4#1)(2007-11#2)(2007-2#4)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-4#2)(2009-8#2)(2010-10#1)(2010-6#2)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
stated they would##3##3##(1992-2#1)(1996-12#1)(2013-1#1)
stated##143##1##(1990-10#1)(1990-11#1)(1990-4#1)(1991-2#3)(1991-3#1)(1991-6#2)(1992-11#2)(1992-2#4)(1992-6#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#3)(1995-5#1)(1995-6#2)(1996-1#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-7#6)(2006-10#3)(2006-12#1)(2006-4#1)(2006-8#2)(2006-9#1)(2007-11#6)(2007-12#2)(2007-2#6)(2007-4#2)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2009-4#2)(2009-8#3)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#2)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#7)(2013-8#1)
stateless##2##1##(2008-10#1)(2011-2#1)
statement by the##3##3##(1996-3#1)(2011-2#1)(2012-12#1)
statement by##4##2##(1996-3#1)(2007-1#1)(2011-2#1)(2012-12#1)
statement can be made##2##4##(2011-2#2)
statement for the##2##3##(2008-12#1)(2010-6#1)
statement for##3##2##(1996-8#1)(2008-12#1)(2010-6#1)
statement from the##3##3##(2008-7#1)(2009-10#1)(2013-7#1)
statement from##4##2##(2008-7#1)(2009-10#1)(2012-2#1)(2013-7#1)
statement in##2##2##(1992-5#1)(1993-3#1)
statement is##4##2##(1996-2#1)(2006-8#2)(2007-7#1)
statement of the##6##3##(1996-1#1)(2007-4#1)(2007-9#2)(2008-3#1)(2009-11#1)
statement of##13##2##(1990-2#1)(1992-10#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-4#1)(2006-7#1)(2007-4#1)(2007-9#2)(2008-3#1)(2009-11#1)(2010-12#1)
statement on the##4##3##(1991-3#1)(2009-10#1)(2009-8#2)
statement on##25##2##(1991-3#1)(1993-3#2)(1994-9#1)(1995-11#2)(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-5#1)(2005-8#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-10#1)(2009-4#1)(2009-8#2)(2012-2#2)
statement regarding the##4##3##(1995-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
statement regarding##5##2##(1995-12#1)(2007-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
statement that &quot##2##3##(2005-10#1)(2008-11#1)
statement that##5##2##(1997-1#1)(2005-10#1)(2008-11#2)(2008-3#1)
statement to be##2##3##(1993-11#1)(2007-4#1)
statement to##3##2##(1993-11#1)(2007-4#1)(2008-6#1)
statement was##3##2##(1996-11#1)(2008-10#1)(2010-11#1)
statement were##2##2##(2008-10#1)(2009-8#1)
statement##131##1##(1990-2#1)(1991-11#1)(1991-3#1)(1992-10#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-3#4)(1994-1#1)(1994-9#1)(1995-11#2)(1995-12#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#9)(1996-3#2)(1996-4#2)(1996-8#1)(1997-1#1)(1997-5#1)(2005-10#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-3#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-4#9)(2007-7#2)(2007-9#2)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#5)(2008-9#1)(2009-10#2)(2009-11#1)(2009-4#2)(2009-6#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#4)(2013-1#4)(2013-7#1)
statements about##6##2##(2006-6#3)(2012-1#1)(2013-1#2)
statements and their##2##3##(1992-2#1)(2007-4#1)
statements and##6##2##(1992-12#1)(1992-2#1)(1992-4#1)(2004-9#1)(2007-4#1)(2008-10#1)
statements are available##2##3##(1990-5#1)(2005-8#1)
statements are##4##2##(1990-5#1)(2005-8#1)(2008-4#1)(2009-4#1)
statements by##2##2##(1996-11#1)(2011-2#1)
statements can be##2##3##(2006-8#1)(2007-4#1)
statements concerning##5##2##(2006-10#1)(2006-6#2)(2007-12#1)(2007-5#1)
statements in the##2##3##(2007-4#1)(2008-9#1)
statements in these##2##3##(2006-10#1)(2011-2#1)
statements in##6##2##(2006-10#1)(2007-4#2)(2008-9#1)(2011-1#1)(2011-2#1)
statements made by the##2##4##(1990-11#1)(1996-11#1)
statements made##3##2##(1990-11#1)(1996-11#2)
statements more##2##2##(1990-5#1)(1997-3#1)
statements of the##3##3##(2007-3#1)(2013-1#2)
statements of##5##2##(2006-7#1)(2007-3#1)(2008-5#1)(2013-1#2)
statements on##4##2##(1991-12#1)(2006-9#1)(2009-11#1)(2010-2#1)
statements regarding the management of##2##5##(2008-11#1)(2010-11#1)
statements regarding##4##2##(1997-1#1)(2006-12#1)(2008-11#1)(2010-11#1)
statements that were##2##3##(2009-8#1)(2011-2#1)
statements that##7##2##(1992-2#1)(2007-4#1)(2008-11#2)(2009-8#1)(2011-2#2)
statements were##5##2##(1992-12#1)(1993-1#1)(2008-3#1)(2008-9#1)(2009-8#1)
statements##100##1##(1990-11#1)(1990-5#2)(1991-1#1)(1991-12#1)(1992-12#2)(1992-2#2)(1992-4#1)(1993-1#1)(1993-12#2)(1996-11#3)(1997-1#2)(1997-3#2)(2004-9#1)(2005-7#2)(2005-8#2)(2006-10#2)(2006-12#2)(2006-3#1)(2006-6#5)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#7)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-9#2)(2009-11#2)(2009-4#2)(2009-8#3)(2010-11#1)(2010-2#1)(2011-1#2)(2011-2#8)(2012-1#4)(2012-12#1)(2013-1#10)
states (e##3##2##(2008-4#3)
states (such as##2##3##(2008-3#2)
states (the##2##2##(2008-8#1)(2009-8#1)
states II##2##2##(2006-10#2)
states a##2##2##(2006-10#1)(2008-2#1)
states along##2##2##(1995-5#1)(2007-6#1)
states and for##2##3##(1997-2#1)(2008-3#1)
states and in##3##3##(1992-12#1)(2005-7#1)(2006-10#1)
states and the District of Columbia##2##6##(2010-5#1)(2010-9#1)
states and the##10##3##(1993-6#1)(1994-11#1)(1995-2#1)(2008-2#1)(2009-1#1)(2009-6#1)(2009-8#1)(2010-5#1)(2010-9#1)(2013-1#1)
states and##58##2##(1992-12#1)(1993-5#1)(1993-6#2)(1994-11#1)(1995-2#1)(1995-4#2)(1995-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(2005-7#1)(2006-10#2)(2006-6#1)(2006-7#2)(2007-11#2)(2007-12#1)(2007-9#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-1#1)(2009-2#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2012-12#1)(2012-3#2)(2013-1#1)
states and/or##2##2##(2008-11#1)(2010-7#1)
states are 0##2##3##(1994-11#2)
states are also##2##3##(2009-2#1)(2013-8#1)
states are not##3##3##(1990-8#1)(2008-7#1)(2011-2#1)
states are##36##2##(1990-8#1)(1991-12#1)(1991-4#1)(1992-3#2)(1993-11#1)(1994-11#2)(1994-3#1)(1996-11#1)(1996-12#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-4#2)(2008-7#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-9#1)(2011-2#1)(2012-2#2)(2013-8#1)
states as well as##4##4##(1996-7#1)(2008-10#1)(2009-10#1)(2012-3#1)
states as##9##2##(1996-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-10#1)(2010-2#1)(2010-9#1)(2012-3#1)
states associated with##2##3##(1997-7#1)(2008-2#1)
states at the##2##3##(1991-6#1)(1995-11#1)
states at##7##2##(1991-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#1)(2008-10#2)
states being##2##2##(2006-10#1)(2010-6#1)
states but also##2##3##(2008-12#1)(2009-10#1)
states but##5##2##(2007-6#1)(2008-12#1)(2009-10#1)(2011-1#1)(2012-3#1)
states by##4##2##(1990-5#1)(1996-5#1)(2007-12#1)(2009-11#1)
states can be##7##3##(1990-3#1)(1990-9#1)(2007-11#1)(2008-4#1)(2008-7#1)(2012-2#1)(2012-3#1)
states can propagate##2##3##(2007-11#1)(2007-12#1)
states can##14##2##(1990-3#1)(1990-9#1)(1994-2#1)(1995-9#1)(2006-12#1)(2007-11#2)(2007-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2012-2#1)(2012-3#1)
states characterized by##2##3##(2008-3#1)(2008-4#1)
states determines##2##2##(2008-2#1)(2009-11#1)
states due to##2##3##(1996-9#1)(2008-7#1)
states during the##2##3##(1991-6#1)(2009-2#1)
states during##6##2##(1991-6#1)(1996-10#1)(2007-11#1)(2007-12#1)(2009-2#1)(2009-5#1)
states following##2##2##(2008-3#1)(2008-7#1)
states for the##3##3##(1992-6#1)(1994-8#1)(2010-5#1)
states for##14##2##(1991-9#1)(1992-6#1)(1994-8#1)(1996-5#1)(1996-7#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-5#1)(2012-12#1)
states from##2##2##(2008-11#1)(2010-2#1)
states has##3##2##(1993-3#1)(2007-5#1)(2008-3#1)
states have been##4##3##(2005-4#1)(2007-11#2)(2007-5#1)
states have##8##2##(1997-3#1)(2005-4#1)(2007-11#2)(2007-2#1)(2007-5#1)(2010-4#1)(2012-1#1)
states in India##6##3##(2006-4#1)(2007-6#1)(2008-1#1)(2011-12#1)(2012-3#2)
states in a##4##3##(1995-3#1)(2007-11#1)(2007-12#1)(2012-2#1)
states in terms of##2##4##(1990-8#1)(2010-4#1)
states in the USA##2##4##(2006-2#1)(2013-8#1)
states in the##22##3##(1991-6#1)(1995-9#1)(1996-2#1)(1996-6#1)(1997-4#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-10#1)(2013-1#2)(2013-8#1)
states in which##2##3##(2005-7#1)(2008-1#1)
states in##89##2##(1990-7#1)(1990-8#1)(1990-9#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-2#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-2#3)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-4#1)(2007-11#4)(2007-12#8)(2007-5#1)(2007-6#1)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#6)(2008-8#2)(2009-11#1)(2009-12#1)(2009-2#2)(2010-10#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#1)
states involved##3##2##(1992-1#1)(1996-4#1)(2006-5#1)
states is##9##2##(1991-8#1)(1994-1#2)(1994-4#1)(2007-12#1)(2008-3#2)(2008-7#1)(2013-1#1)
states like##2##2##(1997-2#2)
states may be##3##3##(2008-1#1)(2012-1#2)
states may##9##2##(1992-2#1)(1992-5#1)(1993-6#1)(1993-9#1)(2008-1#1)(2012-1#3)(2012-2#1)
states near##2##2##(1992-8#1)(2005-4#1)
states of India##2##3##(2004-8#1)(2009-5#1)
states of a##4##3##(1993-5#1)(1993-8#1)(2007-11#1)(2008-2#1)
states of activation##2##3##(2006-11#2)
states of cytochrome c##2##4##(1994-8#1)(2009-9#1)
states of different##2##3##(2006-4#1)(2012-2#1)
states of fac-Re(CO)(3)(dpknph)Cl##2##3##(2008-10#2)
states of interest##2##3##(2008-11#1)(2011-2#1)
states of polarization##9##3##(2007-11#2)(2007-12#4)(2008-2#2)(2008-3#1)
states of the DNA##2##4##(1994-3#1)(2012-2#1)
states of the channels##2##4##(1995-2#1)(2007-12#1)
states of the neurons##2##4##(2008-11#1)(2009-8#1)
states of the protein##3##4##(1991-2#1)(1991-6#1)(1994-11#1)
states of the sodium##2##4##(1992-9#1)(2008-3#1)
states of the##54##3##(1990-5#1)(1990-8#2)(1991-2#1)(1991-4#1)(1991-6#2)(1992-12#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-11#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#1)(1996-6#1)(1997-4#2)(1997-7#3)(2005-4#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#2)(2009-8#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-8#1)
states of##175##2##(1990-2#4)(1990-5#2)(1990-6#1)(1990-8#3)(1991-12#1)(1991-2#1)(1991-4#3)(1991-6#2)(1991-7#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-3#2)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#1)(1996-11#2)(1996-2#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#3)(1997-7#6)(1997-8#1)(2004-8#1)(2005-4#5)(2006-10#2)(2006-11#3)(2006-12#1)(2006-2#1)(2006-4#3)(2007-1#1)(2007-11#5)(2007-12#13)(2007-3#2)(2007-4#1)(2007-9#2)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#8)(2008-5#2)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2011-1#6)(2011-2#3)(2012-2#3)(2012-3#1)(2012-4#1)(2013-7#1)(2013-8#2)
states on the basis of##2##5##(1991-4#1)(2012-2#1)
states on the##5##3##(1991-4#1)(1993-4#1)(1996-4#1)(2008-7#1)(2012-2#1)
states on##7##2##(1991-4#1)(1993-4#1)(1996-4#1)(2008-4#1)(2008-7#1)(2009-5#1)(2012-2#1)
states or##4##2##(1994-3#1)(1995-4#1)(2008-2#1)(2009-12#1)
states over a##2##3##(2007-9#1)(2011-2#1)
states rather than##2##3##(2006-10#1)(2008-10#1)
states reported##2##2##(1991-6#1)(1992-1#1)
states should be##2##3##(2008-3#1)(2010-4#1)
states should##3##2##(1996-12#1)(2008-3#1)(2010-4#1)
states such as##4##3##(1991-8#1)(1993-11#1)(1995-12#1)(2006-10#1)
states that are##4##3##(2006-10#1)(2008-2#1)(2010-12#1)(2010-4#1)
states that differ##2##3##(2007-12#1)(2010-2#1)
states that it is##3##4##(1995-6#1)(1996-1#1)(2013-7#1)
states that the##3##3##(1996-5#1)(2007-11#1)(2008-4#1)
states that##41##2##(1991-6#1)(1993-2#1)(1995-6#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#2)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#3)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
states this##3##2##(1991-4#2)(1997-1#1)
states to##12##2##(1994-5#1)(1995-12#1)(1995-3#1)(1996-5#1)(1997-1#3)(1997-3#1)(2008-10#1)(2008-4#1)(2009-11#1)(2012-2#1)
states under##4##2##(1997-2#1)(2006-6#1)(2008-11#1)(2011-2#1)
states using the##2##3##(1993-3#1)(2013-1#1)
states using##4##2##(1993-3#1)(2006-1#1)(2007-9#1)(2013-1#1)
states was##8##2##(1990-10#1)(1995-4#1)(1995-7#1)(1996-5#1)(2007-5#1)(2008-10#1)(2008-7#1)(2012-2#1)
states were also##2##3##(2008-9#1)(2012-12#1)
states were induced##2##3##(1990-3#1)(2013-8#1)
states were measured##2##3##(2007-12#1)(2008-6#1)
states were##20##2##(1990-3#1)(1993-11#1)(1994-6#1)(1995-12#1)(1995-3#2)(1995-9#1)(1996-1#1)(2004-9#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2012-12#1)(2013-8#1)
states when##2##2##(2008-3#1)(2010-12#1)
states where the##2##3##(2008-11#1)(2011-2#1)
states where##4##2##(1996-12#1)(2008-11#1)(2010-12#1)(2011-2#1)
states which do not##2##4##(1994-2#1)(1996-1#1)
states which##5##2##(1993-5#1)(1994-2#2)(1996-1#1)(2008-7#1)
states will##2##2##(2007-10#1)(2008-10#1)
states with the##3##3##(2006-7#1)(2008-10#1)(2008-7#1)
states with##24##2##(1992-6#1)(1992-8#1)(1994-2#2)(1995-4#1)(1996-11#1)(1996-8#1)(2006-7#1)(2007-12#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#3)(2009-7#1)(2012-1#1)(2012-2#1)(2012-3#2)
states within the##2##3##(2008-10#1)(2009-3#1)
states within##3##2##(2008-10#2)(2009-3#1)
states without##3##2##(1994-12#1)(1994-2#1)(2011-2#1)
states##1138##1##(1990-10#2)(1990-11#7)(1990-12#1)(1990-2#4)(1990-3#3)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#3)(1990-8#6)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#3)(1991-4#9)(1991-5#1)(1991-6#8)(1991-7#4)(1991-8#4)(1991-9#4)(1992-1#4)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#3)(1992-3#4)(1992-4#2)(1992-5#6)(1992-6#7)(1992-7#2)(1992-8#10)(1992-9#4)(1993-1#1)(1993-11#5)(1993-12#4)(1993-2#2)(1993-3#7)(1993-4#3)(1993-5#4)(1993-6#6)(1993-7#1)(1993-8#4)(1993-9#2)(1994-1#4)(1994-10#2)(1994-11#12)(1994-12#6)(1994-2#10)(1994-3#5)(1994-4#2)(1994-5#3)(1994-6#4)(1994-8#5)(1994-9#2)(1995-1#5)(1995-10#2)(1995-11#4)(1995-12#10)(1995-2#9)(1995-3#8)(1995-4#8)(1995-5#9)(1995-6#4)(1995-7#3)(1995-8#4)(1995-9#6)(1996-1#5)(1996-10#1)(1996-11#9)(1996-12#3)(1996-2#5)(1996-3#4)(1996-4#3)(1996-5#7)(1996-6#4)(1996-7#6)(1996-8#4)(1996-9#2)(1997-1#8)(1997-2#9)(1997-3#6)(1997-4#10)(1997-5#2)(1997-6#1)(1997-7#12)(1997-8#2)(2004-8#1)(2004-9#2)(2005-11#4)(2005-12#1)(2005-4#10)(2005-7#4)(2005-8#3)(2006-1#1)(2006-10#30)(2006-11#6)(2006-12#6)(2006-2#5)(2006-3#2)(2006-4#4)(2006-5#2)(2006-6#4)(2006-7#5)(2007-1#2)(2007-10#2)(2007-11#33)(2007-12#51)(2007-2#2)(2007-3#4)(2007-4#3)(2007-5#5)(2007-6#4)(2007-7#7)(2007-8#5)(2007-9#16)(2008-1#8)(2008-10#66)(2008-11#24)(2008-12#7)(2008-2#33)(2008-3#44)(2008-4#23)(2008-5#13)(2008-6#1)(2008-7#37)(2008-8#15)(2008-9#8)(2009-1#1)(2009-10#10)(2009-11#6)(2009-12#4)(2009-2#7)(2009-3#4)(2009-5#4)(2009-6#2)(2009-7#2)(2009-8#8)(2009-9#4)(2010-10#4)(2010-11#1)(2010-12#13)(2010-2#6)(2010-3#1)(2010-4#10)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#7)(2010-9#4)(2011-1#15)(2011-12#2)(2011-2#22)(2012-1#9)(2012-12#10)(2012-2#26)(2012-3#20)(2012-4#1)(2013-1#21)(2013-7#2)(2013-8#11)
states'##6##1##(1997-1#2)(2005-11#1)(2006-2#1)(2008-11#1)(2012-3#1)
states)##7##1##(1993-1#1)(1994-2#3)(2007-12#1)(2008-10#1)(2009-5#1)
states?##2##1##(1997-5#1)(1997-7#1)
statesman##4##1##(2007-10#1)(2007-4#1)(2008-12#1)(2009-10#1)
statewide hospital##3##2##(1996-12#1)(2013-1#2)
statewide##32##1##(1991-2#1)(1992-1#1)(1993-2#1)(1994-12#1)(1995-1#2)(1995-12#2)(1996-1#2)(1996-11#1)(1996-12#2)(1996-3#2)(1997-1#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-4#2)(2008-2#1)(2008-6#3)(2008-9#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
static Fourier-transform spectrometer##2##3##(2008-2#1)(2008-3#1)
static Fourier-transform##4##2##(2008-2#2)(2008-3#2)
static SDME##2##2##(2008-10#2)
static and dynamic balance##2##4##(1990-6#1)(2006-10#1)
static and dynamic conditions##2##4##(2007-4#1)(2010-2#1)
static and dynamic light scattering##4##5##(1994-3#1)(2006-10#1)(2008-2#1)(2008-4#1)
static and dynamic light-scattering##2##4##(2008-2#1)(2008-3#1)
static and dynamic modes##2##4##(2008-10#1)(2010-7#1)
static and dynamic proprioception of the knee##2##7##(2007-11#1)(2007-7#1)
static and dynamic##39##3##(1990-6#1)(1990-7#1)(1993-12#1)(1994-3#1)(1995-12#1)(1995-3#1)(2004-9#1)(2006-10#2)(2006-11#2)(2006-7#1)(2007-11#3)(2007-4#2)(2007-7#2)(2007-8#1)(2008-10#7)(2008-2#2)(2008-3#5)(2008-4#1)(2008-9#1)(2010-2#1)(2010-7#1)(2011-2#1)
static and moving objects##2##4##(1996-1#1)(2008-2#1)
static and time-varying##3##3##(2006-10#1)(2008-2#1)(2008-3#1)
static and##58##2##(1990-6#1)(1990-7#1)(1992-3#1)(1993-12#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-1#1)(1997-4#1)(2004-9#1)(2006-10#3)(2006-11#2)(2006-7#1)(2007-11#3)(2007-4#2)(2007-7#2)(2007-8#2)(2008-10#9)(2008-11#1)(2008-2#6)(2008-3#8)(2008-4#1)(2008-9#1)(2009-1#2)(2010-2#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-7#1)
static balance##2##2##(1996-7#1)(2009-10#1)
static biofilm systems##2##3##(2008-9#2)
static biofilm##3##2##(2008-9#3)
static case##2##2##(1997-6#1)(2008-11#1)
static cell##4##2##(2006-12#1)(2008-2#1)(2008-3#2)
static compliance##2##2##(1991-9#2)
static conditions##7##2##(1990-12#2)(2005-11#1)(2007-4#1)(2008-11#1)(2008-4#1)(2009-12#1)
static culture##7##2##(1994-10#1)(2008-11#2)(2008-5#3)(2008-6#1)
static cytometry##2##2##(1991-6#1)(2008-9#1)
static electric field##3##3##(2007-12#3)
static electric##4##2##(2005-11#1)(2007-12#3)
static extraction time##2##3##(2008-10#2)
static extraction##4##2##(2008-10#4)
static face##2##2##(2008-4#2)
static force##2##2##(2005-11#1)(2007-5#1)
static forces##2##2##(2005-11#1)(2007-5#1)
static friction##2##2##(2008-5#2)
static headspace (HS)##2##3##(2008-10#2)
static headspace gas chromatographic##2##4##(2008-10#2)
static headspace gas##3##3##(2008-10#3)
static headspace##5##2##(2008-10#5)
static images##4##2##(2013-1#4)
static imaging method##2##3##(2008-10#2)
static imaging##4##2##(2008-10#3)(2008-2#1)
static incubation##2##2##(1991-5#1)(2008-11#1)
static interference##3##2##(2007-12#1)(2013-8#2)
static layer##2##2##(2005-11#2)
static light scattering##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#1)
static light-scattering instrument##2##3##(2007-11#2)
static light-scattering##6##2##(1991-7#1)(2007-11#3)(2008-3#2)
static magnetic field##4##3##(2007-12#3)(2010-2#1)
static magnetic fields##2##3##(1992-3#1)(1994-5#1)
static magnetic##6##2##(1992-3#1)(1994-5#1)(2007-12#3)(2010-2#1)
static mechanical##4##2##(2004-9#2)(2008-7#1)(2011-2#1)
static mercury drop electrode (SMDE)##4##5##(2008-10#4)
static mercury drop electrode##10##4##(2008-10#10)
static mode sampling##2##3##(2008-10#2)
static mode##3##2##(2008-10#3)
static objects##3##2##(2008-2#2)(2008-3#1)
static or##5##2##(1992-12#1)(1994-9#1)(2008-3#1)(2008-8#1)(2011-2#1)
static out-of-position airbag tests##2##4##(2007-4#2)
static out-of-position airbag##3##3##(2007-4#3)
static phase##4##2##(2008-2#1)(2008-3#3)
static picture##2##2##(2008-7#1)(2010-2#1)
static quenching effect##2##3##(2008-10#2)
static quenching##4##2##(1997-1#1)(2008-10#3)
static seeding##3##2##(2011-2#3)
static strain##2##2##(2007-12#1)(2008-2#1)
static strength##2##2##(2004-9#1)(2006-11#1)
static structure##4##2##(2006-5#1)(2008-2#2)(2008-4#1)
static tester##2##2##(2008-3#2)
static time##2##2##(2008-10#2)
static ultrasonic##3##2##(2008-10#3)
static##363##1##(1990-10#1)(1990-12#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-5#5)(1991-6#1)(1991-7#1)(1991-9#3)(1992-12#2)(1992-3#2)(1992-6#2)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-3#2)(1994-5#1)(1994-8#4)(1994-9#1)(1995-1#3)(1995-10#4)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-9#4)(2005-11#13)(2005-12#1)(2005-4#1)(2006-10#5)(2006-11#5)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#13)(2007-12#14)(2007-4#10)(2007-5#2)(2007-7#4)(2007-8#3)(2008-10#58)(2008-11#12)(2008-12#1)(2008-2#22)(2008-3#34)(2008-4#8)(2008-5#9)(2008-6#4)(2008-7#5)(2008-8#3)(2008-9#9)(2009-1#3)(2009-10#2)(2009-12#2)(2009-3#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#5)(2010-3#2)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#8)(2012-1#4)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#3)(2013-8#8)
statically##7##1##(1990-8#1)(2007-9#1)(2008-10#1)(2008-3#2)(2010-2#1)(2011-2#1)
statics##2##1##(2007-7#1)(2010-12#1)
statin dose##2##2##(2013-1#2)
statin drugs##3##2##(2006-10#1)(2010-2#1)(2011-1#1)
statin medication##2##2##(2006-10#1)(2008-3#1)
statin therapy in##6##3##(1997-2#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)
statin therapy is##2##3##(2008-3#1)(2008-7#1)
statin therapy##24##2##(1997-2#3)(2008-11#1)(2008-3#4)(2008-7#2)(2009-11#3)(2009-12#1)(2010-12#2)(2010-4#1)(2011-2#2)(2013-1#2)(2013-8#3)
statin treatment##12##2##(2007-8#4)(2009-10#1)(2009-5#4)(2011-2#2)(2013-8#1)
statin use##4##2##(2007-8#2)(2009-5#1)(2010-12#1)
statin##71##1##(1991-6#1)(1993-11#2)(1997-2#3)(2005-10#1)(2005-9#1)(2006-10#5)(2006-5#1)(2007-1#1)(2007-8#7)(2008-11#1)(2008-3#5)(2008-7#2)(2009-10#1)(2009-11#9)(2009-12#1)(2009-4#2)(2009-5#5)(2010-12#4)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-3#1)(2013-1#5)(2013-8#5)
stating that a##2##3##(1993-7#1)(1996-5#1)
stating that the##2##3##(1996-11#1)(2009-2#1)
stating that##18##2##(1992-6#1)(1993-7#1)(1995-6#2)(1996-11#4)(1996-2#1)(1996-5#1)(2005-11#1)(2009-2#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#1)
stating##23##1##(1992-6#1)(1993-7#1)(1995-6#2)(1996-1#1)(1996-11#5)(1996-2#1)(1996-5#2)(2005-11#1)(2009-12#1)(2009-2#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
statins and fibrates##2##3##(2011-1#1)(2012-2#1)
statins and##9##2##(2006-5#1)(2008-10#1)(2008-12#1)(2009-4#1)(2009-6#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
statins are##2##2##(2013-1#2)
statins have##2##2##(2010-10#1)(2010-4#1)
statins in##9##2##(2006-2#1)(2006-5#1)(2008-5#1)(2009-11#1)(2010-9#1)(2012-1#1)(2013-1#3)
statins is##2##2##(2006-5#1)(2013-1#1)
statins to##3##2##(1997-2#1)(2008-1#1)(2010-12#1)
statins##93##1##(1997-2#1)(2005-10#2)(2005-7#1)(2005-8#2)(2006-10#3)(2006-2#1)(2006-5#9)(2007-1#4)(2007-11#2)(2007-8#2)(2008-1#6)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2009-11#2)(2009-4#2)(2009-6#3)(2010-10#4)(2010-12#1)(2010-2#2)(2010-4#7)(2010-8#1)(2010-9#2)(2011-1#2)(2012-1#1)(2012-2#2)(2012-3#1)(2012-6#1)(2013-1#13)(2013-8#3)
station 3 was##2##3##(2007-8#2)
station 3##3##2##(2007-8#3)
station during##2##2##(1994-11#1)(2007-5#1)
station in the##3##3##(2008-7#1)(2011-1#1)(2011-2#1)
station in##6##2##(2007-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2011-1#1)(2011-2#1)
station is##3##2##(2008-2#2)(2008-3#1)
station of the##2##3##(2008-10#1)(2010-1#1)
station of##4##2##(1993-12#1)(2008-10#1)(2008-12#1)(2010-1#1)
station were##2##2##(2007-5#1)(2012-2#1)
station##77##1##(1990-12#1)(1991-3#1)(1991-7#1)(1993-12#1)(1994-11#1)(1994-6#1)(1997-3#1)(2004-7#1)(2005-7#1)(2006-5#3)(2006-6#1)(2007-10#3)(2007-12#1)(2007-5#7)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#9)(2008-3#7)(2008-5#3)(2008-7#1)(2009-6#2)(2010-1#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#1)
stationarity##4##1##(2008-2#1)(2008-8#2)(2009-2#1)
stationary and##5##2##(1996-5#1)(1997-1#1)(2006-12#1)(2008-2#1)(2008-3#1)
stationary conditions##3##2##(2007-11#1)(2008-10#1)(2008-7#1)
stationary distribution##2##2##(1990-2#1)(2008-7#1)
stationary growth phase##2##3##(2008-11#1)(2008-8#1)
stationary growth##3##2##(1990-3#1)(2008-11#1)(2008-8#1)
stationary phase Chromosorb 105##2##4##(2008-10#2)
stationary phase and a##2##4##(2008-10#2)
stationary phase and an##2##4##(2008-10#1)(2008-5#1)
stationary phase and##15##3##(1996-5#1)(1996-8#1)(1997-3#1)(1997-5#1)(2008-10#8)(2008-4#1)(2008-5#1)(2008-7#1)
stationary phase at##3##3##(2008-10#2)(2008-11#1)
stationary phase by HPLC##3##4##(2008-10#3)
stationary phase by##4##3##(2008-10#4)
stationary phase for hydrophilic interaction chromatography##2##6##(2012-12#2)
stationary phase for the##2##4##(2008-10#2)
stationary phase for##14##3##(1991-5#2)(2008-10#6)(2012-12#2)(2013-8#4)
stationary phase has##2##3##(1996-8#1)(2012-12#1)
stationary phase in the##4##4##(1990-8#1)(2008-10#3)
stationary phase in##11##3##(1990-8#2)(1997-2#1)(2007-12#1)(2008-10#6)(2013-8#1)
stationary phase is##4##3##(1997-6#1)(2007-11#1)(2008-10#1)(2008-5#1)
stationary phase of growth##4##4##(1990-12#1)(2006-8#1)(2006-9#1)(2008-5#1)
stationary phase of the##2##4##(1997-4#1)(2008-10#1)
stationary phase of##11##3##(1990-12#1)(1997-4#1)(2005-12#1)(2006-8#1)(2006-9#1)(2008-10#4)(2008-11#1)(2008-5#1)
stationary phase surface##2##3##(2008-10#1)(2008-11#1)
stationary phase was##7##3##(1996-8#1)(2008-10#5)(2008-7#1)
stationary phase when##2##3##(1995-8#1)(2011-2#1)
stationary phase with##4##3##(2008-10#2)(2010-12#1)(2012-12#1)
stationary phase##194##2##(1990-12#3)(1990-7#1)(1990-8#2)(1991-12#2)(1991-3#1)(1991-5#3)(1992-1#2)(1992-2#2)(1993-2#1)(1994-9#1)(1995-3#1)(1995-8#3)(1996-11#2)(1996-5#1)(1996-8#5)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#5)(1997-8#1)(2005-11#1)(2005-12#2)(2006-10#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#2)(2007-8#3)(2008-10#95)(2008-11#8)(2008-4#1)(2008-5#4)(2008-7#6)(2009-6#1)(2010-12#1)(2010-2#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#6)(2012-2#1)(2012-3#1)(2013-8#7)
stationary phases and##4##3##(2008-10#3)(2013-8#1)
stationary phases by##2##3##(1997-8#1)(2008-10#1)
stationary phases for steroids were##2##5##(2008-10#2)
stationary phases for##7##3##(2008-10#6)(2011-1#1)
stationary phases in##3##3##(1996-5#1)(1997-8#1)(2008-10#1)
stationary phases is##2##3##(1996-8#2)
stationary phases of different##4##4##(2005-12#2)(2008-10#2)
stationary phases of##5##3##(2005-12#2)(2006-8#1)(2008-10#2)
stationary phases under##2##3##(1997-8#1)(2008-10#1)
stationary phases were##5##3##(2008-10#3)(2008-11#1)(2010-11#1)
stationary phases with the##2##4##(2008-10#2)
stationary phases with##3##3##(2008-10#2)(2011-1#1)
stationary phases##58##2##(1990-12#2)(1990-8#1)(1996-5#1)(1996-8#3)(1997-2#2)(1997-8#5)(2005-12#4)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#27)(2008-11#2)(2009-8#1)(2010-11#1)(2011-1#4)(2013-8#2)
stationary points##2##2##(2007-11#2)
stationary random##2##2##(2008-2#2)
stationary signal wave##2##3##(2008-3#2)
stationary solutions##2##2##(2007-12#2)
stationary state##2##2##(2008-3#1)(2012-1#1)
stationary states##3##2##(1990-3#3)
stationary time series##2##3##(2010-1#1)(2012-1#1)
stationary##345##1##(1990-12#5)(1990-2#1)(1990-3#4)(1990-7#1)(1990-8#3)(1991-12#2)(1991-3#1)(1991-5#3)(1992-1#2)(1992-2#3)(1993-2#2)(1994-10#1)(1994-2#1)(1994-9#1)(1995-3#3)(1995-8#3)(1996-11#3)(1996-5#4)(1996-8#8)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#5)(1997-8#6)(2005-11#1)(2005-12#6)(2006-10#1)(2006-12#1)(2006-8#3)(2006-9#1)(2007-11#8)(2007-12#16)(2007-8#5)(2008-1#1)(2008-10#128)(2008-11#16)(2008-2#12)(2008-3#9)(2008-4#1)(2008-5#6)(2008-7#8)(2008-8#2)(2008-9#3)(2009-6#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-8#1)(2011-1#6)(2011-2#5)(2012-1#4)(2012-12#7)(2012-2#2)(2012-3#2)(2013-8#9)
stationary-phase##3##1##(2007-12#2)(2012-3#1)
stations and the##2##3##(2008-2#1)(2009-4#1)
stations and##6##2##(1992-7#1)(2007-5#1)(2008-2#1)(2009-4#1)(2011-2#1)(2013-7#1)
stations are##2##2##(2008-10#1)(2013-7#1)
stations between##2##2##(2008-5#1)(2013-7#1)
stations during##3##2##(1997-4#1)(2011-2#2)
stations from##3##2##(2007-5#2)(2008-3#1)
stations in the##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2013-8#1)
stations in##13##2##(1991-12#1)(1991-9#1)(1993-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2009-6#1)(2011-2#1)(2013-8#2)
stations of the##2##3##(1990-3#1)(2008-5#1)
stations of##4##2##(1990-3#1)(2008-5#2)(2013-7#1)
stations were established##2##3##(2007-5#1)(2011-2#1)
stations were##8##2##(1997-4#1)(2007-3#1)(2007-5#2)(2008-10#1)(2008-5#1)(2011-2#1)(2012-1#1)
stations where##2##2##(1993-9#1)(2008-10#1)
stations within a##2##3##(2008-10#1)(2013-8#1)
stations##90##1##(1990-3#1)(1991-12#1)(1991-9#1)(1992-7#1)(1993-3#1)(1993-9#2)(1996-2#1)(1996-8#1)(1997-4#2)(1997-6#1)(2006-4#1)(2007-10#1)(2007-3#1)(2007-4#2)(2007-5#13)(2008-10#16)(2008-11#2)(2008-2#1)(2008-3#5)(2008-5#8)(2008-8#1)(2009-4#1)(2009-6#1)(2011-1#2)(2011-2#11)(2012-1#3)(2012-2#1)(2013-7#5)(2013-8#3)
stations) and##2##2##(2008-10#1)(2008-5#1)
stations)##5##1##(2008-10#1)(2008-5#3)(2012-2#1)
statistic analyses##2##2##(1994-9#1)(2006-9#1)
statistic analysis##3##2##(1990-10#1)(2009-8#1)(2013-1#1)
statistic and##3##2##(1994-8#1)(2007-8#1)(2011-1#1)
statistic based on##2##3##(1995-2#1)(1996-3#1)
statistic difference (P##2##3##(2005-4#2)
statistic difference##3##2##(2005-4#2)(2007-8#1)
statistic for##8##2##(1995-12#1)(1996-3#1)(1997-3#1)(2008-12#1)(2010-2#1)(2012-3#1)(2013-1#2)
statistic has##2##2##(2006-6#1)(2007-2#1)
statistic in a##2##3##(1995-6#1)(2006-6#1)
statistic in##4##2##(1995-6#1)(1996-3#1)(2006-6#1)(2006-7#1)
statistic is based on##2##4##(1995-4#1)(1997-3#1)
statistic is##7##2##(1992-9#1)(1995-4#1)(1996-3#1)(1997-3#2)(2008-10#1)(2013-8#1)
statistic that##3##2##(2008-10#1)(2008-8#1)(2012-3#1)
statistic to##2##2##(1995-4#1)(2006-7#1)
statistic was used##2##3##(2008-10#1)(2011-1#1)
statistic was##5##2##(2006-7#1)(2008-10#2)(2010-2#1)(2011-1#1)
statistic##107##1##(1990-10#1)(1990-3#1)(1990-8#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#1)(1994-4#1)(1994-5#1)(1994-8#1)(1994-9#3)(1995-12#1)(1995-2#3)(1995-4#2)(1995-6#2)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#6)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#5)(2005-4#2)(2006-6#2)(2006-7#4)(2006-9#1)(2007-11#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#13)(2008-12#1)(2008-2#2)(2008-3#3)(2008-7#1)(2008-8#2)(2009-12#1)(2009-2#2)(2009-8#1)(2010-2#8)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#2)(2012-3#2)(2013-1#3)(2013-8#5)
statistic)##2##1##(2008-7#2)
statistical agreement with##2##3##(2008-10#2)
statistical agreement##3##2##(2008-10#3)
statistical algorithm##2##2##(2008-2#2)
statistical analyses are##2##3##(1992-12#1)(2010-7#1)
statistical analyses of##3##3##(2008-7#2)(2008-8#1)
statistical analyses were conducted##2##4##(2008-5#1)(2008-7#1)
statistical analyses were##4##3##(2007-10#1)(2008-5#1)(2008-7#1)(2013-8#1)
statistical analyses##20##2##(1992-12#1)(2007-10#1)(2008-1#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
statistical analysis and##3##3##(2007-1#1)(2008-1#1)(2008-7#1)
statistical analysis are##2##3##(2008-10#1)(2008-8#1)
statistical analysis for##4##3##(2008-7#1)(2013-1#3)
statistical analysis is##4##3##(1990-5#1)(1992-3#1)(2008-2#1)(2008-4#1)
statistical analysis of the data##3##5##(2008-10#2)(2010-4#1)
statistical analysis of the obtained##2##5##(2007-5#1)(2009-11#1)
statistical analysis of the results##3##5##(1991-12#1)(2008-10#2)
statistical analysis of the various##2##5##(1990-3#1)(2008-2#1)
statistical analysis of the##23##4##(1990-3#2)(1990-9#1)(1991-12#1)(1997-7#1)(2007-11#1)(2007-5#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#2)(2008-9#1)(2009-11#1)(2009-3#1)(2010-4#1)(2013-1#2)
statistical analysis of##47##3##(1990-2#1)(1990-3#2)(1990-7#1)(1990-9#1)(1991-10#2)(1991-12#1)(1993-9#1)(1994-6#1)(1995-5#1)(1997-4#1)(1997-7#1)(2005-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
statistical analysis revealed##2##3##(2007-12#1)(2013-8#1)
statistical analysis showed a##2##4##(2006-11#1)(2008-10#1)
statistical analysis showed that##5##4##(1993-3#1)(1995-5#1)(2008-7#1)(2009-2#1)(2011-2#1)
statistical analysis showed##9##3##(1990-9#1)(1993-3#1)(1995-5#1)(2006-11#1)(2008-10#1)(2008-7#1)(2009-2#1)(2011-2#2)
statistical analysis shows##2##3##(2008-5#1)(2008-9#1)
statistical analysis to##2##3##(1993-2#1)(2010-9#1)
statistical analysis was done by##4##5##(2013-8#4)
statistical analysis was done##5##4##(2008-6#1)(2013-8#4)
statistical analysis was performed using##2##5##(2011-2#2)
statistical analysis was performed##3##4##(2011-2#2)(2013-1#1)
statistical analysis was##11##3##(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#4)
statistical analysis we##3##3##(2007-7#2)(2012-2#1)
statistical analysis##146##2##(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#1)(1990-9#3)(1991-10#2)(1991-12#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-6#2)(1994-9#1)(1995-3#1)(1995-5#2)(1996-12#1)(1996-2#2)(1996-7#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-10#2)(2005-11#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#4)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#3)(2009-11#2)(2009-2#2)(2009-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#6)(2013-8#10)
statistical and analytical##2##3##(2008-11#1)(2008-8#1)
statistical and computational##2##3##(2008-4#1)(2010-2#1)
statistical and##15##2##(1993-12#1)(1997-8#1)(2005-11#1)(2006-12#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2009-11#1)(2010-2#1)(2013-7#1)
statistical applications##2##2##(2008-10#2)
statistical approach to##2##3##(2008-3#1)(2008-4#1)
statistical approach##8##2##(1997-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2010-5#1)
statistical approaches##7##2##(1996-12#1)(1996-2#1)(2008-10#1)(2008-7#2)(2008-9#1)(2009-5#1)
statistical artifact##3##2##(2008-8#3)
statistical artifacts##2##2##(2008-8#2)
statistical association between##2##3##(2011-2#1)(2012-12#1)
statistical association was##2##3##(2011-2#1)(2012-12#1)
statistical association##8##2##(2006-10#1)(2008-7#1)(2009-7#1)(2011-2#2)(2012-12#3)
statistical assumptions##3##2##(1997-4#1)(2006-12#1)(2010-9#1)
statistical averaging##3##2##(2008-9#3)
statistical challenges##3##2##(1996-12#1)(2008-7#1)(2009-4#1)
statistical characteristics and##2##3##(2008-2#1)(2010-3#1)
statistical characteristics of##2##3##(2008-2#1)(2008-3#1)
statistical characteristics##6##2##(2008-2#2)(2008-3#3)(2010-3#1)
statistical classification strategy gave##2##4##(2008-6#2)
statistical classification strategy##4##3##(2008-6#4)
statistical classification##5##2##(1994-5#1)(2008-6#4)
statistical comparison of 2 working dilution procedures##2##7##(2007-8#2)
statistical comparison of##7##3##(2007-8#2)(2008-10#2)(2010-8#1)(2011-1#1)(2013-1#1)
statistical comparison##10##2##(2007-8#2)(2008-10#4)(2010-11#1)(2010-8#1)(2011-1#1)(2013-1#1)
statistical comparisons##2##2##(2005-10#1)(2013-8#1)
statistical concepts##2##2##(2008-10#1)(2008-2#1)
statistical considerations##2##2##(2008-10#2)
statistical correction##3##2##(2007-12#1)(2009-12#1)(2013-1#1)
statistical correlation between##6##3##(1992-12#1)(2007-11#1)(2008-10#1)(2013-1#1)(2013-8#2)
statistical correlation with the##2##4##(2008-7#2)
statistical correlation##11##2##(1992-12#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#2)(2012-4#1)(2013-1#1)(2013-8#2)
statistical correlations##3##2##(1992-6#1)(2008-2#1)(2009-9#1)
statistical data##6##2##(1995-1#1)(1997-8#1)(2005-10#1)(2008-10#1)(2008-7#1)(2009-4#1)
statistical description of##2##3##(2009-11#1)(2010-10#1)
statistical description##3##2##(2009-11#1)(2009-3#1)(2010-10#1)
statistical design##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
statistical difference between##11##3##(1996-12#1)(1996-6#1)(2005-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-2#2)(2012-3#1)(2013-1#1)
statistical difference in the##4##4##(1991-5#1)(2004-9#1)(2011-1#1)(2011-2#1)
statistical difference in##10##3##(1990-12#1)(1991-5#1)(1995-10#1)(2004-9#1)(2006-10#1)(2007-6#1)(2008-8#1)(2010-2#1)(2011-1#1)(2011-2#1)
statistical difference was found between##2##5##(2006-8#1)(2010-8#1)
statistical difference was found##6##4##(1991-6#1)(1994-3#1)(1996-7#1)(2006-8#1)(2010-8#1)(2013-8#1)
statistical difference was##10##3##(1991-6#1)(1994-3#1)(1996-7#1)(2006-8#2)(2008-10#1)(2010-10#1)(2010-8#1)(2012-2#1)(2013-8#1)
statistical difference##44##2##(1990-12#1)(1991-5#1)(1991-6#1)(1994-3#1)(1995-10#1)(1995-7#1)(1996-12#1)(1996-6#1)(1996-7#1)(2004-12#1)(2004-9#1)(2005-7#1)(2006-10#1)(2006-6#2)(2006-8#3)(2007-6#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-10#1)(2010-2#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
statistical differences between the##4##4##(2005-10#1)(2006-7#1)(2008-1#1)(2008-7#1)
statistical differences between##5##3##(2005-10#1)(2006-7#1)(2008-1#1)(2008-7#1)(2012-2#1)
statistical differences in##6##3##(2008-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
statistical differences were found between##2##5##(2008-9#1)(2012-12#1)
statistical differences were found##4##4##(2008-10#2)(2008-9#1)(2012-12#1)
statistical differences were noted##2##4##(2006-8#1)(2010-3#1)
statistical differences were##8##3##(2006-8#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-3#1)(2011-1#1)(2012-12#1)
statistical differences##26##2##(2005-10#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-1#2)(2008-10#3)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#3)
statistical distribution##3##2##(2008-1#1)(2008-3#1)(2009-10#1)
statistical distributions##2##2##(2008-11#1)(2013-1#1)
statistical error##6##2##(2008-2#4)(2008-3#1)(2008-6#1)
statistical errors##3##2##(2008-3#3)
statistical estimation##3##2##(1997-8#1)(2013-1#2)
statistical evaluation of the##3##4##(2006-5#1)(2008-10#1)(2011-3#1)
statistical evaluation of##5##3##(1994-2#1)(2006-5#1)(2008-10#1)(2008-7#1)(2011-3#1)
statistical evaluation##12##2##(1994-2#1)(2004-11#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#1)(2010-12#1)(2011-2#1)(2011-3#1)
statistical evidence##5##2##(1996-3#1)(2011-1#1)(2011-2#3)
statistical features##2##2##(2007-6#1)(2008-11#1)
statistical framework##2##2##(2010-7#1)(2012-3#1)
statistical genetics##2##2##(2008-8#1)(2010-2#1)
statistical geometry##3##2##(1997-6#3)
statistical hypothesis##3##2##(2012-2#1)(2013-1#2)
statistical image analysis##2##3##(2013-1#2)
statistical image##3##2##(2008-2#1)(2013-1#2)
statistical independence##2##2##(2008-8#1)(2010-1#1)
statistical inevitability##2##2##(2008-9#2)
statistical inference##7##2##(1995-6#1)(2007-7#1)(2008-10#1)(2008-11#2)(2009-9#1)(2010-2#1)
statistical information##3##2##(1993-4#1)(2006-5#1)(2006-8#1)
statistical interaction between##2##3##(2007-10#1)(2008-9#1)
statistical issues##2##2##(1996-12#1)(2007-8#1)
statistical learning##7##2##(2010-6#2)(2012-1#5)
statistical measures##5##2##(2007-11#1)(2008-10#2)(2013-1#2)
statistical mechanical theory##2##3##(2006-10#2)
statistical mechanical##8##2##(1991-2#1)(1996-4#1)(2006-10#4)(2007-3#1)(2012-3#1)
statistical mechanics##4##2##(1994-2#1)(2006-12#2)(2008-3#1)
statistical memory##4##2##(1997-7#4)
statistical method for##3##3##(1997-8#1)(2008-2#1)(2008-9#1)
statistical method has##2##3##(2008-2#1)(2013-8#1)
statistical method to##3##3##(2008-4#1)(2012-3#2)
statistical method##18##2##(1997-8#1)(2006-10#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-3#3)(2013-1#2)(2013-8#1)
statistical methodology for##2##3##(2008-12#1)(2011-1#1)
statistical methodology used##2##3##(1997-8#1)(2013-8#1)
statistical methodology##12##2##(1997-8#1)(2008-10#2)(2008-12#1)(2009-3#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
statistical methods are##2##3##(2008-10#1)(2012-3#1)
statistical methods for##4##3##(1996-8#1)(1997-4#2)(2012-3#1)
statistical methods have been##2##4##(2012-2#1)(2012-3#1)
statistical methods in##2##3##(2008-9#1)(2010-11#1)
statistical methods that can##2##4##(2008-4#1)(2012-3#1)
statistical methods that##3##3##(2008-4#1)(2010-2#1)(2012-3#1)
statistical methods to##2##3##(2008-10#1)(2008-3#1)
statistical methods were used##2##4##(2009-6#1)(2010-8#1)
statistical methods were##3##3##(1997-3#1)(2009-6#1)(2010-8#1)
statistical methods##53##2##(1990-2#1)(1990-9#1)(1993-11#1)(1993-2#1)(1994-6#2)(1995-12#1)(1996-1#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#2)(2005-10#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#8)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-11#2)(2010-2#1)(2010-8#1)(2012-1#1)(2012-2#5)(2012-3#4)(2013-1#1)
statistical model for##7##3##(1993-11#2)(1994-8#1)(1995-12#1)(2008-10#1)(2013-1#2)
statistical model of##3##3##(1992-2#1)(2008-2#1)(2009-11#1)
statistical model to##2##3##(2008-3#1)(2012-3#1)
statistical model was##2##3##(2008-5#1)(2013-8#1)
statistical model##33##2##(1990-10#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-5#1)(1994-8#1)(1995-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#2)(2008-8#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-8#1)(2012-3#1)(2013-1#2)(2013-8#2)
statistical modeling##2##2##(2008-3#1)(2010-12#1)
statistical models and##2##3##(2008-10#1)(2012-11#1)
statistical models for##5##3##(1996-3#1)(2008-1#1)(2008-2#1)(2008-4#1)(2010-1#1)
statistical models that can##2##4##(1997-8#1)(2008-10#1)
statistical models##12##2##(1992-2#1)(1996-3#1)(1997-8#1)(2005-10#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#1)(2010-1#1)(2012-11#1)
statistical network analysis##2##3##(2008-5#2)
statistical package for social sciences##2##5##(2012-2#2)
statistical package##3##2##(2008-7#1)(2012-2#2)
statistical packages##3##2##(1994-8#1)(1997-2#1)(2008-7#1)
statistical parameters that##2##3##(2008-10#1)(2008-3#1)
statistical parameters##8##2##(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2013-1#1)
statistical power and##2##3##(1996-12#1)(2012-3#1)
statistical power for##2##3##(1994-4#1)(2008-11#1)
statistical power to detect##5##4##(2004-1#1)(2008-8#1)(2010-8#1)(2012-3#2)
statistical power##26##2##(1992-9#1)(1994-2#1)(1994-4#1)(1996-12#1)(1997-6#1)(2004-1#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-8#3)(2010-12#1)(2010-8#1)(2012-2#1)(2012-3#6)(2013-1#1)
statistical precision##2##2##(2008-2#1)(2012-11#1)
statistical probability##2##2##(2007-3#1)(2008-10#1)
statistical problems##4##2##(1995-2#1)(2010-12#1)(2011-1#1)(2011-2#1)
statistical procedures for##2##3##(1996-6#1)(2008-10#1)
statistical procedures##3##2##(1995-6#1)(1996-6#1)(2008-10#1)
statistical process control (SPC)##2##4##(1996-1#1)(2008-10#1)
statistical process control##5##3##(1995-2#1)(1996-1#1)(2008-10#1)(2008-3#2)
statistical process##7##2##(1995-2#1)(1996-1#1)(2008-10#1)(2008-3#2)(2013-8#2)
statistical proof##2##2##(2008-10#2)
statistical properties of the##9##4##(1991-12#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-2#2)(2010-8#1)(2012-3#1)
statistical properties of##17##3##(1991-12#1)(2007-11#2)(2007-12#3)(2008-11#1)(2008-2#4)(2008-3#2)(2010-10#1)(2010-8#1)(2012-3#2)
statistical properties##22##2##(1991-12#1)(1997-8#1)(2007-11#2)(2007-12#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#3)(2010-10#1)(2010-8#1)(2012-3#2)
statistical regression##4##2##(2008-10#2)(2011-1#1)(2013-8#1)
statistical relation##2##2##(2007-11#1)(2008-11#1)
statistical relationship##2##2##(2007-10#1)(2010-1#1)
statistical relevance##6##2##(1991-2#1)(1996-2#1)(2005-10#1)(2006-8#2)(2011-2#1)
statistical results##7##2##(1992-4#1)(1996-12#1)(2006-12#1)(2008-12#2)(2008-7#1)(2012-2#1)
statistical sampling##6##2##(1992-2#5)(2009-9#1)
statistical scoring procedures##2##3##(2009-11#2)
statistical significance (P##2##3##(1991-2#1)(2008-10#1)
statistical significance (P=0##2##3##(2008-11#1)(2008-7#1)
statistical significance (p##3##3##(1991-4#1)(2009-4#1)(2009-8#1)
statistical significance between##3##3##(1990-12#1)(2006-10#1)(2011-2#1)
statistical significance for##4##3##(2007-2#1)(2008-11#1)(2012-2#1)(2012-3#1)
statistical significance in##6##3##(1990-12#1)(1991-8#1)(1997-5#1)(2008-6#1)(2009-2#1)(2012-3#1)
statistical significance of the##3##4##(2007-12#1)(2009-5#1)(2010-8#1)
statistical significance of##7##3##(1990-6#1)(1994-6#1)(2007-12#1)(2007-7#1)(2008-4#1)(2009-5#1)(2010-8#1)
statistical significance was observed##2##4##(2008-7#1)(2011-1#1)
statistical significance was set at##2##5##(2009-7#1)(2013-1#1)
statistical significance was##8##3##(1993-3#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)(2011-1#1)(2013-1#1)
statistical significance when the##2##4##(1992-11#1)(2009-7#1)
statistical significance when##5##3##(1992-11#1)(1997-2#1)(2009-7#1)(2013-1#2)
statistical significance##106##2##(1990-12#2)(1990-6#2)(1990-7#1)(1991-12#1)(1991-2#3)(1991-4#1)(1991-8#1)(1992-11#1)(1993-3#1)(1994-10#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-6#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#1)(2005-10#3)(2006-10#2)(2006-12#1)(2006-5#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#5)(2007-8#2)(2007-9#4)(2008-1#2)(2008-10#3)(2008-11#4)(2008-12#1)(2008-4#5)(2008-5#2)(2008-6#3)(2008-7#5)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#2)(2010-1#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#1)
statistical significant decrease##2##3##(2013-8#2)
statistical significant difference##3##3##(2006-2#1)(2008-11#1)(2013-1#1)
statistical significant##7##2##(1995-5#1)(2006-2#1)(2006-6#1)(2008-11#1)(2013-1#1)(2013-8#2)
statistical software##6##2##(1997-7#1)(2007-12#1)(2008-10#2)(2011-2#1)(2012-12#1)
statistical studies##3##2##(2013-1#3)
statistical study of##2##3##(2008-10#1)(2008-6#1)
statistical study##6##2##(2008-1#1)(2008-10#3)(2008-6#1)(2012-12#1)
statistical support##8##2##(1994-3#1)(1997-4#1)(1997-7#1)(2006-7#1)(2008-8#2)(2012-3#1)(2013-7#1)
statistical technique to obtain##2##4##(2008-2#1)(2013-1#1)
statistical technique to##3##3##(2008-2#2)(2013-1#1)
statistical technique##5##2##(1995-12#1)(2008-2#2)(2012-3#1)(2013-1#1)
statistical techniques to##2##3##(2007-12#1)(2008-10#1)
statistical techniques##13##2##(1996-12#1)(1996-3#1)(2007-12#1)(2007-8#2)(2008-10#3)(2008-4#1)(2010-8#1)(2012-12#1)(2012-3#2)
statistical test for##3##3##(1996-12#1)(2013-1#2)
statistical test is##2##3##(1997-4#1)(2008-4#1)
statistical test##12##2##(1996-12#1)(1997-4#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-2#1)(2012-2#1)(2013-1#4)
statistical tests and##2##3##(2009-4#1)(2011-1#1)
statistical tests for##3##3##(1996-12#1)(1997-3#1)(2009-4#1)
statistical tests that##2##3##(1997-3#1)(2008-10#1)
statistical tests##15##2##(1994-1#1)(1996-12#1)(1997-3#2)(2006-5#1)(2008-10#4)(2008-4#1)(2009-4#2)(2011-1#1)(2012-2#1)(2012-3#1)
statistical theory of##2##3##(2008-10#1)(2010-2#1)
statistical theory##5##2##(1992-8#1)(2008-10#3)(2010-2#1)
statistical thermodynamic##4##2##(1990-8#1)(1996-4#1)(1997-2#2)
statistical thermodynamics##2##2##(2008-3#2)
statistical tools for early detection of##2##6##(2008-8#2)
statistical tools to##3##3##(1996-3#1)(2009-3#1)(2010-8#1)
statistical tools##10##2##(1993-3#1)(1996-3#1)(2008-10#2)(2008-8#2)(2009-3#1)(2010-8#2)(2013-8#1)
statistical treatment of##2##3##(2008-10#2)
statistical treatment##5##2##(1990-6#1)(2008-10#3)(2008-3#1)
statistical uncertainty##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
statistical validity##2##2##(2006-10#1)(2008-11#1)
statistical variations##2##2##(2008-2#1)(2008-3#1)
statistical viewpoint##2##2##(1994-11#1)(2013-8#1)
statistical##1080##1##(1990-10#1)(1990-12#3)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#5)(1990-7#2)(1990-8#1)(1990-9#5)(1991-10#2)(1991-12#3)(1991-2#5)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#7)(1992-3#1)(1992-4#2)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#5)(1993-4#1)(1993-5#1)(1993-9#1)(1994-1#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#4)(1994-4#2)(1994-5#2)(1994-6#5)(1994-8#3)(1994-9#3)(1995-1#3)(1995-10#1)(1995-12#4)(1995-2#3)(1995-3#2)(1995-5#3)(1995-6#3)(1995-7#1)(1996-1#3)(1996-12#13)(1996-2#5)(1996-3#4)(1996-4#3)(1996-6#2)(1996-7#2)(1996-8#2)(1997-1#2)(1997-2#6)(1997-3#4)(1997-4#7)(1997-5#2)(1997-6#4)(1997-7#7)(1997-8#11)(2004-1#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-10#11)(2005-11#5)(2005-7#1)(2006-10#12)(2006-11#1)(2006-12#7)(2006-2#1)(2006-5#5)(2006-6#3)(2006-7#5)(2006-8#9)(2007-1#2)(2007-10#6)(2007-11#15)(2007-12#17)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#11)(2007-8#13)(2007-9#5)(2008-1#9)(2008-10#112)(2008-11#28)(2008-12#11)(2008-2#44)(2008-3#46)(2008-4#20)(2008-5#21)(2008-6#15)(2008-7#39)(2008-8#27)(2008-9#23)(2009-10#3)(2009-11#10)(2009-12#3)(2009-2#6)(2009-3#6)(2009-4#9)(2009-5#6)(2009-6#2)(2009-7#4)(2009-8#2)(2009-9#5)(2010-1#6)(2010-10#4)(2010-11#4)(2010-12#4)(2010-2#12)(2010-3#5)(2010-4#2)(2010-5#5)(2010-6#2)(2010-7#3)(2010-8#12)(2010-9#4)(2011-1#19)(2011-2#25)(2011-3#1)(2012-1#9)(2012-11#2)(2012-12#16)(2012-2#31)(2012-3#35)(2012-4#1)(2013-1#55)(2013-7#4)(2013-8#28)
statistically (p &lt##2##3##(2010-8#1)(2011-1#1)
statistically analysed##3##2##(2006-8#1)(2008-10#1)(2008-9#1)
statistically analyzed and compared##2##4##(2008-11#1)(2012-3#1)
statistically analyzed using a##2##4##(2004-9#1)(2009-2#1)
statistically analyzed using##6##3##(2004-9#1)(2009-2#1)(2012-12#2)(2012-3#1)(2013-8#1)
statistically analyzed##13##2##(1994-8#1)(2004-9#1)(2006-12#1)(2008-10#1)(2008-11#1)(2009-2#1)(2010-5#1)(2010-8#1)(2012-12#2)(2012-3#2)(2013-8#1)
statistically and clinically##2##3##(1997-6#1)(2012-2#1)
statistically and##12##2##(1996-12#1)(1997-6#1)(2008-10#1)(2008-8#1)(2010-12#1)(2010-2#2)(2010-5#4)(2012-2#1)
statistically associated with##5##3##(1990-3#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-1#1)
statistically better##4##2##(2004-1#1)(2007-7#1)(2008-3#1)(2010-7#1)
statistically by the##2##3##(2007-12#1)(2013-1#1)
statistically by##7##2##(1993-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2013-1#1)
statistically comparable##3##2##(2008-10#3)
statistically compared with those##2##4##(2008-10#2)
statistically compared with##6##3##(2008-10#6)
statistically compared##8##2##(2007-8#1)(2008-10#7)
statistically correlated##2##2##(1993-12#1)(2008-10#1)
statistically different (P &lt##2##4##(2007-2#2)
statistically different between##6##3##(1990-3#1)(2007-8#1)(2008-7#1)(2012-2#1)(2012-3#2)
statistically different from the##2##4##(2008-10#1)(2010-3#1)
statistically different from##9##3##(1992-5#1)(1993-4#1)(2008-10#3)(2010-3#1)(2011-1#2)(2012-3#1)
statistically different##31##2##(1990-3#1)(1991-12#1)(1992-5#1)(1993-4#1)(1994-2#1)(1996-7#1)(1997-8#1)(2006-10#1)(2007-2#2)(2007-8#1)(2008-10#5)(2008-5#3)(2008-7#1)(2009-1#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)
statistically elevated##2##2##(2008-10#1)(2008-5#1)
statistically equivalent to##4##3##(1995-10#1)(2008-10#3)
statistically equivalent##7##2##(1995-10#1)(2007-8#1)(2008-10#3)(2011-2#2)
statistically evaluated for its accuracy and precision##2##7##(2008-10#2)
statistically evaluated for##3##3##(2006-1#1)(2008-10#2)
statistically evaluated using##2##3##(2008-12#2)
statistically evaluated##11##2##(1990-8#1)(2006-1#1)(2008-10#4)(2008-12#2)(2008-7#1)(2009-1#1)(2013-1#1)
statistically from##2##2##(1992-2#1)(2011-1#1)
statistically greater##4##2##(1995-9#1)(2008-3#1)(2010-2#1)(2013-1#1)
statistically higher in the##3##4##(1995-4#1)(2008-4#1)(2010-1#1)
statistically higher in##6##3##(1995-4#1)(2006-8#2)(2008-4#1)(2008-9#1)(2010-1#1)
statistically higher than##3##3##(2008-11#1)(2010-2#1)(2010-8#1)
statistically higher##17##2##(1995-12#1)(1995-4#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-8#2)
statistically highly significant (P &lt##2##5##(2008-8#2)
statistically highly significant##6##3##(2007-7#1)(2007-9#1)(2008-8#3)(2009-6#1)
statistically highly##7##2##(2007-7#1)(2007-9#1)(2008-8#3)(2009-6#1)(2011-2#1)
statistically important influence##2##3##(2008-5#2)
statistically important##4##2##(1990-10#1)(2007-11#1)(2008-5#2)
statistically in##6##2##(1997-8#1)(2004-12#1)(2008-10#1)(2008-12#1)(2009-3#1)(2013-7#1)
statistically independent region##2##3##(2007-12#2)
statistically independent##7##2##(1996-12#1)(2007-12#3)(2008-12#1)(2008-2#1)(2008-3#1)
statistically indistinguishable from##3##3##(1991-1#1)(1995-10#1)(2008-10#1)
statistically indistinguishable##5##2##(1991-1#1)(1993-3#1)(1995-10#1)(2008-10#2)
statistically insignificant##10##2##(1991-4#1)(1992-10#1)(1992-3#1)(1993-6#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-2#1)(2010-4#1)(2012-12#1)
statistically less##2##2##(1992-2#1)(1997-3#1)
statistically lower##2##2##(1993-11#1)(2007-9#1)
statistically meaningful##4##2##(1991-10#1)(1996-5#1)(2008-7#1)(2010-7#1)
statistically most##2##2##(2006-6#1)(2011-1#1)
statistically non-significant##3##2##(1992-11#1)(2008-10#2)
statistically nonsignificant##2##2##(1995-12#1)(2007-2#1)
statistically not##3##2##(2007-9#1)(2008-1#1)(2008-7#1)
statistically processed##3##2##(1995-6#1)(2008-8#1)(2013-1#1)
statistically related to##2##3##(1992-2#1)(2008-9#1)
statistically reliable##3##2##(1997-2#1)(2008-11#1)(2010-2#1)
statistically satisfactory##3##2##(1990-11#1)(2008-10#2)
statistically separated##2##2##(2008-10#2)
statistically significant (P &gt##2##4##(2007-7#1)(2009-6#1)
statistically significant (P &lt##12##4##(1994-12#1)(1996-11#1)(1996-12#1)(1996-6#2)(2006-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#2)(2012-1#1)
statistically significant (P##17##3##(1990-3#1)(1994-12#1)(1996-11#1)(1996-12#1)(1996-6#2)(2006-12#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-6#1)(2011-2#1)(2012-1#1)
statistically significant (p &lt##16##4##(1993-9#1)(1995-12#1)(1996-8#1)(1997-2#1)(2006-6#1)(2006-9#1)(2007-9#1)(2008-12#2)(2008-9#3)(2010-7#1)(2011-2#2)(2012-2#1)
statistically significant (p = 0##9##5##(1991-4#1)(1997-6#1)(2006-12#1)(2007-2#1)(2008-1#1)(2008-9#1)(2012-2#2)(2013-1#1)
statistically significant (p less than 0##2##6##(1990-12#1)(1991-7#1)
statistically significant (p##29##3##(1990-12#1)(1991-4#1)(1991-7#1)(1993-9#2)(1995-12#1)(1996-8#1)(1997-2#1)(1997-6#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-12#3)(2008-9#4)(2010-7#1)(2011-2#2)(2012-2#3)(2013-1#1)
statistically significant (p&lt##6##3##(2006-7#1)(2011-12#1)(2013-1#1)(2013-8#3)
statistically significant (p=0##3##3##(2004-9#1)(2006-1#1)(2006-6#1)
statistically significant after adjusting for##2##5##(1990-6#1)(1995-12#1)
statistically significant and##4##3##(1995-1#1)(2006-11#1)(2008-10#1)(2008-8#1)
statistically significant association between##3##4##(2004-1#1)(2008-1#1)(2011-2#1)
statistically significant association##6##3##(2004-1#1)(2007-12#1)(2008-1#1)(2008-5#1)(2011-2#1)(2012-12#1)
statistically significant associations between##3##4##(2008-8#2)(2012-12#1)
statistically significant associations were found between##2##6##(1997-3#1)(2012-5#1)
statistically significant associations with##2##4##(2011-12#1)(2011-2#1)
statistically significant associations##8##3##(1997-3#1)(2008-8#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-5#1)(2013-1#1)
statistically significant at the##2##4##(2007-1#1)(2008-6#1)
statistically significant at##9##3##(1993-11#1)(2006-7#1)(2007-1#1)(2007-6#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-6#1)(2013-1#1)
statistically significant benefit##2##3##(2007-9#1)(2013-8#1)
statistically significant between the##2##4##(2007-8#1)(2011-2#1)
statistically significant between##4##3##(2006-9#1)(2007-8#1)(2011-2#2)
statistically significant change in the##2##5##(2008-8#1)(2009-9#1)
statistically significant change in##4##4##(2007-10#1)(2008-8#1)(2009-9#1)(2010-3#1)
statistically significant change was observed in##2##6##(2006-10#1)(2007-10#1)
statistically significant change##8##3##(1996-9#1)(2006-10#1)(2007-10#2)(2008-8#1)(2009-9#1)(2010-3#1)(2013-1#1)
statistically significant changes in the##4##5##(2008-11#1)(2008-5#1)(2009-9#1)(2013-7#1)
statistically significant changes were found##2##5##(2009-8#1)(2012-3#1)
statistically significant changes##7##3##(2008-11#1)(2008-5#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-7#1)
statistically significant correlation between the##2##5##(1994-3#1)(1997-6#1)
statistically significant correlation between##10##4##(1994-3#1)(1996-8#1)(1997-6#1)(2007-7#1)(2007-8#1)(2008-4#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
statistically significant correlation was found between##2##6##(1994-5#1)(1995-5#1)
statistically significant correlation was##4##4##(1994-5#1)(1995-5#1)(2007-8#1)(2008-5#1)
statistically significant correlation##18##3##(1994-3#1)(1994-5#1)(1995-5#1)(1996-8#1)(1997-6#1)(2007-7#1)(2007-8#3)(2008-4#1)(2008-5#1)(2008-8#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
statistically significant correlations##2##3##(2010-5#1)(2013-8#1)
statistically significant decrease in the##3##5##(1996-9#1)(2006-12#1)(2013-7#1)
statistically significant decrease in##11##4##(1991-2#1)(1996-3#1)(1996-9#1)(2006-12#1)(2007-11#1)(2008-5#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
statistically significant decrease##14##3##(1991-2#1)(1993-10#1)(1996-3#1)(1996-9#1)(2006-12#1)(2006-7#1)(2007-11#1)(2008-3#1)(2008-5#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
statistically significant decreases in##2##4##(1990-3#1)(2008-5#1)
statistically significant decreases##4##3##(1990-3#1)(2008-5#2)(2011-2#1)
statistically significant difference (P = 0##3##6##(2006-10#1)(2006-8#2)
statistically significant difference (p##4##4##(2010-12#1)(2010-7#1)(2011-1#1)(2013-1#1)
statistically significant difference (p&gt##2##4##(2013-1#2)
statistically significant difference between the two groups##3##7##(2007-2#1)(2007-7#1)(2008-12#1)
statistically significant difference between the two##5##6##(2007-2#1)(2007-7#1)(2008-12#2)(2009-8#1)
statistically significant difference between the##18##5##(1992-11#1)(1996-3#1)(2004-10#1)(2005-10#2)(2005-11#1)(2006-5#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-12#2)(2008-4#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-3#1)
statistically significant difference between##25##4##(1992-11#1)(1996-3#1)(2004-10#1)(2005-10#3)(2005-11#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
statistically significant difference for##2##4##(2007-4#1)(2009-7#1)
statistically significant difference in the rate of##2##7##(2011-2#1)(2013-1#1)
statistically significant difference in the##11##5##(1993-2#1)(1993-3#1)(2005-10#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
statistically significant difference in##34##4##(1990-10#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-2#1)(1995-10#1)(1996-6#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-9#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
statistically significant difference was found between##4##6##(2004-12#1)(2006-8#1)(2011-2#1)(2012-12#1)
statistically significant difference was found##10##5##(2004-12#1)(2006-2#1)(2006-8#1)(2007-8#1)(2008-10#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)
statistically significant difference was noted between##2##6##(2007-7#1)(2008-9#1)
statistically significant difference was observed in##2##6##(1993-11#1)(2009-11#1)
statistically significant difference was observed##5##5##(1992-2#1)(1993-11#1)(2004-12#1)(2009-11#1)(2013-1#1)
statistically significant difference was##23##4##(1992-2#1)(1993-11#1)(1993-9#1)(2004-12#2)(2006-2#1)(2006-8#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-9#1)(2009-11#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#2)
statistically significant difference##105##3##(1990-10#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-2#1)(1995-10#2)(1996-3#1)(1996-6#1)(2004-10#1)(2004-12#2)(2005-10#4)(2005-11#1)(2006-10#2)(2006-2#2)(2006-5#2)(2006-8#3)(2006-9#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#2)(2007-6#1)(2007-7#4)(2007-8#3)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#3)(2008-4#2)(2008-5#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-12#2)(2010-7#1)(2010-9#3)(2011-1#5)(2011-2#7)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#8)(2013-8#4)
statistically significant differences (P##2##4##(1996-12#1)(2006-10#1)
statistically significant differences among the##2##5##(2006-10#1)(2008-9#1)
statistically significant differences among##3##4##(2006-10#1)(2008-9#1)(2012-12#1)
statistically significant differences between groups##2##5##(2005-1#1)(2013-1#1)
statistically significant differences between the two groups##4##7##(1992-11#1)(2007-9#1)(2013-1#2)
statistically significant differences between the##9##5##(1992-11#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-10#1)(2011-1#1)(2013-1#2)
statistically significant differences between##22##4##(1992-11#1)(1997-7#1)(2005-1#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-5#2)(2009-10#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
statistically significant differences for##2##4##(2008-12#1)(2013-8#1)
statistically significant differences in the##8##5##(1990-12#1)(1991-3#1)(1991-4#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-7#1)(2012-3#1)
statistically significant differences in##25##4##(1990-10#1)(1990-12#1)(1991-3#1)(1991-4#1)(1994-2#1)(1996-1#1)(1996-12#1)(1996-7#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-3#1)(2007-8#3)(2008-11#1)(2008-12#1)(2008-7#1)(2009-7#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
statistically significant differences were found##2##5##(1992-12#1)(2012-12#1)
statistically significant differences were##11##4##(1992-12#1)(1992-2#1)(1996-7#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-12#2)(2012-12#1)(2012-3#1)
statistically significant differences##83##3##(1990-10#1)(1990-12#1)(1990-6#1)(1990-9#1)(1991-3#1)(1991-4#1)(1992-11#1)(1992-12#1)(1992-2#1)(1994-2#1)(1996-1#1)(1996-12#2)(1996-7#2)(1997-4#1)(1997-6#1)(1997-7#1)(2004-9#1)(2005-1#1)(2006-10#4)(2006-9#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-12#4)(2010-7#1)(2011-1#2)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#9)(2013-8#2)
statistically significant different##2##3##(2007-8#2)
statistically significant effect on the##4##5##(1994-6#1)(2008-11#1)(2009-1#1)(2009-8#1)
statistically significant effect on##8##4##(1994-6#1)(1997-3#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-8#1)
statistically significant effect##16##3##(1990-10#1)(1994-6#1)(1994-9#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-1#1)(2009-3#1)(2009-8#1)(2013-8#1)
statistically significant effects##3##3##(1991-2#1)(1992-5#1)(2013-8#1)
statistically significant evidence of##2##4##(1993-7#1)(1997-1#1)
statistically significant evidence##3##3##(1993-7#1)(1997-1#1)(2008-9#1)
statistically significant factors##2##3##(2008-10#1)(2011-2#1)
statistically significant for the##2##4##(1997-8#1)(2008-5#1)
statistically significant for##13##3##(1990-2#2)(1991-1#1)(1993-1#1)(1996-5#1)(1997-8#1)(2005-10#1)(2006-12#1)(2008-5#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
statistically significant higher##9##3##(1990-8#1)(1996-12#1)(1996-3#1)(2006-8#1)(2008-1#1)(2010-2#1)(2012-12#1)(2013-1#1)(2013-4#1)
statistically significant improvement in the##2##5##(2006-6#1)(2007-11#1)
statistically significant improvement in##6##4##(1990-8#1)(1994-12#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-3#1)
statistically significant improvement of##2##4##(2007-11#1)(2013-1#1)
statistically significant improvement##11##3##(1990-8#1)(1994-12#1)(2006-6#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-12#1)(2008-3#1)(2012-12#1)(2013-1#1)
statistically significant improvements in##2##4##(1991-2#1)(1993-1#1)
statistically significant improvements##4##3##(1991-2#2)(1993-1#1)(2008-7#1)
statistically significant in the##4##4##(2006-5#1)(2008-6#1)(2008-7#1)(2010-1#1)
statistically significant in##11##3##(1991-10#1)(1992-1#1)(2006-5#1)(2008-11#1)(2008-6#1)(2008-7#2)(2010-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
statistically significant increase in the##6##5##(2006-10#1)(2007-8#1)(2008-5#1)(2009-8#2)(2010-10#1)
statistically significant increase in##13##4##(1990-2#1)(1992-11#1)(1992-2#1)(1992-3#1)(1994-3#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-5#1)(2009-8#3)(2010-10#1)
statistically significant increase of##2##4##(1991-11#1)(2011-2#1)
statistically significant increase##18##3##(1990-2#1)(1991-11#1)(1992-11#1)(1992-2#1)(1992-3#1)(1994-3#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-5#2)(2008-7#1)(2009-8#3)(2010-10#1)(2011-2#1)(2013-1#1)
statistically significant increased##2##3##(2007-4#1)(2008-8#1)
statistically significant increases in##3##4##(1990-7#1)(1992-4#1)(2006-12#1)
statistically significant increases##5##3##(1990-7#1)(1992-4#1)(2006-12#1)(2006-8#1)(2008-9#1)
statistically significant influence on##3##4##(2009-2#1)(2011-2#2)
statistically significant influence##4##3##(2009-2#1)(2011-2#3)
statistically significant inhibition of##2##4##(2006-1#1)(2008-12#1)
statistically significant inverse##3##3##(2008-12#1)(2008-4#1)(2013-1#1)
statistically significant linear##2##3##(2009-3#1)(2010-4#1)
statistically significant lower##6##3##(2007-4#1)(2007-9#1)(2009-10#1)(2010-3#1)(2012-2#1)(2013-1#1)
statistically significant only in the presence of##2##7##(1992-4#2)
statistically significant only in the##3##5##(1992-4#2)(2008-10#1)
statistically significant only in##4##4##(1992-4#2)(1993-4#1)(2008-10#1)
statistically significant or##2##3##(1993-9#1)(2004-1#1)
statistically significant positive correlation##2##4##(2013-1#1)(2013-8#1)
statistically significant positive##5##3##(1994-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
statistically significant pre- to post-intervention##2##5##(2008-12#2)
statistically significant reduction in the##4##5##(1992-9#1)(1994-8#1)(1996-9#1)(2007-8#1)
statistically significant reduction in##10##4##(1991-9#1)(1992-9#1)(1994-8#1)(1996-9#2)(2006-8#1)(2007-8#2)(2008-7#1)(2009-10#1)
statistically significant reduction##14##3##(1991-9#1)(1992-9#1)(1994-8#1)(1996-1#1)(1996-9#2)(2006-8#1)(2007-11#1)(2007-8#2)(2008-7#1)(2009-10#1)(2011-1#1)(2013-1#1)
statistically significant reductions in##2##4##(2006-11#1)(2007-10#1)
statistically significant relationship between##4##4##(2006-8#1)(2008-11#1)(2011-2#1)(2012-2#1)
statistically significant relationship##7##3##(2006-8#1)(2008-11#1)(2009-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
statistically significant results##5##3##(2008-10#1)(2012-12#1)(2012-3#3)
statistically significant sex differences##2##4##(1993-9#1)(1996-12#1)
statistically significant##754##2##(1990-10#3)(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#3)(1990-4#2)(1990-5#2)(1990-6#3)(1990-7#2)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#3)(1991-2#5)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#2)(1991-7#2)(1991-9#1)(1992-1#1)(1992-11#4)(1992-12#2)(1992-2#4)(1992-3#2)(1992-4#5)(1992-5#2)(1992-6#1)(1992-7#3)(1992-9#1)(1993-1#3)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#4)(1993-3#1)(1993-4#1)(1993-7#4)(1993-9#8)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#5)(1994-3#2)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#2)(1995-12#3)(1995-5#2)(1995-6#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#7)(1996-2#1)(1996-3#6)(1996-5#1)(1996-6#3)(1996-7#2)(1996-8#2)(1996-9#4)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#2)(2004-1#2)(2004-10#2)(2004-11#2)(2004-12#2)(2004-9#2)(2005-1#2)(2005-10#6)(2005-11#1)(2005-12#1)(2006-1#2)(2006-10#12)(2006-11#2)(2006-12#5)(2006-2#2)(2006-5#6)(2006-6#6)(2006-7#4)(2006-8#11)(2006-9#4)(2007-1#1)(2007-10#7)(2007-11#12)(2007-12#5)(2007-2#8)(2007-3#1)(2007-4#6)(2007-5#1)(2007-6#3)(2007-7#12)(2007-8#26)(2007-9#6)(2008-1#8)(2008-10#33)(2008-11#11)(2008-12#15)(2008-2#2)(2008-3#4)(2008-4#7)(2008-5#29)(2008-6#4)(2008-7#15)(2008-8#14)(2008-9#12)(2009-1#1)(2009-10#5)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#8)(2009-5#1)(2009-6#4)(2009-7#4)(2009-8#10)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#9)(2010-2#4)(2010-3#5)(2010-4#3)(2010-5#2)(2010-7#5)(2010-8#2)(2010-9#6)(2011-1#9)(2011-12#2)(2011-2#46)(2011-7#1)(2012-1#1)(2012-12#19)(2012-2#17)(2012-3#12)(2012-5#1)(2012-6#1)(2013-1#44)(2013-4#1)(2013-7#6)(2013-8#25)
statistically significant)##3##2##(2007-10#1)(2008-9#1)(2013-1#1)
statistically significantly different##3##3##(2008-5#1)(2010-10#1)(2011-2#1)
statistically significantly greater##2##3##(2008-3#1)(2009-2#1)
statistically significantly higher##6##3##(2004-2#1)(2007-6#1)(2008-12#1)(2008-7#1)(2013-1#2)
statistically significantly##26##2##(1990-12#1)(1997-5#1)(2004-2#1)(2007-6#1)(2007-8#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2013-1#2)(2013-7#1)(2013-8#1)
statistically similar to##2##3##(2008-10#1)(2013-1#1)
statistically similar##8##2##(2006-8#1)(2007-3#2)(2008-10#1)(2013-1#4)
statistically sound##3##2##(1993-3#1)(2008-2#2)
statistically superior to##2##3##(2008-12#1)(2012-12#1)
statistically tested##2##2##(2007-4#1)(2008-10#1)
statistically that the##2##3##(2008-1#1)(2008-8#1)
statistically the most significant##2##4##(2008-10#1)(2009-3#1)
statistically the##3##2##(2008-10#1)(2008-3#1)(2009-3#1)
statistically using one-way ANOVA##2##4##(2008-12#1)(2013-1#1)
statistically using##4##2##(2006-9#1)(2007-11#1)(2008-12#1)(2013-1#1)
statistically very highly significant##3##4##(2012-12#3)
statistically##1096##1##(1990-10#4)(1990-11#3)(1990-12#3)(1990-2#3)(1990-3#5)(1990-4#2)(1990-5#2)(1990-6#3)(1990-7#2)(1990-8#5)(1990-9#1)(1991-1#2)(1991-10#3)(1991-11#3)(1991-12#1)(1991-2#6)(1991-3#2)(1991-4#3)(1991-5#1)(1991-6#2)(1991-7#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#5)(1992-12#2)(1992-2#8)(1992-3#3)(1992-4#5)(1992-5#3)(1992-6#1)(1992-7#3)(1992-9#1)(1993-1#3)(1993-10#1)(1993-11#3)(1993-12#3)(1993-2#4)(1993-3#3)(1993-4#2)(1993-6#2)(1993-7#4)(1993-8#1)(1993-9#9)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#6)(1994-3#3)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#5)(1994-9#1)(1995-1#1)(1995-10#4)(1995-12#5)(1995-4#1)(1995-5#2)(1995-6#3)(1995-9#2)(1996-1#2)(1996-11#2)(1996-12#9)(1996-2#1)(1996-3#6)(1996-5#2)(1996-6#3)(1996-7#3)(1996-8#2)(1996-9#4)(1997-1#1)(1997-2#4)(1997-3#4)(1997-4#2)(1997-5#2)(1997-6#5)(1997-7#2)(1997-8#4)(2004-1#3)(2004-10#2)(2004-11#2)(2004-12#4)(2004-2#1)(2004-9#3)(2005-1#2)(2005-10#6)(2005-11#1)(2005-12#1)(2006-1#3)(2006-10#13)(2006-11#2)(2006-12#6)(2006-2#2)(2006-5#6)(2006-6#8)(2006-7#4)(2006-8#15)(2006-9#5)(2007-1#1)(2007-10#10)(2007-11#16)(2007-12#10)(2007-2#13)(2007-3#5)(2007-4#7)(2007-5#1)(2007-6#4)(2007-7#20)(2007-8#33)(2007-9#11)(2008-1#10)(2008-10#84)(2008-11#17)(2008-12#23)(2008-2#9)(2008-3#11)(2008-4#11)(2008-5#37)(2008-6#4)(2008-7#24)(2008-8#29)(2008-9#20)(2009-1#3)(2009-10#6)(2009-11#2)(2009-12#1)(2009-2#4)(2009-3#11)(2009-5#1)(2009-6#6)(2009-7#4)(2009-8#11)(2009-9#5)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#12)(2010-2#9)(2010-3#8)(2010-4#4)(2010-5#8)(2010-7#7)(2010-8#7)(2010-9#7)(2011-1#17)(2011-12#5)(2011-2#54)(2011-7#1)(2012-1#3)(2012-12#27)(2012-2#20)(2012-3#18)(2012-5#1)(2012-6#1)(2013-1#63)(2013-4#1)(2013-7#8)(2013-8#29)
statistically-significant##2##1##(2010-2#1)(2013-1#1)
statistician##3##1##(1995-12#1)(2009-11#1)(2009-2#1)
statisticians and##3##2##(1993-9#1)(1996-2#1)(2010-8#1)
statisticians##10##1##(1993-9#2)(1995-2#1)(1996-2#1)(2008-10#1)(2008-7#1)(2009-3#1)(2010-1#1)(2010-8#1)(2012-2#1)
statistics also##2##2##(1996-3#1)(2008-9#1)
statistics and correlation analysis##2##4##(2008-3#2)
statistics and data analysis##2##4##(2008-6#1)(2011-2#1)
statistics and the##4##3##(2005-5#1)(2007-10#1)(2008-4#1)(2008-7#1)
statistics and##33##2##(1991-3#1)(1992-9#1)(1993-12#1)(1995-9#1)(2005-11#1)(2005-5#1)(2006-12#1)(2007-10#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2009-6#1)(2010-2#2)(2010-5#1)(2011-1#3)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
statistics are used##2##3##(2010-7#1)(2012-3#1)
statistics are##17##2##(1992-2#1)(1993-4#1)(1994-6#1)(2007-12#1)(2007-4#1)(2008-2#2)(2008-3#3)(2008-9#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-7#1)(2012-12#1)(2012-3#1)
statistics as a##2##3##(1990-8#1)(2008-2#1)
statistics as##4##2##(1990-8#1)(1996-12#1)(2008-1#1)(2008-2#1)
statistics available for##2##3##(1990-2#1)(2007-5#1)
statistics based##2##2##(2009-12#1)(2010-9#1)
statistics by the##2##3##(1991-3#1)(1995-11#1)
statistics by##5##2##(1991-3#1)(1995-11#1)(2007-4#1)(2008-1#1)(2010-9#1)
statistics can be##2##3##(2012-1#1)(2013-1#1)
statistics can##3##2##(2008-2#1)(2012-1#1)(2013-1#1)
statistics data##2##2##(1991-12#1)(2006-11#1)
statistics during##2##2##(2007-12#1)(2008-3#1)
statistics for a##2##3##(2008-2#2)
statistics for comparing##2##3##(2008-7#1)(2012-3#1)
statistics for the##2##3##(1995-2#1)(2008-1#1)
statistics for##26##2##(1990-4#1)(1992-2#2)(1992-9#1)(1995-1#1)(1995-2#1)(1997-1#1)(1997-4#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#4)(2008-5#1)(2008-7#2)(2008-9#1)(2009-4#1)(2010-2#1)(2011-3#1)(2012-3#2)(2013-1#1)
statistics from##3##2##(2007-9#1)(2011-2#1)(2012-2#1)
statistics in medical research##2##4##(1992-2#2)
statistics in terms of the##2##5##(1995-2#1)(2008-3#1)
statistics in the##7##3##(1990-11#1)(1990-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-12#1)
statistics in##20##2##(1990-11#1)(1990-8#1)(1991-12#1)(1992-2#2)(1995-11#1)(1995-2#1)(1996-3#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#4)(2008-8#1)(2012-12#1)(2013-8#1)
statistics is##2##2##(2008-8#1)(2013-8#1)
statistics of a##2##3##(2008-3#1)(2010-3#1)
statistics of the signal##2##4##(1991-12#2)
statistics of the##22##3##(1990-7#1)(1990-9#1)(1991-12#2)(1993-5#1)(1997-8#1)(2007-12#2)(2008-10#1)(2008-2#7)(2008-3#3)(2009-6#1)(2011-2#1)(2013-8#1)
statistics of##53##2##(1990-4#1)(1990-7#2)(1990-9#2)(1991-12#2)(1993-5#1)(1995-7#1)(1997-8#1)(2004-9#1)(2007-11#3)(2007-12#6)(2008-10#2)(2008-2#11)(2008-3#10)(2008-8#1)(2009-11#1)(2009-6#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
statistics offer##2##2##(1993-2#1)(2004-9#1)
statistics on the##3##3##(1994-12#1)(2006-7#1)(2008-11#1)
statistics on##7##2##(1990-8#1)(1994-12#1)(2006-7#1)(2008-11#1)(2010-7#1)(2012-12#1)(2013-1#1)
statistics provide##2##2##(1992-6#1)(2008-9#1)
statistics such as##2##3##(2008-10#1)(2009-12#1)
statistics that are##4##3##(1992-6#1)(1997-8#1)(2007-12#1)(2012-3#1)
statistics that##10##2##(1992-11#1)(1992-6#1)(1997-8#1)(2005-11#1)(2007-12#1)(2007-2#1)(2011-1#2)(2012-3#1)(2013-1#1)
statistics to##11##2##(1997-3#1)(1997-8#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-3#1)(2011-2#1)(2012-3#1)
statistics were calculated to##2##4##(2008-10#1)(2012-12#1)
statistics were calculated##3##3##(2008-10#1)(2008-11#1)(2012-12#1)
statistics were evaluated##2##3##(1997-3#1)(2008-11#1)
statistics were used for##2##4##(2012-12#2)
statistics were used to assess##3##5##(2013-1#2)(2013-7#1)
statistics were used to##5##4##(2010-3#1)(2013-1#3)(2013-7#1)
statistics were used##8##3##(2010-3#1)(2012-12#2)(2013-1#4)(2013-7#1)
statistics were##17##2##(1993-12#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2010-3#1)(2012-12#4)(2013-1#4)(2013-7#1)
statistics with##2##2##(2006-10#1)(2011-2#1)
statistics within##2##2##(2005-11#1)(2008-10#1)
statistics##446##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#6)(1990-9#3)(1991-1#1)(1991-12#4)(1991-2#2)(1991-3#2)(1991-9#2)(1992-11#2)(1992-2#6)(1992-6#3)(1992-9#3)(1993-12#3)(1993-2#3)(1993-4#1)(1993-5#1)(1993-8#1)(1994-12#3)(1994-6#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-2#3)(1995-3#1)(1995-6#1)(1995-7#2)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#1)(1997-1#1)(1997-2#1)(1997-3#8)(1997-4#1)(1997-8#6)(2004-11#1)(2004-9#2)(2005-11#3)(2005-5#1)(2006-10#5)(2006-11#2)(2006-12#1)(2006-6#1)(2006-7#3)(2006-8#1)(2007-10#4)(2007-11#7)(2007-12#15)(2007-2#4)(2007-4#3)(2007-5#1)(2007-6#1)(2007-8#4)(2007-9#4)(2008-1#6)(2008-10#23)(2008-11#10)(2008-12#2)(2008-2#33)(2008-3#39)(2008-4#4)(2008-5#8)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#5)(2009-10#3)(2009-11#3)(2009-12#2)(2009-3#2)(2009-4#5)(2009-5#3)(2009-6#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#4)(2010-2#5)(2010-3#2)(2010-5#2)(2010-7#5)(2010-8#5)(2010-9#3)(2011-1#8)(2011-12#1)(2011-2#14)(2011-3#1)(2012-1#6)(2012-12#21)(2012-2#5)(2012-3#12)(2013-1#17)(2013-7#2)(2013-8#9)
statistics]##2##1##(1990-12#1)(2013-8#1)
statnet##2##1##(2008-3#1)(2008-5#1)
statocyst and##2##2##(1991-6#1)(1995-8#1)
statocytes##5##1##(2009-8#5)
statolith removal##5##2##(2008-5#5)
stator arginine##4##2##(2008-4#4)
stator##5##1##(2008-4#5)
stature and##11##2##(1996-12#1)(2004-11#1)(2006-2#1)(2006-9#1)(2008-10#1)(2008-4#2)(2010-12#2)(2012-1#1)(2012-12#1)
stature can be##2##3##(2008-4#1)(2013-1#1)
stature of##2##2##(2006-9#1)(2008-4#1)
stature with##3##2##(2012-2#1)(2013-1#2)
stature##77##1##(1991-12#1)(1991-5#1)(1993-6#1)(1996-12#4)(1996-3#3)(1996-6#2)(1996-8#1)(1997-1#1)(2004-11#1)(2006-10#1)(2006-2#1)(2006-9#2)(2007-1#8)(2007-11#2)(2007-12#1)(2007-8#7)(2008-1#1)(2008-10#2)(2008-4#4)(2008-7#1)(2008-9#2)(2009-11#1)(2010-12#3)(2010-3#2)(2010-6#1)(2011-1#4)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#8)
statured forest##2##2##(2007-3#2)
status (ECOG) was##2##3##(1992-2#1)(1992-8#1)
status (OR =##2##3##(2012-1#1)(2012-3#1)
status (OR##5##2##(2007-10#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-3#1)
status (P =##2##3##(2009-9#1)(2011-1#1)
status (SES)##6##2##(2009-9#1)(2010-11#1)(2011-1#2)(2012-12#1)(2012-2#1)
status (p =##2##3##(2006-10#1)(2010-8#1)
status (p##4##2##(1990-2#1)(2006-10#1)(2010-12#1)(2010-8#1)
status affects##2##2##(2009-7#1)(2011-2#1)
status after##10##2##(1991-12#1)(1994-3#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#1)(2013-1#1)
status against##3##2##(1993-9#1)(2008-10#1)(2008-4#1)
status among immediately adjacent trees##2##5##(2008-10#2)
status among the##3##3##(1994-2#1)(2006-10#1)(2011-1#1)
status among##18##2##(1991-8#1)(1992-12#1)(1994-2#1)(1996-6#1)(2005-9#1)(2006-10#1)(2007-12#2)(2007-8#2)(2008-10#2)(2008-11#1)(2011-1#3)(2011-2#2)
status and a##2##3##(1995-9#1)(2011-2#1)
status and age##2##3##(2010-2#1)(2013-1#1)
status and cardiovascular risk##2##4##(1991-12#1)(2010-12#1)
status and family##2##3##(2009-8#1)(2013-8#1)
status and feeding practices of##2##5##(2008-2#2)
status and found that##2##4##(2009-4#1)(2012-3#1)
status and future directions##3##4##(2010-12#1)(2012-12#1)(2013-1#1)
status and future perspectives##2##4##(1994-9#1)(2012-3#1)
status and future##16##3##(1994-9#1)(1995-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(2006-9#1)(2007-11#1)(2008-11#1)(2008-7#1)(2009-11#1)(2010-12#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
status and health##7##3##(1990-12#1)(1996-2#1)(2005-9#1)(2006-10#2)(2009-5#1)(2010-2#1)
status and high##2##3##(2005-10#1)(2010-12#1)
status and in##2##3##(2007-12#1)(2012-1#1)
status and organization of astrocytes##2##5##(1997-5#2)
status and prevalence of##2##4##(2007-7#1)(2008-1#1)
status and problems of##2##4##(2007-5#1)(2013-7#1)
status and prospects##2##3##(2011-7#1)(2013-7#1)
status and quality of life##5##5##(1997-1#1)(2006-10#1)(2007-11#1)(2009-12#1)(2010-12#1)
status and research##4##3##(1996-8#1)(2010-11#1)(2013-1#2)
status and risk factors##2##4##(2011-1#1)(2013-1#1)
status and risk##3##3##(1993-11#1)(2011-1#1)(2013-1#1)
status and sex##2##3##(2009-11#1)(2010-8#1)
status and strategy of##2##4##(2005-10#1)(2008-2#1)
status and the risk##2##4##(1991-12#1)(2007-12#1)
status and the##19##3##(1991-12#1)(1993-4#1)(1997-1#1)(2004-1#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
status and their##2##3##(2006-9#1)(2007-12#1)
status and to##2##3##(2008-12#1)(2013-7#1)
status and treatment##2##3##(2008-1#1)(2012-2#1)
status and use of##2##4##(2005-10#1)(2007-11#1)
status and whether##2##3##(2007-6#1)(2008-7#1)
status and##278##2##(1990-12#1)(1990-5#1)(1990-6#2)(1991-12#4)(1991-4#1)(1991-6#1)(1992-3#1)(1992-9#4)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-7#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-7#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#3)(2004-1#1)(2004-11#1)(2005-10#5)(2005-11#2)(2005-3#1)(2005-5#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#6)(2006-12#1)(2006-2#3)(2006-7#3)(2006-8#2)(2006-9#2)(2007-10#2)(2007-11#5)(2007-12#9)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#3)(2007-7#4)(2007-8#1)(2008-1#5)(2008-10#3)(2008-11#7)(2008-12#5)(2008-2#3)(2008-3#3)(2008-4#5)(2008-5#1)(2008-7#7)(2008-9#3)(2009-10#1)(2009-11#3)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#3)(2010-10#2)(2010-11#3)(2010-12#6)(2010-2#5)(2010-3#2)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#7)(2010-9#1)(2011-1#8)(2011-12#2)(2011-2#13)(2011-7#1)(2011-9#1)(2012-1#5)(2012-12#8)(2012-2#6)(2012-3#4)(2013-1#18)(2013-7#7)(2013-8#4)
status are##15##2##(1991-2#1)(1992-10#1)(1996-9#1)(2005-10#1)(2006-10#2)(2006-2#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-6#2)(2009-10#1)(2011-1#1)
status as a##4##3##(1995-2#1)(2007-9#1)(2012-12#1)(2012-3#1)
status as an##2##3##(1997-3#1)(2006-3#1)
status as well as##2##4##(2008-5#1)(2012-12#1)
status as well##3##3##(1994-12#1)(2008-5#1)(2012-12#1)
status as##24##2##(1992-12#1)(1994-12#2)(1995-12#1)(1995-2#1)(1997-3#2)(2006-10#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-8#1)(2007-9#2)(2008-11#1)(2008-5#2)(2008-8#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-3#2)
status assessment for##2##3##(1992-9#1)(2012-3#1)
status assessment in##2##3##(2012-3#1)(2013-1#1)
status assessment##7##2##(1992-9#1)(2007-5#1)(2008-3#1)(2012-3#2)(2013-1#1)(2013-8#1)
status asthmaticus##4##2##(2007-2#4)
status at a given##2##4##(1992-6#1)(2008-5#1)
status at a##3##3##(1992-6#1)(1995-5#1)(2008-5#1)
status at the time of##3##5##(1991-7#1)(2006-4#1)(2007-10#1)
status at the##10##3##(1991-7#1)(1992-8#1)(1995-5#2)(2006-4#1)(2007-10#1)(2008-3#1)(2010-12#1)(2013-1#2)
status at##23##2##(1991-6#1)(1991-7#1)(1992-6#1)(1992-8#1)(1994-1#1)(1995-5#3)(1997-6#1)(2006-4#1)(2007-10#1)(2008-3#2)(2008-5#1)(2009-12#1)(2010-12#1)(2010-3#2)(2012-1#1)(2012-2#1)(2013-1#3)
status based on##2##3##(1996-2#1)(2006-10#1)
status before##3##2##(2006-8#1)(2008-1#1)(2008-7#1)
status between the##3##3##(1994-1#1)(1997-4#1)(2007-10#1)
status between##10##2##(1994-1#1)(1997-4#1)(2006-11#1)(2007-10#1)(2008-1#1)(2008-6#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
status but##3##2##(2010-7#2)(2012-11#1)
status by the##2##3##(2010-12#1)(2010-5#1)
status by##11##2##(1990-2#1)(1995-10#1)(2006-10#1)(2006-12#1)(2009-5#2)(2010-12#1)(2010-5#1)(2010-8#1)(2012-12#1)(2013-8#1)
status can be##2##3##(1996-12#1)(2005-1#1)
status can##4##2##(1996-12#1)(2005-1#1)(2008-2#1)(2012-12#1)
status change##2##2##(1993-6#1)(2006-10#1)
status clearly##2##2##(1996-10#1)(2012-2#1)
status compared##2##2##(2006-2#1)(2012-3#1)
status could##4##2##(2006-10#1)(2006-2#1)(2008-6#1)(2011-2#1)
status data##2##2##(1996-12#1)(2010-5#1)
status determines##2##2##(2004-2#1)(2011-2#1)
status did not##6##3##(1993-5#1)(1995-12#1)(2007-11#1)(2008-11#1)(2008-7#1)(2010-2#1)
status during the##6##3##(1990-6#3)(2007-12#1)(2010-9#1)(2013-8#1)
status during##9##2##(1990-6#3)(1995-9#1)(2007-10#1)(2007-12#1)(2010-7#1)(2010-9#1)(2013-8#1)
status epilepticus##16##2##(1993-5#1)(1994-11#1)(1997-5#2)(2006-4#1)(2008-7#2)(2009-3#3)(2009-9#1)(2010-11#1)(2010-7#1)(2012-2#2)(2013-8#1)
status exchange##3##2##(2012-12#3)
status for both##2##3##(2008-10#1)(2012-12#1)
status for the##2##3##(2010-12#1)(2011-3#1)
status for##20##2##(1993-2#1)(1994-1#1)(1996-7#1)(1997-1#1)(2007-4#1)(2007-6#1)(2007-8#2)(2008-10#1)(2008-5#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-12#3)(2013-1#2)
status from the##4##3##(1996-5#1)(2008-5#1)(2012-12#2)
status from##14##2##(1991-3#1)(1995-4#1)(1996-11#1)(1996-5#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-5#1)(2008-9#1)(2010-4#1)(2012-12#2)(2012-2#1)
status group##2##2##(2008-7#1)(2013-1#1)
status had a##2##3##(1990-10#1)(2009-9#1)
status has been##3##3##(2007-2#1)(2008-10#1)(2011-1#1)
status has##6##2##(1996-3#1)(2005-1#1)(2007-2#1)(2007-7#1)(2008-10#1)(2011-1#1)
status have##3##2##(1994-4#1)(2008-9#1)(2012-12#1)
status improved in##3##3##(2006-6#2)(2007-8#1)
status improved##6##2##(1990-6#1)(2006-6#3)(2006-8#1)(2007-8#1)
status in Asian##2##3##(2007-12#1)(2010-10#1)
status in Canada##2##3##(2005-7#1)(2007-12#1)
status in a sample of##2##5##(2008-12#1)(2012-2#1)
status in a##5##3##(1991-12#1)(1992-9#1)(2006-2#1)(2008-12#1)(2012-2#1)
status in cancer##2##3##(2005-11#1)(2008-7#1)
status in children with##2##4##(2006-10#1)(2006-12#1)
status in children##3##3##(2006-10#2)(2006-12#1)
status in clinical trials##2##4##(1992-10#1)(2008-5#1)
status in elderly##2##3##(2006-10#1)(2006-6#1)
status in neonatal##2##3##(2007-2#2)
status in patients with##5##4##(2008-10#1)(2009-8#1)(2012-2#2)(2013-1#1)
status in patients##9##3##(2007-10#1)(2007-9#1)(2008-10#1)(2009-8#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
status in pregnant##2##3##(1995-4#1)(2012-12#1)
status in rats##3##3##(2008-12#1)(2009-6#2)
status in streptozotocin-diabetic rats##2##4##(2007-9#2)
status in the elderly##3##4##(2008-10#1)(2008-7#1)(2012-3#1)
status in the two##2##4##(2005-4#1)(2006-1#1)
status in the##33##3##(1990-1#1)(1990-5#1)(1992-3#2)(1993-4#1)(1996-5#1)(2004-12#1)(2005-4#1)(2006-1#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#2)(2009-3#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-7#2)(2010-8#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
status in these patients##2##4##(2007-2#1)(2011-2#1)
status in these##3##3##(1997-7#1)(2007-2#1)(2011-2#1)
status in##160##2##(1990-1#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-10#1)(1992-3#2)(1992-9#2)(1993-10#1)(1993-12#1)(1993-4#1)(1995-4#1)(1995-7#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-7#3)(1997-8#1)(2004-12#1)(2005-11#1)(2005-4#1)(2005-7#2)(2005-9#1)(2006-1#1)(2006-10#3)(2006-12#2)(2006-2#5)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#5)(2007-7#1)(2007-8#3)(2007-9#4)(2008-1#1)(2008-10#10)(2008-12#2)(2008-5#3)(2008-7#5)(2008-8#5)(2008-9#1)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#1)(2009-9#3)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#3)(2010-8#3)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#5)(2012-2#8)(2012-3#2)(2013-1#9)(2013-7#2)(2013-8#7)
status information##4##2##(1996-1#2)(2008-10#1)(2010-3#1)
status is a##3##3##(1996-5#1)(2010-10#1)(2010-2#1)
status is an##3##3##(2007-11#1)(2007-2#1)(2007-7#1)
status is not##2##3##(2009-7#1)(2010-12#1)
status is to##2##3##(1991-10#1)(1995-1#1)
status is##35##2##(1991-10#1)(1991-12#1)(1993-1#1)(1995-1#1)(1995-2#1)(1996-5#2)(1997-3#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-5#1)(2009-7#1)(2010-10#2)(2010-12#2)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
status may be##2##3##(2005-10#1)(2007-4#1)
status may##8##2##(1993-1#1)(1994-6#1)(2005-10#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#1)(2013-8#1)
status might be##4##3##(2006-10#1)(2006-2#1)(2012-2#1)(2013-1#1)
status of 12##2##3##(1993-9#1)(2012-3#1)
status of Goodeidae familiy fishes (Cyprinodontiformes) from the Mexican Central##2##10##(2008-5#2)
status of HIV##2##3##(2010-9#1)(2013-1#1)
status of Medicare##2##3##(1993-3#1)(1997-2#1)
status of a patient##3##4##(2007-8#1)(2013-1#2)
status of a##18##3##(1991-7#1)(1993-2#1)(1996-3#1)(1996-9#1)(2005-11#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#2)
status of all##4##3##(2005-9#1)(2007-11#1)(2007-8#1)(2008-10#1)
status of an adult##2##4##(2006-2#1)(2009-12#1)
status of an individual##2##4##(2006-2#1)(2007-12#1)
status of an##6##3##(2006-2#2)(2007-12#1)(2008-11#1)(2009-12#1)(2011-2#1)
status of bone##2##3##(2009-3#1)(2012-11#1)
status of bovine spermatozoa##2##4##(2006-5#2)
status of cancer##2##3##(2005-10#1)(2007-11#1)
status of cardiac##2##3##(2006-10#1)(2012-12#1)
status of cellular##2##3##(2005-1#1)(2009-2#1)
status of cerebral palsy##2##4##(2010-12#2)
status of cerebral##3##3##(2006-7#1)(2010-12#2)
status of children and##2##4##(2007-3#1)(2013-1#1)
status of children##8##3##(1990-3#1)(1996-1#1)(2007-3#1)(2007-4#1)(2008-11#1)(2010-5#1)(2010-6#1)(2013-1#1)
status of clinical##2##3##(2006-3#1)(2008-5#1)
status of displaced persons##2##4##(1994-9#2)
status of experiential learning##2##4##(1995-1#2)
status of human##2##3##(1993-6#1)(2005-6#1)
status of individual##2##3##(2007-1#1)(2008-10#1)
status of individuals##3##3##(1994-11#1)(1996-12#1)(2006-10#1)
status of knowledge##4##3##(2007-5#1)(2008-11#1)(2012-11#1)(2013-1#1)
status of large##2##3##(1997-8#1)(2006-10#1)
status of liver and##2##4##(1990-2#1)(2009-10#1)
status of many##2##3##(2006-4#1)(2008-5#1)
status of older people##2##4##(2010-10#1)(2013-8#1)
status of older##4##3##(2008-5#1)(2010-10#2)(2013-8#1)
status of our understanding##2##4##(1994-10#1)(2012-11#1)
status of our##3##3##(1994-10#1)(2012-11#1)(2013-1#1)
status of patients in##3##4##(1992-3#1)(1995-3#1)(2011-2#1)
status of patients on##5##4##(2008-1#1)(2013-8#4)
status of patients with##9##4##(1992-3#1)(1996-1#1)(2006-10#1)(2006-6#1)(2007-11#2)(2008-7#1)(2011-1#1)(2012-3#1)
status of patients##22##3##(1992-3#2)(1995-3#1)(1996-1#1)(1996-2#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#3)(2007-6#1)(2008-1#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#4)
status of populations##2##3##(1995-12#2)
status of subjects was##2##4##(2011-2#1)(2012-2#1)
status of subjects##3##3##(2008-12#1)(2011-2#1)(2012-2#1)
status of the National##2##4##(1997-3#1)(2007-3#1)
status of the U##2##4##(2009-4#1)(2012-1#1)
status of the animal##3##4##(1990-4#2)(2008-4#1)
status of the cell and##2##5##(2005-8#1)(2008-9#1)
status of the cell##5##4##(1991-9#1)(1997-6#1)(2005-8#1)(2008-9#1)(2012-1#1)
status of the embryo##4##4##(2006-7#1)(2007-10#3)
status of the lesion##2##4##(2008-9#1)(2010-6#1)
status of the patient and##2##5##(1991-6#1)(2006-10#1)
status of the patient##8##4##(1991-6#1)(1992-8#1)(2006-10#2)(2006-4#2)(2008-7#1)(2009-10#1)
status of the patients was evaluated##2##6##(2007-9#1)(2008-1#1)
status of the patients with##2##5##(2007-8#1)(2008-6#1)
status of the patients##6##4##(1995-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-6#1)
status of the population##3##4##(1997-5#1)(2007-7#1)(2008-1#1)
status of the populations##3##4##(1996-12#1)(2006-4#1)(2007-5#1)
status of the primary##2##4##(2008-11#1)(2013-1#1)
status of the study##2##4##(1994-2#1)(2010-2#1)
status of the##171##3##(1990-10#1)(1990-11#1)(1990-4#2)(1990-6#2)(1990-8#2)(1990-9#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-3#2)(1992-4#1)(1992-8#1)(1993-11#1)(1993-3#2)(1993-7#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#3)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2005-11#1)(2005-8#1)(2006-10#7)(2006-11#2)(2006-12#2)(2006-4#3)(2006-5#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#5)(2007-11#3)(2007-12#4)(2007-2#3)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#4)(2008-12#2)(2008-4#6)(2008-5#5)(2008-6#2)(2008-7#5)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#3)
status of their##6##3##(1995-2#1)(2007-2#1)(2009-5#1)(2011-2#1)(2013-1#2)
status of these##15##3##(1994-1#1)(1994-12#1)(1995-3#1)(1997-1#1)(2005-7#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-3#2)(2010-9#1)
status of this##6##3##(1996-12#1)(2005-11#1)(2006-10#1)(2006-2#1)(2010-8#1)(2010-9#1)
status of various##3##3##(1990-12#1)(2005-11#1)(2008-10#1)
status of women and##2##4##(2007-7#1)(2013-1#1)
status of women##5##3##(1993-6#1)(2006-12#1)(2007-7#1)(2010-4#1)(2013-1#1)
status of##639##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#4)(1990-4#2)(1990-6#3)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#4)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#6)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-11#2)(1993-2#1)(1993-3#4)(1993-4#1)(1993-6#3)(1993-7#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#8)(1994-2#3)(1994-3#7)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#2)(1995-11#3)(1995-12#4)(1995-2#6)(1995-3#4)(1995-4#1)(1995-5#2)(1996-1#3)(1996-11#2)(1996-12#5)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#2)(1996-9#3)(1997-1#2)(1997-2#4)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#4)(2004-11#4)(2004-12#1)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#6)(2005-5#1)(2005-6#3)(2005-7#6)(2005-8#3)(2005-9#2)(2006-10#20)(2006-11#3)(2006-12#6)(2006-2#6)(2006-3#3)(2006-4#5)(2006-5#3)(2006-6#1)(2006-7#2)(2006-8#4)(2006-9#2)(2007-1#2)(2007-10#10)(2007-11#12)(2007-12#9)(2007-2#10)(2007-3#4)(2007-4#8)(2007-5#5)(2007-6#3)(2007-7#9)(2007-8#8)(2007-9#2)(2008-1#12)(2008-10#28)(2008-11#17)(2008-12#7)(2008-2#3)(2008-3#2)(2008-4#18)(2008-5#13)(2008-6#4)(2008-7#13)(2008-8#3)(2008-9#8)(2009-10#3)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#6)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#11)(2010-2#2)(2010-3#1)(2010-4#6)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#7)(2010-9#4)(2011-1#11)(2011-12#1)(2011-2#20)(2011-7#1)(2012-1#5)(2012-10#1)(2012-11#6)(2012-12#10)(2012-2#20)(2012-3#11)(2013-1#24)(2013-7#3)(2013-8#12)
status on admission##2##3##(2008-11#1)(2012-2#1)
status on the##6##3##(1990-4#1)(1993-3#1)(2004-11#2)(2012-12#1)(2013-8#1)
status on##22##2##(1990-4#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-12#1)(2004-11#2)(2004-2#1)(2005-10#1)(2006-2#1)(2008-11#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#2)
status or nuclear chromatin##2##4##(2009-6#2)
status or##16##2##(1990-10#1)(1990-12#1)(1991-12#1)(1993-10#1)(1995-5#1)(2005-10#1)(2006-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-6#2)(2013-1#2)
status over the##2##3##(2008-11#1)(2012-12#1)
status over##3##2##(2008-11#1)(2012-12#1)(2013-1#1)
status quo##5##2##(1994-12#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-12#1)
status remained##2##2##(2006-12#1)(2010-12#1)
status remains##2##2##(2004-11#1)(2008-10#1)
status report##6##2##(1990-5#1)(1996-12#1)(2007-3#1)(2009-4#1)(2010-12#1)(2011-1#1)
status scale##2##2##(2007-7#1)(2008-12#1)
status seems to##2##3##(1990-2#1)(1996-11#1)
status should be##6##3##(1996-12#1)(2005-1#1)(2006-2#1)(2007-9#1)(2010-7#2)
status should##8##2##(1996-12#1)(2005-1#1)(2006-2#1)(2007-12#1)(2007-9#1)(2009-3#1)(2010-7#2)
status showed that##2##3##(1993-9#1)(2010-12#1)
status showed##7##2##(1992-10#1)(1993-11#1)(1993-9#1)(1996-4#1)(2006-8#1)(2010-12#1)(2011-2#1)
status spontaneously##2##2##(2010-12#1)(2012-12#1)
status survey##2##2##(2007-7#1)(2007-8#1)
status than##5##2##(2006-10#1)(2006-7#1)(2010-2#1)(2010-6#1)(2013-8#1)
status that##3##2##(2006-5#1)(2007-10#1)(2008-6#1)
status the##2##2##(1993-1#1)(2006-10#1)
status through##2##2##(2008-10#1)(2012-2#1)
status to the##2##3##(2007-8#1)(2008-10#1)
status to their##3##3##(2007-12#1)(2012-12#2)
status to##17##2##(1992-9#1)(1994-3#1)(1995-12#1)(1997-6#1)(2005-10#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#1)(2010-10#1)(2010-3#1)(2010-4#1)(2012-12#3)(2013-1#1)
status using##2##2##(1996-6#1)(2008-7#1)
status was also##2##3##(1997-1#1)(2007-2#1)
status was assessed by##2##4##(1993-3#1)(2008-7#1)
status was assessed##6##3##(1991-12#1)(1991-2#1)(1993-3#1)(2008-1#1)(2008-7#1)(2008-9#1)
status was confirmed by##2##4##(1992-10#1)(2010-12#1)
status was determined by##3##4##(1993-11#1)(2007-8#1)(2008-8#1)
status was determined##5##3##(1993-11#1)(2007-8#1)(2008-11#1)(2008-8#2)
status was evaluated after##2##4##(2006-2#1)(2008-10#1)
status was evaluated##4##3##(1990-9#1)(2006-2#1)(2008-10#1)(2011-1#1)
status was found to##2##4##(2007-12#1)(2011-2#1)
status was found##4##3##(2004-1#1)(2007-12#1)(2011-2#1)(2013-1#1)
status was identified##2##3##(2009-4#1)(2012-12#1)
status was investigated##2##3##(1991-12#1)(2012-2#1)
status was known##3##3##(2012-12#3)
status was not##4##3##(2008-10#1)(2011-2#2)(2013-8#1)
status was##62##2##(1990-9#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-6#1)(1992-1#1)(1992-10#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-7#2)(1995-1#1)(1997-1#1)(1997-4#1)(1997-7#1)(2004-1#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#2)(2010-12#2)(2011-1#1)(2011-2#3)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
status were assessed in##2##4##(2008-12#1)(2010-3#1)
status were assessed##5##3##(1997-4#1)(2006-2#1)(2008-12#1)(2010-3#1)(2012-3#1)
status were evaluated##4##3##(2006-10#1)(2008-6#1)(2012-2#2)
status were##30##2##(1992-10#2)(1995-2#1)(1995-7#1)(1997-4#2)(1997-7#1)(2005-10#1)(2006-10#2)(2006-2#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
status when##2##2##(2006-10#1)(2006-4#1)
status which##3##2##(1994-12#1)(2005-7#1)(2008-8#1)
status while##3##2##(1995-2#1)(2010-3#1)(2011-2#1)
status will be##3##3##(1991-10#2)(1995-3#1)
status with##16##2##(1997-2#1)(1997-8#1)(2007-4#1)(2008-10#1)(2008-5#1)(2009-11#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-7#2)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
status within##3##2##(2008-10#1)(2008-8#1)(2009-8#1)
status##2504##1##(1990-1#1)(1990-10#4)(1990-11#3)(1990-12#5)(1990-2#5)(1990-3#7)(1990-4#5)(1990-5#5)(1990-6#9)(1990-8#3)(1990-9#4)(1991-1#2)(1991-10#6)(1991-11#2)(1991-12#18)(1991-2#9)(1991-3#1)(1991-4#5)(1991-5#2)(1991-6#9)(1991-7#3)(1991-8#4)(1991-9#3)(1992-1#1)(1992-10#9)(1992-11#2)(1992-12#7)(1992-2#6)(1992-3#10)(1992-4#1)(1992-6#3)(1992-8#5)(1992-9#9)(1993-1#10)(1993-10#3)(1993-11#8)(1993-12#9)(1993-2#5)(1993-3#11)(1993-4#5)(1993-5#3)(1993-6#6)(1993-7#5)(1993-8#3)(1993-9#5)(1994-1#5)(1994-10#1)(1994-11#3)(1994-12#23)(1994-2#7)(1994-3#17)(1994-4#2)(1994-5#4)(1994-6#5)(1994-7#5)(1994-8#1)(1994-9#4)(1995-1#7)(1995-10#5)(1995-11#3)(1995-12#13)(1995-2#14)(1995-3#7)(1995-4#5)(1995-5#9)(1995-6#3)(1995-7#5)(1995-8#1)(1995-9#6)(1996-1#9)(1996-10#1)(1996-11#7)(1996-12#16)(1996-2#7)(1996-3#7)(1996-4#4)(1996-5#8)(1996-6#5)(1996-7#3)(1996-8#5)(1996-9#11)(1997-1#9)(1997-2#9)(1997-3#12)(1997-4#10)(1997-5#14)(1997-6#4)(1997-7#10)(1997-8#9)(2004-1#5)(2004-10#1)(2004-11#10)(2004-12#5)(2004-2#3)(2004-4#1)(2004-9#3)(2005-1#5)(2005-10#25)(2005-11#10)(2005-3#1)(2005-4#1)(2005-5#2)(2005-6#3)(2005-7#9)(2005-8#6)(2005-9#7)(2006-1#4)(2006-10#69)(2006-11#4)(2006-12#15)(2006-2#30)(2006-3#4)(2006-4#11)(2006-5#6)(2006-6#9)(2006-7#8)(2006-8#23)(2006-9#7)(2007-1#4)(2007-10#29)(2007-11#43)(2007-12#49)(2007-2#35)(2007-3#10)(2007-4#14)(2007-5#11)(2007-6#18)(2007-7#37)(2007-8#40)(2007-9#15)(2008-1#35)(2008-10#81)(2008-11#45)(2008-12#28)(2008-2#11)(2008-3#16)(2008-4#38)(2008-5#39)(2008-6#20)(2008-7#52)(2008-8#30)(2008-9#25)(2009-10#7)(2009-11#11)(2009-12#10)(2009-2#3)(2009-3#19)(2009-4#17)(2009-5#23)(2009-6#6)(2009-7#16)(2009-8#17)(2009-9#14)(2010-1#2)(2010-10#14)(2010-11#14)(2010-12#46)(2010-2#24)(2010-3#10)(2010-4#17)(2010-5#8)(2010-6#9)(2010-7#23)(2010-8#26)(2010-9#7)(2011-1#57)(2011-11#1)(2011-12#13)(2011-2#104)(2011-3#2)(2011-7#2)(2011-9#1)(2012-1#25)(2012-10#1)(2012-11#9)(2012-12#66)(2012-2#75)(2012-3#45)(2013-1#121)(2013-7#17)(2013-8#54)
status) were##2##2##(2008-6#1)(2009-4#1)
status)##16##1##(1992-12#1)(1993-3#1)(2004-11#1)(2006-4#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-4#1)(2010-1#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
status?##3##1##(2006-10#1)(2006-8#1)(2009-6#1)
status?]##2##1##(1990-10#1)(2006-2#1)
status]##2##1##(1991-3#1)(1993-11#1)
statuses of##2##2##(2009-5#1)(2013-8#1)
statuses##11##1##(2007-8#1)(2009-5#2)(2009-7#1)(2010-11#1)(2010-7#1)(2012-11#1)(2012-12#1)(2013-8#3)
statute and##3##2##(1993-1#2)(1994-2#1)
statute of limitations##5##3##(1996-12#1)(1996-5#2)(1996-6#2)
statute of##7##2##(1996-12#1)(1996-5#3)(1996-6#2)(2012-2#1)
statute that##2##2##(1996-5#1)(1997-5#1)
statute was##3##2##(1990-12#1)(1995-12#1)(2006-8#1)
statute##41##1##(1990-12#2)(1992-12#2)(1992-3#1)(1992-6#1)(1993-1#6)(1993-2#3)(1994-2#1)(1994-3#1)(1995-12#2)(1995-6#2)(1996-11#1)(1996-12#1)(1996-5#5)(1996-6#3)(1997-1#3)(1997-5#1)(1997-6#1)(1997-7#2)(2006-7#1)(2006-8#1)(2012-2#1)
statutes##9##1##(1992-12#1)(1993-12#1)(1994-1#2)(1996-1#1)(1996-12#1)(1997-6#1)(2007-3#1)(2011-2#1)
statutory and case law##2##4##(1992-12#1)(2006-8#1)
statutory and##5##2##(1991-12#1)(1992-12#1)(2006-7#1)(2006-8#1)(2008-11#1)
statutory health insurance##2##3##(1992-12#1)(2008-11#1)
statutory health##3##2##(1992-12#2)(2008-11#1)
statutory provisions##2##2##(1993-1#1)(2012-3#1)
statutory requirements##2##2##(1996-3#1)(2007-10#1)
statutory##34##1##(1991-12#1)(1991-7#1)(1992-12#6)(1992-2#1)(1992-3#2)(1992-5#1)(1993-1#1)(1994-1#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-7#1)(2006-7#1)(2006-8#1)(2007-10#1)(2008-10#1)(2008-11#4)(2009-3#2)(2012-1#2)(2012-3#1)(2013-8#1)
staufen##4##1##(1994-12#4)
staurosporin##2##1##(1990-8#1)(1997-1#1)
staurosporine and calphostin C##2##4##(1995-7#2)
staurosporine and sphingosine##2##3##(1990-8#1)(1991-5#1)
staurosporine and##10##2##(1990-8#1)(1991-2#2)(1991-5#1)(1991-9#1)(1993-4#1)(1993-6#1)(1995-7#2)(2005-8#1)
staurosporine inhibited##2##2##(1992-3#1)(1995-12#1)
staurosporine on##2##2##(1995-12#1)(1995-7#1)
staurosporine or##4##2##(1990-10#1)(1990-8#1)(1991-7#1)(1996-8#1)
staurosporine treatment led to##2##4##(2005-8#2)
staurosporine treatment##4##2##(2005-8#3)(2011-1#1)
staurosporine was##2##2##(1994-12#1)(1995-11#1)
staurosporine##68##1##(1990-10#1)(1990-11#1)(1990-12#4)(1990-8#4)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#4)(1992-12#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-9#3)(1993-3#3)(1993-4#1)(1993-6#3)(1993-9#1)(1994-12#1)(1994-2#2)(1995-11#2)(1995-12#5)(1995-3#3)(1995-5#1)(1995-7#3)(1996-11#1)(1996-5#2)(1996-8#1)(1997-7#1)(2005-8#4)(2008-10#1)(2008-11#2)(2008-4#1)(2011-1#1)
stave off##3##2##(1993-9#1)(2007-9#1)(2013-7#1)
stavudine##13##1##(2007-11#1)(2008-10#3)(2008-5#2)(2008-7#2)(2009-4#1)(2010-7#4)
stay (LOS) and##2##3##(2005-10#1)(2006-1#1)
stay (LOS)##18##2##(1990-8#1)(1991-12#1)(1993-12#3)(1994-12#1)(1994-3#1)(1995-3#1)(1997-1#1)(2004-1#1)(2005-10#1)(2006-1#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-3#1)(2011-2#1)
stay (median##2##2##(2007-8#2)
stay afloat##2##2##(1991-4#2)
stay after##2##2##(2006-10#1)(2012-2#1)
stay and a##3##3##(1995-12#1)(2007-8#1)(2008-10#1)
stay and costs##2##3##(2006-10#1)(2011-2#1)
stay and ward stay##2##4##(2007-8#2)
stay and##42##2##(1990-12#2)(1993-3#1)(1994-5#1)(1995-12#2)(1995-3#1)(1996-3#1)(1996-9#1)(2006-1#2)(2006-10#3)(2006-4#1)(2006-6#1)(2006-8#1)(2007-5#1)(2007-8#8)(2007-9#1)(2008-10#1)(2008-5#2)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
stay at##5##2##(1990-8#1)(1997-7#1)(2004-7#1)(2007-4#1)(2008-2#1)
stay by##3##2##(1992-3#1)(1995-3#1)(2008-3#1)
stay focused on##2##3##(1991-12#1)(2008-6#1)
stay for a##2##3##(1992-4#1)(1993-2#1)
stay for the##3##3##(1990-12#1)(1992-2#1)(2008-10#1)
stay for##13##2##(1990-12#1)(1992-12#2)(1992-2#1)(1992-4#1)(1993-12#1)(1993-2#2)(2005-5#1)(2007-8#2)(2008-10#1)(2008-4#1)
stay in hospital and##2##4##(1992-3#1)(1997-2#1)
stay in hospital was##4##4##(1990-5#1)(1993-1#1)(1997-8#1)(2007-7#1)
stay in hospital##14##3##(1990-5#1)(1990-6#1)(1992-3#1)(1992-5#1)(1993-1#1)(1996-1#1)(1997-2#1)(1997-4#2)(1997-8#1)(2007-7#1)(2008-4#1)(2011-2#1)(2013-1#1)
stay in patients##3##3##(1995-9#1)(2007-9#1)(2010-6#1)
stay in the ICU##2##4##(2008-9#1)(2013-8#1)
stay in the hospital##3##4##(1996-2#1)(2008-5#1)(2013-8#1)
stay in the##21##3##(1991-12#1)(1995-9#1)(1996-1#1)(1996-2#1)(2006-10#2)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-2#1)(2012-2#2)(2013-1#1)(2013-8#2)
stay in##54##2##(1990-5#1)(1990-6#1)(1991-12#1)(1992-10#1)(1992-3#1)(1992-5#1)(1993-1#1)(1994-12#1)(1994-3#1)(1995-9#2)(1996-1#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-8#1)(2006-10#3)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#2)
stay of the##3##3##(1990-9#1)(1997-6#1)(2008-8#1)
stay of##14##2##(1990-10#1)(1990-9#1)(1991-1#1)(1991-12#1)(1992-12#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-9#1)(2008-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
stay on the##2##3##(1995-12#1)(1997-2#1)
stay on##9##2##(1991-1#1)(1992-3#1)(1994-3#1)(1995-1#1)(1995-12#1)(1997-2#1)(2008-7#1)(2009-7#1)(2013-1#1)
stay sutures are##4##3##(2008-11#3)(2013-1#1)
stay sutures##5##2##(2008-11#4)(2013-1#1)
stay than those##2##3##(2007-10#1)(2010-8#1)
stay than##5##2##(1993-2#1)(2006-6#1)(2007-10#1)(2007-8#1)(2010-8#1)
stay the##2##2##(1992-9#1)(1996-1#1)
stay to##3##2##(1992-5#1)(2010-8#1)(2012-2#1)
stay was 1##2##3##(2007-8#1)(2013-1#1)
stay was 12##2##3##(2008-10#1)(2011-11#1)
stay was 13##2##3##(2007-8#1)(2007-9#1)
stay was found##2##3##(1992-12#1)(2007-1#1)
stay was##41##2##(1992-12#1)(1996-11#1)(1996-12#1)(2006-10#1)(2006-12#1)(2006-6#3)(2007-1#1)(2007-10#1)(2007-6#2)(2007-7#2)(2007-8#9)(2007-9#3)(2008-10#2)(2008-3#1)(2011-11#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#2)
stay were similar##2##3##(1994-3#1)(2007-8#1)
stay were##7##2##(1990-9#1)(1994-1#1)(1994-3#1)(1996-3#1)(2007-8#2)(2007-9#1)
stay with##3##2##(2007-1#1)(2007-8#1)(2008-10#1)
stay without##2##2##(2012-2#2)
stay##443##1##(1990-10#1)(1990-12#4)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#2)(1991-1#2)(1991-12#8)(1991-3#1)(1991-4#2)(1992-1#3)(1992-10#1)(1992-12#11)(1992-2#3)(1992-3#5)(1992-4#1)(1992-5#3)(1992-9#1)(1993-1#5)(1993-12#9)(1993-2#5)(1993-3#2)(1994-1#2)(1994-12#5)(1994-3#9)(1994-5#1)(1994-6#1)(1995-1#3)(1995-12#4)(1995-2#1)(1995-3#7)(1995-5#1)(1995-9#2)(1996-1#5)(1996-11#1)(1996-12#3)(1996-2#4)(1996-3#4)(1996-9#1)(1997-1#4)(1997-2#3)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(2004-1#1)(2004-4#1)(2004-7#1)(2005-10#1)(2005-5#1)(2005-8#1)(2006-1#3)(2006-10#18)(2006-12#4)(2006-4#3)(2006-6#7)(2006-7#2)(2006-8#3)(2007-1#4)(2007-10#7)(2007-11#4)(2007-12#4)(2007-2#9)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#6)(2007-8#47)(2007-9#13)(2008-1#2)(2008-10#8)(2008-11#8)(2008-2#1)(2008-3#11)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#5)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#1)(2011-11#2)(2011-2#23)(2012-12#2)(2012-2#19)(2012-3#5)(2013-1#27)(2013-7#1)(2013-8#10)
stay)##4##1##(2006-8#1)(2007-8#2)(2010-11#1)
stay]##2##1##(1990-4#1)(2013-8#1)
stayed for##2##2##(1994-3#1)(2012-3#1)
stayed in the##5##3##(1993-5#1)(1994-2#1)(2006-8#1)(2007-9#1)(2008-10#1)
stayed in##10##2##(1993-5#1)(1994-2#1)(1994-3#2)(2006-8#1)(2007-1#1)(2007-4#1)(2007-9#1)(2008-10#1)(2012-3#1)
stayed on##2##2##(2008-1#1)(2012-2#1)
stayed viable##2##2##(2006-2#1)(2008-10#1)
stayed##32##1##(1993-5#1)(1994-2#1)(1994-3#3)(1994-6#1)(1994-8#1)(1995-3#1)(1997-8#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-6#1)(2009-4#2)(2009-8#1)(2010-4#1)(2012-2#1)(2012-3#2)(2013-1#1)
stayers##3##1##(2008-7#2)(2008-8#1)
staying &gt##3##2##(2013-1#3)
staying asleep##3##2##(2008-8#1)(2013-1#2)
staying at##2##2##(2007-7#1)(2008-12#1)
staying in hospital##2##3##(1994-8#1)(2006-6#1)
staying in the##3##3##(2004-5#1)(2008-10#1)(2009-12#1)
staying in##9##2##(1994-8#1)(2004-5#1)(2006-6#1)(2008-10#1)(2009-12#1)(2010-10#2)(2011-12#1)(2013-1#1)
staying##27##1##(1994-8#1)(2004-5#1)(2006-6#1)(2007-2#2)(2007-7#2)(2008-10#1)(2008-12#1)(2008-8#4)(2009-12#1)(2009-9#1)(2010-10#2)(2011-12#1)(2011-3#1)(2012-3#2)(2013-1#6)
stays and##4##2##(1993-3#1)(2007-8#1)(2011-12#1)(2011-2#1)
stays are##3##2##(1993-1#1)(2010-8#2)
stays for##4##2##(1996-1#2)(1996-12#1)(1997-1#1)
stays in a##2##3##(2010-8#1)(2013-1#1)
stays in the same##2##4##(1997-8#1)(2008-11#1)
stays in the##3##3##(1997-8#1)(2008-11#1)(2013-8#1)
stays in##7##2##(1990-12#1)(1997-8#1)(2008-11#1)(2010-8#1)(2013-1#2)(2013-8#1)
stays##55##1##(1990-12#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-1#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-8#1)(2004-1#1)(2006-10#2)(2006-9#1)(2007-2#2)(2007-8#4)(2007-9#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-7#3)(2010-8#5)(2011-12#1)(2011-2#2)(2012-11#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
ste11##2##1##(1997-4#2)
ste7##2##1##(1997-4#2)
steadfast##2##1##(2009-4#1)(2012-3#1)
steadily declining##2##2##(1992-1#1)(1993-12#1)
steadily from 2##2##3##(1994-12#1)(2008-10#1)
steadily from##4##2##(1992-4#1)(1994-12#1)(2008-10#1)(2009-4#1)
steadily growing##2##2##(2006-10#1)(2008-1#1)
steadily improving##3##2##(1997-8#1)(2007-4#1)(2012-1#1)
steadily in the##2##3##(1990-12#1)(2008-5#1)
steadily in##4##2##(1990-12#1)(1996-2#1)(1997-2#1)(2008-5#1)
steadily increased##5##2##(1995-3#1)(1997-7#1)(2006-10#1)(2008-10#1)(2012-2#1)
steadily increases##2##2##(2007-10#1)(2008-5#1)
steadily increasing in##2##3##(2011-2#2)
steadily increasing##14##2##(1990-10#1)(1991-11#1)(1997-6#2)(2006-8#1)(2008-1#2)(2008-3#1)(2008-8#1)(2010-12#1)(2010-7#1)(2011-2#2)(2013-8#1)
steadily more##2##2##(1996-2#1)(2004-9#1)
steadily over the##4##3##(1990-12#1)(2006-8#1)(2008-10#1)(2013-8#1)
steadily over##5##2##(1990-12#1)(1995-2#1)(2006-8#1)(2008-10#1)(2013-8#1)
steadily throughout##3##2##(1993-6#1)(1994-10#1)(2004-9#1)
steadily to##2##2##(1990-5#1)(2005-3#1)
steadily with age##3##3##(1997-7#1)(2006-2#2)
steadily with##7##2##(1993-6#1)(1995-8#1)(1997-7#1)(2006-2#2)(2007-8#1)(2008-5#1)
steadily##92##1##(1990-10#2)(1990-12#3)(1990-5#2)(1990-7#1)(1991-11#1)(1992-1#1)(1992-12#1)(1992-4#1)(1993-12#2)(1993-6#3)(1994-10#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#2)(1997-2#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-9#2)(2005-3#1)(2006-10#6)(2006-2#2)(2006-3#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-8#3)(2008-1#4)(2008-10#5)(2008-3#1)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#2)(2009-4#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#2)(2013-8#5)
steady and unsteady##4##3##(2008-11#1)(2008-6#1)(2013-1#1)(2013-8#1)
steady and##7##2##(2005-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-6#1)(2013-1#1)(2013-8#1)
steady decline##7##2##(1990-10#1)(1994-6#1)(2007-9#2)(2008-10#1)(2009-8#1)(2011-2#1)
steady flow##2##2##(2006-10#1)(2008-10#1)
steady growth##3##2##(2007-11#2)(2012-1#1)
steady in##2##2##(2008-11#2)
steady increase in the##7##4##(1997-7#1)(2006-10#1)(2006-9#1)(2009-7#1)(2009-9#1)(2010-9#1)(2012-2#1)
steady increase in##12##3##(1997-7#1)(2006-10#1)(2006-9#1)(2007-12#1)(2008-12#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-8#1)(2010-9#1)(2012-2#1)(2013-8#1)
steady increase##17##2##(1997-3#1)(1997-7#1)(2006-10#2)(2006-12#1)(2006-9#2)(2007-12#1)(2008-12#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-8#1)(2010-9#1)(2012-2#1)(2013-8#1)
steady levels##2##2##(1990-11#1)(1993-12#1)
steady state and dynamic##2##4##(1994-9#1)(2008-7#1)
steady state and##16##3##(1994-11#1)(1994-9#1)(1996-2#1)(2005-11#2)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#4)(2008-7#3)(2010-6#1)
steady state anisotropy##3##3##(1996-11#2)(2008-10#1)
steady state concentrations##2##3##(1990-5#1)(2008-10#1)
steady state conditions##3##3##(2008-1#1)(2008-10#2)
steady state experiments##2##3##(2008-7#2)
steady state fluorescence##3##3##(1994-8#1)(1995-3#1)(2008-10#1)
steady state fluxes##2##3##(2008-7#2)
steady state haematocrit##4##3##(2012-12#4)
steady state is##3##3##(2008-10#2)(2008-7#1)
steady state isotopomer##2##3##(2008-7#2)
steady state level##4##3##(1994-12#2)(1994-6#1)(1996-5#1)
steady state levels of##11##4##(1990-3#1)(1991-12#1)(1991-5#1)(1992-8#1)(1993-12#2)(1994-3#1)(1994-8#1)(1994-9#1)(1997-2#1)(2008-11#1)
steady state levels##13##3##(1990-3#1)(1991-12#1)(1991-5#1)(1992-3#1)(1992-8#1)(1993-12#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-3#1)(1997-2#1)(2008-11#1)
steady state mRNA levels for IFN-gamma##2##6##(1995-2#2)
steady state mRNA##3##3##(1995-2#3)
steady state of##4##3##(1990-3#1)(1995-1#1)(2007-12#1)(2008-6#1)
steady state was##5##3##(1991-12#1)(1992-9#1)(1993-12#2)(2010-6#1)
steady state whole cell current##2##5##(1994-3#2)
steady state##154##2##(1990-12#2)(1990-2#1)(1990-3#3)(1990-5#1)(1990-8#1)(1991-12#2)(1991-5#1)(1991-7#3)(1992-3#1)(1992-8#2)(1992-9#1)(1993-12#5)(1994-11#5)(1994-12#2)(1994-3#6)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-2#4)(1995-3#2)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-2#1)(1997-6#2)(1997-7#2)(2004-9#1)(2005-11#3)(2006-10#5)(2006-7#1)(2006-8#1)(2007-10#2)(2007-12#3)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#23)(2008-11#5)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#15)(2008-9#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-5#1)(2010-6#5)(2010-8#1)(2011-2#3)(2012-12#4)(2013-8#2)
steady states in##4##3##(1992-2#2)(2006-10#1)(2007-12#1)
steady states##14##2##(1990-8#1)(1992-11#1)(1992-2#2)(1992-7#1)(1992-8#1)(1996-8#1)(1997-1#1)(2006-10#3)(2007-11#1)(2007-12#1)(2007-9#1)
steady swimming##2##2##(2010-8#2)
steady##285##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#3)(1990-5#1)(1990-7#2)(1990-8#2)(1991-12#2)(1991-3#1)(1991-5#1)(1991-7#4)(1991-9#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-7#1)(1992-8#3)(1992-9#3)(1993-12#8)(1994-11#5)(1994-12#2)(1994-3#8)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#3)(1995-1#2)(1995-2#4)(1995-3#2)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-6#2)(1997-7#3)(2004-9#2)(2005-11#9)(2006-10#15)(2006-12#1)(2006-6#1)(2006-7#2)(2006-8#4)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#6)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#4)(2008-1#2)(2008-10#30)(2008-11#11)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#3)(2008-6#5)(2008-7#18)(2008-8#1)(2008-9#3)(2009-10#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#5)(2010-7#1)(2010-8#5)(2010-9#1)(2011-2#5)(2012-1#1)(2012-12#6)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#7)
steady-state APP mRNA levels##2##4##(1994-9#2)
steady-state DO concentration##3##3##(2008-10#3)
steady-state Young's relaxation modulus##2##4##(2009-7#2)
steady-state accumulation of##2##3##(1994-11#1)(2008-10#1)
steady-state and time-resolved fluorescence##4##4##(1990-2#1)(1991-7#1)(2008-5#1)(2008-8#1)
steady-state and time-resolved##6##3##(1990-2#1)(1991-7#1)(1996-11#1)(2006-10#1)(2008-5#1)(2008-8#1)
steady-state and##10##2##(1990-2#1)(1991-7#1)(1993-11#1)(1994-8#1)(1995-11#1)(1996-11#1)(2006-10#1)(2007-11#1)(2008-5#1)(2008-8#1)
steady-state c-myb mRNA levels##2##4##(1995-3#2)
steady-state component##2##2##(1990-5#2)
steady-state concentration of##4##3##(1990-8#2)(1992-11#1)(2008-6#1)
steady-state concentration##7##2##(1990-3#1)(1990-8#2)(1992-11#1)(2008-10#2)(2008-6#1)
steady-state conditions##8##2##(1991-1#1)(1992-1#1)(1994-5#1)(1997-1#1)(1997-2#1)(2005-11#1)(2007-3#1)(2011-2#1)
steady-state currents##2##2##(2007-8#1)(2008-10#1)
steady-state distribution##3##2##(2008-3#2)(2009-5#1)
steady-state fluorescence emission##2##3##(1992-6#1)(2008-10#1)
steady-state fluorescence polarization##3##3##(1990-12#1)(1991-5#1)(1991-9#1)
steady-state fluorescence quenching##2##3##(1993-3#1)(1996-9#1)
steady-state fluorescence spectra##2##3##(2008-10#1)(2009-2#1)
steady-state fluorescence spectroscopy##2##3##(2008-10#1)(2008-4#1)
steady-state fluorescence##16##2##(1990-12#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-3#1)(1993-6#1)(1996-8#1)(1996-9#1)(2008-10#4)(2008-3#1)(2008-4#1)(2009-2#1)
steady-state free calcium##2##3##(1992-8#2)
steady-state growth##5##2##(1993-9#2)(2008-11#1)(2008-6#1)(2008-7#1)
steady-state hydrolysis##2##2##(1990-7#2)
steady-state inactivation##5##2##(1992-9#1)(1996-10#2)(1996-9#1)(1997-5#1)
steady-state kinetic model##2##3##(1990-3#1)(1997-2#1)
steady-state kinetic##8##2##(1990-3#1)(1993-11#1)(1993-6#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-7#1)(1997-2#1)
steady-state kinetics##5##2##(1990-8#1)(1991-2#1)(1992-9#1)(1993-11#1)(1995-2#1)
steady-state level of the mRNA##2##5##(1990-11#1)(1992-1#1)
steady-state level of the##4##4##(1990-11#1)(1991-2#2)(1992-1#1)
steady-state level of##17##3##(1990-11#1)(1991-2#3)(1992-1#1)(1992-9#1)(1993-6#1)(1994-12#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-5#1)(1997-1#2)(2007-8#1)(2008-10#1)(2008-4#1)
steady-state level##20##2##(1990-11#1)(1991-2#3)(1992-1#1)(1992-9#1)(1993-6#1)(1994-12#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-5#1)(1997-1#2)(1997-2#2)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)
steady-state levels of mRNA for##2##5##(1995-12#1)(1997-7#1)
steady-state levels of mRNAs##2##4##(1995-2#1)(1997-1#1)
steady-state levels of##30##3##(1990-11#1)(1991-1#1)(1991-5#2)(1992-11#4)(1992-12#1)(1992-5#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#3)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-7#1)(1997-1#1)(1997-7#2)(2005-8#1)(2006-9#1)(2008-10#1)(2008-8#1)(2012-2#1)
steady-state light distribution##2##3##(2008-3#2)
steady-state mRNA level##2##3##(1997-2#1)(2008-8#1)
steady-state mRNA levels of##2##4##(1992-9#1)(2008-9#1)
steady-state mRNA levels##6##3##(1992-10#1)(1992-9#1)(1994-9#1)(1995-7#1)(1997-7#1)(2008-9#1)
steady-state mRNA##11##2##(1990-8#1)(1992-10#1)(1992-9#1)(1993-11#1)(1993-5#1)(1994-9#1)(1995-7#1)(1997-2#1)(1997-7#1)(2008-8#1)(2008-9#1)
steady-state measurement##2##2##(1993-4#1)(2008-10#1)
steady-state measurements##3##2##(1993-3#1)(2008-3#1)(2008-7#1)
steady-state method##2##2##(1991-5#1)(2008-2#1)
steady-state pHi##3##2##(1990-2#2)(1994-11#1)
steady-state performance##2##2##(1997-3#1)(2008-2#1)
steady-state photorefractive##3##2##(2007-11#1)(2007-12#1)(2008-1#1)
steady-state rate of##2##3##(1990-12#1)(1997-6#1)
steady-state rate##3##2##(1990-12#1)(1994-3#1)(1997-6#1)
steady-state reflectance##2##2##(2008-2#2)
steady-state response was##2##3##(2007-9#1)(2008-10#1)
steady-state response##5##2##(2007-8#1)(2007-9#2)(2008-10#1)(2008-9#1)
steady-state responses##2##2##(2007-9#1)(2008-9#1)
steady-state results##2##2##(1994-5#1)(2009-5#1)
steady-state##300##1##(1990-11#2)(1990-12#3)(1990-2#4)(1990-3#3)(1990-5#5)(1990-7#2)(1990-8#5)(1991-1#3)(1991-12#2)(1991-2#4)(1991-3#1)(1991-4#4)(1991-5#4)(1991-7#5)(1991-8#2)(1991-9#2)(1992-1#3)(1992-10#1)(1992-11#5)(1992-12#2)(1992-5#2)(1992-6#4)(1992-7#1)(1992-8#3)(1992-9#5)(1993-11#4)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#3)(1993-9#3)(1994-11#2)(1994-12#1)(1994-3#2)(1994-5#5)(1994-6#3)(1994-8#1)(1994-9#3)(1995-1#2)(1995-10#5)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#3)(1995-6#4)(1995-7#2)(1995-8#2)(1996-10#3)(1996-11#1)(1996-3#1)(1996-5#2)(1996-7#3)(1996-8#1)(1996-9#2)(1997-1#7)(1997-2#6)(1997-3#2)(1997-5#1)(1997-6#3)(1997-7#4)(1997-8#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-5#1)(2006-7#1)(2006-9#1)(2007-11#4)(2007-12#12)(2007-3#3)(2007-4#1)(2007-8#3)(2007-9#4)(2008-1#1)(2008-10#22)(2008-11#5)(2008-12#1)(2008-2#8)(2008-3#14)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#3)(2009-2#1)(2009-5#4)(2009-7#2)(2010-4#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
steadystate##2##1##(2008-7#1)(2013-1#1)
steak##2##1##(1997-2#1)(2012-12#1)
steaks and DC steaks enhanced with##2##6##(2010-4#2)
steaks and##3##2##(2010-4#3)
steaks from##2##2##(2010-4#2)
steaks##21##1##(2010-4#18)(2012-12#3)
steal syndrome##7##2##(1993-3#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#2)
steal##16##1##(1991-7#1)(1993-3#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#2)(2008-8#1)(2010-5#1)
steam activation##3##2##(2005-11#3)
steam distillation##5##2##(2006-12#1)(2007-11#2)(2007-8#1)(2008-10#1)
steam explosion##2##2##(2008-6#1)(2013-1#1)
steam generator##3##2##(2008-10#1)(2009-10#2)
steam pretreated##2##2##(2008-5#1)(2008-6#1)
steam pretreatment##2##2##(2008-5#2)
steam sterilizable##2##2##(1994-11#1)(2008-7#1)
steam sterilization##2##2##(2005-11#1)(2007-7#1)
steam##36##1##(1990-11#1)(1993-2#1)(1994-11#1)(2005-11#4)(2006-12#1)(2006-6#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-5#3)(2008-6#4)(2008-7#1)(2009-10#3)(2011-2#1)(2013-1#1)
steam-exploded barley straw##2##3##(2008-5#2)
steam-exploded poplar##3##2##(2008-6#3)
steam-exploded##5##1##(2008-5#2)(2008-6#3)
steam-pretreated willow##2##2##(2008-6#2)
steam-pretreated##3##1##(2008-6#2)(2011-2#1)
steamed potting mix##2##3##(2008-10#2)
steaming and Al##2##3##(2008-10#2)
steaming##4##1##(2005-11#1)(2008-1#1)(2008-10#2)
stearate (18##2##2##(1990-2#1)(1995-8#1)
stearate as##2##2##(1994-3#1)(2008-5#1)
stearate##14##1##(1990-2#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-8#1)(2004-12#2)(2005-11#1)(2008-10#2)(2008-5#1)(2010-5#1)(2013-8#1)
stearates##2##1##(2008-5#2)
stearic acid was##3##3##(1996-4#1)(2008-10#2)
stearic acid##18##2##(1991-3#2)(1991-7#1)(1992-1#1)(1992-11#2)(1996-4#1)(2005-11#3)(2006-1#1)(2006-12#1)(2007-8#1)(2008-10#5)
stearic##29##1##(1991-3#2)(1991-7#1)(1992-1#1)(1992-11#2)(1993-6#1)(1994-11#1)(1994-8#2)(1996-2#1)(1996-4#1)(2005-11#3)(2006-1#1)(2006-12#3)(2007-8#1)(2008-10#8)(2008-7#1)
stearothermophilus K1041##2##2##(1994-12#2)
stearothermophilus and##2##2##(1994-12#1)(1997-5#1)
stearothermophilus is##3##2##(1992-3#1)(1993-11#1)(1995-5#1)
stearothermophilus spores##2##2##(2007-7#2)
stearothermophilus##37##1##(1990-11#3)(1990-7#4)(1991-9#1)(1992-3#4)(1993-11#5)(1994-12#4)(1995-2#2)(1995-5#2)(1996-8#4)(1997-5#2)(2007-7#2)(2008-6#2)(2008-7#1)(2011-2#1)
stearoyl##3##1##(1991-7#1)(1995-12#1)(2005-11#1)
stearyl##2##1##(2008-5#1)(2013-8#1)
stearylamine##4##1##(1990-2#1)(1990-5#1)(2008-10#1)(2008-8#1)
steato-hepatitis##2##1##(2008-1#1)(2013-1#1)
steatocystoma multiplex##2##2##(2012-3#2)
steatohepatitis (NASH)##8##2##(2005-10#1)(2006-2#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-2#1)(2013-1#2)
steatohepatitis##19##1##(2004-11#1)(2005-10#1)(2005-12#1)(2006-10#3)(2006-2#2)(2007-5#1)(2007-8#2)(2008-9#1)(2009-3#1)(2010-12#1)(2011-2#1)(2013-1#4)
steatonecrosis of##2##2##(1992-10#1)(2013-1#1)
steatorrhea and##2##2##(1992-5#1)(2004-11#1)
steatorrhea##7##1##(1992-5#1)(2004-11#1)(2005-10#1)(2006-10#1)(2006-6#1)(2013-1#1)(2013-7#1)
steatosis and##4##2##(2006-10#1)(2007-3#1)(2011-2#1)(2012-3#1)
steatosis is##2##2##(2007-5#1)(2013-1#1)
steatosis on##2##2##(2007-8#1)(2011-2#1)
steatosis##28##1##(1994-6#1)(2004-11#1)(2006-10#5)(2006-6#2)(2007-3#1)(2007-5#1)(2007-8#3)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
steatotic grafts##5##2##(2009-2#5)
steatotic##10##1##(2006-8#1)(2009-2#8)(2009-8#1)
steel and brass##2##3##(2008-10#2)
steel and##10##2##(2007-12#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-7#1)
steel as##2##2##(2008-10#1)(2013-7#1)
steel ball##3##2##(2004-9#1)(2008-3#1)(2009-4#1)
steel by##3##2##(2007-11#1)(2008-10#1)(2010-4#1)
steel factor##3##2##(2008-4#3)
steel industry##2##2##(1995-5#1)(2008-10#1)
steel or##2##2##(2007-11#1)(2013-8#1)
steel pin##2##2##(2008-10#1)(2012-2#1)
steel plate##2##2##(2008-12#2)
steel plates##4##2##(2008-12#2)(2012-12#2)
steel production##2##2##(2008-10#2)
steel sample##3##2##(2008-10#3)
steel samples##7##2##(2007-12#1)(2008-10#6)
steel slag filters##2##3##(2013-1#2)
steel standards##2##2##(2008-10#2)
steel wire and##3##3##(2009-3#3)
steel wire##8##2##(2007-8#2)(2008-10#1)(2009-3#4)(2012-1#1)
steel wires##2##2##(2007-8#1)(2008-10#1)
steel with##2##2##(2007-11#1)(2008-10#1)
steel##141##1##(1990-11#1)(1991-12#1)(1992-1#1)(1995-5#1)(1996-12#4)(1996-3#3)(1996-8#1)(2004-9#2)(2005-11#1)(2005-4#1)(2006-12#2)(2006-3#1)(2007-11#8)(2007-12#3)(2007-4#1)(2007-8#4)(2008-10#50)(2008-11#1)(2008-12#5)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#2)(2008-7#3)(2009-3#4)(2009-4#1)(2010-4#2)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#4)(2013-1#7)(2013-7#1)(2013-8#5)
steel)##4##1##(2008-10#2)(2011-2#1)(2013-1#1)
steelhead##3##1##(2009-6#1)(2010-8#2)
steelmaking##2##1##(2008-10#2)
steels by##3##2##(2007-12#1)(2008-10#1)(2009-5#1)
steels is##2##2##(2008-10#2)
steels##22##1##(2007-11#1)(2007-12#1)(2008-10#11)(2009-5#8)(2012-2#1)
steels)##4##1##(2008-10#4)
steep decrease in##3##3##(1992-6#1)(2008-3#1)(2008-8#1)
steep learning curve for##2##4##(2007-8#1)(2008-11#1)
steep learning curve##3##3##(2007-8#1)(2008-11#1)(2012-2#1)
steep learning##4##2##(2007-8#1)(2008-11#2)(2012-2#1)
steep rise##4##2##(1992-12#1)(1992-8#1)(2006-10#1)(2007-9#1)
steep slopes of##2##3##(2007-5#1)(2008-12#1)
steep slopes##5##2##(2007-5#1)(2008-10#1)(2008-12#1)(2011-12#2)
steep trajectory##2##2##(1995-12#2)
steep##57##1##(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1995-11#1)(1995-12#3)(1995-5#1)(1995-6#1)(1996-4#1)(2005-12#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-5#2)(2007-8#1)(2007-9#3)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#6)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2009-12#1)(2010-12#1)(2011-12#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
steep)##2##1##(2008-10#1)(2008-8#1)
steeper in##2##2##(1993-7#1)(1995-8#1)
steeper than##4##2##(1995-12#1)(2008-8#2)(2012-1#1)
steeper##19##1##(1991-10#1)(1992-4#1)(1993-11#2)(1993-12#1)(1993-7#1)(1993-8#1)(1995-12#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-8#3)(2009-6#2)(2012-1#1)(2012-12#1)
steepest##4##1##(2007-8#1)(2008-3#1)(2009-3#1)(2013-7#1)
steeply##12##1##(1990-10#1)(1990-9#2)(2005-12#1)(2006-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#2)(2011-1#1)
steepness of the##2##3##(2005-12#1)(2007-7#1)
steepness##6##1##(1995-3#1)(2005-12#1)(2007-7#1)(2008-10#1)(2008-3#2)
steer the##6##2##(2007-11#1)(2008-2#2)(2008-6#1)(2012-1#2)
steer##13##1##(1994-6#1)(2005-7#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#2)(2008-6#1)(2011-1#1)(2012-1#2)(2013-7#1)
steerable tip##3##2##(2006-6#3)
steerable##9##1##(2006-6#6)(2008-2#1)(2008-7#1)(2010-12#1)
steered and rotated##2##3##(2008-3#2)
steered molecular dynamics##2##3##(2009-9#2)
steered the##2##2##(2007-12#1)(2008-10#1)
steered##14##1##(2005-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-9#2)(2012-1#1)
steering committee for##2##3##(1993-3#1)(1995-12#1)
steering committee##4##2##(1993-3#1)(1995-12#1)(1997-3#1)(2007-10#1)
steering in##5##2##(2007-11#3)(2007-12#1)(2008-2#1)
steering is##2##2##(2008-2#1)(2008-3#1)
steering of spatial solitons in##2##5##(2007-12#2)
steering of the##2##3##(2006-6#1)(2007-12#1)
steering of##5##2##(2006-6#1)(2007-12#3)(2012-1#1)
steering the##3##2##(2008-3#1)(2008-5#1)(2013-8#1)
steering wheel##3##2##(2006-11#2)(2012-1#1)
steering with##3##2##(2007-12#1)(2008-2#1)(2012-1#1)
steering##48##1##(1993-3#1)(1994-6#1)(1995-12#1)(1997-3#1)(2006-11#2)(2006-12#1)(2006-6#2)(2007-10#1)(2007-11#3)(2007-12#6)(2008-12#1)(2008-2#9)(2008-3#8)(2008-5#1)(2009-11#1)(2012-1#7)(2013-8#2)
steers of##2##2##(2012-2#2)
steers were##2##2##(2010-4#1)(2012-2#1)
steers##12##1##(1996-12#2)(1997-5#1)(2005-8#1)(2010-4#3)(2012-2#4)(2013-1#1)
stefin A##5##2##(1992-1#1)(1995-2#4)
stefins##3##1##(1992-1#2)(1995-2#1)
stele##4##1##(2008-10#4)
stellar coronagraph##4##2##(2007-11#4)
stellar interferometer with##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
stellar interferometer##8##2##(2007-11#4)(2007-12#1)(2008-3#3)
stellar interferometry##2##2##(2008-2#2)
stellar interiors##2##2##(1996-5#2)
stellar occultation##2##2##(2008-2#1)(2008-3#1)
stellar##32##1##(1992-3#1)(1992-9#1)(1996-5#3)(1997-8#1)(2006-10#1)(2007-11#9)(2007-12#1)(2007-9#1)(2008-2#4)(2008-3#8)(2009-10#1)(2012-12#1)
stellate cell line##2##3##(2008-11#2)
stellate cell##5##2##(2008-11#4)(2009-3#1)
stellate cells are##2##3##(2006-10#1)(2009-3#1)
stellate cells of##2##3##(1994-10#1)(1997-3#1)
stellate cells were##3##3##(1993-12#1)(1994-10#1)(2008-11#1)
stellate cells##26##2##(1993-12#1)(1994-10#5)(1997-3#1)(2006-10#3)(2008-11#5)(2008-9#1)(2009-3#1)(2009-7#1)(2012-12#6)(2013-8#2)
stellate ganglion block##2##3##(2006-12#2)
stellate ganglion##9##2##(1992-1#1)(1995-12#1)(1995-5#1)(2006-12#3)(2008-7#1)(2009-2#2)
stellate##43##1##(1992-1#1)(1993-12#1)(1994-10#5)(1995-12#1)(1995-5#3)(1997-3#1)(2006-10#3)(2006-12#3)(2008-11#10)(2008-7#1)(2008-9#1)(2009-2#2)(2009-3#2)(2009-7#1)(2012-12#6)(2013-8#2)
stellite##2##1##(1994-6#1)(1997-8#1)
stem (ES) cells##23##3##(1992-12#1)(1993-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-10#1)(1997-8#1)(2008-1#3)(2008-11#4)(2008-8#1)(2008-9#4)(2009-12#1)(2009-3#1)(2012-12#1)
stem (ES)##26##2##(1992-12#1)(1993-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-10#1)(1997-8#1)(2008-1#3)(2008-11#6)(2008-8#1)(2008-9#4)(2009-12#1)(2009-3#1)(2009-4#1)(2012-12#1)
stem anatomy##2##2##(2007-3#2)
stem and leaf##3##3##(2008-10#2)(2012-12#1)
stem and loop##3##3##(1997-5#1)(2008-8#1)(2011-3#1)
stem and progenitor cell##3##4##(1995-12#1)(2008-4#1)(2009-4#1)
stem and progenitor cells of##2##5##(2008-9#1)(2010-12#1)
stem and progenitor cells##15##4##(1995-12#3)(2006-6#1)(2008-9#2)(2009-4#2)(2010-11#1)(2010-12#2)(2012-1#1)(2012-12#2)(2012-2#1)
stem and progenitor##18##3##(1995-12#4)(2006-6#1)(2008-4#1)(2008-9#2)(2009-4#3)(2010-11#1)(2010-12#2)(2012-1#1)(2012-12#2)(2012-2#1)
stem and root##2##3##(2011-1#1)(2012-11#1)
stem and##50##2##(1990-9#1)(1991-6#3)(1994-5#1)(1995-12#4)(1995-4#1)(1996-10#1)(1997-5#1)(2006-6#1)(2008-10#9)(2008-12#2)(2008-4#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-4#3)(2010-10#1)(2010-11#1)(2010-12#2)(2011-1#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2013-1#1)
stem bark of M##2##4##(2011-2#2)
stem bark of##9##3##(2007-1#1)(2007-11#1)(2008-8#1)(2010-12#3)(2010-5#1)(2011-2#2)
stem bark##13##2##(2007-1#2)(2007-11#1)(2008-8#1)(2010-12#4)(2010-2#2)(2010-5#1)(2011-2#2)
stem base tissue##2##3##(2008-10#2)
stem base##4##2##(2008-10#4)
stem borers##2##2##(2006-12#1)(2008-10#1)
stem but not##2##3##(1993-4#1)(2011-2#1)
stem can be##2##3##(2008-10#2)
stem canker of##4##3##(2008-10#4)
stem canker##6##2##(2008-10#6)
stem cankers##2##2##(2008-10#1)(2010-3#1)
stem cell (MSC) therapy##2##4##(2008-4#1)(2012-7#1)
stem cell (MSC)##3##3##(2008-4#1)(2012-12#1)(2012-7#1)
stem cell application##3##3##(2012-12#2)(2012-5#1)
stem cell banks##3##3##(2007-8#1)(2008-11#2)
stem cell behavior##3##3##(2008-11#1)(2009-3#1)(2009-4#1)
stem cell biology and##5##4##(1997-6#1)(2008-10#1)(2008-11#1)(2009-12#1)(2010-12#1)
stem cell biology##14##3##(1997-6#1)(2008-10#1)(2008-11#4)(2008-5#1)(2009-12#1)(2009-3#2)(2009-9#1)(2010-12#2)(2010-4#1)
stem cell characteristics##3##3##(1996-5#1)(2012-12#2)
stem cell compartment##3##3##(2008-10#1)(2008-7#1)(2010-4#1)
stem cell culture##5##3##(2008-1#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)
stem cell deficiency and##2##4##(2010-10#1)(2010-11#1)
stem cell deficiency##8##3##(2006-11#1)(2009-8#2)(2010-10#1)(2010-11#1)(2012-12#3)
stem cell derived##3##3##(2008-1#2)(2011-1#1)
stem cell differentiation into##2##4##(2008-11#1)(2012-7#1)
stem cell differentiation##17##3##(2008-1#1)(2008-11#5)(2008-7#1)(2009-3#3)(2009-4#1)(2010-12#2)(2010-6#1)(2011-2#1)(2012-7#1)(2013-7#1)
stem cell division##2##3##(2007-10#2)
stem cell factor##8##3##(1993-5#1)(1995-1#1)(1995-2#1)(1996-5#1)(1997-4#1)(2008-4#1)(2011-2#1)(2012-12#1)
stem cell fate##8##3##(2008-1#1)(2008-11#4)(2009-3#1)(2010-11#1)(2012-1#1)
stem cell field##2##3##(2007-10#1)(2010-4#1)
stem cell function##3##3##(2008-8#1)(2009-3#1)(2009-8#1)
stem cell gene therapy##4##4##(1995-1#1)(2007-11#2)(2008-1#1)
stem cell graft##2##3##(2007-11#2)
stem cell grafting##2##3##(1995-12#1)(2005-12#1)
stem cell growth##2##3##(1990-12#1)(2008-11#1)
stem cell has##2##3##(2012-12#1)(2012-2#1)
stem cell imaging techniques##2##4##(2012-1#2)
stem cell is##5##3##(2008-10#1)(2008-7#1)(2010-8#1)(2012-12#2)
stem cell line##7##3##(1997-6#2)(2008-11#2)(2008-8#1)(2012-12#1)(2013-1#1)
stem cell lineages##3##3##(2008-6#1)(2009-3#2)
stem cell lines##8##3##(1994-12#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#2)
stem cell maintenance and##2##4##(2009-8#1)(2013-8#1)
stem cell marker##8##3##(2008-1#1)(2009-10#1)(2010-11#1)(2012-12#4)(2012-5#1)
stem cell markers##3##3##(2009-12#1)(2012-12#1)(2012-5#1)
stem cell niche##16##3##(2007-10#1)(2007-12#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-10#1)(2011-1#2)(2012-12#2)(2012-2#2)(2012-3#2)
stem cell niches in##2##4##(2010-10#1)(2012-12#1)
stem cell niches##4##3##(2010-10#2)(2011-1#1)(2012-12#1)
stem cell pool##4##3##(2010-11#1)(2012-1#1)(2012-2#1)(2013-1#1)
stem cell population and##3##4##(2010-4#1)(2012-12#2)
stem cell population in Aplastic##2##5##(2010-11#2)
stem cell population in the##2##5##(2008-11#1)(2010-7#1)
stem cell population in##4##4##(2008-11#1)(2010-11#2)(2010-7#1)
stem cell population##16##3##(2008-11#6)(2008-4#1)(2010-11#2)(2010-4#1)(2010-7#3)(2012-12#3)
stem cell populations##7##3##(2008-1#2)(2008-11#1)(2009-8#1)(2010-11#2)(2010-6#1)
stem cell procedures##2##3##(2005-11#2)
stem cell proliferation and##2##4##(1996-4#1)(2007-10#1)
stem cell proliferation##3##3##(1994-11#1)(1996-4#1)(2007-10#1)
stem cell proteome##4##3##(2008-1#4)
stem cell regulatory##2##3##(2009-4#1)(2010-10#1)
stem cell renewal##2##3##(2011-1#1)(2012-2#1)
stem cell research is##2##4##(2008-9#1)(2012-11#1)
stem cell research##27##3##(2005-11#1)(2006-7#1)(2007-3#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-9#3)(2009-3#1)(2010-11#1)(2010-12#2)(2012-11#5)(2012-12#5)(2013-8#1)
stem cell self-renewal##2##3##(2007-10#1)(2008-11#1)
stem cell state##3##3##(2008-1#1)(2009-3#2)
stem cell support##3##3##(1996-11#1)(2008-7#1)(2010-3#1)
stem cell systems biology##2##4##(2009-3#2)
stem cell systems##3##3##(2008-11#1)(2009-3#2)
stem cell therapies##4##3##(2008-1#3)(2008-11#1)
stem cell therapy##11##3##(2008-1#1)(2008-10#1)(2008-8#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-3#1)(2012-1#1)(2012-4#1)(2013-1#2)
stem cell to##2##3##(2007-12#1)(2008-7#1)
stem cell transplant##11##3##(1995-12#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-10#1)(2010-11#2)(2012-12#3)
stem cell transplantation (HSCT) has become an##2##7##(2007-2#1)(2013-8#1)
stem cell transplantation (HSCT)##11##4##(2006-10#1)(2007-2#1)(2008-1#1)(2010-11#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#2)
stem cell transplantation (PBSCT)##2##4##(1997-3#1)(2010-4#1)
stem cell transplantation and##2##4##(2012-10#1)(2013-8#1)
stem cell transplantation for##5##4##(2009-8#1)(2010-10#1)(2010-12#1)(2012-2#2)
stem cell transplantation has been##2##5##(2005-8#1)(2008-1#1)
stem cell transplantation has##3##4##(2005-8#1)(2008-1#1)(2010-11#1)
stem cell transplantation in a##2##5##(2006-10#1)(2011-2#1)
stem cell transplantation in childhood##2##5##(2008-10#1)(2012-10#1)
stem cell transplantation in##12##4##(2006-10#1)(2008-10#1)(2009-7#1)(2009-8#1)(2010-11#2)(2011-2#1)(2012-10#2)(2012-12#2)(2013-8#1)
stem cell transplantation is##7##4##(1995-12#1)(1997-8#1)(2007-11#1)(2012-12#3)(2012-2#1)
stem cell transplantation to##2##4##(2008-1#1)(2008-7#1)
stem cell transplantation##106##3##(1995-12#2)(1997-3#2)(1997-8#1)(2005-11#4)(2005-12#1)(2005-8#2)(2006-10#2)(2006-11#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#5)(2009-10#2)(2009-3#1)(2009-7#1)(2009-8#3)(2010-10#1)(2010-11#9)(2010-12#3)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#8)(2012-10#4)(2012-12#13)(2012-2#8)(2013-1#2)(2013-8#6)
stem cell transplantation]##4##3##(1997-3#1)(2005-11#1)(2011-2#1)(2012-2#1)
stem cell transplantations##3##3##(2012-12#3)
stem cell transplants were performed##2##5##(2013-1#2)
stem cell types##4##3##(2007-8#1)(2008-1#1)(2008-9#1)(2012-5#1)
stem cell##502##2##(1990-12#1)(1991-11#1)(1992-12#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-1#2)(1995-12#6)(1995-2#1)(1995-6#1)(1996-11#1)(1996-4#1)(1996-5#2)(1997-3#3)(1997-4#1)(1997-6#3)(1997-8#1)(2005-11#9)(2005-12#3)(2005-8#3)(2006-10#5)(2006-11#2)(2006-7#1)(2007-10#7)(2007-11#6)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#6)(2008-1#36)(2008-10#12)(2008-11#52)(2008-3#1)(2008-4#8)(2008-5#5)(2008-6#5)(2008-7#13)(2008-8#7)(2008-9#11)(2009-10#5)(2009-12#5)(2009-3#21)(2009-4#5)(2009-7#1)(2009-8#10)(2009-9#2)(2010-10#8)(2010-11#22)(2010-12#11)(2010-2#1)(2010-3#2)(2010-4#8)(2010-5#2)(2010-6#3)(2010-7#4)(2010-8#4)(2011-1#9)(2011-2#18)(2012-1#8)(2012-10#4)(2012-11#5)(2012-12#60)(2012-2#20)(2012-3#4)(2012-4#1)(2012-5#5)(2012-7#3)(2013-1#13)(2013-7#2)(2013-8#9)
stem cell)##2##2##(2008-11#1)(2010-11#1)
stem cell-based cardiopatches##2##3##(2012-12#2)
stem cell-based therapeutic products##4##4##(2012-12#4)
stem cell-based therapeutics##4##3##(2012-12#4)
stem cell-based##13##2##(2012-12#12)(2013-8#1)
stem cell-derived##5##2##(2008-9#1)(2010-10#1)(2011-2#2)(2012-12#1)
stem cell-like character##2##3##(1993-9#1)(2012-5#1)
stem cell-like##3##2##(1993-9#1)(2012-5#1)(2013-1#1)
stem cells (ADSCs)##4##3##(2012-12#2)(2012-2#1)(2012-3#1)
stem cells (ASCs)##2##3##(2012-12#1)(2012-4#1)
stem cells (CSCs)##5##3##(2008-10#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#1)
stem cells (ESC)##3##3##(2008-10#1)(2008-11#2)
stem cells (ESCs)##5##3##(2008-1#1)(2008-9#3)(2012-12#1)
stem cells (HSC)##5##3##(2008-1#3)(2008-10#1)(2013-8#1)
stem cells (HSCs)##9##3##(1993-8#1)(1994-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-11#1)(2012-12#1)
stem cells (LSCs)##3##3##(2010-11#1)(2011-1#1)(2011-2#1)
stem cells (MSC) and##2##4##(2008-1#1)(2008-5#1)
stem cells (MSC)##5##3##(2008-1#2)(2008-5#3)
stem cells (MSCs) have##2##4##(2008-1#1)(2008-9#1)
stem cells (MSCs)##14##3##(2008-1#2)(2008-11#2)(2008-5#3)(2008-9#1)(2010-2#1)(2010-8#1)(2012-12#3)(2012-7#1)
stem cells (NSCs)##5##3##(2008-1#2)(2008-11#1)(2008-4#1)(2012-12#1)
stem cells and a##2##4##(2008-1#1)(2010-12#1)
stem cells and the##2##4##(2010-3#1)(2011-1#1)
stem cells and their##6##4##(2005-8#1)(2010-10#1)(2011-2#1)(2012-12#2)(2012-4#1)
stem cells and##44##3##(1995-1#1)(2004-2#1)(2005-8#1)(2006-5#1)(2006-8#1)(2008-1#4)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#1)(2011-1#2)(2011-2#1)(2012-11#2)(2012-12#8)(2012-4#1)(2013-1#1)(2013-7#2)(2013-8#1)
stem cells are##22##3##(1995-12#1)(2006-10#2)(2006-6#1)(2006-7#1)(2008-1#3)(2008-11#4)(2008-4#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-10#2)(2010-6#1)(2012-12#2)
stem cells as well as##2##5##(1995-3#1)(2008-9#1)
stem cells as##4##3##(1995-3#1)(2008-9#1)(2009-6#1)(2011-2#1)
stem cells because they##2##4##(2009-3#1)(2012-12#1)
stem cells both##2##3##(2008-11#2)
stem cells but also##2##4##(2008-11#1)(2012-12#1)
stem cells but##3##3##(2008-11#1)(2009-3#1)(2012-12#1)
stem cells by##5##3##(2008-1#1)(2008-11#2)(2010-6#1)(2012-12#1)
stem cells can be##9##4##(1993-12#1)(2006-10#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-11#1)
stem cells can##12##3##(1993-12#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#2)(2010-11#1)
stem cells capable of##2##4##(1993-2#1)(1995-12#1)
stem cells could##2##3##(2009-12#1)(2012-2#1)
stem cells derived from##7##4##(1993-2#1)(2008-4#1)(2010-2#1)(2010-3#1)(2012-1#1)(2012-12#2)
stem cells differentiated##2##3##(2009-12#1)(2012-1#1)
stem cells during aging and##2##5##(2008-8#2)
stem cells during aging##3##4##(2008-8#3)
stem cells during##4##3##(2008-8#3)(2009-4#1)
stem cells for the treatment of##2##6##(2008-11#1)(2010-6#1)
stem cells for the##3##4##(2008-11#1)(2010-6#1)(2012-12#1)
stem cells for tissue engineering##2##5##(2008-5#1)(2012-5#1)
stem cells for transplantation##2##4##(2006-10#1)(2012-12#1)
stem cells for##26##3##(2006-10#1)(2006-7#2)(2006-8#7)(2008-1#2)(2008-11#2)(2008-5#1)(2010-6#1)(2012-1#1)(2012-12#8)(2012-5#1)
stem cells from a##2##4##(2008-1#1)(2008-8#1)
stem cells from adult##2##4##(2008-9#1)(2012-12#1)
stem cells from human cord blood##2##6##(2008-9#2)
stem cells from human##4##4##(2008-9#2)(2012-1#1)(2012-12#1)
stem cells from patients with##2##5##(2012-12#2)
stem cells from the##5##4##(1990-12#1)(2007-11#1)(2008-1#1)(2008-9#1)(2012-1#1)
stem cells from##30##3##(1990-12#1)(1994-11#1)(2006-7#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#6)(2009-12#1)(2010-7#1)(2012-1#2)(2012-12#7)(2012-2#2)(2013-8#1)
stem cells have a##3##4##(2008-1#1)(2008-7#1)(2012-12#1)
stem cells have been##6##4##(2006-10#1)(2008-1#1)(2008-11#1)(2010-12#1)(2010-6#1)(2012-12#1)
stem cells have the##3##4##(2008-1#1)(2008-11#1)(2008-8#1)
stem cells have##17##3##(2006-10#2)(2008-1#5)(2008-11#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-6#2)(2011-2#1)(2012-12#2)
stem cells improves##2##3##(2012-1#1)(2012-12#1)
stem cells in a##3##4##(2008-11#1)(2010-10#1)(2012-12#1)
stem cells in hepatic repair##2##5##(2012-2#2)
stem cells in the bone marrow##2##6##(2012-12#1)(2012-3#1)
stem cells in the##6##4##(2008-1#2)(2010-6#1)(2012-12#1)(2012-3#1)(2013-8#1)
stem cells in vitro##3##4##(2008-5#1)(2009-10#1)(2010-2#1)
stem cells in vivo##2##4##(2012-1#1)(2012-12#1)
stem cells in wound##2##4##(2008-9#1)(2012-12#1)
stem cells in##46##3##(1990-12#1)(1990-6#1)(2006-10#1)(2007-8#2)(2008-1#5)(2008-11#2)(2008-5#2)(2008-9#2)(2009-10#1)(2009-3#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2012-1#4)(2012-12#9)(2012-2#2)(2012-3#2)(2012-5#1)(2013-8#2)
stem cells into the##2##4##(2010-11#1)(2012-2#1)
stem cells into##12##3##(2008-11#5)(2008-4#2)(2008-9#1)(2010-11#1)(2012-12#2)(2012-2#1)
stem cells involved in the##2##5##(2007-12#1)(2012-1#1)
stem cells is##10##3##(1994-3#1)(1995-12#1)(2008-1#3)(2008-3#1)(2008-9#1)(2009-3#1)(2012-1#1)(2012-2#1)
stem cells isolated from##3##4##(2010-12#1)(2012-2#1)(2013-1#1)
stem cells led to##2##4##(2010-12#1)(2012-12#1)
stem cells may be important##2##5##(1993-8#1)(2012-2#1)
stem cells may be##3##4##(1993-8#1)(2009-8#1)(2012-2#1)
stem cells may##6##3##(1993-8#1)(2007-8#1)(2008-1#1)(2009-8#1)(2012-2#1)(2013-1#1)
stem cells of##2##3##(1997-8#1)(2013-1#1)
stem cells on the##2##4##(2012-2#2)
stem cells on##10##3##(2007-8#1)(2008-11#1)(2008-5#1)(2010-12#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-7#1)
stem cells onto##2##3##(2008-11#2)
stem cells or their##2##4##(2008-11#1)(2008-7#1)
stem cells or##8##3##(2008-1#1)(2008-11#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-10#1)(2011-1#1)
stem cells research##2##3##(2007-10#1)(2008-1#1)
stem cells reside in the##2##5##(1990-6#2)
stem cells seem to##2##4##(2005-11#1)(2008-1#1)
stem cells should##2##3##(2006-8#1)(2008-10#1)
stem cells that can##2##4##(2007-8#1)(2012-12#1)
stem cells that##7##3##(2006-6#1)(2007-8#1)(2008-1#1)(2009-3#1)(2012-12#2)(2012-2#1)
stem cells through a##2##4##(2012-12#1)(2012-3#1)
stem cells through##3##3##(2012-12#2)(2012-3#1)
stem cells to generate##2##4##(1995-2#1)(2012-12#1)
stem cells to restore##2##4##(2008-1#1)(2009-3#1)
stem cells to##16##3##(1995-12#1)(1995-2#1)(1995-8#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-8#1)(2008-9#1)(2009-3#1)(2012-1#1)(2012-12#2)(2013-8#1)
stem cells transplantation##3##3##(2006-10#1)(2008-5#1)(2013-8#1)
stem cells under##2##3##(2010-12#1)(2010-6#1)
stem cells using##5##3##(1990-8#1)(2008-11#2)(2008-5#1)(2013-7#1)
stem cells was##2##3##(1992-5#1)(1995-2#1)
stem cells were##5##3##(1995-1#1)(2008-11#1)(2009-12#1)(2010-6#1)(2012-2#1)
stem cells will##4##3##(2008-11#2)(2009-3#1)(2010-12#1)
stem cells with a##3##4##(2006-8#1)(2008-11#2)
stem cells with##9##3##(2006-8#1)(2008-1#2)(2008-11#3)(2008-9#1)(2010-11#1)(2012-1#1)
stem cells without##2##3##(2011-2#1)(2012-12#1)
stem cells##753##2##(1990-12#2)(1990-6#4)(1990-8#1)(1991-10#1)(1991-11#1)(1991-6#2)(1992-12#1)(1992-5#2)(1993-12#1)(1993-2#5)(1993-8#5)(1994-11#3)(1994-3#3)(1994-4#1)(1994-5#1)(1994-9#2)(1995-1#5)(1995-11#1)(1995-12#9)(1995-2#5)(1995-3#1)(1995-6#1)(1995-8#1)(1996-8#1)(1997-4#1)(1997-8#1)(2004-2#1)(2005-1#1)(2005-11#3)(2005-12#3)(2005-6#1)(2005-8#2)(2006-10#14)(2006-11#2)(2006-5#1)(2006-6#4)(2006-7#7)(2006-8#13)(2007-10#1)(2007-11#4)(2007-12#4)(2007-8#10)(2007-9#2)(2008-1#72)(2008-10#14)(2008-11#91)(2008-3#3)(2008-4#13)(2008-5#23)(2008-6#1)(2008-7#7)(2008-8#10)(2008-9#46)(2009-10#3)(2009-11#1)(2009-12#9)(2009-2#1)(2009-3#25)(2009-4#4)(2009-6#4)(2009-8#3)(2009-9#1)(2010-10#8)(2010-11#12)(2010-12#18)(2010-2#3)(2010-3#4)(2010-4#2)(2010-6#9)(2010-7#2)(2010-8#2)(2011-1#10)(2011-2#15)(2012-1#25)(2012-10#1)(2012-11#2)(2012-12#105)(2012-2#26)(2012-3#8)(2012-4#2)(2012-5#5)(2012-6#1)(2012-7#2)(2013-1#10)(2013-7#6)(2013-8#10)
stem cells)##4##2##(2006-10#1)(2006-2#1)(2009-3#1)(2011-1#1)
stem cells]##2##2##(2012-2#1)(2013-7#1)
stem colonization##2##2##(2008-10#2)
stem contraction##2##2##(2009-6#2)
stem designed for##2##3##(2007-11#1)(2011-2#1)
stem diameter##9##2##(2008-10#5)(2008-9#1)(2013-7#3)
stem elongation##3##2##(2006-12#1)(2008-10#2)
stem for##2##2##(2008-10#1)(2013-1#1)
stem from a##3##3##(1990-11#1)(2007-12#1)(2008-1#1)
stem from difficulties in##2##4##(1993-12#1)(2008-4#1)
stem from the fact that the##2##6##(2008-7#1)(2011-3#1)
stem from the##11##3##(1991-2#1)(2005-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-3#1)
stem from##29##2##(1990-11#1)(1991-2#1)(1993-10#1)(1993-12#1)(1995-11#1)(2005-10#1)(2005-7#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2010-2#1)(2010-8#1)(2011-3#1)(2011-9#1)(2012-1#1)
stem gall##9##2##(2008-10#9)
stem girdling##2##2##(2008-10#2)
stem grooving##3##2##(2008-10#3)
stem height##2##2##(2008-10#1)(2012-5#1)
stem hm-2##5##2##(2013-8#5)
stem hydration##2##2##(2008-10#2)
stem in the##2##3##(1995-1#1)(2013-1#1)
stem in##4##2##(1995-1#1)(2008-10#1)(2013-1#2)
stem infection##5##2##(2008-10#5)
stem infections##2##2##(2008-10#2)
stem inoculation##2##2##(2008-10#2)
stem internodes##3##2##(2006-12#1)(2008-10#1)(2008-11#1)
stem is##5##2##(1992-11#1)(1996-1#1)(2007-7#1)(2010-3#1)(2013-1#1)
stem lesions##6##2##(2008-10#5)(2008-7#1)
stem loops##2##2##(1993-12#1)(1996-5#1)
stem loosening##6##2##(2008-1#5)(2008-3#1)
stem necrosis##2##2##(2008-10#2)
stem of the##3##3##(2008-10#1)(2008-4#2)
stem of##10##2##(1995-6#1)(2008-10#2)(2008-12#1)(2008-4#3)(2008-9#1)(2009-6#1)(2013-1#1)
stem or progenitor cells##2##4##(2009-6#2)
stem or##4##2##(2009-4#1)(2009-6#2)(2011-2#1)
stem pieces##3##2##(2008-10#3)
stem pitting virus##4##3##(2008-10#4)
stem pitting##6##2##(2008-10#6)
stem reflexes##2##2##(2006-4#1)(2010-1#1)
stem regions##4##2##(1990-7#3)(1995-1#1)
stem responses##3##2##(2006-10#2)(2009-6#1)
stem rot caused by##2##4##(2008-10#2)
stem rot in##5##3##(2008-10#5)
stem rot of soybean##5##4##(2008-10#5)
stem rot of soybeans##2##4##(2008-10#2)
stem rot of##8##3##(2008-10#8)
stem rot or##2##3##(2008-10#2)
stem rot prevalence##2##3##(2008-10#2)
stem rot was##6##3##(2008-10#6)
stem rot##44##2##(2008-10#44)
stem rust of perennial ryegrass##2##5##(2008-10#2)
stem rust races##2##3##(2008-10#2)
stem rust resistance genes##2##4##(2008-10#2)
stem rust resistance in the##2##5##(2008-10#2)
stem rust resistance in##4##4##(2008-10#4)
stem rust resistance##9##3##(2008-10#9)
stem rust##24##2##(2008-10#23)(2012-2#1)
stem rust)##2##2##(2008-10#2)
stem samples##7##2##(2007-3#1)(2008-10#6)
stem segments##3##2##(2008-10#3)
stem showed##3##2##(1993-4#1)(2013-1#2)
stem structures##4##2##(1995-1#1)(1995-12#1)(2011-1#2)
stem the##2##2##(1996-3#1)(1997-3#1)
stem tissue##9##2##(2004-4#1)(2008-10#7)(2008-11#1)
stem tissues##4##2##(2008-10#4)
stem to##4##2##(2008-10#4)
stem was##4##2##(1990-9#1)(1992-12#1)(1995-3#1)(2005-9#1)
stem weevil##2##2##(2011-12#2)
stem were##3##2##(2007-11#1)(2008-1#1)(2008-10#1)
stem with##2##2##(2011-2#2)
stem##1863##1##(1990-11#1)(1990-12#3)(1990-4#1)(1990-5#2)(1990-6#4)(1990-7#3)(1990-8#1)(1990-9#3)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#5)(1991-8#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#4)(1992-5#2)(1992-6#1)(1993-10#1)(1993-12#3)(1993-2#7)(1993-3#1)(1993-4#4)(1993-5#2)(1993-8#5)(1993-9#2)(1994-11#4)(1994-12#1)(1994-2#2)(1994-3#5)(1994-4#1)(1994-5#3)(1994-8#1)(1994-9#3)(1995-1#11)(1995-11#6)(1995-12#27)(1995-2#7)(1995-3#2)(1995-4#1)(1995-6#3)(1995-7#3)(1995-8#1)(1996-1#2)(1996-10#3)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#5)(1996-5#4)(1996-7#1)(1996-8#1)(1996-9#1)(1997-3#4)(1997-4#2)(1997-5#2)(1997-6#3)(1997-8#3)(2004-2#1)(2004-4#1)(2005-1#1)(2005-10#1)(2005-11#12)(2005-12#6)(2005-6#1)(2005-7#1)(2005-8#6)(2005-9#1)(2006-1#2)(2006-10#22)(2006-11#4)(2006-12#6)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#6)(2006-7#8)(2006-8#13)(2006-9#1)(2007-1#2)(2007-10#9)(2007-11#18)(2007-12#10)(2007-2#1)(2007-3#4)(2007-5#1)(2007-6#1)(2007-7#11)(2007-8#19)(2007-9#9)(2008-1#123)(2008-10#249)(2008-11#155)(2008-12#7)(2008-2#3)(2008-3#11)(2008-4#28)(2008-5#30)(2008-6#6)(2008-7#29)(2008-8#23)(2008-9#67)(2009-10#9)(2009-11#2)(2009-12#16)(2009-2#1)(2009-3#52)(2009-4#18)(2009-5#2)(2009-6#14)(2009-7#6)(2009-8#15)(2009-9#3)(2010-1#1)(2010-10#19)(2010-11#36)(2010-12#37)(2010-2#7)(2010-3#8)(2010-4#10)(2010-5#3)(2010-6#12)(2010-7#6)(2010-8#7)(2011-1#23)(2011-12#4)(2011-2#48)(2011-3#2)(2011-9#1)(2012-1#37)(2012-10#5)(2012-11#8)(2012-12#187)(2012-2#50)(2012-3#13)(2012-4#3)(2012-5#14)(2012-6#1)(2012-7#5)(2013-1#43)(2013-7#12)(2013-8#26)
stem)##3##1##(1990-4#1)(1991-12#1)(1992-11#1)
stem-and-loop region##2##2##(1993-6#2)
stem-cell research##2##2##(2007-3#1)(2008-5#1)
stem-cell transplantation##3##2##(1997-1#1)(2008-1#1)(2013-1#1)
stem-cell##11##1##(1997-1#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-3#1)(2008-1#2)(2008-5#1)(2008-9#1)(2009-4#1)(2013-1#1)
stem-cell-fate specification##2##2##(2009-3#2)
stem-cell-fate##3##1##(2009-3#3)
stem-group##2##1##(2007-12#2)
stem-like cells##5##2##(2012-12#4)(2013-8#1)
stem-like##10##1##(1994-9#1)(2012-12#8)(2013-8#1)
stem-loop at##2##2##(1995-8#2)
stem-loop sequence##3##2##(1990-3#1)(1996-4#1)(2008-4#1)
stem-loop structures##4##2##(1991-7#1)(1992-9#1)(1997-2#1)(2011-1#1)
stem-loop##25##1##(1990-11#1)(1990-3#1)(1991-2#1)(1991-7#1)(1992-9#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#4)(1996-4#1)(1996-7#2)(1997-2#1)(1997-4#1)(1997-6#2)(2008-10#2)(2008-4#1)(2011-1#1)(2013-1#1)
stem-loops##3##1##(1994-11#1)(1995-8#1)(2008-10#1)
stem-pitting##3##1##(2008-10#3)
stem/progenitor cells##9##2##(1995-1#2)(1995-12#1)(2007-5#1)(2008-1#1)(2008-4#1)(2010-11#1)(2012-12#1)(2012-2#1)
stem/progenitor##11##1##(1995-1#2)(1995-12#1)(2007-5#1)(2008-1#1)(2008-11#2)(2008-4#1)(2010-11#1)(2012-12#1)(2012-2#1)
stemmed from a##3##3##(1990-11#1)(1990-9#1)(1992-5#1)
stemmed from##7##2##(1990-11#1)(1990-9#1)(1992-5#1)(2008-1#1)(2008-2#1)(2013-1#2)
stemmed##8##1##(1990-11#1)(1990-9#1)(1992-5#1)(1995-5#1)(2008-1#1)(2008-2#1)(2013-1#2)
stemming from the##5##3##(1991-3#1)(2007-7#2)(2009-12#1)(2011-2#1)
stemming from##14##2##(1991-12#1)(1991-3#2)(2006-4#1)(2007-12#1)(2007-7#2)(2008-11#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-4#1)(2011-2#2)
stemming##17##1##(1991-1#1)(1991-12#1)(1991-3#2)(2006-4#1)(2007-12#1)(2007-7#2)(2007-9#1)(2008-11#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-4#1)(2011-2#2)
stemness##3##1##(2008-11#1)(2008-5#1)(2011-2#1)
stems after##2##2##(2008-10#1)(2011-10#1)
stems and leaves of##4##4##(2005-4#1)(2008-10#2)(2008-5#1)
stems and leaves##11##3##(2005-4#1)(2007-1#1)(2008-10#4)(2008-12#1)(2008-5#1)(2011-2#2)(2013-8#1)
stems and roots##3##3##(2008-10#1)(2011-10#2)
stems and##22##2##(1990-7#1)(2005-4#1)(2007-1#1)(2008-10#11)(2008-12#1)(2008-5#2)(2011-10#2)(2011-2#2)(2013-8#1)
stems are##2##2##(1993-11#1)(2009-4#1)
stems as##3##2##(2008-10#2)(2008-7#1)
stems by##2##2##(2008-10#2)
stems from the fact that##3##5##(1991-11#1)(2013-1#2)
stems from their##2##3##(2006-12#1)(2011-1#1)
stems from##16##2##(1990-6#1)(1991-11#1)(1995-10#1)(1996-3#1)(2006-12#2)(2008-3#1)(2008-8#1)(2009-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
stems in##2##2##(2008-10#1)(2010-12#1)
stems is##2##2##(2008-10#1)(2008-11#1)
stems of peach##2##3##(2008-10#2)
stems of##22##2##(1991-8#2)(1995-3#1)(2005-10#1)(2007-1#1)(2008-10#11)(2008-11#2)(2008-4#1)(2010-10#1)(2011-12#1)(2011-2#1)
stems to##2##2##(2008-6#1)(2009-3#1)
stems were##6##2##(1991-8#1)(2008-10#4)(2008-3#1)
stems with##12##2##(2008-10#11)(2012-1#1)
stems##172##1##(1990-6#1)(1990-7#1)(1991-11#1)(1991-7#1)(1991-8#3)(1992-9#1)(1993-11#1)(1995-1#1)(1995-10#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-5#1)(2004-4#1)(2005-10#1)(2005-4#1)(2006-12#2)(2007-1#4)(2007-11#1)(2007-3#1)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#91)(2008-11#5)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-3#1)(2009-4#5)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-10#4)(2011-12#2)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
stenophagy##6##1##(2012-3#6)
stenosed##2##1##(2008-7#2)
stenoses in##6##2##(1992-5#1)(1993-10#1)(2007-7#1)(2008-10#1)(2008-7#2)
stenoses of the##7##3##(1992-5#1)(2006-10#1)(2006-6#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-7#1)
stenoses of##10##2##(1990-8#1)(1992-5#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-9#1)
stenoses or##2##2##(2007-9#1)(2012-3#1)
stenoses was##2##2##(2006-11#1)(2007-7#1)
stenoses were##5##2##(2006-11#1)(2007-7#1)(2008-7#3)
stenoses within##2##2##(2007-7#1)(2009-12#1)
stenoses##59##1##(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-4#1)(1992-1#1)(1992-5#2)(1993-10#1)(1993-6#1)(1996-6#1)(2005-12#1)(2005-9#1)(2006-10#2)(2006-11#4)(2006-6#1)(2007-5#1)(2007-7#8)(2007-9#4)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#8)(2008-8#1)(2009-12#1)(2010-12#1)(2010-9#1)(2012-12#1)(2012-2#2)(2012-3#1)
stenoses]##3##1##(1991-3#1)(1994-9#1)(2009-2#1)
stenosing##10##1##(1990-7#1)(1992-5#1)(2006-10#1)(2008-7#1)(2008-9#1)(2009-2#1)(2012-3#1)(2013-1#3)
stenosis &gt##4##2##(1995-12#1)(2007-10#3)
stenosis (CAS)##2##2##(2011-2#2)
stenosis (n =##4##3##(1993-8#2)(1997-8#1)(2008-7#1)
stenosis after##6##2##(1993-12#1)(1993-2#1)(1994-4#1)(2006-10#1)(2007-8#2)
stenosis and angiodysplasia##2##3##(2007-8#2)
stenosis and left##2##3##(1991-6#1)(1995-6#1)
stenosis and membranous##2##3##(2007-9#1)(2013-8#1)
stenosis and occlusion of##2##4##(1993-10#1)(2008-7#1)
stenosis and occlusion##3##3##(1993-10#1)(1996-2#1)(2008-7#1)
stenosis and the##8##3##(1990-2#1)(1991-3#1)(1992-1#1)(2007-10#1)(2007-9#1)(2008-4#1)(2008-5#1)(2008-8#1)
stenosis and##65##2##(1990-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-4#1)(1993-10#1)(1993-12#1)(1993-5#1)(1993-7#3)(1993-8#1)(1995-6#2)(1996-2#1)(1997-8#1)(2006-10#1)(2006-11#3)(2006-12#1)(2006-5#2)(2006-6#1)(2007-10#2)(2007-5#2)(2007-7#1)(2007-8#9)(2007-9#5)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-4#1)(2010-7#1)(2011-2#2)(2012-2#4)(2012-3#2)(2013-7#1)(2013-8#1)
stenosis are##5##2##(1992-9#1)(2006-10#1)(2006-11#1)(2007-7#2)
stenosis as##4##2##(1992-5#1)(2006-10#1)(2006-11#1)(2007-8#1)
stenosis at the##6##3##(1990-6#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-7#1)(2007-8#1)
stenosis at##11##2##(1990-6#1)(1993-12#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-7#1)(2007-8#2)(2008-7#1)(2008-8#1)(2011-2#1)
stenosis by##4##2##(2008-12#2)(2012-2#1)(2013-1#1)
stenosis can be##2##3##(1994-3#1)(2012-12#1)
stenosis caused by##4##3##(1990-3#1)(1991-4#1)(2007-8#1)(2008-1#1)
stenosis detected##2##2##(2007-8#1)(2008-7#1)
stenosis due to##3##3##(1990-3#1)(1993-2#1)(2007-2#1)
stenosis during##3##2##(1990-9#1)(2008-4#1)(2013-8#1)
stenosis following##4##2##(2007-7#1)(2008-3#1)(2009-9#2)
stenosis group##4##2##(2007-10#4)
stenosis has been##3##3##(2006-10#2)(2008-11#1)
stenosis has##7##2##(2006-10#2)(2006-11#1)(2008-11#1)(2009-2#1)(2011-2#1)(2013-1#1)
stenosis in a##4##3##(2007-10#1)(2007-9#1)(2008-1#1)(2010-12#1)
stenosis in one##4##3##(1997-2#1)(2006-11#1)(2008-1#1)(2013-8#1)
stenosis in patients##2##3##(2008-7#1)(2009-10#1)
stenosis in the##13##3##(1990-3#1)(1990-9#1)(1991-3#1)(1997-8#1)(2005-12#1)(2007-10#3)(2007-8#2)(2008-5#1)(2008-8#1)(2011-2#1)
stenosis in##50##2##(1990-3#1)(1990-7#1)(1990-9#1)(1991-3#1)(1992-2#1)(1992-9#1)(1993-5#1)(1993-8#1)(1996-8#1)(1997-2#1)(1997-8#1)(2005-10#1)(2005-12#1)(2006-11#2)(2006-5#2)(2007-10#5)(2007-7#1)(2007-8#6)(2007-9#3)(2008-1#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-11#2)(2010-12#2)(2011-2#1)(2012-2#1)(2013-8#1)
stenosis involving##2##2##(2008-11#1)(2008-4#1)
stenosis is a##4##3##(2007-8#2)(2013-1#2)
stenosis is an##2##3##(2008-8#2)
stenosis is increasing##2##3##(2008-12#1)(2009-5#1)
stenosis is usually##2##3##(2008-1#2)
stenosis is##21##2##(1991-10#1)(1993-12#1)(1996-2#1)(1997-2#1)(2005-10#1)(2006-10#1)(2007-8#3)(2008-1#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-5#1)(2013-1#3)
stenosis may##2##2##(1992-1#1)(2007-9#1)
stenosis of the accessory duct##2##5##(1990-3#2)
stenosis of the internal carotid artery (ICA)##2##7##(2007-10#1)(2007-9#1)
stenosis of the internal carotid artery##4##6##(2006-11#1)(2007-10#1)(2007-9#1)(2010-12#1)
stenosis of the left##2##4##(1996-3#1)(2013-1#1)
stenosis of the vertebral arteries##2##5##(1995-3#2)
stenosis of the vertebral canal and intervertebral##2##7##(2007-11#1)(2007-8#1)
stenosis of the vertebral##5##4##(1991-8#1)(1995-3#2)(2007-11#1)(2007-8#1)
stenosis of the##31##3##(1990-2#1)(1990-3#3)(1991-8#1)(1992-10#1)(1992-11#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-3#2)(1996-3#1)(2005-1#1)(2006-11#2)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-2#2)(2013-1#2)
stenosis of##46##2##(1990-11#1)(1990-2#1)(1990-3#3)(1991-10#1)(1991-11#1)(1991-8#1)(1992-10#1)(1992-11#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-3#3)(1996-2#1)(1996-3#1)(2005-1#1)(2006-11#2)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-7#1)(2011-2#4)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#3)
stenosis on##2##2##(1990-9#1)(2007-9#1)
stenosis or occlusion of the##2##5##(1996-2#1)(2007-11#1)
stenosis or occlusion of##4##4##(1996-2#2)(2007-11#1)(2008-8#1)
stenosis or occlusion##5##3##(1996-2#2)(2007-11#1)(2007-7#1)(2008-8#1)
stenosis or##18##2##(1993-10#2)(1993-12#1)(1996-2#2)(2007-10#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-5#1)
stenosis progression##2##2##(2008-7#1)(2013-1#1)
stenosis surgery##2##2##(2005-2#1)(2010-5#1)
stenosis than in those with##2##5##(1992-1#1)(1995-12#1)
stenosis than in##3##3##(1992-1#1)(1995-12#1)(1995-6#1)
stenosis than##5##2##(1990-7#2)(1992-1#1)(1995-12#1)(1995-6#1)
stenosis the##4##2##(1990-8#1)(2005-10#1)(2009-2#1)(2013-1#1)
stenosis through##3##2##(1992-9#1)(2007-9#2)
stenosis to be##2##3##(1990-7#1)(2008-5#1)
stenosis treated with##2##3##(1990-9#1)(2009-12#1)
stenosis treated##3##2##(1990-9#1)(2009-12#1)(2011-2#1)
stenosis underwent##2##2##(2007-8#1)(2012-12#1)
stenosis was##15##2##(1992-1#1)(1993-12#1)(1993-8#1)(1996-12#1)(1997-8#1)(2006-11#1)(2007-10#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-9#1)(2012-2#1)(2013-1#3)
stenosis were##9##2##(1993-8#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-7#2)(2011-1#1)(2011-2#1)
stenosis who##2##2##(2006-10#1)(2011-2#1)
stenosis with##17##2##(1996-9#1)(2005-10#1)(2006-2#1)(2007-10#1)(2007-8#5)(2007-9#1)(2008-12#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#3)
stenosis without##3##2##(2005-12#1)(2008-1#1)(2013-1#1)
stenosis##640##1##(1990-11#2)(1990-2#2)(1990-3#8)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#5)(1990-8#2)(1990-9#4)(1991-10#2)(1991-11#1)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-1#5)(1992-10#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-5#2)(1992-9#3)(1993-1#1)(1993-10#4)(1993-12#9)(1993-2#5)(1993-3#1)(1993-5#2)(1993-7#3)(1993-8#7)(1994-11#2)(1994-3#2)(1994-4#1)(1995-10#2)(1995-12#2)(1995-3#3)(1995-6#5)(1996-12#4)(1996-2#5)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-8#6)(2005-1#1)(2005-10#5)(2005-12#2)(2005-2#1)(2006-10#19)(2006-11#24)(2006-12#2)(2006-2#4)(2006-5#5)(2006-6#1)(2006-7#4)(2006-8#9)(2006-9#1)(2007-10#39)(2007-11#2)(2007-2#1)(2007-3#1)(2007-5#5)(2007-7#21)(2007-8#70)(2007-9#30)(2008-1#21)(2008-10#3)(2008-11#8)(2008-12#11)(2008-2#3)(2008-3#7)(2008-4#9)(2008-5#15)(2008-6#2)(2008-7#25)(2008-8#16)(2008-9#3)(2009-10#9)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#9)(2009-8#2)(2009-9#4)(2010-10#1)(2010-11#4)(2010-12#6)(2010-2#5)(2010-5#2)(2010-7#3)(2011-1#3)(2011-2#24)(2012-1#2)(2012-12#7)(2012-2#17)(2012-3#6)(2013-1#26)(2013-4#2)(2013-7#1)(2013-8#8)
stenosis)##5##1##(1997-2#1)(2005-1#1)(2010-2#1)(2012-3#1)(2013-8#1)
stenosis?##2##1##(2007-8#1)(2008-8#1)
stenosis]##8##1##(1990-8#1)(1990-9#1)(1992-3#1)(1995-3#1)(2006-6#1)(2007-2#1)(2008-7#1)(2013-1#1)
stenothermic##2##1##(2011-2#1)(2012-2#1)
stenotic arterial##2##2##(1997-8#1)(2008-12#1)
stenotic canal##4##2##(2013-1#4)
stenotic coronary arteries##2##3##(2006-10#2)
stenotic coronary##4##2##(2006-10#2)(2006-7#1)(2008-5#1)
stenotic lesion##3##2##(2008-5#3)
stenotic lesions of the##3##4##(2006-10#1)(2006-11#1)(2008-7#1)
stenotic lesions of##4##3##(1994-5#1)(2006-10#1)(2006-11#1)(2008-7#1)
stenotic lesions##11##2##(1994-5#1)(2006-10#2)(2006-11#1)(2007-11#1)(2008-12#1)(2008-4#1)(2008-7#3)(2011-2#1)
stenotic##47##1##(1990-9#1)(1993-10#1)(1993-5#1)(1994-5#1)(1996-6#1)(1997-8#1)(2005-12#1)(2006-10#4)(2006-11#2)(2006-2#3)(2006-6#1)(2006-7#2)(2007-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#6)(2008-7#3)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#5)(2013-7#1)
stent and##5##2##(2007-8#1)(2008-1#1)(2008-11#1)(2009-5#1)(2010-12#1)
stent deployment##3##2##(1994-11#1)(1997-8#1)(2007-8#1)
stent designs##3##2##(2006-10#1)(2008-11#1)(2008-5#1)
stent for##9##2##(1992-4#1)(2007-8#1)(2009-5#1)(2010-12#2)(2011-12#1)(2013-1#3)
stent fracture##3##2##(2010-10#2)(2011-2#1)
stent geometries##2##2##(2008-5#1)(2008-7#1)
stent graft repair of##3##4##(2007-8#1)(2010-12#2)
stent graft##10##2##(2006-1#2)(2007-8#2)(2008-1#1)(2008-11#2)(2010-12#2)(2011-3#1)
stent grafting##2##2##(2006-1#1)(2011-2#1)
stent grafts have been developed and##2##6##(2010-12#1)(2010-8#1)
stent grafts##9##2##(2008-11#1)(2009-5#1)(2010-12#3)(2010-8#3)(2011-2#1)
stent implantation and##3##3##(2007-9#1)(2008-11#1)(2008-4#1)
stent implantation for##4##3##(2007-8#1)(2008-12#1)(2009-5#1)(2010-10#1)
stent implantation in patients##2##4##(2009-5#2)
stent implantation in##5##3##(1994-4#1)(2007-8#1)(2008-11#1)(2009-5#2)
stent implantation was##2##3##(2007-8#1)(2008-11#1)
stent implantation##30##2##(1994-11#1)(1994-4#1)(1996-8#1)(2007-11#3)(2007-8#5)(2007-9#2)(2008-11#4)(2008-12#2)(2008-4#1)(2009-11#1)(2009-12#1)(2009-5#4)(2010-10#1)(2010-5#1)(2011-2#2)
stent implantations##2##2##(2006-5#1)(2008-8#1)
stent in a patient with##2##5##(2007-8#1)(2010-5#1)
stent in a##4##3##(2007-8#3)(2010-5#1)
stent in the##4##3##(2006-11#1)(2007-8#2)(2010-12#1)
stent in##12##2##(1990-8#1)(2006-11#1)(2006-6#1)(2007-8#5)(2008-11#1)(2008-5#1)(2010-12#1)(2010-5#1)
stent induced rectal pain##2##4##(2010-12#2)
stent induced##3##2##(2010-12#3)
stent insertion##4##2##(2006-10#1)(2007-7#1)(2008-11#1)(2013-1#1)
stent into##2##2##(2007-8#1)(2008-7#1)
stent is##4##2##(1994-4#1)(2007-5#1)(2008-11#1)(2009-10#1)
stent malapposition##2##2##(2008-8#1)(2010-5#1)
stent material##2##2##(2009-7#2)
stent migration##3##2##(2008-12#1)(2010-12#1)(2013-1#1)
stent on##2##2##(2009-5#1)(2013-8#1)
stent or graft thrombosis##2##4##(2011-2#2)
stent or##4##2##(2010-5#1)(2011-2#3)
stent patency in##2##3##(1990-8#1)(2006-11#1)
stent placed##2##2##(2006-11#1)(2013-7#1)
stent placement and##3##3##(2006-11#1)(2008-12#1)(2008-2#1)
stent placement at##2##3##(2009-6#1)(2012-2#1)
stent placement for##6##3##(2006-11#3)(2008-12#1)(2008-3#1)(2008-8#1)
stent placement in##3##3##(2005-10#1)(2009-1#1)(2009-6#1)
stent placement##26##2##(2005-10#1)(2006-10#1)(2006-11#8)(2007-10#2)(2007-5#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-1#1)(2009-12#1)(2009-6#2)(2010-10#1)(2010-12#1)(2012-2#1)
stent restenosis##3##2##(2007-8#2)(2010-5#1)
stent technology##2##2##(2006-10#2)
stent thrombosis after##4##3##(2008-11#1)(2008-12#2)(2011-2#1)
stent thrombosis and##3##3##(2009-1#1)(2010-12#2)
stent thrombosis##16##2##(2007-11#2)(2008-11#2)(2008-12#2)(2009-1#2)(2009-12#1)(2009-5#1)(2010-12#2)(2010-5#2)(2011-2#1)(2013-8#1)
stent to##2##2##(2006-6#1)(2008-12#1)
stent was##9##2##(2007-8#3)(2008-11#2)(2011-2#1)(2013-1#3)
stent##284##1##(1990-12#1)(1990-8#3)(1992-3#1)(1992-4#1)(1994-11#4)(1994-4#2)(1996-8#1)(1997-8#1)(2005-10#1)(2006-1#4)(2006-10#6)(2006-11#11)(2006-5#1)(2006-6#3)(2006-8#1)(2007-10#2)(2007-11#7)(2007-5#3)(2007-7#1)(2007-8#37)(2007-9#2)(2008-1#3)(2008-10#2)(2008-11#24)(2008-12#13)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#7)(2008-7#10)(2008-8#4)(2009-1#3)(2009-10#1)(2009-11#1)(2009-12#4)(2009-2#1)(2009-5#12)(2009-6#2)(2009-7#5)(2010-10#6)(2010-12#23)(2010-4#2)(2010-5#12)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#17)(2011-3#1)(2012-2#5)(2013-1#16)(2013-7#2)(2013-8#3)
stent-assisted coiling##2##2##(2011-2#1)(2012-3#1)
stent-assisted##4##1##(2011-2#1)(2012-3#2)(2013-8#1)
stent-graft implantation technique##2##3##(2007-8#2)
stent-graft placement##3##2##(2011-2#1)(2012-2#2)
stent-graft treatment##2##2##(2007-8#2)
stent-graft##13##1##(2007-8#6)(2008-11#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-2#3)
stent-grafting##2##1##(2006-10#1)(2007-8#1)
stent-grafts were##2##2##(2008-8#1)(2012-2#1)
stent-grafts##4##1##(2007-8#1)(2008-8#1)(2011-2#1)(2012-2#1)
stent]##2##1##(2005-10#1)(2013-1#1)
stented##11##1##(2007-11#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#4)(2010-8#1)(2013-1#1)
stentgraft##2##1##(2011-3#2)
stenting (CAS)##3##2##(2007-8#1)(2008-5#1)(2009-10#1)
stenting and##11##2##(2005-12#1)(2006-10#1)(2006-11#1)(2007-5#1)(2007-8#3)(2008-12#1)(2008-3#1)(2010-11#1)(2011-2#1)
stenting as##2##2##(2008-11#1)(2009-12#1)
stenting for##6##2##(2006-10#1)(2006-11#3)(2008-5#1)(2010-7#1)
stenting in##6##2##(2008-12#1)(2008-3#1)(2008-6#1)(2009-5#1)(2011-2#2)
stenting is currently the most##2##5##(2008-6#1)(2008-8#1)
stenting is##5##2##(2007-10#1)(2008-12#1)(2008-6#1)(2008-8#1)(2013-1#1)
stenting of the##8##3##(1994-4#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2013-1#2)
stenting of##18##2##(1994-4#1)(2006-10#1)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#2)(2008-11#2)(2009-5#1)(2011-2#1)(2012-1#1)(2013-1#2)
stenting or##2##2##(2008-11#1)(2012-3#1)
stenting prior to coronary artery bypass##2##6##(2008-11#2)
stenting to##4##2##(2006-11#1)(2007-7#1)(2013-1#2)
stenting versus gastrojejunostomy##2##3##(2012-2#2)
stenting with the##2##3##(2009-12#1)(2009-5#1)
stenting with##4##2##(2007-10#1)(2009-12#1)(2009-5#1)(2011-2#1)
stenting##133##1##(1992-4#1)(1994-4#1)(1997-8#1)(2005-12#1)(2006-10#8)(2006-11#13)(2007-10#3)(2007-5#2)(2007-7#4)(2007-8#19)(2008-1#3)(2008-10#3)(2008-11#9)(2008-12#4)(2008-3#5)(2008-4#2)(2008-5#4)(2008-6#4)(2008-8#1)(2009-10#3)(2009-12#5)(2009-5#4)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#5)(2010-5#1)(2010-7#2)(2011-2#10)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#7)
stenting?##2##1##(2007-8#1)(2008-10#1)
stentless pericardial##3##2##(2007-8#2)(2009-4#1)
stentless##5##1##(2007-8#4)(2009-4#1)
stents (DES)##2##2##(2009-1#1)(2010-5#1)
stents and the##2##3##(1993-10#1)(2006-10#1)
stents and##11##2##(1993-10#1)(2006-10#2)(2007-5#1)(2007-8#1)(2008-5#1)(2011-2#5)
stents are##8##2##(1993-10#1)(2006-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-5#1)(2013-1#2)
stents as##2##2##(2006-2#1)(2007-5#1)
stents for##7##2##(1993-2#1)(2006-10#1)(2008-12#1)(2009-12#1)(2009-5#3)
stents has##5##2##(1994-11#1)(2006-10#1)(2008-11#1)(2008-12#1)(2010-5#1)
stents have been##2##3##(2008-12#1)(2008-7#1)
stents have##5##2##(2006-10#1)(2008-11#2)(2008-12#1)(2008-7#1)
stents in patients with##3##4##(2007-11#1)(2009-12#1)(2012-12#1)
stents in the##4##3##(2007-5#1)(2008-12#1)(2008-3#1)(2009-5#1)
stents in##17##2##(1990-8#1)(1994-11#1)(2007-11#1)(2007-5#1)(2008-11#3)(2008-12#1)(2008-3#2)(2009-12#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#3)
stents is a##2##3##(2008-11#1)(2011-2#1)
stents is##3##2##(2008-11#1)(2010-12#1)(2011-2#1)
stents should be##2##3##(2008-3#1)(2009-12#1)
stents should##3##2##(2008-3#1)(2009-12#2)
stents to##2##2##(2007-8#1)(2010-12#1)
stents was##4##2##(2006-7#1)(2006-8#1)(2008-11#1)(2008-12#1)
stents were implanted in##2##4##(1990-8#1)(2007-8#1)
stents were implanted##3##3##(1990-8#1)(2007-11#1)(2007-8#1)
stents were placed##2##3##(2006-11#2)
stents were##7##2##(1990-8#2)(2006-11#2)(2007-11#1)(2007-8#1)(2008-6#1)
stents##182##1##(1990-8#4)(1991-5#1)(1992-5#3)(1993-10#2)(1993-2#1)(1994-11#4)(1994-9#1)(1996-2#1)(2005-9#1)(2006-10#9)(2006-11#3)(2006-2#2)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#4)(2007-5#5)(2007-8#6)(2008-11#18)(2008-12#10)(2008-3#8)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#4)(2009-1#3)(2009-10#1)(2009-11#1)(2009-12#13)(2009-5#13)(2009-6#1)(2009-7#1)(2010-12#10)(2010-4#1)(2010-5#7)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#11)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#2)
stents]##4##1##(1991-3#1)(1991-5#1)(2007-8#1)(2008-12#1)
step 1##2##2##(1990-11#1)(2008-3#1)
step affinity##2##2##(1992-11#1)(2008-11#1)
step ahead##2##2##(2011-1#1)(2011-12#1)
step allowed##2##2##(1991-5#1)(2010-2#1)
step and ramp components of target motion##2##7##(1996-1#2)
step and the##5##3##(1990-9#1)(2008-10#3)(2008-3#1)
step and##27##2##(1990-11#1)(1990-9#1)(1992-9#1)(1993-8#1)(1994-9#1)(1995-3#1)(1996-1#2)(1996-4#1)(1997-2#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-3#2)(2008-6#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)
step approach##2##2##(2008-1#1)(2011-1#1)
step are##4##2##(1994-3#1)(1997-1#1)(2008-10#2)
step associated with##2##3##(1991-9#1)(2008-10#1)
step at the##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#1)
step at##8##2##(1995-10#1)(1997-7#1)(2008-10#3)(2008-3#1)(2008-5#1)(2012-2#1)
step away##2##2##(2007-9#1)(2011-1#1)
step becomes##2##2##(1991-9#1)(1997-4#1)
step before##4##2##(1997-3#1)(2008-1#1)(2008-10#1)(2008-4#1)
step between##2##2##(2008-3#1)(2008-4#1)
step beyond##3##2##(1992-11#1)(2012-12#2)
step by a##2##3##(1994-9#1)(2005-11#1)
step by step##4##3##(1991-4#1)(1992-9#1)(1997-1#1)(2008-11#1)
step by##21##2##(1991-4#1)(1992-6#1)(1992-9#1)(1994-12#1)(1994-9#1)(1995-3#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-3#1)(2005-11#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-8#1)(2009-2#1)(2011-1#1)
step can be##5##3##(1991-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-9#1)
step can##8##2##(1991-5#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)
step closer to##5##3##(2007-9#2)(2008-10#1)(2008-6#1)(2011-2#1)
step consisting of##2##3##(1990-12#1)(2008-10#1)
step consists in##3##3##(2008-10#1)(2012-11#2)
step consists##4##2##(2008-10#1)(2011-2#1)(2012-11#2)
step cycle in##2##3##(2007-12#2)
step cycle##3##2##(1997-2#1)(2007-12#2)
step dopamine-synthesizing enzyme)##2##3##(1997-8#2)
step duration##2##2##(2008-10#1)(2012-1#1)
step during##8##2##(1992-8#1)(1994-12#1)(1995-6#1)(2007-8#1)(2008-7#1)(2009-12#1)(2012-12#2)
step edges##2##2##(2008-2#1)(2008-3#1)
step followed by##4##3##(1992-8#1)(1996-8#1)(2008-10#2)
step following the##2##3##(2008-10#1)(2008-3#1)
step following##4##2##(1990-8#1)(1992-1#1)(2008-10#1)(2008-3#1)
step for a##2##3##(2012-3#1)(2013-1#1)
step for further##2##3##(1991-8#1)(2008-10#1)
step for the development of##2##5##(2008-3#1)(2012-2#1)
step for the##11##3##(1992-1#1)(1992-6#1)(1993-11#1)(1993-6#1)(1994-11#1)(2007-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
step for##49##2##(1991-8#1)(1992-1#1)(1992-6#1)(1993-11#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-11#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-7#1)(1997-6#1)(2004-3#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#7)
step forward in the##3##4##(2008-5#2)(2008-7#1)
step forward in##10##3##(1993-6#1)(2004-12#1)(2008-5#2)(2008-7#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-9#1)(2012-2#1)
step forward##24##2##(1990-8#1)(1992-3#1)(1993-1#1)(1993-6#1)(1994-11#1)(1994-9#1)(2004-12#1)(2005-11#1)(2007-4#1)(2008-1#2)(2008-5#2)(2008-7#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-9#1)(2011-1#2)(2012-2#1)
step from a##2##3##(1991-9#1)(2008-10#1)
step from the##2##3##(1994-12#1)(2008-10#1)
step from##8##2##(1991-7#1)(1991-9#1)(1994-12#1)(1994-9#1)(1995-12#1)(2006-12#1)(2008-10#2)
step function##3##2##(2008-2#2)(2011-2#1)
step further and##2##3##(2008-2#1)(2008-9#1)
step further##8##2##(1994-2#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#2)(2009-9#1)(2012-2#1)
step gives##2##2##(2008-10#1)(2008-4#1)
step gradient##7##2##(1990-2#1)(1997-2#1)(2008-10#2)(2008-4#2)(2008-7#1)
step has been##2##3##(1992-9#1)(2008-10#1)
step has##4##2##(1992-9#1)(2006-10#1)(2008-1#1)(2008-10#1)
step height measurement##2##3##(2007-11#1)(2008-3#1)
step height##10##2##(2007-11#2)(2008-1#1)(2008-2#1)(2008-3#2)(2011-2#4)
step in a##10##3##(1991-8#1)(1994-10#1)(1995-12#1)(2006-10#1)(2006-6#1)(2008-10#2)(2008-4#1)(2008-9#1)(2009-4#1)
step in all##2##3##(2008-4#1)(2013-1#1)
step in analyzing##3##3##(1990-9#1)(1996-10#1)(2008-3#1)
step in assessing##2##3##(1997-2#1)(2008-12#1)
step in cancer##2##3##(2011-2#1)(2013-7#1)
step in colonization##2##3##(2008-5#1)(2008-9#1)
step in cytokinesis##2##3##(2009-8#2)
step in de novo pyrimidine biosynthesis##2##6##(1990-7#1)(1995-5#1)
step in degradation##2##3##(2004-4#2)
step in designing##2##3##(2007-12#1)(2007-2#1)
step in determining the##3##4##(1990-11#1)(1995-8#1)(2008-11#1)
step in developing##2##3##(2008-11#1)(2010-2#1)
step in establishing##2##3##(2007-8#1)(2010-9#1)
step in many##2##3##(2008-11#1)(2008-2#1)
step in order to##2##4##(2008-10#1)(2010-12#1)
step in plant##2##3##(2009-8#1)(2011-1#1)
step in steroid##2##3##(1990-3#1)(2008-4#1)
step in the analysis##2##4##(1995-4#1)(2008-10#1)
step in the catalytic##2##4##(1994-11#1)(1997-4#1)
step in the design##2##4##(2007-2#1)(2008-9#1)
step in the development of##5##5##(1994-12#1)(1995-2#1)(1996-6#1)(2006-5#1)(2010-7#1)
step in the development##6##4##(1994-12#1)(1995-2#1)(1996-6#1)(2006-5#1)(2009-7#1)(2010-7#1)
step in the evolution##2##4##(2006-10#1)(2012-1#1)
step in the formation of##4##5##(1994-12#1)(1996-8#1)(2007-11#1)(2008-9#1)
step in the pathogenesis of##2##5##(1996-8#1)(2007-7#1)
step in the pathway##3##4##(1995-10#1)(2008-9#1)(2013-1#1)
step in the preparation of##2##5##(1992-3#1)(2008-7#1)
step in the process of##5##5##(1992-7#1)(1994-1#1)(2008-10#1)(2010-10#1)(2010-4#1)
step in the reaction##2##4##(1990-3#1)(1991-9#1)
step in the recruitment of##2##5##(2008-1#1)(2008-3#1)
step in the study of##3##5##(2008-11#1)(2008-2#1)(2008-4#1)
step in the treatment##2##4##(2007-2#1)(2008-1#1)
step in the##109##3##(1990-10#1)(1990-2#2)(1990-3#1)(1990-5#3)(1991-7#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-11#2)(1994-1#1)(1994-11#1)(1994-12#4)(1994-3#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#3)(1995-4#2)(1995-6#2)(1995-8#2)(1996-1#1)(1996-6#1)(1996-8#2)(1997-1#2)(1997-2#1)(1997-4#4)(1997-5#1)(1997-6#1)(1997-8#1)(2004-8#1)(2006-10#2)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-7#1)(2008-1#3)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#3)(2009-11#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
step in their##2##3##(1994-2#1)(2008-1#1)
step in this direction##2##4##(2006-2#1)(2008-3#1)
step in this process is##2##5##(1995-7#1)(2012-3#1)
step in this process##4##4##(1992-3#1)(1995-7#1)(2008-4#1)(2012-3#1)
step in this##13##3##(1992-3#1)(1992-8#1)(1995-7#1)(1996-2#1)(2005-7#1)(2006-2#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-4#1)(2009-2#1)(2012-3#1)
step in understanding the evolution of##2##6##(2012-2#1)(2013-1#1)
step in understanding the##3##4##(2011-1#1)(2012-2#1)(2013-1#1)
step in understanding##5##3##(2007-4#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
step in which the##2##4##(1991-9#1)(1994-3#1)
step in##287##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#6)(1990-7#1)(1990-8#2)(1990-9#1)(1991-3#2)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#2)(1993-11#2)(1993-4#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#4)(1994-12#4)(1994-2#1)(1994-3#5)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#4)(1995-10#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-4#2)(1995-5#1)(1995-6#6)(1995-7#1)(1995-8#4)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#4)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#3)(1997-2#3)(1997-3#2)(1997-4#6)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-4#3)(2004-8#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-5#1)(2005-7#1)(2006-10#4)(2006-12#2)(2006-2#2)(2006-5#2)(2006-6#2)(2006-8#1)(2007-11#2)(2007-12#2)(2007-2#4)(2007-4#1)(2007-7#2)(2007-8#4)(2008-1#6)(2008-10#13)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#6)(2008-5#10)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#2)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
step includes an##2##3##(2008-10#2)
step includes##3##2##(2007-3#1)(2008-10#2)
step into the##2##3##(1991-3#1)(2010-5#1)
step into##3##2##(1991-3#1)(2010-5#1)(2011-1#1)
step involving##3##2##(1991-5#1)(1991-9#1)(2005-7#1)
step is a##3##3##(2007-11#1)(2008-10#1)(2009-3#1)
step is carried out##2##4##(1996-7#1)(2007-11#1)
step is formation of##2##4##(1995-4#2)
step is rate-limiting##3##3##(1991-7#1)(1995-10#2)
step is required##3##3##(1993-3#1)(2008-11#1)(2008-2#1)
step is the##6##3##(1995-2#1)(1996-5#1)(1997-2#1)(2005-11#1)(2010-12#1)(2011-12#1)
step is to##8##3##(1995-12#2)(1996-2#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)
step is used to##3##4##(1992-2#1)(2008-2#1)(2008-8#1)
step is##57##2##(1991-7#1)(1992-2#1)(1992-6#1)(1993-3#2)(1993-8#1)(1994-8#1)(1995-10#2)(1995-12#2)(1995-2#1)(1995-4#2)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#2)(1997-4#1)(2005-11#1)(2007-11#2)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#1)(2008-2#5)(2008-4#2)(2008-5#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-12#1)(2011-12#1)(2012-3#1)
step it##2##2##(2008-10#1)(2011-2#1)
step length##5##2##(2011-2#2)(2012-1#2)(2013-1#1)
step occurs##2##2##(1997-4#1)(2010-12#1)
step of a##4##3##(1995-2#1)(1997-5#1)(2008-10#1)(2010-10#1)
step of analysis##2##3##(1991-5#1)(2009-11#1)
step of chiral inversion##2##4##(1994-8#2)
step of chiral##3##3##(1994-8#3)
step of evolution##2##3##(2007-3#2)
step of glucose##2##3##(1990-11#1)(1994-11#1)
step of hepatic##2##3##(1993-8#1)(2008-6#1)
step of its##3##3##(1992-12#1)(1992-6#1)(1994-12#1)
step of protein##4##3##(1993-8#2)(2008-4#1)(2011-2#1)
step of steroidogenesis##3##3##(1991-9#1)(2012-2#2)
step of the process##2##4##(1992-2#1)(2008-11#1)
step of the purification##2##4##(1990-9#1)(1996-2#1)
step of the reaction##3##4##(1993-3#1)(2008-10#2)
step of the synthesis##3##4##(2006-12#1)(2008-12#1)(2010-6#1)
step of the##50##3##(1990-2#1)(1990-9#2)(1991-10#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-9#1)(1995-2#2)(1995-4#1)(1996-2#1)(1996-8#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-5#1)(2005-7#1)(2006-10#1)(2006-12#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-6#2)(2012-2#1)(2012-3#1)(2013-8#1)
step of##146##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#2)(1990-9#2)(1991-10#1)(1991-2#1)(1991-5#2)(1991-9#2)(1992-12#4)(1992-2#2)(1992-5#2)(1992-6#2)(1992-8#1)(1993-3#1)(1993-8#3)(1994-11#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#4)(1994-9#2)(1995-11#1)(1995-2#3)(1995-4#1)(1995-8#2)(1995-9#2)(1996-1#1)(1996-2#2)(1996-8#2)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(2005-11#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-6#1)(2007-10#1)(2007-12#2)(2007-3#3)(2008-10#17)(2008-11#3)(2008-12#3)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-6#2)(2011-2#3)(2012-1#1)(2012-2#5)(2012-3#4)(2013-1#1)(2013-8#2)
step on the##2##3##(1995-4#1)(2012-3#1)
step on##4##2##(1992-11#1)(1995-4#1)(2009-11#1)(2012-3#1)
step or##5##2##(1991-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)
step potential##2##2##(2008-10#2)
step prior to the##2##4##(1994-12#1)(2008-10#1)
step prior to##6##3##(1991-8#1)(1994-12#1)(2008-10#3)(2010-8#1)
step procedure##5##2##(1991-10#1)(1991-5#1)(1994-3#2)(2010-11#1)
step process##6##2##(1991-3#1)(1997-2#1)(2006-10#1)(2008-1#1)(2008-5#1)(2010-3#1)
step purification procedure##2##3##(1992-1#1)(1992-12#1)
step purification##4##2##(1992-1#1)(1992-12#1)(2008-7#1)(2013-1#1)
step required for##3##3##(1995-10#1)(2012-11#2)
step required##5##2##(1990-8#1)(1995-10#1)(2008-10#1)(2012-11#2)
step sequential extraction procedure##3##4##(2008-10#3)
step showed##2##2##(2012-12#1)(2012-2#1)
step size of##5##3##(1990-3#1)(1995-3#1)(1997-4#1)(2009-4#2)
step size##15##2##(1990-3#1)(1995-3#1)(1996-4#1)(1997-4#1)(2008-2#2)(2008-3#4)(2009-2#2)(2009-4#2)(2011-2#1)
step sizes##2##2##(2008-6#1)(2011-2#1)
step test##4##2##(1996-3#3)(2012-2#1)
step that##10##2##(1993-11#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-5#1)(2006-10#1)(2007-9#1)(2008-3#1)(2008-4#1)
step the##5##2##(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#2)
step through##2##2##(1990-11#1)(2010-2#1)
step to a##3##3##(1991-11#1)(2004-12#1)(2008-10#1)
step to obtain##2##3##(1994-6#1)(2008-10#1)
step to the##4##3##(1994-12#1)(1997-3#1)(2006-8#1)(2006-9#1)
step to##49##2##(1991-11#1)(1991-9#1)(1992-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-6#2)(1995-6#1)(1997-2#1)(1997-3#1)(2004-12#1)(2006-2#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#4)(2008-10#9)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-6#1)(2010-10#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
step toward a##7##3##(1992-6#1)(2007-12#1)(2007-7#1)(2012-12#2)(2012-2#1)(2012-3#1)
step toward demonstrating##2##3##(2007-12#1)(2007-9#1)
step toward identifying novel##2##4##(1990-11#1)(2008-11#1)
step toward identifying the##2##4##(1993-11#1)(1997-2#1)
step toward identifying##4##3##(1990-11#1)(1993-11#1)(1997-2#1)(2008-11#1)
step toward the##12##3##(1992-3#1)(1995-1#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2009-1#1)(2009-4#1)(2009-7#1)(2010-7#1)(2012-2#1)(2012-3#1)
step toward understanding##6##3##(1991-12#1)(1995-3#1)(1996-7#1)(1997-6#1)(2006-12#1)(2013-8#1)
step toward##63##2##(1990-11#1)(1991-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#2)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#2)(1996-7#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-12#2)(2007-11#3)(2007-12#3)(2007-5#1)(2007-7#3)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-1#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-8#1)
step towards developing a##2##4##(1994-12#1)(2009-7#1)
step towards developing##3##3##(1994-12#1)(2008-11#1)(2009-7#1)
step towards future##2##3##(1992-2#1)(2013-1#1)
step towards the development of##2##5##(2008-10#1)(2008-4#1)
step towards the##8##3##(1990-11#1)(2006-12#1)(2008-10#2)(2008-4#1)(2008-8#1)(2012-11#2)
step towards this##2##3##(2007-8#1)(2012-2#1)
step towards##31##2##(1990-11#1)(1991-6#1)(1992-2#1)(1994-11#1)(1994-12#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-7#1)(2010-12#1)(2011-1#2)(2012-11#2)(2012-2#2)(2013-1#1)
step under##2##2##(1990-5#1)(2007-11#1)
step up##2##2##(2008-4#1)(2013-1#1)
step used##2##2##(2007-8#1)(2008-2#1)
step using##6##2##(1996-11#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-9#1)(2013-7#1)
step was carried out using##3##5##(2008-10#3)
step was carried out##5##4##(2008-10#5)
step was developed##2##3##(2007-11#1)(2012-12#1)
step was not##2##3##(1990-3#1)(2008-3#1)
step was performed##5##3##(1996-5#1)(2007-8#2)(2008-10#2)
step was to##4##3##(1990-12#1)(2007-10#2)(2009-12#1)
step was##38##2##(1990-12#1)(1990-3#1)(1993-9#1)(1994-11#1)(1996-5#1)(1997-8#1)(2006-10#1)(2007-10#3)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-10#13)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2011-2#1)(2012-12#1)
step we##3##2##(1990-2#1)(2008-10#1)(2008-7#1)
step were##2##2##(2008-10#2)
step while##2##2##(2011-1#1)(2012-2#1)
step with a##5##3##(2008-10#2)(2010-12#1)(2013-1#2)
step with the##5##3##(2008-1#1)(2008-10#2)(2008-9#1)(2012-12#1)
step with##18##2##(1996-3#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-6#1)(2008-9#1)(2010-12#1)(2012-12#1)(2013-1#2)
step without##2##2##(1994-12#1)(2008-2#1)
step##1489##1##(1990-10#1)(1990-11#9)(1990-12#4)(1990-2#12)(1990-3#4)(1990-4#3)(1990-5#7)(1990-6#1)(1990-7#3)(1990-8#9)(1990-9#4)(1991-10#5)(1991-11#2)(1991-12#3)(1991-2#4)(1991-3#6)(1991-4#3)(1991-5#7)(1991-6#1)(1991-7#7)(1991-8#4)(1991-9#11)(1992-1#6)(1992-11#7)(1992-12#8)(1992-2#8)(1992-3#5)(1992-4#3)(1992-5#3)(1992-6#9)(1992-7#2)(1992-8#7)(1992-9#5)(1993-1#1)(1993-11#7)(1993-12#2)(1993-2#2)(1993-3#3)(1993-4#2)(1993-6#6)(1993-7#1)(1993-8#7)(1993-9#3)(1994-1#3)(1994-10#3)(1994-11#15)(1994-12#16)(1994-2#4)(1994-3#14)(1994-5#1)(1994-6#7)(1994-8#16)(1994-9#11)(1995-1#6)(1995-10#10)(1995-11#2)(1995-12#7)(1995-2#11)(1995-3#7)(1995-4#7)(1995-5#5)(1995-6#14)(1995-7#1)(1995-8#8)(1995-9#3)(1996-1#5)(1996-10#3)(1996-11#3)(1996-12#4)(1996-2#12)(1996-3#9)(1996-4#3)(1996-5#4)(1996-6#3)(1996-7#10)(1996-8#7)(1997-1#10)(1997-2#16)(1997-3#12)(1997-4#15)(1997-5#5)(1997-6#5)(1997-7#4)(1997-8#7)(2004-12#2)(2004-3#1)(2004-4#3)(2004-8#2)(2004-9#5)(2005-10#3)(2005-11#7)(2005-12#1)(2005-4#1)(2005-5#2)(2005-7#4)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#17)(2006-11#4)(2006-12#10)(2006-2#4)(2006-3#1)(2006-5#2)(2006-6#5)(2006-8#5)(2006-9#1)(2007-10#9)(2007-11#21)(2007-12#19)(2007-2#5)(2007-3#4)(2007-4#5)(2007-5#1)(2007-6#2)(2007-7#7)(2007-8#24)(2007-9#10)(2008-1#28)(2008-10#224)(2008-11#35)(2008-12#4)(2008-2#38)(2008-3#58)(2008-4#28)(2008-5#26)(2008-6#17)(2008-7#19)(2008-8#9)(2008-9#22)(2009-1#1)(2009-10#6)(2009-11#3)(2009-12#3)(2009-2#8)(2009-3#5)(2009-4#8)(2009-5#4)(2009-6#4)(2009-7#4)(2009-8#13)(2009-9#2)(2010-1#1)(2010-10#4)(2010-11#5)(2010-12#12)(2010-2#9)(2010-3#4)(2010-4#1)(2010-5#2)(2010-6#4)(2010-7#4)(2010-8#2)(2010-9#4)(2011-1#19)(2011-12#2)(2011-2#31)(2012-1#10)(2012-11#9)(2012-12#14)(2012-2#26)(2012-3#15)(2013-1#27)(2013-7#2)(2013-8#7)
step&quot##3##1##(2006-10#1)(2008-5#1)(2012-2#1)
step'##4##1##(1995-3#1)(1996-10#3)
step(s)##3##1##(1997-1#2)(2008-10#1)
step)##3##1##(2007-8#1)(2008-10#2)
step-19 spermatids##2##2##(2008-3#1)(2008-5#1)
step-by-step approach##2##2##(2006-2#1)(2008-7#1)
step-by-step protocol for##2##3##(2008-11#2)
step-by-step protocols##2##2##(2008-4#1)(2010-12#1)
step-by-step##45##1##(1990-12#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-3#1)(1993-4#1)(1994-2#1)(1994-3#1)(1995-1#1)(1997-1#1)(2005-2#1)(2006-10#1)(2006-2#1)(2008-10#3)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#7)(2008-7#2)(2008-9#3)(2009-2#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
step-down heating##5##2##(1995-5#5)
step-down##13##1##(1994-5#2)(1994-6#1)(1995-5#5)(2009-9#4)(2010-12#1)
step-gradient##4##1##(2008-4#2)(2011-3#2)
step-index POF's##2##2##(2008-3#2)
step-index fiber##7##2##(2007-12#1)(2008-2#2)(2008-3#4)
step-index profile is##2##3##(2007-12#1)(2008-1#1)
step-index##18##1##(2007-12#4)(2008-1#1)(2008-2#4)(2008-3#9)
step-motor##2##1##(2005-4#2)
step-profile measurement##3##2##(2008-2#2)(2008-3#1)
step-ramp targets##3##2##(1993-2#3)
step-ramp##4##1##(1993-2#3)(1996-1#1)
step-scan##7##1##(2006-12#2)(2007-12#3)(2008-2#2)
step-through inhibitory avoidance##2##3##(1994-3#1)(2012-2#1)
step-through latencies when##2##3##(1992-10#1)(2012-2#1)
step-through latencies##3##2##(1992-10#2)(2012-2#1)
step-through##10##1##(1992-10#4)(1993-3#1)(1994-3#2)(1994-5#1)(2012-2#2)
step-to-step transition types##6##3##(2012-12#6)
step-to-step transition##8##2##(2012-12#8)
step-to-step##10##1##(2012-12#10)
step-up##3##1##(1996-12#1)(2008-8#1)(2012-3#1)
step-wise##8##1##(1992-11#1)(1996-12#1)(2007-3#1)(2008-10#2)(2008-3#1)(2010-7#1)(2011-2#1)
stepfathers and nonresident fathers##2##4##(2008-2#2)
stepfathers##3##1##(2008-2#3)
stephensi embryos##2##2##(2008-11#2)
stephensi##10##1##(2008-11#2)(2008-8#4)(2013-1#4)
stepless##2##1##(2011-2#2)
steplike##5##1##(2007-12#3)(2008-3#2)
stepped wedge##2##2##(2012-3#2)
stepped##15##1##(1990-3#1)(1992-8#1)(1996-12#1)(1997-4#1)(1997-5#2)(2008-3#4)(2008-6#2)(2011-1#1)(2012-3#2)
stepped-care##2##1##(1996-9#1)(2012-2#1)
stepped-up##2##1##(1990-5#1)(1996-11#1)
stepper motor##4##2##(2007-12#1)(2008-10#1)(2008-3#2)
stepper##5##1##(2007-12#1)(2008-10#1)(2008-3#3)
stepping motors##2##2##(2008-3#1)(2009-8#1)
stepping pattern##2##2##(1990-4#1)(2013-1#1)
stepping stone to##3##3##(1993-12#1)(2006-12#1)(2013-8#1)
stepping stone&quot##2##2##(2011-1#2)
stepping velocities##2##2##(2012-1#2)
stepping##33##1##(1990-4#4)(1993-12#1)(1995-5#1)(1997-2#1)(1997-4#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#3)(2009-10#1)(2009-8#1)(2011-1#3)(2012-1#2)(2012-12#1)(2013-1#4)(2013-8#1)
stepping-stone##2##1##(2008-11#1)(2008-9#1)
steps 1 and 2##4##4##(2008-12#1)(2012-3#3)
steps 1 and##6##3##(2008-12#1)(2008-4#2)(2012-3#3)
steps a##2##2##(1995-3#1)(1996-2#1)
steps along the##2##3##(1994-9#1)(2008-4#1)
steps and the##8##3##(1994-5#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-3#1)(2010-1#1)
steps and##31##2##(1992-8#1)(1993-4#1)(1994-12#1)(1994-5#1)(1997-4#1)(2006-2#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#2)(2010-1#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
steps are discussed##2##3##(2007-1#1)(2008-10#1)
steps are performed##2##3##(2008-11#1)(2008-3#1)
steps are quite##2##3##(2008-10#1)(2008-4#1)
steps are required##4##3##(2005-11#1)(2005-5#1)(2008-10#1)(2010-11#1)
steps are##37##2##(1991-12#1)(1992-2#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-10#1)(2005-11#2)(2005-5#1)(2006-10#1)(2006-8#1)(2007-1#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#5)(2008-8#1)(2009-8#1)(2010-11#1)(2010-12#1)(2012-1#1)(2012-2#1)
steps at##2##2##(2008-10#1)(2009-7#1)
steps based on##2##3##(2008-10#2)
steps between##4##2##(1992-7#1)(1993-2#1)(2007-12#1)(2008-11#1)
steps by##2##2##(1993-9#1)(2008-3#1)
steps can be##4##3##(1990-3#1)(1994-3#1)(2007-4#1)(2008-7#1)
steps can##5##2##(1990-3#1)(1994-3#1)(2007-4#1)(2008-7#1)(2013-7#1)
steps during the##4##3##(1995-6#1)(2010-7#1)(2012-12#2)
steps during##5##2##(1992-3#1)(1995-6#1)(2010-7#1)(2012-12#2)
steps for developing a##2##4##(2009-4#1)(2012-12#1)
steps for developing##3##3##(2007-1#1)(2009-4#1)(2012-12#1)
steps for each##2##3##(2008-2#1)(2008-4#1)
steps for improving##2##3##(2006-7#1)(2007-9#1)
steps for the##3##3##(2007-8#1)(2008-4#1)(2012-3#1)
steps for##29##2##(1991-3#1)(1997-7#1)(2006-7#1)(2007-1#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#5)(2008-3#1)(2008-4#5)(2008-8#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-8#1)(2010-9#1)(2012-12#2)(2012-3#1)
steps forward in##2##3##(2012-12#2)
steps forward##3##2##(2008-8#1)(2012-12#2)
steps from the##3##3##(1995-1#1)(2008-8#1)(2012-2#1)
steps from##18##2##(1991-10#1)(1992-5#1)(1993-12#1)(1993-4#1)(1995-1#1)(1996-5#1)(1996-8#1)(2006-12#2)(2006-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-6#2)(2012-2#1)(2012-3#1)
steps has##2##2##(1990-9#1)(2008-10#1)
steps have been taken to##2##5##(2006-4#1)(2008-8#1)
steps have##3##2##(1997-3#1)(2006-4#1)(2008-8#1)
steps in a##4##3##(2006-10#1)(2007-12#1)(2008-10#1)(2011-3#1)
steps in the biosynthesis of the##2##6##(1990-9#1)(1994-8#1)
steps in the biosynthesis of##3##5##(1990-9#1)(1994-8#1)(2013-1#1)
steps in the development of##3##5##(1997-5#1)(2008-8#1)(2009-12#1)
steps in the management of this##2##6##(2006-2#1)(2009-9#1)
steps in the pathway##3##4##(1996-10#1)(1997-8#1)(2006-12#1)
steps in the process##2##4##(1993-12#1)(2008-9#1)
steps in the reaction##3##4##(1991-11#1)(1997-1#1)(2010-6#1)
steps in the synthesis of##2##5##(1994-9#1)(2012-3#1)
steps in the synthesis##3##4##(1994-9#1)(2009-7#1)(2012-3#1)
steps in the##53##3##(1990-7#1)(1990-9#1)(1991-10#1)(1991-11#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-8#2)(1994-9#1)(1995-10#2)(1995-2#1)(1996-1#1)(1996-10#1)(1997-1#2)(1997-5#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-11#1)(2008-1#3)(2008-10#4)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
steps in this##4##3##(1992-1#1)(1997-7#1)(2008-2#1)(2009-4#1)
steps in which##2##3##(2006-10#1)(2008-4#1)
steps in##113##2##(1990-11#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-11#1)(1992-1#1)(1992-3#1)(1992-6#3)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-7#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#2)(1995-2#1)(1996-1#1)(1996-10#1)(1996-6#1)(1996-7#3)(1996-8#1)(1997-1#2)(1997-5#1)(1997-7#2)(1997-8#1)(2004-10#1)(2005-10#2)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#5)(2007-4#1)(2007-9#1)(2008-1#4)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
steps include##4##2##(1990-12#1)(2006-9#1)(2008-3#1)(2008-6#1)
steps including##2##2##(2008-4#1)(2009-12#1)
steps involve##3##2##(1991-6#1)(1997-7#1)(2010-2#1)
steps involved in the##3##4##(2008-10#1)(2008-2#1)(2008-7#1)
steps involved in##13##3##(1992-3#1)(1994-2#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-4#3)(2008-7#1)(2009-8#1)
steps involved##16##2##(1992-3#1)(1994-2#1)(1994-9#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#3)(2008-7#1)(2009-8#1)
steps may##2##2##(1996-8#1)(2011-2#1)
steps must be taken##2##4##(2010-1#1)(2010-2#1)
steps necessary to##2##3##(1997-1#1)(2009-8#1)
steps necessary##3##2##(1997-1#1)(2008-4#1)(2009-8#1)
steps needed to##4##3##(1996-12#1)(2004-2#1)(2013-1#2)
steps of a##3##3##(1991-2#1)(2007-11#1)(2008-4#1)
steps of ammonium sulfate precipitation##2##5##(1991-9#1)(2005-11#1)
steps of chromatography##2##3##(1994-10#1)(1997-2#1)
steps of data##2##3##(2006-5#1)(2008-2#1)
steps of invasion##2##3##(1993-4#1)(2008-10#1)
steps of the process##2##4##(1992-2#1)(2010-2#1)
steps of the##46##3##(1990-12#1)(1990-4#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-6#1)(1994-8#2)(1994-9#1)(1995-8#1)(1995-9#1)(1997-4#2)(2005-11#2)(2006-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-3#3)(2008-4#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-6#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
steps of this##2##3##(1995-2#1)(2008-4#1)
steps of##128##2##(1990-12#3)(1990-4#2)(1990-8#1)(1991-2#3)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-6#1)(1992-7#1)(1993-11#1)(1993-2#2)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-10#1)(1994-8#3)(1994-9#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#1)(2005-10#1)(2005-11#4)(2006-10#1)(2006-2#1)(2006-5#3)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#4)(2008-3#7)(2008-4#5)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#1)(2009-6#2)(2009-7#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)
steps on##4##2##(1992-12#1)(1994-12#1)(2008-10#1)(2009-3#1)
steps or##4##2##(1990-12#1)(2006-5#1)(2008-10#1)(2008-3#1)
steps required for##2##3##(2008-1#1)(2010-3#1)
steps required to##2##3##(2006-12#1)(2007-4#1)
steps required##7##2##(2006-12#1)(2007-4#1)(2008-1#1)(2008-11#2)(2009-5#1)(2010-3#1)
steps resulting##2##2##(2008-2#1)(2012-12#1)
steps should##3##2##(2005-11#1)(2007-2#1)(2009-4#1)
steps starting with##4##3##(2008-2#1)(2008-4#2)(2011-1#1)
steps taken##10##2##(1993-1#1)(2007-2#1)(2007-9#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#2)(2013-1#1)
steps that are##4##3##(2008-4#3)(2009-3#1)
steps that can be taken##2##5##(2010-2#1)(2012-2#1)
steps that must be##2##4##(2008-4#1)(2008-8#1)
steps that should be completed to ensure appropriate##2##8##(2010-9#2)
steps that should be##4##4##(2010-9#4)
steps that will##2##3##(1992-1#1)(2008-11#1)
steps that##26##2##(1991-6#1)(1992-1#1)(1996-2#1)(1996-8#1)(2007-4#1)(2008-1#1)(2008-11#3)(2008-4#4)(2008-8#1)(2009-3#1)(2010-2#1)(2010-9#5)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
steps to be##2##3##(2010-4#1)(2012-2#1)
steps to ensure##2##3##(2007-11#1)(2007-6#1)
steps to follow##2##3##(2009-11#1)(2011-2#1)
steps to improve##3##3##(1994-2#1)(1996-2#1)(2007-10#1)
steps to promote##2##3##(2009-9#1)(2011-12#1)
steps to##62##2##(1990-9#1)(1991-10#1)(1991-12#1)(1991-9#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-2#2)(1995-12#1)(1995-8#1)(1996-11#1)(1996-2#2)(1996-3#1)(1997-2#3)(1997-3#1)(1997-6#3)(2006-1#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-4#5)(2008-8#2)(2008-9#1)(2009-11#2)(2009-9#1)(2010-4#1)(2010-5#1)(2011-12#2)(2011-2#1)(2012-12#1)(2012-2#3)(2013-7#1)
steps toward a##2##3##(1994-1#1)(2008-6#1)
steps toward##7##2##(1994-1#1)(1995-8#1)(1996-1#2)(2007-8#1)(2008-11#1)(2008-6#1)
steps towards the##6##3##(2007-2#1)(2007-9#1)(2011-2#1)(2012-3#1)(2013-1#2)
steps towards##11##2##(2006-10#2)(2007-2#1)(2007-9#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
steps used##2##2##(1995-6#1)(2007-4#1)
steps using##4##2##(2008-10#3)(2008-4#1)
steps was##2##2##(1996-7#1)(2008-10#1)
steps were also##2##3##(1993-3#1)(2008-10#1)
steps were carried out##2##4##(1991-3#1)(2008-10#1)
steps were required##3##3##(1994-3#1)(2008-10#2)
steps were##23##2##(1991-3#1)(1993-3#2)(1994-3#1)(1997-8#1)(2008-10#13)(2008-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
steps which##2##2##(1995-10#1)(2007-2#1)
steps with a##4##3##(1990-12#1)(1992-6#1)(2008-10#1)(2008-3#1)
steps with##8##2##(1990-12#1)(1992-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-12#1)(2012-1#1)
steps you##2##2##(2005-8#1)(2011-2#1)
steps##921##1##(1990-11#1)(1990-12#10)(1990-3#2)(1990-4#3)(1990-6#1)(1990-7#2)(1990-8#4)(1990-9#5)(1991-10#3)(1991-11#1)(1991-12#4)(1991-2#5)(1991-3#2)(1991-6#4)(1991-9#2)(1992-1#2)(1992-11#2)(1992-12#5)(1992-2#5)(1992-3#3)(1992-5#4)(1992-6#7)(1992-7#4)(1992-8#4)(1992-9#1)(1993-1#3)(1993-11#2)(1993-12#2)(1993-2#6)(1993-3#3)(1993-4#3)(1993-6#1)(1993-8#2)(1993-9#5)(1994-1#1)(1994-10#2)(1994-11#2)(1994-12#9)(1994-2#5)(1994-3#4)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#9)(1994-9#6)(1995-1#5)(1995-10#4)(1995-12#3)(1995-2#5)(1995-3#4)(1995-4#3)(1995-6#3)(1995-7#1)(1995-8#4)(1995-9#1)(1996-1#4)(1996-10#3)(1996-11#1)(1996-12#3)(1996-2#5)(1996-3#5)(1996-4#2)(1996-5#3)(1996-6#1)(1996-7#7)(1996-8#4)(1997-1#3)(1997-2#5)(1997-3#3)(1997-4#5)(1997-5#2)(1997-6#5)(1997-7#7)(1997-8#2)(2004-10#1)(2004-2#1)(2004-5#1)(2005-10#4)(2005-11#11)(2005-5#1)(2005-8#3)(2006-1#1)(2006-10#9)(2006-12#7)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#5)(2006-6#2)(2006-7#2)(2006-8#2)(2006-9#2)(2007-1#5)(2007-10#11)(2007-11#13)(2007-12#16)(2007-2#7)(2007-3#1)(2007-4#8)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#9)(2007-9#6)(2008-1#14)(2008-10#100)(2008-11#22)(2008-12#3)(2008-2#32)(2008-3#28)(2008-4#55)(2008-5#9)(2008-6#7)(2008-7#13)(2008-8#17)(2008-9#11)(2009-10#3)(2009-11#4)(2009-12#7)(2009-2#6)(2009-3#10)(2009-4#5)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#7)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#3)(2010-12#5)(2010-2#11)(2010-3#5)(2010-4#2)(2010-5#2)(2010-6#4)(2010-7#2)(2010-8#2)(2010-9#6)(2011-1#12)(2011-12#3)(2011-2#21)(2011-3#2)(2012-1#7)(2012-11#1)(2012-12#19)(2012-2#15)(2012-3#11)(2013-1#16)(2013-7#3)(2013-8#5)
steps)##3##1##(1992-7#1)(2008-7#1)(2009-5#1)
steps/day##2##1##(2013-1#2)
stepwise addition of##2##3##(2008-11#1)(2010-5#1)
stepwise and##2##2##(2008-10#1)(2010-4#1)
stepwise approach to##3##3##(2008-7#1)(2010-12#1)(2010-2#1)
stepwise approach##10##2##(1996-7#1)(2008-4#2)(2008-6#1)(2008-7#1)(2010-12#2)(2010-2#1)(2012-3#2)
stepwise elution with##2##3##(1991-5#1)(1995-11#1)
stepwise elution##3##2##(1991-5#1)(1995-11#1)(2008-10#1)
stepwise evolution of##2##3##(1992-12#1)(2008-10#1)
stepwise evolution##3##2##(1992-12#1)(2008-10#1)(2010-4#1)
stepwise increase in##2##3##(2008-11#1)(2011-2#1)
stepwise increase##3##2##(2008-11#2)(2011-2#1)
stepwise increases##2##2##(2008-7#1)(2012-3#1)
stepwise linear discriminant analysis##2##4##(2008-10#2)
stepwise linear discriminant##3##3##(2008-10#3)
stepwise linear##6##2##(2008-10#3)(2008-11#1)(2010-5#2)
stepwise logistic regression analysis##3##4##(2007-8#1)(2008-10#1)(2012-2#1)
stepwise logistic regression##7##3##(1994-12#1)(1995-6#1)(2007-8#2)(2008-10#1)(2008-7#1)(2012-2#1)
stepwise logistic##8##2##(1993-1#1)(1994-12#1)(1995-6#1)(2007-8#2)(2008-10#1)(2008-7#1)(2012-2#1)
stepwise manner##4##2##(2007-12#2)(2008-10#2)
stepwise mechanism##2##2##(1994-8#1)(2008-8#1)
stepwise multiple regression analysis##5##4##(1991-10#1)(1992-9#1)(1994-9#1)(2006-9#1)(2007-8#1)
stepwise multiple regression##7##3##(1991-10#1)(1991-6#1)(1992-9#1)(1994-9#1)(2005-12#1)(2006-9#1)(2007-8#1)
stepwise oxidation##2##2##(1994-5#1)(2009-9#1)
stepwise pattern##3##2##(2008-10#3)
stepwise procedure##3##2##(1996-5#1)(2008-10#1)(2012-12#1)
stepwise process##2##2##(2008-11#1)(2009-12#1)
stepwise reduction of##2##3##(2008-7#1)(2009-5#1)
stepwise regression analysis##7##3##(1995-6#2)(1996-3#1)(1996-5#1)(1997-2#1)(2011-1#1)(2012-2#1)
stepwise regression##15##2##(1993-4#1)(1995-6#2)(1996-3#1)(1996-5#1)(1997-2#1)(2008-10#2)(2008-6#1)(2008-9#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
stepwise selection##2##2##(1997-2#1)(2012-3#1)
stepwise##148##1##(1990-10#1)(1990-11#2)(1991-10#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-9#1)(1993-1#2)(1993-4#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#5)(1994-9#1)(1995-11#1)(1995-6#4)(1996-12#1)(1996-3#1)(1996-5#2)(1996-7#2)(1997-2#3)(1997-3#1)(1997-4#3)(2005-11#2)(2005-12#1)(2006-12#3)(2006-9#1)(2007-10#1)(2007-12#6)(2007-4#1)(2007-8#4)(2008-10#24)(2008-11#7)(2008-3#6)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#3)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#5)(2013-8#2)
stercoralis in##2##2##(2007-7#1)(2012-12#1)
stercoralis##21##1##(1990-12#1)(1993-10#1)(1993-8#1)(1997-3#1)(2007-12#7)(2007-7#2)(2007-8#1)(2011-1#1)(2012-12#4)(2012-2#2)
stereo image##2##2##(2008-2#2)
stereo microscope##2##2##(2008-3#2)
stereo vision##3##2##(2008-3#2)(2008-9#1)
stereo##28##1##(1991-1#1)(1994-8#1)(2006-7#1)(2007-5#1)(2008-11#1)(2008-2#6)(2008-3#5)(2008-6#2)(2008-9#1)(2009-3#5)(2010-8#1)(2012-12#2)(2013-7#1)
stereo-specific##2##1##(2009-10#1)(2012-2#1)
stereocamera for particle image velocimetry##2##5##(2008-2#2)
stereocamera##4##1##(2008-2#4)
stereocenter##2##1##(2008-6#1)(2009-10#1)
stereocenters of the##2##3##(2008-6#1)(2010-2#1)
stereocenters##3##1##(2008-6#1)(2010-2#1)(2010-7#1)
stereochemical analysis##4##2##(1991-2#2)(2009-12#2)
stereochemical configuration##3##2##(1994-8#2)(2010-6#1)
stereochemical course of##3##3##(1990-7#1)(1992-7#1)(1996-5#1)
stereochemical mechanism##2##2##(1990-7#1)(1991-5#1)
stereochemical notation for##2##3##(2008-4#2)
stereochemical outcome##4##2##(1995-5#1)(2008-7#2)(2010-7#1)
stereochemical outcomes##3##2##(1996-5#1)(2008-9#1)(2009-12#1)
stereochemical##38##1##(1990-7#5)(1991-2#3)(1991-5#2)(1992-7#1)(1992-8#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-5#1)(1996-5#2)(1997-1#1)(2006-12#3)(2008-10#1)(2008-4#3)(2008-7#2)(2008-9#1)(2009-12#3)(2009-9#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#1)
stereochemically defined##2##2##(1996-11#1)(1996-7#1)
stereochemically##9##1##(1990-6#1)(1992-12#1)(1992-4#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-7#1)
stereochemistry and##4##2##(1992-11#1)(1996-7#1)(2010-2#2)
stereochemistry at the##3##3##(1992-6#1)(1995-3#1)(2008-10#1)
stereochemistry of the##8##3##(1990-10#1)(1990-8#1)(1995-10#1)(1995-5#1)(1997-2#1)(2007-1#1)(2007-11#1)(2009-7#1)
stereochemistry of##21##2##(1990-10#1)(1990-12#1)(1990-8#1)(1992-11#1)(1992-6#1)(1992-8#1)(1995-10#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-2#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-11#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-2#1)
stereochemistry##47##1##(1990-10#1)(1990-12#2)(1990-8#1)(1992-11#2)(1992-6#3)(1992-8#2)(1993-6#1)(1993-8#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#1)(2006-10#1)(2007-1#2)(2007-11#1)(2007-7#1)(2008-10#3)(2008-5#3)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-12#2)(2010-2#3)(2010-6#1)(2011-2#1)
stereocontrolled##3##1##(2008-3#1)(2009-9#1)(2010-6#1)
stereodefined PS-oligos##3##2##(2008-4#3)
stereodefined##4##1##(2008-4#4)
stereoelectronic control##2##2##(1992-12#1)(2009-8#1)
stereoelectronic##3##1##(1992-12#1)(1994-9#1)(2009-8#1)
stereogenic centers##2##2##(2006-12#1)(2010-6#1)
stereogenic##6##1##(1996-3#1)(2006-12#1)(2008-8#1)(2010-6#1)(2013-1#1)(2013-8#1)
stereoisomer of##2##2##(1995-6#1)(2009-12#1)
stereoisomer##9##1##(1992-1#2)(1992-5#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-6#1)(2007-11#1)(2009-12#1)
stereoisomeric##6##1##(1990-6#2)(1995-1#1)(1996-7#2)(2008-5#1)
stereoisomers in##3##2##(1995-10#1)(2010-2#2)
stereoisomers of the##2##3##(1990-6#1)(2006-12#1)
stereoisomers of##8##2##(1990-6#1)(1991-2#1)(1994-8#1)(1995-10#1)(2006-12#2)(2010-2#2)
stereoisomers##29##1##(1990-10#1)(1990-6#1)(1991-2#4)(1992-9#1)(1994-8#2)(1994-9#2)(1995-10#3)(1995-3#1)(1995-7#1)(1996-6#1)(2005-8#1)(2006-12#2)(2008-11#1)(2008-6#1)(2008-8#1)(2010-2#6)
stereolithographic##5##1##(2008-3#2)(2010-9#1)(2013-1#2)
stereolithography##3##1##(2007-12#1)(2008-3#1)(2008-4#1)
stereological methods##2##2##(1995-8#1)(2008-4#1)
stereological study##2##2##(2006-11#1)(2008-12#1)
stereological##16##1##(1995-5#1)(1995-8#1)(1996-10#1)(1996-12#1)(2006-11#1)(2007-12#4)(2008-12#1)(2008-4#1)(2008-5#3)(2011-2#1)(2012-3#1)
stereology##3##1##(1992-12#1)(1995-5#1)(1996-9#1)
stereomicroscopy##3##1##(2008-10#2)(2013-1#1)
stereopsis and##2##2##(1992-7#1)(2009-3#1)
stereopsis##6##1##(1992-7#1)(1994-8#1)(2008-9#2)(2009-3#1)(2012-12#1)
stereoscopic image##3##2##(2008-2#3)
stereoscopic view##2##2##(2007-5#2)
stereoscopic vision##2##2##(2008-3#1)(2012-1#1)
stereoscopic##16##1##(1990-8#1)(2006-5#1)(2007-5#2)(2008-2#6)(2008-3#2)(2008-9#1)(2011-2#1)(2011-7#1)(2012-1#1)
stereoselective and##4##2##(1993-9#1)(1996-12#1)(1997-3#1)(1997-5#1)
stereoselective assay was##2##3##(1990-6#2)
stereoselective inhibitors of##2##3##(1992-7#1)(1994-9#1)
stereoselective intramolecular##2##2##(1996-5#1)(2005-8#1)
stereoselective recognition##2##2##(1994-2#1)(1996-5#1)
stereoselective synthesis of##2##3##(2009-12#1)(2010-2#1)
stereoselective synthesis##3##2##(2006-12#1)(2009-12#1)(2010-2#1)
stereoselective##52##1##(1990-12#1)(1990-6#2)(1991-1#1)(1991-5#1)(1991-9#1)(1992-11#2)(1992-7#1)(1993-2#3)(1993-9#1)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#1)(1996-12#1)(1996-4#1)(1996-5#6)(1996-9#1)(1997-3#2)(1997-5#1)(2004-2#1)(2005-11#1)(2005-8#2)(2006-12#3)(2007-11#2)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#2)(2010-2#2)(2010-4#1)(2010-6#2)(2010-8#1)
stereoselectively##4##1##(1996-5#1)(2006-12#1)(2007-11#1)(2009-4#1)
stereoselectivity in the##2##3##(2006-12#1)(2007-6#1)
stereoselectivity in##3##2##(1990-6#1)(2006-12#1)(2007-6#1)
stereoselectivity of##8##2##(1991-12#1)(1993-2#2)(1995-5#1)(1996-5#1)(2006-12#1)(2007-6#1)(2008-10#1)
stereoselectivity##26##1##(1990-6#1)(1991-12#2)(1992-12#1)(1992-2#1)(1992-7#1)(1993-2#2)(1995-3#1)(1995-5#2)(1996-5#3)(2005-11#1)(2005-8#1)(2006-12#2)(2007-11#1)(2007-6#3)(2008-10#1)(2009-2#2)(2009-5#1)
stereospecific and##3##2##(1993-12#1)(1993-7#1)(1994-8#1)
stereospecific site##2##2##(1996-10#1)(2008-10#1)
stereospecific##29##1##(1990-6#1)(1991-11#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-7#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-10#2)(1996-7#1)(1996-9#3)(2005-8#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-6#2)(2009-11#1)
stereospecifically##7##1##(1990-11#1)(1992-1#1)(1993-12#1)(1994-11#1)(1996-7#3)
stereospecificity in##5##2##(1990-4#2)(1990-5#1)(1990-7#2)
stereospecificity of the##3##3##(1994-11#1)(1994-8#1)(1996-7#1)
stereospecificity of##5##2##(1990-5#1)(1994-11#1)(1994-8#1)(1996-7#1)(1997-4#1)
stereospecificity##21##1##(1990-4#2)(1990-5#2)(1990-7#2)(1991-1#1)(1991-5#1)(1993-11#1)(1993-6#2)(1994-11#1)(1994-2#1)(1994-8#2)(1996-5#1)(1996-7#1)(1996-9#2)(1997-4#1)(2006-9#1)
stereotactic aspirations##2##2##(2008-7#2)
stereotactic biopsy##6##2##(2006-10#1)(2007-12#2)(2008-7#2)(2013-1#1)
stereotactic body radiation##2##3##(2007-4#2)
stereotactic guidance##2##2##(2006-12#1)(2008-7#1)
stereotactic pallidotomy##3##2##(2008-7#3)
stereotactic procedures##3##2##(2007-12#1)(2008-7#2)
stereotactic radiation##2##2##(1997-6#1)(2007-4#1)
stereotactic radiosurgery and##2##3##(2009-5#1)(2011-2#1)
stereotactic radiosurgery##16##2##(1993-4#1)(1994-9#1)(1995-8#1)(2004-1#1)(2005-5#1)(2006-11#1)(2006-7#1)(2007-9#1)(2008-7#2)(2009-5#1)(2011-2#5)
stereotactic radiotherapy##8##2##(1994-3#1)(2006-6#1)(2007-4#1)(2008-3#1)(2008-7#1)(2012-1#1)(2012-2#2)
stereotactic surgery##3##2##(2006-3#1)(2006-5#1)(2008-11#1)
stereotactic system##2##2##(1993-8#1)(2006-12#1)
stereotactic##82##1##(1991-11#4)(1993-4#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-8#1)(1995-9#1)(1997-6#1)(2004-1#2)(2005-5#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-3#3)(2006-5#2)(2006-6#1)(2006-7#1)(2006-9#4)(2007-1#1)(2007-12#6)(2007-4#4)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#19)(2008-9#1)(2009-5#1)(2010-12#1)(2011-2#5)(2012-1#1)(2012-2#4)(2013-1#2)
stereotactically##5##1##(2005-10#1)(2006-6#1)(2006-7#1)(2007-1#1)(2013-7#1)
stereotaxic##8##1##(1992-8#1)(1993-6#1)(1997-4#1)(2008-7#2)(2009-10#1)(2010-12#1)(2010-2#1)
stereotaxically##4##1##(1990-7#2)(1991-1#1)(1993-4#1)
stereotaxis##2##1##(1991-11#1)(2006-12#1)
stereotype endorsement and##2##3##(2010-7#2)
stereotype endorsement##3##2##(2010-7#3)
stereotype group was exposed to##2##5##(2008-11#2)
stereotype group was##3##3##(2008-11#3)
stereotype group##4##2##(2008-11#4)
stereotype of a##2##3##(2012-3#2)
stereotype of##4##2##(2008-11#1)(2010-12#1)(2012-3#2)
stereotype that##2##2##(2008-11#1)(2009-9#1)
stereotype threat##4##2##(2008-5#4)
stereotype threats##3##2##(2008-5#3)
stereotype##28##1##(1993-2#1)(1993-5#1)(1994-8#1)(2008-11#8)(2008-4#1)(2008-5#8)(2009-9#1)(2010-12#1)(2010-7#3)(2011-2#1)(2012-3#2)
stereotyped behavior in##2##3##(1990-7#1)(1993-6#1)
stereotyped behavior##4##2##(1990-7#1)(1993-4#1)(1993-6#1)(1996-10#1)
stereotyped behaviour##2##2##(1993-11#1)(2008-12#1)
stereotyped patterns of##2##3##(2012-2#2)
stereotyped##24##1##(1990-7#1)(1993-11#1)(1993-12#1)(1993-4#2)(1993-6#1)(1995-12#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-4#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-9#1)(2012-2#2)
stereotypes of##2##2##(1990-2#1)(2012-3#1)
stereotypes that##2##2##(1994-12#1)(2008-7#1)
stereotypes##27##1##(1990-2#1)(1992-2#1)(1993-5#1)(1994-12#1)(2007-8#1)(2008-11#2)(2008-7#1)(2010-11#1)(2010-2#1)(2010-7#1)(2011-1#5)(2011-2#2)(2012-12#3)(2012-3#6)
stereotypic and repetitive##2##3##(2009-4#2)
stereotypic and##3##2##(2009-4#2)(2011-12#1)
stereotypic behavior##5##2##(1997-5#1)(2009-4#4)
stereotypic behaviors##2##2##(2009-4#2)
stereotypic##14##1##(1995-12#2)(1997-5#1)(2007-12#2)(2009-4#8)(2011-12#1)
stereotypical##5##1##(2007-6#1)(2008-1#1)(2008-10#1)(2010-3#1)(2012-2#1)
stereotypies##5##1##(2007-6#1)(2008-11#3)(2009-4#1)
stereotyping##5##1##(2006-10#1)(2006-2#1)(2007-9#1)(2009-4#1)(2012-3#1)
stereotypy in##3##2##(1991-8#1)(2009-4#2)
stereotypy performance##3##2##(2008-11#3)
stereotypy##16##1##(1991-5#1)(1991-8#1)(1993-6#1)(1995-12#2)(1995-3#2)(1996-10#1)(1997-8#2)(2008-11#3)(2008-4#1)(2009-4#2)
stereovision##4##1##(2008-2#2)(2008-6#1)(2011-2#1)
steric accessibility of##2##3##(1995-2#1)(2008-10#1)
steric accessibility##3##2##(1995-2#1)(2008-10#2)
steric and electronic effects##2##4##(1992-10#1)(2010-6#1)
steric and electronic##4##3##(1992-10#1)(1993-4#1)(1996-5#1)(2010-6#1)
steric and electrostatic##2##3##(1995-4#1)(2010-12#1)
steric and##7##2##(1990-7#1)(1992-10#1)(1993-4#1)(1995-4#1)(1996-5#1)(2010-12#1)(2010-6#1)
steric bulk of the##3##4##(1997-7#1)(2008-8#1)(2009-11#1)
steric bulk of##4##3##(1997-7#1)(2008-8#1)(2009-11#1)(2010-5#1)
steric bulk##7##2##(1996-8#3)(1997-7#1)(2008-8#1)(2009-11#1)(2010-5#1)
steric crowding##2##2##(1991-4#1)(2008-6#1)
steric effect##2##2##(2007-11#1)(2008-10#1)
steric effects##3##2##(2006-10#1)(2008-10#2)
steric factors##5##2##(1991-4#1)(2005-11#1)(2007-11#2)(2012-12#1)
steric hinderance##2##2##(1991-1#1)(2010-5#1)
steric hindrance and##4##3##(2006-12#1)(2007-11#1)(2008-10#1)(2012-1#1)
steric hindrance between the##2##4##(1990-8#1)(2011-2#1)
steric hindrance between##3##3##(1990-8#1)(2004-9#1)(2011-2#1)
steric hindrance of##3##3##(2006-12#1)(2008-10#1)(2013-7#1)
steric hindrance##19##2##(1990-8#1)(1994-11#1)(1994-9#1)(2004-9#1)(2006-12#2)(2007-11#1)(2008-10#4)(2008-5#1)(2009-12#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-7#1)
steric hindrances##3##2##(1990-11#1)(2008-5#1)(2008-9#1)
steric influence on the##2##4##(1994-5#1)(2008-10#1)
steric influence##3##2##(1994-5#1)(2006-12#1)(2008-10#1)
steric interaction of the##2##4##(1995-1#1)(1996-5#1)
steric interactions between##2##3##(1994-8#1)(1997-7#1)
steric interactions##5##2##(1994-8#1)(1996-8#1)(1997-6#1)(1997-7#1)(2008-5#1)
steric interference##2##2##(1994-9#1)(2010-11#1)
steric repulsion##6##2##(1996-8#1)(1997-1#2)(1997-2#1)(1997-7#1)(2005-11#1)
steric repulsions##2##2##(2008-10#1)(2010-5#1)
steric requirements##3##2##(1996-2#1)(2012-3#1)(2013-1#1)
steric restriction##2##2##(2008-10#2)
steric##99##1##(1990-11#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-4#2)(1991-5#2)(1992-10#1)(1992-11#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-5#2)(1994-8#1)(1994-9#4)(1995-1#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-2#2)(1996-5#2)(1996-8#5)(1997-1#2)(1997-2#1)(1997-6#1)(1997-7#3)(2004-9#1)(2005-11#3)(2006-10#1)(2006-12#3)(2007-11#4)(2008-10#16)(2008-11#1)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-5#4)(2010-6#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
sterical##3##1##(1993-9#1)(2007-8#1)(2010-5#1)
sterically demanding##6##2##(1996-5#1)(2006-4#1)(2007-10#1)(2008-11#1)(2008-9#1)(2010-5#1)
sterically encumbered##3##2##(1993-4#1)(2010-5#2)
sterically hindered##6##2##(1991-8#1)(1994-9#1)(1995-1#1)(1996-2#1)(1996-5#1)(2008-10#1)
sterically stabilized liposomes##8##3##(1995-2#1)(2006-10#1)(2008-5#6)
sterically stabilized##10##2##(1995-2#1)(2005-11#1)(2006-10#1)(2008-5#7)
sterically##43##1##(1991-8#1)(1991-9#1)(1993-4#1)(1994-9#3)(1995-1#1)(1995-2#1)(1995-6#1)(1996-2#2)(1996-5#3)(1996-7#1)(1997-2#1)(2005-11#3)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#9)(2008-9#1)(2009-8#1)(2010-12#1)(2010-5#5)(2010-7#1)
sterics##2##1##(2006-12#1)(2009-4#1)
sterigmatocystin##2##1##(1990-12#1)(1991-4#1)
sterilant##5##1##(2013-8#5)
sterile and fertile##4##3##(2008-8#2)(2009-12#1)(2013-7#1)
sterile and non-pyrogenic##2##3##(1992-8#2)
sterile and##10##2##(1992-8#2)(2007-12#1)(2007-7#1)(2008-8#2)(2009-12#1)(2011-1#2)(2013-7#1)
sterile anther##3##2##(2008-8#3)
sterile because##2##2##(2012-2#1)(2012-3#1)
sterile conditions##4##2##(1990-12#1)(2008-11#2)(2008-8#1)
sterile distilled water##2##3##(2008-10#1)(2008-5#1)
sterile fungus StFCh1-1##3##3##(2008-12#3)
sterile fungus##4##2##(2008-10#1)(2008-12#3)
sterile gauze in the##2##4##(2008-5#2)
sterile in##2##2##(2006-10#1)(2008-10#1)
sterile individuals##2##2##(1994-8#1)(2013-8#1)
sterile leaves##2##2##(2013-7#2)
sterile lemmas##2##2##(2007-3#1)(2008-5#1)
sterile males to##3##3##(2011-2#1)(2012-12#2)
sterile males##5##2##(2011-2#1)(2012-12#4)
sterile phenotype##2##2##(1994-12#1)(1996-10#1)
sterile plants##4##2##(1994-8#1)(2011-12#2)(2012-2#1)
sterile plastic bag##2##3##(2007-7#2)
sterile production##3##2##(2012-2#3)
sterile pustules on##3##3##(2010-6#1)(2013-1#2)
sterile sites##2##2##(2007-12#1)(2011-2#1)
sterile technique##8##2##(2008-11#1)(2008-2#2)(2008-4#2)(2008-9#1)(2009-5#2)
sterile tissue##2##2##(2008-11#1)(2008-4#1)
sterile water##5##2##(1992-2#1)(1996-12#2)(2007-10#2)
sterile##159##1##(1990-12#1)(1990-5#1)(1992-2#1)(1992-8#3)(1994-12#2)(1994-5#1)(1994-8#3)(1995-6#1)(1996-10#1)(1996-12#2)(1996-3#1)(1997-3#1)(2004-2#1)(2004-4#1)(2006-10#2)(2006-12#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#6)(2007-8#1)(2007-9#1)(2008-10#14)(2008-11#8)(2008-12#7)(2008-2#4)(2008-4#4)(2008-5#6)(2008-7#2)(2008-8#7)(2008-9#2)(2009-12#3)(2009-2#3)(2009-5#4)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#4)(2011-12#2)(2011-2#10)(2012-1#2)(2012-12#10)(2012-2#10)(2012-3#2)(2013-1#4)(2013-7#3)(2013-8#3)
sterilis in Israel##2##3##(2008-10#2)
sterilis##9##1##(2008-10#9)
sterilisation of##2##2##(2005-9#2)
sterilisation##12##1##(1995-7#1)(1996-8#1)(2004-10#4)(2005-9#3)(2006-6#1)(2007-7#1)(2008-7#1)
sterilised##2##1##(2008-10#1)(2010-4#1)
sterility and##7##2##(1993-8#1)(1995-8#1)(2006-11#1)(2007-7#1)(2008-10#1)(2012-12#1)(2012-3#1)
sterility in##4##2##(1994-8#1)(1996-5#1)(2011-12#1)(2012-11#1)
sterility is##2##2##(2013-8#2)
sterility mosaic disease##2##3##(2008-10#2)
sterility mosaic##4##2##(2008-10#4)
sterility of the final product##2##5##(2012-2#2)
sterility of the##4##3##(2008-11#1)(2012-2#3)
sterility of##6##2##(2008-11#1)(2008-9#1)(2011-2#1)(2012-2#3)
sterility testing##2##2##(2012-2#2)
sterility with##2##2##(2011-2#1)(2013-8#1)
sterility##60##1##(1990-2#1)(1991-10#1)(1993-8#1)(1994-12#3)(1994-8#2)(1995-8#3)(1996-5#2)(2006-11#1)(2007-7#1)(2008-10#5)(2008-11#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#6)(2009-12#1)(2010-3#1)(2011-12#1)(2011-2#7)(2012-11#1)(2012-12#1)(2012-2#8)(2012-3#1)(2013-8#5)
sterilization and##3##2##(1992-12#1)(2010-7#1)(2011-2#1)
sterilization at##2##2##(1991-4#1)(1995-1#1)
sterilization by##2##2##(2011-2#2)
sterilization can##2##2##(2006-6#1)(2011-2#1)
sterilization in##4##2##(1990-9#1)(1992-12#1)(2010-7#1)(2012-12#1)
sterilization of the##7##3##(2004-11#1)(2008-1#1)(2008-9#3)(2011-2#1)(2012-2#1)
sterilization of##17##2##(1990-2#1)(1992-12#1)(1996-8#1)(1997-2#1)(2004-11#1)(2007-2#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#3)(2009-5#1)(2011-2#1)(2012-2#1)
sterilization on##2##2##(2007-2#1)(2011-1#1)
sterilization procedure##3##2##(1991-3#1)(1995-1#1)(1996-8#1)
sterilization status##2##2##(2013-8#2)
sterilization using##2##2##(1992-12#1)(2009-11#1)
sterilization validation##2##2##(2007-4#2)
sterilization was##2##2##(1996-3#1)(2009-11#1)
sterilization were##2##2##(1995-1#1)(2005-11#1)
sterilization##87##1##(1990-2#1)(1990-9#1)(1991-11#1)(1991-3#5)(1991-4#2)(1991-6#1)(1992-12#7)(1993-1#1)(1993-3#2)(1994-3#1)(1995-1#6)(1995-9#1)(1996-3#4)(1996-8#2)(1997-2#1)(2004-11#1)(2005-11#1)(2005-12#2)(2006-4#3)(2006-6#3)(2007-1#1)(2007-2#2)(2007-4#3)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#5)(2008-5#2)(2008-9#3)(2009-11#3)(2009-5#1)(2009-7#1)(2010-1#1)(2010-7#2)(2011-1#1)(2011-2#6)(2012-11#1)(2012-12#1)(2012-2#2)(2013-8#2)
sterilizations##3##1##(2005-12#1)(2007-3#1)(2009-7#1)
sterilize##3##1##(2005-12#1)(2008-11#1)(2008-9#1)
sterilized and unsterilized##2##3##(2006-9#2)
sterilized##23##1##(1990-3#1)(1991-3#1)(1995-3#1)(2004-11#1)(2005-12#1)(2006-8#1)(2006-9#2)(2007-7#1)(2008-10#5)(2008-11#4)(2008-4#1)(2009-7#2)(2012-2#1)(2013-1#1)
sterilizes##2##1##(2008-11#1)(2008-9#1)
sterilizing and##2##2##(2010-12#1)(2010-7#1)
sterilizing pathogens##3##2##(2008-8#3)
sterilizing##10##1##(2007-2#1)(2008-11#1)(2008-7#1)(2008-8#3)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)
steriod##3##1##(1990-11#1)(1997-1#1)(2007-11#1)
steris##2##1##(2011-2#2)
sterling##10##1##(2004-2#1)(2005-8#4)(2005-9#2)(2006-12#3)
sternal and##2##2##(1993-12#1)(2007-8#1)
sternal cleft##3##2##(2007-8#3)
sternal compressions alone##2##3##(2006-10#2)
sternal epithelium##2##2##(2007-12#2)
sternal nonunion##5##2##(2012-2#5)
sternal notch##3##2##(2007-8#3)
sternal recumbency##2##2##(1994-7#2)
sternal wound dehiscence##3##3##(2007-8#3)
sternal wound infection after##5##4##(2007-8#4)(2013-1#1)
sternal wound infection##9##3##(2007-8#5)(2012-2#3)(2013-1#1)
sternal wound infections##4##3##(2007-8#4)
sternal wound##17##2##(2007-8#13)(2012-2#3)(2013-1#1)
sternal wounds##2##2##(2007-8#2)
sternal##62##1##(1993-12#2)(1994-2#1)(1994-7#2)(1995-11#1)(1997-8#2)(2006-10#2)(2006-11#1)(2007-12#4)(2007-8#31)(2008-1#1)(2008-4#1)(2011-12#1)(2012-2#11)(2013-1#1)(2013-8#1)
sternite##3##1##(2007-12#3)
sternites##4##1##(2007-12#4)
sternoclavicular joint##8##2##(2007-1#2)(2007-4#1)(2007-8#2)(2009-3#3)
sternoclavicular##12##1##(2007-1#2)(2007-4#1)(2007-8#2)(2009-3#5)(2009-6#1)(2012-2#1)
sternocleidomastoid muscle##3##2##(2006-8#1)(2007-1#1)(2007-11#1)
sternocleidomastoid##9##1##(2006-12#1)(2006-8#1)(2007-1#3)(2007-11#1)(2010-9#2)(2011-2#1)
sternotomy between##3##2##(2007-8#3)
sternotomy in##6##2##(2007-8#5)(2007-9#1)
sternotomy or##3##2##(2006-10#1)(2008-11#1)(2012-2#1)
sternotomy was##2##2##(2007-8#1)(2010-9#1)
sternotomy with##5##2##(2007-8#3)(2009-3#1)(2010-6#1)
sternotomy wound##2##2##(2007-8#2)
sternotomy##76##1##(1993-3#1)(2006-10#1)(2007-5#1)(2007-8#57)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
sternum and##4##2##(2007-1#1)(2007-4#1)(2007-8#2)
sternum is##2##2##(1995-6#1)(2007-8#1)
sternum was##3##2##(1995-6#1)(2007-8#2)
sternum##34##1##(1995-6#4)(1996-12#1)(2006-11#2)(2007-1#1)(2007-11#1)(2007-4#4)(2007-8#17)(2008-4#1)(2012-1#1)(2012-2#2)
sternums##2##1##(1995-6#1)(2008-4#1)
steroid - TSPO interactions##2##4##(2012-2#2)
steroid 21-hydroxylase##3##2##(1992-8#2)(2010-12#1)
steroid 5##6##2##(1990-11#3)(1994-11#1)(1995-9#1)(1996-4#1)
steroid 9alpha-hydroxylase##4##2##(2008-11#4)
steroid administration##9##2##(1991-6#1)(2006-8#2)(2007-8#4)(2008-7#1)(2009-3#1)
steroid and phenol sulfotransferase genes##3##5##(1995-8#3)
steroid and phenol sulfotransferase##5##4##(1995-8#5)
steroid and phenol sulfotransferases##2##4##(1995-8#2)
steroid and phenol##7##3##(1995-8#7)
steroid and##20##2##(1990-11#1)(1993-11#1)(1994-12#1)(1995-8#8)(1995-9#1)(1996-2#1)(2006-11#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-8#1)(2010-2#1)(2012-2#1)
steroid at##2##2##(1994-11#1)(2006-9#1)
steroid binding protein 1 (MSBP1) stimulates##2##6##(2009-10#2)
steroid binding protein##7##3##(1990-10#1)(1992-5#1)(1996-4#2)(2009-10#3)
steroid binding##15##2##(1990-10#1)(1990-12#1)(1991-12#3)(1992-12#1)(1992-5#1)(1996-4#2)(1996-5#2)(2006-10#1)(2009-10#3)
steroid biosynthesis##2##2##(1990-3#1)(2012-2#1)
steroid cells##2##2##(1996-5#2)
steroid concentration##3##2##(1991-7#2)(1997-1#1)
steroid consumption##2##2##(2009-3#2)
steroid dependence##2##2##(1994-5#1)(2008-1#1)
steroid dependency##2##2##(2006-10#2)
steroid dependent nephrotic syndrome##3##4##(2007-7#2)(2007-8#1)
steroid dependent##5##2##(2007-7#3)(2007-8#1)(2008-1#1)
steroid derivative##3##2##(1994-8#1)(2008-10#1)(2008-5#1)
steroid discontinuation##2##2##(2010-7#2)
steroid dosage##5##2##(2006-10#3)(2007-11#2)
steroid dose##2##2##(1994-7#1)(2008-1#1)
steroid drugs##3##2##(1996-5#1)(2008-10#2)
steroid feedback##2##2##(1994-11#1)(1996-2#1)
steroid for##2##2##(1991-9#1)(1994-9#1)
steroid group##2##2##(1995-8#2)
steroid hormone 1 alpha##3##4##(1992-12#1)(1994-5#2)
steroid hormone action##3##3##(1996-4#2)(2008-4#1)
steroid hormone biosynthesis##2##3##(1993-11#1)(1995-12#1)
steroid hormone metabolism##2##3##(1992-9#1)(2010-12#1)
steroid hormone milieu##2##3##(1996-4#2)
steroid hormone receptor##5##3##(1992-2#1)(1995-2#1)(1995-6#1)(2007-4#1)(2008-4#1)
steroid hormone receptors##2##3##(1992-5#1)(2008-4#1)
steroid hormone recognition##2##3##(1994-8#2)
steroid hormone##36##2##(1990-2#1)(1991-4#1)(1991-8#2)(1992-12#2)(1992-2#1)(1992-5#1)(1992-9#1)(1993-11#1)(1994-10#1)(1994-5#2)(1994-8#3)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#2)(1996-4#5)(1997-4#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-4#4)(2009-4#1)(2010-12#1)
steroid hormones act##2##3##(2010-8#2)
steroid hormones and##3##3##(1994-9#1)(2008-4#1)(2008-6#1)
steroid hormones appear to##2##4##(2006-9#2)
steroid hormones are##2##3##(1995-2#1)(2008-3#1)
steroid hormones in##4##3##(1990-9#1)(2010-10#1)(2011-1#2)
steroid hormones on the##3##4##(1990-9#1)(1995-10#1)(2012-3#1)
steroid hormones on##4##3##(1990-9#1)(1994-9#1)(1995-10#1)(2012-3#1)
steroid hormones##42##2##(1990-11#1)(1990-9#2)(1991-11#1)(1992-11#1)(1992-7#1)(1993-2#1)(1994-6#1)(1994-9#4)(1995-10#1)(1995-2#1)(1996-4#1)(1997-5#1)(2005-8#1)(2006-10#1)(2006-9#8)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2009-4#1)(2010-10#1)(2010-3#1)(2010-8#4)(2011-1#2)(2012-3#1)
steroid hydroxylases##2##2##(1994-3#1)(1995-11#1)
steroid in##4##2##(1990-11#1)(1993-11#1)(2007-7#1)(2008-10#1)
steroid induced##2##2##(2007-7#1)(2009-3#1)
steroid injection##9##2##(1991-3#1)(2006-7#2)(2006-8#1)(2007-11#1)(2010-12#2)(2010-3#1)(2012-2#1)
steroid injections and##3##3##(2006-8#2)(2011-12#1)
steroid injections are##2##3##(1995-4#1)(2006-7#1)
steroid injections##23##2##(1995-4#1)(2006-12#1)(2006-7#5)(2006-8#10)(2007-11#1)(2007-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-12#1)
steroid levels##2##2##(2006-6#1)(2012-2#1)
steroid molecules##2##2##(1990-2#1)(1991-8#1)
steroid nucleus##5##2##(1994-8#1)(1996-5#1)(2006-12#1)(2008-11#2)
steroid preparations##2##2##(2005-8#1)(2006-10#1)
steroid production##5##2##(1995-12#1)(1996-8#1)(2010-8#1)(2012-2#1)(2013-1#1)
steroid receptor complexes##3##3##(1990-5#1)(1992-11#2)
steroid receptor superfamily##3##3##(1993-9#1)(1997-1#1)(2009-4#1)
steroid receptor##14##2##(1990-5#1)(1991-12#1)(1992-11#2)(1993-2#1)(1993-9#1)(1994-6#2)(1996-5#1)(1997-1#1)(2008-4#1)(2009-4#1)(2010-3#1)(2011-2#1)
steroid receptors and##3##3##(1992-11#1)(1993-8#1)(1997-4#1)
steroid receptors in##2##3##(2006-5#1)(2008-4#1)
steroid receptors##15##2##(1990-5#1)(1991-12#1)(1992-11#1)(1992-9#1)(1993-8#2)(1995-5#1)(1996-5#1)(1997-4#1)(2006-5#1)(2008-4#2)(2008-7#1)(2010-12#1)(2012-12#1)
steroid resistance##2##2##(2005-8#1)(2007-7#1)
steroid resistant nephrotic syndrome##2##4##(2007-7#1)(2007-8#1)
steroid resistant##7##2##(2007-7#5)(2007-8#2)
steroid responsive##3##2##(2006-10#2)(2007-7#1)
steroid saponins from##2##3##(2013-7#2)
steroid saponins##4##2##(2013-7#4)
steroid secretion and##3##3##(1995-12#1)(2008-12#1)(2010-8#1)
steroid secretion by##2##3##(2008-12#2)
steroid secretion##6##2##(1995-12#1)(2006-5#1)(2008-12#3)(2010-8#1)
steroid side##2##2##(2007-7#2)
steroid spray##2##2##(2008-7#1)(2013-8#1)
steroid structure##2##2##(1996-2#1)(2008-10#1)
steroid substrates##3##2##(1990-11#2)(1990-9#1)
steroid sulfatase##4##2##(1996-4#1)(2009-2#2)(2013-8#1)
steroid sulfate levels were##2##4##(1992-8#2)
steroid synthesis##3##2##(2008-4#1)(2008-5#1)(2011-2#1)
steroid therapy and##2##3##(2008-3#1)(2011-2#1)
steroid therapy in##2##3##(2006-10#1)(2013-1#1)
steroid therapy##36##2##(1990-11#1)(1991-6#1)(1994-6#1)(2004-10#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-2#1)(2007-7#5)(2008-1#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-2#1)(2010-7#1)(2011-2#3)(2012-1#2)(2012-12#1)(2013-1#4)
steroid to##4##2##(1990-11#1)(1993-11#1)(1997-5#1)(2006-12#1)
steroid treatment##10##2##(1992-12#1)(1994-6#1)(1996-11#1)(1996-2#1)(1996-5#1)(2006-10#1)(2006-8#1)(2008-4#2)(2013-8#1)
steroid use##5##2##(2005-11#1)(2006-9#1)(2009-3#2)(2009-4#1)
steroid was##4##2##(1990-11#1)(2008-10#1)(2008-5#1)(2012-2#1)
steroid withdrawal##5##2##(2006-5#1)(2007-11#1)(2007-5#1)(2007-8#1)(2011-2#1)
steroid##495##1##(1990-10#4)(1990-11#16)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#2)(1990-9#4)(1991-11#1)(1991-12#5)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#2)(1991-8#4)(1991-9#1)(1992-11#4)(1992-12#5)(1992-2#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#4)(1992-9#2)(1993-1#1)(1993-11#6)(1993-2#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-3#3)(1994-5#7)(1994-6#8)(1994-7#1)(1994-8#6)(1994-9#6)(1995-10#1)(1995-11#1)(1995-12#6)(1995-2#2)(1995-4#4)(1995-5#1)(1995-6#1)(1995-8#12)(1995-9#2)(1996-11#4)(1996-2#6)(1996-3#1)(1996-4#12)(1996-5#11)(1996-6#1)(1996-8#1)(1997-1#4)(1997-3#1)(1997-4#2)(1997-5#5)(1997-7#1)(2004-10#1)(2005-11#2)(2005-7#1)(2005-8#6)(2006-10#15)(2006-11#1)(2006-12#7)(2006-4#2)(2006-5#3)(2006-6#1)(2006-7#8)(2006-8#21)(2006-9#12)(2007-1#2)(2007-11#11)(2007-12#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#27)(2007-8#11)(2008-1#7)(2008-10#10)(2008-11#11)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#19)(2008-5#8)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#1)(2009-10#3)(2009-2#2)(2009-3#6)(2009-4#4)(2009-8#1)(2010-10#3)(2010-12#7)(2010-2#2)(2010-3#3)(2010-6#1)(2010-7#4)(2010-8#6)(2011-1#4)(2011-12#1)(2011-2#6)(2012-1#3)(2012-12#3)(2012-2#10)(2012-3#2)(2013-1#5)(2013-7#4)(2013-8#3)
steroid-binding domain##3##2##(1990-11#3)
steroid-binding##10##1##(1990-11#4)(1994-8#2)(1995-7#1)(1996-7#1)(2008-4#2)
steroid-dependent##9##1##(2006-10#2)(2007-9#1)(2008-4#1)(2010-12#3)(2012-2#2)
steroid-free immunosuppression##2##2##(2007-8#2)
steroid-free remission##2##2##(1991-6#1)(2006-2#1)
steroid-free##6##1##(1991-6#1)(2006-2#1)(2007-8#2)(2008-1#1)(2008-10#1)
steroid-induced##5##1##(1990-12#1)(2004-3#1)(2007-2#1)(2008-7#2)
steroid-producing cells##5##2##(2005-8#5)
steroid-receptor##4##1##(1994-6#1)(1994-8#1)(2006-10#2)
steroid-resistant FSGS##3##2##(2007-8#3)
steroid-resistant rejection##2##2##(2007-11#1)(2008-1#1)
steroid-resistant##13##1##(2005-8#2)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#6)(2008-1#1)(2008-4#1)
steroid-responsive##2##1##(2007-7#2)
steroid-responsiveness in COPD##2##3##(2006-9#2)
steroid-responsiveness in##3##2##(2006-9#3)
steroid-sensitive##3##1##(1993-12#1)(2006-10#1)(2007-11#1)
steroid-sparing agents##2##2##(2007-11#2)
steroid-sparing##6##1##(2005-8#1)(2007-11#2)(2008-3#1)(2010-12#1)(2012-3#1)
steroid-triggered switch in E74 transcription factor isoforms##2##7##(1997-4#2)
steroidal alkaloids##2##2##(2007-1#1)(2009-11#1)
steroidal and##2##2##(1991-8#1)(2006-4#1)
steroidal anti-inflammatory drug##3##3##(1997-1#1)(2007-9#1)(2012-12#1)
steroidal anti-inflammatory##4##2##(1997-1#1)(2007-9#1)(2010-4#1)(2012-12#1)
steroidal contraception##2##2##(1990-12#1)(2006-10#1)
steroidal glycosides##5##2##(2007-8#5)
steroidal saponin##3##2##(1992-8#1)(2007-1#1)(2008-10#1)
steroidal saponins##7##2##(2007-1#4)(2008-11#3)
steroidal##45##1##(1990-11#1)(1990-12#1)(1990-9#1)(1991-10#4)(1991-12#1)(1991-8#1)(1992-8#1)(1994-9#1)(1995-2#1)(1996-5#1)(1997-1#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-1#6)(2007-11#3)(2007-5#1)(2007-8#6)(2007-9#1)(2008-10#2)(2008-11#3)(2008-9#1)(2009-11#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
steroidogenesis and##2##2##(1991-3#1)(2012-2#1)
steroidogenesis in adrenal cortex##2##4##(1991-5#1)(1996-2#1)
steroidogenesis in rat adrenal##2##4##(1996-2#2)
steroidogenesis in rat##3##3##(1990-2#1)(1996-2#2)
steroidogenesis in the##3##3##(1990-10#1)(1990-3#1)(1996-8#1)
steroidogenesis in##8##2##(1990-10#1)(1990-2#1)(1990-3#1)(1991-5#1)(1996-2#3)(1996-8#1)
steroidogenesis##41##1##(1990-10#2)(1990-11#1)(1990-2#6)(1990-3#1)(1991-10#3)(1991-3#2)(1991-5#1)(1991-7#2)(1991-9#1)(1992-3#1)(1994-3#1)(1995-12#2)(1996-11#2)(1996-2#3)(1996-8#2)(2010-3#1)(2011-2#1)(2012-2#8)(2013-1#1)
steroidogenic P-450##2##2##(1991-10#1)(1995-3#1)
steroidogenic action##3##2##(1990-10#2)(1991-3#1)
steroidogenic acute regulatory protein (StAR) gene##2##6##(2006-9#1)(2008-4#1)
steroidogenic acute regulatory protein##4##4##(1995-12#1)(2006-9#2)(2008-4#1)
steroidogenic acute regulatory##5##3##(1995-12#2)(2006-9#2)(2008-4#1)
steroidogenic cytochromes P450##2##3##(1993-11#2)
steroidogenic enzyme##2##2##(1995-10#1)(2008-7#1)
steroidogenic enzymes##5##2##(1990-11#1)(1995-10#1)(1996-11#1)(2010-10#2)
steroidogenic factor-1 (SF-1)##2##3##(1996-8#1)(2008-4#1)
steroidogenic tissues##5##2##(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(2012-2#1)
steroidogenic##32##1##(1990-10#2)(1990-11#1)(1991-10#1)(1991-3#1)(1993-11#2)(1994-2#1)(1995-10#4)(1995-11#3)(1995-12#3)(1995-2#1)(1995-3#3)(1996-11#1)(1996-8#1)(2006-9#2)(2008-4#2)(2008-7#1)(2010-10#2)(2012-2#1)
steroids also##2##2##(1991-6#2)
steroids and a##2##3##(1991-12#1)(1995-10#1)
steroids and cytotoxic##2##3##(2007-7#1)(2008-1#1)
steroids and dapsone##2##3##(2007-7#1)(2007-8#1)
steroids and immunosuppressive##4##3##(2009-6#1)(2010-12#1)(2013-1#2)
steroids and non-steroidal##2##3##(1995-12#1)(2009-5#1)
steroids and other hormones##2##4##(1990-11#1)(1997-2#1)
steroids and other##4##3##(1990-11#1)(1991-3#1)(1997-2#1)(2007-7#1)
steroids and tamoxifen##2##3##(2011-2#2)
steroids and the##2##3##(2007-7#1)(2012-2#1)
steroids and##41##2##(1990-11#1)(1991-12#1)(1991-3#1)(1991-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-6#1)(1997-2#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-7#5)(2007-8#3)(2008-1#1)(2008-5#2)(2008-6#1)(2009-5#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#2)(2013-8#1)
steroids are also##2##3##(2010-6#1)(2012-2#1)
steroids are##17##2##(1991-10#1)(1993-4#1)(2006-1#1)(2006-10#1)(2006-12#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-11#2)(2010-6#1)(2012-2#1)
steroids as well as##2##4##(2006-10#1)(2008-3#1)
steroids as##7##2##(2005-8#1)(2006-10#2)(2007-11#1)(2007-9#1)(2008-11#1)(2008-3#1)
steroids at the##2##3##(1995-10#1)(2008-7#1)
steroids at##4##2##(1995-10#1)(2008-7#1)(2011-1#2)
steroids for##6##2##(1991-4#1)(2005-8#1)(2006-9#2)(2010-12#1)(2010-2#1)
steroids has##2##2##(1994-11#1)(1996-11#1)
steroids have been##4##3##(1991-11#1)(1991-6#1)(2006-8#1)(2007-11#1)
steroids have not##2##3##(2006-12#1)(2006-9#1)
steroids have##10##2##(1991-11#1)(1991-6#1)(2006-12#1)(2006-8#3)(2006-9#2)(2007-11#1)(2008-4#1)
steroids having##3##2##(1990-8#1)(1997-1#2)
steroids in a##2##3##(2007-8#1)(2013-7#1)
steroids in the##5##3##(1994-5#1)(1996-3#1)(2006-8#1)(2008-4#1)(2009-5#1)
steroids in##28##2##(1992-1#1)(1994-11#1)(1994-5#2)(1994-9#1)(1995-12#2)(1996-3#1)(1997-1#1)(1997-8#2)(2006-10#1)(2006-8#3)(2006-9#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-4#2)(2009-5#1)(2010-11#1)(2011-1#1)(2012-3#1)(2013-7#1)
steroids is##6##2##(1993-11#1)(1995-2#1)(2006-8#1)(2007-2#1)(2007-8#1)(2009-5#1)
steroids may##4##2##(1992-1#1)(1995-12#1)(2007-2#1)(2007-8#1)
steroids on##6##2##(1993-5#1)(1995-12#1)(1997-6#1)(2006-8#1)(2008-7#1)(2012-2#1)
steroids or other##2##3##(2006-8#1)(2010-4#1)
steroids or##6##2##(1993-5#1)(2005-8#1)(2006-8#1)(2007-8#1)(2010-4#1)(2011-2#1)
steroids should##2##2##(1997-8#1)(2008-4#1)
steroids such as##3##3##(1991-12#1)(1994-11#1)(2009-3#1)
steroids tested##4##2##(1990-11#2)(1994-9#1)(1996-2#1)
steroids that##2##2##(2008-10#1)(2010-8#1)
steroids to##8##2##(1990-11#1)(1996-4#1)(1997-1#2)(2007-8#1)(2009-5#1)(2009-6#1)(2012-2#1)
steroids was##3##2##(1996-5#1)(1997-8#1)(2006-1#1)
steroids were found in##2##4##(1990-11#2)
steroids were found##3##3##(1990-11#2)(1991-5#1)
steroids were##9##2##(1990-11#3)(1991-5#1)(1994-8#1)(2008-10#2)(2008-11#1)(2013-8#1)
steroids with##6##2##(1990-11#2)(1997-1#1)(2006-8#1)(2007-11#1)(2008-5#1)
steroids##338##1##(1990-11#16)(1990-2#4)(1990-5#1)(1990-8#1)(1991-10#1)(1991-11#3)(1991-12#2)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#4)(1991-7#1)(1991-8#1)(1992-1#3)(1992-3#2)(1992-5#4)(1992-6#1)(1992-9#1)(1993-11#3)(1993-4#1)(1993-5#3)(1994-11#6)(1994-2#1)(1994-5#5)(1994-7#1)(1994-8#2)(1994-9#5)(1995-10#3)(1995-12#9)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#3)(1997-1#6)(1997-2#2)(1997-6#2)(1997-8#4)(2004-10#1)(2005-3#1)(2005-7#2)(2005-8#6)(2006-1#2)(2006-10#19)(2006-12#5)(2006-4#1)(2006-6#2)(2006-7#2)(2006-8#19)(2006-9#7)(2007-10#1)(2007-11#9)(2007-12#1)(2007-2#5)(2007-3#1)(2007-7#8)(2007-8#14)(2007-9#1)(2008-1#3)(2008-10#7)(2008-11#8)(2008-12#1)(2008-3#1)(2008-4#9)(2008-5#8)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#2)(2009-3#2)(2009-5#4)(2009-6#2)(2009-7#1)(2010-11#7)(2010-12#6)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#7)(2011-2#5)(2012-2#7)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#3)
steroids]##2##1##(1991-3#1)(2013-7#1)
sterol 27-hydroxylase##2##2##(1994-8#2)
sterol and##3##2##(2008-10#1)(2008-6#1)(2009-3#1)
sterol biosynthesis in##3##3##(1991-5#1)(1996-5#1)(2008-5#1)
sterol biosynthesis##7##2##(1991-5#1)(1992-7#1)(1995-4#1)(1996-5#1)(1997-1#1)(2006-12#1)(2008-5#1)
sterol biosynthetic##2##2##(2006-12#2)
sterol carrier protein 2)##2##4##(1990-4#1)(1994-12#1)
sterol carrier protein##3##3##(1990-4#1)(1994-12#1)(1997-7#1)
sterol delta 14-reductase##3##3##(1991-5#3)
sterol demethylation inhibitors (DMIs)##2##4##(2008-10#2)
sterol demethylation##4##2##(1992-11#1)(2008-10#3)
sterol dimers##2##2##(2010-6#2)
sterol ester##2##2##(1996-5#2)
sterol in##2##2##(1991-2#1)(2006-12#1)
sterol levels by##2##3##(2006-12#2)
sterol levels##5##2##(1992-6#1)(1997-1#2)(2006-12#2)
sterol metabolism##3##2##(1996-12#2)(2009-4#1)
sterol of##3##2##(1997-2#2)(2006-12#1)
sterol side##2##2##(1990-11#1)(2007-11#1)
sterol synthesis in##2##3##(1990-7#2)
sterol synthesis##5##2##(1990-7#2)(1992-3#1)(1993-6#1)(1994-5#1)
sterol to##2##2##(1990-3#1)(1997-7#1)
sterol##88##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#2)(1991-10#2)(1991-2#1)(1991-5#4)(1992-1#1)(1992-11#1)(1992-3#4)(1992-6#2)(1992-7#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-10#1)(1995-4#2)(1996-12#2)(1996-5#7)(1996-8#1)(1997-1#5)(1997-2#2)(1997-7#3)(2006-12#8)(2006-2#1)(2007-11#4)(2007-8#1)(2008-10#10)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-6#2)(2011-2#1)(2012-2#1)
sterolicum##4##1##(1990-10#3)(1990-12#1)
sterols and##5##2##(1997-1#1)(2008-6#1)(2009-4#2)(2009-7#1)
sterols by##2##2##(1995-4#1)(2009-4#1)
sterols from the##2##3##(2007-1#1)(2008-10#1)
sterols having##2##2##(1992-3#2)
sterols in the##2##3##(1997-2#1)(2008-10#1)
sterols in##7##2##(1990-2#1)(1992-11#1)(1997-2#1)(2008-10#2)(2009-4#2)
sterols of##2##2##(2006-10#1)(2008-12#1)
sterols was##2##2##(1996-5#1)(1997-1#1)
sterols were##2##2##(1992-6#1)(2009-4#1)
sterols##63##1##(1990-11#2)(1990-2#3)(1992-11#2)(1992-3#2)(1992-6#2)(1992-7#2)(1994-11#2)(1994-2#1)(1994-3#1)(1995-4#1)(1996-5#2)(1997-1#3)(1997-2#4)(2006-10#6)(2007-1#1)(2007-5#2)(2007-8#2)(2008-10#6)(2008-12#2)(2008-5#2)(2008-6#1)(2009-4#7)(2009-7#5)(2010-2#1)(2012-11#1)
sterols)##3##1##(1997-1#1)(2006-12#1)(2007-8#1)
stethoscope##10##1##(1993-12#1)(1996-12#2)(2008-10#1)(2009-6#1)(2010-2#3)(2010-8#1)(2012-3#1)
stethoscopes##8##1##(1996-12#4)(2009-6#4)
stevia extracts##2##2##(2013-1#2)
stevia##7##1##(2008-10#2)(2010-2#1)(2013-1#4)
steviol glycosides##3##2##(2013-1#1)(2013-7#2)
steviol##4##1##(2013-1#2)(2013-7#2)
stevioside##2##1##(2007-5#2)
stewardship and##3##2##(2009-8#2)(2011-2#1)
stewardship in##8##2##(2009-5#1)(2012-2#3)(2013-1#4)
stewardship programs (ASPs)##3##3##(2013-1#3)
stewardship programs##6##2##(2013-1#6)
stewardship##38##1##(2007-12#2)(2007-9#1)(2009-10#1)(2009-5#1)(2009-8#2)(2010-8#2)(2011-2#3)(2012-2#7)(2013-1#19)
stewartii ranged from 0##3##4##(2008-10#3)
stewartii##6##1##(2008-10#6)
stewartii-infested corn flea beetles##2##4##(2008-10#2)
stewartii-infested corn flea##3##3##(2008-10#3)
stewartii-infested##5##1##(2008-10#5)
stewed##2##1##(2008-10#1)(2008-6#1)
stibine generation##2##2##(2008-10#2)
stibine##4##1##(2008-10#4)
stick injuries##4##2##(2007-7#2)(2009-3#1)(2012-12#1)
stick insect Carausius morosus##2##4##(1992-12#1)(2007-12#1)
stick insect##6##2##(1992-12#2)(2007-12#4)
stick to##2##2##(1996-3#1)(2008-10#1)
stick##34##1##(1990-8#1)(1992-12#2)(1995-8#1)(1996-3#1)(1997-7#1)(2006-10#1)(2007-10#3)(2007-12#4)(2007-2#2)(2007-7#3)(2007-8#1)(2008-10#2)(2008-5#3)(2009-11#1)(2009-2#3)(2009-3#1)(2010-8#2)(2012-12#2)
stick-slip motion##4##2##(1993-2#3)(1994-5#1)
stick-slip##7##1##(1993-2#5)(1994-5#1)(1996-4#1)
stickers##2##1##(1991-10#1)(1996-2#1)
sticking to##2##2##(2008-10#1)(2012-12#1)
sticking##13##1##(1995-2#1)(1995-9#1)(2004-12#1)(2005-11#1)(2007-7#2)(2008-10#1)(2009-11#1)(2009-7#1)(2011-1#2)(2012-12#1)(2013-8#1)
stickleback Gasterosteus aculeatus##19##3##(2010-8#19)
stickleback Gasterosteus##20##2##(2010-8#20)
stickleback##21##1##(2010-8#21)
sticklebacks Gasterosteus aculeatus##11##3##(2010-8#11)
sticklebacks##15##1##(2008-9#1)(2010-8#14)
sticks##11##1##(1994-12#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-2#3)
sticky platelet syndrome##2##3##(1997-6#2)
sticky platelet##4##2##(1997-6#3)(2010-3#1)
sticky traps than on##2##4##(2011-12#2)
sticky traps##8##2##(2011-12#6)(2011-2#1)(2012-12#1)
sticky##24##1##(1997-6#3)(2005-10#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-12#7)(2011-2#1)(2012-12#1)(2013-8#2)
sticky&quot##2##1##(2008-4#1)(2008-9#1)
stiff and##4##2##(2007-11#1)(2007-4#1)(2009-8#1)(2012-1#1)
stiff backing##2##2##(2008-5#2)
stiff padding##3##2##(2007-4#3)
stiff##33##1##(1991-7#1)(1992-9#1)(1993-9#1)(1997-5#1)(2005-11#1)(2006-11#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#6)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-4#2)(2012-1#2)(2013-1#1)
stiff-man syndrome##6##2##(1990-5#5)(1996-8#1)
stiffened##2##1##(1991-7#1)(2007-7#1)
stiffening effect##2##2##(2007-1#2)
stiffening of##2##2##(2007-11#1)(2012-2#1)
stiffening##9##1##(2007-1#2)(2007-11#1)(2007-4#1)(2008-7#1)(2009-5#1)(2012-12#1)(2012-2#2)
stiffer and less##2##3##(2008-5#1)(2010-4#1)
stiffer in##2##2##(2007-1#1)(2008-8#1)
stiffer than##4##2##(1991-4#1)(1993-3#1)(2006-11#1)(2009-6#1)
stiffer tissue##2##2##(2009-8#1)(2010-8#1)
stiffer##16##1##(1991-4#1)(1993-3#1)(1995-2#1)(2006-11#2)(2007-1#1)(2008-5#2)(2008-8#2)(2009-6#1)(2009-8#1)(2010-4#1)(2010-8#1)(2012-11#2)
stiffness after total knee replacement##2##5##(2008-8#2)
stiffness after##5##2##(2006-3#1)(2008-8#3)(2011-2#1)
stiffness and limited motion##4##4##(2008-6#1)(2012-2#3)
stiffness and ultimate failure##2##4##(2007-4#2)
stiffness and##26##2##(2006-11#1)(2006-3#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-4#3)(2008-11#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-1#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-7#1)(2012-2#4)
stiffness as##2##2##(2008-9#1)(2009-7#1)
stiffness at 10 MPa##2##4##(1991-10#2)
stiffness at##3##2##(1991-10#3)
stiffness by##3##2##(2009-12#1)(2012-1#2)
stiffness coefficient##4##2##(2013-1#4)
stiffness coefficients##3##2##(1992-7#1)(2013-1#2)
stiffness for##3##2##(1995-7#1)(2006-10#1)(2006-11#1)
stiffness in a##2##3##(2011-2#1)(2012-1#1)
stiffness in adult##2##3##(2008-4#1)(2013-8#1)
stiffness in the##2##3##(2009-6#1)(2010-5#1)
stiffness in##11##2##(1994-6#1)(2007-9#1)(2008-4#1)(2008-8#1)(2009-6#1)(2009-7#1)(2010-5#1)(2011-2#1)(2012-1#2)(2013-8#1)
stiffness is##6##2##(2006-11#1)(2008-9#1)(2012-1#3)(2013-7#1)
stiffness of alveolar##2##3##(2011-2#2)
stiffness of the polymer##2##4##(2007-12#1)(2009-10#1)
stiffness of the##17##3##(1991-7#1)(1996-11#1)(2005-10#1)(2006-11#1)(2007-1#3)(2007-12#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-10#1)(2009-7#1)(2011-2#1)(2012-1#3)
stiffness of##31##2##(1991-10#1)(1991-7#1)(1996-11#1)(1997-5#1)(2005-10#1)(2006-10#3)(2006-11#1)(2007-1#3)(2007-12#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-4#1)(2011-2#4)(2012-1#4)(2013-7#1)
stiffness on gait selection of dynamic bipedal walking with flat feet##2##11##(2012-1#2)
stiffness on##3##2##(2009-6#1)(2012-1#2)
stiffness or##2##2##(2008-9#1)(2013-8#1)
stiffness parameter##2##2##(2007-4#2)
stiffness was##3##2##(1997-4#1)(2007-1#1)(2007-9#1)
stiffness##206##1##(1991-10#4)(1991-7#1)(1992-5#1)(1992-7#1)(1994-4#1)(1994-6#1)(1995-7#1)(1996-11#4)(1996-5#1)(1997-3#1)(1997-4#1)(1997-5#1)(2005-10#1)(2006-10#11)(2006-11#14)(2006-3#2)(2006-6#1)(2006-7#1)(2007-1#6)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#8)(2007-7#2)(2007-8#2)(2007-9#5)(2008-1#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#8)(2008-6#7)(2008-7#1)(2008-8#7)(2008-9#9)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#3)(2009-4#1)(2009-6#6)(2009-7#9)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#10)(2012-1#25)(2012-2#7)(2012-3#2)(2013-1#7)(2013-3#2)(2013-7#6)(2013-8#2)
stiffness)##2##1##(1992-3#1)(2008-6#1)
stiffnesses##4##1##(2012-1#4)
stifle##13##1##(1996-1#1)(2005-7#9)(2012-3#3)
stigma and discrimination in Nigeria##2##5##(2010-8#2)
stigma and discrimination##12##3##(2006-2#1)(2007-7#3)(2010-4#1)(2010-8#3)(2011-1#1)(2012-12#2)(2013-1#1)
stigma and how to##2##4##(2008-12#1)(2013-1#1)
stigma and##26##2##(2006-2#1)(2006-9#1)(2007-7#4)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2009-12#2)(2010-2#1)(2010-4#1)(2010-8#4)(2011-1#2)(2012-12#2)(2012-2#1)(2013-1#2)
stigma associated with##3##3##(2007-2#1)(2007-7#1)(2012-12#1)
stigma attached to##2##3##(2012-3#1)(2013-7#1)
stigma in Chinese immigrants##2##4##(2012-1#2)
stigma in rural##4##3##(2009-5#1)(2013-1#3)
stigma in the##2##3##(2007-7#1)(2013-1#1)
stigma in##12##2##(2007-1#1)(2007-7#2)(2008-10#1)(2009-5#1)(2011-1#1)(2012-1#2)(2013-1#4)
stigma instrument##3##2##(2012-1#3)
stigma is##6##2##(2007-7#1)(2008-10#1)(2009-12#1)(2011-1#1)(2012-1#2)
stigma items##2##2##(2012-1#2)
stigma on##3##2##(2006-9#1)(2007-7#1)(2011-1#1)
stigma scores##2##2##(2012-1#2)
stigma surrounding##3##2##(2011-2#1)(2012-2#2)
stigma was##3##2##(2008-10#1)(2011-1#1)(2013-1#1)
stigma##125##1##(1990-6#1)(1992-8#1)(1996-5#1)(2006-2#1)(2006-9#6)(2007-1#1)(2007-12#1)(2007-2#1)(2007-7#21)(2007-9#1)(2008-1#2)(2008-10#9)(2008-12#1)(2008-4#2)(2008-6#2)(2008-7#2)(2009-11#1)(2009-12#5)(2009-5#6)(2009-7#3)(2010-2#1)(2010-4#1)(2010-8#8)(2011-1#11)(2011-10#1)(2011-2#1)(2011-7#1)(2012-1#14)(2012-12#5)(2012-2#3)(2012-3#3)(2013-1#7)(2013-7#1)
stigma?##6##1##(2006-9#2)(2007-7#4)
stigmas and##2##2##(2008-10#2)
stigmas of detached crab apple blossoms##2##6##(2008-10#2)
stigmas##14##1##(2004-9#1)(2005-10#1)(2008-10#11)(2012-2#1)
stigmasterol and beta-sitosterol##2##3##(2008-12#2)
stigmasterol and##3##2##(1990-2#1)(2008-12#2)
stigmasterol to##2##2##(1990-2#1)(2006-10#1)
stigmasterol##13##1##(1990-2#2)(2006-10#6)(2007-1#1)(2007-11#1)(2008-11#1)(2008-12#2)
stigmata and##2##2##(1991-2#1)(2007-12#1)
stigmata of bleeding##3##3##(2007-8#3)
stigmata of##9##2##(1991-4#1)(1993-2#1)(1994-11#1)(2007-8#3)(2008-3#1)(2010-6#1)(2012-12#1)
stigmata were inoculated##2##3##(2008-10#2)
stigmata##18##1##(1991-12#1)(1991-2#1)(1991-4#1)(1993-2#1)(1994-11#1)(2007-12#1)(2007-8#3)(2008-10#5)(2008-3#1)(2009-2#1)(2010-6#1)(2012-12#1)
stigmatic##9##1##(1994-6#1)(2008-10#2)(2008-2#2)(2008-3#2)(2009-12#1)(2013-1#1)
stigmatisation as##2##2##(2007-3#1)(2010-12#1)
stigmatisation##3##1##(2007-3#1)(2010-12#1)(2012-12#1)
stigmatization of##6##2##(2004-9#1)(2008-11#1)(2008-9#2)(2011-2#2)
stigmatization##15##1##(1993-9#1)(1997-6#1)(2004-9#1)(2006-9#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-9#3)(2011-2#2)(2012-12#3)
stigmatize##2##1##(2004-9#1)(2008-9#1)
stigmatized##9##1##(2005-9#1)(2006-9#1)(2008-9#2)(2009-7#1)(2010-7#1)(2011-1#1)(2012-2#2)
stigmatizing experiences##2##2##(2007-12#2)
stigmatizing of##2##2##(2008-11#2)
stigmatizing##8##1##(1996-5#1)(2007-12#2)(2008-11#2)(2008-9#1)(2010-4#1)(2012-3#1)
stigonocarpa##3##1##(2008-5#3)
stilbene derivative##2##2##(1992-12#1)(2007-1#1)
stilbene derivatives##2##2##(1993-3#1)(2008-1#1)
stilbene oxidase##2##2##(2008-10#2)
stilbene trans-resveratrol##2##2##(1995-3#1)(2008-10#1)
stilbene##21##1##(1992-12#2)(1993-3#1)(1995-3#1)(1997-1#2)(1997-7#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-8#4)(2012-12#1)
stilbenes##7##1##(2007-11#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-3#1)(2012-2#1)
stilbenoid##2##1##(2007-1#1)(2007-12#1)
still a challenge##5##3##(2005-11#1)(2007-11#1)(2008-6#1)(2012-3#1)(2013-7#1)
still a concern##3##3##(1991-12#1)(2006-10#1)(2009-8#1)
still a large##4##3##(1991-12#1)(1991-3#1)(2011-1#1)(2011-2#1)
still a major cause of mortality and morbidity##2##8##(2006-8#1)(2012-1#1)
still a major cause of##3##5##(2006-10#1)(2006-8#1)(2012-1#1)
still a major##6##3##(1993-6#1)(2006-10#1)(2006-8#1)(2008-9#1)(2009-2#1)(2012-1#1)
still a matter of controversy##5##5##(1994-6#1)(1997-3#1)(2006-10#2)(2006-9#1)
still a matter of debate##4##5##(1990-8#1)(2008-1#2)(2008-5#1)
still a matter of##13##4##(1990-8#1)(1994-6#1)(1994-8#1)(1997-3#1)(1997-6#1)(2006-10#2)(2006-9#1)(2008-1#3)(2008-5#1)(2011-1#1)
still a matter##16##3##(1990-8#1)(1994-6#1)(1994-8#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-10#3)(2006-9#1)(2007-7#1)(2008-1#3)(2008-5#1)(2011-1#1)
still a problem in##2##4##(2010-11#1)(2012-2#1)
still a problem##3##3##(2006-10#1)(2010-11#1)(2012-2#1)
still a relatively new##2##4##(2006-12#1)(2010-10#1)
still a##112##2##(1990-10#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-12#2)(1991-2#1)(1991-3#1)(1992-8#1)(1993-6#1)(1994-6#3)(1994-8#1)(1995-11#1)(1995-5#1)(1996-11#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#10)(2006-12#2)(2006-2#2)(2006-6#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#3)(2007-2#1)(2007-5#1)(2007-7#2)(2008-1#4)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#2)(2008-9#1)(2009-2#1)(2009-5#3)(2009-6#1)(2009-8#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-6#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#2)(2013-7#2)(2013-8#1)
still able to bind##2##4##(1990-7#1)(2006-12#1)
still able to##12##3##(1990-2#1)(1990-7#1)(1993-8#1)(1994-11#1)(1995-1#1)(1996-5#1)(2006-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#1)
still account for##2##3##(2006-10#1)(2008-7#1)
still achieve##2##2##(2007-8#1)(2008-3#1)
still active##5##2##(1990-11#1)(1991-2#1)(1991-6#1)(2006-4#1)(2011-2#1)
still alive after##3##3##(2006-7#1)(2007-2#1)(2008-7#1)
still alive in##2##3##(1992-9#1)(1997-2#1)
still alive##24##2##(1990-6#1)(1990-9#1)(1991-4#1)(1992-10#1)(1992-6#1)(1992-9#2)(1993-3#1)(1993-7#1)(1995-2#1)(1996-11#1)(1997-2#1)(1997-4#1)(1997-5#1)(2006-6#1)(2006-7#2)(2007-2#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-2#2)(2013-8#1)
still an important problem in##2##5##(2006-10#1)(2008-12#1)
still an important##6##3##(1992-3#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-12#1)
still an##21##2##(1990-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(2006-10#2)(2006-6#2)(2007-11#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-2#2)(2013-1#1)
still apparent##4##2##(1994-2#1)(1995-12#1)(1996-12#1)(2006-8#1)
still appear##2##2##(2007-8#1)(2010-6#1)
still applicable##2##2##(2007-12#1)(2009-3#1)
still apply##2##2##(2008-3#1)(2011-2#1)
still are##2##2##(2004-9#1)(2007-8#1)
still as##4##2##(1996-11#1)(2006-10#1)(2006-12#1)(2013-1#1)
still associated with##6##3##(1996-8#1)(1997-6#1)(2006-3#1)(2008-4#1)(2009-5#1)(2012-12#1)
still at the##2##3##(1995-12#1)(2011-1#1)
still at##10##2##(1991-3#1)(1995-12#1)(2006-10#1)(2007-1#1)(2007-10#1)(2008-11#1)(2008-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
still be a##3##3##(2007-7#1)(2007-8#1)(2008-8#1)
still be detected##4##3##(1994-3#1)(1994-9#1)(2006-4#1)(2007-11#1)
still be required to##2##4##(1996-2#1)(2006-8#1)
still be the##2##3##(1994-2#1)(2006-9#1)
still be used for##2##4##(2007-9#1)(2008-10#1)
still be used##4##3##(1992-6#1)(2007-9#1)(2008-10#1)(2008-2#1)
still be##50##2##(1990-3#1)(1992-2#1)(1992-6#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-11#1)(1996-2#1)(1996-4#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-4#1)(2006-8#1)(2006-9#1)(2007-11#4)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
still been##2##2##(1996-3#1)(2008-11#1)
still being##24##2##(1991-5#1)(1991-8#1)(1996-12#1)(1997-5#1)(2005-11#1)(2006-10#2)(2006-6#3)(2006-9#1)(2007-12#2)(2007-6#1)(2008-11#2)(2008-7#2)(2008-8#1)(2009-8#1)(2010-1#2)(2013-1#1)(2013-7#1)
still below##4##2##(1992-9#1)(2006-4#1)(2007-2#1)(2013-8#1)
still bind and respond to##2##5##(2008-4#2)
still birth##2##2##(1996-11#1)(2012-3#1)
still blocked##2##2##(1994-12#1)(1995-12#1)
still bound to##2##3##(1992-6#1)(1995-4#1)
still bound##3##2##(1992-6#1)(1994-12#1)(1995-4#1)
still calls##2##2##(1995-9#1)(2013-1#1)
still can be##2##3##(2008-5#1)(2008-9#1)
still can produce##2##3##(1992-9#1)(1997-5#1)
still can##7##2##(1992-9#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-9#1)(2009-3#1)
still cannot##3##2##(1995-3#1)(2005-7#1)(2006-10#1)
still capable of##2##3##(1993-3#1)(2004-8#1)
still carries a##3##3##(2006-10#2)(2008-3#1)
still caused##2##2##(1992-5#1)(2008-10#1)
still clearly##3##2##(2008-1#1)(2008-10#1)(2008-11#1)
still common in##2##3##(1990-12#1)(2006-4#1)
still complains of##2##3##(2006-12#1)(2013-1#1)
still considerably##2##2##(2005-11#1)(2009-7#1)
still considered a##2##3##(1995-5#1)(2010-4#1)
still considered as##2##3##(2006-10#1)(2012-12#1)
still considered##11##2##(1993-2#1)(1995-2#1)(1995-5#1)(2006-10#2)(2007-7#1)(2008-2#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-7#1)
still constitutes a##2##3##(2007-3#1)(2011-2#1)
still constitutes##3##2##(2007-3#1)(2011-2#1)(2012-1#1)
still contained##3##2##(1992-10#1)(1994-12#1)(1997-7#1)
still continue to##2##3##(2005-11#1)(2011-2#1)
still continued##2##2##(2008-8#1)(2009-3#1)
still continues##4##2##(1994-7#1)(2004-1#1)(2007-9#1)(2008-9#1)
still controversial##34##2##(1990-12#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-10#1)(1994-12#1)(1995-2#1)(1996-9#1)(1997-5#1)(1997-6#1)(2005-3#1)(2005-5#1)(2006-10#3)(2006-12#1)(2007-1#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#3)(2008-7#1)(2008-8#1)(2010-12#2)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
still debated##11##2##(1992-8#2)(2006-10#3)(2007-7#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-3#1)
still decreased##2##2##(1991-6#1)(1996-5#1)
still dependent##2##2##(1993-12#1)(1994-11#1)
still detectable in the##2##4##(1996-12#1)(2008-4#1)
still detectable##3##2##(1996-12#1)(2008-4#1)(2009-10#1)
still detected##2##2##(2008-10#1)(2008-5#1)
still develop##3##2##(2007-11#1)(2008-1#2)
still did##3##2##(1993-12#1)(2012-2#2)
still discussed##5##2##(1990-5#1)(1993-6#1)(2006-10#1)(2008-8#1)(2009-1#1)
still disease with##2##3##(2006-10#2)
still disease##3##2##(1990-10#1)(2006-10#2)
still do not##5##3##(2006-10#1)(2007-4#1)(2008-12#1)(2010-12#1)(2012-2#1)
still does##2##2##(2008-6#1)(2009-10#1)
still dominated by##2##3##(2008-10#1)(2011-1#1)
still elevated##4##2##(1991-2#1)(1995-7#1)(1996-7#1)(2008-10#1)
still elusive##4##2##(2008-11#1)(2008-7#1)(2009-5#1)(2010-11#1)
still engage in##2##3##(2010-7#1)(2011-2#1)
still evaluated##2##2##(1991-10#1)(2009-1#1)
still evident##4##2##(1990-5#1)(1996-9#1)(2008-10#1)(2013-1#1)
still exhibit##2##2##(1995-8#1)(1997-2#1)
still exhibited##3##2##(1993-12#1)(2008-10#1)(2012-3#1)
still exist in##2##3##(2009-3#1)(2013-7#1)
still exist##16##2##(2006-10#1)(2006-2#2)(2008-12#1)(2008-8#1)(2009-3#1)(2010-2#1)(2011-1#1)(2011-12#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-7#1)
still existed##2##2##(1993-7#1)(2007-8#1)
still exists in the##2##4##(2006-10#1)(2008-4#1)
still exists##13##2##(1991-8#1)(1992-12#1)(1993-8#1)(1994-8#1)(1996-2#1)(2006-10#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-8#1)(2012-3#1)
still experience##4##2##(1990-12#1)(2007-12#1)(2008-7#1)(2013-8#1)
still experiencing##2##2##(2004-10#1)(2008-11#1)
still experimental##5##2##(2007-11#2)(2009-5#1)(2009-6#1)(2010-12#1)
still exposed to##2##3##(1994-6#1)(2011-1#1)
still expressed##3##2##(1991-2#1)(1995-6#1)(2008-8#1)
still face##4##2##(1997-3#1)(2008-11#1)(2013-8#2)
still fail to##2##3##(2008-10#1)(2011-2#1)
still far away##3##3##(2005-8#1)(2006-10#1)(2010-12#1)
still far from being##2##4##(2008-5#1)(2012-2#1)
still far from##5##3##(1993-4#1)(2006-2#1)(2008-5#1)(2012-2#2)
still far##8##2##(1993-4#1)(2005-8#1)(2006-10#1)(2006-2#1)(2008-5#1)(2010-12#1)(2012-2#2)
still feasible##2##2##(2006-12#1)(2013-1#1)
still form##2##2##(1995-4#1)(2013-8#1)
still formed##2##2##(1990-3#1)(1992-12#1)
still forms##2##2##(1991-10#1)(2008-1#1)
still found in the##2##4##(1996-1#1)(2007-12#1)
still free##3##2##(1997-3#1)(2007-8#1)(2013-1#1)
still frequently##3##2##(2006-10#1)(2008-8#1)(2010-12#1)
still function##3##2##(1996-8#1)(2009-8#1)(2010-2#1)
still functional##4##2##(1994-9#1)(1995-2#1)(2008-6#1)(2008-7#1)
still further##2##2##(2008-4#1)(2009-8#1)
still growing##5##2##(2007-11#1)(2007-12#1)(2007-8#1)(2008-4#1)(2010-3#1)
still had a##2##3##(1990-7#1)(1992-5#1)
still had##16##2##(1990-11#1)(1990-7#1)(1991-9#1)(1992-5#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-9#1)(2005-11#1)(2006-8#1)(2007-8#1)(2008-4#1)(2008-6#1)(2008-7#1)(2011-2#1)
still has a##4##3##(1997-3#1)(2007-9#1)(2010-8#1)(2011-1#1)
still has##11##2##(1993-5#1)(1997-3#1)(2005-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-3#1)(2010-8#1)(2011-1#2)(2012-2#1)
still have a role in##2##5##(1993-11#1)(2010-12#1)
still have a role##3##4##(1993-11#1)(2009-6#1)(2010-12#1)
still have a##6##3##(1993-11#1)(1996-11#1)(1996-8#1)(2008-9#1)(2009-6#1)(2010-12#1)
still have high##2##3##(2007-12#1)(2013-1#1)
still have much to##3##4##(2009-3#1)(2012-12#2)
still have much##4##3##(2009-3#1)(2010-9#1)(2012-12#2)
still have some##3##3##(2005-7#1)(2009-4#1)(2013-8#1)
still have the##2##3##(1993-12#1)(2008-10#1)
still have to be##3##4##(2011-1#1)(2012-2#2)
still have##38##2##(1991-12#1)(1991-3#1)(1993-11#1)(1993-12#2)(1993-4#1)(1994-9#1)(1996-11#1)(1996-8#1)(1996-9#1)(1997-6#1)(2005-7#1)(2006-10#3)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-12#2)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#1)
still high##8##2##(1994-12#1)(1996-11#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-1#1)(2010-5#1)(2011-1#1)
still higher in the##2##4##(1990-7#1)(1994-11#1)
still higher than the##2##4##(2008-7#1)(2008-8#1)
still higher than##6##3##(1997-5#1)(2007-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)
still higher##10##2##(1990-7#1)(1994-11#1)(1997-2#1)(1997-5#1)(2005-8#1)(2007-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)
still highly##4##2##(1990-10#1)(1993-6#1)(1996-12#1)(2007-7#1)
still images##3##2##(2008-11#1)(2008-2#1)(2009-10#1)
still important##3##2##(2010-10#1)(2012-2#1)(2012-3#1)
still in a##2##3##(2009-9#1)(2012-1#1)
still in hospital##2##3##(2007-1#1)(2007-7#1)
still in its infancy##6##4##(1995-5#1)(1996-2#1)(1996-4#1)(2006-10#1)(2006-12#1)(2008-10#1)
still in its##9##3##(1995-5#1)(1996-2#1)(1996-4#1)(2006-10#1)(2006-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2011-2#1)
still in progress##2##3##(2007-11#1)(2007-6#1)
still in the##8##3##(1991-12#1)(1995-12#1)(2006-10#2)(2006-6#1)(2006-7#1)(2012-1#1)(2012-2#1)
still in use##5##3##(1995-12#1)(2005-7#1)(2009-5#1)(2010-9#1)(2013-7#1)
still in##48##2##(1990-11#1)(1990-2#1)(1991-12#1)(1991-5#1)(1992-5#1)(1994-4#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-2#1)(1996-4#1)(1997-5#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-6#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-7#2)
still incompletely understood##3##3##(2008-7#1)(2010-11#1)(2011-2#1)
still incompletely##6##2##(1993-6#1)(2007-11#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-2#1)
still increasing##7##2##(1990-12#1)(1996-5#1)(1997-8#1)(2004-4#1)(2008-5#1)(2011-2#1)(2013-7#1)
still inhibited##3##2##(1993-9#1)(1994-9#1)(2008-11#1)
still insufficient##7##2##(1994-4#1)(1994-6#1)(1995-11#1)(2006-10#1)(2009-7#1)(2010-12#1)(2012-2#1)
still intact##2##2##(2008-10#1)(2011-2#1)
still investigational##2##2##(1993-10#1)(2010-7#1)
still is a##2##3##(2007-5#1)(2008-11#1)
still is the##2##3##(2008-10#1)(2010-6#1)
still is##8##2##(1997-6#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2010-6#1)
still lack##3##2##(1995-6#1)(2005-8#1)(2013-8#1)
still lacking##28##2##(1992-6#1)(1996-8#1)(1997-6#1)(1997-8#1)(2006-10#2)(2006-6#3)(2006-7#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-1#1)(2010-11#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
still largely unknown##4##3##(1993-3#1)(2007-2#1)(2007-5#1)(2012-1#1)
still largely##13##2##(1990-6#1)(1993-3#1)(1994-12#1)(1996-12#1)(2007-2#1)(2007-5#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-6#1)(2012-1#1)(2012-12#1)
still leave##2##2##(1991-2#1)(1995-12#1)
still led to##2##3##(1997-7#1)(2008-10#1)
still less than##3##3##(2004-4#1)(2008-10#1)(2009-4#1)
still less##5##2##(2004-4#1)(2008-10#1)(2009-4#1)(2010-3#1)(2012-3#1)
still lies##2##2##(2004-12#1)(2012-11#1)
still limited##21##2##(1991-10#1)(1991-12#1)(1994-12#1)(1994-3#1)(1996-5#1)(1997-7#2)(2005-7#1)(2006-10#1)(2006-4#1)(2008-10#1)(2008-11#3)(2008-7#1)(2009-4#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)
still low in##2##3##(1994-12#1)(2007-6#1)
still low##10##2##(1992-10#1)(1994-12#1)(2005-3#1)(2007-11#1)(2007-6#1)(2007-9#1)(2009-5#1)(2011-2#3)
still mainly##3##2##(1991-11#1)(1991-7#1)(2011-2#1)
still maintained##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
still major##3##2##(2007-5#1)(2008-11#1)(2011-1#1)
still makes it##2##3##(2008-8#1)(2010-5#1)
still markedly##2##2##(1992-8#1)(1993-3#1)
still mild##2##2##(2008-1#1)(2012-2#1)
still missing##3##2##(2008-8#1)(2010-12#1)(2011-2#1)
still more##9##2##(1994-1#1)(1994-5#1)(2005-7#1)(2006-6#1)(2008-5#1)(2009-6#1)(2010-10#1)(2012-12#1)(2012-3#1)
still much lower##2##3##(1995-4#1)(1996-2#1)
still much##13##2##(1990-9#1)(1995-4#1)(1996-2#1)(2006-10#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-1#1)
still need to be overcome##2##5##(2009-12#1)(2009-3#1)
still need to be##12##4##(1992-10#1)(1993-3#1)(2006-10#2)(2007-12#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-10#1)(2011-2#1)(2013-1#1)
still need to##19##3##(1992-10#1)(1993-3#1)(1994-1#1)(1995-9#1)(2006-10#2)(2007-12#1)(2007-6#1)(2008-1#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-3#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
still need##22##2##(1992-10#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-9#1)(2006-10#2)(2007-12#1)(2007-6#1)(2008-1#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-6#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
still needed to##3##3##(2007-12#1)(2007-9#1)(2009-3#1)
still needed##11##2##(1990-9#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#1)(2009-2#2)(2009-3#1)(2010-12#2)
still needs to be##7##4##(1996-4#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-7#1)
still needs to##9##3##(1994-12#1)(1996-4#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-1#1)(2011-2#1)(2013-7#1)
still needs##12##2##(1994-12#1)(1996-4#1)(2007-11#2)(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-1#1)(2011-2#1)(2011-3#1)(2013-7#1)
still no significant##2##3##(1997-5#1)(2004-10#1)
still no##18##2##(1990-9#1)(1991-4#1)(1997-5#1)(2004-10#1)(2006-10#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-7#1)(2011-7#1)(2013-1#2)
still not available##4##3##(2005-10#1)(2007-11#1)(2008-5#1)(2011-2#1)
still not clear and##3##4##(2007-8#1)(2011-2#1)(2013-1#1)
still not clear##16##3##(2006-10#2)(2006-6#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-5#1)(2009-5#1)(2009-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
still not completely elucidated##3##4##(2008-10#1)(2009-12#1)(2010-7#1)
still not completely understood##4##4##(2005-8#1)(2006-10#1)(2008-2#1)(2011-1#1)
still not completely##7##3##(2005-8#1)(2006-10#1)(2008-10#1)(2008-2#1)(2009-12#1)(2010-7#1)(2011-1#1)
still not fully understood##7##4##(1993-6#1)(1994-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-3#1)
still not fully##10##3##(1993-12#1)(1993-6#1)(1994-11#1)(1995-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-3#1)(2009-9#1)
still not known##3##3##(2008-12#1)(2012-12#1)(2013-1#1)
still not statistically significant##2##4##(2007-10#1)(2008-10#1)
still not understood##2##3##(2006-6#1)(2008-7#1)
still not well understood##5##4##(2006-10#2)(2007-7#1)(2008-1#1)(2012-12#1)
still not##87##2##(1992-8#1)(1993-12#1)(1993-6#1)(1994-11#1)(1995-10#1)(1995-11#1)(1996-5#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#6)(2006-2#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#2)(2008-5#2)(2008-7#3)(2008-8#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#10)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
still obscure##3##2##(1990-12#1)(1991-10#1)(2008-6#1)
still observable##2##2##(2006-6#1)(2008-9#1)
still observed in##2##3##(1997-4#1)(2010-4#1)
still observed##7##2##(1990-7#1)(1994-2#1)(1997-4#1)(2008-3#1)(2008-9#1)(2009-12#1)(2010-4#1)
still obtained##2##2##(2008-10#1)(2008-2#1)
still occur in##3##3##(1997-3#1)(2005-10#1)(2012-1#1)
still occur##9##2##(1997-3#1)(1997-7#1)(2005-10#1)(2006-10#2)(2006-12#1)(2007-11#1)(2008-10#1)(2012-1#1)
still occurred##3##2##(1990-2#1)(1991-11#1)(1997-2#1)
still occurs##6##2##(1994-5#1)(1996-5#1)(2006-11#1)(2008-10#1)(2010-10#1)(2010-4#1)
still of##4##2##(2007-10#1)(2011-2#1)(2011-3#1)(2012-3#1)
still on the##3##3##(1995-2#1)(2007-8#1)(2008-4#1)
still on##8##2##(1990-5#1)(1994-6#1)(1995-2#1)(1995-5#1)(2007-7#1)(2007-8#1)(2008-4#1)(2013-7#1)
still other##6##2##(1994-11#1)(1995-3#1)(1995-8#1)(2012-1#1)(2012-12#2)
still others##3##2##(1994-1#1)(1994-10#1)(2007-12#1)
still over##5##2##(2007-5#1)(2008-10#3)(2009-5#1)
still persist##2##2##(2008-11#1)(2008-4#1)
still persists##3##2##(1990-10#1)(2010-2#1)(2013-1#1)
still play##2##2##(2011-2#2)
still plays a role##2##4##(1990-8#1)(1994-6#1)
still plays a##4##3##(1990-8#1)(1994-6#1)(2010-11#1)(2013-1#1)
still plays##5##2##(1990-8#1)(1994-6#1)(2010-11#1)(2012-3#1)(2013-1#1)
still poor##6##2##(1990-10#1)(2005-10#1)(2006-2#1)(2008-5#1)(2013-1#2)
still poorly characterized##2##3##(2008-11#1)(2008-4#1)
still poorly known##2##3##(2008-4#1)(2013-7#1)
still poorly understood##15##3##(1991-11#1)(1996-1#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#2)
still poorly##21##2##(1991-11#1)(1996-1#1)(1996-5#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#2)
still possible##4##2##(1996-1#1)(2006-4#1)(2007-8#1)(2008-10#1)
still potentially##2##2##(2011-2#1)(2012-3#1)
still prefer##2##2##(2006-10#1)(2008-11#1)
still present after##2##3##(1992-6#1)(1992-7#1)
still present and##2##3##(1990-12#1)(2008-7#1)
still present in the##5##4##(1995-2#1)(2008-10#1)(2008-8#1)(2009-12#1)(2012-9#1)
still present in##7##3##(1991-3#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-12#1)(2012-9#1)
still present##31##2##(1990-12#1)(1991-3#1)(1991-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1994-2#1)(1994-9#1)(1995-2#1)(1996-3#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-9#1)(2013-1#1)
still presents a##2##3##(2008-1#1)(2010-12#1)
still presents##4##2##(2006-2#1)(2008-1#1)(2008-10#1)(2010-12#1)
still prevalent##2##2##(1990-7#1)(2012-2#1)
still prevented##2##2##(1997-1#1)(2004-9#1)
still produced##3##2##(1997-5#1)(2008-5#1)(2013-8#1)
still provide significant##2##3##(1995-12#1)(2006-10#1)
still provide##5##2##(1995-12#1)(1997-8#1)(2006-10#1)(2008-4#1)(2010-9#1)
still provides##2##2##(1995-9#1)(1997-4#1)
still rare##2##2##(2005-8#1)(2008-7#1)
still rather##2##2##(2006-10#1)(2009-5#1)
still recommended##3##2##(1993-3#1)(1994-12#1)(2006-8#1)
still reduced##2##2##(1990-4#1)(1996-5#1)
still regarded as##2##3##(2007-8#1)(2012-2#1)
still relatively##7##2##(1995-5#1)(2005-7#1)(2007-4#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-6#1)
still relevant##4##2##(1993-4#1)(2007-11#1)(2009-3#1)(2010-12#1)
still remain about##2##3##(2008-11#1)(2012-12#1)
still remain as##2##3##(1993-9#1)(2011-3#1)
still remain to be##4##4##(2006-10#2)(2008-7#1)(2012-2#1)
still remain##27##2##(1992-3#1)(1993-9#2)(1996-1#2)(2005-1#1)(2006-10#4)(2007-11#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-7#1)(2011-2#2)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)
still remained##8##2##(1991-3#1)(1993-5#1)(1994-6#1)(2005-12#1)(2007-6#1)(2008-7#1)(2011-1#1)(2012-2#1)
still remaining in##2##3##(2006-8#1)(2011-2#1)
still remains a challenge##4##4##(2008-7#1)(2009-8#1)(2011-12#1)(2012-2#1)
still remains a##12##3##(2006-12#1)(2007-11#1)(2008-1#1)(2008-7#2)(2009-8#1)(2010-10#1)(2010-4#1)(2010-6#1)(2011-12#2)(2012-2#1)
still remains as##2##3##(2011-2#2)
still remains obscure##2##3##(1997-6#1)(2013-8#1)
still remains the most##4##4##(1991-4#1)(2008-5#1)(2008-7#1)(2012-2#1)
still remains the##9##3##(1991-4#1)(2006-6#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-2#3)
still remains to be elucidated##2##5##(2006-2#1)(2007-11#1)
still remains to be##6##4##(1994-2#1)(1997-4#1)(2006-10#1)(2006-2#1)(2007-11#1)(2009-5#1)
still remains unknown##4##3##(2008-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
still remains##53##2##(1991-4#1)(1993-5#1)(1994-2#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-8#2)(2008-1#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-12#3)(2011-2#5)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#2)
still represent a##2##3##(1997-5#1)(2006-6#1)
still represent the##2##3##(2008-10#1)(2010-11#1)
still represent##4##2##(1997-5#1)(2006-6#1)(2008-10#1)(2010-11#1)
still represents the most##2##4##(1993-3#1)(2005-8#1)
still represents the##3##3##(1993-3#1)(2005-8#1)(2008-8#1)
still represents##5##2##(1993-3#1)(1995-1#1)(2005-8#1)(2008-11#1)(2008-8#1)
still require##10##2##(1992-3#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-3#1)(2010-12#1)(2012-12#2)(2013-1#1)
still required to##6##3##(2006-6#1)(2007-10#1)(2009-10#1)(2010-11#1)(2011-1#1)(2011-2#1)
still required##12##2##(1997-1#1)(1997-4#1)(2006-6#1)(2007-10#1)(2007-8#1)(2008-8#1)(2009-10#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#2)
still requires##4##2##(2005-8#1)(2008-1#1)(2008-3#1)(2008-7#1)
still retain a##2##3##(2008-10#1)(2008-11#1)
still retain##4##2##(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)
still retained##3##2##(1992-6#1)(1993-12#1)(1996-2#1)
still retains##2##2##(2007-3#1)(2013-1#1)
still revealed##2##2##(1997-8#1)(2013-8#1)
still scanty##2##2##(2007-3#1)(2008-1#1)
still showed##2##2##(1995-5#1)(2012-2#1)
still showing##3##2##(2007-3#1)(2013-1#2)
still significant##12##2##(1991-7#2)(1994-12#1)(1994-8#1)(1995-10#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-8#1)(2012-2#1)(2013-1#1)
still significantly elevated##2##3##(1990-10#1)(1996-12#1)
still significantly lower##2##3##(2007-10#1)(2008-4#1)
still significantly##9##2##(1990-10#1)(1990-12#1)(1991-2#1)(1991-9#1)(1994-5#1)(1996-12#1)(2007-10#1)(2008-4#1)(2012-11#1)
still some##7##2##(1996-11#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-4#1)(2011-3#1)
still speculative##2##2##(2006-2#1)(2012-2#1)
still stable##2##2##(1992-12#1)(2013-1#1)
still subject to##4##3##(2008-5#1)(2010-10#1)(2012-12#1)(2013-1#1)
still substantial##4##2##(1993-7#1)(2004-2#1)(2007-2#1)(2012-3#1)
still suffer from##2##3##(1996-6#1)(2007-8#1)
still suffer##4##2##(1996-6#1)(2007-8#1)(2010-12#1)(2010-9#1)
still suffering##2##2##(2008-11#1)(2013-8#1)
still sufficiently##5##2##(2005-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2010-8#1)
still support##2##2##(2005-10#1)(2008-10#1)
still take place##2##3##(2007-11#1)(2011-1#1)
still tend to##2##3##(2008-12#1)(2008-5#1)
still the drug##2##3##(1991-10#1)(2006-10#1)
still the most common##5##4##(2005-12#1)(2006-10#2)(2006-2#1)(2011-2#1)
still the most frequently##3##4##(2006-10#1)(2007-11#1)(2007-7#1)
still the most##10##3##(2005-12#1)(2006-10#4)(2006-2#1)(2007-11#1)(2007-7#1)(2011-2#2)
still the##43##2##(1990-5#1)(1991-10#1)(1991-4#1)(1995-8#1)(1996-8#2)(1997-4#1)(1997-8#1)(2005-12#1)(2005-9#1)(2006-10#9)(2006-2#2)(2007-11#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#1)
still there is##2##3##(2007-11#1)(2012-3#1)
still there##3##2##(2007-11#1)(2008-7#1)(2012-3#1)
still to be demonstrated##2##4##(1994-9#1)(2008-3#1)
still to be found##2##4##(1996-3#1)(2010-12#1)
still to be##14##3##(1990-10#1)(1990-12#1)(1991-12#1)(1993-3#1)(1994-9#1)(1996-3#1)(1996-4#1)(1997-8#1)(2005-6#1)(2007-8#1)(2008-3#1)(2008-5#1)(2010-12#1)(2013-8#1)
still to##15##2##(1990-10#1)(1990-12#1)(1991-12#1)(1993-3#1)(1994-9#1)(1996-3#1)(1996-4#1)(1997-8#1)(2005-6#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-12#1)(2013-8#1)
still today##2##2##(1994-6#1)(2007-1#1)
still unanswered##2##2##(2006-10#1)(2007-11#1)
still uncertain##9##2##(1993-2#1)(2006-10#1)(2008-8#1)(2009-8#1)(2011-2#1)(2013-1#4)
still unclear but##2##3##(1995-10#1)(2008-1#1)
still unclear how##2##3##(2009-8#1)(2013-1#1)
still unclear##56##2##(1991-3#1)(1992-2#1)(1992-8#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-10#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2009-8#3)(2010-10#1)(2010-12#2)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#3)
still under debate##7##3##(1993-8#1)(1995-11#1)(2007-8#2)(2008-3#1)(2008-7#1)(2012-12#1)
still under investigation##8##3##(2005-7#1)(2006-11#1)(2006-2#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
still under##23##2##(1990-3#1)(1992-5#1)(1993-8#1)(1995-11#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-11#1)(2006-2#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-7#2)(2009-10#1)(2009-3#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
still unidentified##2##2##(1991-7#1)(1996-12#1)
still unknown##59##2##(1990-2#1)(1990-4#1)(1990-5#2)(1991-10#1)(1991-3#1)(1991-6#1)(1992-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-3#1)(1996-3#1)(1997-3#2)(2006-2#1)(2006-8#1)(2007-11#4)(2007-12#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-6#1)(2011-12#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#5)
still unresolved##4##2##(1995-8#1)(2007-12#1)(2008-11#1)(2012-12#1)
still unsatisfactory##3##2##(2008-11#1)(2008-2#1)(2011-2#1)
still unsettled##2##2##(2011-1#1)(2012-2#1)
still unsolved##3##2##(1990-12#1)(2006-10#1)(2008-12#1)
still use##4##2##(1996-2#2)(2008-1#1)(2008-4#1)
still used##7##2##(2005-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-12#1)(2013-1#2)
still useful##2##2##(2006-10#1)(2008-4#1)
still useful?##2##2##(2010-12#1)(2011-2#1)
still using##2##2##(1991-2#1)(2008-3#1)
still valid##7##2##(1992-9#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#2)
still very##15##2##(1991-1#1)(1991-6#1)(1994-2#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-2#1)(2010-3#1)(2011-2#3)(2012-2#1)(2013-8#1)
still was##2##2##(2008-10#1)(2008-12#1)
still water##3##2##(2008-10#1)(2010-12#1)(2011-1#1)
still were##2##2##(1997-6#1)(2008-10#1)
still widely used##3##3##(2006-10#1)(2006-9#1)(2008-12#1)
still widely##7##2##(2006-10#1)(2006-9#1)(2008-10#1)(2008-12#2)(2008-7#1)(2009-3#1)
still within##4##2##(1996-12#1)(2006-9#1)(2007-12#1)(2008-5#1)
still working##4##2##(1991-12#1)(1994-6#1)(1997-7#1)(2006-10#1)
still##2215##1##(1990-10#7)(1990-11#5)(1990-12#10)(1990-2#4)(1990-3#6)(1990-4#5)(1990-5#7)(1990-6#4)(1990-7#5)(1990-8#5)(1990-9#6)(1991-1#2)(1991-10#6)(1991-11#5)(1991-12#12)(1991-2#10)(1991-3#8)(1991-4#5)(1991-5#4)(1991-6#5)(1991-7#4)(1991-8#4)(1991-9#5)(1992-10#5)(1992-11#3)(1992-12#4)(1992-2#5)(1992-3#4)(1992-5#5)(1992-6#11)(1992-7#3)(1992-8#10)(1992-9#6)(1993-10#3)(1993-11#7)(1993-12#7)(1993-2#5)(1993-3#11)(1993-4#3)(1993-5#3)(1993-6#7)(1993-7#3)(1993-8#5)(1993-9#9)(1994-1#6)(1994-10#1)(1994-11#6)(1994-12#13)(1994-2#10)(1994-3#6)(1994-4#4)(1994-5#4)(1994-6#13)(1994-7#2)(1994-8#4)(1994-9#10)(1995-1#4)(1995-10#4)(1995-11#5)(1995-12#10)(1995-2#9)(1995-3#6)(1995-4#5)(1995-5#7)(1995-6#8)(1995-7#2)(1995-8#7)(1995-9#6)(1996-1#6)(1996-10#2)(1996-11#11)(1996-12#9)(1996-2#7)(1996-3#7)(1996-4#9)(1996-5#10)(1996-6#3)(1996-7#1)(1996-8#7)(1996-9#4)(1997-1#3)(1997-2#11)(1997-3#7)(1997-4#12)(1997-5#12)(1997-6#10)(1997-7#9)(1997-8#11)(2004-1#1)(2004-10#4)(2004-11#2)(2004-12#1)(2004-2#1)(2004-4#2)(2004-8#1)(2004-9#2)(2005-1#1)(2005-10#5)(2005-11#11)(2005-12#5)(2005-3#2)(2005-5#1)(2005-6#2)(2005-7#9)(2005-8#16)(2005-9#3)(2006-1#1)(2006-10#112)(2006-11#2)(2006-12#14)(2006-2#21)(2006-3#2)(2006-4#10)(2006-5#1)(2006-6#25)(2006-7#7)(2006-8#12)(2006-9#9)(2007-1#9)(2007-10#8)(2007-11#43)(2007-12#30)(2007-2#13)(2007-3#11)(2007-4#6)(2007-5#12)(2007-6#8)(2007-7#24)(2007-8#51)(2007-9#13)(2008-1#43)(2008-10#94)(2008-11#55)(2008-12#15)(2008-2#24)(2008-3#43)(2008-4#37)(2008-5#43)(2008-6#18)(2008-7#58)(2008-8#44)(2008-9#22)(2009-1#3)(2009-10#9)(2009-11#2)(2009-12#4)(2009-2#5)(2009-3#16)(2009-4#9)(2009-5#17)(2009-6#8)(2009-7#6)(2009-8#12)(2009-9#6)(2010-1#4)(2010-10#15)(2010-11#15)(2010-12#39)(2010-2#9)(2010-3#6)(2010-4#6)(2010-5#7)(2010-6#8)(2010-7#8)(2010-8#14)(2010-9#8)(2011-1#34)(2011-12#7)(2011-2#84)(2011-3#7)(2011-7#2)(2012-1#11)(2012-10#1)(2012-11#5)(2012-12#51)(2012-2#68)(2012-3#34)(2012-9#1)(2013-1#58)(2013-7#17)(2013-8#34)
still-face##2##1##(2006-8#2)
stillage##7##1##(2008-5#1)(2008-6#1)(2011-2#5)
stillbirth rate##4##2##(1992-5#2)(2006-2#1)(2012-12#1)
stillbirth##18##1##(1992-4#1)(1992-5#2)(1993-1#2)(1995-6#1)(1996-11#1)(2005-7#1)(2006-2#1)(2007-10#3)(2007-2#2)(2008-12#1)(2011-12#1)(2012-12#1)(2013-1#1)
stillbirths and##2##2##(2012-12#2)
stillbirths##13##1##(1992-5#1)(2008-1#2)(2011-2#1)(2012-12#8)(2013-1#1)
stillborn##7##1##(1993-5#1)(1995-8#1)(2007-2#1)(2008-11#1)(2008-7#1)(2009-3#1)(2012-1#1)
stillness##2##1##(2008-2#1)(2010-12#1)
stills##2##1##(1993-6#2)
stimulability##2##1##(1990-6#1)(2008-9#1)
stimulant effects of##2##3##(1993-6#1)(1995-11#1)
stimulant effects##4##2##(1991-5#1)(1993-12#1)(1993-6#1)(1995-11#1)
stimulant injection##3##2##(1993-3#3)
stimulant medication for##2##3##(2008-4#1)(2011-2#1)
stimulant medication##6##2##(1995-1#1)(1996-6#2)(2008-4#1)(2010-11#1)(2011-2#1)
stimulant medications##3##2##(2010-11#2)(2011-2#1)
stimulant of##2##2##(1993-9#1)(2007-1#1)
stimulant on##2##2##(2006-12#1)(2013-1#1)
stimulant##42##1##(1991-5#1)(1992-3#1)(1993-12#1)(1993-3#5)(1993-6#1)(1993-9#1)(1994-6#1)(1995-1#1)(1995-11#1)(1996-10#1)(1996-6#2)(1996-9#1)(1997-5#1)(2005-10#1)(2006-12#2)(2007-1#1)(2007-2#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-7#2)(2009-8#1)(2010-11#3)(2011-2#5)(2013-1#2)(2013-7#1)
stimulants and##2##2##(2008-3#1)(2008-8#1)
stimulants in##4##2##(2008-10#3)(2008-6#1)
stimulants such as##2##3##(1996-10#1)(2008-6#1)
stimulants were##2##2##(2008-10#1)(2013-8#1)
stimulants##36##1##(1990-3#2)(1991-1#1)(1991-2#1)(1992-10#1)(1992-9#1)(1993-6#1)(1994-2#1)(1995-11#1)(1996-10#1)(2005-10#1)(2006-10#3)(2007-2#2)(2008-10#7)(2008-11#3)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-7#1)(2011-2#1)(2013-7#1)(2013-8#1)
stimulants]##2##1##(1990-5#1)(2007-1#1)
stimulate DNA synthesis##10##3##(1990-11#1)(1990-12#1)(1990-9#1)(1992-3#1)(1992-9#1)(1995-1#1)(1995-5#1)(1997-7#1)(2008-8#1)(2009-8#1)
stimulate DNA##11##2##(1990-11#1)(1990-12#1)(1990-9#1)(1992-3#1)(1992-9#1)(1995-1#1)(1995-5#1)(1997-7#1)(2008-7#1)(2008-8#1)(2009-8#1)
stimulate MAPK##3##2##(1995-1#2)(1995-6#1)
stimulate PI turnover##3##3##(1991-5#2)(1993-9#1)
stimulate PI##4##2##(1991-5#2)(1993-9#1)(1994-9#1)
stimulate PKC##2##2##(1991-5#1)(1991-9#1)
stimulate SOS##2##2##(1994-9#2)
stimulate a debate##2##3##(2008-11#1)(2010-9#1)
stimulate a##12##2##(1990-9#1)(1993-3#1)(1993-6#1)(1994-6#1)(1995-2#1)(1996-5#2)(1997-7#1)(2006-7#1)(2008-10#1)(2008-11#1)(2010-9#1)
stimulate adenylate cyclase##5##3##(1990-3#1)(1990-9#1)(1991-9#1)(1995-1#1)(1997-7#1)
stimulate adenylyl cyclase in##2##4##(1995-11#1)(1996-8#1)
stimulate adenylyl cyclase##3##3##(1993-3#1)(1995-11#1)(1996-8#1)
stimulate adrenal##2##2##(1991-3#1)(1994-10#1)
stimulate an increase##2##3##(2008-12#1)(2008-4#1)
stimulate an##7##2##(1994-12#1)(1995-6#1)(1996-11#1)(2008-12#1)(2008-4#1)(2009-5#1)(2010-1#1)
stimulate and##2##2##(2008-7#1)(2012-3#1)
stimulate any##2##2##(1992-9#1)(2008-10#1)
stimulate ascospore##2##2##(2008-10#2)
stimulate bone formation##4##3##(2008-3#1)(2008-8#1)(2012-11#2)
stimulate bone resorption##3##3##(1990-9#1)(1991-3#1)(1997-7#1)
stimulate bone##8##2##(1990-9#1)(1991-3#1)(1997-7#1)(2008-3#1)(2008-8#2)(2012-11#2)
stimulate both##8##2##(1991-4#2)(1992-3#1)(1995-12#1)(1995-8#1)(1997-1#1)(2008-10#1)(2008-11#1)
stimulate cAMP formation##2##3##(1991-12#1)(1994-3#1)
stimulate cAMP##3##2##(1991-12#1)(1994-3#1)(1996-10#1)
stimulate calcium##3##2##(1991-1#1)(1994-9#1)(2008-4#1)
stimulate cell growth##2##3##(1992-11#1)(2008-11#1)
stimulate cell##4##2##(1992-11#1)(1996-5#1)(2008-11#1)(2008-3#1)
stimulate channel##2##2##(2008-8#2)
stimulate cognitive##2##2##(1996-12#2)
stimulate diacylglycerol generation in##2##4##(1991-8#2)
stimulate endothelial##3##2##(1995-8#3)
stimulate expression of##3##3##(1995-12#1)(1996-4#1)(2008-4#1)
stimulate further##7##2##(1997-5#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-12#1)(2011-1#1)(2013-1#1)
stimulate fusion##2##2##(1992-6#2)
stimulate gastric##2##2##(1996-9#1)(2007-1#1)
stimulate gene expression##2##3##(1994-8#1)(1997-7#1)
stimulate glucose uptake##3##3##(2008-1#1)(2008-11#1)(2008-8#1)
stimulate glucose##7##2##(1994-8#1)(1997-7#1)(1997-8#1)(2008-1#2)(2008-11#1)(2008-8#1)
stimulate growth hormone##2##3##(2007-11#1)(2008-3#1)
stimulate growth of normal##2##4##(2008-11#2)
stimulate growth of##3##3##(1994-10#1)(2008-11#2)
stimulate growth##6##2##(1994-10#1)(1996-5#1)(2007-11#1)(2008-11#2)(2008-3#1)
stimulate guanine nucleotide exchange##3##4##(1992-7#2)(1994-12#1)
stimulate host##2##2##(2006-7#1)(2010-4#1)
stimulate increased expression of##2##4##(2008-5#1)(2010-12#1)
stimulate innovation##2##2##(2007-8#1)(2013-8#1)
stimulate insulin secretion##5##3##(1991-10#1)(1992-4#1)(1995-8#1)(2005-7#1)(2008-1#1)
stimulate insulin##7##2##(1990-8#1)(1991-10#1)(1992-4#1)(1995-8#1)(2004-11#1)(2005-7#1)(2008-1#1)
stimulate macrophages##3##2##(1990-11#1)(1993-4#2)
stimulate maximal discharge##2##3##(2012-12#2)
stimulate more##5##2##(2006-10#1)(2006-5#1)(2009-2#1)(2012-2#2)
stimulate muscle cell differentiation##2##4##(1992-3#2)
stimulate naive##2##2##(2005-11#1)(2008-11#1)
stimulate net muscle protein synthesis in##2##6##(2004-11#2)
stimulate neurite outgrowth##2##3##(1990-3#1)(1991-1#1)
stimulate new##2##2##(2007-8#1)(2011-2#1)
stimulate or##4##2##(1994-8#1)(1995-2#1)(2006-10#1)(2008-9#1)
stimulate phosphatidylinositol##2##2##(1994-2#1)(2008-8#1)
stimulate phosphorylation of##2##3##(1992-3#1)(1992-8#1)
stimulate plant##2##2##(2008-10#2)
stimulate production##5##2##(1991-12#2)(1995-10#1)(2008-10#1)(2012-2#1)
stimulate prolactin##2##2##(1994-6#1)(1995-10#1)
stimulate proliferation of##6##3##(1994-3#1)(1995-10#1)(2008-4#4)
stimulate proliferation##8##2##(1994-3#1)(1995-10#1)(1996-11#1)(2008-4#5)
stimulate protective##3##2##(2006-10#1)(2010-12#1)(2011-2#1)
stimulate protein synthesis##4##3##(2008-11#2)(2008-5#2)
stimulate protein##6##2##(1992-2#1)(1997-5#1)(2008-11#2)(2008-5#2)
stimulate rat##2##2##(1990-5#1)(1992-7#1)
stimulate release of##2##3##(1995-2#1)(2008-1#1)
stimulate research in##2##3##(1996-3#1)(2012-12#1)
stimulate researchers##2##2##(2007-11#1)(2013-8#1)
stimulate secretion of##2##3##(1990-2#1)(2008-7#1)
stimulate sexual##2##2##(2010-8#1)(2012-1#1)
stimulate some##2##2##(1993-9#1)(2012-3#1)
stimulate the ATPase##3##3##(1992-6#1)(1994-12#1)(1994-9#1)
stimulate the cell##2##3##(1994-9#1)(2009-8#1)
stimulate the development of##3##4##(1990-10#1)(1995-4#1)(2008-10#1)
stimulate the expression of##2##4##(1997-6#1)(2008-10#1)
stimulate the formation of##2##4##(1990-12#1)(2012-1#1)
stimulate the growth of##4##4##(1995-3#1)(2006-10#1)(2008-4#1)(2010-12#1)
stimulate the growth##5##3##(1995-3#1)(2006-10#1)(2008-4#1)(2010-12#1)(2011-2#1)
stimulate the immune response##2##4##(2004-12#2)
stimulate the immune system##3##4##(1990-5#1)(2006-7#1)(2008-7#1)
stimulate the immune##6##3##(1990-5#1)(1997-2#1)(2004-12#2)(2006-7#1)(2008-7#1)
stimulate the phosphorylation of the##2##5##(1990-10#1)(1996-2#1)
stimulate the phosphorylation of##6##4##(1990-10#1)(1990-3#1)(1991-5#1)(1992-9#1)(1996-2#2)
stimulate the production of##5##4##(1990-9#1)(2008-11#1)(2008-6#1)(2008-7#1)(2012-12#1)
stimulate the proliferation and differentiation of##2##6##(1996-10#1)(2008-5#1)
stimulate the proliferation and##3##4##(1995-2#1)(1996-10#1)(2008-5#1)
stimulate the proliferation of the##3##5##(1993-9#1)(2008-4#2)
stimulate the proliferation of##6##4##(1993-9#1)(2008-11#1)(2008-4#3)(2008-8#1)
stimulate the proliferation##9##3##(1993-9#1)(1995-2#1)(1996-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-8#1)
stimulate the secretion of##2##4##(2005-11#1)(2007-12#1)
stimulate the synthesis of##3##4##(1993-12#1)(1994-2#1)(2008-5#1)
stimulate the transcription of the##2##5##(1994-9#1)(1995-6#1)
stimulate the##117##2##(1990-10#2)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-9#2)(1991-5#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-9#2)(1993-12#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#2)(1994-9#4)(1995-10#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#2)(1995-8#2)(1996-10#1)(1996-2#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#2)(2004-12#2)(2005-11#2)(2006-10#1)(2006-6#2)(2006-7#1)(2007-11#1)(2007-12#1)(2007-3#3)(2007-8#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#7)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#2)(2009-10#1)(2009-4#1)(2009-8#2)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#1)
stimulate this##3##2##(1994-7#1)(2008-5#1)(2008-7#1)
stimulate transcription##6##2##(1991-5#1)(1993-8#1)(1994-2#1)(1996-2#1)(1996-8#1)(2011-1#1)
stimulate transglutaminase##2##2##(1994-9#2)
stimulate##567##1##(1990-10#5)(1990-11#5)(1990-12#7)(1990-2#5)(1990-3#6)(1990-5#3)(1990-6#1)(1990-8#3)(1990-9#8)(1991-1#4)(1991-10#5)(1991-12#6)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#12)(1991-6#1)(1991-8#3)(1991-9#3)(1992-10#2)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#8)(1992-4#2)(1992-5#3)(1992-6#5)(1992-7#4)(1992-8#3)(1992-9#5)(1993-12#3)(1993-2#1)(1993-3#3)(1993-4#2)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#4)(1994-1#1)(1994-10#4)(1994-11#2)(1994-12#8)(1994-2#9)(1994-3#5)(1994-5#1)(1994-6#6)(1994-7#1)(1994-8#7)(1994-9#12)(1995-1#4)(1995-10#5)(1995-11#2)(1995-12#4)(1995-2#8)(1995-3#7)(1995-4#1)(1995-5#1)(1995-6#8)(1995-8#8)(1996-10#2)(1996-11#3)(1996-12#5)(1996-2#3)(1996-3#2)(1996-4#3)(1996-5#6)(1996-7#2)(1996-8#4)(1996-9#3)(1997-1#6)(1997-2#6)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#5)(1997-7#7)(1997-8#2)(2004-11#3)(2004-12#4)(2004-3#2)(2005-11#5)(2005-12#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#7)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#4)(2006-7#4)(2007-1#1)(2007-11#6)(2007-12#2)(2007-3#3)(2007-8#4)(2008-1#9)(2008-10#15)(2008-11#16)(2008-12#4)(2008-3#5)(2008-4#25)(2008-5#18)(2008-6#2)(2008-7#14)(2008-8#17)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-8#4)(2009-9#1)(2010-1#2)(2010-11#3)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#6)(2012-1#4)(2012-11#2)(2012-12#10)(2012-2#6)(2012-3#5)(2013-1#6)(2013-8#4)
stimulate(s)##2##1##(1992-9#2)
stimulated 1##2##2##(1990-11#1)(1991-2#1)
stimulated AC activity was##2##4##(1991-11#1)(1991-7#1)
stimulated AC activity##3##3##(1991-11#1)(1991-7#2)
stimulated B cells##2##3##(1993-11#2)
stimulated Brillouin scattering (SBS) in##2##5##(2007-11#1)(2007-12#1)
stimulated Brillouin scattering (SBS)##6##4##(2007-11#1)(2007-12#3)(2008-2#2)
stimulated Brillouin scattering in a##3##5##(2007-12#2)(2008-2#1)
stimulated Brillouin scattering in optical fiber##3##6##(2007-11#2)(2007-12#1)
stimulated Brillouin scattering in##7##4##(2007-11#3)(2007-12#3)(2008-2#1)
stimulated Brillouin scattering mirror##2##4##(2007-12#1)(2008-2#1)
stimulated Brillouin scattering##21##3##(2007-11#8)(2007-12#9)(2008-2#4)
stimulated Brillouin##24##2##(2007-11#8)(2007-12#12)(2008-2#4)
stimulated C-peptide##2##2##(2007-5#2)
stimulated Ca2+##2##2##(1991-1#1)(1993-11#1)
stimulated DNA synthesis and##2##4##(1995-3#1)(1996-8#1)
stimulated DNA synthesis in##4##4##(1990-10#1)(1992-9#1)(1994-9#1)(1996-12#1)
stimulated DNA synthesis of##2##4##(1991-3#1)(1996-2#1)
stimulated DNA synthesis##10##3##(1990-10#1)(1991-3#1)(1992-9#1)(1994-12#1)(1994-9#1)(1995-10#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-8#1)
stimulated GTH-II release##2##3##(1994-8#2)
stimulated IgM production##2##3##(2008-11#2)
stimulated Raman scattering (SRS)##3##4##(2008-2#2)(2008-3#1)
stimulated Raman scattering and##3##4##(2007-12#1)(2008-2#1)(2010-7#1)
stimulated Raman scattering in optical##2##5##(2008-1#2)
stimulated Raman scattering in##10##4##(2007-11#1)(2007-12#6)(2008-1#2)(2008-2#1)
stimulated Raman scattering of##2##4##(2008-1#1)(2008-2#1)
stimulated Raman scattering##28##3##(2007-11#4)(2007-12#12)(2007-8#1)(2008-1#3)(2008-2#5)(2008-3#1)(2010-7#2)
stimulated Raman spectroscopy (FSRS)##3##4##(2006-12#1)(2006-4#1)(2006-5#1)
stimulated Raman spectroscopy##5##3##(2006-12#2)(2006-4#2)(2006-5#1)
stimulated Raman##41##2##(2006-12#3)(2006-4#2)(2006-5#2)(2007-11#6)(2007-12#14)(2007-8#1)(2008-1#3)(2008-2#5)(2008-3#2)(2010-12#1)(2010-7#2)
stimulated Rayleigh-Brillouin scattering at##2##4##(2007-12#2)
stimulated T##2##2##(1997-8#1)(2008-4#1)
stimulated T-lymphocytes##2##2##(1997-5#1)(2008-7#1)
stimulated a transient##2##3##(1991-8#1)(2008-4#1)
stimulated a##14##2##(1990-2#1)(1991-8#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-9#1)(2007-8#1)(2008-4#3)(2012-2#1)
stimulated acid output##2##3##(1991-2#1)(1995-11#1)
stimulated acid secretion##2##3##(1990-2#1)(1993-11#1)
stimulated acid##5##2##(1990-2#1)(1991-2#1)(1993-11#1)(1995-11#1)(2006-10#1)
stimulated activity of##2##3##(1994-11#2)
stimulated activity##5##2##(1994-11#2)(1995-7#1)(1997-6#1)(1997-8#1)
stimulated adenylate cyclase activity##2##4##(1990-10#1)(1994-12#1)
stimulated amylase release##2##3##(1990-3#1)(1991-5#1)
stimulated amylase##4##2##(1990-3#1)(1991-2#2)(1991-5#1)
stimulated an increase in##2##4##(1991-9#1)(2008-10#1)
stimulated an##9##2##(1991-9#1)(1996-12#1)(1996-8#1)(2008-10#1)(2008-4#1)(2011-2#4)
stimulated and##4##2##(1990-11#1)(1991-11#1)(1993-2#1)(2010-12#1)
stimulated animals##2##2##(1992-8#1)(2008-7#1)
stimulated anti-Stokes-Raman scattering##2##3##(2008-2#2)
stimulated apoptosis##2##2##(2008-10#1)(2010-12#1)
stimulated approximately##2##2##(1992-6#1)(1996-7#1)
stimulated area##2##2##(1996-8#1)(2008-7#1)
stimulated at a##2##3##(1997-3#1)(2005-4#1)
stimulated at##8##2##(1990-3#1)(1990-4#1)(1991-4#1)(1991-8#1)(1993-8#1)(1995-11#1)(1997-3#1)(2005-4#1)
stimulated both##6##2##(1990-9#1)(1992-6#1)(1994-12#1)(1996-4#1)(1996-8#1)(2008-10#1)
stimulated by 1##2##3##(1990-11#1)(1991-7#1)
stimulated by 10##2##3##(1993-2#1)(1995-10#1)
stimulated by 7##2##3##(1990-12#1)(1994-8#1)
stimulated by Ca2+##3##3##(1990-11#1)(1994-3#1)(2007-12#1)
stimulated by GH##2##3##(1994-2#1)(1995-10#1)
stimulated by IGF-I##3##3##(1990-10#1)(1991-5#1)(1996-11#1)
stimulated by Na+##2##3##(1990-11#2)
stimulated by TNF##2##3##(1991-1#2)
stimulated by a##7##3##(1990-7#1)(1992-6#1)(1995-8#2)(1996-12#1)(2008-4#1)(2008-5#1)
stimulated by all##3##3##(1995-12#1)(1996-8#1)(1997-1#1)
stimulated by cAMP##2##3##(1990-7#1)(1995-10#1)
stimulated by carbachol##2##3##(1991-2#1)(1995-7#1)
stimulated by either##3##3##(1994-3#1)(1995-8#1)(2007-1#1)
stimulated by exogenous##5##3##(1991-7#1)(1992-1#1)(1994-3#1)(1996-7#1)(1997-2#1)
stimulated by fMLP##2##3##(1996-5#1)(2012-12#1)
stimulated by growth##2##3##(1994-2#1)(2007-9#1)
stimulated by insulin##2##3##(1990-10#1)(1994-11#1)
stimulated by microinjection of##2##4##(1995-3#1)(1996-9#1)
stimulated by noradrenaline##2##3##(1993-11#1)(1995-9#1)
stimulated by parathyroid hormone##3##4##(1991-7#1)(1991-8#1)(1993-6#1)
stimulated by phorbol 12-myristate 13-acetate##2##5##(1990-11#1)(1992-6#1)
stimulated by phorbol##4##3##(1990-11#1)(1990-12#1)(1992-6#1)(1995-6#1)
stimulated by spermine##3##3##(1990-3#2)(1991-8#1)
stimulated by tetrachlorohydroquinone##2##3##(2009-3#2)
stimulated by the addition of##2##5##(1993-9#1)(2008-11#1)
stimulated by the presence of##4##5##(1990-5#1)(1991-5#1)(1991-9#1)(1996-5#1)
stimulated by the##27##3##(1990-5#1)(1990-8#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-3#2)(1994-6#1)(1994-9#1)(1996-11#2)(1996-5#1)(1997-5#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-1#1)(2010-12#1)(2012-1#1)
stimulated by these##2##3##(1995-11#1)(2008-6#1)
stimulated by transforming growth##2##4##(1990-10#1)(2006-9#1)
stimulated by various##3##3##(1990-7#1)(1994-6#1)(1995-6#1)
stimulated by##238##2##(1990-10#3)(1990-11#8)(1990-12#4)(1990-2#5)(1990-3#5)(1990-5#4)(1990-7#5)(1990-8#2)(1990-9#2)(1991-1#6)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-5#2)(1991-6#1)(1991-7#6)(1991-8#3)(1991-9#4)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#5)(1992-7#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#4)(1993-6#1)(1993-8#1)(1993-9#2)(1994-10#2)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#10)(1994-6#5)(1994-8#5)(1994-9#3)(1995-1#1)(1995-10#3)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#3)(1995-7#2)(1995-8#8)(1995-9#1)(1996-11#5)(1996-12#3)(1996-5#7)(1996-7#2)(1996-8#2)(1996-9#3)(1997-1#2)(1997-2#1)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#1)(2004-4#1)(2005-10#1)(2005-12#1)(2005-4#1)(2005-8#1)(2006-10#2)(2006-6#1)(2006-9#1)(2007-1#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-9#2)(2008-10#4)(2008-11#4)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#3)(2011-1#1)(2012-1#2)(2012-12#1)(2012-2#2)(2013-8#1)
stimulated cAMP formation in##4##4##(1991-9#1)(1993-12#1)(1995-6#1)(1997-8#1)
stimulated cAMP formation##5##3##(1991-9#1)(1993-12#1)(1994-9#1)(1995-6#1)(1997-8#1)
stimulated cAMP production##2##3##(1994-12#1)(1996-5#1)
stimulated cAMP##7##2##(1991-9#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-6#1)(1996-5#1)(1997-8#1)
stimulated cell growth##3##3##(1991-2#1)(1993-12#1)(2007-11#1)
stimulated cell proliferation##5##3##(1992-5#1)(1994-12#1)(1994-2#1)(1995-10#1)(2008-11#1)
stimulated cell##8##2##(1991-2#1)(1992-5#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-10#1)(2007-11#1)(2008-11#1)
stimulated cells from##2##3##(1992-2#1)(2007-2#1)
stimulated cells##8##2##(1992-12#1)(1992-2#1)(1994-12#1)(1994-3#2)(1997-4#1)(2007-2#1)(2012-2#1)
stimulated conditions##3##2##(1992-4#1)(2007-11#1)(2008-8#1)
stimulated contractile##2##2##(1995-3#1)(1997-5#1)
stimulated contractions of the##2##4##(1992-3#1)(1993-3#1)
stimulated during##3##2##(1996-1#1)(1997-2#1)(2011-1#1)
stimulated either##2##2##(1991-1#1)(1994-2#1)
stimulated electrically##3##2##(1992-9#1)(1993-12#1)(2008-9#1)
stimulated emission and##2##3##(2007-11#1)(2008-3#1)
stimulated emission from##2##3##(2007-11#1)(2008-3#1)
stimulated emission##14##2##(2006-4#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#3)
stimulated endothelial##2##2##(1990-11#1)(1995-8#1)
stimulated enzyme##2##2##(1994-9#1)(1997-8#1)
stimulated for the##2##3##(1990-7#1)(2012-1#1)
stimulated for##6##2##(1990-7#1)(1993-6#1)(1994-6#1)(1997-3#1)(2012-1#1)(2013-8#1)
stimulated formation of##2##3##(1994-2#1)(2008-11#1)
stimulated four-wave mixing##3##3##(2007-11#3)
stimulated glucose transport##2##3##(1992-11#1)(1997-1#1)
stimulated glucose uptake##3##3##(1990-8#1)(1994-12#1)(2008-1#1)
stimulated glucose##6##2##(1990-8#1)(1992-11#1)(1994-12#1)(1994-6#1)(1997-1#1)(2008-1#1)
stimulated group##3##2##(1995-3#1)(2007-10#2)
stimulated growth##2##2##(1991-8#1)(1992-7#1)
stimulated guanylate cyclase activity##3##4##(1990-3#1)(1994-9#2)
stimulated human##10##2##(1991-3#1)(1991-9#1)(1992-5#1)(1992-6#1)(1993-11#1)(1994-12#1)(1994-5#1)(1995-8#1)(2008-5#2)
stimulated in a##3##3##(1990-3#1)(1991-12#1)(2008-8#1)
stimulated in the##4##3##(1990-12#1)(1991-2#1)(2008-6#1)(2008-9#1)
stimulated in vitro with##5##4##(1992-11#1)(1995-8#1)(1996-10#1)(2008-5#1)(2012-1#1)
stimulated in vitro##9##3##(1991-11#1)(1992-11#1)(1992-5#1)(1994-9#1)(1995-8#1)(1996-10#1)(2008-4#1)(2008-5#1)(2012-1#1)
stimulated in##23##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-5#1)(1993-11#1)(1994-11#1)(1994-9#1)(1995-8#1)(1996-10#1)(2005-10#1)(2006-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-1#2)
stimulated inositol trisphosphate production##2##4##(1990-8#1)(1993-3#1)
stimulated insulin secretion##4##3##(1990-12#1)(1991-7#1)(1991-8#1)(1997-4#1)
stimulated insulin##5##2##(1990-12#1)(1991-7#1)(1991-8#1)(1995-8#1)(1997-4#1)
stimulated invasion of##2##3##(1993-9#1)(2008-4#1)
stimulated its##2##2##(1994-2#1)(1997-2#1)
stimulated luminescence##2##2##(2008-10#2)
stimulated lymphocytes##3##2##(1991-9#1)(1996-4#1)(2008-11#1)
stimulated macrophages##3##2##(1990-2#1)(1992-9#1)(1994-3#1)
stimulated much##2##2##(2006-10#1)(2008-5#1)
stimulated muscle##3##2##(1992-11#1)(1995-3#1)(1995-8#1)
stimulated neutrophils##2##2##(1993-11#1)(1994-3#1)
stimulated nitric oxide##2##3##(1994-11#1)(1997-6#1)
stimulated or##4##2##(1991-5#1)(1997-5#1)(2006-10#1)(2008-9#1)
stimulated pancreatic##4##2##(1991-2#2)(1992-6#1)(1996-4#1)
stimulated peripheral blood##3##3##(1992-8#1)(1995-2#1)(2010-6#1)
stimulated phosphoinositide metabolism at a##2##5##(1993-12#2)
stimulated phosphoinositide##4##2##(1990-2#1)(1993-12#3)
stimulated phosphorylation of a##2##4##(1993-3#1)(1994-8#1)
stimulated phosphorylation of##6##3##(1993-1#1)(1993-3#1)(1994-8#1)(1995-3#2)(2011-1#1)
stimulated photon echoes##4##3##(2007-11#1)(2007-12#3)
stimulated plasma##2##2##(2006-10#1)(2008-1#1)
stimulated production of##5##3##(1991-11#1)(1992-9#1)(1995-10#2)(2010-12#1)
stimulated proliferation of##3##3##(1994-2#1)(2008-11#1)(2010-12#1)
stimulated proliferation##7##2##(1994-2#1)(1995-10#1)(2008-11#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-12#1)
stimulated prostacyclin##2##2##(1991-5#1)(1994-5#1)
stimulated protein synthesis##3##3##(2008-11#3)
stimulated protein##4##2##(1995-11#1)(2008-11#3)
stimulated rat##2##2##(1994-12#1)(1994-6#1)
stimulated release of##4##3##(1993-2#3)(1993-3#1)
stimulated release##7##2##(1993-2#3)(1993-3#1)(1995-12#3)
stimulated research to##2##3##(1991-12#1)(2008-1#1)
stimulated research##5##2##(1991-12#1)(1994-12#1)(2008-1#1)(2008-6#1)(2008-7#1)
stimulated response##2##2##(1995-12#1)(2006-1#1)
stimulated saliva##3##2##(2007-11#1)(2011-12#1)(2012-12#1)
stimulated secretion of##2##3##(1992-6#1)(2006-9#1)
stimulated several fold##2##3##(1992-12#1)(1996-5#1)
stimulated state##2##2##(1994-10#1)(2010-2#1)
stimulated syngeneic##2##2##(1993-4#1)(1994-6#1)
stimulated synthesis of##2##3##(1994-9#1)(1995-7#1)
stimulated synthesis##3##2##(1994-6#1)(1994-9#1)(1995-7#1)
stimulated the ATPase activity##3##4##(1993-3#1)(1997-6#1)(1997-7#1)
stimulated the DNA##2##3##(1992-6#1)(1996-8#1)
stimulated the GTPase##2##3##(1992-11#1)(1995-5#1)
stimulated the Na+##2##3##(1990-2#2)
stimulated the activity of##4##4##(1994-2#1)(1995-2#1)(1996-10#1)(2005-11#1)
stimulated the activity##6##3##(1992-6#1)(1993-8#1)(1994-2#1)(1995-2#1)(1996-10#1)(2005-11#1)
stimulated the expression of##4##4##(1996-8#1)(1997-2#1)(2008-11#1)(2011-1#1)
stimulated the formation of inositol phosphates##2##6##(1990-9#1)(1994-2#1)
stimulated the formation of inositol##3##5##(1990-7#1)(1990-9#1)(1994-2#1)
stimulated the growth of##7##4##(1990-7#1)(1991-10#1)(1993-9#1)(1995-3#1)(1995-5#1)(2006-8#1)(2008-11#1)
stimulated the incorporation of##3##4##(1990-11#1)(1991-3#1)(1995-3#1)
stimulated the phosphorylation of##3##4##(1990-4#1)(1997-6#1)(2008-10#1)
stimulated the production of##6##4##(1990-7#1)(1992-4#2)(2008-10#2)(2008-3#1)
stimulated the proliferation of##2##4##(1991-9#1)(2008-11#1)
stimulated the proliferation##4##3##(1991-9#1)(2008-11#3)
stimulated the release of 45Ca and##2##6##(1991-3#1)(1995-3#1)
stimulated the release of##7##4##(1991-3#1)(1993-8#1)(1994-8#1)(1995-3#2)(1997-4#1)(2008-5#1)
stimulated the release##8##3##(1991-3#1)(1991-8#1)(1993-8#1)(1994-8#1)(1995-3#2)(1997-4#1)(2008-5#1)
stimulated the synthesis of##3##4##(1992-6#1)(1993-3#1)(1996-2#1)
stimulated the synthesis##4##3##(1992-6#1)(1992-9#1)(1993-3#1)(1996-2#1)
stimulated the##112##2##(1990-11#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-7#4)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-2#5)(1991-3#2)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-4#4)(1992-6#3)(1992-8#1)(1992-9#1)(1993-3#2)(1993-4#1)(1993-8#2)(1993-9#1)(1994-12#3)(1994-2#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#5)(1995-5#2)(1995-8#1)(1996-10#2)(1996-11#1)(1996-2#2)(1996-5#1)(1996-6#1)(1996-8#2)(1997-2#2)(1997-4#1)(1997-6#4)(1997-7#1)(1997-8#2)(2005-11#1)(2006-8#1)(2008-10#3)(2008-11#9)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
stimulated thermal scattering##2##3##(2008-2#2)
stimulated through a##2##3##(1996-8#1)(2008-4#1)
stimulated through the##2##3##(1992-4#1)(2008-4#1)
stimulated through##4##2##(1992-4#1)(1996-8#1)(2008-4#2)
stimulated to a greater extent##2##5##(1990-5#1)(1993-3#1)
stimulated to a##3##3##(1990-5#1)(1991-6#1)(1993-3#1)
stimulated to express##2##3##(1993-6#1)(1995-12#1)
stimulated to produce##2##3##(1993-4#1)(2008-10#1)
stimulated to proliferate by##2##4##(2008-4#1)(2012-2#1)
stimulated to proliferate##5##3##(1990-12#1)(1990-6#1)(2008-4#1)(2008-7#1)(2012-2#1)
stimulated to##23##2##(1990-12#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-6#2)(1992-12#1)(1992-2#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-8#1)(1997-6#1)(2006-5#1)(2008-10#1)(2008-4#2)(2008-7#1)(2012-2#1)
stimulated transcription in##2##3##(1990-12#1)(1990-8#1)
stimulated transcription##3##2##(1990-12#1)(1990-8#1)(1995-10#1)
stimulated two##2##2##(1991-2#1)(1994-2#1)
stimulated tyrosine phosphorylation of##3##4##(1994-12#1)(1994-9#1)(1996-5#1)
stimulated up to##2##3##(1994-9#1)(1996-5#1)
stimulated vortex gyration##2##3##(2012-2#2)
stimulated whole##2##2##(2008-9#1)(2013-8#1)
stimulated with LPS##4##3##(1993-9#1)(1994-3#1)(2006-8#1)(2008-11#1)
stimulated with LPS-A##5##3##(2006-8#5)
stimulated with a##3##3##(1990-2#1)(1992-6#1)(2010-12#1)
stimulated with antigen and##2##4##(1991-12#1)(1992-7#1)
stimulated with antigen##3##3##(1991-12#1)(1992-7#1)(1993-3#1)
stimulated with concanavalin A##2##4##(1991-8#1)(2008-11#1)
stimulated with different##4##3##(1996-2#2)(2008-10#2)
stimulated with growth factors##2##4##(1991-5#1)(1993-6#1)
stimulated with hVEGF(165)##2##3##(2008-8#2)
stimulated with lipopolysaccharide##2##3##(1993-3#1)(2006-8#1)
stimulated with opsonized zymosan##2##4##(1991-2#1)(1992-8#1)
stimulated with phorbol##3##3##(1994-6#1)(1994-8#1)(1994-9#1)
stimulated with the##9##3##(1991-5#2)(1994-6#1)(1994-8#1)(2007-8#1)(2008-5#1)(2008-8#2)(2012-12#1)
stimulated with thrombin##2##3##(1992-6#1)(1997-7#1)
stimulated with##95##2##(1990-11#1)(1990-2#3)(1990-3#1)(1990-4#1)(1990-7#4)(1990-9#1)(1991-10#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#3)(1991-6#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-9#3)(1994-10#2)(1994-3#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#2)(1997-2#1)(1997-7#2)(1997-8#2)(2006-10#2)(2006-8#7)(2007-8#1)(2008-10#3)(2008-11#6)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#5)(2010-12#1)(2010-2#1)(2011-2#2)(2012-12#1)
stimulated within##4##2##(1991-10#1)(1991-6#1)(1991-7#1)(2007-1#1)
stimulated##1177##1##(1990-10#6)(1990-11#16)(1990-12#10)(1990-2#15)(1990-3#14)(1990-4#4)(1990-5#10)(1990-6#2)(1990-7#20)(1990-8#8)(1990-9#10)(1991-1#12)(1991-10#6)(1991-11#6)(1991-12#9)(1991-2#21)(1991-3#10)(1991-4#1)(1991-5#12)(1991-6#7)(1991-7#12)(1991-8#11)(1991-9#14)(1992-1#1)(1992-11#10)(1992-12#9)(1992-2#5)(1992-3#3)(1992-4#11)(1992-5#4)(1992-6#23)(1992-7#5)(1992-8#9)(1992-9#10)(1993-1#1)(1993-11#16)(1993-12#8)(1993-2#6)(1993-3#19)(1993-4#3)(1993-6#9)(1993-7#2)(1993-8#6)(1993-9#9)(1994-10#5)(1994-11#12)(1994-12#22)(1994-2#15)(1994-3#22)(1994-5#4)(1994-6#15)(1994-8#15)(1994-9#18)(1995-1#4)(1995-10#13)(1995-11#10)(1995-12#13)(1995-2#7)(1995-3#18)(1995-5#5)(1995-6#4)(1995-7#4)(1995-8#18)(1995-9#1)(1996-1#4)(1996-10#3)(1996-11#10)(1996-12#6)(1996-2#8)(1996-4#3)(1996-5#16)(1996-6#1)(1996-7#4)(1996-8#11)(1996-9#5)(1997-1#10)(1997-2#9)(1997-3#3)(1997-4#5)(1997-5#5)(1997-6#14)(1997-7#8)(1997-8#9)(2004-12#1)(2004-4#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-4#2)(2005-7#1)(2005-8#1)(2006-1#3)(2006-10#16)(2006-12#3)(2006-3#1)(2006-4#4)(2006-5#6)(2006-6#1)(2006-7#2)(2006-8#9)(2006-9#3)(2007-1#3)(2007-10#4)(2007-11#30)(2007-12#37)(2007-2#1)(2007-3#1)(2007-5#2)(2007-8#3)(2007-9#4)(2008-1#10)(2008-10#36)(2008-11#35)(2008-2#21)(2008-3#11)(2008-4#18)(2008-5#11)(2008-6#4)(2008-7#9)(2008-8#14)(2008-9#8)(2009-10#2)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#2)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#8)(2010-2#6)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#7)(2011-12#2)(2011-2#12)(2012-1#5)(2012-12#7)(2012-2#8)(2012-6#1)(2013-1#6)(2013-8#4)
stimulated-Brillouin-scattering resonator##2##2##(2007-12#2)
stimulates 45Ca2+ uptake in##2##4##(1990-7#2)
stimulates Ca2+##2##2##(1990-2#1)(1994-3#1)
stimulates DNA synthesis in##3##4##(1994-3#1)(1995-11#1)(1997-1#1)
stimulates DNA synthesis##4##3##(1991-10#1)(1994-3#1)(1995-11#1)(1997-1#1)
stimulates DNA##5##2##(1991-10#1)(1994-3#1)(1994-7#1)(1995-11#1)(1997-1#1)
stimulates T##3##2##(1992-9#1)(1996-10#1)(2006-1#1)
stimulates a rapid##2##3##(1990-3#1)(1993-6#1)
stimulates a##8##2##(1990-3#1)(1990-8#1)(1991-10#1)(1993-6#1)(1994-12#1)(1997-4#1)(2008-8#1)(2012-3#1)
stimulates adenylyl cyclase##2##3##(1992-11#1)(1995-3#1)
stimulates angiogenesis##2##2##(1992-9#1)(2012-1#1)
stimulates binding##3##2##(1991-11#1)(1992-12#1)(1997-5#1)
stimulates bone##2##2##(1997-7#1)(2010-10#1)
stimulates c-fos##2##2##(1994-9#1)(1996-12#1)
stimulates cAMP##2##2##(1993-12#1)(1995-1#1)
stimulates calcium##2##2##(1993-11#1)(1997-1#1)
stimulates cardiac##2##2##(1992-3#1)(2010-8#1)
stimulates cell proliferation##3##3##(1990-11#1)(1996-5#1)(2008-4#1)
stimulates cell##5##2##(1990-11#1)(1996-5#1)(1997-6#1)(2008-4#1)(2012-12#1)
stimulates cells##2##2##(1996-11#1)(2008-4#1)
stimulates cellular##2##2##(1992-5#1)(1997-7#1)
stimulates endothelial##2##2##(1990-9#1)(1994-7#1)
stimulates expression of##2##3##(2011-2#1)(2012-12#1)
stimulates expression##3##2##(1994-9#1)(2011-2#1)(2012-12#1)
stimulates food##2##2##(2008-3#1)(2013-8#1)
stimulates gastric##2##2##(1991-2#1)(1996-9#1)
stimulates glucose transport##2##3##(1991-5#1)(1994-11#1)
stimulates glucose##5##2##(1991-5#1)(1994-11#1)(1994-12#1)(1997-8#1)(2008-3#1)
stimulates glutamate##2##2##(1994-8#1)(1997-4#1)
stimulates growth of##3##3##(1991-2#1)(1991-3#1)(1993-9#1)
stimulates growth##4##2##(1991-2#1)(1991-3#1)(1993-9#1)(2008-4#1)
stimulates human##3##2##(1992-1#1)(1994-11#1)(1995-2#1)
stimulates in##2##2##(1991-9#1)(1994-2#1)
stimulates insulin secretion##2##3##(1991-8#1)(2007-5#1)
stimulates insulin##6##2##(1991-8#1)(1994-2#1)(1994-6#1)(1994-8#1)(1997-4#1)(2007-5#1)
stimulates intracellular##3##2##(1997-7#1)(2009-3#1)(2010-2#1)
stimulates invasion and growth of##2##5##(1993-9#2)
stimulates mitochondrial##2##2##(1991-2#1)(2012-3#1)
stimulates mitogenesis in##2##3##(1993-8#2)
stimulates mitogenesis##4##2##(1993-8#2)(1995-3#1)(1997-7#1)
stimulates neurite outgrowth##2##3##(1997-6#1)(2008-4#1)
stimulates osteoblast mitogenesis and##2##4##(1993-8#2)
stimulates osteoblasts##2##2##(1997-7#1)(2007-11#1)
stimulates phosphatidylinositol##2##2##(1990-10#1)(1991-8#1)
stimulates phosphorylation of##2##3##(1991-2#1)(1997-6#1)
stimulates production of##2##3##(1994-6#1)(1996-1#1)
stimulates production##3##2##(1994-6#1)(1996-1#1)(2006-9#1)
stimulates proliferation and differentiation of##2##5##(1993-9#1)(2008-11#1)
stimulates proliferation and differentiation##3##4##(1993-9#1)(1994-12#1)(2008-11#1)
stimulates proliferation and##4##3##(1993-9#1)(1994-12#1)(1995-1#1)(2008-11#1)
stimulates proliferation of##3##3##(1993-8#1)(2004-12#1)(2008-6#1)
stimulates proliferation##7##2##(1993-8#1)(1993-9#1)(1994-12#1)(1995-1#1)(2004-12#1)(2008-11#1)(2008-6#1)
stimulates prostacyclin production in##2##4##(1991-8#1)(1991-9#1)
stimulates prostacyclin production##4##3##(1991-8#1)(1991-9#1)(1994-9#2)
stimulates protein kinase C##3##4##(1990-11#1)(1990-9#1)(1993-4#1)
stimulates protein##6##2##(1990-11#1)(1990-9#1)(1991-2#1)(1993-4#1)(1995-11#1)(1997-8#1)
stimulates pyruvate kinase activity in confluent-phase##2##6##(1995-12#2)
stimulates rapid##2##2##(1993-6#1)(1995-11#1)
stimulates release of##2##3##(1992-6#1)(2008-1#1)
stimulates secretion of##3##3##(1991-5#1)(1993-8#1)(1995-4#1)
stimulates synthesis##2##2##(1990-9#1)(2005-7#1)
stimulates the activity of##2##4##(1994-8#1)(1996-2#1)
stimulates the expression of##4##4##(1992-6#1)(1994-11#1)(1994-9#1)(1996-8#1)
stimulates the formation of##4##4##(1990-3#1)(1993-8#1)(1994-2#1)(2008-8#1)
stimulates the growth of some##2##5##(1994-10#1)(2006-8#1)
stimulates the growth of##5##4##(1991-2#1)(1992-11#1)(1994-10#1)(2006-8#1)(2007-11#1)
stimulates the mitochondrial metabolism transmitted by the##2##7##(1994-8#2)
stimulates the parietal cell directly via##4##6##(2006-10#4)
stimulates the parietal cell##5##4##(2006-10#5)
stimulates the phosphorylation of##2##4##(1996-2#1)(2009-3#1)
stimulates the production of##2##4##(1992-12#1)(1992-4#1)
stimulates the release of##6##4##(1992-11#1)(1995-1#1)(1995-11#1)(1995-12#1)(2011-1#1)(2013-1#1)
stimulates the secretion of##3##4##(1990-12#1)(1990-9#1)(1996-12#1)
stimulates the synthesis of##2##4##(1992-6#1)(2008-5#1)
stimulates the##84##2##(1990-12#1)(1990-3#1)(1990-5#3)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#3)(1991-5#1)(1992-11#3)(1992-12#1)(1992-4#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#3)(1993-8#1)(1994-10#1)(1994-11#3)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-6#2)(1996-12#1)(1996-2#2)(1996-8#1)(1997-6#2)(1997-7#1)(1997-8#1)(2006-10#6)(2006-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#3)(2009-10#2)(2009-3#1)(2010-1#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#2)
stimulates their##3##2##(1990-11#1)(1995-10#1)(2009-10#1)
stimulates thymidine incorporation##2##3##(1991-10#1)(1992-8#1)
stimulates tyrosine phosphorylation of##2##4##(1992-10#2)
stimulates uterine##2##2##(1995-10#1)(2008-4#1)
stimulates vascular##2##2##(1991-5#1)(1995-12#1)
stimulates##374##1##(1990-10#3)(1990-11#7)(1990-12#1)(1990-2#1)(1990-3#3)(1990-5#3)(1990-6#2)(1990-7#5)(1990-8#1)(1990-9#5)(1991-1#1)(1991-10#6)(1991-11#1)(1991-12#2)(1991-2#13)(1991-3#1)(1991-5#6)(1991-7#1)(1991-8#3)(1991-9#3)(1992-1#2)(1992-10#2)(1992-11#5)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#6)(1992-7#1)(1992-8#4)(1992-9#6)(1993-11#4)(1993-12#3)(1993-3#3)(1993-4#1)(1993-6#6)(1993-8#8)(1993-9#6)(1994-10#1)(1994-11#7)(1994-12#6)(1994-2#3)(1994-3#5)(1994-5#5)(1994-6#3)(1994-7#2)(1994-8#9)(1994-9#6)(1995-1#3)(1995-10#4)(1995-11#8)(1995-12#8)(1995-2#2)(1995-3#7)(1995-4#1)(1995-5#1)(1995-6#4)(1995-8#1)(1996-1#1)(1996-10#2)(1996-11#4)(1996-12#2)(1996-2#2)(1996-5#5)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#1)(1997-4#5)(1997-5#3)(1997-6#5)(1997-7#7)(1997-8#4)(2004-12#2)(2005-1#1)(2005-12#1)(2005-7#2)(2006-1#3)(2006-10#8)(2006-7#1)(2006-8#3)(2006-9#2)(2007-11#6)(2007-12#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#8)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#1)(2009-10#4)(2009-3#3)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-2#2)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#3)(2012-12#3)(2012-3#3)(2013-1#2)(2013-8#1)
stimulating T##2##2##(1997-6#1)(2011-1#1)
stimulating a##3##2##(1996-12#1)(2007-11#1)(2012-2#1)
stimulating activation##2##2##(1990-2#1)(2010-2#1)
stimulating activities##5##2##(1991-10#1)(1991-12#1)(1991-9#2)(1994-12#1)
stimulating activity of##6##3##(1990-4#1)(1991-5#1)(1994-8#1)(2008-11#3)
stimulating activity was##2##3##(1990-7#1)(1991-9#1)
stimulating activity##14##2##(1990-4#1)(1990-7#1)(1991-5#1)(1991-9#2)(1992-9#2)(1993-3#1)(1994-12#2)(1994-8#1)(2008-11#3)
stimulating agent##3##2##(1990-7#1)(1992-9#1)(2008-4#1)
stimulating agents##2##2##(2008-11#1)(2008-4#1)
stimulating and##3##2##(1997-6#1)(2008-4#1)(2013-7#1)
stimulating angiogenesis##3##2##(1990-4#1)(2007-11#1)(2012-3#1)
stimulating antibodies##4##2##(1990-9#1)(1991-8#1)(1991-9#1)(1994-11#1)
stimulating antigen##2##2##(2008-4#2)
stimulating concentrations of##2##3##(1990-5#2)
stimulating cytokine##2##2##(2008-5#1)(2008-8#1)
stimulating effect of ET-1##2##4##(1994-8#2)
stimulating effect of##9##3##(1992-12#1)(1993-5#1)(1994-8#2)(1996-10#1)(1996-2#1)(2008-11#1)(2010-12#2)
stimulating effect on antibody production##2##5##(2008-11#2)
stimulating effect on##8##3##(1993-12#1)(1995-11#1)(1997-2#2)(2006-12#1)(2008-11#2)(2009-2#1)
stimulating effect##18##2##(1992-12#1)(1993-12#1)(1993-5#1)(1994-8#2)(1995-11#1)(1996-10#1)(1996-2#1)(1997-2#2)(2006-12#1)(2008-11#3)(2009-2#1)(2010-12#2)(2012-3#1)
stimulating effects of##2##3##(1993-6#1)(1994-2#1)
stimulating effects##6##2##(1993-6#1)(1994-2#1)(1995-3#1)(1996-5#1)(1997-3#1)(2012-3#1)
stimulating either the##2##3##(1996-1#1)(1997-5#1)
stimulating factor (M-CSF)##3##3##(1991-5#1)(2007-11#1)(2008-11#1)
stimulating factor in##2##3##(1990-5#1)(2007-11#1)
stimulating factor##32##2##(1990-12#1)(1990-5#2)(1991-5#1)(1991-6#1)(1992-3#3)(1992-8#1)(1993-12#1)(1993-3#2)(1993-6#2)(1994-3#1)(1995-2#1)(1996-5#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-11#3)(2008-6#1)(2009-7#1)(2011-2#2)(2012-2#3)(2012-3#1)
stimulating factors##7##2##(1991-8#1)(2006-1#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)
stimulating glucose##2##2##(1993-8#1)(2008-11#1)
stimulating glutamate##2##2##(1990-12#1)(1997-4#1)
stimulating hormone (FSH)##9##3##(1990-11#1)(1991-3#1)(1993-11#2)(2007-7#1)(2011-2#1)(2012-12#1)(2012-2#2)
stimulating hormone (TSH)##8##3##(1990-8#1)(1994-9#1)(1995-5#1)(2006-1#1)(2007-9#1)(2008-6#1)(2010-7#1)(2011-12#1)
stimulating hormone##27##2##(1990-11#1)(1990-8#1)(1991-3#1)(1992-7#1)(1993-11#2)(1994-9#1)(1995-5#1)(2006-1#1)(2007-1#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#5)
stimulating hormone)##2##2##(1990-5#2)
stimulating human##2##2##(2008-2#1)(2013-8#1)
stimulating its##3##2##(1995-8#1)(1996-8#1)(2008-5#1)
stimulating proliferation##2##2##(1997-2#1)(2008-7#1)
stimulating protein##3##2##(1990-11#1)(2008-10#1)(2008-8#1)
stimulating sound-pulses##4##2##(2008-8#4)
stimulating the development of##2##4##(2008-7#1)(2008-9#1)
stimulating the immune##2##3##(2004-12#1)(2008-10#1)
stimulating the production of##4##4##(1990-8#1)(2010-2#1)(2010-3#1)(2012-3#1)
stimulating the synthesis of##2##4##(1993-9#1)(1995-8#1)
stimulating the##40##2##(1990-8#1)(1990-9#2)(1991-6#1)(1992-10#1)(1992-11#1)(1992-3#1)(1993-9#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-6#1)(2004-12#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-2#2)(2010-3#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
stimulating tyrosine phosphorylation##2##3##(1993-4#1)(1993-6#1)
stimulating##324##1##(1990-11#4)(1990-12#2)(1990-2#2)(1990-4#2)(1990-5#7)(1990-7#4)(1990-8#3)(1990-9#4)(1991-10#1)(1991-12#4)(1991-3#1)(1991-5#4)(1991-6#2)(1991-7#3)(1991-8#3)(1991-9#7)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#7)(1992-3#4)(1992-6#2)(1992-7#3)(1992-8#2)(1992-9#3)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#5)(1993-4#1)(1993-5#1)(1993-6#5)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#2)(1995-10#1)(1995-11#2)(1995-12#5)(1995-2#1)(1995-3#5)(1995-5#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-8#2)(1997-1#1)(1997-2#6)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#4)(1997-8#1)(2004-12#1)(2005-11#1)(2005-6#1)(2005-8#1)(2006-1#2)(2006-10#5)(2006-12#2)(2006-2#1)(2006-7#1)(2007-1#2)(2007-10#1)(2007-11#7)(2007-5#2)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#5)(2008-10#13)(2008-11#17)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#12)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#6)(2008-9#4)(2009-10#1)(2009-12#2)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#3)(2011-1#2)(2011-12#1)(2011-2#7)(2012-12#2)(2012-2#12)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#2)
stimulation (0##3##2##(1993-2#1)(1994-6#1)(2008-9#1)
stimulation (100##2##2##(1994-2#1)(2010-12#1)
stimulation (DBS)##12##2##(1996-9#1)(2005-10#1)(2008-1#1)(2008-11#1)(2009-8#1)(2009-9#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#2)
stimulation (HFS) of the##2##4##(1991-3#1)(1996-8#1)
stimulation (HFS)##3##2##(1991-3#1)(1996-8#1)(2009-5#1)
stimulation (P&lt##2##2##(2009-10#2)
stimulation activates##2##2##(1994-9#1)(2010-12#1)
stimulation also evoked EPSP-IPSP sequences##2##5##(1992-7#2)
stimulation also##6##2##(1991-9#1)(1992-7#2)(1992-8#1)(1994-6#1)(2012-2#1)
stimulation and inhibition of##3##4##(2007-10#1)(2008-11#1)(2008-8#1)
stimulation and was##2##3##(1991-8#1)(2007-8#1)
stimulation and##55##2##(1990-8#2)(1991-1#1)(1991-2#3)(1991-3#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#2)(1994-3#1)(1995-2#1)(1996-11#1)(1997-1#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-4#3)(2009-9#1)(2011-12#1)(2012-2#1)(2013-1#1)
stimulation appears to##2##3##(1992-9#1)(1996-12#1)
stimulation applied to##2##3##(1992-11#1)(2011-2#1)
stimulation applied##4##2##(1992-11#1)(1994-2#1)(2009-10#1)(2011-2#1)
stimulation are##5##2##(1994-2#2)(1996-9#1)(2006-10#1)(2007-11#1)
stimulation as a##2##3##(1993-5#1)(2008-11#1)
stimulation as##8##2##(1992-8#1)(1993-5#1)(1994-2#1)(1995-8#1)(1996-3#1)(1996-8#1)(2008-11#1)(2013-1#1)
stimulation assays##2##2##(2008-4#2)
stimulation associated with##2##3##(1991-12#1)(1994-9#1)
stimulation at 3##2##3##(2013-1#2)
stimulation at low frequency##2##4##(1996-5#1)(2012-2#1)
stimulation at low##3##3##(1993-4#1)(1996-5#1)(2012-2#1)
stimulation at##15##2##(1992-7#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-8#1)(1995-12#1)(1996-5#1)(1996-9#1)(2006-9#1)(2008-10#1)(2012-2#1)(2013-1#3)
stimulation both##2##2##(1994-6#1)(2008-6#1)
stimulation by TPA##2##3##(1990-9#1)(1996-8#1)
stimulation by a##2##3##(1990-5#1)(2008-8#1)
stimulation by both##2##3##(1990-5#1)(1995-8#1)
stimulation by extracellular##2##3##(2008-4#2)
stimulation by the##4##3##(1992-3#1)(1994-11#1)(1996-8#1)(2008-4#1)
stimulation by##70##2##(1990-11#1)(1990-3#1)(1990-5#4)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-11#3)(1992-3#1)(1992-6#3)(1992-8#1)(1993-12#1)(1993-3#2)(1993-7#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#3)(1995-3#2)(1995-8#2)(1996-11#2)(1996-2#2)(1996-7#1)(1996-8#4)(1997-6#1)(2007-10#1)(2007-11#1)(2008-11#6)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2010-12#1)
stimulation can be##3##3##(1996-9#1)(2008-4#1)(2010-4#1)
stimulation can##7##2##(1996-9#1)(2007-11#1)(2007-5#1)(2008-3#1)(2008-4#1)(2010-4#1)(2012-2#1)
stimulation caused##4##2##(1994-6#1)(1997-8#1)(2008-4#1)(2011-2#1)
stimulation causes##3##2##(1992-12#1)(1997-1#1)(2006-10#1)
stimulation compared with##2##3##(2007-12#1)(2008-2#1)
stimulation conditions##2##2##(2007-9#1)(2009-9#1)
stimulation could be##2##3##(1990-11#1)(1994-10#1)
stimulation could##5##2##(1990-11#1)(1991-2#1)(1993-8#1)(1994-10#1)(2008-9#1)
stimulation decreased##2##2##(1993-3#1)(2009-10#1)
stimulation depended on the##3##4##(1994-12#1)(1994-9#1)(2013-1#1)
stimulation depending##2##2##(2008-4#1)(2013-1#1)
stimulation did not##9##3##(1991-1#1)(1992-12#1)(1994-12#2)(1995-6#1)(1996-1#1)(1996-5#2)(2006-7#1)
stimulation did##10##2##(1991-1#1)(1991-3#1)(1992-12#1)(1994-12#2)(1995-6#1)(1996-1#1)(1996-5#2)(2006-7#1)
stimulation do not##2##3##(1994-2#1)(1996-9#1)
stimulation due to##2##3##(1990-12#1)(1991-6#1)
stimulation during the##3##3##(1992-7#1)(1994-2#1)(2013-8#1)
stimulation during##7##2##(1992-3#1)(1992-7#1)(1994-2#1)(1996-9#1)(2007-2#1)(2011-1#1)(2013-8#1)
stimulation encoding strategy for##2##4##(2009-12#2)
stimulation encoding strategy##3##3##(2009-12#3)
stimulation evoked a##3##3##(1991-2#1)(1993-12#1)(1996-12#1)
stimulation evoked##4##2##(1991-2#1)(1993-12#1)(1996-12#2)
stimulation factor##2##2##(1995-6#1)(1996-2#1)
stimulation followed by##2##3##(1990-11#1)(1995-7#1)
stimulation for neuropathic pain##2##4##(2006-3#1)(2008-9#1)
stimulation for the treatment of##2##5##(2006-8#1)(2010-6#1)
stimulation for the##4##3##(1992-6#1)(2006-8#1)(2009-8#1)(2010-6#1)
stimulation for treatment of##2##4##(2006-8#1)(2013-7#1)
stimulation for##27##2##(1990-7#1)(1992-6#1)(1995-11#1)(1996-9#1)(1997-2#1)(2006-3#3)(2006-8#2)(2008-1#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#3)(2012-2#1)(2013-1#1)(2013-7#1)
stimulation frequency##4##2##(1993-6#1)(1996-12#3)
stimulation from the##2##3##(1997-3#1)(2006-11#1)
stimulation from##3##2##(1997-3#1)(2006-11#1)(2009-4#1)
stimulation had##2##2##(1990-2#1)(2012-2#1)
stimulation has been##5##3##(1990-7#1)(1997-3#1)(2007-10#1)(2008-4#1)(2010-12#1)
stimulation has##8##2##(1990-7#1)(1996-1#1)(1997-3#1)(2007-10#1)(2008-4#1)(2009-10#1)(2010-12#2)
stimulation improves##4##2##(1992-8#2)(2012-2#1)(2012-3#1)
stimulation in a##8##3##(1990-10#1)(1990-12#1)(1990-2#1)(1994-5#1)(1994-6#1)(2009-8#1)(2009-9#1)(2012-3#1)
stimulation in humans##3##3##(1993-12#1)(1995-3#1)(2010-7#1)
stimulation in rat hippocampal##2##4##(1994-2#1)(1995-3#1)
stimulation in rat##3##3##(1990-2#1)(1994-2#1)(1995-3#1)
stimulation in rats##2##3##(1990-2#1)(1992-9#1)
stimulation in symptomatic##2##3##(1991-3#1)(2010-7#1)
stimulation in the presence of##2##5##(1990-4#1)(1997-5#1)
stimulation in the treatment of chronic##2##6##(1991-2#1)(2010-12#1)
stimulation in the##22##3##(1990-4#2)(1991-2#1)(1991-5#4)(1991-6#1)(1992-9#2)(1993-11#1)(1993-2#1)(1994-2#1)(1994-8#1)(1996-11#1)(1997-5#1)(2008-1#1)(2008-2#1)(2008-7#1)(2010-12#1)(2010-6#1)(2013-1#1)
stimulation in vitro##2##3##(1994-3#1)(2011-1#1)
stimulation in##97##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#3)(1990-4#3)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#4)(1991-6#1)(1992-6#1)(1992-9#5)(1993-11#2)(1993-12#2)(1993-2#2)(1993-8#1)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-3#2)(1996-1#2)(1996-11#2)(1996-2#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#2)(2006-10#2)(2006-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-7#3)(2008-9#3)(2009-4#1)(2009-8#2)(2009-9#2)(2010-12#2)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#5)(2012-3#2)(2013-1#2)(2013-7#2)
stimulation increased the##2##3##(1996-6#1)(2007-4#1)
stimulation increased##5##2##(1993-3#1)(1996-6#1)(2007-4#1)(2009-6#1)(2011-2#1)
stimulation index (SI)##2##3##(2008-5#1)(2011-2#1)
stimulation index of##2##3##(2008-10#2)
stimulation index##7##2##(1992-8#1)(2008-10#2)(2008-5#1)(2010-4#2)(2011-2#1)
stimulation induced by##3##3##(1996-4#2)(2008-4#1)
stimulation induced##11##2##(1993-11#1)(1994-10#1)(1994-9#1)(1996-3#1)(1996-4#2)(1997-3#1)(1997-7#1)(2006-7#1)(2006-8#1)(2008-4#1)
stimulation induces a##2##3##(1991-5#1)(1994-12#1)
stimulation is a##4##3##(1993-2#1)(1996-4#1)(2006-12#1)(2013-7#1)
stimulation is an##2##3##(1991-2#1)(2006-3#1)
stimulation is associated with##3##4##(2006-10#1)(2013-1#2)
stimulation is not##3##3##(1991-12#1)(1991-3#1)(1993-12#1)
stimulation is the##3##3##(1994-2#1)(2006-8#1)(2009-8#1)
stimulation is##33##2##(1990-12#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#1)(1993-12#1)(1993-2#1)(1994-2#2)(1995-11#1)(1996-3#1)(1996-4#1)(1996-9#1)(2006-10#2)(2006-12#1)(2006-3#3)(2006-7#1)(2006-8#2)(2009-5#1)(2009-8#1)(2010-12#1)(2010-7#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-7#1)
stimulation lasted##2##2##(1991-8#1)(2012-3#1)
stimulation mapping##3##2##(2008-9#2)(2010-2#1)
stimulation may be##2##3##(1991-12#1)(2006-7#1)
stimulation may##9##2##(1990-4#1)(1991-12#2)(1991-6#1)(1993-12#1)(2006-7#1)(2008-1#1)(2008-9#1)(2013-8#1)
stimulation might##2##2##(1993-11#1)(1996-1#1)
stimulation mode##2##2##(1992-5#1)(2008-9#1)
stimulation of 125I-IGF-II binding by Man6P##2##6##(1990-5#2)
stimulation of 5-HT1A##2##3##(1991-2#1)(1996-12#1)
stimulation of AC by beta gamma##2##6##(1995-3#2)
stimulation of AC##3##3##(1993-2#1)(1995-3#2)
stimulation of ACh release##3##4##(1993-9#3)
stimulation of Ca2+ influx##2##4##(1995-3#1)(1996-5#1)
stimulation of Ca2+##4##3##(1995-3#1)(1996-2#2)(1996-5#1)
stimulation of DNA synthesis in rat##2##6##(1990-8#1)(1991-10#1)
stimulation of DNA synthesis##5##4##(1990-8#2)(1991-10#1)(1997-1#1)(1997-7#1)
stimulation of DNA##7##3##(1990-8#2)(1991-10#1)(1993-3#1)(1994-2#1)(1997-1#1)(1997-7#1)
stimulation of GTH-II and GH release##2##6##(1994-8#2)
stimulation of IP3 accumulation##2##4##(1990-10#1)(1993-3#1)
stimulation of IP3##3##3##(1990-10#1)(1993-3#1)(1996-1#1)
stimulation of NAT##2##3##(1994-2#2)
stimulation of NCF##2##3##(1991-3#2)
stimulation of NH(inf4)(sup+)-dependent O(inf2) uptake activity##2##6##(2006-3#2)
stimulation of NO##2##3##(1996-5#1)(2008-1#1)
stimulation of ODC##3##3##(1991-11#3)
stimulation of PI##3##3##(1990-9#1)(1991-8#1)(1994-11#1)
stimulation of PLD in##2##4##(1995-8#1)(1997-3#1)
stimulation of PLD##3##3##(1995-8#2)(1997-3#1)
stimulation of Schaffer collateral/commissural fibers##2##5##(1993-12#1)(1994-10#1)
stimulation of Schaffer##3##3##(1991-12#1)(1993-12#1)(1994-10#1)
stimulation of T cell##3##4##(1994-9#1)(2008-11#1)(2008-4#1)
stimulation of T cells##2##4##(1995-5#1)(2008-9#1)
stimulation of T##5##3##(1994-9#1)(1995-5#1)(2008-11#1)(2008-4#1)(2008-9#1)
stimulation of TNF-alpha##2##3##(1992-12#1)(1994-8#1)
stimulation of a single brain region by drugs or small electrical current##2##12##(2008-4#2)
stimulation of a##10##3##(1993-5#1)(1994-12#1)(1995-11#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#1)(2010-8#1)
stimulation of acetylcholine release##2##4##(1992-3#1)(1995-1#1)
stimulation of acetylcholine##4##3##(1992-3#1)(1995-1#1)(2013-1#2)
stimulation of activity##2##3##(1991-3#1)(1994-12#1)
stimulation of adenosine##2##3##(1995-12#1)(2009-6#1)
stimulation of adenylate cyclase##5##4##(1991-11#1)(1992-6#1)(1992-8#1)(1994-8#1)(1996-9#1)
stimulation of adenylyl cyclase##5##4##(1993-3#1)(1994-11#1)(1994-3#1)(1995-12#1)(1996-5#1)
stimulation of an##2##3##(1991-12#1)(1993-12#1)
stimulation of antibody production##3##4##(2008-11#3)
stimulation of basal##2##3##(1992-7#1)(2008-5#1)
stimulation of bone##2##3##(1995-9#1)(2008-7#1)
stimulation of both the##2##4##(1991-5#1)(2010-1#1)
stimulation of both##7##3##(1991-1#1)(1991-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1997-1#1)(2010-1#1)
stimulation of c-fos##2##3##(1994-11#1)(1995-1#1)
stimulation of cGMP accumulation##3##4##(1992-3#3)
stimulation of cell growth##3##4##(1994-2#1)(2008-11#2)
stimulation of cell##7##3##(1994-2#1)(1996-5#1)(2008-11#4)(2012-12#1)
stimulation of cells with##2##4##(1995-12#1)(1996-5#1)
stimulation of cells##3##3##(1992-12#1)(1995-12#1)(1996-5#1)
stimulation of chromaffin##2##3##(1997-6#2)
stimulation of collagen synthesis##2##4##(2008-5#2)
stimulation of collagen##3##3##(2008-5#3)
stimulation of corticosterone synthesis##2##4##(1996-2#2)
stimulation of cultured##2##3##(2008-11#2)
stimulation of cyanide-insensitive##2##3##(1993-8#2)
stimulation of different##4##3##(2008-8#1)(2010-12#1)(2013-1#2)
stimulation of dopamine##2##3##(1990-5#1)(1997-7#1)
stimulation of ecdysteroid secretion##2##4##(1995-11#2)
stimulation of either##3##3##(1990-5#1)(1995-8#1)(2009-8#1)
stimulation of expression##4##3##(1993-12#1)(1994-8#1)(2011-1#2)
stimulation of flux through##2##4##(1990-3#2)
stimulation of glucose transport into L6##2##6##(1994-11#2)
stimulation of glucose utilization##3##4##(1994-8#2)(1997-8#1)
stimulation of glucose##9##3##(1994-11#2)(1994-8#3)(1997-6#1)(1997-8#2)(2006-10#1)
stimulation of growth by##2##4##(1991-10#1)(1995-2#1)
stimulation of growth##6##3##(1991-10#1)(1992-3#1)(1993-6#2)(1994-8#1)(1995-2#1)
stimulation of guanylate cyclase##2##4##(1997-4#1)(2006-10#1)
stimulation of human##8##3##(1992-3#1)(1992-6#1)(1993-6#1)(1993-7#1)(1994-11#1)(1997-1#1)(2006-10#1)(2006-5#1)
stimulation of immunity by##2##4##(2008-7#2)
stimulation of in vitro##3##4##(1993-3#1)(1994-9#1)(2008-4#1)
stimulation of inositol##3##3##(1993-3#1)(1995-12#1)(1997-2#1)
stimulation of insulin secretion##3##4##(1995-12#1)(1996-5#1)(2011-1#1)
stimulation of intestinal##4##3##(1992-12#1)(1996-5#1)(1997-6#1)(2008-11#1)
stimulation of ipsilateral intraoral structures##2##5##(1995-11#2)
stimulation of lipid peroxidation by##2##5##(1995-6#2)
stimulation of lipogenesis##3##3##(1991-12#1)(2010-4#1)(2012-2#1)
stimulation of mu-opioid receptors##2##4##(1997-2#2)
stimulation of neurite outgrowth##2##4##(1990-8#1)(1991-2#1)
stimulation of normal##2##3##(1995-2#1)(1996-1#1)
stimulation of ornithine##2##3##(1991-11#1)(1992-5#1)
stimulation of osteoblast##2##3##(1991-12#1)(2008-8#1)
stimulation of p55 TNFR##2##4##(1996-5#2)
stimulation of peripheral nerves##2##4##(1995-12#1)(2013-8#1)
stimulation of peripheral##3##3##(1992-2#1)(1995-12#1)(2013-8#1)
stimulation of phosphatidylinositol (PI)##2##4##(1994-12#1)(1995-3#1)
stimulation of phosphatidylinositol##4##3##(1994-12#1)(1994-2#1)(1995-3#1)(1995-6#1)
stimulation of phosphoinositide hydrolysis##3##4##(1994-6#3)
stimulation of phosphoinositide metabolism##2##4##(1992-4#1)(1993-12#1)
stimulation of phosphoinositide##5##3##(1992-4#1)(1993-12#1)(1994-6#3)
stimulation of phospholipase C activity##2##5##(1995-5#2)
stimulation of phospholipase C##3##4##(1991-10#1)(1995-5#2)
stimulation of phospholipase D in##2##5##(1995-8#1)(1996-5#1)
stimulation of phospholipase##5##3##(1991-10#1)(1995-5#2)(1995-8#1)(1996-5#1)
stimulation of platelets##3##3##(1990-5#1)(1992-6#1)(2008-8#1)
stimulation of proliferation##2##3##(1993-9#1)(2010-12#1)
stimulation of prostacyclin##2##3##(1991-5#1)(1991-8#1)
stimulation of protein kinase C##2##5##(1991-4#1)(1995-3#1)
stimulation of protein kinase##3##4##(1991-4#1)(1994-3#1)(1995-3#1)
stimulation of protein synthesis##3##4##(1990-10#1)(2008-11#1)(2008-5#1)
stimulation of protein##6##3##(1990-10#1)(1991-4#1)(1994-3#1)(1995-3#1)(2008-11#1)(2008-5#1)
stimulation of quiescent cells##2##4##(1991-2#1)(1992-2#1)
stimulation of quiescent##3##3##(1991-2#1)(1992-2#1)(1993-12#1)
stimulation of receptor##2##3##(1990-3#1)(1990-7#1)
stimulation of respiration##2##3##(1991-3#1)(1994-12#1)
stimulation of single digits##2##4##(1995-12#2)
stimulation of specific##3##3##(1997-7#1)(2005-7#1)(2013-7#1)
stimulation of splenocytes##2##3##(1995-2#2)
stimulation of steroidogenesis##3##3##(1990-2#1)(1991-3#1)(1996-2#1)
stimulation of the 53 kDa protein kinase##2##7##(1997-6#2)
stimulation of the NTS significantly##2##5##(1997-5#2)
stimulation of the NTS##4##4##(1997-5#4)
stimulation of the RVLM##2##4##(1995-3#2)
stimulation of the activity of##3##5##(1996-5#1)(1997-2#1)(2008-8#1)
stimulation of the adjacent dorsal root##2##6##(1995-12#2)
stimulation of the amygdala##2##4##(1991-5#1)(1993-12#1)
stimulation of the basal##2##4##(1990-7#1)(2008-11#1)
stimulation of the brain##3##4##(1992-11#1)(2008-1#2)
stimulation of the cells with 8-BrcAMP##2##6##(1994-11#2)
stimulation of the cells##3##4##(1994-11#2)(2007-2#1)
stimulation of the dorsal##2##4##(1993-12#1)(2006-8#1)
stimulation of the enzyme##2##4##(1990-2#1)(1996-7#1)
stimulation of the femoral nerve##2##5##(1993-12#1)(1994-2#1)
stimulation of the hippocampal formation##2##5##(1992-7#2)
stimulation of the hypothalamic paraventricular##3##5##(1993-12#1)(1994-8#2)
stimulation of the hypothalamic##4##4##(1991-8#1)(1993-12#1)(1994-8#2)
stimulation of the hypothalamus##2##4##(1993-12#1)(1996-2#1)
stimulation of the innate immune system##2##6##(2010-12#1)(2011-1#1)
stimulation of the internal##2##4##(1996-8#1)(2008-11#1)
stimulation of the ipsilateral##3##4##(1992-3#1)(1992-8#1)(2010-12#1)
stimulation of the lateral hypothalamus in starving and satiated rabbits##2##10##(2012-1#2)
stimulation of the lateral hypothalamus in##3##6##(2012-1#3)
stimulation of the lateral hypothalamus##4##5##(1996-2#1)(2012-1#3)
stimulation of the lateral##7##4##(1993-5#1)(1995-5#1)(1996-2#1)(1996-7#1)(2012-1#3)
stimulation of the lumbar sympathetic trunk##2##6##(2006-7#2)
stimulation of the lumbar##3##4##(1994-2#1)(2006-7#2)
stimulation of the neuron##2##4##(1993-12#2)
stimulation of the nucleus##3##4##(1992-8#1)(1997-5#2)
stimulation of the occipital nerve##2##5##(2006-7#2)
stimulation of the paraventricular nucleus##2##5##(1993-2#2)
stimulation of the pelvic##2##4##(1990-4#1)(1992-3#1)
stimulation of the perforant path##5##5##(1990-7#1)(1992-9#2)(1996-7#1)(1997-5#1)
stimulation of the posterior##3##4##(1991-2#1)(1991-4#1)(1993-12#1)
stimulation of the same##2##4##(1995-11#1)(1997-3#1)
stimulation of the saphenous##2##4##(1992-3#1)(1995-11#1)
stimulation of the sciatic nerve##3##5##(1990-7#2)(1994-2#1)
stimulation of the spinal cord##2##5##(1991-6#1)(1995-3#1)
stimulation of the spinal##3##4##(1991-6#1)(1994-2#1)(1995-3#1)
stimulation of the stratum radiatum##2##5##(1995-3#1)(1997-5#1)
stimulation of the subthalamic nucleus##4##5##(1997-7#1)(2008-11#2)(2012-2#1)
stimulation of the subthalamic##5##4##(1997-7#1)(2008-11#2)(2012-1#1)(2012-2#1)
stimulation of the tail##2##4##(1990-4#1)(1992-9#1)
stimulation of the vagus nerve##2##5##(1995-12#1)(1996-1#1)
stimulation of the ventral##2##4##(1993-12#1)(1993-5#1)
stimulation of the##225##3##(1990-10#2)(1990-2#3)(1990-4#3)(1990-5#4)(1990-7#5)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#5)(1992-6#1)(1992-7#2)(1992-8#5)(1992-9#5)(1993-11#1)(1993-12#18)(1993-2#3)(1993-4#2)(1993-5#2)(1993-6#2)(1993-7#1)(1994-11#3)(1994-12#1)(1994-2#6)(1994-5#1)(1994-6#2)(1994-8#4)(1994-9#4)(1995-11#3)(1995-12#3)(1995-2#1)(1995-3#6)(1995-5#2)(1995-7#1)(1995-8#1)(1996-1#4)(1996-12#1)(1996-2#4)(1996-3#1)(1996-5#4)(1996-7#4)(1996-8#4)(1997-2#2)(1997-3#3)(1997-5#8)(1997-6#4)(1997-7#5)(1997-8#1)(2005-1#1)(2006-10#2)(2006-4#1)(2006-6#1)(2006-7#4)(2006-8#1)(2007-11#1)(2007-2#1)(2008-1#2)(2008-10#2)(2008-11#7)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#4)(2010-12#2)(2010-6#1)(2010-7#3)(2011-1#1)(2011-2#1)(2012-1#7)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
stimulation of these##4##3##(1993-7#1)(1994-12#1)(1996-12#1)(1996-7#1)
stimulation of this##2##3##(1996-12#1)(2008-12#1)
stimulation of transcription##3##3##(1992-7#1)(1993-3#1)(2008-11#1)
stimulation of tumor##2##3##(1993-4#1)(2008-6#1)
stimulation of widespread somatic structures##2##5##(1991-8#2)
stimulation of##771##2##(1990-10#5)(1990-11#2)(1990-12#3)(1990-2#7)(1990-3#5)(1990-4#10)(1990-5#13)(1990-6#1)(1990-7#8)(1990-8#6)(1990-9#3)(1991-1#3)(1991-10#7)(1991-11#10)(1991-12#7)(1991-2#7)(1991-3#8)(1991-4#2)(1991-5#9)(1991-6#6)(1991-7#4)(1991-8#9)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#5)(1992-12#5)(1992-2#6)(1992-3#15)(1992-4#4)(1992-5#1)(1992-6#6)(1992-7#6)(1992-8#7)(1992-9#5)(1993-11#8)(1993-12#28)(1993-2#5)(1993-3#9)(1993-4#3)(1993-5#4)(1993-6#6)(1993-7#8)(1993-8#3)(1993-9#7)(1994-10#1)(1994-11#12)(1994-12#12)(1994-2#14)(1994-3#7)(1994-4#1)(1994-5#4)(1994-6#7)(1994-8#17)(1994-9#10)(1995-1#3)(1995-10#2)(1995-11#10)(1995-12#18)(1995-2#7)(1995-3#18)(1995-5#7)(1995-6#7)(1995-7#1)(1995-8#5)(1995-9#1)(1996-1#12)(1996-10#3)(1996-12#6)(1996-2#11)(1996-3#1)(1996-5#20)(1996-7#5)(1996-8#6)(1996-9#1)(1997-1#4)(1997-2#5)(1997-3#6)(1997-4#4)(1997-5#11)(1997-6#12)(1997-7#12)(1997-8#6)(2004-12#1)(2005-1#2)(2005-10#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#8)(2006-11#1)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#6)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-2#2)(2007-9#1)(2008-1#3)(2008-10#8)(2008-11#31)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#10)(2008-5#12)(2008-6#1)(2008-7#12)(2008-8#8)(2008-9#7)(2009-10#2)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#2)(2010-1#2)(2010-12#5)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#2)(2011-1#6)(2011-12#1)(2011-2#3)(2012-1#10)(2012-12#2)(2012-2#4)(2013-1#7)(2013-7#5)(2013-8#3)
stimulation on inositol##2##3##(1990-7#2)
stimulation on the##5##3##(1990-10#1)(1991-8#1)(1994-2#1)(2011-1#1)(2013-1#1)
stimulation on##27##2##(1990-10#1)(1990-7#2)(1991-6#1)(1991-8#1)(1992-8#1)(1994-2#2)(1995-8#1)(1996-1#2)(1996-12#1)(1996-8#1)(1997-5#2)(1997-7#1)(2006-3#1)(2006-8#1)(2008-11#1)(2008-7#1)(2008-9#2)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
stimulation or##12##2##(1992-5#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-2#1)(1995-12#1)(2004-2#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-7#1)
stimulation over##2##2##(2006-7#1)(2010-5#1)
stimulation parameter##2##2##(2012-1#2)
stimulation parameters##4##2##(1994-3#1)(2006-8#1)(2011-2#1)(2012-2#1)
stimulation produced##3##2##(1991-9#1)(2011-2#2)
stimulation produces##3##2##(1991-5#1)(1991-6#1)(1993-7#1)
stimulation protocol##2##2##(2008-2#1)(2011-2#1)
stimulation protocols##2##2##(2007-11#1)(2009-8#1)
stimulation rate on##2##3##(2008-9#2)
stimulation rate##5##2##(2008-9#5)
stimulation rates##3##2##(2008-9#3)
stimulation reduces##3##2##(1991-5#1)(2006-3#1)(2009-8#1)
stimulation required to##2##3##(1996-11#1)(2013-1#1)
stimulation resulted in a##4##4##(1991-5#1)(1997-5#1)(1997-7#1)(2006-9#1)
stimulation resulted in##8##3##(1991-5#1)(1996-10#1)(1997-3#1)(1997-5#1)(1997-7#1)(2006-9#1)(2008-5#1)(2009-4#1)
stimulation results in##2##3##(1995-3#1)(1997-7#1)
stimulation revealed##2##2##(1996-9#1)(2012-3#1)
stimulation showed##2##2##(1992-9#1)(2009-10#1)
stimulation sites##3##2##(2011-1#1)(2012-1#2)
stimulation technique##2##2##(1993-12#1)(1995-12#1)
stimulation techniques##4##2##(2005-10#1)(2008-7#1)(2009-10#1)(2009-12#1)
stimulation test##9##2##(1996-2#1)(2006-10#1)(2008-1#1)(2008-9#2)(2009-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
stimulation testing##2##2##(2008-4#1)(2012-3#1)
stimulation tests##3##2##(1994-6#1)(1996-11#2)
stimulation than##2##2##(1994-8#1)(1996-10#1)
stimulation that##7##2##(1993-11#1)(1993-12#1)(1993-7#1)(1997-3#1)(2008-10#1)(2010-6#2)
stimulation the##7##2##(1992-12#1)(1993-6#1)(1994-8#1)(1997-8#1)(2004-12#1)(2007-9#1)(2008-2#1)
stimulation through the##3##3##(1991-2#1)(1995-3#1)(2008-7#1)
stimulation through##4##2##(1991-2#1)(1995-3#1)(2008-10#1)(2008-7#1)
stimulation to the##4##3##(1993-8#1)(2008-8#1)(2008-9#1)(2010-7#1)
stimulation to##13##2##(1993-8#1)(1996-11#1)(1997-6#1)(2006-12#1)(2006-7#2)(2008-10#2)(2008-8#1)(2008-9#1)(2010-7#1)(2012-1#1)(2012-12#1)
stimulation trials##2##2##(1994-6#1)(2006-8#1)
stimulation under##3##2##(1996-6#1)(2008-9#1)(2011-1#1)
stimulation using a##2##3##(2006-7#1)(2008-11#1)
stimulation using##6##2##(1992-9#1)(1995-3#1)(2006-12#1)(2006-7#1)(2006-9#1)(2008-11#1)
stimulation via the##2##3##(2011-1#1)(2013-8#1)
stimulation via##4##2##(1991-2#1)(2011-1#1)(2013-1#1)(2013-8#1)
stimulation was abolished##2##3##(1990-5#1)(1995-12#1)
stimulation was accompanied by##2##4##(1990-7#1)(1995-12#1)
stimulation was also##2##3##(2011-1#1)(2012-2#1)
stimulation was applied to the##2##5##(1996-1#1)(2009-12#1)
stimulation was examined in##2##4##(1990-5#1)(2006-10#1)
stimulation was given##2##3##(1991-6#1)(1993-3#1)
stimulation was observed##2##3##(1993-12#1)(1993-3#1)
stimulation was performed##2##3##(1995-12#1)(2008-7#1)
stimulation was seen##2##3##(1991-12#1)(2004-12#1)
stimulation was significantly##3##3##(2007-8#1)(2008-7#2)
stimulation was used##2##3##(2008-7#2)
stimulation was##61##2##(1990-2#2)(1990-5#3)(1990-7#1)(1991-12#1)(1991-5#1)(1991-6#3)(1992-3#1)(1992-7#1)(1993-12#2)(1993-3#3)(1993-7#1)(1994-2#3)(1994-8#1)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-5#1)(1997-7#1)(2004-12#1)(2005-10#1)(2006-10#1)(2006-7#2)(2006-9#1)(2007-8#2)(2008-10#2)(2008-7#7)(2009-12#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
stimulation wave##4##2##(2008-7#4)
stimulation were recorded##2##3##(2005-10#1)(2008-7#1)
stimulation were used to##2##4##(1993-1#1)(2006-3#1)
stimulation were##19##2##(1991-11#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-6#1)(1994-10#1)(1995-11#1)(1996-10#2)(1996-5#1)(1997-7#1)(2005-10#1)(2006-3#1)(2008-10#1)(2008-7#3)(2010-12#1)
stimulation when##2##2##(2008-10#1)(2011-1#1)
stimulation which##2##2##(1994-3#1)(2006-9#1)
stimulation with 1##2##3##(1991-10#1)(2008-11#1)
stimulation with AF102B##2##3##(1994-8#2)
stimulation with LPS##2##3##(2006-8#1)(2011-2#1)
stimulation with PDGF##2##3##(1990-3#1)(1995-3#1)
stimulation with TPA##2##3##(1990-2#1)(1992-6#1)
stimulation with a##5##3##(1990-5#1)(1992-6#1)(1994-3#1)(2011-2#1)(2012-1#1)
stimulation with an##4##3##(1991-5#1)(1994-12#1)(1995-5#1)(2008-6#1)
stimulation with bradykinin##3##3##(1991-12#2)(1996-5#1)
stimulation with fmlp##2##3##(1990-6#2)
stimulation with lipopolysaccharide##4##3##(1991-2#1)(1994-9#2)(1995-3#1)
stimulation with serum##2##3##(1994-5#1)(1995-3#1)
stimulation with the##9##3##(1992-1#1)(1994-9#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#3)(2013-8#1)
stimulation with these##2##3##(1993-6#1)(1995-8#1)
stimulation with##126##2##(1990-2#1)(1990-3#1)(1990-5#4)(1990-6#4)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#5)(1991-2#2)(1991-5#5)(1991-8#1)(1992-1#2)(1992-6#4)(1992-8#2)(1992-9#1)(1993-4#1)(1993-6#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#5)(1994-9#5)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#3)(1995-9#1)(1996-10#1)(1996-12#3)(1996-2#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-3#1)(2006-7#2)(2006-8#2)(2007-2#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#5)(2008-3#2)(2008-5#3)(2008-6#1)(2008-9#3)(2009-12#1)(2009-4#1)(2010-6#1)(2011-1#1)(2011-2#6)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
stimulation within the##3##3##(1990-10#1)(1993-7#1)(1995-12#1)
stimulation within##4##2##(1990-10#1)(1990-4#1)(1993-7#1)(1995-12#1)
stimulation##2304##1##(1990-10#13)(1990-11#12)(1990-12#9)(1990-2#19)(1990-3#10)(1990-4#17)(1990-5#30)(1990-6#6)(1990-7#25)(1990-8#13)(1990-9#7)(1991-1#9)(1991-10#11)(1991-11#14)(1991-12#29)(1991-2#23)(1991-3#23)(1991-4#4)(1991-5#31)(1991-6#18)(1991-7#6)(1991-8#18)(1991-9#4)(1992-1#5)(1992-10#2)(1992-11#15)(1992-12#19)(1992-2#7)(1992-3#30)(1992-4#6)(1992-5#6)(1992-6#20)(1992-7#12)(1992-8#25)(1992-9#24)(1993-1#2)(1993-11#23)(1993-12#56)(1993-2#14)(1993-3#19)(1993-4#6)(1993-5#5)(1993-6#19)(1993-7#16)(1993-8#10)(1993-9#10)(1994-10#10)(1994-11#16)(1994-12#28)(1994-2#44)(1994-3#18)(1994-4#1)(1994-5#11)(1994-6#21)(1994-8#30)(1994-9#20)(1995-1#4)(1995-10#4)(1995-11#22)(1995-12#41)(1995-2#12)(1995-3#34)(1995-4#2)(1995-5#13)(1995-6#14)(1995-7#4)(1995-8#18)(1995-9#2)(1996-1#23)(1996-10#9)(1996-11#11)(1996-12#26)(1996-2#22)(1996-3#5)(1996-4#4)(1996-5#41)(1996-6#6)(1996-7#10)(1996-8#20)(1996-9#16)(1997-1#12)(1997-2#16)(1997-3#17)(1997-4#7)(1997-5#26)(1997-6#23)(1997-7#27)(1997-8#13)(2004-12#6)(2004-2#1)(2005-1#2)(2005-10#11)(2005-7#2)(2005-9#1)(2006-1#1)(2006-10#25)(2006-11#2)(2006-12#10)(2006-2#1)(2006-3#20)(2006-4#3)(2006-5#1)(2006-6#2)(2006-7#21)(2006-8#20)(2006-9#9)(2007-1#1)(2007-10#9)(2007-11#14)(2007-12#3)(2007-2#7)(2007-4#1)(2007-5#4)(2007-7#1)(2007-8#6)(2007-9#8)(2008-1#17)(2008-10#32)(2008-11#64)(2008-12#4)(2008-2#9)(2008-3#9)(2008-4#34)(2008-5#24)(2008-6#5)(2008-7#52)(2008-8#17)(2008-9#52)(2009-1#1)(2009-10#15)(2009-12#8)(2009-2#3)(2009-4#11)(2009-5#4)(2009-6#2)(2009-8#17)(2009-9#9)(2010-1#4)(2010-10#5)(2010-12#26)(2010-2#3)(2010-3#2)(2010-4#6)(2010-5#3)(2010-6#10)(2010-7#30)(2010-8#5)(2011-1#31)(2011-12#6)(2011-2#33)(2012-1#30)(2012-12#8)(2012-2#36)(2012-3#14)(2012-7#1)(2013-1#38)(2013-7#13)(2013-8#14)
stimulation)##3##1##(2007-11#1)(2011-2#2)
stimulation-evoked [3H]NE release##2##3##(1991-2#2)
stimulation-evoked##4##1##(1991-2#2)(1992-9#1)(1995-7#1)
stimulation-induced feeding in the##3##4##(1994-3#3)
stimulation-induced feeding##5##2##(1994-3#5)
stimulation-induced##17##1##(1992-3#1)(1993-7#1)(1994-3#5)(1994-6#2)(1994-8#1)(1996-10#1)(1996-12#2)(1997-1#1)(1997-5#1)(2008-9#1)(2010-12#1)
stimulation?##2##1##(2008-11#1)(2010-7#1)
stimulation]##2##1##(2010-12#1)(2013-1#1)
stimulations and##4##2##(1994-3#1)(2006-4#1)(2008-4#1)(2012-1#1)
stimulations of the##2##3##(1991-11#1)(2012-3#1)
stimulations of##4##2##(1991-11#1)(1993-8#1)(2008-11#1)(2012-3#1)
stimulations were##2##2##(1993-3#1)(1995-8#1)
stimulations##25##1##(1990-7#1)(1991-11#2)(1992-11#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-5#1)(1995-8#1)(1996-5#2)(2006-4#1)(2008-10#1)(2008-11#1)(2008-4#2)(2009-8#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
stimulative effects##2##2##(1995-8#1)(2008-11#1)
stimulator and##4##2##(1991-10#1)(2007-7#1)(2008-4#1)(2008-7#1)
stimulator for##3##2##(1993-11#1)(1994-8#2)
stimulator is##2##2##(2006-12#1)(2008-5#1)
stimulator of##20##2##(1990-11#1)(1990-9#2)(1991-10#1)(1991-2#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-12#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(2004-11#1)(2008-6#1)(2008-7#1)
stimulator was##2##2##(2012-3#2)
stimulator##55##1##(1990-11#1)(1990-9#2)(1991-10#2)(1991-2#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(2004-11#1)(2006-12#3)(2006-7#5)(2007-7#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2010-1#2)(2010-12#1)(2010-7#1)(2012-3#5)
stimulators (eg##2##2##(2008-3#1)(2010-1#1)
stimulators and##5##2##(1991-2#1)(1993-9#1)(1994-3#1)(2008-5#1)(2011-2#1)
stimulators of##3##2##(1996-8#1)(1997-2#1)(2008-4#1)
stimulators##25##1##(1991-10#1)(1991-2#1)(1993-11#1)(1993-9#1)(1994-2#2)(1994-3#1)(1996-4#1)(1996-8#1)(1997-2#1)(2004-12#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-1#1)(2011-2#1)(2012-1#1)(2013-1#2)
stimulatory G protein##3##3##(1994-6#2)(1995-8#1)
stimulatory G##4##2##(1994-6#2)(1995-6#1)(1995-8#1)
stimulatory GDP/GTP exchange##3##3##(1992-1#1)(1992-5#1)(1994-9#1)
stimulatory ability##5##2##(2008-8#5)
stimulatory action of L-histidine on protein synthesis in L6 myotubes##2##10##(2008-11#2)
stimulatory action of L-histidine on protein synthesis##3##7##(2008-11#3)
stimulatory action of##8##3##(1990-2#1)(1990-5#1)(1991-1#1)(1992-5#1)(1994-9#1)(2008-11#3)
stimulatory action##10##2##(1990-2#2)(1990-5#1)(1991-1#1)(1991-3#1)(1992-5#1)(1994-9#1)(2008-11#3)
stimulatory actions of L-leucine and KIC on protein synthesis##4##9##(2008-11#4)
stimulatory actions of L-leucine and KIC##5##6##(2008-11#5)
stimulatory actions of L-leucine and##6##5##(2008-11#6)
stimulatory actions of##9##3##(2008-10#1)(2008-11#6)(2010-11#2)
stimulatory actions##11##2##(2008-10#1)(2008-11#8)(2010-11#2)
stimulatory activity of##3##3##(1991-6#1)(1993-6#1)(2006-12#1)
stimulatory activity##13##2##(1991-6#1)(1991-8#1)(1993-12#1)(1993-6#2)(1994-12#2)(1994-8#1)(1996-9#3)(2006-12#1)(2007-11#1)
stimulatory and inhibitory effects##2##4##(1991-3#1)(1991-9#1)
stimulatory and inhibitory##6##3##(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1994-3#1)(1997-5#1)
stimulatory and##7##2##(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1994-3#1)(1996-2#1)(1997-5#1)
stimulatory effect is##2##3##(1992-3#1)(1995-7#1)
stimulatory effect of immunosine on##3##5##(2004-12#3)
stimulatory effect of the##3##4##(1990-3#1)(1993-3#1)(1997-8#1)
stimulatory effect of##36##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#2)(1992-6#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-6#1)(1996-1#1)(1996-9#1)(1997-6#4)(1997-8#1)(2004-12#3)(2007-2#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
stimulatory effect on##16##3##(1990-12#1)(1991-12#1)(1991-6#1)(1992-2#1)(1992-9#1)(1993-12#1)(1994-2#1)(1996-9#1)(1997-7#1)(1997-8#1)(2006-8#2)(2006-9#1)(2007-11#2)(2008-5#1)
stimulatory effect##63##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-5#2)(1991-6#1)(1992-2#3)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-9#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-6#1)(1995-7#1)(1996-1#1)(1996-9#2)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#3)(2004-12#3)(2006-8#2)(2006-9#1)(2007-11#2)(2007-2#1)(2008-11#1)(2008-5#1)(2010-10#2)(2010-11#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#2)
stimulatory effects of##12##3##(1991-5#1)(1991-9#1)(1992-7#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-5#1)(1997-8#1)(2007-11#1)(2008-6#1)(2008-7#1)
stimulatory effects on##4##3##(1995-3#1)(1996-11#1)(2008-8#1)(2011-2#1)
stimulatory effects##24##2##(1990-12#1)(1990-2#3)(1990-5#1)(1991-5#1)(1991-9#1)(1992-7#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-3#2)(1995-5#1)(1996-11#2)(1997-8#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)
stimulatory growth##2##2##(1994-12#1)(2010-12#1)
stimulatory guanine nucleotide binding##2##4##(1992-3#1)(1994-2#1)
stimulatory in##2##2##(1990-11#1)(1995-3#1)
stimulatory or inhibitory##2##3##(1997-7#1)(2013-1#1)
stimulatory or##3##2##(1994-8#1)(1997-7#1)(2013-1#1)
stimulatory response##4##2##(1991-11#2)(1992-4#1)(2008-7#1)
stimulatory responses were##2##3##(1997-2#1)(2008-7#1)
stimulatory responses##3##2##(1997-2#1)(2008-7#2)
stimulatory to##2##2##(1995-12#1)(2008-5#1)
stimulatory##191##1##(1990-11#2)(1990-12#3)(1990-2#6)(1990-3#1)(1990-5#2)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-3#3)(1991-5#4)(1991-6#2)(1991-8#2)(1991-9#2)(1992-1#2)(1992-2#3)(1992-3#4)(1992-4#2)(1992-5#2)(1992-6#3)(1992-7#2)(1992-9#1)(1993-11#1)(1993-12#5)(1993-3#3)(1993-5#1)(1993-6#3)(1993-7#1)(1993-9#2)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#4)(1994-8#5)(1994-9#2)(1995-10#1)(1995-12#5)(1995-3#3)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-2#1)(1996-5#1)(1996-9#5)(1997-2#2)(1997-3#1)(1997-5#2)(1997-6#4)(1997-7#3)(1997-8#4)(2004-12#3)(2006-10#1)(2006-12#1)(2006-8#2)(2006-9#1)(2007-11#4)(2007-2#1)(2008-10#5)(2008-11#13)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#6)(2010-10#2)(2010-11#3)(2010-12#4)(2011-2#2)(2013-1#3)(2013-8#2)
stimuli (e##3##2##(2008-4#1)(2008-5#1)(2012-12#1)
stimuli activate##4##2##(2006-12#3)(2009-9#1)
stimuli after##2##2##(1995-11#1)(1995-8#1)
stimuli alone were presented##2##4##(2010-2#2)
stimuli alone##5##2##(2008-4#1)(2010-2#4)
stimuli and is##2##3##(2008-4#1)(2010-10#1)
stimuli and may##2##3##(1995-3#1)(1996-1#1)
stimuli and the##5##3##(1990-9#1)(1993-2#1)(2006-11#1)(2008-9#1)(2009-9#1)
stimuli and their##2##3##(2008-10#1)(2008-4#1)
stimuli and##51##2##(1990-11#1)(1990-9#1)(1991-11#3)(1991-5#1)(1991-9#1)(1992-5#1)(1993-12#1)(1993-2#2)(1995-3#1)(1996-1#1)(1996-7#1)(2006-10#2)(2006-11#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-4#7)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#2)(2009-6#1)(2009-9#2)(2010-1#1)(2010-10#1)(2011-12#1)(2012-2#1)(2012-7#1)(2013-8#1)
stimuli applied to the##3##4##(1992-11#1)(1994-10#1)(2008-7#1)
stimuli applied to##4##3##(1992-11#1)(1994-10#1)(2008-7#1)(2009-9#1)
stimuli are##14##2##(1991-9#1)(1992-10#2)(1992-4#1)(1992-9#1)(1995-11#1)(1995-12#1)(1997-7#1)(2004-11#1)(2008-10#1)(2008-9#1)(2009-4#1)(2010-5#1)(2012-3#1)
stimuli as##4##2##(2008-7#1)(2008-8#1)(2009-4#1)(2012-2#1)
stimuli associated with##2##3##(1993-6#1)(2010-2#1)
stimuli at the##3##3##(1995-12#1)(2010-2#1)(2012-1#1)
stimuli at##6##2##(1992-11#2)(1995-12#1)(2010-2#1)(2012-1#1)(2012-12#1)
stimuli before##2##2##(1993-12#1)(2010-1#1)
stimuli between##3##2##(1997-1#2)(2008-9#1)
stimuli but##2##2##(1990-10#1)(1996-5#1)
stimuli by##4##2##(1992-6#1)(2005-7#1)(2007-9#1)(2013-1#1)
stimuli can be##2##3##(1997-6#1)(2008-2#1)
stimuli can##8##2##(1996-9#1)(1997-6#1)(2006-11#1)(2008-1#1)(2008-2#1)(2008-5#2)(2008-7#1)
stimuli causing##2##2##(1990-11#1)(2007-7#1)
stimuli comprised of##2##3##(2013-8#2)
stimuli could be##2##3##(2006-8#1)(2013-1#1)
stimuli did##2##2##(1990-11#1)(1995-11#1)
stimuli during##6##2##(1990-4#1)(1992-1#1)(1992-10#1)(2005-7#2)(2013-8#1)
stimuli elicited##2##2##(1995-11#1)(2012-1#1)
stimuli for the##3##3##(1990-10#1)(1992-9#1)(2008-11#1)
stimuli for##9##2##(1990-10#1)(1992-9#1)(1993-11#1)(1993-12#1)(2004-11#1)(2007-3#1)(2008-11#1)(2008-5#1)(2012-12#1)
stimuli from the environment##2##4##(1997-2#1)(2008-1#1)
stimuli from##5##2##(1997-2#1)(2008-1#1)(2008-4#1)(2008-8#1)(2011-2#1)
stimuli have been##2##3##(2008-4#1)(2009-12#1)
stimuli have##4##2##(2008-1#1)(2008-4#1)(2009-12#1)(2010-2#1)
stimuli in a manner##2##4##(2009-12#1)(2013-1#1)
stimuli in a##4##3##(1993-12#1)(1996-5#1)(2009-12#1)(2013-1#1)
stimuli in infants##2##3##(1990-11#1)(2006-5#1)
stimuli in the##5##3##(1992-5#1)(1992-7#1)(1993-2#1)(2008-5#1)(2009-2#1)
stimuli in##41##2##(1990-11#1)(1991-1#1)(1991-10#1)(1991-6#1)(1992-5#1)(1992-7#2)(1993-12#2)(1993-2#1)(1994-11#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-7#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-4#2)(2008-5#2)(2008-7#3)(2009-12#1)(2009-2#1)(2009-6#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-1#2)(2012-2#2)(2013-1#1)
stimuli include##2##2##(1991-11#1)(1997-1#1)
stimuli including##6##2##(1990-2#1)(1995-11#1)(1996-5#1)(2008-1#1)(2009-6#1)(2012-1#1)
stimuli induce##2##2##(1990-7#1)(1995-12#1)
stimuli is##4##2##(1992-7#1)(1992-9#1)(1993-2#1)(2007-1#1)
stimuli located##2##2##(2006-3#1)(2008-6#1)
stimuli may##4##2##(1993-6#1)(1996-5#1)(2008-4#1)(2012-12#1)
stimuli of different##2##3##(1996-2#1)(2013-1#1)
stimuli of the##2##3##(1996-5#1)(2011-2#1)
stimuli of##9##2##(1996-2#1)(1996-5#1)(1996-6#1)(1997-5#1)(2006-9#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
stimuli on a##2##3##(2011-2#1)(2012-1#1)
stimuli on the##5##3##(2008-2#1)(2008-4#1)(2008-8#1)(2009-4#1)(2011-2#1)
stimuli on##13##2##(1990-12#1)(1992-11#1)(1995-12#1)(1996-12#1)(2006-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-4#1)(2011-2#3)(2012-1#1)
stimuli or##5##2##(1996-2#1)(2007-11#1)(2008-2#1)(2008-4#1)(2011-12#1)
stimuli presented##3##2##(1994-8#2)(1996-2#1)
stimuli related to##4##3##(2010-2#4)
stimuli results in##2##3##(2006-5#1)(2008-4#1)
stimuli should##2##2##(1993-12#2)
stimuli such as##8##3##(1993-12#1)(1993-6#1)(2004-12#1)(2007-9#1)(2008-10#1)(2008-4#1)(2009-8#1)(2010-12#1)
stimuli that activate##2##3##(1991-5#1)(2007-1#1)
stimuli that are##2##3##(1992-6#1)(2008-4#1)
stimuli that were##4##3##(1992-8#1)(2008-4#1)(2010-5#1)(2012-2#1)
stimuli that##21##2##(1990-12#1)(1991-5#1)(1991-8#1)(1992-6#1)(1992-8#1)(1994-10#1)(1995-12#1)(1995-8#1)(1996-10#1)(1997-1#2)(2007-1#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-10#1)(2010-5#1)(2011-9#1)(2012-1#1)(2012-2#1)
stimuli through##2##2##(2006-10#1)(2012-12#1)
stimuli to be##4##3##(1992-11#1)(1993-12#1)(2006-7#1)(2009-2#1)
stimuli to influence##2##3##(1993-6#1)(2006-8#1)
stimuli to##16##2##(1992-11#1)(1993-12#2)(1993-6#1)(1995-12#1)(1996-3#1)(1997-7#1)(2005-11#1)(2006-7#1)(2006-8#1)(2008-1#1)(2008-11#2)(2008-8#1)(2009-2#1)(2012-12#1)
stimuli under##3##2##(1995-5#1)(1996-10#1)(2008-8#1)
stimuli using##3##2##(1992-9#1)(2009-10#1)(2012-12#1)
stimuli was##7##2##(1990-12#1)(1991-2#1)(1991-5#1)(2008-11#1)(2008-8#2)(2011-2#1)
stimuli were also##2##3##(1991-8#1)(2007-12#1)
stimuli were applied##2##3##(2008-8#1)(2008-9#1)
stimuli were delivered##3##3##(1992-7#2)(1992-8#1)
stimuli were introduced##2##3##(1993-12#1)(1993-3#1)
stimuli were located##2##3##(1993-2#1)(1996-5#1)
stimuli were presented##7##3##(1992-11#1)(1993-2#2)(2006-5#2)(2008-5#1)(2010-2#1)
stimuli were used to##2##4##(2008-9#1)(2009-2#1)
stimuli were used##3##3##(2008-9#1)(2009-2#2)
stimuli were##47##2##(1990-10#1)(1990-11#1)(1990-5#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-8#3)(1992-11#1)(1992-2#1)(1992-7#2)(1992-8#1)(1993-12#2)(1993-2#3)(1993-3#2)(1995-1#1)(1995-11#2)(1996-1#1)(1996-5#3)(1996-8#1)(2006-5#2)(2007-12#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-2#2)(2009-4#1)(2010-12#2)(2010-2#1)(2011-2#1)(2012-1#2)(2012-2#1)
stimuli when##3##2##(1990-12#1)(1995-8#1)(2013-8#1)
stimuli which were##2##3##(1990-4#1)(2012-1#1)
stimuli which##6##2##(1990-4#1)(1990-6#1)(1994-3#1)(1996-5#1)(2008-6#1)(2012-1#1)
stimuli with a##2##3##(1992-7#1)(1993-11#1)
stimuli with##11##2##(1992-7#1)(1993-11#1)(1995-12#1)(1996-8#1)(2005-1#1)(2008-11#1)(2008-4#2)(2008-9#2)(2013-8#1)
stimuli within the##2##3##(1993-6#1)(2008-1#1)
stimuli within##3##2##(1993-6#1)(1995-11#1)(2008-1#1)
stimuli##772##1##(1990-10#4)(1990-11#9)(1990-12#6)(1990-2#2)(1990-4#5)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#2)(1991-1#4)(1991-10#3)(1991-11#12)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#9)(1991-6#2)(1991-7#3)(1991-8#6)(1991-9#3)(1992-1#2)(1992-10#7)(1992-11#11)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#4)(1992-6#3)(1992-7#7)(1992-8#4)(1992-9#6)(1993-11#3)(1993-12#16)(1993-2#9)(1993-3#5)(1993-4#1)(1993-5#2)(1993-6#11)(1993-7#1)(1993-9#4)(1994-10#2)(1994-11#3)(1994-2#4)(1994-3#5)(1994-5#1)(1994-6#5)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#13)(1995-12#16)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#2)(1995-8#8)(1996-1#5)(1996-10#2)(1996-12#4)(1996-2#11)(1996-3#4)(1996-5#16)(1996-6#5)(1996-7#4)(1996-8#5)(1996-9#3)(1997-1#7)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#6)(1997-8#3)(2004-10#1)(2004-11#2)(2004-12#1)(2005-1#1)(2005-10#2)(2005-11#1)(2005-7#3)(2006-10#9)(2006-11#3)(2006-12#4)(2006-2#2)(2006-3#1)(2006-5#5)(2006-7#5)(2006-8#2)(2006-9#2)(2007-1#4)(2007-10#1)(2007-11#4)(2007-12#5)(2007-2#1)(2007-3#4)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#8)(2008-10#10)(2008-11#18)(2008-2#8)(2008-3#2)(2008-4#48)(2008-5#18)(2008-6#6)(2008-7#21)(2008-8#18)(2008-9#19)(2009-10#6)(2009-11#6)(2009-12#4)(2009-2#10)(2009-3#2)(2009-4#9)(2009-5#2)(2009-6#6)(2009-8#8)(2009-9#7)(2010-1#2)(2010-10#2)(2010-12#4)(2010-2#12)(2010-3#3)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-12#6)(2011-2#17)(2011-9#2)(2012-1#17)(2012-11#1)(2012-12#16)(2012-2#19)(2012-3#2)(2012-7#1)(2013-1#9)(2013-7#2)(2013-8#14)
stimuli)##5##1##(1995-1#2)(2008-1#2)(2010-2#1)
stimuli-responsive##4##1##(1995-11#1)(2008-8#1)(2010-4#2)
stimuli-sensitive##2##1##(1991-11#1)(2012-2#1)
stimulus (e##2##2##(2008-5#2)
stimulus and##17##2##(1991-1#1)(1991-11#1)(1991-3#2)(1992-10#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1995-11#1)(1996-2#1)(2007-5#1)(2007-9#1)(2008-10#1)(2010-12#1)(2012-2#2)
stimulus at##4##2##(2006-12#1)(2006-5#1)(2007-3#1)(2008-4#1)
stimulus attributes##3##2##(1995-5#1)(1996-12#1)(1997-8#1)
stimulus but##2##2##(1992-11#1)(1994-10#1)
stimulus by##2##2##(1991-6#1)(1993-9#1)
stimulus categories##2##2##(2008-11#1)(2009-4#1)
stimulus conditions##4##2##(1992-7#1)(1995-11#1)(1996-2#1)(2008-11#1)
stimulus configuration##3##2##(1993-12#1)(2008-9#2)
stimulus control##2##2##(2011-2#2)
stimulus density##3##2##(2008-1#3)
stimulus duration and the##2##4##(2009-2#2)
stimulus duration and##5##3##(2008-9#2)(2009-2#3)
stimulus duration##10##2##(1997-7#1)(2008-9#4)(2009-2#5)
stimulus during##4##2##(2006-5#1)(2008-5#2)(2010-4#1)
stimulus effects of##6##3##(1991-1#2)(1996-10#1)(1997-5#2)(1997-7#1)
stimulus effects##9##2##(1991-1#3)(1991-12#2)(1996-10#1)(1997-5#2)(1997-7#1)
stimulus features##2##2##(1990-5#1)(2008-11#1)
stimulus for the development##2##4##(2007-12#1)(2008-3#1)
stimulus for the##5##3##(1995-12#1)(2007-12#2)(2008-3#1)(2012-1#1)
stimulus for this##2##3##(1993-6#1)(2013-8#1)
stimulus for##17##2##(1993-1#1)(1993-12#1)(1993-6#1)(1995-12#1)(1997-2#1)(1997-5#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-3#2)(2008-8#1)(2009-6#1)(2010-4#1)(2012-1#1)(2013-8#1)
stimulus had##2##2##(1994-8#1)(2010-5#1)
stimulus has##3##2##(2008-6#1)(2009-10#1)(2009-4#1)
stimulus in the##5##3##(1991-12#1)(1993-5#2)(2006-9#1)(2010-10#1)
stimulus in##9##2##(1991-12#1)(1991-9#1)(1992-4#1)(1993-5#2)(1996-5#1)(2006-9#1)(2008-1#1)(2010-10#1)
stimulus intensities##7##2##(1991-1#1)(1993-12#2)(1993-2#2)(1997-5#1)(2011-2#1)
stimulus intensity and##2##3##(1991-12#1)(2008-4#1)
stimulus intensity on##2##3##(2011-2#2)
stimulus intensity threshold for induction of##2##6##(1997-1#2)
stimulus intensity##16##2##(1991-12#1)(1993-2#1)(1997-1#3)(1997-5#1)(2008-4#1)(2008-7#3)(2011-2#6)
stimulus into##2##2##(2005-10#1)(2008-10#1)
stimulus is##10##2##(1990-4#1)(1991-9#1)(1993-2#1)(1995-12#1)(1997-4#1)(1997-6#1)(2006-5#1)(2008-11#1)(2008-4#1)(2013-7#1)
stimulus may be##2##3##(1993-9#1)(1997-2#1)
stimulus may##3##2##(1993-9#1)(1994-2#1)(1997-2#1)
stimulus object##3##2##(1994-6#3)
stimulus of##8##2##(1995-8#1)(1997-5#1)(2007-12#1)(2008-5#2)(2010-2#1)(2010-4#1)(2013-1#1)
stimulus on##3##2##(1991-12#1)(2008-6#1)(2010-5#1)
stimulus onset##4##2##(1992-7#1)(1993-7#1)(2008-2#1)(2012-2#1)
stimulus or##2##2##(1993-5#1)(2011-1#1)
stimulus package##2##2##(2010-5#1)(2010-8#1)
stimulus parameters##3##2##(1993-7#1)(1995-11#1)(2008-4#1)
stimulus perception##2##2##(1996-5#1)(2009-8#1)
stimulus preexposure##3##2##(2008-10#2)(2008-4#1)
stimulus presentation##6##2##(1991-3#1)(1993-2#1)(1994-6#1)(2006-3#1)(2008-5#2)
stimulus properties##5##2##(1993-12#2)(1997-7#2)(2010-8#1)
stimulus rate##4##2##(2008-9#4)
stimulus significantly##2##2##(1997-2#1)(2008-7#1)
stimulus specific##2##2##(2008-5#1)(2009-2#1)
stimulus specificity##2##2##(1994-6#1)(2009-4#1)
stimulus strengths##2##2##(1992-7#1)(2013-1#1)
stimulus such as##2##3##(2008-1#1)(2008-4#1)
stimulus tends to be identified as a##2##7##(2013-8#2)
stimulus that##4##2##(1993-12#1)(1993-2#1)(1996-7#1)(1997-7#1)
stimulus to the##4##3##(1993-9#1)(1994-12#1)(2008-4#1)(2012-2#1)
stimulus to##16##2##(1991-9#1)(1993-5#1)(1993-9#1)(1994-12#1)(1995-5#1)(1997-5#2)(2004-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-5#1)(2012-2#2)(2013-8#1)
stimulus train##2##2##(1993-12#1)(1997-2#1)
stimulus was delivered##2##3##(1997-2#1)(2011-2#1)
stimulus was familiar##2##3##(2006-5#2)
stimulus was##24##2##(1990-5#1)(1991-11#1)(1991-5#1)(1992-11#1)(1992-9#2)(1994-10#1)(1996-2#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#1)(2006-5#2)(2008-5#3)(2009-11#1)(2010-5#3)(2011-2#1)(2013-7#1)
stimulus were##3##2##(1997-8#1)(2007-9#1)(2008-4#1)
stimulus when the##2##3##(1992-7#1)(2007-12#1)
stimulus when##3##2##(1992-7#1)(2007-12#1)(2012-12#1)
stimulus which##3##2##(1992-7#1)(1993-6#1)(1996-9#1)
stimulus with an##2##3##(1997-5#1)(2008-5#1)
stimulus with##4##2##(1992-9#1)(1993-6#1)(1997-5#1)(2008-5#1)
stimulus##492##1##(1990-10#2)(1990-12#2)(1990-4#2)(1990-5#5)(1990-8#3)(1990-9#2)(1991-1#8)(1991-11#3)(1991-12#6)(1991-2#1)(1991-3#6)(1991-5#2)(1991-6#3)(1991-8#1)(1991-9#6)(1992-10#2)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#2)(1992-6#1)(1992-7#8)(1992-9#5)(1993-1#1)(1993-12#10)(1993-2#12)(1993-3#1)(1993-5#6)(1993-6#3)(1993-7#3)(1993-9#5)(1994-10#5)(1994-12#2)(1994-2#2)(1994-3#5)(1994-6#6)(1994-8#2)(1995-1#2)(1995-11#7)(1995-12#8)(1995-3#2)(1995-5#5)(1995-8#1)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#8)(1996-5#4)(1996-6#1)(1996-7#5)(1996-9#4)(1997-1#10)(1997-2#5)(1997-3#1)(1997-4#1)(1997-5#12)(1997-6#1)(1997-7#8)(1997-8#10)(2004-11#1)(2005-10#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#6)(2006-7#5)(2006-9#2)(2007-12#9)(2007-3#1)(2007-5#2)(2007-8#6)(2007-9#8)(2008-1#8)(2008-10#5)(2008-11#14)(2008-2#1)(2008-3#2)(2008-4#16)(2008-5#19)(2008-6#2)(2008-7#7)(2008-8#5)(2008-9#12)(2009-10#1)(2009-11#4)(2009-12#1)(2009-2#8)(2009-4#4)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#4)(2009-9#2)(2010-10#2)(2010-12#3)(2010-2#4)(2010-4#4)(2010-5#10)(2010-6#1)(2010-8#2)(2011-1#6)(2011-12#2)(2011-2#11)(2012-1#8)(2012-12#2)(2012-2#8)(2012-3#1)(2013-1#5)(2013-7#3)(2013-8#9)
stimulus)##5##1##(1993-11#1)(1995-7#1)(1996-1#1)(1997-8#1)(2013-1#1)
stimulus--reward learning##2##2##(1993-6#2)
stimulus--reward##3##1##(1993-6#3)
stimulus-bound discharges##2##2##(1990-4#2)
stimulus-dependent##2##1##(1995-11#1)(1997-8#1)
stimulus-driven##2##1##(2008-1#1)(2009-4#1)
stimulus-evoked [3H]NE##2##2##(1995-7#2)
stimulus-evoked##11##1##(1990-4#2)(1990-7#1)(1992-12#1)(1993-12#1)(1995-7#4)(1996-5#1)(2007-9#1)
stimulus-frequency##3##1##(2009-5#3)
stimulus-induced activity##3##2##(2013-8#3)
stimulus-induced##8##1##(1990-7#1)(1996-5#1)(1997-5#1)(2008-4#1)(2010-12#1)(2013-8#3)
stimulus-locked##2##1##(2007-9#1)(2009-10#1)
stimulus-pairs were##2##2##(1996-6#2)
stimulus-response mappings##2##2##(2012-3#2)
stimulus-response##5##1##(1991-5#1)(1991-8#1)(1997-5#1)(2012-3#2)
stimulus-reward associations##3##2##(1991-1#3)
stimulus-specific##4##1##(1991-5#1)(1995-11#1)(2009-8#1)(2013-8#1)
stimulus-transcription coupling##2##2##(1991-3#1)(1996-5#1)
sting##15##1##(1993-5#1)(2006-8#2)(2007-12#2)(2007-2#1)(2008-6#1)(2008-8#1)(2010-4#1)(2012-3#6)
sting]##2##1##(1991-6#1)(1993-10#1)
stinging##4##1##(1992-4#1)(2006-8#1)(2008-5#2)
stingray##3##1##(1994-5#1)(1995-12#1)(2011-2#1)
stings and##2##2##(2006-2#1)(2009-6#1)
stings##12##1##(1996-9#1)(2006-2#3)(2006-5#1)(2007-2#1)(2008-8#2)(2009-6#1)(2010-4#2)(2012-3#1)
stink bug (Hemiptera##2##3##(2011-2#2)
stink bug feeding##2##3##(2011-2#2)
stink bug number##3##3##(2011-2#3)
stink bug##11##2##(2011-2#11)
stink##12##1##(2011-2#12)
stipe##3##1##(1995-2#1)(2008-5#2)
stipes and apothecia##2##3##(2008-10#2)
stipes##5##1##(2008-10#4)(2013-7#1)
stipitis##8##1##(1995-8#1)(2006-8#5)(2008-5#2)
stipulacea##3##1##(2011-2#3)
stipulate##2##1##(1990-2#1)(2006-10#1)
stipulated##4##1##(1997-6#1)(2008-10#1)(2009-8#1)(2011-1#1)
stipulates that##3##2##(2006-6#1)(2009-11#1)(2009-4#1)
stipulates##4##1##(2006-6#1)(2009-11#1)(2009-4#1)(2012-1#1)
stir bar sorptive extraction (SBSE)##2##5##(2008-10#2)
stir bar##4##2##(2008-10#4)
stir##8##1##(2007-2#1)(2007-3#1)(2008-10#4)(2010-4#2)
stirred at##3##2##(2007-8#1)(2008-10#1)(2008-11#1)
stirred bioreactors##2##2##(2008-11#1)(2008-7#1)
stirred cell##2##2##(2008-7#1)(2009-8#1)
stirred reactor##4##2##(2008-10#2)(2008-11#1)(2013-1#1)
stirred sample##2##2##(2008-10#2)
stirred tank bioreactor##10##3##(2008-11#10)
stirred tank reactor##8##3##(1997-2#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#4)
stirred tank reactors##2##3##(2004-4#1)(2008-11#1)
stirred tank##22##2##(1997-2#1)(2004-4#1)(2006-10#1)(2008-10#1)(2008-11#13)(2008-7#5)
stirred tankreactor##2##2##(2008-11#2)
stirred##65##1##(1996-3#1)(1997-2#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-10#12)(2008-11#30)(2008-7#8)(2009-6#2)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
stirred-tank reactor##2##2##(2008-10#1)(2008-11#1)
stirred-tank##4##1##(2008-10#1)(2008-11#1)(2008-6#1)(2012-3#1)
stirrer##5##1##(1994-11#1)(2008-10#1)(2008-11#2)(2010-5#1)
stirring and ultrasonic##2##3##(2005-11#1)(2008-5#1)
stirring and##4##2##(2005-11#2)(2008-5#1)(2010-2#1)
stirring for##4##2##(2007-8#1)(2008-10#3)
stirring of##2##2##(2008-10#2)
stirring rate##13##2##(2007-8#3)(2008-10#10)
stirring rates##3##2##(2005-11#1)(2008-11#2)
stirring speed##3##2##(2008-10#1)(2008-11#2)
stirring time from##2##3##(2008-10#2)
stirring time of##3##3##(2005-11#1)(2008-10#2)
stirring time##12##2##(2005-11#1)(2008-10#11)
stirring##62##1##(2005-11#6)(2006-2#1)(2006-6#1)(2007-10#1)(2007-8#5)(2008-10#38)(2008-11#6)(2008-5#1)(2010-2#2)(2012-2#1)
stirring)##2##1##(1996-6#1)(2008-10#1)
stitch in##2##2##(1991-2#1)(2007-10#1)
stitch technique##3##2##(2007-8#2)(2013-1#1)
stitch##16##1##(1991-2#6)(2007-10#1)(2007-12#1)(2007-8#3)(2008-6#2)(2012-12#2)(2013-1#1)
stitched##2##1##(2007-12#1)(2011-1#1)
stitches##6##1##(1990-4#1)(1993-9#1)(1996-3#1)(1997-7#1)(2007-12#1)(2007-8#1)
stitching algorithm##2##2##(2007-12#1)(2008-3#1)
stitching##4##1##(2007-12#1)(2008-2#1)(2008-3#2)
stochastic and deterministic##2##3##(1991-12#1)(2008-11#1)
stochastic and##4##2##(1991-12#1)(1995-6#1)(2008-11#2)
stochastic approximation##6##2##(2006-10#1)(2011-1#5)
stochastic circulatory models##4##3##(2007-9#4)
stochastic classifier##2##2##(2006-2#2)
stochastic component##2##2##(1997-4#1)(2008-8#1)
stochastic differential equations##3##3##(2007-11#1)(2008-6#2)
stochastic effects##10##2##(1996-6#4)(2008-7#1)(2008-8#2)(2009-5#1)(2010-7#1)(2012-2#1)
stochastic effects)##2##2##(2008-12#1)(2008-7#1)
stochastic extinction##3##2##(2008-8#3)
stochastic fluctuations##4##2##(2008-7#1)(2010-10#1)(2013-8#2)
stochastic gene expression##2##3##(2009-4#2)
stochastic gradient##4##2##(2008-2#3)(2008-3#1)
stochastic harvesting in##2##3##(2008-8#2)
stochastic juvenile survival##2##3##(2008-8#2)
stochastic kinetic models##2##3##(2010-7#1)(2011-2#1)
stochastic learning##3##2##(2008-2#3)
stochastic logic##5##2##(2008-2#5)
stochastic model for the##2##4##(2008-2#1)(2008-3#1)
stochastic model for##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
stochastic model to##3##3##(1994-4#1)(1996-1#1)(2008-10#1)
stochastic model##14##2##(1994-4#1)(1996-1#1)(2008-10#4)(2008-2#3)(2008-3#3)(2008-7#1)(2008-9#1)
stochastic modeling##3##2##(2008-10#2)(2008-11#1)
stochastic models of both##2##4##(2008-8#1)(2010-6#1)
stochastic models of##4##3##(2008-8#2)(2010-6#1)(2013-8#1)
stochastic models##6##2##(1995-5#1)(2008-11#1)(2008-8#2)(2010-6#1)(2013-8#1)
stochastic nature of the##2##4##(2006-10#1)(2008-8#1)
stochastic nature of##5##3##(1997-5#1)(2006-10#1)(2008-8#1)(2008-9#1)(2013-7#1)
stochastic ordering##2##2##(1992-6#1)(1995-6#1)
stochastic parallel##3##2##(2007-11#1)(2008-3#2)
stochastic process##8##2##(1992-2#2)(1993-4#1)(2008-2#1)(2008-9#1)(2009-12#1)(2010-8#1)(2010-9#1)
stochastic processes##2##2##(2009-8#2)
stochastic properties##2##2##(2008-2#2)
stochastic resonance##9##2##(2007-12#2)(2008-10#7)
stochastic secretion at##2##3##(1991-6#2)
stochastic simulation##10##2##(1991-12#2)(1994-3#1)(1994-5#1)(1997-3#1)(2006-10#1)(2008-2#1)(2009-3#1)(2010-7#1)(2013-7#1)
stochastic simulations##3##2##(2008-10#1)(2008-2#1)(2008-8#1)
stochastic spatial##2##2##(2008-8#2)
stochastic systems in##2##3##(2013-8#2)
stochastic texture##2##2##(2008-2#2)
stochastic theory##2##2##(2006-10#1)(2007-12#1)
stochastic threshold##3##2##(2008-7#2)(2010-12#1)
stochastic transition##3##2##(2008-7#2)(2010-7#1)
stochastic transitions##3##2##(2008-7#3)
stochastic two-stage cancer model##2##4##(2008-7#2)
stochastic variability in##2##3##(1991-6#2)
stochastic variability##5##2##(1991-6#5)
stochastic##245##1##(1990-11#1)(1991-12#3)(1991-2#3)(1991-6#7)(1992-2#2)(1992-6#1)(1992-9#1)(1993-2#1)(1993-4#1)(1994-3#1)(1994-4#1)(1994-5#2)(1995-11#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#2)(1996-6#4)(1997-3#1)(1997-4#1)(1997-5#1)(2006-10#6)(2006-2#3)(2006-4#1)(2006-5#1)(2007-11#4)(2007-12#4)(2007-3#1)(2007-9#7)(2008-1#1)(2008-10#20)(2008-11#6)(2008-12#1)(2008-2#33)(2008-3#14)(2008-6#3)(2008-7#18)(2008-8#26)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#3)(2010-10#2)(2010-12#2)(2010-2#1)(2010-6#2)(2010-7#6)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#4)(2012-1#1)(2012-2#4)(2012-3#2)(2013-7#2)(2013-8#8)
stochastically##5##1##(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
stochasticity and##3##2##(2007-9#1)(2008-8#1)(2008-9#1)
stochasticity in##4##2##(2008-8#1)(2008-9#1)(2013-8#2)
stochasticity of##2##2##(2010-6#1)(2013-8#1)
stochasticity##17##1##(2007-9#1)(2008-8#6)(2008-9#5)(2010-6#1)(2013-8#4)
stock and##9##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#2)(2010-1#1)(2010-3#2)
stock control##2##2##(2010-3#2)
stock cultures##2##2##(2006-5#1)(2008-9#1)
stock enhancement##2##2##(2013-8#2)
stock farmers' exposure to##2##4##(2006-12#2)
stock farmers'##3##2##(2006-12#3)
stock for##3##2##(2007-7#1)(2008-10#1)(2008-9#1)
stock is##2##2##(2008-5#1)(2013-8#1)
stock of the##2##3##(2006-10#1)(2009-10#1)
stock of##11##2##(1991-1#1)(1996-12#1)(1997-2#1)(2006-10#1)(2006-5#1)(2007-6#2)(2008-12#2)(2009-10#1)(2011-2#1)
stock solutions for##2##3##(1996-8#1)(2008-4#1)
stock solutions of##2##3##(2008-10#1)(2008-4#1)
stock solutions##8##2##(1990-12#1)(1996-8#2)(2008-10#1)(2008-4#3)(2008-9#1)
stock structure of E##2##4##(2010-8#2)
stock types##2##2##(2008-10#2)
stock##125##1##(1990-12#2)(1991-1#1)(1992-3#1)(1993-3#1)(1993-5#1)(1994-2#1)(1994-5#1)(1995-10#2)(1995-2#1)(1996-12#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-3#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-12#3)(2006-2#1)(2006-5#2)(2006-8#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#2)(2007-6#4)(2007-7#3)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#4)(2008-3#3)(2008-4#6)(2008-5#7)(2008-6#1)(2008-8#2)(2008-9#7)(2009-10#1)(2009-2#3)(2009-3#2)(2009-5#1)(2009-7#1)(2010-1#2)(2010-12#1)(2010-3#7)(2010-8#3)(2011-1#1)(2011-2#8)(2013-1#3)(2013-7#1)(2013-8#5)
stocked in##2##2##(1996-3#1)(2011-2#1)
stocked##5##1##(1996-3#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
stocking density##2##2##(2005-7#1)(2010-8#1)
stocking rate##15##2##(1996-12#10)(2008-5#5)
stocking rates and##2##3##(2006-10#1)(2008-5#1)
stocking rates##3##2##(2006-10#1)(2008-5#2)
stocking##24##1##(1996-12#10)(2005-7#1)(2006-10#1)(2008-5#8)(2010-8#1)(2011-3#1)(2012-2#1)(2013-7#1)
stockings##2##1##(2007-10#1)(2007-2#1)
stockpiling of##2##2##(2007-12#1)(2008-2#1)
stockpiling##3##1##(2005-7#1)(2007-12#1)(2008-2#1)
stocks and##8##2##(1992-9#1)(2008-10#1)(2008-4#4)(2011-1#1)(2013-7#1)
stocks are##5##2##(2008-4#1)(2008-9#2)(2009-5#1)(2012-2#1)
stocks in##2##2##(2008-9#1)(2009-5#1)
stocks of##11##2##(2008-4#2)(2008-9#2)(2009-5#1)(2009-9#1)(2010-8#3)(2012-12#1)(2012-2#1)
stocks were##2##2##(1995-7#1)(2011-1#1)
stocks##72##1##(1992-9#1)(1995-7#1)(2007-6#1)(2008-10#11)(2008-11#2)(2008-2#3)(2008-4#14)(2008-5#1)(2008-9#10)(2009-2#2)(2009-5#6)(2009-9#1)(2010-8#4)(2010-9#1)(2011-1#6)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
stoichiometric LiNbO(3)##2##2##(2007-12#2)
stoichiometric LiTaO(3)##2##2##(2007-12#2)
stoichiometric amounts of##9##3##(1990-11#2)(1990-9#1)(1991-5#2)(1994-9#1)(1995-6#1)(1996-2#1)(2005-12#1)
stoichiometric binding of##2##3##(1990-7#1)(1991-2#1)
stoichiometric binding##5##2##(1990-7#1)(1990-8#2)(1991-2#1)(1997-2#1)
stoichiometric data##2##2##(1994-3#1)(2008-10#1)
stoichiometric model##3##2##(1996-2#1)(2008-11#1)(2008-7#1)
stoichiometric quantities of##3##3##(1995-8#1)(1996-2#1)(2008-10#1)
stoichiometric ratio##3##2##(2008-10#2)(2008-11#1)
stoichiometric reaction##3##2##(1995-1#1)(2006-12#1)(2008-10#1)
stoichiometric relationship between##2##3##(1992-3#1)(1993-9#1)
stoichiometric##106##1##(1990-11#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#2)(1992-12#1)(1992-3#1)(1993-2#1)(1993-9#4)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-2#6)(1997-2#3)(1997-6#1)(1997-7#1)(2005-11#2)(2005-12#1)(2006-12#1)(2006-3#2)(2006-8#1)(2007-11#2)(2007-12#9)(2007-5#1)(2008-1#1)(2008-10#18)(2008-11#7)(2008-2#1)(2008-5#4)(2008-7#6)(2009-5#2)(2010-12#1)(2010-2#1)(2010-6#1)(2010-9#1)(2012-2#1)(2013-7#1)(2013-8#1)
stoichiometrically in##2##2##(1991-5#1)(1995-1#1)
stoichiometrically to##4##2##(1992-11#1)(1992-4#1)(2008-3#1)(2009-10#1)
stoichiometrically##17##1##(1990-12#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-4#1)(1993-12#2)(1994-11#2)(1995-1#2)(1995-2#1)(1995-5#1)(2008-10#2)(2008-3#1)(2009-10#1)
stoichiometries and##3##2##(2008-10#1)(2008-4#1)(2011-1#1)
stoichiometries of##4##2##(2008-1#1)(2008-10#1)(2008-5#1)(2009-9#1)
stoichiometries##18##1##(1995-3#2)(1996-8#2)(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#6)(2008-4#1)(2008-5#1)(2009-9#1)(2010-5#1)(2011-1#1)
stoichiometry and distance##2##3##(2010-5#2)
stoichiometry and##18##2##(1991-11#1)(1993-9#1)(1994-5#1)(1995-2#1)(1995-8#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2010-5#2)(2012-2#1)(2013-8#3)
stoichiometry between the##3##3##(1993-12#1)(1996-11#1)(1996-2#1)
stoichiometry between##5##2##(1993-12#2)(1993-3#1)(1996-11#1)(1996-2#1)
stoichiometry for##3##2##(1992-12#1)(1996-2#1)(2007-11#1)
stoichiometry in the##3##3##(1990-9#1)(1992-3#2)
stoichiometry in##6##2##(1990-9#1)(1992-3#2)(1995-1#2)(2008-10#1)
stoichiometry of 1##5##3##(1990-3#1)(1991-7#1)(1994-11#1)(1996-5#1)(2008-10#1)
stoichiometry of binding of the##2##5##(1995-3#2)
stoichiometry of binding##4##3##(1991-5#1)(1995-3#2)(2007-11#1)
stoichiometry of the complex##4##4##(2006-10#1)(2008-10#3)
stoichiometry of the species##2##4##(2008-10#2)
stoichiometry of the##22##3##(1990-2#1)(1991-1#1)(1993-3#1)(1993-8#1)(1995-3#3)(2006-10#1)(2008-10#10)(2008-5#3)(2008-7#1)
stoichiometry of##62##2##(1990-2#2)(1990-3#4)(1990-7#2)(1991-1#1)(1991-5#2)(1991-7#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#2)(1994-8#2)(1995-11#1)(1995-3#5)(1995-6#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#15)(2008-4#2)(2008-5#3)(2008-7#1)(2010-2#1)(2012-2#1)
stoichiometry to##2##2##(1993-11#1)(1995-7#1)
stoichiometry was 1##3##3##(1991-5#1)(1996-9#1)(1997-7#1)
stoichiometry was##5##2##(1991-5#1)(1992-3#1)(1996-9#1)(1997-7#1)(2008-10#1)
stoichiometry were##2##2##(2008-10#2)
stoichiometry with##3##2##(1995-11#1)(2008-10#1)(2010-4#1)
stoichiometry##149##1##(1990-2#2)(1990-3#4)(1990-7#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-5#4)(1991-7#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#4)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#3)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-5#1)(1994-6#2)(1994-8#3)(1995-1#2)(1995-10#1)(1995-11#2)(1995-2#1)(1995-3#7)(1995-6#1)(1995-7#1)(1995-8#3)(1996-1#1)(1996-11#1)(1996-2#2)(1996-5#1)(1996-7#1)(1996-9#2)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#2)(2004-1#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-8#4)(2008-10#36)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#1)(2010-2#1)(2010-4#1)(2010-5#3)(2012-2#2)(2013-8#3)
stoichiometry)##2##1##(1995-1#1)(1997-5#1)
stokes##2##1##(2008-2#1)(2008-3#1)
stolbur phytoplasma##4##2##(2008-10#4)
stolbur##5##1##(2008-10#5)
stole##2##1##(1996-11#1)(2007-9#1)
stolon connections##2##2##(2009-8#2)
stolon regression and##2##3##(2009-8#2)
stolon regression##4##2##(2009-8#4)
stolon##9##1##(2008-10#1)(2009-8#8)
stolonifer##5##1##(2006-12#1)(2007-11#2)(2008-5#2)
stolons of##2##2##(2008-10#2)
stolons##4##1##(2008-10#3)(2009-8#1)
stoma##17##1##(1992-4#4)(1993-6#1)(2005-10#1)(2006-5#4)(2007-8#3)(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)
stomach (p = 0##2##4##(2008-7#2)
stomach and duodenum##8##3##(2006-10#7)(2011-2#1)
stomach and esophageal cancers in##2##5##(2011-2#2)
stomach and esophagus##2##3##(2011-2#2)
stomach and intestine##4##3##(2008-12#1)(2008-5#2)(2013-8#1)
stomach and pancreas##4##3##(1992-2#3)(2008-7#1)
stomach and##54##2##(1990-12#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-2#3)(1992-5#2)(1994-12#1)(1994-2#1)(1996-11#1)(1996-12#2)(1996-3#1)(1997-1#1)(2006-10#9)(2006-2#1)(2006-4#1)(2008-10#1)(2008-12#1)(2008-5#4)(2008-6#1)(2008-7#3)(2010-1#1)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
stomach are##6##2##(1990-4#1)(1992-8#1)(2008-4#1)(2008-5#1)(2012-2#1)(2012-3#1)
stomach by##2##2##(1992-9#1)(1995-5#1)
stomach cancer cells##3##3##(2008-8#1)(2009-9#2)
stomach cancer incidence##3##3##(2011-2#1)(2012-12#2)
stomach cancer patients##2##3##(1990-12#1)(2009-2#1)
stomach cancer##30##2##(1990-10#1)(1990-12#2)(1990-9#1)(1991-6#2)(1992-11#2)(1992-12#1)(1992-8#1)(1993-11#1)(1995-6#1)(1995-9#1)(1997-3#2)(2008-5#2)(2008-8#1)(2009-2#1)(2009-9#2)(2010-12#1)(2011-2#2)(2012-12#5)(2012-3#1)
stomach compartment##2##2##(2011-2#2)
stomach contain##2##2##(1995-6#1)(2006-12#1)
stomach contents of##3##3##(2007-3#2)(2008-12#1)
stomach contents##11##2##(1991-11#1)(1992-12#1)(1995-11#1)(1996-7#2)(2007-3#3)(2008-12#1)(2011-2#1)(2012-12#1)
stomach emptying##2##2##(2008-4#1)(2012-1#1)
stomach following##2##2##(1992-12#1)(1993-2#1)
stomach for##5##2##(2006-10#1)(2008-4#1)(2011-1#1)(2012-2#2)
stomach group I PLA2##2##4##(1992-2#2)
stomach in a##3##3##(1993-10#1)(2011-12#2)
stomach in the##4##3##(1990-4#1)(1994-4#1)(2006-10#1)(2008-7#1)
stomach in##18##2##(1990-4#1)(1990-8#1)(1991-6#1)(1993-10#1)(1993-9#1)(1994-4#2)(1997-1#1)(2006-10#2)(2008-4#1)(2008-7#1)(2009-2#1)(2011-12#2)(2011-2#1)(2013-8#2)
stomach is a##3##3##(1993-2#1)(2008-5#1)(2010-8#1)
stomach is##7##2##(1993-2#1)(1994-4#1)(1997-1#1)(2008-5#1)(2010-8#1)(2012-2#1)(2012-3#1)
stomach lavage and cloacal##2##4##(1996-12#2)
stomach lavage##3##2##(1996-12#3)
stomach lumen-perfused rats##2##3##(1990-2#2)
stomach mucosa##8##2##(1992-2#1)(1992-8#1)(1992-9#2)(1993-11#3)(1997-7#1)
stomach of##5##2##(1993-4#1)(1997-1#1)(2007-2#1)(2010-8#1)(2011-2#1)
stomach or duodenal##2##3##(2008-10#1)(2008-8#1)
stomach or##5##2##(1996-10#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-8#1)
stomach phosphorylase kinase##2##3##(1991-1#2)
stomach samples##4##2##(1996-12#3)(2012-12#1)
stomach tissue##3##2##(1997-7#1)(2010-12#2)
stomach to##3##2##(1992-6#1)(1993-8#1)(2008-6#1)
stomach ulcer##3##2##(1990-3#1)(1990-9#1)(1994-8#1)
stomach wall##2##2##(2007-8#1)(2008-12#1)
stomach was##6##2##(1991-9#1)(2006-8#1)(2008-5#1)(2011-12#1)(2011-2#1)(2012-2#1)
stomach which##2##2##(1992-11#1)(2008-5#1)
stomach with##8##2##(1991-8#1)(1992-6#1)(1993-10#1)(2007-3#1)(2007-8#1)(2008-1#1)(2012-1#1)(2012-12#1)
stomach##450##1##(1990-10#3)(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#2)(1990-4#7)(1990-8#5)(1990-9#4)(1991-1#4)(1991-10#1)(1991-11#1)(1991-2#4)(1991-4#1)(1991-5#5)(1991-6#3)(1991-8#1)(1991-9#9)(1992-10#1)(1992-11#6)(1992-12#4)(1992-2#7)(1992-3#2)(1992-4#1)(1992-5#5)(1992-6#4)(1992-7#1)(1992-8#7)(1992-9#7)(1993-1#1)(1993-10#3)(1993-11#7)(1993-12#1)(1993-2#4)(1993-4#4)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-12#3)(1994-2#2)(1994-3#2)(1994-4#7)(1994-5#1)(1994-8#4)(1995-11#3)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#5)(1995-9#1)(1996-10#4)(1996-11#2)(1996-12#11)(1996-2#1)(1996-3#1)(1996-7#3)(1997-1#6)(1997-3#2)(1997-4#2)(1997-7#6)(1997-8#1)(2005-1#1)(2005-12#1)(2005-3#1)(2005-8#3)(2006-1#1)(2006-10#26)(2006-12#4)(2006-2#4)(2006-4#1)(2006-6#1)(2006-8#2)(2007-12#1)(2007-2#5)(2007-3#5)(2007-4#1)(2007-5#2)(2007-8#7)(2008-1#4)(2008-10#5)(2008-11#3)(2008-12#6)(2008-3#2)(2008-4#7)(2008-5#20)(2008-6#3)(2008-7#19)(2008-8#6)(2008-9#4)(2009-12#1)(2009-2#4)(2009-3#3)(2009-5#1)(2009-8#4)(2009-9#2)(2010-1#2)(2010-12#3)(2010-6#1)(2010-8#4)(2011-1#3)(2011-12#11)(2011-2#28)(2012-1#5)(2012-12#11)(2012-2#8)(2012-3#4)(2013-1#4)(2013-7#3)(2013-8#6)
stomach)##2##1##(1995-5#1)(1997-7#1)
stomachs##11##1##(1993-12#1)(1995-11#1)(1996-7#1)(2006-10#1)(2007-1#1)(2008-12#3)(2008-5#1)(2010-8#2)
stomal##6##1##(1992-4#2)(2006-9#2)(2012-1#2)
stomata of##2##2##(2008-10#1)(2013-8#1)
stomata were##3##2##(2008-10#2)(2011-10#1)
stomata##29##1##(1993-6#1)(2007-12#1)(2007-3#1)(2008-10#19)(2009-8#2)(2011-10#1)(2012-1#1)(2013-7#2)(2013-8#1)
stomatal aperture##2##2##(2008-10#2)
stomatal closure and##2##3##(2008-10#2)
stomatal closure##3##2##(2008-10#2)(2012-6#1)
stomatal conductance##7##2##(2004-4#1)(2008-10#1)(2008-12#1)(2012-7#1)(2013-8#3)
stomatal movement##4##2##(2008-8#4)
stomatal opening##5##2##(1997-4#1)(2008-10#1)(2008-8#2)(2012-6#1)
stomatal regulation##2##2##(2009-8#1)(2013-8#1)
stomatal##34##1##(1994-11#1)(1997-4#1)(2004-4#1)(2008-10#11)(2008-12#1)(2008-8#6)(2009-8#4)(2012-6#2)(2012-7#1)(2013-7#2)(2013-8#4)
stomatitis and##2##2##(1992-2#1)(2006-12#1)
stomatitis in##2##2##(1990-10#1)(1991-10#1)
stomatitis##41##1##(1990-10#1)(1990-2#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-8#2)(1997-1#2)(1997-4#2)(2005-5#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-4#3)(2008-5#1)(2008-6#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
stomatocytic##4##1##(1997-1#4)
stomatocytosis##3##1##(1997-1#2)(2013-1#1)
stomatogastric nervous##2##2##(1994-8#1)(1995-11#1)
stomatogastric##3##1##(1993-9#1)(1994-8#1)(1995-11#1)
stomatognathic##2##1##(1990-6#1)(2008-10#1)
stomatologic##2##1##(2008-10#1)(2011-1#1)
stomatopod##4##1##(2007-12#4)
stomodaeum##2##1##(2007-12#2)
stomy##2##1##(2008-4#1)(2011-12#1)
stone and##2##2##(2005-12#1)(2013-8#1)
stone cutting##2##2##(1994-6#2)
stone disease##3##2##(1993-9#1)(1997-8#1)(2012-12#1)
stone formation is##2##3##(1992-9#1)(2007-7#1)
stone formation##10##2##(1992-4#1)(1992-9#3)(1993-6#1)(1996-3#1)(2006-10#2)(2007-7#2)
stone formers and##5##3##(1991-12#1)(1995-7#3)(2006-9#1)
stone formers##15##2##(1991-12#6)(1995-7#8)(2006-9#1)
stone free##3##2##(1992-5#1)(2007-6#1)(2007-7#1)
stone fruit trees##3##3##(2008-10#3)
stone fruit##12##2##(2008-10#12)
stone fruits##4##2##(2008-10#4)
stone in a##2##3##(2008-8#1)(2011-11#1)
stone in the##2##3##(2008-10#1)(2009-6#1)
stone in##8##2##(2007-3#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-6#1)(2011-11#1)(2011-2#1)
stone of the##2##3##(2007-7#1)(2011-1#1)
stone of##3##2##(2007-7#1)(2009-1#1)(2011-1#1)
stone part to the##3##4##(1997-4#3)
stone recurrence##7##2##(2007-7#2)(2008-5#4)(2013-7#1)
stone removal##6##2##(1993-5#1)(2006-10#1)(2008-5#2)(2013-7#2)
stone risk factors##2##3##(1995-7#1)(2007-8#1)
stone risk##3##2##(1995-7#1)(2007-8#2)
stone to##4##2##(1993-12#1)(2006-12#1)(2006-2#1)(2013-8#1)
stone##142##1##(1990-12#1)(1991-12#6)(1991-4#2)(1991-8#2)(1992-4#5)(1992-5#2)(1992-9#3)(1993-10#2)(1993-12#1)(1993-5#2)(1993-6#2)(1993-9#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-7#9)(1995-8#1)(1996-3#1)(1997-2#3)(1997-4#4)(1997-8#1)(2005-12#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-6#1)(2006-9#3)(2007-12#1)(2007-3#4)(2007-5#1)(2007-6#2)(2007-7#6)(2007-8#4)(2008-1#2)(2008-10#19)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#6)(2008-8#2)(2008-9#1)(2009-1#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-12#4)(2011-1#2)(2011-11#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-7#3)(2013-8#4)
stone-fruit-growing##2##1##(2008-10#2)
stone?##2##1##(2007-5#1)(2008-10#1)
stones and##18##2##(1991-9#1)(2005-12#1)(2006-9#2)(2007-3#2)(2007-7#1)(2008-1#1)(2008-5#1)(2010-8#1)(2011-2#3)(2013-7#2)(2013-8#3)
stones are##7##2##(1993-5#1)(1994-6#1)(2008-3#1)(2010-12#3)(2012-2#1)
stones by##4##2##(1991-12#1)(2006-10#1)(2007-6#1)(2009-6#1)
stones can be treated with##2##5##(1990-12#1)(1991-3#1)
stones can be##4##3##(1990-12#2)(1991-3#1)(1997-8#1)
stones have been##2##3##(2011-2#1)(2013-8#1)
stones in the##5##3##(1992-5#3)(2010-12#1)(2013-8#1)
stones in##15##2##(1991-3#1)(1992-5#3)(1994-6#1)(2007-3#2)(2007-7#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-8#2)
stones is##4##2##(1993-5#1)(2008-3#1)(2012-2#1)(2013-8#1)
stones or##2##2##(1990-12#1)(1993-5#1)
stones was##3##2##(1994-5#1)(2006-6#1)(2010-12#1)
stones were removed endoscopically##2##4##(1993-5#1)(2011-2#1)
stones were removed##3##3##(1991-3#1)(1993-5#1)(2011-2#1)
stones were##9##2##(1991-3#1)(1993-5#1)(2007-6#1)(2007-7#1)(2008-5#1)(2011-2#2)(2013-7#1)(2013-8#1)
stones with##4##2##(1991-12#1)(1993-6#1)(2005-10#1)(2011-2#1)
stones##141##1##(1990-12#6)(1990-5#1)(1990-6#1)(1991-12#5)(1991-3#4)(1991-8#1)(1991-9#1)(1992-5#9)(1993-5#4)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#2)(1996-3#1)(1997-8#2)(2005-10#1)(2005-12#1)(2006-10#5)(2006-6#2)(2006-9#5)(2007-3#5)(2007-6#3)(2007-7#5)(2008-1#4)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#6)(2008-4#2)(2008-5#5)(2008-7#2)(2009-11#1)(2009-6#1)(2009-7#1)(2010-12#7)(2010-5#1)(2010-8#1)(2011-2#15)(2012-2#4)(2013-1#2)(2013-7#4)(2013-8#12)
stones)##2##1##(2008-10#1)(2011-2#1)
stony coral##3##2##(2007-3#3)
stony##8##1##(1997-5#2)(2007-3#4)(2013-1#2)
stood at##2##2##(2008-5#1)(2011-2#1)
stood out##3##2##(2006-10#1)(2008-5#1)(2013-1#1)
stood##8##1##(1990-3#1)(2006-10#1)(2006-9#1)(2008-10#1)(2008-5#2)(2011-2#1)(2013-1#1)
stool and##4##2##(2006-2#1)(2011-1#1)(2011-2#1)(2013-8#1)
stool as##2##2##(1993-3#1)(2011-2#1)
stool bed cuttings##2##3##(2008-10#2)
stool culture##4##2##(1993-7#1)(2010-9#2)(2012-2#1)
stool cultures##3##2##(1991-6#1)(2007-2#2)
stool examination##2##2##(1995-10#1)(2012-3#1)
stool examinations##2##2##(1990-3#1)(1991-12#1)
stool height##4##2##(2008-6#4)
stool of a##2##3##(2008-6#1)(2011-2#1)
stool samples and##3##3##(2006-8#1)(2011-1#2)
stool samples examined##3##3##(2009-10#1)(2011-2#1)(2012-3#1)
stool samples from##6##3##(2006-2#1)(2006-8#1)(2007-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
stool samples were collected##2##4##(2011-1#2)
stool samples were##6##3##(2007-7#1)(2011-1#3)(2011-2#1)(2012-2#1)
stool samples##25##2##(2006-2#1)(2006-8#2)(2007-12#1)(2007-7#4)(2007-8#1)(2008-10#2)(2009-10#1)(2011-1#6)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
stool softeners##2##2##(2008-7#1)(2011-2#1)
stool specimens of##3##3##(1991-10#1)(2007-2#2)
stool specimens were collected from##2##5##(2007-2#1)(2011-2#1)
stool specimens##15##2##(1990-12#1)(1991-10#1)(1993-8#1)(2006-10#1)(2006-2#2)(2007-2#3)(2010-4#1)(2011-2#1)(2012-2#3)(2013-8#1)
stool test##2##2##(2012-3#1)(2013-7#1)
stool##99##1##(1990-12#1)(1990-3#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-6#2)(1991-8#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-3#1)(1993-7#1)(1993-8#1)(1995-10#1)(1996-1#2)(2005-11#4)(2006-10#4)(2006-2#4)(2006-6#2)(2006-8#3)(2007-12#2)(2007-2#6)(2007-7#6)(2007-8#2)(2008-10#4)(2008-6#6)(2008-7#1)(2009-10#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-9#2)(2011-1#8)(2011-2#8)(2012-2#6)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#3)
stools and##6##2##(1990-12#1)(1990-3#1)(2006-6#1)(2008-4#1)(2013-1#1)(2013-8#1)
stools from adults who##2##4##(2007-2#2)
stools from##3##2##(2007-12#1)(2007-2#2)
stools##28##1##(1990-12#2)(1990-3#2)(1991-6#1)(1992-9#2)(1993-10#1)(1995-1#1)(2006-2#1)(2006-6#1)(2006-8#2)(2007-12#1)(2007-2#3)(2008-4#2)(2008-8#1)(2009-1#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-11#1)(2013-1#2)(2013-8#1)
stop and start##2##3##(1990-3#1)(1994-9#1)
stop and##6##2##(1990-3#1)(1994-7#1)(1994-9#1)(1996-2#1)(2008-3#1)(2010-9#1)
stop array##2##2##(2007-12#1)(2012-1#1)
stop at a##2##3##(1993-2#1)(2009-10#1)
stop at##4##2##(1993-2#1)(1994-12#1)(2009-10#1)(2011-2#1)
stop band of the grating##2##5##(2007-12#1)(2008-3#1)
stop band of##3##3##(2007-12#2)(2008-3#1)
stop band##13##2##(2007-12#6)(2008-2#4)(2008-3#3)
stop being##2##2##(1991-12#1)(2013-8#1)
stop bleeding##4##2##(2005-10#1)(2006-9#1)(2008-3#2)
stop codon (UAA)##3##3##(1990-11#1)(1990-7#1)(1992-11#1)
stop codon and##2##3##(1995-8#1)(2008-9#1)
stop codon at the beginning of##2##6##(2006-9#1)(2008-10#1)
stop codon at##3##3##(1991-12#1)(2006-9#1)(2008-10#1)
stop codon in##2##3##(1990-11#1)(2013-1#1)
stop codon mutation##2##3##(1995-8#1)(1996-8#1)
stop codon of##4##3##(1994-12#1)(1996-10#1)(1997-6#1)(1997-7#1)
stop codon was##2##3##(1996-7#1)(2009-8#1)
stop codon##53##2##(1990-11#2)(1990-5#2)(1990-7#3)(1991-10#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-3#1)(1993-11#3)(1993-12#1)(1994-11#1)(1994-12#4)(1994-8#1)(1995-10#1)(1995-2#2)(1995-8#3)(1996-10#1)(1996-7#3)(1996-8#2)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(2006-11#1)(2006-9#1)(2007-2#1)(2008-10#2)(2008-4#2)(2008-9#2)(2009-5#1)(2009-8#1)(2013-1#1)
stop codons and##3##3##(1993-11#1)(1993-12#1)(1996-7#1)
stop codons in##2##3##(1990-10#1)(2008-11#1)
stop codons##11##2##(1990-10#1)(1990-11#1)(1990-3#2)(1992-2#1)(1993-11#1)(1993-12#1)(1993-2#1)(1996-7#2)(2008-11#1)
stop drinking##2##2##(1995-11#1)(2007-9#1)
stop in##3##2##(1996-11#1)(1997-2#1)(1997-4#1)
stop is##2##2##(2008-2#2)
stop of##2##2##(1993-8#1)(2012-2#1)
stop or prevent##2##3##(2007-11#1)(2011-2#1)
stop or##6##2##(2006-10#1)(2007-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)
stop signal and##2##3##(1994-12#1)(1994-9#1)
stop signal##9##2##(1990-8#1)(1993-6#1)(1994-12#4)(1994-3#1)(1994-9#1)(2008-3#1)
stop signals##3##2##(1994-12#2)(1994-9#1)
stop smoking##7##2##(1990-6#1)(1994-7#1)(1996-8#1)(2006-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
stop the progression of curvature##2##5##(2007-7#1)(2007-8#1)
stop the progression of##4##4##(2007-7#2)(2007-8#1)(2008-3#1)
stop the##23##2##(1990-11#1)(1995-6#1)(1996-9#1)(1997-6#1)(2006-1#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-2#1)(2012-2#3)(2012-3#1)(2013-1#1)
stop this##3##2##(2006-12#1)(2006-8#1)(2008-8#1)
stop treatment##2##2##(2007-7#1)(2011-2#1)
stop using##2##2##(1996-11#1)(2008-7#1)
stop##233##1##(1990-10#2)(1990-11#7)(1990-12#1)(1990-2#1)(1990-3#3)(1990-5#2)(1990-6#1)(1990-7#3)(1990-8#2)(1991-10#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-6#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#4)(1993-12#2)(1993-2#4)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#12)(1994-2#1)(1994-3#1)(1994-7#2)(1994-8#1)(1994-9#4)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#3)(1995-8#3)(1996-10#1)(1996-11#2)(1996-2#1)(1996-7#5)(1996-8#5)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#1)(2004-5#1)(2005-10#2)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-5#1)(2006-6#1)(2006-8#3)(2006-9#2)(2007-11#2)(2007-12#8)(2007-2#2)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#15)(2008-3#12)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#5)(2008-9#5)(2009-10#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-2#1)(2010-4#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#4)(2013-8#2)
stop-band##2##1##(2007-11#1)(2008-3#1)
stop-codon##2##1##(1997-7#1)(2012-2#1)
stop-flow##6##1##(2006-6#4)(2007-1#1)(2008-10#1)
stop-start##2##1##(1991-1#1)(1993-9#1)
stopband##3##1##(2008-1#1)(2008-3#2)
stopbands##5##1##(2008-3#5)
stopgaps##3##1##(2007-11#3)
stoppage##2##1##(2007-8#1)(2011-2#1)
stopped after the##2##3##(1996-11#1)(2008-10#1)
stopped and##6##2##(1993-1#1)(2007-7#1)(2008-7#1)(2010-12#1)(2011-3#1)(2012-12#1)
stopped at##3##2##(1990-8#1)(1994-5#1)(2008-8#1)
stopped before##3##2##(2006-10#1)(2008-1#1)(2009-5#1)
stopped by the##3##3##(1996-6#1)(2004-9#1)(2007-10#1)
stopped by##7##2##(1991-6#1)(1994-9#1)(1996-6#1)(2004-9#1)(2007-10#1)(2008-7#2)
stopped flow##11##2##(1991-7#1)(1994-11#1)(1994-9#2)(2008-10#7)
stopped for a##2##3##(1996-3#1)(2006-4#1)
stopped for##3##2##(1996-3#1)(2006-4#1)(2008-8#1)
stopped her##2##2##(2010-5#1)(2012-2#1)
stopped in##4##2##(2006-4#1)(2007-7#1)(2008-10#1)(2008-3#1)
stopped or##3##2##(2006-10#1)(2013-1#2)
stopped smoking##4##2##(1990-12#1)(1996-8#1)(1997-3#1)(2007-3#1)
stopped taking##2##2##(2005-9#1)(2007-7#1)
stopped temporarily##2##2##(1993-2#1)(2008-11#1)
stopped the##7##2##(1990-12#1)(1990-3#1)(1996-9#1)(1997-4#1)(2007-8#1)(2008-12#1)(2008-8#1)
stopped within##3##2##(2005-11#1)(2012-2#2)
stopped##122##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-5#1)(1993-1#1)(1993-2#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-9#3)(1995-10#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2004-9#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-4#3)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-3#1)(2007-4#1)(2007-7#5)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#6)(2008-8#4)(2009-3#2)(2009-5#2)(2010-1#2)(2010-12#1)(2010-5#2)(2010-9#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#4)(2013-1#4)
stopped-FI##3##1##(2008-10#3)
stopped-flow fluorescence polarization immunoassay##2##4##(2008-10#2)
stopped-flow fluorescence##6##2##(1990-5#1)(1994-5#1)(1995-11#1)(2008-10#2)(2008-4#1)
stopped-flow injection##4##2##(2008-10#4)
stopped-flow mixing technique##7##3##(2008-10#7)
stopped-flow spectrophotometric##2##2##(2008-10#2)
stopped-flow spectrophotometry##3##2##(1991-2#1)(1994-11#1)(2008-10#1)
stopped-flow spectroscopy##3##2##(1995-1#1)(1995-2#1)(2006-12#1)
stopped-flow studies of##3##3##(1991-9#1)(1995-10#1)(2006-10#1)
stopped-flow technique##2##2##(2008-10#2)
stopped-flow techniques##3##2##(1991-2#1)(1994-8#1)(2008-10#1)
stopped-flow##56##1##(1990-2#1)(1990-3#1)(1990-5#1)(1991-2#3)(1991-7#1)(1991-9#2)(1992-8#1)(1994-11#2)(1994-5#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-8#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-12#1)(2008-10#28)(2008-4#2)
stopping guidelines##2##2##(1993-5#2)
stopping power##2##2##(2012-12#2)
stopping rule is##2##3##(1995-2#1)(2012-2#1)
stopping rule##3##2##(1995-2#1)(2008-2#1)(2012-2#1)
stopping the drug##2##3##(1993-8#1)(2010-2#1)
stopping the infusion and##2##4##(1997-6#1)(2008-7#1)
stopping the infusion##3##3##(1990-11#1)(1997-6#1)(2008-7#1)
stopping the##13##2##(1990-11#1)(1990-12#2)(1992-3#1)(1993-8#1)(1994-6#1)(1997-6#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-2#1)(2011-1#1)
stopping therapy##2##2##(1995-3#1)(2006-10#1)
stopping treatment##2##2##(1995-3#1)(2011-2#1)
stopping##63##1##(1990-11#1)(1990-12#3)(1992-3#1)(1993-5#3)(1993-8#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-3#2)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(2004-1#1)(2005-1#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-11#2)(2007-5#1)(2007-7#4)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#4)(2012-2#1)(2013-1#1)(2013-8#3)
stops at the##2##3##(1991-7#1)(1992-1#1)
stops##22##1##(1990-11#1)(1990-4#1)(1991-7#1)(1992-1#1)(1992-10#1)(1993-2#3)(1996-2#1)(1997-5#1)(1997-6#1)(2006-10#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-1#2)
stopwatch##2##1##(2007-2#1)(2008-8#1)
storage (&gt##2##2##(2008-10#1)(2013-1#1)
storage and distribution##2##3##(2006-1#1)(2006-11#1)
storage and preparation##2##3##(2012-2#2)
storage and release of##2##4##(1995-12#1)(2010-4#1)
storage and release##3##3##(1995-12#1)(2008-10#1)(2010-4#1)
storage and retrieval##3##3##(1993-6#1)(2008-11#1)(2009-8#1)
storage and transmission of information##2##5##(2010-8#2)
storage and transmission of##3##4##(2006-8#1)(2010-8#2)
storage and transport##2##3##(2006-10#1)(2008-7#1)
storage and transportation##3##3##(2005-5#1)(2012-2#1)(2013-1#1)
storage and use##2##3##(1997-6#1)(2007-12#1)
storage and##80##2##(1991-3#1)(1991-5#1)(1992-1#2)(1992-3#1)(1993-6#1)(1994-11#1)(1994-3#2)(1995-12#2)(1995-7#1)(1996-8#1)(1997-6#1)(2005-5#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-2#2)(2006-6#1)(2006-8#1)(2007-12#9)(2007-9#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-4#3)(2010-8#5)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#6)
storage are##4##2##(1994-8#1)(2006-2#1)(2007-12#1)(2011-2#1)
storage area at Vikuge##2##4##(2008-10#2)
storage at +4 degrees C##2##5##(1995-7#1)(2008-10#1)
storage at -80##2##3##(1993-12#1)(2008-10#1)
storage at 2 degrees C##2##5##(2007-3#2)
storage at 4 degrees C and##2##6##(2008-10#2)
storage at 4 degrees C##10##5##(1992-8#1)(1994-12#3)(2008-10#5)(2012-2#1)
storage at 4##11##3##(1992-8#1)(1994-12#3)(2008-10#5)(2012-2#1)(2013-1#1)
storage at different temperatures##2##4##(2008-5#1)(2013-1#1)
storage at different##3##3##(1991-3#1)(2008-5#1)(2013-1#1)
storage at room temperature and##2##5##(2008-10#1)(2008-5#1)
storage at room temperature##9##4##(1990-11#1)(1996-12#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2010-4#1)
storage at##47##2##(1990-11#1)(1991-3#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-12#3)(1995-7#1)(1996-12#1)(1997-4#1)(2006-5#2)(2007-11#1)(2007-3#3)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-5#5)(2008-7#1)(2010-4#3)(2012-2#1)(2013-1#2)
storage bags##3##2##(2008-10#2)(2010-7#1)
storage based on##2##3##(2007-12#1)(2008-3#1)
storage because##3##2##(1995-6#1)(1996-8#1)(2010-8#1)
storage by##14##2##(1990-11#1)(1992-2#1)(1995-6#1)(2007-12#3)(2007-8#1)(2008-1#2)(2008-2#1)(2008-3#2)(2008-8#1)(2010-4#1)
storage capacity and the##2##4##(2008-2#1)(2008-3#1)
storage capacity and##5##3##(1996-8#1)(2007-12#1)(2008-2#1)(2008-3#2)
storage capacity of##6##3##(2007-12#3)(2008-2#1)(2008-3#2)
storage capacity##21##2##(1996-8#1)(2007-12#5)(2007-8#1)(2008-2#5)(2008-3#7)(2010-2#1)(2012-11#1)
storage condition##2##2##(1996-12#1)(2011-2#1)
storage conditions and##3##3##(1996-5#1)(1996-6#1)(2007-8#1)
storage conditions for##3##3##(1997-3#1)(2006-2#1)(2007-12#1)
storage conditions of##2##3##(2007-1#1)(2008-5#1)
storage conditions were##2##3##(1996-12#1)(1996-7#1)
storage conditions##21##2##(1991-3#1)(1992-8#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-3#1)(2006-1#1)(2006-2#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#3)(2010-4#3)(2010-8#1)
storage day##3##2##(2007-3#2)(2010-7#1)
storage densities##7##2##(2007-12#2)(2008-2#1)(2008-3#4)
storage density in##2##3##(2007-12#1)(2008-2#1)
storage density of##3##3##(2008-2#1)(2008-3#2)
storage density##14##2##(2007-12#5)(2008-1#1)(2008-2#2)(2008-3#5)(2008-7#1)
storage depot##3##2##(1991-4#1)(2006-2#1)(2008-3#1)
storage disease##21##2##(1990-11#2)(1990-2#1)(1990-8#1)(1991-1#1)(1992-10#1)(1993-12#1)(1994-3#1)(1994-9#2)(1995-6#2)(2007-2#1)(2007-3#1)(2007-7#1)(2008-7#2)(2010-8#3)(2012-2#1)
storage diseases##13##2##(1990-11#1)(1990-2#1)(1993-9#2)(1996-4#2)(1996-5#2)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
storage disorder##7##2##(1990-8#1)(1991-9#1)(1994-3#2)(1996-8#1)(2006-10#1)(2008-10#1)
storage disorders##6##2##(1990-11#1)(1990-2#2)(2008-11#2)(2012-1#1)
storage due to##2##3##(2007-12#1)(2008-10#1)
storage facility##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
storage for a##2##3##(1993-12#1)(1995-6#1)
storage for six months at -20##2##6##(2013-7#2)
storage for the##2##3##(2004-9#1)(2008-10#1)
storage for##17##2##(1993-12#1)(1995-11#1)(1995-6#1)(1995-7#1)(2004-9#1)(2008-10#1)(2008-3#2)(2008-5#3)(2008-9#1)(2009-7#1)(2010-4#2)(2013-7#2)
storage form##2##2##(1991-5#1)(1996-5#1)
storage from##2##2##(2010-4#1)(2012-2#1)
storage function##2##2##(1996-7#1)(2010-8#1)
storage have##2##2##(1990-2#1)(2009-4#1)
storage in a##12##3##(1995-7#1)(2004-9#1)(2007-12#3)(2007-2#1)(2008-10#2)(2008-3#3)(2008-5#1)
storage in liquid nitrogen##3##4##(1992-2#1)(2007-7#1)(2010-8#1)
storage in methylsalicylate##2##3##(2009-2#2)
storage in the##11##3##(1990-4#1)(1991-7#1)(1992-3#1)(1995-12#1)(2006-3#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2012-5#1)(2013-8#1)
storage in this##2##3##(1996-9#1)(2008-3#1)
storage in which##2##3##(2007-7#1)(2008-3#1)
storage in##54##2##(1990-4#1)(1991-7#1)(1992-2#1)(1992-3#1)(1995-12#1)(1995-7#1)(1996-6#1)(1996-9#1)(2004-9#2)(2006-3#1)(2006-5#1)(2007-12#8)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#3)(2008-10#5)(2008-3#6)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#2)(2009-7#1)(2010-4#2)(2010-8#2)(2012-5#1)(2013-8#2)
storage is##4##2##(1994-5#1)(2007-12#1)(2008-3#1)(2009-10#1)
storage material##4##2##(1990-4#3)(2007-12#1)
storage materials##5##2##(1996-2#1)(2007-12#1)(2007-8#1)(2010-4#2)
storage media##6##2##(1995-7#1)(2007-12#3)(2009-9#2)
storage medium##10##2##(2007-12#1)(2008-12#1)(2008-3#3)(2008-5#1)(2013-1#4)
storage of data##2##3##(1996-12#1)(2007-3#1)
storage of glycogen##2##3##(2008-7#1)(2012-2#1)
storage of samples##4##3##(1992-3#1)(2008-10#2)(2009-2#1)
storage of the##9##3##(1990-1#1)(1990-9#1)(1993-11#1)(2004-12#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-9#1)
storage of##77##2##(1990-1#1)(1990-2#1)(1990-9#1)(1991-12#1)(1991-3#1)(1992-3#1)(1993-11#1)(1993-12#3)(1993-2#1)(1994-3#2)(1995-11#1)(1995-9#1)(1996-12#1)(2004-12#1)(2006-5#1)(2007-12#5)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-2#2)(2008-3#3)(2008-4#5)(2008-7#2)(2008-9#9)(2009-2#3)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#2)(2013-8#1)
storage on##4##2##(1992-6#1)(2008-3#1)(2010-4#1)(2011-2#1)
storage or##10##2##(1994-10#1)(1994-11#1)(1994-8#1)(1995-10#1)(2008-10#2)(2008-3#2)(2008-8#1)(2013-8#1)
storage organ##4##2##(2007-12#2)(2008-1#1)(2010-8#1)
storage organelles##2##2##(1990-5#1)(1996-5#1)
storage period at##2##3##(2008-5#1)(2012-2#1)
storage period in##3##3##(2007-3#1)(2008-5#1)(2012-2#1)
storage period##13##2##(1997-8#1)(2006-5#1)(2007-3#1)(2008-11#1)(2008-5#2)(2010-4#3)(2012-2#4)
storage periods##3##2##(1996-12#1)(2010-4#1)(2010-8#1)
storage pixels##2##2##(2008-3#2)
storage pool##5##2##(1992-4#2)(1997-7#1)(2007-10#2)
storage procedures##4##2##(1992-8#2)(2008-10#1)(2010-2#1)
storage protein in cottonseed##2##4##(2006-11#2)
storage protein in##3##3##(2006-11#2)(2008-10#1)
storage protein##14##2##(1993-11#1)(1993-4#1)(1994-12#1)(1994-3#1)(1995-8#1)(1996-7#1)(2006-11#2)(2006-12#3)(2008-10#1)(2008-9#1)(2009-10#1)
storage proteins##10##2##(1991-12#1)(2006-12#4)(2008-10#1)(2009-10#2)(2010-4#1)(2012-1#1)
storage protocols##4##2##(2008-10#4)
storage requirements##2##2##(2008-2#1)(2008-3#1)
storage ring##17##2##(1990-12#1)(1992-3#1)(1993-8#1)(1995-5#1)(2006-5#13)
storage rings##2##2##(2006-4#1)(2006-5#1)
storage root##5##2##(1992-11#1)(2009-6#4)
storage roots##4##2##(1992-11#1)(2008-10#2)(2009-6#1)
storage sites##5##2##(1991-12#1)(1994-8#1)(1995-12#1)(2004-12#1)(2008-7#1)
storage space##4##2##(1994-3#2)(1996-1#1)(2009-9#1)
storage stability and##2##3##(2008-5#1)(2008-6#1)
storage stability at 4 degrees C##2##6##(2008-10#1)(2010-5#1)
storage stability of the##3##4##(2008-10#2)(2008-5#1)
storage stability of##7##3##(2008-10#5)(2008-5#2)
storage stability##27##2##(2008-10#18)(2008-5#6)(2008-6#1)(2008-7#1)(2010-5#1)
storage system are##2##3##(2007-12#1)(2008-2#1)
storage system##15##2##(1994-3#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#7)(2008-3#2)
storage systems that##2##3##(2008-2#2)
storage systems##10##2##(2007-11#2)(2008-2#5)(2008-3#3)
storage tanks##3##2##(1995-2#1)(2009-10#1)(2011-1#1)
storage temperature##5##2##(2006-5#2)(2008-10#1)(2008-5#1)(2012-2#1)
storage than##2##2##(2008-10#1)(2008-2#1)
storage that##2##2##(2007-12#1)(2008-3#1)
storage the##2##2##(2006-12#1)(2008-3#1)
storage time and temperature##2##4##(1997-8#2)
storage time and##6##3##(1997-8#2)(2008-10#2)(2010-4#2)
storage time of##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
storage time on##2##3##(2007-12#1)(2013-1#1)
storage time##19##2##(1993-12#1)(1997-8#3)(2007-12#2)(2007-3#1)(2008-10#4)(2008-3#1)(2009-5#1)(2010-4#4)(2012-2#1)(2013-1#1)
storage times##5##2##(2007-12#3)(2011-3#1)(2012-1#1)
storage to##2##2##(2007-12#1)(2007-9#1)
storage under##2##2##(2007-12#1)(2012-1#1)
storage using##2##2##(2007-12#1)(2010-12#1)
storage was##3##2##(1997-4#1)(2010-7#1)(2012-2#1)
storage were##2##2##(2006-5#1)(2008-10#1)
storage with##9##2##(2007-11#1)(2007-12#2)(2008-1#1)(2008-3#5)
storage within##2##2##(1996-7#1)(2008-3#1)
storage##999##1##(1990-1#1)(1990-11#6)(1990-12#2)(1990-2#6)(1990-4#8)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#3)(1991-3#4)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#5)(1992-4#2)(1992-6#1)(1992-8#4)(1992-9#1)(1993-11#3)(1993-12#9)(1993-2#2)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#4)(1994-3#16)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-10#1)(1995-11#2)(1995-12#8)(1995-2#3)(1995-5#1)(1995-6#5)(1995-7#10)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#5)(1996-2#1)(1996-3#1)(1996-4#3)(1996-5#5)(1996-6#2)(1996-7#5)(1996-8#4)(1996-9#1)(1997-3#2)(1997-4#3)(1997-6#2)(1997-7#2)(1997-8#4)(2004-12#2)(2004-9#6)(2005-11#3)(2005-5#1)(2005-8#1)(2006-1#2)(2006-10#2)(2006-11#3)(2006-12#10)(2006-2#6)(2006-3#1)(2006-4#1)(2006-5#36)(2006-6#2)(2006-8#1)(2007-1#2)(2007-10#3)(2007-11#5)(2007-12#91)(2007-2#3)(2007-3#14)(2007-4#2)(2007-5#1)(2007-7#4)(2007-8#12)(2007-9#3)(2008-1#12)(2008-10#118)(2008-11#16)(2008-12#5)(2008-2#38)(2008-3#87)(2008-4#16)(2008-5#35)(2008-6#3)(2008-7#18)(2008-8#8)(2008-9#27)(2009-10#6)(2009-12#2)(2009-2#5)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#6)(2009-7#4)(2009-8#1)(2009-9#3)(2010-11#2)(2010-12#7)(2010-2#3)(2010-3#1)(2010-4#46)(2010-5#1)(2010-7#3)(2010-8#18)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#17)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#2)(2012-2#24)(2012-5#1)(2013-1#20)(2013-7#8)(2013-8#17)
storage)##2##1##(2008-9#1)(2010-4#1)
store UCB##2##2##(2012-11#2)
store a##2##2##(2007-8#1)(2008-7#1)
store and retrieve the details of patient care##2##8##(2013-1#2)
store and##13##2##(1991-8#1)(1993-8#1)(1995-9#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-5#1)(2012-1#1)(2013-1#2)
store depletion##3##2##(1996-9#2)(2008-8#1)
store employee##2##2##(1996-5#2)
store food##2##2##(2008-1#1)(2011-2#1)
store in##4##2##(1996-5#1)(1997-5#1)(2008-4#1)(2011-2#1)
store information##2##2##(2008-11#1)(2008-4#1)
store is##2##2##(1990-10#1)(1990-2#1)
store it in a##2##4##(2008-6#1)(2012-11#1)
store it##4##2##(2008-1#1)(2008-6#1)(2011-1#1)(2012-11#1)
store of##4##2##(1994-6#1)(2011-1#1)(2013-1#2)
store the##9##2##(1996-11#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2013-7#1)
store their##2##2##(2008-7#2)
store them##3##2##(1994-3#1)(1997-4#1)(2008-4#1)
store##104##1##(1990-10#1)(1990-11#2)(1990-2#1)(1990-3#1)(1991-12#2)(1991-8#1)(1993-3#1)(1993-8#2)(1994-3#1)(1994-6#1)(1995-12#1)(1995-9#1)(1996-11#1)(1996-5#4)(1996-9#2)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#4)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#9)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#4)(2012-2#1)(2013-1#6)(2013-7#2)
store(s) in human vascular endothelial cells##2##6##(1990-3#2)
store-operated Ca2+ influx##4##3##(1996-9#4)
store-operated Ca2+##6##2##(1996-12#1)(1996-9#5)
store-operated##9##1##(1996-12#2)(1996-9#5)(2008-8#1)(2010-2#1)
stored Ca2+##3##2##(1991-12#1)(1992-7#1)(1996-8#1)
stored LH##2##2##(1996-2#2)
stored and analysed##2##3##(2008-1#1)(2013-1#1)
stored and processed##2##3##(2009-5#1)(2010-8#1)
stored and##14##2##(1995-12#1)(2006-10#1)(2007-9#1)(2008-1#5)(2008-10#1)(2008-2#1)(2009-5#1)(2010-8#1)(2011-9#1)(2013-1#1)
stored apples##2##2##(2008-10#2)
stored as a##2##3##(2007-12#1)(2008-10#1)
stored as glycogen##2##3##(2008-1#1)(2011-2#1)
stored as##10##2##(1995-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#3)(2008-7#1)(2011-2#1)
stored at -20 degrees C for##2##6##(1997-3#1)(2008-10#1)
stored at -20 degrees C##5##5##(1997-3#1)(2008-10#2)(2008-11#1)(2010-3#1)
stored at -70 degrees C##2##5##(1994-3#1)(1996-12#1)
stored at 20 degrees C##2##5##(2008-10#1)(2008-5#1)
stored at 20##3##3##(2008-10#2)(2008-5#1)
stored at 4 degrees C for##3##6##(1990-12#1)(1991-11#1)(2006-5#1)
stored at 4 degrees C##11##5##(1990-11#1)(1990-12#1)(1991-11#1)(1993-8#1)(1997-3#1)(1997-4#1)(2006-5#1)(2008-10#4)
stored at 5 degrees C##3##5##(2008-10#1)(2008-5#1)(2010-4#1)
stored at room temperature in the##2##6##(1990-11#1)(2008-10#1)
stored at room temperature##7##4##(1990-11#2)(1994-7#1)(2007-8#1)(2008-10#2)(2010-9#1)
stored at##51##2##(1990-11#3)(1990-12#1)(1991-11#1)(1993-2#1)(1993-8#1)(1994-3#1)(1994-7#1)(1996-12#1)(1997-3#2)(1997-4#1)(2005-10#1)(2006-5#2)(2007-7#1)(2007-8#1)(2008-10#14)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2010-3#3)(2010-4#2)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-1#2)
stored between##2##2##(1990-9#1)(2007-12#1)
stored by##3##2##(1991-2#1)(2012-12#2)
stored cells##2##2##(1994-3#2)
stored data##2##2##(2008-9#2)
stored energy##3##2##(2008-3#2)(2010-8#1)
stored food##2##2##(1993-2#1)(1997-6#1)
stored for 2##2##3##(1997-8#1)(2008-9#1)
stored for 4 d at##2##5##(2006-5#2)
stored for 6##2##3##(2008-10#1)(2008-11#1)
stored for##21##2##(1990-12#1)(1992-2#1)(1993-12#2)(1994-3#1)(1995-2#1)(1995-7#1)(1996-7#1)(1997-8#1)(2006-5#2)(2006-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-9#2)(2010-2#1)(2010-4#1)
stored frozen##2##2##(2008-4#1)(2011-2#1)
stored groundnuts##2##2##(2008-10#2)
stored holographically in a photorefractive material##2##6##(2007-12#1)(2008-3#1)
stored holographically in a photorefractive##3##5##(2007-12#1)(2008-3#2)
stored holographically in a##4##4##(2007-12#1)(2008-3#3)
stored holographically##5##2##(2007-12#1)(2008-3#4)
stored images##2##2##(2008-2#1)(2008-3#1)
stored in WF##4##3##(2006-5#4)
stored in a database##3##4##(2006-7#2)(2008-11#1)
stored in a##18##3##(1994-6#1)(2006-10#1)(2006-12#1)(2006-7#2)(2007-11#1)(2007-12#3)(2007-3#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2010-8#1)
stored in an##2##3##(2007-8#1)(2008-2#1)
stored in distilled water##2##4##(2009-8#1)(2010-2#1)
stored in each##2##3##(2006-5#1)(2008-12#1)
stored in normal conditions##2##4##(2006-10#2)
stored in secretory granules##2##4##(1996-4#1)(2008-4#1)
stored in the volume##2##4##(2008-3#1)(2008-6#1)
stored in the##28##3##(1991-7#2)(1992-4#1)(1994-8#1)(1995-7#1)(2006-10#1)(2006-5#2)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#5)(2008-8#3)(2013-1#1)
stored in##104##2##(1990-11#1)(1991-4#1)(1991-7#2)(1992-4#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-5#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-3#1)(1995-7#1)(1996-4#1)(1997-1#1)(1997-6#2)(2004-9#1)(2006-10#4)(2006-12#1)(2006-5#8)(2006-7#2)(2007-1#1)(2007-11#3)(2007-12#8)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#3)(2008-2#6)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#1)(2009-7#2)(2009-8#1)(2010-2#1)(2010-3#1)(2010-8#2)(2012-3#1)(2013-1#5)(2013-8#1)
stored information##3##2##(1993-5#1)(1995-12#1)(2008-3#1)
stored maize##2##2##(2007-6#1)(2008-12#1)
stored material##2##2##(1990-11#1)(1996-7#1)
stored on##6##2##(2006-6#1)(2007-9#1)(2008-10#1)(2008-2#1)(2013-1#2)
stored or##2##2##(1990-11#1)(2005-12#1)
stored pollen samples##2##3##(2011-2#2)
stored pollen##4##2##(2011-2#4)
stored reference signal##2##3##(2008-2#2)
stored six months at -20 degreeC##2##6##(2013-7#2)
stored sperm##3##2##(1994-8#1)(2007-12#1)(2008-6#1)
stored supplies##4##2##(2008-8#4)
stored under##9##2##(1993-3#1)(2005-11#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-7#1)(2010-4#2)
stored within##2##2##(1997-7#1)(2010-9#1)
stored##356##1##(1990-11#6)(1990-12#3)(1990-2#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-1#1)(1993-10#1)(1993-12#3)(1993-2#3)(1993-3#1)(1993-5#2)(1993-8#1)(1994-3#7)(1994-6#1)(1994-7#1)(1994-8#5)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-7#2)(1995-8#2)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-6#4)(1997-7#1)(1997-8#4)(2004-9#1)(2005-10#1)(2005-11#4)(2005-12#1)(2006-10#6)(2006-12#2)(2006-5#15)(2006-6#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-11#5)(2007-12#12)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#10)(2008-10#38)(2008-11#9)(2008-12#5)(2008-2#19)(2008-3#23)(2008-4#4)(2008-5#5)(2008-6#3)(2008-7#12)(2008-8#7)(2008-9#6)(2009-2#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-2#3)(2010-3#4)(2010-4#10)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#10)(2011-9#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#10)(2013-7#2)(2013-8#1)
stores and the##3##3##(1996-5#1)(2008-10#1)(2012-2#1)
stores and##24##2##(1990-12#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-7#1)(1992-9#1)(1993-9#1)(1995-12#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-2#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
stores in rat##2##3##(1996-5#1)(1997-7#1)
stores in the##2##3##(2007-12#1)(2013-1#1)
stores in##13##2##(1992-1#1)(1995-2#1)(1996-5#1)(1997-7#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-3#2)(2011-2#1)(2012-3#1)(2013-1#1)
stores is##5##2##(1994-8#1)(1995-3#2)(1997-1#1)(2008-4#1)
stores may##2##2##(1995-12#1)(2009-10#1)
stores of calcium##2##3##(1990-10#1)(1992-3#1)
stores of##8##2##(1990-10#1)(1992-1#1)(1992-3#1)(1992-8#1)(1996-5#1)(2007-9#1)(2009-3#1)(2013-1#1)
stores to the##3##3##(1990-12#1)(1994-9#1)(2006-10#1)
stores to##5##2##(1990-12#1)(1994-9#1)(2006-10#2)(2012-3#1)
stores via##2##2##(1997-5#1)(2008-7#1)
stores##152##1##(1990-10#1)(1990-12#2)(1990-4#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-1#5)(1992-11#1)(1992-3#1)(1992-4#1)(1992-7#3)(1992-8#1)(1992-9#1)(1993-6#1)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#6)(1995-2#3)(1995-3#5)(1996-1#3)(1996-12#1)(1996-5#5)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#3)(1997-2#1)(1997-5#1)(1997-7#4)(2004-12#1)(2006-10#6)(2006-2#1)(2006-3#1)(2007-10#4)(2007-11#1)(2007-12#4)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#5)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#3)(2009-3#1)(2009-5#1)(2010-12#1)(2010-5#2)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#12)
stories about##8##2##(2007-9#1)(2009-5#3)(2010-10#1)(2010-3#1)(2012-12#1)(2012-2#1)
stories and##5##2##(2008-11#1)(2008-2#1)(2008-9#1)(2009-3#1)(2012-12#1)
stories as a##2##3##(2007-2#2)
stories as##3##2##(2004-3#1)(2007-2#2)
stories have##2##2##(2007-2#1)(2008-7#1)
stories illustrated##2##2##(2005-10#1)(2008-11#1)
stories in##2##2##(2009-12#1)(2010-12#1)
stories of the##2##3##(2009-7#1)(2012-2#1)
stories of##11##2##(2007-2#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
stories that##2##2##(1992-12#1)(2006-9#1)
stories were##3##2##(2008-12#1)(2010-10#1)(2012-12#1)
stories##79##1##(1992-12#1)(1992-3#2)(1993-1#1)(1994-10#1)(1995-5#1)(1996-3#2)(1997-3#1)(2004-3#2)(2005-10#1)(2006-9#1)(2007-11#1)(2007-2#9)(2007-8#2)(2007-9#1)(2008-11#5)(2008-12#5)(2008-2#1)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-7#1)(2009-9#1)(2010-10#2)(2010-12#4)(2010-3#1)(2010-9#2)(2011-1#2)(2012-12#6)(2012-2#3)(2013-1#1)(2013-8#1)
storiform pattern##2##2##(2007-2#1)(2007-7#1)
storing and##3##2##(1994-3#2)(2008-11#1)
storing data##2##2##(2008-3#1)(2008-4#1)
storing more##2##2##(1991-4#1)(2008-6#1)
storing the##4##2##(2006-10#2)(2008-3#1)(2010-8#1)
storing up##2##2##(1996-7#1)(2009-2#1)
storing##38##1##(1990-10#1)(1990-11#2)(1991-11#1)(1991-4#1)(1992-12#1)(1994-3#3)(1994-8#1)(1995-11#1)(1996-12#1)(1996-7#1)(2006-10#2)(2007-1#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-1#1)
storks (Ciconia##2##2##(2008-5#2)
storks##4##1##(1995-11#1)(2008-5#3)
storm damage##3##2##(2011-2#3)
storm of##2##2##(2007-9#1)(2008-2#1)
storm over##2##2##(1990-11#1)(2008-11#1)
storm water##3##2##(2010-2#3)
storm##41##1##(1990-11#1)(1993-2#1)(1993-3#1)(1995-10#1)(1995-12#1)(1997-3#1)(2006-3#1)(2007-3#1)(2007-4#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#11)(2008-9#1)(2010-2#3)(2010-7#1)(2011-2#6)(2012-12#4)(2013-7#1)(2013-8#1)
storms##4##1##(1993-1#1)(2009-4#1)(2010-12#1)(2011-2#1)
story about##2##2##(2007-7#1)(2008-7#1)
story and##3##2##(2007-8#1)(2008-11#1)(2009-7#1)
story in##2##2##(2007-8#1)(2008-2#1)
story of a##5##3##(2007-2#2)(2008-11#1)(2008-2#1)(2012-2#1)
story of how##3##3##(2007-10#1)(2007-2#1)(2011-2#1)
story of the##2##3##(2007-10#1)(2008-8#1)
story of##34##2##(1991-4#1)(1995-12#1)(1996-3#1)(1997-9#1)(2005-11#1)(2005-8#1)(2006-12#1)(2007-10#3)(2007-2#4)(2007-4#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-8#2)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#2)(2013-8#1)
story recall##2##2##(2006-4#1)(2008-12#1)
story that##3##2##(2007-2#2)(2011-2#1)
story will be##2##3##(2007-9#1)(2009-10#1)
story##108##1##(1990-12#1)(1991-4#1)(1991-8#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-11#4)(1995-12#1)(1996-3#2)(1997-3#1)(1997-9#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-4#1)(2006-7#1)(2007-10#3)(2007-2#9)(2007-4#3)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#7)(2008-12#4)(2008-2#4)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#2)(2009-2#3)(2009-4#3)(2009-7#1)(2010-1#1)(2010-12#2)(2010-8#1)(2011-1#5)(2011-2#4)(2011-3#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#5)
story)##3##1##(2007-9#2)(2010-7#1)
story-telling##2##1##(1996-6#1)(2008-5#1)
story?##2##1##(2008-11#1)(2013-1#1)
story]##3##1##(1991-12#1)(1996-1#1)(2005-7#1)
storytelling and narrative##3##3##(2008-11#3)
storytelling as a##3##3##(2008-11#2)(2008-12#1)
storytelling##15##1##(1992-3#1)(2007-8#3)(2008-11#6)(2008-12#4)(2008-5#1)
stover##24##1##(2008-10#1)(2008-5#18)(2008-6#1)(2011-12#1)(2011-2#2)(2013-1#1)
str##11##1##(1990-6#1)(1997-5#5)(2008-3#1)(2008-5#1)(2011-2#1)(2012-11#1)(2013-7#1)
strabismus surgery##5##2##(1992-2#1)(2006-10#1)(2008-5#2)(2010-9#1)
strabismus##17##1##(1992-2#3)(1992-7#6)(2006-10#1)(2008-12#1)(2008-5#3)(2010-9#1)(2011-12#1)(2013-7#1)
straddle##2##1##(2008-2#1)(2010-7#1)
straddling patent foramen ovale thrombus##2##5##(2011-2#2)
straddling the##2##2##(2006-10#1)(2008-10#1)
straddling##5##1##(2006-10#1)(2008-10#1)(2008-2#1)(2011-2#2)
straight and##7##2##(1992-9#1)(2005-11#1)(2005-4#1)(2008-2#1)(2008-3#1)(2009-7#1)(2010-7#1)
straight back##5##2##(2007-7#2)(2007-8#2)(2011-12#1)
straight forward##4##2##(1993-8#1)(1995-7#1)(2008-11#1)(2010-12#1)
straight line##15##2##(1991-5#1)(1995-8#2)(1997-6#1)(2005-11#1)(2008-10#7)(2008-2#1)(2008-3#2)
straight lines##3##2##(1990-10#1)(2008-10#2)
straight loss of##3##3##(2007-12#2)(2008-3#1)
straight portion##6##2##(1997-8#1)(2007-9#5)
straight stem##2##2##(1993-12#1)(2008-3#1)
straight to##2##2##(2008-6#1)(2011-2#1)
straight tube##2##2##(2008-7#1)(2009-6#1)
straight tubules##3##2##(1991-3#1)(1992-8#2)
straight waveguide##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
straight when the knee was##2##5##(1997-8#2)
straight wire##4##2##(2009-7#4)
straight##115##1##(1990-10#1)(1990-7#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-12#3)(1993-8#1)(1995-3#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-5#1)(1996-6#1)(1997-6#1)(1997-8#3)(2005-11#3)(2005-4#1)(2006-10#2)(2006-12#3)(2006-8#1)(2007-11#5)(2007-12#7)(2007-3#2)(2007-7#2)(2007-8#3)(2007-9#5)(2008-10#13)(2008-11#2)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-6#2)(2009-7#5)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)
straight-ahead##2##1##(1993-7#2)
straight-chain##2##1##(1992-2#1)(2011-1#1)
straight-forward##2##1##(2008-9#1)(2010-8#1)
straight-line##3##1##(2008-10#2)(2008-3#1)
straightening##2##1##(1996-11#1)(2006-11#1)
straightforward and fast##2##3##(2008-11#1)(2008-2#1)
straightforward and##18##2##(1991-8#1)(1995-12#1)(2006-12#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2009-5#1)(2010-3#1)(2010-4#1)(2013-7#1)
straightforward approach##2##2##(2008-7#1)(2012-12#1)
straightforward method for##2##3##(2008-11#1)(2008-4#1)
straightforward method##6##2##(1997-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-10#1)(2012-2#1)
straightforward procedure##3##2##(2008-2#1)(2008-9#1)(2011-2#1)
straightforward synthesis of##3##3##(2007-10#1)(2008-8#1)(2009-10#1)
straightforward to determine##2##3##(2008-3#1)(2008-8#1)
straightforward to##7##2##(1995-12#1)(1997-6#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-7#1)
straightforward##145##1##(1990-12#1)(1991-2#1)(1991-8#1)(1992-7#1)(1992-9#1)(1993-12#1)(1994-11#2)(1994-5#1)(1995-12#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-8#1)(1997-1#2)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-4#1)(2007-10#2)(2007-11#4)(2007-12#9)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#13)(2008-11#4)(2008-12#1)(2008-2#9)(2008-3#7)(2008-4#10)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#6)(2009-10#2)(2009-12#1)(2009-5#3)(2009-6#1)(2009-7#3)(2009-9#1)(2010-10#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#2)
straightforwardly##2##1##(2005-11#1)(2007-12#1)
straightness##2##1##(2008-3#2)
strain (0##3##2##(1992-9#1)(2008-4#1)(2008-6#1)
strain (ATCC##2##2##(2008-12#1)(2011-2#1)
strain (H8)##3##2##(1997-6#3)
strain (designated##2##2##(2008-10#2)
strain (up to##2##3##(2006-11#1)(2007-4#1)
strain 1##5##2##(1991-8#4)(2008-10#1)
strain 10##2##2##(2008-10#2)
strain 1032##2##2##(2006-8#2)
strain 1295-22##3##2##(2008-10#3)
strain 1609##4##2##(2008-10#4)
strain 16C1##3##2##(2005-12#3)
strain 2##5##2##(1991-8#3)(2008-10#2)
strain 2308##4##2##(1996-12#4)
strain 248##4##2##(1991-9#4)
strain 4/4 was##2##3##(2008-10#2)
strain 4/4##4##2##(2008-10#4)
strain 50##4##2##(2008-10#2)(2008-5#2)
strain 7##2##2##(1997-7#2)
strain 70T01 was##2##3##(2008-10#2)
strain 70T01##9##2##(2008-10#9)
strain 90-166##3##2##(2008-10#3)
strain A mice##2##3##(1994-2#2)
strain A##4##2##(1994-2#2)(2007-1#1)(2008-5#1)
strain A1##2##2##(2011-2#2)
strain A506##12##2##(2008-10#12)
strain AA301##2##2##(2008-4#2)
strain AAV-2##4##2##(2008-8#4)
strain AF2240##2##2##(2008-11#2)
strain ALA-1(T)##3##2##(2006-8#3)
strain ATCC##5##2##(2006-5#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-2#1)
strain B##3##2##(1993-3#1)(2006-8#1)(2011-2#1)
strain B1##4##2##(2006-8#4)
strain BK18 of##2##3##(2008-10#2)
strain BK18##3##2##(2008-10#3)
strain BV-15##4##2##(2008-10#4)
strain C##4##2##(1994-6#1)(2008-10#2)(2008-8#1)
strain C3 produces##2##3##(2008-10#2)
strain C3##8##2##(2008-10#8)
strain C9-1##3##2##(2008-10#3)
strain CF600##2##2##(1994-12#1)(1995-2#1)
strain CVI988##2##2##(2013-8#2)
strain DC3000##2##2##(2008-10#2)
strain DCY55(T)##6##2##(2012-2#6)
strain E278Ar##2##2##(2008-10#2)
strain EA1##3##2##(1996-7#3)
strain F11(T)##3##2##(2012-2#3)
strain F2365 and the##3##4##(2006-9#3)
strain F2365##7##2##(2006-9#7)
strain F62##2##2##(1992-12#1)(1993-9#1)
strain Fo47##5##2##(2008-10#5)
strain G-5##3##2##(2008-10#3)
strain GZ6##2##2##(2005-11#2)
strain H46A##2##2##(2012-2#2)
strain IFO##3##2##(1993-12#2)(2008-6#1)
strain IL-Cb1##2##2##(2008-10#2)
strain JC1 and Hydrogenophaga pseudoflava##2##5##(1997-6#2)
strain JJ45##2##2##(2009-6#2)
strain K##7##2##(2008-10#7)
strain K84##4##2##(2008-10#4)
strain Kh5##2##2##(2008-10#2)
strain Kluyveromyces##2##2##(2008-10#1)(2008-6#1)
strain LB400##7##2##(2011-12#7)
strain Liaoning##2##2##(2008-9#2)
strain M##2##2##(2008-10#2)
strain M41##3##2##(1997-6#2)(2008-5#1)
strain MET2(T)##3##2##(2006-8#3)
strain MKB 158##4##3##(2008-10#4)
strain MKB##5##2##(2008-10#5)
strain MPF 57##2##3##(2008-5#2)
strain MS11mk##2##2##(1992-12#2)
strain Md5##2##2##(2013-8#2)
strain PAV##2##2##(2008-10#2)
strain PCC 6301##2##3##(1996-6#2)
strain PCC 6803##2##3##(1996-12#2)
strain PCC 7120##3##3##(1991-4#1)(1995-1#2)
strain PCC##7##2##(1991-4#1)(1995-1#2)(1996-12#2)(1996-6#2)
strain PCC6803 by amino-terminal##2##4##(1996-8#1)(1997-6#1)
strain PCC6803 by##3##3##(1996-8#1)(1997-6#2)
strain PCC6803##14##2##(1995-12#2)(1995-6#2)(1995-8#2)(1996-12#1)(1996-6#3)(1996-8#1)(1997-2#1)(1997-6#2)
strain PG31##2##2##(2008-5#2)
strain Q2-87##2##2##(2008-10#2)
strain Q8r1-96##3##2##(2008-10#3)
strain R-100##2##2##(2008-5#2)
strain R1534##3##2##(1997-1#3)
strain RC/79##3##2##(2006-10#3)
strain RT37-1##2##2##(2008-10#2)
strain S##2##2##(2005-11#1)(2007-7#1)
strain SHZH98##3##2##(2008-8#3)
strain SR12(T)##3##2##(2006-8#3)
strain SSB17##2##2##(2008-10#2)
strain T32##2##2##(2008-9#2)
strain W260##2##2##(2008-10#2)
strain able to##2##3##(2004-4#1)(2011-1#1)
strain accumulated##2##2##(2008-5#1)(2009-10#1)
strain against##4##2##(2005-11#1)(2007-12#1)(2012-11#2)
strain amplitude##3##2##(2008-10#2)(2012-7#1)
strain and a##6##3##(1995-6#1)(2006-6#1)(2008-6#1)(2009-12#1)(2009-9#1)(2011-2#1)
strain and an##2##3##(1994-10#1)(2011-2#1)
strain and forskolin##3##3##(1993-3#3)
strain and its associated factors among lecturers##2##7##(2008-10#2)
strain and its##5##3##(2008-10#5)
strain and lower##2##3##(2009-7#1)(2011-1#1)
strain and mutant##2##3##(1997-2#1)(1997-3#1)
strain and strain rate##4##4##(2006-11#2)(2009-7#1)(2010-5#1)
strain and strain##5##3##(2006-11#2)(2008-5#1)(2009-7#1)(2010-5#1)
strain and temperature measurement##2##4##(2007-12#1)(2008-3#1)
strain and temperature sensor##2##4##(2007-12#1)(2008-3#1)
strain and temperature with##2##4##(2008-3#2)
strain and temperature##17##3##(2007-12#4)(2008-2#1)(2008-3#12)
strain and the##11##3##(1996-2#1)(1997-6#1)(2006-6#1)(2007-11#1)(2008-5#2)(2008-8#1)(2008-9#2)(2011-1#1)(2013-8#1)
strain and two##2##3##(1996-7#1)(2011-2#1)
strain and##112##2##(1992-2#1)(1992-7#1)(1993-3#3)(1994-10#1)(1994-12#1)(1995-6#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-6#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-9#1)(2006-10#2)(2006-11#3)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#1)(2007-1#2)(2007-11#1)(2007-12#5)(2007-8#2)(2008-10#8)(2008-11#2)(2008-2#2)(2008-3#12)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-5#2)(2010-8#1)(2011-1#4)(2011-2#4)(2012-1#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#4)
strain applied to##2##3##(2008-11#1)(2008-2#1)
strain applied##3##2##(1997-6#1)(2008-11#1)(2008-2#1)
strain are##4##2##(1997-6#1)(2006-1#1)(2008-8#1)(2011-1#1)
strain as##6##2##(1993-9#1)(1995-12#1)(2008-10#1)(2008-5#1)(2011-1#2)
strain at 60##2##3##(1990-8#1)(1994-11#1)
strain at failure##2##3##(2005-11#1)(2007-1#1)
strain at fracture##2##3##(2008-7#2)
strain at the##2##3##(2009-11#1)(2013-1#1)
strain at##14##2##(1990-8#1)(1994-11#1)(1995-12#1)(1997-4#1)(1997-6#1)(2005-11#1)(2007-1#1)(2008-10#1)(2008-4#1)(2008-7#2)(2009-11#1)(2009-3#1)(2013-1#1)
strain bearing##2##2##(1990-4#1)(1997-8#1)
strain before##2##2##(2006-6#1)(2007-11#1)
strain but also##2##3##(2008-10#1)(2008-7#1)
strain but not in the reference or##2##7##(2011-2#2)
strain but##7##2##(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#3)
strain by##4##2##(1995-8#1)(2005-11#1)(2008-5#1)(2008-9#1)
strain can be##4##3##(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
strain can##7##2##(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#1)(2013-1#1)
strain capable of##2##3##(1997-8#1)(2008-10#1)
strain carrying a##3##3##(1990-9#1)(1993-3#1)(1997-4#1)
strain carrying the##3##3##(1991-6#2)(1995-2#1)
strain carrying##6##2##(1990-9#1)(1991-6#2)(1993-3#1)(1995-2#1)(1997-4#1)
strain caused by the##2##4##(1996-5#1)(2009-1#1)
strain caused##4##2##(1996-5#1)(1997-3#1)(1997-6#1)(2009-1#1)
strain changes##3##2##(1996-4#2)(2008-10#1)
strain characterization of##2##3##(2007-7#1)(2008-3#1)
strain characterization##3##2##(2007-7#1)(2008-10#1)(2008-3#1)
strain clustered##2##2##(2008-10#1)(2013-8#1)
strain collection##2##2##(2008-2#1)(2008-5#1)
strain combination##2##2##(1995-2#1)(2012-2#1)
strain compared##2##2##(1996-12#1)(2008-10#1)
strain constitutes##2##2##(1991-2#1)(2008-10#1)
strain containing##2##2##(1990-5#1)(1994-12#1)
strain correlates with##2##3##(2011-1#1)(2013-7#1)
strain could##5##2##(1990-5#1)(1993-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
strain decreased##3##2##(2008-10#1)(2009-8#1)(2012-2#1)
strain defective in##2##3##(1993-3#1)(1996-7#1)
strain deficient in##2##3##(1994-9#1)(2008-7#1)
strain deleted for the##3##4##(1997-3#2)(2008-7#1)
strain deleted for##4##3##(1991-7#1)(1997-3#2)(2008-7#1)
strain deleted##5##2##(1991-7#1)(1997-3#3)(2008-7#1)
strain demonstrated that##2##3##(1996-7#1)(2012-3#1)
strain demonstrated##3##2##(1996-7#1)(2012-3#2)
strain designated##2##2##(1997-7#1)(2006-8#1)
strain did not##5##3##(1992-12#1)(2009-9#1)(2010-9#1)(2011-1#1)(2011-2#1)
strain difference##4##2##(1990-7#1)(1991-1#1)(1993-3#1)(1994-3#1)
strain differences in##4##3##(1993-3#1)(1995-2#1)(1996-12#1)(2013-1#1)
strain differences##8##2##(1992-11#1)(1992-7#1)(1993-3#1)(1994-8#2)(1995-2#1)(1996-12#1)(2013-1#1)
strain differentiation##2##2##(2013-1#2)
strain distribution profiles##2##3##(2008-3#2)
strain distribution##5##2##(2008-12#1)(2008-3#3)(2010-8#1)
strain distributions##13##2##(2007-12#1)(2008-2#3)(2008-8#4)(2009-7#2)(2013-1#3)
strain diversity##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
strain does not##2##3##(1997-6#1)(2012-3#1)
strain due to##2##3##(2007-10#1)(2009-7#1)
strain during##2##2##(2007-4#1)(2007-6#1)
strain dynamic behaviour of##2##4##(2007-4#2)
strain energy##4##2##(1993-3#1)(2005-10#1)(2006-10#1)(2009-7#1)
strain expressing##4##2##(1991-9#1)(1997-6#1)(2008-8#1)(2011-2#1)
strain failed to##5##3##(2008-10#3)(2008-8#1)(2012-3#1)
strain field in##2##3##(2007-12#1)(2007-4#1)
strain for##8##2##(1996-10#1)(2008-10#3)(2008-4#2)(2008-6#1)(2013-1#1)
strain from a##3##3##(1991-2#1)(2008-5#2)
strain from##10##2##(1991-2#1)(1996-12#1)(1996-2#1)(2006-8#1)(2008-10#3)(2008-5#2)(2011-1#1)
strain gage##2##2##(2007-1#1)(2008-2#1)
strain gages##2##2##(2008-2#2)
strain gauge##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
strain group##2##2##(2008-10#2)
strain had##7##2##(1993-3#1)(1997-8#1)(2006-8#1)(2008-10#2)(2012-12#1)(2013-8#1)
strain harboring##2##2##(1990-10#1)(1993-9#1)
strain has been##5##3##(1997-7#1)(2007-2#1)(2008-10#1)(2008-2#1)(2011-2#1)
strain has##9##2##(1990-11#1)(1996-5#1)(1997-7#1)(2007-2#1)(2008-10#1)(2008-2#1)(2010-12#1)(2011-2#1)(2012-3#1)
strain having##2##2##(2008-4#1)(2013-8#1)
strain identification and##2##3##(1993-9#1)(2008-10#1)
strain in a##3##3##(1991-7#1)(1992-11#1)(2008-7#1)
strain in culture##2##3##(2006-9#1)(2008-10#1)
strain in the##12##3##(1991-4#1)(1994-11#1)(1995-1#1)(1996-11#1)(2006-8#1)(2007-1#1)(2007-4#3)(2008-5#1)(2008-9#1)(2009-7#1)
strain in which the##2##4##(1990-5#1)(2008-8#1)
strain in which##3##3##(1990-5#1)(1993-9#1)(2008-8#1)
strain in##47##2##(1990-5#1)(1991-4#1)(1991-7#1)(1992-11#1)(1993-12#1)(1993-9#1)(1994-11#1)(1995-1#1)(1995-2#1)(1996-11#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-4#3)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-7#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-8#1)
strain increased##2##2##(2008-10#1)(2013-1#1)
strain induced##2##2##(1993-3#1)(2009-7#1)
strain is a##2##3##(2008-10#1)(2013-8#1)
strain is not##2##3##(1997-6#1)(2012-12#1)
strain is##24##2##(1993-11#1)(1993-3#1)(1996-10#1)(1997-6#1)(2005-11#1)(2006-11#1)(2006-8#2)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-6#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
strain isolated from a commercial##2##5##(2012-2#2)
strain isolated from##10##3##(2007-7#1)(2008-10#3)(2008-5#2)(2012-2#3)(2013-8#1)
strain isolated in##3##3##(2010-12#1)(2013-8#2)
strain isolated##13##2##(2007-7#1)(2008-10#3)(2008-5#2)(2010-12#1)(2012-2#3)(2013-8#3)
strain isolates##13##2##(2008-10#13)
strain lacking##4##2##(1992-10#1)(1995-11#1)(2009-10#1)(2009-8#1)
strain level##3##2##(2007-4#1)(2008-3#1)(2011-1#1)
strain m6418##2##2##(2008-10#2)
strain maintained##2##2##(2008-10#1)(2013-8#1)
strain mapping##2##2##(2006-11#1)(2009-12#1)
strain may##3##2##(2007-8#2)(2011-2#1)
strain measurement in##2##3##(2008-2#1)(2013-8#1)
strain measurement##9##2##(2007-11#1)(2008-2#2)(2008-3#3)(2013-8#3)
strain measurements##7##2##(2007-12#2)(2008-2#1)(2008-3#2)(2009-10#1)(2009-8#1)
strain microscope##2##2##(2008-3#2)
strain observed##2##2##(2007-4#1)(2009-7#1)
strain obtained from##2##3##(1991-2#1)(2007-11#1)
strain of A##6##3##(1991-12#1)(1996-7#1)(2008-10#4)
strain of B##4##3##(2004-11#1)(2006-8#1)(2008-10#2)
strain of BYDV##2##3##(2008-10#2)
strain of Bacillus##2##3##(1992-3#1)(2004-11#1)
strain of Bean common mosaic necrosis virus (BCMNV)##2##8##(2008-10#2)
strain of C##4##3##(2008-10#3)(2009-10#1)
strain of E##8##3##(1995-8#1)(1997-7#3)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)
strain of Escherichia coli##5##4##(1991-10#1)(1994-8#1)(1995-6#1)(1996-7#1)(1997-6#1)
strain of H##2##3##(1997-3#1)(2011-2#1)
strain of HIV-1##3##3##(1991-9#1)(1992-8#1)(1994-10#1)
strain of Japanese##2##3##(1997-3#2)
strain of M##4##3##(1993-11#1)(2005-7#1)(2008-10#1)(2008-5#1)
strain of MDV##5##3##(2013-8#5)
strain of Marek's disease virus##6##5##(2008-5#2)(2013-8#4)
strain of P##5##3##(1997-2#1)(2008-10#1)(2008-12#1)(2012-2#1)(2012-3#1)
strain of Pseudomonas aeruginosa##6##4##(2006-10#1)(2008-5#2)(2008-6#1)(2012-2#1)(2012-3#1)
strain of Pseudomonas##8##3##(2006-10#1)(2008-5#2)(2008-6#1)(2010-12#1)(2012-2#2)(2012-3#1)
strain of S##11##3##(1996-12#1)(1996-6#1)(2006-6#1)(2006-8#1)(2008-10#3)(2008-5#1)(2009-9#3)
strain of Salmonella##2##3##(2008-5#1)(2011-2#1)
strain of Staphylococcus##2##3##(2006-12#1)(2009-9#1)
strain of X##2##3##(2008-10#2)
strain of a##5##3##(2006-8#1)(2008-10#1)(2008-2#1)(2011-2#2)
strain of avian##2##3##(2005-9#1)(2007-6#1)
strain of group##2##3##(2008-8#1)(2012-2#1)
strain of infectious bronchitis virus (IBV)##3##6##(1997-6#2)(2008-5#1)
strain of infectious bronchitis virus##5##5##(1992-5#1)(1997-6#3)(2008-5#1)
strain of infectious##6##3##(1992-5#1)(1997-6#3)(2008-5#1)(2013-8#1)
strain of mice that##2##4##(1993-12#1)(2011-1#1)
strain of mice##5##3##(1993-12#1)(1995-2#1)(1997-8#1)(2008-12#1)(2011-1#1)
strain of mutant##2##3##(1995-6#1)(2008-8#1)
strain of rats##4##3##(1993-12#1)(1995-12#1)(2007-10#1)(2008-11#1)
strain of the virus##2##4##(1992-10#1)(2010-1#1)
strain of the##20##3##(1992-10#1)(1992-3#1)(1993-3#1)(1995-2#1)(2007-12#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-9#2)(2010-1#1)(2011-2#5)(2013-8#1)
strain of virus##2##3##(2008-5#2)
strain of yeast##3##3##(1990-12#1)(1994-6#1)(2008-8#1)
strain of##253##2##(1990-12#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-3#2)(1992-5#2)(1992-8#2)(1993-11#1)(1993-12#3)(1993-3#1)(1993-7#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-7#3)(1997-2#2)(1997-3#3)(1997-6#6)(1997-7#4)(1997-8#1)(2004-11#2)(2005-11#3)(2005-7#3)(2005-9#1)(2006-10#2)(2006-11#2)(2006-12#2)(2006-5#1)(2006-6#1)(2006-8#3)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#3)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#56)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#20)(2008-6#6)(2008-8#6)(2008-9#6)(2009-10#3)(2009-7#1)(2009-9#6)(2010-1#1)(2010-10#1)(2010-12#3)(2011-1#1)(2011-2#10)(2012-11#1)(2012-2#6)(2012-3#3)(2013-7#1)(2013-8#16)
strain on the##2##3##(2007-12#1)(2009-1#1)
strain on##13##2##(1996-1#1)(1996-6#1)(1997-2#1)(2006-1#1)(2007-12#1)(2008-10#4)(2009-1#1)(2009-6#1)(2011-2#1)(2012-12#1)
strain or##6##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#1)
strain over##2##2##(2008-10#1)(2008-2#1)
strain presented##2##2##(2005-12#1)(2007-10#1)
strain produced##2##2##(2008-10#1)(2008-8#1)
strain producing##5##2##(1994-2#1)(2005-11#1)(2005-9#1)(2007-12#1)(2008-11#1)
strain profile##3##2##(2006-4#1)(2007-12#2)
strain rate and##3##3##(2009-3#1)(2009-7#2)
strain rate imaging##2##3##(2009-10#1)(2010-5#1)
strain rate##17##2##(1996-4#1)(2006-11#3)(2007-1#1)(2007-4#2)(2008-11#1)(2009-10#1)(2009-3#1)(2009-7#4)(2010-5#3)
strain rates##3##2##(2007-4#1)(2009-7#2)
strain rats##4##2##(1993-3#1)(2008-10#1)(2009-6#1)(2011-2#1)
strain relaxation in the##2##4##(2007-11#1)(2008-3#1)
strain relaxation##3##2##(2007-11#2)(2008-3#1)
strain requires##2##2##(2006-8#1)(2008-5#1)
strain resolution of##3##3##(2007-12#2)(2008-3#1)
strain resolution##4##2##(2007-12#2)(2008-3#2)
strain selected##2##2##(1993-11#1)(2008-5#1)
strain sensing##5##2##(2007-12#3)(2008-2#1)(2008-3#1)
strain sensitivities##3##2##(2007-11#1)(2008-3#1)(2008-7#1)
strain sensitivity of the##2##4##(2008-3#2)
strain sensitivity of##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
strain sensitivity##8##2##(2007-12#1)(2008-2#2)(2008-3#4)(2013-8#1)
strain sensor based on##2##4##(2005-10#1)(2008-3#1)
strain sensor in a white-light interferometer##2##6##(2008-2#2)
strain sensor##14##2##(2005-10#1)(2007-12#3)(2008-2#7)(2008-3#3)
strain sensors##6##2##(2005-10#1)(2006-6#1)(2007-12#1)(2008-2#3)
strain showed that the##2##4##(1994-2#1)(2008-12#1)
strain showed##6##2##(1994-2#1)(1996-9#1)(1997-6#1)(2008-12#2)(2012-2#1)
strain specific##6##2##(1991-12#1)(1994-8#2)(2008-10#2)(2011-2#1)
strain stimulates##2##2##(1994-11#2)
strain structure can##2##3##(2008-8#2)
strain structure##3##2##(2008-8#3)
strain subgroups##2##2##(2008-10#2)
strain tested##2##2##(2007-10#1)(2008-5#1)
strain that has##2##3##(2007-11#1)(2008-4#1)
strain that is##2##3##(1997-6#1)(2008-10#1)
strain that produces##3##3##(1997-4#1)(2008-10#1)(2008-6#1)
strain that was susceptible to##2##5##(2011-2#2)
strain that was##4##3##(2008-10#1)(2011-1#1)(2011-2#2)
strain that##17##2##(1994-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-11#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#2)
strain time##2##2##(2007-4#2)
strain to be##2##3##(1991-7#1)(1992-5#1)
strain to failure##2##3##(2007-4#1)(2012-2#1)
strain to##18##2##(1991-7#1)(1992-5#1)(1993-9#1)(1994-12#1)(1994-7#1)(1996-5#1)(1997-3#1)(2006-8#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
strain under##7##2##(1997-1#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#2)
strain used##7##2##(2007-7#1)(2008-10#2)(2008-4#2)(2008-6#1)(2010-10#1)
strain using the##2##3##(1992-12#1)(2012-3#1)
strain using##6##2##(1992-12#1)(2008-4#2)(2009-9#1)(2011-2#1)(2012-3#1)
strain vaccine##4##2##(2007-11#3)(2008-5#1)
strain was able to##3##4##(2008-10#1)(2008-5#1)(2008-6#1)
strain was also##2##3##(2008-10#2)
strain was analyzed##2##3##(2008-8#1)(2012-2#1)
strain was found to be##2##5##(2008-6#1)(2013-1#1)
strain was found to##3##4##(2008-10#1)(2008-6#1)(2013-1#1)
strain was found##5##3##(1993-9#1)(2007-7#1)(2008-10#1)(2008-6#1)(2013-1#1)
strain was isolated from a##3##5##(1991-8#1)(2006-8#1)(2008-9#1)
strain was isolated from##4##4##(1991-8#1)(2006-8#1)(2008-9#1)(2011-2#1)
strain was isolated##5##3##(1991-8#1)(2006-8#1)(2008-10#1)(2008-9#1)(2011-2#1)
strain was observed##2##3##(1994-2#1)(2008-6#1)
strain was obtained##2##3##(2008-10#1)(2013-8#1)
strain was significantly##2##3##(2008-10#1)(2009-7#1)
strain was susceptible to##2##4##(2011-2#1)(2012-2#1)
strain was used for##2##4##(1997-6#1)(1997-7#1)
strain was used##4##3##(1997-6#1)(1997-7#1)(2008-5#1)(2012-2#1)
strain was##82##2##(1991-3#1)(1991-8#1)(1993-9#2)(1994-2#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-6#1)(1997-7#1)(2004-11#1)(2005-11#2)(2006-12#1)(2006-8#3)(2007-4#2)(2007-7#1)(2008-10#14)(2008-12#2)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#4)(2012-12#3)(2012-2#6)(2013-1#2)(2013-8#4)
strain were used##3##3##(2007-1#1)(2008-10#1)(2011-12#1)
strain were##25##2##(1991-9#1)(1994-12#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-11#1)(2006-11#1)(2006-8#1)(2007-1#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
strain when grown##2##3##(1997-4#1)(2008-10#1)
strain when##4##2##(1997-4#1)(2008-10#2)(2009-7#1)
strain which is##2##3##(1990-3#1)(2011-3#1)
strain which##11##2##(1990-11#1)(1990-3#1)(1991-7#1)(1994-2#1)(1995-3#1)(1997-1#1)(2008-10#1)(2008-8#1)(2011-3#1)(2012-2#1)(2013-1#1)
strain whose##2##2##(2008-3#1)(2008-5#1)
strain with high##2##3##(2005-11#1)(2006-10#1)
strain with the##3##3##(1990-11#1)(1996-6#1)(2006-8#1)
strain with##15##2##(1990-11#1)(1996-6#1)(1997-2#1)(2005-11#2)(2006-10#2)(2006-8#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-8#1)(2012-2#1)(2013-1#1)
strain##2382##1##(1990-1#1)(1990-10#1)(1990-11#5)(1990-12#6)(1990-2#2)(1990-3#1)(1990-4#4)(1990-5#4)(1990-6#1)(1990-7#5)(1990-8#1)(1990-9#4)(1991-1#3)(1991-10#2)(1991-11#1)(1991-12#5)(1991-2#6)(1991-3#2)(1991-4#4)(1991-6#5)(1991-7#7)(1991-8#10)(1991-9#14)(1992-10#6)(1992-11#4)(1992-12#8)(1992-2#4)(1992-3#5)(1992-4#1)(1992-5#4)(1992-7#5)(1992-8#3)(1992-9#4)(1993-11#7)(1993-12#12)(1993-2#1)(1993-3#20)(1993-4#1)(1993-5#1)(1993-7#2)(1993-8#1)(1993-9#19)(1994-10#3)(1994-11#9)(1994-12#16)(1994-2#11)(1994-3#8)(1994-5#3)(1994-6#6)(1994-7#3)(1994-8#8)(1994-9#7)(1995-1#5)(1995-11#5)(1995-12#9)(1995-2#14)(1995-3#1)(1995-4#4)(1995-5#2)(1995-6#8)(1995-7#1)(1995-8#15)(1996-1#3)(1996-10#4)(1996-11#1)(1996-12#15)(1996-2#8)(1996-4#5)(1996-5#6)(1996-6#11)(1996-7#12)(1996-8#2)(1996-9#2)(1997-1#9)(1997-2#12)(1997-3#17)(1997-4#10)(1997-5#1)(1997-6#32)(1997-7#13)(1997-8#12)(2004-11#3)(2004-4#3)(2004-9#1)(2005-10#6)(2005-11#43)(2005-12#5)(2005-7#3)(2005-8#1)(2005-9#4)(2006-1#2)(2006-10#13)(2006-11#21)(2006-12#6)(2006-3#5)(2006-4#5)(2006-5#4)(2006-6#7)(2006-7#2)(2006-8#58)(2006-9#11)(2007-1#19)(2007-10#13)(2007-11#24)(2007-12#51)(2007-2#5)(2007-4#24)(2007-6#5)(2007-7#8)(2007-8#6)(2007-9#3)(2008-1#1)(2008-10#504)(2008-11#25)(2008-12#17)(2008-2#43)(2008-3#49)(2008-4#41)(2008-5#105)(2008-6#39)(2008-7#33)(2008-8#61)(2008-9#30)(2009-1#2)(2009-10#13)(2009-11#3)(2009-12#2)(2009-2#2)(2009-3#8)(2009-4#3)(2009-5#2)(2009-6#12)(2009-7#27)(2009-8#5)(2009-9#14)(2010-1#2)(2010-10#4)(2010-11#1)(2010-12#18)(2010-2#4)(2010-4#7)(2010-5#6)(2010-6#5)(2010-7#1)(2010-8#7)(2010-9#2)(2011-1#22)(2011-10#1)(2011-12#12)(2011-2#130)(2011-3#3)(2012-1#4)(2012-11#6)(2012-12#11)(2012-2#49)(2012-3#29)(2012-7#1)(2013-1#59)(2013-7#6)(2013-8#75)
strain&quot##3##1##(1995-12#1)(2008-10#2)
strain) and##5##2##(1990-4#1)(2007-10#1)(2008-3#1)(2011-1#1)(2012-1#1)
strain) was##2##2##(2008-5#1)(2013-8#1)
strain)##35##1##(1990-4#1)(1990-5#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-8#1)(1997-3#1)(2004-11#2)(2005-11#1)(2006-8#3)(2007-10#2)(2007-5#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-5#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-3#1)(2013-8#2)
strain-based plasticity##2##2##(2013-1#2)
strain-based##4##1##(2013-1#4)
strain-dependent##3##1##(1990-2#1)(1994-2#1)(2008-10#1)
strain-induced##6##1##(1994-11#1)(1995-2#3)(2008-3#2)
strain-sensing##2##1##(2008-2#1)(2008-3#1)
strain-specific monoclonal antibodies##2##3##(2008-10#2)
strain-specific monoclonal##3##2##(2008-10#3)
strain-specific##21##1##(1990-7#1)(1994-5#1)(1996-12#1)(2008-10#9)(2008-12#3)(2008-5#1)(2008-7#1)(2009-8#1)(2010-10#1)(2011-2#1)(2013-8#1)
strain]##9##1##(2005-11#2)(2005-9#1)(2008-4#2)(2010-1#1)(2010-12#1)(2011-2#1)(2013-8#1)
strained and unstrained##2##3##(2007-12#1)(2008-2#1)
strained##22##1##(1990-8#2)(1992-3#1)(1992-5#1)(1993-8#1)(1994-5#1)(1995-4#1)(1996-11#1)(1996-8#1)(2004-3#1)(2006-6#2)(2006-8#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
straining##5##1##(1993-1#1)(2007-12#1)(2007-8#1)(2010-12#1)(2012-3#1)
strains (&gt##2##2##(2008-10#1)(2008-2#1)
strains (ATCC##3##2##(1992-2#1)(2006-10#1)(2008-12#1)
strains (F##2##2##(2008-10#2)
strains (MIC##3##2##(2006-10#2)(2008-10#1)
strains (from##2##2##(2008-10#2)
strains A##2##2##(2007-1#1)(2008-10#1)
strains ER##2##2##(2008-10#2)
strains H17c##2##2##(2006-8#2)
strains TA98##2##2##(2008-8#1)(2008-9#1)
strains a##2##2##(2008-4#1)(2008-5#1)
strains able to##3##3##(1991-3#1)(1995-4#1)(2008-10#1)
strains above 1%##3##3##(2006-11#1)(2007-1#1)(2007-4#1)
strains after##3##2##(2008-10#2)(2008-11#1)
strains against##2##2##(2008-10#1)(2012-2#1)
strains also##5##2##(1992-7#1)(1994-12#1)(2008-10#2)(2013-8#1)
strains among##4##2##(2006-8#1)(2008-10#1)(2010-4#1)(2011-2#1)
strains and a##5##3##(2007-7#1)(2008-10#2)(2011-1#1)(2012-2#1)
strains and clinical isolates of##2##5##(2007-7#1)(2008-8#1)
strains and in##3##3##(1995-4#1)(2008-10#2)
strains and isolates##4##3##(2008-10#2)(2008-5#2)
strains and other##2##3##(2008-10#2)
strains and the##12##3##(1991-7#1)(2006-8#1)(2007-10#1)(2008-10#3)(2008-12#1)(2008-5#2)(2009-12#1)(2011-1#1)(2013-1#1)
strains and their##6##3##(1993-7#1)(2008-12#4)(2008-4#1)
strains and two##2##3##(2007-11#1)(2008-10#1)
strains and was##2##3##(2008-10#1)(2008-5#1)
strains and##101##2##(1991-7#1)(1992-2#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-7#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-10#2)(1997-2#1)(1997-6#1)(2006-10#1)(2006-8#3)(2007-10#2)(2007-11#1)(2007-12#1)(2007-4#2)(2007-6#1)(2007-7#2)(2007-8#3)(2008-10#29)(2008-11#1)(2008-12#6)(2008-2#2)(2008-4#3)(2008-5#9)(2008-8#1)(2009-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
strains appear to##3##3##(1991-1#1)(2007-6#1)(2007-8#1)
strains are able to##2##4##(2008-10#2)
strains are discussed##2##3##(1993-9#1)(1995-12#1)
strains are##38##2##(1990-5#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-5#1)(1993-9#1)(1995-12#1)(1995-8#1)(2005-11#1)(2006-5#1)(2006-8#3)(2008-10#10)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
strains as S##5##3##(2011-1#5)
strains as X##2##3##(2008-10#2)
strains as compared to##2##4##(1994-2#1)(2007-8#1)
strains as well as##3##4##(2008-10#1)(2008-12#1)(2010-4#1)
strains as##25##2##(1993-5#1)(1994-2#1)(1996-6#1)(1996-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-9#1)(2009-2#1)(2010-4#1)(2011-1#5)(2011-12#1)
strains associated with diseased##2##4##(2008-10#2)
strains associated with##4##3##(2006-8#1)(2008-10#3)
strains at 16xMIC##2##3##(2006-8#2)
strains at all##2##3##(2008-10#1)(2011-12#1)
strains at the##4##3##(1991-6#1)(1996-2#1)(2008-10#1)(2011-2#1)
strains at##15##2##(1990-2#1)(1991-6#1)(1996-2#1)(2006-11#1)(2006-8#2)(2006-9#1)(2007-4#1)(2008-10#3)(2011-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
strains based on##4##3##(1997-3#1)(2008-10#2)(2013-1#1)
strains became##2##2##(2008-10#1)(2010-7#1)
strains belong to##2##3##(2008-10#1)(2008-4#1)
strains belonged to##5##3##(1993-2#1)(2008-10#2)(2008-12#1)(2013-8#1)
strains belonging to genomospecies 1##2##5##(2008-10#2)
strains belonging to genomospecies##3##4##(2008-10#3)
strains belonging to other##2##4##(2008-10#2)
strains belonging to the##2##4##(1997-4#1)(2013-8#1)
strains belonging to##11##3##(1991-3#1)(1997-4#1)(2006-8#1)(2007-7#1)(2008-10#5)(2012-12#1)(2013-8#1)
strains but##3##2##(1993-3#1)(2008-10#2)
strains by conventional##2##3##(2007-12#1)(2008-10#1)
strains by##18##2##(1992-11#1)(1997-3#1)(2006-8#1)(2007-12#1)(2008-10#7)(2008-3#1)(2008-4#1)(2008-5#3)(2008-9#1)(2012-2#1)
strains can be##3##3##(1990-12#1)(2005-7#1)(2008-10#1)
strains can##13##2##(1990-12#2)(2005-7#1)(2007-12#1)(2007-9#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-8#1)
strains carried##3##2##(1990-5#1)(2012-12#1)(2012-3#1)
strains carry multiple##2##3##(2008-10#1)(2012-3#1)
strains carry##4##2##(1995-1#1)(1996-6#1)(2008-10#1)(2012-3#1)
strains carrying multiple##2##3##(1995-8#1)(2008-10#1)
strains carrying the##4##3##(1990-11#1)(1991-7#1)(1997-4#1)(2008-11#1)
strains carrying##12##2##(1990-11#1)(1990-5#1)(1991-12#1)(1991-7#1)(1992-10#1)(1995-8#1)(1996-9#1)(1997-4#2)(2006-10#1)(2008-10#1)(2008-11#1)
strains caused##3##2##(2008-10#3)
strains causing##3##2##(2007-12#1)(2008-12#1)(2013-8#1)
strains circulating in##2##3##(2012-12#1)(2013-7#1)
strains clearly##2##2##(2008-10#1)(2008-5#1)
strains clustered##4##2##(2008-10#3)(2013-8#1)
strains collected from##4##3##(2008-10#4)
strains collected##7##2##(2008-10#7)
strains compared to##2##3##(1990-5#1)(2013-8#1)
strains compared##3##2##(1990-5#1)(2007-11#1)(2013-8#1)
strains contain##2##2##(1993-11#1)(1995-8#1)
strains contained##2##2##(2006-8#1)(2008-10#1)
strains containing the##2##3##(1995-5#1)(2008-10#1)
strains containing##8##2##(1993-11#1)(1993-9#1)(1995-5#1)(1996-7#1)(2008-10#2)(2009-2#1)(2011-2#1)
strains could be identified##2##4##(2005-11#1)(2007-8#1)
strains could be##14##3##(1993-2#1)(1995-8#1)(2005-11#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-7#1)(2010-8#1)(2013-8#1)
strains could##18##2##(1993-2#1)(1995-8#1)(2005-11#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-5#2)(2008-7#1)(2010-8#1)(2012-2#1)(2013-8#2)
strains derived from##5##3##(1990-7#1)(1991-3#1)(1995-4#1)(2008-10#2)
strains detected##3##2##(1996-6#1)(2006-2#1)(2008-10#1)
strains developed##2##2##(1994-11#1)(2008-12#1)
strains did not differ##2##4##(2007-7#1)(2008-10#1)
strains did not##8##3##(2007-10#1)(2007-7#1)(2008-10#4)(2008-5#2)
strains differ##3##2##(1996-5#1)(2005-9#1)(2008-4#1)
strains displayed##2##2##(2009-6#1)(2013-1#1)
strains displaying##3##2##(1994-7#1)(2008-10#2)
strains do not##6##3##(1994-9#1)(1995-8#1)(2006-11#1)(2008-10#1)(2008-9#1)(2012-2#1)
strains during the##2##3##(1993-9#1)(2006-5#1)
strains during##4##2##(1993-9#1)(1995-6#1)(2006-5#1)(2008-10#1)
strains evaluated##2##2##(1997-3#1)(2008-10#1)
strains examined were##2##3##(1997-4#1)(2008-10#1)
strains examined##5##2##(1990-7#1)(1997-4#1)(2008-10#3)
strains except##2##2##(2008-5#1)(2010-3#1)
strains exhibit##2##2##(2008-5#1)(2008-8#1)
strains exhibited resistance to##2##4##(2010-4#2)
strains exhibited##9##2##(1992-7#1)(2005-11#1)(2006-5#1)(2008-10#4)(2010-4#2)
strains expressed##3##2##(1993-11#1)(2008-5#1)(2008-9#1)
strains expressing the##2##3##(1997-2#1)(2012-3#1)
strains expressing##4##2##(1997-2#1)(2010-11#1)(2012-3#1)(2013-1#1)
strains for##10##2##(1996-12#1)(2006-8#1)(2008-10#3)(2008-4#2)(2010-7#1)(2011-2#1)(2012-3#1)
strains formed a##2##3##(1996-12#1)(2008-10#1)
strains found##3##2##(2006-8#2)(2008-10#1)
strains from Costa Rica##6##4##(2008-10#6)
strains from São Paulo##2##4##(2008-10#2)
strains from a##2##3##(2008-10#2)
strains from all other##2##4##(2008-10#2)
strains from all##6##3##(2008-10#6)
strains from cantaloupe and##2##4##(2008-10#2)
strains from citrus##2##3##(2008-10#2)
strains from different geographical##2##4##(2008-10#2)
strains from different regions##2##4##(2008-10#1)(2009-2#1)
strains from different##7##3##(2008-10#6)(2009-2#1)
strains from each##2##3##(2008-10#1)(2008-7#1)
strains from ginger##4##3##(2008-10#4)
strains from hazelnut##3##3##(2008-10#3)
strains from ornamental##2##3##(2008-10#1)(2011-2#1)
strains from other##3##3##(2008-10#3)
strains from the United##2##4##(2008-10#1)(2008-5#1)
strains from the same##2##4##(2006-3#1)(2008-10#1)
strains from the##10##3##(2006-11#1)(2006-3#2)(2008-10#5)(2008-5#2)
strains from tomato##2##3##(2008-10#2)
strains from various other##2##4##(1997-3#1)(2011-2#1)
strains from various##3##3##(1993-3#1)(1997-3#1)(2011-2#1)
strains from##105##2##(1992-2#1)(1993-3#1)(1994-4#1)(1997-3#1)(2006-11#1)(2006-3#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#77)(2008-2#1)(2008-4#1)(2008-5#5)(2008-7#1)(2008-9#1)(2009-2#1)(2011-2#3)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#2)
strains gave##3##2##(2006-5#1)(2006-8#1)(2008-10#1)
strains grew##6##2##(1991-8#1)(2006-5#1)(2008-10#3)(2010-4#1)
strains grouped##3##2##(2008-10#3)
strains grow##2##2##(1991-3#1)(2012-3#1)
strains had##9##2##(1994-7#1)(1997-6#1)(2008-10#4)(2008-5#1)(2010-4#1)(2013-8#1)
strains has been##4##3##(1995-3#1)(1995-6#1)(2005-11#1)(2008-10#1)
strains has##6##2##(1995-3#1)(1995-6#1)(1995-9#1)(2005-11#1)(2008-10#1)(2008-4#1)
strains have a##2##3##(2008-11#1)(2012-12#1)
strains have an##2##3##(2012-2#2)
strains have been obtained##2##4##(2008-10#1)(2008-8#1)
strains have been reported##2##4##(2006-10#1)(2008-10#1)
strains have been##9##3##(1996-12#1)(2006-10#1)(2008-10#3)(2008-6#1)(2008-8#1)(2010-9#1)(2012-3#1)
strains have not##3##3##(2006-11#1)(2008-10#1)(2008-5#1)
strains have##22##2##(1991-1#1)(1996-12#1)(1997-6#1)(2006-10#1)(2006-11#2)(2006-6#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-9#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
strains having##2##2##(1992-8#1)(2008-6#1)
strains identified##2##2##(2008-10#2)
strains in a##8##3##(1996-1#1)(2008-10#5)(2011-2#1)(2013-8#1)
strains in all##2##3##(2008-10#1)(2013-8#1)
strains in cucurbits##2##3##(2008-10#2)
strains in culture##2##3##(1991-2#1)(2008-10#1)
strains in different##2##3##(2007-4#1)(2008-5#1)
strains in our##3##3##(2008-10#2)(2013-1#1)
strains in patients##2##3##(2006-8#1)(2013-1#1)
strains in the exoskeleton##2##4##(2007-12#2)
strains in the##21##3##(1991-6#1)(1997-6#1)(2006-11#1)(2006-9#1)(2007-10#1)(2007-12#2)(2008-10#4)(2008-5#2)(2008-9#3)(2012-12#1)(2012-2#1)(2013-8#3)
strains in which##4##3##(1991-8#1)(1995-2#2)(2008-10#1)
strains in##86##2##(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#1)(1995-2#2)(1996-1#1)(1997-6#1)(2005-11#1)(2006-11#2)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-4#2)(2007-6#1)(2008-10#31)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#5)(2009-5#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#7)
strains including##2##2##(2005-11#1)(2008-10#1)
strains increased##5##2##(1991-12#1)(2006-9#1)(2008-10#3)
strains indicated that##2##3##(1995-8#1)(2008-10#1)
strains induced##4##2##(2006-10#1)(2008-10#2)(2008-2#1)
strains infecting##2##2##(2008-10#2)
strains into three##3##3##(2008-10#3)
strains into two distinct groups##2##5##(2008-10#2)
strains into##11##2##(2008-10#10)(2012-3#1)
strains investigated##3##2##(1997-4#1)(2008-4#1)(2010-6#1)
strains is a##3##3##(1996-6#1)(2008-9#1)(2012-12#1)
strains is the##2##3##(1994-3#1)(2008-2#1)
strains is##15##2##(1990-5#1)(1993-5#1)(1994-12#1)(1994-3#1)(1996-6#1)(2005-11#1)(2006-11#1)(2006-8#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2012-12#1)(2013-8#1)
strains isolated from HIV-positive patients##2##5##(2009-2#2)
strains isolated from different##2##4##(2005-11#1)(2008-5#1)
strains isolated from patients with##3##5##(2006-8#1)(2011-1#1)(2013-1#1)
strains isolated from patients##6##4##(1992-10#1)(2006-8#1)(2007-12#1)(2008-5#1)(2011-1#1)(2013-1#1)
strains isolated from the##5##4##(2006-10#1)(2006-8#1)(2008-10#1)(2008-5#2)
strains isolated from various##2##4##(2007-8#1)(2009-6#1)
strains isolated from##57##3##(1992-10#1)(2005-11#2)(2006-10#1)(2006-8#5)(2007-12#1)(2007-8#1)(2008-10#22)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#6)(2009-2#5)(2009-5#1)(2009-6#2)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
strains isolated in Romania##4##4##(2008-10#1)(2008-4#1)(2009-6#1)(2010-4#1)
strains isolated in the##4##4##(1990-2#1)(2008-12#1)(2011-1#1)(2013-8#1)
strains isolated in##16##3##(1990-2#1)(2005-9#1)(2006-8#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2009-6#1)(2010-4#1)(2011-1#2)(2012-2#1)(2013-8#1)
strains isolated were##3##3##(2006-8#1)(2011-2#1)(2012-12#1)
strains isolated##84##2##(1990-2#1)(1992-10#1)(1997-6#1)(2005-11#2)(2005-9#1)(2006-10#1)(2006-8#7)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#24)(2008-11#3)(2008-12#4)(2008-4#2)(2008-5#12)(2009-2#5)(2009-5#1)(2009-6#3)(2010-4#2)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#2)
strains lacked##2##2##(2008-10#2)
strains lacking##3##2##(1992-10#1)(2007-7#1)(2009-10#1)
strains may be##4##3##(1997-7#1)(2008-10#2)(2008-4#1)
strains may##7##2##(1997-3#1)(1997-7#1)(2006-10#1)(2008-10#2)(2008-4#1)(2008-5#1)
strains might##2##2##(1992-2#1)(2008-10#1)
strains not##2##2##(2008-10#1)(2008-12#1)
strains occurred##2##2##(2006-8#1)(2007-7#1)
strains of A##7##3##(2008-1#3)(2008-10#1)(2008-11#2)(2009-3#1)
strains of Aeromonas##2##3##(2007-10#1)(2007-7#1)
strains of Aspergillus fumigatus##3##4##(2007-7#1)(2012-11#2)
strains of Aspergillus##4##3##(2007-7#1)(2009-3#1)(2012-11#2)
strains of B##4##3##(2006-10#1)(2006-5#1)(2008-10#1)(2008-11#1)
strains of Bacillus subtilis##2##4##(1994-2#1)(2011-12#1)
strains of Bacillus##4##3##(1994-2#1)(2008-10#2)(2011-12#1)
strains of Butyrivibrio##2##3##(2006-8#2)
strains of C##9##3##(2006-5#1)(2006-8#2)(2007-6#1)(2008-10#2)(2009-10#1)(2009-2#1)(2010-8#1)
strains of Campylobacter jejuni##2##4##(1993-9#1)(2005-9#1)
strains of Candida albicans##3##4##(1990-3#1)(1991-12#1)(2007-7#1)
strains of Candida##4##3##(1990-3#1)(1991-12#1)(2007-7#1)(2008-3#1)
strains of Chlamydia psittaci##2##4##(1990-5#1)(1993-2#1)
strains of Clostridium difficile##2##4##(2006-8#2)
strains of Clostridium spiroforme##2##4##(1991-8#2)
strains of Clostridium##7##3##(1991-8#2)(1997-4#1)(2006-8#3)(2008-5#1)
strains of E##9##3##(1990-2#1)(2007-7#1)(2008-10#4)(2008-12#1)(2012-12#1)(2012-3#1)
strains of Escherichia coli isolated from##2##6##(2007-11#1)(2008-5#1)
strains of Escherichia coli##9##4##(1990-12#1)(1993-12#1)(1996-4#1)(1997-2#1)(2007-11#1)(2008-5#2)(2011-1#1)(2013-8#1)
strains of F##5##3##(2008-10#4)(2013-1#1)
strains of Fusarium oxysporum##3##4##(2008-10#3)
strains of Fusarium##4##3##(2008-10#3)(2009-3#1)
strains of Fusobacterium##2##3##(2006-8#2)
strains of H contortus##2##4##(1991-8#2)
strains of H##9##3##(1990-5#1)(1991-8#2)(1997-6#1)(2006-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2012-12#1)
strains of HIV-1##6##3##(1991-9#1)(1994-6#3)(2008-4#1)(2013-7#1)
strains of Helicobacter pylori##3##4##(1997-8#1)(2007-11#1)(2008-12#1)
strains of IBV##2##3##(2008-5#2)
strains of M##9##3##(1991-9#1)(1997-3#2)(2005-7#3)(2007-7#1)(2008-10#1)(2008-5#1)
strains of Methylobacterium##2##3##(2007-12#2)
strains of Mycobacterium tuberculosis##4##4##(1994-7#1)(2007-11#1)(2010-10#1)(2011-2#1)
strains of Mycobacterium##5##3##(1991-8#1)(1994-7#1)(2007-11#1)(2010-10#1)(2011-2#1)
strains of Mycoplasma##2##3##(1992-7#1)(2008-5#1)
strains of NDV##2##3##(2008-5#1)(2008-9#1)
strains of P##17##3##(1991-12#1)(2006-4#1)(2006-8#1)(2007-2#1)(2008-10#8)(2008-11#3)(2008-5#1)(2010-3#1)
strains of Pantoea agglomerans##2##4##(2008-10#2)
strains of Pantoea##3##3##(2008-10#3)
strains of Pseudomonas aeruginosa##2##4##(2008-7#1)(2012-2#1)
strains of Pseudomonas##7##3##(1997-2#1)(2008-10#4)(2008-7#1)(2012-2#1)
strains of R##4##3##(1991-8#1)(2008-10#3)
strains of S##18##3##(1990-9#1)(1995-1#1)(1996-11#1)(1997-3#2)(2008-10#5)(2008-7#2)(2008-9#1)(2009-9#2)(2012-12#1)(2012-3#2)
strains of SCMV and SrMV##2##5##(2008-10#2)
strains of Saccharomyces cerevisiae##4##4##(1990-12#1)(1995-1#1)(1996-6#1)(2007-12#1)
strains of Salmonella##4##3##(1990-6#1)(1995-5#1)(2011-12#1)(2013-8#1)
strains of Staphylococcus aureus##3##4##(1997-4#1)(2008-1#1)(2010-12#1)
strains of Streptococcus pneumoniae##2##4##(1991-12#1)(1994-11#1)
strains of T##6##3##(1992-8#2)(2008-10#1)(2008-4#1)(2011-12#1)(2012-12#1)
strains of Trichoderma##2##3##(2008-10#2)
strains of V##3##3##(1997-1#1)(2008-10#2)
strains of X##11##3##(2008-10#11)
strains of Xanthomonas albilineans from##2##5##(2008-10#2)
strains of Xanthomonas axonopodis pv##3##5##(2008-10#3)
strains of Xanthomonas campestris pv##2##5##(2008-10#2)
strains of Xanthomonas oryzae pv##2##5##(2008-10#2)
strains of Xanthomonas##12##3##(2008-10#11)(2008-8#1)
strains of Xylella fastidiosa##3##4##(2008-10#3)
strains of a##3##3##(2008-10#2)(2008-5#1)
strains of actinomycetes##2##3##(2005-11#2)
strains of anaerobic bacteria##2##4##(2006-8#2)
strains of anaerobic##4##3##(2006-8#4)
strains of avian##3##3##(1997-6#1)(2007-6#1)(2008-4#1)
strains of bacteria and##2##4##(2008-8#1)(2010-2#1)
strains of bacteria##9##3##(1990-5#1)(1994-12#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-2#1)(2012-11#1)
strains of beet##2##3##(2008-10#2)
strains of binucleate Rhizoctonia##2##4##(2008-10#2)
strains of coagulase-negative Staphylococcus##2##4##(2006-10#2)
strains of coagulase-negative staphylococci##2##4##(2008-7#1)(2010-4#1)
strains of coagulase-negative##4##3##(2006-10#2)(2008-7#1)(2010-4#1)
strains of each species##3##4##(2006-5#1)(2008-10#1)(2008-12#1)
strains of fungi##2##3##(2010-2#1)(2012-11#1)
strains of group##2##3##(2008-11#2)
strains of infectious bronchitis virus (IBV) were##2##7##(2008-5#2)
strains of infectious bronchitis virus isolated from the##2##8##(2008-5#2)
strains of infectious bronchitis virus##5##5##(1996-11#1)(2008-5#4)
strains of influenza virus##2##4##(1995-5#1)(2006-10#1)
strains of influenza##3##3##(1995-5#1)(2005-8#1)(2006-10#1)
strains of methicillin-resistant##2##3##(1993-5#1)(1996-4#1)
strains of mice and rats##2##5##(2008-10#1)(2008-5#1)
strains of mice and##5##4##(1990-7#1)(1991-12#1)(1992-1#1)(2008-10#1)(2008-5#1)
strains of mice that differ##2##5##(1994-5#1)(2008-4#1)
strains of mice were##3##4##(1991-12#1)(2008-10#1)(2012-2#1)
strains of mice with##3##4##(1990-2#1)(1996-6#1)(2008-12#1)
strains of mice##44##3##(1990-2#3)(1990-4#1)(1990-7#2)(1991-10#2)(1991-12#4)(1992-1#2)(1992-4#1)(1993-12#1)(1994-2#2)(1994-5#3)(1994-8#1)(1996-12#1)(1996-5#2)(1996-6#1)(1997-2#2)(2006-2#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#3)(2008-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
strains of microorganisms which##2##4##(2005-11#1)(2007-6#1)
strains of microorganisms##3##3##(2005-11#1)(2007-6#1)(2008-10#1)
strains of mutant mice##2##4##(2008-8#2)
strains of other##5##3##(2006-5#1)(2008-10#4)
strains of plant growth-promoting rhizobacteria (PGPR)##2##6##(2008-10#2)
strains of probiotic##2##3##(2006-5#1)(2010-9#1)
strains of race##2##3##(2008-10#2)
strains of rainbow trout##2##4##(2005-10#1)(2012-3#1)
strains of rat##2##3##(1994-2#1)(2008-11#1)
strains of rats##5##3##(1993-12#1)(1997-7#2)(2008-10#1)(2008-4#1)
strains of serotypes##2##3##(1996-12#1)(2007-11#1)
strains of the bacterial##2##4##(2008-10#2)
strains of the bacterium##2##4##(2008-1#1)(2008-10#1)
strains of the fragilis##2##4##(2006-8#2)
strains of the fungus##2##4##(1991-5#1)(2008-10#1)
strains of the organism##2##4##(2005-7#1)(2007-7#1)
strains of the other##2##4##(2006-8#1)(2008-10#1)
strains of the parasite##2##4##(2008-4#1)(2008-5#1)
strains of the pathogen##7##4##(2008-10#7)
strains of the same species##2##5##(2008-10#1)(2012-2#1)
strains of the same##5##4##(1997-2#1)(2008-10#2)(2008-4#1)(2012-2#1)
strains of the species##3##4##(2008-10#3)
strains of the virus##2##4##(2008-10#2)
strains of the##52##3##(1991-5#1)(1993-12#1)(1994-11#1)(1997-2#1)(2005-7#1)(2005-8#1)(2006-8#3)(2007-12#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#28)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#3)(2008-7#1)(2010-12#1)(2012-2#1)
strains of this virus##2##4##(2008-9#1)(2013-8#1)
strains of this##3##3##(2008-10#1)(2008-9#1)(2013-8#1)
strains of##507##2##(1990-12#2)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-9#2)(1991-10#2)(1991-12#7)(1991-5#1)(1991-8#7)(1991-9#2)(1992-1#2)(1992-4#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-5#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#4)(1994-3#1)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#2)(1995-1#2)(1995-4#1)(1995-5#2)(1995-8#1)(1995-9#1)(1996-11#2)(1996-12#3)(1996-4#2)(1996-5#2)(1996-6#2)(1996-7#1)(1997-1#1)(1997-2#6)(1997-3#4)(1997-4#4)(1997-6#3)(1997-7#2)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#5)(2005-7#5)(2005-8#2)(2005-9#1)(2006-10#6)(2006-12#2)(2006-2#3)(2006-4#1)(2006-5#6)(2006-8#19)(2007-10#2)(2007-11#7)(2007-12#5)(2007-2#1)(2007-6#4)(2007-7#8)(2007-8#2)(2008-1#6)(2008-10#151)(2008-11#14)(2008-12#13)(2008-2#1)(2008-3#1)(2008-4#11)(2008-5#31)(2008-6#1)(2008-7#7)(2008-8#6)(2008-9#4)(2009-10#1)(2009-2#1)(2009-3#5)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#3)(2011-2#3)(2012-11#5)(2012-12#5)(2012-2#7)(2012-3#8)(2013-1#3)(2013-7#1)(2013-8#8)
strains on the basis of##3##5##(2008-10#2)(2013-1#1)
strains on the##8##3##(2006-6#1)(2006-8#1)(2008-10#2)(2009-3#1)(2011-2#1)(2013-1#2)
strains on##18##2##(2006-6#1)(2006-8#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2009-3#1)(2011-2#1)(2013-1#2)(2013-8#1)
strains or##5##2##(2008-1#1)(2008-10#2)(2008-9#1)(2013-8#1)
strains originating from##3##3##(1991-2#1)(2008-10#1)(2008-5#1)
strains pathogenic to##3##3##(2008-10#3)
strains pathogenic##4##2##(2008-10#4)
strains persisted##2##2##(2008-10#1)(2008-5#1)
strains present in##2##3##(2005-7#1)(2008-10#1)
strains presented##2##2##(2006-10#1)(2011-1#1)
strains previously##2##2##(2007-2#1)(2012-11#1)
strains produced##17##2##(1991-8#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-8#1)(2008-10#11)(2010-12#1)
strains producing##5##2##(1997-7#1)(2008-10#2)(2008-5#1)(2012-12#1)
strains proved##2##2##(2009-6#1)(2010-4#1)
strains recovered from##2##3##(1996-12#1)(2006-8#1)
strains represent##2##2##(2008-10#2)
strains representing the##3##3##(2008-10#2)(2010-3#1)
strains representing##6##2##(1997-4#1)(2008-10#3)(2010-3#1)(2012-12#1)
strains required##2##2##(2008-10#1)(2012-3#1)
strains resistant to##7##3##(2005-7#1)(2005-8#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-5#1)(2012-12#1)
strains responded##2##2##(1990-2#1)(1996-10#1)
strains revealed that the##3##4##(1997-2#1)(2008-4#1)(2009-6#1)
strains revealed that##4##3##(1992-7#1)(1997-2#1)(2008-4#1)(2009-6#1)
strains revealed##10##2##(1992-7#1)(1994-10#1)(1997-2#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-6#2)(2012-11#1)
strains reveals##2##2##(1993-2#1)(2011-2#1)
strains selected for##2##3##(1994-6#1)(2008-6#1)
strains selected only for their bioremediation properties##2##7##(2008-6#2)
strains selected##4##2##(1994-6#1)(2008-6#3)
strains sensitive##3##2##(2008-10#3)
strains show##2##2##(2006-10#1)(2007-9#1)
strains showed a##2##3##(1993-7#1)(2008-2#1)
strains showed resistance to##3##4##(2007-6#1)(2007-8#1)(2008-5#1)
strains showed unique PCR fingerprints##2##5##(2006-8#2)
strains showed##27##2##(1993-7#1)(1995-4#1)(1995-6#1)(2004-11#1)(2005-11#1)(2006-5#1)(2006-8#3)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-5#4)(2011-12#1)(2012-11#1)
strains significantly reduced##2##3##(2008-10#2)
strains studied##2##2##(2006-8#1)(2007-7#1)
strains such as##4##3##(1991-7#1)(2008-5#1)(2009-12#1)(2010-3#1)
strains suggests that##2##3##(2008-10#1)(2010-5#1)
strains tended to##2##3##(2007-7#1)(2008-10#1)
strains tested from##3##3##(2006-8#2)(2008-10#1)
strains tested were##3##3##(2006-8#1)(2008-10#1)(2009-5#1)
strains tested##26##2##(1993-7#1)(1995-1#1)(1997-4#1)(2006-8#6)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#8)(2008-5#2)(2009-5#1)(2011-2#1)
strains than##3##2##(1996-7#1)(2011-2#1)(2013-8#1)
strains that are resistant to##2##5##(2008-5#1)(2012-3#1)
strains that are sensitive to##2##5##(2008-7#1)(2010-4#1)
strains that are##9##3##(2006-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-3#2)
strains that differ in##2##4##(1996-12#1)(2008-10#1)
strains that might##2##3##(1992-12#1)(2011-2#1)
strains that were isolated##3##4##(2008-10#1)(2008-12#1)(2008-6#1)
strains that were##13##3##(2007-7#2)(2008-10#7)(2008-12#1)(2008-4#1)(2008-6#1)(2011-2#1)
strains that##47##2##(1992-12#1)(1993-9#1)(1995-8#1)(1996-12#1)(1997-6#1)(2006-10#1)(2007-7#2)(2008-10#20)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2010-2#1)(2010-4#1)(2011-2#3)(2012-2#1)(2012-3#2)
strains the##2##2##(2006-8#1)(2008-9#1)
strains to the##2##3##(1993-12#1)(2008-2#1)
strains to##25##2##(1991-12#1)(1992-10#1)(1992-6#1)(1993-12#1)(1995-6#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-6#1)(2007-7#2)(2008-10#6)(2008-2#1)(2008-4#2)(2009-5#1)(2010-4#2)(2011-2#2)
strains together with the##2##4##(2007-11#1)(2008-10#1)
strains transformed with##2##3##(1993-11#1)(1997-1#1)
strains up to##2##3##(2007-4#1)(2008-10#1)
strains used in this study##2##5##(2008-10#1)(2008-5#1)
strains used in##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
strains used##7##2##(2008-10#3)(2008-5#2)(2013-8#2)
strains using different##2##3##(2008-7#1)(2009-6#1)
strains using the##2##3##(2007-7#1)(2008-10#1)
strains using##12##2##(1990-8#1)(1990-9#1)(2007-7#1)(2008-10#6)(2008-7#1)(2009-6#1)(2011-2#1)
strains varied significantly##2##3##(2008-10#1)(2008-12#1)
strains was analyzed##2##3##(2008-10#2)
strains was evaluated##4##3##(2007-10#1)(2007-7#1)(2008-10#1)(2008-5#1)
strains was found##3##3##(2007-8#1)(2008-10#1)(2008-12#1)
strains was identified##2##3##(2006-10#1)(2008-10#1)
strains was revealed by RFLP##2##5##(2008-10#2)
strains was shown##2##3##(1993-3#1)(2007-1#1)
strains was##44##2##(1991-3#2)(1991-8#2)(1992-2#1)(1993-11#1)(1993-3#1)(1996-2#1)(1996-9#1)(1997-7#2)(2006-10#1)(2006-11#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-10#18)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2012-3#1)(2013-1#1)
strains were able to##4##4##(1992-3#1)(1996-12#1)(1997-6#1)(2006-3#1)
strains were also##6##3##(1991-3#1)(1993-11#1)(1996-12#1)(2008-10#1)(2010-4#1)(2011-12#1)
strains were analysed##3##3##(1993-5#1)(2010-10#1)(2013-8#1)
strains were classified##2##3##(2008-10#1)(2008-2#1)
strains were collected from##3##4##(2008-10#1)(2008-12#1)(2012-2#1)
strains were compared by##2##4##(2006-3#1)(2008-10#1)
strains were compared with##2##4##(2008-10#1)(2008-6#1)
strains were compared##6##3##(1996-5#1)(2006-3#1)(2008-10#3)(2008-6#1)
strains were constructed##2##3##(1995-8#1)(2008-10#1)
strains were detected##4##3##(2006-10#2)(2008-10#2)
strains were divided into two##2##5##(2008-10#2)
strains were divided into##4##4##(2008-10#4)
strains were established##2##3##(1993-11#1)(2008-10#1)
strains were evaluated for their##2##5##(2009-3#1)(2012-3#1)
strains were evaluated for##3##4##(2008-10#1)(2009-3#1)(2012-3#1)
strains were evaluated##4##3##(2008-10#2)(2009-3#1)(2012-3#1)
strains were examined##2##3##(2008-10#1)(2008-5#1)
strains were found to be##2##5##(2008-4#1)(2008-5#1)
strains were found to##3##4##(2008-4#1)(2008-5#1)(2009-7#1)
strains were found##7##3##(1997-2#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#2)(2009-7#1)
strains were further##3##3##(2006-8#1)(2008-10#2)
strains were grouped into##2##4##(2008-5#2)
strains were grouped##5##3##(2008-10#3)(2008-5#2)
strains were grown##2##3##(2008-10#1)(2008-6#1)
strains were highly pathogenic on Andean##2##6##(2008-10#2)
strains were highly pathogenic on##3##5##(2008-10#3)
strains were identified as##4##4##(2008-10#3)(2009-6#1)
strains were identified by##2##4##(2008-11#1)(2012-11#1)
strains were identified##10##3##(2008-10#7)(2008-11#1)(2009-6#1)(2012-11#1)
strains were inoculated##4##3##(1992-2#1)(2006-3#1)(2008-10#2)
strains were isolated from##12##4##(2006-5#1)(2008-10#5)(2008-5#2)(2008-6#1)(2010-12#1)(2012-12#1)(2013-1#1)
strains were isolated in##2##4##(1992-12#1)(2008-5#1)
strains were isolated##22##3##(1992-12#1)(1994-3#1)(2006-10#1)(2006-5#1)(2006-8#2)(2007-7#1)(2008-10#5)(2008-2#1)(2008-5#4)(2008-6#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
strains were less##2##3##(2008-10#2)
strains were more##6##3##(2004-11#1)(2008-10#2)(2008-5#2)(2011-1#1)
strains were mostly in serotype##2##5##(1993-2#2)
strains were not detected##2##4##(2008-5#1)(2013-1#1)
strains were not##8##3##(2005-9#1)(2006-8#1)(2008-10#3)(2008-5#1)(2011-1#1)(2013-1#1)
strains were obtained##3##3##(2006-10#1)(2007-6#1)(2008-5#1)
strains were pathogenic on##2##4##(2008-10#2)
strains were pathogenic##3##3##(2008-10#3)
strains were placed in##2##4##(2008-10#2)
strains were placed##3##3##(2008-10#3)
strains were present##2##3##(2008-10#2)
strains were resistant to##5##4##(1993-5#2)(2006-8#1)(2007-8#1)(2008-12#1)
strains were screened##2##3##(2006-9#1)(2012-2#1)
strains were selected from##2##4##(2008-6#1)(2013-1#1)
strains were selected##4##3##(2008-10#1)(2008-5#1)(2008-6#1)(2013-1#1)
strains were sensitive to##4##4##(1990-6#1)(2006-8#1)(2007-10#1)(2008-10#1)
strains were separated##2##3##(2008-10#2)
strains were significantly##2##3##(2008-10#1)(2008-12#1)
strains were similar##2##3##(2008-10#1)(2011-2#1)
strains were subjected to##2##4##(2008-10#1)(2013-1#1)
strains were susceptible to##4##4##(1993-5#1)(2006-10#1)(2006-8#1)(2009-6#1)
strains were susceptible##5##3##(1993-5#1)(2006-10#1)(2006-8#2)(2009-6#1)
strains were tested for##3##4##(2007-8#1)(2008-10#2)
strains were tested##7##3##(1993-5#1)(2006-8#2)(2007-8#1)(2008-10#3)
strains were the most##2##4##(2008-10#1)(2011-2#1)
strains were then##2##3##(2008-10#1)(2011-2#1)
strains were used to##4##4##(2008-10#2)(2010-8#1)(2012-12#1)
strains were##247##2##(1990-6#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-11#2)(1993-2#2)(1993-5#5)(1994-12#1)(1994-3#1)(1995-8#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-11#2)(2005-11#1)(2005-9#2)(2006-10#6)(2006-3#4)(2006-5#1)(2006-8#13)(2006-9#1)(2007-10#1)(2007-4#1)(2007-6#2)(2007-7#4)(2007-8#2)(2008-10#101)(2008-11#1)(2008-12#6)(2008-2#4)(2008-4#3)(2008-5#18)(2008-6#4)(2008-7#1)(2009-2#2)(2009-3#1)(2009-6#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#8)(2011-12#1)(2011-2#7)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#3)
strains when##2##2##(2006-9#1)(2012-2#1)
strains whereas##2##2##(2008-11#1)(2008-5#1)
strains which are##2##3##(2006-8#2)
strains which were##2##3##(2008-6#1)(2011-1#1)
strains which##8##2##(2005-12#1)(2006-5#1)(2006-8#2)(2008-5#2)(2008-6#1)(2011-1#1)
strains with an##2##3##(1991-12#1)(2008-7#1)
strains with similar##2##3##(1991-9#1)(2008-10#1)
strains with the##2##3##(1997-4#1)(2008-10#1)
strains with##50##2##(1991-12#2)(1991-9#1)(1993-11#1)(1993-5#1)(1993-8#1)(1993-9#1)(1995-4#1)(1997-4#2)(2005-11#1)(2006-10#3)(2006-11#1)(2006-8#4)(2007-11#1)(2007-12#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2011-1#2)(2011-2#4)(2012-12#3)(2012-3#1)
strains within the##3##3##(2006-8#1)(2008-10#1)(2010-4#1)
strains within this##2##3##(2008-10#1)(2008-5#1)
strains within##8##2##(2006-8#1)(2008-10#5)(2008-5#1)(2010-4#1)
strains without##3##2##(2008-10#3)
strains##2929##1##(1990-11#5)(1990-12#9)(1990-2#9)(1990-3#6)(1990-4#4)(1990-5#14)(1990-6#2)(1990-7#6)(1990-8#2)(1990-9#6)(1991-1#6)(1991-10#2)(1991-11#1)(1991-12#15)(1991-2#4)(1991-3#12)(1991-4#3)(1991-5#2)(1991-6#4)(1991-7#5)(1991-8#12)(1991-9#5)(1992-1#2)(1992-10#6)(1992-11#2)(1992-12#2)(1992-2#12)(1992-3#1)(1992-4#3)(1992-5#3)(1992-6#2)(1992-7#5)(1992-8#4)(1992-9#1)(1993-11#13)(1993-12#13)(1993-2#7)(1993-3#5)(1993-4#1)(1993-5#12)(1993-7#3)(1993-8#1)(1993-9#10)(1994-10#1)(1994-11#4)(1994-12#5)(1994-2#14)(1994-3#7)(1994-4#1)(1994-5#8)(1994-6#4)(1994-7#6)(1994-8#9)(1994-9#1)(1995-1#4)(1995-11#1)(1995-12#1)(1995-2#8)(1995-3#1)(1995-4#9)(1995-5#4)(1995-6#9)(1995-8#15)(1995-9#2)(1996-1#1)(1996-10#7)(1996-11#2)(1996-12#15)(1996-2#3)(1996-4#4)(1996-5#4)(1996-6#7)(1996-7#5)(1996-9#3)(1997-1#4)(1997-2#13)(1997-3#13)(1997-4#20)(1997-5#2)(1997-6#27)(1997-7#10)(1997-8#6)(1997-9#2)(2004-11#10)(2005-10#2)(2005-11#27)(2005-12#2)(2005-7#8)(2005-8#6)(2005-9#7)(2006-1#1)(2006-10#41)(2006-11#14)(2006-12#4)(2006-2#7)(2006-3#14)(2006-4#2)(2006-5#16)(2006-6#2)(2006-8#115)(2006-9#7)(2007-1#5)(2007-10#14)(2007-11#29)(2007-12#21)(2007-2#5)(2007-4#9)(2007-6#15)(2007-7#48)(2007-8#23)(2007-9#3)(2008-1#12)(2008-10#958)(2008-11#29)(2008-12#47)(2008-2#26)(2008-3#6)(2008-4#59)(2008-5#173)(2008-6#24)(2008-7#32)(2008-8#31)(2008-9#34)(2009-10#6)(2009-11#1)(2009-12#3)(2009-2#13)(2009-3#9)(2009-4#2)(2009-5#5)(2009-6#20)(2009-7#4)(2009-8#1)(2009-9#5)(2010-1#2)(2010-10#3)(2010-11#3)(2010-12#9)(2010-2#7)(2010-3#8)(2010-4#28)(2010-5#2)(2010-6#2)(2010-7#7)(2010-8#8)(2010-9#2)(2011-1#53)(2011-12#10)(2011-2#65)(2011-3#1)(2012-1#4)(2012-11#14)(2012-12#40)(2012-2#38)(2012-3#50)(2013-1#44)(2013-7#4)(2013-8#64)
strains'##5##1##(1994-2#1)(2008-10#3)(2008-6#1)
strains) and##6##2##(1991-8#1)(1993-2#1)(1994-7#1)(2006-8#1)(2008-10#2)
strains) were##3##2##(1991-8#1)(2006-8#1)(2008-10#1)
strains)##27##1##(1990-12#1)(1990-4#1)(1991-8#2)(1993-2#2)(1994-7#2)(1996-12#1)(2006-8#6)(2007-9#1)(2008-10#6)(2008-7#1)(2010-8#1)(2011-1#2)(2013-8#1)
strains]##4##1##(2005-11#1)(2011-1#1)(2012-12#1)(2013-8#1)
stramenopiles##2##1##(2012-2#2)
straminea##5##1##(1993-6#4)(1994-6#1)
stramineus##2##1##(2007-12#1)(2008-5#1)
stramonium SPDS1##2##2##(2013-8#2)
stramonium##8##1##(2008-10#5)(2008-7#1)(2013-8#2)
strand DNA##5##2##(1990-11#1)(1991-5#1)(1997-2#1)(2008-10#1)(2011-1#1)
strand RNA##4##2##(1990-11#1)(1991-3#2)(2008-10#1)
strand and the##2##3##(1990-5#1)(1995-3#1)
strand and##8##2##(1990-5#1)(1990-7#1)(1995-3#1)(1995-8#1)(1996-7#1)(1997-2#1)(2009-9#1)(2013-7#1)
strand annealing##2##2##(1995-6#1)(2011-1#1)
strand as##2##2##(1990-5#1)(2008-10#1)
strand at##3##2##(1992-3#1)(1995-10#1)(1997-1#1)
strand break repair##2##3##(1994-5#1)(1996-2#1)
strand break##8##2##(1992-9#1)(1994-5#1)(1996-2#2)(2006-8#1)(2007-3#1)(2011-1#1)(2013-1#1)
strand breaks and##6##3##(1994-11#1)(1996-2#1)(1997-8#1)(2006-8#1)(2007-9#1)(2011-2#1)
strand breaks at##2##3##(1992-9#1)(2012-3#1)
strand breaks in DNA induced by##2##6##(1993-4#2)
strand breaks in plasmid DNA##2##5##(1994-7#1)(2008-3#1)
strand breaks in##7##3##(1993-4#2)(1993-9#1)(1994-7#1)(1995-10#1)(2008-3#1)(2008-4#1)
strand breaks produced by##2##4##(2007-3#2)
strand breaks##49##2##(1990-4#1)(1991-12#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#4)(1993-4#2)(1993-9#1)(1994-10#1)(1994-11#3)(1994-3#1)(1994-5#1)(1994-7#1)(1995-10#1)(1995-6#1)(1996-2#1)(1996-5#2)(1997-4#3)(1997-8#3)(2006-8#1)(2007-3#4)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#4)(2011-1#1)(2011-2#1)(2012-3#1)
strand cDNA##4##2##(1994-11#1)(1994-9#1)(1997-2#1)(2008-9#1)
strand cleavage##3##2##(1995-10#1)(1997-4#1)(2008-11#1)
strand configuration##2##2##(1995-12#2)
strand conformation polymorphism##4##3##(1992-2#2)(1992-3#1)(2008-8#1)
strand containing##2##2##(1994-8#1)(1994-9#1)
strand diameter of##3##3##(2006-10#3)
strand displacement##2##2##(1990-5#1)(2008-12#1)
strand encodes a protein of##2##5##(2008-10#2)
strand exchange reaction##2##3##(1995-8#2)
strand exchange##8##2##(1995-8#7)(2006-10#1)
strand from##2##2##(1991-7#1)(2008-2#1)
strand in a##2##3##(2008-4#1)(2008-5#1)
strand in##5##2##(1992-12#1)(1994-9#1)(2008-4#1)(2008-5#1)(2011-2#1)
strand is##8##2##(1990-12#1)(1991-7#1)(1994-8#2)(1995-3#1)(1997-4#1)(2008-4#1)(2008-8#1)
strand of a##2##3##(1996-5#1)(1997-7#1)
strand of an##2##3##(1994-8#1)(1995-10#1)
strand of the##18##3##(1992-8#2)(1993-12#1)(1993-3#1)(1994-8#1)(1994-9#2)(1995-3#2)(1996-11#1)(1996-5#1)(1997-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2009-2#1)
strand of this##2##3##(1990-10#1)(2008-10#1)
strand of##40##2##(1990-10#1)(1991-3#1)(1992-11#1)(1992-8#2)(1993-12#1)(1993-3#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-10#2)(1995-3#2)(1996-11#1)(1996-5#3)(1997-1#1)(1997-7#1)(1997-9#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-8#2)(2009-2#1)(2009-3#1)(2009-4#1)(2010-5#1)(2011-1#1)
strand passage##3##2##(1995-6#1)(1997-4#2)
strand scission##5##2##(1990-5#1)(1990-7#2)(1995-6#1)(2008-5#1)
strand separation##2##2##(1995-12#1)(2012-2#1)
strand strong stop DNA was##2##5##(1990-11#2)
strand strong stop DNA##3##4##(1990-11#3)
strand synthesis##3##2##(1997-2#1)(2008-4#1)(2011-1#1)
strand transfer##5##2##(1995-3#1)(1995-8#2)(2009-11#2)
strand was##3##2##(1991-7#1)(1995-3#1)(2006-10#1)
strand with the##2##3##(2008-10#1)(2008-4#1)
strand with##3##2##(2007-9#1)(2008-10#1)(2008-4#1)
strand##309##1##(1990-10#4)(1990-11#7)(1990-12#4)(1990-4#1)(1990-5#7)(1990-7#3)(1991-12#2)(1991-3#3)(1991-5#3)(1991-7#4)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#5)(1993-11#1)(1993-12#3)(1993-3#8)(1993-4#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#5)(1994-3#1)(1994-5#2)(1994-6#2)(1994-7#2)(1994-8#12)(1994-9#7)(1995-1#3)(1995-10#6)(1995-12#5)(1995-3#9)(1995-4#3)(1995-6#5)(1995-8#16)(1996-11#1)(1996-2#3)(1996-5#8)(1996-6#4)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#1)(1997-4#9)(1997-5#4)(1997-6#1)(1997-7#1)(1997-8#3)(1997-9#1)(2005-11#1)(2006-10#5)(2006-12#5)(2006-8#2)(2007-3#5)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#17)(2008-11#7)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#7)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#8)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-2#2)(2010-5#1)(2011-1#6)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#2)
strand)##4##1##(1993-11#2)(2008-2#1)(2011-1#1)
strand-loop&quot##2##1##(1992-11#2)
strand-specific##4##1##(1994-8#1)(1997-2#1)(2008-10#1)(2012-3#1)
stranded DNA##18##2##(1990-12#1)(1992-6#1)(1994-11#1)(1996-11#1)(1997-1#1)(2006-2#1)(2007-11#3)(2008-1#1)(2008-10#5)(2008-5#1)(2009-3#1)(2013-8#1)
stranded RNA##3##2##(2007-6#1)(2008-1#1)(2008-10#1)
stranded in##2##2##(2012-2#2)
stranded nucleic##3##2##(2008-10#2)(2008-3#1)
stranded oligonucleotides##3##2##(1991-1#1)(2008-10#2)
stranded##52##1##(1990-12#1)(1990-5#1)(1991-1#1)(1991-7#3)(1992-12#1)(1992-6#3)(1994-11#1)(1994-3#2)(1994-8#1)(1996-11#1)(1997-1#1)(2006-10#4)(2006-2#1)(2007-11#3)(2007-6#1)(2008-1#2)(2008-10#15)(2008-11#1)(2008-3#1)(2008-5#1)(2009-3#1)(2009-7#1)(2011-2#1)(2012-2#3)(2013-8#1)
strands (a##2##2##(1994-9#2)
strands and##7##2##(1995-3#1)(1996-11#1)(2006-12#1)(2008-10#1)(2008-4#2)(2012-2#1)
strands are##8##2##(1993-11#1)(1994-9#1)(1997-1#1)(2006-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-7#1)
strands but##2##2##(1990-12#1)(1994-8#1)
strands from##3##2##(2006-12#1)(2008-10#1)(2008-2#1)
strands in##2##2##(1992-4#1)(1995-12#1)
strands is##3##2##(1990-12#1)(1992-3#1)(1995-6#1)
strands of DNA##4##3##(1995-3#1)(1995-6#1)(1996-6#1)(2008-5#1)
strands of a##3##3##(1992-8#1)(1994-11#1)(1995-7#1)
strands of antiparallel beta-sheet##2##4##(1995-3#1)(2008-9#1)
strands of nucleic##2##3##(1997-6#1)(2011-12#1)
strands of the##6##3##(1993-3#1)(1994-12#1)(1994-8#1)(1995-10#1)(1996-5#1)(2011-1#1)
strands of##31##2##(1990-5#1)(1991-1#1)(1991-4#1)(1991-7#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-8#4)(1994-9#1)(1995-10#1)(1995-3#2)(1995-6#1)(1995-7#1)(1996-11#1)(1996-5#2)(1996-6#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-9#1)(2011-1#2)(2011-12#1)
strands on##2##2##(2008-4#1)(2011-2#1)
strands or##2##2##(2008-5#1)(2008-8#1)
strands to##2##2##(2006-12#1)(2009-5#1)
strands were##5##2##(1992-6#1)(1993-3#1)(1994-8#2)(2006-12#1)
strands##125##1##(1990-12#2)(1990-5#1)(1991-1#1)(1991-4#2)(1991-7#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#3)(1993-8#2)(1994-11#2)(1994-12#1)(1994-8#11)(1994-9#5)(1995-1#2)(1995-10#2)(1995-11#1)(1995-12#2)(1995-3#3)(1995-4#1)(1995-6#3)(1995-7#2)(1995-8#3)(1996-11#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#2)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2005-11#1)(2006-10#3)(2006-12#9)(2006-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-4#7)(2008-5#6)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#3)(2012-3#1)
strange##16##1##(1990-11#2)(1990-7#1)(2006-12#1)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-10#2)(2010-6#1)(2010-7#1)(2012-2#1)(2013-1#2)
stranger to##2##2##(2008-2#2)
stranger##5##1##(2006-10#2)(2007-5#1)(2008-2#2)
strangers##8##1##(2006-10#4)(2007-8#1)(2009-6#1)(2011-1#1)(2011-2#1)
strangled inguinal##2##2##(2011-1#2)
strangled##3##1##(2011-1#3)
strangles##4##1##(1993-8#1)(2007-2#1)(2013-8#2)
strangulated##4##1##(1990-10#1)(2007-8#1)(2009-7#1)(2009-8#1)
strangulation##9##1##(1995-3#2)(1996-5#1)(1996-9#1)(2011-1#2)(2012-12#1)(2012-2#2)
straps##2##1##(2008-6#1)(2009-1#1)
strata and##3##2##(1991-6#1)(2013-1#1)(2013-8#1)
strata children##2##2##(2013-1#2)
strata in##2##2##(2008-1#1)(2008-9#1)
strata of society##2##3##(2008-1#1)(2013-1#1)
strata of the population##2##4##(1990-7#1)(2006-4#1)
strata of the##3##3##(1990-7#1)(2006-4#1)(2011-1#1)
strata of##9##2##(1990-7#1)(1991-7#1)(1993-9#1)(1994-6#1)(2006-4#1)(2008-1#1)(2008-8#1)(2011-1#1)(2013-1#1)
strata##46##1##(1990-7#1)(1990-8#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-9#1)(1997-7#2)(2004-4#1)(2006-10#1)(2006-4#1)(2008-1#3)(2008-5#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#9)(2013-7#4)(2013-8#1)
strata-matched case-control studies##2##3##(1992-2#2)
strategic alliances##5##2##(1992-1#2)(1997-3#1)(2005-5#1)(2008-11#1)
strategic and##7##2##(1990-12#1)(2007-4#1)(2008-11#2)(2008-12#2)(2012-12#1)
strategic approach to the##2##4##(2007-7#1)(2008-11#1)
strategic approach to##4##3##(1992-12#1)(2007-4#1)(2007-7#1)(2008-11#1)
strategic approach##6##2##(1992-12#1)(1996-3#1)(2007-4#1)(2007-7#2)(2008-11#1)
strategic approaches##2##2##(2008-4#2)
strategic behavior##2##2##(2006-7#1)(2010-7#1)
strategic choices##4##2##(1995-12#1)(1996-3#2)(1997-1#1)
strategic considerations##4##2##(1995-12#1)(1997-1#1)(2008-9#1)(2012-3#1)
strategic decision##6##2##(1996-12#1)(1997-3#1)(2007-4#1)(2013-1#3)
strategic decisions##2##2##(2010-8#2)
strategic directions##2##2##(1994-2#1)(2011-2#1)
strategic documents##2##2##(2008-1#1)(2012-2#1)
strategic effectiveness##2##2##(1992-1#1)(1994-2#1)
strategic environmental assessment##2##3##(2013-1#2)
strategic goals##7##2##(1990-12#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-3#1)(1996-3#1)(2009-4#1)
strategic impact##3##2##(2012-3#3)
strategic importance##2##2##(1993-3#1)(2008-4#1)
strategic infarct dementia##2##3##(2007-10#2)
strategic issues##3##2##(2008-11#1)(2010-2#1)(2012-12#1)
strategic management of##4##3##(1992-12#1)(2008-3#1)(2011-2#2)
strategic management##11##2##(1992-12#1)(1992-3#1)(1993-12#3)(1993-2#1)(1994-3#1)(1997-3#1)(2008-3#1)(2011-2#2)
strategic marketing##2##2##(1994-2#2)
strategic objectives##2##2##(1995-12#1)(1995-3#1)
strategic or##2##2##(1994-3#1)(1997-1#1)
strategic performance##2##2##(2008-11#1)(2013-8#1)
strategic plan are##3##3##(1991-2#1)(1992-3#1)(1993-3#1)
strategic plan for##3##3##(1992-3#1)(1994-2#1)(1995-2#1)
strategic plan to##2##3##(1995-2#1)(2011-1#1)
strategic plan with##3##3##(1992-3#1)(2007-7#1)(2011-1#1)
strategic plan##20##2##(1991-2#2)(1992-3#5)(1993-2#1)(1993-3#1)(1994-1#2)(1994-2#2)(1995-2#2)(1997-1#1)(2007-7#1)(2011-1#3)
strategic planning and management##2##4##(1993-2#1)(1994-1#1)
strategic planning and##7##3##(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#1)(1996-3#1)(2005-11#1)(2008-10#1)
strategic planning for##2##3##(1992-3#1)(2007-10#1)
strategic planning in##5##3##(1991-1#1)(1992-1#1)(1995-1#1)(2007-7#1)(2008-11#1)
strategic planning process at##2##4##(1993-3#1)(1994-2#1)
strategic planning process used by##2##5##(1991-2#1)(1992-2#1)
strategic planning process used##3##4##(1991-2#1)(1992-2#1)(1994-2#1)
strategic planning process##18##3##(1990-12#1)(1991-2#2)(1992-2#1)(1993-3#2)(1994-2#6)(1994-3#1)(1995-1#1)(1996-1#1)(1997-1#2)(2013-7#1)
strategic planning##62##2##(1990-12#2)(1991-1#2)(1991-2#3)(1991-3#1)(1992-1#1)(1992-2#1)(1992-3#3)(1993-1#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-12#1)(1994-2#10)(1994-3#4)(1995-1#5)(1995-2#2)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#5)(2005-11#1)(2007-1#2)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-7#2)
strategic plans##3##2##(1994-2#1)(1995-1#1)(2008-1#1)
strategic position##3##2##(1994-11#1)(1996-1#1)(2008-4#1)
strategic preparedness planning##2##3##(2008-8#2)
strategic purposes##2##2##(1992-8#1)(2008-12#1)
strategic quality planning##2##3##(1994-2#2)
strategic quality##3##2##(1994-2#2)(1997-3#1)
strategic response##2##2##(1996-3#1)(1997-2#1)
strategic responses##2##2##(2010-9#2)
strategic role in##2##3##(2007-11#1)(2011-1#1)
strategic role##3##2##(2007-11#1)(2008-9#1)(2011-1#1)
strategic use of##2##3##(1991-8#2)
strategic##278##1##(1990-12#5)(1991-1#2)(1991-2#5)(1991-3#2)(1991-8#3)(1992-1#4)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#9)(1992-8#1)(1993-1#1)(1993-12#4)(1993-2#6)(1993-3#9)(1994-1#5)(1994-11#1)(1994-12#3)(1994-2#22)(1994-3#10)(1994-8#1)(1995-1#6)(1995-10#1)(1995-12#3)(1995-2#5)(1995-3#4)(1996-1#6)(1996-12#3)(1996-2#3)(1996-3#8)(1997-1#12)(1997-2#2)(1997-3#4)(2005-11#1)(2005-5#1)(2005-8#2)(2006-7#1)(2007-1#2)(2007-10#4)(2007-11#4)(2007-4#6)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#10)(2008-12#8)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#6)(2009-10#1)(2009-4#1)(2009-9#2)(2010-2#3)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#4)(2011-2#3)(2011-3#1)(2012-12#3)(2012-2#3)(2012-3#9)(2013-1#6)(2013-7#3)(2013-8#3)
strategically located at##2##3##(2009-10#1)(2009-6#1)
strategically##19##1##(1994-12#1)(1996-1#1)(1996-2#2)(1996-3#2)(1997-3#1)(2005-5#1)(2006-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-8#1)
strategies (i##4##2##(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#1)
strategies (such as##2##3##(2008-10#2)
strategies -##2##2##(2009-4#1)(2012-3#1)
strategies according to the##2##4##(1991-6#1)(2006-4#1)
strategies according to##3##3##(1991-6#1)(2006-4#1)(2010-12#1)
strategies across##3##2##(2006-10#1)(2008-10#1)(2009-4#1)
strategies adopted by##2##3##(2008-6#1)(2012-12#1)
strategies adopted for##3##3##(2012-12#1)(2013-1#2)
strategies adopted##9##2##(2005-8#1)(2006-1#1)(2008-6#1)(2009-10#1)(2012-12#2)(2012-3#1)(2013-1#2)
strategies against##12##2##(1997-4#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)
strategies aimed at controlling the##2##5##(2010-4#1)(2013-1#1)
strategies aimed at preventing##2##4##(1991-7#1)(2005-7#1)
strategies aimed at##14##3##(1991-7#1)(1994-3#1)(2005-7#2)(2006-10#1)(2006-5#1)(2007-5#2)(2007-9#1)(2008-4#1)(2010-4#1)(2011-12#1)(2013-1#1)(2013-8#1)
strategies allow##2##2##(2008-3#1)(2009-4#1)
strategies among##2##2##(2008-8#1)(2011-2#1)
strategies and activities##2##3##(2007-2#1)(2009-4#1)
strategies and challenges##2##3##(2007-8#1)(2009-5#1)
strategies and early##2##3##(1991-6#1)(2006-2#1)
strategies and future##3##3##(2006-6#1)(2013-1#1)(2013-8#1)
strategies and methods##4##3##(1996-12#1)(2008-10#1)(2008-2#1)(2010-10#1)
strategies and new##2##3##(2008-1#1)(2008-7#1)
strategies and programs to##2##4##(1996-1#1)(2012-12#1)
strategies and recommendations##2##3##(2007-3#1)(2010-12#1)
strategies and tactics to##2##4##(1994-12#1)(2013-1#1)
strategies and tactics##3##3##(1994-12#1)(2008-9#1)(2013-1#1)
strategies and techniques##3##3##(2006-10#1)(2007-7#1)(2008-4#1)
strategies and that##2##3##(1993-12#1)(2008-3#1)
strategies and the##4##3##(2006-10#1)(2008-12#1)(2009-12#1)(2010-11#1)
strategies and their##4##3##(2008-7#1)(2009-8#1)(2012-2#1)(2012-3#1)
strategies and therapeutics##2##3##(2008-11#1)(2009-12#1)
strategies and to##2##3##(1995-9#1)(2008-8#1)
strategies and##115##2##(1991-11#1)(1991-6#1)(1992-10#1)(1992-3#2)(1992-9#1)(1993-1#1)(1993-12#3)(1993-6#1)(1994-1#1)(1994-12#1)(1995-12#3)(1995-3#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-3#1)(1997-7#1)(2004-12#1)(2005-10#1)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#3)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-7#5)(2008-8#1)(2008-9#2)(2009-12#3)(2009-2#1)(2009-4#1)(2009-5#2)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#4)(2010-5#2)(2010-8#1)(2011-10#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
strategies are also discussed##2##4##(2008-4#1)(2008-7#1)
strategies are also##5##3##(1991-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)
strategies are an##2##3##(2009-9#1)(2011-2#1)
strategies are available for##3##4##(2008-4#1)(2010-11#1)(2012-2#1)
strategies are available##5##3##(2007-7#1)(2007-8#1)(2008-4#1)(2010-11#1)(2012-2#1)
strategies are based on##3##4##(1993-11#1)(1996-11#1)(2010-11#1)
strategies are being developed##2##4##(2006-9#1)(2011-1#1)
strategies are being##3##3##(2006-9#1)(2010-5#1)(2011-1#1)
strategies are considered##4##3##(2006-10#1)(2008-2#1)(2008-3#1)(2010-1#1)
strategies are currently being##2##4##(2006-10#1)(2007-5#1)
strategies are currently##5##3##(1995-8#1)(1996-6#1)(2006-10#1)(2007-5#1)(2008-9#1)
strategies are described##3##3##(2006-2#1)(2006-6#1)(2007-8#1)
strategies are discussed in##2##4##(1995-8#1)(2008-4#1)
strategies are discussed##11##3##(1993-2#1)(1995-8#1)(1996-5#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
strategies are employed##3##3##(2007-11#1)(2008-4#1)(2010-12#1)
strategies are evolving##2##3##(2006-1#1)(2008-6#1)
strategies are most likely to##2##5##(1993-1#1)(2008-8#1)
strategies are needed to##6##4##(1994-3#1)(2006-10#2)(2009-12#1)(2013-1#2)
strategies are needed##8##3##(1994-3#1)(2006-10#2)(2007-11#1)(2008-6#1)(2009-12#1)(2013-1#2)
strategies are not##2##3##(2007-9#1)(2010-2#1)
strategies are outlined##2##3##(2006-6#1)(2008-11#1)
strategies are presented##4##3##(1997-6#1)(2008-2#1)(2008-6#1)(2012-2#1)
strategies are required##2##3##(2007-8#1)(2008-11#1)
strategies are urgently needed##2##4##(2006-1#1)(2012-12#1)
strategies are urgently##3##3##(2006-1#1)(2008-4#1)(2012-12#1)
strategies are usually##2##3##(2012-12#1)(2013-7#1)
strategies are##118##2##(1991-7#1)(1992-1#1)(1992-3#1)(1993-1#2)(1993-11#1)(1993-2#1)(1994-2#1)(1994-3#4)(1995-12#1)(1995-8#2)(1996-11#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-1#2)(2006-10#6)(2006-2#2)(2006-3#1)(2006-6#2)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#6)(2008-2#4)(2008-3#2)(2008-4#5)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#7)(2008-9#1)(2009-12#1)(2009-9#2)(2010-1#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#5)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#1)
strategies around##2##2##(2010-5#1)(2012-3#1)
strategies as well as##3##4##(2007-5#1)(2010-8#1)(2011-2#1)
strategies as##7##2##(1997-4#1)(2005-11#1)(2007-5#1)(2007-6#1)(2010-8#1)(2011-2#2)
strategies at##7##2##(2007-2#1)(2008-10#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
strategies available for##2##3##(2005-8#1)(2012-3#1)
strategies available##5##2##(1994-4#1)(2005-8#1)(2006-2#1)(2012-3#1)(2013-1#1)
strategies based on the##4##4##(2008-1#2)(2010-8#2)
strategies based on##12##3##(1991-8#1)(2006-10#1)(2007-6#1)(2008-1#2)(2008-10#2)(2008-2#1)(2010-8#2)(2010-9#1)(2011-2#1)
strategies based##14##2##(1991-8#1)(2005-8#1)(2006-10#1)(2007-6#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-8#1)(2010-8#2)(2010-9#1)(2011-2#1)
strategies because##2##2##(2008-10#1)(2008-4#1)
strategies become##2##2##(1994-3#1)(2012-3#1)
strategies being##3##2##(2008-3#1)(2012-1#1)(2012-12#1)
strategies by##7##2##(1996-1#1)(2005-12#1)(2007-10#1)(2010-7#1)(2012-2#1)(2013-1#2)
strategies can be formulated##2##4##(2006-9#1)(2012-4#1)
strategies can be##13##3##(1991-11#1)(1993-11#1)(1997-3#1)(1997-6#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-12#1)(2012-12#1)(2012-3#1)(2012-4#1)
strategies can##22##2##(1991-11#1)(1993-11#1)(1995-1#1)(1996-12#1)(1997-3#1)(1997-6#2)(2006-10#1)(2006-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2012-1#1)(2012-12#1)(2012-3#1)(2012-4#1)
strategies could##5##2##(2007-9#1)(2008-10#1)(2008-6#1)(2010-7#1)(2012-12#1)
strategies designed to##3##3##(2005-8#1)(2008-7#1)(2011-2#1)
strategies developed##2##2##(2004-9#1)(2008-5#1)
strategies differ in##2##3##(2006-7#1)(2008-9#1)
strategies directed against##2##3##(2005-7#1)(2011-2#1)
strategies emerge##2##2##(1997-4#1)(2006-5#1)
strategies employed by##2##3##(2010-12#1)(2012-2#1)
strategies employed in##4##3##(2008-1#1)(2008-11#1)(2010-9#1)(2012-2#1)
strategies employed to facilitate the detection##2##6##(2008-10#2)
strategies employed to##3##3##(2008-10#2)(2011-2#1)
strategies employed##13##2##(2006-10#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#2)
strategies for RNAi##2##3##(2008-2#1)(2008-4#1)
strategies for a##2##3##(2011-2#1)(2012-1#1)
strategies for achieving##2##3##(2008-8#1)(2013-7#1)
strategies for attaining##2##3##(2008-10#1)(2008-9#1)
strategies for both##2##3##(2008-4#1)(2008-9#1)
strategies for care##2##3##(2007-6#1)(2008-11#1)
strategies for chronic##3##3##(2009-11#1)(2012-11#1)(2012-12#1)
strategies for clinical##2##3##(1993-11#1)(2008-1#1)
strategies for communicating##2##3##(1997-3#1)(2010-4#1)
strategies for control of##3##4##(1991-12#1)(2007-6#1)(2008-1#1)
strategies for control##6##3##(1991-12#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-3#1)(2008-6#1)
strategies for controlling iron deficiency##2##5##(1994-6#2)
strategies for controlling##4##3##(1994-6#2)(2008-11#1)(2009-10#1)
strategies for depression in##2##4##(1996-12#1)(2008-1#1)
strategies for detection##2##3##(2010-11#1)(2010-7#1)
strategies for developing##2##3##(1992-2#1)(2006-7#1)
strategies for early diagnosis##2##4##(2007-8#1)(2009-4#1)
strategies for early##3##3##(2007-8#1)(2009-4#1)(2010-5#1)
strategies for effective##4##3##(2008-1#1)(2009-4#1)(2013-1#2)
strategies for enhancing##6##3##(1993-2#1)(2007-3#1)(2008-1#1)(2008-11#1)(2011-1#2)
strategies for evaluating##2##3##(2008-3#1)(2010-12#1)
strategies for future##3##3##(1991-1#1)(2008-10#2)
strategies for generating##2##3##(2008-2#2)
strategies for implementing these##2##4##(1994-1#1)(1996-2#1)
strategies for implementing##3##3##(1994-1#2)(1996-2#1)
strategies for improving the##2##4##(1993-2#1)(2008-6#1)
strategies for improving##8##3##(1993-2#1)(1996-12#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-8#1)(2013-1#1)
strategies for increasing##3##3##(2005-9#1)(2008-4#1)(2008-9#1)
strategies for inducing##2##3##(1994-6#1)(1996-9#1)
strategies for infectious diseases##2##4##(2005-7#2)
strategies for integrating##2##3##(2008-10#1)(2008-6#1)
strategies for making##2##3##(1995-7#1)(2010-11#1)
strategies for management of##3##4##(2008-1#1)(2008-10#1)(2008-9#1)
strategies for management##6##3##(1994-1#1)(2006-10#2)(2008-1#1)(2008-10#1)(2008-9#1)
strategies for managing##4##3##(2005-11#1)(2007-11#1)(2011-1#1)(2012-2#1)
strategies for minimising##2##3##(2008-8#1)(2012-2#1)
strategies for minimizing##4##3##(2010-9#2)(2011-2#2)
strategies for nurses##2##3##(2010-7#1)(2011-1#1)
strategies for pain##2##3##(1996-2#1)(2008-3#1)
strategies for patients with##3##4##(2008-2#1)(2008-8#1)(2010-10#1)
strategies for patients##4##3##(2007-12#1)(2008-2#1)(2008-8#1)(2010-10#1)
strategies for people##2##3##(1993-1#1)(2008-1#1)
strategies for preventing##5##3##(1993-5#1)(2005-10#1)(2008-3#1)(2011-1#1)(2013-1#1)
strategies for prevention and treatment of##2##6##(2008-7#1)(2009-8#1)
strategies for prevention##7##3##(2007-11#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-11#1)
strategies for protecting##2##3##(2008-1#1)(2008-9#1)
strategies for providing##2##3##(1997-3#1)(2010-8#1)
strategies for reducing the##3##4##(2006-10#1)(2009-8#1)(2013-1#1)
strategies for reducing##5##3##(1996-9#1)(2006-10#1)(2009-8#1)(2012-3#1)(2013-1#1)
strategies for stroke##2##3##(1997-8#1)(2007-10#1)
strategies for successful##2##3##(2007-1#1)(2007-12#1)
strategies for surgery##2##3##(2006-2#1)(2013-1#1)
strategies for targeting##2##3##(2006-10#1)(2008-5#1)
strategies for teaching##2##3##(2006-10#1)(2007-2#1)
strategies for the analysis of##4##5##(1996-5#1)(2007-11#1)(2008-10#2)
strategies for the control of##2##5##(2007-6#1)(2011-2#1)
strategies for the detection of##2##5##(2008-10#1)(2010-5#1)
strategies for the detection##3##4##(1997-8#1)(2008-10#1)(2010-5#1)
strategies for the development of##2##5##(2006-6#1)(2009-5#1)
strategies for the management of##3##5##(2008-1#1)(2008-4#1)(2009-9#1)
strategies for the prevention of##2##5##(2005-8#1)(2008-3#1)
strategies for the prevention##3##4##(2005-8#1)(2008-3#1)(2010-2#1)
strategies for the primary##3##4##(1996-12#1)(2008-11#1)(2010-3#1)
strategies for the treatment of##8##5##(2006-10#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
strategies for the treatment##9##4##(2006-10#1)(2007-11#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
strategies for the##54##3##(1993-4#1)(1994-12#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-7#1)(1997-8#1)(2005-8#1)(2006-10#3)(2006-6#1)(2006-9#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-6#3)(2008-1#3)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#2)(2011-9#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#1)
strategies for their##2##3##(2008-8#1)(2009-10#1)
strategies for these##5##3##(2006-10#2)(2008-6#1)(2009-5#1)(2012-3#1)
strategies for this##3##3##(2008-6#1)(2009-7#1)(2012-12#1)
strategies for tissue##2##3##(2010-10#2)
strategies for treating##6##3##(1994-5#1)(2005-9#1)(2006-10#2)(2008-3#1)(2011-2#1)
strategies for treatment of##2##4##(2008-4#1)(2012-12#1)
strategies for treatment##6##3##(1990-10#1)(2004-1#1)(2006-2#1)(2008-4#1)(2010-5#1)(2012-12#1)
strategies for use##2##3##(2010-5#1)(2013-1#1)
strategies for weaning##2##3##(2006-10#2)
strategies for women##2##3##(1996-9#1)(2006-5#1)
strategies for##445##2##(1990-10#1)(1991-1#2)(1991-12#1)(1991-5#1)(1991-9#1)(1992-2#3)(1992-3#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-4#1)(1993-5#1)(1993-9#1)(1994-1#4)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#6)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-7#1)(1996-1#2)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-9#3)(1997-1#2)(1997-3#4)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#3)(2004-1#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-7#4)(2005-8#4)(2005-9#3)(2006-10#20)(2006-11#2)(2006-12#1)(2006-2#4)(2006-3#1)(2006-5#3)(2006-6#2)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#9)(2007-12#3)(2007-2#3)(2007-3#2)(2007-5#2)(2007-6#5)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#16)(2008-10#22)(2008-11#10)(2008-12#3)(2008-2#6)(2008-3#8)(2008-4#15)(2008-5#8)(2008-6#6)(2008-7#10)(2008-8#9)(2008-9#10)(2009-10#6)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#5)(2009-7#2)(2009-8#5)(2009-9#2)(2010-10#5)(2010-11#6)(2010-12#4)(2010-2#2)(2010-3#4)(2010-4#2)(2010-5#7)(2010-7#8)(2010-8#1)(2010-9#3)(2011-1#7)(2011-10#1)(2011-2#12)(2011-9#1)(2012-1#3)(2012-11#2)(2012-12#11)(2012-2#6)(2012-3#15)(2013-1#22)(2013-7#4)(2013-8#4)
strategies from the##2##3##(2005-8#1)(2006-10#1)
strategies from##4##2##(1995-5#1)(2005-8#1)(2006-10#1)(2008-8#1)
strategies generally##2##2##(2006-10#1)(2007-6#1)
strategies has been##2##3##(2007-6#1)(2012-3#1)
strategies has##5##2##(2006-10#1)(2007-6#1)(2008-3#1)(2008-7#1)(2012-3#1)
strategies have been described##2##4##(2006-8#1)(2008-10#1)
strategies have been developed##2##4##(1990-6#1)(2006-5#1)
strategies have been employed to##2##5##(2010-12#1)(2010-2#1)
strategies have been evaluated##2##4##(2006-10#1)(2011-2#1)
strategies have been investigated##2##4##(2008-7#1)(2009-11#1)
strategies have been proposed##4##4##(1993-11#1)(2006-10#1)(2010-11#1)(2012-12#1)
strategies have been used to##2##5##(2009-12#1)(2010-3#1)
strategies have been used##3##4##(2009-12#1)(2010-3#1)(2011-1#1)
strategies have been##30##3##(1990-6#1)(1993-11#1)(2004-2#1)(2006-10#3)(2006-5#1)(2006-8#1)(2007-3#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
strategies have focused on##2##4##(2007-8#1)(2011-2#1)
strategies have focused##3##3##(2007-8#1)(2010-3#1)(2011-2#1)
strategies have included##2##3##(2007-11#2)
strategies have not been##2##4##(1993-12#1)(2005-7#1)
strategies have##49##2##(1990-6#1)(1993-11#1)(1993-12#1)(1995-3#1)(2004-2#1)(2005-7#3)(2005-8#1)(2006-10#3)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#3)(2007-3#1)(2007-8#3)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-7#1)
strategies implemented##2##2##(2011-1#1)(2011-2#1)
strategies in AD##2##3##(1993-11#1)(2004-12#1)
strategies in a##4##3##(1994-3#1)(2008-3#1)(2010-12#2)
strategies in cancer##2##3##(2007-3#1)(2008-8#1)
strategies in clinical##3##3##(2009-8#1)(2010-10#1)(2011-1#1)
strategies in conjunction with##2##4##(2006-10#1)(2011-2#1)
strategies in line with##2##4##(2004-3#1)(2005-8#1)
strategies in order to##5##4##(2005-5#1)(2008-11#2)(2009-8#1)(2012-3#1)
strategies in patients with##3##4##(2008-3#1)(2009-10#1)(2009-11#1)
strategies in patients##5##3##(2006-10#1)(2008-3#1)(2009-10#1)(2009-11#1)(2011-1#1)
strategies in reducing##2##3##(2010-10#2)
strategies in the context of##2##5##(2006-10#1)(2007-6#1)
strategies in the treatment of##5##5##(2005-8#1)(2006-10#2)(2008-1#1)(2013-7#1)
strategies in the##31##3##(1993-2#1)(1993-3#1)(1994-1#1)(1995-7#2)(1997-3#2)(2005-8#1)(2006-10#5)(2006-5#1)(2006-9#1)(2007-6#2)(2007-8#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#2)(2010-11#1)(2010-12#1)(2010-8#1)(2011-12#1)(2012-3#1)(2013-7#1)
strategies in this##2##3##(1996-3#1)(2008-3#1)
strategies in which current investments##2##5##(2008-8#2)
strategies in which##4##3##(2007-1#1)(2008-8#2)(2010-12#1)
strategies in##128##2##(1990-12#1)(1992-10#1)(1992-12#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-1#1)(1994-3#1)(1995-7#2)(1996-11#1)(1996-3#1)(1996-9#1)(1997-3#3)(1997-4#1)(1997-6#1)(2004-10#1)(2004-12#2)(2004-3#1)(2005-5#1)(2005-8#2)(2006-10#8)(2006-5#1)(2006-7#1)(2006-9#1)(2007-1#4)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-6#3)(2007-8#1)(2008-1#3)(2008-10#6)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#4)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#5)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#2)(2009-8#2)(2010-10#3)(2010-11#3)(2010-12#4)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#2)(2012-2#1)(2012-3#4)(2013-1#2)(2013-7#1)
strategies include the##2##3##(2008-4#1)(2009-8#1)
strategies include##11##2##(1993-9#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-8#1)(2011-12#1)(2012-2#1)
strategies included##4##2##(1994-12#1)(2007-10#1)(2008-5#1)(2010-8#1)
strategies including##7##2##(2005-7#1)(2006-10#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-8#1)(2011-1#1)
strategies into##5##2##(1994-2#1)(2005-11#1)(2008-11#1)(2008-12#1)(2009-9#1)
strategies involving##2##2##(2007-12#1)(2011-2#1)
strategies is critical##2##3##(2008-10#1)(2010-5#1)
strategies is provided##2##3##(2010-10#1)(2013-8#1)
strategies is##20##2##(1990-6#1)(1991-6#1)(1995-2#1)(2006-1#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-5#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2012-12#1)(2013-8#1)
strategies may be##6##3##(1993-2#1)(1995-12#1)(1995-4#1)(2007-9#1)(2008-6#1)(2012-2#1)
strategies may have##3##3##(2008-1#1)(2012-1#1)(2012-2#1)
strategies may##18##2##(1993-2#1)(1995-12#1)(1995-4#1)(2005-8#1)(2006-10#2)(2007-11#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-6#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#2)
strategies more##3##2##(1997-3#1)(2008-11#1)(2009-9#1)
strategies must be##3##3##(2008-10#1)(2009-5#1)(2013-1#1)
strategies must##4##2##(2008-10#1)(2009-5#1)(2010-3#1)(2013-1#1)
strategies need to be##3##4##(1994-2#1)(2006-10#1)(2008-3#1)
strategies need to##5##3##(1994-2#1)(1995-5#1)(2006-10#1)(2008-3#2)
strategies of a##2##3##(1993-12#1)(2012-3#1)
strategies of measurement instruments and their validity as adopted in##4##10##(2013-1#4)
strategies of the##6##3##(1990-8#1)(1991-11#1)(1996-9#1)(2009-8#1)(2010-8#1)(2012-12#1)
strategies of these##2##3##(2012-2#1)(2012-3#1)
strategies of women##2##3##(2008-5#1)(2010-1#1)
strategies of##73##2##(1990-8#1)(1991-11#3)(1993-12#1)(1993-3#1)(1993-7#1)(1994-8#1)(1995-5#1)(1996-9#1)(1997-3#1)(1997-4#1)(2004-12#1)(2004-4#1)(2005-10#1)(2005-6#1)(2006-10#3)(2006-6#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-8#3)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#3)
strategies on a wide scale##2##5##(2010-6#1)(2013-8#1)
strategies on a##3##3##(2004-10#1)(2010-6#1)(2013-8#1)
strategies on the##4##3##(1993-1#2)(2013-1#2)
strategies on##17##2##(1993-1#2)(2004-10#1)(2006-10#2)(2008-2#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-6#1)(2010-8#1)(2013-1#4)(2013-8#2)
strategies or##2##2##(2010-11#1)(2012-1#1)
strategies proposed##2##2##(2006-10#1)(2007-10#1)
strategies related to##3##3##(1995-12#1)(2008-12#1)(2012-2#1)
strategies seem##2##2##(1993-2#1)(2010-7#1)
strategies should be##7##3##(1991-6#1)(2006-10#2)(2008-1#1)(2008-11#1)(2010-10#1)(2012-12#1)
strategies should consider##2##3##(1995-3#1)(2011-2#1)
strategies should include##3##3##(1994-4#1)(2007-1#1)(2007-10#1)
strategies should incorporate##2##3##(2008-1#1)(2013-1#1)
strategies should##16##2##(1991-6#1)(1994-4#1)(1995-3#1)(2006-10#2)(2007-1#1)(2007-10#1)(2008-1#2)(2008-11#2)(2009-4#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
strategies showed##2##2##(1997-2#1)(2010-10#1)
strategies significantly##2##2##(2007-8#1)(2011-1#1)
strategies such as the##2##4##(1996-3#1)(2008-10#1)
strategies such as##10##3##(1996-3#1)(2006-2#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#2)(2013-1#1)
strategies support##2##2##(2008-12#1)(2011-2#1)
strategies targeted##2##2##(2007-5#1)(2011-2#1)
strategies targeting##6##2##(1994-2#1)(2010-4#1)(2012-12#1)(2012-2#2)(2013-1#1)
strategies than##3##2##(2008-11#1)(2008-8#2)
strategies that are##5##3##(2006-10#1)(2008-1#1)(2008-9#1)(2009-12#1)(2010-3#1)
strategies that can be employed##2##5##(2007-11#1)(2008-4#1)
strategies that can be used##3##5##(2005-7#1)(2008-4#1)(2011-2#1)
strategies that can be##6##4##(2005-7#1)(2007-11#1)(2008-4#2)(2009-3#1)(2011-2#1)
strategies that can help##2##4##(1997-2#1)(2012-3#1)
strategies that can##11##3##(1997-2#1)(2005-7#1)(2007-11#1)(2008-4#2)(2008-9#1)(2009-3#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
strategies that could be##2##4##(2008-1#1)(2012-2#1)
strategies that could##3##3##(1996-2#1)(2008-1#1)(2012-2#1)
strategies that have been developed##3##5##(2008-1#1)(2010-12#1)(2010-7#1)
strategies that have been evaluated##2##5##(1992-2#1)(2009-1#1)
strategies that have been##7##4##(1992-2#1)(2007-1#1)(2008-1#1)(2009-1#1)(2010-12#1)(2010-7#2)
strategies that have##9##3##(1992-2#1)(2006-11#1)(2007-1#1)(2008-1#1)(2009-1#1)(2010-12#1)(2010-7#2)(2013-1#1)
strategies that may##6##3##(1993-2#1)(1994-2#1)(2006-10#1)(2006-8#1)(2008-10#1)(2013-8#1)
strategies that might##2##3##(2005-7#1)(2006-10#1)
strategies that reduce##3##3##(1991-11#1)(1997-4#1)(2008-4#1)
strategies that rely on##2##4##(1996-2#1)(2009-9#1)
strategies that rely##3##3##(1996-2#1)(2007-12#1)(2009-9#1)
strategies that use##2##3##(1994-5#1)(2008-11#1)
strategies that##98##2##(1991-11#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-3#3)(1994-5#1)(1996-2#2)(1997-2#1)(1997-4#1)(1997-6#1)(2005-7#2)(2006-10#4)(2006-11#1)(2006-2#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#5)(2008-12#2)(2008-2#3)(2008-4#4)(2008-7#1)(2008-8#3)(2008-9#4)(2009-1#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#4)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#6)(2013-1#3)(2013-8#2)
strategies the##3##2##(1997-2#1)(2006-10#1)(2012-12#1)
strategies these pathogens##2##3##(2012-2#2)
strategies they use##2##3##(2011-2#2)
strategies they##5##2##(2008-5#1)(2010-6#1)(2011-2#2)(2012-3#1)
strategies to address the##2##4##(2012-3#1)(2013-1#1)
strategies to address##3##3##(2009-8#1)(2012-3#1)(2013-1#1)
strategies to be##3##3##(1997-6#1)(2007-2#1)(2010-3#1)
strategies to block##3##3##(1994-8#1)(1996-10#1)(2008-11#1)
strategies to circumvent##2##3##(2007-11#1)(2008-1#1)
strategies to combat##4##3##(2007-2#1)(2008-1#1)(2008-7#1)(2010-6#1)
strategies to compete##2##3##(1993-12#1)(2008-10#1)
strategies to control##7##3##(1997-2#1)(2006-10#1)(2008-11#1)(2008-8#1)(2009-12#1)(2009-4#1)(2012-1#1)
strategies to correct##2##3##(2006-10#1)(2011-1#1)
strategies to create##2##3##(2008-1#1)(2009-4#1)
strategies to deal with##4##4##(1997-5#1)(2008-11#1)(2008-6#1)(2008-8#1)
strategies to decrease##3##3##(2006-7#1)(2007-12#1)(2008-6#1)
strategies to determine##2##3##(2007-10#1)(2008-4#1)
strategies to develop##4##3##(1994-3#1)(1997-2#1)(2012-11#1)(2013-1#1)
strategies to enable##2##3##(2009-12#1)(2011-12#1)
strategies to enhance##3##3##(1997-8#1)(2008-1#1)(2008-11#1)
strategies to ensure##2##3##(1995-2#1)(2008-11#1)
strategies to facilitate##2##3##(2006-12#1)(2009-10#1)
strategies to find##2##3##(1995-11#1)(2008-7#1)
strategies to help##5##3##(1991-1#1)(2004-10#1)(2007-7#1)(2008-10#1)(2010-1#1)
strategies to identify##5##3##(2008-10#1)(2008-7#2)(2009-10#1)(2011-1#1)
strategies to improve outcomes##2##4##(1997-1#1)(2007-12#1)
strategies to improve the##4##4##(1991-11#1)(2005-6#1)(2007-10#1)(2008-10#1)
strategies to improve##16##3##(1991-11#1)(1997-1#1)(2005-6#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
strategies to increase the##2##4##(1993-10#1)(2008-4#1)
strategies to increase vaccination coverage in##2##6##(2011-2#1)(2012-12#1)
strategies to increase##7##3##(1993-10#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-12#3)
strategies to induce##2##3##(2007-11#1)(2012-1#1)
strategies to inhibit##2##3##(2005-8#1)(2012-2#1)
strategies to limit##2##3##(2007-9#2)
strategies to manage##2##3##(2007-3#1)(2009-4#1)
strategies to meet the##3##4##(1994-2#1)(2007-2#1)(2010-3#1)
strategies to minimize the##2##4##(1996-9#1)(2011-2#1)
strategies to minimize##4##3##(1996-9#1)(2006-10#1)(2008-7#1)(2011-2#1)
strategies to monitor##2##3##(2006-10#1)(2011-1#1)
strategies to optimize the##2##4##(2006-12#1)(2008-10#1)
strategies to optimize##5##3##(2006-12#1)(2006-5#1)(2008-10#1)(2008-6#1)(2009-8#1)
strategies to overcome these##2##4##(2009-5#1)(2013-1#1)
strategies to overcome##6##3##(2007-9#1)(2008-11#1)(2008-5#1)(2009-5#1)(2010-10#1)(2013-1#1)
strategies to prevent and manage##2##5##(2012-3#1)(2013-1#1)
strategies to prevent and##5##4##(2006-10#1)(2008-5#1)(2009-3#1)(2012-3#1)(2013-1#1)
strategies to prevent or##3##4##(2008-5#1)(2010-10#1)(2011-1#1)
strategies to prevent##19##3##(1990-12#1)(2005-11#1)(2006-10#4)(2006-2#1)(2007-11#1)(2008-10#1)(2008-5#2)(2009-3#1)(2010-10#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
strategies to promote##5##3##(2006-3#1)(2007-12#1)(2010-2#1)(2012-3#1)(2013-1#1)
strategies to protect##2##3##(1994-3#1)(1996-12#1)
strategies to reduce patient##2##4##(1996-2#1)(2010-12#1)
strategies to reduce salt##3##4##(2012-2#3)
strategies to reduce the##3##4##(2007-12#1)(2008-8#1)(2013-1#1)
strategies to reduce##18##3##(1994-12#1)(1996-2#1)(2005-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-12#2)(2010-9#1)(2011-12#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
strategies to retain##2##3##(1994-3#1)(2011-1#1)
strategies to show that##2##4##(1991-11#1)(2013-8#1)
strategies to support##2##3##(2007-3#1)(2008-4#1)
strategies to treat##2##3##(1996-1#1)(2010-5#1)
strategies to use##3##3##(2008-4#1)(2008-9#1)(2013-7#1)
strategies to##234##2##(1990-12#1)(1991-1#1)(1991-11#2)(1993-10#1)(1993-12#2)(1994-12#1)(1994-2#1)(1994-3#4)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-5#1)(1997-6#1)(1997-8#1)(2004-10#1)(2005-10#1)(2005-11#1)(2005-6#1)(2005-8#1)(2005-9#1)(2006-10#14)(2006-11#1)(2006-12#2)(2006-2#2)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#4)(2007-12#6)(2007-2#7)(2007-3#4)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#7)(2008-10#9)(2008-11#14)(2008-12#2)(2008-4#7)(2008-5#3)(2008-6#4)(2008-7#6)(2008-8#4)(2008-9#2)(2009-10#2)(2009-12#2)(2009-3#2)(2009-4#3)(2009-5#1)(2009-8#3)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#2)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#7)(2011-12#2)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#7)(2012-2#7)(2012-3#6)(2013-1#13)(2013-7#2)(2013-8#2)
strategies under##2##2##(2006-10#1)(2007-9#1)
strategies upon##2##2##(1992-9#1)(2008-11#1)
strategies used by the##3##4##(2008-7#1)(2009-8#1)(2010-11#1)
strategies used by##14##3##(1990-12#1)(1994-12#1)(1996-12#1)(2004-12#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-7#1)(2013-1#1)(2013-8#2)
strategies used in##6##3##(2007-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#2)
strategies used to##13##3##(1990-5#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2009-5#1)(2011-1#1)(2013-1#1)(2013-8#2)
strategies used##39##2##(1990-12#1)(1990-5#1)(1994-12#1)(1996-12#1)(2004-12#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-10#2)(2010-11#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-3#3)(2013-1#2)(2013-8#4)
strategies using the##2##3##(2006-5#1)(2012-3#1)
strategies using##9##2##(1994-5#1)(2006-5#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2012-3#2)
strategies utilized##2##2##(1993-3#1)(2013-8#1)
strategies was##2##2##(2005-10#1)(2009-9#1)
strategies we##2##2##(1993-2#1)(2010-10#1)
strategies were also##2##3##(2009-9#1)(2011-1#1)
strategies were developed##2##3##(2005-7#1)(2008-1#1)
strategies were discussed##2##3##(1994-12#1)(2005-8#1)
strategies were employed##2##3##(1996-9#1)(2008-9#1)
strategies were implemented##2##3##(1997-2#1)(2007-10#1)
strategies were used to##3##4##(1995-2#1)(2005-12#1)(2008-10#1)
strategies were used##4##3##(1995-2#1)(2005-12#1)(2008-10#1)(2010-9#1)
strategies were##27##2##(1994-12#1)(1995-1#1)(1995-2#1)(1996-9#1)(1997-2#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-12#2)(2009-9#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-3#1)
strategies when##2##2##(2010-12#1)(2011-2#1)
strategies which are##2##3##(2010-3#1)(2013-8#1)
strategies which have been implemented to##2##6##(2008-11#1)(2008-5#1)
strategies which have##3##3##(2008-11#1)(2008-5#1)(2011-2#1)
strategies which##11##2##(1991-6#1)(2004-4#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2010-3#1)(2011-2#1)(2013-8#1)
strategies will be##6##3##(1992-3#1)(1994-3#1)(2007-6#1)(2010-7#1)(2011-3#1)(2012-12#1)
strategies will##9##2##(1992-3#1)(1994-3#1)(2007-11#2)(2007-6#1)(2008-1#1)(2010-7#1)(2011-3#1)(2012-12#1)
strategies with##11##2##(1991-3#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)(2012-12#1)(2012-2#1)
strategies within the##2##3##(2008-10#1)(2012-3#1)
strategies within##5##2##(1996-3#1)(2006-10#1)(2008-10#1)(2011-2#1)(2012-3#1)
strategies##2353##1##(1990-10#2)(1990-11#1)(1990-12#7)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#2)(1991-1#4)(1991-11#10)(1991-12#4)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#6)(1991-7#3)(1991-8#1)(1991-9#1)(1992-1#3)(1992-10#2)(1992-12#2)(1992-2#6)(1992-3#8)(1992-8#1)(1992-9#3)(1993-1#7)(1993-10#2)(1993-11#7)(1993-12#12)(1993-2#13)(1993-3#5)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#4)(1994-1#9)(1994-11#2)(1994-12#10)(1994-2#13)(1994-3#20)(1994-4#3)(1994-5#5)(1994-6#8)(1994-8#2)(1994-9#3)(1995-1#5)(1995-10#1)(1995-11#2)(1995-12#8)(1995-2#11)(1995-3#7)(1995-4#1)(1995-5#5)(1995-6#2)(1995-7#3)(1995-8#2)(1995-9#1)(1996-1#7)(1996-10#1)(1996-11#3)(1996-12#8)(1996-2#8)(1996-3#6)(1996-4#1)(1996-5#3)(1996-6#3)(1996-8#1)(1996-9#7)(1997-1#4)(1997-2#11)(1997-3#14)(1997-4#11)(1997-5#1)(1997-6#8)(1997-7#2)(1997-8#6)(2004-1#2)(2004-10#3)(2004-11#1)(2004-12#5)(2004-2#1)(2004-3#1)(2004-4#2)(2004-9#1)(2005-10#6)(2005-11#11)(2005-12#5)(2005-5#2)(2005-6#2)(2005-7#17)(2005-8#25)(2005-9#10)(2006-1#6)(2006-10#120)(2006-11#9)(2006-12#8)(2006-2#21)(2006-3#3)(2006-4#1)(2006-5#15)(2006-6#10)(2006-7#13)(2006-8#8)(2006-9#11)(2007-1#14)(2007-10#18)(2007-11#37)(2007-12#28)(2007-2#21)(2007-3#16)(2007-4#4)(2007-5#12)(2007-6#20)(2007-7#16)(2007-8#28)(2007-9#15)(2008-1#60)(2008-10#115)(2008-11#86)(2008-12#32)(2008-2#31)(2008-3#32)(2008-4#44)(2008-5#36)(2008-6#22)(2008-7#47)(2008-8#64)(2008-9#41)(2009-1#2)(2009-10#12)(2009-11#8)(2009-12#18)(2009-2#6)(2009-3#7)(2009-4#15)(2009-5#17)(2009-6#3)(2009-7#3)(2009-8#18)(2009-9#16)(2010-1#7)(2010-10#24)(2010-11#25)(2010-12#31)(2010-2#14)(2010-3#14)(2010-4#8)(2010-5#18)(2010-6#10)(2010-7#29)(2010-8#18)(2010-9#13)(2011-1#50)(2011-10#2)(2011-12#9)(2011-2#84)(2011-3#5)(2011-9#1)(2012-1#21)(2012-11#9)(2012-12#63)(2012-2#51)(2012-3#67)(2012-4#1)(2013-1#90)(2013-7#13)(2013-8#37)
strategies)##5##1##(1993-2#1)(2008-10#1)(2008-8#1)(2009-7#1)(2010-6#1)
strategies]##4##1##(2006-2#1)(2008-6#1)(2010-9#1)(2012-12#1)
strategy (strating treatment with##2##4##(2005-1#2)
strategy adopted##2##2##(2007-9#1)(2009-12#1)
strategy against##2##2##(2013-1#2)
strategy aimed at##4##3##(1990-2#1)(2008-1#1)(2008-11#1)(2008-4#1)
strategy aimed##5##2##(1990-2#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-4#1)
strategy allowed a##2##3##(2008-10#1)(2008-8#1)
strategy allowed##6##2##(1994-2#1)(2007-3#1)(2008-10#2)(2008-8#1)(2013-1#1)
strategy allows##4##2##(2007-8#1)(2008-5#1)(2009-9#1)(2012-1#1)
strategy and a##3##3##(1991-6#1)(1996-1#1)(2012-1#1)
strategy and implementation##4##3##(1996-1#2)(1996-2#1)(2013-8#1)
strategy and local##2##3##(2006-8#1)(2007-8#1)
strategy and precisely located on the physical map of chromosome 5##2##11##(1997-6#1)(1997-8#1)
strategy and the##6##3##(1991-11#1)(1992-12#1)(1992-9#1)(2008-3#2)(2008-8#1)
strategy and##50##2##(1990-8#1)(1991-11#2)(1991-12#1)(1991-6#1)(1992-12#1)(1992-9#1)(1993-1#1)(1994-3#1)(1995-12#1)(1996-1#3)(1996-2#1)(1997-6#1)(1997-8#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-6#2)(2010-11#1)(2010-3#1)(2011-1#1)(2011-12#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-8#3)
strategy are discussed##3##3##(2007-8#1)(2008-2#2)
strategy are##12##2##(1991-5#1)(1993-1#1)(1996-2#1)(2006-10#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-8#1)(2008-9#1)
strategy as a##3##3##(2007-11#1)(2007-8#1)(2009-9#1)
strategy as##6##2##(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-4#1)(2009-9#1)
strategy at##5##2##(2012-3#1)(2013-1#4)
strategy based on the##9##4##(1991-2#1)(2006-11#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2012-3#1)
strategy based on three##2##4##(2006-12#1)(2008-2#1)
strategy based on##23##3##(1991-2#1)(1996-11#1)(2006-11#1)(2006-12#1)(2007-11#2)(2007-6#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2010-12#1)(2011-1#1)(2012-3#1)(2013-7#1)
strategy because##2##2##(2008-7#2)
strategy by##5##2##(1995-3#1)(2004-4#1)(2007-12#1)(2008-10#1)(2013-1#1)
strategy can be used to##2##5##(2004-11#1)(2009-4#1)
strategy can be##5##3##(2004-11#1)(2008-3#1)(2008-7#1)(2009-4#1)(2011-2#1)
strategy can##12##2##(1994-1#1)(2004-11#1)(2007-5#1)(2008-2#1)(2008-3#2)(2008-7#2)(2009-12#1)(2009-4#1)(2010-9#1)(2011-2#1)
strategy combines##3##2##(2005-8#1)(2008-11#1)(2010-7#1)
strategy combining##2##2##(2008-10#1)(2008-5#1)
strategy consisted##2##2##(1993-12#1)(2010-9#1)
strategy consists in##2##3##(2008-3#1)(2013-1#1)
strategy consists##3##2##(1994-2#1)(2008-3#1)(2013-1#1)
strategy could be used##2##4##(2006-11#1)(2011-3#1)
strategy could be##7##3##(2006-11#1)(2008-2#1)(2008-5#1)(2010-10#1)(2011-3#1)(2012-12#2)
strategy could##8##2##(2006-11#1)(2008-2#1)(2008-5#1)(2010-10#1)(2011-3#1)(2012-1#1)(2012-12#2)
strategy depends on the##2##4##(1994-2#1)(2008-7#1)
strategy depends on##3##3##(1994-2#1)(2008-7#1)(2012-2#1)
strategy described##3##2##(1990-6#1)(1991-3#1)(1993-12#1)
strategy designed to##3##3##(1996-2#1)(2008-7#1)(2010-3#1)
strategy designed##4##2##(1996-2#1)(2008-12#1)(2008-7#1)(2010-3#1)
strategy developed##2##2##(2006-5#1)(2009-7#1)
strategy during##4##2##(1997-8#1)(2006-3#1)(2008-11#1)(2008-12#1)
strategy employed##4##2##(1992-5#1)(1993-12#1)(1993-5#1)(2006-10#1)
strategy entailed##2##2##(1996-3#1)(2008-10#1)
strategy facilitates##2##2##(1992-1#1)(1992-11#1)
strategy for a##3##3##(2007-10#1)(2008-9#1)(2012-3#1)
strategy for accurate##2##3##(2006-9#1)(2013-7#1)
strategy for achieving##3##3##(1994-12#1)(2007-10#1)(2009-3#1)
strategy for assessing##2##3##(2008-3#1)(2010-2#1)
strategy for blood##2##3##(2007-12#1)(2013-8#1)
strategy for cancer##2##3##(2008-11#1)(2012-11#1)
strategy for creating##2##3##(2008-7#1)(2013-8#1)
strategy for detection of##2##4##(2008-1#1)(2008-10#1)
strategy for determining##2##3##(2008-10#2)
strategy for developing##2##3##(2008-10#1)(2008-9#1)
strategy for effective##4##3##(1992-1#1)(1993-12#1)(1996-4#1)(2005-8#1)
strategy for efficient##2##3##(1994-3#1)(2005-10#1)
strategy for enhanced##2##3##(1996-12#1)(2008-7#1)
strategy for health##2##3##(1997-3#1)(2012-12#1)
strategy for implementing##3##3##(2007-8#1)(2008-11#1)(2008-9#1)
strategy for improving the##2##4##(2008-10#1)(2013-1#1)
strategy for improving##4##3##(2008-10#1)(2008-4#1)(2010-7#1)(2013-1#1)
strategy for increasing##2##3##(1997-2#1)(2013-8#1)
strategy for managing##3##3##(2004-11#1)(2008-6#1)(2010-12#1)
strategy for mapping##3##3##(1996-2#1)(1996-5#1)(2008-4#1)
strategy for nursing##5##3##(1990-10#4)(2008-12#1)
strategy for obtaining##2##3##(2006-12#1)(2012-3#1)
strategy for patients who##3##4##(2008-3#2)(2010-5#1)
strategy for patients with##2##4##(1993-3#1)(2013-8#1)
strategy for patients##5##3##(1993-3#1)(2008-3#2)(2010-5#1)(2013-8#1)
strategy for preventing##4##3##(1997-4#1)(2008-1#1)(2008-11#1)(2013-1#1)
strategy for prevention and treatment of##2##6##(2005-7#1)(2006-10#1)
strategy for prevention and##3##4##(2005-7#1)(2006-10#1)(2011-2#1)
strategy for prevention of##2##4##(2010-9#1)(2011-2#1)
strategy for prevention##5##3##(2005-7#1)(2006-10#1)(2010-9#1)(2011-2#2)
strategy for producing##2##3##(2007-8#1)(2009-2#1)
strategy for rapid##2##3##(2010-10#1)(2011-2#1)
strategy for reducing the##2##4##(2008-10#1)(2008-11#1)
strategy for reducing##6##3##(2008-10#2)(2008-11#1)(2008-6#1)(2009-3#1)(2012-2#1)
strategy for severe##3##3##(2012-11#1)(2012-2#1)(2013-8#1)
strategy for such##2##3##(2008-3#1)(2009-12#1)
strategy for the determination of##2##5##(2008-10#2)
strategy for the management of##2##5##(2008-10#1)(2011-1#1)
strategy for the prevention of##2##5##(1993-9#1)(2005-8#1)
strategy for the prevention##4##4##(1993-9#1)(2005-8#1)(2011-2#1)(2013-1#1)
strategy for the synthesis of##3##5##(1991-11#1)(1996-4#1)(2010-6#1)
strategy for the treatment of the##2##6##(2005-7#1)(2013-7#1)
strategy for the treatment of##10##5##(1992-8#1)(2005-7#1)(2006-6#1)(2006-7#1)(2008-3#1)(2008-7#1)(2009-3#1)(2011-2#1)(2013-1#1)(2013-7#1)
strategy for the##63##3##(1990-12#1)(1990-6#1)(1991-11#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-6#1)(1993-9#1)(1995-3#1)(1995-4#1)(1996-4#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-6#1)(2006-7#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-12#1)(2009-3#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-6#1)(2011-1#4)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#2)
strategy for these##2##3##(2006-6#1)(2008-7#1)
strategy for treating##2##3##(2008-8#1)(2012-11#1)
strategy for##334##2##(1990-10#5)(1990-12#1)(1990-6#2)(1991-11#2)(1992-1#1)(1992-2#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#3)(1993-3#2)(1993-6#1)(1993-9#2)(1994-1#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#3)(1995-4#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#2)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#1)(1997-8#1)(2004-11#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#2)(2005-8#4)(2006-10#7)(2006-11#1)(2006-12#5)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-3#2)(2007-4#1)(2007-8#4)(2008-1#7)(2008-10#33)(2008-11#11)(2008-12#3)(2008-2#10)(2008-3#8)(2008-4#8)(2008-5#7)(2008-6#5)(2008-7#11)(2008-8#5)(2008-9#9)(2009-12#5)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#1)(2010-1#1)(2010-10#5)(2010-12#3)(2010-2#4)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#10)(2011-3#1)(2012-1#5)(2012-11#6)(2012-12#5)(2012-2#7)(2012-3#5)(2013-1#13)(2013-7#9)(2013-8#6)
strategy formulation##2##2##(1993-2#1)(1993-3#1)
strategy from##6##2##(2008-10#1)(2008-11#2)(2009-6#1)(2010-2#1)(2013-1#1)
strategy has been adopted##2##4##(1994-9#1)(2006-12#1)
strategy has been developed and##2##5##(1996-1#1)(2008-11#1)
strategy has been developed##3##4##(1996-1#1)(2008-10#1)(2008-11#1)
strategy has been to##2##4##(2008-10#1)(2008-11#1)
strategy has been##11##3##(1994-9#1)(1996-1#1)(1997-2#1)(2006-12#1)(2008-10#2)(2008-11#2)(2008-7#1)(2011-2#1)(2013-7#1)
strategy has not##3##3##(2006-10#1)(2006-12#1)(2008-7#1)
strategy has##22##2##(1991-12#1)(1994-9#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-12#2)(2007-8#1)(2008-10#3)(2008-11#2)(2008-7#2)(2009-10#1)(2010-10#1)(2011-2#1)(2013-7#1)
strategy identified##3##2##(1995-2#1)(2006-8#1)(2012-2#1)
strategy if##2##2##(2008-10#1)(2008-8#1)
strategy improves##2##2##(2008-3#1)(2010-7#1)
strategy in a##3##3##(1991-2#1)(2008-11#1)(2008-7#1)
strategy in acute##2##3##(2006-6#1)(2008-7#1)
strategy in conjunction with##2##4##(1996-4#1)(2008-11#1)
strategy in patients with##6##4##(2006-6#1)(2007-8#3)(2008-9#1)(2010-11#1)
strategy in the treatment of##2##5##(2011-11#1)(2012-12#1)
strategy in the##20##3##(1990-3#1)(1990-4#1)(1992-1#1)(1993-3#1)(1994-9#1)(2007-2#1)(2007-4#1)(2008-10#2)(2008-4#1)(2009-2#1)(2009-8#1)(2010-9#1)(2011-11#1)(2011-2#2)(2012-11#2)(2012-12#1)(2013-8#1)
strategy in this##2##3##(2011-3#1)(2012-3#1)
strategy in which##3##3##(1995-10#1)(2004-11#1)(2008-2#1)
strategy in##79##2##(1990-12#1)(1990-3#1)(1990-4#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-1#2)(1993-3#1)(1994-9#2)(1995-10#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-8#1)(2004-11#1)(2005-10#1)(2006-10#1)(2006-4#1)(2006-6#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#3)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-2#1)(2009-8#1)(2010-11#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-11#1)(2011-2#5)(2011-3#2)(2012-1#1)(2012-11#2)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#2)
strategy included##3##2##(2007-3#1)(2010-8#1)(2011-2#1)
strategy involves##2##2##(2007-11#1)(2008-4#1)
strategy involving##5##2##(1992-12#1)(2006-12#1)(2007-8#1)(2008-12#1)(2011-1#1)
strategy is a##3##3##(1991-2#1)(1997-1#1)(2008-3#1)
strategy is also##3##3##(1992-9#1)(2008-11#1)(2008-8#1)
strategy is based on the##4##5##(1990-4#1)(1995-7#1)(2008-5#1)(2008-6#1)
strategy is based on##5##4##(1990-4#1)(1991-6#1)(1995-7#1)(2008-5#1)(2008-6#1)
strategy is described##2##3##(1996-5#1)(2007-2#1)
strategy is developed##2##3##(1993-4#1)(2012-2#1)
strategy is illustrated##2##3##(1994-2#1)(2007-11#1)
strategy is implemented##2##3##(2007-11#1)(2008-6#1)
strategy is not##2##3##(1996-9#1)(2005-10#1)
strategy is proposed for##2##4##(2007-12#1)(2012-12#1)
strategy is proposed##3##3##(1997-7#1)(2007-12#1)(2012-12#1)
strategy is the##6##3##(1995-10#1)(1997-1#1)(2007-8#1)(2008-6#1)(2008-9#1)(2011-2#1)
strategy is to##5##3##(1996-2#1)(2007-8#1)(2008-10#1)(2008-8#1)(2012-12#1)
strategy is##75##2##(1990-4#1)(1991-2#1)(1991-6#1)(1992-9#1)(1993-1#1)(1993-4#1)(1994-2#1)(1995-10#2)(1995-3#1)(1995-7#1)(1995-9#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-6#1)(1997-7#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#3)(2008-1#1)(2008-10#6)(2008-11#4)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-5#2)(2010-7#2)(2010-9#1)(2011-2#3)(2012-11#2)(2012-12#2)(2012-2#2)
strategy may be##7##3##(1997-3#1)(2005-12#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-6#1)(2011-1#1)
strategy may##9##2##(1997-3#1)(2005-12#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-6#1)(2011-1#1)(2013-1#1)
strategy not##2##2##(1993-8#1)(2007-9#1)
strategy of an##2##3##(2008-10#1)(2008-8#1)
strategy of gene##3##3##(2008-8#2)(2008-9#1)
strategy of introducing##2##3##(1997-4#1)(2008-8#1)
strategy of localized##2##3##(1997-7#1)(2012-12#1)
strategy of the##9##3##(2007-11#1)(2007-3#2)(2007-8#1)(2008-4#2)(2008-7#2)(2012-1#1)
strategy of this##3##3##(1995-6#1)(2008-10#1)(2011-2#1)
strategy of##85##2##(1990-6#1)(1991-1#1)(1993-5#1)(1994-2#1)(1994-3#1)(1995-6#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#2)(2005-10#2)(2005-6#1)(2006-10#2)(2006-12#2)(2006-4#1)(2007-11#2)(2007-3#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#3)(2008-2#4)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#2)(2009-12#1)(2009-2#1)(2009-4#1)(2010-1#1)(2010-8#3)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
strategy offers a##2##3##(2008-7#1)(2009-10#1)
strategy offers##4##2##(1995-12#1)(2008-10#1)(2008-7#1)(2009-10#1)
strategy on the##4##3##(1993-2#1)(1994-11#1)(2007-11#1)(2008-8#1)
strategy on##7##2##(1993-2#1)(1994-11#1)(2004-3#1)(2007-11#1)(2008-10#1)(2008-8#1)(2011-2#1)
strategy or##2##2##(2008-3#1)(2012-1#1)
strategy presented here##2##3##(1996-2#1)(2008-4#1)
strategy presented##3##2##(1996-2#1)(2008-4#1)(2008-7#1)
strategy provides a##2##3##(2006-5#1)(2008-10#1)
strategy provides##3##2##(2006-5#1)(2008-10#1)(2011-2#1)
strategy represents a##2##3##(1994-9#1)(2010-5#1)
strategy represents##3##2##(1994-9#1)(2008-8#1)(2010-5#1)
strategy should be useful in##2##5##(2007-8#1)(2008-4#1)
strategy should be##8##3##(1991-6#1)(1994-5#1)(2007-11#1)(2007-8#1)(2008-4#1)(2012-3#1)(2013-1#2)
strategy should##12##2##(1991-6#1)(1994-5#1)(1995-7#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-4#1)(2009-6#1)(2012-3#1)(2013-1#2)
strategy than##3##2##(2010-12#1)(2010-6#1)(2010-8#1)
strategy that aims##2##3##(2008-7#1)(2011-1#1)
strategy that avoids##2##3##(1996-2#1)(2007-8#1)
strategy that can be used##3##5##(2008-12#1)(2012-12#1)(2012-2#1)
strategy that can be##4##4##(2008-10#1)(2008-12#1)(2012-12#1)(2012-2#1)
strategy that can##7##3##(2008-10#1)(2008-12#1)(2008-8#1)(2009-8#1)(2010-12#1)(2012-12#1)(2012-2#1)
strategy that combines##3##3##(2008-6#1)(2012-12#2)
strategy that has been##2##4##(2008-12#1)(2012-2#1)
strategy that has##3##3##(2008-12#1)(2009-8#1)(2012-2#1)
strategy that involves##3##3##(2004-2#1)(2008-10#1)(2011-1#1)
strategy that is##3##3##(1993-2#1)(1997-2#1)(2012-2#1)
strategy that will##4##3##(1994-3#2)(2007-8#1)(2012-12#1)
strategy that##60##2##(1993-12#1)(1993-2#2)(1994-2#1)(1994-3#3)(1995-3#1)(1995-6#1)(1996-2#1)(1997-2#1)(2004-2#1)(2005-8#1)(2006-10#1)(2006-2#3)(2007-2#1)(2007-3#1)(2007-8#2)(2008-10#4)(2008-11#2)(2008-12#3)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-6#1)(2009-8#4)(2010-12#1)(2011-1#2)(2011-2#2)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#2)
strategy to a##2##3##(1997-4#1)(2010-11#1)
strategy to achieve##2##3##(1991-3#1)(2012-12#1)
strategy to address the##2##4##(2007-1#1)(2013-1#1)
strategy to address##3##3##(1997-2#1)(2007-1#1)(2013-1#1)
strategy to assess##2##3##(2006-12#1)(2013-1#1)
strategy to attain##2##3##(1997-2#1)(2009-6#1)
strategy to avoid##2##3##(1997-2#1)(2007-8#1)
strategy to be##3##3##(1994-4#1)(2007-8#1)(2009-9#1)
strategy to combat the##3##4##(2007-11#1)(2007-7#1)(2008-3#1)
strategy to combine##3##3##(2006-5#1)(2013-1#2)
strategy to construct##2##3##(2007-8#1)(2008-10#1)
strategy to control##5##3##(1991-3#1)(1996-1#2)(2008-10#1)(2009-3#1)
strategy to correct##2##3##(2007-11#1)(2010-3#1)
strategy to create##4##3##(1993-11#1)(1993-9#1)(2007-7#1)(2010-10#1)
strategy to delete##2##3##(1990-2#1)(1995-1#1)
strategy to detect##2##3##(1992-1#1)(2012-3#1)
strategy to enhance##3##3##(2008-7#1)(2010-10#1)(2013-8#1)
strategy to identify##5##3##(1993-2#1)(1995-1#1)(2008-10#1)(2008-7#1)(2009-5#1)
strategy to improve the##5##4##(1990-11#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
strategy to improve##12##3##(1990-11#1)(1991-1#1)(1996-12#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2012-2#2)(2013-1#1)
strategy to increase##3##3##(2008-11#1)(2008-12#1)(2009-1#1)
strategy to inhibit the##2##4##(1996-12#1)(2006-12#1)
strategy to inhibit##3##3##(1996-12#1)(2006-12#1)(2012-12#1)
strategy to integrate##2##3##(1993-1#1)(2008-10#1)
strategy to minimize##2##3##(2010-12#1)(2010-6#1)
strategy to obtain##7##3##(1993-12#1)(2007-8#2)(2008-2#1)(2010-12#1)(2010-4#1)(2012-3#1)
strategy to optimize##3##3##(2008-3#1)(2012-2#1)(2013-7#1)
strategy to overcome##2##3##(1991-2#1)(1997-3#1)
strategy to prevent##6##3##(2007-11#1)(2008-1#2)(2008-10#1)(2011-2#1)(2013-8#1)
strategy to promote##3##3##(1996-1#2)(2005-12#1)
strategy to reduce the##2##4##(2007-8#1)(2010-4#1)
strategy to reduce##9##3##(1995-1#1)(1996-4#1)(2006-12#1)(2007-8#2)(2009-4#1)(2010-2#1)(2010-4#1)(2011-2#1)
strategy to the##3##3##(1994-5#1)(2008-11#1)(2012-3#1)
strategy to treat##4##3##(2007-11#1)(2012-12#3)
strategy to##177##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-9#1)(1991-1#1)(1991-2#1)(1991-3#2)(1991-6#1)(1992-1#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-5#1)(1994-8#1)(1995-1#3)(1996-1#5)(1996-10#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-7#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-8#1)(2004-10#1)(2005-12#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-12#4)(2006-4#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#1)(2007-6#1)(2007-7#3)(2007-8#9)(2008-1#2)(2008-10#9)(2008-11#5)(2008-12#5)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#4)(2008-8#2)(2009-1#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#8)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#7)(2012-2#6)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#4)
strategy towards##2##2##(1991-2#1)(2007-11#1)
strategy under##2##2##(2010-8#1)(2013-8#1)
strategy use##5##2##(2008-9#1)(2009-1#3)(2009-5#1)
strategy used by the##2##4##(2009-12#1)(2010-8#1)
strategy used by##3##3##(2009-12#1)(2010-12#1)(2010-8#1)
strategy used in##2##3##(1995-8#1)(2008-3#1)
strategy used to##2##3##(2006-8#1)(2008-4#1)
strategy used##13##2##(1995-8#1)(2006-8#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#2)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)
strategy using##4##2##(2005-11#1)(2008-11#1)(2008-2#1)(2008-9#1)
strategy was based on##2##4##(2006-12#1)(2008-10#1)
strategy was developed to##2##4##(1997-5#1)(2007-7#1)
strategy was developed##3##3##(1990-12#1)(1997-5#1)(2007-7#1)
strategy was employed to##3##4##(1994-12#1)(1994-3#1)(1995-5#1)
strategy was employed##5##3##(1994-12#1)(1994-3#1)(1995-5#1)(2008-3#1)(2010-5#1)
strategy was proposed for the##2##5##(2007-8#1)(2008-10#1)
strategy was proposed##5##3##(2006-10#1)(2007-8#1)(2008-10#2)(2013-1#1)
strategy was to##2##3##(1995-11#1)(2007-11#1)
strategy was used to##7##4##(1990-6#1)(1995-2#1)(2006-12#1)(2008-10#2)(2008-4#1)(2009-11#1)
strategy was used##10##3##(1990-2#1)(1990-6#1)(1995-2#2)(2005-6#1)(2006-12#1)(2008-10#2)(2008-4#1)(2009-11#1)
strategy was##53##2##(1990-12#1)(1990-2#1)(1990-6#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-2#2)(1995-5#1)(1997-5#1)(2004-12#1)(2005-12#1)(2005-6#1)(2006-10#1)(2006-12#3)(2007-10#3)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
strategy we##3##2##(2008-11#1)(2008-5#1)(2010-12#1)
strategy were##3##2##(2007-6#1)(2008-10#1)(2008-9#1)
strategy where##2##2##(1995-2#1)(2008-10#1)
strategy which##6##2##(1993-2#1)(1995-7#1)(2008-2#1)(2011-2#1)(2012-3#2)
strategy will be##2##3##(1993-1#1)(1996-11#1)
strategy will##5##2##(1993-1#1)(1994-6#1)(1996-11#1)(1997-3#1)(2013-1#1)
strategy with emphasis on##4##4##(2011-12#1)(2012-3#3)
strategy with regard to##2##4##(1997-2#1)(2010-8#1)
strategy with the##2##3##(2005-11#1)(2006-10#1)
strategy with##19##2##(1992-3#1)(1993-12#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#2)(2010-8#1)(2011-12#1)(2012-3#3)(2013-1#1)
strategy would allow the##2##4##(2008-3#1)(2008-7#1)
strategy would##8##2##(1993-1#1)(2008-3#1)(2008-7#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#2)
strategy##1661##1##(1990-10#7)(1990-11#1)(1990-12#5)(1990-2#4)(1990-3#1)(1990-4#2)(1990-6#5)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#3)(1991-11#5)(1991-12#2)(1991-2#5)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#6)(1992-1#7)(1992-10#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#6)(1992-5#1)(1992-6#4)(1992-8#2)(1992-9#4)(1993-1#8)(1993-10#1)(1993-11#3)(1993-12#9)(1993-2#14)(1993-3#6)(1993-4#1)(1993-5#4)(1993-6#1)(1993-8#2)(1993-9#3)(1994-1#3)(1994-11#3)(1994-12#8)(1994-2#11)(1994-3#9)(1994-4#1)(1994-5#3)(1994-6#2)(1994-8#2)(1994-9#6)(1995-1#3)(1995-10#3)(1995-11#2)(1995-12#7)(1995-2#5)(1995-3#9)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#7)(1995-8#4)(1995-9#4)(1996-1#13)(1996-10#3)(1996-11#2)(1996-12#11)(1996-2#13)(1996-3#8)(1996-4#7)(1996-5#4)(1996-6#2)(1996-7#3)(1996-9#3)(1997-1#7)(1997-2#10)(1997-3#8)(1997-4#3)(1997-5#3)(1997-6#4)(1997-7#5)(1997-8#7)(2004-10#2)(2004-11#3)(2004-12#1)(2004-2#1)(2004-3#1)(2004-4#2)(2004-8#2)(2005-1#2)(2005-10#6)(2005-11#4)(2005-12#6)(2005-3#1)(2005-5#1)(2005-6#2)(2005-7#5)(2005-8#6)(2005-9#1)(2006-1#1)(2006-10#27)(2006-11#4)(2006-12#21)(2006-2#4)(2006-3#1)(2006-4#4)(2006-5#5)(2006-6#5)(2006-7#2)(2006-8#9)(2006-9#4)(2007-1#3)(2007-10#9)(2007-11#22)(2007-12#14)(2007-2#5)(2007-3#8)(2007-4#7)(2007-5#3)(2007-6#5)(2007-7#12)(2007-8#41)(2007-9#9)(2008-1#17)(2008-10#117)(2008-11#70)(2008-12#27)(2008-2#39)(2008-3#39)(2008-4#29)(2008-5#33)(2008-6#19)(2008-7#48)(2008-8#45)(2008-9#42)(2009-1#5)(2009-10#5)(2009-11#2)(2009-12#14)(2009-2#3)(2009-3#6)(2009-4#9)(2009-5#6)(2009-6#11)(2009-7#2)(2009-8#13)(2009-9#7)(2010-1#3)(2010-10#12)(2010-11#5)(2010-12#20)(2010-2#8)(2010-3#7)(2010-4#6)(2010-5#13)(2010-6#7)(2010-7#13)(2010-8#17)(2010-9#5)(2011-1#25)(2011-11#1)(2011-12#6)(2011-2#47)(2011-3#4)(2012-1#20)(2012-11#12)(2012-12#35)(2012-2#34)(2012-3#39)(2012-7#1)(2013-1#53)(2013-7#15)(2013-8#22)
strategy&quot##3##1##(1994-3#1)(2007-4#1)(2012-12#1)
strategy?##3##1##(1994-3#1)(2007-11#1)(2008-2#1)
strategy]##2##1##(1990-5#1)(2012-3#1)
stratification and##7##2##(2008-3#2)(2008-9#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
stratification as##2##2##(2008-8#1)(2009-9#1)
stratification by##3##2##(1992-10#1)(2013-1#2)
stratification for estrogen receptor status##2##5##(1994-7#1)(1995-4#1)
stratification for##8##2##(1992-10#1)(1994-7#1)(1995-4#1)(2006-6#1)(2008-8#1)(2012-1#1)(2012-2#1)(2012-3#1)
stratification has##2##2##(2008-8#1)(2009-9#1)
stratification in##9##2##(2006-11#1)(2007-10#1)(2008-10#1)(2008-8#1)(2010-5#1)(2010-6#1)(2010-9#1)(2012-3#1)(2013-7#1)
stratification is##6##2##(2006-5#1)(2008-3#2)(2008-7#1)(2011-1#1)(2012-2#1)
stratification may##2##2##(2007-8#1)(2008-8#1)
stratification model##2##2##(2008-3#1)(2009-9#1)
stratification of patients into##2##4##(2008-7#1)(2013-8#1)
stratification of patients with##4##4##(2006-10#3)(2010-11#1)
stratification of patients##10##3##(2006-10#4)(2008-7#1)(2009-4#1)(2010-11#1)(2010-3#1)(2011-2#1)(2013-8#1)
stratification of the water column##2##5##(2007-5#1)(2008-3#1)
stratification of the##7##3##(1994-9#1)(2007-10#1)(2007-5#1)(2008-3#1)(2010-12#1)(2011-2#2)
stratification of##35##2##(1994-9#1)(1996-4#1)(2006-10#4)(2007-10#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-7#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-3#1)(2011-2#7)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
stratification to##3##2##(2009-9#2)(2011-2#1)
stratification with##2##2##(2012-3#1)(2013-8#1)
stratification##137##1##(1991-6#1)(1992-10#2)(1992-12#1)(1994-7#1)(1994-9#1)(1995-2#1)(1995-4#1)(1996-4#2)(1996-8#1)(1997-2#1)(2006-10#6)(2006-11#2)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#2)(2007-5#1)(2007-7#2)(2007-8#7)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#12)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#6)(2008-9#1)(2009-1#1)(2009-10#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-9#5)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-9#2)(2011-1#3)(2011-2#13)(2012-1#1)(2012-2#5)(2012-3#10)(2013-1#5)(2013-7#3)(2013-8#3)
stratified according to age##2##4##(2006-8#1)(2011-2#1)
stratified according to##7##3##(1990-5#1)(1994-12#1)(2006-10#1)(2006-8#1)(2010-3#1)(2011-2#2)
stratified analyses##2##2##(1997-7#1)(2012-3#1)
stratified analysis##3##2##(1991-8#1)(1996-7#1)(2012-12#1)
stratified and##2##2##(2007-12#1)(2011-1#1)
stratified as to##2##3##(1995-11#1)(2008-8#1)
stratified as##3##2##(1995-11#1)(2007-12#1)(2008-8#1)
stratified by age and##3##4##(1991-2#1)(2006-10#1)(2006-12#1)
stratified by gender##2##3##(2008-3#1)(2009-5#1)
stratified by sex##4##3##(1992-6#1)(2006-10#1)(2006-12#1)(2008-7#1)
stratified by the##4##3##(1995-2#1)(2007-7#1)(2008-5#1)(2013-1#1)
stratified by##32##2##(1991-2#1)(1992-3#1)(1992-6#1)(1993-9#1)(1995-1#1)(1995-2#2)(1996-3#1)(2004-11#1)(2006-10#2)(2006-12#2)(2006-5#1)(2007-2#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-5#1)(2010-12#1)(2010-3#1)(2011-2#2)(2011-9#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
stratified case-control studies##2##3##(1992-2#2)
stratified epithelial cells##2##3##(2012-2#2)
stratified epithelium##2##2##(2010-3#1)(2010-7#1)
stratified for##2##2##(2006-2#1)(2008-3#1)
stratified group##2##2##(2013-1#2)
stratified in##2##2##(2007-5#1)(2011-1#1)
stratified into##11##2##(2006-12#1)(2006-2#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-12#2)(2011-2#3)(2012-2#1)
stratified last stage random##2##4##(2012-3#2)
stratified on##2##2##(2008-10#1)(2010-11#1)
stratified probability##2##2##(2007-3#1)(2009-9#1)
stratified random sample of##4##4##(1996-8#1)(2012-3#3)
stratified random sample##5##3##(1996-8#1)(1997-3#1)(2012-3#3)
stratified random sampling##4##3##(1993-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
stratified random##11##2##(1993-12#1)(1996-8#1)(1997-3#1)(2008-2#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#1)
stratified sample of##4##3##(1994-6#1)(2006-10#1)(2008-10#1)(2011-1#1)
stratified sample##5##2##(1994-6#1)(2006-10#1)(2008-10#1)(2010-1#1)(2011-1#1)
stratified sampling##2##2##(2007-3#1)(2010-3#1)
stratified squamous##2##2##(1991-11#1)(1995-8#1)
stratified structures##2##2##(2008-3#2)
stratified water body##2##3##(2008-2#2)
stratified water##3##2##(2008-2#3)
stratified##145##1##(1990-11#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-8#1)(1995-9#2)(1996-3#1)(1996-7#2)(1996-8#2)(1997-3#1)(1997-7#1)(2004-11#1)(2006-10#5)(2006-12#3)(2006-2#2)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#10)(2008-3#9)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#4)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#7)(2011-9#2)(2012-11#1)(2012-12#5)(2012-2#8)(2012-3#10)(2012-5#1)(2013-1#5)(2013-8#1)
stratifies##2##1##(2008-10#1)(2010-11#1)
stratify patients at##2##3##(1996-4#1)(2006-10#1)
stratify patients##8##2##(1996-4#1)(2006-10#1)(2007-12#1)(2010-11#1)(2012-2#1)(2013-1#3)
stratify the##3##2##(1997-6#1)(2008-10#1)(2008-11#1)
stratify##18##1##(1994-3#1)(1995-12#1)(1996-4#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#2)(2010-11#1)(2012-2#2)(2013-1#5)
stratifying by##2##2##(2011-2#2)
stratifying the##4##2##(1997-6#1)(2011-1#1)(2011-2#2)
stratifying##11##1##(1997-6#1)(2006-10#1)(2008-3#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-12#1)
stratigraphic##7##1##(1990-8#1)(1993-4#1)(1997-5#3)(2010-6#1)(2010-8#1)
stratosphere from##2##2##(2008-3#2)
stratosphere was##2##2##(2008-2#1)(2008-3#1)
stratosphere##27##1##(1991-5#4)(1991-6#1)(1996-5#1)(2007-9#1)(2008-1#1)(2008-2#5)(2008-3#13)(2012-12#1)
stratospheric aerosol##12##2##(2008-2#10)(2008-3#2)
stratospheric aerosols##7##2##(2008-2#6)(2008-3#1)
stratospheric ozone##7##2##(1995-3#1)(1996-1#1)(1996-5#1)(2008-10#2)(2008-3#1)(2012-2#1)
stratospheric sulfuric##2##2##(2008-3#2)
stratospheric temperature##2##2##(2008-2#1)(2008-3#1)
stratospheric##59##1##(1991-5#3)(1994-7#1)(1995-3#1)(1996-1#2)(1996-5#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#23)(2008-3#20)(2012-2#3)
stratum corneum (SC)##10##3##(2008-10#1)(2008-5#9)
stratum corneum and##5##3##(2008-5#5)
stratum corneum barrier function##2##4##(2008-5#2)
stratum corneum barrier##3##3##(2006-9#1)(2008-5#2)
stratum corneum by##2##3##(2008-5#2)
stratum corneum hydration and##2##4##(2008-5#1)(2012-2#1)
stratum corneum hydration in##2##4##(2012-2#1)(2013-1#1)
stratum corneum hydration##6##3##(2008-5#3)(2012-2#2)(2013-1#1)
stratum corneum is##4##3##(2007-7#2)(2008-5#2)
stratum corneum layer##2##3##(1993-5#1)(2008-5#1)
stratum corneum lipid##3##3##(2008-10#1)(2008-5#2)
stratum corneum lipids##13##3##(1991-9#1)(1996-5#4)(2008-5#8)
stratum corneum maturation##2##3##(2008-5#2)
stratum corneum samples##2##3##(2008-5#2)
stratum corneum structure##2##3##(1996-5#1)(2008-5#1)
stratum corneum tryptic enzyme##2##4##(2008-5#2)
stratum corneum water barrier##2##4##(2008-5#2)
stratum corneum water##3##3##(2008-5#3)
stratum corneum were##4##3##(2008-5#3)(2012-2#1)
stratum corneum with##3##3##(1996-5#1)(2008-5#2)
stratum corneum##154##2##(1991-9#5)(1992-8#2)(1993-5#1)(1994-8#1)(1996-5#6)(2005-11#2)(2006-9#1)(2007-7#4)(2008-10#3)(2008-5#121)(2010-8#2)(2012-2#4)(2013-1#2)
stratum granulosum##3##2##(2008-5#3)
stratum oriens##2##2##(1990-4#1)(1991-6#1)
stratum radiatum and the##2##4##(1991-6#1)(1994-10#1)
stratum radiatum and##3##3##(1991-6#1)(1994-10#1)(2011-2#1)
stratum radiatum##12##2##(1990-4#1)(1991-6#1)(1991-9#1)(1994-10#1)(1994-2#1)(1995-12#1)(1995-3#1)(1997-5#1)(2007-10#1)(2008-7#1)(2011-2#2)
stratum##190##1##(1990-4#2)(1990-5#1)(1990-7#1)(1991-6#2)(1991-9#6)(1992-7#1)(1992-8#2)(1993-5#1)(1994-10#2)(1994-2#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-5#6)(1997-1#2)(1997-3#1)(1997-5#2)(1997-7#1)(2005-11#2)(2006-9#1)(2007-10#1)(2007-7#4)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#126)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#2)
straw and##2##2##(2008-5#1)(2013-8#1)
straw degradation##2##2##(2006-8#2)
straw in##2##2##(1996-9#1)(2013-1#1)
straw pretreated by##3##3##(2013-1#3)
straw pretreated##5##2##(2008-5#2)(2013-1#3)
straw##38##1##(1992-10#1)(1992-6#2)(1996-9#1)(2006-8#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#7)(2008-6#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#10)(2013-8#3)
straw-to-solvent ratio##2##2##(2008-5#2)
strawberry and##9##2##(2008-10#9)
strawberry fields##6##2##(2008-10#6)
strawberry isolates##4##2##(2008-10#4)
strawberry leaf blight##3##3##(2008-10#3)
strawberry leaf##4##2##(2008-10#4)
strawberry leaflets##4##2##(2008-10#4)
strawberry leaves and##2##3##(2008-10#2)
strawberry leaves##9##2##(2008-10#9)
strawberry plants were##2##3##(2006-12#1)(2008-10#1)
strawberry plants##7##2##(2006-12#2)(2008-10#5)
strawberry production fields##2##3##(2008-10#2)
strawberry production##5##2##(2008-10#5)
strawberry tree honey##2##3##(2008-10#2)
strawberry was##3##2##(2008-10#3)
strawberry##111##1##(2006-12#3)(2006-3#1)(2007-7#1)(2008-10#101)(2008-12#1)(2008-8#1)(2009-3#2)(2013-7#1)
straws##3##1##(2006-5#2)(2011-1#1)
stray dogs##4##2##(1996-12#1)(2008-7#1)(2011-1#2)
stray light and the##2##4##(2008-3#2)
stray light and##3##3##(2006-12#1)(2008-3#2)
stray light##11##2##(2006-12#1)(2008-2#2)(2008-3#8)
stray radiation##8##2##(2008-2#1)(2010-9#7)
stray##31##1##(1994-2#1)(1996-12#3)(2006-12#1)(2007-12#1)(2007-4#1)(2008-12#1)(2008-2#3)(2008-3#9)(2008-7#1)(2010-9#7)(2011-1#2)(2013-8#1)
stray-light##4##1##(2008-2#1)(2008-3#3)
streak camera has been##2##4##(2008-1#2)
streak camera with a##3##4##(2007-11#1)(2008-3#2)
streak camera##18##2##(2007-11#2)(2007-12#4)(2008-1#6)(2008-2#4)(2008-3#2)
streak cameras##2##2##(2007-11#1)(2008-1#1)
streak disease##2##2##(2008-10#2)
streak method##2##2##(2008-11#1)(2012-2#1)
streak mosaic virus (WSMV)##3##4##(2008-10#3)
streak mosaic virus##10##3##(2008-10#9)(2008-8#1)
streak mosaic##12##2##(2008-10#11)(2008-8#1)
streak ovary##2##2##(1996-12#2)
streak virus (MSV)##3##3##(2008-10#3)
streak virus Isolates from##2##4##(2008-10#2)
streak virus##12##2##(2006-12#1)(2008-10#11)
streak##62##1##(1996-12#2)(1996-4#1)(1996-6#1)(2005-11#1)(2006-11#1)(2006-12#1)(2007-11#3)(2007-12#4)(2008-1#7)(2008-10#26)(2008-11#1)(2008-2#8)(2008-3#4)(2008-8#1)(2012-2#1)
streaking##3##1##(2008-2#1)(2008-8#1)(2008-9#1)
streaks##9##1##(1995-3#1)(1997-4#1)(2008-10#7)
stream (flow rate##3##3##(2008-10#3)
stream and can##2##3##(2008-3#1)(2008-7#1)
stream and passed through the##2##5##(2008-10#2)
stream and the##3##3##(2008-10#3)
stream and##14##2##(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2013-1#1)
stream as##2##2##(2007-12#1)(2008-10#1)
stream at##4##2##(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)
stream by##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
stream cipher##2##2##(2008-1#2)
stream containing 0##4##3##(2008-10#4)
stream containing##9##2##(2008-10#9)
stream flow##2##2##(2008-10#1)(2011-2#1)
stream flowing##2##2##(2008-10#1)(2009-11#1)
stream formation##3##2##(1997-3#1)(2009-8#2)
stream from##3##2##(1991-2#1)(2007-12#1)(2008-6#1)
stream in the##2##3##(2007-9#1)(2008-10#1)
stream in##4##2##(2007-9#1)(2008-1#1)(2008-10#2)
stream infections##4##2##(2006-10#1)(2007-3#1)(2013-1#2)
stream into a##2##3##(2008-10#1)(2009-11#1)
stream into##3##2##(1995-3#1)(2008-10#1)(2009-11#1)
stream is##7##2##(2004-8#1)(2005-11#1)(2007-12#1)(2008-10#3)(2013-8#1)
stream of N(2)##2##3##(2008-10#2)
stream of a##2##3##(2007-11#1)(2008-10#1)
stream of sodium##2##3##(2008-10#2)
stream of the##6##3##(1996-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)
stream of##49##2##(1993-2#1)(1995-12#1)(1995-2#1)(1996-4#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#27)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#2)(2010-10#4)(2011-2#1)
stream sediment##4##2##(2008-10#4)
stream that##5##2##(2007-10#1)(2007-8#1)(2008-7#1)(2008-8#1)(2011-2#1)
stream then returns to the reservoir##2##6##(2008-10#2)
stream to be##3##3##(2008-10#3)
stream to the##4##3##(1995-12#1)(2008-1#1)(2008-2#1)(2008-6#1)
stream to##10##2##(1995-12#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-6#1)
stream was monitored##3##3##(2007-8#1)(2008-10#2)
stream was##13##2##(2007-8#2)(2008-10#9)(2008-5#2)
stream water##4##2##(2004-4#1)(2008-10#3)
stream with a##2##3##(2008-10#2)
stream with##5##2##(2008-10#3)(2009-9#1)(2013-1#1)
stream##253##1##(1991-12#1)(1991-2#1)(1992-1#1)(1993-2#1)(1994-6#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#1)(1996-4#2)(1997-3#2)(2004-4#1)(2004-8#3)(2005-10#1)(2005-11#2)(2006-10#2)(2006-2#2)(2006-5#1)(2007-10#2)(2007-11#1)(2007-12#8)(2007-3#1)(2007-8#7)(2007-9#1)(2008-1#4)(2008-10#130)(2008-11#3)(2008-2#6)(2008-3#7)(2008-4#1)(2008-5#9)(2008-6#5)(2008-7#2)(2008-8#5)(2008-9#3)(2009-11#2)(2009-2#1)(2009-8#4)(2009-9#1)(2010-10#4)(2010-2#1)(2010-8#5)(2011-2#4)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#1)
stream)##2##1##(1992-5#1)(2008-10#1)
streaming in##3##2##(1994-9#1)(2005-11#1)(2008-11#1)
streaming potential and##2##3##(2005-11#2)
streaming potential##5##2##(2005-11#5)
streaming video##2##2##(2006-6#1)(2008-2#1)
streaming##22##1##(1991-11#1)(1993-12#1)(1994-9#2)(1997-3#1)(2005-11#7)(2006-6#1)(2007-1#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#2)(2009-10#1)
streamline the##2##2##(1994-3#1)(2010-10#1)
streamline##10##1##(1990-12#1)(1994-3#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-10#1)(2010-9#1)(2012-1#1)(2012-3#1)
streamlined and##2##2##(1997-3#1)(2012-2#1)
streamlined procedure for##2##3##(2008-11#1)(2008-2#1)
streamlined procedure##3##2##(1994-3#1)(2008-11#1)(2008-2#1)
streamlined##18##1##(1994-3#1)(1997-3#2)(2004-10#1)(2005-8#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-7#1)(2009-10#1)(2009-7#1)(2010-11#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
streamlines##2##1##(1992-3#1)(2005-11#1)
streamlining the process##2##3##(1997-2#1)(2007-11#1)
streamlining the##3##2##(1997-2#2)(2007-11#1)
streamlining##12##1##(1992-8#1)(1993-1#1)(1995-3#1)(1997-2#2)(2006-10#1)(2007-11#1)(2008-3#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
streams and##8##2##(1996-2#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-3#2)(2012-1#1)
streams at the##2##3##(2008-10#1)(2008-3#1)
streams from##3##2##(1996-1#1)(2008-5#1)(2008-6#1)
streams in##3##2##(2004-4#1)(2008-6#1)(2009-6#1)
streams of glass##2##3##(2010-8#2)
streams of information##3##3##(1995-12#1)(1997-3#1)(2007-9#1)
streams of##20##2##(1995-12#1)(1996-1#1)(1997-3#1)(2006-2#1)(2007-9#3)(2008-10#5)(2008-2#3)(2008-8#2)(2009-8#1)(2010-8#2)
streams that##4##2##(2008-3#1)(2010-8#1)(2012-2#2)
streams the##2##2##(1993-6#1)(2004-4#1)
streams was##2##2##(2008-10#2)
streams were##4##2##(1993-6#1)(2004-4#1)(2007-8#1)(2008-10#1)
streams with##4##2##(2008-10#2)(2008-8#1)(2009-11#1)
streams##95##1##(1992-6#1)(1993-6#2)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-1#2)(1996-2#1)(1997-3#1)(1997-8#1)(2004-4#5)(2005-10#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-10#23)(2008-11#2)(2008-2#5)(2008-3#4)(2008-5#3)(2008-6#5)(2008-8#5)(2008-9#1)(2009-11#1)(2009-6#1)(2009-8#3)(2010-8#5)(2012-1#3)(2012-2#5)
streamwater##3##1##(2008-10#3)
street air##2##2##(2008-11#2)
street children##3##2##(1992-5#1)(1997-6#2)
street dust samples##2##3##(2008-10#2)
street dust##3##2##(2008-10#3)
street sex workers##2##3##(2012-11#2)
street sweepers##4##2##(2007-1#4)
street##31##1##(1992-5#1)(1993-5#1)(1993-9#1)(1996-5#1)(1997-6#2)(2006-8#1)(2007-1#5)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-8#1)(2009-10#1)(2009-9#2)(2012-11#2)(2012-2#1)(2012-3#3)(2013-1#1)
street&quot##2##1##(2006-8#2)
street-involved youth##4##2##(2007-4#1)(2013-1#3)
street-involved##5##1##(2007-4#1)(2013-1#4)
streets in walking##3##3##(2007-11#1)(2007-12#2)
streets##10##1##(1992-5#1)(1994-12#1)(1995-8#1)(1997-1#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2012-2#1)
strength (N)##2##2##(2007-7#1)(2008-11#1)
strength (quadriceps##2##2##(2013-1#2)
strength (r = 0##2##2##(2011-12#2)
strength after surgery##3##3##(2007-7#1)(2008-9#1)(2013-1#1)
strength after##10##2##(2005-1#1)(2007-7#2)(2008-9#5)(2010-4#1)(2013-1#1)
strength and a##3##3##(2006-10#1)(2008-8#1)(2010-7#1)
strength and endurance training##4##4##(2009-6#4)
strength and endurance##7##3##(2009-6#4)(2010-12#2)(2011-2#1)
strength and fatigue##2##3##(2012-2#1)(2012-3#1)
strength and function##3##3##(2013-1#3)
strength and functional ability##9##4##(2007-2#9)
strength and functional##11##3##(2007-2#9)(2010-1#1)(2013-1#1)
strength and in##2##3##(1993-3#1)(2010-5#1)
strength and microhardness of a composite resin##2##7##(2008-12#2)
strength and motor control##2##4##(2012-1#2)
strength and muscle mass##2##4##(2006-9#1)(2008-5#1)
strength and pH of##4##4##(1997-3#1)(2008-10#3)
strength and pH##8##3##(1990-12#1)(1996-8#1)(1997-3#1)(2008-10#5)
strength and power and##2##4##(2006-10#1)(2007-2#1)
strength and power##3##3##(2006-10#2)(2007-2#1)
strength and the##8##3##(1990-5#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-3#1)(2012-1#1)
strength and##155##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1992-9#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-3#2)(2004-9#1)(2005-11#1)(2005-12#1)(2006-10#5)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#11)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#19)(2008-11#2)(2008-12#7)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-5#2)(2009-6#4)(2009-7#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-5#2)(2010-7#1)(2011-2#1)(2012-1#4)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#4)
strength are##5##2##(2006-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-10#1)
strength as a##2##3##(1992-9#1)(2007-2#1)
strength as##4##2##(1992-9#1)(2007-2#1)(2008-12#1)(2013-1#1)
strength at##6##2##(1991-2#1)(1993-11#1)(2005-11#1)(2007-7#1)(2008-2#1)(2009-2#1)
strength averaged##2##2##(2008-9#1)(2009-3#1)
strength between the##2##3##(2007-12#1)(2013-1#1)
strength between##5##2##(1997-4#1)(2005-11#1)(2007-12#1)(2012-1#1)(2013-1#1)
strength but##4##2##(1993-11#1)(2007-12#1)(2008-10#1)(2010-5#1)
strength by##7##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-12#1)
strength characteristics##3##2##(2007-4#3)
strength compared##2##2##(1995-2#1)(2008-3#1)
strength conditions##2##2##(1993-9#1)(1997-2#1)
strength data##2##2##(2008-3#1)(2009-11#1)
strength deficit##2##2##(2013-1#2)
strength dependencies##2##2##(1995-1#1)(1997-7#1)
strength development and##3##3##(2006-3#1)(2007-10#2)
strength exerted##2##2##(2008-6#2)
strength for the##2##3##(1996-6#1)(2007-12#1)
strength for##12##2##(1990-2#1)(1993-12#1)(1993-5#1)(1996-6#1)(2007-12#2)(2008-12#1)(2008-6#1)(2009-8#1)(2010-12#1)(2012-12#1)(2013-7#1)
strength from##2##2##(1996-12#1)(2005-11#1)
strength has##3##2##(1992-3#1)(1992-4#1)(2005-12#1)
strength imaging##2##2##(2010-4#2)
strength in the##12##3##(1992-8#1)(2004-1#1)(2005-11#1)(2007-7#4)(2007-8#3)(2008-10#1)(2013-1#1)
strength in this##2##3##(1990-12#1)(1991-2#1)
strength in##34##2##(1990-12#1)(1990-5#1)(1991-2#1)(1992-8#1)(1997-5#1)(1997-6#1)(2004-1#1)(2004-9#2)(2005-11#1)(2007-4#1)(2007-7#4)(2007-8#4)(2008-10#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-7#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
strength increased to##3##3##(2007-11#2)(2007-8#1)
strength increased##5##2##(1992-12#1)(1992-9#1)(2007-11#2)(2007-8#1)
strength increases##2##2##(2007-12#1)(2008-3#1)
strength interphase results in##2##4##(2009-6#2)
strength is attributed to##2##4##(1990-12#1)(2004-9#1)
strength is found##2##3##(2006-6#1)(2008-9#1)
strength is reported##2##3##(2008-3#1)(2008-9#1)
strength is##20##2##(1990-12#1)(1994-8#1)(1996-8#1)(2004-9#1)(2006-6#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-9#3)(2013-1#1)(2013-8#2)
strength magnetic resonance imaging##2##4##(2008-4#1)(2010-4#1)
strength measurements##2##2##(2005-11#1)(2008-3#1)
strength necessary##2##2##(1995-2#1)(2009-9#1)
strength of a##3##3##(1991-2#1)(2012-2#1)(2013-1#1)
strength of an##4##3##(2007-9#1)(2008-3#1)(2008-7#1)(2010-4#1)
strength of association between##6##4##(2007-7#1)(2008-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
strength of association##9##3##(2005-10#1)(2007-7#1)(2008-3#3)(2012-2#1)(2013-1#2)(2013-8#1)
strength of evidence for##2##4##(2011-1#1)(2012-12#1)
strength of evidence##8##3##(2009-6#1)(2011-1#1)(2012-12#6)
strength of experimentally filled resins##2##5##(2009-7#2)
strength of local density regulation##2##5##(2008-8#2)
strength of local##3##3##(2008-8#2)(2009-10#1)
strength of optical##2##3##(2008-2#1)(2011-1#1)
strength of selection on##3##4##(2008-8#1)(2008-9#2)
strength of selection##8##3##(2008-8#4)(2008-9#2)(2010-4#1)(2013-1#1)
strength of sexual selection on##2##5##(2008-8#1)(2010-8#1)
strength of the SNARE complex##2##5##(2009-12#2)
strength of the SNARE##3##4##(2009-12#3)
strength of the composite##2##4##(2008-5#1)(2009-7#1)
strength of the evidence##3##4##(2008-3#1)(2008-7#1)(2008-8#1)
strength of the feedback##2##4##(2008-2#1)(2008-8#1)
strength of the medium##4##4##(1991-2#1)(1992-6#1)(2008-2#1)(2008-3#1)
strength of the muscles##2##4##(2007-7#1)(2007-8#1)
strength of the neck##2##4##(2006-3#1)(2007-1#1)
strength of the##130##3##(1990-4#1)(1990-5#3)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-4#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#4)(2005-10#1)(2005-11#3)(2005-4#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#6)(2007-7#3)(2007-8#9)(2007-9#1)(2008-10#7)(2008-11#2)(2008-2#6)(2008-3#10)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#3)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#4)(2010-10#1)(2010-2#4)(2010-4#3)(2010-7#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#3)
strength of their##5##3##(1995-10#1)(1997-1#1)(2006-11#1)(2006-9#1)(2008-4#1)
strength of these##4##3##(2007-8#2)(2008-4#1)(2008-9#1)
strength of##343##2##(1990-12#1)(1990-4#1)(1990-5#4)(1990-9#2)(1991-1#1)(1991-10#1)(1991-2#4)(1991-3#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-4#1)(1994-8#3)(1995-10#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-12#2)(1996-4#1)(1996-5#1)(1996-6#2)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#2)(1997-7#2)(1997-8#6)(2004-9#7)(2005-10#2)(2005-11#10)(2005-4#2)(2006-1#1)(2006-10#3)(2006-11#2)(2006-12#4)(2006-3#1)(2006-7#2)(2006-8#1)(2006-9#2)(2007-1#1)(2007-11#6)(2007-12#12)(2007-2#2)(2007-7#4)(2007-8#16)(2007-9#4)(2008-10#19)(2008-11#5)(2008-12#7)(2008-2#9)(2008-3#18)(2008-4#7)(2008-5#16)(2008-6#1)(2008-7#7)(2008-8#17)(2008-9#8)(2009-10#2)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#10)(2009-8#2)(2010-10#1)(2010-12#2)(2010-2#5)(2010-4#7)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#8)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#7)(2012-2#7)(2012-3#2)(2013-1#12)(2013-8#4)
strength on the##6##3##(2005-11#1)(2007-11#2)(2007-8#1)(2008-10#2)
strength on##12##2##(1993-12#1)(2005-11#2)(2007-11#2)(2007-8#1)(2008-10#3)(2008-9#1)(2009-9#1)(2010-9#1)
strength optimization##2##2##(2006-6#2)
strength or##5##2##(1991-8#1)(1994-9#1)(2004-9#1)(2008-10#1)(2009-3#1)
strength over##2##2##(2008-8#1)(2010-4#1)
strength parameter##2##2##(2007-12#1)(2008-1#1)
strength scores##2##2##(2008-12#1)(2013-1#1)
strength supplemented with##2##3##(2008-12#1)(2010-2#1)
strength test was performed##2##4##(2009-7#1)(2013-1#1)
strength test##4##2##(2008-5#1)(2009-7#1)(2013-1#1)(2013-8#1)
strength tests were performed##2##4##(2008-12#2)
strength tests were##3##3##(2007-8#1)(2008-12#2)
strength tests##4##2##(2007-8#1)(2008-12#2)(2011-2#1)
strength than##2##2##(2007-12#1)(2009-7#1)
strength that##4##2##(1995-1#1)(2007-12#1)(2008-3#1)(2012-12#1)
strength the##3##2##(1996-9#1)(2005-11#1)(2007-12#1)
strength through##2##2##(2010-10#1)(2013-8#1)
strength to the##2##3##(2006-11#1)(2013-7#1)
strength to##13##2##(1990-5#2)(1993-12#1)(1993-6#1)(1996-4#1)(1996-7#1)(2006-11#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-6#1)(2013-7#1)
strength training and##2##3##(2010-5#1)(2013-8#1)
strength training on##3##3##(2006-10#1)(2006-3#1)(2007-10#1)
strength training##17##2##(2006-10#1)(2006-3#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-8#1)(2009-6#2)(2010-1#1)(2010-5#1)(2012-1#2)(2013-8#2)
strength up to##2##3##(1993-6#1)(2007-11#1)
strength using##2##2##(2008-10#1)(2010-12#1)
strength value##2##2##(2008-10#1)(2013-8#1)
strength values of the##2##4##(2008-10#1)(2008-5#1)
strength values##9##2##(2004-9#2)(2008-10#1)(2008-5#3)(2009-3#1)(2009-7#1)(2013-1#1)
strength was also measured##2##4##(2006-8#1)(2013-1#1)
strength was also##3##3##(2006-8#1)(2010-6#1)(2013-1#1)
strength was determined##2##3##(1990-5#1)(1991-11#1)
strength was found to##2##4##(2007-11#1)(2008-6#1)
strength was greater in##2##4##(2007-1#1)(2009-3#1)
strength was measured##2##3##(2009-7#1)(2011-2#1)
strength was observed##2##3##(2004-9#1)(2013-1#1)
strength was##29##2##(1990-5#1)(1991-11#1)(1997-2#2)(2004-9#2)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-7#4)(2010-6#1)(2011-2#1)(2013-1#2)
strength were studied##2##3##(2004-9#1)(2008-10#1)
strength were##13##2##(2004-9#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-9#2)(2010-10#1)(2012-2#3)
strength when##6##2##(2008-12#1)(2008-5#1)(2009-3#1)(2011-2#1)(2013-1#2)
strength with##7##2##(2004-9#1)(2008-10#1)(2008-12#1)(2009-11#1)(2009-3#1)(2012-1#1)(2012-2#1)
strength##1237##1##(1990-11#7)(1990-12#4)(1990-2#4)(1990-4#2)(1990-5#17)(1990-6#1)(1990-7#4)(1990-9#4)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#11)(1991-3#2)(1991-4#1)(1991-5#2)(1991-7#2)(1991-8#2)(1991-9#2)(1992-12#4)(1992-3#5)(1992-4#1)(1992-6#1)(1992-8#4)(1992-9#5)(1993-1#1)(1993-11#5)(1993-12#5)(1993-3#2)(1993-5#1)(1993-6#5)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-4#1)(1994-5#4)(1994-6#1)(1994-8#11)(1994-9#1)(1995-1#4)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#8)(1995-3#1)(1995-4#1)(1995-5#4)(1995-7#1)(1995-8#1)(1996-12#4)(1996-2#2)(1996-4#5)(1996-5#3)(1996-6#4)(1996-7#2)(1996-8#5)(1996-9#3)(1997-1#3)(1997-2#6)(1997-3#5)(1997-4#2)(1997-5#4)(1997-6#1)(1997-7#4)(1997-8#6)(2004-1#2)(2004-2#2)(2004-9#21)(2005-1#2)(2005-10#3)(2005-11#48)(2005-12#2)(2005-4#2)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#16)(2006-11#3)(2006-12#6)(2006-3#9)(2006-5#1)(2006-6#5)(2006-7#6)(2006-8#4)(2006-9#8)(2007-1#4)(2007-10#8)(2007-11#25)(2007-12#38)(2007-2#16)(2007-4#5)(2007-6#2)(2007-7#17)(2007-8#32)(2007-9#9)(2008-1#2)(2008-10#108)(2008-11#11)(2008-12#30)(2008-2#23)(2008-3#36)(2008-4#16)(2008-5#48)(2008-6#10)(2008-7#20)(2008-8#25)(2008-9#34)(2009-1#1)(2009-10#2)(2009-11#4)(2009-12#5)(2009-2#4)(2009-3#18)(2009-4#4)(2009-5#6)(2009-6#11)(2009-7#33)(2009-8#6)(2009-9#5)(2010-1#4)(2010-10#6)(2010-11#1)(2010-12#11)(2010-2#9)(2010-3#2)(2010-4#16)(2010-5#7)(2010-6#9)(2010-7#3)(2010-8#2)(2010-9#5)(2011-1#10)(2011-12#8)(2011-2#17)(2012-1#15)(2012-12#13)(2012-2#24)(2012-3#6)(2013-1#62)(2013-7#4)(2013-8#23)
strength)##8##1##(1992-3#1)(1992-8#1)(1995-11#1)(2008-10#4)(2010-4#1)
strength/power athletes##4##2##(2008-5#4)
strengthen and maintain##2##3##(1997-1#1)(2008-1#1)
strengthen and##4##2##(1992-3#1)(1997-1#1)(2008-1#1)(2008-7#1)
strengthen health##2##2##(2007-7#1)(2012-12#1)
strengthen the concept of##2##4##(1995-2#1)(2008-7#1)
strengthen the immune system##2##4##(2008-12#1)(2008-5#1)
strengthen the notion##2##3##(1992-8#1)(2011-1#1)
strengthen the public health##3##4##(1995-12#1)(1996-2#1)(1997-2#1)
strengthen the##56##2##(1992-6#1)(1992-8#1)(1993-12#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-2#1)(1997-2#1)(2004-12#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#3)(2012-3#6)(2013-1#2)(2013-7#1)(2013-8#2)
strengthen their##5##2##(1991-2#1)(1992-3#1)(1997-2#1)(2010-3#1)(2012-12#1)
strengthen##97##1##(1990-4#1)(1991-2#1)(1991-5#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1995-1#2)(1995-12#2)(1995-2#2)(1995-5#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#2)(2004-12#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-12#3)(2007-7#2)(2008-1#2)(2008-10#3)(2008-11#4)(2008-12#2)(2008-3#2)(2008-5#4)(2008-6#2)(2008-7#2)(2009-10#1)(2009-7#1)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#8)(2012-2#4)(2012-3#7)(2013-1#2)(2013-7#1)(2013-8#2)
strengthened among##2##2##(2008-2#1)(2011-1#1)
strengthened and##2##2##(2008-2#1)(2013-8#1)
strengthened by the##3##3##(1997-3#1)(2008-1#1)(2011-1#1)
strengthened by##9##2##(1990-8#1)(1991-7#1)(1997-3#1)(2006-10#2)(2008-1#1)(2009-6#1)(2011-1#1)(2012-12#1)
strengthened in##2##2##(2008-7#1)(2012-12#1)
strengthened the##3##2##(2005-10#1)(2007-7#1)(2012-12#1)
strengthened through##4##2##(1995-3#1)(2008-10#1)(2009-11#1)(2013-1#1)
strengthened##46##1##(1990-10#1)(1990-8#1)(1991-7#1)(1995-10#1)(1995-3#1)(1995-5#1)(1996-8#1)(1997-3#1)(2005-10#1)(2005-5#1)(2006-10#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2011-1#2)(2011-12#2)(2011-2#1)(2012-11#1)(2012-12#4)(2012-3#3)(2013-1#2)(2013-8#4)
strengthening Shen'##2##2##(2013-8#2)
strengthening and##5##2##(1996-2#1)(2006-8#1)(2009-6#1)(2012-1#1)(2013-1#1)
strengthening civil registration and vital statistics##2##6##(2012-12#2)
strengthening exercise##4##2##(2011-2#3)(2013-1#1)
strengthening national##2##2##(2007-2#1)(2009-7#1)
strengthening of the field##2##4##(2008-7#2)
strengthening of the##9##3##(1997-8#1)(2008-1#1)(2008-10#1)(2008-7#2)(2011-2#1)(2012-1#2)(2013-1#1)
strengthening of##17##2##(1992-1#1)(1997-2#1)(1997-8#1)(2005-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-5#1)(2011-2#3)(2012-1#2)(2013-1#1)
strengthening the hypothesis that##2##4##(2008-10#2)
strengthening the##20##2##(1991-2#1)(1991-3#1)(1992-6#1)(1993-6#1)(2004-4#1)(2006-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-4#1)(2009-5#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
strengthening##99##1##(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1992-1#1)(1992-6#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-8#1)(2004-4#1)(2005-5#2)(2005-8#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-2#2)(2007-5#1)(2007-8#1)(2008-1#4)(2008-10#6)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#3)(2008-9#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#3)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#10)(2012-1#4)(2012-11#1)(2012-12#6)(2012-2#1)(2012-3#5)(2013-1#7)(2013-8#6)
strengthens its##3##2##(1991-2#1)(1992-6#1)(1995-11#1)
strengthens the hypothesis that##2##4##(1991-2#1)(1993-5#1)
strengthens the##13##2##(1991-1#1)(1991-2#1)(1992-5#1)(1993-1#1)(1993-5#1)(1994-6#2)(1996-6#1)(2005-10#1)(2006-2#1)(2007-9#1)(2010-9#1)(2012-12#1)
strengthens##21##1##(1991-1#1)(1991-2#2)(1991-4#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-5#1)(1994-6#2)(1995-11#1)(1996-6#1)(2005-10#1)(2006-2#1)(2007-9#1)(2008-12#1)(2009-4#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-7#1)
strengths and limitations are##2##4##(1993-4#1)(2012-1#1)
strengths and limitations of the##5##5##(2005-10#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
strengths and limitations of this##2##5##(1993-1#1)(2006-10#1)
strengths and limitations of##11##4##(1993-1#1)(2005-10#1)(2006-10#2)(2008-10#1)(2008-7#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
strengths and limitations##16##3##(1993-1#1)(1993-4#1)(1996-3#1)(2005-10#1)(2006-10#3)(2008-10#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
strengths and weaknesses and##2##4##(1996-2#1)(2008-9#1)
strengths and weaknesses of the##7##5##(1992-12#1)(1994-1#1)(2006-12#1)(2007-1#1)(2007-8#1)(2008-2#1)(2012-1#1)
strengths and weaknesses of##18##4##(1992-12#1)(1994-1#1)(1994-6#1)(1996-3#1)(1997-2#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-2#1)(2011-12#1)(2011-2#2)(2012-1#1)
strengths and weaknesses within##2##4##(1994-1#1)(2008-11#1)
strengths and weaknesses##37##3##(1992-12#1)(1993-2#1)(1994-1#2)(1994-3#1)(1994-6#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-8#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-8#2)(2008-11#2)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-5#1)(2010-2#1)(2011-12#1)(2011-2#3)(2012-1#1)(2013-1#1)
strengths and##73##2##(1992-12#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-1#2)(1994-3#2)(1994-6#1)(1996-2#1)(1996-3#3)(1997-2#1)(1997-8#1)(2005-10#1)(2005-11#3)(2006-10#5)(2006-12#1)(2006-6#1)(2007-1#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-1#1)(2009-4#1)(2009-5#2)(2010-11#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#3)
strengths as##2##2##(2007-9#1)(2008-6#1)
strengths for##3##2##(1992-9#1)(1995-1#1)(2005-4#1)
strengths has been##2##3##(1995-2#1)(1997-6#1)
strengths in the##2##3##(2005-4#1)(2008-10#1)
strengths in##9##2##(1991-12#1)(1993-6#1)(2005-4#1)(2008-10#3)(2008-3#1)(2013-1#1)(2013-8#1)
strengths of the##16##3##(1995-11#1)(1995-2#1)(1995-9#1)(1996-2#1)(1997-4#1)(2006-12#1)(2006-4#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-8#1)(2009-12#2)(2012-3#1)(2013-1#2)
strengths of##43##2##(1995-11#2)(1995-2#2)(1995-5#1)(1995-9#2)(1996-1#1)(1996-2#1)(1997-4#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-12#2)(2007-3#1)(2008-1#3)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)(2009-12#2)(2009-2#1)(2010-2#1)(2010-3#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#4)
strengths ranging from 0##2##4##(2008-10#1)(2009-7#1)
strengths such as##2##3##(2010-8#1)(2011-2#1)
strengths than##3##2##(2008-11#1)(2008-12#1)(2009-7#1)
strengths that##2##2##(2008-12#1)(2011-1#1)
strengths were##3##2##(2007-9#1)(2008-10#1)(2008-6#1)
strengths##209##1##(1990-3#1)(1990-8#1)(1991-1#1)(1991-12#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-1#2)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-2#5)(1995-5#1)(1995-9#2)(1996-1#2)(1996-2#2)(1996-3#3)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-9#1)(2005-10#1)(2005-11#5)(2005-4#3)(2006-10#7)(2006-12#2)(2006-4#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-4#1)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#16)(2008-11#5)(2008-12#6)(2008-2#4)(2008-3#9)(2008-4#4)(2008-5#3)(2008-6#5)(2008-7#6)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#2)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#2)(2010-11#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#6)(2011-12#1)(2011-2#7)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#11)(2013-8#3)
strengths&quot##2##1##(1992-12#1)(2011-1#1)
strenuous exercise##3##2##(1990-11#1)(1995-12#1)(2013-8#1)
strenuous##12##1##(1990-11#2)(1995-12#1)(2007-4#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-9#1)(2013-1#2)(2013-8#1)
strenuously##2##1##(2005-12#1)(2009-3#1)
streptavidin and##4##2##(1991-4#1)(1992-8#2)(2008-10#1)
streptavidin as a##2##3##(1995-11#1)(2009-12#1)
streptavidin as##3##2##(1995-11#2)(2009-12#1)
streptavidin conjugated##2##2##(1990-12#1)(2008-10#1)
streptavidin is##3##2##(2008-4#3)
streptavidin modified screen-printed carbon electrodes##2##5##(2008-10#2)
streptavidin moiety##2##2##(1991-4#1)(2008-4#1)
streptavidin moves to the##2##4##(2009-12#2)
streptavidin to##4##2##(1990-2#1)(1995-11#1)(2008-11#1)(2008-7#1)
streptavidin was##4##2##(1990-12#1)(1993-6#1)(2008-10#2)
streptavidin with##3##2##(1991-4#1)(1995-11#2)
streptavidin##72##1##(1990-12#2)(1990-2#2)(1990-4#7)(1991-4#4)(1992-8#2)(1993-6#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#6)(1995-2#2)(1995-8#1)(1997-2#5)(2005-12#1)(2008-10#14)(2008-11#1)(2008-4#7)(2008-7#2)(2008-9#3)(2009-12#8)
streptavidin)##2##1##(1995-8#1)(2008-4#1)
streptavidin-agarose##2##1##(1990-2#1)(2008-4#1)
streptavidin-biotin##8##1##(1991-10#2)(1991-4#1)(1995-11#1)(1995-2#2)(2008-10#1)(2011-2#1)
streptavidin-bound##4##1##(1995-11#4)
streptavidin-coated magnetic beads##3##3##(1995-6#3)
streptavidin-coated##4##1##(1995-6#3)(2008-9#1)
streptavidin-containing chimeric proteins##3##3##(1991-4#3)
streptococcal binding##3##2##(1990-12#3)
streptococcal disease##2##2##(1991-8#1)(2007-12#1)
streptococcal infection##6##2##(2006-10#2)(2007-8#1)(2011-2#3)
streptococcal infections and rheumatoid##2##4##(2007-7#2)
streptococcal infections##9##2##(1990-8#1)(1992-2#1)(1995-6#1)(2006-10#1)(2007-12#1)(2007-7#3)(2011-2#1)
streptococcal pharyngitis##3##2##(1991-12#1)(2007-7#1)(2008-4#1)
streptococcal protein G##3##3##(1992-7#2)(1994-11#1)
streptococcal species##4##2##(2010-12#1)(2011-1#2)(2012-2#1)
streptococcal toxic shock syndrome##5##4##(2006-10#4)(2007-12#1)
streptococcal##55##1##(1990-11#1)(1990-12#3)(1990-8#2)(1991-12#2)(1991-8#3)(1992-2#1)(1992-7#2)(1994-11#1)(1994-2#1)(1995-6#1)(1995-8#1)(2006-10#10)(2006-4#1)(2007-12#4)(2007-7#5)(2007-8#2)(2008-10#1)(2008-4#2)(2009-9#1)(2010-12#1)(2010-5#1)(2011-1#3)(2011-2#5)(2012-2#1)
streptococci (GBS)##3##2##(1991-8#1)(2006-7#1)(2007-8#1)
streptococci and##6##2##(2005-7#1)(2006-10#1)(2006-6#1)(2006-8#1)(2011-1#2)
streptococci isolated from##2##3##(2006-8#1)(2010-4#1)
streptococci that##2##2##(1991-8#1)(1995-11#1)
streptococci##57##1##(1990-10#1)(1990-12#1)(1990-8#3)(1991-11#1)(1991-4#1)(1991-8#3)(1993-10#1)(1993-5#1)(1994-8#2)(1995-11#1)(1995-8#1)(1997-4#1)(2005-7#2)(2005-8#1)(2006-1#2)(2006-10#4)(2006-6#2)(2006-7#2)(2006-8#7)(2007-7#3)(2007-8#4)(2008-3#1)(2010-4#1)(2011-1#7)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
streptococci)##2##1##(1997-3#1)(2007-7#1)
streptococci]##5##1##(1990-8#4)(1993-5#1)
streptococcus mutans##2##2##(2013-1#2)
streptococcus##29##1##(1991-2#1)(1992-10#1)(1992-12#1)(1995-5#1)(1997-2#2)(2006-10#2)(2007-12#7)(2007-3#1)(2007-7#1)(2007-8#1)(2008-2#1)(2009-5#1)(2010-2#1)(2010-4#2)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
streptokinase (SK)##2##2##(1990-12#1)(1993-8#1)
streptokinase and##6##2##(1990-3#1)(1995-6#1)(1997-4#1)(2007-11#1)(2008-8#1)(2012-2#1)
streptokinase by##3##2##(1990-3#1)(2012-2#2)
streptokinase for##2##2##(1995-6#2)
streptokinase in a##2##3##(1990-10#2)
streptokinase in##4##2##(1990-10#2)(1993-12#1)(2007-11#1)
streptokinase infusion##3##2##(1995-6#3)
streptokinase or##2##2##(1990-6#1)(1991-9#1)
streptokinase treatment##2##2##(1993-12#1)(2012-2#1)
streptokinase##51##1##(1990-10#2)(1990-12#1)(1990-3#3)(1990-6#1)(1991-9#1)(1993-12#4)(1993-8#2)(1993-9#1)(1994-12#1)(1994-6#1)(1995-6#8)(1997-2#1)(1997-4#2)(1997-8#2)(2007-10#1)(2007-11#3)(2008-10#1)(2008-7#1)(2008-8#2)(2010-12#1)(2012-2#12)
streptolysin##2##1##(1990-2#1)(1996-5#1)
streptolysin-O permeabilized##2##2##(1992-12#2)
streptolysin-O##3##1##(1992-12#2)(2012-1#1)
streptomycete##5##1##(1993-11#1)(2006-9#1)(2008-10#3)
streptomycetes were##2##2##(2008-10#2)
streptomycetes##7##1##(2007-12#1)(2008-10#5)(2011-1#1)
streptomycin and##2##2##(2006-11#1)(2010-3#1)
streptomycin or##2##2##(2008-10#2)
streptomycin sulfate##8##2##(2008-10#6)(2008-6#1)(2008-8#1)
streptomycin##36##1##(1993-12#1)(1993-8#2)(1994-7#1)(1997-2#2)(2006-11#2)(2006-8#2)(2008-10#17)(2008-5#1)(2008-6#1)(2008-8#2)(2009-6#1)(2010-10#1)(2010-2#1)(2010-3#1)(2013-1#1)
streptomycin-resistant##3##1##(1994-7#1)(2008-10#2)
streptozocin##5##1##(1990-2#1)(1995-5#3)(2011-3#1)
streptozotocin (STZ)##5##2##(1994-11#1)(1996-12#1)(2010-11#1)(2011-3#1)(2012-2#1)
streptozotocin (STZ)-induced diabetic rats##2##4##(1991-12#1)(2008-4#1)
streptozotocin (STZ)-induced diabetic##4##3##(1991-12#1)(2008-1#1)(2008-4#2)
streptozotocin (STZ)-induced##5##2##(1991-12#1)(2008-1#1)(2008-10#1)(2008-4#2)
streptozotocin administration##2##2##(1994-8#1)(2012-3#1)
streptozotocin and floxuridine##2##3##(1990-8#2)
streptozotocin and##5##2##(1990-2#1)(1990-8#2)(1995-10#1)(1996-6#1)
streptozotocin induced diabetic rats##3##4##(2007-1#3)
streptozotocin induced##4##2##(2007-1#3)(2010-2#1)
streptozotocin or alloxan##2##3##(1995-10#1)(2008-1#1)
streptozotocin##45##1##(1990-2#1)(1990-8#2)(1991-12#1)(1991-6#1)(1992-1#1)(1994-11#2)(1994-8#2)(1995-1#1)(1995-10#3)(1996-12#1)(1996-6#1)(2007-1#3)(2007-9#1)(2008-1#2)(2008-10#4)(2008-12#2)(2008-4#2)(2009-11#1)(2009-6#1)(2010-11#3)(2010-12#3)(2010-2#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#3)
streptozotocin-diabetic rats##5##2##(1994-8#1)(1996-12#1)(2007-6#1)(2007-9#2)
streptozotocin-induced diabetic rat##3##3##(1993-11#1)(1994-8#1)(2011-1#1)
streptozotocin-induced diabetic rats##8##3##(1993-11#1)(1994-3#1)(1995-1#1)(2004-11#1)(2008-12#1)(2008-4#1)(2011-3#2)
streptozotocin-induced diabetic##14##2##(1993-11#2)(1994-3#1)(1994-8#1)(1995-1#1)(2004-11#2)(2008-12#2)(2008-4#1)(2011-1#1)(2011-3#3)
streptozotocin-induced##17##1##(1993-11#2)(1994-11#1)(1994-3#1)(1994-8#1)(1995-1#1)(2004-11#2)(2008-12#3)(2008-4#1)(2011-1#1)(2011-3#3)(2012-3#1)
stress (p &lt##2##3##(2008-10#1)(2008-6#1)
stress -##2##2##(2008-11#1)(2008-7#1)
stress a##2##2##(1996-7#1)(2008-5#1)
stress adaptation##3##2##(1994-11#1)(2009-6#1)(2011-2#1)
stress affecting##2##2##(2012-12#1)(2013-8#1)
stress affects##3##2##(1996-1#2)(2008-5#1)
stress after##4##2##(1994-11#1)(1995-1#1)(1995-7#1)(2012-1#1)
stress all##2##2##(1991-4#1)(2012-2#1)
stress also##2##2##(2008-11#1)(2009-11#1)
stress among the##2##3##(2008-11#1)(2010-8#1)
stress among##10##2##(1992-12#1)(2005-10#1)(2008-11#1)(2008-4#2)(2010-10#1)(2010-8#1)(2011-2#1)(2012-2#2)
stress analysis##2##2##(2008-3#1)(2009-4#1)
stress and a##2##3##(2010-12#1)(2011-1#1)
stress and aging in##2##4##(1995-6#1)(2009-5#1)
stress and aging##4##3##(1995-12#1)(1995-6#1)(2009-5#2)
stress and antioxidant status in##2##5##(2008-7#1)(2009-8#1)
stress and antioxidant##7##3##(2005-10#1)(2008-7#2)(2009-6#1)(2009-8#1)(2010-8#1)(2012-12#1)
stress and anxiety##3##3##(2008-5#1)(2010-4#1)(2013-7#1)
stress and burnout##7##3##(1996-2#1)(2006-3#1)(2007-10#1)(2010-7#1)(2010-9#2)(2012-2#1)
stress and by##2##3##(1991-7#1)(1997-6#1)
stress and coping model##2##4##(1995-1#2)
stress and coping##10##3##(1992-1#1)(1995-1#2)(2007-10#1)(2008-11#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-2#2)
stress and defense##2##3##(2009-8#1)(2010-10#1)
stress and depression##2##3##(2008-1#2)
stress and depressive symptoms among##2##5##(2006-9#1)(2008-7#1)
stress and depressive symptoms##11##4##(2006-9#2)(2008-7#1)(2012-1#1)(2012-11#7)
stress and disease##2##3##(1994-11#1)(2004-12#1)
stress and energy##2##3##(2008-8#1)(2009-8#1)
stress and have##2##3##(2007-12#1)(2008-7#1)
stress and high##2##3##(2008-1#1)(2008-2#1)
stress and hypertension##2##3##(2008-7#1)(2013-7#1)
stress and infection##2##3##(1995-12#2)
stress and injury##4##3##(2008-11#1)(2008-4#2)(2011-2#1)
stress and its##6##3##(1997-6#1)(2008-10#1)(2008-7#1)(2009-7#1)(2009-8#1)(2012-1#1)
stress and low##2##3##(2007-12#1)(2008-8#1)
stress and may##2##3##(2006-6#1)(2008-10#1)
stress and mental health in##2##5##(2010-2#1)(2010-8#1)
stress and mental health##3##4##(2010-2#2)(2010-8#1)
stress and mental##4##3##(2006-9#1)(2010-2#2)(2010-8#1)
stress and metabolism##3##3##(2008-10#1)(2010-3#2)
stress and more##2##3##(2007-11#1)(2013-1#1)
stress and other##3##3##(2008-10#1)(2009-7#1)(2011-1#1)
stress and pathological##2##3##(1995-12#1)(2010-4#1)
stress and somatic##2##3##(2008-2#1)(2011-2#1)
stress and strain distributions##2##4##(2013-1#2)
stress and strain##7##3##(1996-4#1)(2007-4#1)(2008-7#1)(2009-4#2)(2013-1#2)
stress and stress##2##3##(2009-7#1)(2012-2#1)
stress and the increase##2##4##(1992-1#1)(1997-8#1)
stress and the##13##3##(1992-1#1)(1992-2#1)(1992-3#1)(1995-12#1)(1996-10#2)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)
stress and to##5##3##(1993-3#1)(1994-2#1)(2008-7#2)(2010-2#1)
stress and##277##2##(1990-5#1)(1991-12#1)(1991-7#1)(1992-1#3)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-10#1)(1994-11#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#12)(1995-3#3)(1995-5#1)(1995-6#1)(1996-10#2)(1996-2#1)(1996-4#3)(1996-5#1)(1996-8#1)(1996-9#3)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#1)(2004-12#1)(2005-10#2)(2005-7#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#6)(2007-1#2)(2007-10#2)(2007-11#1)(2007-12#5)(2007-4#2)(2007-5#1)(2007-8#1)(2008-1#5)(2008-10#14)(2008-11#8)(2008-2#4)(2008-3#3)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#14)(2008-8#3)(2008-9#6)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#4)(2009-8#8)(2009-9#3)(2010-10#4)(2010-12#3)(2010-2#5)(2010-3#2)(2010-4#5)(2010-5#3)(2010-7#4)(2010-8#2)(2010-9#3)(2011-1#3)(2011-12#1)(2011-2#8)(2012-1#6)(2012-11#7)(2012-12#6)(2012-2#13)(2012-5#2)(2012-6#1)(2013-1#10)(2013-7#2)(2013-8#4)
stress and/or##7##2##(1995-12#2)(1996-2#1)(2007-4#1)(2008-1#1)(2010-3#1)(2011-1#1)
stress anisotropy##3##2##(2007-12#1)(2008-3#2)
stress appear to##2##3##(1995-12#1)(2007-9#1)
stress are##10##2##(1994-6#1)(1995-5#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-12#1)
stress as a mediator##2##4##(2007-8#1)(2009-8#1)
stress as a##7##3##(1994-10#1)(1995-12#2)(2007-4#1)(2007-8#1)(2009-5#1)(2009-8#1)
stress as an important##2##4##(2011-1#1)(2012-1#1)
stress as the##2##3##(1995-12#1)(2010-4#1)
stress as well as##2##4##(1994-11#1)(2007-11#1)
stress as##19##2##(1994-10#1)(1994-11#1)(1995-12#3)(2004-11#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-5#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-4#1)(2011-1#1)(2012-1#1)
stress associated with the##2##4##(2008-8#1)(2009-4#1)
stress associated with##7##3##(2006-3#2)(2007-9#1)(2008-8#3)(2009-4#1)
stress at breaking point##2##4##(2004-9#2)
stress at fracture##5##3##(2008-7#5)
stress at the##6##3##(1997-8#1)(2005-9#1)(2007-11#2)(2008-3#1)(2009-6#1)
stress at##22##2##(1990-12#1)(1995-12#1)(1997-3#1)(1997-8#1)(2004-9#2)(2005-9#1)(2006-3#1)(2007-1#1)(2007-11#2)(2007-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#5)(2009-6#1)(2013-8#1)
stress because of##2##3##(1997-2#1)(2011-1#1)
stress behaviors##3##2##(1991-12#3)
stress being laid on##2##4##(1990-10#1)(1990-3#1)
stress biomarkers##5##2##(2007-8#3)(2010-5#1)(2011-2#1)
stress birefringence##2##2##(2007-12#1)(2008-3#1)
stress but##2##2##(1995-5#1)(2013-1#1)
stress by##22##2##(1991-4#1)(1991-9#1)(1994-11#1)(1994-6#2)(1997-7#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#1)(2011-2#3)(2012-2#2)(2013-7#1)(2013-8#1)
stress can be##4##3##(2005-1#1)(2008-1#1)(2008-2#1)(2010-10#1)
stress can##15##2##(1993-11#1)(1996-10#1)(2005-1#1)(2005-9#1)(2008-1#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-7#1)(2010-10#1)
stress cause##2##2##(1995-3#1)(2006-10#1)
stress caused by##5##3##(1997-6#1)(1997-7#1)(2008-10#1)(2008-7#1)(2010-7#1)
stress caused##7##2##(1997-6#1)(1997-7#1)(2008-10#1)(2008-7#1)(2010-7#1)(2011-10#1)(2012-1#1)
stress causes##4##2##(1995-12#1)(1997-8#1)(2008-6#1)(2009-6#1)
stress changes##3##2##(1996-4#2)(2007-12#1)
stress components##2##2##(2007-11#1)(2008-2#1)
stress concentration##5##2##(2004-9#2)(2005-10#1)(2006-12#1)(2012-2#1)
stress condition##3##2##(2007-12#1)(2008-12#1)(2009-6#1)
stress conditions and##2##3##(2009-8#1)(2012-11#1)
stress conditions in##2##3##(2011-2#1)(2013-7#1)
stress conditions##36##2##(1995-12#1)(1997-4#1)(2006-12#3)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2009-6#1)(2009-8#3)(2010-10#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#1)(2012-7#1)(2013-7#5)
stress connected with##2##3##(2007-7#1)(2007-9#1)
stress contributes to the##4##4##(2005-11#1)(2009-6#1)(2010-8#1)(2011-2#1)
stress contributes##5##2##(1991-11#1)(2005-11#1)(2009-6#1)(2010-8#1)(2011-2#1)
stress could##7##2##(1991-5#1)(2006-12#1)(2008-10#2)(2008-12#1)(2011-10#1)(2013-8#1)
stress decreased the##2##3##(1997-8#1)(2013-8#1)
stress decreased##4##2##(1997-8#1)(2011-1#1)(2012-1#1)(2013-8#1)
stress defense##2##2##(2009-8#1)(2010-11#1)
stress dependent##2##2##(1995-12#1)(2007-12#1)
stress developed##2##2##(2008-3#1)(2009-7#1)
stress did not##3##3##(1993-7#1)(1995-5#1)(2008-11#1)
stress disorder (PTSD) and##4##4##(2006-8#1)(2008-8#1)(2008-9#1)(2012-12#1)
stress disorder (PTSD) is a##2##5##(2005-10#1)(2008-6#1)
stress disorder (PTSD) is##6##4##(1996-7#1)(2005-10#1)(2008-6#2)(2008-9#1)(2012-12#1)
stress disorder (PTSD)##26##3##(1995-11#1)(1996-7#1)(2005-10#2)(2006-8#1)(2007-7#1)(2008-6#3)(2008-8#1)(2008-9#2)(2009-11#1)(2009-7#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#5)(2013-1#1)(2013-7#1)(2013-8#1)
stress disorder and##4##3##(1991-2#1)(2009-9#1)(2012-12#1)(2013-8#1)
stress disorder in##4##3##(2008-11#1)(2009-6#1)(2010-12#1)(2013-7#1)
stress disorder patients##3##3##(1996-5#2)(2008-6#1)
stress disorder##66##2##(1991-2#1)(1994-11#1)(1995-11#1)(1995-12#1)(1996-11#1)(1996-5#2)(1996-7#2)(2005-10#3)(2006-3#1)(2006-8#3)(2007-12#1)(2007-7#2)(2008-11#1)(2008-6#7)(2008-8#1)(2008-9#3)(2009-11#3)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#3)(2011-1#1)(2011-2#2)(2012-1#5)(2012-12#7)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#5)
stress disorders##2##2##(1991-2#1)(2006-10#1)
stress distribution in a##2##4##(2008-2#1)(2008-3#1)
stress distribution in the##2##4##(2006-11#1)(2010-2#1)
stress distribution in##5##3##(2006-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-2#1)
stress distribution##13##2##(1996-4#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2010-2#1)(2013-1#1)(2013-8#2)
stress do not##2##3##(1992-1#1)(1992-5#1)
stress does not##2##3##(1991-9#1)(2008-2#1)
stress drop##5##2##(1996-4#5)
stress due to##3##3##(2007-11#1)(2008-7#1)(2010-2#1)
stress during##10##2##(1990-12#2)(1992-1#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2010-8#1)
stress dynamic##3##2##(1992-12#3)
stress echocardiography was##2##3##(1994-11#1)(2009-5#1)
stress echocardiography##7##2##(1994-11#2)(2009-10#2)(2009-4#1)(2009-5#2)
stress effect##2##2##(1997-5#1)(2008-8#1)
stress environment##2##2##(2008-9#1)(2009-6#1)
stress even##2##2##(1993-12#1)(2013-1#1)
stress exerted##2##2##(2005-11#1)(2008-7#1)
stress experienced by##4##3##(1991-12#1)(1992-2#1)(2008-11#1)(2009-8#1)
stress experiences##2##2##(2007-2#1)(2013-1#1)
stress exposure and##2##3##(2009-7#1)(2012-3#1)
stress exposure##11##2##(1991-10#1)(2008-5#1)(2009-7#1)(2010-12#3)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
stress factor##2##2##(2007-3#1)(2012-1#1)
stress factors##11##2##(1990-6#1)(1990-9#1)(2006-12#1)(2007-8#2)(2008-10#1)(2008-12#1)(2009-5#1)(2009-6#1)(2010-9#1)(2011-1#1)
stress fiber formation##2##3##(1997-6#2)
stress fiber##3##2##(1997-6#2)(1997-7#1)
stress fibers were##2##3##(2008-6#1)(2008-7#1)
stress fibers##10##2##(1994-8#1)(1997-4#1)(2008-6#5)(2008-7#2)(2010-2#1)
stress fibres##2##2##(1993-6#1)(2007-8#1)
stress field##7##2##(1996-4#1)(2007-12#1)(2008-2#1)(2008-7#1)(2009-7#2)(2013-8#1)
stress fields##2##2##(2006-6#1)(2008-7#1)
stress followed by a##2##4##(1996-11#1)(2008-2#1)
stress following##2##2##(2007-11#1)(2013-8#1)
stress for##10##2##(1992-9#1)(1995-12#1)(2007-10#1)(2008-11#1)(2008-6#1)(2009-2#1)(2009-6#1)(2010-1#1)(2010-10#1)(2013-8#1)
stress fracture of##2##3##(1993-11#1)(2007-11#1)
stress fracture##4##2##(1993-11#1)(1996-6#1)(2007-11#1)(2010-12#1)
stress fractures of the##3##4##(1991-11#3)
stress fractures of##4##3##(1991-11#3)(2008-7#1)
stress fractures##10##2##(1991-11#5)(2007-11#1)(2008-7#1)(2009-11#1)(2010-4#1)(2012-11#1)
stress from the##2##3##(1995-6#1)(2008-3#1)
stress from##8##2##(1991-11#1)(1995-6#1)(1996-9#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-3#2)
stress generation##2##2##(2009-7#1)(2012-12#1)
stress genes##2##2##(1995-8#1)(2011-1#1)
stress granules##2##2##(2012-12#1)(2012-2#1)
stress has been associated with##2##5##(1995-11#1)(2012-2#1)
stress has been##7##3##(1995-11#1)(1995-12#1)(2008-10#2)(2009-3#1)(2012-2#1)(2012-3#1)
stress has##11##2##(1993-11#1)(1995-11#1)(1995-12#1)(1997-4#1)(2008-10#2)(2008-7#1)(2009-3#1)(2010-4#1)(2012-2#1)(2012-3#1)
stress have been##9##3##(2005-10#1)(2006-3#1)(2006-8#1)(2007-8#1)(2008-7#1)(2008-8#1)(2012-11#2)(2013-1#1)
stress have##10##2##(2005-10#1)(2006-3#1)(2006-8#1)(2007-8#1)(2008-7#1)(2008-8#1)(2012-11#2)(2013-1#1)(2013-7#1)
stress hormone##4##2##(1995-12#2)(2007-2#1)(2008-5#1)
stress hormones##8##2##(1995-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-3#1)(2011-12#1)(2013-1#2)
stress imposed by##2##3##(2008-1#1)(2009-12#1)
stress imposed##3##2##(2008-1#1)(2008-5#1)(2009-12#1)
stress in a##6##3##(2005-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-4#1)
stress in adult rats##2##4##(2004-11#1)(2008-11#1)
stress in adult##3##3##(1996-11#1)(2004-11#1)(2008-11#1)
stress in chronic##2##3##(1995-1#1)(2013-7#1)
stress in cultured##2##3##(1997-8#1)(2010-3#1)
stress in human##2##3##(1994-3#1)(1996-8#1)
stress in isolated##2##3##(1995-3#1)(2013-1#1)
stress in mice##4##3##(1991-1#1)(1993-9#1)(1995-12#1)(2010-5#1)
stress in order to##2##4##(2006-6#1)(2013-1#1)
stress in protein##4##3##(1996-5#1)(2006-6#3)
stress in rabbits##2##3##(2012-1#2)
stress in rats##2##3##(1991-10#1)(2012-2#1)
stress in that##2##3##(1990-8#1)(1995-12#1)
stress in the brain##2##4##(1994-11#1)(2008-8#1)
stress in the human##2##4##(2008-11#1)(2010-9#1)
stress in the##45##3##(1990-4#1)(1992-8#1)(1994-11#1)(1994-2#1)(1995-12#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-9#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-7#4)(2008-8#1)(2009-10#2)(2009-4#1)(2009-7#3)(2010-11#2)(2010-12#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2012-1#1)(2012-2#1)(2013-1#3)(2013-7#1)
stress in vivo##4##3##(1997-2#3)(2006-12#1)
stress in women##2##3##(2007-10#1)(2009-6#1)
stress in##187##2##(1990-10#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-12#6)(1995-3#1)(1995-5#1)(1995-8#2)(1996-11#1)(1996-3#1)(1996-5#1)(1996-8#2)(1996-9#3)(1997-2#4)(1997-5#1)(1997-6#1)(1997-8#2)(2004-11#1)(2004-2#1)(2004-9#1)(2005-10#2)(2005-11#1)(2006-12#1)(2006-3#1)(2006-5#2)(2006-6#4)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#10)(2008-2#4)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#8)(2008-8#2)(2008-9#1)(2009-10#3)(2009-12#2)(2009-2#1)(2009-4#2)(2009-6#9)(2009-7#3)(2009-8#2)(2010-11#2)(2010-12#3)(2010-3#3)(2010-4#5)(2010-5#2)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#7)(2011-2#3)(2012-1#4)(2012-12#1)(2012-2#4)(2012-5#1)(2012-7#1)(2013-1#12)(2013-7#2)(2013-8#3)
stress incontinence##13##2##(1990-12#1)(1994-3#2)(1995-5#2)(1996-12#1)(2006-7#1)(2006-9#2)(2007-12#1)(2007-4#2)(2008-1#1)
stress increase##2##2##(1991-12#1)(1993-7#1)
stress increased the##2##3##(1996-8#1)(2008-11#1)
stress increased##4##2##(1996-8#1)(2008-11#1)(2012-11#1)(2013-1#1)
stress increases##7##2##(1992-11#1)(1993-11#1)(1993-7#1)(1995-12#1)(2007-12#1)(2009-5#2)
stress induced by##10##3##(1990-7#1)(1993-9#1)(1995-2#1)(2007-1#1)(2007-6#1)(2008-3#1)(2008-7#1)(2009-7#1)(2012-2#1)(2013-1#1)
stress induced##21##2##(1990-7#1)(1993-9#1)(1994-11#1)(1995-12#1)(1995-2#1)(2007-1#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-2#2)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
stress induces##3##2##(1994-3#1)(1997-3#1)(2009-8#1)
stress influenced##3##2##(2008-9#1)(2010-2#1)(2012-12#1)
stress intensity factor##2##3##(2005-11#1)(2008-2#1)
stress is a##8##3##(1995-6#1)(2005-11#1)(2006-2#1)(2008-1#1)(2008-5#1)(2009-8#1)(2010-2#1)(2013-1#1)
stress is an important##2##4##(1992-9#1)(2012-2#1)
stress is an##3##3##(1992-9#1)(2012-2#1)(2013-8#1)
stress is associated with a##2##5##(2012-2#1)(2013-1#1)
stress is associated with##3##4##(2008-7#1)(2012-2#1)(2013-1#1)
stress is laid on the importance of##2##7##(1990-3#1)(2007-7#1)
stress is laid on##3##4##(1990-3#2)(2007-7#1)
stress is not##2##3##(1990-5#1)(2009-6#1)
stress is one of the##2##5##(2008-12#1)(2011-2#1)
stress is one##3##3##(2008-12#1)(2009-9#1)(2011-2#1)
stress is reduced##2##3##(1991-8#1)(2007-12#1)
stress is thought to##2##4##(1995-12#1)(2013-1#1)
stress is##55##2##(1990-3#2)(1990-5#1)(1991-8#1)(1992-9#1)(1993-12#1)(1994-2#1)(1995-12#2)(1995-6#1)(2005-10#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#4)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#1)(2008-12#2)(2008-2#1)(2008-5#2)(2008-7#1)(2009-10#2)(2009-5#1)(2009-6#2)(2009-8#2)(2009-9#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#3)(2013-1#3)(2013-8#1)
stress kinase##3##2##(2011-2#1)(2012-12#1)(2013-7#1)
stress led to##2##3##(2008-10#1)(2013-1#1)
stress level and##2##3##(2008-4#1)(2010-10#1)
stress level##4##2##(1996-9#1)(2008-4#2)(2010-10#1)
stress levels as a##2##4##(2008-8#1)(2009-5#1)
stress levels of##4##3##(2008-7#1)(2010-10#1)(2010-2#1)(2012-1#1)
stress levels##18##2##(2006-6#1)(2007-3#1)(2007-9#1)(2008-2#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-7#1)(2010-10#3)(2010-2#1)(2011-1#1)(2012-1#1)(2013-8#1)
stress made##2##2##(2011-2#1)(2013-8#1)
stress management techniques##2##3##(2006-3#2)
stress management##14##2##(1994-2#1)(1996-2#1)(2006-3#4)(2007-3#1)(2008-4#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-1#2)(2013-1#1)
stress marker##2##2##(2009-10#1)(2012-2#1)
stress markers in##5##3##(2009-6#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-1#1)
stress markers##13##2##(2009-6#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-5#2)(2013-1#3)
stress may be##6##3##(1994-10#1)(1994-11#1)(1994-3#1)(1995-9#1)(1996-4#1)(2008-9#1)
stress may##14##2##(1991-9#1)(1992-12#1)(1994-10#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-9#1)(1996-4#1)(2004-12#2)(2008-2#1)(2008-9#1)(2012-1#1)(2013-8#1)
stress measurement##2##2##(2007-11#1)(2007-12#1)
stress measurements##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
stress measures##2##2##(2009-7#1)(2012-3#1)
stress mechanisms##2##2##(2006-6#1)(2008-5#1)
stress mediators##2##2##(1995-12#1)(2009-3#1)
stress might##2##2##(1991-6#1)(1996-8#1)
stress model##4##2##(2007-10#1)(2008-11#1)(2008-4#1)(2010-8#1)
stress models##2##2##(1995-12#1)(2008-2#1)
stress occurring##2##2##(2008-3#1)(2009-4#1)
stress occurs##2##2##(1996-3#1)(2006-6#1)
stress of a##3##3##(2008-2#1)(2008-3#1)(2011-2#1)
stress of being restrained##2##4##(1996-1#2)
stress of surgery##2##3##(2006-10#2)
stress of the##6##3##(2006-10#1)(2007-12#1)(2007-7#1)(2008-7#2)(2012-3#1)
stress of various##2##3##(2008-5#1)(2013-1#1)
stress of workers##2##3##(2008-2#1)(2010-12#1)
stress of##51##2##(1990-7#1)(1991-10#2)(1991-4#1)(1992-6#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1996-1#2)(2004-11#1)(2005-9#1)(2006-10#3)(2006-5#1)(2007-10#2)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#4)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#3)(2009-7#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
stress on cell##2##3##(2008-11#1)(2009-12#1)
stress on disturbances in##2##4##(2010-12#2)
stress on hippocampal##2##3##(1995-12#1)(2008-7#1)
stress on plasma##2##3##(1992-1#1)(2013-1#1)
stress on sleep##2##3##(1997-3#1)(2012-2#1)
stress on the upper limbs##2##5##(1993-12#1)(2013-7#1)
stress on the##28##3##(1990-8#1)(1991-6#1)(1991-9#1)(1993-12#1)(1995-12#1)(1995-5#1)(1997-4#1)(2005-11#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-8#2)(2010-8#1)(2011-1#2)(2012-3#1)(2013-7#1)(2013-8#1)
stress on##85##2##(1990-8#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-7#2)(1994-10#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-12#5)(1995-5#1)(1995-6#1)(1996-5#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#5)(2008-12#5)(2008-2#1)(2008-5#1)(2008-6#3)(2008-7#5)(2009-12#1)(2009-6#2)(2009-8#2)(2010-12#8)(2010-2#1)(2010-8#1)(2011-1#3)(2012-2#2)(2012-3#5)(2013-1#3)(2013-7#1)(2013-8#1)
stress only##2##2##(2008-1#1)(2008-11#1)
stress or injury##2##3##(2008-1#1)(2010-5#1)
stress or##17##2##(1995-12#1)(1995-5#1)(1996-5#2)(2005-11#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-1#2)(2013-1#1)
stress parameters##2##2##(2007-9#1)(2008-11#1)
stress pathways##4##2##(2007-11#1)(2010-4#1)(2012-12#2)
stress physiology##2##2##(2010-2#2)
stress play##3##2##(2008-12#1)(2008-7#1)(2012-2#1)
stress process##2##2##(2006-9#1)(2013-1#1)
stress processes##3##2##(2010-2#3)
stress produced##2##2##(2009-8#2)
stress profile##4##2##(2007-11#4)
stress profiles##3##2##(2009-11#2)(2011-12#1)
stress promotes##2##2##(2007-11#1)(2013-7#1)
stress protein in##2##3##(2009-7#1)(2013-8#1)
stress protein##11##2##(1993-12#2)(1993-6#1)(1994-11#1)(1995-3#1)(1996-1#1)(2008-7#1)(2009-7#2)(2013-8#2)
stress proteins in##6##3##(1992-5#1)(1993-6#1)(1994-11#1)(1994-8#1)(2008-7#2)
stress proteins##19##2##(1990-4#1)(1990-5#1)(1992-5#3)(1993-6#1)(1994-11#2)(1994-8#1)(1995-6#1)(1996-1#1)(1996-9#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#3)
stress rather than##2##3##(2008-5#1)(2010-7#1)
stress rats##2##2##(1995-12#1)(2008-10#1)
stress reaction##10##2##(2006-3#2)(2006-9#1)(2008-5#3)(2009-7#1)(2010-12#1)(2011-2#2)
stress reactions and##2##3##(1993-6#1)(2011-2#1)
stress reactions##3##2##(1993-6#1)(2008-11#1)(2011-2#1)
stress reduction##3##2##(1993-6#1)(2007-2#1)(2010-7#1)
stress reductions##2##2##(2008-12#1)(2009-9#1)
stress related##3##2##(2007-7#1)(2008-7#1)(2011-2#1)
stress relaxation in the##2##4##(2007-12#1)(2008-3#1)
stress relaxation##9##2##(2007-1#1)(2007-12#3)(2007-4#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-7#1)
stress relief proteins in##2##4##(1996-9#2)
stress relief proteins##3##3##(1996-9#3)
stress relief##4##2##(1996-9#3)(2013-1#1)
stress research##2##2##(1991-4#1)(2011-2#1)
stress resistance and##2##3##(2008-4#1)(2011-2#1)
stress resistance##12##2##(2006-12#1)(2008-12#2)(2008-4#2)(2008-6#1)(2008-8#1)(2009-5#3)(2011-2#2)
stress response and the##2##4##(2006-10#1)(2012-12#1)
stress response and##4##3##(2006-10#1)(2012-12#2)(2013-7#1)
stress response behaviors##2##3##(2008-7#2)
stress response by##2##3##(2008-7#2)
stress response genes##5##3##(1994-5#1)(2010-12#1)(2012-2#1)(2013-8#2)
stress response has##2##3##(2008-10#1)(2011-2#1)
stress response in##9##3##(1997-2#1)(2006-10#1)(2007-11#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-7#1)
stress response is the##2##4##(2006-8#1)(2012-12#1)
stress response is##3##3##(1994-3#1)(2006-8#1)(2012-12#1)
stress response mechanisms##2##3##(2008-2#1)(2008-7#1)
stress response of##4##3##(1995-8#1)(2006-8#1)(2009-8#2)
stress response pathway##2##3##(2006-12#1)(2012-2#1)
stress response protein##4##3##(1997-7#2)(2007-12#1)(2011-2#1)
stress response to##8##3##(1995-8#3)(1997-2#1)(2008-10#1)(2008-11#2)(2012-3#1)
stress response was##2##3##(1997-2#1)(2010-12#1)
stress response##99##2##(1992-12#1)(1994-11#1)(1994-3#2)(1994-5#1)(1995-12#8)(1995-8#4)(1996-4#1)(1996-9#1)(1997-2#6)(1997-7#2)(2006-10#6)(2006-12#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#7)(2008-8#1)(2009-8#6)(2010-11#1)(2010-12#5)(2011-1#2)(2011-2#7)(2012-12#6)(2012-2#5)(2012-3#3)(2013-7#2)(2013-8#2)
stress responses and##4##3##(2009-8#1)(2012-1#2)(2012-12#1)
stress responses by##2##3##(2008-7#1)(2009-6#1)
stress responses for##2##3##(2008-3#1)(2012-1#1)
stress responses in##5##3##(1997-8#2)(2008-7#2)(2011-2#1)
stress responses including##2##3##(2009-8#1)(2012-1#1)
stress responses of the##2##4##(1995-12#1)(2013-1#1)
stress responses##46##2##(1991-11#1)(1994-11#1)(1995-12#1)(1997-8#2)(2006-10#1)(2006-11#1)(2006-12#1)(2008-10#2)(2008-3#4)(2008-4#1)(2008-7#4)(2008-9#1)(2009-10#1)(2009-6#3)(2009-8#6)(2010-2#1)(2011-2#3)(2012-1#6)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
stress responsiveness##2##2##(1994-11#1)(1995-12#1)
stress resulted in##2##3##(1995-12#1)(2008-5#1)
stress resulting from##3##3##(1993-12#1)(1994-8#1)(2008-9#1)
stress resulting##4##2##(1993-12#1)(1994-8#1)(2008-11#1)(2008-9#1)
stress results in##2##3##(2007-11#1)(2012-3#1)
stress sensitivity##2##2##(1994-11#1)(2011-1#1)
stress shielding##4##2##(2007-11#1)(2008-5#2)(2009-7#1)
stress should##2##2##(2006-6#1)(2008-7#1)
stress signaling##2##2##(2009-8#1)(2013-7#1)
stress signals##4##2##(2009-6#2)(2009-8#1)(2011-2#1)
stress significantly##2##2##(1990-3#1)(2008-7#1)
stress situations##2##2##(1995-12#1)(2009-5#1)
stress specific genes##3##3##(2013-8#3)
stress specific##4##2##(1994-2#1)(2013-8#3)
stress states##3##2##(1995-12#1)(2004-9#1)(2008-7#1)
stress stimuli##4##2##(1995-12#2)(2007-9#1)(2008-11#1)
stress studies##4##2##(1997-8#1)(2010-12#1)(2010-2#1)(2012-12#1)
stress study##2##2##(2010-12#2)
stress such as##4##3##(1995-12#1)(1997-6#1)(2006-10#1)(2006-12#1)
stress symptoms##15##2##(2008-11#1)(2008-7#1)(2009-11#2)(2009-7#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#3)
stress syndrome##2##2##(1996-11#1)(2005-8#1)
stress system##6##2##(1995-12#4)(2012-3#2)
stress tensor##6##2##(2007-11#3)(2008-3#1)(2009-10#2)
stress test with##2##3##(1997-8#1)(2012-2#1)
stress test##15##2##(1996-4#1)(1997-4#1)(1997-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-8#2)(2012-2#4)
stress testing of##3##3##(1997-8#1)(2010-12#1)(2011-1#1)
stress testing##10##2##(1991-4#1)(1997-6#1)(1997-8#1)(2008-3#2)(2008-7#2)(2009-10#1)(2010-12#1)(2011-1#1)
stress tests##6##2##(1990-3#1)(2008-10#1)(2008-3#2)(2012-2#1)(2013-1#1)
stress thallium cardiac imaging services##2##5##(1992-12#2)
stress than##11##2##(1990-6#1)(1992-11#1)(1995-9#1)(2006-12#1)(2008-4#2)(2008-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-7#1)
stress that in turn##2##4##(1991-9#1)(1996-4#1)
stress that is##2##3##(2009-3#1)(2012-1#1)
stress that the##3##3##(2008-9#1)(2009-9#1)(2013-1#1)
stress that##21##2##(1990-11#1)(1991-4#1)(1991-9#1)(1993-9#1)(1996-12#1)(1996-4#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-2#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#1)
stress the importance of their##2##5##(1992-2#1)(2007-11#1)
stress the importance of using##2##5##(2004-4#1)(2007-8#1)
stress the importance of##18##4##(1990-9#1)(1991-10#1)(1992-12#1)(1992-2#1)(2004-4#1)(2005-11#1)(2005-6#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-4#1)
stress the need for##5##4##(1992-4#1)(1992-7#1)(2008-10#1)(2012-2#1)(2013-1#1)
stress the need##6##3##(1992-4#1)(1992-7#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#1)
stress the usefulness##2##3##(1997-6#1)(2011-2#1)
stress the##44##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-10#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-5#1)(1992-7#1)(1993-2#1)(1994-2#1)(1994-6#1)(1997-6#1)(2004-4#1)(2005-11#1)(2005-6#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)
stress theory##5##2##(1995-12#1)(2006-3#1)(2009-5#2)(2010-2#1)
stress they##2##2##(1996-4#1)(2008-1#1)
stress time##2##2##(2007-4#1)(2013-8#1)
stress to either##3##3##(2006-11#1)(2006-12#1)(2009-8#1)
stress to the cells##2##4##(2006-5#1)(2008-11#1)
stress to the##3##3##(2006-5#1)(2008-11#1)(2008-12#1)
stress to##18##2##(1994-3#1)(1996-2#1)(2004-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#2)(2013-8#1)
stress tolerance in plants##3##4##(2006-11#1)(2011-2#2)
stress tolerance in##4##3##(2006-11#1)(2008-7#1)(2011-2#2)
stress tolerance##14##2##(2006-11#1)(2006-12#1)(2006-9#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-8#1)(2011-2#3)(2012-11#1)(2012-7#1)
stress transfer between##2##3##(2009-6#1)(2012-2#1)
stress treatment##3##2##(1997-6#1)(2008-12#1)(2009-8#1)
stress ulcer##3##2##(2008-9#1)(2012-3#2)
stress ulcers of the stomach##2##5##(2008-8#2)
stress ulcers##3##2##(2008-8#3)
stress under##3##2##(1996-9#1)(2008-10#1)(2013-1#1)
stress upon##2##2##(1994-7#1)(2009-7#1)
stress urinary incontinence (SUI)##4##4##(2007-8#1)(2008-8#1)(2011-1#1)(2011-2#1)
stress urinary incontinence caused by##2##5##(2006-10#2)
stress urinary incontinence in##3##4##(2008-10#1)(2013-1#2)
stress urinary incontinence##23##3##(1991-3#1)(1994-5#1)(2006-10#4)(2006-7#1)(2006-9#7)(2007-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#3)
stress using a##2##3##(2007-11#1)(2012-2#1)
stress using##6##2##(2007-11#1)(2008-11#1)(2008-9#1)(2009-10#1)(2009-3#1)(2012-2#1)
stress was also##2##3##(2007-3#1)(2012-1#1)
stress was assessed##4##3##(1995-3#1)(2005-8#1)(2012-2#1)(2013-8#1)
stress was evaluated by##2##4##(2006-10#1)(2010-4#1)
stress was observed in##2##4##(2008-4#1)(2009-4#1)
stress was observed##4##3##(2008-10#1)(2008-4#1)(2009-4#1)(2012-11#1)
stress was studied in##2##4##(2008-12#1)(2008-8#1)
stress was##38##2##(1992-1#1)(1992-5#1)(1995-3#1)(1996-1#1)(2004-9#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#2)(2013-1#1)(2013-8#1)
stress were##16##2##(1990-5#1)(1994-12#1)(1995-12#1)(2006-11#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-2#1)(2011-2#2)(2011-3#1)(2012-1#1)(2013-8#3)
stress which##5##2##(1992-1#1)(1994-11#1)(1995-12#1)(1996-1#1)(2009-6#1)
stress while##2##2##(1992-1#1)(1995-6#1)
stress whilst##2##2##(1994-2#1)(2008-1#1)
stress with##7##2##(1994-11#2)(2008-6#1)(2009-8#1)(2011-2#2)(2012-1#1)
stress words##3##2##(2009-11#3)
stress##2996##1##(1990-10#2)(1990-11#3)(1990-12#10)(1990-2#3)(1990-3#5)(1990-4#3)(1990-5#6)(1990-6#5)(1990-7#6)(1990-8#3)(1990-9#5)(1991-1#1)(1991-10#7)(1991-11#9)(1991-12#10)(1991-2#5)(1991-3#1)(1991-4#8)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#9)(1992-1#16)(1992-11#2)(1992-12#12)(1992-2#4)(1992-3#10)(1992-4#1)(1992-5#8)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#5)(1993-1#1)(1993-11#7)(1993-12#13)(1993-2#11)(1993-3#1)(1993-6#9)(1993-7#8)(1993-8#1)(1993-9#3)(1994-1#1)(1994-10#8)(1994-11#30)(1994-12#7)(1994-2#16)(1994-3#18)(1994-5#4)(1994-6#15)(1994-7#1)(1994-8#7)(1994-9#2)(1995-1#11)(1995-11#5)(1995-12#137)(1995-2#3)(1995-3#11)(1995-5#16)(1995-6#8)(1995-7#1)(1995-8#7)(1995-9#3)(1996-1#12)(1996-10#6)(1996-11#5)(1996-12#3)(1996-2#9)(1996-3#4)(1996-4#22)(1996-5#8)(1996-6#1)(1996-7#5)(1996-8#7)(1996-9#18)(1997-1#1)(1997-2#14)(1997-3#6)(1997-4#11)(1997-5#10)(1997-6#16)(1997-7#12)(1997-8#16)(2004-10#1)(2004-11#6)(2004-12#3)(2004-2#2)(2004-4#3)(2004-9#9)(2005-1#4)(2005-10#16)(2005-11#18)(2005-12#1)(2005-6#2)(2005-7#2)(2005-8#10)(2005-9#3)(2006-1#1)(2006-10#31)(2006-11#6)(2006-12#33)(2006-2#5)(2006-3#14)(2006-4#1)(2006-5#7)(2006-6#15)(2006-7#4)(2006-8#16)(2006-9#22)(2007-1#10)(2007-10#21)(2007-11#44)(2007-12#39)(2007-2#14)(2007-3#7)(2007-4#10)(2007-5#3)(2007-6#4)(2007-7#14)(2007-8#37)(2007-9#13)(2008-1#39)(2008-10#98)(2008-11#106)(2008-12#32)(2008-2#40)(2008-3#45)(2008-4#47)(2008-5#75)(2008-6#31)(2008-7#136)(2008-8#32)(2008-9#31)(2009-1#2)(2009-10#39)(2009-11#20)(2009-12#8)(2009-2#4)(2009-3#9)(2009-4#13)(2009-5#21)(2009-6#44)(2009-7#36)(2009-8#67)(2009-9#10)(2010-1#5)(2010-10#17)(2010-11#4)(2010-12#47)(2010-2#34)(2010-3#7)(2010-4#37)(2010-5#14)(2010-6#1)(2010-7#16)(2010-8#21)(2010-9#7)(2011-1#44)(2011-10#2)(2011-12#7)(2011-2#107)(2011-3#2)(2012-1#76)(2012-11#20)(2012-12#48)(2012-2#83)(2012-3#29)(2012-5#5)(2012-6#2)(2012-7#5)(2013-1#93)(2013-7#33)(2013-8#70)
stress&quot##3##1##(1991-9#1)(1994-5#1)(1995-12#1)
stress) or##2##2##(2007-11#1)(2008-7#1)
stress)##11##1##(2007-11#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-1#1)(2013-1#1)
stress-##2##1##(2008-11#1)(2008-4#1)
stress-activated protein kinase##2##3##(1996-5#1)(1996-8#1)
stress-activated protein##4##2##(1996-5#2)(1996-8#1)(2007-8#1)
stress-activated##7##1##(1994-11#1)(1996-5#2)(1996-8#1)(2005-8#1)(2007-8#1)(2013-8#1)
stress-associated neuropeptides##2##2##(2006-10#2)
stress-associated protein##2##2##(2009-10#2)
stress-associated##8##1##(1995-12#1)(2006-10#3)(2009-10#2)(2009-2#1)(2010-7#1)
stress-based##3##1##(1991-2#1)(2013-1#2)
stress-exacerbation##2##1##(2006-9#2)
stress-free##2##1##(2008-7#1)(2012-11#1)
stress-induced ABA accumulation##5##3##(2008-8#5)
stress-induced ACTH##3##2##(1994-11#1)(2008-4#2)
stress-induced activation of the HPA##2##5##(1995-12#2)
stress-induced activation of the##4##4##(1994-2#1)(1995-12#2)(1996-11#1)
stress-induced adrenocortical##3##2##(1994-2#2)(2008-11#1)
stress-induced analgesia##3##2##(1990-7#3)
stress-induced anxiety##3##2##(2011-2#1)(2012-2#1)(2013-8#1)
stress-induced birefringence##6##2##(2007-12#1)(2008-2#1)(2008-3#4)
stress-induced cell##3##2##(2009-6#1)(2010-12#2)
stress-induced changes in##3##3##(1995-12#1)(2008-11#1)(2008-7#1)
stress-induced corticosteroids##2##2##(2008-7#2)
stress-induced hypothalamic somatostatin release in##2##5##(1996-11#2)
stress-induced##86##1##(1990-10#1)(1990-11#1)(1990-7#3)(1992-3#1)(1993-11#1)(1993-9#1)(1994-11#2)(1994-2#4)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#12)(1995-5#1)(1996-11#4)(1996-9#1)(1997-4#1)(1997-8#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-3#4)(2008-4#3)(2008-7#3)(2008-8#5)(2009-10#2)(2009-5#1)(2009-6#1)(2009-8#5)(2010-10#1)(2010-12#2)(2010-4#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-8#2)
stress-inducible protein##2##2##(1997-7#2)
stress-inducible proteins##2##2##(1997-7#1)(2008-7#1)
stress-inducible##11##1##(1994-3#1)(1996-5#1)(1997-7#3)(1997-8#2)(2007-1#1)(2008-7#1)(2009-6#2)
stress-inducing agents##3##2##(2007-1#3)
stress-inducing##5##1##(1995-12#1)(2007-1#4)
stress-mediated##2##1##(2008-7#1)(2009-8#1)
stress-reactive rumination##3##2##(2010-8#3)
stress-related changes##3##2##(1992-1#1)(1997-2#1)(2012-1#1)
stress-related hormone##2##2##(2008-10#1)(2009-8#1)
stress-related parameters in##3##3##(1997-7#1)(2010-12#2)
stress-related parameters##8##2##(1997-2#3)(1997-7#1)(2010-12#3)(2012-1#1)
stress-related symptoms##2##2##(1991-2#2)
stress-related##29##1##(1991-2#2)(1992-1#1)(1995-6#1)(1995-8#1)(1996-11#1)(1997-2#4)(1997-7#1)(1997-8#1)(2006-10#1)(2008-10#3)(2008-4#1)(2008-6#2)(2008-9#1)(2009-2#1)(2009-8#2)(2010-12#3)(2011-1#1)(2012-1#2)
stress-relaxation##2##1##(2005-11#1)(2006-11#1)
stress-response proteins##2##2##(1996-10#2)
stress-response##8##1##(1996-10#3)(2004-9#1)(2007-1#1)(2010-12#1)(2011-1#1)(2012-12#1)
stress-responsive genes##2##2##(2008-9#1)(2011-2#1)
stress-responsive##4##1##(1996-2#1)(2008-9#1)(2009-10#1)(2011-2#1)
stress-restress&quot##2##1##(2013-7#2)
stress-strain##5##1##(1992-9#1)(2006-11#1)(2006-12#1)(2010-12#1)(2010-9#1)
stress/strain##6##1##(2004-9#1)(2007-4#2)(2008-5#1)(2010-10#1)(2011-2#1)
stress? What##2##2##(2012-12#2)
stress?##4##1##(1995-12#1)(2009-6#1)(2012-12#2)
stress]##9##1##(1991-5#1)(1991-6#1)(1993-10#1)(1993-3#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
stressed and##5##2##(1997-7#1)(2006-2#1)(2008-5#1)(2011-1#1)(2011-2#1)
stressed animals##4##2##(1994-6#1)(1995-12#1)(2008-7#1)(2013-1#1)
stressed by##2##2##(2008-5#1)(2011-2#1)
stressed cells##6##2##(2006-10#1)(2007-12#4)(2008-4#1)
stressed in the##2##3##(1996-9#1)(2008-5#1)
stressed in##5##2##(1996-9#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)
stressed mice##2##2##(2008-7#2)
stressed plants##2##2##(2004-2#1)(2008-11#1)
stressed rats##5##2##(1995-12#4)(2013-1#1)
stressed that it is##2##4##(1991-5#1)(1996-3#1)
stressed that the##2##3##(1990-11#1)(2008-5#1)
stressed that##15##2##(1990-11#1)(1990-9#1)(1991-4#1)(1991-5#1)(1992-12#1)(1993-10#1)(1994-9#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2011-2#1)
stressed the importance of##4##4##(1992-6#1)(2008-1#1)(2010-10#1)(2013-7#1)
stressed the need##2##3##(2008-11#1)(2009-4#1)
stressed the##11##2##(1992-6#1)(1994-3#1)(1997-6#1)(2008-1#2)(2008-11#1)(2009-4#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-7#1)
stressed to##3##2##(1991-7#1)(1995-6#1)(2006-8#1)
stressed volumes##2##2##(2009-7#2)
stressed word##2##2##(2008-2#2)
stressed##158##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-6#2)(1993-10#1)(1993-2#1)(1993-5#1)(1994-3#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#7)(1995-6#1)(1996-1#1)(1996-3#2)(1996-8#2)(1996-9#2)(1997-6#1)(1997-7#2)(2004-2#1)(2005-8#2)(2006-10#2)(2006-2#1)(2006-3#1)(2006-8#2)(2007-1#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-4#2)(2007-7#1)(2008-1#3)(2008-10#6)(2008-11#11)(2008-2#7)(2008-3#2)(2008-4#3)(2008-5#5)(2008-7#5)(2008-8#1)(2008-9#7)(2009-10#2)(2009-4#1)(2009-7#3)(2009-8#1)(2010-10#1)(2010-12#1)(2010-9#2)(2011-1#1)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#3)(2013-8#1)
stresses and##13##2##(1992-9#1)(1995-4#1)(1996-9#1)(2004-9#1)(2005-11#1)(2008-7#1)(2009-4#2)(2009-7#4)(2011-2#1)
stresses are transferred to the##2##5##(2007-9#1)(2009-7#1)
stresses are##12##2##(2005-11#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-9#1)(2008-4#1)(2008-5#1)(2009-4#1)(2009-6#1)(2009-7#3)
stresses associated with##3##3##(2006-11#1)(2008-10#1)(2008-7#1)
stresses by##2##2##(2009-8#1)(2012-12#1)
stresses can##3##2##(2006-11#1)(2008-7#1)(2012-3#1)
stresses caused by##2##3##(2007-9#1)(2011-2#1)
stresses generated##2##2##(2004-9#1)(2007-12#1)
stresses how##2##2##(1992-2#1)(1995-12#1)
stresses in the##4##3##(2006-11#2)(2006-8#1)(2008-7#1)
stresses in##12##2##(1990-2#1)(1992-6#1)(2006-11#3)(2006-8#1)(2008-3#1)(2008-7#2)(2009-8#2)(2010-10#1)
stresses of the##2##3##(1996-1#1)(2009-5#1)
stresses of##10##2##(1996-1#1)(1997-4#3)(2004-9#1)(2006-11#1)(2006-7#1)(2007-2#1)(2008-10#1)(2009-5#1)
stresses on##4##2##(2008-2#1)(2009-3#1)(2009-7#1)(2012-2#1)
stresses such as drought##2##4##(1997-2#1)(2011-2#1)
stresses such as##5##3##(1994-6#1)(1996-2#1)(1997-2#1)(2008-1#1)(2011-2#1)
stresses that##4##2##(1994-7#1)(2007-4#2)(2008-4#1)
stresses the importance of##12##4##(1990-10#1)(1990-4#1)(1993-3#1)(1993-7#1)(1994-9#1)(1995-5#1)(1995-6#1)(2006-8#1)(2008-11#1)(2009-10#1)(2012-2#1)(2013-1#1)
stresses the need for##3##4##(2007-7#1)(2008-11#1)(2011-2#1)
stresses the need to##2##4##(2007-7#1)(2010-7#1)
stresses the need##6##3##(2007-7#2)(2008-11#1)(2010-7#1)(2011-2#1)(2012-2#1)
stresses the##22##2##(1990-10#1)(1990-4#1)(1993-3#1)(1993-7#1)(1994-6#1)(1994-9#1)(1995-5#1)(1995-6#1)(2006-8#1)(2007-11#1)(2007-7#2)(2007-9#1)(2008-11#2)(2009-10#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#1)
stresses were##5##2##(2004-9#1)(2008-7#1)(2009-7#1)(2010-2#2)
stresses##198##1##(1990-10#1)(1990-2#1)(1990-4#1)(1991-1#2)(1991-12#1)(1991-5#2)(1992-2#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-4#1)(1993-7#1)(1994-11#3)(1994-6#2)(1994-7#1)(1994-9#1)(1995-12#6)(1995-4#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#2)(1996-9#1)(1997-2#1)(1997-4#3)(1997-6#1)(2004-9#4)(2005-11#3)(2006-10#2)(2006-11#9)(2006-12#3)(2006-6#2)(2006-7#1)(2006-8#2)(2007-11#1)(2007-12#4)(2007-2#1)(2007-4#4)(2007-5#1)(2007-7#2)(2007-9#3)(2008-1#3)(2008-10#6)(2008-11#6)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#3)(2008-7#13)(2008-8#3)(2008-9#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#15)(2009-8#10)(2010-10#4)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#10)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#4)(2013-8#2)
stressful and##3##2##(2005-7#1)(2008-11#2)
stressful conditions##4##2##(1995-12#1)(2009-6#1)(2012-3#2)
stressful effects##2##2##(2008-11#1)(2008-7#1)
stressful events having a negative impact##2##6##(1992-1#2)
stressful events##6##2##(1992-1#3)(1996-12#1)(2008-2#1)(2013-1#1)
stressful experience##3##2##(1994-2#1)(2008-5#1)(2011-2#1)
stressful experiences##2##2##(2006-8#1)(2008-2#1)
stressful life events and##3##4##(2007-12#1)(2011-2#2)
stressful life events##11##3##(2006-3#2)(2007-12#1)(2007-6#2)(2008-11#1)(2011-2#5)
stressful life##12##2##(2006-3#2)(2007-12#1)(2007-6#2)(2008-11#1)(2011-2#5)(2012-1#1)
stressful situations##3##2##(2004-12#1)(2010-2#1)(2013-1#1)
stressful stimuli##6##2##(1990-12#2)(1994-2#2)(2007-11#1)(2013-1#1)
stressful than race-neutral discussions##2##4##(2009-7#2)
stressful than##3##2##(1995-12#1)(2009-7#2)
stressful##80##1##(1990-12#2)(1991-4#1)(1992-1#3)(1992-2#2)(1993-9#1)(1994-12#5)(1994-2#4)(1995-12#2)(1996-12#1)(1996-9#2)(2004-12#1)(2004-4#1)(2005-7#1)(2006-10#1)(2006-3#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#2)(2008-10#2)(2008-11#6)(2008-2#3)(2008-5#1)(2008-6#2)(2008-7#2)(2009-6#1)(2009-7#2)(2010-2#1)(2011-1#1)(2011-2#9)(2012-1#2)(2012-12#1)(2012-3#3)(2013-1#3)(2013-8#1)
stressing that##3##2##(1991-1#1)(1995-11#1)(2008-9#1)
stressing the importance of##2##4##(2008-1#1)(2008-9#1)
stressing the need for##3##4##(1994-2#1)(2008-10#1)(2008-11#1)
stressing the##11##2##(1990-6#1)(1993-9#1)(1994-2#1)(1996-5#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-6#1)
stressing##22##1##(1990-6#1)(1991-1#1)(1993-9#1)(1994-2#1)(1995-11#1)(1996-5#1)(1997-3#1)(1997-6#1)(2004-12#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#3)(2009-6#1)(2013-1#1)(2013-7#1)(2013-8#1)
stressor (restraint)##2##2##(1994-6#1)(2008-10#1)
stressor effects on##2##3##(1992-7#1)(2008-11#1)
stressor effects##3##2##(1992-7#1)(2008-11#2)
stressor exposure##3##2##(2010-2#3)
stressor in##2##2##(2010-12#1)(2010-8#1)
stressor is##3##2##(1993-6#1)(1995-12#1)(2008-6#1)
stressor of living##2##3##(2004-12#1)(2008-2#1)
stressor of##4##2##(2004-12#1)(2007-12#1)(2008-2#1)(2010-2#1)
stressor on##2##2##(1990-3#1)(2012-2#1)
stressor##59##1##(1990-3#2)(1990-4#1)(1992-7#1)(1993-6#2)(1994-12#1)(1994-6#1)(1995-12#2)(1996-10#1)(2004-12#2)(2006-8#1)(2007-12#4)(2008-10#1)(2008-11#10)(2008-2#1)(2008-4#3)(2008-6#3)(2008-7#1)(2009-11#1)(2010-12#1)(2010-2#4)(2010-4#2)(2010-5#1)(2010-8#3)(2011-2#1)(2012-1#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
stressor)##2##1##(2011-1#1)(2012-1#1)
stressors and distress##2##3##(2012-3#2)
stressors and parenting##2##3##(2010-2#2)
stressors and##20##2##(1990-5#1)(1995-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2009-7#1)(2009-8#2)(2010-2#3)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-3#2)(2013-8#1)
stressors are##4##2##(2009-8#1)(2010-2#1)(2011-2#1)(2012-1#1)
stressors compared to##2##3##(2008-4#2)
stressors for##2##2##(2010-10#1)(2012-1#1)
stressors in the##3##3##(1993-6#1)(2007-2#1)(2012-3#1)
stressors in##8##2##(1993-6#1)(1995-12#1)(2007-2#1)(2008-4#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-3#1)
stressors is##2##2##(2008-4#1)(2010-12#1)
stressors may##3##2##(1990-3#1)(1997-3#1)(2004-3#1)
stressors of first-time##2##3##(2007-2#2)
stressors of##5##2##(1997-6#1)(2007-2#2)(2009-2#1)(2012-3#1)
stressors on##7##2##(1995-12#1)(2007-11#1)(2008-11#1)(2009-7#1)(2010-2#1)(2010-8#1)(2012-2#1)
stressors such as##6##3##(1995-12#1)(2004-4#1)(2008-5#1)(2009-3#1)(2010-4#1)(2011-2#1)
stressors that can##2##3##(1995-12#1)(2012-12#1)
stressors that##5##2##(1995-12#1)(2008-2#1)(2010-3#1)(2011-2#1)(2012-12#1)
stressors##132##1##(1990-3#1)(1990-4#1)(1990-5#1)(1992-4#1)(1993-6#1)(1994-2#1)(1995-12#11)(1996-12#1)(1997-3#1)(1997-6#1)(2004-3#1)(2004-4#1)(2005-8#1)(2006-10#1)(2006-3#1)(2006-4#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-2#4)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#5)(2008-12#3)(2008-2#3)(2008-4#6)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#4)(2010-10#1)(2010-12#3)(2010-2#8)(2010-3#1)(2010-4#5)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#8)(2012-1#7)(2012-12#1)(2012-2#4)(2012-3#6)(2012-6#1)(2013-1#2)(2013-8#1)
stressosome##7##1##(2009-8#7)
stretch and##5##2##(1991-10#1)(1992-8#1)(2008-12#1)(2011-1#1)(2012-2#1)
stretch features##2##2##(2009-3#2)
stretch in##2##2##(1994-12#1)(2008-3#1)
stretch may be##2##3##(1990-2#1)(1990-7#1)
stretch may##3##2##(1990-12#1)(1990-2#1)(1990-7#1)
stretch of the##3##3##(1992-11#1)(2005-6#1)(2007-11#1)
stretch of##23##2##(1990-1#1)(1990-11#3)(1990-6#1)(1992-11#2)(1992-12#1)(1992-8#1)(1993-6#1)(1994-12#1)(1994-5#2)(1995-8#2)(1996-3#1)(1996-5#1)(1997-3#1)(1997-6#1)(2005-6#1)(2007-11#1)(2009-10#1)(2013-7#1)
stretch on the##2##3##(1990-12#1)(2008-6#1)
stretch or##2##2##(1990-8#1)(2011-2#1)
stretch receptor##3##2##(1995-11#1)(2007-12#2)
stretch receptors##3##2##(2007-12#3)
stretch reflexes##4##2##(2012-1#4)
stretch region##2##2##(1995-11#1)(2008-3#1)
stretch the##2##2##(2007-12#1)(2009-3#1)
stretch vibrations of##3##3##(1994-9#1)(2007-11#2)
stretch##117##1##(1990-1#1)(1990-11#3)(1990-12#3)(1990-2#3)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#3)(1990-8#6)(1991-10#1)(1992-11#2)(1992-12#1)(1992-7#1)(1992-8#2)(1993-12#1)(1993-2#2)(1993-6#1)(1993-9#4)(1994-12#3)(1994-5#2)(1994-9#2)(1995-11#2)(1995-6#2)(1995-8#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(2005-4#1)(2005-6#1)(2006-12#2)(2007-1#4)(2007-11#3)(2007-12#7)(2007-4#2)(2008-1#5)(2008-11#1)(2008-12#2)(2008-3#6)(2008-4#1)(2008-6#2)(2008-8#1)(2009-10#1)(2009-3#3)(2009-7#2)(2010-10#1)(2010-5#2)(2011-1#2)(2011-2#1)(2012-1#4)(2012-2#2)(2013-7#1)
stretch-induced##8##1##(1990-11#2)(1990-12#2)(1990-8#3)(2008-6#1)
stretchability##2##1##(2008-7#1)(2009-9#1)
stretchable MEA##4##2##(2013-7#4)
stretchable electronics##2##2##(2008-7#1)(2013-7#1)
stretchable##7##1##(2008-7#1)(2013-7#6)
stretched and##2##2##(2008-12#1)(2008-3#1)
stretched at##2##2##(1990-8#1)(2012-7#1)
stretched by##2##2##(2007-12#1)(2013-8#1)
stretched exponential##2##2##(2007-12#1)(2012-2#1)
stretched pulse##2##2##(2008-3#2)
stretched##35##1##(1990-8#1)(1992-7#1)(1992-9#1)(1993-11#1)(1995-6#1)(2005-11#2)(2007-12#3)(2007-9#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#5)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-2#4)(2012-7#3)(2013-8#1)
stretched-pulse fiber laser with a nonlinear optical loop mirror##2##9##(2007-11#2)
stretched-pulse fiber laser##4##3##(2007-11#3)(2007-12#1)
stretched-pulse fiber##7##2##(2007-11#4)(2007-12#3)
stretched-pulse##11##1##(2007-11#7)(2007-12#4)
stretcher##9##1##(2007-11#3)(2007-12#4)(2008-1#1)(2008-2#1)
stretcher-compressor##2##1##(2007-11#1)(2008-1#1)
stretchers##3##1##(2007-7#1)(2008-3#1)(2011-1#1)
stretches and##3##2##(1991-11#1)(2007-11#1)(2008-10#1)
stretches are##3##2##(1990-2#1)(2006-12#2)
stretches had##2##2##(1993-9#2)
stretches in##2##2##(1995-2#1)(1996-7#1)
stretches of rivers##2##3##(1990-6#1)(1993-9#1)
stretches of speech##2##3##(2008-4#2)
stretches of the##5##3##(2006-12#2)(2008-2#1)(2008-4#2)
stretches of##27##2##(1990-6#1)(1990-8#1)(1992-3#1)(1993-6#1)(1993-9#3)(1994-12#2)(1994-5#1)(1995-11#1)(1995-7#1)(1996-9#1)(1997-2#1)(2006-10#1)(2006-12#4)(2008-1#1)(2008-2#1)(2008-4#4)(2008-8#1)(2009-5#1)
stretches##55##1##(1990-11#1)(1990-2#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-7#1)(1992-3#1)(1992-9#1)(1993-6#1)(1993-9#7)(1994-12#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-7#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-6#1)(2005-6#1)(2006-10#1)(2006-12#7)(2007-11#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-4#7)(2008-7#1)(2008-8#1)(2009-5#1)
stretching and##4##2##(1992-8#1)(2007-11#1)(2008-10#1)(2008-2#1)
stretching are##2##2##(2008-2#1)(2008-3#1)
stretching at##2##2##(1990-2#1)(2007-11#1)
stretching band##9##2##(1990-2#2)(1991-9#1)(2008-10#4)(2008-2#2)
stretching bands##4##2##(1996-2#1)(2008-10#3)
stretching exercises##2##2##(2009-1#2)
stretching force##2##2##(1996-2#1)(2008-10#1)
stretching frequencies of the##2##4##(1990-2#1)(1994-3#1)
stretching frequencies##9##2##(1990-2#1)(1990-5#1)(1994-3#2)(1995-5#3)(1996-2#1)(2008-5#1)
stretching frequency measurements##2##3##(1994-3#2)
stretching frequency##5##2##(1994-3#2)(2007-11#1)(2008-2#1)(2008-5#1)
stretching mode of##3##3##(1995-5#1)(2008-10#1)(2008-8#1)
stretching mode##12##2##(1990-8#1)(1992-12#1)(1993-6#2)(1995-5#1)(2005-4#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-10#1)
stretching modes##5##2##(1993-6#1)(1996-2#1)(2005-11#1)(2008-3#1)(2008-5#1)
stretching of a##2##3##(2007-11#1)(2009-7#1)
stretching of the##11##3##(1990-2#2)(1995-6#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#2)(2009-3#1)(2009-7#2)
stretching of##23##2##(1990-11#1)(1990-2#2)(1990-8#1)(1994-11#1)(1995-6#1)(2005-10#1)(2007-11#3)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-7#1)(2009-3#1)(2009-7#3)
stretching region##2##2##(2008-8#1)(2010-2#1)
stretching techniques##2##2##(2009-1#2)
stretching the##3##2##(1995-8#1)(2007-8#1)(2012-7#1)
stretching vibration mode##2##3##(2008-10#2)
stretching vibration of##4##3##(1994-11#1)(2007-8#1)(2008-10#2)
stretching vibration was##2##3##(2005-4#1)(2006-12#1)
stretching vibration##15##2##(1991-5#1)(1994-11#1)(1996-2#1)(2005-4#4)(2006-12#1)(2007-8#1)(2008-10#5)(2008-2#1)
stretching vibrational##4##2##(1995-10#1)(1995-5#1)(2007-12#1)(2008-6#1)
stretching vibrations of the##2##4##(1995-10#1)(2007-12#1)
stretching vibrations of##4##3##(1995-10#1)(2005-4#2)(2007-12#1)
stretching vibrations##10##2##(1991-5#1)(1994-12#1)(1995-1#1)(1995-10#1)(2005-11#1)(2005-4#2)(2007-11#1)(2007-12#1)(2008-10#1)
stretching##158##1##(1990-11#3)(1990-2#7)(1990-4#1)(1990-5#1)(1990-8#2)(1991-5#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-11#2)(1993-6#4)(1994-11#2)(1994-12#1)(1994-3#4)(1995-1#1)(1995-10#2)(1995-5#5)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#5)(2005-10#1)(2005-11#3)(2005-4#7)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#8)(2007-12#6)(2007-8#3)(2007-9#2)(2008-10#21)(2008-12#1)(2008-2#10)(2008-3#6)(2008-5#3)(2008-6#5)(2008-7#2)(2008-8#2)(2009-1#7)(2009-3#1)(2009-7#5)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#2)(2012-1#1)(2012-2#2)(2012-7#1)(2013-1#1)
stria terminalis##14##2##(1992-7#3)(1992-8#1)(1993-12#1)(1994-2#1)(1995-5#1)(1995-6#2)(1997-3#1)(1997-8#3)(2008-9#1)
stria vascularis##2##2##(2009-8#2)
stria##17##1##(1992-7#3)(1992-8#1)(1993-12#1)(1994-2#1)(1995-5#1)(1995-6#2)(1996-4#1)(1997-3#1)(1997-8#3)(2008-9#1)(2009-8#2)
striae distensae##2##2##(2008-5#1)(2010-9#1)
striae##9##1##(2007-7#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-9#1)(2011-2#1)(2013-7#3)
striata were##2##2##(1994-2#1)(1995-10#1)
striata##16##1##(1990-2#2)(1993-2#1)(1993-9#2)(1994-10#1)(1994-2#1)(1995-10#2)(1995-8#1)(1996-12#2)(1996-3#1)(1996-5#2)(1996-9#1)
striatal D-2 receptor##2##3##(1993-12#2)
striatal D-2##3##2##(1993-12#3)
striatal D2 receptor##2##3##(1996-7#2)
striatal DA##8##2##(1991-12#2)(1993-12#1)(1996-10#1)(1996-6#1)(1997-2#1)(1997-8#2)
striatal acetylcholine##3##2##(1993-9#1)(1994-8#1)(1995-10#1)
striatal and NA##2##3##(1993-7#1)(1994-8#1)
striatal and cortical##2##3##(1990-7#1)(1991-11#1)
striatal and##7##2##(1990-7#1)(1991-11#1)(1991-6#1)(1992-10#1)(1993-7#1)(1994-8#1)(1997-8#1)
striatal atrophy##2##2##(1992-10#1)(2013-1#1)
striatal cells with##2##3##(1995-12#1)(1996-1#1)
striatal cells##6##2##(1993-12#1)(1995-10#1)(1995-12#1)(1995-5#1)(1996-1#1)(2008-11#1)
striatal circuitry##2##2##(1995-10#1)(1996-8#1)
striatal compartment##5##2##(1997-6#5)
striatal dopamine and##2##3##(1991-3#1)(2008-7#1)
striatal dopamine receptor##2##3##(1994-5#1)(1995-2#1)
striatal dopamine release##5##3##(1991-3#2)(1993-4#1)(1995-12#1)(2008-2#1)
striatal dopamine transporter##4##3##(1996-2#4)
striatal dopamine##35##2##(1991-3#5)(1993-12#1)(1993-4#5)(1993-6#2)(1994-5#2)(1994-8#1)(1995-12#1)(1995-2#2)(1996-10#3)(1996-12#1)(1996-2#4)(1996-6#1)(1997-1#1)(1997-5#1)(2007-1#1)(2008-11#2)(2008-2#1)(2008-7#1)
striatal dopaminergic activity##2##3##(1991-5#1)(1996-12#1)
striatal dopaminergic neurotoxicity##2##3##(1996-10#2)
striatal dopaminergic##9##2##(1991-5#1)(1996-10#2)(1996-12#1)(1997-8#2)(2007-11#1)(2008-7#1)(2013-8#1)
striatal gene##2##2##(1996-9#1)(2009-10#1)
striatal glutamate##2##2##(1995-12#1)(2008-7#1)
striatal hyperactivity##2##2##(2013-8#2)
striatal interactions##2##2##(1993-6#2)
striatal lesions##2##2##(1994-5#2)
striatal membrane##2##2##(1990-8#2)
striatal membranes##8##2##(1990-7#1)(1993-7#1)(1995-11#1)(1995-7#2)(1996-5#1)(1997-5#2)
striatal neurones in##2##3##(1995-5#2)
striatal neurones##6##2##(1995-5#3)(1996-1#3)
striatal neurons that##2##3##(2008-5#1)(2011-1#1)
striatal neurons##13##2##(1990-10#2)(1990-5#1)(1991-3#2)(1991-6#1)(1992-9#1)(1994-5#1)(1995-12#1)(2007-11#1)(2008-4#1)(2008-5#1)(2011-1#1)
striatal or##2##2##(1994-10#1)(1996-12#1)
striatal pathology##3##2##(2008-11#3)
striatal projection##3##2##(1996-1#1)(1996-12#1)(1996-2#1)
striatal radioactivity##2##2##(1997-8#2)
striatal receptors##2##2##(1996-5#1)(1997-5#1)
striatal regions##3##2##(1995-6#1)(1996-5#2)
striatal slices##8##2##(1991-6#1)(1993-12#1)(1995-12#4)(2007-11#1)(2008-5#1)
striatal subregions##2##2##(1993-12#1)(1994-2#1)
striatal synaptic facilitation##2##3##(2007-11#2)
striatal synaptosomal##2##2##(1990-7#1)(1995-1#1)
striatal synaptosomes##4##2##(1994-9#1)(1995-11#2)(1996-2#1)
striatal tissue##2##2##(1993-7#1)(1996-3#1)
striatal tyrosine hydroxylase (TH)##2##4##(1990-7#1)(1991-12#1)
striatal uptake##2##2##(1993-9#1)(2008-7#1)
striatal##230##1##(1990-10#2)(1990-2#2)(1990-5#2)(1990-7#7)(1990-8#2)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#7)(1991-5#1)(1991-6#4)(1992-10#3)(1992-9#1)(1993-12#11)(1993-2#1)(1993-4#6)(1993-6#4)(1993-7#3)(1993-9#2)(1994-10#1)(1994-2#3)(1994-5#6)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#3)(1995-11#3)(1995-12#16)(1995-2#2)(1995-5#8)(1995-6#1)(1995-7#2)(1995-8#1)(1995-9#4)(1996-1#6)(1996-10#8)(1996-12#6)(1996-2#7)(1996-3#3)(1996-5#4)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#3)(1997-5#6)(1997-6#5)(1997-8#11)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#7)(2008-11#11)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#6)(2009-10#1)(2011-1#2)(2012-1#1)(2013-1#1)(2013-8#4)
striate cortex damage##2##3##(1995-8#2)
striate cortex of adult##2##4##(1994-8#1)(1997-7#1)
striate cortex##11##2##(1994-8#2)(1995-5#1)(1995-8#4)(1997-7#3)(2008-11#1)
striate cortical cells in the monkey##2##6##(2008-8#2)
striate##23##1##(1994-8#2)(1995-5#1)(1995-8#6)(1997-7#3)(2008-10#2)(2008-11#1)(2008-8#2)(2009-4#6)
striated muscle alpha-tropomyosin##2##3##(1994-9#2)
striated muscle cells##2##3##(1994-5#1)(2003-11#1)
striated muscle contraction##2##3##(1995-8#1)(1996-5#1)
striated muscle fibers##3##3##(1995-3#2)(1996-1#1)
striated muscle myosin of Xenopus laevis##2##6##(1995-12#2)
striated muscle##20##2##(1992-6#1)(1993-4#1)(1994-5#2)(1994-9#4)(1995-12#2)(1995-3#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-5#1)(2003-11#1)(2010-5#1)(2012-11#1)
striated muscles of##2##3##(1990-7#1)(1995-3#1)
striated muscles##3##2##(1990-7#1)(1995-3#2)
striated skeletal muscle##3##3##(1993-12#2)(2010-6#1)
striated##36##1##(1990-7#1)(1992-6#1)(1992-7#1)(1993-12#2)(1993-4#1)(1994-5#2)(1994-9#7)(1995-12#3)(1995-3#4)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-5#1)(2003-11#1)(2009-5#1)(2009-9#2)(2010-5#1)(2010-6#1)(2012-11#1)(2012-12#1)
striation##2##1##(1991-2#1)(2007-10#1)
striations##3##1##(1990-10#1)(2008-5#2)
striatocapsular##2##1##(2007-9#2)
striatum &gt##2##2##(1993-9#1)(1997-2#1)
striatum (ST)##2##2##(1994-2#1)(1997-8#1)
striatum (STR)##2##2##(1991-4#1)(1991-9#1)
striatum after dopamine##2##3##(1996-12#1)(1996-2#1)
striatum after##5##2##(1992-3#1)(1996-10#1)(1996-12#1)(1996-2#1)(1997-5#1)
striatum and NA##2##3##(1993-7#1)(1994-8#1)
striatum and frontal cortex in pilocarpine group##2##7##(2010-7#2)
striatum and frontal cortex##4##4##(1997-7#1)(2010-7#3)
striatum and hippocampus##4##3##(1995-8#1)(1996-3#1)(2008-11#1)(2012-1#1)
striatum and motor cortex##3##4##(1991-6#3)
striatum and nucleus accumbens##6##4##(1991-9#1)(1993-12#1)(1994-8#3)(1996-10#1)
striatum and spinal cord##2##4##(1996-2#1)(1997-2#1)
striatum and##47##2##(1991-3#1)(1991-6#4)(1991-9#1)(1992-10#2)(1993-12#2)(1993-2#1)(1993-5#1)(1993-7#1)(1994-10#1)(1994-8#4)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#2)(1997-2#2)(1997-3#2)(1997-7#2)(1997-8#1)(2008-11#2)(2008-4#1)(2008-7#2)(2010-7#3)(2011-1#1)(2012-1#1)
striatum as well as##2##4##(1993-5#1)(1995-12#1)
striatum as##4##2##(1993-5#1)(1994-2#1)(1995-12#1)(1996-10#1)
striatum at##6##2##(1991-12#1)(1996-10#3)(1996-5#1)(2013-7#1)
striatum but##2##2##(1993-12#1)(1997-2#1)
striatum by##5##2##(1990-10#1)(1992-7#1)(1994-10#2)(1997-2#1)
striatum compared to##2##3##(1993-7#1)(1997-2#1)
striatum compared##3##2##(1993-7#1)(1996-2#1)(1997-2#1)
striatum from##2##2##(1993-6#1)(2007-11#1)
striatum in the##3##3##(1993-6#1)(1996-3#1)(1996-5#1)
striatum in##7##2##(1993-6#1)(1993-9#1)(1994-10#1)(1995-5#1)(1996-3#1)(1996-5#2)
striatum of aged rats##2##4##(1993-2#1)(1997-2#1)
striatum of aged##3##3##(1993-2#2)(1997-2#1)
striatum of ovariectomized##2##3##(1993-4#1)(1993-6#1)
striatum of rats##5##3##(1993-2#2)(1996-5#2)(1997-2#1)
striatum of the##11##3##(1990-5#1)(1991-9#1)(1993-2#4)(1993-6#1)(1996-10#1)(2008-10#1)(2008-7#1)(2013-8#1)
striatum of##40##2##(1990-5#1)(1991-5#1)(1991-9#2)(1993-12#1)(1993-2#10)(1993-3#1)(1993-4#1)(1993-6#2)(1995-11#1)(1995-12#2)(1996-1#1)(1996-10#2)(1996-3#1)(1996-5#3)(1996-9#1)(1997-2#3)(2008-10#1)(2008-7#2)(2009-8#1)(2010-7#1)(2012-3#1)(2013-8#1)
striatum significantly##3##2##(1996-1#2)(2009-10#1)
striatum to##3##2##(1995-11#1)(1996-5#1)(2008-11#1)
striatum was##7##2##(1990-10#1)(1992-7#1)(1993-12#1)(1995-11#1)(1996-10#1)(1997-5#1)(2006-11#1)
striatum were measured##2##3##(1996-6#1)(2006-11#1)
striatum were##4##2##(1996-6#1)(2006-11#3)
striatum when##2##2##(1990-10#1)(1995-7#1)
striatum while##2##2##(1993-12#1)(1996-5#1)
striatum##336##1##(1990-10#5)(1990-2#6)(1990-5#2)(1990-7#4)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#9)(1991-9#8)(1992-10#6)(1992-3#1)(1992-7#3)(1992-8#1)(1993-12#6)(1993-2#18)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#9)(1993-7#4)(1993-9#4)(1994-10#5)(1994-12#1)(1994-2#9)(1994-6#3)(1994-8#6)(1995-1#1)(1995-10#1)(1995-11#11)(1995-12#11)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#3)(1995-7#7)(1995-8#1)(1995-9#1)(1996-1#7)(1996-10#12)(1996-11#1)(1996-12#8)(1996-2#8)(1996-3#6)(1996-4#3)(1996-5#16)(1996-6#3)(1996-9#3)(1997-1#1)(1997-2#12)(1997-3#3)(1997-5#4)(1997-6#3)(1997-7#5)(1997-8#6)(2005-7#1)(2006-11#4)(2006-12#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#6)(2008-3#1)(2008-4#5)(2008-5#1)(2008-7#11)(2009-10#1)(2009-12#1)(2009-2#2)(2009-8#1)(2009-9#1)(2010-2#1)(2010-7#7)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-7#2)(2013-8#8)
striatum)##3##1##(1993-12#1)(1996-12#1)(2012-2#1)
striatus is##2##2##(2007-11#2)
striatus##14##1##(2007-11#4)(2007-3#2)(2007-8#3)(2008-10#5)
stricken##2##1##(1996-5#1)(2009-6#1)
strict BP control was##2##4##(2007-10#2)
strict BP control##3##3##(2007-10#3)
strict adherence to the##2##4##(2006-3#1)(2007-8#1)
strict adherence to##5##3##(2006-2#1)(2006-3#1)(2007-8#1)(2008-7#1)(2011-2#1)
strict anaerobe##3##2##(1990-8#1)(2006-8#2)
strict anaerobic##2##2##(2006-8#1)(2009-10#1)
strict and##2##2##(2007-8#1)(2008-12#1)
strict compliance with the##2##4##(2007-7#1)(2013-8#1)
strict conservation##2##2##(1990-5#1)(1995-2#1)
strict control of##5##3##(1994-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2009-8#1)
strict correlation between##2##3##(1991-10#1)(1994-5#1)
strict correlation##3##2##(1991-10#1)(1994-5#1)(2008-4#1)
strict criteria##2##2##(1991-8#1)(2007-8#1)
strict definition##2##2##(1991-1#1)(2010-12#1)
strict dietary##2##2##(2006-4#1)(2008-5#1)
strict examination of##2##3##(1990-8#1)(2011-1#1)
strict genetic##2##2##(2008-11#1)(2008-6#1)
strict glycaemic control##2##3##(2005-7#2)
strict inclusion##2##2##(1993-11#1)(2007-9#1)
strict quality##2##2##(2007-12#1)(2008-1#1)
strict regulation##3##2##(1990-11#1)(2008-10#1)(2013-7#1)
strict requirements##3##2##(2008-10#1)(2008-11#1)(2009-3#1)
strict selection of##2##3##(2007-8#1)(2013-1#1)
strict selection##5##2##(1990-3#1)(1996-6#1)(1996-8#1)(2007-8#1)(2013-1#1)
strict specificity for##2##3##(1994-8#1)(2008-4#1)
strict specificity##4##2##(1992-11#1)(1994-8#1)(2008-4#1)(2008-8#1)
strict stereospecificity##3##2##(1994-8#2)(1997-4#1)
strict surveillance##2##2##(2008-6#1)(2012-12#1)
strict temporal##2##2##(2012-2#1)(2012-3#1)
strict##137##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-9#1)(1993-11#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#3)(1995-2#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#2)(2005-7#2)(2005-8#1)(2006-10#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#3)(2007-10#3)(2007-11#2)(2007-12#6)(2007-2#1)(2007-4#2)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#5)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#6)(2008-4#4)(2008-5#2)(2008-6#4)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
stricter##6##1##(1992-12#1)(1995-6#1)(2007-2#1)(2007-7#1)(2013-1#2)
strictly anaerobic and##3##3##(2006-8#1)(2011-2#2)
strictly anaerobic##10##2##(1992-4#1)(2005-12#1)(2006-5#1)(2006-8#2)(2011-2#5)
strictly associated with##2##3##(2007-11#1)(2007-6#1)
strictly by the##2##3##(1992-3#1)(1994-12#1)
strictly by##3##2##(1992-3#1)(1994-12#1)(1996-5#1)
strictly clonal##3##2##(2008-10#3)
strictly conserved##8##2##(1990-2#1)(1990-5#1)(1991-5#1)(1995-2#2)(1995-5#1)(1995-8#1)(2008-10#1)
strictly controlled##10##2##(1995-12#1)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-1#1)(2010-10#2)(2012-2#1)
strictly correlated to##2##3##(1993-6#1)(2006-2#1)
strictly correlated with the##2##4##(2004-9#1)(2008-11#1)
strictly correlated##4##2##(1993-6#1)(2004-9#1)(2006-2#1)(2008-11#1)
strictly defined##4##2##(1996-11#1)(2008-10#1)(2009-4#2)
strictly depend on the##2##4##(1990-1#1)(1991-2#1)
strictly dependent on##11##3##(1990-4#1)(1990-9#1)(1991-7#1)(1993-11#1)(1993-5#1)(1994-8#1)(1995-5#1)(2005-12#1)(2008-10#1)(2010-11#1)(2010-2#1)
strictly dependent##12##2##(1990-2#1)(1990-4#1)(1990-9#1)(1991-7#1)(1993-11#1)(1993-5#1)(1994-8#1)(1995-5#1)(2005-12#1)(2008-10#1)(2010-11#1)(2010-2#1)
strictly identical##2##2##(1992-7#1)(2006-4#1)
strictly limited##6##2##(1997-3#1)(2006-7#1)(2007-11#1)(2008-11#1)(2012-12#2)
strictly on the##2##3##(1994-9#1)(2008-8#1)
strictly on##3##2##(1994-9#1)(2008-8#1)(2012-2#1)
strictly only##2##2##(2007-12#1)(2008-12#1)
strictly regulated##4##2##(1996-8#1)(1997-6#1)(2009-8#1)(2011-2#1)
strictly related to the##3##4##(1994-2#1)(2013-1#1)(2013-7#1)
strictly related to##9##3##(1990-7#1)(1994-2#1)(2006-6#1)(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#1)(2013-7#2)
strictly related##10##2##(1990-7#1)(1994-2#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)(2013-1#1)(2013-7#2)
strictly symmetric initial##2##3##(2007-8#2)
strictly unilateral##2##2##(2006-10#1)(2013-1#1)
strictly##185##1##(1990-1#1)(1990-11#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-7#2)(1992-1#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-5#1)(1993-6#2)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-6#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(2004-9#1)(2005-11#1)(2005-12#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-10#13)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#5)(2008-7#3)(2008-8#3)(2008-9#3)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-2#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#7)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
strictum##9##1##(2008-10#9)
stricture after##3##2##(2007-7#1)(2013-7#2)
stricture and##4##2##(1991-4#1)(1996-3#1)(2007-8#1)(2009-1#1)
stricture can##2##2##(2007-5#1)(2013-7#1)
stricture following##2##2##(2008-3#1)(2012-2#1)
stricture formation##2##2##(2008-3#1)(2013-8#1)
stricture in##2##2##(1995-10#1)(2012-11#1)
stricture is not a##2##4##(2008-11#1)(2013-1#1)
stricture is##4##2##(2005-12#1)(2008-11#1)(2013-1#1)(2013-8#1)
stricture of the##4##3##(1993-2#1)(2007-5#1)(2007-8#1)(2013-8#1)
stricture of##6##2##(1993-2#1)(2007-5#1)(2007-8#1)(2010-12#1)(2013-1#1)(2013-8#1)
stricture was##3##2##(2010-12#1)(2013-1#1)(2013-7#1)
stricture which##2##2##(2011-2#1)(2013-8#1)
stricture##60##1##(1990-4#2)(1990-6#1)(1991-4#1)(1993-2#1)(1993-8#1)(1995-10#1)(1995-4#1)(1996-3#1)(2005-12#1)(2006-1#1)(2006-2#1)(2007-5#2)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2009-1#1)(2009-4#1)(2009-5#4)(2009-8#1)(2010-12#3)(2010-4#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#10)(2013-7#6)(2013-8#4)
stricture]##2##1##(1990-4#1)(2013-1#1)
strictures and##5##2##(1991-4#1)(2006-7#1)(2008-5#1)(2012-2#1)(2012-3#1)
strictures are those in which it is not possible to##2##10##(2010-12#2)
strictures are##6##2##(1995-8#1)(2007-5#2)(2010-12#3)
strictures can be classified into##2##5##(2007-5#1)(2010-12#1)
strictures in the absence of prior surgery##2##7##(2008-5#2)
strictures in##4##2##(2006-10#1)(2006-6#1)(2008-5#2)
strictures is##2##2##(2007-5#1)(2013-1#1)
strictures of the##3##3##(2006-6#1)(2008-10#1)(2008-6#1)
strictures of##4##2##(2006-6#1)(2008-10#2)(2008-6#1)
strictures that##2##2##(2008-10#1)(2008-3#1)
strictures were##3##2##(2006-6#1)(2008-5#1)(2013-1#1)
strictures##74##1##(1990-4#1)(1990-5#1)(1991-4#1)(1993-2#1)(1995-8#1)(2004-11#1)(2006-10#5)(2006-2#1)(2006-6#7)(2006-7#3)(2006-9#1)(2007-12#1)(2007-5#10)(2007-7#1)(2007-9#1)(2008-10#4)(2008-3#2)(2008-5#5)(2008-6#1)(2010-12#13)(2012-2#1)(2012-3#1)(2013-1#8)(2013-8#3)
stricturing##3##1##(1990-9#1)(2006-10#1)(2010-12#1)
stricturoplasty##2##1##(2006-10#1)(2010-12#1)
stride and##2##2##(1994-8#1)(2012-1#1)
stride length##5##2##(1994-12#1)(2007-9#1)(2008-7#1)(2010-8#1)(2013-1#1)
stride##9##1##(1994-12#1)(1994-8#1)(2007-9#1)(2008-7#2)(2010-8#1)(2012-1#1)(2013-1#2)
strides have been made in##3##5##(1995-12#1)(2008-11#1)(2013-1#1)
strides have been made##4##4##(1995-12#1)(2008-11#2)(2013-1#1)
strides in the##2##3##(2006-10#1)(2008-8#1)
strides in##5##2##(1997-1#1)(2006-10#1)(2008-10#1)(2008-7#1)(2008-8#1)
strides to##2##2##(1994-12#1)(2012-3#1)
strides##21##1##(1994-12#1)(1995-12#1)(1997-1#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-9#1)(2012-12#7)(2012-3#1)(2013-1#1)
stridor and##4##2##(1991-11#1)(2008-11#1)(2010-7#1)(2012-1#1)
stridor##15##1##(1991-11#2)(1996-1#1)(2005-11#1)(2007-8#2)(2007-9#1)(2008-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-8#1)
stridulation##3##1##(2007-12#3)
strife##4##1##(1993-12#1)(1995-9#1)(2007-7#1)(2008-7#1)
striga emergence##4##2##(2008-10#4)
striga per host plant##2##4##(2008-10#2)
striga##14##1##(2008-10#14)
strigosa##3##1##(2007-3#2)(2008-10#1)
striiformis f##30##2##(2008-10#30)
striiformis in##2##2##(2008-10#2)
striiformis##42##1##(2008-10#42)
strike a##4##2##(1997-6#1)(2006-2#1)(2008-2#1)(2008-4#1)
strike back##3##2##(1995-5#1)(1996-11#1)(1997-4#1)
strike is##2##2##(2007-12#2)
strike slip##2##2##(1990-11#2)
strike the right balance##2##4##(1990-9#1)(2006-8#1)
strike the##4##2##(1990-9#1)(1996-5#1)(2006-8#1)(2010-1#1)
strike##31##1##(1990-11#2)(1990-9#1)(1991-11#1)(1993-12#1)(1994-4#4)(1995-5#1)(1996-11#1)(1996-5#2)(1997-4#1)(1997-6#1)(2006-2#1)(2006-8#1)(2006-9#2)(2007-12#3)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-1#1)(2010-1#1)(2010-3#1)(2012-3#2)
strikes a##2##2##(2007-12#1)(2008-7#1)
strikes the##3##2##(2006-4#1)(2008-7#1)(2010-5#1)
strikes##14##1##(1992-2#1)(1992-9#1)(2006-4#1)(2007-12#1)(2008-2#1)(2008-7#3)(2010-12#2)(2010-5#1)(2010-8#1)(2012-3#1)(2013-1#1)
striking back##2##2##(1995-5#1)(1995-9#1)
striking contrast to the##5##4##(1991-4#1)(1995-3#2)(1995-8#1)(2007-5#1)
striking contrast to##7##3##(1991-4#1)(1995-3#2)(1995-8#1)(1996-12#1)(2007-5#1)(2010-7#1)
striking contrast##10##2##(1990-10#1)(1991-4#1)(1994-12#1)(1995-3#2)(1995-8#1)(1996-12#1)(2007-5#1)(2008-9#1)(2010-7#1)
striking correlation between the##2##4##(1997-4#1)(1997-7#1)
striking demonstration##2##2##(1995-8#1)(2007-9#1)
striking difference between##3##3##(2008-10#2)(2010-3#1)
striking difference in##2##3##(1995-1#1)(2008-4#1)
striking difference##9##2##(1995-1#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-4#1)(2010-3#1)(2011-1#1)
striking differences between##2##3##(1991-5#1)(2008-2#1)
striking differences in##4##3##(1996-6#1)(2008-10#2)(2012-3#1)
striking differences##8##2##(1990-9#1)(1991-5#1)(1996-6#1)(2007-11#1)(2008-10#2)(2008-2#1)(2012-3#1)
striking dominance of##2##3##(1996-11#1)(2008-8#1)
striking down##2##2##(1996-5#1)(2005-11#1)
striking feature in##2##3##(1991-5#1)(2007-12#1)
striking feature of##3##3##(1990-6#1)(1994-5#1)(2008-10#1)
striking feature##6##2##(1990-6#1)(1991-5#1)(1994-5#1)(1996-6#1)(2007-12#1)(2008-10#1)
striking finding was the high##2##5##(1992-5#1)(1996-11#1)
striking finding was##4##3##(1992-5#1)(1996-10#1)(1996-11#1)(2008-7#1)
striking finding##5##2##(1992-5#1)(1996-10#1)(1996-11#1)(2008-7#1)(2008-8#1)
striking homology with##2##3##(1990-1#1)(1990-9#1)
striking homology##6##2##(1990-1#1)(1990-5#1)(1990-9#1)(1991-8#1)(1993-11#2)
striking in the##2##3##(1991-8#1)(1993-5#1)
striking in##3##2##(1991-8#1)(1993-5#1)(2007-12#1)
striking increase in##4##3##(1991-12#1)(1992-8#1)(2007-7#1)(2008-10#1)
striking phenomenon##2##2##(2009-11#1)(2011-12#1)
striking reduction in##2##3##(1993-11#1)(2011-2#1)
striking results##2##2##(2006-10#1)(2011-12#1)
striking sequence##4##2##(1992-11#1)(1993-6#1)(1993-8#1)(1994-9#1)
striking similarities in##2##3##(1997-1#1)(2009-4#1)
striking similarities##7##2##(1996-4#1)(1997-1#1)(1997-7#1)(2008-10#1)(2009-3#1)(2009-4#1)(2009-5#1)
striking similarity to a##2##4##(1994-5#1)(1996-6#1)
striking similarity to##4##3##(1993-3#1)(1994-5#1)(1995-2#1)(1996-6#1)
striking similarity##7##2##(1990-2#1)(1993-3#1)(1994-5#1)(1995-2#1)(1996-6#1)(2007-12#2)
striking structural##3##2##(1993-12#1)(2008-10#1)(2012-2#1)
striking the##2##2##(1990-9#1)(2007-1#1)
striking##199##1##(1990-1#1)(1990-10#1)(1990-11#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-9#3)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-8#5)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#3)(1994-3#2)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#3)(1995-11#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#4)(1995-9#1)(1996-10#1)(1996-11#4)(1996-12#1)(1996-3#3)(1996-4#2)(1996-5#1)(1996-6#3)(1997-1#1)(1997-3#1)(1997-4#3)(1997-7#3)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#3)(2007-12#10)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#4)(2009-7#1)(2009-8#1)(2010-3#1)(2010-7#2)(2011-1#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#3)
strikingly different##7##2##(1992-3#1)(1994-3#1)(1994-8#1)(2008-11#2)(2008-7#1)(2008-9#1)
strikingly from##2##2##(1990-3#1)(1990-5#1)
strikingly increased in##3##3##(1991-8#1)(1991-9#1)(1993-2#1)
strikingly increased##6##2##(1990-5#1)(1991-8#1)(1991-9#1)(1993-2#1)(1993-9#1)(1994-9#1)
strikingly similar to that of##2##5##(1993-3#1)(1996-4#1)
strikingly similar to##10##3##(1990-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-4#1)(2007-12#1)(2008-5#2)(2012-2#1)
strikingly similar##16##2##(1990-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-10#1)(1996-4#1)(2007-11#1)(2007-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#1)(2012-2#1)
strikingly##55##1##(1990-2#1)(1990-3#1)(1990-5#2)(1991-12#1)(1991-8#1)(1991-9#1)(1992-3#2)(1992-7#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-4#2)(1996-5#1)(1997-1#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
string and##3##2##(2005-10#1)(2013-1#2)
string matching##3##2##(2008-12#1)(2008-2#1)(2008-7#1)
string quartets##2##2##(2013-1#2)
string test##4##2##(2007-7#4)
string##41##1##(1990-4#1)(1994-3#1)(1996-1#2)(2005-10#2)(2006-10#3)(2007-11#2)(2007-12#1)(2007-7#5)(2007-8#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-7#8)(2008-9#1)(2009-11#1)(2009-8#1)(2010-2#1)(2012-12#1)(2013-1#4)
stringency PCR##2##2##(1992-9#1)(1996-2#1)
stringency and the##2##3##(1990-12#1)(2007-6#1)
stringency of##4##2##(1995-5#1)(1996-2#1)(2008-1#1)(2010-12#1)
stringency##24##1##(1990-12#1)(1990-2#1)(1991-5#1)(1992-9#1)(1993-11#1)(1993-7#1)(1994-12#1)(1995-2#1)(1995-5#2)(1996-12#1)(1996-2#2)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-12#1)(2013-1#2)
stringent conditions##3##2##(1992-4#1)(1995-7#1)(2008-5#1)
stringent environmental##2##2##(1990-9#1)(2008-10#1)
stringent factor##2##2##(2007-12#2)
stringent in##3##2##(1995-6#1)(2007-11#1)(2008-11#1)
stringent monitoring##2##2##(2006-10#1)(2010-2#1)
stringent requirements for##4##3##(1994-3#1)(1996-1#1)(2008-8#1)(2011-2#1)
stringent requirements##6##2##(1994-3#1)(1996-1#1)(2008-3#1)(2008-8#1)(2009-5#1)(2011-2#1)
stringent starvation protein##2##3##(1994-5#1)(1996-4#1)
stringent than##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
stringent##77##1##(1990-3#1)(1990-9#1)(1991-10#2)(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-4#1)(1993-1#2)(1993-11#1)(1994-3#3)(1994-5#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-7#2)(1996-1#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-5#1)(2006-10#1)(2007-11#2)(2007-12#4)(2007-3#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#2)(2010-12#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)
strings and the##2##3##(2006-10#1)(2008-3#1)
strings and to##2##3##(2005-10#1)(2008-5#1)
strings and##4##2##(2005-10#1)(2006-10#1)(2008-3#1)(2008-5#1)
strings of##5##2##(1990-8#1)(1997-6#1)(2007-12#1)(2008-5#1)(2008-7#1)
strings##25##1##(1990-8#1)(1997-6#1)(2005-10#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-5#7)(2008-7#7)(2011-1#1)
strip agent##2##2##(2008-10#2)
strip and##2##2##(1997-3#1)(2008-10#1)
strip coating material##2##3##(2008-3#2)
strip electrode##4##2##(1997-3#2)(2008-10#2)
strip loins##3##2##(2010-4#3)
strip mask##2##2##(2008-2#2)
strip of##5##2##(2004-2#1)(2008-10#2)(2008-3#1)(2008-5#1)
strip test for##2##3##(1996-9#1)(2007-12#1)
strip test##5##2##(1996-9#1)(2007-12#1)(2012-3#3)
strip tillage##3##2##(2008-10#3)
strip waveguide##2##2##(2007-12#1)(2008-2#1)
strip##75##1##(1990-7#1)(1995-9#1)(1996-1#1)(1996-12#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#4)(2004-2#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-12#5)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#24)(2008-2#8)(2008-3#4)(2008-5#3)(2010-4#3)(2011-1#2)(2012-3#5)
stripe 2##3##2##(1991-11#3)
stripe is##2##2##(2007-12#1)(2008-10#1)
stripe rust and##2##3##(2008-10#2)
stripe rust epidemics##2##3##(2008-10#2)
stripe rust in##3##3##(2008-10#3)
stripe rust pathogen##2##3##(2008-10#2)
stripe rust resistance gene##2##4##(2008-10#2)
stripe rust resistance##6##3##(2008-10#6)
stripe rust severity and infection type##2##6##(2008-10#2)
stripe rust severity##5##3##(2008-10#5)
stripe rust was##4##3##(2008-10#4)
stripe rust when introgressed into##2##5##(2008-10#2)
stripe rust##46##2##(2008-10#46)
stripe test##4##2##(2009-8#4)
stripe tests##2##2##(2009-8#2)
stripe virus##4##2##(2008-10#4)
stripe wear##3##2##(2009-7#3)
stripe width of##2##3##(2008-3#2)
stripe##88##1##(1991-11#6)(1993-12#1)(1995-11#1)(1997-3#1)(2006-5#1)(2007-12#7)(2008-10#54)(2008-2#1)(2008-3#5)(2008-7#1)(2009-7#3)(2009-8#6)(2012-12#1)
striped and##2##2##(2008-1#1)(2008-10#1)
striped marlin##3##2##(2007-3#3)
striped##10##1##(2007-3#3)(2008-1#2)(2008-10#1)(2008-3#1)(2009-8#2)(2011-2#1)
stripes in##3##2##(1991-11#1)(1992-9#1)(2008-3#1)
stripes is##2##2##(2007-12#1)(2008-3#1)
stripes##19##1##(1991-11#1)(1992-9#2)(1993-2#1)(2007-12#3)(2007-2#1)(2007-9#1)(2008-2#1)(2008-3#4)(2010-8#1)(2011-2#4)
striping##5##1##(2008-10#3)(2008-2#2)
stripped and##3##2##(2008-10#1)(2008-2#1)(2008-4#1)
stripped from organic phase with##2##5##(2008-10#2)
stripped from the organic phase with##2##6##(2008-10#2)
stripped from the##11##3##(1993-1#1)(2007-8#1)(2008-10#8)(2008-5#1)
stripped from##14##2##(1993-1#1)(2007-8#1)(2008-10#10)(2008-4#1)(2008-5#1)
stripped of##2##2##(1990-2#1)(2007-9#1)
stripped##28##1##(1990-2#1)(1993-1#1)(2007-8#1)(2007-9#1)(2008-10#16)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-8#1)
stripping analysis (PSA)##2##3##(2008-10#2)
stripping analysis##8##2##(2008-10#8)
stripping and##8##2##(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)
stripping chronopotentiometric##3##2##(2008-10#3)
stripping current##4##2##(2008-10#4)
stripping differential pulse voltammetry##2##4##(2008-10#2)
stripping differential pulse##4##3##(2008-10#4)
stripping method for the##2##4##(2008-10#2)
stripping method##3##2##(2008-10#3)
stripping mode with an accumulation time##2##6##(2008-10#2)
stripping mode##3##2##(2008-10#3)
stripping of the##4##3##(2008-10#4)
stripping of##12##2##(2007-8#1)(2008-10#10)(2008-11#1)
stripping peak current##4##3##(2008-10#4)
stripping peak was##2##3##(2008-10#2)
stripping peak##8##2##(2008-10#8)
stripping peaks##2##2##(2008-10#2)
stripping performance##3##2##(2008-10#3)
stripping potentiometry##3##2##(2008-10#3)
stripping procedure for##2##3##(2008-10#2)
stripping response is##2##3##(2008-10#2)
stripping response##5##2##(2008-10#5)
stripping square-wave voltammetry##3##3##(2008-10#3)
stripping square-wave##6##2##(2008-10#6)
stripping step##3##2##(2008-10#3)
stripping technique##4##2##(2008-10#4)
stripping voltammetric assay of##2##4##(2008-10#2)
stripping voltammetric detection##5##3##(2008-10#5)
stripping voltammetric determination of the##2##5##(2008-10#2)
stripping voltammetric determination of##14##4##(2007-8#1)(2008-10#13)
stripping voltammetric determination##15##3##(2007-8#1)(2008-10#14)
stripping voltammetric measurement##2##3##(2008-10#2)
stripping voltammetric measurements##3##3##(2008-10#3)
stripping voltammetric method for the##2##5##(2008-10#2)
stripping voltammetric method is##2##4##(2008-10#2)
stripping voltammetric method##4##3##(2008-10#4)
stripping voltammetric procedure for##2##4##(2008-10#2)
stripping voltammetric procedure##7##3##(2008-10#7)
stripping voltammetric##48##2##(2007-8#1)(2008-10#47)
stripping voltammetry (CSV)##4##3##(2007-8#1)(2008-10#3)
stripping voltammetry (DPASV)##5##3##(2008-10#5)
stripping voltammetry and##4##3##(2008-10#4)
stripping voltammetry at a##4##4##(2008-10#4)
stripping voltammetry at##8##3##(2008-10#8)
stripping voltammetry in##2##3##(2008-10#2)
stripping voltammetry is##3##3##(2008-10#2)(2010-2#1)
stripping voltammetry of cysteine##2##4##(2008-10#2)
stripping voltammetry of##12##3##(2008-10#12)
stripping voltammetry on a##4##4##(2008-10#4)
stripping voltammetry on##6##3##(2008-10#6)
stripping voltammetry the##2##3##(2008-10#2)
stripping voltammetry using##9##3##(2007-8#2)(2008-10#7)
stripping voltammetry with a mercury##2##5##(2008-10#2)
stripping voltammetry with a##5##4##(2008-10#5)
stripping voltammetry with##10##3##(2008-10#10)
stripping voltammetry##159##2##(2006-6#2)(2007-8#6)(2008-10#150)(2010-2#1)
stripping was##2##2##(2008-10#2)
stripping with##4##2##(2008-10#2)(2008-5#1)(2013-7#1)
stripping##350##1##(1991-10#1)(2005-11#1)(2006-6#2)(2007-11#1)(2007-8#11)(2008-10#314)(2008-11#2)(2008-4#2)(2008-5#10)(2010-2#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
strippings##4##1##(2008-5#4)
strips are##2##2##(2008-2#2)
strips from##4##2##(1990-5#1)(2007-10#1)(2009-11#2)
strips in vitro##2##3##(1992-6#1)(1995-5#1)
strips in##4##2##(1990-8#1)(1992-6#1)(1995-5#1)(1996-12#1)
strips of rabbit##2##3##(1990-7#1)(1994-11#1)
strips of the##3##3##(1991-10#1)(1991-12#1)(2008-4#1)
strips of##9##2##(1990-7#1)(1991-10#1)(1991-12#1)(1994-11#1)(1997-5#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-4#1)
strips were##6##2##(1991-9#1)(2007-10#1)(2008-4#2)(2009-7#1)(2012-12#1)
strips##67##1##(1990-4#1)(1990-5#2)(1990-7#3)(1990-8#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-6#1)(1994-11#1)(1995-5#4)(1996-1#1)(1996-12#4)(1997-5#2)(2004-9#1)(2005-12#1)(2007-10#2)(2007-11#2)(2007-3#2)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#5)(2009-2#1)(2009-7#1)(2010-6#1)(2012-12#1)
strive for##4##2##(2007-11#1)(2008-10#1)(2009-7#1)(2012-1#1)
strive to##16##2##(1991-12#1)(1994-1#1)(1994-3#3)(1995-1#1)(1995-3#1)(2005-8#1)(2006-2#1)(2007-2#1)(2007-7#1)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
strive##22##1##(1991-12#1)(1994-1#1)(1994-3#3)(1995-1#1)(1995-3#1)(2005-8#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-12#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
strived##2##1##(2010-5#1)(2013-1#1)
strives to##8##2##(1992-12#1)(2006-9#1)(2007-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#1)(2013-7#1)
strives##9##1##(1992-12#1)(1994-1#1)(2006-9#1)(2007-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#1)(2013-7#1)
striving for##3##2##(1997-2#1)(2009-2#1)(2010-9#1)
striving to improve##3##3##(1993-1#1)(2010-8#1)(2011-2#1)
striving to##8##2##(1993-1#1)(2008-11#1)(2008-5#1)(2008-9#2)(2010-4#1)(2010-8#1)(2011-2#1)
striving##15##1##(1993-1#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#2)(2009-2#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-2#1)
strobilurin resistance in##2##3##(2008-10#2)
strobilurin##5##1##(2008-10#5)
stroboscopic##8##1##(2007-12#4)(2008-3#3)(2012-2#1)
strobus##2##1##(2008-10#2)
stroke (2##2##2##(2007-10#1)(2013-1#1)
stroke (OR##2##2##(2007-8#1)(2010-4#1)
stroke (adjusted##2##2##(2007-10#1)(2007-8#1)
stroke (mean age##2##3##(2007-10#1)(2007-9#1)
stroke (n =##3##3##(2007-10#1)(2008-7#1)(2010-7#1)
stroke and AF##2##3##(2008-5#2)
stroke and atrial fibrillation##2##4##(2008-10#1)(2008-5#1)
stroke and coronary heart disease##2##5##(1993-2#1)(2005-10#1)
stroke and death##4##3##(1991-11#1)(2005-8#1)(2006-7#1)(2007-10#1)
stroke and is##2##3##(2007-10#1)(2008-8#1)
stroke and its##2##3##(2005-8#1)(2007-10#1)
stroke and mortality##2##3##(2007-10#2)
stroke and myocardial infarction##2##4##(2005-9#1)(2007-4#1)
stroke and neurodegenerative##2##3##(2007-11#1)(2012-11#1)
stroke and other##4##3##(1996-6#1)(2006-10#1)(2008-8#2)
stroke and peripheral embolism##2##4##(2008-7#1)(2008-8#1)
stroke and spinal cord injury##3##5##(2012-1#3)
stroke and stroke##2##3##(2007-10#1)(2013-1#1)
stroke and suggests##2##3##(1996-2#1)(2009-11#1)
stroke and the##6##3##(1994-2#1)(2007-10#1)(2007-9#2)(2010-10#1)(2011-1#1)
stroke and their##5##3##(2007-10#2)(2010-9#2)(2011-1#1)
stroke and to##3##3##(2008-8#1)(2010-12#1)(2011-1#1)
stroke and were##2##3##(2007-10#1)(2007-9#1)
stroke and##120##2##(1990-3#3)(1991-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-3#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(2005-10#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#3)(2006-11#1)(2006-5#1)(2006-7#1)(2007-10#27)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#11)(2008-1#2)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#4)(2008-7#2)(2008-8#9)(2009-11#2)(2010-10#1)(2010-12#2)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#1)(2012-1#6)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
stroke are##18##2##(2007-10#6)(2007-9#3)(2008-8#5)(2010-12#1)(2011-1#1)(2012-11#1)(2013-1#1)
stroke as a##3##3##(2007-9#1)(2008-7#2)
stroke as##5##2##(2007-10#1)(2007-9#1)(2008-7#2)(2010-11#1)
stroke associated with##2##3##(2007-9#2)
stroke at young age##2##4##(2007-10#2)
stroke at##7##2##(2007-10#5)(2007-8#1)(2013-1#1)
stroke attack rates in rural##2##5##(2007-10#2)
stroke attack rates in##3##4##(2007-10#3)
stroke attack rates##4##3##(2007-10#4)
stroke attack##6##2##(2007-10#5)(2008-8#1)
stroke awareness##3##2##(2007-10#2)(2010-10#1)
stroke based##2##2##(2005-8#1)(2007-10#1)
stroke between##2##2##(2007-9#1)(2008-8#1)
stroke but##4##2##(2007-9#1)(2008-7#1)(2008-8#2)
stroke by##6##2##(1995-9#1)(2007-10#3)(2008-8#1)(2011-2#1)
stroke can##4##2##(2007-10#1)(2008-12#1)(2008-5#1)(2008-8#1)
stroke care##7##2##(2005-8#1)(2006-10#1)(2007-10#2)(2007-9#1)(2008-8#1)(2013-8#1)
stroke cases##6##2##(2007-10#4)(2009-9#1)(2011-1#1)
stroke caused by##7##3##(2007-10#6)(2008-12#1)
stroke center##2##2##(2007-9#1)(2013-8#1)
stroke centers##3##2##(2007-10#1)(2007-9#2)
stroke damage##3##2##(2007-11#1)(2008-1#1)(2010-12#1)
stroke dementia patients##2##3##(1990-3#2)
stroke dementia##4##2##(1990-3#4)
stroke department##2##2##(2007-10#2)
stroke discharge##2##2##(2007-10#2)
stroke due to infective endocarditis##2##5##(2010-8#2)
stroke due to##6##3##(2007-10#1)(2009-6#1)(2010-11#1)(2010-8#3)
stroke during cardiac surgery?##2##4##(2007-8#2)
stroke during the##3##3##(1995-9#1)(2007-8#1)(2008-8#1)
stroke during##8##2##(1995-9#1)(2007-10#2)(2007-8#3)(2007-9#1)(2008-8#1)
stroke event##2##2##(2008-9#1)(2009-10#1)
stroke events##3##2##(2007-10#1)(2008-8#1)(2009-11#1)
stroke following##3##2##(1990-3#1)(2012-2#2)
stroke for##3##2##(2007-10#1)(2008-8#1)(2008-9#1)
stroke from##4##2##(2007-10#3)(2008-8#1)
stroke had##4##2##(2006-11#1)(2007-10#2)(2008-7#1)
stroke has been##3##3##(2004-12#1)(2007-9#1)(2008-8#1)
stroke has declined##2##3##(1995-5#2)
stroke has##12##2##(1995-5#2)(2004-12#1)(2005-9#1)(2007-10#4)(2007-9#2)(2008-8#1)(2012-3#1)
stroke have been##3##3##(2007-9#2)(2008-8#1)
stroke have##5##2##(2007-10#2)(2007-9#2)(2008-8#1)
stroke in China##2##3##(2008-8#2)
stroke in Han##3##3##(2011-1#3)
stroke in Seoul##2##3##(2007-9#2)
stroke in a patient with##2##5##(2007-9#1)(2008-4#1)
stroke in a##7##3##(2007-10#2)(2007-9#2)(2008-4#1)(2008-5#1)(2009-9#1)
stroke in an##2##3##(2007-10#1)(2007-2#1)
stroke in patients undergoing coronary artery bypass grafting##2##8##(2007-10#2)
stroke in patients undergoing coronary artery bypass##3##7##(1997-8#1)(2007-10#2)
stroke in patients with##8##4##(2007-10#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-5#2)(2008-8#1)
stroke in patients##11##3##(1997-8#1)(2007-10#3)(2007-7#1)(2007-8#2)(2008-1#1)(2008-5#2)(2008-8#1)
stroke in the##21##3##(1992-2#1)(1996-6#1)(2007-10#1)(2007-8#2)(2007-9#6)(2008-3#1)(2008-8#2)(2009-4#1)(2009-7#1)(2010-12#1)(2012-1#1)(2013-1#2)(2013-7#1)
stroke in these##3##3##(1991-6#1)(2007-10#1)(2010-5#1)
stroke in women##4##3##(2006-10#1)(2007-9#2)(2011-1#1)
stroke in##99##2##(1991-6#1)(1992-2#1)(1994-4#1)(1995-5#1)(1996-6#1)(1997-8#2)(2006-10#2)(2006-2#1)(2007-10#19)(2007-2#1)(2007-7#1)(2007-8#6)(2007-9#15)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#17)(2009-4#1)(2009-7#1)(2009-9#3)(2010-12#4)(2010-5#1)(2011-1#5)(2012-1#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
stroke incidence##9##2##(1992-4#2)(2007-10#2)(2007-9#1)(2008-8#3)(2012-1#1)
stroke is a##3##3##(2007-10#1)(2009-11#1)(2010-8#1)
stroke is common##2##3##(2007-10#1)(2008-8#1)
stroke is now##2##3##(2006-7#1)(2007-10#1)
stroke is##29##2##(2005-1#1)(2005-7#1)(2006-7#1)(2007-10#6)(2007-11#1)(2007-8#1)(2007-9#6)(2008-5#1)(2008-8#3)(2008-9#3)(2009-11#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)
stroke lesion##3##2##(2007-10#1)(2012-12#2)
stroke location##6##2##(2007-10#5)(2009-6#1)
stroke management##6##2##(2006-10#2)(2007-9#2)(2008-8#2)
stroke may##7##2##(1990-10#1)(2007-10#2)(2007-9#4)
stroke mechanism##6##2##(2007-10#4)(2007-9#2)
stroke mechanisms##3##2##(2007-10#1)(2007-9#2)
stroke model##7##2##(1994-5#1)(2007-10#2)(2007-9#1)(2008-7#2)(2009-3#1)
stroke models##3##2##(2007-9#2)(2008-2#1)
stroke mortality##3##2##(2007-9#1)(2008-1#1)(2008-8#1)
stroke must be##2##3##(2007-9#2)
stroke number##2##2##(2008-7#2)
stroke occurred##2##2##(2007-10#2)
stroke occurrence##2##2##(2007-10#2)
stroke occurring in##2##3##(2005-8#1)(2007-10#1)
stroke of##9##2##(2007-10#4)(2007-11#1)(2007-9#1)(2008-8#2)(2010-10#1)
stroke on##5##2##(2007-10#1)(2007-9#4)
stroke onset and##2##3##(2006-7#1)(2007-10#1)
stroke onset is##2##3##(2007-10#2)
stroke onset##24##2##(2006-7#1)(2007-10#12)(2007-9#5)(2008-3#1)(2008-7#1)(2008-8#1)(2013-1#2)(2013-7#1)
stroke or TIA##4##3##(1994-6#1)(2007-10#3)
stroke or brain injury##2##4##(2008-2#2)
stroke or death##3##3##(1991-11#1)(2007-8#1)(2008-8#1)
stroke or transient ischemic attack (TIA)##2##6##(2007-10#1)(2007-9#1)
stroke or transient ischemic attack were##2##6##(2007-10#1)(2010-12#1)
stroke or transient ischemic attack##6##5##(2007-10#4)(2007-9#1)(2010-12#1)
stroke or transient ischemic attacks##3##5##(1994-6#1)(2007-10#1)(2007-7#1)
stroke or transient ischemic##10##4##(1994-6#1)(2007-10#5)(2007-7#1)(2007-9#1)(2008-8#1)(2010-12#1)
stroke or##36##2##(1991-11#2)(1993-12#1)(1994-6#2)(2006-11#1)(2007-10#12)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-2#2)(2008-8#4)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#2)
stroke outcome##5##2##(2007-10#1)(2007-9#2)(2008-8#1)(2010-12#1)
stroke over the##2##3##(2007-10#1)(2011-2#1)
stroke participant##2##2##(2012-1#2)
stroke pathophysiology##2##2##(2007-10#1)(2007-9#1)
stroke patient with##2##3##(2012-1#2)
stroke patient##9##2##(1995-5#1)(2005-8#1)(2007-10#1)(2007-9#1)(2012-1#5)
stroke patients (n =##2##4##(2007-10#2)
stroke patients admitted to a single##2##6##(2007-10#2)
stroke patients admitted to##5##4##(2007-10#4)(2007-9#1)
stroke patients admitted##8##3##(2007-10#6)(2007-9#2)
stroke patients and##3##3##(2007-10#1)(2007-9#2)
stroke patients at##3##3##(2007-10#1)(2007-9#2)
stroke patients for##2##3##(2007-9#1)(2008-8#1)
stroke patients in##6##3##(1990-2#1)(1995-5#1)(1995-9#1)(2007-9#3)
stroke patients is##4##3##(2007-10#2)(2007-9#1)(2008-8#1)
stroke patients presenting##2##3##(2007-10#2)
stroke patients to##3##3##(2007-10#1)(2007-9#1)(2012-1#1)
stroke patients transported##2##3##(2007-9#2)
stroke patients were##2##3##(2007-10#1)(2007-9#1)
stroke patients who were##2##4##(2007-10#1)(2007-9#1)
stroke patients who##3##3##(2007-10#2)(2007-9#1)
stroke patients with##8##3##(2007-10#5)(2007-12#1)(2012-1#2)
stroke patients##119##2##(1990-2#1)(1995-3#1)(1995-5#1)(1995-9#3)(2005-10#1)(2005-8#1)(2005-9#1)(2007-10#45)(2007-12#1)(2007-2#2)(2007-9#30)(2008-2#3)(2008-3#2)(2008-8#10)(2010-12#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-1#9)(2012-12#3)
stroke population##5##2##(2007-10#4)(2007-9#1)
stroke presenting##2##2##(2007-9#1)(2013-8#1)
stroke prevalence##2##2##(2007-10#1)(2008-8#1)
stroke prevention and##4##3##(2007-10#1)(2007-9#2)(2013-1#1)
stroke prevention but##2##3##(2008-8#1)(2012-12#1)
stroke prevention efforts##2##3##(2007-10#1)(2008-8#1)
stroke prevention in##3##3##(2007-10#1)(2008-1#1)(2012-2#1)
stroke prevention study##2##3##(2007-9#2)
stroke prevention with antiplatelet##2##4##(2007-10#1)(2008-8#1)
stroke prevention with##3##3##(2007-10#1)(2008-8#1)(2012-12#1)
stroke prevention##40##2##(1993-9#1)(1994-9#1)(2005-8#1)(2006-7#1)(2007-10#14)(2007-9#8)(2008-1#1)(2008-8#5)(2010-12#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)
stroke probability##2##2##(2007-10#2)
stroke published##2##2##(2007-10#1)(2008-8#1)
stroke rate and##2##3##(2007-10#1)(2009-1#1)
stroke rate##3##2##(2007-10#1)(2007-8#1)(2009-1#1)
stroke rates##3##2##(2005-10#2)(2006-11#1)
stroke recovery and##2##3##(2007-9#1)(2008-8#1)
stroke recovery##8##2##(2007-9#3)(2008-8#2)(2013-1#1)(2013-8#2)
stroke recurrence##7##2##(2007-10#1)(2007-9#5)(2012-3#1)
stroke registry##5##2##(1994-5#1)(2007-10#1)(2007-9#2)(2008-8#1)
stroke rehabilitation patients##3##3##(2007-9#3)
stroke rehabilitation population##2##3##(2007-10#1)(2007-9#1)
stroke rehabilitation system##2##3##(2012-1#2)
stroke rehabilitation##20##2##(1990-8#1)(2007-10#1)(2007-9#4)(2011-2#1)(2012-1#11)(2013-1#2)
stroke related##4##2##(2005-9#1)(2007-10#1)(2012-2#2)
stroke research##7##2##(1997-5#1)(2007-10#1)(2008-8#4)(2013-1#1)
stroke risk factor##3##3##(2007-10#2)(2007-9#1)
stroke risk factor-adjusted OR = 2##2##6##(2007-10#2)
stroke risk factor-adjusted OR =##4##5##(2007-10#4)
stroke risk factor-adjusted##5##3##(2007-10#5)
stroke risk factors in##2##4##(2007-9#2)
stroke risk factors##17##3##(2007-10#6)(2007-9#9)(2008-2#2)
stroke risk in the elderly##3##5##(2007-9#3)
stroke risk in##6##3##(2007-10#1)(2007-9#4)(2008-8#1)
stroke risk was##2##3##(2007-10#2)
stroke risk##46##2##(2007-10#17)(2007-9#14)(2008-2#3)(2008-8#3)(2010-5#1)(2012-1#2)(2012-2#1)(2013-1#3)(2013-7#2)
stroke scale##5##2##(2007-10#2)(2007-9#1)(2012-11#2)
stroke scales##6##2##(2007-10#1)(2007-9#4)(2008-5#1)
stroke services##4##2##(2008-8#3)(2013-8#1)
stroke severity##12##2##(2007-10#7)(2007-9#3)(2008-3#2)
stroke studies##2##2##(2007-9#1)(2008-8#1)
stroke study##10##2##(2007-10#5)(2007-9#5)
stroke subject##2##2##(2012-1#2)
stroke subtype##10##2##(2007-10#8)(2007-9#2)
stroke subtypes##7##2##(2007-10#5)(2007-9#2)
stroke survivors and##2##3##(2007-10#1)(2010-7#1)
stroke survivors in##2##3##(2007-10#1)(2013-1#1)
stroke survivors is##2##3##(2007-10#2)
stroke survivors##27##2##(2007-10#11)(2007-9#1)(2010-12#1)(2010-7#1)(2012-1#10)(2013-1#2)(2013-8#1)
stroke survivors'##2##2##(2013-1#2)
stroke symptoms##9##2##(2007-10#2)(2007-9#5)(2010-10#2)
stroke syndrome##2##2##(2007-10#2)
stroke syndromes##2##2##(2007-9#2)
stroke team##4##2##(2007-9#3)(2008-8#1)
stroke than those##2##3##(2007-10#2)
stroke than##6##2##(2006-7#1)(2007-10#5)
stroke therapeutics##2##2##(2005-7#2)
stroke therapies##5##2##(2007-10#1)(2007-9#2)(2008-8#2)
stroke therapy##6##2##(2007-10#2)(2007-9#3)(2012-1#1)
stroke to##6##2##(1995-9#1)(2007-10#2)(2007-9#1)(2008-7#1)(2012-1#1)
stroke treatment trials##3##3##(2007-10#1)(2007-9#2)
stroke treatment##16##2##(2007-10#6)(2007-9#8)(2008-8#2)
stroke trial##4##2##(2007-10#1)(2008-8#3)
stroke trials##3##2##(2007-10#2)(2007-9#1)
stroke type##5##2##(2007-10#4)(2007-9#1)
stroke unit and##2##3##(2007-10#1)(2008-7#1)
stroke unit##10##2##(1995-5#1)(2007-10#5)(2007-9#1)(2008-7#1)(2008-8#1)(2013-8#1)
stroke units##7##2##(2007-9#1)(2008-8#1)(2011-1#5)
stroke using##2##2##(2007-9#1)(2012-1#1)
stroke victims 6 months post-stroke##2##5##(2012-2#2)
stroke victims in a rural##2##5##(2008-5#2)
stroke victims##9##2##(2007-10#1)(2008-5#2)(2008-8#1)(2012-2#5)
stroke volume##10##2##(2007-10#2)(2007-2#1)(2008-10#1)(2008-4#1)(2010-12#1)(2012-2#2)(2012-3#2)
stroke was##13##2##(1991-11#1)(2007-10#4)(2007-9#3)(2008-3#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-8#1)
stroke were significantly##2##3##(2007-10#2)
stroke were##10##2##(2007-10#7)(2008-4#1)(2009-9#1)(2012-1#1)
stroke when##2##2##(2006-11#1)(2011-1#1)
stroke while##2##2##(2007-10#2)
stroke who##7##2##(2006-10#1)(2007-10#4)(2009-4#1)(2012-1#1)
stroke will##3##2##(1995-5#1)(2007-9#1)(2011-1#1)
stroke with##5##2##(2007-10#1)(2008-8#1)(2010-10#1)(2012-1#1)(2012-2#1)
stroke within##4##2##(2007-10#3)(2007-9#1)
stroke##1928##1##(1990-10#1)(1990-2#1)(1990-3#9)(1990-8#1)(1991-10#1)(1991-11#10)(1991-5#1)(1991-6#2)(1992-10#1)(1992-12#1)(1992-2#4)(1992-4#5)(1992-8#1)(1993-10#1)(1993-12#3)(1993-2#1)(1993-6#2)(1993-7#2)(1993-9#2)(1994-12#1)(1994-2#3)(1994-4#1)(1994-5#2)(1994-6#2)(1994-9#1)(1995-2#1)(1995-3#2)(1995-5#12)(1995-8#1)(1995-9#10)(1996-11#5)(1996-2#4)(1996-3#2)(1996-6#4)(1996-8#3)(1996-9#4)(1997-2#3)(1997-4#1)(1997-5#3)(1997-6#1)(1997-8#4)(2004-12#2)(2005-1#2)(2005-10#9)(2005-12#1)(2005-7#9)(2005-8#11)(2005-9#6)(2006-10#12)(2006-11#9)(2006-2#3)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#16)(2006-8#3)(2007-10#613)(2007-11#12)(2007-12#1)(2007-2#5)(2007-4#2)(2007-7#13)(2007-8#23)(2007-9#329)(2008-1#11)(2008-10#6)(2008-11#6)(2008-12#3)(2008-2#17)(2008-3#15)(2008-4#3)(2008-5#13)(2008-6#2)(2008-7#30)(2008-8#185)(2008-9#12)(2009-1#3)(2009-10#4)(2009-11#13)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#4)(2009-6#4)(2009-7#1)(2009-9#10)(2010-1#1)(2010-10#7)(2010-11#8)(2010-12#22)(2010-2#1)(2010-3#2)(2010-4#8)(2010-5#2)(2010-7#3)(2010-8#7)(2010-9#14)(2011-1#33)(2011-12#1)(2011-2#19)(2012-1#84)(2012-11#11)(2012-12#24)(2012-2#29)(2012-3#11)(2013-1#41)(2013-7#16)(2013-8#35)
stroke)##5##1##(2005-10#1)(2007-11#1)(2008-3#1)(2008-7#1)(2009-11#1)
stroke-induced##3##1##(2007-10#1)(2008-8#1)(2012-11#1)
stroke-like##9##1##(1990-12#1)(1991-1#2)(1991-4#1)(1993-12#1)(1995-1#1)(2007-10#1)(2008-8#1)(2012-2#1)
stroke-prone spontaneously hypertensive rats##4##4##(1995-12#4)
stroke-prone spontaneously hypertensive##5##3##(1991-12#1)(1995-12#4)
stroke-prone##7##1##(1990-3#1)(1991-12#1)(1991-6#1)(1995-12#4)
stroke-related disability##2##2##(2007-10#2)
stroke-related dysphagia##2##2##(2007-10#2)
stroke-related##9##1##(1992-8#1)(2007-10#6)(2007-7#2)
stroke-specific##2##1##(2007-10#1)(2007-9#1)
stroke/TIA##2##1##(2007-10#1)(2008-8#1)
stroke?##8##1##(1995-5#1)(1997-5#2)(2007-10#1)(2007-2#1)(2008-8#1)(2009-10#1)(2010-12#1)
stroke]##7##1##(1990-8#1)(1995-5#1)(1995-8#1)(1997-3#1)(2005-1#1)(2006-8#1)(2010-12#1)
strokectomy##3##1##(2012-3#3)
strokes and##7##2##(1995-5#1)(2007-10#4)(2008-8#1)(2013-1#1)
strokes are##4##2##(2007-9#1)(2008-5#1)(2008-7#1)(2010-9#1)
strokes in##6##2##(2007-10#3)(2008-7#2)(2011-2#1)
strokes occur##2##2##(2007-10#1)(2008-3#1)
strokes on##2##2##(2007-10#1)(2008-7#1)
strokes that occurred##2##3##(2007-10#2)
strokes##70##1##(1990-11#1)(1990-12#1)(1990-3#1)(1991-11#1)(1993-8#1)(1995-5#1)(1996-2#2)(2006-11#2)(2006-12#1)(2007-10#27)(2007-2#1)(2007-8#1)(2007-9#8)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#2)(2009-10#2)(2009-11#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-1#1)
strokes)##2##1##(1996-2#1)(2013-8#1)
stroma I##2##2##(2013-1#2)
stroma and microcirculation##2##3##(2011-12#2)
stroma and the##2##3##(1993-12#1)(1994-2#1)
stroma and##13##2##(1993-12#1)(1994-2#1)(2007-2#1)(2008-11#1)(2008-9#1)(2010-12#1)(2011-12#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
stroma has##2##2##(2007-5#1)(2008-11#1)
stroma in the##4##3##(1992-12#1)(2008-10#1)(2008-4#1)(2008-5#1)
stroma in##5##2##(1992-12#1)(1995-12#1)(2008-10#1)(2008-4#1)(2008-5#1)
stroma is##5##2##(1991-8#1)(1996-4#1)(2005-12#1)(2011-12#1)(2013-8#1)
stroma of the##7##3##(1995-1#1)(1996-4#1)(1997-3#1)(2007-7#1)(2008-11#1)(2008-5#2)
stroma of##13##2##(1994-2#1)(1995-1#1)(1996-4#2)(1996-9#1)(1997-3#1)(2005-12#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-5#2)(2011-2#1)
stroma was##3##2##(1997-7#1)(2008-5#1)(2008-9#1)
stroma with##4##2##(1994-6#1)(2010-12#1)(2011-2#1)(2013-1#1)
stroma##116##1##(1991-6#1)(1991-8#1)(1992-12#4)(1992-2#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#5)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-5#1)(1996-3#1)(1996-4#4)(1996-9#1)(1997-3#1)(1997-7#1)(2005-11#1)(2005-12#2)(2006-10#2)(2006-11#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#5)(2008-12#5)(2008-2#1)(2008-4#2)(2008-5#5)(2008-6#1)(2008-8#1)(2008-9#4)(2009-2#1)(2010-12#3)(2010-3#1)(2010-7#3)(2011-1#2)(2011-12#3)(2011-2#4)(2012-12#7)(2012-3#3)(2013-1#13)(2013-7#1)(2013-8#4)
stromal and##4##2##(2007-9#1)(2009-6#1)(2012-1#1)(2013-8#1)
stromal cell cultures##2##3##(1994-9#2)
stromal cell line##13##3##(1994-12#1)(1994-6#2)(1995-2#1)(1996-8#1)(2008-10#1)(2008-11#4)(2008-8#2)(2009-9#1)
stromal cell proliferation##2##3##(1996-4#1)(2010-3#1)
stromal cell types##3##3##(1990-10#1)(2011-1#1)(2012-3#1)
stromal cell##37##2##(1990-10#2)(1993-7#2)(1994-12#1)(1994-6#2)(1994-9#4)(1995-1#1)(1995-12#2)(1995-2#2)(1996-4#1)(1996-8#1)(2008-10#1)(2008-11#6)(2008-8#4)(2009-10#1)(2009-4#1)(2009-9#1)(2010-3#1)(2011-1#2)(2012-1#1)(2012-3#1)
stromal cell-derived##2##2##(2008-8#1)(2011-1#1)
stromal cells (BMSC)##2##3##(2008-8#1)(2010-4#1)
stromal cells (MSCs)##2##3##(2008-3#1)(2009-10#1)
stromal cells and##6##3##(1993-7#1)(2005-9#1)(2008-5#1)(2010-3#1)(2011-1#1)(2012-12#1)
stromal cells from##3##3##(1994-9#1)(2011-2#2)
stromal cells in##5##3##(1992-6#1)(1995-12#1)(2008-3#1)(2009-3#1)(2012-1#1)
stromal cells may##2##3##(1995-12#1)(2008-8#1)
stromal cells of##2##3##(2006-10#1)(2007-7#1)
stromal cells or##2##3##(2008-11#1)(2008-4#1)
stromal cells produce##2##3##(1996-8#1)(2008-5#1)
stromal cells were##2##3##(2008-9#1)(2012-1#1)
stromal cells with##3##3##(1995-12#1)(2012-1#2)
stromal cells##91##2##(1990-9#1)(1992-12#1)(1992-6#3)(1993-11#1)(1993-4#1)(1993-7#1)(1993-9#4)(1994-12#1)(1994-9#7)(1995-1#1)(1995-12#7)(1996-8#1)(1997-7#1)(2005-9#1)(2006-10#1)(2007-7#1)(2008-11#6)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#1)(2008-8#6)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#4)(2009-4#6)(2009-9#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-1#8)(2012-12#3)(2012-3#1)
stromal compartment##2##2##(1994-3#1)(2012-1#1)
stromal components##2##2##(1996-6#1)(2011-1#1)
stromal elements##3##2##(1993-9#1)(2009-3#1)(2011-1#1)
stromal fibroblast##3##2##(1990-5#1)(1995-11#1)(2013-1#1)
stromal fibroblasts and##4##3##(2008-8#1)(2011-1#1)(2013-1#2)
stromal fibroblasts##12##2##(2006-11#1)(2008-8#1)(2011-1#4)(2013-1#6)
stromal invasion##2##2##(2007-6#1)(2011-2#1)
stromal layer##2##2##(1993-2#1)(2009-8#1)
stromal microcalcifications##2##2##(2005-12#2)
stromal sarcoma (ESS)##4##3##(2006-9#1)(2008-3#2)(2009-5#1)
stromal sarcoma##15##2##(1991-9#1)(1992-1#3)(1994-7#4)(2006-9#1)(2008-3#3)(2009-5#3)
stromal stem cells##3##3##(2012-1#2)(2012-12#1)
stromal stem##4##2##(2012-1#3)(2012-12#1)
stromal tissue of##2##3##(1996-4#2)
stromal tissue##5##2##(1990-5#1)(1996-4#4)
stromal tumor (GIST)##2##3##(2008-7#1)(2009-7#1)
stromal tumor of the##2##4##(2007-4#1)(2013-1#1)
stromal tumor##18##2##(2006-2#1)(2006-6#1)(2007-11#1)(2007-4#2)(2007-9#1)(2008-10#1)(2008-7#1)(2009-7#2)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
stromal tumors##19##2##(1992-9#1)(2007-9#1)(2008-6#2)(2009-4#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)
stromal tumour##3##2##(2006-2#1)(2006-6#1)(2008-6#1)
stromal tumours##6##2##(2006-6#1)(2008-6#4)(2013-7#1)
stromal vascular fraction##5##3##(2008-11#1)(2012-12#4)
stromal vascular##6##2##(2008-11#2)(2012-12#4)
stromal##275##1##(1990-10#2)(1990-5#2)(1990-9#1)(1991-9#1)(1992-1#3)(1992-12#1)(1992-6#3)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-6#1)(1993-7#3)(1993-9#5)(1994-12#3)(1994-3#1)(1994-6#2)(1994-7#4)(1994-8#1)(1994-9#12)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#9)(1995-2#2)(1996-4#5)(1996-6#1)(1996-8#2)(1997-7#1)(2005-12#3)(2005-9#1)(2006-10#2)(2006-11#4)(2006-2#2)(2006-6#3)(2006-9#1)(2007-11#2)(2007-4#2)(2007-6#1)(2007-7#1)(2007-9#4)(2008-10#2)(2008-11#17)(2008-3#6)(2008-4#2)(2008-5#6)(2008-6#8)(2008-7#1)(2008-8#12)(2008-9#1)(2009-10#2)(2009-2#1)(2009-3#5)(2009-4#8)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-12#2)(2010-3#2)(2010-4#2)(2010-5#2)(2010-8#1)(2011-1#12)(2011-12#1)(2011-2#8)(2012-1#15)(2012-12#11)(2012-2#7)(2012-3#5)(2013-1#17)(2013-7#2)(2013-8#5)
stromata##7##1##(2008-10#5)(2011-1#2)
stromaticum##13##1##(2008-10#13)
stromatoporoids##3##1##(1990-11#3)
stromelysin##8##1##(1990-7#1)(1992-4#1)(1992-6#3)(1994-12#2)(1994-3#1)
stromelysin-1 gene expression##2##3##(1996-5#2)
stromelysin-1 gene##3##2##(1996-5#3)
stromelysin-1 promoter##3##2##(1996-5#3)
stromelysin-1##6##1##(1996-5#6)
strong B##2##2##(2007-11#1)(2007-12#1)
strong DNA##2##2##(1993-3#1)(1993-4#1)
strong O(3)##3##2##(2008-2#2)(2008-3#1)
strong RTP##2##2##(2008-10#2)
strong Raman##2##2##(2008-10#2)
strong T##2##2##(1995-3#1)(1995-5#1)
strong ability to##2##3##(2008-10#1)(2010-11#1)
strong absorbance##2##2##(1997-6#1)(2008-10#1)
strong absorption and##2##3##(2007-12#1)(2008-10#1)
strong absorption at##3##3##(2005-4#2)(2008-10#1)
strong absorption of##2##3##(2008-10#1)(2008-2#1)
strong absorption##13##2##(2005-4#2)(2007-12#1)(2008-10#3)(2008-2#4)(2008-3#3)
strong acid##10##2##(1990-6#1)(1995-8#1)(1997-4#1)(2008-10#6)(2010-2#1)
strong acidic##6##2##(2008-10#5)(2008-11#1)
strong acids##3##2##(2008-10#3)
strong activation of##3##3##(2008-11#1)(2008-4#1)(2009-8#1)
strong activation##4##2##(1997-8#1)(2008-11#1)(2008-4#1)(2009-8#1)
strong activity##2##2##(1994-9#1)(2012-12#1)
strong adsorption of##3##3##(2008-10#3)
strong affinity for the##3##4##(2005-11#1)(2008-10#2)
strong affinity for##5##3##(1994-2#1)(2005-11#1)(2008-10#3)
strong affinity of##2##3##(2008-10#1)(2011-2#1)
strong affinity##9##2##(1994-2#1)(1995-8#1)(1996-7#1)(2005-11#1)(2008-10#4)(2011-2#1)
strong alkaline##2##2##(2008-10#2)
strong and broad##2##3##(2008-10#1)(2008-3#1)
strong and important##2##3##(2008-3#2)
strong and independent##2##3##(2011-2#1)(2012-3#1)
strong and specific##2##3##(1991-4#1)(2008-7#1)
strong and stable electrocatalytic##2##4##(2008-10#2)
strong and that##2##3##(1995-5#1)(2008-8#1)
strong and the##3##3##(1995-8#1)(2007-11#1)(2007-12#1)
strong and weak##7##3##(1993-4#1)(2007-8#1)(2007-9#1)(2008-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
strong and##40##2##(1991-4#1)(1993-4#1)(1994-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-3#1)(1997-7#1)(2006-12#1)(2006-3#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#5)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
strong anharmonicity##2##2##(1995-3#1)(2006-4#1)
strong anion exchange chromatography coupled with molecular exclusion##2##8##(2012-12#2)
strong anion exchange column##2##4##(2008-10#1)(2012-12#1)
strong anion exchange##5##3##(2008-10#2)(2012-12#3)
strong anion exchanger##4##3##(1992-1#1)(2007-8#1)(2008-10#2)
strong anion##11##2##(1991-7#1)(1992-1#1)(2007-8#1)(2008-10#5)(2012-12#3)
strong anion-exchange##2##2##(1996-8#1)(2008-10#1)
strong anisotropy of##2##3##(2008-2#2)
strong anisotropy##3##2##(2008-10#1)(2008-2#2)
strong anomalous##2##2##(2006-4#2)
strong antibacterial activity##3##3##(2005-11#1)(2008-3#1)(2010-3#1)
strong antibacterial##4##2##(2005-11#2)(2008-3#1)(2010-3#1)
strong antifungal activities against##2##4##(1994-2#1)(2013-1#1)
strong antifungal activities##3##3##(1994-2#1)(2008-10#1)(2013-1#1)
strong antifungal##5##2##(1994-2#1)(2006-9#1)(2008-10#1)(2008-8#1)(2013-1#1)
strong antimicrobial activity##2##3##(2008-10#1)(2010-2#1)
strong antimicrobial##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2010-2#1)
strong antioxidant activity##2##3##(2008-10#1)(2008-11#1)
strong antioxidant properties##2##3##(2008-5#1)(2013-1#1)
strong antioxidant##7##2##(2008-10#2)(2008-11#1)(2008-5#1)(2009-6#1)(2010-4#1)(2013-1#1)
strong argument##3##2##(1994-11#1)(2006-10#1)(2008-9#1)
strong association between the##3##4##(2008-1#1)(2008-6#1)(2008-8#1)
strong association between##22##3##(1990-8#1)(1994-3#1)(1997-8#1)(2005-10#2)(2006-2#1)(2006-8#2)(2008-1#1)(2008-4#1)(2008-6#2)(2008-8#2)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
strong association of##3##3##(2008-10#1)(2008-3#2)
strong association with##6##3##(2008-9#1)(2009-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
strong association##33##2##(1990-8#1)(1994-3#1)(1997-8#1)(2004-11#1)(2005-10#2)(2006-2#1)(2006-8#2)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-8#2)(2008-9#1)(2009-2#1)(2010-10#1)(2010-12#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-8#1)
strong associations between##3##3##(1997-2#1)(2005-10#1)(2009-3#1)
strong associations##5##2##(1990-8#1)(1997-2#1)(2005-10#1)(2009-3#1)(2013-8#1)
strong at##2##2##(1992-4#1)(2008-10#1)
strong background in##3##3##(1995-1#1)(2007-11#1)(2008-9#1)
strong background##4##2##(1995-1#1)(2007-11#1)(2008-10#1)(2008-9#1)
strong base##4##2##(2007-11#1)(2008-10#3)
strong basic##2##2##(1997-1#1)(2008-10#1)
strong belief##2##2##(2006-2#1)(2009-2#1)
strong binding of the##2##4##(2008-5#1)(2010-6#1)
strong binding of##6##3##(1990-10#1)(1990-5#1)(2006-12#1)(2008-10#1)(2008-5#1)(2010-6#1)
strong binding to##3##3##(1993-3#1)(1994-9#1)(2008-5#1)
strong binding##13##2##(1990-10#1)(1990-5#1)(1991-3#1)(1993-3#1)(1994-9#1)(1996-8#1)(2006-12#2)(2008-10#1)(2008-5#2)(2009-5#1)(2010-6#1)
strong biological activity##2##3##(2004-2#1)(2008-8#1)
strong bootstrap support##3##3##(2008-10#3)
strong but##6##2##(1997-2#1)(2008-10#1)(2008-8#2)(2009-8#1)(2010-8#1)
strong candidate for##2##3##(2008-10#1)(2009-6#1)
strong candidate##4##2##(1997-4#1)(2008-10#1)(2009-6#1)(2013-7#1)
strong candidates##3##2##(1996-8#1)(2008-11#1)(2008-7#1)
strong case##3##2##(1994-1#1)(2006-7#1)(2008-6#1)
strong cation exchange##3##3##(1992-3#1)(2008-10#1)(2013-8#1)
strong cation##7##2##(1990-12#1)(1991-7#1)(1992-3#1)(2008-10#1)(2010-1#1)(2013-8#2)
strong cation-exchange##4##2##(1990-8#1)(1996-8#1)(1997-3#2)
strong cell-mediated immune responses##2##4##(1995-2#1)(2013-8#1)
strong cell-mediated immune##3##3##(1995-2#1)(2006-10#1)(2013-8#1)
strong changes in##2##3##(2007-11#1)(2011-1#1)
strong clinical suspicion##5##3##(2005-11#1)(2006-10#1)(2009-11#1)(2013-1#2)
strong clinical##9##2##(1997-2#1)(2005-11#1)(2005-8#1)(2006-10#2)(2009-11#1)(2010-10#1)(2013-1#2)
strong commitment to##3##3##(1996-2#1)(2006-4#1)(2006-9#1)
strong competition for##2##3##(2008-7#1)(2008-8#1)
strong competitive##3##2##(1990-11#1)(1993-4#1)(1993-6#1)
strong concentration-dependent##2##2##(1995-1#1)(1995-11#1)
strong confinement##2##2##(2007-12#2)
strong connections##3##2##(1996-2#1)(1997-8#1)(2013-1#1)
strong conservation of##3##3##(1991-4#1)(1994-9#1)(1995-11#1)
strong conservation##4##2##(1991-4#1)(1994-9#1)(1995-11#1)(1996-10#1)
strong contrast##3##2##(1992-3#1)(2006-12#1)(2007-11#1)
strong contribution to##2##3##(2007-12#1)(2008-11#1)
strong contribution##3##2##(2007-12#1)(2008-11#1)(2008-3#1)
strong contributions##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
strong correlated##2##2##(2008-8#2)
strong correlation (P##2##3##(1994-3#1)(2008-7#1)
strong correlation (r = 0##6##5##(1992-7#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-8#1)
strong correlation between the##12##4##(1990-11#1)(1991-6#1)(1995-2#1)(1997-3#1)(2004-4#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#1)
strong correlation between##34##3##(1990-11#1)(1990-8#1)(1991-5#1)(1991-6#1)(1993-6#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-1#2)(1997-3#1)(2004-4#1)(2006-10#1)(2006-7#1)(2007-2#1)(2007-8#3)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
strong correlation with##12##3##(1992-12#1)(1992-8#1)(2005-11#1)(2006-1#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-5#1)(2012-3#1)(2013-8#1)
strong correlation##64##2##(1990-11#1)(1990-8#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-3#1)(1997-1#2)(1997-3#1)(2004-4#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-8#3)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
strong correlations##3##2##(2008-10#1)(2010-4#1)(2012-1#1)
strong coupling between the##3##4##(2008-11#1)(2008-3#1)(2013-7#1)
strong coupling between##5##3##(2008-11#1)(2008-3#2)(2009-8#1)(2013-7#1)
strong coupling to the##2##4##(2007-12#1)(2009-3#1)
strong coupling to##3##3##(2007-12#2)(2009-3#1)
strong coupling##13##2##(1994-11#2)(1995-10#1)(2006-7#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#2)(2009-3#1)(2009-8#1)(2013-7#1)
strong cross-reactivity with##2##3##(1993-11#1)(1996-5#1)
strong cultural##2##2##(2009-11#1)(2012-3#1)
strong data support the##2##4##(2005-10#1)(2011-2#1)
strong decrease in##4##3##(2004-4#1)(2007-12#1)(2009-8#1)(2011-12#1)
strong decrease##5##2##(2004-4#1)(2007-12#1)(2008-10#1)(2009-8#1)(2011-12#1)
strong dependence of the##3##4##(2007-11#1)(2008-2#1)(2012-2#1)
strong dependence of##6##3##(2007-11#2)(2007-12#1)(2008-2#2)(2012-2#1)
strong dependence on##5##3##(2005-11#1)(2007-11#1)(2008-10#2)(2008-7#1)
strong dependence##14##2##(2005-11#1)(2007-11#3)(2007-12#1)(2007-3#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-7#1)(2012-2#1)
strong directional##3##2##(2007-12#1)(2008-8#1)(2009-8#1)
strong dispersion management##11##3##(2007-12#9)(2008-1#2)
strong dispersion##15##2##(2007-11#1)(2007-12#11)(2008-1#2)(2008-2#1)
strong divergent selection##2##3##(2010-8#2)
strong divergent##4##2##(2008-10#1)(2009-9#1)(2010-8#2)
strong dominant##2##2##(1995-10#1)(2012-3#1)
strong earthquakes##4##2##(1996-4#4)
strong effect of##2##3##(2007-12#1)(2013-8#1)
strong effect on##11##3##(2005-11#1)(2005-12#1)(2005-7#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-10#1)(2011-3#1)
strong effect##15##2##(2005-11#1)(2005-12#1)(2005-7#1)(2007-12#2)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-12#1)(2010-10#1)(2010-4#1)(2011-3#1)(2013-8#1)
strong effects of##2##3##(2008-10#1)(2008-8#1)
strong effects on##2##3##(1993-4#1)(2010-4#1)
strong effects##6##2##(1990-10#1)(1993-4#1)(2008-10#1)(2008-8#1)(2010-4#1)(2012-3#1)
strong elastic##2##2##(2007-11#1)(2007-12#1)
strong electrolyte##2##2##(2007-8#2)
strong electron##4##2##(1994-8#1)(2008-10#2)(2011-1#1)
strong electronic##2##2##(2006-12#1)(2013-1#1)
strong emphasis on the##4##4##(1993-12#1)(2008-2#1)(2008-7#1)(2011-2#1)
strong emphasis on##6##3##(1993-12#1)(2006-10#1)(2008-1#1)(2008-2#1)(2008-7#1)(2011-2#1)
strong emphasis##8##2##(1993-12#1)(2006-10#1)(2008-1#2)(2008-2#1)(2008-7#1)(2011-2#1)(2013-8#1)
strong enhancement of##2##3##(2007-12#2)
strong enhancement##4##2##(2007-12#2)(2008-10#1)(2013-1#1)
strong enough to##10##3##(1992-1#1)(1996-8#1)(1997-7#1)(2006-7#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-2#2)
strong enough##15##2##(1992-1#1)(1994-2#1)(1996-8#1)(1997-7#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-8#1)(2012-2#2)(2012-3#1)
strong environmental##2##2##(2008-8#1)(2008-9#1)
strong even after##2##3##(2007-6#1)(2010-8#1)
strong evidence against##3##3##(1991-2#1)(1995-11#1)(1995-12#1)
strong evidence for a##2##4##(1990-5#1)(2007-12#1)
strong evidence for the##4##4##(1990-11#1)(1995-2#1)(1997-3#1)(2013-1#1)
strong evidence for##16##3##(1990-11#2)(1990-5#1)(1993-4#1)(1995-2#1)(1997-3#2)(2006-1#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
strong evidence of##4##3##(1993-3#1)(1997-2#1)(2008-5#1)(2009-5#1)
strong evidence that the##8##4##(1990-8#1)(1991-3#1)(1993-12#1)(1996-1#1)(1996-8#1)(1997-8#1)(2006-2#1)(2008-7#1)
strong evidence that this##4##4##(1990-3#1)(1991-5#1)(2007-8#1)(2008-1#1)
strong evidence that##38##3##(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-3#2)(1991-5#1)(1993-12#1)(1994-1#1)(1994-9#1)(1996-1#1)(1996-8#1)(1997-4#3)(1997-8#2)(2005-10#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#3)(2009-2#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-8#1)
strong evidence to suggest##3##4##(2007-1#1)(2008-8#2)
strong evidence to##8##3##(2006-12#1)(2006-8#1)(2007-1#1)(2008-8#2)(2009-9#1)(2010-12#1)(2012-2#1)
strong evidence##76##2##(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-3#2)(1991-5#1)(1992-2#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-1#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-8#2)(2005-10#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-8#2)(2007-1#2)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#6)(2009-2#2)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-1#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
strong expression of##13##3##(1993-3#1)(1995-8#1)(1997-4#2)(2007-3#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#2)
strong expression##15##2##(1993-3#1)(1995-5#1)(1995-8#1)(1997-4#2)(2007-3#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#2)(2012-2#1)
strong familial##2##2##(2009-6#1)(2013-8#1)
strong fibrinolytic enzyme (nattokinase)##2##4##(1993-12#2)
strong fluorescence##12##2##(1991-2#1)(1992-7#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-2#1)(2012-11#2)
strong for##6##2##(1993-9#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)
strong functional##3##2##(1993-12#1)(1995-11#1)(2012-3#1)
strong genetic component##3##3##(2006-10#1)(2007-2#1)(2012-12#1)
strong genetic##9##2##(2004-11#1)(2006-10#1)(2006-12#1)(2007-2#1)(2008-10#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-7#1)
strong growth##2##2##(1992-12#1)(2008-11#1)
strong harmonic##2##2##(2007-12#1)(2008-1#1)
strong health##2##2##(2011-1#1)(2012-12#1)
strong helper##2##2##(1994-11#1)(2006-10#1)
strong homology to##8##3##(1990-10#1)(1990-3#1)(1992-5#1)(1993-12#1)(1995-6#1)(1996-4#1)(1996-6#1)(1997-7#1)
strong homology with##5##3##(1992-12#1)(1992-8#1)(1995-5#1)(1996-6#1)(1997-4#1)
strong homology##14##2##(1990-10#1)(1990-3#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-2#1)(1995-5#1)(1995-6#1)(1996-4#1)(1996-6#2)(1997-4#1)(1997-7#1)
strong humoral and cellular immune responses##2##6##(1997-4#1)(2005-11#1)
strong hybridization signals##2##3##(1991-6#1)(2008-8#1)
strong hybridization##3##2##(1991-12#1)(1991-6#1)(2008-8#1)
strong hydrogen bonding in the transition state##2##7##(1997-4#2)
strong hydrogen bonding##6##3##(1991-8#2)(1997-4#2)(2008-10#1)(2008-3#1)
strong hydrogen bonds##2##3##(2007-11#1)(2008-10#1)
strong hydrogen##9##2##(1990-5#1)(1991-8#2)(1997-4#2)(2007-11#1)(2008-10#2)(2008-3#1)
strong hydrophobic##3##2##(1991-7#1)(2007-11#1)(2010-5#1)
strong hydrophobicity##2##2##(2008-10#1)(2008-8#1)
strong immunohistochemical##2##2##(1990-3#1)(2006-12#1)
strong immunoreactivity##4##2##(1996-1#1)(1997-6#1)(2010-12#2)
strong impact on the##2##4##(1990-4#1)(2011-2#1)
strong impact on##7##3##(1990-4#1)(2008-11#1)(2008-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
strong impact##8##2##(1990-4#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
strong impacts on##2##3##(1991-6#1)(2011-12#1)
strong implications##3##2##(2010-10#1)(2011-2#1)(2013-1#1)
strong in the##4##3##(1995-1#1)(1996-12#1)(2006-8#1)(2009-7#1)
strong in##9##2##(1995-1#1)(1995-11#1)(1996-12#1)(2005-11#1)(2005-8#1)(2006-8#1)(2008-8#1)(2009-7#1)(2009-8#1)
strong increase in the##3##4##(2005-11#1)(2006-3#1)(2008-11#1)
strong increase in##9##3##(1991-1#1)(1991-9#1)(1997-3#1)(2005-11#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)
strong increase of the##2##4##(2008-10#1)(2009-12#1)
strong increase##12##2##(1991-1#1)(1991-9#1)(1992-9#1)(1997-3#1)(2005-11#1)(2006-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)(2009-12#1)
strong independent##3##2##(1993-2#1)(2008-2#1)(2012-2#1)
strong indications of##2##3##(2005-9#1)(2007-11#1)
strong indications##4##2##(1996-9#1)(1997-8#1)(2005-9#1)(2007-11#1)
strong indicators##4##2##(1990-9#1)(2006-2#1)(2013-1#2)
strong induction of##3##3##(1992-8#1)(1992-9#1)(1996-12#1)
strong inflammatory##4##2##(2006-6#1)(2008-10#1)(2008-11#1)(2009-11#1)
strong influence of the##7##4##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)(2009-7#1)(2010-5#1)(2012-1#1)
strong influence of##13##3##(1990-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2009-7#1)(2010-5#1)(2012-1#1)(2012-3#1)
strong influence on the##8##4##(1996-4#1)(2006-10#1)(2006-2#1)(2008-10#3)(2012-2#1)(2012-8#1)
strong influence on##14##3##(1996-4#1)(2006-10#1)(2006-2#1)(2008-10#5)(2008-11#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-2#1)(2012-8#1)
strong influence##30##2##(1990-2#1)(1996-4#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2012-8#1)
strong inhibition of##5##3##(1990-7#1)(1991-9#1)(1994-6#1)(2004-2#1)(2008-10#1)
strong inhibition##10##2##(1990-7#1)(1991-9#1)(1992-12#1)(1994-6#1)(2004-2#1)(2008-10#1)(2008-5#1)(2008-8#2)(2009-10#1)
strong inhibitors##2##2##(1990-10#1)(1993-3#1)
strong inhibitory activities##3##3##(2011-3#3)
strong inhibitory activity##4##3##(1995-3#1)(2004-2#1)(2008-10#1)(2013-1#1)
strong inhibitory##16##2##(1992-3#1)(1992-5#1)(1993-5#1)(1994-10#1)(1994-11#1)(1995-3#1)(1996-6#1)(2004-2#1)(2007-1#1)(2008-10#3)(2011-3#3)(2013-1#1)
strong input##2##2##(1996-8#1)(1996-9#1)
strong interaction between the##3##4##(2007-8#1)(2010-1#1)(2010-4#1)
strong interaction##8##2##(1992-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-1#1)(2010-4#1)(2012-1#1)
strong interactions between##2##3##(2005-11#1)(2008-8#1)
strong interactions##4##2##(2005-11#1)(2006-10#1)(2008-8#1)(2010-5#1)
strong interest##4##2##(1990-12#1)(2006-12#1)(2007-11#1)(2008-10#1)
strong intermolecular##3##2##(2005-11#1)(2008-10#1)(2008-5#1)
strong intramolecular##3##2##(1996-2#1)(2006-12#1)(2008-5#1)
strong inverse##6##2##(1990-12#1)(1991-5#1)(1995-3#1)(2008-11#1)(2008-3#2)
strong inward rectification##2##3##(1996-2#1)(2008-4#1)
strong ion##2##2##(2006-4#1)(2007-8#1)
strong ionic##2##2##(1992-6#1)(2008-10#1)
strong iron chelator##2##3##(1990-12#1)(1996-8#1)
strong is##2##2##(2008-8#1)(2011-2#1)
strong labeling##2##2##(2007-12#2)
strong leadership##4##2##(1990-12#1)(1995-2#1)(1997-3#1)(2008-12#1)
strong light scattering##3##3##(2008-10#2)(2008-8#1)
strong light##6##2##(1991-12#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)
strong likelihood##2##2##(1994-2#1)(2006-11#1)
strong linkage disequilibrium##4##3##(1997-8#1)(2012-3#3)
strong linkage##6##2##(1997-8#1)(2008-12#1)(2012-3#4)
strong luminescence##2##2##(1996-12#1)(2008-10#1)
strong magnetic##4##2##(1990-2#1)(1993-6#2)(2009-5#1)
strong matrix##2##2##(2008-10#2)
strong membrane##2##2##(1990-4#1)(1991-9#1)
strong metabolic##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
strong mode##2##2##(2007-11#1)(2008-3#1)
strong molecular##3##2##(2008-3#1)(2012-12#1)(2012-3#1)
strong morphological##2##2##(2011-1#1)(2011-2#1)
strong motivation##2##2##(1990-12#1)(2012-1#1)
strong natural##2##2##(2008-5#1)(2008-8#1)
strong need for##4##3##(2007-9#1)(2010-8#1)(2012-2#1)(2012-3#1)
strong need##5##2##(2007-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
strong negative##13##2##(1991-2#1)(1994-12#2)(1994-3#1)(1997-7#1)(2007-6#1)(2008-10#1)(2008-5#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-6#1)(2012-2#1)
strong opioid##2##2##(2006-10#1)(2008-3#1)
strong optical##4##2##(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#1)
strong periodic##4##2##(2007-11#1)(2007-12#2)(2008-9#1)
strong polarization##2##2##(2007-11#1)(2008-3#1)
strong position##2##2##(1994-1#1)(2011-2#1)
strong positive association between##2##4##(1991-9#1)(2009-4#1)
strong positive association with##4##4##(1991-5#1)(2012-11#1)(2013-1#2)
strong positive association##6##3##(1991-5#1)(1991-9#1)(2009-4#1)(2012-11#1)(2013-1#2)
strong positive cooperativity##2##3##(1994-12#1)(1997-6#1)
strong positive correlation between##2##4##(1997-8#1)(2013-8#1)
strong positive correlation of##5##4##(1995-12#1)(2008-11#1)(2008-5#1)(2009-9#2)
strong positive correlation with##2##4##(2007-8#1)(2010-8#1)
strong positive correlation##9##3##(1995-12#1)(1997-8#1)(2007-8#1)(2008-11#1)(2008-5#1)(2009-9#2)(2010-8#1)(2013-8#1)
strong positive results##2##3##(2012-2#2)
strong positive##33##2##(1991-2#1)(1991-5#1)(1991-9#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1997-6#1)(1997-8#1)(2004-11#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-9#2)(2010-8#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
strong potential for##2##3##(2008-3#1)(2012-12#1)
strong potential of##2##3##(2008-1#1)(2012-1#1)
strong potential##7##2##(2008-1#1)(2008-3#2)(2008-5#1)(2010-5#1)(2012-1#1)(2012-12#1)
strong power##2##2##(2007-11#1)(2008-1#1)
strong predictor of##7##3##(1996-8#1)(2007-12#1)(2008-1#1)(2008-9#1)(2010-12#1)(2012-2#1)(2013-1#1)
strong predictors of##8##3##(1992-4#1)(1993-1#1)(2007-7#1)(2007-9#1)(2008-2#1)(2008-7#1)(2013-1#2)
strong predictors##9##2##(1991-8#1)(1992-4#1)(1993-1#1)(2007-7#1)(2007-9#1)(2008-2#1)(2008-7#1)(2013-1#2)
strong preference##5##2##(1990-11#1)(1990-7#1)(1991-5#1)(1992-7#1)(1994-12#1)
strong premating##2##2##(2008-8#1)(2008-9#1)
strong pressure##2##2##(1991-7#1)(2007-11#1)
strong prognostic##3##2##(1996-11#1)(2009-10#1)(2013-1#1)
strong promoter activity in Escherichia coli##2##6##(1991-9#2)
strong promoter activity in##3##4##(1991-9#2)(2008-9#1)
strong promoter activity##4##3##(1991-9#2)(1992-5#1)(2008-9#1)
strong promoter##6##2##(1991-9#2)(1992-5#1)(1996-5#1)(2008-9#2)
strong propensity##3##2##(1991-10#1)(2008-1#1)(2010-11#1)
strong protection##2##2##(2008-11#1)(2008-6#1)
strong psychometric properties##2##3##(2010-10#1)(2010-9#1)
strong pump beam##2##3##(2007-11#1)(2007-12#1)
strong pump##3##2##(2007-11#1)(2007-12#2)
strong quenching of the##2##4##(1993-3#1)(2008-5#1)
strong reaction##2##2##(1993-6#1)(2008-8#1)
strong reactivity with##2##3##(1992-8#1)(2008-5#1)
strong reactivity##4##2##(1992-8#1)(2008-5#1)(2013-1#2)
strong reduction of the##2##4##(2007-11#2)
strong reduction of##3##3##(1997-3#1)(2007-11#2)
strong reduction##4##2##(1997-3#1)(2007-11#2)(2010-11#1)
strong relation between##4##3##(2008-12#1)(2008-2#1)(2008-3#1)(2012-12#1)
strong relation##5##2##(1994-6#1)(2008-12#1)(2008-2#1)(2008-3#1)(2012-12#1)
strong relationship between##7##3##(1995-6#1)(2006-5#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-12#1)
strong relationship with##3##3##(2006-10#1)(2008-10#1)(2012-3#1)
strong relationship##13##2##(1990-12#1)(1995-6#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-9#1)(2009-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
strong relationships##2##2##(1993-11#1)(2010-5#1)
strong research##2##2##(2007-10#1)(2007-4#1)
strong resistance to the##2##4##(1996-7#1)(2008-10#1)
strong resistance to##6##3##(1996-7#1)(2005-11#1)(2008-10#3)(2012-2#1)
strong resistance##8##2##(1996-7#1)(2005-11#1)(2008-10#4)(2008-8#1)(2012-2#1)
strong retention of##2##3##(2008-10#2)
strong risk factor##2##3##(1993-11#1)(2008-3#1)
strong risk##3##2##(1993-11#1)(2006-10#1)(2008-3#1)
strong room temperature phosphorescence (RTP)##2##5##(2008-10#2)
strong selection against##2##3##(1996-10#1)(2012-2#1)
strong selection##7##2##(1991-8#1)(1996-10#1)(2006-4#1)(2008-3#1)(2008-9#1)(2010-8#1)(2012-2#1)
strong selective pressure to##2##4##(1991-2#1)(2008-7#1)
strong selective##5##2##(1991-2#1)(2008-7#1)(2008-8#2)(2013-1#1)
strong selectivity for##2##3##(1997-2#1)(2008-10#1)
strong self-focusing##2##2##(2007-12#2)
strong sequence homology to the##2##5##(1994-8#1)(1997-7#1)
strong sequence homology to##4##4##(1991-9#1)(1994-8#1)(1997-7#2)
strong sequence similarity##2##3##(1993-3#1)(1996-4#1)
strong sequence##6##2##(1991-9#1)(1993-3#1)(1994-8#1)(1996-4#1)(1997-7#2)
strong short-term##2##2##(2008-9#2)
strong similarities##5##2##(1990-12#1)(1990-5#1)(1991-2#1)(1993-2#1)(1993-6#1)
strong similarity to the##3##4##(1990-3#1)(1995-8#1)(2008-7#1)
strong similarity to##4##3##(1990-3#1)(1995-8#1)(1996-6#1)(2008-7#1)
strong similarity##8##2##(1990-3#1)(1992-2#1)(1994-8#1)(1995-8#1)(1996-6#1)(1997-4#1)(2008-2#1)(2008-7#1)
strong solvent##2##2##(1995-4#1)(2008-10#1)
strong spatial##3##2##(2007-12#1)(2008-10#1)(2010-2#1)
strong spectral##4##2##(2008-10#3)(2010-5#1)
strong staining##3##2##(1994-12#1)(1995-10#1)(2010-12#1)
strong statistical##5##2##(1994-3#1)(1997-4#2)(2006-10#1)(2008-8#1)
strong stimulation of##2##3##(1994-8#1)(1997-7#1)
strong structure breaker##2##3##(2005-11#2)
strong structure##3##2##(2005-11#3)
strong support for a##2##4##(2008-1#1)(2010-9#1)
strong support for the##9##4##(1991-1#1)(1994-2#1)(2007-8#1)(2008-11#1)(2009-11#1)(2012-3#2)(2013-1#2)
strong support for##14##3##(1991-1#2)(1992-2#1)(1994-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2009-11#1)(2010-9#1)(2012-3#2)(2013-1#2)
strong support from##3##3##(2007-4#1)(2009-11#1)(2011-12#1)
strong support to the##2##4##(1990-11#1)(2012-3#1)
strong support##22##2##(1990-11#1)(1990-3#1)(1991-1#2)(1992-2#1)(1994-2#1)(2006-9#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-11#1)(2009-11#2)(2010-9#1)(2011-12#1)(2012-3#3)(2013-1#2)
strong surface##2##2##(1995-2#1)(2007-12#1)
strong suspicion of##3##3##(2008-3#2)(2012-3#1)
strong suspicion##4##2##(2008-3#2)(2012-3#1)(2013-1#1)
strong synergistic##4##2##(1993-8#1)(2008-10#1)(2012-12#1)(2012-2#1)
strong temporal##3##2##(2008-11#1)(2008-8#1)(2009-6#1)
strong thyroid stimulating##2##3##(1991-9#2)
strong to##3##2##(1996-5#1)(2008-10#1)(2011-2#1)
strong transactivation##2##2##(1995-6#1)(1997-4#1)
strong transcriptional activator##3##3##(1991-7#1)(1994-8#2)
strong transcriptional##6##2##(1991-7#1)(1991-8#1)(1991-9#1)(1994-8#2)(1996-10#1)
strong two-photon##3##2##(2007-11#1)(2007-12#2)
strong variation##2##2##(2008-5#1)(2009-5#1)
strong vertical##2##2##(1992-7#1)(2007-5#1)
strong visible light##2##3##(2010-7#1)(2011-2#1)
strong visible##3##2##(2008-8#1)(2010-7#1)(2011-2#1)
strong water vapor absorption##2##4##(2008-2#1)(2008-3#1)
strong##1910##1##(1990-1#2)(1990-10#6)(1990-11#11)(1990-12#11)(1990-2#3)(1990-3#7)(1990-4#3)(1990-5#7)(1990-6#3)(1990-7#5)(1990-8#9)(1990-9#1)(1991-1#3)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#6)(1991-3#4)(1991-4#3)(1991-5#9)(1991-6#5)(1991-7#9)(1991-8#7)(1991-9#12)(1992-1#6)(1992-11#3)(1992-12#6)(1992-2#6)(1992-3#6)(1992-4#3)(1992-5#4)(1992-6#2)(1992-7#6)(1992-8#11)(1992-9#9)(1993-1#2)(1993-11#4)(1993-12#11)(1993-2#5)(1993-3#14)(1993-4#5)(1993-5#1)(1993-6#10)(1993-7#1)(1993-8#4)(1993-9#2)(1994-1#3)(1994-10#2)(1994-11#8)(1994-12#14)(1994-2#9)(1994-3#12)(1994-4#1)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#10)(1994-9#9)(1995-1#3)(1995-10#3)(1995-11#8)(1995-12#9)(1995-2#11)(1995-3#11)(1995-4#6)(1995-5#7)(1995-6#7)(1995-7#1)(1995-8#7)(1995-9#1)(1996-1#4)(1996-10#6)(1996-11#1)(1996-12#4)(1996-2#8)(1996-3#4)(1996-4#9)(1996-5#5)(1996-6#9)(1996-7#4)(1996-8#12)(1996-9#6)(1997-1#3)(1997-2#9)(1997-3#11)(1997-4#20)(1997-5#4)(1997-6#3)(1997-7#10)(1997-8#12)(2004-11#3)(2004-2#4)(2004-4#3)(2004-9#2)(2005-10#7)(2005-11#25)(2005-12#2)(2005-4#5)(2005-5#1)(2005-7#1)(2005-8#6)(2005-9#1)(2006-1#3)(2006-10#26)(2006-11#3)(2006-12#24)(2006-2#7)(2006-3#2)(2006-4#8)(2006-5#2)(2006-6#6)(2006-7#7)(2006-8#8)(2006-9#3)(2007-1#5)(2007-10#6)(2007-11#48)(2007-12#80)(2007-2#5)(2007-3#3)(2007-4#5)(2007-5#6)(2007-6#4)(2007-7#6)(2007-8#23)(2007-9#8)(2008-1#22)(2008-10#219)(2008-11#42)(2008-12#10)(2008-2#55)(2008-3#65)(2008-4#10)(2008-5#42)(2008-6#10)(2008-7#30)(2008-8#61)(2008-9#28)(2009-10#7)(2009-11#5)(2009-12#3)(2009-2#8)(2009-3#4)(2009-4#6)(2009-5#7)(2009-6#10)(2009-7#7)(2009-8#9)(2009-9#7)(2010-1#4)(2010-10#7)(2010-11#4)(2010-12#13)(2010-2#9)(2010-3#1)(2010-4#13)(2010-5#16)(2010-6#3)(2010-7#6)(2010-8#14)(2010-9#4)(2011-1#19)(2011-12#9)(2011-2#29)(2011-3#6)(2012-1#10)(2012-11#6)(2012-12#29)(2012-2#32)(2012-3#34)(2012-6#1)(2012-8#1)(2012-9#1)(2013-1#42)(2013-7#5)(2013-8#22)
strong-acid##2##1##(2005-11#1)(2008-10#1)
stronger activations##2##2##(2009-1#2)
stronger activity than##3##3##(1997-1#1)(2004-2#1)(2008-10#1)
stronger affinity for##3##3##(1997-1#1)(2008-10#1)(2011-2#1)
stronger and##8##2##(1990-5#1)(1997-6#1)(2006-7#1)(2007-12#1)(2008-3#1)(2009-8#1)(2011-2#1)(2013-8#1)
stronger at##2##2##(2008-3#1)(2009-4#1)
stronger binding of##2##3##(2008-4#1)(2013-1#1)
stronger binding##4##2##(1991-4#1)(2008-4#1)(2010-5#1)(2013-1#1)
stronger correlations were##2##3##(2008-1#1)(2008-10#1)
stronger delayed absorbable suture materials##2##5##(1991-1#2)
stronger effect on the action threshold##2##6##(2008-4#2)
stronger effect on##4##3##(2008-4#2)(2008-8#2)
stronger effects on##3##3##(1995-1#1)(2008-2#1)(2012-2#1)
stronger effects##5##2##(1995-1#1)(2008-2#1)(2012-2#3)
stronger evidence##3##2##(1997-2#1)(2005-10#1)(2008-2#1)
stronger for females##2##3##(2006-7#1)(2009-8#1)
stronger for the##2##3##(2008-10#1)(2012-2#1)
stronger for##12##2##(2006-7#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-8#2)(2010-1#1)(2012-2#2)(2013-1#1)
stronger genetic##2##2##(2012-3#1)(2013-1#1)
stronger in men##2##3##(2009-1#1)(2010-2#1)
stronger in the##5##3##(1993-2#1)(1995-11#1)(1996-5#1)(2007-1#1)(2011-2#1)
stronger in##23##2##(1993-2#1)(1993-9#1)(1995-10#1)(1995-11#1)(1996-11#1)(1996-5#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-1#1)(2010-10#1)(2010-2#2)(2011-2#1)(2013-8#1)
stronger influence on##2##3##(2006-6#1)(2006-8#1)
stronger inhibitory##2##2##(2006-12#1)(2008-10#1)
stronger interaction##4##2##(1991-7#1)(2005-11#2)(2008-10#1)
stronger or##3##2##(1992-7#1)(2008-8#1)(2008-9#1)
stronger predictors of##3##3##(2008-5#1)(2009-7#1)(2012-3#1)
stronger relationship##2##2##(1993-12#1)(1993-2#1)
stronger resonance scattering##2##3##(2008-10#2)
stronger rhythms##2##2##(2008-6#2)
stronger signal##3##2##(1997-4#1)(2008-3#1)(2013-8#1)
stronger than any##2##3##(1997-8#1)(2011-2#1)
stronger than in##2##3##(1997-7#1)(2011-2#1)
stronger than on##2##3##(1995-6#1)(2008-8#1)
stronger than that of##8##4##(1995-6#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-8#3)(2009-8#1)
stronger than that##11##3##(1991-5#1)(1995-6#1)(1996-2#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-8#4)(2009-8#1)
stronger than the##14##3##(1990-4#1)(1991-5#1)(1992-5#1)(1995-2#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-12#1)(2012-2#2)(2013-1#1)
stronger than those##2##3##(1994-3#1)(2004-9#1)
stronger than##52##2##(1990-4#1)(1990-5#1)(1991-5#2)(1992-5#1)(1993-2#1)(1993-5#1)(1994-3#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#2)(2005-7#1)(2006-9#1)(2007-11#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#6)(2009-8#1)(2010-4#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
stronger when##6##2##(1993-2#1)(2008-1#1)(2008-9#1)(2009-10#2)(2010-5#1)
stronger with the##2##3##(1995-12#1)(2008-10#1)
stronger with##7##2##(1993-6#2)(1995-12#1)(2004-11#1)(2008-10#2)(2008-8#1)
stronger##318##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#4)(1990-7#3)(1991-1#2)(1991-12#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#4)(1993-3#1)(1993-5#1)(1993-6#4)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#4)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#3)(2004-12#1)(2004-2#1)(2004-9#1)(2005-10#3)(2005-11#9)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#3)(2006-2#1)(2006-4#3)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#4)(2008-1#2)(2008-10#30)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#13)(2008-4#3)(2008-5#7)(2008-6#4)(2008-7#1)(2008-8#15)(2008-9#8)(2009-1#3)(2009-10#3)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#6)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#5)(2010-4#4)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#12)(2012-3#6)(2012-5#1)(2013-1#5)(2013-7#5)(2013-8#6)
strongest and most consistent##2##4##(2007-1#1)(2007-3#1)
strongest and most##3##3##(1996-2#1)(2007-1#1)(2007-3#1)
strongest and##5##2##(1996-2#1)(2007-1#1)(2007-3#1)(2007-9#1)(2009-5#1)
strongest being##2##2##(2005-11#1)(2008-10#1)
strongest correlation##2##2##(2010-12#1)(2011-2#1)
strongest effect##2##2##(2008-10#1)(2008-5#1)
strongest evidence##4##2##(2006-9#1)(2007-8#1)(2007-9#1)(2008-6#1)
strongest for##2##2##(1991-5#1)(2010-5#1)
strongest in the##4##3##(1995-11#1)(1996-9#1)(2005-11#1)(2008-10#1)
strongest in##8##2##(1991-7#1)(1992-4#1)(1995-11#1)(1996-9#2)(2005-11#1)(2008-10#1)(2008-11#1)
strongest predictor of##12##3##(1995-5#1)(2005-8#1)(2006-5#1)(2007-10#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-3#1)
strongest predictor##13##2##(1995-5#1)(2005-8#1)(2006-5#1)(2007-10#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-3#2)
strongest predictors##4##2##(1992-12#1)(2007-12#1)(2009-9#1)(2012-12#1)
strongest when##4##2##(1995-3#1)(2008-1#1)(2008-8#1)(2010-12#1)
strongest##138##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-4#1)(1992-7#2)(1993-4#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-3#2)(1995-4#1)(1995-5#2)(1995-8#1)(1996-2#2)(1996-9#2)(1997-3#1)(1997-4#2)(1997-5#1)(2004-9#1)(2005-11#3)(2005-8#1)(2006-1#1)(2006-12#1)(2006-2#2)(2006-3#2)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-12#3)(2007-3#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#17)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#9)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-12#4)(2010-2#2)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#5)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#2)
strongly a##2##2##(2008-10#1)(2008-2#1)
strongly aberrated##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
strongly absorbing aerosols##6##3##(2008-2#5)(2008-3#1)
strongly absorbing##15##2##(2007-12#1)(2008-2#7)(2008-3#5)(2010-4#1)(2013-1#1)
strongly acidic resins##2##3##(2008-10#2)
strongly acidic solution##3##3##(2008-10#3)
strongly acidic##12##2##(1994-5#1)(2008-10#10)(2011-12#1)
strongly activated by##2##3##(1995-6#1)(1996-5#1)
strongly activated##5##2##(1995-2#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-2#1)
strongly adherent##3##2##(2006-8#2)(2008-10#1)
strongly adsorbed##2##2##(2008-10#2)
strongly advised##3##2##(2004-10#1)(2006-10#1)(2007-2#1)
strongly affect##2##2##(1994-8#1)(2009-2#1)
strongly affected by the##7##4##(1990-11#1)(1994-9#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)
strongly affected by##16##3##(1990-11#1)(1994-9#1)(2005-8#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)(2009-6#1)(2009-8#1)(2011-1#1)
strongly affected the##2##3##(2008-10#1)(2008-9#1)
strongly affected##23##2##(1990-11#1)(1994-9#1)(2005-8#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-6#2)(2009-8#2)(2011-1#2)(2012-2#1)
strongly affecting the##2##3##(2011-2#1)(2012-3#1)
strongly affects the##2##3##(1993-9#1)(2008-10#1)
strongly affects##4##2##(1993-9#1)(2005-11#1)(2008-10#1)(2009-12#1)
strongly against the##2##3##(1990-12#1)(1997-2#1)
strongly aggregated##2##2##(2008-10#2)
strongly alter the##2##3##(1994-11#1)(1994-9#1)
strongly and irreversibly##2##3##(2008-10#2)
strongly and specifically##2##3##(1991-8#1)(1992-4#1)
strongly and weakly##2##3##(2006-10#1)(2006-4#1)
strongly and##18##2##(1991-8#1)(1992-3#1)(1992-4#1)(1993-7#1)(1994-11#1)(1994-2#1)(1994-4#1)(1995-5#1)(2006-10#1)(2006-4#1)(2008-10#3)(2008-5#2)(2009-5#1)(2010-3#1)(2013-1#1)
strongly anharmonic systems##2##3##(2006-4#2)
strongly argues##2##2##(1996-2#1)(2008-8#1)
strongly associated to##2##3##(1991-6#1)(2011-1#1)
strongly associated with a##2##4##(2008-6#1)(2012-12#1)
strongly associated with suicidal risk##2##5##(2009-7#2)
strongly associated with the development of##2##6##(2005-8#1)(2008-10#1)
strongly associated with the occurrence of##2##6##(1995-2#1)(2010-12#1)
strongly associated with the presence of##2##6##(2011-1#1)(2011-2#1)
strongly associated with the##8##4##(1995-2#1)(2005-8#1)(2008-10#2)(2008-3#1)(2010-12#1)(2011-1#1)(2011-2#1)
strongly associated with##61##3##(1991-11#1)(1991-3#1)(1991-9#1)(1994-3#1)(1995-2#1)(1996-1#1)(1997-8#1)(2004-10#1)(2004-3#2)(2005-8#1)(2006-12#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#6)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-4#2)(2009-7#3)(2009-9#2)(2010-12#2)(2010-8#1)(2011-1#2)(2011-2#3)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)
strongly associated##65##2##(1991-11#1)(1991-3#1)(1991-6#1)(1991-9#1)(1994-3#1)(1995-2#1)(1996-1#1)(1997-8#1)(2004-10#1)(2004-3#2)(2005-8#1)(2006-12#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#6)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-4#2)(2009-7#3)(2009-9#2)(2010-12#2)(2010-8#1)(2011-1#4)(2011-2#3)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)
strongly attached##3##2##(2008-10#1)(2008-11#2)
strongly attenuated by##3##3##(1996-11#1)(1996-8#1)(2012-12#1)
strongly attenuated##5##2##(1995-1#1)(1996-11#1)(1996-8#1)(2008-3#1)(2012-12#1)
strongly basic anion##2##3##(2005-4#1)(2008-10#1)
strongly believe##2##2##(2008-7#1)(2012-2#1)
strongly believed that##2##3##(2006-7#1)(2012-1#1)
strongly between##2##2##(2009-4#1)(2010-7#1)
strongly binding##2##2##(1996-5#1)(2008-10#1)
strongly birefringent##2##2##(2007-11#1)(2008-3#1)
strongly blocked##2##2##(1990-12#1)(2008-11#1)
strongly bound water molecules##2##4##(2006-10#2)
strongly bound water##3##3##(2006-10#3)
strongly bound##7##2##(1994-11#1)(1996-3#1)(2006-10#3)(2010-7#1)(2011-2#1)
strongly by the##2##3##(2008-2#1)(2009-9#1)
strongly by##7##2##(1990-2#1)(1992-4#1)(1993-3#1)(2005-11#1)(2006-10#1)(2008-2#1)(2009-9#1)
strongly competing species##2##3##(2008-8#2)
strongly conserved in##3##3##(1990-10#1)(1997-3#1)(2013-8#1)
strongly conserved##7##2##(1990-10#1)(1993-6#1)(1997-1#1)(1997-3#1)(2008-5#1)(2012-2#1)(2013-8#1)
strongly coordinates with the##2##4##(2008-10#2)
strongly correlate##2##2##(2007-1#1)(2012-2#1)
strongly correlated (r = 0##3##5##(1991-12#1)(2004-3#1)(2008-10#1)
strongly correlated (r =##4##4##(1991-12#1)(2004-3#1)(2008-10#1)(2009-8#1)
strongly correlated with low##2##4##(1995-3#1)(2008-10#1)
strongly correlated with the degree##2##5##(1990-5#1)(1995-3#1)
strongly correlated with the##11##4##(1990-2#1)(1990-5#1)(1995-3#2)(2008-1#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-4#1)(2010-5#1)
strongly correlated with##32##3##(1990-2#1)(1990-5#1)(1991-8#2)(1992-11#1)(1995-3#3)(1996-9#1)(2006-2#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-5#2)(2012-1#2)(2012-3#3)(2013-1#1)
strongly correlated##50##2##(1990-2#1)(1990-5#1)(1991-12#1)(1991-8#2)(1992-11#1)(1992-9#1)(1993-3#1)(1995-3#3)(1996-9#1)(2004-3#1)(2004-4#1)(2006-2#2)(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#3)(2009-3#1)(2009-8#2)(2010-11#1)(2010-4#1)(2010-5#2)(2011-1#1)(2012-1#2)(2012-2#2)(2012-3#3)(2013-1#1)
strongly coupled to a##2##4##(2006-7#1)(2007-12#1)
strongly coupled##8##2##(2006-7#1)(2007-11#2)(2007-12#2)(2008-11#1)(2008-3#1)(2009-9#1)
strongly curved##2##2##(1996-11#1)(2008-3#1)
strongly decrease##2##2##(1992-9#1)(2005-11#1)
strongly decreased##11##2##(1990-12#1)(1992-8#1)(1994-12#1)(1995-5#2)(1995-8#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
strongly depend on the##5##4##(1993-11#1)(2008-10#1)(2008-5#2)(2009-2#1)
strongly depend on##9##3##(1990-11#1)(1993-11#1)(2004-2#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-2#1)
strongly depend##10##2##(1990-11#1)(1993-11#1)(2004-2#1)(2005-11#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-2#1)
strongly depended on the##2##4##(2008-10#1)(2011-2#1)
strongly depended on##3##3##(1996-5#1)(2008-10#1)(2011-2#1)
strongly dependent on both##3##4##(2008-2#1)(2008-3#1)(2011-1#1)
strongly dependent on the presence of##3##6##(1995-6#1)(1997-7#1)(2008-10#1)
strongly dependent on the##35##4##(1990-6#1)(1990-8#1)(1992-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#2)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-4#1)(2011-2#2)
strongly dependent on##50##3##(1990-4#1)(1990-6#1)(1990-8#1)(1992-3#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#2)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#7)(2008-2#3)(2008-3#7)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#3)(2013-1#1)
strongly dependent upon the##2##4##(2006-10#1)(2008-10#1)
strongly dependent upon##4##3##(1994-12#1)(2006-10#1)(2008-10#2)
strongly dependent##55##2##(1990-4#1)(1990-6#1)(1990-8#1)(1992-3#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#2)(2006-10#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#10)(2008-2#3)(2008-3#7)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#3)(2013-1#1)
strongly depends on the nature of##2##6##(1990-5#1)(2008-5#1)
strongly depends on the##10##4##(1990-5#1)(1996-6#1)(2005-11#3)(2008-3#2)(2008-5#1)(2008-6#1)(2009-3#1)
strongly depends on##12##3##(1990-5#1)(1996-6#1)(2005-11#3)(2006-10#1)(2008-3#2)(2008-5#2)(2008-6#1)(2009-3#1)
strongly differed between##2##3##(2008-11#1)(2008-8#1)
strongly differentiated##3##2##(1997-7#1)(2008-10#1)(2010-5#1)
strongly dispersion-managed fiber-optic communication systems##2##5##(2007-12#2)
strongly dispersion-managed fiber-optic communication##3##4##(2007-12#3)
strongly dispersion-managed##13##2##(2007-11#5)(2007-12#8)
strongly driven##2##2##(1995-7#1)(2007-12#1)
strongly encourage the##2##3##(2008-4#1)(2008-5#1)
strongly enhance the##3##3##(2007-12#1)(2008-10#2)
strongly enhance##4##2##(1995-2#1)(2007-12#1)(2008-10#2)
strongly enhanced by##6##3##(1995-3#1)(1997-4#1)(2008-10#2)(2008-3#1)(2011-2#1)
strongly enhanced the##2##3##(2008-8#1)(2009-8#1)
strongly enhanced##14##2##(1991-2#1)(1992-7#1)(1994-11#1)(1995-3#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2009-8#1)(2011-2#1)
strongly enhances##2##2##(1994-12#1)(2008-8#1)
strongly experienced##2##2##(2004-11#1)(2008-12#1)
strongly express##2##2##(2009-8#1)(2011-2#1)
strongly expressed by##2##3##(1997-5#1)(1997-7#1)
strongly expressed in the##3##4##(1994-9#1)(1996-2#1)(2010-7#1)
strongly expressed in##9##3##(1992-12#1)(1994-9#1)(1996-2#1)(1997-7#1)(2006-9#1)(2010-7#1)(2012-12#2)(2012-2#1)
strongly expressed##17##2##(1992-12#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-4#1)(1995-5#1)(1996-2#1)(1997-5#1)(1997-7#2)(2006-9#1)(2008-6#1)(2008-9#1)(2010-7#1)(2012-12#2)(2012-2#1)
strongly favor##2##2##(1997-5#1)(2012-12#1)
strongly fluorescent##3##2##(2007-11#1)(2008-10#2)
strongly focused on##2##3##(2009-5#1)(2011-2#1)
strongly focused##7##2##(2007-11#2)(2007-12#3)(2009-5#1)(2011-2#1)
strongly for##3##2##(1991-11#1)(2008-1#1)(2008-11#1)
strongly from the##2##3##(1996-8#1)(2007-12#1)
strongly from##4##2##(1996-8#1)(2007-12#2)(2008-2#1)
strongly hybridized to the probe##2##5##(1996-7#1)(2008-9#1)
strongly hybridized to the##3##4##(1990-9#1)(1996-7#1)(2008-9#1)
strongly hydrophobic##2##2##(1990-5#1)(1995-10#1)
strongly hyperosmotic media##3##3##(1992-5#3)
strongly immunostained##2##2##(2008-6#1)(2008-9#1)
strongly impacted##2##2##(2008-11#1)(2010-12#1)
strongly impaired##2##2##(1994-12#1)(2008-10#1)
strongly implicate##3##2##(1990-5#1)(1995-5#1)(2008-1#1)
strongly implicated in##4##3##(1995-10#1)(2004-12#1)(2007-8#1)(2008-7#1)
strongly implicated##5##2##(1995-10#1)(2004-12#1)(2007-8#1)(2008-7#1)(2010-12#1)
strongly improved##3##2##(2006-8#1)(2007-11#1)(2011-1#1)
strongly in the##5##3##(1994-8#1)(2006-7#1)(2007-8#1)(2008-10#1)(2011-2#1)
strongly in##15##2##(1990-3#1)(1992-11#1)(1994-8#1)(1995-2#1)(1995-5#2)(1995-7#1)(1997-4#1)(2006-7#1)(2007-8#1)(2008-10#1)(2010-12#1)(2011-2#2)(2012-2#1)
strongly increased the##2##3##(1990-4#1)(1995-12#1)
strongly increased##9##2##(1990-4#1)(1991-5#1)(1993-8#1)(1995-12#1)(1995-3#1)(1996-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
strongly indicate that the##2##4##(1993-12#1)(2013-1#1)
strongly indicate that##9##3##(1990-3#2)(1991-12#1)(1993-12#1)(1993-8#1)(1997-7#2)(2012-12#1)(2013-1#1)
strongly indicate##10##2##(1990-3#2)(1991-12#1)(1993-12#1)(1993-8#1)(1997-7#2)(2008-10#1)(2012-12#1)(2013-1#1)
strongly indicated a##2##3##(2006-10#1)(2008-10#1)
strongly indicated##4##2##(2006-10#1)(2008-10#1)(2008-3#1)(2011-12#1)
strongly indicates that the##2##4##(1990-7#1)(2011-2#1)
strongly indicates that##6##3##(1990-2#1)(1990-7#1)(1995-1#1)(1996-1#1)(2011-2#1)(2013-1#1)
strongly indicates##9##2##(1990-2#1)(1990-7#1)(1995-1#1)(1996-1#1)(2005-11#1)(2008-8#1)(2010-7#1)(2011-2#1)(2013-1#1)
strongly indicating that the##3##4##(1993-3#1)(1994-7#1)(2008-10#1)
strongly indicating that##5##3##(1993-3#1)(1993-7#1)(1994-7#1)(2008-10#2)
strongly indicating##6##2##(1993-3#1)(1993-7#1)(1994-7#1)(2008-10#2)(2009-7#1)
strongly induced by##2##3##(1990-7#1)(1991-2#1)
strongly induced in##2##3##(1995-2#1)(1996-11#1)
strongly induced under##2##3##(1994-5#1)(2009-10#1)
strongly induced##10##2##(1990-7#1)(1991-2#1)(1993-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1996-11#1)(2008-10#2)(2009-10#1)
strongly influence the##9##3##(1995-8#1)(2007-6#1)(2008-10#2)(2008-3#2)(2008-9#2)(2009-2#1)
strongly influence##16##2##(1992-6#1)(1994-3#1)(1995-8#1)(1997-4#1)(2007-1#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-9#2)(2009-2#1)(2009-5#1)(2010-12#1)
strongly influenced by the nature of the##2##7##(1990-9#1)(1996-4#1)
strongly influenced by the##14##4##(1990-6#1)(1990-9#1)(1996-4#1)(2005-11#1)(2006-10#1)(2007-3#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-1#1)(2012-1#1)
strongly influenced by##37##3##(1990-10#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-9#1)(1995-3#1)(1995-8#1)(1996-4#2)(2005-11#2)(2006-10#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-8#3)(2009-5#1)(2010-4#1)(2011-1#2)(2011-12#1)(2012-1#1)(2013-1#1)(2013-7#1)
strongly influenced the##3##3##(1993-3#1)(1995-8#1)(2008-10#1)
strongly influenced##41##2##(1990-10#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-9#1)(1993-3#1)(1995-3#1)(1995-8#2)(1996-4#2)(2005-11#2)(2005-8#1)(2006-10#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#3)(2008-8#3)(2009-5#1)(2010-4#1)(2011-1#2)(2011-12#1)(2012-1#1)(2013-1#1)(2013-7#1)
strongly influences the##5##3##(1990-9#1)(1997-4#1)(2005-11#1)(2008-9#1)(2012-12#1)
strongly influences##11##2##(1990-9#1)(1992-12#1)(1992-2#1)(1997-4#1)(2005-11#1)(2007-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2012-1#1)(2012-12#1)
strongly inhibit##4##2##(1991-2#1)(1994-9#1)(2006-12#1)(2013-1#1)
strongly inhibited by the##2##4##(1990-11#1)(2010-2#1)
strongly inhibited by##27##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1991-10#1)(1991-2#1)(1991-5#3)(1991-7#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-9#2)(1994-3#1)(1994-9#3)(1995-6#1)(1997-2#1)(2005-11#1)(2006-8#1)(2008-10#1)(2008-11#1)(2010-2#1)
strongly inhibited growth##3##3##(1993-11#1)(2008-11#1)(2011-2#1)
strongly inhibited in##3##3##(1992-11#1)(1995-2#1)(1996-2#1)
strongly inhibited the growth of the##2##6##(1992-3#1)(1992-8#1)
strongly inhibited the growth of##3##5##(1992-3#1)(1992-8#1)(2010-6#1)
strongly inhibited the##12##3##(1991-2#1)(1992-3#1)(1992-8#2)(1995-6#2)(1996-2#1)(1997-1#1)(1997-7#2)(2008-5#1)(2010-6#1)
strongly inhibited##72##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#1)(1990-4#1)(1991-1#1)(1991-10#1)(1991-2#2)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#3)(1993-11#3)(1993-8#1)(1993-9#2)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#4)(1995-2#1)(1995-6#3)(1996-12#1)(1996-2#2)(1996-4#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#2)(2005-11#1)(2006-11#1)(2006-8#2)(2008-10#5)(2008-11#4)(2008-5#2)(2009-3#1)(2010-2#1)(2010-6#1)(2011-2#1)(2013-1#1)
strongly inhibits nuclear##2##3##(1990-6#2)
strongly inhibits##5##2##(1990-6#2)(1990-7#1)(1993-3#1)(1994-9#1)
strongly interacting##2##2##(1990-12#1)(2008-9#1)
strongly involved in##2##3##(1992-9#1)(2010-10#1)
strongly limited##4##2##(2006-12#1)(2006-4#1)(2006-8#1)(2008-3#1)
strongly linked to##6##3##(1991-12#1)(2006-2#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-2#1)
strongly linked with##2##3##(2004-9#1)(2007-8#1)
strongly linked##9##2##(1991-12#1)(1992-6#1)(2004-9#1)(2006-2#1)(2007-8#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-2#1)
strongly localized##5##2##(1993-3#1)(2007-11#1)(2009-5#1)(2012-12#2)
strongly needed##5##2##(2007-10#2)(2010-11#1)(2010-5#1)(2011-2#1)
strongly on the##29##3##(1992-8#1)(1993-4#1)(1994-8#1)(1994-9#1)(1995-1#1)(2005-11#1)(2007-11#4)(2007-12#3)(2008-1#1)(2008-10#2)(2008-2#6)(2008-3#3)(2008-5#1)(2008-9#1)(2010-12#1)(2010-4#1)
strongly on##38##2##(1990-4#1)(1992-8#1)(1993-4#1)(1994-8#1)(1994-9#1)(1995-1#1)(2005-11#2)(2007-11#6)(2007-12#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#7)(2008-3#3)(2008-5#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2013-1#1)
strongly overlapped##2##2##(2008-10#2)
strongly overlapping##3##2##(2008-10#3)
strongly pH-dependent##4##2##(1997-3#1)(1997-5#1)(2008-10#1)(2012-2#1)
strongly point##2##2##(2008-3#1)(2008-5#1)
strongly polar compounds##2##3##(2012-12#2)
strongly polar##4##2##(2012-12#4)
strongly positive for##4##3##(1991-9#1)(1993-8#1)(2007-5#1)(2008-5#1)
strongly positive##13##2##(1991-9#2)(1993-12#1)(1993-8#1)(1994-7#1)(1996-3#2)(2005-12#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-2#1)
strongly positively##2##2##(1995-12#1)(2008-3#1)
strongly predicted##4##2##(1997-8#1)(2009-9#1)(2013-1#2)
strongly predicts##2##2##(2010-7#1)(2012-2#1)
strongly preferred to##2##3##(2008-10#1)(2009-5#1)
strongly preferred##4##2##(1991-4#1)(2007-8#1)(2008-10#1)(2009-5#1)
strongly promote##2##2##(2008-8#1)(2009-8#1)
strongly protective against##2##3##(1995-12#1)(2008-1#1)
strongly recognized##2##2##(1990-7#1)(1993-8#1)
strongly recommend##3##2##(1990-12#1)(1994-9#1)(2007-3#1)
strongly recommended##10##2##(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-7#2)(2010-8#1)(2011-2#1)
strongly reduce the##2##3##(2008-2#1)(2008-3#1)
strongly reduce##3##2##(1997-1#1)(2008-2#1)(2008-3#1)
strongly reduced by##4##3##(1997-1#1)(2008-5#1)(2008-7#1)(2008-8#1)
strongly reduced in##4##3##(1993-9#1)(1995-5#1)(2007-11#1)(2008-10#1)
strongly reduced##25##2##(1992-6#1)(1992-9#1)(1993-9#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-5#1)(1997-7#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-2#1)(2012-8#1)
strongly reduces the##3##3##(1990-12#1)(2008-10#1)(2011-1#1)
strongly reduces##6##2##(1990-12#1)(1994-6#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-1#1)
strongly reducing##4##2##(2008-10#3)(2008-3#1)
strongly regulated##3##2##(1996-8#1)(2006-3#1)(2008-8#1)
strongly related to the##10##4##(1991-12#1)(2006-6#1)(2008-10#4)(2008-12#1)(2008-3#1)(2011-2#1)(2012-1#1)
strongly related to##24##3##(1991-12#1)(1991-9#1)(1992-4#2)(2006-6#1)(2007-10#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-9#1)(2009-7#1)(2010-2#1)(2011-12#1)(2011-2#2)(2012-1#3)(2013-8#1)
strongly related##25##2##(1991-12#1)(1991-9#1)(1992-4#2)(2006-6#1)(2007-10#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-9#1)(2009-7#1)(2010-2#1)(2011-12#1)(2011-2#2)(2012-1#3)(2012-11#1)(2013-8#1)
strongly retained##2##2##(2008-10#1)(2010-5#1)
strongly scattering media##5##3##(1992-8#1)(2007-12#2)(2008-2#2)
strongly scattering##8##2##(1992-8#1)(2007-11#1)(2007-12#2)(2008-2#4)
strongly stabilizing##3##2##(1991-7#1)(2008-9#2)
strongly stained##5##2##(1991-9#1)(1992-12#1)(1993-12#1)(1996-6#1)(2010-1#1)
strongly stimulated both##2##3##(1990-9#1)(1996-4#1)
strongly stimulated by##3##3##(1991-1#1)(1993-8#1)(1996-5#1)
strongly stimulated the##3##3##(1994-9#1)(1996-10#1)(1997-2#1)
strongly stimulated##11##2##(1990-9#2)(1991-1#1)(1993-8#1)(1994-8#1)(1994-9#1)(1996-10#1)(1996-4#1)(1996-5#1)(1997-2#2)
strongly stimulates##4##2##(1995-10#1)(2006-1#1)(2007-7#1)(2010-11#1)
strongly suggest a##4##3##(1993-12#1)(2006-10#1)(2007-6#1)(2009-2#1)
strongly suggest an##3##3##(1991-2#1)(2008-2#1)(2009-12#1)
strongly suggest that Si##2##4##(2008-10#2)
strongly suggest that a##2##4##(1991-1#1)(1991-12#1)
strongly suggest that the##18##4##(1991-1#1)(1991-12#1)(1991-5#1)(1992-6#1)(1993-6#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-4#1)(1997-6#1)(2005-11#1)(2007-1#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#1)
strongly suggest that this##2##4##(1993-9#1)(1994-11#1)
strongly suggest that##76##3##(1990-3#1)(1990-4#1)(1990-7#3)(1991-1#2)(1991-11#1)(1991-12#4)(1991-5#2)(1991-6#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#3)(1996-8#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-3#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
strongly suggest the##6##3##(1994-5#1)(1995-3#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-11#1)
strongly suggest##91##2##(1990-3#1)(1990-4#1)(1990-7#3)(1991-1#2)(1991-11#1)(1991-12#4)(1991-2#1)(1991-5#2)(1991-6#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#3)(1996-8#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-7#1)(2010-11#1)(2010-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
strongly suggested a##2##3##(2007-11#1)(2007-3#1)
strongly suggested that the##3##4##(1993-5#1)(1994-9#1)(2008-4#1)
strongly suggested that##14##3##(1990-5#1)(1991-11#1)(1992-11#1)(1992-5#1)(1992-7#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#1)(2012-2#1)
strongly suggested the presence of##2##5##(1990-5#1)(2008-8#1)
strongly suggested##21##2##(1990-5#2)(1991-11#1)(1992-11#1)(1992-5#1)(1992-7#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-9#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#2)
strongly suggesting that the##2##4##(2008-2#1)(2010-12#1)
strongly suggesting that##7##3##(1991-11#1)(1994-8#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-2#1)(2010-12#1)
strongly suggesting the##2##3##(2005-11#1)(2006-2#1)
strongly suggesting##9##2##(1991-11#1)(1994-8#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-2#1)(2008-10#1)(2008-2#1)(2010-12#1)
strongly suggestive of##3##3##(2005-8#1)(2008-7#1)(2008-8#1)
strongly suggestive##4##2##(1991-4#1)(2005-8#1)(2008-7#1)(2008-8#1)
strongly suggests a##3##3##(1991-7#1)(1996-7#1)(1997-4#1)
strongly suggests that both##2##4##(2008-8#1)(2009-3#1)
strongly suggests that the##7##4##(1990-12#1)(1993-12#1)(1993-6#1)(1995-5#1)(1995-8#1)(1996-7#1)(2008-5#1)
strongly suggests that these##2##4##(1995-2#1)(2008-12#1)
strongly suggests that##34##3##(1990-12#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-3#1)(1995-2#1)(1995-5#2)(1995-8#3)(1995-9#1)(1996-7#1)(1997-7#1)(2005-1#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-12#1)(2012-1#2)(2012-3#1)
strongly suggests the existence of##3##5##(1990-5#1)(2005-10#1)(2009-10#1)
strongly suggests the##4##3##(1990-5#1)(1994-12#1)(2005-10#1)(2009-10#1)
strongly suggests##42##2##(1990-12#1)(1990-5#1)(1991-7#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-5#2)(1995-8#3)(1995-9#1)(1996-7#2)(1997-4#1)(1997-7#1)(2005-1#1)(2005-10#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#2)(2009-3#1)(2010-12#1)(2012-1#2)(2012-3#1)
strongly support a role for##2##5##(1993-12#1)(1993-6#1)
strongly support a##5##3##(1990-11#1)(1993-12#1)(1993-6#1)(1995-6#1)(1997-4#1)
strongly support the concept##2##4##(1996-5#1)(1997-8#1)
strongly support the hypothesis that the##2##6##(1996-8#1)(2008-3#1)
strongly support the hypothesis that##8##5##(1993-12#1)(1994-8#1)(1995-12#1)(1996-8#1)(1997-6#1)(2007-3#1)(2008-3#1)(2010-8#1)
strongly support the idea##2##4##(1997-7#1)(2011-12#1)
strongly support the##26##3##(1992-3#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-12#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-8#1)(2011-12#1)(2012-3#1)(2013-1#1)
strongly support##37##2##(1990-11#1)(1991-8#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-12#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-8#1)(2011-12#1)(2012-3#1)(2013-1#2)
strongly supported by##2##3##(1992-7#1)(2013-8#1)
strongly supported the##3##3##(1994-12#1)(2008-10#1)(2009-2#1)
strongly supported##13##2##(1992-7#1)(1993-2#1)(1994-12#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-2#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
strongly supports the##7##3##(1990-10#1)(1990-8#1)(1997-2#1)(2006-10#2)(2006-9#1)(2010-7#1)
strongly supports##10##2##(1990-10#1)(1990-8#1)(1997-2#1)(2005-8#1)(2006-10#2)(2006-9#1)(2008-1#1)(2010-7#1)(2012-2#1)
strongly suppress##2##2##(1992-5#1)(2005-3#1)
strongly suppressed##7##2##(1991-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2009-4#1)(2011-2#1)
strongly suppresses##2##2##(1992-6#1)(2009-12#1)
strongly suspected##3##2##(2007-7#1)(2012-12#1)(2013-8#1)
strongly temperature dependent##3##3##(1990-8#1)(1996-2#1)(2008-2#1)
strongly that the##3##3##(1991-8#1)(1996-7#1)(2008-7#1)
strongly that these##2##3##(1993-12#1)(2010-3#1)
strongly that##13##2##(1991-8#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-7#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-5#1)
strongly the##10##2##(1991-9#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#2)(2011-1#1)(2011-12#1)
strongly to the##6##3##(1996-4#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-8#1)(2012-2#1)
strongly to vesicles##2##3##(1992-12#2)
strongly to##30##2##(1990-11#1)(1990-2#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-12#2)(1993-3#1)(1994-11#1)(1994-2#1)(1995-3#1)(1996-4#1)(1996-8#1)(2005-11#2)(2006-10#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#2)(2010-4#2)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)
strongly toxic##2##2##(1992-3#1)(2008-8#1)
strongly turbid suspensions##2##3##(2008-3#2)
strongly up-regulated by##2##3##(1996-11#1)(2008-8#1)
strongly upregulated##3##2##(1996-10#1)(2012-3#1)(2013-8#1)
strongly value##2##2##(2006-7#2)
strongly warranted##2##2##(2007-6#1)(2011-2#1)
strongly wavelength-dependent##2##2##(2007-11#1)(2007-12#1)
strongly when##2##2##(1997-2#1)(2006-11#1)
strongly with a##3##3##(1993-6#1)(1994-6#1)(2008-10#1)
strongly with an##2##3##(1993-6#1)(2008-3#1)
strongly with depression##2##3##(2010-2#1)(2012-1#1)
strongly with the##18##3##(1990-5#1)(1991-2#1)(1991-4#1)(1991-8#1)(1991-9#2)(1993-3#1)(1994-9#1)(1996-10#1)(2005-11#1)(2006-8#1)(2007-12#1)(2008-10#4)(2008-11#1)(2009-3#1)
strongly with##60##2##(1990-5#1)(1991-2#1)(1991-4#4)(1991-8#1)(1991-9#3)(1992-12#1)(1992-6#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#1)(1996-10#1)(1996-4#1)(1996-6#1)(1997-3#1)(2005-10#1)(2005-11#1)(2006-8#1)(2007-1#2)(2007-12#2)(2007-4#1)(2008-10#10)(2008-11#2)(2008-3#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-3#1)(2010-2#2)(2010-5#1)(2011-2#1)(2012-1#1)(2012-4#1)
strongly##1559##1##(1990-10#5)(1990-11#8)(1990-12#8)(1990-2#5)(1990-3#5)(1990-4#5)(1990-5#8)(1990-6#4)(1990-7#9)(1990-8#4)(1990-9#6)(1991-1#5)(1991-10#1)(1991-11#6)(1991-12#8)(1991-2#14)(1991-3#3)(1991-4#7)(1991-5#8)(1991-6#3)(1991-7#3)(1991-8#9)(1991-9#11)(1992-11#5)(1992-12#10)(1992-2#1)(1992-3#9)(1992-4#4)(1992-5#5)(1992-6#8)(1992-7#3)(1992-8#8)(1992-9#7)(1993-1#2)(1993-11#7)(1993-12#12)(1993-2#5)(1993-3#14)(1993-4#2)(1993-5#1)(1993-6#7)(1993-7#2)(1993-8#9)(1993-9#6)(1994-11#11)(1994-12#10)(1994-2#7)(1994-3#7)(1994-4#1)(1994-5#6)(1994-6#4)(1994-7#2)(1994-8#10)(1994-9#24)(1995-1#8)(1995-10#4)(1995-11#1)(1995-12#6)(1995-2#11)(1995-3#15)(1995-4#2)(1995-5#13)(1995-6#9)(1995-7#3)(1995-8#14)(1995-9#2)(1996-1#6)(1996-10#3)(1996-11#4)(1996-12#2)(1996-2#11)(1996-3#4)(1996-4#6)(1996-5#10)(1996-6#4)(1996-7#5)(1996-8#7)(1996-9#2)(1997-1#6)(1997-2#11)(1997-3#4)(1997-4#9)(1997-5#6)(1997-6#6)(1997-7#15)(1997-8#8)(2004-10#2)(2004-11#1)(2004-12#1)(2004-2#1)(2004-3#3)(2004-4#2)(2004-9#1)(2005-1#1)(2005-10#3)(2005-11#29)(2005-12#1)(2005-3#1)(2005-4#2)(2005-5#1)(2005-8#6)(2006-1#1)(2006-10#21)(2006-11#2)(2006-12#8)(2006-2#4)(2006-3#1)(2006-4#4)(2006-5#1)(2006-6#3)(2006-7#6)(2006-8#7)(2006-9#3)(2007-1#6)(2007-10#7)(2007-11#36)(2007-12#50)(2007-2#5)(2007-3#6)(2007-4#2)(2007-5#2)(2007-6#3)(2007-7#5)(2007-8#10)(2008-1#21)(2008-10#165)(2008-11#34)(2008-12#5)(2008-2#39)(2008-3#49)(2008-4#10)(2008-5#32)(2008-6#7)(2008-7#20)(2008-8#41)(2008-9#24)(2009-10#8)(2009-11#2)(2009-12#3)(2009-2#8)(2009-3#9)(2009-4#6)(2009-5#7)(2009-6#3)(2009-7#8)(2009-8#9)(2009-9#5)(2010-1#1)(2010-10#3)(2010-11#4)(2010-12#13)(2010-2#4)(2010-3#3)(2010-4#10)(2010-5#10)(2010-6#3)(2010-7#7)(2010-8#5)(2011-1#17)(2011-12#6)(2011-2#33)(2011-7#1)(2012-1#11)(2012-11#1)(2012-12#21)(2012-2#22)(2012-3#14)(2012-4#1)(2012-5#1)(2012-8#1)(2013-1#21)(2013-7#3)(2013-8#9)
strongylids##4##1##(2007-12#1)(2008-4#3)
strongylocentrotid##2##1##(2009-2#2)
strongyloidiasis in##2##2##(2007-7#2)
strongyloidiasis##7##1##(1990-12#1)(1993-8#3)(2007-7#2)(2011-1#1)
strontium (Sr)##3##2##(1996-3#1)(2010-8#1)(2012-2#1)
strontium 89##7##2##(2007-11#7)
strontium and lanthanum##2##3##(2008-10#2)
strontium barium niobate crystal##7##4##(2007-11#2)(2007-12#1)(2008-1#2)(2008-3#2)
strontium barium niobate waveguide##2##4##(2007-12#2)
strontium barium niobate waveguides##2##4##(2007-12#2)
strontium barium niobate##18##3##(2007-11#2)(2007-12#8)(2008-1#2)(2008-3#6)
strontium ion##4##2##(2008-10#4)
strontium is##2##2##(2004-9#1)(2008-10#1)
strontium or lanthanum was##2##4##(2008-10#2)
strontium or lanthanum##4##3##(2008-10#4)
strontium or##5##2##(1993-6#1)(2008-10#4)
strontium oxide powder##2##3##(2004-9#2)
strontium oxide##3##2##(2004-9#3)
strontium ranelate##4##2##(2008-3#1)(2013-1#3)
strontium##76##1##(1990-10#2)(1991-2#6)(1993-11#1)(1993-6#1)(1995-8#1)(1996-3#1)(2004-9#5)(2007-11#10)(2007-12#8)(2008-1#2)(2008-10#24)(2008-2#1)(2008-3#7)(2010-8#2)(2012-2#2)(2013-1#3)
strontium(II)##2##1##(2008-10#2)
strontium-89##2##1##(2007-11#2)
strontium/calcium ratios##2##2##(1992-7#2)
struck a##2##2##(2008-7#1)(2009-10#1)
struck by the##3##3##(1993-6#1)(1997-4#1)(2010-7#1)
struck by##5##2##(1993-6#1)(1997-4#1)(2008-12#1)(2008-2#1)(2010-7#1)
struck down##4##2##(1996-6#4)
struck side##2##2##(2006-11#1)(2007-4#1)
struck the##2##2##(1993-3#1)(2009-4#1)
struck with##2##2##(2007-3#1)(2008-6#1)
struck##22##1##(1993-3#1)(1993-6#1)(1996-3#1)(1996-6#4)(1997-4#1)(2006-11#1)(2007-3#1)(2007-4#3)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-4#2)(2010-12#1)(2010-7#1)
structural MRI##2##2##(2009-10#1)(2009-9#1)
structural RNA##2##2##(1995-8#1)(2013-1#1)
structural abnormalities in##2##3##(1990-4#1)(2013-7#1)
structural abnormalities of the##4##4##(1996-2#1)(2005-11#1)(2007-12#1)(2010-8#1)
structural abnormalities##16##2##(1990-4#1)(1996-2#1)(2005-11#1)(2006-9#1)(2007-12#2)(2008-11#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-1#1)(2010-8#1)(2010-9#1)(2011-1#1)(2013-1#1)(2013-7#1)
structural abnormality##3##2##(1996-12#1)(1997-8#1)(2008-7#1)
structural alignment and analysis of##2##5##(1994-9#1)(2008-10#1)
structural alignment of##3##3##(1997-6#1)(2008-10#1)(2011-2#1)
structural alignment##6##2##(1994-9#1)(1997-6#1)(2008-10#3)(2011-2#1)
structural alignments##3##2##(2008-4#1)(2011-3#2)
structural alteration of the##3##4##(1992-9#1)(1995-12#1)(1995-8#1)
structural alteration##6##2##(1992-2#1)(1992-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(2013-8#1)
structural alterations are##2##3##(1990-7#1)(1993-9#1)
structural alterations of##3##3##(1991-5#1)(1995-6#1)(2008-10#1)
structural alterations##11##2##(1990-7#1)(1991-5#1)(1991-7#1)(1993-9#1)(1995-6#1)(2004-12#1)(2006-11#1)(2007-1#1)(2008-10#1)(2008-8#1)(2011-2#1)
structural analog that##2##3##(1995-2#1)(1996-6#1)
structural analog##6##2##(1991-8#1)(1995-1#1)(1995-2#1)(1996-6#1)(1997-6#2)
structural analogs##5##2##(1992-12#1)(1995-1#2)(1997-4#1)(2011-2#1)
structural analogue##3##2##(1993-11#1)(2007-7#2)
structural analogues of##3##3##(1990-3#1)(1992-6#1)(1996-12#1)
structural analogues##7##2##(1990-3#1)(1992-6#1)(1994-3#3)(1996-12#1)(2010-1#1)
structural analysis and##3##3##(2006-5#1)(2008-5#1)(2010-11#1)
structural analysis by##3##3##(1991-2#1)(1991-3#1)(1994-5#1)
structural analysis of the Yersinia##2##5##(2013-8#2)
structural analysis of the##9##4##(1990-3#1)(1990-7#2)(1991-9#1)(1995-8#1)(1997-6#1)(2008-11#1)(2013-8#2)
structural analysis of##23##3##(1990-3#1)(1990-4#1)(1990-7#2)(1991-9#1)(1992-6#1)(1993-8#1)(1994-9#1)(1995-2#1)(1995-8#1)(1997-6#1)(2007-12#2)(2008-11#1)(2008-4#1)(2009-3#1)(2010-7#1)(2011-1#1)(2013-1#2)(2013-8#3)
structural analysis to##2##3##(1997-6#1)(2006-7#1)
structural analysis##49##2##(1990-3#1)(1990-4#1)(1990-7#2)(1991-2#1)(1991-3#1)(1991-9#1)(1992-6#1)(1993-8#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-8#1)(1996-5#1)(1997-4#1)(1997-6#2)(1997-9#2)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-4#4)(2008-5#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#3)
structural and a##2##3##(1997-2#1)(2008-11#1)
structural and biochemical data##2##4##(1996-9#1)(2012-1#1)
structural and biochemical##6##3##(1995-8#1)(1996-9#1)(2008-10#1)(2008-8#1)(2009-12#1)(2012-1#1)
structural and compositional##2##3##(2007-8#1)(2008-3#1)
structural and dynamical##2##3##(2012-2#2)
structural and enzymatic##2##3##(1995-3#1)(2012-2#1)
structural and expressional##2##3##(1993-11#1)(2008-8#1)
structural and functional abnormalities##3##4##(2008-6#1)(2009-10#1)(2010-8#1)
structural and functional alterations##2##4##(2007-6#1)(2008-1#1)
structural and functional analyses##2##4##(1995-6#1)(2012-2#1)
structural and functional analysis##3##4##(1993-6#1)(2008-10#1)(2008-9#1)
structural and functional changes in##3##5##(2007-7#1)(2008-5#1)(2010-10#1)
structural and functional changes##5##4##(2007-7#1)(2008-5#2)(2010-10#1)(2012-12#1)
structural and functional characteristics of the##2##6##(2008-5#1)(2012-1#1)
structural and functional characteristics of##3##5##(2008-5#1)(2011-2#1)(2012-1#1)
structural and functional data##2##4##(2005-10#1)(2009-10#1)
structural and functional features of##2##5##(1991-9#1)(2008-4#1)
structural and functional features##3##4##(1991-9#1)(1993-6#1)(2008-4#1)
structural and functional genomics##2##4##(2008-4#1)(2008-7#1)
structural and functional imaging##3##4##(2007-7#1)(2008-11#1)(2010-12#1)
structural and functional importance of##2##5##(1994-8#1)(2011-1#1)
structural and functional information from##2##5##(1991-3#1)(2006-12#1)
structural and functional information##3##4##(1991-3#1)(1996-7#1)(2006-12#1)
structural and functional integrity##3##4##(1997-4#1)(2006-12#1)(2007-11#1)
structural and functional plasticity##2##4##(2008-1#1)(2012-12#1)
structural and functional properties of##5##5##(1990-12#1)(1994-9#1)(2008-5#1)(2008-8#1)(2009-8#1)
structural and functional properties##8##4##(1990-12#1)(1994-9#1)(1995-7#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-8#1)
structural and functional similarities##2##4##(2005-11#1)(2012-2#1)
structural and functional studies##2##4##(1991-3#1)(1997-7#1)
structural and functional##88##3##(1990-12#1)(1990-5#1)(1991-11#1)(1991-3#2)(1991-9#1)(1993-6#4)(1994-8#1)(1994-9#2)(1995-12#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-3#1)(1996-7#1)(1997-4#2)(1997-6#1)(1997-7#1)(2005-10#2)(2005-11#1)(2006-10#1)(2006-12#4)(2006-8#1)(2007-11#1)(2007-12#2)(2007-6#3)(2007-7#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#3)(2009-11#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#4)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-8#1)
structural and magnetic##2##3##(1996-2#1)(2007-11#1)
structural and material##2##3##(2007-12#1)(2009-7#1)
structural and mechanical properties of##2##5##(2007-8#1)(2013-8#1)
structural and mechanistic##2##3##(1990-4#1)(2009-2#1)
structural and molecular##2##3##(1993-6#1)(2009-8#1)
structural and organizational##2##3##(2007-9#1)(2008-2#1)
structural and quantitative##2##3##(1995-1#1)(2006-5#1)
structural and regulatory##2##3##(1997-7#1)(2012-12#1)
structural and sequence##2##3##(1991-6#1)(1992-12#1)
structural and##167##2##(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-3#2)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-6#6)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(2005-10#2)(2005-11#1)(2005-8#1)(2006-10#3)(2006-12#6)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#3)(2007-12#5)(2007-6#3)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#5)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#4)(2011-2#1)(2012-1#4)(2012-11#1)(2012-12#3)(2012-2#7)(2012-3#4)(2013-7#1)(2013-8#2)
structural and/or functional##3##3##(1991-3#1)(2009-5#1)(2012-12#1)
structural and/or##4##2##(1991-3#1)(1996-8#1)(2009-5#1)(2012-12#1)
structural anisotropy##2##2##(2008-2#1)(2008-7#1)
structural anomalies in##2##3##(1993-10#1)(2008-2#1)
structural anomalies##3##2##(1993-10#1)(2008-1#1)(2008-2#1)
structural arrangement##2##2##(1992-6#1)(1993-12#1)
structural arrangements##2##2##(1995-8#1)(2008-4#1)
structural aspects of the##2##4##(2008-5#1)(2009-12#1)
structural aspects of##4##3##(2008-5#1)(2009-12#1)(2011-1#1)(2013-1#1)
structural aspects##5##2##(2008-5#1)(2008-8#1)(2009-12#1)(2011-1#1)(2013-1#1)
structural association##2##2##(1993-8#1)(1997-6#1)
structural asymmetries##2##2##(1995-12#1)(2011-12#1)
structural barriers##3##2##(1996-2#1)(2011-2#1)(2012-3#1)
structural basis for the##7##4##(1992-10#1)(1993-11#2)(1995-8#1)(1997-2#1)(2005-11#1)(2011-1#1)
structural basis for this##2##4##(1991-11#1)(1992-11#1)
structural basis for##16##3##(1991-11#1)(1992-10#1)(1992-11#2)(1992-4#1)(1993-11#2)(1995-2#1)(1995-8#1)(1997-2#2)(1997-4#1)(2005-11#1)(2011-1#3)
structural basis of##11##3##(1990-3#1)(1994-8#1)(1995-3#1)(1997-9#2)(2007-12#1)(2008-4#1)(2008-9#1)(2009-7#1)(2012-2#2)
structural basis##29##2##(1990-3#1)(1991-11#1)(1992-10#1)(1992-11#2)(1992-4#1)(1993-11#2)(1993-8#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-2#2)(1997-4#1)(1997-9#2)(2005-11#1)(2007-12#1)(2008-4#2)(2008-9#1)(2009-7#1)(2011-1#3)(2012-2#2)
structural bioinformatics##2##2##(2008-4#1)(2008-7#1)
structural biology##4##2##(1995-4#1)(2005-8#1)(2006-3#1)(2009-12#1)
structural bone##2##2##(2006-8#1)(2008-5#1)
structural brain abnormalities##3##3##(1995-1#1)(1996-5#1)(1997-8#1)
structural brain##6##2##(1995-1#1)(1996-12#1)(1996-5#1)(1997-8#1)(2008-2#1)(2008-4#1)
structural carbohydrates##2##2##(2008-10#1)(2010-2#1)
structural cardiac disease##2##3##(2010-8#1)(2011-2#1)
structural change in##6##3##(1990-8#1)(1991-4#1)(1994-3#1)(1997-6#2)(2007-6#1)
structural change occurring at approximately##2##5##(2005-11#2)
structural change of BSA##2##4##(2005-11#2)
structural change of##9##3##(1990-5#1)(1995-10#1)(2005-11#2)(2008-10#2)(2008-3#1)(2008-8#2)
structural change##39##2##(1990-10#1)(1990-5#1)(1990-8#2)(1991-4#6)(1991-5#1)(1994-3#1)(1995-10#3)(1996-9#1)(1997-1#1)(1997-6#2)(2005-11#4)(2006-11#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#3)(2009-5#1)(2010-6#1)(2011-2#1)(2012-12#1)
structural changes and##3##3##(1993-8#1)(2007-6#1)(2007-8#1)
structural changes as##2##3##(1993-8#1)(2008-9#1)
structural changes at the##4##4##(1995-5#1)(2006-11#1)(2009-8#1)(2013-1#1)
structural changes at##6##3##(1991-4#1)(1994-11#1)(1995-5#1)(2006-11#1)(2009-8#1)(2013-1#1)
structural changes have been##2##4##(1994-9#1)(2005-7#1)
structural changes in the last##2##5##(1997-4#2)
structural changes in the membrane##2##5##(2006-10#1)(2008-10#1)
structural changes in the##22##4##(1990-7#1)(1991-12#1)(1991-4#1)(1992-3#1)(1992-6#1)(1993-6#1)(1995-5#2)(1996-3#1)(1997-4#3)(1997-7#1)(2006-10#2)(2006-6#1)(2008-10#3)(2008-8#1)(2012-1#1)(2013-1#1)
structural changes in##36##3##(1990-7#1)(1990-8#1)(1991-12#1)(1991-4#1)(1992-3#1)(1992-6#1)(1993-11#2)(1993-6#1)(1994-11#1)(1994-6#1)(1995-5#4)(1996-3#1)(1997-4#3)(1997-7#2)(2006-10#2)(2006-6#1)(2007-1#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-1#1)(2012-12#1)(2013-1#1)
structural changes is##2##3##(1990-3#1)(2006-6#1)
structural changes occurring in##2##4##(2008-3#1)(2008-5#1)
structural changes occurring##4##3##(1991-3#1)(1994-2#1)(2008-3#1)(2008-5#1)
structural changes of the membrane##2##5##(2006-10#1)(2010-4#1)
structural changes of the##6##4##(1992-3#1)(1995-10#1)(2006-10#1)(2007-6#1)(2010-4#1)(2011-2#1)
structural changes of##17##3##(1992-3#1)(1995-10#1)(1995-11#1)(1997-4#1)(2005-11#2)(2006-10#1)(2006-6#2)(2007-6#1)(2007-9#1)(2008-10#2)(2008-7#1)(2009-8#1)(2010-4#1)(2011-2#1)
structural changes take place##2##4##(1992-1#1)(1995-2#1)
structural changes that##6##3##(1991-7#1)(1996-11#1)(1997-1#1)(2008-3#1)(2008-4#1)(2012-12#1)
structural changes were##2##3##(1993-9#1)(1995-1#1)
structural changes##135##2##(1990-3#2)(1990-7#4)(1990-8#1)(1991-12#1)(1991-3#2)(1991-4#3)(1991-5#2)(1991-7#1)(1992-1#2)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#3)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-5#7)(1996-11#1)(1996-3#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-4#7)(1997-6#1)(1997-7#2)(2005-11#4)(2005-7#1)(2006-10#3)(2006-11#2)(2006-6#4)(2006-7#1)(2007-1#1)(2007-11#1)(2007-6#3)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#7)(2008-11#2)(2008-3#5)(2008-4#2)(2008-5#3)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#2)(2009-8#2)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)
structural character##2##2##(1992-12#1)(2009-3#1)
structural characterisation of##3##3##(2008-10#1)(2010-5#2)
structural characterisation##4##2##(2008-10#1)(2010-5#3)
structural characteristics of the##3##4##(2008-11#1)(2008-8#1)(2013-7#1)
structural characteristics of##9##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
structural characteristics##18##2##(1990-2#1)(1992-8#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#3)
structural characterization by##4##3##(1990-2#1)(1991-2#1)(1994-12#1)(2008-10#1)
structural characterization of the##8##4##(1993-8#1)(1995-2#1)(1996-4#1)(1997-2#1)(2007-10#1)(2008-10#2)(2008-4#1)
structural characterization of two new##2##5##(1996-2#1)(2006-12#1)
structural characterization of##22##3##(1992-8#1)(1993-8#1)(1994-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-2#2)(1996-4#1)(1996-8#1)(1997-2#1)(1997-5#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-4#1)
structural characterization##34##2##(1990-2#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-7#1)(1996-2#2)(1996-4#1)(1996-8#1)(1997-2#1)(1997-5#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-4#1)(2008-6#1)(2009-9#1)
structural chemistry##2##2##(1990-11#1)(1997-1#1)
structural chromosome aberrations##2##3##(2008-9#1)(2010-12#1)
structural chromosome##3##2##(2008-4#1)(2008-9#1)(2010-12#1)
structural class##3##2##(1994-9#1)(1996-8#1)(2008-5#1)
structural classes##6##2##(1992-4#1)(1993-4#1)(1993-6#1)(1995-6#1)(2008-11#1)(2008-4#1)
structural comparison with##2##3##(1992-8#1)(2010-5#1)
structural comparison##5##2##(1992-11#1)(1992-8#1)(2008-4#1)(2008-7#1)(2010-5#1)
structural comparisons##2##2##(2005-11#1)(2008-7#1)
structural complexes##2##2##(2007-6#1)(2008-4#1)
structural complexity##5##2##(2006-12#1)(2007-12#1)(2009-5#1)(2011-12#1)(2012-2#1)
structural component of the##2##4##(1992-3#1)(1996-2#1)
structural component of##4##3##(1992-3#1)(1996-2#1)(2008-10#1)(2008-7#1)
structural component##8##2##(1992-3#1)(1995-2#1)(1996-2#1)(2008-10#1)(2008-7#1)(2013-1#1)(2013-8#2)
structural components in##2##3##(1997-6#1)(2009-2#1)
structural components of the##3##4##(1997-8#1)(2008-4#1)(2008-8#1)
structural components of##7##3##(1992-12#1)(1992-5#1)(1997-8#1)(2006-10#1)(2008-4#1)(2008-8#1)(2013-1#1)
structural components##16##2##(1992-12#1)(1992-5#1)(1994-9#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-4#1)(2008-8#1)(2009-10#2)(2009-2#1)(2009-6#1)(2010-8#1)(2013-1#1)
structural composition of##3##3##(1995-6#1)(2008-10#1)(2008-3#1)
structural composition##4##2##(1995-6#1)(2008-10#2)(2008-3#1)
structural configuration##2##2##(2006-12#1)(2009-4#1)
structural conformation##3##2##(1997-8#3)
structural connectivity##2##2##(2010-8#2)
structural conservation##2##2##(1997-2#1)(2012-12#1)
structural constituents##3##2##(2008-12#1)(2011-12#2)
structural constraints for##2##3##(2007-11#1)(2011-1#1)
structural constraints on the##2##4##(1994-5#1)(2009-5#1)
structural constraints##7##2##(1994-11#1)(1994-5#2)(2007-11#1)(2008-7#1)(2009-5#1)(2011-1#1)
structural crisis##2##2##(2013-1#2)
structural criteria##2##2##(1991-10#1)(1992-6#1)
structural cues##2##2##(2010-1#1)(2011-2#1)
structural damage in##3##3##(1990-7#2)(2007-8#1)
structural damage##13##2##(1990-7#2)(2007-10#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-8#2)
structural data are##2##3##(2007-4#1)(2008-5#1)
structural data from##2##3##(2008-10#1)(2012-2#1)
structural data on complexes between##2##5##(2009-2#1)(2013-1#1)
structural data##28##2##(1990-12#1)(1990-7#1)(1992-7#1)(1996-7#2)(1997-4#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-12#1)(2009-2#2)(2011-2#2)(2012-2#1)(2013-1#4)
structural database##2##2##(2008-10#2)
structural defect of##2##3##(1994-12#1)(1997-3#1)
structural defects in the##4##4##(1995-3#1)(2005-11#1)(2012-12#2)
structural defects in##7##3##(1990-5#1)(1995-3#1)(2005-11#1)(2008-2#1)(2012-12#2)(2012-2#1)
structural defects##16##2##(1990-5#1)(1995-3#1)(1996-12#2)(1997-6#2)(2005-11#2)(2008-10#2)(2008-2#1)(2008-3#1)(2010-3#1)(2012-12#2)(2012-2#1)
structural defense responses##2##3##(2008-10#2)
structural defense##3##2##(2008-10#3)
structural deficit in the##2##4##(1996-7#2)
structural definition of##2##3##(2008-4#2)
structural definition##4##2##(2008-10#1)(2008-4#2)(2011-1#1)
structural derivative of##2##3##(1996-9#1)(2008-10#1)
structural description of##3##3##(1995-4#1)(2008-3#1)(2012-2#1)
structural description##4##2##(1995-4#1)(1997-8#1)(2008-3#1)(2012-2#1)
structural design of cemented doublets##2##5##(2008-3#2)
structural design of##3##3##(2008-3#2)(2008-7#1)
structural design##4##2##(2008-3#3)(2008-7#1)
structural detail to##2##3##(1992-1#1)(1994-5#1)
structural detail##5##2##(1992-1#1)(1994-5#1)(1997-2#1)(2007-12#1)(2008-7#1)
structural details of the##5##4##(1993-8#1)(1994-8#1)(1995-3#1)(2007-12#1)(2007-7#1)
structural details of##6##3##(1993-8#1)(1994-8#1)(1995-3#1)(2007-12#1)(2007-7#1)(2012-2#1)
structural details##11##2##(1992-6#1)(1993-8#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(2007-12#1)(2007-7#1)(2009-10#1)(2012-2#1)
structural determinants for##4##3##(1993-6#1)(1996-8#1)(2008-8#1)(2013-1#1)
structural determinants of##3##3##(1992-12#1)(1995-3#1)(2008-4#1)
structural determinants##10##2##(1992-12#2)(1993-6#1)(1994-11#1)(1994-5#1)(1995-3#1)(1996-8#1)(2008-4#1)(2008-8#1)(2013-1#1)
structural determination of##2##3##(1994-5#1)(1995-11#1)
structural determination##3##2##(1994-5#1)(1995-11#1)(1997-7#1)
structural development##2##2##(2006-11#1)(2008-11#1)
structural differences among the##2##4##(1993-11#1)(2012-3#1)
structural differences among##4##3##(1991-8#1)(1993-11#1)(1993-12#1)(2012-3#1)
structural differences between them##2##4##(1995-8#1)(2007-6#1)
structural differences between##7##3##(1990-12#1)(1992-8#1)(1995-1#1)(1995-8#1)(2007-6#1)(2008-10#1)(2008-5#1)
structural differences compared to##2##4##(1992-7#1)(2011-1#1)
structural differences exist##2##3##(2008-5#1)(2011-12#1)
structural differences in the##2##4##(1994-8#1)(2007-12#1)
structural differences in##4##3##(1994-8#1)(2007-12#1)(2008-11#1)(2012-2#1)
structural differences of##2##3##(2007-11#1)(2008-7#1)
structural differences were##2##3##(1992-5#1)(2009-2#1)
structural differences##31##2##(1990-12#1)(1991-2#1)(1991-8#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-8#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-5#3)(2008-7#2)(2009-2#1)(2011-1#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
structural diversity of the##2##4##(1992-6#1)(2008-7#1)
structural diversity of##5##3##(1992-6#1)(1993-6#1)(2007-12#1)(2008-5#1)(2008-7#1)
structural diversity##12##2##(1992-6#1)(1993-6#1)(1996-6#1)(2005-7#1)(2006-12#1)(2007-12#2)(2008-10#1)(2008-5#1)(2008-7#1)(2011-3#1)(2012-11#1)
structural domain##4##2##(1990-11#2)(1993-1#1)(1996-2#1)
structural domains of##3##3##(1990-8#1)(1993-3#1)(1995-6#1)
structural domains##12##2##(1990-5#1)(1990-8#1)(1991-4#1)(1992-11#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-6#2)(1995-8#1)(2005-8#1)(2009-7#1)
structural dynamics and##3##3##(2006-3#1)(2008-4#2)
structural dynamics##9##2##(1990-8#1)(1997-5#1)(2006-3#1)(2008-10#2)(2008-4#2)(2008-7#1)(2008-8#1)
structural effects##7##2##(1991-5#1)(1991-9#1)(1994-11#1)(1994-3#1)(1994-9#1)(2008-10#1)(2008-2#1)
structural element##5##2##(1992-12#1)(1992-3#1)(1992-5#1)(1994-11#1)(1994-8#1)
structural elements and##4##3##(1995-5#1)(1997-4#1)(2006-10#1)(2008-1#1)
structural elements are##3##3##(1994-11#1)(1994-8#1)(1995-6#1)
structural elements found in##2##4##(1994-8#1)(1995-5#1)
structural elements of the tooth##2##5##(1997-4#2)
structural elements of the##6##4##(1994-5#3)(1996-5#1)(1997-4#2)
structural elements of##10##3##(1992-4#1)(1992-9#1)(1994-11#1)(1994-5#3)(1996-5#1)(1997-4#2)(2012-12#1)
structural elements##36##2##(1990-7#1)(1991-12#1)(1991-4#2)(1992-4#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-11#2)(1994-5#3)(1994-8#2)(1995-5#3)(1995-6#1)(1996-5#1)(1997-4#4)(2006-10#3)(2007-11#1)(2008-1#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-4#1)(2012-12#3)
structural elucidation of the##2##4##(1992-12#1)(2008-10#1)
structural elucidation of##9##3##(1992-12#1)(1997-8#1)(2007-1#3)(2008-10#1)(2008-6#1)(2010-7#1)(2011-2#1)
structural elucidation##10##2##(1992-12#1)(1997-8#1)(2007-1#3)(2008-10#1)(2008-6#1)(2010-2#1)(2010-7#1)(2011-2#1)
structural encoding##3##2##(2008-11#1)(2009-4#2)
structural equation model##4##3##(2004-11#1)(2007-12#1)(2010-2#1)(2013-8#1)
structural equation modeling (SEM)##3##4##(2009-7#1)(2010-2#1)(2012-3#1)
structural equation modeling approach##2##4##(2013-8#2)
structural equation modeling##21##3##(2005-10#1)(2007-10#1)(2007-12#2)(2008-11#1)(2008-12#1)(2009-11#1)(2009-3#1)(2009-7#2)(2009-8#1)(2010-2#2)(2010-4#1)(2010-6#1)(2011-12#1)(2012-3#3)(2013-8#2)
structural equation models##3##3##(2007-11#1)(2008-12#1)(2009-7#1)
structural equation##30##2##(2004-11#1)(2005-10#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-11#1)(2008-12#2)(2009-11#1)(2009-3#2)(2009-7#3)(2009-8#1)(2010-2#3)(2010-4#1)(2010-6#1)(2011-12#1)(2012-2#1)(2012-3#3)(2013-8#3)
structural evidence for##2##3##(1990-4#1)(1991-3#1)
structural evidence##3##2##(1990-4#1)(1991-3#1)(2006-6#1)
structural factors##9##2##(1990-9#1)(1996-1#1)(1996-9#1)(2005-11#1)(2008-10#1)(2008-2#1)(2009-3#1)(2009-9#1)(2012-12#1)
structural failure##2##2##(2008-6#1)(2009-7#1)
structural families##3##2##(1994-9#1)(1997-2#1)(2008-8#1)
structural feature that##2##3##(1995-3#1)(2007-9#1)
structural feature##9##2##(1990-4#1)(1991-8#1)(1992-12#1)(1994-11#1)(1995-3#1)(1995-8#1)(2007-9#1)(2008-4#1)(2009-8#1)
structural features and##3##3##(1997-6#1)(2008-7#1)(2010-2#1)
structural features are##2##3##(1992-6#1)(1996-12#1)
structural features for##2##3##(1991-9#1)(2007-7#1)
structural features have##2##3##(2008-5#1)(2012-2#1)
structural features in##4##3##(1991-10#1)(1992-11#1)(2008-10#1)(2008-5#1)
structural features necessary for##2##4##(1991-6#1)(1992-9#1)
structural features of the##6##4##(1994-3#1)(1995-8#1)(2006-10#1)(2008-5#2)(2009-2#1)
structural features of these##2##4##(1997-1#1)(2013-1#1)
structural features of this##3##4##(1993-1#1)(1996-10#1)(2008-4#1)
structural features of##35##3##(1992-10#1)(1993-1#1)(1993-4#1)(1994-11#1)(1994-3#1)(1994-9#2)(1995-8#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-5#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-5#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
structural features required for##2##4##(1995-4#1)(1996-8#1)
structural features that are##2##4##(1994-5#1)(2010-10#1)
structural features that##5##3##(1994-5#1)(1995-8#1)(2008-5#1)(2010-10#1)(2011-2#1)
structural features typical##2##3##(1996-7#1)(2011-1#1)
structural features with##3##3##(1995-3#1)(1997-5#1)(2008-10#1)
structural features##95##2##(1990-10#1)(1990-5#1)(1990-7#1)(1991-10#2)(1991-11#1)(1991-2#1)(1991-6#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-4#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-8#3)(1994-9#2)(1995-1#1)(1995-3#3)(1995-4#1)(1995-8#2)(1996-10#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-10#5)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#1)(2009-12#2)(2009-2#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#4)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#2)
structural flexibility and##2##3##(2007-9#1)(2008-6#1)
structural flexibility of##2##3##(1991-5#1)(2010-7#1)
structural flexibility##9##2##(1991-5#1)(1994-9#2)(2007-4#1)(2007-9#1)(2008-6#1)(2009-8#1)(2010-7#1)(2012-12#1)
structural fluctuations##3##2##(1994-11#1)(2006-12#1)(2008-10#1)
structural function##2##2##(1995-3#1)(2007-8#1)
structural functions in##2##3##(2010-11#1)(2013-8#1)
structural functions##4##2##(2006-4#2)(2010-11#1)(2013-8#1)
structural gene encoding##8##3##(1991-12#3)(1993-9#1)(1995-1#1)(1995-8#1)(2007-12#1)(2008-5#1)
structural gene for##8##3##(1990-3#2)(1991-4#1)(1992-3#1)(1994-12#3)(1996-7#1)
structural gene in##4##3##(1990-3#1)(1991-4#1)(1992-9#1)(2006-10#1)
structural gene of##5##3##(1992-4#1)(1994-12#1)(1995-6#1)(2008-8#2)
structural gene##54##2##(1990-3#6)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#4)(1991-4#2)(1991-9#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-2#1)(1993-4#1)(1993-6#2)(1993-9#1)(1994-12#5)(1995-1#2)(1995-12#1)(1995-2#1)(1995-6#3)(1995-8#1)(1996-7#1)(1996-9#2)(1997-4#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#3)(2011-1#1)
structural genes involved in##2##4##(1990-1#1)(2008-9#1)
structural genes were isolated##2##4##(1990-11#1)(2008-8#1)
structural genes were##3##3##(1990-11#1)(1993-9#1)(2008-8#1)
structural genes##22##2##(1990-1#1)(1990-10#1)(1990-11#2)(1990-3#3)(1990-5#1)(1993-9#1)(1994-10#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-7#1)(1996-9#1)(2008-1#1)(2008-11#1)(2008-8#2)(2008-9#2)(2011-2#1)
structural genomics effort##2##3##(2008-4#1)(2008-7#1)
structural genomics##11##2##(2006-4#1)(2008-4#1)(2008-7#5)(2010-11#1)(2010-2#1)(2011-1#1)(2012-1#1)
structural heart disease##5##3##(2006-10#1)(2006-9#1)(2010-5#1)(2011-2#1)(2013-7#1)
structural heterogeneity in##2##3##(1993-11#1)(1997-1#1)
structural heterogeneity of##2##3##(1997-1#1)(2010-11#1)
structural heterogeneity##6##2##(1993-11#1)(1997-1#2)(2006-12#1)(2008-11#1)(2010-11#1)
structural homology to##5##3##(1990-10#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-3#1)
structural homology with the##2##4##(1991-5#1)(1995-3#1)
structural homology with##8##3##(1991-5#1)(1992-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-2#1)(1995-3#1)
structural homology##15##2##(1990-10#1)(1991-4#1)(1991-5#1)(1992-11#1)(1993-12#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-3#2)(1996-10#1)
structural identification of##4##3##(1990-12#1)(2004-2#1)(2010-11#1)(2013-7#1)
structural identification##6##2##(1990-12#1)(2004-2#1)(2006-12#1)(2007-11#1)(2010-11#1)(2013-7#1)
structural images##2##2##(2007-12#1)(2011-1#1)
structural imaging##3##2##(2008-1#1)(2010-12#1)(2010-8#1)
structural importance of##2##3##(1990-7#1)(1995-1#1)
structural inequalities and##2##3##(2011-1#1)(2012-3#1)
structural inequalities##3##2##(2008-11#1)(2011-1#1)(2012-3#1)
structural information about the##4##4##(1990-12#1)(2007-8#1)(2008-7#1)(2008-8#1)
structural information about##6##3##(1990-12#1)(1991-4#1)(2007-8#1)(2008-7#1)(2008-8#1)(2011-1#1)
structural information available##3##3##(1991-11#1)(1994-11#1)(2013-1#1)
structural information for##2##3##(1997-1#1)(2007-3#1)
structural information of##2##3##(2010-2#1)(2012-3#1)
structural information on##4##3##(1991-6#1)(2008-10#1)(2008-11#1)(2008-4#1)
structural information with##3##3##(2007-12#1)(2008-4#2)
structural information##52##2##(1990-12#1)(1990-8#1)(1991-11#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-3#1)(1993-11#1)(1994-11#1)(1995-11#1)(1995-8#1)(1997-1#2)(1997-4#1)(2007-1#1)(2007-12#3)(2007-3#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#5)(2008-7#2)(2008-8#1)(2009-9#1)(2010-11#2)(2010-2#1)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
structural inhomogeneities##2##2##(2004-9#1)(2009-7#1)
structural injury##2##2##(2007-10#1)(2011-2#1)
structural integrity of the##6##4##(1990-12#1)(1994-2#1)(2006-10#1)(2007-2#1)(2008-7#1)(2010-12#1)
structural integrity of##13##3##(1990-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-8#1)(2006-10#1)(2007-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-11#2)
structural integrity##22##2##(1990-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-12#1)(2007-2#1)(2008-4#1)(2008-7#2)(2008-9#3)(2010-10#1)(2010-12#1)(2010-8#1)(2012-11#2)(2013-8#1)
structural interactions##3##2##(1995-5#1)(2012-2#2)
structural interpretation of the##2##4##(2007-11#2)
structural isomers of##2##3##(2008-10#1)(2008-7#1)
structural isomers##4##2##(1993-2#1)(1996-2#1)(2008-10#1)(2008-7#1)
structural issues##2##2##(1994-3#1)(2009-5#1)
structural knowledge##2##2##(2006-10#1)(2008-8#1)
structural lesions##4##2##(2008-5#1)(2008-9#1)(2010-3#1)(2011-2#1)
structural levels##2##2##(2006-10#1)(2008-4#1)
structural link##2##2##(1995-12#1)(2006-6#1)
structural materials##4##2##(1992-2#2)(2007-7#1)(2011-1#1)
structural methods##2##2##(2010-2#1)(2011-2#1)
structural mimic##2##2##(1995-3#1)(2012-12#1)
structural model index##2##3##(2010-10#2)
structural model of PBS##2##4##(2008-8#2)
structural model of the##4##4##(1991-9#1)(1994-12#1)(1995-2#1)(2008-4#1)
structural model of##8##3##(1991-9#1)(1994-12#1)(1995-2#1)(1997-3#1)(2008-4#1)(2008-8#2)(2011-1#1)
structural model was##6##3##(2006-12#1)(2008-4#1)(2008-6#1)(2012-12#1)(2012-2#2)
structural model##26##2##(1990-9#1)(1991-9#1)(1992-9#1)(1993-11#2)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#1)(1997-3#1)(1997-4#1)(2005-11#2)(2006-12#1)(2008-4#2)(2008-6#1)(2008-8#2)(2010-10#2)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#2)
structural modeling##2##2##(2009-5#1)(2013-8#1)
structural models of the##2##4##(2006-10#1)(2010-4#1)
structural models##6##2##(1996-12#1)(2006-10#1)(2008-3#1)(2009-4#1)(2010-12#1)(2010-4#1)
structural modification of##4##3##(1992-9#1)(1994-8#1)(2006-10#1)(2008-9#1)
structural modification##8##2##(1992-3#1)(1992-9#1)(1994-8#1)(1995-3#1)(1996-1#1)(2006-10#1)(2008-9#1)(2012-3#1)
structural modifications of the A-ring##2##5##(1996-9#2)
structural modifications of the##3##4##(1996-9#2)(2009-5#1)
structural modifications of##5##3##(1996-9#2)(2008-10#1)(2009-5#1)(2012-3#1)
structural modifications##17##2##(1994-9#1)(1995-3#2)(1996-9#3)(2005-11#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#3)(2009-5#1)(2012-3#2)
structural moiety##2##2##(2009-12#1)(2010-7#1)
structural morphology##2##2##(2005-11#1)(2011-1#1)
structural motif for##2##3##(1991-4#2)
structural motif##10##2##(1991-4#2)(1991-5#1)(1992-6#1)(1993-2#1)(1995-6#1)(1996-7#1)(1996-8#1)(2007-3#1)(2013-8#1)
structural motifs and##3##3##(1995-5#1)(1996-10#1)(2006-10#1)
structural motifs in##2##3##(2006-10#1)(2007-10#1)
structural motifs of##2##3##(1997-8#1)(2013-1#1)
structural motifs that##2##3##(1994-9#1)(1995-6#1)
structural motifs##20##2##(1990-6#1)(1991-12#1)(1992-11#1)(1994-9#4)(1995-2#1)(1995-5#1)(1995-6#1)(1996-10#1)(1997-4#1)(1997-8#1)(1997-9#1)(2006-10#2)(2006-12#1)(2007-10#1)(2008-4#1)(2013-1#1)
structural nature##2##2##(1990-10#1)(1997-8#1)
structural or functional##2##3##(2008-4#1)(2010-11#1)
structural or##4##2##(1997-3#1)(2006-8#1)(2008-4#1)(2010-11#1)
structural order##2##2##(2006-4#1)(2008-4#1)
structural organization and##3##3##(1990-5#1)(1991-9#1)(2006-10#1)
structural organization in##2##3##(1996-8#1)(2008-7#1)
structural organization of the##9##4##(1991-6#1)(1992-9#1)(1993-9#1)(1996-2#1)(2008-10#1)(2008-5#2)(2009-3#1)(2009-8#1)
structural organization of##17##3##(1991-6#1)(1992-9#1)(1993-2#1)(1993-9#1)(1995-2#1)(1996-2#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-8#1)(2012-12#1)
structural organization##30##2##(1990-5#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-9#1)(1993-2#1)(1993-9#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-2#1)(1996-8#1)(1997-4#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-8#2)(2010-8#1)(2012-12#1)
structural origin of##2##3##(1994-5#1)(2007-11#1)
structural parameterization##2##2##(1997-2#2)
structural parameters for the##2##4##(2008-10#2)
structural parameters for##3##3##(2008-10#2)(2008-5#1)
structural parameters of##5##3##(2005-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-1#1)
structural parameters##16##2##(1990-4#1)(1995-5#1)(2005-11#1)(2007-11#1)(2007-12#4)(2008-10#4)(2008-3#1)(2008-5#1)(2011-1#1)(2012-12#1)
structural pattern##4##2##(1994-12#1)(1994-3#1)(2013-1#2)
structural patterns of##2##3##(1994-6#1)(2013-7#1)
structural patterns##6##2##(1994-6#1)(1996-3#1)(2007-8#1)(2012-2#1)(2013-7#2)
structural peculiarities##2##2##(1996-6#1)(2011-12#1)
structural performance##2##2##(2007-12#1)(2007-5#1)
structural perturbation##3##2##(1990-2#1)(1990-5#1)(1995-5#1)
structural phase##2##2##(2006-5#1)(2007-12#1)
structural plasticity##4##2##(1996-3#1)(2008-7#1)(2009-6#1)(2012-2#1)
structural principles##2##2##(1997-1#1)(1997-4#1)
structural probes##3##2##(1991-3#1)(1993-4#1)(1996-4#1)
structural processes##2##2##(2008-12#1)(2008-4#1)
structural propensity##2##2##(2008-10#1)(2008-4#1)
structural properties and##2##3##(1991-10#1)(2005-11#1)
structural properties of the##5##4##(1991-7#1)(1996-9#1)(2007-10#1)(2010-10#1)(2010-2#1)
structural properties of this##2##4##(1994-11#1)(2006-10#1)
structural properties of##23##3##(1990-2#1)(1990-8#1)(1991-2#1)(1991-7#1)(1994-11#1)(1996-5#1)(1996-9#1)(2005-8#1)(2006-10#1)(2006-12#2)(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-2#3)(2010-10#1)(2010-2#2)(2010-5#1)
structural properties that##3##3##(1991-6#1)(2007-8#1)(2012-1#1)
structural properties##40##2##(1990-2#2)(1990-8#1)(1991-10#1)(1991-2#1)(1991-6#1)(1991-7#1)(1993-12#1)(1993-9#1)(1994-11#1)(1996-5#1)(1996-9#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#2)(2007-1#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#3)(2008-10#1)(2008-2#3)(2008-4#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-5#1)(2012-1#1)(2012-2#1)
structural protein Gag and##3##4##(2011-3#3)
structural protein in##2##3##(1991-1#1)(2009-7#1)
structural protein of##4##3##(1991-10#2)(1993-12#1)(1993-9#1)
structural protein##21##2##(1991-1#2)(1991-10#2)(1993-12#3)(1993-9#1)(1994-3#1)(1995-2#1)(2005-11#1)(2008-10#2)(2008-4#1)(2009-5#1)(2009-7#1)(2010-5#1)(2011-2#1)(2011-3#3)
structural proteins of##5##3##(1994-12#1)(2005-11#1)(2008-10#1)(2008-8#1)(2008-9#1)
structural proteins##16##2##(1993-12#1)(1994-12#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-1#1)(2011-12#2)(2012-12#1)(2012-2#1)
structural rearrangement##3##2##(1993-9#1)(2005-11#1)(2010-12#1)
structural rearrangements##8##2##(1993-9#2)(1995-1#1)(1995-4#1)(1995-5#1)(1996-10#1)(2008-10#1)(2009-5#1)
structural recognition motif##2##3##(1990-11#1)(1995-3#1)
structural regions that##2##3##(1993-6#1)(1995-11#1)
structural regions##6##2##(1990-3#1)(1993-6#1)(1995-11#1)(1995-3#1)(2008-7#2)
structural relationship between##2##3##(1995-4#1)(2008-7#1)
structural relationship##4##2##(1992-3#1)(1995-4#1)(2008-10#1)(2008-7#1)
structural relaxation of the##2##4##(1991-5#1)(1995-3#1)
structural relaxation##5##2##(1991-5#1)(1995-3#1)(1995-7#1)(1997-7#1)(2008-10#1)
structural remodeling of##2##3##(2009-2#1)(2012-12#1)
structural remodeling##3##2##(2008-7#1)(2009-2#1)(2012-12#1)
structural remodelling##2##2##(1995-11#1)(2006-10#1)
structural reorganization of the##3##4##(1997-2#1)(2011-2#1)(2013-1#1)
structural reorganization##7##2##(1995-5#1)(1997-2#1)(2005-11#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
structural requirement for##2##3##(1991-10#1)(1996-2#1)
structural requirement##3##2##(1991-10#1)(1993-9#1)(1996-2#1)
structural requirements for##13##3##(1990-5#1)(1992-9#1)(1993-4#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-7#1)(1997-1#1)(1997-2#1)(2010-4#1)(2011-2#1)
structural requirements of##5##3##(1991-7#1)(1992-3#1)(1994-9#1)(1995-5#1)(1997-2#1)
structural requirements##23##2##(1990-5#1)(1991-7#1)(1992-3#1)(1992-9#1)(1993-4#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#4)(1995-1#1)(1995-5#1)(1995-7#1)(1997-1#1)(1997-2#3)(2006-12#1)(2010-4#1)(2011-2#1)
structural resemblance to##2##3##(1992-5#1)(2007-6#1)
structural resemblance##4##2##(1992-1#1)(1992-5#1)(2007-6#1)(2012-2#1)
structural response##2##2##(2008-10#2)
structural rigidity of the##2##4##(1994-9#1)(1995-1#1)
structural rigidity of##3##3##(1994-9#1)(1995-1#1)(2008-10#1)
structural rigidity##4##2##(1994-9#1)(1995-1#1)(2008-10#1)(2009-12#1)
structural robustness of metabolic networks##2##5##(2006-10#2)
structural robustness##3##2##(2006-10#3)
structural role at##2##3##(1995-10#1)(2009-8#1)
structural role in the##2##4##(1993-8#1)(2008-10#1)
structural role in##3##3##(1993-8#1)(1995-6#1)(2008-10#1)
structural role of##4##3##(1992-12#1)(1992-3#2)(2008-10#1)
structural role##17##2##(1991-4#2)(1992-12#1)(1992-3#2)(1992-7#1)(1993-6#1)(1993-8#1)(1994-9#1)(1995-10#1)(1995-6#1)(2008-10#2)(2008-5#1)(2009-8#1)(2011-2#1)(2013-8#1)
structural scaffold for##2##3##(1996-5#1)(2008-11#1)
structural scaffold##4##2##(1995-4#1)(1996-5#1)(2008-11#1)(2010-1#1)
structural similarities and##2##3##(1990-5#1)(2008-4#1)
structural similarities to##4##3##(1996-10#1)(2008-8#1)(2009-4#1)(2010-10#1)
structural similarities with##2##3##(1991-12#1)(1992-9#1)
structural similarities##16##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-9#1)(1992-8#1)(1992-9#1)(1994-11#1)(1996-10#1)(1997-6#1)(2006-12#1)(2008-10#1)(2008-4#2)(2008-8#1)(2009-4#1)(2010-10#1)
structural similarity between the##2##4##(1990-4#1)(1995-3#1)
structural similarity between trout P450 LMC5 and human P450IIIA4##2##9##(1991-4#2)
structural similarity between##5##3##(1990-4#1)(1991-4#2)(1995-3#1)(2010-8#1)
structural similarity of##3##3##(1990-7#1)(1991-6#1)(2008-10#1)
structural similarity to the##4##4##(1995-3#1)(1996-4#1)(1997-7#2)
structural similarity to##12##3##(1992-6#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-2#1)(1996-4#1)(1997-7#2)(2008-8#1)(2010-10#2)
structural similarity##25##2##(1990-4#1)(1990-7#1)(1991-4#2)(1991-6#1)(1992-5#1)(1992-6#1)(1993-6#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-3#2)(1996-2#1)(1996-4#1)(1997-7#2)(2008-10#2)(2008-8#1)(2010-10#2)(2010-8#2)(2011-1#1)
structural solarization##4##2##(2008-10#4)
structural specificity of##2##3##(1991-10#1)(1994-8#1)
structural specificity##3##2##(1991-10#1)(1994-8#1)(1994-9#1)
structural stability and##2##3##(1994-11#1)(2008-11#1)
structural stability of##6##3##(1991-4#1)(1995-8#4)(2008-10#1)
structural stability##15##2##(1991-4#1)(1993-12#1)(1994-11#1)(1994-9#1)(1995-2#1)(1995-8#4)(2005-11#1)(2007-11#1)(2008-10#2)(2008-11#1)(2009-8#1)
structural state##3##2##(2008-4#2)(2011-1#1)
structural states##2##2##(1992-6#2)
structural stress##3##2##(2005-11#3)
structural studies by##2##3##(1993-11#1)(2012-2#1)
structural studies have##2##3##(2011-2#1)(2013-1#1)
structural studies of the##4##4##(1991-7#1)(1992-9#1)(1993-11#1)(1995-1#1)
structural studies of##10##3##(1991-7#1)(1992-3#1)(1992-9#1)(1993-11#1)(1995-1#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)
structural studies on##2##3##(1990-4#1)(2005-11#1)
structural studies##29##2##(1990-4#1)(1990-6#1)(1991-7#1)(1992-3#1)(1992-9#1)(1993-11#2)(1994-2#1)(1995-1#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
structural study of##2##3##(1991-12#1)(2005-11#1)
structural study##7##2##(1991-12#2)(2005-11#1)(2005-4#1)(2008-6#1)(2009-8#1)(2010-12#1)
structural support##5##2##(2006-12#1)(2010-6#1)(2010-9#1)(2012-1#1)(2012-2#1)
structural transformation of##3##3##(2008-1#1)(2009-5#1)(2012-1#1)
structural transformation##5##2##(1997-6#1)(2007-12#1)(2008-1#1)(2009-5#1)(2012-1#1)
structural transformations##2##2##(1997-1#1)(2008-10#1)
structural transition##2##2##(1991-5#1)(2007-9#1)
structural transitions##4##2##(1992-9#1)(1995-10#1)(1995-3#1)(2007-9#1)
structural type##2##2##(1990-9#1)(2010-5#1)
structural types##4##2##(1992-6#1)(1996-2#1)(2005-7#1)(2008-5#1)
structural unit##2##2##(1991-2#1)(2009-8#1)
structural units##5##2##(1991-5#1)(1992-1#1)(1992-4#1)(2007-7#1)(2008-5#1)
structural variables##2##2##(2010-8#1)(2012-2#1)
structural variants have been##2##4##(2012-11#1)(2013-1#1)
structural variants of##3##3##(1994-6#1)(1995-7#1)(1997-9#1)
structural variants##6##2##(1994-6#1)(1994-8#1)(1995-7#1)(1997-9#1)(2012-11#1)(2013-1#1)
structural variation of##2##3##(2009-11#1)(2013-8#1)
structural variation##6##2##(2009-11#1)(2010-2#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
structural variations##7##2##(1992-12#1)(1992-4#1)(2007-11#1)(2009-12#1)(2012-11#1)(2012-3#2)
structural water##5##2##(1994-5#1)(1995-1#1)(1996-8#3)
structural##2211##1##(1990-1#2)(1990-10#5)(1990-11#6)(1990-12#10)(1990-2#8)(1990-3#17)(1990-4#13)(1990-5#12)(1990-6#2)(1990-7#15)(1990-8#9)(1990-9#6)(1991-1#4)(1991-10#8)(1991-11#6)(1991-12#12)(1991-2#6)(1991-3#9)(1991-4#25)(1991-5#12)(1991-6#8)(1991-7#7)(1991-8#7)(1991-9#10)(1992-1#5)(1992-10#2)(1992-11#8)(1992-12#14)(1992-2#4)(1992-3#15)(1992-4#6)(1992-5#7)(1992-6#17)(1992-7#4)(1992-8#8)(1992-9#13)(1993-1#2)(1993-10#1)(1993-11#19)(1993-12#9)(1993-2#5)(1993-3#7)(1993-4#5)(1993-6#15)(1993-8#13)(1993-9#14)(1994-10#2)(1994-11#17)(1994-12#18)(1994-2#6)(1994-3#11)(1994-5#19)(1994-6#7)(1994-8#22)(1994-9#34)(1995-1#20)(1995-10#10)(1995-11#6)(1995-12#9)(1995-2#20)(1995-3#28)(1995-4#10)(1995-5#24)(1995-6#15)(1995-7#6)(1995-8#23)(1996-1#2)(1996-10#6)(1996-11#1)(1996-12#8)(1996-2#15)(1996-3#8)(1996-4#4)(1996-5#11)(1996-6#7)(1996-7#10)(1996-8#12)(1996-9#12)(1997-1#12)(1997-2#18)(1997-3#5)(1997-4#29)(1997-5#5)(1997-6#18)(1997-7#12)(1997-8#12)(1997-9#6)(2004-11#1)(2004-12#1)(2004-2#1)(2004-9#2)(2005-10#5)(2005-11#41)(2005-4#1)(2005-7#5)(2005-8#5)(2006-10#29)(2006-11#7)(2006-12#28)(2006-2#1)(2006-3#3)(2006-4#5)(2006-5#4)(2006-6#8)(2006-7#7)(2006-8#4)(2006-9#2)(2007-1#8)(2007-10#7)(2007-11#33)(2007-12#46)(2007-2#2)(2007-3#5)(2007-4#3)(2007-5#2)(2007-6#15)(2007-7#14)(2007-8#16)(2007-9#8)(2008-1#13)(2008-10#107)(2008-11#26)(2008-12#5)(2008-2#26)(2008-3#21)(2008-4#61)(2008-5#41)(2008-6#12)(2008-7#61)(2008-8#39)(2008-9#24)(2009-10#15)(2009-11#6)(2009-12#11)(2009-2#13)(2009-3#9)(2009-4#8)(2009-5#15)(2009-6#2)(2009-7#12)(2009-8#15)(2009-9#7)(2010-1#4)(2010-10#11)(2010-11#10)(2010-12#15)(2010-2#16)(2010-3#2)(2010-4#10)(2010-5#15)(2010-6#5)(2010-7#7)(2010-8#19)(2010-9#2)(2011-1#42)(2011-12#9)(2011-2#35)(2011-3#8)(2012-1#15)(2012-11#7)(2012-12#28)(2012-2#51)(2012-3#20)(2012-9#1)(2013-1#41)(2013-7#11)(2013-8#27)
structural-functional##3##1##(2008-4#1)(2010-8#1)(2011-7#1)
structural/functional properties of the##2##4##(2009-2#1)(2012-2#1)
structurally abnormal collagen##2##3##(1990-4#2)
structurally analogous to the##2##4##(1991-4#1)(1992-4#1)
structurally and functionally distinct##2##4##(1991-2#1)(1991-3#1)
structurally and functionally related##2##4##(1995-12#1)(2007-12#1)
structurally and functionally similar to##2##5##(1996-10#1)(2013-8#1)
structurally and functionally##15##3##(1991-2#1)(1991-3#1)(1991-4#1)(1992-6#1)(1993-3#1)(1993-6#1)(1995-12#1)(1995-3#1)(1996-10#1)(2007-12#2)(2008-10#1)(2008-11#1)(2009-9#1)(2013-8#1)
structurally and##21##2##(1990-6#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-6#1)(1993-3#1)(1993-6#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-2#1)(1997-7#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-10#1)(2013-8#1)
structurally characterized by##2##3##(1994-5#1)(2009-4#1)
structurally characterized##12##2##(1992-9#1)(1994-5#3)(1994-8#1)(1995-3#1)(1996-2#1)(1997-7#2)(2008-10#1)(2008-3#1)(2009-4#1)
structurally complex##3##2##(2005-10#1)(2011-1#1)(2012-2#1)
structurally defined##2##2##(2010-4#2)
structurally different from the##2##4##(2007-12#1)(2012-12#1)
structurally different from##3##3##(2007-12#1)(2012-12#1)(2013-7#1)
structurally different##12##2##(1991-1#1)(1992-2#1)(2005-12#1)(2007-12#2)(2008-10#1)(2008-5#1)(2009-12#2)(2012-1#1)(2012-12#1)(2013-7#1)
structurally dissimilar##4##2##(1992-12#1)(2008-5#1)(2008-7#1)(2012-2#1)
structurally distinct from##4##3##(1990-8#1)(1994-10#1)(1995-2#1)(1996-7#1)
structurally distinct##11##2##(1990-8#1)(1992-5#1)(1992-8#1)(1994-10#1)(1995-2#1)(1996-2#1)(1996-7#2)(1997-7#1)(2008-5#1)(2009-12#1)
structurally diverse compounds##2##3##(1997-4#1)(2008-11#1)
structurally diverse##8##2##(1992-2#1)(1992-8#1)(1995-8#1)(1997-4#2)(2008-1#1)(2008-11#1)(2012-2#1)
structurally equivalent##3##2##(1990-11#1)(1990-7#1)(2013-1#1)
structurally heterogeneous##2##2##(2008-1#1)(2010-4#1)
structurally homologous to##3##3##(1990-10#1)(1990-11#1)(1996-5#1)
structurally homologous##9##2##(1990-10#1)(1990-11#1)(1991-12#1)(1992-12#1)(1992-8#1)(1993-2#1)(1995-5#1)(1995-6#1)(1996-5#1)
structurally identical##3##2##(1991-9#1)(1995-2#1)(2008-4#1)
structurally intact##2##2##(1992-8#1)(1994-12#1)
structurally mimic##2##2##(1995-3#1)(2012-2#1)
structurally normal heart##6##3##(2008-12#2)(2008-7#1)(2009-5#1)(2009-7#1)(2011-2#1)
structurally normal hearts##2##3##(1996-4#1)(2008-3#1)
structurally normal##10##2##(1994-8#1)(1996-4#1)(2008-12#2)(2008-3#1)(2008-7#1)(2009-5#2)(2009-7#1)(2011-2#1)
structurally novel##3##2##(1991-1#1)(1992-8#1)(1994-5#1)
structurally related compounds were##2##4##(1990-10#1)(2008-6#1)
structurally related compounds##5##3##(1990-1#1)(1990-10#1)(1993-4#1)(2006-12#1)(2008-6#1)
structurally related peptides##2##3##(1992-11#1)(1994-3#1)
structurally related protein##2##3##(1994-12#1)(1994-8#1)
structurally related proteins##3##3##(1994-3#1)(1994-8#1)(1996-3#1)
structurally related to leucopyrokinin##2##4##(1992-1#2)
structurally related to the AGL2 family and##2##7##(1997-2#1)(1997-8#1)
structurally related to the##4##4##(1994-8#2)(1997-2#1)(1997-8#1)
structurally related to##21##3##(1990-11#1)(1991-12#1)(1992-1#2)(1993-12#1)(1994-8#2)(1994-9#1)(1995-5#2)(1996-5#2)(1997-2#2)(1997-8#1)(2005-7#1)(2005-8#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-4#1)
structurally related##69##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-5#1)(1991-12#1)(1991-4#1)(1992-1#2)(1992-11#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-4#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#3)(1995-6#1)(1996-12#3)(1996-3#1)(1996-5#2)(1997-2#2)(1997-3#2)(1997-7#1)(1997-8#2)(2005-12#1)(2005-7#1)(2005-8#2)(2006-12#3)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2011-2#3)(2013-7#1)
structurally resemble##2##2##(2010-5#1)(2012-2#1)
structurally similar compounds##3##3##(1991-4#1)(2007-11#1)(2008-10#1)
structurally similar stilbene compounds##2##4##(2008-8#2)
structurally similar to the##4##4##(1990-11#1)(1991-6#1)(2008-3#1)(2010-10#1)
structurally similar to##9##3##(1990-11#1)(1991-6#1)(1993-8#1)(1996-10#1)(2007-12#1)(2008-3#1)(2010-10#1)(2011-1#1)(2012-2#1)
structurally similar##30##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-3#1)(1996-10#1)(1996-5#1)(1996-7#2)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#2)(2010-10#1)(2010-5#1)(2011-1#1)(2012-11#1)(2012-2#1)
structurally simplified##2##2##(2008-10#1)(2013-8#1)
structurally stable##2##2##(1993-12#1)(2012-12#1)
structurally to the##2##3##(1994-8#1)(1995-10#1)
structurally unique##4##2##(1995-11#1)(1995-6#1)(2006-3#1)(2010-7#1)
structurally unrelated##6##2##(1995-1#1)(1997-4#1)(2007-11#1)(2008-11#1)(2008-4#1)(2010-8#1)
structurally very##3##2##(1992-7#1)(1994-3#1)(2006-12#1)
structurally well-defined##3##2##(1991-11#1)(2008-1#1)(2010-12#1)
structurally##293##1##(1990-1#1)(1990-10#2)(1990-11#4)(1990-2#1)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-4#5)(1991-5#1)(1991-6#2)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#5)(1992-9#3)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#3)(1994-10#1)(1994-11#2)(1994-12#3)(1994-3#3)(1994-5#7)(1994-6#2)(1994-8#8)(1994-9#3)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#5)(1995-5#5)(1995-6#4)(1995-8#1)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#4)(1996-7#4)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#3)(1997-5#1)(1997-7#5)(1997-8#3)(2005-10#1)(2005-12#3)(2005-7#2)(2005-8#2)(2006-12#6)(2006-3#1)(2007-1#1)(2007-11#4)(2007-12#5)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#9)(2008-11#5)(2008-12#2)(2008-3#4)(2008-4#7)(2008-5#6)(2008-6#1)(2008-7#8)(2008-8#4)(2009-10#1)(2009-12#3)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-4#3)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#9)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#3)
structurally-related##3##1##(1990-9#1)(2005-7#1)(2008-5#1)
structure (&quot##2##2##(2005-11#1)(2005-8#1)
structure (e##2##2##(1994-12#1)(2006-10#1)
structure [formula##3##2##(1991-12#2)(1991-7#1)
structure about##2##2##(2005-11#1)(2007-12#1)
structure according to##3##3##(2008-10#2)(2010-2#1)
structure across##4##2##(1992-6#1)(2009-2#1)(2012-3#1)(2013-1#1)
structure activity relationship##2##3##(2007-11#1)(2011-1#1)
structure activity relationships##3##3##(2010-8#2)(2012-2#1)
structure activity##5##2##(2007-11#1)(2010-8#2)(2011-1#1)(2012-2#1)
structure adopted by the##2##4##(1997-3#1)(2012-1#1)
structure adopted by##3##3##(1997-3#1)(2008-5#1)(2012-1#1)
structure affects insect herbivore species richness and abundance##2##8##(2013-7#2)
structure affects##3##2##(2010-3#1)(2013-7#2)
structure after##2##2##(2007-8#1)(2010-8#1)
structure against the##2##3##(1995-6#1)(2008-4#1)
structure against##3##2##(1995-6#1)(2008-4#1)(2011-3#1)
structure allow##2##2##(1995-5#1)(2011-1#1)
structure allows for##2##3##(2008-2#1)(2008-8#1)
structure allows the##2##3##(1992-12#1)(2008-3#1)
structure allows##6##2##(1992-12#1)(1995-1#1)(2008-2#1)(2008-3#2)(2008-8#1)
structure along the##2##3##(2007-12#1)(2008-2#1)
structure also##4##2##(1990-5#1)(1991-11#1)(1996-6#1)(2008-8#1)
structure alteration##2##2##(2012-3#1)(2013-1#1)
structure among##6##2##(2007-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-11#1)
structure analogous to##2##3##(1992-7#1)(1997-2#1)
structure analyses##2##2##(2008-10#1)(2010-2#1)
structure analysis and##2##3##(1990-10#1)(1992-4#1)
structure analysis in##2##3##(2008-5#1)(2012-11#1)
structure analysis of the##3##4##(1996-2#1)(2010-3#1)(2011-2#1)
structure analysis of##12##3##(1993-8#1)(1994-11#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-7#1)(2007-7#1)(2008-4#1)(2009-5#1)(2010-3#1)(2011-2#1)(2013-8#1)
structure analysis using the##2##4##(1992-4#1)(2008-4#1)
structure analysis using##5##3##(1992-4#1)(2008-4#2)(2012-3#2)
structure analysis##39##2##(1990-10#1)(1992-4#2)(1992-6#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-6#1)(1996-2#1)(1996-5#2)(1996-7#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-5#2)(2007-11#1)(2007-7#1)(2008-10#2)(2008-4#4)(2008-5#2)(2008-8#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-2#2)(2012-3#2)(2013-8#1)
structure and DNA##2##3##(1994-8#1)(2011-2#1)
structure and a##7##3##(1992-12#1)(1992-6#1)(1992-8#1)(1995-1#1)(2008-4#1)(2012-2#1)(2013-1#1)
structure and activity##6##3##(1990-2#1)(1995-8#1)(2008-2#1)(2008-5#2)(2013-1#1)
structure and an##4##3##(1991-6#1)(1993-12#1)(1993-4#1)(2008-7#1)
structure and are##3##3##(1990-6#1)(1992-8#1)(1995-12#1)
structure and behavior of##2##4##(2008-2#1)(2008-5#1)
structure and binding##2##3##(2006-12#1)(2008-8#1)
structure and biological activity##2##4##(2006-10#1)(2010-4#1)
structure and biological##5##3##(2006-10#1)(2006-12#1)(2008-5#1)(2010-12#1)(2010-4#1)
structure and can##3##3##(1990-12#1)(2008-7#1)(2012-1#1)
structure and characteristics of a##2##5##(1993-3#1)(2008-10#1)
structure and characterization of##2##4##(2007-10#1)(2007-11#1)
structure and chemical composition##2##4##(2008-3#1)(2009-7#1)
structure and chemical##5##3##(1991-4#1)(2008-3#1)(2008-4#1)(2009-7#1)(2012-2#1)
structure and composition of the##2##5##(1994-9#1)(2011-2#1)
structure and composition of##3##4##(1994-9#1)(2010-7#1)(2011-2#1)
structure and composition##9##3##(1994-9#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-3#1)(2009-10#1)(2010-7#1)(2011-2#1)(2012-2#1)
structure and degree of##2##4##(1992-9#1)(2005-11#1)
structure and development of the##2##5##(1994-7#1)(2007-12#1)
structure and different##2##3##(1994-12#1)(2013-8#1)
structure and distribution of the##2##5##(2008-5#1)(2013-8#1)
structure and distribution of##3##4##(2008-11#1)(2008-5#1)(2013-8#1)
structure and distribution##6##3##(1991-9#1)(1996-11#1)(2007-12#1)(2008-11#1)(2008-5#1)(2013-8#1)
structure and diversity##2##3##(2008-8#1)(2013-8#1)
structure and dynamics of the##9##5##(1991-5#1)(1991-7#1)(1996-5#1)(1997-4#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-4#1)(2011-1#1)
structure and dynamics of##20##4##(1991-5#2)(1991-7#1)(1992-3#1)(1995-10#1)(1996-5#1)(1997-4#1)(1997-7#1)(2004-4#1)(2006-10#1)(2006-4#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#1)(2011-1#1)
structure and dynamics##28##3##(1991-5#2)(1991-7#1)(1992-3#1)(1995-10#2)(1996-5#1)(1997-4#1)(1997-7#1)(2004-4#1)(2006-10#1)(2006-4#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-2#1)(2008-4#4)(2008-5#1)(2008-9#1)(2009-8#1)(2011-1#2)(2012-3#1)
structure and energy of##2##4##(1992-12#1)(1995-11#1)
structure and enzymatic activity##2##4##(1992-11#1)(2008-7#1)
structure and expression of the##4##5##(1990-11#1)(1991-9#1)(1992-6#1)(1993-12#1)
structure and expression of##6##4##(1990-11#1)(1990-9#1)(1991-9#1)(1992-6#1)(1993-12#1)(1995-5#1)
structure and expression##10##3##(1990-11#1)(1990-9#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-12#1)(1995-5#1)(1997-6#1)(1997-7#1)(1997-9#1)
structure and folding##3##3##(1990-2#1)(2008-4#1)(2008-7#1)
structure and fracture##2##3##(2004-9#2)
structure and function are##2##4##(1990-6#1)(1991-1#1)
structure and function can##2##4##(2006-2#1)(2008-7#1)
structure and function in the##5##5##(1995-2#1)(1997-4#1)(2008-3#1)(2009-5#2)
structure and function in##10##4##(1992-11#1)(1995-2#1)(1997-4#1)(2008-3#1)(2008-5#2)(2009-1#1)(2009-5#2)(2012-12#1)
structure and function is##2##4##(2007-9#1)(2012-3#1)
structure and function of a##2##5##(1991-8#1)(1996-11#1)
structure and function of proteins##5##5##(1997-4#1)(2006-10#1)(2008-2#1)(2008-4#1)(2008-7#1)
structure and function of the##21##5##(1990-5#1)(1994-9#1)(1996-2#1)(1996-8#2)(2005-10#2)(2005-3#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#2)(2009-10#1)(2010-12#1)(2012-11#1)(2012-2#2)
structure and function of these##6##5##(1990-5#1)(1994-8#1)(2005-1#1)(2008-5#1)(2010-5#2)
structure and function of##68##4##(1990-10#1)(1990-5#3)(1991-5#1)(1991-8#1)(1992-11#2)(1992-3#1)(1994-12#1)(1994-8#2)(1994-9#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-2#1)(1996-8#2)(1997-2#1)(1997-4#1)(2005-1#1)(2005-10#2)(2005-3#1)(2005-7#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2010-12#1)(2010-5#2)(2011-1#2)(2012-11#1)(2012-2#3)
structure and function was##2##4##(1993-4#1)(2008-7#1)
structure and function##142##3##(1990-10#1)(1990-5#3)(1990-6#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-11#3)(1992-3#1)(1992-6#1)(1993-12#1)(1993-4#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#3)(1994-9#1)(1995-12#1)(1995-2#2)(1995-6#2)(1995-8#1)(1996-11#2)(1996-2#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(2005-1#1)(2005-10#2)(2005-3#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#4)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#11)(2008-5#5)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-5#2)(2009-7#2)(2009-8#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
structure and functional##5##3##(1994-12#1)(1995-4#1)(1997-7#1)(2005-11#1)(2006-10#1)
structure and functions of##6##4##(1994-1#1)(2003-11#1)(2005-5#1)(2007-11#1)(2008-10#1)(2011-2#1)
structure and functions##7##3##(1994-1#1)(2003-11#1)(2005-5#1)(2007-11#1)(2008-10#1)(2011-2#2)
structure and have##2##3##(2007-12#1)(2008-8#1)
structure and hormonal##2##3##(1992-3#1)(2012-1#1)
structure and how##2##3##(2008-11#1)(2012-1#1)
structure and hydration##2##3##(1994-3#2)
structure and implementation##2##3##(2006-5#1)(2008-7#1)
structure and in##4##3##(2008-1#1)(2008-12#1)(2008-6#1)(2012-3#1)
structure and interactions##4##3##(1992-6#1)(1992-9#1)(2008-4#1)(2009-2#1)
structure and is##2##3##(2008-7#1)(2013-1#1)
structure and its##7##3##(1993-3#1)(1995-2#1)(2006-12#1)(2007-11#1)(2011-1#1)(2012-2#1)(2012-3#1)
structure and magnetic##2##3##(2009-11#1)(2010-5#1)
structure and material##2##3##(1992-9#1)(2007-12#1)
structure and mechanical##3##3##(1992-9#1)(2010-7#1)(2012-1#1)
structure and mechanism##2##3##(2008-5#2)
structure and metabolism##2##3##(1993-9#1)(2011-1#1)
structure and metal-binding##3##3##(1991-4#1)(2008-4#2)
structure and molecular##3##3##(1996-4#1)(2008-10#1)(2008-9#1)
structure and of##4##3##(1991-10#1)(1992-3#1)(1993-8#1)(2005-10#1)
structure and on the##2##4##(2010-7#1)(2012-2#1)
structure and on##3##3##(1991-9#1)(2010-7#1)(2012-2#1)
structure and organization##2##3##(1991-6#1)(2007-9#1)
structure and orientation of##2##4##(1992-9#1)(2011-3#1)
structure and orientation##3##3##(1991-3#1)(1992-9#1)(2011-3#1)
structure and performance of##2##4##(2006-4#1)(2013-8#1)
structure and phase##3##3##(2006-10#2)(2010-4#1)
structure and population##2##3##(2007-3#1)(2010-8#1)
structure and process##5##3##(1994-3#1)(1995-4#1)(2008-9#3)
structure and properties of##2##4##(2005-8#1)(2006-10#1)
structure and properties##4##3##(1995-3#1)(2005-8#1)(2006-10#1)(2007-8#1)
structure and reactivity of##3##4##(1997-7#1)(2007-11#1)(2010-5#1)
structure and reactivity##5##3##(1995-5#1)(1997-7#1)(2007-11#1)(2009-10#1)(2010-5#1)
structure and regulation of the##2##5##(1990-5#1)(1993-2#1)
structure and regulation##3##3##(1990-5#1)(1993-2#1)(2008-4#1)
structure and role of##2##4##(2009-8#1)(2013-1#1)
structure and sequence of the##2##5##(1995-2#1)(2011-1#1)
structure and sequence of##5##4##(1991-6#1)(1993-6#2)(1995-2#1)(2011-1#1)
structure and sequence##9##3##(1991-6#1)(1993-6#3)(1995-2#1)(1996-9#1)(2008-10#1)(2010-7#1)(2011-1#1)
structure and size##3##3##(1997-4#1)(2006-12#1)(2007-12#1)
structure and stability of the##2##5##(1993-3#1)(2007-11#1)
structure and stability of##6##4##(1993-3#2)(1996-2#1)(2007-11#1)(2008-1#2)
structure and surface##2##3##(2005-11#1)(2008-5#1)
structure and that the##2##4##(2008-5#1)(2008-7#1)
structure and that##4##3##(2007-12#1)(2008-2#1)(2008-5#1)(2008-7#1)
structure and the mechanism of the##2##6##(1992-2#1)(2008-4#1)
structure and the##56##3##(1990-11#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-2#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-10#1)(1995-6#3)(1996-5#1)(1997-3#1)(1997-7#1)(2005-11#2)(2006-5#1)(2006-9#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#2)(2009-2#2)(2009-3#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
structure and their##2##3##(1992-2#1)(1992-6#1)
structure and thereby##2##3##(1993-8#1)(2012-2#1)
structure and thermal##2##3##(2005-11#2)
structure and thus##2##3##(1996-11#1)(2010-7#1)
structure and two##3##3##(2008-10#1)(2013-1#2)
structure and underlying##2##3##(1995-1#1)(2008-9#1)
structure and was##2##3##(2004-2#1)(2007-12#1)
structure and##688##2##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#3)(1990-3#2)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#3)(1991-4#2)(1991-5#5)(1991-6#4)(1991-7#2)(1991-8#2)(1991-9#3)(1992-11#5)(1992-12#5)(1992-2#2)(1992-3#5)(1992-4#1)(1992-6#7)(1992-7#1)(1992-8#3)(1992-9#6)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#7)(1993-4#4)(1993-5#1)(1993-6#6)(1993-7#1)(1993-8#4)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#5)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#5)(1994-9#2)(1995-1#2)(1995-10#4)(1995-11#3)(1995-12#3)(1995-2#5)(1995-3#3)(1995-4#2)(1995-5#2)(1995-6#6)(1995-8#5)(1996-10#1)(1996-11#4)(1996-12#3)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#7)(1997-5#1)(1997-6#2)(1997-7#8)(1997-8#2)(1997-9#1)(2003-11#1)(2004-2#1)(2004-4#1)(2004-9#2)(2005-1#1)(2005-10#4)(2005-11#13)(2005-3#1)(2005-5#2)(2005-7#2)(2005-8#3)(2006-10#13)(2006-12#6)(2006-2#3)(2006-4#2)(2006-5#2)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#19)(2007-12#14)(2007-3#2)(2007-4#2)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#4)(2008-1#9)(2008-10#30)(2008-11#8)(2008-12#3)(2008-2#11)(2008-3#13)(2008-4#30)(2008-5#22)(2008-6#4)(2008-7#24)(2008-8#12)(2008-9#13)(2009-1#1)(2009-10#6)(2009-11#3)(2009-12#2)(2009-2#7)(2009-3#4)(2009-5#2)(2009-7#4)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#6)(2010-5#7)(2010-7#8)(2010-8#6)(2011-1#14)(2011-12#2)(2011-2#9)(2011-3#1)(2012-1#7)(2012-11#2)(2012-12#1)(2012-2#13)(2012-3#12)(2012-7#1)(2013-1#14)(2013-7#2)(2013-8#13)
structure and/or##4##2##(1990-3#1)(1995-5#1)(1997-3#1)(2008-10#1)
structure appears to be##3##4##(1995-1#1)(1997-2#1)(2008-10#1)
structure appears to##4##3##(1991-10#1)(1995-1#1)(1997-2#1)(2008-10#1)
structure are important##2##3##(2008-10#2)
structure are presented##2##3##(1995-4#1)(2013-1#1)
structure are related to##2##4##(2007-12#1)(2008-2#1)
structure are studied##2##3##(1993-12#1)(2007-11#1)
structure are##32##2##(1990-2#1)(1990-7#1)(1991-4#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-8#1)(1995-1#1)(1995-4#2)(1996-11#2)(1997-4#1)(2004-11#1)(2006-10#1)(2007-11#2)(2007-12#5)(2008-10#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
structure arises##2##2##(1990-10#1)(2012-1#1)
structure around the##5##3##(1991-6#1)(1995-1#1)(1995-10#1)(1997-2#1)(2005-11#1)
structure around##9##2##(1991-6#1)(1992-5#1)(1995-1#1)(1995-10#1)(1995-8#1)(1997-2#1)(2005-11#1)(2006-10#1)(2008-10#1)
structure as a##10##3##(1990-11#1)(1991-7#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-2#3)(2010-2#1)(2012-3#1)
structure as determined by##2##4##(1993-11#1)(1995-6#1)
structure as the##8##3##(1990-2#1)(1991-2#1)(1997-8#1)(2006-10#1)(2006-2#1)(2008-11#1)(2008-2#1)(2011-2#1)
structure as well as the##2##5##(1996-11#1)(2011-2#1)
structure as well as##6##4##(1996-11#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-1#1)(2013-8#1)
structure as##47##2##(1990-11#1)(1990-2#2)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1997-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#2)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-2#1)(2011-2#2)(2012-1#2)(2012-3#1)(2013-8#1)
structure associated with##3##3##(1993-3#1)(2008-10#1)(2008-6#1)
structure associated##4##2##(1992-1#1)(1993-3#1)(2008-10#1)(2008-6#1)
structure at high##2##3##(2005-11#1)(2008-6#1)
structure at one##2##3##(1993-2#1)(2008-10#1)
structure at positions##2##3##(1992-3#2)
structure at the##8##3##(1990-7#1)(1992-9#1)(1993-4#1)(1997-5#1)(2007-12#1)(2008-11#1)(2008-3#1)(2012-2#1)
structure at##29##2##(1990-10#1)(1990-7#1)(1992-12#1)(1992-3#3)(1992-9#1)(1993-2#1)(1993-4#1)(1995-1#1)(1996-7#1)(1997-4#1)(1997-5#1)(2005-11#2)(2006-10#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2012-11#1)(2012-2#1)(2013-8#1)
structure based on##9##3##(1990-10#1)(1992-5#1)(1992-7#1)(1993-2#1)(1995-2#1)(1996-2#1)(2008-10#1)(2008-7#1)(2013-8#1)
structure based##13##2##(1990-10#1)(1992-12#1)(1992-5#1)(1992-7#1)(1993-2#1)(1995-2#1)(1996-2#1)(2008-10#1)(2008-7#2)(2010-2#1)(2012-2#1)(2013-8#1)
structure being formed##2##3##(1995-12#1)(1996-11#1)
structure being##6##2##(1991-7#1)(1995-12#1)(1996-11#1)(2008-11#1)(2010-8#1)(2013-8#1)
structure between the##4##3##(1990-2#1)(1993-12#1)(1997-6#1)(2007-9#1)
structure between##11##2##(1990-2#1)(1991-5#1)(1991-8#1)(1992-9#1)(1993-12#1)(1997-6#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-8#1)(2012-3#1)
structure breaker##3##2##(2005-11#3)
structure but also##2##3##(1997-7#1)(1997-8#1)
structure but##7##2##(1990-8#1)(1994-10#1)(1997-6#1)(1997-7#1)(1997-8#1)(2010-8#1)(2012-3#1)
structure by the##3##3##(1996-2#1)(2007-12#1)(2008-10#1)
structure by using##2##3##(1993-11#1)(2008-3#1)
structure by##25##2##(1990-4#1)(1990-9#1)(1991-5#1)(1993-11#3)(1994-12#1)(1994-2#1)(1994-9#1)(1996-12#1)(1996-2#1)(2006-2#1)(2006-7#1)(2007-12#3)(2007-6#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-2#1)(2011-2#1)
structure calculations on##2##3##(1994-7#1)(2007-11#1)
structure calculations##6##2##(1994-7#1)(2007-11#1)(2008-5#1)(2010-4#1)(2010-5#1)(2012-1#1)
structure can be used##3##4##(2008-2#2)(2009-7#1)
structure can be##21##3##(1995-1#1)(2006-12#1)(2006-3#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#2)(2008-8#1)(2009-7#1)(2010-5#1)
structure can enhance##2##3##(2006-7#1)(2008-8#1)
structure can##40##2##(1991-3#1)(1992-2#1)(1994-12#1)(1994-5#1)(1995-1#1)(1996-7#1)(2005-10#1)(2005-11#1)(2006-12#1)(2006-3#1)(2006-7#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#2)(2008-8#4)(2008-9#1)(2009-7#1)(2010-5#1)(2012-1#2)(2012-2#1)(2012-3#1)
structure caused by##3##3##(1997-4#1)(2008-10#1)(2008-2#1)
structure change##2##2##(1997-4#1)(2010-4#1)
structure changes##6##2##(1991-5#1)(1994-9#1)(1997-4#1)(2005-11#1)(2005-4#1)(2008-7#1)
structure characteristic C(n)(2)##2##3##(2007-12#2)
structure characteristic##3##2##(1993-8#1)(2007-12#2)
structure characteristics##2##2##(2012-11#1)(2013-1#1)
structure common to all##2##4##(2006-12#1)(2008-4#1)
structure common to##5##3##(2006-12#1)(2008-4#3)(2008-8#1)
structure comparison##2##2##(1994-3#1)(2008-4#1)
structure components##2##2##(2006-6#1)(2008-3#1)
structure composed of##6##3##(1991-10#1)(1995-12#1)(1997-4#1)(2008-3#1)(2008-8#1)(2010-5#1)
structure comprising##3##2##(2007-11#1)(2007-12#2)
structure consisted of a##2##4##(1994-8#1)(2007-12#1)
structure consistent with the##2##4##(2009-2#1)(2012-12#1)
structure consistent with##4##3##(1992-2#1)(2008-10#1)(2009-2#1)(2012-12#1)
structure consisting of a##4##4##(1993-2#1)(2007-12#1)(2008-3#1)(2008-7#1)
structure consisting of##8##3##(1993-2#1)(1996-6#1)(1997-7#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
structure consisting##9##2##(1993-2#1)(1996-6#1)(1996-8#1)(1997-7#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
structure consists of a##3##4##(1991-4#1)(1991-5#1)(1997-7#1)
structure consists of##11##3##(1990-11#1)(1991-4#1)(1991-5#1)(1995-11#1)(1995-5#1)(1996-2#2)(1997-5#1)(1997-7#1)(2007-11#1)(2012-1#1)
structure containing##3##2##(1992-5#1)(1993-8#1)(2008-5#1)
structure contains##3##2##(1994-3#1)(1995-1#1)(2007-11#1)
structure content##5##2##(1991-5#1)(1992-9#1)(1994-11#1)(2007-11#1)(2012-2#1)
structure corresponding to##2##3##(2006-1#1)(2008-4#1)
structure could be altered##2##4##(2009-3#1)(2010-8#1)
structure could be used to##2##5##(2006-12#1)(2010-2#1)
structure could be##5##3##(1990-5#1)(2006-12#1)(2009-3#1)(2010-2#1)(2010-8#1)
structure could##6##2##(1990-5#1)(2006-12#1)(2009-3#1)(2010-2#1)(2010-4#1)(2010-8#1)
structure data for##2##3##(1996-2#1)(2008-4#1)
structure data##5##2##(1990-7#1)(1996-2#1)(2007-11#1)(2008-4#2)
structure depends##2##2##(1996-7#1)(2008-1#1)
structure derived from##2##3##(1992-12#1)(2012-2#1)
structure described##2##2##(1995-6#1)(2008-10#1)
structure determination and##3##3##(1993-3#1)(1993-8#1)(2012-1#1)
structure determination by X-ray crystallography##3##5##(1995-6#1)(2008-4#1)(2009-3#1)
structure determination of the##5##4##(1991-11#1)(1991-4#1)(1993-8#1)(2008-4#1)(2009-7#1)
structure determination of##13##3##(1991-11#1)(1991-4#1)(1992-11#1)(1992-6#1)(1993-8#1)(2006-12#1)(2008-4#2)(2008-9#1)(2009-3#1)(2009-7#1)(2012-3#1)(2012-8#1)
structure determination using##3##3##(2007-10#1)(2009-7#1)(2012-1#1)
structure determination##49##2##(1991-11#2)(1991-4#2)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-8#2)(1994-6#1)(1995-6#1)(1996-2#1)(1997-4#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-5#1)(2008-10#1)(2008-4#4)(2008-5#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#4)(2009-6#1)(2009-7#5)(2010-7#1)(2011-1#1)(2012-1#2)(2012-3#1)(2012-8#1)
structure determinations##3##2##(1996-2#1)(1997-7#2)
structure determined by##2##3##(1997-7#1)(2008-2#1)
structure determined##5##2##(1991-3#1)(1995-11#1)(1997-7#1)(2007-1#1)(2008-2#1)
structure does not##5##3##(1992-9#1)(1995-5#1)(2007-11#1)(2008-2#1)(2008-8#1)
structure does##6##2##(1992-9#1)(1995-5#1)(2007-11#2)(2008-2#1)(2008-8#1)
structure due to##3##3##(2007-2#1)(2008-8#2)
structure during the##5##3##(1991-6#1)(1995-8#1)(1997-9#1)(2005-11#1)(2011-1#1)
structure during##9##2##(1991-6#1)(1992-5#1)(1995-8#1)(1997-1#1)(1997-9#1)(2005-11#1)(2008-11#1)(2008-5#1)(2011-1#1)
structure effects##2##2##(2008-10#1)(2010-2#1)
structure elements##5##2##(1995-2#1)(1996-8#1)(1997-2#1)(2008-8#1)(2013-1#1)
structure elucidation of a##3##4##(1997-2#1)(2007-11#2)
structure elucidation of small molecules##2##5##(2011-2#2)
structure elucidation of the##2##4##(2008-12#1)(2008-9#1)
structure elucidation of##11##3##(1993-4#1)(1994-8#1)(1997-2#1)(2007-1#2)(2007-11#2)(2008-12#1)(2008-9#1)(2011-2#2)
structure elucidation##15##2##(1993-4#1)(1994-8#1)(1997-2#1)(2006-12#1)(2006-4#1)(2007-1#2)(2007-11#2)(2008-12#1)(2008-9#1)(2009-7#1)(2010-11#1)(2011-2#2)
structure enables##2##2##(1996-5#1)(2007-12#1)
structure established##2##2##(1995-8#1)(1997-8#1)
structure evolves##3##2##(1994-7#1)(2005-11#1)(2010-2#1)
structure factor##5##2##(1993-3#1)(2008-2#2)(2008-3#1)(2010-8#1)
structure factors##2##2##(2006-5#2)
structure features##4##2##(2008-4#1)(2010-5#2)(2013-1#1)
structure following##2##2##(1994-8#1)(1995-2#1)
structure for a##3##3##(1993-12#1)(2007-11#2)
structure for an##3##3##(2008-2#1)(2008-7#1)(2010-5#1)
structure for the##17##3##(1993-8#1)(1995-1#1)(1996-4#2)(1996-6#1)(1997-5#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#1)
structure for##70##2##(1990-11#1)(1990-2#2)(1990-5#1)(1993-12#1)(1993-8#1)(1994-10#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-2#2)(1996-4#2)(1996-6#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-9#1)(2005-7#1)(2006-10#1)(2006-2#2)(2007-11#6)(2007-12#3)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#5)(2008-5#6)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
structure form##3##2##(1995-5#1)(1997-6#1)(2008-10#1)
structure formation##11##2##(1993-6#2)(1995-2#1)(1995-4#1)(1997-4#1)(2005-11#1)(2008-10#1)(2008-4#1)(2010-11#1)(2012-11#1)(2013-8#1)
structure formed by##2##3##(2008-10#1)(2012-2#1)
structure from a sample##2##4##(1994-9#1)(2007-12#1)
structure from a##5##3##(1993-6#1)(1994-9#1)(2007-12#1)(2008-3#1)(2008-5#1)
structure from sequence##2##3##(1991-11#1)(2008-4#1)
structure from the##5##3##(1992-1#1)(2007-10#1)(2007-11#1)(2013-1#2)
structure from##29##2##(1990-2#1)(1991-11#1)(1991-2#2)(1992-1#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-9#3)(1997-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2013-1#2)(2013-8#1)
structure function##2##2##(1995-2#1)(2007-12#1)
structure had##4##2##(1992-7#1)(1993-2#1)(2008-11#1)(2008-9#1)
structure has a##2##3##(1993-3#1)(2008-3#1)
structure has been determined for##2##5##(1993-3#1)(1994-5#1)
structure has been determined##7##4##(1991-7#1)(1992-4#1)(1993-3#1)(1994-5#1)(1994-6#1)(1996-2#1)(1997-7#1)
structure has been reported##2##4##(2007-11#1)(2010-10#1)
structure has been##28##3##(1990-10#1)(1991-7#1)(1992-4#1)(1993-3#1)(1993-6#3)(1994-5#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-3#1)(1996-10#1)(1996-2#2)(1996-6#1)(1997-4#1)(1997-7#1)(2007-11#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2010-10#1)(2011-1#1)(2012-3#1)
structure has not##2##3##(2009-12#1)(2012-1#1)
structure has the##2##3##(2007-12#2)
structure has##44##2##(1990-10#1)(1991-7#1)(1992-4#1)(1992-5#1)(1993-3#4)(1993-6#3)(1994-5#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-3#1)(1996-10#1)(1996-2#2)(1996-6#1)(1997-4#1)(1997-7#1)(2007-11#3)(2007-12#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-12#1)(2010-10#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
structure have been synthesized##3##4##(1994-8#1)(2006-12#1)(2008-10#1)
structure have been##11##3##(1990-3#1)(1991-2#1)(1994-8#1)(1996-2#1)(2005-4#2)(2006-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)
structure have##15##2##(1990-3#1)(1991-2#1)(1994-8#1)(1995-8#1)(1996-2#1)(2004-4#1)(2005-4#2)(2006-12#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-7#1)
structure homology##2##2##(1991-1#1)(1993-6#1)
structure in a##7##3##(1991-2#1)(1992-3#1)(1993-2#1)(1994-3#1)(2007-11#2)(2008-5#1)
structure in all##2##3##(2008-10#1)(2013-8#1)
structure in an##5##3##(2007-12#2)(2008-3#2)(2010-6#1)
structure in aqueous solution##2##4##(1990-10#1)(2008-9#1)
structure in solution##2##3##(1993-9#1)(2013-7#1)
structure in the presence of##2##5##(1995-3#1)(2009-7#1)
structure in the two##2##4##(2006-10#1)(2007-12#1)
structure in the vicinity of##2##5##(1991-7#1)(2006-10#1)
structure in the##57##3##(1990-5#1)(1990-7#1)(1991-10#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-3#1)(1992-4#1)(1992-5#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-10#2)(1995-3#1)(1995-4#1)(1995-6#1)(1996-11#1)(1996-6#1)(1997-4#2)(1997-8#1)(2006-10#2)(2006-7#2)(2006-8#1)(2007-11#2)(2007-12#2)(2007-5#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
structure in these##2##3##(1995-10#1)(2009-2#1)
structure in this##3##3##(1991-4#1)(1992-6#1)(2008-11#1)
structure in which the##5##4##(1996-2#1)(1997-6#1)(2007-12#1)(2008-7#1)(2010-5#1)
structure in which##9##3##(1990-2#1)(1994-12#1)(1995-6#1)(1996-2#1)(1997-6#1)(2006-2#1)(2007-12#1)(2008-7#1)(2010-5#1)
structure in##161##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-9#3)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#2)(1994-7#2)(1995-1#1)(1995-10#4)(1995-2#2)(1995-3#1)(1995-4#2)(1995-5#1)(1995-6#2)(1995-7#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#2)(1997-2#1)(1997-4#2)(1997-6#1)(1997-8#2)(2005-11#2)(2005-8#2)(2006-10#2)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#2)(2006-8#1)(2007-11#5)(2007-12#10)(2007-5#1)(2008-1#1)(2008-10#10)(2008-11#7)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#2)(2009-2#2)(2009-4#1)(2009-7#1)(2010-12#4)(2010-2#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#3)
structure includes##5##2##(1992-2#1)(1993-2#1)(1995-3#1)(2007-10#1)(2008-7#1)
structure information##2##2##(2010-7#1)(2013-8#1)
structure into a##2##3##(2006-12#1)(2012-1#1)
structure into##7##2##(2006-12#1)(2007-3#1)(2008-7#1)(2009-4#1)(2010-7#1)(2012-1#1)(2012-3#1)
structure involved in##2##3##(1992-3#1)(1994-2#1)
structure involving##2##2##(1991-5#1)(1995-4#1)
structure is a##6##3##(1994-12#1)(2007-7#1)(2008-10#2)(2008-7#1)(2012-3#1)
structure is also##3##3##(1997-5#1)(2007-11#1)(2008-10#1)
structure is described in##2##4##(2006-10#1)(2008-2#1)
structure is described##3##3##(2006-10#1)(2007-12#1)(2008-2#1)
structure is examined##2##3##(1994-2#1)(2005-11#1)
structure is formed by##2##4##(2011-2#1)(2013-8#1)
structure is formed##4##3##(1997-4#1)(2008-3#1)(2011-2#1)(2013-8#1)
structure is found to be nearly##2##6##(1997-4#1)(2007-12#1)
structure is found to##3##4##(1997-4#1)(2007-12#1)(2008-3#1)
structure is found##6##3##(1997-4#1)(2007-12#2)(2008-3#1)(2008-4#2)
structure is highly##2##3##(1995-8#1)(1996-7#1)
structure is in##3##3##(1991-2#1)(1996-6#1)(2007-12#1)
structure is known##2##3##(1990-9#1)(1992-4#1)
structure is largely##3##3##(1991-5#1)(2012-12#2)
structure is not the only##2##5##(2008-10#1)(2010-2#1)
structure is not##8##3##(1993-6#1)(1995-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-2#1)
structure is observed##2##3##(2005-11#1)(2007-12#1)
structure is obtained##3##3##(2008-2#1)(2008-3#1)(2011-1#1)
structure is presented##3##3##(1991-7#1)(2008-11#1)(2008-3#1)
structure is proposed##2##3##(2007-12#2)
structure is quite##2##3##(1996-2#1)(2007-12#1)
structure is shared##2##3##(1993-4#1)(1994-9#1)
structure is shown to##2##4##(2007-12#1)(2009-2#1)
structure is similar to that of the##2##7##(1992-3#1)(1995-5#1)
structure is similar to that of##5##6##(1992-12#1)(1992-3#1)(1994-12#1)(1995-5#1)(2008-5#1)
structure is similar to that##6##5##(1992-12#1)(1992-3#1)(1994-12#1)(1995-5#1)(1997-7#1)(2008-5#1)
structure is similar to##7##4##(1992-12#1)(1992-3#1)(1994-12#1)(1995-4#1)(1995-5#1)(1997-7#1)(2008-5#1)
structure is similar##9##3##(1992-12#1)(1992-3#1)(1992-4#1)(1993-8#1)(1994-12#1)(1995-4#1)(1995-5#1)(1997-7#1)(2008-5#1)
structure is stabilized##3##3##(1990-7#1)(1992-12#1)(1995-6#1)
structure is suggested##2##3##(1991-3#1)(2011-2#1)
structure is the##6##3##(1990-7#1)(1994-5#1)(1995-11#1)(1996-7#1)(2008-7#1)(2012-1#1)
structure is typical##2##3##(1997-7#1)(2008-12#1)
structure is used##3##3##(2008-3#1)(2008-7#1)(2009-9#1)
structure is very similar to that##2##6##(1993-8#1)(1994-5#1)
structure is very similar to##4##5##(1993-8#1)(1994-12#1)(1994-5#1)(2010-11#1)
structure is very##5##3##(1993-8#1)(1994-12#1)(1994-5#1)(1997-2#1)(2010-11#1)
structure is##182##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-7#2)(1990-9#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#5)(1991-7#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-4#2)(1993-2#1)(1993-4#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#3)(1994-8#1)(1994-9#1)(1995-1#4)(1995-10#2)(1995-11#3)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-6#1)(1996-7#3)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#2)(2004-9#1)(2005-11#6)(2005-4#1)(2005-7#1)(2006-10#3)(2006-2#1)(2006-5#1)(2006-7#1)(2007-10#2)(2007-11#3)(2007-12#18)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#14)(2008-4#6)(2008-5#1)(2008-7#5)(2008-8#4)(2009-2#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#2)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-3#3)(2013-1#1)(2013-8#1)
structure learning##3##2##(2008-2#1)(2013-1#2)
structure made##2##2##(2006-12#1)(2007-11#1)
structure maker##2##2##(2005-11#2)
structure may be##6##3##(1990-5#1)(1992-5#1)(1992-7#1)(1994-9#1)(2008-8#1)(2011-12#1)
structure may##13##2##(1990-5#1)(1992-5#1)(1992-7#1)(1994-9#1)(1996-12#1)(1996-6#1)(2006-10#2)(2008-8#1)(2009-8#1)(2009-9#1)(2011-12#1)(2012-1#1)
structure model for##3##3##(1993-5#1)(1995-10#1)(1996-7#1)
structure model of##2##3##(1996-7#1)(2005-4#1)
structure model##8##2##(1992-2#1)(1993-5#1)(1995-10#1)(1996-7#2)(1996-9#1)(2005-4#1)(2008-4#1)
structure modeling##3##2##(2008-4#2)(2013-8#1)
structure modelling##2##2##(1994-6#1)(2008-1#1)
structure more##2##2##(1995-2#1)(1997-8#1)
structure must##4##2##(2008-12#1)(2008-4#2)(2012-12#1)
structure near the##2##3##(2007-12#1)(2007-8#1)
structure near##4##2##(1995-8#1)(2007-12#1)(2007-8#1)(2008-8#1)
structure observed in##2##3##(1996-12#1)(2008-5#1)
structure observed##3##2##(1996-12#1)(2008-5#1)(2008-6#1)
structure obtained##2##2##(1995-6#1)(2013-8#1)
structure occur##2##2##(1991-4#1)(1994-2#1)
structure occurs##2##2##(1997-2#1)(2005-11#1)
structure of 1 was determined by##2##6##(2006-4#1)(2007-1#1)
structure of 1 was##3##4##(2006-12#1)(2006-4#1)(2007-1#1)
structure of 1##4##3##(1995-6#1)(2006-12#1)(2006-4#1)(2007-1#1)
structure of 3##2##3##(1996-2#1)(2010-5#1)
structure of A##4##3##(2008-10#1)(2011-2#2)(2013-8#1)
structure of APPI##2##3##(1991-11#2)
structure of Anthrax Toxin Receptor##2##5##(2013-1#2)
structure of CaN-B##2##3##(1994-8#2)
structure of DNA and its##2##5##(2008-4#1)(2011-1#1)
structure of DNA and##4##4##(1994-11#1)(2008-4#1)(2011-1#1)(2011-2#1)
structure of DNA photolyase from Escherichia coli##2##7##(1995-6#2)
structure of DNA##15##3##(1990-2#1)(1992-1#1)(1992-11#1)(1994-11#1)(1995-5#2)(1995-6#2)(2006-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-1#1)(2011-2#1)
structure of E##4##3##(1990-5#1)(2010-8#2)(2012-2#1)
structure of Escherichia coli##6##4##(1990-7#1)(1991-2#1)(1991-5#1)(1993-8#1)(1994-3#1)(1997-6#1)
structure of GZEL##2##3##(2011-1#2)
structure of Heterobasidion annosum##2##4##(2008-10#2)
structure of Jann_2411##2##3##(2010-10#2)
structure of P##4##3##(2008-10#2)(2011-2#2)
structure of P-450cam##2##3##(1992-12#2)
structure of PBS##2##3##(2008-8#2)
structure of Phytophthora infestans##3##4##(2008-10#3)
structure of Pseudomonas##2##3##(1994-8#1)(2008-10#1)
structure of RNA##2##3##(1991-8#1)(2008-4#1)
structure of S##4##3##(2008-10#4)
structure of SP-B##2##3##(1994-3#1)(2007-11#1)
structure of X##4##3##(1993-6#1)(2008-10#3)
structure of a DNA##4##4##(1994-8#1)(1995-1#2)(2007-10#1)
structure of a complex of the##2##6##(1995-11#1)(1995-8#1)
structure of a complex of##3##5##(1992-3#1)(1995-11#1)(1995-8#1)
structure of a given##2##4##(2007-12#1)(2008-4#1)
structure of a human##2##4##(1994-8#1)(1996-5#1)
structure of a natural alternating d(TA)n sequence##2##7##(1997-3#2)
structure of a natural##3##4##(1992-1#1)(1997-3#2)
structure of a new##7##4##(1995-11#1)(2007-11#5)(2010-2#1)
structure of a novel##3##4##(1992-1#1)(1995-5#1)(2011-1#1)
structure of a protein##2##4##(1991-4#1)(2008-10#1)
structure of a surface##2##4##(2008-7#1)(2010-7#1)
structure of a##101##3##(1990-11#1)(1990-7#1)(1991-4#3)(1991-5#3)(1991-9#1)(1992-1#4)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#3)(1992-9#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-8#2)(1995-1#5)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#3)(1995-8#2)(1996-5#1)(1996-6#2)(1996-7#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2005-11#3)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#7)(2007-12#4)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#2)(2009-2#1)(2010-10#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2012-3#2)(2013-8#2)
structure of about##2##3##(1992-12#1)(2007-6#1)
structure of an RNA &quot##2##5##(1997-5#2)
structure of an active##2##4##(1991-12#1)(1997-2#1)
structure of an immunoglobulin##2##4##(1994-11#1)(1994-9#1)
structure of an##25##3##(1990-11#1)(1990-9#1)(1991-12#1)(1991-4#1)(1992-3#1)(1994-11#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-6#2)(1995-7#1)(1996-11#1)(1996-7#1)(1997-2#1)(1997-5#2)(2005-4#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-10#1)(2009-5#1)(2012-12#1)
structure of animal##2##3##(2008-1#1)(2008-11#1)
structure of bacterial##3##3##(1996-2#2)(2012-3#1)
structure of biological##4##3##(1994-5#1)(2006-10#1)(2008-7#1)(2010-4#1)
structure of blue##2##3##(1995-5#1)(2010-8#1)
structure of bovine##4##3##(1991-5#1)(1992-2#1)(1993-6#1)(1994-9#1)
structure of brazzein##2##3##(2008-9#2)
structure of broad-area vertical-cavity regenerative amplifiers##2##6##(2007-12#2)
structure of chaotic##2##3##(1995-2#1)(2008-11#1)
structure of chicken##2##3##(1991-4#1)(1993-11#1)
structure of clinical concepts (represented by UMLS codes) extracted from the unstructured nursing notes with physiologic data (from SAPS-I) for hospital mortality prediction##2##23##(2013-1#2)
structure of clinical##4##3##(2013-1#4)
structure of complex##4##3##(2007-12#2)(2008-3#1)(2011-2#1)
structure of compound 1 was elucidated##3##6##(2007-1#2)(2007-11#1)
structure of compound 1 was##4##5##(2007-1#3)(2007-11#1)
structure of compound##5##3##(2007-1#4)(2007-11#1)
structure of compounds##2##3##(2008-10#2)
structure of cucumisin##2##3##(1994-12#2)
structure of cytochrome##2##3##(1992-12#1)(1994-8#1)
structure of deacetyl-1##2##3##(2008-7#2)
structure of delta-Am2766##3##3##(2006-12#3)
structure of each of the##2##5##(2007-11#1)(2010-8#1)
structure of each##6##3##(1996-11#1)(2007-11#1)(2008-10#1)(2009-4#1)(2009-5#1)(2010-8#1)
structure of echistatin##3##3##(1991-7#2)(1992-7#1)
structure of employee##2##3##(1994-3#2)
structure of eukaryotic##2##3##(2008-10#1)(2008-8#1)
structure of glycine with##2##4##(2006-2#2)
structure of glycine##3##3##(2006-2#3)
structure of goat##4##3##(2010-4#4)
structure of horse heart ferrocytochrome c##2##6##(1994-5#2)
structure of human recombinant interleukin-4##2##5##(1992-8#2)
structure of human serum##2##4##(1992-12#1)(1996-11#1)
structure of human trypsin 1##2##5##(1996-6#2)
structure of human##21##3##(1990-5#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-8#2)(1994-8#1)(1994-9#3)(1995-8#1)(1996-11#1)(1996-6#2)(1997-6#1)(2008-2#1)(2008-6#1)(2009-7#1)(2011-1#1)
structure of individual##2##3##(2006-10#1)(2012-1#1)
structure of information##2##3##(1994-2#1)(2011-1#1)
structure of inorganic##2##3##(1997-6#1)(2008-11#1)
structure of intermediate##2##3##(1995-10#2)
structure of its##4##3##(1990-5#1)(2007-11#1)(2007-12#1)(2011-2#1)
structure of l-aspartate ammonia-lyase##2##4##(1997-7#2)
structure of malaria populations##2##4##(2006-10#2)
structure of male##2##3##(2007-12#1)(2010-4#1)
structure of membrane##4##3##(2005-11#1)(2008-8#3)
structure of molecular##2##3##(1995-2#1)(2008-3#1)
structure of natural##3##3##(2007-12#1)(2008-8#1)(2012-3#1)
structure of nerve##2##3##(1992-3#1)(2008-7#1)
structure of neural##2##3##(1990-5#1)(2008-10#1)
structure of normal##2##3##(1991-8#1)(2008-8#1)
structure of nucleic acids##4##4##(1995-6#3)(2012-2#1)
structure of nucleic##5##3##(1995-6#3)(2008-10#1)(2012-2#1)
structure of nursing research programs##2##5##(2010-9#2)
structure of nursing##3##3##(2010-9#2)(2011-2#1)
structure of other##3##3##(1990-9#1)(1993-11#1)(1994-9#1)
structure of oxidized##3##3##(1993-9#1)(1994-5#2)
structure of paper##2##3##(2008-3#1)(2008-9#1)
structure of populations of##4##4##(2008-10#3)(2011-2#1)
structure of populations##7##3##(2007-5#1)(2008-10#5)(2011-2#1)
structure of protein##5##3##(1993-11#1)(1996-11#2)(2005-11#1)(2012-2#1)
structure of rat adipocyte plasma membranes##2##6##(1997-1#2)
structure of rat liver 3##2##5##(1994-3#2)
structure of rat liver##4##4##(1993-12#1)(1994-3#2)(1994-8#1)
structure of rat##13##3##(1992-5#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-4#2)(1994-3#2)(1994-5#2)(1994-8#1)(1997-1#2)
structure of recombinant human##2##4##(1993-8#1)(1995-3#1)
structure of recombinant##3##3##(1993-8#1)(1995-3#1)(2008-4#1)
structure of ribosomal##2##3##(1993-11#1)(2005-10#1)
structure of several##3##3##(1990-8#1)(2010-5#1)(2011-2#1)
structure of silk##3##3##(2012-2#3)
structure of soil arthropod##2##4##(2013-8#2)
structure of soil##3##3##(2013-7#1)(2013-8#2)
structure of sperm##2##3##(1993-3#1)(2007-9#1)
structure of subtilisin Carlsberg##2##4##(1995-7#1)(1997-4#1)
structure of subtilisin##4##3##(1995-7#1)(1997-4#1)(2008-7#2)
structure of such##2##3##(1995-4#1)(2008-10#1)
structure of tetranectin##2##3##(1992-8#1)(1997-7#1)
structure of the (-)-cis-anti-[BP]dG##4##4##(1996-7#4)
structure of the 1##2##4##(2005-11#1)(2007-12#1)
structure of the 18-kDa##2##4##(1992-3#1)(1997-7#1)
structure of the 20 S proteasome##2##6##(1994-10#2)
structure of the 5'##3##4##(1990-7#1)(1991-11#1)(1991-9#1)
structure of the C##2##4##(1994-12#1)(2007-12#1)
structure of the C-terminal domain of##3##6##(1995-2#1)(2011-1#2)
structure of the C-terminal domain##4##5##(1995-2#2)(2011-1#2)
structure of the C-terminal##5##4##(1990-11#1)(1995-2#2)(2011-1#2)
structure of the DNA##3##4##(1995-2#1)(2006-10#2)
structure of the DNA-binding domain##2##5##(1990-11#2)
structure of the LDL receptor-binding domain of##2##7##(1991-6#2)
structure of the N-terminal##6##4##(1990-7#1)(1992-8#1)(1995-1#2)(1996-11#1)(1996-7#1)
structure of the Na##2##4##(1992-11#1)(1994-8#1)
structure of the Peruvian scallop Argopecten purpuratus##2##7##(2013-8#2)
structure of the Ras-binding domain of##2##6##(1995-5#2)
structure of the accessory##2##4##(1997-7#1)(2008-7#1)
structure of the activated##5##4##(1991-11#1)(1991-4#1)(1995-5#1)(1997-1#1)(2005-11#1)
structure of the annexin XII hexamer##2##6##(1995-11#2)
structure of the apoenzyme##2##4##(1994-8#1)(1997-7#1)
structure of the azobenzene arsonic acid compound##2##7##(2008-10#2)
structure of the biotin carboxylase##2##5##(1994-8#2)
structure of the brain##2##4##(2007-12#1)(2009-7#1)
structure of the catalytic##2##4##(1990-5#1)(1995-8#1)
structure of the chicken##2##4##(1991-6#1)(1993-2#1)
structure of the complex between##3##5##(1992-3#1)(1994-11#1)(1997-1#1)
structure of the complex of##3##5##(1996-7#1)(1996-8#1)(1997-1#1)
structure of the complex##11##4##(1990-4#1)(1990-5#1)(1991-5#1)(1992-3#1)(1993-3#1)(1994-11#1)(1996-7#1)(1996-8#1)(1997-1#2)(2007-12#1)
structure of the complexes##5##4##(2008-10#2)(2008-3#1)(2008-5#1)(2010-5#1)
structure of the compound##4##4##(2006-12#1)(2007-12#1)(2009-10#1)(2009-6#1)
structure of the compounds##2##4##(2008-10#1)(2010-12#1)
structure of the d(T-C-G-A) duplex at acidic pH##2##8##(1994-9#2)
structure of the d(T-C-G-A)##3##4##(1994-9#3)
structure of the data##2##4##(2008-3#1)(2008-6#1)
structure of the disc##2##4##(2006-7#1)(2007-8#1)
structure of the duplex##2##4##(1995-1#2)
structure of the egg##2##4##(1994-2#1)(2010-8#1)
structure of the environment##2##4##(1995-12#1)(2008-8#1)
structure of the enzyme was##2##5##(1992-1#1)(1997-2#1)
structure of the enzyme##7##4##(1990-5#1)(1991-2#1)(1992-1#2)(1994-12#1)(1996-7#1)(1997-2#1)
structure of the expressed##3##4##(1993-8#1)(1997-4#1)(2008-2#1)
structure of the extracellular##3##4##(1995-3#1)(2008-8#1)(2012-2#1)
structure of the first##5##4##(1993-6#1)(1995-3#1)(2010-10#2)(2013-1#1)
structure of the former##2##4##(2005-11#1)(2007-11#1)
structure of the fungal##2##4##(2008-10#2)
structure of the gene and##2##5##(1996-2#1)(1996-8#1)
structure of the gene##6##4##(1991-12#1)(1993-2#1)(1993-4#1)(1996-2#1)(1996-8#1)(1997-7#1)
structure of the granular starch binding domain##2##7##(1996-6#2)
structure of the human##9##4##(1991-12#1)(1991-9#1)(1994-3#1)(1994-9#1)(1996-2#1)(1997-2#1)(2008-11#1)(2008-4#1)(2008-7#1)
structure of the inner##3##4##(2008-8#2)(2013-8#1)
structure of the isolated##3##4##(1996-6#1)(2007-9#1)(2012-11#1)
structure of the liquid##3##4##(2005-11#1)(2007-11#1)(2010-8#1)
structure of the mammalian##2##4##(1990-7#1)(2008-11#1)
structure of the modified##2##4##(1997-2#1)(2008-5#1)
structure of the molecule##5##4##(1990-5#1)(1990-7#1)(1992-3#1)(2008-10#1)(2008-4#1)
structure of the monomers##2##4##(2010-12#1)(2010-4#1)
structure of the mouse##5##4##(1992-12#1)(1995-11#1)(1995-5#1)(1996-11#1)(1997-7#1)
structure of the native##2##4##(1990-5#1)(1996-5#1)
structure of the natural##3##4##(2006-12#1)(2008-5#1)(2009-10#1)
structure of the new compound was established##2##7##(2007-1#2)
structure of the new compound was##4##6##(2007-1#3)(2008-4#1)
structure of the new##6##4##(1997-7#1)(2007-1#4)(2008-4#1)
structure of the parent##3##4##(2007-8#1)(2008-10#1)(2008-3#1)
structure of the peptide cycle##2##5##(1994-2#2)
structure of the peptide##11##4##(1990-3#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-6#1)(1994-11#1)(1994-2#2)(1996-8#1)(2006-12#1)
structure of the peptides##2##4##(1990-10#1)(2006-10#1)
structure of the planarian CNS##2##5##(2008-5#2)
structure of the population##2##4##(2006-2#1)(2008-10#1)
structure of the primary##2##4##(1991-6#1)(2008-8#1)
structure of the products##2##4##(2007-11#2)
structure of the protein##17##4##(1990-12#1)(1990-3#1)(1991-9#1)(1992-11#1)(1994-9#1)(1996-7#1)(2005-11#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-9#2)(2010-2#2)(2010-7#1)
structure of the putative##2##4##(1994-10#1)(1997-7#1)
structure of the rat##4##4##(1995-1#1)(1997-8#1)(2009-5#1)(2011-2#1)
structure of the receptor##3##4##(1993-6#1)(1994-12#1)(2006-12#1)
structure of the resultant##2##4##(2005-11#1)(2008-5#1)
structure of the sodium##2##4##(2007-10#1)(2007-12#1)
structure of the surfactant##3##4##(1991-2#1)(1992-9#1)(2008-5#1)
structure of the ternary complex##2##5##(1994-8#1)(1995-5#1)
structure of the title compound##2##5##(2007-11#1)(2008-11#1)
structure of the title##3##4##(1991-12#1)(2007-11#1)(2008-11#1)
structure of the trp operator##2##5##(1994-3#2)
structure of the trp##3##4##(1994-3#3)
structure of the vesicles##2##4##(1991-4#1)(2008-5#1)
structure of the vesosome##2##4##(2008-9#2)
structure of the##687##3##(1990-10#2)(1990-11#4)(1990-12#6)(1990-2#3)(1990-3#5)(1990-4#3)(1990-5#8)(1990-7#9)(1990-8#4)(1990-9#2)(1991-1#3)(1991-11#2)(1991-12#3)(1991-2#9)(1991-3#2)(1991-4#5)(1991-5#6)(1991-6#6)(1991-7#3)(1991-8#1)(1991-9#6)(1992-1#7)(1992-11#4)(1992-12#6)(1992-2#2)(1992-3#5)(1992-4#1)(1992-5#4)(1992-6#6)(1992-7#1)(1992-8#2)(1992-9#5)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#4)(1993-4#1)(1993-6#7)(1993-8#4)(1993-9#3)(1994-1#1)(1994-10#3)(1994-11#8)(1994-12#11)(1994-2#4)(1994-3#8)(1994-5#5)(1994-6#1)(1994-8#11)(1994-9#9)(1995-1#17)(1995-11#6)(1995-12#2)(1995-2#5)(1995-3#8)(1995-4#2)(1995-5#6)(1995-6#3)(1995-7#2)(1995-8#3)(1995-9#1)(1996-11#3)(1996-12#1)(1996-2#4)(1996-4#2)(1996-5#5)(1996-6#7)(1996-7#19)(1996-8#8)(1997-1#5)(1997-2#7)(1997-3#2)(1997-4#6)(1997-5#5)(1997-6#2)(1997-7#9)(1997-8#2)(2005-1#1)(2005-11#19)(2005-12#2)(2005-3#1)(2005-4#1)(2006-10#5)(2006-11#1)(2006-12#9)(2006-2#3)(2006-3#3)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#4)(2007-10#2)(2007-11#14)(2007-12#16)(2007-3#4)(2007-5#2)(2007-6#1)(2007-8#4)(2007-9#3)(2008-1#1)(2008-10#35)(2008-11#14)(2008-12#2)(2008-2#9)(2008-3#7)(2008-4#9)(2008-5#19)(2008-6#3)(2008-7#6)(2008-8#11)(2008-9#7)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#2)(2010-11#2)(2010-12#6)(2010-2#5)(2010-4#6)(2010-5#2)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#7)(2012-1#5)(2012-11#2)(2012-12#1)(2012-2#7)(2012-3#7)(2013-1#8)(2013-7#1)(2013-8#7)
structure of their##7##3##(1996-8#1)(2006-12#1)(2006-5#1)(2007-11#1)(2011-2#1)(2012-12#2)
structure of thermostable alpha-amylase from Bacillus licheniformis##2##7##(1997-4#2)
structure of these compounds##2##4##(2006-10#1)(2012-2#1)
structure of these##17##3##(1990-7#1)(1992-1#1)(1996-12#1)(1996-2#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2009-7#1)(2009-9#1)(2010-4#2)(2012-12#1)(2012-2#1)(2012-3#1)
structure of this protein is##2##5##(1991-9#1)(1994-9#1)
structure of this protein##4##4##(1991-9#1)(1994-6#1)(1994-9#1)(2009-3#1)
structure of this##27##3##(1990-5#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-3#1)(1992-8#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-3#1)(2006-2#1)(2006-3#1)(2006-7#1)(2007-12#1)(2007-9#1)(2008-10#2)(2009-3#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)
structure of three##2##3##(1991-8#1)(2009-8#1)
structure of unliganded##3##3##(1990-7#1)(1991-2#2)
structure of viral##2##3##(2008-10#2)
structure of water##2##3##(1991-3#1)(2006-10#1)
structure of##1717##2##(1990-1#1)(1990-10#3)(1990-11#7)(1990-12#8)(1990-2#7)(1990-3#6)(1990-4#5)(1990-5#13)(1990-6#1)(1990-7#16)(1990-8#8)(1990-9#6)(1991-1#3)(1991-10#1)(1991-11#7)(1991-12#9)(1991-2#17)(1991-3#3)(1991-4#13)(1991-5#19)(1991-6#9)(1991-7#6)(1991-8#4)(1991-9#9)(1992-1#14)(1992-11#9)(1992-12#24)(1992-2#5)(1992-3#16)(1992-4#8)(1992-5#7)(1992-6#7)(1992-7#2)(1992-8#13)(1992-9#9)(1993-1#1)(1993-11#13)(1993-12#2)(1993-2#8)(1993-3#11)(1993-4#4)(1993-5#1)(1993-6#13)(1993-7#1)(1993-8#9)(1993-9#6)(1994-1#1)(1994-10#3)(1994-11#16)(1994-12#16)(1994-2#7)(1994-3#19)(1994-5#17)(1994-6#4)(1994-7#1)(1994-8#26)(1994-9#25)(1995-1#25)(1995-10#4)(1995-11#15)(1995-12#4)(1995-2#11)(1995-3#17)(1995-4#4)(1995-5#16)(1995-6#16)(1995-7#5)(1995-8#12)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#11)(1996-12#3)(1996-2#17)(1996-4#2)(1996-5#9)(1996-6#11)(1996-7#27)(1996-8#12)(1997-1#9)(1997-2#17)(1997-3#9)(1997-4#14)(1997-5#10)(1997-6#11)(1997-7#18)(1997-8#8)(1997-9#1)(2004-11#1)(2004-12#1)(2004-4#1)(2005-1#2)(2005-10#2)(2005-11#35)(2005-12#2)(2005-3#2)(2005-4#9)(2005-8#1)(2006-10#19)(2006-11#1)(2006-12#20)(2006-2#9)(2006-3#6)(2006-4#7)(2006-5#4)(2006-7#2)(2006-8#2)(2007-1#13)(2007-10#5)(2007-11#39)(2007-12#47)(2007-3#6)(2007-5#6)(2007-6#3)(2007-8#4)(2007-9#7)(2008-1#5)(2008-10#120)(2008-11#27)(2008-12#11)(2008-2#23)(2008-3#22)(2008-4#26)(2008-5#32)(2008-6#9)(2008-7#20)(2008-8#45)(2008-9#13)(2009-10#4)(2009-11#2)(2009-12#3)(2009-2#3)(2009-3#5)(2009-4#3)(2009-5#6)(2009-6#1)(2009-7#7)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#10)(2010-11#2)(2010-12#10)(2010-2#8)(2010-3#1)(2010-4#16)(2010-5#8)(2010-7#7)(2010-8#8)(2010-9#3)(2011-1#22)(2011-12#3)(2011-2#37)(2011-3#1)(2012-1#11)(2012-11#6)(2012-12#6)(2012-2#22)(2012-3#14)(2013-1#24)(2013-7#6)(2013-8#22)
structure offers##2##2##(2008-3#1)(2012-3#1)
structure on a##2##3##(2008-4#1)(2012-3#1)
structure on the##16##3##(1991-12#1)(1994-11#2)(2005-10#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#4)(2008-4#2)(2009-9#1)(2010-6#1)(2013-1#1)
structure on##37##2##(1991-12#1)(1994-11#2)(1995-11#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-6#1)(2005-10#1)(2005-11#2)(2006-10#1)(2006-4#1)(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#3)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-6#1)(2012-1#2)(2012-3#1)(2013-1#2)
structure or function##6##3##(1991-5#1)(1993-11#1)(2007-12#1)(2008-4#2)(2012-2#1)
structure or the##4##3##(1992-8#1)(1994-11#1)(2008-10#1)(2008-11#1)
structure or##19##2##(1991-11#1)(1991-5#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-9#2)(1996-3#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
structure over##2##2##(1996-1#1)(2010-12#1)
structure parameter##2##2##(2008-2#2)
structure parameters of##2##3##(2005-11#1)(2013-8#1)
structure parameters##6##2##(2005-11#1)(2008-10#2)(2008-6#1)(2013-7#1)(2013-8#1)
structure prediction and##4##3##(1992-7#1)(2008-4#2)(2008-7#1)
structure prediction for##2##3##(1995-8#1)(2008-4#1)
structure prediction is##2##3##(2008-4#2)
structure prediction of##3##3##(2008-10#1)(2008-9#1)(2010-7#1)
structure prediction problem##2##3##(1993-6#1)(2010-7#1)
structure prediction##26##2##(1990-4#1)(1990-9#1)(1992-7#1)(1993-6#1)(1994-10#2)(1995-7#1)(1995-8#1)(1996-11#2)(2008-10#1)(2008-4#7)(2008-7#2)(2008-8#1)(2008-9#1)(2010-7#3)(2013-1#1)
structure predictions##3##2##(1995-6#1)(1995-8#1)(2010-7#1)
structure present##2##2##(1994-12#1)(1994-9#1)
structure presented##2##2##(1994-8#1)(2008-3#1)
structure proposed##2##2##(2009-4#1)(2013-7#1)
structure provides##3##2##(1991-6#1)(2008-5#1)(2010-10#1)
structure remained##2##2##(1996-12#1)(2007-12#1)
structure remains##3##2##(2007-8#1)(2009-7#1)(2012-2#1)
structure represents the##2##3##(1994-6#1)(2012-12#1)
structure represents##3##2##(1994-6#1)(1997-5#1)(2012-12#1)
structure requirements for##2##3##(2008-10#1)(2008-8#1)
structure requirements##3##2##(1994-9#1)(2008-10#1)(2008-8#1)
structure responsible for##2##3##(1994-1#1)(2010-2#1)
structure reveals that##2##3##(1991-12#1)(2010-10#1)
structure reveals the##2##3##(1995-8#1)(1997-5#1)
structure reveals##6##2##(1991-12#1)(1995-8#1)(1996-2#1)(1997-5#1)(2010-10#1)(2013-8#1)
structure should be##2##3##(2008-3#1)(2008-8#1)
structure should##5##2##(1994-8#1)(1996-2#1)(2008-3#1)(2008-8#1)(2011-1#1)
structure showed that##2##3##(2008-8#1)(2013-1#1)
structure showed##4##2##(1995-1#1)(2008-8#1)(2008-9#1)(2013-1#1)
structure showing##2##2##(1997-3#1)(1997-4#1)
structure shown##2##2##(1996-2#2)
structure shows a##2##3##(1990-9#1)(2007-12#1)
structure shows that the##2##4##(1995-11#1)(2010-4#1)
structure shows that##4##3##(1995-11#1)(1995-5#2)(2010-4#1)
structure shows##7##2##(1990-9#2)(1995-11#1)(1995-5#2)(2007-12#1)(2010-4#1)
structure similar to that of human##2##6##(1993-11#1)(2008-6#1)
structure similar to that of the##3##6##(1992-6#1)(2008-2#1)(2008-5#1)
structure similar to that of##9##5##(1990-4#1)(1991-4#1)(1992-6#1)(1993-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2013-8#1)
structure similar to that##12##4##(1990-4#1)(1991-4#1)(1992-6#1)(1993-11#1)(1995-1#1)(1996-8#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2013-8#1)
structure similar to the##3##4##(1990-11#1)(1991-4#1)(2007-12#1)
structure similar to##22##3##(1990-11#1)(1990-4#1)(1990-7#1)(1991-4#2)(1992-6#1)(1993-11#1)(1995-1#1)(1996-8#1)(1997-8#1)(2005-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-5#2)(2008-6#1)(2013-1#1)(2013-8#1)
structure similarity##2##2##(2008-10#1)(2013-1#1)
structure solution##4##2##(1991-7#1)(1997-7#2)(2006-4#1)
structure strongly##3##2##(1990-10#1)(1992-2#1)(2008-8#1)
structure such as the##2##4##(1994-9#1)(1997-6#1)
structure such as##3##3##(1994-8#1)(1994-9#1)(1997-6#1)
structure suggests that the##2##4##(1991-5#1)(1997-7#1)
structure suggests that##5##3##(1991-5#1)(1995-2#1)(1997-6#1)(1997-7#1)(2008-8#1)
structure suggests##7##2##(1991-12#1)(1991-5#1)(1995-2#1)(1997-6#1)(1997-7#1)(2008-6#1)(2008-8#1)
structure tensor##4##2##(2008-2#3)(2008-6#1)
structure termed##2##2##(2008-7#1)(2008-8#1)
structure than the##2##3##(2008-2#1)(2008-4#1)
structure than those##2##3##(2005-11#1)(2012-2#1)
structure than##9##2##(1991-4#1)(1996-11#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-4#1)(2012-2#1)
structure that can be##2##4##(2006-4#1)(2010-7#1)
structure that can##3##3##(2006-4#1)(2007-6#1)(2010-7#1)
structure that enables##3##3##(2007-11#1)(2012-1#1)(2012-12#1)
structure that is##13##3##(1992-8#1)(1993-11#1)(1993-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-10#1)(2007-12#2)(2008-3#1)(2009-12#1)(2009-9#1)(2011-2#1)
structure that we##2##3##(2008-1#1)(2008-10#1)
structure that##59##2##(1991-9#2)(1992-8#1)(1993-11#1)(1993-12#1)(1994-1#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-10#1)(1996-2#1)(2005-10#1)(2005-5#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#7)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
structure the##9##2##(1990-5#1)(1992-4#1)(2007-12#2)(2008-3#1)(2008-8#1)(2009-10#1)(2010-2#1)(2011-1#1)
structure they##2##2##(2007-12#1)(2008-10#1)
structure through the##2##3##(2009-2#1)(2011-2#1)
structure through##5##2##(2006-9#1)(2008-8#2)(2009-2#1)(2011-2#1)
structure throughout##2##2##(2007-12#1)(2010-5#1)
structure to a##2##3##(2006-2#1)(2007-10#1)
structure to be##4##3##(1995-8#1)(1997-1#1)(2007-9#1)(2008-3#1)
structure to determine##2##3##(2009-2#1)(2013-7#1)
structure to facilitate##2##3##(1996-1#1)(2010-10#1)
structure to function##3##3##(1993-6#2)(1996-2#1)
structure to produce##2##3##(2008-5#1)(2008-9#1)
structure to that of##3##4##(1991-2#1)(1992-5#1)(1993-3#1)
structure to the##2##3##(1994-12#1)(2005-11#1)
structure to##49##2##(1990-5#2)(1991-2#1)(1991-7#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-6#2)(1994-12#2)(1994-2#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-2#1)(1996-7#1)(1997-1#1)(2005-11#3)(2005-8#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-7#1)(2012-3#1)(2012-5#1)(2013-7#1)
structure transition##2##2##(1993-9#1)(2008-8#1)
structure type##4##2##(1996-2#2)(2007-6#1)(2010-2#1)
structure typical of##3##3##(1997-4#2)(2008-10#1)
structure under##7##2##(1990-8#1)(1994-11#1)(2007-12#1)(2008-3#1)(2008-4#1)(2009-9#1)(2012-2#1)
structure underlying##2##2##(2006-6#1)(2008-11#1)
structure upon##6##2##(1992-11#1)(1994-2#1)(1996-5#1)(2007-11#2)(2013-7#1)
structure using a##3##3##(2004-4#1)(2008-9#1)(2013-7#1)
structure using##14##2##(1991-9#1)(1994-3#1)(2004-4#1)(2008-10#2)(2008-2#1)(2008-7#2)(2008-9#2)(2011-1#1)(2012-1#2)(2013-7#1)
structure via##2##2##(2005-11#1)(2010-1#1)
structure was a##2##3##(1992-3#1)(2012-3#1)
structure was able to##2##4##(2006-10#1)(2008-11#1)
structure was compared with##2##4##(2006-12#1)(2008-9#1)
structure was confirmed by##2##4##(2007-11#1)(2008-10#1)
structure was designed to##2##4##(1992-2#1)(2007-11#1)
structure was determined by single##2##5##(1995-11#1)(2008-5#1)
structure was determined by##11##4##(1990-5#1)(1991-2#1)(1992-3#1)(1992-8#1)(1995-11#1)(1995-6#1)(1996-5#1)(2007-1#1)(2008-5#1)(2008-8#1)(2009-10#1)
structure was determined to be##2##5##(1994-12#1)(2007-1#1)
structure was determined to##3##4##(1994-12#1)(2007-1#1)(2010-10#1)
structure was determined##19##3##(1990-2#1)(1990-5#1)(1991-2#1)(1992-3#1)(1992-8#1)(1994-12#1)(1995-11#1)(1995-6#1)(1996-5#1)(1997-7#1)(2007-1#3)(2008-5#3)(2008-8#1)(2009-10#1)(2010-10#1)
structure was done##2##3##(2010-7#1)(2012-2#1)
structure was elucidated by##3##4##(2006-12#1)(2007-1#1)(2007-11#1)
structure was elucidated##7##3##(1994-3#1)(2006-12#1)(2007-1#4)(2007-11#1)
structure was established##3##3##(1992-11#1)(2006-12#2)
structure was evaluated##2##3##(1994-3#1)(2010-7#1)
structure was examined##2##3##(2008-10#1)(2013-1#1)
structure was found to be##3##5##(1992-12#1)(1995-11#1)(2004-9#1)
structure was investigated##2##3##(2007-12#1)(2008-10#1)
structure was not##2##3##(2008-7#2)
structure was produced##2##3##(2008-10#2)
structure was proposed##2##3##(2005-5#1)(2010-4#1)
structure was solved by##6##4##(1991-12#1)(1992-12#1)(1994-8#1)(1996-2#1)(1997-7#1)(2008-8#1)
structure was##122##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-6#2)(1991-7#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-3#2)(1993-8#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-11#3)(1995-5#1)(1995-6#2)(1996-1#1)(1996-2#2)(1996-5#1)(1996-7#1)(1997-1#1)(1997-7#2)(2004-9#1)(2005-11#2)(2005-4#1)(2005-5#1)(2005-7#1)(2006-10#1)(2006-12#5)(2006-5#1)(2007-1#7)(2007-11#6)(2007-12#2)(2007-4#1)(2008-10#12)(2008-11#1)(2008-3#2)(2008-5#5)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-4#2)(2010-6#1)(2010-7#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
structure we##4##2##(1995-11#1)(2007-3#1)(2012-12#2)
structure were discussed##2##3##(2005-4#1)(2008-10#1)
structure were investigated##2##3##(2008-10#1)(2008-12#1)
structure were observed##2##3##(2005-11#1)(2012-3#1)
structure were used to##2##4##(2008-7#1)(2012-3#1)
structure were##23##2##(1991-10#2)(1992-6#1)(1996-11#1)(1997-8#1)(2005-11#1)(2005-4#1)(2006-1#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2009-7#1)(2010-2#1)(2012-3#2)(2013-8#1)
structure when##15##2##(1990-12#1)(1994-11#1)(1994-3#1)(1995-2#1)(2005-9#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-8#1)(2013-1#1)
structure where##2##2##(1997-3#1)(2012-2#1)
structure which has##2##3##(2009-7#1)(2012-2#1)
structure which is##5##3##(1995-4#1)(2008-2#1)(2008-5#1)(2009-10#1)(2012-2#1)
structure which##18##2##(1990-4#1)(1992-6#1)(1993-11#1)(1995-4#1)(1995-5#1)(1996-9#1)(1997-2#1)(2005-11#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#1)(2009-10#1)(2009-12#1)(2009-7#1)(2012-2#2)
structure while the##2##3##(1990-9#1)(1995-3#1)
structure while##3##2##(1990-9#1)(1995-3#1)(2012-5#1)
structure whose##3##2##(2005-11#1)(2006-10#1)(2008-7#1)
structure will##2##2##(1996-1#1)(1996-11#1)
structure with a diameter of##2##5##(2008-5#1)(2013-1#1)
structure with a##17##3##(1990-7#1)(1991-7#1)(1992-9#1)(1994-11#1)(1995-5#1)(1995-6#1)(1997-4#1)(2005-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-11#1)(2009-2#1)(2010-4#1)(2013-1#1)
structure with an##3##3##(1993-3#1)(2007-11#1)(2008-2#1)
structure with respect to the##2##5##(1995-10#1)(2008-3#1)
structure with the##9##3##(1995-8#1)(1996-2#1)(1997-7#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-8#1)
structure with three##2##3##(1996-2#1)(2007-12#1)
structure with##74##2##(1990-10#1)(1990-3#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-2#3)(1996-7#2)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#2)(2005-11#3)(2005-4#1)(2006-1#1)(2006-10#1)(2007-11#2)(2007-12#3)(2007-7#2)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#4)(2008-5#5)(2008-7#2)(2008-8#2)(2009-11#1)(2009-2#2)(2009-3#1)(2009-7#1)(2010-11#1)(2010-4#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-7#1)
structure within the##6##3##(1991-5#1)(1995-3#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-3#1)
structure within##9##2##(1991-5#1)(1995-3#1)(1995-8#1)(1997-2#1)(2005-11#1)(2006-12#2)(2008-10#1)(2008-3#1)
structure without##3##2##(2008-2#1)(2008-6#1)(2009-3#1)
structure yielded##2##2##(1995-3#1)(2008-4#1)
structure yields a##2##3##(1995-1#1)(1995-6#1)
structure##5697##1##(1990-1#1)(1990-10#14)(1990-11#19)(1990-12#20)(1990-2#26)(1990-3#17)(1990-4#18)(1990-5#41)(1990-6#3)(1990-7#38)(1990-8#15)(1990-9#15)(1991-1#11)(1991-10#7)(1991-11#22)(1991-12#24)(1991-2#39)(1991-3#13)(1991-4#38)(1991-5#46)(1991-6#25)(1991-7#25)(1991-8#9)(1991-9#19)(1992-1#22)(1992-10#1)(1992-11#23)(1992-12#48)(1992-2#17)(1992-3#39)(1992-4#18)(1992-5#24)(1992-6#32)(1992-7#10)(1992-8#24)(1992-9#32)(1993-1#3)(1993-11#30)(1993-12#14)(1993-2#19)(1993-3#36)(1993-4#16)(1993-5#5)(1993-6#40)(1993-7#2)(1993-8#30)(1993-9#13)(1994-1#6)(1994-10#9)(1994-11#38)(1994-12#49)(1994-2#22)(1994-3#39)(1994-4#1)(1994-5#40)(1994-6#16)(1994-7#11)(1994-8#55)(1994-9#50)(1995-1#52)(1995-10#20)(1995-11#39)(1995-12#12)(1995-2#39)(1995-3#46)(1995-4#27)(1995-5#47)(1995-6#46)(1995-7#11)(1995-8#45)(1995-9#3)(1996-1#12)(1996-10#8)(1996-11#30)(1996-12#19)(1996-2#58)(1996-3#6)(1996-4#7)(1996-5#22)(1996-6#20)(1996-7#55)(1996-8#23)(1996-9#7)(1997-1#25)(1997-2#44)(1997-3#19)(1997-4#50)(1997-5#21)(1997-6#32)(1997-7#56)(1997-8#24)(1997-9#4)(2003-11#1)(2004-11#3)(2004-12#3)(2004-2#1)(2004-4#4)(2004-9#8)(2005-1#4)(2005-10#18)(2005-11#115)(2005-12#2)(2005-3#3)(2005-4#20)(2005-5#4)(2005-7#6)(2005-8#12)(2005-9#2)(2006-1#3)(2006-10#67)(2006-11#3)(2006-12#64)(2006-2#24)(2006-3#12)(2006-4#16)(2006-5#21)(2006-6#4)(2006-7#10)(2006-8#11)(2006-9#3)(2007-1#27)(2007-10#22)(2007-11#144)(2007-12#207)(2007-2#2)(2007-3#13)(2007-4#9)(2007-5#14)(2007-6#11)(2007-7#13)(2007-8#22)(2007-9#21)(2008-1#27)(2008-10#325)(2008-11#86)(2008-12#25)(2008-2#134)(2008-3#151)(2008-4#179)(2008-5#136)(2008-6#37)(2008-7#124)(2008-8#131)(2008-9#76)(2009-1#1)(2009-10#21)(2009-11#14)(2009-12#16)(2009-2#30)(2009-3#23)(2009-4#11)(2009-5#18)(2009-6#6)(2009-7#32)(2009-8#13)(2009-9#11)(2010-1#4)(2010-10#22)(2010-11#12)(2010-12#28)(2010-2#33)(2010-3#7)(2010-4#41)(2010-5#33)(2010-6#5)(2010-7#34)(2010-8#31)(2010-9#6)(2011-1#63)(2011-12#9)(2011-2#87)(2011-3#4)(2012-1#54)(2012-11#17)(2012-12#27)(2012-2#79)(2012-3#61)(2012-5#2)(2012-7#1)(2012-8#2)(2013-1#88)(2013-7#24)(2013-8#79)
structure&quot##3##1##(1995-8#1)(1996-9#1)(2008-9#1)
structure's##3##1##(2008-2#1)(2009-7#1)(2011-2#1)
structure(s)##2##1##(1995-1#1)(1995-5#1)
structure) of##3##2##(1990-5#1)(2007-12#1)(2007-5#1)
structure)##15##1##(1990-5#2)(1996-7#1)(2005-1#1)(2006-10#1)(2006-5#2)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#2)(2008-5#1)(2011-1#1)(2011-2#1)
structure--activity##4##1##(1995-3#3)(2013-1#1)
structure--the##2##1##(1992-12#1)(2008-5#1)
structure-activity analysis##4##2##(1991-2#1)(1992-6#1)(1992-8#1)(1996-12#1)
structure-activity relationship (SAR) studies##2##4##(2008-5#1)(2008-8#1)
structure-activity relationship (SAR)##3##3##(1997-2#1)(2008-5#1)(2008-8#1)
structure-activity relationship for the##2##4##(1996-8#1)(1997-3#1)
structure-activity relationship in##2##3##(2008-5#1)(2012-2#1)
structure-activity relationship of##5##3##(1994-3#1)(1997-2#1)(2008-11#1)(2009-3#1)(2011-3#1)
structure-activity relationship studies##4##3##(1994-11#1)(1994-5#1)(1994-9#1)(1995-3#1)
structure-activity relationship##29##2##(1994-11#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-8#3)(1997-2#5)(1997-3#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-5#3)(2008-8#1)(2009-3#2)(2010-12#1)(2011-3#1)(2012-2#1)
structure-activity relationships (QSAR)##2##3##(1993-4#1)(2006-12#1)
structure-activity relationships (SAR)##3##3##(2008-7#1)(2013-1#2)
structure-activity relationships and##2##3##(1996-10#1)(2008-10#1)
structure-activity relationships as##2##3##(1997-2#1)(2005-7#1)
structure-activity relationships for##3##3##(1991-3#1)(1994-9#1)(1995-6#1)
structure-activity relationships in##2##3##(1992-5#1)(2009-10#1)
structure-activity relationships of##20##3##(1992-5#2)(1992-6#1)(1993-4#3)(1994-9#2)(1995-3#1)(1996-8#3)(1997-1#3)(1997-8#1)(2005-7#1)(2005-8#1)(2008-10#1)(2012-3#1)
structure-activity relationships##52##2##(1990-7#1)(1991-3#1)(1992-1#1)(1992-5#3)(1992-6#1)(1993-12#2)(1993-4#4)(1994-9#4)(1995-1#1)(1995-3#2)(1995-6#1)(1996-10#1)(1996-8#4)(1997-1#4)(1997-2#1)(1997-8#1)(2005-7#2)(2005-8#1)(2006-12#2)(2007-11#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-11#1)(2011-2#2)(2012-11#1)(2012-3#1)(2013-1#2)
structure-activity##94##1##(1990-7#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-4#2)(1992-5#3)(1992-6#2)(1992-8#1)(1993-12#2)(1993-4#4)(1994-11#2)(1994-3#2)(1994-5#1)(1994-9#6)(1995-1#1)(1995-12#1)(1995-3#3)(1995-6#1)(1996-10#1)(1996-12#1)(1996-8#7)(1996-9#1)(1997-1#4)(1997-2#6)(1997-3#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-12#3)(2007-1#1)(2007-11#2)(2008-10#4)(2008-11#2)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#2)(2010-11#1)(2010-12#1)(2011-2#2)(2011-3#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
structure-activity-relationship (SAR) studies##2##3##(2006-12#1)(2010-2#1)
structure-activity-relationship (SAR)##3##2##(2006-12#2)(2010-2#1)
structure-activity-relationship##4##1##(2006-12#2)(2009-3#1)(2010-2#1)
structure-affinity##2##1##(1995-3#1)(1997-1#1)
structure-antioxidant activity##2##2##(2007-11#2)
structure-based drug design##4##3##(1996-7#1)(2010-6#1)(2012-2#1)(2012-3#1)
structure-based drug##5##2##(1996-7#1)(2010-3#1)(2010-6#1)(2012-2#1)(2012-3#1)
structure-based##19##1##(1992-8#1)(1994-3#1)(1995-11#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-3#1)(2010-6#1)(2011-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
structure-chromatographic retention relationship study##2##4##(1996-5#2)
structure-from-motion##2##1##(2009-3#2)
structure-function analyses##3##2##(1991-2#1)(2011-1#1)(2011-2#1)
structure-function analysis of##4##3##(1994-9#1)(1997-4#1)(2007-3#2)
structure-function analysis##8##2##(1991-2#1)(1994-3#1)(1994-9#1)(1996-4#1)(1997-4#2)(2007-3#2)
structure-function and##3##2##(1992-12#1)(1992-6#1)(1995-10#1)
structure-function properties##2##2##(1996-8#1)(2008-5#1)
structure-function relationship of##8##3##(1993-10#1)(1993-3#1)(1994-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
structure-function relationship##10##2##(1993-10#1)(1993-3#1)(1994-11#1)(1994-3#1)(1997-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
structure-function relationships and##2##3##(1991-5#1)(1996-11#1)
structure-function relationships in##4##3##(1990-7#1)(1994-8#1)(2007-6#1)(2008-11#1)
structure-function relationships of##4##3##(1990-6#1)(1992-8#1)(1994-3#1)(2006-10#1)
structure-function relationships##14##2##(1990-5#1)(1990-6#1)(1990-7#1)(1991-5#1)(1992-8#1)(1994-3#1)(1994-8#1)(1995-1#1)(1996-10#1)(1996-11#1)(2006-10#1)(2007-6#1)(2008-11#2)
structure-function studies of##3##3##(1991-12#1)(1994-3#1)(2008-11#1)
structure-function studies##6##2##(1991-12#1)(1994-11#1)(1994-3#1)(1995-7#1)(2008-11#1)(2008-8#1)
structure-function##52##1##(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-5#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-3#1)(1994-11#2)(1994-3#4)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-7#1)(1996-10#1)(1996-11#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-4#3)(2006-10#1)(2006-6#1)(2007-3#2)(2007-6#1)(2007-8#1)(2008-11#4)(2008-5#2)(2008-8#2)(2008-9#1)(2011-1#2)(2011-2#2)
structure-functional##2##1##(1995-8#1)(2008-3#1)
structure-odor relationship##2##2##(2006-12#1)(2012-2#1)
structure-odor relationships##3##2##(2006-12#3)
structure-odor##5##1##(2006-12#4)(2012-2#1)
structure-property correlations##2##2##(2009-8#2)
structure-property relationship study##2##3##(2008-10#2)
structure-property relationship##4##2##(2008-10#3)(2009-7#1)
structure-property relationships of##3##3##(2010-4#2)(2011-2#1)
structure-property relationships##5##2##(2007-11#2)(2010-4#2)(2011-2#1)
structure-property##16##1##(1994-7#1)(2007-11#2)(2008-10#4)(2009-7#1)(2009-8#2)(2010-4#2)(2011-2#2)(2013-1#2)
structure-retention relationship (QSRR)##3##3##(2008-10#3)
structure-retention##5##1##(2005-12#1)(2007-8#1)(2008-10#3)
structure/activity relationships##3##2##(1995-10#1)(2006-12#1)(2012-1#1)
structure/function may##2##2##(1996-7#1)(2011-2#1)
structure/function relationship##3##2##(1991-10#1)(1996-5#1)(2006-2#1)
structure/function studies##3##2##(1990-12#1)(1995-8#2)
structure/function##13##1##(1990-12#1)(1990-5#1)(1991-10#1)(1992-4#1)(1995-8#2)(1996-5#1)(1996-7#1)(1997-2#1)(2006-2#1)(2009-3#1)(2011-2#1)(2012-3#1)
structure]##2##1##(1991-9#1)(2012-3#1)
structured RNA##5##2##(2008-4#3)(2013-8#2)
structured and unstructured##3##3##(2010-8#1)(2013-1#2)
structured and##13##2##(1993-12#1)(1993-3#1)(1995-1#1)(1995-2#1)(2005-11#1)(2007-3#1)(2008-8#2)(2010-8#1)(2011-1#2)(2013-1#2)
structured approach to##3##3##(2004-7#1)(2006-10#1)(2011-2#1)
structured approach##5##2##(1996-3#1)(2004-7#1)(2006-10#1)(2008-3#1)(2011-2#1)
structured arrays##2##2##(2008-9#1)(2009-10#1)
structured as a##3##3##(2007-7#1)(2008-8#1)(2012-2#1)
structured as##4##2##(2007-7#1)(2008-3#1)(2008-8#1)(2012-2#1)
structured assessments##3##2##(2007-5#1)(2008-11#2)
structured by a##2##3##(2008-5#1)(2009-2#1)
structured by the##2##3##(2008-9#1)(2009-4#1)
structured by##8##2##(2007-12#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2011-2#1)
structured clinical##9##2##(1994-2#2)(1996-1#1)(2006-10#1)(2008-11#3)(2011-1#1)(2013-8#1)
structured data##4##2##(1992-4#1)(2008-8#1)(2013-1#2)
structured educational##2##2##(2007-7#1)(2008-11#1)
structured electronic##2##2##(2012-12#1)(2013-1#1)
structured entry##4##2##(2013-1#4)
structured format##4##2##(1993-12#1)(2007-4#1)(2013-1#2)
structured illumination##3##2##(2007-12#1)(2008-3#2)
structured in##5##2##(1991-1#1)(1994-8#1)(2008-1#1)(2008-7#1)(2009-4#1)
structured information##3##2##(2008-4#1)(2013-1#2)
structured intermediate##3##2##(1995-5#1)(1995-8#1)(1996-11#1)
structured interview on##3##3##(2007-7#1)(2008-1#1)(2011-2#1)
structured interview##10##2##(1993-6#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
structured interviews##11##2##(1996-1#1)(2007-10#1)(2008-8#1)(2008-9#1)(2010-3#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
structured into##5##2##(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-1#1)
structured light##4##2##(2008-1#1)(2008-2#1)(2008-3#1)(2011-1#1)
structured metapopulation models##2##3##(2008-8#2)
structured model##3##2##(2008-5#1)(2008-7#2)
structured monomers##2##2##(1994-8#1)(1995-4#1)
structured on##3##2##(2008-2#1)(2008-9#1)(2013-1#1)
structured orders##4##2##(2013-1#4)
structured patient##3##2##(2010-3#1)(2012-12#1)(2013-1#1)
structured peer assessment##4##3##(2013-7#4)
structured populations##6##2##(2008-11#1)(2008-8#4)(2009-8#1)
structured psychiatric##2##2##(2009-10#1)(2009-4#1)
structured questionnaire by##2##3##(2011-1#1)(2012-2#1)
structured questionnaire was##8##3##(2006-12#1)(2006-4#1)(2007-2#1)(2008-4#1)(2010-8#1)(2013-1#1)(2013-8#2)
structured questionnaire##30##2##(1995-10#1)(2006-12#1)(2006-4#1)(2007-10#3)(2007-2#2)(2008-11#2)(2008-4#1)(2008-8#2)(2010-1#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
structured questionnaires were##2##3##(2010-3#1)(2011-1#1)
structured questionnaires##6##2##(2007-10#1)(2008-8#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-12#1)
structured student tutorial support##3##4##(2008-11#3)
structured support##3##2##(2007-7#2)(2008-11#1)
structured the##2##2##(2006-4#1)(2008-11#1)
structured to##11##2##(1992-2#1)(1994-3#2)(2005-5#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-11#1)(2012-1#1)
structured training and##2##3##(1995-1#1)(2012-2#1)
structured training##3##2##(1995-1#1)(2010-3#1)(2012-2#1)
structured trees##2##2##(2008-7#2)
structured tutorial support##2##3##(2008-11#2)
structured vocabularies##3##2##(2008-9#3)
structured##425##1##(1990-5#1)(1991-1#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#3)(1994-2#3)(1994-3#2)(1994-8#3)(1995-1#5)(1995-10#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-8#2)(1996-1#2)(1996-11#4)(1996-2#1)(1996-3#3)(1997-1#1)(1997-2#2)(1997-4#4)(1997-5#1)(1997-6#1)(2004-7#1)(2005-11#2)(2005-5#1)(2006-10#6)(2006-12#2)(2006-4#3)(2006-5#1)(2006-9#1)(2007-10#6)(2007-11#2)(2007-12#8)(2007-2#2)(2007-3#3)(2007-4#2)(2007-5#2)(2007-6#3)(2007-7#7)(2007-8#62)(2007-9#3)(2008-1#5)(2008-10#7)(2008-11#21)(2008-12#1)(2008-2#9)(2008-3#8)(2008-4#7)(2008-5#5)(2008-7#11)(2008-8#21)(2008-9#12)(2009-10#2)(2009-11#3)(2009-12#1)(2009-2#1)(2009-4#4)(2009-5#3)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#7)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#8)(2011-2#13)(2012-1#2)(2012-11#1)(2012-12#12)(2012-2#9)(2012-3#6)(2013-1#37)(2013-7#8)(2013-8#12)
structures (e##2##2##(2006-12#1)(2009-5#1)
structures Galp beta##2##3##(1995-3#2)
structures against##2##2##(2008-4#1)(2012-1#1)
structures along##2##2##(1990-8#1)(2008-7#1)
structures among##3##2##(2007-12#1)(2008-11#1)(2010-1#1)
structures analyzed##2##2##(1995-10#1)(1995-11#1)
structures and activities##2##3##(2005-5#1)(2011-3#1)
structures and biological##3##3##(2007-7#1)(2008-5#1)(2008-9#1)
structures and could##2##3##(1991-7#1)(2008-7#1)
structures and energetics of##2##4##(1993-6#1)(2006-4#1)
structures and experiments##2##3##(2010-7#2)
structures and functions of##4##4##(1991-2#1)(2005-5#1)(2008-9#1)(2013-1#1)
structures and functions##5##3##(1991-2#1)(1992-11#1)(2005-5#1)(2008-9#1)(2013-1#1)
structures and interactions##3##3##(1991-2#1)(1995-11#1)(2013-1#1)
structures and processes##4##3##(2007-1#1)(2008-12#2)(2008-6#1)
structures and properties of C60-gold nanocontacts##2##6##(2009-2#2)
structures and properties of##4##4##(1996-11#1)(2009-2#2)(2010-12#1)
structures and properties##5##3##(1996-11#1)(2008-10#1)(2009-2#2)(2010-12#1)
structures and that##2##3##(1995-11#1)(2009-8#1)
structures and the##18##3##(1992-4#1)(1992-9#1)(1995-1#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-5#1)(2011-2#1)(2012-12#1)
structures and their##5##3##(1993-9#1)(1995-3#1)(2008-10#1)(2008-2#1)(2012-12#1)
structures and to##2##3##(2005-5#1)(2008-4#1)
structures and##194##2##(1990-10#1)(1990-6#1)(1990-8#1)(1991-2#2)(1991-4#1)(1991-7#1)(1991-8#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#5)(1993-5#1)(1993-6#1)(1993-9#2)(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#4)(1995-10#2)(1995-11#2)(1995-2#2)(1995-3#3)(1996-11#2)(1996-2#2)(1996-3#3)(1996-7#1)(1996-8#1)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#3)(2005-4#1)(2005-5#3)(2005-7#1)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#1)(2007-1#2)(2007-10#2)(2007-11#3)(2007-12#7)(2007-4#3)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#3)(2008-12#7)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#9)(2008-8#1)(2008-9#4)(2009-11#1)(2009-2#4)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-12#2)(2010-4#2)(2010-5#6)(2010-7#4)(2010-8#1)(2011-1#1)(2011-2#7)(2011-3#1)(2011-7#1)(2012-12#3)(2012-2#4)(2013-1#4)(2013-8#3)
structures appear to be##2##4##(1991-7#1)(2007-12#1)
structures appeared##2##2##(2008-10#1)(2012-2#1)
structures are a##2##3##(1990-11#1)(2008-11#1)
structures are fabricated##2##3##(2007-12#1)(2008-3#1)
structures are highly##2##3##(1990-12#1)(1997-7#1)
structures are involved in##2##4##(2008-11#1)(2013-8#1)
structures are known##3##3##(1995-8#1)(1997-5#1)(2008-7#1)
structures are likely##2##3##(2006-4#1)(2008-1#1)
structures are necessary##2##3##(1992-8#1)(2010-9#1)
structures are not##3##3##(1994-12#1)(1997-1#1)(2008-1#1)
structures are presented in##2##4##(2007-1#1)(2007-10#1)
structures are presented##6##3##(2007-1#1)(2007-10#1)(2008-3#3)(2009-9#1)
structures are produced by##2##4##(1990-11#1)(2008-3#1)
structures are produced##3##3##(1990-11#1)(2008-3#1)(2008-8#1)
structures are proposed##3##3##(2008-1#1)(2008-3#2)
structures are responsible for##2##4##(1996-1#1)(1997-5#1)
structures are shown##2##3##(2008-3#1)(2009-2#1)
structures are similar to those##2##5##(1993-11#1)(1995-11#1)
structures are used##2##3##(1997-6#1)(2008-12#1)
structures are##90##2##(1990-11#2)(1990-12#1)(1990-5#1)(1992-8#1)(1993-11#2)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#4)(1997-6#1)(1997-7#2)(1997-8#1)(2005-5#1)(2006-11#1)(2006-12#1)(2006-4#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#7)(2007-3#1)(2007-9#3)(2008-1#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#10)(2008-5#2)(2008-7#5)(2008-8#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
structures as well as##3##4##(1995-2#1)(2006-4#1)(2008-2#1)
structures as##10##2##(1992-2#1)(1993-7#1)(1995-1#1)(1995-2#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-2#1)(2011-2#1)
structures associated with##2##3##(1995-3#1)(2008-10#1)
structures at higher##2##3##(2005-11#2)
structures at the##5##3##(2005-11#1)(2008-11#1)(2011-2#2)(2013-1#1)
structures at##20##2##(1992-9#1)(1996-1#1)(1996-2#2)(2005-11#7)(2006-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-8#1)(2010-4#1)(2011-2#2)(2013-1#1)
structures based on##6##3##(2007-9#1)(2008-10#1)(2008-3#1)(2009-11#1)(2009-3#1)(2010-4#1)
structures based##7##2##(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-3#1)(2010-4#1)
structures before##2##2##(1996-4#1)(2011-1#1)
structures between##2##2##(1994-9#1)(2009-4#1)
structures but##3##2##(1991-3#1)(1992-12#1)(2006-3#1)
structures by X-ray crystallography and##2##5##(1993-11#1)(2011-2#1)
structures by##26##2##(1992-5#1)(1992-8#1)(1993-11#1)(1994-2#1)(1994-8#2)(1997-1#1)(1997-7#1)(2007-11#2)(2008-10#1)(2008-2#2)(2008-3#5)(2008-4#4)(2011-2#2)(2012-11#1)(2013-1#1)
structures called##3##2##(1990-5#1)(2008-11#1)(2009-8#1)
structures can be identified##2##4##(2005-11#1)(2009-12#1)
structures can be used as##2##5##(1995-1#1)(2010-1#1)
structures can be used to##2##5##(2007-12#1)(2008-3#1)
structures can be used##4##4##(1995-1#1)(2007-12#1)(2008-3#1)(2010-1#1)
structures can be##17##3##(1990-11#1)(1991-11#1)(1992-9#1)(1995-1#1)(1995-7#1)(2005-11#1)(2006-10#1)(2007-12#3)(2008-1#2)(2008-3#1)(2008-4#1)(2009-12#1)(2010-1#1)(2010-7#1)
structures can##23##2##(1990-11#1)(1991-11#1)(1992-9#2)(1995-1#1)(1995-7#1)(1997-3#1)(2005-11#1)(2006-10#1)(2007-12#4)(2008-1#2)(2008-3#1)(2008-4#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-7#1)(2012-2#1)
structures characteristic of##2##3##(1992-9#1)(2013-1#1)
structures close to##2##3##(2008-3#2)
structures composed of##6##3##(1990-5#1)(1994-3#1)(2006-10#1)(2008-3#1)(2008-8#1)(2009-7#1)
structures comprising##2##2##(2007-11#2)
structures consist of##2##3##(2007-12#1)(2008-2#1)
structures consisting of##2##3##(1994-6#1)(1995-7#1)
structures containing##8##2##(1997-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-2#1)(2010-7#1)(2011-1#1)
structures could be##4##3##(1994-3#1)(1996-3#1)(2006-11#1)(2007-3#1)
structures could##8##2##(1994-11#1)(1994-3#1)(1995-6#1)(1996-3#1)(2006-11#1)(2007-3#1)(2008-7#1)(2009-3#1)
structures deposited in##2##3##(2011-2#2)
structures deposited##4##2##(2008-2#2)(2011-2#2)
structures derived from##4##3##(1991-1#1)(1996-5#1)(2009-10#1)(2012-12#1)
structures derived##5##2##(1991-1#1)(1996-5#1)(2009-10#1)(2012-12#1)(2012-2#1)
structures determined by X-ray crystallography##2##5##(2007-6#1)(2008-4#1)
structures determined##3##2##(2006-12#1)(2007-6#1)(2008-4#1)
structures did not##2##3##(1997-5#1)(2008-5#1)
structures during##4##2##(2007-12#1)(2007-8#1)(2008-5#1)(2013-1#1)
structures embedded in##2##3##(2008-2#1)(2008-3#1)
structures evoked##2##2##(1992-7#2)
structures examined##3##2##(1991-10#2)(1995-3#1)
structures exhibit##3##2##(1994-8#1)(2006-10#1)(2007-4#1)
structures fabricated##2##2##(2004-9#1)(2009-6#1)
structures for the##6##3##(1993-6#1)(1994-9#1)(1996-2#2)(2008-11#1)(2008-7#1)
structures for use##2##3##(2008-2#2)
structures for##36##2##(1991-7#1)(1992-11#1)(1993-6#1)(1994-9#1)(1995-6#1)(1996-2#3)(1996-7#1)(1997-2#1)(1997-4#1)(2004-9#1)(2006-1#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-2#1)
structures form##3##2##(1995-3#1)(1997-3#1)(2011-2#1)
structures found##2##2##(1996-2#1)(2012-2#1)
structures from the##6##3##(1995-1#2)(1997-4#1)(2006-6#1)(2007-12#1)(2009-12#1)
structures from##26##2##(1990-2#1)(1993-11#1)(1995-1#3)(1997-4#1)(1997-7#1)(2006-6#1)(2007-12#3)(2007-4#1)(2007-9#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)
structures has been##3##3##(2006-11#1)(2009-7#1)(2011-2#1)
structures has##6##2##(1993-3#1)(1995-1#1)(2006-11#1)(2008-7#1)(2009-7#1)(2011-2#1)
structures have an##2##3##(1995-5#1)(2007-11#1)
structures have been elucidated by##2##5##(2007-1#1)(2008-10#1)
structures have been elucidated##6##4##(1995-9#1)(2007-1#3)(2008-10#1)(2012-2#1)
structures have been proposed##3##4##(2007-11#1)(2009-7#1)(2013-1#1)
structures have been##18##3##(1995-9#1)(1996-2#1)(2006-12#1)(2007-1#3)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2009-11#1)(2009-7#1)(2010-10#1)(2010-4#2)(2012-2#1)(2013-1#1)
structures have##29##2##(1994-3#1)(1995-5#1)(1995-9#1)(1996-2#1)(2006-12#1)(2006-9#1)(2007-1#3)(2007-11#3)(2007-12#2)(2008-1#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-7#1)(2010-10#1)(2010-4#2)(2012-2#3)(2013-1#1)
structures having##3##2##(1997-1#1)(2007-11#1)(2007-12#1)
structures in a##10##3##(1990-5#1)(1994-6#1)(2007-11#3)(2007-3#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
structures in different##2##3##(1997-4#1)(2008-9#1)
structures in order to##2##4##(1994-2#1)(2012-12#1)
structures in the posterior##2##4##(1991-11#1)(1996-12#1)
structures in the presence of##2##5##(1992-9#1)(2008-6#1)
structures in the##58##3##(1990-10#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-2#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-9#1)(1993-11#1)(1993-5#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-9#2)(1995-12#1)(1995-3#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-5#1)(2006-12#1)(2007-11#3)(2007-12#5)(2007-8#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-3#1)(2009-5#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
structures in their##2##3##(1991-2#1)(2006-8#1)
structures in two dimensions##2##4##(2007-12#1)(2010-7#1)
structures in two##3##3##(2007-12#1)(2010-10#1)(2010-7#1)
structures in vitro##2##3##(1990-12#1)(2012-2#1)
structures in vivo##2##3##(2009-10#1)(2010-12#1)
structures in which##6##3##(1995-5#1)(2006-1#1)(2006-2#1)(2008-1#1)(2009-9#1)(2012-2#1)
structures in##169##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-2#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-7#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-9#2)(1995-1#3)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-4#3)(1997-5#1)(2006-1#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-8#2)(2007-10#1)(2007-11#6)(2007-12#14)(2007-3#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#5)(2008-2#5)(2008-3#6)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#3)(2010-4#2)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#3)
structures including pseudoknots##3##3##(2006-10#2)(2009-11#1)
structures including the##2##3##(2007-8#1)(2013-8#1)
structures including##6##2##(2004-11#1)(2006-10#2)(2007-8#1)(2009-11#1)(2013-8#1)
structures increased##2##2##(2008-10#2)
structures indicated that the##2##4##(1992-6#1)(1996-7#1)
structures into##5##2##(1990-8#1)(2007-12#2)(2008-12#1)(2013-8#1)
structures investigated##2##2##(1996-12#1)(2006-4#1)
structures involved in the##2##4##(1993-2#1)(2008-5#1)
structures involved in##5##3##(1993-2#1)(2006-8#1)(2008-11#1)(2008-5#1)(2010-2#1)
structures involved##6##2##(1993-2#1)(2006-8#1)(2008-11#1)(2008-5#1)(2010-2#1)(2011-2#1)
structures involving##2##2##(2006-7#1)(2008-4#1)
structures is a##4##3##(1990-8#1)(1991-2#1)(1996-11#1)(2008-10#1)
structures is an##2##3##(1997-1#1)(2007-8#1)
structures is not##2##3##(2006-12#1)(2013-7#1)
structures is##26##2##(1990-8#1)(1991-2#1)(1991-3#1)(1994-6#1)(1995-3#1)(1996-11#1)(1997-1#1)(1997-6#1)(2005-7#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-6#1)(2012-2#2)(2013-7#1)
structures known##2##2##(1995-6#1)(2007-9#1)
structures like##5##2##(1990-12#1)(1997-6#1)(2007-8#1)(2009-8#1)(2012-2#1)
structures linked##2##2##(1991-2#1)(1992-12#1)
structures located in the##2##4##(1992-8#1)(2008-3#1)
structures located in##3##3##(1992-8#1)(2008-3#2)
structures located##4##2##(1992-8#1)(1993-9#1)(2008-3#2)
structures made from##2##3##(2007-11#1)(2009-5#1)
structures makes##2##2##(2008-3#1)(2008-6#1)
structures may be##5##3##(1990-7#1)(1992-1#1)(1992-10#1)(2007-4#1)(2008-3#1)
structures may contribute to##2##4##(2008-1#1)(2008-10#1)
structures may represent a##2##4##(1992-12#1)(2011-1#1)
structures may##14##2##(1990-12#1)(1990-7#1)(1991-1#1)(1992-1#1)(1992-10#1)(1992-12#1)(1995-2#1)(1996-2#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-3#1)(2011-1#1)(2013-1#1)
structures might##2##2##(1991-5#1)(2008-5#1)
structures more##2##2##(1992-9#1)(2008-3#1)
structures must be developed##2##4##(2007-9#1)(2008-11#1)
structures must##3##2##(2007-9#1)(2008-11#2)
structures near the##2##3##(2007-5#1)(2008-7#1)
structures near##3##2##(2007-5#2)(2008-7#1)
structures observed in the##2##4##(1992-4#1)(2008-8#1)
structures observed in##3##3##(1992-4#1)(1995-3#1)(2008-8#1)
structures observed##7##2##(1991-9#1)(1992-4#1)(1992-8#2)(1995-3#1)(2007-12#1)(2008-8#1)
structures obtained by##2##3##(2007-11#1)(2009-9#1)
structures obtained##4##2##(2007-11#1)(2008-3#1)(2009-7#1)(2009-9#1)
structures of 1 and 2##2##5##(2007-1#1)(2010-5#1)
structures of 1 and##3##4##(2007-1#1)(2008-8#1)(2010-5#1)
structures of 1##4##3##(2007-1#2)(2008-8#1)(2010-5#1)
structures of 15##2##3##(1991-1#1)(2007-8#1)
structures of Escherichia coli dihydrofolate reductase##2##6##(1995-2#2)
structures of HIV-1##2##3##(1992-8#1)(2011-1#1)
structures of a##7##3##(1990-12#1)(1990-5#1)(1997-3#1)(2008-1#1)(2010-11#1)(2010-2#2)
structures of all the new##2##5##(2007-11#1)(2012-11#1)
structures of all the##6##4##(1995-4#1)(1996-2#1)(2007-11#3)(2012-11#1)
structures of all##11##3##(1991-6#1)(1995-4#1)(1996-2#1)(2007-11#4)(2007-3#1)(2010-6#1)(2012-11#1)(2012-2#1)
structures of both the##2##4##(1992-3#1)(1992-9#1)
structures of both##11##3##(1990-12#1)(1990-8#1)(1991-11#1)(1991-2#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-7#1)(1996-11#1)(1996-7#1)(2008-10#1)
structures of catalytic##2##3##(1990-10#1)(2011-1#1)
structures of enzyme##2##3##(1995-8#1)(2012-2#1)
structures of high##2##3##(1995-7#1)(2008-2#1)
structures of human##6##3##(1991-2#1)(1992-2#1)(1992-9#1)(1995-3#2)(1996-7#1)
structures of interest##4##3##(2007-4#2)(2008-4#1)(2009-4#1)
structures of mammalian##2##3##(1991-2#1)(1994-5#1)
structures of proteins##5##3##(2008-4#2)(2008-7#1)(2009-3#1)(2010-7#1)
structures of related##2##3##(1994-8#1)(2013-8#1)
structures of several##3##3##(2005-8#1)(2008-11#1)(2008-5#1)
structures of some##2##3##(2008-10#1)(2008-3#1)
structures of ten##2##3##(1993-12#1)(2008-6#1)
structures of the complexes##4##4##(1991-2#1)(1996-7#1)(1996-8#1)(2008-10#1)
structures of the developing##2##4##(1995-8#1)(2008-7#1)
structures of the isolated##4##4##(1994-5#1)(2006-12#1)(2007-1#1)(2008-11#1)
structures of the knee##2##4##(2012-2#1)(2013-1#1)
structures of the newly synthesized##3##5##(1997-5#1)(2007-11#2)
structures of the oligosaccharides##2##4##(1990-9#1)(1997-7#1)
structures of the products##2##4##(2007-11#1)(2008-3#1)
structures of the three##2##4##(1993-9#1)(1995-6#1)
structures of the two##6##4##(1990-7#1)(1991-12#1)(1992-1#1)(1992-6#1)(1996-5#1)(2007-1#1)
structures of the##131##3##(1990-2#1)(1990-7#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-3#1)(1992-6#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-5#3)(1996-7#2)(1996-8#2)(1996-9#1)(1997-4#2)(1997-5#3)(1997-7#1)(1997-8#1)(2005-1#1)(2005-11#1)(2005-4#1)(2005-7#1)(2006-10#1)(2006-12#4)(2006-3#1)(2006-8#1)(2007-1#5)(2007-10#1)(2007-11#10)(2007-12#1)(2007-6#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2009-2#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-12#1)(2010-2#1)(2011-1#1)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#1)
structures of these new##3##4##(1994-3#1)(2007-1#1)(2007-11#1)
structures of these two##5##4##(1990-5#1)(1995-3#1)(1997-7#1)(2007-10#1)(2008-5#1)
structures of these##25##3##(1990-5#1)(1994-3#1)(1995-10#1)(1995-3#1)(1997-7#2)(2005-11#1)(2006-12#2)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#3)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#2)(2011-1#1)
structures of this##3##3##(1991-2#1)(2006-4#1)(2008-3#1)
structures of three of##2##4##(2009-11#1)(2010-5#1)
structures of three##5##3##(1995-10#1)(1995-8#1)(2007-1#1)(2009-11#1)(2010-5#1)
structures of two##12##3##(1990-7#1)(1992-12#2)(1993-7#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-5#1)(1996-5#1)(2007-1#1)(2007-11#1)(2008-10#1)
structures of##423##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#3)(1990-7#6)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#6)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#4)(1992-8#4)(1992-9#3)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-7#3)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#4)(1994-5#6)(1994-8#6)(1994-9#2)(1995-1#4)(1995-10#3)(1995-11#6)(1995-2#4)(1995-3#4)(1995-4#2)(1995-5#3)(1995-6#2)(1995-7#2)(1995-8#4)(1996-11#4)(1996-12#1)(1996-2#4)(1996-5#6)(1996-6#2)(1996-7#5)(1996-8#2)(1996-9#2)(1997-3#6)(1997-4#4)(1997-5#3)(1997-6#2)(1997-7#4)(1997-8#1)(2005-1#1)(2005-11#5)(2005-4#2)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#10)(2006-2#4)(2006-3#1)(2006-4#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#13)(2007-10#4)(2007-11#23)(2007-12#3)(2007-3#2)(2007-4#2)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#17)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#12)(2008-5#11)(2008-6#4)(2008-7#4)(2008-8#10)(2008-9#3)(2009-11#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-11#3)(2010-12#1)(2010-2#3)(2010-4#2)(2010-5#5)(2010-6#3)(2010-7#2)(2010-8#1)(2011-1#8)(2011-2#5)(2011-3#2)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#13)(2012-3#2)(2013-1#7)(2013-7#3)(2013-8#4)
structures on the surface of the##2##6##(2008-5#1)(2009-12#1)
structures on the surface of##4##5##(2008-5#3)(2009-12#1)
structures on the##10##3##(1994-6#1)(1997-5#1)(2006-7#1)(2007-12#1)(2007-5#1)(2008-5#3)(2008-8#1)(2009-12#1)
structures on##27##2##(1990-2#1)(1992-9#1)(1993-4#1)(1994-6#2)(1997-2#1)(1997-5#1)(2006-7#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#2)(2012-2#1)(2013-8#1)
structures only##2##2##(1992-2#1)(2008-10#1)
structures or##13##2##(1992-2#1)(1992-8#1)(1994-2#1)(1995-3#1)(2005-7#1)(2006-12#1)(2006-7#1)(2007-8#1)(2008-3#1)(2010-2#1)(2012-12#2)(2013-1#1)
structures other than the##2##4##(1997-4#1)(2007-1#1)
structures placed on##2##3##(2007-12#1)(2008-12#1)
structures predicted##3##2##(1990-5#1)(1992-12#1)(1994-8#1)
structures present##2##2##(1992-5#1)(2008-4#1)
structures produced by##2##3##(2006-12#1)(2008-10#1)
structures produced##3##2##(2006-12#1)(2008-10#1)(2008-3#1)
structures provide a##2##3##(1995-4#1)(2008-7#1)
structures provide##4##2##(1995-4#1)(2006-12#1)(2008-7#1)(2011-1#1)
structures recorded in##2##3##(2008-1#1)(2008-2#1)
structures related to##2##3##(2006-7#1)(2011-2#1)
structures related##3##2##(2006-7#1)(2007-4#1)(2011-2#1)
structures relative to the##2##4##(1990-7#1)(1997-5#1)
structures relative to##3##3##(1990-7#2)(1997-5#1)
structures remains##2##2##(1996-2#1)(2011-2#1)
structures reported##2##2##(1992-12#1)(2007-9#1)
structures resembling##3##2##(1990-11#1)(2008-10#1)(2009-8#1)
structures result##2##2##(1990-7#1)(1992-6#1)
structures show that##2##3##(1994-5#1)(2012-12#1)
structures show##5##2##(1994-5#1)(2008-2#1)(2009-6#1)(2012-12#1)(2012-2#1)
structures showed##2##2##(1996-2#1)(2013-7#1)
structures shows##4##2##(1991-12#1)(1996-6#2)(2008-3#1)
structures significantly##2##2##(1993-6#1)(2012-2#1)
structures similar to##2##3##(2008-10#1)(2008-3#1)
structures such as the##8##4##(1993-12#1)(1994-10#1)(1996-4#1)(2005-9#1)(2007-12#2)(2008-3#1)(2008-6#1)
structures such as##28##3##(1992-6#1)(1993-12#1)(1994-10#1)(1994-8#1)(1995-11#1)(1996-1#1)(1996-4#1)(1997-8#1)(2005-9#1)(2007-11#1)(2007-12#5)(2008-10#1)(2008-3#3)(2008-4#1)(2008-6#2)(2009-10#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#1)
structures suggest that##4##3##(1990-8#1)(1992-12#1)(1993-5#1)(1996-12#1)
structures suggest##6##2##(1990-8#1)(1992-12#1)(1993-5#1)(1996-12#1)(2005-7#1)(2008-5#1)
structures surrounding the##2##3##(2006-12#1)(2008-7#1)
structures surrounding##3##2##(2006-12#1)(2008-7#1)(2008-8#1)
structures than the##2##3##(2008-1#1)(2009-3#1)
structures than##7##2##(1995-6#1)(2007-12#1)(2007-9#1)(2008-1#1)(2009-3#1)(2011-2#2)
structures that allow##2##3##(2010-4#1)(2011-2#1)
structures that are highly conserved##2##5##(2006-10#1)(2012-2#1)
structures that are most##2##4##(1993-11#1)(2010-2#1)
structures that are not##3##4##(2007-12#2)(2008-3#1)
structures that are##15##3##(1993-11#1)(1995-1#3)(2006-10#1)(2007-12#2)(2008-3#2)(2008-5#2)(2008-7#1)(2009-8#1)(2010-2#1)(2012-2#1)
structures that can##3##3##(1990-10#1)(2008-2#1)(2008-7#1)
structures that consist of##2##4##(2008-3#2)
structures that could##3##3##(1995-6#1)(2008-10#1)(2012-2#1)
structures that mimic the##2##4##(1997-4#1)(2010-2#1)
structures that mimic##3##3##(1997-4#1)(2010-2#1)(2010-9#1)
structures that regulate##2##3##(1992-9#1)(2008-12#1)
structures that##74##2##(1990-10#1)(1992-11#1)(1992-4#1)(1992-9#1)(1993-11#2)(1993-12#1)(1995-1#3)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-8#1)(1997-3#1)(1997-4#1)(2005-10#1)(2005-11#1)(2006-10#2)(2007-1#1)(2007-10#1)(2007-12#5)(2007-4#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#6)(2008-5#2)(2008-6#1)(2008-7#5)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-11#3)(2012-12#4)(2012-2#3)(2013-8#1)
structures the##3##2##(1994-6#1)(2006-8#1)(2008-3#1)
structures through##3##2##(1994-11#1)(2007-12#1)(2010-5#1)
structures thus##3##2##(1994-5#1)(2007-7#1)(2008-3#1)
structures to be##4##3##(2007-12#2)(2008-11#1)(2012-2#1)
structures to the##5##3##(1991-3#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-2#1)
structures to##28##2##(1990-5#1)(1991-11#1)(1991-2#1)(1991-3#1)(1996-1#1)(1996-6#1)(2006-4#1)(2006-6#1)(2007-12#4)(2007-8#3)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2009-2#1)(2009-7#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
structures under##3##2##(2007-12#3)
structures using##6##2##(1990-7#1)(1991-12#1)(1994-2#1)(2006-2#1)(2007-11#1)(2008-4#1)
structures was investigated by##2##4##(1996-8#1)(2009-9#1)
structures was##19##2##(1992-5#1)(1993-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-8#1)(2005-8#1)(2006-12#2)(2007-11#1)(2007-3#1)(2008-5#1)(2009-2#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#1)(2013-1#1)
structures were assigned##3##3##(1997-7#1)(2007-1#1)(2010-6#1)
structures were calculated##2##3##(1991-4#1)(1995-1#1)
structures were characterized##2##3##(2006-12#1)(2008-8#1)
structures were confirmed by##3##4##(1997-8#1)(2006-12#1)(2011-1#1)
structures were confirmed##5##3##(1997-8#1)(2006-12#1)(2010-2#1)(2011-1#1)(2011-3#1)
structures were determined by spectroscopic methods##3##6##(2007-1#3)
structures were determined by spectroscopic##4##5##(2007-1#3)(2010-6#1)
structures were determined by##10##4##(2005-11#1)(2006-12#2)(2007-1#4)(2010-5#1)(2010-6#1)(2012-12#1)
structures were determined on the basis of##2##7##(2006-12#1)(2008-4#1)
structures were determined##17##3##(1997-2#1)(1997-7#1)(2005-11#1)(2006-12#4)(2007-1#4)(2007-11#1)(2008-12#1)(2008-4#1)(2010-5#1)(2010-6#1)(2012-12#1)
structures were elucidated by spectroscopic methods including##2##7##(2007-1#2)
structures were elucidated by spectroscopic methods##3##6##(2007-1#3)
structures were elucidated by spectroscopic##4##5##(2007-1#4)
structures were elucidated by##12##4##(1995-11#1)(2006-12#3)(2007-1#7)(2011-3#1)
structures were elucidated on the basis of##3##7##(2007-1#1)(2007-11#1)(2008-10#1)
structures were elucidated##23##3##(1995-11#1)(2006-12#5)(2007-1#12)(2007-11#1)(2007-3#1)(2008-10#1)(2011-2#1)(2011-3#1)
structures were established as##3##4##(2007-1#2)(2007-11#1)
structures were established by##5##4##(2006-12#1)(2007-1#1)(2007-11#1)(2008-11#1)(2010-5#1)
structures were established on the basis of##2##7##(2007-11#1)(2008-5#1)
structures were established##11##3##(2006-12#1)(2007-1#3)(2007-11#3)(2008-11#1)(2008-5#1)(2010-5#1)(2013-1#1)
structures were fabricated##3##3##(2007-12#1)(2008-2#1)(2008-5#1)
structures were found##3##3##(1995-1#1)(2008-10#1)(2008-8#1)
structures were obtained##3##3##(1994-5#1)(2006-12#1)(2010-4#1)
structures were then##2##3##(1995-3#1)(2008-7#1)
structures were visualized##2##3##(1991-9#1)(2007-12#1)
structures were##123##2##(1990-6#1)(1990-7#1)(1991-4#1)(1991-7#1)(1991-9#1)(1994-5#1)(1995-1#2)(1995-11#1)(1995-3#2)(1996-11#1)(1996-9#1)(1997-2#1)(1997-7#2)(1997-8#2)(2005-11#1)(2005-7#1)(2006-12#14)(2006-5#1)(2007-1#24)(2007-10#1)(2007-11#7)(2007-12#3)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2009-12#2)(2009-2#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#3)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
structures when##2##2##(1992-5#1)(1997-8#1)
structures which##10##2##(1990-2#1)(1994-12#1)(1994-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2009-5#1)(2010-9#1)(2011-2#1)(2013-1#1)
structures while##4##2##(1990-7#1)(2008-11#1)(2010-2#1)(2012-2#1)
structures with a view to##2##5##(2005-10#1)(2011-2#1)
structures with a##10##3##(1992-9#1)(1996-3#1)(2005-10#1)(2007-8#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
structures with an##4##3##(1992-6#1)(1992-9#1)(2007-12#1)(2012-2#1)
structures with different##3##3##(2005-4#1)(2008-3#1)(2008-7#1)
structures with only a##2##4##(2008-5#1)(2011-2#1)
structures with pairwise rms##2##4##(1994-5#1)(1995-10#1)
structures with the##3##3##(1994-2#1)(2008-3#1)(2008-8#1)
structures with##74##2##(1990-7#1)(1991-11#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-10#1)(1993-7#1)(1994-2#1)(1994-5#2)(1994-9#1)(1995-10#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-3#1)(2005-10#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-2#2)(2007-11#3)(2007-12#5)(2007-8#2)(2007-9#3)(2008-12#1)(2008-2#6)(2008-3#6)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-3#1)(2009-5#1)(2011-2#3)(2012-2#3)(2013-1#4)
structures within the##5##3##(1995-5#1)(1996-12#1)(2006-8#1)(2008-12#1)(2008-2#1)
structures within##14##2##(1995-2#2)(1995-5#1)(1996-12#1)(2006-5#1)(2006-8#1)(2008-12#2)(2008-2#1)(2008-6#1)(2009-2#1)(2010-4#1)(2010-7#1)(2011-1#1)
structures without##3##2##(2006-9#1)(2007-11#1)(2008-7#1)
structures would##2##2##(1995-6#1)(2006-12#1)
structures##2663##1##(1990-10#4)(1990-11#9)(1990-12#9)(1990-2#9)(1990-3#3)(1990-4#3)(1990-5#13)(1990-6#2)(1990-7#17)(1990-8#10)(1990-9#3)(1991-1#10)(1991-10#6)(1991-11#11)(1991-12#4)(1991-2#20)(1991-3#9)(1991-4#5)(1991-5#6)(1991-6#4)(1991-7#10)(1991-8#2)(1991-9#7)(1992-1#8)(1992-10#2)(1992-11#9)(1992-12#12)(1992-2#9)(1992-3#8)(1992-4#4)(1992-5#7)(1992-6#15)(1992-7#2)(1992-8#13)(1992-9#18)(1993-10#1)(1993-11#11)(1993-12#15)(1993-2#6)(1993-3#16)(1993-4#4)(1993-5#3)(1993-6#8)(1993-7#9)(1993-8#2)(1993-9#6)(1994-1#2)(1994-10#3)(1994-11#8)(1994-12#8)(1994-2#10)(1994-3#16)(1994-5#17)(1994-6#7)(1994-7#1)(1994-8#15)(1994-9#13)(1995-1#29)(1995-10#7)(1995-11#24)(1995-12#4)(1995-2#17)(1995-3#30)(1995-4#6)(1995-5#14)(1995-6#19)(1995-7#10)(1995-8#11)(1995-9#2)(1996-1#8)(1996-10#2)(1996-11#10)(1996-12#7)(1996-2#21)(1996-3#7)(1996-4#3)(1996-5#11)(1996-6#7)(1996-7#11)(1996-8#10)(1996-9#5)(1997-1#9)(1997-2#9)(1997-3#10)(1997-4#17)(1997-5#19)(1997-6#7)(1997-7#14)(1997-8#11)(1997-9#1)(2004-11#1)(2004-7#1)(2004-9#5)(2005-1#1)(2005-10#7)(2005-11#25)(2005-12#1)(2005-4#4)(2005-5#6)(2005-6#1)(2005-7#8)(2005-8#5)(2005-9#3)(2006-1#3)(2006-10#20)(2006-11#4)(2006-12#54)(2006-2#14)(2006-3#4)(2006-4#14)(2006-5#4)(2006-6#7)(2006-7#7)(2006-8#16)(2006-9#4)(2007-1#47)(2007-10#11)(2007-11#82)(2007-12#129)(2007-3#9)(2007-4#18)(2007-5#7)(2007-6#7)(2007-7#11)(2007-8#33)(2007-9#30)(2008-1#33)(2008-10#95)(2008-11#51)(2008-12#19)(2008-2#68)(2008-3#119)(2008-4#59)(2008-5#65)(2008-6#19)(2008-7#72)(2008-8#31)(2008-9#14)(2009-10#8)(2009-11#8)(2009-12#10)(2009-2#25)(2009-3#11)(2009-4#5)(2009-5#12)(2009-6#3)(2009-7#10)(2009-8#17)(2009-9#11)(2010-1#2)(2010-10#8)(2010-11#6)(2010-12#19)(2010-2#19)(2010-3#3)(2010-4#23)(2010-5#23)(2010-6#12)(2010-7#17)(2010-8#11)(2010-9#11)(2011-1#31)(2011-12#2)(2011-2#57)(2011-3#8)(2011-7#1)(2012-1#17)(2012-11#11)(2012-12#26)(2012-2#70)(2012-3#14)(2013-1#32)(2013-7#12)(2013-8#24)
structures) in##2##2##(1996-3#1)(2005-11#1)
structures)##8##1##(1993-7#1)(1996-3#1)(2005-11#1)(2006-12#1)(2007-1#1)(2008-8#1)(2009-11#1)(2010-7#1)
structures/organs##4##1##(2007-8#4)
structures]##4##1##(1990-11#1)(2008-10#1)(2008-4#1)(2008-6#1)
structuring elements##2##2##(2008-2#2)
structuring of##10##2##(1993-12#2)(1993-2#1)(1993-3#1)(1994-1#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-8#1)
structuring on##2##2##(2008-2#1)(2009-9#1)
structuring##44##1##(1991-1#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-1#1)(1995-3#1)(1995-8#1)(2005-11#1)(2006-10#1)(2007-12#2)(2007-4#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-8#4)(2011-1#1)(2011-2#2)(2012-2#2)
struggle against##3##2##(1990-8#1)(1993-11#1)(2006-10#1)
struggle for##6##2##(1994-6#1)(1995-2#1)(2007-10#1)(2008-6#1)(2009-4#1)(2012-11#1)
struggle over health care##2##4##(1995-1#1)(1997-3#1)
struggle over##3##2##(1995-1#1)(1997-3#1)(2008-10#1)
struggle to survive##2##3##(1995-8#1)(1996-1#1)
struggle to##14##2##(1991-12#1)(1992-10#1)(1995-8#1)(1996-1#2)(2006-7#1)(2007-3#1)(2008-6#1)(2010-1#1)(2010-8#1)(2012-2#1)(2013-1#3)
struggle with the##2##3##(2008-4#1)(2008-9#1)
struggle with##8##2##(1997-6#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-4#1)(2012-12#1)
struggle##46##1##(1990-8#1)(1991-12#1)(1992-10#1)(1993-11#3)(1994-6#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-1#2)(1997-3#1)(1997-6#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-10#1)(2009-4#2)(2009-7#1)(2010-1#1)(2010-8#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#4)
struggled to##3##2##(1995-1#1)(2008-7#1)(2013-1#1)
struggled with##5##2##(1996-1#1)(2007-5#1)(2010-2#2)(2012-11#1)
struggled##9##1##(1995-1#1)(1996-1#1)(2007-5#1)(2008-10#1)(2008-7#1)(2010-2#2)(2012-11#1)(2013-1#1)
struggles to##5##2##(1994-10#1)(1996-1#2)(1996-12#1)(2007-8#1)
struggles##11##1##(1994-10#1)(1996-1#2)(1996-12#1)(1997-8#1)(2007-8#1)(2008-9#1)(2009-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
struggling to develop##2##3##(1995-12#1)(2006-1#1)
struggling to##9##2##(1995-12#1)(2005-10#1)(2006-1#1)(2007-9#2)(2008-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
struggling with##2##2##(2008-1#1)(2010-8#1)
struggling##11##1##(1995-12#1)(2005-10#1)(2006-1#1)(2007-9#2)(2008-1#1)(2008-12#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
struma ovarii##4##2##(1994-12#2)(1994-6#1)(2009-5#1)
struma##5##1##(1990-6#1)(1994-12#2)(1994-6#1)(2009-5#1)
strut bone##2##2##(2012-3#2)
strut##6##1##(2006-8#1)(2011-2#2)(2012-3#2)(2013-8#1)
struts of##2##2##(2007-9#1)(2010-12#1)
struts##11##1##(2007-9#5)(2008-5#2)(2008-7#2)(2010-12#1)(2010-8#1)
struvite urolithiasis##3##2##(2010-2#3)
struvite##5##1##(2010-2#4)(2011-2#1)
strychnine and brucine##4##3##(2007-8#4)
strychnine and##7##2##(1991-10#1)(1995-2#1)(1995-3#1)(2007-8#4)
strychnine binding##3##2##(1990-7#3)
strychnine##21##1##(1990-7#6)(1991-10#2)(1991-5#1)(1992-1#1)(1993-7#1)(1995-12#1)(1995-2#2)(1995-3#1)(1997-3#2)(2007-8#4)
strychnine-insensitive glycine receptors##2##3##(1995-11#2)
strychnine-insensitive glycine##6##2##(1991-11#1)(1994-2#3)(1995-11#2)
strychnine-insensitive##7##1##(1990-7#1)(1991-11#1)(1994-2#3)(1995-11#2)
strychnine-sensitive glycine##2##2##(1990-7#2)
strychnine-sensitive inhibitory##2##2##(1995-3#1)(1997-3#1)
strychnine-sensitive receptor##2##2##(1990-7#2)
strychnine-sensitive##6##1##(1990-7#4)(1995-3#1)(1997-3#1)
stubble##6##1##(2008-10#6)
stubborn##2##1##(1992-10#1)(2008-5#1)
stubby##3##1##(1995-4#1)(2008-10#1)(2010-7#1)
stubs##2##1##(1991-12#2)
stuck in##2##2##(2008-10#1)(2010-9#1)
stuck##9##1##(1996-12#1)(1996-6#1)(2008-10#4)(2010-9#1)(2011-12#1)(2013-8#1)
stud##3##1##(1990-11#1)(2008-11#1)(2012-3#1)
studded##2##1##(2005-7#1)(2008-7#1)
student academic##2##2##(2008-12#1)(2012-3#1)
student achievement##3##2##(2007-8#1)(2008-12#1)(2009-7#1)
student and qualified nurses##2##4##(2005-7#2)
student and##9##2##(2005-12#2)(2005-7#2)(2008-11#2)(2011-1#1)(2013-1#2)
student applicants##2##2##(2012-3#2)
student assessment##2##2##(1996-2#1)(2008-11#1)
student at the University of##2##5##(2010-8#1)(2012-3#1)
student at##3##2##(2010-8#1)(2012-3#1)(2013-1#1)
student attitudes##2##2##(2008-11#1)(2012-12#1)
student clinical##3##2##(2006-5#1)(2008-12#1)(2012-3#1)
student cohorts##2##2##(2008-12#2)
student competence##3##2##(2008-11#1)(2008-6#2)
student described##2##2##(2005-7#1)(2008-11#1)
student evaluation##6##2##(2006-5#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-12#1)
student exchange##2##2##(2008-12#1)(2010-3#1)
student experience of##2##3##(2008-11#1)(2013-1#1)
student experience##7##2##(2008-11#6)(2013-1#1)
student feedback##3##2##(2008-11#1)(2013-1#2)
student for##2##2##(2008-11#1)(2008-6#1)
student group##2##2##(2008-11#1)(2008-12#1)
student groups##4##2##(2005-10#1)(2008-11#1)(2012-12#1)(2013-8#1)
student health##4##2##(1990-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
student in##4##2##(1994-3#1)(2008-11#1)(2008-8#2)
student interaction##2##2##(2007-5#1)(2008-11#1)
student is##2##2##(2007-1#1)(2008-11#1)
student journal club##3##3##(2008-12#3)
student learning and##3##3##(1994-2#1)(2007-12#1)(2009-9#1)
student learning in##2##3##(2008-12#1)(2009-12#1)
student learning outcomes##2##3##(2007-10#1)(2008-12#1)
student learning##22##2##(1994-2#1)(2006-2#1)(2007-10#1)(2007-12#3)(2008-11#4)(2008-12#6)(2009-12#1)(2009-9#2)(2012-1#1)(2012-12#2)
student math aptitude and success on a medication calculation assessment##2##10##(2010-3#2)
student midwives##3##2##(2008-11#3)
student nurse anesthetist##2##3##(2011-2#2)
student nurse education##2##3##(2008-12#1)(2013-8#1)
student nurse##11##2##(2008-11#6)(2008-12#2)(2011-2#2)(2013-8#1)
student nurses and##2##3##(2008-11#1)(2008-12#1)
student nurses at the##2##4##(2008-11#1)(2012-3#1)
student nurses at##3##3##(2008-11#2)(2012-3#1)
student nurses in##2##3##(2007-8#1)(2008-11#1)
student nurses on##4##3##(2008-11#1)(2008-12#3)
student nurses to##5##3##(2008-11#3)(2008-12#1)(2013-8#1)
student nurses who##5##3##(2008-11#4)(2010-3#1)
student nurses##46##2##(2006-5#1)(2007-8#1)(2008-11#27)(2008-12#9)(2010-3#4)(2011-2#1)(2012-3#1)(2013-8#2)
student nurses' attitudes towards older people##2##6##(2012-3#2)
student nurses'##4##2##(2008-11#2)(2012-3#2)
student outcomes in##2##3##(2007-12#1)(2011-2#1)
student outcomes##3##2##(2007-12#2)(2011-2#1)
student perceptions of##2##3##(2008-12#1)(2012-1#1)
student perceptions##4##2##(2008-12#1)(2012-1#1)(2012-3#1)(2013-1#1)
student performance in##2##3##(2005-10#1)(2006-12#1)
student performance##6##2##(2005-10#2)(2006-12#1)(2008-11#1)(2008-12#1)(2010-3#1)
student perspective##2##2##(2007-11#1)(2009-12#1)
student population and##2##3##(2008-12#1)(2012-1#1)
student population##5##2##(2008-11#1)(2008-12#1)(2012-1#3)
student projects##2##2##(1995-1#1)(1996-2#1)
student psychiatric nurses##3##3##(2007-3#1)(2008-11#1)(2008-12#1)
student psychiatric nurses'##2##3##(2008-11#1)(2008-12#1)
student psychiatric##5##2##(2007-3#1)(2008-11#2)(2008-12#2)
student research##4##2##(2008-6#1)(2009-8#1)(2010-9#1)(2013-1#1)
student response system##3##3##(2010-3#3)
student responses##2##2##(2008-11#1)(2008-12#1)
student stress##4##2##(2008-11#4)
student success##2##2##(2006-12#1)(2008-12#1)
student support##5##2##(2008-11#4)(2008-12#1)
student survey##2##2##(1996-1#1)(2008-12#1)
student symposium##3##2##(2008-10#2)(2008-5#1)
student to##8##2##(2006-5#1)(2008-11#2)(2008-12#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#1)
student training##3##2##(2010-6#1)(2013-1#2)
student tutorial##4##2##(2006-12#1)(2008-11#3)
student voice##4##2##(2008-11#1)(2013-1#3)
student was##2##2##(1995-3#1)(1995-4#1)
student who##2##2##(2008-11#1)(2012-2#1)
student with##2##2##(2010-3#1)(2012-3#1)
student##368##1##(1990-12#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#3)(1992-3#1)(1992-6#2)(1993-1#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-3#5)(1995-4#1)(1996-1#4)(1996-2#3)(1996-6#1)(1997-2#2)(1997-3#1)(2005-10#3)(2005-11#1)(2005-12#4)(2005-7#3)(2005-8#1)(2006-12#7)(2006-2#2)(2006-5#10)(2006-7#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#8)(2007-3#1)(2007-4#2)(2007-5#2)(2007-8#3)(2008-1#1)(2008-10#3)(2008-11#104)(2008-12#46)(2008-2#1)(2008-5#1)(2008-6#9)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#2)(2009-4#2)(2009-7#3)(2009-8#3)(2009-9#3)(2010-12#1)(2010-3#16)(2010-5#3)(2010-6#2)(2010-8#2)(2010-9#3)(2011-1#2)(2011-2#12)(2012-1#6)(2012-11#2)(2012-12#6)(2012-2#5)(2012-3#12)(2013-1#16)(2013-7#1)(2013-8#5)
student's##28##1##(2006-5#1)(2007-12#1)(2007-8#1)(2008-11#11)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#1)(2009-7#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
student-centered and##2##2##(2007-1#1)(2008-12#1)
student-centered##4##1##(2007-1#1)(2008-12#2)(2012-12#1)
student-centred learning##2##2##(2006-2#1)(2008-11#1)
student-centred##5##1##(2006-2#2)(2006-8#1)(2008-11#2)
student-focused##2##1##(2011-2#2)
student-level##2##1##(2008-12#1)(2013-7#1)
students &quot##2##2##(1992-6#1)(2012-3#1)
students (N =##4##3##(2006-1#1)(2006-7#2)(2013-8#1)
students (mean age##2##3##(2006-2#1)(2013-1#1)
students (n =##3##3##(2009-12#1)(2012-3#1)(2013-7#1)
students a##2##2##(2008-11#1)(2011-2#1)
students about their##3##3##(2008-11#2)(2012-12#1)
students about##9##2##(1992-6#1)(1995-12#2)(2006-5#1)(2008-11#2)(2009-8#1)(2012-12#1)(2012-3#1)
students across##2##2##(2012-12#2)
students aged##3##2##(2007-12#1)(2012-3#1)(2013-8#1)
students agreed##2##2##(2012-2#1)(2013-1#1)
students and Practice Nurses##2##4##(2008-11#2)
students and a##3##3##(2006-10#1)(2007-12#1)(2008-11#1)
students and academics##2##3##(2008-11#2)
students and examiners##2##3##(2012-1#2)
students and factory workers##2##4##(2008-11#2)
students and faculty##6##3##(2004-12#1)(2006-2#1)(2008-11#1)(2008-12#1)(2009-4#1)(2012-3#1)
students and graduates##3##3##(2013-1#2)(2013-8#1)
students and in##2##3##(1997-5#1)(2010-2#1)
students and lecturers##2##3##(2008-11#2)
students and nurse##3##3##(2008-11#2)(2008-12#1)
students and research]##2##3##(1992-6#2)
students and staff##3##3##(1993-1#1)(2008-12#1)(2008-9#1)
students and teachers##6##3##(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2010-9#1)
students and the##3##3##(2007-3#1)(2008-12#1)(2009-11#1)
students and their##4##3##(2007-12#1)(2008-11#1)(2009-7#1)(2013-8#1)
students and##106##2##(1990-12#2)(1991-6#1)(1992-6#2)(1993-1#1)(1994-4#1)(1994-6#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-5#2)(2004-12#2)(2005-12#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-7#3)(2006-8#2)(2007-10#2)(2007-12#4)(2007-3#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#18)(2008-12#10)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-4#3)(2009-7#1)(2010-1#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#4)
students are also##2##3##(2008-11#1)(2008-12#1)
students are expected to##2##4##(2005-10#1)(2008-12#1)
students are##29##2##(1990-2#1)(1996-1#1)(1997-3#1)(1997-5#1)(2005-10#1)(2005-8#1)(2006-6#1)(2006-7#2)(2007-4#1)(2007-8#1)(2008-11#9)(2008-12#3)(2008-4#1)(2008-8#1)(2010-3#1)(2011-2#2)(2012-1#1)
students as participants in##2##4##(2008-12#1)(2008-5#1)
students as well as##3##4##(2012-1#1)(2012-2#1)(2013-8#1)
students as##9##2##(2008-11#1)(2008-12#1)(2008-5#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-8#2)
students at King##2##3##(2011-12#1)(2012-1#1)
students at a##4##3##(2008-12#1)(2009-5#1)(2011-2#1)(2012-3#1)
students at risk##2##3##(1992-3#1)(2007-3#1)
students at the University of##7##5##(1992-6#2)(1996-1#1)(2008-4#2)(2009-12#1)(2012-2#1)
students at the University##8##4##(1992-6#2)(1996-1#1)(2007-3#1)(2008-4#2)(2009-12#1)(2012-2#1)
students at the end of the##2##6##(2007-10#1)(2008-10#1)
students at the##17##3##(1992-6#2)(1994-6#2)(1995-4#1)(1996-1#1)(2007-10#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-4#2)(2009-12#1)(2010-9#1)(2011-2#2)(2012-2#1)
students at##38##2##(1991-6#1)(1992-3#1)(1992-6#2)(1993-3#1)(1994-6#2)(1995-4#1)(1996-1#2)(1996-2#1)(2007-1#1)(2007-10#1)(2007-3#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#3)(2008-4#2)(2009-12#1)(2009-5#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)
students attending##7##2##(2007-1#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-2#2)
students believed mental illness could be##2##6##(2008-4#2)
students benefited from##2##3##(2007-3#1)(2010-1#1)
students between##2##2##(2011-2#1)(2012-1#1)
students born to##2##3##(2008-8#2)
students can##5##2##(1996-12#1)(2006-10#1)(2008-11#2)(2012-1#1)
students choose##3##2##(2007-4#2)(2008-12#1)
students completed an##2##3##(1991-9#1)(2013-8#1)
students completed the##3##3##(2007-12#1)(2007-2#1)(2012-12#1)
students completed##11##2##(1991-9#1)(1997-2#1)(2007-12#2)(2007-2#2)(2007-9#1)(2008-12#1)(2012-12#1)(2012-3#1)(2013-8#1)
students critically##2##2##(2005-10#1)(2008-11#1)
students delivered between##3##3##(2013-1#3)
students delivered##4##2##(2013-1#4)
students demonstrated##2##2##(2008-11#1)(2012-12#1)
students developed##3##2##(2008-12#2)(2009-9#1)
students did##2##2##(2008-1#1)(2008-12#1)
students due to##2##3##(2010-12#1)(2010-3#1)
students during clinical##2##3##(2009-9#1)(2010-3#1)
students during their clinical placements##2##5##(1995-3#1)(2010-3#1)
students during their clinical##3##4##(1995-3#1)(2007-10#1)(2010-3#1)
students during their##10##3##(1995-3#1)(2007-10#1)(2007-6#4)(2008-11#1)(2008-4#1)(2009-9#1)(2010-3#1)
students during##15##2##(1995-3#1)(2007-10#2)(2007-6#4)(2008-11#2)(2008-4#1)(2009-9#2)(2010-3#2)(2012-2#1)
students eager##2##2##(2007-9#1)(2008-10#1)
students early in their##2##4##(2012-12#1)(2012-3#1)
students enrolled in a##4##4##(2006-12#2)(2007-12#1)(2008-11#1)
students enrolled in##9##3##(1992-1#1)(1996-1#1)(2006-12#2)(2007-12#2)(2008-11#1)(2011-1#1)(2012-2#1)
students exposed to##2##3##(2008-2#1)(2010-8#1)
students expressed##2##2##(1992-6#1)(2012-1#1)
students felt##2##2##(2006-10#1)(2008-12#1)
students for##4##2##(1995-2#1)(2005-12#1)(2008-12#1)(2010-10#1)
students found the##2##3##(2010-10#1)(2013-8#1)
students found##5##2##(1996-1#1)(2008-11#1)(2008-12#1)(2010-10#1)(2013-8#1)
students from 15##2##3##(2007-5#1)(2013-1#1)
students from a##3##3##(1993-6#1)(2011-2#1)(2012-12#1)
students from an##2##3##(1992-6#1)(2010-4#1)
students from different##2##3##(2008-12#1)(2011-2#1)
students from non-English speaking backgrounds##3##5##(2008-11#1)(2008-12#2)
students from public##2##3##(2006-7#1)(2011-2#1)
students from the##4##3##(1990-2#1)(2005-8#1)(2008-10#1)(2011-2#1)
students from##44##2##(1990-2#1)(1992-5#1)(1992-6#2)(1993-6#1)(1997-2#1)(2005-8#1)(2006-5#1)(2006-7#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#6)(2008-8#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#7)(2012-12#1)(2013-1#4)(2013-7#1)(2013-8#2)
students generally##2##2##(2007-8#1)(2010-3#1)
students had a positive##2##4##(1997-2#1)(2008-11#1)
students had##15##2##(1991-9#1)(1992-5#1)(1992-6#1)(1997-2#1)(2008-11#5)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
students has been##3##3##(2008-11#2)(2009-4#1)
students has##5##2##(2008-11#4)(2009-4#1)
students have experienced##2##3##(1996-1#2)
students have##16##2##(1996-1#2)(1997-2#2)(2005-10#1)(2006-10#1)(2008-1#1)(2008-11#3)(2008-7#1)(2009-4#1)(2010-3#1)(2012-1#1)(2012-12#1)(2013-8#1)
students identified##3##2##(2008-11#2)(2012-1#1)
students in Abha##3##3##(2007-2#1)(2007-3#2)
students in India##3##3##(2013-1#3)
students in Years##2##3##(2008-12#1)(2011-1#1)
students in a##8##3##(2006-8#1)(2008-12#1)(2008-7#1)(2009-4#1)(2011-2#2)(2012-12#1)(2012-2#1)
students in developing##2##3##(2008-11#1)(2010-3#1)
students in faculty research##2##4##(2008-12#1)(2010-3#1)
students in four##5##3##(1991-2#1)(2013-7#4)
students in grades K - 12##2##6##(2012-12#2)
students in grades##3##3##(2012-12#2)(2013-7#1)
students in need of##3##4##(2008-12#1)(2013-7#2)
students in paediatric##2##3##(2011-2#1)(2012-12#1)
students in the public and##2##5##(2011-2#1)(2013-7#1)
students in the public##3##4##(2008-5#1)(2011-2#1)(2013-7#1)
students in the##29##3##(1991-1#1)(1996-1#1)(2005-10#1)(2006-8#1)(2007-1#1)(2007-3#1)(2008-11#5)(2008-12#5)(2008-4#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
students in this study##2##4##(2008-11#1)(2013-8#1)
students in##128##2##(1991-1#1)(1991-2#2)(1992-6#1)(1993-3#1)(1996-1#1)(2004-12#1)(2004-3#1)(2005-10#1)(2005-12#1)(2006-5#1)(2006-7#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-2#2)(2007-3#3)(2007-4#1)(2007-5#2)(2007-7#1)(2008-1#2)(2008-11#13)(2008-12#12)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-2#1)(2009-4#2)(2009-6#2)(2010-2#1)(2010-3#5)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#9)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#5)(2013-1#12)(2013-7#12)(2013-8#3)
students into##2##2##(2007-12#1)(2010-3#1)
students is##7##2##(2005-10#1)(2007-12#1)(2008-11#2)(2011-2#1)(2012-1#1)(2013-1#1)
students learn to##2##3##(2008-11#1)(2009-9#1)
students learn##8##2##(1992-12#1)(2005-12#1)(2008-11#3)(2009-11#1)(2009-9#1)(2013-8#1)
students learned about the##2##4##(2007-12#2)
students learning##2##2##(2008-11#1)(2012-1#1)
students living##2##2##(2010-9#1)(2013-1#1)
students made##2##2##(2008-11#1)(2009-9#1)
students may##5##2##(1993-3#1)(2007-2#1)(2008-1#1)(2008-12#1)(2012-1#1)
students might##4##2##(2007-12#1)(2008-11#1)(2009-5#1)(2013-1#1)
students must be##4##3##(2008-11#1)(2008-12#1)(2010-3#1)(2011-1#1)
students must##7##2##(1992-6#1)(1996-1#1)(2005-10#1)(2008-11#1)(2008-12#1)(2010-3#1)(2011-1#1)
students need to achieve##2##4##(2008-11#2)
students need to##4##3##(1996-1#1)(2008-11#3)
students need##5##2##(1996-1#1)(2008-11#3)(2008-12#1)
students of Medicine##2##3##(2007-1#1)(2013-1#1)
students of a##3##3##(2012-2#2)(2013-1#1)
students of color##3##3##(2004-12#3)
students of human##2##3##(1991-11#1)(1993-12#1)
students of nursing to##2##4##(2008-12#2)
students of nursing##4##3##(2008-11#1)(2008-12#3)
students of the##9##3##(1994-6#1)(2007-1#1)(2007-3#2)(2008-4#1)(2008-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
students of##49##2##(1991-11#1)(1993-12#1)(1994-5#1)(1994-6#1)(1997-3#1)(2004-12#4)(2006-5#2)(2006-8#1)(2007-1#2)(2007-2#2)(2007-3#3)(2008-1#1)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-5#2)(2010-2#1)(2011-1#2)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
students on##6##2##(1995-3#1)(1997-1#1)(2005-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
students or##6##2##(1991-3#1)(2007-3#1)(2008-4#1)(2012-2#1)(2013-1#2)
students over##2##2##(2008-12#1)(2008-2#1)
students participated in a##3##4##(1996-6#1)(2008-8#1)(2010-10#1)
students participated##4##2##(1996-6#1)(2006-10#1)(2008-8#1)(2010-10#1)
students participating in##2##3##(2012-2#1)(2013-7#1)
students perceive##2##2##(2007-12#1)(2013-8#1)
students perceived##2##2##(2008-11#1)(2012-3#1)
students presenting to Geta Eye Hospital##3##6##(2011-1#3)
students presenting to##4##3##(2011-1#4)
students presenting##5##2##(1992-1#1)(2011-1#4)
students reacted##2##2##(2005-10#1)(2007-5#1)
students receive##2##2##(2008-11#2)
students received##2##2##(2008-12#1)(2009-11#1)
students reported that##4##3##(1993-3#1)(2008-11#1)(2012-12#2)
students reported##20##2##(1991-9#1)(1993-3#1)(1994-4#1)(2006-10#2)(2006-7#1)(2007-1#2)(2008-11#1)(2008-12#2)(2010-12#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
students say##2##2##(2006-10#1)(2012-3#1)
students should be##3##3##(1992-6#1)(2008-11#1)(2008-6#1)
students should have##2##3##(2005-10#1)(2008-8#1)
students should##6##2##(1992-6#1)(2005-10#1)(2006-10#1)(2008-11#1)(2008-6#1)(2008-8#1)
students stated##2##2##(2005-7#1)(2008-12#1)
students studied##2##2##(2008-12#1)(2012-3#1)
students teach##2##2##(2009-11#1)(2011-2#1)
students than black##2##3##(2012-12#2)
students that could##2##3##(2004-12#1)(2008-10#1)
students that##9##2##(2004-12#1)(2007-10#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2012-1#1)(2012-3#1)
students the##5##2##(1990-2#1)(1995-3#1)(2007-3#1)(2010-12#1)(2013-8#1)
students thought##2##2##(1993-3#1)(2006-5#1)
students through the##2##3##(2005-12#1)(2010-9#1)
students through##4##2##(2005-12#1)(2009-9#1)(2010-9#1)(2011-2#1)
students to apply##2##3##(1996-1#1)(2008-11#1)
students to be##2##3##(2008-11#1)(2008-3#1)
students to become##3##3##(1997-2#1)(2005-10#1)(2013-8#1)
students to develop skills##2##4##(2006-2#1)(2008-11#1)
students to develop##5##3##(1991-3#1)(2006-2#1)(2008-11#3)
students to participate in##2##4##(1992-6#1)(2010-3#1)
students to take##2##3##(2008-11#1)(2013-8#1)
students to the##6##3##(1992-2#1)(1992-6#1)(1997-1#1)(2007-12#2)(2009-8#1)
students to use##2##3##(2008-12#1)(2012-2#1)
students to##76##2##(1990-10#1)(1991-3#1)(1992-2#2)(1992-3#1)(1992-6#2)(1992-7#1)(1993-1#2)(1996-1#1)(1996-12#1)(1997-1#1)(1997-2#1)(2004-12#1)(2005-10#3)(2005-7#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-12#3)(2007-8#1)(2008-11#21)(2008-12#5)(2008-3#1)(2008-4#1)(2009-8#1)(2009-9#1)(2010-3#2)(2010-6#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#4)
students took the course##2##4##(2005-10#2)
students took##3##2##(2005-10#2)(2011-2#1)
students towards##6##2##(2008-1#1)(2008-8#2)(2009-7#1)(2012-1#2)
students trained with the##2##4##(2012-3#2)
students understand the##2##3##(2005-10#1)(2008-12#1)
students undertaking a##3##3##(2008-11#3)
students undertaking##7##2##(2008-11#6)(2008-12#1)
students used##3##2##(2009-12#1)(2013-1#1)(2013-8#1)
students using the##2##3##(2012-12#1)(2012-2#1)
students using##5##2##(2008-2#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
students volunteered to##2##3##(2008-11#1)(2008-12#1)
students was##14##2##(1992-2#1)(1995-3#1)(1997-5#1)(2005-10#1)(2007-10#2)(2009-5#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)
students were also asked to##2##5##(2008-11#1)(2013-8#1)
students were asked to##2##4##(2008-11#1)(2008-12#1)
students were asked##3##3##(2005-10#1)(2008-11#1)(2008-12#1)
students were assessed on##2##4##(2009-11#2)
students were assessed using##2##4##(2004-3#1)(2008-1#1)
students were assessed##4##3##(2004-3#1)(2008-1#1)(2009-11#2)
students were collected##3##3##(2011-1#1)(2012-2#1)(2013-1#1)
students were compared##2##3##(2005-10#1)(2012-2#1)
students were enrolled##2##3##(2007-2#1)(2008-8#1)
students were found to##2##4##(2006-8#1)(2011-1#1)
students were given##2##3##(2007-2#1)(2008-11#1)
students were in##3##3##(2008-11#1)(2008-7#1)(2011-1#1)
students were randomly assigned to##4##5##(1992-12#1)(2006-10#1)(2008-12#1)(2009-11#1)
students were satisfied with##2##4##(2008-12#1)(2010-3#1)
students were selected##2##3##(2011-1#1)(2012-12#1)
students were significantly more##2##4##(2007-3#1)(2012-3#1)
students were tested##2##3##(1997-2#1)(2007-9#1)
students were##68##2##(1992-12#1)(1992-5#1)(1996-1#1)(1997-2#1)(2004-3#1)(2005-10#2)(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-3#3)(2007-9#1)(2008-1#2)(2008-11#7)(2008-12#12)(2008-7#1)(2008-8#1)(2009-11#3)(2010-2#1)(2010-3#4)(2011-1#6)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
students when##2##2##(1993-3#1)(2008-11#1)
students whilst##2##2##(2008-11#1)(2008-12#1)
students who are##6##3##(1996-2#1)(2008-11#1)(2008-12#1)(2009-4#1)(2011-2#2)
students who failed##2##3##(2008-11#2)
students who followed##2##3##(1994-4#2)
students who had just completed##2##5##(2008-11#2)
students who had rotated in psychiatry and those who had not##2##11##(2008-4#2)
students who had##9##3##(1992-1#1)(2007-10#1)(2008-11#3)(2008-4#3)(2013-1#1)
students who have##3##3##(1996-1#1)(2008-11#1)(2009-5#1)
students who participated in the##3##5##(2010-3#1)(2010-9#1)(2013-7#1)
students who received the##2##4##(2007-3#1)(2008-12#1)
students who studied##2##3##(2008-10#1)(2008-9#1)
students who were##4##3##(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
students who##51##2##(1992-1#1)(1994-4#2)(1996-1#1)(1996-2#1)(2004-12#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#14)(2008-12#2)(2008-4#3)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#4)(2013-1#1)(2013-7#3)(2013-8#1)
students whose mothers were##2##4##(2009-5#2)
students whose##3##2##(2008-11#1)(2009-5#2)
students will##3##2##(2004-3#1)(2006-12#1)(2013-1#1)
students with a##3##3##(2005-10#1)(2006-5#1)(2007-9#1)
students with an opportunity to##2##5##(1993-3#1)(2008-11#1)
students with an##4##3##(1993-3#1)(2005-10#1)(2008-11#1)(2013-8#1)
students with dyslexia##3##3##(2008-12#3)
students with limited##2##3##(1996-2#1)(2008-12#1)
students with similar records of achievement##2##6##(2008-12#2)
students with the##5##3##(2005-10#1)(2008-11#1)(2012-1#1)(2013-1#2)
students with##41##2##(1993-3#1)(1996-2#2)(1997-2#1)(2005-10#3)(2006-5#1)(2006-7#1)(2007-9#1)(2008-11#3)(2008-12#9)(2008-5#1)(2009-8#1)(2010-3#1)(2010-5#2)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
students within##2##2##(2007-1#1)(2008-11#1)
students without##2##2##(2010-3#1)(2013-1#1)
students worked in##2##3##(1992-6#1)(2008-12#1)
students worked##3##2##(1992-6#1)(2008-12#1)(2010-11#1)
students would##6##2##(1993-3#2)(2007-2#1)(2007-9#1)(2008-11#2)
students##1548##1##(1990-10#1)(1990-12#3)(1990-2#5)(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#3)(1991-3#2)(1991-6#2)(1991-9#3)(1992-1#4)(1992-12#2)(1992-2#5)(1992-3#3)(1992-5#4)(1992-6#19)(1992-7#1)(1993-1#3)(1993-12#1)(1993-2#2)(1993-3#12)(1993-6#2)(1993-7#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#6)(1994-5#1)(1994-6#5)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#9)(1995-4#1)(1996-1#20)(1996-12#3)(1996-2#7)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#13)(1997-3#3)(1997-5#5)(2004-12#14)(2004-3#4)(2004-8#2)(2005-10#28)(2005-12#9)(2005-7#2)(2005-8#4)(2005-9#1)(2006-1#2)(2006-10#21)(2006-12#8)(2006-2#5)(2006-4#2)(2006-5#19)(2006-6#3)(2006-7#22)(2006-8#11)(2006-9#1)(2007-1#13)(2007-10#17)(2007-11#1)(2007-12#31)(2007-2#15)(2007-3#20)(2007-4#8)(2007-5#4)(2007-6#5)(2007-7#3)(2007-8#10)(2007-9#6)(2008-1#20)(2008-10#12)(2008-11#224)(2008-12#140)(2008-2#6)(2008-3#6)(2008-4#23)(2008-5#7)(2008-6#6)(2008-7#9)(2008-8#12)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#11)(2009-12#5)(2009-2#2)(2009-3#1)(2009-4#19)(2009-5#12)(2009-6#3)(2009-7#8)(2009-8#5)(2009-9#13)(2010-1#5)(2010-10#7)(2010-11#2)(2010-12#12)(2010-2#11)(2010-3#31)(2010-4#4)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#3)(2010-9#11)(2011-1#39)(2011-12#1)(2011-2#72)(2012-1#31)(2012-11#2)(2012-12#51)(2012-2#42)(2012-3#31)(2013-1#90)(2013-7#30)(2013-8#51)
students' ability to##2##3##(2008-11#1)(2008-12#1)
students' academic performance##3##3##(2011-2#1)(2012-3#2)
students' academic##5##2##(2007-12#2)(2011-2#1)(2012-3#2)
students' access to##2##3##(2008-11#1)(2008-12#1)
students' and##5##2##(2008-11#1)(2009-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
students' approaches to learning##3##4##(2011-1#2)(2011-2#1)
students' attitude##2##2##(2008-8#2)
students' attitudes##3##2##(1996-1#1)(2007-3#1)(2008-4#1)
students' awareness##2##2##(2006-5#1)(2013-1#1)
students' career##2##2##(2005-9#1)(2011-2#1)
students' clinical learning##2##3##(2008-11#1)(2008-12#1)
students' clinical##4##2##(2008-11#1)(2008-12#2)(2011-2#1)
students' competence and confidence##2##4##(2008-11#1)(2008-12#1)
students' competence and##3##3##(2008-11#1)(2008-12#1)(2012-3#1)
students' competence##5##2##(1993-1#1)(2008-11#2)(2008-12#1)(2012-3#1)
students' current##2##2##(2007-12#1)(2008-12#1)
students' evaluation of the##2##4##(1990-5#1)(2010-3#1)
students' evaluation of##3##3##(1990-5#1)(2008-11#1)(2010-3#1)
students' evaluation##4##2##(1990-5#1)(1995-4#1)(2008-11#1)(2010-3#1)
students' examination performance##2##3##(2013-1#2)
students' experience of##4##3##(2005-7#4)
students' experiences of##3##3##(2007-8#1)(2008-11#1)(2008-12#1)
students' experiences##9##2##(2005-8#1)(2007-8#1)(2008-11#3)(2008-12#3)(2009-8#1)
students' interest##2##2##(2006-5#1)(2010-9#1)
students' knowledge##3##2##(2005-10#2)(2011-2#1)
students' learning in##2##3##(2006-5#1)(2008-11#1)
students' learning##5##2##(2006-5#1)(2008-10#1)(2008-11#2)(2013-1#1)
students' needs for##2##3##(1995-1#1)(2010-2#1)
students' needs##5##2##(1995-1#1)(2008-12#2)(2010-2#1)(2012-3#1)
students' perception of##2##3##(2008-12#1)(2012-12#1)
students' perceptions and##2##3##(2008-11#1)(2009-7#1)
students' perceptions of ethical behavior in##2##6##(2008-12#2)
students' perceptions of their learning##2##5##(2008-11#1)(2013-1#1)
students' perceptions of their##5##4##(2008-11#2)(2008-2#2)(2013-1#1)
students' perceptions of##18##3##(2006-10#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-11#5)(2008-12#2)(2008-2#2)(2009-12#1)(2011-2#1)(2012-3#2)(2013-1#1)
students' perceptions##23##2##(2006-10#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-11#6)(2008-12#2)(2008-2#2)(2009-12#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#2)(2013-8#1)
students' perspectives on##3##3##(2008-11#1)(2012-2#1)(2013-1#1)
students' perspectives##6##2##(2008-11#2)(2010-3#1)(2012-2#1)(2013-1#2)
students' reading self-concept##3##3##(2010-3#3)
students' reading##4##2##(2010-3#4)
students' reflection-in-learning##2##2##(2013-1#2)
students' self-esteem##2##2##(2008-11#1)(2008-12#1)
students' successful##2##2##(2011-1#1)(2012-3#1)
students' theoretical##2##2##(2008-11#1)(2010-10#1)
students' understanding of##2##3##(2009-8#1)(2012-3#1)
students'##200##1##(1990-5#1)(1993-1#1)(1995-1#1)(1995-3#1)(1995-4#1)(1996-1#1)(2004-12#3)(2005-10#5)(2005-7#4)(2005-8#2)(2005-9#1)(2006-10#2)(2006-12#2)(2006-2#2)(2006-5#3)(2006-7#1)(2007-10#1)(2007-12#4)(2007-3#1)(2007-4#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#37)(2008-12#29)(2008-2#3)(2008-4#2)(2008-8#2)(2009-12#2)(2009-7#2)(2009-8#3)(2009-9#2)(2010-10#2)(2010-2#2)(2010-3#12)(2010-9#1)(2011-1#3)(2011-2#10)(2012-1#3)(2012-12#4)(2012-2#2)(2012-3#12)(2013-1#12)(2013-7#3)(2013-8#8)
students)##5##1##(2007-1#1)(2008-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
students?##3##1##(2006-6#1)(2012-1#1)(2013-8#1)
students]##10##1##(1993-10#1)(1994-4#1)(1994-8#1)(1995-2#1)(1997-8#1)(2006-8#1)(2008-1#1)(2008-9#1)(2010-5#1)(2010-6#1)
studied (0##2##2##(2005-7#1)(2007-8#1)
studied (2##2##2##(1994-3#1)(2007-8#1)
studied (i##2##2##(1997-6#1)(2009-7#1)
studied (n =##2##3##(2005-11#1)(2011-2#1)
studied 1##3##2##(1994-12#1)(1995-6#1)(2011-2#1)
studied 10##2##2##(2006-8#1)(2009-4#1)
studied 135##2##2##(2006-10#1)(2008-4#1)
studied 14##2##2##(1991-5#1)(2008-4#1)
studied 17 patients##2##3##(2007-7#1)(2007-8#1)
studied 17##4##2##(1991-9#1)(1996-9#1)(2007-7#1)(2007-8#1)
studied 18##2##2##(1994-11#1)(2008-7#1)
studied 40##3##2##(1990-12#1)(2007-9#1)(2012-3#1)
studied 43 patients##2##3##(2008-7#2)
studied 45##2##2##(2007-11#1)(2007-9#1)
studied 60##2##2##(1997-8#1)(2010-7#1)
studied 66##3##2##(2007-8#1)(2013-1#2)
studied 81##2##2##(1990-4#1)(2012-3#1)
studied a total of##2##4##(2007-4#1)(2008-1#1)
studied a##25##2##(1990-3#1)(1992-8#1)(1993-6#2)(1995-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-4#1)(2008-1#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
studied according to a##2##4##(2006-10#1)(2008-7#1)
studied according to##3##3##(2006-10#1)(2008-7#1)(2009-10#1)
studied activity##2##2##(2012-1#1)(2013-7#1)
studied after##15##2##(1991-11#1)(1993-12#1)(1995-12#2)(1996-5#1)(2004-9#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-3#1)(2008-5#1)(2010-12#1)(2012-1#3)
studied against bacterial##2##3##(2008-5#2)
studied against##6##2##(1990-5#1)(1995-12#1)(1997-5#1)(2007-7#1)(2008-5#2)
studied all##3##2##(2005-4#1)(2006-10#1)(2008-3#1)
studied along##2##2##(2008-2#1)(2008-9#1)
studied also##2##2##(1996-1#1)(2008-10#1)
studied among##5##2##(2004-10#1)(2005-8#1)(2006-6#1)(2007-7#1)(2008-10#1)
studied an##2##2##(1990-12#1)(1997-2#1)
studied and a##4##3##(1990-11#1)(2008-10#2)(2008-11#1)
studied and applied##2##3##(2005-6#1)(2007-7#1)
studied and compared to##3##4##(1992-2#1)(2008-10#1)(2011-2#1)
studied and compared with a##2##5##(2008-2#1)(2008-3#1)
studied and compared with the##2##5##(2008-10#1)(2008-5#1)
studied and compared with those of##2##6##(2008-10#1)(2008-3#1)
studied and compared with those##3##5##(2008-10#2)(2008-3#1)
studied and compared with##11##4##(1990-7#1)(1992-6#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)
studied and compared##20##3##(1990-7#1)(1992-2#1)(1992-6#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2011-2#1)(2011-3#1)
studied and correlated with##2##4##(1990-12#1)(2008-10#1)
studied and evaluated##3##3##(2008-10#3)
studied and is##2##3##(2008-3#1)(2008-9#1)
studied and it was##4##4##(1995-2#1)(2007-11#1)(2008-10#2)
studied and its##2##3##(2008-7#1)(2013-8#1)
studied and optimized##17##3##(2005-12#1)(2006-5#1)(2007-10#1)(2008-10#13)(2013-8#1)
studied and reported##3##3##(2008-10#2)(2008-5#1)
studied and the##24##3##(1990-11#1)(1990-4#1)(2005-4#2)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#13)(2008-12#1)(2008-5#1)(2010-5#1)(2013-1#1)
studied and their##3##3##(2005-4#1)(2008-10#1)(2008-2#1)
studied and to##2##3##(1991-9#1)(2008-3#1)
studied and##161##2##(1990-11#2)(1990-12#1)(1990-4#1)(1990-7#2)(1991-11#1)(1991-12#1)(1991-9#1)(1992-2#1)(1992-6#1)(1994-2#2)(1994-3#1)(1994-5#1)(1995-2#1)(1995-5#1)(2004-11#2)(2005-11#1)(2005-12#1)(2005-4#3)(2005-6#1)(2005-8#1)(2006-5#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#66)(2008-11#1)(2008-12#3)(2008-2#5)(2008-3#9)(2008-5#6)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2010-12#1)(2010-3#2)(2010-5#2)(2010-7#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#3)
studied are a##2##3##(2005-11#1)(2013-7#1)
studied are##13##2##(1990-1#1)(1991-7#1)(1993-5#1)(2005-11#1)(2008-10#2)(2008-3#2)(2008-6#1)(2008-9#1)(2010-10#1)(2012-5#1)(2013-7#1)
studied areas##3##2##(2006-2#1)(2008-10#1)(2011-1#1)
studied as a function of pH##4##6##(1990-5#1)(1991-4#1)(1994-8#1)(2008-10#1)
studied as a function of temperature##2##6##(1997-4#1)(2013-8#1)
studied as a function of the##5##6##(1996-1#1)(2007-11#1)(2008-10#2)(2009-10#1)
studied as a function of##20##5##(1990-11#1)(1990-5#1)(1991-4#1)(1993-11#1)(1994-8#1)(1996-1#1)(1997-4#1)(2005-11#2)(2007-11#2)(2008-10#3)(2008-3#4)(2009-10#1)(2013-8#1)
studied as a model##2##4##(1993-6#1)(2008-9#1)
studied as a possible##2##4##(1996-11#1)(2005-7#1)
studied as a##43##3##(1990-11#1)(1990-5#1)(1990-8#1)(1991-4#1)(1991-8#1)(1992-6#1)(1993-11#1)(1993-6#1)(1994-6#1)(1994-8#1)(1996-1#1)(1996-11#1)(1997-4#1)(2005-11#2)(2005-7#1)(2006-10#1)(2007-11#3)(2008-10#11)(2008-3#6)(2008-4#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-2#1)(2013-8#1)
studied as an##2##3##(2005-7#1)(2008-8#1)
studied as potential##3##3##(1996-5#1)(2007-3#1)(2010-2#1)
studied as well##8##3##(1990-5#1)(2005-11#1)(2006-2#1)(2008-10#3)(2008-2#1)(2010-7#1)
studied as##81##2##(1990-11#1)(1990-5#2)(1990-8#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-4#1)(2005-11#4)(2005-7#2)(2006-10#3)(2006-2#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#19)(2008-2#2)(2008-3#7)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#2)(2010-12#1)(2010-2#2)(2010-4#2)(2010-7#1)(2011-1#1)(2013-1#2)(2013-8#2)
studied at 1##5##3##(1994-3#1)(2008-10#3)(2010-5#1)
studied at 25 degrees C##4##5##(1997-7#1)(2008-10#3)
studied at King##2##3##(2008-1#2)
studied at a##6##3##(1994-4#1)(2007-11#1)(2007-9#1)(2008-10#3)
studied at pH 5##2##4##(1990-6#1)(2008-10#1)
studied at pH##6##3##(1990-6#1)(1991-2#1)(1995-5#1)(1996-3#1)(2008-10#2)
studied at room temperature##3##4##(2006-12#1)(2007-10#1)(2009-11#1)
studied at the single cell level##2##6##(1991-10#1)(2007-12#1)
studied at the##23##3##(1991-10#1)(1992-3#1)(1993-2#1)(1996-1#1)(2005-8#1)(2006-10#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-8#1)(2010-12#1)(2011-10#1)(2012-3#1)(2013-1#2)(2013-7#1)
studied at##88##2##(1990-6#2)(1990-8#1)(1991-10#1)(1991-2#1)(1991-4#1)(1992-3#1)(1992-6#1)(1993-2#1)(1994-3#1)(1994-4#1)(1994-7#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-1#3)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-3#2)(2007-5#1)(2007-6#1)(2007-9#3)(2008-1#2)(2008-10#20)(2008-3#3)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-12#1)(2010-5#1)(2011-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
studied based on##2##3##(2005-4#1)(2006-8#1)
studied because of##4##3##(1990-12#1)(1997-7#1)(2008-10#1)(2013-7#1)
studied before and after##2##4##(1991-12#1)(1996-1#1)
studied before##3##2##(1991-12#1)(1995-9#1)(1996-1#1)
studied between##3##2##(1994-6#1)(2008-10#1)(2008-3#1)
studied biological##3##2##(1990-8#1)(2008-4#1)(2010-10#1)
studied both in##5##3##(1996-7#1)(2006-8#1)(2008-11#1)(2008-2#2)
studied both theoretically and experimentally##3##5##(1995-1#1)(2008-2#1)(2008-3#1)
studied both##11##2##(1995-1#1)(1996-7#1)(2004-9#1)(2006-2#1)(2006-8#1)(2008-11#1)(2008-2#3)(2008-3#1)(2012-3#1)
studied by (1)H##2##3##(1996-5#1)(2008-5#1)
studied by EPR and pulsed EPR spectroscopy##2##7##(1996-7#2)
studied by EPR##3##3##(1993-8#1)(1996-7#2)
studied by ID##2##3##(2008-5#2)
studied by NMR##5##3##(1992-4#1)(1995-3#1)(2005-4#1)(2006-10#1)(2006-12#1)
studied by UV-vis##2##3##(2007-9#1)(2010-4#1)
studied by X-ray crystallography##3##4##(1993-3#1)(1994-8#1)(2006-12#1)
studied by X-ray powder##2##4##(2006-12#1)(2013-8#1)
studied by X-ray##7##3##(1993-3#1)(1994-8#1)(2006-12#2)(2008-10#2)(2013-8#1)
studied by XPS##2##3##(2005-11#1)(2005-4#1)
studied by a combination of##2##5##(2005-11#1)(2008-1#1)
studied by a##12##3##(1990-4#1)(1993-12#1)(1997-4#1)(2005-10#1)(2005-11#1)(2005-4#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)
studied by an##4##3##(1994-6#1)(1996-1#1)(1996-9#1)(2010-3#1)
studied by analyzing##2##3##(1992-9#1)(2006-10#1)
studied by applying##5##3##(1995-4#1)(2008-10#4)
studied by both##2##3##(2008-10#2)
studied by circular dichroism (CD)##3##5##(1994-11#1)(1997-1#1)(2010-8#1)
studied by circular##4##3##(1991-8#1)(1994-11#1)(1997-1#1)(2010-8#1)
studied by comparing the##5##4##(1990-7#1)(1991-1#1)(1994-5#1)(2010-12#1)(2010-4#1)
studied by comparing##10##3##(1990-7#1)(1991-1#1)(1991-5#1)(1994-5#1)(1997-4#1)(2008-10#1)(2010-12#2)(2010-4#2)
studied by confocal##3##3##(2005-11#1)(2008-10#2)
studied by conventional##3##3##(2005-4#1)(2008-10#1)(2008-5#1)
studied by cyclic voltammetry (CV)##4##5##(2008-10#4)
studied by cyclic voltammetry and##2##5##(2005-11#1)(2007-8#1)
studied by cyclic voltammetry##12##4##(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#9)
studied by cyclic##13##3##(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#10)
studied by determining the##3##4##(1990-2#1)(1990-5#1)(2005-11#1)
studied by determining their##2##4##(2007-2#1)(2010-6#1)
studied by determining##5##3##(1990-2#1)(1990-5#1)(2005-11#1)(2007-2#1)(2010-6#1)
studied by deuterium NMR spectroscopy##2##5##(1990-12#1)(1991-2#1)
studied by deuterium##3##3##(1990-12#1)(1991-2#1)(1994-8#1)
studied by differential scanning calorimetry##6##5##(1992-3#1)(1993-8#2)(1997-2#1)(2005-11#1)(2011-2#1)
studied by enzyme-linked immunosorbent assay##2##5##(1990-8#1)(2009-5#1)
studied by flow cytometry##3##4##(1993-11#1)(2008-5#1)(2012-1#1)
studied by flow##5##3##(1993-11#1)(1994-5#1)(2008-10#1)(2008-5#1)(2012-1#1)
studied by fluorescence##3##3##(1994-2#1)(1995-1#1)(2005-11#1)
studied by gas##2##3##(1993-12#1)(2008-10#1)
studied by graphite furnace atomic absorption spectrometry##2##7##(2005-4#1)(2008-10#1)
studied by high-performance liquid chromatography##2##5##(1990-6#1)(1990-8#1)
studied by immunohistochemistry##3##3##(1996-5#1)(1997-7#1)(2013-8#1)
studied by in situ hybridization##2##5##(1993-5#1)(2012-1#1)
studied by in situ##4##4##(1993-5#1)(2008-10#1)(2010-11#1)(2012-1#1)
studied by in vivo##4##4##(1991-5#2)(1993-7#1)(2008-5#1)
studied by in##10##3##(1991-5#2)(1993-5#1)(1993-7#1)(2004-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-11#1)(2012-1#1)
studied by investigating##3##3##(1995-3#1)(1997-2#1)(2008-10#1)
studied by light and##3##4##(2007-7#1)(2008-10#1)(2012-2#1)
studied by light microscopy##3##4##(2007-12#1)(2010-12#1)(2012-1#1)
studied by light##6##3##(2007-12#1)(2007-7#1)(2008-10#1)(2010-12#1)(2012-1#1)(2012-2#1)
studied by liquid chromatography##2##4##(2008-10#2)
studied by low-temperature##2##3##(1991-7#1)(2005-11#1)
studied by magnetic##2##3##(1992-12#1)(2007-10#1)
studied by means of an##2##5##(1992-11#1)(1995-5#1)
studied by means of circular dichroism##2##6##(1991-9#1)(2006-12#1)
studied by means of different##2##5##(2006-4#1)(2008-10#1)
studied by means of the##2##5##(2008-10#2)
studied by means of##24##4##(1991-9#1)(1992-11#1)(1993-3#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-4#1)(1996-9#1)(2005-11#1)(2005-4#1)(2006-12#3)(2006-4#1)(2007-10#1)(2007-12#1)(2008-10#5)(2008-5#1)(2010-5#1)(2013-8#1)
studied by measurement of##3##4##(2007-11#1)(2008-2#1)(2008-5#1)
studied by measuring the##2##4##(2009-5#1)(2012-2#1)
studied by measuring##12##3##(1990-1#1)(1990-12#1)(1991-1#1)(1992-3#1)(1995-5#1)(2005-11#2)(2008-10#1)(2008-8#1)(2008-9#1)(2009-5#1)(2012-2#1)
studied by microdialysis##2##3##(1992-3#1)(2007-8#1)
studied by molecular##2##3##(2008-10#1)(2008-8#1)
studied by optical##4##3##(1990-2#1)(1994-12#1)(1995-2#1)(2006-12#1)
studied by proton##2##3##(1991-2#1)(1995-11#1)
studied by pulsed-field gradient##2##4##(2008-3#2)
studied by quantitative##3##3##(2008-7#1)(2009-2#1)(2012-1#1)
studied by site-directed##2##3##(1992-8#1)(1995-10#1)
studied by spectrofluorimetry##2##3##(2008-10#2)
studied by spectrophotometry##3##3##(2008-10#3)
studied by stopped-flow##4##3##(1990-2#1)(1990-3#1)(1991-2#1)(1995-2#1)
studied by surface##3##3##(2005-11#2)(2008-10#1)
studied by the##23##3##(1990-5#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-2#1)(2005-1#1)(2005-11#2)(2007-8#1)(2008-1#1)(2008-10#7)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
studied by this method##2##4##(1995-3#1)(2008-8#1)
studied by three##2##3##(1996-3#1)(2013-8#1)
studied by time-resolved fluorescence##2##4##(1991-7#1)(1993-8#1)
studied by time-resolved##4##3##(1990-8#1)(1991-7#1)(1993-8#1)(1994-11#1)
studied by transmission electron microscopy##3##5##(1996-5#1)(2008-12#1)(2009-2#1)
studied by two-dimensional##2##3##(1991-7#1)(2008-8#1)
studied by use of##5##4##(1993-8#1)(2006-4#1)(2007-12#1)(2008-2#2)
studied by using a##6##4##(1993-12#1)(1997-2#1)(2008-10#3)(2008-3#1)
studied by using different##2##4##(2008-10#1)(2010-5#1)
studied by using##32##3##(1990-10#1)(1990-12#1)(1991-1#1)(1991-11#1)(1991-7#1)(1992-11#1)(1992-7#1)(1993-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(2005-4#2)(2007-8#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#2)(2008-9#1)(2010-5#1)(2013-1#1)
studied by varying##2##3##(2005-12#1)(2008-10#1)
studied by##523##2##(1990-1#1)(1990-10#2)(1990-11#2)(1990-12#4)(1990-2#6)(1990-3#1)(1990-4#1)(1990-5#6)(1990-6#2)(1990-7#2)(1990-8#4)(1990-9#1)(1991-1#3)(1991-11#2)(1991-12#2)(1991-2#4)(1991-4#1)(1991-5#4)(1991-6#1)(1991-7#4)(1991-8#5)(1991-9#2)(1992-10#1)(1992-11#5)(1992-12#4)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#4)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#5)(1993-5#1)(1993-7#1)(1993-8#6)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#3)(1994-8#5)(1994-9#1)(1995-1#3)(1995-10#2)(1995-11#4)(1995-12#1)(1995-2#4)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#2)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#3)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#6)(1997-3#3)(1997-4#3)(1997-6#1)(1997-7#2)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#24)(2005-12#2)(2005-4#14)(2006-10#6)(2006-12#8)(2006-2#2)(2006-4#2)(2006-5#1)(2006-7#1)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#6)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#8)(2007-9#3)(2008-1#4)(2008-10#111)(2008-11#4)(2008-12#3)(2008-2#7)(2008-3#10)(2008-4#6)(2008-5#17)(2008-7#1)(2008-8#9)(2008-9#4)(2009-11#2)(2009-12#1)(2009-2#3)(2009-4#1)(2009-5#2)(2010-1#2)(2010-11#1)(2010-12#3)(2010-3#2)(2010-4#5)(2010-5#4)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#7)(2012-2#5)(2012-3#2)(2013-1#6)(2013-8#8)
studied can be##2##3##(2007-8#1)(2008-10#1)
studied can##4##2##(2006-9#1)(2007-8#1)(2008-10#2)
studied cases##4##2##(1993-2#1)(2008-11#1)(2011-2#1)(2013-8#1)
studied combinations##2##2##(2008-10#1)(2010-12#1)
studied compounds were##2##3##(2008-10#2)
studied compounds##9##2##(2008-10#7)(2008-5#1)(2012-2#1)
studied consisted of##2##3##(1993-9#1)(2011-2#1)
studied could be##2##3##(2008-10#1)(2011-1#1)
studied could##4##2##(2007-9#1)(2008-10#1)(2011-1#1)(2012-2#1)
studied countries##2##2##(2010-8#2)
studied different##2##2##(2006-8#1)(2008-7#1)
studied directly##3##2##(1994-11#1)(2007-12#1)(2007-9#1)
studied do not##4##3##(2008-10#3)(2013-1#1)
studied drug in##2##3##(2008-10#2)
studied drug##5##2##(2008-10#5)
studied drugs in##3##3##(2008-10#3)
studied drugs##6##2##(2008-10#6)
studied during a##6##3##(1995-2#1)(2007-2#3)(2008-10#1)(2008-4#1)
studied during the period##2##4##(1994-12#1)(2011-1#1)
studied during the##8##3##(1994-12#1)(1994-4#1)(1996-4#1)(2008-2#1)(2008-5#1)(2009-8#1)(2010-12#1)(2011-1#1)
studied during##27##2##(1990-4#1)(1992-2#1)(1992-6#1)(1994-12#1)(1994-4#1)(1995-2#1)(1996-4#1)(2007-2#3)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-1#3)(2012-2#1)(2013-7#2)
studied either##2##2##(2008-4#1)(2010-11#1)
studied elements##2##2##(2008-10#2)
studied employing##3##2##(1991-10#1)(2008-10#1)(2008-6#1)
studied even##2##2##(2008-10#2)
studied except##2##2##(2008-4#1)(2008-5#1)
studied exhibited##3##2##(1994-8#1)(2005-11#1)(2010-5#1)
studied experimentally and##2##3##(2007-12#1)(2008-2#1)
studied experimentally using##2##3##(2007-3#1)(2008-10#1)
studied experimentally##14##2##(2005-11#1)(2007-12#2)(2007-3#1)(2008-10#1)(2008-2#5)(2008-3#2)(2008-7#1)(2008-9#1)
studied expression of the##2##4##(1992-12#1)(1997-5#1)
studied extensively as##2##3##(2008-10#1)(2010-5#1)
studied extensively##24##2##(1995-2#1)(2005-11#1)(2005-9#1)(2007-1#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-8#2)(2010-10#1)(2010-2#1)(2010-5#1)(2010-7#1)(2012-12#1)(2012-2#2)(2013-8#2)
studied factors that##2##3##(2011-2#1)(2013-1#1)
studied factors##3##2##(2007-8#1)(2011-2#1)(2013-1#1)
studied following##3##2##(1994-11#1)(2008-10#1)(2008-5#1)
studied for a##6##3##(1996-5#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
studied for about##2##3##(1994-6#1)(2009-5#1)
studied for both##4##3##(2005-10#1)(2007-10#1)(2007-11#1)(2008-2#1)
studied for comparison##3##3##(1994-8#1)(2005-11#1)(2008-10#1)
studied for different##2##3##(2008-10#1)(2008-3#1)
studied for its##3##3##(1991-7#1)(2009-2#1)(2010-12#1)
studied for more than##2##4##(1995-12#1)(2006-6#1)
studied for possible##2##3##(1991-9#1)(2008-7#1)
studied for serological##2##3##(2007-7#1)(2008-1#1)
studied for several##3##3##(1994-11#1)(2008-10#1)(2013-1#1)
studied for the first time in##2##6##(1992-8#1)(1993-2#1)
studied for the first time##8##5##(1992-8#1)(1993-2#1)(2007-3#1)(2008-10#2)(2008-12#1)(2010-3#1)(2010-4#1)
studied for the presence of##4##5##(1991-2#1)(2007-7#1)(2008-10#1)(2013-8#1)
studied for the##33##3##(1990-12#1)(1990-8#1)(1991-2#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-2#1)(1997-8#1)(2006-6#1)(2007-3#1)(2007-7#1)(2008-10#10)(2008-12#1)(2008-2#1)(2009-2#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-8#3)
studied for their ability to##3##5##(1992-2#1)(1995-12#1)(2010-5#1)
studied for their##12##3##(1992-2#1)(1992-5#1)(1995-12#1)(1995-3#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-4#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-8#1)
studied for##137##2##(1990-12#2)(1990-8#1)(1991-10#1)(1991-2#2)(1991-4#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-8#2)(1992-9#2)(1993-12#1)(1993-2#1)(1994-11#1)(1994-6#1)(1994-8#3)(1995-12#4)(1995-2#1)(1995-3#1)(1995-4#1)(1996-12#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-8#1)(2005-10#1)(2005-11#2)(2006-1#1)(2006-10#1)(2006-6#2)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#4)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#31)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-2#2)(2009-5#2)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#6)
studied from a##3##3##(1994-6#1)(2005-4#1)(2008-10#1)
studied from the##4##3##(1991-2#1)(1992-1#1)(2008-10#1)(2013-1#1)
studied from this##2##3##(2007-12#1)(2008-4#1)
studied from##28##2##(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-7#1)(1994-6#1)(2005-11#1)(2005-4#1)(2006-10#1)(2007-12#1)(2007-3#2)(2007-6#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2009-9#1)(2013-1#1)
studied further##4##2##(1992-9#1)(2008-7#1)(2008-9#1)(2013-8#1)
studied gene##5##2##(2008-2#1)(2008-4#1)(2010-12#1)(2012-2#1)(2012-3#1)
studied group##2##2##(2007-11#1)(2011-2#1)
studied groups##3##2##(1995-12#1)(2013-8#2)
studied had##3##2##(1993-12#2)(2007-7#1)
studied have been##2##3##(2008-10#2)
studied have##5##2##(2007-11#1)(2008-10#3)(2008-11#1)
studied here##13##2##(1990-3#1)(1993-11#1)(1997-1#1)(1997-7#1)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-12#1)
studied herein##2##2##(2011-2#1)(2013-8#1)
studied histopathologically##2##2##(1994-12#1)(2011-2#1)
studied how##5##2##(1994-12#1)(1995-5#1)(2006-7#1)(2008-10#2)
studied human##2##2##(1994-5#1)(2008-5#1)
studied if##2##2##(1997-5#1)(2007-3#1)
studied immunohistochemically##2##2##(1995-7#1)(1996-7#1)
studied in 13##3##3##(1993-12#1)(1995-11#1)(1996-11#1)
studied in 14##3##3##(1991-8#1)(2006-12#1)(2008-5#1)
studied in 15##3##3##(1990-9#1)(2008-10#1)(2010-6#1)
studied in Wistar rats##2##4##(1991-4#1)(1992-9#1)
studied in a group of##2##5##(1991-8#1)(1996-7#1)
studied in a group##3##4##(1991-8#1)(1992-7#1)(1996-7#1)
studied in a human##2##4##(1993-7#1)(1996-4#1)
studied in a mouse model of##2##6##(1995-1#1)(2008-10#1)
studied in a mouse model##3##5##(1994-5#1)(1995-1#1)(2008-10#1)
studied in a number of##2##5##(2008-10#1)(2011-1#1)
studied in a patient##2##4##(1993-12#1)(2008-7#1)
studied in a rabbit##2##4##(1993-4#1)(2005-11#1)
studied in a sample of##2##5##(2007-2#1)(2008-7#1)
studied in a series of##3##5##(1997-4#1)(2005-8#1)(2008-7#1)
studied in a systematic##2##4##(2009-9#1)(2012-1#1)
studied in a##79##3##(1990-10#1)(1990-11#1)(1990-5#1)(1991-1#1)(1991-8#1)(1992-10#1)(1992-7#2)(1993-11#2)(1993-12#1)(1993-4#1)(1993-7#2)(1994-5#1)(1995-1#2)(1995-6#2)(1996-12#1)(1996-4#1)(1996-7#1)(1997-4#2)(2004-10#1)(2005-11#3)(2005-8#1)(2006-1#1)(2006-10#1)(2006-7#2)(2006-8#2)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#4)(2009-12#2)(2009-2#1)(2009-9#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#3)
studied in adult##3##3##(1992-8#1)(2007-1#1)(2010-12#1)
studied in all##2##3##(2007-8#1)(2012-2#1)
studied in an##13##3##(1993-12#1)(1993-2#1)(2004-4#1)(2006-3#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)
studied in animal##2##3##(1994-6#1)(2005-8#1)
studied in aqueous solution##5##4##(1996-2#1)(2008-10#3)(2008-3#1)
studied in aqueous##9##3##(1996-2#1)(2005-11#1)(2008-10#6)(2008-3#1)
studied in batch##3##3##(2008-10#2)(2008-11#1)
studied in both##5##3##(1990-5#1)(1991-5#1)(2008-10#1)(2009-2#1)(2012-2#1)
studied in cells##5##3##(1992-7#1)(1995-11#1)(1997-4#1)(2007-11#1)(2007-12#1)
studied in chloroform solutions##2##4##(1994-3#1)(2007-11#1)
studied in comparison##2##3##(2008-10#1)(2013-7#1)
studied in conscious##2##3##(1991-2#1)(1991-9#1)
studied in control##2##3##(1993-7#1)(1995-3#1)
studied in cultured##7##3##(1990-11#1)(1993-7#1)(1994-6#1)(1995-11#1)(1995-2#1)(1997-1#1)(2008-11#1)
studied in depth and##2##4##(2006-1#1)(2008-10#1)
studied in detail and##3##4##(2008-10#2)(2011-12#1)
studied in detail by using##2##5##(2005-4#1)(2008-10#1)
studied in detail by##5##4##(1990-12#1)(2005-4#1)(2008-10#2)(2010-4#1)
studied in detail in##2##4##(2008-3#1)(2010-3#1)
studied in detail to optimize the conditions for their##2##9##(2008-10#2)
studied in detail to optimize the conditions for##7##8##(2008-10#7)
studied in detail to optimize the conditions##8##7##(2008-10#8)
studied in detail##54##3##(1990-12#3)(1991-12#1)(1992-3#1)(1993-2#1)(2005-4#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#29)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2009-3#1)(2010-3#1)(2010-4#1)(2011-12#1)(2013-1#1)(2013-8#1)
studied in details##2##3##(2006-10#1)(2007-8#1)
studied in developing##2##3##(1991-12#1)(1995-11#1)
studied in different##5##3##(1992-6#1)(2006-10#1)(2007-1#1)(2007-12#1)(2009-3#1)
studied in experimental##3##3##(2008-10#1)(2010-12#1)(2013-7#1)
studied in female##2##3##(1990-3#1)(1997-3#1)
studied in fibroblasts from##2##4##(1993-8#1)(1995-3#1)
studied in fibroblasts##3##3##(1993-8#1)(1995-3#1)(2012-12#1)
studied in five##2##3##(1993-9#1)(1996-5#1)
studied in four##5##3##(1997-5#1)(2007-8#1)(2008-10#1)(2009-9#1)(2010-8#1)
studied in freshly##4##3##(1990-10#1)(1991-8#1)(1997-1#2)
studied in greater detail##2##4##(1993-1#1)(1995-6#1)
studied in human##5##3##(1990-9#1)(1994-3#1)(1996-5#1)(2008-11#2)
studied in humans##4##3##(1991-11#1)(1993-12#1)(1995-12#1)(2008-8#1)
studied in intact##2##3##(1993-8#1)(2008-5#1)
studied in isolated##4##3##(1991-1#1)(1993-8#1)(1995-8#2)
studied in isolation##2##3##(2006-10#1)(2008-9#1)
studied in long-term##2##3##(2008-10#1)(2008-11#1)
studied in male Fischer 344 rats##3##6##(1990-3#1)(1992-12#1)(2008-7#1)
studied in male##6##3##(1990-3#1)(1992-12#1)(1995-12#1)(2008-5#1)(2008-7#1)(2011-1#1)
studied in many laboratories##2##4##(1990-5#1)(2004-4#1)
studied in many##3##3##(1990-5#1)(2004-4#1)(2013-7#1)
studied in mice##2##3##(1993-11#1)(1993-3#1)
studied in more detail##3##4##(1997-3#1)(2007-7#1)(2008-4#1)
studied in mouse##3##3##(1990-5#1)(1994-11#1)(2013-1#1)
studied in nine##3##3##(1993-8#1)(1996-2#1)(2008-5#1)
studied in old##2##3##(1993-4#1)(2010-12#1)
studied in order to increase##2##5##(1995-6#1)(2008-10#1)
studied in order to##17##4##(1990-4#1)(1990-8#1)(1993-2#1)(1994-11#1)(1995-6#1)(2005-11#1)(2007-2#1)(2008-10#7)(2008-5#1)(2010-8#1)(2013-1#1)
studied in other##2##3##(2008-2#1)(2008-4#1)
studied in patients with##4##4##(1990-12#1)(1995-4#1)(1996-3#1)(2005-10#1)
studied in patients##5##3##(1990-12#1)(1995-4#1)(1996-3#1)(2005-10#1)(2008-1#1)
studied in peripheral blood##2##4##(2007-6#1)(2009-9#1)
studied in phase##2##3##(1996-8#1)(2008-5#1)
studied in pregnant##2##3##(1992-1#1)(2009-6#1)
studied in rat hippocampal slices##2##5##(1996-3#1)(1997-2#1)
studied in rat##10##3##(1990-2#1)(1991-9#1)(1992-11#1)(1994-3#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-3#1)(1996-5#1)(1997-2#1)
studied in rats and##2##4##(1991-5#1)(2011-1#1)
studied in rats with##3##4##(1993-2#1)(2010-12#1)(2012-1#1)
studied in rats##19##3##(1990-11#1)(1991-2#1)(1991-5#1)(1992-11#1)(1993-2#1)(1994-5#1)(1995-12#1)(1995-5#1)(1996-12#1)(2007-8#1)(2007-9#1)(2009-2#1)(2010-12#3)(2011-1#1)(2011-2#1)(2012-1#2)
studied in recent years##2##4##(2008-11#1)(2008-8#1)
studied in regard to##2##4##(1993-8#1)(1994-2#1)
studied in relation to##11##4##(1995-1#1)(1995-6#1)(1997-7#1)(2005-11#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-11#1)(2012-1#1)
studied in rodent##2##3##(1992-7#1)(1996-1#1)
studied in several##4##3##(1996-9#1)(2006-10#1)(2010-8#1)(2012-3#1)
studied in six##2##3##(1995-11#1)(2007-3#1)
studied in solution by##2##4##(1994-5#1)(2008-10#1)
studied in solution##3##3##(1993-3#1)(1994-5#1)(2008-10#1)
studied in synaptic##2##3##(1990-3#1)(1992-6#1)
studied in ten##3##3##(1993-11#1)(2006-12#1)(2008-1#1)
studied in terms of the##3##5##(1990-7#1)(1996-11#1)(2008-2#1)
studied in terms of##11##4##(1990-7#1)(1991-5#1)(1992-6#1)(1996-11#1)(2004-9#1)(2005-11#1)(2008-10#2)(2008-2#1)(2009-9#1)(2010-2#1)
studied in the adult##2##4##(1992-7#1)(1997-3#1)
studied in the context of##2##5##(1994-2#1)(2008-7#1)
studied in the field and##2##5##(2008-10#1)(2008-5#1)
studied in the field##3##4##(2008-10#2)(2008-5#1)
studied in the liver of##2##5##(1990-3#1)(2008-5#1)
studied in the past##4##4##(2006-10#1)(2007-12#1)(2008-1#1)(2012-7#1)
studied in the presence and absence of##2##7##(2008-10#2)
studied in the presence of##3##5##(2008-10#3)
studied in the presence##5##4##(2008-10#5)
studied in the present##2##4##(2008-11#1)(2008-5#1)
studied in the range of##3##5##(1990-5#1)(2008-10#2)
studied in the rat##7##4##(1992-7#1)(1994-2#1)(1995-12#1)(1996-12#2)(1996-2#1)(1997-2#1)
studied in the##109##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#3)(1990-7#3)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-12#1)(1994-2#5)(1994-5#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-7#2)(1995-8#1)(1996-11#2)(1996-12#3)(1996-2#2)(1996-4#1)(1996-7#1)(1997-2#3)(1997-3#2)(1997-5#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-9#1)(2011-2#1)(2012-3#1)(2012-7#1)(2013-1#1)(2013-8#2)
studied in their##2##3##(1991-4#1)(2008-10#1)
studied in these##2##3##(1994-11#1)(2006-10#1)
studied in this paper##6##4##(1993-6#1)(2005-4#1)(2008-10#3)(2012-1#1)
studied in this population##2##4##(2007-7#1)(2009-4#1)
studied in this work##5##4##(2007-11#1)(2008-3#1)(2010-1#1)(2010-7#1)(2011-1#1)
studied in this##17##3##(1990-12#1)(1993-6#1)(1994-6#1)(2005-4#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-3#1)(2009-4#1)(2010-1#1)(2010-7#1)(2011-1#1)(2012-1#1)(2013-1#1)
studied in three##2##3##(1996-2#1)(2010-8#1)
studied in transgenic##2##3##(1997-2#1)(1997-5#1)
studied in transmission##2##3##(2009-7#1)(2011-1#1)
studied in two##13##3##(1991-12#1)(1992-8#1)(1993-5#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-4#2)(2011-2#1)
studied in various##2##3##(2008-2#1)(2009-5#1)
studied in vitro and ex vivo##2##6##(2008-11#1)(2012-1#1)
studied in vitro and in vivo##3##6##(1996-5#1)(2008-5#1)(2013-8#1)
studied in vitro and##5##4##(1996-5#1)(2008-11#1)(2008-5#1)(2012-1#1)(2013-8#1)
studied in vitro using##3##4##(1993-9#1)(2008-10#1)(2009-10#1)
studied in vitro##25##3##(1990-7#1)(1990-9#1)(1991-2#1)(1992-9#1)(1993-12#2)(1993-3#2)(1993-9#1)(1994-2#1)(1996-11#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-8#1)(2009-10#1)(2012-1#1)(2013-1#1)(2013-8#1)
studied in vivo##6##3##(1992-7#1)(1993-12#1)(1993-4#1)(2007-12#1)(2008-5#1)(2010-3#1)
studied in yeast##3##3##(1997-6#1)(2005-8#1)(2008-11#1)
studied in##870##2##(1990-10#3)(1990-11#7)(1990-12#5)(1990-2#4)(1990-3#7)(1990-4#6)(1990-5#10)(1990-6#2)(1990-7#8)(1990-8#1)(1990-9#3)(1991-1#2)(1991-11#1)(1991-12#6)(1991-2#7)(1991-3#3)(1991-4#2)(1991-5#7)(1991-6#3)(1991-7#1)(1991-8#4)(1991-9#5)(1992-1#2)(1992-10#2)(1992-11#5)(1992-12#3)(1992-2#4)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#6)(1992-7#10)(1992-8#4)(1992-9#6)(1993-1#3)(1993-11#6)(1993-12#11)(1993-2#6)(1993-3#6)(1993-4#4)(1993-5#1)(1993-6#2)(1993-7#5)(1993-8#5)(1993-9#4)(1994-11#5)(1994-12#5)(1994-2#10)(1994-3#5)(1994-4#2)(1994-5#5)(1994-6#7)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#3)(1995-11#10)(1995-12#6)(1995-2#2)(1995-3#3)(1995-4#3)(1995-5#3)(1995-6#6)(1995-7#2)(1995-8#4)(1995-9#2)(1996-1#6)(1996-10#5)(1996-11#7)(1996-12#5)(1996-2#11)(1996-3#3)(1996-4#2)(1996-5#7)(1996-6#2)(1996-7#3)(1996-8#1)(1996-9#3)(1997-1#3)(1997-2#7)(1997-3#5)(1997-4#3)(1997-5#5)(1997-6#3)(1997-7#3)(1997-8#1)(2004-10#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-4#4)(2004-9#2)(2005-10#1)(2005-11#10)(2005-4#4)(2005-8#3)(2006-1#3)(2006-10#8)(2006-11#1)(2006-12#6)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#1)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#3)(2007-10#3)(2007-11#9)(2007-12#14)(2007-2#4)(2007-3#6)(2007-6#2)(2007-7#8)(2007-8#9)(2007-9#3)(2008-1#4)(2008-10#123)(2008-11#17)(2008-12#5)(2008-2#5)(2008-3#13)(2008-4#9)(2008-5#38)(2008-6#8)(2008-7#18)(2008-8#8)(2008-9#6)(2009-10#1)(2009-11#2)(2009-12#3)(2009-2#4)(2009-3#2)(2009-4#3)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#5)(2010-1#2)(2010-11#1)(2010-12#12)(2010-2#3)(2010-3#4)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#5)(2011-1#8)(2011-12#1)(2011-2#9)(2011-3#1)(2012-1#11)(2012-12#3)(2012-2#9)(2012-3#3)(2012-5#1)(2012-7#1)(2013-1#7)(2013-7#8)(2013-8#5)
studied include the##3##3##(2007-10#1)(2008-10#2)
studied include##9##2##(2005-11#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-6#1)(2012-2#1)
studied included##5##2##(1992-3#1)(1994-3#1)(2007-8#1)(2008-1#1)(2008-10#1)
studied including##5##2##(2006-2#1)(2006-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
studied is the##2##3##(2008-10#1)(2008-2#1)
studied is then##2##3##(2008-4#2)
studied is##12##2##(1993-3#1)(1994-8#1)(1995-11#1)(1997-3#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#1)
studied isolates##3##2##(2008-10#1)(2010-4#2)
studied its expression in##2##4##(1990-11#1)(1997-4#1)
studied its##15##2##(1990-11#1)(1991-1#1)(1991-2#1)(1991-6#1)(1994-8#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-9#2)(2011-2#1)(2012-3#2)
studied law##2##2##(2008-1#1)(2010-12#1)
studied mainly##2##2##(2008-10#1)(2010-5#1)
studied medicine##2##2##(2007-5#1)(2010-1#1)
studied methods##2##2##(2008-10#2)
studied more##3##2##(2008-10#2)(2009-3#1)
studied nine patients##2##3##(2006-7#1)(2008-1#1)
studied nine##4##2##(1996-12#1)(1997-5#1)(2006-7#1)(2008-1#1)
studied numerically##3##2##(2007-11#1)(2007-12#2)
studied of the##2##3##(1993-6#1)(2006-8#1)
studied of these##3##3##(1990-4#1)(2008-1#1)(2008-11#1)
studied of##11##2##(1990-4#1)(1990-9#1)(1993-6#1)(2005-10#1)(2006-6#3)(2006-8#1)(2008-1#2)(2008-11#1)
studied on a##7##3##(2008-10#5)(2008-5#1)(2010-4#1)
studied on bovine##2##3##(1991-4#1)(1994-8#1)
studied on five##2##3##(2008-10#1)(2009-8#1)
studied on human##3##3##(1990-8#1)(1996-12#1)(2010-12#1)
studied on the basis of##2##5##(2007-12#1)(2007-2#1)
studied on the##10##3##(1991-9#1)(1996-5#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-1#1)(2013-8#1)
studied on##55##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-8#1)(1993-6#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-5#1)(2005-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2008-10#14)(2008-11#1)(2008-4#1)(2008-5#4)(2009-12#1)(2009-8#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-1#3)(2013-8#1)
studied only in##2##3##(1997-7#1)(2010-1#1)
studied or##3##2##(2006-11#1)(2008-12#1)(2008-5#1)
studied over a period of##4##5##(1991-6#1)(1997-7#1)(2007-8#1)(2008-1#1)
studied over a wide##2##4##(2005-11#1)(2008-3#1)
studied over a##9##3##(1991-6#1)(1994-7#1)(1997-2#1)(1997-7#1)(2005-11#1)(2007-8#1)(2008-1#1)(2008-3#2)
studied over the past##3##4##(2005-7#1)(2007-8#1)(2009-2#1)
studied over the range##2##4##(1995-2#1)(2008-10#1)
studied over the##9##3##(1995-2#1)(1995-5#1)(1997-1#1)(2005-7#1)(2007-8#1)(2008-10#1)(2008-6#1)(2009-2#1)(2010-12#1)
studied over##23##2##(1991-6#1)(1994-7#1)(1995-2#1)(1995-5#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-1#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#2)(2009-2#1)(2010-12#1)(2013-1#2)
studied pH range##2##3##(2008-10#2)
studied pairs of##2##3##(2009-12#1)(2009-8#1)
studied parameters were##3##3##(2007-1#1)(2008-10#1)(2009-6#1)
studied parameters##12##2##(2006-6#2)(2007-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2009-6#1)(2009-9#1)
studied pathological##2##2##(2006-8#1)(2008-10#1)
studied patients with##3##3##(1997-8#1)(2008-1#1)(2008-5#1)
studied patients##7##2##(1990-6#1)(1997-8#1)(2006-2#2)(2008-1#1)(2008-5#1)(2013-1#1)
studied population was##3##3##(2007-7#1)(2008-3#1)(2011-2#1)
studied population##11##2##(2005-10#1)(2006-10#1)(2007-7#2)(2008-10#1)(2008-3#1)(2009-1#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#1)
studied populations were##2##3##(1997-7#1)(2008-10#1)
studied potentiometrically (H(+)-glass electrode)##3##4##(2008-10#3)
studied potentiometrically##6##2##(2008-10#6)
studied pre- and##2##3##(1997-1#1)(2007-7#1)
studied presented##2##2##(2006-8#1)(2007-11#1)
studied previously##7##2##(1990-5#1)(1991-11#1)(2005-10#1)(2006-3#1)(2007-5#1)(2008-7#1)(2012-7#1)
studied prospectively in##3##3##(1990-9#1)(1991-4#1)(2007-9#1)
studied prospectively##10##2##(1990-9#1)(1991-4#1)(1994-1#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2013-8#1)
studied proteins##3##2##(2008-4#1)(2012-12#1)(2013-8#1)
studied quantitatively##3##2##(1994-8#1)(2008-10#1)(2008-5#1)
studied ranged from##2##3##(2011-2#1)(2012-1#1)
studied ranged##3##2##(2007-3#1)(2011-2#1)(2012-1#1)
studied reaction##2##2##(1990-10#1)(2008-10#1)
studied retrospectively in##2##3##(1994-7#1)(2011-11#1)
studied retrospectively##16##2##(1990-9#1)(1994-7#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-8#1)(2004-10#1)(2005-10#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-4#1)(2011-1#1)(2011-11#1)(2011-2#1)
studied samples##2##2##(2007-10#1)(2008-10#1)
studied separately##3##2##(1996-2#1)(2004-12#1)(2009-8#1)
studied seven##2##2##(2008-10#1)(2011-1#1)
studied showing that##2##3##(1996-11#1)(2008-2#1)
studied showing##3##2##(1996-11#1)(2008-10#1)(2008-2#1)
studied since##4##2##(2005-7#1)(2007-1#1)(2012-12#1)(2012-2#1)
studied sites##2##2##(2008-10#1)(2008-5#1)
studied so far##5##3##(1993-9#1)(1997-6#1)(2008-5#1)(2008-7#2)
studied soils##2##2##(2008-10#2)
studied species##9##2##(1997-2#1)(2007-3#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-3#1)(2012-2#1)
studied spectrophotometrically##6##2##(2008-10#6)
studied strains and##2##3##(2007-10#1)(2012-12#1)
studied strains##6##2##(2007-10#1)(2007-7#1)(2010-2#1)(2010-4#1)(2012-12#2)
studied subjects##5##2##(1997-1#1)(2007-2#1)(2007-9#1)(2011-1#1)(2013-1#1)
studied such##2##2##(2008-5#1)(2013-1#1)
studied systematically##3##2##(2008-1#1)(2008-10#2)
studied systems##2##2##(1994-9#1)(2008-2#1)
studied the ability of##3##4##(1991-1#1)(2007-11#1)(2008-4#1)
studied the action of##2##4##(1992-4#1)(2010-4#1)
studied the association between##2##4##(2008-11#1)(2012-3#1)
studied the association of##2##4##(1991-12#1)(2008-10#1)
studied the association##4##3##(1991-12#1)(2008-10#1)(2008-11#1)(2012-3#1)
studied the behavior of##2##4##(1991-4#1)(2008-2#1)
studied the binding of##5##4##(1990-4#1)(1992-12#1)(1994-12#1)(1995-11#1)(1997-4#1)
studied the binding##6##3##(1990-4#1)(1992-12#1)(1994-12#1)(1995-11#1)(1997-4#1)(1997-6#1)
studied the blood##2##3##(2007-7#1)(2008-1#1)
studied the changes in##3##4##(1994-10#1)(2009-8#1)(2013-8#1)
studied the changes of##2##4##(2011-2#1)(2013-8#1)
studied the changes##5##3##(1994-10#1)(2009-8#1)(2011-2#1)(2013-8#2)
studied the clinical##4##3##(1991-11#1)(1991-5#1)(1991-8#1)(2010-12#1)
studied the contribution of##2##4##(1990-7#1)(2012-1#1)
studied the dependence##2##3##(1994-11#1)(2006-10#1)
studied the direct effects of##2##5##(1996-2#1)(2011-12#1)
studied the distribution of##5##4##(1995-5#1)(2005-8#1)(2008-10#1)(2010-12#1)(2013-1#1)
studied the dynamic changes##2##4##(1991-11#1)(2013-8#1)
studied the dynamic##3##3##(1991-11#1)(1995-2#1)(2013-8#1)
studied the effect of a##2##5##(1992-6#1)(1997-8#1)
studied the effect of an##2##5##(1994-4#1)(2007-5#1)
studied the effect of parathyroid hormone (PTH) and##2##8##(1992-6#1)(1994-11#1)
studied the effect of the##2##5##(1992-9#1)(1995-12#1)
studied the effect of##61##4##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-4#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-4#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-7#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-12#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-5#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#3)(2008-7#1)(2009-10#1)(2010-12#3)(2010-4#1)(2011-2#1)(2012-1#3)(2012-2#1)
studied the effects of a##2##5##(1997-5#1)(2008-12#1)
studied the effects of the##6##5##(1991-7#1)(1994-8#1)(1994-9#1)(1995-3#2)(2008-3#1)
studied the effects of two##3##5##(1994-10#1)(1997-7#1)(1997-8#1)
studied the effects of##51##4##(1990-11#1)(1991-10#1)(1991-7#1)(1991-9#1)(1992-4#1)(1993-1#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-3#3)(1996-11#1)(1997-1#1)(1997-5#2)(1997-7#2)(1997-8#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-9#1)(2010-2#1)(2011-10#1)(2012-1#3)(2013-1#1)(2013-8#5)
studied the effects##53##3##(1990-11#1)(1991-10#1)(1991-7#1)(1991-9#1)(1992-4#1)(1993-1#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-3#3)(1996-11#1)(1996-2#1)(1997-1#1)(1997-5#3)(1997-7#2)(1997-8#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-9#1)(2010-2#1)(2011-10#1)(2012-1#3)(2013-1#1)(2013-8#5)
studied the evolution of##4##4##(2006-12#1)(2008-2#1)(2008-9#1)(2012-3#1)
studied the expression of##10##4##(1992-5#1)(1993-8#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-6#1)(2008-7#1)(2008-9#2)(2013-8#1)
studied the expression##12##3##(1992-5#1)(1993-8#1)(1994-5#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-6#1)(2008-10#1)(2008-7#1)(2008-9#2)(2013-8#1)
studied the function of##2##4##(2008-8#1)(2012-2#1)
studied the functional##3##3##(1990-9#1)(1991-5#1)(2008-8#1)
studied the impact of two##2##5##(2008-5#1)(2013-1#1)
studied the impact of##4##4##(2007-8#1)(2008-5#1)(2008-7#1)(2013-1#1)
studied the influence of##14##4##(1991-12#1)(1993-11#1)(1994-6#1)(1994-8#1)(1996-5#1)(2007-10#1)(2007-12#1)(2008-3#2)(2008-5#3)(2008-8#1)(2011-1#1)
studied the interaction of##5##4##(1992-12#1)(1997-2#1)(2008-3#2)(2010-7#1)
studied the interaction##6##3##(1992-12#1)(1996-11#1)(1997-2#1)(2008-3#2)(2010-7#1)
studied the long term effects of##2##6##(1992-8#1)(2008-5#1)
studied the molecular##5##3##(1993-6#1)(1995-3#1)(1997-4#1)(1997-6#1)(2008-8#1)
studied the outcome of##2##4##(1990-9#1)(1991-11#1)
studied the physiological##2##3##(1997-4#1)(2007-2#1)
studied the prevalence of##2##4##(1990-12#1)(2013-1#1)
studied the prevalence##3##3##(1990-12#1)(2006-10#1)(2013-1#1)
studied the rate of##2##4##(2007-10#1)(2012-2#1)
studied the relationship between the##2##5##(1991-5#1)(2007-3#1)
studied the relationship between##7##4##(1991-5#1)(1992-9#1)(1994-12#1)(1997-2#1)(2006-4#1)(2007-3#1)(2008-5#1)
studied the reproductive##2##3##(2007-3#1)(2009-12#1)
studied the response of##2##4##(2010-7#1)(2013-7#1)
studied the response##3##3##(1992-12#1)(2010-7#1)(2013-7#1)
studied the role of##13##4##(1990-3#1)(1992-5#1)(1992-7#1)(1993-7#1)(1995-12#2)(1996-12#1)(1997-6#1)(2007-2#1)(2008-4#1)(2010-10#1)(2012-1#2)
studied the secretion##2##3##(1993-3#1)(1995-1#1)
studied the structure##2##3##(1992-12#1)(2006-10#1)
studied the survival##2##3##(2006-8#1)(2008-1#1)
studied the time##2##3##(1995-3#1)(2008-5#1)
studied the##465##2##(1990-1#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#3)(1991-12#3)(1991-3#1)(1991-4#3)(1991-5#5)(1991-7#2)(1991-8#3)(1991-9#4)(1992-10#1)(1992-11#2)(1992-12#7)(1992-2#1)(1992-3#2)(1992-4#3)(1992-5#3)(1992-6#3)(1992-7#4)(1992-8#3)(1992-9#2)(1993-1#3)(1993-11#3)(1993-12#1)(1993-3#1)(1993-4#3)(1993-5#3)(1993-6#2)(1993-7#1)(1993-8#4)(1993-9#2)(1994-10#3)(1994-11#7)(1994-12#6)(1994-2#2)(1994-3#1)(1994-4#1)(1994-5#4)(1994-6#2)(1994-8#3)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#4)(1995-12#7)(1995-2#5)(1995-3#7)(1995-4#1)(1995-5#3)(1995-6#1)(1995-7#4)(1996-1#1)(1996-10#1)(1996-11#5)(1996-12#3)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#2)(1996-8#2)(1996-9#4)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#4)(1997-5#5)(1997-6#4)(1997-7#5)(1997-8#3)(2004-11#1)(2004-12#2)(2005-11#4)(2005-12#1)(2005-4#2)(2005-8#1)(2006-10#6)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#1)(2006-8#6)(2006-9#1)(2007-1#1)(2007-10#6)(2007-11#2)(2007-12#5)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#3)(2007-9#3)(2008-1#3)(2008-10#17)(2008-11#8)(2008-12#3)(2008-2#13)(2008-3#17)(2008-4#10)(2008-5#17)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#6)(2009-10#2)(2009-11#1)(2009-12#3)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#6)(2010-2#3)(2010-4#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-10#1)(2011-12#2)(2011-2#3)(2012-1#12)(2012-2#5)(2012-3#3)(2012-9#1)(2013-1#8)(2013-7#3)(2013-8#17)
studied their##6##2##(1991-12#1)(2008-10#1)(2008-9#1)(2012-12#1)(2013-8#2)
studied theoretically and experimentally##2##4##(2007-12#1)(2008-3#1)
studied theoretically##7##2##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#1)
studied there##2##2##(1995-5#1)(1996-5#1)
studied this##3##2##(1990-2#1)(1991-11#1)(2008-4#1)
studied through a##4##3##(2007-11#1)(2008-3#1)(2008-7#1)(2008-9#1)
studied through the##3##3##(2005-11#1)(2008-10#1)(2012-12#1)
studied through##14##2##(2005-11#2)(2007-11#1)(2007-3#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-9#3)(2011-2#1)(2012-12#1)
studied thus far##2##3##(2007-12#1)(2012-2#1)
studied to assess the##2##4##(1991-9#1)(2008-10#1)
studied to assess##5##3##(1991-9#1)(1995-2#2)(2008-10#2)
studied to clarify##2##3##(1995-11#1)(1997-2#1)
studied to date##10##3##(1990-2#1)(1992-2#1)(1993-2#1)(1995-1#1)(1997-4#1)(1997-6#1)(2006-12#1)(2007-6#1)(2010-3#1)(2012-3#1)
studied to determine the##4##4##(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
studied to determine##12##3##(1993-11#1)(2005-10#1)(2005-4#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
studied to ensure##2##3##(2008-10#2)
studied to estimate##2##3##(1995-10#1)(2008-3#1)
studied to evaluate##6##3##(1991-8#1)(1997-6#1)(2007-9#1)(2008-10#1)(2008-5#1)(2012-2#1)
studied to find out##2##4##(2007-8#1)(2012-2#1)
studied to get##2##3##(2007-8#1)(2008-10#1)
studied to identify##2##3##(1990-4#1)(2008-5#1)
studied to test##2##3##(2008-10#2)
studied to understand##2##3##(2008-10#1)(2010-8#1)
studied to##75##2##(1990-2#1)(1990-4#1)(1991-1#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-2#2)(1992-3#1)(1993-11#1)(1993-2#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#2)(1996-1#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#2)(2005-10#1)(2005-11#1)(2005-4#1)(2006-12#2)(2007-10#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#4)(2008-7#2)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#2)
studied tumors##2##2##(2009-10#1)(2012-2#1)
studied two##5##2##(1993-4#1)(1995-5#1)(1995-6#1)(2008-10#1)(2008-5#1)
studied under conditions##4##3##(1992-3#1)(1996-5#1)(2010-12#1)(2012-1#1)
studied under different##3##3##(2008-10#3)
studied under laboratory conditions##3##4##(2007-6#1)(2008-12#1)(2011-2#1)
studied under the same##2##4##(1990-8#1)(2009-5#1)
studied under the##4##3##(1990-8#1)(2008-10#1)(2008-9#1)(2009-5#1)
studied under two##2##3##(1995-7#1)(2008-12#1)
studied under various##2##3##(1995-3#1)(1996-6#1)
studied under##34##2##(1990-8#1)(1991-2#2)(1992-2#1)(1992-3#1)(1992-8#1)(1995-3#1)(1995-7#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-11#2)(2006-1#1)(2007-6#1)(2008-10#7)(2008-12#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
studied until the##2##3##(1997-2#1)(2010-1#1)
studied up##2##2##(1996-7#1)(2011-2#1)
studied upon##3##2##(1991-2#1)(1996-7#1)(2008-3#1)
studied using a bioluminescent strain##2##5##(2008-10#2)
studied using a new##2##4##(2005-11#1)(2008-10#1)
studied using a##22##3##(1997-7#1)(2004-1#1)(2005-11#1)(2006-10#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-4#1)(2008-5#2)(2008-9#1)(2010-10#1)(2010-2#1)(2010-6#1)
studied using an##10##3##(1990-9#1)(1994-8#1)(1996-2#1)(1997-6#1)(1997-7#1)(2006-7#1)(2008-10#3)(2010-5#1)
studied using both##2##3##(2007-8#1)(2008-10#1)
studied using cyclic voltammetry##2##4##(2007-9#1)(2008-10#1)
studied using cyclic##3##3##(2007-9#1)(2008-10#2)
studied using digital##2##3##(1996-8#1)(2008-10#1)
studied using immersion tests##2##4##(2012-2#2)
studied using in##2##3##(1995-3#1)(1997-8#1)
studied using isolated##2##3##(1990-4#1)(1991-1#1)
studied using methanol##2##3##(1994-9#1)(2008-10#1)
studied using murine##2##3##(1996-6#1)(2008-5#1)
studied using quantitative##2##3##(1992-9#1)(1997-8#1)
studied using scanning electron##3##4##(1995-6#1)(2009-12#1)(2009-3#1)
studied using scanning##4##3##(1995-6#1)(2009-12#1)(2009-3#1)(2010-8#1)
studied using the##26##3##(1990-3#2)(1991-9#1)(1992-12#1)(1993-3#2)(1994-9#1)(1995-10#1)(1995-5#1)(1996-10#1)(1996-5#1)(1996-8#2)(1997-5#1)(2005-11#1)(2006-10#1)(2006-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-12#1)
studied using two##3##3##(2005-11#1)(2008-10#1)(2009-8#1)
studied using various##3##3##(1990-4#1)(1997-7#1)(2012-11#1)
studied using##232##2##(1990-11#1)(1990-3#3)(1990-4#4)(1990-5#1)(1990-9#1)(1991-1#2)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-10#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-11#2)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#4)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#4)(1995-6#2)(1995-7#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#4)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#4)(1997-2#1)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#3)(2004-1#1)(2004-9#1)(2005-11#9)(2005-4#1)(2006-10#7)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#51)(2008-11#1)(2008-12#2)(2008-4#2)(2008-5#9)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-11#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#2)
studied variables##2##2##(2007-8#1)(2011-2#1)
studied variation##2##2##(2006-12#1)(2008-8#1)
studied via##4##2##(1994-6#1)(1995-10#1)(2011-2#1)(2013-1#1)
studied was##15##2##(1991-12#2)(1992-7#1)(1993-6#1)(2005-11#2)(2007-10#1)(2007-7#1)(2008-10#3)(2008-6#1)(2009-5#1)(2012-2#2)
studied were also##2##3##(1997-4#1)(2008-2#1)
studied were higher than##2##4##(2008-10#1)(2008-5#1)
studied were higher##3##3##(2008-10#1)(2008-5#1)(2010-4#1)
studied were positive##2##3##(1996-12#1)(2007-6#1)
studied were the##4##3##(1991-4#1)(1994-5#1)(1996-5#1)(2008-10#1)
studied were##47##2##(1990-2#1)(1990-4#1)(1991-4#1)(1992-1#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-12#1)(1996-5#1)(1997-4#1)(2005-8#1)(2007-10#2)(2007-6#1)(2007-7#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-8#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-8#1)
studied when the##2##3##(2007-8#1)(2008-3#1)
studied when##6##2##(1990-9#1)(1992-6#1)(2007-8#1)(2008-10#2)(2008-3#1)
studied whether##9##2##(1992-12#1)(1993-7#2)(1994-6#1)(1996-10#1)(1997-3#1)(1997-8#1)(2011-12#1)(2012-3#1)
studied which indicates that##2##4##(1995-6#1)(2007-8#1)
studied which##3##2##(1995-6#1)(1997-2#1)(2007-8#1)
studied with Monte Carlo##2##4##(2008-3#2)
studied with a##11##3##(1995-8#1)(1996-6#1)(1997-4#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#1)(2012-11#1)(2012-2#1)
studied with an##4##3##(1990-12#1)(2005-11#1)(2007-8#1)(2008-2#1)
studied with polymerase chain reaction##2##5##(1996-6#1)(2008-10#1)
studied with reference to##2##4##(2007-7#1)(2008-2#1)
studied with regard to##4##4##(1996-2#1)(2006-8#1)(2008-10#2)
studied with respect to the##2##5##(2006-4#1)(2008-10#1)
studied with respect to their##2##5##(1990-11#1)(1993-6#1)
studied with respect to##7##4##(1990-11#1)(1993-10#1)(1993-6#1)(2006-4#1)(2008-10#1)(2008-5#1)(2010-2#1)
studied with the eyes##2##4##(1990-2#2)
studied with the##18##3##(1990-2#2)(1993-12#2)(2006-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
studied with##109##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#3)(1991-11#2)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-10#1)(1993-12#3)(1993-6#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#2)(1996-6#2)(1996-7#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-11#5)(2006-11#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-12#7)(2007-7#1)(2007-8#1)(2008-10#15)(2008-2#7)(2008-3#9)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
studied yet##2##2##(2007-11#1)(2013-8#1)
studied##5676##1##(1990-1#3)(1990-10#10)(1990-11#27)(1990-12#24)(1990-2#23)(1990-3#24)(1990-4#22)(1990-5#33)(1990-6#9)(1990-7#29)(1990-8#21)(1990-9#14)(1991-1#15)(1991-10#10)(1991-11#19)(1991-12#26)(1991-2#32)(1991-3#8)(1991-4#17)(1991-5#26)(1991-6#11)(1991-7#10)(1991-8#22)(1991-9#25)(1992-1#8)(1992-10#8)(1992-11#15)(1992-12#23)(1992-2#16)(1992-3#24)(1992-4#12)(1992-5#14)(1992-6#20)(1992-7#20)(1992-8#28)(1992-9#24)(1993-1#6)(1993-10#4)(1993-11#19)(1993-12#31)(1993-2#16)(1993-3#22)(1993-4#14)(1993-5#9)(1993-6#15)(1993-7#13)(1993-8#17)(1993-9#17)(1994-1#1)(1994-10#5)(1994-11#30)(1994-12#22)(1994-2#24)(1994-3#22)(1994-4#6)(1994-5#23)(1994-6#30)(1994-7#6)(1994-8#27)(1994-9#17)(1995-1#18)(1995-10#10)(1995-11#27)(1995-12#41)(1995-2#25)(1995-3#23)(1995-4#8)(1995-5#21)(1995-6#24)(1995-7#16)(1995-8#11)(1995-9#9)(1996-1#23)(1996-10#8)(1996-11#20)(1996-12#22)(1996-2#34)(1996-3#10)(1996-4#5)(1996-5#31)(1996-6#13)(1996-7#20)(1996-8#15)(1996-9#14)(1997-1#20)(1997-2#36)(1997-3#22)(1997-4#26)(1997-5#24)(1997-6#21)(1997-7#23)(1997-8#18)(2003-11#1)(2004-1#1)(2004-10#4)(2004-11#7)(2004-12#14)(2004-2#1)(2004-4#5)(2004-8#1)(2004-9#10)(2005-1#1)(2005-10#11)(2005-11#118)(2005-12#7)(2005-4#46)(2005-6#1)(2005-7#8)(2005-8#15)(2005-9#4)(2006-1#9)(2006-10#64)(2006-11#8)(2006-12#33)(2006-2#18)(2006-3#5)(2006-4#10)(2006-5#8)(2006-6#13)(2006-7#8)(2006-8#37)(2006-9#10)(2007-1#19)(2007-10#45)(2007-11#78)(2007-12#104)(2007-2#22)(2007-3#33)(2007-4#6)(2007-5#9)(2007-6#9)(2007-7#73)(2007-8#130)(2007-9#34)(2008-1#45)(2008-10#1040)(2008-11#66)(2008-12#47)(2008-2#103)(2008-3#152)(2008-4#69)(2008-5#193)(2008-6#37)(2008-7#81)(2008-8#72)(2008-9#62)(2009-1#3)(2009-10#11)(2009-11#13)(2009-12#13)(2009-2#19)(2009-3#17)(2009-4#12)(2009-5#15)(2009-6#6)(2009-7#7)(2009-8#25)(2009-9#10)(2010-1#9)(2010-10#8)(2010-11#11)(2010-12#57)(2010-2#21)(2010-3#16)(2010-4#34)(2010-5#17)(2010-6#3)(2010-7#16)(2010-8#19)(2010-9#2)(2011-1#51)(2011-10#4)(2011-11#1)(2011-12#9)(2011-2#86)(2011-3#5)(2012-1#67)(2012-11#8)(2012-12#35)(2012-2#80)(2012-3#48)(2012-5#2)(2012-7#2)(2012-8#1)(2012-9#1)(2013-1#85)(2013-7#30)(2013-8#84)
studied)##2##1##(1995-9#1)(2008-10#1)
studies (computed tomography##2##3##(2008-6#1)(2010-12#1)
studies (e##2##2##(1991-8#1)(2008-4#1)
studies (i##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
studies (level of evidence##2##4##(2011-12#2)
studies (n##2##2##(2008-10#1)(2009-8#1)
studies (up to##2##3##(2008-10#1)(2011-2#1)
studies - a##2##3##(2008-10#2)
studies -##3##2##(2008-10#2)(2010-8#1)
studies a##8##2##(1991-5#1)(1994-2#1)(2007-11#1)(2008-10#2)(2008-2#1)(2011-2#1)(2013-1#1)
studies about its##2##3##(2006-10#1)(2011-2#1)
studies about the##3##3##(2008-10#1)(2012-3#2)
studies about##11##2##(2006-10#2)(2008-10#2)(2008-9#1)(2011-12#1)(2011-2#1)(2012-3#2)(2013-1#2)
studies address the##2##3##(1993-12#1)(2010-10#1)
studies address##4##2##(1993-12#1)(2006-10#1)(2007-2#1)(2010-10#1)
studies addressing the##4##3##(2006-10#1)(2008-8#1)(2012-1#2)
studies addressing this##2##3##(2006-10#1)(2010-10#1)
studies addressing##10##2##(2006-10#2)(2007-11#1)(2007-2#1)(2008-8#2)(2010-10#1)(2012-1#2)(2012-2#1)
studies after##6##2##(1992-6#1)(2007-10#1)(2008-5#1)(2009-7#1)(2012-12#1)(2013-8#1)
studies agree##2##2##(1996-2#1)(2008-3#1)
studies aim to##2##3##(2008-2#1)(2008-6#1)
studies aimed at dissecting##2##4##(1994-5#1)(2005-10#1)
studies aimed at identifying##2##4##(2007-11#1)(2011-2#1)
studies aimed at understanding the##4##5##(1995-6#1)(2007-9#1)(2008-7#1)(2009-6#1)
studies aimed at understanding##6##4##(1995-6#1)(2006-2#1)(2007-9#1)(2008-7#2)(2009-6#1)
studies aimed at##21##3##(1991-5#1)(1993-3#1)(1994-5#1)(1995-6#1)(2005-10#1)(2006-2#2)(2007-11#1)(2007-9#1)(2008-5#1)(2008-7#2)(2009-3#1)(2009-6#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#3)
studies aimed to##2##3##(1990-10#1)(2009-4#1)
studies aimed##23##2##(1990-10#1)(1991-5#1)(1993-3#1)(1994-5#1)(1995-6#1)(2005-10#1)(2006-2#2)(2007-11#1)(2007-9#1)(2008-5#1)(2008-7#2)(2009-3#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#3)
studies all##2##2##(2007-12#1)(2009-7#1)
studies allow##2##2##(2008-11#1)(2008-2#1)
studies allowed##2##2##(1994-3#1)(2009-7#1)
studies also demonstrate that##3##4##(1996-10#1)(1997-4#1)(2005-7#1)
studies also demonstrated that##2##4##(2006-8#1)(2012-12#1)
studies also demonstrated##3##3##(2006-10#1)(2006-8#1)(2012-12#1)
studies also showed that the##3##5##(1997-6#1)(2008-5#1)(2012-2#1)
studies also showed that##5##4##(1991-7#1)(1996-12#1)(1997-6#1)(2008-5#1)(2012-2#1)
studies also suggest that the##3##5##(1995-10#1)(2011-2#1)(2013-8#1)
studies also suggest that##4##4##(1995-10#1)(2008-8#1)(2011-2#1)(2013-8#1)
studies also##39##2##(1990-10#1)(1991-1#1)(1991-7#1)(1992-8#1)(1994-10#1)(1995-10#1)(1996-10#1)(1996-12#1)(1997-4#1)(1997-6#1)(2005-7#2)(2006-10#2)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#3)(2009-4#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
studies among##2##2##(1994-3#1)(2009-2#1)
studies analyzing##2##2##(2008-11#1)(2008-2#1)
studies and a##8##3##(1993-8#1)(1996-11#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-7#1)(2010-12#1)(2012-12#1)
studies and also##2##3##(2008-4#1)(2008-5#1)
studies and an##3##3##(2007-11#1)(2009-10#1)(2011-2#1)
studies and are##4##3##(1991-2#1)(2007-11#2)(2010-12#1)
studies and assessment of##2##4##(1992-7#1)(2008-10#1)
studies and by##8##3##(1990-8#1)(1994-9#1)(1996-5#1)(1997-5#1)(2006-10#1)(2006-12#1)(2007-6#1)(2008-10#1)
studies and case reports##3##4##(2007-10#1)(2007-11#1)(2007-2#1)
studies and clinical trials have##2##5##(2004-1#1)(2008-8#1)
studies and clinical trials##6##4##(1993-11#1)(2004-1#1)(2005-10#1)(2008-8#1)(2010-4#1)(2010-8#1)
studies and clinical##12##3##(1992-6#1)(1993-11#1)(1993-5#1)(1997-1#2)(2004-1#1)(2005-10#1)(2006-10#1)(2008-8#1)(2010-4#1)(2010-8#1)(2012-3#1)
studies and computer-aided##2##3##(2006-12#1)(2007-11#1)
studies and data##2##3##(2008-7#1)(2009-12#1)
studies and discuss##2##3##(2008-11#1)(2012-1#1)
studies and early##2##3##(1996-8#1)(2006-6#1)
studies and experimental##2##3##(2009-10#1)(2010-10#1)
studies and for##5##3##(1992-7#2)(2008-4#1)(2008-9#1)(2011-2#1)
studies and four##2##3##(2008-12#1)(2010-10#1)
studies and from##3##3##(1990-5#1)(1996-8#1)(1997-7#1)
studies and functional##2##3##(2007-11#1)(2012-12#1)
studies and future##2##3##(2010-8#1)(2013-1#1)
studies and have##3##3##(2008-2#1)(2008-5#1)(2010-8#1)
studies and in##10##3##(1992-12#1)(1997-3#1)(2006-4#1)(2006-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-9#1)
studies and initial clinical##2##4##(2005-2#1)(2013-8#1)
studies and is##4##3##(1991-7#1)(2006-6#1)(2010-12#1)(2010-2#1)
studies and it has##2##4##(1996-2#1)(2009-3#1)
studies and new##3##3##(2008-1#2)(2013-1#1)
studies and one##5##3##(1990-5#1)(2005-8#1)(2008-8#1)(2012-3#1)(2013-7#1)
studies and other##4##3##(1990-4#1)(2007-11#1)(2008-8#1)(2010-10#1)
studies and our##2##3##(1997-2#1)(2009-2#1)
studies and patents##2##3##(2008-1#2)
studies and prospective##2##3##(2008-8#2)
studies and provide##2##3##(2008-3#1)(2009-2#1)
studies and provides##3##3##(2008-4#1)(2009-5#2)
studies and publications##2##3##(2011-2#1)(2012-12#1)
studies and purification##2##3##(1990-2#1)(2008-10#1)
studies and randomized controlled trials##2##5##(2005-10#1)(2006-5#1)
studies and reports of##2##4##(2006-10#1)(2007-5#1)
studies and several##3##3##(1990-1#1)(2007-8#1)(2008-3#1)
studies and spectroscopic data##2##4##(2007-1#1)(2009-3#1)
studies and studies##3##3##(2006-10#1)(2008-11#1)(2008-7#1)
studies and suggest that##2##4##(2006-10#1)(2010-8#1)
studies and that##2##3##(2009-4#1)(2012-2#1)
studies and the methodology##2##4##(2008-5#1)(2008-7#1)
studies and the##24##3##(1991-12#1)(1993-6#1)(1994-2#1)(1995-3#1)(1995-7#1)(2005-6#1)(2005-7#1)(2006-6#1)(2007-11#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-12#1)(2010-2#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#1)
studies and their##6##3##(1993-2#1)(2006-10#1)(2007-8#1)(2008-8#1)(2013-1#2)
studies and then##2##3##(2005-8#1)(2011-1#1)
studies and to##6##3##(2008-4#1)(2008-9#1)(2009-5#1)(2012-12#2)(2012-3#1)
studies and two##3##3##(2008-5#1)(2011-2#1)(2012-12#1)
studies and with##2##3##(1996-9#1)(2008-12#1)
studies and##360##2##(1990-1#1)(1990-2#2)(1990-4#1)(1990-5#2)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-7#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-6#3)(1992-7#3)(1992-8#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-8#3)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-1#1)(2004-12#1)(2004-4#1)(2004-7#1)(2005-10#5)(2005-2#1)(2005-6#1)(2005-7#3)(2005-8#4)(2006-10#12)(2006-12#3)(2006-2#3)(2006-4#1)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#14)(2007-12#1)(2007-2#2)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#6)(2008-10#20)(2008-11#9)(2008-12#4)(2008-2#2)(2008-3#5)(2008-4#7)(2008-5#11)(2008-6#2)(2008-7#8)(2008-8#12)(2008-9#4)(2009-10#3)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#6)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#3)(2010-12#6)(2010-2#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#8)(2010-9#1)(2011-1#8)(2011-2#12)(2012-1#1)(2012-11#1)(2012-12#11)(2012-2#5)(2012-3#9)(2013-1#12)(2013-7#2)(2013-8#6)
studies appear to##2##3##(2006-2#1)(2010-6#1)
studies applied##2##2##(2008-7#1)(2009-6#1)
studies applying##3##2##(2006-2#1)(2008-12#1)(2010-3#1)
studies are also##6##3##(1995-4#1)(2007-12#2)(2009-6#1)(2009-8#1)(2012-3#1)
studies are analysed##2##3##(1990-10#1)(1993-4#1)
studies are available##2##3##(2011-2#1)(2013-8#1)
studies are based on the##2##5##(2012-2#1)(2012-3#1)
studies are based on##3##4##(2008-7#1)(2012-2#1)(2012-3#1)
studies are being##3##3##(1994-6#1)(2005-7#1)(2013-8#1)
studies are carried out in##2##5##(2008-7#1)(2009-12#1)
studies are carried out##4##4##(2008-7#1)(2009-12#1)(2010-11#1)(2010-8#1)
studies are conducted to##2##4##(2008-10#1)(2009-10#1)
studies are consistent with an##2##5##(1994-11#1)(1995-12#1)
studies are consistent with the##4##5##(1994-8#1)(1997-1#1)(2007-8#1)(2008-10#1)
studies are consistent with##7##4##(1991-10#1)(1994-11#1)(1994-8#1)(1995-12#1)(1997-1#1)(2007-8#1)(2008-10#1)
studies are described##4##3##(2006-10#1)(2009-11#1)(2010-2#1)(2012-1#1)
studies are descriptive##2##3##(2011-2#1)(2012-2#1)
studies are difficult to##2##4##(1994-3#1)(2007-8#1)
studies are difficult##3##3##(1994-3#1)(2007-8#1)(2008-10#1)
studies are discussed##10##3##(1993-12#1)(1996-3#1)(2007-7#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-1#1)(2012-3#1)
studies are essential##3##3##(1993-12#1)(2011-2#2)
studies are examined##2##3##(2008-8#1)(2011-2#1)
studies are further##2##3##(2005-8#1)(2011-1#1)
studies are generally##2##3##(2008-2#1)(2010-11#1)
studies are identified##2##3##(2011-2#2)
studies are important for##3##4##(2008-2#1)(2011-1#1)(2013-8#1)
studies are important in##2##4##(1996-3#1)(2006-10#1)
studies are important##6##3##(1996-3#1)(2006-10#1)(2007-9#1)(2008-2#1)(2011-1#1)(2013-8#1)
studies are in progress to##2##5##(2006-12#1)(2008-12#1)
studies are in progress##3##4##(1993-11#1)(2006-12#1)(2008-12#1)
studies are in##5##3##(1991-9#1)(1993-11#1)(2006-12#1)(2008-12#1)(2008-9#1)
studies are lacking##5##3##(2005-10#1)(2006-10#2)(2006-12#1)(2012-12#1)
studies are limited in##2##4##(2008-1#1)(2010-8#1)
studies are limited##3##3##(2007-5#1)(2008-1#1)(2010-8#1)
studies are necessary before##2##4##(1996-3#1)(2012-12#1)
studies are necessary in##3##4##(2007-10#2)(2013-8#1)
studies are necessary to confirm these results##2##7##(2007-8#1)(2008-3#1)
studies are necessary to confirm##4##5##(2007-8#1)(2008-3#1)(2012-12#1)(2013-1#1)
studies are necessary to determine the##3##6##(2006-7#1)(2009-12#1)(2011-2#1)
studies are necessary to determine##6##5##(1993-7#1)(2006-7#1)(2007-8#1)(2009-12#1)(2011-2#1)(2013-8#1)
studies are necessary to##19##4##(1992-3#1)(1993-7#1)(2006-7#1)(2007-10#1)(2007-8#4)(2008-1#1)(2008-3#1)(2009-12#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
studies are necessary##28##3##(1992-3#1)(1993-7#1)(1996-3#1)(2006-10#1)(2006-7#1)(2007-10#3)(2007-8#4)(2008-1#1)(2008-3#2)(2009-12#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#3)(2012-2#2)(2013-1#1)(2013-8#2)
studies are needed for##2##4##(2008-10#1)(2008-12#1)
studies are needed in order to##3##6##(2008-10#1)(2011-1#1)(2013-1#1)
studies are needed to better understand the##2##7##(2010-4#1)(2013-1#1)
studies are needed to clarify the effects of##2##8##(2010-12#1)(2012-3#1)
studies are needed to clarify the##5##6##(1996-6#1)(2006-10#1)(2010-12#1)(2012-3#1)(2013-8#1)
studies are needed to clarify whether##2##6##(1991-3#1)(2007-11#1)
studies are needed to clarify##7##5##(1991-3#1)(1996-6#1)(2006-10#1)(2007-11#1)(2010-12#1)(2012-3#1)(2013-8#1)
studies are needed to confirm these##2##6##(2004-3#1)(2008-10#1)
studies are needed to confirm this##2##6##(2006-2#1)(2008-8#1)
studies are needed to confirm##9##5##(1995-12#1)(2004-3#1)(2006-2#1)(2008-10#2)(2008-4#1)(2008-8#1)(2011-2#1)(2013-8#1)
studies are needed to determine the role of##2##8##(1994-10#1)(2004-11#1)
studies are needed to determine the##5##6##(1994-10#1)(2004-11#1)(2006-5#1)(2007-11#1)(2008-9#1)
studies are needed to determine whether##2##6##(1993-11#1)(1993-8#1)
studies are needed to determine##11##5##(1993-11#1)(1993-8#1)(1994-10#1)(2004-11#1)(2004-3#1)(2006-5#1)(2007-10#1)(2007-11#1)(2008-12#1)(2008-9#1)(2009-4#1)
studies are needed to elucidate##5##5##(1995-6#1)(2007-9#1)(2008-3#1)(2010-10#1)(2012-12#1)
studies are needed to establish the##4##6##(1994-6#1)(2007-10#1)(2012-2#2)
studies are needed to establish##10##5##(1994-6#1)(2004-10#1)(2007-10#1)(2008-5#1)(2008-7#1)(2010-7#1)(2012-2#2)(2012-3#1)(2013-1#1)
studies are needed to evaluate the efficacy##2##7##(2007-3#1)(2009-11#1)
studies are needed to evaluate the##4##6##(2007-3#1)(2009-11#1)(2009-5#1)(2009-8#1)
studies are needed to evaluate##8##5##(1994-10#1)(2007-3#1)(2007-8#1)(2008-3#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-12#1)
studies are needed to further##3##5##(2007-2#1)(2008-7#1)(2011-2#1)
studies are needed to identify the##3##6##(1997-8#1)(2007-2#1)(2008-3#1)
studies are needed to investigate##3##5##(2006-10#1)(2006-2#1)(2008-1#1)
studies are needed to substantiate##2##5##(2011-2#1)(2012-12#1)
studies are needed to##83##4##(1991-3#1)(1991-6#1)(1993-11#1)(1993-8#1)(1994-10#2)(1994-6#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-6#1)(1997-8#1)(2004-10#1)(2004-11#1)(2004-3#2)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-5#1)(2007-10#3)(2007-11#2)(2007-2#2)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#4)(2012-11#2)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#3)
studies are needed##103##3##(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1993-11#1)(1993-8#1)(1994-10#2)(1994-6#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-6#1)(1996-8#1)(1997-8#1)(2004-10#1)(2004-11#1)(2004-3#2)(2005-7#1)(2006-10#4)(2006-12#1)(2006-2#2)(2006-5#1)(2007-10#3)(2007-11#3)(2007-2#2)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-11#2)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#3)
studies are not conclusive##2##4##(1997-6#1)(2011-1#1)
studies are not yet available##2##5##(1997-3#1)(2006-12#1)
studies are not##10##3##(1990-6#1)(1994-6#1)(1997-3#1)(1997-6#1)(2006-12#1)(2007-8#1)(2008-5#1)(2010-2#1)(2011-1#2)
studies are now##3##3##(1997-3#1)(2005-11#1)(2008-9#1)
studies are of##2##3##(2008-9#1)(2011-2#1)
studies are often##7##3##(1997-3#1)(2006-2#1)(2006-8#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
studies are ongoing##2##3##(2005-8#1)(2011-2#1)
studies are outlined##2##3##(1991-9#1)(1996-4#1)
studies are performed##5##3##(1992-12#1)(1997-3#1)(2006-10#1)(2006-8#1)(2008-7#1)
studies are planned to##3##4##(2008-10#1)(2008-11#1)(2008-6#1)
studies are presented##11##3##(1990-5#1)(1995-5#1)(2006-3#1)(2006-9#1)(2007-9#1)(2008-2#1)(2008-3#3)(2011-2#1)(2012-2#1)
studies are recommended##2##3##(1991-2#1)(2008-8#1)
studies are reported for##3##4##(1991-11#1)(2008-10#2)
studies are reported in##2##4##(2004-12#1)(2008-5#1)
studies are reported##8##3##(1991-11#1)(2004-12#1)(2008-10#3)(2008-12#1)(2008-5#1)(2012-12#1)
studies are required as##2##4##(2008-10#1)(2010-12#1)
studies are required to assess the##2##6##(2007-11#1)(2007-9#1)
studies are required to clarify the##4##6##(1992-9#1)(2007-11#1)(2010-8#1)(2012-2#1)
studies are required to clarify##5##5##(1992-9#1)(1994-9#1)(2007-11#1)(2010-8#1)(2012-2#1)
studies are required to determine the##3##6##(2007-11#1)(2007-7#1)(2008-2#1)
studies are required to determine##4##5##(1992-7#1)(2007-11#1)(2007-7#1)(2008-2#1)
studies are required to elucidate the##2##6##(2008-6#1)(2012-2#1)
studies are required to establish##3##5##(1996-9#1)(2012-2#1)(2013-1#1)
studies are required to##34##4##(1990-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-9#1)(1996-6#1)(1996-9#1)(2005-10#1)(2005-11#1)(2007-11#3)(2007-2#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-6#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#2)
studies are required##46##3##(1990-6#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-9#1)(1995-8#1)(1996-6#1)(1996-9#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-11#4)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#2)
studies are reviewed##6##3##(2007-2#1)(2008-1#1)(2009-4#1)(2012-1#1)(2012-2#2)
studies are still lacking##2##4##(2008-10#1)(2008-3#1)
studies are still##3##3##(2008-10#1)(2008-3#1)(2009-3#1)
studies are the##3##3##(1995-5#1)(2008-10#1)(2008-5#1)
studies are undertaken##2##3##(2012-2#1)(2012-3#1)
studies are underway to##3##4##(2005-7#1)(2007-11#1)(2009-1#1)
studies are underway##4##3##(2005-7#1)(2007-11#2)(2009-1#1)
studies are urgently##2##3##(2005-11#1)(2008-8#1)
studies are used to##3##4##(2008-4#1)(2010-2#1)(2010-5#1)
studies are used##4##3##(1990-3#1)(2008-4#1)(2010-2#1)(2010-5#1)
studies are warranted to elucidate the##2##6##(2006-10#1)(2007-8#1)
studies are warranted to##13##4##(1995-12#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#2)(2011-2#1)
studies are warranted##21##3##(1995-12#1)(2004-3#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-6#2)(2006-7#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
studies are##461##2##(1990-10#2)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-12#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-10#2)(1994-11#2)(1994-3#2)(1994-6#3)(1994-8#1)(1994-9#1)(1995-12#3)(1995-4#1)(1995-5#3)(1995-6#2)(1995-8#1)(1996-10#1)(1996-3#4)(1996-4#1)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#4)(1997-6#1)(1997-7#1)(1997-8#3)(2004-10#1)(2004-11#1)(2004-12#2)(2004-3#3)(2005-10#2)(2005-11#4)(2005-7#3)(2005-8#3)(2006-1#1)(2006-10#15)(2006-12#4)(2006-2#5)(2006-3#2)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#3)(2006-9#3)(2007-10#8)(2007-11#14)(2007-12#2)(2007-2#4)(2007-3#2)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#13)(2007-9#4)(2008-1#6)(2008-10#22)(2008-11#6)(2008-12#6)(2008-2#8)(2008-3#12)(2008-4#11)(2008-5#10)(2008-6#3)(2008-7#9)(2008-8#9)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#2)(2010-10#1)(2010-11#4)(2010-12#9)(2010-2#4)(2010-3#2)(2010-4#1)(2010-5#3)(2010-7#2)(2010-8#5)(2011-1#9)(2011-12#1)(2011-2#22)(2012-1#5)(2012-11#2)(2012-12#11)(2012-2#19)(2012-3#12)(2013-1#14)(2013-8#12)
studies as a function of##2##5##(1997-8#1)(2008-10#1)
studies as a##7##3##(1997-8#1)(2006-12#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-12#1)
studies as an##2##3##(2009-8#1)(2010-8#1)
studies as the##2##3##(1995-3#1)(1997-6#1)
studies as to the##2##4##(2003-11#1)(2008-12#1)
studies as well as gene##2##5##(1996-6#1)(1996-9#1)
studies as well as the##2##5##(2007-11#1)(2012-11#1)
studies as well as##13##4##(1990-6#1)(1994-10#1)(1996-6#1)(1996-9#1)(2005-10#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-4#1)(2010-12#1)(2010-6#1)(2012-11#1)
studies as well##16##3##(1990-6#1)(1994-10#1)(1995-9#1)(1996-6#1)(1996-9#1)(2005-10#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-4#1)(2009-6#1)(2010-12#1)(2010-6#1)(2012-11#1)(2013-1#1)
studies as##37##2##(1990-6#1)(1994-10#1)(1994-12#1)(1994-9#1)(1995-3#1)(1995-9#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-6#1)(1997-8#1)(2003-11#1)(2005-10#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-6#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-8#1)(2012-11#1)(2012-2#1)(2012-5#1)(2013-1#1)
studies assessing the##2##3##(1997-2#1)(2006-10#1)
studies assessing##4##2##(1997-2#1)(2005-11#1)(2006-10#1)(2008-11#1)
studies at pH##2##3##(1990-12#1)(2008-10#1)
studies at the##7##3##(1994-2#1)(1995-12#1)(2005-10#1)(2006-4#1)(2007-8#1)(2008-7#1)(2013-8#1)
studies at##28##2##(1990-12#1)(1992-11#1)(1994-2#1)(1995-12#1)(2005-10#1)(2005-3#1)(2005-9#1)(2006-10#2)(2006-4#1)(2007-8#2)(2008-10#5)(2008-4#1)(2008-5#4)(2008-7#1)(2008-9#1)(2011-2#2)(2012-11#1)(2013-8#1)
studies attempted to##2##3##(2006-12#1)(2008-3#1)
studies available to##3##3##(2007-11#2)(2013-1#1)
studies available##5##2##(1995-11#1)(2006-12#1)(2007-11#2)(2013-1#1)
studies based on the##9##4##(1991-4#1)(1992-9#1)(2008-1#2)(2008-10#1)(2008-5#1)(2009-2#1)(2009-7#1)(2012-1#1)
studies based on##19##3##(1991-4#1)(1991-8#1)(1992-9#2)(1996-2#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-5#1)(2009-2#1)(2009-5#1)(2009-7#1)(2012-1#1)(2012-12#1)(2013-8#1)
studies be##2##2##(2007-2#1)(2008-10#1)
studies because of##2##3##(2008-2#1)(2008-5#1)
studies because they##2##3##(2007-12#1)(2010-8#1)
studies because##6##2##(2006-10#1)(2007-12#1)(2008-2#1)(2008-5#1)(2010-8#1)(2011-2#1)
studies before##4##2##(2006-6#1)(2008-6#1)(2012-12#1)(2012-2#1)
studies between##9##2##(1990-7#1)(2008-10#2)(2008-6#1)(2008-7#1)(2010-2#1)(2010-9#1)(2012-3#1)(2013-8#1)
studies but is##2##3##(1996-5#1)(2007-11#1)
studies but##10##2##(1996-5#1)(2007-11#2)(2008-11#1)(2008-3#2)(2008-5#1)(2009-6#1)(2011-2#1)(2012-3#1)
studies by incorporating##3##3##(1992-9#1)(2012-2#2)
studies by the##2##3##(2008-8#1)(2008-9#1)
studies by##32##2##(1990-10#1)(1990-11#1)(1992-8#2)(1992-9#1)(1993-11#1)(1994-11#1)(1994-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-8#1)(2005-4#1)(2005-7#1)(2006-11#1)(2007-11#1)(2007-4#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#2)(2008-8#1)(2008-9#1)(2010-11#1)(2012-2#4)
studies can be applied##2##4##(2008-10#1)(2008-11#1)
studies can be used to##2##5##(2008-10#1)(2008-9#1)
studies can be used##3##4##(2008-10#1)(2008-9#1)(2011-2#1)
studies can be##15##3##(2007-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)
studies can define the##2##4##(2005-7#1)(2008-7#1)
studies can help to##2##4##(2006-10#1)(2008-4#1)
studies can##25##2##(2005-7#1)(2006-10#1)(2007-1#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#3)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#3)
studies cannot be##2##3##(1996-12#1)(2009-9#1)
studies cannot##6##2##(1996-12#1)(2006-12#1)(2006-7#1)(2009-9#1)(2012-2#1)(2013-1#1)
studies carried out in the##4##5##(1994-6#1)(2008-10#2)(2008-7#1)
studies carried out in##11##4##(1994-6#1)(1996-7#1)(1997-2#1)(1997-8#1)(2007-2#2)(2008-10#3)(2008-7#1)(2010-5#1)
studies carried out on##2##4##(2008-10#1)(2013-7#1)
studies carried out through##2##4##(2008-10#1)(2012-2#1)
studies carried out to##3##4##(2007-10#1)(2008-10#2)
studies carried out with##3##4##(1990-5#1)(1991-9#1)(1995-3#1)
studies carried out##22##3##(1990-5#1)(1991-9#1)(1994-11#1)(1994-6#1)(1995-3#1)(1996-7#1)(1997-2#1)(1997-8#1)(2007-10#1)(2007-2#2)(2008-10#7)(2008-7#1)(2010-5#1)(2012-2#1)(2013-7#1)
studies clearly##3##2##(1990-7#1)(1995-12#1)(1996-2#1)
studies combined##2##2##(2012-12#1)(2013-1#1)
studies combining##2##2##(2007-11#1)(2008-9#1)
studies compared##10##2##(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2011-12#2)(2012-12#2)(2012-2#1)
studies comparing the##7##3##(1990-2#1)(1996-6#1)(2006-2#1)(2006-3#1)(2007-11#1)(2008-3#1)(2009-7#1)
studies comparing##22##2##(1990-2#1)(1992-1#1)(1992-9#1)(1993-11#1)(1993-8#1)(1996-6#1)(2006-2#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
studies concerning the##3##3##(1994-6#1)(2005-7#1)(2013-1#1)
studies concerning##10##2##(1992-9#1)(1994-6#1)(1995-8#1)(2005-7#1)(2006-10#1)(2008-8#1)(2010-11#1)(2013-1#2)(2013-7#1)
studies concluding that##3##3##(1992-4#1)(2006-8#1)(2012-3#1)
studies conducted across##2##3##(2008-8#1)(2009-5#1)
studies conducted at##2##3##(2007-12#1)(2012-1#1)
studies conducted by the authors##2##5##(1995-1#1)(2012-3#1)
studies conducted by the##3##4##(1995-1#1)(2006-10#1)(2012-3#1)
studies conducted by##4##3##(1995-1#1)(2006-10#1)(2011-2#1)(2012-3#1)
studies conducted during##2##3##(2008-10#1)(2008-11#1)
studies conducted for##2##3##(2008-10#1)(2008-2#1)
studies conducted in the##4##4##(1990-8#1)(1991-9#1)(1994-9#1)(1995-1#1)
studies conducted in##17##3##(1990-8#1)(1991-5#2)(1991-9#1)(1994-9#1)(1995-1#1)(1996-1#1)(2006-4#1)(2008-10#2)(2008-7#1)(2009-1#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#2)
studies conducted on the##2##4##(2011-2#1)(2013-1#1)
studies conducted on##4##3##(1995-3#1)(1997-4#1)(2011-2#1)(2013-1#1)
studies conducted over##2##3##(2008-12#1)(2012-1#1)
studies conducted to##2##3##(1995-9#1)(2007-11#1)
studies conducted with##2##3##(2008-5#2)
studies conducted##49##2##(1990-8#1)(1991-5#2)(1991-9#1)(1992-10#1)(1994-9#1)(1995-1#2)(1995-3#1)(1995-9#1)(1996-1#1)(1997-4#1)(2006-1#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-3#1)(2013-1#1)(2013-7#1)
studies confirm that##7##3##(1991-2#1)(1993-6#1)(1995-2#1)(2004-11#1)(2007-10#1)(2008-9#1)(2010-1#1)
studies confirm the presence of##2##5##(2008-3#1)(2008-5#1)
studies confirm the##6##3##(2006-10#1)(2008-3#1)(2008-5#4)
studies confirm##20##2##(1991-2#1)(1991-7#1)(1993-2#1)(1993-6#1)(1995-2#1)(2004-11#1)(2006-10#3)(2007-10#1)(2008-3#2)(2008-5#5)(2008-7#1)(2008-9#1)(2010-1#1)
studies confirmed a##2##3##(1997-8#1)(2006-10#1)
studies confirmed that the##2##4##(2006-8#1)(2008-10#1)
studies confirmed that##6##3##(1994-5#1)(1997-1#1)(2006-10#1)(2006-8#1)(2008-10#1)(2010-12#1)
studies confirmed the##4##3##(1992-6#1)(2006-12#1)(2008-12#1)(2010-12#1)
studies confirmed##15##2##(1992-6#1)(1994-11#1)(1994-5#1)(1997-1#1)(1997-8#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-12#2)
studies confirming that##2##3##(1990-5#1)(2008-10#1)
studies consider the##2##3##(1992-3#1)(2007-12#1)
studies consider##3##2##(1992-3#1)(2007-12#1)(2009-5#1)
studies contained##2##2##(2006-2#1)(2011-2#1)
studies continue to##3##3##(2006-9#1)(2008-5#1)(2008-8#1)
studies controlling##2##2##(2009-8#1)(2013-1#1)
studies could be##2##3##(2006-8#1)(2007-11#1)
studies could##5##2##(2006-8#1)(2006-9#1)(2007-11#1)(2007-9#1)(2011-2#1)
studies covering##2##2##(2008-1#1)(2008-4#1)
studies dealing with the##2##4##(1997-7#1)(2010-5#1)
studies dealing with##7##3##(1996-5#1)(1996-6#1)(1997-7#1)(2006-2#1)(2010-5#1)(2011-2#1)(2012-7#1)
studies dealt with##2##3##(2006-10#1)(2008-11#1)
studies define##3##2##(2006-10#1)(2008-3#1)(2012-12#1)
studies defined a##2##3##(1993-1#1)(2005-7#1)
studies demonstrate a##4##3##(1991-5#1)(2008-3#1)(2008-5#1)(2011-1#1)
studies demonstrate an##2##3##(1990-12#1)(2006-1#1)
studies demonstrate that both##2##4##(1995-10#1)(1997-6#1)
studies demonstrate that it##2##4##(1994-10#1)(2008-7#1)
studies demonstrate that the##14##4##(1990-10#2)(1990-2#1)(1995-2#1)(1995-3#1)(1996-7#1)(1997-6#1)(2006-9#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)
studies demonstrate that these##3##4##(2005-7#1)(2010-2#1)(2010-7#1)
studies demonstrate that##50##3##(1990-10#2)(1990-2#1)(1991-12#2)(1991-4#1)(1992-2#1)(1992-7#2)(1992-8#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-8#1)(1995-10#1)(1995-2#2)(1995-3#2)(1995-7#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-6#2)(2005-10#1)(2005-7#1)(2006-9#2)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-2#2)(2010-7#1)(2011-2#2)(2012-1#1)(2013-1#1)
studies demonstrate the##5##3##(1990-12#1)(1991-8#1)(2008-10#1)(2008-4#1)(2008-7#1)
studies demonstrate##71##2##(1990-10#2)(1990-12#2)(1990-2#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-7#2)(1992-8#1)(1993-7#1)(1993-8#1)(1994-10#2)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-7#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-6#2)(2005-10#1)(2005-7#1)(2006-1#1)(2006-9#2)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)
studies demonstrated a high##2##4##(2008-10#1)(2010-11#1)
studies demonstrated a##8##3##(1994-3#1)(2006-11#1)(2006-6#1)(2008-10#1)(2008-9#1)(2009-5#1)(2010-11#1)(2013-1#1)
studies demonstrated that all##2##4##(1991-9#1)(2009-8#1)
studies demonstrated that the##11##4##(1990-2#1)(1991-11#1)(1993-3#1)(1993-5#1)(1994-8#1)(1995-3#1)(1995-6#1)(2006-3#1)(2008-10#1)(2008-11#1)(2011-2#1)
studies demonstrated that##40##3##(1990-2#1)(1990-4#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-7#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-6#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#4)(2009-12#1)(2009-8#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
studies demonstrated the feasibility of##2##5##(2007-8#1)(2011-2#1)
studies demonstrated the##8##3##(1990-5#1)(1994-2#1)(1994-3#1)(2007-8#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-3#1)
studies demonstrated##72##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-3#1)(2006-6#1)(2007-11#4)(2007-8#2)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#3)(2008-8#5)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#3)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
studies demonstrating associations between##2##4##(2008-1#1)(2012-1#1)
studies demonstrating that the##2##4##(2004-10#1)(2008-12#1)
studies demonstrating that##4##3##(2004-10#1)(2008-11#1)(2008-12#1)(2011-1#1)
studies demonstrating the##3##3##(1993-7#1)(2008-3#1)(2011-2#1)
studies demonstrating##16##2##(1993-7#1)(2004-10#1)(2004-11#1)(2005-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#4)
studies describe the##4##3##(1991-5#1)(1992-6#1)(2007-12#2)
studies describe##6##2##(1991-5#1)(1992-6#1)(2006-10#1)(2007-12#2)(2011-2#1)
studies described here##3##3##(1994-11#1)(1994-8#1)(1997-4#1)
studies described in this report##2##5##(1993-6#1)(2008-11#1)
studies described##9##2##(1993-6#1)(1994-11#1)(1994-8#1)(1996-1#1)(1997-4#1)(2006-2#1)(2007-12#1)(2008-11#1)(2008-7#1)
studies describing the##4##3##(1994-2#1)(2004-1#1)(2008-11#1)(2010-7#1)
studies describing##6##2##(1994-2#1)(2004-1#1)(2008-11#1)(2010-7#1)(2012-3#2)
studies designed to##8##3##(1992-11#1)(1994-10#1)(2008-2#1)(2008-5#1)(2010-4#1)(2011-1#1)(2012-11#1)(2012-3#1)
studies designed##10##2##(1992-11#1)(1994-10#1)(2006-5#1)(2008-2#1)(2008-5#1)(2010-4#1)(2011-1#1)(2012-11#1)(2012-3#2)
studies detailed##2##2##(1990-12#1)(1996-8#1)
studies did not determine an exposure level at which no adverse effects occur##2##13##(2005-7#2)
studies did not##9##3##(1992-11#1)(2005-7#2)(2008-7#1)(2009-2#1)(2010-12#1)(2010-2#1)(2011-2#1)(2013-1#1)
studies did##10##2##(1992-11#1)(2005-7#2)(2008-7#1)(2009-10#1)(2009-2#1)(2010-12#1)(2010-2#1)(2011-2#1)(2013-1#1)
studies directly##2##2##(1995-2#1)(2008-3#1)
studies do not##11##3##(1991-12#1)(1992-9#1)(1994-3#1)(1996-1#1)(1997-8#1)(2007-6#1)(2007-9#1)(2008-11#1)(2008-5#1)(2010-3#1)(2012-2#1)
studies documenting##2##2##(2005-10#1)(2013-1#1)
studies done in##4##3##(1990-12#1)(1992-12#1)(2008-10#2)
studies done on##2##3##(2008-8#1)(2010-2#1)
studies done##8##2##(1990-12#1)(1992-12#1)(2008-1#1)(2008-10#2)(2008-8#1)(2010-12#1)(2010-2#1)
studies due to##3##3##(1990-11#1)(1992-3#1)(2011-1#1)
studies during the last##3##4##(2006-10#1)(2008-1#1)(2010-12#1)
studies during the##4##3##(1995-5#1)(2006-10#1)(2008-1#1)(2010-12#1)
studies during##8##2##(1993-9#1)(1995-5#1)(2006-10#1)(2008-1#1)(2008-3#1)(2008-7#2)(2010-12#1)
studies emphasize the##2##3##(1993-4#1)(2007-8#1)
studies employ##3##2##(1996-9#2)(2008-8#1)
studies employed a##2##3##(1995-4#1)(2012-1#1)
studies employing a##2##3##(2009-4#1)(2010-10#1)
studies employing these##2##3##(1994-5#1)(2007-12#1)
studies employing##13##2##(1993-6#1)(1994-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-10#1)(2010-2#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-2#1)
studies establish that##2##3##(1995-2#1)(2008-5#1)
studies establish##5##2##(1994-11#1)(1995-2#1)(2006-12#1)(2008-5#1)(2009-11#1)
studies established the##2##3##(1993-11#1)(1994-8#1)
studies established##4##2##(1993-11#1)(1994-8#1)(1996-8#1)(2008-5#1)
studies evaluated##3##2##(2007-4#1)(2008-2#1)(2012-3#1)
studies evaluating the##7##3##(2006-10#1)(2006-8#1)(2007-10#1)(2008-7#1)(2010-12#1)(2013-1#2)
studies evaluating##14##2##(1995-1#1)(1995-12#1)(2006-10#2)(2006-8#1)(2007-10#1)(2008-2#1)(2008-7#1)(2010-1#2)(2010-12#1)(2012-1#1)(2013-1#2)
studies evidenced##3##2##(1996-12#1)(2008-10#1)(2010-12#1)
studies examine##2##2##(2008-3#1)(2009-7#1)
studies examined musculoskeletal injuries in the##2##6##(2013-1#2)
studies examined musculoskeletal injuries##3##4##(2013-1#3)
studies examined the##2##3##(1994-12#1)(2010-4#1)
studies examined##11##2##(1994-12#1)(1997-7#1)(2005-9#1)(2006-10#1)(2007-12#1)(2008-2#1)(2009-2#1)(2010-4#1)(2013-1#3)
studies examining the effect of##2##5##(1994-9#1)(2006-3#1)
studies examining the##10##3##(1993-11#1)(1994-9#1)(1996-3#1)(2006-10#2)(2006-3#1)(2006-9#1)(2008-7#1)(2011-1#1)(2013-1#1)
studies examining this##2##3##(2008-1#1)(2011-12#1)
studies examining##25##2##(1993-11#1)(1994-9#1)(1996-3#1)(2006-10#3)(2006-2#1)(2006-3#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2013-1#1)
studies exemplify##2##2##(1991-1#1)(2012-2#1)
studies exist##4##2##(1993-9#1)(2007-11#1)(2011-1#1)(2013-1#1)
studies exploring the##3##3##(2010-2#1)(2010-7#1)(2011-1#1)
studies exploring##4##2##(2009-4#1)(2010-2#1)(2010-7#1)(2011-1#1)
studies failed to demonstrate##2##4##(1993-7#1)(2011-1#1)
studies failed to##11##3##(1990-11#1)(1991-8#1)(1993-7#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-11#1)(2011-1#1)
studies find##3##2##(2006-2#1)(2008-1#1)(2013-1#1)
studies focus on##2##3##(2008-10#1)(2011-1#1)
studies focused on the##3##4##(2006-10#1)(2008-1#1)(2008-11#1)
studies focused on##10##3##(2006-10#1)(2006-4#1)(2007-4#1)(2008-1#1)(2008-11#1)(2009-7#1)(2010-11#1)(2012-11#1)(2012-12#1)(2013-1#1)
studies focused##11##2##(2006-10#1)(2006-4#1)(2007-4#1)(2008-1#1)(2008-11#1)(2009-7#1)(2010-11#1)(2010-12#1)(2012-11#1)(2012-12#1)(2013-1#1)
studies focusing on the##4##4##(1993-12#1)(2006-10#1)(2010-12#1)(2010-4#1)
studies focusing on this##4##4##(2004-12#1)(2008-9#1)(2010-4#1)(2011-2#1)
studies focusing on##11##3##(1993-12#1)(2004-12#1)(2006-10#1)(2008-9#1)(2009-12#1)(2010-12#2)(2010-4#2)(2011-2#1)(2012-3#1)
studies focusing##12##2##(1993-12#1)(2004-12#1)(2006-10#1)(2008-10#1)(2008-9#1)(2009-12#1)(2010-12#2)(2010-4#2)(2011-2#1)(2012-3#1)
studies following##2##2##(1992-4#1)(1996-6#1)
studies for a##3##3##(1995-3#1)(1997-2#1)(2009-3#1)
studies for stem cell-based##4##4##(2012-12#4)
studies for tebuconazole effect on##2##5##(2008-10#2)
studies for the##6##3##(2005-10#1)(2008-10#3)(2009-7#1)(2012-2#1)
studies for##61##2##(1990-6#1)(1991-8#1)(1992-8#1)(1992-9#1)(1994-7#1)(1994-8#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-2#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-6#1)(2005-8#1)(2006-11#1)(2007-1#1)(2007-2#1)(2007-8#1)(2008-10#10)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#3)(2013-8#1)
studies found a##2##3##(2008-1#1)(2009-5#1)
studies found evidence##2##3##(2007-8#1)(2009-10#1)
studies found in##2##3##(2007-8#1)(2011-2#1)
studies found no difference##2##4##(2007-8#1)(2009-4#1)
studies found no##3##3##(2007-8#1)(2009-4#1)(2011-2#1)
studies found statistically significant##2##4##(2008-12#1)(2013-8#1)
studies found that##6##3##(2007-8#1)(2008-5#1)(2010-2#1)(2012-1#1)(2013-7#1)(2013-8#1)
studies found##23##2##(2005-12#1)(2007-11#1)(2007-8#4)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-2#1)(2011-2#4)(2012-1#1)(2013-7#1)(2013-8#2)
studies from other countries##3##4##(2006-10#2)(2006-8#1)
studies from other##5##3##(2006-10#2)(2006-4#1)(2006-8#1)(2008-2#1)
studies from our group and##2##5##(2009-8#1)(2012-12#1)
studies from our group##5##4##(1994-9#1)(1995-5#1)(2008-1#1)(2009-8#1)(2012-12#1)
studies from our laboratory have##2##5##(2007-11#1)(2008-10#1)
studies from our laboratory##3##4##(2007-11#2)(2008-10#1)
studies from our##9##3##(1994-9#1)(1995-5#1)(2007-11#2)(2008-1#1)(2008-10#1)(2009-8#1)(2011-1#1)(2012-12#1)
studies from the United States and##2##6##(2009-12#1)(2012-1#1)
studies from the United States##3##5##(2006-5#1)(2009-12#1)(2012-1#1)
studies from the##8##3##(1992-1#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-8#1)(2009-12#1)(2009-2#1)(2012-1#1)
studies from this laboratory##8##4##(1990-11#2)(1991-3#1)(1991-4#1)(1995-12#1)(1995-6#1)(1996-11#1)(2005-10#1)
studies from##57##2##(1990-11#2)(1991-3#1)(1991-4#1)(1992-1#1)(1993-11#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-3#1)(2005-10#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-4#2)(2006-5#1)(2006-8#3)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-6#1)(2009-12#2)(2009-2#2)(2009-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#2)
studies further##5##2##(1990-10#1)(1996-12#1)(1996-4#1)(2013-1#1)(2013-8#1)
studies gave##5##2##(1992-11#1)(1994-9#1)(2006-10#1)(2007-7#1)(2008-10#1)
studies generally##3##2##(2006-10#1)(2010-8#1)(2011-2#1)
studies give##2##2##(1990-3#1)(2012-1#1)
studies had##3##2##(1991-12#1)(2008-1#1)(2012-2#1)
studies has been##3##3##(1994-1#1)(1996-9#1)(2008-10#1)
studies has resulted in##2##4##(2007-10#1)(2009-10#1)
studies has varied##2##3##(1996-12#1)(2008-1#1)
studies has##20##2##(1993-7#1)(1994-1#1)(1996-12#1)(1996-9#1)(1997-4#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-10#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-6#1)(2011-1#1)
studies have a##2##3##(1990-3#1)(2009-12#1)
studies have addressed the##5##4##(2007-8#1)(2010-2#1)(2010-7#1)(2012-2#1)(2013-1#1)
studies have addressed##9##3##(2006-3#1)(2007-8#1)(2008-1#1)(2010-2#1)(2010-7#1)(2012-12#1)(2012-2#2)(2013-1#1)
studies have advanced our understanding##2##5##(2006-10#1)(2009-3#1)
studies have all##2##3##(1994-11#1)(2005-8#1)
studies have allowed##2##3##(2006-10#1)(2008-2#1)
studies have already##3##3##(1995-8#1)(1997-4#1)(2007-7#1)
studies have also demonstrated that##2##5##(2005-7#1)(2007-11#1)
studies have also noted##2##4##(2008-6#1)(2011-1#1)
studies have also revealed that##2##5##(2008-10#1)(2009-10#1)
studies have also shown that##4##5##(1993-12#1)(1996-9#1)(2008-10#1)(2010-10#1)
studies have also shown##7##4##(1993-12#1)(1996-9#1)(2005-9#1)(2007-8#1)(2008-10#1)(2010-10#1)(2010-12#1)
studies have also##18##3##(1993-12#1)(1996-9#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-9#2)(2007-11#2)(2007-8#1)(2008-10#2)(2008-6#1)(2009-10#1)(2010-10#1)(2010-12#1)(2011-1#1)
studies have analyzed##2##3##(2010-6#1)(2012-2#1)
studies have associated##3##3##(2005-9#1)(2008-10#1)(2012-2#1)
studies have attempted to##3##4##(2006-10#1)(2008-1#1)(2011-2#1)
studies have been aimed at##2##5##(1996-12#1)(2007-4#1)
studies have been carried out in##3##6##(1994-5#1)(2008-11#1)(2011-1#1)
studies have been carried out on the##3##7##(1993-9#1)(2007-6#1)(2008-10#1)
studies have been carried out on##4##6##(1993-9#1)(1995-11#1)(2007-6#1)(2008-10#1)
studies have been carried out to##3##6##(2006-10#1)(2007-7#1)(2008-11#1)
studies have been carried out##16##5##(1993-3#1)(1993-9#1)(1994-5#1)(1995-11#1)(2006-10#2)(2006-8#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-7#1)(2011-1#1)(2012-3#1)
studies have been completed##2##4##(2006-12#1)(2013-7#1)
studies have been conducted in##7##5##(2005-8#1)(2006-12#1)(2008-7#1)(2009-2#1)(2010-12#1)(2013-1#2)
studies have been conducted on the##3##6##(2008-4#1)(2011-2#1)(2012-12#1)
studies have been conducted on##4##5##(2008-4#1)(2011-12#1)(2011-2#1)(2012-12#1)
studies have been conducted to evaluate the##2##7##(2006-10#1)(2008-12#1)
studies have been conducted to##6##5##(2006-10#1)(2008-12#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
studies have been conducted##24##4##(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
studies have been done in##2##5##(2009-6#1)(2011-2#1)
studies have been done##6##4##(2006-8#1)(2007-11#1)(2009-6#1)(2010-12#1)(2011-2#1)(2013-8#1)
studies have been extended to##2##5##(1995-2#1)(1995-5#1)
studies have been focused on##2##5##(2006-10#1)(2008-5#1)
studies have been focused##3##4##(2006-10#1)(2007-5#1)(2008-5#1)
studies have been limited to##2##5##(2008-11#1)(2011-1#1)
studies have been limited##4##4##(2006-8#1)(2008-11#1)(2009-8#1)(2011-1#1)
studies have been made##3##4##(1997-6#1)(2008-2#1)(2012-12#1)
studies have been performed for##2##5##(2006-5#1)(2012-2#1)
studies have been performed in##5##5##(1990-12#1)(1996-2#1)(2006-1#1)(2007-11#1)(2010-7#1)
studies have been performed to examine##2##6##(2005-10#1)(2007-10#1)
studies have been performed to##8##5##(2005-10#1)(2007-10#1)(2007-2#1)(2008-11#1)(2008-3#2)(2008-4#1)(2009-1#1)
studies have been performed##24##4##(1990-12#1)(1996-2#1)(2005-10#1)(2006-1#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2009-1#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-1#2)
studies have been published in##2##5##(2006-10#1)(2011-1#1)
studies have been published on the##3##6##(2006-10#2)(2007-1#1)
studies have been published##16##4##(1995-5#1)(1996-1#1)(1997-6#1)(2006-10#5)(2007-1#1)(2007-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-1#1)(2012-12#1)
studies have been reported##4##4##(1990-11#1)(1990-8#1)(2008-10#1)(2008-5#1)
studies have been undertaken to##3##5##(2008-7#1)(2012-3#1)(2013-1#1)
studies have been undertaken##4##4##(2005-10#1)(2008-7#1)(2012-3#1)(2013-1#1)
studies have been used##2##4##(2008-5#1)(2012-3#1)
studies have been##136##3##(1990-11#1)(1990-12#1)(1990-8#1)(1990-9#1)(1992-12#1)(1993-3#1)(1993-9#1)(1994-5#2)(1995-11#1)(1995-2#1)(1995-5#2)(1996-1#1)(1996-12#1)(1996-2#1)(1997-4#1)(1997-6#2)(2005-10#3)(2005-8#1)(2006-1#1)(2006-10#12)(2006-12#2)(2006-2#1)(2006-5#1)(2006-8#5)(2007-1#2)(2007-10#1)(2007-11#4)(2007-2#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#6)(2008-7#4)(2009-1#1)(2009-2#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#5)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#1)
studies have begun to##4##4##(2007-8#1)(2008-1#1)(2008-10#1)(2011-2#1)
studies have cast##2##3##(2006-10#1)(2008-1#1)
studies have characterized##2##3##(1991-3#1)(1996-4#1)
studies have claimed that##3##4##(2007-5#1)(2009-2#1)(2010-8#1)
studies have clearly shown that the##3##6##(1990-6#1)(1995-12#1)(2007-7#1)
studies have clearly##6##3##(1990-6#1)(1995-12#1)(1996-3#1)(2007-7#1)(2012-12#1)(2013-1#1)
studies have compared the##2##4##(2011-2#1)(2013-1#1)
studies have compared##7##3##(1991-3#1)(2006-9#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
studies have concluded that the##2##5##(2007-11#1)(2009-4#1)
studies have concluded that##4##4##(2007-11#1)(2007-4#1)(2008-9#1)(2009-4#1)
studies have confirmed that##6##4##(2007-10#1)(2008-12#1)(2008-8#1)(2009-12#1)(2012-3#1)(2013-1#1)
studies have confirmed the##8##4##(1992-11#1)(2006-10#3)(2007-8#1)(2008-1#1)(2008-6#1)(2011-2#1)
studies have confirmed##17##3##(1992-11#1)(1995-2#1)(2004-1#1)(2006-10#3)(2007-10#1)(2007-8#1)(2008-1#1)(2008-12#2)(2008-6#1)(2008-8#1)(2009-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
studies have considered##2##3##(2009-2#1)(2013-7#1)
studies have consistently##2##3##(2005-12#1)(2009-7#1)
studies have defined##2##3##(2006-10#2)
studies have demonstrated a##6##4##(1993-5#1)(2005-8#1)(2007-12#1)(2008-3#1)(2008-4#1)(2011-12#1)
studies have demonstrated increased##2##4##(2006-10#1)(2011-2#1)
studies have demonstrated that the##12##5##(1990-3#1)(1994-8#2)(1995-3#1)(1996-10#1)(2005-7#1)(2007-1#1)(2008-4#1)(2008-7#2)(2011-1#1)(2011-3#1)
studies have demonstrated that##58##4##(1990-12#1)(1990-3#1)(1990-9#1)(1991-10#1)(1991-11#1)(1992-8#1)(1993-12#2)(1993-7#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-3#1)(1996-10#2)(1996-2#1)(1996-9#1)(1997-7#1)(1997-8#2)(2005-10#1)(2005-7#2)(2005-8#2)(2006-10#2)(2006-2#1)(2007-1#1)(2007-11#1)(2008-1#4)(2008-4#1)(2008-7#4)(2008-9#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#1)
studies have demonstrated the existence of##2##6##(1992-1#1)(2008-11#1)
studies have demonstrated the feasibility of##2##6##(2010-12#1)(2012-2#1)
studies have demonstrated the feasibility##3##5##(1992-10#1)(2010-12#1)(2012-2#1)
studies have demonstrated the importance of##3##6##(1997-4#1)(1997-6#1)(2008-4#1)
studies have demonstrated the presence of a##2##7##(1995-3#1)(2012-2#1)
studies have demonstrated the##20##4##(1992-1#2)(1992-10#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-4#1)(1997-6#1)(2006-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2010-12#1)(2011-1#1)(2012-2#2)
studies have demonstrated##104##3##(1990-12#1)(1990-3#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-3#1)(1992-1#2)(1992-10#1)(1992-7#1)(1992-8#1)(1993-12#2)(1993-5#1)(1993-7#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-2#2)(1995-3#2)(1996-10#2)(1996-2#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-2#1)(2005-10#1)(2005-7#3)(2005-8#4)(2006-10#5)(2006-2#1)(2006-3#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#5)(2011-3#1)(2012-12#2)(2012-2#3)(2013-1#1)
studies have described##4##3##(2008-12#1)(2008-9#1)(2009-3#1)(2012-12#1)
studies have documented that##2##4##(2007-9#1)(2012-12#1)
studies have documented##4##3##(2006-8#1)(2007-9#1)(2009-3#1)(2012-12#1)
studies have emphasized the##2##4##(2009-2#1)(2012-2#1)
studies have emphasized##3##3##(2009-2#1)(2012-2#1)(2013-1#1)
studies have established a##3##4##(1995-8#1)(2009-12#1)(2010-12#1)
studies have established that##4##4##(1995-11#1)(2008-5#1)(2011-12#1)(2013-1#1)
studies have established the##3##4##(2006-10#1)(2007-11#1)(2007-8#1)
studies have established##11##3##(1995-1#1)(1995-11#1)(1995-8#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-5#1)(2009-12#1)(2010-12#1)(2011-12#1)(2013-1#1)
studies have estimated##2##3##(2008-10#1)(2012-12#1)
studies have evaluated the##10##4##(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-8#1)
studies have evaluated##18##3##(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-3#1)(2010-8#2)(2013-8#4)
studies have evidenced that##2##4##(2008-5#1)(2010-11#1)
studies have examined the association between##2##6##(2006-3#1)(2011-2#1)
studies have examined the impact of##2##6##(2007-10#1)(2013-1#1)
studies have examined the##17##4##(1991-11#1)(1993-1#1)(1997-4#1)(2006-3#1)(2007-10#2)(2007-11#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-5#2)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
studies have examined##26##3##(1991-11#1)(1993-1#1)(1997-4#1)(2006-10#1)(2006-3#1)(2007-10#3)(2007-11#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
studies have explored the##5##4##(2005-10#1)(2008-2#1)(2009-10#1)(2010-1#1)(2010-12#1)
studies have explored##6##3##(2005-10#1)(2008-2#1)(2008-8#1)(2009-10#1)(2010-1#1)(2010-12#1)
studies have failed to show##2##5##(1994-2#1)(2006-12#1)
studies have failed to##5##4##(1993-11#1)(1994-2#1)(2006-12#1)(2006-2#1)(2008-7#1)
studies have focused on the##6##5##(2005-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
studies have focused on##17##4##(1995-12#1)(2005-10#1)(2005-8#2)(2005-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2011-2#1)(2012-3#1)
studies have focused##18##3##(1995-12#1)(2005-10#1)(2005-8#2)(2005-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2011-2#1)(2012-3#1)
studies have found no association##2##5##(1996-3#1)(2010-10#1)
studies have found that##6##4##(2006-7#1)(2010-10#1)(2010-7#1)(2012-2#1)(2013-1#2)
studies have found##21##3##(1990-9#1)(1996-3#1)(1996-7#1)(2005-8#1)(2006-3#1)(2006-7#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2010-10#2)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
studies have further##2##3##(2006-10#2)
studies have given##2##3##(1991-10#1)(2012-2#1)
studies have greatly##3##3##(2005-11#1)(2006-10#1)(2006-5#1)
studies have had##2##3##(2007-4#1)(2012-3#1)
studies have highlighted##3##3##(2012-12#1)(2013-1#2)
studies have identified many##2##4##(2007-12#2)
studies have identified risk factors for##3##6##(2007-8#1)(2008-3#1)(2012-3#1)
studies have identified several##2##4##(2005-10#1)(2009-10#1)
studies have identified the##4##4##(2006-10#1)(2007-10#1)(2008-10#1)(2008-6#1)
studies have identified##28##3##(1990-2#1)(1990-8#1)(1993-1#1)(1994-7#1)(1995-6#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-3#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-6#1)(2009-9#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
studies have implicated the##3##4##(1993-2#1)(1994-3#1)(2013-1#1)
studies have implicated##11##3##(1992-4#1)(1993-11#1)(1993-2#1)(1994-3#1)(1997-7#1)(2008-11#1)(2008-4#1)(2009-10#1)(2010-8#1)(2013-1#1)(2013-7#1)
studies have increased our understanding of the##2##7##(2008-7#1)(2009-8#1)
studies have increased##3##3##(2006-10#1)(2008-7#1)(2009-8#1)
studies have indicated a##2##4##(1994-6#1)(2005-8#1)
studies have indicated an##2##4##(1996-12#1)(2010-12#1)
studies have indicated that the##9##5##(1992-4#1)(1993-7#1)(1995-12#1)(1995-6#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-11#1)(2012-2#1)
studies have indicated that##35##4##(1991-2#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-12#2)(1993-7#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-5#1)(1996-7#1)(1996-9#1)(2005-7#1)(2006-10#3)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-8#3)(2010-10#1)(2010-11#1)(2011-2#3)(2012-12#1)(2012-2#2)
studies have indicated the##2##4##(2008-11#1)(2013-1#1)
studies have indicated##47##3##(1991-2#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-12#2)(1993-7#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-4#1)(2005-7#1)(2005-8#1)(2006-10#6)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)
studies have investigated female##2##4##(2009-9#1)(2012-3#1)
studies have investigated the##7##4##(1991-11#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2010-6#1)(2013-1#1)
studies have investigated##13##3##(1991-11#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-9#1)(2010-2#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
studies have isolated##2##3##(1995-8#1)(2004-9#1)
studies have led to the##3##5##(1995-8#1)(1996-11#1)(1997-8#1)
studies have led to##6##4##(1995-8#1)(1996-11#1)(1997-8#1)(2008-3#1)(2008-7#1)(2012-1#1)
studies have linked##4##3##(2006-12#1)(2008-5#1)(2010-12#1)(2013-8#1)
studies have localized##3##3##(1992-1#1)(1993-6#1)(1995-12#1)
studies have looked at##3##4##(1997-2#1)(2006-10#1)(2009-10#1)
studies have looked##4##3##(1997-2#1)(2006-10#1)(2007-1#1)(2009-10#1)
studies have measured##2##3##(2008-8#1)(2010-6#1)
studies have not been##6##4##(1992-4#1)(2006-2#1)(2008-1#1)(2008-11#2)(2012-2#1)
studies have not provided##2##4##(1991-2#1)(1992-3#1)
studies have not##15##3##(1991-2#1)(1991-4#1)(1991-6#1)(1992-3#1)(1992-4#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-9#1)(2009-4#1)(2009-8#1)(2012-2#1)
studies have noted##2##3##(2008-7#1)(2012-11#1)
studies have now demonstrated that##3##5##(1997-1#1)(2008-11#1)(2009-2#1)
studies have now##6##3##(1991-12#1)(1993-2#1)(1997-1#1)(2007-11#1)(2008-11#1)(2009-2#1)
studies have proved that the##2##5##(2008-10#1)(2013-8#1)
studies have proved that##3##4##(2008-10#1)(2010-2#1)(2013-8#1)
studies have proved##5##3##(2008-10#1)(2008-5#1)(2010-2#1)(2012-12#1)(2013-8#1)
studies have provided a##4##4##(1992-8#1)(2007-12#1)(2007-8#1)(2011-2#1)
studies have provided evidence for##2##5##(1991-3#1)(1996-5#1)
studies have provided evidence##3##4##(1991-3#1)(1996-5#1)(2008-1#1)
studies have provided further##2##4##(2006-10#1)(2011-2#1)
studies have provided insights into the##2##6##(2009-11#1)(2011-1#1)
studies have provided insights into##3##5##(2006-10#1)(2009-11#1)(2011-1#1)
studies have provided new##2##4##(1996-8#1)(2007-12#1)
studies have provided##28##3##(1991-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1996-10#1)(1996-5#1)(1996-8#1)(2005-8#1)(2006-10#4)(2007-12#3)(2007-8#1)(2008-1#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
studies have quantified the##2##4##(2006-4#1)(2008-9#1)
studies have quantified##3##3##(2006-4#1)(2008-9#1)(2012-2#1)
studies have raised##2##3##(2007-8#1)(2009-4#1)
studies have relied on##3##4##(1990-8#1)(2010-5#1)(2013-8#1)
studies have reported a correlation between##2##6##(1992-9#1)(2011-1#1)
studies have reported a##4##4##(1992-9#1)(2007-10#1)(2008-9#1)(2011-1#1)
studies have reported improved##2##4##(2007-8#1)(2011-2#1)
studies have reported on the##3##5##(1995-9#1)(2006-2#1)(2008-8#1)
studies have reported on##5##4##(1995-9#1)(2005-7#1)(2006-10#1)(2006-2#1)(2008-8#1)
studies have reported that the##3##5##(2008-11#1)(2008-3#1)(2009-11#1)
studies have reported that##7##4##(2008-10#1)(2008-11#1)(2008-3#1)(2009-11#1)(2012-3#1)(2013-1#2)
studies have reported the##4##4##(1993-10#1)(2006-10#1)(2008-11#1)(2013-8#1)
studies have reported##37##3##(1992-9#1)(1993-10#1)(1995-9#1)(1996-3#1)(1996-7#1)(2005-7#1)(2006-10#3)(2006-2#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#5)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
studies have resulted in##2##4##(2005-10#1)(2008-10#1)
studies have revealed a##3##4##(1996-11#1)(2008-9#1)(2010-5#1)
studies have revealed several##2##4##(2011-2#1)(2012-2#1)
studies have revealed that exercise##2##5##(2012-2#2)
studies have revealed that the##2##5##(2008-12#1)(2012-1#1)
studies have revealed that##17##4##(1992-10#1)(1993-12#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2010-10#1)(2010-2#1)(2012-1#1)(2012-2#2)(2013-8#2)
studies have revealed the##3##4##(2007-12#1)(2008-7#1)(2009-1#1)
studies have revealed##38##3##(1992-10#1)(1993-12#1)(1995-11#1)(1996-11#1)(1996-4#1)(1996-9#1)(1997-8#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-2#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-2#4)(2013-1#1)(2013-8#2)
studies have shown a relationship between##2##6##(2007-5#1)(2012-12#1)
studies have shown a##13##4##(1992-4#1)(1997-2#1)(1997-4#1)(2005-7#1)(2006-10#2)(2007-12#1)(2007-2#1)(2007-5#2)(2008-1#1)(2009-10#1)(2012-12#1)
studies have shown an increased##2##5##(2006-11#1)(2013-1#1)
studies have shown an##4##4##(2006-11#1)(2007-8#1)(2008-3#1)(2013-1#1)
studies have shown excellent##2##4##(2009-5#1)(2010-8#1)
studies have shown that a##4##5##(1994-8#1)(2008-5#1)(2011-2#2)
studies have shown that adjuvant##2##5##(2007-5#1)(2008-5#1)
studies have shown that consumption of##2##6##(2008-10#1)(2012-12#1)
studies have shown that factors##3##5##(2012-12#1)(2013-1#2)
studies have shown that it##2##5##(2010-4#1)(2011-1#1)
studies have shown that low##2##5##(2008-11#1)(2012-2#1)
studies have shown that probiotics##2##5##(2006-10#1)(2012-1#1)
studies have shown that some##2##5##(2008-3#1)(2008-9#1)
studies have shown that spatial##2##5##(1995-11#1)(2008-8#1)
studies have shown that the##38##5##(1990-11#1)(1990-2#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-4#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-3#1)(1994-5#3)(1995-6#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#1)(2008-8#2)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
studies have shown that these##3##5##(1995-2#1)(2008-11#1)(2008-8#1)
studies have shown that this##6##5##(1993-6#1)(2006-10#1)(2008-7#2)(2011-2#2)
studies have shown that##192##4##(1990-11#1)(1990-2#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-3#3)(1994-5#5)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#3)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#1)(2006-10#6)(2006-11#2)(2006-7#3)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#2)(2007-2#1)(2007-5#2)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#8)(2008-8#7)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-11#2)(2010-12#2)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#10)(2012-1#1)(2012-11#3)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#3)
studies have shown the association##2##5##(2008-1#1)(2013-7#1)
studies have shown the effect of##2##6##(2007-4#1)(2012-2#1)
studies have shown the potential##2##5##(2009-11#1)(2009-7#1)
studies have shown the##13##4##(1990-2#1)(1992-2#1)(1994-3#1)(2006-10#1)(2007-4#1)(2008-1#1)(2008-2#1)(2008-7#1)(2009-11#1)(2009-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
studies have shown##264##3##(1990-11#1)(1990-2#2)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#3)(1992-5#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-2#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-3#4)(1994-5#5)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#2)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#3)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#5)(1997-4#3)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#2)(2005-11#1)(2005-6#1)(2005-7#1)(2006-10#11)(2006-11#3)(2006-7#4)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#5)(2007-12#3)(2007-2#3)(2007-4#3)(2007-5#4)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#7)(2008-10#4)(2008-11#4)(2008-12#3)(2008-2#4)(2008-3#7)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#10)(2008-8#10)(2008-9#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#3)(2009-7#2)(2010-11#2)(2010-12#3)(2010-3#2)(2010-4#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#12)(2012-1#1)(2012-11#3)(2012-12#5)(2012-2#6)(2012-3#3)(2013-1#8)(2013-7#2)(2013-8#3)
studies have successfully##2##3##(2010-8#1)(2012-3#1)
studies have suggested a beneficial effect##3##6##(2006-7#1)(2013-1#2)
studies have suggested a possible##2##5##(2013-1#2)
studies have suggested a##8##4##(1991-1#1)(1997-6#1)(2006-7#1)(2008-5#1)(2013-1#4)
studies have suggested that the##3##5##(1992-2#1)(2010-7#1)(2011-2#1)
studies have suggested that##29##4##(1990-5#1)(1991-1#1)(1992-2#1)(1992-3#1)(1992-7#1)(1994-10#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-3#1)(1997-7#1)(1997-8#1)(2005-4#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-7#1)(2009-10#2)(2009-3#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-12#1)(2013-1#1)
studies have suggested##42##3##(1990-5#1)(1991-1#2)(1992-2#1)(1992-3#1)(1992-7#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-4#1)(2006-2#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-9#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-3#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-12#1)(2013-1#5)
studies have supported the##3##4##(2006-2#1)(2007-12#1)(2008-3#1)
studies have tested##4##3##(2008-11#1)(2008-5#1)(2008-9#1)(2011-1#1)
studies have tried to##2##4##(2009-5#1)(2011-1#1)
studies have uncovered##4##3##(2007-11#1)(2009-9#1)(2012-3#1)(2013-1#1)
studies have used##10##3##(2006-10#1)(2006-8#1)(2007-6#1)(2008-12#1)(2008-2#1)(2009-5#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
studies have yielded a##2##4##(1990-8#1)(2007-11#1)
studies have yielded##4##3##(1990-8#1)(2007-11#1)(2012-3#1)(2013-1#1)
studies have##1155##2##(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#3)(1991-1#3)(1991-10#2)(1991-11#3)(1991-12#2)(1991-2#3)(1991-3#5)(1991-4#2)(1991-5#2)(1991-6#1)(1992-1#3)(1992-10#3)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#3)(1992-4#6)(1992-5#2)(1992-7#3)(1992-8#3)(1992-9#4)(1993-1#3)(1993-10#1)(1993-11#3)(1993-12#6)(1993-2#4)(1993-3#1)(1993-5#1)(1993-6#4)(1993-7#2)(1993-8#1)(1993-9#2)(1994-10#2)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#7)(1994-5#8)(1994-6#4)(1994-7#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#6)(1995-12#8)(1995-2#5)(1995-3#5)(1995-4#2)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#6)(1995-9#2)(1996-1#1)(1996-10#4)(1996-11#2)(1996-12#3)(1996-2#4)(1996-3#5)(1996-4#4)(1996-5#6)(1996-6#2)(1996-7#4)(1996-8#3)(1996-9#5)(1997-1#2)(1997-2#6)(1997-4#8)(1997-5#2)(1997-6#5)(1997-7#4)(1997-8#6)(2004-1#1)(2004-11#2)(2004-2#1)(2004-9#1)(2005-10#8)(2005-11#4)(2005-12#1)(2005-4#1)(2005-6#1)(2005-7#7)(2005-8#13)(2005-9#3)(2006-1#1)(2006-10#68)(2006-11#4)(2006-12#4)(2006-2#9)(2006-3#4)(2006-4#3)(2006-5#2)(2006-6#2)(2006-7#7)(2006-8#11)(2006-9#4)(2007-1#7)(2007-10#12)(2007-11#29)(2007-12#15)(2007-2#8)(2007-4#7)(2007-5#6)(2007-6#4)(2007-7#5)(2007-8#18)(2007-9#4)(2008-1#29)(2008-10#26)(2008-11#30)(2008-12#13)(2008-2#12)(2008-3#26)(2008-4#14)(2008-5#28)(2008-6#6)(2008-7#31)(2008-8#21)(2008-9#21)(2009-1#2)(2009-10#12)(2009-11#5)(2009-12#4)(2009-2#8)(2009-3#8)(2009-4#4)(2009-5#7)(2009-6#2)(2009-7#5)(2009-8#8)(2009-9#3)(2010-1#2)(2010-10#7)(2010-11#5)(2010-12#18)(2010-2#5)(2010-3#4)(2010-4#3)(2010-5#4)(2010-6#4)(2010-7#5)(2010-8#10)(2010-9#3)(2011-1#22)(2011-12#6)(2011-2#42)(2011-3#1)(2012-1#8)(2012-11#4)(2012-12#23)(2012-2#35)(2012-3#21)(2013-1#45)(2013-7#6)(2013-8#17)
studies highlight the##3##3##(2006-10#1)(2007-11#1)(2008-9#1)
studies highlight##5##2##(1993-11#1)(2006-10#1)(2007-11#1)(2008-9#1)(2013-1#1)
studies however##2##2##(1993-11#1)(2010-1#1)
studies identified the##2##3##(2006-10#1)(2012-2#1)
studies identified##8##2##(1995-7#1)(2005-10#1)(2006-10#1)(2008-7#1)(2009-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
studies identifying changes in##2##4##(2010-12#2)
studies identifying##4##2##(2010-12#2)(2010-5#1)(2012-3#1)
studies illustrate the##2##3##(1996-3#1)(2008-7#1)
studies illustrate##5##2##(1992-11#1)(1994-10#1)(1996-3#1)(2008-10#1)(2008-7#1)
studies implicate##4##2##(1992-11#1)(1995-4#1)(2008-9#1)(2009-7#1)
studies imply that##3##3##(2005-11#1)(2009-2#1)(2011-2#1)
studies in Arabidopsis##2##3##(2009-6#1)(2009-8#1)
studies in Drosophila##3##3##(2008-10#1)(2008-9#2)
studies in English##2##3##(2008-9#1)(2011-2#1)
studies in Western countries##2##4##(1992-10#1)(2010-12#1)
studies in a variety of##2##5##(1991-7#1)(2007-11#1)
studies in a##11##3##(1991-7#1)(1992-8#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-5#1)(2010-4#1)(2010-5#1)(2012-3#1)
studies in addition to##2##4##(2007-12#2)
studies in adult##2##3##(1994-2#1)(2006-10#1)
studies in adults##2##3##(1995-1#1)(2011-2#1)
studies in an##2##3##(1995-1#1)(2010-12#1)
studies in animal models have##2##5##(2007-11#1)(2009-5#1)
studies in animal models##8##4##(2006-6#1)(2007-11#1)(2008-10#1)(2009-11#1)(2009-5#1)(2010-10#1)(2010-6#1)(2012-3#1)
studies in animal##9##3##(2006-10#1)(2006-6#1)(2007-11#1)(2008-10#1)(2009-11#1)(2009-5#1)(2010-10#1)(2010-6#1)(2012-3#1)
studies in animals##5##3##(1990-4#1)(1995-5#1)(1997-2#1)(1997-7#1)(2009-8#1)
studies in basic##2##3##(2004-4#1)(2006-10#1)
studies in bovine##2##3##(2008-10#1)(2008-11#1)
studies in children and##2##4##(2006-12#1)(2009-5#1)
studies in children##5##3##(2006-12#1)(2007-11#1)(2007-6#1)(2008-8#1)(2009-5#1)
studies in developmental biology##2##4##(2007-12#1)(2008-5#1)
studies in different##5##3##(1996-5#1)(2004-11#1)(2008-12#1)(2012-2#1)(2013-1#1)
studies in health##3##3##(1992-2#1)(2006-5#1)(2011-2#1)
studies in human volunteers##2##4##(1995-12#1)(2008-10#1)
studies in human##8##3##(1992-8#1)(1995-12#1)(1997-6#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
studies in humans and##3##4##(2006-10#1)(2008-5#1)(2010-12#1)
studies in humans have##4##4##(2007-11#1)(2007-2#1)(2009-12#1)(2009-8#1)
studies in humans##15##3##(1996-8#1)(2006-1#1)(2006-10#1)(2007-11#2)(2007-2#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#2)(2010-12#1)
studies in large##3##3##(2005-11#1)(2008-10#1)(2009-8#1)
studies in mice##5##3##(1996-5#1)(2005-7#1)(2011-2#1)(2012-1#1)(2012-12#1)
studies in oncology##2##3##(2006-10#1)(2008-7#1)
studies in order to##4##4##(2008-11#1)(2008-8#1)(2011-1#1)(2013-1#1)
studies in other countries##3##4##(2006-10#2)(2008-5#1)
studies in other##8##3##(1995-3#1)(2005-7#1)(2006-10#2)(2007-12#1)(2008-5#1)(2008-8#1)(2009-4#1)
studies in our laboratory have##3##5##(1991-2#1)(1996-9#1)(2007-11#1)
studies in our laboratory##5##4##(1991-2#1)(1993-4#1)(1996-9#1)(2007-11#1)(2009-4#1)
studies in our##8##3##(1991-2#1)(1993-4#1)(1996-9#1)(2007-11#1)(2008-7#1)(2009-4#1)(2009-6#1)(2013-8#1)
studies in patients with##13##4##(1996-7#1)(2005-7#1)(2005-8#1)(2007-10#1)(2007-11#3)(2008-10#1)(2008-3#1)(2008-5#1)(2010-11#1)(2010-12#1)(2011-2#1)
studies in patients##16##3##(1990-12#1)(1996-7#1)(2005-7#1)(2005-8#2)(2007-10#1)(2007-11#3)(2008-10#1)(2008-3#2)(2008-5#1)(2010-11#1)(2010-12#1)(2011-2#1)
studies in rat liver##2##4##(1994-11#1)(1996-12#1)
studies in rat##6##3##(1990-11#1)(1992-11#1)(1994-11#1)(1996-12#1)(1997-2#1)(2012-1#1)
studies in rats##6##3##(1990-5#1)(1991-12#1)(1992-2#1)(1997-1#1)(2008-5#1)(2008-7#1)
studies in recent years##2##4##(2008-3#1)(2008-9#1)
studies in relation to##2##4##(2007-11#1)(2010-7#1)
studies in reptiles##2##3##(2010-3#1)(2012-2#1)
studies in rodents##2##3##(2008-1#1)(2008-10#1)
studies in schizophrenia##2##3##(2006-3#1)(2011-1#1)
studies in simulated##2##3##(2008-5#1)(2010-12#1)
studies in the absence##3##4##(1992-6#1)(1993-3#1)(2008-11#1)
studies in the context of##2##5##(2008-11#1)(2013-8#1)
studies in the field##3##4##(2009-10#2)(2013-8#1)
studies in the late##2##4##(2006-8#1)(2008-3#1)
studies in the literature##4##4##(1994-1#1)(2006-11#1)(2007-8#1)(2012-12#1)
studies in the presence of##5##5##(1991-7#1)(1994-8#1)(2008-10#1)(2008-4#1)(2012-3#1)
studies in the##56##3##(1990-6#1)(1991-7#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-8#2)(1996-1#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-4#1)(2004-11#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-8#2)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2009-10#3)(2009-12#1)(2009-8#2)(2009-9#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
studies in these##5##3##(2006-12#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-11#1)
studies in this area##6##4##(1996-8#1)(2008-1#1)(2008-11#1)(2010-2#1)(2011-1#1)(2012-12#1)
studies in this field##2##4##(2008-3#1)(2011-1#1)
studies in this##13##3##(1990-8#1)(1996-8#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-12#2)(2010-2#1)(2010-3#1)(2011-1#2)(2012-12#1)
studies in vivo##5##3##(1995-9#1)(1996-5#2)(1997-1#1)(2008-5#1)
studies in which the##8##4##(1992-3#1)(1994-6#1)(1994-8#1)(2006-5#1)(2007-2#1)(2008-7#1)(2013-1#1)(2013-8#1)
studies in which##21##3##(1991-8#1)(1992-3#1)(1992-6#1)(1994-6#1)(1994-8#1)(2005-10#1)(2006-5#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-9#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
studies in yeast##3##3##(1996-7#1)(1997-7#1)(2009-5#1)
studies in##449##2##(1990-11#2)(1990-12#3)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#2)(1990-9#2)(1991-10#1)(1991-12#2)(1991-2#2)(1991-7#4)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-4#3)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#3)(1993-10#1)(1993-11#4)(1993-12#3)(1993-2#1)(1993-3#1)(1993-4#2)(1994-1#1)(1994-11#1)(1994-2#4)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#2)(1995-3#2)(1995-5#3)(1995-9#3)(1996-1#1)(1996-12#2)(1996-5#4)(1996-6#2)(1996-7#3)(1996-8#4)(1996-9#2)(1997-1#2)(1997-2#4)(1997-4#2)(1997-6#2)(1997-7#3)(1997-8#1)(2004-11#2)(2004-4#1)(2005-10#3)(2005-11#2)(2005-4#1)(2005-7#4)(2005-8#2)(2005-9#1)(2006-1#2)(2006-10#13)(2006-11#1)(2006-12#3)(2006-2#2)(2006-3#1)(2006-5#2)(2006-6#2)(2006-8#5)(2006-9#2)(2007-10#1)(2007-11#16)(2007-12#11)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#7)(2008-10#20)(2008-11#10)(2008-12#6)(2008-2#1)(2008-3#11)(2008-4#7)(2008-5#13)(2008-6#3)(2008-7#15)(2008-8#10)(2008-9#10)(2009-10#5)(2009-11#2)(2009-12#2)(2009-2#2)(2009-4#3)(2009-5#5)(2009-6#2)(2009-8#8)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#9)(2010-2#3)(2010-3#3)(2010-4#4)(2010-5#4)(2010-6#2)(2010-7#3)(2010-8#2)(2011-1#9)(2011-12#1)(2011-2#10)(2011-8#1)(2012-1#4)(2012-12#6)(2012-2#10)(2012-3#8)(2013-1#8)(2013-7#1)(2013-8#8)
studies include the##3##3##(2008-6#1)(2008-9#1)(2009-2#1)
studies include##6##2##(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-7#1)(2012-1#1)
studies included the##2##3##(2004-12#1)(2008-3#1)
studies included##9##2##(2004-12#1)(2006-8#1)(2008-10#1)(2008-3#1)(2009-8#1)(2012-11#1)(2012-2#1)(2013-8#2)
studies including a##2##3##(1991-11#1)(2008-1#1)
studies including##21##2##(1991-11#2)(1993-1#1)(1994-12#1)(1996-3#1)(1996-5#1)(1997-4#1)(2005-10#1)(2007-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-12#2)(2012-3#1)
studies increased##3##2##(1996-10#1)(2008-5#2)
studies indicate a novel##2##4##(2008-1#1)(2008-3#1)
studies indicate a##8##3##(1993-11#1)(1996-8#1)(2007-12#1)(2008-1#1)(2008-3#1)(2009-12#1)(2010-5#1)(2013-1#1)
studies indicate an##2##3##(1994-10#1)(2008-11#1)
studies indicate that both##4##4##(1990-9#1)(1991-5#1)(1994-11#1)(1995-11#1)
studies indicate that in##4##4##(1990-8#1)(2008-10#1)(2008-3#1)(2008-4#1)
studies indicate that it may##2##5##(2007-11#1)(2012-11#1)
studies indicate that many of##2##5##(2008-10#1)(2009-4#1)
studies indicate that some##2##4##(1990-12#1)(2006-10#1)
studies indicate that the##25##4##(1990-11#2)(1990-5#1)(1991-12#1)(1991-9#1)(1993-3#1)(1993-9#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-2#1)(1997-3#1)(1997-8#1)(2005-7#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-11#1)(2010-2#1)(2011-2#1)
studies indicate that there are##3##5##(1997-8#1)(2007-8#1)(2008-3#1)
studies indicate that this##2##4##(1994-8#1)(2012-12#1)
studies indicate that##131##3##(1990-11#3)(1990-12#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-12#2)(1991-5#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-5#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#3)(1997-8#2)(2005-10#2)(2005-11#1)(2005-7#1)(2006-10#5)(2006-12#2)(2006-2#2)(2006-5#1)(2006-9#1)(2007-1#1)(2007-11#6)(2007-2#1)(2007-6#1)(2007-8#2)(2008-1#4)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#5)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#2)(2009-4#1)(2009-8#1)(2010-11#1)(2010-2#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
studies indicate the##3##3##(1995-12#1)(2006-8#1)(2007-11#1)
studies indicate##155##2##(1990-11#3)(1990-12#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-12#2)(1991-5#1)(1991-7#1)(1991-9#3)(1992-1#1)(1992-5#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-8#1)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-7#3)(1997-8#2)(2005-10#2)(2005-11#1)(2005-7#1)(2006-10#5)(2006-12#2)(2006-2#3)(2006-5#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#8)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#2)(2008-1#5)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#5)(2008-4#5)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#2)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#2)(2010-5#2)(2011-1#1)(2011-2#3)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
studies indicated a##3##3##(1994-10#1)(1994-2#2)
studies indicated an##2##3##(1992-1#1)(2007-8#1)
studies indicated that a##2##4##(1990-11#1)(2006-12#1)
studies indicated that the##10##4##(1990-4#1)(1993-12#1)(1995-3#1)(1996-12#1)(1997-4#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-2#1)
studies indicated that this##2##4##(1995-8#1)(2008-8#1)
studies indicated that##46##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1991-1#1)(1992-7#1)(1993-12#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-3#1)(1995-8#1)(1996-12#2)(1996-5#1)(1996-6#1)(1997-4#3)(1997-5#1)(2005-3#1)(2006-12#1)(2008-1#1)(2008-10#8)(2008-5#1)(2008-8#2)(2008-9#2)(2010-10#1)(2010-12#2)(2010-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
studies indicated the##6##3##(1992-3#1)(1995-1#1)(2008-10#2)(2010-2#1)(2012-1#1)
studies indicated##65##2##(1990-11#1)(1990-2#2)(1990-3#1)(1990-4#1)(1991-1#1)(1992-1#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-12#1)(1994-10#1)(1994-2#2)(1994-9#1)(1995-1#3)(1995-11#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-5#1)(1996-6#1)(1997-4#3)(1997-5#1)(2005-3#1)(2006-12#1)(2006-8#1)(2007-8#2)(2008-1#1)(2008-10#10)(2008-5#1)(2008-8#2)(2008-9#2)(2010-10#1)(2010-12#4)(2010-2#4)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
studies indicating that##7##3##(1994-2#1)(1994-5#1)(1995-6#1)(2006-10#1)(2011-2#2)(2013-1#1)
studies indicating##9##2##(1994-2#1)(1994-5#1)(1995-12#1)(1995-6#1)(2006-10#1)(2006-3#1)(2011-2#2)(2013-1#1)
studies initiated##3##2##(1992-5#1)(1996-7#1)(2007-11#1)
studies intended to##2##3##(1993-5#1)(2008-7#1)
studies into the##7##3##(1995-6#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)
studies into##18##2##(1994-2#1)(1995-6#1)(2006-10#1)(2006-5#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-2#1)
studies investigated the##4##3##(1996-12#1)(2008-11#1)(2009-9#1)(2012-3#1)
studies investigated##7##2##(1995-12#1)(1996-10#1)(1996-12#1)(2008-10#1)(2008-11#1)(2009-9#1)(2012-3#1)
studies investigating the effect of##2##5##(2006-8#1)(2008-8#1)
studies investigating the##18##3##(1995-12#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-10#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#2)(2009-1#1)(2011-1#1)(2012-2#2)(2013-1#2)
studies investigating##27##2##(1995-12#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-7#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-1#1)(2010-4#1)(2011-1#1)(2012-2#3)(2012-3#1)(2013-1#2)
studies involved##6##2##(1997-5#1)(2007-4#1)(2008-4#1)(2011-1#1)(2011-12#1)(2011-2#1)
studies involving a##3##3##(2006-8#1)(2007-3#1)(2008-5#1)
studies involving larger##2##3##(2007-11#1)(2012-3#1)
studies involving the##4##3##(2008-10#3)(2008-5#1)
studies involving##40##2##(1991-7#1)(1994-3#1)(1996-11#1)(1996-9#1)(1997-3#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#4)(2008-6#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#1)
studies is a##2##3##(2010-11#1)(2012-3#1)
studies is described##2##3##(2008-2#1)(2008-9#1)
studies is difficult##2##3##(1993-5#1)(2008-7#1)
studies is discussed##4##3##(1991-9#1)(1993-11#1)(2007-3#1)(2008-4#1)
studies is presented##2##3##(2005-7#1)(2008-2#1)
studies is that##5##3##(1990-7#1)(1990-8#1)(1997-2#1)(2008-7#1)(2008-9#1)
studies is the##8##3##(1993-12#1)(2005-7#1)(2008-10#3)(2008-7#1)(2010-5#1)(2013-1#1)
studies is to identify##2##4##(2006-2#1)(2009-12#1)
studies is to##5##3##(2006-2#1)(2008-6#1)(2009-12#1)(2009-6#1)(2010-12#1)
studies is##59##2##(1990-7#1)(1990-8#1)(1991-9#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-7#1)(1994-2#1)(1995-9#1)(1996-12#1)(1996-9#1)(1997-2#1)(2005-11#1)(2005-7#2)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-11#1)(2007-3#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#2)(2009-12#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)
studies it has been##2##4##(1992-10#1)(2009-8#1)
studies it is##3##3##(1991-10#1)(2004-9#1)(2011-2#1)
studies it may be##2##4##(2008-3#1)(2008-8#1)
studies it##10##2##(1991-10#1)(1992-10#2)(2004-9#1)(2006-7#1)(2008-3#1)(2008-8#2)(2009-8#1)(2011-2#1)
studies leading to the##2##4##(2009-11#1)(2010-7#1)
studies leading to##6##3##(2006-4#1)(2008-8#1)(2008-9#1)(2009-11#2)(2010-7#1)
studies led to##2##3##(2008-3#1)(2011-2#1)
studies looking at##3##3##(2008-7#1)(2010-8#1)(2013-8#1)
studies may be##10##3##(1991-6#1)(1992-9#1)(1993-9#1)(1996-12#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-2#1)(2010-7#1)(2012-2#1)
studies may help##2##3##(1993-12#1)(2005-10#1)
studies may provide##3##3##(2008-7#1)(2009-3#1)(2012-1#1)
studies may reflect##2##3##(1995-11#1)(2012-3#1)
studies may##31##2##(1990-5#1)(1990-8#1)(1991-6#1)(1992-1#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-12#1)(1995-11#1)(1995-5#1)(1996-12#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-3#1)(2010-11#1)(2010-7#1)(2012-1#1)(2012-2#1)(2012-3#1)
studies measuring##2##2##(1996-10#1)(2010-2#1)
studies met inclusion criteria##3##4##(2007-12#1)(2012-12#2)
studies met the inclusion criteria##2##5##(2012-12#1)(2013-1#1)
studies met the inclusion##3##4##(2007-11#1)(2012-12#1)(2013-1#1)
studies met the##4##3##(2007-11#1)(2012-12#1)(2013-1#2)
studies met##10##2##(2007-11#1)(2007-12#2)(2012-12#4)(2013-1#3)
studies might##3##2##(1996-8#1)(2008-11#1)(2011-2#1)
studies must be##2##3##(2007-6#1)(2010-11#1)
studies must##4##2##(2007-6#1)(2008-4#1)(2010-11#1)(2010-12#1)
studies need to be##3##4##(2006-10#1)(2008-9#1)(2010-12#1)
studies need to##4##3##(2006-10#1)(2008-9#1)(2009-10#1)(2010-12#1)
studies need##5##2##(1992-8#1)(2006-10#1)(2008-9#1)(2009-10#1)(2010-12#1)
studies not only##2##3##(2007-10#1)(2013-1#1)
studies not##6##2##(1996-9#1)(2007-10#1)(2010-11#1)(2013-1#3)
studies now##3##2##(1994-5#1)(2006-5#1)(2009-3#1)
studies obtained##3##2##(1995-2#1)(2006-10#1)(2006-8#1)
studies of 11##2##3##(2010-9#1)(2012-2#1)
studies of 2##2##3##(1994-4#1)(2008-8#1)
studies of DNA##5##3##(1990-3#1)(1991-6#1)(1993-8#1)(1994-7#1)(2008-7#1)
studies of Escherichia coli##2##4##(1991-4#1)(2008-7#1)
studies of RNA##2##3##(1995-6#1)(1997-6#1)
studies of Saccharomyces cerevisiae##2##4##(1997-6#1)(2008-7#1)
studies of T cell##2##4##(1990-12#1)(2008-4#1)
studies of a new##2##4##(2007-10#1)(2007-11#1)
studies of a novel##3##4##(1993-11#1)(2007-12#1)(2008-8#1)
studies of a##19##3##(1990-6#1)(1991-7#1)(1992-12#1)(1993-11#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-8#2)(2009-11#1)(2012-3#1)(2013-1#2)
studies of acesulfame potassium##2##4##(2008-9#2)
studies of adolescents##2##3##(2006-9#1)(2008-11#1)
studies of adult##3##3##(1996-9#1)(2005-8#1)(2007-12#1)
studies of aging##2##3##(2008-9#1)(2009-7#1)
studies of air##2##3##(2008-4#1)(2010-2#1)
studies of alkali metal##2##4##(2008-2#1)(2012-2#1)
studies of all##2##3##(1996-2#1)(2011-2#1)
studies of an##5##3##(1991-7#1)(1996-2#1)(2008-10#1)(2008-3#1)(2011-1#1)
studies of anaphor comprehension##2##4##(2007-12#2)
studies of aqueous##2##3##(2005-11#1)(2008-12#1)
studies of aspartame##3##3##(2008-8#3)
studies of basic##2##3##(2008-4#2)
studies of both##7##3##(1993-3#1)(1997-5#1)(2007-10#2)(2008-11#1)(2008-3#1)(2008-5#1)
studies of brain##7##3##(1990-9#1)(1992-3#1)(1996-2#1)(1997-5#1)(2007-9#1)(2008-4#1)(2012-3#1)
studies of bromodichloromethane##2##3##(2008-9#2)
studies of cancer##4##3##(1994-12#1)(2008-7#1)(2009-4#1)(2012-12#1)
studies of candidate genes##2##4##(1996-3#1)(2010-12#1)
studies of cell##4##3##(1991-10#1)(2008-11#1)(2008-2#1)(2009-9#1)
studies of cellular##4##3##(1997-4#1)(2008-4#2)(2008-9#1)
studies of cerebral##2##3##(1996-5#1)(2012-12#1)
studies of children##2##3##(1991-1#1)(2010-5#1)
studies of chimeric##2##3##(1993-3#1)(1996-7#1)
studies of chronic##2##3##(1991-1#1)(2007-7#1)
studies of clinical##3##3##(1996-2#1)(2007-11#1)(2008-9#1)
studies of cocaine##2##3##(1996-3#1)(1997-5#1)
studies of cognitive##2##3##(2006-10#1)(2006-7#1)
studies of complex##4##3##(1992-4#1)(2007-10#1)(2008-10#1)(2008-9#1)
studies of copper##2##3##(1994-12#1)(2008-5#1)
studies of cytochrome##2##3##(1995-11#1)(1995-8#1)
studies of dichloroacetic acid##2##4##(2008-9#2)
studies of different##3##3##(1996-6#1)(2008-10#2)
studies of direct##2##3##(1991-9#1)(1993-6#1)
studies of disease##2##3##(1997-3#1)(2012-2#1)
studies of drug##3##3##(1996-1#1)(1996-9#1)(2010-2#1)
studies of drugs##2##3##(1991-1#1)(2006-10#1)
studies of each##2##3##(1993-11#1)(1997-2#1)
studies of early##2##3##(1994-10#1)(2008-10#1)
studies of efficacy and safety of##2##6##(2011-1#1)(2012-2#1)
studies of efficacy##4##3##(1995-1#1)(2011-1#1)(2012-1#1)(2012-2#1)
studies of enzyme##2##3##(2010-10#1)(2012-2#1)
studies of enzymes##2##3##(1996-12#1)(2008-4#1)
studies of gene expression in##3##5##(2008-7#2)(2010-2#1)
studies of gene expression##5##4##(2008-1#1)(2008-7#2)(2010-2#1)(2011-12#1)
studies of gene##9##3##(1994-3#2)(1995-2#1)(1995-8#1)(2008-1#1)(2008-7#2)(2010-2#1)(2011-12#1)
studies of genes##2##3##(1991-12#1)(2008-8#1)
studies of genetic variation##2##4##(2008-10#1)(2009-9#1)
studies of genetic##4##3##(2005-10#1)(2008-10#1)(2008-7#1)(2009-9#1)
studies of growth##2##3##(1990-5#1)(1993-7#1)
studies of high##2##3##(1991-8#1)(2011-2#1)
studies of how##2##3##(2008-10#2)
studies of human##11##3##(1991-7#2)(1994-10#1)(1995-12#1)(1995-6#1)(1996-11#1)(2008-11#1)(2008-4#1)(2011-1#1)(2012-12#1)(2012-2#1)
studies of humans##4##3##(1997-5#2)(2008-4#1)(2012-2#1)
studies of hydrogen##2##3##(1991-6#1)(2010-4#1)
studies of hydrozoans##2##3##(2010-2#2)
studies of immunization##2##3##(1996-12#1)(2006-10#1)
studies of in vivo##2##4##(2007-11#1)(2008-3#1)
studies of insect##2##3##(1994-10#1)(2011-12#1)
studies of insulin##2##3##(1996-11#1)(2008-1#1)
studies of its##6##3##(1992-5#1)(1994-10#1)(1994-12#1)(1997-6#1)(2008-10#1)(2008-7#1)
studies of laser##2##3##(2008-2#1)(2008-3#1)
studies of liver##2##3##(1992-2#1)(2008-10#1)
studies of male##2##3##(2007-12#1)(2012-3#1)
studies of malignant##2##3##(1992-3#1)(2012-2#1)
studies of manufacturing workers##2##4##(2010-8#2)
studies of many##2##3##(2008-10#1)(2008-9#1)
studies of methylphenidate##2##3##(1995-11#2)
studies of multiple##2##3##(2008-7#1)(2010-11#1)
studies of muscle##2##3##(1990-6#1)(1994-11#1)
studies of natural##3##3##(2007-11#1)(2008-10#1)(2008-9#1)
studies of new##3##3##(1991-1#1)(2007-10#1)(2007-7#1)
studies of nickel and chromium in wastewater from##2##8##(2008-10#2)
studies of novel##2##3##(2006-2#1)(2010-7#1)
studies of organic##2##3##(2007-11#1)(2007-8#1)
studies of other##7##3##(1990-2#1)(1991-5#1)(1991-6#2)(2005-11#1)(2008-5#1)(2012-3#1)
studies of outcome##2##3##(2006-10#1)(2008-11#1)
studies of pain##2##3##(1996-1#1)(2009-9#1)
studies of patients with chronic##2##5##(2008-10#1)(2012-1#1)
studies of patients with##9##4##(1990-12#1)(1991-4#1)(2006-5#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-7#1)(2012-1#1)(2012-3#1)
studies of patients##12##3##(1990-12#1)(1991-4#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-1#1)(2012-2#1)(2012-3#1)
studies of plant##3##3##(1990-6#1)(2008-9#1)(2009-8#1)
studies of platelet heterogeneity and##2##5##(1990-12#2)
studies of platelet##3##3##(1990-12#2)(2008-9#1)
studies of population##2##3##(2008-9#1)(2010-12#1)
studies of potassium##2##3##(2007-5#1)(2009-5#1)
studies of prenatal##2##3##(2008-2#2)
studies of primary##3##3##(1997-3#1)(2007-10#1)(2010-4#1)
studies of processes##2##3##(1994-3#1)(2010-6#1)
studies of protein structure##2##4##(1995-4#1)(2012-3#1)
studies of protein##4##3##(1991-9#1)(1995-4#1)(2011-2#1)(2012-3#1)
studies of protein-protein interactions##2##4##(2008-11#1)(2008-7#1)
studies of protein-protein##3##3##(1993-12#1)(2008-11#1)(2008-7#1)
studies of rat##3##3##(1992-8#1)(1993-2#1)(1994-9#1)
studies of receptor##3##3##(1993-3#1)(2011-1#1)(2012-2#1)
studies of recombinant##2##3##(1991-7#1)(2008-5#1)
studies of reverse-correlation have##2##4##(2013-8#2)
studies of selected##2##3##(2007-11#1)(2008-11#1)
studies of several##2##3##(1994-6#1)(2009-12#1)
studies of sexual selection##2##4##(2008-8#1)(2009-9#1)
studies of six##3##3##(1991-12#2)(1992-9#1)
studies of social##2##3##(2008-11#1)(2008-5#1)
studies of sodium bromate##2##4##(2008-9#2)
studies of spinach##3##3##(1994-11#1)(1994-12#1)(1994-9#1)
studies of stroke incidence##2##4##(2008-8#2)
studies of stroke##5##3##(2007-10#1)(2008-8#4)
studies of such##4##3##(1993-11#1)(2007-11#1)(2008-10#1)(2009-7#1)
studies of the D-galactose##3##4##(1990-5#1)(1991-4#2)
studies of the binary and ternary complexes involving##2##8##(2008-10#2)
studies of the biosensor##4##4##(2008-10#4)
studies of the cloned receptor##2##5##(1992-11#1)(1992-3#1)
studies of the conformations of##2##5##(1991-4#1)(1994-11#1)
studies of the development of##2##5##(1992-12#1)(2008-11#1)
studies of the ecology##2##4##(2008-8#1)(2009-5#1)
studies of the effect of##6##5##(1997-4#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-9#1)
studies of the effect##7##4##(1997-4#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-3#1)(2008-9#1)
studies of the effects of##5##5##(1996-2#1)(2006-10#1)(2006-2#1)(2007-11#1)(2009-11#1)
studies of the efficacy##2##4##(1990-12#1)(1994-2#1)
studies of the enzyme##2##4##(1991-4#1)(2008-7#1)
studies of the function of##4##5##(1993-11#1)(1996-11#1)(2007-1#1)(2008-8#1)
studies of the functional##2##4##(2008-7#1)(2010-2#1)
studies of the genetic##2##4##(2008-8#1)(2013-8#1)
studies of the genus##2##4##(2008-4#1)(2008-7#1)
studies of the interaction between##4##5##(1992-3#1)(1993-12#1)(1994-11#1)(2008-10#1)
studies of the interaction##6##4##(1992-3#1)(1993-11#1)(1993-12#1)(1994-11#1)(2008-10#2)
studies of the mechanisms##2##4##(1993-4#1)(2009-2#1)
studies of the reaction##3##4##(2006-10#1)(2008-10#1)(2009-8#1)
studies of the reactions of##3##5##(1990-10#1)(1995-10#1)(2008-5#1)
studies of the relationship between##3##5##(2006-7#1)(2008-12#1)(2010-5#1)
studies of the relationships##2##4##(2007-12#1)(2010-12#1)
studies of the resulting##2##4##(2008-10#1)(2010-4#1)
studies of the role of##3##5##(1992-11#1)(2009-6#1)(2010-8#1)
studies of the sick building syndrome##2##6##(1992-4#2)
studies of the##263##3##(1990-10#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#3)(1990-7#2)(1990-8#3)(1990-9#2)(1991-1#1)(1991-11#1)(1991-3#2)(1991-4#5)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-11#2)(1992-12#5)(1992-3#3)(1992-4#2)(1992-6#2)(1992-7#1)(1992-9#1)(1993-11#3)(1993-12#2)(1993-3#3)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#2)(1995-5#1)(1995-6#2)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#3)(1997-7#2)(1997-8#1)(2004-12#1)(2004-2#1)(2005-10#1)(2005-11#2)(2005-12#1)(2006-10#7)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#6)(2007-12#5)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#26)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#5)(2008-5#6)(2008-7#9)(2008-8#9)(2008-9#3)(2009-11#1)(2009-2#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#6)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-11#1)(2012-2#5)(2012-3#2)(2013-8#2)
studies of their##2##3##(2006-7#1)(2008-5#1)
studies of these##16##3##(1990-5#1)(1991-3#1)(1992-4#1)(1993-12#1)(1994-9#1)(1995-2#1)(2005-11#1)(2006-3#1)(2008-11#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-2#1)(2012-11#1)
studies of this important##3##4##(2008-10#2)(2009-8#1)
studies of this pathogen##3##4##(2008-10#3)
studies of this process##2##4##(1995-2#1)(2008-5#1)
studies of this##26##3##(1990-12#1)(1991-12#1)(1991-9#1)(1994-11#1)(1995-2#1)(1996-9#1)(1997-2#1)(2006-12#1)(2006-4#1)(2007-1#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-5#2)(2009-8#1)(2010-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
studies of three##3##3##(1993-3#1)(1996-3#1)(2007-3#1)
studies of tissue##3##3##(1997-6#1)(2008-3#1)(2011-12#1)
studies of translational properties of##2##5##(2005-11#2)
studies of translational##3##3##(1992-8#1)(2005-11#2)
studies of two##3##3##(1994-12#1)(2008-12#1)(2012-12#1)
studies of utilization##2##3##(1995-1#1)(2012-12#1)
studies of variable##2##3##(2007-11#1)(2011-12#1)
studies of various##4##3##(1992-4#1)(1992-6#1)(2006-8#1)(2009-8#1)
studies of ventricular brain CSF in assorted psychiatric and##2##9##(1993-1#2)
studies of vitamin##2##3##(2005-4#1)(2008-10#1)
studies of water##3##3##(1997-6#1)(2006-10#1)(2009-3#1)
studies of##1251##2##(1990-10#2)(1990-11#1)(1990-12#8)(1990-2#4)(1990-3#1)(1990-4#3)(1990-5#9)(1990-6#4)(1990-7#6)(1990-8#6)(1990-9#4)(1991-1#6)(1991-10#2)(1991-11#3)(1991-12#7)(1991-2#2)(1991-3#4)(1991-4#7)(1991-5#5)(1991-6#7)(1991-7#10)(1991-8#4)(1991-9#9)(1992-10#3)(1992-11#5)(1992-12#8)(1992-2#2)(1992-3#10)(1992-4#8)(1992-5#1)(1992-6#6)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#3)(1993-10#1)(1993-11#9)(1993-12#9)(1993-2#1)(1993-3#10)(1993-4#2)(1993-6#4)(1993-7#2)(1993-8#5)(1993-9#2)(1994-10#4)(1994-11#11)(1994-12#5)(1994-2#2)(1994-3#5)(1994-4#2)(1994-5#4)(1994-6#3)(1994-7#3)(1994-8#1)(1994-9#9)(1995-1#4)(1995-10#4)(1995-11#7)(1995-12#2)(1995-2#7)(1995-3#4)(1995-4#5)(1995-5#4)(1995-6#7)(1995-7#1)(1995-8#2)(1995-9#4)(1996-1#3)(1996-11#7)(1996-12#6)(1996-2#8)(1996-3#6)(1996-4#5)(1996-5#3)(1996-6#7)(1996-7#3)(1996-8#2)(1996-9#4)(1997-1#2)(1997-2#5)(1997-3#3)(1997-4#5)(1997-5#14)(1997-6#8)(1997-7#5)(1997-8#6)(2004-12#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-10#11)(2005-11#11)(2005-12#3)(2005-4#3)(2005-7#2)(2005-8#4)(2006-1#2)(2006-10#34)(2006-11#1)(2006-12#9)(2006-2#6)(2006-3#4)(2006-4#3)(2006-5#5)(2006-7#3)(2006-8#4)(2006-9#4)(2007-1#3)(2007-10#11)(2007-11#25)(2007-12#27)(2007-2#3)(2007-3#2)(2007-4#3)(2007-5#5)(2007-6#1)(2007-7#7)(2007-8#8)(2007-9#4)(2008-1#12)(2008-10#102)(2008-11#36)(2008-12#7)(2008-2#12)(2008-3#24)(2008-4#25)(2008-5#30)(2008-6#6)(2008-7#33)(2008-8#36)(2008-9#40)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#4)(2009-2#5)(2009-3#4)(2009-4#2)(2009-5#4)(2009-6#3)(2009-7#6)(2009-8#11)(2009-9#8)(2010-1#1)(2010-10#4)(2010-11#6)(2010-12#8)(2010-2#17)(2010-3#3)(2010-4#6)(2010-5#11)(2010-6#4)(2010-7#5)(2010-8#10)(2010-9#5)(2011-1#12)(2011-12#5)(2011-2#18)(2011-3#2)(2011-7#1)(2012-1#8)(2012-11#7)(2012-12#11)(2012-2#22)(2012-3#17)(2012-4#1)(2012-9#1)(2013-1#12)(2013-7#7)(2013-8#7)
studies offer##2##2##(2008-11#1)(2008-8#1)
studies often##6##2##(1994-6#1)(1996-6#1)(2006-10#1)(2007-7#1)(2008-7#1)(2009-5#1)
studies on Al##2##3##(1996-8#2)
studies on a##6##3##(1994-8#1)(1996-7#1)(2008-1#1)(2008-4#1)(2008-5#1)(2011-2#1)
studies on adult##2##3##(2007-1#1)(2012-3#1)
studies on alcohol##2##3##(1996-6#2)
studies on antiarrhythmic##3##3##(2004-11#1)(2013-1#2)
studies on biological##2##3##(2010-12#1)(2011-2#1)
studies on cancer##6##3##(1990-9#1)(2006-11#1)(2007-3#1)(2008-7#1)(2009-3#1)(2012-1#1)
studies on clinical##2##3##(2013-1#1)(2013-7#1)
studies on coordination##2##3##(2008-2#1)(2011-12#1)
studies on cytotoxic##2##3##(2007-11#1)(2010-5#1)
studies on different##3##3##(1990-6#1)(2006-10#1)(2010-5#1)
studies on early##2##3##(1994-9#1)(1995-2#1)
studies on effect of##2##4##(1994-6#1)(2007-1#1)
studies on gene##2##3##(1994-3#1)(1996-4#1)
studies on growth##2##3##(2007-11#1)(2012-2#1)
studies on human##7##3##(1990-11#1)(1990-5#1)(1992-7#1)(1995-8#1)(2007-2#1)(2008-11#1)(2008-8#1)
studies on incidence##2##3##(1995-5#2)
studies on isolated##3##3##(2006-2#1)(2009-4#1)(2010-2#1)
studies on its##4##3##(2006-5#1)(2008-10#1)(2008-12#1)(2012-3#1)
studies on lipid##2##3##(1992-9#1)(2007-8#1)
studies on molecular##2##3##(1991-2#1)(2013-1#1)
studies on natural##3##3##(2008-10#3)
studies on other##2##3##(2008-10#1)(2009-6#1)
studies on patients##2##3##(1991-5#1)(2007-11#1)
studies on production of##2##4##(2005-11#1)(2006-9#1)
studies on social support##2##4##(1992-3#2)
studies on structure-function##2##3##(1995-1#1)(2011-1#1)
studies on ten##2##3##(2007-6#1)(2009-10#1)
studies on the association between##3##5##(2007-6#1)(2010-10#1)(2010-9#1)
studies on the association##4##4##(1993-12#1)(2007-6#1)(2010-10#1)(2010-9#1)
studies on the basis of##2##5##(2006-6#1)(2011-2#1)
studies on the control of##2##5##(1994-3#1)(2011-2#1)
studies on the development of the##2##6##(2007-12#1)(2008-10#1)
studies on the development of##3##5##(2007-12#1)(2008-10#1)(2009-6#1)
studies on the distribution##2##4##(1995-5#1)(2008-11#1)
studies on the effect of##3##5##(2006-10#1)(2006-5#1)(2008-3#1)
studies on the effect##4##4##(1994-2#1)(2006-10#1)(2006-5#1)(2008-3#1)
studies on the effectiveness of##2##5##(2007-12#1)(2012-2#1)
studies on the effects of##7##5##(1991-6#1)(2006-10#1)(2006-8#1)(2008-11#1)(2008-5#1)(2009-9#1)(2012-12#1)
studies on the effects##8##4##(1991-6#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-11#1)(2008-5#1)(2009-9#1)(2012-12#1)
studies on the expression of##2##5##(1994-8#1)(2013-8#1)
studies on the free##2##4##(1994-6#1)(1997-4#1)
studies on the immune##3##4##(1993-8#1)(1997-4#1)(2007-2#1)
studies on the impact of##2##5##(1990-1#1)(2012-2#1)
studies on the interaction of##3##5##(1991-2#1)(1996-7#1)(2008-11#1)
studies on the interaction##5##4##(1991-1#1)(1991-2#1)(1996-7#1)(2008-11#1)(2012-12#1)
studies on the interactions of##2##5##(1991-7#1)(2008-3#1)
studies on the interactions##3##4##(1991-7#1)(1995-1#1)(2008-3#1)
studies on the mechanism of action##2##6##(1993-9#1)(2008-5#1)
studies on the mechanism of##7##5##(1992-11#1)(1993-9#1)(2007-11#1)(2007-12#1)(2008-5#1)(2013-1#2)
studies on the molecular mechanisms##2##5##(2008-9#1)(2012-12#1)
studies on the molecular##5##4##(1994-5#1)(2008-9#1)(2009-10#1)(2011-3#1)(2012-12#1)
studies on the prevalence of##4##5##(2006-7#1)(2009-1#1)(2010-12#1)(2012-2#1)
studies on the relationship between##5##5##(1996-8#1)(2005-11#1)(2006-8#1)(2007-11#1)(2008-1#1)
studies on the role of##4##5##(2008-7#1)(2009-8#1)(2010-10#1)(2011-1#1)
studies on the social##2##4##(1995-5#1)(2008-11#1)
studies on the solution##2##4##(1991-2#1)(2009-3#1)
studies on the structure##3##4##(2008-1#1)(2008-4#1)(2008-9#1)
studies on the subject##3##4##(2007-7#1)(2008-9#1)(2011-2#1)
studies on the use of##2##5##(2007-11#1)(2008-5#1)
studies on the##224##3##(1990-1#1)(1990-2#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#4)(1991-4#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-3#2)(1992-4#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#3)(1993-5#2)(1993-6#1)(1993-8#2)(1993-9#2)(1994-12#2)(1994-2#3)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#3)(1994-8#3)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#2)(1995-7#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#3)(1996-8#1)(1997-2#2)(1997-4#2)(1997-6#1)(2004-11#1)(2005-11#2)(2005-4#1)(2005-7#2)(2006-10#6)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#6)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#10)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#9)(2008-7#3)(2008-8#2)(2008-9#5)(2009-1#1)(2009-10#2)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#3)(2010-2#2)(2010-3#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#4)(2013-1#6)(2013-7#1)(2013-8#1)
studies on their##4##3##(2006-10#1)(2008-5#1)(2008-7#1)(2008-8#1)
studies on these##8##3##(1993-11#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-7#2)(2013-7#1)(2013-8#1)
studies on this issue##2##4##(2008-11#2)
studies on this topic##2##4##(2006-10#1)(2012-1#1)
studies on this##11##3##(1990-7#1)(1997-8#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-11#2)(2009-9#1)(2010-5#1)(2011-2#1)(2012-1#1)
studies on various##3##3##(2006-10#2)(2010-10#1)
studies on virus##2##3##(2007-12#1)(2008-10#1)
studies on##607##2##(1990-1#2)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#5)(1990-6#2)(1990-7#3)(1990-8#3)(1990-9#2)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#6)(1991-4#4)(1991-5#4)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#2)(1992-3#5)(1992-4#4)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#4)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#2)(1993-4#1)(1993-5#2)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#4)(1994-2#4)(1994-3#3)(1994-4#1)(1994-5#2)(1994-6#5)(1994-7#1)(1994-8#7)(1994-9#1)(1995-1#4)(1995-11#3)(1995-12#3)(1995-2#2)(1995-3#4)(1995-5#5)(1995-6#2)(1995-7#2)(1995-8#2)(1996-12#1)(1996-3#1)(1996-4#2)(1996-5#3)(1996-6#4)(1996-7#4)(1996-8#4)(1997-1#2)(1997-2#2)(1997-4#3)(1997-5#2)(1997-6#4)(1997-8#2)(2004-11#2)(2004-12#1)(2004-9#1)(2005-11#6)(2005-4#1)(2005-6#1)(2005-7#2)(2005-9#1)(2006-1#1)(2006-10#18)(2006-11#1)(2006-12#3)(2006-2#5)(2006-3#2)(2006-4#2)(2006-5#4)(2006-6#5)(2006-7#1)(2006-8#6)(2006-9#1)(2007-1#3)(2007-10#3)(2007-11#20)(2007-12#7)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#3)(2007-6#3)(2007-7#3)(2007-8#4)(2007-9#3)(2008-1#7)(2008-10#31)(2008-11#13)(2008-12#7)(2008-2#8)(2008-3#10)(2008-4#7)(2008-5#20)(2008-6#2)(2008-7#17)(2008-8#10)(2008-9#10)(2009-1#1)(2009-10#3)(2009-12#3)(2009-2#1)(2009-3#4)(2009-4#6)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#4)(2009-9#4)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#7)(2010-2#5)(2010-3#2)(2010-4#4)(2010-5#6)(2010-7#4)(2010-8#3)(2010-9#6)(2011-1#10)(2011-12#3)(2011-2#13)(2011-3#1)(2012-1#8)(2012-11#2)(2012-12#6)(2012-2#13)(2012-3#7)(2013-1#17)(2013-7#7)(2013-8#4)
studies only##3##2##(2006-12#1)(2010-12#1)(2013-1#1)
studies or for##2##3##(2008-4#1)(2008-9#1)
studies or##13##2##(1992-6#1)(1994-12#1)(2007-10#1)(2008-1#1)(2008-2#1)(2008-4#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-5#1)(2010-8#1)(2013-1#1)
studies over the##2##3##(2006-7#1)(2006-9#1)
studies over##5##2##(1996-2#1)(2006-7#1)(2006-9#1)(2008-9#1)(2012-11#1)
studies performed at##4##3##(1992-2#1)(1994-11#1)(1995-12#1)(1996-9#1)
studies performed for U(VI) and Th(IV)##2##6##(2008-10#2)
studies performed for U(VI)##3##4##(2008-10#3)
studies performed in##5##3##(2006-1#1)(2007-4#1)(2010-11#1)(2012-3#1)(2013-8#1)
studies performed on##4##3##(1990-7#1)(1992-5#1)(1994-6#1)(2008-10#1)
studies performed over the##2##4##(2008-7#1)(2009-4#1)
studies performed over##3##3##(2008-10#1)(2008-7#1)(2009-4#1)
studies performed under##3##3##(1992-6#1)(2008-10#2)
studies performed with##4##3##(1997-4#1)(2008-10#1)(2008-7#1)(2012-12#1)
studies performed##33##2##(1990-7#1)(1992-2#1)(1992-5#1)(1992-6#1)(1994-11#1)(1994-6#1)(1995-12#1)(1996-9#1)(1997-4#1)(1997-8#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-10#9)(2008-7#4)(2009-4#1)(2010-11#1)(2012-12#1)(2012-3#1)(2013-8#1)
studies pertaining to##3##3##(1990-7#1)(2006-10#1)(2008-10#1)
studies point to the##3##4##(1992-11#1)(2010-12#1)(2013-7#1)
studies point to##4##3##(1992-11#1)(2006-10#1)(2010-12#1)(2013-7#1)
studies predict##2##2##(2008-10#1)(2008-8#1)
studies present##2##2##(2009-2#1)(2011-2#1)
studies presented here##3##3##(1992-11#1)(1995-12#1)(2011-2#1)
studies presented in this##3##4##(2006-1#1)(2006-8#1)(2008-11#1)
studies presented in##4##3##(2006-1#1)(2006-8#1)(2008-11#1)(2008-12#1)
studies presented##15##2##(1991-2#1)(1992-11#1)(1994-9#1)(1995-12#1)(1995-2#1)(2005-8#1)(2006-1#1)(2006-8#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#1)
studies probing##2##2##(1994-11#1)(2011-1#1)
studies prove that##2##3##(1990-11#1)(2008-3#1)
studies proved that the##2##4##(1992-2#1)(2008-10#1)
studies proved that##3##3##(1992-2#1)(2008-10#1)(2010-4#1)
studies proved to be the most##2##6##(2007-3#1)(2008-9#1)
studies proved##7##2##(1992-2#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-4#1)
studies provide a##5##3##(1993-11#1)(2008-10#2)(2008-2#1)(2013-8#1)
studies provide evidence of##2##4##(2007-12#1)(2007-8#1)
studies provide evidence that##5##4##(1991-9#1)(1994-6#1)(1994-9#1)(1997-8#1)(2008-11#1)
studies provide evidence##8##3##(1991-9#1)(1994-12#1)(1994-6#1)(1994-9#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-11#1)
studies provide further support for##2##5##(1991-9#1)(2008-8#1)
studies provide insights##2##3##(2006-10#1)(2012-12#1)
studies provide more##3##3##(2005-10#1)(2006-10#1)(2011-2#1)
studies provide new##3##3##(1992-7#1)(2008-5#2)
studies provide strong evidence that##2##5##(1997-4#1)(2013-8#1)
studies provide the first##4##4##(1991-10#1)(2010-11#1)(2010-4#1)(2012-12#1)
studies provide the most reliable##2##5##(2005-10#2)
studies provide the##7##3##(1991-10#1)(1992-8#1)(2005-10#2)(2010-11#1)(2010-4#1)(2012-12#1)
studies provide##44##2##(1990-11#1)(1991-10#1)(1991-9#2)(1992-11#1)(1992-7#1)(1992-8#1)(1993-11#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-8#1)(1997-4#1)(1997-8#1)(2005-10#3)(2006-10#4)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2009-7#1)(2010-11#2)(2010-4#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-8#2)
studies provided##6##2##(2005-7#1)(2006-5#1)(2007-12#1)(2008-10#1)(2009-10#1)(2010-12#1)
studies published between##5##3##(2008-1#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-8#1)
studies published by##2##3##(1993-4#1)(2007-7#1)
studies published during the##2##4##(2006-10#1)(2011-12#1)
studies published in the##2##4##(2006-10#1)(2008-3#1)
studies published in##6##3##(1993-12#1)(2006-10#2)(2008-3#1)(2008-7#1)(2008-8#1)
studies published##22##2##(1990-6#1)(1993-12#1)(1993-4#1)(1997-3#1)(2006-10#3)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#2)(2010-5#1)(2011-12#1)(2012-12#2)(2013-1#1)(2013-8#1)
studies recently##2##2##(1991-4#1)(1995-2#1)
studies regarding the##7##3##(1992-7#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-7#2)
studies regarding##16##2##(1992-7#1)(1993-11#1)(1994-5#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-7#2)(2011-12#1)(2012-3#2)(2013-1#1)
studies related to##10##3##(2007-2#2)(2008-10#3)(2008-11#1)(2008-4#1)(2009-5#1)(2012-12#1)(2013-1#1)
studies relating to##2##3##(2006-10#1)(2006-2#1)
studies relating##6##2##(1993-9#1)(2005-7#1)(2006-10#1)(2006-2#1)(2008-4#1)(2008-9#1)
studies relevant to##3##3##(1991-2#1)(2008-9#1)(2011-2#1)
studies remain##4##2##(2008-1#1)(2010-12#1)(2010-7#1)(2012-1#1)
studies report the##3##3##(1993-9#1)(2006-12#1)(2008-5#1)
studies report##11##2##(1993-9#1)(2005-10#1)(2006-12#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2010-11#1)(2011-1#1)(2012-8#1)
studies reported an##2##3##(2008-10#1)(2011-1#1)
studies reported here##7##3##(1990-5#1)(1994-11#1)(1995-8#2)(2007-11#1)(2008-10#1)(2009-2#1)
studies reported in the literature##3##5##(1993-11#1)(2007-4#1)(2008-11#1)
studies reported in##4##3##(1992-6#1)(1993-11#1)(2007-4#1)(2008-11#1)
studies reported to date##2##4##(1991-12#1)(2011-2#1)
studies reported##27##2##(1990-5#2)(1990-6#1)(1991-12#1)(1992-6#1)(1993-11#2)(1994-11#1)(1995-8#2)(2007-11#2)(2007-4#1)(2007-8#2)(2008-10#2)(2008-11#1)(2009-2#1)(2009-5#2)(2011-1#3)(2011-2#1)(2012-3#1)(2013-1#1)
studies reporting a##3##3##(2005-10#1)(2008-7#1)(2011-2#1)
studies reporting long-term (≥ 48 months)##2##6##(2012-12#2)
studies reporting the##2##3##(2005-10#1)(2013-1#1)
studies reporting##16##2##(2005-10#3)(2005-11#1)(2006-10#1)(2008-10#2)(2008-7#2)(2010-7#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
studies require##4##2##(1990-11#1)(2005-8#1)(2008-4#1)(2013-7#1)
studies resulted in a##2##4##(1990-8#1)(1997-4#1)
studies resulted in##3##3##(1990-8#1)(1997-4#1)(2008-10#1)
studies resulted##4##2##(1990-8#1)(1997-4#1)(2008-10#1)(2008-4#1)
studies reveal a##4##3##(1990-12#1)(1992-6#1)(1996-2#1)(2012-12#1)
studies reveal an##2##3##(1996-8#1)(2006-8#1)
studies reveal that the##5##4##(1994-6#1)(2007-10#1)(2008-11#1)(2009-4#1)(2012-3#1)
studies reveal that##18##3##(1990-7#1)(1992-6#1)(1993-3#1)(1994-3#1)(1994-5#1)(1994-6#1)(1996-8#1)(2006-12#1)(2007-10#1)(2008-11#2)(2008-8#1)(2009-4#1)(2010-2#1)(2010-4#1)(2012-2#2)(2012-3#1)
studies reveal the##2##3##(1991-4#1)(2010-6#1)
studies reveal##30##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-4#1)(1992-6#2)(1993-11#1)(1993-3#1)(1994-3#1)(1994-5#1)(1994-6#1)(1996-2#1)(1996-8#2)(2006-12#1)(2006-8#1)(2007-10#1)(2008-11#2)(2008-8#1)(2009-12#1)(2009-4#1)(2010-2#1)(2010-4#1)(2010-6#1)(2012-12#2)(2012-2#2)(2012-3#1)
studies revealed a##10##3##(1992-1#1)(1992-11#1)(1993-2#1)(1995-7#1)(1997-7#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-9#1)(2011-2#1)
studies revealed no##2##3##(1996-5#1)(2008-7#1)
studies revealed significant##2##3##(1996-1#1)(1996-3#1)
studies revealed that both##4##4##(1991-2#1)(1994-12#1)(1995-8#1)(2012-3#1)
studies revealed that most##3##4##(1997-2#1)(2006-12#1)(2009-4#1)
studies revealed that the##15##4##(1990-2#1)(1993-12#1)(1997-4#1)(2005-11#2)(2007-12#1)(2008-10#5)(2009-5#1)(2010-5#1)(2012-2#1)(2013-1#1)
studies revealed that##56##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-2#1)(1993-12#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-9#2)(1995-5#1)(1995-8#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#2)(2005-11#2)(2006-12#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-4#1)(2008-5#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
studies revealed the presence of a##2##6##(1994-8#1)(2007-11#1)
studies revealed the presence of##6##5##(1994-10#1)(1994-8#1)(1996-9#1)(2007-11#1)(2008-7#1)(2010-7#1)
studies revealed the##12##3##(1992-2#1)(1994-10#1)(1994-8#1)(1996-9#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#2)(2008-8#1)(2010-7#1)
studies revealed##107##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#1)(1991-2#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-10#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-6#2)(1997-7#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
studies revealing##4##2##(2008-6#1)(2011-1#1)(2011-2#1)(2012-1#1)
studies reviewed here##3##3##(1994-12#1)(2008-1#1)(2011-12#1)
studies reviewed##9##2##(1994-12#1)(2008-1#1)(2008-7#1)(2009-4#1)(2009-6#1)(2011-1#1)(2011-12#2)(2013-1#1)
studies searching for##2##3##(2008-5#1)(2012-2#1)
studies seek to##2##3##(2008-8#1)(2010-12#1)
studies seem to##5##3##(1991-6#1)(1992-12#1)(1994-9#1)(2006-2#1)(2008-10#1)
studies shed##3##2##(1995-12#1)(2008-11#1)(2012-12#1)
studies should also##2##3##(1991-12#1)(2006-10#1)
studies should assess##2##3##(2010-8#1)(2012-2#1)
studies should be carried out to##2##6##(2006-8#1)(2012-12#1)
studies should be carried out##4##5##(1994-6#1)(2006-8#1)(2008-5#1)(2012-12#1)
studies should be performed##2##4##(1996-12#1)(2008-5#1)
studies should be undertaken##2##4##(1992-12#1)(1993-6#1)
studies should be##20##3##(1990-6#1)(1992-12#1)(1993-6#1)(1994-6#1)(1995-5#1)(1996-12#1)(2004-9#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-5#2)(2008-8#1)(2011-2#2)(2012-1#1)(2012-12#1)
studies should##43##2##(1990-3#1)(1990-6#1)(1991-12#1)(1992-12#1)(1993-6#1)(1994-6#1)(1995-5#1)(1996-12#2)(1997-2#1)(2004-9#1)(2005-10#2)(2006-10#3)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#3)(2010-2#1)(2010-8#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)
studies show a##9##3##(1991-9#1)(1996-3#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-7#1)(2011-2#1)(2012-1#1)
studies show that a##4##4##(1994-9#1)(2007-12#1)(2007-4#1)(2008-9#1)
studies show that both##2##4##(1992-9#1)(2012-1#1)
studies show that in##2##4##(1990-11#1)(1996-10#1)
studies show that it##2##4##(1995-10#1)(2006-10#1)
studies show that most##3##4##(1996-8#1)(2010-12#1)(2011-2#1)
studies show that the##31##4##(1990-8#1)(1991-10#1)(1991-12#1)(1991-9#1)(1992-1#1)(1995-3#1)(1996-9#1)(1997-8#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#3)(2008-8#2)(2009-10#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
studies show that there##3##4##(1996-6#1)(2008-5#1)(2012-12#1)
studies show that these##3##4##(2006-10#1)(2008-7#1)(2009-8#1)
studies show that when##2##4##(1992-2#1)(2010-2#1)
studies show that##104##3##(1990-11#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-4#1)(1994-10#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-5#1)(1997-8#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-10#10)(2008-2#1)(2008-3#4)(2008-5#3)(2008-7#2)(2008-8#5)(2008-9#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-6#1)(2009-8#2)(2010-12#4)(2010-2#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
studies show the##8##3##(1990-10#1)(1991-5#1)(2006-8#1)(2007-11#1)(2008-3#1)(2008-5#1)(2009-11#1)(2013-1#1)
studies show##138##2##(1990-10#1)(1990-11#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-4#1)(1994-10#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-7#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-8#2)(2006-9#1)(2007-11#3)(2007-12#2)(2007-4#1)(2007-8#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#5)(2008-5#4)(2008-7#3)(2008-8#5)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-6#1)(2009-8#3)(2010-12#4)(2010-2#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)
studies showed a mass##2##4##(2011-2#1)(2012-2#1)
studies showed a statistically##2##4##(1990-12#1)(1994-2#1)
studies showed a##16##3##(1990-11#1)(1990-12#1)(1994-2#1)(1997-4#1)(2008-10#3)(2008-7#2)(2009-8#2)(2010-11#2)(2011-12#1)(2011-2#1)(2012-2#1)
studies showed an##4##3##(1992-11#1)(1993-2#1)(2007-9#1)(2009-2#1)
studies showed evidence##2##3##(1997-8#1)(2011-2#1)
studies showed good##2##3##(1995-5#1)(2012-12#1)
studies showed no##6##3##(1993-6#1)(2005-11#1)(2007-8#1)(2010-2#1)(2011-2#1)(2012-12#1)
studies showed positive##2##3##(2005-10#1)(2006-8#1)
studies showed significant##2##3##(2008-10#1)(2008-4#1)
studies showed that a##3##4##(2006-12#1)(2008-10#1)(2010-5#1)
studies showed that in##3##4##(1991-5#1)(2008-7#1)(2013-7#1)
studies showed that low##3##4##(2005-3#1)(2008-7#1)(2012-12#1)
studies showed that such##2##4##(2009-10#1)(2009-9#1)
studies showed that the occurrence##2##5##(2008-7#1)(2010-5#1)
studies showed that the##22##4##(1991-8#1)(1994-3#1)(1995-11#1)(1997-4#1)(2005-11#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-7#2)(2009-12#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-12#1)(2012-2#1)(2013-8#1)
studies showed that these##2##4##(1997-4#1)(2010-10#1)
studies showed that they are##2##5##(2007-11#1)(2008-1#1)
studies showed that##98##3##(1990-11#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-8#1)(1993-7#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-4#3)(2005-10#1)(2005-11#1)(2005-3#1)(2005-8#2)(2006-12#1)(2006-6#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-3#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#3)(2010-5#2)(2010-8#1)(2011-12#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#2)(2013-8#2)
studies showed the presence of##2##5##(1991-2#1)(2006-12#1)
studies showed the##6##3##(1991-2#1)(2006-12#1)(2007-7#1)(2008-5#3)
studies showed##161##2##(1990-11#2)(1990-12#1)(1990-5#1)(1991-2#2)(1991-5#2)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-8#1)(1993-2#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-4#4)(1997-8#1)(2005-10#2)(2005-11#2)(2005-3#1)(2005-8#2)(2006-12#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#16)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#9)(2008-7#8)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-5#4)(2010-8#1)(2011-12#2)(2011-2#4)(2012-1#2)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#3)
studies showing a##2##3##(2007-7#1)(2008-1#1)
studies showing improvement##2##3##(2006-10#1)(2007-12#1)
studies showing positive##2##3##(1997-5#1)(2008-9#1)
studies showing that the##3##4##(1991-11#1)(1993-6#1)(2010-8#1)
studies showing that##10##3##(1991-11#1)(1993-6#1)(1995-12#1)(2006-12#1)(2007-8#1)(2008-2#1)(2008-5#1)(2010-8#2)(2012-3#1)
studies showing the##2##3##(2008-1#1)(2008-4#1)
studies showing##22##2##(1991-11#1)(1993-6#1)(1995-12#1)(1997-5#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-8#2)(2012-3#1)
studies shows that##2##3##(1997-7#1)(2006-12#1)
studies since the##2##3##(2010-9#1)(2012-12#1)
studies since##4##2##(2008-10#1)(2008-3#1)(2010-9#1)(2012-12#1)
studies so far have##3##4##(1995-3#1)(2008-1#1)(2008-3#1)
studies so far##5##3##(1995-3#1)(2008-1#1)(2008-3#1)(2008-6#1)(2010-12#1)
studies so that##2##3##(2008-4#1)(2008-8#1)
studies so##8##2##(1995-3#1)(1997-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-12#1)
studies sought to##2##3##(1994-11#1)(2006-10#1)
studies sponsored by##2##3##(2007-6#1)(2009-11#1)
studies still need to be##2##5##(2006-10#1)(2011-2#1)
studies still##3##2##(2006-10#1)(2008-10#1)(2011-2#1)
studies strongly suggest##2##3##(2008-10#1)(2009-12#1)
studies strongly##5##2##(2004-2#1)(2006-10#1)(2008-10#1)(2008-3#1)(2009-12#1)
studies such as##2##3##(2007-10#1)(2008-10#1)
studies suggest a role for##2##5##(2008-6#1)(2010-4#1)
studies suggest a##8##3##(1991-8#1)(1994-9#1)(1995-12#1)(2005-7#1)(2006-10#1)(2008-6#1)(2010-4#1)(2012-3#1)
studies suggest that CGRP##3##4##(1990-6#1)(1992-6#2)
studies suggest that PKC##2##4##(1990-5#1)(1992-8#1)
studies suggest that a##5##4##(1990-2#1)(2005-10#1)(2006-10#1)(2006-12#1)(2012-2#1)
studies suggest that all##2##4##(2007-12#1)(2013-7#1)
studies suggest that at least##2##5##(1992-12#1)(1993-3#1)
studies suggest that several##2##4##(1997-7#1)(2010-2#1)
studies suggest that the presence of##2##6##(1992-9#1)(2010-7#1)
studies suggest that the##34##4##(1991-6#1)(1991-7#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-4#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-1#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#1)
studies suggest that there##2##4##(1992-11#1)(2013-8#1)
studies suggest that these##5##4##(1990-8#1)(1995-2#1)(1997-5#1)(2004-12#1)(2010-5#1)
studies suggest that this##4##4##(1991-8#1)(1997-7#1)(2006-10#1)(2009-5#1)
studies suggest that vitamin##2##4##(2008-8#1)(2010-6#1)
studies suggest that##177##3##(1990-2#2)(1990-5#1)(1990-6#2)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#1)(1994-3#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-7#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-4#2)(1997-5#1)(1997-7#2)(2004-12#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-8#4)(2006-10#10)(2006-11#2)(2006-12#1)(2006-2#2)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#2)(2009-5#1)(2009-6#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#3)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#2)
studies suggest the involvement of##2##5##(2008-11#1)(2008-4#1)
studies suggest the possibility of##2##5##(1990-6#1)(1995-11#1)
studies suggest the presence of##2##5##(1996-1#1)(1997-8#1)
studies suggest the##10##3##(1990-6#1)(1995-11#1)(1996-1#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-4#1)(2010-10#1)(2010-5#1)
studies suggest##209##2##(1990-2#2)(1990-5#2)(1990-6#3)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#3)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#1)(1994-3#3)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-4#2)(1997-5#1)(1997-7#2)(1997-8#1)(2004-12#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#4)(2006-10#12)(2006-11#2)(2006-12#1)(2006-2#2)(2006-7#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#4)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#3)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#6)(2013-1#4)(2013-7#1)(2013-8#2)
studies suggested a##2##3##(1990-6#1)(2007-11#1)
studies suggested that the##6##4##(1992-11#1)(1993-12#1)(1996-10#1)(1997-6#1)(2007-11#1)(2013-1#1)
studies suggested that##17##3##(1991-11#1)(1992-11#1)(1992-7#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-8#1)(1996-10#1)(1997-6#1)(2005-10#1)(2006-10#1)(2007-11#1)(2008-11#1)(2012-12#1)(2013-1#2)
studies suggested the possibility##2##4##(2005-10#1)(2011-2#1)
studies suggested##26##2##(1990-6#1)(1991-11#1)(1992-11#1)(1992-7#2)(1993-12#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-8#1)(1996-10#1)(1997-6#1)(2005-10#2)(2006-10#1)(2006-9#1)(2007-11#2)(2007-8#1)(2008-11#1)(2011-2#3)(2012-12#1)(2013-1#2)
studies suggesting a##3##3##(1995-7#1)(2009-3#1)(2010-2#1)
studies suggesting that the##2##4##(2007-12#1)(2008-11#1)
studies suggesting that##7##3##(2006-10#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-7#2)(2012-3#1)
studies suggesting##12##2##(1995-7#1)(1996-5#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-3#1)(2010-2#1)(2010-6#1)(2012-3#1)
studies suggests that the##3##4##(2006-10#1)(2006-9#1)(2009-7#1)
studies suggests that##6##3##(1996-5#1)(2006-10#1)(2006-9#1)(2008-4#1)(2009-7#1)(2012-2#1)
studies support a##3##3##(1992-4#1)(1994-2#1)(2011-2#1)
studies support the concept that##2##5##(1996-9#1)(1997-4#1)
studies support the hypothesis that##2##5##(1996-5#1)(2008-3#1)
studies support the notion that##2##5##(2008-5#1)(2011-2#1)
studies support the notion##3##4##(2008-5#1)(2011-1#1)(2011-2#1)
studies support the##23##3##(1993-3#1)(1993-6#1)(1995-12#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-8#2)(2005-7#1)(2007-11#2)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2011-1#1)(2011-2#1)
studies support these##2##3##(2008-10#1)(2009-6#1)
studies support##30##2##(1992-4#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-12#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-8#2)(2005-7#1)(2006-8#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-6#1)(2011-1#1)(2011-2#2)
studies supporting##4##2##(1990-12#1)(2006-10#1)(2006-7#1)(2010-5#1)
studies tested##2##2##(2008-10#1)(2009-9#1)
studies than##2##2##(1991-5#1)(2006-8#1)
studies that are##7##3##(1992-6#1)(1997-8#1)(2006-11#1)(2007-2#1)(2008-10#1)(2009-5#1)(2010-12#1)
studies that can be##2##4##(2006-10#1)(2008-7#1)
studies that can##3##3##(2006-10#1)(2008-7#1)(2010-9#1)
studies that compare##4##3##(2008-10#1)(2010-12#1)(2010-6#1)(2013-1#1)
studies that compared##3##3##(1997-5#1)(2013-8#2)
studies that confirm##2##3##(2007-2#1)(2010-7#1)
studies that confirmed##2##3##(2006-2#1)(2012-12#1)
studies that dealt##2##3##(2007-6#2)
studies that describe##2##3##(2009-6#1)(2013-1#1)
studies that directly##2##3##(2011-2#1)(2012-2#1)
studies that employ##3##3##(1996-1#1)(2008-3#1)(2008-8#1)
studies that evaluated the##2##4##(2007-1#1)(2012-3#1)
studies that evaluated##5##3##(2006-2#1)(2007-1#1)(2008-2#1)(2012-3#1)(2013-1#1)
studies that examine the##4##4##(2008-11#1)(2008-7#2)(2012-2#1)
studies that examine##8##3##(2007-2#1)(2008-11#1)(2008-7#2)(2009-5#1)(2009-9#1)(2011-1#1)(2012-2#1)
studies that examined##3##3##(1996-8#1)(2007-8#1)(2008-4#1)
studies that expression of##2##4##(1990-11#1)(1997-2#1)
studies that fail to##3##4##(2008-9#1)(2009-10#1)(2010-12#1)
studies that focused on##2##4##(2008-11#1)(2008-7#1)
studies that found##3##3##(2010-2#1)(2011-2#2)
studies that have addressed##2##4##(2008-6#1)(2012-3#1)
studies that have been published##2##5##(2004-11#1)(2006-11#1)
studies that have been##7##4##(1993-11#1)(2004-11#1)(2006-11#1)(2006-6#1)(2007-3#1)(2007-6#1)(2010-9#1)
studies that have evaluated##2##4##(2008-7#1)(2012-2#1)
studies that have examined##2##4##(1992-3#1)(2008-2#1)
studies that have focused on the##2##6##(2004-11#1)(2009-3#1)
studies that have investigated##2##4##(2009-2#1)(2012-1#1)
studies that have led to##2##5##(1997-2#1)(2010-10#1)
studies that have used##2##4##(2012-2#1)(2012-3#1)
studies that have##35##3##(1991-8#1)(1992-3#1)(1993-11#1)(1995-3#1)(1997-2#1)(2004-10#1)(2004-11#2)(2005-6#1)(2006-11#1)(2006-6#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#2)(2009-2#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-9#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)
studies that illustrate##3##3##(1994-2#1)(2007-12#1)(2010-11#1)
studies that indicate##3##3##(2005-8#1)(2007-7#1)(2008-11#1)
studies that investigate##2##3##(1997-8#1)(2007-10#1)
studies that involve##4##3##(1995-6#1)(1997-4#1)(2007-12#1)(2008-1#1)
studies that met our##2##4##(2013-1#2)
studies that met the##2##4##(2005-8#1)(2007-10#1)
studies that met##6##3##(2005-8#1)(2007-10#1)(2013-1#4)
studies that reported relevant data##3##5##(2009-2#3)
studies that reported##4##3##(1997-1#1)(2009-2#3)
studies that show##5##3##(1997-1#1)(2006-9#1)(2008-5#1)(2008-7#1)(2008-8#1)
studies that showed##2##3##(1994-11#1)(2008-5#1)
studies that suggest##2##3##(2006-7#1)(2009-10#1)
studies that support##2##3##(1994-3#1)(2010-11#1)
studies that the##5##3##(1994-12#1)(1996-9#1)(2008-10#1)(2008-7#1)(2009-9#1)
studies that used only##2##4##(2006-8#1)(2009-10#1)
studies that used##4##3##(1997-5#1)(2006-8#1)(2007-10#1)(2009-10#1)
studies that we identified##2##4##(2007-8#2)
studies that we##3##3##(2007-8#2)(2008-7#1)
studies that were##6##3##(2006-2#1)(2006-5#1)(2008-11#1)(2008-5#1)(2010-4#2)
studies that will##3##3##(2004-11#1)(2006-4#1)(2010-12#1)
studies that##217##2##(1990-11#1)(1990-8#1)(1991-2#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-11#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-9#1)(1995-10#1)(1995-3#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-5#2)(1997-8#2)(2004-10#1)(2004-11#3)(2004-12#1)(2005-6#1)(2005-7#1)(2005-8#3)(2006-10#3)(2006-11#3)(2006-2#5)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#4)(2007-11#3)(2007-12#3)(2007-2#4)(2007-3#1)(2007-6#3)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#8)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#13)(2008-8#6)(2008-9#2)(2009-10#5)(2009-2#4)(2009-3#1)(2009-5#3)(2009-6#1)(2009-8#4)(2009-9#3)(2010-10#1)(2010-11#3)(2010-12#5)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#10)(2013-7#1)(2013-8#4)
studies the effect of##2##4##(1996-7#1)(2009-8#1)
studies the effect##3##3##(1996-7#1)(2007-11#1)(2009-8#1)
studies the possibility##2##3##(2013-1#1)(2013-7#1)
studies the##37##2##(1990-10#1)(1990-3#1)(1990-6#1)(1993-10#1)(1994-2#1)(1994-4#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-4#1)(1996-2#1)(1996-7#1)(2005-10#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)
studies thus##3##2##(1990-12#1)(1991-6#1)(2012-2#1)
studies to assess the##2##4##(2008-10#1)(2008-5#1)
studies to assess##5##3##(2006-10#1)(2008-10#2)(2008-11#1)(2008-5#1)
studies to be performed##2##4##(2008-11#1)(2008-4#1)
studies to be##8##3##(1991-5#1)(1994-11#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-4#1)
studies to better##2##3##(2006-10#1)(2012-3#1)
studies to compare##2##3##(1997-5#1)(2012-2#1)
studies to date have examined##2##5##(2012-1#1)(2013-1#1)
studies to date have##4##4##(2008-11#1)(2008-3#1)(2012-1#1)(2013-1#1)
studies to date on##2##4##(2006-10#1)(2008-10#1)
studies to date##11##3##(2006-10#2)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
studies to define the##2##4##(1997-1#1)(2007-11#1)
studies to demonstrate##2##3##(1991-7#1)(2005-8#1)
studies to detect##2##3##(1995-1#1)(2008-4#1)
studies to determine the##5##4##(1990-7#1)(1991-2#1)(2005-7#1)(2008-10#1)(2010-3#1)
studies to determine##11##3##(1990-7#1)(1991-11#1)(1991-2#1)(1994-12#1)(1997-5#1)(2005-7#1)(2008-10#2)(2010-3#1)(2012-2#1)(2013-1#1)
studies to elucidate##3##3##(1992-4#1)(2006-10#1)(2012-1#1)
studies to establish##2##3##(2007-8#1)(2009-6#1)
studies to evaluate the efficacy##2##5##(2007-9#1)(2009-11#1)
studies to evaluate the##6##4##(2005-7#1)(2007-9#1)(2008-7#1)(2009-11#1)(2010-6#1)(2011-2#1)
studies to evaluate##15##3##(1993-8#1)(1994-3#1)(2005-7#1)(2007-11#1)(2007-9#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
studies to examine##3##3##(1992-6#1)(2008-5#1)(2013-1#1)
studies to find##2##3##(2007-6#1)(2008-10#1)
studies to identify##3##3##(2006-10#1)(2008-11#1)(2011-1#1)
studies to illustrate the##3##4##(2009-10#1)(2009-12#1)(2011-2#1)
studies to include##4##3##(1996-9#1)(1997-4#1)(2006-10#1)(2011-2#1)
studies to investigate the##3##4##(1992-9#1)(1995-8#1)(2012-12#1)
studies to investigate##10##3##(1992-9#1)(1995-8#1)(1996-8#1)(2006-10#1)(2006-12#3)(2007-11#1)(2012-12#2)
studies to prevent##2##3##(2008-3#1)(2008-7#1)
studies to support##4##3##(2008-10#1)(2010-8#1)(2012-12#2)
studies to the##3##3##(1995-4#1)(2005-7#1)(2007-9#1)
studies to understand the##5##4##(1994-11#1)(2007-11#1)(2007-7#1)(2008-10#1)(2013-1#1)
studies to##161##2##(1990-4#1)(1990-7#1)(1991-11#2)(1991-2#1)(1991-5#1)(1991-7#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-5#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-4#1)(1995-8#2)(1996-12#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#2)(2005-7#3)(2005-8#1)(2006-10#8)(2006-12#3)(2006-3#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#8)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#13)(2008-11#6)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#6)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#5)(2012-11#1)(2012-12#7)(2012-2#4)(2012-3#3)(2013-1#6)(2013-8#2)
studies toward##2##2##(2009-11#1)(2010-6#1)
studies under##4##2##(2008-1#1)(2008-10#2)(2008-11#1)
studies underline the##4##3##(1993-6#1)(2008-2#1)(2008-7#1)(2011-1#1)
studies underscore the##2##3##(1992-11#1)(2009-5#1)
studies used a##5##3##(1993-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-2#1)
studies used##12##2##(1991-11#1)(1993-11#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-11#1)
studies using a##9##3##(1991-8#1)(1997-7#1)(2004-12#1)(2006-6#1)(2006-8#1)(2007-12#1)(2008-10#1)(2009-12#1)(2009-9#1)
studies using animal models##2##4##(2010-6#1)(2012-2#1)
studies using animal##3##3##(2007-12#1)(2010-6#1)(2012-2#1)
studies using antibodies##2##3##(1990-6#1)(1993-6#1)
studies using different##2##3##(1995-9#1)(2008-10#1)
studies using molecular##2##3##(2006-8#1)(2009-3#1)
studies using novel##2##3##(2009-2#1)(2012-12#1)
studies using pure##2##3##(1995-3#1)(2010-2#1)
studies using purified##2##3##(1992-8#1)(1997-7#1)
studies using reverse##2##3##(2007-12#1)(2008-7#1)
studies using the##16##3##(1992-8#1)(1993-9#1)(1994-6#1)(1995-3#1)(1995-6#1)(1996-10#1)(1997-2#1)(2005-11#1)(2007-12#1)(2008-11#1)(2008-3#2)(2009-10#1)(2009-2#1)(2011-2#1)(2012-12#1)
studies using these##4##3##(1993-11#1)(1994-11#1)(1994-2#1)(1997-2#1)
studies using this##3##3##(2005-6#1)(2008-3#1)(2008-4#1)
studies using##163##2##(1990-12#3)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-4#1)(1992-8#5)(1992-9#2)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-3#3)(1995-6#2)(1995-7#1)(1995-9#1)(1996-10#3)(1996-12#2)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#2)(2004-12#1)(2005-10#1)(2005-11#1)(2005-6#1)(2005-7#1)(2006-10#3)(2006-5#2)(2006-6#2)(2006-8#2)(2007-11#4)(2007-12#4)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#17)(2008-11#5)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-2#5)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#2)(2012-3#5)(2013-1#2)(2013-8#1)
studies utilized##2##2##(2011-1#1)(2012-3#1)
studies utilizing##7##2##(2008-10#2)(2008-11#2)(2010-11#1)(2012-2#1)(2012-3#1)
studies verified##2##2##(2009-8#1)(2009-9#1)
studies very difficult##2##3##(2007-2#1)(2013-1#1)
studies via##2##2##(1990-11#1)(2008-9#1)
studies was a##2##3##(1993-6#1)(1994-11#1)
studies was less than##2##4##(1996-7#1)(2008-7#1)
studies was performed##2##3##(1995-2#1)(2007-2#1)
studies was to##5##3##(1995-1#1)(2008-10#1)(2008-3#2)(2008-5#1)
studies was##28##2##(1992-11#1)(1993-12#1)(1993-6#1)(1994-10#1)(1994-11#1)(1995-1#1)(1995-2#1)(1996-7#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2011-2#2)(2012-12#1)(2013-1#2)
studies we examined##3##3##(1993-3#1)(2008-3#1)(2013-1#1)
studies we have shown that##2##5##(2008-7#2)
studies we have##5##3##(1996-10#1)(2008-10#1)(2008-7#2)(2012-12#1)
studies we investigated##2##3##(2008-8#1)(2012-3#1)
studies we showed that##2##4##(1990-4#1)(1996-10#1)
studies we##21##2##(1990-4#1)(1990-6#1)(1991-2#1)(1993-3#1)(1996-10#2)(1996-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#3)(2008-7#2)(2008-8#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
studies were aimed at##2##4##(1995-2#1)(2012-1#1)
studies were also carried out##2##5##(1991-4#1)(2008-10#1)
studies were also done##2##4##(1993-11#1)(2008-5#1)
studies were also##7##3##(1990-8#1)(1991-4#1)(1993-11#1)(1994-10#1)(2007-7#1)(2008-10#1)(2008-5#1)
studies were based on##2##4##(2008-11#1)(2011-1#1)
studies were carried out by##2##5##(2008-10#1)(2012-12#1)
studies were carried out in##3##5##(2007-7#1)(2008-6#1)(2010-12#1)
studies were carried out on the##2##6##(2007-6#1)(2008-10#1)
studies were carried out on##7##5##(1990-2#1)(1994-12#1)(1994-5#1)(2007-6#1)(2008-10#1)(2008-12#1)(2011-2#1)
studies were carried out to assess##2##6##(2005-9#1)(2008-5#1)
studies were carried out to##6##5##(1996-2#1)(2005-9#1)(2008-10#2)(2008-5#2)
studies were carried out using##5##5##(1996-12#1)(1996-5#1)(2008-5#1)(2010-5#1)(2013-1#1)
studies were carried out##28##4##(1990-2#1)(1994-12#1)(1994-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(2005-9#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#5)(2008-12#1)(2008-5#3)(2008-6#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
studies were combined##3##3##(2008-7#1)(2012-12#2)
studies were compared##2##3##(2008-7#1)(2010-1#1)
studies were completed##2##3##(1991-11#1)(2007-10#1)
studies were conducted by##2##4##(2008-10#1)(2008-11#1)
studies were conducted in##15##4##(2008-1#1)(2008-8#2)(2008-9#8)(2010-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
studies were conducted to determine##2##5##(1995-2#1)(2011-2#1)
studies were conducted to further##2##5##(2007-11#1)(2008-10#1)
studies were conducted to identify##2##5##(2008-10#1)(2008-7#1)
studies were conducted to##12##4##(1995-2#1)(2007-11#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#2)
studies were conducted using##2##4##(1995-3#1)(2012-1#1)
studies were conducted with##5##4##(1991-8#1)(1993-9#1)(2004-8#1)(2007-12#1)(2008-5#1)
studies were conducted##42##3##(1991-8#1)(1993-9#1)(1994-6#1)(1995-2#1)(1995-3#1)(2004-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#8)(2009-11#1)(2009-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
studies were considered##2##3##(2008-8#1)(2012-2#1)
studies were consistent with##3##4##(1991-12#1)(2006-10#1)(2007-9#1)
studies were designed to compare the##2##6##(1990-7#1)(2007-11#1)
studies were designed to delineate##2##5##(1995-10#1)(1995-5#1)
studies were designed to##7##4##(1990-11#1)(1990-7#1)(1991-3#1)(1991-9#1)(1995-10#1)(1995-5#1)(2007-11#1)
studies were done on##2##4##(1996-3#1)(2012-2#1)
studies were done##8##3##(1991-3#1)(1994-9#1)(1996-12#1)(1996-3#1)(2008-10#2)(2011-1#1)(2012-2#1)
studies were found to##2##4##(2006-8#1)(2008-10#1)
studies were found##4##3##(2006-8#1)(2008-10#1)(2012-12#1)(2013-8#1)
studies were identified and##4##4##(2008-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
studies were identified##11##3##(2005-10#1)(2006-2#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2012-12#1)(2013-1#3)(2013-8#1)
studies were included in the review##2##6##(2006-8#1)(2009-11#1)
studies were included in the##3##5##(2006-8#1)(2008-8#1)(2009-11#1)
studies were included in##4##4##(2006-8#1)(2008-10#1)(2008-8#1)(2009-11#1)
studies were included##11##3##(2006-8#1)(2008-10#2)(2008-8#1)(2009-11#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
studies were initiated##2##3##(2008-7#1)(2009-3#1)
studies were made##5##3##(1992-6#1)(1994-6#1)(2006-6#1)(2008-10#1)(2008-5#1)
studies were not performed##2##4##(1994-12#1)(1995-11#1)
studies were not##6##3##(1994-12#1)(1995-11#1)(2006-4#1)(2007-11#1)(2012-1#1)(2012-12#1)
studies were obtained##2##3##(2008-11#1)(2008-7#1)
studies were performed by##4##4##(1994-8#1)(2007-8#1)(2008-10#1)(2008-5#1)
studies were performed in order to##2##6##(1990-8#1)(1995-12#1)
studies were performed in##12##4##(1990-8#1)(1995-12#1)(1997-8#1)(2006-10#2)(2006-5#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-2#1)(2013-8#1)
studies were performed on a##2##5##(1992-9#1)(2011-1#1)
studies were performed on the##3##5##(2007-5#1)(2008-5#1)(2010-8#1)
studies were performed on##11##4##(1990-5#1)(1992-9#1)(1997-7#1)(2006-5#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-8#1)(2011-1#1)
studies were performed to characterize##2##5##(1990-3#1)(1996-11#1)
studies were performed to determine the##2##6##(1997-6#1)(2009-4#1)
studies were performed to determine##4##5##(1997-1#1)(1997-6#1)(2008-10#1)(2009-4#1)
studies were performed to elucidate##2##5##(1996-10#1)(2008-10#1)
studies were performed to##15##4##(1990-3#1)(1993-7#1)(1996-10#1)(1996-11#1)(1997-1#1)(1997-6#1)(2005-11#1)(2006-10#1)(2008-10#3)(2008-3#1)(2009-4#1)(2011-2#1)(2012-12#1)
studies were performed using##2##4##(1991-5#1)(2008-5#1)
studies were performed with##3##4##(1994-5#1)(2008-1#1)(2008-10#1)
studies were performed##58##3##(1990-3#1)(1990-5#1)(1990-8#1)(1991-5#1)(1992-9#1)(1993-7#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-10#1)(1996-11#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#3)(2006-5#2)(2006-8#1)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-3#3)(2008-5#6)(2008-7#3)(2009-10#1)(2009-2#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
studies were presented##3##3##(2004-12#2)(2008-5#1)
studies were required##2##3##(2006-8#1)(2013-1#1)
studies were reviewed##3##3##(2008-10#1)(2010-9#1)(2013-1#1)
studies were undertaken to determine##2##5##(1993-11#1)(2004-11#1)
studies were undertaken to##7##4##(1993-11#1)(1994-11#1)(1994-6#1)(1997-7#1)(2004-11#1)(2007-10#1)(2010-5#1)
studies were undertaken##10##3##(1992-10#1)(1993-11#1)(1994-11#1)(1994-6#1)(1997-7#1)(2004-11#1)(2006-4#1)(2007-10#1)(2010-5#1)(2013-1#1)
studies were used to assess##2##5##(1990-5#1)(2008-5#1)
studies were used to##5##4##(1990-5#1)(1992-12#1)(1994-11#1)(2008-10#1)(2008-5#1)
studies were used##7##3##(1990-5#1)(1992-12#1)(1994-11#1)(1995-11#1)(1997-6#1)(2008-10#1)(2008-5#1)
studies were##290##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#2)(1991-11#1)(1991-12#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-5#2)(1994-6#4)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-11#1)(2004-12#2)(2004-8#1)(2005-10#2)(2005-11#1)(2005-7#2)(2005-9#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-5#2)(2006-6#1)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#1)(2007-2#1)(2007-4#2)(2007-5#3)(2007-6#2)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#33)(2008-11#6)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#16)(2008-6#1)(2008-7#9)(2008-8#6)(2008-9#9)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-8#1)(2010-1#2)(2010-12#3)(2010-2#1)(2010-5#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#6)(2012-1#3)(2012-12#8)(2012-2#6)(2012-3#3)(2013-1#17)(2013-7#1)(2013-8#6)
studies when the##4##3##(1993-5#1)(1994-6#1)(2013-1#2)
studies when##9##2##(1992-2#1)(1993-4#1)(1993-5#1)(1994-6#1)(1996-7#1)(2008-10#1)(2010-8#1)(2013-1#2)
studies where the##5##3##(1995-4#1)(2009-10#2)(2009-9#1)(2013-8#1)
studies where##13##2##(1991-1#1)(1995-4#1)(2006-10#1)(2006-2#1)(2008-7#1)(2009-10#2)(2009-12#1)(2009-9#1)(2012-12#2)(2012-3#1)(2013-8#1)
studies which have evaluated the##2##5##(2007-12#1)(2009-6#1)
studies which have shown##2##4##(1997-1#1)(2012-2#1)
studies which have##9##3##(1990-8#1)(1994-2#1)(1997-1#1)(1997-8#1)(2005-10#1)(2007-12#1)(2009-6#1)(2012-2#1)(2013-8#1)
studies which show##2##3##(1994-8#1)(2008-2#1)
studies which##24##2##(1990-8#2)(1994-2#2)(1994-8#1)(1997-1#1)(1997-8#1)(2005-10#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-6#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#2)
studies will allow##2##3##(2010-4#1)(2012-2#1)
studies will be necessary to##2##5##(2009-5#1)(2013-1#1)
studies will be necessary##3##4##(2009-5#1)(2009-8#1)(2013-1#1)
studies will be needed to##3##5##(1991-12#1)(2008-7#1)(2009-1#1)
studies will be##11##3##(1990-4#1)(1991-12#1)(2006-10#1)(2008-1#1)(2008-4#2)(2008-7#1)(2009-1#1)(2009-5#1)(2009-8#1)(2013-1#1)
studies will involve##2##3##(1994-6#1)(2008-5#1)
studies will make##2##3##(2009-9#1)(2010-12#1)
studies will provide##2##3##(2007-1#1)(2007-12#1)
studies will##48##2##(1990-4#1)(1991-12#2)(1992-3#1)(1993-11#2)(1993-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-6#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#3)(2009-1#1)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-12#2)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
studies with a small number of##2##6##(2006-10#1)(2010-12#1)
studies with a total of##2##5##(2007-12#1)(2013-8#1)
studies with a##17##3##(1990-12#1)(1992-2#1)(1994-12#1)(1995-12#1)(1995-5#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-6#1)(2010-12#1)(2011-2#2)(2013-8#1)
studies with an##4##3##(1995-3#1)(1996-11#1)(2005-11#1)(2012-1#1)
studies with animal models##3##4##(2007-11#1)(2008-7#1)(2010-12#1)
studies with appropriate epidemiological##2##4##(2006-2#1)(2007-11#1)
studies with appropriate##3##3##(2006-2#1)(2007-11#1)(2011-1#1)
studies with binary##3##3##(1993-1#2)(1994-6#1)
studies with different##3##3##(1994-2#1)(2008-10#1)(2013-1#1)
studies with healthy##2##3##(2008-10#1)(2008-5#1)
studies with human##3##3##(2005-11#1)(2006-11#1)(2010-4#1)
studies with larger##4##3##(2007-10#1)(2008-12#1)(2010-5#1)(2012-3#1)
studies with long-term follow-up##2##4##(2012-12#2)
studies with longer##2##3##(2012-12#1)(2013-1#1)
studies with one##2##3##(2008-10#1)(2012-2#1)
studies with other##2##3##(1991-12#1)(2008-4#1)
studies with provocative##2##3##(2006-10#1)(2012-12#1)
studies with respect to##2##4##(1996-1#1)(2010-7#1)
studies with spacer mutants show that the##2##7##(1995-8#2)
studies with synthetic##2##3##(1991-2#1)(1996-5#1)
studies with targeted toxins##2##4##(2008-5#2)
studies with the##17##3##(1990-12#1)(1991-10#1)(1991-12#1)(1991-3#1)(1992-2#1)(1992-4#1)(1993-12#1)(2005-7#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-3#2)(2010-1#1)(2012-1#1)(2013-8#1)
studies with these##2##3##(1993-5#1)(2006-10#1)
studies with this##2##3##(1991-9#1)(2007-11#1)
studies with three##2##3##(1996-8#1)(2004-12#1)
studies with##266##2##(1990-10#1)(1990-12#2)(1990-2#2)(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-7#2)(1991-9#1)(1992-2#4)(1992-3#1)(1992-4#1)(1992-6#2)(1993-1#3)(1993-12#3)(1993-3#1)(1993-4#2)(1993-5#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#3)(1994-8#3)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#3)(1995-6#2)(1995-8#5)(1996-1#3)(1996-11#2)(1996-12#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#3)(1997-1#3)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#2)(1997-9#1)(2004-12#2)(2004-4#1)(2005-10#1)(2005-11#3)(2005-7#2)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#7)(2006-11#2)(2006-2#1)(2006-6#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#11)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#26)(2008-11#5)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#10)(2008-6#5)(2008-7#4)(2008-8#7)(2008-9#2)(2009-3#3)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#2)(2011-1#3)(2011-2#5)(2012-1#3)(2012-12#6)(2012-2#5)(2012-3#4)(2013-1#2)(2013-8#2)
studies without##2##2##(1992-2#1)(2007-11#1)
studies worldwide##2##2##(2011-1#1)(2012-2#1)
studies would be##3##3##(1992-2#1)(1994-9#1)(2011-3#1)
studies would##5##2##(1990-2#1)(1992-2#1)(1994-9#1)(2010-12#1)(2011-3#1)
studies##10806##1##(1990-1#4)(1990-10#19)(1990-11#32)(1990-12#39)(1990-2#28)(1990-3#20)(1990-4#12)(1990-5#40)(1990-6#27)(1990-7#27)(1990-8#45)(1990-9#19)(1991-1#20)(1991-10#15)(1991-11#23)(1991-12#42)(1991-2#40)(1991-3#20)(1991-4#24)(1991-5#28)(1991-6#20)(1991-7#29)(1991-8#24)(1991-9#35)(1992-1#13)(1992-10#18)(1992-11#33)(1992-12#29)(1992-2#24)(1992-3#50)(1992-4#35)(1992-5#15)(1992-6#41)(1992-7#26)(1992-8#32)(1992-9#34)(1993-1#14)(1993-10#7)(1993-11#59)(1993-12#52)(1993-2#18)(1993-3#29)(1993-4#20)(1993-5#18)(1993-6#35)(1993-7#16)(1993-8#22)(1993-9#27)(1994-1#4)(1994-10#27)(1994-11#51)(1994-12#42)(1994-2#56)(1994-3#47)(1994-4#5)(1994-5#30)(1994-6#50)(1994-7#7)(1994-8#37)(1994-9#51)(1995-1#35)(1995-10#19)(1995-11#40)(1995-12#55)(1995-2#41)(1995-3#47)(1995-4#23)(1995-5#41)(1995-6#39)(1995-7#17)(1995-8#38)(1995-9#22)(1996-1#23)(1996-10#24)(1996-11#22)(1996-12#49)(1996-2#38)(1996-3#38)(1996-4#14)(1996-5#35)(1996-6#29)(1996-7#34)(1996-8#39)(1996-9#40)(1997-1#34)(1997-2#43)(1997-3#24)(1997-4#56)(1997-5#33)(1997-6#46)(1997-7#38)(1997-8#50)(1997-9#2)(2003-11#1)(2004-1#6)(2004-10#3)(2004-11#15)(2004-12#16)(2004-2#4)(2004-3#5)(2004-4#4)(2004-7#1)(2004-8#1)(2004-9#5)(2005-1#1)(2005-10#82)(2005-11#56)(2005-12#9)(2005-2#2)(2005-3#4)(2005-4#8)(2005-5#1)(2005-6#6)(2005-7#66)(2005-8#57)(2005-9#10)(2006-1#15)(2006-10#345)(2006-11#30)(2006-12#77)(2006-2#73)(2006-3#23)(2006-4#27)(2006-5#46)(2006-6#36)(2006-7#27)(2006-8#92)(2006-9#38)(2007-1#33)(2007-10#71)(2007-11#266)(2007-12#147)(2007-2#61)(2007-3#24)(2007-4#43)(2007-5#30)(2007-6#30)(2007-7#48)(2007-8#124)(2007-9#43)(2008-1#146)(2008-10#681)(2008-11#269)(2008-12#90)(2008-2#115)(2008-3#196)(2008-4#167)(2008-5#301)(2008-6#75)(2008-7#302)(2008-8#224)(2008-9#195)(2009-1#11)(2009-10#63)(2009-11#37)(2009-12#45)(2009-2#56)(2009-3#42)(2009-4#45)(2009-5#67)(2009-6#44)(2009-7#42)(2009-8#75)(2009-9#46)(2010-1#23)(2010-10#50)(2010-11#52)(2010-12#147)(2010-2#111)(2010-3#26)(2010-4#40)(2010-5#76)(2010-6#29)(2010-7#48)(2010-8#74)(2010-9#30)(2011-1#156)(2011-10#1)(2011-12#41)(2011-2#313)(2011-3#6)(2011-7#1)(2011-8#1)(2012-1#100)(2012-10#1)(2012-11#42)(2012-12#212)(2012-2#242)(2012-3#201)(2012-4#2)(2012-5#2)(2012-7#1)(2012-8#1)(2012-9#1)(2013-1#306)(2013-7#52)(2013-8#138)
studies&quot##2##1##(2008-10#2)
studies'##2##1##(2007-2#1)(2010-2#1)
studies) and carcinogenicity studies of##3##5##(2008-9#3)
studies) and##4##2##(2008-9#3)(2012-2#1)
studies) are##2##2##(2007-7#1)(2011-1#1)
studies) may be##2##3##(1992-7#1)(2013-8#1)
studies) or##2##2##(1991-12#1)(2008-3#1)
studies) were##2##2##(2009-2#1)(2012-2#1)
studies)##37##1##(1991-12#3)(1992-7#1)(1996-7#1)(2005-10#1)(2005-5#1)(2006-12#1)(2006-6#1)(2007-7#1)(2008-3#1)(2008-5#2)(2008-8#3)(2008-9#10)(2009-2#2)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
studies--including##2##1##(2006-10#1)(2007-12#1)
studies?##6##1##(1991-3#1)(1993-11#1)(2007-11#2)(2009-4#1)(2009-6#1)
studies]##16##1##(1990-3#2)(1993-1#1)(1993-10#1)(1995-10#1)(1995-5#1)(1996-4#1)(1996-6#1)(2007-8#1)(2008-4#1)(2008-8#1)(2010-9#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
study &quot##2##2##(1997-7#1)(2006-6#1)
study (N =##6##3##(1997-8#1)(2008-5#1)(2008-8#1)(2010-10#1)(2010-2#1)(2013-8#1)
study (age##3##2##(1993-6#1)(2008-3#1)(2008-4#1)
study (i##2##2##(2007-3#1)(2010-7#1)
study (n = 4)##2##4##(2008-5#1)(2009-2#1)
study (n =##7##3##(2008-10#1)(2008-11#1)(2008-5#1)(2009-2#1)(2010-2#1)(2010-5#1)(2013-1#1)
study (period##2##2##(2011-2#2)
study (the##2##2##(2006-11#1)(2012-2#1)
study -##2##2##(2007-10#1)(2012-3#1)
study 1##2##2##(2008-3#1)(2008-9#1)
study 15##2##2##(2007-7#1)(2009-4#1)
study 40##2##2##(1990-11#1)(2011-2#1)
study FTC-302##2##2##(2005-8#2)
study [1]##2##2##(1997-6#1)(2010-2#1)
study a new##4##3##(2006-10#1)(2008-7#1)(2010-3#1)(2011-2#1)
study a simple##2##3##(1996-4#1)(2008-8#1)
study a##54##2##(1990-12#1)(1990-7#1)(1991-11#1)(1991-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-8#1)(1995-5#1)(1996-4#1)(1996-6#1)(1996-8#1)(2006-10#1)(2006-6#1)(2006-8#2)(2007-12#2)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
study about the##6##3##(1990-4#1)(2006-2#1)(2007-3#1)(2008-10#1)(2011-2#1)(2013-1#1)
study about##11##2##(1990-4#1)(1995-3#1)(2006-2#1)(2007-3#1)(2008-10#1)(2009-1#1)(2009-5#1)(2011-2#1)(2013-1#3)
study addressed the##3##3##(2007-3#1)(2010-8#1)(2013-1#1)
study addressed##6##2##(1993-12#1)(2007-3#1)(2010-10#1)(2010-8#1)(2012-11#1)(2013-1#1)
study addresses the##12##3##(1990-4#1)(1992-1#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-4#1)(2012-1#1)(2012-12#1)
study addresses##17##2##(1990-4#1)(1992-1#1)(1994-1#2)(2006-7#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-9#1)(2009-11#1)(2009-4#2)(2012-1#1)(2012-12#1)
study addressing##2##2##(2008-5#1)(2011-12#1)
study adds to##2##3##(2009-8#1)(2010-5#1)
study adds##4##2##(2009-8#1)(2010-5#1)(2011-2#1)(2013-1#1)
study adopted##2##2##(2013-1#2)
study adopts##2##2##(2008-6#1)(2010-5#1)
study affords##2##2##(1991-10#1)(2011-1#1)
study after the##2##3##(2007-11#1)(2008-5#1)
study after##5##2##(2004-11#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-7#1)
study aimed at assessing the feasibility of##2##7##(2011-1#1)(2013-8#1)
study aimed at assessing the##3##5##(2008-8#1)(2011-1#1)(2013-8#1)
study aimed at evaluating the##2##5##(2006-6#1)(2011-2#1)
study aimed at identifying##2##4##(2008-10#1)(2010-2#1)
study aimed at investigating the##2##5##(2012-3#1)(2013-8#1)
study aimed at##29##3##(1992-9#1)(1993-12#1)(1995-3#1)(1997-7#1)(2005-11#1)(2005-5#1)(2006-12#1)(2006-6#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-2#2)(2008-5#1)(2008-8#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-8#2)
study aimed to assess the##7##5##(1991-5#1)(2007-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-7#2)
study aimed to assess##9##4##(1991-5#1)(2007-8#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#2)
study aimed to clarify##3##4##(2007-10#1)(2008-10#1)(2011-1#1)
study aimed to compare##4##4##(2010-1#1)(2010-3#1)(2013-1#1)(2013-8#1)
study aimed to describe the##5##5##(1996-1#1)(2010-3#1)(2012-12#2)(2012-3#1)
study aimed to describe##8##4##(1996-1#1)(2010-3#1)(2010-7#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)
study aimed to determine the##7##5##(2006-10#1)(2007-1#1)(2007-10#1)(2007-7#1)(2009-5#1)(2012-3#1)(2013-1#1)
study aimed to determine##12##4##(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2009-5#1)(2011-1#3)(2012-3#1)(2013-1#1)
study aimed to elucidate##2##4##(2012-2#1)(2012-6#1)
study aimed to estimate the##2##5##(1996-12#1)(2013-8#1)
study aimed to evaluate the##13##5##(1995-1#1)(2006-6#1)(2008-11#1)(2008-4#1)(2010-4#1)(2010-5#1)(2011-2#3)(2012-3#1)(2013-8#3)
study aimed to evaluate##17##4##(1995-1#1)(2006-6#1)(2007-8#1)(2008-11#1)(2008-4#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-3#1)(2013-8#3)
study aimed to explore the##4##5##(2006-10#1)(2007-12#1)(2007-9#1)(2013-1#1)
study aimed to explore##9##4##(2006-10#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-9#1)(2009-10#1)(2011-1#1)(2013-1#2)
study aimed to find out##2##5##(2007-7#1)(2008-5#1)
study aimed to find##3##4##(2007-7#1)(2008-12#1)(2008-5#1)
study aimed to identify risk factors##2##6##(2010-10#1)(2011-2#1)
study aimed to identify##9##4##(1992-2#1)(2010-10#1)(2011-2#2)(2012-12#1)(2012-3#2)(2012-8#1)(2013-7#1)
study aimed to investigate the##10##5##(2007-11#1)(2007-2#1)(2008-10#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
study aimed to investigate whether##2##5##(2010-5#1)(2013-1#1)
study aimed to investigate##15##4##(2007-11#1)(2007-2#2)(2008-10#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
study aimed to verify##2##4##(2011-1#1)(2011-12#1)
study aimed to##126##3##(1991-5#1)(1992-2#1)(1995-1#1)(1996-1#1)(1996-12#1)(2003-11#1)(2004-9#1)(2006-10#2)(2006-2#2)(2006-6#2)(2006-7#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#2)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-1#2)(2010-10#1)(2010-3#3)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#3)(2011-1#8)(2011-11#1)(2011-12#1)(2011-2#8)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#10)(2012-6#1)(2012-8#1)(2013-1#12)(2013-7#5)(2013-8#10)
study aimed##155##2##(1991-5#1)(1992-2#1)(1992-9#1)(1993-12#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-7#1)(2003-11#1)(2004-9#1)(2005-11#1)(2005-5#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-6#3)(2006-7#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-1#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#3)(2011-1#9)(2011-11#1)(2011-12#1)(2011-2#10)(2012-1#2)(2012-12#5)(2012-2#6)(2012-3#13)(2012-6#1)(2012-8#1)(2013-1#12)(2013-7#5)(2013-8#12)
study aiming to##2##3##(2009-4#1)(2011-1#1)
study aiming##3##2##(2008-2#1)(2009-4#1)(2011-1#1)
study aims at identifying##2##4##(2007-7#1)(2013-8#1)
study aims at##7##3##(1994-6#1)(2007-7#1)(2008-4#1)(2009-11#1)(2009-12#1)(2011-1#1)(2013-8#1)
study aims to assess the##2##5##(2010-6#1)(2012-3#1)
study aims to assess##4##4##(2008-8#1)(2010-6#1)(2012-3#1)(2013-8#1)
study aims to compare the##2##5##(2008-7#1)(2011-2#1)
study aims to determine the##3##5##(2011-1#2)(2011-2#1)
study aims to determine##4##4##(2008-4#1)(2011-1#2)(2011-2#1)
study aims to evaluate the##6##5##(2007-8#1)(2008-5#1)(2012-2#1)(2012-3#1)(2013-1#2)
study aims to evaluate##7##4##(2007-8#1)(2008-10#1)(2008-5#1)(2012-2#1)(2012-3#1)(2013-1#2)
study aims to identify##4##4##(2008-8#1)(2010-10#1)(2010-2#1)(2013-1#1)
study aims to present##2##4##(2012-12#1)(2013-8#1)
study aims to study the##2##5##(2009-7#1)(2012-2#1)
study aims to##48##3##(1994-4#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-6#1)(2011-1#4)(2011-12#1)(2011-2#4)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#3)
study aims##56##2##(1994-4#1)(1994-6#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-10#2)(2010-2#1)(2010-6#1)(2011-1#5)(2011-12#1)(2011-2#4)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#4)
study all##3##2##(2008-12#1)(2009-4#1)(2012-3#1)
study allowed the##2##3##(2009-9#1)(2010-4#1)
study allowed to##2##3##(2007-11#1)(2012-3#1)
study allowed##5##2##(2007-11#1)(2008-5#1)(2009-9#1)(2010-4#1)(2012-3#1)
study allows us to##2##4##(2008-5#1)(2008-7#1)
study allows##5##2##(2008-10#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#1)
study also compared##2##3##(1994-8#1)(2008-4#1)
study also demonstrated that##7##4##(1992-12#1)(1996-12#1)(2006-10#1)(2006-8#1)(2008-5#1)(2010-10#1)(2010-8#1)
study also demonstrated##8##3##(1992-12#1)(1996-1#1)(1996-12#1)(2006-10#1)(2006-8#1)(2008-5#1)(2010-10#1)(2010-8#1)
study also demonstrates that##5##4##(2005-8#1)(2008-10#2)(2008-3#1)(2009-4#1)
study also demonstrates##6##3##(1995-11#1)(2005-8#1)(2008-10#2)(2008-3#1)(2009-4#1)
study also describes the experimental conditions and the##2##8##(2008-10#2)
study also examined##3##3##(2006-10#1)(2008-11#1)(2008-12#1)
study also found significant##2##4##(2007-7#1)(2009-7#1)
study also found##4##3##(1997-3#1)(2007-7#1)(2009-7#1)(2010-3#1)
study also highlighted the##2##4##(1992-10#1)(2007-7#1)
study also indicate that##2##4##(1997-7#1)(2009-11#1)
study also indicated##3##3##(1995-5#1)(1996-8#1)(2011-1#1)
study also indicates that the##2##5##(2004-11#1)(2008-10#1)
study also indicates##3##3##(2004-11#1)(2008-10#1)(2008-9#1)
study also investigated the##2##4##(2007-9#1)(2008-12#1)
study also revealed that##2##4##(1991-6#1)(2011-2#1)
study also revealed##4##3##(1991-6#1)(1997-7#1)(2008-10#1)(2011-2#1)
study also reveals that##2##4##(1996-3#1)(2008-2#1)
study also showed a##2##4##(2006-8#2)
study also showed##8##3##(2006-8#5)(2006-9#1)(2007-12#1)(2008-1#1)
study also shows that##4##4##(1992-8#1)(2006-12#1)(2008-10#1)(2010-8#1)
study also shows##6##3##(1992-8#1)(2006-12#1)(2008-10#2)(2008-5#1)(2010-8#1)
study also suggests that##3##4##(1994-6#1)(2008-8#1)(2011-3#1)
study also suggests##4##3##(1994-6#1)(2008-8#1)(2010-3#1)(2011-3#1)
study also##101##2##(1991-12#2)(1991-6#1)(1992-10#1)(1992-12#2)(1992-3#2)(1992-8#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-3#2)(1997-7#3)(2004-11#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-7#1)(2006-8#6)(2006-9#1)(2007-12#1)(2007-5#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-7#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#2)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#2)(2011-3#1)(2012-11#1)(2012-3#1)(2013-1#3)(2013-8#2)
study among hospital##2##3##(1996-1#1)(2012-1#1)
study among##21##2##(1990-12#1)(1991-4#1)(1991-6#1)(1992-7#1)(1993-3#1)(1995-1#1)(1995-6#2)(1996-1#1)(1996-4#1)(2005-8#1)(2007-2#1)(2008-3#2)(2008-4#1)(2010-3#1)(2011-2#3)(2012-1#1)(2013-1#1)
study an##6##2##(1990-12#1)(1990-6#1)(1992-2#1)(2008-11#1)(2008-3#1)(2009-9#1)
study analysed the##3##3##(2007-7#1)(2011-2#1)(2012-1#1)
study analysed##6##2##(2007-7#1)(2008-12#1)(2011-2#2)(2012-1#1)(2013-8#1)
study analyses the##3##3##(2007-3#1)(2009-12#1)(2013-8#1)
study analyses##9##2##(1990-11#1)(1992-8#1)(1994-2#1)(2006-12#1)(2007-12#1)(2007-3#1)(2009-12#2)(2013-8#1)
study analytically##2##2##(2007-12#1)(2009-9#1)
study analyzed the##9##3##(2005-11#1)(2009-4#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-7#1)
study analyzed##17##2##(1995-12#1)(2005-11#1)(2008-11#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#6)(2013-7#1)
study analyzes the##9##3##(1992-5#1)(1993-3#1)(1996-3#1)(2008-2#2)(2010-10#1)(2011-1#2)(2013-1#1)
study analyzes##17##2##(1992-5#1)(1993-3#1)(1993-6#1)(1995-2#1)(1996-3#2)(2004-2#1)(2008-2#2)(2010-10#1)(2010-3#1)(2010-7#1)(2011-1#3)(2011-2#1)(2013-1#1)
study and a##7##3##(1990-9#1)(1991-3#1)(1995-3#1)(2007-1#1)(2007-2#1)(2007-6#1)(2010-1#1)
study and analysis of##3##4##(2008-10#2)(2012-3#1)
study and analytical applications of##2##5##(2008-10#2)
study and application of##3##4##(2008-10#2)(2008-5#1)
study and clinical##2##3##(2012-12#1)(2012-2#1)
study and compare##3##3##(1992-3#1)(2007-11#1)(2007-7#1)
study and control##3##3##(2011-11#1)(2012-12#1)(2013-8#1)
study and discussion##2##3##(1993-5#1)(2008-8#1)
study and for##2##3##(1993-2#1)(2007-8#1)
study and implications for##2##4##(1997-8#1)(2008-12#1)
study and in##2##3##(2006-10#1)(2011-1#1)
study and kinetic##2##3##(2008-10#1)(2010-5#1)
study and literature##3##3##(2005-7#1)(2012-12#1)(2013-1#1)
study and predict##2##3##(2007-2#1)(2008-7#1)
study and previous##3##3##(1991-2#1)(2006-10#1)(2008-10#1)
study and report##2##3##(1993-2#1)(2011-2#1)
study and review##8##3##(2006-2#1)(2006-8#1)(2007-7#2)(2009-2#1)(2013-1#3)
study and several##2##3##(2007-12#1)(2011-1#1)
study and suggests that##2##4##(1995-3#1)(2008-9#1)
study and the##21##3##(1990-6#1)(1991-12#1)(1992-5#1)(1993-12#1)(1994-2#1)(1996-2#1)(2006-4#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-11#1)(2009-2#1)(2012-3#1)
study and they were divided##2##5##(2012-2#1)(2013-8#1)
study and those##2##3##(2008-1#1)(2008-9#1)
study and to##2##3##(2009-11#1)(2012-2#1)
study and treated##2##3##(2006-2#1)(2006-6#1)
study and treatment of##2##4##(2006-10#1)(2006-8#1)
study and two##3##3##(1990-1#1)(2008-3#1)(2009-6#1)
study and were divided into four groups##2##7##(2008-11#1)(2010-4#1)
study and were divided into##3##5##(2008-11#1)(2010-4#2)
study and were divided##4##4##(2007-6#1)(2008-11#1)(2010-4#2)
study and were##10##3##(1991-2#1)(1992-10#1)(2006-10#1)(2007-1#1)(2007-6#1)(2008-11#1)(2010-4#2)(2011-2#2)
study and with##2##3##(1992-9#1)(1994-3#1)
study and work##2##3##(2012-12#1)(2013-8#1)
study and##228##2##(1990-1#1)(1990-10#2)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-9#1)(1993-12#1)(1993-2#3)(1993-5#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-5#2)(1996-8#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#7)(2006-12#2)(2006-2#2)(2006-4#1)(2006-6#1)(2006-8#6)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#3)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#20)(2008-11#2)(2008-12#6)(2008-2#1)(2008-3#3)(2008-5#8)(2008-6#2)(2008-7#9)(2008-8#4)(2008-9#5)(2009-10#4)(2009-11#4)(2009-12#1)(2009-2#3)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-1#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#4)(2011-11#1)(2011-2#7)(2012-1#1)(2012-12#6)(2012-2#8)(2012-3#5)(2013-1#13)(2013-8#7)
study applies##3##2##(1997-1#1)(2008-10#2)
study approach##6##2##(1996-1#1)(2005-8#1)(2007-10#1)(2008-11#1)(2009-4#1)(2011-2#1)
study are also##2##3##(2008-10#1)(2008-2#1)
study are consistent with the##3##5##(1992-8#1)(2007-12#1)(2008-11#1)
study are consistent with##4##4##(1992-8#1)(2006-9#1)(2007-12#1)(2008-11#1)
study are discussed##5##3##(1993-1#1)(1993-7#1)(2007-11#1)(2008-3#1)(2013-8#1)
study are encouraging##2##3##(1996-12#1)(2010-12#1)
study are presented##6##3##(1992-2#1)(1995-1#1)(1996-7#1)(2008-11#1)(2008-3#1)(2009-12#1)
study are proposed##2##3##(1993-6#1)(2010-8#1)
study are the##4##3##(1993-3#1)(2008-10#1)(2008-3#1)(2011-2#1)
study are to##9##3##(1997-8#1)(2005-11#1)(2008-5#1)(2008-6#1)(2010-8#1)(2012-12#1)(2012-2#2)(2013-1#1)
study are##92##2##(1990-1#1)(1990-10#1)(1990-3#1)(1992-2#1)(1992-8#2)(1993-1#2)(1993-3#2)(1993-6#2)(1993-7#1)(1993-9#1)(1994-3#2)(1995-1#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-11#1)(2005-11#1)(2005-7#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#4)(2008-9#1)(2009-11#1)(2009-12#1)(2009-9#1)(2010-12#2)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
study area and##2##3##(2008-10#1)(2008-12#1)
study area is##2##3##(2007-10#1)(2008-12#1)
study area##35##2##(1995-9#3)(2006-4#1)(2007-10#3)(2007-2#2)(2007-5#2)(2007-6#1)(2008-10#2)(2008-12#6)(2008-5#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
study areas##6##2##(1995-3#1)(2004-11#1)(2008-10#2)(2011-1#1)(2013-1#1)
study arose##3##2##(1994-1#2)(2010-8#1)
study as a##6##3##(1997-5#1)(2008-11#3)(2008-9#1)(2011-2#1)
study as an example##2##4##(2010-8#1)(2012-3#1)
study as well as##2##4##(1997-3#1)(2008-5#1)
study as well##3##3##(1997-3#1)(2008-5#1)(2012-3#1)
study as##17##2##(1992-11#1)(1997-3#1)(1997-5#1)(1997-6#1)(2006-11#1)(2006-8#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-9#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-3#2)
study asks##3##2##(1993-3#1)(2009-11#1)(2013-7#1)
study assessed the effects of the##2##6##(1996-2#1)(2004-3#1)
study assessed the effects of##5##5##(1993-3#1)(1996-2#1)(2004-3#1)(2008-7#1)(2012-2#1)
study assessed the efficacy of##2##5##(2010-3#1)(2011-2#1)
study assessed the efficacy##3##4##(2008-7#1)(2010-3#1)(2011-2#1)
study assessed the potential##2##4##(2009-3#1)(2010-4#1)
study assessed the rate of##2##5##(2007-10#1)(2013-1#1)
study assessed the##37##3##(1991-3#1)(1991-9#1)(1993-3#1)(1996-2#1)(1996-7#1)(2004-3#1)(2006-12#2)(2007-10#2)(2007-7#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-7#4)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#2)(2013-7#1)
study assessed##54##2##(1991-3#1)(1991-9#1)(1993-2#1)(1993-3#1)(1995-2#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-8#1)(2004-3#1)(2005-10#1)(2006-12#2)(2007-10#2)(2007-7#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#1)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#3)
study assesses the##14##3##(1991-4#1)(1994-12#1)(1996-12#1)(2006-12#1)(2006-4#1)(2007-9#1)(2008-11#3)(2008-3#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
study assesses##18##2##(1991-10#1)(1991-4#1)(1994-12#1)(1996-12#1)(1997-3#1)(2006-12#1)(2006-4#1)(2007-9#1)(2008-11#3)(2008-3#1)(2008-9#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#1)
study assessing the##4##3##(2006-8#1)(2008-9#1)(2011-2#2)
study assessing##10##2##(2006-8#1)(2007-9#1)(2008-5#2)(2008-9#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
study at a##7##3##(1991-11#1)(1995-2#1)(2006-1#1)(2009-10#1)(2012-3#2)(2013-1#1)
study at the##9##3##(1991-12#1)(2005-7#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-6#1)(2013-8#1)
study at##34##2##(1990-11#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#1)(1993-11#1)(1995-2#1)(1995-8#1)(1997-7#1)(2005-7#1)(2006-1#1)(2007-7#4)(2008-1#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-6#1)(2009-10#1)(2010-12#1)(2011-1#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
study attempt##2##2##(2008-10#1)(2010-8#1)
study attempted to identify##3##4##(1992-9#1)(1996-8#1)(2007-9#1)
study attempted to##12##3##(1990-2#1)(1992-9#1)(1993-2#1)(1994-3#1)(1996-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)
study attempts to determine##2##4##(2008-2#2)
study attempts to##11##3##(1992-1#1)(1993-12#1)(1994-6#1)(1996-3#1)(2007-10#1)(2008-2#2)(2008-9#1)(2010-2#1)(2010-5#1)(2011-2#1)
study attempts##12##2##(1992-1#1)(1993-12#1)(1994-6#1)(1996-3#1)(2007-10#1)(2008-2#2)(2008-9#1)(2010-2#1)(2010-5#1)(2011-2#1)(2013-8#1)
study based on a##2##4##(2007-7#1)(2010-12#1)
study based on the##6##4##(2008-1#1)(2008-10#2)(2008-3#1)(2011-1#1)(2013-1#1)
study based on##18##3##(1990-12#1)(1991-8#1)(1996-12#1)(1996-2#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
study based##19##2##(1990-12#1)(1991-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
study because of the##2##4##(2008-1#1)(2008-9#1)
study because of##3##3##(1992-8#1)(2008-1#1)(2008-9#1)
study because##9##2##(1992-8#1)(1994-12#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-9#1)(2010-1#1)(2013-1#1)
study before and##2##3##(2008-10#2)
study beginning##3##2##(1994-1#1)(2008-5#2)
study begins##2##2##(2008-3#1)(2008-4#1)
study being conducted##3##3##(2006-6#1)(2007-2#1)(2009-2#1)
study being##4##2##(2006-6#1)(2007-2#1)(2007-8#1)(2009-2#1)
study between a##2##3##(1997-5#1)(2008-10#1)
study between the##5##3##(1991-10#1)(2008-5#1)(2008-8#1)(2009-12#1)(2011-1#1)
study between##22##2##(1991-10#1)(1997-5#1)(2006-1#1)(2006-2#1)(2007-10#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-4#1)(2011-1#2)(2011-12#1)(2012-2#2)
study brain##3##2##(1996-7#1)(2008-11#1)(2008-8#1)
study but##2##2##(2008-12#1)(2008-5#1)
study by the United States Environmental Protection Agency##2##8##(2008-9#2)
study by the##9##3##(1991-4#1)(1992-1#1)(1993-5#1)(1995-3#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-9#2)
study by##57##2##(1990-12#1)(1991-4#1)(1992-1#1)(1992-12#1)(1992-7#1)(1993-11#1)(1993-5#1)(1995-3#1)(1996-12#1)(1996-3#2)(1997-2#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#8)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#3)(2009-6#1)(2009-9#1)(2010-11#1)(2010-8#1)(2011-2#1)(2013-1#3)
study can be considered##2##4##(1993-10#1)(2009-6#1)
study can be used to##4##5##(1997-7#1)(2007-2#1)(2008-2#1)(2012-2#1)
study can be used##8##4##(1997-7#1)(2005-8#1)(2007-2#1)(2008-12#1)(2008-2#2)(2012-2#1)(2013-1#1)
study can be##16##3##(1992-6#1)(1993-10#1)(1994-3#1)(1995-9#1)(1997-7#1)(2005-8#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-2#3)(2009-1#1)(2009-6#1)(2012-2#1)(2013-1#1)
study can provide a##2##4##(2008-11#1)(2013-1#1)
study can##29##2##(1990-3#1)(1992-6#1)(1993-10#1)(1993-2#1)(1994-3#1)(1995-9#1)(1997-7#1)(2005-8#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#3)(2009-1#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#4)
study cannot##2##2##(1995-2#1)(2007-8#1)
study carried out among##2##4##(2007-7#1)(2012-12#1)
study carried out by##2##4##(1994-6#1)(1996-3#1)
study carried out in the##3##5##(2006-2#1)(2008-12#1)(2008-2#1)
study carried out in##12##4##(1992-10#2)(1993-3#1)(1996-7#1)(2006-12#1)(2006-2#2)(2006-6#1)(2008-12#1)(2008-2#1)(2011-2#1)(2012-3#1)
study carried out on 16##2##5##(2008-11#1)(2008-5#1)
study carried out on##7##4##(1991-6#1)(1997-4#1)(2006-10#1)(2008-11#1)(2008-5#2)(2010-1#1)
study carried out##28##3##(1991-6#1)(1992-10#2)(1993-3#1)(1993-5#1)(1994-6#1)(1996-3#1)(1996-7#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-6#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#3)(2010-1#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-3#1)
study cases##2##2##(2008-2#1)(2011-2#1)
study cell##5##2##(2008-10#1)(2008-4#2)(2009-12#1)(2011-1#1)
study cells##2##2##(1996-11#1)(2008-11#1)
study certain##2##2##(1990-7#1)(2006-6#1)
study changes in##3##3##(1992-11#1)(1995-5#1)(2008-10#1)
study characterized the##3##3##(2010-1#1)(2010-11#1)(2013-1#1)
study characterized##4##2##(2008-10#1)(2010-1#1)(2010-11#1)(2013-1#1)
study characterizes the##3##3##(2007-12#1)(2008-10#2)
study characterizes##4##2##(1993-6#1)(2007-12#1)(2008-10#2)
study clearly demonstrated##2##3##(2007-1#1)(2012-2#1)
study clearly showed that the##2##5##(2008-10#2)
study clearly showed##4##3##(1992-9#1)(2008-10#2)(2011-2#1)
study clearly shows that##3##4##(1993-2#1)(1994-7#1)(2004-4#1)
study clearly##19##2##(1992-9#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-6#1)(1994-7#1)(2004-4#1)(2006-1#1)(2007-1#1)(2008-10#4)(2008-11#4)(2011-2#1)(2012-2#1)
study clinical##3##2##(2007-8#2)(2012-3#1)
study cohort and##4##3##(1993-8#1)(2009-10#3)
study cohort##9##2##(1993-8#1)(2006-8#1)(2007-10#1)(2008-2#1)(2009-10#4)(2010-2#1)
study collagen##2##2##(2010-8#1)(2012-2#1)
study combined##4##2##(1995-12#1)(2007-10#1)(2008-5#1)(2010-11#1)
study come##2##2##(2005-11#1)(2010-6#1)
study commissioned by the##2##4##(1996-1#1)(2011-2#1)
study compared a##2##3##(2009-11#1)(2012-12#1)
study compared the effects of##3##5##(1993-3#1)(2007-8#1)(2010-1#1)
study compared the efficacy of##3##5##(2006-10#1)(2011-1#1)(2012-3#1)
study compared the efficacy##4##4##(1993-1#1)(2006-10#1)(2011-1#1)(2012-3#1)
study compared the results of##2##5##(2009-3#1)(2011-2#1)
study compared the##33##3##(1993-1#1)(1993-3#1)(1995-2#1)(1996-1#1)(2004-10#1)(2004-11#1)(2004-9#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#3)(2010-1#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
study compared to##3##3##(1992-12#1)(2008-5#1)(2010-2#1)
study compared two methods of##2##5##(2009-4#1)(2011-2#1)
study compared two##4##3##(2008-4#1)(2009-3#1)(2009-4#1)(2011-2#1)
study compared##68##2##(1990-12#1)(1992-12#1)(1993-1#1)(1993-3#2)(1994-10#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-7#1)(2004-10#1)(2004-11#1)(2004-9#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#7)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
study compares the##13##3##(1993-12#1)(1993-3#1)(1994-10#1)(1994-2#1)(1996-12#1)(1997-3#1)(2006-8#1)(2007-4#1)(2007-8#1)(2008-3#1)(2008-8#1)(2009-4#1)(2012-1#1)
study compares##24##2##(1991-9#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-2#1)(1996-12#1)(1997-3#1)(2006-1#1)(2006-8#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-4#1)(2009-7#1)(2011-12#1)(2012-1#1)(2012-3#1)
study comparing a##4##3##(1992-4#1)(1994-3#2)(1995-2#1)
study comparing clinical##2##3##(1996-12#1)(2008-11#1)
study comparing the##5##3##(1991-2#1)(1994-3#1)(1996-1#1)(2008-10#1)(2008-6#1)
study comparing three##2##3##(1992-3#1)(2008-5#1)
study comparing##28##2##(1990-1#1)(1990-12#1)(1991-2#1)(1992-11#1)(1992-3#1)(1992-4#1)(1994-3#3)(1994-8#1)(1995-2#1)(1996-1#1)(1996-12#1)(2006-10#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#2)(2011-2#2)(2012-3#2)(2013-1#1)
study completed##2##2##(2007-9#1)(2008-7#1)
study completion##2##2##(2006-12#1)(2008-7#1)
study complex##2##2##(2009-9#1)(2010-7#1)
study comprised of##3##3##(2011-1#1)(2013-8#2)
study comprised##17##2##(1990-4#1)(1992-12#1)(1996-4#1)(1997-3#1)(2007-2#1)(2007-3#1)(2007-9#3)(2008-5#1)(2009-4#1)(2009-8#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#2)
study concerned##3##2##(1992-10#1)(1993-2#1)(2008-10#1)
study concerning##6##2##(1990-3#1)(1990-5#1)(1991-9#1)(1994-5#1)(2008-3#1)(2011-2#1)
study concerns the##3##3##(1996-1#1)(1997-2#1)(2008-8#1)
study concerns##6##2##(1994-6#1)(1996-1#1)(1997-2#1)(2008-11#1)(2008-8#1)(2009-9#1)
study concluded that##13##3##(1997-4#1)(2008-11#2)(2008-4#1)(2010-7#1)(2010-9#1)(2011-1#3)(2012-12#2)(2013-1#2)
study concludes by##2##3##(2004-3#1)(2012-12#1)
study concludes that the##5##4##(1991-2#1)(1994-3#1)(1996-1#1)(2007-11#1)(2008-11#1)
study concludes that##14##3##(1991-2#1)(1994-3#1)(1996-1#2)(2007-11#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-11#1)(2009-4#1)(2011-1#1)(2012-3#2)(2013-1#1)
study concludes##17##2##(1991-2#1)(1994-3#1)(1995-12#1)(1996-1#2)(2004-3#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-11#1)(2009-4#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
study conclusions##2##2##(2006-2#1)(2011-2#1)
study conclusively##2##2##(2007-9#1)(2008-3#1)
study conditions##2##2##(1991-10#1)(2013-8#1)
study conducted at the##3##4##(2008-2#1)(2009-7#1)(2012-12#1)
study conducted at##5##3##(1991-11#1)(2008-2#1)(2009-7#1)(2012-12#1)(2013-8#1)
study conducted by the##4##4##(1994-12#1)(1997-5#1)(2008-7#1)(2008-8#1)
study conducted by##5##3##(1994-12#1)(1996-12#1)(1997-5#1)(2008-7#1)(2008-8#1)
study conducted in patients##2##4##(2006-1#1)(2008-3#1)
study conducted in the##7##4##(1990-8#1)(1991-7#1)(2006-4#1)(2007-2#1)(2008-6#1)(2009-6#1)(2010-12#1)
study conducted in##28##3##(1990-8#1)(1991-7#1)(1992-9#1)(1993-9#1)(1994-5#1)(1995-11#1)(2005-9#1)(2006-1#1)(2006-11#1)(2006-4#2)(2007-2#2)(2007-7#1)(2008-10#2)(2008-3#2)(2008-6#1)(2009-10#2)(2009-4#1)(2009-6#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
study conducted on##5##3##(1992-5#1)(2006-1#1)(2008-5#1)(2009-5#1)(2013-8#1)
study conducted##56##2##(1990-4#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-7#1)(1992-5#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-11#1)(1996-12#1)(1997-5#1)(2005-9#1)(2006-1#2)(2006-10#1)(2006-11#1)(2006-4#2)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#2)(2010-3#1)(2011-2#3)(2012-12#3)(2013-1#1)(2013-8#4)
study confirm the##3##3##(2005-10#1)(2009-1#1)(2012-3#1)
study confirm##6##2##(1990-12#1)(2005-10#1)(2006-8#1)(2007-1#1)(2009-1#1)(2012-3#1)
study confirmed that the##3##4##(1993-12#1)(2007-8#1)(2013-8#1)
study confirmed that##10##3##(1993-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2010-10#2)(2011-2#2)(2012-2#1)(2013-8#1)
study confirmed the##6##3##(1993-2#1)(2007-4#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-12#1)
study confirmed##17##2##(1993-12#1)(1993-2#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-3#1)(2010-10#2)(2010-3#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#1)
study confirms that##15##3##(1990-2#1)(1992-6#1)(1996-1#1)(2006-10#1)(2007-1#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-9#1)(2009-2#1)(2010-5#1)(2012-11#1)
study confirms the value of##3##5##(1993-10#1)(1995-2#1)(2008-6#1)
study confirms the##17##3##(1990-8#1)(1992-8#1)(1993-10#1)(1994-6#2)(1995-2#1)(1996-5#1)(2004-9#1)(2006-6#1)(2008-10#3)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
study confirms##38##2##(1990-2#1)(1990-8#1)(1992-6#1)(1992-8#1)(1993-10#1)(1994-3#1)(1994-6#2)(1995-2#1)(1996-1#1)(1996-5#1)(1996-7#1)(2004-9#1)(2006-10#2)(2006-6#1)(2007-1#1)(2007-2#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-10#5)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)
study consisted of a##2##4##(2009-4#1)(2010-8#1)
study consisted of##18##3##(1990-8#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-2#1)(2009-4#1)(2010-1#2)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#1)
study consisting of##3##3##(2007-10#1)(2007-8#1)(2012-11#1)
study consists of##2##3##(2009-7#1)(2012-2#1)
study constitutes##2##2##(1995-1#1)(2013-8#1)
study constructs##2##2##(1993-2#1)(2013-1#1)
study contains##2##2##(2008-10#1)(2012-3#1)
study contribute to##3##3##(2007-3#1)(2008-5#1)(2012-3#1)
study contributed to##2##3##(1990-3#1)(2012-12#1)
study contributes to##3##3##(2008-10#1)(2011-1#1)(2012-12#1)
study contributes##7##2##(2008-10#1)(2010-10#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#2)
study could also be##2##4##(2010-7#1)(2013-8#1)
study could be##11##3##(1992-8#1)(2005-10#1)(2006-12#2)(2007-6#1)(2008-10#1)(2008-12#1)(2008-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
study could##21##2##(1992-8#1)(2005-10#1)(2006-12#2)(2007-11#1)(2007-6#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-7#1)(2011-3#1)(2012-2#1)(2013-1#2)(2013-8#3)
study covered##4##2##(2008-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
study covering a##3##3##(1992-12#1)(2011-1#1)(2012-12#1)
study covering##4##2##(1992-12#1)(2011-1#1)(2012-12#1)(2013-8#1)
study criteria##3##2##(2007-10#2)(2012-12#1)
study current##2##2##(1996-2#1)(2008-8#1)
study data##12##2##(2005-8#1)(2007-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2010-5#1)(2012-2#1)(2012-3#2)(2013-1#2)
study data)##2##2##(1993-11#2)
study dealing with the##3##4##(1993-3#1)(2006-6#1)(2008-10#1)
study dealing with##4##3##(1993-3#2)(2006-6#1)(2008-10#1)
study deals with a##2##4##(1995-12#1)(2008-10#1)
study deals with the##11##4##(1994-4#1)(1994-9#1)(2004-9#1)(2006-1#1)(2007-7#1)(2008-10#2)(2008-5#2)(2012-2#1)(2013-1#1)
study deals with##16##3##(1994-4#1)(1994-9#1)(1995-12#1)(2004-9#1)(2006-1#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-5#2)(2009-2#1)(2012-2#2)(2013-1#1)
study deals##17##2##(1994-4#1)(1994-9#1)(1995-12#1)(2004-9#1)(2006-1#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#2)(2009-2#1)(2012-2#2)(2013-1#1)
study dealt with##2##3##(2007-10#1)(2011-2#1)
study defines the##2##3##(1990-12#1)(1996-3#1)
study defines##3##2##(1990-12#1)(1993-5#1)(1996-3#1)
study demonstrate that##13##3##(1992-11#1)(1994-10#1)(1994-3#1)(1994-6#1)(2005-10#1)(2005-12#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#1)(2012-11#1)
study demonstrate the feasibility of##2##5##(1993-9#1)(2012-1#1)
study demonstrate the##9##3##(1992-7#1)(1993-9#1)(1997-3#1)(2006-12#1)(2008-5#1)(2010-12#1)(2012-1#1)(2013-1#2)
study demonstrate##24##2##(1992-11#1)(1992-7#1)(1993-9#1)(1994-10#1)(1994-3#1)(1994-6#1)(1997-3#1)(2005-10#1)(2005-12#1)(2006-12#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-1#1)(2012-11#1)(2013-1#2)
study demonstrated a##7##3##(2006-7#1)(2006-8#2)(2007-11#1)(2008-7#1)(2011-2#1)(2012-1#1)
study demonstrated that a##3##4##(1992-2#1)(2007-8#1)(2008-5#1)
study demonstrated that the##17##4##(1994-11#1)(1996-1#1)(1996-3#1)(2006-8#2)(2007-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-8#1)
study demonstrated that there##2##4##(1990-5#1)(2007-2#1)
study demonstrated that##61##3##(1990-5#1)(1991-10#1)(1992-2#1)(1992-9#1)(1994-11#1)(1994-3#1)(1995-10#1)(1995-11#1)(1996-1#1)(1996-2#1)(1996-3#1)(2005-11#1)(2006-10#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#2)(2009-4#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#2)(2010-9#1)(2011-2#5)(2012-12#2)(2012-2#2)(2013-8#2)
study demonstrated the high##2##4##(2004-11#1)(2008-6#1)
study demonstrated the##12##3##(1997-1#1)(2004-11#1)(2007-9#1)(2008-10#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-1#1)(2011-1#1)(2013-1#1)
study demonstrated##88##2##(1990-5#1)(1991-10#1)(1992-2#1)(1992-9#1)(1994-11#1)(1994-3#1)(1995-10#1)(1995-11#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#2)(2004-11#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-7#1)(2006-8#4)(2007-10#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-10#4)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#6)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-1#1)(2009-3#3)(2009-4#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#2)
study demonstrates a##10##3##(1990-11#1)(1991-1#1)(1994-5#1)(1995-12#1)(1996-2#1)(1996-3#1)(2008-10#2)(2008-7#1)(2011-2#1)
study demonstrates an##2##3##(2007-11#1)(2010-4#1)
study demonstrates for the first time##2##6##(2008-7#1)(2010-12#1)
study demonstrates that a##2##4##(1993-2#1)(2008-6#1)
study demonstrates that the##19##4##(1991-8#2)(1994-11#1)(1996-6#1)(1997-7#1)(2005-11#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-4#1)(2011-12#1)(2012-12#3)
study demonstrates that this##2##4##(2013-1#1)(2013-8#1)
study demonstrates that##70##3##(1990-6#1)(1991-12#1)(1991-8#2)(1992-6#2)(1992-7#1)(1993-11#2)(1993-2#1)(1994-11#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1995-2#2)(1996-6#1)(1997-6#1)(1997-7#1)(2004-1#1)(2005-11#1)(2005-6#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#2)(2008-10#4)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-1#2)(2011-12#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
study demonstrates the efficacy of##3##5##(2008-8#1)(2010-1#1)(2013-1#1)
study demonstrates the feasibility of##4##5##(2006-6#1)(2007-8#1)(2008-11#1)(2008-6#1)
study demonstrates the importance of##3##5##(2008-6#1)(2009-5#1)(2012-12#1)
study demonstrates the potential of##2##5##(2012-1#2)
study demonstrates the potential##4##4##(1992-1#1)(2008-5#1)(2012-1#2)
study demonstrates the viability##2##4##(2008-5#1)(2009-9#1)
study demonstrates the##39##3##(1990-5#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-7#1)(1997-7#1)(2005-11#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#1)(2013-1#2)(2013-7#1)
study demonstrates##132##2##(1990-11#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-8#3)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#2)(1993-11#2)(1993-2#1)(1993-3#1)(1994-11#2)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#1)(1995-12#1)(1995-2#2)(1996-2#1)(1996-3#1)(1996-6#1)(1997-6#1)(1997-7#2)(2004-1#1)(2005-11#2)(2005-6#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-6#2)(2007-10#1)(2007-11#3)(2007-2#2)(2007-5#1)(2007-8#4)(2008-10#9)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#5)(2008-7#3)(2008-8#4)(2008-9#3)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
study demonstrating the##2##3##(2008-10#1)(2008-3#1)
study demonstrating##4##2##(2006-10#1)(2007-9#1)(2008-10#1)(2008-3#1)
study described a##2##3##(2010-12#1)(2013-1#1)
study described here##5##3##(1993-3#1)(2007-2#1)(2008-11#1)(2011-2#1)(2012-1#1)
study described in this article##2##5##(1991-2#1)(1996-3#1)
study described##11##2##(1991-2#1)(1993-3#1)(1996-3#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
study describes a case of##3##5##(2005-10#1)(2008-10#1)(2012-3#1)
study describes a##14##3##(1990-11#1)(2005-10#1)(2007-11#1)(2007-6#1)(2008-10#4)(2008-11#1)(2008-6#1)(2009-6#1)(2012-12#1)(2012-3#2)
study describes how##4##3##(1991-1#1)(2010-10#1)(2010-4#1)(2010-9#1)
study describes the effect of##2##5##(2006-2#1)(2008-9#1)
study describes the effects of##2##5##(2005-10#1)(2008-8#1)
study describes the##43##3##(1991-9#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-6#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-8#1)(2005-10#2)(2005-11#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-3#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#2)
study describes##88##2##(1990-10#1)(1990-11#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-12#1)(1994-2#2)(1994-6#2)(1994-8#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-8#2)(2005-10#3)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#9)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
study describing the##3##3##(2008-10#1)(2011-1#1)(2012-2#1)
study design and analysis##3##4##(2005-10#1)(2008-6#1)(2009-4#1)
study design and data##2##4##(2011-2#1)(2012-2#1)
study design and results##2##4##(2013-1#2)
study design and##20##3##(1992-3#1)(1996-11#1)(2005-10#1)(2006-2#1)(2006-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-4#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
study design in##2##3##(2008-6#1)(2012-2#1)
study design includes##2##3##(2010-2#1)(2010-3#1)
study design is##2##3##(2008-11#1)(2011-2#1)
study design to##3##3##(2011-1#1)(2011-2#1)(2012-2#1)
study design was used to##2##5##(2007-10#1)(2011-2#1)
study design was used##5##4##(2007-10#1)(2008-11#1)(2008-9#1)(2011-1#1)(2011-2#1)
study design was##11##3##(1994-3#1)(2006-10#1)(2007-10#1)(2008-11#1)(2008-9#2)(2011-1#3)(2011-2#1)(2013-7#1)
study design with##3##3##(2006-3#1)(2013-1#2)
study design##85##2##(1990-11#1)(1990-12#1)(1992-3#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-8#1)(1996-11#1)(1997-7#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-2#2)(2006-3#1)(2006-5#1)(2007-10#3)(2007-11#1)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-1#1)(2009-4#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#7)(2012-11#1)(2012-2#5)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#1)
study designed to evaluate the##2##5##(1990-12#1)(2006-2#1)
study designed to investigate the##3##5##(2006-12#1)(2008-11#2)
study designed to##9##3##(1990-12#1)(1996-12#1)(1996-7#1)(2006-12#1)(2006-2#1)(2007-12#1)(2008-11#2)(2010-2#1)
study designs and##5##3##(2007-5#1)(2007-7#1)(2012-1#1)(2013-1#2)
study designs are##2##3##(1994-3#1)(2012-3#1)
study designs##17##2##(1994-3#1)(1995-9#2)(1996-3#1)(2006-10#1)(2007-5#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-1#1)(2012-3#2)(2013-1#2)
study determined the##11##3##(1993-2#1)(1993-4#1)(1996-1#1)(2006-2#1)(2006-8#1)(2009-12#1)(2009-3#1)(2010-12#1)(2012-2#1)(2012-5#1)(2013-1#1)
study determined##23##2##(1993-2#1)(1993-4#1)(1994-6#1)(1996-1#1)(1996-12#1)(1997-7#1)(2006-2#1)(2006-8#1)(2007-10#2)(2007-2#1)(2008-10#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-6#2)(2012-2#1)(2012-5#1)(2013-1#2)(2013-7#1)
study determines the##2##3##(2008-4#1)(2011-12#1)
study developed a##2##3##(1997-1#1)(2007-7#1)
study developed##7##2##(1997-1#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-2#1)
study develops##2##2##(2006-11#1)(2011-2#1)
study did not find##2##4##(2009-10#1)(2013-1#1)
study did not show any##2##5##(1997-8#1)(2010-8#1)
study did not show##3##4##(1997-8#1)(2009-11#1)(2010-8#1)
study did not##14##3##(1992-1#1)(1996-5#1)(1997-8#1)(2006-7#1)(2007-2#1)(2008-11#1)(2008-12#1)(2009-10#1)(2009-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#2)
study different types of##2##4##(2008-2#1)(2009-7#1)
study different##5##2##(2007-10#1)(2007-2#1)(2008-2#1)(2009-7#1)(2010-5#1)
study differs##3##2##(1995-9#1)(2008-10#1)(2008-11#1)
study directly##3##2##(1993-7#1)(1994-3#1)(2008-11#1)
study disclosed##2##2##(2008-7#1)(2010-12#1)
study discusses the role of##2##5##(2008-12#1)(2008-7#1)
study discusses the##3##3##(2008-12#1)(2008-7#1)(2013-7#1)
study discusses##4##2##(1994-6#1)(2008-12#1)(2008-7#1)(2013-7#1)
study diseases##2##2##(2008-10#1)(2013-8#1)
study do not##6##3##(1996-9#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)
study do##7##2##(1996-9#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
study documented a##2##3##(2006-2#1)(2007-12#1)
study documented##4##2##(2006-2#1)(2007-12#1)(2007-2#1)(2007-4#1)
study documents the##2##3##(2008-6#1)(2012-3#1)
study documents##10##2##(1993-9#1)(2006-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-9#1)(2012-3#1)(2013-1#2)(2013-8#1)
study does not support the hypothesis of##2##7##(1992-5#1)(2007-9#1)
study does not support the hypothesis##3##6##(1991-7#1)(1992-5#1)(2007-9#1)
study does not support the##7##5##(1990-9#1)(1991-7#1)(1992-5#1)(1993-3#1)(2007-11#1)(2007-9#1)(2008-9#1)
study does not support##10##4##(1990-12#1)(1990-9#1)(1991-7#1)(1991-8#1)(1992-5#1)(1993-3#1)(2007-11#1)(2007-9#1)(2008-9#1)(2010-5#1)
study does not##12##3##(1990-12#1)(1990-9#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-5#1)(1993-3#1)(2005-1#1)(2007-11#1)(2007-9#1)(2008-9#1)(2010-5#1)
study done in a##2##4##(1993-3#1)(2008-3#1)
study done in##4##3##(1993-3#1)(1996-11#1)(2008-3#1)(2008-7#1)
study done##7##2##(1993-3#1)(1996-11#1)(2006-1#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#1)
study draws##4##2##(2005-9#1)(2009-12#1)(2012-11#1)(2012-2#1)
study drug##4##2##(1992-11#1)(2004-1#2)(2007-8#1)
study drugs##2##2##(2006-6#1)(2007-8#1)
study due to##7##3##(1990-5#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#1)(2012-2#1)(2013-8#1)
study duration in comparison with##2##5##(2008-5#2)
study duration##9##2##(2008-5#3)(2008-7#1)(2011-2#1)(2012-3#4)
study during##4##2##(1993-4#1)(1995-12#1)(2010-3#1)(2013-1#1)
study effects of##5##3##(2006-10#1)(2008-11#1)(2008-2#1)(2010-10#1)(2010-2#1)
study effects##6##2##(2006-10#1)(2006-12#1)(2008-11#1)(2008-2#1)(2010-10#1)(2010-2#1)
study elucidated##2##2##(2007-8#1)(2008-10#1)
study emphasizes the##3##3##(1997-4#1)(2008-11#1)(2013-8#1)
study emphasizes##4##2##(1997-4#1)(2008-11#1)(2009-3#1)(2013-8#1)
study empirically##2##2##(2004-10#1)(2004-11#1)
study employed a##4##3##(2007-12#1)(2007-8#1)(2008-12#1)(2008-9#1)
study employed an##2##3##(1995-5#1)(2011-1#1)
study employed##12##2##(1995-11#1)(1995-5#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-9#1)(2010-3#1)(2011-1#2)(2013-1#1)
study employs##3##2##(1997-5#1)(2007-7#1)(2008-5#1)
study end##3##2##(1993-12#1)(2007-11#1)(2008-10#1)
study enrolled##3##2##(2011-2#2)(2013-8#1)
study enrollment##5##2##(2007-9#4)(2011-2#1)
study entitled##3##2##(2013-1#2)(2013-8#1)
study entry##8##2##(1993-7#1)(1995-6#1)(2010-11#1)(2011-1#1)(2011-2#4)
study established##4##2##(1992-4#1)(2008-11#1)(2008-3#1)(2012-3#1)
study establishes the##3##3##(2007-6#1)(2008-10#1)(2013-1#1)
study establishes##6##2##(1991-8#1)(1994-10#1)(1995-1#1)(2007-6#1)(2008-10#1)(2013-1#1)
study estimated##3##2##(1997-1#1)(1997-5#1)(2012-12#1)
study estimates the##4##3##(2007-2#1)(2009-12#1)(2012-1#1)(2013-8#1)
study estimates##6##2##(2007-2#1)(2009-12#1)(2009-9#1)(2010-7#1)(2012-1#1)(2013-8#1)
study evaluated a range of##2##5##(2008-9#1)(2012-2#1)
study evaluated the acute##2##4##(2008-10#1)(2008-6#1)
study evaluated the effect of##5##5##(1991-1#1)(1991-2#1)(2008-12#1)(2011-1#1)(2012-2#1)
study evaluated the effects of##5##5##(1995-11#1)(1995-12#1)(1997-3#1)(1997-5#1)(2012-2#1)
study evaluated the efficacy and safety of##2##7##(2004-3#1)(2006-1#1)
study evaluated the efficacy and##3##5##(2004-3#1)(2006-1#1)(2011-2#1)
study evaluated the efficacy##4##4##(1997-5#1)(2004-3#1)(2006-1#1)(2011-2#1)
study evaluated the use of##2##5##(2008-10#1)(2008-8#1)
study evaluated the use##3##4##(2008-10#1)(2008-8#1)(2013-1#1)
study evaluated the##62##3##(1991-1#1)(1991-2#1)(1993-1#1)(1995-11#1)(1995-12#2)(1997-3#1)(1997-5#2)(1997-6#1)(2004-11#1)(2004-3#1)(2005-9#1)(2006-1#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-2#1)(2007-4#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#4)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#3)(2012-2#6)(2012-3#1)(2013-1#8)
study evaluated whether##3##3##(1993-4#1)(2009-11#1)(2013-1#1)
study evaluated##98##2##(1991-1#1)(1991-2#1)(1993-1#1)(1993-4#1)(1995-11#1)(1995-12#2)(1996-1#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#1)(2004-11#1)(2004-3#1)(2005-4#1)(2005-9#1)(2006-1#1)(2006-12#1)(2006-3#1)(2006-7#2)(2006-8#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-12#5)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-11#1)(2009-3#3)(2010-2#2)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-1#3)(2012-12#2)(2012-2#9)(2012-3#1)(2013-1#11)(2013-7#1)
study evaluates a##4##3##(2006-10#1)(2012-2#1)(2013-1#2)
study evaluates the effect of##5##5##(1991-3#1)(2006-9#1)(2007-1#1)(2008-7#1)(2013-8#1)
study evaluates the effectiveness of##2##5##(2010-5#1)(2013-7#1)
study evaluates the effects of##2##5##(1990-12#1)(1996-2#1)
study evaluates the##27##3##(1990-12#1)(1991-3#1)(1993-2#1)(1993-3#1)(1993-7#1)(1996-2#2)(1997-2#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-7#3)(2008-9#1)(2010-2#1)(2010-5#1)(2012-2#1)(2013-7#1)(2013-8#1)
study evaluates##39##2##(1990-12#1)(1991-3#1)(1993-2#1)(1993-3#1)(1993-7#1)(1996-2#2)(1997-2#1)(2006-10#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-3#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#3)(2008-9#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-7#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
study evaluating the##4##3##(2006-1#1)(2009-9#1)(2012-1#1)(2013-1#1)
study evaluating##9##2##(2006-1#1)(2008-12#1)(2008-6#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
study evidenced##2##2##(2008-5#1)(2010-11#1)
study examined a##3##3##(1996-10#1)(2007-1#1)(2007-6#1)
study examined associations between##3##4##(2007-10#1)(2010-2#1)(2011-2#1)
study examined associations##4##3##(2006-7#1)(2007-10#1)(2010-2#1)(2011-2#1)
study examined differences##2##3##(2009-5#1)(2010-10#1)
study examined how##3##3##(1997-8#1)(2010-10#1)(2010-12#1)
study examined the association between##3##5##(2007-12#1)(2009-9#1)(2013-1#1)
study examined the association##4##4##(2007-12#2)(2009-9#1)(2013-1#1)
study examined the effect of##19##5##(1990-4#1)(1990-7#1)(1991-1#1)(1991-2#2)(1991-6#1)(1994-10#2)(1994-5#1)(1994-6#1)(1995-12#1)(1995-3#1)(2004-9#1)(2006-5#1)(2007-12#1)(2007-4#1)(2010-4#1)(2011-2#1)(2013-1#1)
study examined the effectiveness of the##2##6##(2008-12#1)(2010-2#1)
study examined the effectiveness of##3##5##(2008-12#1)(2008-5#1)(2010-2#1)
study examined the effects of##18##5##(1990-9#1)(1994-8#1)(1996-10#1)(1996-12#2)(1997-6#1)(2006-11#1)(2006-5#1)(2007-12#2)(2008-12#1)(2008-6#1)(2009-3#1)(2009-7#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)
study examined the hypothesis that##2##5##(2007-11#1)(2008-4#1)
study examined the impact of##2##5##(2008-4#1)(2009-7#1)
study examined the longitudinal##2##4##(2010-10#1)(2012-12#1)
study examined the prevalence of##2##5##(2008-5#1)(2012-1#1)
study examined the relationship between two##2##6##(2007-10#1)(2007-12#1)
study examined the relationship between##12##5##(2004-12#1)(2007-10#1)(2007-12#1)(2008-7#1)(2009-11#1)(2009-5#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)
study examined the relationship##13##4##(2004-12#1)(2007-10#1)(2007-12#1)(2008-7#1)(2009-11#1)(2009-5#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)
study examined the response of##2##5##(1992-9#1)(1995-5#1)
study examined the role of the##2##6##(1992-9#1)(2008-10#1)
study examined the role of##5##5##(1991-12#1)(1992-8#1)(1992-9#1)(2006-4#1)(2008-10#1)
study examined the utility of##2##5##(2007-12#1)(2011-2#1)
study examined the##138##3##(1990-4#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-6#2)(1991-8#2)(1991-9#1)(1992-11#1)(1992-2#1)(1992-8#1)(1992-9#3)(1993-10#1)(1994-10#2)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-10#1)(1996-12#2)(1996-8#1)(1997-6#1)(2004-12#2)(2004-9#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#3)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#10)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#5)(2009-9#3)(2010-1#3)(2010-10#1)(2010-2#6)(2010-4#3)(2010-6#3)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#6)(2012-1#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)
study examined whether the##4##4##(1992-12#1)(1996-5#1)(2007-12#1)(2010-9#1)
study examined whether##22##3##(1992-12#1)(1992-6#1)(1994-12#1)(1994-8#1)(1995-12#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-8#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-12#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#2)
study examined##250##2##(1990-2#1)(1990-4#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#3)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-10#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-1#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-5#1)(1996-8#1)(1997-1#1)(1997-6#2)(1997-8#2)(2003-11#1)(2004-12#3)(2004-9#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#3)(2006-7#2)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#16)(2007-2#1)(2007-4#2)(2007-6#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#3)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#3)(2009-11#4)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#3)(2009-5#4)(2009-7#10)(2009-9#5)(2010-1#4)(2010-10#3)(2010-12#1)(2010-2#8)(2010-4#6)(2010-5#1)(2010-6#3)(2010-7#2)(2010-9#2)(2011-1#4)(2011-2#13)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#10)(2013-7#1)(2013-8#1)
study examines and##3##3##(2007-8#1)(2008-11#1)(2008-9#1)
study examines how##6##3##(2008-12#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-8#1)
study examines the effect##2##4##(1994-2#1)(2008-12#1)
study examines the effects of##3##5##(1991-5#1)(1993-3#1)(2008-5#1)
study examines the experiences##2##4##(2008-11#1)(2012-3#1)
study examines the impact of##2##5##(1994-2#1)(2008-11#1)
study examines the importance##2##4##(1993-6#1)(1995-1#1)
study examines the influence of##2##5##(2008-6#1)(2010-2#1)
study examines the influence##3##4##(2008-6#1)(2010-2#1)(2012-3#1)
study examines the relationship between the##2##6##(1997-3#1)(2009-5#1)
study examines the relationship between##5##5##(1995-12#1)(1997-3#1)(1997-8#1)(2009-5#1)(2010-7#1)
study examines the relationship##6##4##(1995-12#1)(1997-3#1)(1997-8#1)(2007-12#1)(2009-5#1)(2010-7#1)
study examines the role of##3##5##(1992-12#1)(1994-12#1)(2012-11#1)
study examines the views##2##4##(2008-5#1)(2009-4#1)
study examines the##62##3##(1990-2#1)(1991-1#1)(1991-5#1)(1992-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-6#1)(1995-1#1)(1995-12#1)(1995-7#2)(1996-12#1)(1997-3#1)(1997-8#1)(2006-11#1)(2006-7#2)(2007-12#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#1)(2010-10#1)(2010-2#1)(2010-3#2)(2010-7#2)(2010-8#2)(2011-2#2)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#1)
study examines two##3##3##(1993-6#1)(2010-4#1)(2013-7#1)
study examines whether##6##3##(1993-3#1)(1994-12#1)(2004-3#1)(2006-5#1)(2010-7#2)
study examines##109##2##(1990-2#1)(1991-1#1)(1991-5#1)(1992-12#1)(1993-1#1)(1993-3#2)(1993-4#1)(1993-6#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-7#2)(1996-1#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-8#1)(2004-3#1)(2006-11#1)(2006-5#1)(2006-7#2)(2007-12#4)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#4)(2008-2#2)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-7#4)(2010-10#1)(2010-11#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#4)(2010-8#3)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#1)
study examining the effect of##2##5##(2008-5#1)(2010-8#1)
study examining the##5##3##(2007-3#1)(2008-5#1)(2008-9#1)(2010-1#1)(2010-8#1)
study examining##10##2##(1997-7#1)(2005-11#1)(2007-3#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-3#1)
study excluded##2##2##(2010-10#1)(2011-1#1)
study exhibits##2##2##(2008-10#1)(2012-12#1)
study expands our##2##3##(2008-11#1)(2009-12#1)
study explored how##2##3##(2008-11#1)(2013-1#1)
study explored the perceptions##2##4##(2010-11#1)(2010-9#1)
study explored the relation##2##4##(1994-3#1)(2008-9#1)
study explored the##18##3##(1993-12#1)(1994-3#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#1)
study explored##31##2##(1993-12#1)(1994-3#1)(1995-12#1)(2005-10#1)(2006-7#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#4)(2013-7#1)
study explores how the##2##4##(2009-5#1)(2013-8#1)
study explores how##5##3##(2006-7#1)(2008-3#1)(2009-5#1)(2010-9#1)(2013-8#1)
study explores the relationship##2##4##(1996-2#1)(2007-2#1)
study explores the role of##2##5##(2008-12#1)(2011-1#1)
study explores the role##3##4##(2008-1#1)(2008-12#1)(2011-1#1)
study explores the##24##3##(1995-1#1)(1996-2#1)(1997-1#1)(2004-12#2)(2005-10#1)(2005-11#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-12#2)(2008-6#1)(2008-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-8#1)
study explores whether##2##3##(1992-6#1)(2009-1#1)
study explores##45##2##(1992-6#1)(1994-2#1)(1995-1#1)(1996-2#1)(1997-1#1)(1997-3#1)(2004-12#2)(2005-10#1)(2005-11#1)(2006-4#1)(2006-7#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-12#4)(2008-3#1)(2008-6#1)(2008-8#1)(2009-1#1)(2009-11#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
study exploring the##5##3##(2006-7#1)(2007-10#1)(2008-11#3)
study exploring##6##2##(2006-7#1)(2007-10#1)(2008-11#3)(2013-8#1)
study exposure to##2##3##(2008-11#1)(2011-1#1)
study extended previous##2##3##(2008-9#1)(2009-7#1)
study extended##5##2##(1994-2#1)(2007-12#1)(2008-9#1)(2009-7#1)(2010-8#1)
study extends previous##3##3##(1994-3#1)(2010-2#1)(2013-8#1)
study extends##10##2##(1991-12#1)(1993-12#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-10#1)(2010-2#1)(2013-8#1)
study factors##3##2##(1990-3#1)(2008-8#1)(2011-1#1)
study failed to show##3##4##(2008-5#1)(2009-6#1)(2011-12#1)
study failed to##6##3##(1997-8#1)(2007-7#1)(2007-9#1)(2008-5#1)(2009-6#1)(2011-12#1)
study fills##2##2##(2012-3#1)(2013-1#1)
study findings are##3##3##(1991-2#1)(2011-12#1)(2013-1#1)
study findings can##2##3##(2012-12#1)(2012-2#1)
study findings##20##2##(1991-12#2)(1991-2#1)(1993-1#1)(1993-12#1)(1995-1#1)(2006-1#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-6#1)(2011-1#2)(2011-12#2)(2012-12#1)(2012-2#2)(2013-1#1)
study finds that##3##3##(1994-2#1)(2009-9#1)(2010-2#1)
study finds##8##2##(1990-7#1)(1994-2#1)(2007-1#2)(2008-11#1)(2009-9#1)(2010-2#1)(2012-11#1)
study first##2##2##(1994-2#1)(2008-11#1)
study focused on the##15##4##(1993-12#1)(2006-2#1)(2007-12#1)(2008-10#2)(2008-8#1)(2009-3#1)(2010-12#1)(2010-4#1)(2011-1#2)(2012-2#1)(2013-1#3)
study focused on##24##3##(1993-12#1)(1995-9#1)(2006-2#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#4)(2013-7#2)
study focused##26##2##(1993-12#1)(1995-9#1)(1996-10#1)(2004-10#1)(2006-2#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#4)(2013-7#2)
study focuses on the##17##4##(1990-6#1)(1992-8#1)(1993-5#1)(1996-8#1)(2007-2#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-3#1)(2010-8#1)(2011-12#2)(2011-2#1)(2012-3#1)(2013-8#1)
study focuses on##27##3##(1990-6#1)(1992-8#1)(1993-5#1)(1994-12#1)(1995-3#1)(1996-8#1)(2007-2#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-11#3)(2008-3#2)(2009-11#1)(2010-12#1)(2010-8#1)(2011-12#2)(2011-2#2)(2012-12#2)(2012-3#1)(2013-8#2)
study followed the##2##3##(2008-9#1)(2013-1#1)
study followed##5##2##(1994-12#1)(2008-10#1)(2008-9#1)(2009-4#1)(2013-1#1)
study follows##3##2##(1991-3#2)(2009-5#1)
study for a##5##3##(1992-3#1)(1996-7#1)(2006-10#1)(2008-3#2)
study for each##2##3##(2008-10#1)(2008-7#1)
study for sexually transmitted diseases in patients attending STD clinics in##2##11##(2007-7#2)
study for the analysis of##2##5##(2008-10#1)(2010-6#1)
study for the first time##3##5##(2005-10#1)(2008-10#1)(2010-12#1)
study for the##18##3##(1990-10#1)(1993-3#1)(1994-12#1)(1994-3#1)(2005-10#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-5#1)(2009-4#1)(2010-12#1)(2010-6#1)(2011-2#1)(2013-8#1)
study for##81##2##(1990-10#1)(1992-3#1)(1993-1#1)(1993-3#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-7#1)(1996-7#1)(1997-2#1)(1997-3#2)(1997-6#1)(2004-12#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-9#2)(2007-10#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#3)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#3)(2013-1#1)(2013-8#2)
study found no##2##3##(1997-8#1)(2008-7#1)
study found that the##3##4##(1995-2#1)(2008-11#1)(2012-12#1)
study found that##20##3##(1995-2#1)(1995-3#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-7#1)(2008-11#2)(2009-11#1)(2009-4#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#2)
study found##33##2##(1995-2#1)(1995-3#2)(1997-3#1)(1997-5#1)(1997-8#2)(2004-3#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-7#1)(2007-9#1)(2008-11#3)(2008-3#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-4#2)(2009-9#1)(2010-10#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#2)
study four##3##2##(2008-5#1)(2008-6#1)(2011-2#1)
study four-wave mixing##2##3##(2007-11#1)(2007-12#1)
study from 1991##2##3##(2006-12#1)(2006-2#1)
study from January##2##3##(2007-10#1)(2011-2#1)
study from a##9##3##(2007-10#1)(2007-8#1)(2008-10#1)(2009-10#1)(2009-9#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
study from the##4##3##(1993-6#1)(1995-3#1)(2007-10#1)(2013-8#1)
study from##49##2##(1991-5#1)(1992-11#1)(1992-7#1)(1993-6#1)(1993-8#1)(1993-9#1)(1995-3#1)(2006-12#1)(2006-2#1)(2007-10#3)(2007-2#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#3)(2009-3#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
study further revealed##2##3##(1993-6#1)(2009-8#1)
study further##17##2##(1993-6#1)(1994-8#1)(2004-4#1)(2005-11#1)(2007-2#2)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-8#1)(2012-12#1)(2012-3#1)
study gel##2##2##(2007-7#2)
study gives the##3##3##(1993-9#1)(2007-8#1)(2008-10#1)
study gives##7##2##(1991-4#1)(1993-9#1)(2007-8#1)(2008-10#3)(2011-12#1)
study group (76##2##3##(2007-9#1)(2013-1#1)
study group (n =##3##4##(1993-12#1)(2007-11#1)(2009-10#1)
study group and##6##3##(2009-10#1)(2009-8#2)(2010-2#1)(2011-1#1)(2011-2#1)
study group as compared to##3##5##(2007-7#1)(2013-8#2)
study group as##4##3##(2007-7#1)(2008-6#1)(2013-8#2)
study group comprised##9##3##(1991-12#1)(1993-5#1)(2007-10#2)(2007-3#1)(2009-6#1)(2011-1#1)(2011-12#1)(2013-1#1)
study group patients##2##3##(2008-7#1)(2013-8#1)
study group was compared##2##4##(2007-7#1)(2008-5#1)
study group was##11##3##(2006-6#1)(2007-10#1)(2007-7#4)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
study group with##2##3##(2006-8#1)(2011-2#1)
study group##115##2##(1990-11#1)(1991-12#2)(1992-11#1)(1992-6#1)(1993-12#6)(1993-5#1)(1993-7#1)(1993-8#1)(1994-3#1)(1994-6#1)(1996-7#1)(2004-10#2)(2005-8#1)(2006-10#3)(2006-6#1)(2006-7#2)(2006-8#6)(2007-10#5)(2007-11#2)(2007-3#1)(2007-6#1)(2007-7#14)(2007-8#1)(2007-9#5)(2008-1#3)(2008-10#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#3)(2009-10#5)(2009-3#1)(2009-6#1)(2009-8#2)(2010-2#2)(2011-1#8)(2011-12#1)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#6)
study groups was##2##3##(1991-11#1)(2007-10#1)
study groups were##5##3##(2007-7#1)(2007-8#2)(2012-12#1)(2013-8#1)
study groups##27##2##(1991-11#1)(1991-8#1)(1995-11#2)(1997-2#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-7#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-8#3)
study had a##2##3##(2010-12#1)(2013-1#1)
study had been##2##3##(1991-5#1)(2005-7#1)
study had the##2##3##(1995-3#1)(2011-2#1)
study had##14##2##(1990-6#1)(1991-5#1)(1992-2#1)(1994-3#1)(1995-3#1)(2005-7#1)(2007-10#1)(2008-2#1)(2010-12#1)(2011-2#1)(2013-1#2)(2013-8#2)
study has a##4##3##(1995-11#1)(2010-7#1)(2012-3#1)(2013-8#1)
study has allowed##2##3##(2008-2#1)(2013-1#1)
study has an##2##3##(1992-9#1)(2006-9#1)
study has attempted to##2##4##(2008-10#1)(2012-2#1)
study has been carried out on##2##6##(2008-3#1)(2011-2#1)
study has been carried out to##3##6##(2006-4#1)(2007-7#1)(2009-6#1)
study has been carried out##11##5##(1990-10#1)(1990-9#1)(2006-4#1)(2007-7#1)(2008-10#2)(2008-3#2)(2009-6#1)(2010-3#1)(2011-2#1)
study has been carried##12##4##(1990-10#1)(1990-9#1)(2006-4#1)(2006-6#1)(2007-7#1)(2008-10#2)(2008-3#2)(2009-6#1)(2010-3#1)(2011-2#1)
study has been completed##2##4##(2008-5#2)
study has been conducted in##2##5##(1992-10#1)(2012-1#1)
study has been conducted##4##4##(1992-10#1)(2008-2#1)(2009-5#1)(2012-1#1)
study has been done##3##4##(2006-1#1)(2012-2#1)(2013-8#1)
study has been made of##3##5##(1992-3#1)(2006-5#1)(2007-12#1)
study has been made##5##4##(1992-3#1)(2006-5#1)(2007-12#2)(2008-10#1)
study has been performed on the##2##6##(2006-12#1)(2008-2#1)
study has been performed##4##4##(2006-12#1)(2008-10#1)(2008-2#1)(2008-6#1)
study has been undertaken to##5##5##(1993-2#1)(2007-10#3)(2008-10#1)
study has been##47##3##(1990-10#1)(1990-9#1)(1991-10#1)(1992-10#1)(1992-3#1)(1993-2#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#3)(2007-12#2)(2007-7#1)(2007-9#2)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#4)(2008-6#1)(2009-5#1)(2009-6#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
study has compared the##2##4##(2007-12#1)(2008-8#1)
study has demonstrated that##3##4##(2007-7#1)(2011-2#2)
study has demonstrated the high##2##5##(2007-5#1)(2008-6#1)
study has demonstrated the##7##4##(2004-4#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-6#1)(2008-8#1)(2011-2#1)
study has demonstrated##10##3##(2004-4#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-6#1)(2008-8#1)(2011-2#3)
study has enrolled##2##3##(2005-9#1)(2008-5#1)
study has examined the##2##4##(1994-11#1)(2011-2#1)
study has found that##4##4##(1992-7#1)(1995-9#1)(2006-3#1)(2008-8#1)
study has found##6##3##(1992-7#1)(1995-9#1)(1997-2#1)(2006-3#1)(2008-8#1)(2011-2#1)
study has investigated##2##3##(1995-1#1)(2011-2#1)
study has not been##3##4##(2007-1#1)(2008-12#1)(2011-1#1)
study has provided##6##3##(2007-10#1)(2008-4#1)(2008-9#1)(2009-6#1)(2010-8#1)(2013-1#1)
study has revealed a##2##4##(1992-6#1)(2009-8#1)
study has revealed that##2##4##(1993-11#1)(1997-1#1)
study has revealed##5##3##(1992-6#1)(1993-11#1)(1997-1#1)(1997-3#1)(2009-8#1)
study has shown a##2##4##(1991-5#1)(2005-10#1)
study has shown that the##3##5##(2008-10#1)(2010-12#1)(2012-3#1)
study has shown that##15##4##(1990-6#1)(1995-6#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-12#2)(2011-1#1)(2012-3#1)
study has shown##24##3##(1990-6#1)(1991-5#1)(1995-6#1)(1997-4#1)(1997-6#1)(2005-10#1)(2006-10#3)(2007-12#1)(2007-2#1)(2008-10#1)(2008-5#4)(2008-7#1)(2008-9#1)(2009-6#1)(2010-12#2)(2011-1#2)(2012-3#1)
study has suggested that the##2##5##(2006-10#1)(2009-7#1)
study has suggested that##3##4##(2006-10#1)(2007-11#1)(2009-7#1)
study has therefore##2##3##(1991-12#1)(2007-7#1)
study has##180##2##(1990-10#1)(1990-2#2)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-5#2)(1992-10#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-2#2)(1993-6#1)(1994-1#1)(1994-11#1)(1995-1#1)(1995-11#1)(1995-6#1)(1995-9#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-4#1)(2005-10#1)(2005-9#1)(2006-1#1)(2006-10#8)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#6)(2007-11#3)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#3)(2007-9#2)(2008-10#14)(2008-11#1)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#11)(2008-6#3)(2008-7#1)(2008-8#5)(2008-9#2)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#1)(2010-1#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#10)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#3)
study have also##2##3##(2008-1#1)(2010-6#1)
study have been##5##3##(1991-1#1)(1994-3#1)(2007-1#1)(2008-10#1)(2012-12#1)
study have shown that the##2##5##(2008-1#1)(2008-10#1)
study have shown that##5##4##(2007-9#2)(2008-1#2)(2008-10#1)
study have subsequently##2##3##(2010-12#1)(2011-2#1)
study have##34##2##(1990-5#1)(1991-1#1)(1993-2#1)(1994-3#1)(1996-9#1)(1997-1#1)(2004-9#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-9#3)(2008-1#3)(2008-10#5)(2008-6#1)(2008-8#2)(2009-8#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
study highlighted##3##2##(2008-1#1)(2011-2#2)
study highlights that##2##3##(2007-7#1)(2011-2#1)
study highlights the importance of##6##5##(2007-10#1)(2007-2#1)(2008-10#2)(2008-5#1)(2010-8#1)
study highlights the potential##3##4##(1994-6#1)(2013-1#2)
study highlights the##16##3##(1994-6#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#4)
study highlights##24##2##(1994-6#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-1#1)(2013-1#6)(2013-8#1)
study hospitals##2##2##(1991-3#1)(1996-3#1)
study how the##2##3##(2008-5#1)(2008-8#1)
study how##14##2##(1994-11#1)(1995-11#1)(1996-11#1)(2007-12#1)(2008-10#2)(2008-5#2)(2008-8#2)(2010-4#1)(2010-8#1)(2013-1#2)
study human##6##2##(1992-6#1)(1995-10#1)(1996-5#1)(2006-12#1)(2008-10#1)(2011-2#1)
study hypothesis##4##2##(2008-8#1)(2011-1#1)(2011-2#2)
study hypothesized that##2##3##(2006-11#1)(2009-11#1)
study identified a number of##3##5##(2007-9#1)(2008-9#1)(2011-1#1)
study identified a##6##3##(2006-2#1)(2007-9#1)(2008-9#1)(2009-4#1)(2011-1#1)(2011-2#1)
study identified that##3##3##(2008-1#1)(2009-4#1)(2012-2#1)
study identified the##6##3##(2006-12#1)(2007-3#1)(2007-8#1)(2012-12#1)(2013-1#2)
study identified##25##2##(2004-12#1)(2005-5#1)(2006-12#1)(2006-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-4#2)(2010-2#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#3)(2013-1#2)
study identifies##10##2##(1990-12#1)(1996-1#1)(1997-2#1)(2007-11#1)(2008-12#1)(2008-4#1)(2009-12#1)(2009-2#1)(2012-2#1)(2013-8#1)
study identify##2##2##(1993-2#1)(2011-2#1)
study if##2##2##(1992-8#1)(2007-2#1)
study illustrates a##2##3##(2008-7#1)(2013-1#1)
study illustrates how##2##3##(2007-4#1)(2010-3#1)
study illustrates that##3##3##(2006-8#1)(2008-9#1)(2010-2#1)
study illustrates the##3##3##(1996-12#1)(2008-1#1)(2013-1#1)
study illustrates##10##2##(1996-12#1)(2006-8#1)(2007-4#1)(2008-1#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-3#1)(2013-1#2)
study implies that##3##3##(1995-2#1)(2007-12#1)(2007-8#1)
study implies##4##2##(1995-2#1)(2005-11#1)(2007-12#1)(2007-8#1)
study in 20##2##3##(1991-11#1)(1992-8#1)
study in 3##2##3##(1991-11#1)(1993-11#1)
study in 31##2##3##(1990-9#1)(2008-5#1)
study in India##2##3##(2011-12#1)(2013-1#1)
study in Korea##2##3##(2009-8#1)(2010-6#1)
study in Okinawa##2##3##(2008-10#1)(2009-7#1)
study in Sweden##2##3##(1997-7#1)(2013-8#1)
study in a tertiary care hospital##2##6##(2008-7#1)(2012-2#1)
study in a##24##3##(1990-11#1)(1993-5#1)(1996-7#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-12#1)(2008-7#3)(2010-4#1)(2010-9#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
study in an##4##3##(1992-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
study in breast cancer##2##4##(1990-10#1)(2013-1#1)
study in children with##2##4##(2007-11#1)(2011-2#1)
study in children##4##3##(2007-11#1)(2007-9#1)(2009-8#1)(2011-2#1)
study in combination with##2##4##(1991-6#1)(2007-8#1)
study in community##2##3##(1995-12#1)(2010-3#1)
study in comparison with##2##4##(2006-10#1)(2011-2#1)
study in detail the##3##4##(1991-3#1)(2008-2#1)(2008-3#1)
study in dogs##2##3##(1994-7#1)(2009-4#1)
study in healthy volunteers##2##4##(1997-6#1)(2008-8#1)
study in healthy##4##3##(1997-6#1)(2008-5#1)(2008-6#1)(2008-8#1)
study in labour##2##3##(1993-4#2)
study in order to##7##4##(1990-4#1)(1994-10#1)(2005-8#1)(2007-8#1)(2010-11#1)(2010-12#1)(2011-2#1)
study in our##4##3##(1992-10#1)(2006-6#1)(2008-10#1)(2013-1#1)
study in patients with chronic hepatitis C##2##7##(2007-11#2)
study in patients with##7##4##(1997-8#1)(2007-11#2)(2007-9#1)(2008-7#1)(2010-12#1)(2012-2#1)
study in patients##10##3##(1992-2#1)(1997-8#1)(2007-11#2)(2007-9#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
study in rats##5##3##(2008-5#2)(2008-7#1)(2009-4#1)(2011-2#1)
study in rural##4##3##(2004-8#1)(2008-12#1)(2008-3#1)(2010-12#1)
study in situ##2##3##(2007-12#1)(2008-8#1)
study in taiwan##2##3##(2010-8#1)(2012-1#1)
study in terms of##2##4##(2008-10#1)(2008-3#1)
study in the diagnosis of##4##5##(1991-4#1)(2007-8#1)(2008-7#2)
study in the rat##10##4##(1990-7#2)(1992-8#1)(1993-12#1)(1995-12#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)
study in the##41##3##(1990-6#1)(1990-7#2)(1991-12#1)(1991-4#2)(1992-8#1)(1993-12#1)(1993-7#1)(1995-11#1)(1995-12#2)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(2005-7#1)(2006-5#1)(2006-6#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-10#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-7#1)
study in this area##2##4##(2008-5#1)(2013-8#1)
study in this##5##3##(1996-4#1)(2008-3#1)(2008-5#1)(2008-6#1)(2013-8#1)
study in three##5##3##(1995-3#1)(2007-7#1)(2008-10#1)(2008-9#1)(2011-2#1)
study in two hospitals##2##4##(2010-4#1)(2013-8#1)
study in two##7##3##(1996-6#1)(2006-4#1)(2008-11#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-8#1)
study in urban##2##3##(2005-9#1)(2013-8#1)
study in which patients##2##4##(1993-2#1)(2008-11#1)
study in which the##3##4##(1994-11#1)(2008-7#1)(2008-9#1)
study in which we##4##4##(2008-6#1)(2008-7#1)(2010-11#1)(2010-9#1)
study in which##23##3##(1993-2#1)(1994-11#1)(1996-2#1)(1996-8#1)(1997-4#1)(2006-10#2)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2010-10#2)(2010-11#1)(2010-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
study in##374##2##(1990-10#1)(1990-11#3)(1990-4#1)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#4)(1991-11#4)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#3)(1991-6#5)(1991-8#1)(1992-10#1)(1992-2#2)(1992-4#1)(1992-5#2)(1992-8#2)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#4)(1993-2#1)(1993-4#2)(1993-5#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#3)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#3)(1996-6#4)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#4)(2004-8#1)(2005-4#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#8)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#2)(2006-6#4)(2006-8#2)(2007-11#7)(2007-12#5)(2007-2#5)(2007-3#3)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#5)(2007-9#4)(2008-1#2)(2008-10#14)(2008-11#6)(2008-12#5)(2008-2#3)(2008-3#6)(2008-4#3)(2008-5#15)(2008-6#5)(2008-7#14)(2008-8#4)(2008-9#9)(2009-10#1)(2009-2#1)(2009-4#2)(2009-7#2)(2009-8#3)(2010-1#1)(2010-10#4)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#2)(2010-9#4)(2011-1#3)(2011-12#3)(2011-2#18)(2012-1#6)(2012-11#1)(2012-12#7)(2012-2#9)(2012-3#7)(2013-1#20)(2013-7#3)(2013-8#12)
study include##10##2##(2007-12#1)(2007-4#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#2)(2012-3#1)(2013-1#2)
study included 1##2##3##(1991-6#1)(2011-2#1)
study included 100 patients##3##4##(2006-8#1)(2008-11#1)(2013-1#1)
study included 100##5##3##(1993-11#1)(2006-8#1)(2008-11#1)(2013-1#2)
study included 20##3##3##(2005-10#1)(2007-10#1)(2013-8#1)
study included 30##2##3##(2006-5#1)(2013-8#1)
study included 82 patients##2##4##(2007-10#1)(2013-1#1)
study included a##4##3##(1991-1#1)(2007-10#1)(2008-6#1)(2013-1#1)
study included all##2##3##(2007-8#1)(2008-8#1)
study included patients with##2##4##(2006-6#1)(2012-2#1)
study included patients##3##3##(2006-6#1)(2011-2#1)(2012-2#1)
study included the##2##3##(1993-1#1)(2010-4#1)
study included two##2##3##(1996-1#1)(2006-8#1)
study included##91##2##(1990-2#2)(1991-1#1)(1991-6#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-8#1)(1994-1#1)(1994-6#1)(1996-1#2)(1997-2#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#2)(2006-8#2)(2007-10#4)(2007-11#4)(2007-4#1)(2007-7#3)(2007-8#3)(2008-10#2)(2008-11#4)(2008-12#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#3)(2010-4#1)(2011-1#4)(2011-2#6)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#2)
study includes results##2##3##(2007-4#1)(2008-3#1)
study includes the##3##3##(2005-11#1)(2008-10#1)(2009-2#1)
study includes##23##2##(1997-8#1)(2004-2#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-4#2)(2007-9#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-7#1)(2009-2#1)(2011-2#2)
study including the##2##3##(2007-10#1)(2007-8#1)
study including##9##2##(1990-8#1)(1993-8#1)(1997-6#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-10#1)
study indicate that a##2##4##(2007-2#1)(2008-4#1)
study indicate that the##9##4##(1996-3#1)(1996-4#1)(2006-6#1)(2007-7#1)(2008-10#2)(2008-12#1)(2009-7#1)(2010-2#1)
study indicate that##58##3##(1990-4#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-11#1)(1992-5#1)(1992-8#1)(1993-4#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-8#1)(2005-8#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#3)(2008-10#6)(2008-12#2)(2008-4#1)(2008-6#2)(2009-2#1)(2009-7#1)(2009-9#1)(2010-2#2)(2010-4#1)(2010-5#2)(2011-1#2)(2011-12#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
study indicate the##4##3##(2007-8#1)(2008-11#1)(2008-12#2)
study indicate##67##2##(1990-4#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-11#1)(1992-5#1)(1992-8#1)(1993-4#2)(1994-8#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-8#1)(2005-8#1)(2006-1#1)(2006-11#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-10#6)(2008-11#1)(2008-12#4)(2008-4#1)(2008-6#2)(2009-2#1)(2009-7#1)(2009-9#1)(2010-2#2)(2010-4#1)(2010-5#2)(2011-1#2)(2011-12#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
study indicated a##2##3##(1995-2#1)(2011-2#1)
study indicated some##2##3##(2007-2#1)(2008-10#1)
study indicated that in##2##4##(1993-12#1)(2008-9#1)
study indicated that the##14##4##(1994-3#1)(2007-10#1)(2007-4#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-6#2)(2008-9#2)(2010-12#1)(2012-12#1)
study indicated that##37##3##(1991-8#1)(1992-8#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-3#1)(2004-4#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#3)(2008-6#2)(2008-9#3)(2009-4#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
study indicated the##2##3##(1992-8#1)(2008-10#1)
study indicated##46##2##(1991-8#1)(1992-8#2)(1993-12#1)(1993-5#1)(1993-8#1)(1994-3#1)(1995-2#1)(2004-4#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#4)(2008-6#2)(2008-9#4)(2009-4#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)
study indicates a##4##3##(1991-7#1)(2007-1#1)(2008-9#1)(2013-8#1)
study indicates that an##2##4##(1994-2#1)(2011-2#1)
study indicates that the##15##4##(1991-7#1)(1994-2#1)(1994-5#1)(1996-12#1)(2006-8#1)(2007-9#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-2#1)(2011-2#1)(2013-1#2)
study indicates that##63##3##(1990-10#1)(1991-4#1)(1991-7#1)(1992-4#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#3)(1994-4#1)(1994-5#1)(1996-12#1)(1996-2#1)(1996-6#3)(1996-9#2)(2004-11#1)(2005-10#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-2#2)(2013-1#4)(2013-8#2)
study indicates the need for##3##5##(1995-2#1)(2007-3#1)(2011-1#1)
study indicates the##7##3##(1990-2#1)(1994-2#1)(1995-11#1)(1995-2#1)(1996-11#1)(2007-3#1)(2011-1#1)
study indicates##82##2##(1990-10#1)(1990-2#1)(1991-4#1)(1991-7#2)(1992-4#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#4)(1994-4#1)(1994-5#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#3)(1996-9#2)(2004-11#1)(2005-10#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-8#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#3)
study indicating##3##2##(2007-11#1)(2007-6#1)(2008-10#1)
study intended to##3##3##(2008-7#1)(2011-2#1)(2013-8#1)
study intended##4##2##(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
study interviewed##2##2##(2011-1#1)(2012-1#1)
study into the##8##3##(1994-11#1)(2006-6#2)(2007-10#1)(2007-6#1)(2008-10#1)(2008-5#1)(2009-8#1)
study into##9##2##(1994-11#1)(2006-6#2)(2007-10#2)(2007-6#1)(2008-10#1)(2008-5#1)(2009-8#1)
study investigated differences in##2##4##(2006-12#1)(2010-3#1)
study investigated how##3##3##(2007-4#1)(2010-2#1)(2010-4#1)
study investigated the association##2##4##(2007-8#1)(2011-1#1)
study investigated the effect of##8##5##(1993-12#1)(2008-12#1)(2008-4#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
study investigated the effects of##12##5##(1991-9#2)(2005-10#1)(2005-12#1)(2006-12#1)(2007-12#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
study investigated the functional##2##4##(2011-2#2)
study investigated the impact of##2##5##(2011-2#1)(2012-12#1)
study investigated the influence##4##4##(1994-12#1)(2008-11#1)(2009-7#1)(2010-2#1)
study investigated the possible##4##4##(1994-11#1)(1995-12#1)(2011-2#1)(2012-3#1)
study investigated the protective effect of##2##6##(2008-10#1)(2013-1#1)
study investigated the relationship between##5##5##(2006-10#1)(2007-12#1)(2008-7#1)(2009-11#1)(2010-10#1)
study investigated the relationship##7##4##(2006-10#1)(2006-7#1)(2007-12#1)(2008-7#1)(2009-11#1)(2010-10#1)(2011-1#1)
study investigated the relationships##2##4##(1996-2#1)(2010-3#1)
study investigated the role of##4##5##(2006-2#1)(2008-12#1)(2008-4#1)(2013-8#1)
study investigated the use of##3##5##(1992-1#1)(1997-1#1)(2010-8#1)
study investigated the##100##3##(1991-9#2)(1992-1#1)(1993-12#2)(1993-2#2)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-12#2)(1995-2#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-4#2)(1997-5#1)(2004-9#1)(2005-10#1)(2005-12#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#3)(2008-9#3)(2009-11#1)(2009-7#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-10#1)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#3)
study investigated whether the##2##4##(2008-6#1)(2009-7#1)
study investigated whether##14##3##(1994-2#1)(1994-6#1)(1994-8#1)(2007-12#1)(2008-6#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-7#1)(2011-2#1)(2012-1#2)(2012-2#1)
study investigated##154##2##(1990-11#1)(1990-7#1)(1991-2#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-7#1)(1993-12#2)(1993-2#2)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#2)(1994-8#1)(1995-12#2)(1995-2#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-1#1)(1997-4#2)(1997-5#1)(2004-9#2)(2005-10#1)(2005-12#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-7#1)(2007-10#2)(2007-12#6)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-10#3)(2008-11#5)(2008-12#4)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#4)(2008-7#5)(2008-9#5)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#3)(2010-4#1)(2010-8#4)(2010-9#1)(2011-1#5)(2011-10#1)(2011-2#12)(2012-1#4)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#5)
study investigates the##36##3##(1990-2#1)(1991-12#1)(1992-10#1)(1992-3#1)(1995-1#1)(1995-10#1)(1995-5#1)(1996-12#1)(1996-5#2)(2004-9#1)(2006-1#1)(2007-10#2)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
study investigates whether##4##3##(1995-11#1)(1995-12#1)(2011-2#1)(2013-1#1)
study investigates##56##2##(1990-2#1)(1991-12#1)(1992-10#1)(1992-3#1)(1993-12#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-5#2)(2004-9#1)(2006-1#1)(2007-10#2)(2007-12#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#2)
study investigating the effects of a##2##6##(2009-6#1)(2010-7#1)
study investigating the##4##3##(2007-11#1)(2008-11#1)(2009-6#1)(2010-7#1)
study investigating##6##2##(2007-11#1)(2008-11#1)(2009-6#1)(2009-7#1)(2010-7#1)(2011-2#1)
study involved a##7##3##(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
study involved the##4##3##(2007-12#1)(2008-11#1)(2012-2#1)(2013-1#1)
study involved##36##2##(1991-9#1)(1995-1#1)(1995-4#1)(1996-1#1)(1996-9#1)(1997-4#1)(2005-11#1)(2006-7#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#2)(2009-10#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-4#1)(2013-1#3)
study involves the##4##3##(1997-2#1)(2006-5#1)(2009-10#1)(2011-3#1)
study involves##8##2##(1997-2#1)(2006-5#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-3#1)(2012-12#1)
study involving 26##2##3##(1993-12#1)(2011-2#1)
study involving a larger##2##4##(2004-2#1)(2008-10#1)
study involving a##3##3##(1991-2#1)(2004-2#1)(2008-10#1)
study involving##31##2##(1990-11#1)(1991-2#1)(1991-5#1)(1992-11#1)(1993-12#1)(1994-2#1)(1996-4#1)(1997-8#1)(2004-2#1)(2005-7#1)(2006-10#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-6#1)(2010-12#1)(2011-1#1)(2011-11#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#4)(2013-7#1)
study is a descriptive##2##4##(2010-4#1)(2010-8#1)
study is a retrospective analysis of##3##6##(2007-8#3)
study is a retrospective##7##4##(2007-2#1)(2007-8#3)(2008-4#1)(2008-7#1)(2011-2#1)
study is a review##2##4##(2007-7#1)(2007-9#1)
study is a##30##3##(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
study is about##2##3##(2008-7#1)(2012-1#1)
study is aimed at##5##4##(2005-10#1)(2007-1#1)(2007-9#1)(2009-1#1)(2012-3#1)
study is aimed to##2##4##(2007-8#1)(2010-7#1)
study is aimed##7##3##(2005-10#1)(2007-1#1)(2007-8#1)(2007-9#1)(2009-1#1)(2010-7#1)(2012-3#1)
study is an analysis of##2##5##(1990-8#1)(2007-2#1)
study is an attempt##2##4##(2007-11#1)(2007-8#1)
study is an extension of##3##5##(1993-9#1)(2008-10#1)(2008-2#1)
study is an##18##3##(1990-7#1)(1990-8#1)(1993-3#1)(1993-9#1)(1997-3#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
study is available##2##3##(1992-6#1)(2008-1#1)
study is based on the##5##5##(2008-2#1)(2008-7#1)(2010-12#1)(2012-2#2)
study is based on##20##4##(1991-12#1)(1995-11#1)(1997-3#1)(2006-4#1)(2006-8#1)(2008-12#1)(2008-2#2)(2008-7#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-11#1)(2012-2#2)
study is being conducted##3##4##(1995-9#1)(2008-5#1)(2010-8#1)
study is believed to##2##4##(2005-11#2)
study is carried out to##2##5##(2008-12#1)(2008-2#1)
study is centered##2##3##(1996-1#1)(2012-12#1)
study is concerned with##3##4##(1994-3#1)(1997-5#1)(2008-10#1)
study is conducted##8##3##(1992-2#1)(1994-6#1)(2008-3#2)(2008-9#1)(2010-2#1)(2010-8#1)(2013-1#1)
study is critical to##2##4##(2011-2#1)(2012-3#1)
study is currently##2##3##(2008-4#1)(2008-7#1)
study is described##4##3##(2005-8#1)(2006-7#1)(2007-4#1)(2010-2#1)
study is expected to##2##4##(2006-6#1)(2011-2#1)
study is focused on the##3##5##(1994-5#1)(2006-11#1)(2012-11#1)
study is focused on##7##4##(1994-5#1)(2006-11#1)(2008-11#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-11#1)
study is focused##8##3##(1994-5#1)(2006-11#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-11#1)
study is important in##2##4##(2007-2#1)(2010-12#1)
study is important##5##3##(1995-3#1)(2007-2#1)(2008-1#1)(2010-12#1)(2012-12#1)
study is intended to##2##4##(2006-10#1)(2013-1#1)
study is limited by##2##4##(1991-3#1)(2008-12#1)
study is made##3##3##(2005-11#1)(2008-10#2)
study is necessary##2##3##(2005-3#1)(2009-8#1)
study is needed to determine the##2##6##(1996-12#1)(2007-12#1)
study is needed to determine##3##5##(1996-12#1)(2007-12#1)(2009-2#1)
study is needed to##7##4##(1996-12#1)(2007-12#1)(2007-8#1)(2008-9#1)(2009-2#1)(2010-10#1)(2012-3#1)
study is needed##11##3##(1996-12#1)(2006-9#1)(2007-12#2)(2007-8#1)(2008-2#1)(2008-9#1)(2009-2#1)(2010-10#1)(2012-3#1)(2013-1#1)
study is not##2##3##(1990-9#1)(2007-10#1)
study is of##2##3##(2009-11#1)(2009-3#1)
study is on the##2##4##(2008-8#1)(2010-10#1)
study is one of the##2##5##(2012-3#1)(2013-7#1)
study is ongoing##3##3##(1991-10#1)(2006-6#1)(2012-2#1)
study is part of a##2##5##(1992-1#1)(2008-10#1)
study is part of##4##4##(1992-1#1)(2008-10#1)(2008-7#1)(2010-4#1)
study is performed##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
study is presented of##2##4##(1997-5#1)(2008-2#1)
study is presented to##2##4##(1990-8#1)(2007-4#1)
study is presented##6##3##(1990-4#1)(1990-8#1)(1997-5#1)(2007-4#1)(2008-10#1)(2008-2#1)
study is reported##2##3##(1990-8#1)(2010-12#1)
study is required to##5##4##(1992-12#1)(2006-10#1)(2007-11#1)(2008-1#1)(2011-2#1)
study is required##6##3##(1992-12#1)(2006-10#1)(2007-11#1)(2008-1#1)(2011-2#2)
study is still needed##3##4##(2006-10#1)(2007-4#1)(2007-9#1)
study is still##6##3##(2006-10#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-8#1)
study is suggested##2##3##(2007-10#1)(2008-10#1)
study is that##12##3##(1995-11#1)(1997-8#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-6#1)(2010-12#1)(2013-1#1)(2013-8#3)
study is the first attempt##2##5##(2010-2#1)(2013-8#1)
study is the first to demonstrate that##2##7##(1997-7#1)(2009-12#1)
study is the first to demonstrate##3##6##(1994-11#1)(1997-7#1)(2009-12#1)
study is the first to show##2##6##(2011-2#1)(2013-3#1)
study is the first to##11##5##(1993-1#1)(1994-11#1)(1997-7#1)(2008-11#1)(2008-6#1)(2009-12#2)(2010-11#1)(2010-4#1)(2011-2#1)(2013-3#1)
study is the first##20##4##(1993-1#1)(1994-11#1)(1997-3#1)(1997-7#2)(2007-4#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-12#2)(2010-11#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-3#1)(2013-8#2)
study is the##39##3##(1991-11#1)(1993-1#1)(1994-11#1)(1994-6#1)(1997-3#1)(1997-7#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2009-12#2)(2009-2#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-5#1)(2013-3#1)(2013-8#2)
study is to analyze the##4##5##(1996-3#1)(2007-8#1)(2011-7#1)(2013-1#1)
study is to analyze##7##4##(1996-3#1)(2007-8#1)(2008-4#1)(2008-9#1)(2009-2#1)(2011-7#1)(2013-1#1)
study is to assess the##15##5##(1993-7#1)(2005-10#1)(2006-1#1)(2006-2#1)(2007-2#1)(2007-9#1)(2008-11#2)(2008-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)
study is to assess##19##4##(1993-7#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)
study is to characterize the##2##5##(2006-6#1)(2011-2#1)
study is to clarify##3##4##(2008-4#1)(2008-5#1)(2011-2#1)
study is to compare efficiency and safety of##2##8##(2012-3#2)
study is to compare the##5##5##(2007-7#1)(2007-8#1)(2010-5#1)(2011-2#1)(2012-12#1)
study is to compare##10##4##(2007-7#3)(2007-8#1)(2008-10#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#2)
study is to describe the##11##5##(1993-1#1)(1995-4#1)(2006-7#2)(2006-8#1)(2007-8#1)(2009-5#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
study is to describe##13##4##(1993-1#1)(1995-4#1)(2006-7#2)(2006-8#1)(2007-3#1)(2007-8#1)(2008-11#1)(2009-5#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
study is to determine the##6##5##(2008-11#1)(2011-12#1)(2011-2#1)(2013-1#2)(2013-7#1)
study is to determine whether the##2##6##(1993-9#1)(2008-12#1)
study is to determine whether##6##5##(1993-9#1)(2004-2#1)(2008-12#1)(2008-5#1)(2011-2#1)(2013-1#1)
study is to determine##17##4##(1993-9#1)(2004-2#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-9#1)(2011-12#1)(2011-2#3)(2013-1#3)(2013-7#1)(2013-8#1)
study is to discover##2##4##(2012-1#1)(2012-3#1)
study is to discuss the##3##5##(2008-12#1)(2008-7#1)(2013-8#1)
study is to discuss##4##4##(2008-12#1)(2008-7#1)(2011-2#1)(2013-8#1)
study is to elucidate the##2##5##(2006-10#1)(2007-9#1)
study is to elucidate##4##4##(1991-12#1)(2006-10#1)(2007-9#1)(2010-5#1)
study is to establish a##2##5##(2007-10#1)(2007-4#1)
study is to establish##6##4##(1992-10#1)(2007-10#1)(2007-4#1)(2007-8#1)(2008-3#1)(2013-1#1)
study is to evaluate the##28##5##(1991-4#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#1)(2009-2#1)(2010-8#3)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#1)
study is to evaluate whether##4##5##(2006-11#1)(2007-7#1)(2008-4#1)(2011-2#1)
study is to evaluate##41##4##(1991-4#1)(2006-11#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-8#3)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#2)(2013-1#2)
study is to examine the relationship between##3##7##(2013-1#2)(2013-8#1)
study is to examine the##5##5##(2007-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
study is to examine whether##4##5##(1994-2#1)(2008-11#1)(2011-1#1)(2012-1#1)
study is to examine##13##4##(1994-2#1)(2006-9#1)(2007-9#1)(2008-10#1)(2008-11#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#2)
study is to explore the##5##5##(2008-11#1)(2010-10#1)(2011-2#1)(2011-3#1)(2012-12#1)
study is to explore##7##4##(2008-11#1)(2010-10#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-12#1)
study is to highlight the##2##5##(2008-4#1)(2011-2#1)
study is to highlight##3##4##(2008-4#1)(2011-2#2)
study is to identify##8##4##(2005-12#1)(2007-12#2)(2008-12#1)(2010-2#1)(2012-3#1)(2013-8#2)
study is to illustrate##2##4##(2008-7#1)(2013-1#1)
study is to investigate the effect of##2##7##(2007-1#1)(2011-3#1)
study is to investigate the effects##2##6##(2008-10#1)(2011-3#1)
study is to investigate the##15##5##(2007-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-3#2)(2012-2#1)(2012-3#1)(2013-1#2)
study is to investigate##21##4##(1995-12#1)(2007-1#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-1#1)(2010-12#1)(2010-8#2)(2011-3#2)(2012-2#1)(2012-3#2)(2013-1#2)
study is to observe the##3##5##(2007-7#1)(2008-12#1)(2011-3#1)
study is to prepare##2##4##(2011-3#1)(2012-3#1)
study is to present the##2##5##(1997-3#1)(2013-7#1)
study is to present##9##4##(1992-10#1)(1996-1#1)(1997-3#1)(2007-8#1)(2008-10#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-7#1)
study is to propose a##3##5##(2006-6#1)(2011-2#1)(2012-1#1)
study is to propose##4##4##(2006-6#1)(2010-8#1)(2011-2#1)(2012-1#1)
study is to provide##6##4##(2007-4#1)(2008-6#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-7#1)
study is to report##5##4##(1996-12#1)(2008-7#1)(2012-12#2)(2013-1#1)
study is to review##5##4##(2007-12#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)
study is to see##2##4##(2006-10#1)(2007-8#1)
study is to show##3##4##(2008-10#1)(2011-2#1)(2012-12#1)
study is to test the##3##5##(2008-1#1)(2009-3#1)(2012-12#1)
study is to validate##2##4##(2007-8#1)(2013-1#1)
study is to verify##2##4##(2006-8#1)(2012-2#1)
study is to##272##3##(1991-12#1)(1991-4#1)(1992-10#2)(1992-12#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-2#1)(1995-12#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-3#1)(2004-2#1)(2005-10#1)(2005-12#1)(2006-1#1)(2006-10#4)(2006-11#2)(2006-2#1)(2006-6#3)(2006-7#2)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#4)(2007-6#1)(2007-7#10)(2007-8#13)(2007-9#5)(2008-1#6)(2008-10#12)(2008-11#7)(2008-12#4)(2008-3#3)(2008-4#5)(2008-5#6)(2008-6#3)(2008-7#8)(2008-8#1)(2008-9#5)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#3)(2010-7#1)(2010-8#7)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#24)(2011-3#5)(2011-7#1)(2012-1#6)(2012-12#10)(2012-2#8)(2012-3#11)(2013-1#17)(2013-7#3)(2013-8#9)
study is used to demonstrate##2##5##(2008-6#1)(2008-9#1)
study is warranted to##3##4##(2005-8#1)(2007-7#1)(2007-9#1)
study is warranted##4##3##(2005-8#1)(2007-11#1)(2007-7#1)(2007-9#1)
study is##589##2##(1990-2#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#2)(1992-1#1)(1992-10#2)(1992-12#2)(1992-2#2)(1992-6#1)(1992-7#1)(1993-1#2)(1993-12#1)(1993-3#2)(1993-7#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#3)(1995-11#2)(1995-12#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-12#2)(1996-3#1)(1996-6#1)(1996-8#1)(1997-3#4)(1997-5#2)(1997-7#2)(1997-8#1)(2004-2#1)(2005-10#2)(2005-11#3)(2005-12#1)(2005-3#1)(2005-8#2)(2006-1#2)(2006-10#8)(2006-11#4)(2006-2#2)(2006-4#1)(2006-6#6)(2006-7#3)(2006-8#7)(2006-9#3)(2007-1#4)(2007-10#8)(2007-11#10)(2007-12#7)(2007-2#5)(2007-3#1)(2007-4#10)(2007-5#1)(2007-6#1)(2007-7#14)(2007-8#21)(2007-9#9)(2008-1#10)(2008-10#30)(2008-11#12)(2008-12#11)(2008-2#9)(2008-3#13)(2008-4#7)(2008-5#14)(2008-6#6)(2008-7#14)(2008-8#6)(2008-9#10)(2009-1#1)(2009-10#1)(2009-11#3)(2009-12#3)(2009-2#4)(2009-3#2)(2009-5#1)(2009-6#3)(2009-7#4)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#4)(2010-11#1)(2010-12#7)(2010-2#6)(2010-3#3)(2010-4#3)(2010-5#5)(2010-6#2)(2010-7#2)(2010-8#14)(2010-9#3)(2011-1#10)(2011-12#1)(2011-2#36)(2011-3#6)(2011-7#1)(2012-1#8)(2012-11#2)(2012-12#14)(2012-2#17)(2012-3#19)(2012-5#1)(2013-1#27)(2013-3#1)(2013-7#5)(2013-8#17)
study it is concluded that##2##5##(2008-11#1)(2008-6#1)
study it is##4##3##(1990-12#1)(2008-11#1)(2008-2#1)(2008-6#1)
study it was found that##4##5##(1992-4#1)(2008-2#1)(2008-5#1)(2012-2#1)
study it was##10##3##(1992-4#1)(1994-11#1)(1996-12#1)(1997-1#1)(2006-5#1)(2008-2#1)(2008-5#1)(2011-12#2)(2012-2#1)
study it##18##2##(1990-12#1)(1992-4#1)(1992-6#1)(1994-11#1)(1996-12#1)(1997-1#1)(2006-5#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#1)(2011-12#2)(2012-2#2)(2013-8#1)
study its performance##3##3##(1994-9#1)(2008-6#1)(2012-3#1)
study its##21##2##(1991-8#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-6#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-2#2)(2010-3#1)(2012-12#2)(2012-3#1)(2013-7#1)(2013-8#1)
study kinetic##2##2##(2008-10#1)(2009-9#1)
study led to##3##3##(1995-1#1)(1996-5#1)(2011-1#1)
study limitations were##2##3##(2007-12#1)(2007-2#1)
study limitations##3##2##(2007-11#1)(2007-12#1)(2007-2#1)
study looked at the##2##4##(2004-10#1)(2008-8#1)
study looked at##4##3##(2004-10#1)(2007-12#1)(2008-8#1)(2010-2#1)
study looked##5##2##(2004-10#1)(2007-12#1)(2008-8#1)(2010-2#1)(2011-2#1)
study looking at##2##3##(2007-1#1)(2007-8#1)
study looking##3##2##(2006-10#1)(2007-1#1)(2007-8#1)
study made##4##2##(1990-3#1)(2007-9#1)(2008-10#1)(2013-1#1)
study may be used to##2##5##(2007-10#1)(2013-1#1)
study may be used##3##4##(2007-10#1)(2008-10#1)(2013-1#1)
study may be##11##3##(1996-2#1)(2007-10#1)(2007-4#1)(2008-10#2)(2008-2#1)(2010-9#1)(2011-12#1)(2012-1#1)(2012-12#1)(2013-1#1)
study may provide##2##3##(1997-4#1)(2013-1#1)
study may serve as a##2##5##(1996-5#1)(2012-12#1)
study may##28##2##(1990-2#1)(1994-2#1)(1994-5#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(2005-4#1)(2007-10#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-7#1)(2010-12#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
study measured the effect of##2##5##(1995-1#1)(2008-12#1)
study measured the##3##3##(1995-1#1)(1996-2#1)(2008-12#1)
study measured##9##2##(1995-1#1)(1995-5#1)(1996-2#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-5#1)(2012-6#1)(2013-1#1)
study measures##2##2##(2009-9#1)(2013-1#1)
study measuring##2##2##(2007-10#1)(2013-8#1)
study mechanisms involved in##2##4##(2008-1#1)(2008-7#1)
study mechanisms of##7##3##(1992-11#1)(1996-10#1)(2008-10#1)(2008-4#1)(2008-6#1)(2013-1#2)
study mechanisms##10##2##(1991-11#1)(1992-11#1)(1996-10#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2013-1#2)
study medication was##2##3##(2008-7#1)(2011-2#1)
study medication##5##2##(1996-2#1)(2007-8#1)(2008-7#1)(2011-2#1)(2012-12#1)
study methodology##5##2##(2005-8#1)(2008-12#1)(2009-8#1)(2009-9#1)(2012-1#1)
study methods for##2##3##(1996-9#1)(2008-6#1)
study methods##3##2##(1992-5#1)(1996-9#1)(2008-6#1)
study might##2##2##(2007-12#1)(2008-10#1)
study model##2##2##(2008-10#1)(2010-5#1)
study monitored the##2##3##(1997-4#1)(2007-5#1)
study monitored##3##2##(1994-11#1)(1997-4#1)(2007-5#1)
study more than##2##3##(1997-3#1)(2012-2#1)
study more##3##2##(1997-3#1)(2008-2#1)(2012-2#1)
study natural##2##2##(2008-8#1)(2010-5#1)
study no##5##2##(1992-12#1)(2007-2#1)(2008-6#1)(2008-7#1)(2009-6#1)
study not only##2##3##(2007-10#1)(2012-3#1)
study numerically##3##2##(2007-12#1)(2008-2#1)(2013-8#1)
study nurse##3##2##(2007-2#3)
study objective was to determine##2##5##(2008-5#1)(2009-5#1)
study objective was to##3##4##(2008-5#1)(2009-5#1)(2010-2#1)
study objective was##4##3##(2007-11#1)(2008-5#1)(2009-5#1)(2010-2#1)
study objective##5##2##(2007-11#1)(2008-5#1)(2009-5#1)(2010-10#1)(2010-2#1)
study of &quot##2##3##(1990-8#1)(2006-12#1)
study of 1##4##3##(1990-2#1)(1993-5#1)(1993-6#1)(1997-3#1)
study of 10 cases##2##4##(1992-4#1)(2008-1#1)
study of 10##9##3##(1992-4#1)(1993-2#1)(1994-3#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-7#1)(2011-1#1)
study of 100##2##3##(2007-9#1)(2009-5#1)
study of 106##2##3##(1996-12#1)(2007-8#1)
study of 107##4##3##(2006-2#1)(2007-7#1)(2007-9#1)(2012-12#1)
study of 12##3##3##(2006-10#1)(2012-1#2)
study of 120 cases##2##4##(2007-8#2)
study of 13##3##3##(1991-5#1)(2006-10#1)(2010-5#1)
study of 150 patients##2##4##(1992-11#1)(2007-8#1)
study of 152##2##3##(1991-7#1)(2009-5#1)
study of 159 patients##2##4##(2007-11#1)(2013-8#1)
study of 16##4##3##(1990-5#1)(2008-12#1)(2013-1#2)
study of 19##3##3##(1990-5#1)(1997-2#1)(2008-9#1)
study of 2##3##3##(1992-6#1)(1993-11#1)(1993-6#1)
study of 20##5##3##(1990-4#1)(1991-9#1)(2006-12#1)(2006-9#1)(2010-7#1)
study of 200##3##3##(2007-8#1)(2008-4#1)(2008-8#1)
study of 211##2##3##(2007-7#2)
study of 24##2##3##(2007-11#1)(2008-8#1)
study of 25 cases of##2##5##(2007-7#1)(2011-12#1)
study of 25##3##3##(2007-7#1)(2010-11#1)(2011-12#1)
study of 3##2##3##(1990-9#1)(2010-4#1)
study of 30##4##3##(1990-2#1)(2007-7#1)(2008-10#1)(2008-8#1)
study of 32 patients with##2##5##(1995-2#1)(2004-3#1)
study of 33 patients##2##4##(1995-4#1)(2012-12#1)
study of 36##4##3##(1994-6#1)(1995-5#1)(2007-11#2)
study of 38##3##3##(2008-4#1)(2008-7#1)(2011-2#1)
study of 4##2##3##(1991-5#1)(2013-1#1)
study of 40 patients##2##4##(2010-6#1)(2012-1#1)
study of 40##4##3##(1995-2#1)(2008-10#1)(2010-6#1)(2012-1#1)
study of 43##2##3##(1997-2#1)(2006-8#1)
study of 45##2##3##(1990-6#1)(2008-7#1)
study of 47##2##3##(2008-10#1)(2010-7#1)
study of 4771 patients##2##4##(2008-6#2)
study of 48##2##3##(1995-7#1)(2009-10#1)
study of 49##2##3##(1996-9#1)(2011-1#1)
study of 5 cases##2##4##(1991-4#1)(1991-8#1)
study of 5##3##3##(1991-4#1)(1991-8#1)(2009-10#1)
study of 52##3##3##(2007-12#1)(2007-8#1)(2008-6#1)
study of 55##3##3##(1990-10#1)(1990-3#1)(2007-10#1)
study of 6##2##3##(1990-6#1)(1995-6#1)
study of 60##5##3##(2007-8#2)(2011-12#1)(2011-2#1)(2012-2#1)
study of 61##3##3##(1992-3#1)(2007-3#1)(2007-8#1)
study of 7 patients with##2##5##(2007-11#1)(2012-12#1)
study of 70##2##3##(1990-2#1)(1996-3#1)
study of AG-3340##2##3##(2005-8#2)
study of B cell development##3##5##(2008-4#3)
study of Cd(II)##2##3##(2008-10#2)
study of DNA##2##3##(1996-7#1)(2008-8#1)
study of HIV##5##3##(1997-3#1)(2004-9#1)(2007-7#1)(2010-6#1)(2010-8#1)
study of HIV-infected##2##3##(1996-12#1)(1996-2#1)
study of Michigan##2##3##(1996-3#1)(2011-1#1)
study of Phoenix##2##3##(2010-8#2)
study of QTLs##2##3##(2008-9#2)
study of RNA##3##3##(1996-4#1)(1996-8#1)(2011-3#1)
study of S##2##3##(2005-9#1)(2008-9#1)
study of a group##2##4##(1991-7#1)(2012-2#1)
study of a new##5##4##(2008-2#2)(2008-4#1)(2010-12#1)(2010-5#1)
study of a patient##2##4##(2008-7#1)(2008-9#1)
study of a school-based##2##4##(2010-12#1)(2012-2#1)
study of a series of##6##5##(1994-9#1)(1996-7#1)(1996-9#1)(2004-9#1)(2007-11#1)(2008-3#1)
study of a young##2##4##(2011-2#1)(2012-3#1)
study of a##88##3##(1990-7#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-12#1)(1992-2#1)(1993-4#1)(1994-1#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-5#2)(1995-6#1)(1996-10#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-2#2)(2004-1#1)(2004-9#1)(2005-11#1)(2005-7#2)(2006-2#1)(2006-4#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2008-10#4)(2008-11#3)(2008-12#3)(2008-2#5)(2008-3#4)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#4)
study of acute##2##3##(1994-3#1)(2010-12#1)
study of adaptive radiations##2##4##(2008-8#2)
study of adolescent##4##3##(1994-5#1)(2006-9#1)(2009-9#1)(2010-10#1)
study of adolescents##2##3##(1993-1#1)(2006-3#1)
study of aging##2##3##(2008-3#1)(2009-12#1)
study of all cases of##3##5##(1997-2#1)(2006-2#1)(2011-2#1)
study of all patients##2##4##(1995-1#1)(2006-7#1)
study of all the##2##4##(2005-11#1)(2006-3#1)
study of all##16##3##(1995-1#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-7#1)(2007-12#1)(2007-7#1)(2008-1#1)(2009-2#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
study of an##19##3##(1990-5#1)(1991-1#1)(1994-2#1)(2006-7#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#1)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#3)
study of ancient##3##3##(2007-8#1)(2008-10#2)
study of antibodies##2##3##(2011-1#1)(2013-1#1)
study of antihypertensive##2##3##(2010-5#1)(2011-1#1)
study of antioxidants##2##3##(2008-10#1)(2008-4#1)
study of any##2##3##(2008-10#1)(2013-8#1)
study of apoptosis##2##3##(2008-9#1)(2013-1#1)
study of attitudes##2##3##(1995-12#1)(2006-8#1)
study of auditory##2##3##(2008-2#1)(2013-1#1)
study of bacterial##4##3##(2006-10#1)(2006-8#1)(2008-4#1)(2012-3#1)
study of beliefs##3##3##(1996-12#1)(2008-4#1)(2010-3#1)
study of biochemical##2##3##(2008-4#1)(2011-12#1)
study of biomolecular##2##3##(2006-10#1)(2008-9#1)
study of bipolar##2##3##(1996-3#1)(1997-5#1)
study of bladder##3##3##(1995-9#1)(2007-10#2)
study of body##2##3##(1990-5#1)(2007-12#1)
study of bone##7##3##(1992-5#1)(2004-9#1)(2007-8#1)(2008-6#1)(2009-9#1)(2012-2#1)(2012-3#1)
study of both##5##3##(1990-5#1)(1993-12#1)(1996-8#1)(2008-2#1)(2008-4#1)
study of cadmium##2##3##(2005-11#1)(2008-10#1)
study of cancer##7##3##(1992-10#1)(1994-2#2)(2007-10#1)(2007-6#1)(2008-9#1)(2009-5#1)
study of cardiovascular##3##3##(1992-10#1)(2008-3#1)(2011-1#1)
study of cases of##3##4##(2012-11#2)(2012-3#1)
study of cases##4##3##(2004-10#1)(2012-11#2)(2012-3#1)
study of cell##7##3##(1992-4#1)(1995-11#1)(2007-12#1)(2008-1#1)(2008-9#1)(2011-2#1)(2012-1#1)
study of changes in##3##4##(2007-12#2)(2008-10#1)
study of characteristics##2##3##(2005-11#1)(2013-8#1)
study of chemical##2##3##(2008-4#1)(2013-1#1)
study of children and##2##4##(2006-10#1)(2006-7#1)
study of children with##2##4##(1994-6#1)(2012-12#1)
study of children##7##3##(1994-6#1)(1996-2#1)(2006-10#1)(2006-7#1)(2009-12#1)(2012-12#1)(2013-1#1)
study of chronic##4##3##(1994-7#1)(2006-2#1)(2007-7#1)(2009-10#1)
study of clinical##6##3##(1994-12#1)(2006-8#2)(2007-10#1)(2007-8#1)(2010-11#1)
study of complex##4##3##(2007-12#2)(2008-10#1)(2011-1#1)
study of critical##2##3##(2008-11#2)
study of cultured##2##3##(1996-4#1)(2008-11#1)
study of dermatophytosis in##2##4##(2007-7#2)
study of determinants##2##3##(1990-12#1)(1992-5#1)
study of different types of##2##5##(1991-10#1)(2008-10#1)
study of different##7##3##(1991-10#1)(2004-10#1)(2006-7#1)(2008-10#2)(2008-11#1)(2010-7#1)
study of diispropylcarbodiimide##2##3##(2008-9#2)
study of dissolved##2##3##(2008-10#1)(2008-3#1)
study of distribution##2##3##(1993-11#1)(2008-8#1)
study of drug##3##3##(2007-8#1)(2008-11#1)(2008-6#1)
study of dynamics of##2##4##(2008-8#1)(2011-1#1)
study of each##2##3##(2008-10#1)(2011-2#1)
study of eating attitudes##2##4##(2006-4#2)
study of eating##4##3##(2006-4#2)(2006-7#1)(2008-9#1)
study of efficacy and safety of##2##6##(2005-10#1)(2008-7#1)
study of efficacy##3##3##(2005-10#1)(2008-7#1)(2011-2#1)
study of eight##3##3##(2008-11#1)(2010-2#1)(2011-2#1)
study of environmental##3##3##(1996-3#1)(2012-1#1)(2013-1#1)
study of epidemiology##2##3##(2004-9#1)(2012-3#1)
study of ethics##3##3##(1993-1#1)(1994-1#2)
study of factors##2##3##(2007-12#1)(2007-8#1)
study of familial##2##3##(1997-5#1)(2004-10#1)
study of filgrastim##2##3##(2008-7#2)
study of five##2##3##(1991-8#1)(2009-5#1)
study of fluoxetine##2##3##(1996-3#1)(1997-3#1)
study of four patients##2##4##(1993-5#1)(2010-12#1)
study of four##6##3##(1992-10#2)(1993-5#1)(2008-7#2)(2010-12#1)
study of functional genomics##2##4##(2009-5#1)(2013-8#1)
study of functional##5##3##(2006-12#1)(2008-7#1)(2009-10#1)(2009-5#1)(2013-8#1)
study of fungal##2##3##(2005-7#1)(2007-2#1)
study of gallbladder##2##3##(1990-12#1)(2006-2#1)
study of gemcitabine##2##3##(2009-8#1)(2011-12#1)
study of gene##9##3##(1990-10#1)(1994-3#1)(2006-10#1)(2007-6#1)(2008-4#2)(2008-8#1)(2008-9#2)
study of genes##2##3##(2008-7#1)(2010-3#1)
study of genetic##3##3##(1990-12#1)(1993-9#1)(1997-5#1)
study of growth and development##2##5##(2006-10#1)(2010-8#1)
study of growth##3##3##(1993-8#1)(2006-10#1)(2010-8#1)
study of health##5##3##(1995-2#1)(2007-4#1)(2007-9#1)(2009-4#1)(2009-6#1)
study of heart rate variability##2##5##(2010-5#1)(2013-1#1)
study of heart##3##3##(2007-9#1)(2010-5#1)(2013-1#1)
study of hepatitis##3##3##(1990-12#1)(2007-7#1)(2008-12#1)
study of high-dose cisplatin##2##4##(1990-12#1)(1992-8#1)
study of his##2##3##(2007-8#1)(2012-12#1)
study of how##6##3##(1990-8#1)(1995-3#1)(1997-2#1)(2008-8#2)(2009-5#1)
study of human##22##3##(1991-10#1)(1992-10#2)(1993-12#1)(1997-6#1)(2005-10#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#3)(2008-7#1)(2008-8#1)(2012-1#1)(2012-2#1)(2012-3#2)
study of images##2##3##(2008-3#1)(2009-2#1)
study of immediate##2##3##(1990-3#1)(2008-4#1)
study of immunity##2##3##(2009-12#1)(2011-1#1)
study of in##2##3##(2008-8#1)(2013-8#1)
study of institutionalized##2##3##(1991-6#1)(2006-8#1)
study of interferences##2##3##(2008-10#2)
study of interfering##2##3##(2008-10#2)
study of intratracheal##2##3##(2008-10#1)(2010-1#1)
study of intrinsic##2##3##(1997-6#1)(2007-12#1)
study of invasive fungal##2##4##(2006-10#1)(2013-1#1)
study of iron##2##3##(1995-6#1)(2012-11#1)
study of its##14##3##(1990-4#1)(1990-7#1)(1990-9#1)(1992-3#1)(1994-11#1)(2005-8#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)
study of liquid##2##3##(2008-10#1)(2008-2#1)
study of liver##2##3##(2005-6#1)(2012-3#1)
study of local and global##2##5##(2007-4#1)(2013-8#1)
study of local##5##3##(1991-9#1)(2007-4#1)(2007-7#1)(2008-7#1)(2013-8#1)
study of long-term health##2##4##(1992-2#1)(2010-4#1)
study of long-term##5##3##(1991-12#1)(1992-2#1)(1997-3#1)(2007-9#1)(2010-4#1)
study of lung##2##3##(2007-1#1)(2008-9#1)
study of matrix##3##3##(1990-9#1)(2008-10#1)(2008-4#1)
study of medical and##2##4##(2007-2#1)(2009-9#1)
study of medical##3##3##(2007-2#1)(2009-7#1)(2009-9#1)
study of mental##2##3##(1997-1#1)(2006-9#1)
study of metal##2##3##(2005-11#1)(2012-1#1)
study of model##2##3##(2005-11#1)(2008-10#1)
study of molecular##5##3##(1990-4#1)(2007-11#1)(2008-7#2)(2011-2#1)
study of more##2##3##(2006-6#1)(2008-8#1)
study of mortality##2##3##(1993-3#1)(2013-1#1)
study of mouse##2##3##(1995-5#1)(2008-2#1)
study of mutations##2##3##(2004-2#1)(2010-7#1)
study of natural##3##3##(1991-12#1)(2007-3#1)(2008-9#1)
study of new##3##3##(1991-5#1)(2007-12#1)(2008-7#1)
study of nine##2##3##(2007-8#1)(2008-7#1)
study of normal and abnormal##2##5##(1995-2#1)(2006-10#1)
study of normal and##4##4##(1991-5#1)(1995-2#1)(1996-11#1)(2006-10#1)
study of normal##5##3##(1991-5#1)(1995-2#1)(1996-11#1)(1997-5#1)(2006-10#1)
study of nuclear##2##3##(1996-12#1)(2008-8#1)
study of nurses'##3##3##(2005-10#1)(2007-10#1)(2013-8#1)
study of nursing care##2##4##(1990-2#1)(2006-1#1)
study of nursing##4##3##(1990-2#1)(2006-1#1)(2008-12#1)(2010-10#1)
study of obesity##2##3##(2008-1#1)(2012-2#1)
study of ocular##2##3##(2011-1#1)(2013-8#1)
study of one##2##3##(2006-11#1)(2007-7#1)
study of oral##3##3##(1993-8#1)(2007-7#2)
study of ovarian cancer##3##4##(1993-9#2)(1994-6#1)
study of over##3##3##(1994-7#1)(2005-6#1)(2010-3#1)
study of p53##3##3##(1995-9#1)(2009-2#1)(2012-3#1)
study of pain##3##3##(1992-2#1)(2006-12#1)(2010-10#1)
study of patients who##2##4##(2007-11#1)(2008-3#1)
study of patients with coronary##2##5##(1996-5#1)(2008-7#1)
study of patients with##11##4##(1992-9#1)(1996-5#1)(2006-11#1)(2008-7#2)(2008-9#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
study of patients##18##3##(1990-8#1)(1992-9#1)(1993-11#1)(1996-5#1)(2006-11#1)(2006-8#1)(2007-11#1)(2008-3#1)(2008-7#3)(2008-9#2)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
study of patients'##3##3##(1997-5#1)(2006-5#1)(2008-11#1)
study of persons##2##3##(2008-7#1)(2013-1#1)
study of pharmacokinetic##2##3##(2004-12#1)(2008-8#1)
study of plant##5##3##(2008-10#1)(2008-11#1)(2008-9#1)(2013-8#2)
study of plants##2##3##(2008-8#1)(2012-2#1)
study of postoperative##2##3##(1997-7#1)(2007-4#1)
study of predictors of##3##4##(2006-7#1)(2008-11#1)(2008-12#1)
study of pretreatment methods for the determination of##2##8##(2008-10#2)
study of preventive##2##3##(2008-4#1)(2008-5#1)
study of protein##4##3##(1991-12#1)(2008-2#1)(2011-1#1)(2012-1#1)
study of proteinaceous binding media##2##5##(2008-10#2)
study of pulmonary##2##3##(1995-3#1)(2007-7#1)
study of reaction between##2##4##(2008-10#2)
study of reaction##3##3##(2008-10#2)(2008-7#1)
study of regional##2##3##(2006-9#1)(2013-1#1)
study of relationships##3##3##(2008-4#1)(2013-1#2)
study of renal##2##3##(2007-11#1)(2007-7#1)
study of risk factors##2##4##(2008-10#1)(2008-6#1)
study of risk##3##3##(1994-2#1)(2008-10#1)(2008-6#1)
study of robustness##2##3##(2008-10#2)
study of routine##2##3##(1993-1#1)(2010-9#1)
study of salbutamol##2##3##(2008-10#2)
study of schizophrenia##2##3##(1997-5#1)(2011-2#1)
study of screening for##2##4##(1991-7#1)(1996-11#1)
study of seven##4##3##(1991-12#1)(1991-6#1)(2006-9#1)(2009-5#1)
study of sexual##2##3##(1997-5#1)(2012-3#1)
study of single##2##3##(2007-12#1)(2008-2#1)
study of six##2##3##(1996-5#1)(2009-5#1)
study of skin##2##3##(2007-7#1)(2007-8#1)
study of sleep##2##3##(2006-10#1)(2010-3#1)
study of soft##2##3##(2008-6#1)(2010-3#1)
study of some##6##3##(2006-5#1)(2007-11#1)(2008-10#1)(2008-12#1)(2009-7#1)(2012-2#1)
study of spatial##2##3##(2007-9#1)(2008-11#1)
study of specific##5##3##(1995-11#1)(1995-6#1)(2007-2#1)(2008-7#1)(2010-5#1)
study of sperm##2##3##(2006-5#1)(2012-2#1)
study of subjects##2##3##(1993-7#1)(2008-3#1)
study of synaptic plasticity in##2##5##(2008-4#2)
study of synaptic plasticity##3##4##(2008-4#3)
study of systems##2##3##(1994-3#1)(2008-10#1)
study of temporal##2##3##(2007-11#1)(2008-1#1)
study of the adsorption of##2##5##(2005-11#1)(2008-10#1)
study of the adsorption##4##4##(2005-11#1)(2008-10#3)
study of the analytical##3##4##(2008-10#3)
study of the association between##2##5##(2008-8#1)(2009-6#1)
study of the association of##2##5##(2005-11#1)(2012-2#1)
study of the association##4##4##(2005-11#1)(2008-8#1)(2009-6#1)(2012-2#1)
study of the best##2##4##(2008-10#1)(2008-3#1)
study of the binding of##3##5##(1990-5#1)(1996-2#1)(1997-2#1)
study of the binding##4##4##(1990-5#1)(1996-2#1)(1997-2#1)(2006-1#1)
study of the brain##2##4##(1997-5#1)(2007-9#1)
study of the characteristics##2##4##(2008-10#1)(2008-7#1)
study of the clinical##3##4##(2008-2#1)(2009-8#1)(2011-1#1)
study of the dependence of##2##5##(2007-12#1)(2008-3#1)
study of the development of##2##5##(2008-10#1)(2008-12#1)
study of the development##3##4##(2008-10#1)(2008-11#1)(2008-12#1)
study of the disease##2##4##(2007-7#1)(2012-12#1)
study of the distribution of##2##5##(1995-7#1)(2008-10#1)
study of the dynamic##2##4##(2008-3#1)(2011-1#1)
study of the effect of##14##5##(1991-2#1)(1994-10#1)(1995-1#1)(2005-11#2)(2008-10#3)(2008-2#1)(2008-7#1)(2010-10#1)(2011-2#1)(2011-3#1)(2013-8#1)
study of the effect##15##4##(1991-2#1)(1994-10#1)(1995-1#1)(2005-11#2)(2008-10#3)(2008-2#1)(2008-7#1)(2010-10#1)(2011-2#1)(2011-3#1)(2013-7#1)(2013-8#1)
study of the effectiveness##2##4##(1997-1#1)(2007-11#1)
study of the effects of a##2##6##(1992-8#1)(2008-2#1)
study of the effects of tail##2##6##(1994-4#2)
study of the effects of the##2##6##(2007-12#1)(2008-1#1)
study of the effects of##20##5##(1990-5#1)(1991-7#1)(1992-8#1)(1994-10#1)(1994-4#2)(1994-9#1)(1995-5#1)(1996-8#1)(2007-12#2)(2008-1#2)(2008-2#1)(2008-9#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-7#1)
study of the effects##22##4##(1990-5#1)(1991-7#1)(1992-8#1)(1994-10#1)(1994-4#2)(1994-9#1)(1995-2#1)(1995-5#1)(1996-8#1)(2007-12#2)(2008-1#2)(2008-10#1)(2008-2#1)(2008-9#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-7#1)
study of the efficacy##2##4##(2012-12#1)(2013-7#1)
study of the enhanced##2##4##(2007-12#1)(2008-10#1)
study of the enzyme##2##4##(1995-6#1)(2008-10#1)
study of the equilibrium##2##4##(1991-4#1)(2005-11#1)
study of the evolution of the##2##6##(2008-2#1)(2008-3#1)
study of the evolution of##3##5##(2008-2#1)(2008-3#1)(2008-7#1)
study of the evolution##4##4##(2008-2#1)(2008-3#1)(2008-7#1)(2009-5#1)
study of the excised##2##4##(1990-12#1)(2012-12#1)
study of the experiences of##3##5##(2008-11#1)(2008-9#1)(2013-1#1)
study of the expression of##2##5##(1991-11#1)(1993-6#1)
study of the first##3##4##(1990-3#1)(2008-3#1)(2013-8#1)
study of the four##2##4##(1997-8#1)(2012-2#1)
study of the functional##4##4##(1992-11#1)(2007-11#1)(2007-7#1)(2013-8#1)
study of the gastrointestinal##2##4##(2009-10#1)(2012-2#1)
study of the genetic##2##4##(2008-10#1)(2010-10#1)
study of the health##2##4##(1992-5#1)(2010-9#1)
study of the impact of##2##5##(1995-6#1)(2012-2#1)
study of the implementation of##3##5##(2008-12#1)(2013-1#2)
study of the inclusion##2##4##(2008-10#2)
study of the influence of##2##5##(2008-10#1)(2010-10#1)
study of the interaction between##3##5##(1992-12#1)(1992-4#1)(2008-10#1)
study of the interaction of##5##5##(1994-10#1)(2004-9#1)(2007-8#1)(2008-10#2)
study of the interaction##9##4##(1992-12#1)(1992-4#1)(1994-10#1)(2004-9#1)(2007-8#1)(2008-10#3)(2008-5#1)
study of the interactions between##2##5##(1994-9#1)(2010-11#1)
study of the literature##3##4##(1991-4#1)(1993-5#1)(1997-6#1)
study of the main##3##4##(2008-10#3)
study of the mechanism of action of##2##7##(1991-5#1)(2010-12#1)
study of the mechanism of##6##5##(1991-5#1)(2007-11#1)(2007-4#1)(2008-6#1)(2008-9#1)(2010-12#1)
study of the mechanisms of##4##5##(1994-11#1)(1996-6#1)(2009-10#1)(2010-12#1)
study of the mechanisms##5##4##(1994-11#1)(1996-6#1)(2007-11#1)(2009-10#1)(2010-12#1)
study of the molecular##5##4##(1997-7#1)(2006-10#1)(2008-10#2)(2009-3#1)
study of the natural##2##4##(2006-5#1)(2007-12#1)
study of the optical properties of##2##6##(2006-7#1)(2008-3#1)
study of the optical##6##4##(2006-7#1)(2007-11#1)(2008-3#4)
study of the origin##2##4##(2008-1#1)(2008-10#1)
study of the oxidation##2##4##(2008-10#2)
study of the pathogenesis##2##4##(1992-12#1)(2012-1#1)
study of the physiological##2##4##(2008-5#2)
study of the prostate##2##4##(2006-1#1)(2008-7#1)
study of the psychobiological##2##4##(2008-1#1)(2008-4#1)
study of the quality of##3##5##(1993-3#1)(1997-4#1)(2008-9#1)
study of the reaction##3##4##(2007-11#1)(2008-10#2)
study of the reduction of##2##5##(2008-10#2)
study of the reduction##3##4##(2008-10#2)(2008-8#1)
study of the relation##2##4##(1996-2#1)(2009-5#1)
study of the relationship between##8##5##(1994-2#1)(2007-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-10#1)(2012-1#1)(2012-3#1)
study of the relationship##9##4##(1994-2#1)(2007-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-10#1)(2012-1#1)(2012-3#1)
study of the relationships between##3##5##(1991-6#1)(2008-9#1)(2010-8#1)
study of the resistance##2##4##(2008-10#1)(2008-5#1)
study of the retention behaviour in##2##6##(1996-5#1)(2008-10#1)
study of the role of##2##5##(1990-4#1)(1997-2#1)
study of the scattering##2##4##(2007-12#1)(2008-2#1)
study of the sensitivity##2##4##(1990-7#1)(2008-3#1)
study of the simultaneous##2##4##(2008-10#1)(2009-7#1)
study of the small##2##4##(1992-5#1)(2010-11#1)
study of the solution##2##4##(1991-2#1)(1992-1#1)
study of the stability of##2##5##(1992-2#1)(2008-5#1)
study of the structure##2##4##(1995-5#1)(2006-4#1)
study of the sugar##2##4##(1991-8#1)(1993-11#1)
study of the surface##2##4##(2004-9#1)(2005-4#1)
study of the transport##2##4##(1992-6#1)(2008-10#1)
study of the use of##7##5##(1990-4#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-3#1)
study of the works of##2##5##(2009-10#1)(2009-7#1)
study of the##602##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#2)(1990-4#2)(1990-5#4)(1990-7#2)(1990-8#1)(1990-9#1)(1991-11#3)(1991-12#4)(1991-2#2)(1991-4#3)(1991-5#3)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#6)(1992-12#3)(1992-2#2)(1992-3#2)(1992-4#3)(1992-5#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#4)(1994-11#4)(1994-2#2)(1994-3#8)(1994-4#2)(1994-5#3)(1994-8#1)(1994-9#3)(1995-1#3)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#3)(1995-7#2)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-5#4)(1996-6#1)(1996-8#3)(1996-9#1)(1997-1#4)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#1)(2003-11#1)(2004-1#1)(2004-4#1)(2004-9#2)(2005-11#12)(2005-12#2)(2005-4#4)(2005-7#1)(2005-9#1)(2006-1#2)(2006-10#3)(2006-11#4)(2006-12#2)(2006-2#2)(2006-4#3)(2006-5#4)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#9)(2007-12#15)(2007-2#2)(2007-3#5)(2007-4#3)(2007-6#1)(2007-7#6)(2007-8#6)(2007-9#3)(2008-1#10)(2008-10#94)(2008-11#9)(2008-12#2)(2008-2#24)(2008-3#23)(2008-4#9)(2008-5#14)(2008-6#4)(2008-7#14)(2008-8#5)(2008-9#12)(2009-10#3)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#7)(2010-2#6)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#11)(2011-10#2)(2011-2#11)(2011-3#2)(2012-1#6)(2012-11#1)(2012-12#7)(2012-2#13)(2012-3#5)(2013-1#12)(2013-7#4)(2013-8#6)
study of their##8##3##(1994-6#1)(1996-12#1)(2007-10#1)(2008-2#1)(2008-5#1)(2009-2#1)(2009-6#1)(2010-5#1)
study of therapeutic##2##3##(1994-8#1)(2008-7#1)
study of thermal##2##3##(2008-10#2)
study of thermally##3##3##(2007-12#1)(2008-2#2)
study of these complexes##2##4##(1994-8#1)(2008-10#1)
study of these compounds##2##4##(2008-11#1)(2008-5#1)
study of these##22##3##(1991-7#1)(1993-9#1)(1994-5#1)(1994-8#1)(1997-3#1)(2004-9#1)(2005-10#1)(2006-10#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
study of this##11##3##(1990-5#1)(1997-7#1)(2005-8#1)(2006-5#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-6#1)(2012-12#1)
study of three##5##3##(1990-12#1)(2007-11#1)(2008-7#1)(2010-8#1)(2012-12#1)
study of tissue##2##3##(2004-9#1)(2008-5#1)
study of treatment of##2##4##(1990-2#1)(2008-12#1)
study of treatment##4##3##(1990-2#1)(1993-2#1)(2005-6#1)(2008-12#1)
study of tumor##2##3##(1995-10#1)(2008-11#1)
study of tumor-associated##2##3##(2008-6#1)(2012-1#1)
study of two cases##3##4##(1993-8#1)(1994-10#1)(2006-9#1)
study of two##15##3##(1990-3#1)(1991-12#1)(1993-5#1)(1993-8#1)(1994-10#1)(1997-8#1)(2006-9#1)(2007-12#1)(2008-10#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
study of type 1##2##4##(1993-6#1)(2007-2#1)
study of type##3##3##(1993-6#1)(2007-2#1)(2008-1#1)
study of urinary##3##3##(1993-11#1)(1995-7#1)(2005-12#1)
study of variation##2##3##(2009-6#1)(2010-5#1)
study of various##8##3##(2005-9#1)(2006-10#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)
study of vascular##2##3##(1991-6#1)(1994-5#1)
study of women##2##3##(2007-12#1)(2007-2#1)
study of women's##3##3##(1996-3#1)(2009-5#1)(2010-12#1)
study of##2679##2##(1990-1#2)(1990-10#6)(1990-11#4)(1990-12#10)(1990-2#10)(1990-3#9)(1990-4#8)(1990-5#16)(1990-6#7)(1990-7#7)(1990-8#7)(1990-9#7)(1991-1#3)(1991-10#5)(1991-11#4)(1991-12#13)(1991-2#8)(1991-3#3)(1991-4#6)(1991-5#17)(1991-6#7)(1991-7#8)(1991-8#5)(1991-9#10)(1992-1#6)(1992-10#10)(1992-11#11)(1992-12#7)(1992-2#7)(1992-3#5)(1992-4#6)(1992-5#6)(1992-6#8)(1992-7#2)(1992-8#6)(1992-9#6)(1993-1#7)(1993-10#7)(1993-11#8)(1993-12#6)(1993-2#10)(1993-3#9)(1993-4#8)(1993-5#4)(1993-6#10)(1993-7#4)(1993-8#8)(1993-9#13)(1994-1#3)(1994-10#9)(1994-11#7)(1994-12#3)(1994-2#10)(1994-3#18)(1994-4#5)(1994-5#9)(1994-6#12)(1994-7#2)(1994-8#5)(1994-9#5)(1995-1#7)(1995-10#5)(1995-11#9)(1995-12#5)(1995-2#10)(1995-3#5)(1995-4#3)(1995-5#13)(1995-6#11)(1995-7#5)(1995-8#3)(1995-9#7)(1996-1#8)(1996-10#3)(1996-11#6)(1996-12#12)(1996-2#9)(1996-3#16)(1996-4#5)(1996-5#9)(1996-6#4)(1996-7#3)(1996-8#10)(1996-9#4)(1997-1#8)(1997-2#15)(1997-3#10)(1997-4#6)(1997-5#12)(1997-6#5)(1997-7#11)(1997-8#8)(2003-11#1)(2004-1#3)(2004-10#6)(2004-11#1)(2004-12#3)(2004-2#1)(2004-3#3)(2004-4#1)(2004-7#1)(2004-9#12)(2005-10#9)(2005-11#25)(2005-12#5)(2005-4#8)(2005-6#3)(2005-7#4)(2005-8#8)(2005-9#7)(2006-1#6)(2006-10#39)(2006-11#8)(2006-12#13)(2006-2#13)(2006-3#4)(2006-4#11)(2006-5#11)(2006-6#4)(2006-7#10)(2006-8#14)(2006-9#8)(2007-1#5)(2007-10#18)(2007-11#43)(2007-12#55)(2007-2#20)(2007-3#12)(2007-4#8)(2007-5#5)(2007-6#6)(2007-7#48)(2007-8#42)(2007-9#16)(2008-1#29)(2008-10#260)(2008-11#52)(2008-12#29)(2008-2#63)(2008-3#79)(2008-4#57)(2008-5#46)(2008-6#22)(2008-7#76)(2008-8#38)(2008-9#55)(2009-1#5)(2009-10#14)(2009-11#2)(2009-12#10)(2009-2#7)(2009-3#9)(2009-4#20)(2009-5#16)(2009-6#11)(2009-7#10)(2009-8#10)(2009-9#9)(2010-1#5)(2010-10#10)(2010-11#8)(2010-12#21)(2010-2#13)(2010-3#7)(2010-4#9)(2010-5#17)(2010-6#10)(2010-7#9)(2010-8#14)(2010-9#7)(2011-1#47)(2011-10#2)(2011-12#11)(2011-2#53)(2011-3#7)(2012-1#26)(2012-11#8)(2012-12#30)(2012-2#50)(2012-3#46)(2012-8#1)(2013-1#76)(2013-7#10)(2013-8#42)
study offers a##4##3##(1996-6#1)(2010-12#1)(2012-2#1)(2013-8#1)
study offers##6##2##(1996-6#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
study on 21 patients##2##4##(1991-4#1)(1993-9#1)
study on 30##2##3##(1996-1#1)(2006-6#1)
study on a##15##3##(1990-8#1)(1991-9#1)(1993-6#1)(1994-12#1)(1997-8#1)(2006-2#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-8#2)(2009-3#1)(2013-1#1)
study on an##2##3##(1990-10#1)(1991-12#1)
study on effects of##2##4##(1994-5#1)(2013-8#1)
study on healthy##2##3##(2008-5#1)(2010-12#1)
study on intestinal parasitosis##2##4##(2006-4#2)
study on isolated rat##2##4##(1994-12#2)
study on primary##3##3##(1995-11#1)(2008-8#1)(2013-8#1)
study on recurrent##2##3##(1994-11#1)(2007-10#1)
study on several##2##3##(2007-8#1)(2008-7#1)
study on the association between##2##5##(2006-12#1)(2007-10#1)
study on the determination of##2##5##(2008-10#2)
study on the distribution##2##4##(1997-8#1)(2011-1#1)
study on the effect of##11##5##(1990-12#1)(1990-8#1)(1994-6#1)(2007-10#1)(2007-8#1)(2008-10#1)(2010-3#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-3#1)
study on the effects of##4##5##(1990-3#1)(2007-1#1)(2009-11#1)(2013-1#1)
study on the efficacy of##2##5##(1990-3#1)(2008-6#1)
study on the expression of##3##5##(1996-12#1)(2005-9#1)(2010-12#1)
study on the influence of##4##5##(1996-3#1)(2005-10#1)(2010-2#1)(2011-1#1)
study on the interaction of##5##5##(2005-11#1)(2007-8#1)(2008-10#2)(2008-9#1)
study on the interaction##6##4##(2005-11#1)(2007-8#1)(2008-10#3)(2008-9#1)
study on the metabolism of##2##5##(1997-2#1)(2008-11#1)
study on the role of##2##5##(2009-10#1)(2013-1#1)
study on the thermal##2##4##(1991-2#2)
study on the##136##3##(1990-10#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#5)(1992-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-9#1)(1996-12#1)(1996-3#2)(1996-9#1)(1997-2#1)(1997-8#1)(2004-7#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-4#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#6)(2008-9#2)(2009-10#2)(2009-11#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#7)(2013-7#2)(2013-8#5)
study on their##3##3##(1995-8#1)(2008-10#1)(2012-2#1)
study on this##3##3##(1993-3#1)(2006-12#1)(2012-12#1)
study on treatment of##3##4##(2005-10#1)(2012-2#1)(2013-8#1)
study on women's journey of recovery##2##6##(2010-3#2)
study on##398##2##(1990-10#3)(1990-12#4)(1990-2#2)(1990-3#3)(1990-5#1)(1990-7#1)(1990-8#5)(1990-9#2)(1991-1#2)(1991-12#2)(1991-2#6)(1991-4#1)(1991-8#1)(1991-9#2)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#4)(1994-3#1)(1994-5#5)(1994-6#4)(1994-8#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#1)(1996-9#3)(1997-2#1)(1997-5#1)(1997-8#3)(2004-7#2)(2004-8#1)(2004-9#3)(2005-10#3)(2005-11#7)(2005-12#1)(2005-4#3)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#3)(2006-2#5)(2006-4#3)(2006-5#1)(2006-6#3)(2006-7#4)(2006-8#6)(2007-1#2)(2007-10#4)(2007-11#1)(2007-12#2)(2007-2#4)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#5)(2008-1#2)(2008-10#28)(2008-11#5)(2008-12#4)(2008-2#8)(2008-3#3)(2008-4#2)(2008-5#13)(2008-6#3)(2008-7#15)(2008-8#17)(2008-9#7)(2009-10#5)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#8)(2010-2#3)(2010-3#5)(2010-4#4)(2010-6#2)(2010-7#1)(2010-8#5)(2011-1#9)(2011-12#3)(2011-2#6)(2012-1#1)(2012-12#5)(2012-2#14)(2012-3#10)(2013-1#19)(2013-7#3)(2013-8#11)
study one##2##2##(2008-11#1)(2008-2#1)
study only##2##2##(2007-8#1)(2007-9#1)
study opens##4##2##(2008-10#1)(2008-5#1)(2010-12#1)(2011-2#1)
study or clinical##2##3##(1991-1#1)(2008-10#1)
study or##9##2##(1991-1#2)(1997-7#1)(2006-7#1)(2008-10#1)(2008-6#1)(2010-11#1)(2010-3#1)(2013-1#1)
study our##3##2##(2007-8#1)(2008-3#1)(2010-2#1)
study out of##2##3##(2007-12#1)(2008-5#1)
study outlines##2##2##(2004-12#1)(2012-2#1)
study over 1 year##2##4##(2008-7#2)
study over the##2##3##(1994-3#1)(1996-11#1)
study over##12##2##(1992-11#1)(1993-5#1)(1994-3#1)(1996-11#2)(1997-3#1)(2008-10#1)(2008-2#1)(2008-7#2)(2011-2#1)(2012-12#1)
study participants assigned to the##2##5##(2011-1#1)(2012-3#1)
study participants were##3##3##(2007-7#1)(2008-12#1)(2013-7#1)
study participants##26##2##(1994-2#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-4#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#3)(2012-3#2)(2013-1#3)(2013-7#1)
study participants'##2##2##(2011-2#1)(2012-3#1)
study participation##3##2##(2008-3#1)(2009-4#1)(2013-1#1)
study patients were##9##3##(1991-7#1)(2007-7#3)(2008-1#5)
study patients##37##2##(1991-7#1)(1992-7#1)(1993-12#1)(2004-3#1)(2007-7#9)(2008-1#19)(2008-4#1)(2010-12#1)(2011-1#1)(2013-1#2)
study patterns of##4##3##(1997-6#1)(2007-10#1)(2008-7#1)(2009-2#1)
study performed by##2##3##(1990-9#1)(2004-12#1)
study performed in##6##3##(1990-6#1)(1992-2#1)(2006-11#1)(2008-5#1)(2010-12#1)(2011-2#1)
study performed on##3##3##(1992-10#1)(2005-11#1)(2008-5#1)
study performed##19##2##(1990-3#1)(1990-6#1)(1990-9#1)(1992-10#1)(1992-2#1)(1997-8#1)(2004-12#1)(2005-11#1)(2006-11#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-12#2)(2008-5#2)(2010-12#1)(2011-1#1)(2011-2#1)
study period and##6##3##(2007-11#1)(2007-7#2)(2008-10#1)(2013-1#2)
study period for##3##3##(2006-8#2)(2008-11#1)
study period had##2##3##(2007-10#1)(2008-7#1)
study period in##2##3##(2007-10#1)(2008-5#1)
study period was##5##3##(2006-8#2)(2010-3#1)(2012-12#1)(2012-2#1)
study period were##5##3##(2006-8#1)(2007-12#1)(2008-7#1)(2010-9#1)(2013-1#1)
study period##148##2##(1990-5#1)(1990-8#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-5#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-7#1)(1997-5#1)(2006-10#12)(2006-12#3)(2006-7#1)(2006-8#15)(2007-10#4)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#4)(2007-5#2)(2007-7#7)(2007-8#4)(2007-9#3)(2008-1#2)(2008-10#4)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#1)(2009-10#1)(2009-7#1)(2010-11#1)(2010-3#3)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#7)(2012-2#8)(2012-3#1)(2013-1#11)(2013-7#4)(2013-8#4)
study period)##2##2##(2008-9#1)(2013-8#1)
study periods##4##2##(2006-8#1)(2007-10#1)(2010-11#1)(2011-2#1)
study permits##2##2##(1990-2#1)(2008-7#1)
study phase##3##2##(1991-3#1)(2008-3#1)(2008-4#1)
study plasma##2##2##(1996-1#1)(1997-7#1)
study points out that##2##4##(2008-4#1)(2013-7#1)
study points out##3##3##(1992-8#1)(2008-4#1)(2013-7#1)
study points to the##2##4##(1994-12#1)(1994-6#1)
study points##5##2##(1992-8#1)(1994-12#1)(1994-6#1)(2008-4#1)(2013-7#1)
study population and##2##3##(1993-7#1)(2008-11#1)
study population included##3##3##(1997-1#1)(2011-2#1)(2012-12#1)
study population is##2##3##(2007-3#1)(2008-8#1)
study population of##4##3##(1990-2#1)(2007-8#1)(2011-2#2)
study population showed that##2##4##(2006-10#1)(2007-7#1)
study population was##15##3##(1997-2#1)(2004-10#1)(2006-12#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-1#1)(2011-1#2)(2013-1#2)
study population##79##2##(1990-2#2)(1993-12#1)(1993-7#1)(1993-9#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#1)(2004-10#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-4#1)(2006-8#2)(2007-2#1)(2007-3#2)(2007-7#7)(2007-8#5)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-1#1)(2010-2#1)(2011-1#6)(2011-11#1)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
study populations##5##2##(1992-11#1)(2008-11#1)(2008-8#1)(2009-7#1)(2012-1#1)
study practices##2##2##(2007-12#1)(2010-5#1)
study present##2##2##(2007-11#1)(2008-10#1)
study presented a##2##3##(2007-2#1)(2011-12#1)
study presented##8##2##(1991-1#1)(1995-3#1)(2007-2#1)(2008-12#1)(2008-4#1)(2010-2#1)(2011-12#2)
study presents a##16##3##(2005-11#1)(2006-7#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#3)(2009-8#1)(2010-10#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#1)
study presents the case of a##2##6##(2012-2#1)(2013-8#1)
study presents the##15##3##(1991-3#1)(1991-9#1)(2006-11#1)(2007-11#2)(2007-3#1)(2007-8#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#2)
study presents##46##2##(1991-3#1)(1991-6#1)(1991-9#1)(1992-4#1)(1994-8#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-11#1)(2006-12#1)(2006-7#2)(2007-11#4)(2007-3#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-10#3)(2008-6#1)(2008-7#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#3)
study prevalence##5##2##(2006-6#1)(2007-7#1)(2008-12#1)(2011-2#1)(2013-1#1)
study produced##3##2##(1991-3#1)(2008-10#1)(2012-2#1)
study proposed a##2##3##(2011-2#1)(2013-1#1)
study proposed##7##2##(2008-7#1)(2010-1#1)(2010-11#1)(2011-12#1)(2011-2#1)(2013-1#2)
study proposes a new##2##4##(2008-10#1)(2008-5#1)
study proposes a##5##3##(1994-3#1)(2007-1#2)(2008-10#1)(2008-5#1)
study proposes##7##2##(1994-3#1)(2007-1#2)(2008-10#1)(2008-5#1)(2009-10#1)(2013-7#1)
study protease##2##2##(2008-4#1)(2009-4#1)
study protein##4##2##(2007-6#1)(2008-4#1)(2008-9#1)(2012-2#1)
study proteins##2##2##(1994-5#1)(2008-4#1)
study protocol##6##2##(1992-11#1)(1997-5#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
study protocols##5##2##(2007-1#1)(2008-5#1)(2008-6#1)(2010-12#1)(2010-3#1)
study proves##4##2##(1990-6#1)(2007-5#1)(2008-10#1)(2012-12#1)
study provide evidence that##2##4##(1991-8#1)(2008-5#1)
study provide the first##3##4##(2008-10#1)(2011-2#1)(2012-12#1)
study provide##17##2##(1991-8#1)(1993-2#1)(2006-11#1)(2007-2#2)(2007-4#2)(2008-10#2)(2008-12#1)(2008-5#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
study provided a##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
study provided evidence for##2##4##(1994-11#1)(1995-1#1)
study provided evidence that##4##4##(1992-12#1)(2006-7#1)(2009-11#1)(2010-1#1)
study provided evidence##6##3##(1992-12#1)(1994-11#1)(1995-1#1)(2006-7#1)(2009-11#1)(2010-1#1)
study provided the##2##3##(2008-5#1)(2013-1#1)
study provided##23##2##(1991-12#1)(1991-2#1)(1992-12#1)(1994-11#1)(1995-1#1)(2006-7#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-1#1)(2013-1#2)
study provides a basis##3##4##(2010-12#1)(2010-8#1)(2012-12#1)
study provides a##13##3##(2007-7#1)(2008-10#3)(2009-2#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-12#2)(2012-3#1)(2013-1#1)
study provides an##6##3##(2009-11#1)(2010-12#2)(2011-1#1)(2013-1#2)
study provides evidence for a##2##5##(1995-1#1)(1995-12#1)
study provides evidence for the##3##5##(1990-7#1)(1993-7#1)(1994-8#1)
study provides evidence for##7##4##(1990-7#1)(1993-7#1)(1994-8#1)(1995-1#1)(1995-12#1)(2013-1#1)(2013-8#1)
study provides evidence that##3##4##(1994-6#1)(2008-10#1)(2008-9#1)
study provides evidence##12##3##(1990-3#1)(1990-7#1)(1993-7#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(2008-10#2)(2008-9#1)(2013-1#1)(2013-8#1)
study provides for the first time##2##6##(2011-2#1)(2012-2#1)
study provides further##5##3##(1994-2#1)(1994-8#1)(2006-12#1)(2008-7#1)(2010-12#1)
study provides insight into##4##4##(2009-3#1)(2010-12#1)(2013-1#2)
study provides insights into the##2##5##(2010-4#1)(2013-1#1)
study provides insights into##3##4##(2010-4#1)(2012-2#1)(2013-1#1)
study provides new insights into the##3##6##(2008-10#1)(2008-5#1)(2009-9#1)
study provides new##4##3##(2008-10#1)(2008-5#1)(2009-9#1)(2012-1#1)
study provides novel##2##3##(2008-10#1)(2013-1#1)
study provides preliminary##3##3##(2006-12#1)(2008-12#1)(2011-2#1)
study provides the first proof##2##5##(1990-7#1)(2012-1#1)
study provides the first##9##4##(1990-7#1)(1993-3#1)(1995-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-1#1)(2012-1#1)
study provides##102##2##(1990-3#1)(1990-7#2)(1991-2#1)(1991-3#1)(1993-3#1)(1993-7#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-7#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-12#2)(2006-3#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#14)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-9#1)(2010-1#1)(2010-12#5)(2010-4#2)(2010-5#1)(2010-8#3)(2011-1#1)(2011-12#2)(2011-2#4)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#13)(2013-8#1)
study published in##2##3##(2009-8#1)(2010-9#1)
study quantified##2##2##(2010-8#1)(2013-1#1)
study quantifies the##3##3##(1992-1#1)(1992-7#1)(2012-2#1)
study quantifies##4##2##(1992-1#1)(1992-7#1)(2009-11#1)(2012-2#1)
study question##4##2##(1996-9#1)(2004-12#1)(2012-12#2)
study questions the##2##3##(1997-7#1)(2011-2#1)
study questions##3##2##(1994-2#1)(1997-7#1)(2011-2#1)
study rats were##2##3##(2008-9#2)
study rats##5##2##(1996-1#2)(2008-9#3)
study realized##2##2##(1994-2#1)(2008-2#1)
study received##3##2##(2008-2#1)(2010-4#1)(2010-8#1)
study recommends##4##2##(2007-7#1)(2008-10#1)(2008-11#1)(2011-1#1)
study regarding##2##2##(1994-3#1)(2007-9#1)
study related to##3##3##(2008-1#1)(2008-12#1)(2009-10#1)
study related##4##2##(2007-8#1)(2008-1#1)(2008-12#1)(2009-10#1)
study replicates##4##2##(1993-6#1)(1994-2#1)(1996-2#1)(2009-8#1)
study report the##2##3##(1997-4#1)(2008-12#1)
study report##4##2##(1997-4#1)(2008-1#1)(2008-12#1)(2008-8#1)
study reported here is##2##4##(2010-5#1)(2010-7#1)
study reported here was##3##4##(2008-12#1)(2008-5#2)
study reported here##15##3##(1990-9#1)(1992-3#1)(1995-8#1)(2007-2#1)(2008-12#1)(2008-5#2)(2009-4#1)(2010-5#1)(2010-7#1)(2011-2#4)(2013-8#1)
study reported that##5##3##(1991-12#1)(1994-3#1)(1997-2#1)(2007-8#1)(2008-5#1)
study reported##28##2##(1990-9#1)(1991-12#1)(1992-3#1)(1994-3#1)(1995-8#1)(1997-2#1)(2007-2#2)(2007-8#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-8#1)(2009-2#1)(2009-4#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#5)(2012-12#1)(2013-8#1)
study reports a case of##2##5##(1994-6#1)(2007-12#1)
study reports a##5##3##(1994-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-2#1)
study reports an##2##3##(2013-1#1)(2013-7#1)
study reports on the##8##4##(1993-1#1)(1994-2#1)(2006-4#1)(2007-7#1)(2008-2#1)(2008-7#1)(2008-9#1)(2012-1#1)
study reports on##13##3##(1993-1#2)(1994-2#1)(2006-4#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-9#1)(2012-1#1)
study reports the development and##2##5##(1994-3#1)(2007-12#1)
study reports the##21##3##(1993-8#1)(1994-3#1)(1995-1#1)(1997-7#1)(2004-4#1)(2006-2#1)(2006-4#2)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-7#1)(2013-1#1)
study reports##51##2##(1990-12#1)(1991-2#1)(1993-1#2)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-6#2)(1997-7#1)(2004-4#1)(2006-2#1)(2006-4#3)(2006-8#1)(2007-12#3)(2007-7#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-7#1)(2013-1#3)(2013-7#1)
study represents a first##2##4##(2009-7#1)(2012-2#1)
study represents a##4##3##(2009-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
study represents an##3##3##(2004-3#1)(2008-3#1)(2011-2#1)
study represents the first##5##4##(1995-12#1)(1997-8#1)(2008-10#1)(2008-9#1)(2010-3#1)
study represents##14##2##(1995-12#1)(1997-8#1)(2004-3#1)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
study resulted in a##2##4##(2006-12#1)(2008-10#1)
study resulted in##5##3##(2006-11#1)(2006-12#1)(2008-10#1)(2012-1#1)(2013-7#1)
study results and##2##3##(1993-12#1)(2006-8#1)
study results are##3##3##(2012-12#1)(2013-1#2)
study results have been##2##4##(2006-10#1)(2008-5#1)
study results have##3##3##(2006-10#1)(2007-11#1)(2008-5#1)
study results indicate##2##3##(2007-11#1)(2010-6#1)
study results##38##2##(1991-7#2)(1992-12#1)(1993-12#3)(1995-2#1)(1996-7#1)(2004-9#1)(2006-10#2)(2006-11#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-6#2)(2010-7#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
study retrospectively##3##2##(2006-12#1)(2008-3#1)(2012-3#1)
study reveal that the##3##4##(2008-12#1)(2009-10#1)(2010-8#1)
study reveal that##4##3##(2007-2#1)(2008-12#1)(2009-10#1)(2010-8#1)
study reveal##6##2##(2007-2#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-8#1)
study revealed a##9##3##(1992-10#1)(1994-12#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-12#1)(2009-3#1)(2010-12#1)(2013-7#1)
study revealed higher##3##3##(2007-8#1)(2012-1#1)(2013-8#1)
study revealed no##3##3##(2007-12#1)(2007-2#1)(2008-10#1)
study revealed that (i)##2##4##(2008-8#1)(2012-2#1)
study revealed that both##2##4##(2008-10#1)(2012-3#1)
study revealed that the##15##4##(1995-3#1)(1996-12#1)(2004-11#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-8#1)
study revealed that##54##3##(1990-4#1)(1991-2#1)(1991-7#1)(1992-6#1)(1993-7#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-8#1)(2004-11#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#2)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
study revealed the##8##3##(1990-12#1)(1991-10#1)(2006-1#1)(2007-3#1)(2007-7#1)(2008-5#1)(2008-7#1)(2012-3#1)
study revealed three##2##3##(1994-12#1)(2012-3#1)
study revealed##95##2##(1990-12#1)(1990-4#1)(1991-10#1)(1991-2#1)(1991-7#1)(1992-10#1)(1992-6#1)(1993-7#1)(1994-12#2)(1994-8#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-8#1)(2004-11#1)(2006-1#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#4)(2008-3#1)(2008-5#5)(2008-7#2)(2008-8#2)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#6)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#3)
study reveals a##7##3##(2005-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2010-10#1)(2012-2#1)
study reveals that the##9##4##(1991-3#1)(1991-4#1)(2007-2#1)(2008-1#1)(2008-3#1)(2009-5#1)(2010-12#1)(2012-12#1)(2012-2#1)
study reveals that##16##3##(1991-3#1)(1991-4#1)(1997-5#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
study reveals the##7##3##(1994-3#1)(1997-4#1)(2006-9#1)(2007-10#1)(2007-12#1)(2011-1#1)(2013-1#1)
study reveals##34##2##(1991-3#1)(1991-4#1)(1994-3#1)(1995-5#1)(1997-4#1)(1997-5#1)(2005-8#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2011-1#2)(2012-12#1)(2012-2#4)(2013-1#4)
study reviewed##5##2##(2006-6#1)(2007-2#2)(2007-8#1)(2013-7#1)
study reviews the##5##3##(2006-3#1)(2010-4#1)(2011-2#1)(2012-2#2)
study reviews##7##2##(1995-2#1)(1996-1#1)(2006-3#1)(2010-4#1)(2011-2#1)(2012-2#2)
study sample was##2##3##(2012-2#1)(2012-3#1)
study sample##21##2##(1991-4#1)(1991-9#1)(1995-1#1)(1996-9#1)(1997-5#1)(2006-11#1)(2006-9#1)(2007-10#1)(2008-12#1)(2008-3#1)(2008-7#2)(2009-7#1)(2010-11#1)(2010-2#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
study samples##3##2##(2010-11#2)(2010-4#1)
study says##2##2##(1994-10#1)(1997-5#1)
study seeks to identify##2##4##(2005-10#1)(2005-2#1)
study seeks to##10##3##(1995-12#1)(2005-10#1)(2005-2#1)(2007-11#1)(2007-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
study seems to##2##3##(2008-7#1)(2010-8#1)
study selected##2##2##(1993-4#1)(1995-6#1)
study selection##2##2##(2007-7#1)(2012-3#1)
study set out to determine the prevalence of##2##8##(2010-12#1)(2012-12#1)
study set out to determine##3##5##(2010-12#2)(2012-12#1)
study set out to##5##4##(2007-3#1)(2008-7#1)(2010-12#2)(2012-12#1)
study set##6##2##(2007-3#1)(2008-7#1)(2010-12#2)(2012-1#1)(2012-12#1)
study sets out to##2##4##(2006-12#1)(2007-12#1)
study setting##2##2##(1994-2#1)(1995-12#1)
study several##3##2##(1990-12#1)(2008-10#1)(2009-11#1)
study should address##2##3##(2009-5#1)(2010-8#1)
study should be conducted##2##4##(2006-7#1)(2008-8#1)
study should be interpreted##2##4##(1991-4#1)(1995-5#1)
study should be undertaken##2##4##(1993-1#1)(2013-8#1)
study should be##14##3##(1991-12#1)(1991-4#1)(1993-1#1)(1995-5#1)(1996-8#1)(2006-2#1)(2006-7#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-4#1)(2013-8#2)
study should prove useful##2##4##(2008-10#1)(2012-2#1)
study should##25##2##(1991-12#1)(1991-4#1)(1993-1#1)(1995-5#1)(1996-12#1)(1996-8#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-7#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-5#1)(2010-10#1)(2010-4#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#2)
study show a##3##3##(2006-12#1)(2008-3#1)(2011-2#1)
study show that##30##3##(1990-12#1)(1991-5#1)(1994-3#1)(1995-1#1)(1995-10#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-8#3)(2006-9#1)(2007-10#2)(2007-2#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#2)(2010-2#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
study show##38##2##(1990-12#1)(1991-5#1)(1994-3#1)(1995-1#1)(1995-10#1)(2005-11#1)(2006-10#2)(2006-12#2)(2006-8#3)(2006-9#1)(2007-10#2)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2009-4#1)(2010-2#1)(2010-3#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#4)
study showed a high##3##4##(2006-10#1)(2007-7#1)(2010-4#1)
study showed a significant##2##4##(1996-2#1)(2007-2#1)
study showed a##19##3##(1996-2#1)(1997-4#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-7#2)(2008-5#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#2)(2012-6#1)(2013-1#1)
study showed an##4##3##(2006-8#1)(2007-8#1)(2007-9#1)(2011-2#1)
study showed conclusively that the##2##5##(2007-3#1)(2008-10#1)
study showed good##3##3##(1990-6#1)(2006-11#1)(2008-10#1)
study showed no##5##3##(2007-9#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
study showed significant##2##3##(2007-6#1)(2008-8#1)
study showed that a##5##4##(1994-2#1)(1995-1#1)(2006-10#1)(2007-2#1)(2008-5#1)
study showed that all##3##4##(2007-2#1)(2008-9#1)(2012-3#1)
study showed that both##4##4##(1992-1#1)(2008-5#1)(2008-7#1)(2013-7#1)
study showed that no##2##4##(2008-1#1)(2008-10#1)
study showed that the##40##4##(1990-11#1)(1994-3#1)(1997-2#1)(2005-11#1)(2006-10#1)(2007-10#2)(2007-3#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#6)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-12#1)(2011-12#1)(2011-2#3)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#3)
study showed that there was a##3##6##(2007-10#1)(2008-12#1)(2011-1#1)
study showed that there was##4##5##(2007-10#1)(2008-12#1)(2011-1#1)(2013-8#1)
study showed that there##5##4##(2007-10#1)(2008-12#1)(2011-1#1)(2012-1#1)(2013-8#1)
study showed that##143##3##(1990-11#1)(1990-2#1)(1992-1#1)(1992-12#1)(1992-4#2)(1992-6#1)(1994-10#1)(1994-2#3)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-7#1)(1996-5#1)(1997-2#1)(2005-11#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-2#1)(2006-8#1)(2007-1#1)(2007-10#4)(2007-11#1)(2007-12#1)(2007-2#3)(2007-3#2)(2007-4#1)(2007-7#3)(2007-8#2)(2008-1#4)(2008-10#12)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#3)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-12#2)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#12)(2013-7#4)(2013-8#6)
study showed the##5##3##(1997-7#1)(2006-11#1)(2011-1#2)(2013-7#1)
study showed##215##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1992-1#1)(1992-12#2)(1992-4#2)(1992-6#1)(1994-10#1)(1994-2#3)(1994-3#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-7#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-9#1)(2006-1#1)(2006-10#5)(2006-11#2)(2006-2#1)(2006-8#3)(2007-1#1)(2007-10#4)(2007-11#3)(2007-12#1)(2007-2#6)(2007-3#3)(2007-4#1)(2007-6#1)(2007-7#6)(2007-8#3)(2007-9#3)(2008-1#6)(2008-10#17)(2008-11#1)(2008-12#6)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#8)(2008-6#3)(2008-7#8)(2008-8#4)(2008-9#4)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#12)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#3)(2012-6#1)(2013-1#14)(2013-7#5)(2013-8#8)
study showing that##3##3##(1995-12#1)(2008-10#1)(2011-2#1)
study showing##4##2##(1995-12#1)(2008-10#1)(2010-5#1)(2011-2#1)
study shows a high##2##4##(1996-3#1)(2007-8#1)
study shows a##10##3##(1991-8#1)(1992-2#1)(1993-12#1)(1996-3#1)(2004-9#1)(2006-8#1)(2007-3#1)(2007-8#1)(2012-12#2)
study shows how oral##2##4##(2008-5#2)
study shows how##7##3##(1993-2#1)(2008-5#2)(2008-7#1)(2009-11#1)(2009-5#1)(2013-1#1)
study shows no##2##3##(1992-3#1)(2006-4#1)
study shows that a##4##4##(1993-2#1)(2005-11#1)(2008-10#1)(2010-6#1)
study shows that at##2##4##(1990-8#1)(2006-7#1)
study shows that by##2##4##(2008-12#1)(2009-3#1)
study shows that the proposed##2##5##(2013-1#1)(2013-8#1)
study shows that the use of##2##6##(1990-7#1)(2006-6#1)
study shows that the##33##4##(1990-11#1)(1990-7#1)(1992-9#2)(1995-6#2)(1996-1#1)(1996-11#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#1)(2006-12#1)(2006-6#1)(2007-10#1)(2008-1#2)(2008-3#4)(2008-5#4)(2008-6#1)(2008-7#2)(2010-5#1)(2012-3#1)(2013-1#2)(2013-8#1)
study shows that this##4##4##(2008-10#1)(2008-5#1)(2009-6#1)(2010-5#1)
study shows that##119##3##(1990-11#2)(1990-4#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-5#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-2#2)(1994-12#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-6#4)(1995-7#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-8#1)(2004-1#2)(2005-11#1)(2005-12#1)(2006-10#1)(2006-12#2)(2006-6#1)(2006-7#1)(2006-8#5)(2007-10#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-12#3)(2008-3#6)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-3#2)(2009-5#1)(2009-6#2)(2010-11#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#6)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
study shows the##7##3##(2006-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-12#1)(2013-1#1)(2013-7#1)
study shows##159##2##(1990-11#2)(1990-4#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-5#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#2)(1993-2#3)(1994-12#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-6#4)(1995-7#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#3)(1996-5#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-8#1)(2004-1#2)(2004-9#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-12#3)(2006-4#2)(2006-6#1)(2006-7#1)(2006-8#6)(2007-10#3)(2007-3#1)(2007-5#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-12#3)(2008-3#6)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#5)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#4)(2009-4#1)(2009-5#2)(2009-6#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#2)(2011-2#6)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#2)
study since##4##2##(1993-3#1)(2008-10#1)(2008-7#1)(2012-12#1)
study site##11##2##(2004-11#1)(2006-12#1)(2006-8#2)(2007-3#2)(2008-10#2)(2008-5#2)(2011-12#1)
study sites##26##2##(2006-2#1)(2006-8#11)(2007-2#3)(2008-10#3)(2008-12#2)(2008-4#1)(2008-5#1)(2009-5#1)(2010-6#1)(2012-12#1)(2012-3#1)
study some of the##2##4##(2006-10#1)(2012-2#1)
study some##4##2##(1990-3#1)(2006-10#1)(2012-11#1)(2012-2#1)
study sought to determine the##5##5##(2008-7#1)(2012-3#1)(2013-1#1)(2013-8#2)
study sought to determine##8##4##(1992-11#1)(2007-8#1)(2008-7#1)(2010-9#1)(2012-3#1)(2013-1#1)(2013-8#2)
study sought to examine the##3##5##(2007-11#1)(2011-1#1)(2012-2#1)
study sought to examine##5##4##(2007-11#1)(2008-6#1)(2010-8#1)(2011-1#1)(2012-2#1)
study sought to identify##5##4##(2005-12#1)(2009-4#1)(2011-1#1)(2011-2#2)
study sought to##36##3##(1992-11#1)(1995-9#1)(2005-12#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-11#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-1#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-11#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
study species##5##2##(2008-8#1)(2012-12#4)
study specifically##3##2##(1992-11#1)(2006-10#1)(2008-11#1)
study strongly##5##2##(1994-3#1)(2008-10#2)(2008-7#1)(2010-12#1)
study subjects had been##2##4##(2006-8#1)(2010-12#1)
study subjects was##2##3##(1990-4#1)(2012-2#1)
study subjects were##7##3##(1996-3#1)(1997-2#1)(2008-1#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)
study subjects##25##2##(1990-4#1)(1990-8#1)(1992-12#1)(1994-2#1)(1996-3#1)(1997-2#1)(2006-8#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-8#1)(2009-11#1)(2010-12#3)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#4)
study such##3##2##(2008-10#1)(2012-1#1)(2013-1#1)
study suggest that a##2##4##(2006-9#1)(2008-8#1)
study suggest that the##17##4##(1990-2#1)(1992-10#1)(1992-12#1)(1992-6#1)(1994-2#1)(1996-5#1)(1997-3#1)(2004-11#1)(2007-7#1)(2008-5#1)(2008-6#2)(2009-2#1)(2009-7#1)(2011-2#2)(2013-1#1)
study suggest that these##2##4##(2007-12#1)(2008-10#1)
study suggest that##79##3##(1990-2#1)(1991-3#1)(1991-4#1)(1992-10#1)(1992-12#2)(1992-6#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-10#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(2004-11#1)(2006-10#2)(2006-12#1)(2006-8#2)(2006-9#2)(2007-10#3)(2007-12#1)(2007-7#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-11#1)(2010-12#2)(2011-1#1)(2011-2#4)(2012-5#1)(2013-1#4)
study suggest the##4##3##(1992-8#1)(1996-1#1)(1996-11#1)(2010-8#1)
study suggest##92##2##(1990-2#1)(1991-1#1)(1991-3#2)(1991-4#1)(1992-10#1)(1992-12#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-10#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(2004-11#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-8#2)(2006-9#2)(2007-10#4)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-11#1)(2010-12#2)(2010-8#1)(2011-1#2)(2011-2#4)(2012-3#1)(2012-5#1)(2013-1#4)
study suggested that an##2##4##(1992-12#1)(1992-2#1)
study suggested that the##5##4##(1997-2#1)(2007-3#1)(2008-5#1)(2008-6#1)(2009-2#1)
study suggested that##21##3##(1990-12#1)(1992-12#1)(1992-2#1)(1994-2#1)(1995-4#1)(1995-8#1)(1997-2#1)(2006-10#1)(2006-12#2)(2007-3#1)(2008-5#1)(2008-6#1)(2009-2#1)(2009-3#1)(2011-3#1)(2013-1#3)(2013-8#2)
study suggested##23##2##(1990-12#1)(1992-12#1)(1992-2#1)(1994-2#1)(1995-4#1)(1995-8#1)(1997-2#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-3#1)(2008-5#1)(2008-6#1)(2009-2#1)(2009-3#1)(2009-5#1)(2011-3#1)(2013-1#3)(2013-8#2)
study suggests a##5##3##(1994-11#1)(2007-4#1)(2008-5#2)(2013-4#1)
study suggests that a high##2##5##(2007-9#1)(2011-1#1)
study suggests that a##7##4##(1992-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-3#1)
study suggests that both##2##4##(2007-8#1)(2008-5#1)
study suggests that in##3##4##(2007-2#1)(2008-9#1)(2010-10#1)
study suggests that one##2##4##(2006-12#1)(2012-2#1)
study suggests that routine##2##4##(1990-2#1)(1990-8#1)
study suggests that the##25##4##(1990-4#1)(1990-7#1)(1991-3#1)(1991-7#1)(1992-8#1)(1992-9#1)(1995-12#1)(1996-10#1)(2007-1#1)(2007-7#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-8#2)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
study suggests that there##2##4##(2008-9#1)(2011-2#1)
study suggests that##131##3##(1990-12#1)(1990-2#1)(1990-4#2)(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-9#1)(1994-12#1)(1994-6#1)(1995-12#2)(1995-5#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-5#1)(2004-2#1)(2005-10#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-4#1)(2007-1#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#6)(2007-8#4)(2007-9#2)(2008-1#6)(2008-10#7)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#3)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#4)(2011-12#1)(2011-2#9)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#4)
study suggests the need for##2##5##(2006-10#1)(2008-1#1)
study suggests the##8##3##(1990-3#1)(1992-12#1)(1994-8#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2011-2#1)
study suggests##152##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-5#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-5#1)(2004-2#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-4#1)(2007-1#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#7)(2007-8#4)(2007-9#2)(2008-1#7)(2008-10#8)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#3)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#10)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#9)(2013-4#1)(2013-7#1)(2013-8#4)
study summarizes the##4##3##(1993-12#1)(2006-11#1)(2006-6#1)(2008-1#1)
study support the##9##3##(1991-12#1)(2006-12#1)(2007-6#1)(2008-10#2)(2008-5#1)(2010-2#1)(2012-1#1)(2012-12#1)
study support##14##2##(1991-12#1)(1991-9#1)(2004-9#1)(2006-12#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-5#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
study supported the##2##3##(2007-12#1)(2012-1#1)
study supported##3##2##(2007-12#1)(2008-11#1)(2012-1#1)
study supports a##2##3##(1992-8#1)(1996-2#1)
study supports the hypothesis that##5##5##(1993-6#1)(1996-12#1)(1996-3#1)(2010-10#1)(2013-1#1)
study supports the use of##4##5##(2008-11#1)(2009-4#1)(2011-1#1)(2012-3#1)
study supports the##17##3##(1990-5#1)(1993-6#1)(1996-12#1)(1996-3#1)(2006-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-4#1)(2010-10#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
study supports##24##2##(1990-5#1)(1992-3#1)(1992-8#1)(1993-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-6#1)(2006-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-7#2)(2009-4#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
study surveyed##2##2##(2007-9#1)(2008-6#1)
study systematically##2##2##(2008-10#1)(2009-4#1)
study takes a##3##3##(2008-1#1)(2011-1#1)(2011-2#1)
study takes##5##2##(2006-4#1)(2008-1#1)(2008-3#1)(2011-1#1)(2011-2#1)
study tested the hypothesis that the##4##6##(1993-6#1)(2007-12#1)(2008-3#1)(2012-12#1)
study tested the hypothesis that##8##5##(1993-6#1)(1995-12#1)(2007-12#1)(2008-3#2)(2008-5#1)(2008-8#1)(2012-12#1)
study tested the##19##3##(1993-6#1)(1995-12#1)(1996-5#1)(2007-12#1)(2007-8#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-2#1)(2010-8#1)(2012-12#3)(2012-2#1)
study tested##23##2##(1993-6#1)(1995-12#1)(1996-5#1)(2007-12#2)(2007-8#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-8#1)(2012-12#3)(2012-2#1)
study testing##2##2##(2006-10#1)(2007-8#1)
study tests the##3##3##(1991-9#1)(2007-3#1)(2013-8#1)
study tests whether the##2##4##(2010-2#1)(2010-3#1)
study tests whether##3##3##(1995-5#1)(2010-2#1)(2010-3#1)
study tests##11##2##(1991-9#1)(1995-2#1)(1995-5#1)(2007-3#1)(2008-9#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-8#1)(2012-12#1)(2013-8#1)
study than in##2##3##(1992-6#1)(2008-6#1)
study than##4##2##(1992-6#1)(1994-12#1)(2005-8#1)(2008-6#1)
study that a##2##3##(2008-8#1)(2010-6#1)
study that assessed##2##3##(2006-10#1)(2013-1#1)
study that compares##3##3##(1993-9#1)(1995-8#1)(1997-3#1)
study that enrolled##2##3##(2009-10#1)(2012-3#1)
study that evaluated##3##3##(1990-5#1)(2006-8#1)(2013-1#1)
study that explored the##4##4##(2006-9#1)(2007-10#1)(2008-12#1)(2011-1#1)
study that explored##5##3##(2006-9#1)(2007-10#1)(2008-12#1)(2009-5#1)(2011-1#1)
study that had##2##3##(2008-10#1)(2012-1#1)
study that has##2##3##(2008-5#1)(2009-1#1)
study that included##3##3##(2006-10#1)(2008-10#1)(2011-2#1)
study that investigated the##2##4##(2007-10#1)(2010-3#1)
study that investigated##3##3##(1996-3#1)(2007-10#1)(2010-3#1)
study that involved##2##3##(1991-5#1)(1994-3#1)
study that the##4##3##(1991-9#1)(1995-12#1)(2011-2#1)(2012-2#1)
study that was##4##3##(2005-10#1)(2008-4#1)(2009-11#1)(2010-3#1)
study that##89##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-1#1)(1991-5#1)(1991-9#1)(1992-10#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-7#3)(1997-2#1)(1997-3#1)(1997-7#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-4#2)(2009-5#1)(2010-3#2)(2010-6#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#1)
study the ability of##2##4##(2008-2#1)(2010-7#1)
study the accuracy and##2##4##(2008-3#1)(2010-8#1)
study the action of##2##4##(1992-4#1)(2010-6#1)
study the activity##3##3##(1991-5#1)(2013-1#2)
study the analgesic##2##3##(2011-2#1)(2012-2#1)
study the association between##3##4##(1993-12#1)(2010-12#1)(2011-1#1)
study the association of##2##4##(2008-10#1)(2008-5#1)
study the association##5##3##(1993-12#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-1#1)
study the authors##6##3##(1991-6#1)(2006-2#1)(2007-4#1)(2007-8#1)(2008-4#1)(2008-8#1)
study the behavior of##3##4##(1991-3#1)(2008-2#1)(2011-2#1)
study the behavior##4##3##(1991-3#1)(2008-2#1)(2008-3#1)(2011-2#1)
study the biological##3##3##(1995-6#1)(1996-12#1)(2013-8#1)
study the blood##3##3##(1996-3#1)(2006-5#1)(2008-12#1)
study the chemical##4##3##(2006-12#1)(2008-10#1)(2012-2#1)(2013-8#1)
study the consequences of##2##4##(2008-10#1)(2008-8#1)
study the correlation between##3##4##(2007-6#1)(2008-8#1)(2012-3#1)
study the correlation##5##3##(2005-12#1)(2006-1#1)(2007-6#1)(2008-8#1)(2012-3#1)
study the coupling##2##3##(2007-12#1)(2009-11#1)
study the development of##2##4##(2007-8#1)(2008-12#1)
study the development##3##3##(1995-9#1)(2007-8#1)(2008-12#1)
study the different##2##3##(2008-9#1)(2011-1#1)
study the dynamics of the##5##5##(2007-12#1)(2008-1#2)(2008-3#1)(2010-11#1)
study the dynamics of##8##4##(2005-11#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-7#1)(2010-11#1)
study the dynamics##10##3##(2005-11#1)(2007-12#2)(2008-1#2)(2008-10#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-11#1)
study the effect of a##3##5##(1991-6#1)(2008-7#1)(2008-9#1)
study the effect of the##9##5##(1994-10#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-3#1)(2013-1#1)(2013-7#2)
study the effect of##74##4##(1990-11#1)(1990-2#1)(1991-2#1)(1991-6#1)(1991-7#2)(1991-8#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-12#2)(1993-8#1)(1994-10#1)(1994-12#1)(1994-5#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#2)(2004-9#1)(2006-11#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-2#4)(2007-5#1)(2008-1#1)(2008-10#8)(2008-12#3)(2008-2#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#1)
study the effect##77##3##(1990-11#1)(1990-2#1)(1991-2#1)(1991-6#1)(1991-7#2)(1991-8#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-12#2)(1993-8#1)(1994-10#1)(1994-12#1)(1994-5#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#2)(1997-1#1)(1997-2#2)(2004-9#1)(2006-11#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-2#4)(2007-5#1)(2008-1#1)(2008-10#8)(2008-12#3)(2008-2#3)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#1)
study the effects of##54##4##(1991-1#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1995-12#1)(1995-8#1)(1996-7#1)(1996-8#1)(1997-3#2)(1997-5#1)(1997-7#2)(2005-11#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-4#2)(2010-5#2)(2011-3#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
study the effects##56##3##(1991-1#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1995-12#1)(1995-8#1)(1996-7#1)(1996-8#1)(1997-3#2)(1997-5#1)(1997-7#2)(2005-11#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-8#1)(2010-4#2)(2010-5#2)(2011-3#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
study the efficacy of##5##4##(1991-11#1)(1991-7#1)(1997-1#1)(2008-12#1)(2008-5#1)
study the efficacy##6##3##(1991-11#1)(1991-7#1)(1997-1#1)(2007-10#1)(2008-12#1)(2008-5#1)
study the evolution of the##2##5##(2008-2#1)(2008-8#1)
study the evolution of##6##4##(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#3)
study the expression of##4##4##(1991-9#1)(1992-3#1)(2008-9#1)(2013-8#1)
study the expression##6##3##(1990-9#1)(1991-9#1)(1992-3#1)(2008-9#2)(2013-8#1)
study the factors associated with the##2##6##(2008-1#1)(2011-2#1)
study the factors##5##3##(1993-2#1)(2008-1#1)(2008-7#1)(2011-2#1)(2012-12#1)
study the feasibility of##2##4##(2008-10#1)(2008-3#1)
study the feasibility##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
study the frequency##2##3##(2007-12#1)(2008-10#1)
study the function and##2##4##(2008-4#1)(2008-6#1)
study the function of##8##4##(1995-8#1)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#2)(2013-8#1)
study the function##10##3##(1995-8#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2013-8#1)
study the functional##6##3##(1992-11#1)(1996-3#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-6#1)
study the gene##2##3##(2008-10#1)(2008-9#1)
study the genetic##6##3##(2008-10#2)(2008-4#1)(2008-7#1)(2010-4#1)(2011-1#1)
study the impact of##6##4##(2008-10#1)(2008-4#1)(2010-12#1)(2010-2#1)(2011-1#1)(2013-8#1)
study the impact##7##3##(2006-11#1)(2008-10#1)(2008-4#1)(2010-12#1)(2010-2#1)(2011-1#1)(2013-8#1)
study the importance of##2##4##(1991-4#1)(1996-6#1)
study the influence of the##6##5##(2005-11#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#1)
study the influence of##27##4##(1991-8#1)(1992-6#1)(1993-9#1)(1994-8#1)(1996-3#1)(1997-8#1)(2004-11#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#1)(2008-5#3)(2010-4#1)(2011-1#1)(2012-2#1)(2013-8#1)
study the interaction between##8##4##(1996-7#1)(1997-6#1)(2005-11#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-6#1)(2011-1#1)
study the interaction##14##3##(1990-4#1)(1994-2#1)(1996-7#1)(1997-6#1)(2005-11#1)(2007-5#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-1#1)
study the interactions##5##3##(2007-12#1)(2008-9#2)(2010-12#1)(2011-2#1)
study the involvement of##4##4##(1993-2#1)(1996-3#1)(2008-11#1)(2012-3#1)
study the mechanism of##10##4##(1990-10#1)(1991-1#2)(1992-8#1)(1995-6#1)(1996-8#1)(2007-4#1)(2008-1#1)(2008-11#1)(2009-7#1)
study the mechanism##12##3##(1990-10#1)(1991-1#2)(1992-3#1)(1992-8#1)(1994-6#1)(1995-6#1)(1996-8#1)(2007-4#1)(2008-1#1)(2008-11#1)(2009-7#1)
study the mechanisms of##6##4##(1993-4#1)(2008-11#1)(2008-8#1)(2009-11#1)(2010-12#1)(2013-8#1)
study the mechanisms underlying##2##4##(1990-6#1)(2008-8#1)
study the mechanisms##10##3##(1990-6#1)(1993-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#2)(2009-11#1)(2010-12#1)(2013-8#1)
study the molecular mechanisms##3##4##(1991-6#1)(1991-7#1)(2013-1#1)
study the molecular##12##3##(1990-7#1)(1991-6#1)(1991-7#1)(1992-8#1)(1995-10#1)(1995-2#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#2)(2013-1#1)
study the natural history##2##4##(2006-2#1)(2013-1#1)
study the origin and##2##4##(1995-11#1)(2008-10#1)
study the oxidation##2##3##(1995-1#1)(2008-10#1)
study the performance of##3##4##(2008-3#1)(2009-9#1)(2010-5#1)
study the physiological##3##3##(1992-3#1)(2005-7#1)(2008-10#1)
study the physiology##2##3##(1992-9#1)(2008-9#1)
study the possible mechanism of##3##5##(2008-10#2)(2009-12#1)
study the possible##8##3##(1990-1#1)(1991-9#1)(1992-12#1)(1997-1#1)(2007-12#1)(2008-10#2)(2009-12#1)
study the potential##3##3##(1994-6#1)(1995-1#1)(2008-10#1)
study the prevalence##8##3##(1990-9#1)(1997-2#1)(2006-7#1)(2007-10#1)(2007-3#1)(2011-1#1)(2011-12#1)(2013-8#1)
study the problem##2##3##(1993-7#1)(2007-1#1)
study the propagation##3##3##(2007-12#3)
study the properties of##3##4##(1996-7#1)(2008-2#1)(2008-8#1)
study the reaction##2##3##(1996-3#1)(2008-5#1)
study the regulation of the##2##5##(1991-2#1)(1992-12#1)
study the regulation of##6##4##(1991-2#1)(1992-12#1)(1994-8#1)(1994-9#1)(1995-10#1)(2008-4#1)
study the relation between##3##4##(1992-3#1)(2010-2#1)(2012-1#1)
study the relationship between the##6##5##(1991-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-1#1)(2013-8#1)
study the relationship between##13##4##(1991-1#1)(1991-11#1)(2006-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-8#2)
study the relationship##17##3##(1991-1#1)(1991-11#1)(2006-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#2)
study the relationships between##2##4##(2007-4#1)(2009-12#1)
study the relative##3##3##(1994-2#1)(2008-3#1)(2008-4#1)
study the resistance##3##3##(2006-5#1)(2008-1#1)(2008-10#1)
study the role of the##4##5##(1993-8#2)(2006-10#1)(2008-11#1)
study the role of##30##4##(1990-4#2)(1990-5#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-8#2)(1994-12#1)(1994-8#1)(1995-3#1)(1996-11#1)(1996-3#1)(1997-4#1)(2005-8#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
study the role##31##3##(1990-4#2)(1990-5#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-8#2)(1994-12#1)(1994-8#1)(1995-3#1)(1996-11#1)(1996-3#1)(1997-4#1)(2005-8#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
study the roles of##4##4##(1993-7#1)(2007-8#1)(2008-10#1)(2012-2#1)
study the safety and efficacy of##3##6##(2007-7#2)(2012-3#1)
study the sensitivity##2##3##(2007-3#1)(2008-2#1)
study the spatial##2##3##(2008-11#1)(2008-3#1)
study the specificity and##2##4##(1991-6#1)(1997-7#1)
study the structural##2##3##(2006-10#1)(2007-11#1)
study the use of##6##4##(1993-3#1)(2006-8#1)(2008-10#2)(2008-2#1)(2010-2#1)
study the##950##2##(1990-1#1)(1990-10#2)(1990-11#2)(1990-12#5)(1990-2#2)(1990-3#1)(1990-4#5)(1990-5#3)(1990-6#3)(1990-7#2)(1990-9#2)(1991-1#5)(1991-10#1)(1991-11#3)(1991-12#4)(1991-2#4)(1991-3#3)(1991-4#3)(1991-5#2)(1991-6#5)(1991-7#5)(1991-8#4)(1991-9#3)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#6)(1992-4#2)(1992-5#2)(1992-6#3)(1992-8#5)(1992-9#4)(1993-1#2)(1993-11#4)(1993-12#7)(1993-2#4)(1993-3#3)(1993-4#2)(1993-5#2)(1993-6#3)(1993-7#2)(1993-8#6)(1993-9#2)(1994-1#1)(1994-10#3)(1994-11#2)(1994-12#4)(1994-2#4)(1994-3#2)(1994-5#4)(1994-6#5)(1994-8#6)(1994-9#2)(1995-1#5)(1995-10#2)(1995-11#1)(1995-12#7)(1995-2#2)(1995-3#4)(1995-5#5)(1995-6#2)(1995-7#1)(1995-8#6)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#4)(1996-12#3)(1996-2#1)(1996-3#8)(1996-5#1)(1996-6#2)(1996-7#3)(1996-8#2)(1996-9#2)(1997-1#7)(1997-2#6)(1997-3#4)(1997-4#4)(1997-5#2)(1997-6#4)(1997-7#9)(1997-8#4)(2004-11#1)(2004-9#4)(2005-10#2)(2005-11#11)(2005-12#2)(2005-4#1)(2005-7#1)(2005-8#2)(2006-1#2)(2006-10#6)(2006-11#5)(2006-12#4)(2006-2#3)(2006-4#3)(2006-5#4)(2006-6#3)(2006-7#5)(2006-8#5)(2006-9#1)(2007-1#3)(2007-10#7)(2007-11#15)(2007-12#22)(2007-2#8)(2007-3#3)(2007-4#4)(2007-5#2)(2007-6#1)(2007-7#8)(2007-8#12)(2007-9#6)(2008-1#11)(2008-10#97)(2008-11#23)(2008-12#10)(2008-2#37)(2008-3#21)(2008-4#22)(2008-5#30)(2008-6#10)(2008-7#19)(2008-8#27)(2008-9#19)(2009-1#1)(2009-11#3)(2009-12#4)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#4)(2009-8#3)(2009-9#5)(2010-10#1)(2010-11#2)(2010-12#10)(2010-2#6)(2010-3#1)(2010-4#9)(2010-5#6)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#16)(2011-10#1)(2011-12#2)(2011-2#16)(2011-3#3)(2011-7#1)(2012-1#4)(2012-11#1)(2012-12#7)(2012-2#16)(2012-3#8)(2013-1#14)(2013-7#5)(2013-8#28)
study their##19##2##(1991-5#1)(1992-1#1)(1994-12#1)(1994-6#1)(1995-12#1)(1996-3#1)(2005-12#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#1)(2013-7#1)
study there##2##2##(2006-10#1)(2008-2#1)
study therefore##9##2##(1992-4#1)(1994-3#1)(1994-9#1)(2007-3#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-3#1)(2010-9#1)
study these##10##2##(1992-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-7#1)(2010-11#1)
study this effect##3##3##(1997-4#1)(2008-10#1)(2008-3#1)
study this phenomenon##2##3##(1996-7#1)(2008-2#1)
study this process##3##3##(1991-6#1)(1993-4#1)(1994-9#1)
study this##28##2##(1991-12#1)(1991-6#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-9#1)(1995-12#1)(1996-7#1)(1997-4#1)(1997-7#1)(2006-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-12#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
study three months##3##3##(1990-5#1)(2013-1#2)
study three##5##2##(1990-10#1)(1990-5#1)(1994-8#1)(2013-1#2)
study through##3##2##(2004-12#1)(2007-12#1)(2012-2#1)
study throughout##2##2##(2007-2#1)(2011-2#1)
study thus indicate##2##3##(2008-10#1)(2008-4#1)
study thus##10##2##(1993-7#1)(1994-8#1)(1995-11#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2009-4#1)(2012-2#1)
study to analyze##2##3##(2007-6#1)(2008-10#1)
study to assess the effect of##3##6##(2005-8#1)(2009-6#1)(2012-3#1)
study to assess the effect##4##5##(2005-8#1)(2009-6#1)(2012-3#1)(2013-7#1)
study to assess the##16##4##(1996-12#1)(2004-10#1)(2005-8#1)(2007-10#2)(2007-7#2)(2009-12#1)(2009-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
study to assess##25##3##(1996-12#1)(2004-10#1)(2005-8#1)(2006-12#1)(2007-10#2)(2007-7#2)(2008-10#1)(2008-2#1)(2008-5#1)(2009-12#1)(2009-6#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
study to be##3##3##(2007-8#1)(2008-10#2)
study to characterize the##2##4##(2008-2#1)(2010-12#1)
study to characterize##3##3##(1996-11#1)(2008-2#1)(2010-12#1)
study to compare the##5##4##(1996-3#1)(2006-12#1)(2007-7#1)(2008-1#1)(2011-2#1)
study to compare two##2##4##(2013-1#2)
study to compare##10##3##(1996-3#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-5#1)(2011-2#2)(2013-1#2)
study to determine if##3##4##(1996-7#1)(2008-11#1)(2010-6#1)
study to determine the prevalence of##2##6##(2007-7#1)(2012-2#1)
study to determine the prevalence##3##5##(2007-7#1)(2008-1#1)(2012-2#1)
study to determine the##14##4##(1990-10#1)(2006-10#1)(2006-8#1)(2007-6#1)(2007-7#3)(2008-1#1)(2008-2#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
study to determine whether##4##4##(2006-9#1)(2007-10#1)(2010-3#1)(2010-4#1)
study to determine##33##3##(1990-10#1)(1993-12#1)(1996-7#1)(2006-10#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-6#1)(2007-7#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-7#1)(2008-8#1)(2009-1#1)(2009-4#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)
study to develop a##2##4##(2007-7#1)(2009-10#1)
study to develop##3##3##(2007-7#1)(2008-10#1)(2009-10#1)
study to elucidate the##3##4##(2008-9#1)(2009-8#1)(2011-2#1)
study to enhance##2##3##(2007-7#1)(2008-12#1)
study to establish##2##3##(1990-11#1)(2013-7#1)
study to estimate the##5##4##(1992-10#1)(2007-7#1)(2010-6#1)(2012-12#2)
study to evaluate a##2##4##(2008-7#1)(2012-2#1)
study to evaluate the clinical##2##5##(2006-10#1)(2012-12#1)
study to evaluate the effect of##4##6##(1993-3#1)(1994-11#1)(2007-7#1)(2010-7#1)
study to evaluate the efficacy and##2##6##(1990-2#1)(2007-7#1)
study to evaluate the efficacy of##2##6##(2010-4#1)(2011-2#1)
study to evaluate the efficacy##4##5##(1990-2#1)(2007-7#1)(2010-4#1)(2011-2#1)
study to evaluate the##25##4##(1990-2#1)(1991-3#1)(1993-3#1)(1994-11#1)(2004-10#1)(2006-10#1)(2007-5#1)(2007-7#3)(2008-1#1)(2008-5#2)(2008-7#1)(2009-10#2)(2009-8#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)
study to evaluate##41##3##(1990-2#2)(1991-3#1)(1993-3#1)(1994-11#1)(2004-10#1)(2005-11#1)(2006-10#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#2)(2008-5#2)(2008-7#2)(2009-10#2)(2009-8#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#1)
study to examine the effect of##3##6##(2006-7#1)(2008-12#1)(2009-12#1)
study to examine the effect##4##5##(1997-2#1)(2006-7#1)(2008-12#1)(2009-12#1)
study to examine the effects of##3##6##(2007-12#1)(2008-10#1)(2010-8#1)
study to examine the##13##4##(1990-11#1)(1995-4#1)(1997-2#1)(2005-11#1)(2006-4#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-12#1)(2009-12#1)(2010-12#1)(2010-8#1)(2011-2#1)
study to examine##15##3##(1990-11#1)(1995-4#1)(1996-3#1)(1997-2#1)(2005-11#1)(2006-4#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-8#1)(2011-2#1)
study to explore##3##3##(2007-5#1)(2010-8#1)(2011-2#1)
study to find##2##3##(2009-5#1)(2013-8#1)
study to identify possible##2##4##(2008-10#1)(2012-12#1)
study to identify the##2##4##(1990-11#1)(2008-5#1)
study to identify##11##3##(1990-11#1)(2006-9#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-11#1)(2012-12#1)(2013-1#2)
study to illustrate the##2##4##(2008-11#1)(2013-7#1)
study to illustrate##3##3##(2008-11#1)(2011-1#1)(2013-7#1)
study to improve the##3##4##(2007-8#1)(2010-5#1)(2012-11#1)
study to improve##6##3##(2007-8#1)(2010-5#1)(2011-2#1)(2012-11#1)(2013-1#2)
study to inform##2##3##(2011-1#1)(2012-3#1)
study to investigate the##5##4##(1994-6#1)(1996-12#1)(2007-3#1)(2010-9#1)(2011-2#1)
study to investigate##8##3##(1990-12#1)(1994-6#1)(1996-12#1)(1996-8#1)(2007-3#1)(2010-2#1)(2010-9#1)(2011-2#1)
study to make##2##3##(2010-6#1)(2013-1#1)
study to measure##2##3##(1991-6#1)(2011-2#1)
study to monitor the##3##4##(2007-8#1)(2008-10#1)(2010-4#1)
study to receive##2##3##(1991-2#1)(2013-1#1)
study to show##3##3##(1992-5#1)(2013-1#2)
study to test the##4##4##(1990-12#1)(2004-4#1)(2008-11#1)(2012-3#1)
study to test##6##3##(1990-12#1)(1997-3#1)(2004-4#1)(2008-11#1)(2010-5#1)(2012-3#1)
study to the##2##3##(2008-10#1)(2011-2#1)
study to understand the##2##4##(2011-1#1)(2012-12#1)
study to##258##2##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#2)(1991-2#1)(1991-3#1)(1991-6#2)(1991-7#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-4#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-6#1)(1996-7#1)(1996-8#3)(1997-2#1)(1997-3#1)(2004-10#2)(2004-11#1)(2004-4#1)(2005-11#2)(2005-8#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#6)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#14)(2007-8#7)(2008-1#5)(2008-10#17)(2008-11#4)(2008-12#4)(2008-2#7)(2008-3#5)(2008-5#7)(2008-7#5)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#3)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#3)(2010-4#4)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#16)(2012-11#2)(2012-12#7)(2012-2#6)(2012-3#4)(2013-1#15)(2013-7#5)(2013-8#3)
study took place in##4##4##(1991-3#1)(1992-8#1)(1997-6#1)(2011-2#1)
study took place##5##3##(1991-3#1)(1992-8#1)(1997-6#1)(2010-3#1)(2011-2#1)
study took##6##2##(1991-3#1)(1992-8#1)(1997-6#1)(2007-8#1)(2010-3#1)(2011-2#1)
study transient##2##2##(2007-12#1)(2008-11#1)
study tries to##3##3##(2008-8#1)(2011-2#1)(2013-1#1)
study two##6##2##(1990-3#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-5#1)(2011-1#1)
study type##56##2##(2007-8#55)(2008-10#1)
study under##2##2##(1991-7#1)(2008-10#1)
study underscores the##5##3##(1993-9#1)(1997-3#1)(2007-11#1)(2007-9#1)(2008-7#1)
study undertaken##3##2##(2007-2#1)(2008-11#1)(2008-7#1)
study underwent##2##2##(2006-10#1)(2007-8#1)
study use of##2##3##(1991-8#1)(2009-5#1)
study used a mixed method##2##5##(2013-1#2)
study used a qualitative methodology##2##5##(2007-12#1)(2009-4#1)
study used a qualitative##4##4##(2007-12#1)(2008-4#1)(2009-4#1)(2013-1#1)
study used a##21##3##(1993-12#1)(2004-7#1)(2004-9#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-9#1)(2009-10#1)(2009-4#3)(2010-6#1)(2012-12#1)(2013-1#4)
study used qualitative##3##3##(2012-12#1)(2012-3#1)(2013-1#1)
study used the##4##3##(2008-5#1)(2010-7#1)(2011-1#2)
study used##59##2##(1990-6#1)(1991-6#1)(1993-12#1)(1993-7#1)(1996-1#1)(1996-12#1)(1997-2#1)(2004-7#1)(2004-9#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-4#2)(2008-5#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#3)(2009-5#1)(2009-8#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#3)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#9)
study uses a##2##3##(2009-5#1)(2010-7#1)
study uses data##2##3##(2010-8#1)(2012-12#1)
study uses meta-analytic##2##3##(2008-5#1)(2012-2#1)
study uses##18##2##(1995-2#2)(1997-3#1)(2008-2#2)(2008-5#1)(2008-7#1)(2009-12#1)(2009-5#2)(2009-7#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#1)
study using a human##2##4##(1993-12#1)(2007-3#1)
study using a##12##3##(1993-12#1)(1995-2#1)(2005-7#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-8#1)(2012-12#1)(2013-1#2)
study using an##3##3##(1995-5#1)(2008-11#1)(2011-2#1)
study using data from##2##4##(2006-4#1)(2011-2#1)
study using different##2##3##(1991-2#1)(2008-10#1)
study using focus groups was##2##5##(2008-11#1)(2008-12#1)
study using focus##3##3##(2008-11#1)(2008-12#1)(2010-10#1)
study using the##9##3##(1990-11#1)(1997-2#1)(2006-4#1)(2007-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-3#1)(2013-7#1)
study using##76##2##(1990-11#2)(1991-2#1)(1991-9#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-8#1)(1995-11#1)(1995-2#2)(1995-5#1)(1996-10#1)(1997-2#1)(1997-5#2)(1997-7#2)(2005-7#2)(2006-12#1)(2006-4#2)(2006-6#1)(2007-11#2)(2007-3#1)(2007-5#1)(2007-7#2)(2008-10#7)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-8#3)(2010-10#1)(2010-12#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
study utilises a##2##3##(2007-3#1)(2008-12#1)
study utilized a##2##3##(2009-7#1)(2012-1#1)
study utilized##7##2##(1993-2#1)(1994-2#2)(2009-7#1)(2009-8#1)(2012-1#1)(2013-1#1)
study utilizing a##3##3##(2008-10#1)(2012-11#1)(2013-7#1)
study utilizing##7##2##(1993-3#1)(2008-10#1)(2008-11#1)(2010-9#1)(2011-12#1)(2012-11#1)(2013-7#1)
study various##6##2##(1990-9#1)(2008-2#1)(2009-10#1)(2010-10#1)(2010-6#1)(2012-2#1)
study vascular##2##2##(2008-11#2)
study versus placebo##2##3##(1992-11#1)(2008-7#1)
study was 0##2##3##(2007-7#1)(2011-2#1)
study was 14##3##3##(2007-2#1)(2007-8#1)(2013-1#1)
study was a descriptive##2##4##(2010-10#1)(2011-2#1)
study was a retrospective study on##2##6##(2009-10#1)(2009-9#1)
study was a retrospective study##3##5##(2009-10#1)(2009-9#1)(2011-1#1)
study was a retrospective##5##4##(2007-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2011-1#1)
study was a##22##3##(1992-8#2)(1993-3#1)(1995-9#1)(2006-10#3)(2007-11#1)(2007-7#1)(2007-8#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
study was aimed at assessing the##2##6##(2007-8#1)(2013-8#1)
study was aimed at investigating the##5##6##(2010-12#1)(2010-7#1)(2012-12#3)
study was aimed at investigating##7##5##(1990-6#1)(2010-12#1)(2010-7#2)(2012-12#3)
study was aimed at##23##4##(1990-2#1)(1990-6#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-5#1)(2007-7#1)(2007-8#1)(2008-3#2)(2008-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-7#2)(2011-2#1)(2012-12#3)(2013-1#1)(2013-8#2)
study was aimed to assess the efficacy##2##7##(2008-3#1)(2010-12#1)
study was aimed to assess the##3##6##(2008-3#2)(2010-12#1)
study was aimed to assess##4##5##(1991-6#1)(2008-3#2)(2010-12#1)
study was aimed to describe the##2##6##(2006-6#1)(2013-7#1)
study was aimed to determine##3##5##(2009-12#1)(2010-4#1)(2011-2#1)
study was aimed to develop##2##5##(2010-5#1)(2012-3#1)
study was aimed to investigate the##2##6##(2010-8#1)(2012-3#1)
study was aimed to##22##4##(1991-6#1)(2006-6#1)(2007-8#1)(2008-12#1)(2008-3#3)(2008-5#2)(2009-12#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
study was aimed##45##3##(1990-2#1)(1990-6#1)(1991-6#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-5#1)(2006-6#1)(2007-7#1)(2007-8#2)(2008-12#1)(2008-3#5)(2008-4#1)(2008-5#2)(2009-12#1)(2009-5#1)(2009-6#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-2#2)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
study was also##4##3##(1994-8#1)(2008-10#2)(2011-2#1)
study was an evaluation of##3##5##(2007-11#1)(2007-2#1)(2008-11#1)
study was an uncontrolled##2##4##(2006-10#1)(2007-10#1)
study was an##5##3##(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-11#1)
study was attempted to##3##4##(1990-8#1)(2006-4#1)(2008-6#1)
study was based on a##3##5##(1990-6#1)(1990-9#1)(2010-11#1)
study was based on the##3##5##(1993-7#1)(2008-4#1)(2012-12#1)
study was based on##16##4##(1990-6#1)(1990-9#1)(1991-12#1)(1992-12#1)(1993-7#1)(1994-5#1)(1997-7#2)(2006-8#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-11#1)(2012-12#1)
study was based##18##3##(1990-6#1)(1990-9#1)(1991-12#1)(1992-12#1)(1993-7#1)(1994-5#1)(1997-7#2)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-11#1)(2012-12#1)
study was carried out among the##2##6##(2007-2#1)(2011-1#1)
study was carried out among##6##5##(1991-11#1)(1994-6#1)(2005-9#1)(2007-2#1)(2011-1#2)
study was carried out at the##2##6##(2004-10#1)(2008-12#1)
study was carried out at##7##5##(2004-10#1)(2007-7#1)(2008-12#1)(2011-2#1)(2013-8#3)
study was carried out by using##2##6##(2007-9#1)(2011-1#1)
study was carried out by##8##5##(1991-12#1)(1992-12#1)(1994-11#1)(2006-5#1)(2007-9#1)(2008-10#1)(2010-2#1)(2011-1#1)
study was carried out during##2##5##(2006-4#1)(2011-2#1)
study was carried out for##3##5##(2008-5#1)(2010-2#1)(2011-1#1)
study was carried out in a##3##6##(2006-4#1)(2007-9#1)(2011-2#1)
study was carried out in order to##3##7##(1990-10#1)(1997-8#1)(2005-11#1)
study was carried out in two##3##6##(1994-6#1)(2011-1#2)
study was carried out in##33##5##(1990-10#1)(1990-12#1)(1992-10#1)(1992-5#1)(1994-6#1)(1996-7#1)(1997-3#1)(1997-8#1)(2004-11#1)(2005-11#1)(2006-2#2)(2006-4#1)(2007-2#2)(2007-6#1)(2007-7#1)(2007-9#2)(2008-10#1)(2011-1#3)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#2)
study was carried out on 100##2##6##(2011-2#1)(2013-8#1)
study was carried out on 2##2##6##(2007-1#1)(2010-12#1)
study was carried out on 60##2##6##(2012-12#1)(2013-1#1)
study was carried out on a##5##6##(1991-10#1)(2006-2#1)(2008-2#1)(2008-7#1)(2013-1#1)
study was carried out on##27##5##(1990-6#1)(1991-10#1)(1992-12#1)(1994-6#3)(1996-2#1)(2006-2#2)(2007-1#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#3)(2008-8#1)(2010-12#2)(2011-2#3)(2012-12#1)(2013-1#2)(2013-8#1)
study was carried out to assess the##3##7##(2008-2#1)(2008-6#1)(2013-1#1)
study was carried out to assess##5##6##(1996-6#1)(2008-2#1)(2008-6#1)(2011-2#1)(2013-1#1)
study was carried out to describe##2##6##(2008-10#1)(2008-4#1)
study was carried out to determine the prevalence of##2##9##(2010-8#1)(2011-2#1)
study was carried out to determine the##12##7##(1990-8#1)(1994-3#1)(2004-9#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
study was carried out to determine whether##3##7##(1993-7#1)(1997-5#1)(2012-2#1)
study was carried out to determine##18##6##(1990-8#1)(1993-7#1)(1994-3#1)(1995-7#1)(1997-5#1)(2004-9#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
study was carried out to develop##3##6##(2008-10#1)(2011-2#1)(2013-1#1)
study was carried out to estimate the##2##7##(2008-4#1)(2008-5#1)
study was carried out to estimate##3##6##(1994-3#1)(2008-4#1)(2008-5#1)
study was carried out to evaluate the##8##7##(1990-2#1)(1992-4#1)(1992-6#1)(1996-1#1)(2007-1#2)(2011-12#1)(2013-8#1)
study was carried out to evaluate##10##6##(1990-11#1)(1990-2#1)(1992-4#1)(1992-6#1)(1996-1#1)(2007-1#2)(2008-8#1)(2011-12#1)(2013-8#1)
study was carried out to investigate the effect of##2##9##(1997-8#1)(2012-11#1)
study was carried out to investigate the effects of##2##9##(1990-3#1)(2009-7#1)
study was carried out to investigate the##10##7##(1990-3#1)(1991-6#1)(1997-5#1)(1997-8#1)(2008-12#1)(2008-5#2)(2009-12#1)(2009-7#1)(2012-11#1)
study was carried out to investigate##13##6##(1990-3#1)(1991-6#1)(1997-5#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2009-12#1)(2009-7#1)(2012-11#2)
study was carried out to understand the##3##7##(2007-3#1)(2008-5#1)(2008-7#1)
study was carried out to##68##5##(1990-11#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-6#1)(1992-4#1)(1992-6#1)(1993-7#1)(1994-3#2)(1995-12#1)(1995-7#1)(1996-1#1)(1996-6#1)(1997-5#2)(1997-8#1)(2004-9#1)(2007-1#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-5#1)(2009-7#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#3)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
study was carried out using##3##5##(2006-5#1)(2008-11#1)(2012-2#1)
study was carried out with the##3##6##(1992-10#1)(2010-4#1)(2011-2#1)
study was carried out with##6##5##(1992-10#1)(2008-3#1)(2010-4#1)(2011-2#2)(2013-1#1)
study was carried out##178##4##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#2)(1992-10#2)(1992-12#2)(1992-4#1)(1992-5#1)(1992-6#1)(1993-7#1)(1994-11#1)(1994-3#2)(1994-6#5)(1995-12#1)(1995-5#1)(1995-7#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-5#2)(1997-8#3)(2004-10#1)(2004-11#1)(2004-9#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-2#4)(2006-4#3)(2006-5#2)(2007-1#3)(2007-12#1)(2007-2#4)(2007-3#2)(2007-6#2)(2007-7#3)(2007-8#1)(2007-9#4)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#3)(2009-12#1)(2009-5#1)(2009-7#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-8#2)(2011-1#9)(2011-12#1)(2011-2#16)(2012-11#2)(2012-12#6)(2012-2#4)(2012-3#2)(2013-1#8)(2013-8#7)
study was carried##179##3##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#2)(1992-10#2)(1992-12#2)(1992-4#1)(1992-5#1)(1992-6#1)(1993-7#1)(1994-11#1)(1994-3#2)(1994-6#5)(1995-12#1)(1995-5#1)(1995-7#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-5#2)(1997-8#3)(2004-10#1)(2004-11#1)(2004-9#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-2#4)(2006-4#3)(2006-5#2)(2007-1#3)(2007-12#1)(2007-2#4)(2007-3#2)(2007-6#2)(2007-7#3)(2007-8#1)(2007-9#4)(2008-10#5)(2008-11#3)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#3)(2009-12#1)(2009-5#1)(2009-7#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-8#2)(2011-1#9)(2011-12#1)(2011-2#16)(2012-11#2)(2012-12#6)(2012-2#4)(2012-3#2)(2013-1#8)(2013-8#7)
study was closed##4##3##(1990-12#1)(1992-2#1)(2004-1#1)(2008-6#1)
study was completed##3##3##(1991-12#1)(1994-3#1)(2008-11#1)
study was comprised of##3##4##(2008-10#2)(2013-1#1)
study was concerned with##2##4##(2009-2#1)(2012-1#1)
study was concerned##3##3##(2009-2#1)(2010-8#1)(2012-1#1)
study was conducted among##6##4##(2009-10#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
study was conducted as a##2##5##(2008-10#1)(2008-3#1)
study was conducted as##3##4##(2007-8#1)(2008-10#1)(2008-3#1)
study was conducted at the##7##5##(1994-1#1)(2007-3#1)(2007-7#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-12#1)
study was conducted at##12##4##(1994-1#1)(2007-3#2)(2007-7#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
study was conducted between##4##4##(2006-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
study was conducted by##4##4##(2007-11#1)(2007-6#1)(2008-4#1)(2010-5#1)
study was conducted during##2##4##(2007-11#1)(2013-7#1)
study was conducted from January##2##5##(2005-8#1)(2012-2#1)
study was conducted from October##2##5##(2006-7#1)(2007-7#1)
study was conducted from##10##4##(1990-10#1)(2005-8#1)(2006-7#1)(2007-7#2)(2007-8#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-7#1)
study was conducted in 15##2##5##(1993-5#1)(2012-3#1)
study was conducted in a##10##5##(2004-11#1)(2006-8#1)(2007-7#1)(2009-12#1)(2009-5#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
study was conducted in order to assess the##2##8##(1996-8#1)(2004-11#1)
study was conducted in order to##7##6##(1996-8#1)(1997-7#1)(2004-11#1)(2008-12#1)(2008-5#1)(2008-9#2)
study was conducted in the Department of##2##7##(2013-8#2)
study was conducted in the##14##5##(1992-2#1)(2006-2#1)(2007-10#1)(2007-7#1)(2008-1#2)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#4)
study was conducted in which##4##5##(1993-1#1)(2004-2#1)(2006-5#1)(2011-2#1)
study was conducted in##59##4##(1992-2#1)(1993-1#1)(1993-5#1)(1996-10#1)(1996-8#1)(1997-7#2)(2004-11#2)(2004-2#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-7#2)(2008-1#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#3)(2009-12#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#4)
study was conducted of##3##4##(2007-8#1)(2008-9#1)(2009-10#1)
study was conducted on 104##2##5##(2007-3#1)(2008-5#1)
study was conducted on a##3##5##(2008-5#1)(2012-1#1)(2012-5#1)
study was conducted on##42##4##(1995-10#1)(1997-6#1)(2006-2#1)(2007-12#1)(2007-2#3)(2007-3#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-5#3)(2008-7#1)(2009-11#1)(2009-6#2)(2010-12#2)(2011-1#4)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-5#1)(2013-1#1)(2013-7#1)(2013-8#1)
study was conducted over a period of##2##7##(2007-8#1)(2012-12#1)
study was conducted over##3##4##(2007-8#1)(2008-10#1)(2012-12#1)
study was conducted to assess the##9##6##(2006-5#1)(2007-7#2)(2008-10#1)(2008-5#1)(2010-5#1)(2011-12#2)(2012-1#1)
study was conducted to assess##10##5##(2006-5#1)(2007-7#2)(2008-10#2)(2008-5#1)(2010-5#1)(2011-12#2)(2012-1#1)
study was conducted to characterize##2##5##(2004-11#1)(2008-5#1)
study was conducted to compare the##3##6##(1993-1#1)(2012-12#1)(2012-2#1)
study was conducted to compare##7##5##(1993-1#1)(2007-3#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)
study was conducted to delineate##2##5##(1997-6#1)(2013-1#1)
study was conducted to determine if##3##6##(1995-3#1)(2008-10#2)
study was conducted to determine the effects of##3##8##(2007-4#1)(2008-7#1)(2012-2#1)
study was conducted to determine the extent of##2##8##(2008-11#1)(2013-1#1)
study was conducted to determine the prevalence of##2##8##(2007-2#1)(2013-8#1)
study was conducted to determine the##20##6##(1994-6#1)(1995-1#1)(1995-11#1)(1997-6#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-4#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
study was conducted to determine whether##3##6##(1995-8#1)(2008-10#1)(2013-7#1)
study was conducted to determine##33##5##(1994-6#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-8#1)(1997-6#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
study was conducted to evaluate the effects of##2##8##(2010-4#1)(2012-12#1)
study was conducted to evaluate the##14##6##(2007-8#1)(2008-10#2)(2008-11#1)(2009-6#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
study was conducted to evaluate##21##5##(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#2)(2009-6#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#2)(2012-12#2)(2012-2#2)(2013-8#1)
study was conducted to examine the##4##6##(1990-4#1)(2007-10#1)(2007-3#1)(2008-10#1)
study was conducted to examine whether##2##6##(2004-11#1)(2008-11#1)
study was conducted to examine##8##5##(1990-4#1)(1994-1#1)(2004-11#1)(2007-10#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-11#1)
study was conducted to explore##2##5##(2008-11#1)(2009-5#1)
study was conducted to further##2##5##(2006-10#1)(2007-12#1)
study was conducted to identify the##4##6##(1995-10#1)(2008-10#1)(2009-6#1)(2012-2#1)
study was conducted to identify##6##5##(1995-10#1)(2005-5#1)(2008-10#1)(2009-6#1)(2010-11#1)(2012-2#1)
study was conducted to investigate the effect of##2##8##(2008-12#1)(2011-2#1)
study was conducted to investigate the possible##2##7##(2005-10#1)(2009-9#1)
study was conducted to investigate the##9##6##(2005-10#2)(2008-10#1)(2008-12#1)(2009-9#1)(2010-2#1)(2011-2#2)(2013-1#1)
study was conducted to investigate whether##3##6##(1996-1#1)(2008-9#1)(2012-2#1)
study was conducted to investigate##13##5##(1991-3#1)(1996-1#1)(2005-10#2)(2008-10#1)(2008-12#1)(2008-9#1)(2009-9#1)(2010-2#1)(2011-2#2)(2012-2#1)(2013-1#1)
study was conducted to provide##3##5##(1990-12#1)(2008-10#1)(2010-5#1)
study was conducted to study##3##5##(2004-11#1)(2007-7#1)(2008-3#1)
study was conducted to test the hypothesis##2##7##(1991-2#1)(2012-2#1)
study was conducted to test the##3##6##(1991-2#1)(2009-10#1)(2012-2#1)
study was conducted to test##5##5##(1991-2#1)(1997-8#1)(2008-10#1)(2009-10#1)(2012-2#1)
study was conducted to##139##4##(1990-12#1)(1990-4#1)(1991-2#1)(1991-3#1)(1993-1#1)(1994-1#1)(1994-6#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1997-6#2)(1997-8#1)(2004-11#3)(2005-10#2)(2005-5#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-8#2)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#4)(2007-3#3)(2007-4#3)(2007-6#1)(2007-7#4)(2007-8#3)(2008-1#1)(2008-10#13)(2008-11#4)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#3)(2010-8#2)(2011-1#2)(2011-12#4)(2011-2#9)(2012-1#2)(2012-12#4)(2012-2#9)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
study was conducted using a##3##5##(2008-10#1)(2012-2#1)(2013-1#1)
study was conducted using##6##4##(2008-10#2)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
study was conducted with a##2##5##(2007-2#1)(2011-2#1)
study was conducted with the aim to##2##7##(2011-2#1)(2013-7#1)
study was conducted with the aim##3##6##(2007-7#1)(2011-2#1)(2013-7#1)
study was conducted with the##4##5##(2007-11#1)(2007-7#1)(2011-2#1)(2013-7#1)
study was conducted with##9##4##(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)
study was conducted##319##3##(1990-10#1)(1990-12#1)(1990-4#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-2#1)(1993-1#2)(1993-5#1)(1994-1#2)(1994-6#1)(1995-1#1)(1995-10#3)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-8#1)(1997-6#3)(1997-7#2)(1997-8#1)(2004-11#5)(2004-2#1)(2005-10#2)(2005-5#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-2#2)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#6)(2007-10#4)(2007-11#4)(2007-12#3)(2007-2#9)(2007-3#6)(2007-4#3)(2007-6#2)(2007-7#14)(2007-8#8)(2008-1#5)(2008-10#20)(2008-11#5)(2008-12#6)(2008-3#8)(2008-4#3)(2008-5#9)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#7)(2009-10#4)(2009-11#1)(2009-12#1)(2009-5#3)(2009-6#4)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-5#5)(2010-8#4)(2011-1#11)(2011-12#6)(2011-2#23)(2012-1#4)(2012-12#13)(2012-2#18)(2012-3#3)(2012-5#1)(2013-1#12)(2013-7#6)(2013-8#10)
study was designed as a##7##5##(1996-1#1)(2004-1#1)(2010-3#1)(2010-4#1)(2011-2#2)(2013-1#1)
study was designed as##8##4##(1993-3#1)(1996-1#1)(2004-1#1)(2010-3#1)(2010-4#1)(2011-2#2)(2013-1#1)
study was designed in order to##3##6##(1996-12#1)(2005-11#1)(2011-1#1)
study was designed in##5##4##(1994-2#1)(1996-12#1)(2005-11#1)(2010-8#1)(2011-1#1)
study was designed to assess the value of##2##8##(1992-12#1)(2007-2#1)
study was designed to assess the##10##6##(1991-9#1)(1992-12#1)(1994-6#1)(2005-5#1)(2007-2#2)(2009-9#1)(2011-2#2)(2012-2#1)
study was designed to assess whether##3##6##(1994-3#1)(2006-5#1)(2007-10#1)
study was designed to assess##13##5##(1991-9#1)(1992-12#1)(1994-3#1)(1994-6#1)(2005-5#1)(2006-5#1)(2007-10#1)(2007-2#2)(2009-9#1)(2011-2#2)(2012-2#1)
study was designed to clarify##2##5##(1991-7#1)(2008-5#1)
study was designed to compare the efficacy##2##7##(1993-4#1)(2007-7#1)
study was designed to compare the##8##6##(1991-12#1)(1993-4#1)(1994-12#1)(1996-3#1)(2007-7#1)(2008-5#1)(2012-2#1)(2013-8#1)
study was designed to compare##15##5##(1991-12#1)(1993-4#1)(1994-12#1)(1996-3#2)(2007-1#1)(2007-7#1)(2007-9#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
study was designed to determine if##5##6##(1991-1#1)(1994-2#1)(1997-8#1)(2006-12#1)(2008-7#1)
study was designed to determine the effects of##2##8##(1990-5#1)(2008-4#1)
study was designed to determine the prevalence of##2##8##(2006-7#1)(2006-8#1)
study was designed to determine the prevalence##3##7##(2006-10#1)(2006-7#1)(2006-8#1)
study was designed to determine the##13##6##(1990-5#1)(1993-9#1)(1997-3#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-4#1)(2011-2#1)(2012-3#1)
study was designed to determine whether##5##6##(1992-11#1)(1992-3#1)(1996-1#1)(1996-7#1)(2009-4#1)
study was designed to determine##24##5##(1990-5#1)(1991-1#1)(1992-11#1)(1992-3#1)(1993-9#1)(1994-2#1)(1996-1#1)(1996-7#1)(1997-3#1)(1997-8#1)(2006-10#2)(2006-12#1)(2006-7#1)(2006-8#1)(2007-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-4#1)(2011-2#1)(2012-3#1)
study was designed to develop##3##5##(2008-10#1)(2009-10#1)(2011-2#1)
study was designed to estimate the##2##6##(2008-12#1)(2010-3#1)
study was designed to evaluate the effects of##2##8##(2011-1#1)(2011-2#1)
study was designed to evaluate the##17##6##(1994-9#1)(1995-8#1)(2006-6#1)(2007-11#1)(2007-7#3)(2007-9#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#2)
study was designed to evaluate##28##5##(1993-12#1)(1994-9#1)(1995-8#1)(2006-6#1)(2006-8#6)(2007-11#1)(2007-7#3)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#4)
study was designed to examine the effects of##3##8##(2006-10#1)(2008-10#1)(2012-2#1)
study was designed to examine the relationship between##2##8##(1992-2#1)(2011-2#1)
study was designed to examine the##10##6##(1992-2#1)(1992-8#1)(1993-12#1)(1994-11#1)(1996-5#1)(2006-10#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#1)
study was designed to examine whether##2##6##(1993-12#1)(1993-4#1)
study was designed to examine##12##5##(1992-2#1)(1992-8#1)(1993-12#2)(1993-4#1)(1994-11#1)(1996-5#1)(2006-10#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#1)
study was designed to explore the##4##6##(2006-10#1)(2007-10#1)(2008-3#1)(2011-2#1)
study was designed to identify##2##5##(1994-9#1)(2013-8#1)
study was designed to investigate the effect of##3##8##(2008-12#1)(2010-5#1)(2012-12#1)
study was designed to investigate the effects of##4##8##(1997-8#1)(2006-11#1)(2006-12#1)(2010-11#1)
study was designed to investigate the influence of##3##8##(1993-11#1)(2007-2#1)(2011-2#1)
study was designed to investigate the role of##3##8##(1993-11#1)(1995-3#1)(2009-5#1)
study was designed to investigate the##27##6##(1993-11#2)(1993-12#1)(1993-3#1)(1995-3#1)(1997-6#1)(1997-8#1)(2004-10#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-8#2)(2007-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-5#2)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#4)(2012-12#1)
study was designed to investigate whether##4##6##(1995-11#1)(1997-7#1)(2009-5#1)(2011-2#1)
study was designed to investigate##35##5##(1993-11#2)(1993-12#1)(1993-3#1)(1995-11#1)(1995-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-10#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-8#2)(2007-2#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-5#3)(2009-8#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-2#5)(2012-12#1)
study was designed to observe##2##5##(2007-10#1)(2012-3#1)
study was designed to study the##3##6##(2010-4#1)(2011-1#2)
study was designed to study##4##5##(2010-4#1)(2011-1#2)(2012-3#1)
study was designed to test the effects of##2##8##(1992-1#2)
study was designed to test the##4##6##(1992-1#2)(2006-8#1)(2008-7#1)
study was designed to##169##4##(1990-5#1)(1991-1#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#2)(1993-12#4)(1993-3#1)(1993-4#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-3#2)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-10#1)(2005-5#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#11)(2007-1#2)(2007-10#3)(2007-11#2)(2007-2#5)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#5)(2008-9#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2011-1#3)(2011-12#1)(2011-2#13)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#5)(2013-8#2)
study was designed##188##3##(1990-5#1)(1991-1#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#2)(1993-12#4)(1993-3#2)(1993-4#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-3#2)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-1#1)(2004-10#1)(2005-11#1)(2005-5#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#11)(2007-1#2)(2007-10#3)(2007-11#2)(2007-2#5)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#3)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#2)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#16)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#6)(2013-8#2)
study was developed##4##3##(2006-1#1)(2008-10#1)(2011-2#1)(2012-3#1)
study was done among##3##4##(2008-8#1)(2011-12#1)(2013-8#1)
study was done in order to##2##6##(1990-10#1)(2007-5#1)
study was done in##10##4##(1990-10#1)(1994-10#1)(1997-1#1)(1997-8#1)(2006-4#1)(2007-5#1)(2008-12#1)(2011-1#1)(2011-2#1)(2013-7#1)
study was done on 60##2##5##(2011-12#1)(2013-8#1)
study was done on patients##2##5##(2006-2#1)(2007-7#1)
study was done on##7##4##(2006-2#1)(2007-12#1)(2007-7#1)(2011-12#1)(2012-12#1)(2013-8#2)
study was done to assess the##4##6##(2008-4#1)(2010-4#1)(2011-1#1)(2013-8#1)
study was done to compare the##2##6##(2007-7#1)(2010-7#1)
study was done to evaluate##2##5##(2008-12#1)(2013-8#1)
study was done to##13##4##(2007-7#2)(2007-8#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-4#1)(2010-7#1)(2011-1#2)(2013-8#3)
study was done##43##3##(1990-10#1)(1994-10#1)(1995-3#1)(1996-11#1)(1997-1#1)(1997-8#1)(2006-2#1)(2006-4#1)(2007-12#2)(2007-5#1)(2007-7#4)(2007-8#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-4#1)(2010-7#1)(2011-1#3)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#7)
study was focused on##2##4##(2008-10#1)(2011-1#1)
study was initiated##4##3##(2008-10#3)(2008-4#1)
study was intended to##2##4##(2007-10#1)(2011-1#1)
study was made of the##3##5##(1993-2#1)(1997-6#1)(2008-10#1)
study was made of##8##4##(1992-5#1)(1992-8#1)(1993-2#1)(1997-6#1)(2006-2#1)(2006-8#1)(2008-10#1)(2012-12#1)
study was made on the##3##5##(2008-10#1)(2008-8#1)(2013-8#1)
study was made on##6##4##(1994-4#1)(2006-6#1)(2008-10#2)(2008-8#1)(2013-8#1)
study was made##23##3##(1990-2#1)(1992-5#1)(1992-8#1)(1993-2#1)(1994-4#1)(1997-6#1)(2006-2#1)(2006-6#2)(2006-8#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#2)(2012-12#2)(2013-1#1)(2013-8#1)
study was not##3##3##(1996-9#1)(2006-8#1)(2010-10#1)
study was part of a##3##5##(2006-7#1)(2006-8#1)(2013-1#1)
study was performed by##3##4##(1996-12#1)(2005-11#1)(2008-12#1)
study was performed in an interventional pain management##2##8##(2006-7#1)(2006-8#1)
study was performed in order to##7##6##(1996-6#1)(1997-5#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-7#1)(2009-7#1)
study was performed in the##2##5##(1991-12#1)(2011-2#1)
study was performed in##25##4##(1991-12#1)(1991-6#1)(1992-10#1)(1996-5#1)(1996-6#1)(1997-5#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-2#1)(2009-7#1)(2010-5#1)(2011-2#1)(2013-1#1)
study was performed on the##4##5##(2008-10#1)(2008-5#1)(2013-1#1)(2013-8#1)
study was performed on##21##4##(1990-6#1)(1991-6#1)(1996-5#1)(2005-10#1)(2005-5#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-12#1)(2010-3#1)(2011-12#1)(2013-1#2)(2013-8#2)
study was performed to assess the##5##6##(2006-12#2)(2007-10#1)(2008-5#1)(2013-1#1)
study was performed to characterize##2##5##(1993-2#1)(1994-2#1)
study was performed to compare##3##5##(1990-12#1)(1991-8#1)(2008-7#1)
study was performed to determine whether##3##6##(1990-11#1)(2008-7#1)(2011-2#1)
study was performed to determine##6##5##(1990-11#1)(2006-12#1)(2008-3#1)(2008-7#1)(2010-9#1)(2011-2#1)
study was performed to evaluate the##7##6##(1994-9#1)(2006-6#1)(2008-1#1)(2008-10#1)(2011-2#2)(2012-1#1)
study was performed to evaluate##8##5##(1994-9#1)(2006-6#1)(2008-1#1)(2008-10#1)(2011-2#2)(2012-1#1)(2013-8#1)
study was performed to examine the##3##6##(1994-2#1)(2008-2#1)(2008-7#1)
study was performed to investigate the effect of##2##8##(1992-8#1)(1996-12#1)
study was performed to investigate the##6##6##(1992-8#1)(1994-10#1)(1996-11#1)(1996-12#1)(1997-6#1)(2005-11#1)
study was performed to investigate##8##5##(1992-8#1)(1994-10#1)(1996-11#1)(1996-12#1)(1997-6#1)(2005-11#1)(2007-12#1)(2007-9#1)
study was performed to optimize##2##5##(2008-5#2)
study was performed to test the hypothesis that##2##8##(1997-2#1)(2004-11#1)
study was performed to##50##4##(1990-11#1)(1990-12#1)(1990-5#1)(1991-8#1)(1992-8#1)(1993-2#1)(1994-10#1)(1994-2#2)(1994-9#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-6#1)(1997-7#1)(2004-11#1)(2005-11#1)(2006-12#3)(2006-6#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#4)(2009-2#1)(2009-5#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-1#1)(2013-1#1)(2013-8#1)
study was performed using##3##4##(2007-10#1)(2008-10#1)(2010-5#1)
study was performed with##6##4##(1990-3#1)(1991-6#1)(2008-10#2)(2011-2#1)(2013-1#1)
study was performed##127##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-6#4)(1991-8#1)(1992-10#1)(1992-12#1)(1992-8#1)(1993-2#1)(1994-10#1)(1994-2#2)(1994-9#1)(1996-11#1)(1996-12#3)(1996-5#2)(1996-6#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-5#1)(2006-10#2)(2006-12#3)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-12#2)(2007-2#5)(2007-3#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#7)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#6)(2008-7#7)(2008-8#1)(2009-1#1)(2009-2#2)(2009-5#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-5#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#3)(2013-1#5)(2013-8#3)
study was planned as##2##4##(1990-6#1)(2010-7#1)
study was planned to##7##4##(1994-11#1)(1994-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
study was planned##11##3##(1990-3#1)(1990-6#1)(1994-11#1)(1994-12#1)(2010-7#1)(2012-3#1)(2013-1#1)(2013-8#4)
study was probably##2##3##(2010-8#1)(2011-2#1)
study was prospective##2##3##(2007-12#1)(2009-9#1)
study was published##2##3##(2006-10#1)(2009-2#1)
study was realized##2##3##(2008-2#1)(2013-1#1)
study was retrospective##4##3##(2006-8#1)(2007-11#1)(2009-9#1)(2012-3#1)
study was seen##2##3##(2007-7#1)(2008-10#1)
study was set up to##2##5##(1990-3#1)(2007-11#1)
study was set##4##3##(1990-3#1)(2007-11#1)(2011-2#1)(2012-3#1)
study was significantly##2##3##(1996-5#1)(2007-6#1)
study was started##3##3##(1991-6#1)(2008-11#1)(2008-8#1)
study was that##6##3##(2006-9#1)(2008-10#1)(2009-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
study was the determination of the##3##6##(1992-8#1)(1994-7#1)(2007-8#1)
study was the determination of##4##5##(1992-8#1)(1994-7#1)(2007-8#1)(2010-5#1)
study was the evaluation of##4##5##(2006-6#1)(2007-2#1)(2008-5#1)(2012-12#1)
study was the##26##3##(1992-8#1)(1993-4#1)(1994-2#1)(1994-7#1)(2006-6#1)(2007-11#3)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-9#1)(2010-5#1)(2012-12#2)(2012-2#2)(2013-1#1)
study was therefore carried out##2##5##(2010-10#1)(2011-2#1)
study was therefore designed to##3##5##(1994-12#2)(2009-5#1)
study was therefore to##2##4##(1990-5#1)(2009-6#1)
study was therefore##10##3##(1990-5#1)(1994-12#2)(2008-6#1)(2009-5#1)(2009-6#1)(2010-10#1)(2011-2#2)(2012-2#1)
study was to analyse the##11##5##(2007-10#1)(2007-8#2)(2008-5#1)(2008-6#1)(2009-2#1)(2010-3#1)(2011-1#1)(2011-12#1)(2013-1#1)(2013-8#1)
study was to analyse##16##4##(2007-10#1)(2007-11#1)(2007-8#3)(2008-5#1)(2008-6#1)(2009-2#1)(2010-3#1)(2011-1#2)(2011-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
study was to analyze the effect of##2##7##(1995-8#1)(2006-11#1)
study was to analyze the outcome of##2##7##(2007-3#1)(2007-8#1)
study was to analyze the##23##5##(1995-8#1)(1997-8#1)(2006-11#1)(2006-5#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#4)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-3#1)
study was to analyze##38##4##(1995-8#1)(1997-8#1)(2004-2#1)(2005-5#1)(2006-11#1)(2006-4#1)(2006-5#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#5)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#2)(2010-4#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#1)
study was to answer the##2##5##(1994-8#1)(2007-8#1)
study was to ascertain the##5##5##(1991-12#1)(2007-7#1)(2007-8#1)(2008-9#1)(2011-1#1)
study was to ascertain whether##2##5##(1997-8#1)(2010-7#1)
study was to ascertain##9##4##(1991-12#1)(1992-3#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-9#1)(2010-7#1)(2011-1#1)
study was to asses the##4##5##(2007-11#1)(2007-9#1)(2008-12#1)(2008-7#1)
study was to assess the effectiveness and safety of##2##9##(2006-6#1)(2008-3#1)
study was to assess the effectiveness of##7##7##(1993-9#1)(2007-7#2)(2011-2#2)(2012-12#1)(2012-3#1)
study was to assess the effectiveness##9##6##(1993-9#1)(2006-6#1)(2007-7#2)(2008-3#1)(2011-2#2)(2012-12#1)(2012-3#1)
study was to assess the efficacy of##3##7##(2007-7#1)(2008-5#1)(2009-2#1)
study was to assess the efficacy##4##6##(2006-7#1)(2007-7#1)(2008-5#1)(2009-2#1)
study was to assess the feasibility of##2##7##(1997-8#1)(2007-8#1)
study was to assess the feasibility##4##6##(1997-8#1)(2006-6#1)(2007-10#1)(2007-8#1)
study was to assess the influence of##4##7##(2008-5#1)(2009-2#1)(2010-10#1)(2013-7#1)
study was to assess the possible##2##6##(2007-9#1)(2012-3#1)
study was to assess the prevalence of##5##7##(2006-8#1)(2007-2#1)(2010-12#1)(2011-2#1)(2012-3#1)
study was to assess the prevalence##6##6##(2006-8#1)(2007-1#1)(2007-2#1)(2010-12#1)(2011-2#1)(2012-3#1)
study was to assess the risk##2##6##(2007-10#1)(2007-7#1)
study was to assess the##97##5##(1990-6#1)(1992-10#2)(1992-12#1)(1993-3#1)(1993-5#1)(1993-9#1)(1996-12#1)(1996-9#2)(1997-8#1)(2004-12#1)(2004-9#1)(2005-1#1)(2006-10#1)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-2#2)(2007-3#1)(2007-7#10)(2007-8#9)(2007-9#4)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#1)(2009-2#2)(2009-4#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#3)
study was to assess whether the##3##6##(1995-6#1)(2007-7#1)(2012-2#1)
study was to assess whether##9##5##(1991-6#1)(1995-6#1)(2006-7#1)(2006-8#2)(2007-7#1)(2008-5#1)(2008-7#1)(2012-2#1)
study was to assess##132##4##(1990-6#1)(1990-8#1)(1991-6#1)(1992-10#2)(1992-12#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-3#1)(1995-6#1)(1996-12#1)(1996-9#2)(1997-8#1)(2004-12#1)(2004-9#1)(2005-1#1)(2006-10#3)(2006-2#1)(2006-6#2)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-2#3)(2007-3#1)(2007-7#14)(2007-8#10)(2007-9#4)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#6)(2008-8#2)(2008-9#1)(2009-2#2)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#3)
study was to carry out##2##5##(2008-1#1)(2008-3#1)
study was to characterize and compare##2##6##(2008-11#1)(2013-1#1)
study was to characterize and##3##5##(2008-11#1)(2008-5#1)(2013-1#1)
study was to characterize the##6##5##(2004-9#1)(2007-8#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)
study was to characterize##15##4##(1993-1#1)(1994-8#1)(1996-11#1)(2004-9#1)(2007-8#1)(2008-11#2)(2008-5#3)(2009-11#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
study was to clarify the mechanism of##2##7##(2007-10#1)(2011-2#1)
study was to clarify the##4##5##(2007-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
study was to clarify##6##4##(2007-10#1)(2007-2#1)(2011-2#1)(2012-2#1)(2013-8#2)
study was to compare clinical##2##5##(2008-12#1)(2012-12#1)
study was to compare outcome in##2##6##(1990-2#1)(2007-8#1)
study was to compare the accuracy of##2##7##(2007-10#1)(2013-8#1)
study was to compare the effects of##5##7##(2006-11#1)(2007-8#3)(2013-1#1)
study was to compare the efficacy of##3##7##(2007-9#1)(2011-12#1)(2013-1#1)
study was to compare the incidence of##3##7##(2007-7#1)(2008-7#1)(2009-7#1)
study was to compare the results of##2##7##(2007-8#1)(2008-12#1)
study was to compare the results##4##6##(2007-7#1)(2007-8#1)(2008-12#1)(2013-1#1)
study was to compare the##58##5##(1992-10#1)(1994-3#1)(1996-6#1)(1997-5#1)(1997-8#2)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2007-10#2)(2007-4#1)(2007-7#5)(2007-8#6)(2007-9#3)(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-9#1)(2011-12#1)(2011-2#5)(2012-12#1)(2013-1#5)(2013-8#3)
study was to compare total##2##5##(1993-12#1)(2011-1#1)
study was to compare##97##4##(1990-2#1)(1992-10#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-3#1)(1996-6#1)(1997-5#1)(1997-8#3)(2004-1#1)(2004-9#1)(2005-8#1)(2006-10#2)(2006-11#2)(2006-12#1)(2007-10#2)(2007-2#2)(2007-4#1)(2007-7#6)(2007-8#11)(2007-9#3)(2008-10#1)(2008-11#1)(2008-12#5)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#4)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-12#3)(2013-1#7)(2013-7#1)(2013-8#4)
study was to confirm##4##4##(2006-4#1)(2007-8#1)(2008-10#1)(2012-2#1)
study was to correlate##2##4##(2004-12#1)(2013-8#1)
study was to define the effects of##2##7##(1997-7#1)(2007-9#1)
study was to define the effects##3##6##(1995-2#1)(1997-7#1)(2007-9#1)
study was to define the##5##5##(1995-2#1)(1997-7#1)(2007-9#1)(2011-2#1)(2013-7#1)
study was to define##10##4##(1991-5#1)(1995-2#1)(1997-7#1)(2006-11#1)(2007-9#1)(2008-9#1)(2011-2#1)(2013-1#2)(2013-7#1)
study was to delineate the##2##5##(2010-12#1)(2012-12#1)
study was to demonstrate the##2##5##(2007-8#1)(2009-2#1)
study was to describe and##4##5##(2007-1#1)(2009-5#1)(2012-12#1)(2013-1#1)
study was to describe the experiences##2##6##(2007-2#1)(2008-11#1)
study was to describe the health##2##6##(2006-7#1)(2010-10#1)
study was to describe the##18##5##(1992-8#1)(1993-12#1)(2006-7#1)(2007-2#2)(2008-11#1)(2008-4#1)(2009-3#1)(2009-7#1)(2010-10#1)(2010-5#1)(2011-1#1)(2012-12#2)(2013-1#3)(2013-7#1)
study was to describe##30##4##(1992-8#1)(1993-12#1)(1996-9#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-2#2)(2007-8#1)(2008-11#1)(2008-12#1)(2008-4#2)(2009-3#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-5#2)(2011-1#1)(2011-2#1)(2011-7#1)(2012-12#3)(2013-1#4)(2013-7#1)
study was to design a##2##5##(2008-10#1)(2008-5#1)
study was to detect##5##4##(1997-8#1)(2009-2#1)(2010-8#1)(2011-1#1)(2013-1#1)
study was to determine how##3##5##(1996-2#1)(2007-7#1)(2007-8#1)
study was to determine if a##6##6##(1997-3#1)(2006-1#1)(2008-12#1)(2008-9#1)(2009-10#1)(2010-8#1)
study was to determine if the##4##6##(1996-5#1)(2006-7#1)(2008-10#1)(2010-10#1)
study was to determine if##23##5##(1993-7#1)(1995-2#1)(1995-6#1)(1996-5#2)(1997-3#1)(2006-1#1)(2006-7#1)(2008-10#2)(2008-12#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2012-12#1)
study was to determine the changes in##3##7##(2011-1#1)(2012-2#2)
study was to determine the effect of##8##7##(1991-8#1)(1994-2#1)(1995-7#1)(2007-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)
study was to determine the effect on##2##7##(2004-9#1)(2008-8#1)
study was to determine the effect##10##6##(1991-8#1)(1994-2#1)(1995-7#1)(2004-9#1)(2007-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#1)
study was to determine the effects of##13##7##(1993-7#1)(2005-12#1)(2007-2#1)(2008-10#1)(2008-5#3)(2010-4#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#2)
study was to determine the efficacy and##2##7##(2007-7#1)(2008-6#1)
study was to determine the efficacy##4##6##(2006-5#1)(2007-7#2)(2008-6#1)
study was to determine the extent##3##6##(1996-12#1)(2006-8#1)(2007-7#1)
study was to determine the genetic diversity##2##7##(2006-4#1)(2007-2#1)
study was to determine the influence of##8##7##(2004-11#1)(2006-8#1)(2007-11#1)(2007-8#1)(2009-2#1)(2009-5#1)(2011-2#2)
study was to determine the presence##2##6##(2006-10#1)(2012-12#1)
study was to determine the prevalence of##9##7##(1993-12#1)(2006-8#1)(2007-2#1)(2008-12#2)(2008-3#1)(2008-4#1)(2010-2#1)(2013-1#1)
study was to determine the prevalence##11##6##(1993-12#1)(2006-8#2)(2007-2#1)(2008-12#2)(2008-3#1)(2008-4#1)(2010-2#1)(2013-1#1)(2013-8#1)
study was to determine the relationship of##2##7##(2009-5#1)(2011-2#1)
study was to determine the relationship##8##6##(2007-3#1)(2008-10#1)(2008-12#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-8#1)
study was to determine the usefulness of##2##7##(2005-12#1)(2008-5#1)
study was to determine the##156##5##(1990-12#1)(1991-11#1)(1991-8#1)(1992-11#1)(1993-12#1)(1993-7#1)(1994-2#1)(1994-5#1)(1995-7#1)(1996-12#2)(1996-4#1)(1996-9#1)(1997-6#1)(2004-10#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-12#3)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-8#6)(2007-1#1)(2007-10#2)(2007-11#1)(2007-2#11)(2007-3#2)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#6)(2008-3#2)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-2#2)(2009-5#3)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#12)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#1)(2012-6#1)(2013-1#6)(2013-3#1)(2013-7#1)(2013-8#8)
study was to determine what##2##5##(2006-2#1)(2006-5#1)
study was to determine whether or not the##2##8##(2006-8#1)(2007-7#1)
study was to determine whether the##3##6##(1990-8#1)(1995-12#1)(2007-7#1)
study was to determine whether##46##5##(1990-10#1)(1990-3#1)(1990-8#1)(1991-2#1)(1992-11#1)(1992-7#1)(1993-3#1)(1993-9#1)(1994-11#1)(1995-12#1)(1995-3#2)(1997-8#1)(2006-12#1)(2006-5#2)(2006-7#1)(2006-8#2)(2007-10#4)(2007-2#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#1)(2013-7#1)
study was to determine which##7##5##(1995-5#1)(2006-1#1)(2007-8#1)(2008-11#1)(2009-2#1)(2012-2#1)(2013-1#1)
study was to determine##260##4##(1990-10#1)(1990-12#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-11#2)(1992-7#1)(1993-12#1)(1993-3#1)(1993-7#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#1)(1996-12#3)(1996-2#1)(1996-4#1)(1996-5#2)(1996-9#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-10#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-12#3)(2005-8#1)(2006-1#2)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#5)(2006-7#2)(2006-8#8)(2007-1#1)(2007-10#8)(2007-11#1)(2007-2#16)(2007-3#2)(2007-4#2)(2007-7#8)(2007-8#8)(2007-9#3)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#8)(2008-3#2)(2008-4#4)(2008-5#9)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#5)(2009-10#1)(2009-2#4)(2009-5#4)(2009-6#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#2)(2010-6#3)(2010-7#2)(2010-8#3)(2011-1#5)(2011-2#18)(2012-1#2)(2012-12#3)(2012-2#7)(2012-3#3)(2012-6#1)(2013-1#8)(2013-3#1)(2013-7#2)(2013-8#10)
study was to develop a##27##5##(1993-11#1)(1993-12#1)(1997-3#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-4#2)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#3)(2008-6#1)(2010-2#1)(2010-9#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-4#1)(2013-1#2)(2013-7#2)
study was to develop and validate##4##6##(2006-11#1)(2011-1#1)(2012-1#2)
study was to develop and##11##5##(2006-11#1)(2007-7#1)(2008-10#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-2#1)
study was to develop novel##2##5##(2008-5#1)(2009-4#1)
study was to develop##55##4##(1993-11#1)(1993-12#1)(1997-3#1)(2006-11#2)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-4#2)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#4)(2008-4#1)(2008-5#6)(2008-6#1)(2009-4#1)(2010-2#1)(2010-3#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-1#5)(2012-12#1)(2012-2#3)(2012-4#1)(2013-1#5)(2013-7#2)
study was to document the##2##5##(2008-10#1)(2009-2#1)
study was to document##4##4##(2006-10#1)(2006-2#1)(2008-10#1)(2009-2#1)
study was to elucidate whether##2##5##(1992-12#1)(2013-1#1)
study was to elucidate##10##4##(1992-12#1)(1995-6#1)(2005-10#1)(2006-11#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-8#1)(2013-1#1)(2013-8#1)
study was to establish a##6##5##(1990-10#1)(1992-8#1)(2007-10#1)(2007-5#1)(2010-6#1)(2013-1#1)
study was to establish an##2##5##(1997-8#1)(2010-4#1)
study was to establish the##5##5##(1994-2#1)(2007-11#1)(2007-3#1)(2012-3#1)(2013-7#1)
study was to establish##19##4##(1990-10#1)(1992-8#1)(1994-2#1)(1997-8#1)(2004-9#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-3#1)(2007-5#1)(2008-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2012-3#1)(2013-1#1)(2013-7#1)
study was to estimate the prevalence of##3##7##(2007-3#1)(2008-3#1)(2013-8#1)
study was to estimate the prevalence##4##6##(2007-3#1)(2008-3#1)(2013-7#1)(2013-8#1)
study was to estimate the##17##5##(1996-1#1)(2006-8#1)(2007-2#1)(2007-3#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#2)
study was to estimate##21##4##(1996-1#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#2)
study was to evaluate a new##2##6##(2006-10#1)(2007-7#1)
study was to evaluate a##9##5##(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#2)(2009-5#1)(2012-2#1)(2013-8#1)
study was to evaluate and compare the##3##7##(2007-11#1)(2011-12#1)(2013-8#1)
study was to evaluate and##5##5##(1992-12#1)(2007-11#1)(2007-8#1)(2011-12#1)(2013-8#1)
study was to evaluate changes in##2##6##(2006-6#1)(2008-12#1)
study was to evaluate clinical##2##5##(2007-8#1)(2013-8#1)
study was to evaluate effects of##2##6##(2008-12#1)(2010-7#1)
study was to evaluate if##2##5##(1996-3#1)(1996-9#1)
study was to evaluate the antimicrobial activity of##2##8##(2008-5#1)(2011-1#1)
study was to evaluate the association between##3##7##(2006-6#1)(2010-12#1)(2011-1#1)
study was to evaluate the clinical##3##6##(1990-10#1)(2006-12#1)(2013-1#1)
study was to evaluate the effect of different##2##8##(2008-5#1)(2012-2#1)
study was to evaluate the effect of##15##7##(1992-8#1)(1996-2#1)(2004-1#1)(2006-5#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-5#2)(2010-10#1)(2012-2#3)(2013-1#1)
study was to evaluate the effect##16##6##(1992-8#1)(1996-2#1)(2004-1#1)(2006-5#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-5#2)(2010-10#1)(2010-4#1)(2012-2#3)(2013-1#1)
study was to evaluate the effectiveness of a##3##8##(2006-2#1)(2006-6#1)(2008-9#1)
study was to evaluate the effectiveness of the##3##8##(2007-7#1)(2007-8#2)
study was to evaluate the effectiveness of##10##7##(2006-2#1)(2006-6#1)(2006-8#1)(2007-7#3)(2007-8#2)(2008-9#1)(2013-1#1)
study was to evaluate the efficacy of##8##7##(2006-10#1)(2007-7#2)(2008-5#2)(2009-8#1)(2013-1#1)(2013-7#1)
study was to evaluate the feasibility##2##6##(2006-11#1)(2013-1#1)
study was to evaluate the impact##4##6##(1996-1#1)(2006-8#1)(2007-11#1)(2008-12#1)
study was to evaluate the in##2##6##(2007-9#1)(2008-5#1)
study was to evaluate the influence of##8##7##(2006-10#1)(2006-9#1)(2007-7#1)(2007-9#1)(2008-12#1)(2009-8#1)(2013-1#1)(2013-8#1)
study was to evaluate the influence##9##6##(2006-10#1)(2006-9#1)(2007-7#1)(2007-9#1)(2008-12#1)(2008-7#1)(2009-8#1)(2013-1#1)(2013-8#1)
study was to evaluate the long-term##2##6##(2010-3#1)(2013-1#1)
study was to evaluate the possibility##2##6##(2007-7#1)(2007-8#1)
study was to evaluate the reliability##2##6##(2007-12#1)(2010-10#1)
study was to evaluate the results of##5##7##(1997-8#1)(2007-11#1)(2007-7#1)(2008-9#1)(2011-2#1)
study was to evaluate the role of##6##7##(2005-10#1)(2007-7#1)(2007-8#1)(2008-5#1)(2011-2#1)(2013-1#1)
study was to evaluate the utility of##2##7##(2007-7#1)(2008-7#1)
study was to evaluate the validity of##2##7##(2007-8#1)(2012-1#1)
study was to evaluate the validity##3##6##(2007-12#1)(2007-8#1)(2012-1#1)
study was to evaluate the##178##5##(1990-10#1)(1990-11#1)(1991-3#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-11#1)(1996-1#1)(1996-2#1)(1997-3#1)(1997-6#1)(1997-8#4)(2004-1#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#4)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#2)(2007-2#1)(2007-7#11)(2007-8#13)(2007-9#4)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#8)(2008-3#2)(2008-4#1)(2008-5#11)(2008-7#4)(2008-8#2)(2008-9#4)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#2)(2010-12#1)(2010-3#2)(2010-4#5)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#2)(2011-2#6)(2012-1#3)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#17)(2013-7#1)(2013-8#3)
study was to evaluate this##2##5##(1993-6#1)(1994-5#1)
study was to evaluate three##2##5##(2004-12#1)(2010-11#1)
study was to evaluate whether##12##5##(1992-2#1)(2006-10#1)(2006-8#2)(2007-11#1)(2008-11#1)(2008-7#1)(2010-11#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
study was to evaluate##268##4##(1990-10#1)(1990-11#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#7)(2004-1#1)(2004-12#1)(2005-10#2)(2005-11#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#3)(2006-6#5)(2006-7#4)(2006-8#5)(2006-9#1)(2007-10#1)(2007-11#9)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#14)(2007-8#18)(2007-9#5)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#10)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#15)(2008-6#1)(2008-7#9)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#1)(2010-3#2)(2010-4#5)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#5)(2011-12#3)(2011-2#11)(2012-1#3)(2012-12#3)(2012-2#12)(2012-3#2)(2013-1#19)(2013-7#1)(2013-8#10)
study was to examine the effect of##5##7##(1995-10#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-6#1)
study was to examine the effects of a##2##8##(2007-12#1)(2013-8#1)
study was to examine the effects of##10##7##(1991-12#1)(2005-11#1)(2007-12#1)(2007-9#1)(2008-5#1)(2008-6#1)(2009-7#1)(2013-1#1)(2013-8#2)
study was to examine the feasibility of##3##7##(1995-2#1)(2007-8#1)(2008-11#1)
study was to examine the possible##3##6##(1996-2#1)(2011-2#1)(2012-12#1)
study was to examine the relationship between##5##7##(1997-7#1)(2007-1#1)(2007-12#1)(2010-2#1)(2011-2#1)
study was to examine the relationship##6##6##(1997-7#1)(2007-1#1)(2007-12#1)(2010-2#1)(2011-2#2)
study was to examine the safety and efficacy of##3##9##(2004-1#1)(2006-4#1)(2008-5#1)
study was to examine the##81##5##(1991-12#1)(1992-2#1)(1992-6#1)(1993-12#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-3#1)(1997-7#1)(2004-1#1)(2005-11#1)(2006-4#1)(2006-7#1)(2006-8#2)(2007-1#2)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#3)(2008-12#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-7#3)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-9#1)(2011-1#4)(2011-2#7)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#4)
study was to examine whether##6##5##(1991-10#1)(1994-10#1)(1997-2#1)(2006-7#1)(2007-6#1)(2013-1#1)
study was to examine##115##4##(1991-10#1)(1991-12#1)(1992-2#2)(1992-6#1)(1993-12#1)(1994-10#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-1#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-4#1)(2006-7#3)(2006-8#2)(2007-1#2)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#2)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#4)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#2)(2009-5#2)(2009-7#4)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-9#1)(2011-1#4)(2011-2#9)(2012-11#1)(2012-12#2)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#4)
study was to explore the effect of##2##7##(2007-1#1)(2008-1#1)
study was to explore the relationship between##3##7##(2006-8#1)(2007-3#1)(2010-11#1)
study was to explore the##25##5##(1996-3#1)(2004-9#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-3#1)(2007-7#2)(2008-1#1)(2008-12#1)(2008-7#2)(2009-11#1)(2009-9#1)(2010-11#1)(2010-12#2)(2011-2#2)(2012-1#2)(2012-12#1)(2013-1#1)(2013-8#1)
study was to explore##44##4##(1996-3#1)(1997-7#1)(2004-9#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#3)(2008-1#1)(2008-11#1)(2008-12#3)(2008-7#2)(2009-11#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
study was to extend##2##4##(2011-2#1)(2012-2#1)
study was to find a##2##5##(2008-6#1)(2009-10#1)
study was to find out##6##5##(1990-2#1)(2006-8#1)(2007-1#1)(2007-3#1)(2007-6#1)(2007-8#1)
study was to find##9##4##(1990-2#1)(2006-8#1)(2007-1#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-6#1)(2009-10#1)(2012-12#1)
study was to formulate##3##4##(2008-5#1)(2010-2#1)(2012-7#1)
study was to further evaluate##2##5##(1995-2#1)(2011-2#1)
study was to further##7##4##(1992-12#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-5#1)(2011-2#1)
study was to gather##2##4##(2006-10#1)(2006-6#1)
study was to identify and##2##5##(2009-8#1)(2010-3#1)
study was to identify the prevalence##2##6##(2011-2#2)
study was to identify the##26##5##(1994-5#1)(1996-12#1)(2006-12#1)(2007-11#2)(2007-2#2)(2007-3#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-1#1)(2009-2#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-9#1)(2011-2#5)(2012-11#1)
study was to identify##54##4##(1990-2#1)(1994-5#1)(1996-12#1)(1997-8#1)(2004-10#1)(2006-10#2)(2006-12#1)(2007-11#2)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-1#1)(2009-2#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-9#1)(2011-1#1)(2011-2#9)(2012-1#1)(2012-11#1)(2013-1#1)
study was to improve##4##4##(1994-2#1)(2008-11#1)(2009-4#1)(2012-3#1)
study was to investigate an##2##5##(2008-9#1)(2010-2#1)
study was to investigate possible##4##5##(1995-12#1)(2006-6#1)(2008-10#1)(2012-2#1)
study was to investigate the distribution of##2##7##(1992-11#1)(2006-8#1)
study was to investigate the effect of a##2##8##(2009-12#1)(2011-12#1)
study was to investigate the effect of##25##7##(1994-6#1)(1995-3#1)(1996-7#1)(2005-8#1)(2007-10#2)(2007-8#1)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-6#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#2)(2011-1#1)(2011-11#1)(2011-12#1)(2012-2#1)
study was to investigate the effectiveness of##4##7##(2007-3#1)(2007-8#1)(2013-1#2)
study was to investigate the effects of##12##7##(1990-8#1)(1990-9#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
study was to investigate the effects##13##6##(1990-8#1)(1990-9#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
study was to investigate the efficacy of##3##7##(2008-10#1)(2008-3#1)(2013-1#1)
study was to investigate the influence of##7##7##(1995-12#1)(2007-2#1)(2008-12#1)(2009-6#1)(2010-2#1)(2011-1#1)(2011-2#1)
study was to investigate the mechanism##2##6##(2008-4#1)(2012-12#1)
study was to investigate the relationship between the##4##8##(2008-5#1)(2008-8#1)(2009-7#1)(2010-12#1)
study was to investigate the relationship between##11##7##(1991-10#1)(2006-7#1)(2008-5#1)(2008-8#1)(2009-7#2)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#2)
study was to investigate the relationships##3##6##(2007-12#1)(2008-10#1)(2013-1#1)
study was to investigate the##149##5##(1990-8#1)(1990-9#1)(1991-10#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-7#1)(2006-8#3)(2007-10#4)(2007-11#1)(2007-12#1)(2007-2#3)(2007-3#1)(2007-4#2)(2007-6#1)(2007-8#8)(2008-1#1)(2008-10#7)(2008-12#4)(2008-3#3)(2008-4#2)(2008-5#8)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-6#3)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#6)(2010-2#3)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#4)(2011-11#1)(2011-12#2)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#6)(2013-1#11)(2013-7#2)(2013-8#4)
study was to investigate whether and##2##6##(2008-11#1)(2011-2#1)
study was to investigate whether the##6##6##(1995-4#1)(1997-7#1)(2007-10#1)(2008-5#1)(2010-7#1)(2012-12#1)
study was to investigate whether there is##2##7##(2011-1#1)(2012-1#1)
study was to investigate whether##23##5##(1995-4#1)(1995-9#1)(1997-7#1)(2006-5#1)(2007-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2010-3#1)(2010-7#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#2)
study was to investigate##219##4##(1990-8#1)(1990-9#1)(1991-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#2)(2005-10#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#6)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#1)(2007-12#2)(2007-2#4)(2007-3#1)(2007-4#2)(2007-6#2)(2007-8#8)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-12#5)(2008-3#3)(2008-4#3)(2008-5#12)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#4)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-6#3)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#6)(2010-2#4)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#5)(2011-11#1)(2011-12#3)(2011-2#9)(2012-1#3)(2012-12#5)(2012-2#7)(2012-3#2)(2013-1#13)(2013-7#5)(2013-8#4)
study was to isolate##5##4##(1991-7#1)(1993-8#1)(2007-4#1)(2008-10#1)(2008-5#1)
study was to localize the##2##5##(1993-8#1)(1995-2#1)
study was to localize##3##4##(1993-8#1)(1995-2#1)(2006-8#1)
study was to look##3##4##(2004-10#1)(2006-8#1)(2007-2#1)
study was to measure the##8##5##(1990-8#1)(2006-7#1)(2007-1#1)(2008-5#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)
study was to measure##11##4##(1990-8#1)(1992-3#1)(2006-7#1)(2007-1#1)(2008-5#1)(2009-7#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#2)
study was to monitor##3##4##(1994-12#1)(2007-8#1)(2010-5#1)
study was to observe##2##4##(2011-2#1)(2013-1#1)
study was to obtain##8##4##(1993-1#1)(1996-4#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-6#1)
study was to prepare and characterize##2##6##(2010-12#1)(2012-12#1)
study was to prepare##5##4##(2008-5#3)(2010-12#1)(2012-12#1)
study was to present the##3##5##(2005-10#1)(2011-2#1)(2012-12#1)
study was to present##8##4##(1994-2#1)(2005-10#1)(2008-10#2)(2008-6#1)(2011-2#2)(2012-12#1)
study was to produce##2##4##(1996-12#1)(2012-2#1)
study was to provide a##5##5##(1995-2#1)(2007-5#1)(2007-8#1)(2009-5#1)(2012-1#1)
study was to provide the##2##5##(2011-2#1)(2013-8#1)
study was to provide##10##4##(1995-2#1)(2004-3#1)(2007-2#1)(2007-5#1)(2007-8#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
study was to quantify##8##4##(1996-6#1)(2007-1#1)(2007-10#1)(2007-4#2)(2008-10#1)(2009-5#1)(2010-9#1)
study was to report a##4##5##(2008-5#1)(2013-1#1)(2013-8#2)
study was to report##7##4##(2008-5#1)(2008-9#2)(2012-1#1)(2013-1#1)(2013-8#2)
study was to review the##6##5##(2006-10#1)(2006-2#1)(2007-2#1)(2008-10#1)(2008-9#1)(2012-12#1)
study was to review##13##4##(1996-2#1)(2005-4#1)(2006-10#2)(2006-2#1)(2007-2#2)(2007-3#1)(2008-10#1)(2008-9#1)(2012-1#1)(2012-12#1)(2013-8#1)
study was to screen##3##4##(2007-2#1)(2008-10#1)(2008-3#1)
study was to search for##4##5##(2007-8#1)(2008-12#1)(2008-4#1)(2008-7#1)
study was to see the##2##5##(2011-2#1)(2012-2#1)
study was to see##3##4##(2008-12#1)(2011-2#1)(2012-2#1)
study was to show##4##4##(1995-7#1)(2006-8#1)(2007-11#1)(2008-12#1)
study was to specify##2##4##(2007-8#2)
study was to systematically##2##4##(1993-2#1)(2007-10#1)
study was to test the hypothesis that##6##7##(1990-8#1)(1993-12#1)(1996-9#1)(2006-9#1)(2007-10#1)(2009-6#1)
study was to test the##11##5##(1990-8#1)(1993-12#1)(1996-9#1)(2006-9#1)(2007-10#1)(2008-2#1)(2008-8#1)(2009-2#1)(2009-6#1)(2010-3#1)(2012-1#1)
study was to test##18##4##(1990-8#1)(1993-12#2)(1995-11#1)(1995-3#1)(1996-9#1)(2006-9#1)(2007-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2009-1#1)(2009-2#1)(2009-6#1)(2010-3#1)(2012-1#1)(2012-3#1)
study was to use##11##4##(1993-12#1)(2006-3#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#2)
study was to validate the##4##5##(2007-8#1)(2008-12#1)(2008-9#1)(2013-1#1)
study was to validate##5##4##(2007-8#1)(2008-12#1)(2008-8#1)(2008-9#1)(2013-1#1)
study was to verify whether the##3##6##(1997-1#1)(2007-3#1)(2010-9#1)
study was to verify##10##4##(1996-3#1)(1997-1#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-6#2)(2008-7#2)(2010-9#1)
study was to##1736##3##(1990-10#3)(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-6#1)(1990-8#5)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-10#3)(1992-11#3)(1992-12#4)(1992-2#4)(1992-3#5)(1992-6#1)(1992-7#1)(1992-8#4)(1993-1#3)(1993-11#1)(1993-12#11)(1993-2#3)(1993-3#3)(1993-5#1)(1993-6#1)(1993-7#2)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#6)(1994-3#2)(1994-5#4)(1994-6#1)(1994-8#2)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#6)(1995-3#5)(1995-4#1)(1995-5#1)(1995-6#4)(1995-7#2)(1995-8#1)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#1)(1996-12#8)(1996-2#4)(1996-3#5)(1996-4#2)(1996-5#2)(1996-6#3)(1996-7#1)(1996-9#7)(1997-1#1)(1997-2#3)(1997-3#6)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#21)(2004-1#3)(2004-10#3)(2004-11#1)(2004-12#4)(2004-2#1)(2004-3#1)(2004-9#6)(2005-1#1)(2005-10#7)(2005-11#3)(2005-12#3)(2005-4#1)(2005-5#1)(2005-7#1)(2005-8#3)(2006-1#3)(2006-10#24)(2006-11#12)(2006-12#6)(2006-2#8)(2006-3#1)(2006-4#4)(2006-5#13)(2006-6#9)(2006-7#14)(2006-8#35)(2006-9#6)(2007-1#12)(2007-10#35)(2007-11#25)(2007-12#11)(2007-2#40)(2007-3#14)(2007-4#11)(2007-5#4)(2007-6#8)(2007-7#56)(2007-8#83)(2007-9#25)(2008-1#7)(2008-10#55)(2008-11#29)(2008-12#45)(2008-2#4)(2008-3#19)(2008-4#20)(2008-5#75)(2008-6#25)(2008-7#39)(2008-8#18)(2008-9#31)(2009-1#4)(2009-10#4)(2009-11#5)(2009-12#4)(2009-2#15)(2009-3#4)(2009-4#9)(2009-5#13)(2009-6#7)(2009-7#12)(2009-8#9)(2009-9#7)(2010-1#4)(2010-10#13)(2010-11#4)(2010-12#18)(2010-2#11)(2010-3#14)(2010-4#16)(2010-5#8)(2010-6#8)(2010-7#7)(2010-8#11)(2010-9#11)(2011-1#38)(2011-11#1)(2011-12#11)(2011-2#102)(2011-7#1)(2012-1#25)(2012-11#4)(2012-12#34)(2012-2#44)(2012-3#23)(2012-4#1)(2012-6#1)(2012-7#1)(2013-1#86)(2013-3#1)(2013-7#20)(2013-8#50)
study was undertaken among##3##4##(2007-7#1)(2011-12#1)(2012-2#1)
study was undertaken during##2##4##(2008-4#1)(2011-1#1)
study was undertaken in order to##3##6##(1991-5#1)(2006-6#1)(2007-10#1)
study was undertaken in the##4##5##(2008-5#2)(2009-6#1)(2011-2#1)
study was undertaken in##13##4##(1990-10#1)(1991-5#1)(1992-3#1)(2005-8#1)(2006-6#1)(2007-10#1)(2008-10#1)(2008-3#2)(2008-5#2)(2009-6#1)(2011-2#1)
study was undertaken of##3##4##(1990-12#1)(2004-10#1)(2005-9#1)
study was undertaken on##3##4##(2011-1#1)(2012-2#1)(2012-3#1)
study was undertaken to analyze the##2##6##(2007-11#1)(2010-8#1)
study was undertaken to analyze##3##5##(2005-10#1)(2007-11#1)(2010-8#1)
study was undertaken to assess the##8##6##(1991-12#1)(1994-6#1)(1997-2#1)(2008-10#1)(2008-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
study was undertaken to assess##9##5##(1991-12#1)(1993-12#1)(1994-6#1)(1997-2#1)(2008-10#1)(2008-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
study was undertaken to compare the##3##6##(1995-2#1)(2008-5#1)(2011-2#1)
study was undertaken to compare##5##5##(1992-3#1)(1995-2#1)(2008-5#2)(2011-2#1)
study was undertaken to determine the effects of##2##8##(1995-10#1)(1996-2#1)
study was undertaken to determine the prevalence##2##7##(2006-10#1)(2012-12#1)
study was undertaken to determine the##15##6##(1993-4#1)(1994-2#1)(1995-10#1)(1995-3#1)(1996-2#1)(2006-10#2)(2007-8#2)(2008-12#1)(2008-7#2)(2009-3#1)(2010-4#1)(2012-12#1)
study was undertaken to determine whether direct##2##7##(2007-1#1)(2008-6#1)
study was undertaken to determine whether##6##6##(1993-2#1)(1993-6#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-6#1)
study was undertaken to determine##25##5##(1993-2#1)(1993-4#1)(1993-6#1)(1994-2#1)(1995-10#1)(1995-3#1)(1996-2#1)(1996-5#1)(2006-10#2)(2007-1#1)(2007-12#1)(2007-8#3)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#2)(2009-3#1)(2010-4#1)(2010-6#1)(2012-12#1)(2013-8#1)
study was undertaken to establish##3##5##(2008-10#1)(2012-2#2)
study was undertaken to evaluate the effect of##2##8##(1991-4#1)(2006-1#1)
study was undertaken to evaluate the efficacy of##3##8##(2007-2#1)(2007-7#1)(2008-7#1)
study was undertaken to evaluate the##13##6##(1991-4#1)(1996-1#1)(2006-1#1)(2006-5#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#2)(2010-9#1)(2011-1#1)(2013-1#1)
study was undertaken to evaluate##17##5##(1991-4#1)(1996-1#1)(2006-1#1)(2006-5#1)(2006-8#3)(2007-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#2)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
study was undertaken to examine the##3##6##(1991-8#1)(1996-6#1)(2009-12#1)
study was undertaken to examine##9##5##(1991-8#1)(1996-6#1)(2007-3#1)(2007-8#1)(2008-5#1)(2009-12#1)(2010-8#1)(2011-2#2)
study was undertaken to find out##3##6##(2007-7#1)(2007-8#1)(2009-6#1)
study was undertaken to investigate the effect of##2##8##(2007-9#1)(2008-7#1)
study was undertaken to investigate the##8##6##(1994-12#1)(2006-9#1)(2007-9#1)(2008-7#1)(2008-8#1)(2010-3#1)(2012-2#2)
study was undertaken to investigate##11##5##(1994-12#1)(1997-2#1)(1997-8#1)(2006-9#1)(2007-9#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-3#1)(2012-2#2)
study was undertaken to study the##6##6##(1994-12#1)(2006-1#2)(2011-2#1)(2012-12#1)(2013-8#1)
study was undertaken to test the##5##6##(1993-9#1)(1994-1#1)(2007-11#1)(2008-10#1)(2008-5#1)
study was undertaken to test##6##5##(1993-9#1)(1994-1#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-5#1)
study was undertaken to##113##4##(1991-10#1)(1991-12#1)(1991-4#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-6#1)(1993-9#2)(1994-1#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-8#1)(2005-10#1)(2005-12#1)(2006-1#3)(2006-10#2)(2006-5#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#2)(2007-7#4)(2007-8#5)(2007-9#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#1)(2009-12#1)(2009-3#1)(2009-6#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#3)
study was undertaken with the aim of evaluating the effect of associated atopy on severity and age at onset of alopecia areata in north Indians##2##25##(2007-7#1)(2007-8#1)
study was undertaken with the##3##5##(2007-7#1)(2007-8#1)(2011-1#1)
study was undertaken##150##3##(1990-10#1)(1990-12#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-3#2)(1993-12#2)(1993-2#1)(1993-4#1)(1993-6#1)(1993-9#2)(1994-1#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-8#1)(2004-10#1)(2005-10#1)(2005-12#1)(2005-8#1)(2005-9#1)(2006-1#3)(2006-10#2)(2006-5#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#3)(2007-7#7)(2007-8#6)(2007-9#1)(2008-10#6)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-6#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#6)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#5)
study was used to##3##4##(1991-8#1)(2010-3#1)(2010-6#1)
study was used##6##3##(1991-8#1)(2004-8#1)(2007-12#1)(2010-3#1)(2010-6#1)(2011-1#1)
study was##3111##2##(1990-10#9)(1990-11#4)(1990-12#7)(1990-2#6)(1990-3#5)(1990-4#1)(1990-5#3)(1990-6#6)(1990-7#1)(1990-8#8)(1990-9#2)(1991-1#2)(1991-10#5)(1991-11#2)(1991-12#8)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#8)(1991-7#2)(1991-8#6)(1991-9#2)(1992-1#2)(1992-10#6)(1992-11#5)(1992-12#9)(1992-2#7)(1992-3#8)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#10)(1993-1#5)(1993-11#3)(1993-12#18)(1993-2#6)(1993-3#7)(1993-4#5)(1993-5#2)(1993-6#2)(1993-7#4)(1993-8#2)(1993-9#6)(1994-1#4)(1994-10#3)(1994-11#5)(1994-12#12)(1994-2#13)(1994-3#6)(1994-4#1)(1994-5#5)(1994-6#10)(1994-7#1)(1994-8#4)(1994-9#3)(1995-1#4)(1995-10#5)(1995-11#4)(1995-12#4)(1995-2#9)(1995-3#10)(1995-4#1)(1995-5#3)(1995-6#4)(1995-7#3)(1995-8#3)(1995-9#3)(1996-1#9)(1996-10#2)(1996-11#4)(1996-12#13)(1996-2#8)(1996-3#8)(1996-4#2)(1996-5#7)(1996-6#6)(1996-7#3)(1996-8#1)(1996-9#8)(1997-1#2)(1997-2#7)(1997-3#9)(1997-4#2)(1997-5#4)(1997-6#9)(1997-7#10)(1997-8#29)(2004-1#6)(2004-10#6)(2004-11#8)(2004-12#4)(2004-2#2)(2004-3#1)(2004-8#1)(2004-9#8)(2005-1#1)(2005-10#12)(2005-11#7)(2005-12#4)(2005-4#1)(2005-5#4)(2005-7#1)(2005-8#5)(2005-9#2)(2006-1#7)(2006-10#48)(2006-11#14)(2006-12#13)(2006-2#18)(2006-3#1)(2006-4#10)(2006-5#19)(2006-6#18)(2006-7#19)(2006-8#63)(2006-9#9)(2007-1#19)(2007-10#50)(2007-11#42)(2007-12#24)(2007-2#70)(2007-3#28)(2007-4#15)(2007-5#5)(2007-6#19)(2007-7#99)(2007-8#118)(2007-9#33)(2008-1#17)(2008-10#124)(2008-11#46)(2008-12#70)(2008-2#12)(2008-3#46)(2008-4#37)(2008-5#124)(2008-6#35)(2008-7#72)(2008-8#28)(2008-9#42)(2009-1#5)(2009-10#11)(2009-11#6)(2009-12#10)(2009-2#21)(2009-3#6)(2009-4#10)(2009-5#23)(2009-6#17)(2009-7#15)(2009-8#11)(2009-9#12)(2010-1#4)(2010-10#16)(2010-11#8)(2010-12#28)(2010-2#16)(2010-3#24)(2010-4#27)(2010-5#21)(2010-6#10)(2010-7#11)(2010-8#28)(2010-9#15)(2011-1#80)(2011-11#1)(2011-12#25)(2011-2#193)(2011-7#1)(2012-1#35)(2012-11#6)(2012-12#70)(2012-2#82)(2012-3#45)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#1)(2013-1#135)(2013-3#1)(2013-7#29)(2013-8#91)
study we address##2##3##(2007-8#1)(2008-11#1)
study we aimed to##6##4##(2004-2#1)(2007-8#1)(2008-1#1)(2010-3#1)(2012-3#2)
study we analyzed##5##3##(1990-11#1)(1995-12#1)(1996-4#1)(2007-7#1)(2013-1#1)
study we assessed the##2##4##(1993-5#1)(1995-5#1)
study we compare the##3##4##(1993-11#1)(1996-9#1)(1997-2#1)
study we compare##4##3##(1993-11#1)(1996-9#1)(1997-2#1)(2007-7#1)
study we compared the effect of##2##6##(1994-12#1)(2006-7#1)
study we compared the##8##4##(1993-11#1)(1994-12#1)(1994-2#1)(1995-11#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-7#1)
study we compared##11##3##(1990-4#1)(1993-11#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-12#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-7#1)(2010-7#1)
study we conclude that##4##4##(1990-9#1)(1994-5#1)(1996-6#1)(2007-11#1)
study we conducted##4##3##(2008-11#1)(2009-9#1)(2012-2#1)(2013-1#1)
study we confirm that##3##4##(1994-8#1)(2012-12#2)
study we demonstrate that##6##4##(1992-7#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-1#1)
study we demonstrate##7##3##(1992-7#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-1#1)
study we demonstrated that##2##4##(1994-8#1)(1996-5#1)
study we describe##8##3##(1994-12#1)(1994-6#1)(2006-10#1)(2007-8#1)(2008-5#1)(2008-7#1)(2012-12#2)
study we evaluated the##7##4##(1992-12#1)(1994-8#1)(1996-3#1)(1997-2#1)(2005-12#1)(2008-4#1)(2013-1#1)
study we evaluated##10##3##(1991-10#1)(1992-12#1)(1994-8#1)(1996-3#2)(1997-2#1)(2005-12#1)(2008-4#1)(2009-6#1)(2013-1#1)
study we examined the effect of##2##6##(1994-8#1)(1996-4#1)
study we examined the effects of##6##6##(1995-8#1)(1996-12#1)(1996-9#1)(1997-5#1)(2006-5#1)(2009-7#1)
study we examined the##19##4##(1993-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-8#1)(2006-5#1)(2009-4#1)(2009-7#1)(2010-2#1)(2013-7#1)
study we examined whether##2##4##(1995-10#1)(2006-8#1)
study we examined##27##3##(1990-7#1)(1993-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#3)(1995-2#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-8#1)(2006-5#1)(2006-8#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-7#1)(2012-1#1)(2013-7#1)
study we found##4##3##(2007-7#1)(2011-1#1)(2013-1#2)
study we have analyzed the##2##5##(1995-7#1)(1997-8#1)
study we have demonstrated that##2##5##(1994-11#1)(2004-12#1)
study we have evaluated##3##4##(1992-12#1)(2011-2#1)(2012-3#1)
study we have examined the##3##5##(1991-3#1)(1996-11#1)(2007-10#1)
study we have examined##6##4##(1991-3#1)(1996-11#1)(1997-2#1)(2005-10#1)(2006-6#1)(2007-10#1)
study we have found##3##4##(1996-8#1)(2008-11#1)(2012-2#1)
study we have identified##2##4##(2010-11#1)(2011-2#1)
study we have investigated the##7##5##(1994-11#1)(1994-12#1)(1995-12#1)(1996-10#1)(1997-3#1)(2008-12#1)(2012-2#1)
study we have investigated##11##4##(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-10#1)(1997-3#1)(1997-7#1)(2008-12#1)(2012-2#1)
study we have isolated##2##4##(1991-2#1)(1992-10#1)
study we have used a##3##5##(1991-11#1)(1991-7#1)(1992-12#1)
study we have used the##2##5##(1993-12#1)(2009-4#1)
study we have used##13##4##(1991-11#1)(1991-7#1)(1992-12#1)(1993-12#1)(1994-8#1)(1995-3#1)(1996-12#2)(2008-7#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
study we have##70##3##(1990-10#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-7#2)(1992-10#1)(1992-12#2)(1993-12#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#2)(1995-3#2)(1995-6#1)(1995-7#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-12#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-7#2)(2008-11#2)(2008-12#1)(2008-7#2)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
study we identified##4##3##(2007-2#1)(2008-10#1)(2008-6#1)(2012-3#1)
study we investigated the##21##4##(1991-2#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-5#1)(1995-7#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-12#1)(2008-7#1)(2008-8#2)(2009-2#1)(2013-1#1)(2013-8#2)
study we investigated whether##6##4##(1995-10#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-7#1)(2010-6#1)
study we investigated##39##3##(1991-2#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-10#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-2#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-7#1)(2013-1#1)(2013-8#2)
study we looked at the##3##5##(1990-7#1)(1997-7#1)(2006-6#1)
study we measured##3##3##(1991-10#1)(1992-8#1)(1994-12#1)
study we present a new##3##5##(1993-8#1)(1997-3#1)(2007-11#1)
study we present a##5##4##(1992-8#1)(1993-8#1)(1997-3#1)(2007-11#1)(2013-7#1)
study we present##7##3##(1991-9#1)(1992-8#1)(1993-8#1)(1997-3#1)(2007-11#1)(2008-5#1)(2013-7#1)
study we propose a##2##4##(2008-10#1)(2008-9#1)
study we provide evidence that##4##5##(1990-11#1)(1996-9#1)(1997-6#1)(2006-8#1)
study we report that the##3##5##(1991-3#1)(1992-11#1)(1997-2#1)
study we report that##5##4##(1991-3#1)(1992-11#1)(1997-2#1)(2011-1#1)(2012-2#1)
study we report the##3##4##(1990-2#1)(2008-6#1)(2012-12#1)
study we report##12##3##(1990-2#1)(1991-3#1)(1992-11#1)(1997-2#1)(2007-3#1)(2008-2#1)(2008-6#1)(2009-5#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)
study we reviewed##2##3##(1996-11#1)(2007-2#1)
study we show that the##5##5##(1994-11#1)(1994-9#1)(1995-9#1)(1997-2#1)(1997-3#1)
study we show that##20##4##(1990-10#1)(1990-5#1)(1992-5#1)(1992-8#1)(1993-8#2)(1994-11#1)(1994-3#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-9#1)(1996-4#2)(1997-2#1)(1997-3#1)(1997-7#1)(2008-7#1)(2012-2#1)
study we show##21##3##(1990-10#1)(1990-5#1)(1992-5#1)(1992-8#1)(1993-8#2)(1994-11#1)(1994-3#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-9#1)(1996-11#1)(1996-4#2)(1997-2#1)(1997-3#1)(1997-7#1)(2008-7#1)(2012-2#1)
study we showed that##3##4##(1993-9#1)(1995-12#1)(2009-8#1)
study we suggest##2##3##(1990-2#1)(2011-2#1)
study we tested##2##3##(1997-8#1)(2013-1#1)
study we used a##3##4##(1996-3#1)(2009-8#1)(2011-2#1)
study we used the##2##4##(1991-7#1)(2009-9#1)
study we used##10##3##(1991-3#1)(1991-7#1)(1992-10#1)(1996-3#1)(2008-12#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
study we wanted to compare##2##5##(2011-2#1)(2013-1#1)
study we wanted to##6##4##(1995-5#1)(2008-10#1)(2011-12#1)(2011-2#2)(2013-1#1)
study we##366##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#2)(1990-9#2)(1991-10#2)(1991-11#1)(1991-2#3)(1991-3#4)(1991-4#1)(1991-5#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#3)(1992-5#1)(1992-7#2)(1992-8#5)(1993-11#2)(1993-12#5)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#3)(1993-9#3)(1994-11#3)(1994-12#5)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#3)(1994-8#9)(1994-9#6)(1995-10#4)(1995-11#2)(1995-12#7)(1995-2#3)(1995-3#3)(1995-5#3)(1995-6#2)(1995-7#2)(1995-8#3)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#3)(1996-12#4)(1996-2#1)(1996-3#5)(1996-4#4)(1996-5#4)(1996-6#2)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#7)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#4)(1997-8#5)(2004-10#1)(2004-12#1)(2004-2#1)(2005-10#1)(2005-12#2)(2006-10#3)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#4)(2007-11#3)(2007-12#2)(2007-2#2)(2007-3#1)(2007-7#7)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#8)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#5)(2011-12#2)(2011-2#14)(2012-1#1)(2012-12#8)(2012-2#8)(2012-3#7)(2012-5#1)(2012-7#1)(2013-1#13)(2013-7#5)(2013-8#5)
study weights##2##2##(2009-12#2)
study were (i)##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
study were 1) to##2##4##(2008-10#1)(2013-1#1)
study were analyzed##3##3##(1995-9#1)(2012-3#1)(2013-1#1)
study were as follows##6##4##(1990-10#1)(1991-2#1)(1997-2#1)(2004-11#1)(2007-8#1)(2007-9#1)
study were found##2##3##(2009-6#1)(2012-12#1)
study were in##3##3##(2007-8#1)(2008-10#1)(2012-1#1)
study were obtained from##2##4##(2007-3#1)(2012-12#1)
study were obtained##4##3##(1990-10#1)(2007-3#1)(2012-12#1)(2012-2#1)
study were similar to those observed##2##6##(2007-1#1)(2007-9#1)
study were similar to those of the vehicle control groups##2##10##(2008-9#2)
study were similar to those##4##5##(2007-1#1)(2007-9#1)(2008-9#2)
study were the##3##3##(1991-10#1)(1995-11#1)(2007-5#1)
study were to assess the prevalence of##2##7##(1991-5#1)(2012-3#1)
study were to assess the##7##5##(1991-5#1)(2007-2#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
study were to assess##9##4##(1991-5#1)(1994-6#1)(2007-2#1)(2007-7#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
study were to characterize##4##4##(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
study were to describe the##4##5##(1996-3#1)(2006-10#1)(2008-6#1)(2013-1#1)
study were to describe##5##4##(1996-3#1)(2006-10#1)(2008-6#1)(2009-5#1)(2013-1#1)
study were to determine the prevalence of##4##7##(2008-12#1)(2008-3#1)(2008-8#2)
study were to determine the##12##5##(1996-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#2)(2011-12#1)(2011-2#1)(2012-11#1)
study were to determine##18##4##(1996-1#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
study were to evaluate the repeatability (r) and reproducibility (R) when different laboratories conduct the test##2##16##(2008-10#2)
study were to evaluate the##6##5##(2008-10#2)(2008-12#1)(2008-5#1)(2012-3#2)
study were to evaluate##10##4##(2008-10#4)(2008-12#1)(2008-5#1)(2009-8#1)(2010-3#1)(2012-3#2)
study were to examine the##4##5##(2007-10#1)(2008-11#1)(2010-11#1)(2012-2#1)
study were to examine##5##4##(2007-10#1)(2008-11#1)(2008-6#1)(2010-11#1)(2012-2#1)
study were to identify##6##4##(2008-1#1)(2008-10#2)(2008-11#1)(2009-9#1)(2013-1#1)
study were to investigate the##5##5##(1995-10#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#1)
study were to investigate##8##4##(1995-10#1)(2006-8#1)(2007-10#1)(2008-12#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#1)
study were to review the##2##5##(2007-12#1)(2007-8#1)
study were to##105##3##(1990-10#1)(1991-5#1)(1994-6#1)(1995-10#1)(1996-1#1)(1996-3#1)(1996-4#1)(2006-10#2)(2006-8#3)(2007-1#1)(2007-10#3)(2007-12#1)(2007-2#2)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#4)(2008-12#3)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#2)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#11)(2013-7#1)(2013-8#2)
study were used##3##3##(2007-8#2)(2008-8#1)
study were##241##2##(1990-10#6)(1990-12#1)(1990-8#1)(1991-1#1)(1991-10#2)(1991-2#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-7#1)(1995-9#1)(1996-1#2)(1996-3#1)(1996-4#1)(1997-2#2)(1997-4#1)(1997-8#2)(2004-11#1)(2005-10#1)(2005-11#2)(2006-10#2)(2006-12#1)(2006-4#2)(2006-6#1)(2006-7#1)(2006-8#6)(2007-1#2)(2007-10#8)(2007-11#1)(2007-12#2)(2007-2#6)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#26)(2008-11#9)(2008-12#5)(2008-3#2)(2008-4#2)(2008-5#11)(2008-6#3)(2008-7#2)(2008-8#7)(2008-9#2)(2009-10#1)(2009-2#2)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-12#3)(2011-2#8)(2012-1#4)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#7)(2013-1#16)(2013-7#2)(2013-8#2)
study when##4##2##(2008-3#1)(2008-7#1)(2013-1#2)
study where##7##2##(1991-12#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-7#1)(2010-8#1)(2011-2#1)
study whether##6##2##(1991-9#1)(1993-9#1)(1996-8#1)(2008-7#1)(2009-8#1)(2011-2#1)
study which aimed to##2##4##(2011-2#1)(2012-3#1)
study which included##3##3##(2009-2#1)(2012-12#1)(2013-1#1)
study which is##2##3##(2007-9#1)(2010-3#1)
study which was done##2##4##(2013-8#2)
study which was##5##3##(1991-5#1)(1996-1#1)(2013-8#3)
study which##28##2##(1990-10#1)(1991-5#1)(1992-10#1)(1993-1#1)(1993-12#2)(1993-6#1)(1996-1#1)(1997-3#1)(1997-8#1)(2007-9#1)(2008-1#1)(2008-11#4)(2009-2#1)(2009-4#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#4)
study will be used to##3##5##(2006-10#1)(2009-9#1)(2012-1#1)
study will be useful##2##4##(2006-2#1)(2010-11#1)
study will be##14##3##(2005-8#1)(2006-10#1)(2006-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-5#2)(2009-9#1)(2010-11#1)(2012-1#1)(2012-3#1)
study will enroll##2##3##(2008-5#2)
study will help##4##3##(1990-8#1)(2005-11#1)(2008-10#1)(2010-1#1)
study will provide##2##3##(2007-1#1)(2007-10#1)
study will show that##3##4##(1994-3#2)(2008-5#1)
study will##47##2##(1990-8#1)(1993-3#1)(1994-3#3)(1994-8#1)(1995-10#1)(1996-3#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-10#1)(2007-3#1)(2007-7#2)(2007-8#3)(2008-10#5)(2008-4#1)(2008-5#7)(2008-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)
study with 20##2##3##(1992-2#1)(2008-5#1)
study with a##18##3##(1990-6#1)(1992-2#1)(1996-8#2)(2005-11#1)(2006-1#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
study with an##2##3##(1991-3#1)(2008-3#1)
study with emphasis on##2##4##(1990-12#1)(2013-1#1)
study with healthy##3##3##(1991-8#2)(2008-5#1)
study with normal##2##3##(1991-8#1)(2007-2#1)
study with other##2##3##(2011-2#1)(2013-8#1)
study with review of literature##2##5##(2007-11#1)(2009-5#1)
study with the##7##3##(1990-7#1)(1994-5#1)(1994-9#1)(2008-1#1)(2008-11#1)(2010-8#1)(2012-2#1)
study with two##2##3##(1994-11#1)(2013-8#1)
study with##145##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#3)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-4#2)(1996-5#1)(1996-8#2)(2005-11#1)(2005-4#1)(2005-7#4)(2006-1#1)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#4)(2008-9#1)(2009-10#1)(2009-5#3)(2009-7#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#6)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#7)(2013-8#6)
study within##2##2##(2010-4#1)(2010-6#1)
study would provide##2##3##(1994-5#1)(2006-1#1)
study would##10##2##(1993-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1997-3#1)(2006-1#1)(2009-10#1)(2011-7#1)(2012-11#1)(2013-1#1)
study years##4##2##(1993-3#2)(2007-6#1)(2013-7#1)
study yielded##3##2##(1994-12#1)(2007-7#1)(2011-2#1)
study##21922##1##(1990-1#6)(1990-10#50)(1990-11#49)(1990-12#69)(1990-2#53)(1990-3#48)(1990-4#33)(1990-5#50)(1990-6#40)(1990-7#38)(1990-8#45)(1990-9#39)(1991-1#45)(1991-10#33)(1991-11#32)(1991-12#74)(1991-2#74)(1991-3#46)(1991-4#38)(1991-5#50)(1991-6#44)(1991-7#42)(1991-8#50)(1991-9#44)(1992-1#31)(1992-10#40)(1992-11#46)(1992-12#68)(1992-2#40)(1992-3#46)(1992-4#28)(1992-5#36)(1992-6#42)(1992-7#25)(1992-8#67)(1992-9#38)(1993-1#47)(1993-10#13)(1993-11#45)(1993-12#105)(1993-2#64)(1993-3#74)(1993-4#37)(1993-5#27)(1993-6#54)(1993-7#30)(1993-8#43)(1993-9#67)(1994-1#19)(1994-10#29)(1994-11#53)(1994-12#72)(1994-2#107)(1994-3#95)(1994-4#10)(1994-5#49)(1994-6#88)(1994-7#12)(1994-8#72)(1994-9#35)(1995-1#59)(1995-10#32)(1995-11#50)(1995-12#89)(1995-2#91)(1995-3#59)(1995-4#13)(1995-5#52)(1995-6#53)(1995-7#21)(1995-8#39)(1995-9#41)(1996-1#85)(1996-10#16)(1996-11#44)(1996-12#95)(1996-2#70)(1996-3#93)(1996-4#36)(1996-5#71)(1996-6#46)(1996-7#41)(1996-8#51)(1996-9#44)(1997-1#50)(1997-2#98)(1997-3#87)(1997-4#57)(1997-5#53)(1997-6#60)(1997-7#74)(1997-8#110)(2003-11#4)(2004-1#19)(2004-10#28)(2004-11#38)(2004-12#30)(2004-2#13)(2004-3#14)(2004-4#10)(2004-7#4)(2004-8#5)(2004-9#45)(2005-1#3)(2005-10#60)(2005-11#107)(2005-12#28)(2005-2#1)(2005-3#1)(2005-4#18)(2005-5#9)(2005-6#5)(2005-7#31)(2005-8#46)(2005-9#25)(2006-1#37)(2006-10#301)(2006-11#78)(2006-12#130)(2006-2#94)(2006-3#16)(2006-4#64)(2006-5#70)(2006-6#89)(2006-7#89)(2006-8#242)(2006-9#56)(2007-1#93)(2007-10#273)(2007-11#251)(2007-12#288)(2007-2#280)(2007-3#118)(2007-4#88)(2007-5#63)(2007-6#79)(2007-7#466)(2007-8#526)(2007-9#181)(2008-1#218)(2008-10#1417)(2008-11#489)(2008-12#356)(2008-2#252)(2008-3#365)(2008-4#289)(2008-5#625)(2008-6#226)(2008-7#500)(2008-8#301)(2008-9#365)(2009-1#25)(2009-10#109)(2009-11#69)(2009-12#75)(2009-2#76)(2009-3#89)(2009-4#118)(2009-5#135)(2009-6#78)(2009-7#115)(2009-8#91)(2009-9#74)(2010-1#63)(2010-10#100)(2010-11#72)(2010-12#220)(2010-2#138)(2010-3#141)(2010-4#138)(2010-5#121)(2010-6#79)(2010-7#89)(2010-8#191)(2010-9#79)(2011-1#458)(2011-10#5)(2011-11#7)(2011-12#117)(2011-2#898)(2011-3#24)(2011-7#5)(2012-1#209)(2012-11#62)(2012-12#437)(2012-2#539)(2012-3#388)(2012-4#3)(2012-5#8)(2012-6#5)(2012-7#5)(2012-8#2)(2012-9#1)(2013-1#955)(2013-3#2)(2013-4#2)(2013-7#167)(2013-8#493)
study&quot##2##1##(1990-9#1)(2009-4#1)
study's findings##4##2##(1995-1#1)(2006-5#1)(2008-11#1)(2012-3#1)
study's limitations##2##2##(2007-12#2)
study's objective was to##2##4##(2008-2#1)(2012-2#1)
study's primary##2##2##(2010-2#1)(2013-1#1)
study's purpose was to##2##4##(1993-2#1)(2013-1#1)
study's purpose##3##2##(1993-2#1)(2012-3#1)(2013-1#1)
study's results##3##2##(1992-10#1)(1996-1#1)(2011-2#1)
study's##25##1##(1991-2#1)(1992-10#1)(1993-2#1)(1995-1#2)(1996-1#1)(2006-5#1)(2007-10#2)(2007-12#4)(2008-11#1)(2008-2#1)(2008-7#1)(2010-10#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
study) and##6##2##(1993-7#1)(2006-10#1)(2008-10#1)(2010-9#1)(2012-12#1)(2013-1#1)
study)##39##1##(1991-3#1)(1992-2#1)(1993-11#1)(1993-7#1)(1995-12#1)(1995-4#1)(1996-12#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#5)(2009-3#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-9#3)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#4)
study)]##3##1##(2006-7#1)(2008-8#1)(2009-3#1)
study-specific##3##1##(1995-12#1)(2008-10#1)(2013-1#1)
study]##111##1##(1990-10#1)(1990-11#1)(1990-3#3)(1990-4#4)(1990-5#2)(1990-6#2)(1990-7#1)(1990-9#1)(1991-11#1)(1991-3#3)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-11#2)(1992-5#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-8#2)(1994-11#2)(1994-4#1)(1994-6#2)(1994-8#2)(1995-4#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-6#2)(1996-9#2)(1997-2#1)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#1)(2005-1#2)(2005-10#3)(2006-2#2)(2006-8#2)(2007-1#1)(2007-10#2)(2007-6#1)(2007-9#2)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-4#1)(2009-5#2)(2010-12#2)(2010-3#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-3#4)(2013-1#5)(2013-7#4)(2013-8#3)
studying a variety of##2##4##(1996-3#1)(2007-12#1)
studying a##7##2##(1993-9#1)(1996-3#1)(1997-1#1)(2007-12#1)(2009-5#1)(2011-2#1)(2012-3#1)
studying adsorption##2##2##(2005-11#1)(2008-10#1)
studying an##2##2##(2008-11#1)(2008-2#1)
studying and##5##2##(2006-10#1)(2008-11#1)(2008-12#1)(2009-7#1)(2010-3#1)
studying both##4##2##(1997-5#1)(2008-10#1)(2008-5#1)(2012-2#1)
studying cell##2##2##(1990-5#1)(2008-11#1)
studying cellular##5##2##(1997-4#1)(2007-9#1)(2008-11#3)
studying changes in##3##3##(1992-4#1)(2008-10#1)(2008-8#1)
studying functional##2##2##(1992-7#1)(2009-2#1)
studying gene function in##2##4##(2007-12#1)(2008-2#1)
studying gene function##4##3##(1993-9#1)(2007-12#1)(2008-2#1)(2008-7#1)
studying gene##7##2##(1993-9#1)(1995-3#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-7#1)
studying how##3##2##(1993-12#1)(1993-4#1)(1995-2#1)
studying human##3##2##(1993-6#1)(2008-11#1)(2008-7#1)
studying important##2##2##(2007-6#1)(2011-1#1)
studying its##6##2##(1991-9#1)(2005-11#1)(2005-7#1)(2007-12#1)(2008-10#2)
studying living##3##2##(2007-12#1)(2008-7#1)(2012-2#1)
studying mechanisms of##6##3##(1995-3#1)(1996-1#1)(2006-10#2)(2008-11#1)(2008-4#1)
studying nonlinear##2##2##(2006-11#1)(2007-11#1)
studying other##2##2##(1994-3#1)(1995-2#1)
studying population dynamics##2##3##(2008-10#1)(2008-8#1)
studying protein##4##2##(2008-10#1)(2008-4#1)(2008-9#1)(2009-5#1)
studying small##2##2##(2008-11#1)(2012-12#1)
studying the aggregation##2##3##(2005-11#1)(2013-1#1)
studying the behavior of##3##4##(2008-11#1)(2008-2#1)(2008-3#1)
studying the binding##3##3##(1990-12#1)(1991-4#1)(1994-8#1)
studying the biochemical##2##3##(1994-11#1)(1994-8#1)
studying the biological##4##3##(1996-8#1)(2008-4#2)(2008-9#1)
studying the dynamics of##3##4##(1992-3#1)(2008-3#1)(2013-8#1)
studying the effect of##10##4##(1990-2#1)(1991-8#1)(1991-9#1)(1995-11#1)(1995-3#1)(1997-6#1)(2007-8#1)(2008-10#3)
studying the effects of##13##4##(1991-10#1)(1993-2#1)(1994-11#1)(1995-1#1)(1995-2#1)(1996-2#1)(1997-8#1)(2006-10#1)(2008-11#1)(2008-2#2)(2008-6#1)(2012-12#1)
studying the evolution of##3##4##(2006-5#1)(2008-8#1)(2009-2#1)
studying the expression of##2##4##(1995-2#1)(2008-4#1)
studying the expression##3##3##(1994-11#1)(1995-2#1)(2008-4#1)
studying the functional##2##3##(1995-11#1)(2008-8#1)
studying the impact of##2##4##(2012-12#1)(2012-3#1)
studying the influence##2##3##(2005-11#1)(2008-11#1)
studying the interactions between##3##4##(1990-2#1)(1996-12#1)(2009-3#1)
studying the interactions##4##3##(1990-2#1)(1996-12#1)(2008-11#1)(2009-3#1)
studying the isoform##2##3##(1996-12#2)
studying the kinetics of##2##4##(1997-2#1)(2005-11#1)
studying the mechanism of##5##4##(1992-7#1)(1994-6#1)(2005-4#1)(2006-12#1)(2008-9#1)
studying the molecular##7##3##(1995-8#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-8#1)
studying the phase##2##3##(2005-11#1)(2008-2#1)
studying the regulation of##3##4##(1990-8#1)(1991-6#1)(1993-6#1)
studying the relationship between##2##4##(1993-12#1)(2011-1#1)
studying the role of##4##4##(1991-8#1)(1992-12#1)(2008-4#1)(2012-12#1)
studying the role##5##3##(1990-5#1)(1991-8#1)(1992-12#1)(2008-4#1)(2012-12#1)
studying the shape##2##3##(2006-11#1)(2008-4#1)
studying the structure##5##3##(1991-8#1)(1992-6#1)(1993-11#1)(1996-11#1)(2006-5#1)
studying the substrate##2##3##(2007-11#1)(2008-4#1)
studying the time course of##2##5##(1990-9#1)(1996-2#1)
studying the time##3##3##(1990-9#1)(1996-2#1)(2008-1#1)
studying the##231##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#2)(1990-8#1)(1990-9#1)(1991-10#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#4)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#4)(1995-1#1)(1995-11#3)(1995-12#2)(1995-2#3)(1995-3#3)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-8#1)(1997-2#1)(1997-6#3)(1997-7#3)(1997-8#4)(2005-10#1)(2005-11#4)(2005-4#2)(2006-10#10)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#4)(2007-10#1)(2007-11#3)(2007-12#6)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#17)(2008-11#10)(2008-2#8)(2008-3#7)(2008-4#14)(2008-5#7)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#5)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-8#2)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
studying their interaction with##2##4##(2005-11#1)(2008-10#1)
studying their interactions##2##3##(2007-6#1)(2011-1#1)
studying their##10##2##(2005-11#1)(2007-6#1)(2008-1#1)(2008-10#1)(2009-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
studying these##7##2##(2007-1#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-8#1)(2009-4#1)(2012-11#1)
studying this##4##2##(2007-9#1)(2008-2#1)(2008-8#1)(2010-2#1)
studying which##2##2##(1990-4#1)(2004-2#1)
studying##558##1##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#6)(1990-7#2)(1990-8#2)(1990-9#1)(1991-10#3)(1991-3#1)(1991-4#4)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#3)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#2)(1992-9#1)(1993-11#4)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#2)(1993-6#3)(1993-8#1)(1993-9#2)(1994-11#5)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#5)(1995-1#3)(1995-11#4)(1995-12#3)(1995-2#9)(1995-3#6)(1995-5#1)(1995-8#4)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#5)(1996-2#4)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#4)(1997-7#3)(1997-8#5)(2004-11#2)(2004-2#1)(2005-10#1)(2005-11#10)(2005-4#3)(2005-7#3)(2005-8#2)(2006-10#15)(2006-11#5)(2006-12#3)(2006-2#1)(2006-5#4)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#7)(2007-12#15)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#3)(2007-7#1)(2007-8#3)(2007-9#6)(2008-1#8)(2008-10#38)(2008-11#27)(2008-12#4)(2008-2#16)(2008-3#14)(2008-4#34)(2008-5#12)(2008-6#3)(2008-7#10)(2008-8#17)(2008-9#16)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#7)(2009-3#1)(2009-4#1)(2009-5#5)(2009-6#1)(2009-7#2)(2009-8#4)(2010-11#3)(2010-12#1)(2010-2#4)(2010-3#2)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#6)(2011-12#3)(2011-2#10)(2012-11#1)(2012-12#8)(2012-2#10)(2012-3#9)(2013-1#9)(2013-8#5)
stuff##6##1##(1992-2#1)(1994-1#1)(2007-9#1)(2008-10#1)(2012-2#1)(2012-3#1)
stuffed##2##1##(1992-3#2)
stumbling block##2##2##(1995-11#1)(2009-9#1)
stumbling blocks##3##2##(2010-3#1)(2012-3#2)
stumbling##6##1##(1995-11#1)(2009-9#1)(2010-3#1)(2012-1#1)(2012-3#2)
stump after##4##2##(1992-8#1)(2006-9#1)(2008-8#2)
stump and##3##2##(1991-6#1)(2007-11#1)(2009-6#1)
stump neuroma##2##2##(2009-3#2)
stump of the##4##3##(2007-11#1)(2007-8#1)(2008-12#1)(2013-7#1)
stump of##7##2##(1991-6#1)(1994-2#1)(2007-11#1)(2007-8#2)(2008-12#1)(2013-7#1)
stump with##3##2##(1990-4#1)(2011-2#2)
stump##44##1##(1990-4#3)(1990-6#1)(1991-6#3)(1992-6#1)(1992-8#1)(1992-9#2)(1994-2#1)(2006-3#1)(2006-9#1)(2007-11#3)(2007-7#1)(2007-8#4)(2008-10#2)(2008-12#2)(2008-5#1)(2008-8#3)(2009-3#2)(2009-6#2)(2010-3#1)(2010-8#1)(2011-2#6)(2012-12#1)(2013-7#1)
stumps and##4##2##(2006-3#1)(2008-10#1)(2008-5#1)(2009-3#1)
stumps of##2##2##(1994-2#1)(2008-9#1)
stumps##19##1##(1990-4#1)(1991-11#1)(1994-2#1)(2006-3#4)(2007-3#1)(2008-10#6)(2008-5#1)(2008-9#3)(2009-3#1)
stung by##2##2##(1992-6#1)(2012-3#1)
stung##3##1##(1991-6#1)(1992-6#1)(2012-3#1)
stunned myocardium##2##2##(2006-10#1)(2013-1#1)
stunned myocardium&quot##2##2##(1991-3#1)(2013-1#1)
stunned##9##1##(1991-3#1)(1996-9#2)(2006-10#1)(2010-4#3)(2013-1#2)
stunning and##4##2##(2006-10#2)(2008-3#1)(2011-1#1)
stunning following##2##2##(1996-9#2)
stunning in##5##2##(1996-9#2)(2007-8#1)(2010-2#1)(2011-1#1)
stunning methods##2##2##(2010-4#2)
stunning was##2##2##(2010-2#1)(2010-4#1)
stunning##45##1##(1990-9#3)(1991-3#3)(1996-8#1)(1996-9#8)(2006-10#2)(2007-8#3)(2007-9#1)(2008-10#1)(2008-3#3)(2010-2#5)(2010-4#7)(2011-1#7)(2013-1#1)
stunning&quot##4##1##(1990-9#1)(1991-3#2)(1996-9#1)
stunt viroid##4##2##(2008-10#4)
stunt virus (PSV)##4##3##(2008-10#3)(2012-11#1)
stunt virus##21##2##(2008-10#17)(2008-9#2)(2012-11#2)
stunt##30##1##(2008-10#23)(2008-8#2)(2008-9#2)(2009-3#1)(2012-11#2)
stunted growth##3##2##(2007-2#1)(2008-10#2)
stunted##13##1##(2007-2#1)(2008-10#3)(2008-4#2)(2008-5#1)(2010-6#3)(2011-1#1)(2012-2#1)(2013-7#1)
stunting and##6##2##(2008-1#1)(2008-10#4)(2010-6#1)
stunting syndrome##2##2##(2008-5#2)
stunting##28##1##(1990-12#1)(2006-4#2)(2008-1#1)(2008-10#16)(2008-5#2)(2009-8#1)(2010-6#2)(2011-1#1)(2013-1#1)(2013-7#1)
stupor##7##1##(1994-2#1)(1996-11#1)(1996-6#1)(2007-8#2)(2008-1#1)(2012-12#1)
sturdy##3##1##(1991-7#1)(1993-5#1)(2008-4#1)
sturgeon##3##1##(2010-8#3)
stutter##13##1##(2008-2#8)(2008-4#1)(2011-12#1)(2012-12#3)
stuttering in##2##2##(2008-2#2)
stuttering is##4##2##(2012-12#4)
stuttering oppositional defiant##2##3##(1996-5#2)
stuttering##30##1##(1991-11#1)(1996-5#3)(2006-9#1)(2008-2#8)(2008-8#2)(2012-12#15)
stutters##2##1##(2008-12#1)(2012-12#1)
stutzeri and##3##2##(1991-3#2)(2009-7#1)
stutzeri##5##1##(1991-3#2)(2007-12#2)(2009-7#1)
stylalgia##6##1##(2013-8#6)
style (more##2##2##(2006-1#1)(2008-12#1)
style and##19##2##(1992-2#1)(1993-11#1)(2006-1#1)(2007-3#1)(2008-10#2)(2008-5#1)(2009-12#1)(2009-7#2)(2009-8#1)(2010-10#3)(2010-12#1)(2010-5#2)(2010-8#1)(2012-3#1)
style are##2##2##(2008-7#1)(2009-7#1)
style is##5##2##(1990-6#1)(2007-10#1)(2008-11#1)(2013-1#1)(2013-8#1)
style of##22##2##(1992-1#1)(1996-4#2)(2005-10#1)(2005-8#1)(2006-1#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-12#2)(2010-9#1)(2011-1#1)(2013-1#2)
style that##5##2##(1992-11#1)(1994-2#1)(2007-5#1)(2008-6#1)(2012-2#1)
style to##3##2##(1993-12#1)(2008-9#1)(2009-12#1)
style was##9##2##(1992-3#1)(2004-11#1)(2007-11#1)(2009-12#1)(2010-1#1)(2010-5#1)(2012-1#1)(2012-2#1)(2012-3#1)
style##168##1##(1990-12#2)(1990-6#2)(1991-1#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-2#6)(1992-3#2)(1992-8#1)(1993-11#1)(1993-12#3)(1993-9#2)(1994-1#1)(1994-2#1)(1995-10#1)(1995-3#1)(1996-4#2)(1997-3#1)(2004-11#5)(2005-10#1)(2005-8#1)(2006-1#3)(2006-10#1)(2006-12#2)(2006-2#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#3)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#4)(2008-12#1)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#10)(2009-4#2)(2009-7#5)(2009-8#1)(2010-1#11)(2010-10#7)(2010-11#2)(2010-12#1)(2010-5#4)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#7)(2013-1#6)(2013-8#1)
style) and##2##2##(2005-10#1)(2012-1#1)
styles and theories##3##3##(2013-8#3)
styles and##15##2##(1997-3#1)(2005-10#1)(2005-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-7#1)(2010-12#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-8#4)
styles are##2##2##(2008-6#1)(2009-7#1)
styles not##2##2##(2007-12#1)(2008-11#1)
styles of women##2##3##(2006-10#1)(2006-9#1)
styles of##15##2##(1995-2#1)(1997-6#1)(2006-10#1)(2006-9#1)(2008-10#2)(2008-6#1)(2008-7#2)(2009-11#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-8#2)
styles##75##1##(1990-9#1)(1992-2#1)(1992-3#1)(1992-7#1)(1994-5#1)(1995-2#1)(1996-12#1)(1997-3#2)(1997-6#1)(2004-11#1)(2004-12#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-11#3)(2008-12#4)(2008-4#1)(2008-6#4)(2008-7#2)(2008-9#3)(2009-11#3)(2009-7#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-9#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#9)
stylet inserted in the tube facilitates##2##6##(1997-5#2)
stylet knobs##2##2##(2008-10#1)(2009-3#1)
stylet##14##1##(1997-5#3)(2007-12#2)(2008-10#6)(2009-3#1)(2010-8#2)
stylets##3##1##(2007-12#2)(2008-10#1)
styling##5##1##(2006-12#1)(2008-5#4)
stylo (Stylosanthes guianensis Sw##2##4##(2012-2#2)
stylo silage##2##2##(2012-2#2)
stylo##6##1##(2005-11#2)(2012-2#4)
styloconic sensilla##3##2##(2010-11#3)
styloconicum##6##1##(2008-8#6)
stylohyoid ligament##3##2##(2012-2#3)
styloid process##3##2##(2012-2#1)(2013-8#2)
stylus tip##2##2##(2008-2#2)
stylus##7##1##(2007-6#2)(2008-2#4)(2008-6#1)
stymied by##2##2##(1997-2#1)(2007-10#1)
stymied##4##1##(1997-2#1)(2007-10#3)
styrene and SO##2##3##(1997-8#2)
styrene and##6##2##(1997-8#2)(2008-10#2)(2008-11#1)(2010-2#1)
styrene for##2##2##(1997-8#2)
styrene on cotton##2##3##(2005-11#2)
styrene oxide##3##2##(2005-11#3)
styrene polymerization##2##2##(2005-8#1)(2010-4#1)
styrene was##2##2##(1997-8#1)(2005-11#1)
styrene##55##1##(1994-8#1)(1995-10#4)(1996-5#3)(1997-8#10)(2005-11#8)(2005-8#2)(2007-11#1)(2008-10#6)(2008-11#1)(2008-12#5)(2008-3#2)(2008-5#2)(2009-9#1)(2010-2#6)(2010-4#2)(2010-5#1)
styrene-7##2##1##(1997-8#2)
styrene-butadiene-styrene (SBS)##2##2##(2008-10#1)(2009-11#1)
styrene-divinyl benzene##3##2##(2008-10#3)
styrene-divinylbenzene copolymer##3##2##(1996-11#1)(2008-10#2)
styrene-divinylbenzene##6##1##(1996-11#1)(2007-8#1)(2008-10#4)
styrenes##2##1##(2010-6#2)
styryl dye##4##2##(1997-4#2)(2007-12#1)(2008-8#1)
styryl dyes##2##2##(1996-1#1)(1996-12#1)
styryl##7##1##(1996-1#1)(1996-12#1)(1997-4#2)(2007-11#1)(2007-12#1)(2008-8#1)
styryl-based##2##1##(1991-11#2)
stysi##4##1##(2013-8#4)
su(f)##2##1##(1995-6#2)
suPAR levels in##2##3##(2013-1#2)
suPAR levels##6##2##(2013-1#6)
suaveolens Ledeb##2##2##(2008-10#2)
sub Saharan##2##2##(2008-2#1)(2013-1#1)
sub classification##2##2##(2007-2#1)(2010-3#1)
sub classified##2##2##(2010-3#1)(2013-8#1)
sub group##4##2##(2007-1#1)(2007-8#1)(2008-11#2)
sub groups##2##2##(1997-1#1)(2008-11#1)
sub mug l(-1)##2##3##(2008-10#2)
sub##37##1##(1990-12#1)(1993-7#1)(1994-9#1)(1997-1#1)(2007-1#1)(2007-12#1)(2007-2#2)(2007-8#3)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#1)(2009-11#1)(2009-2#1)(2010-3#2)(2010-7#1)(2011-2#1)(2012-12#3)(2013-1#2)(2013-8#2)
sub- and##2##2##(2008-10#1)(2012-2#1)
sub-##3##1##(2007-12#1)(2008-10#1)(2012-2#1)
sub-10-fs light##2##2##(2007-12#2)
sub-10-fs optical##2##2##(2007-12#2)
sub-10-fs pulse generation##2##3##(2007-11#1)(2007-12#1)
sub-10-fs pulse##5##2##(2007-11#1)(2007-12#2)(2008-1#2)
sub-10-fs pulses with##2##3##(2007-12#2)
sub-10-fs pulses##7##2##(2007-11#1)(2007-12#6)
sub-10-fs##18##1##(2007-11#2)(2007-12#14)(2008-1#2)
sub-100-fs pulses##2##2##(2007-11#1)(2008-1#1)
sub-100-fs##8##1##(2007-11#4)(2007-12#3)(2008-1#1)
sub-100-nm##2##1##(2008-7#2)
sub-20-fs##3##1##(2007-11#1)(2007-12#1)(2008-1#1)
sub-30-fs##3##1##(2007-12#3)
sub-50-fs pulses##2##2##(2007-12#2)
sub-6-fs##3##1##(2007-12#3)
sub-Doppler lines##3##2##(2008-2#3)
sub-Doppler##8##1##(2007-11#1)(2007-12#4)(2008-2#3)
sub-Nernstian##3##1##(2008-10#3)
sub-Poissonian##2##1##(2007-12#2)
sub-Saharan Africa##45##2##(1995-12#1)(1996-8#1)(1997-4#1)(2005-10#1)(2005-8#2)(2006-4#1)(2006-8#2)(2007-1#1)(2007-12#1)(2007-2#1)(2007-7#6)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-6#1)(2009-7#2)(2010-12#3)(2010-2#1)(2010-8#1)(2011-1#3)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
sub-Saharan African countries##7##3##(2007-3#1)(2007-7#2)(2010-12#1)(2012-1#1)(2012-11#2)
sub-Saharan African##8##2##(2007-3#1)(2007-7#2)(2010-12#1)(2010-2#1)(2012-1#1)(2012-11#2)
sub-Saharan##59##1##(1995-12#1)(1996-8#1)(1997-4#1)(2005-10#1)(2005-8#2)(2006-10#1)(2006-4#2)(2006-8#2)(2007-1#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#10)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-12#4)(2010-2#2)(2010-8#1)(2011-1#3)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
sub-acute and chronic##2##3##(2008-10#1)(2012-2#1)
sub-acute##5##1##(1997-8#1)(2008-10#2)(2008-12#1)(2012-2#1)
sub-boiling distillation##3##2##(2008-10#3)
sub-catastrophic##2##1##(2007-4#2)
sub-categories##3##1##(2005-8#1)(2006-9#1)(2008-11#1)
sub-cellular compartments##3##2##(2010-2#3)
sub-cellular distribution of##2##3##(2009-10#1)(2009-8#1)
sub-cellular fractions##2##2##(2006-8#1)(2009-6#1)
sub-cellular localization##5##2##(2009-10#3)(2010-2#2)
sub-cellular location##2##2##(2008-7#1)(2012-2#1)
sub-cellular##25##1##(2006-8#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-10#4)(2009-12#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-2#6)(2011-1#1)(2012-12#1)(2012-2#2)
sub-chronic oral##2##2##(1996-12#1)(2010-12#1)
sub-chronic##10##1##(1991-12#1)(1996-12#2)(1997-3#2)(2008-5#1)(2010-12#3)(2013-7#1)
sub-circuits##2##1##(2008-11#2)
sub-city##4##1##(2010-8#4)
sub-class##2##1##(1991-7#1)(1996-7#1)
sub-classes of##2##2##(1995-12#1)(2008-1#1)
sub-classification of##2##2##(2010-12#1)(2012-1#1)
sub-clinical mastitis##2##2##(2012-1#2)
sub-clinical##10##1##(1992-5#1)(2006-6#1)(2006-8#1)(2008-2#1)(2008-9#1)(2010-4#1)(2011-1#1)(2012-1#3)
sub-cutaneous##3##1##(2008-8#2)(2012-2#1)
sub-diffraction-limit-sized##2##1##(2007-12#2)
sub-discipline of##2##2##(1990-6#1)(2008-12#1)
sub-domains##2##1##(1997-2#1)(1997-7#1)
sub-evergreen##2##1##(2013-7#2)
sub-family##3##1##(1990-8#1)(1994-2#1)(2009-8#1)
sub-formulations##2##1##(2008-5#2)
sub-graph motifs##4##2##(2013-1#4)
sub-group of patients##2##3##(1993-9#1)(1995-11#1)
sub-group of the##2##3##(2008-10#1)(2008-5#1)
sub-group of##7##2##(1992-1#1)(1993-9#1)(1995-11#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-5#1)
sub-group##11##1##(1990-12#1)(1992-1#1)(1993-9#1)(1995-11#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-6#1)(2012-11#2)
sub-groups of##3##2##(1992-2#1)(2007-11#1)(2008-10#1)
sub-groups##18##1##(1992-1#1)(1992-2#1)(1996-11#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-7#1)(2010-8#1)(2011-2#1)(2012-11#1)(2013-1#2)
sub-injection##2##1##(2008-10#2)
sub-isoforms##3##1##(2008-10#3)
sub-lethal concentration##3##2##(2011-12#2)(2013-1#1)
sub-lethal concentrations of##2##3##(2011-1#1)(2011-12#1)
sub-lethal##11##1##(1992-5#1)(1993-11#1)(1996-12#1)(2007-12#1)(2008-7#1)(2011-1#1)(2011-12#3)(2013-1#2)
sub-microgram##2##1##(1990-2#1)(1993-8#1)
sub-micrometer##3##1##(2006-12#2)(2013-8#1)
sub-micrometer-sized##2##1##(2005-11#1)(2010-5#1)
sub-micromolar##3##1##(2008-10#2)(2010-3#1)
sub-micron particles##2##2##(2005-11#1)(2007-8#1)
sub-micron##6##1##(2004-9#1)(2005-11#1)(2007-8#1)(2008-10#1)(2010-4#1)(2011-1#1)
sub-microscopic##2##1##(2008-4#1)(2008-7#1)
sub-mitral aneurysms##2##2##(2007-8#2)
sub-models were##2##2##(2007-1#2)
sub-models##3##1##(2007-1#2)(2013-8#1)
sub-monolayer##3##1##(1997-8#1)(2007-8#1)(2008-5#1)
sub-nanogram levels##4##2##(1996-6#1)(2008-10#3)
sub-nanogram per liter##3##3##(2008-10#3)
sub-nanogram per##4##2##(2008-10#4)
sub-nanogram##10##1##(1996-6#1)(2008-10#9)
sub-nanogram/gram##2##1##(2008-10#2)
sub-nanometer##4##1##(1990-4#1)(2006-12#1)(2008-9#1)(2012-2#1)
sub-nephrotic proteinuria##2##2##(2008-1#2)
sub-ng##3##1##(2008-10#3)
sub-occlusive##2##1##(1991-4#1)(2011-2#1)
sub-optimal##11##1##(1990-4#1)(2004-1#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-11#2)(2008-5#1)(2008-6#1)(2009-10#1)(2011-12#1)
sub-optimum##2##1##(2009-4#2)
sub-part per trillion levels##2##4##(2008-10#2)
sub-physiological##3##1##(2008-11#3)
sub-picosecond time##2##2##(1995-1#1)(2009-11#1)
sub-picosecond##5##1##(1995-1#3)(1996-7#1)(2009-11#1)
sub-pixel##2##1##(2008-2#1)(2011-1#1)
sub-pleural##3##1##(2010-12#3)
sub-population of##6##2##(1992-10#1)(1992-3#1)(1992-8#1)(1993-8#1)(1996-9#1)(2008-11#1)
sub-population##8##1##(1992-10#1)(1992-3#1)(1992-8#1)(1993-8#1)(1996-9#1)(2008-11#2)(2013-1#1)
sub-populations of##3##2##(1990-8#1)(2008-9#1)(2009-4#1)
sub-populations##12##1##(1990-8#2)(2005-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-8#4)(2008-9#1)(2009-4#1)
sub-ppb##3##1##(2007-8#1)(2008-10#2)
sub-proteome##2##1##(2007-8#1)(2008-4#1)
sub-region##3##1##(2007-2#1)(2012-2#2)
sub-regional##3##1##(2008-11#2)(2011-2#1)
sub-regions##2##1##(2007-12#1)(2008-2#1)
sub-saharan##2##1##(2006-10#1)(2007-7#1)
sub-sample of##11##2##(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-9#1)(2009-4#1)(2010-8#1)(2013-1#2)
sub-sample##18##1##(1997-2#2)(2007-7#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-4#1)(2008-9#1)(2009-4#1)(2010-8#1)(2013-1#2)
sub-samples##2##1##(2008-10#2)
sub-scale of the##2##3##(1992-1#1)(1997-8#1)
sub-scale of##3##2##(1992-1#1)(1997-8#1)(2011-1#1)
sub-scale##7##1##(1992-1#1)(1997-8#1)(2006-10#1)(2008-11#1)(2010-9#1)(2011-1#2)
sub-scales##3##1##(2006-10#2)(2010-9#1)
sub-second##3##1##(2008-10#2)(2008-7#1)
sub-set of##3##2##(1996-2#1)(2009-9#1)(2011-2#1)
sub-specialization##2##1##(1990-10#1)(1994-12#1)
sub-stoichiometric amounts##2##2##(1992-8#1)(1994-9#1)
sub-stoichiometric##3##1##(1992-8#1)(1994-9#2)
sub-surface##6##1##(2007-1#1)(2008-1#1)(2008-11#1)(2009-7#3)
sub-system##2##1##(2007-8#2)
sub-telomeric##2##1##(1993-9#1)(2008-8#1)
sub-tropical##9##1##(1991-11#1)(1994-9#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-7#1)(2013-8#3)
sub-type of##2##2##(2007-9#1)(2009-4#1)
sub-type##12##1##(1991-12#1)(1992-3#1)(1993-9#2)(1997-5#4)(2007-9#1)(2008-6#2)(2009-4#1)
sub-types##7##1##(1992-8#1)(1995-10#1)(1995-5#1)(2006-11#1)(2007-12#2)(2009-4#1)
sub-unit of##5##2##(1992-12#1)(1992-7#2)(1993-11#2)
sub-unit##10##1##(1992-12#2)(1992-7#2)(1993-11#2)(2008-10#2)(2008-7#1)(2010-4#1)
sub-valvar##2##1##(2007-8#2)
sub-volume##4##1##(2009-4#4)
sub-volumes acquired##2##2##(2009-4#2)
sub-volumes##5##1##(2009-4#5)
subacromial bursa##2##2##(2006-10#1)(2007-11#1)
subacromial decompression##4##2##(2007-11#2)(2007-12#1)(2008-7#1)
subacromial impingement##3##2##(2006-10#1)(2007-11#1)(2008-12#1)
subacromial injection with##2##3##(2008-7#2)
subacromial injection##5##2##(2006-10#2)(2008-7#3)
subacromial##19##1##(1995-5#1)(2006-10#5)(2007-11#6)(2007-12#1)(2008-12#1)(2008-7#4)(2010-9#1)
subacute PCP##6##2##(1996-10#6)
subacute and chronic occlusions##2##4##(2011-2#2)
subacute and chronic##8##3##(2007-11#1)(2008-7#1)(2011-2#3)(2012-1#3)
subacute and##10##2##(2006-10#1)(2007-11#1)(2008-7#1)(2011-2#3)(2012-1#4)
subacute bacterial endocarditis##3##3##(1991-3#1)(2007-11#1)(2012-12#1)
subacute combined degeneration of the spinal cord##3##7##(2008-7#2)(2013-7#1)
subacute cutaneous lupus##2##3##(2007-8#1)(2012-3#1)
subacute intestinal obstruction##2##3##(2009-5#1)(2009-7#1)
subacute intestinal##3##2##(1990-6#1)(2009-5#1)(2009-7#1)
subacute myelo-optic neuropathy##2##3##(2012-11#2)
subacute onset of##2##3##(2006-10#1)(2006-7#1)
subacute or chronic##6##3##(1991-2#1)(2006-8#1)(2007-11#2)(2011-2#2)
subacute or##7##2##(1991-2#1)(2006-10#1)(2006-8#1)(2007-11#2)(2011-2#2)
subacute osteomyelitis##3##2##(1993-10#3)
subacute phase##5##2##(1995-9#3)(2005-8#1)(2007-10#1)
subacute presentation##2##2##(2006-10#1)(2011-2#1)
subacute sclerosing panencephalitis##2##3##(1991-8#1)(2012-12#1)
subacute stage##2##2##(1997-3#1)(2008-12#1)
subacute stroke patient##2##3##(2012-1#2)
subacute stroke##5##2##(2007-10#2)(2007-9#1)(2012-1#2)
subacute subdural effusion in the posterior fossa associated with secondary acute hydrocephalus##2##12##(2008-5#2)
subacute subdural##3##2##(2008-5#2)(2010-11#1)
subacute thyroiditis##3##2##(1990-6#1)(2006-9#1)(2009-9#1)
subacute toxicity##4##2##(1995-5#2)(1997-3#2)
subacute##113##1##(1990-2#1)(1990-6#3)(1991-11#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-5#1)(1993-10#3)(1993-12#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-12#3)(1995-5#2)(1995-9#3)(1996-10#7)(1996-9#1)(1997-3#3)(1997-8#1)(2005-7#1)(2005-8#4)(2006-10#6)(2006-12#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#3)(2007-11#4)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-1#8)(2012-11#2)(2012-12#2)(2012-3#1)(2013-1#4)(2013-7#2)
subacutely##2##1##(2008-12#1)(2008-9#1)
subadult alligators##2##2##(2007-2#2)
subadult##7##1##(1997-9#1)(2007-2#3)(2008-5#1)(2010-4#2)
subadventitial layer of##3##3##(2011-2#3)
subadventitial##4##1##(2008-7#1)(2011-2#3)
subanalyses of##2##2##(1994-9#1)(2007-8#1)
subanalysis##2##1##(2006-10#2)
subaortic stenosis##2##2##(2007-8#1)(2013-1#1)
subaortic##5##1##(1992-5#1)(2007-8#1)(2012-3#1)(2013-1#2)
subaperture##2##1##(2008-3#2)
subapertures##3##1##(2007-12#2)(2008-3#1)
subapical growth##2##2##(2008-10#1)(2009-8#1)
subapical##7##1##(1995-2#1)(2008-10#2)(2008-7#1)(2009-8#2)(2010-11#1)
subarachnoid CSF flow##2##3##(2006-5#2)
subarachnoid and##3##2##(2006-12#1)(2007-10#1)(2007-8#1)
subarachnoid block##3##2##(2006-12#1)(2009-4#2)
subarachnoid haemorrhage (SAH)##8##3##(1994-10#1)(2006-1#1)(2008-7#6)
subarachnoid haemorrhage and##3##3##(2008-7#3)
subarachnoid haemorrhage on computed tomography##2##5##(2008-7#2)
subarachnoid haemorrhage##37##2##(1994-10#1)(1995-11#1)(1995-9#1)(1996-9#3)(1997-3#1)(2005-11#1)(2006-1#1)(2006-10#2)(2006-4#2)(2008-7#24)
subarachnoid hemorrhage (SAH)##10##3##(2005-9#1)(2006-11#2)(2006-5#1)(2007-10#2)(2012-3#2)(2013-8#2)
subarachnoid hemorrhage and##4##3##(2007-10#2)(2007-9#1)(2010-12#1)
subarachnoid hemorrhage were##2##3##(1995-11#1)(2007-10#1)
subarachnoid hemorrhage with##2##3##(2007-10#2)
subarachnoid hemorrhage##71##2##(1991-8#1)(1995-11#4)(1995-5#1)(2005-9#1)(2006-11#5)(2006-4#1)(2006-5#2)(2007-10#16)(2007-11#2)(2007-7#2)(2007-9#15)(2008-2#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-12#2)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#5)(2013-8#3)
subarachnoid or##2##2##(2008-7#1)(2009-6#1)
subarachnoid pressure##2##2##(2006-5#1)(2008-7#1)
subarachnoid space and##3##3##(2008-12#1)(2008-7#1)(2009-8#1)
subarachnoid space is##2##3##(2006-7#1)(2008-12#1)
subarachnoid space with##2##3##(2006-5#2)
subarachnoid space##27##2##(1992-8#1)(1995-7#2)(1996-8#1)(2006-12#2)(2006-5#6)(2006-7#1)(2008-12#2)(2008-7#9)(2009-6#1)(2009-8#2)
subarachnoid spaces##4##2##(1995-11#1)(2006-5#2)(2008-5#1)
subarachnoid##171##1##(1991-8#1)(1992-8#1)(1994-10#1)(1995-11#6)(1995-5#1)(1995-7#2)(1995-9#1)(1996-8#1)(1996-9#3)(1997-3#1)(2005-11#1)(2005-9#1)(2006-1#2)(2006-10#2)(2006-11#5)(2006-12#4)(2006-4#3)(2006-5#14)(2006-7#1)(2007-10#20)(2007-11#2)(2007-7#3)(2007-8#2)(2007-9#16)(2008-12#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#39)(2008-9#1)(2009-4#4)(2009-6#2)(2009-8#2)(2010-12#2)(2010-4#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#6)(2013-8#5)
subarachnoid-extradural anesthesia##2##2##(2007-8#2)
subarachnoidal##2##1##(2006-10#1)(2009-8#1)
subarea##3##1##(1996-10#1)(2007-3#1)(2013-1#1)
subaxial cervical##2##2##(2008-4#1)(2012-3#1)
subaxial##3##1##(2008-4#1)(2011-1#1)(2012-3#1)
subband and##2##2##(1997-8#1)(2008-2#1)
subband of##2##2##(1997-8#1)(2007-12#1)
subband##6##1##(1997-8#2)(2007-12#1)(2008-2#3)
subbands##4##1##(1990-12#1)(2008-2#3)
subcapital growth plate of the##2##5##(2007-11#2)
subcapital growth plate##3##3##(2007-11#3)
subcapital##4##1##(2007-11#3)(2007-8#1)
subcapitata##4##1##(2008-7#1)(2012-2#3)
subcapsular hematoma##3##2##(2010-11#2)(2012-3#1)
subcapsular or##2##2##(2005-10#1)(2012-12#1)
subcapsular##16##1##(1990-5#1)(1997-3#1)(2005-10#1)(2006-10#1)(2008-11#1)(2010-11#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
subcardinal##2##1##(2008-7#1)(2010-11#1)
subcatastrophic##4##1##(2007-1#4)
subcategories of##2##2##(1992-1#1)(2006-10#1)
subcategories##6##1##(1990-12#2)(1991-12#1)(1992-1#1)(1997-8#1)(2006-10#1)
subcategory##5##1##(1990-12#2)(1991-12#1)(2008-11#1)(2010-5#1)
subcaudate tractotomy##2##2##(2007-7#1)(2009-9#1)
subcellular and##2##2##(2008-1#1)(2008-4#1)
subcellular compartmentation##2##2##(1995-6#1)(1997-7#1)
subcellular compartments##6##2##(1990-5#1)(1997-7#1)(2006-10#1)(2006-12#1)(2008-4#1)(2008-9#1)
subcellular components##2##2##(2006-2#1)(2009-7#1)
subcellular distribution and substrate specificity##2##5##(1995-8#2)
subcellular distribution and##3##3##(1993-2#1)(1995-8#2)
subcellular distribution in##7##3##(1991-1#1)(1991-10#1)(1991-2#1)(1994-10#1)(2008-4#1)(2008-9#2)
subcellular distribution of PC1##2##4##(1992-8#2)
subcellular distribution of the##5##4##(1990-2#1)(1993-9#1)(1995-6#1)(1996-5#1)(1997-6#1)
subcellular distribution of##24##3##(1990-2#2)(1990-4#2)(1990-6#1)(1991-7#1)(1992-8#2)(1993-9#2)(1994-10#1)(1994-12#2)(1994-3#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-6#1)(2005-7#1)(2008-10#1)(2008-9#1)
subcellular distribution##35##2##(1990-2#2)(1990-4#2)(1990-6#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-7#1)(1992-8#2)(1993-2#1)(1993-9#2)(1994-10#2)(1994-12#2)(1994-3#1)(1995-2#1)(1995-6#1)(1995-8#4)(1996-2#1)(1996-5#1)(1996-8#1)(1997-6#1)(2005-7#1)(2008-10#1)(2008-4#1)(2008-9#3)
subcellular distributions of##4##3##(1991-1#1)(1991-2#1)(1997-7#1)(2008-4#1)
subcellular distributions##5##2##(1991-1#1)(1991-2#1)(1995-7#1)(1997-7#1)(2008-4#1)
subcellular fractionation studies##2##3##(1994-10#1)(1995-6#1)
subcellular fractionation##11##2##(1990-3#1)(1990-5#2)(1991-1#1)(1994-10#1)(1995-6#2)(1997-4#1)(2008-1#1)(2008-4#2)
subcellular fractions from rat##2##4##(1991-1#1)(1995-9#1)
subcellular fractions from##4##3##(1991-1#1)(1991-5#1)(1995-3#1)(1995-9#1)
subcellular fractions of##5##3##(1992-4#1)(1993-12#1)(1993-6#1)(1994-3#1)(1995-12#1)
subcellular fractions showed that##2##4##(1990-12#1)(1995-8#1)
subcellular fractions##26##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-5#2)(1992-4#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#3)(1995-5#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-6#1)(2008-1#1)(2008-2#1)(2008-4#1)
subcellular level##4##2##(2008-4#2)(2012-11#2)
subcellular localisation of##4##3##(1991-5#1)(2006-8#2)(2008-11#1)
subcellular localization and##6##3##(2008-1#1)(2009-8#1)(2012-12#4)
subcellular localization of pituitary hormone and its mRNA##3##8##(2007-12#3)
subcellular localization of the##7##4##(1993-9#1)(1997-2#1)(1997-4#1)(2006-12#1)(2007-8#1)(2009-8#1)(2011-1#1)
subcellular localization of##27##3##(1990-5#1)(1992-6#1)(1992-8#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-7#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-12#1)(2006-7#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-7#2)(2009-5#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#1)
subcellular localization was##2##3##(1994-12#1)(1996-6#1)
subcellular localization##58##2##(1990-11#1)(1990-5#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-5#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-9#1)(1995-2#1)(1995-5#1)(1995-7#1)(1996-2#1)(1996-6#2)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(2006-12#1)(2006-7#1)(2007-12#3)(2007-8#1)(2008-1#2)(2008-11#2)(2008-2#1)(2008-4#2)(2008-7#6)(2008-9#1)(2009-5#1)(2009-8#2)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#5)(2012-2#2)
subcellular localizations##2##2##(2008-7#1)(2009-8#1)
subcellular location of##2##3##(1992-11#1)(2010-11#1)
subcellular location##3##2##(1992-11#1)(2008-4#1)(2010-11#1)
subcellular locations of##3##3##(2008-4#1)(2008-5#1)(2011-2#1)
subcellular locations##4##2##(2008-1#1)(2008-4#1)(2008-5#1)(2011-2#1)
subcellular organelle##2##2##(1996-9#1)(2005-11#1)
subcellular organelles##6##2##(1990-11#1)(1993-9#1)(1996-9#1)(2008-4#1)(2009-8#1)(2010-12#1)
subcellular sites of##2##3##(1996-4#1)(2009-6#1)
subcellular structures##4##2##(1994-6#1)(2006-10#1)(2008-4#1)(2011-1#1)
subcellular##212##1##(1990-11#4)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#5)(1990-6#2)(1990-7#1)(1990-9#1)(1991-1#4)(1991-10#1)(1991-2#3)(1991-5#3)(1991-7#1)(1992-11#4)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#3)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#4)(1994-10#3)(1994-11#2)(1994-12#5)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#4)(1995-7#3)(1995-8#5)(1995-9#1)(1996-2#4)(1996-4#2)(1996-5#2)(1996-6#3)(1996-8#1)(1996-9#2)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#3)(2005-11#1)(2005-7#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-7#1)(2006-8#2)(2007-12#5)(2007-8#1)(2008-1#8)(2008-10#3)(2008-11#4)(2008-2#2)(2008-4#15)(2008-5#1)(2008-7#8)(2008-9#6)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-11#1)(2010-12#2)(2010-2#1)(2010-9#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#10)(2012-2#2)
subcentimeter pulmonary nodules##2##3##(2008-6#2)
subcentimeter##3##1##(2007-12#1)(2008-6#2)
subceruleus##4##1##(1992-1#4)
subchannel##3##1##(2007-11#2)(2008-3#1)
subchannel-multiplexed##2##1##(2007-11#2)
subchapters##3##1##(2011-12#3)
subchondral bone and##3##3##(2007-11#1)(2007-7#1)(2013-1#1)
subchondral bone##17##2##(2005-3#1)(2005-7#1)(2006-10#2)(2006-3#1)(2007-11#5)(2007-4#2)(2007-7#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
subchondral erosions in##2##3##(2011-2#2)
subchondral erosions##3##2##(2011-2#3)
subchondral##28##1##(2005-3#1)(2005-7#1)(2006-10#2)(2006-3#1)(2007-11#10)(2007-4#2)(2007-7#1)(2008-4#1)(2008-5#2)(2008-8#1)(2011-2#5)(2013-1#1)
subchondrial##2##1##(2007-11#1)(2007-7#1)
subchronic continuous##2##2##(1992-10#2)
subchronic nicotine treatment##2##3##(1996-10#2)
subchronic nicotine##3##2##(1996-10#3)
subchronic##19##1##(1992-10#3)(1995-3#3)(1996-10#6)(2006-10#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-8#1)(2013-8#1)
subchronically exposed to nicotine##2##4##(1996-10#2)
subchronically##4##1##(1996-10#3)(2012-2#1)
subclades##2##1##(2008-10#2)
subclass and##3##2##(1991-4#1)(2008-8#1)(2009-4#1)
subclass from the web of##2##5##(2006-12#2)
subclass in##2##2##(1991-5#1)(1995-3#1)
subclass of##11##2##(1991-2#1)(1991-4#2)(1992-8#1)(1997-1#1)(2005-8#1)(2006-10#1)(2006-12#2)(2008-3#1)(2009-9#1)
subclass##46##1##(1991-11#2)(1991-2#2)(1991-4#3)(1991-5#1)(1992-8#3)(1993-11#1)(1993-12#1)(1993-6#2)(1994-9#1)(1995-3#2)(1996-10#1)(1997-1#1)(2005-8#1)(2006-10#1)(2006-12#4)(2007-2#3)(2008-10#1)(2008-3#4)(2008-4#2)(2008-8#3)(2009-4#1)(2009-9#2)(2010-7#1)(2011-2#1)(2013-1#2)
subclasses and##2##2##(2006-10#1)(2008-12#1)
subclasses compared to##2##3##(1996-8#1)(2013-1#1)
subclasses compared##3##2##(1995-2#1)(1996-8#1)(2013-1#1)
subclasses in##3##2##(1996-8#1)(2007-2#1)(2008-8#1)
subclasses of##11##2##(1994-5#1)(1996-2#1)(1996-3#2)(2005-10#1)(2007-11#2)(2008-11#1)(2008-4#2)(2009-12#1)
subclasses were##3##2##(2008-12#2)(2009-6#1)
subclasses##38##1##(1993-12#1)(1994-11#1)(1994-12#2)(1994-5#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-8#5)(2005-10#1)(2006-10#1)(2007-11#2)(2007-2#1)(2008-11#1)(2008-12#4)(2008-3#1)(2008-4#3)(2008-8#2)(2009-10#1)(2009-12#1)(2009-6#1)(2013-1#2)
subclassification of##5##2##(2006-10#2)(2008-6#1)(2009-11#1)(2009-3#1)
subclassification##10##1##(1996-5#1)(2006-10#2)(2007-4#1)(2008-6#1)(2008-8#3)(2009-11#1)(2009-3#1)
subclassified as##2##2##(1991-11#1)(2013-8#1)
subclassified##3##1##(1991-11#1)(1992-6#1)(2013-8#1)
subclavian and##4##2##(2007-7#2)(2007-9#1)(2011-2#1)
subclavian arteries##3##2##(2011-2#2)(2012-2#1)
subclavian artery and##3##3##(2007-7#1)(2009-3#1)(2010-7#1)
subclavian artery aneurysm##2##3##(2010-5#2)
subclavian artery stenosis##2##3##(2008-7#1)(2010-10#1)
subclavian artery to##2##3##(2007-8#1)(2008-4#1)
subclavian artery##31##2##(1991-11#2)(1993-3#3)(1997-8#1)(2006-2#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#4)(2008-11#3)(2008-4#1)(2008-7#5)(2009-10#1)(2009-3#2)(2010-10#1)(2010-5#2)(2010-7#1)(2012-2#1)
subclavian catheter##3##2##(2007-12#1)(2007-7#1)(2009-6#1)
subclavian steal##2##2##(2007-11#1)(2007-9#1)
subclavian vein for##2##3##(2007-7#2)
subclavian vein##18##2##(2007-7#8)(2007-8#1)(2007-9#1)(2008-1#2)(2008-12#2)(2008-4#1)(2012-2#2)(2013-1#1)
subclavian veins##3##2##(2007-7#2)(2008-12#1)
subclavian##75##1##(1991-11#3)(1993-3#3)(1997-8#1)(2006-2#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#18)(2007-8#5)(2007-9#3)(2008-1#2)(2008-11#4)(2008-12#3)(2008-4#2)(2008-7#7)(2009-10#1)(2009-3#2)(2009-6#1)(2010-10#1)(2010-5#2)(2010-7#1)(2011-2#5)(2012-2#4)(2013-1#1)
subclavicular##7##1##(1996-6#1)(2012-12#6)
subclinical alterations##2##2##(1997-5#1)(2013-1#1)
subclinical atherosclerosis##10##2##(2008-11#3)(2008-3#4)(2010-9#1)(2013-1#2)
subclinical coronary atherosclerosis##3##3##(2013-4#3)
subclinical cryptosporidiosis##4##2##(1996-12#4)
subclinical decline in the##2##4##(2013-8#2)
subclinical hypothyroidism (TSH##2##3##(2012-3#2)
subclinical hypothyroidism##8##2##(1997-8#1)(2006-10#2)(2006-9#1)(2010-8#1)(2012-2#1)(2012-3#2)
subclinical inflammation##3##2##(2008-5#1)(2010-4#1)(2011-2#1)
subclinical lesions##2##2##(1991-2#1)(2012-3#1)
subclinical rejection##3##2##(1995-2#1)(2007-8#1)(2012-3#1)
subclinical renal##2##2##(1994-6#1)(2007-11#1)
subclinical##101##1##(1990-11#1)(1990-12#1)(1990-4#1)(1991-2#3)(1993-12#1)(1993-2#1)(1994-10#1)(1994-6#2)(1995-1#1)(1995-2#2)(1995-4#1)(1996-12#5)(1997-5#4)(1997-8#1)(2005-10#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-2#3)(2008-3#4)(2008-5#2)(2008-7#1)(2008-8#3)(2009-10#3)(2009-12#1)(2009-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#6)(2013-4#3)(2013-8#4)
subclinically##3##1##(1996-12#1)(2005-7#1)(2007-2#1)
subclone of the##2##3##(1991-11#1)(1992-8#1)
subclone of##5##2##(1991-11#1)(1991-9#1)(1992-8#1)(1997-8#2)
subclone with##2##2##(1993-9#1)(1996-5#1)
subclone##8##1##(1991-11#1)(1991-9#1)(1992-8#1)(1993-9#1)(1996-5#1)(1997-8#2)(2008-10#1)
subcloned and sequenced##3##3##(1990-10#1)(1991-11#1)(1993-11#1)
subcloned and##4##2##(1990-10#1)(1991-11#1)(1991-9#1)(1993-11#1)
subcloned from##2##2##(1992-3#1)(1996-5#1)
subcloned in the expression vector##2##5##(1990-5#1)(1997-6#1)
subcloned in##5##2##(1990-11#1)(1990-4#1)(1990-5#1)(1995-8#1)(1997-6#1)
subcloned into a##2##3##(1992-11#1)(1996-12#1)
subcloned into the expression vector pT7-7##2##6##(1994-5#2)
subcloned into the expression vector##3##5##(1993-12#1)(1994-5#2)
subcloned into the##9##3##(1993-12#1)(1994-12#1)(1994-5#2)(1995-8#1)(1996-10#1)(2005-11#1)(2008-10#1)(2008-11#1)
subcloned into##22##2##(1990-12#1)(1991-2#1)(1992-11#1)(1993-12#1)(1993-4#1)(1994-12#2)(1994-5#2)(1994-8#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-12#1)(1997-4#1)(2005-10#1)(2005-11#2)(2008-10#1)(2008-11#2)(2008-9#1)
subcloned##40##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-9#1)(1992-11#2)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-5#1)(1994-12#4)(1994-5#2)(1994-8#1)(1995-3#1)(1995-8#2)(1996-10#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-6#1)(2005-10#1)(2005-11#2)(2008-10#1)(2008-11#2)(2008-9#1)
subclones and##2##2##(1992-6#1)(1994-3#1)
subclones of##2##2##(1990-6#1)(1994-3#1)
subclones##19##1##(1990-3#2)(1990-6#1)(1992-6#1)(1993-1#1)(1993-11#1)(1994-3#5)(1994-6#2)(1995-8#1)(2008-10#1)(2008-11#3)(2008-8#1)
subcloning and##4##2##(1990-3#1)(1990-5#1)(1991-7#1)(1993-9#1)
subcloning of the insert##2##4##(1991-5#1)(1996-10#1)
subcloning of##4##2##(1990-1#1)(1991-5#1)(1996-10#1)(1997-7#1)
subcloning the##2##2##(1996-11#1)(2008-10#1)
subcloning##28##1##(1990-1#2)(1990-3#4)(1990-5#1)(1990-7#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-5#1)(1991-7#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-6#1)(1995-8#1)(1996-10#2)(1996-11#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-4#2)
subclusters##4##1##(2008-10#2)(2008-5#1)(2013-8#1)
subcoeruleus##2##1##(1993-2#1)(1997-2#1)
subcommissural organ##2##2##(1997-5#2)
subcommissural##4##1##(1993-6#1)(1997-5#2)(2007-8#1)
subcommittee##4##1##(1995-12#1)(1995-6#1)(1996-6#1)(1997-3#1)
subcompartments##3##1##(1990-7#1)(1994-8#1)(2008-1#1)
subcomplex consisting of##2##3##(2012-12#2)
subcomplexes##3##1##(1990-2#1)(2011-2#2)
subcomponent of the##2##3##(1997-3#1)(2008-11#1)
subcomponent##4##1##(1997-3#1)(2005-8#1)(2008-11#1)(2009-11#1)
subcomponents##3##1##(1992-1#1)(1997-1#1)(2008-12#1)
subconductance states##2##2##(1994-3#2)
subconfluent##3##1##(1992-3#1)(1994-9#1)(2008-11#1)
subconjunctival application##3##2##(2008-12#3)
subconjunctival##4##1##(2008-12#3)(2012-3#1)
subcontinent##14##1##(1990-10#1)(1996-8#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
subconvulsant doses##2##2##(1990-5#1)(1991-3#1)
subconvulsant##3##1##(1990-5#1)(1991-3#1)(1996-10#1)
subcorneal##2##1##(1995-8#1)(2005-11#1)
subcortex##4##1##(2007-9#3)(2008-3#1)
subcortical and cortical##2##3##(1992-7#1)(2008-7#1)
subcortical areas##5##2##(2008-11#1)(2009-6#4)
subcortical dementia##8##2##(2006-10#3)(2007-10#3)(2007-11#1)(2008-7#1)
subcortical involvement##2##2##(2007-9#2)
subcortical lesions##3##2##(1993-8#1)(1993-9#2)
subcortical nuclei##2##2##(2008-11#1)(2009-10#1)
subcortical regions##3##2##(1993-2#1)(2008-11#1)(2012-12#1)
subcortical structures are##2##3##(1993-9#1)(2008-1#1)
subcortical structures##5##2##(1993-4#1)(1993-9#1)(2007-1#1)(2008-1#1)(2010-9#1)
subcortical white matter ischaemia##2##4##(2009-10#2)
subcortical white matter##8##3##(1993-12#1)(2006-1#1)(2007-10#3)(2009-10#3)
subcortical##70##1##(1990-7#1)(1991-11#1)(1991-3#2)(1992-10#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-4#1)(1993-8#1)(1993-9#3)(1996-3#2)(1996-5#1)(2004-12#1)(2006-1#1)(2006-10#3)(2006-9#2)(2007-1#1)(2007-10#8)(2007-11#1)(2007-9#2)(2008-1#1)(2008-11#5)(2008-2#1)(2008-4#2)(2008-7#4)(2008-8#1)(2009-10#5)(2009-6#4)(2010-12#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
subcortically lesioned rat##2##3##(1993-11#2)
subcostal##3##1##(2007-8#1)(2010-12#2)
subcranial##2##1##(2006-12#1)(2007-12#1)
subcritical water extraction##3##3##(2008-10#3)
subcritical water##4##2##(2008-10#4)
subcritical##7##1##(1994-2#1)(2005-11#1)(2008-10#4)(2010-10#1)
subcultivation##3##1##(2008-11#3)
subculture and##2##2##(2008-9#1)(2010-8#1)
subculture of##2##2##(2008-11#1)(2008-4#1)
subculture##14##1##(1991-2#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-9#1)(2009-10#1)(2010-8#1)(2013-1#2)(2013-8#1)
subcultured and##2##2##(2006-10#1)(2008-8#1)
subcultured in##3##2##(2008-10#2)(2013-8#1)
subcultured on##2##2##(2008-10#2)
subcultured##21##1##(1991-9#1)(1993-4#1)(1996-5#1)(1997-2#1)(2006-10#2)(2008-10#9)(2008-8#1)(2010-3#1)(2012-12#3)(2013-8#1)
subcultures and##2##2##(1991-1#1)(2008-10#1)
subcultures##7##1##(1991-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-12#1)
subculturing of##2##2##(1997-4#1)(2008-2#1)
subculturing##12##1##(1997-4#3)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#2)(2008-9#1)(2013-8#1)
subcutaneous (SC) injection##2##3##(2006-10#1)(2008-5#1)
subcutaneous (SC)##3##2##(1994-12#1)(2006-10#1)(2008-5#1)
subcutaneous (s##5##2##(1991-9#1)(1996-12#1)(1996-2#1)(2008-5#1)(2008-6#1)
subcutaneous IL-2##2##2##(1991-6#1)(2006-6#1)
subcutaneous LMS##2##2##(2008-6#2)
subcutaneous adipocytes##5##2##(2007-7#1)(2008-1#1)(2008-11#1)(2010-4#2)
subcutaneous adipose tissue##7##3##(2007-8#3)(2007-9#1)(2008-1#1)(2008-11#1)(2008-5#1)
subcutaneous adipose##8##2##(2007-8#3)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)
subcutaneous administration of##10##3##(1990-10#1)(1991-12#1)(1992-3#1)(1995-2#1)(1996-10#2)(1997-7#1)(2007-1#1)(2010-2#1)(2012-2#1)
subcutaneous administration to##2##3##(1996-2#1)(2004-1#1)
subcutaneous administration##14##2##(1990-10#1)(1991-12#1)(1992-3#1)(1995-12#1)(1995-2#1)(1996-10#2)(1996-2#1)(1997-7#1)(2004-1#1)(2007-1#1)(2009-6#1)(2010-2#1)(2012-2#1)
subcutaneous alemtuzumab##3##2##(2009-12#3)
subcutaneous and intravenous##2##3##(2007-11#1)(2009-5#1)
subcutaneous and visceral##2##3##(2008-7#2)
subcutaneous and##10##2##(1996-8#1)(2004-12#1)(2006-4#2)(2007-11#1)(2008-11#1)(2008-7#2)(2009-5#1)(2010-2#1)
subcutaneous atrophy##3##2##(2011-2#3)
subcutaneous connective tissue##2##3##(1997-3#2)
subcutaneous continuous infusion##2##3##(2012-3#2)
subcutaneous continuous##3##2##(1992-5#1)(2012-3#2)
subcutaneous drug delivery##2##3##(1991-3#1)(1992-5#1)
subcutaneous emphysema following##2##3##(1991-5#1)(2011-2#1)
subcutaneous emphysema in##2##3##(2009-6#1)(2011-2#1)
subcutaneous emphysema##6##2##(1991-5#1)(2009-6#2)(2011-2#2)(2013-8#1)
subcutaneous fat and##3##3##(2007-6#1)(2010-4#1)(2011-1#1)
subcutaneous fat##24##2##(1996-3#1)(2007-6#1)(2008-1#2)(2008-3#1)(2008-5#2)(2008-7#2)(2010-11#1)(2010-2#1)(2010-4#3)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#5)(2012-4#1)
subcutaneous glucose##2##2##(2004-9#2)
subcutaneous heparin##3##2##(1993-5#1)(1994-3#1)(1997-5#1)
subcutaneous immunization##2##2##(1995-12#1)(2008-5#1)
subcutaneous immunotherapy##4##2##(1993-12#1)(2007-11#1)(2008-8#1)(2013-1#1)
subcutaneous implantation of##4##3##(2006-9#1)(2007-9#1)(2008-11#1)(2012-2#1)
subcutaneous implantation##6##2##(2006-9#2)(2007-9#1)(2008-11#2)(2012-2#1)
subcutaneous infusion in terminal##2##4##(1990-3#1)(1992-5#1)
subcutaneous infusion of##3##3##(1992-10#1)(2011-2#2)
subcutaneous infusion##9##2##(1990-3#1)(1990-8#1)(1992-10#1)(1992-5#1)(1994-4#1)(1996-5#1)(2006-6#1)(2011-2#2)
subcutaneous injection of a##2##4##(1993-1#1)(2008-6#1)
subcutaneous injection of formalin into##2##5##(1995-11#1)(1996-3#1)
subcutaneous injection of##17##3##(1993-1#1)(1993-4#1)(1994-2#1)(1995-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(2007-11#3)(2008-10#1)(2008-6#1)(2008-7#1)(2012-2#1)(2013-1#2)(2013-7#1)
subcutaneous injection##23##2##(1991-3#1)(1993-1#1)(1993-4#1)(1994-2#1)(1995-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-2#1)(2007-11#4)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2012-2#1)(2013-1#4)(2013-7#1)
subcutaneous injections of either##2##4##(1993-11#1)(1996-5#1)
subcutaneous injections of##11##3##(1990-11#1)(1990-12#1)(1992-5#1)(1993-11#1)(1995-6#1)(1996-10#1)(1996-3#1)(1996-5#1)(1997-5#1)(2008-5#1)(2009-9#1)
subcutaneous injections##12##2##(1990-11#1)(1990-12#1)(1992-5#1)(1993-11#1)(1995-6#1)(1996-10#1)(1996-3#1)(1996-5#1)(1997-5#1)(2004-12#1)(2008-5#1)(2009-9#1)
subcutaneous inoculation##3##2##(1992-2#1)(1995-5#1)(2008-8#1)
subcutaneous insulin infusion (CSII)##4##4##(1991-10#1)(2006-1#3)
subcutaneous insulin infusion##7##3##(1991-10#1)(2006-1#3)(2008-1#1)(2008-7#1)(2009-11#1)
subcutaneous insulin##8##2##(1991-10#1)(1997-8#1)(2006-1#3)(2008-1#1)(2008-7#1)(2009-11#1)
subcutaneous interleukin-2##4##2##(1991-6#1)(1992-2#1)(1993-10#1)(1994-12#1)
subcutaneous mass in the right##2##5##(1994-8#1)(2012-1#1)
subcutaneous mass in the##3##4##(1994-8#1)(2012-1#1)(2013-1#1)
subcutaneous mass in##4##3##(1994-8#1)(2012-1#1)(2012-2#1)(2013-1#1)
subcutaneous mass##6##2##(1994-8#1)(2008-10#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
subcutaneous nodules##12##2##(1990-2#2)(2006-10#3)(2006-2#1)(2007-10#1)(2007-7#1)(2013-1#3)(2013-8#1)
subcutaneous or intravenous##2##3##(1995-2#1)(2013-1#1)
subcutaneous or##3##2##(1995-2#1)(1997-6#1)(2013-1#1)
subcutaneous route##3##2##(2007-10#2)(2007-11#1)
subcutaneous sermorelin 30 microg/kg bodyweight##4##5##(2007-11#4)
subcutaneous sermorelin##5##2##(2007-11#5)
subcutaneous sites##2##2##(2008-5#1)(2012-2#1)
subcutaneous somatropin##2##2##(2007-11#2)
subcutaneous swelling##3##2##(1997-3#1)(2007-7#1)(2011-1#1)
subcutaneous therapy##2##2##(1991-6#1)(1993-8#1)
subcutaneous tissue and##4##3##(1990-8#1)(2006-10#2)(2012-12#1)
subcutaneous tissue chamber##2##3##(2004-9#2)
subcutaneous tissue fluid##6##3##(2004-9#6)
subcutaneous tissue of##4##3##(1997-3#1)(2004-9#1)(2008-5#2)
subcutaneous tissue##32##2##(1990-11#2)(1990-8#1)(1997-3#1)(2004-9#11)(2006-10#2)(2007-7#1)(2008-5#3)(2008-9#2)(2009-2#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
subcutaneous tissues and##2##3##(2006-10#2)
subcutaneous tissues of##2##3##(1990-11#1)(2006-9#1)
subcutaneous tissues##13##2##(1990-11#1)(1990-12#1)(1991-10#1)(2005-7#1)(2006-10#2)(2006-4#1)(2006-9#1)(2007-8#1)(2010-2#1)(2010-4#1)(2012-3#1)(2013-8#1)
subcutaneous treatment with##2##3##(1997-5#1)(2008-10#1)
subcutaneous tumor model##3##3##(2008-11#1)(2008-8#2)
subcutaneous tumor##5##2##(2008-11#2)(2008-8#2)(2012-3#1)
subcutaneous tumors in##2##3##(1995-5#1)(1996-10#1)
subcutaneous##361##1##(1990-10#1)(1990-11#5)(1990-12#2)(1990-2#2)(1990-3#1)(1990-8#2)(1991-1#1)(1991-10#2)(1991-12#1)(1991-3#3)(1991-5#1)(1991-6#5)(1991-9#2)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#7)(1992-6#1)(1992-9#1)(1993-1#3)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-4#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-5#5)(1995-6#1)(1996-10#4)(1996-12#2)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#2)(1996-8#2)(1997-2#1)(1997-3#5)(1997-4#2)(1997-5#4)(1997-6#2)(1997-7#2)(1997-8#3)(2004-1#1)(2004-12#2)(2004-9#15)(2005-7#1)(2006-1#3)(2006-10#10)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#3)(2006-6#3)(2006-8#1)(2006-9#3)(2007-1#1)(2007-10#4)(2007-11#19)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#15)(2007-8#6)(2007-9#2)(2008-1#7)(2008-10#4)(2008-11#9)(2008-3#4)(2008-4#6)(2008-5#13)(2008-6#5)(2008-7#6)(2008-8#4)(2008-9#2)(2009-11#1)(2009-12#3)(2009-2#1)(2009-5#3)(2009-6#3)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#5)(2010-4#7)(2010-6#2)(2011-1#4)(2011-12#4)(2011-2#10)(2012-1#3)(2012-12#3)(2012-2#15)(2012-3#5)(2012-4#1)(2013-1#16)(2013-7#1)(2013-8#6)
subcutaneously and##2##2##(1991-3#1)(1997-6#1)
subcutaneously every##3##2##(1990-2#1)(2008-7#1)(2010-5#1)
subcutaneously for##4##2##(1991-12#1)(2006-9#1)(2007-11#1)(2010-6#1)
subcutaneously implanted##2##2##(1997-4#1)(2008-5#1)
subcutaneously in a##2##3##(2008-5#1)(2013-8#1)
subcutaneously in##8##2##(1994-6#1)(2004-9#1)(2006-9#1)(2008-5#2)(2009-10#1)(2012-12#1)(2013-8#1)
subcutaneously injected##2##2##(1992-10#1)(2009-12#1)
subcutaneously into nude mice##2##4##(2008-11#1)(2008-8#1)
subcutaneously into##5##2##(1992-5#1)(1994-8#1)(2008-11#1)(2008-5#1)(2008-8#1)
subcutaneously on##3##2##(1992-2#1)(2004-1#1)(2007-8#1)
subcutaneously once##2##2##(2008-7#1)(2008-8#1)
subcutaneously to##3##2##(2007-7#1)(2008-10#1)(2008-11#1)
subcutaneously with##6##2##(1991-6#1)(1995-11#1)(1996-10#1)(1996-12#1)(2004-11#1)(2012-3#1)
subcutaneously##75##1##(1990-12#1)(1990-2#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-3#1)(1995-5#2)(1996-10#3)(1996-12#1)(1997-4#1)(1997-6#1)(2004-1#1)(2004-11#1)(2004-9#1)(2006-10#1)(2006-9#2)(2007-11#5)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-6#2)(2010-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
subcutaneously) and##2##2##(2007-2#1)(2013-8#1)
subcutaneously)##7##1##(1993-2#1)(2007-10#2)(2007-11#1)(2007-2#1)(2012-3#1)(2013-8#1)
subcuticular hyphae##2##2##(2008-10#2)
subcuticular space##2##2##(2007-12#1)(2011-1#1)
subcuticular##6##1##(2007-12#2)(2008-10#3)(2011-1#1)
subcutis##10##1##(2005-11#1)(2005-7#3)(2007-12#1)(2008-5#2)(2008-6#1)(2010-6#2)
subcycle pulses##2##2##(2007-11#2)
subcycle##4##1##(2007-11#3)(2007-12#1)
subdermal##2##1##(1996-6#1)(2008-1#1)
subdiaphragmatic vagotomy##4##2##(1991-1#1)(1994-6#1)(1995-12#1)(1996-9#1)
subdiaphragmatic##8##1##(1991-1#1)(1992-6#1)(1993-12#2)(1994-6#1)(1995-12#1)(1996-9#1)(2011-2#1)
subdiploid##2##1##(1995-8#1)(1997-6#1)
subdisciplines of##2##2##(2007-8#1)(2008-8#1)
subdivide the##4##2##(1995-3#1)(2007-11#1)(2008-10#1)(2012-2#1)
subdivide##5##1##(1995-3#1)(2007-11#1)(2008-10#1)(2010-1#1)(2012-2#1)
subdivided by##3##2##(2007-12#1)(2008-10#1)(2009-2#1)
subdivided in##5##2##(1997-6#1)(2005-1#1)(2006-10#1)(2006-12#1)(2008-1#1)
subdivided into four##6##3##(1997-6#1)(2005-8#1)(2008-11#1)(2008-12#1)(2013-1#2)
subdivided into the##3##3##(1993-10#1)(1995-7#1)(2006-10#1)
subdivided into three groups##4##4##(1990-4#1)(2006-10#1)(2007-12#1)(2013-1#1)
subdivided into three stages##2##4##(2005-11#1)(2007-10#1)
subdivided into three##10##3##(1990-4#1)(1994-4#1)(1994-6#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-12#1)(2009-2#1)(2013-1#1)(2013-8#1)
subdivided into two groups##3##4##(1992-10#1)(1992-8#1)(2008-12#1)
subdivided into two##7##3##(1992-10#1)(1992-8#1)(1995-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2012-1#1)
subdivided into##61##2##(1990-4#1)(1990-8#1)(1991-11#2)(1991-5#1)(1992-10#1)(1992-8#1)(1992-9#1)(1993-10#1)(1994-11#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-7#1)(1995-8#2)(1996-3#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-10#2)(2005-11#1)(2005-8#2)(2006-10#4)(2007-1#1)(2007-10#1)(2007-12#2)(2007-3#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-8#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#2)
subdivided population structure and cryptic species##2##6##(1995-8#2)
subdivided population structure##3##3##(1995-8#2)(2010-5#1)
subdivided the##3##2##(1997-2#1)(2008-1#1)(2013-1#1)
subdivided##85##1##(1990-4#1)(1990-8#2)(1991-11#2)(1991-5#1)(1992-10#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-10#1)(1994-11#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-7#1)(1995-8#4)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(2005-1#1)(2005-10#2)(2005-11#1)(2005-8#2)(2006-10#5)(2006-12#1)(2007-1#1)(2007-10#1)(2007-12#3)(2007-3#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-2#2)(2009-8#2)(2010-5#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#2)
subdividing##3##1##(1992-2#1)(1996-5#1)(2008-10#1)
subdivision among all##2##3##(2008-10#2)
subdivision and##2##2##(2008-10#1)(2009-2#1)
subdivision hierarchy##2##2##(2008-6#2)
subdivision of the central nuclear complex##2##6##(1997-6#2)
subdivision of the##10##3##(1991-3#1)(1993-5#1)(1997-1#1)(1997-6#3)(2006-8#1)(2007-12#1)(2008-2#1)(2010-10#1)
subdivision of##16##2##(1991-3#1)(1993-5#1)(1997-1#2)(1997-4#1)(1997-6#3)(2006-8#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-8#1)(2010-10#1)
subdivision##34##1##(1991-3#1)(1993-5#1)(1997-1#2)(1997-4#2)(1997-6#4)(2006-8#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-6#5)(2008-8#3)(2008-9#3)(2009-2#2)(2010-10#1)
subdivisions and##2##2##(1997-2#1)(1997-6#1)
subdivisions in the##2##3##(1997-6#1)(1997-7#1)
subdivisions of the medial##2##4##(1994-5#1)(1997-6#1)
subdivisions of the##6##3##(1991-11#1)(1991-3#1)(1993-12#2)(1994-5#1)(1997-6#1)
subdivisions of##8##2##(1991-11#1)(1991-3#1)(1993-12#2)(1994-2#1)(1994-5#1)(1997-6#1)(1997-8#1)
subdivisions##21##1##(1990-5#1)(1991-11#1)(1991-3#1)(1993-12#4)(1994-2#1)(1994-5#1)(1995-8#1)(1996-9#1)(1997-2#3)(1997-6#3)(1997-7#1)(1997-8#1)(2008-3#1)(2012-3#1)
subdomain and a##2##3##(1992-11#1)(1997-5#1)
subdomain and##4##2##(1992-11#1)(1992-6#2)(1997-5#1)
subdomain of the CPAP protein##2##5##(2009-7#2)
subdomain##19##1##(1990-9#1)(1991-4#2)(1992-11#2)(1992-4#1)(1992-6#2)(1996-11#1)(1996-12#1)(1997-5#3)(1997-6#1)(2007-6#1)(2008-3#1)(2008-5#1)(2009-7#2)
subdomains are##2##2##(1992-11#1)(1992-6#1)
subdomains of##2##2##(1992-11#1)(2007-6#1)
subdomains##16##1##(1992-11#4)(1992-6#3)(1995-2#2)(1995-4#1)(1997-4#1)(1997-7#1)(2007-6#1)(2008-10#2)(2008-7#1)
subducting##3##1##(1993-4#2)(1995-6#1)
subduction zone volcanism##2##3##(1993-4#2)
subduction zone##5##2##(1990-11#3)(1993-4#2)
subduction##7##1##(1990-11#3)(1993-4#3)(1995-6#1)
subdural and##2##2##(1991-11#1)(2008-7#1)
subdural effusion in the posterior fossa##3##6##(2008-5#3)
subdural effusion##9##2##(2006-3#1)(2006-8#1)(2008-5#7)
subdural electrode##2##2##(2008-11#1)(2010-7#1)
subdural fluid collections##4##3##(2006-8#3)(2009-6#1)
subdural haematoma##5##2##(2008-7#5)
subdural hematoma in a##2##4##(2012-2#2)
subdural hematoma in##3##3##(2008-5#1)(2012-2#2)
subdural hematoma on the##2##4##(2008-7#2)
subdural hematoma was##2##3##(2006-8#1)(2008-7#1)
subdural hematoma##30##2##(1995-3#1)(1996-11#1)(2006-11#1)(2006-7#3)(2006-8#2)(2007-10#2)(2008-5#1)(2008-7#11)(2010-11#1)(2012-12#2)(2012-2#4)(2013-7#1)
subdural hematomas##4##2##(2006-12#1)(2006-8#1)(2008-9#2)
subdural##74##1##(1990-5#1)(1991-11#1)(1994-2#1)(1995-3#1)(1996-11#1)(1997-3#1)(1997-6#1)(2006-11#1)(2006-12#3)(2006-3#1)(2006-7#3)(2006-8#10)(2007-10#2)(2008-10#1)(2008-11#1)(2008-5#8)(2008-7#18)(2008-9#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-7#1)(2012-12#5)(2012-2#5)(2013-7#1)
subendocardial ischemia##2##2##(2008-7#1)(2009-4#1)
subendocardial##12##1##(1991-3#2)(1997-8#1)(2008-7#3)(2009-12#1)(2009-4#3)(2013-7#2)
subendocardium##3##1##(2008-8#2)(2010-11#1)
subendothelial deposits##2##2##(1996-6#1)(2013-8#1)
subendothelial##8##1##(1996-6#1)(1997-2#1)(2008-11#2)(2008-8#1)(2010-4#1)(2013-8#2)
subependymal##4##1##(1995-7#1)(1996-3#1)(2006-12#1)(2008-11#1)
subependymomas##3##1##(2006-5#2)(2008-7#1)
subepidermal##8##1##(2007-12#2)(2007-8#1)(2008-10#2)(2008-8#1)(2009-6#1)(2011-1#1)
subepithelial lymphocytic infiltrates##2##3##(2013-1#2)
subepithelial##20##1##(1991-2#1)(1992-7#2)(1996-7#1)(1997-1#1)(2005-8#1)(2006-10#1)(2006-8#2)(2007-3#1)(2007-8#1)(2008-11#1)(2009-8#1)(2011-12#1)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#1)
suberate##6##1##(1990-3#1)(1990-7#1)(1992-2#1)(1994-2#1)(1994-9#1)(2008-4#1)
suberized##2##1##(2008-10#2)
suberoylanilide hydroxamic acid##4##3##(2008-5#1)(2010-12#1)(2012-12#2)
subesophageal##6##1##(1995-5#1)(2007-12#1)(2008-5#3)(2008-9#1)
subfamilies of##3##2##(1995-3#1)(1995-6#1)(2008-4#1)
subfamilies were##3##2##(1995-3#2)(2007-3#1)
subfamilies##42##1##(1992-6#1)(1992-8#1)(1993-11#1)(1993-9#1)(1995-3#8)(1995-6#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-4#1)(2006-12#1)(2007-3#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#2)(2008-8#3)(2008-9#1)(2010-2#2)(2012-12#1)(2013-7#1)(2013-8#6)
subfamily and##5##2##(1994-12#1)(1994-3#1)(1994-5#1)(2008-5#1)(2012-12#1)
subfamily contains##2##2##(1995-8#1)(2008-11#1)
subfamily in##4##2##(1994-8#1)(1995-8#1)(2011-2#1)(2013-8#1)
subfamily members##3##2##(1996-2#1)(2008-10#1)(2008-4#1)
subfamily of##9##2##(1991-5#1)(1993-2#1)(1994-12#1)(1994-5#1)(1995-6#2)(1996-12#2)(1997-2#1)
subfamily that##2##2##(1994-12#1)(2011-3#1)
subfamily was##2##2##(1991-10#1)(1994-6#1)
subfamily##84##1##(1990-12#1)(1990-5#1)(1991-10#2)(1991-3#1)(1991-5#3)(1992-5#1)(1993-2#1)(1993-6#2)(1994-11#1)(1994-12#5)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#6)(1995-11#3)(1995-3#5)(1995-6#2)(1995-8#2)(1996-12#2)(1996-2#3)(1996-5#1)(1997-2#1)(1997-4#3)(1997-7#1)(2005-10#1)(2006-8#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#4)(2008-8#2)(2010-3#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2013-7#3)(2013-8#3)
subfascial endoscopic perforator surgery (SEPS)##2##5##(2006-6#2)
subfascial endoscopic perforator##3##3##(2006-6#3)
subfascial##4##1##(2006-6#4)
subfemtomole##2##1##(1996-8#1)(2008-4#1)
subfemtosecond##3##1##(2007-11#1)(2007-12#2)
subfertile##4##1##(2006-5#2)(2007-9#1)(2012-2#1)
subfertility##9##1##(1991-11#1)(1995-8#1)(2006-10#3)(2007-7#1)(2008-4#1)(2011-1#2)
subfield of the hippocampus##4##4##(1990-4#1)(1994-10#1)(1995-5#1)(1997-7#1)
subfield of the##9##3##(1990-4#2)(1990-7#1)(1994-10#4)(1995-5#1)(1997-7#1)
subfield of##14##2##(1990-4#2)(1990-7#2)(1994-10#5)(1995-3#1)(1995-5#1)(1997-7#1)(2008-12#1)(2012-1#1)
subfield##22##1##(1990-2#1)(1990-4#3)(1990-5#2)(1990-7#2)(1994-10#5)(1995-3#1)(1995-5#2)(1996-7#1)(1997-7#1)(2008-12#1)(2008-3#1)(2012-1#1)(2013-1#1)
subfields CA##2##2##(1995-3#2)
subfields of the hippocampus##4##4##(1994-10#1)(1997-7#3)
subfields##15##1##(1994-10#1)(1995-3#5)(1995-5#1)(1995-7#1)(1997-7#3)(1997-8#4)
subform##2##1##(1991-2#2)
subfornical organ##8##2##(1993-12#1)(1994-2#2)(1995-6#4)(2008-4#1)
subfossil##2##1##(1990-11#1)(1997-4#1)
subfraction distribution##2##2##(1997-2#2)
subfraction##12##1##(1991-7#1)(1991-9#2)(1995-2#2)(1995-6#1)(1996-3#1)(1997-2#3)(2005-8#1)(2010-6#1)
subfractionated##3##1##(1993-8#1)(1995-11#1)(1997-2#1)
subfractionation##4##1##(1991-1#1)(1992-8#1)(1997-1#2)
subfractions as##4##2##(1995-11#1)(1995-4#1)(1995-6#1)(2008-4#1)
subfractions by##2##2##(1990-10#1)(1991-4#1)
subfractions in the##2##3##(1995-6#2)
subfractions in##3##2##(1995-6#2)(1997-2#1)
subfractions of##3##2##(1995-1#1)(1995-5#2)
subfractions showed##2##2##(1994-3#1)(1994-6#1)
subfractions##30##1##(1990-10#1)(1990-3#3)(1991-3#1)(1991-4#1)(1991-7#1)(1993-6#1)(1994-3#2)(1994-6#1)(1995-1#2)(1995-11#1)(1995-4#3)(1995-5#2)(1995-6#6)(1997-2#1)(2005-8#2)(2008-10#1)(2008-4#1)
subfracture&quot##4##1##(2007-4#4)
subfragment 1 and##4##3##(1991-10#1)(1991-4#1)(1992-4#1)(1996-11#1)
subfragment 1##16##2##(1991-10#4)(1991-4#2)(1992-4#2)(1994-3#1)(1994-5#1)(1994-8#2)(1996-11#2)(1996-5#2)
subfragment##22##1##(1990-7#1)(1991-10#4)(1991-4#2)(1991-7#1)(1991-9#1)(1992-4#2)(1994-3#1)(1994-5#2)(1994-8#2)(1995-1#2)(1996-11#2)(1996-5#2)
subfragment-1##10##1##(1990-12#2)(1991-2#4)(1992-3#1)(1995-2#1)(1995-3#2)
subfragments##3##1##(1990-3#2)(2008-3#1)
subfrontal approach##2##2##(2005-5#2)
subfrontal##4##1##(2005-5#2)(2006-12#1)(2011-2#1)
subgel phase##4##2##(2006-10#4)
subgel phases##5##2##(2006-10#5)
subgel##9##1##(2006-10#9)
subgenera##5##1##(1996-3#1)(2007-5#1)(2008-6#1)(2011-2#2)
subgenogroup B5##3##2##(2008-12#3)
subgenogroup##4##1##(2008-12#4)
subgenogroups (C1##2##2##(2008-12#2)
subgenogroups##3##1##(2008-12#3)
subgenomic RNA##5##2##(1994-8#1)(2008-10#4)
subgenomic library##2##2##(1997-8#1)(2008-10#1)
subgenomic##14##1##(1994-8#1)(1995-2#1)(1997-8#1)(2008-10#6)(2008-4#1)(2008-9#2)(2012-12#1)(2013-1#1)
subgenotype##4##1##(2009-3#1)(2010-12#1)(2013-8#2)
subgenus##11##1##(1997-4#2)(2008-1#1)(2008-6#3)(2011-2#1)(2013-1#3)(2013-8#1)
subgingival irrigation with##2##3##(2011-2#1)(2012-2#1)
subgingival microbiota in##2##3##(2012-12#2)
subgingival microbiota##5##2##(2008-5#1)(2012-12#4)
subgingival##10##1##(2006-2#1)(2008-12#2)(2008-5#1)(2011-2#1)(2012-12#4)(2012-2#1)
subglobal scales##2##2##(2008-8#2)
subglottic hemangiomas##2##2##(2011-2#1)(2012-2#1)
subglottic laryngitis in##2##3##(2007-9#2)
subglottic laryngitis##8##2##(2007-9#8)
subglottic larynx##2##2##(2013-1#2)
subglottic stenosis##3##2##(2006-10#2)(2012-1#1)
subglottic##19##1##(2006-10#2)(2007-9#9)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
subglottis##2##1##(2008-5#1)(2009-10#1)
subglutinans from##2##2##(2008-10#2)
subglutinans in##2##2##(2008-10#2)
subglutinans##13##1##(2008-10#12)(2010-10#1)
subgranular zone##2##2##(2011-2#2)
subgraphs##3##1##(2008-2#1)(2010-10#2)
subgroup (N =##3##3##(2006-6#3)
subgroup 16SrI-A phytoplasma strains##2##4##(2008-10#2)
subgroup 16SrI-A##4##2##(2008-10#4)
subgroup 16SrI-B##2##2##(2008-10#2)
subgroup C##2##2##(2008-5#2)
subgroup I and##3##3##(2008-10#3)
subgroup I strains##3##3##(2008-10#3)
subgroup I##17##2##(1992-8#2)(2008-10#15)
subgroup II strains##4##3##(2008-10#4)
subgroup II##18##2##(1992-8#2)(2008-10#16)
subgroup III##4##2##(2008-10#3)(2008-9#1)
subgroup analyses##4##2##(2008-4#1)(2011-2#2)(2013-8#1)
subgroup analysis are##2##3##(2006-8#1)(2007-9#1)
subgroup analysis##11##2##(2005-10#1)(2006-10#1)(2006-8#1)(2007-3#1)(2007-8#1)(2007-9#2)(2008-7#1)(2011-2#1)(2013-1#2)
subgroup and the other##2##4##(2008-10#2)
subgroup and the##4##3##(1990-5#1)(2008-10#2)(2012-2#1)
subgroup and##9##2##(1990-5#1)(1994-11#1)(2008-10#3)(2009-12#1)(2009-2#1)(2010-12#1)(2012-2#1)
subgroup are##2##2##(2008-10#2)
subgroup comparison##2##2##(2007-9#1)(2009-11#1)
subgroup had##3##2##(1991-11#1)(2007-2#1)(2008-10#1)
subgroup in the##2##3##(2008-10#2)
subgroup in##3##2##(1994-12#1)(2008-10#2)
subgroup of 31##2##3##(2007-7#1)(2007-8#1)
subgroup of children##2##3##(2011-1#1)(2011-2#1)
subgroup of patients with##8##4##(1992-9#1)(1997-8#2)(2006-6#1)(2006-9#1)(2008-4#1)(2008-6#1)(2008-8#1)
subgroup of patients##26##3##(1992-9#1)(1993-1#1)(1994-6#1)(1995-1#1)(1997-8#2)(2005-9#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-3#1)(2008-4#1)(2008-6#3)(2008-8#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-2#1)
subgroup of the##8##3##(1993-11#1)(1994-12#1)(1996-2#1)(1997-5#1)(1997-7#1)(2007-9#1)(2011-1#1)(2013-8#1)
subgroup of women##2##3##(2004-3#1)(2006-7#1)
subgroup of young people##2##4##(2006-7#1)(2007-7#1)
subgroup of##78##2##(1990-11#1)(1990-2#1)(1991-4#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-6#1)(1996-2#1)(1996-7#1)(1997-5#1)(1997-7#2)(1997-8#2)(2004-3#1)(2005-10#1)(2005-12#1)(2005-9#1)(2006-10#3)(2006-2#1)(2006-3#1)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#2)(2007-1#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#3)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#5)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#1)
subgroup specific##2##2##(2008-10#2)
subgroup that##4##2##(1990-11#1)(2008-10#3)
subgroup was##4##2##(2006-10#1)(2007-11#1)(2008-5#1)(2009-7#1)
subgroup were##2##2##(2007-11#1)(2008-10#1)
subgroup with##6##2##(1990-1#1)(2005-1#1)(2006-10#1)(2007-9#1)(2008-7#1)(2011-2#1)
subgroup within##4##2##(2008-10#3)(2009-2#1)
subgroup##266##1##(1990-1#1)(1990-11#2)(1990-2#1)(1990-5#4)(1991-11#1)(1991-12#1)(1991-4#1)(1992-11#1)(1992-5#2)(1992-8#5)(1992-9#1)(1993-1#1)(1993-11#3)(1994-11#1)(1994-12#3)(1994-6#1)(1995-1#1)(1995-12#2)(1995-6#1)(1996-10#2)(1996-2#2)(1996-6#1)(1996-7#1)(1996-9#3)(1997-5#1)(1997-7#2)(1997-8#2)(2004-11#1)(2004-3#1)(2005-1#4)(2005-10#2)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#6)(2006-2#1)(2006-3#1)(2006-6#4)(2006-7#3)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#4)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#7)(2008-10#84)(2008-12#2)(2008-3#2)(2008-4#4)(2008-5#6)(2008-6#6)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#5)(2009-7#3)(2009-8#1)(2009-9#3)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#8)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#2)
subgrouping of##3##2##(2008-10#1)(2012-2#2)
subgrouping##4##1##(2008-10#2)(2012-2#2)
subgroups A and B##2##4##(2008-5#2)
subgroups I and II##4##4##(2008-10#4)
subgroups I##5##2##(2008-10#5)
subgroups according to the##4##4##(1993-2#1)(1994-5#1)(2008-10#1)(2011-2#1)
subgroups according to##6##3##(1993-2#1)(1994-5#1)(2006-11#1)(2008-10#1)(2009-8#1)(2011-2#1)
subgroups and the##2##3##(2008-1#1)(2008-10#1)
subgroups and##6##2##(1993-11#1)(1996-9#1)(2007-10#1)(2008-1#1)(2008-10#1)(2009-9#1)
subgroups are more##2##3##(2013-1#2)
subgroups are##3##2##(2008-2#1)(2013-1#2)
subgroups based on##2##3##(2008-10#1)(2008-12#1)
subgroups based##3##2##(2008-10#1)(2008-12#1)(2008-6#1)
subgroups categorized##2##2##(1996-2#1)(1996-3#1)
subgroups from##2##2##(1991-6#1)(2007-9#1)
subgroups in##4##2##(2005-8#1)(2007-8#1)(2008-10#1)(2010-8#1)
subgroups is##2##2##(1997-1#2)
subgroups may##2##2##(2008-7#1)(2011-1#1)
subgroups of healthy##2##3##(2006-6#1)(2013-1#1)
subgroups of isolates##2##3##(2008-10#2)
subgroups of patients who##2##4##(1994-3#1)(2008-7#1)
subgroups of patients with##4##4##(2006-10#2)(2008-7#1)(2012-12#1)
subgroups of patients##10##3##(1991-3#1)(1994-3#1)(1997-6#1)(2006-10#3)(2008-10#1)(2008-7#2)(2012-12#1)
subgroups of the population##3##4##(1994-9#1)(1997-1#1)(2010-9#1)
subgroups of the##9##3##(1994-9#1)(1996-2#1)(1997-1#1)(2005-10#1)(2007-12#1)(2008-7#1)(2010-9#1)(2011-2#1)(2012-1#1)
subgroups of##57##2##(1990-9#1)(1991-3#2)(1993-11#1)(1993-12#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-6#1)(2004-10#1)(2005-1#1)(2005-10#1)(2005-12#1)(2006-10#6)(2006-6#2)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#7)(2009-12#1)(2009-2#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
subgroups suggests that##2##3##(1997-7#1)(2008-5#1)
subgroups that are##2##3##(1995-12#1)(2008-10#1)
subgroups that##5##2##(1995-12#1)(2006-10#1)(2008-10#1)(2009-4#1)(2013-8#1)
subgroups were not##2##3##(1990-8#1)(1995-2#1)
subgroups were##13##2##(1990-8#1)(1995-2#1)(1996-10#1)(2004-11#1)(2006-10#2)(2007-12#1)(2007-9#1)(2008-10#2)(2008-5#1)(2010-10#1)(2012-2#1)
subgroups where the##2##3##(1996-3#1)(1997-8#1)
subgroups with##6##2##(1991-4#1)(1996-9#1)(2008-12#3)(2008-2#1)
subgroups within the##5##3##(1994-1#1)(1996-3#1)(2008-10#2)(2008-7#1)
subgroups within##7##2##(1994-1#1)(1995-8#1)(1996-3#1)(2008-10#3)(2008-7#1)
subgroups##254##1##(1990-8#2)(1990-9#1)(1991-3#2)(1991-4#1)(1991-6#2)(1992-4#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#1)(1994-1#1)(1994-10#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-12#5)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-10#2)(1996-2#3)(1996-3#4)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#2)(1997-1#4)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#2)(2004-10#4)(2004-11#2)(2005-1#1)(2005-10#3)(2005-12#1)(2005-8#2)(2006-10#11)(2006-11#2)(2006-6#2)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#2)(2007-8#7)(2007-9#3)(2008-1#1)(2008-10#49)(2008-12#8)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#14)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#6)(2013-8#2)
subharmonic pulses##4##2##(2007-12#4)
subharmonic##7##1##(2007-12#6)(2008-3#1)
subheading information##2##2##(1995-1#2)
subheading##3##1##(1995-1#3)
subheadings##5##1##(1993-3#1)(1995-1#3)(2011-2#1)
subhertz##2##1##(2007-12#2)
subhuman##2##1##(1992-8#1)(2007-10#1)
subicular complex)##2##2##(1992-11#1)(1992-7#1)
subicular##5##1##(1992-11#1)(1992-7#1)(1993-12#2)(2010-12#1)
subiculum and##5##2##(1993-6#2)(1994-12#1)(1995-3#1)(2008-1#1)
subiculum were##2##2##(1990-5#1)(2010-12#1)
subiculum##20##1##(1990-5#1)(1991-10#1)(1991-12#1)(1992-7#1)(1993-6#5)(1994-12#1)(1994-2#1)(1995-10#1)(1995-3#1)(1997-7#1)(2008-1#1)(2010-12#5)
subimage##4##1##(2008-2#2)(2008-3#2)
subimages##5##1##(2008-2#3)(2008-3#2)
subisoforms##5##1##(2008-10#5)
subisolates obtained##2##2##(2008-10#2)
subisolates##3##1##(2008-10#3)
subitizing and##2##2##(2012-1#2)
subitizing##5##1##(2012-1#5)
subitum##2##1##(1992-11#1)(1993-11#1)
subjacent##4##1##(1992-12#1)(1995-2#1)(1997-3#1)(2008-1#1)
subject according to##2##3##(1992-9#1)(2008-3#1)
subject after##4##2##(2007-4#1)(2008-10#1)(2010-12#1)(2012-1#1)
subject age##4##2##(1991-1#2)(2006-11#1)(2007-1#1)
subject and a##2##3##(1992-9#1)(1995-12#1)
subject and have##2##3##(1994-11#1)(2007-6#1)
subject and the##4##3##(2006-7#1)(2007-1#1)(2007-8#1)(2008-9#1)
subject and to##2##3##(2008-11#1)(2008-4#1)
subject and##27##2##(1992-12#1)(1992-9#1)(1993-10#1)(1993-11#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-12#1)(1997-2#1)(1997-6#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-3#1)(2007-6#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#2)(2009-11#1)(2009-3#1)(2009-7#1)(2012-1#1)
subject are##3##2##(2008-3#1)(2008-4#1)(2012-1#1)
subject area##5##2##(1996-12#1)(2008-11#1)(2008-3#1)(2008-9#1)(2013-1#1)
subject areas##3##2##(2006-2#1)(2008-1#1)(2013-1#1)
subject at the##3##3##(2006-11#1)(2008-5#1)(2013-8#1)
subject both##2##2##(1993-7#1)(2006-8#1)
subject chipmunks##2##2##(2008-5#2)
subject could##3##2##(1996-12#1)(1996-3#1)(2008-11#1)
subject during##3##2##(1996-6#1)(2008-5#1)(2010-9#1)
subject for investigating##2##3##(1994-2#1)(2012-12#1)
subject for the##2##3##(1996-6#1)(2011-1#1)
subject for##9##2##(1990-10#1)(1993-8#1)(1994-2#1)(1996-6#1)(2006-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
subject from##3##2##(1992-1#1)(1994-6#1)(1997-4#1)
subject groups##7##2##(1991-4#1)(1991-8#1)(1992-4#1)(1994-12#1)(2007-1#1)(2007-3#1)(2008-2#1)
subject had##3##2##(2006-11#1)(2006-8#1)(2013-1#1)
subject has##5##2##(1991-4#1)(2008-10#2)(2008-11#1)(2011-2#1)
subject in the##3##3##(1994-9#1)(2008-11#1)(2011-2#1)
subject in##12##2##(1991-12#1)(1991-4#1)(1994-9#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-6#1)(2011-1#1)(2011-2#1)
subject is##21##2##(1991-5#1)(1992-8#1)(1993-10#1)(1994-11#1)(1996-12#1)(1997-4#1)(2006-6#1)(2007-1#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2012-1#2)(2013-8#1)
subject matter and##2##3##(2008-6#1)(2009-4#1)
subject matter##11##2##(1991-8#1)(1993-1#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-3#1)(2009-4#2)(2012-1#1)
subject of a##5##3##(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)
subject of controversy##6##3##(1990-11#1)(1993-11#1)(1996-11#1)(2006-2#1)(2007-11#1)(2013-8#1)
subject of debate##4##3##(1996-8#1)(2006-4#1)(2008-11#1)(2009-5#1)
subject of great interest##3##4##(2007-8#1)(2008-7#1)(2010-5#1)
subject of great##4##3##(2007-8#1)(2008-7#1)(2009-5#1)(2010-5#1)
subject of intense##9##3##(2005-1#1)(2005-10#1)(2005-7#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-1#1)
subject of intensive research##3##4##(1990-6#1)(2005-10#1)(2008-8#1)
subject of intensive##5##3##(1990-6#1)(2005-10#1)(2005-7#1)(2008-5#1)(2008-8#1)
subject of our##2##3##(1994-12#1)(2007-8#1)
subject of research in##2##4##(1994-2#1)(2008-2#1)
subject of research##4##3##(1994-2#1)(2008-2#1)(2012-1#1)(2013-7#1)
subject of the study##2##4##(2008-10#1)(2008-12#1)
subject of the##14##3##(1991-9#1)(1992-2#1)(1993-6#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-7#1)(2010-4#1)(2011-1#1)(2012-2#1)
subject of this article##2##4##(1992-6#1)(2013-7#1)
subject of this work##2##4##(2005-10#1)(2008-10#1)
subject of this##10##3##(1992-6#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-2#1)(2011-2#1)(2013-7#1)
subject of##133##2##(1990-11#1)(1990-2#1)(1990-6#1)(1991-1#1)(1991-4#2)(1991-9#1)(1992-2#2)(1992-6#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-3#1)(2005-1#1)(2005-10#5)(2005-7#3)(2005-8#4)(2006-10#6)(2006-2#1)(2006-4#1)(2006-6#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#6)(2008-11#4)(2008-12#5)(2008-2#3)(2008-3#5)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#4)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#3)(2013-8#1)
subject or##4##2##(1996-5#1)(2010-8#1)(2013-1#1)(2013-8#1)
subject over##2##2##(2005-12#1)(2007-7#1)
subject presented##3##2##(1992-1#1)(1994-6#1)(2009-2#1)
subject risk##2##2##(2009-4#2)
subject should be##2##3##(1990-6#1)(2007-11#1)
subject should##3##2##(1990-6#1)(1996-1#1)(2007-11#1)
subject showed a##2##3##(2007-4#1)(2012-1#1)
subject showed##5##2##(1996-6#1)(2007-4#1)(2008-6#1)(2012-1#2)
subject suffered from##2##3##(2007-10#1)(2013-1#1)
subject that##3##2##(2009-3#1)(2010-2#1)(2013-8#1)
subject the##3##2##(2006-10#1)(2008-10#1)(2009-6#1)
subject to a precipitation/dissolution process##2##5##(2008-10#2)
subject to a##16##3##(1991-6#1)(1993-5#1)(1994-7#1)(1995-12#1)(2006-11#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-1#1)(2012-2#1)(2012-3#1)
subject to an##5##3##(2004-9#1)(2006-12#1)(2007-12#1)(2008-12#1)(2013-1#1)
subject to both##3##3##(2007-2#1)(2010-5#1)(2012-3#1)
subject to certain##2##3##(1992-2#1)(2008-5#1)
subject to coherent optical feedback##2##5##(2007-11#1)(2007-12#1)
subject to considerable##3##3##(1995-11#1)(2008-11#1)(2008-8#1)
subject to constraints##2##3##(1997-8#1)(2008-8#1)
subject to error##2##3##(2008-10#1)(2008-4#1)
subject to further##3##3##(1996-1#1)(2008-8#1)(2013-8#1)
subject to incoherent optical feedback and##2##6##(2007-12#2)
subject to interference from##2##4##(2008-10#2)
subject to optical feedback##2##4##(2007-12#1)(2008-3#1)
subject to pharmacological##2##3##(1995-6#1)(2011-12#1)
subject to physiological##2##3##(1994-11#1)(2008-7#1)
subject to public##2##3##(1992-11#1)(2008-5#1)
subject to random##3##3##(1993-6#1)(2008-10#1)(2010-4#1)
subject to selection##2##3##(2006-12#1)(2012-3#1)
subject to study##2##3##(2011-2#1)(2012-12#1)
subject to the##15##3##(1994-8#1)(1997-2#1)(1997-8#1)(2005-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-5#2)(2009-6#1)(2009-8#1)(2011-2#3)(2013-1#1)
subject to this##3##3##(2008-5#1)(2008-8#1)(2009-2#1)
subject to two##2##3##(2007-11#1)(2009-3#1)
subject to various##2##3##(1990-9#1)(2009-12#1)
subject to##228##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#2)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#3)(1992-12#1)(1992-2#2)(1993-12#1)(1993-5#1)(1993-6#3)(1993-9#1)(1994-11#1)(1994-4#1)(1994-7#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#5)(1995-3#2)(1995-6#2)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-8#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#3)(2004-9#1)(2005-11#3)(2005-8#1)(2006-10#2)(2006-11#3)(2006-12#3)(2006-7#1)(2007-10#1)(2007-11#4)(2007-12#14)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-8#3)(2007-9#2)(2008-10#10)(2008-11#9)(2008-12#3)(2008-2#5)(2008-3#11)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#5)(2009-1#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#4)(2009-5#2)(2009-6#1)(2009-8#3)(2010-1#4)(2010-10#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#3)(2012-12#7)(2012-2#5)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#2)
subject was a##3##3##(2012-12#1)(2013-1#2)
subject was asked to##2##4##(1991-3#1)(2009-8#1)
subject was found##2##3##(1994-10#1)(2008-10#1)
subject was##26##2##(1990-3#1)(1990-8#1)(1991-3#1)(1994-10#2)(1995-11#1)(1996-3#1)(2004-11#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-7#1)(2013-1#4)
subject we##3##2##(2008-5#1)(2008-8#1)(2011-2#1)
subject who##5##2##(1991-3#1)(1994-6#2)(2008-10#1)(2013-1#1)
subject with##15##2##(1992-9#1)(1993-2#1)(1993-9#1)(1995-8#2)(1996-5#1)(1997-2#1)(2008-12#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)
subject##828##1##(1990-10#3)(1990-11#3)(1990-2#2)(1990-3#2)(1990-4#2)(1990-5#2)(1990-6#2)(1990-8#3)(1990-9#2)(1991-1#7)(1991-10#1)(1991-12#5)(1991-2#1)(1991-3#5)(1991-4#5)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#3)(1992-11#3)(1992-12#6)(1992-2#6)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#4)(1993-1#1)(1993-10#2)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#2)(1993-5#1)(1993-6#5)(1993-7#2)(1993-8#2)(1993-9#3)(1994-1#1)(1994-10#2)(1994-11#3)(1994-12#4)(1994-2#2)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#6)(1994-7#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#3)(1995-12#6)(1995-2#1)(1995-3#4)(1995-4#1)(1995-6#2)(1995-8#4)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#1)(1996-3#3)(1996-5#3)(1996-6#4)(1996-8#4)(1996-9#1)(1997-2#4)(1997-3#3)(1997-4#5)(1997-5#4)(1997-6#1)(1997-8#7)(2004-11#1)(2004-9#1)(2005-1#3)(2005-10#6)(2005-11#3)(2005-12#1)(2005-3#4)(2005-7#4)(2005-8#5)(2005-9#1)(2006-10#14)(2006-11#9)(2006-12#3)(2006-2#5)(2006-4#4)(2006-6#3)(2006-7#4)(2006-8#5)(2006-9#2)(2007-1#7)(2007-10#5)(2007-11#12)(2007-12#18)(2007-2#3)(2007-3#5)(2007-4#10)(2007-5#5)(2007-6#5)(2007-7#7)(2007-8#8)(2007-9#2)(2008-1#6)(2008-10#30)(2008-11#29)(2008-12#14)(2008-2#14)(2008-3#23)(2008-4#17)(2008-5#23)(2008-6#6)(2008-7#23)(2008-8#11)(2008-9#16)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#4)(2009-3#8)(2009-4#7)(2009-5#7)(2009-6#8)(2009-7#4)(2009-8#11)(2010-1#4)(2010-10#1)(2010-11#3)(2010-12#5)(2010-2#8)(2010-3#2)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#10)(2010-9#2)(2011-1#17)(2011-12#2)(2011-2#21)(2012-1#31)(2012-12#15)(2012-2#11)(2012-3#10)(2012-7#1)(2013-1#27)(2013-7#5)(2013-8#11)
subject'##2##1##(2005-7#1)(2011-2#1)
subject's body##2##2##(2012-1#2)
subject's##40##1##(1990-12#1)(1990-5#1)(1992-1#1)(1992-2#1)(1993-7#1)(1994-2#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-8#1)(1996-5#1)(1997-5#2)(1997-8#1)(2006-11#2)(2007-1#1)(2007-10#2)(2007-5#1)(2007-6#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-11#1)(2009-12#1)(2010-7#1)(2011-2#1)(2012-1#5)(2012-2#1)(2013-1#1)(2013-8#1)
subject-based##4##1##(1997-6#2)(2006-2#1)(2006-8#1)
subject-specific##5##1##(1997-3#1)(2008-6#1)(2010-2#1)(2013-1#2)
subject]##3##1##(1994-4#1)(2008-10#1)(2009-5#1)
subjected for##4##2##(2007-7#1)(2008-8#1)(2011-1#1)(2013-8#1)
subjected in##3##2##(1993-3#1)(2008-12#1)(2009-12#1)
subjected it to##2##3##(1994-11#1)(2008-10#1)
subjected to 10 min of ischemia##2##6##(1997-1#2)
subjected to 16S rDNA##2##4##(2011-12#1)(2013-7#1)
subjected to 30 min##4##4##(1995-12#1)(1996-5#1)(2007-8#1)(2013-1#1)
subjected to SDS-PAGE and##2##4##(2006-8#1)(2008-12#1)
subjected to SDS-PAGE##6##3##(1992-7#1)(1992-8#1)(1994-3#1)(2006-8#1)(2008-10#1)(2008-12#1)
subjected to a chemical##2##4##(2008-3#1)(2013-1#1)
subjected to a high static electric field##2##7##(2007-12#2)
subjected to a high##3##4##(2007-12#2)(2010-7#1)
subjected to a higher##2##4##(1997-2#1)(2004-11#1)
subjected to a modified##2##4##(2007-3#1)(2008-2#1)
subjected to a series of##2##5##(1995-10#1)(1995-5#1)
subjected to a##65##3##(1990-2#1)(1990-6#1)(1993-11#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-12#1)(1997-2#2)(1997-3#1)(1997-7#1)(2004-11#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-11#1)(2006-8#1)(2007-1#1)(2007-12#4)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#2)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-7#1)(2012-12#3)(2013-1#5)(2013-8#2)
subjected to accelerated stability##2##4##(2008-5#1)(2011-1#1)
subjected to acid##6##3##(2008-10#4)(2010-2#1)(2012-12#1)
subjected to amino acid sequencing##2##5##(1994-9#1)(1997-4#1)
subjected to amino acid##3##4##(1992-12#1)(1994-9#1)(1997-4#1)
subjected to an##17##3##(1993-6#1)(1996-5#1)(1997-2#1)(2004-9#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2010-5#1)(2010-8#1)(2013-1#1)(2013-8#1)
subjected to antibacterial##2##3##(2006-12#1)(2010-12#1)
subjected to any##2##3##(2004-4#1)(2008-11#1)
subjected to bilateral##2##3##(2009-12#1)(2013-1#1)
subjected to both##3##3##(2008-3#1)(2008-5#1)(2011-1#1)
subjected to charcoal fire roasting##2##5##(2008-4#2)
subjected to complete##3##3##(1994-3#1)(1995-2#1)(2011-12#1)
subjected to continuous##3##3##(2008-8#1)(2011-1#1)(2013-1#1)
subjected to cyclic##3##3##(2008-4#1)(2008-6#1)(2009-7#1)
subjected to different##13##3##(2006-11#1)(2006-12#2)(2007-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-2#1)(2010-2#1)(2012-12#1)(2013-1#2)
subjected to direct##2##3##(2012-2#2)
subjected to either##2##3##(2008-8#1)(2010-3#1)
subjected to extensive##3##3##(1996-1#1)(2007-4#1)(2007-5#1)
subjected to external optical injection##2##5##(2007-11#2)
subjected to four different##2##4##(2007-8#1)(2008-10#1)
subjected to four##3##3##(2007-8#1)(2008-10#1)(2008-12#1)
subjected to further##3##3##(2006-3#1)(2008-10#1)(2011-12#1)
subjected to gel filtration##2##4##(1990-12#1)(1997-6#1)
subjected to global##2##3##(1996-9#1)(2013-7#1)
subjected to hypoxia##2##3##(1994-3#1)(1994-5#1)
subjected to in vitro##4##4##(1992-7#1)(1995-10#1)(2006-9#1)(2010-5#1)
subjected to invasive##2##3##(1994-6#1)(2009-9#1)
subjected to ischemia##2##3##(2010-1#1)(2011-2#1)
subjected to knee##2##3##(2007-11#1)(2007-4#1)
subjected to lead poisoning##2##4##(2012-1#2)
subjected to major##2##3##(1991-9#1)(2005-10#1)
subjected to mass spectrometric analysis and##2##6##(1990-7#1)(2008-5#1)
subjected to middle cerebral artery##2##5##(1996-3#1)(1997-2#1)
subjected to multiple##2##3##(2007-4#1)(2008-4#1)
subjected to multivariate analysis##2##4##(1995-9#1)(2009-6#1)
subjected to multivariate##3##3##(1995-9#1)(2008-10#1)(2009-6#1)
subjected to nucleotide##2##3##(1992-11#1)(2006-10#1)
subjected to one of##2##4##(2009-7#1)(2012-9#1)
subjected to one##3##3##(2008-5#1)(2009-7#1)(2012-9#1)
subjected to optical feedback##2##4##(2007-12#2)
subjected to quantitative analysis##2##4##(1997-5#1)(2008-4#1)
subjected to rear impact##2##4##(2006-11#1)(2007-4#1)
subjected to repeated##2##3##(1992-8#1)(2008-7#1)
subjected to reversible##2##3##(1995-7#1)(2012-2#1)
subjected to rigorous##4##3##(1992-1#1)(2006-10#1)(2012-3#2)
subjected to single##2##3##(2007-1#1)(2007-9#1)
subjected to statistical##2##3##(1990-6#1)(2008-1#1)
subjected to structural##2##3##(1994-12#1)(2008-7#1)
subjected to such##3##3##(1994-9#1)(2007-9#1)(2008-5#1)
subjected to surgical treatment##2##4##(1990-10#1)(2004-1#1)
subjected to surgical##4##3##(1990-10#1)(1993-10#1)(2004-1#1)(2008-1#1)
subjected to the following##2##4##(2006-5#1)(2007-12#1)
subjected to the same##2##4##(1997-5#1)(2009-3#1)
subjected to the stress##2##4##(2008-11#1)(2012-12#1)
subjected to the##30##3##(1990-3#1)(1993-8#1)(1996-4#1)(1997-4#3)(1997-5#1)(2006-5#1)(2007-12#1)(2007-2#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
subjected to thermal##2##3##(2009-6#1)(2013-8#1)
subjected to two-dimensional##2##3##(2008-4#1)(2008-9#1)
subjected to unilateral##2##3##(1994-6#1)(1996-1#1)
subjected to various##7##3##(1992-8#1)(1996-12#1)(2004-9#1)(2006-12#1)(2007-11#1)(2008-3#1)(2008-5#1)
subjected to water##2##3##(2005-8#1)(2009-8#1)
subjected to##624##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#3)(1990-5#1)(1990-6#2)(1990-7#3)(1990-8#3)(1991-10#1)(1991-12#3)(1991-3#1)(1991-5#3)(1991-6#2)(1991-9#2)(1992-1#4)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#3)(1992-6#1)(1992-7#4)(1992-8#3)(1993-10#3)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#4)(1993-4#3)(1993-5#1)(1993-6#3)(1993-8#2)(1994-11#2)(1994-12#2)(1994-3#3)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#2)(1995-10#3)(1995-11#2)(1995-12#7)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#5)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#2)(1996-6#2)(1996-9#3)(1997-1#7)(1997-2#5)(1997-3#1)(1997-4#4)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#1)(2004-1#1)(2004-11#1)(2004-4#4)(2004-9#5)(2005-1#1)(2005-10#3)(2005-11#4)(2005-8#2)(2006-10#4)(2006-11#7)(2006-12#5)(2006-2#4)(2006-3#1)(2006-5#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-1#5)(2007-10#2)(2007-11#9)(2007-12#9)(2007-2#2)(2007-3#2)(2007-4#11)(2007-5#1)(2007-6#2)(2007-7#14)(2007-8#12)(2007-9#6)(2008-1#6)(2008-10#63)(2008-11#20)(2008-12#9)(2008-2#5)(2008-3#8)(2008-4#9)(2008-5#25)(2008-6#5)(2008-7#7)(2008-8#5)(2008-9#9)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#4)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#7)(2009-8#2)(2009-9#2)(2010-1#2)(2010-11#1)(2010-12#2)(2010-2#6)(2010-3#2)(2010-4#5)(2010-5#4)(2010-7#2)(2010-8#1)(2011-1#13)(2011-12#4)(2011-2#11)(2012-1#6)(2012-11#1)(2012-12#13)(2012-2#9)(2012-3#9)(2012-7#1)(2012-9#1)(2013-1#27)(2013-7#9)(2013-8#12)
subjected##643##1##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#3)(1990-5#1)(1990-6#2)(1990-7#4)(1990-8#3)(1991-10#1)(1991-12#3)(1991-3#1)(1991-5#3)(1991-6#2)(1991-9#2)(1992-1#4)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#3)(1992-6#1)(1992-7#4)(1992-8#3)(1993-10#3)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#5)(1993-4#3)(1993-5#1)(1993-6#3)(1993-8#2)(1994-11#3)(1994-12#2)(1994-3#3)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#2)(1995-10#3)(1995-11#2)(1995-12#7)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#5)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#3)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#2)(1996-6#2)(1996-9#3)(1997-1#7)(1997-2#5)(1997-3#1)(1997-4#4)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#1)(2004-1#1)(2004-11#1)(2004-4#4)(2004-9#6)(2005-1#1)(2005-10#3)(2005-11#4)(2005-8#2)(2006-10#4)(2006-11#7)(2006-12#6)(2006-2#4)(2006-3#1)(2006-5#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-1#5)(2007-10#2)(2007-11#9)(2007-12#9)(2007-2#2)(2007-3#2)(2007-4#11)(2007-5#1)(2007-6#2)(2007-7#15)(2007-8#12)(2007-9#6)(2008-1#6)(2008-10#66)(2008-11#20)(2008-12#10)(2008-2#5)(2008-3#8)(2008-4#9)(2008-5#26)(2008-6#5)(2008-7#7)(2008-8#6)(2008-9#10)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#4)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#7)(2009-8#2)(2009-9#2)(2010-1#2)(2010-11#1)(2010-12#2)(2010-2#7)(2010-3#2)(2010-4#5)(2010-5#4)(2010-7#2)(2010-8#1)(2011-1#14)(2011-12#4)(2011-2#11)(2012-1#6)(2012-11#1)(2012-12#13)(2012-2#10)(2012-3#9)(2012-7#1)(2012-9#1)(2013-1#27)(2013-7#9)(2013-8#13)
subjecting a##2##2##(1995-12#1)(2010-12#1)
subjecting the##9##2##(1991-6#1)(1991-9#1)(1992-3#1)(1994-12#1)(2006-10#1)(2008-10#1)(2009-11#1)(2010-5#1)(2010-8#1)
subjecting##16##1##(1990-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#1)(1994-12#1)(1995-12#1)(1996-8#1)(2006-10#1)(2007-6#1)(2008-10#1)(2009-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2013-1#1)
subjective SA##4##2##(2011-2#4)
subjective and objective performance##2##4##(2008-10#1)(2008-2#1)
subjective and objective##18##3##(1992-9#2)(1997-6#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-9#2)(2010-5#1)(2012-12#1)(2013-1#1)
subjective and##29##2##(1991-1#1)(1992-10#1)(1992-9#2)(1993-6#1)(1997-6#1)(2007-12#4)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#3)(2009-10#1)(2009-7#1)(2009-9#2)(2010-5#1)(2010-7#1)(2010-8#1)(2012-12#1)(2013-1#1)
subjective aspects of##4##3##(1992-5#1)(2008-10#1)(2013-1#2)
subjective assessment of##2##3##(2007-2#1)(2010-4#1)
subjective assessment##5##2##(2007-2#1)(2008-3#1)(2010-4#1)(2012-3#1)(2013-1#1)
subjective burn scar severity##3##4##(2007-12#3)
subjective clinical##2##2##(2007-6#1)(2012-1#1)
subjective complaints##3##2##(2006-8#1)(2009-10#1)(2009-5#1)
subjective component##2##2##(2004-3#1)(2008-5#1)
subjective criteria##3##2##(2006-6#1)(2007-8#1)(2011-2#1)
subjective day and##2##3##(1995-12#1)(1997-8#1)
subjective day##5##2##(1995-12#1)(1996-6#1)(1997-8#2)(2008-5#1)
subjective discomfort rating##2##3##(2007-4#1)(2008-6#1)
subjective distress##2##2##(1995-12#1)(2008-7#1)
subjective effects##4##2##(1991-1#2)(1991-5#1)(1995-10#1)
subjective evaluation of##7##3##(1990-3#1)(2006-6#2)(2007-7#1)(2008-10#1)(2008-6#1)(2012-12#1)
subjective evaluation##8##2##(1990-3#1)(2006-6#2)(2007-7#1)(2008-10#1)(2008-2#1)(2008-6#1)(2012-12#1)
subjective evaluations##3##2##(1993-1#2)(2007-8#1)
subjective experience of##4##3##(1997-8#1)(2007-8#1)(2008-7#1)(2012-2#1)
subjective experience##6##2##(1997-8#1)(2006-6#1)(2007-8#1)(2008-7#1)(2009-5#1)(2012-2#1)
subjective experiences##4##2##(2008-1#1)(2008-6#1)(2009-7#1)(2012-2#1)
subjective feelings##2##2##(2008-5#1)(2013-1#1)
subjective global assessment##3##3##(2006-10#1)(2007-12#1)(2013-1#1)
subjective health status##2##3##(2012-12#1)(2013-1#1)
subjective health##8##2##(2008-7#2)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
subjective impression##2##2##(2004-9#1)(2008-11#1)
subjective improvement in##5##3##(1992-8#1)(2006-10#1)(2006-8#1)(2007-8#2)
subjective improvements##2##2##(2007-8#1)(2010-10#1)
subjective information##2##2##(1991-6#1)(2012-1#1)
subjective judgement and##2##3##(2008-5#1)(2008-9#1)
subjective judgment##3##2##(2007-11#1)(2013-1#2)
subjective knee##2##2##(2013-1#2)
subjective measures of##2##3##(2007-11#1)(2011-1#1)
subjective measures##3##2##(2007-11#1)(2011-1#2)
subjective memory##3##2##(2009-11#3)
subjective night##6##2##(1994-2#2)(1995-12#1)(2008-5#3)
subjective norm and##2##3##(1993-12#2)
subjective norm##3##2##(1993-12#3)
subjective norms##3##2##(2006-9#1)(2008-3#1)(2012-3#1)
subjective opinion##3##2##(2007-11#1)(2007-7#1)(2013-1#1)
subjective pain##5##2##(2006-3#1)(2007-11#1)(2008-9#2)(2009-7#1)
subjective patient##4##2##(2008-4#1)(2010-2#1)(2011-2#1)(2013-7#1)
subjective perception during landing##2##4##(2011-2#2)
subjective perception of##2##3##(2011-12#1)(2011-2#1)
subjective perception##6##2##(2011-12#1)(2011-2#4)(2013-1#1)
subjective perceptions of##3##3##(2007-12#1)(2007-9#1)(2012-2#1)
subjective quality of life##3##4##(1997-1#1)(2010-8#1)(2012-12#1)
subjective quality##5##2##(1997-1#1)(2004-9#1)(2008-2#1)(2010-8#1)(2012-12#1)
subjective rankings##2##2##(1992-2#1)(1997-3#1)
subjective rating of##3##3##(1996-12#1)(2007-12#1)(2012-1#1)
subjective ratings and##3##3##(2010-2#1)(2013-1#2)
subjective ratings##8##2##(1995-12#1)(2007-12#1)(2008-5#2)(2010-2#2)(2013-1#2)
subjective religiosity##2##2##(2010-2#2)
subjective report##2##2##(1996-3#1)(2012-1#1)
subjective responses to##2##3##(2009-6#1)(2011-2#1)
subjective responses##3##2##(1995-12#1)(2009-6#1)(2011-2#1)
subjective results were##2##3##(1996-9#2)
subjective results##4##2##(1996-9#2)(2009-9#1)(2012-2#1)
subjective satisfaction##2##2##(1997-3#1)(2011-2#1)
subjective scoring##2##2##(1992-9#1)(2012-1#1)
subjective sense of##2##3##(1996-5#1)(2008-5#1)
subjective side effects##2##3##(1991-8#1)(2008-1#1)
subjective symptoms of dry##2##4##(2006-10#2)
subjective symptoms were##2##3##(1990-8#1)(2007-11#1)
subjective symptoms##14##2##(1990-8#2)(1991-4#1)(1991-6#1)(1996-12#1)(2006-10#2)(2007-11#6)(2010-1#1)
subjective test##2##2##(1991-6#1)(2004-9#1)
subjective tests##2##2##(1991-6#1)(2005-9#1)
subjective well-being##10##2##(1990-2#2)(2008-10#1)(2008-12#2)(2008-7#3)(2011-2#1)(2013-1#1)
subjective wellbeing of##2##3##(2010-9#1)(2011-1#1)
subjective wellbeing##4##2##(2010-9#3)(2011-1#1)
subjective##365##1##(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-8#2)(1991-1#3)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#4)(1991-8#3)(1992-10#1)(1992-12#3)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#3)(1993-1#2)(1993-12#6)(1993-3#2)(1993-6#1)(1994-2#2)(1994-4#1)(1994-7#1)(1995-10#1)(1995-11#2)(1995-12#6)(1995-6#1)(1995-8#1)(1996-11#2)(1996-12#3)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#3)(1997-1#2)(1997-3#2)(1997-6#2)(1997-8#3)(2004-10#1)(2004-3#2)(2004-9#3)(2005-11#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-3#2)(2006-6#4)(2006-7#2)(2006-8#2)(2006-9#1)(2007-11#14)(2007-12#15)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#6)(2007-8#9)(2007-9#5)(2008-1#4)(2008-10#9)(2008-11#5)(2008-12#2)(2008-2#7)(2008-3#3)(2008-4#3)(2008-5#19)(2008-6#3)(2008-7#16)(2008-9#11)(2009-10#3)(2009-11#4)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#3)(2009-9#8)(2010-1#2)(2010-10#2)(2010-12#1)(2010-2#5)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#3)(2011-1#6)(2011-12#1)(2011-2#17)(2011-3#1)(2012-1#6)(2012-11#1)(2012-12#7)(2012-2#6)(2012-3#2)(2013-1#21)(2013-7#4)(2013-8#3)
subjectively assessed##2##2##(2006-5#1)(2013-1#1)
subjectively rated##4##2##(2007-12#2)(2007-7#1)(2013-8#1)
subjectively##22##1##(1995-1#1)(1995-5#1)(1997-3#1)(1997-6#1)(2006-3#2)(2006-5#1)(2007-12#3)(2007-3#1)(2007-7#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-8#1)(2012-1#1)(2012-11#1)(2013-1#1)(2013-8#1)
subjectivity and##2##2##(2006-2#1)(2013-7#1)
subjectivity of##3##2##(2006-12#1)(2007-3#1)(2010-4#1)
subjectivity##12##1##(2006-12#1)(2006-2#1)(2007-1#1)(2007-12#1)(2007-3#1)(2008-11#1)(2008-5#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
subjects &gt##4##2##(2007-7#1)(2008-7#2)(2012-12#1)
subjects (&gt##2##2##(2008-5#1)(2013-8#1)
subjects (1##2##2##(1992-3#1)(1993-11#1)
subjects (11##3##2##(1995-5#2)(2007-7#1)
subjects (19##2##2##(1992-3#1)(2013-1#1)
subjects (2##3##2##(1994-12#1)(1994-6#1)(2010-10#1)
subjects (24##2##2##(1994-1#1)(2004-11#1)
subjects (30##2##2##(2007-11#1)(2011-2#1)
subjects (5##2##2##(1990-6#1)(2010-3#1)
subjects (50##2##2##(2007-4#1)(2012-2#1)
subjects (66##3##2##(1993-11#1)(2008-3#1)(2010-10#1)
subjects (8##2##2##(1991-12#1)(2008-5#1)
subjects (90##2##2##(1995-1#1)(2007-2#1)
subjects (P =##2##3##(1994-3#1)(2007-10#1)
subjects (P less than 0##2##5##(1991-2#1)(1991-8#1)
subjects (P##5##2##(1991-2#1)(1991-8#1)(1994-12#1)(1994-3#1)(2007-10#1)
subjects (P&lt##2##2##(2008-7#1)(2012-2#1)
subjects (aged##3##2##(1992-12#1)(2007-6#1)(2008-5#1)
subjects (both##2##2##(2008-11#1)(2008-8#1)
subjects (group##5##2##(1996-6#1)(2006-9#1)(2008-1#1)(2008-8#1)(2011-1#1)
subjects (mean age##4##3##(2007-9#1)(2008-12#1)(2008-4#1)(2008-7#1)
subjects (mean##6##2##(1993-12#1)(1995-9#1)(2007-9#1)(2008-12#1)(2008-4#1)(2008-7#1)
subjects (n = 10)##2##4##(1996-2#1)(1996-9#1)
subjects (n =##20##3##(1993-12#1)(1993-9#1)(1994-6#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-7#2)(1996-8#1)(1996-9#1)(2006-8#1)(2008-10#1)(2008-5#2)(2009-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
subjects (n=10)##2##2##(2009-12#1)(2013-1#1)
subjects (n=5) were cooled using##2##5##(2007-10#2)
subjects (p &lt##2##3##(2006-10#1)(2007-4#1)
subjects (p##4##2##(2006-10#1)(2007-4#1)(2012-2#1)(2013-1#1)
subjects a##2##2##(1991-3#1)(2005-3#1)
subjects achieved##2##2##(1991-8#1)(2013-8#1)
subjects affected by##3##3##(1990-9#1)(1993-12#1)(2008-1#1)
subjects after##9##2##(1992-6#1)(1996-1#1)(1997-1#1)(2006-1#1)(2007-9#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
subjects aged between##3##3##(1996-5#1)(2007-1#1)(2008-10#1)
subjects aged over##2##3##(1991-8#1)(2012-1#1)
subjects aged##25##2##(1991-8#1)(1993-12#1)(1994-3#1)(1996-5#1)(1997-1#1)(2006-1#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-1#1)(2007-9#2)(2008-10#2)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
subjects also##4##2##(1996-8#1)(1997-5#1)(2008-5#2)
subjects and 1##2##3##(2012-1#1)(2012-2#1)
subjects and a##4##3##(1990-5#1)(1991-2#1)(2010-12#1)(2012-3#1)
subjects and all##2##3##(2011-1#1)(2012-3#1)
subjects and also##2##3##(1994-6#1)(2009-8#1)
subjects and compared##2##3##(2012-2#1)(2012-3#1)
subjects and controls##2##3##(2006-2#1)(2008-10#1)
subjects and four##2##3##(1994-12#1)(2007-8#1)
subjects and from##2##3##(1996-1#1)(2006-6#1)
subjects and healthy controls##2##4##(1992-12#1)(2011-2#1)
subjects and in##11##3##(1990-10#1)(1990-11#1)(1991-1#1)(1992-12#1)(1993-1#1)(1997-8#1)(2005-10#1)(2008-4#2)(2012-3#1)(2013-1#1)
subjects and of##2##3##(1991-2#2)
subjects and patients with Alzheimer's disease##3##6##(1990-10#1)(1993-12#2)
subjects and patients with##12##4##(1990-10#1)(1993-12#2)(1996-12#1)(1996-9#1)(2006-10#1)(2008-10#1)(2010-12#2)(2012-1#1)(2012-2#2)
subjects and patients##16##3##(1990-10#1)(1993-11#1)(1993-12#2)(1996-1#2)(1996-12#1)(1996-9#1)(1997-2#1)(2006-10#1)(2008-10#1)(2010-12#2)(2012-1#1)(2012-2#2)
subjects and requires##2##3##(2010-4#1)(2012-12#1)
subjects and schizophrenic patients##2##4##(1996-1#1)(1996-3#1)
subjects and the##10##3##(1990-8#1)(1991-2#1)(1993-7#1)(1994-3#1)(1996-1#1)(2007-4#1)(2009-6#1)(2011-2#2)(2012-2#1)
subjects and then##2##3##(1991-1#1)(2005-10#1)
subjects and to##3##3##(2012-2#1)(2013-8#2)
subjects and were##2##3##(1991-6#1)(1996-12#1)
subjects and with##3##3##(1990-6#1)(1991-3#1)(1994-10#1)
subjects and##145##2##(1990-10#2)(1990-11#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#3)(1991-10#2)(1991-2#4)(1991-3#1)(1991-5#2)(1991-6#2)(1992-12#2)(1993-1#1)(1993-11#2)(1993-12#2)(1993-7#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-6#2)(1995-1#2)(1995-12#1)(1995-6#1)(1996-1#7)(1996-12#3)(1996-3#1)(1996-5#1)(1996-9#2)(1997-1#5)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-11#2)(2005-10#3)(2006-10#1)(2006-2#1)(2006-6#1)(2006-8#4)(2006-9#1)(2007-1#1)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#3)(2008-9#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#4)(2010-2#2)(2010-4#1)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#7)(2012-1#4)(2012-12#2)(2012-2#7)(2012-3#6)(2013-1#3)(2013-8#3)
subjects appears to be##2##4##(1997-1#1)(2013-1#1)
subjects are required to##2##4##(2008-11#1)(2012-1#1)
subjects are required##3##3##(2008-11#1)(2012-1#1)(2012-3#1)
subjects are##21##2##(1990-6#1)(1991-3#1)(1992-9#1)(1994-5#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-3#1)(2006-12#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-3#2)(2013-1#1)
subjects as compared to##2##4##(2013-1#1)(2013-8#1)
subjects as controls##2##3##(2008-1#1)(2008-10#1)
subjects as well as in##3##5##(1990-11#1)(1992-3#1)(1994-6#1)
subjects as well as##8##4##(1990-11#1)(1992-3#1)(1994-6#1)(1997-5#1)(2008-11#1)(2008-3#1)(2009-8#2)
subjects as##22##2##(1990-11#1)(1991-10#1)(1992-3#1)(1994-6#1)(1995-4#1)(1997-5#1)(2006-2#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-1#2)(2009-4#1)(2009-8#2)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
subjects at a##2##3##(2008-5#1)(2010-5#1)
subjects at day##2##3##(2006-7#1)(2008-4#1)
subjects at risk of##2##4##(1997-7#1)(2012-3#1)
subjects at risk##6##3##(1997-7#3)(2008-12#1)(2011-2#1)(2012-3#1)
subjects at##21##2##(1992-12#1)(1994-1#1)(1997-7#3)(2004-11#1)(2006-7#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-3#1)
subjects before and##2##3##(1990-5#1)(1991-8#1)
subjects before##5##2##(1990-5#1)(1991-8#1)(1996-2#1)(1996-3#1)(2011-1#1)
subjects belonging to##3##3##(2008-1#1)(2008-8#1)(2009-12#1)
subjects between##6##2##(2007-4#1)(2007-6#1)(2008-3#1)(2009-4#1)(2011-2#1)(2012-12#1)
subjects but##7##2##(1990-5#1)(1991-1#1)(1996-7#1)(2006-8#1)(2006-9#1)(2008-5#1)(2012-2#1)
subjects by##8##2##(1990-3#1)(1992-3#1)(1996-1#1)(2005-10#1)(2008-4#1)(2009-8#1)(2010-5#1)(2011-2#1)
subjects can be classified as##2##5##(1991-3#1)(2008-10#1)
subjects can be##3##3##(1991-3#1)(1996-12#1)(2008-10#1)
subjects can##10##2##(1991-3#1)(1996-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-1#1)(2012-12#1)(2013-8#2)
subjects compared to##2##3##(2007-1#1)(2011-2#1)
subjects compared with##3##3##(1995-11#1)(2006-5#1)(2012-12#1)
subjects compared##5##2##(1995-11#1)(2006-5#1)(2007-1#1)(2011-2#1)(2012-12#1)
subjects completed an##2##3##(2013-1#1)(2013-8#1)
subjects completed the study##4##4##(1991-2#1)(2006-8#1)(2008-3#1)(2008-5#1)
subjects completed##11##2##(1991-2#1)(1996-7#1)(2006-8#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-3#1)(2013-1#1)(2013-8#1)
subjects considered##3##2##(1993-11#1)(1993-5#1)(2006-10#1)
subjects consuming##2##2##(1996-3#1)(2006-10#1)
subjects could be##2##3##(1990-12#1)(1996-1#1)
subjects could##5##2##(1990-12#1)(1996-1#2)(1996-5#1)(2009-4#1)
subjects covered##3##2##(2007-1#1)(2008-10#1)(2012-3#1)
subjects demonstrated##3##2##(1991-12#1)(1996-5#1)(2007-7#1)
subjects developed##2##2##(1994-2#1)(1994-3#1)
subjects did not perform any##2##5##(2009-1#1)(2009-3#1)
subjects did not show any##2##5##(2005-8#1)(2008-5#1)
subjects did not##6##3##(2004-10#1)(2005-8#1)(2007-9#1)(2008-5#1)(2009-1#1)(2009-3#1)
subjects displayed##3##2##(1990-12#1)(1996-3#1)(2008-7#1)
subjects during a##2##3##(1991-2#1)(2007-11#1)
subjects during##15##2##(1990-6#1)(1991-2#1)(1992-4#1)(1995-12#2)(1995-6#1)(1996-1#1)(1996-5#1)(1996-6#2)(2007-11#1)(2007-4#2)(2008-5#1)(2012-1#1)
subjects employed in##2##3##(1994-9#1)(2008-11#1)
subjects enrolled in the##2##4##(1990-5#1)(1997-3#1)
subjects enter##2##2##(1995-8#1)(2008-4#1)
subjects especially##2##2##(2008-1#1)(2008-12#1)
subjects examined##2##2##(2008-1#1)(2011-1#1)
subjects excreted##2##2##(1991-12#1)(1993-9#1)
subjects experienced##2##2##(2004-3#1)(2006-10#1)
subjects exposed to##6##3##(1992-3#1)(1994-6#2)(1995-6#1)(2011-2#1)(2012-2#1)
subjects exposed##8##2##(1992-3#1)(1994-6#2)(1995-6#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
subjects expressed##2##2##(1994-2#1)(2012-12#1)
subjects followed##2##2##(1996-5#1)(2012-2#1)
subjects following##4##2##(1995-9#1)(1997-3#1)(2011-2#1)(2012-2#1)
subjects for sequencing##2##3##(2012-3#2)
subjects for whom##2##3##(1990-6#1)(2006-8#1)
subjects for##20##2##(1990-6#1)(1991-2#1)(1992-11#1)(1993-12#1)(1996-3#1)(1997-5#1)(1997-8#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-12#1)(2008-11#1)(2008-4#1)(2010-7#1)(2011-2#1)(2012-3#4)(2013-1#1)
subjects from Ahmedabad##2##3##(2013-1#2)
subjects from Crikvenica##2##3##(2011-2#2)
subjects from Kostrena##2##3##(2011-2#2)
subjects from a##4##3##(2008-11#1)(2008-12#1)(2012-11#1)(2013-1#1)
subjects from the##6##3##(1997-2#2)(2005-11#1)(2008-7#1)(2011-11#1)(2012-3#1)
subjects from##30##2##(1994-4#1)(1997-2#2)(1997-4#1)(1997-5#1)(2005-10#1)(2005-11#1)(2006-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-11#1)(2011-2#4)(2011-3#1)(2012-11#1)(2012-3#2)(2013-1#3)(2013-8#1)
subjects had a##6##3##(1996-12#1)(2004-3#1)(2007-9#1)(2008-11#1)(2012-3#1)(2013-1#1)
subjects had been##3##3##(1997-8#1)(2006-8#1)(2010-12#1)
subjects had high##2##3##(2008-1#2)
subjects had more##2##3##(1995-11#1)(2012-1#1)
subjects had normal##2##3##(1993-7#1)(1996-5#1)
subjects had reduced##2##3##(1994-12#1)(2008-6#1)
subjects had significantly##2##3##(2008-3#1)(2011-2#1)
subjects had to##2##3##(1995-11#1)(2008-5#1)
subjects had##46##2##(1991-8#2)(1992-6#1)(1993-7#1)(1994-10#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#2)(1996-12#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-8#1)(2004-11#1)(2004-3#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-1#1)(2009-6#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
subjects has been a##2##4##(1993-3#1)(1994-12#1)
subjects has been##4##3##(1993-3#1)(1994-12#1)(2006-8#1)(2012-1#1)
subjects has##5##2##(1993-3#1)(1994-11#1)(1994-12#1)(2006-8#1)(2012-1#1)
subjects have been##3##3##(1992-4#1)(2011-1#2)
subjects have##8##2##(1992-12#1)(1992-3#2)(1992-4#1)(2008-1#1)(2008-3#1)(2011-1#2)
subjects having##3##2##(2007-12#1)(2008-2#1)(2012-12#1)
subjects homozygous for the##3##4##(1995-9#2)(1996-5#1)
subjects homozygous##4##2##(1995-9#2)(1996-5#2)
subjects in The Netherlands]##2##4##(1992-5#2)
subjects in a##12##3##(1994-6#1)(1995-5#1)(1995-9#1)(1996-2#2)(1996-3#1)(2004-12#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
subjects in caries-free group and##2##5##(2012-12#2)
subjects in clinical trials of##2##5##(2009-11#2)
subjects in each group##3##4##(1995-5#1)(2008-5#1)(2013-8#1)
subjects in group 1##2##4##(2008-1#2)
subjects in order to investigate##2##5##(1997-8#1)(2012-1#1)
subjects in order to##7##4##(1990-11#1)(1997-8#1)(2004-11#1)(2007-4#1)(2008-7#1)(2012-1#1)(2012-3#1)
subjects in the same##2##4##(1996-11#1)(2010-11#1)
subjects in the study##2##4##(2011-1#1)(2011-2#1)
subjects in the##31##3##(1990-12#2)(1990-4#1)(1992-3#1)(1995-5#1)(1996-11#1)(1996-2#2)(2005-10#1)(2006-3#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#1)
subjects in three##2##3##(1992-1#1)(2007-7#1)
subjects in##92##2##(1990-11#1)(1990-12#2)(1990-4#2)(1991-1#1)(1992-1#1)(1992-3#1)(1992-5#3)(1993-9#1)(1994-6#1)(1995-5#3)(1995-9#1)(1996-11#1)(1996-2#4)(1996-3#2)(1997-6#1)(1997-8#1)(2004-11#1)(2004-12#1)(2005-10#1)(2006-10#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#4)(2008-1#2)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#3)(2008-7#2)(2008-9#1)(2009-11#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#4)(2013-1#2)(2013-8#3)
subjects included##5##2##(1990-12#1)(2006-4#1)(2009-8#1)(2011-2#1)(2013-1#1)
subjects indicated a##2##3##(1990-12#1)(2010-8#1)
subjects initially##2##2##(2013-1#2)
subjects into##2##2##(2007-7#1)(2011-1#1)
subjects is##8##2##(1990-12#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-3#2)(1997-1#1)(2005-7#1)
subjects it was found that##2##5##(1990-10#1)(2008-7#1)
subjects it was##3##3##(1990-10#1)(2008-7#1)(2012-1#1)
subjects it##4##2##(1990-10#1)(1992-9#1)(2008-7#1)(2012-1#1)
subjects listening to##3##3##(2007-6#3)
subjects living in rural communities had the highest and lowest percentages of##2##12##(1997-1#2)
subjects living in the##2##4##(1992-8#1)(2011-2#1)
subjects living in##7##3##(1990-8#1)(1991-7#1)(1992-8#1)(1997-1#2)(2010-12#1)(2011-2#1)
subjects made##4##2##(1996-1#1)(2007-2#1)(2009-5#1)(2012-12#1)
subjects may be##3##3##(1997-5#1)(2005-8#1)(2008-6#1)
subjects may have##2##3##(2006-8#1)(2013-7#1)
subjects may##6##2##(1997-5#1)(2005-8#1)(2006-8#1)(2008-10#1)(2008-6#1)(2013-7#1)
subjects meeting the##2##3##(1997-8#1)(2009-10#1)
subjects meeting##5##2##(1997-8#1)(2008-6#1)(2009-10#1)(2011-2#2)
subjects met criteria for##2##4##(1990-12#1)(2004-3#1)
subjects met##3##2##(1990-12#1)(1991-2#1)(2004-3#1)
subjects might##4##2##(1990-2#1)(1990-9#1)(1994-2#1)(1994-6#1)
subjects naturally##2##2##(1992-9#1)(1994-8#1)
subjects not##7##2##(1990-10#2)(1991-3#1)(2007-5#1)(2007-6#1)(2008-12#1)(2013-1#1)
subjects of age##2##3##(1991-10#1)(2012-3#1)
subjects of both sexes##3##4##(2006-8#1)(2008-5#1)(2010-12#1)
subjects of both##5##3##(2006-8#1)(2006-9#2)(2008-5#1)(2010-12#1)
subjects of the study were##4##5##(1990-10#1)(1991-1#1)(2007-10#1)(2008-8#1)
subjects of the study##6##4##(1990-10#1)(1991-1#1)(2007-10#1)(2007-7#1)(2008-8#1)(2011-1#1)
subjects of the##11##3##(1990-10#1)(1990-11#1)(1991-1#1)(1991-8#1)(1993-9#1)(2007-10#1)(2007-7#1)(2008-5#2)(2008-8#1)(2011-1#1)
subjects of this study##4##4##(1990-8#1)(2007-10#1)(2007-7#2)
subjects of this##8##3##(1990-8#1)(1991-2#1)(1994-5#1)(2006-9#1)(2007-10#1)(2007-7#2)(2008-3#1)
subjects of##47##2##(1990-10#1)(1990-11#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-8#1)(1993-9#1)(1994-5#1)(1996-7#1)(1997-6#1)(2006-10#1)(2006-8#2)(2006-9#3)(2007-10#2)(2007-2#1)(2007-7#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#2)
subjects offered##2##2##(1993-9#1)(2010-9#1)
subjects on a##3##3##(2008-1#1)(2008-5#1)(2011-2#1)
subjects on the##5##3##(1991-6#1)(1996-3#1)(1996-7#1)(1997-8#1)(2008-7#1)
subjects on this##2##3##(1991-2#1)(1997-8#1)
subjects on##17##2##(1990-3#1)(1991-2#1)(1991-6#1)(1994-6#1)(1996-3#1)(1996-7#2)(1997-8#2)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-7#1)(2011-1#1)(2011-2#2)
subjects or##3##2##(1996-1#1)(2008-11#1)(2012-3#1)
subjects over##5##2##(1992-2#1)(1993-10#1)(1996-7#1)(2006-3#1)(2008-7#1)
subjects participated in a##2##4##(2004-3#1)(2008-9#1)
subjects participated in the study##3##5##(2007-6#1)(2010-12#1)(2010-4#1)
subjects participated in the##4##4##(2007-6#1)(2010-12#1)(2010-4#1)(2012-1#1)
subjects participated in this##3##4##(2007-10#1)(2007-4#1)(2013-1#1)
subjects participated in##10##3##(2004-3#1)(2007-10#1)(2007-4#1)(2007-6#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2012-1#1)(2013-1#1)
subjects participated##11##2##(2004-3#1)(2007-10#1)(2007-4#1)(2007-6#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2012-1#2)(2013-1#1)
subjects participating in##2##3##(1993-7#1)(2005-1#1)
subjects per##2##2##(2008-5#2)
subjects perceived##2##2##(1991-2#1)(2008-5#1)
subjects performed the##2##3##(1996-3#1)(2008-7#1)
subjects performed voluntary##2##3##(1992-8#1)(2008-11#1)
subjects performed##12##2##(1992-8#1)(1996-3#2)(2007-4#1)(2008-11#1)(2008-6#1)(2008-7#2)(2009-8#1)(2010-5#1)(2012-1#1)(2013-8#1)
subjects performing##3##2##(1994-8#1)(2007-10#1)(2012-2#1)
subjects pointed##3##2##(1992-10#1)(1995-12#1)(2012-12#1)
subjects positive for##4##3##(1991-7#1)(1991-9#2)(1993-7#1)
subjects positive##5##2##(1991-7#1)(1991-9#2)(1993-7#1)(2011-2#1)
subjects ran##3##2##(1995-1#3)
subjects randomized to##2##3##(2008-3#1)(2010-11#1)
subjects randomly selected from##3##4##(1990-12#1)(2008-12#1)(2008-7#1)
subjects randomly##4##2##(1990-12#1)(2004-12#1)(2008-12#1)(2008-7#1)
subjects ranked##2##2##(2007-5#1)(2008-9#1)
subjects rated their##2##3##(2008-5#1)(2008-7#1)
subjects reached##2##2##(1995-12#1)(2007-10#1)
subjects received a##3##3##(1994-6#2)(2008-6#1)
subjects received##13##2##(1994-6#2)(1996-12#1)(1996-5#1)(2005-8#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2013-1#1)
subjects receiving##8##2##(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
subjects recruited##2##2##(2007-8#1)(2008-7#1)
subjects reported##5##2##(1996-1#1)(2004-3#1)(2008-5#1)(2008-7#1)(2012-12#1)
subjects respectively##3##2##(1991-2#1)(2011-11#1)(2011-2#1)
subjects responded to##2##3##(1991-5#1)(2007-9#1)
subjects revealed##3##2##(1993-8#1)(1997-7#1)(2013-1#1)
subjects saw##2##2##(1992-11#1)(2012-1#1)
subjects selected##5##2##(1991-7#1)(1993-12#1)(2007-1#1)(2011-1#1)(2012-3#1)
subjects should be##3##3##(2005-3#1)(2010-10#1)(2012-2#1)
subjects should##4##2##(1992-4#1)(2005-3#1)(2010-10#1)(2012-2#1)
subjects showed a##5##3##(1992-6#1)(1995-1#1)(1995-12#1)(2008-5#1)(2008-7#1)
subjects showed significant##3##3##(1990-3#1)(1991-2#1)(1997-7#1)
subjects showed that the##2##4##(2007-4#1)(2011-1#1)
subjects showed that##3##3##(2006-10#1)(2007-4#1)(2011-1#1)
subjects showed##18##2##(1990-3#1)(1991-12#2)(1991-2#1)(1992-10#1)(1992-6#1)(1995-1#1)(1995-12#1)(1997-7#2)(2006-10#1)(2007-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2011-1#1)(2012-1#1)
subjects showing##2##2##(1995-11#1)(2012-2#1)
subjects simultaneously##2##2##(2008-4#1)(2010-7#1)
subjects studied##8##2##(1990-2#1)(1991-2#1)(1994-12#1)(1994-3#1)(2006-2#1)(2007-6#1)(2008-12#1)(2012-1#1)
subjects such as##2##3##(1996-1#2)
subjects suffering from##2##3##(1990-9#1)(1992-3#1)
subjects suffering##4##2##(1990-9#1)(1992-3#1)(2011-2#1)(2012-12#1)
subjects surveyed##2##2##(1993-7#1)(2008-4#1)
subjects tend to##2##3##(2008-11#1)(2009-11#1)
subjects tested##3##2##(1990-3#1)(1991-3#1)(2006-11#1)
subjects than##5##2##(1991-11#1)(2008-10#1)(2008-5#1)(2009-2#1)(2013-1#1)
subjects that##7##2##(1990-6#1)(1991-10#1)(1991-8#1)(1996-7#1)(1997-6#1)(2006-10#1)(2007-11#1)
subjects the##5##2##(1991-1#1)(1993-1#1)(2008-10#1)(2008-3#1)(2008-7#1)
subjects to a##2##3##(1994-12#1)(2012-1#1)
subjects to the##2##3##(1994-11#1)(1997-5#1)
subjects to##24##2##(1990-5#1)(1994-11#1)(1994-12#1)(1994-3#1)(1997-5#1)(2005-11#1)(2006-10#1)(2006-5#3)(2006-6#1)(2007-10#1)(2007-9#1)(2008-2#1)(2008-7#1)(2010-2#2)(2012-1#4)(2012-12#1)(2012-2#1)(2012-3#1)
subjects took##2##2##(1990-3#1)(2008-7#1)
subjects treated with##4##3##(1991-1#1)(2008-10#1)(2008-5#1)(2008-8#1)
subjects treated##7##2##(1991-1#1)(1991-6#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-8#2)
subjects under a##2##3##(1995-12#1)(2011-2#1)
subjects under the effect of##2##5##(2013-8#2)
subjects under the##4##3##(1991-12#1)(1993-12#1)(2013-8#2)
subjects under##10##2##(1991-12#1)(1991-3#1)(1992-12#1)(1993-12#1)(1994-8#1)(1995-12#1)(2007-4#1)(2011-2#1)(2013-8#2)
subjects undergoing##7##2##(1990-6#1)(2007-12#1)(2008-11#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
subjects underwent a##4##3##(2008-7#1)(2010-5#1)(2011-2#1)(2013-8#1)
subjects underwent##14##2##(1993-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-7#1)(2010-5#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-8#1)
subjects until##2##2##(1995-9#1)(1996-3#1)
subjects used a##2##3##(1992-9#1)(1996-7#1)
subjects used the##2##3##(1992-2#1)(2008-12#1)
subjects used##6##2##(1992-2#1)(1992-9#1)(1996-7#1)(2008-11#1)(2008-12#1)(2008-2#1)
subjects using a##2##3##(1991-9#1)(1996-3#1)
subjects using cochlear implants##2##4##(2008-9#2)
subjects using##10##2##(1991-12#1)(1991-9#1)(1992-2#1)(1996-2#1)(1996-3#1)(2007-11#1)(2008-9#2)(2012-2#2)
subjects utilized##2##2##(1996-2#1)(2012-1#1)
subjects viewed a series of##2##5##(1996-5#1)(2006-3#1)
subjects viewed##3##2##(1996-5#1)(2006-3#1)(2008-11#1)
subjects walking##2##2##(2007-10#1)(2012-1#1)
subjects was 0##3##3##(1991-5#2)(1992-2#1)
subjects was a##2##3##(2006-9#1)(2013-1#1)
subjects was found##4##3##(1990-10#1)(1995-1#1)(2008-7#1)(2012-3#1)
subjects was measured##2##3##(1993-11#1)(1996-5#1)
subjects was significantly higher than that##2##6##(2007-4#1)(2008-2#1)
subjects was##45##2##(1990-10#1)(1990-4#1)(1991-1#1)(1991-5#2)(1991-6#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1995-1#1)(1995-12#1)(1996-3#1)(1996-5#1)(2006-9#2)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-4#4)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#3)(2011-12#2)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
subjects we##3##2##(2008-7#1)(2010-5#1)(2012-12#1)
subjects wearing##2##2##(2005-11#1)(2013-1#1)
subjects were able to##2##4##(2010-5#1)(2013-8#1)
subjects were administered##2##3##(2008-10#1)(2012-12#1)
subjects were affected##2##3##(1991-10#1)(2008-7#1)
subjects were aged##2##3##(2008-4#1)(2009-5#1)
subjects were analyzed##2##3##(1996-11#1)(2008-9#1)
subjects were asked to##6##4##(1991-9#1)(1996-2#1)(2005-10#1)(2008-6#1)(2013-1#1)(2013-8#1)
subjects were assessed with the##2##5##(1995-11#2)
subjects were assigned to##4##4##(1991-3#1)(2007-5#1)(2008-5#1)(2012-2#1)
subjects were assigned##6##3##(1991-3#1)(1993-7#1)(2007-5#1)(2008-5#1)(2010-8#1)(2012-2#1)
subjects were at##2##3##(2011-2#1)(2012-12#1)
subjects were categorized into##2##4##(2013-8#2)
subjects were categorized##3##3##(2011-2#1)(2013-8#2)
subjects were classified##2##3##(2006-7#1)(2011-2#1)
subjects were compared with##2##4##(2008-3#1)(2011-2#1)
subjects were compared##5##3##(1995-4#1)(1997-2#1)(2008-3#1)(2008-9#1)(2011-2#1)
subjects were considered##2##3##(2006-10#1)(2008-5#1)
subjects were divided into three##2##5##(2008-7#1)(2010-12#1)
subjects were divided into two groups##2##6##(1992-8#1)(2013-8#1)
subjects were divided into two##3##5##(1992-8#1)(2008-6#1)(2013-8#1)
subjects were divided into##8##4##(1992-12#1)(1992-8#1)(1997-8#1)(2007-2#1)(2008-6#1)(2008-7#1)(2010-12#1)(2013-8#1)
subjects were divided##9##3##(1992-12#1)(1992-8#1)(1997-8#1)(2007-2#1)(2008-6#1)(2008-7#2)(2010-12#1)(2013-8#1)
subjects were either##2##3##(1992-11#1)(1993-6#1)
subjects were evaluated##3##3##(2006-10#1)(2011-2#1)(2012-1#1)
subjects were examined by##2##4##(2008-4#1)(2008-7#1)
subjects were examined##6##3##(2007-7#1)(2008-4#1)(2008-7#2)(2012-3#1)(2013-1#1)
subjects were found to be##3##5##(1996-2#1)(2008-7#1)(2010-9#1)
subjects were found to##4##4##(1996-2#1)(2008-7#1)(2010-9#1)(2012-2#1)
subjects were found##5##3##(1996-2#1)(2008-7#2)(2010-9#1)(2012-2#1)
subjects were generally##2##3##(1996-8#1)(2008-4#1)
subjects were given##4##3##(1993-9#1)(1996-5#1)(2008-10#1)(2013-1#1)
subjects were grouped##2##3##(2004-11#1)(2006-2#1)
subjects were identified##3##3##(1991-9#1)(2013-1#1)(2013-8#1)
subjects were in the##2##4##(2008-1#1)(2008-4#1)
subjects were in##3##3##(2008-1#1)(2008-12#1)(2008-4#1)
subjects were included in the study##2##6##(1997-8#1)(2008-7#1)
subjects were included in the##3##5##(1997-8#1)(2008-7#1)(2008-8#1)
subjects were included in##5##4##(1997-8#1)(2007-2#1)(2008-5#1)(2008-7#1)(2008-8#1)
subjects were included##8##3##(1997-8#1)(2005-4#1)(2006-10#1)(2007-2#1)(2008-5#1)(2008-7#1)(2008-8#2)
subjects were instructed to##4##4##(1997-1#1)(2006-10#1)(2008-9#1)(2012-2#1)
subjects were interviewed##3##3##(2006-4#1)(2008-7#1)(2011-2#1)
subjects were invited##2##3##(2006-7#1)(2011-1#1)
subjects were male##3##3##(2010-1#1)(2011-2#2)
subjects were not##2##3##(1991-3#1)(2012-12#1)
subjects were older and##2##4##(2008-3#1)(2010-12#1)
subjects were older##3##3##(2008-3#1)(2008-4#1)(2010-12#1)
subjects were randomized to##2##4##(2010-12#1)(2012-1#1)
subjects were randomly assigned to##4##5##(2008-11#1)(2008-12#1)(2011-2#1)(2012-12#1)
subjects were randomly##5##3##(1997-2#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-12#1)
subjects were recruited for##2##4##(2008-8#1)(2013-1#1)
subjects were recruited##8##3##(2004-3#1)(2006-7#1)(2008-1#1)(2008-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
subjects were required to##2##4##(1991-1#1)(2008-11#1)
subjects were screened##2##3##(2011-1#2)
subjects were selected##3##3##(1997-8#1)(2007-2#1)(2011-2#1)
subjects were significantly##2##3##(1990-4#1)(1991-7#1)
subjects were studied##2##3##(1991-2#1)(2008-5#1)
subjects were tested for##3##4##(1991-8#1)(2008-7#1)(2012-2#1)
subjects were tested##6##3##(1991-8#1)(2008-10#1)(2008-12#1)(2008-7#2)(2012-2#1)
subjects were trained##2##3##(1993-9#1)(2008-10#1)
subjects were treated##2##3##(2008-5#1)(2011-2#1)
subjects were##249##2##(1990-12#1)(1990-4#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#4)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-8#2)(1993-12#3)(1993-2#1)(1993-6#1)(1993-7#1)(1993-9#4)(1994-12#3)(1995-11#5)(1995-4#1)(1996-1#5)(1996-11#1)(1996-2#3)(1996-3#2)(1996-5#1)(1996-7#1)(1996-8#3)(1997-1#1)(1997-2#3)(1997-6#1)(1997-8#4)(2004-11#2)(2004-3#1)(2005-10#2)(2005-4#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-4#1)(2006-7#3)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-2#6)(2007-3#1)(2007-4#2)(2007-5#3)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#5)(2008-10#7)(2008-11#5)(2008-12#3)(2008-3#4)(2008-4#6)(2008-5#5)(2008-6#2)(2008-7#15)(2008-8#4)(2008-9#6)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#3)(2010-12#6)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#14)(2012-1#5)(2012-12#7)(2012-2#7)(2012-3#4)(2013-1#10)(2013-8#10)
subjects when compared to##3##4##(1996-7#1)(2008-1#1)(2008-7#1)
subjects when compared##4##3##(1996-7#1)(1996-8#1)(2008-1#1)(2008-7#1)
subjects when##5##2##(1996-7#1)(1996-8#1)(1997-4#1)(2008-1#1)(2008-7#1)
subjects which had##2##3##(1993-7#2)
subjects which impacted##2##3##(2007-4#2)
subjects which##8##2##(1993-7#2)(1994-2#2)(1996-3#1)(1997-1#1)(2007-4#2)
subjects while##6##2##(1993-5#1)(1993-9#1)(1994-6#1)(2006-8#1)(2008-3#1)(2013-1#1)
subjects who attended the##2##4##(2008-3#1)(2013-1#1)
subjects who became blind##2##4##(1990-2#2)
subjects who entered##2##3##(1992-6#1)(2004-3#1)
subjects who had##15##3##(1990-12#1)(1991-8#1)(1994-4#1)(1994-6#1)(1995-12#2)(1996-5#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-1#1)(2010-5#1)(2011-2#1)
subjects who have##2##3##(1996-7#1)(2013-1#1)
subjects who received##2##3##(2006-10#1)(2007-12#1)
subjects who reported##4##3##(1993-9#1)(2006-10#1)(2006-2#1)(2008-11#1)
subjects who underwent a##2##4##(2006-5#1)(2011-2#1)
subjects who underwent##3##3##(2006-5#1)(2011-2#1)(2013-4#1)
subjects who were given##2##4##(2007-12#1)(2012-2#1)
subjects who were##16##3##(1991-7#1)(1994-3#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#3)(2009-10#1)(2011-1#1)(2012-2#1)(2013-8#2)
subjects who##75##2##(1990-12#1)(1990-2#2)(1991-3#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-9#1)(1994-3#1)(1994-4#1)(1994-6#2)(1995-12#2)(1995-9#1)(1996-5#1)(1996-7#1)(2004-3#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-2#2)(2006-5#2)(2006-6#1)(2007-10#4)(2007-12#2)(2007-3#1)(2007-5#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#5)(2008-4#1)(2008-5#4)(2008-7#1)(2009-10#1)(2009-11#1)(2009-9#1)(2010-1#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#3)(2013-4#1)(2013-8#3)
subjects whose##5##2##(2006-5#1)(2008-5#1)(2008-7#1)(2010-11#1)(2012-2#1)
subjects will##3##2##(1996-3#1)(2008-5#1)(2008-8#1)
subjects with BMI##2##3##(2008-6#2)
subjects with CUS##2##3##(2006-6#2)
subjects with PD showed more fluctuations in their##2##8##(2008-7#2)
subjects with PD##9##3##(2008-7#9)
subjects with PWS##2##3##(2006-10#2)
subjects with Parkinson's disease (PD)##3##5##(2008-7#2)(2013-1#1)
subjects with Parkinson's disease##4##4##(2008-7#3)(2013-1#1)
subjects with SBI##2##3##(2007-10#2)
subjects with SI joint dysfunction##4##5##(2012-2#4)
subjects with Type 2 diabetes##2##5##(1994-12#2)
subjects with a history of##5##5##(1996-10#1)(2007-11#3)(2011-1#1)
subjects with a##14##3##(1992-3#1)(1995-4#1)(1996-1#1)(1996-10#1)(1997-1#1)(2004-11#1)(2005-10#1)(2007-11#3)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)
subjects with abnormal##2##3##(2012-12#1)(2013-8#1)
subjects with active##2##3##(2007-11#1)(2011-1#1)
subjects with an eGFR &gt##2##5##(2012-2#2)
subjects with an eGFR &lt##2##5##(2012-2#2)
subjects with an eGFR##4##4##(2012-2#4)
subjects with an##6##3##(1996-9#1)(2012-2#4)(2012-3#1)
subjects with and without##8##4##(1990-2#1)(1991-3#1)(1996-1#1)(2008-12#1)(2008-3#1)(2012-2#1)(2013-1#2)
subjects with asymptomatic##2##3##(2012-2#2)
subjects with at least##2##4##(1995-12#1)(2008-10#1)
subjects with bipolar disorder##2##4##(1995-11#2)
subjects with bipolar##5##3##(1995-11#4)(2010-12#1)
subjects with chronic##9##3##(1996-6#1)(1997-8#1)(2006-6#2)(2008-4#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-3#1)
subjects with cirrhosis##2##3##(2010-5#2)
subjects with clinically##2##3##(1996-12#1)(2008-7#1)
subjects with coronary##3##3##(2008-3#1)(2008-7#2)
subjects with diabetes##3##3##(2008-3#1)(2012-3#2)
subjects with different##4##3##(1994-11#1)(2008-7#1)(2010-10#1)(2012-1#1)
subjects with disorders of peroxisome biogenesis##2##6##(1993-12#2)
subjects with either##2##3##(1997-5#1)(2008-11#1)
subjects with healthy##2##3##(2006-2#1)(2007-12#1)
subjects with heterozygous##2##3##(1997-2#2)
subjects with high##4##3##(1992-8#1)(1997-1#1)(2008-7#1)(2009-1#1)
subjects with hypertriglyceridemia##2##3##(1997-2#2)
subjects with impaired fasting glucose##3##5##(2008-7#1)(2011-1#1)(2013-1#1)
subjects with impaired##5##3##(2007-7#1)(2008-7#2)(2011-1#1)(2013-1#1)
subjects with insulin resistance##2##4##(2008-1#1)(2009-7#1)
subjects with low##6##3##(1992-8#1)(1995-12#1)(1997-1#1)(2010-8#1)(2012-1#1)(2013-8#1)
subjects with lower##2##3##(1995-6#1)(2012-2#1)
subjects with mild acne vulgaris##2##5##(2008-5#2)
subjects with no##5##3##(2006-8#1)(2007-10#1)(2008-1#1)(2012-2#2)
subjects with normal skin##2##4##(2008-5#2)
subjects with normal sperm##2##4##(2010-8#2)
subjects with normal##14##3##(1990-8#1)(1991-4#1)(1992-11#1)(1993-11#1)(1996-2#1)(2006-6#1)(2008-5#2)(2010-3#1)(2010-8#2)(2011-1#1)(2012-7#1)(2013-8#1)
subjects with normolipidemia (0##2##4##(1997-2#2)
subjects with normolipidemia##5##3##(1997-2#5)
subjects with persistent MAP psychosis had##2##6##(1996-10#1)(1996-7#1)
subjects with persistent MAP psychosis##4##5##(1996-10#2)(1996-7#2)
subjects with persistent##6##3##(1996-10#2)(1996-7#2)(2012-3#2)
subjects with primary##2##3##(1996-11#1)(2012-2#1)
subjects with schizophrenia##4##3##(1995-1#1)(1995-12#2)(1996-3#1)
subjects with severe##2##3##(2010-1#1)(2012-1#1)
subjects with significant##2##3##(2008-3#1)(2011-2#1)
subjects with skin of colour##2##5##(2008-5#2)
subjects with the##18##3##(1990-4#1)(1991-12#1)(1991-5#1)(1991-8#1)(1997-2#1)(1997-7#1)(2006-7#1)(2006-9#1)(2007-4#2)(2008-3#2)(2008-4#1)(2008-7#2)(2009-9#1)(2012-12#1)(2012-2#1)
subjects with this##2##3##(2008-5#1)(2010-11#1)
subjects with type 2 diabetes##4##5##(2008-7#1)(2012-11#1)(2012-2#1)(2013-7#1)
subjects with type##5##3##(2008-7#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-7#1)
subjects with very high##2##4##(1991-6#1)(2008-8#1)
subjects with xerotic skin##2##4##(2008-5#2)
subjects with##362##2##(1990-10#1)(1990-12#2)(1990-2#2)(1990-4#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-12#3)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#4)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#3)(1995-1#1)(1995-11#8)(1995-12#4)(1995-4#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#4)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#3)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#2)(1997-1#4)(1997-2#16)(1997-5#4)(1997-7#1)(1997-8#1)(2004-11#3)(2004-3#1)(2005-1#3)(2005-10#1)(2006-10#4)(2006-2#2)(2006-5#1)(2006-6#5)(2006-7#1)(2006-8#3)(2006-9#3)(2007-10#7)(2007-11#5)(2007-12#2)(2007-2#2)(2007-4#3)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#6)(2008-11#9)(2008-12#2)(2008-3#6)(2008-4#3)(2008-5#14)(2008-6#3)(2008-7#33)(2008-8#3)(2008-9#4)(2009-1#1)(2009-10#2)(2009-11#2)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#5)(2010-6#1)(2010-8#5)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#11)(2012-1#7)(2012-11#1)(2012-12#3)(2012-2#21)(2012-3#8)(2012-7#2)(2013-1#14)(2013-7#1)(2013-8#6)
subjects without atherosclerotic lesions##2##4##(2006-6#2)
subjects without diabetes##2##3##(2005-10#1)(2012-3#1)
subjects without the##2##3##(2006-7#1)(2008-3#1)
subjects without##25##2##(1990-3#1)(1990-5#1)(1997-2#1)(1997-5#3)(2005-10#1)(2006-5#1)(2006-6#2)(2006-7#1)(2007-1#1)(2007-10#1)(2008-12#1)(2008-3#1)(2008-7#3)(2008-9#1)(2011-1#1)(2012-3#2)(2013-1#2)(2013-8#1)
subjects younger##3##2##(1990-12#1)(2006-6#1)(2007-9#1)
subjects##3015##1##(1990-10#12)(1990-11#7)(1990-12#17)(1990-2#13)(1990-3#12)(1990-4#8)(1990-5#10)(1990-6#10)(1990-7#1)(1990-8#10)(1990-9#8)(1991-1#14)(1991-10#7)(1991-11#10)(1991-12#14)(1991-2#28)(1991-3#18)(1991-4#2)(1991-5#12)(1991-6#7)(1991-7#7)(1991-8#16)(1991-9#8)(1992-1#7)(1992-10#2)(1992-11#7)(1992-12#14)(1992-2#7)(1992-3#13)(1992-4#4)(1992-5#4)(1992-6#7)(1992-8#11)(1992-9#6)(1993-1#9)(1993-10#4)(1993-11#10)(1993-12#21)(1993-2#5)(1993-3#2)(1993-4#1)(1993-5#11)(1993-6#2)(1993-7#11)(1993-8#7)(1993-9#23)(1994-1#3)(1994-10#5)(1994-11#9)(1994-12#20)(1994-2#7)(1994-3#14)(1994-4#4)(1994-5#4)(1994-6#29)(1994-7#1)(1994-8#4)(1994-9#2)(1995-1#17)(1995-11#34)(1995-12#28)(1995-2#3)(1995-3#1)(1995-4#5)(1995-5#23)(1995-6#11)(1995-7#1)(1995-8#7)(1995-9#13)(1996-1#43)(1996-10#4)(1996-11#8)(1996-12#12)(1996-2#23)(1996-3#30)(1996-5#29)(1996-6#6)(1996-7#32)(1996-8#15)(1996-9#11)(1997-1#38)(1997-2#31)(1997-3#5)(1997-4#3)(1997-5#15)(1997-6#8)(1997-7#20)(1997-8#24)(2004-10#2)(2004-11#19)(2004-12#4)(2004-3#9)(2005-1#5)(2005-10#22)(2005-11#8)(2005-3#3)(2005-4#1)(2005-7#1)(2005-8#6)(2005-9#1)(2006-1#3)(2006-10#39)(2006-11#7)(2006-12#2)(2006-2#15)(2006-3#7)(2006-4#5)(2006-5#15)(2006-6#19)(2006-7#6)(2006-8#28)(2006-9#27)(2007-1#20)(2007-10#39)(2007-11#25)(2007-12#18)(2007-2#29)(2007-3#5)(2007-4#30)(2007-5#12)(2007-6#13)(2007-7#31)(2007-8#10)(2007-9#25)(2008-1#31)(2008-10#59)(2008-11#61)(2008-12#41)(2008-2#16)(2008-3#55)(2008-4#51)(2008-5#100)(2008-6#22)(2008-7#132)(2008-8#24)(2008-9#32)(2009-1#7)(2009-10#6)(2009-11#13)(2009-12#4)(2009-2#6)(2009-3#3)(2009-4#16)(2009-5#3)(2009-6#8)(2009-7#4)(2009-8#16)(2009-9#6)(2010-1#8)(2010-10#8)(2010-11#6)(2010-12#31)(2010-2#8)(2010-3#3)(2010-4#4)(2010-5#17)(2010-6#3)(2010-7#6)(2010-8#17)(2010-9#9)(2011-1#63)(2011-11#4)(2011-12#8)(2011-2#100)(2011-3#1)(2012-1#59)(2012-11#4)(2012-12#60)(2012-2#88)(2012-3#62)(2012-7#2)(2013-1#108)(2013-4#1)(2013-7#4)(2013-8#63)
subjects' performance##2##2##(1997-2#1)(2008-2#1)
subjects'##36##1##(1991-1#1)(1992-12#1)(1992-2#1)(1993-7#1)(1993-9#1)(1994-6#1)(1995-3#1)(1997-2#1)(2006-3#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-5#2)(2007-9#1)(2008-11#1)(2008-12#3)(2008-2#2)(2008-4#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-8#1)(2011-2#3)(2012-1#2)(2012-2#1)(2013-1#2)(2013-8#1)
subjects) and##2##2##(1995-12#1)(2008-11#1)
subjects) were##2##2##(1994-6#1)(2011-1#1)
subjects)##24##1##(1992-8#1)(1994-12#2)(1994-6#2)(1995-12#2)(1995-5#2)(1995-9#2)(1996-1#1)(1997-6#1)(2005-1#2)(2007-12#1)(2008-11#1)(2008-7#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
subjects]##2##1##(1993-11#1)(1996-12#1)
subjugated##2##1##(2008-11#1)(2008-12#1)
subkingdom##2##1##(2007-12#2)
sublabral foramen##3##2##(2009-3#3)
sublamina b of the inner plexiform layer##2##7##(1990-12#2)
sublamina b##3##2##(1990-12#3)
sublamina##5##1##(1990-12#4)(2007-8#1)
sublayer##4##1##(2005-11#3)(2008-2#1)
sublethal concentrations of##3##3##(1991-12#1)(2006-8#1)(2011-1#1)
sublethal concentrations##6##2##(1991-12#1)(2006-8#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#1)
sublethal dose of##2##3##(2008-7#2)
sublethal dose##3##2##(2008-7#2)(2011-2#1)
sublethal doses of PAF##2##4##(2007-11#2)
sublethal doses of##3##3##(1995-6#1)(2007-11#2)
sublethal doses##4##2##(1995-6#1)(2007-11#3)
sublethal level##2##2##(2008-1#1)(2012-3#1)
sublethal##37##1##(1991-12#1)(1993-12#1)(1994-2#1)(1994-5#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-6#2)(2004-4#1)(2005-10#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-11#3)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2009-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
sublethally injured##2##2##(2008-10#1)(2009-6#1)
sublethally##3##1##(1996-10#1)(2008-10#1)(2009-6#1)
sublevel##3##1##(1990-2#2)(2008-3#1)
sublevels##3##1##(2007-12#1)(2008-1#1)(2008-2#1)
sublibraries##3##1##(1994-12#1)(1994-6#1)(1997-3#1)
sublimation of##2##2##(1990-8#1)(2007-11#1)
sublimation##9##1##(1990-8#2)(1991-11#1)(1997-7#1)(2005-11#1)(2007-11#1)(2008-5#3)
subliminal fringe##3##2##(1991-3#3)
subliminal##8##1##(1990-9#1)(1991-3#3)(1996-8#1)(2008-1#1)(2010-5#1)(2012-12#1)
subline of##4##2##(1993-4#1)(1995-2#1)(2008-4#2)
subline resistant to the##2##4##(1991-7#2)
subline resistant to##3##3##(1991-7#3)
subline were##2##2##(1992-2#1)(1997-4#1)
subline##22##1##(1990-10#4)(1990-2#2)(1991-1#2)(1991-11#1)(1991-7#4)(1992-2#1)(1992-9#1)(1993-4#1)(1995-2#1)(1995-5#1)(1997-4#1)(2008-11#1)(2008-4#2)
sublineages##7##1##(1990-8#1)(1995-3#4)(2005-11#2)
sublinear##2##1##(1990-4#1)(2007-12#1)
sublineolum##6##1##(2008-10#6)
sublineolum)##2##1##(2008-10#2)
sublines (R1##2##2##(1991-7#1)(1994-8#1)
sublines derived from##2##3##(1992-6#1)(2008-9#1)
sublines is##2##2##(1992-6#1)(2008-11#1)
sublines of Sprague-Dawley rats##2##4##(1990-10#1)(1993-9#1)
sublines of human tumor cells##2##5##(1990-10#2)
sublines of##8##2##(1990-10#3)(1991-1#1)(1991-4#1)(1993-9#1)(1994-3#1)(1997-4#1)
sublines were##3##2##(1991-1#1)(1991-7#1)(1992-9#1)
sublines with##2##2##(1992-8#1)(2008-11#1)
sublines##46##1##(1990-10#5)(1991-1#3)(1991-4#1)(1991-7#3)(1992-2#1)(1992-6#3)(1992-8#1)(1992-9#4)(1993-9#4)(1994-3#3)(1994-8#1)(1997-4#7)(2008-11#6)(2008-4#3)(2008-9#1)
sublingual##18##1##(1991-1#1)(1996-9#1)(1997-2#1)(1997-6#3)(2006-12#1)(2007-2#3)(2008-3#3)(2008-8#1)(2010-12#4)
sublittoral epifaunal##2##2##(2007-3#2)
sublittoral##5##1##(2007-3#2)(2007-5#1)(2012-2#2)
sublocalized##2##1##(1992-11#1)(1997-3#1)
subluxated and##2##2##(2007-11#1)(2007-7#1)
subluxated##4##1##(2007-11#1)(2007-7#2)(2012-2#1)
subluxation and dislocation##2##3##(2007-11#1)(2013-7#1)
subluxation of intervertebral##2##3##(2005-10#2)
subluxation of##4##2##(1996-12#1)(2005-10#2)(2012-3#1)
subluxation or dislocation in the##2##5##(2007-7#2)
subluxation##19##1##(1993-3#1)(1996-12#1)(2005-10#2)(2007-11#2)(2007-7#5)(2008-4#2)(2010-3#1)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
subluxations of the##2##3##(1990-6#1)(2009-8#1)
subluxations##8##1##(1990-6#1)(1993-3#1)(2007-11#3)(2007-7#1)(2008-6#1)(2009-8#1)
sublytic##3##1##(1990-2#1)(1990-3#1)(1994-2#1)
submandibular gland and in##2##4##(1996-2#1)(2007-3#1)
submandibular gland and##3##3##(1996-2#1)(2007-3#1)(2011-1#1)
submandibular gland##13##2##(1990-12#1)(1991-9#1)(1992-5#3)(1996-2#1)(2007-11#2)(2007-3#2)(2008-8#1)(2011-1#1)(2011-2#1)
submandibular salivary gland##5##3##(1990-5#3)(1995-11#1)(2009-7#1)
submandibular sialadenitis##2##2##(2011-1#2)
submandibular##36##1##(1990-12#1)(1990-5#3)(1991-9#1)(1992-5#3)(1993-8#1)(1995-11#1)(1995-2#2)(1996-2#1)(2005-7#1)(2007-11#5)(2007-3#4)(2007-6#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-11#1)(2011-1#3)(2011-2#2)(2012-1#1)(2013-8#1)
submarine##4##1##(2007-9#1)(2010-2#3)
submarines##3##1##(2010-2#3)
submaxillary gland##4##2##(1991-2#1)(1993-11#2)(1994-9#1)
submaxillary##7##1##(1991-2#1)(1993-11#2)(1994-9#4)
submaximal stimulus##2##2##(1993-12#2)
submaximal sustained##2##2##(2013-8#2)
submaximal##24##1##(1990-10#1)(1990-2#1)(1990-3#1)(1991-3#1)(1991-8#1)(1991-9#1)(1993-12#3)(1994-10#1)(1994-11#1)(1994-3#1)(1995-8#1)(1996-8#1)(1997-2#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#4)
submaximally##2##1##(1990-5#1)(1997-4#1)
submegahertz##2##1##(2007-11#1)(2007-12#1)
submental fat compartment##2##3##(2010-11#2)
submental##11##1##(2010-11#5)(2013-1#6)
submerged culture##3##2##(2005-11#2)(2008-5#1)
submerged cultures##3##2##(2008-10#1)(2008-2#2)
submerged fermentation##6##2##(2006-9#1)(2008-5#3)(2008-7#1)(2008-8#1)
submerged in a##2##3##(2008-10#1)(2008-8#1)
submerged in##4##2##(2005-4#1)(2008-10#1)(2008-3#1)(2008-8#1)
submerged to##2##2##(2005-8#1)(2008-5#1)
submerged##36##1##(1990-7#1)(1993-12#1)(1994-3#1)(2005-11#3)(2005-4#1)(2005-8#1)(2006-2#1)(2006-9#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#7)(2008-7#4)(2008-8#2)(2009-12#1)(2009-6#1)(2011-2#1)
submersed##2##1##(2008-10#1)(2009-2#1)
submersible flow##2##2##(2008-10#2)
submersible##3##1##(2008-10#3)
submersion in##2##2##(1990-9#1)(2005-8#1)
submersion##9##1##(1990-9#1)(1993-3#1)(2005-8#2)(2007-7#1)(2008-4#1)(2011-1#1)(2011-12#1)(2013-1#1)
submicellar##5##1##(1996-5#4)(2008-10#1)
submicroliter##2##1##(1996-11#1)(1997-4#1)
submicrometer grid patterning on curved surfaces##2##6##(2008-2#2)
submicrometer level##2##2##(2006-5#1)(2008-2#1)
submicrometer patterning##2##2##(2008-1#1)(2008-3#1)
submicrometer resolution##6##2##(2006-12#1)(2007-12#2)(2008-3#2)(2008-4#1)
submicrometer scale##2##2##(1992-1#1)(2007-12#1)
submicrometer structures##3##2##(2007-11#1)(2008-3#2)
submicrometer##43##1##(1992-1#1)(2005-11#1)(2006-12#2)(2006-5#1)(2007-11#2)(2007-12#8)(2008-1#2)(2008-10#2)(2008-2#10)(2008-3#13)(2008-4#1)
submicrometer-sized particles##3##2##(2004-9#2)(2008-2#1)
submicrometer-sized##6##1##(1992-5#1)(2004-9#2)(2007-11#1)(2007-12#1)(2008-2#1)
submicrometer-thick optical polarizing films##2##4##(2008-3#2)
submicromolar concentrations of calcium##2##4##(1991-7#1)(1992-4#1)
submicromolar concentrations of##3##3##(1991-7#1)(1992-4#1)(1994-11#1)
submicromolar concentrations##4##2##(1991-7#1)(1992-4#1)(1994-11#1)(1996-4#1)
submicromolar##13##1##(1990-5#1)(1991-7#1)(1992-4#1)(1993-4#1)(1994-11#1)(1994-9#1)(1996-4#1)(2008-10#3)(2008-7#1)(2013-1#2)
submicron particles##5##2##(2008-5#5)
submicron##12##1##(2005-11#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#5)(2009-11#1)(2013-8#1)
submicroscopic##7##1##(1995-10#1)(1996-6#1)(1997-3#2)(2008-1#1)(2008-3#1)(2012-12#1)
submicrospheres##8##1##(2005-11#8)
submicrostructural##2##1##(2005-11#2)
submillimeter radiometer##2##2##(2008-3#2)
submillimeter##24##1##(2007-12#3)(2008-2#12)(2008-3#7)(2009-5#2)
submillimetric##3##1##(2008-3#3)
submillisecond##4##1##(2007-10#1)(2007-11#1)(2008-3#1)(2011-12#1)
submission and##4##2##(2006-5#1)(2013-1#2)(2013-7#1)
submission from CAEP to the Romanow Commission##2##7##(2007-7#2)
submission of##6##2##(1996-8#1)(2006-5#1)(2008-11#1)(2008-5#1)(2011-1#1)(2012-1#1)
submission rate##2##2##(1992-1#1)(2008-1#1)
submission to the##3##3##(1996-1#1)(2005-8#1)(2012-11#1)
submission to##8##2##(1992-3#1)(1993-2#1)(1996-1#1)(2005-7#1)(2005-8#1)(2006-5#2)(2012-11#1)
submission##36##1##(1991-12#1)(1992-1#1)(1992-3#1)(1993-2#1)(1996-1#2)(1996-2#1)(1996-8#1)(2005-7#1)(2005-8#3)(2006-5#4)(2007-10#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2013-1#2)(2013-7#1)
submissions are##3##2##(2005-8#2)(2006-5#1)
submissions for the##2##3##(1996-1#1)(2007-9#1)
submissions to the##2##3##(1994-1#1)(2008-4#1)
submissions to##5##2##(1994-1#1)(2007-11#1)(2008-4#2)(2008-7#1)
submissions##13##1##(1994-1#1)(1996-1#1)(2005-8#2)(2006-5#2)(2007-11#1)(2007-9#1)(2008-4#2)(2008-7#2)(2011-2#1)
submissive##4##1##(1993-5#1)(2008-11#2)(2010-12#1)
submit that the##2##3##(1990-4#1)(2008-2#1)
submit that##3##2##(1990-4#1)(2008-2#1)(2013-8#1)
submit the##3##2##(2005-1#1)(2008-10#1)(2008-5#1)
submit their##3##2##(2008-11#1)(2008-7#2)
submit##23##1##(1990-4#2)(1992-1#1)(1996-12#1)(1996-5#1)(2005-1#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#4)(2008-8#1)(2010-11#1)(2012-2#1)(2013-8#1)
submitochondrial particles (SMP)##3##3##(1994-11#1)(1995-6#1)(2005-8#1)
submitochondrial particles from##2##3##(1990-8#1)(1994-11#1)
submitochondrial particles isolated from##2##4##(1995-1#2)
submitochondrial particles##18##2##(1990-5#1)(1990-8#2)(1992-11#5)(1992-6#2)(1994-11#2)(1995-1#2)(1995-6#1)(1997-1#1)(2005-8#2)
submitochondrial##19##1##(1990-5#1)(1990-8#2)(1992-11#5)(1992-6#2)(1993-3#1)(1994-11#2)(1995-1#2)(1995-6#1)(1997-1#1)(2005-8#2)
submits##6##1##(1990-11#2)(1991-2#1)(1993-5#1)(2005-11#1)(2009-6#1)
submittal##3##1##(2008-1#3)
submitted a##3##2##(1995-6#1)(2005-9#1)(2012-12#1)
submitted an NDA##3##3##(2005-6#1)(2005-7#1)(2008-5#1)
submitted by##3##2##(1992-5#1)(1994-3#1)(2005-7#1)
submitted electronically##2##2##(2005-10#1)(2006-7#1)
submitted for assessment of##2##4##(1993-3#1)(2006-6#1)
submitted for publication##2##3##(2008-5#1)(2010-4#1)
submitted for##23##2##(1992-3#1)(1992-5#1)(1992-8#1)(1993-3#1)(1994-2#1)(2004-12#1)(2006-6#2)(2007-2#2)(2007-4#1)(2008-10#2)(2008-5#5)(2008-9#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#1)
submitted from##3##2##(1994-1#1)(2005-9#1)(2006-5#1)
submitted in the##2##3##(2009-2#1)(2009-7#1)
submitted in##6##2##(1993-3#1)(2005-8#1)(2009-2#1)(2009-7#1)(2011-1#2)
submitted paper##3##2##(1995-5#1)(2006-6#2)
submitted the##4##2##(1990-4#1)(1992-5#1)(1995-11#1)(2012-2#1)
submitted to HPLC##2##3##(1991-3#2)
submitted to a##17##3##(1991-12#1)(1993-6#1)(1994-2#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-3#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-7#1)(2011-2#2)(2012-3#1)(2013-1#3)
submitted to adjuvant##2##3##(1992-12#1)(1993-9#1)
submitted to an##9##3##(1996-1#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2010-2#1)(2013-8#1)
submitted to chronic##2##3##(1991-6#1)(2007-9#1)
submitted to clinical##3##3##(1991-2#1)(1991-9#1)(2008-3#1)
submitted to different##2##3##(2008-12#1)(2008-5#1)
submitted to esophagectomy alone##2##4##(2013-8#2)
submitted to esophagectomy##3##3##(2013-8#3)
submitted to histological##2##3##(2008-5#1)(2013-1#1)
submitted to neoadjuvant chemoradiotherapy##2##4##(2013-8#2)
submitted to neoadjuvant radiotherapy##2##4##(2013-8#2)
submitted to neoadjuvant##4##3##(2013-8#4)
submitted to surgical treatment##2##4##(2010-1#1)(2011-2#1)
submitted to surgical##3##3##(1990-3#1)(2010-1#1)(2011-2#1)
submitted to the##26##3##(1990-7#1)(1992-2#1)(1992-7#1)(1993-3#1)(1997-6#1)(2005-9#1)(2006-10#1)(2006-6#1)(2006-8#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2009-2#1)(2010-1#1)(2010-6#1)(2010-7#1)(2011-2#1)(2013-1#1)
submitted to three##3##3##(2007-1#1)(2008-10#1)(2013-1#1)
submitted to treatment with##2##4##(1992-1#1)(2008-5#1)
submitted to ultrasound##2##3##(2007-7#1)(2011-2#1)
submitted to##186##2##(1990-10#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#3)(1991-3#5)(1991-6#3)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#3)(1993-12#1)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#1)(1993-9#3)(1994-10#1)(1994-2#1)(1994-6#2)(1995-1#1)(1995-4#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-8#3)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-9#1)(2006-10#1)(2006-6#1)(2006-8#2)(2007-1#2)(2007-10#2)(2007-2#2)(2007-3#3)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#5)(2008-2#2)(2008-3#1)(2008-5#10)(2008-6#2)(2008-7#7)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#3)(2009-5#1)(2009-7#2)(2010-1#3)(2010-12#3)(2010-2#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#8)(2012-2#1)(2012-3#1)(2013-1#13)(2013-7#1)(2013-8#8)
submitted##274##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#2)(1990-4#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#5)(1991-6#3)(1991-9#1)(1992-1#2)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#4)(1992-6#1)(1992-7#3)(1992-8#4)(1993-12#1)(1993-2#2)(1993-3#4)(1993-5#1)(1993-6#1)(1993-9#3)(1994-1#1)(1994-10#1)(1994-2#3)(1994-3#1)(1994-6#3)(1995-1#1)(1995-11#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#4)(1996-12#1)(1996-2#1)(1996-6#1)(1996-8#3)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-12#1)(2005-1#1)(2005-10#1)(2005-6#1)(2005-7#2)(2005-8#1)(2005-9#4)(2006-10#1)(2006-5#1)(2006-6#9)(2006-7#1)(2006-8#2)(2007-1#2)(2007-10#2)(2007-2#4)(2007-3#3)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#3)(2008-1#3)(2008-10#14)(2008-11#4)(2008-12#6)(2008-2#2)(2008-3#1)(2008-5#19)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#2)(2009-4#3)(2009-5#1)(2009-7#3)(2010-1#4)(2010-10#1)(2010-12#3)(2010-2#3)(2010-4#1)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#10)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#15)(2013-7#1)(2013-8#9)
submitted)##3##1##(1991-2#1)(1991-9#1)(1994-2#1)
submitting data##4##2##(2008-4#3)(2008-7#1)
submitting##12##1##(1997-8#1)(2008-1#2)(2008-4#4)(2008-7#2)(2009-8#1)(2011-2#1)(2013-7#1)
submonolayer##2##1##(2006-5#1)(2007-11#1)
submorsitans##2##1##(2006-2#1)(2006-5#1)
submucosa##17##1##(1990-9#1)(1992-2#1)(1993-12#1)(1995-3#1)(1996-11#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-5#1)(2008-8#1)(2009-4#1)(2011-12#1)(2011-2#1)
submucosal dissection (ESD)##4##3##(2010-12#1)(2012-2#1)(2013-8#2)
submucosal dissection##11##2##(2008-3#1)(2009-3#2)(2010-12#2)(2012-2#2)(2013-1#2)(2013-8#2)
submucosal hematoma of the esophagus##3##5##(2011-2#3)
submucosal injection##2##2##(2008-5#2)
submucosal invasive carcinoma##2##3##(2010-5#1)(2012-1#1)
submucosal invasive##3##2##(2010-5#1)(2012-1#2)
submucosal layer##7##2##(1991-9#2)(2008-5#3)(2013-7#2)
submucosal layers##2##2##(1997-4#1)(2006-10#1)
submucosal plexus##2##2##(2006-10#1)(2013-8#1)
submucosal tumor##9##2##(2007-8#2)(2007-9#1)(2008-12#5)(2012-2#1)
submucosal tumors##4##2##(1991-9#1)(1992-9#1)(2011-12#1)(2013-1#1)
submucosal##70##1##(1990-10#2)(1990-5#1)(1991-7#1)(1991-9#3)(1992-2#2)(1992-9#1)(1993-5#1)(1993-8#1)(1993-9#3)(1994-2#1)(1995-9#1)(1996-9#1)(1997-4#1)(2005-8#1)(2006-10#3)(2006-9#1)(2007-12#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-12#5)(2008-3#1)(2008-5#7)(2008-7#1)(2009-3#2)(2010-12#3)(2010-5#2)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#4)(2013-7#2)(2013-8#3)
submucosally invasive colorectal carcinomas##2##4##(2008-5#2)
submucous fibrosis and##4##3##(2009-6#1)(2013-1#2)(2013-8#1)
submucous fibrosis is##4##3##(2013-1#4)
submucous fibrosis##15##2##(1991-5#1)(1996-6#1)(2009-6#1)(2012-12#1)(2013-1#10)(2013-8#1)
submucous leiomyomas##4##2##(1991-2#4)
submucous##23##1##(1991-2#5)(1991-5#1)(1996-6#1)(1997-6#1)(2007-8#1)(2009-6#1)(2009-8#1)(2012-12#1)(2013-1#10)(2013-8#1)
subnail infections##2##2##(2006-12#2)
subnanometer uncertainty##2##2##(2008-2#1)(2008-3#1)
subnanometer##11##1##(2007-11#1)(2007-12#3)(2007-2#1)(2008-1#1)(2008-2#1)(2008-3#4)
subnanomolar range##3##2##(1994-9#1)(1996-5#1)(1996-8#1)
subnanomolar##10##1##(1994-9#1)(1995-2#1)(1995-5#1)(1996-5#2)(1996-8#1)(1997-1#2)(2005-6#1)(2008-10#1)
subnanosecond##8##1##(2006-10#1)(2007-12#4)(2008-2#1)(2008-3#2)
subnormal basal and stimulated##2##4##(2006-10#2)
subnormal in##3##2##(1990-2#1)(2006-5#1)(2009-5#1)
subnormal levels of##2##3##(1995-7#1)(2008-1#1)
subnormal##15##1##(1990-2#1)(1990-9#1)(1992-11#1)(1992-12#1)(1995-7#1)(2006-10#2)(2006-5#1)(2006-9#2)(2007-11#1)(2008-1#1)(2008-8#1)(2009-5#2)
subnuclear##2##1##(1992-12#1)(2011-12#1)
subnuclei of the##4##3##(1997-1#1)(1997-5#2)(2009-2#1)
subnuclei##12##1##(1992-1#1)(1993-12#1)(1993-7#1)(1995-7#3)(1997-1#1)(1997-5#3)(2009-2#1)(2010-12#1)
subnucleus of the##6##3##(1992-9#2)(1994-10#1)(1996-9#1)(1997-5#1)(2009-2#1)
subnucleus##13##1##(1991-8#2)(1992-9#2)(1994-10#1)(1994-2#1)(1995-5#2)(1996-9#1)(1997-5#2)(2009-2#2)
suboccipital craniectomy##3##2##(2006-12#1)(2008-5#1)(2013-1#1)
suboccipital craniotomy and##2##3##(2006-5#1)(2012-3#1)
suboccipital craniotomy##8##2##(2004-12#1)(2006-5#4)(2008-7#2)(2012-3#1)
suboccipital muscles##2##2##(2010-9#2)
suboccipital##22##1##(2004-12#4)(2006-12#2)(2006-5#4)(2006-7#1)(2008-5#1)(2008-7#4)(2010-9#2)(2011-2#2)(2012-3#1)(2013-1#1)
suboesophageal##5##1##(2007-12#4)(2008-8#1)
suboptimal dietary##3##2##(2012-1#1)(2012-2#2)
suboptimal doses of 7##2##4##(1990-6#2)
suboptimal doses of##3##3##(1990-6#2)(1996-10#1)
suboptimal for growth##2##3##(2008-10#1)(2008-5#1)
suboptimal in##2##2##(2007-9#1)(2009-12#1)
suboptimal intake##2##2##(2008-5#1)(2012-2#1)
suboptimal treatment##2##2##(2008-6#1)(2008-8#1)
suboptimal##81##1##(1990-10#1)(1990-3#1)(1990-6#2)(1991-6#1)(1994-2#1)(1995-4#1)(1996-10#1)(1997-4#1)(2004-12#1)(2004-9#2)(2005-10#1)(2005-7#1)(2006-10#2)(2006-9#1)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#3)(2008-2#4)(2008-3#7)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2009-1#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#2)(2009-8#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#6)(2013-8#1)
suboptimally##2##1##(2008-3#1)(2008-4#1)
suborder##8##1##(1993-3#1)(1996-12#1)(2008-7#1)(2010-3#1)(2011-2#2)(2012-12#1)(2013-7#1)
subordinate male##3##2##(1992-1#1)(2008-8#2)
subordinate to##5##2##(1990-3#1)(1996-11#1)(2008-11#1)(2008-8#1)(2013-1#1)
subordinate##29##1##(1990-3#1)(1992-1#2)(1996-11#1)(1997-5#3)(2006-2#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-6#1)(2008-8#8)(2008-9#1)(2010-8#3)(2013-1#2)(2013-8#2)
subordinated to##2##2##(1990-12#1)(2011-7#1)
subordinates and##3##2##(2008-8#3)
subordinates##20##1##(1992-1#2)(2007-8#1)(2008-8#9)(2010-8#8)
subordination##4##1##(1997-5#2)(2013-1#2)
subpattern##2##1##(2008-3#2)
subpatterns##2##1##(2008-3#2)
subperiderm cells##2##2##(2007-9#2)
subperiderm or subsheath cells##2##4##(2007-9#2)
subperiderm##5##1##(2007-9#5)
subperiosteal abscess and##2##3##(2011-1#1)(2012-8#1)
subperiosteal##8##1##(1991-11#1)(2008-4#1)(2008-8#1)(2009-3#2)(2011-1#1)(2011-2#1)(2012-8#1)
subperitoneal space##3##2##(2008-1#3)
subphase at##2##2##(1995-8#1)(2009-7#1)
subphase of##2##2##(1990-4#1)(2012-2#1)
subphase##29##1##(1990-4#1)(1991-3#1)(1992-12#1)(1992-6#1)(1994-3#3)(1994-5#1)(1994-6#1)(1995-8#2)(1996-8#2)(1997-2#2)(2005-11#9)(2007-9#2)(2009-7#2)(2012-2#1)
subphases##6##1##(1990-2#2)(2005-11#3)(2012-2#1)
subphrenic abscess##3##2##(1992-10#1)(2007-8#1)(2010-12#1)
subphrenic##4##1##(1992-10#1)(2007-8#1)(2010-12#2)
subpial##3##1##(1992-1#1)(1997-3#1)(2008-7#1)
subpicosecond laser pulses##2##3##(2008-2#1)(2008-3#1)
subpicosecond laser##3##2##(2008-2#1)(2008-3#2)
subpicosecond optical##2##2##(2007-12#2)
subpicosecond pulses##4##2##(2007-11#2)(2007-12#2)
subpicosecond terahertz##2##2##(2007-11#2)
subpicosecond ultraviolet laser##2##3##(2007-12#1)(2008-1#1)
subpicosecond##27##1##(1996-2#1)(1997-4#1)(2006-3#1)(2007-11#5)(2007-12#13)(2008-1#2)(2008-2#1)(2008-3#2)(2009-4#1)
subpixel##5##1##(2008-2#4)(2008-3#1)
subplasmalemmal##3##1##(1991-11#1)(1996-1#2)
subpleural##11##1##(1991-6#1)(2005-8#1)(2006-10#2)(2007-8#1)(2008-1#4)(2010-12#2)
subplots##7##1##(2008-10#3)(2008-12#3)(2008-9#1)
subpopulation (clusters##2##2##(2008-10#2)
subpopulation data##2##2##(2008-12#1)(2010-2#1)
subpopulation of cells##3##3##(1994-3#1)(2008-7#2)
subpopulation of neuronal perikarya##2##4##(1991-12#1)(1997-7#1)
subpopulation of neuronal##3##3##(1991-12#1)(1995-12#1)(1997-7#1)
subpopulation of neurons##2##3##(1995-7#1)(2009-8#1)
subpopulation of patients##6##3##(2005-10#1)(2006-7#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
subpopulation of the##4##3##(1992-7#1)(1992-8#1)(1994-2#1)(2008-10#1)
subpopulation of##65##2##(1990-6#1)(1991-12#3)(1991-8#1)(1992-3#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-12#1)(1993-7#1)(1994-2#3)(1994-3#2)(1995-11#4)(1995-12#2)(1995-5#1)(1995-7#1)(1995-8#1)(1996-3#1)(1997-3#2)(1997-6#1)(1997-7#2)(2005-10#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#3)(2009-8#1)(2010-5#1)(2011-2#3)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#2)
subpopulation that can be##2##4##(2006-10#1)(2011-2#1)
subpopulation that##5##2##(2006-10#1)(2008-4#1)(2010-11#1)(2011-2#2)
subpopulation##123##1##(1990-12#1)(1990-6#1)(1991-12#4)(1991-8#1)(1992-3#1)(1992-7#2)(1992-8#3)(1992-9#1)(1993-12#1)(1993-5#1)(1993-7#2)(1994-2#4)(1994-3#3)(1995-11#4)(1995-12#2)(1995-5#1)(1995-7#1)(1995-8#1)(1996-3#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#4)(2005-10#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-6#2)(2007-9#1)(2008-10#21)(2008-11#6)(2008-12#2)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#1)(2009-4#3)(2009-8#1)(2010-11#1)(2010-2#2)(2010-5#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#10)(2012-2#3)(2012-3#2)(2013-1#3)
subpopulations after##2##2##(1994-6#1)(2010-2#1)
subpopulations and##7##2##(1990-12#1)(1990-6#1)(1991-5#1)(1997-7#1)(2008-10#2)(2008-9#1)
subpopulations are##2##2##(2007-12#1)(2008-10#1)
subpopulations based on##2##3##(2008-10#1)(2008-4#1)
subpopulations because##2##2##(2011-2#1)(2013-7#1)
subpopulations but not##2##3##(1994-10#1)(2009-12#1)
subpopulations by##2##2##(1993-4#1)(2010-2#1)
subpopulations for##2##2##(1990-10#1)(2008-10#1)
subpopulations from##6##2##(2008-10#2)(2008-11#1)(2008-4#1)(2011-2#2)
subpopulations have been##2##3##(2008-7#1)(2013-1#1)
subpopulations have##3##2##(2008-7#2)(2013-1#1)
subpopulations in the##5##3##(2008-10#3)(2008-4#1)(2013-1#1)
subpopulations in##18##2##(1995-12#1)(1996-9#1)(2008-10#8)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#2)(2010-11#1)(2013-1#1)
subpopulations of cells that##2##4##(1994-8#1)(2008-4#1)
subpopulations of cells##4##3##(1994-8#1)(1997-4#1)(2008-4#1)(2010-6#1)
subpopulations of lymphocytes in##2##4##(2008-11#1)(2008-5#1)
subpopulations of lymphocytes##4##3##(1992-10#1)(2006-1#1)(2008-11#1)(2008-5#1)
subpopulations of neurons##2##3##(1995-8#1)(1997-3#1)
subpopulations of the##4##3##(1991-12#1)(2008-10#2)(2010-10#1)
subpopulations of##43##2##(1990-12#2)(1991-12#1)(1991-8#1)(1992-10#1)(1993-8#1)(1994-10#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-3#4)(1997-3#1)(1997-4#1)(1997-5#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-4#2)(2008-5#1)(2008-6#1)(2009-8#1)(2010-10#1)(2010-6#1)
subpopulations using the##2##3##(2008-4#2)
subpopulations using##3##2##(2008-4#2)(2008-9#1)
subpopulations were##9##2##(2008-10#5)(2008-11#1)(2008-4#1)(2008-9#1)(2012-2#1)
subpopulations which##2##2##(1990-12#1)(2012-12#1)
subpopulations with##2##2##(2008-11#1)(2008-4#1)
subpopulations within##4##2##(2008-10#4)
subpopulations##199##1##(1990-10#2)(1990-12#4)(1990-6#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-9#1)(1993-12#1)(1993-4#2)(1993-8#1)(1994-10#2)(1994-5#2)(1994-6#2)(1994-8#2)(1995-10#1)(1995-11#1)(1995-12#8)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-3#4)(1996-5#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(2005-10#2)(2005-7#1)(2006-1#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#60)(2008-11#9)(2008-4#17)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#7)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#1)
subproducts##2##1##(2008-5#2)
subproteome of##2##2##(2012-3#1)(2013-1#1)
subproteome##3##1##(2009-6#1)(2012-3#1)(2013-1#1)
subpulmonary infundibulum##2##2##(2007-8#2)
subpupil forms##3##2##(2008-3#3)
subrange of##2##2##(2008-2#1)(2008-3#1)
subregion##3##1##(2008-3#1)(2008-5#1)(2008-8#1)
subregional##4##1##(1995-5#2)(2011-2#1)(2013-1#1)
subregions of the##3##3##(1996-6#1)(2008-7#1)(2009-1#1)
subregions of##6##2##(1994-12#1)(1996-6#1)(2007-8#1)(2008-2#1)(2008-7#1)(2009-1#1)
subregions##18##1##(1993-12#1)(1994-12#1)(1994-2#1)(1996-12#1)(1996-6#1)(2007-8#1)(2008-2#1)(2008-3#4)(2008-7#1)(2008-8#2)(2009-1#1)(2010-12#1)(2010-2#1)(2012-1#1)
subregistry##2##1##(2006-12#2)
subretinal electrical stimulation##2##3##(1997-3#2)
subretinal fluid##2##2##(2011-7#1)(2013-8#1)
subretinal space##9##2##(1997-3#3)(2008-3#5)(2008-4#1)
subretinal##16##1##(1997-3#5)(2008-3#5)(2008-4#2)(2011-7#3)(2013-8#1)
subring cavity##2##2##(2007-12#2)
subsample of 423 patients##2##4##(1997-3#2)
subsample of these##3##3##(2006-10#1)(2011-1#1)(2013-8#1)
subsample of##14##2##(1993-12#1)(1997-3#2)(2005-8#1)(2006-10#1)(2008-10#2)(2008-4#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
subsample##21##1##(1993-12#1)(1993-6#1)(1996-3#1)(1997-3#2)(2005-8#1)(2006-10#1)(2008-10#3)(2008-4#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
subsamples of##4##2##(2007-5#1)(2008-10#1)(2010-12#1)(2012-12#1)
subsamples were##2##2##(2004-11#1)(2008-10#1)
subsamples##15##1##(2004-11#1)(2006-3#1)(2007-5#1)(2008-10#3)(2009-12#1)(2010-12#1)(2012-12#3)(2012-3#1)(2013-7#3)
subsampling##4##1##(2007-3#2)(2008-10#1)(2010-2#1)
subsarcolemmal##4##1##(1995-12#1)(1996-1#1)(2005-12#1)(2009-7#1)
subsaturating##3##1##(1992-6#1)(1995-1#1)(1996-9#1)
subscale score##2##2##(2006-12#1)(2008-7#1)
subscale scores were##3##3##(2007-12#3)
subscale##31##1##(2004-11#1)(2004-3#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-12#7)(2008-1#1)(2008-12#1)(2008-7#1)(2008-8#3)(2009-12#1)(2009-9#1)(2010-6#1)(2010-8#2)(2012-1#1)(2012-2#5)(2013-1#1)
subscales and##5##2##(2006-3#2)(2007-12#1)(2008-11#1)(2010-6#1)
subscales are##2##2##(2007-12#1)(2009-1#1)
subscales correlated with##2##3##(2007-10#2)
subscales in##2##2##(2006-8#1)(2007-12#1)
subscales of the##8##3##(2006-7#1)(2007-12#1)(2007-5#1)(2008-10#2)(2009-4#1)(2010-7#1)(2012-2#1)
subscales of##12##2##(2006-4#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-5#2)(2008-10#2)(2009-4#1)(2010-7#1)(2011-1#1)(2012-2#1)
subscales were##4##2##(2006-7#1)(2007-12#1)(2008-7#1)(2013-7#1)
subscales within##2##2##(2006-7#1)(2008-7#1)
subscales##63##1##(1994-6#1)(2006-12#3)(2006-3#2)(2006-4#1)(2006-7#3)(2006-8#1)(2007-10#2)(2007-12#13)(2007-2#2)(2007-5#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#4)(2008-8#1)(2009-1#2)(2009-4#5)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#2)(2010-6#1)(2010-7#1)(2011-1#3)(2012-2#5)(2013-7#1)
subscapular artery##2##2##(2008-7#2)
subscapular region##3##2##(2006-10#3)
subscapular##8##1##(2006-10#4)(2007-9#1)(2008-7#3)
subscapularis and infraspinatus##3##3##(2009-9#1)(2012-12#2)
subscapularis##6##1##(2009-9#2)(2012-12#3)(2013-1#1)
subscore##2##1##(2008-7#1)(2009-10#1)
subscores##3##1##(1997-8#1)(2007-2#1)(2008-7#1)
subscribe to##4##2##(1995-12#1)(2007-12#1)(2013-1#2)
subscribe##5##1##(1995-12#1)(2006-1#1)(2007-12#1)(2013-1#2)
subscriber##5##1##(1994-12#2)(1996-3#1)(2006-8#1)(2011-3#1)
subscribers##6##1##(1994-1#2)(1997-1#1)(2005-7#2)(2007-4#1)
subscription##4##1##(1991-12#2)(2013-1#2)
subscripts##4##1##(2007-3#1)(2008-10#1)(2008-3#2)
subseafloor##2##1##(2012-2#2)
subsegmental pulmonary embolism##2##3##(2005-10#2)
subsegmental##3##1##(2005-10#2)(2010-8#1)
subsensitivity of striatal##2##3##(1995-12#2)
subsensitivity of##5##2##(1991-8#2)(1995-12#3)
subsensitivity##9##1##(1991-8#4)(1992-11#1)(1995-11#1)(1995-12#3)
subsequent 1##2##2##(2008-7#1)(2010-8#1)
subsequent 3##2##2##(2008-10#1)(2012-2#1)
subsequent CT##2##2##(1994-2#1)(2012-3#1)
subsequent DHAA reduction##2##3##(1993-3#2)
subsequent IV analyses##2##3##(2012-12#2)
subsequent SOM##2##2##(1995-2#2)
subsequent ability##2##2##(1990-9#1)(2009-3#1)
subsequent action##3##2##(1990-7#1)(1991-3#1)(1992-2#1)
subsequent activation of##4##3##(2005-7#1)(2007-11#1)(2009-8#1)(2012-2#1)
subsequent activation##5##2##(1994-6#1)(2005-7#1)(2007-11#1)(2009-8#1)(2012-2#1)
subsequent acute##5##2##(2008-7#1)(2009-9#1)(2010-8#1)(2012-1#1)(2012-2#1)
subsequent addition of##4##3##(1990-3#1)(1991-1#1)(1991-6#1)(1994-2#1)
subsequent administration of GCV##2##4##(2007-3#2)
subsequent administration of##9##3##(1992-5#1)(1992-7#1)(1993-8#1)(1995-2#1)(1997-5#1)(1997-6#1)(2007-3#2)(2007-7#1)
subsequent aerobic##2##2##(2007-6#1)(2010-4#1)
subsequent age group##2##3##(1991-6#2)
subsequent age##3##2##(1990-6#1)(1991-6#2)
subsequent amelioration of##2##3##(2008-1#1)(2008-4#1)
subsequent analyses##4##2##(1996-7#1)(2007-12#1)(2008-4#1)(2012-11#1)
subsequent analysis and##2##3##(2006-8#1)(2008-2#1)
subsequent analysis of##7##3##(2008-10#1)(2008-2#2)(2008-7#1)(2008-9#1)(2013-1#2)
subsequent analysis##21##2##(1990-9#1)(2006-8#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-4#4)(2008-7#1)(2008-9#3)(2011-2#1)(2013-1#2)
subsequent application##2##2##(1992-4#1)(1995-2#1)
subsequent association with##3##3##(1994-12#2)(2012-2#1)
subsequent association##4##2##(1992-2#1)(1994-12#2)(2012-2#1)
subsequent atomic##2##2##(1992-7#1)(2008-10#1)
subsequent attachment of##4##3##(1993-6#1)(1994-9#1)(2008-10#2)
subsequent binding of##6##3##(1991-1#1)(1991-2#1)(1993-11#1)(1994-9#1)(1995-1#1)(2010-1#1)
subsequent binding to##2##3##(1992-1#1)(1997-2#1)
subsequent binding##8##2##(1991-1#1)(1991-2#1)(1992-1#1)(1993-11#1)(1994-9#1)(1995-1#1)(1997-2#1)(2010-1#1)
subsequent biological activity##2##3##(1991-4#1)(2011-1#1)
subsequent blood##2##2##(1992-6#1)(2007-12#1)
subsequent bone##3##2##(2005-3#1)(2007-12#1)(2007-7#1)
subsequent cell##3##2##(1994-8#1)(1996-9#1)(2008-7#1)
subsequent challenge with##3##3##(1991-12#1)(1996-10#1)(2008-3#1)
subsequent challenge##6##2##(1991-12#1)(1996-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#1)
subsequent changes in##4##3##(1996-10#1)(2008-10#1)(2008-5#1)(2013-1#1)
subsequent changes##5##2##(1996-10#1)(2007-10#1)(2008-10#1)(2008-5#1)(2013-1#1)
subsequent characterization##2##2##(1991-10#1)(2008-3#1)
subsequent chemical##4##2##(1997-5#1)(2007-8#1)(2009-12#1)(2010-12#1)
subsequent chemiluminescence##2##2##(2007-8#1)(2008-10#1)
subsequent children##2##2##(2007-2#1)(2008-12#1)
subsequent chromium##4##2##(2007-10#2)(2008-10#2)
subsequent clinical course##2##3##(1990-6#1)(2007-12#1)
subsequent clinical##11##2##(1990-6#1)(1991-5#1)(2005-9#1)(2006-9#1)(2007-12#1)(2008-11#2)(2008-5#1)(2008-9#1)(2009-8#1)(2013-8#1)
subsequent comparison##2##2##(2007-5#1)(2010-8#1)
subsequent complex formation##2##3##(2008-10#2)
subsequent complications##3##2##(2007-10#1)(2008-7#1)(2012-12#1)
subsequent conditioned performance##2##3##(1993-12#2)
subsequent course and##2##3##(2006-12#1)(2006-3#1)
subsequent course##4##2##(1996-10#1)(2006-12#1)(2006-3#1)(2006-6#1)
subsequent day##2##2##(1994-8#1)(2010-3#1)
subsequent days##4##2##(1995-3#1)(1996-7#1)(2006-4#1)(2010-2#1)
subsequent decline##2##2##(1992-5#1)(2008-7#1)
subsequent decrease in the##4##4##(1995-12#1)(2007-9#1)(2008-10#1)(2009-6#1)
subsequent decrease in##6##3##(1992-2#1)(1995-12#1)(2007-9#1)(2008-10#1)(2009-6#1)(2012-3#1)
subsequent decrease##8##2##(1991-9#1)(1992-2#1)(1994-6#1)(1995-12#1)(2007-9#1)(2008-10#1)(2009-6#1)(2012-3#1)
subsequent degradation##3##2##(1994-9#1)(2007-5#1)(2008-8#1)
subsequent delivery##2##2##(2008-3#1)(2011-2#1)
subsequent destructive##2##2##(2008-5#1)(2011-1#1)
subsequent detection of##4##3##(2008-10#1)(2008-3#2)(2008-7#1)
subsequent detection##6##2##(2008-10#3)(2008-3#2)(2008-7#1)
subsequent determination by##5##3##(2008-10#5)
subsequent determination of##3##3##(2007-8#1)(2008-10#2)
subsequent determination##10##2##(2007-8#1)(2008-10#9)
subsequent development of colorectal##2##4##(1994-2#1)(2009-2#1)
subsequent development of##23##3##(1991-12#1)(1991-9#1)(1992-10#1)(1993-6#1)(1994-2#1)(1995-3#1)(1997-6#1)(1997-8#1)(2005-6#1)(2006-10#2)(2006-9#1)(2007-2#1)(2008-10#5)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-2#1)
subsequent development##29##2##(1991-12#1)(1991-9#1)(1992-10#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-3#1)(1997-6#1)(1997-8#1)(2005-6#1)(2006-10#2)(2006-5#1)(2006-9#1)(2007-2#1)(2008-10#5)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-2#1)(2012-12#2)
subsequent developmental##2##2##(1996-4#1)(2012-12#1)
subsequent discovery##3##2##(2005-9#1)(2008-11#1)(2008-8#1)
subsequent disease##5##2##(1990-3#1)(1996-7#1)(2008-10#1)(2008-6#1)(2008-8#1)
subsequent displacement##2##2##(1990-12#1)(2008-2#1)
subsequent drying##3##2##(1997-8#1)(2005-11#1)(2008-10#1)
subsequent effects##3##2##(1991-5#1)(2008-4#2)
subsequent elution of##4##3##(2008-10#4)
subsequent elution##6##2##(2007-8#1)(2008-10#5)
subsequent embryonic development##2##3##(2006-5#2)
subsequent embryonic##3##2##(1992-12#1)(2006-5#2)
subsequent establishment of##2##3##(1996-3#1)(2008-10#1)
subsequent evaluation##4##2##(2008-12#1)(2008-4#1)(2011-1#1)(2012-3#1)
subsequent events in##2##3##(1994-8#1)(2008-7#1)
subsequent events##3##2##(1994-8#1)(2008-7#2)
subsequent evolutionary##2##2##(2007-10#1)(2008-9#1)
subsequent examination##2##2##(1993-5#2)
subsequent exams##2##2##(1991-3#2)
subsequent experiments using##2##3##(1996-8#1)(2008-5#1)
subsequent experiments##8##2##(1990-9#1)(1996-8#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-2#2)(2012-3#1)
subsequent exposure to the##2##4##(1996-4#1)(2008-10#1)
subsequent exposure to##5##3##(1994-3#1)(1995-8#1)(1996-4#1)(2008-10#2)
subsequent expression of##3##3##(1992-3#1)(1994-3#1)(2008-10#1)
subsequent extension##2##2##(1997-2#1)(2008-4#1)
subsequent fermentation##3##2##(2007-12#3)
subsequent fibrosis##3##2##(1992-5#1)(2007-11#1)(2013-1#1)
subsequent formation of##3##3##(2006-11#1)(2007-3#1)(2008-8#1)
subsequent fractures##2##2##(1993-11#2)
subsequent gene##3##2##(2008-1#1)(2008-7#1)(2012-3#1)
subsequent generations##6##2##(1990-4#1)(1992-2#1)(2006-12#2)(2008-2#1)(2010-4#1)
subsequent germination##2##2##(2008-10#2)
subsequent growth of##3##3##(2008-1#1)(2011-1#1)(2013-1#1)
subsequent growth##5##2##(2008-1#1)(2010-7#1)(2010-8#1)(2011-1#1)(2013-1#1)
subsequent health##5##2##(1993-1#1)(2009-10#1)(2009-5#2)(2012-12#1)
subsequent hysterectomy##2##2##(1994-12#1)(2006-10#1)
subsequent identification of the##2##4##(2007-8#1)(2008-1#1)
subsequent identification of##4##3##(2007-8#1)(2008-1#1)(2008-4#1)(2010-2#1)
subsequent image##2##2##(2009-2#1)(2013-1#1)
subsequent immobilization##3##2##(1996-4#1)(2008-4#1)(2010-4#1)
subsequent immune##4##2##(2006-5#1)(2008-1#1)(2008-4#2)
subsequent implementation##3##2##(2013-1#2)(2013-7#1)
subsequent in##2##2##(2006-5#1)(2007-8#1)
subsequent inclusion##2##2##(2007-11#1)(2008-4#1)
subsequent increase in##8##3##(1991-12#1)(1992-11#1)(1993-4#1)(2007-11#1)(2008-5#1)(2010-7#1)(2012-2#1)(2013-7#1)
subsequent increase of##2##3##(1996-1#1)(2008-8#1)
subsequent increase##12##2##(1991-12#1)(1992-11#1)(1993-4#1)(1996-1#1)(1997-7#1)(2007-11#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-7#1)
subsequent incubation##3##2##(1992-6#2)(2013-1#1)
subsequent induction of##3##3##(1996-10#1)(1996-6#1)(2008-5#1)
subsequent infusions##2##2##(2007-11#1)(2012-12#1)
subsequent inhibition of the##2##4##(1993-6#1)(2010-12#1)
subsequent inhibition of##3##3##(1991-9#1)(1993-6#1)(2010-12#1)
subsequent injection##3##2##(2006-8#1)(2008-10#1)(2008-4#1)
subsequent injury##2##2##(1996-1#1)(2011-2#1)
subsequent intracellular##2##2##(1990-2#1)(2007-12#1)
subsequent invasive##2##2##(1993-9#1)(2010-1#1)
subsequent ischemic##2##2##(1994-11#1)(2007-10#1)
subsequent isolation of##3##3##(2008-10#1)(2008-2#1)(2008-9#1)
subsequent large##2##2##(2008-7#1)(2010-2#1)
subsequent leaching##2##2##(2008-10#1)(2008-11#1)
subsequent ligation##2##2##(1996-12#1)(1996-8#1)
subsequent liver##3##2##(1994-6#1)(2009-7#1)(2010-11#1)
subsequent localization##2##2##(2008-5#2)
subsequent maintenance of##3##3##(1996-12#1)(2006-10#1)(2008-10#1)
subsequent maintenance##4##2##(1996-12#1)(1997-3#1)(2006-10#1)(2008-10#1)
subsequent management of##5##3##(1994-5#1)(2005-8#1)(2006-12#2)(2007-12#1)
subsequent management##9##2##(1994-5#1)(2005-8#1)(2006-12#2)(2007-12#1)(2008-9#1)(2009-8#1)(2012-2#2)
subsequent measurement by##2##3##(2008-10#2)
subsequent measurement of##4##3##(2008-10#2)(2008-4#1)(2012-3#1)
subsequent measurement##6##2##(2008-10#4)(2008-4#1)(2012-3#1)
subsequent measurements##2##2##(2008-10#1)(2008-7#1)
subsequent medical##2##2##(1993-11#1)(2008-12#1)
subsequent membrane##2##2##(1993-11#1)(2008-11#1)
subsequent memory##2##2##(1993-12#1)(2013-1#1)
subsequent metabolism##2##2##(2004-11#1)(2011-2#1)
subsequent migration##2##2##(1996-5#1)(2007-7#1)
subsequent miscarriage##2##2##(1990-2#1)(1994-9#1)
subsequent monitoring of##2##3##(2008-1#1)(2008-9#1)
subsequent multiple##2##2##(1990-12#1)(2012-11#1)
subsequent negative##2##2##(2006-12#1)(2008-11#1)
subsequent nuclear##3##2##(1994-11#1)(1994-6#1)(2012-2#1)
subsequent occurrence of##2##3##(1993-9#1)(2012-12#1)
subsequent open##2##2##(2007-2#1)(2010-4#1)
subsequent oxidation of##3##3##(1996-2#2)(2008-10#1)
subsequent oxidation##7##2##(1996-2#2)(2007-8#1)(2008-10#3)(2012-12#1)
subsequent oxidative stress##2##3##(1991-9#1)(2008-11#1)
subsequent oxidative##3##2##(1991-9#1)(2008-10#1)(2008-11#1)
subsequent papers##2##2##(2008-10#2)
subsequent passage##2##2##(2008-3#1)(2010-3#1)
subsequent passages##2##2##(1992-9#1)(2011-3#1)
subsequent performance of##3##3##(1993-5#1)(2008-2#1)(2013-8#1)
subsequent performance##4##2##(1993-5#1)(1993-7#1)(2008-2#1)(2013-8#1)
subsequent pharmacokinetic##2##2##(1996-11#1)(2008-8#1)
subsequent phase##2##2##(1992-4#1)(2008-8#1)
subsequent potentiation##2##2##(1995-12#1)(1996-9#1)
subsequent precipitation##2##2##(2004-9#1)(2011-12#1)
subsequent pregnancies##8##2##(2004-10#1)(2006-9#1)(2007-11#1)(2007-2#1)(2008-11#1)(2011-2#1)(2012-1#1)(2012-2#1)
subsequent pregnancy and##2##3##(2007-2#1)(2012-2#1)
subsequent pregnancy##7##2##(2004-10#2)(2007-2#4)(2012-2#1)
subsequent preparation##2##2##(2007-6#1)(2008-8#1)
subsequent primary##2##2##(2011-2#1)(2013-7#1)
subsequent processes##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
subsequent production of nitric oxide##2##5##(1996-8#1)(2008-7#1)
subsequent production of##3##3##(1996-2#1)(1996-8#1)(2008-7#1)
subsequent pseudothecium##2##2##(2008-10#2)
subsequent purification of##2##3##(1992-2#1)(1995-8#1)
subsequent purification##4##2##(1990-9#1)(1992-2#1)(1994-12#1)(1995-8#1)
subsequent rapid##2##2##(2008-10#2)
subsequent rate##2##2##(1990-11#2)
subsequent reaction with##4##3##(2007-11#1)(2008-10#3)
subsequent reaction##9##2##(1991-11#1)(1992-8#1)(1993-3#1)(2007-11#1)(2008-10#5)
subsequent reactions of the##2##4##(1991-3#1)(2007-11#1)
subsequent reactions with##2##3##(2007-11#2)
subsequent reactions##7##2##(1991-3#1)(1992-5#1)(1997-4#1)(2007-11#3)(2008-10#1)
subsequent reconstruction##2##2##(2007-12#1)(2010-6#1)
subsequent recurrence##2##2##(2006-11#1)(2007-8#1)
subsequent reduction in##2##3##(2008-1#1)(2008-11#1)
subsequent reduction##5##2##(1993-11#1)(2007-11#1)(2008-1#1)(2008-11#1)(2011-1#1)
subsequent relapses##2##2##(2010-11#1)(2011-2#1)
subsequent release of##8##3##(1991-5#1)(1992-7#1)(1995-3#1)(1995-5#1)(2006-6#1)(2008-11#2)(2012-2#1)
subsequent release##10##2##(1991-5#1)(1991-9#1)(1992-7#1)(1995-3#1)(1995-5#1)(1997-4#1)(2006-6#1)(2008-11#2)(2012-2#1)
subsequent removal of##2##3##(2009-10#1)(2010-12#1)
subsequent removal##4##2##(2007-8#1)(2008-2#1)(2009-10#1)(2010-12#1)
subsequent repair##2##2##(2006-8#1)(2012-12#1)
subsequent response##4##2##(1991-9#1)(2006-10#1)(2007-12#1)(2012-2#1)
subsequent rise in##2##3##(1997-3#1)(2006-9#1)
subsequent rise##3##2##(1996-5#1)(1997-3#1)(2006-9#1)
subsequent risk##2##2##(2008-11#1)(2010-4#1)
subsequent scanning##2##2##(2006-12#1)(2008-5#1)
subsequent screening##2##2##(2008-10#1)(2008-4#1)
subsequent secretion##3##2##(1994-11#1)(2006-12#1)(2012-2#1)
subsequent seizures##2##2##(1991-8#1)(1997-5#1)
subsequent sequencing##2##2##(1991-9#1)(2011-2#1)
subsequent space use##2##3##(2008-9#2)
subsequent spread##2##2##(2005-8#1)(2011-1#1)
subsequent stages##2##2##(2007-5#1)(2008-12#1)
subsequent staining##2##2##(1995-12#1)(2008-2#1)
subsequent steps of##4##3##(1992-11#1)(1995-3#1)(2008-10#1)(2009-3#1)
subsequent steps##7##2##(1991-12#1)(1992-11#1)(1992-5#1)(1995-3#1)(1997-1#1)(2008-10#1)(2009-3#1)
subsequent stimulation##3##2##(1993-3#1)(1994-12#1)(2011-2#1)
subsequent stroke##6##2##(1995-9#1)(2006-11#2)(2007-10#3)
subsequent studies##3##2##(2004-10#1)(2008-8#1)(2012-12#1)
subsequent study##4##2##(1996-4#1)(2008-8#1)(2008-9#1)(2009-8#1)
subsequent successful##3##2##(1996-1#1)(2007-8#1)(2008-9#1)
subsequent surgery##5##2##(2006-2#1)(2007-5#1)(2008-9#1)(2012-2#1)(2013-1#1)
subsequent surgical##3##2##(2007-11#1)(2007-5#1)(2012-12#1)
subsequent survey##2##2##(2008-11#1)(2013-1#1)
subsequent survival##2##2##(2008-6#2)
subsequent switch effects##3##3##(2012-3#3)
subsequent synthesis of##2##3##(1995-3#1)(2008-6#1)
subsequent systemic##2##2##(2009-10#1)(2011-2#1)
subsequent time points##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
subsequent to a##2##3##(1991-6#1)(1994-2#1)
subsequent to activation##2##3##(1991-8#1)(1994-2#1)
subsequent to its##2##3##(1992-12#1)(1994-3#1)
subsequent to the##13##3##(1990-5#1)(1993-6#1)(1994-4#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-2#1)(2008-11#1)(2008-5#1)
subsequent to##52##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-6#2)(1997-8#1)(2004-9#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2009-3#1)(2010-11#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-2#1)(2013-7#1)
subsequent toxicity##2##2##(1993-12#1)(2007-11#1)
subsequent treatment outcomes##2##3##(2009-3#2)
subsequent treatment##18##2##(1990-8#1)(1992-12#1)(2004-12#1)(2005-6#1)(2005-8#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-3#2)(2010-11#1)(2010-12#1)(2010-6#1)(2012-12#1)(2012-2#1)
subsequent use in##3##3##(2006-12#1)(2008-4#1)(2009-5#1)
subsequent use##7##2##(1994-12#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-5#1)(2011-1#1)
subsequent validation##2##2##(2006-5#1)(2008-4#1)
subsequent viability##2##2##(2005-8#2)
subsequent washout##2##2##(1993-6#1)(2007-10#1)
subsequent waves##2##2##(2010-11#1)(2012-3#1)
subsequent years##5##2##(2008-10#3)(2010-2#1)(2011-2#1)
subsequent##1565##1##(1990-11#6)(1990-12#8)(1990-2#5)(1990-3#6)(1990-4#2)(1990-5#4)(1990-6#3)(1990-7#2)(1990-8#2)(1990-9#9)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#7)(1991-2#5)(1991-3#5)(1991-4#1)(1991-5#6)(1991-6#4)(1991-7#4)(1991-8#5)(1991-9#14)(1992-1#4)(1992-10#6)(1992-11#5)(1992-12#9)(1992-2#7)(1992-3#5)(1992-4#6)(1992-5#7)(1992-6#7)(1992-7#4)(1992-8#2)(1992-9#4)(1993-1#1)(1993-11#10)(1993-12#8)(1993-2#3)(1993-3#8)(1993-4#1)(1993-5#5)(1993-6#8)(1993-7#3)(1993-8#2)(1993-9#6)(1994-11#8)(1994-12#9)(1994-2#14)(1994-3#4)(1994-4#1)(1994-5#3)(1994-6#7)(1994-8#7)(1994-9#6)(1995-1#4)(1995-10#2)(1995-11#3)(1995-12#4)(1995-2#13)(1995-3#13)(1995-5#4)(1995-6#6)(1995-8#3)(1995-9#5)(1996-1#9)(1996-10#6)(1996-11#3)(1996-12#4)(1996-2#9)(1996-3#3)(1996-4#10)(1996-5#8)(1996-6#6)(1996-7#9)(1996-8#6)(1996-9#7)(1997-1#5)(1997-2#6)(1997-3#2)(1997-4#3)(1997-5#4)(1997-6#7)(1997-7#4)(1997-8#9)(2003-11#1)(2004-1#2)(2004-10#5)(2004-11#3)(2004-12#2)(2004-2#1)(2004-9#4)(2005-1#1)(2005-10#5)(2005-11#6)(2005-12#1)(2005-3#1)(2005-6#3)(2005-7#3)(2005-8#5)(2005-9#3)(2006-1#1)(2006-10#25)(2006-11#6)(2006-12#14)(2006-2#5)(2006-3#2)(2006-4#4)(2006-5#14)(2006-6#6)(2006-7#3)(2006-8#7)(2006-9#8)(2007-1#2)(2007-10#18)(2007-11#45)(2007-12#25)(2007-2#12)(2007-3#5)(2007-4#4)(2007-5#9)(2007-6#4)(2007-7#10)(2007-8#27)(2007-9#4)(2008-1#17)(2008-10#170)(2008-11#30)(2008-12#12)(2008-2#26)(2008-3#24)(2008-4#41)(2008-5#27)(2008-6#16)(2008-7#37)(2008-8#23)(2008-9#28)(2009-10#9)(2009-11#3)(2009-12#3)(2009-2#2)(2009-3#6)(2009-4#5)(2009-5#4)(2009-6#4)(2009-7#7)(2009-8#9)(2009-9#3)(2010-1#5)(2010-10#3)(2010-11#5)(2010-12#11)(2010-2#14)(2010-3#5)(2010-4#13)(2010-5#4)(2010-6#5)(2010-7#4)(2010-8#7)(2010-9#3)(2011-1#16)(2011-12#7)(2011-2#33)(2011-3#1)(2012-1#8)(2012-11#3)(2012-12#31)(2012-2#36)(2012-3#23)(2013-1#35)(2013-7#6)(2013-8#15)
subsequently a##3##2##(1990-12#1)(1994-12#1)(2013-8#1)
subsequently achieved##3##2##(1993-7#1)(2008-8#1)(2012-2#1)
subsequently amplified##2##2##(1990-4#1)(2008-11#1)
subsequently analysed by##4##3##(1993-9#1)(2007-1#1)(2008-10#1)(2008-11#1)
subsequently analysed##5##2##(1993-9#1)(2006-10#1)(2007-1#1)(2008-10#1)(2008-11#1)
subsequently analyzed##5##2##(1996-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-1#1)
subsequently applied to##4##3##(2006-11#1)(2011-1#2)(2012-12#1)
subsequently are##2##2##(2008-10#1)(2009-5#1)
subsequently assessed##3##2##(1994-3#1)(2007-6#1)(2013-8#1)
subsequently be used##2##3##(1994-6#1)(2009-2#1)
subsequently be##6##2##(1990-12#1)(1994-6#1)(2008-10#1)(2009-2#1)(2010-5#1)(2013-8#1)
subsequently became infected##2##3##(2006-10#1)(2008-10#1)
subsequently became##3##2##(2006-10#1)(2008-10#1)(2010-1#1)
subsequently been##9##2##(1990-11#1)(1994-6#1)(1995-8#1)(2008-3#2)(2008-7#1)(2010-12#2)(2011-2#1)
subsequently by##2##2##(2008-11#1)(2009-11#1)
subsequently characterized##2##2##(2008-3#2)
subsequently cleaved##2##2##(1990-2#1)(1997-4#1)
subsequently cloned##2##2##(1993-6#1)(1996-6#1)
subsequently compared to the##2##4##(2008-5#1)(2010-8#1)
subsequently compared##3##2##(2008-5#1)(2010-8#1)(2012-1#1)
subsequently confirmed by##4##3##(1993-11#1)(1994-7#1)(2008-7#1)(2010-4#1)
subsequently confirmed##7##2##(1993-11#1)(1994-7#1)(2008-12#1)(2008-7#1)(2010-4#1)(2012-3#1)(2013-7#1)
subsequently declined##2##2##(1992-11#1)(1994-11#1)
subsequently decreased##3##2##(2007-7#1)(2008-10#1)(2010-4#1)
subsequently degraded##3##2##(1990-12#1)(1991-3#1)(1995-3#1)
subsequently delivered##2##2##(1994-3#1)(2008-10#1)
subsequently detected##3##2##(1994-5#1)(2007-12#1)(2008-10#1)
subsequently determined by##3##3##(2007-8#1)(2008-10#2)
subsequently determined with##2##3##(2008-10#2)
subsequently determined##7##2##(2007-8#2)(2008-10#5)
subsequently develop##3##2##(2005-9#1)(2010-6#1)(2012-1#1)
subsequently developed the##2##3##(1993-11#1)(2008-7#1)
subsequently developed##15##2##(1993-11#1)(1995-2#1)(2006-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-6#1)(2008-7#2)(2011-2#2)(2012-2#1)(2013-1#1)
subsequently diagnosed with##2##3##(1993-2#1)(2004-2#1)
subsequently diagnosed##6##2##(1993-2#1)(1996-12#1)(2004-2#1)(2006-4#1)(2007-7#1)(2013-1#1)
subsequently died##3##2##(1994-3#1)(2006-10#1)(2007-2#1)
subsequently discovered##2##2##(2010-3#1)(2012-3#1)
subsequently dispersed in##2##3##(2009-7#1)(2010-3#1)
subsequently eluted with##7##3##(2006-12#1)(2008-10#6)
subsequently eluted##8##2##(2006-12#1)(2008-10#7)
subsequently evaluated in##3##3##(1996-2#1)(2011-2#1)(2013-1#1)
subsequently evaluated##4##2##(1996-2#1)(2010-12#1)(2011-2#1)(2013-1#1)
subsequently examined##3##2##(1995-6#1)(1997-3#1)(2009-2#1)
subsequently excluded##2##2##(1997-4#1)(2005-10#1)
subsequently exposed##2##2##(2008-10#1)(2008-3#1)
subsequently followed##2##2##(2007-3#1)(2012-12#1)
subsequently forms##2##2##(2008-10#1)(2008-11#1)
subsequently found to have##4##4##(2005-9#1)(2006-10#1)(2008-7#1)(2012-2#1)
subsequently found to##5##3##(2005-12#1)(2005-9#1)(2006-10#1)(2008-7#1)(2012-2#1)
subsequently genotyped##3##2##(2008-7#1)(2010-12#1)(2012-1#1)
subsequently had an##2##3##(2009-3#1)(2009-6#1)
subsequently had##4##2##(1995-8#1)(2007-8#1)(2009-3#1)(2009-6#1)
subsequently identified##5##2##(1991-3#1)(1993-9#1)(1996-3#1)(2008-6#1)(2009-8#1)
subsequently increase##2##2##(1993-11#1)(2008-8#1)
subsequently incubated##3##2##(1992-6#1)(2008-4#1)(2011-12#1)
subsequently integrated##2##2##(2006-12#1)(2007-8#1)
subsequently introduced##4##2##(1990-5#1)(2007-8#1)(2008-10#1)(2012-1#1)
subsequently investigated##4##2##(1996-9#1)(1997-4#1)(2010-4#1)(2010-5#1)
subsequently lead to##4##3##(1990-8#1)(1996-9#1)(2007-9#1)(2010-12#1)
subsequently led to##2##3##(2007-2#1)(2011-2#1)
subsequently lost##2##2##(1993-9#1)(1996-11#1)
subsequently managed##2##2##(2006-10#1)(2013-1#1)
subsequently measured##6##2##(1991-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-9#1)
subsequently modified by##2##3##(1997-2#1)(2008-10#1)
subsequently observed##7##2##(1990-5#1)(1992-3#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-12#1)(2008-9#1)
subsequently oxidized##2##2##(2008-4#1)(2010-8#1)
subsequently placed##2##2##(2008-11#1)(2011-2#1)
subsequently presented##3##2##(1996-6#1)(2008-8#1)(2009-8#1)
subsequently purified##3##2##(1991-4#1)(1993-8#1)(1996-5#1)
subsequently rapidly##2##2##(1993-8#1)(2007-10#1)
subsequently received##4##2##(1993-6#1)(1994-12#1)(2007-6#1)(2010-1#1)
subsequently recognized##2##2##(2008-10#1)(2008-5#1)
subsequently reduced to##2##3##(2007-11#1)(2007-12#1)
subsequently reduced##4##2##(1995-12#1)(2007-11#1)(2007-12#1)(2008-12#1)
subsequently released##2##2##(2008-10#1)(2011-2#1)
subsequently removed##2##2##(2007-8#1)(2010-1#1)
subsequently retained##2##2##(2007-8#1)(2013-1#1)
subsequently screened##4##2##(1992-4#1)(2004-2#1)(2008-7#1)(2010-2#1)
subsequently secreted##2##2##(2008-8#1)(2012-2#1)
subsequently separated on##2##3##(1996-5#1)(2008-10#1)
subsequently separated##5##2##(1996-5#2)(1997-5#1)(2008-10#2)
subsequently shown to##5##3##(1990-10#1)(1991-2#1)(1996-10#1)(2008-10#1)(2008-7#1)
subsequently shown##6##2##(1990-10#1)(1991-2#1)(1992-6#1)(1996-10#1)(2008-10#1)(2008-7#1)
subsequently stimulated by##2##3##(1990-3#1)(1991-7#1)
subsequently stimulated##3##2##(1990-3#1)(1991-12#1)(1991-7#1)
subsequently subjected to##3##3##(2007-8#1)(2008-10#1)(2013-1#1)
subsequently tested##8##2##(1991-2#1)(1991-7#1)(1994-2#1)(2008-10#1)(2008-5#1)(2010-4#2)(2013-8#1)
subsequently the##11##2##(1992-12#1)(1993-11#1)(1996-9#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-6#1)(2012-1#1)(2012-2#1)
subsequently to the##2##3##(2008-2#1)(2009-12#1)
subsequently to##12##2##(1990-12#1)(1990-3#1)(1991-8#1)(1991-9#1)(2006-11#1)(2007-7#1)(2007-9#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-10#1)
subsequently treated with##12##3##(1990-4#1)(1991-10#1)(1991-9#1)(1993-6#1)(1993-8#1)(1994-2#1)(1995-1#1)(2006-1#1)(2008-10#1)(2008-11#2)(2010-7#1)
subsequently treated##14##2##(1990-4#1)(1991-10#1)(1991-9#1)(1993-6#1)(1993-8#2)(1994-2#1)(1995-1#1)(2006-1#1)(2008-10#2)(2008-11#2)(2010-7#1)
subsequently undergo##3##2##(1995-3#1)(1996-5#1)(2008-10#1)
subsequently underwent a##3##3##(1994-12#1)(2008-6#1)(2008-9#1)
subsequently underwent##13##2##(1992-8#1)(1994-12#1)(1995-11#1)(2005-5#1)(2007-5#1)(2008-6#2)(2008-9#2)(2013-1#4)
subsequently used for the##2##4##(1996-5#1)(2006-12#1)
subsequently used for##4##3##(1995-2#1)(1996-5#1)(2006-12#1)(2007-9#1)
subsequently used in##3##3##(1997-7#1)(2008-3#1)(2008-8#1)
subsequently used to##5##3##(1996-2#1)(2006-6#1)(2008-10#2)(2008-2#1)
subsequently used##14##2##(1993-3#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-7#1)(2006-12#1)(2006-6#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2010-6#1)
subsequently validated##3##2##(2008-10#1)(2010-2#1)(2012-2#1)
subsequently was##5##2##(1995-5#1)(1996-8#1)(2006-10#1)(2008-10#1)(2013-1#1)
subsequently were##2##2##(2008-10#1)(2012-12#1)
subsequently with##5##2##(1990-9#1)(1994-10#1)(2008-10#3)
subsequently##657##1##(1990-10#2)(1990-11#3)(1990-12#4)(1990-2#1)(1990-3#3)(1990-4#2)(1990-5#3)(1990-6#1)(1990-8#1)(1990-9#2)(1991-10#3)(1991-11#1)(1991-12#1)(1991-2#6)(1991-3#3)(1991-4#1)(1991-7#4)(1991-8#3)(1991-9#4)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-8#4)(1993-11#7)(1993-12#2)(1993-2#2)(1993-3#3)(1993-6#4)(1993-7#2)(1993-8#4)(1993-9#6)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#5)(1994-3#5)(1994-5#3)(1994-6#4)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#5)(1995-5#2)(1995-6#2)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#4)(1996-3#2)(1996-5#5)(1996-6#2)(1996-8#2)(1996-9#4)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-10#1)(2004-12#1)(2004-2#2)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#5)(2005-12#2)(2005-3#1)(2005-4#1)(2005-5#1)(2005-9#3)(2006-1#1)(2006-10#9)(2006-11#2)(2006-12#8)(2006-4#2)(2006-5#3)(2006-6#3)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#3)(2007-11#12)(2007-12#13)(2007-2#2)(2007-3#2)(2007-4#2)(2007-5#2)(2007-6#3)(2007-7#5)(2007-8#16)(2007-9#5)(2008-1#7)(2008-10#81)(2008-11#17)(2008-12#4)(2008-2#11)(2008-3#11)(2008-4#9)(2008-5#15)(2008-6#8)(2008-7#19)(2008-8#12)(2008-9#11)(2009-1#2)(2009-11#4)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#5)(2010-10#2)(2010-12#6)(2010-2#7)(2010-3#2)(2010-4#7)(2010-5#3)(2010-6#4)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#9)(2011-12#3)(2011-2#13)(2012-1#8)(2012-11#3)(2012-12#6)(2012-2#17)(2012-3#2)(2012-7#1)(2013-1#16)(2013-7#1)(2013-8#11)
subserosal##5##1##(1990-10#1)(1993-9#1)(1994-2#1)(2011-2#1)(2013-8#1)
subserve##7##1##(1991-5#1)(1993-3#1)(1993-6#1)(1995-6#1)(2008-11#1)(2008-4#1)(2010-12#1)
subserved by##4##2##(1995-12#1)(1997-4#1)(2010-8#1)(2013-1#1)
subserves##2##1##(1992-1#1)(2008-1#1)
subserving##12##1##(1991-1#2)(1992-12#1)(1992-3#1)(1992-7#1)(1993-3#1)(1993-6#1)(1995-12#1)(1995-8#1)(1997-8#1)(2008-11#1)(2008-4#1)
subset analysis##2##2##(2008-4#1)(2009-4#1)
subset are##3##2##(1996-8#1)(2008-2#1)(2010-12#1)
subset composition##2##2##(2008-11#2)
subset is##3##2##(2008-9#2)(2010-8#1)
subset of 13##2##3##(1993-12#1)(2006-10#1)
subset of T cells##3##4##(2008-4#2)(2012-2#1)
subset of all##3##3##(2008-6#1)(2010-10#1)(2010-2#1)
subset of cells##3##3##(1991-5#1)(2009-5#1)(2009-8#1)
subset of children##3##3##(2006-8#1)(2008-11#1)(2012-1#1)
subset of five##2##3##(1997-7#1)(2007-12#1)
subset of genes##2##3##(2008-7#2)
subset of individuals##3##3##(1995-1#1)(2007-2#1)(2012-2#1)
subset of neurons in the##2##5##(2008-8#1)(2009-8#1)
subset of neurons##5##3##(1994-12#1)(1995-12#1)(1996-3#1)(2008-8#1)(2009-8#1)
subset of particularly##2##3##(1997-7#1)(2009-11#1)
subset of patients who##3##4##(1993-12#1)(2008-9#1)(2011-2#1)
subset of patients with##14##4##(1993-3#1)(1995-5#1)(2005-10#1)(2005-6#1)(2006-10#3)(2006-7#2)(2007-10#1)(2008-7#1)(2010-12#1)(2010-5#2)
subset of patients##32##3##(1993-12#1)(1993-3#1)(1995-5#1)(1997-1#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-6#1)(2006-10#6)(2006-11#1)(2006-6#1)(2006-7#2)(2007-10#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-12#2)(2010-5#2)(2011-2#1)(2012-1#1)
subset of subjects##3##3##(2006-2#1)(2008-10#1)(2011-2#1)
subset of the##37##3##(1990-10#1)(1991-5#1)(1992-9#2)(1996-4#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2009-11#1)(2009-8#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)
subset of these##11##3##(1995-5#1)(1995-8#1)(1996-5#2)(1996-9#1)(2006-3#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-4#1)
subset of this##3##3##(2007-12#1)(2008-6#1)(2008-9#1)
subset of women##2##3##(2007-6#1)(2008-3#1)
subset of##267##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-7#1)(1990-8#2)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-7#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#3)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#5)(1995-8#3)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#3)(1996-4#2)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#3)(2005-10#4)(2005-11#1)(2005-6#1)(2005-8#1)(2006-10#15)(2006-11#1)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#3)(2007-10#3)(2007-11#1)(2007-12#7)(2007-2#2)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#22)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#7)(2008-5#5)(2008-6#4)(2008-7#7)(2008-8#4)(2008-9#3)(2009-11#3)(2009-12#1)(2009-3#4)(2009-5#2)(2009-7#2)(2009-8#6)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#4)(2010-8#2)(2011-1#4)(2011-2#3)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#7)(2013-1#10)
subset partitioning##3##2##(2008-10#2)(2013-8#1)
subset selection##2##2##(2008-11#1)(2008-6#1)
subset were##3##2##(2007-10#1)(2007-12#1)(2008-9#1)
subset##345##1##(1990-10#1)(1990-11#2)(1990-12#4)(1990-7#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-7#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#3)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#2)(1995-5#6)(1995-8#3)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#3)(1996-4#2)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#3)(2005-10#4)(2005-11#1)(2005-6#1)(2005-8#1)(2006-10#16)(2006-11#1)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#3)(2007-10#11)(2007-11#2)(2007-12#9)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#2)(2008-10#27)(2008-11#7)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#11)(2008-5#6)(2008-6#6)(2008-7#9)(2008-8#5)(2008-9#8)(2009-11#3)(2009-12#1)(2009-3#5)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#7)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#7)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#8)(2010-8#3)(2011-1#5)(2011-2#4)(2012-1#4)(2012-11#1)(2012-12#8)(2012-2#3)(2012-3#7)(2013-1#11)(2013-8#1)
subsets and their##3##3##(1991-6#1)(1995-12#1)(2010-12#1)
subsets and##10##2##(1991-6#1)(1995-12#1)(1996-10#1)(1997-7#1)(2005-9#1)(2008-10#1)(2008-7#1)(2010-12#1)(2012-1#1)(2012-11#1)
subsets by##2##2##(2008-4#1)(2010-8#1)
subsets for##3##2##(2008-10#1)(2012-12#1)(2013-7#1)
subsets in a##2##3##(1997-7#1)(2007-12#1)
subsets in the##3##3##(1993-12#1)(1993-8#1)(2012-2#1)
subsets in##18##2##(1990-2#1)(1991-6#1)(1993-12#1)(1993-8#1)(1995-2#1)(1996-10#1)(1997-7#1)(2007-12#1)(2007-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
subsets is##2##2##(2008-4#1)(2012-2#1)
subsets of AG-2 were##2##4##(2008-10#2)
subsets of AG-2##4##3##(2008-10#4)
subsets of T##2##3##(1994-8#1)(2008-4#1)
subsets of cells##2##3##(1995-1#1)(2008-7#1)
subsets of data##2##3##(1991-8#1)(2008-7#1)
subsets of interest##2##3##(1997-4#1)(2008-9#1)
subsets of neurons##2##3##(1993-12#1)(1997-3#1)
subsets of patients##7##3##(1990-4#1)(1995-12#1)(2006-10#2)(2007-11#1)(2009-6#1)(2010-11#1)
subsets of the population##2##4##(1995-12#1)(2006-10#1)
subsets of the##5##3##(1995-12#1)(2006-10#1)(2008-2#2)(2009-8#1)
subsets of##75##2##(1990-4#1)(1990-5#1)(1991-8#1)(1992-10#1)(1992-4#1)(1993-12#2)(1994-11#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-5#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-11#2)(2010-4#1)(2010-5#1)(2011-3#1)(2012-11#1)(2012-3#2)(2013-1#6)
subsets so##2##2##(2007-12#1)(2008-2#1)
subsets to##3##2##(2004-11#1)(2007-10#2)
subsets was##2##2##(2007-12#1)(2008-7#1)
subsets##202##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1991-12#2)(1991-2#1)(1991-6#3)(1991-8#1)(1992-10#1)(1992-4#1)(1992-9#1)(1993-12#3)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-12#6)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-10#2)(1996-11#2)(1996-3#2)(1997-2#3)(1997-3#1)(1997-4#4)(1997-5#1)(1997-7#4)(1997-8#1)(2004-11#1)(2005-9#1)(2006-10#6)(2006-12#1)(2006-6#1)(2007-10#3)(2007-11#1)(2007-12#8)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#16)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#1)(2008-4#19)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#10)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#2)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#5)(2012-11#3)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#4)
subside##4##1##(1995-6#1)(2007-11#1)(2007-7#1)(2012-2#1)
subsided after##3##2##(1993-12#1)(2010-9#1)(2011-2#1)
subsided and the##2##3##(1992-1#1)(2006-10#1)
subsided and##5##2##(1992-1#1)(1992-3#1)(2006-10#1)(2008-1#1)(2009-8#1)
subsided completely##2##2##(2005-1#1)(2007-11#1)
subsided in the##2##3##(2007-7#1)(2009-3#1)
subsided in##5##2##(1992-6#1)(1996-12#1)(2007-7#1)(2007-8#1)(2009-3#1)
subsided with##3##2##(2007-7#1)(2010-3#1)(2012-12#1)
subsided##31##1##(1990-12#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1996-12#1)(2005-1#1)(2006-10#2)(2006-4#1)(2007-11#2)(2007-2#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-5#1)(2009-3#1)(2009-8#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
subsidence of symptoms##2##3##(1990-7#1)(2007-11#1)
subsidence of##3##2##(1990-12#1)(1990-7#1)(2007-11#1)
subsidence##9##1##(1990-12#1)(1990-7#1)(1993-4#1)(2007-11#3)(2009-3#2)(2010-5#1)
subsidiary of U##2##3##(1996-12#1)(1997-1#1)
subsidiary of##6##2##(1990-2#1)(1996-12#1)(1997-1#1)(2005-9#1)(2008-5#2)
subsidiary##11##1##(1990-2#1)(1995-1#1)(1996-12#1)(1997-1#1)(2005-9#1)(2008-10#1)(2008-5#2)(2010-9#3)
subsidies for##3##2##(1993-6#1)(2008-12#1)(2010-2#1)
subsidies in##3##2##(2008-4#1)(2008-7#1)(2011-12#1)
subsidies should be##2##3##(1996-3#1)(2010-8#1)
subsidies to##2##2##(1992-3#1)(1995-6#1)
subsidies##23##1##(1992-12#1)(1992-3#2)(1992-5#1)(1993-6#1)(1994-2#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#3)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-12#1)(2013-8#1)
subsiding##5##1##(1992-11#1)(1996-5#1)(1997-4#1)(2007-2#1)(2007-7#1)
subsidized by##2##2##(1990-12#1)(1997-5#1)
subsidized##11##1##(1990-12#1)(1991-12#1)(1992-2#1)(1997-5#1)(2006-2#1)(2006-3#1)(2006-5#1)(2008-7#1)(2009-10#1)(2010-8#1)(2012-12#1)
subsidizing##2##1##(1996-3#1)(2012-12#1)
subsidy by##2##2##(2007-9#1)(2008-7#1)
subsidy##14##1##(1990-12#1)(1992-3#1)(1994-2#1)(1996-2#2)(2006-4#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-7#3)(2011-12#2)
subsist##3##1##(1991-11#1)(1995-5#1)(2008-11#1)
subsistence farmers##3##2##(2005-11#2)(2008-10#1)
subsistence##10##1##(1991-11#1)(1991-12#1)(2005-11#2)(2008-1#1)(2008-10#2)(2010-6#1)(2013-7#2)
subsite F##2##2##(1996-7#2)
subsite is##2##2##(1996-11#2)
subsite specificities##2##2##(1993-6#1)(1994-12#1)
subsite structure of bacterial saccharifying alpha-amylase##2##6##(1996-2#2)
subsite##36##1##(1990-12#1)(1990-7#2)(1991-2#1)(1991-4#1)(1991-6#2)(1991-9#2)(1992-12#1)(1992-2#1)(1992-9#1)(1993-6#4)(1994-12#1)(1994-9#1)(1995-11#2)(1995-5#1)(1996-11#7)(1996-2#3)(1996-7#4)(2010-12#1)
subsites in##3##2##(1995-1#1)(1996-11#2)
subsites of the##2##3##(1993-6#1)(2010-7#1)
subsites of##5##2##(1990-4#1)(1991-6#1)(1992-3#1)(1993-6#1)(2010-7#1)
subsites##20##1##(1990-4#2)(1991-2#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-6#2)(1994-12#3)(1995-1#1)(1996-11#2)(1996-2#2)(1996-7#1)(2004-12#1)(2010-7#1)
subsonic##4##1##(2008-3#4)
subsp##149##1##(1990-5#2)(1990-9#1)(1991-10#4)(1993-12#2)(1993-9#2)(1994-12#2)(1994-3#1)(1994-6#2)(1995-8#2)(2004-11#2)(2005-12#1)(2005-7#1)(2006-10#2)(2006-8#5)(2007-1#5)(2007-12#1)(2007-6#2)(2008-10#76)(2008-5#2)(2008-6#1)(2008-7#3)(2009-5#2)(2009-8#1)(2010-12#3)(2010-4#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#6)(2012-3#5)(2013-1#5)(2013-7#2)
subspace##12##1##(2007-11#1)(2008-2#4)(2008-7#2)(2009-9#3)(2012-1#2)
subspecialists##3##1##(2008-11#1)(2011-1#1)(2013-1#1)
subspecialization##3##1##(1994-12#1)(2007-3#1)(2007-8#1)
subspecialties##7##1##(1991-6#1)(1994-12#1)(1995-1#1)(2005-8#1)(2007-4#2)(2008-11#1)
subspecialty in##3##2##(2005-9#1)(2008-8#1)(2009-5#1)
subspecialty of##3##2##(2007-5#1)(2007-7#2)
subspecialty training and certification in radiation oncology##2##7##(2007-4#2)
subspecialty training##3##2##(2007-4#3)
subspecialty##26##1##(1993-12#1)(1994-12#1)(1994-3#1)(2005-9#1)(2006-10#5)(2007-12#1)(2007-4#4)(2007-5#1)(2007-7#2)(2008-2#1)(2008-8#1)(2009-5#1)(2011-1#4)(2012-3#1)(2013-1#1)
subspeciation##2##1##(2013-1#2)
subspecies and##2##2##(2007-1#1)(2008-3#1)
subspecies are##2##2##(1990-9#1)(2010-8#1)
subspecies in##2##2##(1990-9#1)(2011-1#1)
subspecies level##2##2##(2008-10#1)(2011-1#1)
subspecies of the white-crowned sparrow##2##5##(2008-3#2)
subspecies of the##5##3##(1994-3#1)(1996-1#1)(2008-3#2)(2008-5#1)
subspecies of##15##2##(1994-3#1)(1994-6#1)(1996-1#1)(2006-8#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-3#3)(2008-5#3)(2008-9#1)(2013-1#1)
subspecies were##3##2##(1990-8#1)(1991-8#1)(2006-8#1)
subspecies##67##1##(1990-8#2)(1990-9#5)(1991-10#2)(1991-8#1)(1994-3#2)(1994-6#1)(1996-1#5)(2004-11#1)(2006-8#3)(2007-1#5)(2007-5#1)(2007-8#1)(2008-10#10)(2008-11#2)(2008-12#3)(2008-3#5)(2008-4#1)(2008-5#4)(2008-9#1)(2010-12#1)(2010-8#1)(2011-1#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
subspecies-specific##3##1##(2008-10#2)(2011-1#1)
subspecific groups##2##2##(2008-10#2)
subspecific##4##1##(2008-10#4)
substance (MIS)##3##2##(1995-11#2)(2008-4#1)
substance (TBARS)##3##2##(1994-6#1)(2012-2#1)(2012-5#1)
substance P (NK1)##2##3##(1992-8#2)
substance P (SP) and calcitonin gene-related peptide (CGRP)##2##8##(1997-3#1)(2007-2#1)
substance P (SP) and##7##4##(1992-3#1)(1992-9#1)(1995-5#2)(1997-3#1)(2007-2#1)(2007-6#1)
substance P (SP)##18##3##(1990-11#1)(1991-8#1)(1992-3#1)(1992-7#1)(1992-9#1)(1994-10#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-3#1)(1997-3#1)(1997-4#1)(1997-6#1)(2004-3#1)(2007-2#1)(2007-6#1)
substance P and CGRP##2##4##(1992-3#1)(1996-3#1)
substance P and bronchoalveolar lavage##2##5##(1992-3#2)
substance P and calcitonin gene-related peptide##2##6##(1992-3#1)(1996-3#1)
substance P and neurokinin A##2##5##(1990-5#1)(1993-8#1)
substance P and##10##3##(1990-5#1)(1992-3#4)(1993-12#1)(1993-8#1)(1994-2#1)(1996-3#2)
substance P antagonist##6##3##(1990-11#1)(1990-2#2)(1991-9#1)(1994-2#1)(1994-9#1)
substance P has##2##3##(1994-3#1)(1994-8#1)
substance P in a##2##4##(1994-8#1)(1996-12#1)
substance P in the##2##4##(1992-3#1)(2009-11#1)
substance P in##6##3##(1992-3#1)(1994-8#1)(1995-12#1)(1995-9#1)(1996-12#1)(2009-11#1)
substance P induces##3##3##(1993-11#1)(1994-3#1)(1994-8#1)
substance P is##2##3##(1993-11#1)(2006-10#1)
substance P levels##2##3##(1992-3#1)(2006-10#1)
substance P may##2##3##(1991-8#1)(1996-7#1)
substance P on##3##3##(1990-2#1)(1994-6#1)(1994-8#1)
substance P or##2##3##(1991-12#1)(1994-8#1)
substance P was##4##3##(1990-2#2)(1992-3#1)(1995-11#1)
substance P##130##2##(1990-11#3)(1990-2#8)(1990-5#1)(1991-10#1)(1991-12#2)(1991-4#2)(1991-8#4)(1991-9#4)(1992-10#1)(1992-3#13)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#5)(1993-12#1)(1993-8#4)(1994-10#1)(1994-2#7)(1994-3#5)(1994-6#2)(1994-8#8)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-5#2)(1995-9#2)(1996-12#5)(1996-3#5)(1996-7#2)(1996-8#2)(1997-1#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(2004-3#1)(2005-8#1)(2006-10#7)(2006-2#1)(2007-2#1)(2007-6#1)(2007-8#2)(2008-4#3)(2008-7#1)(2009-11#1)(2013-8#1)
substance P- and##2##3##(1997-3#1)(2011-2#1)
substance P-##4##2##(1990-7#1)(1994-8#1)(1997-3#1)(2011-2#1)
substance P-induced##4##2##(1991-8#1)(1993-11#1)(1994-2#1)(1997-5#1)
substance P-like##2##2##(1990-11#1)(1997-2#1)
substance abuse and comorbid##2##4##(2008-6#1)(2009-5#1)
substance abuse and mental health##5##5##(1995-1#1)(2008-6#1)(2013-8#3)
substance abuse and##12##3##(1991-1#1)(1994-2#1)(1995-1#1)(2006-8#1)(2008-6#2)(2009-5#1)(2009-9#2)(2013-8#3)
substance abuse diagnosis##2##3##(1994-2#1)(1995-1#1)
substance abuse disorders##2##3##(2006-9#1)(2008-6#1)
substance abuse histories##3##3##(1996-5#2)(1996-8#1)
substance abuse in##5##3##(1994-3#1)(2006-7#1)(2006-8#2)(2013-8#1)
substance abuse is##3##3##(1992-1#1)(2006-1#1)(2006-8#1)
substance abuse issues##3##3##(2005-10#1)(2008-3#2)
substance abuse or dependence##2##4##(1992-1#1)(2008-6#1)
substance abuse patients##2##3##(1991-1#1)(2008-6#1)
substance abuse prevention and treatment##2##5##(2008-7#1)(2010-2#1)
substance abuse prevention##4##3##(1995-12#1)(2008-7#1)(2010-2#2)
substance abuse problems##3##3##(1993-2#1)(2006-9#1)(2008-4#1)
substance abuse treatment and##3##4##(2008-6#2)(2010-6#1)
substance abuse treatment programs##3##4##(2008-3#1)(2008-6#1)(2009-9#1)
substance abuse treatment##22##3##(2005-9#2)(2007-1#1)(2007-10#1)(2008-3#4)(2008-6#3)(2008-7#1)(2009-9#2)(2010-11#3)(2010-2#3)(2010-6#1)(2012-12#1)
substance abuse was##3##3##(2006-8#2)(2008-3#1)
substance abuse##119##2##(1991-1#3)(1991-2#1)(1992-1#2)(1993-2#1)(1994-12#1)(1994-2#6)(1994-3#1)(1995-1#3)(1995-12#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-8#2)(1997-2#1)(2005-10#1)(2005-9#3)(2006-1#2)(2006-4#1)(2006-7#1)(2006-8#8)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#1)(2007-2#1)(2007-8#2)(2008-11#1)(2008-2#2)(2008-3#8)(2008-4#3)(2008-6#15)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#7)(2010-11#4)(2010-2#5)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#4)(2013-1#1)(2013-8#5)
substance abuse-prevention##2##2##(2008-7#2)
substance abuse?##2##2##(2008-4#1)(2012-11#1)
substance abusers##11##2##(1991-1#6)(1994-2#2)(2006-1#1)(2011-1#2)
substance abusing##3##2##(1994-12#1)(2009-9#1)(2013-7#1)
substance and a##2##3##(2007-10#1)(2007-12#1)
substance and volume loss were##2##5##(2011-2#2)
substance and volume loss##3##4##(2011-2#3)
substance and##8##2##(2007-10#1)(2007-12#1)(2010-4#2)(2011-2#3)(2012-2#1)
substance as##2##2##(2008-10#2)
substance by##3##2##(1997-3#1)(2008-10#1)(2008-5#1)
substance can##2##2##(1997-6#1)(2008-3#1)
substance code##2##2##(2010-8#2)
substance dependence##6##2##(1991-1#1)(2011-1#1)(2012-2#2)(2013-8#2)
substance did not##2##3##(1997-6#1)(2008-10#1)
substance for##3##2##(1994-11#1)(2005-7#1)(2011-1#1)
substance from##3##2##(2008-12#1)(2008-5#2)
substance has##2##2##(2008-9#1)(2009-6#1)
substance have been##2##3##(2008-10#2)
substance in the##6##3##(1992-2#1)(1992-6#1)(1995-12#1)(2008-11#1)(2008-4#1)(2008-9#1)
substance in##17##2##(1991-12#1)(1991-4#1)(1992-2#2)(1992-6#1)(1992-7#1)(1994-9#1)(1995-12#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
substance inhibited##3##2##(1993-3#1)(1995-12#1)(1997-6#1)
substance is##14##2##(1990-7#1)(1991-6#1)(1991-7#1)(1993-11#1)(1993-7#1)(1995-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-5#1)(2013-8#1)
substance misuse prevention##4##3##(2010-2#4)
substance misuse##11##2##(2006-9#1)(2008-12#1)(2009-9#2)(2010-2#6)(2012-12#1)
substance of abuse and dependence##2##5##(2009-6#2)
substance of abuse##4##3##(2008-8#1)(2009-11#1)(2009-6#2)
substance of the##3##3##(1992-3#1)(2008-5#1)(2009-2#1)
substance of##17##2##(1992-3#1)(1993-12#2)(2005-4#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#2)(2009-6#2)(2013-1#1)
substance on the##2##3##(2008-10#1)(2008-5#1)
substance on##3##2##(2005-10#1)(2008-10#1)(2008-5#1)
substance or##3##2##(2007-11#1)(2012-12#2)
substance present in##2##3##(2005-10#1)(2008-11#1)
substance released from##2##3##(1997-4#1)(2008-6#1)
substance testing##2##2##(2012-3#2)
substance that appears to##2##4##(2008-11#2)
substance that can##2##3##(1991-8#1)(2008-3#1)
substance that##11##2##(1991-8#1)(1991-9#1)(1994-5#1)(1996-11#1)(1996-2#1)(1997-6#1)(2008-11#2)(2008-3#1)(2010-12#1)(2012-2#1)
substance toxicity##2##2##(2005-10#1)(2010-6#1)
substance use across##2##3##(2008-5#1)(2009-7#1)
substance use among##4##3##(2008-5#3)(2009-7#1)
substance use and the##2##4##(2008-5#1)(2008-9#1)
substance use and##11##3##(2008-5#1)(2008-6#1)(2008-9#2)(2009-7#1)(2010-2#1)(2010-7#1)(2012-2#1)(2013-1#2)(2013-8#1)
substance use are##4##3##(2008-11#1)(2008-9#2)(2013-7#1)
substance use behaviors##2##3##(2013-1#2)
substance use disorder in##2##4##(2012-12#1)(2012-3#1)
substance use disorder##7##3##(2008-6#1)(2009-11#2)(2010-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
substance use disorders in##3##4##(2004-3#1)(2008-6#1)(2012-12#1)
substance use disorders##18##3##(1997-5#2)(2004-3#1)(2005-6#1)(2008-6#2)(2009-10#1)(2009-9#1)(2010-2#2)(2010-6#3)(2011-12#1)(2012-12#4)
substance use in##9##3##(2005-9#1)(2007-11#1)(2008-6#2)(2009-7#2)(2011-12#1)(2012-3#1)(2013-1#1)
substance use is##2##3##(2007-8#1)(2011-12#1)
substance use or##3##3##(2011-12#1)(2013-7#2)
substance use risk##2##3##(2013-1#2)
substance use than##2##3##(2008-6#1)(2013-1#1)
substance use##113##2##(1994-2#1)(1997-5#2)(2004-3#1)(2004-8#1)(2005-6#1)(2005-9#1)(2006-1#1)(2007-11#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#7)(2008-6#7)(2008-9#5)(2009-10#1)(2009-11#3)(2009-5#3)(2009-7#13)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#10)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#5)(2011-2#1)(2012-12#7)(2012-2#2)(2012-3#2)(2013-1#14)(2013-7#5)(2013-8#2)
substance used in##2##3##(1990-6#1)(2008-5#1)
substance users##7##2##(1991-1#2)(2007-1#1)(2008-5#3)(2010-2#1)
substance using##2##2##(2009-7#1)(2012-12#1)
substance was##15##2##(1990-12#1)(1990-5#1)(1990-6#1)(1997-7#1)(2005-10#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2010-12#2)(2010-4#2)(2012-12#1)
substance were##4##2##(2005-10#1)(2007-10#1)(2008-11#1)(2008-5#1)
substance which##4##2##(1992-7#1)(1992-8#1)(1997-1#1)(1997-7#1)
substance##724##1##(1990-11#4)(1990-12#1)(1990-2#9)(1990-4#1)(1990-5#2)(1990-6#5)(1990-7#4)(1991-1#13)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#4)(1991-6#1)(1991-7#1)(1991-8#7)(1991-9#7)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#4)(1992-3#14)(1992-6#2)(1992-7#4)(1992-8#5)(1992-9#1)(1993-10#1)(1993-11#7)(1993-12#5)(1993-2#2)(1993-3#2)(1993-6#1)(1993-7#1)(1993-8#4)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#21)(1994-3#6)(1994-5#1)(1994-6#4)(1994-8#9)(1994-9#2)(1995-1#3)(1995-11#7)(1995-12#8)(1995-2#1)(1995-5#3)(1995-9#2)(1996-1#2)(1996-11#1)(1996-12#6)(1996-2#3)(1996-3#7)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#6)(1997-1#2)(1997-2#3)(1997-3#5)(1997-4#5)(1997-5#4)(1997-6#5)(1997-7#3)(1997-8#3)(2004-3#2)(2004-8#2)(2005-1#1)(2005-10#10)(2005-11#2)(2005-4#1)(2005-6#1)(2005-7#1)(2005-8#1)(2005-9#4)(2006-1#4)(2006-10#8)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#13)(2006-9#3)(2007-1#6)(2007-10#4)(2007-11#3)(2007-12#2)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#9)(2008-10#34)(2008-11#25)(2008-12#3)(2008-2#3)(2008-3#13)(2008-4#16)(2008-5#32)(2008-6#28)(2008-7#9)(2008-8#3)(2008-9#10)(2009-10#2)(2009-11#6)(2009-12#1)(2009-2#2)(2009-4#3)(2009-5#4)(2009-6#6)(2009-7#15)(2009-9#11)(2010-10#2)(2010-11#4)(2010-12#4)(2010-2#23)(2010-4#6)(2010-5#1)(2010-6#5)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#7)(2011-12#5)(2011-2#11)(2012-11#1)(2012-12#15)(2012-2#16)(2012-3#5)(2012-5#1)(2013-1#19)(2013-7#6)(2013-8#11)
substance&quot##2##1##(2007-5#1)(2007-8#1)
substance(s) in##2##2##(1991-8#1)(1992-8#1)
substance(s)##6##1##(1991-5#1)(1991-8#1)(1992-8#1)(2008-10#2)(2008-5#1)
substance)##3##1##(1991-6#1)(1996-3#1)(2007-3#1)
substance-P immunoreactivity in##2##3##(1995-12#2)
substance-P immunoreactivity##3##2##(1995-12#3)
substance-P##6##1##(1991-2#1)(1995-12#5)
substance-abusing##2##1##(2008-6#1)(2012-3#1)
substance-dependent##7##1##(1996-7#1)(2008-3#1)(2011-1#5)
substance-related disorders##5##2##(2005-7#1)(2009-7#3)(2010-12#1)
substance-specific##2##1##(2008-3#1)(2008-4#1)
substances (HS) and##2##3##(2008-10#2)
substances (HS)##6##2##(2005-11#1)(2008-10#5)
substances (TBARS)##17##2##(1993-2#1)(1995-1#1)(1995-3#2)(1995-6#1)(1996-3#1)(1997-8#1)(2004-12#1)(2007-9#1)(2008-10#2)(2010-4#2)(2011-2#3)(2013-8#1)
substances (TBARs)##2##2##(2010-4#1)(2011-2#1)
substances and drugs##2##3##(1990-11#1)(1992-2#1)
substances and the##8##3##(2005-4#1)(2007-1#1)(2007-8#1)(2008-11#1)(2008-5#2)(2008-7#1)(2013-7#1)
substances and their##5##3##(1996-12#1)(2008-10#3)(2010-4#1)
substances and##46##2##(1990-11#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#1)(1994-3#2)(1996-12#1)(2005-11#1)(2005-4#1)(2006-12#1)(2006-8#3)(2007-1#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-5#7)(2008-7#2)(2008-9#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
substances are also discussed##2##4##(1997-7#1)(2007-10#1)
substances are responsible for##2##4##(2008-10#1)(2008-11#1)
substances are used##2##3##(2006-2#1)(2012-1#1)
substances are##19##2##(1990-3#1)(1991-3#1)(1992-10#1)(1993-11#1)(1994-9#1)(1995-9#1)(1996-1#1)(1996-9#1)(1997-7#1)(2005-11#2)(2006-2#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-7#2)(2012-1#1)
substances as well as##3##4##(1997-2#1)(2009-10#1)(2010-5#1)
substances as##7##2##(1992-5#1)(1997-2#1)(2008-11#1)(2008-3#1)(2009-10#1)(2010-5#1)(2011-1#1)
substances at the##2##3##(2006-1#1)(2008-5#1)
substances at##4##2##(2006-1#1)(2007-8#1)(2008-5#1)(2010-11#1)
substances between the##3##3##(1990-6#2)(2008-3#1)
substances by the##2##3##(1990-12#1)(2008-10#1)
substances by##6##2##(1990-12#1)(1996-9#1)(2005-11#1)(2008-10#3)
substances can##2##2##(2007-8#1)(2008-11#1)
substances contained in the##2##4##(2008-10#1)(2008-11#1)
substances contained in##3##3##(1996-1#1)(2008-10#1)(2008-11#1)
substances could##2##2##(1992-3#1)(1992-6#1)
substances during##3##2##(1994-3#1)(2005-10#1)(2006-2#1)
substances existing in##2##3##(2008-11#1)(2009-11#1)
substances for the##5##3##(2006-8#1)(2008-11#3)(2013-1#1)
substances for##15##2##(1990-4#1)(1992-3#1)(1996-3#1)(2006-8#2)(2007-8#1)(2008-11#3)(2008-12#1)(2008-5#1)(2010-8#1)(2010-9#1)(2012-12#1)(2013-1#1)
substances formation##2##2##(2004-11#1)(2005-8#1)
substances from the##5##3##(1991-10#1)(2007-12#1)(2008-5#1)(2008-7#2)
substances from##12##2##(1990-2#1)(1991-10#1)(1997-1#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-12#1)(2008-5#1)(2008-7#2)(2012-1#1)(2012-12#1)
substances had##2##2##(2008-8#1)(2012-12#1)
substances has##3##2##(1992-8#1)(2006-12#1)(2007-1#1)
substances have been##5##3##(1996-5#1)(2006-10#1)(2007-11#3)
substances have##10##2##(1995-12#1)(1996-5#1)(1997-4#1)(2006-10#1)(2007-11#3)(2008-5#1)(2008-7#1)(2012-2#1)
substances having a##2##3##(2008-10#1)(2008-11#1)
substances in a##3##3##(2006-7#1)(2008-11#1)(2013-8#1)
substances in biological##2##3##(2008-10#1)(2010-11#1)
substances in foods##2##3##(1990-9#1)(1996-1#1)
substances in human##2##3##(2008-10#1)(2010-11#1)
substances in pharmaceutical##2##3##(2010-12#1)(2010-2#1)
substances in plasma##3##3##(1992-3#1)(2008-10#2)
substances in the initial activity range##2##6##(1997-7#2)
substances in the##20##3##(1991-11#1)(1991-7#1)(1994-8#1)(1995-12#1)(1997-7#2)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-6#1)(2008-7#1)(2009-4#1)(2010-4#1)(2012-2#1)(2013-8#2)
substances in##68##2##(1990-9#2)(1991-11#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-8#2)(1994-8#1)(1995-12#1)(1996-1#1)(1997-4#1)(1997-7#2)(2005-10#2)(2005-11#1)(2006-2#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-12#2)(2008-10#16)(2008-11#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2010-11#4)(2010-12#1)(2010-2#1)(2010-4#1)(2010-9#1)(2012-12#4)(2012-2#1)(2013-7#1)(2013-8#4)
substances including##3##2##(1994-8#1)(1997-4#1)(2010-9#1)
substances involved in##2##3##(2007-11#1)(2008-1#1)
substances is##5##2##(1990-3#1)(1995-11#1)(2006-8#1)(2008-5#1)(2013-1#1)
substances like##2##2##(1991-12#1)(1993-12#1)
substances may be##2##3##(2010-12#1)(2010-4#1)
substances may##4##2##(2008-11#1)(2008-5#1)(2010-12#1)(2010-4#1)
substances occurring in##2##3##(2008-10#1)(2009-7#1)
substances of abuse##2##3##(2008-3#1)(2010-9#1)
substances of##11##2##(1991-8#1)(1993-3#1)(1994-8#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-9#1)
substances on the##8##3##(1991-11#1)(1992-12#1)(1996-10#1)(1997-6#1)(1997-8#1)(2007-9#1)(2008-10#1)(2008-5#1)
substances on##9##2##(1991-11#1)(1992-12#1)(1993-2#1)(1996-10#1)(1997-6#1)(1997-8#1)(2007-9#1)(2008-10#1)(2008-5#1)
substances or##4##2##(2008-2#1)(2008-4#1)(2008-6#1)(2011-2#1)
substances present in the##4##4##(1994-3#1)(2006-10#1)(2008-10#1)(2008-3#1)
substances present in##5##3##(1994-3#1)(2006-10#1)(2008-10#2)(2008-3#1)
substances produced by##4##3##(2007-11#1)(2010-1#1)(2010-10#1)(2010-7#1)
substances produced##6##2##(2007-11#1)(2008-10#1)(2008-5#1)(2010-1#1)(2010-10#1)(2010-7#1)
substances released##4##2##(1994-12#1)(2007-9#1)(2008-11#1)(2012-2#1)
substances solutions##2##2##(2008-10#1)(2009-6#1)
substances such as nitric oxide##2##5##(2008-3#1)(2011-2#1)
substances such as vitamin C##2##5##(1992-9#1)(2008-1#1)
substances such as##16##3##(1992-11#1)(1992-9#1)(1994-6#1)(1997-1#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-8#1)(2010-9#1)(2011-2#1)(2012-2#2)
substances tested##2##2##(1993-12#1)(2008-11#1)
substances that are##6##3##(2008-10#1)(2008-3#1)(2008-5#3)(2013-1#1)
substances that can##2##3##(2008-5#1)(2013-8#1)
substances that could##2##3##(2007-11#1)(2008-11#1)
substances that fulfill##2##3##(2007-11#2)
substances that have##3##3##(1990-2#2)(2006-10#1)
substances that##27##2##(1990-2#2)(1991-12#1)(1992-5#1)(1993-9#1)(1995-1#1)(1995-12#1)(2005-8#1)(2005-9#1)(2006-10#1)(2007-11#3)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#4)(2008-7#1)(2009-9#1)(2013-1#2)(2013-8#1)
substances to##5##2##(1997-8#1)(2006-10#1)(2006-9#1)(2008-10#1)(2008-5#1)
substances used for##2##3##(2008-10#1)(2008-7#1)
substances used##5##2##(2007-3#1)(2008-1#1)(2008-10#1)(2008-7#1)(2013-8#1)
substances using##2##2##(1997-3#1)(2008-10#1)
substances was studied##2##3##(2008-10#1)(2008-8#1)
substances was##11##2##(1991-8#1)(2006-11#1)(2006-8#1)(2007-1#1)(2008-10#5)(2008-8#1)(2013-1#1)
substances were studied##2##3##(1996-8#1)(2008-10#1)
substances were##23##2##(1992-5#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-8#1)(2005-12#1)(2006-8#1)(2007-1#1)(2008-10#7)(2008-11#1)(2008-5#2)(2008-6#1)(2013-1#1)
substances which can##3##3##(2006-12#1)(2008-10#1)(2013-8#1)
substances which##11##2##(1994-2#1)(1996-1#1)(1997-3#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-5#1)(2012-12#1)(2013-8#1)
substances with##9##2##(1993-2#1)(2005-1#2)(2006-2#1)(2008-10#3)(2010-9#1)(2011-1#1)
substances##726##1##(1990-11#2)(1990-12#4)(1990-2#4)(1990-3#3)(1990-4#1)(1990-6#2)(1990-7#2)(1990-9#2)(1991-10#3)(1991-11#4)(1991-12#3)(1991-2#1)(1991-3#3)(1991-6#3)(1991-7#3)(1991-8#5)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#5)(1992-4#2)(1992-5#7)(1992-6#3)(1992-8#3)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#4)(1993-3#3)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#6)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#6)(1995-2#3)(1995-3#4)(1995-5#1)(1995-6#1)(1995-9#2)(1996-1#8)(1996-10#2)(1996-12#1)(1996-3#4)(1996-5#3)(1996-6#1)(1996-7#3)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#1)(1997-3#3)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#4)(1997-8#5)(2004-11#1)(2004-12#1)(2004-4#1)(2005-1#2)(2005-10#5)(2005-11#13)(2005-12#2)(2005-4#5)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#8)(2006-11#2)(2006-12#6)(2006-2#5)(2006-6#2)(2006-7#3)(2006-8#18)(2006-9#3)(2007-1#6)(2007-10#4)(2007-11#16)(2007-12#5)(2007-3#1)(2007-7#2)(2007-8#11)(2007-9#10)(2008-1#11)(2008-10#139)(2008-11#37)(2008-12#2)(2008-2#5)(2008-3#8)(2008-4#6)(2008-5#41)(2008-6#5)(2008-7#13)(2008-8#4)(2008-9#3)(2009-10#3)(2009-11#1)(2009-2#2)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#4)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#5)(2010-12#9)(2010-2#3)(2010-4#7)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#7)(2011-1#7)(2011-12#1)(2011-2#8)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#12)(2012-2#9)(2012-3#1)(2013-1#18)(2013-7#6)(2013-8#10)
substances&quot##2##1##(2007-8#1)(2008-10#1)
substances)##3##1##(1990-3#1)(1995-5#1)(2008-11#1)
substantia gelatinosa##2##2##(1992-8#2)
substantia innominata (SI)##2##3##(1991-5#1)(1994-10#1)
substantia innominata##8##2##(1991-1#2)(1991-5#2)(1994-10#1)(1997-2#1)(1997-3#2)
substantia nigra (SN)##8##3##(1992-11#1)(1994-2#2)(1994-5#1)(1996-9#1)(2008-11#1)(2008-7#1)(2012-2#1)
substantia nigra and ventral tegmental##2##5##(1991-9#1)(1996-10#1)
substantia nigra and##15##3##(1991-11#1)(1991-9#1)(1992-10#1)(1995-12#1)(1996-10#1)(1996-12#2)(1996-4#1)(2008-11#2)(2008-7#5)
substantia nigra compacta##2##3##(1991-12#1)(1996-4#1)
substantia nigra dopamine neurones##2##4##(1992-1#2)
substantia nigra dopaminergic neurons##2##4##(1991-1#1)(2005-8#1)
substantia nigra from##2##3##(1990-5#1)(2008-11#1)
substantia nigra has##2##3##(1990-5#2)
substantia nigra in##4##3##(1990-2#1)(1992-10#1)(1992-9#1)(1995-5#1)
substantia nigra of##4##3##(1993-4#1)(1994-2#2)(1996-9#1)
substantia nigra pars compacta##10##4##(1991-11#1)(1991-3#1)(1991-9#1)(1994-12#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#2)(2008-7#1)
substantia nigra pars reticulata##6##4##(1992-10#1)(1995-12#1)(1995-2#1)(2008-11#1)(2008-12#1)(2009-10#1)
substantia nigra pars##16##3##(1991-11#1)(1991-3#1)(1991-9#1)(1992-10#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)
substantia nigra##106##2##(1990-2#4)(1990-4#1)(1990-5#7)(1991-1#3)(1991-11#3)(1991-12#1)(1991-2#1)(1991-3#2)(1991-9#5)(1992-1#3)(1992-10#3)(1992-11#1)(1992-9#2)(1993-12#4)(1993-4#3)(1994-10#2)(1994-12#2)(1994-2#5)(1994-5#1)(1995-12#5)(1995-2#4)(1995-3#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#6)(1996-4#4)(1996-9#2)(1997-3#1)(1997-6#1)(1997-7#1)(2005-8#1)(2008-11#6)(2008-12#1)(2008-3#1)(2008-7#10)(2009-10#1)(2012-1#1)(2012-12#1)(2012-2#1)
substantia##122##1##(1990-2#4)(1990-4#1)(1990-5#7)(1991-1#5)(1991-11#3)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-9#6)(1992-1#3)(1992-10#3)(1992-11#1)(1992-7#1)(1992-8#3)(1992-9#2)(1993-12#4)(1993-4#3)(1994-10#3)(1994-12#2)(1994-2#5)(1994-5#1)(1995-12#5)(1995-2#4)(1995-3#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#6)(1996-4#5)(1996-9#2)(1997-2#1)(1997-3#3)(1997-6#2)(1997-7#1)(2005-8#1)(2006-6#1)(2008-11#6)(2008-12#1)(2008-3#1)(2008-7#10)(2009-10#1)(2012-1#1)(2012-12#1)(2012-2#1)
substantial activity##4##2##(1990-11#1)(1991-4#1)(1993-6#1)(2013-1#1)
substantial advances in##2##3##(2006-10#1)(2010-5#1)
substantial advances##4##2##(1995-5#1)(2006-10#1)(2010-5#1)(2011-2#1)
substantial advantages##2##2##(1991-11#1)(1994-11#1)
substantial affinity##2##2##(1992-5#1)(1995-2#1)
substantial amino acid##2##3##(1993-3#1)(2008-9#1)
substantial amount of the##3##4##(1995-6#1)(2009-9#1)(2010-9#1)
substantial amount of##12##3##(1991-5#1)(1995-1#1)(1995-6#1)(1997-3#1)(2005-11#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-9#1)(2012-1#1)(2013-8#1)
substantial amounts of##10##3##(1990-10#1)(1990-11#1)(1991-12#2)(1991-5#1)(1992-11#1)(1992-7#1)(2006-5#1)(2007-11#1)(2008-10#1)
substantial and##9##2##(1990-9#1)(1997-8#1)(2006-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-3#1)
substantial benefit in##2##3##(2008-7#1)(2010-12#1)
substantial benefit##4##2##(2006-10#1)(2008-7#1)(2010-12#1)(2012-3#1)
substantial benefits in##2##3##(2008-7#1)(2010-10#1)
substantial benefits##5##2##(2007-8#1)(2008-2#1)(2008-7#1)(2010-10#1)(2011-2#1)
substantial bone##2##2##(2007-7#1)(2011-1#1)
substantial challenges##2##2##(2007-4#1)(2013-8#1)
substantial change in the##3##4##(1991-7#1)(2005-11#1)(2013-8#1)
substantial change in##4##3##(1991-7#1)(1992-6#1)(2005-11#1)(2013-8#1)
substantial change##5##2##(1991-7#1)(1992-6#1)(1994-12#1)(2005-11#1)(2013-8#1)
substantial changes in the##3##4##(1991-1#1)(2007-6#1)(2009-5#1)
substantial changes in##9##3##(1991-1#1)(1997-1#1)(2006-10#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-5#1)(2010-1#1)
substantial changes of##2##3##(2008-10#2)
substantial changes##15##2##(1991-1#1)(1993-3#1)(1997-1#1)(2006-10#1)(2006-9#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-7#1)(2009-5#1)(2010-1#1)(2010-5#1)(2012-12#1)
substantial correlation##2##2##(1992-3#1)(2008-4#1)
substantial cost##2##2##(1996-12#1)(2007-8#1)
substantial decline in##3##3##(2007-7#1)(2008-10#1)(2012-1#1)
substantial decline##4##2##(2007-7#1)(2008-10#1)(2011-2#1)(2012-1#1)
substantial decrease in##5##3##(1991-6#1)(1992-5#1)(1994-3#1)(1997-1#1)(2008-10#1)
substantial decrease##7##2##(1991-6#1)(1992-5#1)(1993-6#1)(1994-3#1)(1997-1#1)(2008-10#1)(2010-2#1)
substantial degradation of##2##3##(1997-2#1)(2008-2#1)
substantial degree of##2##3##(2010-2#1)(2012-3#1)
substantial difference##5##2##(1990-5#1)(1992-3#1)(2006-8#1)(2007-3#1)(2012-1#1)
substantial differences in the##8##4##(1992-7#1)(1996-1#1)(1997-6#1)(2005-11#1)(2007-12#1)(2009-10#1)(2011-2#1)(2012-3#1)
substantial differences in##13##3##(1992-6#1)(1992-7#1)(1996-1#1)(1997-6#1)(2005-11#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-3#1)(2009-10#1)(2011-2#1)(2012-3#1)
substantial differences##16##2##(1992-6#1)(1992-7#1)(1995-3#1)(1996-1#1)(1997-6#1)(2005-11#1)(2006-11#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-3#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-3#1)
substantial effects on##3##3##(2008-10#1)(2010-2#1)(2012-2#1)
substantial effects##4##2##(1995-3#1)(2008-10#1)(2010-2#1)(2012-2#1)
substantial effort to##2##3##(2008-3#1)(2011-2#1)
substantial effort##3##2##(2008-3#1)(2011-2#2)
substantial enhancement##4##2##(1997-3#1)(1997-6#1)(2008-10#1)(2008-3#1)
substantial evidence that##3##3##(1992-5#1)(1994-11#1)(2008-11#1)
substantial evidence##13##2##(1991-8#1)(1992-5#1)(1994-11#1)(2005-10#1)(2005-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-3#1)(2012-2#1)(2013-1#2)
substantial excitation##2##2##(1994-2#1)(2012-12#1)
substantial financial##4##2##(2006-8#1)(2007-11#1)(2009-7#1)(2012-12#1)
substantial gains##3##2##(1997-7#1)(2008-3#1)(2012-3#1)
substantial genetic##2##2##(2009-5#1)(2012-3#1)
substantial health care##2##3##(1995-3#1)(2010-2#1)
substantial impact of##2##3##(2007-7#1)(2008-8#1)
substantial impact on##6##3##(1993-8#1)(1995-5#1)(2006-10#1)(2008-5#1)(2010-12#1)(2012-12#1)
substantial impact##10##2##(1993-8#1)(1995-1#1)(1995-5#1)(2006-10#1)(2007-7#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-3#1)(2012-12#1)
substantial improvement in the##4##4##(1995-12#1)(2007-12#1)(2007-8#1)(2008-10#1)
substantial improvement in##8##3##(1995-12#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-6#1)
substantial improvement of##2##3##(1990-10#1)(1997-1#1)
substantial improvement##14##2##(1990-10#1)(1995-12#1)(1997-1#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#2)(2012-2#1)
substantial improvements in the##3##4##(1991-4#1)(2009-11#1)(2010-5#1)
substantial improvements in##10##3##(1991-4#1)(1994-12#1)(1994-2#1)(2006-6#1)(2007-4#1)(2009-11#1)(2010-5#1)(2011-1#1)(2012-1#1)(2013-1#1)
substantial improvements##12##2##(1991-4#1)(1994-12#1)(1994-2#1)(2006-6#1)(2007-4#1)(2007-5#1)(2009-11#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-1#1)(2013-1#1)
substantial increase in the##7##4##(1990-8#1)(1992-2#1)(1997-3#1)(2008-1#1)(2008-10#2)(2011-2#1)
substantial increase in##24##3##(1990-8#1)(1991-2#1)(1991-8#1)(1992-2#1)(1993-5#1)(1994-12#1)(1995-1#1)(1995-3#1)(1997-3#1)(2005-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2009-11#1)(2009-5#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
substantial increase of the##2##4##(1994-2#1)(2008-10#1)
substantial increase of##4##3##(1991-6#1)(1994-2#1)(2008-10#2)
substantial increase##31##2##(1990-8#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-2#1)(1993-5#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-3#1)(1997-3#1)(2005-11#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#2)(2009-11#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#2)(2013-1#1)
substantial increases in##5##3##(1990-12#2)(1996-7#1)(2008-8#1)(2012-2#1)
substantial increases##6##2##(1990-12#2)(1996-7#1)(2008-10#1)(2008-8#1)(2012-2#1)
substantial influence on the##2##4##(2005-10#1)(2008-10#1)
substantial influence##3##2##(2005-10#1)(2008-10#1)(2009-7#1)
substantial information##3##2##(1991-2#1)(1993-11#1)(2007-1#1)
substantial inhibition##2##2##(1992-8#1)(1993-8#1)
substantial intraobserver reproducibility##2##3##(1997-8#1)(2011-2#1)
substantial involvement of the##2##4##(1995-11#1)(2006-10#1)
substantial levels of##4##3##(1990-12#1)(1995-12#1)(1996-4#1)(2007-11#1)
substantial levels##5##2##(1990-12#1)(1990-8#1)(1995-12#1)(1996-4#1)(2007-11#1)
substantial loss of##4##3##(1994-9#1)(2006-7#1)(2008-5#1)(2013-1#1)
substantial minority of##3##3##(2006-10#1)(2006-7#1)(2013-1#1)
substantial morbidity and mortality##4##4##(2006-8#1)(2007-8#1)(2008-7#1)(2008-8#1)
substantial morbidity and##5##3##(2006-8#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-11#1)
substantial morbidity##6##2##(2006-8#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)
substantial number of individuals##2##4##(2008-2#1)(2010-12#1)
substantial number of patients##7##4##(2005-6#2)(2006-10#1)(2007-2#1)(2008-6#2)(2009-2#1)
substantial number of##20##3##(1992-2#1)(1993-1#1)(1994-11#1)(1994-6#1)(2005-6#2)(2006-10#1)(2006-8#2)(2007-2#2)(2007-4#1)(2007-7#1)(2008-2#1)(2008-6#2)(2009-2#1)(2010-12#1)(2012-12#1)(2013-1#1)
substantial numbers of##4##3##(1990-7#1)(1995-12#1)(1996-9#1)(2008-12#1)
substantial numbers##5##2##(1990-7#1)(1995-12#1)(1996-9#1)(2007-8#1)(2008-12#1)
substantial obstacles##2##2##(1992-6#1)(2012-12#1)
substantial overlap in the##2##4##(1994-3#1)(2012-11#1)
substantial part of the##4##4##(1990-5#1)(1992-2#1)(1995-1#1)(2008-7#1)
substantial part of##6##3##(1990-5#1)(1992-2#1)(1995-1#1)(2007-9#1)(2008-7#1)(2011-2#1)
substantial part##7##2##(1990-5#1)(1992-2#1)(1995-1#1)(2007-9#1)(2008-11#1)(2008-7#1)(2011-2#1)
substantial percentage of##3##3##(2007-11#1)(2007-7#1)(2013-1#1)
substantial percentage##4##2##(1992-9#1)(2007-11#1)(2007-7#1)(2013-1#1)
substantial potential##2##2##(2007-12#1)(2012-2#1)
substantial problem for##4##3##(1991-12#1)(1997-7#1)(2007-1#1)(2008-7#1)
substantial problem##6##2##(1991-12#1)(1997-7#1)(2007-1#1)(2008-7#1)(2009-4#1)(2011-1#1)
substantial progress has been made in the understanding of##2##9##(1992-2#1)(1995-11#1)
substantial progress has been made in##4##6##(1992-2#1)(1995-11#1)(2008-3#1)(2012-12#1)
substantial progress in the##2##4##(2005-11#1)(2007-12#1)
substantial progress in##3##3##(2005-11#1)(2007-12#1)(2010-12#1)
substantial progress##8##2##(1992-2#1)(1995-11#1)(2005-11#1)(2005-8#1)(2007-12#1)(2008-3#1)(2010-12#1)(2012-12#1)
substantial proportion of##13##3##(1991-9#1)(1996-4#1)(2005-7#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-5#1)(2008-3#1)(2010-1#1)(2010-12#1)(2013-1#2)(2013-8#1)
substantial proportion##15##2##(1991-9#1)(1996-4#1)(2005-7#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-5#1)(2008-12#1)(2008-3#1)(2010-1#1)(2010-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
substantial proportions of##2##3##(2007-12#1)(2012-3#1)
substantial proportions##3##2##(1991-2#1)(2007-12#1)(2012-3#1)
substantial protection against##3##3##(1990-11#1)(1990-8#1)(2008-5#1)
substantial protection##4##2##(1990-11#1)(1990-8#1)(2008-5#1)(2011-2#1)
substantial public health##4##3##(1993-12#1)(2008-1#1)(2011-2#1)(2013-8#1)
substantial quantities of##3##3##(1992-10#1)(1992-8#1)(1994-11#1)
substantial reduction in##7##3##(1991-12#1)(1993-1#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2012-12#1)
substantial reduction of##4##3##(1990-8#1)(1991-5#1)(1991-8#1)(2010-2#1)
substantial reduction##11##2##(1990-8#1)(1991-12#1)(1991-5#1)(1991-8#1)(1993-1#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2010-2#1)(2012-12#1)
substantial reductions in##6##3##(1992-2#1)(1992-4#1)(2008-10#1)(2011-3#1)(2012-3#1)(2013-7#1)
substantial results##2##2##(1990-4#1)(1993-3#1)
substantial risk of##4##3##(2005-8#1)(2007-11#1)(2009-11#1)(2013-1#1)
substantial risk##7##2##(1990-11#1)(2005-8#1)(2007-10#1)(2007-11#1)(2008-4#1)(2009-11#1)(2013-1#1)
substantial savings in##2##3##(1993-3#1)(2008-3#1)
substantial sequence##3##2##(1990-7#1)(1997-7#1)(2008-10#1)
substantial suppression of##2##3##(2007-11#1)(2008-1#1)
substantial uncertainty##2##2##(2011-2#2)
substantial variation in##5##3##(1992-12#1)(1995-6#1)(2008-10#1)(2010-3#1)(2012-12#1)
substantial variations in##2##3##(1991-1#1)(1993-11#1)
substantial variations##3##2##(1991-1#1)(1993-11#1)(1997-1#1)
substantial##695##1##(1990-10#2)(1990-11#5)(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#3)(1990-7#3)(1990-8#6)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#4)(1991-2#4)(1991-3#4)(1991-4#2)(1991-5#4)(1991-6#4)(1991-7#3)(1991-8#3)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#8)(1992-3#4)(1992-4#2)(1992-5#3)(1992-6#4)(1992-7#2)(1992-8#4)(1992-9#2)(1993-1#2)(1993-11#4)(1993-12#4)(1993-2#3)(1993-3#6)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#3)(1993-9#1)(1994-10#2)(1994-11#7)(1994-12#5)(1994-2#5)(1994-3#6)(1994-6#5)(1994-8#3)(1994-9#2)(1995-1#5)(1995-10#1)(1995-11#4)(1995-12#4)(1995-2#2)(1995-3#7)(1995-4#1)(1995-5#3)(1995-6#3)(1995-8#3)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#3)(1996-7#1)(1996-9#1)(1997-1#6)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#4)(1997-8#7)(2004-10#1)(2004-2#1)(2005-10#3)(2005-11#6)(2005-12#1)(2005-6#2)(2005-7#6)(2005-8#3)(2006-10#18)(2006-11#1)(2006-12#6)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#3)(2006-8#9)(2006-9#1)(2007-1#4)(2007-10#7)(2007-11#17)(2007-12#7)(2007-2#5)(2007-3#1)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#9)(2007-8#7)(2007-9#4)(2008-1#6)(2008-10#32)(2008-11#14)(2008-12#8)(2008-2#8)(2008-3#20)(2008-4#6)(2008-5#9)(2008-6#8)(2008-7#14)(2008-8#15)(2008-9#3)(2009-10#3)(2009-11#4)(2009-12#3)(2009-2#3)(2009-3#3)(2009-4#2)(2009-5#6)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#2)(2010-1#3)(2010-10#4)(2010-11#3)(2010-12#10)(2010-2#9)(2010-3#7)(2010-4#4)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#5)(2011-12#2)(2011-2#17)(2011-3#1)(2012-1#6)(2012-11#2)(2012-12#13)(2012-2#15)(2012-3#8)(2013-1#21)(2013-7#1)(2013-8#12)
substantially affect##2##2##(2007-11#1)(2012-2#1)
substantially affected by the##2##4##(1990-8#1)(2008-10#1)
substantially affected by##4##3##(1990-8#1)(2005-11#1)(2008-10#1)(2012-3#1)
substantially after##3##2##(1990-9#1)(2007-11#1)(2008-7#1)
substantially alleviated##2##2##(1994-3#1)(2008-10#1)
substantially alter the##2##3##(2005-11#1)(2010-3#1)
substantially alter##5##2##(1993-12#1)(1995-1#1)(2005-11#1)(2010-3#1)(2012-1#1)
substantially altered the##2##3##(1995-10#1)(1997-3#1)
substantially altered##5##2##(1993-4#1)(1995-10#1)(1997-2#1)(1997-3#1)(2008-10#1)
substantially as the##2##3##(2007-12#1)(2008-2#1)
substantially at##2##2##(1990-5#1)(2008-9#1)
substantially attenuated##2##2##(1996-12#1)(2008-5#1)
substantially better results than##2##4##(1991-6#1)(2007-12#1)
substantially better##6##2##(1991-6#1)(1993-9#1)(2007-12#2)(2008-2#1)(2011-2#1)
substantially between##4##2##(1994-5#1)(2006-12#1)(2008-10#1)(2008-11#1)
substantially by##5##2##(1991-3#1)(1992-6#1)(2007-9#1)(2008-3#1)(2012-3#1)
substantially contribute to##3##3##(1995-6#1)(2008-8#1)(2009-4#1)
substantially contributed to##2##3##(2006-10#1)(2008-8#1)
substantially correlated with##2##3##(2011-1#1)(2012-3#1)
substantially decrease##4##2##(2006-4#1)(2007-11#1)(2008-7#1)(2010-1#1)
substantially decreased the##3##3##(1990-11#1)(1992-5#1)(1996-7#1)
substantially decreased##10##2##(1990-11#1)(1992-2#1)(1992-5#1)(1995-11#1)(1996-11#2)(1996-7#1)(2008-4#1)(2009-10#1)(2010-2#1)
substantially decreases##2##2##(1995-1#1)(2009-5#1)
substantially delayed##2##2##(1997-3#2)
substantially different from that of##2##5##(2007-11#1)(2008-3#1)
substantially different from##3##3##(1992-12#1)(2007-11#1)(2008-3#1)
substantially different##9##2##(1992-12#1)(1993-4#1)(1994-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-12#1)(2013-8#1)
substantially during the##2##3##(2008-3#1)(2009-3#1)
substantially during##3##2##(2008-3#1)(2009-3#1)(2012-1#1)
substantially elevated##3##2##(1994-9#1)(1996-5#1)(2009-8#1)
substantially enhance##2##2##(2007-12#1)(2008-10#1)
substantially enhanced##3##2##(1991-5#1)(1993-8#1)(2006-12#1)
substantially fewer##2##2##(1995-9#1)(1996-3#1)
substantially from those of##2##4##(1990-8#1)(2008-7#1)
substantially from those##4##3##(1990-8#1)(1994-1#1)(1997-5#1)(2008-7#1)
substantially from##15##2##(1990-8#1)(1994-1#1)(1997-2#1)(1997-5#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-1#1)(2011-12#1)(2013-1#2)(2013-8#1)
substantially greater than that##2##4##(1991-2#1)(2008-2#1)
substantially greater than##5##3##(1991-2#1)(1992-9#1)(1994-3#1)(2008-2#1)(2010-10#1)
substantially greater##10##2##(1991-2#1)(1992-9#1)(1994-3#1)(1996-12#1)(2005-10#1)(2007-12#1)(2008-2#1)(2010-10#2)(2012-12#1)
substantially high##2##2##(2007-12#1)(2008-10#1)
substantially higher rates##2##3##(1995-2#1)(2006-5#1)
substantially higher risk##2##3##(2012-3#1)(2013-7#1)
substantially higher than the##2##4##(1991-9#1)(2007-12#1)
substantially higher than those in##2##5##(1995-8#1)(2008-6#1)
substantially higher than those##3##4##(1995-8#1)(2008-6#1)(2011-1#1)
substantially higher than##9##3##(1991-9#1)(1992-12#1)(1995-8#1)(1997-7#1)(2007-12#1)(2007-4#1)(2008-6#1)(2011-1#1)(2012-2#1)
substantially higher##24##2##(1991-9#2)(1992-12#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-7#1)(2006-5#1)(2007-12#1)(2007-4#1)(2008-3#1)(2008-6#1)(2009-10#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
substantially improve the performance of##2##5##(2007-12#1)(2008-10#1)
substantially improve the performance##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
substantially improve##8##2##(1990-12#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-12#1)
substantially improved and##2##3##(1992-3#1)(2008-3#1)
substantially improved by##2##3##(1993-12#1)(2008-7#1)
substantially improved##12##2##(1992-3#1)(1993-12#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-7#2)(2010-8#1)(2013-1#3)
substantially improves the##3##3##(2007-11#2)(2012-12#1)
substantially in recent years##3##4##(1994-6#1)(2008-5#1)(2008-7#1)
substantially in recent##4##3##(1994-6#1)(2008-5#1)(2008-7#1)(2012-2#1)
substantially in response to##2##4##(2008-5#1)(2009-9#1)
substantially in##18##2##(1994-6#1)(1996-9#1)(2006-10#2)(2006-8#1)(2007-10#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-9#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#2)
substantially increase the##4##3##(2007-12#1)(2007-8#1)(2008-8#2)
substantially increased in##3##3##(1994-3#1)(2008-10#1)(2008-6#1)
substantially increased##14##2##(1992-8#1)(1992-9#1)(1994-3#2)(1996-5#1)(1997-7#1)(2006-10#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-6#1)(2013-8#1)
substantially increases the##5##3##(1992-9#1)(2007-11#1)(2008-2#1)(2008-6#2)
substantially increases##6##2##(1992-9#1)(2007-11#1)(2008-2#1)(2008-6#2)(2008-8#1)
substantially influence the aging process##2##5##(1994-6#1)(2009-12#1)
substantially influence the##3##3##(1994-6#1)(2009-12#1)(2011-1#1)
substantially influence##4##2##(1994-6#1)(1996-3#1)(2009-12#1)(2011-1#1)
substantially inhibited the##2##3##(2004-9#1)(2008-6#1)
substantially inhibited##3##2##(1995-2#1)(2004-9#1)(2008-6#1)
substantially larger than##3##3##(2005-11#1)(2005-8#1)(2012-1#1)
substantially larger##5##2##(2005-11#2)(2005-8#1)(2012-1#1)(2012-2#1)
substantially less##11##2##(1992-2#1)(1993-2#1)(1994-5#1)(1994-9#1)(2007-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-3#1)(2013-1#1)
substantially longer than##2##3##(2006-10#1)(2009-4#1)
substantially lower than##4##3##(1993-12#1)(1993-3#1)(1995-1#1)(2008-10#1)
substantially lower##19##2##(1991-12#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-5#1)(1997-2#2)(2007-10#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-5#1)
substantially more##14##2##(1990-12#1)(1991-3#1)(1993-12#1)(1994-3#1)(1994-9#1)(1995-4#1)(2006-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-3#1)
substantially normal##2##2##(1991-2#1)(2009-2#1)
substantially on##4##2##(2006-10#1)(2008-10#1)(2010-8#1)(2012-12#1)
substantially over the##2##3##(1992-5#1)(2006-2#1)
substantially over##3##2##(1992-5#1)(2006-2#1)(2007-8#1)
substantially reduce the##13##3##(1992-8#1)(1993-12#1)(1994-11#1)(1995-10#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#2)(2008-6#1)(2008-8#1)(2011-1#1)
substantially reduce##15##2##(1992-8#1)(1993-12#1)(1994-11#1)(1994-12#1)(1995-10#1)(2006-4#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#2)(2008-6#1)(2008-8#1)(2011-1#1)
substantially reduced for##2##3##(1992-6#1)(2008-2#1)
substantially reduced in##2##3##(1990-8#1)(2008-8#1)
substantially reduced the##3##3##(1993-11#1)(1994-5#1)(2008-10#1)
substantially reduced##29##2##(1990-8#1)(1991-12#1)(1992-1#1)(1992-4#1)(1992-6#1)(1993-11#1)(1994-10#1)(1994-3#2)(1994-5#1)(1997-3#1)(1997-7#1)(2004-4#1)(2005-12#1)(2007-1#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#1)
substantially reduces the##4##3##(1995-2#1)(1995-8#1)(2008-2#1)(2008-6#1)
substantially reduces##7##2##(1995-2#1)(1995-8#1)(2005-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)
substantially reducing the##2##3##(1990-12#1)(1992-9#1)
substantially reducing##4##2##(1990-12#1)(1992-9#1)(1995-3#1)(2008-10#1)
substantially similar##3##2##(1990-3#1)(1992-11#1)(2008-1#1)
substantially the##8##2##(1993-3#1)(1994-9#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-9#1)(2011-2#1)(2012-2#1)
substantially to the##9##3##(1991-8#1)(1995-8#1)(1996-3#2)(1997-2#1)(2005-1#1)(2007-8#1)(2007-9#1)(2008-3#1)
substantially to##16##2##(1991-8#1)(1992-9#1)(1995-8#1)(1996-3#2)(1997-2#1)(2005-1#1)(2007-8#2)(2007-9#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-7#1)(2011-2#1)(2012-3#1)
substantially while##2##2##(1997-2#1)(2010-2#1)
substantially with##7##2##(1991-3#1)(1992-5#1)(1994-6#1)(1997-6#1)(2006-11#1)(2009-3#1)(2010-12#1)
substantially##490##1##(1990-1#2)(1990-10#1)(1990-11#2)(1990-12#5)(1990-3#2)(1990-5#1)(1990-8#3)(1990-9#1)(1991-12#3)(1991-2#3)(1991-3#3)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#4)(1992-1#4)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#2)(1992-5#4)(1992-6#2)(1992-8#2)(1992-9#5)(1993-1#1)(1993-11#1)(1993-12#6)(1993-2#2)(1993-3#3)(1993-4#3)(1993-5#1)(1993-8#2)(1993-9#4)(1994-1#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#8)(1994-5#3)(1994-6#5)(1994-8#1)(1994-9#5)(1995-1#3)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#4)(1995-9#1)(1996-11#2)(1996-12#5)(1996-3#6)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#7)(1997-3#4)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2004-12#1)(2004-4#2)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#6)(2005-12#1)(2005-8#1)(2006-10#10)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#10)(2007-12#20)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#5)(2008-1#1)(2008-10#32)(2008-11#6)(2008-2#16)(2008-3#18)(2008-4#5)(2008-5#7)(2008-6#7)(2008-7#14)(2008-8#15)(2008-9#4)(2009-10#4)(2009-12#3)(2009-2#1)(2009-3#4)(2009-4#2)(2009-5#4)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#3)(2010-7#3)(2010-8#5)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#4)(2012-1#8)(2012-12#4)(2012-2#6)(2012-3#12)(2012-4#1)(2013-1#8)(2013-7#1)(2013-8#4)
substantiate the hypothesis that##2##4##(1992-12#1)(1995-10#1)
substantiate the##13##2##(1990-2#1)(1991-3#1)(1992-12#1)(1993-3#1)(1995-10#1)(1996-8#1)(2007-5#1)(2008-11#2)(2008-7#2)(2009-9#1)(2012-1#1)
substantiate this##2##2##(1992-5#1)(1995-12#1)
substantiate##24##1##(1990-2#1)(1991-3#1)(1992-12#1)(1992-5#1)(1992-7#1)(1993-3#1)(1995-10#1)(1995-12#1)(1996-8#1)(2006-12#1)(2007-11#1)(2007-5#1)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
substantiated and##2##2##(2006-10#1)(2008-3#1)
substantiated by##14##2##(1990-5#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-3#1)(2006-3#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)
substantiated that##2##2##(2008-10#1)(2012-12#1)
substantiated with##2##2##(2008-5#1)(2010-5#1)
substantiated##35##1##(1990-12#1)(1990-3#1)(1990-5#1)(1991-10#1)(1991-3#1)(1992-11#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-3#1)(2006-10#2)(2006-3#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)(2009-2#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
substantiates the##6##2##(1991-6#1)(1994-12#1)(2007-2#1)(2008-10#2)(2009-3#1)
substantiates##8##1##(1991-2#1)(1991-6#1)(1994-12#1)(2007-2#1)(2008-10#2)(2008-8#1)(2009-3#1)
substantiating##4##1##(1991-3#1)(2008-10#2)(2009-3#1)
substantiation of##2##2##(2011-1#2)
substantiation##3##1##(2008-5#1)(2011-1#2)
substantive clinical##2##2##(2005-6#1)(2007-10#1)
substantive factors##2##2##(1997-2#1)(2008-6#1)
substantive##23##1##(1995-8#1)(1996-1#1)(1996-3#1)(1997-2#1)(2004-10#1)(2005-10#1)(2005-6#1)(2006-11#1)(2007-10#2)(2008-1#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-12#1)(2009-4#3)(2010-7#1)(2010-8#1)(2012-11#1)(2012-2#1)(2013-1#1)
substantively##6##1##(1995-8#2)(2008-4#1)(2011-1#1)(2013-1#2)
substantivity to##2##2##(2008-5#2)
substantivity##9##1##(2006-2#1)(2008-5#8)
substate##5##1##(1990-8#3)(1994-12#1)(1997-1#1)
substates##3##1##(1992-12#1)(1994-3#1)(1997-4#1)
substituent as##2##2##(1995-3#1)(1997-4#1)
substituent at C-2##3##3##(1996-5#2)(1997-2#1)
substituent at C3##2##3##(1991-10#1)(1993-4#1)
substituent at the##6##3##(1995-2#1)(1995-3#1)(1997-1#1)(2005-11#1)(2006-12#1)(2009-8#1)
substituent at##14##2##(1991-10#1)(1993-4#2)(1995-2#1)(1995-3#1)(1996-5#2)(1997-1#2)(1997-2#1)(2005-11#1)(2006-12#2)(2009-8#1)
substituent constants##2##2##(2005-8#1)(2007-11#1)
substituent effects##4##2##(2005-8#1)(2007-11#1)(2009-5#1)(2010-12#1)
substituent group##3##2##(1991-4#2)(2008-10#1)
substituent groups##3##2##(2005-11#1)(2007-11#1)(2010-11#1)
substituent in the##4##3##(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#1)
substituent in##8##2##(1994-9#1)(1997-2#1)(1997-4#1)(2005-10#1)(2007-11#1)(2008-10#2)(2010-5#1)
substituent is##6##2##(1990-7#1)(1995-3#1)(1996-5#1)(1997-1#1)(2006-12#1)(2008-10#1)
substituent of 2##2##3##(1996-8#2)
substituent of the##2##3##(1992-11#1)(1994-9#1)
substituent of##11##2##(1992-11#1)(1994-9#1)(1995-2#1)(1996-2#2)(1996-8#3)(1997-1#1)(1997-7#1)(2010-11#1)
substituent on the##4##3##(1992-3#2)(1992-6#1)(2007-11#1)
substituent on##5##2##(1991-5#1)(1992-3#2)(1992-6#1)(2007-11#1)
substituent to##2##2##(1995-3#1)(1996-2#1)
substituent was##3##2##(1994-9#1)(2008-10#2)
substituent##107##1##(1990-12#1)(1990-3#1)(1990-5#2)(1990-7#1)(1991-10#2)(1991-2#1)(1991-4#5)(1991-5#1)(1992-11#1)(1992-3#2)(1992-6#1)(1993-4#4)(1994-5#1)(1994-9#5)(1995-2#4)(1995-3#6)(1995-7#1)(1996-2#4)(1996-5#4)(1996-8#3)(1996-9#1)(1997-1#5)(1997-2#3)(1997-4#2)(1997-7#1)(2005-10#1)(2005-11#2)(2005-4#1)(2005-8#2)(2006-12#5)(2007-11#8)(2007-12#1)(2008-10#10)(2008-2#1)(2008-5#1)(2008-6#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-5#2)(2010-8#1)(2012-3#1)
substituent's##2##1##(2008-10#2)
substituents and##4##2##(1996-8#2)(2007-11#1)(2008-3#1)
substituents are##4##2##(1992-3#1)(1993-12#1)(2004-7#1)(2008-10#1)
substituents at the##3##3##(1995-3#1)(2009-10#1)(2010-6#1)
substituents at##10##2##(1992-6#1)(1993-9#1)(1994-9#1)(1995-3#1)(1997-1#2)(2007-11#1)(2009-10#2)(2010-6#1)
substituents in a##2##3##(2008-4#1)(2010-5#1)
substituents in positions##2##3##(1992-1#1)(2006-3#1)
substituents in the##6##3##(1990-11#1)(1991-9#1)(1995-5#2)(1996-2#1)(1996-8#1)
substituents in##14##2##(1990-11#1)(1991-9#1)(1992-1#1)(1992-8#1)(1995-5#2)(1996-2#2)(1996-8#1)(2006-3#1)(2008-10#2)(2008-4#1)(2010-5#1)
substituents is##3##2##(1995-4#1)(2007-11#1)(2009-7#1)
substituents of##5##2##(1993-6#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-5#1)
substituents on the##8##3##(1992-8#1)(1994-5#1)(1994-9#3)(1997-1#1)(2009-10#1)(2009-9#1)
substituents on##10##2##(1992-8#1)(1994-5#1)(1994-9#4)(1997-1#1)(2007-11#1)(2009-10#1)(2009-9#1)
substituents to the##2##3##(1994-5#1)(1994-7#1)
substituents was##2##2##(1993-4#1)(2007-11#1)
substituents were##5##2##(1994-9#1)(1997-2#1)(1997-8#1)(2005-11#1)(2007-11#1)
substituents##112##1##(1990-11#1)(1990-12#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-4#5)(1993-6#1)(1993-9#1)(1994-5#2)(1994-7#1)(1994-8#1)(1994-9#7)(1995-11#1)(1995-3#1)(1995-4#2)(1995-5#3)(1995-6#2)(1996-2#6)(1996-5#2)(1996-8#3)(1997-1#4)(1997-2#1)(1997-4#1)(1997-7#3)(1997-8#1)(2004-7#1)(2005-11#1)(2006-12#3)(2006-3#3)(2007-10#2)(2007-11#10)(2008-10#6)(2008-3#2)(2008-4#2)(2008-5#3)(2009-10#3)(2009-5#1)(2009-7#2)(2009-9#3)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#2)(2012-3#1)
substitutable##5##1##(1996-3#1)(2008-8#2)(2013-1#2)
substitute a##2##2##(2006-4#1)(2008-9#1)
substitute decision-maker##2##2##(1991-6#2)
substitute for a##4##3##(1990-11#1)(1992-3#1)(2008-10#1)(2008-3#1)
substitute for ethanol##2##3##(1996-10#1)(1997-7#1)
substitute for inpatient##2##3##(1991-1#1)(1996-3#1)
substitute for soybean meal##2##4##(2012-2#2)
substitute for the##15##3##(1992-7#1)(1993-3#1)(1993-9#1)(1995-11#1)(1995-2#1)(1996-3#1)(1996-4#1)(1996-9#2)(2007-8#2)(2008-10#2)(2008-3#1)(2008-5#1)
substitute for##76##2##(1990-11#3)(1991-1#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-9#2)(1995-1#2)(1995-11#3)(1995-2#4)(1995-3#1)(1996-10#1)(1996-3#3)(1996-4#1)(1996-8#1)(1996-9#3)(1997-7#1)(2006-10#1)(2007-1#1)(2007-10#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#2)(2012-2#2)(2012-3#2)(2013-1#1)
substitute or##2##2##(1996-9#1)(2010-10#1)
substitute the##8##2##(1997-2#1)(2006-10#2)(2008-11#3)(2008-8#1)(2010-11#1)
substitute to##4##2##(2006-7#1)(2008-2#1)(2008-8#1)(2010-2#1)
substitute was##2##2##(1994-12#1)(2010-4#1)
substitute with##2##2##(2007-8#1)(2008-7#1)
substitute##148##1##(1990-11#3)(1991-1#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-9#3)(1995-1#2)(1995-11#4)(1995-2#4)(1995-3#1)(1995-8#1)(1996-1#1)(1996-10#2)(1996-3#3)(1996-4#1)(1996-8#1)(1996-9#4)(1997-1#1)(1997-2#2)(1997-5#1)(1997-7#1)(2005-7#2)(2006-10#3)(2006-11#1)(2006-3#1)(2006-4#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#10)(2008-11#6)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#2)(2009-7#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-4#3)(2010-5#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-2#2)(2012-3#5)(2013-1#3)
substituted 6##2##2##(2007-10#2)
substituted L-CCG-IV##2##2##(1991-5#2)
substituted alkenes##2##2##(2007-11#1)(2010-7#1)
substituted amino acid##2##3##(1996-5#1)(2011-2#1)
substituted analogs##5##2##(1994-8#1)(1996-4#4)
substituted analogue##3##2##(1991-7#2)(2006-10#1)
substituted and##2##2##(1990-4#1)(2005-11#1)
substituted aromatic##2##2##(2008-10#1)(2011-1#1)
substituted at position##5##3##(1992-6#2)(1994-11#1)(1996-5#1)(1997-6#1)
substituted at positions##3##3##(1990-2#1)(1991-2#2)
substituted at the##5##3##(1995-5#1)(2005-11#1)(2007-11#2)(2010-6#1)
substituted at##16##2##(1990-2#1)(1991-2#2)(1992-2#1)(1992-6#2)(1994-11#1)(1995-2#2)(1995-5#1)(1996-5#1)(1997-6#1)(2005-11#1)(2007-11#2)(2010-6#1)
substituted benzaldehyde##2##2##(1995-7#1)(2012-3#1)
substituted benzamides##3##2##(1990-5#1)(2008-10#1)(2008-7#1)
substituted benzenes##2##2##(2008-10#2)
substituted by a##6##3##(1992-8#1)(1994-9#1)(1995-2#1)(1996-9#1)(2008-10#1)(2010-8#1)
substituted by##28##2##(1990-10#1)(1990-12#1)(1990-7#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-8#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-9#1)(1997-4#1)(2005-4#1)(2008-10#4)(2008-11#1)(2008-8#2)(2010-8#1)
substituted consent##3##2##(1995-2#3)
substituted dTTP##2##2##(1997-6#2)
substituted derivatives##3##2##(1997-8#2)(2008-5#1)
substituted fluorenes##3##2##(2009-3#3)
substituted for by##2##3##(1995-5#1)(2012-12#1)
substituted for one##2##3##(2005-11#1)(2011-2#1)
substituted for the##11##3##(1990-12#2)(1990-8#1)(1992-8#1)(1992-9#1)(1995-3#1)(2007-12#1)(2008-10#2)(2008-2#1)(2013-8#1)
substituted for##38##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-7#1)(1990-8#1)(1991-7#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-8#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-7#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-12#2)(2007-12#1)(2008-10#2)(2008-2#2)(2008-5#1)(2008-8#1)(2011-12#1)(2011-2#3)(2012-12#1)(2013-8#1)
substituted in the##7##3##(1992-6#1)(1993-4#1)(1996-5#1)(1997-2#1)(1997-8#1)(2008-4#1)(2008-7#1)
substituted in##9##2##(1992-6#1)(1993-4#1)(1996-5#2)(1997-2#1)(1997-8#1)(2008-4#1)(2008-7#1)(2009-3#1)
substituted into##3##2##(1991-7#1)(2008-10#1)(2008-3#1)
substituted isoxazolines-2##2##2##(2008-5#2)
substituted mutants##2##2##(1993-11#1)(1995-5#1)
substituted on the##2##3##(2008-11#1)(2009-9#1)
substituted or##2##2##(2008-10#1)(2008-2#1)
substituted purines##3##2##(1992-2#3)
substituted residues##3##2##(1992-9#1)(1997-6#2)
substituted the##2##2##(1994-8#1)(2008-8#1)
substituted with a##7##3##(1992-6#1)(1993-6#1)(1994-5#1)(1994-9#1)(1995-11#1)(2008-10#1)(2009-5#1)
substituted with fluorine##2##3##(1992-5#1)(2009-9#1)
substituted with one##2##3##(1996-10#1)(2008-10#1)
substituted with the##3##3##(1996-5#1)(2008-10#1)(2011-2#1)
substituted with##34##2##(1990-8#2)(1991-2#1)(1992-11#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-6#1)(1994-10#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#2)(1996-10#3)(1996-5#1)(1996-8#1)(1997-3#1)(2005-11#1)(2008-10#4)(2008-5#2)(2009-5#1)(2009-6#1)(2009-9#1)(2011-2#1)(2013-8#1)
substituted xylose##2##2##(1992-3#2)
substituted##321##1##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#2)(1990-4#2)(1990-5#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-12#1)(1991-2#4)(1991-4#1)(1991-5#4)(1991-6#1)(1991-7#4)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#4)(1992-3#2)(1992-5#1)(1992-6#9)(1992-7#1)(1992-8#4)(1992-9#2)(1993-11#3)(1993-12#1)(1993-4#1)(1993-6#2)(1993-8#2)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#3)(1995-2#7)(1995-3#3)(1995-5#6)(1995-6#3)(1995-7#1)(1996-10#7)(1996-11#1)(1996-2#2)(1996-4#5)(1996-5#9)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#6)(1997-7#1)(1997-8#4)(2005-11#4)(2005-4#2)(2006-10#2)(2006-12#5)(2006-4#1)(2007-10#6)(2007-11#18)(2007-12#1)(2008-1#1)(2008-10#33)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#15)(2008-6#1)(2008-7#2)(2008-8#12)(2009-3#8)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#5)(2010-11#2)(2010-12#2)(2010-2#3)(2010-6#4)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-3#2)(2013-8#4)
substituted-4-aminoquinazoline##2##1##(2007-10#2)
substitutes and##3##2##(1996-7#1)(2008-7#1)(2008-8#1)
substitutes are a##2##3##(1991-11#1)(2005-7#1)
substitutes are##4##2##(1991-11#1)(2005-7#1)(2006-10#1)(2008-7#1)
substitutes for the##4##3##(1993-12#1)(1995-4#1)(1996-10#1)(2012-3#1)
substitutes for##22##2##(1990-3#1)(1990-4#1)(1992-12#1)(1992-3#1)(1993-12#1)(1995-1#1)(1995-4#1)(1996-10#1)(1996-12#1)(2006-10#1)(2007-11#3)(2007-8#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-3#2)
substitutes have##4##2##(2005-7#1)(2006-10#1)(2007-8#1)(2010-6#1)
substitutes in##5##2##(1994-3#1)(2006-9#2)(2008-11#1)(2008-5#1)
substitutes is##2##2##(2008-7#1)(2012-12#1)
substitutes that##2##2##(2006-6#1)(2013-1#1)
substitutes the##3##2##(1994-12#1)(2006-10#1)(2008-10#1)
substitutes to##5##2##(2005-7#1)(2006-9#1)(2007-7#1)(2011-2#1)(2013-1#1)
substitutes used##2##2##(2005-7#1)(2008-8#1)
substitutes were##3##2##(2006-9#2)(2008-8#1)
substitutes##94##1##(1990-3#1)(1990-4#1)(1991-1#1)(1991-11#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-3#2)(1993-12#1)(1994-12#1)(1994-3#1)(1995-1#2)(1995-3#1)(1995-4#1)(1996-10#1)(1996-12#1)(1996-7#1)(1997-4#1)(2005-7#6)(2006-10#7)(2006-6#1)(2006-9#6)(2007-11#4)(2007-12#3)(2007-4#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-10#2)(2008-11#7)(2008-5#3)(2008-7#4)(2008-8#5)(2008-9#1)(2009-4#1)(2009-7#3)(2010-6#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
substitutes) in##2##2##(1997-6#1)(2006-10#1)
substituting the##10##2##(1992-4#1)(1994-11#1)(1995-5#1)(1997-2#1)(1997-4#1)(2007-2#1)(2008-10#2)(2008-11#1)(2012-3#1)
substituting##43##1##(1990-12#1)(1990-2#1)(1990-5#1)(1991-2#1)(1992-3#1)(1992-4#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#3)(1994-9#2)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1997-2#1)(1997-4#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-5#1)(2010-4#3)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
substitution abolished the##2##3##(1995-3#1)(1995-5#1)
substitution abolished##3##2##(1995-3#1)(1995-5#2)
substitution and the##2##3##(1991-8#1)(2010-4#1)
substitution and##18##2##(1990-7#1)(1991-7#1)(1991-8#1)(1994-6#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-11#2)(2008-4#1)(2008-7#2)(2008-9#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-11#2)
substitution at amino acid##3##4##(1993-6#1)(1994-3#1)(1995-12#1)
substitution at cDNA##2##3##(1991-10#2)
substitution at position##7##3##(1991-9#1)(1992-8#1)(1996-5#1)(1997-6#1)(2006-6#1)(2008-3#2)
substitution at residue##2##3##(1991-9#1)(1995-2#1)
substitution at the##6##3##(1993-4#1)(1994-11#3)(1997-6#1)(2011-1#1)
substitution at##35##2##(1990-7#1)(1991-10#2)(1991-12#1)(1991-9#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-11#3)(1994-3#1)(1995-12#1)(1995-2#1)(1996-2#2)(1996-4#1)(1996-5#1)(1997-1#1)(1997-6#2)(2006-6#1)(2007-11#1)(2008-2#1)(2008-3#4)(2008-9#1)(2009-3#1)(2009-5#1)(2011-1#1)
substitution by##7##2##(1990-8#1)(1992-3#2)(1994-8#1)(1995-5#1)(1997-7#1)(2007-11#1)
substitution caused##2##2##(1995-6#1)(1996-1#1)
substitution degree##3##2##(2008-10#1)(2008-5#2)
substitution favored A3##2##3##(1994-9#2)
substitution for ethanol##2##3##(1997-7#2)
substitution for the##2##3##(2008-4#1)(2013-7#1)
substitution for##7##2##(1992-4#1)(1996-8#1)(1997-7#2)(2005-4#1)(2008-4#1)(2013-7#1)
substitution gradients##2##2##(2010-3#2)
substitution had##2##2##(1990-8#1)(1991-4#1)
substitution has##2##2##(1990-12#1)(2008-10#1)
substitution in a##2##3##(1990-2#1)(2005-6#1)
substitution in exon##2##3##(2008-5#1)(2011-1#1)
substitution in the conserved##2##4##(1992-2#1)(1996-10#1)
substitution in the##19##3##(1990-10#1)(1991-1#1)(1991-11#1)(1991-2#1)(1992-2#1)(1992-4#1)(1993-3#2)(1994-8#1)(1994-9#1)(1995-8#1)(1996-10#1)(1996-5#1)(2007-2#1)(2008-10#3)(2008-6#1)(2008-9#1)
substitution in##38##2##(1990-10#1)(1990-11#1)(1990-2#1)(1991-1#1)(1991-11#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-3#3)(1993-6#1)(1994-1#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-5#1)(1997-5#1)(2005-6#1)(2007-2#1)(2007-6#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-9#2)(2010-4#1)(2011-1#1)(2012-1#1)
substitution is##5##2##(1993-11#1)(1997-6#1)(2005-11#1)(2008-2#1)(2008-9#1)
substitution line##10##2##(2008-10#7)(2008-5#1)(2008-8#2)
substitution lines##3##2##(2008-10#3)
substitution may##2##2##(1997-5#1)(1997-7#1)
substitution mutagenesis##2##2##(1995-11#1)(1997-4#1)
substitution mutant##2##2##(1991-2#1)(2008-10#1)
substitution mutants##3##2##(1994-9#1)(1995-11#1)(1997-1#1)
substitution mutations##2##2##(1992-3#1)(1995-3#1)
substitution of Ala##2##3##(1990-3#1)(1992-4#1)
substitution of a glycine##2##4##(1996-7#1)(1996-8#1)
substitution of a single amino acid##2##6##(1991-4#1)(1995-3#1)
substitution of a single##3##4##(1991-4#1)(1995-3#1)(1995-4#1)
substitution of a##14##3##(1991-10#1)(1991-12#1)(1991-4#1)(1991-7#1)(1993-3#1)(1993-8#1)(1995-3#1)(1995-4#1)(1996-7#1)(1996-8#1)(2006-12#1)(2007-3#1)(2008-10#1)(2011-2#1)
substitution of amino acids##2##4##(1995-8#1)(2008-10#1)
substitution of an##4##3##(1995-1#1)(1995-6#1)(1996-2#1)(2011-2#1)
substitution of aspartic acid for##2##5##(1990-12#1)(1991-4#1)
substitution of beta2AR sequence into##2##5##(1996-5#2)
substitution of beta2AR sequence##3##4##(1996-5#3)
substitution of fluoride##2##3##(1994-9#1)(1996-2#1)
substitution of generic##2##3##(1990-12#1)(2011-1#1)
substitution of glutamine##2##3##(1990-8#1)(1991-5#1)
substitution of leucine for##2##4##(1992-8#1)(1994-9#1)
substitution of leucine##3##3##(1992-8#1)(1994-11#1)(1994-9#1)
substitution of lysine for##2##4##(1991-8#2)
substitution of one of the##2##5##(1995-5#1)(2009-9#1)
substitution of one##4##3##(1995-5#1)(1996-6#1)(1997-7#1)(2009-9#1)
substitution of proline##3##3##(1994-12#1)(1995-1#1)(2011-1#1)
substitution of serine for##2##4##(1991-9#1)(1994-9#1)
substitution of serine##3##3##(1991-9#1)(1994-11#1)(1994-9#1)
substitution of the##20##3##(1990-12#1)(1990-7#1)(1990-8#1)(1992-9#1)(1993-11#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1996-2#1)(1996-8#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#2)(2010-4#2)
substitution of##151##2##(1990-11#1)(1990-12#6)(1990-2#2)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#2)(1990-8#3)(1991-10#1)(1991-12#2)(1991-4#2)(1991-5#1)(1991-7#4)(1991-8#2)(1991-9#3)(1992-1#1)(1992-11#2)(1992-4#3)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#2)(1993-3#3)(1993-7#1)(1993-8#2)(1994-11#5)(1994-12#1)(1994-2#2)(1994-3#1)(1994-4#2)(1994-5#2)(1994-9#6)(1995-1#3)(1995-10#1)(1995-11#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-2#3)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#3)(1997-4#1)(1997-7#4)(2005-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-6#1)(2007-8#3)(2007-9#2)(2008-10#6)(2008-11#3)(2008-4#2)(2008-5#4)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-4#3)(2010-5#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#2)
substitution on the##6##3##(1992-5#1)(1997-2#1)(2007-8#1)(2008-8#2)(2009-7#1)
substitution on##10##2##(1992-12#1)(1992-5#1)(1997-2#1)(2007-8#2)(2008-10#1)(2008-8#2)(2009-7#1)(2010-4#1)
substitution or##2##2##(1996-2#1)(2008-5#1)
substitution pattern and##3##3##(1990-12#2)(2005-7#1)
substitution pattern of##4##3##(1996-8#1)(1997-1#1)(2007-1#1)(2009-9#1)
substitution pattern was##2##3##(1991-7#1)(1996-9#1)
substitution pattern##16##2##(1990-12#2)(1991-7#1)(1995-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(2005-7#3)(2007-1#1)(2008-10#2)(2009-9#1)(2012-12#1)
substitution patterns##5##2##(1996-8#1)(2006-12#1)(2007-11#1)(2008-6#1)(2013-1#1)
substitution process##4##2##(1991-2#3)(2010-3#1)
substitution rate##3##2##(2008-10#1)(2008-4#1)(2009-5#1)
substitution rates##3##2##(1997-6#1)(2008-8#1)(2010-3#1)
substitution reaction in metallic complex##2##5##(2008-10#2)
substitution reaction##8##2##(1990-8#1)(2006-9#1)(2008-10#4)(2008-6#1)(2010-4#1)
substitution reactions##3##2##(2007-11#1)(2008-12#1)(2008-5#1)
substitution resulted in##3##3##(1992-2#1)(1994-8#1)(1995-2#1)
substitution results in##2##3##(1993-6#1)(2008-10#1)
substitution technique##2##2##(2008-2#1)(2008-3#1)
substitution that##3##2##(1990-8#1)(1994-5#1)(1994-6#1)
substitution therapy##8##2##(1996-8#1)(2006-10#2)(2006-9#1)(2012-1#2)(2013-8#2)
substitution to##6##2##(1990-7#1)(1992-3#1)(1994-9#1)(1997-5#1)(2007-10#1)(2008-4#1)
substitution treatment##2##2##(2005-1#1)(2009-7#1)
substitution using##2##2##(2006-10#1)(2008-10#1)
substitution was identified##2##3##(1993-3#1)(2010-11#1)
substitution was##7##2##(1992-6#1)(1993-3#1)(1993-8#1)(1996-9#1)(2008-2#1)(2010-11#1)(2010-4#1)
substitution were##3##2##(1991-9#1)(2008-10#1)(2008-7#1)
substitution which##4##2##(1990-10#1)(1991-8#1)(1995-4#1)(1996-7#1)
substitution with##15##2##(1990-4#1)(1991-2#2)(1993-4#1)(1994-9#1)(1995-1#1)(1996-6#1)(1997-2#1)(2005-10#1)(2006-9#1)(2008-10#1)(2009-2#1)(2010-8#1)(2011-1#1)(2012-12#1)
substitution within the##2##3##(1991-2#1)(2008-10#1)
substitution##566##1##(1990-10#2)(1990-11#3)(1990-12#11)(1990-2#4)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#5)(1990-8#8)(1991-1#1)(1991-10#5)(1991-11#1)(1991-12#7)(1991-2#9)(1991-4#4)(1991-5#3)(1991-6#1)(1991-7#12)(1991-8#4)(1991-9#7)(1992-1#1)(1992-11#3)(1992-12#5)(1992-2#2)(1992-3#7)(1992-4#5)(1992-5#2)(1992-6#3)(1992-8#3)(1992-9#2)(1993-11#4)(1993-12#3)(1993-2#4)(1993-3#7)(1993-4#2)(1993-6#6)(1993-7#1)(1993-8#4)(1994-1#1)(1994-11#8)(1994-12#2)(1994-2#2)(1994-3#3)(1994-4#2)(1994-5#5)(1994-6#3)(1994-8#4)(1994-9#15)(1995-1#4)(1995-10#1)(1995-11#4)(1995-12#1)(1995-2#2)(1995-3#5)(1995-4#2)(1995-5#9)(1995-6#3)(1995-8#4)(1996-1#1)(1996-10#1)(1996-2#7)(1996-4#1)(1996-5#9)(1996-6#4)(1996-7#2)(1996-8#8)(1996-9#2)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#5)(1997-5#8)(1997-6#6)(1997-7#11)(1997-8#2)(2005-1#1)(2005-10#1)(2005-11#6)(2005-4#1)(2005-6#1)(2005-7#3)(2005-8#1)(2006-10#6)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#4)(2006-8#1)(2006-9#4)(2007-1#2)(2007-10#4)(2007-11#13)(2007-12#6)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#3)(2007-8#6)(2007-9#5)(2008-1#2)(2008-10#45)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#12)(2008-5#11)(2008-6#3)(2008-7#5)(2008-8#13)(2008-9#6)(2009-10#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#2)(2009-9#3)(2010-11#2)(2010-2#2)(2010-3#4)(2010-4#11)(2010-5#2)(2010-6#2)(2010-8#1)(2011-1#7)(2011-2#4)(2011-3#1)(2012-1#4)(2012-11#3)(2012-12#3)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#2)
substitution)##2##1##(1996-9#1)(2008-2#1)
substitutional##5##1##(2006-6#1)(2008-10#1)(2008-8#1)(2009-2#1)(2009-3#1)
substitutions and##9##2##(1993-11#1)(1994-5#2)(1995-6#2)(1996-8#1)(2008-10#1)(2008-4#1)(2008-8#1)
substitutions are##6##2##(1993-4#1)(1996-4#1)(1996-5#1)(1997-9#1)(2006-12#1)(2013-1#1)
substitutions as##2##2##(1992-6#1)(2008-4#1)
substitutions at codon##2##3##(1990-4#1)(1991-10#1)
substitutions at each position##2##4##(1992-6#1)(1994-12#1)
substitutions at each##3##3##(1992-6#1)(1994-12#1)(1994-3#1)
substitutions at position##5##3##(1994-3#2)(1994-8#3)
substitutions at positions##4##3##(1990-3#1)(1991-12#1)(1997-4#1)(1997-8#1)
substitutions at residues##2##3##(1990-4#1)(1990-8#1)
substitutions at the##8##3##(1991-10#1)(1992-6#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-3#1)(2008-4#1)(2009-3#1)
substitutions at##37##2##(1990-3#3)(1990-4#3)(1990-7#1)(1990-8#1)(1991-10#2)(1991-12#1)(1992-6#2)(1993-11#1)(1993-3#1)(1994-12#1)(1994-3#4)(1994-8#3)(1994-9#2)(1995-1#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-7#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-4#2)(2009-3#1)
substitutions between##4##2##(1990-7#1)(1993-6#1)(2008-6#1)(2009-8#1)
substitutions compared with##2##3##(1997-8#2)
substitutions could##2##2##(1990-2#1)(1995-8#1)
substitutions did not##2##3##(1991-2#1)(1995-8#1)
substitutions for lactate dehydrogenase genes A (muscle) and B (heart)##2##10##(1990-4#2)
substitutions for the##2##3##(1990-4#1)(1993-11#1)
substitutions for##6##2##(1990-4#3)(1993-11#1)(1996-7#1)(2008-7#1)
substitutions had##2##2##(1991-8#1)(1997-7#1)
substitutions have##2##2##(1996-8#1)(1997-4#1)
substitutions in the smectite layer##2##5##(2005-11#2)
substitutions in the##26##3##(1991-2#1)(1991-6#1)(1991-9#1)(1993-12#2)(1993-6#1)(1994-2#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-8#3)(1996-10#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-7#1)(2005-11#3)(2008-10#2)(2012-12#1)(2013-8#1)
substitutions in##49##2##(1990-11#1)(1991-10#2)(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-2#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-2#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-3#1)(1995-8#3)(1996-10#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-5#1)(1997-7#1)(2005-11#3)(2007-11#1)(2008-10#2)(2008-4#1)(2008-8#2)(2008-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-8#3)
substitutions occur disproportionately often in nonbranching enzymes##2##7##(2013-1#2)
substitutions occur disproportionately often in##3##5##(2013-1#3)
substitutions occur##4##2##(2008-10#1)(2013-1#3)
substitutions occurring at##2##3##(1990-7#1)(1993-3#1)
substitutions of the##2##3##(1992-6#1)(1992-9#1)
substitutions of##17##2##(1992-2#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-3#1)(1994-9#4)(1995-5#1)(1996-5#1)(1996-7#1)(2008-10#1)(2008-6#1)(2010-5#1)
substitutions on the##8##3##(1990-8#1)(1991-7#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-3#1)(1997-3#1)
substitutions on##10##2##(1990-8#1)(1991-7#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-3#1)(2012-11#1)
substitutions or##2##2##(1991-2#1)(1991-9#1)
substitutions significantly##2##2##(1994-3#1)(2009-4#1)
substitutions that##3##2##(1990-8#1)(1995-8#1)(2011-1#1)
substitutions was##3##2##(1990-12#1)(2006-12#1)(2013-1#1)
substitutions were made##3##3##(1991-10#1)(1997-9#1)(2007-11#1)
substitutions were##10##2##(1991-10#1)(1992-5#1)(1993-2#1)(1995-8#1)(1996-7#1)(1997-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)
substitutions within the##2##3##(1994-3#1)(1997-4#1)
substitutions within##5##2##(1990-12#1)(1994-2#1)(1994-3#1)(1995-3#1)(1997-4#1)
substitutions##261##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#3)(1990-4#7)(1990-7#3)(1990-8#8)(1991-10#7)(1991-12#1)(1991-2#4)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-2#3)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#6)(1992-9#2)(1993-11#3)(1993-12#5)(1993-2#2)(1993-3#6)(1993-4#1)(1993-5#1)(1993-6#4)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#9)(1994-5#3)(1994-8#5)(1994-9#11)(1995-1#3)(1995-10#3)(1995-11#2)(1995-2#2)(1995-3#4)(1995-5#2)(1995-6#2)(1995-8#11)(1996-10#2)(1996-11#1)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#3)(1996-6#2)(1996-7#5)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-7#2)(1997-8#3)(1997-9#3)(2005-11#3)(2006-10#2)(2006-12#2)(2007-11#2)(2007-8#1)(2008-10#11)(2008-3#1)(2008-4#13)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#1)(2011-1#2)(2012-1#2)(2012-11#1)(2012-12#1)(2013-1#8)(2013-8#4)
substitutive hormonal##2##2##(1991-11#1)(1993-2#1)
substitutive noise##3##2##(2008-3#3)
substitutive therapy##2##2##(2013-1#2)
substitutive##9##1##(1991-11#1)(1992-3#1)(1993-2#1)(2004-4#1)(2008-3#3)(2013-1#2)
substoichiometric amounts##2##2##(2005-12#1)(2007-10#1)
substoichiometric##6##1##(1995-3#1)(1997-6#1)(2005-12#1)(2007-10#1)(2008-10#2)
substomatal chambers##2##2##(2008-10#2)
substomatal##6##1##(2007-7#2)(2008-10#4)
substrain##4##1##(1995-8#2)(1997-4#1)(2008-6#1)
substrains##2##1##(1993-3#1)(2008-7#1)
substrata and##3##2##(1991-11#1)(1994-8#2)
substrata for##2##2##(2008-5#1)(2010-8#1)
substrata in##2##2##(2006-3#1)(2007-5#1)
substrata##19##1##(1991-11#1)(1992-9#1)(1994-10#1)(1994-8#6)(2006-3#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-5#2)(2008-7#1)(2010-3#1)(2010-8#1)
substrate (Km##3##2##(1991-4#1)(1992-3#1)(1992-9#1)
substrate (e##4##2##(2005-11#1)(2008-10#1)(2008-5#1)(2010-6#1)
substrate (i##2##2##(1990-5#1)(2008-3#1)
substrate (kcat/Km =##2##3##(1992-12#1)(1994-5#1)
substrate (or##2##2##(1992-9#1)(2008-2#1)
substrate RC3/neurogranin##2##2##(1997-2#2)
substrate activity##3##2##(1994-9#1)(1997-6#1)(2008-11#1)
substrate affinities##3##2##(1992-1#1)(1995-2#1)(1995-6#1)
substrate affinity##5##2##(1990-12#1)(1991-5#1)(1994-9#1)(1996-7#1)(1997-7#1)
substrate among##2##2##(1994-12#1)(1994-9#1)
substrate analog##6##2##(1990-8#2)(1994-9#1)(1995-2#1)(1995-8#1)(1997-4#1)
substrate analogs##5##2##(1990-10#1)(1992-5#1)(1992-6#1)(1995-3#1)(2005-11#1)
substrate analogue##6##2##(1992-5#3)(1992-6#1)(1993-11#1)(2008-4#1)
substrate analogues with##2##3##(1992-12#2)
substrate analogues##7##2##(1990-5#1)(1992-12#3)(1996-7#1)(2005-11#1)(2009-9#1)
substrate and a##3##3##(1990-2#1)(1992-11#1)(2010-2#1)
substrate and an##3##3##(1990-7#1)(1991-5#1)(2008-10#1)
substrate and enzyme##2##3##(1990-4#1)(2010-3#1)
substrate and metabolite##2##3##(1991-3#1)(2008-11#1)
substrate and product##5##3##(1990-6#1)(1994-5#1)(1994-8#1)(2008-6#1)(2008-7#1)
substrate and the other##2##4##(2005-11#1)(2007-12#1)
substrate and the##17##3##(1990-2#1)(1991-7#1)(1992-5#1)(1993-4#1)(1994-5#1)(1994-9#1)(2005-11#2)(2007-12#1)(2007-8#1)(2008-2#1)(2008-4#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
substrate and##102##2##(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#1)(1991-10#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#2)(1993-4#1)(1993-8#3)(1994-11#2)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#3)(1995-3#2)(2004-4#1)(2005-11#2)(2005-12#1)(2006-3#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-8#3)(2007-9#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
substrate are##9##2##(1992-3#1)(2005-11#1)(2007-12#1)(2008-2#3)(2008-3#3)
substrate as a##2##3##(1995-2#1)(2006-5#1)
substrate as well as##2##4##(1995-5#1)(1996-5#1)
substrate as##8##2##(1990-7#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-5#1)(2006-5#1)(2008-10#1)(2008-2#1)
substrate assisted##2##2##(1995-3#2)
substrate at a##2##3##(1997-4#1)(2007-12#1)
substrate at low##2##3##(2010-4#1)(2011-2#1)
substrate at the##3##3##(1991-9#1)(1995-10#1)(2011-2#1)
substrate at##11##2##(1991-9#1)(1994-9#1)(1995-10#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-3#1)(2010-4#1)(2011-2#2)
substrate availability##2##2##(2006-5#1)(2013-1#1)
substrate bias##2##2##(2009-4#1)(2010-4#1)
substrate binding and catalytic activity##2##5##(1992-5#1)(1996-5#1)
substrate binding and cleaving-joining##2##4##(1996-5#2)
substrate binding and##10##3##(1992-5#1)(1993-8#1)(1995-10#1)(1995-5#1)(1996-5#3)(2009-9#1)(2012-3#1)(2013-8#1)
substrate binding is##4##3##(1994-8#1)(1995-10#1)(1995-6#1)(2006-10#1)
substrate binding pocket##4##3##(1990-5#1)(1994-5#1)(1995-5#1)(2013-8#1)
substrate binding region##2##3##(1992-6#1)(1994-9#1)
substrate binding site##8##3##(1992-11#1)(1992-3#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-3#1)(1996-7#1)
substrate binding##63##2##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-4#3)(1991-5#1)(1991-7#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#4)(1994-8#1)(1994-9#2)(1995-10#3)(1995-3#1)(1995-5#2)(1995-6#2)(1996-5#6)(1996-7#2)(1997-2#1)(1997-7#1)(2006-10#2)(2007-11#2)(2008-4#1)(2009-9#1)(2011-1#1)(2012-2#3)(2012-3#1)(2013-8#2)
substrate binds##2##2##(1992-3#1)(2008-4#1)
substrate but##6##2##(1991-2#1)(1992-9#1)(1993-6#1)(1995-8#1)(2010-4#1)(2011-2#1)
substrate by a##2##3##(2008-2#2)
substrate by use of##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
substrate by##24##2##(1990-8#1)(1991-8#1)(1992-11#1)(1992-3#1)(1994-12#1)(1995-10#1)(1996-9#1)(2004-1#1)(2005-11#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-2#3)(2008-3#2)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
substrate can##2##2##(2007-11#1)(2008-11#1)
substrate chain##2##2##(1996-7#1)(2012-3#1)
substrate characteristics##4##2##(2008-5#3)(2011-2#1)
substrate colonization##3##2##(2008-10#3)
substrate compared to##2##3##(1993-6#1)(2009-7#1)
substrate compared##3##2##(1992-2#1)(1993-6#1)(2009-7#1)
substrate concentration and##2##3##(2008-7#1)(2010-10#1)
substrate concentration##18##2##(1991-7#1)(1992-3#1)(1994-11#1)(1994-8#1)(1995-10#1)(1995-11#1)(1997-4#1)(2006-8#2)(2008-5#2)(2008-6#2)(2008-7#4)(2010-10#1)
substrate concentrations and##2##3##(1994-9#1)(2006-12#1)
substrate concentrations##18##2##(1990-5#1)(1991-2#1)(1991-7#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-8#1)(1994-9#2)(1996-5#2)(2006-12#1)(2008-10#1)(2008-6#1)(2008-7#2)(2010-7#1)(2011-1#1)
substrate consumption rate##2##3##(2008-7#2)
substrate consumption##9##2##(1996-7#1)(2008-11#1)(2008-7#7)
substrate containing##3##2##(1991-12#1)(1992-3#1)(2006-12#1)
substrate conversion##4##2##(2008-6#2)(2008-7#1)(2011-12#1)
substrate cycles##3##2##(1991-2#3)
substrate degradation##2##2##(1994-5#1)(2007-8#1)
substrate delivery##2##2##(2006-10#1)(2007-9#1)
substrate deprivation and simulated ischemia##2##5##(1994-2#2)
substrate discrimination##3##2##(2009-3#1)(2011-1#2)
substrate does not##3##3##(1991-8#1)(1992-3#1)(1994-11#1)
substrate during a##2##3##(1992-3#1)(1993-12#1)
substrate during the##2##3##(2005-11#1)(2008-5#1)
substrate during##7##2##(1992-3#1)(1993-12#1)(2005-11#1)(2008-2#1)(2008-5#2)(2008-7#1)
substrate efficiency##2##2##(1994-3#2)
substrate exchange##2##2##(1990-9#1)(1991-4#1)
substrate exposed to##2##3##(2008-10#1)(2008-11#1)
substrate factor X##2##3##(1995-8#2)
substrate for SSAO##2##3##(1995-1#2)
substrate for a##4##3##(1991-10#1)(1992-1#1)(1995-5#1)(2012-2#1)
substrate for both##2##3##(1994-11#1)(2012-2#1)
substrate for human##3##3##(1994-11#1)(1996-4#1)(2008-5#1)
substrate for measuring##2##3##(1995-3#1)(2008-10#1)
substrate for producing##2##3##(2008-6#1)(2008-7#1)
substrate for protein kinase C##2##5##(1994-11#1)(1995-6#1)
substrate for protein##6##3##(1994-11#1)(1994-5#1)(1995-11#1)(1995-6#1)(2008-7#1)(2009-9#1)
substrate for src kinase in vitro##2##6##(1994-6#2)
substrate for the V-ATPase##2##4##(1995-6#1)(1996-5#1)
substrate for the enzyme##3##4##(1991-5#1)(1993-3#1)(1994-9#1)
substrate for the preparation of##2##5##(2008-10#2)
substrate for the wild-type enzyme##2##5##(1991-5#1)(1995-8#1)
substrate for the##39##3##(1990-11#1)(1990-4#1)(1990-5#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-5#5)(1992-3#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#3)(1997-4#1)(1997-8#1)(2008-10#6)(2009-6#1)(2013-8#1)
substrate for this enzyme##2##4##(1993-4#1)(1997-4#1)
substrate for this##3##3##(1991-7#1)(1993-4#1)(1997-4#1)
substrate for tyrosine##3##3##(1992-7#1)(1993-9#1)(1996-1#1)
substrate for##162##2##(1990-11#1)(1990-4#1)(1990-5#1)(1990-7#2)(1991-1#1)(1991-10#5)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#7)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-2#2)(1992-3#3)(1992-4#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#5)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#5)(1994-9#3)(1995-1#3)(1995-11#2)(1995-12#1)(1995-2#7)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#2)(1996-5#3)(1996-7#5)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#2)(1997-8#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-9#1)(2008-10#14)(2008-11#3)(2008-4#1)(2008-5#10)(2008-6#2)(2008-7#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
substrate from##3##2##(1991-5#1)(2008-10#2)
substrate had##3##2##(1993-9#1)(2007-11#1)(2008-2#1)
substrate has##4##2##(1995-5#1)(2006-7#1)(2008-11#1)(2008-7#1)
substrate have been##3##3##(1992-12#1)(1994-8#1)(2005-11#1)
substrate have##4##2##(1992-12#1)(1994-8#1)(2005-11#1)(2013-1#1)
substrate hydrolysis by##2##3##(1990-8#1)(1991-2#1)
substrate hydrolysis##8##2##(1990-3#1)(1990-8#1)(1991-2#2)(1991-4#1)(1991-7#1)(1993-8#1)(1994-11#1)
substrate in a##5##3##(1990-5#1)(1995-2#1)(1997-1#1)(2005-11#1)(2011-2#1)
substrate in an##2##3##(1993-8#1)(1995-2#1)
substrate in the##17##3##(1990-10#1)(1990-11#1)(1992-9#1)(1993-2#1)(1994-11#1)(1994-5#1)(1995-8#1)(1996-2#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2009-2#1)(2013-1#1)
substrate in##44##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-11#2)(1994-5#2)(1995-11#1)(1995-2#2)(1995-8#1)(1996-2#1)(1997-1#2)(1997-8#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-2#1)(2009-3#2)(2011-2#1)(2012-2#1)(2013-1#1)
substrate inhibition in ATCase##2##4##(1997-2#2)
substrate inhibition in##4##3##(1996-7#1)(1997-2#2)(2008-7#1)
substrate inhibition of##2##3##(1990-5#1)(1997-2#1)
substrate inhibition with##2##3##(1994-11#1)(1996-7#1)
substrate inhibition##23##2##(1990-5#3)(1991-12#1)(1991-7#1)(1992-3#1)(1992-6#1)(1994-11#1)(1996-7#2)(1997-2#9)(2008-6#1)(2008-7#2)(2010-10#1)
substrate interference##2##2##(2013-7#2)
substrate into##5##2##(1990-5#1)(1990-8#1)(1994-11#2)(1994-6#1)
substrate is a protein##2##4##(1991-10#1)(2008-4#1)
substrate is a##4##3##(1991-10#1)(1995-1#1)(2008-1#1)(2008-4#1)
substrate is bound##2##3##(1994-5#1)(1997-4#1)
substrate is described##2##3##(2007-12#1)(2008-2#1)
substrate is made##2##3##(2008-3#1)(2012-2#1)
substrate is proposed##2##3##(2007-12#1)(2008-3#1)
substrate is rotated##2##3##(2008-3#2)
substrate is##46##2##(1990-12#1)(1990-3#1)(1991-10#1)(1991-5#1)(1992-11#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#2)(1996-4#1)(1996-7#1)(1997-4#1)(2004-9#1)(2007-12#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#6)(2008-3#6)(2008-4#3)(2012-2#1)(2012-3#1)
substrate levels##2##2##(1996-8#2)
substrate luciferin##2##2##(1997-4#1)(2008-10#1)
substrate material for##3##3##(2008-10#1)(2008-3#1)(2013-7#1)
substrate material##6##2##(2008-10#2)(2008-3#2)(2013-7#1)(2013-8#1)
substrate materials##5##2##(2008-3#2)(2010-4#1)(2013-8#2)
substrate may be##2##3##(1990-10#1)(2009-11#1)
substrate metabolism##3##2##(1997-8#1)(2010-8#1)(2012-3#1)
substrate molecule##6##2##(1992-11#1)(1992-3#1)(1995-5#1)(2008-11#1)(2010-7#2)
substrate molecules and##3##3##(1992-3#2)(2008-10#1)
substrate molecules##7##2##(1992-3#5)(1994-8#1)(2008-10#1)
substrate of PKC##2##3##(1991-8#1)(1995-8#1)
substrate of protein kinase C in##2##6##(1990-10#1)(1990-11#1)
substrate of protein kinase C##5##5##(1990-10#1)(1990-11#1)(1990-5#1)(1991-8#1)(1992-6#1)
substrate of protein##6##3##(1990-10#1)(1990-11#1)(1990-5#1)(1991-8#1)(1992-6#1)(1994-5#1)
substrate of staphylococcal nuclease##2##4##(1991-7#2)
substrate of the enzyme##2##4##(1994-3#1)(1994-8#1)
substrate of the##9##3##(1990-11#1)(1992-12#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-3#1)(2007-10#1)(2008-10#1)(2008-11#1)
substrate of this##2##3##(1995-3#1)(2011-1#1)
substrate of##57##2##(1990-10#3)(1990-11#2)(1990-5#2)(1990-7#2)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-3#2)(1995-8#1)(1996-5#1)(1997-2#1)(2005-11#1)(2007-10#2)(2007-8#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#2)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
substrate on##7##2##(1990-10#1)(2006-12#2)(2007-11#1)(2007-8#1)(2008-5#1)(2010-4#1)
substrate optimization##2##2##(1994-12#1)(1997-2#1)
substrate or product##2##3##(1995-5#1)(2008-7#1)
substrate or##12##2##(1990-8#1)(1992-2#1)(1993-6#1)(1995-5#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-9#1)(2011-1#1)
substrate over##2##2##(1991-4#1)(1993-6#1)
substrate oxidation##7##2##(1994-12#2)(1996-1#1)(1997-4#1)(1997-7#1)(2008-7#1)(2009-11#1)
substrate phosphorylation##3##2##(1990-8#1)(2008-4#2)
substrate preference##6##2##(1992-11#3)(1992-8#1)(2008-8#1)(2010-2#1)
substrate preferences##3##2##(1992-11#1)(1995-2#1)(1995-8#1)
substrate present##3##2##(1993-3#1)(1994-12#1)(1995-1#1)
substrate profile##2##2##(2010-12#1)(2011-1#1)
substrate properties of##3##3##(1994-8#2)(1997-6#1)
substrate properties##4##2##(1994-8#2)(1997-6#1)(2008-3#1)
substrate protein##5##2##(1990-10#1)(1991-5#1)(1996-9#2)(2008-4#1)
substrate proteins of PARPs##2##4##(2012-11#2)
substrate proteins##8##2##(1990-9#1)(1992-7#1)(1995-2#1)(1997-4#1)(2009-6#1)(2009-7#1)(2012-11#2)
substrate proteolysis##2##2##(1991-8#2)
substrate provides##2##2##(2007-12#1)(2008-2#1)
substrate ranges##2##2##(1994-12#1)(2011-2#1)
substrate rather than##2##3##(1991-8#1)(2008-7#1)
substrate reaction##2##2##(1990-8#1)(1992-3#1)
substrate reactivity##4##2##(2008-7#4)
substrate recognition by##6##3##(1992-3#1)(1995-6#1)(1996-9#2)(2007-11#1)(2012-3#1)
substrate recognition site##2##3##(1991-6#1)(1992-6#1)
substrate recognition##13##2##(1990-1#1)(1991-2#1)(1991-6#1)(1992-3#1)(1992-6#1)(1995-6#1)(1996-9#3)(1997-4#2)(2007-11#1)(2012-3#1)
substrate recycling##2##2##(2008-10#2)
substrate relative to##2##3##(1993-6#1)(1994-11#1)
substrate release##2##2##(1995-10#2)
substrate resulted in a##3##4##(1990-10#1)(2011-2#2)
substrate resulted in##4##3##(1990-10#1)(2007-8#1)(2011-2#2)
substrate roughness##3##2##(2008-2#1)(2008-3#2)
substrate samples##5##2##(2008-10#1)(2008-3#4)
substrate selection##3##2##(1993-7#1)(1995-11#1)(2009-8#1)
substrate selectivity##3##2##(1997-7#1)(2008-11#1)(2008-5#1)
substrate showed##2##2##(1992-3#1)(2008-7#1)
substrate site##2##2##(1990-3#1)(1995-2#1)
substrate solution##4##2##(2008-10#2)(2008-4#2)
substrate specific##2##2##(2008-11#1)(2010-5#1)
substrate specificities and##5##3##(1992-12#1)(1994-2#1)(2004-4#1)(2010-3#1)(2011-2#1)
substrate specificities of monoamine oxidase##2##5##(1991-12#2)
substrate specificities of the##3##4##(1993-3#1)(1994-12#1)(1994-8#1)
substrate specificities of##10##3##(1991-12#2)(1991-4#1)(1993-3#1)(1994-12#3)(1994-8#1)(2007-11#1)(2011-2#1)
substrate specificities##26##2##(1990-4#1)(1991-12#2)(1991-4#1)(1992-12#1)(1993-3#1)(1994-12#4)(1994-2#1)(1994-3#2)(1994-8#1)(1995-2#1)(1996-4#1)(2004-4#1)(2007-11#1)(2008-4#2)(2008-5#1)(2010-3#2)(2011-1#1)(2011-2#2)
substrate specificity and##15##3##(1990-6#1)(1992-2#1)(1992-4#1)(1992-5#1)(1994-3#1)(1995-2#2)(1997-4#2)(2007-11#1)(2008-10#1)(2008-4#2)(2009-9#1)(2013-1#1)
substrate specificity as##2##3##(1990-10#1)(2006-12#1)
substrate specificity for the##2##4##(1990-9#1)(1993-9#1)
substrate specificity for##7##3##(1990-9#1)(1993-9#1)(1994-11#1)(1997-4#3)(2007-11#1)
substrate specificity of the##9##4##(1990-10#2)(1992-3#1)(1992-8#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-5#1)
substrate specificity of##31##3##(1990-10#2)(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#2)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-2#1)(1994-9#3)(1995-1#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-4#1)(2008-4#2)(2008-7#2)(2013-1#2)(2013-8#1)
substrate specificity studies##2##3##(1990-11#1)(1994-12#1)
substrate specificity##120##2##(1990-10#3)(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-4#2)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-7#2)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#4)(1995-1#3)(1995-2#5)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#3)(1996-2#1)(1996-5#4)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#6)(2006-12#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-3#3)(2008-4#8)(2008-7#2)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#4)(2013-8#1)
substrate structures##2##2##(1992-4#1)(2007-12#1)
substrate supply##3##2##(1990-3#2)(2008-7#1)
substrate surface##8##2##(2005-11#1)(2005-4#1)(2006-4#1)(2007-11#2)(2008-10#1)(2008-3#1)(2010-4#1)
substrate surfaces##3##2##(2005-11#1)(2007-8#2)
substrate syntide 2##2##3##(1993-6#1)(1994-8#1)
substrate temperature##5##2##(2008-2#1)(2008-3#4)
substrate temperatures##2##2##(2008-3#2)
substrate than##5##2##(1991-3#1)(1994-8#1)(2007-7#1)(2008-10#1)(2008-3#1)
substrate that##7##2##(1992-11#1)(1993-3#1)(1996-5#1)(2004-11#1)(2005-11#1)(2006-5#1)(2008-3#1)
substrate thickness##3##2##(2008-2#3)
substrate thicknesses##3##2##(2008-2#2)(2008-3#1)
substrate through##3##2##(1997-2#1)(2008-3#1)(2008-5#1)
substrate to a##3##3##(1994-8#1)(1996-8#1)(2009-5#1)
substrate to form a##2##4##(2008-10#2)
substrate to form##4##3##(1996-12#1)(2008-10#2)(2013-8#1)
substrate to ribozyme##2##3##(1994-9#2)
substrate to the##8##3##(1991-3#1)(1993-2#1)(1993-6#1)(1994-5#1)(1997-2#1)(2006-12#1)(2008-2#1)(2011-1#1)
substrate to which##2##3##(1995-1#1)(2008-7#1)
substrate to##46##2##(1990-2#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-4#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-7#2)(1996-8#1)(1997-2#1)(2005-11#1)(2006-12#1)(2007-12#2)(2007-8#2)(2008-10#4)(2008-2#1)(2008-3#4)(2008-4#2)(2008-6#1)(2008-7#2)(2009-5#1)(2010-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
substrate transport##2##2##(1990-11#1)(2008-11#1)
substrate turnover##2##2##(2008-12#1)(2008-6#1)
substrate types##2##2##(2008-9#1)(2009-2#1)
substrate under##4##2##(1991-1#1)(1997-4#1)(2008-3#1)(2009-6#1)
substrate upon which##2##3##(1990-12#1)(1991-3#1)
substrate uptake##8##2##(1992-6#2)(1996-2#2)(1997-4#1)(2008-7#3)
substrate used##2##2##(2008-10#2)
substrate using a##2##3##(1990-12#1)(2008-11#1)
substrate using##7##2##(1990-12#1)(1993-3#1)(2008-10#1)(2008-11#2)(2010-12#1)(2013-1#1)
substrate utilisation##2##2##(2008-10#2)
substrate utilization and##2##3##(2008-10#1)(2008-7#1)
substrate utilization in##2##3##(2008-8#1)(2010-8#1)
substrate utilization patterns##3##3##(2008-10#2)(2008-7#1)
substrate utilization rate##2##3##(2007-6#1)(2008-6#1)
substrate utilization##15##2##(2007-6#1)(2008-10#7)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2010-8#1)
substrate was 5##2##3##(2008-2#1)(2008-6#1)
substrate was studied##2##3##(1991-7#1)(2005-11#1)
substrate was##34##2##(1990-10#1)(1990-3#1)(1990-7#1)(1991-7#1)(1992-7#1)(1993-12#1)(1993-3#1)(1995-1#1)(1995-2#1)(1996-4#1)(2004-4#1)(2005-11#2)(2007-12#3)(2007-8#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#1)(2009-6#1)(2010-9#1)(2011-1#1)(2013-1#1)
substrate we##2##2##(2008-11#1)(2010-2#1)
substrate were##6##2##(1991-2#1)(1997-4#1)(2006-8#1)(2008-10#1)(2008-2#1)(2013-1#1)
substrate when##2##2##(1991-5#1)(2008-10#1)
substrate which##2##2##(1990-4#1)(1991-10#1)
substrate will give##2##3##(2008-5#1)(2009-7#1)
substrate will##3##2##(1990-5#1)(2008-5#1)(2009-7#1)
substrate with a##6##3##(1991-12#1)(1994-10#1)(2007-11#1)(2007-12#1)(2008-3#2)
substrate with the##4##3##(1995-3#1)(2008-10#1)(2008-5#1)(2013-1#1)
substrate with##27##2##(1990-7#1)(1991-12#1)(1992-2#1)(1994-10#1)(1994-11#1)(1994-8#1)(1995-10#1)(1995-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#2)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
substrate within the##2##3##(1991-8#1)(2008-4#1)
substrate within##5##2##(1990-9#1)(1991-8#1)(1993-1#1)(2008-10#1)(2008-4#1)
substrate would##2##2##(1994-11#1)(2008-5#1)
substrate##2093##1##(1990-1#1)(1990-10#17)(1990-11#13)(1990-12#17)(1990-2#10)(1990-3#14)(1990-4#9)(1990-5#23)(1990-6#3)(1990-7#16)(1990-8#17)(1990-9#8)(1991-1#7)(1991-10#11)(1991-11#3)(1991-12#12)(1991-2#24)(1991-3#9)(1991-4#13)(1991-5#32)(1991-6#4)(1991-7#17)(1991-8#18)(1991-9#16)(1992-1#5)(1992-11#19)(1992-12#15)(1992-2#13)(1992-3#38)(1992-4#10)(1992-5#9)(1992-6#17)(1992-7#9)(1992-8#8)(1992-9#20)(1993-1#1)(1993-11#9)(1993-12#7)(1993-2#5)(1993-3#11)(1993-4#3)(1993-5#1)(1993-6#13)(1993-7#4)(1993-8#17)(1993-9#6)(1994-10#1)(1994-11#32)(1994-12#22)(1994-2#8)(1994-3#17)(1994-5#28)(1994-6#6)(1994-8#28)(1994-9#28)(1995-1#18)(1995-10#16)(1995-11#9)(1995-12#3)(1995-2#44)(1995-3#18)(1995-4#1)(1995-5#16)(1995-6#13)(1995-7#2)(1995-8#19)(1996-1#3)(1996-10#1)(1996-11#3)(1996-12#5)(1996-2#8)(1996-3#1)(1996-4#10)(1996-5#26)(1996-6#2)(1996-7#22)(1996-8#8)(1996-9#11)(1997-1#16)(1997-2#25)(1997-3#4)(1997-4#25)(1997-5#1)(1997-6#8)(1997-7#8)(1997-8#5)(2003-11#1)(2004-1#1)(2004-11#3)(2004-12#1)(2004-4#4)(2004-8#1)(2004-9#3)(2005-11#32)(2005-12#2)(2005-4#1)(2005-8#3)(2006-10#5)(2006-11#1)(2006-12#11)(2006-2#5)(2006-3#1)(2006-4#1)(2006-5#7)(2006-7#3)(2006-8#7)(2007-1#1)(2007-10#4)(2007-11#27)(2007-12#49)(2007-5#3)(2007-6#2)(2007-7#3)(2007-8#30)(2007-9#6)(2008-1#8)(2008-10#148)(2008-11#51)(2008-12#5)(2008-2#48)(2008-3#99)(2008-4#43)(2008-5#51)(2008-6#22)(2008-7#80)(2008-8#6)(2008-9#2)(2009-10#1)(2009-11#8)(2009-12#1)(2009-2#4)(2009-3#4)(2009-4#2)(2009-5#4)(2009-6#5)(2009-7#8)(2009-8#2)(2009-9#9)(2010-1#3)(2010-10#4)(2010-12#6)(2010-2#8)(2010-3#3)(2010-4#12)(2010-5#2)(2010-6#1)(2010-7#7)(2010-8#4)(2010-9#3)(2011-1#20)(2011-12#5)(2011-2#28)(2012-1#1)(2012-11#3)(2012-12#3)(2012-2#25)(2012-3#13)(2013-1#19)(2013-7#7)(2013-8#12)
substrate) and##2##2##(1997-1#1)(2008-8#1)
substrate)##10##1##(1990-10#1)(1991-1#1)(1991-9#1)(1992-8#1)(1995-7#1)(1997-1#1)(2005-11#1)(2008-10#1)(2008-8#1)(2012-12#1)
substrate-GFP fusion protein##2##3##(2008-4#2)
substrate-binding domain##2##2##(1991-9#1)(2008-6#1)
substrate-binding site of the##2##4##(1991-11#1)(1992-8#1)
substrate-binding site of##4##3##(1991-11#1)(1992-8#2)(1995-3#1)
substrate-binding site##5##2##(1991-11#1)(1992-6#1)(1992-8#2)(1995-3#1)
substrate-binding##11##1##(1991-11#1)(1991-9#1)(1992-6#2)(1992-8#2)(1995-3#3)(1996-4#1)(2008-6#1)
substrate-bound##2##1##(1994-5#2)
substrate-induced##2##1##(1992-12#1)(1993-3#1)
substrate-like##2##1##(1991-6#2)
substrate-mode optics##2##2##(2008-2#2)
substrate-mode##3##1##(2008-2#3)
substrate-recognition domains##2##2##(1997-4#2)
substrate-reduced trimethylamine dehydrogenase##2##3##(1995-2#2)
substrate-reduced##3##1##(1995-2#2)(1995-6#1)
substrate-specific##2##1##(1990-11#1)(1991-2#1)
substrate/product##7##1##(1995-5#6)(2006-12#1)
substrates (i##2##2##(1991-10#1)(1995-6#1)
substrates (which##2##2##(1990-3#1)(1995-3#1)
substrates and cofactors##2##3##(2008-10#2)
substrates and electrolytes##2##3##(2008-10#2)
substrates and inhibitors of the##2##5##(1993-6#1)(1994-8#1)
substrates and inhibitors of##3##4##(1993-4#1)(1993-6#1)(1994-8#1)
substrates and inhibitors##6##3##(1991-5#1)(1993-4#1)(1993-6#1)(1994-8#2)(1995-8#1)
substrates and products of##2##4##(1991-2#1)(1991-3#1)
substrates and products##5##3##(1990-5#1)(1991-2#1)(1991-3#1)(1997-6#1)(2008-4#1)
substrates and the use of##3##5##(2006-12#1)(2008-1#1)(2008-2#1)
substrates and the##11##3##(1992-3#1)(1992-6#1)(1993-9#1)(1996-7#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)
substrates and were used##2##4##(1996-5#1)(2008-10#1)
substrates and were##3##3##(1996-5#1)(2005-8#1)(2008-10#1)
substrates and##79##2##(1990-5#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-5#1)(1991-9#1)(1992-3#2)(1992-5#1)(1992-6#2)(1993-12#1)(1993-4#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-5#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-6#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#6)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
substrates and/or##5##2##(1992-8#1)(2008-4#1)(2009-2#2)(2012-2#1)
substrates are investigated##2##3##(2007-5#1)(2008-3#1)
substrates are##24##2##(1990-11#1)(1991-9#1)(1993-3#1)(1993-8#1)(1994-11#1)(1996-5#1)(1996-7#1)(2005-11#2)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#1)(2009-2#1)(2010-4#1)(2013-7#1)
substrates as the##2##3##(1993-6#1)(2007-12#1)
substrates as##7##2##(1990-7#1)(1993-6#1)(1995-2#1)(2006-10#1)(2007-12#1)(2008-3#1)(2013-1#1)
substrates at concentrations##2##3##(1990-7#1)(1995-1#1)
substrates at low##3##3##(2008-5#2)(2011-2#1)
substrates at the##2##3##(1990-9#1)(2008-2#1)
substrates at##12##2##(1990-7#1)(1990-9#1)(1995-1#1)(1996-2#1)(2005-11#1)(2007-11#1)(2008-2#1)(2008-5#2)(2010-4#1)(2011-2#1)(2012-2#1)
substrates because of##3##3##(2008-11#1)(2008-2#2)
substrates being##2##2##(2008-11#1)(2012-2#1)
substrates but##4##2##(1993-8#1)(1994-8#1)(1994-9#1)(2007-6#1)
substrates by a##3##3##(1995-5#1)(2009-2#1)(2010-4#1)
substrates by the##6##3##(1990-8#1)(1991-7#1)(1995-3#1)(1996-8#1)(2008-2#1)(2008-4#1)
substrates by thermolysin##2##3##(1994-5#2)
substrates by##33##2##(1990-2#1)(1990-8#2)(1991-7#1)(1991-9#1)(1992-8#1)(1994-5#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-8#1)(2005-11#1)(2007-12#2)(2008-10#4)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2009-2#1)(2010-4#3)(2012-1#1)(2012-2#1)(2012-3#1)
substrates can be##5##3##(2006-12#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)
substrates can##6##2##(1991-1#1)(2006-12#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)
substrates capable of##2##3##(1990-5#1)(1994-5#1)
substrates compared with the##2##4##(1997-4#1)(2008-5#1)
substrates containing##6##2##(1992-3#1)(1994-5#1)(1995-5#1)(2007-11#1)(2008-11#1)(2013-1#1)
substrates could be##2##3##(1997-8#1)(2008-11#1)
substrates demonstrated that##2##3##(1991-9#1)(1993-3#1)
substrates during##3##2##(2008-2#2)(2008-7#1)
substrates exhibited##2##2##(1992-6#1)(1995-1#1)
substrates for P-gp##2##3##(1992-11#1)(1993-6#1)
substrates for PDGFR##2##3##(1996-9#2)
substrates for molecular##2##3##(2007-9#1)(2013-8#1)
substrates for the determination of##3##5##(1990-2#2)(1996-1#1)
substrates for the enzyme##4##4##(1994-11#2)(1994-5#1)(1994-9#1)
substrates for the formation of##2##5##(2010-1#1)(2012-12#1)
substrates for the##25##3##(1990-2#3)(1990-3#1)(1990-5#1)(1991-1#1)(1991-4#1)(1991-5#2)(1991-9#1)(1994-11#3)(1994-5#1)(1994-9#2)(1996-1#2)(2008-10#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-1#1)(2012-12#1)(2012-2#1)
substrates for this##3##3##(1992-7#1)(1993-6#1)(1994-11#1)
substrates for tyrosine##2##3##(1990-3#1)(1992-8#1)
substrates for##117##2##(1990-12#2)(1990-2#3)(1990-3#2)(1990-5#1)(1991-1#1)(1991-2#2)(1991-4#2)(1991-5#3)(1991-8#1)(1991-9#4)(1992-11#1)(1992-3#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#6)(1994-12#2)(1994-3#1)(1994-5#3)(1994-8#4)(1994-9#4)(1995-1#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-3#1)(1996-6#1)(1996-9#2)(1997-3#2)(1997-4#2)(2005-11#2)(2006-12#2)(2007-11#3)(2007-8#2)(2007-9#1)(2008-10#8)(2008-11#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#1)(2009-11#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#1)(2013-8#1)
substrates has been##3##3##(2005-11#1)(2006-5#1)(2008-10#1)
substrates have been##5##3##(2006-10#1)(2007-8#1)(2008-3#1)(2008-4#1)(2010-4#1)
substrates have##9##2##(1992-11#1)(1994-9#1)(2005-11#1)(2006-10#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-4#1)
substrates having##2##2##(1991-1#1)(2010-2#1)
substrates in a##4##3##(1994-5#2)(2008-7#2)
substrates in cactophilic Drosophila mojavensis##2##5##(2008-8#1)(2008-9#1)
substrates in human##2##3##(1992-9#1)(1993-12#1)
substrates in the##9##3##(1991-5#2)(1993-6#2)(2005-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)
substrates in which##2##3##(1997-2#1)(2008-2#1)
substrates in##39##2##(1990-12#1)(1990-4#1)(1990-9#1)(1991-11#1)(1991-5#4)(1992-10#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-5#2)(1996-12#1)(1996-7#1)(1997-2#1)(1997-3#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
substrates including##2##2##(1990-12#1)(2004-9#1)
substrates into##2##2##(2008-5#2)
substrates is of##2##3##(2008-7#1)(2012-3#1)
substrates is##15##2##(1990-7#1)(1991-2#1)(1991-8#1)(1994-5#1)(1995-1#1)(1995-5#1)(1996-5#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#3)(2011-1#1)(2012-3#1)
substrates like##2##2##(2008-11#1)(2011-2#1)
substrates need to##2##3##(2010-2#2)
substrates of MAO A than##2##5##(1993-4#2)
substrates of MAO A##3##4##(1993-4#3)
substrates of MAO B##2##4##(1993-4#2)
substrates of MAO##5##3##(1993-4#5)
substrates of learning and memory##2##5##(1996-3#1)(2008-4#1)
substrates of the##9##3##(1990-2#1)(1990-3#2)(1992-12#1)(1994-9#1)(1997-2#1)(2008-10#2)(2011-12#1)
substrates of##50##2##(1990-1#1)(1990-2#1)(1990-3#3)(1991-5#2)(1992-11#1)(1992-12#1)(1992-4#1)(1993-4#5)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-1#1)(2007-12#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-12#1)(2012-2#1)
substrates on the##2##3##(2008-3#1)(2010-3#1)
substrates on##4##2##(1990-3#1)(1992-11#1)(2008-3#1)(2010-3#1)
substrates or inhibitors of##2##4##(2009-2#1)(2012-3#1)
substrates or##9##2##(1990-10#1)(1994-5#1)(1995-11#1)(2007-8#1)(2008-2#1)(2008-7#1)(2009-2#1)(2011-1#1)(2012-3#1)
substrates revealed##2##2##(1996-5#1)(2012-3#1)
substrates should be##3##3##(1992-3#1)(2006-12#1)(2008-7#1)
substrates such as glucose##2##4##(2008-10#1)(2011-1#1)
substrates such as##15##3##(1990-12#1)(1990-7#1)(1994-8#1)(1995-11#1)(1995-3#1)(2006-2#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-4#1)(2011-1#1)
substrates tested##5##2##(1992-11#1)(1996-6#1)(2008-10#2)(2008-11#1)
substrates than##3##2##(1996-4#1)(1996-5#1)(1997-4#1)
substrates that are##5##3##(1996-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2012-2#1)
substrates that can##2##3##(1995-5#1)(2008-10#1)
substrates that##11##2##(1995-5#1)(1996-12#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-8#1)(2010-3#1)(2012-2#1)
substrates through##4##2##(2008-7#1)(2009-5#1)(2009-9#1)(2012-12#1)
substrates to produce##3##3##(2008-10#1)(2008-3#1)(2009-11#1)
substrates to the##4##3##(1991-11#1)(1993-12#1)(1994-5#1)(1994-6#1)
substrates to##19##2##(1991-1#1)(1991-11#1)(1991-5#1)(1992-7#1)(1992-8#1)(1993-12#1)(1994-5#3)(1994-6#1)(1996-5#1)(1997-7#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-11#1)(2009-12#1)
substrates up to##2##3##(2008-2#1)(2008-3#1)
substrates used##4##2##(1994-8#1)(2007-12#1)(2012-11#2)
substrates using##3##2##(2007-8#1)(2008-10#1)(2008-4#1)
substrates via##2##2##(2009-11#1)(2010-4#1)
substrates was##19##2##(1990-12#1)(1991-2#1)(1992-3#2)(1992-6#1)(1993-9#1)(1994-12#2)(1994-5#1)(1994-8#1)(1996-4#1)(1996-5#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-7#1)(2010-4#1)
substrates were &quot##2##3##(1991-9#2)
substrates were found to##2##4##(1991-7#1)(2007-8#1)
substrates were prepared by##2##4##(2007-11#1)(2007-12#1)
substrates were prepared##3##3##(1991-4#1)(2007-11#1)(2007-12#1)
substrates were tested##2##3##(2008-11#1)(2011-2#1)
substrates were##28##2##(1991-4#1)(1991-7#1)(1991-9#2)(1992-6#1)(1992-8#1)(1994-12#1)(1995-8#1)(1997-1#1)(1997-4#1)(2004-9#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-2#1)
substrates which##2##2##(2008-10#1)(2010-4#1)
substrates while##4##2##(1991-8#1)(2004-9#1)(2012-11#2)
substrates with a 3' single-stranded overhang##2##6##(2010-2#2)
substrates with a##5##3##(1991-6#1)(2008-10#1)(2010-2#2)(2010-4#1)
substrates with##28##2##(1990-10#1)(1990-9#1)(1991-4#1)(1991-6#1)(1992-9#1)(1995-3#1)(1996-5#2)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#2)(2010-2#2)(2010-4#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-11#6)
substrates##1121##1##(1990-1#1)(1990-10#5)(1990-11#8)(1990-12#12)(1990-2#6)(1990-3#11)(1990-4#4)(1990-5#12)(1990-7#10)(1990-8#6)(1990-9#3)(1991-1#8)(1991-10#3)(1991-11#3)(1991-12#3)(1991-2#17)(1991-3#4)(1991-4#6)(1991-5#18)(1991-6#1)(1991-7#5)(1991-8#6)(1991-9#23)(1992-10#3)(1992-11#7)(1992-12#7)(1992-2#2)(1992-3#14)(1992-4#1)(1992-5#3)(1992-6#16)(1992-7#3)(1992-8#13)(1992-9#6)(1993-11#4)(1993-12#7)(1993-2#3)(1993-3#7)(1993-4#8)(1993-6#10)(1993-8#7)(1993-9#4)(1994-11#11)(1994-12#9)(1994-2#1)(1994-3#9)(1994-5#26)(1994-6#4)(1994-8#18)(1994-9#13)(1995-1#11)(1995-11#4)(1995-12#1)(1995-2#5)(1995-3#8)(1995-4#2)(1995-5#6)(1995-6#5)(1995-7#2)(1995-8#5)(1996-1#3)(1996-10#1)(1996-11#2)(1996-12#7)(1996-2#2)(1996-3#4)(1996-4#3)(1996-5#15)(1996-6#6)(1996-7#5)(1996-8#1)(1996-9#3)(1997-1#3)(1997-2#4)(1997-3#7)(1997-4#9)(1997-6#2)(1997-7#5)(1997-8#3)(2004-4#2)(2004-8#1)(2004-9#4)(2005-1#1)(2005-11#22)(2005-12#1)(2005-4#1)(2005-8#2)(2006-10#3)(2006-12#9)(2006-2#5)(2006-4#3)(2006-5#5)(2006-6#2)(2006-8#3)(2006-9#2)(2007-11#17)(2007-12#19)(2007-3#1)(2007-5#4)(2007-6#1)(2007-8#15)(2007-9#3)(2008-1#8)(2008-10#80)(2008-11#28)(2008-12#1)(2008-2#40)(2008-3#36)(2008-4#24)(2008-5#27)(2008-6#6)(2008-7#34)(2008-8#5)(2008-9#5)(2009-10#1)(2009-11#6)(2009-12#2)(2009-2#13)(2009-3#4)(2009-4#3)(2009-5#5)(2009-6#3)(2009-7#1)(2009-8#4)(2009-9#3)(2010-1#2)(2010-11#1)(2010-12#6)(2010-2#13)(2010-3#2)(2010-4#19)(2010-5#3)(2010-7#4)(2010-8#1)(2010-9#2)(2011-1#11)(2011-12#3)(2011-2#11)(2012-1#3)(2012-11#11)(2012-12#5)(2012-2#18)(2012-3#6)(2013-1#6)(2013-7#1)(2013-8#3)
substrates)##3##1##(1990-11#1)(1996-4#1)(2012-2#1)
substratum and##4##2##(1994-2#1)(1995-3#1)(2007-5#1)(2008-11#1)
substratum in##2##2##(2008-11#1)(2010-3#1)
substratum or##2##2##(1990-12#1)(2011-1#1)
substratum##19##1##(1990-12#1)(1994-2#1)(1994-8#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-5#2)(2007-5#2)(2008-11#4)(2008-9#1)(2010-3#3)(2011-1#1)
substructural##2##1##(2008-7#2)
substructure and##3##2##(2008-12#1)(2012-3#1)(2013-1#1)
substructure of##2##2##(2006-12#1)(2007-12#1)
substructure##20##1##(1994-9#2)(1995-11#1)(1996-7#1)(2006-12#2)(2007-10#3)(2007-11#1)(2007-12#1)(2008-12#2)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-3#2)(2013-1#1)
substructures of the##2##3##(2005-8#1)(2006-11#1)
substructures of##3##2##(2005-8#1)(2006-11#1)(2012-3#1)
substructures##14##1##(1995-4#1)(1996-6#1)(1996-7#1)(1997-6#1)(2005-8#1)(2006-11#1)(2007-12#1)(2008-3#1)(2009-2#1)(2012-3#5)
substructuring##3##1##(2004-11#1)(2008-10#2)
substudy of##3##2##(2008-2#1)(2009-12#1)(2010-2#1)
substudy##7##1##(1993-9#1)(2008-2#1)(2008-3#2)(2009-12#1)(2009-5#1)(2010-2#1)
subsumed##2##1##(2010-9#1)(2013-1#1)
subsurface damage##4##2##(2008-2#4)
subsurface defects##2##2##(2008-2#2)
subsurface drip irrigation##7##3##(2008-10#7)
subsurface drip##9##2##(2008-10#9)
subsurface soil##2##2##(2008-10#2)
subsurface structures##2##2##(2007-12#2)
subsurface water##4##2##(2007-5#1)(2008-1#1)(2009-8#2)
subsurface##52##1##(1996-4#1)(1997-5#1)(1997-7#2)(2004-4#1)(2005-11#1)(2006-12#3)(2006-4#1)(2007-11#1)(2007-12#5)(2007-5#2)(2007-9#2)(2008-1#2)(2008-10#12)(2008-2#10)(2008-3#3)(2008-8#1)(2009-8#2)(2011-1#2)
subsurface-drip irrigation##5##2##(2008-10#5)
subsurface-drip##6##1##(2008-10#6)
subsyndromes##2##1##(1997-2#2)
subsynovial connective tissue##4##3##(2008-9#4)
subsynovial##5##1##(2008-9#4)(2009-3#1)
subsystem is based on##2##4##(2008-10#1)(2008-3#1)
subsystem##15##1##(1993-8#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#4)(2009-1#1)(2011-1#2)
subsystems and the analysis of##2##5##(2008-11#2)
subsystems and##4##2##(2008-11#2)(2008-2#1)(2012-1#1)
subsystems##22##1##(2006-10#2)(2008-10#4)(2008-11#3)(2008-2#4)(2008-3#2)(2010-2#1)(2010-8#1)(2011-1#2)(2012-1#1)(2013-1#2)
subtalar arthrodesis##2##2##(2009-10#1)(2010-7#1)
subtalar arthroereisis##2##2##(2008-8#2)
subtalar dislocation##3##2##(2008-12#2)(2010-3#1)
subtalar joint##8##2##(2008-4#2)(2008-8#1)(2010-3#1)(2011-2#1)(2012-2#3)
subtalar pronation##2##2##(2010-11#2)
subtalar##23##1##(2006-12#1)(2008-12#3)(2008-4#2)(2008-8#4)(2009-10#1)(2010-11#2)(2010-3#4)(2010-7#1)(2011-2#1)(2012-2#4)
subtelocentric##2##1##(2010-3#2)
subtelomere##3##1##(1996-3#1)(2008-9#1)(2009-10#1)
subtelomeric DNA sequence probe were observed at the telomeres of HSA##2##11##(1997-6#2)
subtelomeric DNA##5##2##(1991-7#1)(1997-6#4)
subtelomeric region##3##2##(2008-10#1)(2009-10#1)(2012-3#1)
subtelomeric repeat##4##2##(1995-1#1)(1996-4#1)(1997-6#2)
subtelomeric##19##1##(1990-8#1)(1991-7#2)(1995-1#1)(1996-4#4)(1997-6#6)(2008-10#1)(2009-10#1)(2009-5#2)(2012-3#1)
subtemporal approach##3##2##(2006-12#2)(2008-7#1)
subtemporal##6##1##(2006-12#3)(2008-7#2)(2008-8#1)
subtended##2##1##(1992-9#1)(2008-3#1)
subtending##3##1##(2007-12#1)(2008-10#1)(2009-8#1)
subterahertz##2##1##(2007-11#2)
subterminal##3##1##(1995-8#1)(2008-5#1)(2009-5#1)
subterranea f##8##2##(2008-10#8)
subterranea has##2##2##(2012-2#2)
subterranea##20##1##(2008-10#14)(2012-2#6)
subterranea-specific##2##1##(2008-10#2)
subterranean clover##3##2##(2006-12#2)(2008-10#1)
subterranean termite##3##2##(2009-5#1)(2011-2#2)
subterranean termites (Isoptera##2##3##(2011-2#2)
subterranean termites##3##2##(2009-5#1)(2011-2#2)
subterranean##19##1##(2006-12#3)(2007-12#1)(2008-10#2)(2008-5#2)(2009-5#2)(2011-12#1)(2011-2#5)(2012-3#3)
subterraneus##3##1##(2012-3#3)
subtest scores##3##2##(2012-11#3)
subtest short form##2##3##(1997-8#2)
subtest##7##1##(1997-8#2)(2012-11#3)(2012-12#1)(2013-8#1)
subtests of the##6##3##(2005-10#1)(2006-10#2)(2010-2#1)(2012-11#1)(2012-3#1)
subtests of##10##2##(2005-10#3)(2006-10#3)(2010-2#1)(2012-11#1)(2012-3#1)(2013-7#1)
subtests##16##1##(1995-11#1)(2005-10#3)(2006-10#3)(2006-7#1)(2008-9#1)(2009-10#1)(2010-2#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-7#2)
subtext##3##1##(1992-10#1)(2007-11#2)
subthalamic nuclei##2##2##(1996-12#2)
subthalamic nucleus in##2##3##(2008-12#1)(2008-2#1)
subthalamic nucleus##14##2##(1996-4#1)(1997-7#1)(2008-11#5)(2008-12#1)(2008-2#1)(2008-7#1)(2009-8#1)(2010-12#1)(2012-1#1)(2012-2#1)
subthalamic##20##1##(1996-12#2)(1996-4#1)(1997-7#1)(2008-11#5)(2008-12#1)(2008-2#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-12#1)(2012-1#3)(2012-2#2)
subthemes##3##1##(2012-3#1)(2013-1#1)(2013-7#1)
subtherapeutic##5##1##(1995-2#1)(2007-11#2)(2007-8#1)(2010-10#1)
subthreshold MOS##2##2##(2008-2#2)
subthreshold concentrations##2##2##(1992-4#1)(1994-2#1)
subthreshold dose of##3##3##(1992-10#1)(1994-2#1)(1996-12#1)
subthreshold doses of either##2##4##(1991-8#1)(1995-12#1)
subthreshold doses of##4##3##(1991-8#3)(1995-12#1)
subthreshold for##2##2##(1990-5#1)(1992-3#1)
subthreshold##32##1##(1990-11#1)(1990-5#1)(1991-8#3)(1992-10#1)(1992-3#1)(1992-4#2)(1993-2#1)(1993-9#1)(1994-2#2)(1995-12#1)(1996-12#1)(1996-5#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-11#1)(2008-2#5)(2008-3#1)(2009-6#2)(2009-8#1)(2010-5#1)(2011-1#1)(2012-1#1)
subtidal herbivore##2##2##(2013-8#2)
subtidal##7##1##(2007-5#1)(2008-5#2)(2013-7#2)(2013-8#2)
subtilis 168##3##2##(1990-11#2)(2012-2#1)
subtilis Ffh##5##2##(1994-3#3)(1996-5#2)
subtilis GB03 and##2##3##(2007-12#1)(2008-10#1)
subtilis GB03##3##2##(2007-12#1)(2008-10#2)
subtilis MBI 600##4##3##(2008-10#4)
subtilis and##17##2##(1991-9#2)(1994-8#1)(1995-2#1)(1995-3#2)(1996-6#1)(1997-2#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-2#2)(2009-3#1)(2010-3#1)(2011-2#1)(2012-2#1)
subtilis cells##6##2##(1990-5#1)(1997-2#1)(1997-5#1)(2008-6#2)(2009-8#1)
subtilis chromosomal DNA##2##3##(1990-12#1)(1990-5#1)
subtilis cloning##2##2##(1991-9#2)
subtilis genome##9##2##(1995-12#2)(1996-8#2)(1997-4#3)(1997-7#1)(2008-7#1)
subtilis is##5##2##(1994-2#1)(1995-6#1)(1995-8#1)(2008-7#1)(2009-8#1)
subtilis of a##3##3##(1990-11#1)(1991-6#2)
subtilis strains were##2##3##(1995-8#1)(2011-2#1)
subtilis strains##5##2##(1995-8#1)(2008-10#2)(2011-12#1)(2011-2#1)
subtilis##208##1##(1990-10#1)(1990-11#13)(1990-12#3)(1990-3#1)(1990-5#5)(1990-6#2)(1990-9#11)(1991-5#1)(1991-6#2)(1991-9#5)(1992-3#1)(1992-6#1)(1993-12#3)(1993-3#1)(1993-6#2)(1993-9#1)(1994-12#5)(1994-2#3)(1994-3#6)(1994-6#1)(1994-8#2)(1995-12#2)(1995-2#3)(1995-3#4)(1995-6#4)(1995-8#6)(1996-10#4)(1996-5#3)(1996-6#1)(1996-8#2)(1997-2#6)(1997-4#9)(1997-5#1)(1997-6#1)(1997-7#2)(2005-11#3)(2006-3#2)(2007-1#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-3#5)(2007-8#1)(2008-10#19)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#4)(2008-6#4)(2008-7#3)(2008-8#3)(2008-9#1)(2009-3#2)(2009-6#2)(2009-7#4)(2009-8#3)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#2)(2011-1#4)(2011-12#2)(2011-2#5)(2012-2#4)
subtilis) and##2##2##(2008-10#1)(2011-1#1)
subtilis)##5##1##(2008-10#3)(2008-5#1)(2011-1#1)
subtilisin Carlsberg and##2##3##(1996-9#1)(2008-7#1)
subtilisin Carlsberg in anhydrous dioxane##2##5##(1997-4#2)
subtilisin Carlsberg##10##2##(1994-6#1)(1994-8#3)(1995-7#1)(1996-9#1)(1997-4#2)(2008-7#2)
subtilisin E##3##2##(1992-11#1)(2009-7#2)
subtilisin and its##3##3##(1991-4#1)(1995-11#2)
subtilisin and##5##2##(1991-4#1)(1992-4#1)(1994-12#1)(1995-11#2)
subtilisin cleavage##2##2##(1993-8#1)(1995-5#1)
subtilisin folding##2##2##(1995-11#2)
subtilisin##58##1##(1990-12#3)(1991-2#1)(1991-4#4)(1992-11#2)(1992-4#1)(1992-8#1)(1993-12#1)(1993-8#3)(1994-12#3)(1994-5#1)(1994-6#2)(1994-8#3)(1995-11#11)(1995-3#3)(1995-5#2)(1995-7#2)(1996-9#1)(1997-4#4)(2008-7#5)(2008-8#2)(2009-7#2)(2011-2#1)
subtilisin-like##3##1##(1990-12#1)(1993-12#1)(2008-8#1)
subtilisins##3##1##(1990-12#1)(1993-12#1)(1996-9#1)
subtle alteration in##2##3##(1995-5#1)(2008-8#1)
subtle alterations##4##2##(1991-2#1)(1993-2#1)(1996-12#1)(2006-1#1)
subtle and##7##2##(1993-9#1)(1994-9#1)(1996-12#1)(2006-10#1)(2007-11#1)(2010-11#1)(2012-12#1)
subtle balance between##2##3##(2007-12#1)(2013-8#1)
subtle balance##3##2##(2005-11#1)(2007-12#1)(2013-8#1)
subtle but important##2##3##(1993-3#1)(2005-12#1)
subtle but##6##2##(1992-11#1)(1993-12#1)(1993-3#1)(1994-2#1)(2005-12#1)(2008-10#1)
subtle changes in the##5##4##(1992-12#1)(1994-12#1)(2007-8#1)(2011-2#1)(2012-1#1)
subtle changes in##10##3##(1991-6#1)(1992-12#1)(1993-8#1)(1994-12#1)(1994-9#1)(2007-6#1)(2007-8#1)(2008-5#1)(2011-2#1)(2012-1#1)
subtle changes##13##2##(1991-6#1)(1992-12#1)(1992-6#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-6#1)(2007-6#1)(2007-8#1)(2008-5#1)(2009-9#1)(2011-2#1)(2012-1#1)
subtle differences exist in##2##4##(1994-5#1)(2012-2#1)
subtle differences in the##4##4##(1992-8#1)(2008-3#1)(2008-5#1)(2008-6#1)
subtle differences in their##2##4##(2008-10#1)(2008-7#1)
subtle differences in##14##3##(1990-2#1)(1992-8#1)(1994-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-12#1)(2011-2#1)(2012-1#1)(2013-8#1)
subtle differences##20##2##(1990-2#1)(1992-8#1)(1994-5#1)(1994-9#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#2)(2009-12#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
subtle effects##2##2##(2006-10#1)(2008-3#1)
subtle forms of##2##3##(1994-9#1)(2007-11#1)
subtle genetic##2##2##(1994-12#1)(2009-12#1)
subtle lesions##2##2##(1994-9#1)(2008-5#1)
subtle mutations##2##2##(1994-2#1)(1994-3#1)
subtle structural##4##2##(1992-3#1)(1992-8#1)(2010-2#1)(2010-5#1)
subtle variations##2##2##(2009-10#1)(2009-5#1)
subtle##156##1##(1990-2#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#3)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#5)(1995-1#2)(1995-10#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#1)(1997-2#2)(1997-5#1)(1997-7#1)(1997-8#2)(2005-11#1)(2005-12#1)(2005-3#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-3#1)(2006-5#1)(2006-7#1)(2006-9#3)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#3)(2007-5#1)(2007-6#1)(2007-8#3)(2007-9#3)(2008-1#3)(2008-10#4)(2008-11#2)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2009-10#2)(2009-11#2)(2009-12#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#5)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#2)
subtleties##5##1##(1992-12#1)(1995-12#1)(2007-7#1)(2008-2#1)(2009-5#1)
subtly##5##1##(1990-9#1)(2005-11#1)(2005-6#1)(2008-11#1)(2011-2#1)
subtotal and##2##2##(1990-6#1)(2008-7#1)
subtotal body##2##2##(2006-7#1)(2008-7#1)
subtotal colectomy##3##2##(2008-4#1)(2011-2#1)(2013-1#1)
subtotal esophagectomy##2##2##(2007-6#1)(2010-12#1)
subtotal hysterectomy##3##2##(2004-10#3)
subtotal nephrectomy##2##2##(2008-7#1)(2010-12#1)
subtotal occlusion##3##2##(1997-3#1)(2010-12#1)(2013-1#1)
subtotal pancreatectomy##2##2##(1990-6#1)(2012-12#1)
subtotal parathyroidectomy##3##2##(1991-5#1)(1993-3#2)
subtotal removal##8##2##(2005-5#1)(2006-12#1)(2007-1#4)(2008-7#1)(2012-1#1)
subtotal resection of##2##3##(2005-5#1)(2006-12#1)
subtotal resection##4##2##(2005-5#1)(2006-12#1)(2008-7#1)(2011-2#1)
subtotal thyroidectomy##2##2##(2013-1#2)
subtotal vertebrectomy##2##2##(2008-7#2)
subtotal##54##1##(1990-6#2)(1991-5#2)(1991-8#2)(1993-3#2)(1994-12#1)(1997-1#1)(1997-3#1)(1997-6#1)(2004-10#4)(2005-12#1)(2005-5#3)(2006-12#3)(2006-7#1)(2007-1#4)(2007-6#1)(2008-10#2)(2008-4#1)(2008-7#7)(2008-8#1)(2009-7#1)(2009-8#1)(2010-12#4)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#4)
subtotally##3##1##(2006-12#1)(2008-5#1)(2008-7#1)
subtoxic##4##1##(1991-7#1)(1993-12#1)(1997-3#1)(2008-10#1)
subtract##5##1##(2007-12#2)(2008-11#1)(2008-3#1)(2011-12#1)
subtracted cDNA library##4##3##(2008-2#4)
subtracted cDNA##5##2##(2008-2#5)
subtracted component##2##2##(2008-2#2)
subtracted fragments##2##2##(2008-10#2)
subtracted from the corresponding##2##4##(2008-10#1)(2008-5#1)
subtracted from the##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
subtracted from##8##2##(1996-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-11#1)
subtracted joint transform correlator##2##4##(2008-2#2)
subtracted out##2##2##(2008-3#1)(2013-7#1)
subtracted##30##1##(1992-11#1)(1992-6#1)(1996-1#1)(2007-11#1)(2008-10#3)(2008-2#12)(2008-3#5)(2008-5#1)(2009-11#1)(2011-2#2)(2012-1#1)(2013-7#1)
subtracting the##11##2##(1994-8#1)(1995-12#1)(1995-4#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#2)(2009-12#1)(2012-1#1)
subtracting##21##1##(1992-3#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-4#1)(1996-12#1)(1997-1#1)(2007-9#1)(2008-10#4)(2008-2#3)(2008-3#1)(2008-8#3)(2009-12#1)(2012-1#1)
subtraction and odour detection##2##4##(2008-7#2)
subtraction and##6##2##(2008-3#1)(2008-7#3)(2009-1#1)(2013-7#1)
subtraction angiography (DSA)##6##3##(1993-8#1)(2006-1#1)(2008-7#2)(2012-12#1)(2012-2#1)
subtraction angiography##19##2##(1991-11#1)(1992-7#1)(1993-8#2)(2006-1#1)(2006-11#1)(2007-8#1)(2008-12#1)(2008-6#1)(2008-7#5)(2011-2#2)(2012-12#2)(2012-2#1)
subtraction images##2##2##(1995-4#2)
subtraction is##2##2##(2008-2#2)
subtraction method##3##2##(1996-10#1)(1997-2#1)(2011-12#1)
subtraction of the##6##3##(2007-2#1)(2008-2#1)(2008-3#3)(2013-8#1)
subtraction of these##2##3##(2007-11#1)(2008-5#1)
subtraction of two##2##3##(2008-1#1)(2008-3#1)
subtraction of##15##2##(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-2#2)(2008-3#7)(2008-5#1)(2013-8#1)
subtraction technique##2##2##(2005-4#1)(2008-3#1)
subtraction to##2##2##(2006-8#1)(2008-2#1)
subtraction##96##1##(1990-4#1)(1991-11#1)(1992-11#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-8#2)(1994-11#1)(1995-11#1)(1995-12#1)(1995-4#3)(1996-10#1)(1997-2#1)(1997-8#1)(2005-4#2)(2006-1#1)(2006-11#1)(2006-8#4)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#11)(2008-3#13)(2008-5#1)(2008-6#1)(2008-7#10)(2008-8#1)(2008-9#2)(2009-1#3)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#5)(2012-2#2)(2013-7#1)(2013-8#2)
subtractions##3##1##(2008-2#1)(2008-3#1)(2009-1#1)
subtractive cDNA##2##2##(1994-3#1)(2008-2#1)
subtractive enrichment of##2##3##(1995-12#2)
subtractive hybridization (SSH)##4##3##(2006-12#1)(2008-10#1)(2008-7#1)(2010-4#1)
subtractive hybridization##16##2##(1990-3#2)(1992-11#1)(1994-3#1)(1995-11#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-7#2)(2008-9#1)(2010-4#1)
subtractive immunization##2##2##(2009-4#1)(2010-12#1)
subtractive##32##1##(1990-11#1)(1990-3#2)(1992-11#1)(1994-3#2)(1995-11#1)(1995-12#2)(1995-7#1)(1996-5#1)(2006-12#1)(2008-10#3)(2008-11#2)(2008-2#6)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#2)(2010-4#1)(2012-2#1)
subtractor##3##1##(2008-3#3)
subtribes##3##1##(2006-12#3)
subtrochanteric atypical fractures##2##3##(2013-1#2)
subtrochanteric femoral##3##2##(2013-1#3)
subtrochanteric##8##1##(2009-3#1)(2013-1#7)
subtropical areas##5##2##(1996-3#1)(2007-7#1)(2008-10#2)(2011-2#1)
subtropical regions##6##2##(2007-3#1)(2008-11#1)(2008-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
subtropical##30##1##(1992-4#1)(1993-8#1)(1996-3#1)(2006-4#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-8#2)(2010-10#2)(2010-5#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
subtropics##4##1##(2008-10#1)(2008-3#1)(2011-2#1)(2012-3#1)
subtype 1 (AT1)##2##3##(1993-3#1)(2008-8#1)
subtype 1##3##2##(1993-3#1)(1995-5#1)(2008-8#1)
subtype 2##2##2##(1995-5#1)(2008-8#1)
subtype A##2##2##(1994-12#1)(2010-12#1)
subtype B##4##2##(1994-12#2)(2007-12#1)(2010-12#1)
subtype C##5##2##(1994-12#2)(2006-8#1)(2007-7#1)(2008-12#1)
subtype E##2##2##(1994-12#1)(2006-8#1)
subtype H5N2##2##2##(2008-5#2)
subtype M1##3##2##(1991-8#2)(2008-10#1)
subtype and a##2##3##(1995-12#1)(2013-1#1)
subtype and its##2##3##(2008-2#1)(2013-7#1)
subtype and the##3##3##(1992-7#1)(1996-6#1)(2007-10#1)
subtype and##12##2##(1992-7#1)(1994-2#1)(1995-12#1)(1996-6#1)(2007-10#1)(2008-10#1)(2008-2#1)(2009-12#1)(2011-1#1)(2011-12#1)(2013-1#1)(2013-7#1)
subtype as##2##2##(2005-6#1)(2008-7#1)
subtype avian influenza##3##3##(2005-11#1)(2013-8#2)
subtype family IIa##3##3##(2013-1#3)
subtype family IId##2##3##(2013-1#2)
subtype family##5##2##(2013-1#5)
subtype from##3##2##(1995-1#1)(2008-4#1)(2011-2#1)
subtype has a##2##3##(1992-8#1)(2008-2#1)
subtype has been##2##3##(1993-3#1)(2008-1#1)
subtype has##4##2##(1992-8#1)(1993-3#1)(2008-1#1)(2008-2#1)
subtype in the##5##3##(1991-5#1)(1991-7#1)(1993-12#1)(1997-1#1)(2004-1#1)
subtype in##9##2##(1991-11#1)(1991-5#1)(1991-7#1)(1993-12#1)(1995-11#1)(1997-1#1)(2004-1#1)(2007-10#1)(2011-1#1)
subtype is##6##2##(1993-12#2)(1993-3#1)(1995-11#1)(2007-12#1)(2008-2#1)
subtype of attention-deficit/hyperactivity disorder##2##4##(2008-2#2)
subtype of cystosarcoma phyllodes##2##4##(2011-3#2)
subtype of periodic catatonia##3##4##(1995-11#3)
subtype of schizophrenia##4##3##(1995-11#1)(1996-7#1)(2008-3#1)(2012-11#1)
subtype of the disease##2##4##(2007-11#1)(2007-2#1)
subtype of the##5##3##(1991-7#1)(1993-2#1)(1995-11#1)(2007-11#1)(2007-2#1)
subtype of##81##2##(1990-12#1)(1990-9#1)(1991-5#2)(1991-7#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#2)(1995-11#6)(1995-12#2)(1995-8#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#3)(2005-7#1)(2005-8#2)(2006-10#1)(2006-6#2)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#3)(2009-12#1)(2009-8#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-11#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
subtype selective##4##2##(1991-9#1)(1995-12#1)(1997-5#1)(2006-10#1)
subtype selectivity##4##2##(1991-9#1)(1995-7#1)(1997-1#1)(2010-12#1)
subtype specific##4##2##(1992-12#1)(1994-12#2)(2010-12#1)
subtype specificity##2##2##(1993-8#1)(1994-2#1)
subtype that is##2##3##(1994-5#1)(1995-5#1)
subtype that##3##2##(1994-5#1)(1994-9#1)(1995-5#1)
subtype using##2##2##(1996-5#1)(1997-2#1)
subtype was lacunar##2##3##(2007-10#2)
subtype was##9##2##(1991-9#1)(1992-7#2)(1996-5#1)(1997-2#1)(2007-10#2)(2011-2#2)
subtype were##2##2##(1993-12#1)(2013-8#1)
subtype with##4##2##(1993-8#1)(2007-9#1)(2008-4#1)(2010-12#1)
subtype##362##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-11#3)(1991-2#1)(1991-4#1)(1991-5#3)(1991-7#2)(1991-8#2)(1991-9#5)(1992-10#1)(1992-11#3)(1992-12#3)(1992-3#4)(1992-4#1)(1992-5#2)(1992-7#6)(1992-8#3)(1992-9#2)(1993-11#4)(1993-12#7)(1993-2#1)(1993-3#8)(1993-5#1)(1993-6#1)(1993-7#2)(1993-8#4)(1993-9#1)(1994-12#9)(1994-2#3)(1994-3#7)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#6)(1995-1#1)(1995-11#14)(1995-12#11)(1995-5#3)(1995-7#2)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#6)(1996-2#3)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#4)(1996-9#1)(1997-1#4)(1997-2#7)(1997-4#1)(1997-5#8)(1997-6#1)(1997-7#2)(1997-8#5)(2004-1#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-6#1)(2005-7#1)(2005-8#3)(2006-10#4)(2006-5#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-10#12)(2007-11#2)(2007-12#7)(2007-2#3)(2007-3#2)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#3)(2008-12#3)(2008-2#10)(2008-3#5)(2008-4#13)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#2)(2009-1#1)(2009-11#1)(2009-12#2)(2009-8#1)(2010-12#8)(2010-5#1)(2010-9#3)(2011-1#3)(2011-12#2)(2011-2#11)(2011-3#2)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#14)(2013-7#1)(2013-8#10)
subtype(s)##2##1##(1996-1#1)(1997-1#1)
subtype)##6##1##(1994-8#3)(1996-12#1)(1996-6#2)
subtype-selective ligands##2##2##(1995-11#1)(1997-4#1)
subtype-selective##11##1##(1990-3#1)(1992-7#1)(1994-6#1)(1995-11#1)(1996-3#1)(1997-4#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-2#1)
subtype-specific antibodies##2##2##(1991-7#1)(2008-4#1)
subtype-specific##10##1##(1991-7#1)(1991-9#1)(1993-11#1)(1994-2#2)(1995-10#1)(2007-10#1)(2008-4#2)(2013-8#1)
subtyped by##2##2##(1994-12#1)(1994-2#1)
subtyped##7##1##(1990-12#1)(1994-12#2)(1994-2#2)(2007-10#1)(2007-9#1)
subtypes A##2##2##(1994-12#1)(2006-8#1)
subtypes II##2##2##(1991-4#2)
subtypes according to the##2##4##(1992-4#1)(2007-10#1)
subtypes according to##3##3##(1992-4#1)(2007-10#1)(2011-1#1)
subtypes and##16##2##(1990-12#1)(1990-9#1)(1994-12#1)(1995-12#1)(1995-6#1)(1996-3#1)(2005-7#1)(2005-8#1)(2007-10#1)(2007-9#1)(2008-6#1)(2010-3#1)(2010-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
subtypes are involved in##2##4##(1996-12#1)(2006-10#1)
subtypes are present in##2##4##(1991-11#1)(1995-12#1)
subtypes are##14##2##(1990-5#1)(1991-11#2)(1991-12#1)(1995-12#2)(1996-12#2)(2005-9#1)(2006-10#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
subtypes based on##3##3##(1994-2#2)(2008-9#1)
subtypes by##2##2##(1992-7#1)(2009-4#1)
subtypes expressed##2##2##(1997-2#2)
subtypes from##2##2##(1991-4#1)(1992-7#1)
subtypes have been described##3##4##(2010-6#1)(2011-2#1)(2011-3#1)
subtypes have been##6##3##(1993-12#1)(1995-11#1)(2007-11#1)(2010-6#1)(2011-2#1)(2011-3#1)
subtypes have##7##2##(1993-12#1)(1994-6#1)(1995-11#1)(2007-11#1)(2010-6#1)(2011-2#1)(2011-3#1)
subtypes in human##2##3##(1991-11#1)(1997-7#1)
subtypes in rabbit##2##3##(1990-11#1)(1993-11#1)
subtypes in the rat##3##4##(1991-9#1)(1994-3#2)
subtypes in the##16##3##(1990-11#1)(1990-5#1)(1991-7#1)(1991-9#1)(1994-3#2)(1995-10#2)(1995-12#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-5#1)(2008-3#1)(2008-8#1)(2011-2#1)
subtypes in##36##2##(1990-11#2)(1990-5#1)(1991-1#1)(1991-11#1)(1991-7#1)(1991-9#1)(1993-11#1)(1993-7#1)(1994-3#2)(1995-10#2)(1995-11#1)(1995-12#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-5#2)(1997-7#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-8#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-8#1)
subtypes involved in##2##3##(1994-2#1)(1995-12#1)
subtypes is##3##2##(2005-7#1)(2005-9#1)(2013-1#1)
subtypes may be##2##3##(1994-3#1)(1996-1#1)
subtypes may##3##2##(1994-3#1)(1996-1#1)(1996-12#1)
subtypes of HIV-1##2##3##(1994-12#1)(2008-12#1)
subtypes of glioblastoma##2##3##(2011-12#1)(2011-2#1)
subtypes of melanocortin receptors##2##4##(1996-12#1)(2008-5#1)
subtypes of neuronal nicotinic acetylcholine receptors##2##6##(1995-11#2)
subtypes of neuronal##3##3##(1994-2#1)(1995-11#2)
subtypes of receptors##2##3##(1993-11#1)(2008-5#1)
subtypes of schizophrenia##2##3##(2006-8#1)(2011-1#1)
subtypes of social phobia##2##4##(2006-6#1)(2010-2#1)
subtypes of social##3##3##(2004-11#1)(2006-6#1)(2010-2#1)
subtypes of stroke##2##3##(2007-10#2)
subtypes of the disease##3##4##(1997-3#2)(2013-1#1)
subtypes of the##12##3##(1990-2#1)(1990-5#1)(1991-11#1)(1993-6#1)(1996-8#1)(1997-3#2)(2008-1#1)(2008-12#1)(2010-12#1)(2013-1#1)(2013-8#1)
subtypes of##90##2##(1990-2#1)(1990-5#2)(1990-7#1)(1991-11#2)(1991-5#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#2)(1995-3#1)(1996-12#3)(1996-3#1)(1996-8#2)(1997-2#1)(1997-3#3)(1997-5#1)(1997-8#1)(2004-11#1)(2005-7#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#3)(2007-12#1)(2007-2#3)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#3)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-8#3)(2009-2#1)(2009-4#1)(2009-8#2)(2010-12#2)(2010-2#1)(2010-6#1)(2011-1#2)(2011-12#2)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#3)
subtypes or##2##2##(1992-9#1)(2011-1#1)
subtypes present##2##2##(1992-7#1)(1997-8#1)
subtypes showed##2##2##(1991-4#1)(2008-4#1)
subtypes that##3##2##(1994-3#1)(1994-9#1)(2008-5#1)
subtypes to##2##2##(2007-2#1)(2012-2#1)
subtypes was##3##2##(1991-5#1)(2004-12#1)(2007-10#1)
subtypes were##10##2##(1991-4#1)(1992-7#3)(1993-12#1)(1994-9#1)(1995-10#1)(1997-3#1)(2012-2#1)(2013-1#1)
subtypes with##5##2##(1990-6#1)(1992-4#1)(1997-1#1)(2007-12#1)(2008-8#1)
subtypes##406##1##(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#5)(1990-6#2)(1990-7#1)(1990-9#3)(1991-1#1)(1991-11#9)(1991-12#2)(1991-2#2)(1991-4#6)(1991-5#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#2)(1992-3#1)(1992-4#2)(1992-6#1)(1992-7#8)(1992-8#1)(1992-9#5)(1993-11#3)(1993-12#6)(1993-3#1)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#4)(1994-10#2)(1994-11#1)(1994-12#7)(1994-2#10)(1994-3#7)(1994-5#1)(1994-6#5)(1994-9#7)(1995-10#4)(1995-11#7)(1995-12#10)(1995-2#2)(1995-3#4)(1995-6#1)(1995-7#3)(1996-1#2)(1996-12#10)(1996-2#2)(1996-3#6)(1996-5#3)(1996-7#1)(1996-8#3)(1997-1#2)(1997-2#6)(1997-3#5)(1997-5#4)(1997-7#2)(1997-8#3)(2004-11#2)(2004-12#1)(2005-6#2)(2005-7#3)(2005-8#2)(2005-9#2)(2006-10#4)(2006-6#3)(2006-8#2)(2007-10#12)(2007-11#3)(2007-12#4)(2007-2#6)(2007-3#1)(2007-6#3)(2007-7#1)(2007-8#1)(2007-9#4)(2008-1#4)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#9)(2008-4#13)(2008-5#8)(2008-6#3)(2008-7#2)(2008-8#7)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#4)(2009-8#2)(2010-12#6)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#3)(2011-2#10)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#10)(2012-3#3)(2013-1#13)(2013-7#2)(2013-8#6)
subtypes)##4##1##(1990-5#1)(1996-7#1)(2008-3#1)(2013-8#1)
subtyping is##2##2##(1993-8#1)(2008-1#1)
subtyping of##2##2##(2007-10#1)(2008-1#1)
subtyping##12##1##(1990-12#1)(1993-7#1)(1993-8#1)(1993-9#1)(1997-8#1)(2007-10#1)(2008-1#2)(2008-5#1)(2011-2#2)(2013-1#1)
subumbilical incision##3##2##(2011-2#3)
subungual onychomycosis##2##2##(2007-7#2)
subungual##10##1##(2007-7#5)(2008-9#3)(2010-6#2)
subunit (alpha##3##2##(1990-7#2)(1992-8#1)
subunit 1##3##2##(1996-2#2)(2008-10#1)
subunit 4##3##2##(1995-11#3)
subunit 6 of the##3##4##(1997-7#3)
subunit 6##4##2##(1997-7#4)
subunit 8 of##2##3##(1994-9#2)
subunit 8##16##2##(1992-11#7)(1994-9#9)
subunit 9 of the##3##4##(1992-11#2)(1997-3#1)
subunit 9##4##2##(1992-11#3)(1997-3#1)
subunit A is##2##3##(1992-3#1)(1995-6#1)
subunit A##8##2##(1992-3#5)(1993-2#1)(1994-12#1)(1995-6#1)
subunit B##3##2##(1990-5#1)(1995-6#1)(1997-4#1)
subunit C5##2##2##(1992-1#2)
subunit I of cytochrome##3##4##(1993-2#1)(1997-7#2)
subunit I of the##2##4##(1995-2#1)(2006-8#1)
subunit I of##6##3##(1993-2#2)(1995-2#1)(1997-7#2)(2006-8#1)
subunit I##12##2##(1990-2#2)(1993-2#2)(1995-2#1)(1997-7#2)(2006-8#1)(2010-4#3)(2011-2#1)
subunit II of##2##3##(1994-2#1)(2005-8#1)
subunit II##3##2##(1994-2#1)(2005-8#1)(2009-10#1)
subunit III##3##2##(1990-5#1)(1992-6#1)(2005-8#1)
subunit IV of the##2##4##(1991-3#2)
subunit IV##9##2##(1991-3#5)(1991-9#1)(1992-6#1)(1994-11#1)(2008-10#1)
subunit Mr value##2##3##(1990-8#1)(1991-3#1)
subunit Mr##4##2##(1990-12#1)(1990-8#1)(1991-2#1)(1991-3#1)
subunit VIa##6##2##(1994-12#2)(1997-3#4)
subunit VIb of cytochrome c oxidase##2##6##(1991-6#2)
subunit VIb##8##2##(1991-6#8)
subunit a and the##2##4##(1997-3#1)(2008-4#1)
subunit a##7##2##(1997-3#1)(2008-4#6)
subunit alone##3##2##(1993-9#1)(1995-2#1)(2008-9#1)
subunit and a##2##3##(1992-9#1)(2008-1#1)
subunit and an##2##3##(1994-8#1)(1995-2#1)
subunit and the##7##3##(1992-11#1)(1993-8#1)(1995-5#1)(1995-8#1)(1996-5#1)(2005-7#1)(2008-4#1)
subunit and##42##2##(1990-12#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-8#2)(1995-2#3)(1995-5#1)(1995-8#3)(1996-12#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-7#1)(2006-12#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-8#2)(2010-12#1)(2011-1#1)(2013-8#1)
subunit antigens and##2##3##(2006-12#1)(2007-11#1)
subunit are##4##2##(1990-5#1)(1995-12#1)(1997-1#1)(2008-8#1)
subunit as a##2##3##(1995-6#1)(1995-7#1)
subunit as##7##2##(1994-11#1)(1995-6#1)(1995-7#1)(1996-4#1)(1996-8#1)(1997-6#1)(2008-4#1)
subunit assembly in##3##3##(1990-8#1)(1997-2#1)(2008-8#1)
subunit assembly reactions##2##3##(1990-8#1)(1997-2#1)
subunit assembly##10##2##(1990-8#4)(1997-2#4)(2006-12#1)(2008-8#1)
subunit association and##3##3##(1990-12#1)(1994-9#1)(1995-8#1)
subunit association##7##2##(1990-12#1)(1990-8#1)(1994-11#1)(1994-9#1)(1995-4#1)(1995-8#1)(2008-9#1)
subunit at##4##2##(1990-2#1)(1990-5#1)(1994-11#1)(2012-1#1)
subunit b##6##2##(1990-5#3)(1994-10#1)(1997-2#1)(1997-3#1)
subunit beta##3##2##(1997-4#2)(2013-8#1)
subunit binds##2##2##(1991-2#1)(1994-12#1)
subunit but##4##2##(1993-11#1)(1994-9#1)(1995-8#1)(2008-7#1)
subunit by##5##2##(1990-7#1)(1993-11#1)(1994-3#1)(2006-6#1)(2008-8#1)
subunit c of the##2##4##(1995-3#1)(1997-6#1)
subunit c of##3##3##(1992-11#1)(1995-3#1)(1997-6#1)
subunit c##8##2##(1992-11#1)(1995-3#2)(1997-3#1)(1997-6#4)
subunit c(P2)##3##2##(1997-2#3)
subunit cDNAs##2##2##(1993-9#1)(1997-7#1)
subunit cholera vaccine##2##3##(2006-12#2)
subunit combination Pb2+##2##3##(1995-11#2)
subunit combination##3##2##(1995-11#3)
subunit combinations of##2##3##(1990-7#1)(2008-8#1)
subunit combinations##4##2##(1990-7#1)(1990-8#1)(1995-11#1)(2008-8#1)
subunit composition of##6##3##(1990-5#1)(1991-10#1)(1991-5#1)(1995-8#1)(1997-7#1)(2008-4#1)
subunit composition##11##2##(1990-3#1)(1990-5#1)(1991-10#1)(1991-3#1)(1991-5#1)(1995-11#1)(1995-8#2)(1997-7#1)(2008-3#1)(2008-4#1)
subunit compositions##3##2##(1990-7#1)(2008-2#1)(2008-4#1)
subunit contact##2##2##(1991-3#1)(1996-7#1)
subunit contains##4##2##(1990-12#1)(1990-7#1)(1994-12#1)(1995-8#1)
subunit could##2##2##(1991-3#1)(1995-3#1)
subunit deduced from##2##3##(1990-9#1)(1996-2#1)
subunit different##2##2##(1994-10#1)(1997-7#1)
subunit displayed strong##2##3##(1990-3#1)(1996-8#1)
subunit dissociation##2##2##(1991-5#1)(1993-3#1)
subunit distribution##2##2##(1995-7#1)(1997-7#1)
subunit does not##4##3##(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#1)
subunit expression was not##2##4##(1997-5#1)(2008-8#1)
subunit expression was##3##3##(1997-5#2)(2008-8#1)
subunit expression##9##2##(1996-1#2)(1997-5#3)(1997-8#1)(2008-4#1)(2008-8#1)(2012-1#1)
subunit folding##2##2##(1997-1#1)(2008-4#1)
subunit forms##2##2##(1994-5#1)(1997-7#1)
subunit from a human##2##4##(1993-4#1)(1997-4#1)
subunit from the##3##3##(1991-6#1)(1994-8#1)(2009-7#1)
subunit from##14##2##(1991-6#1)(1993-12#1)(1993-4#1)(1993-8#2)(1994-8#1)(1994-9#2)(1995-8#1)(1997-4#1)(2007-8#1)(2008-11#1)(2009-7#2)
subunit gene expression##2##3##(1992-10#1)(1995-10#1)
subunit gene in##3##3##(1995-3#1)(1996-7#1)(2005-11#1)
subunit gene is##2##3##(1997-7#1)(2008-8#1)
subunit gene of the##2##4##(1990-10#1)(1996-2#1)
subunit gene was##2##3##(2006-12#1)(2008-8#1)
subunit gene##23##2##(1990-10#1)(1992-1#1)(1992-10#1)(1992-9#1)(1993-11#1)(1994-8#1)(1995-10#1)(1995-3#2)(1995-6#2)(1996-2#2)(1996-7#2)(1997-4#2)(1997-7#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-8#2)
subunit genes of the##2##4##(1990-9#1)(1997-5#1)
subunit genes were##3##3##(1991-2#2)(2006-12#1)
subunit genes##14##2##(1990-8#1)(1990-9#1)(1991-2#4)(1992-1#1)(1995-1#1)(1996-2#1)(1997-5#1)(2006-10#2)(2006-12#1)(2008-8#1)
subunit has been##3##3##(1992-9#1)(1994-9#1)(1996-2#1)
subunit has##8##2##(1990-6#1)(1991-12#1)(1992-9#1)(1994-9#1)(1995-2#1)(1996-2#1)(1996-8#1)(1997-1#1)
subunit have been##2##3##(2004-10#1)(2008-9#1)
subunit have##3##2##(1994-12#1)(2004-10#1)(2008-9#1)
subunit homodimer##2##2##(1996-10#1)(2011-1#1)
subunit homologue##2##2##(1993-12#1)(1996-12#1)
subunit in Escherichia coli##2##4##(1990-5#1)(1990-7#1)
subunit in the complex##2##4##(1995-12#1)(1996-10#1)
subunit in the##12##3##(1991-3#1)(1993-8#1)(1993-9#1)(1994-9#1)(1995-12#3)(1995-2#1)(1996-10#1)(1996-8#1)(1997-5#1)(1997-7#1)
subunit in these##2##3##(1990-10#1)(1995-9#1)
subunit in vivo##2##3##(1994-9#1)(1995-2#1)
subunit in##42##2##(1990-10#1)(1990-5#1)(1990-7#1)(1991-3#1)(1992-11#1)(1992-8#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#4)(1994-9#2)(1995-1#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-8#1)(1997-2#1)(1997-5#2)(1997-6#1)(1997-7#3)(2005-8#1)(2008-8#2)(2012-1#1)
subunit interaction##6##2##(1990-8#1)(1991-4#1)(1994-8#1)(1994-9#2)(2008-10#1)
subunit interactions and##2##3##(1994-9#1)(1995-2#1)
subunit interactions##11##2##(1990-8#1)(1991-5#1)(1993-11#1)(1994-5#1)(1994-9#2)(1995-2#1)(1996-7#1)(1997-1#1)(2005-10#1)(2008-9#1)
subunit interface##7##2##(1990-8#2)(1993-6#1)(1994-6#1)(1995-2#1)(1995-8#1)(2007-6#1)
subunit into##3##2##(1992-11#1)(1994-12#1)(1995-12#1)
subunit is a##4##3##(1991-12#1)(1995-3#1)(1995-8#2)
subunit is composed of##2##4##(1993-6#1)(1995-4#1)
subunit is labeled upon modification of##2##6##(1995-6#2)
subunit is not##2##3##(1991-10#1)(2005-8#1)
subunit is sufficient##2##3##(1991-6#1)(2008-8#1)
subunit is the##2##3##(1991-2#1)(1996-12#1)
subunit is##35##2##(1990-12#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-2#1)(1993-6#3)(1994-11#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#3)(1995-8#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-7#1)(2005-8#1)(2008-8#4)(2011-1#1)
subunit isoforms##4##2##(1991-9#1)(1993-9#1)(1994-3#1)(1994-9#1)
subunit mRNA and protein levels##2##5##(1995-10#1)(1997-2#1)
subunit mRNA in the##2##4##(1997-8#2)
subunit mRNA levels##8##3##(1996-12#2)(1997-2#5)(2008-4#1)
subunit mRNA##25##2##(1991-2#2)(1991-9#1)(1994-8#2)(1995-10#2)(1995-5#1)(1996-12#2)(1997-2#8)(1997-8#5)(2008-4#2)
subunit mRNAs##6##2##(1995-11#1)(1996-12#2)(1997-6#3)
subunit may be##3##3##(1991-5#1)(1994-3#1)(1997-5#1)
subunit may##6##2##(1991-5#1)(1992-1#1)(1994-3#1)(1995-8#1)(1997-5#1)(2005-8#1)
subunit molecular mass of##6##4##(1990-5#2)(1992-12#1)(1993-9#1)(1994-5#1)(1995-8#1)
subunit molecular weight of##4##4##(1991-9#1)(1992-2#1)(1994-9#1)(1997-2#1)
subunit molecular weight##5##3##(1991-9#1)(1992-2#1)(1994-9#1)(1995-5#1)(1997-2#1)
subunit molecular weights of##2##4##(1994-8#1)(2005-11#1)
subunit molecular weights##3##3##(1994-8#1)(1997-2#1)(2005-11#1)
subunit molecular##14##2##(1990-5#2)(1991-9#1)(1992-12#1)(1992-2#1)(1993-9#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-8#1)(1997-2#2)(2005-11#1)
subunit occurs##2##2##(1995-1#1)(1996-4#1)
subunit of CODH##2##3##(1994-12#2)
subunit of DNA##2##3##(1994-12#1)(1996-4#1)
subunit of E##2##3##(1991-12#1)(1997-2#1)
subunit of NF-E2##2##3##(1995-3#1)(1996-2#1)
subunit of PKA is##2##4##(1997-5#1)(2008-8#1)
subunit of PKA##6##3##(1994-8#1)(1997-1#3)(1997-5#1)(2008-8#1)
subunit of RNA polymerase II##4##5##(1992-5#1)(1997-2#2)(1997-4#1)
subunit of RNA polymerase##5##4##(1992-5#1)(1994-12#1)(1997-2#2)(1997-4#1)
subunit of RNA##6##3##(1992-5#1)(1994-12#1)(1995-8#1)(1997-2#2)(1997-4#1)
subunit of a##3##3##(1993-11#1)(1994-9#1)(1996-8#1)
subunit of cAMP-dependent protein kinase##9##5##(1990-2#1)(1991-10#1)(1991-6#1)(1993-11#1)(1993-6#1)(1994-3#1)(1995-2#1)(1996-4#1)(1997-5#1)
subunit of cAMP-dependent protein##10##4##(1990-10#1)(1990-2#1)(1991-10#1)(1991-6#1)(1993-11#1)(1993-6#1)(1994-3#1)(1995-2#1)(1996-4#1)(1997-5#1)
subunit of cAMP-dependent##11##3##(1990-10#1)(1990-2#1)(1991-10#1)(1991-6#1)(1993-11#1)(1993-6#1)(1994-3#2)(1995-2#1)(1996-4#1)(1997-5#1)
subunit of complex I from Neurospora crassa##2##7##(1990-9#1)(1996-7#1)
subunit of complex I from##3##5##(1990-9#1)(1996-7#2)
subunit of complex I##5##4##(1990-9#2)(1991-2#1)(1996-7#2)
subunit of cytochrome##2##3##(1994-12#1)(1995-6#1)
subunit of human##8##3##(1993-5#1)(1993-6#1)(1994-8#2)(1995-3#1)(1995-8#1)(2008-11#1)(2011-1#1)
subunit of phosphatase 2A##2##4##(1995-3#2)
subunit of phosphatidylinositol##2##3##(1995-6#1)(1996-2#1)
subunit of phosphorylase kinase##2##4##(1994-9#2)
subunit of protein kinase##3##4##(1992-12#1)(1996-6#1)(1997-6#1)
subunit of protein##5##3##(1992-12#1)(1994-9#1)(1995-8#1)(1996-6#1)(1997-6#1)
subunit of ribonucleotide reductase##2##4##(1990-2#1)(2013-8#1)
subunit of ribulose##2##3##(1991-9#1)(2009-10#1)
subunit of the Na##2##4##(1994-8#1)(1994-9#1)
subunit of the cellulosome##2##4##(1995-2#1)(2006-8#1)
subunit of the enzyme##7##4##(1991-1#1)(1992-8#2)(1994-12#1)(1995-11#1)(1996-8#1)(1997-2#1)
subunit of the glycine receptor##2##5##(1990-7#1)(1992-11#1)
subunit of the human GABAA receptor##2##6##(1994-12#1)(1995-11#1)
subunit of the human platelet fibrinogen receptor##2##7##(2006-6#2)
subunit of the human##5##4##(1994-12#1)(1994-3#1)(1995-11#1)(2006-6#2)
subunit of the peripheral##2##4##(1995-5#1)(1997-1#1)
subunit of the##101##3##(1990-10#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#3)(1991-12#1)(1991-3#2)(1991-5#2)(1992-11#2)(1992-8#2)(1993-12#1)(1993-7#1)(1994-11#1)(1994-12#5)(1994-2#1)(1994-3#5)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#4)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-5#1)(1995-6#6)(1995-8#1)(1996-10#1)(1996-11#1)(1996-4#2)(1996-5#3)(1996-7#1)(1996-8#3)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#4)(2005-7#1)(2005-8#1)(2006-12#1)(2006-4#1)(2006-6#2)(2006-8#1)(2006-9#2)(2008-10#1)(2008-4#1)(2008-8#3)(2009-7#3)(2009-8#1)(2010-12#2)(2010-6#1)(2012-3#1)(2013-1#1)
subunit of this##3##3##(1990-7#1)(1991-5#1)(1992-3#1)
subunit of transducin##3##3##(1990-2#1)(1990-7#1)(1993-3#1)
subunit of yeast proteasomes##2##4##(1992-1#2)
subunit of yeast##3##3##(1992-1#2)(1995-6#1)
subunit of##274##2##(1990-10#2)(1990-2#7)(1990-4#1)(1990-5#2)(1990-7#5)(1990-9#2)(1991-1#4)(1991-10#1)(1991-12#4)(1991-2#2)(1991-3#2)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#3)(1992-8#2)(1993-11#3)(1993-12#3)(1993-3#3)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#11)(1994-2#1)(1994-3#8)(1994-5#6)(1994-6#2)(1994-8#12)(1994-9#12)(1995-1#3)(1995-11#3)(1995-12#3)(1995-2#11)(1995-3#7)(1995-4#1)(1995-5#1)(1995-6#11)(1995-8#6)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-4#4)(1996-5#7)(1996-6#1)(1996-7#3)(1996-8#5)(1997-1#5)(1997-2#4)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#6)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-12#2)(2006-4#1)(2006-6#2)(2006-8#1)(2006-9#2)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
subunit on the##2##3##(1994-5#1)(1995-6#1)
subunit or the##2##3##(1994-11#1)(2007-12#1)
subunit or##4##2##(1992-6#1)(1994-11#1)(2007-11#1)(2007-12#1)
subunit per##2##2##(1996-5#1)(2012-1#1)
subunit plays##2##2##(1992-11#1)(2013-8#1)
subunit polypeptides##2##2##(1995-11#1)(1995-3#1)
subunit protein expression##2##3##(1996-3#1)(1997-5#1)
subunit protein##20##2##(1990-10#1)(1990-5#1)(1990-7#1)(1991-12#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-4#3)(1994-5#2)(1995-5#1)(1996-3#6)(1997-5#1)
subunit proteins in##2##3##(1996-3#1)(2009-5#1)
subunit proteins##7##2##(1995-12#1)(1995-3#1)(1996-3#2)(2008-1#1)(2009-5#1)(2009-8#1)
subunit rDNA##3##2##(1993-11#1)(2008-10#1)(2010-10#1)
subunit recombination##3##2##(1991-3#3)
subunit ribosomal##6##2##(1991-6#1)(1993-11#1)(1994-12#2)(2008-10#1)(2010-4#1)
subunit showed##2##2##(1994-5#1)(2008-8#1)
subunit specificity##2##2##(1994-9#1)(2005-8#1)
subunit stoichiometry##2##2##(1993-9#1)(1995-10#1)
subunit structure and##2##3##(2008-3#1)(2009-9#1)
subunit structure##8##2##(1990-11#1)(1990-7#1)(1996-5#1)(1997-2#1)(2007-7#1)(2008-3#1)(2008-4#1)(2009-9#1)
subunit that##8##2##(1991-11#1)(1991-5#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-2#1)(1997-4#1)(2012-3#1)
subunit to the##2##3##(1990-8#1)(1995-6#1)
subunit to##9##2##(1990-8#1)(1991-8#1)(1992-11#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-4#1)(2009-2#1)
subunit transcripts##2##2##(1995-11#2)
subunit transport##3##2##(2007-8#3)
subunit types##2##2##(1994-9#2)
subunit using##2##2##(1991-5#1)(1994-9#1)
subunit vaccine against##3##3##(1995-12#1)(1995-2#1)(2007-11#1)
subunit vaccine##13##2##(1995-12#1)(1995-2#1)(2006-12#4)(2007-11#6)(2010-10#1)
subunit vaccines##9##2##(1991-5#1)(1994-11#1)(1995-5#1)(2006-10#1)(2007-11#2)(2007-2#1)(2009-8#1)(2013-8#1)
subunit was detected in##2##4##(1996-8#1)(1997-7#1)
subunit was found##4##3##(1990-7#1)(1992-11#2)(1992-9#1)
subunit was##21##2##(1990-10#1)(1990-2#1)(1990-5#2)(1990-7#3)(1991-6#1)(1992-11#2)(1992-9#2)(1993-8#1)(1994-10#1)(1995-2#1)(1996-5#1)(1996-8#1)(1997-5#3)(1997-7#1)
subunit were found##2##3##(1990-10#1)(1993-4#1)
subunit were##9##2##(1990-10#1)(1990-2#1)(1990-6#1)(1992-11#2)(1992-8#1)(1993-4#1)(1994-2#1)(1995-1#1)
subunit when the##2##3##(1994-11#1)(1996-8#1)
subunit when##3##2##(1990-2#1)(1994-11#1)(1996-8#1)
subunit where##2##2##(1994-8#1)(1995-8#1)
subunit with the##2##3##(1994-11#1)(1994-12#1)
subunit with##10##2##(1992-6#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#2)(1995-11#1)(1995-8#1)
subunit without##2##2##(1990-2#1)(1994-3#1)
subunit would##2##2##(1993-11#2)
subunit α##4##2##(2010-11#1)(2010-12#3)
subunit##1397##1##(1990-10#10)(1990-11#2)(1990-12#7)(1990-2#18)(1990-3#3)(1990-4#6)(1990-5#26)(1990-6#4)(1990-7#26)(1990-8#20)(1990-9#8)(1991-1#6)(1991-10#5)(1991-11#1)(1991-12#11)(1991-2#18)(1991-3#19)(1991-4#3)(1991-5#11)(1991-6#15)(1991-7#4)(1991-8#3)(1991-9#5)(1992-1#7)(1992-10#1)(1992-11#30)(1992-12#5)(1992-2#7)(1992-3#14)(1992-4#1)(1992-5#3)(1992-6#11)(1992-7#6)(1992-8#12)(1992-9#15)(1993-11#19)(1993-12#10)(1993-2#4)(1993-3#7)(1993-4#8)(1993-5#1)(1993-6#12)(1993-7#2)(1993-8#12)(1993-9#9)(1994-10#5)(1994-11#21)(1994-12#37)(1994-2#9)(1994-3#24)(1994-5#20)(1994-6#10)(1994-8#38)(1994-9#54)(1995-1#13)(1995-10#4)(1995-11#23)(1995-12#16)(1995-2#39)(1995-3#24)(1995-4#3)(1995-5#11)(1995-6#40)(1995-7#5)(1995-8#38)(1995-9#3)(1996-1#2)(1996-10#7)(1996-11#2)(1996-12#11)(1996-2#14)(1996-3#13)(1996-4#11)(1996-5#25)(1996-6#1)(1996-7#10)(1996-8#17)(1996-9#1)(1997-1#19)(1997-2#33)(1997-3#13)(1997-4#19)(1997-5#14)(1997-6#14)(1997-7#41)(1997-8#6)(2004-10#1)(2005-10#4)(2005-11#3)(2005-7#4)(2005-8#9)(2006-10#3)(2006-12#16)(2006-4#1)(2006-6#4)(2006-8#4)(2006-9#2)(2007-11#10)(2007-12#8)(2007-2#2)(2007-6#2)(2007-7#1)(2007-8#4)(2008-1#5)(2008-10#13)(2008-11#7)(2008-2#1)(2008-3#4)(2008-4#18)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#35)(2008-9#6)(2009-10#2)(2009-11#2)(2009-2#4)(2009-3#1)(2009-5#2)(2009-7#6)(2009-8#4)(2009-9#5)(2010-10#2)(2010-11#2)(2010-12#8)(2010-3#1)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#8)(2011-2#3)(2012-1#5)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#4)(2013-8#7)
subunit)##13##1##(1990-3#1)(1990-9#2)(1991-2#1)(1991-5#1)(1992-11#1)(1992-3#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-6#1)(2008-9#1)
subunit-binding##5##1##(1995-2#2)(1995-6#3)
subunit-specific antibodies co-precipitated the NMDA R2A##2##6##(1994-9#2)
subunit-specific antibodies##3##2##(1994-9#2)(1995-5#1)
subunit-specific##8##1##(1991-7#1)(1994-12#1)(1994-9#2)(1995-12#1)(1995-5#1)(1996-5#1)(2008-8#1)
subunit-subunit interactions##2##2##(1990-8#1)(1992-8#1)
subunit-subunit##4##1##(1990-8#1)(1992-8#1)(1995-8#1)(2007-7#1)
subunits (Gs##2##2##(1995-6#1)(2008-7#1)
subunits (alpha##3##2##(1991-1#1)(1995-8#1)(2005-8#1)
subunits A##4##2##(1994-9#1)(1995-5#1)(1995-6#2)
subunits C##3##2##(1993-11#3)
subunits I##2##2##(1994-8#1)(1997-4#1)
subunits alpha and beta##2##4##(1997-1#1)(1997-4#1)
subunits alpha and##3##3##(1997-1#1)(1997-4#2)
subunits alpha##7##2##(1990-12#1)(1994-6#1)(1995-3#1)(1997-1#1)(1997-4#2)(2010-8#1)
subunits and are##3##3##(1990-8#1)(1995-1#1)(1997-4#1)
subunits and each subunit##2##4##(1996-5#1)(2008-9#1)
subunits and the two##2##4##(1990-8#1)(1993-6#1)
subunits and the##5##3##(1990-8#1)(1993-6#2)(1996-2#1)(1996-5#1)
subunits and their##2##3##(1997-6#1)(2008-9#1)
subunits and three##2##3##(1990-8#1)(1993-11#1)
subunits and##45##2##(1990-2#1)(1990-7#3)(1990-8#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-2#2)(1996-5#2)(1997-1#1)(1997-2#3)(1997-4#1)(1997-6#1)(2005-8#1)(2006-8#1)(2008-7#1)(2008-8#2)(2008-9#2)
subunits are catalytically##2##3##(1992-3#2)
subunits are thought to##2##4##(1992-2#1)(1995-7#1)
subunits are##31##2##(1990-5#1)(1991-10#1)(1991-3#2)(1991-5#1)(1992-2#1)(1992-3#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-7#1)(1995-9#1)(1996-4#1)(1997-3#1)(1997-7#1)(2008-10#2)(2008-4#2)(2009-11#1)(2012-3#1)
subunits as##3##2##(1991-10#1)(1992-8#1)(1995-3#1)
subunits at the##2##3##(2011-1#1)(2012-12#1)
subunits at##4##2##(2006-10#2)(2011-1#1)(2012-12#1)
subunits b and d##2##4##(1994-9#2)
subunits b##3##2##(1994-9#3)
subunits but##2##2##(1990-7#1)(1991-8#1)
subunits by##7##2##(1992-6#1)(1993-6#1)(1994-11#1)(1995-11#1)(1995-3#1)(2008-4#1)(2009-7#1)
subunits can be##2##3##(1994-6#1)(1995-6#1)
subunits can##3##2##(1993-9#1)(1994-6#1)(1995-6#1)
subunits differentially##2##2##(1992-2#1)(2008-8#1)
subunits do not##2##3##(1994-9#1)(2008-8#1)
subunits during##2##2##(1995-3#1)(2008-8#1)
subunits each##3##2##(1990-4#1)(1992-11#1)(2007-3#1)
subunits encoded by##3##3##(1997-1#1)(1997-6#1)(1997-7#1)
subunits encoded##4##2##(1995-6#1)(1997-1#1)(1997-6#1)(1997-7#1)
subunits expressed in##3##3##(1994-2#2)(1996-3#1)
subunits from other##2##3##(1993-8#1)(1994-12#1)
subunits from the##2##3##(1991-5#1)(1994-9#1)
subunits from##8##2##(1991-5#1)(1993-8#1)(1994-12#2)(1994-9#1)(1996-2#1)(1997-4#1)(2008-8#1)
subunits has##2##2##(1992-2#1)(1994-9#1)
subunits have been##3##3##(1992-3#1)(1992-7#1)(1994-8#1)
subunits have##8##2##(1992-3#1)(1992-7#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-6#1)(1997-4#1)(2013-8#1)
subunits in a##2##3##(1995-6#1)(2008-7#1)
subunits in different##2##3##(1995-11#1)(1997-2#1)
subunits in the##20##3##(1990-3#1)(1990-8#1)(1991-12#1)(1992-11#2)(1992-8#2)(1993-4#2)(1994-12#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-10#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-8#2)(2010-8#1)
subunits in##52##2##(1990-3#1)(1990-8#1)(1991-10#2)(1991-12#1)(1991-7#1)(1992-11#3)(1992-6#1)(1992-8#2)(1993-4#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#4)(1995-11#2)(1995-3#2)(1995-5#1)(1995-6#2)(1996-10#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#1)(2007-1#1)(2007-12#1)(2007-7#1)(2008-7#1)(2008-8#5)(2008-9#3)(2010-8#1)(2012-12#1)
subunits into##2##2##(1990-11#1)(2009-2#1)
subunits involved in the##2##4##(1992-11#1)(2012-12#1)
subunits is##4##2##(1994-6#1)(1994-8#1)(1995-6#1)(2009-5#1)
subunits isolated##2##2##(1990-5#1)(1996-12#1)
subunits may be##2##3##(1991-7#1)(1997-6#1)
subunits may##6##2##(1990-3#1)(1990-8#1)(1991-7#1)(1992-7#1)(1997-2#1)(1997-6#1)
subunits mutated at Cys276##2##4##(1994-11#2)
subunits mutated at##3##3##(1994-11#3)
subunits occurred in##3##3##(1990-5#1)(1994-8#1)(2008-8#1)
subunits of Escherichia coli##2##4##(1992-4#1)(1992-9#1)
subunits of G proteins##2##4##(1990-3#1)(1990-7#1)
subunits of G##3##3##(1990-3#1)(1990-7#1)(2008-9#1)
subunits of G-proteins##2##3##(1993-3#1)(2008-8#1)
subunits of a##3##3##(1992-8#1)(1996-5#1)(2008-10#1)
subunits of factor##2##3##(1991-2#1)(1993-12#1)
subunits of hemoglobin##2##3##(1994-8#1)(1997-2#1)
subunits of heterotrimeric GTP-binding proteins##2##5##(1992-2#1)(1996-4#1)
subunits of heterotrimeric##4##3##(1992-2#1)(1994-3#1)(1995-8#1)(1996-4#1)
subunits of human##2##3##(1992-6#1)(2009-2#1)
subunits of interleukin-12##2##3##(1996-10#1)(1997-7#1)
subunits of other##2##3##(1995-1#1)(1997-4#1)
subunits of the catalytic sector##2##5##(1994-9#2)
subunits of the cellulosome##2##4##(1995-2#1)(2006-8#1)
subunits of the enzyme##4##4##(1990-11#1)(1992-6#1)(1996-3#1)(2006-8#1)
subunits of the mitochondrial##2##4##(1991-10#1)(2007-11#1)
subunits of the respiratory chain##2##5##(2005-8#1)(2008-7#1)
subunits of the yeast##2##4##(1992-2#1)(1994-9#1)
subunits of the##54##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-7#5)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-6#1)(1992-9#1)(1994-12#1)(1994-3#1)(1994-9#4)(1995-11#1)(1995-2#2)(1995-3#2)(1995-8#1)(1996-11#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-8#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#2)(2010-12#1)(2013-8#1)
subunits of##172##2##(1990-1#1)(1990-10#3)(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#4)(1990-4#1)(1990-5#3)(1990-7#10)(1990-8#2)(1990-9#2)(1991-1#1)(1991-10#4)(1991-12#1)(1991-2#2)(1991-5#1)(1992-10#1)(1992-11#4)(1992-12#1)(1992-2#3)(1992-4#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#3)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-8#7)(1994-9#6)(1995-1#1)(1995-11#3)(1995-2#4)(1995-3#4)(1995-6#2)(1995-8#4)(1996-10#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#5)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#5)(1997-7#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-8#3)(2006-9#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#5)(2008-9#1)(2009-2#1)(2009-8#2)(2010-12#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#2)
subunits on##2##2##(1990-4#1)(2009-9#1)
subunits or##2##2##(1997-2#1)(2009-8#1)
subunits per##2##2##(1997-6#1)(2008-9#1)
subunits produced##2##2##(1990-3#1)(1995-8#1)
subunits show##2##2##(1992-9#1)(2009-6#1)
subunits that are##2##3##(1992-4#1)(1994-3#1)
subunits that##9##2##(1992-4#1)(1993-6#1)(1994-3#1)(1997-1#1)(1997-2#1)(2005-10#1)(2008-9#1)(2010-12#1)(2012-2#1)
subunits to##9##2##(1991-3#1)(1992-6#1)(1993-11#1)(1994-9#1)(1995-2#1)(1997-6#3)(2008-1#1)
subunits was##6##2##(1992-11#1)(1992-3#1)(1994-8#1)(1995-5#1)(1996-2#1)(2008-3#1)
subunits were expressed in##3##4##(1990-8#1)(1996-5#1)(1997-6#1)
subunits were expressed##4##3##(1990-8#1)(1994-9#1)(1996-5#1)(1997-6#1)
subunits were used to probe##2##5##(1991-9#1)(1995-9#1)
subunits were##22##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-9#1)(1992-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-9#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-8#2)
subunits which##3##2##(1992-8#1)(1993-11#1)(1994-12#1)
subunits whose sequences##2##3##(1994-12#1)(1995-6#1)
subunits whose##3##2##(1990-8#1)(1994-12#1)(1995-6#1)
subunits with a##2##3##(1994-11#1)(1994-9#1)
subunits with an##3##3##(1990-1#2)(1997-2#1)
subunits with molecular##2##3##(1990-12#1)(2008-8#1)
subunits with##12##2##(1990-1#2)(1990-12#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-3#1)(1997-2#1)(2007-8#1)(2008-8#1)
subunits within the##3##3##(1990-8#2)(1994-10#1)
subunits within##4##2##(1990-8#2)(1991-10#1)(1994-10#1)
subunits##804##1##(1990-1#3)(1990-10#4)(1990-11#4)(1990-12#5)(1990-2#6)(1990-3#9)(1990-4#5)(1990-5#9)(1990-7#25)(1990-8#17)(1990-9#4)(1991-1#3)(1991-10#12)(1991-11#2)(1991-12#6)(1991-2#9)(1991-3#4)(1991-5#7)(1991-6#1)(1991-7#5)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#18)(1992-12#2)(1992-2#10)(1992-3#8)(1992-4#4)(1992-6#10)(1992-7#3)(1992-8#6)(1992-9#6)(1993-11#10)(1993-12#2)(1993-2#2)(1993-3#5)(1993-4#3)(1993-6#12)(1993-7#1)(1993-8#6)(1993-9#10)(1994-10#3)(1994-11#11)(1994-12#17)(1994-2#4)(1994-3#15)(1994-5#2)(1994-6#5)(1994-8#18)(1994-9#35)(1995-1#6)(1995-11#13)(1995-12#4)(1995-2#11)(1995-3#18)(1995-4#3)(1995-5#7)(1995-6#26)(1995-7#2)(1995-8#15)(1995-9#3)(1996-1#2)(1996-10#5)(1996-11#1)(1996-12#1)(1996-2#12)(1996-3#4)(1996-4#4)(1996-5#7)(1996-7#2)(1996-8#6)(1996-9#3)(1997-1#6)(1997-2#20)(1997-3#8)(1997-4#11)(1997-5#2)(1997-6#17)(1997-7#22)(1997-8#3)(2005-10#2)(2005-11#2)(2005-8#3)(2006-10#5)(2006-12#1)(2006-3#1)(2006-8#8)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#11)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#7)(2008-2#1)(2008-3#3)(2008-4#11)(2008-5#2)(2008-7#10)(2008-8#33)(2008-9#10)(2009-10#4)(2009-11#2)(2009-2#5)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#7)(2010-12#3)(2010-2#1)(2010-5#3)(2010-8#2)(2011-1#5)(2011-2#5)(2012-12#6)(2012-2#6)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#4)
subunits) and the##2##3##(2009-7#1)(2012-12#1)
subunits)##6##1##(1992-3#1)(1994-12#1)(1995-5#1)(2008-1#1)(2009-7#1)(2012-12#1)
suburb##2##1##(1995-9#1)(2011-2#1)
suburban area of##3##3##(2008-11#1)(2008-3#1)(2011-2#1)
suburban area##4##2##(1992-2#1)(2008-11#1)(2008-3#1)(2011-2#1)
suburban areas##5##2##(2006-10#1)(2008-11#1)(2010-8#1)(2011-2#2)
suburban##19##1##(1992-2#1)(1993-8#1)(1997-5#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2010-8#1)(2011-2#3)(2012-11#2)(2013-1#3)
suburbs of##4##2##(2006-2#1)(2007-9#1)(2008-3#1)(2012-2#1)
suburbs##6##1##(2006-2#1)(2007-2#1)(2007-9#1)(2008-2#1)(2008-3#1)(2012-2#1)
subvalvular##3##1##(1992-9#1)(2013-8#2)
subvectors##2##1##(2008-2#2)
subventricular zone (SVZ)##3##3##(2008-7#1)(2010-12#1)(2012-2#1)
subventricular zone##7##2##(2008-7#2)(2009-10#1)(2010-12#3)(2012-2#1)
subventricular##9##1##(1995-12#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-12#3)(2012-2#1)
subvermispora and P##2##3##(2006-3#2)
subvermispora##6##1##(2006-3#6)
subversion of##2##2##(1992-8#1)(2013-1#1)
subvert the##2##2##(2008-9#1)(2013-1#1)
subvert##4##1##(2006-10#1)(2008-9#1)(2009-6#1)(2013-1#1)
subverted##3##1##(2008-11#1)(2012-1#1)(2013-1#1)
subwavelength aperture##4##2##(2007-12#3)(2008-7#1)
subwavelength dielectric gratings##2##3##(2007-11#2)
subwavelength dielectric##5##2##(2007-11#4)(2008-3#1)
subwavelength diffractive##5##2##(2007-12#3)(2008-3#2)
subwavelength features##2##2##(2007-12#1)(2008-3#1)
subwavelength gratings and##2##3##(2008-3#2)
subwavelength gratings##13##2##(2007-11#3)(2007-12#3)(2008-2#1)(2008-3#6)
subwavelength holes##2##2##(2007-12#2)
subwavelength metal-stripe##2##2##(2007-12#2)
subwavelength optical##3##2##(2007-11#1)(2008-3#1)(2009-2#1)
subwavelength period##4##2##(2007-12#1)(2008-3#3)
subwavelength resolution##2##2##(2007-12#1)(2008-3#1)
subwavelength structures##3##2##(2007-11#2)(2008-3#1)
subwavelength##74##1##(2007-11#14)(2007-12#26)(2008-1#1)(2008-2#6)(2008-3#21)(2008-7#4)(2009-2#2)
subwavelength-sized##3##1##(2007-12#3)
subzero temperatures##5##2##(1995-2#1)(1997-7#1)(2005-11#1)(2008-10#2)
suc1##2##1##(1995-8#2)
succeed in##23##2##(1990-2#1)(1992-6#1)(1994-12#1)(1995-11#1)(1996-11#2)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(2006-5#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2011-2#2)(2013-1#2)
succeed only##2##2##(1992-6#1)(2009-7#1)
succeed##40##1##(1990-2#1)(1991-7#1)(1992-6#2)(1994-12#1)(1994-3#1)(1995-11#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#2)(2006-10#1)(2006-5#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#3)(2009-12#1)(2009-7#1)(2011-2#2)(2012-12#2)(2013-1#2)
succeeded by##4##2##(1990-11#1)(2006-8#1)(2008-5#1)(2012-3#1)
succeeded in creating##2##3##(2007-11#1)(2013-7#1)
succeeded in recording##3##3##(1997-4#1)(2007-12#2)
succeeded in##38##2##(1990-11#1)(1992-12#1)(1992-7#1)(1993-8#1)(1995-3#1)(1995-5#1)(1996-5#1)(1996-8#1)(1997-4#2)(1997-6#1)(2006-12#1)(2006-4#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#2)(2009-5#1)(2010-4#1)(2010-7#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
succeeded##52##1##(1990-11#2)(1992-12#1)(1992-7#1)(1993-8#1)(1994-4#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-5#1)(1996-8#1)(1997-4#2)(1997-6#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#2)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#2)(2010-4#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
succeeding frames##2##2##(2008-2#2)
succeeding##15##1##(1992-6#1)(1993-1#1)(1994-5#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-6#1)(2006-11#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-2#3)(2012-1#1)
succeeds in predicting mothers'##2##4##(2011-1#2)
succeeds in##4##2##(1995-1#1)(2007-8#1)(2011-1#2)
succeeds##8##1##(1995-1#1)(2007-8#1)(2008-2#1)(2011-1#4)(2012-1#1)
succesful##2##1##(2008-5#1)(2013-1#1)
succesfull##3##1##(2007-11#3)
success achieved with##2##3##(1992-8#1)(2011-1#1)
success after##3##2##(2006-7#1)(2008-5#1)(2008-8#1)
success among##4##2##(1991-5#1)(1993-2#1)(2006-10#1)(2008-6#1)
success and clinical##2##3##(2006-10#1)(2008-1#1)
success and complications##2##3##(2006-8#1)(2011-12#1)
success and failure##3##3##(1997-3#1)(2007-12#1)(2008-2#1)
success and low##2##3##(1993-5#1)(2006-9#1)
success and safety##2##3##(2008-7#2)
success and the##5##3##(1995-12#1)(1997-6#1)(2007-7#1)(2008-8#1)(2008-9#1)
success and their##2##3##(1990-9#1)(2013-8#1)
success and##50##2##(1990-9#1)(1991-1#1)(1993-11#1)(1993-5#1)(1994-3#1)(1995-12#1)(1996-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#3)(2009-12#1)(2009-2#1)(2009-9#1)(2010-11#2)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
success are##2##2##(1990-12#1)(1992-1#1)
success as a##4##3##(2006-8#1)(2009-5#1)(2009-7#1)(2012-3#1)
success as##7##2##(1994-2#1)(2006-8#1)(2007-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2012-3#1)
success at the end of##2##5##(2006-8#1)(2008-8#1)
success at the##4##3##(1993-2#1)(1996-12#1)(2006-8#1)(2008-8#1)
success at##9##2##(1993-2#1)(1996-1#1)(1996-12#1)(2004-1#1)(2006-8#1)(2008-8#1)(2008-9#1)(2010-5#1)(2010-6#1)
success between##3##2##(2009-12#2)(2011-2#1)
success but##2##2##(2008-8#1)(2013-1#1)
success by##3##2##(1991-12#1)(2011-1#1)(2012-1#1)
success can be##2##3##(1990-6#1)(2008-5#1)
success can##3##2##(1990-6#1)(1996-8#1)(2008-5#1)
success depends##2##2##(2007-8#1)(2008-8#1)
success factor##2##2##(1996-1#1)(1997-1#1)
success factors for##2##3##(1993-3#1)(1994-2#1)
success factors##9##2##(1993-2#1)(1993-3#1)(1994-2#2)(1995-12#1)(1996-12#1)(2008-12#1)(2008-9#1)(2010-8#1)
success feedback##2##2##(2007-12#2)
success for lower##2##3##(2008-10#1)(2009-12#1)
success for the##3##3##(1992-11#1)(2009-12#1)(2009-7#1)
success for##18##2##(1990-12#1)(1992-11#1)(1994-1#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-9#1)(2009-12#2)(2009-2#1)(2009-7#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-1#1)
success has been##2##3##(2012-12#1)(2012-2#1)
success has##8##2##(1993-12#1)(2007-4#1)(2008-2#1)(2010-10#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
success in a##6##3##(1995-2#1)(2005-8#1)(2007-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
success in continuous quality improvement##2##5##(1996-3#1)(2008-1#1)
success in identifying##2##3##(2012-1#1)(2012-12#1)
success in managing##2##3##(1995-12#1)(2013-1#1)
success in obtaining a dietetic internship##2##6##(1993-3#2)
success in obtaining##3##3##(1992-2#1)(1993-3#2)
success in such##2##3##(2006-6#1)(2008-9#1)
success in terms of##2##4##(1993-2#1)(2008-1#1)
success in the group##2##4##(2006-8#2)
success in the management of##2##5##(2007-11#1)(2008-1#1)
success in the treatment of##2##5##(2007-3#1)(2008-5#1)
success in the##14##3##(1993-2#1)(1996-3#1)(2006-2#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-3#1)(2008-1#2)(2008-5#1)(2008-9#1)(2010-8#1)(2011-1#1)
success in this##4##3##(1996-12#1)(2007-2#1)(2008-12#1)(2012-12#1)
success in##95##2##(1990-12#1)(1992-2#2)(1993-2#3)(1993-3#2)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-3#1)(1997-8#1)(2005-8#1)(2006-2#1)(2006-5#3)(2006-6#1)(2006-8#3)(2007-10#1)(2007-11#6)(2007-2#3)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#6)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#6)(2009-12#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#4)(2011-2#3)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#1)(2013-7#2)(2013-8#1)
success include##2##2##(2007-11#2)
success is dependent##2##3##(2008-11#1)(2008-5#1)
success is in##2##3##(2006-10#1)(2011-2#1)
success is the quality of##2##5##(2008-7#1)(2011-12#1)
success is the##3##3##(1994-9#1)(2008-7#1)(2011-12#1)
success is##17##2##(1991-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
success may##2##2##(1997-3#1)(2008-8#1)
success of a health care##2##5##(1995-1#1)(2013-1#1)
success of a##14##3##(1991-2#1)(1994-2#1)(1995-1#1)(2005-10#1)(2006-5#1)(2007-2#1)(2008-12#1)(2008-5#2)(2008-9#2)(2010-9#1)(2013-1#2)
success of any##3##3##(2008-11#2)(2008-9#1)
success of current##2##3##(2008-10#1)(2009-2#1)
success of many##3##3##(1994-12#1)(2005-8#1)(2007-11#1)
success of percutaneous##4##3##(1990-8#1)(2006-7#1)(2008-11#1)(2008-12#1)
success of some##2##3##(1991-9#1)(2013-7#1)
success of such##3##3##(1991-12#1)(1991-8#1)(2008-2#1)
success of that##2##3##(1994-2#1)(2009-3#1)
success of the procedure##4##4##(2007-12#1)(2007-3#1)(2007-5#1)(2011-1#1)
success of the##41##3##(1990-12#1)(1990-9#1)(1991-5#1)(1993-12#1)(1994-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-5#1)(2006-12#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-8#2)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
success of their##4##3##(1991-8#1)(1992-3#1)(1994-12#1)(2012-2#1)
success of these strategies##2##4##(2008-11#1)(2008-4#1)
success of these##13##3##(1990-12#1)(1991-3#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)(2013-1#3)
success of this approach##3##4##(2008-1#1)(2008-11#1)(2009-6#1)
success of this##28##3##(1994-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-3#1)(2006-10#1)(2006-3#1)(2006-4#1)(2007-12#1)(2007-3#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#2)(2009-6#1)(2010-1#1)(2010-12#1)(2010-5#1)(2012-2#1)(2013-8#1)
success of treatment##6##3##(1992-2#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-6#1)(2011-2#1)
success of##295##2##(1990-12#5)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1994-12#4)(1994-2#4)(1994-3#1)(1994-4#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-8#3)(1996-1#1)(1996-12#3)(1996-3#5)(1996-5#2)(1996-6#1)(1997-1#2)(1997-3#1)(1997-7#1)(2004-3#1)(2005-10#3)(2005-7#1)(2005-8#2)(2006-10#7)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#1)(2006-9#1)(2007-11#7)(2007-12#4)(2007-2#3)(2007-3#5)(2007-4#5)(2007-5#1)(2007-6#2)(2007-7#2)(2007-9#1)(2008-1#4)(2008-10#18)(2008-11#10)(2008-12#6)(2008-2#5)(2008-4#4)(2008-5#6)(2008-6#4)(2008-7#3)(2008-8#8)(2008-9#12)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#4)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#2)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#7)(2010-9#2)(2011-1#4)(2011-2#8)(2012-11#1)(2012-12#4)(2012-2#14)(2012-3#6)(2012-7#1)(2013-1#10)(2013-7#2)(2013-8#3)
success on a##3##3##(1992-9#1)(2010-3#2)
success on the NCLEX-RN##3##4##(2006-12#3)
success on the##5##3##(2006-12#3)(2006-3#1)(2007-12#1)
success on##10##2##(1992-9#1)(2006-12#3)(2006-3#1)(2007-12#1)(2010-3#2)(2011-2#1)(2012-1#1)
success or failure of the##2##5##(1996-2#1)(2008-12#1)
success or failure of##8##4##(1996-2#1)(2005-8#2)(2008-10#2)(2008-12#1)(2008-4#1)(2012-2#1)
success or failure##10##3##(1996-2#1)(2005-8#2)(2007-4#1)(2008-10#2)(2008-12#1)(2008-4#1)(2009-9#1)(2012-2#1)
success or##14##2##(1991-8#1)(1996-2#1)(1996-3#1)(2005-8#2)(2007-4#2)(2008-10#2)(2008-12#1)(2008-4#1)(2008-8#1)(2009-9#1)(2012-2#1)
success rate and##9##3##(1990-10#1)(1996-11#1)(2006-10#3)(2006-8#1)(2007-10#1)(2010-12#1)(2010-7#1)
success rate for PCI##3##4##(2006-10#1)(2006-7#1)(2006-8#1)
success rate for##13##3##(1991-12#1)(2006-10#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
success rate in##8##3##(1990-6#1)(1993-5#1)(1994-12#1)(2006-2#1)(2008-10#1)(2008-12#1)(2012-2#1)(2013-1#1)
success rate is##4##3##(1995-7#1)(2006-10#1)(2008-10#1)(2012-2#1)
success rate of##27##3##(1991-3#1)(1993-10#1)(1994-5#1)(1996-2#1)(1996-8#1)(2006-8#1)(2006-9#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-6#1)(2010-7#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
success rate was 100%##3##4##(1992-10#1)(2006-8#1)(2008-1#1)
success rate was##9##3##(1992-10#1)(2006-7#1)(2006-8#2)(2007-10#1)(2008-1#1)(2008-7#1)(2012-1#1)(2013-7#1)
success rate##102##2##(1990-10#1)(1990-6#2)(1991-12#1)(1991-3#1)(1991-8#1)(1992-10#1)(1993-10#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#2)(1995-3#1)(1995-6#1)(1995-7#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-4#1)(2006-10#5)(2006-11#1)(2006-2#1)(2006-7#2)(2006-8#9)(2006-9#1)(2007-10#2)(2007-11#2)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#5)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-6#1)(2010-7#4)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#6)(2013-1#3)(2013-7#2)(2013-8#1)
success rate)##3##2##(1997-1#1)(2006-8#1)(2009-5#1)
success rates and##4##3##(2006-7#1)(2007-3#1)(2008-3#1)(2011-2#1)
success rates in##4##3##(2006-2#1)(2008-10#1)(2009-4#1)(2012-2#1)
success rates of the##2##4##(2006-9#1)(2010-7#1)
success rates of##5##3##(2006-9#1)(2008-2#1)(2008-8#1)(2010-7#1)(2012-1#1)
success rates were##3##3##(2008-7#1)(2009-6#1)(2013-1#1)
success rates##35##2##(1994-12#1)(2005-12#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-12#1)(2007-3#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-12#2)(2010-7#1)(2011-2#3)(2012-1#3)(2012-2#3)(2013-1#1)(2013-8#1)
success stories##3##2##(1996-3#1)(1997-3#1)(2007-11#1)
success story##5##2##(2008-10#1)(2009-12#1)(2009-4#3)
success than##6##2##(1991-12#1)(2006-10#1)(2008-8#1)(2008-9#2)(2009-7#1)
success that##6##2##(1993-3#2)(1995-1#1)(2007-4#1)(2008-8#1)(2011-1#1)
success through##3##2##(1993-3#1)(1997-1#1)(2006-7#1)
success to##8##2##(1991-5#1)(2005-11#1)(2008-11#1)(2008-4#2)(2010-12#1)(2012-3#1)(2013-1#1)
success using##2##2##(2006-9#1)(2008-9#1)
success was related##2##3##(1994-3#1)(2012-3#1)
success was##21##2##(1991-2#1)(1994-11#1)(1994-3#1)(2006-4#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
success were##3##2##(1992-11#1)(2008-8#2)
success when##2##2##(2005-11#1)(2008-7#1)
success will be##4##3##(1993-1#1)(1996-1#1)(1996-3#1)(2006-10#1)
success will depend on##2##4##(1995-12#1)(2010-12#1)
success will##6##2##(1993-1#1)(1995-12#1)(1996-1#1)(1996-3#1)(2006-10#1)(2010-12#1)
success with a##2##3##(2011-2#1)(2013-7#1)
success with this##2##3##(2006-10#1)(2010-8#1)
success with##20##2##(1991-12#1)(1992-6#1)(1994-1#1)(1995-8#1)(1996-12#1)(1996-2#1)(2005-7#1)(2006-10#2)(2006-9#2)(2007-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-7#1)
success!##3##1##(1992-1#1)(2006-5#1)(2010-11#1)
success##1104##1##(1990-10#2)(1990-11#1)(1990-12#9)(1990-6#3)(1990-7#1)(1990-8#1)(1990-9#3)(1991-1#2)(1991-12#5)(1991-2#2)(1991-3#3)(1991-4#1)(1991-5#4)(1991-6#1)(1991-8#5)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#3)(1992-3#5)(1992-6#2)(1992-8#2)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#2)(1993-2#11)(1993-3#12)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#5)(1994-11#1)(1994-12#9)(1994-2#13)(1994-3#6)(1994-4#2)(1994-5#1)(1994-6#2)(1994-7#1)(1994-9#3)(1995-1#3)(1995-11#3)(1995-12#9)(1995-2#3)(1995-3#9)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#4)(1995-9#1)(1996-1#7)(1996-11#1)(1996-12#9)(1996-2#4)(1996-3#17)(1996-5#2)(1996-6#3)(1996-8#3)(1997-1#6)(1997-2#2)(1997-3#6)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#2)(2004-1#1)(2004-3#1)(2004-4#1)(2004-9#1)(2005-10#4)(2005-11#2)(2005-12#1)(2005-4#1)(2005-7#3)(2005-8#9)(2006-10#30)(2006-11#1)(2006-12#10)(2006-2#6)(2006-3#4)(2006-4#6)(2006-5#6)(2006-6#5)(2006-7#7)(2006-8#19)(2006-9#10)(2007-10#4)(2007-11#23)(2007-12#16)(2007-2#8)(2007-3#9)(2007-4#20)(2007-5#7)(2007-6#3)(2007-7#13)(2007-8#8)(2007-9#4)(2008-1#16)(2008-10#42)(2008-11#33)(2008-12#23)(2008-2#10)(2008-3#6)(2008-4#10)(2008-5#19)(2008-6#7)(2008-7#18)(2008-8#52)(2008-9#46)(2009-10#1)(2009-12#12)(2009-2#5)(2009-3#4)(2009-4#10)(2009-5#6)(2009-6#5)(2009-7#4)(2009-8#5)(2009-9#5)(2010-1#3)(2010-10#6)(2010-11#6)(2010-12#10)(2010-2#7)(2010-3#5)(2010-4#1)(2010-5#5)(2010-6#3)(2010-7#6)(2010-8#15)(2010-9#2)(2011-1#18)(2011-12#4)(2011-2#30)(2011-3#1)(2012-1#16)(2012-11#4)(2012-12#18)(2012-2#35)(2012-3#23)(2012-7#1)(2013-1#30)(2013-7#10)(2013-8#13)
success&quot##2##1##(2013-1#2)
success) and##2##2##(2006-4#1)(2013-1#1)
success)##4##1##(2006-4#1)(2008-4#1)(2010-8#1)(2013-1#1)
success?##4##1##(1995-1#1)(2007-11#1)(2008-4#1)(2012-2#1)
successes achieved##2##2##(2012-12#1)(2013-1#1)
successes and challenges##3##3##(2007-7#1)(2009-5#1)(2012-3#1)
successes and failures##4##3##(1994-3#1)(2008-10#1)(2008-5#1)(2010-11#1)
successes and##12##2##(1992-1#1)(1994-12#1)(1994-3#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-5#1)(2010-11#1)(2012-2#1)(2012-3#1)
successes have##2##2##(1993-3#1)(2005-7#1)
successes in the##2##3##(2007-9#1)(2010-12#1)
successes in##6##2##(1994-12#1)(2005-8#1)(2007-9#1)(2010-12#1)(2012-2#1)(2013-1#1)
successes of##6##2##(1992-5#1)(1995-1#1)(2006-10#1)(2007-11#1)(2009-7#1)(2010-11#1)
successes with##3##2##(1993-2#1)(1995-12#1)(2011-12#1)
successes##49##1##(1990-3#1)(1992-1#1)(1992-5#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-12#1)(1996-1#1)(2005-7#1)(2005-8#1)(2006-10#2)(2007-11#3)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-6#1)(2009-1#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#2)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)
successful PTCA##6##2##(1991-3#1)(1993-12#2)(2007-8#3)
successful adaptation of the##3##4##(2007-7#1)(2008-12#1)(2011-1#1)
successful adaptation to##2##3##(2008-7#1)(2012-1#1)
successful adaptation##6##2##(1995-5#1)(2007-7#1)(2008-12#1)(2008-7#1)(2011-1#1)(2012-1#1)
successful aging##2##2##(2007-12#1)(2011-1#1)
successful alternative for##2##3##(1996-2#1)(1997-4#1)
successful alternative##5##2##(1996-2#1)(1997-4#1)(2007-8#1)(2008-2#1)(2009-9#1)
successful amplification of##3##3##(2008-10#1)(2008-2#1)(2008-9#1)
successful anaesthetic##2##2##(2006-10#1)(2010-7#1)
successful analysis of##4##3##(2005-12#1)(2007-9#1)(2008-10#1)(2010-9#1)
successful analytical investigations of##2##4##(2010-4#2)
successful and unsuccessful##3##3##(1993-7#1)(1995-1#1)(2007-11#1)
successful and##25##2##(1990-9#1)(1992-2#1)(1993-7#2)(1994-1#1)(1995-1#1)(2005-10#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2010-10#1)(2010-5#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
successful angioplasty##2##2##(1996-8#1)(2011-2#1)
successful application of a##3##4##(1995-11#1)(2008-2#1)(2008-9#1)
successful application of the##2##4##(2008-1#1)(2008-9#1)
successful application of##13##3##(1995-1#1)(1995-11#1)(1995-2#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#2)(2012-12#1)(2012-3#1)
successful application##15##2##(1995-1#1)(1995-11#1)(1995-2#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#2)(2010-2#1)(2012-12#1)(2012-3#1)
successful applications of##5##3##(2006-5#1)(2008-10#1)(2008-3#1)(2012-2#1)(2013-8#1)
successful applications##8##2##(2006-5#1)(2008-10#1)(2008-3#1)(2012-2#2)(2013-1#2)(2013-8#1)
successful approach to##3##3##(2006-10#1)(2007-11#1)(2010-9#1)
successful approach##4##2##(2006-10#1)(2007-11#1)(2008-5#1)(2010-9#1)
successful approaches to##2##3##(2009-2#1)(2011-1#1)
successful approaches##5##2##(2007-11#1)(2009-2#1)(2009-3#1)(2010-9#1)(2011-1#1)
successful as##3##2##(2007-2#1)(2008-10#1)(2013-8#1)
successful at##9##2##(1990-3#1)(1994-3#1)(1997-2#1)(2007-7#1)(2008-10#1)(2012-12#1)(2012-2#1)(2013-1#2)
successful attempt##4##2##(2006-7#1)(2008-10#3)
successful because of##2##3##(2006-6#1)(2008-10#1)
successful because##3##2##(2006-6#1)(2008-10#1)(2008-2#1)
successful biological control##2##3##(2008-10#2)
successful birth practices and outcomes##2##5##(2007-2#2)
successful birth##4##2##(2007-2#2)(2009-5#1)(2009-9#1)
successful cannulation##2##2##(2008-1#1)(2011-2#1)
successful cardiopulmonary##2##2##(1990-9#1)(2008-3#1)
successful cases of##3##3##(2008-11#1)(2011-1#1)(2013-8#1)
successful cases##4##2##(2007-8#1)(2008-11#1)(2011-1#1)(2013-8#1)
successful cell##2##2##(2008-11#1)(2012-12#1)
successful change##3##2##(1994-2#1)(1995-12#1)(1996-1#1)
successful clade##2##2##(2007-12#1)(2010-8#1)
successful clinical trials##3##3##(2007-10#1)(2010-10#1)(2012-12#1)
successful clinical##13##2##(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-5#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-5#1)(2012-12#1)(2012-3#1)
successful closed reduction of##3##4##(2009-3#1)(2013-7#2)
successful closed reduction##5##3##(2009-3#1)(2013-7#4)
successful collaboration##3##2##(2006-1#1)(2007-1#1)(2010-3#1)
successful collaborative##2##2##(1995-2#1)(1996-2#1)
successful combined##2##2##(2007-8#2)
successful compensation##2##2##(1991-2#1)(1995-12#1)
successful completion of the##2##4##(2006-5#1)(2008-12#1)
successful completion of##7##3##(2006-5#1)(2007-1#1)(2008-12#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
successful completion##8##2##(2006-5#1)(2007-1#1)(2008-12#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
successful condom use##2##3##(2008-11#2)
successful condom users were more likely to##2##7##(2008-11#2)
successful condom users##3##3##(2008-11#3)
successful condom##5##2##(2008-11#5)
successful control of##4##3##(2006-10#1)(2007-12#1)(2008-8#1)(2009-5#1)
successful control##5##2##(2006-10#1)(2007-12#1)(2008-1#1)(2008-8#1)(2009-5#1)
successful coronary angioplasty##2##3##(1993-12#2)
successful coronary##4##2##(1991-3#1)(1993-12#2)(2007-8#1)
successful course##2##2##(2008-12#1)(2011-2#1)
successful culture##2##2##(2013-1#2)
successful defense of##3##3##(1991-1#1)(1992-2#1)(1993-12#1)
successful demonstration of##2##3##(2007-11#1)(2008-1#1)
successful detection of##3##3##(2008-10#1)(2010-5#1)(2012-3#1)
successful development of##3##3##(2008-1#2)(2008-12#1)
successful development##4##2##(1995-5#1)(2008-1#2)(2008-12#1)
successful diagnosis##2##2##(2010-12#1)(2012-3#1)
successful drug candidates##2##3##(2005-9#2)
successful early##2##2##(2009-8#1)(2011-1#1)
successful efforts##2##2##(2006-4#1)(2008-10#1)
successful elimination##2##2##(2006-10#1)(2008-11#1)
successful endoscopic##3##2##(2008-10#1)(2008-7#1)(2012-12#1)
successful eradication of##2##3##(1992-6#1)(1993-12#1)
successful establishment of##2##3##(2008-10#1)(2008-11#1)
successful evaluation of##2##3##(2006-1#1)(2006-5#1)
successful example of##2##3##(2008-7#1)(2011-12#1)
successful example##3##2##(1994-7#1)(2008-7#1)(2011-12#1)
successful examples of##3##3##(1997-2#1)(2008-10#1)(2010-7#1)
successful execution##2##2##(2008-2#1)(2009-2#1)
successful experience##2##2##(1992-12#1)(2006-10#1)
successful experiences##2##2##(2008-10#1)(2011-2#1)
successful experiment##2##2##(2008-1#1)(2009-4#1)
successful experimental##4##2##(2007-11#1)(2008-2#1)(2010-12#1)(2012-2#1)
successful exploitation##2##2##(2008-11#1)(2008-8#1)
successful extraction of##2##3##(2008-9#1)(2010-6#1)
successful extraction##3##2##(2008-10#1)(2008-9#1)(2010-6#1)
successful for the determination of the enantiopurity of Mtx as raw material##2##12##(2008-10#2)
successful for the##5##3##(2008-10#3)(2008-5#1)(2012-3#1)
successful for two##2##3##(2008-9#1)(2013-7#1)
successful for##17##2##(2007-11#2)(2007-8#2)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-5#1)(2012-3#1)(2013-7#1)
successful fusion##3##2##(2006-8#1)(2006-9#1)(2008-9#1)
successful gene##3##2##(2008-11#1)(2008-4#1)(2010-12#1)
successful growth of##2##3##(2010-4#1)(2011-1#1)
successful hatching##2##2##(2008-5#2)
successful health##3##2##(1994-3#1)(1995-12#1)(1996-3#1)
successful hemodialysis##2##2##(2007-7#2)
successful hemodynamic##2##2##(2006-6#1)(2010-12#1)
successful hospital##5##2##(1990-12#1)(1991-2#1)(1995-1#1)(1996-2#1)(2012-3#1)
successful human##2##2##(1997-2#1)(2007-7#1)
successful implant##2##2##(2007-12#1)(2007-7#1)
successful implantation##2##2##(1994-9#1)(2007-9#1)
successful implementation of a##4##4##(1994-3#1)(2007-12#1)(2008-8#1)(2011-2#1)
successful implementation of the##3##4##(1992-1#1)(2010-3#1)(2013-8#1)
successful implementation of##14##3##(1992-1#1)(1993-12#1)(1994-3#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-3#2)(2011-2#1)(2013-8#1)
successful implementation##18##2##(1992-1#1)(1992-12#1)(1993-12#1)(1994-3#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#2)(2009-6#1)(2010-12#1)(2010-3#2)(2011-2#1)(2012-2#1)(2013-8#2)
successful implementations of##2##3##(2008-2#1)(2012-3#1)
successful in acute##2##3##(2007-8#1)(2010-3#1)
successful in all##6##3##(1991-2#1)(2005-12#1)(2007-12#1)(2007-3#1)(2011-2#1)(2012-2#1)
successful in containing##2##3##(1992-2#1)(1996-2#1)
successful in detecting##2##3##(2008-10#1)(2012-3#1)
successful in eliminating##3##3##(1993-10#1)(1994-2#1)(2012-12#1)
successful in helping##2##3##(2007-4#1)(2008-11#1)
successful in identifying##3##3##(1996-8#1)(2008-4#1)(2012-3#1)
successful in increasing the##2##4##(1997-2#1)(2007-2#1)
successful in many##3##3##(2008-10#1)(2013-1#2)
successful in more than##2##4##(1994-9#1)(2007-3#1)
successful in obtaining##2##3##(1992-2#1)(1993-3#1)
successful in preventing fungal ingress##2##5##(2008-10#2)
successful in preventing##4##3##(1994-12#1)(2008-10#2)(2009-3#1)
successful in reducing##6##3##(2006-10#1)(2008-11#3)(2012-1#1)(2012-2#1)
successful in resolving##2##3##(2007-11#1)(2008-10#1)
successful in terms of both##2##5##(2011-12#1)(2011-2#1)
successful in the treatment of##2##5##(2007-11#1)(2007-8#1)
successful in the##17##3##(1993-9#1)(2004-9#1)(2005-10#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
successful in this##2##3##(2008-1#1)(2008-10#1)
successful in treating the##2##4##(2006-4#1)(2006-5#1)
successful in treating##4##3##(2006-4#1)(2006-5#1)(2007-12#1)(2007-5#1)
successful in women##2##3##(2006-8#1)(2007-2#1)
successful in##139##2##(1990-12#3)(1990-8#1)(1991-2#1)(1992-2#2)(1992-6#1)(1993-1#1)(1993-10#1)(1993-3#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-9#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-8#2)(2004-9#1)(2005-10#1)(2005-12#3)(2005-7#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-4#3)(2006-5#4)(2006-8#3)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#3)(2007-3#3)(2007-4#1)(2007-5#2)(2007-7#6)(2007-8#6)(2008-1#2)(2008-10#12)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#3)(2010-10#1)(2010-12#4)(2010-3#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#1)
successful innovation##2##2##(1991-1#1)(2007-4#1)
successful integration of##4##3##(1992-3#1)(2006-10#2)(2008-3#1)
successful integration##5##2##(1992-3#1)(1995-2#1)(2006-10#2)(2008-3#1)
successful intervention##2##2##(2008-12#1)(2011-2#1)
successful isolation of##3##3##(2008-10#2)(2008-7#1)
successful kidney transplantation in##2##4##(2008-1#1)(2010-4#1)
successful kidney transplantation##3##3##(2006-8#1)(2008-1#1)(2010-4#1)
successful learners##2##2##(2008-6#1)(2013-8#1)
successful liver transplantation##2##3##(2004-11#1)(2006-10#1)
successful management and##2##3##(2007-7#1)(2010-5#1)
successful management of a##5##4##(2004-10#1)(2007-8#2)(2008-10#1)(2012-2#1)
successful management of##19##3##(1994-3#1)(2004-10#1)(2006-10#2)(2007-12#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-7#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#3)(2013-7#1)
successful management##27##2##(1994-3#1)(2004-10#1)(2006-10#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-7#2)(2009-11#1)(2010-5#1)(2010-7#1)(2011-2#4)(2012-12#1)(2012-2#5)(2013-7#1)
successful measurement of##2##3##(1997-4#1)(2008-4#1)
successful medical management##2##3##(2007-10#1)(2010-8#1)
successful medical##6##2##(1995-8#1)(2007-10#1)(2008-10#1)(2008-2#1)(2010-8#1)(2011-12#1)
successful myectomy##2##2##(2007-8#2)
successful of##2##2##(2006-10#1)(2008-10#1)
successful on##4##2##(2006-10#1)(2006-12#1)(2007-7#2)
successful only in##2##3##(2007-8#1)(2008-7#1)
successful only##3##2##(2007-8#1)(2008-5#1)(2008-7#1)
successful open##3##2##(2013-1#2)(2013-8#1)
successful operation##7##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#3)(2010-8#1)
successful or##2##2##(2008-6#1)(2011-1#1)
successful organization##2##2##(1994-12#1)(2007-9#1)
successful outcome of the##2##4##(2008-11#1)(2012-12#1)
successful outcome of##3##3##(1991-6#1)(2008-11#1)(2012-12#1)
successful outcome##22##2##(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-7#2)(2010-9#1)(2012-12#2)(2012-2#2)(2013-1#1)
successful outcomes##4##2##(1991-12#1)(1996-12#1)(2013-1#1)(2013-8#1)
successful over the past##2##4##(1997-1#1)(2006-2#1)
successful palliation of##2##3##(2006-6#1)(2008-6#1)
successful palliation##3##2##(2006-6#1)(2007-4#1)(2008-6#1)
successful past##2##2##(2008-8#1)(2011-2#1)
successful patient##2##2##(2007-8#1)(2011-2#1)
successful percutaneous transluminal coronary angioplasty (PTCA)##2##6##(1991-3#1)(1993-12#1)
successful percutaneous transluminal coronary angioplasty##3##5##(1991-3#1)(1993-12#1)(2007-8#1)
successful percutaneous##4##2##(1991-3#1)(1993-12#1)(2007-8#1)(2009-5#1)
successful practice in##2##3##(1991-1#1)(2007-2#1)
successful practice##5##2##(1991-1#1)(1993-1#1)(2004-12#1)(2007-2#1)(2007-9#1)
successful pregnancy outcome##2##3##(2009-6#1)(2010-8#1)
successful pregnancy##6##2##(1991-3#1)(1996-12#1)(2004-10#1)(2009-6#1)(2010-8#1)(2012-3#1)
successful preparation##2##2##(1991-12#1)(2007-9#1)
successful process##2##2##(1995-1#1)(2008-11#1)
successful production of##2##3##(1991-3#1)(2006-4#1)
successful production##3##2##(1991-3#1)(2006-4#1)(2012-12#1)
successful program##3##2##(1992-12#1)(2007-10#1)(2007-7#1)
successful purification##2##2##(2008-4#2)
successful recovery##3##2##(2008-6#1)(2011-1#1)(2012-3#1)
successful rehabilitation##3##2##(1990-8#1)(1992-3#1)(2008-9#1)
successful removal of##2##3##(2006-10#1)(2012-12#1)
successful removal##4##2##(2006-10#1)(2012-12#3)
successful renal transplantation##3##3##(2006-10#1)(2007-8#1)(2009-5#1)
successful renal##4##2##(1997-3#1)(2006-10#1)(2007-8#1)(2009-5#1)
successful repair##6##2##(1997-1#2)(2007-12#1)(2007-8#1)(2011-2#1)(2012-12#1)
successful reproduction##3##2##(2008-2#1)(2008-9#1)(2012-12#1)
successful research##4##2##(2007-4#1)(2008-8#1)(2010-5#1)(2012-1#1)
successful resection of the##2##4##(2011-2#1)(2013-8#1)
successful resection of##4##3##(2007-8#1)(2008-10#1)(2011-2#1)(2013-8#1)
successful restructuring##2##2##(1994-3#1)(1995-1#1)
successful results##5##2##(2006-10#1)(2008-5#2)(2013-1#2)
successful scale-up of##2##3##(2007-6#1)(2010-11#1)
successful search##2##2##(1993-2#1)(2012-1#1)
successful since##3##2##(1997-3#1)(2007-2#1)(2008-7#1)
successful strategy##5##2##(2007-6#1)(2008-3#1)(2009-4#1)(2009-9#1)(2010-4#1)
successful strokes##2##2##(2007-10#2)
successful surgical excision of##3##4##(2006-9#1)(2013-1#2)
successful surgical repair##2##3##(2007-8#1)(2010-7#1)
successful surgical treatment##2##3##(1997-7#1)(2007-8#1)
successful surgical##13##2##(1997-7#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-12#1)(2007-3#1)(2007-8#3)(2010-7#1)(2011-2#1)(2013-1#2)
successful synthesis of##2##3##(1997-3#1)(2012-2#1)
successful technique##3##2##(2006-9#1)(2008-10#1)(2008-3#1)
successful than##4##2##(1993-2#1)(1996-3#1)(2010-4#1)(2011-2#1)
successful therapeutic##6##2##(1992-8#1)(1995-11#1)(1996-11#1)(2007-9#1)(2008-1#1)(2013-1#1)
successful therapy##10##2##(1995-8#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#2)(2012-12#1)(2012-3#1)
successful thrombolysis##3##2##(1990-3#2)(2007-8#1)
successful to##2##2##(2008-10#1)(2008-11#1)
successful tocolysis##2##2##(2006-1#1)(2012-3#1)
successful training##2##2##(1996-3#1)(2006-6#1)
successful transition##3##2##(1991-12#1)(2010-10#1)(2011-1#1)
successful transmission##4##2##(2007-9#1)(2008-10#2)(2013-8#1)
successful transplantation##4##2##(1995-12#1)(2007-8#1)(2008-5#1)(2008-9#1)
successful treatment by##4##3##(2006-10#1)(2008-7#1)(2009-5#1)(2010-12#1)
successful treatment for##5##3##(1993-4#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-11#1)
successful treatment is early diagnosis##2##5##(2008-1#1)(2011-1#1)
successful treatment is##4##3##(2006-12#1)(2008-1#1)(2008-12#1)(2011-1#1)
successful treatment of the##4##4##(1997-3#1)(2006-10#1)(2007-3#1)(2008-1#1)
successful treatment of##29##3##(1991-4#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-6#1)(1997-3#1)(2004-3#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-10#1)(2009-7#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
successful treatment using##2##3##(2006-10#1)(2007-8#1)
successful treatment with##4##3##(2006-10#1)(2007-7#1)(2009-8#1)(2010-10#1)
successful treatment##65##2##(1991-4#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-6#1)(1995-5#1)(1997-3#1)(2004-3#1)(2005-7#1)(2006-10#6)(2006-11#2)(2006-12#4)(2006-8#3)(2006-9#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-10#2)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-12#1)(2010-3#2)(2010-6#1)(2011-1#2)(2011-2#1)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#1)
successful trials##3##2##(2007-8#1)(2008-8#1)(2012-1#1)
successful use of the##4##4##(2007-8#1)(2008-10#1)(2008-12#1)(2010-12#1)
successful use of##15##3##(1990-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-8#3)(2008-10#2)(2008-11#2)(2008-12#1)(2010-11#1)(2010-12#1)(2010-7#1)
successful use##17##2##(1990-8#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-11#2)(2008-12#1)(2010-11#1)(2010-12#1)(2010-7#1)
successful users to##2##3##(2008-11#2)
successful vaginal##2##2##(2011-1#2)
successful volunteer##2##2##(1997-2#2)
successful weaning##2##2##(2007-8#1)(2012-2#1)
successful when##4##2##(1993-1#1)(1993-8#1)(2006-8#2)
successful with a##2##3##(1993-9#1)(2008-10#1)
successful with##7##2##(1993-9#1)(2004-10#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-9#1)
successful##1390##1##(1990-10#3)(1990-12#9)(1990-3#3)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#4)(1991-1#5)(1991-10#1)(1991-12#7)(1991-2#7)(1991-3#8)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#10)(1992-2#10)(1992-3#4)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#7)(1993-10#2)(1993-11#1)(1993-12#13)(1993-2#7)(1993-3#5)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#3)(1994-1#3)(1994-12#7)(1994-2#5)(1994-3#11)(1994-6#1)(1994-7#2)(1994-9#5)(1995-1#9)(1995-11#4)(1995-12#7)(1995-2#4)(1995-3#2)(1995-5#4)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#2)(1996-1#3)(1996-11#2)(1996-12#10)(1996-2#9)(1996-3#8)(1996-4#1)(1996-5#4)(1996-6#2)(1996-8#4)(1996-9#3)(1997-1#8)(1997-2#11)(1997-3#6)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#3)(2004-10#3)(2004-11#3)(2004-12#1)(2004-3#1)(2004-5#1)(2004-9#1)(2005-10#5)(2005-11#1)(2005-12#5)(2005-2#1)(2005-7#7)(2005-8#5)(2005-9#2)(2006-1#3)(2006-10#37)(2006-11#4)(2006-12#10)(2006-2#6)(2006-3#1)(2006-4#6)(2006-5#13)(2006-6#5)(2006-7#6)(2006-8#15)(2006-9#7)(2007-1#5)(2007-10#10)(2007-11#27)(2007-12#26)(2007-2#17)(2007-3#9)(2007-4#12)(2007-5#6)(2007-6#4)(2007-7#25)(2007-8#61)(2007-9#12)(2008-1#23)(2008-10#100)(2008-11#42)(2008-12#16)(2008-2#21)(2008-3#26)(2008-4#19)(2008-5#22)(2008-6#11)(2008-7#24)(2008-8#17)(2008-9#24)(2009-10#5)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#14)(2009-4#6)(2009-5#9)(2009-6#5)(2009-7#1)(2009-8#9)(2009-9#5)(2010-10#9)(2010-11#5)(2010-12#14)(2010-2#8)(2010-3#9)(2010-4#10)(2010-5#9)(2010-6#6)(2010-7#12)(2010-8#8)(2010-9#5)(2011-1#20)(2011-12#6)(2011-2#35)(2011-3#2)(2012-1#9)(2012-11#1)(2012-12#32)(2012-2#38)(2012-3#29)(2013-1#37)(2013-7#9)(2013-8#23)
successfull##2##1##(2007-8#1)(2008-5#1)
successfully ablated##3##2##(2006-9#1)(2013-1#2)
successfully accomplished##2##2##(1993-2#1)(2007-8#1)
successfully achieved by##2##3##(1990-8#1)(1996-5#1)
successfully achieved via##2##3##(2008-5#1)(2011-2#1)
successfully achieved##12##2##(1990-8#1)(1996-5#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#2)(2013-1#2)
successfully adapted to##2##3##(2005-11#1)(2008-10#1)
successfully addressed##2##2##(2007-11#1)(2013-1#1)
successfully adopted##4##2##(1992-3#1)(2006-10#1)(2008-8#1)(2012-1#1)
successfully amplified by##2##3##(2008-10#2)
successfully amplified polymorphic##2##3##(2008-5#2)
successfully amplified##4##2##(2008-10#2)(2008-5#2)
successfully analyzed by##2##3##(2008-10#1)(2011-1#1)
successfully analyzed##8##2##(2007-8#1)(2008-10#5)(2010-5#1)(2011-1#1)
successfully and##7##2##(2008-10#1)(2008-11#1)(2008-2#1)(2010-1#1)(2010-12#1)(2011-2#1)(2013-8#1)
successfully applied for a##2##4##(1993-3#1)(2008-10#1)
successfully applied for determination of##4##5##(2008-10#4)
successfully applied for simultaneous determination of##2##6##(2008-10#2)
successfully applied for the analysis of##5##6##(2005-12#1)(2007-8#1)(2008-10#3)
successfully applied for the assay of##3##6##(2008-10#3)
successfully applied for the determination of trace##2##7##(2008-10#2)
successfully applied for the determination of##16##6##(2008-10#16)
successfully applied for the##41##4##(2005-12#1)(2007-12#1)(2007-8#1)(2008-10#33)(2009-11#1)(2009-6#1)(2009-8#1)(2012-12#1)(2013-8#1)
successfully applied for##57##3##(1993-3#1)(2005-12#1)(2007-12#1)(2007-8#1)(2008-10#48)(2009-11#1)(2009-6#1)(2009-8#1)(2012-12#1)(2013-8#1)
successfully applied in the##9##4##(2007-8#1)(2008-1#1)(2008-10#3)(2008-9#1)(2011-2#1)(2013-8#2)
successfully applied in##15##3##(2007-8#1)(2008-1#1)(2008-10#8)(2008-9#1)(2011-2#1)(2011-3#1)(2013-8#2)
successfully applied to an##3##4##(1993-2#1)(1996-10#1)(2008-10#1)
successfully applied to analysis of##2##5##(2008-10#2)
successfully applied to analyze##3##4##(2008-10#3)
successfully applied to detect##2##4##(2008-10#1)(2010-5#1)
successfully applied to determination of the##2##6##(2008-10#2)
successfully applied to determination of##5##5##(2008-10#5)
successfully applied to determine the##3##5##(2007-8#1)(2008-10#2)
successfully applied to determine##13##4##(2007-8#1)(2008-10#12)
successfully applied to different##2##4##(2008-10#2)
successfully applied to measure##2##4##(2006-5#1)(2007-8#1)
successfully applied to on-line##2##4##(2008-10#2)
successfully applied to real samples##2##5##(2008-10#1)(2012-11#1)
successfully applied to real##3##4##(2008-10#2)(2012-11#1)
successfully applied to the analysis of the##2##7##(2008-10#2)
successfully applied to the analysis of##17##6##(2007-8#2)(2008-10#14)(2013-1#1)
successfully applied to the determination of atrazine in##2##8##(2008-10#2)
successfully applied to the determination of chromium in##2##8##(2008-10#2)
successfully applied to the determination of glucose in human##2##9##(2008-10#1)(2010-5#1)
successfully applied to the determination of glucose in##3##8##(2008-10#2)(2010-5#1)
successfully applied to the determination of lead in##3##8##(2008-10#3)
successfully applied to the determination of nickel in##2##8##(2008-10#2)
successfully applied to the determination of nickel##3##7##(2008-10#3)
successfully applied to the determination of nitrite in##2##8##(2008-10#2)
successfully applied to the determination of the drug in##2##9##(2008-10#2)
successfully applied to the determination of the##4##7##(2008-10#4)
successfully applied to the determination of these##2##7##(2008-10#2)
successfully applied to the determination of trace amount of##3##9##(2008-10#3)
successfully applied to the determination of trace##7##7##(2008-10#7)
successfully applied to the determination of vanadium in##4##8##(2008-10#4)
successfully applied to the determination of##96##6##(1994-9#1)(1996-5#1)(2007-8#1)(2008-10#91)(2010-5#2)
successfully applied to the determination##97##5##(1994-9#1)(1996-5#1)(2007-8#1)(2008-10#92)(2010-5#2)
successfully applied to the pharmacokinetic study of##2##7##(2008-10#2)
successfully applied to the simultaneous determination of##12##7##(2008-10#12)
successfully applied to the simultaneous##16##5##(2008-10#15)(2008-5#1)
successfully applied to the##167##4##(1991-12#1)(1991-3#1)(1994-9#1)(1996-5#1)(1997-8#2)(2006-5#1)(2007-1#1)(2007-8#4)(2008-10#145)(2008-12#1)(2008-2#1)(2008-5#2)(2010-1#1)(2010-5#2)(2011-2#1)(2012-1#1)(2013-1#1)
successfully applied to##255##3##(1990-11#1)(1990-4#1)(1990-6#1)(1991-12#1)(1991-3#1)(1992-11#1)(1993-2#2)(1994-12#1)(1994-7#1)(1994-9#2)(1995-10#1)(1996-10#1)(1996-5#1)(1997-5#1)(1997-8#2)(2005-6#1)(2006-5#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#9)(2008-10#194)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#3)(2008-7#1)(2009-9#1)(2010-1#1)(2010-5#4)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)
successfully applied##336##2##(1990-11#1)(1990-4#1)(1990-6#1)(1991-12#1)(1991-3#1)(1992-11#1)(1993-2#2)(1993-3#1)(1994-12#1)(1994-7#1)(1994-9#2)(1995-10#1)(1996-10#1)(1996-5#1)(1997-5#1)(1997-8#2)(2005-12#1)(2005-6#1)(2006-5#2)(2007-1#1)(2007-11#1)(2007-12#4)(2007-7#2)(2007-8#11)(2008-1#1)(2008-10#254)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#3)(2008-7#1)(2008-9#1)(2009-11#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-5#4)(2010-6#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#3)
successfully as##2##2##(2008-10#2)
successfully be##4##2##(2007-8#1)(2008-10#2)(2013-8#1)
successfully been used to##2##4##(2007-2#1)(2008-1#1)
successfully been used##3##3##(2007-2#1)(2008-1#1)(2012-11#1)
successfully been##9##2##(2007-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-7#1)(2012-11#1)(2013-1#1)
successfully by this##2##3##(2008-2#1)(2008-3#1)
successfully by##15##2##(1990-9#1)(1993-5#1)(1994-3#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
successfully carried out##3##3##(1991-8#1)(1997-4#1)(2012-12#1)
successfully checked##2##2##(2007-8#1)(2008-10#1)
successfully classified##3##2##(2008-3#1)(2010-8#1)(2011-1#1)
successfully clipped##2##2##(2005-9#1)(2011-2#1)
successfully cloned##4##2##(2005-11#1)(2008-8#1)(2010-11#1)(2010-6#1)
successfully combined##2##2##(2007-11#1)(2008-10#1)
successfully compensated##2##2##(2007-12#1)(2008-10#1)
successfully completed the treatment##2##4##(2007-7#1)(2007-8#1)
successfully completed the##4##3##(2007-7#1)(2007-8#1)(2008-1#1)(2011-2#1)
successfully completed##13##2##(2005-8#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#3)(2009-4#1)(2011-2#1)(2012-1#1)(2012-3#1)
successfully conducting a##2##3##(1992-12#1)(1992-3#1)
successfully confirmed by##3##3##(2008-10#1)(2010-4#1)(2010-5#1)
successfully conservatively##2##2##(2010-11#1)(2012-12#1)
successfully contained the growth of public expenditures on##2##8##(1994-2#2)
successfully control##2##2##(2008-1#1)(2009-2#1)
successfully controlled##6##2##(2005-11#1)(2006-10#1)(2006-4#1)(2008-3#1)(2008-7#1)(2011-1#1)
successfully converted into##2##3##(2005-11#1)(2011-2#1)
successfully coupled with##2##3##(2008-1#1)(2008-10#1)
successfully cultivated##3##2##(1994-5#1)(2008-11#2)
successfully demonstrate##5##2##(1995-12#1)(2007-12#2)(2008-10#1)(2008-3#1)
successfully demonstrated a##2##3##(2007-12#2)
successfully demonstrated by use of##2##5##(2007-12#1)(2008-2#1)
successfully demonstrated for##2##3##(2008-10#2)
successfully demonstrated that##2##3##(1997-4#1)(2010-5#1)
successfully demonstrated the##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
successfully demonstrated##18##2##(1997-4#1)(2007-11#2)(2007-12#4)(2008-10#4)(2008-2#2)(2008-3#3)(2008-7#1)(2010-5#1)
successfully designed##3##2##(2008-3#1)(2010-4#1)(2011-2#1)
successfully detect##3##2##(2008-10#2)(2011-2#1)
successfully detected by##3##3##(2008-10#2)(2008-5#1)
successfully detected in##2##3##(2007-8#1)(2008-10#1)
successfully detected##12##2##(1996-12#1)(2007-8#2)(2008-10#4)(2008-3#1)(2008-5#1)(2009-3#1)(2010-12#1)(2012-3#1)
successfully determined by##3##3##(2008-10#3)
successfully determined##9##2##(1990-8#1)(2008-10#6)(2008-3#1)(2010-12#1)
successfully develop##3##2##(1996-3#1)(2007-11#1)(2010-2#1)
successfully developed a##4##3##(2007-11#1)(2009-7#1)(2010-4#1)(2012-3#1)
successfully developed and##2##3##(1993-3#1)(2012-11#1)
successfully developed##14##2##(1993-3#1)(2005-11#1)(2005-12#1)(2005-8#1)(2007-11#1)(2008-10#3)(2008-11#1)(2009-7#1)(2010-4#2)(2012-11#1)(2012-3#1)
successfully done##3##2##(2008-1#1)(2008-12#1)(2008-6#1)
successfully during##2##2##(2006-5#1)(2010-4#1)
successfully employed for the##4##4##(2008-10#4)
successfully employed for##7##3##(2008-10#5)(2010-2#1)(2012-12#1)
successfully employed in the##4##4##(1990-12#1)(2008-10#2)(2008-11#1)
successfully employed to##3##3##(2008-10#1)(2008-7#1)(2013-7#1)
successfully employed##20##2##(1990-12#1)(2006-11#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-7#1)(2009-12#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-7#1)
successfully established##6##2##(2008-10#1)(2008-11#1)(2008-6#1)(2010-9#1)(2012-12#1)(2012-3#1)
successfully evaluated##4##2##(1991-12#1)(2007-8#1)(2008-10#2)
successfully excised##3##2##(2009-1#1)(2009-10#1)(2009-5#1)
successfully explained##3##2##(2007-12#1)(2008-3#2)
successfully exploited##2##2##(1993-12#1)(2009-10#1)
successfully expressed in##4##3##(2005-11#1)(2008-11#1)(2008-7#1)(2012-2#1)
successfully expressed##7##2##(1991-7#1)(1996-11#1)(2005-11#1)(2008-11#1)(2008-7#2)(2012-2#1)
successfully extracted##4##2##(1992-9#1)(2007-8#1)(2008-10#1)(2008-4#1)
successfully fabricated##6##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2010-4#1)
successfully for a##2##3##(2007-12#1)(2007-8#1)
successfully for the analysis of##4##5##(1997-2#1)(2008-10#1)(2008-3#1)(2010-12#1)
successfully for the##15##3##(1997-2#1)(2008-10#9)(2008-3#1)(2008-7#1)(2009-11#1)(2010-12#1)(2012-1#1)
successfully for##26##2##(1996-12#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-10#12)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2010-12#1)(2012-1#1)
successfully from##3##2##(1990-10#1)(2008-10#1)(2008-8#1)
successfully generate##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
successfully generated##7##2##(1997-4#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-11#1)(2010-7#1)
successfully identified and##2##3##(1995-12#1)(2012-12#1)
successfully identified##9##2##(1995-12#1)(2008-10#1)(2008-11#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
successfully identify##3##2##(2008-10#1)(2010-4#1)(2012-2#1)
successfully if##2##2##(2007-11#1)(2008-9#1)
successfully immobilized on##2##3##(2008-5#1)(2008-7#1)
successfully implanted##5##2##(1992-10#1)(1992-5#1)(2007-7#1)(2007-8#1)(2008-11#1)
successfully implement##6##2##(1994-1#2)(1994-2#1)(2008-10#1)(2008-3#1)(2012-1#1)
successfully implemented in##2##3##(2007-4#1)(2013-7#1)
successfully implemented with##3##3##(2005-9#1)(2008-3#1)(2012-11#1)
successfully implemented##6##2##(1994-12#1)(2005-9#1)(2007-4#1)(2008-3#1)(2012-11#1)(2013-7#1)
successfully in a##2##3##(1996-12#1)(2010-11#1)
successfully in our##2##3##(2007-7#1)(2009-10#1)
successfully in several##2##3##(1992-10#1)(2008-4#1)
successfully in the determination of##3##5##(2008-10#2)(2010-4#1)
successfully in the##12##3##(1993-6#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-4#1)(2009-10#1)(2009-4#1)(2010-4#1)
successfully in##36##2##(1992-10#1)(1993-6#1)(1996-12#1)(2004-4#1)(2006-10#1)(2006-6#2)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-10#9)(2008-4#2)(2008-6#1)(2009-10#2)(2009-4#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-7#1)(2012-1#1)
successfully incorporated into a##3##4##(2008-10#1)(2009-12#1)(2009-9#1)
successfully incorporated into##9##3##(1996-1#1)(2006-12#1)(2008-10#2)(2008-2#1)(2009-12#1)(2009-3#1)(2009-9#1)(2012-2#1)
successfully infected##3##2##(1992-8#1)(2007-6#1)(2008-10#1)
successfully inhibited##2##2##(2008-11#1)(2012-12#1)
successfully inserted##3##2##(1993-11#1)(1997-6#1)(2010-7#1)
successfully integrate##3##2##(1997-2#1)(2004-4#1)(2006-5#1)
successfully integrated into##2##3##(1997-8#1)(2007-8#1)
successfully integrated##6##2##(1997-8#1)(2007-12#1)(2007-8#1)(2009-2#1)(2010-8#1)(2013-1#1)
successfully into##3##2##(2007-8#1)(2008-10#1)(2008-5#1)
successfully introduced##3##2##(2008-11#1)(2012-12#1)(2013-8#1)
successfully investigated##2##2##(2008-2#1)(2012-1#1)
successfully isolated and##2##3##(2008-7#1)(2011-1#1)
successfully isolated##7##2##(1997-3#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-12#1)(2011-1#1)
successfully lased##2##2##(2007-12#1)(2008-2#1)
successfully maintained##2##2##(2006-10#1)(2007-8#1)
successfully managed by##2##3##(2007-8#1)(2013-1#1)
successfully managed with##9##3##(2005-10#1)(2006-10#1)(2006-12#1)(2007-8#2)(2010-10#1)(2011-12#2)(2012-2#1)
successfully managed##13##2##(2005-10#1)(2006-10#1)(2006-12#1)(2007-8#3)(2009-7#1)(2010-10#1)(2011-12#2)(2011-2#1)(2012-2#1)(2013-1#1)
successfully managing##2##2##(2008-10#1)(2008-8#1)
successfully mapped##2##2##(1995-8#1)(2008-8#1)
successfully measure##2##2##(1992-3#1)(2010-8#1)
successfully measured##3##2##(2008-1#1)(2008-10#1)(2008-2#1)
successfully obtained from##3##3##(2007-12#1)(2010-4#1)(2011-1#1)
successfully obtained##14##2##(2007-12#3)(2008-10#3)(2008-2#1)(2008-3#2)(2008-8#1)(2009-8#1)(2010-4#1)(2011-1#1)(2013-7#1)
successfully on##4##2##(1994-2#1)(1995-6#1)(2008-3#1)(2013-8#1)
successfully operated##5##2##(1990-9#1)(1991-11#1)(2008-2#1)(2008-6#1)(2008-7#1)
successfully overcome by##2##3##(1994-3#1)(2008-3#1)
successfully performed for##3##3##(2006-10#1)(2007-8#1)(2009-4#1)
successfully performed in##6##3##(1990-6#1)(2007-7#1)(2007-8#2)(2008-7#1)(2012-3#1)
successfully performed using##2##3##(2007-8#1)(2008-11#1)
successfully performed##30##2##(1990-6#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#7)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
successfully placed in##2##3##(2008-7#1)(2013-7#1)
successfully placed##3##2##(1990-11#1)(2008-7#1)(2013-7#1)
successfully plan##2##2##(2010-7#1)(2013-8#1)
successfully predict##3##2##(1996-4#1)(2006-11#1)(2010-7#1)
successfully prepared##5##2##(1996-2#1)(2005-11#2)(2010-12#1)(2013-1#1)
successfully produced in##2##3##(2006-12#1)(2013-8#1)
successfully produced##5##2##(1995-2#1)(2006-12#1)(2008-5#1)(2012-6#1)(2013-8#1)
successfully recovered##2##2##(2008-10#2)
successfully reduced##7##2##(2004-12#1)(2006-3#1)(2007-11#2)(2007-8#1)(2008-3#1)(2013-1#1)
successfully rehabilitated##2##2##(1996-6#1)(2007-2#1)
successfully removed by##2##3##(2008-2#1)(2013-8#1)
successfully removed##10##2##(1993-7#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-12#2)(2013-8#1)
successfully repaired##3##2##(2007-8#1)(2011-1#1)(2011-2#1)
successfully reproduced with##2##3##(1991-8#1)(1997-7#1)
successfully reproduced##4##2##(1991-8#1)(1997-7#1)(2007-1#1)(2007-12#1)
successfully resected##3##2##(2007-8#1)(2008-6#1)(2013-1#1)
successfully resolved##2##2##(2007-12#1)(2009-8#1)
successfully separated by##3##3##(1997-5#1)(2005-12#1)(2008-10#1)
successfully separated##12##2##(1996-8#1)(1997-2#1)(1997-5#1)(1997-8#1)(2005-12#1)(2007-1#1)(2007-8#1)(2008-10#4)(2013-8#1)
successfully solve##2##2##(2009-12#1)(2009-3#1)
successfully solved##2##2##(2008-10#1)(2011-1#1)
successfully synthesized by##2##3##(1993-6#1)(2006-12#1)
successfully synthesized##8##2##(1993-6#1)(2006-12#1)(2008-12#1)(2008-5#1)(2010-7#1)(2012-11#1)(2012-12#1)(2013-8#1)
successfully tested for##4##3##(1991-6#1)(2008-10#3)
successfully tested in##4##3##(1991-1#1)(2006-6#1)(2007-8#1)(2008-3#1)
successfully tested on##2##3##(2008-10#1)(2009-2#1)
successfully tested##14##2##(1991-1#1)(1991-6#1)(2006-6#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-3#1)(2009-2#1)(2011-2#1)
successfully the##2##2##(1990-3#1)(2004-12#1)
successfully to determine the##2##4##(1996-6#1)(2008-3#1)
successfully to determine##4##3##(1996-6#1)(2008-10#2)(2008-3#1)
successfully to generate##2##3##(1995-2#1)(2005-7#1)
successfully to the##29##3##(1992-4#1)(2007-8#3)(2008-10#24)(2008-5#1)
successfully to##71##2##(1991-5#1)(1992-4#1)(1992-8#1)(1994-6#1)(1995-2#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-11#2)(2007-3#1)(2007-7#1)(2007-8#3)(2008-10#31)(2008-11#2)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#2)(2009-10#1)(2010-2#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-7#1)
successfully transduced##4##2##(1993-2#1)(1994-5#1)(2008-9#1)(2010-12#1)
successfully transferred##4##2##(1994-5#1)(2008-10#2)(2008-8#1)
successfully transmitted##2##2##(2007-12#1)(2008-10#1)
successfully treat##4##2##(1991-3#1)(2008-11#1)(2008-6#1)(2008-7#1)
successfully treated by a##3##4##(1992-2#1)(2009-4#1)(2011-2#1)
successfully treated by endoscopic##3##4##(1991-4#1)(2008-12#1)(2008-5#1)
successfully treated by surgical##2##4##(2007-11#1)(2012-1#1)
successfully treated by##26##3##(1990-8#1)(1991-4#1)(1991-8#1)(1992-2#1)(1992-9#1)(1997-1#1)(2005-9#1)(2007-11#1)(2007-8#5)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)
successfully treated conservatively##4##3##(1993-5#2)(2008-1#1)(2011-2#1)
successfully treated for##2##3##(1997-5#1)(2009-3#1)
successfully treated in##2##3##(1993-5#1)(2008-11#1)
successfully treated patients##2##3##(2008-11#1)(2010-10#1)
successfully treated surgically##2##3##(2005-9#1)(2008-12#1)
successfully treated this##2##3##(2012-12#1)(2013-8#1)
successfully treated using the##2##4##(2006-6#1)(2013-8#1)
successfully treated using##5##3##(1993-10#1)(2006-6#1)(2010-12#1)(2012-12#1)(2013-8#1)
successfully treated with a##10##4##(1993-9#1)(2006-10#1)(2007-11#1)(2007-8#2)(2010-12#1)(2013-1#4)
successfully treated with an##3##4##(1990-8#1)(2008-4#1)(2010-10#1)
successfully treated with antibiotics##2##4##(2007-12#1)(2007-7#1)
successfully treated with intravenous##2##4##(2006-4#1)(2010-8#1)
successfully treated with itraconazole##3##4##(2007-7#1)(2008-5#2)
successfully treated with oral##3##4##(2007-8#1)(2010-12#1)(2012-12#1)
successfully treated with surgery##2##4##(2006-12#1)(2011-2#1)
successfully treated with surgical excision##3##5##(2008-10#1)(2008-2#1)(2012-3#1)
successfully treated with surgical##4##4##(2008-10#1)(2008-2#1)(2012-3#1)(2013-8#1)
successfully treated with topical##3##4##(2007-8#1)(2011-2#1)(2012-3#1)
successfully treated with##81##3##(1990-8#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-6#1)(1995-3#1)(1996-4#1)(1997-3#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#6)(2008-1#4)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2009-5#1)(2010-10#1)(2010-12#3)(2010-5#1)(2010-6#5)(2010-8#2)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#1)
successfully treated##141##2##(1990-8#2)(1991-4#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-10#1)(1993-11#1)(1993-5#3)(1993-9#1)(1994-6#1)(1995-3#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-8#1)(2005-8#1)(2005-9#2)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#2)(2006-7#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-7#3)(2007-8#11)(2008-1#6)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#3)(2009-3#1)(2009-4#1)(2009-5#1)(2010-10#2)(2010-12#4)(2010-4#1)(2010-5#1)(2010-6#5)(2010-8#2)(2011-1#2)(2011-2#10)(2012-1#2)(2012-12#7)(2012-2#5)(2012-3#2)(2013-1#8)(2013-8#5)
successfully treating##2##2##(2006-10#2)
successfully tried##2##2##(2007-7#1)(2009-6#1)
successfully under##2##2##(1992-4#1)(2008-2#1)
successfully underwent##10##2##(1992-12#1)(2007-3#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)(2012-1#1)(2012-2#1)
successfully used as a##5##4##(1994-2#1)(2008-10#1)(2009-10#1)(2010-7#1)(2012-2#1)
successfully used as an indicator electrode in the potentiometric titration of##2##11##(2008-10#2)
successfully used as an indicator electrode in##3##7##(2008-10#3)
successfully used as an##4##4##(1996-3#1)(2008-10#3)
successfully used as##13##3##(1994-2#1)(1996-3#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-2#1)(2009-10#1)(2010-7#1)(2012-2#1)
successfully used for both##2##4##(2007-2#1)(2008-10#1)
successfully used for determination of##2##5##(2008-10#2)
successfully used for the assay of##2##6##(2008-10#2)
successfully used for the separation##2##5##(2008-10#2)
successfully used for the##16##4##(2008-10#12)(2008-5#1)(2009-10#1)(2011-1#1)(2012-12#1)
successfully used for##33##3##(1995-8#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#18)(2008-11#1)(2008-2#2)(2008-5#1)(2009-10#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)
successfully used in a##2##4##(2008-10#2)
successfully used in the treatment of##2##6##(2005-10#1)(2012-12#1)
successfully used in the##11##4##(1994-5#1)(2005-10#1)(2005-4#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#1)(2009-11#1)(2012-12#1)
successfully used in##24##3##(1990-9#1)(1994-5#1)(1996-5#1)(2005-10#2)(2005-4#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)(2011-3#1)(2012-12#1)
successfully used the##2##3##(2009-3#1)(2013-8#1)
successfully used to determine##9##4##(2008-1#1)(2008-10#3)(2010-2#2)(2010-3#1)(2010-5#1)(2012-2#1)
successfully used to perform##2##4##(1994-3#1)(2013-8#1)
successfully used to##51##3##(1994-3#1)(1996-12#1)(1997-6#1)(2004-9#1)(2005-10#1)(2006-7#1)(2007-12#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#2)(2009-11#1)(2009-5#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
successfully used##130##2##(1990-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-6#1)(2004-9#1)(2005-10#3)(2005-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#6)(2008-1#1)(2008-10#39)(2008-11#6)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#2)(2009-3#1)(2009-5#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#3)(2011-3#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
successfully using a##2##3##(1993-3#1)(2008-10#1)
successfully using##4##2##(1993-3#1)(2008-10#1)(2010-12#1)(2013-1#1)
successfully utilized for##3##3##(2008-10#3)
successfully utilized in##4##3##(1996-5#1)(2005-8#1)(2006-10#1)(2009-5#1)
successfully utilized##8##2##(1996-5#1)(1997-8#1)(2005-8#1)(2006-10#1)(2008-10#3)(2009-5#1)
successfully visualized##3##2##(2007-12#1)(2012-11#2)
successfully weaned from##2##3##(1997-3#1)(2007-8#1)
successfully weaned##3##2##(1997-3#1)(2007-8#1)(2012-2#1)
successfully with a combination of##2##5##(1991-6#1)(2007-7#1)
successfully with a##4##3##(1991-6#1)(2007-7#1)(2008-3#1)(2009-8#1)
successfully with##32##2##(1991-12#1)(1991-4#1)(1991-6#1)(1995-11#1)(1995-2#1)(1996-4#1)(2005-2#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-7#3)(2007-8#5)(2008-11#1)(2008-2#1)(2008-3#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-5#1)(2012-2#2)(2013-1#2)
successfully##1669##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-3#1)(1990-4#2)(1990-6#2)(1990-8#5)(1990-9#3)(1991-1#4)(1991-11#1)(1991-12#6)(1991-2#1)(1991-3#4)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#4)(1992-10#2)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#5)(1992-4#2)(1992-5#1)(1992-8#3)(1992-9#3)(1993-10#1)(1993-11#3)(1993-12#2)(1993-2#5)(1993-3#5)(1993-4#1)(1993-5#4)(1993-6#3)(1993-7#2)(1993-9#1)(1994-1#2)(1994-10#1)(1994-11#1)(1994-12#6)(1994-2#5)(1994-3#6)(1994-5#5)(1994-6#2)(1994-7#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#2)(1995-6#2)(1995-8#3)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#3)(1996-4#5)(1996-5#4)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#6)(1997-2#6)(1997-3#4)(1997-4#6)(1997-5#4)(1997-6#2)(1997-7#1)(1997-8#9)(2004-1#1)(2004-11#1)(2004-12#3)(2004-2#1)(2004-4#3)(2004-9#1)(2005-10#8)(2005-11#9)(2005-12#3)(2005-2#1)(2005-4#2)(2005-5#1)(2005-6#2)(2005-7#1)(2005-8#4)(2005-9#5)(2006-1#2)(2006-10#16)(2006-11#3)(2006-12#6)(2006-2#3)(2006-3#2)(2006-4#6)(2006-5#8)(2006-6#10)(2006-7#4)(2006-8#3)(2006-9#4)(2007-1#3)(2007-10#1)(2007-11#25)(2007-12#42)(2007-2#7)(2007-3#3)(2007-4#2)(2007-6#3)(2007-7#20)(2007-8#83)(2008-1#21)(2008-10#482)(2008-11#41)(2008-12#10)(2008-2#40)(2008-3#46)(2008-4#14)(2008-5#32)(2008-6#13)(2008-7#28)(2008-8#21)(2008-9#11)(2009-1#1)(2009-10#8)(2009-11#6)(2009-12#4)(2009-2#4)(2009-3#9)(2009-4#9)(2009-5#7)(2009-6#4)(2009-7#4)(2009-8#5)(2009-9#4)(2010-1#3)(2010-10#4)(2010-11#5)(2010-12#19)(2010-2#8)(2010-3#2)(2010-4#13)(2010-5#12)(2010-6#7)(2010-7#10)(2010-8#11)(2010-9#3)(2011-1#19)(2011-12#5)(2011-2#37)(2011-3#2)(2012-1#15)(2012-11#9)(2012-12#26)(2012-2#35)(2012-3#18)(2012-6#1)(2012-8#1)(2013-1#39)(2013-7#7)(2013-8#23)
successfulness##2##1##(1991-4#1)(2005-10#1)
succession of##10##2##(2004-4#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)
succession##23##1##(1990-2#1)(1997-2#1)(2004-4#1)(2007-10#1)(2007-3#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#4)(2013-1#1)
succession)##2##1##(2008-11#1)(2010-8#1)
successional diversity##3##2##(2008-9#3)
successional##10##1##(2008-5#1)(2008-8#1)(2008-9#7)(2010-2#1)
successive additions of##3##3##(1993-8#1)(2008-10#2)
successive approximation##3##2##(2008-10#1)(2008-2#2)
successive cultures of human##2##4##(2008-11#2)
successive cultures##3##2##(2008-11#3)
successive cycles of##3##3##(2008-10#3)
successive cycles##5##2##(2008-1#1)(2008-10#4)
successive days to##2##3##(1992-5#1)(2005-10#1)
successive days##9##2##(1991-12#1)(1992-5#1)(1993-6#1)(1995-11#1)(1997-3#1)(2005-10#1)(2007-2#1)(2008-10#2)
successive determination of##5##3##(2008-10#5)
successive determinations of##2##3##(2008-10#2)
successive determinations##3##2##(2008-10#3)
successive developmental##2##2##(1990-6#1)(2008-11#1)
successive divisions##2##2##(2008-7#2)
successive generation of##2##3##(2007-12#1)(2008-7#1)
successive generation##3##2##(2007-12#1)(2008-7#1)(2011-2#1)
successive generations##12##2##(1992-7#1)(1996-5#1)(1997-5#2)(2004-4#1)(2007-10#3)(2008-10#2)(2008-2#1)(2008-9#1)
successive images##2##2##(2007-11#1)(2008-3#1)
successive increase##2##2##(2011-2#1)(2013-1#1)
successive injections of##5##3##(2007-8#2)(2008-10#2)(2012-12#1)
successive injections was##2##3##(2008-10#2)
successive injections##11##2##(2007-8#2)(2008-10#8)(2012-12#1)
successive measurements##2##2##(2008-10#2)
successive negative contrast effect##2##4##(1996-10#2)
successive pregnancies##2##2##(1992-6#1)(2006-10#1)
successive reaction##4##2##(1995-6#1)(1995-8#2)(1996-5#1)
successive reduction##2##2##(1997-2#1)(2008-10#1)
successive refinement##3##2##(2008-2#3)
successive stages of##2##3##(1995-2#1)(2007-8#1)
successive stages##5##2##(1995-2#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-8#1)
successive steps of##2##3##(1990-12#1)(2008-3#1)
successive steps##5##2##(1990-12#1)(1994-2#1)(2006-10#1)(2008-2#1)(2008-3#1)
successive waves of##2##3##(2007-2#1)(2010-11#1)
successive years##8##2##(2004-11#1)(2008-10#5)(2010-4#1)(2011-2#1)
successive##245##1##(1990-10#1)(1990-11#2)(1990-12#4)(1990-6#2)(1990-7#2)(1991-1#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-7#3)(1991-8#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-7#2)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#3)(1996-10#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1997-2#4)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#1)(2004-11#1)(2004-4#1)(2005-10#1)(2006-10#2)(2006-12#2)(2006-3#1)(2006-4#1)(2007-10#5)(2007-11#6)(2007-12#4)(2007-2#2)(2007-5#1)(2007-7#3)(2007-8#6)(2008-1#3)(2008-10#52)(2008-11#10)(2008-12#1)(2008-2#18)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-2#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#4)(2011-1#5)(2011-2#6)(2012-12#1)(2013-1#4)
successively by##4##2##(1996-2#1)(2007-12#1)(2008-10#1)(2010-11#1)
successively in##2##2##(1995-11#1)(1997-6#1)
successively presented##2##2##(1992-8#1)(1993-6#1)
successively to##2##2##(2007-8#1)(2008-2#1)
successively with##2##2##(2008-10#1)(2008-2#1)
successively within##2##2##(2007-12#1)(2008-11#1)
successively##60##1##(1990-11#1)(1990-12#1)(1990-8#1)(1991-7#1)(1992-11#1)(1992-5#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1995-11#2)(1995-12#1)(1995-8#1)(1996-2#2)(1996-7#1)(1997-4#5)(1997-6#1)(2003-11#1)(2005-11#1)(2006-5#2)(2007-12#2)(2007-8#1)(2008-10#9)(2008-11#3)(2008-2#6)(2008-3#2)(2009-3#1)(2009-8#1)(2010-11#2)(2011-2#1)(2011-3#1)(2012-12#2)(2013-1#1)
successor of##2##2##(2009-4#1)(2011-2#1)
successor to##2##2##(2007-9#2)
successor##12##1##(1994-5#1)(2007-9#2)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-4#1)(2011-2#1)(2013-1#1)
successors##4##1##(1991-2#1)(1996-11#1)(2007-4#1)(2008-1#1)
succinamic acid##2##2##(2005-11#2)
succinate and##5##2##(1993-11#1)(1993-8#1)(2005-8#1)(2010-12#1)(2012-3#1)
succinate as substrate##2##3##(1993-8#1)(1997-8#1)
succinate as##4##2##(1993-8#1)(1994-3#1)(1997-8#1)(2005-8#1)
succinate cytochrome c reductase##2##4##(1990-11#2)
succinate dehydrogenase##7##2##(1990-7#1)(1993-11#1)(1994-3#1)(1996-8#1)(2006-9#1)(2009-11#2)
succinate was##3##2##(2004-12#1)(2005-8#1)(2008-10#1)
succinate##54##1##(1990-11#2)(1990-5#1)(1990-7#1)(1990-8#3)(1991-7#2)(1992-7#1)(1992-8#1)(1993-11#3)(1993-6#1)(1993-7#1)(1993-8#3)(1994-11#2)(1994-3#2)(1996-8#2)(1997-7#3)(1997-8#1)(2004-12#1)(2005-8#4)(2006-10#1)(2006-9#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-11#2)(2010-12#1)(2012-3#3)
succinate-dependent mitochondrial##3##2##(1992-6#3)
succinate-dependent##5##1##(1992-6#4)(1997-8#1)
succinate-supported##2##1##(1990-8#2)
succinct overview of##3##3##(2008-10#1)(2008-6#1)(2013-8#1)
succinct##7##1##(2006-3#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-8#1)(2011-2#1)(2013-8#1)
succinctly##2##1##(1996-12#1)(2011-2#1)
succinic acid by##2##3##(2008-10#1)(2008-6#1)
succinic acid production##2##3##(2008-6#1)(2013-1#1)
succinic acid##27##2##(1990-5#1)(1990-8#1)(2005-8#2)(2006-12#2)(2008-10#8)(2008-3#1)(2008-5#1)(2008-6#7)(2013-1#4)
succinic anhydride (SA)##2##3##(1995-11#1)(2005-11#1)
succinic anhydride##4##2##(1995-11#1)(1997-3#1)(2005-11#1)(2013-7#1)
succinic semialdehyde reductase in rat brain##2##6##(1997-2#2)
succinic semialdehyde reductase##3##3##(1997-2#3)
succinic semialdehyde##5##2##(1997-2#4)(2008-11#1)
succinic##48##1##(1990-5#1)(1990-8#1)(1994-9#1)(1995-11#1)(1997-2#4)(1997-3#1)(2004-2#1)(2005-11#1)(2005-8#2)(2006-12#2)(2008-10#14)(2008-11#1)(2008-3#1)(2008-5#5)(2008-6#7)(2013-1#4)(2013-7#1)
succinimide ester of biotin##2##4##(1993-6#1)(1993-8#1)
succinimide##7##1##(1993-6#4)(1993-8#1)(1994-9#1)(2005-11#1)
succinimidyl ester##5##2##(1992-9#1)(1994-9#1)(2008-9#1)(2012-3#1)(2013-8#1)
succinimidyl##6##1##(1992-9#1)(1994-9#1)(2008-9#1)(2012-3#1)(2013-8#2)
succinoglycan##5##1##(2008-6#1)(2009-8#4)
succinoyl trehalose##3##2##(2008-11#3)
succinyl L-tyrosine##4##2##(2007-6#4)
succinyl concanavalin A##4##3##(1995-11#4)
succinyl dehydrogenase##2##2##(2012-2#2)
succinyl##10##1##(1995-11#4)(2007-6#4)(2012-2#2)
succinyl-CoA##2##1##(1995-10#1)(2011-1#1)
succinylacetone##2##1##(1992-8#1)(1994-12#1)
succinylated##2##1##(1990-4#1)(1997-2#1)
succinylcholine##8##1##(1990-11#2)(2006-10#1)(2007-3#4)(2012-12#1)
succour##2##1##(2007-11#2)
succulent##2##1##(2007-3#1)(2011-2#1)
succumb to##6##2##(2007-7#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)
succumb##10##1##(2007-2#1)(2007-7#2)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)
succumbed to death##2##3##(2008-12#1)(2012-3#1)
succumbed to##12##2##(2006-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-7#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
succumbed##15##1##(2006-10#2)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-7#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
succumbing to##3##2##(1995-2#1)(2009-10#1)(2009-7#1)
suceptibility##3##1##(1997-8#1)(2008-11#1)(2008-4#1)
sucessfully##2##1##(2006-8#1)(2007-12#1)
such &quot##3##2##(1991-11#1)(2008-10#1)(2012-2#1)
such DNA##3##2##(1997-5#1)(2008-10#1)(2012-12#1)
such FH##2##2##(1993-9#1)(2007-10#1)
such a DNA##2##3##(1991-3#1)(1994-9#1)
such a bias##2##3##(2013-1#2)
such a case in##2##4##(2010-6#1)(2012-2#1)
such a case with##3##4##(2011-12#1)(2012-3#2)
such a case##12##3##(1993-10#1)(1993-4#1)(2009-10#1)(2009-6#1)(2010-6#1)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-8#1)
such a change##7##3##(1994-2#1)(1994-3#1)(1995-1#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-7#1)
such a child##2##3##(1995-5#1)(2008-12#1)
such a clinical##4##3##(1993-10#1)(1997-2#1)(2007-11#1)(2008-4#1)
such a combination##2##3##(2004-12#1)(2008-3#1)
such a combined##4##3##(1990-6#1)(1992-9#2)(2009-4#1)
such a complex##6##3##(1997-6#1)(2006-12#1)(2006-8#1)(2008-10#1)(2009-5#1)(2012-12#1)
such a complication##2##3##(2007-8#1)(2012-12#1)
such a component##2##3##(2007-12#1)(2008-3#1)
such a comprehensive##2##3##(2006-10#1)(2008-5#1)
such a condition##4##3##(1994-6#1)(2006-2#1)(2007-11#1)(2008-5#1)
such a coupler also##2##4##(2008-2#2)
such a crisis##2##3##(1993-12#1)(2012-3#1)
such a critical##3##3##(2007-4#1)(2008-8#2)
such a device##10##3##(2006-6#2)(2007-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-3#1)
such a diagnosis##2##3##(2007-12#1)(2008-1#1)
such a difference was##2##4##(2006-10#1)(2008-3#1)
such a difference##3##3##(2006-10#1)(2008-3#1)(2011-2#1)
such a disease##3##3##(1994-3#1)(2012-2#1)(2013-1#1)
such a distinction##2##3##(1991-2#1)(1992-9#1)
such a division##2##3##(1997-8#1)(2007-1#1)
such a drop##2##3##(1997-5#1)(2005-11#1)
such a drug##2##3##(2008-1#1)(2008-11#1)
such a failure##2##3##(2007-4#1)(2009-3#1)
such a family##2##3##(2007-7#1)(2008-3#1)
such a fiber##2##3##(2007-12#1)(2008-2#1)
such a filter##2##3##(2008-2#1)(2008-3#1)
such a framework##3##3##(1996-12#1)(2006-10#1)(2012-3#1)
such a function##2##3##(1990-10#1)(2008-3#1)
such a grating is##2##4##(2008-3#2)
such a grating##5##3##(2006-4#1)(2007-12#2)(2008-3#2)
such a high##5##3##(2006-6#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-7#1)
such a laser##7##3##(2007-12#2)(2007-6#1)(2008-1#1)(2008-2#2)(2008-3#1)
such a lesion##5##3##(2008-1#2)(2008-4#1)(2008-7#1)(2010-7#1)
such a level##2##3##(2008-12#1)(2008-3#1)
such a manner as to##2##5##(2008-9#1)(2009-9#1)
such a manner as##3##4##(2004-11#1)(2008-9#1)(2009-9#1)
such a manner##11##3##(1991-11#1)(1994-9#1)(1995-11#1)(2004-11#1)(2007-3#1)(2008-10#1)(2008-2#2)(2008-9#1)(2009-9#1)(2010-8#1)
such a measure##2##3##(1991-9#1)(2012-2#1)
such a mechanism##5##3##(1994-2#1)(2007-9#1)(2008-11#1)(2008-7#1)(2013-8#1)
such a medium##2##3##(2007-12#1)(2008-3#1)
such a method in##2##4##(1992-4#1)(2008-7#1)
such a method##9##3##(1992-4#1)(1997-6#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)
such a mixture##2##3##(2008-10#1)(2008-5#1)
such a model to##2##4##(2008-3#1)(2010-10#1)
such a model##13##3##(2006-10#1)(2006-11#1)(2006-7#1)(2007-5#1)(2007-7#1)(2008-11#2)(2008-3#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-10#1)(2010-8#1)
such a network##3##3##(2007-9#1)(2008-3#1)(2013-8#1)
such a parameter##2##3##(1992-10#1)(2009-10#1)
such a patient##3##3##(1992-8#1)(2006-10#1)(2007-8#1)
such a person##2##3##(1993-4#1)(1994-2#1)
such a plan##2##3##(1991-3#1)(2004-10#1)
such a population##2##3##(2007-9#1)(2011-1#1)
such a possibility##2##3##(2008-4#1)(2008-6#1)
such a practice##2##3##(2007-4#2)
such a problem##3##3##(1991-9#1)(2007-8#1)(2008-4#1)
such a procedure##6##3##(1992-2#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)
such a process##4##3##(1991-3#1)(1996-2#1)(2006-5#1)(2012-2#1)
such a program in##2##4##(1992-3#1)(2012-12#1)
such a program##8##3##(1990-12#1)(1992-12#2)(1992-3#1)(1993-11#1)(1993-2#1)(2009-4#1)(2012-12#1)
such a programme##2##3##(2010-10#1)(2010-9#1)
such a protocol##2##3##(2012-1#1)(2012-3#1)
such a rare##2##3##(2007-8#1)(2011-2#1)
such a reaction##3##3##(1997-3#1)(2010-12#1)(2010-6#1)
such a relationship##3##3##(1991-7#1)(2007-8#1)(2008-10#1)
such a response in##2##4##(1992-3#1)(1993-7#1)
such a setting##6##3##(1992-1#1)(1993-1#1)(2009-6#1)(2013-1#2)(2013-8#1)
such a signal##3##3##(1993-3#1)(2008-2#1)(2008-8#1)
such a simple##2##3##(1990-11#1)(2008-3#1)
such a situation##8##3##(1992-3#1)(1992-4#1)(1997-3#1)(2005-8#1)(2008-3#1)(2008-5#1)(2009-4#1)(2011-1#1)
such a small##2##3##(2008-1#1)(2008-10#1)
such a state##3##3##(1995-12#1)(2006-10#1)(2008-12#1)
such a strategy##5##3##(1993-1#1)(1994-9#1)(2008-12#1)(2009-4#1)(2012-3#1)
such a structure##6##3##(1994-12#1)(2006-7#1)(2007-12#2)(2008-3#1)(2008-7#1)
such a study##3##3##(1997-6#1)(2008-5#1)(2009-10#1)
such a system is##2##4##(1992-3#1)(2008-2#1)
such a system##20##3##(1992-2#1)(1992-3#1)(1993-3#2)(1993-8#1)(1994-1#1)(2004-9#2)(2006-6#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#4)(2008-3#4)
such a target##2##3##(2006-10#1)(2011-1#1)
such a task##3##3##(1991-1#1)(2006-10#1)(2007-12#1)
such a team##3##3##(1996-7#1)(2007-6#1)(2007-8#1)
such a technique##3##3##(1992-12#1)(1994-9#1)(2008-7#1)
such a test##5##3##(2006-10#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-8#1)
such a threshold##2##3##(1991-11#1)(2008-7#1)
such a trial##5##3##(1991-11#1)(1995-5#1)(1997-6#1)(2006-10#1)(2012-2#1)
such a type##2##3##(2008-10#2)
such a waveguide##2##3##(2007-11#1)(2010-8#1)
such a way##57##3##(1990-12#2)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-9#1)(1992-12#1)(1994-6#1)(1995-8#1)(1996-2#1)(1997-4#1)(1997-5#2)(2006-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#4)(2008-3#8)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#2)(2013-8#1)
such a wide range of##2##5##(1990-11#1)(2008-10#1)
such a young##2##3##(1990-12#1)(2008-12#1)
such a##648##2##(1990-10#1)(1990-11#3)(1990-12#7)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#3)(1991-11#4)(1991-12#1)(1991-2#2)(1991-3#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#4)(1992-3#5)(1992-4#3)(1992-8#3)(1992-9#4)(1993-1#2)(1993-10#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#4)(1993-4#2)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#2)(1994-6#4)(1994-7#1)(1994-8#4)(1994-9#5)(1995-1#6)(1995-11#2)(1995-12#4)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#3)(1996-10#1)(1996-12#3)(1996-2#3)(1996-3#1)(1996-4#1)(1996-7#1)(1997-1#3)(1997-2#1)(1997-3#5)(1997-4#3)(1997-5#3)(1997-6#5)(1997-8#3)(2004-10#1)(2004-11#2)(2004-12#1)(2004-3#1)(2004-9#2)(2005-10#2)(2005-11#5)(2005-7#2)(2005-8#1)(2006-10#14)(2006-11#2)(2006-12#5)(2006-2#4)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#6)(2006-7#7)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#11)(2007-12#28)(2007-3#2)(2007-4#4)(2007-5#2)(2007-6#4)(2007-7#3)(2007-8#10)(2007-9#6)(2008-1#9)(2008-10#34)(2008-11#19)(2008-12#13)(2008-2#36)(2008-3#50)(2008-4#8)(2008-5#11)(2008-6#6)(2008-7#25)(2008-8#13)(2008-9#4)(2009-1#1)(2009-10#6)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#5)(2009-5#4)(2009-6#6)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#3)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#9)(2011-12#1)(2011-2#6)(2012-1#4)(2012-12#7)(2012-2#10)(2012-3#11)(2013-1#12)(2013-8#8)
such abnormalities##3##2##(1996-3#2)(2008-3#1)
such action##5##2##(1993-10#1)(1995-5#1)(2008-10#3)
such actions##2##2##(1993-3#1)(1997-7#1)
such activities and##2##3##(2010-5#1)(2010-8#1)
such activities##10##2##(1991-12#2)(1996-11#1)(2006-5#1)(2008-11#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)
such activity##6##2##(1990-12#1)(1993-1#1)(2007-7#1)(2008-10#1)(2008-8#1)(2012-2#1)
such acts##2##2##(2005-8#2)
such adaptation##2##2##(2006-6#1)(2008-7#1)
such advances##2##2##(2005-7#1)(2007-3#1)
such advantages##2##2##(2012-11#1)(2012-2#1)
such agent##2##2##(2005-7#1)(2008-7#1)
such agents##4##2##(2005-7#1)(2007-4#1)(2008-5#2)
such algorithms##2##2##(2008-3#1)(2008-6#1)
such alterations are##2##3##(1991-1#1)(1996-1#1)
such alterations may##2##3##(1993-2#1)(1995-10#1)
such alterations##8##2##(1991-1#1)(1993-2#1)(1995-10#1)(1996-1#1)(2008-12#1)(2008-7#1)(2009-7#1)(2011-2#1)
such an action##2##3##(1994-1#1)(2008-7#1)
such an activity##2##3##(1992-11#1)(2006-12#1)
such an analysis##2##3##(1991-2#1)(2008-2#1)
such an application##2##3##(2008-10#1)(2008-12#1)
such an approach is##3##4##(1992-8#1)(1994-2#1)(2013-1#1)
such an approach##17##3##(1992-8#1)(1994-2#1)(1995-2#1)(1996-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#3)
such an arrangement##2##3##(1993-1#1)(1995-6#1)
such an assessment##3##3##(1995-11#1)(2008-11#2)
such an association has not been##2##6##(2006-10#1)(2007-6#1)
such an association##7##3##(2006-10#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-6#1)(2012-2#1)(2013-1#1)
such an effect##7##3##(1990-5#1)(1991-2#1)(1994-6#1)(1995-7#1)(2007-12#1)(2008-4#1)(2009-12#1)
such an effort##4##3##(1996-12#1)(1997-4#1)(2008-2#1)(2010-12#1)
such an entity##2##3##(1996-2#1)(2007-7#1)
such an event can be##2##5##(2007-12#1)(2008-3#1)
such an event##7##3##(1991-2#1)(1997-5#2)(2007-12#1)(2008-11#1)(2008-3#1)(2012-12#1)
such an initiative##2##3##(1997-2#1)(2011-2#1)
such an injury##2##3##(2009-3#2)
such an instrument##2##3##(2008-3#1)(2013-1#1)
such an integrated##3##3##(1995-2#1)(2012-1#1)(2013-8#1)
such an interaction##4##3##(1994-8#1)(1997-2#1)(1997-8#1)(2007-11#1)
such an investigation##2##3##(2010-10#1)(2011-2#1)
such an obligation##2##3##(1994-12#1)(2012-11#1)
such an operation##2##3##(1995-4#1)(2008-7#1)
such an unusual##3##3##(1996-11#1)(2006-10#1)(2007-8#1)
such an##153##2##(1990-10#2)(1990-11#2)(1990-5#1)(1990-6#1)(1991-10#1)(1991-2#3)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-1#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-4#1)(1995-6#1)(1995-7#1)(1995-9#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-4#1)(1997-2#2)(1997-4#1)(1997-5#2)(1997-8#1)(2005-11#2)(2006-10#4)(2006-12#1)(2006-8#1)(2007-11#3)(2007-12#5)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#8)(2008-12#1)(2008-2#11)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#3)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#7)(2013-8#1)
such analyses##8##2##(1996-12#1)(2007-11#1)(2008-10#1)(2008-7#2)(2008-8#1)(2010-11#1)(2010-2#1)
such analysis##4##2##(1995-5#1)(2007-6#1)(2008-11#1)(2011-3#1)
such analytes##2##2##(2008-10#2)
such aneurysms##2##2##(2007-10#1)(2007-8#1)
such anomalies##2##2##(1993-1#1)(1997-4#1)
such antibodies##5##2##(1992-7#1)(2008-10#1)(2008-4#2)(2013-1#1)
such application##2##2##(1991-2#1)(2007-3#1)
such applications range from simple single-step approaches##2##7##(2012-12#2)
such applications##9##2##(1992-9#1)(2005-11#1)(2006-2#1)(2008-2#1)(2008-6#1)(2008-8#1)(2012-12#2)(2012-8#1)
such approach##4##2##(1997-6#1)(2005-11#1)(2005-8#1)(2013-8#1)
such approaches are##3##3##(2008-1#1)(2008-7#2)
such approaches##9##2##(2006-5#1)(2008-1#2)(2008-11#1)(2008-7#2)(2010-3#1)(2012-12#1)(2013-8#1)
such are##3##2##(2007-11#1)(2011-2#1)(2012-11#1)
such areas as##2##3##(1993-1#1)(2008-1#1)
such areas##4##2##(1993-1#1)(2007-2#1)(2008-1#1)(2013-8#1)
such arrays##2##2##(2009-12#1)(2012-2#1)
such arterial##2##2##(1993-10#1)(2008-11#1)
such as &quot##19##3##(1993-11#1)(1993-12#2)(1994-11#1)(1997-3#1)(2008-1#2)(2008-8#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
such as 1##2##3##(2008-10#2)
such as 2##5##3##(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-5#1)
such as AIDS##3##3##(1996-11#1)(2005-7#1)(2008-6#1)
such as ATP##3##3##(2006-4#1)(2013-1#2)
such as African##2##3##(2008-1#1)(2009-5#1)
such as Al##2##3##(2008-10#1)(2009-8#1)
such as Alzheimer's and Parkinson's diseases##2##6##(2005-7#1)(2008-7#1)
such as Alzheimer's and##4##4##(2005-7#1)(2008-5#1)(2008-7#1)(2013-7#1)
such as Alzheimer's disease##9##4##(1993-11#1)(1994-2#1)(1994-9#1)(1996-12#1)(2006-10#1)(2008-11#1)(2009-8#1)(2011-2#2)
such as Alzheimer's##15##3##(1993-11#1)(1994-2#1)(1994-9#1)(1996-12#1)(2005-7#1)(2006-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#2)(2013-7#1)
such as Aspergillus##2##3##(2010-12#1)(2011-2#1)
such as B##3##3##(2006-8#1)(2011-2#1)(2013-7#1)
such as BDNF##2##3##(1997-2#1)(2008-5#1)
such as BrdU##2##3##(2008-9#2)
such as C##4##3##(2005-11#1)(2006-3#1)(2008-10#1)(2008-3#1)
such as CO(2)##2##3##(2008-2#1)(2008-7#1)
such as CT##3##3##(1990-12#1)(1991-10#1)(2012-2#1)
such as Candida##2##3##(2008-3#1)(2008-5#1)
such as Crohn's disease##4##4##(1993-10#1)(2008-11#1)(2009-6#1)(2009-8#1)
such as Cu(II)##4##3##(2008-10#4)
such as DNA and##4##4##(2008-10#1)(2008-4#1)(2008-7#1)(2009-5#1)
such as DNA##10##3##(1992-9#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)
such as EDTA##2##3##(2008-10#2)
such as EGF##3##3##(1990-10#1)(1991-7#1)(1995-10#1)
such as Escherichia coli##7##4##(1994-8#1)(1995-5#1)(2008-10#1)(2008-5#2)(2011-1#1)(2011-2#1)
such as Fe##3##3##(2008-10#1)(2008-12#1)(2013-8#1)
such as GC-MS##2##3##(2008-10#1)(2010-11#1)
such as Gaussian##2##3##(2012-1#1)(2012-2#1)
such as Gly##2##3##(1993-6#1)(1996-5#1)
such as Gram##2##3##(2006-10#1)(2010-6#1)
such as H+##2##3##(1990-8#1)(2013-8#1)
such as HF##2##3##(2007-8#1)(2008-10#1)
such as HIV##9##3##(1991-4#1)(2006-9#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-8#1)(2010-12#1)(2010-2#1)(2012-1#1)
such as HIV-1##2##3##(2007-6#1)(2011-3#1)
such as HIV/AIDS##3##3##(1995-9#1)(2009-4#1)(2012-1#1)
such as ICAM-1##2##3##(1992-6#1)(1994-2#1)
such as IL-1##3##3##(1991-4#1)(1992-3#1)(1995-5#1)
such as IL-2##2##3##(1992-7#1)(2008-9#1)
such as IL-6##3##3##(1997-5#1)(1997-8#1)(2008-11#1)
such as JPEG##2##3##(2008-2#2)
such as Listeria monocytogenes##2##4##(2010-2#1)(2011-1#1)
such as M##2##3##(1997-5#1)(2008-7#1)
such as MDMA##2##3##(2005-9#1)(2013-7#1)
such as MR##2##3##(2010-12#2)
such as MRI##5##3##(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#2)
such as Me31B and Exu##2##5##(2012-12#2)
such as Mg(II)##2##3##(2008-10#2)
such as Mg2+##4##3##(1991-2#1)(1995-1#1)(1995-2#1)(2008-6#1)
such as Mn2+##3##3##(1994-3#1)(1994-6#1)(2008-4#1)
such as Mycobacterium tuberculosis##2##4##(2008-7#2)
such as Mycobacterium##4##3##(2006-10#1)(2008-7#2)(2011-1#1)
such as NF-kappa B##2##4##(1994-11#1)(1995-3#1)
such as NH(3)##2##3##(2008-10#2)
such as Na(+)##2##3##(2008-10#2)
such as Na(+)/K(+)-ATPase and##2##4##(2007-12#1)(2009-8#1)
such as New##2##3##(2012-12#1)(2013-7#1)
such as P##2##3##(2008-10#1)(2012-1#1)
such as PDF1##2##3##(2009-6#1)(2009-8#1)
such as PKC##2##3##(1992-12#1)(1994-2#1)
such as Parkinson's disease (PD) and##2##6##(2008-11#2)
such as Parkinson's disease (PD)##3##5##(2008-11#2)(2012-12#1)
such as Parkinson's disease##6##4##(2005-7#1)(2008-11#2)(2009-10#1)(2012-12#1)(2013-1#1)
such as Parkinson's##7##3##(2005-7#1)(2008-11#2)(2008-4#1)(2009-10#1)(2012-12#1)(2013-1#1)
such as Plasmodium##2##3##(2005-8#1)(2008-11#1)
such as Pseudomonas aeruginosa##2##4##(1997-2#1)(2008-4#1)
such as Pseudomonas##4##3##(1997-2#1)(2007-7#1)(2008-4#1)(2010-4#1)
such as Pythium##2##3##(2008-10#2)
such as R##2##3##(2008-10#1)(2012-2#1)
such as RNAi##2##3##(2008-4#1)(2012-2#1)
such as S##2##3##(1994-11#1)(2008-2#1)
such as Saccharomyces cerevisiae##2##4##(1991-8#1)(2008-7#1)
such as Sp1##2##3##(1992-5#1)(1994-8#1)
such as Squid and Imp##2##5##(2012-12#2)
such as Staphylococcus aureus and##2##5##(2007-11#1)(2007-2#1)
such as Staphylococcus aureus##4##4##(2005-9#1)(2007-11#1)(2007-2#1)(2010-3#1)
such as Superoxide##2##3##(2008-10#1)(2013-8#1)
such as Surveillance##3##3##(2005-7#1)(2013-1#2)
such as T##2##3##(2008-9#1)(2010-3#1)
such as TNFalpha##3##3##(2006-3#1)(2007-11#1)(2010-3#1)
such as UV##2##3##(2008-5#1)(2011-2#1)
such as X-Ray##2##3##(2008-7#1)(2013-1#1)
such as a laser##4##4##(2008-2#1)(2008-3#3)
such as a tumor##2##4##(2008-3#1)(2009-10#1)
such as a##106##3##(1990-8#1)(1991-10#1)(1991-5#1)(1992-2#1)(1993-2#1)(1994-6#1)(1994-8#1)(1996-9#1)(1997-4#1)(1997-6#1)(2005-11#2)(2005-8#1)(2006-1#1)(2006-10#5)(2006-2#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#8)(2008-11#2)(2008-2#9)(2008-3#14)(2008-4#6)(2008-6#2)(2008-7#1)(2008-8#1)(2009-1#1)(2009-10#1)(2009-2#1)(2010-10#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#2)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
such as abdominal pain##2##4##(1990-4#1)(2005-12#1)
such as absorbance##2##3##(2005-11#1)(2011-1#1)
such as access##2##3##(1997-2#1)(2012-3#1)
such as accuracy##3##3##(2008-10#2)(2013-1#1)
such as acetonitrile##2##3##(1994-9#1)(2008-10#1)
such as acetylsalicylic acid##2##4##(2008-10#2)
such as acidic pH and##2##5##(2007-12#1)(2008-8#1)
such as acidic pH##3##4##(2006-8#1)(2007-12#1)(2008-8#1)
such as acidity##3##3##(2008-10#3)
such as actin##2##3##(1993-8#1)(2008-9#1)
such as activated##2##3##(2007-10#1)(2011-2#1)
such as activation of##3##4##(2005-10#1)(2006-10#1)(2006-6#1)
such as activation##4##3##(1996-9#1)(2005-10#1)(2006-10#1)(2006-6#1)
such as acute##4##3##(1990-5#1)(2007-8#1)(2008-8#1)(2012-2#1)
such as adenosine##2##3##(2006-3#1)(2008-10#1)
such as adjustment##2##3##(2010-5#1)(2012-2#1)
such as advanced##4##3##(1993-9#1)(1994-3#1)(2007-3#1)(2009-5#1)
such as adverse##3##3##(2006-8#1)(2009-7#1)(2011-2#1)
such as age and gender##2##5##(1994-3#1)(2009-4#1)
such as age and##6##4##(1990-3#1)(1991-10#1)(1994-3#1)(2009-4#1)(2012-12#1)(2013-8#1)
such as age##22##3##(1990-3#1)(1990-8#1)(1991-10#1)(1992-4#1)(1992-8#1)(1994-3#1)(1995-8#1)(2006-9#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
such as aggressive##3##3##(1996-9#1)(2007-12#1)(2008-11#1)
such as aging##6##3##(1996-4#1)(2005-8#1)(2007-12#1)(2008-10#1)(2009-5#1)(2010-12#1)
such as air##4##3##(2008-11#1)(2008-3#1)(2008-8#1)(2013-8#1)
such as alcohol or##2##4##(1997-5#1)(2009-5#1)
such as alcohol##6##3##(1997-5#1)(2008-8#1)(2009-5#1)(2010-4#1)(2010-5#1)(2013-8#1)
such as alcohols##2##3##(2005-12#1)(2008-10#1)
such as alignment##2##3##(1993-4#1)(2008-2#1)
such as alkali##2##3##(2007-11#1)(2008-10#1)
such as alkaline and acid##2##5##(1993-11#1)(2007-8#1)
such as alkaline##3##3##(1993-11#1)(2007-8#1)(2008-11#1)
such as alkyl##2##3##(2007-11#1)(2008-5#1)
such as allergic##3##3##(2008-3#1)(2011-2#1)(2012-12#1)
such as alpha##3##3##(1991-8#1)(1995-12#1)(2008-4#1)
such as alterations in##2##4##(2007-11#1)(2008-2#1)
such as amino acid##2##4##(1994-2#1)(2008-4#1)
such as amino##3##3##(1994-2#1)(2008-10#1)(2008-4#1)
such as amphetamine and##2##4##(1993-3#1)(2008-10#1)
such as amphetamines##3##3##(2005-10#1)(2007-11#1)(2008-10#1)
such as amplified##2##3##(2007-12#1)(2008-9#1)
such as amplitude##2##3##(1990-9#1)(2007-9#1)
such as amyloid##2##3##(2010-8#1)(2013-1#1)
such as an aircraft##2##4##(1996-12#1)(2008-2#1)
such as an increase in##2##5##(1992-1#1)(1995-11#1)
such as an##31##3##(1990-8#1)(1992-1#1)(1993-4#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-2#1)(2006-9#1)(2007-9#2)(2008-1#3)(2008-10#4)(2008-2#2)(2008-6#1)(2008-9#1)(2009-3#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
such as angioplastic##2##3##(2008-6#2)
such as angiotensin II##2##4##(2007-1#1)(2008-4#1)
such as angiotensin converting enzyme inhibitors##2##6##(2005-10#1)(2010-6#1)
such as angiotensin##5##3##(1991-5#1)(2005-10#1)(2007-1#1)(2008-4#1)(2010-6#1)
such as antibiotics##4##3##(1992-3#1)(2006-10#1)(2008-11#1)(2011-1#1)
such as antibodies or##2##4##(2008-11#1)(2008-4#1)
such as antimicrobial##2##3##(2008-10#1)(2013-1#1)
such as antitumor##2##3##(2011-3#1)(2012-3#1)
such as anxiety and depression##2##5##(2004-11#1)(2008-11#1)
such as anxiety and##3##4##(2004-11#1)(2004-3#1)(2008-11#1)
such as anxiety##5##3##(1990-3#1)(2004-11#1)(2004-3#1)(2008-11#2)
such as aortic##3##3##(1993-10#1)(2007-9#1)(2008-3#1)
such as apoptosis##5##3##(2008-10#1)(2008-11#1)(2009-12#1)(2012-12#1)(2012-2#1)
such as applied##3##3##(2008-10#2)(2008-12#1)
such as appropriate##2##3##(2005-10#1)(2013-7#1)
such as are##3##3##(1995-6#1)(1997-3#1)(2008-9#1)
such as arginine##4##3##(1992-7#1)(2006-10#1)(2006-2#1)(2013-7#1)
such as aromatic##2##3##(2008-10#1)(2010-7#1)
such as arrhythmias##2##3##(2008-1#1)(2008-5#1)
such as arsenic##2##3##(2005-11#1)(2008-12#1)
such as arteriovenous##2##3##(2009-4#1)(2012-12#1)
such as arthritis##4##3##(2006-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
such as artificial##2##3##(2007-2#1)(2012-12#1)
such as asbestos##2##3##(2008-2#1)(2010-8#1)
such as ascorbate##2##3##(2008-10#2)
such as ascorbic acid and##2##5##(1993-2#1)(2008-10#1)
such as ascorbic acid##3##4##(1993-2#1)(2008-10#2)
such as aspartate and glutamate##2##5##(1991-9#1)(2012-1#1)
such as aspirin##3##3##(2005-7#1)(2006-10#1)(2008-11#1)
such as asthma##10##3##(1992-1#1)(1994-11#1)(2005-8#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-9#1)(2012-12#1)
such as at##2##3##(2008-3#1)(2008-7#1)
such as atherosclerosis and coronary##2##5##(2008-3#2)
such as atherosclerosis and##5##4##(2008-3#2)(2010-1#1)(2010-5#1)(2012-12#1)
such as atherosclerosis##13##3##(1997-2#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-1#1)(2010-5#1)(2010-8#1)(2012-12#2)(2012-2#2)
such as atherosclerotic##2##3##(2008-12#1)(2010-12#1)
such as atmospheric##2##3##(2008-11#1)(2008-3#1)
such as atopic dermatitis##2##4##(2008-3#1)(2011-1#1)
such as atrial##3##3##(2007-8#1)(2007-9#1)(2012-12#1)
such as autism##2##3##(2008-11#1)(2011-2#1)
such as autoimmune hepatitis##2##4##(2007-11#1)(2008-12#1)
such as autoimmune##4##3##(2007-11#1)(2007-2#1)(2008-12#1)(2010-3#1)
such as automated reasoners##2##4##(2008-7#2)
such as automated##3##3##(2008-4#1)(2008-7#2)
such as auxin##2##3##(2011-1#2)
such as average##2##3##(1990-9#1)(2008-2#1)
such as azathioprine##2##3##(2008-12#1)(2008-4#1)
such as bacteria##2##3##(2006-10#1)(2008-10#1)
such as balanced##2##3##(2010-8#1)(2013-8#1)
such as baseline##2##3##(2006-1#1)(2008-7#1)
such as bcl-2##3##3##(2008-11#2)(2008-7#1)
such as being##6##3##(2008-11#1)(2008-7#1)(2009-2#1)(2010-5#1)(2013-1#1)(2013-8#1)
such as bending##2##3##(2008-3#1)(2009-7#1)
such as benzene and##3##4##(2007-8#1)(2008-10#2)
such as benzene##5##3##(2007-10#1)(2007-8#1)(2008-10#2)(2008-3#1)
such as benzodiazepines##2##3##(2010-4#1)(2013-1#1)
such as bevacizumab and##2##4##(2010-12#1)(2011-3#1)
such as biliary##2##3##(2006-10#1)(2006-2#1)
such as binder##2##3##(2008-1#1)(2008-10#1)
such as biological##2##3##(2007-2#1)(2008-10#1)
such as biomass##2##3##(2008-5#1)(2008-9#1)
such as biopsy##2##3##(2006-10#1)(2006-8#1)
such as birds##3##3##(2006-10#1)(2008-8#1)(2009-5#1)
such as birth##2##3##(2006-1#1)(2008-4#1)
such as bisphosphonates##2##3##(1996-11#1)(2008-8#1)
such as bladder##2##3##(2008-5#1)(2010-3#1)
such as blebbing##2##3##(2008-4#1)(2012-3#1)
such as blood##11##3##(1997-5#1)(2005-11#1)(2005-12#1)(2008-10#4)(2010-2#1)(2010-4#1)(2012-2#2)
such as body mass index##2##5##(2008-7#2)
such as body##7##3##(2006-5#1)(2008-6#1)(2008-7#2)(2010-5#1)(2013-1#2)
such as bone marrow##2##4##(2006-10#1)(2008-9#1)
such as bone##10##3##(2006-10#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-9#1)(2011-7#1)(2012-12#1)(2012-2#1)
such as bovine serum albumin##2##5##(2005-11#1)(2008-10#1)
such as bovine##5##3##(1997-2#1)(2005-11#1)(2008-10#1)(2008-11#1)(2010-2#1)
such as bowel##2##3##(1992-12#1)(2012-3#1)
such as brain##10##3##(1994-5#1)(1995-6#1)(2006-10#1)(2008-10#1)(2008-6#1)(2010-9#1)(2011-2#2)(2012-11#1)(2012-12#1)
such as branched##2##3##(1991-5#1)(1996-5#1)
such as breast cancer##4##4##(1997-3#1)(1997-8#1)(2009-8#1)(2012-2#1)
such as breast##7##3##(1994-6#1)(1996-8#1)(1997-3#1)(1997-8#1)(2009-8#1)(2010-12#1)(2012-2#1)
such as brushing and linking##2##5##(2013-1#2)
such as buffer##2##3##(1997-8#1)(2008-10#1)
such as business##2##3##(1991-12#1)(2007-4#1)
such as butylated hydroxyanisole##2##4##(1995-8#1)(2008-1#1)
such as butylated##3##3##(1995-8#1)(2008-1#1)(2008-10#1)
such as by##4##3##(1997-3#1)(2008-10#1)(2010-11#1)(2012-3#1)
such as cadmium##2##3##(2008-10#2)
such as calcium##6##3##(1990-10#2)(1992-4#1)(1992-8#1)(1993-6#1)(2010-6#1)
such as calibration##2##3##(2007-12#1)(2008-10#1)
such as calmodulin is##2##4##(1997-1#2)
such as cancer and##3##4##(2010-10#1)(2010-11#1)(2012-2#1)
such as cancer##14##3##(1992-3#1)(1997-6#1)(2006-10#2)(2007-11#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-9#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-2#1)
such as candidate##2##3##(2008-8#1)(2012-3#1)
such as capsaicin##2##3##(2006-9#1)(2009-3#1)
such as carbamazepine##2##3##(1996-1#1)(2011-2#1)
such as carbon tetrachloride##2##4##(1992-3#1)(2005-7#1)
such as carbon##7##3##(1992-3#1)(2005-11#1)(2005-7#1)(2007-12#1)(2008-10#1)(2011-1#1)(2012-3#1)
such as cardiac##5##3##(2006-10#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-12#1)
such as cardiovascular disease##2##4##(2007-11#1)(2010-7#1)
such as cardiovascular diseases and##3##5##(2006-10#1)(2007-1#1)(2008-10#1)
such as cardiovascular diseases##4##4##(1991-11#1)(2006-10#1)(2007-1#1)(2008-10#1)
such as cardiovascular##7##3##(1991-11#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-7#1)
such as care##2##3##(2008-3#1)(2013-8#1)
such as carotid##2##3##(2006-10#1)(2009-7#1)
such as catalase (CAT)##2##4##(2008-11#1)(2012-2#1)
such as catalase##3##3##(2004-4#1)(2008-11#1)(2012-2#1)
such as cathepsin##2##3##(2006-10#1)(2007-7#1)
such as cell adhesion##2##4##(1993-11#1)(2010-12#1)
such as cell cycle progression##2##5##(2009-6#1)(2012-2#1)
such as cell cycle##3##4##(2009-6#1)(2012-12#1)(2012-2#1)
such as cell differentiation##2##4##(2008-7#1)(2012-12#1)
such as cell division##2##4##(2011-1#1)(2011-2#1)
such as cell growth##2##4##(2008-6#1)(2013-1#1)
such as cell proliferation##5##4##(2008-11#1)(2008-8#1)(2009-8#1)(2011-1#1)(2012-12#1)
such as cell signaling##2##4##(2008-9#1)(2011-2#1)
such as cell##30##3##(1993-11#1)(1996-3#2)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#1)(2011-1#3)(2011-2#2)(2012-12#4)(2012-2#1)(2012-5#1)(2013-1#1)(2013-8#1)
such as cells and##2##4##(2005-11#1)(2008-8#1)
such as cells##4##3##(2005-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
such as cellular##4##3##(2004-4#1)(2008-11#1)(2008-4#1)(2011-2#1)
such as cellulose##2##3##(2008-10#1)(2011-2#1)
such as central##2##3##(2008-10#1)(2011-1#1)
such as cerebral palsy##2##4##(2006-10#1)(2012-1#1)
such as cerebral##6##3##(2005-8#1)(2006-10#1)(2007-1#1)(2007-10#1)(2010-12#1)(2012-1#1)
such as cervical##2##3##(2011-2#1)(2012-2#1)
such as cetyltrimethylammonium##2##3##(2008-10#2)
such as changes in##6##4##(1992-12#1)(1992-5#1)(1997-8#1)(2008-8#1)(2008-9#1)(2011-1#1)
such as chemical##5##3##(1994-5#1)(1995-11#1)(1997-8#1)(2008-1#1)(2008-3#1)
such as chemotherapy##3##3##(1990-11#1)(2007-3#1)(2007-4#1)
such as chest pain##3##4##(2007-8#1)(2010-1#1)(2012-3#1)
such as chest##6##3##(2007-4#1)(2007-8#2)(2008-1#1)(2010-1#1)(2012-3#1)
such as chestnut blight##2##4##(2008-10#2)
such as chiropractic##2##3##(1996-12#1)(2007-6#1)
such as chloride##3##3##(1994-5#2)(2008-10#1)
such as chlorophyll##3##3##(1993-12#1)(2008-12#2)
such as cholesterol##3##3##(1993-3#1)(2006-12#1)(2011-2#1)
such as chromatography##2##3##(1995-7#1)(2008-10#1)
such as chronic fatigue##2##4##(1995-12#1)(2006-10#1)
such as chronic obstructive pulmonary disease##2##6##(2006-2#1)(2010-10#1)
such as chronic##14##3##(1991-8#1)(1995-12#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-4#1)(2010-10#1)(2011-2#1)
such as citrate##4##3##(1996-8#2)(2008-10#1)(2010-4#1)
such as cleft lip##2##4##(2007-12#1)(2007-2#1)
such as cleft##4##3##(1993-12#1)(1993-3#1)(2007-12#1)(2007-2#1)
such as climate##2##3##(2008-12#1)(2011-1#1)
such as clinical##5##3##(1990-12#1)(1994-12#1)(1997-4#1)(2007-4#1)(2008-11#1)
such as cluster##3##3##(2008-10#2)(2009-11#1)
such as cocaine##2##3##(1995-12#1)(1996-10#1)
such as coffee##2##3##(2008-7#1)(2011-2#1)
such as cognitive##4##3##(2008-5#1)(2011-2#1)(2012-2#2)
such as collagen##5##3##(2008-5#1)(2008-9#1)(2009-12#1)(2012-2#1)(2013-8#1)
such as collateral##2##3##(2007-10#1)(2010-6#1)
such as colon##2##3##(1993-5#1)(2008-11#1)
such as commercial##3##3##(2008-10#2)(2009-7#1)
such as communication##2##3##(1994-2#1)(2008-12#1)
such as community##2##3##(2008-3#1)(2008-7#1)
such as competition##3##3##(2008-10#1)(2008-9#2)
such as composition and##2##4##(2007-8#1)(2008-10#1)
such as computed tomography and magnetic resonance imaging##2##8##(2008-2#1)(2008-7#1)
such as computed tomography##3##4##(2006-6#1)(2008-2#1)(2008-7#1)
such as concanavalin A##3##4##(1991-8#1)(1994-5#1)(1995-2#1)
such as concentration of##3##4##(2007-8#1)(2008-10#2)
such as confocal##3##3##(2007-11#1)(2008-9#1)(2010-9#1)
such as congenital##2##3##(2005-12#1)(2013-1#1)
such as contact lenses##2##4##(2006-11#1)(2007-1#1)
such as contact##3##3##(2005-8#1)(2006-11#1)(2007-1#1)
such as continuous##4##3##(1997-7#1)(2007-12#1)(2011-1#1)(2013-1#1)
such as controlled##2##3##(2008-10#1)(2008-2#1)
such as conventional##3##3##(1991-3#1)(2007-10#1)(2007-11#1)
such as copper##2##3##(1997-2#1)(2008-10#1)
such as copper(II)##2##3##(2005-11#1)(2008-10#1)
such as corn##3##3##(2008-5#2)(2008-6#1)
such as coronary heart disease##2##5##(1997-2#1)(2008-10#1)
such as coronary##4##3##(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#1)
such as critical flicker##2##4##(2005-9#1)(2011-2#1)
such as critical##7##3##(1991-3#1)(2005-9#1)(2006-11#1)(2008-2#1)(2008-5#1)(2010-8#1)(2011-2#1)
such as crude oil##2##4##(2008-10#2)
such as cucumber##2##3##(2008-10#1)(2013-8#1)
such as culture##2##3##(1996-12#1)(2005-7#1)
such as cyclophosphamide##2##3##(2007-11#1)(2012-3#1)
such as cyclosporin##3##3##(2007-11#3)
such as cyclosporine##2##3##(2008-1#1)(2013-1#1)
such as cystic fibrosis##5##4##(2005-11#2)(2008-5#2)(2011-3#1)
such as cysts##2##3##(2008-1#1)(2009-2#1)
such as cytochrome##2##3##(1991-9#1)(1992-12#1)
such as cytokines##5##3##(2005-10#1)(2007-11#1)(2008-1#1)(2011-2#2)
such as cytotoxicity##3##3##(2007-9#1)(2008-1#1)(2008-11#1)
such as daily##2##3##(2008-8#1)(2009-11#1)
such as deep venous thrombosis##2##5##(2007-12#1)(2012-3#1)
such as deep##3##3##(1994-3#1)(2007-12#1)(2012-3#1)
such as defensins##2##3##(2008-5#1)(2009-8#1)
such as dendritic cells##3##4##(2007-11#1)(2009-9#1)(2010-12#1)
such as dendritic##4##3##(2007-11#1)(2009-9#1)(2010-12#1)(2012-3#1)
such as dental caries##3##4##(2006-10#1)(2012-2#2)
such as dental##4##3##(2006-10#1)(2008-5#1)(2012-2#2)
such as deodorants##2##3##(2008-5#2)
such as deposition##2##3##(2008-10#1)(2008-3#1)
such as depression and##5##4##(1995-12#1)(2004-3#1)(2008-11#2)(2012-2#1)
such as depression##12##3##(1995-12#1)(2004-3#1)(2007-10#1)(2007-11#1)(2008-11#2)(2008-5#1)(2008-9#1)(2009-10#1)(2010-12#1)(2012-12#1)(2012-2#1)
such as detection limit##2##4##(2008-10#2)
such as detection##3##3##(2008-10#3)
such as detector##2##3##(2008-10#1)(2008-2#1)
such as determination##2##3##(2008-4#1)(2011-2#1)
such as dexamethasone##2##3##(1990-12#1)(2012-3#1)
such as diabetes mellitus##5##4##(1996-12#1)(2007-2#1)(2008-3#1)(2010-12#1)(2011-2#1)
such as diabetes##19##3##(1995-1#1)(1995-2#1)(1996-12#1)(1996-9#1)(2005-11#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-8#1)(2010-12#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
such as diabetic##3##3##(2007-8#1)(2008-1#2)
such as diagnostic##3##3##(1990-12#1)(2007-11#1)(2010-5#1)
such as diazepam##4##3##(1991-12#1)(1992-3#1)(1994-5#1)(1996-10#1)
such as diet##3##3##(1990-12#1)(2006-2#1)(2008-10#1)
such as dietary##2##3##(1996-9#1)(2010-8#1)
such as differences in##2##4##(1997-3#1)(2004-4#1)
such as different##3##3##(1995-1#1)(1997-2#1)(1997-4#1)
such as diffractive optical elements##2##5##(2008-3#2)
such as diffractive##3##3##(2008-2#1)(2008-3#2)
such as diffuse##2##3##(2007-5#1)(2012-2#1)
such as diffusion##2##3##(2007-3#1)(2010-12#1)
such as dilatation##2##3##(1991-12#1)(1992-5#1)
such as direct injection of unprocessed or concentrated blood or bone marrow aspirates##2##13##(2012-12#2)
such as direct##9##3##(1997-3#1)(2006-12#1)(2008-2#1)(2008-6#1)(2010-11#1)(2010-4#1)(2012-1#1)(2012-12#2)
such as disease##9##3##(1995-12#1)(1995-2#1)(1996-3#1)(2004-3#1)(2008-10#2)(2009-8#1)(2010-11#1)(2011-2#1)
such as distance##2##3##(2008-4#1)(2008-7#1)
such as dithiothreitol##3##3##(1990-12#1)(1992-4#1)(2009-12#1)
such as dopamine##5##3##(1995-11#1)(1995-8#1)(2008-10#3)
such as double-stranded RNA##2##4##(2007-1#2)
such as drought##3##3##(1997-2#1)(2009-8#1)(2011-2#1)
such as drug##7##3##(1994-5#1)(2005-6#1)(2006-10#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)
such as dual##2##3##(2008-1#1)(2013-8#1)
such as duration of precopulation time##2##6##(2012-12#2)
such as during##2##3##(2006-12#1)(2010-8#1)
such as dyes##2##3##(1993-12#1)(1995-5#1)
such as dynamic##3##3##(2007-12#1)(2007-8#1)(2008-7#1)
such as dysphagia##2##3##(2008-12#1)(2008-5#1)
such as early##4##3##(1991-5#1)(2007-11#1)(2008-10#1)(2013-1#1)
such as eating##2##3##(2009-4#1)(2012-12#1)
such as edema##2##3##(2008-1#1)(2011-2#1)
such as edges##3##3##(2008-2#2)(2008-6#1)
such as education and##2##4##(2010-2#1)(2011-1#1)
such as education##3##3##(2010-2#1)(2011-1#2)
such as effect of##2##4##(2008-10#2)
such as egg##3##3##(2007-12#1)(2008-8#1)(2008-9#1)
such as electrolyte disturbances##2##4##(1996-9#1)(2011-2#1)
such as electron##2##3##(2007-4#1)(2009-2#1)
such as electronic prescribing and test ordering##2##7##(2013-1#2)
such as electronic##3##3##(1994-12#1)(2013-1#2)
such as electrostatic##2##3##(1993-4#1)(2008-11#1)
such as elevated##7##3##(2007-8#1)(2007-9#2)(2008-7#1)(2010-4#1)(2012-2#1)(2013-7#1)
such as emotion##2##3##(2006-8#1)(2008-11#1)
such as emotions##2##3##(1990-3#1)(2013-7#1)
such as encapsulated in genetic pathways##2##6##(2013-1#2)
such as endothelial##2##3##(2008-1#1)(2008-9#1)
such as energy##3##3##(2008-5#1)(2008-8#1)(2013-8#1)
such as enhanced##3##3##(2008-8#1)(2009-6#1)(2012-2#1)
such as enriched##2##3##(2008-7#1)(2010-4#1)
such as environmental##2##3##(2008-10#2)
such as epidermal growth factor##2##5##(1994-12#1)(2008-5#1)
such as ethanol or##3##4##(2008-8#1)(2010-2#2)
such as ethanol##7##3##(2008-10#1)(2008-4#1)(2008-8#1)(2010-2#2)(2010-4#1)(2013-8#1)
such as etidronate##2##3##(2008-3#1)(2008-8#1)
such as evaporation##2##3##(2008-10#1)(2009-11#1)
such as exercise##4##3##(2008-1#1)(2008-7#1)(2011-2#1)(2013-1#1)
such as exposure##2##3##(2006-4#1)(2008-4#1)
such as faces##3##3##(1992-5#1)(1997-8#1)(2011-12#1)
such as facial##2##3##(2008-12#1)(2008-9#1)
such as factor analysis##3##4##(2005-10#1)(2008-10#1)(2010-8#1)
such as family and##2##4##(2007-7#1)(2011-1#1)
such as family history##2##4##(1996-8#1)(2012-2#1)
such as family##6##3##(1992-1#1)(1996-8#1)(2007-7#1)(2008-3#1)(2011-1#1)(2012-2#1)
such as fasting##2##3##(2008-3#1)(2010-9#1)
such as fatigue and##2##4##(2009-1#1)(2012-1#1)
such as fatigue##4##3##(2006-10#1)(2009-1#1)(2012-1#1)(2013-1#1)
such as fatty liver##2##4##(2008-3#2)
such as feeding##2##3##(2008-10#1)(2009-9#1)
such as fetal##2##3##(1996-2#1)(2010-3#1)
such as fever##3##3##(2009-4#1)(2010-2#1)(2012-2#1)
such as fibroblasts##3##3##(2008-4#1)(2008-5#1)(2012-3#1)
such as fibronectin##2##3##(1991-1#1)(2007-7#1)
such as film##3##3##(2008-10#2)(2008-2#1)
such as filtration and##2##4##(2004-9#1)(2008-11#1)
such as fish##3##3##(2008-9#1)(2009-12#1)(2012-12#1)
such as flame##3##3##(2008-10#2)(2008-3#1)
such as flavonoids##3##3##(2008-10#1)(2009-3#1)(2011-2#1)
such as flow cytometry and##2##5##(2008-9#1)(2010-7#1)
such as flow injection analysis (FIA)##2##6##(2008-10#2)
such as flow##8##3##(2008-10#5)(2008-9#1)(2010-7#1)(2011-1#1)
such as fluorescence##4##3##(2007-12#1)(2008-2#1)(2010-7#1)(2012-2#1)
such as fluoride##4##3##(1990-2#1)(2006-10#1)(2008-10#1)(2009-6#1)
such as focal##2##3##(1990-3#1)(2012-2#1)
such as food##2##3##(1994-3#1)(2012-12#1)
such as for##5##3##(1996-10#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-5#1)
such as force##2##3##(2006-11#1)(2008-5#1)
such as formal##2##3##(1996-1#1)(2010-9#1)
such as fragile X syndrome##2##5##(2011-2#1)(2012-2#1)
such as free radicals##2##4##(2007-9#2)
such as freezing##2##3##(2008-11#1)(2008-7#1)
such as frequency##3##3##(2007-11#1)(2012-1#1)(2013-8#1)
such as freshwater##2##3##(2008-12#1)(2008-8#1)
such as friction##2##3##(1993-2#1)(2007-12#1)
such as from##4##3##(1995-11#1)(2008-1#1)(2008-3#1)(2011-1#1)
such as fructose and##2##4##(1995-11#1)(2008-7#1)
such as functional magnetic resonance imaging##2##6##(1997-6#1)(2009-10#1)
such as functional##3##3##(1997-6#1)(2006-10#1)(2009-10#1)
such as fungal##2##3##(2006-12#1)(2007-3#1)
such as furfural and##2##4##(2006-12#1)(2011-1#1)
such as gamma##2##3##(2008-7#1)(2012-2#1)
such as gastrointestinal stromal##2##4##(2010-12#1)(2010-5#1)
such as gastrointestinal##6##3##(2008-11#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-5#1)(2013-7#1)
such as gender and age##2##5##(1993-12#1)(2013-1#1)
such as gender##7##3##(1993-12#1)(2007-12#1)(2007-4#1)(2007-7#2)(2011-2#1)(2013-1#1)
such as gene duplication##3##4##(2008-4#1)(2008-8#1)(2013-1#1)
such as gene expression##5##4##(2008-1#1)(2008-4#1)(2008-8#1)(2010-11#1)(2011-3#1)
such as gene therapy##2##4##(2008-11#1)(2013-8#1)
such as gene##16##3##(2005-9#1)(2006-5#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-8#2)(2010-11#1)(2010-12#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
such as genes and proteins##2##5##(2008-7#1)(2010-11#1)
such as genes and##3##4##(2008-4#1)(2008-7#1)(2010-11#1)
such as genes##5##3##(1995-6#1)(2008-4#1)(2008-7#1)(2009-11#1)(2010-11#1)
such as genetic##10##3##(1995-1#1)(1996-3#1)(2006-10#2)(2007-5#1)(2008-1#1)(2008-11#1)(2008-8#2)(2012-2#1)
such as genetically modified organisms##2##5##(2008-7#1)(2009-4#1)
such as genetically##3##3##(2008-11#1)(2008-7#1)(2009-4#1)
such as genital##2##3##(2006-10#1)(2013-1#1)
such as genome##2##3##(2007-6#1)(2012-11#1)
such as genomics##3##3##(2010-12#1)(2011-2#1)(2013-1#1)
such as geographic##2##3##(1997-1#1)(2008-10#1)
such as geographical##2##3##(2008-11#1)(2013-1#1)
such as glass##3##3##(2008-2#1)(2008-3#1)(2008-4#1)
such as glucose##6##3##(1992-12#1)(1994-8#1)(2008-10#2)(2008-6#1)(2011-1#1)
such as glutamate##4##3##(2007-1#1)(2007-9#2)(2008-11#1)
such as glutathione##7##3##(1992-11#1)(1992-9#1)(2008-11#1)(2008-5#3)(2010-12#1)
such as glycerol##2##3##(2008-11#1)(2008-6#1)
such as goats##2##3##(2008-8#1)(2013-1#1)
such as goiter##2##3##(2008-1#1)(2012-12#1)
such as gold##2##3##(2007-11#1)(2010-4#1)
such as granular##2##3##(1996-3#1)(2008-3#1)
such as growth factors and##2##5##(2008-5#2)
such as growth##8##3##(1991-5#1)(1993-9#1)(1996-9#1)(2008-5#2)(2008-8#1)(2010-5#1)(2011-2#1)
such as having##2##3##(2012-12#1)(2012-2#1)
such as head and neck##2##5##(2006-9#1)(2011-2#1)
such as head##5##3##(1996-9#1)(2006-9#1)(2007-12#1)(2007-4#1)(2011-2#1)
such as health care##2##4##(1995-1#1)(2008-11#1)
such as health##4##3##(1995-1#1)(1996-3#1)(2008-11#1)(2010-12#1)
such as healthy##2##3##(2008-10#1)(2011-2#1)
such as heart attack##2##4##(2008-5#1)(2013-8#1)
such as heart disease##2##4##(1993-9#1)(2012-1#1)
such as heart rate##2##4##(2006-10#1)(2010-8#1)
such as heart##8##3##(1993-9#1)(2006-10#1)(2008-5#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-8#1)
such as heat shock##3##4##(1997-6#1)(2008-1#1)(2010-4#1)
such as heat##5##3##(1996-12#1)(1996-2#1)(1997-6#1)(2008-1#1)(2010-4#1)
such as heavy##2##3##(2008-11#1)(2008-12#1)
such as hemoglobin##2##3##(1990-8#1)(2008-1#1)
such as hepatic##2##3##(2006-10#1)(2008-10#1)
such as hepatitis##5##3##(2005-7#1)(2006-10#1)(2007-12#1)(2013-1#2)
such as high##17##3##(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
such as histamine##3##3##(1997-1#1)(2009-8#1)(2011-2#1)
such as histidine##2##3##(1990-11#1)(2008-1#1)
such as holographic##2##3##(2007-12#1)(2008-3#1)
such as honey##2##3##(2008-10#2)
such as hospital##5##3##(1993-2#1)(1995-3#1)(1996-3#1)(2008-11#1)(2012-12#1)
such as hospitals and##3##4##(1992-3#1)(2006-8#1)(2012-12#1)
such as hospitals##4##3##(1992-3#1)(2006-8#1)(2007-12#1)(2012-12#1)
such as host##2##3##(1997-7#1)(2008-10#1)
such as hostility##2##3##(2012-12#2)
such as household##2##3##(2008-5#1)(2012-3#1)
such as how##4##3##(1993-11#1)(2007-12#1)(2008-11#1)(2009-5#1)
such as human immunodeficiency virus (HIV)##3##6##(1992-12#1)(2008-4#1)(2008-9#1)
such as human immunodeficiency virus##4##5##(1992-12#1)(2008-2#1)(2008-4#1)(2008-9#1)
such as human##16##3##(1990-12#1)(1992-10#1)(1992-12#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#2)(2008-9#1)(2011-2#1)
such as humanized##2##3##(1996-4#1)(2007-8#1)
such as hydrogen peroxide##2##4##(1997-6#1)(2010-5#1)
such as hydrogen##7##3##(1997-6#1)(2007-11#1)(2008-10#2)(2010-12#1)(2010-5#2)
such as hydrophobic interaction##2##4##(2008-10#2)
such as hyperglycemia##2##3##(2008-1#2)
such as hyperhomocysteinemia##2##3##(2005-10#1)(2008-3#1)
such as hypertension and diabetes##4##5##(1996-11#1)(2007-8#1)(2008-1#1)(2008-4#1)
such as hypertension and##9##4##(1996-11#1)(1996-8#1)(1996-9#1)(2005-10#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-4#1)
such as hypertension or diabetes##2##5##(2007-10#1)(2008-3#1)
such as hypertension or##3##4##(2007-10#1)(2008-3#1)(2009-5#1)
such as hypertension##21##3##(1996-11#2)(1996-8#1)(1996-9#1)(2005-10#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-2#1)
such as hypocotyl##2##3##(2008-12#1)(2009-8#1)
such as hypothyroidism##2##3##(2006-6#1)(2008-1#1)
such as hypoxia##2##3##(2006-10#1)(2012-2#1)
such as iNOS##2##3##(1994-3#1)(2013-1#1)
such as illumination##2##3##(1997-8#1)(2008-2#1)
such as image##3##3##(2008-2#1)(2008-6#2)
such as imatinib##3##3##(2010-12#1)(2011-1#1)(2012-12#1)
such as impact##2##3##(1997-3#1)(2008-3#1)
such as improved##5##3##(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
such as in the case of##3##6##(1992-8#1)(2008-10#1)(2009-4#1)
such as in the##13##4##(1990-12#1)(1991-9#1)(1992-8#1)(2006-6#1)(2007-9#1)(2008-10#2)(2008-6#1)(2008-7#2)(2009-4#1)(2011-2#1)(2012-2#1)
such as in vitro##3##4##(1995-3#1)(2009-4#1)(2012-12#1)
such as in##39##3##(1990-12#1)(1991-9#1)(1992-8#1)(1994-8#1)(1995-3#1)(1997-4#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#3)(2009-2#1)(2009-4#2)(2010-12#2)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
such as increase in##2##4##(2006-6#1)(2011-1#1)
such as increased##11##3##(1994-6#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-8#1)(2012-12#1)(2013-8#1)
such as increases in##2##4##(2005-8#1)(2008-4#1)
such as increasing##2##3##(1993-7#1)(1994-9#1)
such as individual##3##3##(2006-8#1)(2009-9#1)(2011-2#1)
such as induction of##2##4##(2010-5#2)
such as infection and##3##4##(2008-10#1)(2009-3#1)(2012-2#1)
such as infection##7##3##(1994-11#1)(2007-9#1)(2008-10#1)(2008-6#1)(2009-3#1)(2012-12#1)(2012-2#1)
such as infections##2##3##(1990-12#1)(2007-11#1)
such as infectious##2##3##(1992-2#1)(2013-1#1)
such as inflammation##4##3##(1992-11#1)(1994-5#1)(2009-11#1)(2011-2#1)
such as inflammatory bowel disease##3##5##(2006-10#1)(2007-11#1)(2012-12#1)
such as influenza##2##3##(2008-8#1)(2013-8#1)
such as information##3##3##(1997-1#1)(2013-1#2)
such as injection##2##3##(2008-10#2)
such as insect##2##3##(2008-9#1)(2009-6#1)
such as insects##2##3##(2009-8#1)(2010-3#1)
such as insufficient##4##3##(1997-6#1)(2010-11#1)(2010-7#2)
such as insulin and##3##4##(1990-8#1)(1997-4#1)(2008-4#1)
such as insulin resistance##4##4##(2007-9#1)(2010-10#1)(2012-11#1)(2013-8#1)
such as insulin##13##3##(1990-8#1)(1991-9#1)(1994-11#1)(1997-4#1)(2007-9#1)(2008-4#1)(2008-8#1)(2010-1#1)(2010-10#1)(2012-11#3)(2013-8#1)
such as intensity##2##3##(1997-1#1)(2008-3#1)
such as interleukin##2##3##(1995-8#1)(2007-11#1)
such as interleukin-1##3##3##(1993-12#1)(1995-11#1)(2007-11#1)
such as interleukin-6##4##3##(2007-9#1)(2008-1#1)(2008-4#2)
such as internal##4##3##(1994-12#1)(1997-2#1)(2010-5#1)(2011-2#1)
such as intestinal##4##3##(2006-10#2)(2008-6#1)(2009-8#1)
such as intracellular##2##3##(2008-1#1)(2008-4#1)
such as ion##4##3##(2004-12#1)(2007-7#1)(2007-9#1)(2008-9#1)
such as ionizing radiation##2##4##(1993-8#1)(2007-10#1)
such as ionizing##3##3##(1993-8#1)(2007-10#1)(2008-8#1)
such as iron and##2##4##(1995-3#1)(2008-10#1)
such as iron deficiency##2##4##(2009-2#1)(2011-2#1)
such as iron##6##3##(1995-3#1)(2007-10#1)(2008-10#2)(2009-2#1)(2011-2#1)
such as irritable bowel syndrome##2##5##(2006-2#1)(2012-12#1)
such as ischemic heart disease##2##5##(1992-9#1)(2008-1#1)
such as ischemic##3##3##(1992-9#1)(2008-1#1)(2008-7#1)
such as itching or##2##4##(2008-5#1)(2010-5#1)
such as its##10##3##(1992-12#1)(2006-2#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2012-1#1)
such as joint##2##3##(2007-7#1)(2012-2#1)
such as keeping##2##3##(2006-10#1)(2007-8#1)
such as keyhole limpet hemocyanin##2##5##(1994-12#1)(2008-4#1)
such as kin##2##3##(2010-4#1)(2013-1#1)
such as lack of##4##4##(1996-4#1)(2006-3#1)(2008-11#1)(2010-3#1)
such as lambda##2##3##(1990-9#1)(1997-1#1)
such as laminin##2##3##(1993-9#1)(1994-8#1)
such as lamotrigine##2##3##(2005-6#1)(2008-8#1)
such as laparoscopic surgery##2##4##(2006-2#1)(2006-6#1)
such as laparoscopic##3##3##(2006-2#1)(2006-6#1)(2009-2#1)
such as large##3##3##(1997-6#1)(2008-1#1)(2010-2#1)
such as laser##4##3##(2006-12#1)(2007-12#1)(2008-3#1)(2008-7#1)
such as lasers##2##3##(2008-2#1)(2008-5#1)
such as lead##3##3##(1995-3#1)(2008-10#1)(2010-9#1)
such as learning##3##3##(1995-1#1)(2008-10#1)(2013-1#1)
such as length##3##3##(1995-12#1)(1995-6#1)(2010-9#1)
such as lesion##3##3##(2008-2#1)(2013-1#2)
such as leucine##2##3##(2006-12#1)(2008-5#1)
such as leukocytes##2##3##(1991-5#1)(1995-7#1)
such as leukotriene modifiers##2##4##(2010-1#2)
such as leukotriene##3##3##(2010-1#2)(2012-12#1)
such as leukotrienes##2##3##(1992-2#1)(2010-1#1)
such as life expectancy##2##4##(2007-11#1)(2012-1#1)
such as ligand binding##2##4##(2006-10#1)(2008-4#1)
such as ligand##3##3##(2006-10#1)(2008-4#1)(2008-5#1)
such as light##2##3##(2007-12#1)(2010-12#1)
such as limited##2##3##(2007-9#1)(2008-7#1)
such as linear discriminant analysis##2##5##(2008-10#2)
such as linear##4##3##(1995-12#1)(2008-10#2)(2008-3#1)
such as linearity##2##3##(2008-10#1)(2009-8#1)
such as linkage analysis##2##4##(2007-7#1)(2010-2#1)
such as lipid##3##3##(1990-5#1)(2006-2#1)(2010-7#1)
such as liquid-liquid extraction##2##4##(2008-10#2)
such as lithium##3##3##(1993-2#1)(2004-3#1)(2005-6#1)
such as liver cirrhosis##2##4##(2006-2#2)
such as liver##5##3##(1990-11#1)(1993-5#1)(2006-2#2)(2008-4#1)
such as local##5##3##(1992-1#1)(1996-4#1)(2007-2#1)(2008-7#1)(2009-9#1)
such as long##4##3##(2008-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
such as long-term##2##3##(1995-2#1)(2012-3#1)
such as loss##2##3##(2008-11#2)
such as low reagent##2##4##(2008-10#1)(2011-2#1)
such as low##9##3##(2007-12#1)(2008-10#2)(2008-2#1)(2009-6#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
such as lower##2##3##(2008-10#1)(2010-9#1)
such as lung##5##3##(2005-11#1)(2005-6#1)(2008-6#1)(2010-8#1)(2010-9#1)
such as lupus erythematosus##2##4##(1992-5#1)(2011-2#1)
such as lupus##4##3##(1992-5#1)(2006-10#1)(2007-5#1)(2011-2#1)
such as lymphocytes##3##3##(1990-12#1)(2008-1#1)(2008-4#1)
such as macrophages and##2##4##(2008-4#2)
such as macrophages##6##3##(1994-3#1)(1995-5#1)(2008-10#1)(2008-4#3)
such as magnesium##2##3##(1995-3#1)(2006-10#1)
such as magnetic field##2##4##(2008-1#1)(2008-2#1)
such as magnetic resonance imaging (MRI)##2##6##(2009-11#1)(2009-5#1)
such as magnetic resonance imaging##4##5##(2008-8#1)(2009-11#1)(2009-4#1)(2009-5#1)
such as magnetic resonance##5##4##(2007-3#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-5#1)
such as magnetic##9##3##(2007-3#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-5#1)(2013-1#1)
such as major##4##3##(2008-7#1)(2010-8#1)(2010-9#1)(2012-1#1)
such as malaria##5##3##(2006-10#1)(2007-2#1)(2008-11#1)(2010-8#1)(2012-12#1)
such as malignancy##2##3##(2005-11#1)(2008-1#1)
such as malignant##2##3##(1994-8#1)(2012-12#1)
such as mammography##2##3##(2010-8#1)(2011-1#1)
such as maps##2##3##(2008-2#1)(2008-6#1)
such as mass##3##3##(2006-7#1)(2008-10#1)(2011-2#1)
such as massive##2##3##(2008-2#1)(2011-1#1)
such as maternal##3##3##(1996-12#1)(2010-6#1)(2011-2#1)
such as measurement##2##3##(1995-2#1)(2005-8#1)
such as meat and##3##4##(2006-4#1)(2008-10#2)
such as mechanical##5##3##(1994-3#1)(2006-10#1)(2006-2#1)(2008-5#1)(2009-12#1)
such as medical decision making##2##5##(2013-1#2)
such as medical##5##3##(2008-11#1)(2008-3#1)(2013-1#3)
such as melanoma##4##3##(1996-10#1)(2008-11#1)(2008-5#2)
such as membrane##3##3##(1995-8#1)(2008-10#1)(2011-12#1)
such as metabolic##4##3##(2009-3#1)(2010-1#1)(2011-2#1)(2012-2#1)
such as metal##4##3##(1996-8#1)(2008-10#2)(2010-7#1)
such as metalaxyl##2##3##(2008-10#2)
such as methadone##2##3##(2008-6#1)(2008-8#1)
such as methanol content##3##4##(2008-10#3)
such as methanol##6##3##(1994-9#1)(2005-11#1)(2007-8#1)(2008-10#3)
such as methicillin-resistant Staphylococcus aureus (MRSA)##2##6##(2005-7#1)(2008-3#1)
such as methicillin-resistant Staphylococcus aureus##3##5##(2005-7#1)(2008-12#1)(2008-3#1)
such as methotrexate (MTX)##2##4##(2008-8#1)(2009-2#1)
such as methotrexate##4##3##(2006-10#1)(2008-8#1)(2009-2#1)(2011-2#1)
such as methyl##4##3##(1992-12#1)(2007-11#1)(2008-10#1)(2008-3#1)
such as microarrays##4##3##(2008-10#1)(2008-7#1)(2010-9#1)(2011-1#1)
such as mild##2##3##(2008-10#1)(2008-3#1)
such as mitochondria##4##3##(2008-11#1)(2008-7#1)(2009-8#2)
such as molecular##6##3##(1997-3#1)(2005-11#1)(2007-9#1)(2008-3#1)(2010-4#1)(2010-7#1)
such as monitoring##3##3##(2007-9#1)(2008-3#1)(2008-7#1)
such as monoclonal antibodies##4##4##(2007-11#1)(2007-8#1)(2010-1#1)(2012-12#1)
such as mood##2##3##(2008-1#1)(2010-8#1)
such as morphine##3##3##(1994-10#1)(2008-11#1)(2008-7#1)
such as morphogenesis##2##3##(2007-7#1)(2009-8#1)
such as mortality and##2##4##(1995-8#1)(2010-9#1)
such as mortality##4##3##(1995-8#1)(2010-9#2)(2012-12#1)
such as motion##2##3##(2007-2#1)(2010-8#1)
such as mouse##2##3##(1995-3#1)(2008-11#1)
such as multiple endocrine neoplasia type##2##6##(2006-9#1)(2013-1#1)
such as multiple sclerosis##6##4##(2007-11#2)(2008-12#1)(2011-2#2)(2012-3#1)
such as multiple##14##3##(2006-10#1)(2006-9#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
such as muscle##6##3##(1992-9#1)(2005-12#1)(2009-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
such as myocardial infarction (MI)##2##5##(2005-7#1)(2013-8#1)
such as myocardial infarction##4##4##(1997-5#1)(1997-6#1)(2005-7#1)(2013-8#1)
such as myocardial##5##3##(1997-5#1)(1997-6#1)(2005-7#1)(2007-1#1)(2013-8#1)
such as naltrexone##2##3##(2008-2#1)(2009-7#1)
such as nanowires##2##3##(2009-11#1)(2012-1#1)
such as natural##3##3##(2008-10#2)(2010-2#1)
such as nausea##2##3##(1995-5#1)(1997-8#1)
such as neural##2##3##(1990-11#1)(2011-2#1)
such as neurological##2##3##(2005-7#1)(2010-12#1)
such as neurons##4##3##(2007-1#1)(2008-11#2)(2008-8#1)
such as nickel##2##3##(2008-10#1)(2008-3#1)
such as nitrate##3##3##(2005-11#1)(2008-10#2)
such as nitric oxide##4##4##(1994-8#1)(2007-11#1)(2008-3#1)(2011-2#1)
such as nitrogen##2##3##(1996-9#1)(2008-10#1)
such as nosocomial##2##3##(1991-2#1)(1996-9#1)
such as nuclear##4##3##(2005-7#1)(2008-4#1)(2013-1#1)(2013-8#1)
such as nucleic acids##2##4##(1996-9#1)(2010-5#1)
such as nucleic##3##3##(1996-9#1)(2007-12#1)(2010-5#1)
such as number of##3##4##(1993-12#1)(2008-9#1)(2012-9#1)
such as nursing##2##3##(1991-3#1)(2008-3#1)
such as nutrient##2##3##(2006-10#1)(2008-10#1)
such as nutrients and##2##4##(2008-10#1)(2009-8#1)
such as nutrition##2##3##(1992-12#1)(2012-2#1)
such as obesity and diabetes##2##5##(2007-5#1)(2010-7#1)
such as obesity and##6##4##(1992-8#1)(1997-1#1)(2007-5#1)(2008-1#1)(2010-7#1)(2011-2#1)
such as obesity##9##3##(1992-8#1)(1997-1#1)(2007-5#1)(2008-1#2)(2008-10#1)(2010-7#1)(2011-2#2)
such as object##3##3##(1994-8#1)(2008-2#1)(2012-1#1)
such as on##2##3##(2008-2#1)(2011-2#1)
such as oncology##2##3##(2006-12#1)(2007-7#1)
such as ondansetron##2##3##(2006-10#1)(2008-7#1)
such as one##3##3##(2007-11#1)(2010-2#1)(2012-11#1)
such as ones##2##3##(1996-2#1)(2010-4#1)
such as optical coherence##2##4##(2008-1#2)
such as optical##14##3##(1996-12#1)(2006-7#1)(2007-9#1)(2008-1#2)(2008-2#2)(2008-3#4)(2009-12#1)(2010-5#1)(2012-2#1)
such as oral##3##3##(2008-7#2)(2011-1#1)
such as organ##3##3##(2006-10#1)(2012-12#1)(2013-1#1)
such as organic matter##2##4##(2008-10#1)(2010-5#1)
such as organic##7##3##(2008-10#3)(2008-12#1)(2008-4#1)(2010-5#1)(2012-12#1)
such as osteoblasts and##2##4##(2008-11#2)
such as osteoporosis and hypercalcemia##2##5##(2005-3#1)(2008-5#1)
such as osteoporosis and##3##4##(1996-8#1)(2005-3#1)(2008-5#1)
such as osteoporosis##6##3##(1996-8#1)(2005-3#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-5#1)
such as oxygen##2##3##(2008-10#1)(2010-4#1)
such as oxytocin##2##3##(2008-4#2)
such as p53##4##3##(1994-12#1)(2004-1#1)(2006-10#1)(2012-2#1)
such as pH and the##2##5##(2008-10#2)
such as pH and##5##4##(2008-10#4)(2011-1#1)
such as pH of##3##4##(2008-10#3)
such as pH value##2##4##(2008-10#2)
such as pH##43##3##(1995-11#1)(1996-5#1)(2006-12#2)(2007-10#2)(2007-8#1)(2008-1#1)(2008-10#29)(2008-5#1)(2008-6#1)(2009-3#1)(2009-6#2)(2011-1#1)
such as pain##8##3##(2006-10#2)(2007-1#1)(2007-11#2)(2007-7#1)(2010-3#1)(2010-7#1)
such as parasites and##2##4##(2005-11#1)(2008-9#1)
such as parathyroid##2##3##(2008-11#1)(2008-3#1)
such as parental##3##3##(2006-10#1)(2009-12#1)(2010-9#1)
such as partial##2##3##(2008-10#2)
such as particle##2##3##(2008-5#1)(2012-2#1)
such as patient condition reporting##2##5##(2013-1#2)
such as patient details##2##4##(2013-1#2)
such as patient##9##3##(2010-2#1)(2010-8#1)(2013-1#6)(2013-8#1)
such as patients with##2##4##(2010-8#1)(2011-2#1)
such as peak##2##3##(2006-10#1)(2008-2#1)
such as peptides and##2##4##(2008-10#1)(2010-12#1)
such as peptides##3##3##(1995-7#1)(2008-10#1)(2010-12#1)
such as perceptions of##2##4##(2009-7#1)(2010-4#1)
such as percutaneous transluminal##2##4##(1995-2#1)(1997-1#1)
such as percutaneous##3##3##(1995-2#1)(1997-1#1)(2010-8#1)
such as peripheral##2##3##(2010-12#1)(2012-12#1)
such as pesticides##2##3##(2007-9#1)(2008-10#1)
such as petroleum##2##3##(2004-4#2)
such as pharmaceutical##2##3##(1996-5#1)(2010-7#1)
such as phencyclidine##2##3##(1991-9#1)(2008-1#1)
such as phosphatidylcholine and phosphatidylethanolamine##2##5##(1990-2#1)(2005-8#1)
such as phosphoinositide##2##3##(1990-10#1)(1991-12#1)
such as phosphorylation##3##3##(2007-11#1)(2008-5#1)(2009-5#1)
such as photosensitivity##2##3##(2006-12#1)(2012-11#1)
such as photosynthesis##2##3##(2008-8#1)(2010-2#1)
such as physical##5##3##(1994-8#1)(2005-11#1)(2008-11#1)(2010-11#1)(2011-2#1)
such as physician##2##3##(1996-1#1)(1997-3#1)
such as pituitary adenomas##2##4##(1994-5#1)(2006-12#1)
such as planning and##2##4##(2008-9#1)(2012-1#1)
such as plant##2##3##(2008-10#1)(2008-12#1)
such as plasma##2##3##(2007-10#1)(2012-12#1)
such as plasmids##2##3##(2006-8#1)(2008-1#1)
such as platelet-derived growth factor##2##5##(1995-11#1)(1995-6#1)
such as platelet-derived growth##3##4##(1995-11#2)(1995-6#1)
such as platinum##2##3##(2005-4#1)(2011-1#1)
such as pneumonia##2##3##(1991-4#1)(2007-7#1)
such as pneumothorax##3##3##(1992-2#1)(2007-7#1)(2013-1#1)
such as polarization##2##3##(2007-12#1)(2008-2#1)
such as polychlorinated##2##3##(2008-10#1)(2008-7#1)
such as polycyclic aromatic##2##4##(2004-4#1)(2008-10#1)
such as polyethylene glycol##2##4##(2008-7#1)(2010-12#1)
such as polymerase chain reaction (PCR)##2##6##(2006-10#1)(2008-10#1)
such as polypyrrole##2##3##(2008-10#1)(2008-4#1)
such as poor##3##3##(2006-5#1)(2008-11#1)(2012-3#1)
such as population##4##3##(2008-11#1)(2008-5#2)(2008-8#1)
such as pore##4##3##(2005-11#1)(2008-7#1)(2009-7#1)(2010-10#1)
such as pork##2##3##(2007-12#1)(2008-10#1)
such as positron emission tomography##2##5##(2008-2#1)(2008-8#1)
such as postoperative pain##2##4##(2006-10#1)(2007-8#1)
such as potassium##5##3##(2005-11#1)(2006-4#1)(2008-10#3)
such as potato##2##3##(2008-10#1)(2008-5#1)
such as predation##2##3##(2008-9#1)(2012-3#1)
such as preeclampsia##2##3##(2008-10#1)(2013-1#1)
such as prematurity##2##3##(2011-1#1)(2011-12#1)
such as presence of##4##4##(2009-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
such as prevention of##5##4##(1996-11#1)(2006-8#1)(2007-11#1)(2013-7#1)(2013-8#1)
such as price##2##3##(1996-3#1)(2008-12#1)
such as primary biliary cirrhosis##2##5##(1992-12#1)(2012-2#1)
such as primary##6##3##(1992-12#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-8#1)
such as principal component analysis##2##5##(2008-10#1)(2013-1#1)
such as principal##3##3##(2008-10#2)(2013-1#1)
such as problems##3##3##(1994-8#1)(2008-2#2)
such as proper##2##3##(2006-10#1)(2008-11#1)
such as propylene glycol##2##4##(1991-5#1)(2008-5#1)
such as prostaglandin##2##3##(1993-7#1)(2013-8#1)
such as prostate cancer##2##4##(2005-3#1)(2009-5#1)
such as protecting##2##3##(1994-9#1)(2008-7#1)
such as protein kinase##2##4##(1997-6#1)(2008-5#1)
such as protein##9##3##(1994-9#1)(1997-6#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-2#1)
such as proteins and##4##4##(2007-11#1)(2007-2#1)(2008-7#1)(2009-8#1)
such as proteins##11##3##(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2009-8#1)(2012-3#1)
such as providing##3##3##(2011-1#1)(2012-12#1)(2012-3#1)
such as psoriasis##3##3##(2006-12#1)(2011-2#1)(2013-1#1)
such as public health##3##4##(1996-1#1)(2013-1#2)
such as public##6##3##(1991-12#1)(1996-1#1)(1996-3#1)(2007-7#1)(2013-1#2)
such as pulmonary##5##3##(2006-10#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
such as pulse##2##3##(2007-12#2)
such as purpose##2##3##(2013-1#2)
such as pyridine##2##3##(2009-9#1)(2012-12#1)
such as quality of##2##4##(2005-10#1)(2008-3#1)
such as quality##4##3##(1992-2#1)(1995-1#1)(2005-10#1)(2008-3#1)
such as quercetin##3##3##(2006-12#1)(2008-10#1)(2008-4#1)
such as radial##2##3##(2006-3#1)(2008-7#1)
such as radiation##2##3##(2007-11#1)(2008-7#1)
such as radiotherapy##2##3##(2007-11#1)(2010-8#1)
such as ranging##2##3##(2008-3#2)
such as ras##2##3##(2004-1#1)(2005-11#1)
such as rates of##2##4##(2007-12#1)(2009-8#1)
such as rats##2##3##(2009-10#2)
such as reactive##3##3##(2006-10#1)(2008-5#1)(2008-7#1)
such as reagent##2##3##(2008-10#2)
such as real-time##2##3##(2008-7#1)(2010-6#1)
such as recent##2##3##(2008-5#1)(2011-1#1)
such as receptor##3##3##(1992-6#1)(2008-7#1)(2009-9#1)
such as recurrent##5##3##(2007-10#1)(2007-5#1)(2008-8#2)(2011-3#1)
such as reduced##6##3##(2006-10#1)(2006-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2013-1#1)
such as reduction of##3##4##(1991-12#1)(2007-11#1)(2008-11#1)
such as refractive##2##3##(2008-2#2)
such as refractory##2##3##(2005-8#1)(2008-10#1)
such as regression##2##3##(1995-12#1)(2008-2#1)
such as relative##3##3##(1990-3#1)(2008-10#1)(2012-2#1)
such as religion##3##3##(2009-6#2)(2009-7#1)
such as renal insufficiency##2##4##(1993-9#1)(2008-7#1)
such as renal##6##3##(1992-8#1)(1993-9#1)(2006-2#1)(2007-7#1)(2008-7#1)(2009-8#1)
such as representing information extracted from clinical text##2##8##(2013-1#2)
such as reproducibility##3##3##(2008-10#3)
such as resolution##2##3##(2007-11#1)(2011-2#1)
such as respiratory##4##3##(1997-8#1)(2006-10#1)(2008-7#1)(2012-2#1)
such as restriction##2##3##(2008-10#1)(2008-2#1)
such as retinitis##2##3##(2009-12#1)(2009-2#1)
such as rhesus macaques##2##4##(2008-4#1)(2012-3#1)
such as rheumatoid arthritis (RA)##3##5##(2007-11#1)(2008-5#1)(2013-1#1)
such as rheumatoid arthritis##8##4##(1990-4#1)(1993-11#1)(2007-11#1)(2008-5#2)(2010-5#1)(2013-1#2)
such as rhodamine##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
such as rigidity and##2##4##(2008-12#1)(2008-7#1)
such as rituximab##2##3##(2005-10#1)(2010-12#1)
such as rodents##2##3##(2008-4#1)(2008-5#1)
such as salts and##3##4##(1995-7#1)(2008-11#1)(2011-2#1)
such as sample and reagents volumes##2##6##(2007-8#1)(2008-10#1)
such as sample volume##2##4##(2008-10#2)
such as sample##9##3##(2007-8#1)(2008-10#7)(2008-2#1)
such as scanning electron microscopy (SEM) and##2##7##(2008-10#1)(2009-7#1)
such as scanning##4##3##(2008-10#3)(2009-7#1)
such as schizophrenia and##2##4##(2009-6#1)(2012-11#1)
such as schizophrenia##9##3##(1991-2#1)(2007-8#1)(2008-11#1)(2008-5#1)(2009-6#1)(2012-1#1)(2012-11#1)(2012-2#2)
such as screening##2##3##(1994-2#1)(2007-8#1)
such as seasonal##2##3##(1995-12#1)(2012-3#1)
such as seawater##2##3##(2008-10#2)
such as secondary##2##3##(2007-1#1)(2008-9#1)
such as segmentation##2##3##(2008-6#1)(2012-12#1)
such as selection of##3##4##(2007-8#1)(2008-10#1)(2008-7#1)
such as selection##4##3##(1992-12#1)(2007-8#1)(2008-10#1)(2008-7#1)
such as selective##4##3##(1990-3#1)(1990-4#1)(1990-9#1)(2008-10#1)
such as selenium and##2##4##(1996-7#1)(2012-12#1)
such as selenium##3##3##(1996-7#2)(2012-12#1)
such as sensitivity##6##3##(2007-9#2)(2008-10#2)(2012-12#1)(2013-1#1)
such as sepsis##3##3##(1995-5#1)(2005-8#1)(2008-5#1)
such as serotonin##3##3##(2008-11#1)(2011-12#1)(2012-2#1)
such as serum cholesterol and##2##5##(1990-12#1)(2006-2#1)
such as serum##12##3##(1990-12#1)(1990-8#1)(1996-2#1)(2005-3#1)(2006-2#2)(2007-11#1)(2008-11#1)(2008-12#1)(2008-4#1)(2010-12#1)(2012-12#1)
such as service##2##3##(1993-3#1)(2008-12#1)
such as severe solar burns during childhood or adolescence##2##9##(2007-11#2)
such as severe##6##3##(2006-6#1)(2007-11#2)(2007-12#1)(2007-2#1)(2009-6#1)
such as sex##4##3##(1993-11#1)(2008-7#1)(2010-3#1)(2013-7#1)
such as sexually transmitted infections##2##5##(2009-5#1)(2011-2#1)
such as shape##3##3##(1992-2#1)(2008-2#1)(2008-3#1)
such as short##2##3##(1993-12#1)(2007-6#1)
such as shorter##2##3##(1993-2#1)(2008-8#1)
such as sickle cell##2##4##(1995-5#1)(2005-11#1)
such as side##2##3##(2007-1#1)(2011-3#1)
such as signal##2##3##(2008-3#1)(2010-9#1)
such as simplicity##2##3##(2007-11#1)(2008-10#1)
such as size##2##3##(1995-12#1)(2008-7#1)
such as skin##10##3##(2006-11#1)(2008-3#2)(2008-5#6)(2010-8#1)
such as sleep##6##3##(2006-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-7#1)(2009-8#1)
such as small##2##3##(2008-11#1)(2008-6#1)
such as smoking and##3##4##(1996-3#1)(2008-3#1)(2010-7#1)
such as smoking##6##3##(1996-3#1)(1996-7#1)(2006-2#1)(2007-2#1)(2008-3#1)(2010-7#1)
such as social##6##3##(1994-6#1)(2006-12#1)(2008-11#1)(2008-8#1)(2012-2#1)(2012-3#1)
such as sodium (Na(+))##2##4##(2008-10#1)(2010-7#1)
such as sodium##10##3##(2004-9#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-4#1)(2010-7#1)(2012-2#1)
such as soil##2##3##(2004-4#1)(2011-2#1)
such as solar##3##3##(2008-2#2)(2008-5#1)
such as solubility and##2##4##(1996-7#1)(2013-1#1)
such as solubility##3##3##(1992-8#1)(1996-7#1)(2013-1#1)
such as solution pH##2##4##(2008-10#2)
such as solution##3##3##(1991-11#1)(2008-10#2)
such as some##3##3##(2006-6#1)(2008-3#1)(2013-7#1)
such as sonication time##5##4##(2008-10#5)
such as sonication##6##3##(2008-10#5)(2008-11#1)
such as spatial##2##3##(1995-8#1)(2008-10#1)
such as special##2##3##(1993-5#1)(2010-12#1)
such as specific##4##3##(1994-9#1)(2006-2#1)(2008-11#1)(2008-4#1)
such as speed##2##3##(2008-10#1)(2008-11#1)
such as squirrel monkeys##2##4##(2008-4#1)(2012-3#1)
such as stabilization of##2##4##(1996-2#1)(2008-10#1)
such as starch##2##3##(1990-12#1)(2008-10#1)
such as stenosis##2##3##(2006-10#1)(2008-3#1)
such as sterols##2##3##(2008-5#1)(2008-6#1)
such as strain##2##3##(2008-2#1)(2013-1#1)
such as stress##6##3##(1993-12#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-8#1)(2009-7#1)
such as stroke##7##3##(1992-8#1)(1996-2#1)(2005-9#1)(2009-2#1)(2010-11#1)(2012-1#1)(2012-11#1)
such as subcutaneous##2##3##(1992-5#1)(1997-8#1)
such as sucrose##2##3##(2008-11#1)(2012-2#1)
such as sulfate##2##3##(1990-5#1)(2012-2#1)
such as sulphate##2##3##(2008-10#1)(2008-5#1)
such as superoxide dismutase (SOD)##2##5##(1991-9#1)(2008-7#1)
such as superoxide dismutase##4##4##(1991-9#1)(1992-9#1)(2008-10#1)(2008-7#1)
such as superoxide##7##3##(1991-2#1)(1991-9#1)(1992-12#1)(1992-9#1)(2008-10#1)(2008-5#1)(2008-7#1)
such as surface##3##3##(2006-10#1)(2006-12#1)(2012-1#1)
such as surgery##3##3##(2006-10#1)(2007-10#1)(2013-8#1)
such as surgical resection and liver transplantation##4##7##(2013-8#4)
such as surgical##8##3##(1996-9#1)(2007-11#2)(2008-7#1)(2013-8#4)
such as survival##2##3##(2007-7#1)(2009-9#1)
such as sustained##3##3##(2006-10#1)(2007-11#1)(2010-12#1)
such as synaptic##3##3##(2008-2#1)(2008-3#1)(2008-4#1)
such as systemic lupus erythematosus (SLE)##2##6##(2012-12#1)(2012-2#1)
such as systemic lupus erythematosus##3##5##(2012-12#1)(2012-2#1)(2013-1#1)
such as systemic lupus##4##4##(2005-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
such as systemic##6##3##(2005-11#1)(2008-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
such as tacrolimus##3##3##(2004-12#1)(2006-10#1)(2007-11#1)
such as tannins##2##3##(2008-12#1)(2013-8#1)
such as temperature##12##3##(2008-1#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2009-5#1)(2013-8#2)
such as temporal##3##3##(1990-9#1)(1997-2#1)(2010-3#1)
such as testicular##2##3##(2006-10#1)(2008-7#1)
such as that found in##2##5##(2008-10#1)(2011-2#1)
such as that in##2##4##(1990-7#1)(2008-1#1)
such as that of the##2##5##(2008-4#1)(2012-2#1)
such as that of##4##4##(1996-4#1)(2008-4#1)(2008-7#1)(2012-2#1)
such as that provided by##2##5##(2005-7#1)(2012-3#1)
such as that##19##3##(1990-6#1)(1990-7#1)(1990-8#1)(1993-4#1)(1995-11#1)(1996-12#1)(1996-4#1)(2005-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)
such as the American##2##4##(2006-12#1)(2010-1#1)
such as the European##2##4##(1995-6#1)(2008-10#1)
such as the International##3##4##(2008-10#1)(2010-11#1)(2013-7#1)
such as the Morris water maze##2##6##(1993-11#2)
such as the National Ignition Facility##2##6##(2008-2#1)(2008-3#1)
such as the National##3##4##(2006-5#1)(2008-2#1)(2008-3#1)
such as the Sun##2##4##(2008-2#2)
such as the U##2##4##(2008-2#1)(2012-2#1)
such as the United States##2##5##(2006-5#1)(2008-5#1)
such as the Wolf method##2##5##(2013-1#2)
such as the ability##2##4##(2005-7#1)(2008-8#1)
such as the absorption##2##4##(2007-12#1)(2008-3#1)
such as the amplitude##2##4##(1991-12#1)(2008-2#1)
such as the anterior cingulate cortex##2##6##(1994-6#1)(2009-10#1)
such as the anterior##3##4##(1994-6#1)(1995-5#1)(2009-10#1)
such as the availability of##3##5##(2007-7#1)(2008-1#1)(2008-7#1)
such as the binding##2##4##(2009-10#1)(2010-4#1)
such as the brain##2##4##(2007-4#1)(2009-3#1)
such as the cell##3##4##(1993-5#1)(1995-3#1)(2008-11#1)
such as the chemical##3##4##(2008-10#1)(2008-3#1)(2008-8#1)
such as the concentration of the##2##6##(1997-8#1)(2010-4#1)
such as the concentration of##3##5##(1997-8#1)(2008-10#1)(2010-4#1)
such as the concentration##4##4##(1997-8#1)(2008-10#2)(2010-4#1)
such as the decision##2##4##(2008-10#1)(2012-3#1)
such as the detection of##5##5##(1997-6#1)(2007-11#1)(2008-10#1)(2008-2#2)
such as the development of##3##5##(2006-10#1)(2007-9#1)(2012-12#1)
such as the dorsal##2##4##(1993-12#2)
such as the dual##2##4##(2007-9#1)(2008-2#1)
such as the elderly##2##4##(2007-1#1)(2013-1#1)
such as the emergence of##2##5##(2006-10#1)(2006-5#1)
such as the enhancement of##2##5##(1995-3#1)(2008-7#1)
such as the existence of##2##5##(2007-12#1)(2008-7#1)
such as the flow##2##4##(2008-10#1)(2008-7#1)
such as the formation of##3##5##(1992-12#1)(2007-12#1)(2012-2#1)
such as the green##2##4##(2008-1#1)(2012-2#1)
such as the heart##2##4##(2008-6#1)(2012-1#1)
such as the hippocampus##2##4##(1997-7#1)(2009-6#1)
such as the human##3##4##(1991-3#1)(1997-6#1)(2005-7#1)
such as the imaging of##2##5##(2008-2#1)(2013-1#1)
such as the impact of##2##5##(2006-4#1)(2012-9#1)
such as the lung##2##4##(2009-5#1)(2012-3#1)
such as the need##2##4##(2008-2#1)(2011-1#1)
such as the number of##3##5##(1992-10#1)(2008-10#1)(2009-3#1)
such as the number##5##4##(1992-10#1)(2008-10#1)(2009-3#1)(2013-1#2)
such as the one##3##4##(1994-6#1)(2008-2#2)
such as the optimization of##2##5##(2008-2#1)(2012-1#1)
such as the orbitofrontal cortex and amygdala that##2##8##(2009-10#2)
such as the pH value##2##5##(2008-10#2)
such as the pH##5##4##(2008-10#4)(2012-12#1)
such as the paraventricular##2##4##(1990-2#1)(1994-10#1)
such as the potential##3##4##(1997-2#1)(2009-12#1)(2013-7#1)
such as the presence of a##2##6##(2006-10#1)(2010-5#1)
such as the presence of##7##5##(1996-3#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-5#1)
such as the presence##8##4##(1996-3#1)(2006-10#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-5#1)
such as the proportion of##2##5##(2008-3#1)(2012-12#1)
such as the role of##3##5##(2006-10#1)(2008-1#1)(2008-4#1)
such as the school##2##4##(1994-4#1)(2008-10#1)
such as the selection of##2##5##(2008-10#1)(2009-8#1)
such as the skin##2##4##(1994-3#1)(2008-10#1)
such as the skull lesions and bone dysplasia which are usually examined using the &quot##2##15##(2013-1#2)
such as the skull##3##4##(2009-3#1)(2013-1#2)
such as the smoking status detection module in the clinical Text Analysis and Knowledge Extraction System (cTAKES)##2##17##(2013-1#2)
such as the spatial##2##4##(2009-5#1)(2010-10#1)
such as the speed##2##4##(2009-9#1)(2012-2#1)
such as the study##2##4##(1991-12#1)(2012-12#1)
such as the surface##2##4##(2008-2#1)(2009-9#1)
such as the thickness##2##4##(1994-11#1)(2008-3#1)
such as the transcription factor##2##5##(2010-11#1)(2012-12#1)
such as the treatment of##3##5##(2005-7#1)(2006-12#1)(2008-5#1)
such as the treatment##4##4##(1996-7#1)(2005-7#1)(2006-12#1)(2008-5#1)
such as the type of##2##5##(2007-12#1)(2008-7#1)
such as the use of##10##5##(1993-6#1)(2007-2#1)(2008-10#5)(2010-4#1)(2011-1#1)(2012-3#1)
such as the viral##2##4##(2007-11#1)(2013-8#1)
such as the##687##3##(1990-11#2)(1990-12#4)(1990-2#1)(1990-4#1)(1990-5#1)(1991-10#1)(1991-12#6)(1991-3#3)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#2)(1992-5#1)(1992-6#1)(1992-8#2)(1993-11#3)(1993-12#4)(1993-2#2)(1993-3#2)(1993-5#2)(1993-6#4)(1993-7#1)(1993-9#1)(1994-10#3)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#5)(1994-8#4)(1994-9#1)(1995-1#2)(1995-11#4)(1995-12#3)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-12#3)(1996-2#1)(1996-3#2)(1996-4#3)(1996-5#2)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#2)(1997-4#2)(1997-5#4)(1997-6#5)(1997-7#4)(1997-8#3)(2004-11#1)(2004-12#1)(2004-2#1)(2005-10#2)(2005-11#4)(2005-12#1)(2005-3#1)(2005-7#7)(2005-8#4)(2005-9#2)(2006-1#1)(2006-10#22)(2006-11#3)(2006-12#5)(2006-2#2)(2006-4#3)(2006-5#6)(2006-6#2)(2006-7#2)(2006-8#1)(2007-1#2)(2007-10#5)(2007-11#7)(2007-12#23)(2007-2#3)(2007-3#2)(2007-4#8)(2007-5#3)(2007-6#4)(2007-7#6)(2007-8#2)(2007-9#7)(2008-1#11)(2008-10#67)(2008-11#14)(2008-12#4)(2008-2#37)(2008-3#26)(2008-4#10)(2008-5#20)(2008-6#8)(2008-7#19)(2008-8#11)(2008-9#6)(2009-1#1)(2009-10#6)(2009-12#3)(2009-2#4)(2009-3#6)(2009-4#3)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#6)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#5)(2010-12#5)(2010-2#5)(2010-3#3)(2010-4#5)(2010-5#5)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#11)(2011-3#2)(2011-4#1)(2012-1#7)(2012-12#16)(2012-2#13)(2012-3#5)(2012-9#1)(2013-1#17)(2013-7#5)(2013-8#10)
such as their##8##3##(1992-5#1)(2006-12#1)(2006-5#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)
such as thermal##3##3##(2008-2#2)(2008-5#1)
such as these are common##2##5##(1994-2#1)(2010-11#1)
such as these##8##3##(1994-2#1)(1997-3#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-11#1)
such as thin##3##3##(2008-12#1)(2012-11#2)
such as this##5##3##(1992-6#1)(1992-8#1)(2008-11#1)(2008-8#1)(2012-12#1)
such as those containing##2##4##(1990-12#1)(2006-10#1)
such as those described##2##4##(1992-6#1)(2008-10#1)
such as those for##2##4##(1996-5#1)(2006-10#1)
such as those from##2##4##(2006-5#1)(2008-4#1)
such as those in the##4##5##(1991-12#1)(1992-4#1)(2010-1#1)(2012-12#1)
such as those involving##2##4##(2006-10#2)
such as those of the##2##5##(1996-8#1)(2006-2#1)
such as those of##7##4##(1996-4#1)(1996-8#1)(2005-11#1)(2006-2#1)(2008-1#1)(2008-11#1)(2013-1#1)
such as those on##3##4##(1996-11#1)(2006-12#1)(2008-3#1)
such as those used in##2##5##(2008-11#1)(2012-2#1)
such as those with##7##4##(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2012-3#1)(2013-1#1)
such as those##65##3##(1990-12#2)(1990-6#1)(1991-12#1)(1992-4#2)(1992-6#1)(1992-7#1)(1993-5#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-8#1)(2005-11#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-6#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#2)
such as thrombin##2##3##(1991-12#1)(2005-7#1)
such as thyroglobulin##2##3##(1990-11#1)(1992-8#1)
such as thyroid##2##3##(1993-4#1)(2010-6#1)
such as time##4##3##(1997-8#1)(2008-11#2)(2010-9#1)
such as tissue##4##3##(2007-12#1)(2008-1#1)(2009-12#1)(2009-8#1)
such as to##6##3##(1993-11#1)(2006-8#1)(2008-11#1)(2008-5#1)(2008-6#1)(2012-1#1)
such as tobacco##5##3##(1991-4#1)(1992-9#1)(2007-11#1)(2008-10#1)(2012-12#1)
such as tocopherols##2##3##(2008-5#2)
such as topography##3##3##(2008-8#1)(2012-11#2)
such as total##3##3##(2011-1#1)(2011-2#1)(2013-1#1)
such as toxicity##3##3##(2005-7#1)(2008-10#1)(2008-8#1)
such as toxins##2##3##(2006-10#1)(2007-11#1)
such as training##2##3##(2004-7#1)(2010-8#1)
such as transcription factors##2##4##(2008-11#1)(2011-2#1)
such as transcription##4##3##(1996-3#1)(2008-11#1)(2008-4#1)(2011-2#1)
such as transepidermal water loss##2##5##(2008-5#2)
such as transforming growth##2##4##(2006-10#2)
such as transthoracic##2##3##(1993-3#1)(2008-12#1)
such as trauma##5##3##(1991-2#1)(1993-8#1)(1996-3#1)(2009-5#1)(2010-9#1)
such as traumatic brain injury##2##5##(2004-12#1)(2007-1#1)
such as traumatic##3##3##(2004-12#1)(2006-10#1)(2007-1#1)
such as treatment of##5##4##(1991-5#1)(2004-2#2)(2011-2#2)
such as treatment##7##3##(1991-5#1)(2004-2#2)(2011-1#1)(2011-2#2)(2012-2#1)
such as tricyclic antidepressants##2##4##(2007-6#1)(2009-9#1)
such as trypsin##2##3##(1990-4#1)(1991-5#1)
such as tryptophan##2##3##(2008-4#1)(2010-6#1)
such as tuberculosis##4##3##(2008-4#1)(2009-7#1)(2010-12#1)(2012-2#1)
such as tumor necrosis factor##2##5##(2007-7#1)(2008-11#1)
such as tumor necrosis factor-alpha##2##5##(1995-3#1)(2008-5#1)
such as tumor necrosis##4##4##(1995-3#1)(2007-7#1)(2008-11#1)(2008-5#1)
such as tumor##8##3##(1991-12#1)(1995-3#1)(2007-7#1)(2008-11#2)(2008-5#1)(2010-12#1)(2010-2#1)
such as tumour necrosis factor-alpha##3##5##(2007-11#3)
such as tumour##4##3##(1996-12#1)(2007-11#3)
such as two-hybrid##2##3##(2008-4#1)(2008-7#1)
such as type 2 diabetes##5##5##(2008-4#1)(2009-11#1)(2010-8#2)(2012-12#1)
such as type of##3##4##(2005-11#1)(2007-9#1)(2008-4#1)
such as type##11##3##(1994-6#1)(2005-11#1)(2006-10#1)(2007-9#1)(2008-4#2)(2009-11#1)(2010-8#2)(2012-12#1)(2012-2#1)
such as types of##5##4##(1994-12#2)(2008-10#2)(2008-2#1)
such as ultrasound##2##3##(1993-5#1)(2012-12#1)
such as ultraviolet (UV)##2##4##(2003-11#1)(2008-5#1)
such as uncertainty and##2##4##(2008-2#1)(2013-1#1)
such as uncertainty##3##3##(2008-2#1)(2009-5#1)(2013-1#1)
such as underlying##2##3##(1991-12#1)(2007-2#1)
such as understanding##2##3##(1997-3#1)(2007-12#1)
such as undifferentiated or##2##4##(1995-6#1)(2011-2#1)
such as unwanted##2##3##(2007-12#1)(2008-1#1)
such as urine and##2##4##(1996-7#1)(2008-10#1)
such as urine##4##3##(1996-7#1)(2008-10#2)(2008-8#1)
such as use of##2##4##(1991-2#1)(2010-2#1)
such as use##3##3##(1991-2#1)(2010-2#1)(2010-8#1)
such as valsartan##2##3##(2007-1#2)
such as variceal##2##3##(2006-10#1)(2013-1#1)
such as vascular endothelial growth factor (VEGF)##4##7##(2005-7#1)(2008-1#2)(2010-7#1)
such as vascular##7##3##(2005-7#1)(2007-5#1)(2008-1#2)(2008-4#1)(2010-7#1)(2011-1#1)
such as ventricular##5##3##(1997-4#2)(2010-6#1)(2010-8#1)(2012-3#1)
such as vertical##2##3##(1997-2#1)(2011-2#1)
such as viruses and##2##4##(2008-4#1)(2010-7#1)
such as viscosity##3##3##(2008-7#1)(2009-4#1)(2011-2#1)
such as vitamin C##3##4##(1992-9#1)(2008-1#2)
such as vitamin E##3##4##(1991-9#1)(2007-2#1)(2008-1#1)
such as vitamin##6##3##(1991-9#1)(1992-9#1)(2007-2#1)(2008-1#3)
such as vitiligo##2##3##(1996-3#1)(2011-2#1)
such as vomiting##2##3##(2006-7#1)(2008-7#1)
such as walking##3##3##(2005-10#1)(2006-10#1)(2008-2#1)
such as water##5##3##(2008-10#3)(2008-3#1)(2008-5#1)
such as wave##2##3##(2008-2#1)(2008-3#1)
such as weight gain##2##4##(2008-10#1)(2011-1#1)
such as weight##6##3##(1996-9#1)(2008-10#1)(2008-4#1)(2010-12#2)(2011-1#1)
such as whole blood##2##4##(1993-11#1)(2009-11#1)
such as whole cell lysates##2##5##(2008-4#2)
such as whole##5##3##(1993-11#1)(2008-4#2)(2008-9#1)(2009-11#1)
such as with glucose and fructose##2##6##(2008-10#2)
such as with##4##3##(2007-11#1)(2008-10#2)(2012-2#1)
such as withdrawal##3##3##(1993-8#1)(2008-6#2)
such as women##3##3##(1996-5#1)(2008-1#1)(2008-7#1)
such as working##2##3##(1991-12#1)(2008-10#1)
such as xeroderma pigmentosum##2##4##(2008-8#1)(2009-3#1)
such as yellow fever##2##4##(2006-10#1)(2007-2#1)
such as zinc##4##3##(2007-2#1)(2009-3#1)(2012-2#1)(2013-7#1)
such as##6891##2##(1990-10#7)(1990-11#14)(1990-12#23)(1990-2#13)(1990-3#12)(1990-4#11)(1990-5#10)(1990-6#5)(1990-7#8)(1990-8#17)(1990-9#8)(1991-1#6)(1991-10#10)(1991-11#6)(1991-12#32)(1991-2#12)(1991-3#10)(1991-4#11)(1991-5#16)(1991-6#4)(1991-7#3)(1991-8#12)(1991-9#18)(1992-1#7)(1992-10#3)(1992-11#8)(1992-12#21)(1992-2#14)(1992-3#10)(1992-4#10)(1992-5#13)(1992-6#9)(1992-7#7)(1992-8#18)(1992-9#14)(1993-1#3)(1993-10#2)(1993-11#25)(1993-12#16)(1993-2#17)(1993-3#14)(1993-4#9)(1993-5#10)(1993-6#10)(1993-7#4)(1993-8#9)(1993-9#18)(1994-10#10)(1994-11#20)(1994-12#21)(1994-2#24)(1994-3#28)(1994-4#4)(1994-5#20)(1994-6#22)(1994-8#27)(1994-9#24)(1995-1#16)(1995-10#1)(1995-11#27)(1995-12#27)(1995-2#16)(1995-3#21)(1995-4#4)(1995-5#19)(1995-6#13)(1995-7#5)(1995-8#15)(1995-9#3)(1996-1#14)(1996-10#6)(1996-11#10)(1996-12#22)(1996-2#14)(1996-3#27)(1996-4#15)(1996-5#26)(1996-6#3)(1996-7#12)(1996-8#22)(1996-9#20)(1997-1#25)(1997-2#27)(1997-3#20)(1997-4#24)(1997-5#14)(1997-6#26)(1997-7#12)(1997-8#24)(2003-11#1)(2004-1#3)(2004-11#5)(2004-12#6)(2004-2#6)(2004-3#5)(2004-4#14)(2004-7#2)(2004-9#4)(2005-1#1)(2005-10#24)(2005-11#55)(2005-12#13)(2005-3#5)(2005-4#2)(2005-5#3)(2005-6#8)(2005-7#42)(2005-8#30)(2005-9#9)(2006-1#7)(2006-10#191)(2006-11#14)(2006-12#64)(2006-2#37)(2006-3#9)(2006-4#11)(2006-5#22)(2006-6#30)(2006-7#16)(2006-8#27)(2006-9#16)(2007-1#30)(2007-10#35)(2007-11#152)(2007-12#121)(2007-2#36)(2007-3#17)(2007-4#33)(2007-5#25)(2007-6#18)(2007-7#50)(2007-8#78)(2007-9#58)(2008-1#124)(2008-10#707)(2008-11#201)(2008-12#66)(2008-2#191)(2008-3#202)(2008-4#151)(2008-5#217)(2008-6#73)(2008-7#207)(2008-8#125)(2008-9#87)(2009-1#4)(2009-10#31)(2009-11#19)(2009-12#26)(2009-2#27)(2009-3#30)(2009-4#34)(2009-5#37)(2009-6#25)(2009-7#21)(2009-8#64)(2009-9#27)(2010-1#17)(2010-10#15)(2010-11#29)(2010-12#104)(2010-2#48)(2010-3#28)(2010-4#47)(2010-5#42)(2010-6#18)(2010-7#32)(2010-8#65)(2010-9#31)(2011-1#92)(2011-11#1)(2011-12#20)(2011-2#193)(2011-3#18)(2011-4#1)(2011-7#3)(2012-1#62)(2012-11#22)(2012-12#157)(2012-2#145)(2012-3#70)(2012-5#2)(2012-6#1)(2012-9#2)(2013-1#194)(2013-7#37)(2013-8#95)
such aspects##3##2##(1992-2#1)(2008-4#1)(2012-12#1)
such assays##5##2##(1992-7#1)(1996-6#1)(2008-1#1)(2008-10#1)(2008-9#1)
such assessments##6##2##(1993-2#1)(1993-5#1)(2004-2#1)(2005-6#1)(2005-9#1)(2010-2#1)
such association was##2##3##(2005-10#1)(2008-9#1)
such association##6##2##(1995-9#1)(2005-10#1)(2006-10#1)(2008-10#2)(2008-9#1)
such associations##3##2##(1997-4#1)(2007-6#1)(2012-12#1)
such atmospheres##2##2##(1996-12#1)(2011-2#1)
such autoantibodies##2##2##(1995-1#1)(2011-2#1)
such beams##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
such behavior##5##2##(1993-11#1)(2006-7#1)(2008-2#1)(2008-3#1)(2008-8#1)
such behaviors in##2##3##(2006-2#1)(2012-3#1)
such behaviors##3##2##(1994-2#1)(2006-2#1)(2012-3#1)
such behaviour##3##2##(1996-11#1)(2008-11#1)(2011-2#1)
such binding##2##2##(1991-12#1)(2009-12#1)
such biological##3##2##(1994-9#1)(2011-2#1)(2013-1#1)
such bone##2##2##(2007-11#1)(2007-8#1)
such books##2##2##(2012-2#2)
such building##2##2##(1991-12#1)(2008-2#1)
such cancers##2##2##(2006-6#1)(2012-12#1)
such candidate##2##2##(1996-2#1)(2008-2#1)
such care##4##2##(1992-5#1)(1996-3#1)(2011-2#1)(2012-12#1)
such case in a##2##4##(2010-5#1)(2011-1#1)
such case in##4##3##(2007-12#1)(2008-7#1)(2010-5#1)(2011-1#1)
such case of##3##3##(2009-10#1)(2012-12#1)(2012-2#1)
such case##20##2##(2007-12#1)(2007-7#3)(2008-11#1)(2008-6#1)(2008-7#3)(2009-10#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
such cases and##3##3##(2005-12#1)(2013-1#2)
such cases are##2##3##(2007-3#1)(2008-3#1)
such cases as##2##3##(1991-5#1)(1995-4#1)
such cases can##2##3##(2011-1#1)(2013-8#1)
such cases have been reported in##2##6##(2010-6#1)(2013-1#1)
such cases have been reported##3##5##(1993-12#1)(2010-6#1)(2013-1#1)
such cases have been##4##4##(1993-12#1)(2010-6#1)(2013-1#2)
such cases have##6##3##(1993-12#1)(2010-6#3)(2013-1#2)
such cases is##5##3##(1996-11#1)(2005-11#1)(2007-7#1)(2010-12#1)(2013-1#1)
such cases of##3##3##(2009-3#1)(2010-7#1)(2011-1#1)
such cases the##2##3##(2008-11#1)(2008-4#1)
such cases##111##2##(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-11#1)(1993-10#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-6#1)(1995-11#1)(1995-4#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-4#1)(1997-8#1)(2004-10#2)(2005-11#1)(2005-12#1)(2005-7#2)(2005-8#1)(2005-9#2)(2006-10#4)(2006-7#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#5)(2007-8#2)(2008-1#2)(2008-11#2)(2008-12#3)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#2)(2009-3#3)(2009-4#1)(2009-8#1)(2009-9#2)(2010-12#3)(2010-5#2)(2010-6#4)(2010-7#2)(2011-1#4)(2011-2#3)(2012-2#3)(2012-3#3)(2013-1#9)(2013-7#4)(2013-8#2)
such cause##2##2##(1994-9#1)(2007-1#1)
such cell##2##2##(1994-3#1)(2008-11#1)
such cells also##2##3##(1996-5#1)(1997-4#1)
such cells in##2##3##(2008-1#1)(2008-11#1)
such cells##17##2##(1990-3#1)(1992-2#1)(1992-5#1)(1994-10#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-5#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2012-12#2)
such cellular functions##2##3##(2005-11#1)(2008-1#1)
such cellular##3##2##(2005-11#1)(2007-8#1)(2008-1#1)
such challenges##2##2##(2010-7#1)(2011-2#1)
such change##5##2##(1996-2#1)(1996-9#1)(2007-7#1)(2008-2#1)(2013-1#1)
such changes could##2##3##(1994-2#1)(2006-10#1)
such changes have been##2##4##(2006-6#1)(2008-6#1)
such changes were##2##3##(1995-12#1)(1995-6#1)
such changes will##2##3##(1994-1#1)(2004-4#1)
such changes##21##2##(1990-6#1)(1993-3#2)(1994-1#2)(1994-2#1)(1995-12#1)(1995-3#1)(1995-6#1)(2004-4#1)(2006-10#2)(2006-6#1)(2006-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-5#1)(2011-1#1)(2013-1#1)
such channels##2##2##(1990-2#1)(2008-8#1)
such characteristics##3##2##(1994-12#1)(2012-3#1)(2013-1#1)
such characterizations##2##2##(2007-12#1)(2008-2#1)
such children##7##2##(1991-10#2)(1993-5#1)(2007-12#1)(2008-10#1)(2010-2#1)(2012-12#1)
such chronic##2##2##(2004-11#1)(2006-10#1)
such circumstances##12##2##(1990-12#1)(1994-2#1)(1997-3#1)(2007-11#1)(2007-7#1)(2008-6#1)(2008-8#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#1)(2013-1#1)
such claims##4##2##(1993-7#1)(2008-5#1)(2009-5#1)(2013-8#1)
such class of##2##3##(2007-10#1)(2011-2#1)
such class##3##2##(1995-8#1)(2007-10#1)(2011-2#1)
such clear##2##2##(2007-10#1)(2008-7#1)
such clones##3##2##(1991-12#1)(1994-3#1)(2008-9#1)
such clusters##2##2##(1993-2#1)(2008-10#1)
such collaboration##2##2##(1992-1#1)(2008-11#1)
such columns##3##2##(2005-12#1)(2007-8#2)
such combination##3##2##(2008-10#1)(2011-2#1)(2012-11#1)
such combinations##2##2##(1993-9#1)(2007-10#1)
such common##4##2##(1995-12#1)(2008-1#1)(2008-10#2)
such communication##2##2##(1996-4#1)(2011-1#1)
such comparison##2##2##(1994-2#1)(2011-2#1)
such complex##10##2##(1992-1#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
such complexes are##2##3##(1994-11#1)(1995-6#1)
such complexes##7##2##(1990-5#1)(1993-7#1)(1994-11#1)(1995-12#1)(1995-6#1)(2008-5#1)(2008-7#1)
such complexity##2##2##(1996-4#1)(2009-4#1)
such complicated##2##2##(2008-3#1)(2012-2#1)
such complication##3##2##(2011-1#1)(2013-1#1)(2013-8#1)
such complications##12##2##(1993-5#1)(1995-9#1)(2006-11#1)(2007-6#1)(2007-7#1)(2008-7#1)(2009-4#1)(2009-6#1)(2011-2#2)(2012-8#1)(2013-7#1)
such components##3##2##(2004-11#1)(2008-3#2)
such compounds##8##2##(1990-1#1)(1991-12#1)(1993-12#1)(1995-6#1)(2005-7#1)(2007-1#1)(2008-1#1)(2008-11#1)
such conditions is necessary##2##4##(2005-11#1)(2013-1#1)
such conditions is##3##3##(2005-11#1)(2008-7#1)(2013-1#1)
such conditions it is##2##4##(1997-4#1)(2008-3#1)
such conditions##26##2##(1990-12#1)(1990-2#1)(1992-10#1)(1994-11#1)(1994-12#2)(1994-4#1)(1996-12#1)(1996-8#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-9#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2011-1#1)(2013-1#1)(2013-8#1)
such conflicts##2##2##(2007-8#1)(2012-11#1)
such contact is##2##3##(2011-2#1)(2012-12#1)
such contact##3##2##(2011-2#1)(2012-12#2)
such content##3##2##(2012-12#1)(2013-1#2)
such contexts##3##2##(2008-7#1)(2010-12#1)(2010-2#1)
such control##2##2##(1996-11#1)(2008-3#1)
such cooperation##2##2##(1993-2#1)(1994-8#1)
such correlation was found##2##4##(2004-4#1)(2008-11#1)
such correlation##3##2##(2004-4#1)(2008-11#1)(2008-8#1)
such correlations were##3##3##(2006-12#1)(2008-10#2)
such correlations##5##2##(2006-12#1)(2008-10#2)(2008-8#1)(2013-8#1)
such costs##2##2##(2008-9#1)(2011-1#1)
such criteria##2##2##(1995-10#1)(2011-2#1)
such critical##2##2##(1994-2#1)(2008-6#1)
such damage##7##2##(1991-2#1)(1995-6#1)(2005-12#1)(2007-11#1)(2008-10#2)(2008-5#1)
such data are##3##3##(1992-6#1)(2008-10#1)(2010-2#1)
such data for##2##3##(1997-4#1)(2008-8#1)
such data to##2##3##(1996-12#1)(2013-1#1)
such data##36##2##(1991-12#2)(1992-1#1)(1992-6#1)(1993-9#1)(1994-8#1)(1996-11#1)(1996-12#2)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-4#1)(2006-10#1)(2007-12#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-3#1)(2012-2#2)(2013-1#3)(2013-7#1)
such databases##2##2##(1997-1#1)(2008-3#1)
such deaths in##3##3##(1996-11#1)(1997-8#1)(2010-1#1)
such deaths##4##2##(1996-11#1)(1997-8#1)(2006-10#1)(2010-1#1)
such decision##3##2##(1994-2#1)(2006-5#1)(2007-7#1)
such defects##4##2##(1995-2#1)(2006-9#1)(2008-4#1)(2012-12#1)
such degradation##3##2##(1996-9#1)(2008-3#1)(2009-8#1)
such depletion##2##2##(1992-8#1)(1994-10#1)
such determinations##2##2##(1993-3#1)(2008-10#1)
such development##2##2##(1996-5#1)(2010-7#1)
such developments##2##2##(2009-8#1)(2013-8#1)
such devices is##3##3##(2008-10#1)(2009-11#1)(2010-5#1)
such devices##19##2##(1990-6#1)(1997-1#1)(2004-9#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-12#3)(2008-10#1)(2008-3#3)(2008-7#1)(2009-11#2)(2010-12#1)(2010-5#1)(2012-2#1)
such dietary##4##2##(2004-11#1)(2008-5#3)
such difference was##2##3##(1992-8#1)(1995-9#1)
such difference##5##2##(1992-8#1)(1995-9#1)(1996-3#1)(2008-5#1)(2013-1#1)
such differences are##4##3##(1995-12#1)(2008-5#1)(2009-2#1)(2013-1#1)
such differences##13##2##(1992-8#1)(1993-12#1)(1995-12#1)(1997-2#2)(2006-5#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-2#1)(2009-7#1)(2013-1#1)
such difficult##2##2##(1994-6#1)(1995-6#1)
such difficulties##2##2##(1993-2#1)(2008-12#1)
such disease##4##2##(1993-9#1)(1995-9#1)(1996-12#1)(2008-10#1)
such diseases as##2##3##(2009-5#1)(2013-1#1)
such diseases##12##2##(1993-9#1)(1995-12#1)(2005-7#1)(2006-2#1)(2008-1#1)(2008-4#2)(2009-4#1)(2009-5#1)(2013-1#1)(2013-7#1)(2013-8#1)
such disorders##5##2##(1997-3#1)(2005-6#1)(2007-1#1)(2011-12#1)(2013-8#1)
such displays##2##2##(2007-12#1)(2012-1#1)
such disturbances##3##2##(2006-6#1)(2008-11#1)(2008-2#1)
such diverse##9##2##(1990-2#1)(1993-4#1)(2006-9#1)(2007-12#1)(2007-8#1)(2008-10#1)(2009-8#1)(2010-7#1)(2011-1#1)
such drugs on##2##3##(2008-9#1)(2012-2#1)
such drugs##10##2##(1991-6#1)(1991-8#1)(1992-11#1)(1997-5#1)(2008-3#1)(2008-9#1)(2010-12#1)(2012-11#1)(2012-2#2)
such dynamic##2##2##(2008-5#1)(2009-5#1)
such effect was##4##3##(1990-11#1)(1991-3#1)(2007-8#1)(2012-12#1)
such effect##9##2##(1990-11#1)(1991-3#1)(1992-9#1)(1994-3#1)(1995-4#1)(2006-6#1)(2007-8#1)(2008-9#1)(2012-12#1)
such effects are##3##3##(1991-8#1)(2007-12#1)(2011-2#1)
such effects in##4##3##(1995-5#1)(1996-8#1)(2008-10#1)(2011-1#1)
such effects is##3##3##(1994-11#1)(1996-1#1)(2008-9#1)
such effects may be##2##4##(2008-10#1)(2012-2#1)
such effects may##3##3##(2008-10#1)(2008-8#1)(2012-2#1)
such effects were##3##3##(1995-3#1)(2008-5#1)(2009-3#1)
such effects##30##2##(1991-5#1)(1991-8#1)(1992-1#2)(1994-11#1)(1994-6#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-6#1)(1996-8#1)(1997-4#1)(2005-11#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
such effort##2##2##(2010-7#1)(2012-12#1)
such efforts##3##2##(1993-2#1)(1994-12#1)(1995-1#1)
such elements in the##2##4##(1993-3#1)(1994-9#1)
such elements in##3##3##(1993-3#1)(1994-9#1)(2008-10#1)
such elements##4##2##(1993-3#1)(1994-9#1)(2008-10#1)(2008-3#1)
such emergencies##2##2##(2007-6#1)(2007-7#1)
such engagement##2##2##(2009-4#1)(2013-1#1)
such enhancement##2##2##(1991-12#1)(2008-9#1)
such environments##7##2##(2007-9#1)(2008-3#1)(2008-8#1)(2011-11#1)(2012-5#1)(2013-1#2)
such enzymes##2##2##(1991-4#1)(2005-11#1)
such errors##5##2##(2007-4#1)(2008-3#1)(2008-4#1)(2013-1#2)
such estimates of##2##3##(1994-11#1)(1997-7#1)
such estimates##7##2##(1992-3#1)(1994-11#1)(1994-5#1)(1997-7#1)(2008-8#1)(2013-1#2)
such evaluations##2##2##(1995-2#1)(2012-1#1)
such events##10##2##(2004-3#1)(2006-2#1)(2006-7#1)(2007-10#1)(2008-10#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-7#1)
such evidence##3##2##(2008-8#1)(2011-2#2)
such evolutionary##2##2##(1995-2#1)(2006-5#1)
such examples of##2##3##(1990-8#1)(2008-11#1)
such examples##5##2##(1990-8#1)(2008-11#1)(2008-12#1)(2009-11#1)(2013-8#1)
such excess expenditures may be due to CCs and MCCs##2##10##(2013-1#2)
such excess##3##2##(2007-11#1)(2013-1#2)
such experience##3##2##(1992-12#1)(1993-12#1)(2008-11#1)
such experiences##4##2##(1991-12#1)(1992-2#1)(2008-11#1)(2009-7#1)
such experimental##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2013-8#1)
such experiments##5##2##(2007-12#1)(2007-4#1)(2008-1#1)(2008-4#1)(2008-7#1)
such exposure##3##2##(1991-12#1)(1996-8#1)(2009-8#1)
such expression##4##2##(1995-12#1)(2008-10#1)(2008-4#1)(2013-1#1)
such facilities##3##2##(2005-8#1)(2008-7#1)(2012-12#1)
such factor##2##2##(1996-11#1)(2012-2#1)
such factors as age##2##4##(2006-11#1)(2013-1#1)
such factors as practitioner##2##4##(2007-6#2)
such factors as the##2##4##(1990-2#1)(2008-8#1)
such factors as##9##3##(1990-2#1)(1995-2#1)(2006-11#1)(2007-11#1)(2007-6#2)(2008-11#1)(2008-8#1)(2013-1#1)
such factors may##2##3##(2007-10#1)(2008-3#1)
such factors##13##2##(1990-2#1)(1991-5#1)(1995-2#1)(2006-11#1)(2007-10#1)(2007-11#2)(2007-6#2)(2008-11#1)(2008-3#1)(2008-8#1)(2013-1#1)
such families##2##2##(2008-12#1)(2012-12#1)
such family##5##2##(1995-2#1)(2004-12#1)(2008-3#1)(2008-7#1)(2013-1#1)
such features as##3##3##(2007-3#1)(2008-2#1)(2013-1#1)
such features##5##2##(1992-3#1)(2007-3#1)(2007-9#1)(2008-2#1)(2013-1#1)
such fibers##5##2##(2007-11#3)(2007-9#1)(2008-2#1)
such fields##2##2##(2007-11#1)(2007-12#1)
such films##3##2##(2007-12#1)(2008-10#1)(2011-2#1)
such filters##5##2##(2007-12#1)(2008-2#2)(2008-3#1)(2008-4#1)
such findings##6##2##(1992-12#1)(1995-11#1)(2007-8#1)(2008-2#1)(2008-8#1)(2013-1#1)
such fixed##2##2##(1995-8#1)(2007-12#1)
such flow##3##2##(1992-8#1)(1996-12#1)(2008-7#1)
such food##4##2##(2008-1#2)(2008-10#1)(2008-11#1)
such fortuitous##2##2##(1996-3#1)(2007-1#1)
such functional##3##2##(2007-8#1)(2008-7#1)(2009-5#1)
such functions##4##2##(1990-11#1)(1992-9#1)(1997-6#1)(2011-2#1)
such gene##2##2##(1997-3#1)(1997-7#1)
such genes is##3##3##(1995-11#1)(2008-10#1)(2008-4#1)
such genes##9##2##(1991-7#1)(1993-10#1)(1993-9#1)(1994-8#1)(1995-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
such goals##3##2##(2007-10#1)(2007-12#1)(2009-7#1)
such gratings##2##2##(2007-12#1)(2008-3#1)
such group##3##2##(1992-6#1)(2006-4#1)(2008-7#1)
such groups##7##2##(1990-4#1)(1991-3#1)(1993-3#1)(1996-4#1)(2007-2#1)(2008-3#1)(2008-8#1)
such guides##2##2##(2008-2#2)
such haemorrhage##2##2##(2008-3#1)(2008-7#1)
such have##2##2##(2006-10#1)(2007-8#1)
such health care##2##3##(1994-12#1)(2010-3#1)
such heterogeneous##2##2##(2006-6#1)(2010-12#1)
such high##10##2##(1994-5#1)(2005-5#1)(2006-10#1)(2006-7#1)(2007-6#1)(2008-3#3)(2009-6#1)(2012-2#1)
such highly##2##2##(1996-10#1)(2005-8#1)
such holograms##2##2##(2007-12#1)(2008-2#1)
such hypothesis##2##2##(2006-10#1)(2008-11#1)
such images##4##2##(2008-3#1)(2008-6#1)(2008-9#1)(2012-2#1)
such implants##3##2##(1992-4#1)(1996-3#1)(2007-11#1)
such important##3##2##(1995-5#1)(1996-1#1)(2008-7#1)
such in##6##2##(1996-5#1)(2004-11#1)(2007-9#1)(2008-7#1)(2009-7#1)(2012-2#1)
such increase occurred##2##3##(1995-11#1)(1996-11#1)
such increase was observed##2##4##(1990-9#1)(1992-6#1)
such increase##6##2##(1990-9#1)(1992-6#1)(1995-11#1)(1996-11#2)(2005-11#1)
such individuals##2##2##(2005-9#1)(2012-2#1)
such induced##2##2##(1992-9#1)(2007-11#1)
such infection##2##2##(2007-3#1)(2011-3#1)
such infections##8##2##(1996-12#1)(2005-7#1)(2007-12#1)(2007-9#1)(2008-2#1)(2009-2#1)(2011-1#1)(2013-8#1)
such information is##4##3##(1994-6#1)(1996-10#1)(2008-4#1)(2013-1#1)
such information##17##2##(1994-6#1)(1995-1#1)(1996-10#1)(1997-3#2)(2006-7#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-4#3)(2008-7#1)(2008-8#1)(2010-2#1)(2013-1#1)
such inhibition##4##2##(1991-1#1)(1991-9#1)(1995-2#1)(1996-11#1)
such inhibitory##2##2##(1995-12#1)(2009-12#1)
such initiatives##5##2##(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)
such injuries are##3##3##(2007-11#1)(2007-3#1)(2011-1#1)
such injuries##10##2##(1990-2#1)(1990-9#1)(1993-3#1)(2007-11#2)(2007-3#1)(2009-10#1)(2009-3#1)(2011-1#1)(2013-1#1)
such injury##3##2##(2006-9#1)(2007-11#1)(2008-5#1)
such institutions##2##2##(2008-7#1)(2013-8#1)
such instruments##2##2##(2006-8#1)(2008-2#1)
such interaction##3##2##(1993-12#1)(2006-10#1)(2009-12#1)
such interactions##16##2##(1992-3#1)(1995-6#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-4#1)(2008-9#1)(2009-5#1)(2010-10#1)(2013-7#1)
such intervention##3##2##(1994-8#1)(2006-8#1)(2007-10#1)
such interventions to##2##3##(2008-11#1)(2010-12#1)
such interventions were##2##3##(2007-1#1)(2012-11#1)
such interventions##11##2##(2005-10#1)(2005-11#1)(2006-2#1)(2006-4#1)(2007-1#1)(2008-11#1)(2008-2#1)(2010-12#1)(2010-5#1)(2012-11#1)(2012-2#1)
such investigations##6##2##(1993-7#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-12#1)(2013-7#1)
such isolates##3##2##(2005-11#1)(2008-10#1)(2011-2#1)
such issues as##4##3##(1996-1#1)(1996-12#1)(2007-11#1)(2007-4#1)
such issues##11##2##(1992-3#1)(1996-1#1)(1996-12#1)(2006-9#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2012-12#1)
such it is##4##3##(2007-11#1)(2008-3#1)(2010-10#1)(2012-12#1)
such kind of##2##3##(2006-11#1)(2008-9#1)
such knowledge to##2##3##(1997-6#1)(2007-11#1)
such knowledge##6##2##(1997-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2011-2#1)(2013-1#1)
such labeling##2##2##(1994-8#1)(2008-4#1)
such large-scale##2##2##(2008-11#1)(2008-8#1)
such lasers##7##2##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#1)
such legislation##2##2##(1991-2#1)(1991-4#1)
such lesions in##2##3##(1996-11#1)(2008-7#1)
such lesions##15##2##(1993-10#1)(1996-11#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
such levels##2##2##(2007-7#2)
such libraries##2##2##(2008-4#2)
such ligands##4##2##(1993-6#1)(1995-3#1)(2008-10#1)(2010-3#1)
such limitations##3##2##(1991-7#1)(2007-11#1)(2008-12#1)
such lines##3##2##(2007-12#1)(2008-11#2)
such links##2##2##(2008-2#1)(2010-3#1)
such low concentrations##2##3##(2008-10#1)(2013-1#1)
such low levels##2##3##(1990-12#1)(2008-10#1)
such low##8##2##(1990-12#1)(1993-12#1)(2008-10#2)(2008-2#1)(2008-8#1)(2013-1#1)(2013-7#1)
such major##2##2##(2006-5#1)(2013-8#1)
such markers##5##2##(1990-4#1)(1992-10#1)(2007-8#1)(2009-10#1)(2010-11#1)
such materials##8##2##(2006-6#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-11#1)(2010-10#1)(2010-2#1)
such measurements are##3##3##(1992-12#1)(2005-11#1)(2007-12#1)
such measurements##13##2##(1992-12#1)(1994-12#1)(2005-11#2)(2006-10#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-7#1)(2013-1#2)
such measures##8##2##(1992-1#1)(2006-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-6#1)(2013-1#1)
such mechanism##3##2##(2008-8#1)(2012-3#2)
such mechanisms##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
such medical##3##2##(2007-10#1)(2008-11#1)(2013-1#1)
such medications##2##2##(2004-3#1)(2011-1#1)
such men##2##2##(1993-8#2)
such method##4##2##(2006-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
such methodological##2##2##(2005-10#1)(2010-9#1)
such methods may##3##3##(1992-3#1)(2008-11#2)
such methods##17##2##(1992-3#1)(1992-6#1)(1993-9#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-1#2)(2012-2#1)(2013-1#2)
such mixtures##2##2##(1991-9#1)(2008-7#1)
such model##4##2##(1997-3#1)(2008-1#1)(2008-9#1)(2013-1#1)
such models are##3##3##(1994-3#1)(2008-7#2)
such models to##2##3##(2008-5#1)(2009-4#1)
such models##24##2##(1994-3#1)(1996-4#1)(2007-12#1)(2007-5#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#4)
such modifications may##2##3##(2006-12#1)(2009-5#1)
such modifications##7##2##(1993-6#1)(1997-6#1)(2006-12#1)(2007-9#1)(2008-10#1)(2009-5#1)(2013-8#1)
such modified##2##2##(1997-3#1)(1997-4#1)
such morphological##2##2##(1992-3#1)(2011-12#1)
such motifs##2##2##(1991-11#1)(1995-2#1)
such motion##2##2##(1996-12#1)(2008-11#1)
such movements##3##2##(1995-8#1)(2008-8#1)(2012-2#1)
such mutants##3##2##(1990-11#1)(1997-4#1)(2008-10#1)
such mutations##4##2##(1990-5#1)(2006-10#1)(2009-5#1)(2011-1#1)
such networks##4##2##(2007-12#1)(2008-11#1)(2010-2#1)(2012-2#1)
such new##4##2##(1997-1#1)(2008-10#2)(2012-2#1)
such noise##2##2##(2008-2#1)(2008-7#1)
such nonlinear JFTCs##2##3##(2008-3#2)
such observational data##3##3##(2008-3#1)(2013-1#2)
such observations##2##2##(2008-8#1)(2012-2#1)
such occurrences##2##2##(1991-3#1)(1992-2#1)
such online health communities##2##4##(2011-2#2)
such operations##2##2##(2008-11#1)(2008-4#1)
such outcomes##2##2##(2008-9#1)(2009-2#1)
such parameters as##3##3##(1993-5#1)(2007-4#1)(2008-11#1)
such parameters##4##2##(1993-5#1)(2007-4#1)(2008-10#1)(2008-11#1)
such parametric##2##2##(2007-12#1)(2010-1#1)
such participation##2##2##(1993-6#1)(1994-12#1)
such particle##2##2##(2008-3#1)(2012-2#1)
such particles##6##2##(1992-6#1)(2005-11#2)(2008-2#1)(2008-3#1)(2010-7#1)
such patient##2##2##(1992-12#1)(2007-2#1)
such patients and##4##3##(1991-12#1)(1995-3#1)(2005-10#1)(2011-3#1)
such patients are##2##3##(2012-3#1)(2013-1#1)
such patients have been##2##4##(2007-10#1)(2007-12#1)
such patients have##4##3##(1994-3#1)(1995-2#1)(2007-10#1)(2007-12#1)
such patients in##4##3##(2006-9#1)(2007-12#1)(2012-2#2)
such patients is a##2##4##(2007-8#1)(2008-9#1)
such patients is##8##3##(1995-11#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-6#1)(2008-9#1)(2009-6#1)
such patients may##2##3##(2007-10#1)(2010-7#1)
such patients should##2##3##(2012-3#1)(2013-1#1)
such patients who##3##3##(2006-10#1)(2006-12#1)(2008-7#1)
such patients with##7##3##(2006-10#1)(2008-7#2)(2009-6#1)(2010-12#1)(2011-2#1)(2013-1#1)
such patients##100##2##(1990-2#1)(1991-11#1)(1991-12#1)(1991-3#3)(1991-9#1)(1992-10#1)(1992-2#1)(1993-12#1)(1993-9#1)(1994-3#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-8#1)(2004-11#1)(2005-10#2)(2005-8#1)(2006-10#3)(2006-12#2)(2006-9#2)(2007-10#2)(2007-11#1)(2007-12#2)(2007-3#2)(2007-7#1)(2007-8#5)(2008-1#4)(2008-10#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#5)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#4)(2010-3#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-11#2)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#7)
such patterns##4##2##(1996-4#1)(2010-12#1)(2011-1#1)(2012-3#1)
such people##3##2##(2007-5#1)(2007-8#1)(2008-3#1)
such peptide##4##2##(1990-2#1)(1992-7#1)(2008-10#1)(2009-6#1)
such peptides##3##2##(1993-12#1)(1994-5#1)(1996-8#1)
such phenomena##2##2##(1995-2#1)(2007-12#1)
such phenomenon##2##2##(2005-10#1)(2009-8#1)
such phenotypes##3##2##(2008-10#1)(2008-4#1)(2012-3#1)
such plants##2##2##(2006-12#1)(2009-8#1)
such polarization##2##2##(2007-12#1)(2011-2#1)
such populations##2##2##(2010-12#1)(2012-2#1)
such positions##2##2##(1991-11#1)(1995-9#1)
such potential##3##2##(1993-11#1)(2007-10#1)(2011-2#1)
such potentially##2##2##(2010-11#1)(2013-7#1)
such practices##5##2##(1991-12#1)(2005-10#1)(2006-2#1)(2008-5#1)(2012-3#1)
such predictions##4##2##(1996-4#2)(2008-11#1)(2013-8#1)
such preparations##4##2##(1991-5#1)(2005-11#1)(2007-11#1)(2008-5#1)
such problem##2##2##(2007-7#1)(2009-2#1)
such problems##15##2##(1990-8#2)(1993-2#1)(1994-6#1)(2005-11#1)(2006-11#1)(2006-2#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-2#1)(2009-10#1)(2010-12#1)(2010-2#1)(2013-1#1)
such procedures##3##2##(1997-6#1)(2007-1#1)(2007-8#1)
such processes as##3##3##(1995-6#1)(2008-4#1)(2008-7#1)
such processes##8##2##(1995-6#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-4#1)(2008-7#1)(2013-1#2)
such processing##3##2##(1990-8#1)(2008-11#2)
such profiles##2##2##(1992-1#1)(2007-12#1)
such programs are##2##3##(1992-3#1)(1996-1#1)
such programs to##2##3##(2008-10#1)(2012-12#1)
such programs##18##2##(1991-1#1)(1992-1#2)(1992-3#1)(1992-9#1)(1993-2#1)(1994-1#1)(1994-2#1)(1995-3#1)(1996-1#1)(1997-5#1)(2006-4#1)(2007-2#1)(2008-10#1)(2012-12#4)
such projections##3##2##(1994-5#1)(2007-11#1)(2008-2#1)
such proliferation##2##2##(2008-10#1)(2012-12#1)
such properties##4##2##(1992-2#1)(2007-6#1)(2009-2#2)
such protective##2##2##(2008-5#1)(2013-1#1)
such protein##2##2##(1992-7#1)(2008-4#1)
such proteins is##2##3##(1993-9#1)(2009-8#1)
such proteins##7##2##(1993-3#1)(1993-9#1)(1994-10#1)(2006-5#1)(2007-11#1)(2008-4#1)(2009-8#1)
such purposes##5##2##(1990-8#1)(2004-12#1)(2008-10#2)(2008-2#1)
such putative##2##2##(1991-3#1)(1992-8#1)
such questions##2##2##(1997-6#1)(2008-11#1)
such rapid##3##2##(2011-1#1)(2011-12#1)(2012-2#1)
such rare##3##2##(2007-8#1)(2011-1#2)
such reconstruction##2##2##(2007-12#1)(2013-1#1)
such records##3##2##(2007-9#1)(2009-3#1)(2012-3#1)
such regimens##3##2##(2005-7#1)(2007-11#1)(2012-1#1)
such regions##5##2##(1992-6#1)(2008-1#1)(2008-2#2)(2012-1#1)
such regulatory##2##2##(1990-8#1)(2009-5#1)
such relationship was##2##3##(2008-7#1)(2012-12#1)
such relationship##6##2##(2007-1#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#2)
such relationships##2##2##(1991-3#1)(2009-4#1)
such release##2##2##(1993-4#2)
such report in##3##3##(1992-2#1)(2007-7#1)(2012-2#1)
such report##5##2##(1992-2#1)(1997-4#1)(2007-7#1)(2010-4#1)(2012-2#1)
such reports##2##2##(2006-10#1)(2007-11#1)
such requirements##2##2##(2008-7#1)(2008-9#1)
such research##8##2##(1992-6#1)(2007-11#1)(2009-12#1)(2009-4#1)(2010-2#1)(2010-3#1)(2011-3#1)(2012-11#1)
such residues##5##2##(1990-7#1)(1994-11#1)(1995-2#1)(1996-11#1)(2008-10#1)
such resistance##2##2##(2008-10#1)(2008-3#1)
such resources##2##2##(2007-2#1)(2008-12#1)
such responses##2##2##(1991-3#1)(2011-1#1)
such results##2##2##(1995-10#1)(2009-6#1)
such roles##3##2##(2007-10#1)(2008-12#1)(2010-7#1)
such samples##7##2##(2008-10#3)(2008-11#3)(2008-12#1)
such secondary##4##2##(1990-10#1)(1995-4#1)(2008-10#1)(2008-6#1)
such selection##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
such selective##2##2##(1994-2#1)(2008-5#1)
such selectivity##2##2##(1991-9#1)(2008-7#1)
such sensors##5##2##(2007-11#1)(2008-10#2)(2012-12#2)
such sequences##7##2##(1990-11#1)(1995-10#1)(1995-2#1)(1997-4#3)(2007-11#1)
such services and##2##3##(1992-12#1)(2012-12#1)
such services##11##2##(1992-12#1)(1992-3#1)(1993-1#1)(1996-1#1)(2005-11#1)(2007-2#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
such sets of##2##3##(2008-10#1)(2008-4#1)
such sets##3##2##(2008-10#1)(2008-4#1)(2010-2#1)
such short##2##2##(1992-5#1)(2008-1#1)
such side effects##2##3##(1996-11#1)(2008-7#1)
such signaling pathways##2##3##(1996-5#1)(2010-12#1)
such signaling##3##2##(1995-3#1)(1996-5#1)(2010-12#1)
such signals##4##2##(2008-9#1)(2010-7#1)(2013-8#2)
such significant##3##2##(2008-1#1)(2011-2#1)(2012-12#1)
such silica##2##2##(1990-12#1)(2005-11#1)
such simulations##3##2##(2011-2#1)(2012-12#1)(2013-1#1)
such sites##4##2##(1995-3#1)(2004-4#1)(2008-7#1)(2009-5#1)
such situations##16##2##(2006-10#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-4#1)(2009-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-11#1)(2012-2#1)
such small##4##2##(1991-5#1)(2009-2#1)(2010-2#1)(2013-8#1)
such smoke##2##2##(1992-3#1)(2008-8#1)
such solutions##5##2##(1993-4#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-5#1)
such sources##4##2##(1995-4#1)(2006-4#1)(2007-12#2)
such specialized##2##2##(1996-1#1)(2012-1#1)
such species##4##2##(2008-10#2)(2008-5#1)(2008-9#1)
such specific##3##2##(2005-7#1)(2008-8#1)(2010-7#1)
such statistics##2##2##(1990-8#1)(2008-12#1)
such steps##2##2##(2005-8#1)(2008-10#1)
such stimulation##2##2##(1992-9#1)(1996-7#1)
such strains##2##2##(2008-10#2)
such strategies are##3##3##(1994-3#1)(2008-8#1)(2010-1#1)
such strategies##6##2##(1994-3#1)(1997-2#1)(2005-11#1)(2008-1#1)(2008-8#1)(2010-1#1)
such structural##5##2##(1992-3#1)(1995-3#1)(1997-1#1)(2008-7#1)(2008-8#1)
such structure##3##2##(1995-5#1)(2008-1#1)(2012-1#1)
such structures##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
such studies and##2##3##(1996-11#1)(2010-12#1)
such studies have been conducted in##2##6##(2006-12#1)(2013-1#1)
such studies have##6##3##(1992-4#1)(2005-8#1)(2006-12#1)(2008-4#1)(2009-10#1)(2013-1#1)
such studies is the##3##4##(1993-12#1)(2008-10#1)(2013-1#1)
such studies is to##2##4##(2008-6#1)(2010-12#1)
such studies is##6##3##(1993-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-12#1)(2013-1#1)
such studies to##2##3##(1993-5#1)(2008-8#1)
such studies##51##2##(1991-5#1)(1992-4#1)(1992-7#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-4#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-1#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-11#1)(2009-3#1)(2010-12#3)(2012-1#1)(2012-3#2)(2013-1#4)
such substances##4##2##(1994-9#1)(2008-10#1)(2013-1#2)
such support##2##2##(2008-11#1)(2011-2#1)
such surgery##3##2##(2006-10#1)(2008-7#1)(2012-12#1)
such symptoms##5##2##(1995-8#1)(2004-3#1)(2006-7#1)(2007-11#1)(2009-7#1)
such syndromes##2##2##(1991-3#1)(2009-5#1)
such system##4##2##(2008-12#1)(2008-2#1)(2008-5#1)(2013-8#1)
such systems in the##2##4##(2006-10#1)(2008-2#1)
such systems is##6##3##(1997-8#1)(2006-6#1)(2007-12#1)(2008-3#1)(2008-9#1)(2013-8#1)
such systems##35##2##(1991-11#1)(1992-12#1)(1993-3#1)(1996-1#1)(1996-7#1)(1997-6#2)(1997-8#1)(2006-10#1)(2006-6#3)(2007-12#2)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#6)(2008-3#3)(2008-9#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
such targets##3##2##(1993-2#1)(2008-5#1)(2011-1#1)
such technique##5##2##(2007-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#1)
such techniques##14##2##(1991-5#1)(1992-6#1)(1994-9#1)(1997-6#1)(2006-10#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2012-3#1)
such technologies##4##2##(2008-11#1)(2008-2#1)(2008-5#1)(2012-2#1)
such technology##3##2##(2008-12#1)(2008-3#1)(2009-6#1)
such terms##5##2##(2010-5#1)(2013-1#4)
such testing##6##2##(1996-12#1)(2005-11#1)(2007-7#1)(2008-12#1)(2012-12#1)(2013-8#1)
such tests##2##2##(2008-10#1)(2008-12#1)
such that a large##2##4##(2007-12#1)(2008-11#1)
such that a##17##3##(1991-9#1)(1992-4#2)(2005-7#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#1)(2013-7#1)
such that any##2##3##(1996-10#1)(2006-12#1)
such that at##2##3##(2008-5#1)(2010-6#1)
such that both the term and the sense assigned to a context in which the term occurs are encoded into vectors representing the surrounding terms in this context##2##28##(2013-1#2)
such that each##3##3##(2008-8#1)(2009-2#1)(2010-12#1)
such that either##3##3##(1993-5#1)(1996-4#1)(2006-4#1)
such that higher##2##3##(2008-10#1)(2010-6#1)
such that it becomes##2##4##(2007-10#1)(2008-8#1)
such that it can be##2##5##(1993-2#1)(2008-3#1)
such that it is##3##4##(2008-2#1)(2009-3#1)(2012-12#1)
such that it##9##3##(1993-2#1)(2007-10#1)(2008-2#1)(2008-3#3)(2008-8#1)(2009-3#1)(2012-12#1)
such that its##2##3##(2007-11#1)(2008-2#1)
such that most##2##3##(2007-11#1)(2012-1#1)
such that no##2##3##(2006-4#1)(2008-3#1)
such that one##3##3##(2008-2#1)(2008-3#1)(2008-8#1)
such that only a##2##4##(2008-2#1)(2008-7#1)
such that only##6##3##(1991-4#1)(1992-7#1)(1997-2#1)(2008-2#2)(2008-7#1)
such that the overall##4##4##(1995-4#1)(2008-2#1)(2012-2#2)
such that the##58##3##(1990-7#2)(1993-3#2)(1994-11#1)(1994-5#2)(1995-3#1)(1995-4#1)(1996-1#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(2004-7#1)(2007-11#3)(2007-12#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#10)(2008-3#9)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2012-1#1)(2012-2#2)(2013-8#1)
such that their##4##3##(2008-10#1)(2012-1#1)(2012-12#1)(2012-3#1)
such that there is##2##4##(2005-11#1)(2011-2#1)
such that these##2##3##(2008-1#1)(2011-2#1)
such that they are##3##4##(2007-8#1)(2008-12#1)(2010-5#1)
such that they were##2##4##(2011-1#1)(2013-8#1)
such that they##8##3##(2006-8#1)(2007-8#1)(2008-12#1)(2008-4#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-8#1)
such that we##3##3##(1997-3#1)(2007-8#1)(2008-8#1)
such that##234##2##(1990-7#2)(1990-8#1)(1991-11#1)(1991-4#1)(1991-9#1)(1992-4#3)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#2)(1993-7#1)(1994-11#1)(1994-3#1)(1994-5#3)(1994-8#1)(1995-12#2)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#2)(1996-4#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(2004-7#1)(2005-11#1)(2005-7#2)(2006-12#2)(2006-4#3)(2006-8#1)(2007-10#1)(2007-11#8)(2007-12#6)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#3)(2008-10#14)(2008-11#6)(2008-12#2)(2008-2#20)(2008-3#28)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#3)(2012-1#5)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#2)
such the##6##2##(2005-11#1)(2006-1#1)(2008-4#1)(2010-2#1)(2013-8#2)
such therapies##7##2##(1995-1#1)(2006-10#2)(2008-8#2)(2012-12#2)
such therapy in##3##3##(1991-5#1)(2006-3#1)(2007-11#1)
such therapy##13##2##(1991-5#1)(1991-7#1)(1991-9#1)(2005-10#2)(2005-8#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-6#1)(2011-12#1)(2013-8#1)
such they are##3##3##(1992-8#1)(2007-9#1)(2008-4#1)
such they##4##2##(1992-8#1)(2007-9#1)(2008-4#1)(2013-1#1)
such things as##4##3##(1995-1#1)(2006-8#1)(2007-11#1)(2012-3#1)
such things##5##2##(1995-1#1)(2005-12#1)(2006-8#1)(2007-11#1)(2012-3#1)
such time##2##2##(2007-4#1)(2011-1#1)
such tissues##3##2##(1995-3#1)(2008-8#1)(2010-2#1)
such tools capture retrospective data intended for clinicians to review##2##10##(2013-1#2)
such tools##8##2##(1993-12#1)(1994-1#1)(2008-2#1)(2013-1#5)
such topics as##4##3##(1994-1#1)(2007-4#1)(2008-9#2)
such training##8##2##(1991-1#1)(1993-1#1)(1997-1#1)(2007-2#1)(2008-1#1)(2010-10#1)(2012-3#1)(2013-8#1)
such traits##4##2##(2007-12#1)(2008-8#3)
such transactions##2##2##(1990-12#1)(2010-5#1)
such transcripts##2##2##(1990-5#1)(2008-7#1)
such transitions##2##2##(2010-8#2)
such translocations##2##2##(2008-6#2)
such trauma##2##2##(2007-5#1)(2009-3#1)
such treatment and##3##3##(1995-1#1)(2008-4#1)(2008-9#1)
such treatment have not##2##4##(2008-7#1)(2012-2#1)
such treatment##26##2##(1990-3#1)(1991-8#1)(1992-5#1)(1994-11#1)(1995-1#1)(1995-4#1)(1995-7#1)(1995-9#1)(1996-9#1)(1997-3#2)(2006-12#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-6#1)(2011-2#2)(2012-2#1)(2013-1#1)
such treatments##10##2##(1994-5#1)(1997-4#1)(2004-9#2)(2007-3#1)(2007-4#1)(2008-12#1)(2008-5#1)(2010-12#1)(2012-12#1)
such trends are##2##3##(1993-5#1)(1996-8#1)
such trials##6##2##(1994-9#1)(2005-7#1)(2008-11#1)(2009-2#1)(2010-3#1)(2013-7#1)
such units##4##2##(1994-9#2)(2007-11#1)(2008-11#1)
such usage##2##2##(1991-4#1)(2008-3#1)
such use##4##2##(1995-11#1)(2006-7#1)(2008-7#1)(2012-1#1)
such variability##2##2##(2012-2#1)(2012-3#1)
such variables as##2##3##(1996-7#1)(2007-12#1)
such variables##5##2##(1996-7#1)(2007-12#1)(2009-12#1)(2009-8#1)(2013-8#1)
such variance##3##2##(1994-3#1)(2007-8#1)(2010-2#1)
such variation##4##2##(2008-5#1)(2008-7#2)(2009-4#1)
such variations##2##2##(2007-3#1)(2008-7#1)
such water##2##2##(1993-5#1)(2011-1#1)
such women##3##2##(1992-2#1)(2006-10#1)(2012-3#1)
such work##3##2##(2006-7#1)(2010-8#1)(2013-8#1)
such##11196##1##(1990-1#1)(1990-10#14)(1990-11#26)(1990-12#42)(1990-2#24)(1990-3#20)(1990-4#17)(1990-5#18)(1990-6#12)(1990-7#13)(1990-8#32)(1990-9#14)(1991-1#14)(1991-10#18)(1991-11#19)(1991-12#51)(1991-2#23)(1991-3#27)(1991-4#19)(1991-5#31)(1991-6#11)(1991-7#13)(1991-8#20)(1991-9#29)(1992-1#21)(1992-10#9)(1992-11#13)(1992-12#36)(1992-2#33)(1992-3#31)(1992-4#21)(1992-5#19)(1992-6#22)(1992-7#14)(1992-8#36)(1992-9#30)(1993-1#13)(1993-10#9)(1993-11#35)(1993-12#30)(1993-2#32)(1993-3#34)(1993-4#18)(1993-5#23)(1993-6#17)(1993-7#12)(1993-8#14)(1993-9#30)(1994-1#11)(1994-10#13)(1994-11#34)(1994-12#42)(1994-2#42)(1994-3#45)(1994-4#5)(1994-5#30)(1994-6#35)(1994-7#1)(1994-8#40)(1994-9#43)(1995-1#33)(1995-10#6)(1995-11#40)(1995-12#43)(1995-2#40)(1995-3#41)(1995-4#15)(1995-5#35)(1995-6#28)(1995-7#8)(1995-8#24)(1995-9#15)(1996-1#30)(1996-10#11)(1996-11#30)(1996-12#44)(1996-2#26)(1996-3#35)(1996-4#29)(1996-5#33)(1996-6#8)(1996-7#21)(1996-8#32)(1996-9#29)(1997-1#38)(1997-2#38)(1997-3#40)(1997-4#55)(1997-5#26)(1997-6#47)(1997-7#20)(1997-8#34)(2003-11#1)(2004-1#3)(2004-10#3)(2004-11#13)(2004-12#9)(2004-2#10)(2004-3#10)(2004-4#20)(2004-7#3)(2004-9#11)(2005-1#1)(2005-10#38)(2005-11#94)(2005-12#18)(2005-3#5)(2005-4#2)(2005-5#5)(2005-6#10)(2005-7#61)(2005-8#46)(2005-9#16)(2006-1#8)(2006-10#264)(2006-11#21)(2006-12#96)(2006-2#49)(2006-3#13)(2006-4#26)(2006-5#33)(2006-6#56)(2006-7#40)(2006-8#36)(2006-9#28)(2007-1#43)(2007-10#63)(2007-11#237)(2007-12#247)(2007-2#48)(2007-3#34)(2007-4#50)(2007-5#36)(2007-6#35)(2007-7#87)(2007-8#131)(2007-9#85)(2008-1#188)(2008-10#937)(2008-11#326)(2008-12#117)(2008-2#342)(2008-3#387)(2008-4#221)(2008-5#294)(2008-6#106)(2008-7#348)(2008-8#219)(2008-9#147)(2009-1#6)(2009-10#55)(2009-11#33)(2009-12#43)(2009-2#44)(2009-3#53)(2009-4#54)(2009-5#64)(2009-6#48)(2009-7#34)(2009-8#86)(2009-9#43)(2010-1#30)(2010-10#26)(2010-11#40)(2010-12#149)(2010-2#79)(2010-3#46)(2010-4#54)(2010-5#67)(2010-6#31)(2010-7#55)(2010-8#87)(2010-9#37)(2011-1#152)(2011-11#2)(2011-12#32)(2011-2#280)(2011-3#23)(2011-4#1)(2011-7#3)(2012-1#93)(2012-11#37)(2012-12#240)(2012-2#241)(2012-3#120)(2012-5#3)(2012-6#1)(2012-8#4)(2012-9#2)(2013-1#355)(2013-7#59)(2013-8#152)
suck##12##1##(1990-8#1)(2009-12#5)(2009-2#1)(2009-6#3)(2012-12#1)(2012-2#1)
sucker##3##1##(2007-12#1)(2008-4#1)(2008-5#1)
sucker-like##2##1##(2008-4#1)(2008-5#1)
suckers and##2##2##(1996-5#2)
suckers##3##1##(1996-5#3)
sucking habit##2##2##(2007-10#1)(2008-10#1)
sucking instinct##3##2##(2007-10#3)
sucking the##4##2##(2007-7#1)(2008-7#3)
sucking##24##1##(1995-12#1)(2007-10#6)(2007-12#2)(2007-7#1)(2008-10#8)(2008-7#3)(2009-8#1)(2010-6#1)(2012-12#1)
suckled##3##1##(1993-2#1)(2006-5#1)(2012-1#1)
suckler##2##1##(1994-4#1)(1997-3#1)
suckling and adult animals##2##4##(1990-11#1)(1992-11#1)
suckling and adult##3##3##(1990-11#1)(1992-11#2)
suckling kids were##2##3##(2010-4#1)(2012-2#1)
suckling kids##6##2##(2010-4#1)(2012-2#5)
suckling lambs##5##2##(2005-7#1)(2010-4#4)
suckling rats##2##2##(2006-10#1)(2008-7#1)
suckling to##3##2##(1990-5#1)(2013-1#2)
suckling##37##1##(1990-11#1)(1990-5#1)(1992-11#4)(1993-2#4)(1993-7#2)(1994-3#1)(2005-7#2)(2006-10#1)(2006-9#1)(2008-7#1)(2008-8#1)(2010-10#2)(2010-4#8)(2012-2#5)(2013-1#3)
suckling-induced prolactin release##2##3##(2010-10#2)
suckling-induced prolactin##3##2##(2010-10#3)
sucralfate##3##1##(1991-3#1)(2007-11#1)(2008-7#1)
sucrase##4##1##(1992-11#1)(1997-8#1)(2004-11#1)(2013-1#1)
sucrase-isomaltase mRNA##2##2##(1990-12#2)
sucrase-isomaltase##7##1##(1990-12#6)(1992-11#1)
sucrose (2%)##2##2##(2013-1#2)
sucrose and 0##2##3##(1993-12#1)(2008-10#1)
sucrose and glucose##2##3##(1990-8#1)(2010-2#1)
sucrose and raffinose##2##3##(1997-2#1)(2008-10#1)
sucrose and starch##2##3##(2004-11#1)(2009-6#1)
sucrose and##27##2##(1990-8#1)(1992-3#1)(1993-12#1)(1994-8#1)(1996-5#1)(1997-2#1)(1997-6#1)(2004-11#1)(2006-4#1)(2006-9#1)(2007-3#1)(2008-10#9)(2008-8#1)(2009-6#1)(2010-2#1)(2011-2#3)(2012-2#1)
sucrose biosensor##2##2##(2008-10#2)
sucrose carrier##2##2##(1992-1#2)
sucrose density centrifugation##2##3##(1991-9#1)(1997-4#1)
sucrose density gradient centrifugation and##2##5##(1992-11#2)
sucrose density gradient centrifugation##7##4##(1991-1#1)(1991-10#1)(1991-11#1)(1992-11#2)(1994-8#1)(1997-3#1)
sucrose density gradient##11##3##(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1992-11#2)(1993-11#1)(1994-8#1)(1995-2#1)(1997-3#1)(2010-12#1)
sucrose density gradients and##2##4##(1992-6#1)(1995-6#1)
sucrose density gradients##6##3##(1992-12#1)(1992-6#1)(1995-6#1)(2008-1#1)(2008-4#1)(2008-8#1)
sucrose density##20##2##(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-9#1)(1992-11#2)(1992-12#2)(1992-6#1)(1993-11#1)(1994-8#1)(1995-2#1)(1995-6#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-4#1)(2008-8#1)(2010-12#1)
sucrose ester##2##2##(2004-2#1)(2008-10#1)
sucrose esters##4##2##(2005-12#4)
sucrose flotation method##2##3##(2007-2#1)(2011-1#1)
sucrose gap##2##2##(1990-5#1)(1997-4#1)
sucrose gradient centrifugation##2##3##(1992-8#1)(1994-9#1)
sucrose gradient##13##2##(1990-7#1)(1991-1#1)(1992-8#1)(1993-12#1)(1994-9#2)(1995-7#1)(1997-4#1)(1997-6#3)(2008-11#1)(2008-8#1)
sucrose gradients in##2##3##(1990-12#1)(1997-3#1)
sucrose gradients##13##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-7#1)(1991-9#1)(1993-12#1)(1994-11#1)(1995-11#1)(1995-7#1)(1997-3#1)(2005-12#1)(2008-1#2)
sucrose in##7##2##(1990-11#1)(1992-3#1)(2008-10#4)(2011-2#1)
sucrose is##2##2##(2008-10#2)
sucrose or##5##2##(1994-12#1)(1994-8#1)(1996-12#1)(2008-10#1)(2008-4#1)
sucrose phosphate synthase##3##3##(1996-10#2)(2011-2#1)
sucrose reinforcement##3##2##(1991-5#1)(1993-6#2)
sucrose sham feeding##2##3##(1991-5#2)
sucrose solution##4##2##(1993-12#1)(1996-2#1)(2008-10#1)(2008-11#1)
sucrose supplemented##2##2##(1995-12#1)(2008-11#1)
sucrose synthase##5##2##(1995-3#1)(1997-6#1)(2009-8#1)(2011-2#2)
sucrose to##3##2##(1994-2#1)(1995-8#1)(2006-5#1)
sucrose transport##3##2##(1992-1#3)
sucrose was not##3##3##(1995-1#1)(2008-5#1)(2009-6#1)
sucrose was##4##2##(1995-1#1)(2008-5#1)(2008-6#1)(2009-6#1)
sucrose with or without non-nutritive sucking (NNS)##2##7##(2008-10#2)
sucrose with or without##3##4##(2008-10#3)
sucrose##253##1##(1990-10#2)(1990-11#3)(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-5#4)(1991-9#2)(1992-1#8)(1992-11#5)(1992-12#2)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#5)(1993-6#3)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#1)(1994-5#1)(1994-8#9)(1994-9#2)(1995-1#2)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#2)(1995-8#1)(1996-10#3)(1996-12#1)(1996-2#1)(1996-4#3)(1996-5#1)(1997-2#1)(1997-3#3)(1997-4#4)(1997-6#5)(2004-11#3)(2004-2#1)(2004-8#3)(2004-9#1)(2005-10#3)(2005-11#3)(2005-12#5)(2006-12#3)(2006-4#1)(2006-5#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-1#5)(2008-10#39)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#9)(2008-6#3)(2008-8#5)(2008-9#1)(2009-6#9)(2009-8#3)(2010-11#2)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#10)(2012-1#3)(2012-2#2)(2012-7#1)(2013-1#4)
sucrose)##5##1##(1997-8#1)(2006-8#1)(2007-8#1)(2010-11#2)
sucrose-cleaving enzymes##2##2##(2009-8#2)
sucrose-specific##2##1##(1990-5#1)(1994-12#1)
suction and##2##2##(2007-10#1)(2012-2#1)
suction bottle##2##2##(2013-1#2)
suction curettage##3##2##(1995-8#2)(2012-2#1)
suction drainage##3##2##(2008-9#1)(2009-3#1)(2011-2#1)
suction in the##2##3##(1991-3#1)(2007-8#1)
suction to##2##2##(2007-8#2)
suction##53##1##(1990-11#1)(1991-3#5)(1992-11#1)(1992-12#2)(1995-3#1)(1995-8#2)(2004-12#1)(2004-7#1)(2005-10#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-10#2)(2007-8#8)(2008-10#1)(2008-11#1)(2008-5#2)(2008-9#1)(2009-2#1)(2009-3#1)(2010-9#1)(2011-2#6)(2012-12#2)(2012-2#4)(2013-1#4)(2013-7#1)
suctorial proboscis in pollen wasps##2##5##(2007-12#2)
sudangrass##3##1##(2008-10#3)
sudden and severe##2##3##(1990-11#1)(2006-4#1)
sudden and unexpected death##2##4##(1990-8#1)(2008-12#1)
sudden and unexpected##4##3##(1990-11#1)(1990-8#1)(2007-11#1)(2008-12#1)
sudden and##12##2##(1990-11#2)(1990-8#1)(1997-1#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-12#1)(2010-11#1)(2011-2#2)
sudden cardiac arrest##2##3##(2010-1#1)(2013-8#1)
sudden cardiac death (SCD)##2##4##(2008-10#1)(2009-9#1)
sudden cardiac death and##3##4##(2007-8#1)(2009-5#1)(2011-1#1)
sudden cardiac death in the##2##5##(2010-3#1)(2013-7#1)
sudden cardiac death in young##2##5##(2008-12#1)(2012-3#1)
sudden cardiac death in##8##4##(1997-8#1)(2007-2#1)(2008-12#1)(2009-10#1)(2010-11#1)(2010-3#1)(2012-3#1)(2013-7#1)
sudden cardiac death is##2##4##(2011-2#2)
sudden cardiac death may##2##4##(1995-3#1)(2006-9#1)
sudden cardiac death##52##3##(1992-6#1)(1993-12#1)(1994-5#2)(1995-2#1)(1995-3#1)(1996-9#1)(1997-8#2)(2005-10#2)(2006-10#2)(2006-7#1)(2006-9#3)(2007-11#1)(2007-2#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-12#2)(2008-4#1)(2008-8#1)(2009-10#3)(2009-5#2)(2009-9#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-3#1)(2013-7#3)(2013-8#1)
sudden cardiac##57##2##(1992-6#1)(1993-12#1)(1994-5#2)(1995-2#1)(1995-3#1)(1996-9#1)(1997-8#2)(2005-10#2)(2006-10#2)(2006-7#1)(2006-9#3)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-12#2)(2008-4#1)(2008-8#1)(2009-10#3)(2009-5#2)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-3#1)(2013-7#4)(2013-8#2)
sudden cardiorespiratory arrest##2##3##(2006-10#2)
sudden change##3##2##(2006-12#1)(2006-6#1)(2008-9#1)
sudden changes in the##2##4##(2007-11#1)(2010-12#1)
sudden changes in##3##3##(2007-11#1)(2010-12#1)(2012-12#1)
sudden collapse##3##2##(1994-4#1)(2006-4#1)(2006-9#1)
sudden coma##2##2##(2006-10#1)(2011-2#1)
sudden contractions##2##2##(2008-7#2)
sudden coronary deaths##2##3##(2010-12#2)
sudden deafness##4##2##(1994-9#3)(2011-2#1)
sudden death and##4##3##(1997-1#2)(2006-9#2)
sudden death in a##3##4##(2007-12#1)(2008-12#1)(2008-3#1)
sudden death in##8##3##(1992-11#1)(1993-8#1)(2007-12#1)(2008-1#1)(2008-12#2)(2008-3#1)(2009-4#1)
sudden death is##3##3##(1992-8#1)(2006-10#1)(2006-9#1)
sudden death of##3##3##(1996-9#1)(2008-10#1)(2013-1#1)
sudden death or##2##3##(2006-9#1)(2010-11#1)
sudden death syndrome##5##3##(2007-8#1)(2008-10#4)
sudden death was##2##3##(2008-10#1)(2011-2#1)
sudden death##74##2##(1991-5#2)(1992-11#1)(1992-8#2)(1993-10#1)(1993-8#2)(1994-11#1)(1996-9#1)(1997-1#3)(1997-2#1)(2005-8#1)(2006-10#4)(2006-5#1)(2006-9#7)(2007-10#1)(2007-12#3)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#2)(2009-10#1)(2009-4#1)(2010-11#3)(2010-12#2)(2010-6#1)(2011-1#2)(2011-2#5)(2012-12#3)(2012-2#3)(2013-1#1)(2013-8#1)
sudden deaths##4##2##(1993-12#1)(2008-1#1)(2008-10#1)(2009-4#1)
sudden decrease##3##2##(1995-3#1)(2008-10#1)(2008-7#1)
sudden drop##2##2##(2006-11#1)(2011-2#1)
sudden exposure to##2##3##(1990-11#1)(1993-12#1)
sudden gains##6##2##(2009-11#6)
sudden hearing loss##3##3##(1995-6#1)(2008-4#1)(2008-7#1)
sudden increase in##4##3##(1991-12#1)(2008-10#1)(2013-1#2)
sudden infant death syndrome (SIDS) and##2##6##(1991-11#1)(1993-12#1)
sudden infant death syndrome (SIDS)##10##5##(1991-11#3)(1991-2#1)(1992-11#1)(1993-12#1)(1993-7#1)(1994-4#1)(2011-1#1)(2013-1#1)
sudden infant death syndrome##26##4##(1991-11#5)(1991-2#1)(1991-8#1)(1991-9#3)(1992-11#1)(1993-12#2)(1993-7#1)(1994-4#2)(1996-11#1)(1996-4#1)(2006-7#1)(2007-12#1)(2007-2#1)(2009-8#1)(2011-1#1)(2012-12#1)(2013-1#2)
sudden infant death##33##3##(1991-11#5)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#4)(1992-11#1)(1992-4#2)(1993-12#2)(1993-7#1)(1994-4#2)(1996-11#1)(1996-4#1)(1996-9#1)(2006-7#1)(2007-12#1)(2007-2#1)(2009-8#1)(2011-1#3)(2012-12#1)(2013-1#2)
sudden infant##36##2##(1991-11#5)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#5)(1992-11#1)(1992-4#2)(1993-12#2)(1993-7#1)(1994-4#2)(1996-11#1)(1996-4#1)(1996-9#1)(2005-6#1)(2005-7#1)(2006-7#1)(2007-12#1)(2007-2#1)(2009-8#1)(2011-1#3)(2012-12#1)(2013-1#2)
sudden jumps##2##2##(2007-11#1)(2008-7#1)
sudden loss of vision##2##4##(2006-10#1)(2012-2#1)
sudden loss of##5##3##(1990-8#1)(1995-3#1)(2006-10#1)(2012-12#1)(2012-2#1)
sudden movements of the##2##4##(2007-3#1)(2011-2#1)
sudden oak death pathogen Phytophthora ramorum##2##6##(2008-10#1)(2009-2#1)
sudden oak death##6##3##(2008-10#5)(2009-2#1)
sudden oak##7##2##(2008-10#6)(2009-2#1)
sudden onset of##12##3##(1996-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#3)(2009-12#1)(2011-2#1)(2012-1#1)
sudden onset##23##2##(1992-12#1)(1993-8#1)(1996-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#4)(2009-12#1)(2011-1#1)(2011-2#1)(2012-1#2)(2013-1#2)
sudden sensorineural hearing loss##4##4##(2008-4#4)
sudden severe anorexia##2##3##(2012-3#2)
sudden severe##3##2##(1993-9#1)(2012-3#2)
sudden unexpected death##2##3##(2005-8#1)(2008-7#1)
sudden unexpected##3##2##(2005-8#1)(2008-7#1)(2013-7#1)
sudden unexplained nocturnal death syndrome##2##5##(2013-7#2)
sudden unexplained nocturnal death##3##4##(1991-11#1)(2013-7#2)
sudden unexplained##5##2##(1991-11#1)(1992-11#1)(1995-1#1)(2013-7#2)
sudden##358##1##(1990-11#4)(1990-8#2)(1991-11#7)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#4)(1991-8#1)(1991-9#6)(1992-10#1)(1992-11#5)(1992-12#2)(1992-4#2)(1992-6#1)(1992-8#2)(1993-10#1)(1993-12#5)(1993-5#1)(1993-7#1)(1993-8#4)(1993-9#1)(1994-11#2)(1994-12#1)(1994-4#3)(1994-5#2)(1994-9#4)(1995-1#2)(1995-2#1)(1995-3#4)(1995-6#3)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#3)(1996-4#1)(1996-7#1)(1996-9#4)(1997-1#5)(1997-2#1)(1997-8#2)(2005-10#2)(2005-6#1)(2005-7#1)(2005-8#2)(2006-10#13)(2006-11#2)(2006-12#2)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#3)(2006-9#12)(2007-10#7)(2007-11#6)(2007-12#8)(2007-2#2)(2007-3#1)(2007-7#2)(2007-8#6)(2008-1#3)(2008-10#29)(2008-11#3)(2008-12#9)(2008-3#3)(2008-4#9)(2008-5#4)(2008-7#11)(2008-8#1)(2008-9#2)(2009-10#4)(2009-11#7)(2009-12#1)(2009-2#2)(2009-4#3)(2009-5#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#6)(2010-12#8)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#9)(2011-12#1)(2011-2#18)(2012-1#2)(2012-12#8)(2012-2#6)(2012-3#3)(2013-1#8)(2013-7#8)(2013-8#5)
sudden-onset##2##1##(2007-12#1)(2011-2#1)
suddenly and unexpectedly##2##3##(1991-9#1)(1996-9#1)
suddenly and##5##2##(1991-9#1)(1996-9#1)(2005-10#1)(2006-10#1)(2008-5#1)
suddenly at##2##2##(1990-6#1)(2009-7#1)
suddenly developed a##2##3##(2005-11#1)(2012-12#1)
suddenly developed##7##2##(1992-1#1)(2005-11#1)(2006-10#1)(2010-12#1)(2010-6#1)(2012-12#1)(2013-8#1)
suddenly shifted##2##2##(2007-12#1)(2009-4#1)
suddenly##37##1##(1990-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1993-2#1)(1993-9#1)(1995-3#1)(1996-1#1)(1996-9#2)(2005-10#1)(2005-11#2)(2006-10#3)(2006-8#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-2#1)(2008-5#1)(2009-4#2)(2009-7#1)(2010-12#2)(2010-6#1)(2010-7#1)(2012-12#2)(2013-1#1)(2013-8#2)
sudomotor##5##1##(1991-11#1)(2009-12#3)(2013-7#1)
sue the##3##2##(1995-12#1)(1996-5#1)(2008-11#1)
sue##14##1##(1991-4#1)(1995-11#1)(1995-12#2)(1995-5#1)(1996-11#1)(1996-12#1)(1996-5#3)(1996-6#1)(1997-5#2)(2008-11#1)
suecica##2##1##(2011-2#2)
sued and##2##2##(1995-6#1)(2007-4#1)
sued for##2##2##(1995-12#1)(1996-6#1)
sued the hospital##3##3##(1995-6#1)(1996-11#2)
sued the##8##2##(1995-6#1)(1996-11#5)(1996-12#1)(1996-6#1)
sued under the Americans with Disabilities Act (ADA) and the##2##10##(1995-12#1)(1996-6#1)
sued##28##1##(1990-3#1)(1993-12#1)(1995-12#3)(1995-6#3)(1996-11#6)(1996-12#2)(1996-6#5)(1997-5#2)(2007-2#1)(2007-4#1)(2008-1#1)(2008-11#1)(2010-3#1)
sues over##2##2##(1994-3#1)(2006-8#1)
sues##3##1##(1992-9#1)(1994-3#1)(2006-8#1)
suf-1##2##1##(1995-6#2)
sufentanil and nitrous oxide##2##4##(1996-6#2)
sufentanil in##4##2##(1991-1#1)(2009-4#1)(2010-7#1)(2013-7#1)
sufentanil##12##1##(1991-1#2)(1993-4#2)(1996-6#2)(2009-4#1)(2010-7#1)(2013-7#1)(2013-8#3)
suffer a##8##2##(2006-10#1)(2006-7#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-8#1)
suffer cardiovascular##2##2##(2008-10#1)(2011-2#1)
suffer chronic##2##2##(2007-10#1)(2013-1#1)
suffer from CI##2##3##(2007-10#2)
suffer from a lack of##2##5##(2008-10#1)(2009-4#1)
suffer from a##14##3##(1990-10#1)(1991-10#1)(1995-1#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-6#1)(2012-2#1)
suffer from an##2##3##(2008-1#1)(2009-8#1)
suffer from both##2##3##(2008-7#1)(2012-2#1)
suffer from chronic##6##3##(1996-2#1)(1997-2#1)(2008-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
suffer from high##3##3##(1997-2#1)(2007-8#1)(2008-1#1)
suffer from mental##3##3##(2008-1#1)(2008-5#1)(2008-9#1)
suffer from negative##3##3##(2013-1#3)
suffer from poor##3##3##(2006-12#1)(2008-2#1)(2008-5#1)
suffer from severe##4##3##(1996-2#1)(2006-8#1)(2010-5#1)(2012-1#1)
suffer from short##2##3##(2007-4#1)(2013-1#1)
suffer from symptoms##2##3##(1996-6#1)(2005-10#1)
suffer from the disadvantages of##2##5##(1990-11#1)(2010-2#1)
suffer from the##7##3##(1990-11#1)(1993-2#1)(2004-12#1)(2007-11#1)(2010-2#1)(2011-12#1)(2012-2#1)
suffer from this##4##3##(2007-10#1)(2008-10#1)(2008-7#1)(2008-9#1)
suffer from##143##2##(1990-10#1)(1990-11#1)(1990-5#1)(1991-10#1)(1991-4#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-11#1)(1995-1#1)(1995-8#1)(1995-9#1)(1996-2#2)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-3#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#3)(2007-11#3)(2007-12#2)(2007-4#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#9)(2008-3#5)(2008-5#3)(2008-6#3)(2008-7#6)(2008-8#2)(2008-9#2)(2009-10#3)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#11)(2013-7#1)(2013-8#1)
suffer in##2##2##(1993-3#1)(2008-1#1)
suffer more##2##2##(1991-4#1)(2008-8#1)
suffer most##2##2##(1991-11#1)(1993-8#1)
suffer of##2##2##(2008-8#1)(2012-12#1)
suffer serious##5##2##(1993-6#1)(2007-10#1)(2008-7#1)(2010-12#1)(2010-7#1)
suffer the##7##2##(2005-8#1)(2008-11#1)(2008-5#1)(2008-8#2)(2009-6#1)(2010-9#1)
suffer##230##1##(1990-10#1)(1990-11#1)(1990-5#1)(1990-6#2)(1991-10#1)(1991-11#1)(1991-2#1)(1991-4#2)(1991-8#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-10#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#2)(1995-1#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-2#2)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-7#1)(1997-8#2)(2004-12#1)(2004-3#1)(2005-10#2)(2005-11#1)(2005-3#1)(2005-7#1)(2005-8#3)(2006-1#2)(2006-10#8)(2006-11#1)(2006-12#2)(2006-2#1)(2006-6#1)(2006-7#2)(2006-8#3)(2007-1#1)(2007-10#7)(2007-11#4)(2007-12#3)(2007-3#1)(2007-4#3)(2007-5#1)(2007-8#3)(2007-9#2)(2008-1#8)(2008-10#10)(2008-11#5)(2008-12#1)(2008-2#9)(2008-3#9)(2008-5#4)(2008-6#3)(2008-7#8)(2008-8#7)(2008-9#3)(2009-10#4)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#8)(2012-3#3)(2013-1#12)(2013-7#1)(2013-8#3)
suffered a fracture##2##3##(2008-11#1)(2008-12#1)
suffered a major##2##3##(1990-9#1)(2006-11#1)
suffered a reduction##2##3##(2008-2#1)(2008-5#1)
suffered a significant##2##3##(2008-12#1)(2012-2#1)
suffered a stroke##3##3##(2007-10#1)(2007-9#1)(2013-1#1)
suffered a##41##2##(1990-9#1)(1992-7#1)(1993-2#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-3#1)(1997-3#1)(1997-6#1)(2005-7#1)(2006-11#3)(2006-4#1)(2006-5#2)(2006-6#1)(2007-10#3)(2007-11#1)(2007-9#3)(2008-11#1)(2008-12#3)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-7#1)(2011-12#1)(2012-2#1)(2013-1#2)
suffered an acute##2##3##(2007-8#1)(2012-12#1)
suffered an injury##2##3##(1995-12#1)(2004-1#1)
suffered an##8##2##(1991-3#1)(1995-12#1)(1997-6#1)(2004-1#1)(2007-8#1)(2007-9#1)(2012-12#1)(2013-8#1)
suffered by the##2##3##(2004-12#1)(2007-4#1)
suffered by##4##2##(2004-12#1)(2007-12#1)(2007-4#1)(2011-2#1)
suffered cardiopulmonary arrest##2##3##(2007-8#1)(2013-1#1)
suffered cerebral infarction##2##3##(2007-10#2)
suffered during their##2##3##(2008-9#2)
suffered during##4##2##(2007-1#1)(2008-9#2)(2009-2#1)
suffered frequent##2##2##(2008-7#1)(2013-1#1)
suffered from a malignant##3##4##(1991-8#1)(1993-2#1)(1995-12#1)
suffered from a##7##3##(1991-8#1)(1993-2#1)(1993-6#1)(1995-12#1)(2007-4#1)(2008-7#1)(2010-7#1)
suffered from acute myocardial infarction##2##5##(1993-12#1)(2007-8#1)
suffered from acute##6##3##(1991-8#1)(1993-12#1)(2006-2#1)(2007-10#1)(2007-8#1)(2013-1#1)
suffered from an##2##3##(2007-8#2)
suffered from any##2##3##(2007-6#1)(2011-12#1)
suffered from chronic##3##3##(1990-3#1)(2009-4#1)(2011-1#1)
suffered from dizziness##2##3##(2007-10#1)(2012-2#1)
suffered from essential##2##3##(1995-10#1)(2010-2#1)
suffered from intermittent##2##3##(1992-2#1)(2013-8#1)
suffered from malnutrition##2##3##(2006-6#2)
suffered from neurological##2##3##(1992-5#1)(1993-6#1)
suffered from recurrent##3##3##(1996-3#1)(2006-5#1)(2007-2#1)
suffered from schizophrenia##3##3##(1991-9#1)(1993-3#1)(2008-7#1)
suffered from severe##5##3##(1991-2#1)(1995-2#1)(2007-8#2)(2012-2#1)
suffered from the##7##3##(1996-5#1)(2005-8#1)(2008-10#1)(2008-5#1)(2012-12#2)(2013-1#1)
suffered from these##2##3##(2008-10#1)(2011-2#1)
suffered from##143##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-6#1)(1991-8#3)(1991-9#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-7#2)(1995-10#1)(1995-12#2)(1995-2#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-5#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#2)(2006-8#2)(2007-10#5)(2007-11#4)(2007-12#1)(2007-2#5)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#15)(2007-9#1)(2008-10#3)(2008-12#1)(2008-5#4)(2008-7#3)(2009-4#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#7)
suffered major##3##2##(1992-9#1)(2008-7#1)(2013-1#1)
suffered more##2##2##(1990-7#1)(2012-9#1)
suffered neurological deterioration##2##3##(2006-8#1)(2007-10#1)
suffered neurological##3##2##(2006-10#1)(2006-8#1)(2007-10#1)
suffered pain in the##2##4##(1997-2#1)(2007-7#1)
suffered pain##3##2##(1992-8#1)(1997-2#1)(2007-7#1)
suffered serious##3##2##(1992-2#1)(1996-3#1)(2012-2#1)
suffered severe##6##2##(1993-7#1)(1996-11#1)(2006-4#1)(2007-8#1)(2008-5#1)(2013-1#1)
suffered the##2##2##(1995-3#1)(2008-5#1)
suffered with##4##2##(2006-7#1)(2008-12#1)(2012-2#1)(2013-1#1)
suffered##306##1##(1990-10#1)(1990-11#2)(1990-12#4)(1990-3#1)(1990-6#1)(1990-7#1)(1990-9#2)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#5)(1991-9#1)(1992-2#2)(1992-5#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-7#2)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#1)(1996-1#2)(1996-11#4)(1996-12#4)(1996-3#3)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-6#3)(1997-7#1)(1997-8#1)(2004-1#1)(2004-12#1)(2005-10#3)(2005-11#1)(2005-12#2)(2005-5#2)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-11#3)(2006-12#1)(2006-2#3)(2006-4#4)(2006-5#5)(2006-6#3)(2006-7#2)(2006-8#5)(2006-9#2)(2007-1#1)(2007-10#13)(2007-11#9)(2007-12#2)(2007-2#5)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#21)(2007-9#7)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#7)(2008-2#3)(2008-5#7)(2008-7#7)(2008-8#2)(2008-9#6)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-1#2)(2010-10#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#4)(2011-12#2)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#3)(2012-9#1)(2013-1#15)(2013-7#1)(2013-8#8)
sufferer##4##1##(1993-6#1)(2011-12#1)(2013-1#2)
sufferers of##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
sufferers##21##1##(1994-2#3)(1996-1#1)(2004-12#2)(2005-11#1)(2006-12#1)(2006-4#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#2)(2010-12#3)(2010-8#1)(2012-12#2)
suffering and##11##2##(1994-12#1)(2005-7#1)(2006-10#2)(2007-7#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
suffering can be##2##3##(2007-8#1)(2009-10#1)
suffering experienced by##2##3##(2005-10#1)(2006-3#1)
suffering for##6##2##(1990-7#1)(1995-5#1)(2005-10#1)(2008-1#1)(2008-11#1)(2013-1#1)
suffering from ADHD##2##3##(2011-2#1)(2013-7#1)
suffering from Alzheimer's disease and##2##5##(2008-7#1)(2011-2#1)
suffering from Alzheimer's disease##3##4##(1994-12#1)(2008-7#1)(2011-2#1)
suffering from MMD and##2##4##(2013-1#2)
suffering from a##13##3##(1990-3#1)(1990-9#1)(1992-12#1)(1992-3#1)(1996-12#2)(2007-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2011-1#1)(2012-12#1)(2012-3#1)
suffering from acute##12##3##(1992-9#1)(1996-7#1)(2006-7#1)(2006-9#1)(2007-2#1)(2007-8#2)(2009-6#1)(2010-1#1)(2010-9#1)(2011-2#2)
suffering from allergic##2##3##(1994-6#1)(2012-2#1)
suffering from both##2##3##(2007-8#1)(2008-2#1)
suffering from breast carcinoma##2##4##(1993-11#1)(2008-7#1)
suffering from bronchial asthma##2##4##(1992-3#1)(2007-2#1)
suffering from cerebral##2##3##(2010-12#1)(2012-2#1)
suffering from chronic low back pain##2##6##(2007-11#1)(2007-7#1)
suffering from chronic renal##2##4##(2008-10#1)(2013-1#1)
suffering from chronic##19##3##(1991-11#1)(1991-2#1)(1991-3#1)(1996-12#1)(1996-4#1)(1996-8#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-8#1)(2010-3#2)(2011-2#2)(2013-1#1)
suffering from clinical depression##2##4##(1991-2#1)(2008-10#1)
suffering from coxarthrosis##4##3##(2007-11#4)
suffering from dementia##2##3##(1992-3#1)(2011-2#1)
suffering from diabetes##4##3##(2006-12#1)(2008-7#1)(2010-12#1)(2010-8#1)
suffering from diarrhea##2##3##(2010-9#1)(2011-1#1)
suffering from diarrhoea##4##3##(2007-2#3)(2007-8#1)
suffering from diseases##2##3##(1990-10#1)(1991-11#1)
suffering from either##2##3##(2007-2#1)(2011-1#1)
suffering from end-stage##2##3##(2012-1#1)(2012-12#1)
suffering from familial##2##3##(2007-4#1)(2012-12#1)
suffering from hemorrhagic##2##3##(2006-10#1)(2008-5#1)
suffering from idiopathic##2##3##(2007-7#1)(2008-7#1)
suffering from knee osteoarthritis##3##4##(2011-1#1)(2012-2#2)
suffering from mental##3##3##(1996-1#2)(2008-7#1)
suffering from moderate to severe##2##5##(1991-11#1)(2008-5#1)
suffering from moderate to##3##4##(1991-11#1)(2008-12#1)(2008-5#1)
suffering from osteoarthritis##3##3##(2010-12#1)(2011-1#1)(2013-1#1)
suffering from paraplegia or paraparesis##2##5##(2012-1#2)
suffering from primary##3##3##(1990-11#2)(1990-8#1)
suffering from pulmonary##2##3##(1990-12#1)(2011-2#1)
suffering from recurrent##7##3##(1991-5#1)(1992-11#1)(1994-12#1)(1994-3#1)(2008-12#1)(2010-6#1)(2012-3#1)
suffering from rheumatoid arthritis and##2##5##(1993-3#1)(2013-1#1)
suffering from rheumatoid arthritis##10##4##(1992-5#1)(1993-3#1)(1997-5#2)(2007-7#2)(2008-3#1)(2012-2#1)(2013-1#2)
suffering from schizophrenia##2##3##(1997-8#2)
suffering from severe##8##3##(2006-6#1)(2006-8#2)(2007-9#1)(2008-2#1)(2008-7#1)(2012-2#1)(2012-3#1)
suffering from surgical diseases##2##4##(1990-5#1)(1991-3#1)
suffering from the same##2##4##(1991-12#1)(2010-2#1)
suffering from the##9##3##(1991-12#1)(1991-9#1)(1993-12#1)(2008-10#1)(2008-2#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-3#1)
suffering from this disease##2##4##(1991-3#1)(2008-6#1)
suffering from this disorder##2##4##(2008-8#1)(2013-8#1)
suffering from this##5##3##(1991-3#1)(2008-6#1)(2008-8#1)(2010-10#1)(2013-8#1)
suffering from toxic##2##3##(1996-5#1)(2010-12#1)
suffering from##364##2##(1990-10#3)(1990-11#5)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#3)(1991-11#5)(1991-12#2)(1991-2#2)(1991-3#7)(1991-4#2)(1991-5#3)(1991-7#1)(1991-9#2)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#3)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#3)(1993-10#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#2)(1994-7#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-9#2)(1996-1#2)(1996-12#4)(1996-2#1)(1996-3#1)(1996-4#3)(1996-5#2)(1996-7#2)(1996-8#3)(1996-9#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#5)(1997-8#2)(2004-3#1)(2004-4#1)(2005-10#1)(2005-7#2)(2005-9#3)(2006-10#4)(2006-12#5)(2006-2#2)(2006-6#3)(2006-7#2)(2006-8#3)(2006-9#1)(2007-10#3)(2007-11#6)(2007-12#1)(2007-2#8)(2007-4#1)(2007-7#8)(2007-8#11)(2007-9#5)(2008-1#3)(2008-10#9)(2008-11#2)(2008-12#4)(2008-2#5)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#17)(2008-8#3)(2008-9#2)(2009-11#1)(2009-4#2)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#4)(2011-1#10)(2011-2#17)(2011-3#1)(2012-1#5)(2012-12#9)(2012-2#11)(2012-3#5)(2013-1#17)(2013-7#3)(2013-8#2)
suffering in##5##2##(1992-5#1)(2008-9#1)(2009-7#1)(2011-1#1)(2012-3#1)
suffering is##2##2##(1991-8#1)(2011-1#1)
suffering of the##2##3##(2008-6#1)(2010-8#1)
suffering of##10##2##(1991-8#1)(2008-2#2)(2008-6#1)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
suffering that##3##2##(1991-8#1)(2006-10#1)(2013-1#1)
suffering the##4##2##(2006-10#1)(2009-10#1)(2011-2#1)(2013-7#1)
suffering to##2##2##(2006-6#1)(2010-12#1)
suffering with##13##2##(2006-12#1)(2006-7#1)(2006-8#7)(2007-8#1)(2010-6#1)(2012-3#2)
suffering##489##1##(1990-10#3)(1990-11#5)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#3)(1991-1#1)(1991-11#5)(1991-12#2)(1991-2#2)(1991-3#7)(1991-4#2)(1991-5#3)(1991-7#1)(1991-8#4)(1991-9#3)(1992-10#1)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#5)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#3)(1993-10#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-6#2)(1994-7#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-9#2)(1996-1#2)(1996-12#5)(1996-2#1)(1996-3#2)(1996-4#3)(1996-5#3)(1996-7#4)(1996-8#3)(1996-9#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#5)(1997-8#2)(2004-3#2)(2004-4#1)(2005-10#4)(2005-7#3)(2005-9#3)(2006-10#9)(2006-11#1)(2006-12#6)(2006-2#2)(2006-3#1)(2006-4#1)(2006-6#4)(2006-7#3)(2006-8#10)(2006-9#1)(2007-10#4)(2007-11#6)(2007-12#1)(2007-2#10)(2007-4#1)(2007-7#10)(2007-8#13)(2007-9#5)(2008-1#5)(2008-10#10)(2008-11#4)(2008-12#5)(2008-2#9)(2008-3#4)(2008-4#2)(2008-5#9)(2008-6#5)(2008-7#21)(2008-8#4)(2008-9#5)(2009-10#4)(2009-11#1)(2009-4#4)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#2)(2010-9#4)(2011-1#13)(2011-2#27)(2011-3#1)(2012-1#5)(2012-12#13)(2012-2#12)(2012-3#13)(2013-1#24)(2013-7#4)(2013-8#5)
suffers from a number of##2##5##(2010-2#1)(2010-6#1)
suffers from a##7##3##(1990-2#1)(1992-10#1)(2005-11#1)(2008-3#1)(2008-5#1)(2010-2#1)(2010-6#1)
suffers from lack of##2##4##(2008-4#1)(2011-1#1)
suffers from poor##2##3##(2008-2#1)(2012-2#1)
suffers from severe##2##3##(2008-10#1)(2010-5#1)
suffers from the fact that the##2##6##(2006-6#1)(2010-5#1)
suffers from the##4##3##(2006-6#1)(2008-5#1)(2008-6#1)(2010-5#1)
suffers from##31##2##(1990-2#1)(1991-1#1)(1992-10#1)(1996-2#1)(1996-6#1)(2004-12#1)(2005-11#1)(2006-12#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2010-2#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
suffers##44##1##(1990-2#1)(1991-1#1)(1992-10#2)(1995-2#1)(1996-2#1)(1996-6#1)(2004-12#1)(2005-11#1)(2006-12#1)(2006-6#1)(2007-12#3)(2007-4#1)(2008-10#7)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#2)(2010-2#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
suffice and##2##2##(2006-6#1)(2008-9#1)
suffice to##3##2##(1990-11#1)(1995-2#1)(2008-2#1)
suffice##12##1##(1990-11#1)(1991-12#1)(1991-2#1)(1995-2#1)(1997-5#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-10#1)(2013-1#1)
suffices for##2##2##(1995-1#1)(2007-12#1)
suffices to##2##2##(1990-11#1)(1995-4#1)
suffices##7##1##(1990-11#1)(1995-1#1)(1995-4#1)(1997-6#1)(2007-12#1)(2008-10#1)(2009-4#1)
sufficiency##8##1##(1990-4#1)(1996-12#1)(1996-3#1)(2007-11#2)(2008-7#1)(2011-2#1)(2012-3#1)
sufficient DNA##2##2##(1997-4#1)(2008-12#1)
sufficient accuracy for##3##3##(2006-9#1)(2008-2#1)(2012-3#1)
sufficient accuracy to##2##3##(2006-9#1)(2008-7#1)
sufficient accuracy##9##2##(2006-9#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2012-3#1)
sufficient affinity to##2##3##(1991-12#1)(1992-12#1)
sufficient amount##11##2##(1990-12#1)(1993-12#1)(1993-2#1)(1997-7#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2011-2#1)
sufficient amounts of the##2##4##(1990-5#1)(1994-9#1)
sufficient amounts of##12##3##(1990-5#1)(1991-12#1)(1992-9#1)(1993-6#1)(1994-5#1)(1994-9#1)(2008-10#1)(2008-11#4)(2011-2#1)
sufficient amounts##16##2##(1990-5#1)(1990-9#1)(1991-12#1)(1992-9#1)(1993-6#1)(1994-5#1)(1994-9#1)(2006-12#1)(2008-10#1)(2008-11#5)(2010-4#1)(2011-2#1)
sufficient and necessary##2##3##(1995-6#1)(2008-2#1)
sufficient and##10##2##(1992-3#1)(1993-1#1)(1994-5#1)(1995-6#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)(2009-8#1)
sufficient attention##3##2##(1990-12#1)(2008-7#1)(2008-9#1)
sufficient blood flow##3##3##(2005-8#1)(2007-9#1)(2008-7#1)
sufficient blood##4##2##(2005-8#1)(2007-9#2)(2008-7#1)
sufficient clinical##2##2##(2007-12#1)(2008-8#1)
sufficient compensation##2##2##(2005-5#1)(2008-3#1)
sufficient concentrations##3##2##(1990-7#1)(2008-3#1)(2010-10#1)
sufficient condition to##2##3##(1996-6#1)(2008-7#1)
sufficient condition##5##2##(1992-9#1)(1996-6#1)(1997-4#1)(2006-7#1)(2008-7#1)
sufficient conditions for checking probabilistic detectabilities##2##6##(2009-12#2)
sufficient conditions for checking##3##4##(2009-12#3)
sufficient contrast##3##2##(2011-1#2)(2012-2#1)
sufficient data for##3##3##(1992-11#1)(1993-8#1)(2012-12#1)
sufficient data##7##2##(1992-11#1)(1993-8#1)(1994-12#1)(2008-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
sufficient detail##4##2##(2005-8#1)(2008-11#2)(2008-8#1)
sufficient empirical##2##2##(2006-12#1)(2011-1#1)
sufficient energy##2##2##(1992-9#1)(2007-12#1)
sufficient epidemiological##2##2##(2008-11#1)(2008-7#1)
sufficient evidence for a##2##4##(2008-1#1)(2012-12#1)
sufficient evidence for##3##3##(2008-1#1)(2008-11#1)(2012-12#1)
sufficient evidence of##2##3##(1990-6#1)(2005-10#1)
sufficient evidence to##4##3##(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#1)
sufficient evidence##11##2##(1990-6#1)(1994-12#1)(2005-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
sufficient follow-up##3##2##(1993-11#1)(2008-10#1)(2011-2#1)
sufficient for a##5##3##(1991-2#1)(2005-9#1)(2007-12#1)(2008-3#1)(2010-4#1)
sufficient for activation of##2##4##(1996-8#1)(2008-4#1)
sufficient for detecting##2##3##(2008-10#1)(2008-3#1)
sufficient for diagnosis##2##3##(2008-7#1)(2010-12#1)
sufficient for expression##2##3##(1993-6#1)(1997-7#1)
sufficient for imaging##2##3##(2007-12#1)(2008-2#1)
sufficient for management of##3##4##(2009-12#1)(2013-1#2)
sufficient for specific##3##3##(1991-5#1)(1993-9#1)(1994-8#1)
sufficient for the development of##2##5##(2008-3#1)(2011-1#1)
sufficient for the treatment of##2##5##(2006-7#1)(2008-10#1)
sufficient for the##31##3##(1991-12#1)(1991-2#2)(1991-6#1)(1992-5#2)(1992-8#1)(1993-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-7#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2009-10#1)(2011-1#2)(2011-2#1)
sufficient for##149##2##(1990-11#1)(1990-3#1)(1990-6#2)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#7)(1995-3#3)(1995-4#1)(1995-8#3)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#3)(1997-8#2)(2005-11#1)(2005-12#1)(2005-9#1)(2006-6#2)(2006-7#1)(2006-9#1)(2007-11#4)(2007-12#5)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-2#2)(2008-3#9)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-1#4)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#2)
sufficient fresh##2##2##(2008-11#1)(2011-12#1)
sufficient funding##2##2##(1991-12#1)(2006-5#1)
sufficient in##6##2##(1992-3#1)(1994-3#1)(1995-3#1)(2004-9#1)(2006-11#1)(2011-2#1)
sufficient information for the##2##4##(1992-8#1)(2013-8#1)
sufficient information for##5##3##(1991-12#1)(1992-8#1)(1994-6#1)(2008-10#1)(2013-8#1)
sufficient information in##2##3##(1992-5#1)(2005-7#1)
sufficient information on the##2##4##(2006-10#1)(2007-10#1)
sufficient information##11##2##(1991-12#1)(1992-5#1)(1992-8#1)(1994-6#1)(2005-7#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-4#1)(2012-2#1)(2013-8#1)
sufficient intensity##2##2##(2004-4#1)(2008-10#1)
sufficient interactions##2##2##(1993-6#1)(2013-8#1)
sufficient level of##2##3##(1990-11#1)(2008-10#1)
sufficient levels of##3##3##(2008-11#1)(2008-5#1)(2010-2#1)
sufficient levels##5##2##(1997-7#1)(2007-8#1)(2008-11#1)(2008-5#1)(2010-2#1)
sufficient number of##10##3##(2006-4#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
sufficient number##11##2##(2006-4#1)(2006-7#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
sufficient numbers of##4##3##(2008-11#1)(2008-7#1)(2008-9#2)
sufficient numbers##5##2##(2008-11#2)(2008-7#1)(2008-9#2)
sufficient or##3##2##(1994-5#1)(2008-2#1)(2008-3#1)
sufficient power to##3##3##(2007-11#1)(2010-8#1)(2012-3#1)
sufficient power##5##2##(2007-11#1)(2008-2#1)(2009-5#1)(2010-8#1)(2012-3#1)
sufficient precision##3##2##(2007-8#1)(2008-10#1)(2013-1#1)
sufficient quality##5##2##(1991-9#1)(2008-10#1)(2008-3#2)(2010-9#1)
sufficient quantities of##4##3##(2007-6#1)(2008-10#2)(2008-11#1)
sufficient quantities##5##2##(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#1)
sufficient rats##2##2##(1994-5#2)
sufficient sample##3##2##(2010-3#1)(2013-1#2)
sufficient selectivity##3##2##(2008-10#3)
sufficient sensitivity to detect##2##4##(2005-8#1)(2008-8#1)
sufficient sensitivity to##4##3##(1995-1#1)(2005-8#1)(2008-10#1)(2008-8#1)
sufficient sensitivity##7##2##(1992-6#1)(1995-1#1)(2005-8#1)(2008-10#2)(2008-3#1)(2008-8#1)
sufficient size##2##2##(2008-8#1)(2009-2#1)
sufficient spatial resolution and##2##4##(2006-6#1)(2008-5#1)
sufficient specificity##2##2##(1996-1#1)(2008-9#1)
sufficient staffing##2##2##(2008-11#1)(2009-4#1)
sufficient temporal##2##2##(2008-3#1)(2011-2#1)
sufficient time for##2##3##(1995-9#1)(2012-3#1)
sufficient time to##2##3##(1994-12#1)(2006-10#1)
sufficient time##4##2##(1994-12#1)(1995-9#1)(2006-10#1)(2012-3#1)
sufficient to account for the##4##5##(1991-3#1)(1995-3#1)(2006-7#1)(2008-7#1)
sufficient to account for##10##4##(1991-2#1)(1991-3#1)(1995-3#1)(1996-8#1)(2006-7#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-11#1)
sufficient to achieve##4##3##(1990-8#1)(1994-5#1)(2005-9#1)(2008-10#1)
sufficient to activate transcription##2##4##(1994-8#1)(1995-2#1)
sufficient to activate##4##3##(1993-4#1)(1994-8#1)(1995-2#1)(2008-4#1)
sufficient to allow##7##3##(1992-12#1)(1994-9#1)(2008-10#2)(2008-3#1)(2008-9#1)(2010-7#1)
sufficient to cause a##2##4##(1995-3#1)(2008-8#1)
sufficient to cause the disease##2##5##(1996-1#1)(1996-6#1)
sufficient to cause the##3##4##(1996-1#1)(1996-6#1)(2010-10#1)
sufficient to cause##11##3##(1993-12#1)(1993-8#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-6#1)(2008-3#1)(2008-8#1)(2010-10#2)(2011-2#1)
sufficient to characterize##2##3##(2006-11#1)(2008-2#1)
sufficient to complete##2##3##(2008-5#1)(2008-9#1)
sufficient to confer increased##2##4##(1995-3#1)(2013-8#1)
sufficient to confer##15##3##(1991-11#1)(1991-7#1)(1992-4#1)(1994-12#1)(1994-9#3)(1995-3#1)(1995-5#1)(1996-5#1)(1997-3#1)(2008-4#1)(2012-11#2)(2013-8#1)
sufficient to control##2##3##(2005-12#1)(2012-12#1)
sufficient to create##2##3##(2007-9#1)(2008-3#1)
sufficient to describe##2##3##(2008-5#1)(2008-6#1)
sufficient to detect##3##3##(2006-9#1)(2008-10#1)(2008-4#1)
sufficient to determine##6##3##(1992-1#1)(1992-11#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
sufficient to direct the##2##4##(1996-5#1)(1997-4#1)
sufficient to elicit##3##3##(1991-2#1)(1992-8#1)(1996-12#1)
sufficient to enhance##2##3##(2007-12#1)(2008-10#1)
sufficient to ensure complete##2##4##(2004-3#1)(2008-11#1)
sufficient to ensure##3##3##(1990-10#1)(2004-3#1)(2008-11#1)
sufficient to excite##2##3##(1992-3#1)(2012-2#1)
sufficient to explain the##12##4##(1992-5#1)(1995-1#1)(1995-8#1)(1996-8#1)(1997-5#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-11#2)(2010-3#1)
sufficient to explain##13##3##(1992-5#1)(1995-1#1)(1995-8#1)(1996-8#1)(1997-5#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-11#2)(2008-8#1)(2010-3#1)
sufficient to generate##2##3##(2008-11#1)(2010-12#1)
sufficient to give##2##3##(1997-6#1)(2008-10#1)
sufficient to identify##4##3##(1992-5#1)(1993-12#1)(2008-1#1)(2008-10#1)
sufficient to increase##5##3##(1992-7#1)(1996-10#1)(2007-8#1)(2008-9#1)(2012-3#1)
sufficient to induce##23##3##(1990-7#1)(1991-5#1)(1992-12#1)(1992-5#1)(1994-2#1)(1994-6#1)(1997-4#3)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-7#1)(2010-11#1)(2010-12#1)(2012-12#2)
sufficient to inhibit##5##3##(1991-10#1)(1991-6#1)(1994-5#1)(1996-1#1)(1996-5#1)
sufficient to initiate##3##3##(1995-2#1)(1997-6#1)(2010-12#1)
sufficient to justify##2##3##(2008-2#1)(2008-7#1)
sufficient to maintain##6##3##(1991-12#1)(1992-12#1)(2006-9#1)(2008-11#1)(2008-8#1)(2010-2#1)
sufficient to make##2##3##(2008-2#1)(2009-8#1)
sufficient to mediate##4##3##(1990-6#1)(1993-8#1)(1994-6#1)(1997-6#1)
sufficient to obtain##4##3##(2006-6#1)(2008-3#2)(2008-9#1)
sufficient to offer protection##2##4##(2008-3#1)(2008-5#1)
sufficient to permit##3##3##(1994-9#1)(1997-7#1)(2007-12#1)
sufficient to prematurely induce##2##4##(1997-4#2)
sufficient to prevent##4##3##(1991-9#1)(1993-11#1)(1994-3#1)(2010-12#1)
sufficient to produce##2##3##(1996-11#1)(2007-12#1)
sufficient to promote##3##3##(1992-3#1)(2008-5#1)(2013-1#1)
sufficient to provide##3##3##(1994-12#1)(2008-10#1)(2008-3#1)
sufficient to raise##2##3##(1996-12#1)(2008-7#1)
sufficient to reach##4##3##(2006-10#1)(2006-12#1)(2008-10#1)(2011-2#1)
sufficient to reduce##3##3##(1995-7#1)(2008-11#1)(2010-4#1)
sufficient to regulate##2##3##(1994-12#1)(1996-5#1)
sufficient to rescue##2##3##(2008-3#1)(2008-9#1)
sufficient to result in##2##4##(2008-10#1)(2010-3#1)
sufficient to stabilize##2##3##(1990-8#1)(1991-9#1)
sufficient to trigger##2##3##(1994-9#1)(1996-10#1)
sufficient to##290##2##(1990-10#1)(1990-2#1)(1990-6#1)(1990-7#2)(1990-8#5)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#4)(1992-3#3)(1992-4#1)(1992-5#3)(1992-7#1)(1992-8#2)(1993-11#3)(1993-12#3)(1993-4#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#5)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#3)(1994-8#3)(1994-9#7)(1995-1#2)(1995-12#2)(1995-2#4)(1995-3#7)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-10#2)(1996-11#3)(1996-12#4)(1996-5#4)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#8)(1997-5#1)(1997-6#8)(1997-7#2)(2004-3#1)(2005-12#1)(2005-3#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#2)(2007-10#1)(2007-11#4)(2007-12#4)(2007-3#1)(2007-5#1)(2007-6#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#19)(2008-11#8)(2008-2#9)(2008-3#12)(2008-4#4)(2008-5#8)(2008-6#3)(2008-7#8)(2008-8#4)(2008-9#6)(2009-10#1)(2009-11#1)(2009-4#1)(2009-8#2)(2010-10#3)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#3)(2010-4#3)(2010-7#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
sufficient##908##1##(1990-10#1)(1990-11#4)(1990-12#4)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#4)(1990-7#3)(1990-8#5)(1990-9#1)(1991-10#3)(1991-11#2)(1991-12#7)(1991-2#7)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#5)(1992-1#1)(1992-11#2)(1992-12#5)(1992-2#2)(1992-3#7)(1992-4#1)(1992-5#6)(1992-6#4)(1992-7#3)(1992-8#6)(1992-9#4)(1993-1#3)(1993-11#7)(1993-12#4)(1993-2#2)(1993-4#2)(1993-5#3)(1993-6#7)(1993-8#7)(1993-9#5)(1994-11#5)(1994-12#8)(1994-2#5)(1994-3#7)(1994-4#1)(1994-5#14)(1994-6#7)(1994-8#6)(1994-9#13)(1995-1#4)(1995-11#2)(1995-12#3)(1995-2#13)(1995-3#12)(1995-4#1)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#6)(1995-9#2)(1996-1#3)(1996-10#3)(1996-11#3)(1996-12#4)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#8)(1996-6#3)(1996-7#1)(1996-8#6)(1996-9#3)(1997-1#4)(1997-2#3)(1997-3#3)(1997-4#13)(1997-5#1)(1997-6#9)(1997-7#9)(1997-8#5)(2004-3#1)(2004-4#1)(2004-9#2)(2005-1#1)(2005-10#1)(2005-11#4)(2005-12#2)(2005-3#1)(2005-4#1)(2005-5#1)(2005-7#2)(2005-8#5)(2005-9#4)(2006-10#8)(2006-11#2)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#4)(2006-6#9)(2006-7#5)(2006-8#1)(2006-9#8)(2007-10#5)(2007-11#15)(2007-12#22)(2007-2#1)(2007-3#2)(2007-4#2)(2007-5#4)(2007-6#5)(2007-8#11)(2007-9#3)(2008-1#8)(2008-10#72)(2008-11#31)(2008-12#5)(2008-2#20)(2008-3#43)(2008-4#13)(2008-5#27)(2008-6#4)(2008-7#24)(2008-8#13)(2008-9#18)(2009-10#3)(2009-11#1)(2009-12#7)(2009-2#1)(2009-4#5)(2009-5#5)(2009-6#3)(2009-7#1)(2009-8#5)(2010-1#1)(2010-10#4)(2010-11#4)(2010-12#7)(2010-2#2)(2010-3#5)(2010-4#6)(2010-5#1)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#9)(2011-12#2)(2011-2#18)(2012-1#2)(2012-11#2)(2012-12#8)(2012-2#11)(2012-3#8)(2013-1#13)(2013-7#1)(2013-8#4)
sufficiently accurate to##2##3##(2009-3#1)(2013-8#1)
sufficiently accurate##6##2##(2006-11#1)(2008-2#1)(2008-3#2)(2009-3#1)(2013-8#1)
sufficiently active##2##2##(1994-8#1)(2006-3#1)
sufficiently demonstrated##2##2##(2008-10#1)(2008-7#1)
sufficiently different##2##2##(1990-7#1)(2008-10#1)
sufficiently divergent##2##2##(2008-10#1)(2008-7#1)
sufficiently extracted##2##2##(2007-1#1)(2008-10#1)
sufficiently flexible to##2##3##(2008-10#1)(2008-11#1)
sufficiently for the##2##3##(1992-7#1)(2005-11#1)
sufficiently for##4##2##(1992-7#1)(2005-11#1)(2008-7#1)(2010-4#1)
sufficiently good##2##2##(2008-3#1)(2012-12#1)
sufficiently high or##2##3##(2008-3#1)(2008-8#1)
sufficiently high to##4##3##(1990-10#1)(2005-7#1)(2008-1#1)(2008-9#1)
sufficiently high##27##2##(1990-10#1)(1990-11#1)(1992-12#1)(1992-3#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-4#1)(2005-7#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-7#1)(2008-8#4)(2008-9#1)(2010-2#1)(2010-6#1)(2011-12#1)(2012-1#1)
sufficiently in##2##2##(2008-10#1)(2008-9#1)
sufficiently intense##2##2##(2007-12#1)(2012-2#1)
sufficiently large to##4##3##(1996-7#1)(2006-12#1)(2007-12#1)(2010-2#1)
sufficiently large##21##2##(1995-3#1)(1996-7#1)(2006-10#1)(2006-12#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-2#1)(2013-8#1)
sufficiently long##4##2##(2005-11#1)(2006-10#1)(2008-11#1)(2012-1#1)
sufficiently low to allow##2##4##(2008-10#1)(2008-3#1)
sufficiently low to##4##3##(2008-10#3)(2008-3#1)
sufficiently low##11##2##(1992-12#1)(1996-2#1)(1997-1#1)(2005-11#2)(2008-10#4)(2008-2#1)(2008-3#1)
sufficiently precise##2##2##(2006-11#1)(2008-10#1)
sufficiently reliable to##2##3##(1990-9#1)(1996-11#1)
sufficiently reliable##4##2##(1990-9#1)(1996-11#1)(2008-10#1)(2013-1#1)
sufficiently rigid to##2##3##(2007-12#1)(2009-7#1)
sufficiently selective##2##2##(2008-10#1)(2008-5#1)
sufficiently sensitive and##2##3##(1990-6#1)(2008-11#1)
sufficiently sensitive to##3##3##(1990-6#1)(2007-8#1)(2008-10#1)
sufficiently sensitive##9##2##(1990-6#2)(1996-8#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-11#2)
sufficiently separated##2##2##(2008-10#1)(2008-3#1)
sufficiently similar##2##2##(1995-5#1)(2008-3#1)
sufficiently simple##3##2##(1997-6#1)(2008-3#1)(2010-8#1)
sufficiently small to##2##3##(1990-9#1)(2008-3#1)
sufficiently small##6##2##(1990-9#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-5#1)
sufficiently soluble##2##2##(1997-8#1)(2012-1#1)
sufficiently stable##4##2##(2007-11#1)(2008-10#1)(2008-11#1)(2009-4#1)
sufficiently strong##2##2##(1996-5#1)(2007-12#1)
sufficiently the##2##2##(1997-8#1)(2007-11#1)
sufficiently to##7##2##(1992-6#1)(1997-2#1)(2005-6#1)(2006-7#1)(2008-10#2)(2013-1#1)
sufficiently using##2##2##(2007-12#1)(2007-8#1)
sufficiently weak##2##2##(1994-5#1)(2007-11#1)
sufficiently##232##1##(1990-1#1)(1990-10#2)(1990-11#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-9#2)(1991-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-2#2)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#2)(1997-8#3)(2005-11#6)(2005-6#1)(2005-7#1)(2006-10#2)(2006-11#2)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-11#4)(2007-12#13)(2007-2#1)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#30)(2008-11#8)(2008-2#17)(2008-3#17)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#7)(2008-9#3)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-12#2)(2012-1#4)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#2)
suffocation##7##1##(1996-6#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
suffruticosa##3##1##(2008-10#1)(2008-5#1)(2011-1#1)
suffusion##2##1##(1990-3#1)(2007-7#1)
sugammadex##3##1##(2010-7#1)(2012-2#2)
sugar (sucrose)##2##2##(1997-8#1)(2008-5#1)
sugar analogs##3##2##(1991-12#1)(1991-4#2)
sugar and methylation analysis##2##4##(1995-11#1)(1995-4#1)
sugar and protein##3##3##(1991-11#1)(2007-3#1)(2008-6#1)
sugar and the##2##3##(2009-9#1)(2013-8#1)
sugar and total##2##3##(2008-12#1)(2011-1#1)
sugar and##23##2##(1991-11#1)(1991-5#1)(1993-9#1)(1995-11#1)(1995-4#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#1)(2009-9#2)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
sugar as##2##2##(1992-12#1)(2008-10#1)
sugar beet (Beta vulgaris)##2##4##(1991-5#1)(2008-10#1)
sugar beet (Beta##3##3##(1991-5#1)(2008-10#1)(2012-3#1)
sugar beet and wheat##3##4##(2008-10#3)
sugar beet and##5##3##(1994-9#1)(2008-10#4)
sugar beet cv##2##3##(2008-12#2)
sugar beet cyst nematode##3##4##(2008-10#1)(2008-12#1)(2009-3#1)
sugar beet genotypes##2##3##(2008-12#2)
sugar beet plant##4##3##(2008-10#2)(2008-12#2)
sugar beet plants##3##3##(2008-10#1)(2008-12#2)
sugar beet seedlings##3##3##(2008-10#3)
sugar beet was##2##3##(2008-10#2)
sugar beet xyloglucan##2##3##(2006-12#2)
sugar beet##59##2##(1991-5#1)(1992-1#1)(1994-9#1)(2006-12#4)(2006-8#1)(2008-10#33)(2008-12#12)(2008-5#3)(2009-3#1)(2012-3#2)
sugar beets and##2##3##(2008-10#2)
sugar beets##4##2##(2008-10#4)
sugar binding sites##2##3##(1991-4#1)(1995-11#1)
sugar binding to the##2##4##(1991-4#2)
sugar binding##11##2##(1991-4#4)(1994-9#1)(1995-11#2)(1996-8#2)(2006-10#1)(2008-10#1)
sugar bound pK(a)##2##3##(2008-10#2)
sugar cane juices using##2##4##(2008-10#2)
sugar cane straw##3##3##(2008-5#3)
sugar cane##10##2##(2008-10#3)(2008-5#5)(2008-6#2)
sugar chain##9##2##(1991-2#1)(2007-11#1)(2008-11#2)(2008-4#1)(2012-11#4)
sugar chains and##2##3##(1991-3#1)(1992-9#1)
sugar chains was##2##3##(1993-11#1)(2012-11#1)
sugar chains were##6##3##(1991-2#2)(1993-11#4)
sugar chains##27##2##(1991-2#6)(1991-3#1)(1992-9#1)(1993-11#10)(1994-11#1)(1994-9#2)(2008-11#1)(2008-4#3)(2012-11#1)(2012-2#1)
sugar composition##4##2##(1990-1#2)(2006-12#1)(2008-5#1)
sugar concentration##4##2##(1994-8#1)(1995-11#2)(2008-7#1)
sugar consumption##3##2##(2008-6#1)(2012-1#2)
sugar content and FW##2##4##(2007-3#2)
sugar content and##3##3##(2007-3#2)(2010-7#1)
sugar content##12##2##(2004-11#1)(2007-11#1)(2007-3#4)(2008-10#3)(2010-7#1)(2013-1#2)
sugar contents##2##2##(2007-3#1)(2008-12#1)
sugar cultivars##2##2##(2011-2#2)
sugar degradation##2##2##(2008-5#2)
sugar derivatives##2##2##(2006-12#1)(2008-5#1)
sugar flux and##2##3##(2009-8#2)
sugar free##2##2##(1995-9#1)(2007-3#1)
sugar in the##7##3##(1991-9#1)(1992-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-1#1)
sugar in##12##2##(1990-2#1)(1991-9#1)(1992-12#1)(1993-9#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
sugar intake##3##2##(1993-9#1)(2008-12#1)(2012-1#1)
sugar into##2##2##(1992-5#1)(2006-10#1)
sugar is##2##2##(1993-9#1)(2005-11#1)
sugar level##5##2##(1994-8#1)(2006-6#2)(2007-9#1)(2008-10#1)
sugar levels##6##2##(1993-11#1)(2008-1#1)(2008-10#3)(2008-3#1)
sugar metabolism##2##2##(1994-6#1)(2009-8#1)
sugar moieties##3##2##(1991-8#1)(2009-8#1)(2012-11#1)
sugar moiety##8##2##(1990-7#1)(1992-6#1)(1993-4#1)(1993-6#1)(1995-12#1)(1996-5#1)(2008-3#1)(2008-4#1)
sugar of the##2##3##(1990-7#1)(1991-10#1)
sugar phosphate##3##2##(2006-12#1)(2008-7#2)
sugar phosphotransferase system##2##3##(1991-12#1)(1995-1#1)
sugar production##6##2##(2008-5#2)(2008-8#1)(2013-1#3)
sugar protons##2##2##(1995-1#1)(1996-7#1)
sugar pucker##2##2##(1991-6#1)(1991-8#1)
sugar puckers##3##2##(1991-7#1)(1991-8#2)
sugar receptors##3##2##(1993-7#3)
sugar recovery from##2##3##(2013-1#2)
sugar recovery##5##2##(2008-5#1)(2013-1#4)
sugar residue##3##2##(1992-12#1)(1992-9#1)(2012-11#1)
sugar residues##7##2##(1991-10#1)(1991-7#1)(1994-11#1)(1995-2#1)(1996-8#1)(2005-11#1)(2006-12#1)
sugar retention##2##2##(2008-10#2)
sugar ring##3##2##(1991-4#1)(1991-8#2)
sugar rings##2##2##(1995-11#1)(2010-2#1)
sugar spheres##6##2##(2008-11#6)
sugar structure##2##2##(1992-2#1)(1996-7#1)
sugar syrup##2##2##(1992-3#1)(2012-2#1)
sugar to##2##2##(1993-9#1)(2011-1#1)
sugar transport in rat##2##4##(1990-4#2)
sugar transport in##3##3##(1990-4#2)(2008-10#1)
sugar transport is##2##3##(1995-11#2)
sugar transport##9##2##(1990-3#2)(1990-4#2)(1991-12#1)(1995-11#2)(2007-6#1)(2008-10#1)
sugar transporter##3##2##(1995-11#1)(2009-8#2)
sugar transporters##4##2##(2006-12#1)(2008-7#1)(2009-8#1)(2010-2#1)
sugar units##3##2##(1994-3#1)(2008-10#1)(2009-10#1)
sugar uptake##6##2##(1995-11#4)(2008-10#1)(2009-3#1)
sugar utilization##3##2##(2008-6#3)
sugar water##3##2##(1997-2#1)(2009-8#1)(2012-12#1)
sugar##445##1##(1990-1#2)(1990-10#2)(1990-2#4)(1990-3#2)(1990-4#2)(1990-5#1)(1990-7#2)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#8)(1991-3#1)(1991-4#10)(1991-5#2)(1991-6#1)(1991-7#4)(1991-8#7)(1991-9#1)(1992-1#1)(1992-12#5)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-11#12)(1993-4#1)(1993-6#1)(1993-7#4)(1993-9#8)(1994-11#2)(1994-12#1)(1994-3#1)(1994-6#3)(1994-8#2)(1994-9#6)(1995-1#4)(1995-11#19)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-11#2)(1996-5#2)(1996-7#3)(1996-8#3)(1997-1#1)(1997-2#2)(1997-8#2)(2004-11#1)(2005-11#6)(2006-10#3)(2006-12#10)(2006-5#1)(2006-6#3)(2006-8#1)(2007-1#1)(2007-11#4)(2007-3#10)(2007-6#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#72)(2008-11#9)(2008-12#20)(2008-2#1)(2008-3#3)(2008-4#14)(2008-5#22)(2008-6#11)(2008-7#4)(2008-8#5)(2008-9#1)(2009-10#2)(2009-12#1)(2009-3#3)(2009-5#2)(2009-6#2)(2009-8#11)(2009-9#5)(2010-10#1)(2010-12#1)(2010-2#3)(2010-6#1)(2010-7#2)(2011-1#8)(2011-2#7)(2012-1#4)(2012-11#7)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#12)(2013-7#1)(2013-8#1)
sugar&quot##3##1##(1996-4#1)(2008-4#2)
sugar)##4##1##(2008-10#2)(2008-6#1)(2010-12#1)
sugar-based##2##1##(2005-11#1)(2007-11#1)
sugar-binding proteins##3##2##(1994-9#2)(2010-10#1)
sugar-binding##7##1##(1990-2#1)(1991-4#1)(1994-9#2)(1995-11#1)(2010-10#1)(2011-1#1)
sugar-centered radicals##2##2##(2007-3#2)
sugar-containing##2##1##(2008-12#1)(2011-2#1)
sugar-coupled TGGs##2##2##(1994-9#2)
sugar-coupled##4##1##(1994-9#4)
sugar-phosphate backbone##3##2##(1992-2#1)(2007-3#1)(2010-7#1)
sugar-specific##3##1##(1991-9#1)(2010-2#2)
sugar-sweetened beverages##4##2##(2011-2#2)(2012-1#2)
sugar-sweetened##5##1##(2010-8#1)(2011-2#2)(2012-1#2)
sugar/salt##2##1##(1991-9#2)
sugarcane and##4##2##(2008-10#4)
sugarcane bagasse hemicellulosic hydrolysate##2##4##(2008-6#2)
sugarcane bagasse##9##2##(2008-5#3)(2008-6#2)(2013-1#4)
sugarcane cultivars##3##2##(2008-10#1)(2011-2#2)
sugarcane cv##2##2##(2008-10#2)
sugarcane in##2##2##(2008-10#2)
sugarcane mosaic virus##3##3##(2008-10#1)(2008-9#2)
sugarcane mosaic##4##2##(2008-10#2)(2008-9#2)
sugarcane rust##2##2##(2008-10#2)
sugarcane straw##2##2##(2013-1#2)
sugarcane##55##1##(2007-12#2)(2008-10#33)(2008-5#6)(2008-6#2)(2008-9#2)(2011-2#4)(2013-1#6)
sugars (glucose##2##2##(2006-2#1)(2008-10#1)
sugars and##19##2##(1990-8#1)(1992-8#1)(1995-8#1)(2006-10#1)(2008-10#8)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2012-1#1)(2012-3#1)
sugars are##3##2##(2007-11#1)(2008-10#1)(2008-5#1)
sugars between##2##2##(1995-11#1)(2011-2#1)
sugars by##3##2##(2004-8#1)(2008-5#1)(2013-1#1)
sugars content##3##2##(2008-10#2)(2008-5#1)
sugars contents##3##2##(2007-3#1)(2008-12#1)(2008-5#1)
sugars for##4##2##(2008-10#1)(2008-5#2)(2011-1#1)
sugars formed##2##2##(1993-11#1)(2008-10#1)
sugars from##2##2##(2004-8#1)(2009-10#1)
sugars in the##5##3##(1990-2#1)(1993-11#1)(2004-11#1)(2008-10#2)
sugars in##14##2##(1990-2#1)(1993-11#1)(1997-2#1)(2004-11#2)(2008-10#5)(2008-5#1)(2010-4#1)(2011-1#1)(2011-2#1)
sugars intake##5##2##(2008-12#4)(2012-1#1)
sugars is##2##2##(2008-5#1)(2008-6#1)
sugars of##4##2##(2009-7#2)(2011-2#1)(2013-1#1)
sugars on##3##2##(2008-5#2)(2012-1#1)
sugars or##5##2##(1990-2#1)(1990-6#1)(1992-12#1)(2008-7#2)
sugars that##2##2##(2011-2#1)(2012-2#1)
sugars to##5##2##(1990-2#1)(1991-12#1)(1993-11#1)(2008-10#1)(2008-5#1)
sugars using##2##2##(2008-10#2)
sugars was##5##2##(1994-8#1)(1997-8#1)(2008-12#2)(2008-6#1)
sugars were##5##2##(1990-9#1)(1992-8#1)(2007-1#1)(2008-5#1)(2008-6#1)
sugars without##2##2##(1995-8#1)(2008-10#1)
sugars##193##1##(1990-2#3)(1990-6#1)(1990-8#1)(1990-9#2)(1991-12#2)(1991-4#1)(1992-1#3)(1992-12#3)(1992-4#2)(1992-8#2)(1993-11#5)(1993-8#1)(1994-3#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#4)(1995-4#1)(1995-6#1)(1995-8#5)(1996-5#1)(1997-2#1)(1997-8#2)(2004-11#2)(2004-8#3)(2005-11#1)(2006-10#1)(2006-2#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#2)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#36)(2008-11#1)(2008-12#17)(2008-2#1)(2008-3#1)(2008-5#21)(2008-6#6)(2008-7#3)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#10)(2012-1#5)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#4)(2013-8#1)
sugars)##2##1##(2008-12#1)(2008-6#1)
sugary drinks##2##2##(2010-8#2)
sugary##4##1##(1997-6#1)(2010-8#3)
suggest (1)##2##2##(1991-5#1)(1997-5#1)
suggest a better##2##3##(2008-5#1)(2008-6#1)
suggest a close##2##3##(1994-2#1)(2007-12#1)
suggest a common##2##3##(1996-3#1)(2010-3#1)
suggest a complex##3##3##(2008-4#1)(2009-11#1)(2009-12#1)
suggest a crucial role of##2##5##(2008-11#1)(2010-5#1)
suggest a direct##6##3##(1991-11#1)(1992-8#1)(1994-9#1)(2007-1#1)(2008-4#1)(2008-7#1)
suggest a fast##2##3##(2008-5#1)(2011-2#1)
suggest a function##2##3##(1993-2#1)(2012-2#1)
suggest a functional##4##3##(1991-5#1)(1993-6#1)(1994-5#1)(2008-8#1)
suggest a general##3##3##(1995-1#1)(1995-8#1)(1997-3#1)
suggest a genetic##2##3##(2007-2#1)(2008-10#1)
suggest a greater##2##3##(1996-12#1)(1996-4#1)
suggest a higher##2##3##(1991-8#1)(1996-7#1)
suggest a key role for##2##5##(1991-3#1)(1996-8#1)
suggest a major##2##3##(2007-10#1)(2011-2#1)
suggest a mechanism for##3##4##(1991-2#1)(1993-11#1)(1994-8#1)
suggest a mechanism of##2##4##(1991-9#1)(1992-3#1)
suggest a mechanism##8##3##(1990-11#1)(1991-2#1)(1991-9#1)(1992-3#1)(1993-11#1)(1994-8#1)(1994-9#1)(1995-8#1)
suggest a method for##3##4##(1996-7#1)(2006-12#1)(2007-12#1)
suggest a model in which##3##5##(1995-2#1)(1995-6#1)(1996-5#1)
suggest a model##6##3##(1995-2#1)(1995-6#1)(1996-5#1)(1997-4#1)(2007-12#1)(2009-8#1)
suggest a molecular basis for the##2##6##(1996-12#1)(2008-8#1)
suggest a molecular##3##3##(1996-12#1)(1997-4#1)(2008-8#1)
suggest a more##2##3##(1997-2#1)(2009-4#1)
suggest a need for##3##4##(1992-7#1)(2009-4#1)(2010-4#1)
suggest a need to##2##4##(1993-10#1)(2011-1#1)
suggest a need##6##3##(1992-7#1)(1993-10#1)(2005-10#1)(2009-4#1)(2010-4#1)(2011-1#1)
suggest a negative##2##3##(2010-11#1)(2011-2#1)
suggest a new##5##3##(1991-2#1)(2007-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
suggest a novel role for##3##5##(1992-2#1)(1997-6#1)(2011-1#1)
suggest a novel##7##3##(1992-2#1)(1994-5#1)(1997-6#1)(2007-11#3)(2011-1#1)
suggest a positive##2##3##(2006-6#1)(2010-6#1)
suggest a possibility that##3##4##(1991-8#1)(1992-4#1)(1994-3#1)
suggest a possible mechanism for##2##5##(1991-3#1)(2011-2#1)
suggest a possible mechanism##3##4##(1991-3#1)(1993-6#1)(2011-2#1)
suggest a possible role for##6##5##(1991-1#2)(1992-3#1)(1997-5#1)(1997-6#1)(2012-2#1)
suggest a possible role of##4##5##(1990-11#1)(1995-3#1)(1995-8#1)(2011-2#1)
suggest a possible role##10##4##(1990-11#1)(1991-1#2)(1992-3#1)(1995-3#1)(1995-8#1)(1997-5#1)(1997-6#1)(2011-2#1)(2012-2#1)
suggest a possible##27##3##(1990-11#1)(1990-8#1)(1991-1#2)(1991-3#1)(1991-5#1)(1992-10#1)(1992-3#1)(1992-5#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-5#2)(1997-6#1)(2006-10#1)(2008-4#1)(2011-2#3)(2012-2#1)(2013-1#2)
suggest a potential for##2##4##(1991-5#1)(2006-11#1)
suggest a potential role for##4##5##(1993-3#1)(2005-7#1)(2006-10#1)(2008-10#1)
suggest a potential role of##2##5##(1995-12#1)(1996-5#1)
suggest a potential role##6##4##(1993-3#1)(1995-12#1)(1996-5#1)(2005-7#1)(2006-10#1)(2008-10#1)
suggest a potential##12##3##(1990-8#1)(1991-5#1)(1993-3#1)(1993-4#1)(1994-9#1)(1995-12#1)(1996-5#1)(2005-7#1)(2006-10#1)(2006-11#1)(2008-10#1)(2013-1#1)
suggest a preferential##2##3##(1997-7#1)(2008-10#1)
suggest a previously##3##3##(2006-8#1)(2013-1#2)
suggest a regulatory role for##2##5##(1990-9#1)(1997-6#1)
suggest a role for this##2##5##(1995-3#1)(2006-8#1)
suggest a role for##24##4##(1990-6#1)(1991-2#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-2#1)(1994-11#1)(1995-3#1)(1996-5#1)(1997-1#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-6#1)(2009-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)
suggest a role of the##2##5##(1992-6#1)(2010-4#1)
suggest a role of##8##4##(1990-10#1)(1990-7#1)(1992-6#1)(1993-11#1)(1994-2#1)(1994-8#1)(2010-4#1)(2013-1#1)
suggest a role##33##3##(1990-10#1)(1990-6#1)(1990-7#1)(1991-2#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#3)(1992-9#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-5#1)(1997-1#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-6#1)(2009-10#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
suggest a secondary##3##3##(2008-9#2)(2009-9#1)
suggest a significant##5##3##(1997-2#1)(2007-11#1)(2009-4#1)(2011-2#1)(2012-3#1)
suggest a simple##3##3##(1994-8#1)(2007-11#1)(2008-9#1)
suggest a specific##6##3##(1991-7#1)(1996-2#1)(1997-6#1)(1997-8#1)(2007-8#1)(2012-2#1)
suggest a strategy##3##3##(2008-10#1)(2010-2#1)(2011-1#1)
suggest a strong##2##3##(2008-12#1)(2012-1#1)
suggest a treatment##2##3##(2007-10#1)(2008-7#1)
suggest a unique##2##3##(2007-12#1)(2013-8#1)
suggest a##317##2##(1990-10#1)(1990-11#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#2)(1991-1#3)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#4)(1991-3#2)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#2)(1992-8#2)(1992-9#2)(1993-10#1)(1993-11#4)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#5)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#6)(1995-1#1)(1995-12#3)(1995-2#3)(1995-3#2)(1995-6#3)(1995-7#1)(1995-8#3)(1996-10#1)(1996-12#3)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#5)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#2)(1997-5#4)(1997-6#4)(1997-7#3)(1997-8#1)(2004-9#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-7#4)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#10)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#3)(2008-10#7)(2008-11#5)(2008-12#3)(2008-3#1)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#4)(2008-8#5)(2008-9#3)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#3)(2009-6#2)(2009-8#1)(2009-9#2)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#1)(2010-6#1)(2011-1#5)(2011-2#14)(2012-1#2)(2012-12#3)(2012-2#9)(2012-3#4)(2012-7#1)(2013-1#9)(2013-7#1)(2013-8#3)
suggest also that##2##3##(1996-8#1)(2006-2#1)
suggest alterations in##2##3##(1994-11#1)(2009-4#1)
suggest an approach##2##3##(2007-9#1)(2008-3#1)
suggest an impact##2##3##(2007-4#1)(2011-1#1)
suggest an impairment of##2##4##(1992-1#1)(1994-3#1)
suggest an impairment##3##3##(1992-1#1)(1994-3#1)(2008-3#1)
suggest an important role for the##2##6##(1995-1#1)(1997-5#1)
suggest an important role for##7##5##(1991-9#1)(1994-3#1)(1995-1#1)(1996-5#1)(1997-5#1)(2008-10#1)(2010-11#1)
suggest an important role of##2##5##(1990-2#1)(1994-3#1)
suggest an important role##9##4##(1990-2#1)(1991-9#1)(1994-3#2)(1995-1#1)(1996-5#1)(1997-5#1)(2008-10#1)(2010-11#1)
suggest an important##12##3##(1990-2#1)(1991-9#1)(1994-3#2)(1995-1#1)(1996-5#1)(1997-5#2)(2008-10#1)(2008-9#1)(2010-11#1)(2010-2#1)
suggest an increased##4##3##(1990-6#1)(2006-10#1)(2008-2#1)(2008-7#1)
suggest an increasing incidence##2##4##(1996-12#1)(2007-12#1)
suggest an inherent effect of the benzyl modification in the mechanism of cell attachment to γ-PGA-Bn scaffolds##2##17##(2012-11#2)
suggest an inhibitory##3##3##(1991-2#1)(1993-12#1)(2008-5#1)
suggest an interaction##4##3##(1990-6#1)(1994-2#1)(1995-12#1)(2008-4#1)
suggest an inverse relationship between##2##5##(2008-3#1)(2010-8#1)
suggest an involvement of##4##4##(1992-12#1)(1992-5#1)(2008-11#2)
suggest an##85##2##(1990-2#1)(1990-6#2)(1990-8#2)(1991-10#2)(1991-12#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-4#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-5#2)(1997-6#2)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-11#2)(2012-12#1)(2013-1#1)
suggest and##2##2##(1995-1#1)(2007-12#1)
suggest any##3##2##(1990-12#1)(1990-6#1)(2008-9#1)
suggest areas##3##2##(1997-5#1)(2010-2#1)(2012-2#1)
suggest better##2##2##(2007-8#1)(2012-2#1)
suggest both##3##2##(1993-2#1)(1994-9#1)(2009-8#1)
suggest caution##3##2##(2006-10#2)(2008-8#1)
suggest changes in the##2##4##(1991-7#1)(1997-3#1)
suggest close##2##2##(2008-7#1)(2012-12#1)
suggest complex##3##2##(1991-1#1)(1992-7#1)(1995-5#1)
suggest decreased##2##2##(1992-7#1)(2012-2#1)
suggest different mechanisms##2##3##(1993-2#1)(1993-4#1)
suggest different patterns##2##3##(2008-10#1)(2013-7#1)
suggest different##10##2##(1993-2#1)(1993-4#1)(1994-3#1)(1997-7#1)(2007-10#1)(2008-10#1)(2008-4#1)(2011-1#1)(2012-2#1)(2013-7#1)
suggest differential##3##2##(1994-12#1)(1994-2#1)(1995-2#1)
suggest diminished atherosclerotic progression in cavernous tissue##2##7##(2009-5#2)
suggest direct##5##2##(1992-6#1)(1995-8#1)(2011-2#1)(2012-12#2)
suggest directions for further##2##4##(1995-12#1)(2008-2#1)
suggest directions for##6##3##(1995-12#1)(2008-11#1)(2008-2#1)(2008-9#1)(2013-1#2)
suggest distinct##3##2##(1992-9#1)(2012-2#1)(2013-8#1)
suggest early##2##2##(1993-9#1)(2006-10#1)
suggest efficacy of##2##3##(2006-10#1)(2006-6#1)
suggest either that##3##3##(1992-8#1)(1993-11#1)(2007-12#1)
suggest either##5##2##(1992-7#1)(1992-8#1)(1993-11#1)(2005-6#1)(2007-12#1)
suggest for the first time that##3##6##(1990-3#1)(1991-8#1)(1992-8#1)
suggest for the first time##4##5##(1990-3#1)(1991-8#1)(1992-8#1)(1994-9#1)
suggest functional##3##2##(1991-2#1)(1994-3#1)(1994-9#1)
suggest further##4##2##(1997-4#1)(2007-12#1)(2008-12#1)(2008-9#1)
suggest future##4##2##(1991-3#1)(2007-10#1)(2011-1#1)(2012-2#1)
suggest great##2##2##(2005-7#1)(2008-10#1)
suggest high##3##2##(2007-8#1)(2008-7#1)(2010-11#1)
suggest higher##3##2##(2007-2#1)(2009-9#1)(2011-1#1)
suggest how future##2##3##(2008-8#1)(2010-7#1)
suggest how##9##2##(1993-2#1)(1994-11#1)(1996-1#1)(2007-11#1)(2008-12#2)(2008-8#1)(2010-3#1)(2010-7#1)
suggest important differences##2##3##(1992-4#1)(2011-2#1)
suggest in##2##2##(2006-5#1)(2008-11#1)
suggest increased##2##2##(2008-10#2)
suggest increasing##2##2##(1994-3#1)(1995-5#1)
suggest interactions##2##2##(1992-6#1)(1996-5#1)
suggest it is##2##3##(2008-10#1)(2008-7#1)
suggest it may##2##3##(2008-10#1)(2011-1#1)
suggest it##8##2##(1994-2#1)(2007-11#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-1#1)(2013-8#1)
suggest its possible##2##3##(2008-12#1)(2013-1#1)
suggest its##10##2##(1992-7#1)(1993-6#1)(1995-12#1)(2007-1#1)(2008-12#1)(2008-5#1)(2009-10#1)(2013-1#2)(2013-7#1)
suggest low##2##2##(2008-10#1)(2008-4#1)
suggest many##2##2##(2008-5#1)(2009-4#1)
suggest marked##2##2##(2007-10#1)(2008-5#1)
suggest moderate##2##2##(2006-5#1)(2008-10#1)
suggest modifications##3##2##(1993-3#1)(2006-10#1)(2013-8#1)
suggest more##4##2##(1993-3#1)(1995-10#1)(2008-10#1)(2010-12#1)
suggest new therapeutic##2##3##(2004-11#1)(2008-7#1)
suggest new##10##2##(1992-6#1)(1997-4#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-3#1)(2008-2#1)(2008-7#2)(2009-12#1)
suggest novel##4##2##(1995-8#1)(2007-11#1)(2008-2#1)(2008-4#1)
suggest possible mechanisms##2##3##(2008-10#1)(2009-8#1)
suggest possible solutions##3##3##(2005-7#1)(2008-6#1)(2008-7#1)
suggest possible##16##2##(1991-9#1)(1995-4#1)(2005-7#1)(2006-3#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-8#2)(2010-2#1)(2012-3#1)
suggest potential##4##2##(2008-5#1)(2009-10#1)(2010-6#1)(2012-3#1)
suggest presence of##2##3##(2005-1#1)(2008-10#1)
suggest relatively##2##2##(2008-1#1)(2012-2#1)
suggest similar##3##2##(2007-10#1)(2010-10#1)(2010-2#1)
suggest some##17##2##(1990-6#1)(1992-12#1)(1992-2#1)(1992-7#1)(1994-10#1)(1997-5#1)(2005-11#1)(2006-10#1)(2007-7#1)(2008-11#1)(2010-2#1)(2010-5#1)(2012-2#1)(2013-1#4)
suggest specific##5##2##(1992-12#1)(1994-8#1)(1997-8#1)(2008-10#2)
suggest strategies to##2##3##(1991-11#1)(2007-2#1)
suggest strategies##3##2##(1991-11#1)(2007-2#1)(2008-12#1)
suggest strongly##3##2##(1991-8#1)(1992-3#1)(1996-2#1)
suggest that (1)##5##3##(1994-5#1)(1995-12#1)(1995-2#1)(2007-9#1)(2011-2#1)
suggest that (a)##5##3##(1993-11#1)(1994-2#1)(1997-8#1)(2008-2#1)(2008-4#1)
suggest that (i) the##2##4##(1995-5#1)(2008-9#1)
suggest that (i)##7##3##(1990-8#1)(1991-11#1)(1991-2#1)(1993-9#1)(1995-5#1)(2008-10#1)(2008-9#1)
suggest that A##2##3##(1994-10#1)(2008-10#1)
suggest that APP##3##3##(1994-11#1)(1994-9#1)(2007-11#1)
suggest that B##2##3##(2008-10#2)
suggest that C##3##3##(2007-2#1)(2008-10#1)(2012-1#1)
suggest that CA##2##3##(1994-12#1)(1995-11#1)
suggest that CB##3##3##(1997-6#1)(2007-8#1)(2010-6#1)
suggest that CC-516##2##3##(2008-5#2)
suggest that CLA##2##3##(2007-8#1)(2008-5#1)
suggest that CRF##2##3##(1994-2#1)(1997-4#1)
suggest that D##3##3##(1995-8#1)(2006-8#1)(2008-10#1)
suggest that DNA##4##3##(1990-6#1)(1990-9#1)(1992-9#1)(2010-5#1)
suggest that EDRF(NO) may##2##4##(1991-12#2)
suggest that EGF##3##3##(1993-9#2)(1995-11#1)
suggest that ET-1 may##2##4##(1991-2#1)(1994-5#1)
suggest that ET-1##3##3##(1991-2#1)(1993-3#1)(1994-5#1)
suggest that EtOH intoxication##2##4##(2007-11#1)(2009-6#1)
suggest that G##4##3##(2007-1#1)(2008-4#1)(2008-5#1)(2010-3#1)
suggest that GH##2##3##(1995-10#1)(1995-3#1)
suggest that GM1##2##3##(1995-5#1)(1996-4#1)
suggest that GR##2##3##(1996-7#1)(2011-2#1)
suggest that HGF may##2##4##(1991-5#1)(1992-9#1)
suggest that HGF##3##3##(1991-5#1)(1992-12#1)(1992-9#1)
suggest that HMG-CoA reductase##2##4##(1994-12#1)(2006-10#1)
suggest that IFN##2##3##(1990-7#1)(1994-8#1)
suggest that IGF-I may##2##4##(1997-4#1)(2008-8#1)
suggest that IGF-I##3##3##(1991-5#1)(1997-4#1)(2008-8#1)
suggest that IL-1 beta##2##4##(1994-9#1)(1996-3#1)
suggest that IL-1##5##3##(1990-12#1)(1994-12#1)(1994-9#1)(1996-3#1)(2007-11#1)
suggest that IVC may##2##4##(1990-10#1)(1990-2#1)
suggest that L-PHP may##2##4##(2013-7#2)
suggest that L-PHP##3##3##(2013-7#3)
suggest that LHRH##2##3##(1995-12#1)(2008-4#1)
suggest that M##2##3##(2008-10#2)
suggest that MT##2##3##(1993-12#1)(2006-9#1)
suggest that NF-kappa B##2##4##(1995-3#1)(1995-8#1)
suggest that NGF may##2##4##(1991-7#1)(1992-7#1)
suggest that NGF##4##3##(1991-7#1)(1992-7#1)(1993-12#1)(1997-6#1)
suggest that NMDA receptors##2##4##(1992-8#1)(1993-5#1)
suggest that NMDA##3##3##(1992-8#1)(1993-5#1)(1996-9#1)
suggest that NO##7##3##(1992-12#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-5#1)(1997-6#1)(2012-2#1)
suggest that P##6##3##(2008-10#4)(2008-12#1)(2012-12#1)
suggest that P2##2##3##(2008-11#1)(2008-4#1)
suggest that PACAP##3##3##(1994-10#1)(1995-11#1)(1997-8#1)
suggest that PAF##2##3##(1991-12#1)(1993-4#1)
suggest that PAI-1##3##3##(1996-2#1)(2007-9#1)(2011-2#1)
suggest that PKC##10##3##(1990-5#1)(1991-4#1)(1991-7#1)(1992-8#1)(1993-3#1)(1993-6#2)(1995-2#1)(1996-8#1)(2008-1#1)
suggest that R##2##3##(1991-4#1)(2008-10#1)
suggest that RA may##2##4##(1992-11#1)(2008-11#1)
suggest that T##3##3##(2006-8#1)(2008-10#1)(2010-2#1)
suggest that TCDD##2##3##(1995-3#1)(2008-10#1)
suggest that TRH##2##3##(1995-5#1)(2013-7#1)
suggest that Zn##2##3##(1993-12#1)(1997-3#1)
suggest that a certain##2##4##(2007-12#1)(2012-2#1)
suggest that a combination of##2##5##(2008-5#1)(2008-6#1)
suggest that a combination##3##4##(2007-11#1)(2008-5#1)(2008-6#1)
suggest that a high concentration of##2##6##(1994-2#1)(2008-10#1)
suggest that a high protein diet##2##6##(1992-9#1)(2008-8#1)
suggest that a high##8##4##(1990-2#1)(1992-9#1)(1993-9#1)(1994-2#1)(2008-10#1)(2008-8#2)(2013-1#1)
suggest that a low##3##4##(1992-1#1)(1993-8#1)(2008-7#1)
suggest that a mechanism##2##4##(1990-4#1)(1995-1#1)
suggest that a model##2##4##(1995-11#1)(2008-10#1)
suggest that a negative##2##4##(1996-8#1)(2006-10#1)
suggest that a number of##2##5##(1993-12#1)(2012-3#1)
suggest that a prolonged##2##4##(1995-3#1)(2005-10#1)
suggest that a reduction in##3##5##(1994-5#1)(2011-2#1)(2013-1#1)
suggest that a significant##2##4##(1992-1#1)(1992-12#1)
suggest that a single##6##4##(1993-3#1)(1996-2#1)(1997-5#1)(2008-10#2)(2009-10#1)
suggest that a small##2##4##(1992-12#1)(2008-1#1)
suggest that a subset of##3##5##(1992-7#1)(1994-12#1)(2006-10#1)
suggest that a##142##3##(1990-10#2)(1990-12#1)(1990-2#3)(1990-4#2)(1990-5#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#4)(1992-12#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-7#1)(1996-2#2)(1996-3#2)(1996-8#3)(1996-9#1)(1997-1#1)(1997-5#1)(1997-8#1)(2004-11#1)(2005-10#1)(2006-10#6)(2006-12#1)(2006-5#2)(2006-6#1)(2006-9#2)(2007-1#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2009-10#4)(2009-8#2)(2010-11#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#6)(2013-8#2)
suggest that abnormal##2##3##(2008-11#1)(2011-2#1)
suggest that acidosis##2##3##(1994-2#1)(1995-7#1)
suggest that activation of##9##4##(1991-2#1)(1992-5#1)(1993-3#1)(1995-10#1)(1995-5#1)(1996-2#1)(2007-7#1)(2008-3#1)(2010-12#1)
suggest that activation##10##3##(1991-2#1)(1992-5#1)(1993-3#1)(1995-10#1)(1995-5#1)(1996-2#1)(2007-7#1)(2008-3#1)(2008-9#1)(2010-12#1)
suggest that activity##2##3##(1990-7#1)(1991-2#1)
suggest that acute##2##3##(1994-3#1)(1997-3#1)
suggest that additional##7##3##(1990-6#1)(1991-9#2)(1993-12#1)(1995-2#1)(2006-7#1)(2012-3#1)
suggest that advanced##2##3##(2006-9#1)(2010-11#1)
suggest that after##2##3##(2004-11#1)(2008-11#1)
suggest that age-related changes##2##4##(2007-12#1)(2008-7#1)
suggest that all the##2##4##(2007-12#1)(2008-8#1)
suggest that all##6##3##(1997-6#1)(2007-12#1)(2008-12#1)(2008-8#1)(2013-7#1)(2013-8#1)
suggest that alpha##4##3##(1990-12#1)(1990-7#1)(1992-1#1)(1994-10#1)
suggest that alterations in##2##4##(1991-1#1)(1995-3#1)
suggest that alterations of##2##4##(1995-10#1)(2008-6#1)
suggest that alterations##4##3##(1991-1#1)(1995-10#1)(1995-3#1)(2008-6#1)
suggest that alternative##4##3##(1991-5#1)(2006-10#1)(2008-6#1)(2009-10#1)
suggest that although beta##2##4##(1991-10#1)(1993-5#1)
suggest that although##16##3##(1991-10#1)(1991-2#1)(1991-4#1)(1993-5#1)(1994-12#1)(1994-8#1)(1996-4#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-12#1)(2010-3#1)(2013-1#3)(2013-8#1)
suggest that ampicillin##2##3##(2008-10#1)(2009-12#1)
suggest that an increase in##2##5##(1991-8#1)(1997-2#1)
suggest that an increase##3##4##(1991-8#1)(1993-6#1)(1997-2#1)
suggest that an##36##3##(1990-2#1)(1990-9#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-2#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-5#1)(1995-3#1)(1995-6#1)(1996-5#2)(1997-2#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-2#1)(2010-6#1)(2012-2#2)(2013-8#1)
suggest that analysis of##2##4##(1995-12#1)(2008-8#1)
suggest that analysis##3##3##(1991-1#1)(1995-12#1)(2008-8#1)
suggest that androgens##2##3##(1990-11#1)(1994-5#1)
suggest that antibodies against the##2##5##(1991-12#1)(2008-4#1)
suggest that any##2##3##(1990-1#1)(1997-5#1)
suggest that apoptosis is##2##4##(1996-2#1)(1997-3#1)
suggest that appropriate##2##3##(1994-10#1)(2008-11#1)
suggest that areas##2##3##(1990-4#1)(1996-5#1)
suggest that artificial turf##2##4##(2013-1#2)
suggest that as##4##3##(1990-11#1)(1995-8#1)(2006-7#1)(2008-8#1)
suggest that astrocytes##2##3##(1993-12#1)(2009-5#1)
suggest that at least some of the##3##7##(1992-12#1)(1996-7#1)(2008-10#1)
suggest that at least some of##4##6##(1992-12#1)(1996-7#1)(2008-10#1)(2012-2#1)
suggest that at least two##2##5##(1993-3#1)(1996-7#1)
suggest that at least##8##4##(1991-3#1)(1991-5#1)(1992-12#1)(1993-3#1)(1996-7#2)(2008-10#1)(2012-2#1)
suggest that at##12##3##(1990-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#1)(1993-3#1)(1995-12#1)(1996-7#3)(2008-10#1)(2012-2#1)
suggest that binding of##2##4##(1993-1#1)(1995-6#1)
suggest that binding##3##3##(1993-1#1)(1993-3#1)(1995-6#1)
suggest that blood##2##3##(2008-5#1)(2013-1#1)
suggest that body##2##3##(2007-12#1)(2013-7#1)
suggest that both T and B##2##6##(1990-4#1)(2006-10#1)
suggest that both of these##2##5##(1994-9#1)(2008-8#1)
suggest that both the##5##4##(1991-12#1)(1991-4#1)(1994-3#1)(1994-9#1)(2013-1#1)
suggest that both##42##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-7#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-12#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#2)(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-5#2)(2012-12#1)(2013-1#1)
suggest that bullying##2##3##(2009-7#2)
suggest that by##4##3##(1994-3#1)(1995-12#1)(2010-2#1)(2010-3#1)
suggest that c-myc##2##3##(1993-11#1)(2008-11#1)
suggest that cAMP##2##3##(1991-3#1)(1994-11#1)
suggest that calcium##2##3##(1991-7#1)(1991-8#1)
suggest that calorie##2##3##(1992-1#1)(2008-5#1)
suggest that cancer##2##3##(1992-4#1)(1992-8#1)
suggest that catechol##2##3##(1993-11#1)(2008-10#1)
suggest that cell##4##3##(1991-1#1)(1992-11#1)(1992-8#1)(2008-11#1)
suggest that cells##2##3##(1995-3#1)(2003-11#1)
suggest that cellular##2##3##(1997-3#1)(2008-5#1)
suggest that certain##9##3##(1994-6#1)(2006-10#1)(2006-9#1)(2007-7#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#1)
suggest that change##2##3##(2008-10#1)(2012-2#1)
suggest that changes in the##3##5##(1991-4#1)(2005-11#1)(2008-5#1)
suggest that changes in##7##4##(1990-3#1)(1991-4#1)(1992-4#1)(2005-11#1)(2008-3#1)(2008-5#1)(2013-1#1)
suggest that children with##3##4##(1990-12#1)(2004-10#1)(2010-2#1)
suggest that children##4##3##(1990-12#1)(2004-10#1)(2010-2#1)(2011-2#1)
suggest that cholinergic##2##3##(1992-8#1)(1993-11#1)
suggest that chronic##7##3##(1992-3#1)(1993-2#1)(1995-12#2)(1996-10#1)(1997-4#1)(2013-1#1)
suggest that circulating##2##3##(2007-11#1)(2012-2#1)
suggest that clinical##2##3##(1995-3#1)(2012-5#1)
suggest that cochlear##2##3##(2012-2#2)
suggest that cognitive##2##3##(1997-8#1)(2012-1#1)
suggest that combination therapy##2##4##(2010-10#1)(2011-2#1)
suggest that combined##2##3##(2008-6#1)(2009-4#1)
suggest that concomitant##2##3##(2011-2#1)(2012-12#1)
suggest that current##3##3##(1992-12#1)(2007-4#1)(2009-12#1)
suggest that cyclic##2##3##(1994-11#1)(2012-7#1)
suggest that cystatin C expression may##2##6##(1990-10#2)
suggest that despite##3##3##(2004-10#1)(2007-8#1)(2008-5#1)
suggest that detection##2##3##(2007-8#1)(2008-2#1)
suggest that dietary##9##3##(1991-2#1)(1992-10#1)(1996-7#1)(2007-8#3)(2008-10#1)(2008-11#1)(2010-2#1)
suggest that diets##2##3##(2008-4#1)(2013-1#1)
suggest that differences in##3##4##(1995-12#1)(2006-10#1)(2008-1#1)
suggest that differences##4##3##(1995-12#1)(2006-10#1)(2008-1#1)(2008-8#1)
suggest that different##11##3##(1990-7#1)(1995-10#1)(1996-5#1)(1997-7#1)(2006-8#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)(2013-8#1)
suggest that diffuse##2##3##(2008-3#1)(2008-7#1)
suggest that direct##3##3##(1992-11#1)(1992-9#1)(2008-10#1)
suggest that disruption of##2##4##(1994-5#1)(2012-2#1)
suggest that distinct##3##3##(1992-3#1)(2004-4#1)(2008-5#1)
suggest that dopamine##2##3##(1993-6#1)(1996-1#1)
suggest that dorsal##2##3##(2004-2#1)(2011-2#1)
suggest that downregulation of##2##4##(2010-12#1)(2013-8#1)
suggest that drugs##2##3##(1996-10#1)(1997-1#1)
suggest that during the##2##4##(1992-9#1)(2007-10#1)
suggest that during##7##3##(1990-7#1)(1991-10#1)(1992-5#1)(1992-9#1)(1994-2#1)(1994-9#1)(2007-10#1)
suggest that dysfunction in##2##4##(2006-8#1)(2008-2#1)
suggest that each##2##3##(1995-10#1)(2009-8#1)
suggest that early##6##3##(1993-12#1)(2007-8#1)(2008-12#1)(2009-1#1)(2012-12#1)(2013-8#1)
suggest that either##9##3##(1993-11#1)(1993-12#1)(1993-2#1)(2006-8#1)(2009-12#1)(2010-12#1)(2010-2#2)(2012-2#1)
suggest that endogenous##8##3##(1990-7#1)(1994-2#1)(1995-12#2)(1996-10#1)(1997-4#1)(2008-3#2)
suggest that endogenously##3##3##(1990-4#1)(1993-9#1)(1994-11#1)
suggest that endometrial##2##3##(1992-12#1)(2006-10#1)
suggest that endothelin##2##3##(1990-6#1)(1992-6#1)
suggest that enhanced##4##3##(1991-9#1)(1996-9#1)(2008-10#1)(2013-1#1)
suggest that enteric##2##3##(2006-10#1)(2008-4#1)
suggest that environmental factors##2##4##(2008-4#1)(2012-2#1)
suggest that environmental##5##3##(1993-11#1)(1996-6#1)(2008-4#1)(2011-12#1)(2012-2#1)
suggest that ethanol##3##3##(1997-8#1)(2006-10#1)(2008-11#1)
suggest that evaluation##2##3##(2006-10#1)(2008-10#1)
suggest that even##4##3##(2007-2#1)(2008-3#1)(2012-2#1)(2013-1#1)
suggest that exposure to the##3##5##(2007-12#2)(2008-10#1)
suggest that exposure to##9##4##(1997-1#1)(2004-4#1)(2007-12#2)(2008-10#1)(2008-5#1)(2009-9#1)(2011-1#1)(2012-3#1)
suggest that exposure##10##3##(1997-1#1)(2004-4#1)(2007-12#2)(2008-10#1)(2008-5#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
suggest that expression of##5##4##(1992-9#2)(1995-3#1)(1995-7#1)(1996-11#1)
suggest that extracellular##6##3##(1990-8#1)(1994-11#1)(1997-1#1)(1997-6#1)(2006-5#1)(2008-8#1)
suggest that facilitation##2##3##(1991-5#1)(1993-2#1)
suggest that factors other than##2##5##(1997-2#1)(2011-2#1)
suggest that factors##4##3##(1993-6#1)(1997-2#1)(2008-8#1)(2011-2#1)
suggest that family planning##2##4##(2006-4#1)(2012-11#1)
suggest that family##5##3##(2006-4#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#1)
suggest that fat##2##3##(1994-11#1)(1996-4#1)
suggest that fatty##2##3##(2006-10#1)(2011-1#1)
suggest that female##2##3##(1993-5#1)(2008-8#1)
suggest that females##2##3##(2008-8#1)(2009-9#1)
suggest that fibroblasts##2##3##(1995-5#1)(2007-2#1)
suggest that for some##2##4##(2008-7#1)(2012-12#1)
suggest that for##10##3##(1990-3#1)(1992-11#1)(1995-2#1)(1996-12#1)(2008-7#1)(2009-12#1)(2009-7#1)(2012-12#2)(2012-2#1)
suggest that free##3##3##(1996-3#1)(2007-9#1)(2008-5#1)
suggest that frequency##2##3##(2006-8#1)(2011-2#1)
suggest that fully##2##3##(1997-5#1)(2008-12#1)
suggest that functional##6##3##(1995-2#1)(1996-10#1)(1996-7#1)(2007-9#1)(2008-11#1)(2008-5#1)
suggest that further studies are needed to##2##7##(1994-10#1)(2013-8#1)
suggest that further studies##4##4##(1990-12#1)(1994-10#1)(2009-8#1)(2013-8#1)
suggest that further##11##3##(1990-12#1)(1993-11#1)(1994-10#1)(2007-4#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
suggest that gene flow##2##4##(2008-10#1)(2012-11#1)
suggest that gene##5##3##(1991-8#1)(1992-8#1)(1997-1#1)(2008-10#1)(2012-11#1)
suggest that genetic##4##3##(2006-10#1)(2008-10#3)
suggest that glucose##3##3##(1994-3#1)(2007-11#1)(2007-8#1)
suggest that growth factors##2##4##(1994-2#1)(1995-12#1)
suggest that growth##5##3##(1991-12#1)(1993-9#1)(1994-2#1)(1995-12#1)(2008-7#1)
suggest that having##2##3##(2008-11#1)(2010-2#1)
suggest that high levels of##2##5##(2008-10#1)(2013-8#1)
suggest that high##5##3##(1992-11#1)(2008-10#1)(2008-8#1)(2010-5#1)(2013-8#1)
suggest that higher##3##3##(1991-12#1)(2008-7#1)(2012-3#1)
suggest that hippocampal##3##3##(1991-5#1)(2008-11#1)(2008-7#1)
suggest that homologous##2##3##(1994-8#1)(1995-6#1)
suggest that hospitals##2##3##(1992-5#1)(1997-1#1)
suggest that human##8##3##(1990-12#1)(1990-2#1)(1990-9#1)(1994-2#1)(2008-2#1)(2008-8#1)(2012-1#1)(2012-11#1)
suggest that impairment of##2##4##(1994-10#1)(1994-6#1)
suggest that implementation##3##3##(2007-8#1)(2012-11#2)
suggest that in addition to##7##5##(1992-7#1)(1992-9#1)(1993-3#1)(1993-9#1)(1996-10#1)(2006-10#1)(2008-4#1)
suggest that in the absence of##3##6##(1990-2#1)(2006-10#1)(2009-8#1)
suggest that in the##10##4##(1990-2#1)(1990-3#1)(1990-5#1)(1992-3#1)(1994-11#1)(1996-1#1)(2006-10#1)(2007-8#1)(2008-10#1)(2009-8#1)
suggest that in vitro##2##4##(1993-1#1)(1994-12#1)
suggest that in##61##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-3#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-12#2)(1995-5#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#2)(2006-10#3)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-8#2)(2010-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
suggest that inclusion of##2##4##(1993-3#1)(1995-1#1)
suggest that increased##16##3##(1992-3#1)(1993-11#1)(1994-3#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-6#1)(1996-9#1)(1997-7#1)(2009-12#1)(2010-4#1)(2010-7#1)(2011-2#2)
suggest that increasing##3##3##(2005-10#1)(2008-11#1)(2008-6#1)
suggest that indirect##2##3##(1990-2#1)(2008-8#1)
suggest that individual differences##2##4##(2008-11#1)(2013-8#1)
suggest that individual##6##3##(1995-12#1)(1996-8#1)(2008-1#1)(2008-11#1)(2012-12#1)(2013-8#1)
suggest that individuals who##2##4##(2007-12#1)(2008-12#1)
suggest that individuals##4##3##(2007-12#1)(2007-2#1)(2008-12#1)(2010-11#1)
suggest that induced resistance is the##2##6##(2008-10#2)
suggest that induced##4##3##(2008-10#3)(2008-8#1)
suggest that induction of##3##4##(1995-5#1)(1995-6#1)(2008-11#1)
suggest that inhibition of##7##4##(1992-5#1)(1992-9#1)(1994-11#1)(1996-1#1)(1996-2#1)(1996-5#1)(2010-11#1)
suggest that inoculum##2##3##(2008-10#2)
suggest that inositol##2##3##(1990-2#1)(1992-8#1)
suggest that insulin##4##3##(1990-10#1)(1990-6#1)(1990-7#1)(2008-7#1)
suggest that interaction of##2##4##(1990-9#1)(2009-8#1)
suggest that interaction##3##3##(1990-9#1)(1992-6#1)(2009-8#1)
suggest that interactions between##2##4##(1996-1#1)(2010-12#1)
suggest that interactions##5##3##(1994-8#1)(1996-1#1)(2008-10#1)(2008-8#1)(2010-12#1)
suggest that intracellular##5##3##(1993-6#1)(1995-8#1)(1996-2#1)(1996-9#1)(2008-10#1)
suggest that it has##4##4##(1996-10#1)(1996-8#1)(2006-10#1)(2008-10#1)
suggest that it is a##3##5##(1994-6#1)(2006-10#1)(2007-9#1)
suggest that it is important to##2##6##(1995-1#1)(2006-4#1)
suggest that it is the##2##5##(1990-2#1)(1995-1#1)
suggest that it is##13##4##(1990-2#1)(1990-4#1)(1994-11#1)(1994-6#1)(1995-1#2)(1996-12#1)(1996-3#1)(2006-10#1)(2006-4#1)(2007-9#1)(2008-10#1)(2011-2#1)
suggest that it may be possible to##3##7##(1997-4#1)(1997-8#1)(2008-3#1)
suggest that it may be##11##5##(1993-2#1)(1997-4#1)(1997-8#1)(2004-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#1)(2011-12#1)(2013-8#1)
suggest that it may play##2##5##(1991-11#1)(1992-12#1)
suggest that it may##14##4##(1991-11#1)(1992-12#1)(1993-2#1)(1997-4#1)(1997-8#1)(2004-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#1)(2011-12#1)(2013-8#1)
suggest that it##41##3##(1990-2#1)(1990-4#1)(1991-11#1)(1991-8#1)(1992-12#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-1#2)(1996-10#1)(1996-12#1)(1996-3#2)(1996-8#1)(1997-4#2)(1997-8#1)(2004-1#1)(2005-9#1)(2006-10#2)(2006-4#1)(2007-9#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
suggest that its##3##3##(1996-3#1)(2007-11#1)(2008-7#1)
suggest that lack of##2##4##(2008-5#1)(2012-11#1)
suggest that large##5##3##(1994-5#1)(1995-12#1)(1996-4#1)(2008-11#1)(2008-8#1)
suggest that lepirudin may be##2##5##(2007-11#2)
suggest that levels of##2##4##(2008-7#1)(2010-2#1)
suggest that ligand##2##3##(1997-5#1)(2003-11#1)
suggest that limited##3##3##(1993-9#1)(1994-8#1)(2009-10#1)
suggest that liver##2##3##(1991-2#1)(2010-8#1)
suggest that local##8##3##(1996-12#2)(2006-10#2)(2008-9#1)(2009-10#1)(2011-2#2)
suggest that long-term##6##3##(1991-2#1)(1991-3#1)(1994-5#1)(1994-6#1)(2008-6#1)(2008-8#1)
suggest that longer##3##3##(1992-2#1)(1992-9#2)
suggest that loss of##3##4##(2011-1#1)(2011-2#1)(2012-12#1)
suggest that low##5##3##(1994-5#1)(1995-12#1)(2008-11#1)(2008-8#1)(2009-2#1)
suggest that lower##3##3##(2004-11#1)(2009-12#1)(2012-1#1)
suggest that lung##3##3##(2005-8#1)(2008-7#1)(2012-12#1)
suggest that malaria##2##3##(2005-8#1)(2008-4#1)
suggest that males##3##3##(2006-6#1)(2008-8#1)(2012-11#1)
suggest that many of the##5##5##(1992-4#1)(1993-3#1)(2008-6#1)(2008-7#1)(2008-9#1)
suggest that many##12##3##(1992-4#1)(1992-8#1)(1993-3#1)(1994-2#1)(1996-6#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2013-1#2)
suggest that maternal##5##3##(1996-11#1)(2007-12#1)(2008-2#1)(2010-8#1)(2011-1#1)
suggest that melatonin##2##3##(1994-5#1)(2008-8#1)
suggest that membrane##3##3##(1994-8#1)(1997-6#1)(2008-4#1)
suggest that metabolic##2##3##(2010-2#1)(2011-2#1)
suggest that miRNAs##2##3##(2010-11#1)(2011-2#1)
suggest that mild##2##3##(2008-5#1)(2008-7#1)
suggest that mirror exposure##2##4##(2006-6#2)
suggest that molecular##3##3##(1995-3#1)(2008-9#1)(2012-2#1)
suggest that monitoring##3##3##(2006-8#1)(2011-2#1)(2013-7#1)
suggest that monkeys with##2##4##(1992-11#1)(1993-11#1)
suggest that monkeys##3##3##(1992-11#2)(1993-11#1)
suggest that more than##2##4##(1997-1#1)(2012-11#1)
suggest that more##4##3##(1997-1#1)(2008-4#1)(2011-2#1)(2012-11#1)
suggest that morphine##2##3##(1991-3#1)(1992-3#1)
suggest that most of the##2##5##(1990-5#1)(1995-1#1)
suggest that most##8##3##(1990-5#1)(1992-12#1)(1995-1#1)(1996-9#1)(1997-2#1)(2007-12#1)(2008-1#1)(2013-1#1)
suggest that mu##2##3##(1993-12#1)(2009-7#1)
suggest that multiple##6##3##(1990-3#1)(1991-6#1)(1992-6#1)(1997-3#1)(2008-10#1)(2012-3#1)
suggest that music##2##3##(2008-11#1)(2008-5#1)
suggest that mutation##2##3##(1995-8#1)(1997-7#1)
suggest that nanoparticle##2##3##(2008-3#1)(2010-9#1)
suggest that neither##5##3##(1990-11#1)(1992-11#1)(1994-8#1)(1995-3#1)(2008-10#1)
suggest that neurons##4##3##(1995-12#1)(1996-6#1)(1997-6#1)(2012-2#1)
suggest that new##3##3##(2007-12#1)(2008-10#1)(2012-11#1)
suggest that nonlinear##2##3##(2007-12#1)(2008-3#1)
suggest that not only##3##4##(1991-9#1)(1992-9#1)(2008-12#1)
suggest that not##4##3##(1991-9#1)(1992-3#1)(1992-9#1)(2008-12#1)
suggest that novel##2##3##(1990-4#1)(2011-2#1)
suggest that nuclear##4##3##(1994-9#1)(1996-1#1)(2012-12#2)
suggest that nucleotide##2##3##(2009-5#1)(2010-3#1)
suggest that obesity##2##3##(1991-7#1)(2006-9#1)
suggest that older##2##3##(2009-7#1)(2012-12#1)
suggest that one##10##3##(1991-11#1)(1991-12#1)(1994-3#1)(1994-9#1)(1995-6#1)(1995-8#1)(2008-2#1)(2008-5#1)(2009-3#1)(2013-8#1)
suggest that only##2##3##(2005-11#1)(2011-2#1)
suggest that optimal##2##3##(1997-7#1)(2008-5#1)
suggest that other##6##3##(1990-2#1)(1990-3#1)(1992-9#1)(1993-6#1)(2013-1#1)(2013-8#1)
suggest that our##8##3##(1990-2#1)(1994-9#1)(1995-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
suggest that overall##2##3##(1997-1#1)(2007-4#1)
suggest that overexpression of##5##4##(1992-12#1)(2008-10#2)(2009-5#1)(2012-2#1)
suggest that p72syk is a##2##5##(1992-6#1)(1993-11#1)
suggest that parental##3##3##(2008-11#1)(2009-10#1)(2010-1#1)
suggest that participants##2##3##(2012-2#1)(2013-8#1)
suggest that patient##2##3##(2006-10#1)(2008-1#1)
suggest that patients who##2##4##(2008-10#1)(2012-1#1)
suggest that patients with schizophrenia##2##5##(1996-7#1)(1996-8#1)
suggest that patients with##7##4##(1993-11#1)(1996-7#1)(1996-8#1)(2007-6#1)(2007-9#1)(2011-2#1)(2012-2#1)
suggest that patients##10##3##(1993-11#1)(1996-7#1)(1996-8#1)(2004-10#1)(2007-6#1)(2007-9#1)(2008-10#1)(2011-2#1)(2012-1#1)(2012-2#1)
suggest that patterns of##2##4##(2008-8#1)(2009-9#1)
suggest that people##2##3##(2009-6#1)(2012-1#1)
suggest that performance##3##3##(1992-11#1)(2009-4#1)(2013-7#1)
suggest that perhaps##2##3##(1994-11#1)(2010-3#1)
suggest that perioperative##2##3##(1997-6#1)(2006-10#1)
suggest that peripheral##4##3##(1990-7#1)(1991-2#1)(1997-2#1)(2012-1#1)
suggest that personality##2##3##(2008-11#1)(2009-12#1)
suggest that pharmacologically##2##3##(1990-5#1)(2012-12#1)
suggest that phosphatidic acid##2##4##(1991-10#1)(1994-3#1)
suggest that phosphorylation of##3##4##(1990-11#1)(1990-3#1)(1994-9#1)
suggest that physicians##2##3##(1991-1#1)(2006-10#1)
suggest that plasma##3##3##(1995-7#1)(2007-9#1)(2012-3#1)
suggest that platelet##3##3##(1990-6#1)(1992-8#2)
suggest that polyamines may##2##4##(1991-10#1)(2008-10#1)
suggest that poor##4##3##(1995-7#1)(2008-11#1)(2009-5#1)(2013-1#1)
suggest that populations##2##3##(2008-10#1)(2010-8#1)
suggest that prenatal exposure to##2##5##(1991-1#1)(2004-11#1)
suggest that prenatal##3##3##(1991-1#1)(2004-11#1)(2008-10#1)
suggest that presynaptic##3##3##(1994-12#1)(1995-12#1)(1997-2#1)
suggest that previous##2##3##(1994-2#1)(2013-8#1)
suggest that previously##2##3##(1990-4#1)(1995-12#1)
suggest that primary##3##3##(1993-12#1)(1994-2#1)(1995-11#1)
suggest that problem-solving therapies##2##4##(1993-2#2)
suggest that progressive##2##3##(2006-8#1)(2012-1#1)
suggest that prolonged##3##3##(1994-11#1)(2006-10#1)(2007-11#1)
suggest that prophylactic administration of##2##5##(2007-11#1)(2008-7#1)
suggest that protein kinase C##2##5##(1990-5#1)(1995-6#1)
suggest that protein kinase##3##4##(1990-5#1)(1992-12#1)(1995-6#1)
suggest that protein##11##3##(1990-5#1)(1990-7#1)(1991-11#1)(1991-6#1)(1992-12#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-6#1)(1997-6#1)
suggest that psychiatric##2##3##(1996-5#1)(2008-1#1)
suggest that quantitative##2##3##(1993-12#1)(2008-2#1)
suggest that rat##2##3##(1990-4#1)(1995-10#1)
suggest that rather than##2##4##(2008-10#2)
suggest that recognition##2##3##(1993-3#1)(2007-12#1)
suggest that recombination##2##3##(2008-10#2)
suggest that red##2##3##(1995-3#1)(2009-3#1)
suggest that reduced##3##3##(1993-8#1)(1994-6#1)(2010-10#1)
suggest that reducing##2##3##(2009-10#1)(2010-8#1)
suggest that regulation of##4##4##(1995-11#1)(1995-12#1)(1996-3#1)(2008-8#1)
suggest that regulation##5##3##(1995-11#1)(1995-12#1)(1996-3#1)(2008-8#1)(2009-10#1)
suggest that release##3##3##(1991-8#1)(1994-12#1)(1996-8#1)
suggest that researchers consider##2##4##(2007-2#1)(2012-12#1)
suggest that researchers##4##3##(2004-10#1)(2007-2#1)(2010-6#1)(2012-12#1)
suggest that resistance##2##3##(2008-10#2)
suggest that respiratory##3##3##(1996-5#1)(2008-7#1)(2013-1#1)
suggest that retinoids##2##3##(1993-12#1)(2008-4#1)
suggest that salt##2##3##(2007-7#1)(2009-6#1)
suggest that schools of nursing##2##5##(2008-11#1)(2010-8#1)
suggest that secondary##2##3##(1994-9#1)(2008-10#1)
suggest that selection##3##3##(1997-7#1)(2008-10#2)
suggest that sequences##3##3##(1992-12#1)(1994-12#1)(1995-2#1)
suggest that serum##3##3##(1990-10#1)(1990-3#1)(2013-8#1)
suggest that several##8##3##(1993-1#1)(1994-9#1)(1997-7#2)(2008-10#1)(2010-12#1)(2010-2#1)(2010-6#1)
suggest that sex##2##3##(1991-12#1)(2008-9#1)
suggest that sexting is##2##4##(2013-1#2)
suggest that short-term##5##3##(2006-10#1)(2006-9#1)(2007-11#1)(2008-10#1)(2010-8#1)
suggest that signal##3##3##(1997-8#1)(2008-10#1)(2010-5#1)
suggest that signaling##2##3##(1996-5#1)(2008-4#1)
suggest that significant##2##3##(1996-2#1)(1997-2#1)
suggest that similar##3##3##(2008-4#1)(2008-8#1)(2012-2#1)
suggest that simple##2##3##(1997-6#1)(2008-7#1)
suggest that single##2##3##(1997-2#1)(2012-1#1)
suggest that skin##2##3##(1994-9#1)(2008-5#1)
suggest that social##2##3##(2006-4#1)(2011-2#1)
suggest that some components of the##2##6##(2006-12#1)(2008-10#1)
suggest that some of the##4##5##(1995-8#1)(1996-6#1)(2008-7#1)(2008-9#1)
suggest that some##17##3##(1990-2#1)(1993-11#1)(1993-12#1)(1993-4#1)(1995-1#1)(1995-8#1)(1996-6#1)(1996-8#1)(2006-12#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#2)(2010-3#1)(2010-9#1)
suggest that species##3##3##(2008-8#2)(2009-4#1)
suggest that specific##9##3##(1990-11#1)(1992-12#1)(1997-1#1)(1997-4#1)(2005-7#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-12#1)
suggest that spinal##2##3##(1997-8#1)(2006-11#1)
suggest that stimulation of##6##4##(1990-9#1)(1994-2#1)(1994-9#1)(1996-12#1)(1997-7#2)
suggest that strategies##2##3##(2009-7#1)(2012-2#1)
suggest that stress##2##3##(1994-11#1)(2004-12#1)
suggest that strong##2##3##(1996-12#1)(2009-8#1)
suggest that such patients##2##4##(2007-10#1)(2010-12#1)
suggest that such##8##3##(1990-7#1)(1993-3#1)(1997-3#1)(1997-5#1)(2007-10#1)(2008-11#1)(2008-12#1)(2010-12#1)
suggest that sugarcane##2##3##(2008-10#2)
suggest that suppression of##3##4##(1992-4#1)(2008-10#1)(2008-11#1)
suggest that surfactant##2##3##(1994-5#1)(2008-10#1)
suggest that surgery##2##3##(2007-11#1)(2007-7#1)
suggest that susceptibility of##2##4##(2007-6#1)(2008-10#1)
suggest that systemic##3##3##(1992-3#1)(1995-2#1)(2008-10#1)
suggest that targeted##3##3##(2006-10#1)(2007-5#1)(2010-10#1)
suggest that targeting##2##3##(2008-1#1)(2012-2#1)
suggest that the &quot##4##4##(1991-1#1)(2007-12#1)(2008-10#1)(2008-11#1)
suggest that the B##2##4##(1992-12#1)(1995-6#1)
suggest that the C-terminal##3##4##(1991-7#1)(1996-5#1)(2008-9#1)
suggest that the ER##3##4##(1991-6#1)(1992-7#1)(1996-9#1)
suggest that the N-terminal region of##2##6##(1991-5#1)(1991-7#1)
suggest that the N-terminal##3##4##(1991-5#1)(1991-7#1)(1997-1#1)
suggest that the ability to##3##5##(1990-11#1)(1992-10#1)(2008-4#1)
suggest that the ability##5##4##(1990-11#1)(1992-10#1)(1995-3#1)(2008-10#1)(2008-4#1)
suggest that the abnormal##2##4##(1991-12#1)(2008-8#1)
suggest that the above##3##4##(1990-9#1)(1991-6#1)(1994-9#1)
suggest that the action of##2##5##(1996-1#1)(2006-10#1)
suggest that the activation of the##2##6##(1995-2#1)(1997-2#1)
suggest that the activation of##3##5##(1995-2#1)(1997-2#1)(2013-1#1)
suggest that the activation##4##4##(1993-12#1)(1995-2#1)(1997-2#1)(2013-1#1)
suggest that the active##2##4##(1994-3#1)(1997-2#1)
suggest that the age-related##2##4##(1995-12#1)(1995-9#1)
suggest that the alpha##5##4##(1994-12#1)(1994-3#1)(1995-10#1)(1997-4#1)(1997-7#1)
suggest that the altered##4##4##(1990-10#1)(1992-10#1)(1997-1#1)(2008-10#1)
suggest that the amount of##2##5##(1996-5#1)(2011-1#1)
suggest that the appearance##3##4##(1992-3#1)(2007-12#1)(2008-6#1)
suggest that the association of##2##5##(2005-8#1)(2008-5#1)
suggest that the association##3##4##(2005-8#1)(2007-12#1)(2008-5#1)
suggest that the barrier##3##4##(2008-10#2)(2008-7#1)
suggest that the basic##2##4##(1992-2#1)(2008-5#1)
suggest that the binding of##3##5##(1990-3#1)(1994-9#1)(1995-1#1)
suggest that the binding##6##4##(1990-3#1)(1994-11#1)(1994-9#1)(1995-1#1)(2008-11#1)(2011-1#1)
suggest that the biological##2##4##(1994-3#1)(2008-11#1)
suggest that the cardiac##2##4##(1993-3#1)(2012-3#1)
suggest that the cell##3##4##(1990-2#1)(1990-4#1)(1992-9#1)
suggest that the cerebellar##2##4##(1992-3#1)(1996-9#1)
suggest that the clinical##2##4##(2008-11#1)(2012-12#1)
suggest that the combination of a##2##6##(1997-1#1)(2008-5#1)
suggest that the combination of##4##5##(1995-6#1)(1997-1#1)(2008-5#1)(2008-9#1)
suggest that the contribution of##2##5##(1991-5#1)(2008-6#1)
suggest that the current##2##4##(2008-11#1)(2008-3#1)
suggest that the cytoplasm of teosinte##2##6##(2008-5#2)
suggest that the cytoplasmic##2##4##(1990-10#1)(2011-1#1)
suggest that the degree##2##4##(2007-8#1)(2008-9#1)
suggest that the deposition of##2##5##(1991-1#1)(1995-6#1)
suggest that the descending##2##4##(2007-10#1)(2008-5#1)
suggest that the differential regulation of##2##6##(1991-5#2)
suggest that the differential##3##4##(1991-5#2)(1997-2#1)
suggest that the disease##3##4##(1990-8#1)(2008-4#1)(2012-12#1)
suggest that the drug##2##4##(1995-4#1)(2007-4#1)
suggest that the early phase of##2##6##(1992-3#1)(2008-9#1)
suggest that the early##6##4##(1992-3#1)(1995-12#1)(1996-12#1)(2007-12#1)(2008-9#1)(2013-8#1)
suggest that the effect of##7##5##(1993-3#2)(1994-11#1)(1994-3#1)(1996-12#1)(2008-8#1)(2009-6#1)
suggest that the effect##8##4##(1993-3#2)(1994-11#1)(1994-2#1)(1994-3#1)(1996-12#1)(2008-8#1)(2009-6#1)
suggest that the effects of##6##5##(1992-9#1)(2006-6#1)(2008-11#1)(2008-8#1)(2009-11#1)(2010-8#1)
suggest that the efficiency##2##4##(2006-12#1)(2008-11#1)
suggest that the existence of##2##5##(1997-2#1)(2007-1#1)
suggest that the expression of##3##5##(1993-8#2)(1997-7#1)
suggest that the extent of##2##5##(1994-10#1)(2006-7#1)
suggest that the failure of##2##5##(1995-1#1)(1995-10#1)
suggest that the failure##3##4##(1991-12#1)(1995-1#1)(1995-10#1)
suggest that the first##2##4##(1990-12#1)(1994-3#1)
suggest that the formation of##4##5##(1991-7#1)(1994-8#1)(1997-2#1)(2008-5#1)
suggest that the formation##5##4##(1991-7#1)(1994-8#1)(1997-2#1)(2007-3#1)(2008-5#1)
suggest that the functional##4##4##(1995-9#1)(2007-10#1)(2008-10#1)(2012-2#1)
suggest that the gene##5##4##(1990-5#1)(1991-10#1)(1995-2#1)(2008-11#1)(2008-9#1)
suggest that the genes##2##4##(1991-9#1)(1994-8#1)
suggest that the genetic##3##4##(1994-12#1)(1995-3#1)(2008-8#1)
suggest that the high##4##4##(1990-8#1)(1991-12#1)(1996-9#1)(2008-6#1)
suggest that the host##2##4##(1992-10#1)(2008-10#1)
suggest that the human##4##4##(1993-6#1)(1997-1#1)(1997-7#1)(2008-11#1)
suggest that the impairment of##2##5##(1996-7#1)(1997-2#1)
suggest that the inability of##4##5##(1990-8#1)(1995-2#1)(2008-4#1)(2010-2#1)
suggest that the incidence##2##4##(2005-11#1)(2007-7#1)
suggest that the increase in##6##5##(1991-9#1)(1995-12#1)(1996-11#1)(1997-2#1)(2008-11#1)(2013-8#1)
suggest that the increase##7##4##(1990-4#1)(1991-9#1)(1995-12#1)(1996-11#1)(1997-2#1)(2008-11#1)(2013-8#1)
suggest that the increased##7##4##(1991-5#1)(1992-8#1)(1992-9#1)(1997-4#1)(1997-7#1)(2008-11#1)(2008-9#1)
suggest that the induction##2##4##(1991-12#1)(1991-6#1)
suggest that the influence of##2##5##(2011-2#1)(2012-2#1)
suggest that the influence##3##4##(2007-12#1)(2011-2#1)(2012-2#1)
suggest that the initial##2##4##(1995-6#1)(2008-3#1)
suggest that the integration of surgical magnification##2##7##(2006-2#2)
suggest that the lack of##2##5##(1994-7#1)(2009-10#1)
suggest that the level of##2##5##(1997-2#1)(2004-11#1)
suggest that the levels##2##4##(1991-9#1)(2008-7#1)
suggest that the local##2##4##(1992-6#1)(1995-2#1)
suggest that the long-term##2##4##(1992-10#1)(2007-10#1)
suggest that the loss of##2##5##(2010-6#1)(2013-8#1)
suggest that the major##2##4##(1991-9#1)(1994-11#1)
suggest that the majority of##3##5##(1997-8#1)(2005-8#1)(2007-3#1)
suggest that the mechanism by which##2##6##(1993-3#1)(1994-3#1)
suggest that the mechanism of action of##2##7##(2008-5#1)(2008-7#1)
suggest that the mechanism of##4##5##(1991-10#1)(1997-2#1)(2008-5#1)(2008-7#1)
suggest that the mechanism##8##4##(1991-10#1)(1993-3#1)(1994-3#1)(1997-2#1)(2007-12#1)(2008-5#1)(2008-7#1)(2013-1#1)
suggest that the mechanisms of##3##5##(2008-5#1)(2010-3#1)(2011-2#1)
suggest that the mechanisms##4##4##(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#1)
suggest that the medial##3##4##(1993-12#1)(2008-11#1)(2008-7#1)
suggest that the membrane##3##4##(1991-9#2)(1992-9#1)
suggest that the method##2##4##(1990-4#1)(2007-8#1)
suggest that the migratory##2##4##(1997-4#1)(2012-3#1)
suggest that the modification of##2##5##(1993-9#1)(2012-11#1)
suggest that the modulation##2##4##(1993-9#1)(2010-12#1)
suggest that the most likely##2##5##(1996-4#1)(2008-10#1)
suggest that the most##5##4##(1996-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-9#1)
suggest that the negative##2##4##(1997-7#1)(2008-8#1)
suggest that the new##2##4##(1996-1#1)(2006-7#1)
suggest that the normal##2##4##(1990-8#1)(1992-9#1)
suggest that the observed##9##4##(1992-12#1)(1994-11#1)(1994-12#1)(1995-10#1)(1995-12#1)(2006-10#1)(2007-12#1)(2008-7#1)(2013-7#1)
suggest that the overall##2##4##(1993-2#1)(2007-12#1)
suggest that the parasite##3##4##(2007-3#1)(2007-6#1)(2008-8#1)
suggest that the patient##2##4##(1994-12#1)(1996-5#1)
suggest that the patients##2##4##(1994-12#1)(2007-7#1)
suggest that the phosphorylation of##3##5##(1991-11#1)(1994-11#1)(1996-2#1)
suggest that the physiological##2##4##(1993-7#1)(2008-4#1)
suggest that the potential##2##4##(1991-8#1)(2004-1#1)
suggest that the presence of##13##5##(1990-5#2)(1992-7#1)(1992-9#1)(1993-3#1)(1995-6#1)(1996-1#1)(2007-7#1)(2008-10#2)(2008-5#1)(2010-7#1)(2013-7#1)
suggest that the prevalence of##3##5##(2007-12#1)(2008-8#1)(2009-3#1)
suggest that the primary##5##4##(1991-5#1)(1994-2#1)(2006-7#1)(2008-7#1)(2009-5#1)
suggest that the process of##2##5##(2008-11#1)(2008-9#1)
suggest that the process##3##4##(2008-11#1)(2008-8#1)(2008-9#1)
suggest that the proportion of##2##5##(1992-9#1)(2008-8#1)
suggest that the proposed##2##4##(2008-10#1)(2013-1#1)
suggest that the protein##4##4##(1990-11#1)(1990-12#1)(1995-10#1)(2008-9#1)
suggest that the rapid##2##4##(1991-7#1)(2011-12#1)
suggest that the reaction##2##4##(1990-10#1)(2008-10#1)
suggest that the reduction in the##2##6##(1991-1#1)(1995-3#1)
suggest that the reduction in##3##5##(1991-1#1)(1995-3#1)(2007-10#1)
suggest that the reduction of##3##5##(1992-4#1)(2007-6#1)(2011-2#1)
suggest that the reduction##6##4##(1991-1#1)(1992-4#1)(1995-3#1)(2007-10#1)(2007-6#1)(2011-2#1)
suggest that the regular##2##4##(1996-4#1)(2008-7#1)
suggest that the regulation of##5##5##(1991-2#1)(1992-8#1)(1994-2#1)(1994-9#2)
suggest that the release of##2##5##(1992-6#1)(2008-10#1)
suggest that the resistance of##3##5##(2008-10#3)
suggest that the response##2##4##(1997-3#1)(2006-10#1)
suggest that the role of##8##5##(1990-3#1)(1991-5#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-12#1)(2007-1#1)(2010-1#1)
suggest that the role##9##4##(1990-3#1)(1991-5#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-12#1)(2007-1#1)(2010-1#1)(2013-1#1)
suggest that the roles##2##4##(1994-1#1)(1996-4#1)
suggest that the same##4##4##(1994-12#1)(1995-2#1)(1996-1#1)(2012-2#1)
suggest that the second##2##4##(2008-2#1)(2009-8#1)
suggest that the specific##2##4##(1992-5#1)(2007-8#1)
suggest that the structure of##2##5##(1992-6#1)(1993-6#1)
suggest that the suppression of##3##5##(1992-4#1)(1994-3#1)(1997-1#1)
suggest that the synthesis##2##4##(1990-11#1)(1995-11#1)
suggest that the system##2##4##(2008-10#1)(2012-1#1)
suggest that the three##2##4##(2011-1#1)(2011-2#1)
suggest that the three-dimensional##2##4##(1993-6#1)(1995-2#1)
suggest that the two##13##4##(1990-4#1)(1990-6#1)(1991-10#1)(1992-8#1)(1996-4#1)(2008-10#1)(2008-11#2)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-7#1)
suggest that the type II##2##5##(1992-5#1)(1995-2#1)
suggest that the type##3##4##(1992-5#1)(1995-2#1)(1995-3#1)
suggest that the use of the##2##6##(2007-8#1)(2013-1#1)
suggest that the use of##14##5##(1990-7#1)(1992-1#1)(1995-10#1)(2006-3#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
suggest that the variant##2##4##(1993-6#1)(2008-12#1)
suggest that the vascular##4##4##(1990-5#1)(1991-9#1)(1994-12#1)(2008-5#1)
suggest that the##1135##3##(1990-10#8)(1990-11#9)(1990-12#5)(1990-2#8)(1990-3#7)(1990-4#9)(1990-5#10)(1990-6#1)(1990-7#4)(1990-8#6)(1990-9#1)(1991-1#7)(1991-10#7)(1991-11#2)(1991-12#11)(1991-2#7)(1991-3#2)(1991-4#2)(1991-5#9)(1991-6#8)(1991-7#10)(1991-8#7)(1991-9#15)(1992-1#5)(1992-10#7)(1992-11#4)(1992-12#12)(1992-2#5)(1992-3#9)(1992-4#3)(1992-5#3)(1992-6#8)(1992-7#6)(1992-8#13)(1992-9#12)(1993-11#3)(1993-12#9)(1993-2#7)(1993-3#15)(1993-4#3)(1993-6#12)(1993-7#4)(1993-8#7)(1993-9#3)(1994-1#1)(1994-10#5)(1994-11#12)(1994-12#14)(1994-2#12)(1994-3#15)(1994-5#6)(1994-6#8)(1994-7#1)(1994-8#9)(1994-9#10)(1995-1#5)(1995-10#6)(1995-11#10)(1995-12#12)(1995-2#11)(1995-3#10)(1995-4#3)(1995-5#5)(1995-6#11)(1995-7#1)(1995-8#4)(1995-9#3)(1996-1#6)(1996-10#6)(1996-11#5)(1996-12#6)(1996-2#5)(1996-4#8)(1996-5#14)(1996-6#2)(1996-7#5)(1996-8#2)(1996-9#5)(1997-1#9)(1997-2#15)(1997-3#3)(1997-4#9)(1997-5#3)(1997-6#8)(1997-7#12)(1997-8#5)(2004-1#1)(2004-10#1)(2004-11#2)(2004-2#1)(2005-10#5)(2005-11#3)(2005-12#2)(2005-4#1)(2005-8#2)(2006-10#16)(2006-11#5)(2006-12#7)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#1)(2006-9#3)(2007-1#4)(2007-10#9)(2007-11#5)(2007-12#19)(2007-2#2)(2007-3#3)(2007-4#4)(2007-6#2)(2007-7#9)(2007-8#9)(2007-9#2)(2008-10#52)(2008-11#32)(2008-12#5)(2008-2#7)(2008-3#9)(2008-4#12)(2008-5#30)(2008-6#10)(2008-7#16)(2008-8#26)(2008-9#20)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#4)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#4)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#4)(2010-3#5)(2010-4#4)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#5)(2010-9#4)(2011-1#8)(2011-12#6)(2011-2#25)(2012-1#6)(2012-11#2)(2012-12#8)(2012-2#20)(2012-3#10)(2013-1#16)(2013-7#5)(2013-8#7)
suggest that their##5##3##(1991-9#1)(1995-12#1)(1995-3#1)(1997-8#1)(2008-10#1)
suggest that therapeutic##2##3##(2007-11#1)(2010-12#1)
suggest that there are at least two##2##7##(1990-8#1)(1992-5#1)
suggest that there are differences in##2##6##(1993-2#1)(1996-10#1)
suggest that there are many##2##5##(1994-2#1)(2007-12#1)
suggest that there are significant##2##5##(1995-9#1)(2007-3#1)
suggest that there are some##2##5##(1992-3#1)(2008-11#1)
suggest that there are##25##4##(1990-2#1)(1990-8#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-9#1)(1996-10#1)(1997-6#1)(2004-4#1)(2005-7#1)(2007-12#1)(2007-3#1)(2008-11#1)(2008-7#1)(2010-4#1)(2013-8#1)
suggest that there is a##13##5##(1990-5#1)(1991-12#1)(1991-6#1)(1991-7#1)(1997-5#1)(2008-3#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#1)
suggest that there is no##4##5##(2007-2#1)(2008-10#1)(2008-11#2)
suggest that there is##28##4##(1990-5#1)(1991-12#1)(1991-6#1)(1991-7#1)(1992-5#1)(1992-9#1)(1994-3#1)(1997-5#1)(2004-7#1)(2005-11#1)(2007-2#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-8#1)(2009-1#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#2)
suggest that there may be a##3##6##(1991-10#1)(2004-3#1)(2013-8#1)
suggest that there may be##9##5##(1991-10#1)(1995-12#1)(1996-1#1)(2004-3#1)(2006-3#1)(2008-12#1)(2009-3#1)(2011-2#1)(2013-8#1)
suggest that there may##11##4##(1991-10#1)(1995-12#1)(1995-5#1)(1996-1#1)(2004-3#1)(2006-3#1)(2008-10#1)(2008-12#1)(2009-3#1)(2011-2#1)(2013-8#1)
suggest that there was##2##4##(1997-4#1)(2008-10#1)
suggest that there##71##3##(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#2)(1992-9#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-3#1)(2004-4#1)(2004-7#1)(2005-11#1)(2005-7#1)(2006-3#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#2)(2009-1#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#3)(2013-8#2)
suggest that these compounds##2##4##(1997-2#1)(2008-10#1)
suggest that these genes may##2##5##(2008-10#1)(2008-7#1)
suggest that these molecules##2##4##(1995-2#1)(2008-5#1)
suggest that these proteins may##3##5##(1995-5#1)(1996-5#1)(2011-1#1)
suggest that these proteins##4##4##(1992-5#1)(1995-5#1)(1996-5#1)(2011-1#1)
suggest that these two phenomena##2##5##(1995-5#1)(2007-12#1)
suggest that these two##6##4##(1990-8#1)(1995-11#1)(1995-5#1)(2007-12#1)(2008-9#1)(2012-1#1)
suggest that these##64##3##(1990-10#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1992-12#2)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-5#2)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#3)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-12#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-12#3)(2007-3#2)(2008-1#1)(2008-10#4)(2008-5#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-5#1)(2011-1#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#2)
suggest that they can be##2##5##(2007-11#1)(2007-12#1)
suggest that they have different##2##5##(1990-11#1)(1991-1#1)
suggest that they may be##2##5##(1990-7#1)(2005-11#1)
suggest that they may##6##4##(1990-7#1)(1996-3#1)(2005-11#1)(2008-10#1)(2008-7#1)(2013-8#1)
suggest that they might##2##4##(1993-4#1)(2009-8#1)
suggest that they##23##3##(1990-11#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-11#1)(1992-2#1)(1993-2#1)(1993-3#1)(1993-4#1)(1996-3#1)(1997-1#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#1)(2013-8#1)
suggest that this approach##2##4##(2008-7#1)(2011-1#1)
suggest that this compound##4##4##(1991-5#1)(1991-8#1)(1993-9#1)(1994-12#1)
suggest that this effect is##2##5##(1992-11#1)(1993-9#1)
suggest that this effect##5##4##(1990-10#1)(1991-9#1)(1992-11#1)(1993-9#1)(2008-4#1)
suggest that this enzyme##2##4##(1992-4#1)(1996-6#1)
suggest that this increase##2##4##(2007-12#1)(2010-8#1)
suggest that this is also##2##5##(1997-5#1)(2008-11#1)
suggest that this is##5##4##(1993-11#1)(1997-5#1)(2006-10#1)(2008-11#1)(2008-3#1)
suggest that this may be##2##5##(1995-6#2)
suggest that this may##3##4##(1995-6#2)(2012-11#1)
suggest that this method##2##4##(2007-11#1)(2008-10#1)
suggest that this methodology##2##4##(1992-11#1)(2011-2#1)
suggest that this new##3##4##(2008-3#1)(2011-7#1)(2012-3#1)
suggest that this procedure##2##4##(2006-6#1)(2008-10#1)
suggest that this protein##2##4##(2010-2#2)
suggest that this region##3##4##(1991-8#1)(1994-12#1)(2008-5#1)
suggest that this##108##3##(1990-10#2)(1990-11#1)(1990-5#2)(1991-1#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-11#2)(1992-4#1)(1992-6#1)(1992-8#3)(1993-1#1)(1993-11#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#3)(1994-8#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-5#2)(1997-7#1)(2004-11#1)(2005-9#1)(2006-10#2)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-1#1)(2009-2#2)(2009-5#1)(2009-6#1)(2010-11#1)(2010-2#3)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)
suggest that those##2##3##(2008-5#1)(2011-2#1)
suggest that thyroid hormone##2##4##(1993-3#1)(2009-5#1)
suggest that thyroid##4##3##(1993-3#1)(1995-7#1)(2009-5#1)(2011-1#1)
suggest that timing of##2##4##(2008-10#1)(2010-7#1)
suggest that to##2##3##(2006-12#1)(2008-6#1)
suggest that tobacco##2##3##(2007-12#1)(2008-4#1)
suggest that traditional##3##3##(2006-2#1)(2008-6#1)(2009-7#1)
suggest that translocation of##3##4##(1991-12#1)(1994-12#1)(1994-8#1)
suggest that treatment with##6##4##(1996-12#1)(1996-7#1)(2006-10#1)(2008-11#1)(2008-3#1)(2010-12#1)
suggest that treatment##7##3##(1996-12#1)(1996-7#1)(2006-10#1)(2008-11#1)(2008-3#1)(2010-12#1)(2012-2#1)
suggest that two##4##3##(1993-6#1)(1994-6#1)(2005-8#1)(2008-6#1)
suggest that type##4##3##(1991-4#1)(1991-7#1)(1995-7#1)(2006-5#1)
suggest that tyrosine##4##3##(1990-3#1)(1993-3#1)(1994-2#1)(1994-3#1)
suggest that under##4##3##(1990-12#1)(1990-7#1)(1991-10#1)(1991-12#1)
suggest that urinary##2##3##(1991-12#1)(1992-3#1)
suggest that use of##4##4##(2008-10#3)(2010-7#1)
suggest that variation in##2##4##(2008-9#1)(2010-4#1)
suggest that variations in##2##4##(1991-12#1)(1995-3#1)
suggest that vascular##2##3##(1990-12#1)(2009-1#1)
suggest that verbal##2##3##(1995-12#1)(2008-2#1)
suggest that vertical transmission##2##4##(2008-8#1)(2008-9#1)
suggest that virus##3##3##(2007-8#1)(2008-10#2)
suggest that visual##5##3##(1990-10#1)(1993-2#1)(1995-11#1)(1996-2#1)(2011-1#1)
suggest that vitamin##4##3##(2008-11#1)(2008-8#1)(2010-12#1)(2010-6#1)
suggest that we can##2##4##(2011-2#1)(2012-12#1)
suggest that we##5##3##(1996-5#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
suggest that what##2##3##(1994-1#1)(2006-10#1)
suggest that when##8##3##(1992-10#1)(1992-8#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-9#1)(2012-2#1)
suggest that while a##2##4##(2009-6#1)(2009-9#1)
suggest that while##5##3##(1994-7#1)(1997-1#1)(2008-11#1)(2009-6#1)(2009-9#1)
suggest that with##3##3##(1992-2#1)(1994-8#1)(1995-2#1)
suggest that within##2##3##(1992-4#1)(1993-3#1)
suggest that women##2##3##(1994-7#1)(2013-1#1)
suggest that young##3##3##(2010-4#1)(2012-12#2)
suggest that zinc##3##3##(2008-10#1)(2008-4#1)(2013-7#1)
suggest that##4845##2##(1990-1#2)(1990-10#23)(1990-11#28)(1990-12#19)(1990-2#46)(1990-3#19)(1990-4#22)(1990-5#37)(1990-6#15)(1990-7#36)(1990-8#17)(1990-9#11)(1991-1#24)(1991-10#23)(1991-11#15)(1991-12#40)(1991-2#21)(1991-3#18)(1991-4#20)(1991-5#33)(1991-6#17)(1991-7#25)(1991-8#24)(1991-9#35)(1992-1#21)(1992-10#9)(1992-11#27)(1992-12#42)(1992-2#14)(1992-3#36)(1992-4#17)(1992-5#19)(1992-6#26)(1992-7#17)(1992-8#40)(1992-9#33)(1993-1#8)(1993-10#1)(1993-11#32)(1993-12#41)(1993-2#26)(1993-3#48)(1993-4#14)(1993-5#6)(1993-6#34)(1993-7#8)(1993-8#22)(1993-9#36)(1994-1#3)(1994-10#15)(1994-11#46)(1994-12#52)(1994-2#43)(1994-3#45)(1994-5#28)(1994-6#32)(1994-7#4)(1994-8#37)(1994-9#48)(1995-1#22)(1995-10#23)(1995-11#41)(1995-12#62)(1995-2#38)(1995-3#50)(1995-4#6)(1995-5#29)(1995-6#33)(1995-7#13)(1995-8#26)(1995-9#8)(1996-1#26)(1996-10#23)(1996-11#18)(1996-12#35)(1996-2#33)(1996-3#19)(1996-4#17)(1996-5#46)(1996-6#18)(1996-7#18)(1996-8#26)(1996-9#21)(1997-1#27)(1997-2#39)(1997-3#19)(1997-4#38)(1997-5#29)(1997-6#31)(1997-7#44)(1997-8#32)(2003-11#3)(2004-1#2)(2004-10#5)(2004-11#10)(2004-12#2)(2004-2#4)(2004-3#2)(2004-4#4)(2004-7#1)(2005-10#14)(2005-11#11)(2005-12#5)(2005-2#1)(2005-3#1)(2005-4#1)(2005-7#5)(2005-8#13)(2005-9#3)(2006-1#1)(2006-10#78)(2006-11#13)(2006-12#25)(2006-2#8)(2006-3#4)(2006-4#7)(2006-5#15)(2006-6#14)(2006-7#13)(2006-8#14)(2006-9#16)(2007-1#11)(2007-10#22)(2007-11#38)(2007-12#62)(2007-2#15)(2007-3#16)(2007-4#10)(2007-5#6)(2007-6#4)(2007-7#22)(2007-8#41)(2007-9#22)(2008-1#23)(2008-10#268)(2008-11#124)(2008-12#24)(2008-2#27)(2008-3#49)(2008-4#49)(2008-5#101)(2008-6#33)(2008-7#82)(2008-8#97)(2008-9#69)(2009-1#5)(2009-10#27)(2009-11#4)(2009-12#15)(2009-2#13)(2009-3#11)(2009-4#19)(2009-5#13)(2009-6#13)(2009-7#20)(2009-8#36)(2009-9#15)(2010-1#4)(2010-10#15)(2010-11#12)(2010-12#34)(2010-2#28)(2010-3#19)(2010-4#21)(2010-5#16)(2010-6#9)(2010-7#6)(2010-8#20)(2010-9#13)(2011-1#34)(2011-10#1)(2011-12#11)(2011-2#97)(2011-7#2)(2012-1#28)(2012-11#18)(2012-12#60)(2012-2#83)(2012-3#41)(2012-5#2)(2012-7#1)(2013-1#90)(2013-7#23)(2013-8#46)
suggest the diagnosis of##2##4##(2006-12#1)(2006-2#1)
suggest the diagnosis##7##3##(1990-5#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-7#1)(2010-12#1)
suggest the effect##2##3##(1994-6#1)(2007-11#1)
suggest the existence of a##11##5##(1990-8#1)(1990-9#1)(1991-2#1)(1992-8#1)(1994-2#1)(1994-5#1)(1995-3#1)(1996-4#1)(2005-8#1)(2008-4#2)
suggest the existence of##24##4##(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-8#1)(1993-7#1)(1994-2#2)(1994-5#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-4#1)(2004-12#1)(2005-8#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-2#1)
suggest the feasibility of##2##4##(1991-10#1)(1995-1#1)
suggest the following##5##3##(1990-7#1)(1992-3#1)(1994-5#1)(1995-3#1)(1996-12#1)
suggest the formation of##3##4##(1994-10#1)(2005-11#1)(2008-3#1)
suggest the importance of##7##4##(1992-8#1)(1994-3#1)(1994-8#1)(2007-12#1)(2008-7#1)(2010-8#1)(2011-1#1)
suggest the involvement of PKC in##2##6##(1997-1#1)(2008-4#1)
suggest the involvement of multiple##2##5##(1996-2#1)(2007-3#1)
suggest the involvement of the##3##5##(1990-12#1)(1996-1#1)(1996-12#1)
suggest the involvement of##17##4##(1990-12#2)(1990-6#1)(1991-10#1)(1992-6#1)(1995-3#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-4#1)
suggest the necessity##2##3##(2010-5#1)(2011-1#1)
suggest the need for##18##4##(1992-2#1)(1995-1#1)(2006-12#1)(2006-7#2)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-1#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-2#1)(2012-3#1)
suggest the need to##4##4##(1991-3#1)(2007-10#1)(2010-2#1)(2010-4#1)
suggest the need##22##3##(1991-3#1)(1992-2#1)(1995-1#1)(2006-12#1)(2006-7#2)(2007-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-2#1)(2012-3#1)
suggest the occurrence of##3##4##(1997-7#1)(2007-6#1)(2008-3#1)
suggest the participation of##2##4##(1992-11#1)(1996-4#1)
suggest the possibilities##2##3##(2008-5#1)(2011-2#1)
suggest the possibility of a##3##5##(1993-12#1)(1994-8#1)(1995-11#1)
suggest the possibility of##14##4##(1990-5#1)(1990-6#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-7#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-11#1)
suggest the possibility that the##2##5##(1990-12#1)(1992-11#1)
suggest the possibility that these##2##5##(1996-12#1)(2008-5#1)
suggest the possibility that##14##4##(1990-12#1)(1990-3#1)(1991-12#1)(1992-11#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-8#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)(2012-2#1)
suggest the possibility##29##3##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-12#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-7#1)(1995-8#1)(1996-12#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-11#1)(2011-1#1)(2012-2#1)
suggest the possible use of##3##5##(2008-10#1)(2008-5#1)(2009-8#1)
suggest the possible##9##3##(2006-6#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#1)(2009-4#1)(2009-8#1)(2010-11#1)
suggest the potential for##2##4##(1995-12#1)(1996-7#1)
suggest the potential of##5##4##(1993-11#1)(1995-10#1)(2007-11#1)(2008-11#1)(2010-10#1)
suggest the potential use##2##4##(2008-9#1)(2010-8#1)
suggest the potential##14##3##(1993-11#1)(1995-10#1)(1995-12#1)(1996-7#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-9#1)(2010-10#1)(2010-8#1)(2012-3#1)(2013-1#1)
suggest the presence of a##9##5##(1991-2#1)(1992-8#1)(1993-11#1)(1994-11#1)(1995-12#1)(1997-5#1)(2008-10#1)(2008-6#1)(2008-9#1)
suggest the presence of an##3##5##(1990-3#1)(2008-4#1)(2010-2#1)
suggest the presence of##24##4##(1990-2#1)(1990-3#2)(1991-2#1)(1991-3#1)(1992-8#1)(1993-11#1)(1993-7#1)(1994-11#1)(1994-8#1)(1995-12#1)(1996-1#1)(1996-5#1)(1997-5#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-2#1)(2013-1#2)(2013-8#1)
suggest the term##2##3##(1990-6#1)(1993-7#1)
suggest the use of a##2##5##(2007-12#1)(2008-2#1)
suggest the use of##7##4##(1992-6#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-8#1)
suggest the usefulness of##3##4##(1990-5#1)(2008-5#1)(2010-8#1)
suggest the##275##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#3)(1990-5#4)(1990-6#3)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#4)(1991-2#3)(1991-3#2)(1991-8#1)(1991-9#1)(1992-10#2)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#2)(1992-6#4)(1992-8#4)(1993-11#2)(1993-12#1)(1993-3#3)(1993-7#5)(1993-8#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#4)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#5)(1995-3#3)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#4)(1996-11#2)(1996-12#4)(1996-2#1)(1996-4#3)(1996-5#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-5#2)(1997-7#1)(1997-8#1)(2004-12#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-12#4)(2006-2#2)(2006-6#1)(2006-7#2)(2006-8#1)(2007-10#3)(2007-11#5)(2007-12#8)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#10)(2008-12#2)(2008-2#2)(2008-3#9)(2008-4#5)(2008-5#6)(2008-6#3)(2008-7#8)(2008-8#2)(2008-9#5)(2009-10#1)(2009-11#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#3)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
suggest their involvement in##2##4##(2008-1#1)(2009-10#1)
suggest their##6##2##(1995-11#1)(2007-12#1)(2008-1#1)(2009-10#1)(2010-4#1)(2011-2#1)
suggest there is a##2##4##(1995-11#1)(2008-10#1)
suggest there is##4##3##(1995-11#1)(1997-1#1)(2008-10#1)(2009-3#1)
suggest there##7##2##(1995-11#1)(1997-1#1)(2007-12#1)(2008-10#1)(2009-3#1)(2010-6#1)(2012-2#1)
suggest these##4##2##(1996-5#1)(2008-1#1)(2009-12#1)(2013-1#1)
suggest they##3##2##(1994-11#1)(2008-10#1)(2012-2#1)
suggest this##8##2##(1990-6#1)(1995-8#1)(1997-8#1)(2007-12#1)(2008-10#1)(2009-8#1)(2012-3#2)
suggest to##9##2##(1990-4#1)(1991-10#1)(1991-9#1)(2006-12#1)(2008-10#1)(2008-2#1)(2009-2#1)(2009-8#1)(2013-1#1)
suggest treatment strategies##2##3##(2012-12#1)(2013-8#1)
suggest two##9##2##(1991-8#1)(1993-11#1)(1994-11#1)(1995-1#1)(1995-2#2)(2008-8#1)(2012-2#1)(2012-3#1)
suggest using a##2##3##(2008-3#1)(2009-8#1)
suggest using##6##2##(1996-2#1)(2005-10#1)(2007-7#1)(2008-10#1)(2008-3#1)(2009-8#1)
suggest ways to improve##3##4##(1996-12#1)(2008-5#1)(2013-8#1)
suggest ways to##4##3##(1996-12#1)(2007-3#1)(2008-5#1)(2013-8#1)
suggest ways##6##2##(1994-3#1)(1996-12#1)(2007-3#1)(2008-5#1)(2010-12#1)(2013-8#1)
suggest what##2##2##(2008-3#1)(2009-4#1)
suggest why##2##2##(2008-1#1)(2012-2#1)
suggest##6053##1##(1990-1#2)(1990-10#24)(1990-11#31)(1990-12#24)(1990-2#51)(1990-3#25)(1990-4#25)(1990-5#43)(1990-6#24)(1990-7#42)(1990-8#23)(1990-9#15)(1991-1#30)(1991-10#29)(1991-11#19)(1991-12#51)(1991-2#32)(1991-3#25)(1991-4#21)(1991-5#37)(1991-6#19)(1991-7#29)(1991-8#32)(1991-9#40)(1992-1#22)(1992-10#15)(1992-11#32)(1992-12#49)(1992-2#22)(1992-3#46)(1992-4#20)(1992-5#21)(1992-6#37)(1992-7#26)(1992-8#49)(1992-9#37)(1993-1#9)(1993-10#2)(1993-11#40)(1993-12#46)(1993-2#32)(1993-3#60)(1993-4#16)(1993-5#7)(1993-6#39)(1993-7#14)(1993-8#25)(1993-9#39)(1994-1#3)(1994-10#19)(1994-11#53)(1994-12#58)(1994-2#52)(1994-3#63)(1994-4#1)(1994-5#35)(1994-6#37)(1994-7#5)(1994-8#46)(1994-9#58)(1995-1#28)(1995-10#25)(1995-11#46)(1995-12#75)(1995-2#46)(1995-3#56)(1995-4#8)(1995-5#33)(1995-6#39)(1995-7#15)(1995-8#35)(1995-9#8)(1996-1#31)(1996-10#24)(1996-11#21)(1996-12#46)(1996-2#39)(1996-3#23)(1996-4#23)(1996-5#59)(1996-6#19)(1996-7#23)(1996-8#29)(1996-9#24)(1997-1#31)(1997-2#42)(1997-3#26)(1997-4#43)(1997-5#40)(1997-6#38)(1997-7#52)(1997-8#38)(2003-11#3)(2004-1#2)(2004-10#5)(2004-11#11)(2004-12#4)(2004-2#4)(2004-3#2)(2004-4#6)(2004-7#1)(2004-9#1)(2005-1#1)(2005-10#18)(2005-11#19)(2005-12#6)(2005-2#1)(2005-3#1)(2005-4#1)(2005-6#1)(2005-7#13)(2005-8#14)(2005-9#3)(2006-1#2)(2006-10#98)(2006-11#15)(2006-12#35)(2006-2#11)(2006-3#6)(2006-4#8)(2006-5#20)(2006-6#19)(2006-7#20)(2006-8#17)(2006-9#19)(2007-1#15)(2007-10#32)(2007-11#55)(2007-12#95)(2007-2#22)(2007-3#18)(2007-4#11)(2007-5#6)(2007-6#8)(2007-7#30)(2007-8#51)(2007-9#25)(2008-1#29)(2008-10#315)(2008-11#151)(2008-12#37)(2008-2#40)(2008-3#69)(2008-4#64)(2008-5#123)(2008-6#44)(2008-7#104)(2008-8#113)(2008-9#83)(2009-1#5)(2009-10#36)(2009-11#9)(2009-12#20)(2009-2#17)(2009-3#15)(2009-4#30)(2009-5#16)(2009-6#16)(2009-7#23)(2009-8#46)(2009-9#18)(2010-1#8)(2010-10#17)(2010-11#20)(2010-12#45)(2010-2#42)(2010-3#22)(2010-4#28)(2010-5#21)(2010-6#13)(2010-7#9)(2010-8#28)(2010-9#14)(2011-1#51)(2011-10#1)(2011-12#14)(2011-2#121)(2011-7#2)(2012-1#33)(2012-11#20)(2012-12#72)(2012-2#115)(2012-3#57)(2012-5#2)(2012-7#2)(2013-1#116)(2013-7#28)(2013-8#61)
suggested a classification##2##3##(1991-3#1)(2008-9#1)
suggested a correlation between##2##4##(1997-2#1)(2013-1#1)
suggested a diagnosis of##3##4##(2006-7#1)(2007-7#1)(2013-8#1)
suggested a high level of##2##5##(2011-1#1)(2012-2#1)
suggested a link between##2##4##(1997-8#1)(2008-10#1)
suggested a possibility that##2##4##(1997-6#1)(2008-11#1)
suggested a possible involvement of##2##5##(1997-2#2)
suggested a possible##11##3##(1990-5#1)(1990-6#1)(1992-8#1)(1997-2#2)(2007-1#1)(2007-11#1)(2007-4#1)(2008-10#1)(2013-1#2)
suggested a potential role##2##4##(1993-9#1)(1994-6#1)
suggested a potential##4##3##(1993-9#1)(1994-6#1)(2007-4#1)(2008-10#1)
suggested a relationship between the##2##5##(1990-10#1)(2008-10#1)
suggested a role for##3##4##(1992-12#1)(2008-5#1)(2008-8#1)
suggested a role##4##3##(1992-12#1)(2008-5#1)(2008-6#1)(2008-8#1)
suggested a significant##2##3##(2006-11#1)(2009-4#1)
suggested a single##2##3##(2008-7#1)(2010-2#1)
suggested a##121##2##(1990-10#2)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-4#1)(1992-8#2)(1993-9#2)(1994-6#1)(1994-7#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-11#2)(1996-5#1)(1996-8#2)(1997-2#4)(1997-6#2)(1997-8#2)(2005-12#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-7#2)(2006-8#2)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#13)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#8)(2008-8#1)(2008-9#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-2#2)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#7)(2013-4#1)(2013-8#2)
suggested aggregation of##2##3##(2008-10#2)
suggested an important##2##3##(1994-9#1)(2012-3#1)
suggested an##11##2##(1991-5#1)(1991-9#1)(1993-12#1)(1994-9#1)(1995-3#1)(2004-9#1)(2008-1#1)(2008-4#1)(2009-6#1)(2012-12#1)(2012-3#1)
suggested and##9##2##(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-11#1)(2012-11#1)(2012-12#2)
suggested approach##2##2##(1990-5#1)(1997-2#1)
suggested as a possible mechanism##2##5##(2007-8#1)(2008-5#1)
suggested as a possible##6##4##(1995-3#1)(2007-8#1)(2008-10#2)(2008-5#1)(2012-12#1)
suggested as a strategy to##2##5##(1997-3#1)(2008-3#1)
suggested as a##26##3##(1990-3#1)(1995-3#1)(1996-4#1)(1997-3#1)(2005-8#1)(2006-12#1)(2007-8#2)(2008-10#7)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2012-12#2)(2012-2#2)
suggested as one##6##3##(1990-12#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-8#1)
suggested as possible##4##3##(1990-11#1)(1992-11#1)(2008-4#1)(2010-6#1)
suggested as the##9##3##(1990-7#1)(1992-8#1)(1995-5#1)(1995-9#1)(2007-12#1)(2008-7#2)(2008-8#1)(2012-3#1)
suggested as##73##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#1)(1992-11#1)(1992-4#1)(1992-8#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-3#2)(1995-5#1)(1995-9#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-3#1)(2004-4#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-9#1)(2007-12#2)(2007-5#1)(2007-8#2)(2008-10#12)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-3#1)(2009-8#1)(2010-3#1)(2010-6#1)(2010-8#1)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#1)
suggested based on##2##3##(1994-6#1)(2011-2#1)
suggested by Vitruvius (De Architectura)##2##5##(2008-10#2)
suggested by a##4##3##(1992-6#1)(2006-9#1)(2008-12#1)(2013-1#1)
suggested by clinical##2##3##(2006-10#1)(2013-8#1)
suggested by earlier##2##3##(1992-3#1)(2006-11#1)
suggested by experiments##2##3##(1994-11#1)(2010-3#1)
suggested by its##3##3##(1990-5#1)(1993-7#1)(2009-12#1)
suggested by one##2##3##(1990-7#1)(2012-2#1)
suggested by our##2##3##(2004-4#1)(2013-1#1)
suggested by some##3##3##(1996-6#1)(2007-11#1)(2008-4#1)
suggested by the International##2##4##(2006-10#1)(2013-8#1)
suggested by the analysis##2##4##(1992-12#1)(1993-11#1)
suggested by the manufacturer##2##4##(2004-12#1)(2013-1#1)
suggested by the observation##2##4##(1991-9#1)(1992-9#1)
suggested by the##30##3##(1990-11#1)(1990-3#1)(1991-10#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-3#1)(1995-7#1)(1996-5#1)(1997-3#1)(1997-5#1)(2004-12#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-10#1)(2008-10#3)(2008-6#1)(2008-7#1)(2009-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
suggested by their##2##3##(2008-8#1)(2010-4#1)
suggested by##119##2##(1990-10#2)(1990-11#1)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#3)(1991-10#1)(1991-12#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-9#2)(1993-11#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-7#1)(1996-3#1)(1996-5#3)(1996-6#1)(1997-3#2)(1997-5#4)(1997-8#1)(2004-12#1)(2004-4#1)(2005-11#3)(2005-4#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#1)(2006-6#1)(2006-9#2)(2007-10#2)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-4#1)(2013-1#3)(2013-8#4)
suggested changes##2##2##(1996-5#1)(2010-9#1)
suggested could be##2##3##(2008-11#1)(2008-9#1)
suggested design##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
suggested earlier##5##2##(1991-11#1)(1994-5#1)(2007-9#1)(2008-3#1)(2009-12#1)
suggested for the##7##3##(2008-10#2)(2008-11#1)(2008-3#1)(2010-6#1)(2011-1#1)(2012-3#1)
suggested for these phenomena##2##4##(1993-6#1)(2010-12#1)
suggested for these##3##3##(1993-6#1)(2008-5#1)(2010-12#1)
suggested for##51##2##(1990-12#1)(1990-6#1)(1991-10#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-6#1)(1995-1#1)(1995-4#1)(1997-3#1)(1997-4#1)(1997-8#2)(2006-10#1)(2007-10#1)(2007-12#2)(2007-4#1)(2008-10#7)(2008-11#2)(2008-2#3)(2008-3#5)(2008-5#5)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-2#2)(2012-3#1)
suggested from##4##2##(1993-9#1)(2006-10#1)(2009-8#1)(2012-2#1)
suggested here##5##2##(1993-7#1)(1997-2#1)(2008-1#1)(2010-4#1)(2012-12#1)
suggested improvements##4##2##(1994-9#1)(2007-8#1)(2010-4#1)(2012-3#1)
suggested in order to##3##4##(2008-10#1)(2008-2#1)(2013-1#1)
suggested in the literature##3##4##(1995-1#1)(2004-10#1)(2011-1#1)
suggested in the##9##3##(1992-5#1)(1995-1#1)(1995-4#1)(2004-10#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-2#2)
suggested in this##2##3##(1991-11#1)(2008-12#1)
suggested in##24##2##(1991-11#1)(1992-5#1)(1992-6#1)(1995-1#1)(1995-4#1)(2004-10#1)(2006-10#1)(2006-7#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#2)(2008-6#1)(2009-11#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#1)
suggested interventions##2##2##(1995-2#1)(2013-1#1)
suggested it##3##2##(2008-5#1)(2012-2#2)
suggested mechanisms for##2##3##(2006-12#1)(2010-12#1)
suggested mechanisms##3##2##(2006-12#1)(2008-8#1)(2010-12#1)
suggested method is##3##3##(2007-8#1)(2008-2#1)(2010-8#1)
suggested method uses##2##3##(2008-10#2)
suggested method##7##2##(2007-8#1)(2008-10#3)(2008-2#2)(2010-8#1)
suggested model##2##2##(2007-12#1)(2010-8#1)
suggested more##2##2##(1994-3#1)(2008-8#1)
suggested no##3##2##(2006-10#1)(2008-3#1)(2011-3#1)
suggested on the basis of##2##5##(1990-3#1)(2007-11#1)
suggested on##5##2##(1990-3#1)(1991-9#1)(1994-12#1)(2007-11#1)(2008-10#1)
suggested or##2##2##(1993-9#1)(2009-2#1)
suggested previously that##2##3##(1992-10#1)(1992-12#1)
suggested previously##7##2##(1990-12#1)(1992-10#1)(1992-12#1)(1995-8#1)(1997-2#1)(2006-8#1)(2007-3#1)
suggested reasons##2##2##(2006-3#1)(2008-12#1)
suggested some##2##2##(1993-8#1)(2008-9#1)
suggested stage-IV disease in##2##4##(2012-12#2)
suggested strategies##2##2##(2008-8#1)(2009-5#1)
suggested system##3##2##(2008-3#1)(2013-1#2)
suggested technique##3##2##(2006-7#1)(2008-3#2)
suggested that (1)##2##3##(1990-3#1)(1993-9#1)
suggested that DNA##3##3##(1995-11#1)(1996-1#1)(2008-10#1)
suggested that PD##2##3##(2008-7#1)(2013-1#1)
suggested that a large##2##4##(1992-3#1)(2013-8#1)
suggested that a single##5##4##(1991-12#1)(1992-1#1)(1997-2#1)(2008-10#2)
suggested that a##44##3##(1991-12#2)(1991-2#1)(1991-3#1)(1992-1#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-8#2)(1997-2#2)(1997-5#1)(2004-11#1)(2005-12#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-10#1)(2009-9#2)(2010-6#1)(2012-2#1)(2013-1#2)(2013-8#1)
suggested that active##4##3##(1991-5#1)(2007-11#1)(2007-7#1)(2008-10#1)
suggested that additional##2##3##(1991-12#1)(2008-5#1)
suggested that all##4##3##(1990-3#1)(1992-3#1)(2008-10#2)
suggested that alterations in##2##4##(1991-1#1)(2011-1#1)
suggested that an important##2##4##(1992-2#1)(2010-12#1)
suggested that an##13##3##(1990-7#1)(1992-12#1)(1992-2#1)(1994-3#1)(1995-12#1)(1995-3#1)(2006-3#1)(2008-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)
suggested that arterial##2##3##(2005-10#1)(2013-7#1)
suggested that at least##2##4##(2008-10#1)(2009-2#1)
suggested that at##3##3##(2008-10#2)(2009-2#1)
suggested that both of##2##4##(1993-12#1)(2008-9#1)
suggested that both##8##3##(1991-12#1)(1991-9#1)(1992-8#1)(1993-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-2#1)
suggested that changes in the##2##5##(1996-2#1)(1996-7#1)
suggested that chromosome##2##3##(1996-6#1)(2008-10#1)
suggested that chronic##2##3##(1994-3#1)(2008-12#1)
suggested that copper aspirinate##2##4##(2008-5#2)
suggested that dietary##2##3##(1990-5#1)(2004-11#1)
suggested that differences in##2##4##(1991-12#1)(2004-11#1)
suggested that each##3##3##(1991-5#1)(2008-10#1)(2012-2#1)
suggested that for##3##3##(2007-5#1)(2013-1#2)
suggested that formation of##2##4##(1990-2#1)(2013-1#1)
suggested that health##2##3##(2008-11#1)(2010-7#1)
suggested that high##4##3##(2007-1#1)(2007-12#1)(2013-1#1)(2013-8#1)
suggested that if##2##3##(1996-6#1)(2008-8#1)
suggested that improved##2##3##(1995-6#1)(2008-10#1)
suggested that in a##2##4##(1993-9#1)(2008-11#1)
suggested that in the##7##4##(1991-7#1)(1992-7#1)(1993-2#1)(2008-4#1)(2013-1#1)(2013-8#2)
suggested that in##14##3##(1991-7#1)(1992-7#1)(1993-2#1)(1993-7#1)(1993-9#1)(2005-4#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#2)
suggested that interaction with##2##4##(1994-9#1)(2008-11#1)
suggested that iron##2##3##(1992-8#1)(1996-2#1)
suggested that it is##3##4##(1992-3#1)(2008-10#1)(2008-4#1)
suggested that it may##2##4##(2007-8#1)(2010-5#1)
suggested that it might##2##4##(2009-8#1)(2012-2#1)
suggested that it was##3##4##(1994-11#1)(2011-2#1)(2013-8#1)
suggested that it##14##3##(1990-11#1)(1990-6#1)(1992-3#1)(1994-11#1)(1997-2#1)(2007-8#2)(2008-10#1)(2008-4#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
suggested that its##2##3##(2008-11#1)(2011-2#1)
suggested that large##2##3##(2004-4#1)(2013-8#1)
suggested that lipoamidase##2##3##(1990-10#2)
suggested that many##3##3##(1990-1#1)(1994-6#1)(2007-8#1)
suggested that most##2##3##(1990-12#1)(2013-8#1)
suggested that multiple##3##3##(1996-10#1)(2007-12#1)(2008-5#1)
suggested that normal##2##3##(2005-10#1)(2008-6#1)
suggested that not##2##3##(2008-10#2)
suggested that nuclear##2##3##(1994-8#1)(2008-8#1)
suggested that one of the##3##5##(1993-12#1)(2008-10#1)(2008-5#1)
suggested that one##5##3##(1992-3#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
suggested that only##2##3##(1994-10#1)(2008-10#1)
suggested that patients##4##3##(1997-8#1)(2008-11#1)(2008-5#1)(2008-6#1)
suggested that personality##2##3##(2006-9#1)(2008-11#1)
suggested that phosphorylation at##2##4##(1994-11#2)
suggested that poor##2##3##(1992-10#1)(1997-8#1)
suggested that protein##3##3##(1996-7#1)(1997-1#1)(2008-9#1)
suggested that pyruvate##2##3##(1992-5#1)(1993-8#1)
suggested that resistance to##2##4##(2006-10#1)(2008-10#1)
suggested that resistance##5##3##(2006-10#1)(2008-10#4)
suggested that several##2##3##(1996-10#1)(2010-12#1)
suggested that some##9##3##(1991-9#1)(1992-11#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2010-4#1)
suggested that specific##2##3##(1994-12#1)(2008-8#1)
suggested that students##2##3##(2008-11#1)(2009-7#1)
suggested that such a##2##4##(1995-12#2)
suggested that such##3##3##(1995-1#1)(1995-12#2)
suggested that the DNA##2##4##(2008-10#1)(2009-5#1)
suggested that the activity##2##4##(1992-2#1)(1994-2#1)
suggested that the cell##2##4##(1997-3#1)(2008-11#1)
suggested that the conformation of##2##5##(2008-10#1)(2008-8#1)
suggested that the difference in##2##5##(1995-3#1)(1997-2#1)
suggested that the efe gene##2##5##(2008-10#2)
suggested that the effect of##2##5##(1995-10#1)(2007-12#1)
suggested that the effects observed##2##5##(1991-5#1)(2011-1#1)
suggested that the expression of##5##5##(1995-3#2)(1996-10#1)(1997-7#1)(2008-9#1)
suggested that the first##2##4##(1991-1#1)(2008-9#1)
suggested that the genetic##2##4##(1993-9#1)(1997-5#1)
suggested that the high##2##4##(1990-5#1)(2008-10#1)
suggested that the higher##2##4##(1990-12#1)(2013-8#1)
suggested that the human##2##4##(2009-2#1)(2011-1#1)
suggested that the hydroxyl##2##4##(1990-2#1)(1995-6#1)
suggested that the incidence of##2##5##(2006-11#1)(2006-9#1)
suggested that the increase in##5##5##(1990-10#1)(1992-9#1)(1993-12#1)(2008-11#1)(2008-4#1)
suggested that the inhibition##2##4##(1991-4#1)(1996-4#1)
suggested that the initial##2##4##(2008-10#1)(2008-12#1)
suggested that the overall##2##4##(2007-8#1)(2008-5#1)
suggested that the primary##2##4##(1990-5#1)(2010-5#1)
suggested that the purified##2##4##(1990-12#1)(1993-5#1)
suggested that the same##2##4##(1994-12#1)(2008-10#1)
suggested that the soluble##2##4##(1992-6#1)(1997-6#1)
suggested that the stability of the##2##6##(1991-9#1)(1995-3#1)
suggested that the system##2##4##(1992-8#1)(2008-12#1)
suggested that the three##2##4##(1991-9#1)(2008-10#1)
suggested that the transcription##2##4##(1996-4#1)(2008-5#1)
suggested that the two##2##4##(1992-11#1)(1995-1#1)
suggested that the use of##3##5##(1994-9#1)(2007-7#1)(2013-8#1)
suggested that the##328##3##(1990-10#2)(1990-11#4)(1990-12#2)(1990-2#5)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#2)(1990-9#1)(1991-1#3)(1991-10#1)(1991-12#1)(1991-2#7)(1991-3#1)(1991-4#3)(1991-5#1)(1991-9#4)(1992-11#3)(1992-12#5)(1992-2#3)(1992-3#2)(1992-4#2)(1992-6#1)(1992-8#3)(1992-9#2)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#1)(1993-8#3)(1993-9#4)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#4)(1994-3#2)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#2)(1995-11#4)(1995-2#1)(1995-3#5)(1995-5#3)(1995-6#4)(1995-8#4)(1996-1#2)(1996-10#5)(1996-12#1)(1996-2#2)(1996-4#2)(1996-5#2)(1996-6#4)(1996-7#1)(1996-9#3)(1997-2#5)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#4)(2004-9#2)(2005-11#7)(2005-4#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#8)(2007-2#2)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#20)(2008-11#14)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#1)(2008-8#9)(2008-9#6)(2009-10#1)(2009-2#3)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#4)(2011-12#5)(2011-2#5)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#5)(2013-8#5)
suggested that there are##3##4##(2007-6#1)(2008-10#1)(2008-5#1)
suggested that there is##5##4##(2007-6#1)(2008-12#1)(2008-8#1)(2011-2#1)(2012-12#1)
suggested that there might be##2##5##(1994-12#1)(2009-10#1)
suggested that there was##2##4##(1991-12#1)(2008-7#1)
suggested that there##15##3##(1991-12#1)(1994-12#1)(1996-12#1)(2006-4#1)(2007-6#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2011-2#1)(2012-12#1)
suggested that these findings##2##4##(2008-10#1)(2011-1#1)
suggested that these##21##3##(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-2#1)(1995-11#1)(1996-12#1)(2006-10#1)(2007-9#1)(2008-10#3)(2008-4#1)(2008-7#1)(2009-10#1)(2011-1#1)
suggested that they were##2##4##(1990-4#1)(2008-6#1)
suggested that they##10##3##(1990-4#1)(1992-12#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-6#1)(2008-7#1)(2010-8#1)(2011-12#1)(2011-2#1)
suggested that this combination##2##4##(1997-7#1)(2013-1#1)
suggested that this may be##4##5##(1990-5#1)(1992-3#1)(2005-11#1)(2009-4#1)
suggested that this protein##2##4##(1990-5#1)(1994-3#1)
suggested that this virus##2##4##(2008-10#2)
suggested that this##42##3##(1990-12#1)(1990-2#1)(1990-4#2)(1990-5#3)(1991-10#1)(1992-3#2)(1993-12#1)(1993-6#2)(1994-11#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-9#1)(1997-2#2)(1997-7#1)(2005-11#2)(2006-9#1)(2007-3#1)(2007-5#1)(2008-10#6)(2008-12#2)(2008-3#1)(2008-8#1)(2009-4#1)(2010-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
suggested that three##2##3##(2008-10#1)(2012-3#1)
suggested that treatment##2##3##(1997-2#1)(2008-10#1)
suggested that two##3##3##(1992-8#1)(1992-9#1)(1995-5#1)
suggested that urinary##2##3##(1993-9#1)(2008-7#1)
suggested that when##2##3##(1996-10#1)(2009-11#1)
suggested that##1183##2##(1990-1#1)(1990-10#4)(1990-11#5)(1990-12#6)(1990-2#10)(1990-3#4)(1990-4#4)(1990-5#8)(1990-6#1)(1990-7#6)(1990-8#2)(1990-9#2)(1991-1#6)(1991-10#6)(1991-11#2)(1991-12#10)(1991-2#10)(1991-3#6)(1991-4#4)(1991-5#4)(1991-6#1)(1991-7#5)(1991-8#1)(1991-9#8)(1992-1#2)(1992-10#2)(1992-11#5)(1992-12#10)(1992-2#5)(1992-3#11)(1992-4#5)(1992-5#6)(1992-6#4)(1992-7#6)(1992-8#10)(1992-9#6)(1993-10#1)(1993-11#3)(1993-12#12)(1993-2#7)(1993-3#4)(1993-4#3)(1993-5#4)(1993-6#6)(1993-7#1)(1993-8#5)(1993-9#9)(1994-10#3)(1994-11#9)(1994-12#6)(1994-2#11)(1994-3#9)(1994-5#1)(1994-6#6)(1994-7#2)(1994-8#5)(1994-9#9)(1995-1#6)(1995-10#3)(1995-11#7)(1995-12#10)(1995-2#6)(1995-3#10)(1995-4#2)(1995-5#5)(1995-6#9)(1995-7#1)(1995-8#12)(1996-1#7)(1996-10#9)(1996-11#1)(1996-12#7)(1996-2#8)(1996-3#2)(1996-4#3)(1996-5#5)(1996-6#6)(1996-7#6)(1996-8#1)(1996-9#5)(1997-1#6)(1997-2#13)(1997-3#4)(1997-4#3)(1997-5#7)(1997-6#5)(1997-7#6)(1997-8#10)(2003-11#2)(2004-1#2)(2004-11#5)(2004-12#1)(2004-4#2)(2004-9#2)(2005-10#8)(2005-11#13)(2005-12#3)(2005-4#3)(2005-7#2)(2005-8#2)(2006-10#9)(2006-11#2)(2006-12#5)(2006-2#2)(2006-3#3)(2006-4#3)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#6)(2006-9#5)(2007-1#1)(2007-10#4)(2007-11#14)(2007-12#21)(2007-2#5)(2007-3#5)(2007-4#1)(2007-5#2)(2007-6#3)(2007-7#7)(2007-8#8)(2007-9#7)(2008-1#8)(2008-10#98)(2008-11#45)(2008-12#10)(2008-2#4)(2008-3#9)(2008-4#12)(2008-5#26)(2008-6#5)(2008-7#21)(2008-8#36)(2008-9#24)(2009-1#1)(2009-10#8)(2009-11#1)(2009-12#1)(2009-2#5)(2009-3#4)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#4)(2009-9#3)(2010-1#2)(2010-10#2)(2010-11#4)(2010-12#8)(2010-2#4)(2010-4#7)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#8)(2010-9#1)(2011-1#15)(2011-12#8)(2011-2#23)(2011-3#3)(2012-1#5)(2012-11#3)(2012-12#14)(2012-2#13)(2012-3#4)(2012-7#1)(2013-1#34)(2013-7#1)(2013-8#28)
suggested the development of##2##4##(2006-6#1)(2008-5#1)
suggested the diagnosis of##2##4##(2006-10#1)(2012-3#1)
suggested the diagnosis##3##3##(2006-10#1)(2008-7#1)(2012-3#1)
suggested the existence of##7##4##(1994-3#1)(1995-2#1)(1997-6#2)(2008-11#1)(2010-8#1)(2012-7#1)
suggested the following##2##3##(2008-10#1)(2008-9#1)
suggested the formation of##2##4##(2007-7#1)(2008-5#1)
suggested the involvement of##4##4##(1990-11#1)(1991-8#1)(1995-1#1)(2008-6#1)
suggested the occurrence of##2##4##(2008-10#2)
suggested the possibility of##4##4##(2005-10#1)(2006-4#1)(2008-5#1)(2009-5#1)
suggested the possibility##5##3##(2005-10#1)(2006-4#1)(2008-5#1)(2009-5#1)(2011-2#1)
suggested the possible##3##3##(1995-1#1)(2010-12#1)(2011-1#1)
suggested the presence of a##6##5##(1990-5#1)(1993-2#1)(1995-6#1)(1997-5#1)(2009-3#1)(2009-7#1)
suggested the presence of two##2##5##(1992-6#1)(1995-2#1)
suggested the presence of##21##4##(1990-10#1)(1990-5#1)(1990-7#1)(1992-12#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-2#1)(1995-6#1)(1997-5#2)(2008-10#1)(2008-12#1)(2008-8#1)(2009-3#1)(2009-6#1)(2009-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
suggested the presence##22##3##(1990-10#1)(1990-5#1)(1990-7#1)(1992-12#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-3#1)(1995-2#1)(1995-6#1)(1997-5#2)(2008-10#1)(2008-12#1)(2008-8#1)(2009-3#1)(2009-6#1)(2009-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
suggested the use of##4##4##(1994-8#1)(2008-11#1)(2008-12#1)(2012-3#1)
suggested the##88##2##(1990-10#1)(1990-11#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-12#2)(1992-6#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-2#2)(1995-6#2)(1996-3#1)(1996-5#1)(1997-5#2)(1997-6#2)(2005-10#1)(2005-11#2)(2005-4#1)(2006-10#3)(2006-4#1)(2006-6#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#1)(2013-7#1)(2013-8#1)
suggested to avoid##3##3##(2006-8#1)(2007-5#1)(2011-2#1)
suggested to be a##9##4##(1990-11#1)(1991-3#1)(1992-11#1)(1994-9#1)(1995-3#1)(2008-3#1)(2008-9#2)(2010-12#1)
suggested to be an##3##4##(1991-2#1)(1994-8#1)(2009-11#1)
suggested to be associated with##2##5##(1996-8#1)(2008-12#1)
suggested to be important for##2##5##(1994-8#1)(2009-8#1)
suggested to be involved in the##2##6##(2008-10#1)(2008-4#1)
suggested to be involved in##9##5##(1991-8#1)(1993-6#1)(1994-2#1)(1995-6#1)(1996-4#1)(2008-10#1)(2008-4#1)(2009-9#1)(2011-2#1)
suggested to be mediated by##3##5##(1993-11#1)(1997-2#1)(2010-8#1)
suggested to be mediated##4##4##(1990-5#1)(1993-11#1)(1997-2#1)(2010-8#1)
suggested to be of##2##4##(1996-5#1)(2008-3#1)
suggested to be one of the##2##6##(1995-10#1)(2013-8#1)
suggested to be related to the##2##6##(1997-6#1)(2008-7#1)
suggested to be responsible for the##3##6##(1992-4#1)(1993-7#1)(2008-7#1)
suggested to be responsible for##5##5##(1992-4#1)(1993-7#1)(2008-7#1)(2011-2#2)
suggested to be the##7##4##(1993-12#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-3#1)(2007-9#1)(2012-1#1)
suggested to be##72##3##(1990-11#3)(1990-5#2)(1990-8#1)(1991-2#2)(1991-3#1)(1991-8#1)(1992-11#1)(1992-4#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-2#1)(1994-8#3)(1994-9#3)(1995-10#1)(1995-3#3)(1995-6#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-6#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#3)(2009-11#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#2)(2013-8#1)
suggested to cause##3##3##(1991-2#1)(1992-11#1)(2011-1#1)
suggested to contribute to##3##4##(1994-11#1)(2008-10#1)(2010-7#1)
suggested to contribute##4##3##(1994-11#2)(2008-10#1)(2010-7#1)
suggested to enhance the##2##4##(1993-3#1)(1996-12#1)
suggested to explain the##3##4##(1997-1#1)(2008-10#1)(2010-4#1)
suggested to explain##5##3##(1990-12#1)(1997-1#1)(2008-10#1)(2010-4#1)(2012-12#1)
suggested to have##4##3##(1993-12#1)(1995-10#1)(2007-10#1)(2008-4#1)
suggested to improve##2##3##(2011-1#1)(2011-2#1)
suggested to increase the##2##4##(2008-12#1)(2010-4#1)
suggested to make##2##3##(2008-2#2)
suggested to modulate##2##3##(1995-11#1)(2008-3#1)
suggested to occur via##3##4##(1990-5#1)(2013-1#2)
suggested to occur##6##3##(1990-5#1)(1996-7#1)(2005-11#1)(2007-10#1)(2013-1#2)
suggested to play a role##3##5##(1992-1#1)(1994-8#1)(2013-1#1)
suggested to play a##9##4##(1992-1#1)(1993-4#1)(1994-12#1)(1994-8#1)(1997-3#1)(2008-11#1)(2013-1#1)(2013-8#2)
suggested to play an important role in##5##7##(1993-12#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-3#1)
suggested to play an##7##4##(1992-9#1)(1993-12#1)(1996-11#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-3#1)
suggested to play##18##3##(1992-1#1)(1992-9#1)(1993-12#1)(1993-4#1)(1994-12#1)(1994-8#1)(1996-11#1)(1997-3#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-8#1)(2013-1#1)(2013-8#2)
suggested to reflect##2##3##(1990-2#1)(1997-8#1)
suggested to##167##2##(1990-11#3)(1990-12#1)(1990-2#2)(1990-5#3)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-8#1)(1992-1#1)(1992-11#2)(1992-4#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#3)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#2)(1994-11#3)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#4)(1994-9#7)(1995-10#2)(1995-11#1)(1995-3#3)(1995-5#1)(1995-6#2)(1995-8#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(2005-11#2)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#3)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-11#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-12#1)(2010-4#3)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#6)(2013-7#1)(2013-8#4)
suggested treatment##2##2##(1997-3#1)(2011-12#1)
suggested##2297##1##(1990-1#1)(1990-10#10)(1990-11#12)(1990-12#11)(1990-2#13)(1990-3#10)(1990-4#4)(1990-5#16)(1990-6#5)(1990-7#11)(1990-8#9)(1990-9#2)(1991-1#9)(1991-10#10)(1991-11#4)(1991-12#13)(1991-2#15)(1991-3#12)(1991-4#5)(1991-5#8)(1991-6#2)(1991-7#6)(1991-8#5)(1991-9#12)(1992-1#5)(1992-10#3)(1992-11#9)(1992-12#17)(1992-2#9)(1992-3#15)(1992-4#9)(1992-5#7)(1992-6#11)(1992-7#8)(1992-8#17)(1992-9#10)(1993-1#1)(1993-10#1)(1993-11#8)(1993-12#21)(1993-2#9)(1993-3#7)(1993-4#6)(1993-5#5)(1993-6#10)(1993-7#8)(1993-8#8)(1993-9#15)(1994-10#3)(1994-11#15)(1994-12#11)(1994-2#18)(1994-3#16)(1994-5#3)(1994-6#9)(1994-7#3)(1994-8#13)(1994-9#23)(1995-1#13)(1995-10#6)(1995-11#11)(1995-12#12)(1995-2#12)(1995-3#19)(1995-4#4)(1995-5#7)(1995-6#13)(1995-7#2)(1995-8#16)(1995-9#1)(1996-1#7)(1996-10#10)(1996-11#5)(1996-12#11)(1996-2#11)(1996-3#4)(1996-4#6)(1996-5#12)(1996-6#9)(1996-7#9)(1996-8#6)(1996-9#6)(1997-1#13)(1997-2#26)(1997-3#11)(1997-4#6)(1997-5#13)(1997-6#12)(1997-7#6)(1997-8#18)(2003-11#2)(2004-1#2)(2004-10#1)(2004-11#5)(2004-12#2)(2004-4#4)(2004-9#3)(2005-10#9)(2005-11#25)(2005-12#4)(2005-4#6)(2005-7#4)(2005-8#4)(2005-9#1)(2006-1#2)(2006-10#30)(2006-11#6)(2006-12#11)(2006-2#6)(2006-3#4)(2006-4#4)(2006-5#3)(2006-6#7)(2006-7#6)(2006-8#12)(2006-9#12)(2007-1#3)(2007-10#14)(2007-11#28)(2007-12#44)(2007-2#7)(2007-3#13)(2007-4#6)(2007-5#8)(2007-6#5)(2007-7#14)(2007-8#18)(2007-9#12)(2008-1#12)(2008-10#199)(2008-11#70)(2008-12#24)(2008-2#31)(2008-3#43)(2008-4#23)(2008-5#53)(2008-6#19)(2008-7#43)(2008-8#53)(2008-9#43)(2009-1#2)(2009-10#9)(2009-11#5)(2009-12#4)(2009-2#7)(2009-3#7)(2009-4#6)(2009-5#5)(2009-6#5)(2009-7#7)(2009-8#11)(2009-9#9)(2010-1#2)(2010-10#4)(2010-11#7)(2010-12#15)(2010-2#10)(2010-3#3)(2010-4#17)(2010-5#6)(2010-6#4)(2010-7#3)(2010-8#17)(2010-9#5)(2011-1#33)(2011-12#13)(2011-2#49)(2011-3#4)(2011-4#1)(2011-7#1)(2012-1#11)(2012-11#5)(2012-12#30)(2012-2#37)(2012-3#14)(2012-4#1)(2012-7#2)(2013-1#64)(2013-4#1)(2013-7#4)(2013-8#42)
suggestedthat the##2##2##(2008-11#2)
suggesting a binding##2##3##(1993-12#1)(2009-4#1)
suggesting a causal relationship##2##4##(1993-5#1)(2012-2#1)
suggesting a central role for the##2##6##(1995-8#1)(2006-10#1)
suggesting a central##3##3##(1995-7#1)(1995-8#1)(2006-10#1)
suggesting a common evolutionary origin##2##5##(1990-5#2)
suggesting a common##6##3##(1990-5#2)(1993-3#1)(1995-5#1)(1997-1#1)(2008-10#1)
suggesting a complex##3##3##(1993-12#1)(1996-5#1)(2008-7#1)
suggesting a condition##2##3##(1991-8#1)(2010-2#1)
suggesting a cooperative##2##3##(2006-12#1)(2010-12#1)
suggesting a crucial role of##2##5##(1991-4#1)(1997-7#1)
suggesting a crucial role##3##4##(1991-4#1)(1993-11#1)(1997-7#1)
suggesting a decrease##2##3##(1990-3#1)(2007-9#1)
suggesting a different##2##3##(1990-3#1)(1994-8#1)
suggesting a direct action of the drug##2##7##(1990-11#1)(1994-8#1)
suggesting a direct action of##3##5##(1990-11#1)(1994-8#1)(1995-10#1)
suggesting a direct role##2##4##(1993-6#2)
suggesting a direct##10##3##(1990-11#1)(1993-6#2)(1994-8#2)(1995-10#1)(1995-8#1)(1997-5#1)(1997-6#1)(2008-5#1)
suggesting a functional##4##3##(1994-9#1)(1995-4#1)(1995-5#1)(1997-7#1)
suggesting a high##4##3##(2007-12#1)(2008-8#1)(2010-5#1)(2011-12#1)
suggesting a higher##2##3##(1990-3#1)(1996-3#1)
suggesting a link between##3##4##(2010-11#1)(2010-2#1)(2013-8#1)
suggesting a mechanism of##2##4##(2008-7#1)(2012-2#1)
suggesting a model##2##3##(2009-12#1)(2010-5#1)
suggesting a more##4##3##(1994-9#1)(1997-7#1)(2008-5#1)(2009-10#1)
suggesting a need to##2##4##(2006-8#1)(2011-2#1)
suggesting a new##5##3##(1997-5#1)(2006-10#1)(2008-11#1)(2008-3#1)(2011-1#1)
suggesting a physiologic role for LIF##2##6##(2008-4#2)
suggesting a possible role for##3##5##(2008-10#2)(2009-12#1)
suggesting a possible role of##4##5##(1991-4#1)(1991-5#1)(1996-9#1)(2011-2#1)
suggesting a possible role##7##4##(1991-4#1)(1991-5#1)(1996-9#1)(2008-10#2)(2009-12#1)(2011-2#1)
suggesting a possible##20##3##(1991-4#1)(1991-5#1)(1991-9#1)(1994-12#1)(1996-9#1)(1997-3#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2009-12#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-7#1)
suggesting a potential role##2##4##(1996-11#1)(2011-2#1)
suggesting a potential##8##3##(1996-11#1)(2007-10#1)(2008-11#1)(2008-9#1)(2011-12#1)(2011-2#2)(2012-12#1)
suggesting a protective##2##3##(2010-4#1)(2011-12#1)
suggesting a relationship##2##3##(1994-2#1)(1996-2#1)
suggesting a requirement for##2##4##(1994-3#1)(1995-6#1)
suggesting a role for the##4##5##(1992-12#1)(1993-3#1)(2007-11#1)(2008-4#1)
suggesting a role for this##2##5##(1995-1#1)(1997-4#1)
suggesting a role for##28##4##(1991-10#1)(1992-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#2)(2006-12#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2009-3#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
suggesting a role in##2##4##(1991-7#1)(2010-11#1)
suggesting a role of##4##4##(2009-9#1)(2010-12#1)(2010-2#1)(2012-3#1)
suggesting a role##34##3##(1991-10#1)(1991-7#1)(1992-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#2)(2006-12#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2009-3#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
suggesting a selective##2##3##(1991-10#1)(1997-1#1)
suggesting a signalling route for triggering chromatin remodelling##2##8##(2012-12#2)
suggesting a significant##2##3##(2012-12#1)(2013-7#1)
suggesting a small##2##3##(1992-12#1)(2008-4#1)
suggesting a specific##2##3##(1991-6#1)(1996-9#1)
suggesting a strong##2##3##(1991-7#1)(2008-5#1)
suggesting a##265##2##(1990-11#3)(1990-3#4)(1990-5#4)(1990-7#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#3)(1992-4#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#3)(1993-5#1)(1993-6#3)(1993-8#2)(1994-10#2)(1994-11#4)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#5)(1994-9#3)(1995-1#3)(1995-10#2)(1995-11#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-5#5)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-9#4)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#4)(2004-4#1)(2005-11#3)(2005-8#2)(2006-10#6)(2006-12#3)(2006-8#2)(2007-10#2)(2007-11#1)(2007-12#5)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#16)(2008-11#8)(2008-2#2)(2008-3#1)(2008-4#6)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#2)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-11#4)(2010-12#3)(2010-2#5)(2010-3#4)(2010-4#1)(2010-5#3)(2010-8#2)(2011-1#3)(2011-12#3)(2011-2#6)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#2)
suggesting alterations in the##2##4##(1994-10#1)(1994-11#1)
suggesting alterations in##3##3##(1994-10#1)(1994-11#1)(1995-11#1)
suggesting an active##2##3##(2007-12#1)(2012-12#1)
suggesting an additional##2##3##(1993-2#1)(2007-8#1)
suggesting an alternative##2##3##(1995-2#2)
suggesting an important role for##3##5##(1991-8#1)(1995-3#1)(2012-3#1)
suggesting an important role of the##3##6##(1994-8#1)(2009-11#1)(2011-1#1)
suggesting an important role##6##4##(1991-8#1)(1994-8#1)(1995-3#1)(2009-11#1)(2011-1#1)(2012-3#1)
suggesting an important##7##3##(1991-8#1)(1994-8#1)(1995-3#1)(1996-7#1)(2009-11#1)(2011-1#1)(2012-3#1)
suggesting an increase in##2##4##(1992-2#1)(1994-5#1)
suggesting an increased flux##2##4##(2008-11#2)
suggesting an increased##8##3##(1996-4#1)(1997-6#1)(2008-11#2)(2008-4#1)(2008-7#2)(2009-8#1)
suggesting an influence of##2##4##(2007-2#1)(2011-1#1)
suggesting an involvement of phosphatidylinositol degradation and activation of protein kinase C##2##12##(2008-11#2)
suggesting an ionic##2##3##(2008-12#1)(2010-4#1)
suggesting an##61##2##(1990-8#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#3)(1997-4#1)(1997-6#1)(2004-4#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#2)(2008-11#4)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-12#1)(2009-8#2)(2010-4#2)(2010-5#1)(2011-1#2)(2011-12#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#1)
suggesting applications##2##2##(2008-10#1)(2008-11#1)
suggesting both##2##2##(1991-1#1)(1991-3#1)
suggesting cell##2##2##(1995-2#1)(2010-2#1)
suggesting central##2##2##(2006-10#1)(2012-3#1)
suggesting delayed##2##2##(2005-7#1)(2008-10#1)
suggesting different mechanisms##2##3##(1991-7#1)(1997-4#1)
suggesting different##7##2##(1991-5#1)(1991-7#1)(1993-8#1)(1997-4#1)(2005-11#1)(2008-11#1)(2013-8#1)
suggesting early diabetic nephropathy##2##4##(2013-1#2)
suggesting either that##3##3##(1995-10#1)(2008-10#2)
suggesting greater##2##2##(2008-10#1)(2013-1#1)
suggesting high##2##2##(1994-12#1)(2009-5#1)
suggesting highly##2##2##(2008-4#1)(2010-7#1)
suggesting how##2##2##(2009-10#1)(2013-1#1)
suggesting impaired##2##2##(2007-11#1)(2008-4#1)
suggesting in vivo##2##3##(1991-9#1)(2008-5#1)
suggesting in##3##2##(1991-9#1)(2007-2#1)(2008-5#1)
suggesting intermolecular##2##2##(1991-10#1)(1993-12#1)
suggesting involvement of##6##3##(1990-7#1)(1993-12#1)(1993-2#1)(2005-12#1)(2008-11#1)(2011-2#1)
suggesting involvement##7##2##(1990-7#1)(1993-12#1)(1993-2#1)(1996-5#1)(2005-12#1)(2008-11#1)(2011-2#1)
suggesting it##5##2##(1995-6#1)(1996-6#1)(2008-10#1)(2009-6#1)(2013-8#1)
suggesting its possible##2##3##(1990-5#1)(2013-1#1)
suggesting its potential##2##3##(2008-7#1)(2008-9#1)
suggesting its##12##2##(1990-5#1)(1991-1#1)(1996-6#1)(1997-4#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
suggesting lack of##3##3##(1994-3#1)(1997-1#1)(2008-5#1)
suggesting more##2##2##(1996-12#1)(2013-8#1)
suggesting multiple##4##2##(1993-11#1)(2008-10#1)(2012-2#2)
suggesting neurotransmitter##2##2##(1990-5#1)(1993-3#1)
suggesting no involvement of arachidonic acid metabolism##2##7##(2008-11#2)
suggesting no##7##2##(1991-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-4#1)
suggesting other##2##2##(1992-7#1)(2009-12#1)
suggesting positive##2##2##(2012-1#1)(2013-1#1)
suggesting possible##6##2##(2008-10#1)(2008-7#1)(2010-12#1)(2012-2#2)(2013-1#1)
suggesting potential##2##2##(1995-3#1)(2013-1#1)
suggesting recent##2##2##(1997-6#1)(2009-10#1)
suggesting reduced##2##2##(2009-10#1)(2013-7#1)
suggesting release##2##2##(1991-2#1)(1994-9#1)
suggesting secretion##2##2##(1995-6#1)(2008-10#1)
suggesting sensitization of##2##3##(1995-12#2)
suggesting several##2##2##(1991-3#1)(1994-12#1)
suggesting significant##3##2##(1991-3#1)(2007-10#1)(2007-11#1)
suggesting similar##3##2##(1997-2#1)(2009-8#2)
suggesting some##3##2##(1993-12#1)(2008-7#1)(2010-8#1)
suggesting specificity##2##2##(1996-5#1)(2012-3#1)
suggesting strongly that##2##3##(1994-9#1)(1996-7#1)
suggesting structural##2##2##(1996-4#1)(2008-5#1)
suggesting substantial##2##2##(1991-1#1)(1993-2#1)
suggesting that D1 receptors play##2##5##(1996-10#2)
suggesting that E##2##3##(2004-4#1)(2008-8#1)
suggesting that MAPKK##2##3##(1994-12#1)(1995-2#1)
suggesting that NGF##3##3##(1993-7#1)(1996-2#1)(1997-2#1)
suggesting that NO##2##3##(1993-4#1)(1995-6#1)
suggesting that P##2##3##(2009-9#1)(2010-8#1)
suggesting that RNA##2##3##(1994-3#1)(2009-3#1)
suggesting that Smad7 depends on the deacetylase activity of its associated HDAC-1 to arrest the cell cycle##2##17##(2012-12#2)
suggesting that TNF may be##2##5##(1990-5#1)(1995-3#1)
suggesting that TNF##3##3##(1990-5#1)(1995-3#2)
suggesting that TSP##2##3##(1991-6#1)(1993-9#1)
suggesting that VIP##2##3##(1995-5#1)(1997-8#1)
suggesting that a high##2##4##(1992-9#1)(1997-7#1)
suggesting that a single##4##4##(2007-2#1)(2008-10#2)(2012-3#1)
suggesting that a##40##3##(1990-6#1)(1990-9#1)(1991-2#1)(1992-11#1)(1992-2#1)(1992-9#2)(1993-11#2)(1993-6#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-2#2)(1997-3#1)(1997-7#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-2#3)(2008-6#2)(2009-12#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
suggesting that accumulation of##2##4##(1996-11#1)(2009-10#1)
suggesting that active##2##3##(1996-7#1)(2012-3#1)
suggesting that additional##6##3##(1992-12#1)(1997-4#1)(2006-10#1)(2008-10#2)(2012-2#1)
suggesting that an##9##3##(1993-12#1)(1994-9#1)(1995-8#1)(1996-10#1)(1996-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)
suggesting that at least some##2##5##(1990-12#1)(2008-10#1)
suggesting that at least two##2##5##(1992-10#1)(1997-6#1)
suggesting that at least##5##4##(1990-12#1)(1992-10#1)(1997-6#1)(2004-8#1)(2008-10#1)
suggesting that at##7##3##(1990-12#1)(1992-10#1)(1994-5#1)(1997-6#1)(2004-8#1)(2008-1#1)(2008-10#1)
suggesting that both##10##3##(1991-5#1)(1993-3#1)(1993-7#1)(1995-5#1)(1996-5#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-2#1)
suggesting that calcium##2##3##(1994-11#1)(1995-7#1)
suggesting that despite##2##3##(1992-2#1)(2009-4#1)
suggesting that differences in##2##4##(1996-8#1)(2008-10#1)
suggesting that differences##3##3##(1994-12#1)(1996-8#1)(2008-10#1)
suggesting that different##6##3##(1993-4#1)(1993-8#1)(2006-10#1)(2010-4#1)(2011-2#1)(2012-12#1)
suggesting that either the##3##4##(1992-9#1)(1997-4#1)(1997-7#1)
suggesting that either##5##3##(1992-9#1)(1997-4#1)(1997-7#1)(2007-2#1)(2013-7#1)
suggesting that endogenous##2##3##(1991-7#1)(1993-12#1)
suggesting that expression of the##2##5##(1990-2#1)(1996-7#1)
suggesting that expression of##3##4##(1990-2#1)(1996-7#1)(1997-3#1)
suggesting that external##2##3##(2006-8#1)(2008-10#1)
suggesting that extracellular##2##3##(1990-3#1)(2008-4#1)
suggesting that glucocorticoid##2##3##(1994-11#1)(1994-9#1)
suggesting that glycosylation##2##3##(1991-8#1)(1994-8#1)
suggesting that human##2##3##(2010-2#1)(2012-3#1)
suggesting that in the##2##4##(2008-1#1)(2008-11#1)
suggesting that in vivo##3##4##(1991-4#1)(1994-6#1)(2006-5#1)
suggesting that in##14##3##(1990-5#1)(1991-4#1)(1994-12#1)(1994-6#1)(1997-4#1)(1997-7#1)(2006-2#1)(2006-5#1)(2006-9#1)(2008-1#1)(2008-11#1)(2008-5#1)(2012-1#1)(2012-2#1)
suggesting that increased##3##3##(1994-8#1)(1994-9#1)(2007-1#1)
suggesting that insulin##2##3##(1990-8#1)(1991-5#1)
suggesting that it could be##3##5##(1997-2#1)(2011-1#1)(2012-2#1)
suggesting that it has##2##4##(1995-8#1)(2009-3#1)
suggesting that it is a##3##5##(1992-12#1)(2007-9#1)(2008-6#1)
suggesting that it is##13##4##(1990-11#1)(1991-5#1)(1992-12#2)(1993-9#1)(1994-6#1)(1995-3#1)(1996-9#1)(1997-3#1)(1997-4#1)(2007-9#1)(2008-6#1)(2011-2#1)
suggesting that it may be##3##5##(1991-5#1)(1997-5#1)(2008-11#1)
suggesting that it may play a##2##6##(1993-3#1)(2008-10#1)
suggesting that it may play##3##5##(1993-3#1)(2008-10#2)
suggesting that it may##10##4##(1990-11#1)(1991-11#1)(1991-5#1)(1993-3#1)(1997-5#1)(2005-8#1)(2008-10#2)(2008-11#1)(2011-2#1)
suggesting that it might be##2##5##(2004-4#1)(2005-11#1)
suggesting that it was##3##4##(1992-5#1)(1993-6#1)(2005-11#1)
suggesting that it##38##3##(1990-11#2)(1991-11#1)(1991-5#2)(1992-12#2)(1992-5#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-6#1)(1995-3#2)(1995-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(2004-4#1)(2005-11#2)(2005-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-2#1)
suggesting that its##9##3##(1992-4#1)(1992-6#1)(1994-8#2)(1995-8#1)(1997-6#1)(2005-8#1)(2007-8#1)(2008-10#1)
suggesting that many of these##2##5##(2007-11#1)(2008-7#1)
suggesting that many of##3##4##(1996-3#1)(2007-11#1)(2008-7#1)
suggesting that many##4##3##(1996-3#1)(2007-11#1)(2008-7#1)(2009-5#1)
suggesting that mapping data resources between models is not a straightforward issue##2##12##(2013-1#2)
suggesting that mechanisms other than##2##5##(1995-9#1)(2008-10#1)
suggesting that mechanisms##3##3##(1995-9#1)(2006-10#1)(2008-10#1)
suggesting that migration##2##3##(2008-10#2)
suggesting that neurons##2##3##(1996-5#1)(1997-8#1)
suggesting that new##2##3##(1995-2#1)(2008-10#1)
suggesting that no##4##3##(1994-8#1)(1996-12#1)(1996-3#1)(2010-2#1)
suggesting that not all##3##4##(1992-12#1)(2007-11#1)(2008-11#1)
suggesting that nuclear##2##3##(1994-9#1)(2008-8#1)
suggesting that one of the##2##5##(1993-8#1)(2008-4#1)
suggesting that one##4##3##(1993-8#1)(1995-8#1)(2008-10#1)(2008-4#1)
suggesting that only##3##3##(1995-5#1)(2008-10#1)(2009-12#1)
suggesting that opioid##2##3##(1990-3#1)(2008-2#1)
suggesting that other factors may##2##5##(1990-6#1)(2006-12#1)
suggesting that other factors##3##4##(1990-6#1)(2006-12#1)(2008-10#1)
suggesting that other mechanisms##2##4##(2008-4#1)(2010-12#1)
suggesting that other##9##3##(1990-6#1)(1991-9#1)(1992-7#1)(1995-2#1)(1996-6#1)(2006-12#1)(2008-10#1)(2008-4#1)(2010-12#1)
suggesting that phosphorylation##2##3##(1996-5#2)
suggesting that potentiation by##2##4##(1991-6#1)(1995-3#1)
suggesting that prolonged##2##3##(1994-12#1)(2006-10#1)
suggesting that protein##3##3##(1991-5#1)(1997-1#1)(2012-3#1)
suggesting that removal of##2##4##(1997-6#1)(2008-7#1)
suggesting that selection##2##3##(2004-1#1)(2008-10#1)
suggesting that sex##2##3##(2008-5#1)(2008-8#1)
suggesting that similar##2##3##(1991-8#1)(1995-10#1)
suggesting that soil##2##3##(2006-3#1)(2013-8#1)
suggesting that some of the##2##5##(2008-5#1)(2012-1#1)
suggesting that some##11##3##(1991-8#1)(1993-6#1)(1994-2#1)(1995-5#1)(1997-3#2)(2006-10#1)(2008-10#2)(2008-5#1)(2012-1#1)
suggesting that the ability to##4##5##(1995-8#1)(2007-5#1)(2008-10#1)(2011-2#1)
suggesting that the absence of##2##5##(1994-12#1)(2013-7#1)
suggesting that the action of##4##5##(1991-5#1)(1992-3#1)(2008-4#1)(2008-9#1)
suggesting that the activity of##2##5##(2007-8#1)(2008-9#1)
suggesting that the amino terminus##2##5##(1991-8#2)
suggesting that the amount of##2##5##(1990-8#1)(1996-6#1)
suggesting that the bacterial##2##4##(1994-6#1)(1995-2#1)
suggesting that the binding##2##4##(1994-9#1)(1995-5#1)
suggesting that the effect of##3##5##(1992-6#1)(2006-10#1)(2010-8#1)
suggesting that the effect##5##4##(1991-5#1)(1992-6#1)(2006-10#1)(2008-11#1)(2010-8#1)
suggesting that the effects were##2##5##(1991-6#1)(1994-2#1)
suggesting that the effects##3##4##(1991-6#1)(1994-2#1)(1996-11#1)
suggesting that the endogenous##3##4##(1990-11#1)(1990-5#1)(2008-5#1)
suggesting that the enzyme##2##4##(1992-4#1)(1994-12#1)
suggesting that the former##2##4##(1997-7#1)(2008-10#1)
suggesting that the function of##2##5##(1997-7#1)(2008-9#1)
suggesting that the functional##2##4##(1997-7#1)(2008-7#1)
suggesting that the gene##2##4##(1993-2#1)(1994-12#1)
suggesting that the genetic##2##4##(1994-3#1)(1996-4#1)
suggesting that the increase in##2##5##(1997-1#1)(2005-11#1)
suggesting that the increased##4##4##(1990-12#1)(1995-2#1)(1996-8#1)(2010-9#1)
suggesting that the inhibitory effect##2##5##(1991-9#2)
suggesting that the interaction##3##4##(1996-5#1)(2008-8#1)(2008-9#1)
suggesting that the latter##3##4##(1995-6#1)(1997-5#1)(2008-5#1)
suggesting that the loss of##2##5##(1997-5#1)(2013-1#1)
suggesting that the major##2##4##(1996-8#1)(2007-6#1)
suggesting that the mechanism of##4##5##(1991-5#1)(2010-10#1)(2012-1#1)(2012-3#1)
suggesting that the mechanisms##2##4##(1993-9#1)(2008-8#1)
suggesting that the modulation##2##4##(1994-6#1)(2012-2#1)
suggesting that the observed##3##4##(1994-3#1)(2005-10#1)(2007-10#1)
suggesting that the presence of##2##5##(1992-3#1)(1995-2#1)
suggesting that the production of##2##5##(1990-3#1)(1994-3#1)
suggesting that the release of##2##5##(2008-11#1)(2008-4#1)
suggesting that the resistance##2##4##(2008-10#2)
suggesting that the simple##2##4##(1993-12#1)(2005-11#1)
suggesting that the species##2##4##(1991-7#1)(2008-8#1)
suggesting that the specific interaction##2##5##(1995-10#1)(1996-5#1)
suggesting that the structures##2##4##(1991-2#1)(1992-6#1)
suggesting that the substrate##2##4##(1993-2#1)(2008-3#1)
suggesting that the transporter##2##4##(1995-6#1)(1996-4#1)
suggesting that the two enzymes##2##5##(1990-9#1)(2008-11#1)
suggesting that the two##5##4##(1990-9#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-11#1)
suggesting that the various##2##4##(1994-8#1)(1995-6#1)
suggesting that the##342##3##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#3)(1990-3#1)(1990-5#4)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#5)(1991-3#1)(1991-4#2)(1991-5#5)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#5)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#5)(1993-2#3)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#3)(1994-12#6)(1994-2#1)(1994-3#4)(1994-5#4)(1994-6#4)(1994-8#3)(1994-9#3)(1995-1#3)(1995-10#2)(1995-11#2)(1995-12#5)(1995-2#7)(1995-3#1)(1995-5#3)(1995-6#9)(1995-8#5)(1995-9#2)(1996-11#6)(1996-12#1)(1996-4#4)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#5)(1997-1#3)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#3)(1997-6#4)(1997-7#5)(1997-9#1)(2003-11#1)(2004-9#1)(2005-10#1)(2005-11#4)(2006-10#2)(2006-11#1)(2006-12#3)(2006-3#1)(2006-8#2)(2007-10#2)(2007-12#3)(2007-3#1)(2007-5#1)(2007-6#2)(2007-8#3)(2008-10#25)(2008-11#10)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#6)(2008-5#9)(2008-6#3)(2008-7#3)(2008-8#10)(2008-9#4)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#5)(2013-8#7)
suggesting that their##8##3##(1992-7#1)(1993-6#1)(1995-1#1)(1995-10#1)(1996-2#1)(2007-12#1)(2008-8#1)(2010-4#1)
suggesting that there are at least two##2##7##(1997-2#1)(1997-6#1)
suggesting that there are##4##4##(1995-6#1)(1997-2#1)(1997-6#1)(2008-8#1)
suggesting that there is a##2##5##(1991-5#1)(1991-6#1)
suggesting that there is##6##4##(1991-5#1)(1991-6#1)(1996-2#1)(1997-8#1)(1997-9#1)(2012-3#1)
suggesting that there may be##2##5##(2007-12#1)(2008-8#1)
suggesting that there was##2##4##(1994-3#1)(2008-9#1)
suggesting that there##14##3##(1991-5#1)(1991-6#1)(1994-3#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-8#1)(1997-9#1)(2007-12#1)(2008-8#2)(2008-9#1)(2012-3#1)
suggesting that these genes##2##4##(1992-3#1)(2008-7#1)
suggesting that these proteins##2##4##(1993-8#1)(2008-7#1)
suggesting that these two##6##4##(1991-8#1)(1992-2#1)(1993-11#1)(2007-3#1)(2008-10#1)(2008-11#1)
suggesting that these##44##3##(1990-7#2)(1991-1#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-6#2)(1995-7#1)(1996-11#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-4#1)(2005-12#1)(2006-10#1)(2006-7#1)(2007-3#2)(2008-10#3)(2008-11#2)(2008-4#1)(2008-7#3)(2008-9#1)(2009-8#2)(2011-1#1)(2012-2#1)(2012-3#1)
suggesting that they are not##2##5##(2004-11#1)(2007-12#1)
suggesting that they are##6##4##(1992-11#1)(2004-11#1)(2007-12#1)(2008-7#1)(2008-9#1)(2010-7#1)
suggesting that they may##3##4##(1991-2#1)(1992-3#1)(2010-4#1)
suggesting that they possess##2##4##(1990-2#1)(1996-2#1)
suggesting that they share##2##4##(1995-2#1)(1997-4#1)
suggesting that they were derived from##2##6##(2008-10#2)
suggesting that they were##5##4##(1991-12#1)(1991-2#1)(2008-10#2)(2008-8#1)
suggesting that they##33##3##(1990-2#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-7#1)(1992-11#1)(1992-3#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-4#1)(1996-2#2)(1996-4#1)(1997-1#1)(1997-4#1)(2004-11#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-7#1)(2012-2#1)
suggesting that this enzyme##2##4##(1995-1#1)(2008-3#1)
suggesting that this gene is part of an operon##2##9##(1990-9#1)(1991-7#1)
suggesting that this gene##3##4##(1990-9#1)(1991-7#1)(2008-2#1)
suggesting that this is a##2##5##(1993-2#1)(2007-12#1)
suggesting that this is##3##4##(1990-12#1)(1993-2#1)(2007-12#1)
suggesting that this may be##2##5##(1991-12#1)(1994-11#1)
suggesting that this region##2##4##(1994-9#1)(2008-11#1)
suggesting that this site##2##4##(1991-1#1)(1992-5#1)
suggesting that this species##2##4##(2008-5#1)(2008-6#1)
suggesting that this##51##3##(1990-12#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-7#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-8#2)(1995-9#1)(1996-12#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-12#1)(2006-10#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-1#1)(2012-11#1)(2012-2#1)
suggesting that two##2##3##(1994-5#1)(2008-10#1)
suggesting that variations in##2##4##(2007-12#1)(2009-5#1)
suggesting that vitamin##2##3##(1995-11#1)(2008-8#1)
suggesting that water##2##3##(2005-11#1)(2008-5#1)
suggesting that we##2##3##(1996-12#1)(2006-3#1)
suggesting that##1312##2##(1990-10#1)(1990-11#8)(1990-12#8)(1990-2#9)(1990-3#5)(1990-5#10)(1990-6#4)(1990-7#4)(1990-8#2)(1990-9#6)(1991-1#4)(1991-11#3)(1991-12#9)(1991-2#13)(1991-3#6)(1991-4#5)(1991-5#14)(1991-6#5)(1991-7#7)(1991-8#9)(1991-9#7)(1992-1#1)(1992-10#1)(1992-11#6)(1992-12#13)(1992-2#6)(1992-3#8)(1992-4#3)(1992-5#5)(1992-6#7)(1992-7#5)(1992-8#4)(1992-9#9)(1993-11#6)(1993-12#10)(1993-2#6)(1993-3#8)(1993-4#3)(1993-6#10)(1993-7#2)(1993-8#10)(1993-9#5)(1994-10#1)(1994-11#7)(1994-12#17)(1994-2#4)(1994-3#12)(1994-5#10)(1994-6#12)(1994-8#14)(1994-9#12)(1995-1#9)(1995-10#6)(1995-11#7)(1995-12#19)(1995-2#20)(1995-3#9)(1995-4#1)(1995-5#9)(1995-6#20)(1995-7#3)(1995-8#20)(1995-9#5)(1996-1#3)(1996-10#7)(1996-11#10)(1996-12#8)(1996-2#7)(1996-3#8)(1996-4#9)(1996-5#16)(1996-6#6)(1996-7#7)(1996-8#8)(1996-9#8)(1997-1#8)(1997-2#11)(1997-3#9)(1997-4#19)(1997-5#10)(1997-6#13)(1997-7#11)(1997-8#8)(1997-9#2)(2003-11#1)(2004-1#1)(2004-11#3)(2004-4#3)(2004-8#1)(2004-9#1)(2005-10#3)(2005-11#9)(2005-12#2)(2005-7#1)(2005-8#2)(2006-10#15)(2006-11#1)(2006-12#6)(2006-2#1)(2006-3#3)(2006-4#1)(2006-5#4)(2006-7#2)(2006-8#5)(2006-9#3)(2007-1#1)(2007-10#4)(2007-11#5)(2007-12#17)(2007-2#2)(2007-3#3)(2007-5#2)(2007-6#3)(2007-8#7)(2007-9#3)(2008-1#3)(2008-10#117)(2008-11#32)(2008-12#4)(2008-2#11)(2008-3#12)(2008-4#22)(2008-5#31)(2008-6#8)(2008-7#17)(2008-8#34)(2008-9#14)(2009-10#4)(2009-12#6)(2009-2#5)(2009-3#5)(2009-4#3)(2009-5#4)(2009-6#2)(2009-8#10)(2009-9#2)(2010-1#4)(2010-10#2)(2010-11#1)(2010-12#7)(2010-2#7)(2010-3#3)(2010-4#10)(2010-5#5)(2010-6#2)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#15)(2011-10#1)(2011-12#4)(2011-2#20)(2012-1#6)(2012-11#2)(2012-12#16)(2012-2#16)(2012-3#17)(2013-1#12)(2013-7#8)(2013-8#13)
suggesting the absence of##3##4##(1992-12#1)(1992-9#1)(1995-2#1)
suggesting the coexistence of##2##4##(1994-9#1)(2008-4#1)
suggesting the control##2##3##(1995-6#1)(2008-7#1)
suggesting the effect##2##3##(2011-2#1)(2012-2#1)
suggesting the existence of a##4##5##(1990-9#1)(1994-12#1)(2008-5#1)(2013-1#1)
suggesting the existence of multiple##2##5##(2007-12#1)(2008-7#1)
suggesting the existence of##13##4##(1990-9#1)(1994-10#1)(1994-12#1)(1994-9#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-2#1)(2010-5#1)(2012-2#1)(2013-1#1)
suggesting the formation of##2##4##(1990-11#1)(2005-11#1)
suggesting the importance of the##2##5##(2008-10#1)(2010-6#1)
suggesting the importance of##9##4##(1991-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-5#1)(2010-6#1)(2012-2#1)
suggesting the involvement of a##4##5##(1993-8#1)(1994-3#1)(1997-4#1)(2008-11#1)
suggesting the involvement of##19##4##(1990-10#1)(1990-11#1)(1991-10#1)(1993-11#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-6#1)(1996-12#1)(1997-4#1)(1997-7#1)(2004-11#1)(2005-8#1)(2008-10#2)(2008-11#2)(2008-4#1)
suggesting the need for##3##4##(2008-4#1)(2009-6#1)(2012-12#1)
suggesting the need to##3##4##(1991-3#1)(2010-2#1)(2012-1#1)
suggesting the need##6##3##(1991-3#1)(2008-4#1)(2009-6#1)(2010-2#1)(2012-1#1)(2012-12#1)
suggesting the occurrence of##5##4##(1994-6#2)(2008-10#3)
suggesting the possibility of##2##4##(2008-6#1)(2008-8#1)
suggesting the possibility that the##3##5##(1994-9#1)(1995-9#1)(2011-2#1)
suggesting the possibility that##5##4##(1994-3#1)(1994-9#1)(1995-9#1)(2006-2#1)(2011-2#1)
suggesting the possibility##7##3##(1994-3#1)(1994-9#1)(1995-9#1)(2006-2#1)(2008-6#1)(2008-8#1)(2011-2#1)
suggesting the possible involvement##2##4##(1994-8#1)(2008-11#1)
suggesting the possible##4##3##(1994-8#1)(1994-9#1)(2007-12#1)(2008-11#1)
suggesting the potential for a##2##5##(2008-10#1)(2012-1#1)
suggesting the potential for##4##4##(2007-12#1)(2008-10#2)(2012-1#1)
suggesting the potential##7##3##(2007-12#1)(2008-10#2)(2008-11#1)(2009-2#1)(2012-1#1)(2012-2#1)
suggesting the presence of a##6##5##(1990-3#1)(1991-1#1)(1994-11#1)(1996-11#1)(1996-4#1)(1997-8#1)
suggesting the presence of an##3##5##(1990-9#1)(1994-12#1)(1997-2#1)
suggesting the presence of##25##4##(1990-3#1)(1990-9#1)(1991-1#1)(1991-10#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-12#2)(1994-6#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#2)(2008-10#2)(2008-5#1)(2008-7#1)(2009-6#1)(2010-6#1)
suggesting the use of##2##4##(2008-6#1)(2008-8#1)
suggesting the##162##2##(1990-10#1)(1990-11#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#1)(1990-9#2)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-10#1)(1992-12#1)(1992-9#1)(1993-11#3)(1993-3#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-11#3)(1994-12#3)(1994-3#2)(1994-5#2)(1994-6#4)(1994-8#1)(1994-9#4)(1995-12#2)(1995-2#1)(1995-6#2)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-4#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-6#2)(1997-7#3)(1997-8#3)(2004-11#1)(2004-8#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-12#3)(2007-7#1)(2007-9#1)(2008-10#17)(2008-11#7)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-2#1)(2010-5#2)(2010-6#2)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#2)
suggesting their##4##2##(1997-3#1)(2007-1#2)(2008-11#1)
suggesting there##2##2##(1996-12#1)(2006-11#1)
suggesting they may##2##3##(1996-7#1)(2010-12#1)
suggesting they##6##2##(1994-11#1)(1994-8#1)(1995-1#1)(1996-7#1)(2008-5#1)(2010-12#1)
suggesting this##3##2##(1994-2#1)(1997-4#1)(2008-8#1)
suggesting two##2##2##(1990-5#1)(2013-1#1)
suggesting ways##2##2##(2008-12#1)(2008-7#1)
suggesting##2108##1##(1990-10#2)(1990-11#15)(1990-12#8)(1990-2#10)(1990-3#11)(1990-4#1)(1990-5#17)(1990-6#4)(1990-7#8)(1990-8#4)(1990-9#8)(1991-1#11)(1991-10#6)(1991-11#6)(1991-12#11)(1991-2#17)(1991-3#11)(1991-4#7)(1991-5#16)(1991-6#8)(1991-7#11)(1991-8#13)(1991-9#10)(1992-1#2)(1992-10#3)(1992-11#8)(1992-12#17)(1992-2#7)(1992-3#8)(1992-4#4)(1992-5#6)(1992-6#7)(1992-7#7)(1992-8#6)(1992-9#12)(1993-11#12)(1993-12#17)(1993-2#9)(1993-3#15)(1993-4#4)(1993-5#1)(1993-6#14)(1993-7#3)(1993-8#16)(1993-9#6)(1994-10#5)(1994-11#20)(1994-12#28)(1994-2#7)(1994-3#17)(1994-5#15)(1994-6#16)(1994-8#22)(1994-9#21)(1995-1#13)(1995-10#10)(1995-11#10)(1995-12#29)(1995-2#25)(1995-3#13)(1995-4#2)(1995-5#14)(1995-6#27)(1995-7#6)(1995-8#24)(1995-9#7)(1996-1#3)(1996-10#11)(1996-11#13)(1996-12#13)(1996-2#12)(1996-3#10)(1996-4#15)(1996-5#23)(1996-6#9)(1996-7#14)(1996-8#9)(1996-9#12)(1997-1#11)(1997-2#19)(1997-3#12)(1997-4#28)(1997-5#13)(1997-6#19)(1997-7#18)(1997-8#11)(1997-9#2)(2003-11#1)(2004-1#1)(2004-11#4)(2004-4#5)(2004-8#2)(2004-9#1)(2005-10#4)(2005-11#16)(2005-12#3)(2005-7#2)(2005-8#5)(2006-10#27)(2006-11#2)(2006-12#12)(2006-2#2)(2006-3#3)(2006-4#1)(2006-5#4)(2006-6#2)(2006-7#2)(2006-8#8)(2006-9#3)(2007-1#3)(2007-10#8)(2007-11#9)(2007-12#29)(2007-2#6)(2007-3#5)(2007-4#1)(2007-5#2)(2007-6#4)(2007-7#5)(2007-8#10)(2007-9#7)(2008-1#5)(2008-10#176)(2008-11#58)(2008-12#6)(2008-2#14)(2008-3#14)(2008-4#41)(2008-5#53)(2008-6#13)(2008-7#33)(2008-8#45)(2008-9#20)(2009-10#9)(2009-11#2)(2009-12#10)(2009-2#7)(2009-3#7)(2009-4#10)(2009-5#9)(2009-6#7)(2009-7#1)(2009-8#18)(2009-9#5)(2010-1#5)(2010-10#2)(2010-11#6)(2010-12#15)(2010-2#15)(2010-3#7)(2010-4#14)(2010-5#14)(2010-6#6)(2010-7#7)(2010-8#7)(2010-9#1)(2011-1#25)(2011-10#1)(2011-12#8)(2011-2#35)(2011-3#1)(2012-1#11)(2012-11#3)(2012-12#31)(2012-2#38)(2012-3#24)(2012-6#1)(2013-1#28)(2013-7#13)(2013-8#21)
suggestion for##5##2##(1994-2#1)(1994-6#1)(2007-12#1)(2007-4#1)(2008-1#1)
suggestion is made that##3##4##(1990-11#1)(1992-6#1)(2009-10#1)
suggestion is made##5##3##(1990-11#1)(1992-6#1)(2008-10#1)(2008-3#1)(2009-10#1)
suggestion is##8##2##(1990-11#1)(1992-6#1)(2006-2#1)(2008-10#1)(2008-3#1)(2009-10#1)(2010-8#1)(2012-3#1)
suggestion of a##3##3##(1995-9#1)(2006-8#1)(2008-1#1)
suggestion of an##2##3##(1991-9#1)(2008-7#1)
suggestion of##13##2##(1991-9#1)(1995-11#1)(1995-9#2)(1996-6#1)(2006-11#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-6#2)(2008-7#1)(2011-2#1)
suggestion that the##7##3##(1990-11#1)(1990-12#1)(1992-1#1)(1993-12#1)(1995-6#1)(1996-2#1)(1997-2#1)
suggestion that##33##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-10#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#2)(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-4#1)(2006-2#1)(2006-3#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-2#1)(2011-2#1)(2013-1#1)
suggestion##70##1##(1990-11#2)(1990-12#1)(1990-8#1)(1991-10#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-6#2)(1992-7#1)(1993-11#1)(1993-12#2)(1994-2#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-4#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(2006-1#1)(2006-11#1)(2006-2#2)(2006-3#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-7#1)(2008-1#3)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#3)(2012-3#1)(2013-1#2)
suggestions about the##2##3##(1994-6#1)(2008-6#1)
suggestions and##5##2##(1990-12#1)(1994-2#1)(2006-10#1)(2008-12#1)(2008-6#1)
suggestions are given##2##3##(2008-4#1)(2009-5#1)
suggestions are made for##5##4##(1996-2#1)(2007-11#1)(2008-12#1)(2008-9#1)(2009-7#1)
suggestions are offered##2##3##(2008-12#1)(2010-2#1)
suggestions are##16##2##(1990-8#1)(1996-2#1)(2006-5#1)(2007-11#1)(2008-12#3)(2008-4#1)(2008-6#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-2#1)
suggestions as to how##2##4##(1994-3#1)(2008-8#1)
suggestions as to##3##3##(1994-3#1)(2004-10#1)(2008-8#1)
suggestions for a##5##3##(2007-7#1)(2008-10#1)(2008-5#1)(2010-8#1)(2011-2#1)
suggestions for developing##2##3##(1995-1#1)(2007-12#1)
suggestions for future action##2##4##(2012-12#2)
suggestions for future research are##5##5##(2008-12#1)(2008-4#1)(2009-5#1)(2011-12#1)(2011-2#1)
suggestions for future research##9##4##(2007-8#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-11#1)(2009-5#1)(2011-12#1)(2011-2#1)
suggestions for future##14##3##(2006-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-12#2)(2008-4#1)(2008-6#1)(2009-11#1)(2009-5#1)(2011-12#1)(2011-2#1)(2012-12#2)
suggestions for improvement##2##3##(2012-2#2)
suggestions for improving the##2##4##(2006-7#1)(2008-9#1)
suggestions for improving##5##3##(1991-3#1)(1995-1#1)(1996-11#1)(2006-7#1)(2008-9#1)
suggestions for physicians##2##3##(1991-2#1)(1992-2#1)
suggestions for practice##2##3##(2010-11#1)(2011-1#1)
suggestions for the##3##3##(1990-2#1)(2008-3#1)(2008-6#1)
suggestions for their##3##3##(1990-8#1)(1991-2#1)(2012-3#1)
suggestions for##83##2##(1990-12#2)(1990-2#1)(1990-8#1)(1991-1#1)(1991-2#3)(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1994-3#1)(1994-5#1)(1995-1#2)(1996-1#2)(1996-11#1)(1996-12#1)(1997-2#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-6#1)(2006-7#1)(2007-12#3)(2007-2#2)(2007-4#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-11#3)(2010-2#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
suggestions from##4##2##(1992-2#1)(1994-3#1)(1997-3#1)(2011-1#1)
suggestions in the##2##3##(2006-5#1)(2012-3#1)
suggestions made by##3##3##(1991-9#1)(1994-11#1)(2008-6#1)
suggestions made##6##2##(1991-9#1)(1994-11#1)(1996-8#1)(1997-2#1)(2008-6#1)(2011-2#1)
suggestions of##5##2##(2006-8#1)(2008-1#1)(2008-2#1)(2010-10#1)(2011-2#1)
suggestions on how to##3##4##(2006-11#1)(2008-11#1)(2011-12#1)
suggestions on the##6##3##(1992-9#1)(1993-6#1)(1995-12#1)(2008-6#1)(2008-9#1)(2012-2#1)
suggestions on which##2##3##(2008-1#1)(2008-6#1)
suggestions on##13##2##(1992-9#1)(1993-2#1)(1993-6#1)(1995-12#1)(2005-11#1)(2006-11#1)(2008-1#1)(2008-11#1)(2008-6#2)(2008-9#1)(2011-12#1)(2012-2#1)
suggestions that##12##2##(1990-10#1)(1993-4#1)(1996-12#1)(1997-3#1)(1997-7#1)(2006-10#1)(2006-4#1)(2007-4#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-12#1)
suggestions to improve##3##3##(2007-8#1)(2008-10#1)(2011-1#1)
suggestions to##6##2##(1992-1#1)(2007-8#1)(2008-10#2)(2008-3#1)(2011-1#1)
suggestions were##4##2##(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
suggestions##186##1##(1990-10#1)(1990-12#3)(1990-2#1)(1990-8#2)(1991-1#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#2)(1995-1#3)(1995-12#1)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-7#1)(2004-10#1)(2005-11#1)(2005-12#1)(2006-10#5)(2006-11#2)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-4#3)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#4)(2008-11#2)(2008-12#7)(2008-2#3)(2008-3#4)(2008-4#5)(2008-5#3)(2008-6#10)(2008-7#2)(2008-8#2)(2008-9#4)(2009-11#1)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#3)(2010-2#3)(2010-8#4)(2011-1#5)(2011-12#3)(2011-2#6)(2012-12#2)(2012-2#7)(2012-3#3)(2013-1#3)(2013-8#2)
suggestive clinical##2##2##(2007-4#1)(2008-3#1)
suggestive evidence##2##2##(1995-2#1)(2008-5#1)
suggestive for a relationship between increased##2##6##(2013-8#2)
suggestive for a##3##3##(1992-6#1)(2013-8#2)
suggestive for an inverse relationship between##2##6##(2013-8#2)
suggestive for##6##2##(1992-6#1)(2013-8#5)
suggestive of a mesenchymal##2##4##(1991-12#1)(2010-9#1)
suggestive of a##25##3##(1990-11#1)(1990-2#1)(1991-1#1)(1991-12#1)(1992-2#1)(1992-7#1)(1993-11#1)(1993-9#1)(1994-8#1)(1995-12#1)(1997-8#1)(2005-10#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-1#1)(2010-6#1)(2010-8#1)(2010-9#1)(2012-12#1)(2013-8#2)
suggestive of acute##4##3##(1993-5#1)(2007-7#1)(2009-8#1)(2011-1#1)
suggestive of an##5##3##(1990-5#1)(1992-12#1)(1995-12#1)(2011-2#1)(2013-1#1)
suggestive of genital##2##3##(2008-10#1)(2013-1#1)
suggestive of increased##3##3##(2008-6#1)(2008-8#1)(2012-2#1)
suggestive of malignancy##2##3##(1990-6#1)(2011-2#1)
suggestive of possible##2##3##(1991-7#1)(1993-12#1)
suggestive of recurrent##2##3##(2004-11#1)(2008-7#1)
suggestive of the##6##3##(1992-6#1)(1995-1#1)(1995-3#1)(2007-6#1)(2012-1#1)(2013-8#1)
suggestive of this##3##3##(1993-6#1)(1994-2#1)(2009-9#1)
suggestive of tuberculosis##3##3##(2007-7#1)(2011-2#1)(2013-8#1)
suggestive of##158##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-7#1)(1992-11#3)(1992-12#1)(1992-2#2)(1992-6#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#3)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-5#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#9)(2007-8#4)(2008-1#4)(2008-10#8)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#8)(2008-8#2)(2009-1#2)(2009-10#1)(2009-12#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#8)(2012-3#1)(2013-1#5)(2013-8#6)
suggestive symptoms##4##2##(1996-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
suggestive##190##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-11#3)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#2)(1992-6#2)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#3)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-5#2)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#9)(2007-8#5)(2007-9#1)(2008-1#4)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#1)(2009-1#2)(2009-10#1)(2009-12#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#8)(2012-1#1)(2012-12#4)(2012-2#10)(2012-3#1)(2013-1#6)(2013-8#14)
suggests a close##2##3##(2006-10#1)(2010-3#1)
suggests a common##2##3##(2007-1#1)(2010-10#1)
suggests a framework##2##3##(2008-5#1)(2012-2#1)
suggests a functional##2##3##(1991-7#1)(1995-12#1)
suggests a general##3##3##(1996-1#1)(1997-5#1)(2008-10#1)
suggests a genetic##2##3##(2008-7#1)(2009-12#1)
suggests a high##2##3##(1991-1#1)(1997-8#1)
suggests a mechanism by which##3##5##(1994-5#1)(1994-8#1)(1995-9#1)
suggests a mechanism for##2##4##(1997-8#1)(2011-2#1)
suggests a mechanism##6##3##(1991-9#1)(1994-5#1)(1994-8#1)(1995-9#1)(1997-8#1)(2011-2#1)
suggests a membrane##2##3##(1997-4#1)(1997-6#1)
suggests a method##2##3##(1996-12#1)(2008-2#1)
suggests a model##2##3##(1994-8#1)(2012-12#1)
suggests a need to##2##4##(1996-2#1)(2008-12#1)
suggests a need##3##3##(1996-2#1)(2008-12#1)(2008-9#1)
suggests a new mechanism for##2##5##(2006-3#1)(2006-8#1)
suggests a new##6##3##(1990-3#1)(2006-3#1)(2006-8#1)(2007-11#1)(2008-3#1)(2010-10#1)
suggests a novel##2##3##(2006-12#1)(2010-10#1)
suggests a number of##3##4##(1991-3#1)(1992-12#1)(2007-4#1)
suggests a pattern of##2##4##(2007-7#1)(2008-5#1)
suggests a possible link##2##4##(2009-12#1)(2012-2#1)
suggests a possible new##2##4##(1996-7#1)(2008-11#1)
suggests a possible role for##2##5##(1992-10#1)(2011-2#1)
suggests a possible role in the##2##6##(1995-12#1)(1996-3#1)
suggests a possible role in##3##5##(1993-12#1)(1995-12#1)(1996-3#1)
suggests a possible role##6##4##(1992-10#1)(1992-6#1)(1993-12#1)(1995-12#1)(1996-3#1)(2011-2#1)
suggests a possible##20##3##(1990-10#1)(1992-1#1)(1992-10#1)(1992-6#1)(1993-12#1)(1994-10#1)(1995-12#1)(1996-3#1)(1996-7#3)(1997-8#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-12#1)(2011-2#1)(2012-2#1)
suggests a potential role##2##4##(1996-2#1)(2006-10#1)
suggests a potential##7##3##(1991-3#1)(1996-2#1)(2006-10#1)(2008-10#1)(2008-12#1)(2012-12#1)(2013-7#1)
suggests a relationship between##3##4##(1994-11#1)(1994-9#1)(2013-8#1)
suggests a role for the##2##5##(1994-11#1)(2010-8#1)
suggests a role for##6##4##(1990-7#1)(1994-11#1)(1997-4#1)(2006-5#1)(2009-6#1)(2010-8#1)
suggests a role in##3##4##(1995-8#1)(2007-12#1)(2009-8#1)
suggests a role of the##2##5##(1992-6#1)(1994-10#1)
suggests a role of##4##4##(1992-6#1)(1994-10#1)(1996-12#1)(2007-8#1)
suggests a role##14##3##(1990-7#1)(1992-6#1)(1994-10#1)(1994-11#1)(1995-8#1)(1996-12#1)(1997-4#1)(2006-5#1)(2007-12#1)(2007-8#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-8#1)
suggests a##176##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#1)(1991-7#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#3)(1993-12#2)(1993-3#2)(1993-8#2)(1993-9#2)(1994-10#2)(1994-11#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#1)(1996-6#2)(1996-7#3)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#5)(2004-10#1)(2006-10#4)(2006-12#3)(2006-3#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#5)(2007-4#3)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#11)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#4)(2008-5#9)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#2)(2009-5#1)(2009-6#1)(2009-8#3)(2010-10#4)(2010-12#1)(2010-3#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-4#1)(2013-7#1)(2013-8#1)
suggests additional##4##2##(2004-9#1)(2006-12#1)(2007-8#1)(2012-12#1)
suggests an additional##2##3##(1995-8#1)(2013-1#1)
suggests an association between##3##4##(2007-11#1)(2008-7#1)(2010-5#1)
suggests an important role for##2##5##(1990-2#1)(1996-12#1)
suggests an important role##4##4##(1990-2#1)(1993-12#1)(1996-12#1)(2009-3#1)
suggests an important##7##3##(1990-2#1)(1993-12#1)(1993-4#1)(1996-12#1)(1997-5#1)(2006-2#1)(2009-3#1)
suggests an##36##2##(1990-2#1)(1990-3#1)(1990-7#2)(1992-11#1)(1993-12#1)(1993-4#1)(1995-1#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-8#1)(2006-11#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
suggests convergent evolution##2##3##(2011-1#2)
suggests different##2##2##(1995-12#1)(1997-3#1)
suggests differential##2##2##(1991-1#1)(1991-4#1)
suggests either a##2##3##(1991-7#1)(2008-10#1)
suggests either that##2##3##(1990-8#1)(1992-11#1)
suggests either##4##2##(1990-8#1)(1991-7#1)(1992-11#1)(2008-10#1)
suggests functional##4##2##(1990-4#1)(1993-6#1)(1995-8#1)(2012-3#1)
suggests further##3##2##(2006-6#1)(2007-11#1)(2008-11#1)
suggests how the##2##3##(1991-3#1)(1995-3#1)
suggests how##9##2##(1990-7#1)(1991-3#1)(1993-12#1)(1995-3#1)(1997-7#1)(2005-9#1)(2006-5#1)(2009-11#1)(2009-9#1)
suggests involvement of##3##3##(1994-9#1)(2005-8#1)(2012-2#1)
suggests involvement##4##2##(1994-9#1)(2005-8#1)(2010-10#1)(2012-2#1)
suggests it has important##2##4##(1996-4#1)(2008-6#1)
suggests it may##3##3##(2006-8#1)(2007-4#1)(2013-8#1)
suggests it##7##2##(1996-4#1)(1997-2#1)(2006-8#1)(2007-4#1)(2008-6#1)(2010-12#1)(2013-8#1)
suggests its involvement in##2##4##(1994-8#1)(1996-2#1)
suggests its possible##2##3##(1991-2#1)(2010-10#1)
suggests its##7##2##(1991-2#1)(1993-4#1)(1994-8#1)(1996-2#1)(2008-2#1)(2010-10#1)(2010-5#1)
suggests low##3##2##(2007-7#2)(2007-8#1)
suggests measures##3##2##(1995-1#1)(2006-10#1)(2011-2#1)
suggests multiple##2##2##(1990-10#1)(2009-8#1)
suggests possible new##2##3##(2008-3#1)(2009-3#1)
suggests possible##5##2##(1995-1#1)(1996-11#1)(2008-3#1)(2008-7#1)(2009-3#1)
suggests potential##2##2##(1996-9#1)(2012-1#1)
suggests several mechanisms##2##3##(1994-9#1)(1996-5#1)
suggests several##5##2##(1991-3#1)(1994-9#1)(1996-5#1)(2005-8#1)(2012-1#1)
suggests some##5##2##(1994-3#1)(1995-2#1)(1996-2#1)(2005-8#1)(2008-5#1)
suggests strategies for##2##3##(2008-4#1)(2008-9#1)
suggests strategies##4##2##(1993-2#1)(1997-1#1)(2008-4#1)(2008-9#1)
suggests that ATP##2##3##(1990-3#1)(1995-12#1)
suggests that DNA##2##3##(1990-7#1)(1995-8#1)
suggests that GC##2##3##(2006-10#1)(2008-11#1)
suggests that H##2##3##(2008-1#1)(2008-5#1)
suggests that NGF##2##3##(1990-7#1)(1994-3#1)
suggests that NO##2##3##(1992-12#1)(1997-2#1)
suggests that P##5##3##(1993-11#1)(1994-3#1)(2006-8#1)(2008-10#2)
suggests that PD##3##3##(2007-8#1)(2008-11#1)(2012-12#1)
suggests that RNA##2##3##(1994-9#1)(2013-8#1)
suggests that S##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
suggests that T##2##3##(2008-10#1)(2011-2#1)
suggests that a combination of##3##5##(2007-6#1)(2007-7#1)(2010-12#1)
suggests that a high##3##4##(1991-11#1)(2007-9#1)(2011-1#1)
suggests that a specific##2##4##(2008-3#1)(2008-7#1)
suggests that a##47##3##(1990-11#1)(1990-2#1)(1990-9#1)(1991-11#1)(1991-7#1)(1992-5#1)(1992-6#1)(1993-3#1)(1994-8#2)(1995-11#1)(1995-5#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#2)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-2#1)(2011-1#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
suggests that about##2##3##(1990-2#1)(2008-10#1)
suggests that active##2##3##(1992-12#1)(2007-7#1)
suggests that additional##3##3##(2007-3#1)(2008-10#1)(2008-3#1)
suggests that adiponectin##2##3##(2010-10#2)
suggests that adolescents##2##3##(2008-11#1)(2012-2#1)
suggests that all##4##3##(1991-7#1)(1995-8#1)(2007-1#1)(2012-2#1)
suggests that although##2##3##(1990-12#1)(2012-12#1)
suggests that an##15##3##(1993-2#1)(1993-7#1)(1994-12#1)(1995-5#1)(1995-6#1)(2006-10#1)(2006-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-3#1)(2009-7#1)(2011-3#1)(2012-1#1)(2013-8#1)
suggests that any##2##3##(1995-11#1)(2009-4#1)
suggests that at least##2##4##(1995-4#1)(2010-3#1)
suggests that at##4##3##(1995-11#1)(1995-4#1)(2008-10#1)(2010-3#1)
suggests that binding of##2##4##(1996-7#1)(1997-8#1)
suggests that both the##2##4##(1990-5#1)(2008-3#1)
suggests that both##24##3##(1990-10#1)(1990-5#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-6#1)(1994-8#1)(1995-10#1)(1995-5#2)(1995-6#1)(1996-7#1)(1997-2#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-8#2)(2009-3#1)(2010-1#1)(2012-12#1)
suggests that brain##2##3##(2008-9#1)(2010-2#1)
suggests that calcium##2##3##(1994-8#1)(1994-9#1)
suggests that cells##2##3##(1992-9#1)(2008-3#1)
suggests that changes in##2##4##(1991-1#1)(1992-7#1)
suggests that children with##3##4##(1995-1#1)(2006-10#2)
suggests that children##5##3##(1995-1#1)(2006-10#2)(2008-2#1)(2009-4#1)
suggests that chronic##2##3##(2008-11#1)(2011-2#1)
suggests that combined##2##3##(2007-4#1)(2011-2#1)
suggests that comparative##2##3##(1991-9#1)(2008-10#1)
suggests that complex##3##3##(2006-8#1)(2012-12#1)(2012-3#1)
suggests that current##3##3##(1990-11#1)(2008-5#1)(2008-7#1)
suggests that despite##2##3##(2008-11#1)(2012-12#1)
suggests that different##4##3##(1995-3#1)(1996-12#1)(2007-12#1)(2008-2#1)
suggests that drugs##2##3##(2005-9#1)(2006-10#1)
suggests that each##2##3##(2008-10#1)(2010-2#1)
suggests that either##3##3##(1990-9#1)(1992-6#1)(2008-5#1)
suggests that estrogens##2##3##(2008-4#1)(2009-7#1)
suggests that even##4##3##(1997-1#1)(1997-4#1)(2009-8#1)(2010-5#1)
suggests that evolutionary##2##3##(2010-10#1)(2010-2#1)
suggests that factors##2##3##(1990-5#1)(1997-2#1)
suggests that fatty acids##2##4##(1995-6#1)(2008-8#1)
suggests that fatty##3##3##(1994-12#1)(1995-6#1)(2008-8#1)
suggests that for##7##3##(1993-11#1)(1994-11#1)(2005-11#1)(2008-1#1)(2008-11#2)(2008-2#1)
suggests that further research##2##4##(2007-12#1)(2009-5#1)
suggests that further##5##3##(1996-8#1)(2007-12#1)(2008-9#1)(2009-5#1)(2012-12#1)
suggests that genetic factors may##2##5##(1995-12#1)(2009-7#1)
suggests that genetic##5##3##(1995-12#1)(2008-10#2)(2008-11#1)(2009-7#1)
suggests that greater##2##3##(2012-1#1)(2013-7#1)
suggests that high##3##3##(2006-10#1)(2008-7#1)(2010-10#1)
suggests that horizontal##2##3##(2008-10#1)(2009-6#1)
suggests that impaired##2##3##(2006-9#1)(2008-1#1)
suggests that in the##4##4##(2006-10#1)(2008-10#1)(2008-8#1)(2013-1#1)
suggests that in##19##3##(1992-6#1)(1993-2#1)(1994-6#1)(1995-6#1)(1996-1#1)(1997-4#1)(2004-11#1)(2006-10#2)(2007-2#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2013-1#1)
suggests that increased##2##3##(1996-3#1)(2008-1#1)
suggests that increases in##2##4##(2008-3#2)
suggests that increasing altitude##2##4##(2009-5#2)
suggests that iron##2##3##(1996-5#1)(2013-1#1)
suggests that it can##2##4##(2012-1#1)(2012-11#1)
suggests that it is a##3##5##(1994-9#1)(2005-11#1)(2008-12#1)
suggests that it is an##2##5##(2008-7#1)(2011-2#1)
suggests that it is not##3##5##(1991-2#1)(1996-2#1)(2008-10#1)
suggests that it is##18##4##(1991-2#1)(1991-8#1)(1991-9#1)(1993-6#1)(1994-12#1)(1994-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(2005-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
suggests that it may be involved in the##2##8##(1997-2#2)
suggests that it may be useful##2##6##(1995-5#1)(2012-2#1)
suggests that it may be##7##5##(1993-6#1)(1995-5#1)(1997-2#2)(2006-8#1)(2009-9#1)(2012-2#1)
suggests that it may##12##4##(1991-5#1)(1992-12#1)(1993-6#1)(1995-5#1)(1997-2#2)(1997-6#1)(2006-8#1)(2008-3#1)(2008-4#1)(2009-9#1)(2012-2#1)
suggests that it might be##2##5##(2008-2#1)(2013-8#1)
suggests that it might##4##4##(2006-10#1)(2008-2#1)(2012-2#1)(2013-8#1)
suggests that it##44##3##(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-6#2)(1994-12#2)(1994-9#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-2#2)(1997-6#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#2)(2013-1#1)(2013-8#1)
suggests that its##2##3##(1992-3#1)(1995-2#1)
suggests that many##5##3##(1993-9#1)(2006-5#1)(2008-11#1)(2011-1#1)(2011-2#1)
suggests that migration##2##3##(1993-9#1)(2008-8#1)
suggests that more##6##3##(1990-2#1)(2004-9#1)(2006-10#1)(2007-9#1)(2008-1#2)
suggests that most of the##2##5##(1992-6#1)(1996-2#1)
suggests that most##4##3##(1992-6#1)(1996-2#1)(2008-5#1)(2013-1#1)
suggests that multicomponent##2##3##(1995-11#1)(2007-11#1)
suggests that multiple##3##3##(1993-11#1)(1995-3#1)(2011-1#1)
suggests that natural##3##3##(2008-11#1)(2008-8#2)
suggests that no##2##3##(1992-3#1)(2008-11#1)
suggests that not##2##3##(1994-9#1)(1995-4#1)
suggests that one of the##2##5##(1997-7#1)(2008-7#1)
suggests that one of##3##4##(1997-7#1)(2006-7#1)(2008-7#1)
suggests that one##10##3##(1991-9#1)(1996-3#1)(1997-7#1)(2006-12#1)(2006-7#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-10#1)(2012-2#1)
suggests that only##3##3##(1991-7#1)(1992-4#1)(2008-8#1)
suggests that other##8##3##(1993-12#1)(1994-5#1)(1996-1#1)(1997-3#1)(2006-8#1)(2008-8#1)(2012-2#1)(2012-3#1)
suggests that outcomes##2##3##(2009-5#1)(2012-12#1)
suggests that parasites##2##3##(2008-8#1)(2009-2#1)
suggests that part of##2##4##(1990-12#1)(2008-1#1)
suggests that patients with##2##4##(1991-5#1)(2006-10#1)
suggests that patients##4##3##(1991-5#1)(1996-3#1)(2006-10#1)(2012-2#1)
suggests that progesterone##2##3##(1993-2#1)(2007-10#1)
suggests that prolonged##2##3##(1996-3#1)(2012-12#1)
suggests that protein##5##3##(1990-8#1)(1991-6#1)(1992-3#1)(1994-2#1)(2008-8#1)
suggests that sea##2##3##(1990-10#1)(2008-5#1)
suggests that selection##2##3##(2008-8#1)(2008-9#1)
suggests that several unknown##2##4##(2008-11#1)(2012-11#1)
suggests that several##6##3##(1992-2#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2012-11#1)
suggests that sexual reproduction##2##4##(2008-10#2)
suggests that sexual##3##3##(1991-8#1)(2008-10#2)
suggests that small##2##3##(1991-1#1)(2008-1#1)
suggests that some of the##2##5##(1995-1#1)(2008-8#1)
suggests that some##8##3##(1995-1#1)(2006-12#1)(2008-8#2)(2009-3#1)(2010-11#1)(2013-1#2)
suggests that such##4##3##(1992-12#1)(2007-12#1)(2009-10#1)(2009-5#1)
suggests that the ability of##2##5##(2008-4#1)(2012-2#1)
suggests that the acute##2##4##(1990-5#1)(1994-8#1)
suggests that the amino-terminal region of##2##6##(1991-8#1)(1994-3#1)
suggests that the binding of##2##5##(1990-12#1)(1996-5#1)
suggests that the brain##2##4##(1995-12#1)(2009-2#1)
suggests that the conformation of the##2##6##(1990-4#1)(1991-4#1)
suggests that the coordination##2##4##(1994-11#1)(1997-4#1)
suggests that the difference##3##4##(1996-4#1)(2007-9#1)(2012-2#1)
suggests that the effects of##3##5##(1996-1#1)(2008-10#1)(2008-8#1)
suggests that the enzyme is##2##5##(1991-7#1)(1992-9#1)
suggests that the exposure##2##4##(2010-12#1)(2011-2#1)
suggests that the factor##2##4##(1992-11#1)(2007-8#1)
suggests that the flexibility of##2##5##(1994-9#1)(1997-1#1)
suggests that the future for##2##5##(1990-2#1)(2008-1#1)
suggests that the future##3##4##(1990-2#1)(2006-10#1)(2008-1#1)
suggests that the gene##2##4##(1990-7#1)(2008-11#1)
suggests that the genetic##3##4##(1991-2#1)(2008-10#1)(2009-8#1)
suggests that the high##2##4##(1990-4#1)(1995-1#1)
suggests that the human##5##4##(1991-2#1)(1991-6#1)(1992-11#1)(2008-10#1)(2008-6#1)
suggests that the immunophilin-heat shock##2##5##(1993-8#2)
suggests that the increase in##3##5##(1990-11#1)(1993-6#1)(1995-6#1)
suggests that the increase##4##4##(1990-11#1)(1993-6#1)(1995-6#1)(1997-8#1)
suggests that the initial##2##4##(2008-10#1)(2013-1#1)
suggests that the local##2##4##(1993-7#1)(1995-4#1)
suggests that the mechanism of##2##5##(1993-11#1)(1995-8#1)
suggests that the mechanism##4##4##(1993-11#1)(1993-2#1)(1995-8#1)(2008-8#1)
suggests that the molecular##3##4##(1990-6#1)(1996-2#1)(2007-12#1)
suggests that the most##2##4##(1994-3#1)(2008-9#1)
suggests that the mutation##2##4##(1990-12#1)(2008-12#1)
suggests that the negative##2##4##(1990-12#1)(2008-11#1)
suggests that the observed##2##4##(1992-9#1)(2008-10#1)
suggests that the overall##2##4##(1991-6#1)(2011-12#1)
suggests that the pathogen##2##4##(2008-10#2)
suggests that the presence of##3##5##(1996-4#1)(2004-11#1)(2008-5#1)
suggests that the presence##4##4##(1996-4#1)(2004-11#1)(2006-10#1)(2008-5#1)
suggests that the presynaptic##2##4##(1992-8#1)(1994-8#1)
suggests that the prevalence of##4##5##(2006-10#1)(2006-9#1)(2007-12#1)(2011-1#1)
suggests that the primary##3##4##(1997-7#1)(2006-5#1)(2008-5#1)
suggests that the protein##3##4##(1990-4#1)(1993-12#1)(1995-8#1)
suggests that the rate##2##4##(2008-10#1)(2013-1#1)
suggests that the reduced##2##4##(1995-12#1)(1996-7#1)
suggests that the response##2##4##(1997-4#1)(2008-11#1)
suggests that the results of##2##5##(2007-7#1)(2008-8#1)
suggests that the role of##2##5##(1994-4#1)(2008-2#1)
suggests that the side chain of##2##6##(1993-6#1)(2013-8#1)
suggests that the structure of##2##5##(1994-3#1)(1997-1#1)
suggests that the two conditions##2##5##(1990-2#1)(2008-4#1)
suggests that the two##5##4##(1990-2#1)(1991-2#1)(1994-3#1)(2008-4#1)(2009-8#1)
suggests that the use of##6##5##(1990-8#1)(2006-10#1)(2007-10#1)(2009-10#1)(2010-12#1)(2013-1#1)
suggests that the##418##3##(1990-11#3)(1990-12#4)(1990-2#3)(1990-3#1)(1990-4#4)(1990-5#3)(1990-6#2)(1990-7#4)(1990-8#2)(1990-9#3)(1991-1#2)(1991-10#2)(1991-11#3)(1991-12#2)(1991-2#5)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#4)(1991-7#5)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#5)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#2)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#4)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#4)(1993-7#1)(1993-8#2)(1993-9#2)(1994-10#2)(1994-11#2)(1994-12#4)(1994-2#3)(1994-3#5)(1994-4#1)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#4)(1995-10#3)(1995-12#4)(1995-2#4)(1995-3#3)(1995-4#1)(1995-5#3)(1995-6#3)(1995-8#4)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#6)(1996-2#5)(1996-3#1)(1996-4#2)(1996-5#6)(1996-6#1)(1996-7#3)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#5)(1997-5#2)(1997-6#1)(1997-7#5)(1997-8#3)(2003-11#1)(2004-11#1)(2004-12#1)(2005-10#2)(2005-11#1)(2005-8#2)(2006-10#12)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#3)(2007-12#11)(2007-2#1)(2007-7#4)(2007-8#4)(2007-9#3)(2008-1#3)(2008-10#26)(2008-11#8)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#4)(2008-5#10)(2008-6#4)(2008-7#5)(2008-8#11)(2008-9#4)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#4)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#7)(2012-1#1)(2012-2#6)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#5)
suggests that therapeutic##2##3##(2008-6#1)(2009-6#1)
suggests that there are two##2##5##(1997-7#1)(2008-4#1)
suggests that there are##18##4##(1991-7#1)(1992-5#1)(1992-8#1)(1993-4#3)(1994-5#2)(1996-1#1)(1997-4#1)(1997-7#1)(2005-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#2)
suggests that there is a strong##2##6##(1991-2#1)(2011-2#1)
suggests that there is a##7##5##(1991-2#1)(1992-6#1)(2008-6#1)(2010-5#1)(2011-2#3)
suggests that there is no##3##5##(1994-5#1)(1997-8#1)(2009-2#1)
suggests that there is##12##4##(1990-7#1)(1991-2#1)(1992-6#1)(1994-5#1)(1997-8#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-5#1)(2011-2#3)
suggests that there may be##3##5##(1994-9#1)(2008-9#1)(2009-11#1)
suggests that there##36##3##(1990-7#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-4#3)(1994-5#3)(1994-9#1)(1996-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-8#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2010-5#1)(2011-2#3)
suggests that these differences are##2##5##(1993-3#1)(2011-12#1)
suggests that these proteins##2##4##(1990-4#1)(1993-5#1)
suggests that these two##4##4##(1992-12#1)(1992-5#1)(1994-3#1)(1995-2#1)
suggests that these##46##3##(1990-12#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-1#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-8#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-6#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-1#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-12#1)(2013-8#1)
suggests that they are not##2##5##(1991-12#1)(1997-6#1)
suggests that they are##13##4##(1990-6#1)(1991-12#1)(1991-5#1)(1993-11#1)(1993-6#1)(1995-12#1)(1995-3#1)(1995-7#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-5#1)(2008-7#1)
suggests that they do not##2##5##(1993-8#1)(1995-5#1)
suggests that they have##3##4##(1992-12#1)(2008-10#2)
suggests that they may be##3##5##(1993-8#1)(2005-7#1)(2008-11#1)
suggests that they may##4##4##(1993-8#1)(2005-7#1)(2008-11#1)(2008-7#1)
suggests that they##30##3##(1990-2#1)(1990-6#1)(1991-12#1)(1991-5#1)(1992-12#1)(1993-11#1)(1993-6#1)(1993-8#2)(1994-7#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-7#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-7#1)(2006-10#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#3)(2013-1#1)
suggests that this interaction##2##4##(1990-8#1)(2008-10#1)
suggests that this may##2##4##(2006-11#1)(2010-2#1)
suggests that this method##2##4##(1991-12#1)(2012-2#1)
suggests that this molecule may##2##5##(1993-12#1)(2012-12#1)
suggests that this molecule##3##4##(1993-12#1)(2005-7#1)(2012-12#1)
suggests that this new##2##4##(2007-12#1)(2007-7#1)
suggests that this protein might##2##5##(1996-12#1)(2008-10#1)
suggests that this region is##2##5##(1990-6#1)(1995-11#1)
suggests that this region##3##4##(1990-6#1)(1991-7#1)(1995-11#1)
suggests that this type of##2##5##(1994-11#1)(1997-7#1)
suggests that this##57##3##(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-3#2)(1993-4#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#2)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-7#2)(2009-8#1)(2010-2#1)(2010-9#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#1)
suggests that tramadol##2##3##(1996-7#2)
suggests that treatment##3##3##(2007-11#1)(2008-7#1)(2009-8#1)
suggests that two##4##3##(1990-4#1)(1991-12#1)(1995-8#1)(2008-4#1)
suggests that up to##2##4##(1997-1#1)(2007-11#1)
suggests that very##2##3##(1991-12#1)(1996-11#1)
suggests that viral##2##3##(1992-11#1)(2013-8#1)
suggests that while##2##3##(1993-9#1)(2012-11#1)
suggests that zinc##2##3##(2008-5#1)(2013-1#1)
suggests that##1746##2##(1990-10#3)(1990-11#9)(1990-12#10)(1990-2#11)(1990-3#6)(1990-4#7)(1990-5#6)(1990-6#7)(1990-7#13)(1990-8#11)(1990-9#6)(1991-1#6)(1991-10#3)(1991-11#5)(1991-12#13)(1991-2#14)(1991-3#4)(1991-4#4)(1991-5#10)(1991-6#7)(1991-7#13)(1991-8#9)(1991-9#11)(1992-1#1)(1992-10#3)(1992-11#10)(1992-12#10)(1992-2#4)(1992-3#11)(1992-4#4)(1992-5#6)(1992-6#12)(1992-7#4)(1992-8#7)(1992-9#9)(1993-1#3)(1993-11#9)(1993-12#10)(1993-2#7)(1993-3#10)(1993-4#9)(1993-5#4)(1993-6#11)(1993-7#4)(1993-8#7)(1993-9#11)(1994-10#3)(1994-11#8)(1994-12#16)(1994-2#19)(1994-3#16)(1994-4#1)(1994-5#7)(1994-6#9)(1994-7#1)(1994-8#11)(1994-9#12)(1995-1#11)(1995-10#5)(1995-11#9)(1995-12#14)(1995-2#10)(1995-3#9)(1995-4#3)(1995-5#17)(1995-6#11)(1995-7#2)(1995-8#14)(1995-9#1)(1996-1#8)(1996-10#4)(1996-11#7)(1996-12#15)(1996-2#9)(1996-3#6)(1996-4#4)(1996-5#16)(1996-6#5)(1996-7#10)(1996-8#7)(1996-9#4)(1997-1#6)(1997-2#13)(1997-3#8)(1997-4#17)(1997-5#8)(1997-6#6)(1997-7#16)(1997-8#9)(1997-9#2)(2003-11#1)(2004-10#1)(2004-11#3)(2004-12#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-1#1)(2005-10#9)(2005-11#6)(2005-12#1)(2005-6#1)(2005-7#4)(2005-8#5)(2005-9#3)(2006-10#46)(2006-11#7)(2006-12#4)(2006-2#6)(2006-3#2)(2006-4#4)(2006-5#4)(2006-6#2)(2006-7#3)(2006-8#7)(2006-9#5)(2007-1#6)(2007-10#8)(2007-11#14)(2007-12#35)(2007-2#5)(2007-3#3)(2007-4#8)(2007-5#3)(2007-6#3)(2007-7#11)(2007-8#21)(2007-9#9)(2008-1#33)(2008-10#92)(2008-11#43)(2008-12#16)(2008-2#10)(2008-3#22)(2008-4#19)(2008-5#43)(2008-6#13)(2008-7#31)(2008-8#49)(2008-9#22)(2009-1#1)(2009-10#10)(2009-11#7)(2009-12#6)(2009-2#5)(2009-3#6)(2009-4#3)(2009-5#10)(2009-6#5)(2009-7#8)(2009-8#15)(2009-9#2)(2010-1#3)(2010-10#9)(2010-11#5)(2010-12#14)(2010-2#11)(2010-3#4)(2010-4#2)(2010-5#12)(2010-6#6)(2010-7#4)(2010-8#3)(2010-9#4)(2011-1#15)(2011-12#6)(2011-2#31)(2011-3#1)(2012-1#10)(2012-11#6)(2012-12#21)(2012-2#32)(2012-3#11)(2012-6#1)(2013-1#42)(2013-7#5)(2013-8#19)
suggests the efficacy##2##3##(2007-7#1)(2012-1#1)
suggests the existence of a##7##5##(1990-5#1)(1992-4#1)(1992-6#1)(1994-8#1)(2007-7#1)(2009-10#1)(2012-2#1)
suggests the existence of##20##4##(1990-5#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-10#1)(2005-10#1)(2007-7#1)(2008-1#1)(2008-9#1)(2009-10#1)(2010-9#1)(2011-2#1)(2012-2#1)
suggests the hypothesis that##2##4##(1991-12#1)(2010-5#1)
suggests the importance of##3##4##(1997-7#1)(2008-10#1)(2008-5#1)
suggests the involvement of a##2##5##(1992-3#1)(1995-5#1)
suggests the involvement of##11##4##(1991-5#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-4#1)(1995-2#1)(1995-5#1)(2008-10#1)(2011-2#1)
suggests the need for the##2##5##(2008-6#1)(2012-12#1)
suggests the need for##12##4##(2006-10#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-8#1)(2010-3#1)(2012-12#2)
suggests the need to##2##4##(2010-8#2)
suggests the need##14##3##(2006-10#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-8#1)(2010-3#1)(2010-8#2)(2012-12#2)
suggests the possibility of##6##4##(1990-4#1)(1990-9#1)(1994-2#1)(1995-11#1)(2007-12#1)(2012-3#1)
suggests the possibility that the##2##5##(1991-2#1)(1992-2#1)
suggests the possibility that##5##4##(1991-2#1)(1992-2#1)(1996-3#1)(1996-7#1)(2007-12#1)
suggests the possibility##11##3##(1990-4#1)(1990-9#1)(1991-2#1)(1992-2#1)(1994-2#1)(1995-11#1)(1996-3#1)(1996-7#1)(2007-12#2)(2012-3#1)
suggests the possible##3##3##(2007-7#1)(2008-7#1)(2009-8#1)
suggests the potential for##3##4##(1995-5#1)(2008-5#1)(2012-3#1)
suggests the potential##8##3##(1995-5#1)(1995-6#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-3#1)
suggests the presence of a##5##5##(1991-6#1)(1995-2#1)(1996-8#1)(2008-3#1)(2010-2#1)
suggests the presence of##9##4##(1991-6#1)(1993-8#1)(1995-2#1)(1996-8#1)(1997-8#1)(2007-10#1)(2008-3#1)(2010-2#1)(2013-1#1)
suggests the role of##2##4##(2007-9#1)(2013-8#1)
suggests the usefulness of##5##4##(1994-12#1)(1994-7#1)(2007-9#1)(2008-10#1)(2011-2#1)
suggests the##129##2##(1990-12#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-7#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-7#1)(1997-8#2)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-7#2)(2007-10#1)(2007-12#3)(2007-6#1)(2007-7#4)(2007-9#2)(2008-1#2)(2008-10#7)(2008-11#3)(2008-3#4)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#2)(2009-8#1)(2010-2#2)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
suggests their##4##2##(1994-11#1)(1995-12#1)(2006-6#1)(2008-11#1)
suggests these##4##2##(1992-6#1)(1993-3#1)(2009-7#1)(2011-1#1)
suggests they##2##2##(2005-8#1)(2007-3#1)
suggests this##8##2##(1996-10#1)(1997-7#1)(2008-1#1)(2008-9#1)(2009-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
suggests to##2##2##(1991-2#1)(2006-5#1)
suggests two##3##2##(1993-6#1)(1997-1#1)(2013-1#1)
suggests utilization of##2##3##(1992-1#1)(2008-5#1)
suggests ways to##5##3##(1990-12#1)(1993-12#1)(2005-7#1)(2008-11#1)(2008-3#1)
suggests ways##6##2##(1990-12#1)(1993-12#1)(2005-7#1)(2008-11#1)(2008-12#1)(2008-3#1)
suggests where##2##2##(2010-10#1)(2013-1#1)
suggests##2360##1##(1990-10#6)(1990-11#9)(1990-12#14)(1990-2#13)(1990-3#11)(1990-4#9)(1990-5#11)(1990-6#7)(1990-7#18)(1990-8#13)(1990-9#8)(1991-1#9)(1991-10#4)(1991-11#7)(1991-12#17)(1991-2#21)(1991-3#9)(1991-4#5)(1991-5#13)(1991-6#9)(1991-7#18)(1991-8#10)(1991-9#13)(1992-1#4)(1992-10#4)(1992-11#12)(1992-12#14)(1992-2#7)(1992-3#15)(1992-4#5)(1992-5#7)(1992-6#18)(1992-7#5)(1992-8#8)(1992-9#9)(1993-1#3)(1993-11#10)(1993-12#17)(1993-2#9)(1993-3#16)(1993-4#12)(1993-5#4)(1993-6#14)(1993-7#4)(1993-8#10)(1993-9#13)(1994-1#1)(1994-10#6)(1994-11#13)(1994-12#17)(1994-2#23)(1994-3#20)(1994-4#1)(1994-5#8)(1994-6#10)(1994-7#2)(1994-8#17)(1994-9#15)(1995-1#15)(1995-10#6)(1995-11#11)(1995-12#18)(1995-2#15)(1995-3#11)(1995-4#3)(1995-5#20)(1995-6#12)(1995-7#2)(1995-8#21)(1995-9#2)(1996-1#9)(1996-10#5)(1996-11#10)(1996-12#18)(1996-2#17)(1996-3#9)(1996-4#5)(1996-5#22)(1996-6#7)(1996-7#14)(1996-8#9)(1996-9#5)(1997-1#9)(1997-2#16)(1997-3#10)(1997-4#22)(1997-5#11)(1997-6#10)(1997-7#20)(1997-8#17)(1997-9#2)(2003-11#1)(2004-10#2)(2004-11#3)(2004-12#1)(2004-2#1)(2004-4#1)(2004-9#2)(2005-1#1)(2005-10#10)(2005-11#7)(2005-12#1)(2005-6#1)(2005-7#5)(2005-8#10)(2005-9#4)(2006-10#54)(2006-11#8)(2006-12#10)(2006-2#7)(2006-3#3)(2006-4#4)(2006-5#7)(2006-6#5)(2006-7#5)(2006-8#11)(2006-9#8)(2007-1#9)(2007-10#9)(2007-11#19)(2007-12#47)(2007-2#7)(2007-3#5)(2007-4#14)(2007-5#3)(2007-6#4)(2007-7#18)(2007-8#29)(2007-9#15)(2008-1#40)(2008-10#114)(2008-11#57)(2008-12#22)(2008-2#16)(2008-3#33)(2008-4#22)(2008-5#58)(2008-6#19)(2008-7#44)(2008-8#56)(2008-9#34)(2009-1#2)(2009-10#12)(2009-11#9)(2009-12#8)(2009-2#7)(2009-3#9)(2009-4#6)(2009-5#11)(2009-6#7)(2009-7#9)(2009-8#21)(2009-9#4)(2010-1#3)(2010-10#17)(2010-11#5)(2010-12#17)(2010-2#16)(2010-3#7)(2010-4#4)(2010-5#18)(2010-6#6)(2010-7#8)(2010-8#8)(2010-9#5)(2011-1#23)(2011-12#6)(2011-2#42)(2011-3#1)(2012-1#16)(2012-11#6)(2012-12#32)(2012-2#45)(2012-3#18)(2012-6#1)(2013-1#56)(2013-4#1)(2013-7#11)(2013-8#27)
suicidal acts##2##2##(2012-1#2)
suicidal and self-injurious behaviours among patients with depression##2##8##(2013-7#2)
suicidal and##4##2##(1995-11#1)(2004-3#1)(2013-7#2)
suicidal behavior and##3##3##(2012-12#2)(2013-1#1)
suicidal behavior in a##2##4##(2010-7#1)(2013-1#1)
suicidal behavior in##4##3##(2010-7#1)(2013-1#1)(2013-8#2)
suicidal behavior##19##2##(2008-7#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-7#1)(2012-1#1)(2012-12#2)(2013-1#7)(2013-8#4)
suicidal behaviors in##2##3##(2011-2#1)(2012-12#1)
suicidal behaviors##8##2##(2005-6#1)(2006-7#1)(2008-11#1)(2011-2#1)(2012-12#3)(2013-1#1)
suicidal behaviour##2##2##(2008-4#1)(2011-2#1)
suicidal hanging##2##2##(2010-7#2)
suicidal high falls##2##3##(2005-9#2)
suicidal ideation and planning##2##4##(2013-1#2)
suicidal ideation and##6##3##(1996-3#1)(2008-10#1)(2010-8#1)(2013-1#2)(2013-8#1)
suicidal ideation##20##2##(1992-1#2)(1996-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-6#2)(2010-8#4)(2012-1#1)(2013-1#4)(2013-8#2)
suicidal intent##4##2##(2007-11#1)(2009-2#1)(2012-2#1)(2013-7#1)
suicidal motives##3##2##(1996-3#3)
suicidal patients##3##2##(2010-6#1)(2010-8#1)(2011-2#1)
suicidal thoughts and behaviors##3##4##(2008-11#2)(2012-12#1)
suicidal thoughts and##4##3##(2008-11#2)(2009-7#1)(2012-12#1)
suicidal thoughts##9##2##(2008-11#2)(2008-6#1)(2009-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-7#2)
suicidal##110##1##(1990-10#1)(1992-1#5)(1992-5#1)(1993-2#2)(1995-11#2)(1996-3#6)(1997-8#1)(2004-3#1)(2005-6#1)(2005-9#2)(2006-7#4)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-7#4)(2009-8#1)(2009-9#1)(2010-6#11)(2010-7#4)(2010-8#6)(2011-1#1)(2011-2#7)(2012-1#4)(2012-12#6)(2012-2#1)(2013-1#13)(2013-7#5)(2013-8#6)
suicidality and substance use disorders##2##5##(2012-12#2)
suicidality##16##1##(1995-11#1)(2008-6#1)(2009-7#4)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#2)
suicide among##2##2##(2008-10#1)(2013-8#1)
suicide and euthanasia are##2##4##(2006-9#2)
suicide and euthanasia##4##3##(2006-9#3)(2007-9#1)
suicide and##16##2##(1990-12#1)(1990-3#1)(1993-7#1)(1996-11#1)(1996-2#1)(2006-9#3)(2007-9#1)(2008-8#2)(2010-12#3)(2011-2#1)(2013-8#1)
suicide are##4##2##(1991-8#1)(2006-10#1)(2011-2#2)
suicide as##2##2##(2009-5#1)(2010-12#1)
suicide attempt##18##2##(1990-12#1)(1992-1#1)(1994-8#2)(1995-11#1)(2008-10#1)(2009-3#2)(2009-6#2)(2010-2#1)(2010-7#2)(2010-8#1)(2011-1#1)(2013-1#1)(2013-7#2)
suicide attempters##3##2##(1990-12#1)(1994-8#2)
suicide attempts and##3##3##(2010-6#1)(2012-2#1)(2013-1#1)
suicide attempts with##2##3##(2006-7#1)(2012-1#1)
suicide attempts##17##2##(1990-12#1)(2006-7#7)(2010-6#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
suicide between##2##2##(1991-12#1)(2009-7#1)
suicide by burning in##2##4##(2011-2#2)
suicide by self-burning##2##3##(2011-2#2)
suicide by##11##2##(1991-8#2)(2005-9#2)(2007-8#1)(2009-2#1)(2009-7#1)(2011-2#4)
suicide cases##2##2##(1996-1#2)
suicide gene therapy using the##2##5##(2007-3#2)
suicide gene therapy##5##3##(2007-3#4)(2013-8#1)
suicide gene##7##2##(2005-6#1)(2007-3#5)(2013-8#1)
suicide genes##2##2##(2005-6#1)(2005-8#1)
suicide has##2##2##(1993-7#1)(2009-5#1)
suicide ideation##2##2##(2013-1#1)(2013-7#1)
suicide in older##3##3##(2009-5#3)
suicide in the##2##3##(2006-7#1)(2013-7#1)
suicide in##21##2##(1990-3#1)(1996-1#2)(1996-3#1)(1997-3#1)(2006-7#1)(2008-11#1)(2008-2#1)(2009-10#1)(2009-5#4)(2010-12#1)(2010-6#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-7#1)
suicide incidence##3##2##(2011-1#3)
suicide intent##2##2##(2011-2#1)(2013-7#1)
suicide is a##2##3##(1991-2#1)(2009-4#1)
suicide is##7##2##(1991-2#1)(2005-9#2)(2006-9#1)(2009-4#1)(2010-6#1)(2013-1#1)
suicide more##2##2##(1993-7#1)(2013-1#1)
suicide mortality##4##2##(1992-8#1)(2012-1#3)
suicide of slaves##2##3##(2009-4#2)
suicide of##5##2##(1991-12#1)(2008-2#2)(2009-4#2)
suicide or##2##2##(2008-8#1)(2010-6#1)
suicide prevention centers##3##3##(1991-12#3)
suicide prevention measures among##2##4##(2011-2#2)
suicide prevention strategy##3##3##(2008-2#3)
suicide prevention##14##2##(1990-12#1)(1991-12#3)(2007-10#1)(2008-2#4)(2009-5#1)(2010-5#1)(2011-2#2)(2012-12#1)
suicide program##2##2##(1995-5#1)(2007-12#1)
suicide rate among##2##3##(2007-10#1)(2008-4#1)
suicide rate##6##2##(1990-3#1)(1993-7#1)(2007-10#2)(2008-4#1)(2011-2#1)
suicide rates in##3##3##(1991-12#1)(1996-1#1)(2013-1#1)
suicide rates tend to##2##4##(2013-1#2)
suicide rates##16##2##(1990-6#1)(1991-12#2)(1993-7#1)(1996-1#1)(2007-10#1)(2008-2#1)(2009-5#1)(2011-2#1)(2013-1#7)
suicide risk among##2##3##(2010-4#1)(2013-1#1)
suicide risk##5##2##(2009-7#2)(2010-4#1)(2011-2#1)(2013-1#1)
suicide substrate##6##2##(1990-8#1)(1991-5#4)(1992-8#1)
suicide vector##3##2##(1991-7#1)(2007-12#1)(2008-9#1)
suicide was##4##2##(1991-8#2)(1992-1#1)(2011-2#1)
suicide with##2##2##(2006-7#1)(2012-1#1)
suicide within##2##2##(1991-2#1)(1993-7#1)
suicide##335##1##(1990-12#6)(1990-3#3)(1990-6#1)(1990-8#2)(1991-10#3)(1991-12#9)(1991-2#3)(1991-5#5)(1991-7#1)(1991-8#10)(1992-1#5)(1992-10#3)(1992-2#1)(1992-8#4)(1993-3#1)(1993-7#12)(1993-9#3)(1994-3#1)(1994-8#6)(1995-11#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#10)(1996-11#3)(1996-12#1)(1996-2#2)(1996-3#3)(1996-6#2)(1996-7#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2004-3#2)(2005-6#3)(2005-8#3)(2005-9#9)(2006-10#4)(2006-12#4)(2006-4#5)(2006-7#13)(2006-9#5)(2007-1#1)(2007-10#4)(2007-12#3)(2007-2#1)(2007-3#6)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#9)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#2)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#8)(2009-6#2)(2009-7#13)(2009-9#1)(2010-12#11)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#6)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#5)(2011-2#20)(2012-1#7)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#21)(2013-7#7)(2013-8#4)
suicide-prevention##2##1##(1990-12#2)
suicide?##4##1##(1991-12#1)(1992-1#1)(2006-7#1)(2007-12#1)
suicide?]##2##1##(1991-2#1)(1995-8#1)
suicide]##4##1##(1990-5#1)(1991-3#1)(2009-10#1)(2010-6#1)
suicides and##2##2##(1990-3#1)(1990-4#1)
suicides committed##2##2##(2011-2#2)
suicides in##4##2##(1990-3#1)(2005-9#2)(2007-1#1)
suicides of##2##2##(2009-4#1)(2011-2#1)
suicides were##4##2##(1991-12#1)(1997-5#1)(2006-10#1)(2011-2#1)
suicides##36##1##(1990-3#5)(1990-4#1)(1991-12#1)(1991-6#1)(1993-7#1)(1993-8#1)(1995-10#1)(1995-11#1)(1995-2#1)(1997-5#5)(2005-8#3)(2005-9#4)(2006-10#1)(2007-1#1)(2007-10#1)(2009-4#1)(2011-2#7)
suillus##4##1##(2011-2#4)
suing for##2##2##(1996-12#1)(1997-5#1)
suing##6##1##(1991-7#1)(1993-3#1)(1994-2#1)(1996-12#1)(1996-5#1)(1997-5#1)
suis in##2##2##(2009-6#1)(2013-1#1)
suis serotype 2##4##3##(2009-6#4)
suis type 2##7##3##(1991-8#4)(2005-11#3)
suis type##8##2##(1991-8#4)(2005-11#4)
suis##25##1##(1991-8#4)(1996-12#2)(2005-11#4)(2007-12#2)(2009-6#9)(2013-1#4)
suit against her##2##3##(1995-12#1)(1996-11#1)
suit against the##3##3##(1995-12#1)(1996-6#1)(1997-5#1)
suit against##8##2##(1993-12#1)(1995-12#2)(1995-8#1)(1996-11#1)(1996-6#1)(1997-5#1)(2010-12#1)
suit filed##2##2##(1996-11#1)(1996-6#1)
suit of##2##2##(2008-3#1)(2010-12#1)
suit over##3##2##(1996-2#1)(1996-5#2)
suit the##9##2##(1991-5#1)(1996-12#1)(1996-6#1)(2009-5#1)(2010-3#2)(2012-12#1)(2012-2#1)(2013-1#1)
suit to##3##2##(1990-5#1)(1992-2#1)(2008-8#1)
suit was##2##2##(1995-12#1)(1995-9#1)
suit##73##1##(1990-5#1)(1991-11#1)(1991-3#1)(1991-5#1)(1992-2#1)(1992-3#1)(1993-12#3)(1993-9#1)(1994-3#1)(1995-12#8)(1995-2#1)(1995-6#5)(1995-8#2)(1995-9#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-5#4)(1996-6#5)(1997-5#2)(2005-10#1)(2005-11#1)(2005-4#1)(2005-7#2)(2005-9#1)(2007-4#1)(2007-6#1)(2007-8#2)(2008-10#1)(2008-2#3)(2008-3#1)(2008-8#1)(2009-5#1)(2010-12#4)(2010-3#2)(2010-4#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
suitability and##7##2##(1990-11#1)(1993-12#1)(1996-5#1)(2005-5#1)(2008-5#2)(2008-8#1)
suitability as##8##2##(2004-9#1)(2005-7#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-7#1)(2013-1#1)
suitability for a##2##3##(2008-2#1)(2011-1#1)
suitability for##24##2##(1992-4#1)(1992-6#1)(1995-11#1)(1995-2#1)(1996-2#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-4#1)(2010-11#1)(2011-1#1)(2013-1#1)
suitability in##4##2##(1991-11#1)(1996-12#1)(2007-11#1)(2008-8#1)
suitability of a##3##3##(1992-6#1)(2006-6#1)(2007-11#1)
suitability of potential##2##3##(2008-8#2)
suitability of the proposed method for##2##6##(2008-10#2)
suitability of the system for##2##5##(2008-11#1)(2008-2#1)
suitability of the##31##3##(1997-2#1)(1997-6#1)(2006-2#1)(2007-11#2)(2007-8#2)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#1)(2010-9#1)(2013-1#1)(2013-7#1)
suitability of these##5##3##(1991-7#1)(1996-3#1)(2007-2#1)(2008-2#1)(2010-2#1)
suitability of this##5##3##(2005-12#1)(2008-10#1)(2008-2#1)(2011-1#1)(2011-2#1)
suitability of using##2##3##(2007-4#1)(2010-4#1)
suitability of##99##2##(1991-7#1)(1992-6#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-2#2)(1995-5#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-6#1)(2005-12#1)(2005-5#2)(2006-2#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#5)(2007-2#1)(2007-4#1)(2007-8#4)(2008-10#23)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-10#2)(2009-12#2)(2009-8#1)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
suitability to identify##2##3##(2006-11#1)(2008-10#1)
suitability to##5##2##(1994-3#1)(2006-11#1)(2008-10#2)(2011-12#1)
suitability with##2##2##(2006-11#1)(2008-8#1)
suitability##167##1##(1990-11#1)(1991-11#1)(1991-7#1)(1992-4#1)(1992-6#2)(1993-12#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#3)(1995-5#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-6#1)(2004-9#1)(2005-12#1)(2005-5#3)(2005-7#1)(2006-11#2)(2006-2#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#7)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#5)(2008-10#37)(2008-11#8)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#9)(2008-9#1)(2009-10#2)(2009-12#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#1)(2010-8#2)(2010-9#3)(2011-1#2)(2011-12#2)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#5)(2013-7#1)(2013-8#1)
suitable also for##2##3##(2006-6#1)(2008-10#1)
suitable alternative to##8##3##(1993-1#1)(1996-1#1)(2004-1#1)(2005-9#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-2#1)
suitable alternative##17##2##(1993-1#1)(1996-1#3)(2004-1#1)(2005-9#1)(2006-12#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-8#2)(2009-2#1)(2010-7#1)(2012-3#1)
suitable amount of##3##3##(2008-10#2)(2010-4#1)
suitable analytical##3##2##(2008-10#3)
suitable and##6##2##(1990-10#1)(1996-1#1)(2006-9#1)(2008-10#2)(2011-2#1)
suitable approach for##4##3##(2008-10#2)(2008-11#1)(2008-3#1)
suitable approaches##2##2##(2008-10#1)(2008-8#1)
suitable as a##7##3##(1994-3#1)(1996-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-3#1)(2011-2#1)
suitable as an##3##3##(1991-3#1)(2008-10#1)(2008-5#1)
suitable as##15##2##(1991-11#1)(1991-3#1)(1994-3#1)(1996-10#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#2)(2010-3#1)(2011-1#1)(2011-2#1)
suitable candidate##6##2##(1997-1#1)(2004-1#1)(2006-10#2)(2008-11#1)(2008-3#1)
suitable candidates for##5##3##(2008-7#1)(2008-9#1)(2009-11#1)(2011-1#1)(2012-12#1)
suitable candidates##6##2##(2008-7#1)(2008-9#1)(2009-11#1)(2010-4#1)(2011-1#1)(2012-12#1)
suitable cell##2##2##(1997-1#1)(2006-5#1)
suitable characteristics##2##2##(2008-10#1)(2012-1#1)
suitable combination##6##2##(1990-12#1)(2007-12#2)(2008-2#1)(2008-3#1)(2010-12#1)
suitable combinations of##2##3##(2007-11#1)(2008-3#1)
suitable conditions for##2##3##(2008-10#2)
suitable conditions##9##2##(2007-11#1)(2008-10#5)(2008-2#1)(2010-1#1)(2013-1#1)
suitable detection##2##2##(2008-10#1)(2012-2#1)
suitable donor##2##2##(2011-2#1)(2011-3#1)
suitable ends on the##2##4##(2008-2#2)
suitable even##2##2##(1992-8#1)(2008-2#1)
suitable experimental##4##2##(1990-9#1)(1997-5#1)(2008-4#1)(2009-3#1)
suitable for DNA sequencing##2##4##(1994-6#2)
suitable for DNA##3##3##(1994-3#1)(1994-6#2)
suitable for X-ray##3##3##(1996-2#1)(1997-6#1)(1997-7#1)
suitable for a variety of##3##5##(2007-12#1)(2008-4#2)
suitable for a##13##3##(2005-11#1)(2005-12#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#2)(2010-2#1)(2011-2#1)
suitable for active##2##3##(2007-11#1)(2008-10#1)
suitable for all##3##3##(2006-8#1)(2010-8#1)(2012-12#1)
suitable for analysis of##5##4##(1991-9#1)(1997-2#1)(2008-10#1)(2010-12#1)(2010-2#1)
suitable for analysis##8##3##(1991-9#1)(1997-2#1)(2008-10#1)(2008-9#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-12#1)
suitable for analyzing##3##3##(2005-11#1)(2008-10#1)(2008-3#1)
suitable for application in skin and##2##6##(2008-5#2)
suitable for application in##5##4##(2008-10#3)(2008-5#2)
suitable for application##7##3##(2008-10#5)(2008-5#2)
suitable for applications in##3##4##(2007-12#1)(2008-11#1)(2013-8#1)
suitable for applications##6##3##(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#1)(2013-8#1)
suitable for automatic and continuous analysis##4##6##(2008-10#4)
suitable for biomimetic bone tissue engineering##2##6##(2009-7#2)
suitable for both##6##3##(1994-12#1)(2007-10#1)(2008-3#2)(2008-5#1)(2011-2#1)
suitable for cell##2##3##(2008-4#1)(2008-5#1)
suitable for certain##2##3##(2008-10#1)(2008-4#1)
suitable for clinical##6##3##(1994-3#1)(2005-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-4#1)
suitable for describing##3##3##(2005-11#1)(2008-2#1)(2008-5#1)
suitable for determination of the##2##5##(2008-10#2)
suitable for determination of##8##4##(1992-3#1)(2005-4#1)(2005-8#1)(2008-10#5)
suitable for determining##3##3##(2007-8#1)(2008-10#1)(2009-8#1)
suitable for developmental studies and##2##5##(1992-7#2)
suitable for direct##3##3##(1994-6#1)(2008-10#1)(2012-12#1)
suitable for engineering##2##3##(1993-3#1)(2010-7#1)
suitable for field##3##3##(2008-10#2)(2008-3#1)
suitable for flow##2##3##(2008-5#2)
suitable for functional##2##3##(1992-11#1)(2012-2#1)
suitable for high throughput##4##4##(2008-10#1)(2009-9#1)(2010-12#1)(2011-2#1)
suitable for high##7##3##(1993-12#1)(2008-10#2)(2009-9#1)(2010-12#1)(2011-2#1)(2013-8#1)
suitable for high-power##2##3##(2008-2#2)
suitable for image##2##3##(2008-2#2)
suitable for imaging##2##3##(2008-2#1)(2009-8#1)
suitable for in vivo##4##4##(1992-1#1)(1994-12#1)(2008-5#1)(2010-6#1)
suitable for in##6##3##(1992-1#1)(1994-12#1)(1996-12#1)(2006-12#1)(2008-5#1)(2010-6#1)
suitable for in-vivo##2##3##(2008-5#1)(2011-1#1)
suitable for industrial##4##3##(1991-5#1)(2008-10#1)(2008-5#1)(2011-2#1)
suitable for inertial confinement fusion##2##5##(2007-11#1)(2008-3#1)
suitable for large-scale##2##3##(2008-2#1)(2008-5#1)
suitable for linking to proteins##2##5##(1996-10#2)
suitable for local##2##3##(1992-6#1)(2008-1#1)
suitable for long-term##3##3##(1993-5#1)(2005-7#1)(2008-2#1)
suitable for making##3##3##(1992-2#1)(2008-10#1)(2012-3#1)
suitable for many##4##3##(1995-2#1)(1996-2#1)(2008-6#1)(2009-8#1)
suitable for measuring the##2##4##(2007-10#1)(2008-10#1)
suitable for measuring##8##3##(1993-11#1)(1994-3#1)(2007-10#1)(2008-10#3)(2008-2#2)
suitable for medical applications##2##4##(2010-4#1)(2012-1#1)
suitable for medical##3##3##(2010-4#1)(2010-9#1)(2012-1#1)
suitable for most##2##3##(2008-10#1)(2011-2#1)
suitable for neonatal screening##2##4##(1991-2#2)
suitable for obtaining##2##3##(2005-5#1)(2008-7#1)
suitable for optical##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
suitable for performing##2##3##(2005-8#1)(2008-2#1)
suitable for pharmacokinetic studies##2##4##(1997-3#1)(1997-8#1)
suitable for practical##2##3##(2008-10#1)(2008-2#1)
suitable for processing##3##3##(2008-3#1)(2010-4#2)
suitable for qualitative##2##3##(2008-10#1)(2012-3#1)
suitable for quantification of##3##4##(2008-10#3)
suitable for quantitating iodate##2##4##(2008-10#2)
suitable for rapid and##2##4##(2007-8#1)(2008-9#1)
suitable for rapid##4##3##(2007-8#1)(2008-11#1)(2008-9#1)(2011-1#1)
suitable for real-time##7##3##(2006-2#1)(2007-11#1)(2008-1#1)(2008-2#3)(2008-3#1)
suitable for routine use##2##4##(1993-5#1)(1996-12#1)
suitable for routine##13##3##(1993-5#1)(1996-11#1)(1996-12#2)(2005-5#1)(2007-11#1)(2008-10#5)(2008-5#1)(2013-1#1)
suitable for screening a##2##4##(2008-4#1)(2011-1#1)
suitable for screening##6##3##(2008-10#3)(2008-4#1)(2011-1#1)(2011-2#1)
suitable for simultaneous##3##3##(2008-10#1)(2008-3#1)(2011-1#1)
suitable for small##2##3##(2008-2#1)(2013-1#1)
suitable for solving##2##3##(2008-2#2)
suitable for structural##2##3##(1993-6#1)(1994-5#1)
suitable for studying the##4##4##(1990-11#1)(1997-7#1)(1997-8#1)(2008-10#1)
suitable for studying##10##3##(1990-11#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)
suitable for the accurate determination of##2##6##(1996-6#1)(2008-10#1)
suitable for the analysis of##6##5##(1993-11#1)(1996-2#1)(2005-12#1)(2008-10#1)(2011-1#2)
suitable for the assay of##2##5##(2008-10#2)
suitable for the assay##3##4##(2008-10#2)(2008-11#1)
suitable for the detection of the##2##6##(1990-12#1)(1991-10#1)
suitable for the detection of##5##5##(1990-12#1)(1991-10#1)(1993-12#1)(2008-10#1)(2010-4#1)
suitable for the determination of##16##5##(1991-5#1)(1996-3#1)(2008-10#10)(2009-8#1)(2011-1#1)(2012-12#2)
suitable for the expression of##2##5##(2008-8#2)
suitable for the identification##2##4##(2008-10#1)(2011-2#1)
suitable for the quality control of##4##6##(2011-1#3)(2012-3#1)
suitable for the routine##6##4##(1991-10#1)(1993-12#1)(1997-3#1)(2008-10#2)(2010-2#1)
suitable for the salivary gland##2##5##(2008-11#2)
suitable for the separation of##4##5##(1990-11#1)(1991-11#1)(2007-1#1)(2008-10#1)
suitable for the separation##5##4##(1990-11#1)(1991-11#1)(2007-1#1)(2008-10#2)
suitable for the simultaneous determination of##3##6##(1990-6#1)(2008-10#2)
suitable for the simultaneous##6##4##(1990-6#1)(2008-10#4)(2012-3#1)
suitable for the specific detection of##2##6##(2007-8#1)(2008-10#1)
suitable for the study of##2##5##(1991-2#1)(2006-10#1)
suitable for the treatment of##3##5##(1990-8#1)(1992-4#1)(2007-11#1)
suitable for the##129##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-10#2)(1991-11#1)(1991-2#1)(1991-5#1)(1992-4#1)(1993-11#1)(1993-12#3)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1997-3#1)(1997-4#1)(2005-11#3)(2005-12#1)(2005-4#2)(2006-10#2)(2006-12#2)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#37)(2008-11#8)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#3)(2010-8#1)(2011-1#6)(2011-2#1)(2012-12#3)(2012-3#2)(2013-1#2)(2013-8#3)
suitable for their##2##3##(2008-10#1)(2012-12#1)
suitable for these##2##3##(2008-10#1)(2008-2#1)
suitable for thin##2##3##(2008-3#1)(2008-9#1)
suitable for this purpose##2##4##(2008-10#1)(2008-12#1)
suitable for this##7##3##(1996-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
suitable for tissue##2##3##(2008-10#1)(2010-4#1)
suitable for treating##2##3##(1995-5#1)(2008-11#1)
suitable for treatment of##2##4##(1991-8#1)(2010-9#1)
suitable for treatment##4##3##(1991-2#1)(1991-8#1)(2007-11#1)(2010-9#1)
suitable for use as a##2##5##(2007-11#1)(2013-8#1)
suitable for use as##4##4##(1990-11#1)(2007-11#1)(2008-11#1)(2013-8#1)
suitable for use at##2##4##(1990-12#1)(2008-3#1)
suitable for use in the##2##5##(2007-5#1)(2008-12#1)
suitable for use in##13##4##(1995-2#1)(2004-2#1)(2006-10#2)(2007-5#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#2)
suitable for use on##2##4##(2008-3#2)
suitable for use with##7##4##(2008-1#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-9#1)(2013-1#1)
suitable for use##31##3##(1990-11#1)(1990-12#1)(1995-2#1)(1996-12#1)(2004-2#1)(2006-10#2)(2007-11#1)(2007-5#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2013-1#1)(2013-8#1)
suitable for##697##2##(1990-11#3)(1990-12#4)(1990-2#3)(1990-5#2)(1990-6#2)(1990-8#3)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#5)(1991-3#1)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#2)(1993-11#2)(1993-12#8)(1993-2#1)(1993-3#2)(1993-5#3)(1993-6#1)(1994-12#3)(1994-3#4)(1994-4#1)(1994-5#2)(1994-6#4)(1994-8#2)(1995-10#1)(1995-2#5)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#5)(1996-2#5)(1996-3#3)(1996-5#4)(1996-6#2)(1996-7#2)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#2)(2004-2#1)(2005-10#2)(2005-11#7)(2005-12#3)(2005-4#3)(2005-5#2)(2005-7#1)(2005-8#2)(2005-9#2)(2006-10#7)(2006-12#10)(2006-2#1)(2006-4#2)(2006-6#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#15)(2007-12#17)(2007-5#4)(2007-7#3)(2007-8#10)(2007-9#2)(2008-1#10)(2008-10#138)(2008-11#25)(2008-12#4)(2008-2#42)(2008-3#47)(2008-4#19)(2008-5#21)(2008-6#6)(2008-7#3)(2008-8#5)(2008-9#9)(2009-12#2)(2009-6#1)(2009-7#3)(2009-8#5)(2009-9#1)(2010-11#1)(2010-12#11)(2010-2#3)(2010-3#1)(2010-4#7)(2010-6#1)(2010-7#5)(2010-8#5)(2010-9#4)(2011-1#16)(2011-12#2)(2011-2#15)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#9)(2012-2#4)(2012-3#7)(2013-1#7)(2013-7#3)(2013-8#8)
suitable habitat##2##2##(2008-10#1)(2008-11#1)
suitable habitats for##2##3##(2008-8#2)
suitable habitats##4##2##(2008-8#3)(2013-8#1)
suitable hosts##4##2##(2008-10#1)(2008-6#1)(2008-8#1)(2011-2#1)
suitable in##8##2##(1992-8#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-5#1)(2010-12#1)(2011-1#1)(2012-2#1)
suitable instrument for##2##3##(2007-11#1)(2010-8#1)
suitable isolation##2##2##(2010-4#2)
suitable material for##4##3##(2008-10#2)(2008-2#1)(2008-4#1)
suitable mathematical##2##2##(2008-1#1)(2008-10#1)
suitable means for##2##3##(1993-3#1)(2007-8#1)
suitable means##3##2##(1993-3#1)(1996-9#1)(2007-8#1)
suitable mechanical##2##2##(2008-5#1)(2010-8#1)
suitable medium for##3##3##(2008-10#2)(2008-3#1)
suitable method for##8##3##(1991-9#1)(1994-10#1)(2008-10#4)(2008-9#1)(2011-12#1)
suitable method##13##2##(1991-9#1)(1994-10#1)(2008-10#6)(2008-5#1)(2008-9#1)(2010-4#1)(2011-12#1)(2012-12#1)
suitable methodology##3##2##(2008-10#2)(2008-12#1)
suitable methods##2##2##(1991-8#1)(2008-11#1)
suitable modality##2##2##(2007-7#1)(2008-5#1)
suitable model system##2##3##(2012-12#1)(2013-1#1)
suitable model##16##2##(1990-8#1)(1992-5#1)(1994-5#1)(1995-12#1)(1995-6#1)(2006-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#3)(2009-5#1)(2012-12#1)(2013-1#2)
suitable models##3##2##(1990-8#1)(1991-5#1)(2013-1#1)
suitable new##2##2##(1996-6#1)(2011-2#1)
suitable not only for##2##4##(1996-5#1)(2008-3#1)
suitable or not##2##3##(2008-10#1)(2008-6#1)
suitable or unsuitable for##2##4##(2005-10#1)(2008-9#1)
suitable or##4##2##(2005-10#1)(2008-10#1)(2008-6#1)(2008-9#1)
suitable pH for##2##3##(2008-10#2)
suitable pH##4##2##(2008-10#3)(2008-5#1)
suitable patient##2##2##(2008-10#1)(2008-11#1)
suitable patients##4##2##(1991-8#1)(1996-3#1)(2005-1#1)(2008-11#1)
suitable precursor##3##2##(1997-7#1)(2008-10#1)(2010-5#1)
suitable properties##2##2##(2008-5#1)(2010-1#1)
suitable protective##2##2##(2006-5#1)(2008-5#1)
suitable reaction##2##2##(1995-10#1)(2008-10#1)
suitable reference##2##2##(1994-6#1)(1996-7#1)
suitable replacement for##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
suitable research##2##2##(2006-8#1)(2007-6#1)
suitable samples##2##2##(2008-3#1)(2008-4#1)
suitable sampling##2##2##(1994-9#1)(2012-12#1)
suitable screening##3##2##(1994-7#2)(2008-11#1)
suitable source of##2##3##(2007-11#1)(2008-5#1)
suitable source##5##2##(2007-11#2)(2008-5#1)(2009-4#1)(2012-2#1)
suitable substrate for the##2##4##(2008-10#1)(2013-8#1)
suitable substrate for##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
suitable substrate##5##2##(1994-10#1)(2008-10#2)(2012-2#1)(2013-8#1)
suitable substrates for##2##3##(1991-9#1)(1996-1#1)
suitable substrates##5##2##(1991-9#1)(1996-1#1)(2008-1#1)(2008-10#1)(2009-11#1)
suitable surgical##3##2##(1990-6#1)(2006-2#1)(2012-11#1)
suitable target##4##2##(2012-12#3)(2012-2#1)
suitable technique for##3##3##(1994-3#1)(2007-12#1)(2008-10#1)
suitable technique##6##2##(1993-8#1)(1994-3#1)(2007-12#1)(2008-10#2)(2009-12#1)
suitable techniques##2##2##(2006-12#1)(2007-5#1)
suitable temperature##2##2##(2008-8#1)(2010-3#1)
suitable therapeutic##2##2##(2010-5#1)(2012-12#1)
suitable therapy##2##2##(2005-7#1)(2008-8#1)
suitable to a##2##3##(2008-10#1)(2008-8#1)
suitable to assess the##2##4##(1993-9#1)(2013-8#1)
suitable to be##4##3##(2005-5#1)(2006-10#1)(2012-2#1)(2013-8#1)
suitable to detect##2##3##(2008-10#1)(2012-2#1)
suitable to form##2##3##(1996-2#1)(2008-11#1)
suitable to study##3##3##(1991-6#1)(2006-10#1)(2008-5#1)
suitable to##33##2##(1990-3#1)(1991-6#1)(1993-9#1)(1996-2#1)(1997-4#1)(1997-7#1)(2005-5#1)(2006-10#2)(2007-12#1)(2007-7#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)(2011-12#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-8#3)
suitable tool for##5##3##(1993-6#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-8#1)
suitable tool to##4##3##(2008-10#2)(2008-3#1)(2012-1#1)
suitable tool##9##2##(1993-6#1)(1994-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2012-1#1)
suitable training##3##2##(1994-6#1)(2004-9#1)(2008-10#1)
suitable treatment##6##2##(1994-2#1)(1995-10#1)(1995-11#1)(2008-1#1)(2008-10#1)(2012-1#1)
suitable##1375##1##(1990-10#3)(1990-11#4)(1990-12#6)(1990-2#5)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#3)(1990-8#6)(1990-9#3)(1991-10#4)(1991-11#3)(1991-12#2)(1991-2#5)(1991-3#2)(1991-5#5)(1991-6#2)(1991-7#2)(1991-8#6)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#3)(1992-2#5)(1992-3#1)(1992-4#3)(1992-5#3)(1992-6#2)(1992-7#4)(1992-8#6)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#8)(1993-2#2)(1993-3#3)(1993-4#1)(1993-5#3)(1993-6#2)(1993-8#3)(1993-9#2)(1994-10#2)(1994-12#3)(1994-2#4)(1994-3#7)(1994-4#1)(1994-5#3)(1994-6#7)(1994-7#2)(1994-8#2)(1994-9#2)(1995-10#4)(1995-11#1)(1995-12#2)(1995-2#6)(1995-3#1)(1995-4#1)(1995-5#4)(1995-6#3)(1995-8#3)(1995-9#2)(1996-1#6)(1996-10#3)(1996-11#3)(1996-12#7)(1996-2#6)(1996-3#4)(1996-5#5)(1996-6#4)(1996-7#3)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#5)(1997-4#3)(1997-5#2)(1997-6#2)(1997-7#5)(1997-8#3)(2004-1#2)(2004-2#1)(2004-9#2)(2005-1#1)(2005-10#4)(2005-11#8)(2005-12#6)(2005-4#3)(2005-5#3)(2005-7#5)(2005-8#2)(2005-9#4)(2006-10#14)(2006-11#1)(2006-12#17)(2006-2#5)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#3)(2006-8#3)(2006-9#3)(2007-1#1)(2007-10#2)(2007-11#31)(2007-12#33)(2007-2#4)(2007-5#8)(2007-6#1)(2007-7#9)(2007-8#20)(2007-9#5)(2008-1#21)(2008-10#278)(2008-11#51)(2008-12#10)(2008-2#64)(2008-3#73)(2008-4#30)(2008-5#51)(2008-6#12)(2008-7#9)(2008-8#23)(2008-9#20)(2009-10#2)(2009-11#4)(2009-12#4)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#2)(2009-6#1)(2009-7#4)(2009-8#7)(2009-9#2)(2010-1#2)(2010-11#2)(2010-12#15)(2010-2#4)(2010-3#4)(2010-4#16)(2010-5#2)(2010-6#2)(2010-7#6)(2010-8#10)(2010-9#4)(2011-1#22)(2011-12#5)(2011-2#26)(2011-3#2)(2012-1#11)(2012-11#7)(2012-12#29)(2012-2#17)(2012-3#11)(2012-5#1)(2013-1#17)(2013-7#3)(2013-8#17)
suitably chosen##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
suitably designed##2##2##(2008-3#2)
suitably low##2##2##(2008-2#1)(2009-7#1)
suitably packed medications##2##3##(2012-12#2)
suitably protected##8##2##(1992-12#1)(1996-4#1)(2008-4#2)(2009-12#1)(2010-2#1)(2010-7#2)
suitably##52##1##(1990-11#1)(1990-12#1)(1992-12#1)(1992-6#1)(1996-4#2)(1996-5#1)(2005-8#1)(2006-10#2)(2007-11#2)(2007-12#2)(2008-10#7)(2008-2#7)(2008-3#8)(2008-4#3)(2009-12#1)(2009-7#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#3)(2011-2#1)(2012-12#2)(2013-1#1)(2013-7#1)
suite for##2##2##(2008-4#1)(2012-2#1)
suite of analysis##2##3##(2008-3#1)(2008-7#1)
suite of traits##2##3##(2008-8#2)
suite of##29##2##(1995-8#1)(1996-12#1)(2007-12#1)(2007-5#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2012-3#1)(2013-1#2)
suite à##3##2##(2012-2#2)(2013-1#1)
suite##48##1##(1995-8#1)(1996-1#1)(1996-12#1)(2007-12#1)(2007-5#2)(2007-7#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#4)(2008-4#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#4)(2009-11#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-2#5)(2012-3#1)(2013-1#3)
suite?##2##1##(2006-10#1)(2008-1#1)
suited as##6##2##(1990-8#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-7#1)
suited for a##3##3##(2008-2#2)(2008-9#1)
suited for applications in##2##4##(1993-11#1)(2007-12#1)
suited for applications##3##3##(1993-11#1)(2007-12#1)(2008-1#1)
suited for high-throughput##2##3##(2009-4#1)(2011-1#1)
suited for rapid##2##3##(2008-2#1)(2008-3#1)
suited for studying##2##3##(2008-4#1)(2012-3#1)
suited for the analysis of##2##5##(2008-10#2)
suited for the determination of##2##5##(1996-8#1)(2008-10#1)
suited for the##21##3##(1990-12#1)(1990-8#1)(1993-7#1)(1996-8#1)(1997-6#1)(2006-2#1)(2006-5#1)(2008-1#1)(2008-10#7)(2008-3#1)(2008-4#2)(2011-1#2)(2011-2#1)
suited for this##6##3##(1995-2#1)(1996-1#1)(2008-10#2)(2008-4#1)(2012-2#1)
suited for use as##3##4##(2007-12#1)(2008-10#1)(2008-11#1)
suited for use in##3##4##(1993-12#1)(2004-2#1)(2007-12#1)
suited for use##7##3##(1993-12#1)(2004-11#1)(2004-2#1)(2007-12#2)(2008-10#1)(2008-11#1)
suited for##116##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-7#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-8#1)(1997-3#1)(1997-6#1)(2004-11#1)(2004-2#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-11#3)(2007-12#10)(2007-8#1)(2008-1#3)(2008-10#19)(2008-11#3)(2008-12#1)(2008-2#9)(2008-3#11)(2008-4#12)(2008-8#2)(2008-9#3)(2009-12#1)(2009-4#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)
suited in##2##2##(1992-1#1)(2009-6#1)
suited to a##4##3##(1993-9#1)(2008-7#1)(2012-1#1)(2012-12#1)
suited to analyzing##2##3##(2008-2#1)(2008-4#1)
suited to clinical##2##3##(2005-7#1)(2010-4#1)
suited to provide##2##3##(2006-12#1)(2009-10#1)
suited to serve as a##2##5##(1990-5#1)(2008-10#1)
suited to study##3##3##(2008-7#1)(2012-12#1)(2012-2#1)
suited to the measurement of##2##5##(2007-12#1)(2008-3#1)
suited to the study of##3##5##(1991-9#1)(2007-6#1)(2008-4#1)
suited to the use of##2##5##(2008-2#1)(2010-2#1)
suited to the##25##3##(1990-9#1)(1991-5#1)(1991-9#1)(1993-12#1)(1995-8#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-6#1)(2008-9#1)(2010-2#1)
suited to##97##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-5#3)(1991-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-2#1)(1995-8#1)(1996-5#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-7#2)(2006-10#3)(2006-12#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-8#3)(2008-10#9)(2008-11#4)(2008-2#5)(2008-3#7)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#7)(2008-9#4)(2009-10#2)(2009-6#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#2)(2013-1#2)
suited##228##1##(1990-11#1)(1990-12#2)(1990-5#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-5#3)(1991-9#2)(1992-1#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-2#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-5#2)(1996-8#1)(1997-3#2)(1997-6#1)(1997-8#1)(2004-11#1)(2004-2#1)(2005-11#1)(2005-7#2)(2006-10#3)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#6)(2007-12#12)(2007-6#1)(2007-8#4)(2008-1#3)(2008-10#29)(2008-11#7)(2008-12#1)(2008-2#16)(2008-3#18)(2008-4#16)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#8)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-6#2)(2009-7#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#4)(2012-1#3)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#2)
suites of##3##2##(1991-6#1)(2007-12#1)(2008-9#1)
suites##10##1##(1991-6#1)(2006-6#1)(2007-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#2)
suits and##2##2##(1992-2#1)(2012-3#1)
suits the##2##2##(2010-12#1)(2012-12#1)
suits##14##1##(1990-12#1)(1991-10#1)(1991-11#1)(1991-12#1)(1992-2#1)(1995-12#1)(1996-5#1)(2007-2#1)(2008-2#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
suivi##4##1##(2012-2#3)(2013-1#1)
sujet âgé##2##2##(2013-1#2)
sujets##2##1##(2008-5#1)(2013-1#1)
sulbactam and##3##2##(1997-3#1)(2012-2#2)
sulbactam##9##1##(1992-10#1)(1994-8#1)(1997-3#1)(2012-2#6)
sulbactam-ampicillin##2##1##(1992-10#1)(2006-2#1)
sulcal prefrontal cortex##4##3##(1994-3#4)
sulcal prominence in##2##3##(1996-7#2)
sulcal prominence##6##2##(1996-7#6)
sulcal##14##1##(1994-3#4)(1995-12#1)(1996-5#1)(1996-7#6)(2008-6#1)(2010-8#1)
sulcata##5##1##(2004-4#2)(2007-3#2)(2012-2#1)
sulci and gyri of##2##4##(1992-8#2)
sulci and gyri##4##3##(1992-8#3)(2010-12#1)
sulci and##5##2##(1992-8#3)(2010-12#2)
sulci##16##1##(1991-12#1)(1992-8#6)(1997-8#1)(2006-11#1)(2008-7#1)(2008-9#1)(2010-12#5)
sulcus and##6##2##(1991-9#1)(1993-2#2)(2008-11#1)(2010-5#1)(2013-1#1)
sulcus hemorrhage##6##2##(2013-1#6)
sulcus was##3##2##(1993-2#1)(1994-8#1)(2006-10#1)
sulcus##33##1##(1990-10#1)(1991-3#1)(1991-9#1)(1993-2#3)(1994-8#1)(1996-9#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#5)(2008-4#1)(2008-7#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#1)(2010-5#1)(2013-1#7)
sulfabenzamide##2##1##(2008-10#2)
sulfacetamide 10%-sulfur 5%##5##3##(2010-8#5)
sulfacetamide with##2##2##(2007-10#1)(2008-5#1)
sulfacetamide##8##1##(2007-10#1)(2008-10#1)(2008-5#1)(2010-8#5)
sulfadiazine##6##1##(1993-5#1)(2008-10#5)
sulfadimethoxine##6##1##(1991-8#1)(2008-10#4)(2010-12#1)
sulfadoxine-pyrimethamine##5##1##(2005-8#1)(2006-2#2)(2007-2#1)(2008-8#1)
sulfadoxine/pyrimethamine caused a similar##2##4##(2008-4#2)
sulfadoxine/pyrimethamine##5##1##(2008-4#5)
sulfaguanidine##8##1##(2008-10#8)
sulfamate derivatives##2##2##(1993-1#2)
sulfamate##4##1##(1993-1#3)(2008-10#1)
sulfamerazine##8##1##(1991-8#1)(2008-10#7)
sulfamethazine##5##1##(1991-8#1)(2008-10#4)
sulfamethizole##2##1##(2008-10#2)
sulfamethoxazole was##2##2##(1994-5#1)(2012-12#1)
sulfamethoxazole##12##1##(1994-5#1)(2008-10#7)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)
sulfamide##3##1##(1994-9#1)(2007-11#1)(2008-10#1)
sulfamonomethoxine##6##1##(1996-6#2)(2008-10#4)
sulfanilamide and##3##2##(2008-10#3)
sulfanilamide##7##1##(1994-5#1)(2008-10#5)(2011-3#1)
sulfanilic acid##5##2##(2008-10#5)
sulfanyl##2##1##(2006-12#2)
sulfapyridine##6##1##(1991-8#1)(2008-10#3)(2013-7#2)
sulfaquinoxaline##2##1##(2008-10#2)
sulfasalazine in##3##2##(1990-6#1)(1992-11#1)(2007-11#1)
sulfasalazine##25##1##(1990-6#1)(1992-11#3)(2005-11#1)(2006-10#2)(2007-11#9)(2007-7#2)(2008-10#3)(2008-8#1)(2010-12#2)(2010-5#1)
sulfatase (GALNS)##2##2##(1996-6#2)
sulfatase activity##3##2##(1991-9#1)(1996-4#1)(2012-2#1)
sulfatase##15##1##(1991-9#1)(1996-4#1)(1996-6#2)(1997-8#1)(2004-4#1)(2009-2#2)(2009-4#1)(2012-2#4)(2013-8#2)
sulfate (1##3##2##(1993-3#1)(2006-5#1)(2013-1#1)
sulfate (CS)##4##2##(1995-10#1)(2008-10#1)(2008-5#1)(2011-1#1)
sulfate (DHEAS)##4##2##(1995-12#3)(2006-6#1)
sulfate (DS)##2##2##(1995-11#1)(2008-10#1)
sulfate (SLES)##2##2##(2008-10#1)(2008-5#1)
sulfate (pH##3##2##(1996-5#2)(2008-10#1)
sulfate aerosol##2##2##(2008-2#1)(2008-3#1)
sulfate aerosols##3##2##(2008-3#3)
sulfate alone##2##2##(1995-5#1)(2008-11#1)
sulfate also##3##2##(1992-6#1)(1993-6#1)(1993-9#1)
sulfate and 0##2##3##(1990-11#1)(2008-10#1)
sulfate and ammonium##2##3##(2008-10#1)(2008-8#1)
sulfate and heparin##4##3##(1991-8#1)(1994-12#1)(1995-5#2)
sulfate and it##2##3##(2008-10#1)(2008-6#1)
sulfate and##46##2##(1990-11#2)(1990-3#1)(1990-7#1)(1991-12#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-5#4)(1996-12#1)(1996-2#1)(1997-1#2)(1997-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-10#9)(2008-6#2)(2008-8#1)(2010-6#1)(2011-2#1)(2013-1#1)
sulfate anion##3##2##(1994-9#1)(2008-10#2)
sulfate anions##3##2##(1992-12#1)(1997-1#1)(1997-7#1)
sulfate as a##3##3##(1993-12#1)(2008-5#1)(2009-12#1)
sulfate as the##2##3##(1990-3#1)(2007-1#1)
sulfate as##8##2##(1990-3#1)(1993-12#1)(1994-3#1)(2007-1#1)(2008-10#2)(2008-5#1)(2009-12#1)
sulfate assimilation##2##2##(2008-7#1)(2009-8#1)
sulfate at##2##2##(1990-2#2)
sulfate based on##2##3##(2008-10#1)(2012-12#1)
sulfate binding sites##2##3##(1990-10#2)
sulfate binding##6##2##(1990-10#4)(1994-9#2)
sulfate by##4##2##(1991-7#1)(1996-5#1)(2007-11#1)(2008-10#1)
sulfate chains##4##2##(1995-5#3)(2008-5#1)
sulfate charring##2##2##(2009-7#2)
sulfate conjugates of##2##3##(1993-2#1)(2008-10#1)
sulfate does not##2##3##(1994-5#1)(1997-1#1)
sulfate droplets##2##2##(2008-3#2)
sulfate fractions##4##2##(1994-3#2)(2008-10#2)
sulfate from##2##2##(1992-12#1)(1995-4#1)
sulfate group##3##2##(1992-12#1)(2005-11#1)(2010-4#1)
sulfate groups##8##2##(1991-7#1)(1994-8#1)(1995-4#1)(1996-5#1)(2008-10#4)
sulfate in the presence of##2##5##(2008-10#1)(2013-1#1)
sulfate in the##5##3##(1990-11#1)(1993-10#1)(2008-10#2)(2013-1#1)
sulfate in##24##2##(1990-11#1)(1990-3#9)(1993-10#1)(1993-2#1)(1995-12#3)(1995-6#2)(1997-7#1)(2007-12#1)(2008-10#3)(2009-4#1)(2013-1#1)
sulfate into##2##2##(1990-11#1)(1990-8#1)
sulfate ion and##2##3##(2008-10#2)
sulfate ion in##2##3##(2008-10#2)
sulfate ion##14##2##(1993-3#1)(1995-11#2)(2005-11#1)(2007-12#1)(2008-10#9)
sulfate ion-selective##2##2##(2008-10#2)
sulfate ions in##2##3##(2008-10#2)
sulfate ions##7##2##(1991-7#1)(2005-11#2)(2008-10#4)
sulfate is##12##2##(1991-1#1)(1991-5#1)(1994-9#1)(1995-5#1)(1997-1#2)(2008-10#2)(2008-8#1)(2009-12#2)(2011-1#1)
sulfate may##2##2##(1993-9#1)(2006-10#1)
sulfate on the##4##3##(1996-5#1)(1997-1#2)(2008-11#1)
sulfate on##8##2##(1993-2#1)(1996-2#1)(1996-5#1)(1997-1#2)(2008-11#1)(2008-7#1)(2013-8#1)
sulfate or##3##2##(1995-5#1)(1996-11#1)(1997-1#1)
sulfate particles##3##2##(1991-10#2)(1992-5#1)
sulfate proteoglycan##12##2##(1990-10#3)(1990-9#1)(1991-7#1)(1992-11#1)(1992-2#1)(1993-4#1)(1994-10#1)(1995-8#1)(2007-10#1)(2008-7#1)
sulfate proteoglycans##8##2##(1994-10#1)(1994-8#1)(1995-10#1)(1995-3#1)(1995-6#2)(1997-4#1)(2011-1#1)
sulfate reducer##2##2##(1990-3#1)(2006-8#1)
sulfate reducing##2##2##(2006-8#1)(2011-2#1)
sulfate reduction and methanogenesis##2##4##(2004-4#1)(2012-2#1)
sulfate reduction##7##2##(2004-4#1)(2006-3#2)(2008-10#1)(2012-2#2)(2013-8#1)
sulfate saline##2##2##(1990-10#1)(2011-2#1)
sulfate showed##2##2##(1991-7#1)(1996-2#1)
sulfate to the##3##3##(1991-5#1)(1996-3#1)(2008-10#1)
sulfate to##10##2##(1990-10#2)(1990-4#1)(1991-3#1)(1991-5#1)(1996-3#1)(1997-3#1)(2008-10#2)(2008-11#1)
sulfate treatment##3##2##(1990-10#1)(1990-6#1)(2008-6#1)
sulfate was the predominant##2##4##(1990-3#2)
sulfate was##16##2##(1990-3#2)(1994-3#3)(1994-9#1)(1997-4#1)(1997-6#1)(2008-10#2)(2008-6#3)(2011-2#2)(2012-12#1)
sulfate were##7##2##(1990-3#1)(1990-7#1)(1991-1#2)(1995-8#1)(1996-3#1)(2008-6#1)
sulfate with##2##2##(1993-8#1)(1996-2#1)
sulfate##621##1##(1990-10#15)(1990-11#13)(1990-2#6)(1990-3#21)(1990-4#2)(1990-5#9)(1990-6#2)(1990-7#4)(1990-8#1)(1990-9#2)(1991-1#7)(1991-10#2)(1991-12#6)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#11)(1991-8#1)(1991-9#8)(1992-1#2)(1992-10#3)(1992-11#2)(1992-12#5)(1992-2#2)(1992-3#3)(1992-5#5)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#7)(1993-3#5)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#5)(1993-9#6)(1994-10#2)(1994-11#1)(1994-12#3)(1994-3#14)(1994-5#1)(1994-6#3)(1994-8#4)(1994-9#9)(1995-10#6)(1995-11#7)(1995-12#9)(1995-2#1)(1995-3#6)(1995-4#3)(1995-5#16)(1995-6#4)(1995-8#2)(1996-10#1)(1996-11#3)(1996-12#2)(1996-2#13)(1996-3#2)(1996-4#1)(1996-5#13)(1997-1#11)(1997-2#1)(1997-3#2)(1997-4#6)(1997-5#1)(1997-6#2)(1997-7#2)(2004-4#2)(2004-9#2)(2005-11#17)(2005-12#3)(2006-10#1)(2006-3#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#6)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#3)(2007-12#4)(2007-3#1)(2007-8#3)(2008-1#3)(2008-10#122)(2008-11#6)(2008-2#3)(2008-3#6)(2008-4#7)(2008-5#11)(2008-6#10)(2008-7#4)(2008-8#7)(2008-9#1)(2009-12#9)(2009-4#2)(2009-7#2)(2009-8#2)(2010-11#2)(2010-2#2)(2010-4#2)(2010-6#1)(2011-1#4)(2011-12#1)(2011-2#8)(2012-12#5)(2012-2#6)(2013-1#9)(2013-7#1)(2013-8#6)
sulfate) and##2##2##(2005-11#1)(2008-6#1)
sulfate)##15##1##(1990-3#2)(1991-5#1)(1993-2#1)(1994-12#1)(1995-12#1)(2005-11#1)(2008-10#7)(2008-6#1)
sulfate- and##2##2##(2004-4#1)(2006-3#1)
sulfate-carbon##2##1##(2008-3#2)
sulfate-induced##2##1##(1996-12#1)(1996-2#1)
sulfate-reducing bacteria##7##2##(1990-3#1)(1994-5#1)(2006-8#4)(2011-1#1)
sulfate-reducing bacterium##6##2##(1991-11#1)(1992-3#1)(2006-3#1)(2006-8#2)(2011-2#1)
sulfate-reducing##20##1##(1990-3#1)(1990-8#1)(1991-11#1)(1992-3#1)(1994-5#1)(2006-3#2)(2006-8#11)(2011-1#1)(2011-2#1)
sulfate/glucosamine ratio##2##2##(1994-9#2)
sulfated Asn-linked oligosaccharides##2##3##(1992-10#2)
sulfated GAGs##2##2##(1993-12#2)
sulfated and sialyl ligands##3##4##(1997-4#3)
sulfated and##5##2##(1992-8#1)(1995-12#1)(1997-4#3)
sulfated beta-cyclodextrin##3##2##(1993-6#1)(2005-12#2)
sulfated gangliosides##3##2##(1991-2#3)
sulfated glycans##3##2##(1991-12#3)
sulfated glycoprotein##2##2##(1991-3#1)(1992-8#1)
sulfated glycosaminoglycans##5##2##(1993-12#3)(1995-2#1)(1995-4#1)
sulfated ligands##3##2##(1992-9#1)(1997-4#2)
sulfated octadecyl ribofuranans with##2##4##(1996-2#2)
sulfated octadecyl ribofuranans##3##3##(1996-2#3)
sulfated octadecyl##4##2##(1996-2#4)
sulfated oligosaccharides##3##2##(1992-10#1)(1997-4#1)(1997-7#1)
sulfated polysaccharide##2##2##(1995-2#1)(2008-11#1)
sulfated polysaccharides##4##2##(1996-5#1)(2011-1#1)(2012-1#2)
sulfated##67##1##(1990-6#1)(1991-12#3)(1991-2#4)(1991-3#2)(1992-10#4)(1992-12#5)(1992-8#2)(1992-9#2)(1993-12#5)(1993-6#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#3)(1996-2#4)(1996-5#1)(1997-4#7)(1997-7#1)(2005-11#2)(2005-12#2)(2005-8#1)(2007-11#2)(2008-11#1)(2008-4#1)(2008-9#2)(2010-6#1)(2011-1#1)(2012-1#2)
sulfates and##2##2##(2005-11#1)(2007-3#1)
sulfates as##2##2##(2005-11#1)(2007-11#1)
sulfates##17##1##(1992-4#1)(1992-8#2)(1995-5#1)(1996-5#2)(1996-6#1)(1997-2#1)(2005-11#3)(2007-10#1)(2007-11#1)(2007-3#1)(2010-5#1)(2010-6#2)
sulfathiazole and##2##2##(2008-10#2)
sulfathiazole##7##1##(2008-10#7)
sulfatide and GM3 ganglioside##4##4##(1995-1#4)
sulfatide and##6##2##(1991-9#1)(1994-12#1)(1995-1#4)
sulfatide by##2##2##(1990-2#2)
sulfatide concentrations in##3##3##(1997-4#3)
sulfatide##20##1##(1990-2#4)(1991-9#3)(1993-9#1)(1994-12#1)(1995-1#4)(1996-5#2)(1997-4#4)(2009-12#1)
sulfation and##2##2##(1990-3#1)(1995-4#1)
sulfation assay##2##2##(2008-1#2)
sulfation of dermatan sulfate##2##4##(1991-7#2)
sulfation of the##2##3##(1990-4#1)(1993-6#1)
sulfation of##12##2##(1990-3#2)(1990-4#1)(1991-7#3)(1993-6#1)(1995-12#1)(1995-5#1)(1996-7#1)(1997-8#1)(2008-11#1)
sulfation was##2##2##(1995-2#1)(1996-7#1)
sulfation##32##1##(1990-3#7)(1990-4#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-7#4)(1993-12#1)(1993-4#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-5#1)(1996-7#2)(1997-8#1)(2008-1#2)(2008-11#1)(2008-4#1)
sulfentrazone##2##1##(2008-10#2)
sulfhydryl (SH)##3##2##(1992-7#1)(2008-10#1)(2012-1#1)
sulfhydryl and amino groups##2##4##(2008-7#1)(2009-8#1)
sulfhydryl and##3##2##(1990-12#1)(2008-7#1)(2009-8#1)
sulfhydryl blocking##2##2##(1991-7#1)(1993-3#1)
sulfhydryl compounds##6##2##(1992-7#1)(1992-8#1)(1992-9#1)(1994-8#1)(1995-6#1)(2008-5#1)
sulfhydryl group of the##2##4##(1993-11#1)(1995-5#1)
sulfhydryl group of##5##3##(1992-5#1)(1993-11#2)(1995-5#1)(2009-11#1)
sulfhydryl group##17##2##(1990-12#1)(1990-5#2)(1992-3#1)(1992-5#1)(1993-11#2)(1995-5#1)(1995-6#2)(1997-1#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-4#1)
sulfhydryl groups in the##5##4##(1991-5#2)(1992-6#3)
sulfhydryl groups in##6##3##(1991-5#2)(1992-6#3)(1993-6#1)
sulfhydryl groups of##6##3##(1990-12#2)(1993-4#1)(1994-9#1)(1996-2#1)(2010-2#1)
sulfhydryl groups##21##2##(1990-12#2)(1991-2#1)(1991-5#2)(1992-5#1)(1992-6#4)(1992-8#2)(1993-4#2)(1993-6#1)(1994-9#1)(1995-5#1)(1996-2#1)(2009-12#1)(2010-2#1)(2013-1#1)
sulfhydryl reagent##4##2##(1992-8#1)(1993-11#1)(1995-8#2)
sulfhydryl reagents##4##2##(1990-10#2)(1993-4#1)(1994-11#1)
sulfhydryl redox##3##2##(1996-2#2)(1997-1#1)
sulfhydryl reducing agents##4##3##(1990-6#1)(1994-12#1)(1997-1#2)
sulfhydryl reducing##5##2##(1990-6#2)(1994-12#1)(1997-1#2)
sulfhydryl##93##1##(1990-10#2)(1990-12#5)(1990-3#1)(1990-5#2)(1990-6#2)(1991-2#1)(1991-5#2)(1991-7#1)(1992-12#2)(1992-3#1)(1992-5#4)(1992-6#5)(1992-7#2)(1992-8#4)(1992-9#1)(1993-11#4)(1993-3#1)(1993-4#3)(1993-6#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-8#1)(1994-9#1)(1995-5#4)(1995-6#3)(1995-8#3)(1996-2#5)(1997-1#4)(2006-12#1)(2006-6#1)(2008-10#4)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-2#2)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#1)
sulfhydryl-reactive agents##2##2##(1991-3#1)(1995-3#1)
sulfhydryl-reactive##4##1##(1991-3#1)(1994-5#2)(1995-3#1)
sulfhydryl-specific##2##1##(1993-11#1)(1993-3#1)
sulfhydryls##8##1##(1990-7#1)(1992-12#1)(1993-4#1)(1994-12#5)
sulfide and diallyl##2##3##(1993-9#2)
sulfide and mercaptans##2##3##(2008-10#1)(2008-6#1)
sulfide and nitrite##2##3##(1993-8#1)(2008-10#1)
sulfide and##15##2##(1993-8#1)(1993-9#2)(2005-8#1)(2006-10#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-6#1)(2011-1#1)
sulfide as##2##2##(1993-6#1)(2008-10#1)
sulfide at##2##2##(2008-10#2)
sulfide based on##2##3##(2008-10#2)
sulfide by##2##2##(2008-10#2)
sulfide can##2##2##(2008-10#1)(2012-2#1)
sulfide concentration##2##2##(2008-10#2)
sulfide determination in##3##3##(2008-10#3)
sulfide determination##6##2##(2008-10#6)
sulfide in different##2##3##(2008-10#2)
sulfide in environmental##2##3##(2008-10#2)
sulfide in the##4##3##(2007-8#2)(2008-10#1)(2013-1#1)
sulfide in##21##2##(1992-5#1)(1996-5#1)(2007-8#2)(2008-10#14)(2011-1#1)(2013-1#2)
sulfide ion##2##2##(2005-11#1)(2008-10#1)
sulfide is determined by##2##4##(2008-10#2)
sulfide is##4##2##(2005-11#1)(2008-10#3)
sulfide on##3##2##(2005-11#1)(2008-10#1)(2013-8#1)
sulfide or##4##2##(1997-1#1)(1997-6#1)(2006-8#1)(2008-5#1)
sulfide oxidation##2##2##(2007-12#1)(2007-8#1)
sulfide solution##2##2##(2008-10#2)
sulfide with##3##2##(2008-10#3)
sulfide##164##1##(1991-8#1)(1992-4#2)(1992-5#3)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-6#3)(1995-3#1)(1996-5#3)(1996-8#2)(1997-1#2)(1997-6#1)(2005-11#10)(2005-8#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-8#2)(2007-11#2)(2007-12#7)(2007-8#9)(2008-10#85)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#3)(2009-12#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
sulfides from##2##2##(2006-3#1)(2008-10#1)
sulfides have been prepared##2##4##(2008-5#2)
sulfides on##4##2##(1993-9#2)(2005-12#2)
sulfides to##2##2##(2008-10#1)(2008-6#1)
sulfides##28##1##(1993-9#3)(2005-11#1)(2005-12#3)(2006-3#2)(2008-10#9)(2008-5#7)(2008-6#2)(2009-8#1)
sulfidic##3##1##(2008-10#2)(2011-2#1)
sulfido##2##1##(2006-4#1)(2010-5#1)
sulfidophilum##4##1##(1995-6#2)(2008-6#2)
sulfinate##4##1##(1991-3#1)(1995-1#1)(1996-5#1)(2010-6#1)
sulfinic##2##1##(1995-1#1)(2009-10#1)
sulfinyl##5##1##(1992-11#1)(1995-2#2)(2010-6#2)
sulfisoxazole was##3##2##(1994-5#1)(2008-12#2)
sulfisoxazole##8##1##(1994-5#1)(2008-10#1)(2008-12#6)
sulfite and sulfide##3##3##(2008-10#3)
sulfite and##6##2##(1993-8#1)(2007-8#1)(2008-10#4)
sulfite as an##2##3##(1991-8#1)(2008-10#1)
sulfite as##3##2##(1991-8#1)(2008-10#2)
sulfite in beer samples using##2##5##(2007-8#2)
sulfite in##13##2##(1991-8#1)(2007-8#6)(2008-10#6)
sulfite ions in##2##3##(2008-10#2)
sulfite ions##5##2##(2008-10#5)
sulfite is used##2##3##(2008-10#2)
sulfite is##5##2##(2007-8#2)(2008-10#3)
sulfite oxidase##4##2##(1992-12#1)(2007-8#2)(2008-10#1)
sulfite reductase hemeprotein subunit##2##4##(1990-5#2)
sulfite reductase##5##2##(1990-5#2)(1993-8#2)(1994-8#1)
sulfite solution##3##2##(2008-10#3)
sulfite toxicity##2##2##(1995-5#2)
sulfite##82##1##(1990-3#2)(1990-5#2)(1991-8#3)(1992-12#1)(1993-3#5)(1993-8#4)(1994-8#1)(1995-5#2)(1997-7#1)(2006-8#1)(2007-8#18)(2008-10#42)
sulfites##5##1##(1995-5#5)
sulfo-SANPAH##2##1##(1992-9#2)
sulfobromophthalein##9##1##(1990-3#3)(1991-1#2)(1992-3#2)(1993-7#1)(1995-2#1)
sulfogalactosylceramide##3##1##(1991-4#3)
sulfoglycolipids##2##1##(1993-9#2)
sulfolipid##2##1##(1990-4#2)
sulfonamide compounds in a mixture##2##5##(2008-10#2)
sulfonamide compounds##3##2##(2008-10#3)
sulfonamide inhibitor##2##2##(1993-3#1)(1996-2#1)
sulfonamide##25##1##(1991-5#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-8#2)(1994-3#1)(1994-9#1)(1996-2#1)(1997-2#2)(1997-8#1)(2006-12#1)(2008-10#7)(2008-5#2)(2009-3#2)(2009-8#1)
sulfonamides and quinolones##4##3##(2008-10#4)
sulfonamides and##5##2##(2008-10#4)(2011-2#1)
sulfonamides as##3##2##(2008-5#3)
sulfonamides in##4##2##(1991-8#1)(2008-10#3)
sulfonamides##29##1##(1991-5#2)(1991-8#2)(2008-10#16)(2008-5#4)(2009-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
sulfonate (SDBS)##2##2##(2008-10#2)
sulfonate and##4##2##(1997-2#1)(2005-11#1)(2008-10#2)
sulfonate donor##2##2##(1995-8#2)
sulfonate group##3##2##(1995-1#2)(2010-6#1)
sulfonate groups and##3##3##(1996-11#2)(2005-11#1)
sulfonate groups##4##2##(1996-11#2)(2005-11#1)(2010-12#1)
sulfonate surfactants##4##2##(2007-11#4)
sulfonate##46##1##(1990-9#1)(1991-10#2)(1991-4#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-5#1)(1995-8#2)(1996-11#2)(1997-2#1)(2005-11#4)(2007-11#4)(2007-12#4)(2008-10#14)(2010-12#2)(2010-2#1)(2010-6#1)
sulfonate) composite material##2##3##(2007-8#1)(2008-10#1)
sulfonate)##8##1##(2007-8#2)(2008-10#5)(2008-12#1)
sulfonate)]##3##1##(2005-11#1)(2007-11#1)(2007-12#1)
sulfonated##10##1##(1992-9#1)(1994-11#1)(1997-1#1)(2007-10#1)(2007-8#1)(2008-10#5)
sulfonates in##2##2##(2008-10#2)
sulfonates##10##1##(1994-9#1)(2005-4#1)(2007-12#1)(2008-10#6)(2010-12#1)
sulfonating##2##1##(2007-8#1)(2008-10#1)
sulfonation##2##1##(2007-8#1)(2009-3#1)
sulfone##12##1##(1992-12#1)(1992-5#1)(1993-3#1)(1994-9#1)(1996-8#1)(1997-2#3)(2006-9#3)(2008-10#1)
sulfonensis##2##1##(2006-9#2)
sulfonephthalein##2##1##(2008-10#2)
sulfones##10##1##(1993-9#5)(1996-8#1)(1997-2#2)(2009-5#1)(2010-5#1)
sulfonic acid##16##2##(1994-9#1)(1995-5#1)(2005-12#1)(2007-8#1)(2008-10#7)(2010-4#2)(2010-6#2)(2012-12#1)
sulfonic acid)##2##2##(2008-10#1)(2012-11#1)
sulfonic acids##3##2##(2008-10#3)
sulfonic groups##2##2##(2008-10#1)(2013-8#1)
sulfonic##25##1##(1994-9#1)(1995-5#1)(2005-12#1)(2007-8#1)(2008-10#12)(2010-4#2)(2010-6#2)(2012-11#1)(2012-12#1)(2012-3#1)(2013-8#2)
sulfonium##5##1##(1990-4#1)(1994-8#3)(2008-4#1)
sulfonyl chloride##2##2##(2008-10#1)(2009-3#1)
sulfonyl chlorides##2##2##(2010-12#2)
sulfonyl derivatives##2##2##(1995-2#1)(2007-11#1)
sulfonyl##10##1##(1990-5#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-3#1)(2010-12#3)
sulfonyl-urea##2##1##(2007-8#2)
sulfonylurea agents on##2##3##(1994-8#2)
sulfonylurea herbicides##3##2##(1994-10#1)(2008-10#2)
sulfonylurea##11##1##(1990-7#1)(1991-7#1)(1992-3#2)(1994-10#1)(1994-8#2)(2007-10#1)(2007-12#1)(2008-10#2)
sulfonylureas or##2##2##(2008-3#1)(2008-8#1)
sulfonylureas##11##1##(1991-1#1)(1991-12#2)(1992-3#6)(2008-3#1)(2008-8#1)
sulfopropyl groups##2##2##(2010-4#2)
sulfopropyl##4##1##(1997-2#1)(2010-4#3)
sulforaphane##2##1##(2010-6#2)
sulforhodamine B##3##2##(2007-8#1)(2008-10#2)
sulforhodamine##6##1##(1993-6#1)(1996-3#1)(2007-8#2)(2008-10#2)
sulforhodamine-GM1 was##2##2##(1996-3#2)
sulforhodamine-GM1##4##1##(1996-3#4)
sulforhodamine-GM2##2##1##(1996-3#2)
sulforhodamine-sphingomyelin##2##1##(1996-3#2)
sulfosalicylic##3##1##(2005-4#1)(2008-10#2)
sulfosuccinate##2##1##(2005-11#1)(2008-10#1)
sulfosuccinimidyl##3##1##(1992-3#1)(1992-9#2)
sulfotransferase activity##3##2##(1990-4#1)(1990-6#2)
sulfotransferase cDNA and##2##3##(1993-4#2)
sulfotransferase cDNA##7##2##(1993-4#6)(1993-8#1)
sulfotransferase cDNAs##3##2##(1993-4#1)(1993-8#2)
sulfotransferase gene##2##2##(1995-8#2)
sulfotransferase genes##4##2##(1995-8#4)
sulfotransferase in##2##2##(1990-4#1)(1995-12#1)
sulfotransferase to##2##2##(1990-6#1)(1994-8#1)
sulfotransferase##38##1##(1990-4#2)(1990-6#3)(1991-12#2)(1992-10#1)(1992-8#2)(1993-12#2)(1993-4#8)(1993-8#3)(1994-8#1)(1995-12#2)(1995-8#10)(2009-4#2)
sulfotransferase-activity levels##2##2##(1993-9#2)
sulfotransferases in##4##2##(1992-8#1)(1993-9#2)(2009-4#1)
sulfotransferases##12##1##(1992-8#1)(1993-4#3)(1993-9#2)(1995-8#2)(1996-4#1)(2008-4#1)(2009-4#2)
sulfoxidation##3##1##(2007-6#2)(2010-12#1)
sulfoxide (DMSO)##12##2##(1994-8#1)(1996-9#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2013-7#1)
sulfoxide and##10##2##(1993-3#2)(1994-9#1)(1996-8#1)(1997-2#1)(2007-8#1)(2008-10#2)(2009-5#1)(2010-5#1)
sulfoxide as##3##2##(1995-5#1)(2007-11#1)(2008-10#1)
sulfoxide in the##2##3##(2005-8#1)(2007-10#1)
sulfoxide is##2##2##(1990-11#1)(1996-5#1)
sulfoxide oxygen##2##2##(2007-10#1)(2008-10#1)
sulfoxide##63##1##(1990-11#4)(1990-12#1)(1990-9#1)(1991-8#1)(1991-9#2)(1992-5#1)(1993-3#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#3)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#4)(1997-7#1)(1997-8#1)(2005-4#2)(2005-8#1)(2007-10#2)(2007-11#2)(2007-8#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#3)(2009-5#1)(2010-1#1)(2010-5#1)(2013-7#2)
sulfoxides##2##1##(1997-2#1)(2005-12#1)
sulfoximine (BSO)##6##2##(1995-1#1)(1997-2#2)(1997-7#1)(2009-10#1)(2012-2#1)
sulfoximine##11##1##(1990-7#1)(1992-11#1)(1992-3#1)(1995-1#2)(1995-11#1)(1997-2#2)(1997-7#1)(2009-10#1)(2012-2#1)
sulfoximine)##2##1##(2007-11#1)(2008-2#1)
sulfoximines##2##1##(2007-11#2)
sulfur amino acids##2##3##(2008-10#1)(2011-2#1)
sulfur amino##3##2##(2008-10#1)(2011-12#1)(2011-2#1)
sulfur and nitrogen atoms##2##4##(1996-2#1)(2008-5#1)
sulfur and nitrogen##4##3##(1994-9#1)(1996-2#1)(2006-12#1)(2008-5#1)
sulfur and oxygen##2##3##(2006-10#1)(2008-5#1)
sulfur and##14##2##(1994-9#1)(1996-2#1)(2006-10#1)(2006-12#1)(2006-4#1)(2008-10#5)(2008-5#2)(2008-9#1)(2013-1#1)
sulfur atom##13##2##(1990-8#1)(1992-12#1)(1993-9#1)(1994-11#1)(1994-3#1)(2007-10#1)(2007-8#5)(2008-4#1)(2010-2#1)
sulfur atoms##3##2##(1991-7#1)(1995-3#1)(1996-5#1)
sulfur by##2##2##(2008-10#1)(2008-11#1)
sulfur colloid##2##2##(1994-2#1)(1997-1#1)
sulfur compounds and##2##3##(2008-10#1)(2009-10#1)
sulfur compounds in##4##3##(2008-10#3)(2008-3#1)
sulfur compounds##17##2##(2006-12#1)(2008-10#11)(2008-3#2)(2009-10#1)(2011-2#1)(2013-1#1)
sulfur containing diesel fuels##2##4##(2008-10#2)
sulfur containing##4##2##(1994-9#1)(2008-10#3)
sulfur content##3##2##(1991-9#1)(2008-10#2)
sulfur dioxide and nitrogen dioxide##4##5##(2005-4#3)(2010-12#1)
sulfur dioxide and##5##3##(2005-4#3)(2008-10#1)(2010-12#1)
sulfur dioxide in air by##2##5##(2008-10#2)
sulfur dioxide in air##3##4##(2008-10#3)
sulfur dioxide in##9##3##(2008-10#9)
sulfur dioxide##24##2##(1996-12#1)(2005-4#3)(2008-1#1)(2008-10#17)(2008-2#1)(2010-12#1)
sulfur donor##2##2##(2010-11#1)(2010-5#1)
sulfur donors is##3##3##(1997-7#3)
sulfur donors##4##2##(1997-7#4)
sulfur in the##3##3##(1994-7#1)(2008-10#2)
sulfur in##5##2##(1994-7#1)(2008-10#4)
sulfur ligands##2##2##(1994-11#2)
sulfur metabolism##2##2##(2007-1#1)(2008-7#1)
sulfur of a##2##3##(1990-2#1)(2008-6#1)
sulfur redox##2##2##(2009-3#1)(2010-4#1)
sulfur solids##2##2##(2008-10#2)
sulfur species##2##2##(2006-3#1)(2008-10#1)
sulfur to##3##2##(2008-10#1)(2010-7#1)(2011-2#1)
sulfur##197##1##(1990-12#1)(1990-2#1)(1990-8#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-4#1)(1993-9#1)(1994-11#5)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#1)(1994-9#3)(1995-10#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#3)(1996-5#1)(1997-1#2)(1997-7#6)(2004-4#1)(2005-11#5)(2005-4#3)(2005-9#1)(2006-10#1)(2006-12#2)(2006-3#1)(2006-4#1)(2006-8#1)(2007-1#3)(2007-10#3)(2007-12#2)(2007-4#1)(2007-8#5)(2008-1#3)(2008-10#76)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#4)(2009-12#1)(2009-3#2)(2010-11#3)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#1)(2011-12#1)(2011-2#9)(2013-1#4)
sulfur)##2##1##(2007-10#1)(2008-10#1)
sulfur-containing amino acids and##2##4##(2012-12#2)
sulfur-containing amino acids##3##3##(2012-12#2)(2012-3#1)
sulfur-containing amino##4##2##(2008-3#1)(2012-12#2)(2012-3#1)
sulfur-containing##8##1##(1990-8#1)(2008-10#2)(2008-3#1)(2009-8#1)(2012-12#2)(2012-3#1)
sulfuric acid and##2##3##(2008-10#2)
sulfuric acid as##2##3##(2008-10#1)(2010-6#1)
sulfuric acid media##4##3##(2008-10#4)
sulfuric acid medium##10##3##(2008-10#10)
sulfuric acid pretreatment##2##3##(2008-5#1)(2013-1#1)
sulfuric acid solution##3##3##(2008-10#3)
sulfuric acid to##2##3##(2008-10#1)(2008-5#1)
sulfuric acid were##3##3##(2007-8#1)(2008-10#1)(2013-1#1)
sulfuric acid with##2##3##(2008-10#2)
sulfuric acid##61##2##(1991-12#1)(1994-11#1)(2005-11#2)(2007-8#2)(2008-10#38)(2008-2#1)(2008-3#4)(2008-5#5)(2009-2#1)(2010-6#3)(2012-12#1)(2013-1#2)
sulfuric acid-assisted continuous twin screw-driven reactor##2##6##(2013-1#2)
sulfuric and##2##2##(2008-10#1)(2009-7#1)
sulfuric##69##1##(1991-12#1)(1994-11#1)(2005-11#3)(2007-8#2)(2008-10#40)(2008-2#1)(2008-3#5)(2008-5#5)(2009-2#1)(2009-7#1)(2010-6#3)(2012-12#1)(2013-1#5)
sulfuric-acid-water##2##1##(2008-3#2)
sulfurreducens##3##1##(2011-1#3)
sulfurs##4##1##(1991-4#2)(1991-7#1)(2008-10#1)
sulfurtransferase##2##1##(1991-10#1)(1992-12#1)
sulglicotide##3##1##(1991-4#3)
sulindac (Clinoril)##2##2##(1992-4#1)(1992-9#1)
sulindac##8##1##(1990-11#1)(1992-3#1)(1992-4#2)(1992-9#2)(1995-9#1)(2009-12#1)
sulisobenzone was##2##2##(2008-5#2)
sulisobenzone##5##1##(2008-5#5)
sulla##2##1##(2010-1#1)(2013-8#1)
sulodexide on the##2##3##(2013-8#2)
sulodexide##3##1##(2013-8#3)
sulpha-drug##2##1##(2008-10#2)
sulphacetamide derivatives##3##2##(2007-9#3)
sulphadiazine##3##1##(2007-7#1)(2011-2#1)(2013-7#1)
sulphamethoxazole##5##1##(1990-12#2)(2007-7#1)(2008-10#2)
sulphamidase gene##3##2##(1996-8#3)
sulphamidase##4##1##(1996-8#4)
sulphanilamide##3##1##(2008-10#2)(2008-5#1)
sulphanilic acid to##2##3##(2008-10#2)
sulphanilic acid##4##2##(2007-8#1)(2008-10#3)
sulphate (SDS)##7##2##(1994-9#1)(2008-10#4)(2008-5#2)
sulphate and chloride##2##3##(2008-10#2)
sulphate and sodium##3##3##(1992-2#1)(2008-5#2)
sulphate and sulphite reduction##2##4##(2008-7#2)
sulphate and##24##2##(1990-11#1)(1992-1#2)(1992-2#1)(2007-3#1)(2008-10#6)(2008-5#5)(2008-7#2)(2010-2#4)(2010-8#1)(2012-6#1)
sulphate as a##2##3##(2006-8#1)(2012-2#1)
sulphate as##5##2##(2006-8#1)(2008-10#1)(2012-2#1)(2013-1#2)
sulphate binding sites##2##3##(1994-9#2)
sulphate binding##3##2##(1994-9#3)
sulphate concentration##2##2##(2007-7#1)(2008-10#1)
sulphate conjugated CA##3##3##(1997-7#3)
sulphate conjugated DA and NA##2##5##(1997-7#2)
sulphate conjugated DA and##3##4##(1997-7#3)
sulphate conjugated NA and Ad##2##5##(1997-7#2)
sulphate conjugated NA##4##3##(1997-7#4)
sulphate conjugated##12##2##(1997-7#12)
sulphate conjugated)##3##2##(1997-7#3)
sulphate conversion##2##2##(2008-7#2)
sulphate fractionation##2##2##(1990-11#1)(1990-7#1)
sulphate hydrate##2##2##(2008-10#2)
sulphate in##13##2##(2006-4#1)(2006-8#1)(2008-10#8)(2010-3#1)(2011-12#1)(2011-2#1)
sulphate ion##3##2##(2008-10#2)(2012-7#1)
sulphate levels##2##2##(1993-2#1)(1995-7#1)
sulphate matrix##3##2##(2008-10#3)
sulphate media##2##2##(2008-10#2)
sulphate or##5##2##(1990-8#1)(2006-10#1)(2008-10#1)(2010-4#1)(2013-1#1)
sulphate therapy##2##2##(2006-10#2)
sulphate to##2##2##(1990-12#1)(1996-7#1)
sulphate was##3##2##(1995-9#1)(1996-7#1)(2008-5#1)
sulphate were##2##2##(1992-1#1)(2008-1#1)
sulphate with##5##2##(2004-4#1)(2008-10#2)(2013-1#2)
sulphate##217##1##(1990-11#5)(1990-12#7)(1990-5#6)(1990-6#1)(1990-7#2)(1990-8#3)(1991-11#3)(1991-3#1)(1991-5#2)(1992-1#4)(1992-11#1)(1992-2#2)(1992-5#2)(1992-8#1)(1993-2#5)(1993-3#1)(1993-6#1)(1993-9#2)(1994-10#1)(1994-5#1)(1994-9#7)(1995-3#1)(1995-5#1)(1995-7#3)(1995-9#1)(1996-12#1)(1996-5#2)(1996-7#3)(1996-8#1)(1997-1#1)(1997-3#8)(1997-5#1)(1997-7#15)(1997-8#1)(2004-1#1)(2004-4#2)(2005-11#1)(2005-4#1)(2006-10#6)(2006-4#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#48)(2008-5#17)(2008-7#5)(2010-2#4)(2010-3#1)(2010-4#1)(2010-8#1)(2011-12#4)(2011-2#1)(2012-12#1)(2012-2#4)(2012-6#3)(2012-7#2)(2013-1#5)(2013-8#4)
sulphate)##4##1##(1994-12#1)(1994-3#1)(2008-10#2)
sulphated##13##1##(1992-9#2)(1993-11#1)(1993-2#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-7#1)(1997-3#1)(2007-11#1)(2010-8#1)(2011-1#1)(2011-10#1)
sulphates##8##1##(1990-11#1)(1992-9#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-6#1)
sulphatide concentration##2##2##(1994-3#2)
sulphation of##2##2##(1993-2#2)
sulphation##3##1##(1992-9#1)(1993-2#2)
sulphhydryl##2##1##(1990-12#1)(1991-2#1)
sulphide and##5##2##(1997-4#1)(2007-7#2)(2008-10#1)(2012-2#1)
sulphide at##3##2##(2008-10#3)
sulphide in##2##2##(2008-10#2)
sulphide is##2##2##(2008-10#2)
sulphide##42##1##(1996-7#7)(1997-4#2)(2007-7#6)(2008-10#24)(2008-7#1)(2012-2#1)(2013-8#1)
sulphides##5##1##(2008-10#5)
sulphite##9##1##(2007-1#1)(2008-10#5)(2008-7#3)
sulphonamides##2##1##(1990-9#1)(2007-8#1)
sulphonate formaldehyde##2##2##(2008-10#2)
sulphonate##8##1##(1991-2#1)(1995-11#1)(1995-12#1)(1995-3#1)(2008-10#3)(2008-5#1)
sulphonated azo dyes in##2##4##(2008-10#2)
sulphonated azo dyes##3##3##(2008-10#3)
sulphonated##7##1##(1994-5#1)(1995-12#1)(2008-10#5)
sulphone##3##1##(1991-8#1)(2007-8#1)(2008-10#1)
sulphonic acid##4##2##(1996-5#1)(2010-2#2)(2010-5#1)
sulphonic acid)##2##2##(2008-10#2)
sulphonic##9##1##(1996-5#1)(2008-10#5)(2010-2#2)(2010-5#1)
sulphonylurea##9##1##(1992-8#1)(1994-12#2)(1994-8#3)(2007-7#1)(2008-3#1)(2010-4#1)
sulphonylureas##5##1##(1994-8#4)(2010-4#1)
sulphonylureas)##2##1##(1996-11#2)
sulphosalicylic##2##1##(1991-5#1)(2008-10#1)
sulphotransferase##8##1##(1993-2#3)(1994-11#4)(1994-3#1)
sulphoxide##5##1##(1991-8#1)(2008-10#1)(2009-11#1)(2010-8#2)
sulphur amino acid##2##3##(1995-7#1)(2010-4#1)
sulphur amino##3##2##(1995-7#1)(2008-8#1)(2010-4#1)
sulphur and##4##2##(2008-10#3)(2008-3#1)
sulphur atoms##2##2##(1991-8#1)(1997-5#1)
sulphur compounds in##2##3##(2006-2#1)(2008-10#1)
sulphur compounds##8##2##(1992-8#1)(1997-4#1)(2006-2#1)(2008-10#5)
sulphur content##4##2##(2006-12#1)(2008-10#2)(2008-11#1)
sulphur dioxide in ambient air##2##5##(2008-10#2)
sulphur dioxide in##3##3##(2008-10#3)
sulphur dioxide were##2##3##(2008-10#2)
sulphur dioxide##12##2##(1996-12#1)(2008-10#11)
sulphur in##6##2##(2008-10#6)
sulphur is##2##2##(2008-10#2)
sulphur mustard##6##2##(2006-12#1)(2006-7#5)
sulphur were##3##2##(2008-10#3)
sulphur##85##1##(1990-12#2)(1991-8#1)(1992-8#1)(1994-3#1)(1995-7#2)(1996-12#1)(1997-4#2)(1997-5#1)(2004-4#1)(2005-11#1)(2005-4#1)(2006-12#6)(2006-2#1)(2006-7#5)(2008-10#47)(2008-11#1)(2008-3#1)(2008-4#4)(2008-6#1)(2008-8#1)(2010-4#1)(2010-8#1)(2011-12#1)(2013-8#1)
sulphur-containing amino acids##2##3##(1997-4#1)(2006-8#1)
sulphur-containing compounds##4##2##(1997-4#2)(2008-10#2)
sulphur-containing##7##1##(1997-4#3)(2006-8#1)(2008-10#2)(2008-11#1)
sulphur-crested cockatoos##3##2##(2008-5#3)
sulphurascens##4##1##(2008-10#4)
sulphureum and##2##2##(2008-10#2)
sulphureum##6##1##(2008-10#6)
sulphuric acid and permanganate##2##4##(2008-10#2)
sulphuric acid and##6##3##(2008-10#4)(2008-5#1)(2009-10#1)
sulphuric acid concentration##3##3##(2008-10#3)
sulphuric acid in the##2##4##(2008-10#1)(2009-10#1)
sulphuric acid media was##2##4##(2008-10#2)
sulphuric acid media##3##3##(2008-10#3)
sulphuric acid medium##4##3##(2008-10#4)
sulphuric acid to##2##3##(2008-10#2)
sulphuric acid with##2##3##(2008-10#2)
sulphuric acid##38##2##(1990-6#1)(2008-10#33)(2008-5#1)(2009-10#3)
sulphuric##46##1##(1990-6#1)(2004-4#1)(2007-5#1)(2007-8#1)(2008-10#38)(2008-5#1)(2009-10#3)
sulphydryl compounds##3##2##(1992-8#3)
sulphydryl groups in##2##3##(1992-7#1)(1993-4#1)
sulphydryl groups##3##2##(1992-7#1)(1993-2#1)(1993-4#1)
sulphydryl##11##1##(1991-2#1)(1992-7#1)(1992-8#3)(1993-2#1)(1993-4#1)(1994-3#2)(2008-10#2)
sulpiride and##2##2##(1992-9#1)(1996-12#1)
sulpiride##23##1##(1990-5#1)(1990-7#1)(1991-1#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-9#3)(1996-1#3)(1996-12#3)(1996-2#1)(1996-3#1)(1997-3#4)(2008-10#2)
sultanate of oman##2##3##(2008-4#1)(2012-2#1)
sultone##2##1##(2008-10#2)
sultopride##2##1##(2008-10#2)
sum frequency generation##3##3##(2008-2#1)(2009-7#1)(2012-1#1)
sum frequency##6##2##(2007-12#2)(2008-2#2)(2009-7#1)(2012-1#1)
sum gene##3##2##(2006-8#3)
sum of a##2##3##(1997-2#1)(2007-12#1)
sum of squares of##2##4##(1995-12#1)(2013-1#1)
sum of squares##7##3##(1995-12#1)(1996-1#1)(2008-10#2)(2008-7#1)(2010-2#1)(2013-1#1)
sum of the##55##3##(1990-12#1)(1990-6#1)(1990-9#1)(1991-12#2)(1993-6#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-11#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#3)(1997-2#2)(1997-5#1)(2005-12#1)(2006-11#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-2#5)(2008-3#3)(2008-4#1)(2008-8#1)(2009-1#1)(2009-10#2)(2010-2#1)(2010-3#1)(2010-8#1)(2013-1#2)
sum of two exponentials##2##4##(1995-3#1)(1997-1#1)
sum of two##10##3##(1991-12#1)(1992-11#1)(1994-11#1)(1995-3#1)(1997-1#1)(1997-7#1)(1997-8#1)(2005-11#2)(2008-10#1)
sum of##137##2##(1990-12#4)(1990-6#1)(1990-9#1)(1991-12#4)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-8#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-11#2)(1995-12#2)(1995-3#2)(1996-1#1)(1996-11#3)(1996-3#1)(1996-5#2)(1996-6#2)(1997-1#4)(1997-2#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-4#1)(2005-11#2)(2005-12#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#2)(2008-10#27)(2008-11#2)(2008-2#7)(2008-3#9)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#2)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
sum rule##3##2##(1993-8#1)(2008-3#2)
sum rules##3##2##(1993-5#1)(2007-12#1)(2008-2#1)
sum score##3##2##(1996-7#1)(2010-3#2)
sum to##2##2##(2008-10#1)(2008-3#1)
sum total of##2##3##(2006-6#1)(2008-10#1)
sum up##3##2##(2007-8#1)(2008-11#1)(2008-3#1)
sum##208##1##(1990-12#4)(1990-6#1)(1990-9#1)(1991-12#4)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-4#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-3#2)(1996-1#1)(1996-11#3)(1996-3#1)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#1)(1997-1#6)(1997-2#3)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-4#1)(2005-11#3)(2005-12#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#1)(2006-8#4)(2007-1#1)(2007-11#4)(2007-12#6)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#31)(2008-11#3)(2008-2#14)(2008-3#21)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#2)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#2)(2010-3#3)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#2)
sum- and difference-frequency##3##3##(2007-12#1)(2008-3#2)
sum-frequency generation (SFG)##4##3##(2007-12#2)(2008-1#1)(2009-4#1)
sum-frequency generation with a##2##4##(2007-12#2)
sum-frequency generation with##4##3##(2007-12#4)
sum-frequency generation##17##2##(2007-12#13)(2008-1#1)(2008-3#2)(2009-4#1)
sum-frequency mixing in##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
sum-frequency mixing of the##2##4##(2007-12#1)(2008-2#1)
sum-frequency mixing of##4##3##(2007-12#2)(2008-1#1)(2008-2#1)
sum-frequency mixing##13##2##(2007-11#2)(2007-12#4)(2008-1#2)(2008-2#3)(2008-3#2)
sum-frequency##35##1##(2007-11#2)(2007-12#19)(2008-1#4)(2008-2#4)(2008-3#4)(2009-4#1)(2010-4#1)
sumatriptan 100 mg##2##3##(2005-7#2)
sumatriptan and##2##2##(1993-7#1)(1997-5#1)
sumatriptan are##2##2##(1996-12#1)(2005-7#1)
sumatriptan succinate##3##2##(2012-3#3)
sumatriptan##32##1##(1992-5#2)(1993-10#1)(1993-7#1)(1993-8#1)(1994-3#3)(1995-12#2)(1996-12#3)(1997-3#3)(1997-5#1)(2005-7#7)(2007-9#2)(2008-6#2)(2008-8#1)(2012-3#3)
summaries and##3##2##(1997-8#1)(2006-10#1)(2008-5#1)
summaries for##4##2##(2007-2#1)(2008-6#1)(2008-9#1)(2012-12#1)
summaries from the##3##3##(2007-5#1)(2013-1#2)
summaries from##5##2##(2007-5#1)(2013-1#4)
summaries in##3##2##(1993-2#1)(1994-3#1)(2012-2#1)
summaries of the##5##3##(1991-12#1)(1991-9#1)(1993-12#1)(1994-3#1)(2006-10#1)
summaries of##12##2##(1991-12#1)(1991-9#1)(1992-12#1)(1993-12#2)(1994-3#1)(1996-6#1)(2006-10#1)(2007-2#1)(2008-10#1)(2009-9#1)(2010-11#1)
summaries##46##1##(1991-12#2)(1991-9#1)(1992-12#1)(1993-12#2)(1993-2#2)(1994-3#2)(1996-6#1)(1997-8#1)(2006-10#2)(2007-2#2)(2007-5#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-9#1)(2010-11#1)(2011-1#2)(2012-12#3)(2012-2#3)(2013-1#15)
summarily##3##1##(1996-4#2)(2008-7#1)
summarise recent##2##2##(2008-4#1)(2008-9#1)
summarise the current##3##3##(2006-10#1)(2007-11#1)(2009-12#1)
summarise the results##2##3##(1996-11#1)(2009-5#1)
summarise the##15##2##(1996-11#1)(1996-8#1)(2006-10#1)(2007-11#3)(2008-1#1)(2008-8#2)(2009-12#1)(2009-5#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#1)
summarise##23##1##(1996-11#1)(1996-8#1)(2006-10#1)(2007-11#5)(2007-4#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2010-3#1)(2011-1#1)(2012-12#2)(2012-2#1)
summarised and##2##2##(2008-11#2)
summarised in the##2##3##(1996-5#1)(2010-5#1)
summarised in this##2##3##(2008-7#1)(2011-3#1)
summarised in##4##2##(1996-5#1)(2008-7#1)(2010-5#1)(2011-3#1)
summarised##17##1##(1994-3#1)(1996-5#1)(1997-7#1)(2005-5#1)(2005-7#1)(2006-6#1)(2006-9#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#1)(2011-3#1)
summarises our current understanding of##2##5##(2011-2#1)(2013-8#1)
summarises our current##3##3##(2007-11#1)(2011-2#1)(2013-8#1)
summarises recent##3##2##(2006-6#1)(2007-5#1)(2008-11#1)
summarises the findings of##2##4##(2004-7#1)(2008-10#1)
summarises the##12##2##(1996-2#1)(1997-7#1)(2004-7#1)(2005-7#1)(2007-11#2)(2007-2#1)(2007-5#1)(2008-10#2)(2011-10#1)(2011-2#1)
summarises##29##1##(1994-3#1)(1996-2#1)(1997-7#1)(2004-7#1)(2005-7#3)(2006-6#1)(2007-11#5)(2007-2#1)(2007-5#2)(2008-10#3)(2008-11#1)(2009-2#1)(2010-5#1)(2011-10#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#1)
summarising the##4##2##(2005-7#1)(2006-10#1)(2012-12#1)(2013-8#1)
summarization##2##1##(2010-1#1)(2010-12#1)
summarize a##4##2##(2010-7#1)(2011-2#1)(2013-1#2)
summarize and##3##2##(2007-12#1)(2009-1#1)(2012-12#1)
summarize current##3##2##(2006-10#1)(2010-11#1)(2011-1#1)
summarize data##2##2##(2006-7#1)(2008-11#1)
summarize evidence##2##2##(2008-5#1)(2012-12#1)
summarize findings##3##2##(2008-11#2)(2008-3#1)
summarize here the##2##3##(2007-3#1)(2012-12#1)
summarize here##3##2##(2007-3#1)(2009-5#1)(2012-12#1)
summarize information##2##2##(2006-10#1)(2007-5#1)
summarize key##3##2##(2007-12#1)(2013-1#2)
summarize mechanisms by which##2##4##(1991-11#1)(2006-10#1)
summarize our current##2##3##(2007-12#1)(2013-8#1)
summarize our results##2##3##(2009-8#1)(2013-1#1)
summarize our##12##2##(2005-11#1)(2006-10#1)(2006-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
summarize recent advances in##2##4##(2006-10#1)(2011-2#1)
summarize recent findings##3##3##(2008-11#1)(2012-12#1)(2012-2#1)
summarize recent studies##3##3##(2006-10#1)(2008-8#1)(2013-8#1)
summarize recent##16##2##(1996-4#1)(2006-10#2)(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
summarize some of the##5##4##(2006-10#1)(2007-5#1)(2008-11#1)(2008-4#1)(2009-10#1)
summarize some##6##2##(2006-10#1)(2007-5#1)(2008-11#1)(2008-4#1)(2009-10#2)
summarize studies##2##2##(1996-4#1)(2008-7#1)
summarize that##3##2##(1990-12#1)(2005-8#1)(2008-10#1)
summarize the available information##2##4##(2006-10#1)(2010-10#1)
summarize the available##4##3##(2005-10#1)(2006-10#1)(2009-10#1)(2010-10#1)
summarize the clinical##4##3##(2006-10#1)(2007-7#1)(2008-5#1)(2011-2#1)
summarize the current knowledge of##3##5##(2011-2#1)(2012-12#1)(2013-7#1)
summarize the current research##2##4##(2008-1#1)(2011-12#1)
summarize the current state of knowledge regarding##2##7##(2009-8#1)(2010-2#1)
summarize the current##13##3##(1996-10#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#2)(2010-2#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-7#1)
summarize the development of##2##4##(2010-12#1)(2010-9#1)
summarize the effects of##2##4##(2008-10#1)(2009-11#1)
summarize the evidence on##2##4##(1995-5#1)(2013-1#1)
summarize the evidence##5##3##(1995-5#1)(2010-1#1)(2010-11#1)(2012-12#1)(2013-1#1)
summarize the existing##2##3##(2008-5#1)(2012-3#1)
summarize the main##3##3##(2006-4#1)(2010-2#1)(2011-1#1)
summarize the major##2##3##(2008-5#1)(2009-11#1)
summarize the most##2##3##(2009-7#1)(2012-12#1)
summarize the possible##2##3##(2008-1#1)(2008-7#1)
summarize the recent##2##3##(2008-3#1)(2010-2#1)
summarize the reported cases of##2##5##(2007-7#1)(2011-2#1)
summarize the results from##2##4##(2006-1#1)(2008-10#1)
summarize the results##3##3##(2006-1#1)(2008-10#1)(2009-2#1)
summarize the role of##3##4##(2008-2#1)(2008-4#2)
summarize the various##3##3##(1993-12#1)(2006-9#1)(2011-2#1)
summarize the##108##2##(1991-11#1)(1993-12#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-5#1)(1996-10#1)(1996-4#1)(1997-8#2)(2004-3#1)(2005-10#1)(2005-9#1)(2006-1#1)(2006-10#6)(2006-12#1)(2006-4#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-4#1)(2007-7#2)(2008-1#6)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#2)(2009-4#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#3)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#4)(2011-12#2)(2011-2#5)(2012-11#2)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#2)
summarize their##2##2##(2007-10#1)(2007-4#1)
summarize these findings and##2##4##(2008-11#1)(2010-12#1)
summarize these##7##2##(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-1#2)(2013-1#1)
summarize what is known about the##2##6##(2007-11#1)(2008-7#1)
summarize what is known about##3##5##(2006-8#1)(2007-11#1)(2008-7#1)
summarize what##4##2##(2006-8#1)(2007-11#1)(2008-4#1)(2008-7#1)
summarize##230##1##(1990-12#1)(1991-11#2)(1993-12#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-10#1)(1996-12#2)(1996-4#3)(1997-2#1)(1997-8#2)(2004-3#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#13)(2006-11#1)(2006-12#2)(2006-4#2)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#4)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#2)(2008-1#10)(2008-10#12)(2008-11#10)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#5)(2008-7#7)(2008-8#6)(2008-9#3)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#4)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#6)(2010-2#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#7)(2011-12#2)(2011-2#10)(2012-1#1)(2012-11#2)(2012-12#9)(2012-2#5)(2012-3#3)(2013-1#16)(2013-7#2)(2013-8#5)
summarized and compared to the##2##5##(1993-2#1)(1995-12#1)
summarized and compared##3##3##(1993-2#1)(1995-12#1)(2008-10#1)
summarized and##11##2##(1993-2#1)(1993-3#1)(1993-5#1)(1995-12#1)(2005-10#1)(2008-10#1)(2008-11#2)(2008-7#2)(2010-12#1)
summarized as follows##11##3##(1990-9#1)(1994-11#1)(1995-11#1)(1995-7#1)(1995-9#2)(1996-9#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
summarized as the##3##3##(1992-11#1)(2007-3#1)(2007-8#1)
summarized as##16##2##(1990-8#1)(1990-9#1)(1992-11#1)(1994-11#1)(1995-11#1)(1995-7#1)(1995-9#2)(1996-9#1)(1997-2#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
summarized by the##2##3##(2008-10#1)(2008-5#1)
summarized by##4##2##(1992-9#1)(2005-4#1)(2008-10#1)(2008-5#1)
summarized herein##2##2##(2008-10#1)(2010-7#1)
summarized in Table 1##2##4##(1996-8#1)(2010-4#1)
summarized in a##3##3##(2008-4#1)(2008-5#1)(2012-12#1)
summarized in the##4##3##(2008-10#1)(2008-8#1)(2009-4#1)(2011-2#1)
summarized in this report##2##4##(1992-5#1)(2005-8#1)
summarized in this review##6##4##(1995-5#1)(2005-7#1)(2008-10#1)(2008-5#1)(2012-3#2)
summarized in this##12##3##(1992-5#1)(1995-5#1)(2005-7#1)(2005-8#1)(2008-10#2)(2008-4#1)(2008-5#2)(2012-12#1)(2012-3#2)
summarized in two##2##3##(1990-11#1)(2013-1#1)
summarized in##29##2##(1990-11#1)(1992-5#1)(1995-5#1)(1996-3#1)(1996-8#1)(2005-7#1)(2005-8#1)(2008-10#5)(2008-3#2)(2008-4#2)(2008-5#3)(2008-8#1)(2009-4#2)(2010-4#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#1)
summarized the recent##2##3##(2011-3#1)(2012-2#1)
summarized the##12##2##(1996-12#1)(1996-2#1)(2005-9#1)(2008-1#2)(2008-5#1)(2011-1#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#2)
summarized to##4##2##(2008-4#1)(2008-7#1)(2011-2#1)(2012-3#1)
summarized under##2##2##(2006-12#1)(2007-7#1)
summarized##194##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#3)(1991-4#1)(1992-11#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-11#2)(1994-6#1)(1995-11#2)(1995-12#1)(1995-4#1)(1995-5#2)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#1)(1997-6#2)(2005-10#1)(2005-4#1)(2005-7#1)(2005-8#2)(2005-9#3)(2006-1#1)(2006-10#5)(2006-12#1)(2007-1#3)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-3#2)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#16)(2008-11#8)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#8)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#3)(2010-4#4)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#4)(2011-3#1)(2011-9#1)(2012-1#2)(2012-12#6)(2012-2#3)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#7)
summarizes a presentation##2##3##(2008-10#1)(2008-4#1)
summarizes a##10##2##(1992-3#1)(1996-11#1)(2005-10#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-10#1)(2010-2#1)(2012-2#1)
summarizes aspects##2##2##(2008-11#1)(2008-4#1)
summarizes current data##2##3##(2010-12#1)(2012-3#1)
summarizes current##7##2##(2007-12#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
summarizes data##2##2##(2006-10#1)(2013-8#1)
summarizes findings##5##2##(1991-3#1)(1994-9#1)(1996-8#1)(2009-8#1)(2012-2#1)
summarizes in##2##2##(1996-3#1)(2008-6#1)
summarizes key##4##2##(2004-10#1)(2007-12#1)(2008-11#1)(2010-4#1)
summarizes new##3##2##(2007-11#1)(2008-11#2)
summarizes our current understanding of##2##5##(2007-8#1)(2008-11#1)
summarizes our current##4##3##(2007-8#1)(2008-1#1)(2008-11#1)(2010-8#1)
summarizes our knowledge##2##3##(2006-12#1)(2008-8#1)
summarizes our##11##2##(1993-2#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#2)(2009-6#1)(2010-8#1)(2011-2#1)
summarizes recent advances##5##3##(2005-8#1)(2007-6#1)(2007-7#1)(2008-1#1)(2010-2#1)
summarizes recent developments in the##2##5##(2006-10#1)(2008-10#1)
summarizes recent research##2##3##(2008-1#1)(2010-2#1)
summarizes recent studies in##2##4##(1994-8#1)(2008-3#1)
summarizes recent##20##2##(1994-8#1)(2005-8#1)(2006-10#6)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-6#1)(2010-2#2)
summarizes recently##2##2##(1991-2#1)(2008-1#1)
summarizes research##3##2##(1994-1#1)(2008-6#1)(2009-11#1)
summarizes results of##3##3##(1991-5#1)(1991-6#1)(2012-3#1)
summarizes several examples##2##3##(2008-10#2)
summarizes some of the most recent##2##6##(2006-10#1)(2008-5#1)
summarizes some of the##8##4##(1993-6#1)(2006-10#1)(2007-4#1)(2008-10#2)(2008-5#1)(2009-3#1)(2010-5#1)
summarizes the advantages and##2##4##(2007-5#1)(2008-10#1)
summarizes the available##2##3##(1993-12#1)(2008-8#1)
summarizes the clinical and##2##4##(2007-5#1)(2008-1#1)
summarizes the current knowledge##3##4##(2005-10#1)(2008-4#2)
summarizes the current state of##2##5##(2006-6#1)(2007-8#1)
summarizes the current state##3##4##(2006-6#1)(2007-8#1)(2008-1#1)
summarizes the current##19##3##(2005-10#2)(2005-6#1)(2005-8#2)(2006-2#1)(2006-6#1)(2007-4#1)(2007-8#1)(2008-1#3)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#2)(2012-3#1)
summarizes the development of##3##4##(1992-12#1)(1992-4#1)(2013-8#1)
summarizes the evidence supporting##3##4##(2008-9#1)(2009-10#1)(2009-12#1)
summarizes the evidence##5##3##(1991-3#1)(2008-2#1)(2008-9#1)(2009-10#1)(2009-12#1)
summarizes the findings##5##3##(1991-3#1)(1994-9#1)(1996-11#2)(1996-6#1)
summarizes the highlights of##2##4##(2005-8#1)(2009-4#1)
summarizes the literature on##2##4##(1992-12#1)(2011-2#1)
summarizes the literature##4##3##(1992-12#1)(2009-5#1)(2010-12#1)(2011-2#1)
summarizes the main##3##3##(1992-3#1)(2006-10#1)(2010-12#1)
summarizes the major##2##3##(2006-2#1)(2008-10#1)
summarizes the most important##2##4##(2008-6#1)(2010-2#1)
summarizes the most recent data##2##5##(2005-8#1)(2006-10#1)
summarizes the most recent studies##2##5##(2006-10#1)(2010-5#1)
summarizes the most recent##5##4##(2005-8#1)(2006-10#2)(2008-10#1)(2010-5#1)
summarizes the most##10##3##(2005-8#1)(2006-10#3)(2007-10#1)(2008-10#2)(2008-6#1)(2010-2#1)(2010-5#1)
summarizes the perspectives##2##3##(1996-3#1)(2009-7#1)
summarizes the present##2##3##(1994-6#1)(2008-11#1)
summarizes the presentations##2##3##(2008-5#1)(2010-11#1)
summarizes the progress##2##3##(2006-10#1)(2008-8#1)
summarizes the recent##4##3##(2007-11#1)(2010-11#1)(2010-8#1)(2012-12#1)
summarizes the recommendations of##2##4##(2008-7#2)
summarizes the results of a##2##5##(1992-12#1)(2011-2#1)
summarizes the results of##4##4##(1992-12#1)(1993-9#1)(1994-11#1)(2011-2#1)
summarizes the role of##2##4##(2011-9#1)(2013-1#1)
summarizes the state of##2##4##(1995-2#1)(2007-4#1)
summarizes the##161##2##(1991-12#1)(1991-3#3)(1991-6#1)(1992-12#3)(1992-3#1)(1992-4#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-11#2)(1996-2#1)(1996-3#2)(1996-6#2)(1996-8#1)(1997-1#1)(2004-11#1)(2005-10#3)(2005-6#1)(2005-8#6)(2006-10#8)(2006-11#1)(2006-12#2)(2006-2#3)(2006-6#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#3)(2007-5#2)(2007-8#1)(2008-1#5)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#5)(2008-5#6)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#9)(2011-9#1)(2012-1#1)(2012-12#5)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
summarizes their##2##2##(2008-4#1)(2008-9#1)
summarizes these##3##2##(2008-10#1)(2008-4#1)(2009-8#1)
summarizes##320##1##(1990-11#1)(1990-12#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#4)(1991-5#1)(1991-6#3)(1991-8#2)(1992-1#2)(1992-12#3)(1992-3#2)(1992-4#2)(1992-5#2)(1992-7#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#2)(1996-1#3)(1996-11#3)(1996-2#1)(1996-3#5)(1996-6#2)(1996-8#2)(1997-1#5)(1997-2#1)(2004-10#1)(2004-11#1)(2005-10#5)(2005-6#1)(2005-8#7)(2006-10#18)(2006-11#1)(2006-12#3)(2006-2#4)(2006-5#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#5)(2007-4#5)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#10)(2008-10#16)(2008-11#7)(2008-12#1)(2008-2#5)(2008-3#1)(2008-4#13)(2008-5#10)(2008-6#11)(2008-7#9)(2008-8#6)(2008-9#5)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#3)(2010-11#2)(2010-12#4)(2010-2#5)(2010-4#2)(2010-5#3)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#1)(2011-2#13)(2011-9#1)(2012-1#2)(2012-12#6)(2012-2#5)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#6)
summarizing and##5##2##(1996-3#1)(2007-8#1)(2011-1#1)(2013-1#2)
summarizing current##3##2##(2007-5#2)(2007-9#1)
summarizing some of the##2##4##(2008-1#1)(2008-4#1)
summarizing the accumulating##2##3##(1993-4#1)(2012-3#1)
summarizing the##7##2##(1993-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2011-2#1)(2012-3#1)
summarizing##27##1##(1993-4#3)(1996-3#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#2)
summary and##7##2##(1991-1#1)(1993-9#1)(2006-10#1)(2007-11#1)(2008-2#1)(2008-5#1)(2011-2#1)
summary data##4##2##(1993-12#1)(1996-12#1)(2008-2#1)(2012-12#1)
summary estimate##2##2##(1992-6#1)(2005-10#1)
summary from##2##2##(1995-4#1)(2005-8#1)
summary is##3##2##(1997-2#1)(2005-7#2)
summary judgement that##2##3##(1996-11#2)
summary judgement##3##2##(1995-12#1)(1996-11#2)
summary judgment##4##2##(1993-7#2)(1995-12#1)(1996-12#1)
summary measure of##2##3##(2008-9#1)(2013-1#1)
summary of a##6##3##(2006-12#2)(2006-6#1)(2010-2#1)(2010-5#1)(2011-2#1)
summary of an##3##3##(1991-1#1)(2008-3#1)(2010-5#1)
summary of initial##2##3##(1994-11#1)(1996-1#1)
summary of published##2##3##(2008-9#1)(2011-2#1)
summary of recent##4##3##(1991-2#1)(2008-11#1)(2009-8#1)(2011-2#1)
summary of some of the##5##5##(1995-4#1)(2005-7#1)(2008-4#2)(2010-6#1)
summary of some##6##3##(1995-4#1)(2005-7#1)(2006-2#1)(2008-4#2)(2010-6#1)
summary of the analytical##2##4##(2008-10#1)(2010-11#1)
summary of the##51##3##(1991-3#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-6#1)(1994-1#1)(1996-8#1)(1997-3#1)(2005-10#1)(2005-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#2)(2008-7#3)(2009-10#2)(2009-12#2)(2009-4#2)(2009-8#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-5#1)(2010-6#1)(2011-2#1)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
summary of##115##2##(1990-2#1)(1991-1#2)(1991-11#1)(1991-2#1)(1991-3#2)(1992-3#2)(1992-5#1)(1992-6#1)(1993-1#1)(1993-6#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-4#1)(1995-8#1)(1996-1#2)(1996-8#1)(1997-3#1)(2004-3#1)(2005-10#1)(2005-7#3)(2006-10#1)(2006-12#3)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-3#2)(2008-4#6)(2008-5#1)(2008-7#4)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-4#2)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#2)(2010-2#3)(2010-3#1)(2010-5#4)(2010-6#2)(2011-12#1)(2011-2#5)(2011-3#1)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
summary report of the##2##4##(1997-2#1)(2008-5#1)
summary score##2##2##(1997-3#1)(2012-2#1)
summary statistic##4##2##(1994-9#3)(1997-3#1)
summary statistics##4##2##(1992-9#3)(2011-12#1)
summary suspension##2##2##(1993-12#1)(1994-2#1)
summary the##2##2##(2005-11#1)(2005-6#1)
summary##370##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-8#1)(1991-1#3)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#4)(1991-6#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#4)(1992-5#1)(1992-6#6)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#6)(1993-2#3)(1993-3#3)(1993-4#1)(1993-6#1)(1993-7#3)(1993-9#1)(1994-1#3)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#6)(1994-3#4)(1994-6#1)(1994-9#4)(1995-1#3)(1995-10#1)(1995-12#2)(1995-3#2)(1995-4#2)(1995-8#3)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#2)(1996-12#4)(1996-3#4)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#3)(1997-2#4)(1997-3#4)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#1)(2004-3#1)(2005-10#2)(2005-11#1)(2005-6#1)(2005-7#8)(2005-8#2)(2006-10#9)(2006-12#4)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#3)(2007-10#1)(2007-11#6)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#3)(2007-6#1)(2007-7#3)(2007-8#7)(2008-1#1)(2008-10#10)(2008-11#12)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#6)(2008-5#5)(2008-6#1)(2008-7#8)(2008-8#6)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#4)(2009-3#1)(2009-4#4)(2009-5#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#4)(2010-12#5)(2010-2#3)(2010-3#1)(2010-5#5)(2010-6#3)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#5)(2011-2#12)(2011-3#1)(2011-7#1)(2012-1#2)(2012-11#1)(2012-12#11)(2012-2#8)(2012-3#5)(2013-1#12)(2013-7#2)(2013-8#6)
summary-statistic based approaches##2##3##(2010-6#2)
summary-statistic based##3##2##(2010-6#3)
summation method##4##2##(2006-10#1)(2010-2#1)(2013-1#2)
summation of multiple##2##3##(2008-2#1)(2011-1#1)
summation of the##4##3##(1990-5#1)(2007-11#3)
summation of##15##2##(1990-5#1)(1995-12#1)(2007-11#3)(2008-10#3)(2008-2#1)(2009-8#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#2)
summation operatorDDT##2##2##(2008-10#2)
summation operatorHCH##2##2##(2008-10#2)
summation over##2##2##(2008-2#1)(2008-3#1)
summation technique##2##2##(1992-6#1)(2008-2#1)
summation##52##1##(1990-11#1)(1990-5#1)(1991-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-12#1)(1995-12#1)(1995-2#1)(1996-11#1)(2006-10#1)(2006-4#1)(2007-11#3)(2007-6#1)(2008-10#7)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#6)(2009-8#1)(2010-2#2)(2010-9#1)(2011-1#5)(2012-2#2)(2013-1#4)
summations##3##1##(1994-3#1)(2008-2#1)(2008-3#1)
summative assessment##2##2##(1996-11#1)(2012-2#1)
summative##7##1##(1993-12#1)(1996-11#1)(2006-12#1)(2008-11#1)(2012-2#1)(2013-1#2)
summed feature##2##2##(2012-2#2)
summed mortality##4##2##(2005-12#4)
summed to##3##2##(2008-3#1)(2011-1#1)(2012-3#1)
summed up##4##2##(1996-12#1)(1997-6#1)(2008-3#1)(2013-7#1)
summed##25##1##(1990-7#1)(1991-12#1)(1993-9#1)(1994-8#1)(1996-12#1)(1996-5#1)(1997-6#1)(2005-12#4)(2006-11#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2011-1#1)(2012-2#4)(2012-3#1)(2013-7#1)
summer (July and August)##2##4##(2008-10#1)(2011-2#1)
summer 2007##2##2##(2010-12#1)(2011-2#1)
summer and autumn##6##3##(1993-9#1)(2005-7#1)(2008-10#2)(2008-5#1)(2011-2#1)
summer and fall##3##3##(2004-11#1)(2007-12#1)(2008-10#1)
summer and spring##2##3##(2008-11#1)(2008-5#1)
summer and winter##6##3##(1994-12#1)(2008-12#1)(2008-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
summer and##28##2##(1993-9#1)(1994-12#1)(1995-1#1)(2004-11#2)(2004-4#1)(2005-7#1)(2007-10#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#5)(2009-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
summer epidemic progress of apple scab##2##6##(2008-10#2)
summer in the##2##3##(2008-5#2)
summer in##5##2##(1993-6#1)(2006-8#1)(2008-5#2)(2011-2#1)
summer light##3##2##(2006-12#2)(2008-8#1)
summer meeting of the British##2##5##(2005-8#1)(2008-3#1)
summer microcosms##2##2##(2011-1#2)
summer months##12##2##(1996-3#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
summer of##27##2##(1990-9#1)(1991-1#1)(1994-3#1)(1995-11#1)(1997-1#1)(2006-10#1)(2007-1#3)(2007-10#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-8#1)(2010-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
summer or##2##2##(2006-12#1)(2008-10#1)
summer season##6##2##(2008-1#1)(2008-5#1)(2011-12#1)(2012-2#1)(2012-3#2)
summer survival##2##2##(2008-10#2)
summer temperatures##2##2##(2008-10#1)(2008-7#1)
summer to##2##2##(2008-10#1)(2008-8#1)
summer vacation##2##2##(1991-2#1)(2008-9#1)
summer##203##1##(1990-11#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#2)(1995-11#2)(1995-3#1)(1995-9#1)(1996-1#3)(1996-3#1)(1997-1#1)(1997-3#1)(2004-11#3)(2004-4#2)(2005-7#1)(2005-8#1)(2006-10#4)(2006-12#6)(2006-2#1)(2006-5#1)(2006-6#2)(2006-8#2)(2007-1#5)(2007-10#3)(2007-12#2)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#34)(2008-11#4)(2008-12#3)(2008-2#4)(2008-3#4)(2008-5#19)(2008-7#5)(2008-8#5)(2008-9#3)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2011-1#4)(2011-12#5)(2011-2#9)(2012-2#10)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#9)
summer)##5##1##(2008-10#1)(2008-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
summer/autumn##2##1##(1992-12#2)
summers in##2##2##(2007-10#1)(2009-12#1)
summers##6##1##(2004-11#1)(2007-10#1)(2008-11#1)(2008-8#1)(2009-12#1)(2009-3#1)
summertime##2##1##(2008-10#1)(2010-7#1)
summing these##2##2##(1993-9#1)(2008-10#1)
summing##13##1##(1991-8#1)(1993-9#1)(1995-11#1)(2006-10#2)(2006-5#1)(2008-10#3)(2008-3#1)(2008-8#1)(2010-9#1)(2011-2#1)
summit on##2##2##(2010-5#1)(2011-2#1)
summit##10##1##(1991-9#1)(2005-8#1)(2005-9#2)(2007-8#1)(2008-11#1)(2010-3#1)(2010-5#1)(2011-2#1)(2013-1#1)
summit-to-sea maps##2##2##(2007-5#2)
sumoylated##2##1##(2008-4#2)
sumoylation##6##1##(2008-4#5)(2012-12#1)
sump##2##1##(1991-3#1)(1996-6#1)
sums assured##2##2##(1997-8#2)
sums for##2##2##(2007-12#1)(2008-2#1)
sums of the##2##3##(2006-9#1)(2008-6#1)
sums of##6##2##(1994-5#1)(1997-3#1)(2004-4#1)(2004-7#1)(2006-9#1)(2008-6#1)
sums up the##3##3##(1990-8#1)(1995-3#1)(1996-11#1)
sums##20##1##(1990-8#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-1#1)(1996-11#1)(1997-3#1)(1997-8#2)(2004-4#1)(2004-7#1)(2006-9#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-6#1)(2009-12#1)(2009-4#1)(2012-3#1)
sun and shade##3##3##(2007-3#3)
sun and##11##2##(1991-6#1)(1994-3#2)(2007-3#5)(2007-9#1)(2008-2#1)(2008-3#1)
sun care##4##2##(2008-5#4)
sun damage##4##2##(2011-2#3)(2012-12#1)
sun dried##2##2##(2008-10#2)
sun exposed areas##2##3##(2007-8#1)(2013-1#1)
sun exposed##3##2##(2007-11#1)(2007-8#1)(2013-1#1)
sun exposure and##3##3##(2008-5#2)(2011-2#1)
sun exposure##29##2##(1995-4#2)(1995-9#1)(2006-12#1)(2007-1#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#10)(2010-12#1)(2010-8#1)(2011-2#8)(2012-12#1)
sun glint contamination##3##3##(2008-3#3)
sun glint correction##3##3##(2008-3#3)
sun glint##11##2##(2008-3#11)
sun or##2##2##(2007-12#1)(2007-3#1)
sun parlour##2##2##(2008-5#2)
sun protection factor (SPF)##4##4##(2008-5#3)(2012-12#1)
sun protection factor##8##3##(1991-6#1)(2008-5#6)(2012-12#1)
sun protection factors (SPF) of##2##5##(2008-5#2)
sun protection factors (SPF)##3##4##(2008-5#3)
sun protection factors##7##3##(2008-5#7)
sun protection##21##2##(1991-6#1)(2008-4#1)(2008-5#13)(2010-9#3)(2011-2#2)(2012-12#1)
sun radiation##6##2##(2011-2#6)
sun reactive skin type##2##4##(2008-5#2)
sun reactive skin##3##3##(1991-6#1)(2008-5#2)
sun valley forum##2##3##(2008-8#2)
sun with##2##2##(1996-5#1)(2011-2#1)
sun##156##1##(1991-6#10)(1992-1#1)(1992-7#1)(1993-3#2)(1994-3#2)(1994-6#1)(1995-4#2)(1995-9#1)(1996-11#1)(1996-5#9)(1996-7#1)(2006-12#1)(2007-1#2)(2007-11#2)(2007-12#1)(2007-2#4)(2007-3#10)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#5)(2008-12#1)(2008-2#4)(2008-3#13)(2008-4#1)(2008-5#36)(2008-8#2)(2010-12#1)(2010-7#1)(2010-8#1)(2010-9#4)(2011-2#26)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#1)
sun's##8##1##(1991-8#1)(1996-5#5)(2007-9#1)(2009-8#1)
sun-exposed areas of the##3##4##(2010-6#1)(2010-8#1)(2011-2#1)
sun-exposed areas##8##2##(2005-11#1)(2007-11#1)(2010-6#2)(2010-8#1)(2011-2#2)(2012-12#1)
sun-exposed skin in the summer##2##5##(2008-5#2)
sun-exposed skin##5##2##(2008-5#2)(2008-8#1)(2011-2#2)
sun-exposed##14##1##(2005-11#1)(2007-11#2)(2008-5#2)(2008-8#1)(2010-6#2)(2010-8#1)(2011-2#4)(2012-12#1)
sun-protected##2##1##(2008-5#1)(2013-1#1)
sunY##2##1##(1991-3#2)
sunbathing##3##1##(2006-12#1)(2007-12#1)(2008-5#1)
sunburn and##2##2##(2007-1#1)(2007-7#1)
sunburn injury##2##2##(2007-1#2)
sunburn##21##1##(1991-6#1)(1992-6#1)(1993-5#1)(1996-6#1)(2005-7#1)(2006-12#1)(2007-1#6)(2007-7#1)(2008-4#1)(2008-5#7)
sunburns##5##1##(2005-11#1)(2011-2#4)
suncare products##2##2##(2008-10#2)
suncare##4##1##(2008-10#3)(2008-5#1)
sunfish##2##1##(2008-10#1)(2008-8#1)
sunflower (Helianthus annuus L##3##4##(1994-12#1)(2006-12#1)(2008-10#1)
sunflower (Helianthus annuus)##2##3##(2008-10#2)
sunflower (Helianthus##5##2##(1994-12#1)(2006-12#1)(2008-10#3)
sunflower and##2##2##(2008-10#2)
sunflower oil (SFO)##2##3##(2010-4#1)(2013-1#1)
sunflower oil##10##2##(1996-11#1)(2004-11#1)(2008-10#2)(2008-2#1)(2010-4#3)(2013-1#2)
sunflower seed albumin##2##3##(2006-12#2)
sunflower seed oil##5##3##(1991-2#4)(2008-5#1)
sunflower seed##8##2##(1991-2#4)(2005-11#1)(2006-12#2)(2008-5#1)
sunflower seeds##2##2##(2005-11#1)(2008-10#1)
sunflower species##4##2##(2008-8#1)(2011-12#3)
sunflower stem##6##2##(2008-10#4)(2009-6#1)(2011-12#1)
sunflower##76##1##(1991-2#4)(1991-5#3)(1992-3#1)(1994-12#3)(1996-11#1)(2004-11#1)(2005-11#2)(2006-12#4)(2008-10#29)(2008-2#6)(2008-5#3)(2008-8#1)(2009-6#1)(2010-4#3)(2011-12#10)(2011-2#2)(2013-1#2)
sunflower)##2##1##(1997-8#1)(2008-11#1)
sunflowers (Helianthus##3##2##(2008-10#1)(2008-8#2)
sunflowers##8##1##(2006-12#1)(2008-10#1)(2008-2#1)(2008-8#3)(2011-12#2)
sunitinib treatment##2##2##(2008-6#1)(2013-1#1)
sunitinib##18##1##(2008-6#7)(2009-11#4)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#4)
sunken##3##1##(2008-10#3)
sunken-level&quot##3##1##(2007-4#3)
sunless tanners##3##2##(2008-5#3)
sunlight and the##2##3##(2008-2#1)(2008-5#1)
sunlight and##8##2##(2007-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#2)(2012-1#1)
sunlight during##2##2##(1994-1#1)(2006-12#1)
sunlight exposure##3##2##(2007-8#1)(2011-12#1)(2013-8#1)
sunlight for##2##2##(2007-7#1)(2008-6#1)
sunlight in##3##2##(2006-12#1)(2008-10#1)(2011-2#1)
sunlight intensity was##2##3##(2008-6#2)
sunlight intensity##8##2##(2008-6#7)(2008-8#1)
sunlight or##2##2##(2006-3#1)(2008-5#1)
sunlight##78##1##(1991-5#1)(1991-9#1)(1994-1#1)(1994-3#3)(1997-1#1)(2005-12#1)(2006-12#3)(2006-3#2)(2007-11#1)(2007-7#3)(2007-8#2)(2008-10#8)(2008-11#3)(2008-2#3)(2008-3#4)(2008-5#10)(2008-6#8)(2008-8#4)(2011-12#2)(2011-2#14)(2012-1#1)(2012-12#1)(2013-8#1)
sunlight-induced##3##1##(1994-6#1)(2006-12#1)(2008-11#1)
sunlit##3##1##(2008-2#3)
sunn hemp pollen##2##3##(2008-6#2)
sunn hemp##4##2##(2008-6#4)
sunny side##5##2##(2004-11#5)
sunny##22##1##(1993-3#1)(1997-6#1)(2004-11#6)(2006-12#2)(2007-3#2)(2008-1#1)(2008-10#5)(2008-11#1)(2012-1#1)(2012-3#1)(2013-8#1)
sunphotometer and##2##2##(2008-3#2)
sunphotometer measurements##2##2##(2008-3#2)
sunphotometer##9##1##(2008-2#4)(2008-3#5)
sunrise and##2##2##(2008-10#2)
sunrise##6##1##(2008-10#6)
sunscreen agent##2##2##(2008-3#1)(2008-5#1)
sunscreen agents in##4##3##(1996-6#2)(2008-10#2)
sunscreen agents##6##2##(1996-6#3)(2008-10#2)(2008-5#1)
sunscreen and##3##2##(2006-10#1)(2008-5#2)
sunscreen application##2##2##(2008-5#2)
sunscreen chemicals##2##2##(2008-3#2)
sunscreen derived from Chinese herbs##2##5##(2008-5#2)
sunscreen derived from natural Chinese herbs##2##6##(2008-5#2)
sunscreen derived from##4##3##(2008-5#4)
sunscreen film##3##2##(2008-5#1)(2012-12#2)
sunscreen films##7##2##(2008-5#6)(2012-12#1)
sunscreen formulation##4##2##(2008-5#3)(2012-12#1)
sunscreen formulations##9##2##(2008-5#7)(2012-12#2)
sunscreen from##2##2##(2008-5#2)
sunscreen lotions containing##3##3##(2008-10#1)(2008-5#2)
sunscreen lotions with##2##3##(2008-5#2)
sunscreen lotions##7##2##(2008-10#1)(2008-5#6)
sunscreen preparations##3##2##(2006-12#1)(2008-5#2)
sunscreen products in the##2##4##(2008-5#2)
sunscreen products in##3##3##(2008-5#3)
sunscreen products##14##2##(2008-10#1)(2008-3#1)(2008-5#12)
sunscreen system##2##2##(2008-5#2)
sunscreen to##2##2##(2008-5#1)(2008-7#1)
sunscreen use##4##2##(2007-1#1)(2008-4#1)(2010-8#1)(2012-2#1)
sunscreen##112##1##(1996-6#3)(2006-10#1)(2006-12#2)(2007-1#2)(2008-10#6)(2008-3#4)(2008-4#1)(2008-5#81)(2008-7#2)(2008-8#1)(2010-8#1)(2012-12#7)(2012-2#1)
sunscreening agents##3##2##(1996-6#1)(2008-5#2)
sunscreening##5##1##(1991-6#1)(1996-6#1)(2008-5#3)
sunscreens are##2##2##(2008-5#2)
sunscreens in##4##2##(2008-5#4)
sunscreens is##3##2##(2008-5#3)
sunscreens should be##2##3##(2008-5#2)
sunscreens were##2##2##(2008-5#2)
sunscreens with##2##2##(1991-6#1)(2012-12#1)
sunscreens##45##1##(1991-6#3)(2006-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#36)(2012-12#2)
sunset to##2##2##(2008-10#2)
sunset yellow FCF##2##3##(2008-10#2)
sunset yellow##5##2##(2008-10#5)
sunset##13##1##(2005-8#1)(2008-10#7)(2008-2#4)(2011-2#1)
sunshine##9##1##(1993-3#4)(2006-12#1)(2008-10#1)(2008-5#1)(2012-1#1)(2013-8#1)
sup2+##2##1##(1996-3#2)
sup5##4##1##(1996-6#4)
supF##4##1##(1991-9#4)
super dentin##2##2##(2013-7#2)
super disintegrants##2##2##(2010-3#1)(2012-2#1)
super family of##2##3##(2009-10#1)(2012-2#1)
super family##10##2##(1996-12#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-12#1)(2011-12#1)(2012-2#2)(2013-8#2)
super high##2##2##(2008-3#1)(2008-9#1)
super high-yielding##2##2##(2008-9#2)
super modified simplex##3##3##(2008-10#3)
super oxide dismutase##2##3##(1996-5#1)(2009-6#1)
super oxide##3##2##(1996-5#1)(2009-6#1)(2010-8#1)
super splines##2##2##(2008-6#2)
super##43##1##(1990-9#1)(1991-12#1)(1992-10#1)(1992-3#1)(1996-12#1)(1996-5#1)(2004-8#1)(2006-3#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#5)(2013-7#2)(2013-8#2)
super&quot##2##1##(1991-12#2)
super-Gaussian and square-shaped beams##2##4##(2007-12#2)
super-Gaussian beam##2##2##(2007-11#2)
super-Gaussian intensity##3##2##(2008-3#3)
super-Gaussian##14##1##(2007-11#2)(2007-12#4)(2008-2#3)(2008-3#5)
super-active octamer##2##2##(2011-1#2)
super-complex##2##1##(2011-1#1)(2013-1#1)
super-family##5##1##(1991-5#1)(1997-6#1)(2005-10#1)(2006-6#1)(2008-11#1)
super-imposition##2##1##(1995-6#1)(2008-7#1)
super-ordinate themes##2##2##(2013-1#2)
super-resolution##2##1##(2008-2#1)(2012-2#1)
super-specialization##2##1##(2006-10#1)(2006-9#1)
superabsorbent polymers##2##2##(2008-11#2)
superabsorbent##5##1##(2008-11#2)(2008-12#3)
superactivity##4##1##(1994-12#4)
superaggregate##2##1##(1994-8#2)
superantigen in##2##2##(1994-9#1)(2007-7#1)
superantigen is##2##2##(1994-12#1)(2007-7#1)
superantigen##20##1##(1990-11#1)(1991-10#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-8#1)(1994-9#3)(2007-11#3)(2007-7#4)(2009-9#2)(2010-9#1)
superantigens or##3##2##(2006-10#1)(2006-4#1)(2013-1#1)
superantigens##17##1##(1991-11#1)(1991-12#1)(2006-10#4)(2006-4#1)(2007-7#3)(2008-4#2)(2009-9#3)(2011-2#1)(2013-1#1)
superb performance##2##2##(2008-10#1)(2008-2#1)
superb##5##1##(2008-10#1)(2008-2#1)(2008-4#1)(2010-5#1)(2010-6#1)
superbugs##4##1##(2006-10#2)(2012-12#2)
supercapacitors##6##1##(2006-12#3)(2010-11#1)(2010-4#2)
superceded##2##1##(2008-10#1)(2010-3#1)
superchannel##2##1##(2011-2#2)
superchirped moiré grating##2##3##(2007-12#2)
supercoil of##2##2##(1992-12#2)
supercoil release##2##2##(1997-4#2)
supercoil##9##1##(1992-12#4)(1997-4#4)(2005-11#1)
supercoil-dependent##2##1##(1992-2#2)
supercoiled DNA was##2##3##(1994-5#1)(1996-2#1)
supercoiled DNA##12##2##(1992-11#1)(1994-5#3)(1995-3#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-7#1)(1997-7#1)(2006-12#1)(2008-9#1)
supercoiled DNA-modified mercury##2##3##(2008-10#2)
supercoiled and##2##2##(1993-8#1)(2008-9#1)
supercoiled double-stranded DNA##2##3##(1994-5#2)
supercoiled plasmid DNA##2##3##(1994-9#1)(1997-4#1)
supercoiled plasmid##5##2##(1992-11#1)(1993-3#1)(1994-9#1)(1997-4#1)(2008-4#1)
supercoiled topoisomers##3##2##(1990-11#3)
supercoiled##33##1##(1990-11#3)(1992-11#2)(1992-5#1)(1993-3#1)(1993-8#1)(1994-5#5)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-7#1)(1997-4#3)(1997-5#1)(1997-7#1)(2006-12#1)(2008-10#3)(2008-4#1)(2008-9#2)(2013-1#1)
supercoiling factor##3##2##(1995-6#3)
supercoiling in##3##2##(1995-2#1)(1995-8#1)(1997-5#1)
supercoiling##19##1##(1992-12#1)(1994-5#1)(1994-9#1)(1995-2#3)(1995-6#4)(1995-8#4)(1997-5#3)(2008-8#1)(2008-9#1)
supercoils into##2##2##(1995-6#1)(1996-2#1)
supercoils##9##1##(1995-6#1)(1996-2#1)(1996-8#1)(1997-4#3)(2005-11#1)(2008-9#2)
supercomputer##2##1##(1993-11#1)(2006-6#1)
supercomputers##3##1##(2007-9#1)(2008-3#1)(2009-11#1)
superconducting leads##2##2##(2008-2#1)(2008-7#1)
superconducting properties##2##2##(1991-3#1)(2005-4#1)
superconducting quantum interference device##3##4##(2008-2#1)(2008-7#2)
superconducting thin films##2##3##(2007-12#2)
superconducting##47##1##(1990-12#1)(1990-4#1)(1990-7#1)(1990-9#1)(1991-3#1)(1991-6#1)(1992-5#2)(1992-6#1)(1992-8#3)(1992-9#2)(1995-11#3)(1995-5#1)(2005-4#1)(2006-5#1)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#4)(2008-7#9)(2010-7#1)(2012-2#4)(2012-3#1)(2013-8#1)
superconductive edge-transition##2##2##(2008-3#2)
superconductivity in##5##2##(1992-12#1)(1993-5#1)(2006-7#1)(2008-7#1)(2012-2#1)
superconductivity##12##1##(1991-3#1)(1991-6#1)(1992-12#1)(1993-5#1)(2006-7#3)(2008-7#2)(2012-2#3)
superconductor##4##1##(1990-12#1)(1993-3#1)(2012-2#2)
superconductors were##2##2##(2005-4#2)
superconductors##30##1##(1990-2#1)(1990-4#2)(1992-12#1)(1992-3#2)(1992-8#3)(1992-9#1)(1993-5#1)(1993-8#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-5#2)(2005-4#2)(2006-7#4)(2008-10#4)(2008-7#1)(2012-2#1)
supercontinuum generation in photonic crystal##2##5##(2007-11#1)(2007-12#1)
supercontinuum generation in##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
supercontinuum generation##6##2##(2007-11#2)(2007-12#3)(2008-3#1)
supercontinuum##23##1##(2007-11#9)(2007-12#13)(2008-3#1)
supercooled##4##1##(1994-10#1)(1995-3#1)(2008-2#2)
supercritical CO(2)##16##2##(2008-10#16)
supercritical and##2##2##(2008-10#1)(2008-2#1)
supercritical carbon dioxide (SC-CO(2))##2##4##(2008-10#1)(2010-4#1)
supercritical carbon dioxide and##2##4##(1990-8#1)(2007-11#1)
supercritical carbon dioxide has been##2##5##(2008-10#2)
supercritical carbon dioxide##28##3##(1990-8#2)(2007-1#2)(2007-11#1)(2008-10#16)(2008-3#4)(2008-7#1)(2010-4#2)
supercritical fluid CO(2)##2##3##(2008-10#2)
supercritical fluid and##2##3##(2008-10#2)
supercritical fluid chromatography (SFC)##4##4##(1996-11#1)(2008-10#3)
supercritical fluid chromatography to##2##4##(1996-11#1)(2008-10#1)
supercritical fluid chromatography##14##3##(1990-8#1)(1990-9#2)(1996-11#2)(2008-10#9)
supercritical fluid extraction (SFE) has##2##5##(2008-10#2)
supercritical fluid extraction (SFE)##11##4##(2008-10#10)(2011-12#1)
supercritical fluid extraction of##3##4##(2008-10#2)(2012-3#1)
supercritical fluid extraction##19##3##(2008-10#16)(2008-11#1)(2011-12#1)(2012-3#1)
supercritical fluid extractor##2##3##(2008-10#2)
supercritical fluid##48##2##(1990-8#1)(1990-9#2)(1996-11#2)(2007-8#1)(2008-10#38)(2008-11#1)(2011-12#1)(2012-2#1)(2012-3#1)
supercritical fluids and their##2##4##(2012-2#2)
supercritical fluids##5##2##(2008-10#2)(2012-2#3)
supercritical##105##1##(1990-8#3)(1990-9#2)(1996-11#2)(2005-11#1)(2007-1#2)(2007-11#1)(2007-8#1)(2008-10#74)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#1)(2009-6#1)(2010-10#1)(2010-4#2)(2011-12#1)(2012-2#5)(2012-3#1)(2013-1#1)
supercurrent##4##1##(2008-7#1)(2012-2#3)
superelastic properties##2##2##(2010-10#2)
superelastic##5##1##(2006-6#2)(2009-9#1)(2010-10#2)
superfamilies##5##1##(2006-10#2)(2008-7#1)(2009-5#1)(2011-1#1)
superfamily and is##2##3##(1995-6#1)(2011-2#1)
superfamily and##5##2##(1994-3#1)(1995-6#1)(2008-5#1)(2010-12#1)(2011-2#1)
superfamily is##3##2##(1992-8#1)(1996-5#1)(2008-7#1)
superfamily members##4##2##(1994-12#1)(1996-10#1)(1996-5#1)(2008-4#1)
superfamily of nuclear##3##3##(1994-12#1)(1995-3#1)(2008-1#1)
superfamily of proteins##9##3##(1991-5#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-8#1)(2009-5#1)(2013-8#1)
superfamily of seven##2##3##(1993-12#1)(1995-11#1)
superfamily of small GTP-binding proteins##3##5##(1993-6#1)(1994-6#1)(2008-6#1)
superfamily of small##4##3##(1993-6#1)(1994-6#1)(1994-9#1)(2008-6#1)
superfamily of transporters##2##3##(1994-9#1)(2008-11#1)
superfamily of##49##2##(1991-11#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-4#1)(1993-12#2)(1993-4#1)(1993-6#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-6#2)(1994-9#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-4#1)(1997-7#1)(2005-7#1)(2006-2#1)(2008-1#1)(2008-11#4)(2008-4#2)(2008-6#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
superfamily or fold##3##3##(2008-7#3)
superfamily search##2##2##(2013-1#2)
superfamily were##2##2##(1997-6#1)(2011-1#1)
superfamily with##2##2##(1994-3#2)
superfamily##186##1##(1990-6#1)(1990-7#1)(1991-11#4)(1991-2#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-4#4)(1992-5#3)(1992-8#1)(1993-12#3)(1993-3#2)(1993-4#1)(1993-6#2)(1993-9#1)(1994-11#3)(1994-12#9)(1994-3#5)(1994-5#2)(1994-6#3)(1994-8#2)(1994-9#4)(1995-1#1)(1995-11#4)(1995-12#2)(1995-2#9)(1995-3#3)(1995-5#4)(1995-6#3)(1995-8#4)(1996-10#3)(1996-11#1)(1996-2#2)(1996-5#5)(1996-8#4)(1996-9#1)(1997-1#2)(1997-4#1)(1997-6#1)(1997-7#5)(2005-7#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-8#1)(2007-12#3)(2007-8#1)(2008-1#3)(2008-11#7)(2008-3#1)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#6)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#4)(2010-12#2)(2010-5#1)(2011-1#4)(2011-2#1)(2012-12#1)(2013-1#5)(2013-8#3)
superficial LMS##5##2##(2008-6#5)
superficial and deep cortical layers and##2##6##(1993-12#1)(1995-10#1)
superficial and deep laminae##2##4##(1993-12#1)(1995-3#1)
superficial and deep layers of##2##5##(1990-2#1)(1991-9#1)
superficial and deep layers##3##4##(1990-2#2)(1991-9#1)
superficial and deep##15##3##(1990-2#2)(1991-9#1)(1993-12#2)(1995-10#1)(1995-3#1)(1996-10#1)(2005-11#2)(2007-10#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-12#1)
superficial and##25##2##(1990-2#2)(1991-10#3)(1991-9#1)(1993-12#2)(1995-10#1)(1995-3#1)(1996-10#1)(2005-11#2)(2007-10#1)(2007-7#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
superficial angiomyxoma with##2##3##(2008-9#2)
superficial antral gastritis##2##3##(1991-4#1)(1997-1#1)
superficial bladder cancer##4##3##(1993-11#1)(2007-10#1)(2007-2#1)(2008-11#1)
superficial bladder carcinoma##2##3##(1993-9#2)
superficial bladder tumours##3##3##(1991-6#3)
superficial bladder##11##2##(1991-6#3)(1993-11#1)(1993-9#3)(2007-10#1)(2007-2#1)(2008-1#1)(2008-11#1)
superficial brachial##2##2##(2008-7#2)
superficial carcinomas##2##2##(2008-5#1)(2012-2#1)
superficial categorical##2##2##(2008-11#2)
superficial cells##3##2##(1996-3#2)(2008-11#1)
superficial cervical plexus##2##3##(2010-7#1)(2012-3#1)
superficial chronic gastritis##2##3##(2008-5#2)
superficial chronic##3##2##(2008-5#3)
superficial corneocytes##2##2##(2008-5#2)
superficial cortical##2##2##(1991-9#1)(2005-8#1)
superficial dorsal horn##5##3##(1990-7#1)(1991-5#1)(1991-9#1)(1994-2#1)(1996-5#1)
superficial dyspareunia##2##2##(2004-10#2)
superficial esophageal##3##2##(2008-5#2)(2010-12#1)
superficial fascia##2##2##(2009-9#2)
superficial fat##2##2##(2010-11#2)
superficial femoral arteries with##2##4##(1990-10#1)(2007-8#1)
superficial femoral artery##4##3##(2007-8#2)(2011-2#2)
superficial femoral vein##5##3##(2007-7#1)(2008-1#2)(2011-3#2)
superficial femoral##13##2##(1990-10#1)(2007-7#1)(2007-8#3)(2008-1#2)(2010-11#1)(2011-2#3)(2011-3#2)
superficial fungal infections##2##3##(2007-7#2)
superficial fungal##3##2##(2007-7#3)
superficial gastritis##3##2##(1991-4#2)(1997-8#1)
superficial involvement of the PU##3##5##(2007-7#3)
superficial laminae##3##2##(1993-12#3)
superficial layer of##3##3##(1994-10#1)(2008-3#1)(2009-2#1)
superficial layer##8##2##(1994-10#2)(1996-12#1)(2008-2#3)(2008-3#1)(2009-2#1)
superficial layers of the stratum corneum##2##6##(2008-5#2)
superficial layers of the##6##4##(1992-2#1)(1996-1#1)(1997-2#1)(2008-5#3)
superficial layers of##8##3##(1992-2#2)(1996-1#1)(1997-2#1)(2008-11#1)(2008-5#3)
superficial layers##20##2##(1990-2#1)(1990-4#1)(1992-2#2)(1993-12#2)(1996-1#1)(1997-2#2)(2008-11#2)(2008-2#1)(2008-5#6)(2011-1#1)(2013-1#1)
superficial lesions and##3##3##(2008-7#1)(2008-9#2)
superficial lesions were##2##3##(1990-9#1)(1993-8#1)
superficial lesions##8##2##(1990-9#1)(1993-8#1)(2007-9#1)(2008-3#1)(2008-7#1)(2008-9#2)(2011-1#1)
superficial mycoses##3##2##(2008-5#2)(2011-2#1)
superficial mycosis##4##2##(2008-5#2)(2011-2#2)
superficial or##2##2##(2007-10#1)(2009-2#1)
superficial porokeratosis##5##2##(2007-7#3)(2010-6#2)
superficial scarring##2##2##(2007-7#2)
superficial siderosis##2##2##(2008-7#2)
superficial skin##3##2##(1992-2#1)(2012-3#1)(2013-8#1)
superficial small##2##2##(1990-6#1)(2007-10#1)
superficial soft##2##2##(1993-10#1)(2007-4#1)
superficial structures##2##2##(2008-5#1)(2011-2#1)
superficial temporal artery to##2##4##(2006-11#1)(2007-9#1)
superficial temporal artery##3##3##(2006-11#1)(2007-9#1)(2011-12#1)
superficial temporal artery-middle cerebral artery anastomosis##2##6##(2006-11#1)(2012-12#1)
superficial temporal artery-middle cerebral artery##3##5##(2006-11#1)(2008-12#1)(2012-12#1)
superficial temporal##10##2##(2006-11#3)(2007-9#1)(2008-12#2)(2011-12#2)(2012-12#1)(2012-3#1)
superficial tissue##2##2##(2006-9#1)(2008-3#1)
superficial tissues##2##2##(2008-6#1)(2010-11#1)
superficial to the##4##3##(2007-4#1)(2010-11#1)(2010-12#1)(2013-8#1)
superficial to##5##2##(2007-4#1)(2008-9#1)(2010-11#1)(2010-12#1)(2013-8#1)
superficial trunk##4##2##(1993-9#1)(2008-6#3)
superficial type##2##2##(1993-4#1)(2008-5#1)
superficial urothelial##3##2##(2007-7#1)(2011-2#2)
superficial vein##3##2##(1990-10#1)(2013-8#2)
superficial veins##2##2##(2008-9#1)(2013-8#1)
superficial velocity##2##2##(2008-6#2)
superficial venous##2##2##(2005-10#1)(2011-3#1)
superficial wound infection##2##3##(1994-2#1)(2006-8#1)
superficial wound##3##2##(1994-2#1)(2006-8#1)(2012-2#1)
superficial zone decreased from##2##4##(1991-10#2)
superficial zone decreased##3##3##(1991-10#3)
superficial zone##5##2##(1991-10#3)(2007-11#2)
superficial##325##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-10#8)(1991-11#2)(1991-3#1)(1991-4#3)(1991-5#1)(1991-6#3)(1991-9#3)(1992-2#3)(1992-6#1)(1992-8#2)(1993-10#2)(1993-11#1)(1993-12#7)(1993-4#1)(1993-8#1)(1993-9#4)(1994-10#3)(1994-2#2)(1995-10#1)(1995-3#1)(1996-1#1)(1996-10#2)(1996-12#1)(1996-3#3)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#1)(2004-10#2)(2004-2#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#3)(2006-12#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#4)(2006-9#1)(2007-10#5)(2007-11#5)(2007-2#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#21)(2007-8#4)(2007-9#3)(2008-1#5)(2008-10#4)(2008-11#6)(2008-12#4)(2008-2#5)(2008-3#6)(2008-5#38)(2008-6#16)(2008-7#7)(2008-9#11)(2009-2#3)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-11#8)(2010-12#5)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#6)(2011-12#2)(2011-2#15)(2011-3#4)(2012-12#4)(2012-2#4)(2012-3#6)(2013-1#1)(2013-8#6)
superficially similar##2##2##(1996-12#1)(2008-9#1)
superficially##10##1##(1996-12#1)(1996-2#1)(2004-9#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-9#1)(2010-12#1)(2012-2#1)
superfine##2##1##(1991-12#1)(2007-11#1)
superfluid helium##3##2##(1993-8#1)(1994-10#1)(2008-7#1)
superfluid##7##1##(1992-6#1)(1993-8#1)(1994-10#1)(1995-10#2)(1995-7#1)(2008-7#1)
superfluids##2##1##(2008-3#1)(2008-7#1)
superfluorescent source##2##2##(2007-12#2)
superfluorescent##5##1##(2007-12#2)(2008-2#2)(2008-3#1)
superfluous##5##1##(1991-6#1)(1993-5#1)(1996-9#1)(2007-12#1)(2008-9#1)
superfolder##2##1##(2010-2#2)
superfusate##4##1##(1990-3#1)(1992-7#1)(1995-12#1)(1997-5#1)
superfused carp retina##2##3##(2008-8#1)(2008-9#1)
superfused isolated##2##2##(1992-8#1)(1994-3#1)
superfused rat##2##2##(1992-8#1)(1995-12#1)
superfused##11##1##(1991-1#1)(1992-7#1)(1992-8#2)(1994-3#1)(1995-12#1)(1995-7#1)(1995-8#1)(2008-7#1)(2008-8#1)(2008-9#1)
superfusion of##3##2##(1993-11#1)(1995-1#1)(1995-12#1)
superfusion system##2##2##(1991-4#1)(2010-2#1)
superfusion with##4##2##(1992-8#1)(1995-11#1)(1995-12#2)
superfusion##15##1##(1990-2#1)(1991-4#1)(1992-1#1)(1992-8#1)(1993-11#1)(1994-10#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#3)(1997-5#1)(2008-11#1)(2010-2#1)
supergene family##2##2##(1990-2#2)
superheated hexane extraction##2##3##(2008-10#2)
superheated hexane##3##2##(2008-10#3)
superheated liquid is##2##3##(2008-2#2)
superheated liquid##5##2##(2008-2#5)
superheated water extraction and##2##4##(2008-10#2)
superheated water extraction##5##3##(2008-10#5)
superheated water##8##2##(2008-10#8)
superheated##18##1##(2008-10#12)(2008-2#6)
superhelical density##2##2##(1990-4#1)(1992-11#1)
superhelical stress##2##2##(1997-3#2)
superhelical##5##1##(1990-4#1)(1992-11#1)(1995-6#1)(1997-3#2)
superhelicity in##3##2##(1994-6#3)
superhelicity##6##1##(1992-11#2)(1994-6#4)
superheterodyne##3##1##(1995-2#1)(2008-2#2)
superhigh##2##1##(2005-4#1)(2007-11#1)
superhigh-reflectivity##2##1##(2007-12#2)
superhigh-yield rice##3##2##(2008-9#3)
superhydrophobic##5##1##(2008-7#1)(2011-1#3)(2013-8#1)
superhydrophobicity##2##1##(2008-7#1)(2010-4#1)
superimposable##7##1##(1990-6#1)(1991-10#1)(1992-10#1)(1992-9#1)(1994-12#1)(1995-8#1)(2007-11#1)
superimpose on##2##2##(1992-9#1)(2008-6#1)
superimpose##4##1##(1992-9#1)(1994-3#1)(2008-2#1)(2008-6#1)
superimposed CT##2##2##(2009-5#2)
superimposed by a##2##3##(1990-4#1)(2008-3#1)
superimposed by##8##2##(1990-4#3)(1993-12#2)(2008-3#1)(2013-1#2)
superimposed chirped##2##2##(2007-12#1)(2008-3#1)
superimposed gratings with reflectivities above##2##5##(2007-11#2)
superimposed gratings##4##2##(2007-11#3)(2008-1#1)
superimposed on a##4##3##(2007-12#1)(2008-11#1)(2008-2#1)(2012-2#1)
superimposed on the##9##3##(1995-2#1)(1995-8#1)(2006-5#1)(2008-2#2)(2008-3#3)(2008-5#1)
superimposed on##23##2##(1995-11#1)(1995-2#1)(1995-8#1)(1996-5#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-12#1)(2012-2#1)
superimposed onto a##2##3##(2006-10#1)(2008-9#1)
superimposed onto##4##2##(1990-8#1)(2006-10#1)(2006-8#1)(2008-9#1)
superimposed over the##2##3##(2007-12#1)(2008-10#1)
superimposed preeclampsia##3##2##(1997-8#1)(2008-11#1)(2012-2#1)
superimposed to##2##2##(2007-12#1)(2008-4#1)
superimposed upon##4##2##(1990-7#1)(1996-1#1)(2007-12#1)(2008-12#1)
superimposed with##2##2##(2007-1#1)(2008-2#1)
superimposed##82##1##(1990-4#3)(1990-7#1)(1990-8#1)(1991-9#1)(1993-12#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#2)(1996-5#1)(1997-1#1)(1997-8#1)(2005-9#1)(2006-10#3)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#7)(2007-12#9)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#10)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#2)(2009-7#1)(2010-12#2)(2011-1#1)(2012-2#2)(2013-1#3)
superimposing a##2##2##(2008-3#1)(2012-2#1)
superimposing##4##1##(2007-11#1)(2007-12#1)(2008-3#1)(2012-2#1)
superimposition images##2##2##(1995-6#2)
superimposition method##2##2##(1995-6#1)(2007-11#1)
superimposition of##3##2##(1996-7#1)(2008-2#1)(2008-8#1)
superimposition##15##1##(1995-6#5)(1996-7#1)(2007-11#1)(2008-2#2)(2008-6#1)(2008-8#1)(2009-2#1)(2010-3#1)(2011-1#1)(2012-2#1)
superinduction of##3##2##(1991-10#1)(1992-6#1)(1992-8#1)
superinduction##5##1##(1991-10#1)(1991-2#1)(1992-6#1)(1992-8#2)
superinfected with group##2##3##(2004-11#2)
superinfected with##3##2##(2004-11#3)
superinfected##4##1##(2004-11#3)(2007-2#1)
superinfection with##3##2##(1993-8#1)(2008-8#1)(2009-4#1)
superinfection##14##1##(1991-12#1)(1991-4#2)(1991-6#1)(1993-8#1)(1997-5#1)(2007-11#1)(2008-8#2)(2009-4#2)(2009-9#1)(2010-12#1)(2013-1#1)
superinfections##6##1##(1991-2#1)(1991-4#1)(1991-5#1)(2008-8#2)(2012-2#1)
superior ability##3##2##(2008-10#2)(2008-8#1)
superior activity##3##2##(1997-1#1)(2007-11#1)(2010-12#1)
superior alleles##2##2##(2012-11#2)
superior and inferior vena cava and##2##6##(1996-3#2)
superior and inferior vena cava##4##5##(1996-3#3)(2007-7#1)
superior and inferior##15##3##(1993-7#1)(1994-6#1)(1996-3#3)(2006-8#3)(2007-7#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-5#1)(2011-2#2)
superior and##19##2##(1993-7#1)(1994-2#2)(1994-6#1)(1995-6#1)(1996-3#3)(1996-8#1)(2006-8#3)(2007-7#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-5#1)(2011-2#2)
superior antioxidant defense##2##3##(2009-5#2)
superior as##2##2##(1992-12#1)(2007-8#1)
superior at##2##2##(2008-10#1)(2008-8#1)
superior attributes##2##2##(1997-3#1)(2011-2#1)
superior axis##2##2##(2008-4#2)
superior binding affinity##3##3##(2008-10#3)
superior cerebellar artery (SCA)##2##4##(2007-10#1)(2008-7#1)
superior cerebellar artery##4##3##(2006-1#1)(2007-10#1)(2008-7#1)(2012-12#1)
superior cerebellar peduncle##5##3##(1991-8#4)(1992-11#1)
superior cerebellar##10##2##(1991-8#4)(1992-11#1)(2006-1#1)(2006-11#1)(2007-10#1)(2008-7#1)(2012-12#1)
superior cervical ganglia##5##3##(1990-8#1)(1993-5#1)(2011-12#3)
superior cervical ganglion in##2##4##(1991-3#1)(1992-1#1)
superior cervical ganglion##7##3##(1991-3#1)(1992-1#1)(1994-5#1)(1996-2#1)(1996-5#1)(2008-8#1)(2011-12#1)
superior cervical##13##2##(1990-8#1)(1991-12#1)(1991-3#1)(1992-1#1)(1993-5#1)(1994-5#1)(1996-2#1)(1996-5#1)(2008-8#1)(2011-12#4)
superior clinical##2##2##(2008-10#1)(2008-3#1)
superior colliculus (SC)##3##3##(1993-3#1)(1993-9#1)(1995-7#1)
superior colliculus and##2##3##(1991-5#1)(2008-7#1)
superior colliculus is##2##3##(1991-5#1)(2008-4#1)
superior colliculus##22##2##(1991-11#1)(1991-3#3)(1991-5#4)(1992-8#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-2#3)(1995-7#1)(2008-4#1)(2008-7#3)
superior compared to##2##3##(2007-8#1)(2008-2#1)
superior compared with##3##3##(2007-10#1)(2008-5#2)
superior compared##5##2##(2007-10#1)(2007-8#1)(2008-2#1)(2008-5#2)
superior competitor##5##2##(2008-8#4)(2010-2#1)
superior control of##2##3##(2008-10#2)
superior efficacy and tolerability of##2##5##(2012-3#2)
superior efficacy##6##2##(2005-7#1)(2007-7#1)(2008-8#1)(2011-2#1)(2012-3#2)
superior for##10##2##(1993-1#1)(1995-3#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2010-2#1)(2011-12#1)(2012-3#1)
superior frontal##3##2##(1996-12#2)(2009-1#1)
superior hypophyseal artery##2##3##(2005-5#1)(2012-3#1)
superior if##2##2##(1996-8#1)(2012-2#1)
superior iliac spine##3##3##(2006-7#1)(2006-8#2)
superior iliac##5##2##(2006-7#2)(2006-8#2)(2008-6#1)
superior image quality##2##3##(2007-12#1)(2010-8#1)
superior in its##2##3##(2008-10#1)(2012-12#1)
superior in terms of##7##4##(2008-10#2)(2008-11#1)(2009-2#1)(2010-8#1)(2011-2#1)(2012-1#1)
superior in##25##2##(1990-8#1)(1995-3#1)(2007-11#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
superior labrum##2##2##(2009-3#2)
superior levels of##2##3##(1995-5#1)(2013-1#1)
superior mediastinum##2##2##(2007-8#1)(2009-3#1)
superior mesenteric artery and##2##4##(1990-10#1)(2011-2#1)
superior mesenteric artery embolism##2##4##(1991-9#2)
superior mesenteric artery syndrome##2##4##(1996-9#1)(2009-6#1)
superior mesenteric artery##26##3##(1990-10#1)(1991-5#1)(1991-9#5)(1992-8#1)(1996-9#1)(2005-10#1)(2006-10#3)(2006-2#1)(2007-5#1)(2008-10#1)(2008-11#1)(2009-6#1)(2011-2#1)(2013-1#7)
superior mesenteric##35##2##(1990-10#3)(1990-3#1)(1991-5#1)(1991-9#5)(1992-8#2)(1996-9#1)(2005-10#1)(2006-10#3)(2006-2#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-1#7)(2013-8#2)
superior mesentric artery##2##3##(2009-6#2)
superior method since##2##3##(2008-9#1)(2011-2#1)
superior oblique muscle##2##3##(2010-9#1)(2011-2#1)
superior oblique##4##2##(2010-9#3)(2011-2#1)
superior or##4##2##(1993-12#1)(2006-7#1)(2008-10#1)(2008-7#1)
superior outcomes##5##2##(1992-11#1)(1995-3#1)(2007-7#1)(2010-6#1)(2012-1#1)
superior pancreaticoduodenal##2##2##(1991-6#2)
superior parietal cortex##2##3##(2013-8#2)
superior parietal lobule##3##3##(1996-2#1)(1996-5#1)(2008-11#1)
superior parietal##6##2##(1996-2#1)(1996-5#1)(2008-11#1)(2010-2#1)(2013-8#2)
superior performance in##2##3##(2008-2#1)(2009-3#1)
superior performance over##2##3##(2011-1#1)(2012-3#1)
superior performance##10##2##(1997-3#1)(2007-12#1)(2007-8#1)(2008-2#3)(2009-3#1)(2010-4#1)(2011-1#1)(2012-3#1)
superior potency##2##2##(2007-11#1)(2012-12#1)
superior properties##2##2##(2005-8#1)(2006-6#1)
superior qualities of##2##3##(2008-7#1)(2013-1#1)
superior quality##3##2##(2008-3#1)(2009-11#1)(2010-2#1)
superior resolution##3##2##(2008-4#1)(2009-12#1)(2013-1#1)
superior results compared##2##3##(2005-7#1)(2006-8#1)
superior results##7##2##(1993-4#1)(2005-7#1)(2006-12#1)(2006-8#2)(2008-10#1)(2008-7#1)
superior safety##2##2##(2007-4#1)(2011-2#1)
superior sagittal sinus thrombosis##4##4##(1997-3#1)(2007-10#1)(2007-9#2)
superior sagittal sinus##11##3##(1992-3#1)(1997-3#3)(2006-5#1)(2007-10#2)(2007-9#3)(2008-7#1)
superior sagittal##12##2##(1992-3#1)(1997-3#3)(1997-6#1)(2006-5#1)(2007-10#2)(2007-9#3)(2008-7#1)
superior soft tissue contrast##2##4##(2008-1#1)(2008-8#1)
superior temporal and##2##3##(2008-10#1)(2008-9#1)
superior temporal gyral volume##2##4##(1996-7#2)
superior temporal gyrus and##2##4##(1996-2#1)(1997-8#1)
superior temporal gyrus##10##3##(1996-2#2)(1996-7#3)(1997-8#1)(2008-11#2)(2009-2#2)
superior temporal sulcus (STS)##5##4##(2007-12#1)(2008-11#2)(2009-2#1)(2009-4#1)
superior temporal sulcus##9##3##(2007-12#1)(2008-11#5)(2009-10#1)(2009-2#1)(2009-4#1)
superior temporal volume##3##3##(1997-8#3)
superior temporal##33##2##(1992-5#1)(1996-2#2)(1996-7#5)(1997-1#1)(1997-8#4)(2007-12#1)(2008-10#1)(2008-11#10)(2008-9#1)(2009-10#2)(2009-2#3)(2009-4#1)(2012-12#1)
superior than##3##2##(1996-6#1)(2008-1#1)(2011-1#1)
superior tibiofibular##2##2##(2006-12#1)(2011-2#1)
superior to CT##2##3##(1990-12#1)(2004-1#1)
superior to a conservative approach##2##5##(2007-8#2)
superior to a conservative##3##4##(2007-8#3)
superior to a##8##3##(1996-12#1)(2007-8#3)(2008-3#1)(2010-3#1)(2012-1#1)(2012-2#1)
superior to all##2##3##(1996-2#1)(2011-2#1)
superior to another##2##3##(2008-9#1)(2013-8#1)
superior to any other##2##4##(2004-7#1)(2010-4#1)
superior to any##3##3##(1996-12#1)(2004-7#1)(2010-4#1)
superior to aspirin in##2##4##(2007-8#1)(2008-8#1)
superior to aspirin##5##3##(2007-8#2)(2008-8#3)
superior to both##4##3##(1993-12#1)(1995-5#1)(2008-10#2)
superior to carotid endarterectomy##2##4##(2007-8#2)
superior to computed tomography##2##4##(1993-5#1)(2006-10#1)
superior to conventional##8##3##(2004-2#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-2#2)
superior to currently available##2##4##(1996-8#1)(2009-12#1)
superior to high-dose##2##3##(2006-7#1)(2007-11#1)
superior to monotherapy##2##3##(1991-2#1)(1997-3#1)
superior to other methods##2##4##(2006-8#1)(2010-2#1)
superior to other##15##3##(1992-9#1)(1993-5#1)(2004-10#1)(2006-10#2)(2006-8#1)(2008-10#1)(2008-5#4)(2010-12#1)(2010-2#1)(2010-6#1)(2012-3#1)
superior to others##2##3##(1997-3#1)(2011-1#1)
superior to pharmacologic##2##3##(2006-10#1)(2007-6#1)
superior to placebo for##2##4##(2008-3#1)(2008-5#1)
superior to placebo in##2##4##(2007-11#1)(2008-3#1)
superior to placebo##8##3##(2005-7#1)(2006-10#2)(2007-11#2)(2008-3#2)(2008-5#1)
superior to standard##3##3##(2006-11#1)(2008-11#1)(2008-5#1)
superior to that for##2##4##(1994-5#1)(2008-10#1)
superior to that observed with##2##5##(2007-11#1)(2008-10#1)
superior to that observed##3##4##(2007-11#1)(2008-10#2)
superior to that of the##3##5##(1995-1#1)(2006-4#1)(2008-11#1)
superior to that of##15##4##(1991-3#1)(1992-2#1)(1995-1#1)(1995-2#1)(1996-2#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2010-3#1)
superior to that##22##3##(1991-3#1)(1992-2#1)(1993-2#1)(1994-5#1)(1995-1#1)(1995-2#1)(1996-2#1)(2006-4#1)(2006-8#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#1)(2010-3#1)
superior to the combination##2##4##(1991-10#1)(1995-5#1)
superior to the conventional##4##4##(1997-8#1)(2008-2#2)(2011-2#1)
superior to the more##2##4##(1994-3#1)(2007-10#1)
superior to the other##7##4##(1993-10#1)(1996-8#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-7#2)
superior to the simple wire technique for closure of the##2##10##(2007-8#2)
superior to the simple wire technique for##3##7##(2007-8#3)
superior to the traditional##2##4##(1992-1#1)(2008-1#1)
superior to the##67##3##(1991-10#1)(1992-1#1)(1992-10#1)(1992-5#1)(1992-8#2)(1993-10#1)(1993-5#1)(1994-3#1)(1994-5#1)(1995-5#1)(1995-9#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-8#2)(2006-11#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#6)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#8)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#1)(2010-12#1)(2010-3#1)(2010-7#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)
superior to those achieved by##2##5##(2007-6#1)(2008-10#1)
superior to those of##7##4##(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)
superior to those##15##3##(1992-8#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-4#1)(2011-1#1)(2013-8#1)
superior to traditional##3##3##(2004-3#1)(2007-7#1)(2008-5#1)
superior to##291##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-7#1)(1992-1#4)(1992-10#1)(1992-2#1)(1992-5#1)(1992-7#1)(1992-8#4)(1992-9#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-5#4)(1993-8#1)(1994-2#1)(1994-3#2)(1994-5#2)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#3)(1995-7#1)(1995-9#2)(1996-12#4)(1996-2#3)(1996-8#2)(1996-9#2)(1997-2#1)(1997-3#2)(1997-8#2)(2004-1#1)(2004-10#1)(2004-2#1)(2004-3#1)(2004-7#1)(2005-12#4)(2005-4#1)(2005-7#3)(2006-10#6)(2006-11#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#3)(2007-10#2)(2007-11#15)(2007-12#6)(2007-2#1)(2007-5#1)(2007-6#3)(2007-7#3)(2007-8#19)(2007-9#2)(2008-1#3)(2008-10#24)(2008-11#10)(2008-12#2)(2008-2#12)(2008-3#12)(2008-4#3)(2008-5#17)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#2)(2010-9#1)(2011-1#3)(2011-2#6)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#2)
superior transgenic##2##2##(2006-11#2)
superior vena cava (SVC) syndrome##3##5##(2007-7#1)(2007-8#1)(2008-1#1)
superior vena cava (SVC)##6##4##(2007-7#1)(2007-8#3)(2008-1#1)(2011-2#1)
superior vena cava and##2##4##(2007-8#2)
superior vena cava syndrome##10##4##(1995-8#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-7#1)(2010-8#1)(2013-1#4)
superior vena cava was##2##4##(2007-7#1)(2007-8#1)
superior vena cava##48##3##(1995-8#1)(1996-3#1)(2007-7#3)(2007-8#19)(2008-1#2)(2008-11#1)(2008-12#3)(2008-7#2)(2010-11#3)(2010-8#1)(2010-9#2)(2011-2#2)(2012-2#3)(2013-1#5)
superior vena##50##2##(1995-6#1)(1995-8#1)(1996-3#1)(2007-7#3)(2007-8#19)(2008-1#2)(2008-11#1)(2008-12#3)(2008-7#2)(2010-11#3)(2010-8#1)(2010-9#2)(2011-2#3)(2012-2#3)(2013-1#5)
superior vestibular##2##2##(1996-9#1)(2011-1#1)
superior visual##2##2##(2004-7#1)(2007-12#1)
superior with##3##2##(2005-11#1)(2007-2#1)(2011-2#1)
superior yields##2##2##(2007-11#1)(2008-6#1)
superior##867##1##(1990-10#4)(1990-11#1)(1990-12#1)(1990-3#2)(1990-8#2)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#6)(1991-5#7)(1991-6#2)(1991-7#1)(1991-8#4)(1991-9#5)(1992-1#5)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-7#1)(1992-8#8)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#6)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#5)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-1#2)(1994-2#6)(1994-3#3)(1994-5#3)(1994-6#1)(1995-1#3)(1995-12#3)(1995-2#1)(1995-3#5)(1995-5#5)(1995-6#3)(1995-7#5)(1995-8#1)(1995-9#2)(1996-12#8)(1996-2#8)(1996-3#4)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#5)(1996-8#4)(1996-9#8)(1997-1#3)(1997-2#1)(1997-3#12)(1997-4#1)(1997-6#2)(1997-8#6)(2004-1#2)(2004-10#1)(2004-2#3)(2004-3#1)(2004-7#2)(2005-10#1)(2005-11#3)(2005-12#4)(2005-4#2)(2005-5#1)(2005-7#5)(2005-8#1)(2006-1#1)(2006-10#12)(2006-11#9)(2006-12#8)(2006-2#1)(2006-4#1)(2006-5#3)(2006-6#2)(2006-7#4)(2006-8#12)(2006-9#1)(2007-10#7)(2007-11#23)(2007-12#14)(2007-2#2)(2007-4#3)(2007-5#3)(2007-6#3)(2007-7#12)(2007-8#60)(2007-9#5)(2008-1#10)(2008-10#63)(2008-11#31)(2008-12#5)(2008-2#23)(2008-3#20)(2008-4#8)(2008-5#23)(2008-6#6)(2008-7#18)(2008-8#16)(2008-9#7)(2009-1#2)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#6)(2009-3#5)(2009-4#4)(2009-5#3)(2009-6#3)(2009-8#1)(2009-9#2)(2010-1#2)(2010-11#5)(2010-12#9)(2010-2#7)(2010-3#4)(2010-4#6)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#3)(2010-9#6)(2011-1#9)(2011-12#9)(2011-2#29)(2012-1#5)(2012-11#3)(2012-12#9)(2012-2#12)(2012-3#12)(2012-8#1)(2012-9#1)(2013-1#40)(2013-7#2)(2013-8#10)
superior-posterior radiograms in##2##3##(2007-8#2)
superior-posterior radiograms##3##2##(2007-8#3)
superiority in##6##2##(2008-10#1)(2008-2#1)(2010-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
superiority of the##11##3##(1995-5#2)(1997-2#1)(2006-5#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2010-2#1)(2012-3#1)
superiority of these##2##3##(2008-5#1)(2008-8#1)
superiority of##43##2##(1990-9#1)(1993-3#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-5#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#4)(2008-7#1)(2008-8#1)(2009-11#1)(2009-7#2)(2009-8#2)(2010-12#1)(2010-2#1)(2010-3#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)
superiority over##8##2##(1992-2#1)(1992-9#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)
superiority to##6##2##(1992-12#1)(2008-7#1)(2013-8#4)
superiority##77##1##(1990-9#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-3#1)(1994-2#1)(1994-6#2)(1995-2#1)(1995-5#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#3)(2008-5#7)(2008-7#2)(2008-8#1)(2009-11#1)(2009-7#2)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#3)(2013-8#8)
superiorly and##3##2##(2005-5#1)(2007-12#1)(2009-2#1)
superiorly to##2##2##(2007-4#1)(2011-1#1)
superiorly##8##1##(2005-5#1)(2007-12#1)(2007-4#1)(2009-2#1)(2011-1#1)(2012-1#1)(2012-12#2)
superiors##2##1##(1995-6#1)(2012-2#1)
superiors'##2##1##(2012-3#2)
superlattice effect##2##2##(1995-5#1)(2008-1#1)
superlattice with##3##2##(2007-12#3)
superlattice##28##1##(1991-12#2)(1993-3#1)(1995-5#1)(2007-11#4)(2007-12#10)(2008-1#2)(2008-2#1)(2008-7#1)(2012-2#6)
superlattices and##2##2##(1992-2#1)(1993-5#1)
superlattices of##5##2##(2006-12#1)(2008-7#3)(2012-2#1)
superlattices on##2##2##(1991-12#1)(1994-10#1)
superlattices with##2##2##(1990-9#1)(2012-2#1)
superlattices##21##1##(1990-2#1)(1990-9#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-5#1)(1994-10#1)(1994-9#1)(1995-11#2)(2006-12#1)(2008-1#1)(2008-7#4)(2012-2#4)
superlinear##3##1##(2007-12#2)(2009-2#1)
superluminal excitation in microdroplets##2##4##(2007-12#2)
superluminal or##2##2##(2007-11#2)
superluminal##6##1##(2007-11#2)(2007-12#3)(2008-3#1)
superluminescent diode is##3##3##(2007-12#1)(2008-2#2)
superluminescent diode##12##2##(2007-1#1)(2007-11#1)(2007-12#4)(2008-2#5)(2008-3#1)
superluminescent diodes##2##2##(2007-11#1)(2008-3#1)
superluminescent##15##1##(2007-1#1)(2007-11#2)(2007-12#4)(2008-2#5)(2008-3#3)
supermacromolecular complex##2##2##(1992-3#2)
supermarket##3##1##(2007-3#2)(2012-2#1)
supermarkets##5##1##(1996-3#1)(2007-7#1)(2008-9#1)(2012-2#1)(2013-8#1)
supermassive star##2##2##(2007-8#2)
supermassive##4##1##(2007-8#2)(2007-9#2)
supermirror##2##1##(2008-2#1)(2008-3#1)
supermode##6##1##(2007-11#3)(2007-12#1)(2008-1#2)
supermodes and##2##2##(2007-11#1)(2008-1#1)
supermodes of the##2##3##(2008-1#1)(2008-3#1)
supermodes of##3##2##(2008-1#1)(2008-3#2)
supermodes##7##1##(2007-11#1)(2007-12#2)(2008-1#2)(2008-3#2)
supernatant analysis##2##2##(1996-4#1)(2008-10#1)
supernatant and pellet##2##3##(1997-4#1)(2008-11#1)
supernatant and##10##2##(1992-7#1)(1996-8#1)(1997-4#1)(2008-10#2)(2008-11#4)(2008-4#1)
supernatant by##5##2##(1990-12#1)(1990-2#1)(1992-2#1)(1992-3#1)(1992-7#1)
supernatant containing##4##2##(1991-6#1)(2008-11#2)(2012-2#1)
supernatant fluid##2##2##(1991-2#1)(1992-12#1)
supernatant fluids##2##2##(2008-4#2)
supernatant fraction of the##2##4##(1991-12#1)(1995-3#1)
supernatant fraction of##3##3##(1991-12#2)(1995-3#1)
supernatant fraction##7##2##(1991-12#2)(1992-12#2)(1995-3#1)(1996-12#1)(2008-10#1)
supernatant fractions##2##2##(1994-11#1)(2009-10#1)
supernatant from##5##2##(1993-12#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-4#1)
supernatant in##2##2##(1996-2#1)(2008-8#1)
supernatant is##7##2##(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#2)
supernatant of B##2##3##(2010-10#1)(2013-1#1)
supernatant of cell##2##3##(2007-2#1)(2008-9#1)
supernatant of human##2##3##(1992-12#1)(2008-11#1)
supernatant of the##4##3##(1996-8#1)(2008-10#1)(2008-2#1)(2012-2#1)
supernatant of##26##2##(1990-4#2)(1992-12#1)(1992-7#1)(1993-11#2)(1993-4#1)(1994-12#1)(1994-2#1)(1996-7#1)(1996-8#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-6#1)(2008-9#2)(2010-10#2)(2012-2#1)(2013-1#3)
supernatant solutions##2##2##(2008-11#2)
supernatant was##16##2##(1990-2#1)(1994-8#1)(1995-3#1)(1996-8#1)(1997-7#1)(1997-8#1)(2005-11#1)(2008-10#3)(2008-11#2)(2008-5#2)(2008-7#1)(2013-8#1)
supernatant were##3##2##(1991-8#1)(2008-5#1)(2010-10#1)
supernatant with##2##2##(1993-2#1)(2010-10#1)
supernatant##162##1##(1990-12#1)(1990-2#2)(1990-4#2)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-12#4)(1992-2#2)(1992-3#1)(1992-7#3)(1993-11#2)(1993-12#1)(1993-2#1)(1993-4#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-6#1)(1994-8#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-4#2)(1996-7#1)(1996-8#4)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#2)(2005-10#1)(2005-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#14)(2008-11#24)(2008-12#2)(2008-2#1)(2008-4#14)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#2)(2009-8#1)(2010-10#9)(2012-2#2)(2013-1#3)(2013-8#4)
supernatants and biological fluids##2##4##(2008-1#2)
supernatants and##7##2##(1992-8#1)(2008-1#3)(2008-4#3)
supernatants by##2##2##(1997-3#1)(2008-5#1)
supernatants for##4##2##(1996-8#1)(2007-2#1)(2008-4#1)(2008-9#1)
supernatants from the##2##3##(2008-10#1)(2011-3#1)
supernatants from##10##2##(1991-1#2)(1991-7#1)(1991-9#1)(1993-6#1)(1997-3#1)(1997-7#2)(2008-10#1)(2011-3#1)
supernatants of spleen##2##3##(1995-11#1)(2008-5#1)
supernatants of##21##2##(1990-11#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1994-12#1)(1995-11#1)(1997-2#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2011-1#1)(2012-12#1)
supernatants to##2##2##(1992-7#1)(1997-7#1)
supernatants was##6##2##(1991-11#1)(1991-3#1)(1996-6#1)(2007-2#1)(2007-6#2)
supernatants were collected##2##3##(2007-2#1)(2011-3#1)
supernatants were##5##2##(1992-7#1)(1992-9#1)(2007-2#1)(2008-11#1)(2011-3#1)
supernatants##99##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#2)(1991-11#3)(1991-12#1)(1991-3#1)(1991-7#1)(1991-9#2)(1992-1#2)(1992-2#1)(1992-3#1)(1992-5#3)(1992-7#2)(1992-8#3)(1992-9#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-2#2)(1995-3#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#3)(1997-7#3)(2006-10#1)(2007-11#1)(2007-2#3)(2007-6#3)(2008-1#3)(2008-10#6)(2008-11#4)(2008-4#13)(2008-5#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#2)(2010-10#1)(2010-12#1)(2011-1#1)(2011-3#2)(2012-12#1)(2012-2#1)(2013-1#2)
supernatural##2##1##(2010-8#1)(2013-1#1)
supernormal controls##2##2##(1997-5#2)
supernova##2##1##(1996-5#2)
supernumeraries of the##2##3##(2008-2#2)
supernumerary chromosomes##4##2##(2008-5#2)(2010-3#2)
supernumerary digit##2##2##(2007-7#1)(2010-3#1)
supernumerary eyes were##2##3##(2008-5#2)
supernumerary eyes##6##2##(2008-5#6)
supernumerary neurons##2##2##(1994-3#1)(1997-7#1)
supernumerary spleen##3##2##(1990-5#3)
supernumerary teeth##3##2##(2008-5#1)(2013-1#2)
supernumerary tooth##4##2##(2008-5#3)(2013-1#1)
supernumerary##46##1##(1990-5#3)(1992-11#1)(1994-3#1)(1996-2#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-3#6)(2008-5#18)(2008-8#1)(2010-3#3)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
supernutritional Se##2##2##(2012-2#2)
supero-medial dermal-glandular pedicle##2##3##(2011-2#2)
supero-medial pedicle technique##2##3##(2011-2#2)
supero-medial##4##1##(2011-2#4)
superolateral##2##1##(2008-8#1)(2012-3#1)
superomedial##2##1##(2009-9#1)(2011-2#1)
superovulated##5##1##(1995-10#1)(1996-8#1)(2006-5#3)
superovulation##7##1##(1992-10#1)(2006-5#5)(2011-1#1)
superovulatory##3##1##(2006-5#3)
superoxide (O2##2##2##(1994-11#1)(2008-5#1)
superoxide (O2-) and##2##3##(1994-3#1)(1996-6#1)
superoxide (O2-)##5##2##(1992-5#1)(1992-6#1)(1994-3#1)(1996-11#1)(1996-6#1)
superoxide O2-##2##2##(1993-12#1)(2007-11#1)
superoxide and hydrogen peroxide##2##4##(2011-2#2)
superoxide and nitric oxide##2##4##(1994-5#1)(2007-10#1)
superoxide and##7##2##(1991-9#1)(1994-12#1)(1994-5#1)(2007-10#1)(2011-2#2)(2012-1#1)
superoxide anion (##3##3##(1991-12#1)(1996-9#1)(2008-10#1)
superoxide anion (O2*-)##4##3##(2006-12#1)(2007-8#1)(2008-4#1)(2013-8#1)
superoxide anion (O2-)##5##3##(1990-2#1)(1993-7#1)(1994-8#1)(1996-2#1)(1997-8#1)
superoxide anion and hydrogen peroxide##3##5##(1994-8#1)(1997-4#1)(2008-10#1)
superoxide anion and##7##3##(1990-5#1)(1991-12#1)(1994-8#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-11#1)
superoxide anion by##2##3##(1993-6#1)(2008-9#1)
superoxide anion generation##5##3##(1992-6#1)(1996-9#2)(1997-8#1)(2008-10#1)
superoxide anion in##2##3##(1992-11#1)(2009-8#1)
superoxide anion production##4##3##(1992-6#1)(1994-3#1)(2008-10#1)(2013-1#1)
superoxide anion radical (O(2)(-))##2##4##(2008-10#2)
superoxide anion radical and hydrogen peroxide##2##6##(1995-6#1)(2008-10#1)
superoxide anion radical##13##3##(1990-5#1)(1991-4#2)(1993-3#1)(1995-6#1)(2008-10#6)(2010-5#1)(2011-1#1)
superoxide anion radicals##8##3##(1990-12#2)(1994-2#1)(2010-4#1)(2012-1#1)(2012-11#2)(2013-8#1)
superoxide anion release##2##3##(1994-11#1)(1996-2#1)
superoxide anion##84##2##(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#3)(1991-12#2)(1991-2#1)(1991-4#2)(1991-9#1)(1992-11#2)(1992-6#4)(1993-3#1)(1993-6#3)(1993-7#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#3)(1995-6#2)(1995-8#1)(1996-2#2)(1996-9#4)(1997-4#2)(1997-8#3)(2005-8#1)(2006-12#2)(2007-8#1)(2008-10#13)(2008-11#2)(2008-4#2)(2008-5#2)(2008-9#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-11#2)(2012-2#3)(2013-1#1)(2013-8#2)
superoxide anions was##2##3##(1990-5#1)(2008-10#1)
superoxide anions##5##2##(1990-5#2)(1992-7#1)(1995-6#1)(2008-10#1)
superoxide as##2##2##(1994-3#1)(2007-11#1)
superoxide dismutase (Cu/Zn##2##3##(1995-1#1)(2005-11#1)
superoxide dismutase (MnSOD)##2##3##(1994-6#1)(1995-6#1)
superoxide dismutase (SOD##2##3##(1992-11#1)(2006-8#1)
superoxide dismutase (SOD) activities##2##4##(2008-12#1)(2013-1#1)
superoxide dismutase (SOD) activity##8##4##(1993-1#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)
superoxide dismutase (SOD) and catalase (CAT)##2##6##(1994-6#1)(2009-5#1)
superoxide dismutase (SOD) and catalase##4##5##(1994-6#1)(1997-2#1)(2008-10#1)(2009-5#1)
superoxide dismutase (SOD) and##13##4##(1990-10#1)(1994-6#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-8#1)(2011-2#2)(2012-2#1)
superoxide dismutase (SOD)##63##3##(1990-10#1)(1990-11#1)(1990-4#2)(1991-9#2)(1992-11#1)(1992-4#1)(1992-9#1)(1993-1#1)(1994-3#1)(1994-6#1)(1996-1#2)(1996-3#1)(1997-2#1)(1997-4#2)(1997-8#4)(2005-8#1)(2006-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#3)(2009-10#1)(2009-5#1)(2009-6#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#3)(2013-1#3)
superoxide dismutase (SOD1) was cloned from##2##6##(1994-6#1)(1996-10#1)
superoxide dismutase (SOD1)##4##3##(1994-6#1)(1996-10#2)(1996-5#1)
superoxide dismutase 1 (SOD1)##3##4##(1996-11#1)(2008-4#1)(2012-12#1)
superoxide dismutase 1##4##3##(1996-11#1)(2008-4#1)(2012-12#2)
superoxide dismutase activities##3##3##(2008-10#2)(2013-1#1)
superoxide dismutase activity in##3##4##(1992-7#1)(2008-5#1)(2008-8#1)
superoxide dismutase activity was##4##4##(1992-12#1)(1997-6#1)(2010-7#1)(2013-8#1)
superoxide dismutase activity##12##3##(1990-5#1)(1992-12#1)(1992-7#1)(1997-6#2)(2006-8#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-7#1)(2013-8#2)
superoxide dismutase and catalase activities in##2##6##(2010-7#1)(2010-8#1)
superoxide dismutase and catalase activities##3##5##(2010-7#1)(2010-8#2)
superoxide dismutase and catalase##8##4##(1992-11#1)(1994-6#2)(1995-6#1)(2010-7#2)(2010-8#2)
superoxide dismutase and glutathione peroxidase activities##2##6##(1991-12#2)
superoxide dismutase and glutathione peroxidase##4##5##(1991-12#2)(1994-6#1)(2004-4#1)
superoxide dismutase and peroxidase##2##4##(1990-11#1)(2008-5#1)
superoxide dismutase and##23##3##(1990-11#2)(1990-5#1)(1990-7#1)(1991-12#2)(1992-11#1)(1992-7#1)(1994-6#3)(1995-6#1)(1997-6#1)(2004-4#1)(2007-11#1)(2008-5#1)(2008-8#2)(2010-7#2)(2010-8#3)
superoxide dismutase by##2##3##(1992-4#1)(1992-6#1)
superoxide dismutase from##6##3##(1992-1#2)(1995-2#1)(1996-4#1)(1997-2#1)(1997-6#1)
superoxide dismutase gene##4##3##(1992-7#1)(1995-1#1)(1996-6#1)(1997-4#1)
superoxide dismutase in##8##3##(1991-1#1)(1991-7#1)(1993-10#1)(1994-6#1)(2008-10#1)(2010-4#1)(2011-12#1)(2013-1#1)
superoxide dismutase or##2##3##(1993-11#1)(1995-3#1)
superoxide dismutase##238##2##(1990-10#1)(1990-11#4)(1990-12#4)(1990-2#3)(1990-3#4)(1990-4#2)(1990-5#2)(1990-7#1)(1991-1#2)(1991-10#1)(1991-12#5)(1991-2#2)(1991-7#1)(1991-9#4)(1992-1#2)(1992-11#4)(1992-12#1)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#5)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-2#1)(1994-3#2)(1994-6#9)(1995-1#2)(1995-2#1)(1995-3#3)(1995-6#5)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#3)(1996-10#4)(1996-11#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#2)(1997-2#2)(1997-4#4)(1997-5#4)(1997-6#6)(1997-8#6)(2004-4#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-11#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#12)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#5)(2008-8#8)(2009-10#3)(2009-5#1)(2009-6#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#4)(2010-8#4)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#9)(2013-8#3)
superoxide dismutases##3##2##(1992-1#2)(1997-2#1)
superoxide formation##5##2##(1991-10#1)(1992-11#2)(1992-3#1)(1994-8#1)
superoxide generation and##2##3##(1991-2#1)(1992-11#1)
superoxide generation by##3##3##(1992-9#1)(1993-6#1)(1994-11#1)
superoxide generation in response to##2##5##(1991-8#1)(1993-6#1)
superoxide generation in##5##3##(1991-8#1)(1993-6#1)(1994-11#2)(2010-7#1)
superoxide generation##19##2##(1990-2#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-9#2)(1993-6#5)(1994-11#4)(1995-1#2)(2007-11#1)(2010-7#1)
superoxide in##2##2##(1992-3#1)(2008-1#1)
superoxide or hydrogen peroxide##2##4##(1992-12#1)(1993-7#1)
superoxide production and##2##3##(1990-8#1)(2005-8#1)
superoxide production by##5##3##(1990-5#1)(1990-8#1)(1992-6#1)(1994-12#1)(2005-8#1)
superoxide production from##3##3##(1992-6#1)(1995-1#2)
superoxide production##14##2##(1990-5#1)(1990-8#2)(1991-7#1)(1992-6#2)(1994-12#1)(1995-1#2)(2005-8#3)(2008-10#1)(2008-4#1)
superoxide radical anion##3##3##(2008-10#1)(2008-5#2)
superoxide radical production##2##3##(2005-8#2)
superoxide radical##18##2##(1990-11#1)(1990-5#1)(1992-12#1)(1994-11#1)(1995-1#1)(1995-7#1)(1996-5#1)(1997-2#1)(1997-8#1)(2005-8#2)(2007-8#1)(2008-10#2)(2008-5#2)(2010-5#1)(2011-2#1)
superoxide radicals and##3##3##(1990-11#1)(2005-8#2)
superoxide radicals in##3##3##(1995-12#1)(2005-8#1)(2013-1#1)
superoxide radicals##16##2##(1990-11#1)(1991-12#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-5#1)(2005-8#4)(2007-11#1)(2007-9#1)(2008-4#1)(2011-2#1)(2013-1#1)
superoxide release##2##2##(1992-5#1)(2008-4#1)
superoxide to##2##2##(1991-4#1)(2006-7#1)
superoxide##462##1##(1990-10#1)(1990-11#7)(1990-12#6)(1990-2#5)(1990-3#7)(1990-4#2)(1990-5#9)(1990-7#1)(1990-8#2)(1991-1#2)(1991-10#2)(1991-12#9)(1991-2#4)(1991-4#3)(1991-7#2)(1991-8#1)(1991-9#6)(1992-1#4)(1992-11#9)(1992-12#3)(1992-3#2)(1992-4#2)(1992-5#3)(1992-6#9)(1992-7#6)(1992-9#5)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#9)(1993-7#3)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#7)(1994-12#4)(1994-2#3)(1994-3#5)(1994-5#1)(1994-6#10)(1994-8#4)(1994-9#1)(1995-1#8)(1995-12#1)(1995-2#1)(1995-3#4)(1995-6#9)(1995-7#2)(1995-8#2)(1995-9#2)(1996-1#4)(1996-10#5)(1996-11#2)(1996-2#5)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#3)(1996-8#1)(1996-9#6)(1997-2#5)(1997-4#6)(1997-5#5)(1997-6#6)(1997-8#11)(2004-12#1)(2004-4#1)(2005-11#1)(2005-8#11)(2006-10#2)(2006-12#3)(2006-5#2)(2006-7#2)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#5)(2007-5#1)(2007-8#3)(2007-9#3)(2008-1#6)(2008-10#31)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#7)(2008-5#16)(2008-6#1)(2008-7#5)(2008-8#12)(2008-9#1)(2009-10#3)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-3#1)(2010-4#4)(2010-5#3)(2010-7#5)(2010-8#4)(2011-1#5)(2011-12#1)(2011-2#9)(2012-1#4)(2012-11#2)(2012-12#2)(2012-2#10)(2012-3#1)(2013-1#11)(2013-8#5)
superoxide-generating activity##3##2##(1990-11#1)(1992-9#2)
superoxide-generating##10##1##(1990-11#1)(1992-9#2)(1993-8#1)(1994-3#1)(1994-8#3)(1995-1#1)(2010-12#1)
superoxidedismutase##3##1##(2008-8#3)
superparamagnetic hematite particles##2##3##(2005-11#2)
superparamagnetic iron oxide (SPIO)##4##4##(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
superparamagnetic iron oxide nanoparticles for##2##5##(2012-12#2)
superparamagnetic iron oxide nanoparticles##8##4##(2009-8#2)(2012-12#4)(2012-2#1)(2013-1#1)
superparamagnetic iron oxide##14##3##(2008-7#1)(2009-8#2)(2012-1#1)(2012-12#5)(2012-2#3)(2013-1#2)
superparamagnetic iron##15##2##(2008-7#1)(2009-8#2)(2012-1#1)(2012-12#6)(2012-2#3)(2013-1#2)
superparamagnetic nanoparticles##2##2##(2010-9#1)(2012-2#1)
superparamagnetic##27##1##(2005-11#3)(2008-5#2)(2008-7#1)(2009-6#1)(2009-8#2)(2010-5#1)(2010-7#1)(2010-9#1)(2012-1#1)(2012-12#6)(2012-2#4)(2013-1#4)
superpolished and precision-ground##2##3##(2008-2#2)
superpolished and##3##2##(2008-2#3)
superpolished##5##1##(2008-2#4)(2008-3#1)
superpopulation models##2##2##(2009-10#2)
superposed by##2##2##(1991-8#1)(2008-3#1)
superposed##7##1##(1991-8#1)(2008-10#1)(2008-3#2)(2008-7#1)(2011-2#2)
superposition of a##3##3##(2008-10#1)(2008-2#1)(2008-7#1)
superposition of the##8##3##(1992-8#1)(2005-10#1)(2007-11#2)(2007-12#1)(2008-3#3)
superposition of two##5##3##(2007-12#5)
superposition of##39##2##(1991-12#2)(1991-9#1)(1992-8#1)(1993-4#1)(1996-2#1)(1997-1#1)(1997-6#1)(2005-10#1)(2007-11#2)(2007-12#9)(2008-10#2)(2008-2#4)(2008-3#11)(2008-7#1)(2011-2#1)
superposition principle##2##2##(1995-3#1)(2008-5#1)
superposition##51##1##(1991-12#3)(1991-9#1)(1992-8#1)(1993-4#1)(1995-3#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-6#1)(2005-10#1)(2007-11#3)(2007-12#11)(2008-10#2)(2008-2#4)(2008-3#12)(2008-5#3)(2008-7#2)(2011-2#1)
superpositions of##2##2##(2007-9#1)(2008-3#1)
superpositions##3##1##(1997-2#1)(2007-9#1)(2008-3#1)
superprecipitation##3##1##(1992-9#3)
superprism##2##1##(2007-11#2)
superpulsed##2##1##(1992-3#1)(2007-12#1)
superregenerative receiver##2##2##(2007-12#2)
superregenerative##5##1##(2007-12#5)
superresolution (SR)##2##2##(2008-3#2)
superresolution disks##3##2##(2008-2#3)
superresolution in##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
superresolution optical##2##2##(2008-2#2)
superresolution##30##1##(2007-11#1)(2007-12#6)(2008-2#11)(2008-3#12)
superresolved##4##1##(2007-12#1)(2008-2#1)(2008-3#2)
superresolving##7##1##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)
supersaturated solutions##2##2##(2005-11#1)(2008-5#1)
supersaturated vapor##2##2##(2005-11#1)(2008-3#1)
supersaturated##9##1##(2005-11#4)(2008-3#1)(2008-5#3)(2013-1#1)
supersaturation and##2##2##(2005-11#1)(2007-8#1)
supersaturation of##5##2##(1992-9#1)(2006-9#1)(2007-8#2)(2008-10#1)
supersaturation##12##1##(1990-11#2)(1992-9#1)(1995-7#1)(2005-11#3)(2006-9#1)(2007-8#3)(2008-10#1)
superscript theta##2##2##(2008-3#2)
supersede the##2##2##(2007-8#2)
supersede##6##1##(1993-12#1)(1994-2#1)(2007-8#2)(2010-12#1)(2013-1#1)
superseded by the##3##3##(1997-6#1)(2006-8#1)(2008-9#1)
superseded by their##2##3##(2007-4#1)(2008-11#1)
superseded by##9##2##(1997-6#1)(2006-8#1)(2007-4#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#2)
superseded##14##1##(1990-11#1)(1997-6#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-2#2)
supersedes##2##1##(2008-11#1)(2010-11#1)
superselective##3##1##(1997-3#1)(1997-6#1)(2006-6#1)
supersensitivity of the pupil##2##4##(2008-7#2)
supersensitivity to##2##2##(1995-12#1)(2008-7#1)
supersensitivity##14##1##(1990-11#1)(1991-1#1)(1992-11#1)(1992-12#1)(1993-12#3)(1994-10#2)(1995-12#1)(1997-8#1)(2008-7#3)
supershift##5##1##(1993-12#1)(1995-3#2)(1995-8#1)(1996-5#1)
supershifted by##3##2##(1996-5#2)(1997-2#1)
supershifted##5##1##(1993-12#1)(1996-5#2)(1997-2#1)(1997-7#1)
supersonic nozzle##2##2##(2007-12#2)
supersonic##15##1##(1992-12#1)(2006-4#1)(2007-12#3)(2008-10#2)(2008-2#2)(2008-3#3)(2009-11#1)(2010-7#1)(2012-12#1)
superstition and##2##2##(1991-5#1)(1993-11#1)
superstition##3##1##(1991-5#1)(1993-11#1)(2009-6#1)
superstrate index##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
superstrate##10##1##(2006-2#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#2)
superstructure of a##2##3##(2006-10#1)(2008-2#1)
superstructure of##3##2##(2006-10#2)(2008-2#1)
superstructure##9##1##(1995-6#1)(1997-4#1)(2006-10#2)(2007-12#2)(2008-2#1)(2008-3#1)(2013-1#1)
supersymmetric##2##1##(1992-3#1)(1995-11#1)
supertrees##2##1##(2010-6#1)(2011-2#1)
supervariant##2##1##(2012-3#2)
supervened##3##1##(1995-12#1)(2006-10#1)(2006-12#1)
supervenes##3##1##(1995-10#1)(2008-6#1)(2012-2#1)
supervenience##2##1##(2012-2#2)
supervise the##2##2##(1991-3#1)(2006-12#1)
supervise##6##1##(1991-3#1)(1992-3#1)(2006-12#1)(2007-8#1)(2009-7#1)(2013-8#1)
supervised and unsupervised##3##3##(2006-5#1)(2008-2#1)(2009-3#1)
supervised by anaesthetists##2##3##(2006-10#1)(2012-2#1)
supervised by the##2##3##(1994-12#1)(2010-1#1)
supervised by##5##2##(1994-12#1)(2006-10#1)(2010-1#1)(2012-2#2)
supervised classification##3##2##(2008-2#1)(2008-3#1)(2013-8#1)
supervised injection##2##2##(2010-12#2)
supervised learning##6##2##(2008-10#3)(2008-11#1)(2008-7#1)(2012-12#1)
supervised machine-learning##4##2##(2013-1#4)
supervised time##4##2##(2009-7#4)
supervised##56##1##(1994-12#1)(1995-3#2)(1997-3#1)(1997-7#1)(2005-9#1)(2006-10#1)(2006-5#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-3#1)(2009-7#6)(2010-1#1)(2010-12#2)(2010-9#1)(2011-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#12)(2013-8#1)
supervises##2##1##(1995-9#1)(2012-12#1)
supervising a student##3##3##(1995-3#3)
supervising##4##1##(1995-2#1)(1995-3#3)
supervision and##10##2##(1992-9#1)(1995-3#1)(1996-1#1)(1997-7#1)(2005-9#1)(2008-7#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-4#1)
supervision as##2##2##(1992-11#1)(2013-1#1)
supervision by##3##2##(1991-6#1)(2008-6#1)(2012-3#1)
supervision during##2##2##(1992-6#1)(2012-2#1)
supervision from##2##2##(2008-11#1)(2012-2#1)
supervision in nursing##2##3##(2009-8#2)
supervision in the##2##3##(1993-8#1)(2008-4#1)
supervision in##13##2##(1991-9#1)(1993-8#1)(1995-6#1)(1996-7#1)(1997-2#1)(2005-5#1)(2008-4#1)(2008-5#1)(2009-8#2)(2012-12#1)(2013-1#2)
supervision is##7##2##(1992-11#2)(1995-10#1)(1997-7#1)(2009-8#1)(2012-3#2)
supervision of a##5##3##(2006-2#1)(2007-10#1)(2007-7#1)(2008-11#1)(2012-12#1)
supervision of the##3##3##(1991-2#1)(2006-11#1)(2006-8#1)
supervision of##14##2##(1991-10#1)(1991-2#1)(2006-11#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-12#1)(2009-2#1)(2011-1#1)(2012-12#1)(2012-2#1)
supervision time##4##2##(1995-3#3)(2009-4#1)
supervision to##2##2##(2007-9#1)(2008-11#1)
supervision##106##1##(1990-2#1)(1991-10#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-9#2)(1992-11#4)(1992-6#3)(1992-9#1)(1993-8#1)(1994-3#1)(1995-10#1)(1995-3#6)(1995-6#4)(1996-1#2)(1996-7#3)(1997-2#1)(1997-7#5)(2005-5#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-8#1)(2007-10#2)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#4)(2008-11#6)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#1)(2009-2#1)(2009-4#3)(2009-8#3)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#4)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#8)(2013-1#5)
supervisor must be##3##3##(1992-11#2)(2008-7#1)
supervisor##17##1##(1992-11#2)(1992-6#1)(1994-1#1)(1995-2#1)(1995-6#2)(1996-11#2)(1996-7#1)(2007-12#1)(2008-12#1)(2008-7#2)(2009-10#1)(2012-11#1)(2013-1#1)
supervisor's##2##1##(1996-11#1)(2012-3#1)
supervisors and##3##2##(2007-3#1)(2007-8#1)(2010-12#1)
supervisors at##2##2##(1996-2#1)(2013-1#1)
supervisors##15##1##(1990-4#1)(1992-3#2)(1996-1#1)(1996-2#1)(1996-3#1)(1997-5#1)(1997-6#1)(2007-3#1)(2007-8#1)(2008-11#1)(2010-12#1)(2010-5#1)(2012-2#1)(2013-1#1)
supervisors'##3##1##(2012-3#2)(2013-1#1)
supervisors)##3##1##(1990-12#1)(2008-11#1)(2011-2#1)
supervisory approaches##2##2##(2013-1#2)
supervisory controller##4##2##(2008-2#4)
supervisory positions##2##2##(1993-1#1)(1996-1#1)
supervisory practices##2##2##(2013-1#2)
supervisory style##4##2##(2012-3#4)
supervisory##25##1##(1992-2#1)(1993-1#1)(1993-2#1)(1996-1#1)(2004-8#1)(2006-3#1)(2008-1#1)(2008-2#4)(2009-3#1)(2009-7#1)(2010-12#1)(2011-1#2)(2012-3#4)(2013-1#5)
supervoxel##2##1##(2012-3#2)
supervoxels##2##1##(2012-3#2)
supination##5##1##(1991-1#1)(2006-11#1)(2006-3#1)(2010-11#2)
supine BP##2##2##(2008-7#2)
supine and##3##2##(2007-2#1)(2010-12#2)
supine diastolic##2##2##(1992-4#1)(1994-3#1)
supine position which##2##3##(2011-2#1)(2012-12#1)
supine position with##2##3##(2011-2#1)(2012-3#1)
supine position##18##2##(1993-9#1)(1995-12#1)(1995-4#1)(2007-2#1)(2008-1#1)(2010-2#1)(2010-3#1)(2011-2#4)(2012-12#2)(2012-3#4)(2013-7#1)
supine posture##5##2##(1996-2#1)(2007-6#2)(2012-3#2)
supine systolic##2##2##(1992-4#1)(1992-8#1)
supine to##2##2##(2006-10#1)(2011-2#1)
supine##53##1##(1992-11#1)(1992-12#1)(1992-4#3)(1992-8#1)(1993-10#1)(1993-12#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-4#1)(1996-2#1)(2005-12#1)(2006-10#2)(2006-7#1)(2007-1#2)(2007-2#3)(2007-6#3)(2008-1#1)(2008-7#4)(2009-6#1)(2010-12#2)(2010-2#2)(2010-3#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#6)(2013-1#1)(2013-7#1)
suplatast tosilate and high-dose inhaled corticosteroid##2##6##(2008-1#2)
suplatast tosilate##3##2##(2008-1#3)
suplatast##6##1##(1996-12#3)(2008-1#3)
supper##2##1##(1991-8#1)(2008-6#1)
supplant##4##1##(1996-2#1)(1997-1#1)(2006-10#1)(2013-1#1)
supplanted##3##1##(1995-5#1)(2008-1#1)(2011-2#1)
supplement and##6##2##(2005-3#1)(2008-12#1)(2008-5#1)(2009-11#1)(2012-1#1)(2013-8#1)
supplement at##3##2##(2013-8#3)
supplement before grazing##2##3##(2012-2#2)
supplement conventional##2##2##(1997-2#1)(1997-4#1)
supplement for animal##2##3##(2008-11#1)(2008-6#1)
supplement for the##2##3##(1994-2#2)
supplement for##10##2##(1994-2#3)(2006-2#1)(2008-11#2)(2008-5#2)(2008-6#1)(2012-6#1)
supplement in serum-free##2##3##(2008-11#2)
supplement in##9##2##(2004-4#1)(2006-10#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-5#1)(2010-7#1)(2013-1#1)
supplement of the##2##3##(2005-11#1)(2008-10#1)
supplement of##5##2##(1991-6#1)(2005-11#1)(2007-11#1)(2008-10#1)(2009-7#1)
supplement on##5##2##(2008-10#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-10#1)
supplement the##16##2##(1996-3#1)(1996-6#1)(1996-7#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-7#1)(2013-1#2)(2013-8#1)
supplement to simulations##2##3##(2010-2#2)
supplement to the##5##3##(1991-6#1)(1997-3#1)(2007-11#1)(2008-7#1)(2010-8#1)
supplement to traditional##2##3##(1990-9#1)(1992-2#1)
supplement to##23##2##(1990-2#1)(1990-9#1)(1991-6#1)(1992-2#1)(1992-3#1)(1993-10#1)(1993-11#1)(1994-2#1)(1994-6#1)(1996-3#1)(1997-3#1)(1997-8#1)(2007-11#3)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-2#2)(2010-8#1)
supplement use and##2##3##(2008-10#2)
supplement use##12##2##(2007-12#1)(2008-10#7)(2009-2#4)
supplement was##4##2##(2006-10#1)(2008-10#2)(2008-3#1)
supplement##182##1##(1990-10#1)(1990-2#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#3)(1992-2#1)(1992-3#2)(1992-9#1)(1993-10#1)(1993-11#1)(1994-2#5)(1994-3#1)(1994-5#1)(1994-6#1)(1996-3#2)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#2)(2004-4#1)(2005-1#1)(2005-10#2)(2005-11#1)(2005-3#2)(2006-10#10)(2006-12#1)(2006-2#3)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#23)(2008-11#11)(2008-12#2)(2008-3#5)(2008-4#1)(2008-5#14)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-2#4)(2009-3#1)(2009-7#1)(2010-12#1)(2010-2#5)(2010-7#2)(2010-8#3)(2011-1#1)(2011-2#1)(2012-1#5)(2012-10#2)(2012-2#4)(2012-6#1)(2013-1#7)(2013-8#9)
supplemental beta-carotene would##2##3##(2006-5#2)
supplemental beta-carotene##3##2##(2006-5#3)
supplemental doses##4##2##(1993-4#3)(2007-2#1)
supplemental flavonoids##2##2##(2008-7#2)
supplemental instruction##3##2##(2007-3#3)
supplemental insurance##2##2##(1994-1#2)
supplemental medium##2##2##(2008-7#2)
supplemental oxygen and##2##3##(1993-1#2)
supplemental oxygen##12##2##(1992-2#1)(1993-1#4)(2007-8#1)(2010-2#4)(2013-1#2)
supplemental reading##2##2##(2007-3#2)
supplemental sources##2##2##(2009-2#2)
supplemental water##2##2##(2008-10#2)
supplemental##62##1##(1992-2#1)(1992-9#2)(1993-1#4)(1993-4#3)(1994-1#2)(1995-2#1)(1996-6#1)(1997-3#1)(2006-5#3)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-2#3)(2007-3#5)(2007-7#1)(2007-8#2)(2008-10#2)(2008-5#1)(2008-7#5)(2009-1#1)(2009-2#2)(2010-10#2)(2010-11#1)(2010-2#4)(2012-12#2)(2012-2#3)(2013-1#4)(2013-7#1)
supplementary feeding is##2##3##(2010-2#1)(2012-2#1)
supplementary feeding##3##2##(2010-2#1)(2012-2#2)
supplementary health insurance##2##3##(1996-3#1)(2008-7#1)
supplementary information##2##2##(1993-3#1)(2013-8#1)
supplementary insurance##4##2##(1995-12#1)(1996-2#1)(1996-3#2)
supplementary method##2##2##(2006-9#1)(2011-2#1)
supplementary motor area##6##3##(1993-9#1)(1995-1#1)(1996-1#1)(2007-9#1)(2008-9#1)(2010-2#1)
supplementary motor##9##2##(1992-9#1)(1993-9#1)(1995-1#1)(1996-1#1)(2007-9#2)(2008-9#1)(2010-2#1)(2013-1#1)
supplementary oxygen##3##2##(1993-5#1)(1993-7#1)(2006-10#1)
supplementary tests##2##2##(1993-2#1)(2007-3#1)
supplementary to##2##2##(1996-5#1)(2010-12#1)
supplementary tool##2##2##(1994-11#1)(2007-8#1)
supplementary treatment with##2##3##(2006-2#1)(2007-9#1)
supplementary treatment##5##2##(1993-2#1)(1996-8#1)(2006-2#2)(2007-9#1)
supplementary##104##1##(1991-12#2)(1991-2#1)(1991-3#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-11#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-3#3)(1996-5#3)(1996-8#2)(1996-9#1)(1997-6#3)(2006-10#1)(2006-2#2)(2006-6#2)(2006-9#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#2)(2010-1#2)(2010-10#4)(2010-12#7)(2010-2#3)(2011-1#8)(2011-2#4)(2012-1#3)(2012-11#2)(2012-12#3)(2012-2#8)(2012-3#3)(2013-1#3)(2013-8#1)
supplementation and##11##2##(1994-2#1)(1994-6#1)(1996-12#1)(2005-7#1)(2006-9#1)(2007-11#1)(2008-7#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
supplementation and/or##2##2##(2007-8#1)(2008-5#1)
supplementation at the##2##3##(2008-11#1)(2013-1#1)
supplementation at##3##2##(2008-11#1)(2008-8#1)(2013-1#1)
supplementation by##5##2##(2006-10#1)(2006-4#1)(2006-7#1)(2010-7#1)(2011-2#1)
supplementation can be##2##3##(2008-5#1)(2009-2#1)
supplementation can##3##2##(2008-5#2)(2009-2#1)
supplementation could##3##2##(2006-9#1)(2008-1#1)(2008-5#1)
supplementation does not##3##3##(1990-3#1)(2008-5#1)(2010-8#1)
supplementation during pregnancy##3##3##(1994-6#1)(2007-11#1)(2011-2#1)
supplementation during##9##2##(1994-6#1)(2007-11#2)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#2)(2012-3#1)
supplementation effects##2##2##(2008-5#1)(2011-1#1)
supplementation for##2##2##(1990-3#1)(2008-11#1)
supplementation from##2##2##(1993-1#1)(2010-11#1)
supplementation groups##3##2##(1990-3#1)(2011-1#2)
supplementation has been##2##3##(2008-5#1)(2013-1#1)
supplementation has##4##2##(2008-5#2)(2010-9#1)(2013-1#1)
supplementation improves##3##2##(2008-5#1)(2010-2#1)(2012-12#1)
supplementation in hemodialysis patients##3##4##(2008-1#3)
supplementation in pregnancy and its##2##5##(2012-3#2)
supplementation in the##4##3##(1994-10#1)(1994-2#1)(2008-7#1)(2010-2#1)
supplementation in##39##2##(1991-1#1)(1994-10#1)(1994-2#1)(1997-1#2)(2005-7#1)(2007-11#3)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#2)(2010-2#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)
supplementation is##9##2##(1997-1#1)(2007-11#1)(2008-1#1)(2008-5#1)(2010-12#1)(2013-1#4)
supplementation may be##3##3##(1997-1#2)(2005-3#1)
supplementation may##5##2##(1997-1#2)(2005-10#1)(2005-3#1)(2010-1#1)
supplementation might##2##2##(2008-7#1)(2010-9#1)
supplementation of Euphorbia heterophylla on##2##5##(2013-1#2)
supplementation of acetate##2##3##(2007-6#2)
supplementation of culture medium##2##4##(2006-5#2)
supplementation of culture##3##3##(2006-5#2)(2008-11#1)
supplementation of omega-3##2##3##(2013-7#2)
supplementation of the##4##3##(1996-12#1)(1997-2#1)(2006-11#1)(2008-11#1)
supplementation of zymosan with morphine##2##5##(2008-12#2)
supplementation of##41##2##(1993-11#1)(1995-6#1)(1996-12#1)(1997-2#1)(2005-11#1)(2006-11#1)(2006-5#2)(2007-6#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#2)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#3)
supplementation on exercise-induced##2##3##(2010-1#1)(2010-8#1)
supplementation on the growth performance and meat quality in finishing##2##10##(2010-2#2)
supplementation on the growth performance##4##5##(2010-2#4)
supplementation on the growth##5##4##(2008-8#1)(2010-2#4)
supplementation on the##7##3##(2007-8#1)(2008-4#1)(2008-8#1)(2010-2#4)
supplementation on##32##2##(1990-3#1)(1991-1#1)(1993-6#1)(1995-1#1)(1995-3#1)(1996-12#2)(1997-2#1)(1997-3#1)(2004-11#1)(2007-11#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2010-1#1)(2010-12#1)(2010-2#4)(2010-8#2)(2011-1#1)(2013-7#2)
supplementation or##3##2##(1995-1#1)(2009-2#1)(2011-2#1)
supplementation period##2##2##(2008-5#1)(2013-1#1)
supplementation resulted in a##2##4##(2007-8#1)(2008-11#1)
supplementation significantly reduced##2##3##(2008-6#1)(2010-12#1)
supplementation significantly##3##2##(2004-11#1)(2008-6#1)(2010-12#1)
supplementation to pregnant##2##3##(1992-11#1)(1996-4#1)
supplementation to##8##2##(1992-11#1)(1996-12#1)(1996-4#1)(2006-5#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#1)
supplementation was##3##2##(2005-7#1)(2007-7#1)(2011-1#1)
supplementation were##2##2##(1994-5#1)(2007-11#1)
supplementation with a##5##3##(1993-12#1)(2006-7#1)(2008-11#1)(2008-5#1)(2011-2#1)
supplementation with high##2##3##(2008-10#1)(2008-11#1)
supplementation with vitamin E##2##4##(1991-12#1)(2008-10#1)
supplementation with vitamin##3##3##(1991-12#1)(2008-10#1)(2008-4#1)
supplementation with##37##2##(1991-12#1)(1991-6#1)(1993-12#2)(1995-5#1)(1996-10#1)(1996-6#1)(1997-8#2)(2005-1#1)(2005-11#1)(2006-12#1)(2006-2#2)(2006-6#1)(2006-7#1)(2007-11#1)(2007-5#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2009-9#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
supplementation##381##1##(1990-3#4)(1990-5#1)(1991-1#4)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-4#3)(1992-9#4)(1993-1#1)(1993-11#1)(1993-12#3)(1993-6#2)(1994-10#1)(1994-2#4)(1994-5#1)(1994-6#3)(1995-1#4)(1995-3#3)(1995-5#1)(1995-6#1)(1996-10#2)(1996-12#5)(1996-4#1)(1996-6#2)(1997-1#5)(1997-2#3)(1997-3#1)(1997-4#2)(1997-8#2)(2004-11#3)(2005-1#1)(2005-10#1)(2005-11#2)(2005-3#3)(2005-7#6)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#3)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#7)(2006-9#2)(2007-11#14)(2007-2#2)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#12)(2008-1#9)(2008-10#6)(2008-11#23)(2008-12#4)(2008-2#1)(2008-3#8)(2008-4#4)(2008-5#42)(2008-6#1)(2008-7#8)(2008-8#6)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#4)(2010-11#2)(2010-12#4)(2010-2#8)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#10)(2010-9#5)(2011-1#10)(2011-2#16)(2012-1#3)(2012-12#4)(2012-2#5)(2012-3#6)(2013-1#24)(2013-7#8)(2013-8#1)
supplementation)##2##1##(2008-3#1)(2012-2#1)
supplementations##5##1##(1996-2#1)(2008-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
supplemented biofilms##2##2##(1995-12#2)
supplemented by a##5##3##(1990-5#1)(1991-4#1)(1992-2#1)(2007-5#1)(2008-3#1)
supplemented by the##6##3##(1990-12#1)(1990-5#1)(2008-10#1)(2008-2#1)(2010-12#1)(2012-12#1)
supplemented by##41##2##(1990-12#1)(1990-5#2)(1990-6#1)(1991-11#1)(1991-4#1)(1992-2#1)(1994-3#1)(1995-9#1)(1996-11#1)(1997-4#1)(1997-6#1)(2005-12#1)(2006-4#2)(2006-7#2)(2007-12#2)(2007-4#2)(2007-5#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-12#2)(2010-4#1)(2012-11#1)(2012-12#2)(2013-8#1)
supplemented cells##2##2##(1991-1#1)(1995-3#1)
supplemented diet##2##2##(1997-6#1)(2006-7#1)
supplemented group##6##2##(1995-5#1)(2006-10#1)(2008-3#4)
supplemented in vitro with##2##4##(1996-5#1)(1997-8#1)
supplemented in##6##2##(1991-7#1)(1996-5#1)(1997-8#1)(2007-11#1)(2008-11#2)
supplemented media##4##2##(1995-11#1)(2006-8#1)(2007-11#1)(2008-7#1)
supplemented medium##7##2##(1990-7#1)(1991-1#1)(1994-2#2)(2008-11#3)
supplemented the##2##2##(1996-6#1)(2013-1#1)
supplemented their##2##2##(2008-3#1)(2008-5#1)
supplemented this##2##2##(2010-7#1)(2013-1#1)
supplemented to##3##2##(2007-8#1)(2008-11#1)(2008-5#1)
supplemented with 0##8##3##(1996-7#1)(2006-8#2)(2008-7#1)(2010-2#1)(2011-12#1)(2012-3#2)
supplemented with 1##7##3##(1995-6#1)(2004-11#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)
supplemented with 1%##2##3##(2008-11#1)(2008-5#1)
supplemented with 10% fetal calf serum##3##6##(1994-9#1)(2006-9#1)(2011-2#1)
supplemented with 10% fetal##4##4##(1994-9#1)(2006-9#1)(2008-11#1)(2011-2#1)
supplemented with 10%##6##3##(1994-9#1)(2006-9#1)(2007-11#1)(2008-11#2)(2011-2#1)
supplemented with 100##3##3##(2008-7#1)(2013-1#2)
supplemented with 2##3##3##(2008-7#1)(2008-8#1)(2010-2#1)
supplemented with 250##2##3##(1996-11#1)(2008-10#1)
supplemented with 5% horse serum##2##5##(2006-8#2)
supplemented with a##7##3##(1996-11#1)(2007-5#1)(2008-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#1)
supplemented with additional##2##3##(1994-5#1)(1996-3#1)
supplemented with copper##2##3##(2011-12#2)
supplemented with dexamethasone##2##3##(2008-5#2)
supplemented with different concentrations##2##4##(1997-2#1)(2013-1#1)
supplemented with different##3##3##(1997-2#1)(2008-12#1)(2013-1#1)
supplemented with fetal bovine serum##2##5##(2008-11#1)(2010-3#1)
supplemented with glucose##5##3##(2008-10#1)(2008-11#4)
supplemented with more##3##3##(1992-12#1)(2008-11#1)(2010-12#1)
supplemented with other##2##3##(2008-10#1)(2010-8#1)
supplemented with peptone##3##3##(2008-5#3)
supplemented with posterior##2##3##(2006-8#1)(2008-11#1)
supplemented with sodium selenite##2##4##(2008-10#1)(2010-11#1)
supplemented with the##3##3##(2007-11#1)(2008-11#2)
supplemented with tryptophan##2##3##(2008-10#1)(2008-7#1)
supplemented with vitamin##3##3##(1993-12#1)(2013-1#1)(2013-8#1)
supplemented with##187##2##(1990-11#1)(1990-2#2)(1990-4#1)(1990-7#1)(1991-10#1)(1991-2#2)(1991-5#1)(1991-9#2)(1992-12#2)(1992-2#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-12#1)(1995-5#1)(1995-6#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-2#2)(1997-6#1)(1997-8#1)(2004-11#1)(2005-8#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#6)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#1)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#14)(2008-11#31)(2008-12#3)(2008-2#1)(2008-4#3)(2008-5#9)(2008-6#3)(2008-7#8)(2008-8#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#4)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#3)(2011-2#6)(2012-12#1)(2012-3#3)(2013-1#13)(2013-8#1)
supplemented##300##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#2)(1991-1#2)(1991-10#1)(1991-11#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-12#2)(1992-2#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-9#2)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#5)(1997-4#1)(1997-6#3)(1997-8#4)(2004-11#2)(2005-12#1)(2005-8#1)(2006-10#1)(2006-4#3)(2006-5#2)(2006-6#1)(2006-7#3)(2006-8#10)(2006-9#1)(2007-1#1)(2007-11#8)(2007-12#3)(2007-3#1)(2007-4#2)(2007-5#3)(2007-6#1)(2007-7#4)(2007-8#4)(2007-9#1)(2008-10#16)(2008-11#41)(2008-12#4)(2008-2#2)(2008-3#7)(2008-4#5)(2008-5#13)(2008-6#3)(2008-7#10)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#5)(2010-2#4)(2010-3#1)(2010-4#2)(2010-7#2)(2010-8#2)(2011-1#1)(2011-12#3)(2011-2#9)(2011-8#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-3#4)(2013-1#15)(2013-7#1)(2013-8#2)
supplementing the##7##2##(2006-4#2)(2006-6#1)(2008-11#1)(2008-2#1)(2008-5#1)(2011-2#1)
supplementing##17##1##(1993-2#1)(1993-8#1)(1995-1#1)(2006-10#1)(2006-4#2)(2006-6#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-4#1)(2010-2#1)(2011-2#1)(2012-3#1)
supplements and##22##2##(1992-9#1)(1994-9#1)(2006-10#1)(2006-8#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-5#7)(2009-5#2)(2010-3#1)(2012-1#1)(2013-7#1)
supplements are##3##2##(2005-10#1)(2005-3#1)(2011-2#1)
supplements as well##2##3##(2008-10#1)(2011-2#1)
supplements as##3##2##(2008-10#1)(2009-5#1)(2011-2#1)
supplements containing##2##2##(2006-10#1)(2008-5#1)
supplements for##4##2##(2008-11#1)(2009-5#1)(2010-3#1)(2011-2#1)
supplements have##2##2##(2005-1#1)(2008-3#1)
supplements in the##2##3##(2008-10#2)
supplements in##9##2##(1994-11#1)(2006-10#1)(2006-8#1)(2008-10#2)(2009-3#1)(2010-8#1)(2011-1#1)(2013-1#1)
supplements is##2##2##(2010-11#1)(2011-2#1)
supplements may##2##2##(2007-8#1)(2010-8#1)
supplements of##3##2##(1990-5#1)(2008-10#1)(2013-1#1)
supplements on the##2##3##(2005-12#1)(2006-10#1)
supplements on##4##2##(2005-10#1)(2005-12#1)(2006-10#1)(2011-2#1)
supplements that##3##2##(2008-5#1)(2012-12#1)(2013-7#1)
supplements to the diet##2##4##(1991-2#1)(2005-10#1)
supplements to##8##2##(1991-2#1)(1997-6#1)(2005-10#1)(2006-2#1)(2008-5#3)(2012-2#1)
supplements was##2##2##(2008-11#1)(2013-1#1)
supplements were##5##2##(1995-11#1)(2008-11#1)(2009-3#1)(2013-7#2)
supplements with##2##2##(2009-3#1)(2013-1#1)
supplements##176##1##(1990-5#3)(1991-2#2)(1992-9#3)(1993-10#1)(1993-11#2)(1993-12#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-11#2)(1995-2#2)(1995-7#1)(1996-2#1)(1997-6#1)(1997-8#1)(2005-1#1)(2005-10#4)(2005-12#1)(2005-3#1)(2006-10#9)(2006-12#2)(2006-2#2)(2006-8#8)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#8)(2008-12#1)(2008-3#3)(2008-5#24)(2008-6#1)(2008-7#1)(2008-8#3)(2009-2#2)(2009-3#7)(2009-4#1)(2009-5#5)(2009-8#1)(2010-11#1)(2010-3#4)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#7)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#5)(2013-7#5)
supplied and##2##2##(2008-3#1)(2011-1#1)
supplied as##4##2##(2006-12#1)(2008-4#1)(2008-7#1)(2012-2#1)
supplied by basal moyamoya vessels##2##5##(2006-11#2)
supplied by the user##2##4##(2008-4#2)
supplied by the##10##3##(1993-7#1)(1994-6#1)(2006-1#1)(2006-12#1)(2007-9#1)(2008-4#2)(2008-5#1)(2011-2#2)
supplied by##28##2##(1991-9#1)(1992-6#1)(1993-11#1)(1993-7#1)(1994-6#1)(1996-9#1)(2005-11#1)(2006-1#1)(2006-11#5)(2006-12#2)(2007-12#2)(2007-9#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-8#2)(2010-12#1)(2011-2#2)
supplied continuously##2##2##(1990-3#1)(2008-11#1)
supplied from the##2##3##(1992-1#1)(2011-2#1)
supplied from##4##2##(1992-1#1)(1996-7#1)(1997-2#1)(2011-2#1)
supplied in the##3##3##(1995-5#1)(1997-2#1)(2010-11#1)
supplied in##7##2##(1995-5#1)(1997-2#1)(2004-11#1)(2008-10#1)(2008-11#1)(2010-11#1)(2012-2#1)
supplied the##6##2##(2006-12#2)(2010-4#1)(2011-2#2)(2012-12#1)
supplied to a##2##3##(2008-10#2)
supplied to the##8##3##(1991-4#1)(1993-3#1)(1994-5#1)(1995-3#1)(2007-11#1)(2008-10#2)(2013-8#1)
supplied to##13##2##(1991-10#1)(1991-4#1)(1993-3#1)(1994-5#1)(1995-3#1)(2006-5#1)(2007-11#1)(2008-10#4)(2008-9#1)(2013-8#1)
supplied with adequate##2##3##(1992-9#1)(2008-11#1)
supplied with the##2##3##(1990-3#1)(2011-1#1)
supplied with##18##2##(1990-11#1)(1990-12#1)(1990-3#1)(1992-10#1)(1992-9#1)(1997-3#1)(2007-1#1)(2007-2#1)(2007-5#1)(2008-11#2)(2008-2#1)(2008-7#1)(2011-1#2)(2011-2#2)(2012-12#1)
supplied##114##1##(1990-11#2)(1990-12#1)(1990-3#2)(1991-10#2)(1991-4#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-3#1)(2004-11#1)(2005-11#1)(2006-1#1)(2006-11#6)(2006-12#5)(2006-3#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-5#1)(2007-9#2)(2008-10#10)(2008-11#6)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#3)(2011-2#7)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
supplier of##2##2##(2010-2#1)(2011-2#1)
supplier##14##1##(1991-12#1)(1992-1#2)(1994-1#1)(1994-12#1)(1994-3#1)(1995-1#2)(2007-11#2)(2008-10#1)(2010-2#1)(2011-2#2)
suppliers and##3##2##(1993-12#1)(1994-1#1)(2008-7#1)
suppliers to##3##2##(1991-10#1)(1994-1#1)(2011-2#1)
suppliers##20##1##(1991-10#1)(1992-3#1)(1993-12#1)(1994-1#3)(1994-3#1)(1995-2#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2011-2#3)
suppliers'##2##1##(2010-11#1)(2011-2#1)
supplies a##5##2##(1995-2#1)(1997-1#1)(2007-5#1)(2008-3#1)(2008-9#1)
supplies and##10##2##(1991-12#1)(1993-10#1)(1993-7#1)(1996-6#1)(2007-1#1)(2007-12#1)(2007-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
supplies are##3##2##(1995-9#1)(2007-10#1)(2007-3#1)
supplies for##2##2##(2008-8#1)(2010-7#1)
supplies in##3##2##(1992-5#1)(2007-6#1)(2011-2#1)
supplies of##6##2##(1990-12#1)(1994-9#1)(1996-6#1)(2007-12#1)(2008-1#1)(2008-7#1)
supplies the##6##2##(1991-6#1)(1994-9#1)(1995-5#1)(2007-12#1)(2011-2#2)
supplies to##2##2##(1993-7#1)(2006-7#1)
supplies##72##1##(1990-12#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-6#1)(1992-5#1)(1993-1#1)(1993-10#1)(1993-3#1)(1993-7#3)(1994-1#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-6#3)(1997-1#1)(1997-6#1)(2004-9#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#6)(2008-9#2)(2009-4#1)(2009-7#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#1)(2013-8#2)
supply a##2##2##(1993-2#1)(2012-1#1)
supply an##3##2##(1995-12#1)(2008-5#1)(2008-8#1)
supply and demand##3##3##(1992-1#1)(1996-9#1)(2007-7#1)
supply and the##4##3##(1990-12#1)(2006-6#1)(2011-2#2)
supply and##34##2##(1990-12#1)(1992-1#1)(1996-9#1)(2004-10#2)(2004-11#1)(2005-11#1)(2006-12#1)(2006-6#2)(2007-11#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
supply are##2##2##(1992-3#1)(1994-1#1)
supply as##3##2##(2007-5#1)(2009-12#1)(2012-1#1)
supply blood##2##2##(2009-2#1)(2013-1#1)
supply both##2##2##(2007-12#1)(2008-9#1)
supply by##4##2##(1995-6#1)(2006-9#1)(2008-7#1)(2008-8#1)
supply chain##3##2##(2007-12#1)(2010-3#1)(2011-2#1)
supply chains##4##2##(2010-4#4)
supply costs##3##2##(1994-3#1)(2010-9#1)(2012-2#1)
supply environment##2##2##(2006-4#2)
supply for##6##2##(1990-11#1)(1996-2#1)(1996-9#1)(2007-9#1)(2008-5#1)(2013-8#1)
supply from the##2##3##(1994-10#1)(1997-6#1)
supply from##6##2##(1994-10#1)(1997-6#1)(2006-8#1)(2007-8#3)
supply has##2##2##(2007-4#1)(2008-10#1)
supply in the##3##3##(2006-10#1)(2009-3#1)(2012-1#1)
supply in##14##2##(2006-10#1)(2006-4#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-4#1)(2011-2#1)(2012-1#1)(2013-8#1)
supply industry##2##2##(1994-2#1)(2011-2#1)
supply is##9##2##(1991-9#2)(1996-3#2)(2006-3#1)(2008-11#1)(2008-6#1)(2009-10#1)(2011-12#1)
supply level##2##2##(2009-8#1)(2011-1#1)
supply of a##3##3##(1991-3#1)(1996-3#1)(2008-2#1)
supply of charity##2##3##(1992-3#2)
supply of cysteine##2##3##(1991-9#1)(2009-8#1)
supply of doctors##2##3##(1991-2#2)
supply of health##2##3##(1990-12#1)(1994-1#1)
supply of human##2##3##(1996-11#1)(2007-11#1)
supply of iron##2##3##(2013-7#2)
supply of new##2##3##(1991-2#1)(2008-5#1)
supply of physicians##2##3##(1991-3#1)(2010-5#1)
supply of the##5##3##(1994-2#1)(2006-10#1)(2007-12#2)(2012-2#1)
supply of these##2##3##(1996-3#1)(2007-4#1)
supply of tissue##2##3##(1991-9#1)(2008-1#1)
supply of volunteer labor##2##4##(1994-3#2)
supply of water##2##3##(2006-8#1)(2011-2#1)
supply of##108##2##(1990-12#2)(1990-8#1)(1991-11#1)(1991-2#3)(1991-3#5)(1991-9#2)(1992-1#1)(1992-10#1)(1992-3#2)(1992-6#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#5)(1994-6#1)(1994-9#1)(1995-11#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-3#3)(1997-1#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-8#1)(2006-9#2)(2007-11#1)(2007-12#3)(2007-2#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#2)(2008-5#4)(2008-7#2)(2008-9#2)(2009-4#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2013-7#2)(2013-8#1)
supply or##6##2##(1996-2#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2013-1#1)
supply ratios##3##2##(2008-8#3)
supply services##2##2##(2012-12#2)
supply system in##3##3##(2008-1#1)(2010-12#1)(2012-1#1)
supply the best##2##3##(1991-2#1)(2008-7#1)
supply the##16##2##(1991-2#1)(1994-2#1)(1996-8#1)(1997-1#2)(2006-10#1)(2007-12#4)(2008-1#1)(2008-11#1)(2008-7#2)(2008-9#1)(2012-3#1)
supply to plants##3##3##(2006-3#1)(2013-8#2)
supply to the tumor##3##4##(1997-8#1)(2006-6#1)(2012-12#1)
supply to the##26##3##(1993-1#1)(1996-2#1)(1997-8#1)(2005-10#1)(2006-6#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-2#2)(2008-5#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)
supply to##39##2##(1993-1#1)(1996-2#1)(1997-8#1)(2005-10#1)(2006-3#1)(2006-6#2)(2006-8#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#1)(2013-8#2)
supply tubing##2##2##(2011-1#2)
supply was##10##2##(1997-1#1)(2006-12#2)(2007-12#1)(2008-11#4)(2008-5#2)
supply were##2##2##(2007-11#1)(2011-2#1)
supply when##2##2##(1991-11#1)(2007-2#1)
supply with##4##2##(2008-1#1)(2008-4#1)(2011-2#1)(2012-1#1)
supply##496##1##(1990-11#1)(1990-12#5)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#3)(1991-2#5)(1991-3#5)(1991-9#4)(1992-1#4)(1992-10#1)(1992-11#1)(1992-3#5)(1992-6#1)(1993-1#2)(1993-12#2)(1993-2#4)(1993-3#1)(1993-6#1)(1994-1#4)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#4)(1994-3#7)(1994-4#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#5)(1995-3#1)(1995-6#2)(1995-8#3)(1995-9#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#7)(1996-6#1)(1996-8#2)(1996-9#6)(1997-1#5)(1997-4#1)(1997-6#2)(1997-8#1)(2004-10#2)(2004-11#2)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-9#1)(2006-1#1)(2006-10#7)(2006-12#5)(2006-2#1)(2006-3#3)(2006-4#4)(2006-6#5)(2006-7#1)(2006-8#5)(2006-9#3)(2007-11#10)(2007-12#21)(2007-2#3)(2007-3#1)(2007-4#3)(2007-5#5)(2007-6#1)(2007-7#5)(2007-8#10)(2007-9#5)(2008-1#10)(2008-10#20)(2008-11#21)(2008-12#6)(2008-2#10)(2008-3#5)(2008-4#5)(2008-5#13)(2008-6#1)(2008-7#13)(2008-8#9)(2008-9#12)(2009-1#1)(2009-10#4)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#4)(2009-6#1)(2009-7#4)(2009-8#7)(2009-9#2)(2010-1#1)(2010-12#4)(2010-2#4)(2010-3#2)(2010-4#5)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#14)(2011-12#3)(2011-2#18)(2011-3#1)(2012-1#9)(2012-11#1)(2012-12#13)(2012-2#5)(2012-3#3)(2013-1#9)(2013-7#4)(2013-8#8)
supply]##2##1##(1990-8#1)(2013-1#1)
supplying a##2##2##(2007-12#1)(2007-4#1)
supplying the##8##2##(1993-11#1)(1995-6#1)(2007-9#1)(2008-2#1)(2008-7#2)(2010-3#1)(2011-2#1)
supplying##29##1##(1991-11#1)(1991-9#2)(1992-3#1)(1992-8#1)(1993-11#1)(1995-12#1)(1995-6#1)(1996-6#1)(1997-2#1)(1997-5#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-5#1)(2010-11#1)(2010-3#2)(2010-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
support (OR 0##2##3##(2007-8#1)(2011-1#1)
support (OR##3##2##(2007-8#1)(2011-1#1)(2013-1#1)
support DNA##2##2##(1994-9#1)(1995-1#1)
support E-AB signaling##3##3##(2010-5#3)
support a continued##2##3##(2007-11#1)(2008-11#1)
support a critical role##2##4##(1995-6#1)(2007-11#1)
support a critical##3##3##(1995-6#1)(2007-11#1)(2008-12#1)
support a direct##2##3##(1995-8#1)(2008-3#1)
support a general##3##3##(1991-5#1)(2008-12#1)(2010-8#1)
support a hypothesis that##3##4##(2009-11#1)(2011-2#1)(2012-3#1)
support a key##2##3##(2008-4#1)(2011-1#1)
support a mechanism of##2##4##(1992-6#1)(1993-11#1)
support a model in which the##3##6##(1995-3#1)(1995-8#1)(2008-4#1)
support a model in which##7##5##(1991-4#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-8#1)(2008-10#1)(2008-4#1)
support a model##13##3##(1991-4#1)(1994-2#1)(1994-6#1)(1994-9#2)(1995-3#1)(1995-8#1)(1996-11#1)(1997-4#1)(2008-10#1)(2008-4#1)(2010-2#1)(2013-8#1)
support a novel##3##3##(1991-12#1)(2012-2#2)
support a patient##2##3##(1993-3#1)(2012-1#1)
support a protective role for##2##5##(1993-5#1)(1997-4#1)
support a protective role##3##4##(1993-5#1)(1997-4#1)(2010-11#1)
support a role for a##2##5##(1992-4#1)(1993-12#1)
support a role for the##2##5##(1991-1#1)(1993-11#1)
support a role for##23##4##(1990-5#1)(1991-1#1)(1991-10#1)(1991-6#1)(1992-4#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-8#1)(1995-1#2)(1995-5#1)(1995-6#1)(1996-10#1)(1997-7#1)(1997-9#1)(2006-10#1)(2008-2#1)(2008-5#1)(2010-6#1)(2012-2#1)(2013-1#1)
support a role##25##3##(1990-5#1)(1991-1#1)(1991-10#1)(1991-6#1)(1992-11#1)(1992-4#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-8#1)(1995-1#2)(1995-5#1)(1995-6#1)(1996-10#1)(1997-7#1)(1997-9#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-6#1)(2012-2#1)(2013-1#1)
support a single##4##3##(1994-3#2)(2007-12#1)(2008-3#1)
support a##145##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-5#2)(1991-6#3)(1992-11#1)(1992-4#2)(1992-5#1)(1992-6#1)(1993-11#3)(1993-12#4)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1994-1#3)(1994-10#1)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#4)(1995-1#2)(1995-3#1)(1995-5#3)(1995-6#2)(1995-8#2)(1996-10#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#3)(1997-5#1)(1997-7#1)(1997-9#1)(2005-5#1)(2006-10#2)(2006-2#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-3#2)(2007-9#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#4)(2008-7#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
support activities##4##2##(1992-2#1)(1994-3#1)(1996-1#1)(2008-7#1)
support after##8##2##(1993-7#1)(1995-6#1)(2007-2#1)(2007-8#2)(2009-5#3)
support all##2##2##(2008-1#1)(2010-7#1)
support among##2##2##(2010-12#1)(2010-5#1)
support an important role for the##2##6##(1995-2#1)(2006-10#1)
support an important role for##3##5##(1991-8#1)(1995-2#1)(2006-10#1)
support an important##4##3##(1991-8#1)(1992-10#1)(1995-2#1)(2006-10#1)
support an##25##2##(1991-2#1)(1991-8#1)(1992-10#1)(1992-3#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#2)(1996-5#1)(1996-8#1)(2005-9#1)(2006-10#2)(2006-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-8#1)
support and a##3##3##(2007-8#1)(2008-11#1)(2008-7#1)
support and education##3##3##(1994-3#2)(2013-1#1)
support and extend##2##3##(1991-2#1)(2008-4#1)
support and guidance##2##3##(2008-12#2)
support and information##2##3##(2008-9#1)(2011-2#1)
support and involvement##2##3##(1992-12#1)(2010-3#1)
support and its##4##3##(1992-3#1)(2008-10#1)(2010-3#1)(2010-7#1)
support and networks##2##3##(2010-10#2)
support and participation##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
support and perceived##2##3##(2009-7#1)(2010-2#1)
support and psychological##2##3##(2010-1#1)(2010-2#1)
support and social undermining##2##4##(2006-9#2)
support and the##12##3##(1994-6#1)(1995-1#1)(1995-8#1)(1997-4#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#2)(2009-7#1)(2010-1#1)(2012-12#1)
support and to##2##3##(2008-5#1)(2010-8#1)
support and well-being##2##3##(1992-3#2)
support and##145##2##(1990-8#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-3#4)(1993-3#1)(1994-1#2)(1994-12#1)(1994-3#3)(1994-6#1)(1994-7#1)(1995-1#2)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-4#1)(2005-10#1)(2005-12#1)(2006-9#3)(2007-10#1)(2007-11#1)(2007-2#4)(2007-3#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#10)(2008-11#6)(2008-12#5)(2008-2#3)(2008-4#3)(2008-5#3)(2008-6#4)(2008-7#3)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#4)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#5)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#7)(2012-1#1)(2012-11#3)(2012-12#7)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#2)
support any##5##2##(1995-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-4#1)
support applications##3##2##(2008-10#1)(2013-1#2)
support are essential##2##3##(1992-1#1)(1992-3#1)
support are##10##2##(1992-1#1)(1992-3#1)(2007-12#2)(2007-2#1)(2008-12#1)(2008-5#1)(2010-10#3)
support as a##6##3##(1992-3#1)(1996-3#1)(2005-10#1)(2008-9#2)(2012-2#1)
support as well as##3##4##(2008-11#2)(2011-2#1)
support as##14##2##(1992-3#1)(1996-3#1)(2005-10#2)(2005-8#1)(2007-2#1)(2008-11#2)(2008-3#1)(2008-9#2)(2010-3#1)(2011-2#1)(2012-2#1)
support at home##3##3##(1992-1#1)(2006-10#2)
support at the##3##3##(1993-9#1)(2010-5#1)(2012-2#1)
support at##9##2##(1992-1#1)(1993-9#1)(2006-10#2)(2010-5#2)(2011-2#1)(2012-1#1)(2012-2#1)
support available##3##2##(1992-2#1)(2007-6#1)(2008-12#1)
support based on the##2##4##(1993-2#1)(2008-2#1)
support based on##4##3##(1993-2#1)(2008-2#1)(2013-1#2)
support both the##2##3##(1995-1#1)(2010-4#1)
support both##6##2##(1995-1#1)(2007-12#1)(2008-1#1)(2009-9#1)(2010-3#1)(2010-4#1)
support breastfeeding##2##2##(2006-9#1)(2007-2#1)
support breeding##3##2##(2007-6#1)(2008-10#2)
support by##6##2##(1992-2#1)(2007-2#1)(2007-8#1)(2008-10#2)(2010-8#1)
support can be##4##3##(1993-10#1)(1994-3#1)(2005-10#1)(2011-2#1)
support can##9##2##(1993-10#1)(1994-3#1)(2005-10#1)(2005-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2011-2#1)
support cell adhesion##2##3##(2009-7#1)(2012-1#1)
support cell growth in##2##4##(1996-2#1)(2008-11#1)
support cell growth##6##3##(1996-2#1)(2006-8#1)(2008-11#2)(2008-5#1)(2012-8#1)
support cell##10##2##(1996-2#1)(2006-8#1)(2008-11#2)(2008-5#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-8#1)(2013-7#1)
support cells##5##2##(1995-2#1)(2007-12#1)(2008-7#1)(2008-9#1)(2009-3#1)
support conversations##2##2##(2007-1#1)(2008-6#1)
support could be##2##3##(2008-10#1)(2011-2#1)
support current##3##2##(1994-8#1)(2008-11#1)(2012-3#1)
support device during##2##3##(2007-8#1)(2013-1#1)
support device##7##2##(2005-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-8#1)(2012-1#1)(2013-1#1)
support devices##2##2##(1991-3#1)(2008-11#1)
support during labor##3##3##(2007-2#2)(2008-6#1)
support during labour##3##3##(2010-3#1)(2013-1#2)
support during the##3##3##(1993-3#1)(2008-11#1)(2008-5#1)
support during##19##2##(1993-3#1)(1997-4#1)(2005-10#1)(2007-10#1)(2007-2#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-3#1)(2012-1#1)(2012-3#1)(2013-1#3)
support each##4##2##(2007-12#1)(2007-2#1)(2008-2#1)(2010-11#1)
support earlier reports##2##3##(2008-10#1)(2008-8#1)
support earlier##4##2##(1996-12#1)(2008-10#1)(2008-8#1)(2009-2#1)
support early##5##2##(1995-5#1)(1997-1#1)(2007-8#1)(2008-9#2)
support efforts to##2##3##(1994-2#1)(2007-4#1)
support either##2##2##(2006-12#1)(2009-11#1)
support equipment##3##2##(2008-10#1)(2012-1#2)
support following##4##2##(2007-4#1)(2007-8#2)(2013-1#1)
support for OSS##2##3##(2007-4#2)
support for a clinical##3##4##(2010-9#1)(2013-1#2)
support for a role of##2##5##(1994-9#1)(2008-8#1)
support for a role##3##4##(1994-9#1)(1995-12#1)(2008-8#1)
support for a##26##3##(1991-9#1)(1994-3#2)(1994-9#2)(1995-12#1)(1997-5#1)(2007-12#1)(2008-1#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-9#2)(2013-1#5)(2013-8#1)
support for all##2##3##(2008-11#1)(2011-2#1)
support for an##6##3##(1993-2#1)(1997-4#1)(2007-8#1)(2008-10#1)(2013-1#2)
support for clinical##2##3##(1995-3#1)(2008-8#1)
support for our##2##3##(2008-8#1)(2013-1#1)
support for patients with##2##4##(1996-6#1)(2006-9#1)
support for patients##5##3##(1996-3#1)(1996-6#1)(2006-12#1)(2006-9#1)(2012-12#1)
support for the concept of##2##5##(1995-12#1)(2008-12#1)
support for the concept##3##4##(1995-12#1)(1995-2#1)(2008-12#1)
support for the first hypothesis##2##5##(2005-10#1)(2011-2#1)
support for the first##3##4##(2005-10#1)(2011-1#1)(2011-2#1)
support for the hypothesis of##2##5##(2008-10#1)(2008-5#1)
support for the hypothesis that##6##5##(1991-1#1)(1991-7#1)(1993-2#1)(1994-2#1)(1994-8#1)(2013-8#1)
support for the hypothesis##9##4##(1991-1#1)(1991-7#1)(1993-2#1)(1994-2#1)(1994-8#1)(2008-10#1)(2008-5#1)(2013-1#1)(2013-8#1)
support for the idea that##2##5##(2008-11#1)(2012-1#1)
support for the involvement of##2##5##(1994-12#1)(1995-1#1)
support for the notion that##2##5##(1990-12#1)(2009-4#1)
support for the presence of##2##5##(2008-8#1)(2013-8#1)
support for the principle of##2##5##(2008-1#1)(2008-11#1)
support for the proposition that women##2##6##(2009-11#2)
support for the proposition that##3##5##(2009-11#3)
support for the reliability and validity of the##2##8##(2008-6#1)(2011-1#1)
support for the research##2##4##(2007-11#1)(2013-1#1)
support for the use of##4##5##(2006-5#1)(2007-10#1)(2008-11#1)(2012-1#1)
support for the utilization of##2##5##(2007-10#1)(2008-12#1)
support for the validity##2##4##(1994-2#1)(2007-9#1)
support for the##114##3##(1990-12#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-3#1)(1993-1#1)(1993-2#2)(1994-12#1)(1994-2#2)(1994-8#1)(1995-1#2)(1995-12#1)(1995-2#3)(1995-5#1)(1995-8#2)(1997-8#1)(2004-12#1)(2005-10#3)(2005-7#1)(2005-8#1)(2006-4#2)(2006-5#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#5)(2008-11#7)(2008-12#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#4)(2009-11#3)(2009-2#1)(2009-4#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#5)(2011-2#4)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#4)(2013-8#2)
support for their##7##3##(2005-7#1)(2007-2#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-3#2)
support for these##5##3##(1990-11#1)(2007-3#1)(2008-6#1)(2010-3#1)(2011-1#1)
support for this##6##3##(1996-4#1)(2007-9#2)(2008-8#1)(2009-5#1)(2011-2#1)
support for use##2##3##(2008-4#1)(2012-2#1)
support for your##2##3##(1991-1#1)(1993-2#1)
support for##322##2##(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#2)(1991-1#3)(1991-12#1)(1991-2#3)(1991-3#1)(1991-7#1)(1991-9#2)(1992-2#1)(1992-3#1)(1993-1#4)(1993-11#1)(1993-2#4)(1993-4#1)(1994-12#1)(1994-2#3)(1994-3#3)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-4#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#3)(1997-5#4)(1997-7#1)(1997-8#1)(2004-12#1)(2004-3#1)(2005-10#5)(2005-5#2)(2005-7#2)(2005-8#1)(2006-10#2)(2006-12#1)(2006-4#5)(2006-5#3)(2006-7#3)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#9)(2007-2#4)(2007-3#1)(2007-4#6)(2007-8#3)(2007-9#6)(2008-1#8)(2008-10#11)(2008-11#13)(2008-12#8)(2008-2#2)(2008-4#6)(2008-5#6)(2008-6#3)(2008-7#4)(2008-8#8)(2008-9#3)(2009-10#1)(2009-11#4)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#5)(2010-4#3)(2010-5#3)(2010-8#2)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#12)(2012-1#5)(2012-11#2)(2012-12#2)(2012-2#6)(2012-3#6)(2013-1#22)(2013-7#2)(2013-8#5)
support from a##3##3##(1997-4#1)(2006-5#1)(2012-3#1)
support from classmates and##2##4##(2009-7#2)
support from family and##2##4##(2006-3#1)(2013-1#1)
support from family##7##3##(2006-3#4)(2008-12#1)(2009-7#1)(2013-1#1)
support from friends and family##2##5##(1994-1#1)(2008-6#1)
support from friends##3##3##(1994-1#1)(2006-4#1)(2008-6#1)
support from medical##3##3##(1995-3#1)(1996-1#1)(2010-2#1)
support from parents##2##3##(2009-7#1)(2011-2#1)
support from the##11##3##(1991-12#1)(1996-3#1)(2005-3#1)(2007-4#2)(2008-2#1)(2009-11#1)(2009-4#2)(2010-10#2)
support from their##5##3##(1991-7#1)(2006-4#1)(2007-4#2)(2009-7#1)
support from##61##2##(1991-12#1)(1991-7#1)(1992-12#1)(1992-3#2)(1994-1#1)(1995-3#1)(1995-5#1)(1996-1#2)(1996-3#1)(1997-4#1)(1997-6#1)(2005-3#1)(2006-3#5)(2006-4#2)(2006-5#1)(2007-1#1)(2007-11#1)(2007-4#5)(2007-9#1)(2008-1#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-3#1)(2009-4#3)(2009-7#7)(2010-10#2)(2010-2#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
support further exploration of##2##4##(2008-1#1)(2009-1#1)
support further study##2##3##(1993-12#1)(2008-7#1)
support further##7##2##(1993-12#1)(2006-8#1)(2008-1#1)(2008-7#1)(2009-1#1)(2010-10#1)(2010-11#1)
support future##6##2##(1995-12#1)(1996-2#1)(2008-5#1)(2013-1#3)
support given##3##2##(2007-2#1)(2011-1#1)(2011-2#1)
support group attendance##2##3##(2006-10#2)
support group for adolescents with##2##5##(1993-3#2)
support group for##6##3##(1991-12#2)(1993-3#2)(2004-12#1)(2011-2#1)
support group##21##2##(1991-12#3)(1992-12#1)(1993-3#2)(2004-12#1)(2006-10#2)(2006-6#3)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-6#2)(2011-2#1)
support groups and##7##3##(1994-3#1)(1996-3#3)(2006-10#1)(2007-2#1)(2008-2#1)
support groups are##3##3##(1992-12#1)(1995-1#1)(2008-5#1)
support groups for##2##3##(1992-12#1)(2007-7#1)
support groups have##2##3##(2006-10#1)(2007-6#1)
support groups in##4##3##(2006-6#1)(2008-12#1)(2009-7#1)(2011-2#1)
support groups##43##2##(1991-12#1)(1992-12#3)(1994-3#1)(1995-1#3)(1996-1#1)(1996-3#6)(2006-10#4)(2006-6#2)(2007-10#2)(2007-2#1)(2007-6#1)(2007-7#4)(2007-9#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#1)(2009-5#2)(2009-7#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
support growth of##4##3##(1993-6#1)(2006-5#1)(2008-4#1)(2011-2#1)
support growth##6##2##(1993-6#1)(1994-2#1)(2006-5#1)(2008-4#1)(2011-2#1)(2012-3#1)
support has been used##2##4##(2008-10#1)(2008-7#1)
support has been##6##3##(2006-10#1)(2008-10#2)(2008-7#1)(2010-10#1)(2010-3#1)
support has##8##2##(2006-10#2)(2007-1#1)(2008-10#2)(2008-7#1)(2010-10#1)(2010-3#1)
support have##2##2##(2008-10#1)(2010-6#1)
support health##3##2##(2012-3#1)(2013-1#2)
support in 1##2##3##(2007-8#1)(2007-9#1)
support in a##4##3##(2007-6#1)(2008-10#1)(2010-2#1)(2010-7#1)
support in acute pancreatitis##2##4##(2005-10#1)(2006-6#1)
support in an##2##3##(1992-3#1)(2008-10#1)
support in children and##2##4##(2008-1#1)(2011-2#1)
support in order##2##3##(2006-1#1)(2012-12#1)
support in principle##2##3##(1992-3#1)(2010-5#1)
support in the form of##2##5##(2006-8#1)(2008-7#1)
support in the##14##3##(2005-10#1)(2006-10#2)(2006-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#2)
support in vitro transcription from##3##5##(1992-1#3)
support in##69##2##(1990-3#1)(1992-1#3)(1992-3#4)(1994-2#1)(1995-1#1)(1996-3#1)(1997-7#1)(2005-10#6)(2005-12#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-5#2)(2010-7#1)(2010-9#1)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
support intervention to##2##3##(2008-6#1)(2011-2#1)
support intervention##8##2##(2008-6#1)(2011-2#5)(2013-1#2)
support interventions##6##2##(1996-3#2)(2007-1#3)(2013-1#1)
support is needed for##2##4##(1990-12#1)(2008-9#1)
support is needed##4##3##(1990-12#1)(2008-7#1)(2008-9#1)(2013-1#1)
support is recommended##2##3##(1991-5#1)(1993-8#1)
support is required##2##3##(1993-10#1)(2005-10#1)
support is shown##2##3##(2008-10#1)(2008-6#1)
support is used##2##3##(2008-10#2)
support is##32##2##(1990-12#1)(1991-5#1)(1992-3#1)(1993-10#1)(1993-8#1)(1994-3#1)(1995-12#1)(1995-2#1)(1997-4#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-2#2)(2007-7#1)(2008-10#5)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#2)(2011-2#1)(2012-11#2)(2013-1#1)
support its use##2##3##(1997-5#1)(2013-8#1)
support its##11##2##(1994-3#1)(1995-5#1)(1997-5#1)(2007-10#1)(2007-7#1)(2008-11#1)(2009-8#1)(2010-11#1)(2010-3#1)(2012-12#1)(2013-8#1)
support large##2##2##(2008-10#1)(2012-3#1)
support long-term##3##2##(2008-11#1)(2009-4#1)(2009-6#1)
support material##6##2##(2008-10#5)(2008-6#1)
support may be##3##3##(2006-2#1)(2009-7#1)(2012-3#1)
support may##7##2##(1996-3#1)(2006-2#1)(2008-11#1)(2009-7#1)(2010-12#1)(2010-6#1)(2012-3#1)
support mechanism for##2##3##(2008-11#2)
support mechanism##3##2##(2008-11#2)(2008-4#1)
support media##3##2##(2008-4#2)(2008-5#1)
support membrane##3##2##(2008-2#1)(2008-4#2)
support models of##2##3##(1997-5#1)(2008-4#1)
support models##5##2##(1992-6#1)(1996-8#1)(1997-5#1)(2008-4#1)(2009-10#1)
support mothers##3##2##(1995-1#1)(2010-1#1)(2012-2#1)
support needed##2##2##(2007-8#1)(2012-1#1)
support needs##3##2##(2008-6#1)(2012-12#2)
support network for##4##3##(2006-9#1)(2008-9#1)(2011-2#2)
support network##9##2##(1991-12#1)(1997-2#1)(2006-4#1)(2006-9#1)(2008-11#2)(2008-9#1)(2011-2#2)
support networks##11##2##(1992-3#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-5#2)(2009-6#1)(2011-2#1)(2012-12#1)
support new##5##2##(1996-12#1)(1997-1#1)(2006-6#1)(2008-2#1)(2008-7#1)
support normal##12##2##(1994-11#1)(1996-6#1)(2007-2#10)
support not only##3##3##(1994-1#1)(1994-3#1)(2012-12#1)
support nurses##2##2##(1992-2#1)(2008-11#1)
support nursing##2##2##(2004-10#1)(2011-2#1)
support of a##10##3##(1991-2#1)(1991-4#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-4#1)(2008-8#2)(2010-5#1)
support of community health##3##4##(2007-4#1)(2013-1#2)
support of community##4##3##(2007-4#1)(2010-2#1)(2013-1#2)
support of early##2##3##(1992-2#1)(2011-2#1)
support of our##6##3##(1996-5#1)(2007-9#1)(2010-11#1)(2010-4#1)(2013-1#2)
support of spirometry##2##3##(2006-5#2)
support of the hypothesis##6##4##(1995-11#1)(1995-2#1)(1997-8#1)(2008-11#1)(2009-2#1)(2009-4#1)
support of the##54##3##(1990-12#1)(1991-1#1)(1991-5#2)(1994-12#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-6#1)(1997-8#1)(2004-12#1)(2005-10#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#3)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-3#1)(2013-1#1)
support of their##2##3##(1996-11#1)(2008-6#1)
support of this hypothesis##3##4##(1990-11#1)(2008-4#1)(2008-7#1)
support of this mechanism##2##4##(1992-11#1)(1995-11#1)
support of this##22##3##(1990-11#1)(1990-2#1)(1991-4#1)(1992-11#1)(1992-4#1)(1993-12#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-6#1)(2004-10#1)(2006-5#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-6#1)(2012-2#1)
support of your##2##3##(1994-12#1)(2007-10#1)
support of##169##2##(1990-11#1)(1990-12#2)(1990-2#1)(1991-1#1)(1991-2#1)(1991-4#2)(1991-5#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1993-12#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#3)(1996-12#2)(1996-2#1)(1996-3#3)(1996-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-10#1)(2004-12#1)(2005-1#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#3)(2007-10#3)(2007-11#2)(2007-12#4)(2007-2#3)(2007-4#2)(2007-6#1)(2007-8#2)(2007-9#3)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#6)(2008-5#2)(2008-6#4)(2008-7#5)(2008-8#3)(2008-9#4)(2009-10#3)(2009-12#1)(2009-2#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#10)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
support offered to the##2##4##(2008-11#1)(2008-6#1)
support offered to##3##3##(2008-11#1)(2008-6#2)
support offered##6##2##(1994-8#1)(2007-2#1)(2008-11#1)(2008-6#2)(2013-1#1)
support on the##2##3##(1996-2#1)(2012-1#1)
support on##12##2##(1994-1#1)(1996-2#1)(2006-10#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-2#1)(2012-1#3)
support or##15##2##(1996-3#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-6#2)(2007-8#1)(2008-2#1)(2008-7#1)(2009-10#1)(2012-1#1)(2012-11#1)(2012-3#1)(2013-7#1)
support other##2##2##(1994-6#1)(2007-2#1)
support our hypothesis that the##3##5##(1993-11#1)(1996-12#1)(1997-5#1)
support our hypothesis that##6##4##(1991-7#1)(1993-11#1)(1994-10#1)(1996-12#1)(1997-5#1)(2009-4#1)
support our hypothesis##7##3##(1991-7#1)(1993-11#1)(1994-10#1)(1996-12#1)(1997-5#1)(2009-4#1)(2012-5#1)
support our previous##2##3##(1996-2#1)(2008-9#1)
support our##20##2##(1991-7#1)(1993-11#1)(1994-10#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-5#1)(2004-9#1)(2007-12#2)(2008-10#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2010-8#1)(2012-2#1)(2012-5#1)(2013-1#1)
support person##2##2##(2007-2#1)(2011-3#1)
support personnel##4##2##(1992-3#1)(1996-6#1)(2006-10#1)(2010-9#1)
support persons##2##2##(2007-2#1)(2011-2#1)
support previous findings that##2##4##(1996-5#1)(2006-7#1)
support previous findings##3##3##(1996-5#1)(2006-7#2)
support previous reports of##2##4##(1997-6#1)(2008-10#1)
support previous research##2##3##(2008-10#1)(2008-11#1)
support previous studies##3##3##(1995-6#1)(2008-5#1)(2008-7#1)
support previous##15##2##(1990-10#1)(1991-1#1)(1993-7#1)(1995-6#1)(1996-5#1)(1997-6#1)(1997-7#1)(2006-7#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
support primary##4##2##(1991-8#1)(2010-11#2)(2012-12#1)
support program##6##2##(1997-2#1)(2006-6#1)(2007-10#1)(2008-2#1)(2010-6#1)(2013-1#1)
support protocol describes a method for##4##6##(2008-2#1)(2008-4#3)
support protocol describes a##8##4##(2008-2#1)(2008-4#7)
support protocol describes how to##5##5##(2008-2#1)(2008-4#4)
support protocol describes the##7##4##(2008-2#1)(2008-4#6)
support protocol describes##32##3##(2008-1#1)(2008-2#5)(2008-4#25)(2008-9#1)
support protocol for##8##3##(2008-1#2)(2008-4#6)
support protocol presents##2##3##(2008-4#2)
support protocol##61##2##(2008-1#3)(2008-2#7)(2008-4#50)(2008-9#1)
support protocols are provided for##2##5##(2008-4#2)
support protocols are provided##4##4##(2008-4#4)
support protocols are##5##3##(2008-4#5)
support protocols describe methods for##2##5##(2008-4#2)
support protocols describe methods##3##4##(2008-4#3)
support protocols describe the preparation of##2##6##(2008-4#2)
support protocols describe the##3##4##(2008-4#3)
support protocols describe##13##3##(2008-4#13)
support protocols detail the##2##4##(2008-4#2)
support protocols detail##3##3##(2008-4#3)
support protocols for##4##3##(2008-1#1)(2008-4#3)
support protocols provide##5##3##(2008-4#4)(2008-9#1)
support protocols##39##2##(2008-1#1)(2008-2#1)(2008-4#35)(2008-9#2)
support provided by##3##3##(2008-10#1)(2008-11#1)(2010-4#1)
support provided##5##2##(1991-5#1)(2008-10#1)(2008-11#1)(2010-4#1)(2011-2#1)
support received##3##2##(1992-3#1)(2009-7#1)(2011-2#1)
support recent##5##2##(1992-4#1)(2007-2#1)(2009-11#1)(2009-8#1)(2010-7#1)
support reflexes##3##2##(1993-9#3)
support required to##2##3##(2007-2#1)(2008-4#1)
support required##3##2##(2007-12#1)(2007-2#1)(2008-4#1)
support resources and##2##3##(1995-1#2)
support resources##3##2##(1995-1#2)(2006-1#1)
support roles for##2##3##(2008-1#1)(2008-8#1)
support roles##5##2##(2008-1#1)(2008-11#3)(2008-8#1)
support rules##3##2##(2007-9#1)(2013-1#2)
support services and##4##3##(2004-12#1)(2006-7#1)(2007-2#1)(2009-5#1)
support services in the##2##4##(1993-1#1)(1993-7#1)
support services##28##2##(1993-1#2)(1993-7#1)(1994-2#1)(1996-1#1)(2004-12#1)(2005-5#1)(2006-1#1)(2006-7#1)(2006-8#1)(2007-10#4)(2007-2#1)(2008-6#1)(2009-5#1)(2010-2#1)(2013-8#10)
support sessions##2##2##(2011-2#2)
support should be##9##3##(1991-7#1)(1992-2#1)(2007-12#1)(2010-7#2)(2012-1#1)(2012-11#2)(2013-1#1)
support social##2##2##(2010-2#1)(2012-12#1)
support some previous##2##3##(2008-11#1)(2008-6#1)
support staff and##2##3##(2008-12#1)(2010-2#1)
support staff##12##2##(1991-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(2005-12#1)(2006-8#1)(2008-12#2)(2010-2#1)(2013-7#1)
support structures##3##2##(2008-11#1)(2008-2#1)(2011-2#1)
support such a##4##3##(1997-8#1)(2007-9#1)(2008-10#1)(2008-4#1)
support such as##2##3##(2005-11#1)(2007-7#1)
support such##15##2##(1992-1#1)(1995-9#1)(1997-1#1)(1997-8#1)(2005-10#1)(2005-11#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2011-1#1)(2012-1#1)(2013-8#1)
support surface##9##2##(1991-4#6)(1993-3#1)(2006-5#1)(2013-8#1)
support system##26##2##(1991-1#1)(1993-2#1)(1995-2#1)(1995-4#1)(1997-3#1)(2006-7#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2009-7#1)(2010-6#1)(2010-8#3)(2012-1#1)(2012-2#1)(2013-1#7)
support systems and##2##3##(2008-1#1)(2009-7#1)
support systems are##3##3##(1997-1#1)(2013-1#2)
support systems for##3##3##(2010-6#1)(2010-8#1)(2012-12#1)
support systems in##3##3##(1993-2#1)(1995-1#1)(1997-3#1)
support systems that##2##3##(2007-2#1)(2008-11#1)
support systems##30##2##(1993-2#2)(1993-3#1)(1995-1#2)(1996-3#1)(1997-1#1)(1997-3#1)(2007-2#1)(2008-1#1)(2008-11#5)(2009-11#1)(2009-7#3)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#2)(2013-1#4)
support team##2##2##(2005-10#1)(2008-6#1)
support teams##2##2##(1997-2#1)(2008-6#1)
support technology##2##2##(2007-12#1)(2010-8#1)
support than##2##2##(1995-4#1)(1996-3#1)
support that the##5##3##(1996-9#1)(2008-3#1)(2008-7#1)(2008-8#1)(2013-1#1)
support that##29##2##(1992-11#1)(1993-2#1)(1995-5#1)(1996-9#1)(1997-4#1)(2006-10#1)(2006-2#1)(2006-3#1)(2007-12#1)(2007-2#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
support the ability of##2##4##(1990-9#1)(2008-7#1)
support the argument that females can gain paternal investment##2##9##(2008-8#2)
support the argument that##4##4##(1997-1#1)(2008-10#1)(2008-8#2)
support the argument##6##3##(1997-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#2)
support the assumption of a##2##5##(2008-4#1)(2010-8#1)
support the assumption of##5##4##(1995-12#1)(2008-4#1)(2010-8#1)(2012-1#1)(2013-8#1)
support the assumption that##3##4##(1992-8#1)(1997-4#1)(2013-1#1)
support the assumption##8##3##(1992-8#1)(1995-12#1)(1997-4#1)(2008-4#1)(2010-8#1)(2012-1#1)(2013-1#1)(2013-8#1)
support the authors'##2##3##(2006-5#1)(2011-1#1)
support the belief that##2##4##(2006-12#1)(2007-8#1)
support the benefits of##3##4##(2007-11#1)(2008-11#1)(2008-6#1)
support the claim that##7##4##(1990-2#1)(1993-12#1)(1997-6#1)(2008-3#1)(2008-4#1)(2008-9#1)(2013-8#1)
support the clinical observations##2##4##(2008-3#1)(2009-4#1)
support the clinical##6##3##(1994-3#1)(2007-11#1)(2008-3#1)(2009-4#1)(2010-8#2)
support the concept of##3##4##(1991-9#1)(1997-8#1)(2011-1#1)
support the concept that the##5##5##(1996-5#1)(1997-8#1)(2008-3#1)(2008-5#1)(2008-7#1)
support the concept that##12##4##(1990-11#1)(1996-5#2)(1996-9#1)(1997-4#1)(1997-8#1)(2006-10#1)(2008-3#2)(2008-5#1)(2008-7#2)
support the concept##16##3##(1990-11#1)(1991-9#1)(1996-5#2)(1996-9#1)(1997-4#1)(1997-8#2)(2006-10#1)(2008-3#3)(2008-5#1)(2008-7#2)(2011-1#1)
support the conclusion that the##6##5##(1992-2#1)(1996-7#1)(1996-8#1)(2008-10#1)(2008-9#1)(2009-12#1)
support the conclusion that##18##4##(1990-5#1)(1991-12#1)(1991-9#1)(1992-2#2)(1992-3#1)(1995-12#2)(1996-7#1)(1996-8#1)(2006-12#1)(2006-5#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-12#1)(2013-8#1)
support the contention that the##3##5##(1994-3#1)(1997-6#1)(2005-7#1)
support the contention that##10##4##(1990-12#1)(1994-3#1)(1995-11#1)(1997-6#1)(2005-7#1)(2007-12#1)(2008-4#1)(2008-9#1)(2010-6#1)(2011-2#1)
support the continued##3##3##(1990-11#1)(2007-12#1)(2008-5#1)
support the development of a##2##5##(2008-7#1)(2010-2#1)
support the development of novel##2##5##(2008-7#1)(2013-1#1)
support the development of##8##4##(2008-7#2)(2010-2#1)(2010-4#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
support the development##10##3##(1994-2#1)(2008-7#2)(2010-2#1)(2010-4#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
support the diagnosis of##4##4##(1997-1#1)(1997-3#1)(2010-9#1)(2011-2#1)
support the efficacy of##4##4##(1996-2#1)(1997-8#1)(2008-4#1)(2008-5#1)
support the evidence for##2##4##(1994-5#1)(2008-4#1)
support the evidence##3##3##(1994-5#1)(2008-10#1)(2008-4#1)
support the existence of a##7##5##(1993-8#1)(1994-12#1)(1996-4#1)(1997-1#1)(2007-4#1)(2008-5#1)(2012-11#1)
support the existence of##13##4##(1991-5#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-8#1)(1996-4#1)(1997-1#1)(2007-4#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-11#1)
support the experimental##2##3##(1992-3#1)(2007-11#1)
support the feasibility and##2##4##(2009-11#1)(2013-8#1)
support the feasibility of##3##4##(2009-7#1)(2013-1#2)
support the feasibility##5##3##(2009-11#1)(2009-7#1)(2013-1#2)(2013-8#1)
support the finding that##2##4##(2007-9#1)(2011-12#1)
support the findings##2##3##(2008-12#1)(2010-8#1)
support the formation of##2##4##(2008-10#1)(2008-11#1)
support the generation of##2##4##(1996-9#1)(2009-6#1)
support the growth of##4##4##(2008-11#2)(2008-5#1)(2008-8#1)
support the growth##5##3##(2008-11#3)(2008-5#1)(2008-8#1)
support the hypotheses that##4##4##(1996-4#1)(2008-10#1)(2008-7#1)(2010-6#1)
support the hypothesis of a regulatory##2##6##(1994-11#1)(1996-12#1)
support the hypothesis of a##9##5##(1991-12#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(2009-11#1)
support the hypothesis of an##2##5##(2006-12#1)(2007-9#1)
support the hypothesis of##17##4##(1991-12#1)(1992-5#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(2006-12#1)(2007-5#1)(2007-9#1)(2008-10#1)(2009-11#1)(2011-2#1)
support the hypothesis that Ca2+##2##5##(1992-1#1)(1992-6#1)
support the hypothesis that IAA-producing bacteria cause cranberry stem gall##2##10##(2008-10#2)
support the hypothesis that a##8##5##(1990-3#1)(1991-6#1)(1992-2#1)(1992-6#1)(1995-7#1)(2004-11#1)(2009-5#1)(2012-1#1)
support the hypothesis that the##20##5##(1991-1#1)(1991-2#1)(1991-6#1)(1992-4#1)(1992-7#1)(1993-3#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-7#1)(1996-6#1)(1996-8#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-4#1)
support the hypothesis that there##2##5##(1997-7#1)(2007-2#1)
support the hypothesis that this##2##5##(1996-5#1)(2006-4#1)
support the hypothesis that##117##4##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#2)(1991-2#2)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#3)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-7#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-12#2)(1995-7#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#1)(2004-10#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-3#2)(2007-9#2)(2008-1#1)(2008-10#11)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#3)(2013-1#1)(2013-7#1)
support the hypothesis##140##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#3)(1992-2#1)(1992-4#1)(1992-5#2)(1992-6#4)(1992-7#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-5#1)(1995-7#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#1)(2004-10#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-3#2)(2007-5#1)(2007-9#3)(2008-1#1)(2008-10#14)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-12#3)(2013-1#1)(2013-7#1)
support the idea of a##2##5##(1994-12#1)(2008-8#1)
support the idea of##7##4##(1994-12#1)(2007-10#1)(2008-1#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-12#1)
support the idea that the##5##5##(1990-5#1)(1993-12#1)(2007-6#1)(2008-5#1)(2008-9#1)
support the idea that##26##4##(1990-5#1)(1990-8#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-9#1)(1993-12#1)(1995-1#1)(1996-6#1)(1997-6#1)(1997-7#1)(2006-8#1)(2007-6#1)(2008-10#4)(2008-5#1)(2008-9#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-12#1)(2013-1#1)
support the idea##35##3##(1990-5#1)(1990-8#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-9#1)(1993-12#1)(1994-12#1)(1995-1#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-8#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-12#2)(2013-1#1)
support the important role of##2##5##(1991-7#1)(2007-9#1)
support the important role##3##4##(1991-7#1)(2007-9#1)(2010-2#1)
support the involvement of##5##4##(1993-4#1)(1993-6#1)(1995-12#1)(1996-12#1)(2008-3#1)
support the model of##2##4##(1994-2#1)(2006-10#1)
support the model##5##3##(1992-12#1)(1994-2#1)(1995-2#1)(1996-5#1)(2006-10#1)
support the need for##4##4##(2009-12#1)(2010-10#1)(2011-2#1)(2013-1#1)
support the new##3##3##(1992-5#1)(2007-12#1)(2008-10#1)
support the notion of a##3##5##(2005-9#1)(2007-9#1)(2011-1#1)
support the notion that a##2##5##(1992-8#1)(2005-6#1)
support the notion that the##11##5##(1991-10#1)(1991-2#1)(1993-11#1)(1994-10#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-4#1)(2008-7#1)(2012-12#1)(2012-3#1)
support the notion that##33##4##(1990-11#1)(1990-2#1)(1990-5#1)(1991-10#1)(1991-2#1)(1991-9#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-10#1)(1994-5#1)(1994-9#2)(1995-2#1)(1995-3#3)(1996-4#1)(1996-8#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-6#1)(2007-2#1)(2007-8#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#1)
support the notion##36##3##(1990-11#1)(1990-2#1)(1990-5#1)(1991-10#1)(1991-2#1)(1991-9#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-10#1)(1994-5#1)(1994-9#2)(1995-2#1)(1995-3#3)(1996-4#1)(1996-8#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-6#1)(2005-9#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
support the possibility of##2##4##(1990-9#1)(2006-12#1)
support the possibility##3##3##(1990-9#1)(2006-12#1)(2008-3#1)
support the potential##10##3##(1991-5#1)(1995-12#2)(1997-1#1)(2006-10#2)(2006-9#1)(2007-12#1)(2008-2#1)(2008-7#1)
support the practice##2##3##(2007-2#1)(2009-10#1)
support the premise that##4##4##(1992-6#1)(1996-11#1)(2008-8#1)(2009-5#1)
support the presence of##3##4##(2007-12#1)(2008-7#1)(2010-8#1)
support the previous##2##3##(1993-8#1)(2007-4#1)
support the proliferation##2##3##(1990-5#1)(2008-5#1)
support the propagation of##2##4##(1994-9#1)(2008-11#1)
support the proposal that the##2##5##(1990-10#1)(1997-2#1)
support the proposal that##7##4##(1990-10#1)(1990-11#1)(1994-11#1)(1996-5#1)(1997-2#1)(2007-2#1)(2009-4#1)
support the proposed##2##3##(1991-10#1)(1992-6#1)
support the rationale##2##3##(2005-9#1)(2007-12#1)
support the recent##3##3##(1995-11#1)(2007-8#1)(2008-10#1)
support the results of##2##4##(2008-5#1)(2010-4#1)
support the role of the##2##5##(2006-6#1)(2012-2#1)
support the role of##9##4##(1993-7#1)(1996-10#1)(2005-10#1)(2006-6#1)(2008-7#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-2#1)
support the role##10##3##(1993-7#1)(1996-10#1)(2005-10#1)(2006-6#1)(2008-11#1)(2008-7#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-2#1)
support the specific##2##3##(2004-11#1)(2013-8#1)
support the suggestion that##5##4##(1990-11#1)(1991-8#1)(1995-8#1)(2007-12#1)(2008-1#1)
support the suggestion##6##3##(1990-11#1)(1991-8#1)(1995-8#1)(1996-5#1)(2007-12#1)(2008-1#1)
support the survival of##2##4##(1993-11#2)
support the systemic##2##3##(2008-10#2)
support the theory that the##2##5##(1994-4#1)(2007-6#1)
support the theory that##7##4##(1994-4#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-6#2)(2011-1#1)
support the theory##9##3##(1994-4#1)(1994-6#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-6#2)(2008-3#1)(2011-1#1)
support the use of##32##4##(1993-9#1)(1995-12#1)(1995-3#1)(1996-4#1)(1997-6#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2012-12#2)(2012-3#1)(2013-1#2)
support the usefulness of##3##4##(1990-9#1)(2008-3#1)(2013-8#1)
support the value of##4##4##(1992-9#1)(2007-3#1)(2007-6#1)(2008-1#1)
support the view that a##2##5##(1993-3#1)(1994-12#1)
support the view that the##4##5##(1990-5#1)(1992-12#1)(1997-6#1)(2009-9#1)
support the view that##40##4##(1990-2#2)(1990-5#1)(1990-7#1)(1992-11#2)(1992-12#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-6#1)(1997-7#1)(2004-3#1)(2005-10#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#2)(2009-11#1)(2009-9#1)(2013-1#1)
support the view##41##3##(1990-2#2)(1990-5#1)(1990-7#1)(1992-11#2)(1992-12#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-6#1)(1997-7#1)(2004-3#1)(2005-10#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#2)(2009-11#1)(2009-9#1)(2013-1#1)
support the visual##2##3##(2009-3#1)(2011-12#1)
support the well-being of##2##4##(2010-11#1)(2010-5#1)
support the widely##2##3##(1993-8#1)(1994-6#1)
support the##753##2##(1990-1#1)(1990-10#1)(1990-11#5)(1990-12#3)(1990-2#7)(1990-3#1)(1990-4#1)(1990-5#7)(1990-7#2)(1990-8#1)(1990-9#4)(1991-1#4)(1991-10#3)(1991-12#3)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#4)(1991-7#2)(1991-8#3)(1991-9#4)(1992-1#4)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#5)(1992-3#3)(1992-4#1)(1992-5#3)(1992-6#7)(1992-7#3)(1992-8#5)(1992-9#3)(1993-11#4)(1993-12#4)(1993-2#2)(1993-3#6)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#4)(1993-8#4)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#6)(1994-3#5)(1994-4#1)(1994-5#3)(1994-6#4)(1994-8#5)(1994-9#5)(1995-1#3)(1995-10#2)(1995-11#4)(1995-12#10)(1995-2#2)(1995-3#6)(1995-5#3)(1995-6#1)(1995-7#2)(1995-8#7)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#3)(1996-2#4)(1996-3#5)(1996-4#5)(1996-5#8)(1996-6#2)(1996-7#4)(1996-8#4)(1996-9#2)(1997-1#4)(1997-2#3)(1997-3#4)(1997-4#6)(1997-5#3)(1997-6#7)(1997-7#5)(1997-8#6)(2004-10#1)(2004-11#2)(2004-3#2)(2005-10#3)(2005-11#3)(2005-6#1)(2005-7#2)(2005-9#2)(2006-10#13)(2006-12#6)(2006-2#2)(2006-4#2)(2006-5#3)(2006-6#1)(2006-7#2)(2006-8#4)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#8)(2007-12#18)(2007-2#5)(2007-3#3)(2007-4#2)(2007-5#2)(2007-6#6)(2007-7#3)(2007-8#10)(2007-9#8)(2008-1#7)(2008-10#44)(2008-11#15)(2008-12#4)(2008-2#8)(2008-3#14)(2008-4#11)(2008-5#20)(2008-6#3)(2008-7#19)(2008-8#14)(2008-9#9)(2009-10#2)(2009-11#5)(2009-12#5)(2009-3#4)(2009-4#5)(2009-5#6)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#4)(2010-2#5)(2010-3#4)(2010-4#6)(2010-5#4)(2010-6#3)(2010-7#4)(2010-8#9)(2010-9#4)(2011-1#7)(2011-12#5)(2011-2#10)(2012-1#8)(2012-11#3)(2012-12#9)(2012-2#6)(2012-3#10)(2013-1#16)(2013-7#4)(2013-8#9)
support their argument##2##3##(1993-3#1)(2010-2#1)
support their##16##2##(1993-12#2)(1993-3#1)(1994-12#1)(2006-11#1)(2007-2#1)(2007-3#1)(2008-3#1)(2008-8#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#2)(2013-8#2)
support them##3##2##(2011-1#1)(2011-12#1)(2012-2#1)
support these predictions##2##3##(2008-6#1)(2009-6#1)
support these##10##2##(1995-1#1)(1995-2#1)(2005-11#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-8#1)(2009-6#1)(2010-11#1)
support they##2##2##(2008-2#2)
support this assumption##3##3##(1996-6#1)(2008-10#1)(2009-3#1)
support this hypothesis##8##3##(1991-3#1)(1994-11#1)(1995-3#1)(1997-3#1)(2008-1#1)(2008-7#1)(2008-8#1)(2012-11#1)
support this interpretation##2##3##(1995-8#1)(2006-3#1)
support this statement##2##3##(2006-12#1)(2009-6#1)
support this view##4##3##(1997-4#1)(2006-10#1)(2008-10#1)(2012-3#1)
support this##42##2##(1991-12#1)(1991-3#1)(1993-3#1)(1994-11#1)(1994-7#1)(1995-3#1)(1995-8#1)(1996-6#1)(1997-3#1)(1997-4#2)(2004-10#1)(2005-5#1)(2006-10#3)(2006-12#1)(2006-3#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-3#1)(2009-6#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#2)(2013-7#1)
support those##3##2##(1994-9#1)(2006-4#1)(2006-5#1)
support to a role for##3##5##(1992-7#1)(1995-8#1)(2008-7#1)
support to a##6##3##(1992-7#1)(1994-2#1)(1995-12#1)(1995-8#1)(2008-7#1)(2013-1#1)
support to cancer patients##2##4##(1992-3#1)(1992-5#1)
support to facilitate the##2##4##(2008-11#2)
support to health##2##3##(2007-2#1)(2010-12#1)
support to improve##3##3##(2009-8#1)(2010-4#1)(2010-5#1)
support to our##2##3##(1995-5#1)(2008-7#1)
support to the assertion that##2##5##(1993-12#1)(2010-2#1)
support to the hypothesis that##8##5##(1991-6#1)(1996-1#1)(1997-2#1)(2007-1#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#1)
support to the use of##2##5##(2008-2#1)(2008-7#1)
support to the##42##3##(1990-11#1)(1990-5#1)(1991-6#1)(1991-7#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-4#1)(1997-2#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-12#1)(2007-1#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-8#1)(2012-2#1)(2012-3#2)(2013-1#1)
support to their##2##3##(1995-1#1)(2010-3#1)
support to this##5##3##(1990-3#1)(1991-8#1)(1995-12#1)(2006-10#2)
support to##120##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-5#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#2)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-2#2)(1997-3#3)(1997-7#2)(1997-8#1)(2004-9#1)(2005-10#1)(2005-5#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-2#2)(2007-5#1)(2007-7#2)(2007-9#2)(2008-10#3)(2008-11#3)(2008-12#4)(2008-2#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#3)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#1)
support tool for##6##3##(2007-4#1)(2008-10#1)(2011-2#2)(2013-1#2)
support tool##9##2##(2007-4#2)(2008-10#1)(2009-6#1)(2010-8#1)(2011-2#2)(2013-1#2)
support tools##4##2##(1993-12#1)(2010-12#1)(2013-1#2)
support two##6##2##(1991-5#1)(1993-12#1)(2007-11#1)(2008-12#1)(2013-1#2)
support uncompensated care##2##3##(1996-1#2)
support under##2##2##(2008-6#1)(2011-2#1)
support using##4##2##(1991-5#1)(2007-12#1)(2008-4#1)(2010-2#1)
support vector machine (SVM)##5##4##(2007-8#1)(2008-2#4)
support vector machine##15##3##(2007-8#2)(2008-2#5)(2010-7#2)(2010-8#2)(2012-2#1)(2012-3#1)(2013-1#2)
support vector machines (SVM)##2##4##(2010-4#1)(2010-8#1)
support vector machines (SVMs) to##2##5##(2006-12#1)(2008-11#1)
support vector machines##10##3##(2006-12#1)(2008-11#1)(2008-2#2)(2009-11#1)(2009-12#1)(2010-4#1)(2010-8#1)(2013-1#1)(2013-8#1)
support vector##27##2##(2006-12#1)(2007-8#2)(2008-11#1)(2008-2#8)(2009-11#1)(2009-12#1)(2010-2#1)(2010-4#1)(2010-7#2)(2010-8#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
support vectors##5##2##(2008-2#5)
support was a robust unique predictor##2##6##(2010-1#2)
support was a##3##3##(2007-5#1)(2010-1#2)
support was an##2##3##(2008-11#1)(2012-12#1)
support was provided##2##3##(1997-2#1)(2008-11#1)
support was revealed for##2##4##(2008-10#1)(2012-2#1)
support was the##3##3##(2007-1#1)(2007-10#1)(2007-11#1)
support was##31##2##(1990-10#1)(1993-8#1)(1996-11#1)(1997-2#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-5#1)(2007-6#1)(2007-9#2)(2008-10#4)(2008-11#2)(2008-7#3)(2009-5#1)(2010-1#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
support were##11##2##(1994-3#1)(1995-1#1)(2005-10#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-5#1)(2012-1#1)(2013-1#2)
support which##4##2##(1993-8#1)(2007-11#1)(2008-7#1)(2013-8#1)
support will##7##2##(1993-2#1)(2006-2#1)(2006-6#1)(2007-6#1)(2007-7#1)(2008-12#1)(2012-3#1)
support with a##2##3##(1996-8#1)(2007-8#1)
support with##16##2##(1990-8#1)(1991-7#1)(1996-8#1)(2006-9#1)(2007-8#3)(2008-10#3)(2009-10#1)(2009-7#1)(2010-1#1)(2010-8#1)(2012-2#1)(2013-1#1)
support##3725##1##(1990-1#1)(1990-10#5)(1990-11#10)(1990-12#14)(1990-2#10)(1990-3#4)(1990-4#1)(1990-5#11)(1990-6#4)(1990-7#6)(1990-8#6)(1990-9#4)(1991-1#13)(1991-10#4)(1991-12#15)(1991-2#13)(1991-3#5)(1991-4#10)(1991-5#14)(1991-6#8)(1991-7#10)(1991-8#6)(1991-9#9)(1992-1#13)(1992-10#2)(1992-11#6)(1992-12#15)(1992-2#14)(1992-3#36)(1992-4#5)(1992-5#8)(1992-6#10)(1992-7#5)(1992-8#5)(1992-9#4)(1993-1#8)(1993-10#3)(1993-11#12)(1993-12#21)(1993-2#13)(1993-3#17)(1993-4#3)(1993-5#4)(1993-6#4)(1993-7#8)(1993-8#8)(1993-9#7)(1994-1#13)(1994-10#4)(1994-11#6)(1994-12#15)(1994-2#23)(1994-3#28)(1994-4#2)(1994-5#5)(1994-6#8)(1994-7#4)(1994-8#12)(1994-9#14)(1995-1#34)(1995-10#4)(1995-11#10)(1995-12#24)(1995-2#17)(1995-3#15)(1995-4#3)(1995-5#17)(1995-6#9)(1995-7#2)(1995-8#22)(1995-9#2)(1996-1#14)(1996-10#3)(1996-11#12)(1996-12#13)(1996-2#17)(1996-3#36)(1996-4#7)(1996-5#12)(1996-6#6)(1996-7#5)(1996-8#10)(1996-9#8)(1997-1#13)(1997-2#15)(1997-3#15)(1997-4#20)(1997-5#15)(1997-6#12)(1997-7#12)(1997-8#11)(1997-9#1)(2004-10#6)(2004-11#2)(2004-12#4)(2004-3#5)(2004-4#2)(2004-7#1)(2004-9#4)(2005-1#1)(2005-10#43)(2005-11#8)(2005-12#3)(2005-3#1)(2005-5#9)(2005-6#1)(2005-7#4)(2005-8#7)(2005-9#3)(2006-1#3)(2006-10#65)(2006-11#3)(2006-12#17)(2006-2#11)(2006-3#7)(2006-4#21)(2006-5#19)(2006-6#11)(2006-7#13)(2006-8#13)(2006-9#19)(2007-1#15)(2007-10#28)(2007-11#28)(2007-12#63)(2007-2#71)(2007-3#10)(2007-4#25)(2007-5#5)(2007-6#19)(2007-7#18)(2007-8#62)(2007-9#36)(2008-1#42)(2008-10#194)(2008-11#127)(2008-12#51)(2008-2#69)(2008-3#32)(2008-4#152)(2008-5#56)(2008-6#47)(2008-7#82)(2008-8#37)(2008-9#47)(2009-1#1)(2009-10#16)(2009-11#20)(2009-12#15)(2009-2#5)(2009-3#15)(2009-4#26)(2009-5#32)(2009-6#14)(2009-7#34)(2009-8#16)(2009-9#13)(2010-1#18)(2010-10#21)(2010-11#22)(2010-12#19)(2010-2#28)(2010-3#26)(2010-4#16)(2010-5#27)(2010-6#18)(2010-7#19)(2010-8#44)(2010-9#11)(2011-1#38)(2011-12#14)(2011-2#118)(2011-3#2)(2011-9#1)(2012-1#48)(2012-11#18)(2012-12#60)(2012-2#47)(2012-3#51)(2012-5#1)(2012-8#1)(2013-1#196)(2013-7#19)(2013-8#49)
support&quot##3##1##(2008-2#1)(2013-1#2)
support) and##3##2##(2008-2#1)(2009-7#2)
support)##8##1##(1991-4#1)(2008-10#1)(2008-2#1)(2009-1#1)(2009-5#1)(2009-7#3)
support]##2##1##(1996-1#1)(2010-8#1)
supportable##3##1##(2006-7#1)(2006-9#1)(2008-10#1)
supported a &quot##2##3##(2004-3#1)(2007-8#1)
supported a##15##2##(1992-1#1)(2004-3#1)(2005-12#1)(2006-4#1)(2006-9#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-6#2)(2009-8#1)(2010-12#1)(2011-1#1)(2012-1#1)
supported an##3##2##(2008-11#1)(2009-10#1)(2009-8#1)
supported and##8##2##(1997-4#1)(2007-2#1)(2008-1#1)(2008-11#1)(2011-2#1)(2012-1#1)(2012-11#2)
supported as a##3##3##(2007-8#2)(2012-3#1)
supported as##4##2##(2007-8#2)(2011-2#1)(2012-3#1)
supported bilayer##5##2##(1994-11#3)(2008-4#1)(2009-12#1)
supported bilayers##4##2##(1994-11#1)(2005-11#2)(2009-12#1)
supported both##3##2##(1993-3#1)(1995-2#1)(2009-4#1)
supported by a thin metal##2##5##(2007-12#1)(2008-1#1)
supported by a##29##3##(1990-8#1)(1992-3#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-7#1)(2010-11#2)(2011-12#1)(2012-1#1)(2012-3#1)(2013-1#3)
supported by actual##2##3##(2008-11#1)(2008-7#1)
supported by all##2##3##(1991-2#1)(2008-12#1)
supported by an##8##3##(1990-9#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2012-1#1)(2013-7#1)
supported by clinical studies##2##4##(2008-1#1)(2009-11#1)
supported by clinical##4##3##(2005-9#1)(2008-1#1)(2008-7#1)(2009-11#1)
supported by comparison of the##2##5##(2006-2#1)(2008-3#1)
supported by data from##4##4##(1996-9#1)(2005-1#1)(2008-1#1)(2008-11#1)
supported by data##5##3##(1996-9#1)(1997-3#1)(2005-1#1)(2008-1#1)(2008-11#1)
supported by empirical##2##3##(2007-6#1)(2008-2#1)
supported by experimental studies##2##4##(1993-10#1)(2006-10#1)
supported by experimental##7##3##(1992-7#1)(1993-10#1)(1994-6#1)(2006-10#1)(2008-2#2)(2008-3#1)
supported by field##2##3##(2008-1#1)(2008-3#1)
supported by findings##2##3##(1993-12#1)(2012-2#1)
supported by fluorescence##2##3##(1994-12#1)(2005-11#1)
supported by in##3##3##(1996-1#1)(2008-3#1)(2008-5#1)
supported by inhibition##2##3##(1990-5#1)(1992-5#1)
supported by many##2##3##(2011-1#1)(2011-2#1)
supported by our data##3##4##(1997-8#1)(2006-4#1)(2008-1#1)
supported by our##5##3##(1990-7#1)(1997-3#1)(1997-8#1)(2006-4#1)(2008-1#1)
supported by recent##3##3##(1997-5#1)(2006-7#1)(2007-12#1)
supported by research##2##3##(2004-11#1)(2008-11#1)
supported by restriction analysis of##2##5##(1996-6#1)(2008-10#1)
supported by results##3##3##(1990-12#1)(1991-11#1)(1992-3#1)
supported by statistical##2##3##(2008-10#1)(2013-1#1)
supported by the ability of##2##5##(1996-4#1)(2011-1#1)
supported by the absence of##2##5##(2007-12#1)(2008-10#1)
supported by the data##4##4##(2007-11#1)(2007-12#1)(2010-8#2)
supported by the demonstration##2##4##(1995-8#1)(1996-10#1)
supported by the fact that##6##5##(1990-2#1)(1991-5#1)(1991-7#1)(2005-7#1)(2007-8#1)(2008-8#1)
supported by the finding that##5##5##(1992-2#1)(1997-5#1)(2008-10#1)(2008-12#1)(2008-7#1)
supported by the identification##2##4##(1991-2#1)(2009-10#1)
supported by the observation that##4##5##(1992-12#1)(1996-8#1)(2007-10#1)(2009-9#1)
supported by the observation##5##4##(1992-12#1)(1996-8#1)(2007-10#1)(2009-9#1)(2013-1#1)
supported by the presence of##2##5##(1996-2#1)(2004-9#1)
supported by the results of##4##5##(2005-11#1)(2007-12#1)(2008-10#2)
supported by the##98##3##(1990-12#1)(1990-2#3)(1991-2#1)(1991-5#1)(1991-7#2)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-10#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-8#2)(1997-3#1)(1997-4#1)(1997-5#1)(2004-9#1)(2005-10#1)(2005-11#3)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2009-10#1)(2009-9#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
supported by this##2##3##(2004-10#1)(2013-1#1)
supported by##320##2##(1990-1#1)(1990-11#1)(1990-12#4)(1990-2#3)(1990-5#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-7#2)(1992-12#1)(1992-2#1)(1992-3#4)(1992-5#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-10#2)(1995-11#1)(1995-12#1)(1995-3#2)(1995-6#2)(1995-8#1)(1996-1#2)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#2)(1997-8#2)(2004-10#1)(2004-11#1)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#8)(2005-3#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#4)(2006-12#4)(2006-2#1)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-10#3)(2007-11#5)(2007-12#11)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#6)(2008-10#29)(2008-11#9)(2008-12#4)(2008-2#9)(2008-3#9)(2008-4#4)(2008-5#6)(2008-6#4)(2008-7#11)(2008-8#8)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#2)(2009-9#1)(2010-11#3)(2010-12#1)(2010-5#3)(2010-6#1)(2010-8#4)(2011-1#2)(2011-12#2)(2011-2#3)(2012-1#3)(2012-11#2)(2012-12#6)(2012-2#5)(2012-3#5)(2013-1#11)(2013-7#3)(2013-8#2)
supported capillary membrane sampling-gas chromatography##2##5##(2008-10#2)
supported clade##2##2##(2008-10#1)(2013-7#1)
supported employment##5##2##(1993-3#2)(2010-9#3)
supported fatty acid##2##3##(1993-9#1)(1994-9#1)
supported for##2##2##(1997-5#1)(2008-9#1)
supported gait##3##2##(2012-1#3)
supported growth of##2##3##(2006-8#1)(2012-3#1)
supported in a##2##3##(2006-11#1)(2008-10#1)
supported in the##8##3##(1991-11#1)(1994-3#1)(1996-4#1)(2008-1#2)(2008-12#1)(2009-9#1)(2012-2#1)
supported in this##2##3##(2007-4#1)(2010-9#1)
supported in##19##2##(1991-11#1)(1993-12#1)(1994-3#1)(1996-4#1)(2006-11#1)(2006-2#1)(2007-3#1)(2007-4#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-9#1)(2010-5#1)(2010-7#1)(2010-9#1)(2012-2#1)
supported lipid bilayer##3##3##(2005-11#2)(2008-7#1)
supported lipid bilayers##3##3##(2008-7#1)(2010-4#1)(2010-7#1)
supported lipid##8##2##(2005-11#2)(2007-12#1)(2008-10#1)(2008-7#2)(2010-4#1)(2010-7#1)
supported liquid membrane (SLM)##3##4##(2008-10#2)(2012-1#1)
supported liquid membrane containing##2##4##(2008-10#2)
supported liquid membrane##12##3##(2008-10#11)(2012-1#1)
supported liquid membranes (SLMs)##2##4##(2008-10#2)
supported liquid membranes##3##3##(2008-10#3)
supported liquid##15##2##(2008-10#14)(2012-1#1)
supported liquid-liquid extraction##2##3##(2012-12#2)
supported metal##2##2##(2005-4#1)(2010-12#1)
supported monophyletic group##2##3##(2008-10#1)(2008-5#1)
supported on a##3##3##(2007-11#1)(2008-10#2)
supported on poly(ethylene-co-vinyl-acetate)##2##3##(2008-10#2)
supported on silica##2##3##(2008-10#1)(2008-2#1)
supported on##17##2##(2005-11#2)(2007-11#3)(2008-10#9)(2008-2#1)(2010-7#1)(2012-1#1)
supported only##3##2##(1990-3#1)(2008-10#1)(2010-6#1)
supported our##4##2##(1990-12#1)(2008-10#1)(2009-8#1)(2011-2#1)
supported planar##2##2##(1994-11#1)(2008-4#1)
supported psychotherapeutic##2##2##(2012-2#2)
supported that the##3##3##(1990-2#1)(2008-10#1)(2009-5#1)
supported that##5##2##(1990-2#1)(2007-12#1)(2008-10#1)(2009-5#1)(2012-12#1)
supported the assumption##2##3##(2005-7#1)(2012-1#1)
supported the development##2##3##(2008-10#1)(2008-11#1)
supported the diagnosis##2##3##(1992-12#1)(2012-2#1)
supported the growth and##2##4##(1995-5#1)(2012-8#1)
supported the hypotheses##2##3##(1996-3#1)(2012-12#1)
supported the hypothesis that the##3##5##(1991-11#1)(1992-1#1)(2008-10#1)
supported the hypothesis that##4##4##(1991-11#1)(1992-1#1)(2007-12#1)(2008-10#1)
supported the hypothesis##5##3##(1991-11#1)(1992-1#1)(2007-12#1)(2008-10#2)
supported the idea that##2##4##(1990-5#1)(2011-1#1)
supported the presence of##3##4##(1991-9#1)(2007-12#1)(2012-2#1)
supported the use of##2##4##(2007-11#1)(2007-12#1)
supported the validity of##2##4##(2008-10#1)(2009-12#1)
supported the##86##2##(1990-10#1)(1990-2#1)(1990-5#1)(1991-11#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1994-12#1)(1994-3#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-4#1)(1997-5#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#7)(2007-6#1)(2007-9#1)(2008-10#18)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-12#2)(2009-2#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#5)(2012-8#1)(2013-1#1)(2013-7#1)(2013-8#2)
supported their learning##2##3##(2008-11#2)
supported their##3##2##(2008-11#2)(2009-8#1)
supported these##3##2##(1990-11#1)(2007-8#1)(2010-2#1)
supported this finding##2##3##(1991-1#1)(2009-4#1)
supported this##8##2##(1990-8#1)(1991-1#1)(2006-10#1)(2007-5#1)(2008-10#1)(2008-5#1)(2009-4#1)(2010-8#1)
supported through##2##2##(2008-12#1)(2008-4#1)
supported to##4##2##(1997-1#1)(2006-7#1)(2008-4#1)(2012-12#1)
supported via##3##2##(2007-12#1)(2008-11#1)(2012-3#1)
supported with an##2##3##(2007-8#1)(2008-10#1)
supported with silver##2##3##(2005-11#2)
supported with##12##2##(2005-11#2)(2006-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
supported##744##1##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#5)(1990-2#5)(1990-3#1)(1990-5#3)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#5)(1991-12#2)(1991-2#3)(1991-4#2)(1991-5#4)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#3)(1992-2#1)(1992-3#4)(1992-5#1)(1992-7#1)(1992-9#3)(1993-1#2)(1993-10#1)(1993-12#5)(1993-2#2)(1993-3#4)(1993-5#1)(1993-6#2)(1993-9#2)(1994-10#2)(1994-11#6)(1994-12#6)(1994-2#2)(1994-3#3)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#3)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-5#1)(1995-6#3)(1995-8#2)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#5)(1996-4#2)(1996-5#4)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#1)(1997-3#4)(1997-4#4)(1997-5#4)(1997-8#2)(2004-10#1)(2004-11#1)(2004-3#1)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#17)(2005-12#1)(2005-3#1)(2005-4#1)(2005-7#3)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#10)(2006-11#1)(2006-12#6)(2006-2#3)(2006-4#2)(2006-5#1)(2006-6#4)(2006-7#4)(2006-8#2)(2006-9#3)(2007-1#1)(2007-10#6)(2007-11#12)(2007-12#27)(2007-2#3)(2007-3#2)(2007-4#5)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#10)(2007-9#3)(2008-1#10)(2008-10#112)(2008-11#26)(2008-12#10)(2008-2#12)(2008-3#11)(2008-4#10)(2008-5#15)(2008-6#9)(2008-7#16)(2008-8#16)(2008-9#4)(2009-10#2)(2009-11#3)(2009-12#7)(2009-2#3)(2009-3#1)(2009-4#5)(2009-5#2)(2009-7#3)(2009-8#6)(2009-9#5)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#4)(2010-6#7)(2010-7#4)(2010-8#5)(2010-9#4)(2011-1#5)(2011-12#4)(2011-2#11)(2012-1#13)(2012-11#4)(2012-12#15)(2012-2#16)(2012-3#10)(2012-8#1)(2013-1#23)(2013-7#6)(2013-8#5)
supporters of##5##2##(1996-2#1)(2004-3#1)(2007-2#1)(2008-9#1)(2010-12#1)
supporters##16##1##(1993-6#1)(1996-2#1)(2004-3#1)(2006-7#3)(2007-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#2)(2010-12#1)(2011-2#1)(2013-7#1)(2013-8#1)
supporting Sertoli cells##2##3##(2009-10#1)(2010-5#1)
supporting Sertoli##3##2##(2009-10#2)(2010-5#1)
supporting a role for##3##4##(1991-9#1)(1996-8#1)(2008-1#1)
supporting a role##5##3##(1991-9#1)(1996-8#1)(2008-1#1)(2008-10#1)(2011-2#1)
supporting a##31##2##(1990-11#1)(1991-9#1)(1992-9#1)(1993-6#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-8#1)(1997-4#1)(2004-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#5)
supporting an##5##2##(1991-3#1)(2006-12#1)(2008-5#1)(2008-7#1)(2012-1#1)
supporting and##5##2##(1991-2#1)(1993-3#1)(2006-10#2)(2007-11#1)
supporting bed##3##2##(2008-5#3)
supporting cell##4##2##(1994-5#1)(1995-11#1)(2008-10#1)(2012-1#1)
supporting cells##7##2##(1993-9#1)(1994-6#1)(2006-11#1)(2012-12#1)(2012-2#3)
supporting computer##2##2##(1994-3#1)(2008-7#1)
supporting data##3##2##(1991-5#1)(2008-4#1)(2011-2#1)
supporting each other##2##3##(1993-3#1)(2006-1#1)
supporting each##3##2##(1993-3#1)(2006-1#1)(2008-8#1)
supporting electrolyte and oxygen removing agent##2##6##(2008-10#2)
supporting electrolyte and##6##3##(2005-11#1)(2008-10#5)
supporting electrolyte in the##2##4##(2008-10#2)
supporting electrolyte on the##2##4##(2008-10#2)
supporting electrolyte solution##2##3##(2008-10#1)(2008-5#1)
supporting electrolyte was##3##3##(2008-10#3)
supporting electrolyte##46##2##(2005-11#4)(2008-10#40)(2008-5#1)(2010-2#1)
supporting electrolytes##7##2##(2008-10#7)
supporting evidence##8##2##(1991-6#1)(1992-10#1)(2005-10#1)(2008-10#1)(2008-3#2)(2011-12#1)(2012-2#1)
supporting functional##2##2##(1996-5#1)(2008-7#1)
supporting growth of##4##3##(1995-11#1)(2008-11#3)
supporting growth##6##2##(1995-11#1)(1995-2#1)(2008-11#4)
supporting health##3##2##(1996-12#1)(2008-12#1)(2012-12#1)
supporting information##2##2##(1997-3#1)(2008-9#1)
supporting it##2##2##(1991-8#1)(1996-12#1)
supporting its##5##2##(1994-12#1)(2008-10#1)(2009-10#1)(2010-10#1)(2010-5#1)
supporting ligands##2##2##(2010-5#1)(2010-8#1)
supporting literature##3##2##(2006-2#1)(2008-4#1)(2008-6#1)
supporting our##6##2##(1995-12#1)(1996-5#1)(2008-11#2)(2008-3#1)(2012-12#1)
supporting patients and##2##3##(2008-7#1)(2010-8#1)
supporting positive##2##2##(2007-12#1)(2013-1#1)
supporting primary school aged children with ASNs##2##7##(2012-12#2)
supporting role##3##2##(1994-8#1)(2008-10#1)(2013-8#1)
supporting structures##4##2##(1997-1#1)(2006-2#1)(2012-3#2)
supporting students##2##2##(2008-11#1)(2008-12#1)
supporting studies and reference literature##2##5##(2006-2#2)
supporting substrate##2##2##(1991-2#1)(2008-7#1)
supporting systems##2##2##(1995-12#1)(2012-1#1)
supporting that##5##2##(1990-12#1)(2007-10#1)(2008-1#1)(2008-5#1)(2012-12#1)
supporting the &quot##2##3##(2012-12#2)
supporting the benefit of##2##4##(2005-7#1)(2010-4#1)
supporting the case for##2##4##(2010-8#1)(2013-1#1)
supporting the concept that##3##4##(2008-5#1)(2008-7#1)(2008-8#1)
supporting the concept##4##3##(1992-12#1)(2008-5#1)(2008-7#1)(2008-8#1)
supporting the conclusion that the##2##5##(2008-4#1)(2008-7#1)
supporting the conclusion that##3##4##(2008-4#1)(2008-7#1)(2012-11#1)
supporting the development of##2##4##(2007-11#1)(2008-3#1)
supporting the diagnosis of##3##4##(1992-8#1)(2008-9#1)(2010-2#1)
supporting the formation of##2##4##(2008-3#1)(2010-4#1)
supporting the highest##2##3##(1996-11#1)(2008-10#1)
supporting the hypothesis of a##2##5##(1990-8#1)(2008-10#1)
supporting the hypothesis of##3##4##(1990-8#1)(2008-10#2)
supporting the hypothesis that the##5##5##(1991-9#1)(1994-10#1)(1995-2#1)(1997-7#1)(2009-3#1)
supporting the hypothesis that this##2##5##(1994-10#1)(2009-8#1)
supporting the hypothesis that##19##4##(1990-5#1)(1991-9#2)(1994-10#2)(1995-2#2)(1997-5#1)(1997-7#1)(2005-7#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#1)(2011-12#1)
supporting the hypothesis##25##3##(1990-5#1)(1990-8#1)(1991-9#2)(1994-10#2)(1995-2#2)(1997-1#1)(1997-5#1)(1997-7#1)(2005-7#1)(2007-1#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#1)(2011-12#1)
supporting the idea of a##2##5##(1995-12#1)(2013-8#1)
supporting the importance of##3##4##(2008-9#1)(2010-3#1)(2010-4#1)
supporting the involvement of##3##4##(2008-7#1)(2011-2#2)
supporting the monophyly of##2##4##(2008-10#1)(2010-3#1)
supporting the need for##2##4##(2007-7#1)(2012-11#1)
supporting the notion that##8##4##(1990-1#1)(1990-5#1)(1994-12#1)(1996-8#1)(2008-11#1)(2010-8#1)(2012-3#1)(2013-8#1)
supporting the reliability##2##3##(2008-12#1)(2011-2#1)
supporting the role of this##2##5##(1995-2#1)(2009-8#1)
supporting the role of##8##4##(1995-2#1)(1997-3#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)
supporting the use of the##2##5##(2011-2#1)(2013-7#1)
supporting the use of##13##4##(2005-7#1)(2005-8#1)(2006-7#1)(2007-7#1)(2007-9#1)(2008-11#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
supporting the validity of##4##4##(1990-2#1)(2008-12#1)(2008-7#1)(2008-8#1)
supporting the view that the##4##5##(1990-5#1)(1994-11#1)(1995-5#1)(2008-1#1)
supporting the view that##11##4##(1990-5#1)(1990-8#1)(1994-11#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-9#1)(2008-1#1)(2008-4#2)(2012-3#1)
supporting the##182##2##(1990-1#1)(1990-2#1)(1990-5#3)(1990-8#3)(1991-1#1)(1991-9#2)(1992-12#2)(1992-2#1)(1992-7#1)(1992-8#2)(1993-12#1)(1994-10#2)(1994-11#1)(1994-12#1)(1995-1#1)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-7#3)(2005-8#1)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#5)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#3)(2009-10#2)(2009-12#1)(2009-3#2)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#3)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#8)(2012-1#1)(2012-11#3)(2012-12#6)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#4)
supporting their validity##2##3##(2008-9#1)(2010-8#1)
supporting their##9##2##(1993-4#1)(2005-7#1)(2007-2#1)(2008-9#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-11#1)
supporting these##5##2##(1994-1#1)(1996-2#1)(2006-10#1)(2008-5#1)(2013-8#1)
supporting this##8##2##(1991-6#1)(1995-8#1)(2007-3#1)(2007-4#1)(2008-12#1)(2008-2#1)(2010-12#1)(2011-2#1)
supporting tissues##3##2##(2004-3#1)(2005-11#1)(2006-8#1)
supporting tools##2##2##(2006-6#1)(2008-4#1)
supporting treatment##3##2##(1992-12#1)(2006-6#1)(2008-5#1)
supporting##550##1##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#3)(1990-8#3)(1991-1#2)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#3)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-3#2)(1993-4#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-10#2)(1994-11#1)(1994-12#4)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#2)(1995-11#2)(1995-12#4)(1995-2#5)(1995-3#1)(1995-5#4)(1995-6#1)(1995-8#1)(1996-1#4)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#3)(1996-3#2)(1996-5#5)(1996-8#2)(1996-9#2)(1997-1#3)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(2004-1#1)(2004-12#1)(2004-3#1)(2005-10#3)(2005-11#8)(2005-5#1)(2005-7#6)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-2#4)(2006-3#1)(2006-5#2)(2006-6#5)(2006-7#2)(2006-8#1)(2006-9#3)(2007-1#1)(2007-10#5)(2007-11#8)(2007-12#5)(2007-2#6)(2007-3#4)(2007-4#4)(2007-5#3)(2007-6#3)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#8)(2008-10#72)(2008-11#21)(2008-12#9)(2008-2#7)(2008-3#12)(2008-4#9)(2008-5#15)(2008-6#6)(2008-7#14)(2008-8#7)(2008-9#6)(2009-10#5)(2009-12#3)(2009-3#4)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#3)(2010-10#1)(2010-12#4)(2010-2#6)(2010-3#2)(2010-4#5)(2010-5#5)(2010-7#2)(2010-8#10)(2011-1#4)(2011-12#3)(2011-2#17)(2012-1#7)(2012-11#10)(2012-12#14)(2012-2#8)(2012-3#10)(2013-1#20)(2013-7#2)(2013-8#9)
supportive acts##2##2##(1992-2#2)
supportive and##4##2##(2006-4#1)(2008-7#1)(2011-1#1)(2012-2#1)
supportive cancer therapy##13##3##(2008-7#13)
supportive cancer##14##2##(2008-7#14)
supportive care and##5##3##(2008-11#1)(2008-3#1)(2008-6#1)(2010-2#1)(2010-9#1)
supportive care for##2##3##(2008-7#1)(2011-2#1)
supportive care in##5##3##(2007-5#1)(2008-7#3)(2012-2#1)
supportive care is##4##3##(2008-7#2)(2012-2#1)(2013-1#1)
supportive care with##2##3##(2008-3#1)(2012-3#1)
supportive care##45##2##(1990-2#1)(1991-8#1)(1994-3#1)(2004-1#1)(2004-3#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-5#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#2)(2008-7#11)(2009-6#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-2#4)(2012-11#2)(2012-2#4)(2012-3#1)(2013-1#2)
supportive cells##3##2##(2007-12#2)(2009-3#1)
supportive design##3##2##(2013-8#3)
supportive designs##2##2##(2013-8#2)
supportive environment##6##2##(1991-3#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-6#1)(2010-9#1)
supportive evidence for the##2##4##(2008-10#1)(2013-1#1)
supportive evidence for##4##3##(2006-8#1)(2008-10#1)(2008-8#1)(2013-1#1)
supportive evidence##10##2##(2006-8#1)(2008-10#2)(2008-11#1)(2008-8#3)(2012-2#1)(2013-1#1)(2013-8#1)
supportive management##2##2##(2005-11#1)(2011-1#1)
supportive measures including##2##3##(2011-2#1)(2012-12#1)
supportive measures##10##2##(1994-4#1)(1995-10#1)(2004-11#1)(2006-10#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
supportive network##2##2##(1997-2#1)(2008-11#1)
supportive of adoption of##2##4##(2010-11#2)
supportive of relational##2##3##(2010-4#2)
supportive of the##6##3##(1995-10#1)(2006-7#1)(2007-7#1)(2008-10#1)(2010-8#1)(2011-1#1)
supportive of##17##2##(1995-10#1)(1995-12#1)(1997-2#1)(2006-7#1)(2006-9#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-12#1)(2010-11#2)(2010-4#2)(2010-8#1)(2011-1#1)(2012-1#1)(2013-1#1)
supportive oral care##2##3##(2008-7#2)
supportive partnership##2##2##(2007-11#1)(2012-2#1)
supportive processes##2##2##(2008-11#1)(2009-4#1)
supportive psychotherapy##2##2##(2005-7#1)(2011-2#1)
supportive role during##2##3##(2010-9#1)(2013-1#1)
supportive role##7##2##(1992-3#1)(1996-1#1)(2005-10#1)(2010-8#1)(2010-9#1)(2013-1#2)
supportive services##2##2##(1993-12#1)(1996-3#1)
supportive supervision##2##2##(2011-1#1)(2012-12#1)
supportive therapies for##2##3##(1995-1#1)(2012-11#1)
supportive therapies##4##2##(1995-1#1)(2007-7#1)(2012-11#1)(2012-12#1)
supportive therapy##11##2##(1992-10#1)(1993-1#1)(1994-6#1)(2007-7#3)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
supportive treatment##8##2##(2005-7#1)(2009-1#1)(2010-12#1)(2010-3#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
supportive treatments##3##2##(2010-5#1)(2013-1#2)
supportive##243##1##(1990-2#1)(1990-3#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-2#2)(1992-3#2)(1993-1#3)(1993-10#2)(1993-12#2)(1993-2#2)(1994-2#2)(1994-3#1)(1994-4#1)(1994-6#1)(1995-1#1)(1995-10#2)(1995-12#1)(1996-1#1)(1996-12#1)(1996-3#2)(1997-2#2)(2004-1#1)(2004-11#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-10#2)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#5)(2007-12#6)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#3)(2007-7#7)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#9)(2008-12#5)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#29)(2008-8#4)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#5)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#8)(2011-12#1)(2011-2#8)(2012-1#2)(2012-11#4)(2012-12#8)(2012-2#8)(2012-3#5)(2013-1#19)(2013-7#1)(2013-8#9)
supportiveness##2##1##(2008-10#1)(2010-9#1)
supports 48 independent##2##3##(2008-3#2)
supports a model in which the##2##6##(1991-7#1)(2008-8#1)
supports a model in which##3##5##(1991-7#1)(1992-7#1)(2008-8#1)
supports a role for##5##4##(1991-2#1)(1996-2#1)(1997-1#1)(2007-11#1)(2009-10#1)
supports a##33##2##(1990-7#1)(1991-2#2)(1991-6#1)(1991-7#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-2#1)(1996-7#1)(1997-1#1)(2005-7#1)(2006-12#1)(2007-11#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-10#1)(2009-2#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-1#1)
supports an##6##2##(1991-5#1)(1992-7#1)(1994-2#1)(1996-6#1)(1997-6#1)(2007-11#1)
supports and extends##2##3##(2007-6#1)(2008-7#1)
supports and##10##2##(1996-1#1)(1997-3#1)(1997-4#1)(2006-10#2)(2007-6#1)(2008-10#2)(2008-7#1)(2010-8#1)
supports at##2##2##(1997-3#1)(2008-7#1)
supports both##3##2##(1995-1#1)(2009-9#1)(2012-1#1)
supports cell##2##2##(1996-12#1)(2008-11#1)
supports earlier##2##2##(1994-9#1)(2008-5#1)
supports for##11##2##(1990-12#1)(2006-12#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-7#1)(2010-4#1)(2010-7#1)(2012-3#1)(2013-1#1)
supports further##3##2##(1993-10#1)(2004-1#1)(2010-3#1)
supports growth of##2##3##(2004-4#1)(2007-7#1)
supports in vitro##2##3##(1994-9#1)(2008-5#1)
supports in##3##2##(1994-9#1)(2008-10#1)(2008-5#1)
supports its##3##2##(1992-7#1)(1997-6#1)(2006-1#1)
supports normal##2##2##(2008-4#1)(2008-5#1)
supports of##2##2##(1996-8#1)(2007-9#1)
supports our##7##2##(1992-1#1)(1992-5#1)(1994-2#1)(1996-11#1)(2005-11#1)(2008-10#1)(2008-2#1)
supports previous##4##2##(1994-2#1)(1996-11#1)(1997-3#1)(2007-12#1)
supports prior##2##2##(2008-3#1)(2009-3#1)
supports regular##2##2##(2008-11#1)(2008-9#1)
supports that##8##2##(1993-3#1)(2007-6#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
supports the beneficial##2##3##(2006-10#1)(2010-7#1)
supports the claim##2##3##(1990-12#1)(2008-9#1)
supports the concept of##6##4##(1997-4#1)(2006-10#2)(2008-4#1)(2009-4#1)(2009-5#1)
supports the concept that##3##4##(1995-12#1)(1997-5#1)(2005-10#1)
supports the concept##9##3##(1995-12#1)(1997-4#1)(1997-5#1)(2005-10#1)(2006-10#2)(2008-4#1)(2009-4#1)(2009-5#1)
supports the conclusion that the##3##5##(1995-11#1)(2008-10#1)(2009-12#1)
supports the conclusion that##5##4##(1993-12#1)(1995-11#1)(2008-10#1)(2008-9#1)(2009-12#1)
supports the existence of##3##4##(1991-3#1)(2010-6#1)(2013-8#1)
supports the fact that##2##4##(1997-4#1)(2011-2#1)
supports the hypothesis of##4##4##(1994-3#1)(1996-12#1)(2008-10#1)(2012-3#1)
supports the hypothesis that a##2##5##(1993-6#1)(2008-10#1)
supports the hypothesis that the##4##5##(1993-9#1)(1997-1#1)(1997-4#1)(2008-8#1)
supports the hypothesis that they##2##5##(1991-10#1)(1992-9#1)
supports the hypothesis that##33##4##(1990-11#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-8#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-9#1)(2006-10#1)(2006-5#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#2)
supports the hypothesis##37##3##(1990-11#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-8#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-3#1)(1994-6#1)(1996-1#1)(1996-12#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-9#1)(2006-10#1)(2006-5#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
supports the idea of##2##4##(2008-5#1)(2008-8#1)
supports the idea that a##2##5##(1990-5#1)(2006-10#1)
supports the idea that this##2##5##(1994-9#1)(2007-5#1)
supports the idea that##17##4##(1990-11#1)(1990-5#1)(1992-7#1)(1994-12#1)(1994-9#1)(1996-3#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-5#1)(2008-10#2)(2008-7#1)(2010-4#1)(2012-2#2)(2013-1#1)
supports the idea##19##3##(1990-11#1)(1990-5#1)(1992-7#1)(1994-12#1)(1994-9#1)(1996-3#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-5#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-2#2)(2013-1#1)
supports the importance of##4##4##(1990-4#1)(1991-10#1)(2008-10#1)(2009-8#1)
supports the increased##2##3##(2011-2#1)(2013-8#1)
supports the interpretation##2##3##(1997-9#1)(2009-11#1)
supports the need for##2##4##(2007-9#1)(2009-9#1)
supports the need##3##3##(2007-9#1)(2008-11#1)(2009-9#1)
supports the notion that##9##4##(1990-8#1)(1992-10#1)(1994-5#1)(1995-10#1)(2005-10#1)(2006-12#1)(2008-3#1)(2009-6#1)(2012-11#1)
supports the possibility of##2##4##(2008-10#1)(2008-4#1)
supports the possibility##3##3##(1993-1#1)(2008-10#1)(2008-4#1)
supports the presence of##2##4##(2008-10#1)(2010-4#1)
supports the recent##2##3##(2008-4#1)(2009-10#1)
supports the recommendation##2##3##(1991-8#1)(2008-3#1)
supports the role of##6##4##(1990-12#1)(1991-9#1)(2008-3#1)(2008-8#1)(2009-5#1)(2012-12#1)
supports the theory that##5##4##(1992-4#1)(2008-1#1)(2008-7#1)(2009-5#1)(2011-12#1)
supports the theory##6##3##(1992-4#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-12#1)
supports the use of the drug##2##6##(2009-10#2)
supports the use of the##3##5##(2008-11#1)(2009-10#2)
supports the use of these##2##5##(2008-3#1)(2008-9#1)
supports the use of##16##4##(1991-12#1)(1994-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-10#2)(2009-4#1)(2010-10#1)(2011-1#1)(2012-3#1)(2013-1#2)
supports the value of##2##4##(2006-9#2)
supports the view that the##3##5##(1990-10#1)(1990-12#1)(1995-12#1)
supports the view that##12##4##(1990-10#1)(1990-12#1)(1992-10#1)(1993-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(1997-7#1)(2007-11#1)(2008-7#1)(2010-4#1)(2013-7#1)
supports the view##14##3##(1990-10#1)(1990-12#1)(1992-10#1)(1993-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(1996-5#1)(1997-7#1)(2006-9#1)(2007-11#1)(2008-7#1)(2010-4#1)(2013-7#1)
supports the##237##2##(1990-10#2)(1990-11#2)(1990-12#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-10#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-3#4)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#3)(1997-4#4)(1997-5#2)(1997-7#2)(1997-9#2)(2005-10#4)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#9)(2006-11#1)(2006-12#2)(2006-4#1)(2006-5#1)(2006-9#4)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-9#2)(2008-1#1)(2008-10#14)(2008-11#6)(2008-2#2)(2008-3#6)(2008-4#5)(2008-5#3)(2008-7#4)(2008-8#5)(2008-9#8)(2009-10#3)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#2)(2010-12#3)(2010-2#1)(2010-4#3)(2010-6#2)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#8)(2013-7#2)(2013-8#3)
supports their##7##2##(1997-6#1)(2004-11#1)(2006-2#1)(2007-11#1)(2008-10#1)(2009-3#1)(2012-12#1)
supports these##3##2##(1990-8#1)(1996-3#1)(2008-2#1)
supports this##8##2##(1991-5#1)(1992-9#1)(2005-6#1)(2006-9#1)(2008-7#1)(2010-10#1)(2010-12#1)(2011-2#1)
supports to##3##2##(1996-1#1)(1997-2#1)(2010-2#1)
supports was##2##2##(2008-10#2)
supports were##2##2##(1990-12#1)(1990-8#1)
supports with##2##2##(2006-12#1)(2008-10#1)
supports##497##1##(1990-10#2)(1990-11#3)(1990-12#5)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#1)(1991-1#2)(1991-10#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#3)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#4)(1992-8#3)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#4)(1994-2#6)(1994-3#5)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#4)(1995-1#2)(1995-10#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-7#1)(1995-8#1)(1996-1#5)(1996-11#4)(1996-12#3)(1996-2#2)(1996-3#6)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#3)(1997-1#4)(1997-2#4)(1997-3#5)(1997-4#7)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#1)(1997-9#2)(2004-1#1)(2004-11#1)(2004-3#1)(2004-4#1)(2004-9#1)(2005-10#4)(2005-11#1)(2005-12#1)(2005-6#1)(2005-7#3)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#14)(2006-11#1)(2006-12#6)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-9#5)(2007-10#2)(2007-11#9)(2007-12#5)(2007-2#1)(2007-4#2)(2007-5#2)(2007-6#3)(2007-7#1)(2007-8#1)(2007-9#5)(2008-1#4)(2008-10#34)(2008-11#12)(2008-12#4)(2008-2#6)(2008-3#13)(2008-4#12)(2008-5#8)(2008-6#2)(2008-7#10)(2008-8#8)(2008-9#12)(2009-10#5)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#5)(2009-4#3)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#6)(2009-9#2)(2010-10#3)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#5)(2010-6#2)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#9)(2012-1#3)(2012-11#1)(2012-12#13)(2012-2#7)(2012-3#5)(2013-1#15)(2013-7#5)(2013-8#4)
suppose that in##2##3##(1990-5#1)(2005-1#1)
suppose that the##2##3##(1991-9#1)(2004-9#1)
suppose that##12##2##(1990-5#1)(1991-9#1)(1994-6#1)(2004-9#1)(2005-1#1)(2008-10#2)(2008-7#1)(2009-8#1)(2010-2#1)(2010-8#1)(2013-1#1)
suppose##16##1##(1990-5#1)(1991-9#1)(1993-6#1)(1994-2#1)(1994-6#1)(2004-9#1)(2005-1#1)(2006-8#1)(2008-10#2)(2008-7#1)(2009-8#1)(2010-2#1)(2010-8#1)(2012-2#1)(2013-1#1)
supposed that the##3##3##(1990-11#1)(2008-10#1)(2008-5#1)
supposed that##7##2##(1990-11#1)(1996-3#1)(1997-7#1)(2008-10#2)(2008-5#1)(2008-8#1)
supposed to be an##2##4##(2008-10#1)(2012-12#1)
supposed to be responsible for##2##5##(1994-10#1)(2008-11#1)
supposed to be##15##3##(1994-10#1)(1997-3#1)(1997-6#1)(2005-7#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
supposed to have##2##3##(2010-5#1)(2013-7#1)
supposed to##37##2##(1990-12#1)(1990-2#1)(1990-6#1)(1994-10#1)(1995-6#1)(1997-3#1)(1997-6#1)(2005-7#1)(2006-10#4)(2006-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#1)(2009-3#1)(2009-5#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
supposed##64##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-10#1)(1993-11#1)(1994-10#1)(1994-11#1)(1995-6#1)(1996-3#1)(1997-3#2)(1997-6#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-10#4)(2006-7#1)(2006-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#3)(2008-7#3)(2008-8#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
supposedly free##2##2##(2012-3#2)
supposedly##14##1##(1993-11#1)(1994-3#1)(1996-3#1)(2006-12#1)(2006-6#1)(2006-7#1)(2008-3#2)(2008-6#1)(2009-3#1)(2012-12#1)(2012-3#3)
supposition is##2##2##(1990-10#1)(2008-2#1)
supposition that##3##2##(1990-8#1)(2008-9#1)(2011-1#1)
supposition##8##1##(1990-10#1)(1990-8#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-7#1)(2011-1#1)
suppositions##3##1##(2007-1#1)(2007-5#1)(2010-2#1)
suppositories##5##1##(1997-6#1)(2005-7#1)(2006-2#1)(2012-12#2)
suppository##5##1##(2005-7#1)(2007-10#1)(2012-12#2)(2012-3#1)
suppress PTGS##2##2##(2008-10#2)
suppress ascospore germination##2##3##(2008-10#2)
suppress cell proliferation##2##3##(1990-8#1)(2013-1#1)
suppress colorectal##2##2##(2007-4#1)(2008-12#1)
suppress foliar##2##2##(2008-10#2)
suppress growth##2##2##(1994-12#1)(1996-5#1)
suppress in vivo##2##3##(1990-12#1)(1995-1#1)
suppress in##4##2##(1990-12#1)(1990-6#1)(1995-1#1)(2007-7#1)
suppress noise##2##2##(2008-2#1)(2010-2#1)
suppress or prevent##2##3##(2006-10#1)(2009-11#1)
suppress or##10##2##(1991-9#1)(1993-6#1)(2006-10#2)(2008-7#1)(2009-11#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)
suppress plasma##2##2##(1994-8#1)(2011-1#1)
suppress populations of##2##3##(2008-10#2)
suppress populations##3##2##(2008-10#3)
suppress proliferation##2##2##(1992-3#1)(2012-12#1)
suppress replication of##2##3##(2007-11#1)(2011-3#1)
suppress the expression of##2##4##(1994-10#1)(1994-8#1)
suppress the growth of##4##4##(2007-11#1)(2008-4#1)(2008-5#1)(2008-9#1)
suppress the internalization of ADH-I##2##5##(2008-11#2)
suppress the severity of##2##4##(2008-10#2)
suppress the##86##2##(1990-11#1)(1990-2#2)(1990-4#1)(1990-5#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#2)(1996-12#2)(1997-4#1)(1997-6#2)(1997-7#1)(2005-11#1)(2005-7#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#10)(2008-11#6)(2008-12#1)(2008-2#7)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-2#1)(2009-5#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
suppress their##2##2##(1990-8#1)(2008-5#1)
suppress this##2##2##(1993-8#1)(2011-1#1)
suppress##291##1##(1990-11#3)(1990-12#1)(1990-2#3)(1990-4#2)(1990-5#1)(1990-6#2)(1990-8#3)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-3#2)(1992-4#2)(1992-5#1)(1992-7#2)(1992-8#5)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-3#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#2)(1995-2#3)(1995-3#3)(1995-5#1)(1996-11#1)(1996-12#3)(1996-5#1)(1996-8#1)(1997-4#4)(1997-5#1)(1997-6#4)(1997-7#3)(2003-11#1)(2004-11#1)(2005-11#1)(2005-3#1)(2005-7#2)(2006-10#4)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#8)(2007-12#10)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#51)(2008-11#8)(2008-12#2)(2008-2#11)(2008-3#12)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#3)(2009-11#1)(2009-2#1)(2009-5#1)(2009-8#4)(2010-12#3)(2010-2#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#4)
suppressant effect##3##2##(1996-9#1)(2008-6#2)
suppressant##7##1##(1992-10#1)(1996-9#1)(2006-10#1)(2008-10#1)(2008-6#2)(2012-2#1)
suppressants##9##1##(1996-12#3)(2006-10#1)(2007-1#1)(2008-2#2)(2012-2#1)(2012-3#1)
suppressed Fusarium wilt##2##3##(2008-10#2)
suppressed P##2##2##(2008-10#2)
suppressed Pythium##2##2##(2008-10#2)
suppressed after##4##2##(1993-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
suppressed an##2##2##(1993-11#1)(2008-10#1)
suppressed and the##3##3##(1993-9#1)(1994-12#1)(2008-5#1)
suppressed and##9##2##(1993-9#1)(1994-12#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-8#1)
suppressed at##3##2##(2008-10#2)(2008-11#1)
suppressed below##3##2##(2007-11#1)(2009-5#1)(2010-12#1)
suppressed both the##4##3##(1994-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
suppressed both##6##2##(1994-12#1)(1994-9#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
suppressed by a##5##3##(1993-8#1)(1994-8#1)(1995-11#1)(2008-2#1)(2012-3#1)
suppressed by an##3##3##(1994-9#1)(2007-11#1)(2011-2#1)
suppressed by follistatin##2##3##(1992-4#1)(1992-8#1)
suppressed by high##2##3##(1994-3#1)(2008-10#1)
suppressed by the addition of##5##5##(1990-3#1)(1991-6#1)(1997-2#1)(2008-10#2)
suppressed by the simultaneous##2##4##(1992-6#1)(2007-12#1)
suppressed by the##26##3##(1990-11#1)(1990-3#1)(1991-1#1)(1991-4#1)(1991-6#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-8#1)(1996-11#1)(1997-1#2)(1997-2#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2012-12#1)(2013-8#1)
suppressed by those of the##2##5##(2013-8#2)
suppressed by treatment with##2##4##(1992-7#1)(2006-10#1)
suppressed by treatment##3##3##(1992-7#1)(2006-10#1)(2008-11#1)
suppressed by use of##3##4##(2007-11#1)(2007-12#2)
suppressed by##114##2##(1990-11#2)(1990-2#3)(1990-3#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#4)(1991-6#2)(1991-7#1)(1992-11#1)(1992-4#2)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#3)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#3)(1995-3#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-1#3)(1997-2#1)(1997-5#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-11#6)(2007-12#5)(2008-10#7)(2008-11#7)(2008-2#3)(2008-3#2)(2008-5#3)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#4)
suppressed conductivity detection##2##3##(1994-9#1)(2013-7#1)
suppressed conductivity##5##2##(1994-9#1)(2005-12#1)(2008-10#2)(2013-7#1)
suppressed damping-off##2##2##(2008-10#2)
suppressed disease##4##2##(2008-10#3)(2012-2#1)
suppressed due to##2##3##(1993-12#1)(2008-8#1)
suppressed during##6##2##(1990-3#1)(1993-12#2)(2009-10#1)(2010-11#1)(2013-8#1)
suppressed either by##3##3##(1993-3#1)(1997-2#1)(2008-4#1)
suppressed for##2##2##(2007-11#1)(2007-12#1)
suppressed growth of##4##3##(2004-1#1)(2008-10#2)(2008-11#1)
suppressed growth##5##2##(2004-1#1)(2006-1#1)(2008-10#2)(2008-11#1)
suppressed in a##2##3##(1994-12#1)(2010-9#1)
suppressed in all##3##3##(2008-10#2)(2011-2#1)
suppressed in comparison with##2##4##(1996-11#1)(1996-6#1)
suppressed in lactating mothers##2##4##(2011-2#2)
suppressed in the presence of##2##5##(1992-8#1)(1994-2#1)
suppressed in the##9##3##(1992-8#1)(1994-2#1)(1997-5#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-8#1)(2013-8#1)
suppressed in##32##2##(1992-4#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-9#1)(1996-11#1)(1996-6#1)(1997-5#1)(2006-8#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-9#1)(2011-2#3)(2013-8#1)
suppressed induction##2##2##(1992-8#1)(2007-11#1)
suppressed it##2##2##(1995-8#1)(2008-11#1)
suppressed its##2##2##(1994-5#1)(1997-4#1)
suppressed mycelial##2##2##(2008-10#2)
suppressed numbers of##2##3##(2008-10#1)(2008-5#1)
suppressed only##4##2##(1991-7#1)(1994-2#1)(1995-10#1)(2008-10#1)
suppressed proliferation##2##2##(1994-3#1)(2009-4#1)
suppressed protein synthesis##2##3##(1994-8#2)
suppressed protein##3##2##(1994-8#2)(2008-10#1)
suppressed secondary axis formation##2##4##(2008-6#2)
suppressed spontaneous##3##2##(1993-5#1)(1997-5#1)(2011-2#1)
suppressed the autologous tumor-specific cytotoxicity##2##5##(1991-9#2)
suppressed the development of##2##4##(1994-2#1)(2008-10#1)
suppressed the disease##3##3##(2008-10#3)
suppressed the expression of##3##4##(2006-12#1)(2009-5#1)(2009-6#1)
suppressed the generation of androstenone##2##5##(2008-5#2)
suppressed the generation of##3##4##(2008-5#2)(2012-12#1)
suppressed the growth of##4##4##(1990-5#1)(1992-11#1)(1993-4#1)(1997-7#1)
suppressed the growth##6##3##(1990-5#1)(1992-11#1)(1993-4#1)(1995-1#1)(1995-2#1)(1997-7#1)
suppressed the invasion of##2##4##(2008-11#2)
suppressed the migration##2##3##(2011-2#1)(2013-8#1)
suppressed the production of##2##4##(1994-8#1)(2006-8#1)
suppressed the responses##2##3##(1994-5#1)(2008-8#1)
suppressed the subsequent##2##3##(1995-2#1)(1996-5#1)
suppressed the uptake of Pb by##2##6##(2008-10#2)
suppressed the uptake of##3##4##(2008-10#3)
suppressed the##109##2##(1990-12#2)(1990-5#3)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-4#2)(1992-5#1)(1993-11#1)(1993-12#3)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-5#3)(1997-1#1)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-3#1)(2008-10#16)(2008-11#6)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
suppressed this##4##2##(1993-11#1)(1995-2#1)(1997-8#1)(2008-11#1)
suppressed to##3##2##(1991-12#1)(1994-8#1)(2008-5#1)
suppressed under##4##2##(1992-4#1)(2008-5#1)(2009-10#1)(2010-11#1)
suppressed weight loss associated with##2##5##(2008-5#2)
suppressed when a##2##3##(2007-12#1)(2008-10#1)
suppressed when##11##2##(1991-4#1)(1992-3#1)(1994-8#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)
suppressed with##5##2##(1994-12#1)(1995-12#2)(1997-2#1)(2008-1#1)
suppressed within##3##2##(2007-12#3)
suppressed##586##1##(1990-11#2)(1990-12#2)(1990-2#5)(1990-3#2)(1990-4#1)(1990-5#4)(1990-7#1)(1990-9#3)(1991-1#1)(1991-11#1)(1991-12#7)(1991-2#3)(1991-3#4)(1991-4#5)(1991-5#2)(1991-6#3)(1991-7#2)(1991-8#1)(1991-9#6)(1992-1#2)(1992-11#4)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#6)(1992-5#2)(1992-6#4)(1992-7#1)(1992-8#5)(1992-9#1)(1993-11#4)(1993-12#9)(1993-2#1)(1993-3#7)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#3)(1993-9#5)(1994-11#1)(1994-12#7)(1994-2#7)(1994-3#3)(1994-5#4)(1994-6#3)(1994-8#12)(1994-9#5)(1995-1#1)(1995-10#1)(1995-11#6)(1995-12#11)(1995-2#8)(1995-3#8)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#5)(1996-1#1)(1996-10#3)(1996-11#2)(1996-12#5)(1996-2#4)(1996-4#1)(1996-5#5)(1996-6#1)(1996-7#1)(1996-9#4)(1997-1#6)(1997-2#5)(1997-4#2)(1997-5#5)(1997-6#6)(1997-7#2)(1997-8#2)(2004-1#1)(2004-11#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-8#2)(2006-9#1)(2007-11#16)(2007-12#18)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#89)(2008-11#35)(2008-12#1)(2008-2#7)(2008-3#5)(2008-4#8)(2008-5#17)(2008-6#4)(2008-7#8)(2008-8#8)(2008-9#4)(2009-10#4)(2009-11#1)(2009-12#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#4)(2010-10#2)(2010-11#2)(2010-12#3)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#14)(2012-1#4)(2012-12#5)(2012-2#3)(2012-3#6)(2013-1#10)(2013-7#2)(2013-8#8)
suppresses a##3##2##(1997-2#1)(1997-8#1)(2008-10#1)
suppresses and delays the##2##4##(1994-8#2)
suppresses any##2##2##(2008-2#1)(2008-3#1)
suppresses both##2##2##(1991-9#1)(2007-12#1)
suppresses endothelial cell##2##3##(1997-1#1)(2010-12#1)
suppresses intestinal##2##2##(2007-11#1)(2009-6#1)
suppresses linear##2##2##(2006-9#1)(2007-12#1)
suppresses long-term potentiation##2##3##(1991-3#1)(1995-2#1)
suppresses the expression of##2##4##(1992-1#1)(2012-2#1)
suppresses the growth of##2##4##(2008-7#1)(2012-3#1)
suppresses the growth##3##3##(1991-5#1)(2008-7#1)(2012-3#1)
suppresses the production of##2##4##(1994-4#1)(1994-6#1)
suppresses the##40##2##(1990-3#1)(1991-5#2)(1991-6#1)(1992-1#1)(1992-6#2)(1992-9#2)(1993-8#1)(1994-12#1)(1994-4#1)(1994-6#2)(1995-12#1)(1995-2#1)(1995-6#2)(1996-12#2)(1996-5#1)(2004-12#1)(2005-3#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
suppresses tumor##3##2##(1996-10#1)(2011-2#1)(2013-1#1)
suppresses##133##1##(1990-2#1)(1990-3#1)(1991-1#1)(1991-3#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#4)(1994-8#3)(1994-9#1)(1995-12#1)(1995-2#4)(1995-6#3)(1996-1#1)(1996-10#1)(1996-12#2)(1996-5#2)(1997-1#2)(1997-2#4)(1997-4#1)(1997-8#1)(2004-11#1)(2004-12#1)(2005-3#2)(2005-7#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-1#1)(2007-11#5)(2007-12#4)(2008-1#1)(2008-10#13)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2009-1#1)(2009-10#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
suppressing DNA##2##2##(2008-10#1)(2008-5#1)
suppressing cell growth##2##3##(2008-11#2)
suppressing cell##4##2##(1994-3#1)(2008-11#2)(2013-1#1)
suppressing effect##2##2##(1993-9#1)(2009-5#1)
suppressing effects##2##2##(1997-7#1)(2011-1#1)
suppressing gastric##2##2##(1994-2#1)(2008-5#1)
suppressing the activity of##3##4##(1990-2#1)(2012-2#1)(2013-1#1)
suppressing the expression of##2##4##(2008-4#1)(2008-8#1)
suppressing the growth of##2##4##(2008-10#1)(2008-5#1)
suppressing the##39##2##(1990-2#1)(1993-7#1)(1994-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(2005-3#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-8#1)(2009-10#1)(2010-10#1)(2010-5#1)(2012-2#1)(2013-1#2)(2013-8#1)
suppressing these##2##2##(2007-12#1)(2008-3#1)
suppressing tumor##2##2##(2012-12#1)(2012-3#1)
suppressing##123##1##(1990-2#1)(1991-1#1)(1991-5#1)(1991-6#1)(1993-12#2)(1993-7#2)(1993-9#2)(1994-11#1)(1994-2#2)(1994-3#1)(1994-8#3)(1996-11#1)(1996-5#2)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(2004-1#1)(2005-10#1)(2005-3#2)(2005-7#1)(2006-1#1)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#5)(2007-5#1)(2007-6#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#21)(2008-11#9)(2008-3#6)(2008-4#2)(2008-5#5)(2008-8#1)(2008-9#1)(2009-10#3)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-8#3)(2011-1#2)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#6)(2013-8#2)
suppression (&gt##2##2##(2007-12#1)(2008-10#1)
suppression and the##2##3##(1995-2#1)(2013-1#1)
suppression and##24##2##(1993-11#1)(1993-12#1)(1994-8#1)(1995-2#2)(2006-10#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-11#2)(2009-3#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
suppression as##2##2##(2008-10#1)(2008-2#1)
suppression assay##2##2##(1994-9#1)(2008-10#1)
suppression at##7##2##(1995-6#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-8#1)
suppression by a##4##3##(2007-12#1)(2008-10#1)(2008-2#2)
suppression by the##4##3##(1997-5#1)(2008-10#3)
suppression by##39##2##(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-8#1)(1995-2#1)(1996-7#1)(1997-1#1)(1997-5#1)(1997-6#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#6)(2008-10#11)(2008-11#1)(2008-2#3)(2008-9#1)(2009-3#1)(2009-9#1)(2011-1#1)(2011-2#1)
suppression can be##2##3##(2007-12#1)(2008-4#1)
suppression can occur by##3##4##(2007-11#3)
suppression can##5##2##(2007-11#3)(2007-12#1)(2008-4#1)
suppression differ##2##2##(2008-10#1)(2010-8#1)
suppression due to##2##3##(1995-8#1)(2007-12#1)
suppression effect of##3##3##(2008-10#2)(2013-8#1)
suppression effect##5##2##(2006-9#1)(2008-10#2)(2013-8#2)
suppression for##2##2##(2008-10#1)(2008-2#1)
suppression has##3##2##(2007-11#1)(2007-7#1)(2008-10#1)
suppression have been##3##3##(2007-11#1)(2009-11#1)(2013-8#1)
suppression have##5##2##(2007-11#1)(2008-10#1)(2008-2#1)(2009-11#1)(2013-8#1)
suppression in a##3##3##(2007-12#2)(2008-10#1)
suppression in the##3##3##(1997-8#3)
suppression in vivo##2##3##(1993-11#1)(1995-3#1)
suppression in##41##2##(1992-10#1)(1992-3#1)(1993-11#1)(1993-5#1)(1994-8#1)(1995-3#2)(1996-4#1)(1997-8#3)(2006-10#2)(2007-11#2)(2007-12#3)(2007-8#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#1)(2009-4#1)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)
suppression induced by##2##3##(1991-8#1)(2011-2#1)
suppression is a##2##3##(2008-2#1)(2011-1#1)
suppression is##24##2##(1991-12#1)(1992-3#1)(1993-11#1)(1995-12#1)(1995-3#3)(1995-8#1)(1996-12#1)(1997-6#1)(2006-2#1)(2007-11#4)(2007-12#3)(2008-10#2)(2008-2#1)(2008-4#1)(2009-3#1)(2011-1#1)
suppression may be##2##3##(2007-11#1)(2008-8#1)
suppression may##4##2##(1993-11#1)(2006-7#1)(2007-11#1)(2008-8#1)
suppression mediated##2##2##(1997-6#1)(2009-11#1)
suppression obtained##2##2##(1997-8#1)(2008-10#1)
suppression occurred##2##2##(1995-2#1)(2008-10#1)
suppression occurs when##2##3##(1996-7#1)(2008-10#1)
suppression occurs##3##2##(1995-3#1)(1996-7#1)(2008-10#1)
suppression of Botrytis cinerea##6##4##(2008-10#6)
suppression of Fusarium crown and root rot of asparagus##2##9##(2008-10#2)
suppression of Fusarium wilt of flax##2##6##(2008-10#2)
suppression of Fusarium wilt##4##4##(2008-10#4)
suppression of Fusarium##6##3##(2008-10#6)
suppression of I(gaba)##2##3##(2008-8#2)
suppression of IAHC##3##3##(2007-7#3)
suppression of IL-6##2##3##(2008-10#1)(2009-9#1)
suppression of LOH in##2##4##(2011-1#2)
suppression of P berghei parasites [P &lt##2##7##(2008-4#2)
suppression of P berghei parasites##3##5##(2008-4#3)
suppression of P##4##3##(2008-10#1)(2008-4#3)
suppression of TdR##3##3##(1991-5#2)(1991-8#1)
suppression of a##4##3##(2006-7#1)(2007-12#1)(2008-10#1)(2008-11#1)
suppression of bacterial amber mutations##2##5##(2009-3#2)
suppression of bacterial##3##3##(2008-10#1)(2009-3#2)
suppression of bone resorption##2##4##(1995-1#1)(2008-3#1)
suppression of both##2##3##(2008-10#1)(2010-1#1)
suppression of cell##7##3##(1992-8#1)(1996-10#1)(2008-10#1)(2008-11#2)(2008-6#1)(2012-12#1)
suppression of cholesterol##3##3##(1996-7#1)(1996-8#1)(2006-12#1)
suppression of colony formation and##3##5##(1997-2#1)(2012-12#2)
suppression of colony formation##4##4##(1990-12#1)(1997-2#1)(2012-12#2)
suppression of complement-induced phagocytosis by##2##5##(1991-4#2)
suppression of damping-off##3##3##(2008-10#3)
suppression of disease##4##3##(1997-8#1)(2008-10#3)
suppression of dollar spot by##2##5##(2008-10#2)
suppression of dollar spot##3##4##(2008-10#3)
suppression of drinking##2##3##(1993-11#1)(2008-4#1)
suppression of endogenous##2##3##(1995-12#1)(2007-11#1)
suppression of fire blight##2##4##(2008-10#2)
suppression of growth##4##3##(1992-10#1)(2006-1#1)(2008-10#1)(2008-8#1)
suppression of hepatitis B virus##2##5##(2008-8#2)
suppression of human##2##3##(1990-7#1)(2008-10#1)
suppression of immune##3##3##(1991-12#1)(2007-11#1)(2013-1#1)
suppression of insects was##2##4##(2007-6#2)
suppression of its##4##3##(1991-9#1)(1992-11#1)(1996-10#1)(2011-2#1)
suppression of maturation##2##3##(2008-5#2)
suppression of neointima formation##2##4##(1992-9#1)(2005-7#1)
suppression of normal##2##3##(1993-11#1)(2008-5#1)
suppression of oxidative stress##2##4##(2011-2#1)(2013-8#1)
suppression of plant pathogens##4##4##(2008-10#4)
suppression of plant##5##3##(2008-10#5)
suppression of plasmin##2##3##(2011-2#2)
suppression of rbcS-m3 expression in MC##2##6##(1994-8#2)
suppression of soilborne##2##3##(2008-10#2)
suppression of spontaneous P-cell##2##4##(1995-7#2)
suppression of stimulated##2##3##(2007-11#1)(2008-3#1)
suppression of the JNK pathway##2##5##(2008-1#2)
suppression of the antibody response##2##5##(2008-10#2)
suppression of the other##2##4##(2008-8#1)(2011-12#1)
suppression of the release of##2##5##(1992-3#1)(2006-8#1)
suppression of the##69##3##(1991-12#1)(1991-2#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#2)(1993-9#1)(1994-6#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-10#1)(1996-11#1)(1996-12#4)(1997-1#1)(1997-2#3)(2004-2#1)(2006-8#2)(2007-11#2)(2007-12#9)(2008-1#2)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-6#3)(2010-11#1)(2010-4#1)(2010-8#1)(2011-12#1)(2012-1#1)(2012-3#1)(2013-1#1)
suppression of their##3##3##(1990-11#1)(2008-11#1)(2008-4#1)
suppression of this##3##3##(2007-9#1)(2008-10#1)(2008-11#1)
suppression of viral load##2##4##(2006-1#1)(2007-11#1)
suppression of viral replication##2##4##(2009-11#2)
suppression of viral##4##3##(2006-1#1)(2007-11#1)(2009-11#2)
suppression of##435##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#1)(1991-11#1)(1991-12#5)(1991-2#1)(1991-4#3)(1991-5#4)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#3)(1992-12#2)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#4)(1992-9#1)(1993-11#3)(1993-12#6)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#3)(1994-10#2)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#5)(1994-8#5)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#8)(1995-2#7)(1995-3#3)(1995-5#1)(1995-6#1)(1995-7#4)(1996-1#1)(1996-10#4)(1996-11#2)(1996-12#5)(1996-2#1)(1996-4#1)(1996-5#4)(1996-7#3)(1996-8#1)(1997-1#3)(1997-2#6)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2004-2#1)(2005-10#1)(2005-6#1)(2005-7#1)(2006-1#3)(2006-10#1)(2006-12#1)(2006-3#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-10#2)(2007-11#13)(2007-12#21)(2007-2#1)(2007-5#2)(2007-6#2)(2007-7#3)(2007-9#1)(2008-1#6)(2008-10#85)(2008-11#15)(2008-2#5)(2008-3#9)(2008-4#10)(2008-5#8)(2008-6#2)(2008-7#6)(2008-8#9)(2008-9#4)(2009-11#2)(2009-2#2)(2009-3#4)(2009-6#5)(2009-8#5)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#2)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#11)(2012-1#2)(2012-12#4)(2012-2#6)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#2)
suppression on##5##2##(1992-1#1)(2007-2#1)(2011-1#1)(2011-2#1)(2012-2#1)
suppression only##2##2##(2008-10#2)
suppression or enhancement##2##3##(2008-10#1)(2010-11#1)
suppression or##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2010-11#1)
suppression resulted##2##2##(2006-12#1)(2006-7#1)
suppression subtractive hybridization##3##3##(2008-11#1)(2008-7#1)(2010-4#1)
suppression test is##2##3##(1995-11#1)(2006-1#1)
suppression test##10##2##(1990-3#2)(1994-11#1)(1995-11#2)(1996-2#1)(2006-1#1)(2006-10#1)(2011-2#2)
suppression therapy##4##2##(2010-10#2)(2010-12#2)
suppression to##2##2##(2008-11#1)(2012-12#1)
suppression using##3##2##(2008-10#3)
suppression was not##2##3##(2008-10#1)(2010-11#1)
suppression was##23##2##(1991-12#2)(1993-5#1)(2007-11#1)(2008-10#14)(2008-11#1)(2008-3#1)(2009-11#1)(2010-11#1)(2013-1#1)
suppression were##2##2##(2008-10#2)
suppression with the##2##3##(1994-2#1)(2011-1#1)
suppression with##5##2##(1994-2#1)(2008-10#3)(2011-1#1)
suppression##845##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#2)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#9)(1991-2#3)(1991-4#3)(1991-5#4)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#3)(1992-3#6)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#4)(1992-9#2)(1993-11#7)(1993-12#12)(1993-2#2)(1993-3#2)(1993-5#3)(1993-6#2)(1993-7#2)(1993-8#2)(1993-9#5)(1994-10#2)(1994-11#3)(1994-12#4)(1994-2#5)(1994-3#2)(1994-5#2)(1994-6#6)(1994-8#7)(1994-9#6)(1995-1#1)(1995-11#3)(1995-12#9)(1995-2#13)(1995-3#10)(1995-5#1)(1995-6#2)(1995-7#4)(1995-8#5)(1996-1#1)(1996-10#4)(1996-11#3)(1996-12#6)(1996-2#3)(1996-4#2)(1996-5#5)(1996-7#6)(1996-8#1)(1997-1#4)(1997-2#6)(1997-4#1)(1997-5#2)(1997-6#4)(1997-7#3)(1997-8#6)(2004-2#1)(2005-10#1)(2005-6#1)(2005-7#2)(2006-1#4)(2006-10#14)(2006-12#3)(2006-2#2)(2006-3#1)(2006-7#7)(2006-8#3)(2006-9#3)(2007-10#2)(2007-11#34)(2007-12#43)(2007-2#2)(2007-5#2)(2007-6#3)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#184)(2008-11#28)(2008-12#1)(2008-2#18)(2008-3#15)(2008-4#16)(2008-5#15)(2008-6#3)(2008-7#10)(2008-8#13)(2008-9#8)(2009-10#1)(2009-11#11)(2009-2#2)(2009-3#7)(2009-4#1)(2009-5#1)(2009-6#5)(2009-8#8)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#4)(2010-12#6)(2010-2#4)(2010-4#5)(2010-5#1)(2010-8#4)(2011-1#12)(2011-12#1)(2011-2#23)(2012-1#4)(2012-12#9)(2012-2#8)(2012-3#12)(2013-1#10)(2013-7#4)(2013-8#5)
suppression)##2##1##(2008-10#1)(2010-12#1)
suppressive action##2##2##(2009-8#2)
suppressive actions##3##2##(1994-11#3)
suppressive activities of##2##3##(1993-8#1)(2008-7#1)
suppressive activity##3##2##(1992-7#1)(1997-2#1)(2011-2#1)
suppressive and##2##2##(2008-10#2)
suppressive effect of##16##3##(1991-3#4)(1991-5#1)(1992-4#1)(1994-3#1)(1995-12#1)(1996-12#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-9#1)(2012-12#1)
suppressive effect on##10##3##(1991-12#1)(1991-7#1)(1991-8#1)(1992-5#1)(1994-2#1)(1996-5#1)(2006-10#1)(2006-6#1)(2008-11#1)(2009-8#1)
suppressive effect was##2##3##(1992-4#1)(2008-5#1)
suppressive effect##31##2##(1991-12#1)(1991-3#4)(1991-5#1)(1991-7#1)(1991-8#1)(1992-4#2)(1992-5#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-5#1)(2006-10#1)(2006-6#1)(2006-8#1)(2008-10#1)(2008-11#2)(2008-5#3)(2008-9#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-12#1)
suppressive effects of##7##3##(1991-4#2)(1994-10#1)(1996-5#1)(2008-10#2)(2008-5#1)
suppressive effects on##2##3##(1996-5#1)(2008-8#1)
suppressive effects##11##2##(1991-4#2)(1994-10#1)(1996-5#2)(2008-10#3)(2008-5#1)(2008-8#1)(2013-8#1)
suppressive function##3##2##(1992-7#1)(1993-3#1)(2008-4#1)
suppressive or conducive##2##3##(2008-10#2)
suppressive or##3##2##(2008-10#3)
suppressive phenotype##3##2##(1996-4#1)(2011-2#2)
suppressive potential of##2##3##(2008-10#1)(2011-12#1)
suppressive response##3##2##(1991-12#3)
suppressive soil and##2##3##(2008-10#2)
suppressive soil had##3##3##(2008-10#3)
suppressive soil##14##2##(2008-10#13)(2009-3#1)
suppressive soils##3##2##(2008-10#3)
suppressive therapy##3##2##(1994-9#1)(2006-10#1)(2008-4#1)
suppressive to##12##2##(2006-3#1)(2007-12#1)(2008-10#9)(2009-3#1)
suppressive##131##1##(1991-10#1)(1991-12#5)(1991-3#4)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-4#2)(1992-5#1)(1992-7#2)(1993-3#1)(1993-4#1)(1993-8#1)(1994-10#1)(1994-11#4)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-4#1)(1996-5#3)(1997-2#1)(1997-6#1)(2006-10#3)(2006-3#1)(2006-6#1)(2006-8#1)(2007-12#1)(2008-10#49)(2008-11#3)(2008-4#4)(2008-5#5)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#3)(2009-8#3)(2010-1#1)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
suppressiveness against##3##2##(2008-10#3)
suppressiveness in the different##2##4##(2008-10#2)
suppressiveness in##3##2##(2008-10#3)
suppressiveness of soils to##2##4##(2008-10#2)
suppressiveness of soils##4##3##(2008-10#4)
suppressiveness of the##2##3##(2008-10#2)
suppressiveness of##10##2##(2008-10#10)
suppressiveness to##3##2##(2008-10#3)
suppressiveness##33##1##(2008-10#33)
suppressor T cell (Ts) clones##2##5##(1991-12#1)(1992-7#1)
suppressor T cell##4##3##(1991-12#1)(1992-7#2)(2007-11#1)
suppressor T cells##2##3##(1990-5#1)(1991-12#1)
suppressor T##8##2##(1990-5#3)(1991-12#2)(1992-7#2)(2007-11#1)
suppressor activity of##2##3##(1995-2#1)(2008-10#1)
suppressor activity##10##2##(1993-11#1)(1994-5#1)(1995-2#1)(1995-6#1)(1997-8#1)(2006-10#1)(2008-10#1)(2009-5#1)(2010-2#1)(2012-12#1)
suppressor and##3##2##(1994-5#1)(2008-9#1)(2012-3#1)
suppressor cells##6##2##(1991-12#1)(1991-6#2)(2008-9#1)(2011-2#1)(2013-1#1)
suppressor factor##2##2##(1990-9#1)(1991-12#1)
suppressor function of##2##3##(1991-5#1)(2009-4#1)
suppressor function##8##2##(1991-12#1)(1991-5#2)(1992-7#1)(1994-12#1)(2008-6#1)(2008-8#1)(2009-4#1)
suppressor functions##3##2##(1991-12#2)(1992-7#1)
suppressor gene in##7##3##(1991-11#1)(1992-3#1)(1993-9#2)(2007-1#1)(2007-5#1)(2008-10#1)
suppressor gene is##5##3##(1994-2#1)(1997-9#1)(2006-8#1)(2009-5#1)(2010-2#1)
suppressor gene of the##3##4##(1995-6#2)(1997-8#1)
suppressor gene p53 may##2##4##(2006-10#1)(2007-9#1)
suppressor gene p53 plays##2##4##(1996-10#1)(2007-11#1)
suppressor gene p53##8##3##(1994-9#1)(1996-10#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-10#2)(2010-12#1)
suppressor gene product p53##2##4##(1996-10#1)(1996-5#1)
suppressor gene product##6##3##(1994-2#1)(1994-8#1)(1996-1#1)(1996-10#1)(1996-5#1)(2009-9#1)
suppressor gene##81##2##(1990-12#1)(1990-6#1)(1991-10#1)(1991-11#2)(1991-2#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-9#2)(1994-12#1)(1994-2#2)(1994-4#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-2#1)(1995-6#2)(1996-1#2)(1996-10#3)(1996-11#1)(1996-5#1)(1996-6#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#2)(2006-10#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#4)(2009-11#1)(2009-5#2)(2009-9#2)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#2)(2013-1#2)
suppressor genes and##3##3##(1993-3#1)(1993-8#1)(2011-2#1)
suppressor genes are##3##3##(1995-2#2)(2013-8#1)
suppressor genes in##4##3##(1990-12#1)(2007-12#1)(2008-7#2)
suppressor genes may##2##3##(1997-2#1)(2007-11#1)
suppressor genes that are##2##4##(1993-3#1)(2009-5#1)
suppressor genes##46##2##(1990-12#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-4#2)(1995-2#3)(1995-6#1)(1995-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2003-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-7#4)(2008-8#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#1)(2011-2#6)(2013-1#2)(2013-8#2)
suppressor in##4##2##(1990-9#1)(2008-1#1)(2008-8#1)(2011-2#1)
suppressor macrophages##2##2##(2008-8#2)
suppressor mechanisms##3##2##(2008-8#1)(2011-1#1)(2012-12#1)
suppressor mutations that##2##3##(1997-1#2)
suppressor mutations##6##2##(1991-6#1)(1993-11#2)(1995-6#1)(1997-1#2)
suppressor of##17##2##(1991-8#1)(1992-5#1)(1992-7#1)(1994-10#1)(1994-12#1)(1994-3#1)(1995-6#2)(1995-8#2)(1996-9#1)(2006-6#1)(2008-10#2)(2009-5#1)(2011-1#1)(2012-12#1)
suppressor p53##7##2##(1991-11#1)(1996-4#2)(2007-8#1)(2009-10#1)(2009-7#1)(2011-2#1)
suppressor protein##9##2##(1994-12#1)(1995-6#1)(1995-7#1)(2003-11#1)(2006-12#1)(2009-9#2)(2010-12#1)(2011-1#1)
suppressor proteins##4##2##(1995-6#1)(2008-11#1)(2009-8#1)(2011-2#1)
suppressor tRNA##4##2##(1993-11#1)(1997-1#1)(2008-9#1)(2009-3#1)
suppressor##282##1##(1990-12#2)(1990-5#3)(1990-6#1)(1990-8#1)(1990-9#3)(1991-10#1)(1991-11#3)(1991-12#9)(1991-2#1)(1991-5#2)(1991-6#3)(1991-8#1)(1991-9#1)(1992-3#1)(1992-5#2)(1992-7#6)(1993-11#6)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#3)(1994-10#1)(1994-12#4)(1994-2#2)(1994-3#1)(1994-4#3)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-2#7)(1995-6#11)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#2)(1996-10#3)(1996-11#1)(1996-4#3)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#3)(1997-2#5)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#3)(1997-9#2)(2003-11#3)(2005-7#1)(2006-10#3)(2006-12#2)(2006-6#1)(2006-8#2)(2007-1#1)(2007-11#7)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#15)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#6)(2008-8#6)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#3)(2009-4#2)(2009-5#5)(2009-7#1)(2009-8#2)(2009-9#5)(2010-12#4)(2010-2#3)(2010-3#2)(2011-1#5)(2011-2#21)(2012-12#8)(2012-2#4)(2012-3#1)(2013-1#9)(2013-8#3)
suppressor&quot##2##1##(1995-5#1)(2010-12#1)
suppressor/cytotoxic##2##1##(1991-6#1)(1992-2#1)
suppressors and##3##2##(1997-2#1)(2009-3#1)(2010-5#1)
suppressors can be##2##3##(2007-11#2)
suppressors derived from##2##3##(1993-11#2)
suppressors of the##2##3##(1996-9#1)(1997-6#1)
suppressors of##11##2##(1993-6#1)(1996-9#1)(1997-2#1)(1997-6#2)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#2)
suppressors##33##1##(1990-5#1)(1993-11#5)(1993-6#1)(1996-9#2)(1997-2#3)(1997-6#2)(2005-7#1)(2007-10#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)(2009-12#2)(2009-3#3)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#2)
suppurated clotted##2##2##(2011-2#2)
suppurated##3##1##(2007-7#1)(2011-2#2)
suppuration##6##1##(2008-7#1)(2011-2#2)(2012-11#1)(2012-12#1)(2013-1#1)
suppurations##4##1##(2008-9#1)(2011-11#1)(2011-2#2)
suppurativa and acne conglobata##3##4##(2007-7#3)
suppurativa##10##1##(1993-8#1)(2006-10#4)(2007-7#3)(2009-4#2)
suppurative hidradenitis##2##2##(1992-6#1)(1993-8#1)
suppurative infection##2##2##(2007-12#1)(2010-12#1)
suppurative inflammation##5##2##(2008-9#4)(2010-12#1)
suppurative otitis media##9##3##(2007-2#2)(2008-9#4)(2010-9#1)(2011-12#2)
suppurative##34##1##(1991-1#1)(1991-8#2)(1992-6#1)(1993-8#1)(1994-12#4)(1995-11#1)(1996-3#1)(1997-1#1)(2005-7#2)(2005-8#1)(2007-12#1)(2007-2#2)(2008-12#1)(2008-9#8)(2010-12#2)(2010-9#1)(2011-12#2)(2013-1#1)(2013-8#1)
supra##5##1##(2004-2#1)(2007-7#1)(2007-8#1)(2011-1#2)
supra- and##4##2##(2008-7#3)(2013-1#1)
supra-additive##3##1##(1996-7#1)(2012-12#2)
supra-annual##2##1##(2008-9#2)
supra-linear##2##1##(2008-7#2)
supra-threshold stimulus response scaling##2##4##(2011-1#2)
suprabasal##3##1##(1995-1#2)(2011-2#1)
supracardiac##2##1##(2007-8#1)(2010-5#1)
supracardinal##2##1##(2008-7#1)(2010-11#1)
supracervical (subtotal) hysterectomy (LASH)##2##4##(1994-2#2)
supracervical##3##1##(1994-2#3)
suprachiasmatic nuclei##4##2##(1993-12#1)(1994-2#1)(1996-6#1)(2006-1#1)
suprachiasmatic nucleus (SCN) is##2##4##(1993-12#1)(2009-2#1)
suprachiasmatic nucleus (SCN)##19##3##(1992-3#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-7#2)(1996-1#1)(1996-9#1)(1997-1#2)(1997-5#2)(1997-8#1)(2008-1#1)(2009-2#1)
suprachiasmatic nucleus and##2##3##(1992-4#1)(1994-10#1)
suprachiasmatic nucleus##35##2##(1992-3#2)(1992-4#1)(1992-8#2)(1993-12#3)(1993-9#1)(1994-10#2)(1994-2#2)(1994-5#1)(1995-11#1)(1995-7#3)(1996-1#3)(1996-9#2)(1997-1#3)(1997-5#3)(1997-6#1)(1997-8#1)(2008-1#2)(2009-2#2)
suprachiasmatic##40##1##(1992-3#2)(1992-4#1)(1992-8#2)(1993-12#4)(1993-9#2)(1994-10#2)(1994-2#3)(1994-5#1)(1995-11#1)(1995-7#3)(1996-1#3)(1996-6#1)(1996-9#2)(1997-1#3)(1997-5#3)(1997-6#1)(1997-8#1)(2006-1#1)(2008-1#2)(2009-2#2)
supraclavicular brachial plexus##3##3##(2006-8#1)(2012-2#2)
supraclavicular lymph nodes##3##3##(1990-8#1)(1997-8#2)
supraclavicular##17##1##(1990-8#1)(1994-12#1)(1997-8#2)(2006-8#2)(2006-9#2)(2007-7#1)(2008-7#2)(2011-2#3)(2012-2#3)
supracompetitive prices##2##2##(2006-4#2)
supraconducive temperatures##2##2##(2008-10#2)
supraconducive##4##1##(2008-10#4)
supracondylar fracture##4##2##(2008-12#1)(2010-11#1)(2013-1#1)(2013-8#1)
supracondylar fractures##5##2##(2008-7#1)(2013-1#1)(2013-8#3)
supracondylar humeral fractures##2##3##(2013-8#2)
supracondylar humeral##3##2##(2012-2#1)(2013-8#2)
supracondylar humerus fractures in children##4##5##(2009-3#2)(2013-1#1)(2013-8#1)
supracondylar humerus fractures in##5##4##(2009-3#2)(2013-1#2)(2013-8#1)
supracondylar humerus fractures##6##3##(2009-3#3)(2013-1#2)(2013-8#1)
supracondylar##21##1##(1993-8#1)(2007-2#1)(2008-12#1)(2008-7#1)(2009-3#4)(2010-11#1)(2012-2#1)(2013-1#4)(2013-8#7)
supragingival##2##1##(2006-2#1)(2012-12#1)
supraglottic airway devices##2##3##(2013-1#2)
supraglottic##9##1##(1996-1#1)(2009-10#1)(2010-7#1)(2012-2#2)(2013-1#2)(2013-8#2)
supraglottoplasty##2##1##(1996-1#2)
supragranular layers##2##2##(1995-11#1)(1995-12#1)
supragranular##3##1##(1993-12#1)(1995-11#1)(1995-12#1)
suprahepatic##4##1##(1992-9#2)(2007-7#1)(2008-8#1)
suprahyoid##2##1##(2010-11#1)(2011-2#1)
supramarginal##2##1##(1995-8#1)(2008-9#1)
supramaximal activation of the intact##2##5##(1991-3#2)
supramaximal activation of the##3##4##(1991-3#3)
supramaximal inhibition##3##2##(1992-8#3)
supramaximal##13##1##(1991-3#3)(1992-8#3)(1993-12#2)(2011-2#1)(2013-8#4)
suprameatal approach##3##2##(2008-9#2)(2011-2#1)
supramolecular aggregates was##2##3##(1994-2#2)
supramolecular aggregates##3##2##(1994-2#3)
supramolecular alcohol##2##2##(2010-12#2)
supramolecular architecture##2##2##(2007-11#1)(2008-10#1)
supramolecular assemblies##3##2##(2006-12#1)(2008-4#1)(2010-7#1)
supramolecular assembly##2##2##(2008-4#1)(2010-12#1)
supramolecular catalytic kinetic##2##3##(2008-10#2)
supramolecular chemistry##3##2##(2006-12#2)(2008-8#1)
supramolecular complex##6##2##(2007-11#2)(2008-10#1)(2009-10#3)
supramolecular glue##2##2##(2010-4#2)
supramolecular liquid crystals##2##3##(2008-7#2)
supramolecular metallacycles and metallacages##2##4##(2009-12#2)
supramolecular particle structures##2##3##(2010-4#2)
supramolecular particle##3##2##(2010-4#3)
supramolecular structure##3##2##(1992-7#1)(1993-8#1)(2008-4#1)
supramolecular structures that##2##3##(1993-12#1)(2010-12#1)
supramolecular structures##3##2##(1993-12#1)(2008-8#1)(2010-12#1)
supramolecular system of##2##3##(2008-10#2)
supramolecular system##4##2##(2008-10#4)
supramolecular##74##1##(1992-7#2)(1993-12#1)(1993-8#1)(1994-2#3)(1996-2#1)(2005-11#1)(2006-10#2)(2006-12#9)(2006-4#1)(2007-11#4)(2007-8#1)(2008-10#16)(2008-4#4)(2008-7#3)(2008-8#3)(2009-10#3)(2009-12#3)(2010-12#4)(2010-2#1)(2010-4#6)(2010-5#1)(2010-7#2)(2012-1#1)(2012-2#1)
supranormal##5##1##(1997-8#1)(2005-8#1)(2006-10#1)(2006-4#1)(2008-8#1)
supranuclear palsy (PSP)##6##3##(1990-7#1)(1991-3#1)(1992-8#1)(2008-11#2)(2012-12#1)
supranuclear palsy##17##2##(1990-7#2)(1991-3#2)(1991-8#1)(1992-8#2)(2007-7#1)(2008-11#6)(2008-7#1)(2012-12#2)
supranuclear##21##1##(1990-7#2)(1991-3#2)(1991-8#1)(1992-8#2)(1995-9#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-11#7)(2008-7#1)(2012-12#2)
supraoptic and paraventricular##2##3##(1993-12#1)(1994-10#1)
supraoptic and##3##2##(1993-12#2)(1994-10#1)
supraoptic neurons in##2##3##(1993-4#2)
supraoptic nucleus (SON)##4##3##(1995-12#1)(1995-7#1)(1996-8#1)(2008-8#1)
supraoptic nucleus##18##2##(1990-5#1)(1993-12#2)(1993-4#1)(1994-10#2)(1994-8#1)(1995-12#2)(1995-7#2)(1996-8#2)(1996-9#4)(2008-8#1)
supraoptic##34##1##(1990-11#1)(1990-5#1)(1993-12#5)(1993-4#4)(1994-10#4)(1994-8#1)(1995-12#3)(1995-7#3)(1996-12#2)(1996-8#2)(1996-9#4)(1997-8#2)(2008-7#1)(2008-8#1)
supraorbital##4##1##(1997-8#1)(2006-12#1)(2006-8#1)(2011-2#1)
supraphysiologic doses##3##2##(1991-4#1)(2006-9#2)
supraphysiologic##5##1##(1991-4#1)(2006-9#2)(2007-8#1)(2012-12#1)
suprapubic area##2##2##(2006-6#1)(2008-10#1)
suprapubic pain##2##2##(2008-7#1)(2012-2#1)
suprapubic##12##1##(1992-12#1)(1994-9#1)(1996-1#2)(2006-6#1)(2008-10#2)(2008-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
suprarenal##10##1##(1991-6#1)(1991-9#2)(2007-7#2)(2008-7#1)(2010-12#1)(2011-1#3)
suprascapular nerve##4##2##(2006-7#2)(2008-9#2)
suprascapular##7##1##(2006-10#1)(2006-7#2)(2006-8#1)(2007-7#1)(2008-9#2)
suprasellar extension##2##2##(1993-2#1)(2011-2#1)
suprasellar region##3##2##(2006-1#1)(2012-1#2)
suprasellar variant superior##2##3##(2012-3#2)
suprasellar##13##1##(1993-2#1)(2006-1#1)(2006-5#1)(2007-1#1)(2009-5#1)(2011-2#1)(2012-1#3)(2012-3#3)(2013-1#1)
supraspinal projection neurons##2##3##(1991-9#2)
supraspinal##10##1##(1990-4#1)(1991-1#1)(1991-9#2)(1992-1#1)(1997-2#2)(2009-7#1)(2010-8#1)(2012-1#1)
supraspinatus tendon##4##2##(2008-7#3)(2011-12#1)
supraspinatus##7##1##(1991-4#1)(1992-9#1)(2006-3#1)(2008-7#3)(2011-12#1)
supratentorial infarction##5##2##(2006-7#1)(2007-9#1)(2012-3#3)
supratentorial intraventricular tumors##2##3##(2006-5#2)
supratentorial primitive neuroectodermal tumor with glioblastomatous differentiation##2##7##(2009-1#2)
supratentorial primitive neuroectodermal tumor with##3##5##(2009-1#3)
supratentorial##31##1##(1991-6#1)(1996-6#1)(1997-6#1)(2005-1#1)(2006-12#4)(2006-5#2)(2006-7#2)(2007-12#1)(2007-9#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#3)(2012-12#2)(2012-2#1)(2012-3#3)
suprathreshold 0##2##2##(2011-2#2)
suprathreshold intensity##2##2##(1992-4#1)(2011-2#1)
suprathreshold tests##3##2##(2008-9#3)
suprathreshold##9##1##(1992-3#1)(1992-4#1)(1992-8#1)(2008-9#3)(2011-2#3)
supravalvular##4##1##(1990-9#1)(1995-6#1)(2008-4#2)
supraventricular and ventricular##2##3##(2005-7#1)(2012-1#1)
supraventricular arrhythmia##3##2##(2005-7#1)(2007-8#1)(2013-8#1)
supraventricular arrhythmias##10##2##(1993-10#1)(1995-6#6)(1996-4#1)(2007-9#1)(2008-10#1)
supraventricular ectopic##2##2##(1995-6#2)
supraventricular extrasystoles##3##2##(1996-6#3)
supraventricular tachycardia (PSVT)##2##3##(2006-4#1)(2010-5#1)
supraventricular tachycardia##21##2##(1992-4#1)(1993-2#2)(1995-6#3)(1996-6#1)(2004-10#1)(2006-4#1)(2006-8#2)(2006-9#5)(2008-7#2)(2010-5#1)(2012-3#1)(2013-8#1)
supraventricular tachycardias##5##2##(1996-4#1)(2006-4#1)(2006-8#1)(2008-10#1)(2010-11#1)
supraventricular##54##1##(1991-11#1)(1992-4#1)(1993-10#1)(1993-2#2)(1995-2#1)(1995-6#11)(1996-4#2)(1996-6#6)(2004-10#1)(2005-7#2)(2006-4#3)(2006-8#3)(2006-9#5)(2007-8#1)(2007-9#2)(2008-10#2)(2008-7#2)(2010-11#1)(2010-2#1)(2010-5#2)(2012-1#1)(2012-3#1)(2013-8#2)
supravesical hernia##2##2##(2008-12#2)
supravesical##3##1##(2008-12#2)(2011-2#1)
supravital##3##1##(2006-5#1)(2006-6#1)(2008-4#1)
supreme##3##1##(1996-1#1)(2008-4#1)(2011-12#1)
supx##6##1##(1996-3#6)
sur la##2##2##(2012-2#1)(2013-1#1)
sur le##5##2##(2009-4#1)(2011-2#1)(2012-2#2)(2013-1#1)
sur les données de##2##4##(2013-1#2)
sur les##7##2##(2005-7#1)(2008-2#1)(2008-5#1)(2009-4#1)(2013-1#3)
sur##22##1##(2005-7#1)(2006-10#1)(2007-3#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-4#2)(2011-2#4)(2012-2#4)(2013-1#6)
sural and optic nerves##3##4##(1993-12#3)
sural nerve##12##2##(1991-10#1)(1992-9#1)(1993-12#5)(1994-2#1)(1995-12#1)(2008-3#2)(2011-2#1)
sural nerves##2##2##(1993-12#1)(1994-2#1)
sural##28##1##(1991-10#1)(1992-9#3)(1993-12#9)(1994-2#4)(1995-12#1)(2008-12#3)(2008-3#2)(2008-4#2)(2009-9#1)(2010-11#1)(2011-2#1)
suramin and##2##2##(1995-11#1)(2008-11#1)
suramin concentration##2##2##(1993-11#1)(1994-9#1)
suramin##36##1##(1990-5#3)(1991-2#1)(1991-7#3)(1993-11#7)(1993-8#1)(1994-9#13)(1995-11#1)(1995-12#4)(1996-9#1)(2008-11#1)(2008-4#1)
sure of the##3##3##(2008-5#1)(2013-1#2)
sure that the##6##3##(1993-1#2)(1995-9#1)(2008-10#1)(2011-1#1)(2011-2#1)
sure that this##2##3##(2006-10#1)(2008-10#1)
sure that##16##2##(1993-1#3)(1993-3#2)(1995-9#2)(2006-10#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#1)
sure to##4##2##(1994-2#1)(2006-10#1)(2008-11#1)(2008-6#1)
sure you##2##2##(2008-11#1)(2010-12#1)
sure##51##1##(1990-8#1)(1993-1#3)(1993-3#2)(1994-2#1)(1994-6#1)(1995-6#1)(1995-9#2)(2004-3#1)(2005-7#1)(2005-9#1)(2006-10#2)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#3)
surely##11##1##(1991-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-1#1)(1995-3#1)(2004-9#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-6#1)
surf clam##3##2##(1992-11#3)
surface (0##4##2##(2008-10#3)(2008-4#1)
surface (triple bond##2##3##(2005-11#2)
surface APP##4##2##(1996-9#4)
surface EMG recording in##3##4##(2011-2#3)
surface EMG recording##4##3##(2011-2#4)
surface EMG##8##2##(1990-6#1)(2011-2#4)(2012-1#1)(2012-2#2)
surface FcepsilonRI expression was##3##4##(2008-11#3)
surface FcepsilonRI expression##4##3##(2008-11#4)
surface H and##2##3##(2008-10#2)
surface a##2##2##(1991-4#1)(2008-4#1)
surface accessibility##3##2##(1992-6#1)(2005-11#2)
surface accumulation##3##2##(2008-9#1)(2009-12#1)(2010-4#1)
surface acidity##4##2##(2005-11#3)(2008-10#1)
surface acoustic wave (SAW) devices##3##5##(2008-10#3)
surface acoustic wave (SAW)##7##4##(2007-12#1)(2007-8#1)(2008-10#4)(2008-3#1)
surface acoustic wave devices##2##4##(2007-12#1)(2008-10#1)
surface acoustic wave##14##3##(2006-5#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#6)(2008-3#1)(2009-5#1)
surface acoustic waves##9##3##(2006-5#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#3)
surface acoustic##24##2##(1995-10#1)(2006-5#2)(2007-11#3)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#7)(2008-3#4)(2009-5#1)
surface active agent in##2##4##(2004-12#2)
surface active agent##5##3##(2004-12#5)
surface active##15##2##(1990-11#1)(2004-12#5)(2005-11#3)(2008-1#1)(2008-10#5)
surface activity is##2##3##(2005-11#1)(2008-10#1)
surface activity of the##4##4##(1990-11#2)(2008-5#1)(2010-4#1)
surface activity of##6##3##(1990-11#2)(2004-12#1)(2008-5#2)(2010-4#1)
surface activity reduction due to##2##5##(2008-10#2)
surface activity was##2##3##(2004-12#1)(2005-11#1)
surface activity##26##2##(1990-11#5)(1994-5#2)(2004-12#3)(2005-11#7)(2008-10#6)(2008-5#2)(2010-4#1)
surface adsorption of##4##3##(2008-1#1)(2011-2#1)(2012-11#2)
surface adsorption##10##2##(2005-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2010-5#1)(2011-2#1)(2012-11#2)
surface after##10##2##(1990-12#1)(1992-1#1)(2005-11#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-5#2)(2013-8#1)
surface air kerma##2##3##(2008-3#2)
surface albedo on##2##3##(2008-2#2)
surface albedo##5##2##(2008-2#4)(2008-3#1)
surface allows the##2##3##(2008-10#2)
surface allows##4##2##(1992-5#1)(2008-10#3)
surface alloying at the##2##4##(2009-11#2)
surface alloying##4##2##(2009-11#4)
surface analysis##8##2##(1995-6#1)(2004-2#1)(2007-5#1)(2008-10#1)(2008-5#1)(2009-11#1)(2009-7#1)(2011-12#1)
surface analytical##2##2##(2005-11#1)(2008-2#1)
surface anchoring##3##2##(2007-12#2)(2009-2#1)
surface and a##8##3##(1990-12#1)(1992-12#1)(1992-6#1)(1995-2#1)(2004-9#1)(2005-11#1)(2008-2#1)(2008-3#1)
surface and an##2##3##(2008-10#1)(2008-3#1)
surface and are##2##3##(2008-1#1)(2008-3#1)
surface and at##2##3##(2008-3#1)(2013-8#1)
surface and bottom##2##3##(2007-5#2)
surface and bulk##2##3##(2008-2#1)(2008-3#1)
surface and ground water##3##4##(2007-10#2)(2008-10#1)
surface and in the##5##4##(1991-1#1)(1992-11#1)(1993-6#1)(2005-11#1)(2008-10#1)
surface and in##8##3##(1991-1#1)(1992-11#1)(1993-6#1)(2005-11#1)(2008-10#2)(2008-3#1)(2008-4#1)
surface and interface##3##3##(2005-11#1)(2006-5#1)(2008-2#1)
surface and intracellular antigens##3##4##(1990-12#2)(2008-9#1)
surface and intracellular##5##3##(1990-12#2)(2008-4#1)(2008-9#2)
surface and is##4##3##(1991-12#1)(1995-5#1)(1996-4#1)(2008-3#1)
surface and middle of##2##4##(2008-9#2)
surface and of##3##3##(1996-12#1)(2005-11#1)(2013-1#1)
surface and on the##2##4##(1992-5#1)(2008-3#1)
surface and subsurface##3##3##(2006-12#2)(2007-5#1)
surface and the##28##3##(1992-6#1)(1993-12#1)(2004-9#2)(2005-11#3)(2006-12#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-7#1)
surface and then##2##3##(2008-1#1)(2008-7#1)
surface and to##5##3##(2008-1#1)(2008-10#2)(2008-5#1)(2012-12#1)
surface and was##2##3##(2008-10#2)
surface and wastewaters##3##3##(2008-10#3)
surface and within##2##3##(2006-6#1)(2010-10#1)
surface and##203##2##(1990-12#4)(1990-4#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-3#1)(1992-11#2)(1992-12#1)(1992-5#2)(1992-6#2)(1993-12#1)(1993-5#1)(1993-6#2)(1994-6#1)(1994-9#1)(1995-2#2)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-6#1)(2004-9#3)(2005-11#14)(2006-10#2)(2006-11#3)(2006-12#4)(2006-2#1)(2006-5#1)(2006-6#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-5#3)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#33)(2008-11#4)(2008-2#9)(2008-3#20)(2008-4#6)(2008-5#7)(2008-7#3)(2008-8#2)(2008-9#8)(2009-12#1)(2009-3#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-4#3)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-12#2)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#1)
surface antigen (HBsAg) and##2##4##(2008-8#1)(2012-3#1)
surface antigen (HBsAg)##18##3##(1991-9#1)(1994-11#1)(1995-2#1)(1997-4#2)(1997-6#1)(2006-1#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
surface antigen and##4##3##(2007-12#1)(2007-2#1)(2008-11#1)(2010-12#1)
surface antigen expressed on##2##4##(2010-12#1)(2011-2#1)
surface antigen expressed##3##3##(1995-5#1)(2010-12#1)(2011-2#1)
surface antigen expression##3##3##(1996-9#1)(2005-10#1)(2008-10#1)
surface antigen from##2##3##(1990-6#1)(1997-5#1)
surface antigen of##2##3##(1991-3#1)(2008-11#1)
surface antigen was##2##3##(1991-9#1)(2005-12#1)
surface antigen##70##2##(1990-6#1)(1991-3#1)(1991-6#1)(1991-9#6)(1992-5#1)(1992-8#1)(1994-11#2)(1994-5#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-5#2)(1996-9#1)(1997-4#4)(1997-5#1)(1997-6#2)(2005-10#1)(2005-12#3)(2006-1#1)(2006-10#1)(2006-12#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#6)(2008-12#1)(2008-4#1)(2008-8#4)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#1)(2010-12#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
surface antigens for##3##3##(2008-8#1)(2012-12#2)
surface antigens on##2##3##(2009-4#1)(2011-2#1)
surface antigens that are##2##4##(1995-6#1)(2008-4#1)
surface antigens that##5##3##(1995-6#1)(2008-4#1)(2011-1#1)(2012-12#2)
surface antigens##30##2##(1992-8#5)(1993-5#1)(1995-6#1)(1997-7#1)(2005-8#1)(2008-10#2)(2008-4#6)(2008-8#1)(2008-9#4)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#4)
surface appearance##2##2##(2008-5#1)(2010-6#1)
surface appeared##2##2##(1997-6#1)(2007-7#1)
surface are discussed##2##3##(2008-3#2)
surface are##15##2##(1992-2#1)(1995-8#1)(2007-11#1)(2008-2#1)(2008-3#7)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)
surface area and a##3##4##(2005-11#1)(2008-7#1)(2012-3#1)
surface area and micropore volume##2##5##(2005-11#2)
surface area and pore size##2##5##(2005-11#1)(2008-10#1)
surface area and pore volume##3##5##(2005-11#2)(2010-4#1)
surface area and pore##6##4##(2005-11#4)(2008-10#1)(2010-4#1)
surface area and the##3##4##(2008-5#1)(2008-7#1)(2010-4#1)
surface area and volume of##2##5##(2006-10#1)(2008-7#1)
surface area and volume##4##4##(2006-10#1)(2007-12#1)(2008-2#1)(2008-7#1)
surface area and##34##3##(1991-4#1)(1994-8#1)(2004-9#1)(2005-11#10)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#3)(2010-1#1)(2010-4#4)(2010-7#1)(2012-2#1)(2012-3#2)
surface area as##3##3##(1992-5#1)(2007-12#1)(2010-10#1)
surface area by##2##3##(2008-10#1)(2013-1#1)
surface area for##2##3##(2010-10#1)(2013-1#1)
surface area from##2##3##(2008-10#1)(2008-11#1)
surface area in##5##3##(2008-11#2)(2010-10#1)(2010-4#1)(2013-1#1)
surface area is##3##3##(1991-2#1)(2005-11#1)(2008-3#1)
surface area of 3##2##4##(2013-1#2)
surface area of a RF##2##5##(2005-11#2)
surface area of a##3##4##(2005-11#2)(2013-1#1)
surface area of the exposed##2##5##(2008-2#1)(2011-2#1)
surface area of the##18##4##(1990-10#1)(1993-7#1)(1994-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(2004-9#2)(2005-11#3)(2006-10#1)(2008-10#2)(2008-2#1)(2008-9#1)(2011-2#2)
surface area of##39##3##(1990-10#1)(1993-12#1)(1993-7#1)(1994-5#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#2)(2004-9#2)(2005-11#5)(2006-10#2)(2008-10#5)(2008-11#2)(2008-2#1)(2008-5#2)(2008-9#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
surface area over diffusion distance (A0/dX) or dialysate over plasma concentration##2##11##(2007-8#2)
surface area over diffusion distance##3##5##(2007-8#3)
surface area per##2##3##(1994-3#1)(2006-10#1)
surface area ratio##2##3##(2005-11#1)(2008-7#1)
surface area than##3##3##(2008-11#1)(2012-12#2)
surface area to the##2##4##(1992-5#1)(2008-10#1)
surface area to##4##3##(1992-5#1)(2008-10#1)(2008-11#1)(2010-12#1)
surface area was##6##3##(1990-11#1)(2004-9#1)(2008-10#2)(2009-11#1)(2013-8#1)
surface area##226##2##(1990-10#1)(1990-11#1)(1990-6#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-4#5)(1992-5#5)(1993-12#3)(1993-7#2)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#2)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#2)(1996-8#3)(1997-1#1)(1997-2#3)(1997-4#1)(1997-7#1)(2004-9#5)(2005-11#31)(2006-10#6)(2006-12#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#5)(2007-9#1)(2008-10#26)(2008-11#7)(2008-2#4)(2008-3#8)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#7)(2008-8#2)(2008-9#2)(2009-11#2)(2009-12#1)(2009-4#2)(2009-7#1)(2010-1#2)(2010-10#4)(2010-12#1)(2010-2#2)(2010-4#8)(2010-5#2)(2010-7#4)(2010-8#1)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#3)
surface area)##2##2##(2004-9#1)(2010-8#1)
surface area-based##2##2##(2006-10#1)(2011-3#1)
surface areas and##2##3##(2007-8#1)(2008-10#1)
surface areas of the##3##4##(1991-4#1)(2004-9#1)(2010-4#1)
surface areas of##9##3##(1990-11#1)(1991-4#1)(1995-1#1)(1995-5#1)(1996-12#1)(2004-9#1)(2008-3#1)(2010-4#1)(2013-1#1)
surface areas were##2##3##(2005-11#1)(2008-10#1)
surface areas##29##2##(1990-11#1)(1990-8#1)(1991-4#2)(1995-1#1)(1995-5#1)(1996-12#1)(1997-2#2)(2004-9#1)(2005-11#3)(2007-12#1)(2007-8#1)(2008-10#5)(2008-3#2)(2010-1#2)(2010-10#1)(2010-2#1)(2010-4#2)(2013-1#1)
surface around##2##2##(1994-5#1)(2008-2#1)
surface as a function of##3##5##(2008-11#1)(2008-3#1)(2008-6#1)
surface as a##5##3##(1994-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)
surface as well as##3##4##(2004-9#1)(2012-11#1)(2012-2#1)
surface as##19##2##(1994-11#1)(1994-8#1)(1996-11#1)(2004-9#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2012-11#1)(2012-2#1)
surface associated with the##2##4##(2008-2#1)(2010-2#1)
surface associated with##3##3##(2008-2#1)(2008-5#1)(2010-2#1)
surface associated##4##2##(1996-12#1)(2008-2#1)(2008-5#1)(2010-2#1)
surface at a##3##3##(2005-11#1)(2008-7#1)(2012-3#1)
surface at different##2##3##(2004-9#1)(2010-4#1)
surface at the##4##3##(2008-3#2)(2008-7#2)
surface at which the##2##4##(2005-11#1)(2007-12#1)
surface at##25##2##(1991-9#1)(1992-6#1)(1994-11#1)(2004-9#1)(2005-11#3)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#3)(2008-7#3)(2010-4#1)(2010-5#1)(2012-3#1)
surface attachment##3##2##(2008-10#2)(2008-11#1)
surface balance##3##2##(1995-8#1)(2005-11#2)
surface based##2##2##(1997-7#1)(2012-11#1)
surface becomes##3##2##(2005-10#1)(2005-11#1)(2012-12#1)
surface before##3##2##(2008-6#1)(2008-7#1)(2013-8#1)
surface between the##4##3##(2006-3#1)(2008-3#1)(2008-8#1)(2009-4#1)
surface between##6##2##(1997-1#1)(2006-3#1)(2008-3#1)(2008-8#1)(2009-4#1)(2013-1#1)
surface binding##7##2##(1990-12#1)(1991-3#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-12#1)(2010-2#1)
surface but##2##2##(1996-2#1)(2009-9#1)
surface by a##3##3##(1990-2#1)(2005-11#1)(2008-5#1)
surface by an##2##3##(2008-10#1)(2008-3#1)
surface by means of##2##4##(2008-2#1)(2008-3#1)
surface by the##5##3##(2005-11#1)(2008-10#1)(2008-5#1)(2009-6#1)(2012-3#1)
surface by use of a##3##5##(2007-12#1)(2008-3#2)
surface by use of##5##4##(2007-12#2)(2008-3#3)
surface by using##3##3##(2008-10#1)(2008-3#1)(2012-12#1)
surface by##49##2##(1990-11#1)(1990-2#1)(1991-7#1)(1994-6#1)(1995-1#1)(2004-4#1)(2005-11#3)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#9)(2008-4#1)(2008-5#3)(2009-6#1)(2010-12#1)(2012-12#1)(2012-3#1)
surface can be##12##3##(1993-12#1)(1994-7#1)(2006-11#1)(2006-7#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2011-1#1)
surface can##15##2##(1993-12#1)(1994-7#1)(2006-11#1)(2006-7#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2011-1#2)(2013-1#1)
surface cell##2##2##(2005-11#1)(2008-10#1)
surface cells##3##2##(2007-11#1)(2008-5#1)(2008-7#1)
surface characteristics and##2##3##(2005-11#1)(2008-10#1)
surface characteristics of the##5##4##(1992-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
surface characteristics of##12##3##(1992-3#1)(2005-11#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-8#1)
surface characteristics##26##2##(1992-3#1)(1997-2#1)(2004-9#1)(2005-11#6)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2012-2#1)(2013-8#5)
surface characterization##3##2##(2005-11#2)(2008-3#1)
surface charge and##2##3##(1994-5#1)(2008-10#1)
surface charge density (about##2##4##(1990-3#2)
surface charge density and the##3##5##(2005-11#1)(2008-5#2)
surface charge density and##4##4##(1990-11#1)(2005-11#1)(2008-5#2)
surface charge density of##2##4##(2008-4#1)(2008-8#1)
surface charge density under##2##4##(2006-10#1)(2008-5#1)
surface charge density##16##3##(1990-11#1)(1990-3#2)(2005-11#2)(2006-10#1)(2008-4#2)(2008-5#4)(2008-8#1)(2008-9#1)(2009-8#2)
surface charge development##2##3##(2008-10#2)
surface charge of##6##3##(1994-3#1)(2005-11#2)(2005-8#1)(2007-8#1)(2013-1#1)
surface charge##56##2##(1990-11#1)(1990-3#3)(1994-3#1)(1994-5#2)(1996-1#1)(1996-7#2)(1997-2#1)(2005-11#12)(2005-8#1)(2006-10#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-4#2)(2008-5#5)(2008-8#6)(2008-9#1)(2009-11#1)(2009-8#3)(2010-2#1)(2010-6#2)(2011-1#1)(2011-2#2)(2013-1#1)
surface charges##10##2##(1994-8#2)(2005-11#7)(2007-9#1)
surface chemical##3##2##(2005-11#1)(2008-5#2)
surface chemistry and##3##3##(2007-11#1)(2007-8#1)(2010-4#1)
surface chemistry changes##2##3##(2006-5#1)(2012-12#1)
surface chemistry in##3##3##(1993-12#1)(2005-11#1)(2008-10#1)
surface chemistry of##4##3##(2005-11#4)
surface chemistry##24##2##(1993-12#2)(1993-3#1)(2005-11#6)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#2)(2010-4#2)(2012-11#2)(2012-12#1)
surface class I##2##3##(2008-4#2)
surface coat##2##2##(1990-2#1)(2006-10#1)
surface coating##7##2##(2008-10#1)(2008-3#2)(2009-2#2)(2010-6#1)(2012-11#1)
surface coatings##3##2##(2008-2#1)(2009-11#1)(2010-4#1)
surface coil##5##2##(1992-3#2)(2012-1#3)
surface coils##4##2##(1990-10#1)(1992-1#1)(1997-8#2)
surface complex##2##2##(1994-8#1)(2005-11#1)
surface complexation models##2##3##(2005-11#2)
surface complexation##3##2##(2005-11#3)
surface complexes##4##2##(2005-11#1)(2008-10#1)(2013-1#2)
surface components##5##2##(1991-12#3)(1991-3#1)(2008-10#1)
surface composed of##2##3##(1994-8#1)(2010-8#1)
surface composition on##2##3##(2005-11#2)
surface composition##7##2##(1993-3#1)(2005-11#3)(2006-12#1)(2008-5#1)(2010-4#1)
surface compositions##2##2##(2008-5#1)(2010-4#1)
surface concentration and flux of##2##5##(2005-11#2)
surface concentration and##3##3##(2005-11#2)(2008-10#1)
surface concentration of the##2##4##(2005-11#1)(2008-10#1)
surface concentration of##10##3##(1990-12#1)(1990-9#1)(1991-2#1)(1991-8#1)(1993-12#1)(2005-11#2)(2008-10#1)(2008-9#1)(2009-2#1)
surface concentration##18##2##(1990-12#1)(1990-9#1)(1991-2#1)(1991-8#1)(1993-12#1)(2005-11#6)(2007-8#1)(2008-10#3)(2008-9#1)(2009-12#1)(2009-2#1)
surface concentrations##2##2##(1991-2#1)(1991-8#1)
surface conditioning procedures##3##3##(2013-8#3)
surface conductance##4##2##(2005-11#4)
surface conformation##2##2##(1990-5#1)(2010-4#1)
surface consists of##2##3##(1993-4#1)(2006-5#1)
surface contact##5##2##(1992-2#1)(1997-6#1)(2007-9#1)(2008-1#1)(2008-6#1)
surface containing##2##2##(2008-10#1)(2010-4#1)
surface contamination##4##2##(2008-10#3)(2008-3#1)
surface contours##2##2##(2008-3#1)(2008-8#1)
surface cooling in##2##3##(1994-5#1)(2007-10#1)
surface cooling##5##2##(1994-5#1)(2006-4#1)(2007-10#1)(2012-2#2)
surface coordination##2##2##(2005-11#1)(2013-1#1)
surface could be##3##3##(2007-9#1)(2008-10#2)
surface coverage by##2##3##(1997-1#1)(2005-11#1)
surface coverage is##2##3##(2005-11#1)(2006-10#1)
surface coverage of the##2##4##(1997-2#1)(2010-4#1)
surface coverage of##5##3##(1997-2#1)(2005-11#1)(2008-10#2)(2010-4#1)
surface coverage##22##2##(1997-1#1)(1997-2#1)(2005-11#5)(2006-10#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#9)(2010-4#2)
surface coverages##2##2##(2005-11#1)(2006-10#1)
surface covered##3##2##(1995-2#1)(2007-12#1)(2008-10#1)
surface curvature##2##2##(1997-2#1)(2009-12#1)
surface curvatures##2##2##(2007-12#1)(2008-3#1)
surface damage in##3##3##(2007-1#1)(2007-12#1)(2008-3#1)
surface damage##9##2##(2006-11#1)(2007-1#2)(2007-12#1)(2008-3#4)(2011-2#1)
surface damages##2##2##(1990-10#1)(2008-3#1)
surface defects of##2##3##(2008-12#1)(2008-3#1)
surface defects##10##2##(1990-7#1)(2007-11#1)(2007-12#2)(2008-12#1)(2008-3#4)(2010-12#1)
surface definition##2##2##(2008-3#2)
surface deformation##9##2##(1990-4#1)(2005-11#2)(2007-12#2)(2008-2#2)(2008-3#1)(2008-8#1)
surface deformations##3##2##(2008-3#1)(2008-6#1)(2009-7#1)
surface densities of##2##3##(1997-2#1)(2005-11#1)
surface densities##10##2##(1993-9#1)(1994-12#1)(1997-2#3)(2005-11#2)(2009-10#3)
surface density of##6##3##(1990-3#1)(1994-2#1)(1994-9#1)(2005-11#2)(2008-9#1)
surface density##7##2##(1990-3#1)(1994-2#1)(1994-9#1)(2005-11#2)(2008-9#1)(2010-4#1)
surface depth##2##2##(2006-12#1)(2008-2#1)
surface details##2##2##(2008-3#2)
surface deviations##2##2##(2008-2#2)
surface diffusion##5##2##(2005-11#3)(2008-7#1)(2010-12#1)
surface dipole##2##2##(1995-8#1)(2007-12#1)
surface disinfection##2##2##(2006-2#2)
surface displacement##3##2##(2007-12#2)(2012-2#1)
surface display of##3##3##(1995-7#1)(1996-10#1)(1997-4#1)
surface display##5##2##(1995-7#1)(1996-10#1)(1997-4#3)
surface distribution##2##2##(1997-6#1)(2005-11#1)
surface does not##2##3##(2008-10#1)(2008-11#1)
surface dose##4##2##(1993-4#1)(2008-3#3)
surface doses##2##2##(2008-3#2)
surface drip system##2##3##(2008-10#2)
surface due to##3##3##(1996-4#1)(2005-11#1)(2008-10#1)
surface during the##3##3##(2005-11#1)(2008-10#1)(2008-5#1)
surface during##12##2##(1992-12#1)(2005-11#1)(2008-10#3)(2008-3#2)(2008-5#1)(2009-12#1)(2010-12#1)(2011-1#1)(2013-8#1)
surface ectoderm and##2##3##(1994-12#2)
surface effects##3##2##(1992-1#1)(2008-2#1)(2008-3#1)
surface elasticity##2##2##(1994-3#1)(2008-10#1)
surface electrodes on##2##3##(2008-2#1)(2011-1#1)
surface electrodes##8##2##(2008-2#1)(2011-1#1)(2011-2#1)(2012-2#5)
surface electrokinetic##2##2##(2005-11#2)
surface electromagnetic wave##2##3##(2007-11#1)(2008-7#1)
surface electromagnetic##4##2##(2007-11#1)(2007-6#2)(2008-7#1)
surface electromyography and##2##3##(1990-6#1)(2008-6#1)
surface electromyography can be used as a tool to##2##9##(2010-6#2)
surface electromyography##10##2##(1990-6#1)(2006-10#1)(2006-3#1)(2007-1#1)(2008-6#1)(2009-6#1)(2010-6#4)
surface elements##2##2##(2005-11#1)(2007-12#1)
surface elevation##2##2##(2007-9#1)(2008-2#1)
surface emission##2##2##(2008-3#2)
surface emissivity in##2##3##(2008-3#1)(2013-8#1)
surface emissivity##4##2##(2008-3#1)(2013-8#3)
surface emitting laser##4##3##(2007-12#1)(2007-8#1)(2008-1#2)
surface emitting##5##2##(2007-12#2)(2007-8#1)(2008-1#2)
surface energies##2##2##(2006-10#1)(2013-8#1)
surface energy##7##2##(1990-7#1)(1994-9#1)(1997-2#1)(2007-8#1)(2009-11#2)(2010-4#1)
surface enhanced Raman scattering of##2##5##(2013-8#2)
surface enhanced Raman scattering##4##4##(2010-7#1)(2013-8#3)
surface enhanced Raman spectroscopy (SERS)##2##5##(2009-8#1)(2010-4#1)
surface enhanced Raman spectroscopy##3##4##(2009-8#1)(2010-4#2)
surface enhanced Raman##8##3##(2005-4#1)(2009-8#1)(2010-4#2)(2010-7#1)(2013-8#3)
surface enhanced laser desorption/ionization time-of-flight##2##5##(2006-9#1)(2011-2#1)
surface enhanced resonance Raman scattering (SERRS)##2##6##(2008-10#2)
surface enhanced resonance Raman scattering##3##5##(2008-10#3)
surface enhanced##14##2##(2005-4#1)(2006-9#1)(2008-10#4)(2009-8#1)(2010-4#2)(2010-7#1)(2011-2#1)(2013-8#3)
surface environment##3##2##(2008-10#1)(2010-5#2)
surface epithelial##5##2##(1991-10#2)(2007-1#1)(2008-6#1)(2013-8#1)
surface epithelium##8##2##(1994-9#1)(1995-12#1)(1997-1#1)(2008-1#1)(2008-4#1)(2008-6#1)(2011-2#2)
surface estimate##2##2##(2008-2#1)(2008-6#1)
surface even##4##2##(1990-12#1)(1994-12#1)(2004-9#1)(2007-8#1)
surface excess##4##2##(1995-8#1)(2005-11#1)(2008-10#2)
surface exhibited a##3##3##(2007-11#1)(2008-10#1)(2010-8#1)
surface exposed##4##2##(1990-11#1)(2009-12#1)(2013-1#2)
surface exposure##2##2##(1995-8#1)(1997-7#1)
surface expression in##2##3##(1993-8#1)(2008-4#1)
surface expression of FcepsilonRI##4##4##(2008-11#4)
surface expression of HLA class I##2##6##(1994-5#1)(1997-9#1)
surface expression of MHC class I##2##6##(1993-9#1)(2007-5#1)
surface expression of the##7##4##(1992-9#1)(1993-12#1)(1993-6#1)(1994-5#1)(2008-11#1)(2008-8#2)
surface expression of##33##3##(1992-11#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#2)(1995-2#4)(1996-2#1)(1997-9#1)(2007-11#1)(2007-5#1)(2008-11#5)(2008-4#1)(2008-8#2)(2008-9#1)
surface expression##43##2##(1992-11#1)(1992-8#1)(1992-9#1)(1993-12#3)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#2)(1994-6#2)(1995-2#5)(1996-11#1)(1996-2#2)(1997-9#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#5)(2008-4#4)(2008-8#2)(2008-9#1)
surface feature##2##2##(2009-11#2)
surface features of##2##3##(2008-3#1)(2009-11#1)
surface features##14##2##(2006-12#1)(2006-5#3)(2007-11#2)(2008-3#2)(2008-5#1)(2009-11#4)(2012-11#1)
surface figure is##2##3##(2008-3#2)
surface figure##4##2##(2007-12#1)(2008-3#3)
surface film##6##2##(1993-3#1)(1996-8#1)(2010-4#2)(2011-2#1)(2013-1#1)
surface flatness##3##2##(2008-2#2)(2008-3#1)
surface flora##2##2##(2010-4#2)
surface fluorescence##4##2##(2008-10#2)(2008-2#1)(2013-8#1)
surface fluorination##2##2##(2008-10#1)(2010-4#1)
surface followed by##3##3##(1997-8#1)(2008-10#2)
surface for a##2##3##(2006-5#1)(2007-12#1)
surface for the##8##3##(1995-2#1)(2006-3#1)(2008-10#3)(2008-3#1)(2009-5#1)(2012-3#1)
surface for##33##2##(1994-11#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-2#1)(2005-11#1)(2006-3#3)(2006-5#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-3#2)(2009-5#1)(2010-4#4)(2011-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
surface force##2##2##(2005-11#2)
surface forces##5##2##(1997-2#1)(2005-11#2)(2006-7#1)(2008-10#1)
surface forms of the same mutant receptor##2##7##(1992-12#2)
surface forms##3##2##(1992-12#2)(2007-12#1)
surface fouling##2##2##(2008-10#1)(2010-5#1)
surface fractal dimensions of the##2##5##(2005-11#2)
surface fractal dimensions of##4##4##(2005-11#4)
surface fractal dimensions##6##3##(2005-11#6)
surface fractal##7##2##(2005-11#6)(2011-2#1)
surface free energies of##2##4##(2005-11#2)
surface free energies##3##3##(2005-11#3)
surface free energy of the##2##5##(2005-11#1)(2010-4#1)
surface free energy of##4##4##(2005-11#3)(2010-4#1)
surface free energy##7##3##(2005-11#4)(2008-5#1)(2009-11#1)(2010-4#1)
surface free##10##2##(2005-11#7)(2008-5#1)(2009-11#1)(2010-4#1)
surface from a##3##3##(2006-7#1)(2008-10#1)(2008-5#1)
surface from water##4##3##(1991-4#2)(1992-5#2)
surface from##18##2##(1991-4#2)(1992-5#2)(1997-1#1)(2006-7#1)(2007-12#1)(2007-4#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-6#1)
surface functional groups##7##3##(2005-11#3)(2008-10#1)(2009-2#1)(2009-7#1)(2012-11#1)
surface functionalities##2##2##(2008-1#1)(2010-5#1)
surface functionalization of##2##3##(2005-11#1)(2010-5#1)
surface functionalization##4##2##(2005-11#1)(2010-2#1)(2010-5#2)
surface galC expression##3##3##(1995-5#3)
surface galC##4##2##(1995-5#4)
surface glycoprotein##11##2##(1990-9#1)(1992-6#1)(1993-11#2)(1993-12#1)(1996-12#1)(1997-7#1)(2005-7#1)(2011-2#1)(2013-1#2)
surface glycoproteins##8##2##(1991-1#1)(1994-12#1)(1994-2#1)(1994-5#1)(1996-4#1)(1997-4#1)(2008-11#1)(2008-9#1)
surface grafted chromophores##2##3##(2008-5#2)
surface grafted##3##2##(2008-5#2)(2010-6#1)
surface gratings##3##2##(2008-2#1)(2008-3#2)
surface groups##4##2##(1990-8#1)(2005-11#3)
surface grown cultures of##2##4##(2008-7#2)
surface had##2##2##(1991-11#1)(2008-10#1)
surface has a##3##3##(2007-12#1)(2008-2#2)
surface has been##3##3##(2008-10#1)(2008-3#1)(2009-11#1)
surface has##10##2##(2005-11#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2009-11#1)(2013-1#1)
surface have been##3##3##(2005-11#2)(2008-10#1)
surface have##5##2##(1993-4#1)(2005-11#2)(2008-10#1)(2008-3#1)
surface height##7##2##(1995-1#4)(2008-3#3)
surface heterogeneity##2##2##(2005-11#1)(2007-12#1)
surface hydration##2##2##(2008-4#1)(2008-5#1)
surface hydrophobicity of##2##3##(1994-2#2)
surface hydrophobicity##8##2##(1994-2#2)(1996-12#2)(2008-10#1)(2010-4#1)(2013-8#2)
surface hydroxyl groups##2##3##(2005-11#1)(2008-10#1)
surface hydroxyl##3##2##(2005-11#2)(2008-10#1)
surface immobilization##2##2##(2006-10#1)(2008-10#1)
surface immunoglobulin##5##2##(1991-2#1)(1991-6#1)(1992-9#1)(1994-3#1)(2008-4#1)
surface in a conical configuration##2##5##(2007-11#1)(2007-12#1)
surface in a##7##3##(1996-5#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2010-4#1)
surface in an##3##3##(2005-4#1)(2010-2#1)(2010-4#1)
surface in terms of##2##4##(2008-2#1)(2008-3#1)
surface in the##12##3##(1994-5#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-2#1)(2010-4#1)(2010-8#1)(2013-8#1)
surface in##51##2##(1990-11#1)(1991-6#1)(1992-7#1)(1994-5#1)(1995-11#1)(1995-2#1)(1996-5#2)(1997-2#1)(2005-11#6)(2005-4#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-10#8)(2008-2#3)(2008-3#3)(2008-5#1)(2008-6#1)(2009-2#1)(2010-2#1)(2010-4#4)(2010-8#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
surface indicated##2##2##(1990-11#1)(2008-10#1)
surface induced##2##2##(2005-11#2)
surface induces##3##2##(1990-2#1)(2007-11#1)(2008-10#1)
surface influences##2##2##(2007-1#2)
surface integrals is##2##3##(2008-3#2)
surface integration##3##2##(2008-3#3)
surface interactions##5##2##(2005-11#1)(2007-12#1)(2008-3#1)(2008-7#1)(2010-4#1)
surface into the##3##3##(1993-3#1)(1995-7#1)(2008-4#1)
surface into##6##2##(1993-3#1)(1995-7#1)(2008-4#1)(2009-12#1)(2010-4#1)(2011-2#1)
surface ions&quot##2##2##(2005-11#2)
surface irregularities##4##2##(2007-12#1)(2008-10#1)(2008-2#2)
surface irregularity##2##2##(2005-11#1)(2008-8#1)
surface is a##2##3##(2007-9#1)(2008-5#1)
surface is calculated##2##3##(2008-2#2)
surface is covered by##2##4##(2008-10#1)(2012-2#1)
surface is covered##3##3##(2007-12#1)(2008-10#1)(2012-2#1)
surface is described##4##3##(2008-3#2)(2008-4#1)(2008-5#1)
surface is illuminated##2##3##(2008-2#2)
surface is presented##3##3##(2007-11#1)(2008-10#2)
surface is proposed##2##3##(2005-11#1)(2007-12#1)
surface is stable##2##3##(2007-8#2)
surface is the##3##3##(2007-12#1)(2008-5#2)
surface is##82##2##(1990-6#1)(1991-5#1)(1991-7#1)(1992-2#1)(1993-12#3)(1993-6#1)(1994-12#1)(1994-5#1)(1994-8#1)(1996-5#1)(2004-9#1)(2005-11#4)(2005-4#1)(2005-7#1)(2006-12#1)(2007-1#1)(2007-11#2)(2007-12#8)(2007-8#2)(2007-9#2)(2008-10#9)(2008-11#3)(2008-2#11)(2008-3#12)(2008-4#1)(2008-5#5)(2009-11#1)(2009-6#1)(2010-10#1)(2010-4#2)(2012-2#1)
surface labeling##3##2##(1992-4#1)(1994-11#1)(1997-4#1)
surface layer of##2##3##(1994-3#1)(2008-10#1)
surface layer##16##2##(1994-3#1)(2005-11#5)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#3)(2013-8#2)
surface layers of##2##3##(2006-12#1)(2008-5#1)
surface layers were##2##3##(2004-9#1)(2005-11#1)
surface layers##18##2##(1992-12#1)(2004-9#6)(2005-11#2)(2006-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2012-2#2)
surface light scattering##3##3##(2008-2#2)(2008-3#1)
surface like##2##2##(2008-10#1)(2011-1#1)
surface lipid##3##2##(1996-5#1)(2008-5#1)(2010-3#1)
surface lipids were##3##3##(1992-5#1)(2008-5#1)(2010-5#1)
surface lipids##11##2##(1992-5#1)(1996-5#1)(2008-4#1)(2008-5#2)(2010-3#4)(2010-5#2)
surface loop##3##2##(1991-5#1)(1995-10#1)(1996-6#1)
surface loops##2##2##(1995-10#1)(1995-3#1)
surface losses##4##2##(2008-2#3)(2008-3#1)
surface lysine residues##2##3##(1990-5#1)(1991-8#1)
surface makes##2##2##(1992-5#1)(2008-10#1)
surface malignancy##5##2##(2006-6#4)(2010-12#1)
surface mapping##4##2##(2008-10#2)(2008-3#2)
surface marker for##2##3##(1994-8#1)(2008-11#1)
surface marker of##2##3##(1995-5#1)(2008-11#1)
surface marker##9##2##(1990-10#1)(1994-8#1)(1995-5#1)(2007-12#1)(2008-11#3)(2011-2#1)(2012-4#1)
surface markers has##2##3##(2008-9#1)(2013-1#1)
surface markers##19##2##(1992-2#1)(1994-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#5)(2008-9#3)(2009-4#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
surface mastoidotomy##2##2##(2008-7#2)
surface materials on marble##2##4##(2008-10#2)
surface materials##4##2##(2008-10#2)(2008-3#1)(2008-8#1)
surface may be##3##3##(1996-4#1)(2008-3#1)(2012-11#1)
surface may##8##2##(1994-2#1)(1996-4#1)(1996-5#1)(1996-8#1)(2007-1#1)(2008-2#1)(2008-3#1)(2012-11#1)
surface measured by##2##3##(2008-2#1)(2008-3#1)
surface measurement##3##2##(2007-7#1)(2008-2#1)(2008-3#1)
surface measurements of##2##3##(2008-2#2)
surface measurements with##2##3##(2008-3#2)
surface measurements##8##2##(2007-7#1)(2008-2#3)(2008-3#4)
surface membrane##4##2##(1990-7#1)(2008-4#2)(2008-8#1)
surface methodology (RSM)##2##3##(2008-10#1)(2008-6#1)
surface methodology##21##2##(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#11)(2008-6#1)(2012-3#2)(2013-1#3)
surface methodology]##3##2##(2012-12#2)(2012-3#1)
surface metrology##4##2##(2008-3#4)
surface microroughness##2##2##(2008-1#1)(2008-2#1)
surface midline##2##2##(1991-3#2)
surface models##2##2##(1994-11#1)(2008-10#1)
surface modification of##3##3##(2005-11#1)(2010-3#2)
surface modification##20##2##(2005-11#4)(2008-10#9)(2008-11#1)(2010-3#2)(2010-8#1)(2010-9#1)(2012-11#1)(2012-2#1)
surface modified##6##2##(2005-4#1)(2007-8#1)(2008-10#2)(2010-1#1)(2013-8#1)
surface modulation##2##2##(2007-12#1)(2008-3#1)
surface molecule##5##2##(1991-6#1)(1995-1#1)(1996-2#2)(1997-7#1)
surface molecules and##6##3##(1991-12#1)(1995-2#1)(2006-6#1)(2008-11#1)(2008-4#1)(2011-1#1)
surface molecules of##2##3##(2008-11#1)(2011-1#1)
surface molecules such as CD4##2##5##(1995-2#1)(2007-11#1)
surface molecules such as##3##4##(1995-2#1)(2007-11#1)(2008-4#1)
surface molecules##23##2##(1990-12#1)(1991-12#1)(1995-2#2)(1996-8#1)(2006-10#3)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-4#4)(2008-8#1)(2008-9#1)(2011-1#3)(2012-2#1)
surface more##3##2##(2004-9#1)(2005-11#1)(2011-2#1)
surface morphologies##3##2##(2008-10#1)(2008-2#1)(2009-7#1)
surface morphology and##2##3##(2009-7#1)(2013-7#1)
surface morphology of deciduous##3##4##(2012-12#3)
surface morphology of the##3##4##(2005-11#1)(2008-5#1)(2012-12#1)
surface morphology of##9##3##(2005-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#4)
surface morphology##25##2##(2004-9#1)(2005-11#2)(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#3)(2008-7#1)(2009-7#2)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#4)(2013-1#1)(2013-7#1)(2013-8#1)
surface mucin##3##2##(1994-9#1)(1996-5#2)
surface mucous cells##2##3##(1993-11#1)(1995-2#1)
surface nanostructure##2##2##(2005-11#1)(2006-6#1)
surface near##3##2##(1997-4#1)(2011-1#1)(2013-8#1)
surface nor##2##2##(2007-11#1)(2009-9#1)
surface normal smoothing##2##3##(2008-6#2)
surface normal##7##2##(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#2)
surface normals##2##2##(2008-6#2)
surface not only##2##3##(2007-12#1)(2008-10#1)
surface occupied by##2##3##(1990-11#1)(2012-1#1)
surface occurs##2##2##(2008-10#1)(2008-7#1)
surface of CCPE##3##3##(2008-10#3)
surface of Escherichia coli##2##4##(1994-11#2)
surface of T##3##3##(1990-11#1)(1991-2#1)(2008-4#1)
surface of a glass plate##2##5##(2008-2#2)
surface of a glass##4##4##(1991-5#1)(2007-8#1)(2008-2#2)
surface of a lens##2##4##(2008-2#1)(2008-3#1)
surface of a metal##3##4##(2005-11#1)(2008-2#1)(2008-7#1)
surface of a quartz crystal##2##5##(2008-10#2)
surface of a thin##4##4##(2005-11#1)(2008-2#2)(2008-3#1)
surface of a##81##3##(1990-12#1)(1990-5#1)(1991-5#1)(1995-4#1)(1996-5#1)(2005-11#2)(2006-4#2)(2006-5#1)(2007-11#1)(2007-12#5)(2007-3#1)(2007-8#3)(2008-1#3)(2008-10#21)(2008-11#1)(2008-2#13)(2008-3#7)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-1#1)
surface of an optical fiber##2##5##(2007-12#2)
surface of an##16##3##(2006-10#1)(2006-4#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#3)(2010-5#1)
surface of both##3##3##(1993-6#1)(2007-11#1)(2008-10#1)
surface of cultured##3##3##(1990-7#1)(1995-6#1)(2008-11#1)
surface of each##2##3##(2007-12#1)(2008-10#1)
surface of fibrin##2##3##(1991-7#2)
surface of human dermal microvascular endothelial##2##6##(1994-8#2)
surface of human##9##3##(1991-5#1)(1994-11#1)(1994-8#2)(1995-2#1)(1996-2#2)(1997-6#1)(2007-11#1)
surface of inoculated##2##3##(2008-10#2)
surface of polystyrene##2##3##(1996-3#1)(2005-11#1)
surface of silica was modified##2##5##(2005-11#1)(2012-12#1)
surface of silica##8##3##(2005-11#2)(2007-11#1)(2008-10#3)(2012-12#1)(2013-8#1)
surface of target cells##4##4##(2006-10#1)(2010-10#1)(2011-1#1)(2012-2#1)
surface of the brain##2##4##(2008-11#1)(2008-4#1)
surface of the chorion##2##4##(2008-12#2)
surface of the cooked##2##4##(2012-12#2)
surface of the dish##2##4##(2011-2#2)
surface of the electrode##7##4##(2007-8#1)(2008-10#6)
surface of the eye##4##4##(2007-1#3)(2008-11#1)
surface of the gap##2##4##(2008-3#2)
surface of the glass##3##4##(2007-12#2)(2010-4#1)
surface of the hollow##2##4##(2007-8#1)(2008-11#1)
surface of the host##4##4##(2008-10#2)(2009-8#1)(2013-1#1)
surface of the left##3##4##(2009-6#1)(2011-2#1)(2012-2#1)
surface of the lens##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
surface of the lipid##3##4##(1994-2#1)(1994-3#1)(2008-11#1)
surface of the plasma membrane##3##5##(1992-12#2)(2008-1#1)
surface of the protein##6##4##(1990-2#1)(1992-9#1)(1993-11#1)(1996-8#1)(1997-5#1)(2006-10#1)
surface of the sample##4##4##(2007-12#1)(2008-10#2)(2008-3#1)
surface of the skin and##2##5##(2008-5#1)(2010-3#1)
surface of the skin##8##4##(2006-7#2)(2008-3#1)(2008-5#3)(2010-3#2)
surface of the substrate##2##4##(2007-12#1)(2008-2#1)
surface of the test##2##4##(2008-11#1)(2008-2#1)
surface of the tibial##2##4##(2008-8#1)(2008-9#1)
surface of the waveguide##2##4##(2007-12#1)(2008-10#1)
surface of the##334##3##(1990-12#1)(1990-2#2)(1990-4#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#3)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-9#1)(1994-11#4)(1994-2#2)(1994-3#2)(1994-4#1)(1994-9#4)(1995-10#1)(1995-11#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-5#3)(1997-7#2)(2004-9#1)(2005-11#12)(2005-12#1)(2005-4#1)(2006-10#4)(2006-12#1)(2006-4#1)(2006-5#4)(2006-6#1)(2006-7#2)(2006-8#1)(2007-1#4)(2007-10#2)(2007-11#5)(2007-12#15)(2007-2#1)(2007-3#1)(2007-5#2)(2007-7#3)(2007-8#10)(2007-9#1)(2008-1#3)(2008-10#62)(2008-11#12)(2008-12#3)(2008-2#11)(2008-3#13)(2008-4#7)(2008-5#19)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#4)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-2#4)(2010-3#2)(2010-4#6)(2010-7#3)(2010-8#1)(2011-1#3)(2011-2#7)(2012-1#3)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#3)(2013-8#3)
surface of these two##2##4##(2008-11#1)(2008-5#1)
surface of these##7##3##(1993-8#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)
surface of##766##2##(1990-11#1)(1990-12#6)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#4)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#5)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#4)(1991-7#5)(1991-8#1)(1991-9#4)(1992-11#1)(1992-12#8)(1992-3#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#3)(1993-11#2)(1993-12#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#1)(1994-11#10)(1994-12#1)(1994-2#3)(1994-3#3)(1994-4#1)(1994-6#1)(1994-8#5)(1994-9#5)(1995-10#1)(1995-11#1)(1995-2#5)(1995-3#5)(1995-4#1)(1995-5#3)(1995-6#5)(1995-7#1)(1995-8#3)(1996-11#2)(1996-2#4)(1996-3#3)(1996-4#1)(1996-5#6)(1996-7#1)(1996-8#3)(1996-9#3)(1997-1#4)(1997-3#2)(1997-4#3)(1997-5#3)(1997-6#1)(1997-7#2)(2004-9#3)(2005-10#1)(2005-11#35)(2005-12#1)(2005-4#1)(2005-5#1)(2005-8#1)(2006-1#2)(2006-10#11)(2006-12#1)(2006-4#4)(2006-5#5)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#5)(2007-10#2)(2007-11#16)(2007-12#27)(2007-2#2)(2007-3#3)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#19)(2007-9#3)(2008-1#10)(2008-10#147)(2008-11#22)(2008-12#3)(2008-2#28)(2008-3#28)(2008-4#16)(2008-5#37)(2008-6#2)(2008-7#14)(2008-8#10)(2008-9#6)(2009-11#3)(2009-12#5)(2009-2#3)(2009-3#3)(2009-4#1)(2009-6#2)(2009-7#3)(2009-8#3)(2010-1#1)(2010-10#2)(2010-12#5)(2010-2#4)(2010-3#2)(2010-4#10)(2010-5#1)(2010-7#6)(2010-8#1)(2010-9#2)(2011-1#5)(2011-12#3)(2011-2#10)(2012-1#4)(2012-11#1)(2012-12#8)(2012-2#8)(2012-3#3)(2013-1#10)(2013-7#1)(2013-8#7)
surface on a##3##3##(2008-10#1)(2008-3#1)(2010-4#1)
surface on the##5##3##(1996-12#1)(2008-10#2)(2010-6#1)(2011-2#1)
surface on##10##2##(1996-12#1)(2008-10#3)(2008-3#1)(2010-4#1)(2010-6#2)(2011-2#1)(2013-8#1)
surface or buried##2##3##(2008-10#2)
surface or##20##2##(1990-3#1)(1991-1#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)
surface orientation##3##2##(2008-5#1)(2008-6#2)
surface oxidation##5##2##(2005-11#2)(2008-10#1)(2008-2#1)(2010-4#1)
surface oxide##4##2##(2004-9#1)(2005-11#1)(2008-3#1)(2009-7#1)
surface oxygen##2##2##(2005-11#1)(2008-11#1)
surface pH and##3##3##(2008-5#3)
surface pH##21##2##(2008-5#20)(2013-1#1)
surface pK(a)##2##2##(2008-10#2)
surface parameterization##2##2##(2008-3#1)(2010-12#1)
surface parameters##2##2##(2008-5#1)(2009-8#1)
surface passivation##3##2##(2005-11#1)(2010-2#1)(2010-4#1)
surface patches##3##2##(2008-6#1)(2008-7#1)(2010-4#1)
surface pattern##2##2##(2007-7#1)(2011-2#1)
surface patterning##2##2##(2006-5#2)
surface patterns of##2##3##(2008-11#1)(2008-5#1)
surface patterns##3##2##(2008-11#1)(2008-2#1)(2008-5#1)
surface physical##2##2##(2005-11#1)(2008-2#1)
surface plasmon microscopy##2##3##(2007-12#2)
surface plasmon polariton##2##3##(2007-11#1)(2008-7#1)
surface plasmon resonance (SPR) biosensor##5##5##(2008-10#3)(2008-11#1)(2008-4#1)
surface plasmon resonance (SPR) sensor##5##5##(2008-10#4)(2008-2#1)
surface plasmon resonance (SPR)##23##4##(2005-11#1)(2008-10#15)(2008-11#1)(2008-2#2)(2008-4#2)(2008-9#1)(2011-1#1)
surface plasmon resonance (SPR)-based##2##4##(2008-4#1)(2013-1#1)
surface plasmon resonance and##2##4##(2008-10#1)(2009-5#1)
surface plasmon resonance biosensor##7##4##(2008-10#7)
surface plasmon resonance biosensors##2##4##(2007-8#1)(2008-10#1)
surface plasmon resonance immunosensor for##2##5##(2007-8#1)(2008-10#1)
surface plasmon resonance sensor with##2##5##(2008-10#2)
surface plasmon resonance sensor##5##4##(2008-10#4)(2008-3#1)
surface plasmon resonance spectroscopy##3##4##(2008-10#1)(2008-3#2)
surface plasmon resonance technique##3##4##(1994-8#1)(1997-4#1)(2008-10#1)
surface plasmon resonance##80##3##(1992-11#1)(1994-11#1)(1994-8#1)(1995-12#1)(1996-7#1)(1997-4#2)(2005-11#1)(2007-11#2)(2007-8#4)(2007-9#1)(2008-10#38)(2008-11#1)(2008-2#5)(2008-3#5)(2008-4#5)(2008-5#2)(2008-9#1)(2009-12#1)(2009-5#1)(2010-2#1)(2010-7#1)(2011-1#2)(2013-1#2)
surface plasmon resonance-based##2##3##(2008-3#1)(2008-4#1)
surface plasmon resonances##3##3##(2008-6#2)(2010-2#1)
surface plasmon##100##2##(1992-11#1)(1994-11#1)(1994-8#1)(1995-12#1)(1996-7#1)(1997-4#2)(2005-11#1)(2007-11#4)(2007-12#5)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#38)(2008-11#1)(2008-2#5)(2008-3#8)(2008-4#6)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-2#2)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#1)(2013-1#2)
surface plasmons and##2##3##(2007-12#2)
surface plasmons at##2##3##(2007-12#2)
surface plasmons can##3##3##(2007-12#1)(2008-2#1)(2008-7#1)
surface plasmons in##2##3##(2008-2#1)(2008-7#1)
surface plasmons##19##2##(2005-11#1)(2007-12#9)(2008-11#1)(2008-2#3)(2008-7#3)(2012-2#2)
surface plays##2##2##(2008-10#1)(2012-1#1)
surface plots##2##2##(2004-12#1)(2008-3#1)
surface possessed##2##2##(1990-12#1)(2008-10#1)
surface potential mapping##2##3##(2008-7#2)
surface potential of##6##3##(2005-11#4)(2005-8#1)(2008-8#1)
surface potential##28##2##(1990-3#1)(1991-3#2)(1991-4#1)(1992-6#1)(1994-5#1)(2005-11#10)(2005-8#1)(2006-7#3)(2008-10#3)(2008-7#4)(2008-8#1)
surface potentials of##2##3##(1992-6#1)(2005-11#1)
surface potentials##7##2##(1991-3#2)(1992-12#1)(1992-6#1)(1994-5#1)(1996-6#1)(2005-11#1)
surface preparation##4##2##(2006-3#1)(2008-4#1)(2008-9#1)(2012-2#1)
surface pressure and##2##3##(1992-12#1)(2008-10#1)
surface pressure measurements##2##3##(2005-11#1)(2009-7#1)
surface pressure necessary for##2##4##(2005-11#2)
surface pressure of##2##3##(1992-12#1)(1997-2#1)
surface pressure##29##2##(1992-12#3)(1992-6#1)(1993-3#1)(1994-3#4)(1994-6#1)(1995-5#1)(1997-2#2)(2005-11#9)(2008-10#3)(2008-2#1)(2009-7#3)
surface pressure-area isotherm##2##3##(2005-11#2)
surface pressures##12##2##(1992-6#1)(1993-3#1)(1995-8#1)(1996-8#1)(2005-11#4)(2008-10#2)(2009-7#2)
surface pretreatment##2##2##(1997-2#1)(2008-10#1)
surface probability##4##2##(1990-4#3)(2008-4#1)
surface profile can be##2##4##(2008-2#1)(2008-5#1)
surface profile of a##3##4##(1992-7#1)(2007-12#1)(2008-3#1)
surface profile of the##2##4##(2008-2#1)(2008-3#1)
surface profile of##6##3##(1992-7#1)(2007-12#1)(2008-2#2)(2008-3#2)
surface profile##22##2##(1992-7#1)(2005-10#1)(2007-11#1)(2007-12#3)(2008-2#7)(2008-3#8)(2008-5#1)
surface profiles##11##2##(2007-12#2)(2008-2#3)(2008-3#5)(2011-2#1)
surface profiling by##2##3##(2008-2#1)(2008-3#1)
surface profiling##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
surface profilometry by wavelength scanning interferometry##2##6##(2008-2#2)
surface profilometry##7##2##(2004-9#1)(2007-12#1)(2008-2#3)(2008-3#1)(2008-5#1)
surface properties and##5##3##(1991-4#1)(2005-11#1)(2007-11#1)(2008-10#1)(2011-1#1)
surface properties of Bacillus licheniformis##2##5##(1990-2#2)
surface properties of the##7##4##(2005-11#4)(2007-7#1)(2008-10#1)(2011-2#1)
surface properties of##18##3##(1990-12#1)(1990-2#2)(1995-8#1)(2005-11#10)(2007-7#1)(2008-10#1)(2011-2#1)(2012-1#1)
surface properties were##2##3##(2005-11#2)
surface properties##43##2##(1990-12#1)(1990-2#2)(1990-4#1)(1991-4#1)(1995-8#1)(2004-9#1)(2005-11#19)(2006-12#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#1)(2009-7#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-1#1)
surface protein##18##2##(1991-12#1)(1991-2#1)(1991-5#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#1)
surface protein-1 (MSP-1)##3##3##(1994-12#2)(2006-4#1)
surface protein-1##4##2##(1994-12#2)(2006-4#1)(2008-4#1)
surface protein-7##2##2##(2012-2#2)
surface proteins may##2##3##(1992-8#1)(1994-6#1)
surface proteins of##2##3##(1996-5#1)(2008-7#1)
surface proteins were##2##3##(1994-2#1)(1997-4#1)
surface proteins##25##2##(1990-10#1)(1991-2#1)(1992-3#1)(1992-8#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-6#2)(1995-7#1)(1995-8#1)(1996-5#1)(1997-4#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#2)(2010-12#1)(2011-1#1)(2011-12#1)(2012-2#1)
surface provides##2##2##(2006-10#1)(2008-10#1)
surface quality and##2##3##(2008-3#2)
surface quality##3##2##(2008-3#3)
surface rather than##4##3##(1993-8#1)(2008-10#3)
surface reaction##3##2##(2005-11#1)(2008-10#2)
surface reactions##6##2##(2005-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2010-12#1)
surface reactivities##2##2##(2010-4#2)
surface reactivity##3##2##(2005-11#1)(2010-4#2)
surface receptor##21##2##(1990-8#2)(1992-12#1)(1992-3#1)(1993-1#1)(1994-11#1)(1994-5#2)(1995-2#1)(1995-8#2)(1996-2#1)(1996-4#1)(2006-10#2)(2007-11#2)(2008-4#1)(2008-7#1)(2010-8#1)(2012-12#1)
surface receptors for##2##3##(1990-2#1)(2008-4#1)
surface receptors on##3##3##(1990-2#1)(2005-12#1)(2007-11#1)
surface receptors##54##2##(1990-2#3)(1991-2#1)(1991-3#1)(1991-5#1)(1992-2#1)(1992-7#1)(1992-8#2)(1993-3#1)(1993-6#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-3#2)(1994-5#1)(1995-2#2)(1995-8#1)(1996-11#1)(1996-2#1)(1997-4#3)(1997-7#1)(2005-12#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-4#9)(2008-7#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-12#2)(2012-2#1)
surface reconstruction##14##2##(2006-11#1)(2007-1#1)(2008-2#3)(2008-5#1)(2008-6#3)(2009-8#2)(2011-1#1)(2012-12#2)
surface reduced##2##2##(2005-11#1)(2008-6#1)
surface reflectance##12##2##(2007-12#1)(2008-2#4)(2008-3#7)
surface reflection##3##2##(2008-2#1)(2008-3#2)
surface reflections##2##2##(2008-3#2)
surface reflectivity##3##2##(2008-2#1)(2008-3#1)(2011-1#1)
surface reflex##3##2##(2007-1#3)
surface region of##2##3##(2008-10#1)(2008-5#1)
surface region##4##2##(2008-10#1)(2008-5#2)(2010-4#1)
surface regions##2##2##(2005-11#1)(2008-7#1)
surface registration##2##2##(2006-12#1)(2009-12#1)
surface relief##9##2##(2007-12#2)(2008-12#1)(2008-2#3)(2008-3#3)
surface reliefs in##2##3##(2008-3#2)
surface reliefs##5##2##(2008-3#5)
surface remained##2##2##(2008-10#1)(2012-2#1)
surface residues of##2##3##(1990-10#1)(1997-4#1)
surface residues##13##2##(1990-10#3)(1990-7#1)(1997-4#1)(1997-8#1)(2008-10#5)(2008-4#1)(2009-3#1)
surface response##4##2##(2007-12#1)(2008-3#1)(2008-5#2)
surface revealed##2##2##(2007-12#1)(2008-10#1)
surface rheological##2##2##(1994-3#1)(2005-11#1)
surface rheology##2##2##(2005-11#1)(2008-10#1)
surface roughening##2##2##(1993-6#1)(2007-12#1)
surface roughness and##11##3##(2004-9#1)(2008-2#5)(2008-3#2)(2009-7#1)(2012-7#1)(2013-1#1)
surface roughness for##3##3##(2008-3#1)(2011-2#1)(2012-2#1)
surface roughness from##2##3##(2007-12#1)(2008-3#1)
surface roughness in##2##3##(2007-12#1)(2008-3#1)
surface roughness is##3##3##(2008-3#3)
surface roughness of the##3##4##(2008-3#2)(2011-2#1)
surface roughness of##16##3##(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#4)(2009-11#1)(2011-2#3)(2012-2#1)
surface roughness on##3##3##(2007-2#1)(2008-3#2)
surface roughness parameters##3##3##(2008-3#1)(2009-7#2)
surface roughness was##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
surface roughness##85##2##(2004-9#1)(2005-11#1)(2006-12#2)(2006-5#2)(2007-11#1)(2007-12#4)(2007-2#5)(2008-10#2)(2008-2#15)(2008-3#33)(2008-7#1)(2009-11#1)(2009-7#4)(2011-1#1)(2011-2#4)(2012-2#4)(2012-7#1)(2013-1#2)(2013-8#1)
surface runoff##2##2##(2006-4#1)(2007-9#1)
surface scattering##9##2##(2007-12#5)(2008-2#1)(2008-3#3)
surface science##3##2##(2008-10#2)(2012-1#1)
surface seawater##3##2##(2008-10#2)(2008-11#1)
surface sediments##5##2##(2007-5#1)(2008-10#2)(2009-8#1)(2011-2#1)
surface segmentation##2##2##(2010-3#2)
surface sensitive techniques##3##3##(1995-12#1)(2010-4#2)
surface sensitive##4##2##(1995-12#1)(2010-4#2)(2010-7#1)
surface shape##9##2##(2005-11#1)(2006-5#1)(2008-2#2)(2008-3#5)
surface signal##2##2##(1995-3#1)(2008-2#1)
surface significantly##2##2##(2007-12#1)(2008-5#1)
surface sites##2##2##(2005-11#2)
surface sloshing##2##2##(2008-2#2)
surface smoothing##4##2##(2005-11#1)(2008-6#3)
surface soil##3##2##(2008-10#2)(2008-11#1)
surface soils##5##2##(2006-12#1)(2008-10#1)(2008-5#2)(2013-8#1)
surface species##3##2##(2005-11#1)(2008-10#1)(2008-2#1)
surface specificity##2##2##(2008-2#1)(2010-7#1)
surface state##3##2##(1995-10#1)(1996-4#1)(2005-11#1)
surface sterilization of##2##3##(2004-11#1)(2008-5#1)
surface sterilized##2##2##(2004-11#1)(2006-9#1)
surface structural##2##2##(1994-8#1)(2008-7#1)
surface structure of##4##3##(1992-1#1)(1997-6#1)(2008-10#1)(2008-11#1)
surface structure##15##2##(1992-1#1)(1997-6#1)(2006-12#1)(2006-7#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2012-1#2)(2013-1#1)
surface structures##7##2##(1990-11#1)(1991-7#1)(1992-2#1)(2005-11#1)(2006-6#1)(2007-12#1)(2008-3#1)
surface studies##2##2##(2008-10#1)(2008-3#1)
surface such that##3##3##(2008-10#2)(2008-2#1)
surface support##2##2##(1996-4#1)(2006-11#1)
surface technology##2##2##(2008-11#1)(2012-2#1)
surface temperature and##3##3##(2008-5#2)(2011-1#1)
surface temperature##24##2##(2006-7#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-2#1)(2008-3#2)(2008-5#6)(2008-7#2)(2008-8#2)(2010-9#1)(2011-1#2)(2012-2#3)
surface temperatures have##2##3##(2008-5#1)(2008-9#1)
surface temperatures##9##2##(1997-2#1)(2006-7#4)(2007-8#1)(2008-3#1)(2008-5#1)(2008-9#1)
surface tension and viscosity of the##2##6##(2008-3#1)(2013-8#1)
surface tension and viscosity of##3##5##(2008-3#1)(2013-8#2)
surface tension and##15##3##(2005-11#9)(2008-2#2)(2008-3#1)(2010-4#1)(2013-8#2)
surface tension at the##2##4##(2005-11#1)(2008-10#1)
surface tension data##3##3##(2005-11#2)(2008-10#1)
surface tension for##2##3##(1996-1#1)(2008-3#1)
surface tension is##7##3##(1992-5#1)(1996-1#2)(2005-11#3)(2010-2#1)
surface tension lowering##5##3##(2005-11#1)(2008-10#4)
surface tension measurements##6##3##(2005-11#3)(2008-10#2)(2011-1#1)
surface tension of a##2##4##(2008-5#2)
surface tension of the##6##4##(1995-3#1)(1996-3#1)(2005-11#3)(2008-5#1)
surface tension of##17##3##(1995-3#1)(1996-3#1)(2005-11#9)(2008-10#1)(2008-5#3)(2008-6#2)
surface tension reduction##3##3##(1994-5#1)(2005-11#2)
surface tension studies##2##3##(2005-11#1)(2011-2#1)
surface tension with##2##3##(2005-11#1)(2008-10#1)
surface tension##122##2##(1990-4#1)(1992-5#2)(1993-3#1)(1994-5#2)(1995-3#1)(1996-1#4)(1996-3#1)(2005-11#48)(2008-10#28)(2008-12#1)(2008-2#3)(2008-3#5)(2008-5#10)(2008-6#2)(2008-8#1)(2009-6#2)(2010-2#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-11#3)(2013-8#2)
surface tensions of solids##2##4##(2005-11#2)
surface tensions of##3##3##(2005-11#2)(2010-4#1)
surface tensions##8##2##(1996-8#1)(2005-11#4)(2006-10#1)(2008-10#1)(2010-4#1)
surface texture##5##2##(2007-5#1)(2008-10#1)(2008-5#2)(2010-4#1)
surface than##4##2##(1991-12#1)(1994-9#1)(2008-10#1)(2008-3#1)
surface that is##7##3##(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-4#1)(2012-3#1)
surface that##19##2##(1992-2#1)(1993-3#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-3#3)(2008-5#3)(2009-7#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-3#1)
surface the##3##2##(2005-11#1)(2007-8#1)(2008-2#1)
surface through a##2##3##(2007-12#1)(2008-10#1)
surface through the##3##3##(2007-8#1)(2008-10#1)(2013-8#1)
surface through##12##2##(1994-8#1)(1995-10#1)(2005-7#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2013-8#2)
surface tissue##2##2##(2008-3#1)(2011-1#1)
surface to be##3##3##(2008-2#1)(2008-3#1)(2010-4#1)
surface to develop##2##3##(2008-10#2)
surface to induce##2##3##(2005-11#2)
surface to the##12##3##(1990-12#1)(1995-6#1)(2007-12#1)(2008-10#2)(2008-3#4)(2008-6#1)(2009-12#1)(2009-7#1)
surface to##36##2##(1990-12#1)(1995-6#1)(1995-8#1)(2005-11#3)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#5)(2008-5#1)(2008-6#1)(2008-8#2)(2009-12#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2013-1#2)(2013-8#1)
surface topographies##2##2##(2004-9#1)(2010-4#1)
surface topography on##2##3##(2004-9#1)(2008-5#1)
surface topography##17##2##(2004-9#4)(2006-4#1)(2006-5#1)(2008-2#2)(2008-3#3)(2008-5#3)(2010-4#2)(2012-2#1)
surface topology##4##2##(2007-8#1)(2008-10#1)(2008-2#2)
surface treated##2##2##(2007-7#1)(2010-4#1)
surface treatment by##2##3##(2008-11#1)(2012-2#1)
surface treatment is required##2##4##(2008-12#1)(2008-2#1)
surface treatment was##2##3##(2008-12#1)(2010-8#1)
surface treatment##20##2##(2004-9#1)(2006-2#1)(2006-3#1)(2006-6#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#3)(2009-7#1)(2009-8#3)(2010-8#1)(2012-2#1)
surface treatments on##2##3##(2005-11#1)(2008-12#1)
surface treatments##9##2##(2005-11#2)(2007-7#1)(2008-11#1)(2008-12#2)(2008-5#1)(2009-11#1)(2009-8#1)
surface type##2##2##(2008-10#1)(2010-4#1)
surface under the##2##3##(2008-10#1)(2008-3#1)
surface under##11##2##(1997-2#1)(2006-3#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#1)(2010-4#1)
surface upon##2##2##(1995-2#1)(2007-12#1)
surface upregulation##2##2##(1994-6#1)(2008-11#1)
surface urothelial involvement##2##3##(2012-2#2)
surface using a##4##3##(2008-10#3)(2012-2#1)
surface using##8##2##(1995-2#1)(2008-10#4)(2012-2#1)(2013-8#2)
surface velocity of a natural debris flow##2##7##(2008-3#2)
surface velocity of##7##3##(2008-2#3)(2008-3#4)
surface vesicles##2##2##(2006-8#1)(2007-9#1)
surface via the##2##3##(1996-10#1)(2008-4#1)
surface via##7##2##(1991-9#1)(1996-10#1)(2005-4#1)(2008-10#2)(2008-4#1)(2010-4#1)
surface viscoelastic##2##2##(2005-11#1)(2008-2#1)
surface viscosity##3##2##(2005-11#1)(2008-10#1)(2008-9#1)
surface was confirmed by##2##4##(2005-11#1)(2010-7#1)
surface was covered with##2##4##(2004-9#1)(2008-10#1)
surface was designed##2##3##(2008-2#1)(2008-3#1)
surface was determined by##2##4##(1990-2#1)(2005-11#1)
surface was determined##5##3##(1990-2#1)(1995-12#1)(2005-11#1)(2008-10#1)(2008-3#1)
surface was found to be##3##5##(2005-11#1)(2007-11#1)(2011-2#1)
surface was found to##4##4##(2005-11#2)(2007-11#1)(2011-2#1)
surface was identified##2##3##(1990-2#1)(2010-10#1)
surface was inhibited##2##3##(1991-3#1)(1992-8#1)
surface was measured by##2##4##(1991-5#2)
surface was monitored with##2##4##(2008-10#1)(2008-2#1)
surface was monitored##3##3##(2008-10#2)(2008-2#1)
surface was optimized##2##3##(2008-10#2)
surface was performed##2##3##(2008-10#1)(2008-11#1)
surface was used##2##3##(2008-10#2)
surface was##80##2##(1990-2#2)(1991-3#1)(1991-5#3)(1991-8#1)(1992-8#1)(1994-12#1)(1994-7#1)(1995-12#1)(1996-11#1)(1997-6#1)(1997-7#1)(2004-9#1)(2005-11#8)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#18)(2008-11#5)(2008-2#4)(2008-3#3)(2008-5#2)(2010-10#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#7)
surface water and##4##3##(2008-10#2)(2008-4#1)(2008-5#1)
surface water in##2##3##(2008-11#1)(2012-2#1)
surface water is##3##3##(2007-8#1)(2008-10#2)
surface water may##2##3##(2008-4#1)(2008-8#1)
surface water samples##7##3##(2008-10#7)
surface water##44##2##(2007-10#1)(2007-2#1)(2007-5#1)(2007-8#3)(2008-10#25)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#1)(2008-8#3)(2009-6#1)(2010-9#1)(2011-2#1)(2012-2#1)
surface waters and sediments##2##4##(2008-10#2)
surface waters and##3##3##(2008-10#3)
surface waters##12##2##(2007-8#2)(2008-10#7)(2008-5#1)(2009-6#1)(2011-12#1)
surface waves in##6##3##(2007-11#2)(2007-12#2)(2008-2#1)(2012-2#1)
surface waves on a vertical##2##5##(2008-2#2)
surface waves on##3##3##(2008-2#2)(2008-3#1)
surface waves that propagate##2##4##(2007-12#1)(2008-3#1)
surface waves whose##2##3##(2007-12#1)(2008-2#1)
surface waves##20##2##(2007-11#4)(2007-12#4)(2008-2#8)(2008-3#3)(2012-2#1)
surface were analyzed##3##3##(2005-11#1)(2009-7#1)(2013-8#1)
surface were observed##2##3##(2006-10#1)(2012-12#1)
surface were##25##2##(1996-11#1)(2005-11#3)(2005-4#1)(2006-10#1)(2006-2#1)(2007-2#1)(2007-7#2)(2008-10#7)(2008-11#1)(2008-2#1)(2008-5#1)(2009-7#1)(2012-12#1)(2012-2#1)(2013-8#2)
surface wetness duration##2##3##(2008-10#2)
surface wetness##4##2##(2008-10#4)
surface where the##3##3##(2008-2#1)(2008-5#1)(2009-11#1)
surface where##4##2##(2008-2#1)(2008-5#1)(2009-11#1)(2009-9#1)
surface which is##3##3##(2008-10#2)(2013-8#1)
surface which##9##2##(1997-3#1)(2008-10#2)(2008-5#3)(2009-7#1)(2009-8#1)(2013-8#1)
surface while##3##2##(2005-11#1)(2007-8#1)(2008-3#1)
surface will##2##2##(2005-11#1)(2008-2#1)
surface wind speed##2##3##(2008-2#2)
surface wind##4##2##(2008-2#4)
surface with a##9##3##(1991-11#1)(1994-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2009-5#1)
surface with the##3##3##(1997-7#1)(2008-10#1)(2010-4#1)
surface with##33##2##(1991-11#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-2#1)(1996-5#1)(1997-7#1)(2006-10#1)(2007-12#2)(2008-10#9)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#3)(2009-10#1)(2009-5#1)(2010-4#2)
surface within##3##2##(1996-8#1)(2007-12#1)(2008-10#1)
surface without##7##2##(1994-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-4#1)
surface##5754##1##(1990-10#10)(1990-11#20)(1990-12#26)(1990-2#19)(1990-3#11)(1990-4#8)(1990-5#15)(1990-6#6)(1990-7#7)(1990-8#13)(1990-9#5)(1991-1#7)(1991-10#6)(1991-11#5)(1991-12#19)(1991-2#12)(1991-3#20)(1991-4#20)(1991-5#19)(1991-6#6)(1991-7#11)(1991-8#8)(1991-9#16)(1992-1#6)(1992-11#7)(1992-12#21)(1992-2#8)(1992-3#11)(1992-4#3)(1992-5#18)(1992-6#15)(1992-7#5)(1992-8#14)(1992-9#9)(1993-1#2)(1993-10#1)(1993-11#6)(1993-12#26)(1993-3#15)(1993-4#6)(1993-5#4)(1993-6#16)(1993-7#5)(1993-8#7)(1993-9#9)(1994-10#2)(1994-11#36)(1994-12#23)(1994-2#17)(1994-3#22)(1994-4#1)(1994-5#24)(1994-6#15)(1994-7#3)(1994-8#25)(1994-9#19)(1995-1#9)(1995-10#11)(1995-11#6)(1995-12#6)(1995-2#32)(1995-3#11)(1995-4#1)(1995-5#21)(1995-6#14)(1995-7#7)(1995-8#21)(1996-1#5)(1996-10#3)(1996-11#10)(1996-12#12)(1996-2#14)(1996-3#7)(1996-4#9)(1996-5#31)(1996-6#2)(1996-7#5)(1996-8#21)(1996-9#10)(1997-1#14)(1997-2#27)(1997-3#4)(1997-4#23)(1997-5#8)(1997-6#13)(1997-7#17)(1997-8#6)(1997-9#1)(2004-11#2)(2004-12#10)(2004-2#1)(2004-4#1)(2004-8#1)(2004-9#47)(2005-10#5)(2005-11#497)(2005-12#8)(2005-4#12)(2005-5#1)(2005-7#7)(2005-8#5)(2005-9#1)(2006-1#4)(2006-10#45)(2006-11#11)(2006-12#33)(2006-2#10)(2006-3#14)(2006-4#11)(2006-5#24)(2006-6#16)(2006-7#20)(2006-8#4)(2006-9#4)(2007-1#39)(2007-10#12)(2007-11#86)(2007-12#198)(2007-2#11)(2007-3#9)(2007-4#3)(2007-5#17)(2007-6#5)(2007-7#24)(2007-8#92)(2007-9#25)(2008-1#45)(2008-10#840)(2008-11#108)(2008-12#21)(2008-2#300)(2008-3#448)(2008-4#115)(2008-5#264)(2008-6#51)(2008-7#88)(2008-8#59)(2008-9#51)(2009-10#5)(2009-11#32)(2009-12#21)(2009-2#14)(2009-3#12)(2009-4#12)(2009-5#6)(2009-6#14)(2009-7#34)(2009-8#28)(2009-9#9)(2010-1#10)(2010-10#13)(2010-11#1)(2010-12#28)(2010-2#22)(2010-3#14)(2010-4#123)(2010-5#21)(2010-6#13)(2010-7#19)(2010-8#18)(2010-9#8)(2011-1#42)(2011-12#10)(2011-2#67)(2011-3#1)(2011-7#1)(2012-1#22)(2012-11#24)(2012-12#48)(2012-2#87)(2012-3#18)(2012-4#1)(2012-5#1)(2012-7#1)(2013-1#85)(2013-7#11)(2013-8#82)
surface)##14##1##(1995-2#1)(1995-3#2)(2006-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-12#2)(2010-12#1)(2011-1#1)(2012-12#1)
surface-acoustic-wave##2##1##(2008-3#2)
surface-active agents##4##2##(2005-11#4)
surface-active compounds##3##2##(2008-10#2)(2008-6#1)
surface-active##17##1##(1994-11#1)(2005-11#6)(2007-8#1)(2008-10#6)(2008-5#1)(2008-6#1)(2009-7#1)
surface-adsorbed##2##1##(1991-1#1)(2007-11#1)
surface-anchored##4##1##(1997-4#2)(2009-11#1)(2010-4#1)
surface-area##7##1##(2008-3#5)(2012-11#2)
surface-associated##4##1##(1996-12#2)(2005-7#1)(2012-2#1)
surface-attached##4##1##(2006-11#1)(2008-9#1)(2009-5#2)
surface-bound HPRG##2##2##(1997-2#2)
surface-bound TSP##2##2##(1991-2#1)(2013-8#1)
surface-bound##14##1##(1990-2#1)(1991-2#1)(1992-3#1)(1996-10#1)(1997-2#3)(2006-2#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2013-8#1)
surface-breaking defects##2##2##(2007-11#2)
surface-breaking##3##1##(2007-11#3)
surface-confined Ru(bpy)(3)(2+)##2##2##(2008-10#2)
surface-confined##4##1##(2008-10#2)(2008-5#1)(2010-4#1)
surface-derived##3##1##(1990-2#3)
surface-disinfested##3##1##(2008-10#3)
surface-emitted##3##1##(2007-11#1)(2007-12#2)
surface-emitting laser (VCSEL)##8##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#4)
surface-emitting laser arrays##4##3##(2007-11#1)(2008-3#3)
surface-emitting laser with##3##3##(2007-12#3)
surface-emitting laser##22##2##(2007-11#2)(2007-12#6)(2008-2#5)(2008-3#9)
surface-emitting lasers##31##2##(2007-11#8)(2007-12#4)(2008-1#2)(2008-2#6)(2008-3#11)
surface-emitting semiconductor laser##4##3##(2007-12#3)(2008-3#1)
surface-emitting semiconductor lasers##3##3##(2007-11#1)(2007-12#2)
surface-emitting semiconductor##7##2##(2007-11#1)(2007-12#5)(2008-3#1)
surface-emitting##62##1##(2007-11#11)(2007-12#16)(2008-1#2)(2008-2#11)(2008-3#22)
surface-enhanced Raman scattering (SERS) activity##2##5##(2007-12#1)(2013-1#1)
surface-enhanced Raman scattering (SERS)##8##4##(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2013-1#1)
surface-enhanced Raman scattering and##2##4##(2007-12#1)(2013-8#1)
surface-enhanced Raman scattering##22##3##(2006-12#2)(2007-11#1)(2007-12#4)(2007-8#2)(2008-10#8)(2012-2#1)(2013-1#1)(2013-8#3)
surface-enhanced Raman spectroscopy (SERS)##7##4##(2007-12#1)(2008-10#2)(2009-2#1)(2012-1#2)(2013-1#1)
surface-enhanced Raman spectroscopy##12##3##(2007-12#2)(2007-8#1)(2008-10#3)(2008-2#1)(2009-2#1)(2012-1#2)(2013-1#1)(2013-8#1)
surface-enhanced Raman##35##2##(2006-12#2)(2007-11#1)(2007-12#6)(2007-8#3)(2008-10#11)(2008-2#1)(2009-2#1)(2012-1#2)(2012-2#1)(2013-1#2)(2013-8#5)
surface-enhanced effects##2##2##(2013-8#2)
surface-enhanced infrared absorption spectroscopy##2##4##(2013-8#2)
surface-enhanced infrared absorption##3##3##(2008-10#1)(2013-8#2)
surface-enhanced laser##2##2##(2007-12#1)(2008-10#1)
surface-enhanced##43##1##(2006-12#2)(2007-11#2)(2007-12#7)(2007-8#3)(2008-10#13)(2008-2#1)(2009-2#1)(2012-1#2)(2012-2#1)(2013-1#2)(2013-8#9)
surface-esterified##3##1##(2005-11#3)
surface-exposed##6##1##(1992-12#1)(1994-3#2)(2011-1#1)(2011-2#1)(2012-2#1)
surface-fitting##2##1##(2008-3#1)(2008-9#1)
surface-height##2##1##(2007-12#1)(2008-2#1)
surface-induced##2##1##(1994-8#1)(2008-10#1)
surface-initiated polymerization##2##2##(2005-12#1)(2009-7#1)
surface-initiated##6##1##(2005-12#1)(2008-10#1)(2009-7#1)(2010-4#3)
surface-light-scattering instrumentation##2##2##(2008-3#2)
surface-light-scattering spectrometer##2##2##(2008-2#2)
surface-light-scattering spectroscopy##2##2##(2008-3#2)
surface-light-scattering##6##1##(2008-2#2)(2008-3#4)
surface-located##5##1##(1995-12#1)(2008-4#4)
surface-mediated reactions##2##2##(2008-10#2)
surface-mediated##6##1##(2007-12#1)(2008-10#2)(2009-10#1)(2009-12#2)
surface-modified by grafting collagen via NH(3) plasma##2##7##(2008-5#2)
surface-modified##9##1##(2007-8#1)(2008-10#2)(2008-5#5)(2010-12#1)
surface-mulched plots amended with##2##4##(2008-10#2)
surface-plasmon microscopy##2##2##(2008-3#2)
surface-plasmon polariton##2##2##(2008-3#2)
surface-plasmon resonance (SPR)##5##3##(2008-3#5)
surface-plasmon resonance for the determination of##2##6##(2008-3#2)
surface-plasmon resonance##12##2##(2008-2#1)(2008-3#11)
surface-plasmon##23##1##(2008-2#4)(2008-3#19)
surface-plasmon-coupled waveguide modes##2##3##(2008-3#2)
surface-profile function zeta(x(1))##2##3##(2008-2#2)
surface-profile##3##1##(2007-12#1)(2008-2#2)
surface-reflected##3##1##(2008-3#3)
surface-relief diffractive optical elements##2##4##(2008-2#1)(2008-3#1)
surface-relief diffractive optical##3##3##(2008-2#1)(2008-3#2)
surface-relief grating##2##2##(2008-2#1)(2008-3#1)
surface-relief structures##2##2##(2008-2#2)
surface-relief##21##1##(2007-12#3)(2008-2#10)(2008-3#8)
surface-scattering##2##1##(2008-2#1)(2008-3#1)
surface-skimming##2##1##(2013-1#2)
surface-sterilized##2##1##(2008-10#1)(2008-5#1)
surface-tension##2##1##(2005-11#2)
surface-to-volume ratio##4##2##(2007-8#1)(2009-11#1)(2010-7#1)(2012-1#1)
surface-wave##3##1##(2007-11#1)(2008-2#1)(2008-3#1)
surfaced endoplasmic reticulum##2##3##(1993-6#1)(2007-12#1)
surfaced##10##1##(1993-6#1)(1997-7#1)(2005-8#1)(2006-10#1)(2007-12#2)(2007-4#1)(2008-7#1)(2011-2#2)
surfaces across##2##2##(2008-3#2)
surfaces after##5##2##(1996-12#1)(2005-11#2)(2008-10#1)(2010-6#1)
surfaces also##2##2##(2008-10#1)(2008-7#1)
surfaces and cell##2##3##(2005-11#1)(2008-5#1)
surfaces and is##2##3##(1994-8#1)(2008-3#1)
surfaces and matrices is##2##4##(1990-2#2)
surfaces and matrices##3##3##(1990-2#3)
surfaces and on the##2##4##(2007-12#1)(2008-7#1)
surfaces and that##2##3##(2008-10#1)(2008-2#1)
surfaces and the##7##3##(1996-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-8#2)
surfaces and their##2##3##(2011-11#1)(2012-1#1)
surfaces and thin##2##3##(2007-5#1)(2008-2#1)
surfaces and##67##2##(1990-2#3)(1993-9#2)(1994-11#1)(1994-8#1)(1996-11#1)(2004-11#1)(2005-11#3)(2006-1#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#8)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-11#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-8#2)
surfaces are not##2##3##(2008-2#1)(2013-1#1)
surfaces are shown to##2##4##(2009-2#1)(2009-3#1)
surfaces are still##2##3##(1996-5#1)(2008-11#1)
surfaces are##28##2##(1992-6#1)(1996-5#1)(2005-7#2)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#7)(2008-3#5)(2008-5#1)(2009-2#1)(2009-3#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
surfaces as an##2##3##(2004-11#1)(2013-8#1)
surfaces as well as##3##4##(2007-8#1)(2008-5#1)(2010-2#1)
surfaces as##10##2##(1991-9#1)(2004-11#1)(2005-11#2)(2006-10#1)(2007-8#1)(2008-2#1)(2008-5#1)(2010-2#1)(2013-8#1)
surfaces at##5##2##(2005-11#1)(2006-3#1)(2008-10#1)(2010-4#1)(2012-2#1)
surfaces by a##2##3##(2005-11#1)(2008-3#1)
surfaces by means of##2##4##(2006-8#1)(2013-8#1)
surfaces by##23##2##(1992-6#1)(2005-11#4)(2006-8#1)(2007-11#1)(2008-10#5)(2008-3#3)(2008-7#2)(2009-3#1)(2010-4#2)(2012-3#1)(2013-8#2)
surfaces can be##4##3##(1990-11#1)(2008-3#1)(2008-7#1)(2011-1#1)
surfaces can##6##2##(1990-11#1)(1993-9#1)(2008-3#1)(2008-7#1)(2010-4#1)(2011-1#1)
surfaces coated with##2##3##(2008-12#1)(2012-11#1)
surfaces could##2##2##(2008-10#1)(2008-7#1)
surfaces during the##2##3##(2004-9#1)(2008-10#1)
surfaces during##5##2##(2004-9#1)(2005-11#1)(2007-7#1)(2008-10#1)(2008-3#1)
surfaces enable##2##2##(1990-9#1)(1997-6#1)
surfaces exposed to##3##3##(2005-11#1)(2008-2#1)(2009-4#1)
surfaces for the##3##3##(2008-3#2)(2010-7#1)
surfaces for##19##2##(1990-5#1)(1996-8#1)(2004-9#2)(2007-11#2)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#3)(2009-11#1)(2009-4#1)(2010-11#1)(2010-7#1)(2011-1#1)
surfaces from##8##2##(1997-4#1)(2006-10#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-3#3)
surfaces functionalized with##2##3##(2008-10#1)(2008-5#1)
surfaces gave##2##2##(2004-9#1)(2008-11#1)
surfaces had##2##2##(2008-10#1)(2008-11#1)
surfaces has been##5##3##(2005-11#1)(2008-2#2)(2012-1#1)(2012-11#1)
surfaces has##7##2##(2005-11#1)(2008-2#3)(2008-5#1)(2012-1#1)(2012-11#1)
surfaces have been obtained##2##4##(2010-4#2)
surfaces have been##8##3##(2005-4#1)(2006-12#1)(2007-11#1)(2008-3#1)(2008-7#1)(2009-6#1)(2010-4#2)
surfaces have##13##2##(1995-3#1)(2005-11#1)(2005-4#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-6#1)(2010-4#2)(2013-1#1)
surfaces having##3##2##(2005-11#1)(2008-5#1)(2013-8#1)
surfaces in a conical configuration##3##5##(2007-11#2)(2007-12#1)
surfaces in a##7##3##(2007-11#2)(2007-12#1)(2007-8#2)(2009-12#1)(2010-4#1)
surfaces in accelerated ageing##2##4##(2008-10#2)
surfaces in the##6##3##(2007-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-4#1)
surfaces in##32##2##(1991-11#1)(1991-5#1)(1992-8#1)(2004-9#1)(2005-11#2)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#5)(2009-12#1)(2010-10#1)(2010-4#2)(2012-1#1)(2013-1#1)
surfaces increase##2##2##(2005-11#1)(2008-3#1)
surfaces is demonstrated##2##3##(2005-11#1)(2007-12#1)
surfaces is described##3##3##(2008-10#1)(2008-3#2)
surfaces is presented##7##3##(2008-10#1)(2008-2#4)(2008-3#2)
surfaces is the##4##3##(2005-11#2)(2008-5#1)(2013-1#1)
surfaces is##38##2##(1993-3#1)(2005-11#4)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-2#8)(2008-3#10)(2008-5#2)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
surfaces may be##2##3##(2012-1#1)(2013-1#1)
surfaces may##5##2##(1995-1#1)(1996-3#1)(2007-9#1)(2012-1#1)(2013-1#1)
surfaces obtained##3##2##(2008-10#1)(2012-11#2)
surfaces of a##5##3##(1996-11#1)(2005-11#1)(2008-2#1)(2008-3#1)(2010-5#1)
surfaces of arbitrary##2##3##(2008-6#2)
surfaces of different##2##3##(2005-11#1)(2008-7#1)
surfaces of the porous silica##3##5##(1990-8#1)(2012-12#2)
surfaces of the proximal##2##4##(2005-7#1)(2006-3#1)
surfaces of the##47##3##(1990-8#1)(1992-11#1)(1993-3#1)(1994-8#2)(1995-1#1)(1996-12#1)(1996-8#1)(2004-9#1)(2005-11#3)(2005-7#1)(2006-3#1)(2007-11#4)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#7)(2008-5#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-7#1)
surfaces of these##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
surfaces of##128##2##(1990-12#1)(1990-8#1)(1991-3#1)(1992-11#1)(1992-5#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#2)(1995-5#2)(1996-11#1)(1996-12#1)(1996-8#1)(1997-2#1)(2004-9#1)(2005-11#8)(2005-12#1)(2005-7#1)(2006-3#1)(2007-11#5)(2007-12#7)(2007-5#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-12#3)(2008-2#12)(2008-3#9)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
surfaces on the##6##3##(1995-3#1)(1997-6#2)(2007-12#1)(2008-10#1)(2008-7#1)
surfaces on##9##2##(1995-3#1)(1997-6#2)(2005-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)
surfaces or##5##2##(2008-3#1)(2008-4#1)(2009-6#1)(2009-8#1)(2012-2#1)
surfaces over a time period of##2##6##(2006-5#2)
surfaces over##5##2##(2006-5#2)(2008-3#2)(2010-7#1)
surfaces produced##3##2##(1991-2#1)(2004-9#1)(2013-1#1)
surfaces show##2##2##(2005-11#1)(2008-2#1)
surfaces that##8##2##(1997-3#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-6#1)(2010-7#1)
surfaces the##2##2##(2005-11#1)(2008-3#1)
surfaces through##3##2##(2005-11#1)(2008-10#1)(2010-4#1)
surfaces to be##3##3##(2006-3#2)(2007-5#1)
surfaces to form##3##3##(2008-10#1)(2008-7#2)
surfaces to##19##2##(2004-11#1)(2005-11#1)(2006-12#1)(2006-3#2)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#2)(2009-11#1)(2009-12#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
surfaces under##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
surfaces using##8##2##(1990-10#1)(2005-11#2)(2006-10#1)(2008-10#2)(2008-3#1)(2013-7#1)
surfaces via##2##2##(2010-4#1)(2010-6#1)
surfaces was characterized##2##3##(1997-4#1)(2008-2#1)
surfaces was initially##2##3##(2010-10#2)
surfaces was observed##3##3##(2005-11#1)(2008-10#1)(2008-7#1)
surfaces was##16##2##(1993-2#1)(1994-11#1)(1997-4#1)(2004-9#1)(2005-11#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-7#1)(2010-10#4)
surfaces were characterized##3##3##(2005-11#1)(2008-5#1)(2012-11#1)
surfaces were fabricated##3##3##(2008-12#1)(2008-2#1)(2009-12#1)
surfaces were modified by##2##4##(2008-10#1)(2008-6#1)
surfaces were##32##2##(1990-8#1)(1995-2#1)(1995-5#1)(2005-11#2)(2005-7#2)(2006-4#1)(2006-8#2)(2008-10#3)(2008-12#3)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2009-12#1)(2009-7#3)(2012-11#2)(2012-12#1)(2013-1#1)(2013-7#1)
surfaces which##3##2##(1996-2#1)(2007-9#1)(2010-12#1)
surfaces with an##3##3##(2008-10#1)(2008-3#1)(2010-2#1)
surfaces with different##2##3##(2008-3#2)
surfaces with water##3##3##(2007-5#1)(2008-7#2)
surfaces with##33##2##(1993-9#1)(2004-9#1)(2005-11#1)(2006-4#1)(2006-5#2)(2007-12#3)(2007-5#1)(2008-10#3)(2008-2#1)(2008-3#6)(2008-4#1)(2008-7#5)(2009-11#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#2)(2012-5#1)
surfaces without##2##2##(2010-2#1)(2012-3#1)
surfaces##1118##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#10)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#4)(1990-9#2)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#2)(1991-9#4)(1992-11#1)(1992-12#3)(1992-2#1)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#1)(1993-2#1)(1993-3#5)(1993-4#1)(1993-6#1)(1993-9#4)(1994-10#1)(1994-11#5)(1994-12#3)(1994-5#3)(1994-6#5)(1994-8#3)(1994-9#1)(1995-1#3)(1995-11#2)(1995-2#2)(1995-3#3)(1995-5#4)(1995-8#1)(1996-11#6)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-8#2)(1997-2#3)(1997-3#1)(1997-4#4)(1997-6#3)(1997-8#3)(2004-11#4)(2004-2#2)(2004-9#17)(2005-10#3)(2005-11#78)(2005-12#1)(2005-4#2)(2005-7#7)(2005-8#1)(2006-1#1)(2006-10#12)(2006-12#8)(2006-2#3)(2006-3#4)(2006-4#7)(2006-5#9)(2006-7#2)(2006-8#3)(2007-10#1)(2007-11#29)(2007-12#47)(2007-5#7)(2007-6#1)(2007-7#2)(2007-8#10)(2007-9#4)(2008-1#5)(2008-10#121)(2008-11#11)(2008-12#14)(2008-2#91)(2008-3#132)(2008-4#8)(2008-5#20)(2008-6#14)(2008-7#33)(2008-8#7)(2008-9#2)(2009-11#11)(2009-12#8)(2009-2#8)(2009-3#6)(2009-4#3)(2009-5#4)(2009-6#5)(2009-7#5)(2009-8#8)(2010-1#1)(2010-10#10)(2010-11#1)(2010-12#4)(2010-2#6)(2010-4#33)(2010-5#3)(2010-6#7)(2010-7#11)(2010-8#2)(2010-9#3)(2011-1#7)(2011-11#2)(2011-12#1)(2011-2#9)(2012-1#9)(2012-11#19)(2012-12#7)(2012-2#10)(2012-3#5)(2012-5#2)(2013-1#28)(2013-7#6)(2013-8#18)
surfaces)##6##1##(2005-11#1)(2007-7#1)(2008-8#1)(2010-12#1)(2012-1#1)(2012-12#1)
surfacing##3##1##(2008-3#1)(2009-6#1)(2012-12#1)
surfactant &gt##3##2##(2008-5#3)
surfactant (Curosurf)##2##2##(1990-11#2)
surfactant CTAB##2##2##(2005-11#1)(2008-8#1)
surfactant Triton X-100##5##3##(1990-11#1)(1990-3#1)(2008-10#2)(2008-12#1)
surfactant Triton##6##2##(1990-11#1)(1990-3#1)(2008-10#3)(2008-12#1)
surfactant administration##4##2##(1996-6#1)(1997-1#1)(2006-10#1)(2008-6#1)
surfactant adsorption##4##2##(2005-11#4)
surfactant aggregates##3##2##(2008-10#3)
surfactant and a##2##3##(2008-10#1)(2008-5#1)
surfactant and its##2##3##(1997-1#1)(2008-5#1)
surfactant and protein##2##3##(2005-11#1)(2009-12#1)
surfactant and##25##2##(1990-5#1)(1993-7#1)(1996-1#1)(1996-5#1)(1997-1#2)(2005-11#4)(2006-6#1)(2008-10#5)(2008-5#4)(2008-6#1)(2009-12#2)(2010-8#1)(2011-1#1)
surfactant as##4##2##(1994-9#1)(1997-1#1)(2005-4#1)(2006-11#1)
surfactant at the##2##3##(2005-11#2)
surfactant at##3##2##(1996-5#1)(2005-11#2)
surfactant but##2##2##(1992-11#1)(2008-5#1)
surfactant by##2##2##(1992-5#1)(2008-5#1)
surfactant can##2##2##(1997-1#1)(2011-2#1)
surfactant concentration and##3##3##(2005-11#1)(2008-10#2)
surfactant concentration was##2##3##(2005-11#1)(2008-10#1)
surfactant concentration##23##2##(1990-9#2)(1992-5#1)(1994-9#1)(1996-5#1)(2005-11#7)(2008-10#8)(2008-5#2)(2011-2#1)
surfactant concentrations##11##2##(1990-12#1)(1990-3#3)(1990-9#1)(1996-5#1)(2005-11#4)(2008-10#1)
surfactant content##2##2##(1997-3#1)(2008-10#1)
surfactant film##2##2##(1997-2#1)(2005-11#1)
surfactant for##4##2##(1994-9#1)(1997-1#1)(2008-12#1)(2008-5#1)
surfactant has been##2##3##(1997-1#1)(2005-11#1)
surfactant head##2##2##(2005-11#2)
surfactant in the##6##3##(1996-5#1)(2005-11#2)(2008-10#2)(2008-5#1)
surfactant in##14##2##(1992-5#1)(1996-12#1)(1996-5#2)(2005-11#2)(2006-6#1)(2008-10#4)(2008-5#1)(2008-8#1)(2011-1#1)
surfactant is a##2##3##(1992-5#1)(2008-8#1)
surfactant is the##2##3##(1997-1#1)(2005-11#1)
surfactant is##14##2##(1992-5#1)(1997-1#1)(2005-11#6)(2006-6#1)(2008-10#4)(2008-8#1)
surfactant lipids##4##2##(1994-12#2)(1996-5#1)(2007-11#1)
surfactant may##5##2##(1994-5#1)(2006-5#3)(2010-3#1)
surfactant micelles##11##2##(1990-10#3)(2005-11#1)(2008-10#7)
surfactant mixtures##5##2##(2005-11#1)(2008-10#2)(2008-5#2)
surfactant molecule##4##2##(1992-5#1)(2005-11#2)(2007-11#1)
surfactant molecules##4##2##(2005-11#3)(2008-5#1)
surfactant monomers##2##2##(2005-11#2)
surfactant on the##2##3##(2008-5#1)(2013-8#1)
surfactant or##3##2##(1994-5#1)(2008-10#1)(2008-5#1)
surfactant phase##2##2##(2008-10#2)
surfactant phospholipid##3##2##(1993-9#1)(1994-5#2)
surfactant preparations##4##2##(1994-5#1)(2007-11#3)
surfactant protein C##2##3##(1995-4#1)(2006-8#1)
surfactant protein##7##2##(1992-9#2)(1994-3#1)(1995-4#1)(1996-8#1)(2006-8#1)(2011-1#1)
surfactant proteins A and D##2##5##(2005-11#1)(2011-1#1)
surfactant proteins##4##2##(2005-11#2)(2007-11#1)(2011-1#1)
surfactant reduced##2##2##(1990-11#1)(1997-1#1)
surfactant replacement##2##2##(2005-11#1)(2012-2#1)
surfactant secretion##2##2##(1990-11#2)
surfactant significantly##2##2##(2006-5#1)(2011-1#1)
surfactant sodium##5##2##(2005-11#1)(2008-10#3)(2010-11#1)
surfactant solution##7##2##(2007-10#1)(2008-10#3)(2008-5#2)(2012-1#1)
surfactant solutions##7##2##(1990-7#1)(2005-11#2)(2008-10#3)(2008-5#1)
surfactant solvent media##2##3##(2008-10#2)
surfactant synthesis##3##2##(1994-12#1)(1994-5#1)(2012-1#1)
surfactant system##3##2##(1997-1#1)(2005-11#1)(2008-10#1)
surfactant systems##4##2##(2005-11#2)(2008-10#1)(2008-5#1)
surfactant therapy##6##2##(2006-10#1)(2006-7#1)(2006-8#2)(2007-11#1)(2008-6#1)
surfactant to##2##2##(2008-10#1)(2008-5#1)
surfactant treatment##2##2##(1990-11#1)(2008-8#1)
surfactant used##3##2##(2008-10#2)(2008-5#1)
surfactant using##2##2##(2008-10#1)(2009-2#1)
surfactant was##8##2##(1990-11#1)(1994-5#1)(1994-9#1)(1997-3#1)(2005-11#1)(2006-5#1)(2008-10#2)
surfactant were##2##2##(2005-11#1)(2008-10#1)
surfactant with##5##2##(1994-5#1)(1996-5#1)(2005-11#2)(2008-10#1)
surfactant##520##1##(1990-10#3)(1990-11#8)(1990-12#2)(1990-3#5)(1990-5#1)(1990-7#1)(1990-9#3)(1991-2#3)(1992-11#3)(1992-5#8)(1992-9#2)(1993-2#2)(1993-3#3)(1993-7#3)(1993-9#2)(1994-12#5)(1994-3#3)(1994-5#10)(1994-9#8)(1995-4#1)(1996-1#3)(1996-12#4)(1996-5#12)(1996-6#1)(1996-8#1)(1997-1#18)(1997-2#5)(1997-3#2)(1997-8#2)(2005-11#117)(2005-4#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-5#5)(2006-6#3)(2006-7#2)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#10)(2007-12#1)(2007-8#1)(2008-10#143)(2008-12#2)(2008-5#47)(2008-6#5)(2008-7#1)(2008-8#10)(2009-10#1)(2009-12#4)(2009-2#1)(2010-1#1)(2010-11#2)(2010-2#5)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#6)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#2)
surfactant)##4##1##(2005-7#1)(2008-10#3)
surfactant-associated proteins##2##2##(1997-5#1)(2005-11#1)
surfactant-associated##3##1##(1994-3#1)(1997-5#1)(2005-11#1)
surfactant-based products##3##2##(2008-5#3)
surfactant-based##6##1##(2006-12#1)(2008-5#5)
surfactant-coated surfaces##2##2##(2005-11#2)
surfactant-coated##4##1##(2005-11#3)(2008-10#1)
surfactant-containing##2##1##(1990-12#1)(2008-5#1)
surfactant-free##2##1##(2008-10#2)
surfactant-induced##2##1##(2005-11#1)(2008-5#1)
surfactant-mediated##4##1##(1990-9#1)(2008-10#3)
surfactant-rich phase##9##2##(2008-10#7)(2008-7#2)
surfactant-rich##10##1##(2008-10#8)(2008-7#2)
surfactant-selective##2##1##(2008-10#2)
surfactants and the##4##3##(1992-11#1)(2008-10#2)(2012-2#1)
surfactants and their##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
surfactants and##19##2##(1992-1#1)(1992-11#1)(1996-1#1)(2005-11#3)(2007-8#1)(2008-10#8)(2008-5#1)(2008-6#1)(2011-2#1)(2012-2#1)
surfactants are##7##2##(1996-1#1)(2005-11#3)(2008-10#3)
surfactants as##4##2##(1992-11#1)(2008-10#1)(2008-5#1)(2010-2#1)
surfactants at the##3##3##(2005-11#2)(2008-10#1)
surfactants at##8##2##(2005-11#5)(2008-10#2)(2012-1#1)
surfactants based on##4##3##(2005-11#2)(2008-10#1)(2009-3#1)
surfactants by##2##2##(2008-10#2)
surfactants have been##2##3##(2005-11#2)
surfactants have##4##2##(2005-11#3)(2008-10#1)
surfactants in the##7##3##(2005-11#2)(2008-10#4)(2008-5#1)
surfactants in water##2##3##(2008-10#2)
surfactants in##21##2##(1996-5#1)(2005-11#2)(2008-10#14)(2008-5#3)(2011-1#1)
surfactants is##7##2##(2005-11#3)(2008-10#3)(2008-5#1)
surfactants of the##4##3##(2005-11#3)(2008-10#1)
surfactants of##7##2##(2005-11#3)(2008-10#4)
surfactants on an##2##3##(1996-5#1)(2008-5#1)
surfactants on the##10##3##(2005-11#3)(2008-10#2)(2008-3#1)(2008-5#4)
surfactants on##17##2##(1996-5#1)(2005-11#4)(2008-10#3)(2008-3#1)(2008-5#6)(2011-1#1)(2012-12#1)
surfactants sodium dodecyl sulfate (SDS) and cetyltrimethylammonium bromide (CTAB)##2##9##(2005-11#2)
surfactants sodium##4##2##(2005-11#3)(2008-5#1)
surfactants such as##2##3##(2008-5#1)(2013-1#1)
surfactants to##3##2##(2005-11#2)(2008-7#1)
surfactants using##4##2##(2005-11#2)(2007-11#1)(2008-10#1)
surfactants was studied by##2##4##(2005-11#2)
surfactants was##6##2##(2005-11#4)(2008-5#2)
surfactants were used##2##3##(1994-12#1)(2008-10#1)
surfactants were##12##2##(1992-11#1)(1994-12#1)(2005-11#2)(2007-11#1)(2008-10#4)(2008-5#2)(2010-2#1)
surfactants which##2##2##(2007-11#1)(2008-5#1)
surfactants with##11##2##(2005-11#7)(2007-11#1)(2008-10#1)(2008-5#2)
surfactants##301##1##(1990-8#1)(1991-8#1)(1992-1#5)(1992-11#8)(1994-12#1)(1996-1#3)(1996-11#3)(1996-2#1)(1996-5#5)(1997-1#5)(2005-11#95)(2006-10#1)(2007-11#7)(2007-8#1)(2008-10#92)(2008-3#2)(2008-5#46)(2008-6#2)(2008-7#2)(2009-3#2)(2010-2#4)(2010-4#1)(2011-1#7)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
surfactants)##3##1##(2005-11#3)
surfactin##2##1##(2008-5#2)
surficial sediments##2##2##(1992-3#1)(2006-6#1)
surficial##7##1##(1990-11#1)(1992-3#2)(1993-4#1)(1996-3#1)(2004-4#1)(2006-6#1)
surge capacity##3##2##(2008-1#1)(2008-8#1)(2009-3#1)
surge in the number of##2##5##(2007-8#1)(2008-10#1)
surge in the##5##3##(2004-4#1)(2007-8#1)(2008-10#2)(2008-7#1)
surge in##7##2##(2004-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)
surge of##10##2##(1990-9#1)(2007-11#1)(2007-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-1#1)
surge##28##1##(1990-9#1)(1992-1#1)(1992-8#1)(1995-10#1)(1995-12#1)(2004-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
surge-inhibiting factor##2##2##(1994-3#2)
surgeon and patient##2##3##(2007-12#1)(2012-2#1)
surgeon and the##3##3##(2006-6#1)(2007-11#1)(2009-9#1)
surgeon and##24##2##(1991-2#1)(1991-4#1)(2006-6#2)(2007-11#1)(2007-12#3)(2007-3#1)(2007-5#2)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-8#1)(2009-9#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
surgeon at##2##2##(2008-8#1)(2009-10#1)
surgeon because of##2##3##(1997-6#1)(2009-10#1)
surgeon can##7##2##(1995-4#1)(2006-6#1)(2007-5#2)(2007-7#1)(2007-8#1)(2012-2#1)
surgeon experience##4##2##(2007-12#1)(2007-8#1)(2008-8#1)(2013-1#1)
surgeon for##3##2##(2007-8#1)(2008-7#1)(2011-12#1)
surgeon in a##2##3##(2007-9#1)(2008-6#1)
surgeon in the##4##3##(1990-9#1)(1993-9#1)(2007-10#1)(2012-12#1)
surgeon in##14##2##(1990-9#1)(1993-9#1)(2007-10#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-9#1)(2011-2#2)(2012-12#2)
surgeon involvement in##2##3##(2006-2#2)
surgeon involvement##3##2##(2006-2#3)
surgeon is##8##2##(1992-1#1)(1993-11#1)(1996-1#1)(2006-6#1)(2007-12#2)(2008-7#1)(2009-4#1)
surgeon must be##2##3##(2009-3#1)(2011-2#1)
surgeon must##4##2##(1992-2#1)(2009-3#1)(2010-8#1)(2011-2#1)
surgeon of##2##2##(2007-5#1)(2011-2#1)
surgeon should be##6##3##(1991-4#1)(2007-8#1)(2008-5#1)(2008-9#1)(2009-9#1)(2013-1#1)
surgeon should##10##2##(1991-4#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-5#1)(2008-9#1)(2009-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
surgeon through##2##2##(2007-5#1)(2010-8#1)
surgeon to assess the##2##4##(2007-7#1)(2009-6#1)
surgeon to be##3##3##(2009-5#1)(2009-9#1)(2013-8#1)
surgeon to create##2##3##(2007-12#1)(2009-4#1)
surgeon to perform##6##3##(2007-11#2)(2007-5#1)(2010-8#2)(2013-7#1)
surgeon to the##3##3##(2006-6#1)(2012-12#2)
surgeon to##38##2##(1992-12#2)(1993-12#1)(2004-2#2)(2006-3#1)(2006-6#2)(2007-11#2)(2007-12#1)(2007-5#3)(2007-7#2)(2007-8#2)(2009-4#4)(2009-5#1)(2009-6#2)(2009-9#1)(2010-7#1)(2010-8#2)(2011-2#3)(2012-12#3)(2012-2#1)(2013-7#1)(2013-8#1)
surgeon volume##3##2##(2008-7#3)
surgeon was##2##2##(2007-5#1)(2008-9#1)
surgeon well-being##2##2##(2012-2#2)
surgeon who##4##2##(1991-4#1)(1993-7#1)(2006-3#1)(2007-12#1)
surgeon with a##2##3##(2006-6#1)(2011-2#1)
surgeon with##5##2##(1990-12#1)(2006-6#1)(2011-2#1)(2012-2#2)
surgeon##319##1##(1990-12#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-4#3)(1991-5#1)(1991-8#1)(1992-1#2)(1992-10#2)(1992-12#2)(1992-2#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-6#1)(1993-7#2)(1993-9#1)(1995-12#2)(1995-4#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-6#2)(2004-2#2)(2005-12#1)(2005-5#1)(2005-9#2)(2006-10#5)(2006-12#1)(2006-2#3)(2006-3#4)(2006-6#14)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#9)(2007-12#24)(2007-3#6)(2007-5#20)(2007-7#7)(2007-8#12)(2007-9#3)(2008-10#7)(2008-11#1)(2008-3#2)(2008-4#8)(2008-5#3)(2008-6#7)(2008-7#10)(2008-8#7)(2008-9#7)(2009-10#3)(2009-12#1)(2009-3#6)(2009-4#7)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#8)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#6)(2011-1#1)(2011-12#3)(2011-2#17)(2012-11#1)(2012-12#9)(2012-2#13)(2012-3#2)(2013-1#13)(2013-7#1)(2013-8#4)
surgeon's ability to##4##3##(2006-12#1)(2006-3#1)(2006-6#1)(2011-2#1)
surgeon's experience##10##2##(2006-6#1)(2007-11#2)(2007-12#1)(2007-8#4)(2010-8#1)(2011-2#1)
surgeon's hand##3##2##(2006-6#2)(2008-11#1)
surgeon's or##2##2##(1995-1#1)(2006-6#1)
surgeon's perspective##3##2##(2007-3#1)(2008-4#1)(2008-9#1)
surgeon's##52##1##(1990-5#1)(1991-9#1)(1994-2#1)(1995-1#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#14)(2007-1#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-5#1)(2007-8#5)(2008-11#1)(2008-4#2)(2008-9#1)(2009-5#1)(2010-8#1)(2010-9#1)(2011-2#5)(2012-12#2)(2013-1#1)
surgeon-specific##2##1##(1994-2#1)(2006-6#1)
surgeon]##2##1##(1992-2#1)(2006-6#1)
surgeonfish is##2##2##(2008-5#2)
surgeonfish##5##1##(2008-5#5)
surgeons according to##2##3##(2006-6#2)
surgeons and other health care##2##5##(2007-12#1)(2008-4#1)
surgeons and their##2##3##(2007-12#1)(2013-7#1)
surgeons and##25##2##(1992-3#1)(1993-12#1)(2006-5#1)(2006-7#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-8#5)(2008-1#1)(2008-10#1)(2008-4#2)(2008-9#1)(2010-8#2)(2011-2#2)(2012-2#1)(2013-7#1)
surgeons are##10##2##(2006-2#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-4#1)(2008-9#1)(2010-9#1)(2012-12#1)(2012-2#1)
surgeons as##2##2##(2008-8#1)(2013-1#1)
surgeons because of##2##3##(2007-7#1)(2009-9#1)
surgeons because##3##2##(2007-7#1)(2009-9#1)(2012-2#1)
surgeons but##2##2##(1995-9#1)(2007-11#1)
surgeons can##3##2##(2006-6#1)(2007-12#1)(2010-12#1)
surgeons for##8##2##(2006-6#1)(2006-9#1)(2007-12#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-8#1)
surgeons have##6##2##(1990-2#1)(1993-10#1)(1993-9#1)(2007-8#1)(2010-12#1)(2013-7#1)
surgeons in the##12##3##(2004-7#1)(2006-6#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-8#1)(2011-2#1)
surgeons in##31##2##(1991-5#1)(1996-9#1)(2004-7#1)(2005-9#1)(2006-6#2)(2007-12#4)(2007-2#1)(2007-3#2)(2007-5#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-4#3)(2008-9#1)(2009-4#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-7#1)
surgeons may##3##2##(2007-12#1)(2008-3#1)(2011-2#1)
surgeons must##4##2##(2007-12#3)(2010-9#1)
surgeons now##2##2##(2007-8#1)(2012-12#1)
surgeons of##3##2##(2007-5#1)(2010-2#1)(2012-2#1)
surgeons performing##2##2##(2006-7#1)(2008-7#1)
surgeons pmc in##2##3##(2011-2#2)
surgeons remain##2##2##(2006-10#1)(2006-6#1)
surgeons should be aware of##2##5##(2008-6#1)(2013-1#1)
surgeons should be##5##3##(1991-3#1)(2008-6#1)(2008-8#1)(2010-2#1)(2013-1#1)
surgeons should##14##2##(1991-3#1)(1991-5#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-6#1)(2008-8#2)(2009-3#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#2)
surgeons still##2##2##(2008-7#1)(2010-2#1)
surgeons that##3##2##(2006-2#1)(2010-8#1)(2013-8#1)
surgeons the##2##2##(2008-4#1)(2012-12#1)
surgeons to perform##2##3##(2006-6#1)(2006-8#1)
surgeons to##25##2##(2006-11#1)(2006-12#1)(2006-3#1)(2006-6#2)(2006-8#1)(2007-12#1)(2007-2#1)(2007-5#2)(2007-8#2)(2007-9#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-8#3)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#2)
surgeons use##3##2##(2007-12#1)(2008-10#1)(2009-2#1)
surgeons using##5##2##(1995-1#1)(1996-9#1)(2007-8#1)(2007-9#1)(2008-3#1)
surgeons were##5##2##(1995-1#1)(1996-3#1)(2006-6#1)(2008-9#2)
surgeons who##7##2##(1991-5#1)(2005-8#1)(2005-9#1)(2006-6#1)(2007-12#1)(2008-7#1)(2009-5#1)
surgeons will##3##2##(1996-9#1)(2006-6#1)(2010-8#1)
surgeons wishing to##2##3##(2009-3#1)(2009-7#1)
surgeons with a##4##3##(2006-10#1)(2007-12#2)(2012-3#1)
surgeons with##8##2##(2006-10#1)(2006-4#1)(2007-12#2)(2008-4#1)(2009-6#1)(2012-12#1)(2012-3#1)
surgeons worldwide##2##2##(2007-12#1)(2007-8#1)
surgeons##380##1##(1990-12#1)(1990-2#1)(1990-4#3)(1990-6#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#1)(1992-3#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#3)(1995-1#2)(1995-9#1)(1996-1#2)(1996-3#1)(1996-9#3)(2004-7#1)(2005-12#1)(2005-8#1)(2005-9#2)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#6)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#19)(2006-7#4)(2006-8#6)(2006-9#4)(2007-10#3)(2007-11#5)(2007-12#31)(2007-2#3)(2007-3#9)(2007-4#2)(2007-5#15)(2007-7#1)(2007-8#29)(2007-9#4)(2008-1#3)(2008-10#5)(2008-3#4)(2008-4#23)(2008-6#6)(2008-7#5)(2008-8#6)(2008-9#11)(2009-1#1)(2009-10#1)(2009-2#3)(2009-3#6)(2009-4#3)(2009-5#3)(2009-6#2)(2009-7#4)(2009-8#1)(2009-9#5)(2010-11#1)(2010-12#3)(2010-2#7)(2010-7#1)(2010-8#16)(2010-9#3)(2011-1#2)(2011-12#1)(2011-2#15)(2012-1#3)(2012-12#9)(2012-2#13)(2012-3#2)(2013-1#13)(2013-7#5)(2013-8#2)
surgeons'##6##1##(1991-9#1)(1993-10#1)(2006-6#1)(2007-11#1)(2008-9#1)(2010-9#1)
surgeons?##3##1##(1993-2#1)(2009-5#1)(2010-8#1)
surgeons]##2##1##(1990-5#1)(1991-6#1)
surgeries and##8##2##(2006-12#1)(2006-6#2)(2006-7#1)(2009-4#1)(2012-2#1)(2013-1#1)(2013-7#1)
surgeries for##2##2##(1996-12#1)(2008-2#1)
surgeries in##3##2##(2008-7#1)(2011-1#1)(2013-7#1)
surgeries performed##3##2##(2006-12#1)(2011-2#1)(2013-8#1)
surgeries were performed##4##3##(2006-12#1)(2006-8#1)(2007-11#1)(2008-8#1)
surgeries were##11##2##(2006-12#1)(2006-8#1)(2007-1#1)(2007-11#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
surgeries with##3##2##(2006-3#1)(2013-1#2)
surgeries##85##1##(1990-9#1)(1992-11#1)(1993-6#1)(1996-12#1)(2006-12#3)(2006-3#1)(2006-6#4)(2006-7#1)(2006-8#2)(2007-1#3)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#2)(2009-6#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#3)(2011-2#8)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#6)(2013-1#10)(2013-7#4)(2013-8#1)
surgery (0##3##2##(2006-7#1)(2013-1#2)
surgery (3D-histology)##2##2##(2005-11#2)
surgery (BCS)##4##2##(2007-11#1)(2007-6#1)(2011-2#1)(2013-1#1)
surgery (CABG)##2##2##(2007-8#2)
surgery (CAS)##4##2##(2005-5#1)(2006-12#1)(2006-6#2)
surgery (HR##2##2##(2007-8#1)(2013-1#1)
surgery (OR##2##2##(2007-10#1)(2012-2#1)
surgery (P=0##2##2##(2007-8#1)(2008-7#1)
surgery (VATS)##14##2##(2007-8#4)(2008-1#1)(2008-10#1)(2008-5#1)(2010-8#1)(2012-12#2)(2012-2#1)(2013-7#3)
surgery (p##3##2##(1991-6#1)(1995-3#1)(2005-10#1)
surgery (with or without##2##4##(1990-12#1)(2006-10#1)
surgery -##3##2##(2006-6#2)(2009-4#1)
surgery 2##2##2##(1990-8#1)(2007-8#1)
surgery a##5##2##(2006-10#1)(2007-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
surgery accounts for a##2##4##(1992-12#1)(2007-1#1)
surgery after the##2##3##(1991-2#1)(2010-8#1)
surgery after##15##2##(1990-6#2)(1991-2#1)(2006-10#1)(2007-1#1)(2007-5#1)(2008-4#1)(2008-6#1)(2008-7#2)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
surgery allows##4##2##(2006-10#1)(2006-12#1)(2007-5#1)(2009-2#1)
surgery alone in##2##3##(2008-6#1)(2013-8#1)
surgery alone##14##2##(1990-8#1)(1991-8#1)(1993-10#1)(1993-5#1)(1995-5#1)(2008-5#1)(2008-6#2)(2009-5#1)(2012-3#3)(2013-1#1)(2013-8#1)
surgery among##3##2##(1991-1#1)(2010-2#1)(2010-9#1)
surgery and 1##3##3##(1995-2#1)(2007-7#1)(2012-12#1)
surgery and a##4##3##(1992-12#1)(2007-2#1)(2007-5#1)(2007-8#1)
surgery and adjuvant##3##3##(1992-10#1)(1992-12#1)(2008-11#1)
surgery and almost##2##3##(1997-8#1)(2008-4#1)
surgery and anesthesia##6##3##(1993-1#1)(2006-10#3)(2010-9#1)(2012-3#1)
surgery and associated complications##2##4##(2007-12#2)
surgery and cardiopulmonary bypass##2##4##(2006-10#1)(2006-4#1)
surgery and cell therapy##2##4##(2008-4#2)
surgery and chemotherapy for##2##4##(2012-12#1)(2013-1#1)
surgery and chemotherapy##14##3##(1990-8#1)(1992-2#1)(2004-1#1)(2006-6#3)(2010-12#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#2)
surgery and followed##2##3##(2008-7#1)(2011-2#1)
surgery and had##3##3##(2009-6#1)(2010-12#1)(2010-5#1)
surgery and have##2##3##(2006-6#1)(2011-2#1)
surgery and histopathology##2##3##(2007-7#1)(2009-9#1)
surgery and immediate loading##2##4##(2008-11#1)(2013-1#1)
surgery and immediate##3##3##(2008-11#1)(2008-4#1)(2013-1#1)
surgery and implantation of##2##4##(2006-8#1)(2013-1#1)
surgery and in patients with##2##5##(2007-11#1)(2007-8#1)
surgery and in##9##3##(2005-5#1)(2006-10#2)(2006-12#1)(2007-11#2)(2007-8#1)(2009-8#1)(2011-1#1)
surgery and intraoperative##2##3##(2006-6#1)(2007-12#1)
surgery and is##3##3##(2007-12#1)(2009-10#1)(2012-2#1)
surgery and its##4##3##(2006-10#1)(2008-10#1)(2013-1#1)(2013-8#1)
surgery and post-operative##2##3##(2007-2#1)(2008-6#1)
surgery and postoperative##4##3##(2006-10#1)(2007-2#1)(2012-12#1)(2013-1#1)
surgery and pulmonary##2##3##(2007-8#1)(2010-5#1)
surgery and radiation therapy##6##4##(1994-8#1)(1995-8#1)(1995-9#1)(1996-3#1)(2004-1#1)(2012-1#1)
surgery and radiation##8##3##(1994-8#1)(1995-8#1)(1995-9#2)(1996-3#1)(2004-1#1)(2007-12#1)(2012-1#1)
surgery and radiotherapy##16##3##(1990-8#1)(1991-4#1)(1992-2#1)(1993-10#1)(1994-4#1)(2004-1#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-2#1)(2007-5#1)(2008-6#5)
surgery and reconstruction##2##3##(2007-12#1)(2011-2#1)
surgery and rehabilitation##2##3##(2006-10#1)(2008-2#1)
surgery and reviews##2##3##(2006-10#1)(2006-5#1)
surgery and the choice of##2##5##(2007-11#2)
surgery and the relationship##2##4##(2007-11#1)(2008-9#1)
surgery and the use of##2##5##(1992-10#1)(2006-10#1)
surgery and the##30##3##(1992-10#1)(1993-10#1)(1993-3#1)(1997-3#1)(2006-10#2)(2006-6#1)(2006-8#2)(2007-11#3)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-2#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-4#1)(2011-1#1)(2012-12#1)(2013-1#3)(2013-8#1)
surgery and their##2##3##(2007-11#1)(2013-1#1)
surgery and these##2##3##(2007-8#1)(2007-9#1)
surgery and to##2##3##(2008-3#1)(2012-3#1)
surgery and with##3##3##(1993-1#1)(1994-3#1)(2013-1#1)
surgery and##329##2##(1990-11#1)(1990-12#1)(1990-8#3)(1990-9#1)(1991-10#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1992-10#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-6#1)(1992-8#2)(1993-1#3)(1993-10#5)(1993-12#1)(1993-3#3)(1993-5#2)(1993-6#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-8#2)(1995-10#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#2)(1995-9#3)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-1#4)(2005-10#1)(2005-12#2)(2005-5#1)(2006-10#29)(2006-11#1)(2006-12#4)(2006-2#1)(2006-4#2)(2006-5#2)(2006-6#7)(2006-7#1)(2006-8#6)(2006-9#2)(2007-1#2)(2007-11#8)(2007-12#9)(2007-2#5)(2007-3#1)(2007-5#5)(2007-7#4)(2007-8#22)(2007-9#3)(2008-1#1)(2008-10#1)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#6)(2008-5#1)(2008-6#10)(2008-7#4)(2008-8#5)(2008-9#5)(2009-10#2)(2009-2#3)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#10)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#14)(2012-1#2)(2012-11#1)(2012-12#11)(2012-2#9)(2012-3#8)(2013-1#16)(2013-8#3)
surgery and/or##5##2##(1991-9#1)(2004-10#1)(2006-10#1)(2008-6#1)(2008-7#1)
surgery appear to be##2##4##(1993-10#1)(2010-7#1)
surgery applications##3##2##(2008-8#1)(2009-12#2)
surgery are also##4##3##(1991-4#1)(1991-5#1)(2006-10#1)(2006-2#1)
surgery are discussed##6##3##(2006-10#1)(2007-8#1)(2010-8#1)(2013-1#3)
surgery are to##2##3##(2006-10#1)(2008-7#1)
surgery are##47##2##(1990-2#1)(1991-1#1)(1991-4#1)(1991-5#1)(1992-8#1)(1993-10#1)(2006-10#9)(2006-11#2)(2006-2#2)(2006-6#2)(2007-11#2)(2007-12#2)(2007-8#5)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-7#1)(2010-12#3)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#3)
surgery as a##3##3##(2006-10#1)(2007-11#1)(2007-8#1)
surgery as compared with##2##4##(1990-9#1)(1996-3#1)
surgery as compared##3##3##(1990-9#1)(1996-3#1)(2008-6#1)
surgery as the##3##3##(2007-8#1)(2009-2#1)(2011-2#1)
surgery as##20##2##(1990-4#1)(1990-9#1)(1993-10#1)(1996-3#1)(2004-1#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-6#2)(2008-9#1)(2009-2#2)(2010-12#1)(2011-2#1)(2012-12#1)
surgery at a##3##3##(2006-4#1)(2011-2#1)(2013-1#1)
surgery at the Department of##2##5##(2007-8#1)(2013-1#1)
surgery at the##11##3##(1991-4#1)(2005-12#1)(2005-7#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-9#1)(2010-12#1)(2013-1#1)(2013-8#1)
surgery at##32##2##(1991-4#1)(1993-10#1)(1996-1#1)(2005-12#1)(2005-7#1)(2006-4#2)(2007-11#3)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#3)(2008-5#1)(2008-6#1)(2008-9#2)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
surgery backup##2##2##(2008-3#2)
surgery because it##2##3##(1993-9#1)(2006-10#1)
surgery because of a##3##4##(2006-10#1)(2007-11#1)(2008-10#1)
surgery because of the##6##4##(1992-10#1)(1992-8#1)(2005-9#1)(2006-4#1)(2011-2#1)(2012-12#1)
surgery because of##10##3##(1992-10#1)(1992-8#1)(2005-9#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
surgery because##16##2##(1991-9#1)(1992-10#1)(1992-8#1)(1993-9#1)(2005-9#1)(2006-10#2)(2006-4#1)(2007-11#1)(2008-10#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
surgery becomes##2##2##(2006-6#1)(2011-2#1)
surgery between##5##2##(1996-5#1)(2007-7#1)(2007-8#1)(2011-2#1)(2013-8#1)
surgery both##3##2##(2007-8#1)(2013-1#2)
surgery but##6##2##(1993-2#1)(1997-2#1)(2008-10#1)(2012-3#2)(2013-8#1)
surgery by a single##2##4##(2009-10#1)(2013-1#1)
surgery by a##4##3##(2006-10#1)(2009-10#1)(2011-2#1)(2013-1#1)
surgery by means of##2##4##(2012-12#1)(2012-2#1)
surgery by##20##2##(1992-3#1)(1997-2#1)(1997-6#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-5#1)(2008-6#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#1)
surgery can be achieved##2##4##(2007-9#1)(2011-1#1)
surgery can be considered##2##4##(1996-2#1)(2008-5#1)
surgery can be performed##4##4##(1990-2#1)(1991-3#1)(2006-9#1)(2008-1#1)
surgery can be##18##3##(1990-2#1)(1990-4#1)(1991-3#1)(1992-9#1)(1996-2#1)(2006-10#1)(2006-9#2)(2007-9#1)(2008-1#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-10#1)(2011-1#1)(2013-1#1)(2013-8#1)
surgery can##28##2##(1990-2#1)(1990-4#1)(1991-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1994-6#1)(1995-9#1)(1996-2#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-9#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
surgery cannot be##2##3##(1997-2#1)(1997-5#1)
surgery carries##2##2##(1992-10#1)(2007-8#1)
surgery center##2##2##(1995-12#1)(2007-3#1)
surgery centers##2##2##(1991-4#1)(2007-8#1)
surgery combined with##5##3##(1997-3#1)(2006-6#1)(2007-8#1)(2008-6#2)
surgery community##2##2##(2009-12#1)(2012-2#1)
surgery continues to##2##3##(2004-2#1)(2009-5#1)
surgery could##3##2##(1990-6#1)(2010-6#1)(2012-12#1)
surgery departments##3##2##(2007-11#1)(2007-7#1)(2007-8#1)
surgery depends on##2##3##(2010-8#1)(2013-1#1)
surgery despite##2##2##(2013-7#2)
surgery developed##2##2##(2008-6#1)(2009-7#1)
surgery did not##2##3##(2012-12#2)
surgery discussed##2##2##(1990-3#1)(1990-9#1)
surgery does not have a##2##5##(2006-6#1)(2007-6#1)
surgery does not##5##3##(1996-2#1)(2006-6#1)(2007-12#1)(2007-6#1)(2008-6#1)
surgery does##7##2##(1996-2#1)(2006-6#1)(2007-12#1)(2007-6#2)(2007-8#1)(2008-6#1)
surgery due to##10##3##(1992-8#1)(1993-10#1)(1993-6#1)(2007-11#2)(2010-6#1)(2010-7#1)(2012-12#1)(2013-1#2)
surgery durations##7##2##(2008-8#1)(2013-1#6)
surgery during the##5##3##(1993-5#1)(1993-6#1)(2011-12#1)(2011-3#1)(2012-2#1)
surgery during##7##2##(1993-5#1)(1993-6#1)(1996-4#1)(2010-2#1)(2011-12#1)(2011-3#1)(2012-2#1)
surgery experience##3##2##(2006-10#1)(2010-4#1)(2013-1#1)
surgery followed by chemotherapy##2##4##(2007-8#1)(2013-8#1)
surgery followed by##5##3##(2005-11#1)(2006-6#1)(2007-8#1)(2008-8#1)(2013-8#1)
surgery for AADA##2##3##(2007-8#2)
surgery for T2##2##3##(2007-8#2)
surgery for a large##2##4##(2008-7#2)
surgery for a##14##3##(1991-10#1)(1992-2#1)(1993-7#1)(2005-5#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-3#1)
surgery for abdominal aortic aneurysm##2##5##(1992-8#1)(2012-2#1)
surgery for atrial septal defect##2##5##(2008-11#1)(2013-1#1)
surgery for benign esophageal##3##4##(2012-1#1)(2013-1#2)
surgery for benign##5##3##(2009-1#1)(2011-2#1)(2012-1#1)(2013-1#2)
surgery for bone##3##3##(2008-6#1)(2013-1#2)
surgery for breast cancer##6##4##(1993-6#1)(1995-10#1)(1996-3#1)(2009-2#1)(2011-2#1)(2013-1#1)
surgery for breast##7##3##(1993-6#1)(1995-10#1)(1996-3#1)(2009-2#2)(2011-2#1)(2013-1#1)
surgery for cancer alone##2##4##(2009-2#2)
surgery for cancer##9##3##(1995-9#1)(2006-12#1)(2007-4#2)(2009-2#2)(2010-11#2)(2013-8#1)
surgery for cerebral##3##3##(1996-6#1)(1996-9#1)(2008-7#1)
surgery for chronic##4##3##(2006-10#1)(2006-12#1)(2012-1#1)(2013-1#1)
surgery for colon##2##3##(2010-1#1)(2013-7#1)
surgery for colorectal cancer##2##4##(2011-1#1)(2012-1#1)
surgery for colorectal##4##3##(2006-6#1)(2011-1#1)(2012-1#2)
surgery for congenital##3##3##(2008-11#1)(2008-4#1)(2011-2#1)
surgery for craniopharyngioma##2##3##(1995-5#1)(2008-7#1)
surgery for early breast##2##4##(1996-3#1)(1996-6#1)
surgery for early##4##3##(1996-3#1)(1996-6#2)(2012-12#1)
surgery for liver##2##3##(1991-8#1)(2008-1#1)
surgery for lumbar disc##2##4##(2006-2#1)(2012-12#1)
surgery for metastatic disease##2##4##(2006-8#1)(2007-11#1)
surgery for metastatic##3##3##(2006-2#1)(2006-8#1)(2007-11#1)
surgery for non-small cell lung cancer##2##6##(2006-4#1)(2013-7#1)
surgery for nurses##2##3##(2008-11#1)(2011-12#1)
surgery for obstructive sleep apnea syndrome##2##6##(2007-12#2)
surgery for ovarian##2##3##(1993-3#1)(2012-12#1)
surgery for patients with##4##4##(1994-9#1)(1995-9#1)(2010-12#1)(2013-1#1)
surgery for patients##5##3##(1994-9#1)(1995-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
surgery for primary##2##3##(1992-10#1)(2008-10#1)
surgery for renal##2##3##(2006-7#1)(2006-9#1)
surgery for the treatment of##3##5##(2010-8#1)(2012-3#1)(2013-8#1)
surgery for the##6##3##(1996-12#1)(2006-10#1)(2007-8#1)(2010-8#1)(2012-3#1)(2013-8#1)
surgery for their##3##3##(1991-3#1)(2008-7#2)
surgery for this condition##2##4##(2007-8#1)(2012-12#1)
surgery for thyroid##3##3##(1994-12#1)(2013-1#2)
surgery for treating##2##3##(2008-11#1)(2008-9#1)
surgery for treatment of##5##4##(1997-7#1)(2005-11#1)(2006-10#1)(2009-12#1)(2011-2#1)
surgery for tumors##2##3##(2010-7#1)(2013-1#1)
surgery for ulcerative colitis##3##4##(2006-10#1)(2009-5#1)(2012-11#1)
surgery for various##2##3##(1990-10#1)(1991-3#1)
surgery for##248##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-6#1)(1990-9#2)(1991-10#1)(1991-3#2)(1991-4#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-5#2)(1993-6#1)(1993-7#1)(1993-9#2)(1994-12#1)(1994-2#2)(1994-5#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-5#1)(1995-9#2)(1996-11#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-6#3)(1996-8#1)(1996-9#1)(1997-7#1)(2005-10#2)(2005-11#1)(2005-5#2)(2006-10#11)(2006-11#1)(2006-12#4)(2006-2#3)(2006-3#2)(2006-4#3)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#8)(2007-2#1)(2007-4#3)(2007-5#1)(2007-7#4)(2007-8#16)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#4)(2008-7#13)(2008-8#2)(2008-9#6)(2009-1#2)(2009-10#2)(2009-12#1)(2009-2#6)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#5)(2011-1#1)(2011-12#2)(2011-2#11)(2012-1#5)(2012-11#2)(2012-12#5)(2012-2#2)(2012-3#5)(2013-1#14)(2013-7#2)(2013-8#3)
surgery from##9##2##(1990-8#1)(1996-8#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-3#1)(2009-4#1)(2011-2#1)(2012-2#1)
surgery gave##2##2##(2008-3#1)(2008-8#1)
surgery given##2##2##(2009-2#1)(2012-3#1)
surgery guidelines##2##2##(2010-9#1)(2013-7#1)
surgery had##4##2##(1992-8#1)(2007-12#2)(2007-2#1)
surgery has a##2##3##(2012-12#1)(2013-1#1)
surgery has become the##3##4##(2004-2#1)(2010-8#1)(2013-1#1)
surgery has become##10##3##(1990-2#1)(1990-5#1)(2004-2#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-5#1)(2010-8#1)(2012-12#1)(2013-1#1)
surgery has been##15##3##(1991-11#1)(1992-3#1)(2006-12#1)(2006-2#1)(2006-6#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-6#1)(2010-12#2)(2012-2#1)(2012-3#2)
surgery has gained##2##3##(2006-10#1)(2012-12#1)
surgery has increased##2##3##(2006-6#1)(2010-8#1)
surgery has the##2##3##(2007-12#1)(2013-1#1)
surgery has##57##2##(1990-2#1)(1990-5#1)(1991-11#1)(1991-3#1)(1991-7#1)(1992-3#2)(2004-1#1)(2004-2#1)(2005-5#1)(2006-10#5)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#6)(2006-9#1)(2007-12#3)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-12#2)(2010-8#4)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#3)
surgery have been##9##3##(2006-10#1)(2006-6#2)(2007-12#1)(2008-10#1)(2008-3#1)(2010-12#1)(2012-2#1)(2012-3#1)
surgery have##18##2##(2005-12#1)(2006-10#2)(2006-6#3)(2006-8#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-8#1)(2010-12#1)(2012-1#1)(2012-2#1)(2012-3#1)
surgery if##3##2##(2008-1#1)(2008-5#1)(2008-8#1)
surgery improves##2##2##(2007-11#1)(2008-8#1)
surgery in 10 cases##2##4##(2008-6#1)(2011-2#1)
surgery in 2 patients##2##4##(2007-7#1)(2007-8#1)
surgery in Poland##3##3##(2007-8#3)
surgery in Vietnam##2##3##(2008-9#1)(2010-10#1)
surgery in West##2##3##(2012-2#2)
surgery in a medical##2##4##(2010-8#1)(2011-1#1)
surgery in a patient with##2##5##(2007-12#1)(2008-5#1)
surgery in a##10##3##(1994-5#1)(2005-12#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-5#2)(2010-8#1)(2011-1#1)
surgery in addition to##2##4##(2005-11#1)(2007-8#1)
surgery in addition##3##3##(2005-11#1)(2007-8#1)(2013-1#1)
surgery in adult##2##3##(2007-7#1)(2008-9#1)
surgery in adults##2##3##(2006-10#1)(2007-8#1)
surgery in an##2##3##(2005-5#1)(2012-3#1)
surgery in both##2##3##(2007-7#1)(2011-2#1)
surgery in breast cancer##3##4##(1991-6#1)(1993-11#2)
surgery in breast##5##3##(1991-2#2)(1991-6#1)(1993-11#2)
surgery in carcinoma of the##2##5##(2008-8#2)
surgery in cases of##2##4##(2006-6#1)(2007-7#1)
surgery in cases##3##3##(2006-6#1)(2007-7#1)(2008-9#1)
surgery in children with##2##4##(1994-7#1)(2010-9#1)
surgery in children##6##3##(1990-3#1)(1994-7#1)(2006-10#3)(2010-9#1)
surgery in elective##2##3##(2007-12#1)(2010-8#1)
surgery in one##2##3##(2007-2#1)(2007-7#1)
surgery in our##3##3##(1995-1#1)(2007-8#1)(2008-5#1)
surgery in patients with##10##4##(2007-11#1)(2007-5#1)(2007-8#3)(2008-6#1)(2009-8#1)(2012-3#1)(2013-7#2)
surgery in patients##16##3##(1994-3#1)(2005-2#1)(2006-12#1)(2007-11#1)(2007-5#1)(2007-8#4)(2008-12#1)(2008-4#1)(2008-6#1)(2009-8#1)(2012-3#1)(2013-7#2)
surgery in pediatric##2##3##(2008-5#1)(2008-9#1)
surgery in relation to the##2##5##(1990-9#1)(2006-12#1)
surgery in selected patients##3##4##(2007-8#1)(2009-5#1)(2013-8#1)
surgery in selected##4##3##(1992-5#1)(2007-8#1)(2009-5#1)(2013-8#1)
surgery in small animals##2##4##(2010-2#2)
surgery in that##2##3##(1991-1#1)(2004-2#1)
surgery in the UK##4##4##(2009-4#2)(2012-12#2)
surgery in the context of##2##5##(2006-9#1)(2011-2#1)
surgery in the elderly##2##4##(2006-10#1)(2006-2#1)
surgery in the management of##5##5##(2004-1#1)(2006-10#1)(2008-3#1)(2008-7#1)(2013-7#1)
surgery in the treatment of##10##5##(1995-8#1)(2005-12#2)(2006-2#1)(2007-11#2)(2007-8#1)(2007-9#1)(2011-2#1)(2012-1#1)
surgery in the upper gastrointestinal tract##2##6##(2012-1#2)
surgery in the upper##3##4##(1991-6#1)(2012-1#2)
surgery in the years##3##4##(2006-8#1)(2013-1#2)
surgery in the##66##3##(1991-6#2)(1993-10#1)(1995-5#1)(1995-8#1)(1995-9#1)(2004-1#1)(2004-2#1)(2005-12#2)(2006-10#4)(2006-2#2)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-11#2)(2007-3#1)(2007-8#8)(2007-9#2)(2008-10#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-4#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#3)(2012-12#2)(2013-1#5)(2013-7#1)
surgery in these##2##3##(1992-8#1)(2011-12#1)
surgery in this##4##3##(2007-8#1)(2008-6#1)(2008-7#1)(2012-3#1)
surgery in treatment of##2##4##(2008-9#1)(2013-7#1)
surgery in ulcerative##2##3##(1990-6#1)(1992-9#1)
surgery in which##5##3##(2006-10#1)(2006-5#2)(2007-11#1)(2009-3#1)
surgery in##266##2##(1990-10#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-4#1)(1991-6#3)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-10#2)(1993-11#3)(1993-4#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-8#1)(1995-9#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-8#2)(2004-1#1)(2004-10#1)(2004-2#5)(2005-11#2)(2005-12#4)(2005-2#1)(2005-5#1)(2006-10#14)(2006-11#1)(2006-12#3)(2006-2#2)(2006-4#1)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#3)(2007-1#3)(2007-11#5)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#11)(2007-8#29)(2007-9#4)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#4)(2008-7#4)(2008-8#2)(2008-9#8)(2009-3#1)(2009-4#3)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#2)(2010-12#3)(2010-2#3)(2010-3#1)(2010-8#6)(2010-9#2)(2011-1#2)(2011-12#3)(2011-2#8)(2011-3#1)(2012-1#4)(2012-12#2)(2012-2#12)(2012-3#5)(2013-1#9)(2013-7#5)(2013-8#2)
surgery include##7##2##(2006-10#1)(2006-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2010-12#1)(2010-7#1)
surgery includes##3##2##(2007-12#1)(2008-7#1)(2011-2#1)
surgery including##3##2##(2007-8#1)(2008-11#1)(2008-7#1)
surgery interventions##2##2##(1991-8#1)(2007-5#1)
surgery into##2##2##(1990-7#1)(2013-7#1)
surgery involving##5##2##(2005-5#1)(2007-12#1)(2007-9#1)(2008-5#1)(2013-1#1)
surgery is a growing##2##4##(2006-10#1)(2006-6#1)
surgery is a significant##2##4##(2011-2#1)(2012-3#1)
surgery is a surgical##2##4##(2007-12#1)(2009-4#1)
surgery is a##15##3##(2006-10#3)(2006-11#1)(2006-6#1)(2007-12#3)(2009-4#2)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#2)
surgery is also##2##3##(1995-4#1)(2010-12#1)
surgery is an##6##3##(1991-4#1)(1996-8#1)(2006-12#1)(2007-12#1)(2008-10#1)(2010-6#1)
surgery is associated with a##3##5##(1997-5#1)(2008-6#1)(2012-2#1)
surgery is based##2##3##(2007-8#1)(2010-8#1)
surgery is considered##2##3##(2012-12#1)(2012-3#1)
surgery is controversial##2##3##(2006-10#1)(2011-2#1)
surgery is currently##2##3##(2007-12#1)(2007-8#1)
surgery is described##2##3##(1993-9#1)(2007-8#1)
surgery is difficult##2##3##(2007-8#1)(2011-2#1)
surgery is indicated for##2##4##(1996-11#1)(2007-3#1)
surgery is indicated##4##3##(1996-11#1)(2007-3#1)(2008-4#1)(2013-1#1)
surgery is more##4##3##(2007-12#1)(2007-8#2)(2012-12#1)
surgery is necessary##2##3##(1993-1#1)(2007-8#1)
surgery is needed##2##3##(2006-10#1)(2008-1#1)
surgery is not##8##3##(1990-10#1)(2006-4#1)(2007-12#1)(2008-1#1)(2008-5#1)(2013-1#2)(2013-8#1)
surgery is now##2##3##(1992-12#1)(2006-10#1)
surgery is often##3##3##(1992-9#1)(2009-8#1)(2012-2#1)
surgery is performed##2##3##(2006-8#1)(2007-1#1)
surgery is possible and##2##4##(1990-12#1)(1993-3#1)
surgery is possible##3##3##(1990-12#1)(1993-3#1)(2008-3#1)
surgery is presented##2##3##(2007-8#1)(2012-3#1)
surgery is rare##5##3##(2007-12#1)(2007-8#2)(2012-12#2)
surgery is recommended##2##3##(2008-7#1)(2012-12#1)
surgery is still the##2##4##(1990-5#1)(2008-11#1)
surgery is still##6##3##(1990-5#1)(2006-10#1)(2006-6#1)(2007-9#1)(2008-11#1)(2011-2#1)
surgery is the mainstay of treatment##2##6##(2008-2#1)(2008-6#1)
surgery is the mainstay of##3##5##(2008-2#1)(2008-6#1)(2010-12#1)
surgery is the most##3##4##(1991-4#1)(2006-2#1)(2009-4#1)
surgery is the preferred treatment##2##5##(2005-12#1)(2007-12#1)
surgery is the treatment of choice##3##6##(1997-2#1)(2008-4#1)(2010-3#1)
surgery is the##16##3##(1991-4#1)(1997-2#1)(2005-12#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-3#1)
surgery is there any##2##4##(2007-8#2)
surgery is there##3##3##(2007-8#3)
surgery is to##5##3##(1997-2#1)(2006-3#1)(2006-6#1)(2007-11#1)(2008-1#1)
surgery is usually##2##3##(2007-7#1)(2012-12#1)
surgery is##174##2##(1990-10#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-9#2)(1991-12#1)(1991-4#2)(1991-7#1)(1992-12#1)(1992-9#2)(1993-1#1)(1993-3#1)(1993-9#1)(1995-4#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-2#2)(1997-5#1)(2004-2#1)(2005-12#1)(2006-10#14)(2006-11#1)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#1)(2006-6#5)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#12)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#18)(2007-9#2)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#3)(2009-2#1)(2009-3#1)(2009-4#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-3#2)(2010-6#1)(2010-7#3)(2010-8#5)(2011-1#1)(2011-2#8)(2011-3#1)(2012-12#9)(2012-2#2)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#1)
surgery leads to##3##3##(2006-10#1)(2007-2#1)(2010-12#1)
surgery malpractice##2##2##(1991-12#1)(2008-7#1)
surgery may be##6##3##(2006-10#1)(2006-2#1)(2006-3#1)(2007-12#1)(2009-4#1)(2011-2#1)
surgery may##18##2##(2004-1#1)(2004-2#1)(2006-10#1)(2006-2#1)(2006-3#2)(2006-5#1)(2007-11#1)(2007-12#1)(2009-2#1)(2009-4#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)
surgery might be##3##3##(2007-11#1)(2008-5#1)(2013-7#1)
surgery might##4##2##(1991-8#1)(2007-11#1)(2008-5#1)(2013-7#1)
surgery more##6##2##(1992-9#1)(2004-2#1)(2007-12#1)(2008-10#1)(2010-5#1)(2012-12#1)
surgery must##3##2##(1991-8#1)(1996-6#1)(2008-4#1)
surgery of a##2##3##(2007-8#1)(2013-1#1)
surgery of aortic##2##3##(1990-10#1)(2011-2#1)
surgery of descending##2##3##(2007-8#1)(2012-3#1)
surgery of early glottic cancer in elderly##2##7##(2011-1#2)
surgery of gastroesophageal reflux##2##4##(1992-3#1)(2006-2#1)
surgery of the human cerebrum##2##5##(2008-9#2)
surgery of the shoulder##2##4##(2007-11#1)(2007-8#1)
surgery of the##30##3##(1992-10#1)(1992-3#1)(1992-9#1)(1995-4#1)(1996-8#1)(2006-10#3)(2006-3#1)(2006-8#1)(2007-11#4)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-6#1)(2008-9#3)(2013-1#1)(2013-7#1)(2013-8#1)
surgery of##80##2##(1990-10#1)(1990-12#1)(1990-6#2)(1990-9#2)(1992-10#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-4#1)(1996-12#1)(1996-8#2)(1997-8#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-11#10)(2007-12#2)(2007-5#1)(2007-7#2)(2007-8#7)(2007-9#2)(2008-6#1)(2008-7#2)(2008-9#5)(2009-2#2)(2010-12#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-11#1)(2012-12#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
surgery offers##2##2##(2007-8#1)(2012-12#1)
surgery on beating##3##3##(2006-6#1)(2012-3#2)
surgery on the##11##3##(1991-8#1)(2004-2#2)(2007-7#1)(2007-8#4)(2010-8#1)(2011-2#1)(2013-1#1)
surgery on##32##2##(1990-2#1)(1990-5#1)(1991-8#1)(1993-12#1)(1996-1#1)(1996-4#1)(2004-2#2)(2005-12#2)(2006-6#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#6)(2008-10#2)(2008-7#1)(2010-8#1)(2011-2#1)(2012-3#4)(2013-1#1)(2013-7#1)
surgery only##3##2##(1990-3#1)(1991-2#1)(2007-2#1)
surgery operations##2##2##(2006-6#1)(2007-8#1)
surgery or chemotherapy##2##3##(1993-9#1)(2008-8#1)
surgery or embolization##2##3##(2008-7#2)
surgery or endovascular##2##3##(1995-11#1)(2008-7#1)
surgery or pain##2##3##(2006-12#1)(2007-10#1)
surgery or radiotherapy##5##3##(2007-8#1)(2008-5#1)(2009-3#1)(2011-12#1)(2012-3#1)
surgery or##56##2##(1990-10#1)(1990-5#1)(1991-10#2)(1991-11#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-6#1)(1993-2#1)(1993-9#1)(1994-12#1)(1995-11#1)(1996-7#1)(1997-4#1)(2004-10#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-8#3)(2008-10#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#1)(2009-3#2)(2009-7#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
surgery outcome##2##2##(2007-11#2)
surgery over a##2##3##(2007-8#1)(2012-12#1)
surgery over##3##2##(2006-6#1)(2007-8#1)(2012-12#1)
surgery patient##4##2##(2007-12#2)(2010-8#1)(2012-2#1)
surgery patients were##2##3##(2010-8#1)(2012-2#1)
surgery patients##26##2##(1993-5#1)(2006-10#1)(2007-12#5)(2007-8#2)(2008-1#1)(2008-11#2)(2008-2#1)(2009-9#1)(2010-4#1)(2010-7#2)(2010-8#5)(2012-2#4)
surgery performed at##3##3##(1990-4#1)(1991-2#1)(2012-12#1)
surgery performed##8##2##(1990-4#1)(1991-2#1)(2006-10#1)(2007-1#1)(2008-11#1)(2009-6#1)(2011-1#1)(2012-12#1)
surgery planning##2##2##(2007-5#1)(2009-4#1)
surgery poses##2##2##(2006-10#1)(2006-6#1)
surgery practice##6##2##(2005-9#1)(2007-12#1)(2008-9#1)(2012-12#1)(2013-1#2)
surgery practices##2##2##(2007-12#1)(2012-12#1)
surgery procedures in the##2##4##(2010-9#1)(2012-12#1)
surgery procedures##6##2##(2007-1#1)(2010-9#2)(2011-2#1)(2012-12#1)(2013-1#1)
surgery program##5##2##(2005-9#1)(2007-5#1)(2010-2#1)(2013-1#2)
surgery programs##3##2##(2007-4#1)(2008-3#1)(2012-3#1)
surgery provided that##2##3##(1990-11#1)(2008-7#1)
surgery received##2##2##(1996-8#1)(2007-11#1)
surgery recently##2##2##(2007-8#1)(2011-1#1)
surgery reduce the incidence of##2##5##(2007-8#2)
surgery reduces the##2##3##(2007-8#1)(2008-8#1)
surgery remains the##4##3##(1991-9#1)(1997-3#1)(2010-3#1)(2012-12#1)
surgery remains##6##2##(1991-9#1)(1997-3#1)(2006-10#1)(2007-8#1)(2010-3#1)(2012-12#1)
surgery represents a##2##3##(2006-5#1)(2008-8#1)
surgery required##2##2##(2006-10#1)(2007-8#1)
surgery requiring##3##2##(2010-7#1)(2011-2#1)(2012-3#1)
surgery residency##2##2##(2008-7#1)(2012-3#1)
surgery residents##3##2##(2007-3#1)(2007-7#1)(2007-8#1)
surgery resulted in##3##3##(1994-12#1)(2007-8#1)(2008-8#1)
surgery revealed##2##2##(2008-7#1)(2012-1#1)
surgery risk##4##2##(2007-8#3)(2012-2#1)
surgery seem to##2##3##(2006-6#1)(2010-6#1)
surgery seems to be##2##4##(2008-7#2)
surgery seems##4##2##(2007-3#1)(2007-7#1)(2008-7#2)
surgery setting to##2##3##(2009-2#1)(2013-1#1)
surgery setting##4##2##(2006-10#1)(2006-8#1)(2009-2#1)(2013-1#1)
surgery she was##2##3##(2008-12#1)(2012-3#1)
surgery should be performed##2##4##(1991-12#1)(1993-10#1)
surgery should be##13##3##(1991-12#1)(1993-10#1)(1996-2#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-3#1)(2008-5#1)
surgery should##14##2##(1991-12#1)(1993-10#1)(1996-2#1)(1996-8#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-3#1)(2008-5#1)
surgery showed a##3##3##(2005-8#1)(2006-8#1)(2008-1#1)
surgery showed##7##2##(1997-8#1)(2005-8#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-7#1)(2013-1#1)
surgery significantly reduces the##2##4##(2007-8#1)(2008-5#1)
surgery significantly##3##2##(2007-8#1)(2008-5#1)(2011-1#1)
surgery simulation##2##2##(2008-6#1)(2009-12#1)
surgery since##3##2##(1990-9#1)(1996-3#1)(2006-8#1)
surgery still plays a##2##4##(1994-6#1)(2013-1#1)
surgery still##6##2##(1990-4#1)(1994-6#1)(2007-8#1)(2009-5#1)(2010-8#1)(2013-1#1)
surgery studies##2##2##(2010-8#1)(2012-2#1)
surgery study##2##2##(1994-2#1)(2008-12#1)
surgery taking##2##2##(2010-8#1)(2012-2#1)
surgery team##2##2##(2011-12#1)(2012-2#1)
surgery technique##3##2##(2007-8#1)(2008-8#1)(2010-7#1)
surgery than##4##2##(1990-4#1)(1993-2#1)(2012-3#1)(2013-1#1)
surgery that can##2##3##(2007-8#1)(2009-9#1)
surgery that was##2##3##(2007-5#1)(2012-1#1)
surgery that##15##2##(1990-3#1)(1990-4#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-5#1)(2007-8#3)(2008-10#1)(2009-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
surgery the patient##4##3##(2005-5#1)(2006-10#1)(2009-2#1)(2012-12#1)
surgery the patients were##2##4##(2007-7#1)(2008-7#1)
surgery the patients##3##3##(2007-7#2)(2008-7#1)
surgery the##21##2##(1992-9#1)(1993-2#1)(1995-9#1)(1996-9#1)(2005-5#2)(2006-10#1)(2006-6#2)(2007-7#4)(2007-9#1)(2008-1#1)(2008-7#2)(2008-9#1)(2009-2#1)(2011-2#1)(2012-12#1)
surgery there was##2##3##(2007-8#1)(2008-6#1)
surgery there##3##2##(2007-8#1)(2008-6#1)(2013-1#1)
surgery they were##2##3##(1991-4#1)(2008-10#1)
surgery through##3##2##(2007-8#1)(2007-9#1)(2012-12#1)
surgery time##11##2##(1993-12#2)(1996-2#3)(2007-7#1)(2011-1#2)(2012-12#3)
surgery to be##3##3##(1994-6#1)(1996-1#1)(2006-8#1)
surgery to correct##3##3##(2006-10#1)(2006-5#1)(2007-7#1)
surgery to reduce##4##3##(2005-5#1)(2007-8#1)(2007-9#1)(2010-10#1)
surgery to remove##5##3##(2006-4#1)(2007-12#1)(2007-8#1)(2013-7#1)(2013-8#1)
surgery to replace##2##3##(2010-12#1)(2013-8#1)
surgery to the##6##3##(2006-3#1)(2007-11#2)(2007-4#1)(2008-6#1)(2012-2#1)
surgery to##51##2##(1994-6#1)(1996-1#2)(1996-9#2)(2005-5#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-5#1)(2010-10#1)(2010-12#2)(2010-3#1)(2011-2#2)(2012-12#4)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#3)
surgery today##2##2##(1991-3#1)(2010-8#1)
surgery training##5##2##(2007-5#1)(2008-6#2)(2011-2#1)(2012-2#1)
surgery under general anaesthesia##2##4##(2010-7#2)
surgery under the##2##3##(1990-8#1)(2008-3#1)
surgery under##14##2##(1990-8#1)(1991-1#1)(1993-1#1)(2005-5#1)(2006-12#1)(2007-1#1)(2007-8#2)(2008-3#1)(2010-5#1)(2010-7#2)(2011-1#1)(2012-2#1)
surgery units##2##2##(2008-7#1)(2013-1#1)
surgery unless##2##2##(1991-5#1)(2008-1#1)
surgery using a##7##3##(1992-9#1)(2007-8#1)(2010-3#1)(2012-2#1)(2013-1#3)
surgery using the##4##3##(1992-10#1)(2007-5#1)(2008-7#1)(2010-8#1)
surgery using##25##2##(1990-9#1)(1992-10#1)(1992-9#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-7#1)(2010-3#2)(2010-8#2)(2012-2#2)(2013-1#5)
surgery versus##2##2##(2011-2#1)(2013-7#1)
surgery vs##6##2##(1992-2#1)(2010-3#4)(2012-12#1)
surgery wards##6##2##(2008-10#1)(2012-2#5)
surgery was 7##2##3##(2007-11#1)(2008-4#1)
surgery was done##5##3##(1993-6#1)(1997-3#1)(2007-8#2)(2009-10#1)
surgery was performed in##2##4##(1990-12#1)(2007-8#1)
surgery was performed on##3##4##(1990-5#1)(2007-9#1)(2013-8#1)
surgery was performed to##2##4##(2007-8#2)
surgery was performed with##2##4##(2007-8#1)(2013-7#1)
surgery was performed##17##3##(1990-12#1)(1990-5#1)(1992-6#1)(1993-9#1)(2007-8#5)(2007-9#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-2#1)(2011-2#1)(2013-7#1)(2013-8#1)
surgery was required##3##3##(1990-6#1)(2006-6#1)(2007-8#1)
surgery was selected##2##3##(2007-11#1)(2008-3#1)
surgery was the##4##3##(1997-3#1)(2010-12#1)(2010-8#1)(2013-1#1)
surgery was to##3##3##(2005-10#1)(2012-2#1)(2013-8#1)
surgery was written according to a structured protocol##60##8##(2007-8#60)
surgery was##163##2##(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-1#1)(1992-10#1)(1992-11#1)(1992-6#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-4#1)(1996-1#1)(1996-6#1)(1997-3#2)(1997-6#1)(2005-10#2)(2006-11#1)(2006-12#2)(2006-6#2)(2006-7#1)(2007-11#5)(2007-12#2)(2007-3#1)(2007-7#7)(2007-8#73)(2007-9#2)(2008-10#1)(2008-3#1)(2008-4#2)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#3)(2009-2#1)(2009-3#2)(2010-10#1)(2010-12#3)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#3)
surgery were analysed##2##3##(1991-11#1)(2013-8#1)
surgery were evaluated##3##3##(1997-3#1)(2007-1#1)(2011-2#1)
surgery were good##4##3##(2007-7#2)(2012-12#2)
surgery were randomly##2##3##(2007-8#1)(2011-2#1)
surgery were recorded##2##3##(2008-9#1)(2012-2#1)
surgery were selected##3##3##(2007-8#1)(2013-1#2)
surgery were studied##2##3##(2012-3#1)(2013-8#1)
surgery were##45##2##(1990-6#1)(1991-11#1)(1991-6#1)(1992-9#1)(1993-10#1)(1993-12#1)(1995-9#1)(1997-3#1)(2005-12#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-7#2)(2008-9#1)(2010-8#1)(2011-2#4)(2012-12#3)(2012-2#3)(2012-3#3)(2012-5#1)(2013-1#3)(2013-8#2)
surgery when##3##2##(1995-9#1)(1996-2#1)(2008-8#1)
surgery where##3##2##(1996-9#1)(2007-4#1)(2007-9#1)
surgery who##3##2##(2005-10#1)(2007-8#1)(2011-2#1)
surgery will be##4##3##(1993-5#1)(2006-6#1)(2009-5#1)(2010-8#1)
surgery will continue to##2##4##(1996-9#1)(2007-12#1)
surgery will##11##2##(1993-5#1)(1996-9#2)(2006-10#1)(2006-6#1)(2006-7#1)(2007-12#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-12#1)
surgery with CPB##3##3##(2007-8#3)
surgery with a##9##3##(1992-12#1)(2006-9#1)(2007-8#1)(2008-7#1)(2009-8#1)(2011-1#1)(2012-2#2)(2013-8#1)
surgery with cardiopulmonary bypass##3##4##(2007-8#2)(2013-1#1)
surgery with different##2##3##(2008-6#1)(2011-1#1)
surgery with extracorporeal circulation##2##4##(2012-3#2)
surgery with extracorporeal##3##3##(2012-3#3)
surgery with or without##4##4##(1995-4#1)(1997-3#1)(2006-12#1)(2012-2#1)
surgery with the##5##3##(2007-7#2)(2007-8#1)(2008-12#1)(2013-8#1)
surgery with##77##2##(1990-4#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-9#1)(1993-1#3)(1993-2#1)(1993-9#1)(1995-4#1)(1995-9#1)(1997-1#1)(1997-3#2)(2006-10#1)(2006-12#5)(2006-8#1)(2006-9#1)(2007-11#1)(2007-3#2)(2007-5#2)(2007-7#2)(2007-8#11)(2007-9#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#2)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#3)
surgery within a##2##3##(2009-10#1)(2010-10#1)
surgery within##6##2##(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2009-10#1)(2010-10#1)
surgery without any##3##3##(2010-12#1)(2011-2#2)
surgery without the##2##3##(2006-10#1)(2008-10#1)
surgery without##15##2##(1990-2#1)(1996-5#1)(2006-10#1)(2006-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2010-12#1)(2011-2#4)(2012-3#1)(2013-8#2)
surgery would##3##2##(1996-12#1)(2007-11#1)(2008-12#1)
surgery##4791##1##(1990-1#2)(1990-10#15)(1990-11#3)(1990-12#25)(1990-2#13)(1990-3#10)(1990-4#13)(1990-5#8)(1990-6#16)(1990-7#3)(1990-8#11)(1990-9#21)(1991-1#10)(1991-10#6)(1991-11#7)(1991-12#7)(1991-2#14)(1991-3#16)(1991-4#19)(1991-5#7)(1991-6#14)(1991-7#4)(1991-8#12)(1991-9#5)(1992-1#2)(1992-10#18)(1992-11#6)(1992-12#7)(1992-2#13)(1992-3#16)(1992-4#2)(1992-5#12)(1992-6#9)(1992-8#15)(1992-9#18)(1993-1#18)(1993-10#25)(1993-11#5)(1993-12#11)(1993-2#11)(1993-3#16)(1993-4#3)(1993-5#17)(1993-6#7)(1993-7#9)(1993-8#1)(1993-9#15)(1994-1#2)(1994-11#4)(1994-12#11)(1994-2#10)(1994-3#7)(1994-4#2)(1994-5#4)(1994-6#9)(1994-7#5)(1994-8#4)(1994-9#5)(1995-1#9)(1995-10#2)(1995-11#5)(1995-12#3)(1995-2#5)(1995-3#5)(1995-4#7)(1995-5#4)(1995-6#2)(1995-7#2)(1995-8#6)(1995-9#14)(1996-1#11)(1996-11#8)(1996-12#7)(1996-2#12)(1996-3#18)(1996-4#5)(1996-5#4)(1996-6#8)(1996-7#1)(1996-8#11)(1996-9#15)(1997-1#8)(1997-2#11)(1997-3#16)(1997-4#9)(1997-5#3)(1997-6#3)(1997-7#4)(1997-8#8)(2004-1#13)(2004-10#5)(2004-2#26)(2004-3#1)(2004-7#1)(2004-9#2)(2005-10#11)(2005-11#10)(2005-12#19)(2005-2#1)(2005-5#15)(2005-7#5)(2005-8#5)(2005-9#6)(2006-1#3)(2006-10#254)(2006-11#18)(2006-12#52)(2006-2#29)(2006-3#19)(2006-4#23)(2006-5#22)(2006-6#130)(2006-7#17)(2006-8#40)(2006-9#25)(2007-1#22)(2007-10#18)(2007-11#124)(2007-12#140)(2007-2#23)(2007-3#30)(2007-4#8)(2007-5#57)(2007-6#3)(2007-7#109)(2007-8#516)(2007-9#75)(2008-1#24)(2008-10#48)(2008-11#32)(2008-12#21)(2008-2#8)(2008-3#29)(2008-4#58)(2008-5#49)(2008-6#69)(2008-7#100)(2008-8#61)(2008-9#67)(2009-1#6)(2009-10#16)(2009-12#7)(2009-2#39)(2009-3#17)(2009-4#30)(2009-5#28)(2009-6#15)(2009-7#14)(2009-8#14)(2009-9#10)(2010-1#3)(2010-10#10)(2010-11#14)(2010-12#77)(2010-2#30)(2010-3#28)(2010-4#11)(2010-5#14)(2010-6#15)(2010-7#38)(2010-8#90)(2010-9#24)(2011-1#39)(2011-12#32)(2011-2#189)(2011-3#7)(2011-7#2)(2012-1#31)(2012-11#6)(2012-12#150)(2012-2#126)(2012-3#97)(2012-5#1)(2012-8#1)(2013-1#215)(2013-7#36)(2013-8#60)
surgery&quot##7##1##(1991-3#1)(2005-11#1)(2007-4#1)(2008-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
surgery'##3##1##(2007-8#1)(2009-2#1)(2011-12#1)
surgery's##3##1##(2008-4#1)(2009-2#1)(2011-2#1)
surgery) and##2##2##(2008-10#1)(2009-6#1)
surgery) were##3##2##(1990-11#1)(2010-7#1)(2012-3#1)
surgery)##19##1##(1990-11#1)(1990-6#1)(1991-3#1)(1993-3#1)(1995-4#1)(1996-8#1)(2006-10#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-6#2)(2010-7#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
surgery--is##2##1##(2006-4#1)(2007-3#1)
surgery-induced##2##1##(2007-11#2)
surgery-related complications##3##2##(1994-12#1)(2006-7#1)(2006-8#1)
surgery-related##9##1##(1994-12#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2010-12#1)
surgery?##34##1##(2006-10#3)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#22)(2008-12#1)(2008-5#1)(2008-7#1)(2010-4#1)(2012-2#2)
surgery?]##4##1##(1993-3#1)(1994-5#1)(1995-9#1)(2007-9#1)
surgery]##90##1##(1990-1#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-6#3)(1990-9#1)(1991-3#2)(1991-6#1)(1992-3#4)(1992-6#3)(1992-9#2)(1993-3#1)(1993-5#1)(1993-9#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#2)(1995-4#1)(1995-8#1)(1996-1#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2005-11#1)(2005-9#2)(2006-2#1)(2007-1#1)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#4)(2008-11#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#2)(2010-1#1)(2010-8#4)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#6)(2013-1#2)(2013-8#5)
surges##5##1##(1992-12#1)(1994-3#1)(1995-1#1)(2006-5#1)(2010-12#1)
surgical ablation of the##2##4##(2006-5#1)(2010-3#1)
surgical ablation of##3##3##(2006-5#1)(2006-6#1)(2010-3#1)
surgical ablation##6##2##(2006-5#1)(2006-6#1)(2007-8#1)(2010-3#2)(2010-8#1)
surgical access##5##2##(1991-9#1)(2007-7#1)(2007-9#1)(2009-4#1)(2013-1#1)
surgical accessibility##2##2##(2007-2#1)(2010-6#1)
surgical activity##2##2##(1992-10#1)(2009-7#1)
surgical aid to##2##3##(2006-6#1)(2006-7#1)
surgical aid##3##2##(2006-6#2)(2006-7#1)
surgical airway##3##2##(2006-10#1)(2013-1#2)
surgical alternative for##3##3##(1991-2#1)(2008-10#1)(2008-7#1)
surgical alternative##5##2##(1991-2#1)(2005-11#1)(2007-1#1)(2008-10#1)(2008-7#1)
surgical anatomy##2##2##(2007-12#2)
surgical and anesthetic management##2##4##(2006-10#1)(2011-2#1)
surgical and anesthetic techniques##2##4##(2006-10#1)(2007-12#1)
surgical and anesthetic##6##3##(2006-10#4)(2007-12#1)(2011-2#1)
surgical and conservative treatment##3##4##(2007-11#1)(2011-2#1)(2013-1#1)
surgical and conservative##4##3##(2007-11#1)(2011-2#1)(2013-1#2)
surgical and diagnostic##2##3##(2006-8#1)(2007-1#1)
surgical and endovascular##2##3##(2007-7#1)(2011-3#1)
surgical and medical complications##2##4##(2008-9#2)
surgical and medical interventions##2##4##(2007-11#1)(2010-3#1)
surgical and medical management##6##4##(2007-10#1)(2007-11#1)(2009-2#2)(2013-1#2)
surgical and medical##17##3##(2006-6#1)(2007-10#1)(2007-11#3)(2007-5#1)(2007-7#1)(2008-9#2)(2009-2#2)(2010-1#1)(2010-12#1)(2010-3#1)(2010-9#1)(2013-1#2)
surgical and non-surgical##4##3##(1994-3#1)(2007-11#2)(2013-8#1)
surgical and nonsurgical##5##3##(2006-7#1)(2007-11#1)(2008-3#2)(2011-1#1)
surgical and##78##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-3#2)(1993-1#1)(1993-5#1)(1994-3#1)(1995-12#1)(1995-6#1)(2005-10#1)(2005-7#1)(2006-10#5)(2006-2#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#3)(2007-5#1)(2007-7#6)(2007-8#2)(2008-3#2)(2008-6#2)(2008-7#1)(2008-9#4)(2009-2#3)(2010-1#1)(2010-12#2)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#4)(2011-3#1)(2013-1#6)(2013-8#3)
surgical applications##2##2##(1991-1#1)(2008-2#1)
surgical approach and the extent of resection##2##7##(2006-6#1)(2010-5#1)
surgical approach and the##4##4##(2006-6#1)(2007-11#1)(2010-11#1)(2010-5#1)
surgical approach and##9##3##(2006-6#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-1#1)
surgical approach for the##3##4##(2006-6#1)(2011-2#2)
surgical approach for##6##3##(1991-4#1)(2006-6#1)(2007-8#2)(2011-2#2)
surgical approach in the##2##4##(1993-6#1)(2011-3#1)
surgical approach in##3##3##(1993-6#1)(2011-1#1)(2011-3#1)
surgical approach is described##2##4##(1996-12#1)(2006-5#1)
surgical approach is##3##3##(1990-3#1)(1996-12#1)(2006-5#1)
surgical approach of##3##3##(1995-12#1)(2007-5#1)(2008-12#1)
surgical approach to the##3##4##(2005-9#1)(2006-10#1)(2006-4#1)
surgical approach to##8##3##(1990-12#1)(2005-9#1)(2006-10#1)(2006-4#1)(2008-10#1)(2009-3#1)(2010-8#1)(2011-2#1)
surgical approach was performed in##2##5##(2006-6#1)(2013-1#1)
surgical approach was##7##3##(1991-6#1)(1993-8#1)(2006-12#1)(2006-6#1)(2007-8#1)(2008-7#1)(2013-1#1)
surgical approach with##2##3##(2013-1#2)
surgical approach##95##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-5#1)(1992-6#1)(1993-6#1)(1993-8#1)(1995-12#1)(1996-12#1)(2005-9#4)(2006-10#2)(2006-12#4)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#7)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#10)(2008-10#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#7)(2011-3#1)(2012-1#2)(2012-2#1)(2012-3#4)(2013-1#7)(2013-8#1)
surgical approach-related trauma##2##3##(2006-8#2)
surgical approaches for the##2##4##(2006-7#1)(2013-8#1)
surgical approaches for##6##3##(2004-12#1)(2006-7#2)(2007-12#1)(2010-7#1)(2013-8#1)
surgical approaches have been##4##4##(2006-2#1)(2007-8#1)(2013-1#2)
surgical approaches have##6##3##(2006-12#1)(2006-2#1)(2007-11#1)(2007-8#1)(2013-1#2)
surgical approaches in##3##3##(1990-4#1)(2008-8#1)(2011-2#1)
surgical approaches to the##3##4##(2007-11#2)(2008-8#1)
surgical approaches to##11##3##(2006-10#1)(2006-5#1)(2007-11#3)(2007-8#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
surgical approaches##52##2##(1990-10#1)(1990-4#1)(1991-3#1)(1993-3#1)(2004-12#1)(2004-2#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#1)(2006-7#2)(2007-1#1)(2007-11#4)(2007-12#5)(2007-5#2)(2007-8#2)(2008-1#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-2#1)(2013-1#6)(2013-8#1)
surgical areas##2##2##(2006-6#2)
surgical aspects of##5##3##(1990-9#1)(2007-12#1)(2008-10#1)(2008-9#1)(2012-12#1)
surgical aspects##10##2##(1990-9#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-9#1)(2009-8#1)(2012-12#1)(2012-2#1)
surgical assistance##2##2##(2006-6#2)
surgical biopsy of the##2##4##(2012-3#1)(2013-8#1)
surgical biopsy of##3##3##(1990-6#1)(2012-3#1)(2013-8#1)
surgical biopsy specimens##2##3##(1992-10#1)(2008-5#1)
surgical biopsy##12##2##(1990-6#1)(1992-10#1)(1994-7#1)(1996-9#1)(2006-4#2)(2007-4#1)(2008-5#1)(2008-6#1)(2012-3#1)(2013-8#2)
surgical blood loss##2##3##(1996-9#1)(2006-5#1)
surgical blood##3##2##(1996-9#2)(2006-5#1)
surgical candidates##6##2##(2006-10#1)(2007-8#3)(2008-3#1)(2008-6#1)
surgical care of##2##3##(2007-12#1)(2013-1#1)
surgical care##22##2##(1991-5#1)(1992-6#1)(1993-12#1)(1995-2#1)(2006-10#1)(2006-2#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-12#1)(2010-8#3)(2010-9#1)(2012-2#1)(2013-1#3)
surgical case##2##2##(2007-8#1)(2013-7#1)
surgical cases##8##2##(1992-12#1)(1993-12#2)(2007-10#2)(2007-11#1)(2008-8#1)(2009-7#1)
surgical castration##5##2##(1990-6#1)(1991-4#2)(2010-4#2)
surgical cement##2##2##(2007-11#2)
surgical center##4##2##(1997-1#2)(2006-11#1)(2011-2#1)
surgical centres##2##2##(2005-12#1)(2008-7#1)
surgical challenge##8##2##(2006-10#1)(2006-5#2)(2007-12#2)(2007-8#1)(2008-3#1)(2011-2#1)
surgical challenges##2##2##(2008-9#1)(2012-3#1)
surgical clipping##3##2##(1997-6#1)(2008-6#1)(2013-8#1)
surgical closure of##7##3##(2006-6#1)(2007-3#1)(2007-8#1)(2008-3#1)(2008-4#1)(2012-12#2)
surgical closure##15##2##(1992-10#1)(2006-6#1)(2007-3#1)(2007-8#3)(2008-3#1)(2008-4#3)(2012-1#2)(2012-10#1)(2012-12#2)
surgical complete##2##2##(1991-1#1)(2007-8#1)
surgical complication##7##2##(2007-8#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#2)(2012-3#1)
surgical complications and##2##3##(2008-3#1)(2013-1#1)
surgical complications are##3##3##(2008-1#1)(2013-1#2)
surgical complications of##2##3##(2007-7#1)(2013-8#1)
surgical complications were##3##3##(2005-9#1)(2010-7#1)(2013-1#1)
surgical complications##29##2##(1993-3#1)(1994-12#1)(2005-9#2)(2006-6#1)(2006-9#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-7#1)(2011-1#1)(2011-2#3)(2013-1#7)(2013-8#1)
surgical conditions##5##2##(2004-2#1)(2006-1#1)(2007-3#1)(2008-7#1)(2010-8#1)
surgical confirmation##2##2##(1991-5#1)(1993-5#1)
surgical correction and##3##3##(2007-7#1)(2007-8#1)(2012-2#1)
surgical correction of hermaphroditism##2##4##(2006-7#2)
surgical correction of scoliosis##5##4##(2007-7#4)(2007-8#1)
surgical correction of the##5##4##(2006-7#1)(2007-12#1)(2007-7#1)(2007-8#1)(2010-10#1)
surgical correction of##19##3##(2006-3#1)(2006-7#3)(2007-12#1)(2007-7#6)(2007-8#4)(2008-8#1)(2009-10#1)(2009-4#1)(2010-10#1)
surgical correction using##2##3##(2005-12#1)(2007-7#1)
surgical correction##35##2##(2005-12#1)(2006-11#1)(2006-3#1)(2006-7#4)(2007-11#1)(2007-12#1)(2007-7#9)(2007-8#7)(2008-11#1)(2008-8#1)(2009-10#1)(2009-4#2)(2010-10#1)(2011-1#1)(2011-2#2)(2012-2#1)
surgical critical care##2##3##(2007-8#1)(2009-6#1)
surgical cure##3##2##(2006-1#2)(2008-7#1)
surgical debridement can be##2##4##(2009-4#1)(2013-1#1)
surgical debridement of##2##3##(2010-12#1)(2010-6#1)
surgical debridement##15##2##(1995-11#1)(1995-2#1)(2006-10#1)(2007-11#1)(2007-8#3)(2008-7#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-6#2)(2012-2#1)(2013-1#1)
surgical debulking##2##2##(2006-7#1)(2008-6#1)
surgical decision##2##2##(1991-10#1)(2005-12#1)
surgical decompression and##2##3##(2006-8#1)(2008-6#1)
surgical decompression is necessary##2##4##(2007-7#1)(2012-12#1)
surgical decompression is##4##3##(2007-7#1)(2011-2#2)(2012-12#1)
surgical decompression of the##2##4##(2007-9#1)(2008-7#1)
surgical decompression of##3##3##(2005-9#1)(2007-9#1)(2008-7#1)
surgical decompression##16##2##(2005-9#1)(2006-3#3)(2006-8#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-9#1)(2011-2#2)(2012-1#1)(2012-12#1)
surgical defects##4##2##(1994-6#1)(2008-8#1)(2013-1#2)
surgical delay##3##2##(2013-1#3)
surgical department##4##2##(1990-5#1)(1993-10#1)(2006-6#1)(2012-3#1)
surgical departments##2##2##(1992-6#1)(1995-9#1)
surgical details##2##2##(2011-2#1)(2013-1#1)
surgical devices##4##2##(1993-6#1)(2006-6#1)(2010-8#1)(2011-2#1)
surgical discectomy##2##2##(1993-11#2)
surgical diseases##4##2##(1990-5#1)(1991-3#1)(2006-2#1)(2008-3#1)
surgical drainage and##5##3##(2007-7#3)(2008-7#1)(2009-2#1)
surgical drainage in##2##3##(1993-5#1)(2011-1#1)
surgical drainage of##2##3##(2011-2#1)(2012-2#1)
surgical drainage##14##2##(1990-4#1)(1993-5#1)(2006-10#1)(2007-7#3)(2008-7#1)(2009-2#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-2#1)
surgical education##4##2##(2007-3#2)(2012-3#1)(2013-1#1)
surgical embolectomy##2##2##(2007-10#1)(2011-12#1)
surgical emergencies in##4##3##(2011-2#2)(2012-12#1)(2013-1#1)
surgical emergencies##9##2##(1991-9#1)(2011-2#3)(2012-12#1)(2013-1#4)
surgical emergency in##3##3##(2005-12#1)(2011-2#1)(2012-2#1)
surgical emergency##7##2##(2005-12#1)(2006-6#1)(2007-3#1)(2009-4#1)(2011-2#2)(2012-2#1)
surgical enucleation##3##2##(1991-9#1)(2009-5#1)(2012-2#1)
surgical equipment##6##2##(2006-10#1)(2006-3#1)(2010-2#1)(2013-1#3)
surgical error##2##2##(2007-7#1)(2007-8#1)
surgical evacuation##2##2##(2007-10#1)(2008-7#1)
surgical excision and##6##3##(1993-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2012-3#1)(2013-1#1)
surgical excision is the treatment of choice##3##7##(2007-7#1)(2007-8#2)
surgical excision is##7##3##(2007-7#1)(2007-8#2)(2008-6#1)(2008-9#1)(2010-3#1)(2010-9#1)
surgical excision of a##6##4##(2006-10#1)(2008-9#1)(2013-1#4)
surgical excision of the lesion##3##5##(2004-1#1)(2008-6#1)(2012-12#1)
surgical excision of the tumor##3##5##(2006-9#1)(2007-2#1)(2007-8#1)
surgical excision of the##10##4##(1991-10#1)(2004-1#1)(2006-9#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-6#2)(2012-12#1)
surgical excision of##24##3##(1991-10#1)(1991-6#1)(2004-1#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#2)(2007-8#2)(2008-6#2)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#4)
surgical excision was done##2##4##(2011-1#1)(2012-3#1)
surgical excision was##7##3##(2006-10#1)(2007-2#1)(2007-7#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
surgical excision were##2##3##(1991-4#1)(2007-2#1)
surgical excision with or without adjuvant##2##6##(2010-7#1)(2012-1#1)
surgical excision with##4##3##(2008-6#1)(2010-7#1)(2011-2#1)(2012-1#1)
surgical excision##82##2##(1990-6#1)(1991-10#1)(1991-4#1)(1991-6#2)(1993-1#1)(1993-6#1)(2004-1#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-2#5)(2007-3#1)(2007-7#6)(2007-8#5)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#4)(2008-9#3)(2009-4#2)(2009-5#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#3)(2012-12#5)(2012-2#1)(2012-3#4)(2013-1#7)(2013-8#1)
surgical exeresis##5##2##(1990-3#1)(1991-11#1)(2007-11#2)(2008-5#1)
surgical experience##3##2##(2007-7#1)(2009-9#1)(2012-2#1)
surgical expertise##2##2##(2007-7#1)(2007-8#1)
surgical exploration and##4##3##(2006-2#1)(2007-3#1)(2008-7#1)(2010-7#1)
surgical exploration is##2##3##(2008-7#1)(2012-3#1)
surgical exploration of the neck##2##5##(2010-12#1)(2011-2#1)
surgical exploration##15##2##(1991-12#1)(1991-3#1)(1993-3#1)(2006-2#1)(2007-3#1)(2008-1#1)(2008-7#2)(2009-10#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-3#1)
surgical exposure and##2##3##(1990-5#1)(2005-9#1)
surgical exposure##7##2##(1990-5#1)(2005-9#1)(2007-8#2)(2008-4#1)(2010-8#1)(2013-1#1)
surgical extirpation##3##2##(1994-5#1)(2006-9#1)(2008-6#1)
surgical field##15##2##(1996-1#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-6#1)(2007-8#1)(2008-11#1)(2008-7#1)(2008-9#2)(2010-8#1)(2012-12#2)(2012-3#1)
surgical findings in##2##3##(1994-2#1)(2011-1#1)
surgical findings##4##2##(1994-2#1)(2008-10#1)(2008-9#1)(2011-1#1)
surgical fixation##3##2##(2007-8#2)(2008-5#1)
surgical glove##4##2##(1993-6#1)(1995-3#2)(2009-2#1)
surgical glue##3##2##(2007-8#3)
surgical histology##2##2##(2007-6#2)
surgical implant is##2##3##(2007-7#1)(2008-6#1)
surgical implantation of##5##3##(2008-4#2)(2010-7#1)(2013-8#2)
surgical implantation on fish##2##4##(2013-8#2)
surgical implantation##9##2##(2008-4#2)(2009-12#1)(2010-7#1)(2013-8#5)
surgical implants##2##2##(2004-9#1)(2010-10#1)
surgical implications##2##2##(1990-2#1)(2011-2#1)
surgical in##2##2##(1993-9#1)(2008-1#1)
surgical incision##3##2##(2005-12#1)(2008-9#1)(2013-8#1)
surgical incisions##4##2##(2008-1#1)(2008-6#1)(2012-11#2)
surgical indication##2##2##(1997-8#1)(2013-1#1)
surgical indications for##2##3##(1990-6#1)(2010-9#1)
surgical indications##8##2##(1990-6#1)(1991-6#1)(2005-9#1)(2006-12#1)(2007-10#1)(2010-12#1)(2010-9#1)(2013-1#1)
surgical infection and##2##3##(1990-6#1)(1992-10#1)
surgical infection##4##2##(1990-6#1)(1992-10#2)(2011-2#1)
surgical infections##4##2##(1990-2#1)(1991-4#1)(1992-6#1)(2006-8#1)
surgical injury to##2##3##(1996-2#1)(2006-9#1)
surgical injury##4##2##(1996-2#1)(2006-9#1)(2007-8#1)(2011-2#1)
surgical instrument##2##2##(2006-6#1)(2012-3#1)
surgical instruments in the##2##4##(2006-10#1)(2006-12#1)
surgical instruments is##2##3##(2008-1#1)(2009-4#1)
surgical instruments##14##2##(2006-10#1)(2006-12#1)(2006-6#3)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2009-12#1)(2009-2#1)(2009-4#1)(2012-3#1)
surgical intervention and improved##2##4##(2007-11#1)(2008-3#1)
surgical intervention and##17##3##(1990-8#1)(2006-7#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-3#1)(2012-2#1)(2013-1#3)
surgical intervention at##2##3##(1997-2#1)(2011-2#1)
surgical intervention can##2##3##(2008-7#1)(2013-8#1)
surgical intervention for##2##3##(1990-2#1)(2005-10#1)
surgical intervention in the##2##4##(2007-12#1)(2007-9#1)
surgical intervention in##11##3##(1994-6#1)(2006-10#2)(2007-12#1)(2007-9#1)(2008-4#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-11#1)(2012-3#1)
surgical intervention is##13##3##(1991-3#1)(1995-5#1)(2007-11#1)(2007-6#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#2)(2013-1#1)(2013-8#2)
surgical intervention of the##2##4##(2006-10#1)(2006-8#1)
surgical intervention on the##2##4##(1990-4#1)(1990-6#1)
surgical intervention on##3##3##(1990-4#1)(1990-6#1)(2007-8#1)
surgical intervention rate was##2##4##(1993-10#2)
surgical intervention to##2##3##(2007-12#1)(2008-7#1)
surgical intervention was##2##3##(2006-11#1)(2008-4#1)
surgical intervention##167##2##(1990-10#1)(1990-2#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#3)(1991-3#1)(1992-2#1)(1992-9#1)(1993-10#3)(1993-5#1)(1994-5#1)(1994-6#1)(1995-5#2)(1996-12#1)(1997-2#1)(1997-3#1)(2005-10#1)(2006-10#5)(2006-11#1)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#5)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#8)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#12)(2007-9#2)(2008-1#1)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#6)(2008-7#9)(2008-8#4)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#3)(2010-2#2)(2010-3#1)(2010-5#1)(2011-1#5)(2011-12#3)(2011-2#9)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#12)(2013-7#1)(2013-8#4)
surgical interventions and##2##3##(2007-12#1)(2011-2#1)
surgical interventions for##5##3##(2006-12#2)(2006-8#1)(2008-8#2)
surgical interventions##31##2##(1991-3#1)(1993-5#1)(1994-5#1)(1996-2#1)(2006-12#2)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#1)(2009-5#2)(2009-8#1)(2010-7#1)(2011-1#3)(2011-2#2)(2013-1#2)(2013-8#2)
surgical invasiveness##2##2##(2007-5#1)(2011-2#1)
surgical journey##2##2##(1992-2#1)(2013-8#1)
surgical knot##3##2##(2007-5#2)(2012-3#1)
surgical knowledge##2##2##(2007-12#1)(2011-3#1)
surgical lesions##2##2##(2006-8#1)(2013-1#1)
surgical light##2##2##(2010-9#1)(2011-2#1)
surgical literature##3##2##(1992-1#1)(1992-10#1)(2011-2#1)
surgical lung biopsies##3##3##(2011-2#1)(2012-12#1)(2013-1#1)
surgical lung biopsy##9##3##(1996-9#1)(2005-8#4)(2012-12#1)(2013-1#3)
surgical lung##12##2##(1996-9#1)(2005-8#4)(2011-2#1)(2012-12#2)(2013-1#4)
surgical magnification##5##2##(2006-2#5)
surgical management and##3##3##(1995-9#1)(2007-7#1)(2011-12#1)
surgical management by##2##3##(2010-12#1)(2013-1#1)
surgical management in##2##3##(2007-8#1)(2008-9#1)
surgical management is controversial##2##4##(2006-1#1)(2010-5#1)
surgical management is##10##3##(2006-1#1)(2007-8#1)(2008-7#1)(2009-9#1)(2010-5#1)(2011-2#1)(2013-1#3)(2013-8#1)
surgical management of a##5##4##(2006-9#1)(2011-12#1)(2012-12#1)(2013-1#2)
surgical management of an##2##4##(2008-6#1)(2012-2#1)
surgical management of patients##2##4##(2011-2#1)(2012-11#1)
surgical management of the##4##4##(2007-8#1)(2010-3#1)(2013-1#2)
surgical management of these##2##4##(2006-3#1)(2010-11#1)
surgical management of this##2##4##(2006-9#1)(2010-3#1)
surgical management of##65##3##(1993-10#1)(1993-5#1)(1994-12#2)(1994-3#1)(1997-2#1)(1997-5#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-4#3)(2006-7#2)(2006-8#1)(2006-9#2)(2007-12#3)(2007-8#8)(2007-9#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-11#4)(2010-12#1)(2010-3#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#1)
surgical management using##2##3##(1992-1#1)(2007-11#1)
surgical management were##2##3##(2006-10#1)(2013-8#1)
surgical management with##2##3##(1993-3#1)(2008-12#1)
surgical management##117##2##(1990-9#1)(1991-3#1)(1992-1#1)(1992-10#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-12#2)(1994-3#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-5#1)(2005-12#2)(2005-8#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-3#1)(2006-4#3)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#2)(2007-11#1)(2007-12#4)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#14)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-9#2)(2010-11#4)(2010-12#2)(2010-2#1)(2010-3#2)(2010-5#1)(2011-1#2)(2011-12#3)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#10)(2013-7#1)(2013-8#5)
surgical maneuvers##3##2##(2006-6#1)(2007-12#1)(2011-7#1)
surgical manipulation##2##2##(2006-12#1)(2008-5#1)
surgical margin achieved##3##3##(2008-6#3)
surgical margin status##2##3##(2008-6#2)
surgical margin##13##2##(2006-9#1)(2008-6#8)(2011-2#1)(2013-1#2)(2013-8#1)
surgical margins in breast##2##4##(1995-4#1)(2013-1#1)
surgical margins in##3##3##(1995-4#1)(2013-1#2)
surgical margins may##2##3##(1997-7#2)
surgical margins were##4##3##(1990-12#1)(1995-4#2)(2012-2#1)
surgical margins##20##2##(1990-12#1)(1995-4#6)(1997-7#2)(2006-6#1)(2006-9#1)(2008-6#2)(2008-9#1)(2011-2#2)(2012-2#1)(2013-1#3)
surgical materials##2##2##(2010-8#2)
surgical measures##4##2##(1990-9#1)(1992-9#1)(2007-10#1)(2013-1#1)
surgical menopause##2##2##(2007-9#1)(2013-1#1)
surgical meshes##3##2##(2012-1#3)
surgical method for##2##3##(2008-5#1)(2008-9#1)
surgical method##9##2##(1991-2#1)(1995-8#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)
surgical methods and##2##3##(2007-11#1)(2008-5#1)
surgical methods are##3##3##(1997-5#1)(2006-12#1)(2006-6#1)
surgical methods in##2##3##(2006-6#1)(2007-12#1)
surgical methods##19##2##(1997-5#1)(2006-10#1)(2006-12#2)(2006-6#3)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#2)(2007-8#3)(2008-5#1)(2008-9#1)(2011-1#1)
surgical microscope##3##2##(2006-10#3)
surgical modalities##3##2##(2007-11#1)(2008-5#1)(2009-8#1)
surgical modality##2##2##(2006-5#1)(2010-12#1)
surgical morbidity##5##2##(2006-10#1)(2006-9#1)(2007-7#1)(2010-12#1)(2012-2#1)
surgical mortality##3##2##(1996-12#1)(2008-4#1)(2010-5#1)
surgical navigation system##3##3##(2006-12#1)(2007-8#1)(2008-9#1)
surgical navigation##6##2##(2006-12#3)(2007-8#1)(2008-9#2)
surgical nurses##4##2##(2010-10#3)(2010-7#1)
surgical nurses' experiences in caring for patients with postoperative pain##2##10##(2010-7#2)
surgical oncology##8##2##(2007-4#1)(2008-10#1)(2010-2#3)(2012-12#1)(2012-2#1)(2012-3#1)
surgical operation##9##2##(1991-9#1)(1993-10#1)(1993-5#1)(1994-6#1)(2006-2#1)(2008-12#1)(2008-7#1)(2010-8#1)(2011-1#1)
surgical operations are##2##3##(2007-8#2)
surgical operations in##2##3##(2005-9#1)(2007-8#1)
surgical operations##15##2##(1992-11#1)(1994-5#1)(2004-10#1)(2005-9#1)(2006-6#2)(2007-11#1)(2007-8#3)(2008-4#1)(2009-4#1)(2010-6#1)(2011-2#1)(2012-2#1)
surgical option for the##2##4##(2006-3#1)(2013-8#1)
surgical option##7##2##(2006-3#1)(2007-8#2)(2009-5#2)(2011-2#1)(2013-8#1)
surgical options##8##2##(2005-8#1)(2007-8#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-3#1)
surgical or endovascular##2##3##(2007-8#1)(2008-1#1)
surgical or medical##2##3##(1996-8#1)(2008-12#1)
surgical or nonsurgical##3##3##(1997-3#1)(2007-12#1)(2010-2#1)
surgical or##16##2##(1993-10#1)(1996-8#1)(1997-1#1)(1997-3#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-12#1)(2008-8#1)(2010-2#1)(2010-8#1)(2011-2#2)(2013-1#1)
surgical orientation##2##2##(2008-9#1)(2011-2#1)
surgical outcome in##3##3##(2007-8#3)
surgical outcome of##5##3##(2007-8#1)(2012-2#3)(2013-8#1)
surgical outcome##23##2##(1991-2#1)(2006-6#2)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#5)(2008-7#2)(2009-4#1)(2009-5#1)(2010-3#1)(2010-8#1)(2012-2#3)(2013-1#2)(2013-8#1)
surgical outcomes and patient satisfaction##2##5##(2006-3#1)(2007-12#1)
surgical outcomes##14##2##(1993-12#1)(2005-10#1)(2006-12#2)(2006-3#1)(2007-12#2)(2008-10#1)(2010-2#1)(2010-3#1)(2010-8#1)(2013-1#3)
surgical outpatient##2##2##(2009-7#1)(2013-1#1)
surgical pathology in##2##3##(2007-5#1)(2013-1#1)
surgical pathology##6##2##(2006-10#1)(2006-8#1)(2007-4#1)(2007-5#1)(2009-5#1)(2013-1#1)
surgical pathway##3##2##(2007-8#3)
surgical patient##14##2##(1996-6#1)(2005-12#1)(2006-10#1)(2006-11#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-4#1)(2009-2#1)(2010-9#1)(2011-12#1)(2013-1#1)
surgical patients and##5##3##(1993-12#1)(2006-10#1)(2007-8#1)(2009-12#1)(2010-12#1)
surgical patients in##2##3##(2005-12#1)(2007-5#1)
surgical patients with##2##3##(2008-12#1)(2008-9#1)
surgical patients##52##2##(1991-4#1)(1991-6#1)(1992-3#1)(1993-12#2)(1996-2#2)(1996-9#1)(2005-12#1)(2006-10#5)(2006-12#1)(2006-8#1)(2007-10#1)(2007-12#5)(2007-5#1)(2007-8#4)(2007-9#4)(2008-1#1)(2008-11#1)(2008-12#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-12#3)(2010-8#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
surgical perspective##2##2##(2008-1#1)(2012-2#1)
surgical plan##2##2##(2007-12#1)(2012-11#1)
surgical planning and##6##3##(2005-12#1)(2006-12#2)(2006-3#1)(2013-1#2)
surgical planning##18##2##(2005-12#1)(2005-5#1)(2006-12#2)(2006-2#1)(2006-3#3)(2006-5#1)(2008-7#1)(2009-12#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#3)
surgical practice and packages##2##4##(2006-8#2)
surgical practice in##4##3##(2006-6#1)(2007-8#1)(2008-11#1)(2008-4#1)
surgical practice##26##2##(2006-6#5)(2006-8#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#3)(2008-11#1)(2008-4#3)(2008-9#3)(2010-2#1)(2010-8#1)(2011-2#2)
surgical principles##3##2##(2006-10#1)(2007-12#1)(2009-5#1)
surgical probe##2##2##(2008-1#1)(2008-3#1)
surgical problems##4##2##(1993-6#1)(1993-9#1)(2007-10#1)(2013-1#1)
surgical procedure and##6##3##(1996-9#1)(2006-6#1)(2007-11#2)(2008-8#1)(2009-5#1)
surgical procedure as well as##2##5##(2007-2#1)(2013-1#1)
surgical procedure can##2##3##(2007-7#1)(2008-8#1)
surgical procedure for the treatment of##2##6##(2006-9#1)(2007-7#1)
surgical procedure for the##3##4##(2006-9#1)(2007-7#2)
surgical procedure for##13##3##(1990-12#1)(1990-5#1)(1990-9#1)(2006-9#1)(2007-11#1)(2007-7#2)(2009-10#1)(2009-2#1)(2010-10#1)(2011-1#2)(2013-7#1)
surgical procedure in##8##3##(1991-4#1)(2006-11#1)(2007-11#1)(2007-12#2)(2009-3#1)(2013-1#1)(2013-7#1)
surgical procedure is##6##3##(1991-12#1)(1994-8#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
surgical procedure or##2##3##(1991-7#1)(2007-12#1)
surgical procedure was##7##3##(1990-12#1)(2007-11#2)(2007-8#1)(2008-7#1)(2010-2#1)(2010-7#1)
surgical procedure with##4##3##(1991-3#1)(2008-8#1)(2008-9#1)(2012-3#1)
surgical procedure##140##2##(1990-12#3)(1990-5#1)(1990-9#3)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#2)(1992-10#1)(1992-3#1)(1993-10#1)(1993-3#1)(1993-4#1)(1993-5#1)(1994-12#1)(1994-8#1)(1994-9#1)(1996-9#2)(2004-2#1)(2005-11#1)(2005-9#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#2)(2007-11#12)(2007-12#6)(2007-2#1)(2007-5#1)(2007-7#8)(2007-8#9)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#2)(2009-10#1)(2009-2#2)(2009-3#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#6)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#1)
surgical procedures and their##2##4##(1994-3#1)(2010-8#1)
surgical procedures and##13##3##(1992-2#1)(1994-3#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-8#2)(2010-11#1)(2010-8#2)(2011-1#1)(2013-8#1)
surgical procedures are being##2##4##(2006-10#1)(2007-5#1)
surgical procedures are performed##3##4##(1990-9#1)(2006-10#1)(2007-11#1)
surgical procedures are##11##3##(1990-3#1)(1990-9#1)(2006-10#2)(2006-3#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-9#1)(2011-1#1)
surgical procedures as a##2##4##(1990-11#1)(2013-1#1)
surgical procedures at##2##3##(2006-12#1)(2012-12#1)
surgical procedures because##2##3##(2006-10#1)(2006-6#1)
surgical procedures for the##2##4##(2007-12#1)(2008-8#1)
surgical procedures for which##2##4##(1996-9#1)(2008-6#1)
surgical procedures for##5##3##(1996-9#1)(2007-12#1)(2008-12#1)(2008-6#1)(2008-8#1)
surgical procedures have##4##3##(1993-2#1)(2006-6#1)(2010-9#1)(2012-11#1)
surgical procedures in##6##3##(1995-8#1)(2006-6#1)(2007-11#1)(2008-7#1)(2012-3#1)(2013-1#1)
surgical procedures included##2##3##(2007-8#1)(2007-9#1)
surgical procedures involving##2##3##(1990-9#1)(2007-7#1)
surgical procedures is##4##3##(2005-11#1)(2006-6#1)(2008-7#1)(2008-8#1)
surgical procedures of##2##3##(1992-3#1)(2007-11#1)
surgical procedures performed##6##3##(2006-10#2)(2007-12#1)(2009-3#1)(2010-12#1)(2012-12#1)
surgical procedures requiring##2##3##(2007-12#1)(2008-8#1)
surgical procedures such as##3##4##(2004-2#1)(2006-10#1)(2010-8#1)
surgical procedures that##2##3##(1992-5#1)(1993-3#1)
surgical procedures to##3##3##(2007-12#2)(2012-11#1)
surgical procedures used in##2##4##(2007-11#1)(2010-2#1)
surgical procedures used##3##3##(2007-11#1)(2010-2#1)(2012-2#1)
surgical procedures were performed on##2##5##(2007-7#1)(2008-8#1)
surgical procedures were performed##6##4##(1991-8#1)(1992-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-8#1)
surgical procedures were##14##3##(1991-8#1)(1992-6#2)(2007-1#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#1)(2008-8#2)(2012-12#1)(2012-3#1)
surgical procedures with##2##3##(1990-5#1)(2007-8#1)
surgical procedures without##3##3##(2011-2#1)(2012-12#2)
surgical procedures##208##2##(1990-11#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-9#3)(1991-1#2)(1991-11#1)(1991-4#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#4)(1993-1#1)(1993-2#1)(1993-3#1)(1993-5#2)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-6#1)(1995-8#2)(1996-1#3)(1996-12#2)(1996-9#3)(2004-2#1)(2005-11#1)(2005-9#1)(2006-10#16)(2006-11#1)(2006-12#2)(2006-3#2)(2006-5#1)(2006-6#8)(2006-8#2)(2006-9#2)(2007-1#1)(2007-11#10)(2007-12#12)(2007-5#8)(2007-7#6)(2007-8#10)(2007-9#3)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#8)(2008-9#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#4)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#10)(2012-2#2)(2012-3#2)(2013-1#13)(2013-8#1)
surgical reconstruction of the##2##4##(2006-4#1)(2010-11#1)
surgical reconstruction of##6##3##(2006-4#1)(2007-11#1)(2007-12#1)(2010-11#1)(2013-1#1)(2013-8#1)
surgical reconstruction##13##2##(2006-4#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-4#2)(2008-7#1)(2010-11#1)(2013-1#2)(2013-8#1)
surgical release##4##2##(2006-3#1)(2006-7#1)(2007-8#1)(2009-5#1)
surgical relief of##2##3##(2013-1#2)
surgical removal and radiotherapy##2##4##(1992-4#2)
surgical removal is##2##3##(1990-1#1)(2005-3#1)
surgical removal of a##2##4##(1992-10#1)(2008-6#1)
surgical removal of an##2##4##(1991-11#1)(2007-8#1)
surgical removal of the tumor##5##5##(1990-9#1)(1995-7#1)(2009-3#1)(2010-9#1)(2011-2#1)
surgical removal of the##21##4##(1990-9#1)(1992-12#1)(1995-12#1)(1995-7#1)(1997-3#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-3#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)
surgical removal of##28##3##(1990-9#1)(1991-11#1)(1992-10#1)(1992-12#1)(1995-12#1)(1995-7#1)(1996-9#1)(1997-3#1)(2006-5#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-3#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-2#1)
surgical removal##42##2##(1990-1#1)(1990-9#1)(1991-11#1)(1992-10#1)(1992-12#1)(1992-4#3)(1993-7#1)(1994-11#1)(1995-12#1)(1995-7#1)(1996-9#1)(1997-3#1)(2005-3#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#3)(2009-3#1)(2009-5#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-2#1)
surgical repair and##4##3##(2006-3#1)(2007-8#1)(2010-12#1)(2013-1#1)
surgical repair at##2##3##(2006-3#1)(2012-3#1)
surgical repair in##2##3##(2006-4#1)(2007-8#1)
surgical repair is##4##3##(2007-7#1)(2007-8#1)(2011-2#2)
surgical repair of a##3##4##(1996-6#1)(2006-4#1)(2007-8#1)
surgical repair of his##2##4##(2006-10#1)(2007-8#1)
surgical repair of the##4##4##(2006-10#1)(2006-12#1)(2008-7#1)(2012-2#1)
surgical repair of##17##3##(1993-1#1)(1996-6#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-11#1)(2007-8#5)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
surgical repair was##3##3##(1993-5#1)(2007-8#1)(2011-2#1)
surgical repair with##2##3##(2007-8#2)
surgical repair##53##2##(1993-1#1)(1993-5#1)(1996-6#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-3#3)(2006-4#2)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#14)(2008-10#1)(2008-12#2)(2008-7#2)(2009-5#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#6)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
surgical repairs##2##2##(2007-9#1)(2008-12#1)
surgical reports##3##2##(1991-5#1)(1993-6#1)(2006-8#1)
surgical repositioning##2##2##(2006-12#1)(2007-12#1)
surgical resection and adjuvant##2##4##(1990-9#1)(2011-3#1)
surgical resection and##17##3##(1990-9#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-11#1)(2008-11#1)(2010-11#1)(2010-3#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-8#5)
surgical resection followed by radiation##2##5##(2011-1#1)(2013-1#1)
surgical resection for##5##3##(2006-10#1)(2007-8#1)(2008-2#1)(2008-6#1)(2009-12#1)
surgical resection in##2##3##(2006-12#1)(2008-7#1)
surgical resection is indicated##2##4##(1997-3#1)(2009-12#1)
surgical resection is the##2##4##(2008-1#1)(2010-12#1)
surgical resection is##6##3##(1997-3#1)(2006-10#1)(2008-1#1)(2008-7#1)(2009-12#1)(2010-12#1)
surgical resection of a##2##4##(2007-8#1)(2011-2#1)
surgical resection of the##7##4##(2005-12#1)(2007-11#2)(2007-12#1)(2007-7#1)(2009-9#1)(2010-7#1)
surgical resection of##21##3##(2005-12#1)(2006-12#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-11#1)(2010-7#2)(2011-2#2)(2012-1#1)(2013-1#2)
surgical resection or##5##3##(1996-3#1)(2006-12#1)(2006-2#1)(2008-5#1)(2013-1#1)
surgical resection to##2##3##(2008-6#1)(2010-3#1)
surgical resection was performed##2##4##(2007-8#1)(2013-8#1)
surgical resection was##4##3##(2007-8#1)(2008-8#1)(2010-12#1)(2013-8#1)
surgical resection with##2##3##(1994-6#1)(2007-8#1)
surgical resection##118##2##(1990-9#1)(1991-12#1)(1991-2#1)(1992-9#1)(1994-4#1)(1994-6#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-3#1)(1997-6#1)(2004-1#4)(2005-12#1)(2006-10#5)(2006-12#6)(2006-2#2)(2006-6#4)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#10)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#6)(2008-7#6)(2008-8#2)(2009-12#2)(2009-4#2)(2009-9#1)(2010-11#2)(2010-12#3)(2010-3#2)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#7)
surgical resections of##2##3##(2006-10#1)(2006-12#1)
surgical resections##3##2##(2006-10#1)(2006-12#1)(2010-3#1)
surgical residents##13##2##(2006-8#1)(2007-3#9)(2008-4#1)(2012-2#1)(2012-3#1)
surgical resources##2##2##(1995-3#2)
surgical result##2##2##(2007-7#1)(2008-4#1)
surgical results and##3##3##(1990-7#1)(2006-10#1)(2008-12#1)
surgical results are##3##3##(1990-6#1)(2006-7#1)(2007-1#1)
surgical results of##3##3##(2006-12#2)(2010-3#1)
surgical results##15##2##(1990-6#1)(1990-7#1)(1991-5#1)(1991-8#1)(2006-10#1)(2006-12#2)(2006-7#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-3#1)
surgical revascularisation##2##2##(2007-7#1)(2007-8#1)
surgical revascularization##4##2##(2008-1#1)(2009-7#2)(2012-3#1)
surgical revision##3##2##(1993-1#1)(1995-5#1)(2006-9#1)
surgical risk was##2##3##(2007-10#2)
surgical risk##18##2##(1991-3#1)(1993-9#1)(2006-12#1)(2007-10#2)(2007-8#3)(2008-10#1)(2008-12#1)(2009-10#1)(2010-8#1)(2011-2#2)(2013-1#4)
surgical risks##3##2##(2006-11#1)(2010-8#1)(2013-8#1)
surgical robot##7##2##(2006-6#2)(2007-5#2)(2007-7#1)(2007-8#2)
surgical salvage##3##2##(1991-8#1)(2011-1#1)(2012-3#1)
surgical scene##2##2##(2006-6#1)(2009-12#1)
surgical series##10##2##(1990-4#1)(1990-6#2)(2006-2#1)(2006-6#2)(2006-7#3)(2006-9#1)
surgical services##7##2##(1990-5#1)(1995-12#2)(2005-12#1)(2007-3#1)(2009-4#1)(2011-2#1)
surgical setting##3##2##(2007-11#1)(2012-3#1)(2013-1#1)
surgical simulation##3##2##(2006-6#1)(2008-6#2)
surgical simulators##3##2##(2006-6#1)(2007-5#2)
surgical site complications##2##3##(2013-1#2)
surgical site infection (SSI)##2##4##(2008-8#1)(2010-12#1)
surgical site infection##7##3##(2007-8#1)(2008-8#3)(2010-12#2)(2012-3#1)
surgical site infections and##2##4##(2010-2#1)(2010-8#1)
surgical site infections in##4##4##(2008-10#2)(2009-3#2)
surgical site infections##22##3##(2006-6#3)(2007-8#1)(2008-10#3)(2009-3#2)(2010-2#1)(2010-8#2)(2012-11#6)(2012-3#3)(2013-1#1)
surgical site##40##2##(2006-6#3)(2007-1#1)(2007-11#2)(2007-8#3)(2008-10#3)(2008-5#1)(2008-8#3)(2009-3#2)(2009-6#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#2)(2012-11#6)(2012-3#5)(2013-1#3)
surgical sites##4##2##(2010-3#1)(2010-7#1)(2011-2#1)(2013-7#1)
surgical skill##4##2##(1996-12#1)(2006-10#1)(2006-6#1)(2008-7#1)
surgical skills##5##2##(1995-6#1)(1996-12#1)(2006-6#1)(2012-3#2)
surgical solution##2##2##(2007-11#2)
surgical solutions##2##2##(2006-6#1)(2007-11#1)
surgical specialties##2##2##(1992-12#1)(2011-2#1)
surgical specialty##4##2##(2008-4#2)(2010-3#1)(2010-8#1)
surgical specimen and##2##3##(2006-8#1)(2013-7#1)
surgical specimen##10##2##(1991-12#1)(1991-9#1)(1992-4#1)(2006-8#1)(2007-8#1)(2008-11#1)(2009-5#1)(2011-2#1)(2013-1#1)(2013-7#1)
surgical specimens and##2##3##(1996-6#1)(2007-12#1)
surgical specimens of##5##3##(1992-3#1)(1995-10#2)(1996-10#1)(2010-11#1)
surgical specimens##12##2##(1992-3#1)(1995-10#2)(1995-3#1)(1996-10#1)(1996-6#1)(2007-12#2)(2008-4#1)(2008-9#1)(2010-11#1)(2011-1#1)
surgical sphincteroplasty of the minor papilla##2##6##(1995-4#1)(2007-5#1)
surgical sponge with##2##3##(2012-3#2)
surgical sponge##5##2##(2007-2#1)(2007-8#2)(2012-3#2)
surgical stabilization consisting of##2##4##(2012-3#2)
surgical stabilization##4##2##(2010-2#1)(2012-3#3)
surgical staff##6##2##(1991-9#1)(2007-5#1)(2009-4#1)(2012-2#1)(2012-3#2)
surgical staging##2##2##(2004-1#1)(2009-5#1)
surgical steps##2##2##(2009-3#1)(2011-1#1)
surgical stimulation##3##2##(2007-2#1)(2011-2#2)
surgical strategies for##2##3##(2005-11#1)(2011-2#1)
surgical strategies##6##2##(2005-11#1)(2006-10#1)(2006-2#1)(2008-7#1)(2008-9#1)(2011-2#1)
surgical strategy in patients with myasthenia gravis##2##7##(2007-8#2)
surgical strategy##10##2##(1992-9#1)(1993-10#1)(1995-12#1)(2006-10#1)(2007-8#3)(2009-4#1)(2010-8#1)(2011-2#1)
surgical stress and##2##3##(1996-8#1)(2006-10#1)
surgical stress in##3##3##(1993-9#1)(1996-8#1)(2008-4#1)
surgical stress##23##2##(1992-5#1)(1993-9#2)(1996-8#2)(2006-10#4)(2007-11#2)(2007-4#1)(2007-7#1)(2007-9#1)(2008-12#1)(2008-4#2)(2009-6#3)(2011-12#1)(2013-1#2)
surgical studies##3##2##(2007-8#2)(2008-8#1)
surgical success##5##2##(1991-9#1)(2005-12#1)(2007-10#1)(2007-12#1)(2007-8#1)
surgical sutures##2##2##(2010-10#2)
surgical synovectomy##2##2##(2006-7#1)(2007-7#1)
surgical system##12##2##(2006-6#3)(2007-5#2)(2007-8#5)(2008-10#1)(2009-4#1)
surgical systems##3##2##(2006-6#1)(2007-8#2)
surgical teaching##2##2##(2007-9#1)(2009-7#1)
surgical team##6##2##(2007-7#1)(2007-8#1)(2008-7#1)(2010-12#1)(2011-3#1)(2012-12#1)
surgical teams##3##2##(1991-3#1)(2010-12#1)(2012-12#1)
surgical technique and the##2##4##(1997-2#1)(2007-11#1)
surgical technique and##13##3##(1990-3#1)(1995-3#1)(1997-2#1)(2006-10#1)(2007-1#1)(2007-11#3)(2007-8#1)(2010-2#1)(2012-2#2)(2013-1#1)
surgical technique employed##2##3##(2005-7#1)(2008-7#1)
surgical technique for the##2##4##(1992-10#1)(2008-7#1)
surgical technique for##12##3##(1990-12#1)(1992-10#1)(2007-1#1)(2007-12#1)(2007-8#2)(2008-7#2)(2008-9#2)(2010-7#2)
surgical technique has##2##3##(2007-7#1)(2011-2#1)
surgical technique in##2##3##(2009-8#1)(2011-2#1)
surgical technique is##3##3##(1990-9#1)(2006-3#1)(2008-5#1)
surgical technique of a##2##4##(2010-11#1)(2013-1#1)
surgical technique of choice##2##4##(1992-8#1)(1992-9#1)
surgical technique of##8##3##(1992-8#1)(1992-9#1)(1996-2#1)(2006-3#1)(2009-3#1)(2010-11#1)(2011-2#1)(2013-1#1)
surgical technique that##3##3##(2007-5#1)(2008-7#1)(2008-8#1)
surgical technique to avoid##2##4##(2007-8#1)(2008-7#1)
surgical technique to##4##3##(1991-5#1)(2006-6#1)(2007-8#1)(2008-7#1)
surgical technique used##2##3##(2007-7#1)(2013-1#1)
surgical technique using##2##3##(2007-8#1)(2011-2#1)
surgical technique was##6##3##(1992-8#1)(1997-8#1)(2007-7#1)(2007-8#2)(2013-1#1)
surgical technique##109##2##(1990-12#1)(1990-3#1)(1990-9#3)(1991-3#1)(1991-5#1)(1992-10#1)(1992-8#2)(1992-9#1)(1993-8#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-8#1)(2005-7#1)(2006-10#3)(2006-2#1)(2006-3#6)(2006-5#1)(2006-6#4)(2006-7#2)(2007-1#2)(2007-11#6)(2007-12#3)(2007-5#1)(2007-7#5)(2007-8#12)(2007-9#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#4)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#2)(2010-11#1)(2010-2#1)(2010-7#2)(2011-2#7)(2011-7#1)(2012-12#1)(2012-2#5)(2013-1#5)(2013-7#1)(2013-8#1)
surgical techniques and the##2##4##(1994-5#1)(2006-10#1)
surgical techniques and##10##3##(1994-5#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-11#1)(2008-6#1)(2011-3#1)(2013-8#1)
surgical techniques are##7##3##(2006-2#1)(2008-3#1)(2008-7#1)(2008-9#2)(2010-11#1)(2011-2#1)
surgical techniques available##2##3##(1990-6#1)(2006-7#1)
surgical techniques both##2##3##(2009-5#1)(2011-2#1)
surgical techniques for the treatment of##2##6##(2007-8#2)
surgical techniques for the##3##4##(2007-8#3)
surgical techniques for##10##3##(2006-10#1)(2006-11#1)(2006-7#1)(2007-8#3)(2008-5#2)(2011-2#2)
surgical techniques has##2##3##(1994-6#1)(2008-8#1)
surgical techniques have been##4##4##(2007-9#1)(2009-10#1)(2011-3#1)(2013-1#1)
surgical techniques have##7##3##(1994-3#1)(1997-1#1)(2006-11#1)(2007-9#1)(2009-10#1)(2011-3#1)(2013-1#1)
surgical techniques in##2##3##(2006-9#1)(2008-9#1)
surgical techniques of##4##3##(1990-3#1)(1990-5#1)(2007-7#1)(2008-6#1)
surgical techniques were##3##3##(2006-10#1)(2006-12#1)(2011-2#1)
surgical techniques##107##2##(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#1)(1991-10#1)(1991-9#1)(1992-6#2)(1992-9#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-8#1)(1997-1#1)(1997-8#1)(2004-2#1)(2006-10#5)(2006-11#2)(2006-12#3)(2006-2#3)(2006-3#2)(2006-4#3)(2006-6#6)(2006-7#2)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#4)(2009-10#1)(2009-5#2)(2009-9#2)(2010-11#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#9)(2011-3#2)(2012-3#4)(2013-1#3)(2013-8#2)
surgical technologies##4##2##(2006-10#1)(2009-2#1)(2009-4#2)
surgical technology##6##2##(2006-10#1)(2006-11#1)(2006-2#1)(2007-3#2)(2009-4#1)
surgical terminology##2##2##(1997-8#2)
surgical therapies are##4##3##(1990-10#1)(2006-2#1)(2006-9#1)(2013-1#1)
surgical therapies for##2##3##(2008-6#1)(2010-6#1)
surgical therapies##10##2##(1990-10#1)(2006-10#1)(2006-2#1)(2006-9#1)(2008-6#2)(2010-12#1)(2010-5#1)(2010-6#1)(2013-1#1)
surgical therapy and##4##3##(1990-5#2)(1992-5#1)(2011-2#1)
surgical therapy for##5##3##(2005-10#1)(2007-5#1)(2009-2#1)(2012-1#1)(2013-7#1)
surgical therapy must be##2##4##(1993-9#1)(2006-10#1)
surgical therapy of##7##3##(1990-6#1)(1990-9#1)(1992-3#1)(1992-8#1)(2008-7#1)(2011-3#2)
surgical therapy##44##2##(1990-5#2)(1990-6#2)(1990-7#1)(1990-9#3)(1991-6#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-9#1)(2005-10#1)(2006-10#1)(2006-2#4)(2006-5#2)(2006-8#1)(2007-11#2)(2007-5#2)(2007-8#2)(2008-7#2)(2009-2#1)(2010-12#1)(2011-2#2)(2011-3#3)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#2)
surgical therapy]##6##2##(1990-4#1)(1992-9#1)(1997-6#2)(2006-2#2)
surgical time##5##2##(1994-2#1)(1996-1#1)(2007-12#1)(2011-2#1)(2012-12#1)
surgical timing##3##2##(2006-4#2)(2013-1#1)
surgical tools##2##2##(2008-3#1)(2009-4#1)
surgical tracheostomy##4##2##(2007-8#1)(2008-2#1)(2012-12#2)
surgical training##10##2##(2006-6#1)(2007-2#1)(2008-4#2)(2008-6#3)(2012-1#1)(2012-2#1)(2012-3#1)
surgical trauma and##2##3##(2006-10#1)(2010-4#1)
surgical trauma to the##2##4##(1993-1#1)(2012-12#1)
surgical trauma##21##2##(1993-1#1)(2006-10#1)(2007-5#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-12#1)(2008-3#1)(2009-6#1)(2010-4#1)(2010-7#1)(2010-8#1)(2012-12#4)(2012-2#1)(2013-1#2)
surgical treatment and the##2##4##(1990-10#1)(2006-2#1)
surgical treatment and##11##3##(1990-10#1)(1990-3#1)(1990-5#1)(2006-2#1)(2006-6#1)(2007-11#2)(2007-8#2)(2008-11#1)(2009-4#1)
surgical treatment are##5##3##(1993-6#1)(1993-9#1)(2007-8#2)(2008-4#1)
surgical treatment as##2##3##(1990-9#1)(2008-6#1)
surgical treatment at##2##3##(2007-8#1)(2008-4#1)
surgical treatment because of##2##4##(1994-9#1)(2011-1#1)
surgical treatment because##3##3##(1990-1#1)(1994-9#1)(2011-1#1)
surgical treatment can be##2##4##(2006-10#1)(2010-6#1)
surgical treatment can##3##3##(2006-10#1)(2007-11#1)(2010-6#1)
surgical treatment for breast cancer##2##5##(2004-1#1)(2005-9#1)
surgical treatment for patients with##2##5##(2006-9#1)(2007-8#1)
surgical treatment for##23##3##(1992-6#1)(2004-1#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-1#1)(2010-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-7#1)
surgical treatment has been##2##4##(2007-8#1)(2010-11#1)
surgical treatment has##3##3##(2007-8#1)(2009-3#1)(2010-11#1)
surgical treatment in a##2##4##(2008-8#1)(2013-1#1)
surgical treatment in the##3##4##(1991-5#1)(1993-3#1)(2008-8#1)
surgical treatment in##13##3##(1990-10#1)(1990-8#1)(1991-5#1)(1993-3#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-8#2)(2012-2#1)(2013-1#1)(2013-7#1)
surgical treatment is indicated##3##4##(2007-8#1)(2008-9#1)(2010-3#1)
surgical treatment is recommended##2##4##(2008-9#1)(2011-2#1)
surgical treatment is still##2##4##(1991-4#1)(2009-9#1)
surgical treatment is##30##3##(1990-4#1)(1991-12#1)(1991-4#1)(1991-8#1)(1992-9#1)(1993-3#1)(2005-11#1)(2007-11#3)(2007-7#2)(2007-8#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#4)(2009-9#1)(2010-3#1)(2011-2#3)(2012-12#1)(2013-1#3)
surgical treatment may be indicated##2##5##(1991-11#1)(2013-1#1)
surgical treatment may be##6##4##(1991-11#1)(1995-5#1)(2006-5#1)(2007-10#1)(2007-8#1)(2013-1#1)
surgical treatment may##7##3##(1991-11#1)(1995-5#1)(2006-5#1)(2007-10#1)(2007-8#1)(2008-7#1)(2013-1#1)
surgical treatment of Zenker's##2##4##(1990-3#1)(2007-8#1)
surgical treatment of a##6##4##(1994-4#1)(2007-8#2)(2008-7#1)(2011-2#1)(2012-12#1)
surgical treatment of acute##3##4##(2006-10#1)(2009-2#1)(2011-12#1)
surgical treatment of atrial fibrillation##2##5##(2007-8#2)
surgical treatment of benign##2##4##(1990-5#1)(2008-10#1)
surgical treatment of bone metastases to##2##6##(2007-11#2)
surgical treatment of bone metastases##5##5##(2007-11#5)
surgical treatment of breast cancer##2##5##(2004-1#2)
surgical treatment of congenital##2##4##(1992-6#1)(2008-7#1)
surgical treatment of familial adenomatous polyposis coli##2##7##(2012-1#2)
surgical treatment of hepatic##2##4##(1993-9#1)(2013-1#1)
surgical treatment of idiopathic scoliosis by##2##6##(2007-11#1)(2007-7#1)
surgical treatment of idiopathic scoliosis##4##5##(2007-11#1)(2007-7#3)
surgical treatment of idiopathic##6##4##(1990-9#1)(2007-11#1)(2007-7#4)
surgical treatment of locally##2##4##(2008-9#1)(2012-1#1)
surgical treatment of lung cancer##2##5##(2007-8#1)(2010-8#1)
surgical treatment of morbid obesity##2##5##(1993-3#1)(2006-5#1)
surgical treatment of patients with##2##5##(2007-11#1)(2008-8#1)
surgical treatment of patients##3##4##(1994-12#1)(2007-11#1)(2008-8#1)
surgical treatment of primary##3##4##(2007-7#2)(2009-2#1)
surgical treatment of rheumatoid arthritis##2##5##(2007-11#2)
surgical treatment of rheumatoid##3##4##(1991-11#1)(2007-11#2)
surgical treatment of scoliosis##2##4##(2007-11#1)(2007-8#1)
surgical treatment of spinal##3##4##(2007-11#2)(2013-8#1)
surgical treatment of symptomatic##2##4##(1995-4#1)(2011-1#1)
surgical treatment of the urinary bladder##2##6##(2011-2#2)
surgical treatment of the##13##4##(1991-6#1)(1993-1#1)(1993-8#1)(2006-10#1)(2006-3#1)(2007-11#2)(2007-9#1)(2008-1#1)(2008-8#1)(2011-12#1)(2011-2#2)
surgical treatment of##175##3##(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#3)(1991-11#1)(1991-3#1)(1991-6#1)(1992-10#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1993-1#1)(1993-10#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-4#1)(1995-4#1)(1995-9#1)(1996-9#2)(1997-2#1)(1997-7#1)(1997-8#1)(2004-1#2)(2005-12#1)(2006-10#4)(2006-11#1)(2006-2#3)(2006-3#2)(2006-4#2)(2006-5#1)(2006-6#6)(2006-7#2)(2007-10#1)(2007-11#27)(2007-12#2)(2007-7#11)(2007-8#13)(2007-9#1)(2008-1#1)(2008-10#3)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#7)(2009-2#6)(2009-3#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#5)(2011-12#2)(2011-2#7)(2012-1#3)(2012-12#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#4)
surgical treatment option##2##3##(2008-6#1)(2009-5#1)
surgical treatment options##9##3##(2006-10#1)(2006-3#1)(2009-2#1)(2009-5#2)(2010-2#2)(2010-6#1)(2013-1#1)
surgical treatment plays an important role##2##6##(2008-8#2)
surgical treatment results##2##3##(2007-11#1)(2013-1#1)
surgical treatment should be##2##4##(1992-2#1)(1993-10#1)
surgical treatment should##3##3##(1992-2#1)(1993-10#1)(2007-11#1)
surgical treatment the##3##3##(2006-4#1)(2007-7#1)(2009-4#1)
surgical treatment to##2##3##(1993-10#1)(2006-11#1)
surgical treatment using##2##3##(2008-9#1)(2012-12#1)
surgical treatment was applied##2##4##(2007-8#2)
surgical treatment was performed##2##4##(1993-9#1)(2007-11#1)
surgical treatment was##17##3##(1990-3#1)(1990-8#1)(1993-10#1)(1993-9#1)(1994-12#1)(2007-11#4)(2007-7#2)(2007-8#2)(2008-8#1)(2009-3#1)(2010-2#1)(2012-3#1)
surgical treatment were##3##3##(1990-9#1)(2007-8#1)(2011-2#1)
surgical treatment with##8##3##(1991-6#1)(2006-12#1)(2007-11#3)(2007-7#2)(2008-10#1)
surgical treatment within##2##3##(2007-11#1)(2011-3#1)
surgical treatment##459##2##(1990-1#1)(1990-10#3)(1990-12#1)(1990-3#5)(1990-4#5)(1990-5#4)(1990-6#2)(1990-8#3)(1990-9#7)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#2)(1992-10#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#5)(1992-8#1)(1992-9#4)(1993-1#1)(1993-10#6)(1993-3#3)(1993-6#2)(1993-8#1)(1993-9#3)(1994-12#2)(1994-2#1)(1994-4#1)(1994-5#1)(1994-9#2)(1995-2#1)(1995-4#1)(1995-5#2)(1995-8#1)(1995-9#1)(1996-12#2)(1996-3#1)(1996-6#1)(1996-9#2)(1997-2#1)(1997-7#1)(1997-8#2)(2004-1#4)(2005-11#1)(2005-12#1)(2005-9#2)(2006-10#9)(2006-11#2)(2006-12#2)(2006-2#6)(2006-3#3)(2006-4#3)(2006-5#3)(2006-6#8)(2006-7#5)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#55)(2007-12#2)(2007-5#1)(2007-7#25)(2007-8#37)(2007-9#2)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#3)(2008-2#1)(2008-4#4)(2008-5#1)(2008-6#8)(2008-7#12)(2008-8#12)(2008-9#17)(2009-1#1)(2009-2#8)(2009-3#5)(2009-4#3)(2009-5#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#4)(2010-3#3)(2010-4#1)(2010-6#4)(2010-7#1)(2010-8#1)(2011-1#10)(2011-12#3)(2011-2#18)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#7)(2012-2#1)(2012-3#3)(2013-1#13)(2013-7#3)(2013-8#6)
surgical treatment]##9##2##(1993-2#1)(1993-5#1)(1994-5#1)(2008-10#1)(2008-4#2)(2008-8#1)(2012-2#1)(2013-8#1)
surgical treatments for##2##3##(2007-12#1)(2008-6#1)
surgical treatments in##2##3##(1990-6#1)(2012-3#1)
surgical treatments##14##2##(1990-6#1)(1991-9#2)(2006-10#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2012-2#1)(2012-3#1)
surgical trials##3##2##(1997-3#1)(2012-3#2)
surgical unit##10##2##(2005-12#1)(2006-7#2)(2007-7#1)(2010-10#2)(2010-12#1)(2012-2#2)(2013-8#1)
surgical use##2##2##(1991-1#1)(2006-6#1)
surgical ward##8##2##(1990-12#1)(1990-8#1)(1996-11#1)(2006-4#1)(2007-4#1)(2008-11#1)(2009-6#1)(2012-2#1)
surgical wards##4##2##(2007-12#2)(2007-2#1)(2008-3#1)
surgical workforce##3##2##(2007-10#1)(2009-6#1)(2012-2#1)
surgical wound healing##2##3##(2007-7#1)(2008-7#1)
surgical wound##11##2##(2007-7#4)(2007-8#1)(2008-5#1)(2008-7#1)(2009-3#3)(2011-2#1)
surgical wounds were##2##3##(2006-2#1)(2008-9#1)
surgical wounds##5##2##(2005-7#1)(2006-2#1)(2007-11#1)(2008-5#1)(2008-9#1)
surgical##3650##1##(1990-1#2)(1990-10#6)(1990-11#2)(1990-12#12)(1990-2#7)(1990-3#14)(1990-4#12)(1990-5#19)(1990-6#19)(1990-7#3)(1990-8#8)(1990-9#25)(1991-1#7)(1991-10#3)(1991-11#6)(1991-12#7)(1991-2#7)(1991-3#18)(1991-4#9)(1991-5#11)(1991-6#13)(1991-7#2)(1991-8#5)(1991-9#11)(1992-1#4)(1992-10#13)(1992-11#1)(1992-12#4)(1992-2#4)(1992-3#9)(1992-4#7)(1992-5#6)(1992-6#17)(1992-8#4)(1992-9#11)(1993-1#8)(1993-10#15)(1993-11#2)(1993-12#8)(1993-2#2)(1993-3#14)(1993-4#2)(1993-5#12)(1993-6#10)(1993-7#1)(1993-8#3)(1993-9#11)(1994-10#1)(1994-11#1)(1994-12#9)(1994-2#3)(1994-3#6)(1994-4#2)(1994-5#7)(1994-6#6)(1994-7#2)(1994-8#2)(1994-9#4)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#8)(1995-2#3)(1995-3#6)(1995-4#9)(1995-5#5)(1995-6#4)(1995-7#1)(1995-8#5)(1995-9#3)(1996-1#7)(1996-10#1)(1996-11#2)(1996-12#11)(1996-2#6)(1996-3#5)(1996-6#4)(1996-8#3)(1996-9#15)(1997-1#4)(1997-2#5)(1997-3#6)(1997-5#2)(1997-6#4)(1997-7#3)(1997-8#9)(2004-1#11)(2004-10#2)(2004-12#1)(2004-2#6)(2004-9#2)(2005-1#1)(2005-10#4)(2005-11#5)(2005-12#22)(2005-3#1)(2005-5#2)(2005-7#4)(2005-8#9)(2005-9#16)(2006-1#6)(2006-10#124)(2006-11#16)(2006-12#48)(2006-2#39)(2006-3#31)(2006-4#22)(2006-5#20)(2006-6#117)(2006-7#36)(2006-8#28)(2006-9#20)(2007-1#13)(2007-10#18)(2007-11#146)(2007-12#89)(2007-2#20)(2007-3#24)(2007-4#8)(2007-5#47)(2007-6#6)(2007-7#112)(2007-8#276)(2007-9#27)(2008-1#30)(2008-10#37)(2008-11#22)(2008-12#24)(2008-2#9)(2008-3#25)(2008-4#49)(2008-5#26)(2008-6#74)(2008-7#94)(2008-8#63)(2008-9#74)(2009-1#1)(2009-10#6)(2009-12#13)(2009-2#24)(2009-3#24)(2009-4#33)(2009-5#28)(2009-6#12)(2009-7#8)(2009-8#10)(2009-9#14)(2010-1#2)(2010-10#11)(2010-11#17)(2010-12#36)(2010-2#23)(2010-3#23)(2010-4#5)(2010-5#10)(2010-6#13)(2010-7#23)(2010-8#39)(2010-9#12)(2011-1#54)(2011-12#15)(2011-2#174)(2011-3#12)(2011-7#2)(2012-1#21)(2012-10#1)(2012-11#14)(2012-12#63)(2012-2#70)(2012-3#73)(2013-1#208)(2013-7#15)(2013-8#60)
surgically and##4##2##(2008-3#1)(2010-7#1)(2011-2#1)(2013-1#1)
surgically by##5##2##(1991-4#1)(2007-8#2)(2008-8#1)(2013-1#1)
surgically castrated##2##2##(2010-4#2)
surgically challenging##3##2##(2007-12#1)(2008-10#1)(2011-2#1)
surgically correctable cause of##2##4##(2006-9#1)(2007-8#1)
surgically correctable##5##2##(2006-10#1)(2006-9#1)(2007-8#1)(2008-11#1)(2008-7#1)
surgically corrected##4##2##(2007-12#1)(2007-8#1)(2010-3#2)
surgically excised##6##2##(1997-8#1)(2008-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
surgically for##8##2##(2004-1#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-4#1)
surgically implanted##4##2##(2006-5#1)(2008-5#1)(2010-6#1)(2013-8#1)
surgically in the##3##3##(2008-4#1)(2008-7#1)(2009-3#1)
surgically in##7##2##(1993-10#1)(1993-8#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-3#1)
surgically inaccessible##2##2##(2006-12#1)(2008-7#1)
surgically induced##2##2##(2006-12#1)(2011-12#1)
surgically managed##4##2##(2007-4#2)(2008-4#1)(2013-8#1)
surgically over##2##2##(1991-4#1)(2007-8#1)
surgically prepared##2##2##(1993-12#1)(2008-9#1)
surgically proven##2##2##(1992-9#1)(1996-1#1)
surgically removed##11##2##(1991-2#1)(1997-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)
surgically resected##17##2##(1991-9#1)(1993-12#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2010-12#1)(2010-5#1)(2010-7#1)(2012-1#1)
surgically treated by##3##3##(1994-6#1)(2006-12#1)(2008-7#1)
surgically treated cases##3##3##(2008-12#1)(2008-7#1)(2011-2#1)
surgically treated for##5##3##(1990-9#1)(2005-9#1)(2007-11#2)(2012-12#1)
surgically treated in childhood##2##4##(1996-11#1)(2007-8#1)
surgically treated in the same center##2##6##(2008-6#2)
surgically treated in the##4##4##(2006-2#1)(2008-6#2)(2012-3#1)
surgically treated in##7##3##(1996-11#1)(2006-2#1)(2007-8#2)(2008-6#2)(2012-3#1)
surgically treated patients##4##3##(2007-12#1)(2008-7#2)(2008-9#1)
surgically treated ruptured##2##3##(2007-10#1)(2008-7#1)
surgically treated using##3##3##(2006-12#1)(2007-7#1)(2011-2#1)
surgically treated with##3##3##(2007-11#1)(2007-8#2)
surgically treated##45##2##(1990-9#1)(1992-9#2)(1994-6#1)(1996-11#1)(2005-9#1)(2006-11#1)(2006-12#3)(2006-2#1)(2006-5#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-7#1)(2007-8#6)(2008-12#1)(2008-6#2)(2008-7#5)(2008-9#1)(2009-5#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#3)
surgically with##9##2##(1991-6#1)(1993-8#1)(2006-7#1)(2007-11#1)(2007-5#1)(2007-7#2)(2007-8#1)(2012-2#1)
surgically##242##1##(1990-10#1)(1990-12#2)(1990-2#3)(1990-6#1)(1990-9#1)(1991-2#1)(1991-4#2)(1991-6#2)(1991-9#1)(1992-9#3)(1993-10#2)(1993-12#2)(1993-2#1)(1993-5#1)(1993-7#1)(1993-8#2)(1994-6#1)(1995-11#1)(1995-4#1)(1996-1#1)(1996-11#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-1#1)(2005-10#1)(2005-12#1)(2005-9#2)(2006-10#2)(2006-11#2)(2006-12#5)(2006-2#2)(2006-3#1)(2006-5#2)(2006-7#1)(2006-9#2)(2007-10#2)(2007-11#14)(2007-12#7)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#14)(2007-8#27)(2007-9#2)(2008-10#1)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#4)(2008-6#3)(2008-7#18)(2008-8#3)(2008-9#5)(2009-1#1)(2009-10#1)(2009-3#2)(2009-5#3)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#5)(2011-12#3)(2011-2#12)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#11)(2013-7#1)(2013-8#2)
surgically)##3##1##(2007-3#1)(2007-7#1)(2008-5#1)
surgically-treated##2##1##(1991-9#1)(2008-7#1)
surging##2##1##(2008-1#1)(2010-8#1)
surimi samples##2##2##(2011-2#2)
surimi seafood products##2##3##(2011-2#2)
surimi##4##1##(2011-2#4)
surmised to##3##2##(1995-1#1)(1995-8#1)(2008-5#1)
surmised##4##1##(1995-1#1)(1995-8#1)(2008-5#1)(2009-10#1)
surmountable##2##1##(1996-12#1)(1996-2#1)
surmounted##3##1##(2008-4#1)(2010-11#1)(2012-3#1)
surname##3##1##(1992-5#1)(1993-12#1)(1997-5#1)
surnames)##2##1##(2013-1#2)
surpass the##3##2##(1993-1#1)(1997-1#1)(2011-2#1)
surpass##9##1##(1993-1#1)(1995-12#1)(1997-1#1)(2006-2#1)(2007-8#1)(2011-1#2)(2011-2#1)(2013-8#1)
surpassed the corresponding parameter in##2##5##(2010-12#1)(2012-1#1)
surpassed the##5##2##(1994-12#1)(2008-10#1)(2008-12#1)(2010-12#1)(2012-1#1)
surpassed##14##1##(1991-5#1)(1994-12#1)(2007-2#1)(2008-10#3)(2008-12#1)(2008-9#1)(2009-3#1)(2010-12#2)(2010-2#1)(2012-1#1)(2012-2#1)
surpasses that of##2##3##(2008-2#1)(2010-12#1)
surpasses##7##1##(1997-1#1)(2005-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2010-12#1)
surpassing##2##1##(2006-12#1)(2008-10#1)
surplus of##3##2##(2006-11#1)(2008-6#1)(2010-2#1)
surplus##10##1##(1991-2#1)(1992-12#1)(1994-11#1)(1996-3#1)(2006-11#1)(2008-6#1)(2008-7#1)(2010-2#1)(2012-12#1)(2013-8#1)
surpluses##4##1##(1991-3#1)(1992-12#1)(2006-7#1)(2008-7#1)
surprise##21##1##(1990-11#2)(1990-3#1)(1990-4#1)(1992-11#1)(1996-5#1)(2006-10#2)(2007-10#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-2#1)(2009-6#2)(2009-8#1)(2010-5#1)(2011-1#1)(2012-12#1)
surprised##2##1##(1992-8#1)(2007-7#1)
surprises and##2##2##(2010-11#1)(2010-12#1)
surprises that##2##2##(2007-9#1)(2008-8#1)
surprises##8##1##(1992-2#1)(2007-1#1)(2007-9#1)(2008-8#1)(2010-11#2)(2010-12#1)(2013-8#1)
surprising and##3##2##(1991-12#1)(2008-5#1)(2008-7#1)
surprising finding##5##2##(1990-5#1)(2008-10#1)(2008-6#1)(2013-1#2)
surprising given the##3##3##(1990-10#1)(2008-10#1)(2010-3#1)
surprising given##4##2##(1990-10#1)(2006-2#1)(2008-10#1)(2010-3#1)
surprising number##5##2##(2007-12#1)(2007-2#1)(2008-11#1)(2010-12#1)(2013-1#1)
surprising result##2##2##(2008-6#1)(2008-7#1)
surprising results##5##2##(1991-6#1)(1996-5#1)(2007-1#1)(2008-3#1)(2012-1#1)
surprising similarities##2##2##(2008-4#1)(2012-2#1)
surprising that the##4##3##(1997-6#1)(2010-3#1)(2011-1#1)(2013-8#1)
surprising that##18##2##(1997-6#2)(2006-10#3)(2006-7#1)(2007-12#1)(2008-1#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-3#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
surprising to find##3##3##(2007-8#1)(2011-1#1)(2012-3#1)
surprising to##4##2##(2007-8#1)(2008-11#1)(2011-1#1)(2012-3#1)
surprising##89##1##(1990-10#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1993-3#1)(1993-7#1)(1994-5#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-6#2)(2006-10#6)(2006-2#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-5#1)(2007-8#5)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-12#1)(2010-3#2)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
surprisingly complex##2##2##(1991-5#1)(2008-8#1)
surprisingly few##3##2##(2005-8#1)(2007-12#1)(2009-10#1)
surprisingly high##9##2##(1991-8#1)(1993-6#1)(1994-8#1)(1997-2#1)(2007-10#1)(2008-9#1)(2011-2#1)(2012-2#2)
surprisingly large##4##2##(1990-6#1)(1996-4#1)(2008-7#1)(2008-8#1)
surprisingly little##6##2##(1992-12#1)(2007-1#1)(2008-11#1)(2009-4#1)(2011-2#1)(2012-3#1)
surprisingly low##4##2##(1992-10#1)(1994-9#1)(2007-5#1)(2013-1#1)
surprisingly short##2##2##(2008-9#1)(2009-2#1)
surprisingly similar##4##2##(1991-3#1)(1995-11#1)(2008-4#1)(2008-8#1)
surprisingly strong##2##2##(2007-12#1)(2012-2#1)
surprisingly well##2##2##(1991-9#1)(2008-3#1)
surprisingly##123##1##(1990-11#2)(1990-6#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1993-12#3)(1993-3#1)(1993-6#3)(1994-12#1)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#1)(1995-3#2)(1995-7#1)(1996-10#1)(1996-12#2)(1996-4#1)(1996-6#1)(1996-7#1)(1997-2#2)(1997-9#1)(2005-8#1)(2006-10#5)(2006-12#4)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-5#3)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#4)(2008-9#6)(2009-10#1)(2009-2#2)(2009-4#2)(2009-6#1)(2009-7#1)(2010-12#2)(2010-8#1)(2010-9#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-2#7)(2012-3#3)(2013-1#1)
surrender##2##1##(2010-12#1)(2011-2#1)
surrogacy##8##1##(2006-10#6)(2010-12#1)(2012-2#1)
surrogate assays##2##2##(2008-9#1)(2011-1#1)
surrogate biomarkers##3##2##(2008-10#1)(2008-12#1)(2010-1#1)
surrogate decision makers##2##3##(1995-12#1)(2010-4#1)
surrogate end points##2##3##(2008-2#1)(2008-8#1)
surrogate end##3##2##(2008-2#1)(2008-8#1)(2009-11#1)
surrogate endpoint##4##2##(2011-2#1)(2012-3#2)(2013-8#1)
surrogate endpoints for##3##3##(2006-9#1)(2008-5#1)(2009-4#1)
surrogate endpoints in clinical trials##2##5##(1994-8#1)(2008-8#1)
surrogate endpoints in##3##3##(1994-8#1)(1994-9#1)(2008-8#1)
surrogate endpoints##8##2##(1994-8#1)(1994-9#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-4#1)
surrogate indices of insulin resistance##2##5##(2005-8#2)
surrogate indices of##3##3##(2005-8#2)(2012-3#1)
surrogate is##2##2##(1992-3#1)(2005-4#1)
surrogate marker for##9##3##(1996-12#1)(2007-10#2)(2007-11#1)(2007-5#1)(2008-1#1)(2009-4#1)(2009-6#1)(2010-12#1)
surrogate marker of##2##3##(2007-2#1)(2011-7#1)
surrogate marker##12##2##(1996-12#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-12#1)(2011-7#1)
surrogate markers of the##2##4##(2007-8#1)(2008-2#1)
surrogate markers of##5##3##(2006-10#1)(2007-8#1)(2008-2#1)(2008-7#1)(2011-11#1)
surrogate markers##11##2##(2005-11#1)(2006-10#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-11#1)(2013-1#1)
surrogate measure##3##2##(1997-3#1)(2006-5#2)
surrogate measures##5##2##(2006-5#3)(2008-1#1)(2008-8#1)
surrogate mother##5##2##(1991-7#4)(2005-7#1)
surrogate motherhood##2##2##(2006-10#2)
surrogate serologic tests##3##3##(1995-5#3)
surrogate standard##2##2##(2008-10#2)
surrogate test##2##2##(1995-1#2)
surrogate##122##1##(1991-7#6)(1992-3#3)(1992-8#1)(1993-2#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-5#3)(1995-6#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-3#1)(2005-11#1)(2005-4#1)(2005-7#1)(2005-8#2)(2006-10#4)(2006-12#3)(2006-5#5)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#1)(2007-2#1)(2007-4#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#6)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-6#3)(2010-1#1)(2010-11#1)(2010-12#3)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-11#1)(2011-2#4)(2011-7#1)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#2)
surrogates for##7##2##(2007-1#1)(2008-10#1)(2009-2#1)(2010-2#2)(2011-1#1)(2011-12#1)
surrogates were##2##2##(2010-4#1)(2010-8#1)
surrogates##22##1##(1994-5#1)(1995-5#1)(2005-4#3)(2006-11#1)(2007-1#1)(2007-4#1)(2007-9#1)(2008-10#3)(2008-8#1)(2009-2#1)(2010-2#3)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2013-1#1)
surround the##8##2##(1990-6#1)(1991-5#1)(1994-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-3#1)
surround##19##1##(1990-4#1)(1990-6#1)(1991-5#1)(1992-7#1)(1994-5#1)(1994-9#1)(1995-11#1)(1996-1#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-3#1)(2011-1#1)
surrounded by BN layers##2##4##(2009-5#2)
surrounded by a narrow##2##4##(1990-9#1)(2012-12#1)
surrounded by a##22##3##(1990-9#1)(1991-11#1)(1991-8#1)(1996-4#1)(2005-10#1)(2005-11#1)(2006-5#1)(2007-10#1)(2007-12#7)(2008-10#2)(2008-7#1)(2012-12#1)(2012-2#2)(2013-8#1)
surrounded by an area of##3##5##(1991-11#1)(2008-10#1)(2011-2#1)
surrounded by an##9##3##(1991-11#1)(2007-12#2)(2008-10#3)(2008-7#1)(2011-12#1)(2011-2#1)
surrounded by approximately##2##3##(2007-12#2)
surrounded by regions with##2##4##(1991-9#1)(2008-10#1)
surrounded by regions##3##3##(1991-9#1)(2007-12#1)(2008-10#1)
surrounded by several##3##3##(1990-3#1)(1994-11#1)(2008-2#1)
surrounded by the##6##3##(1995-11#1)(2005-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2009-10#1)
surrounded by##85##2##(1990-3#1)(1990-7#2)(1990-9#1)(1991-11#2)(1991-8#1)(1991-9#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-11#1)(1995-2#1)(1996-4#1)(1996-7#1)(1997-4#1)(2005-10#1)(2005-11#2)(2006-1#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#14)(2007-3#2)(2007-4#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#3)(2009-10#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-5#1)(2011-12#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-8#1)
surrounded the##3##2##(2006-12#1)(2007-10#1)(2008-10#1)
surrounded##98##1##(1990-3#1)(1990-7#2)(1990-9#1)(1991-11#2)(1991-3#1)(1991-8#1)(1991-9#3)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-11#1)(1995-2#1)(1996-4#1)(1996-7#1)(1997-4#1)(2005-10#1)(2005-11#2)(2006-1#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#15)(2007-3#2)(2007-4#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#4)(2009-10#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-5#1)(2011-12#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2013-8#1)
surrounding OxyContin abuse##2##3##(2008-3#2)
surrounding a central##2##3##(2006-10#1)(2008-1#1)
surrounding a tumor##2##3##(2008-5#1)(2012-2#1)
surrounding a##16##2##(1990-3#1)(1991-5#1)(1992-3#1)(1994-11#1)(1997-4#2)(2006-10#2)(2008-1#1)(2008-3#1)(2008-5#1)(2008-9#2)(2012-2#1)(2012-3#1)(2013-1#1)
surrounding area##7##2##(1990-4#1)(1995-11#3)(2005-8#1)(2006-10#1)(2007-11#1)
surrounding areas##8##2##(1993-6#1)(1994-2#1)(2006-2#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-10#1)(2013-1#1)
surrounding blood##2##2##(1995-12#1)(2011-2#1)
surrounding brain tissue##3##3##(2008-5#1)(2008-7#2)
surrounding brain##4##2##(1995-11#1)(2008-5#1)(2008-7#2)
surrounding cell##2##2##(2008-7#2)
surrounding cells##3##2##(2005-10#1)(2011-2#1)(2012-12#1)
surrounding community on##2##3##(2010-2#2)
surrounding community##11##2##(2010-2#11)
surrounding countries##2##2##(2008-8#1)(2012-12#1)
surrounding each##2##2##(2008-10#1)(2008-8#1)
surrounding environment##10##2##(1993-3#1)(1995-6#1)(2006-10#1)(2008-10#1)(2008-7#1)(2010-10#1)(2010-7#1)(2012-2#1)(2013-1#2)
surrounding it##3##2##(1991-5#1)(1995-8#1)(1997-4#1)
surrounding lipid##2##2##(1990-11#1)(2012-2#1)
surrounding liver##4##2##(1994-6#3)(1997-8#1)
surrounding matrix##7##2##(2008-2#1)(2008-8#2)(2009-12#3)(2010-2#1)
surrounding microenvironment##3##2##(2009-3#1)(2011-1#1)(2011-2#1)
surrounding mucosa##2##2##(2006-6#1)(2011-12#1)
surrounding municipalities##2##2##(1990-2#2)
surrounding muscles##3##2##(2007-4#1)(2008-12#1)(2013-8#1)
surrounding normal structures##2##3##(2006-6#1)(2008-7#1)
surrounding normal tissues##2##3##(2007-4#1)(2010-12#1)
surrounding normal##11##2##(1992-9#1)(2006-6#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-12#1)
surrounding of##2##2##(1991-9#1)(1997-2#1)
surrounding possible##2##2##(2010-7#1)(2012-1#1)
surrounding region##2##2##(1992-7#1)(2007-12#1)
surrounding regions##2##2##(1995-3#1)(2008-4#1)
surrounding soft tissue##4##3##(2007-8#1)(2008-9#1)(2010-6#1)(2013-1#1)
surrounding soft tissues##4##3##(2007-6#1)(2007-8#1)(2008-9#1)(2012-12#1)
surrounding soft##8##2##(2007-6#1)(2007-8#2)(2008-9#2)(2010-6#1)(2012-12#1)(2013-1#1)
surrounding soil##3##2##(2008-12#2)(2008-5#1)
surrounding solvent##4##2##(1993-8#1)(2006-10#1)(2008-10#2)
surrounding structures and##3##3##(2011-2#2)(2013-1#1)
surrounding structures##17##2##(1993-6#1)(2006-12#2)(2006-5#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2009-10#1)(2011-2#3)(2012-11#1)(2012-2#1)(2013-1#1)
surrounding such##2##2##(1993-2#1)(2008-1#1)
surrounding support cells##2##3##(2008-9#1)(2009-3#1)
surrounding the carcinoma##2##3##(1990-3#1)(1996-4#1)
surrounding the city##2##3##(2006-6#1)(2008-10#1)
surrounding the dendritic##2##3##(1995-7#1)(2007-12#1)
surrounding the hip##2##3##(2007-11#2)
surrounding the implant##3##3##(2004-9#1)(2011-12#1)(2013-1#1)
surrounding the initiation##2##3##(1996-8#2)
surrounding the nucleus##2##3##(2008-10#1)(2009-10#1)
surrounding the penetration##2##3##(2008-10#2)
surrounding the potential##2##3##(2008-11#2)
surrounding the translation initiation sites on##2##6##(1996-8#1)(1997-2#1)
surrounding the translation initiation sites##6##5##(1996-8#3)(1997-2#2)(1997-6#1)
surrounding the use of##8##4##(2005-10#1)(2005-8#1)(2007-5#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-6#1)(2013-1#1)
surrounding the##145##2##(1990-3#1)(1990-7#1)(1990-8#1)(1991-10#2)(1991-2#2)(1991-5#3)(1991-7#3)(1992-1#2)(1993-2#1)(1994-2#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-8#5)(1997-1#1)(1997-2#6)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#1)(1997-9#1)(2004-2#1)(2004-4#1)(2004-9#2)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-12#3)(2006-3#2)(2006-6#1)(2006-8#1)(2007-11#6)(2007-12#9)(2007-4#1)(2007-5#2)(2007-7#1)(2007-9#2)(2008-10#7)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#3)(2008-6#4)(2008-7#4)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#2)(2009-12#1)(2009-8#2)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)
surrounding their##2##2##(1995-3#1)(2007-9#1)
surrounding these##3##2##(2006-2#1)(2007-11#1)(2008-1#1)
surrounding this##3##2##(1991-9#1)(1992-3#1)(2008-11#1)
surrounding tissue##13##2##(1990-11#2)(1991-2#2)(1996-7#1)(1997-4#1)(2006-1#1)(2006-6#2)(2006-9#1)(2007-11#1)(2010-2#1)(2013-1#1)
surrounding tissues##15##2##(1990-6#1)(1993-11#1)(1993-9#1)(1996-3#1)(2006-6#1)(2006-7#1)(2007-12#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
surrounding vascular##3##2##(2006-11#1)(2007-8#1)(2012-12#1)
surrounding##562##1##(1990-11#3)(1990-2#3)(1990-3#4)(1990-4#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-10#2)(1991-12#1)(1991-2#6)(1991-3#2)(1991-5#5)(1991-7#5)(1991-9#2)(1992-1#4)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#3)(1993-3#4)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#4)(1994-3#1)(1994-6#5)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#7)(1995-12#3)(1995-2#1)(1995-3#4)(1995-6#6)(1995-7#1)(1995-8#3)(1995-9#1)(1996-12#1)(1996-3#2)(1996-4#3)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#5)(1997-1#1)(1997-2#8)(1997-4#6)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#1)(1997-9#1)(2004-2#1)(2004-4#1)(2004-7#1)(2004-9#2)(2005-10#2)(2005-11#6)(2005-12#2)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#11)(2006-11#2)(2006-12#5)(2006-2#6)(2006-3#3)(2006-5#5)(2006-6#6)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#18)(2007-12#18)(2007-2#4)(2007-3#1)(2007-4#4)(2007-5#5)(2007-6#1)(2007-7#3)(2007-8#6)(2007-9#5)(2008-1#6)(2008-10#24)(2008-11#16)(2008-12#9)(2008-2#13)(2008-3#17)(2008-4#7)(2008-5#12)(2008-6#8)(2008-7#16)(2008-8#17)(2008-9#8)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#5)(2009-2#3)(2009-3#2)(2009-4#1)(2009-6#3)(2009-7#2)(2009-8#4)(2010-10#1)(2010-12#2)(2010-2#17)(2010-5#1)(2010-6#1)(2010-7#6)(2010-8#4)(2011-1#9)(2011-10#1)(2011-12#3)(2011-2#16)(2012-1#3)(2012-11#3)(2012-12#7)(2012-2#14)(2012-3#4)(2013-1#16)(2013-8#3)
surroundings of the##3##3##(1994-3#1)(2008-5#1)(2009-7#1)
surroundings of##4##2##(1994-3#1)(1995-2#1)(2008-5#1)(2009-7#1)
surroundings to##3##2##(1992-2#1)(2008-10#1)(2012-2#1)
surroundings##31##1##(1990-8#1)(1992-2#1)(1993-5#1)(1993-6#1)(1994-3#1)(1995-2#1)(1996-3#1)(1997-3#1)(2005-10#1)(2005-9#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-3#4)(2008-5#2)(2008-9#1)(2009-12#2)(2009-5#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-8#1)
surrounds a##2##2##(2007-12#1)(2011-2#1)
surrounds the##12##2##(1990-6#1)(1991-2#1)(1996-5#1)(2007-12#3)(2008-7#2)(2008-8#1)(2009-4#1)(2010-4#1)(2011-12#1)
surrounds##21##1##(1990-6#1)(1991-2#1)(1996-11#1)(1996-5#1)(2007-10#1)(2007-12#4)(2007-4#1)(2008-2#1)(2008-7#3)(2008-8#1)(2009-3#1)(2009-4#1)(2010-4#2)(2011-12#1)(2011-2#1)
surtout pour##2##2##(2011-2#1)(2012-2#1)
surtout##5##1##(2008-11#1)(2011-2#1)(2012-2#3)
surveillance activities##2##2##(1994-9#1)(2008-8#1)
surveillance and a##2##3##(1990-3#1)(2008-4#1)
surveillance and assessment activities##2##4##(1997-3#2)
surveillance and assessment##3##3##(1997-3#3)
surveillance and control##6##3##(2005-5#1)(2006-10#2)(2011-1#1)(2011-2#1)(2012-12#1)
surveillance and early-warning##2##3##(2011-12#2)
surveillance and information systems##2##4##(1997-3#2)
surveillance and management##3##3##(2009-12#1)(2012-3#2)
surveillance and monitoring##3##3##(1997-1#1)(2007-12#1)(2008-10#1)
surveillance and public health information systems##3##6##(1997-3#3)
surveillance and public health##5##4##(1997-3#3)(2010-12#1)(2010-8#1)
surveillance and research##2##3##(2009-5#1)(2011-2#1)
surveillance and response##6##3##(2006-2#1)(2008-1#2)(2008-11#1)(2012-12#2)
surveillance and screening##2##3##(2007-6#1)(2012-2#1)
surveillance and the##5##3##(1993-5#1)(2008-1#1)(2009-12#1)(2010-4#1)(2011-2#1)
surveillance and##82##2##(1990-12#1)(1990-3#2)(1992-2#1)(1993-1#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-3#1)(1996-6#2)(1997-1#1)(1997-2#2)(1997-3#8)(2005-5#3)(2006-10#2)(2006-2#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-5#1)(2007-6#1)(2008-1#5)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-12#2)(2009-5#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#3)(2011-2#5)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
surveillance are##4##2##(1993-3#1)(1997-3#1)(2005-7#1)(2008-8#1)
surveillance data are##2##3##(1997-3#1)(2008-8#1)
surveillance data for##2##3##(1995-3#1)(2013-8#1)
surveillance data from##2##3##(1997-1#1)(2012-2#1)
surveillance data in##2##3##(1997-3#1)(2011-2#1)
surveillance data##19##2##(1992-5#2)(1995-3#1)(1996-1#1)(1997-1#2)(1997-3#3)(2008-1#1)(2008-3#1)(2008-8#2)(2010-12#1)(2011-2#1)(2012-2#2)(2013-8#2)
surveillance definition##3##2##(1992-9#3)
surveillance efforts##2##2##(2007-12#1)(2010-8#1)
surveillance endoscopy##4##2##(2006-10#2)(2006-2#2)
surveillance following##2##2##(2007-8#1)(2013-1#1)
surveillance for acute##2##3##(2007-12#1)(2008-4#1)
surveillance for infectious diseases##2##4##(1996-6#1)(1997-3#1)
surveillance for prostate cancer##3##4##(2009-5#1)(2010-10#1)(2011-2#1)
surveillance for##30##2##(1990-11#1)(1994-12#1)(1996-6#1)(1997-3#5)(2006-10#1)(2006-2#2)(2007-12#1)(2008-1#4)(2008-10#2)(2008-4#1)(2008-6#1)(2009-11#1)(2009-5#1)(2010-10#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-3#1)
surveillance form##2##2##(2007-12#2)
surveillance from a##2##3##(2006-1#1)(2011-2#1)
surveillance from##4##2##(1996-11#1)(2006-1#1)(2011-2#1)(2012-3#1)
surveillance has##2##2##(1992-6#1)(2006-2#1)
surveillance in intensive care##2##4##(2006-11#1)(2012-12#1)
surveillance in the Pacific##2##4##(2008-1#2)
surveillance in the##8##3##(1997-3#2)(2008-1#3)(2011-1#1)(2011-2#1)(2012-3#1)
surveillance in##33##2##(1991-10#1)(1996-6#1)(1996-9#1)(1997-3#3)(2006-11#1)(2006-2#1)(2007-12#2)(2008-1#7)(2008-12#1)(2008-5#1)(2010-12#1)(2011-1#3)(2011-2#4)(2012-12#3)(2012-3#2)(2013-8#1)
surveillance is based on##2##4##(2006-2#1)(2011-12#1)
surveillance is##14##2##(1991-12#1)(1995-3#1)(1997-3#2)(2006-2#2)(2008-2#1)(2008-6#1)(2010-12#1)(2011-12#2)(2011-2#1)(2012-3#2)
surveillance network based on##2##4##(2011-9#1)(2012-12#1)
surveillance network of schistosomiasis in##2##5##(2011-12#2)
surveillance network of schistosomiasis##4##4##(2011-12#4)
surveillance network##8##2##(1993-7#1)(2011-12#4)(2011-9#2)(2012-12#1)
surveillance of HIV##3##3##(1993-11#1)(2007-12#1)(2007-4#1)
surveillance of acute##2##3##(2007-10#1)(2007-12#1)
surveillance of health and safety in microbiology laboratories##2##8##(1995-3#2)
surveillance of health##4##3##(1995-3#2)(2013-1#2)
surveillance of human##2##3##(1991-2#1)(2007-11#1)
surveillance of invasive##2##3##(2007-12#1)(2012-12#1)
surveillance of patients with##3##4##(2006-10#2)(2007-11#1)
surveillance of patients##5##3##(2006-10#2)(2006-9#1)(2007-11#1)(2008-5#1)
surveillance of the##12##3##(1990-12#1)(1991-11#1)(1991-3#1)(1992-11#1)(1992-5#1)(1997-5#1)(2006-4#1)(2008-1#1)(2008-3#1)(2009-12#1)(2010-9#1)(2012-12#1)
surveillance of these##2##3##(1991-11#1)(2009-12#1)
surveillance of this##2##3##(2009-6#1)(2012-12#1)
surveillance of##83##2##(1990-12#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-5#1)(1993-10#1)(1993-11#1)(1993-6#1)(1994-6#1)(1995-10#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-2#1)(1997-5#1)(1997-6#1)(2006-10#2)(2006-2#1)(2006-4#2)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#2)(2009-12#2)(2009-2#1)(2009-6#1)(2010-12#2)(2010-4#3)(2010-9#3)(2011-1#1)(2011-2#3)(2012-12#6)(2012-3#7)(2013-1#5)(2013-8#1)
surveillance on respiratory##3##3##(2010-12#3)
surveillance on the##3##3##(1996-11#1)(2013-8#2)
surveillance on##7##2##(1996-11#1)(2010-12#3)(2011-2#1)(2013-8#2)
surveillance or##5##2##(2005-5#1)(2006-10#1)(2007-8#1)(2010-12#1)(2012-12#1)
surveillance program##6##2##(1993-1#1)(2007-12#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)
surveillance programme on##2##3##(1994-6#2)
surveillance programme##7##2##(1994-6#4)(2007-1#1)(2007-12#1)(2008-1#1)
surveillance programmes##3##2##(2005-5#2)(2008-1#1)
surveillance programs have##2##3##(1991-12#1)(2012-1#1)
surveillance programs##9##2##(1991-12#2)(2005-8#1)(2008-1#1)(2008-10#1)(2012-1#1)(2012-12#2)(2013-1#1)
surveillance protocol for##3##3##(2006-10#1)(2008-1#1)(2010-12#1)
surveillance protocol##5##2##(2006-10#1)(2008-1#1)(2008-6#2)(2010-12#1)
surveillance reports submittal##2##3##(2008-1#2)
surveillance results##2##2##(2011-2#2)
surveillance scheme##2##2##(1995-6#1)(1996-3#1)
surveillance should be##3##3##(2006-10#1)(2007-12#1)(2007-8#1)
surveillance should##4##2##(2006-10#1)(2007-12#2)(2007-8#1)
surveillance site of##2##3##(2012-3#2)
surveillance site##7##2##(2012-3#7)
surveillance strategies##3##2##(2008-1#1)(2009-5#1)(2011-2#1)
surveillance studies have##2##3##(2007-11#1)(2013-1#1)
surveillance studies##6##2##(1993-2#1)(1996-7#1)(2007-11#1)(2013-1#3)
surveillance study conducted##2##3##(1991-11#1)(2008-3#1)
surveillance study in##2##3##(1991-11#1)(2008-7#1)
surveillance study##12##2##(1991-11#2)(1993-2#1)(1996-4#1)(2006-7#1)(2007-7#2)(2008-3#2)(2008-7#1)(2009-4#1)(2011-1#1)
surveillance system and##2##3##(1997-3#1)(2005-8#1)
surveillance system for the##2##4##(1997-3#1)(2007-5#1)
surveillance system for##7##3##(1990-12#1)(1993-3#1)(1994-2#1)(1997-3#1)(2007-5#1)(2008-1#1)(2012-12#1)
surveillance system in##3##3##(1993-6#1)(2007-12#1)(2011-2#1)
surveillance system is##5##3##(1994-2#1)(1995-12#1)(1997-2#1)(2005-5#1)(2007-8#1)
surveillance system to##2##3##(1996-3#1)(2010-12#1)
surveillance system##40##2##(1990-12#1)(1991-12#1)(1991-8#1)(1993-3#2)(1993-6#2)(1994-2#3)(1994-9#1)(1995-12#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-3#4)(2005-11#1)(2005-5#1)(2005-8#1)(2006-11#1)(2007-1#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-6#1)(2008-8#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#5)
surveillance systems and the##2##4##(1997-3#1)(2008-1#1)
surveillance systems and##3##3##(1997-3#2)(2008-1#1)
surveillance systems for##4##3##(1993-3#1)(1997-3#1)(2006-10#1)(2008-12#1)
surveillance systems were##2##3##(1994-9#1)(1997-3#1)
surveillance systems will##2##3##(1997-3#2)
surveillance systems##32##2##(1990-12#1)(1993-3#1)(1994-9#1)(1997-3#12)(2005-5#2)(2006-10#1)(2008-1#3)(2008-12#1)(2008-3#1)(2008-7#5)(2011-2#1)(2012-12#1)(2013-1#2)
surveillance to##7##2##(2006-4#1)(2007-11#1)(2008-1#1)(2008-7#1)(2010-11#1)(2011-2#2)
surveillance using a##3##3##(1997-3#1)(2013-1#2)
surveillance was##2##2##(2010-12#1)(2011-2#1)
surveillance will##3##2##(1997-3#1)(2008-1#1)(2008-12#1)
surveillance with##2##2##(2011-2#1)(2013-1#1)
surveillance##657##1##(1990-11#1)(1990-12#4)(1990-3#2)(1991-10#2)(1991-11#5)(1991-12#8)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#3)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#3)(1992-5#5)(1992-6#2)(1992-9#4)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#5)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#8)(1994-9#3)(1995-10#3)(1995-12#2)(1995-2#1)(1995-3#4)(1995-6#2)(1996-1#1)(1996-11#4)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#5)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#55)(1997-5#2)(1997-6#1)(2004-11#1)(2005-11#1)(2005-3#1)(2005-5#9)(2005-7#1)(2005-8#5)(2006-1#1)(2006-10#14)(2006-11#3)(2006-12#1)(2006-2#15)(2006-4#3)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#7)(2007-12#31)(2007-2#1)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#4)(2008-1#49)(2008-10#12)(2008-11#4)(2008-12#4)(2008-2#2)(2008-3#7)(2008-4#5)(2008-5#5)(2008-6#7)(2008-7#9)(2008-8#11)(2008-9#2)(2009-11#1)(2009-12#9)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#4)(2009-6#2)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#16)(2010-4#5)(2010-5#5)(2010-7#1)(2010-8#3)(2010-9#5)(2011-1#8)(2011-12#19)(2011-2#40)(2011-3#2)(2011-9#5)(2012-1#2)(2012-11#1)(2012-12#31)(2012-2#10)(2012-3#23)(2013-1#32)(2013-7#2)(2013-8#9)
surveillance)##3##1##(2008-10#1)(2009-12#1)(2010-3#1)
surveillance--United States##5##2##(1991-2#2)(1991-6#1)(1992-5#1)(1997-1#1)
surveillance]##5##1##(1990-9#1)(2010-11#1)(2010-9#2)(2012-11#1)
survenue d'une##2##2##(2012-2#1)(2013-1#1)
survenue##7##1##(2011-2#1)(2012-2#3)(2013-1#3)
survey about##3##2##(1990-3#1)(2012-3#1)(2013-1#1)
survey also##4##2##(1994-12#1)(2006-10#1)(2008-6#1)(2010-5#1)
survey among Canadian##2##3##(2007-12#1)(2009-9#1)
survey among##15##2##(1990-11#1)(1992-3#1)(1993-8#2)(1995-9#1)(2007-12#1)(2007-9#1)(2008-12#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
survey analysis##2##2##(1997-3#1)(2007-7#1)
survey and a##3##3##(1992-5#1)(2007-11#1)(2010-3#1)
survey and administrative data##3##4##(1995-2#1)(1995-3#1)(2010-11#1)
survey and in##2##3##(2008-8#1)(2011-1#1)
survey and the##3##3##(1990-1#1)(2007-2#1)(2008-10#1)
survey and##38##2##(1990-1#1)(1991-11#1)(1991-2#1)(1992-5#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-9#2)(1997-3#1)(2005-10#1)(2005-11#1)(2006-11#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-3#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#3)(2013-7#1)
survey are##7##2##(1990-10#1)(1994-1#1)(1996-3#2)(2006-4#1)(2008-3#1)(2012-12#1)
survey area##2##2##(2007-5#2)
survey as a##4##3##(2007-2#1)(2008-12#1)(2008-9#1)(2009-10#1)
survey as##7##2##(1994-2#1)(2007-10#1)(2007-2#1)(2008-12#1)(2008-9#1)(2009-10#1)(2013-1#1)
survey assessed the##2##3##(1991-6#1)(2007-12#1)
survey assessed##5##2##(1991-6#1)(1995-6#1)(2007-12#1)(2011-2#1)(2012-3#1)
survey assessing##4##2##(2006-7#1)(2008-11#1)(2011-2#1)(2013-1#1)
survey at##3##2##(2006-12#1)(2009-5#1)(2013-1#1)
survey based on##2##3##(2007-2#1)(2010-10#1)
survey based##3##2##(2007-2#1)(2010-10#1)(2010-5#1)
survey by the##2##3##(2007-6#1)(2010-12#1)
survey can##3##2##(1994-9#1)(1995-12#1)(2011-2#1)
survey cards##3##2##(1994-11#3)
survey carried out by the##2##5##(1994-12#1)(2006-10#1)
survey carried out in##2##4##(2006-4#1)(2007-3#1)
survey carried out##5##3##(1994-12#1)(2004-4#1)(2006-10#1)(2006-4#1)(2007-3#1)
survey completed by##2##3##(1996-1#1)(2013-1#1)
survey concerning##2##2##(2004-4#1)(2008-9#1)
survey conducted among the##3##4##(1991-12#1)(1996-1#1)(1997-3#1)
survey conducted among##5##3##(1991-12#1)(1993-1#1)(1996-1#1)(1996-12#1)(1997-3#1)
survey conducted by the##2##4##(2004-9#1)(2010-12#1)
survey conducted by##4##3##(1996-3#1)(2004-9#1)(2010-12#1)(2013-1#1)
survey conducted in##8##3##(1990-10#1)(1991-2#1)(1991-3#1)(1992-2#1)(1996-9#1)(2008-1#1)(2008-10#1)(2012-3#1)
survey conducted##21##2##(1990-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#1)(1993-1#1)(1994-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-8#1)(2004-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-12#1)(2012-3#1)(2013-1#1)
survey confirms##2##2##(1991-11#1)(2007-6#1)
survey consisted of##3##3##(1994-2#1)(1994-6#1)(2008-9#1)
survey consisting of##3##3##(1993-12#1)(1996-1#1)(2008-7#1)
survey data and##3##3##(1997-3#1)(2006-4#1)(2008-10#1)
survey data collected##3##3##(1991-6#1)(2007-12#1)(2013-1#1)
survey data from the##2##4##(1993-3#1)(1997-3#1)
survey data from##5##3##(1992-12#1)(1993-3#1)(1997-3#1)(2010-9#1)(2013-1#1)
survey data on the##2##4##(2006-9#1)(2013-7#1)
survey data on##3##3##(2006-9#1)(2009-11#1)(2013-7#1)
survey data to##4##3##(2007-6#1)(2007-7#1)(2008-9#1)(2013-7#1)
survey data were collected##2##4##(2007-1#1)(2011-2#1)
survey data##44##2##(1991-6#1)(1992-12#1)(1993-2#1)(1993-3#1)(1994-2#1)(1996-3#1)(1997-3#3)(2005-9#1)(2006-4#2)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#2)
survey demonstrated that the##2##4##(1993-9#1)(2012-2#1)
survey demonstrated##3##2##(1993-9#1)(1996-12#1)(2012-2#1)
survey design##3##2##(2007-12#1)(2007-2#1)(2009-9#1)
survey designed to measure the##2##5##(1995-12#1)(2010-4#1)
survey designed to##3##3##(1995-12#1)(2010-4#1)(2010-8#1)
survey documented##2##2##(2005-8#1)(2012-3#1)
survey done##2##2##(1993-2#1)(2005-9#1)
survey during##2##2##(2008-11#1)(2011-1#1)
survey findings##6##2##(1994-1#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#2)
survey for the##2##3##(1994-3#1)(2013-8#1)
survey for##20##2##(1990-12#1)(1991-5#1)(1994-3#2)(1994-8#1)(1995-12#1)(1996-3#1)(2005-7#1)(2006-10#1)(2006-2#1)(2008-10#4)(2008-5#1)(2010-8#1)(2012-2#2)(2013-1#1)(2013-8#1)
survey forms##2##2##(1990-12#1)(2008-7#1)
survey found that##2##3##(2004-10#1)(2008-10#1)
survey from a##2##3##(2011-1#1)(2012-2#1)
survey from##7##2##(1992-3#1)(1995-8#1)(1997-2#1)(2008-8#1)(2011-1#1)(2012-2#2)
survey had##3##2##(2005-10#1)(2009-4#1)(2012-12#1)
survey has been widely##2##4##(1996-1#1)(2013-8#1)
survey has been##4##3##(1990-12#1)(1996-1#1)(2012-2#1)(2013-8#1)
survey has##8##2##(1990-10#1)(1990-12#1)(1991-11#1)(1996-1#1)(1997-8#1)(2005-8#1)(2012-2#1)(2013-8#1)
survey in 1988##2##3##(1990-3#1)(2007-9#1)
survey in 1999##2##3##(2008-10#1)(2012-3#1)
survey in Japan##3##3##(2007-12#1)(2007-8#2)
survey in a##5##3##(2007-2#1)(2008-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
survey in the##9##3##(1991-6#1)(1992-2#1)(1994-3#1)(1995-11#1)(2007-10#1)(2007-9#1)(2009-10#1)(2012-12#1)(2012-2#1)
survey in##61##2##(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-2#1)(1993-11#1)(1993-6#1)(1994-1#1)(1994-3#2)(1994-8#1)(1995-11#1)(1995-6#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#3)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#2)(2007-9#2)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#2)(2009-12#1)(2010-1#1)(2010-4#2)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-8#2)
survey included##5##2##(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2012-3#1)
survey includes##2##2##(1991-12#1)(2008-10#1)
survey indicate that##2##3##(1990-3#1)(1992-11#1)
survey indicate##4##2##(1990-3#1)(1992-11#1)(1995-1#1)(2008-12#1)
survey indicated that##3##3##(2007-7#1)(2008-10#1)(2011-12#1)
survey indicated##4##2##(1995-1#1)(2007-7#1)(2008-10#1)(2011-12#1)
survey indicates##2##2##(1992-6#1)(2010-12#1)
survey information##2##2##(1992-12#1)(1996-2#1)
survey instrument and##3##3##(1994-2#1)(1996-3#1)(2006-10#1)
survey instrument##8##2##(1994-2#1)(1996-1#1)(1996-3#1)(2006-10#1)(2006-2#2)(2009-12#1)(2011-1#1)
survey instruments##2##2##(1996-2#1)(2013-8#1)
survey involving##3##2##(1992-2#1)(2012-1#1)(2013-1#1)
survey is a##2##3##(2007-2#1)(2010-1#1)
survey is presented##3##3##(1996-12#1)(2008-11#1)(2012-1#1)
survey is##13##2##(1995-1#1)(1996-12#1)(1997-8#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-9#1)(2010-1#1)(2012-1#1)(2012-12#1)
survey measurements##2##2##(1990-11#1)(2007-12#1)
survey method##3##2##(1991-3#1)(2006-2#1)(2008-11#1)
survey methods to##2##3##(2009-4#1)(2010-9#1)
survey methods were##2##3##(2012-3#2)
survey methods##11##2##(1994-2#1)(1995-2#1)(1997-1#1)(2008-7#1)(2009-4#1)(2010-1#1)(2010-9#1)(2012-3#2)(2013-7#1)(2013-8#1)
survey of 1##2##3##(1993-1#1)(1996-4#1)
survey of 2##2##3##(1997-4#1)(2008-1#1)
survey of 200##3##3##(1997-2#1)(2008-12#1)(2009-4#1)
survey of 68##2##3##(2008-9#1)(2009-5#1)
survey of Canadian##3##3##(1992-2#1)(1994-12#1)(2008-11#1)
survey of Danish hospitals showed that##2##6##(1995-3#1)(1997-7#1)
survey of U##3##3##(1995-1#1)(2007-12#1)(2012-1#1)
survey of a##3##3##(2008-10#1)(2009-11#1)(2011-1#1)
survey of all##10##3##(1990-12#1)(1991-6#1)(1994-3#2)(1995-5#1)(1996-1#1)(1997-2#1)(2008-1#2)(2010-9#1)
survey of an##2##3##(1996-1#1)(2004-11#1)
survey of attitudes##3##3##(1993-5#1)(1994-3#1)(2006-7#1)
survey of clinical##2##3##(1994-8#1)(2010-7#1)
survey of commercial##2##3##(2008-10#2)
survey of current##6##3##(1995-7#1)(2004-10#1)(2006-12#1)(2007-5#1)(2008-10#1)(2008-9#1)
survey of domestic##2##3##(2007-2#1)(2011-1#1)
survey of emergency physicians##2##4##(2007-7#1)(2009-4#1)
survey of emergency##3##3##(2007-7#2)(2009-4#1)
survey of excipients used in approved injectable products##2##8##(2012-2#2)
survey of general practitioners##2##4##(1997-5#1)(2008-3#1)
survey of health##2##3##(1995-2#1)(2012-11#1)
survey of hospital##2##3##(1994-1#1)(1994-3#1)
survey of key informants##2##4##(2010-8#1)(2012-11#1)
survey of members##3##3##(1994-3#1)(1995-1#1)(1995-2#1)
survey of mental##2##3##(2010-5#1)(2011-1#1)
survey of methods##2##3##(2006-4#1)(2007-5#1)
survey of more than##2##4##(1994-2#1)(2007-7#1)
survey of patients##3##3##(2007-2#1)(2007-9#1)(2008-10#1)
survey of pediatric##2##3##(1992-12#1)(1997-8#1)
survey of physicians##2##3##(1993-3#1)(2010-4#1)
survey of practices in##2##4##(2005-10#1)(2012-2#1)
survey of primary##2##3##(1992-11#1)(2007-2#1)
survey of selected##2##3##(2006-2#1)(2007-2#1)
survey of some##2##3##(2008-4#1)(2011-2#1)
survey of the literature##3##4##(2008-10#1)(2010-3#1)(2013-1#1)
survey of the prevalence##2##4##(1994-6#1)(2007-2#1)
survey of the##54##3##(1990-4#1)(1991-4#1)(1991-8#1)(1992-10#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-9#1)(1996-9#1)(1997-3#1)(1997-7#1)(2005-7#1)(2006-10#2)(2006-3#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#2)(2009-4#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
survey of trypanozoon infection in horses##2##6##(2011-2#2)
survey of users##2##3##(1991-1#2)
survey of##386##2##(1990-1#2)(1990-12#5)(1990-4#1)(1990-5#1)(1991-1#2)(1991-11#1)(1991-2#2)(1991-3#3)(1991-4#1)(1991-6#2)(1991-8#4)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#2)(1992-7#2)(1992-8#1)(1993-1#3)(1993-10#1)(1993-12#4)(1993-2#2)(1993-3#4)(1993-5#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#5)(1994-3#9)(1994-6#6)(1994-8#1)(1994-9#4)(1995-1#4)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-7#2)(1996-1#4)(1996-12#4)(1996-2#1)(1996-3#2)(1996-4#3)(1996-7#2)(1996-8#2)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#5)(1997-7#2)(1997-8#1)(2004-10#3)(2004-11#2)(2004-2#1)(2004-7#2)(2005-10#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-3#2)(2006-4#3)(2006-5#1)(2006-6#3)(2006-7#2)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#2)(2007-2#11)(2007-3#5)(2007-4#3)(2007-5#2)(2007-7#6)(2007-8#2)(2007-9#3)(2008-1#8)(2008-10#23)(2008-11#8)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#7)(2008-6#5)(2008-7#6)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#8)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#3)(2011-1#9)(2011-12#3)(2011-2#10)(2012-1#4)(2012-11#3)(2012-12#9)(2012-2#9)(2012-3#8)(2013-1#11)(2013-7#2)(2013-8#3)
survey on indoor##2##3##(2008-10#2)
survey on knowledge##2##3##(1990-8#1)(1997-6#1)
survey on people migrating from malaria endemic areas to##2##9##(2007-1#2)
survey on the knowledge##2##4##(2007-2#1)(2011-2#1)
survey on the##7##3##(2007-2#1)(2007-3#1)(2007-9#1)(2010-3#1)(2011-2#1)(2012-2#2)
survey on##36##2##(1990-10#1)(1990-11#1)(1990-8#1)(1991-2#1)(1992-4#1)(1992-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-8#1)(1996-1#1)(1997-2#1)(1997-6#1)(2007-1#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#3)(2010-3#1)(2011-1#2)(2011-2#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
survey participation##2##2##(2007-10#2)
survey patients from##2##3##(1992-12#2)
survey performed in 1993##2##4##(2006-10#2)
survey performed##3##2##(1993-11#1)(2006-10#2)
survey points##2##2##(2008-9#1)(2013-8#1)
survey procedures##2##2##(1996-2#1)(2012-3#1)
survey process##2##2##(1997-1#1)(2007-4#1)
survey provides##3##2##(1997-2#1)(2007-2#1)(2008-12#1)
survey questionnaire##7##2##(1991-8#1)(1993-12#1)(1993-5#2)(2007-8#1)(2012-1#1)(2012-2#1)
survey questionnaires##4##2##(2008-12#1)(2012-12#3)
survey questions##4##2##(1993-2#1)(2006-10#1)(2008-7#1)(2013-1#1)
survey report##2##2##(2007-6#1)(2010-11#1)
survey reported##3##2##(2013-1#1)(2013-8#2)
survey research##2##2##(2007-12#1)(2008-7#1)
survey respondents##2##2##(2013-1#2)
survey responses from##2##3##(1996-3#1)(2012-3#1)
survey responses##8##2##(1993-1#1)(1994-12#1)(1995-1#1)(1996-3#1)(2008-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
survey results and##2##3##(1996-3#1)(2007-4#1)
survey results##21##2##(1990-12#1)(1991-3#1)(1992-1#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(2006-2#2)(2007-3#1)(2007-4#1)(2008-11#2)(2008-12#1)(2011-10#1)(2012-3#1)(2013-1#3)(2013-8#1)
survey revealed a##3##3##(1993-8#1)(2008-10#1)(2008-8#1)
survey revealed that##3##3##(1994-3#1)(2008-10#2)
survey revealed##7##2##(1990-12#1)(1993-8#1)(1994-3#1)(2008-10#3)(2008-8#1)
survey reveals that##3##3##(2008-11#1)(2008-9#1)(2013-8#1)
survey reveals##4##2##(2006-10#1)(2008-11#1)(2008-9#1)(2013-8#1)
survey sampling##3##2##(2008-10#1)(2008-12#1)(2008-7#1)
survey scores##2##2##(2006-8#1)(2011-2#1)
survey showed that the##3##4##(2007-11#1)(2008-1#1)(2008-12#1)
survey showed that##8##3##(1993-6#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)
survey showed##13##2##(1993-6#1)(1997-1#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-8#1)
survey showing##2##2##(2008-5#1)(2008-9#1)
survey some##2##2##(1993-12#1)(2006-10#1)
survey study##5##2##(2008-7#1)(2008-8#1)(2009-11#1)(2010-10#1)(2012-2#1)
survey suggest that##2##3##(2008-9#1)(2011-2#1)
survey suggests that##2##3##(1994-12#1)(1996-1#1)
survey suggests##3##2##(1991-2#1)(1994-12#1)(1996-1#1)
survey systems##2##2##(2005-5#1)(2007-10#1)
survey that included##2##3##(1993-11#1)(2012-12#1)
survey that##6##2##(1993-11#1)(1996-3#1)(1997-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
survey the current##2##3##(2010-2#1)(2012-11#1)
survey the##17##2##(1994-9#1)(2006-3#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-3#1)(2008-10#1)(2009-12#1)(2009-9#1)(2010-2#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)
survey to assess##2##3##(1995-12#1)(2012-12#1)
survey to describe##2##3##(2007-3#1)(2007-8#1)
survey to determine the##3##4##(1996-12#1)(2013-1#2)
survey to determine##4##3##(1996-12#1)(2009-11#1)(2013-1#2)
survey to identify##2##3##(2007-8#1)(2013-1#1)
survey to##23##2##(1993-9#1)(1994-11#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(2006-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#2)(2008-11#1)(2008-12#1)(2009-11#1)(2010-11#1)(2012-12#1)(2012-2#1)(2013-1#4)
survey tool##2##2##(2012-12#1)(2013-1#1)
survey tools##2##2##(2007-10#2)
survey two##2##2##(1991-2#1)(2007-8#1)
survey undertaken##3##2##(1996-12#1)(2008-10#1)(2012-2#1)
survey using a##2##3##(2004-11#1)(2011-1#1)
survey using##5##2##(1997-1#1)(2004-11#1)(2008-10#1)(2011-1#1)(2012-12#1)
survey was administered to residents##2##5##(2007-2#1)(2011-2#1)
survey was administered to##7##4##(2007-2#1)(2007-8#1)(2008-12#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
survey was administered##10##3##(2006-7#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#1)
survey was also##2##3##(2010-1#1)(2013-8#1)
survey was applied to##3##4##(2011-2#1)(2012-2#1)(2013-1#1)
survey was carried out in##11##5##(1992-4#1)(1994-6#1)(1996-3#1)(2005-9#1)(2006-10#1)(2007-2#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-5#1)(2013-7#1)
survey was carried out to##5##5##(2007-10#1)(2008-1#1)(2008-7#1)(2009-6#1)(2012-12#1)
survey was carried out##25##4##(1992-4#1)(1994-6#1)(1996-3#1)(1997-3#1)(2005-9#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-2#2)(2007-3#1)(2008-1#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-7#2)
survey was completed by##2##4##(1992-12#1)(2008-11#1)
survey was conducted among##3##4##(1992-6#1)(2007-3#1)(2012-3#1)
survey was conducted in 2007##2##5##(2011-12#1)(2012-3#1)
survey was conducted in a##2##5##(2008-11#1)(2013-8#1)
survey was conducted in early##2##5##(1997-1#1)(2008-9#1)
survey was conducted in##19##4##(1991-3#1)(1994-3#1)(1996-1#1)(1997-1#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
survey was conducted on##6##4##(1997-5#1)(2006-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2013-1#1)
survey was conducted to determine the##2##6##(2004-10#1)(2011-2#1)
survey was conducted to evaluate##2##5##(1992-2#1)(2008-10#1)
survey was conducted to identify##2##5##(1997-1#1)(2012-3#1)
survey was conducted to investigate the##2##6##(2007-4#1)(2012-3#1)
survey was conducted to obtain##3##5##(1993-8#1)(2013-1#2)
survey was conducted to##15##4##(1992-2#1)(1993-8#1)(1994-3#1)(1997-1#1)(2004-10#1)(2007-4#1)(2008-10#2)(2008-2#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
survey was conducted using a##2##5##(1991-12#1)(2010-8#1)
survey was conducted with##2##4##(2008-12#1)(2013-1#1)
survey was conducted##61##3##(1991-12#1)(1991-3#1)(1992-2#1)(1992-6#1)(1993-2#1)(1993-8#1)(1994-2#1)(1994-3#2)(1996-1#2)(1997-1#2)(1997-5#1)(2004-10#1)(2006-10#1)(2007-3#2)(2007-4#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#7)(2013-8#3)
survey was designed to##2##4##(1996-3#1)(2010-3#1)
survey was designed##3##3##(1996-3#1)(2008-8#1)(2010-3#1)
survey was developed##2##3##(2007-10#1)(2008-12#1)
survey was distributed##2##3##(2007-3#1)(2012-12#1)
survey was made##2##3##(1990-12#1)(1991-8#1)
survey was performed in##2##4##(1991-9#1)(2008-2#1)
survey was performed to##2##4##(1990-12#1)(2007-1#1)
survey was performed##6##3##(1990-12#1)(1991-9#1)(2007-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
survey was sent to the##3##5##(2005-10#1)(2007-12#1)(2013-1#1)
survey was sent to##7##4##(1993-1#1)(2005-10#1)(2007-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
survey was sent##8##3##(1993-1#1)(2005-10#1)(2007-12#2)(2011-2#2)(2012-2#1)(2013-1#1)
survey was therefore##2##3##(2007-7#1)(2008-2#1)
survey was to investigate##2##4##(2011-2#1)(2013-1#1)
survey was to##8##3##(1991-12#1)(1993-5#1)(2006-8#1)(2007-5#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
survey was undertaken##4##3##(2007-2#1)(2008-3#1)(2010-1#1)(2013-1#1)
survey was used to##4##4##(1996-3#1)(2008-6#1)(2010-6#1)(2013-7#1)
survey was##163##2##(1990-12#2)(1991-12#2)(1991-3#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#2)(1994-1#1)(1994-2#1)(1994-3#2)(1994-6#1)(1996-1#2)(1996-3#3)(1997-1#2)(1997-3#1)(1997-5#1)(2004-10#1)(2005-10#1)(2005-9#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#4)(2007-3#5)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#6)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#4)(2009-3#1)(2009-6#1)(2010-1#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#10)(2012-1#3)(2012-12#4)(2012-2#4)(2012-3#7)(2013-1#12)(2013-7#3)(2013-8#4)
survey we##2##2##(1997-4#1)(2012-3#1)
survey were in##2##3##(1991-2#1)(1992-1#1)
survey were##15##2##(1991-12#1)(1991-2#1)(1992-1#1)(1994-2#1)(1995-12#1)(1996-1#1)(2006-11#1)(2007-7#2)(2008-10#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)
survey will##2##2##(1996-1#1)(2008-12#1)
survey with an##2##3##(1997-5#1)(2013-7#1)
survey with##8##2##(1990-12#2)(1992-12#1)(1997-5#1)(2008-7#1)(2010-10#1)(2013-1#1)(2013-7#1)
survey##1583##1##(1990-1#4)(1990-10#4)(1990-11#3)(1990-12#19)(1990-3#7)(1990-4#2)(1990-5#1)(1990-6#2)(1990-8#4)(1991-1#2)(1991-11#4)(1991-12#8)(1991-2#11)(1991-3#11)(1991-4#2)(1991-5#4)(1991-6#7)(1991-8#6)(1991-9#1)(1992-1#7)(1992-10#1)(1992-11#3)(1992-12#10)(1992-2#6)(1992-3#6)(1992-4#2)(1992-5#5)(1992-6#6)(1992-7#3)(1992-8#2)(1992-9#3)(1993-1#9)(1993-10#2)(1993-11#3)(1993-12#12)(1993-2#9)(1993-3#8)(1993-5#6)(1993-6#4)(1993-7#1)(1993-8#8)(1993-9#3)(1994-1#12)(1994-11#6)(1994-12#13)(1994-2#22)(1994-3#23)(1994-4#2)(1994-6#11)(1994-8#3)(1994-9#6)(1995-1#10)(1995-11#1)(1995-12#12)(1995-2#11)(1995-3#7)(1995-4#1)(1995-5#1)(1995-6#3)(1995-7#3)(1995-8#3)(1995-9#4)(1996-1#22)(1996-11#1)(1996-12#12)(1996-2#8)(1996-3#21)(1996-4#3)(1996-7#3)(1996-8#3)(1996-9#3)(1997-1#10)(1997-2#11)(1997-3#12)(1997-4#3)(1997-5#8)(1997-6#2)(1997-7#3)(1997-8#8)(2004-10#5)(2004-11#4)(2004-2#1)(2004-4#2)(2004-7#2)(2004-9#1)(2005-10#6)(2005-11#3)(2005-3#1)(2005-5#1)(2005-7#2)(2005-8#6)(2005-9#4)(2006-10#20)(2006-11#2)(2006-12#3)(2006-2#10)(2006-3#3)(2006-4#8)(2006-5#2)(2006-6#4)(2006-7#6)(2006-8#9)(2006-9#3)(2007-1#9)(2007-10#19)(2007-11#12)(2007-12#19)(2007-2#31)(2007-3#16)(2007-4#14)(2007-5#8)(2007-6#6)(2007-7#19)(2007-8#13)(2007-9#15)(2008-1#24)(2008-10#71)(2008-11#34)(2008-12#32)(2008-2#8)(2008-3#11)(2008-4#8)(2008-5#16)(2008-6#9)(2008-7#21)(2008-8#15)(2008-9#25)(2009-10#5)(2009-11#4)(2009-12#4)(2009-2#1)(2009-3#2)(2009-4#12)(2009-5#5)(2009-6#5)(2009-7#1)(2009-8#3)(2009-9#6)(2010-1#7)(2010-10#6)(2010-11#10)(2010-12#9)(2010-2#4)(2010-3#6)(2010-4#7)(2010-5#8)(2010-6#2)(2010-7#6)(2010-8#15)(2010-9#11)(2011-1#41)(2011-10#2)(2011-12#8)(2011-2#50)(2012-1#17)(2012-11#8)(2012-12#41)(2012-2#43)(2012-3#45)(2013-1#77)(2013-7#11)(2013-8#30)
survey]##11##1##(1990-12#1)(1990-8#1)(1993-11#2)(1993-2#1)(1994-5#1)(1997-3#1)(2005-11#1)(2007-3#1)(2008-5#1)(2012-3#1)
surveyed 1##2##2##(1991-2#1)(2010-8#1)
surveyed a##2##2##(1992-3#1)(2007-9#1)
surveyed about##4##2##(2008-12#1)(2008-4#1)(2009-9#1)(2010-4#1)
surveyed areas##2##2##(2008-10#1)(2008-8#1)
surveyed at##3##2##(2007-2#2)(2008-1#1)
surveyed by telephone##2##3##(1995-1#1)(2013-1#1)
surveyed by the##2##3##(1990-12#1)(2010-8#1)
surveyed by##8##2##(1990-12#1)(1995-1#1)(2007-12#1)(2007-5#1)(2008-5#1)(2010-2#1)(2010-8#1)(2013-1#1)
surveyed for##9##2##(1996-12#1)(1997-4#1)(2007-3#1)(2007-5#1)(2008-10#2)(2010-8#1)(2012-2#1)(2012-3#1)
surveyed from##2##2##(2007-5#1)(2012-2#1)
surveyed in the##3##3##(2008-10#1)(2008-11#1)(2010-3#1)
surveyed in##20##2##(1992-3#1)(1993-3#1)(1995-11#1)(1996-2#1)(1997-3#1)(2006-7#1)(2007-3#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2009-4#1)(2010-3#1)(2011-1#1)(2012-12#2)(2012-2#2)
surveyed its members##2##3##(1994-1#1)(1995-3#1)
surveyed its##4##2##(1994-1#1)(1995-3#1)(1996-1#1)(2008-1#1)
surveyed local health##2##3##(1996-3#1)(2012-3#1)
surveyed regarding their##3##3##(1995-1#1)(2007-10#2)
surveyed regarding##7##2##(1991-5#2)(1993-1#1)(1995-1#1)(2007-10#2)(2008-9#1)
surveyed reported that##2##3##(2007-12#1)(2008-9#1)
surveyed the##7##2##(1993-9#1)(2006-4#1)(2007-5#1)(2007-9#1)(2008-6#1)(2010-7#1)(2011-2#1)
surveyed to##9##2##(1990-12#1)(1995-1#1)(1996-1#1)(2004-4#1)(2005-7#1)(2006-12#1)(2007-12#1)(2008-10#1)(2011-2#1)
surveyed were satisfied##2##3##(1992-5#1)(2012-2#1)
surveyed were##5##2##(1992-5#1)(1995-6#1)(1996-12#1)(2008-7#1)(2012-2#1)
surveyed who##2##2##(2007-3#1)(2008-1#1)
surveyed with a##2##3##(1991-2#1)(1995-12#1)
surveyed with##3##2##(1991-2#1)(1995-12#1)(2010-2#1)
surveyed within##2##2##(1997-4#1)(2012-1#1)
surveyed##205##1##(1990-12#2)(1990-8#1)(1991-12#1)(1991-2#2)(1991-5#3)(1991-8#1)(1992-1#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-2#2)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#3)(1996-12#4)(1996-2#3)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#4)(1997-4#2)(1997-6#1)(2004-4#1)(2005-11#1)(2005-7#1)(2006-10#5)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-7#3)(2007-10#3)(2007-11#3)(2007-12#3)(2007-2#2)(2007-3#5)(2007-5#7)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#16)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#5)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#5)(2011-1#6)(2011-10#1)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#5)(2013-1#8)(2013-7#2)(2013-8#1)
surveying the##5##2##(1993-2#1)(2006-10#1)(2007-11#1)(2011-2#1)(2012-12#1)
surveying##20##1##(1993-1#1)(1993-2#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-3#2)(2006-10#1)(2006-2#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-9#1)(2009-2#1)(2011-2#3)(2012-12#1)(2012-2#1)
surveys among##2##2##(2011-2#1)(2012-3#1)
surveys and interviews##2##3##(1993-3#1)(2013-8#1)
surveys and##23##2##(1991-12#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1995-2#1)(1996-3#1)(2007-6#1)(2008-10#5)(2008-7#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
surveys are##9##2##(1993-6#1)(1994-3#2)(1996-3#1)(1997-3#1)(2006-8#1)(2008-8#1)(2010-2#1)(2012-12#1)
surveys as a##2##3##(1996-3#1)(2012-12#1)
surveys assessing##2##2##(2009-5#1)(2010-8#1)
surveys at baseline##2##3##(1994-2#1)(2006-2#1)
surveys at##6##2##(1994-2#1)(2006-2#1)(2009-9#1)(2010-9#1)(2013-1#2)
surveys by##2##2##(2010-2#1)(2010-6#1)
surveys can be##3##3##(1995-9#1)(2010-4#1)(2011-1#1)
surveys carried out##2##3##(2006-4#1)(2008-8#1)
surveys conducted by##3##3##(1996-2#1)(1997-1#1)(2008-9#1)
surveys conducted in##7##3##(1993-1#1)(2008-12#1)(2008-4#1)(2010-9#1)(2011-12#1)(2013-7#1)(2013-8#1)
surveys conducted##13##2##(1993-1#1)(1996-2#1)(1997-1#1)(1997-4#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-9#1)(2011-12#1)(2013-7#1)(2013-8#1)
surveys for##3##2##(1993-6#1)(1995-2#1)(2012-2#1)
surveys from##4##2##(1993-6#1)(1996-12#1)(2005-8#1)(2007-7#1)
surveys have been carried out##2##5##(1991-4#1)(2013-7#1)
surveys have##5##2##(1991-4#1)(2007-2#2)(2008-7#1)(2013-7#1)
surveys in 2000 and##2##4##(2012-3#2)
surveys in the United States##2##5##(2008-12#1)(2013-8#1)
surveys in the##8##3##(1990-8#1)(1993-6#1)(1996-3#1)(2005-8#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-8#1)
surveys in three##2##3##(2007-7#2)
surveys in##27##2##(1990-8#1)(1993-6#2)(1995-3#1)(1996-3#2)(1997-3#1)(2005-8#2)(2007-2#1)(2007-7#3)(2008-10#1)(2008-12#1)(2008-4#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-3#3)(2013-1#1)(2013-8#1)
surveys indicate that the##3##4##(1992-9#1)(2006-4#1)(2010-8#1)
surveys indicate that##5##3##(1992-9#1)(1994-3#1)(2006-4#1)(2010-8#1)(2012-12#1)
surveys indicate##7##2##(1992-9#1)(1994-3#1)(2006-4#1)(2008-3#1)(2008-8#1)(2010-8#1)(2012-12#1)
surveys may##2##2##(2008-10#1)(2011-2#1)
surveys of parents##2##3##(2012-12#2)
surveys of the##6##3##(1996-1#1)(1996-11#1)(2004-9#1)(2006-8#1)(2008-1#1)(2012-12#1)
surveys of##30##2##(1993-6#1)(1993-8#1)(1993-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-4#1)(2004-9#2)(2006-10#1)(2006-12#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-9#1)(2010-2#1)(2011-12#2)(2012-12#4)(2012-2#2)(2012-3#1)
surveys on##7##2##(1991-10#1)(1992-2#1)(1994-2#1)(2006-5#1)(2008-10#2)(2008-2#1)
surveys performed in##2##3##(1992-4#1)(1992-7#1)
surveys regarding##2##2##(2007-12#1)(2008-8#1)
surveys related to##2##3##(1997-2#1)(2007-2#1)
surveys reveal##2##2##(2010-12#1)(2012-2#1)
surveys revealed##3##2##(2006-12#1)(2010-12#1)(2011-2#1)
surveys show that##4##3##(1990-6#1)(2013-8#3)
surveys some of the##2##4##(2008-12#1)(2008-7#1)
surveys that##4##2##(1990-1#1)(1991-3#1)(2006-6#1)(2010-2#1)
surveys the current##2##3##(1991-1#1)(2013-7#1)
surveys the##10##2##(1990-2#1)(1990-8#1)(1991-1#1)(1992-3#1)(1996-5#3)(2007-9#1)(2008-4#1)(2013-7#1)
surveys to##11##2##(1991-9#1)(1992-1#1)(1994-3#1)(1996-3#2)(2008-1#1)(2008-10#1)(2008-8#1)(2010-1#1)(2010-2#1)(2010-8#1)
surveys using##5##2##(1996-7#1)(2007-5#1)(2009-4#1)(2009-8#1)(2012-3#1)
surveys were administered##2##3##(2008-8#1)(2011-1#1)
surveys were carried out##2##4##(1992-9#1)(2008-2#1)
surveys were completed##2##3##(2010-8#1)(2011-2#1)
surveys were conducted at##2##4##(2007-5#1)(2008-4#1)
surveys were conducted in##4##4##(1992-12#1)(1994-9#1)(2007-3#1)(2012-3#1)
surveys were conducted##8##3##(1992-12#1)(1994-9#1)(2007-3#1)(2007-5#2)(2008-4#1)(2010-8#1)(2012-3#1)
surveys were part of the##2##5##(1991-9#1)(2013-8#1)
surveys were received##2##3##(1994-2#1)(2008-12#1)
surveys were returned##3##3##(2007-10#1)(2007-11#1)(2010-11#1)
surveys were used to##6##4##(1996-3#1)(2005-9#1)(2008-6#1)(2013-1#3)
surveys were##41##2##(1991-9#1)(1992-12#1)(1992-9#1)(1993-2#1)(1994-2#1)(1994-9#1)(1996-3#1)(2005-9#1)(2006-2#1)(2007-10#2)(2007-11#1)(2007-3#1)(2007-5#2)(2008-10#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-11#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#3)
surveys where##2##2##(1997-3#1)(2009-12#1)
surveys will##2##2##(1996-3#1)(2008-12#1)
surveys with##5##2##(2007-5#1)(2008-7#1)(2012-3#1)(2013-8#2)
surveys would##2##2##(1996-3#1)(2010-2#1)
surveys##412##1##(1990-1#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#3)(1991-4#1)(1991-9#3)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-1#2)(1993-10#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#7)(1993-8#2)(1993-9#3)(1994-1#1)(1994-12#1)(1994-2#4)(1994-3#5)(1994-4#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#18)(1996-5#4)(1996-7#2)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#2)(1997-6#1)(1997-8#1)(2004-9#2)(2005-11#2)(2005-12#1)(2005-8#3)(2005-9#1)(2006-10#7)(2006-12#3)(2006-2#4)(2006-4#4)(2006-5#1)(2006-6#2)(2006-8#4)(2007-10#6)(2007-11#4)(2007-12#1)(2007-2#6)(2007-3#3)(2007-4#3)(2007-5#7)(2007-6#1)(2007-7#5)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#18)(2008-11#1)(2008-12#7)(2008-2#3)(2008-3#1)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#10)(2008-9#2)(2009-12#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#3)(2010-1#3)(2010-10#1)(2010-11#4)(2010-12#4)(2010-2#20)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#9)(2010-9#2)(2011-1#8)(2011-12#3)(2011-2#8)(2012-1#2)(2012-12#10)(2012-2#11)(2012-3#21)(2013-1#20)(2013-7#7)(2013-8#16)
surveys]##2##1##(2011-1#1)(2013-8#1)
survivability of the##2##3##(1992-6#1)(2008-11#1)
survivability of##5##2##(1992-6#1)(2007-7#1)(2008-11#1)(2008-3#1)(2013-8#1)
survivability##15##1##(1992-6#1)(1994-5#1)(1996-12#5)(2007-6#1)(2007-7#1)(2008-11#1)(2008-3#4)(2013-8#1)
survival (DFS) and overall survival (OS)##3##6##(2007-3#1)(2008-6#1)(2009-4#1)
survival (DFS) and##4##3##(2007-3#1)(2008-5#1)(2008-6#1)(2009-4#1)
survival (DFS)##11##2##(2007-10#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-6#3)(2008-7#1)(2009-4#1)(2010-3#1)(2011-2#1)
survival (OS) for the##2##4##(2008-6#1)(2008-7#1)
survival (OS)##18##2##(1991-8#1)(1992-10#1)(1993-1#1)(2004-2#1)(2007-3#1)(2007-6#1)(2008-10#2)(2008-6#3)(2008-7#1)(2009-4#1)(2010-4#1)(2011-2#4)
survival (P = 0##4##4##(2008-6#1)(2010-7#2)(2013-1#1)
survival (P##5##2##(2008-6#1)(2010-7#2)(2012-3#1)(2013-1#1)
survival (P&lt##2##2##(2007-8#1)(2007-9#1)
survival (RFS)##3##2##(2008-6#1)(2011-2#2)
survival (median##3##2##(1993-10#1)(1993-9#1)(1996-9#1)
survival ability##3##2##(2008-10#2)(2013-8#1)
survival according to##2##3##(2006-8#1)(2012-12#1)
survival advantage for the##2##4##(2008-3#1)(2012-3#1)
survival advantage in GBM##2##4##(2009-4#2)
survival advantage in##11##3##(2006-6#1)(2008-1#1)(2008-3#1)(2009-4#4)(2013-8#4)
survival advantage of##2##3##(2007-12#1)(2007-9#1)
survival advantage was found with##2##5##(2008-7#2)
survival advantage was##3##3##(2008-7#2)(2012-1#1)
survival advantage##34##2##(1995-12#1)(1997-7#1)(2006-6#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#2)(2009-3#2)(2009-4#4)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#4)
survival advantages##2##2##(1992-8#1)(2009-10#1)
survival after PDT##3##3##(2008-5#3)
survival after cardiac##2##3##(2005-9#1)(2007-8#1)
survival after diagnosis##2##3##(1997-3#1)(2006-10#1)
survival after sleeve pneumonectomy combined with the superior vena cava##2##10##(2007-8#2)
survival after surgical treatment##2##4##(2007-11#1)(2007-8#1)
survival after treatment##2##3##(1993-8#1)(2006-12#1)
survival after##45##2##(1990-6#1)(1992-5#1)(1993-5#1)(1993-8#2)(1995-7#1)(1997-3#1)(1997-5#2)(2005-12#2)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-7#3)(2007-11#2)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#2)(2008-5#4)(2008-8#1)(2008-9#1)(2011-2#2)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
survival age##3##2##(1996-2#3)
survival among patients with##3##4##(2007-9#1)(2009-1#1)(2009-5#1)
survival among patients##4##3##(2007-9#1)(2009-1#1)(2009-2#1)(2009-5#1)
survival among women##2##3##(1991-6#1)(2012-12#1)
survival among##14##2##(1990-8#1)(1991-6#1)(1992-2#1)(1996-12#1)(2007-9#1)(2008-4#1)(2009-1#1)(2009-2#2)(2009-5#2)(2010-3#1)(2011-1#1)(2012-12#1)
survival analyses##2##2##(1992-6#1)(2008-2#1)
survival analysis and##2##3##(1993-9#1)(2013-1#1)
survival analysis in##2##3##(1996-2#1)(2008-10#1)
survival analysis was##3##3##(2007-1#1)(2009-5#1)(2011-2#1)
survival analysis##30##2##(1993-5#3)(1993-9#1)(1995-1#1)(1995-11#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-4#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-6#1)(2008-10#4)(2008-6#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#2)
survival and a significant##2##4##(1994-6#1)(2013-7#1)
survival and a##5##3##(1993-1#1)(1994-6#1)(2008-6#1)(2011-1#1)(2013-7#1)
survival and breeding##2##3##(2008-8#2)
survival and chlamydospore production##2##4##(2008-10#2)
survival and development of##2##4##(2008-4#1)(2010-2#1)
survival and development##5##3##(2008-4#1)(2010-2#1)(2013-7#3)
survival and differentiation of##3##4##(1996-12#1)(1996-3#1)(2010-11#1)
survival and differentiation##10##3##(1996-12#1)(1996-3#1)(1996-5#1)(1997-6#2)(2008-5#1)(2009-8#1)(2010-11#1)(2010-8#1)(2012-12#1)
survival and disease-free survival##2##4##(1992-8#1)(2011-2#1)
survival and disease-free##3##3##(1992-8#1)(1994-2#1)(2011-2#1)
survival and dispersal##2##3##(2004-11#2)
survival and efficacy##2##3##(2004-4#1)(2008-10#1)
survival and faster##2##3##(2007-3#1)(2011-12#1)
survival and formation of##2##4##(2008-11#1)(2012-1#1)
survival and function##5##3##(1991-5#1)(1996-6#1)(2009-3#1)(2010-11#2)
survival and functional##2##3##(1995-7#1)(2007-8#1)
survival and growth of##6##4##(1995-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
survival and growth##15##3##(1993-9#1)(1995-11#1)(2007-10#1)(2007-5#2)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#2)(2012-12#2)(2013-7#1)
survival and inactivation of##2##4##(2007-12#1)(2008-5#1)
survival and insufficient neuronal differentiation##2##5##(2009-10#2)
survival and its##2##3##(1994-5#1)(2013-8#1)
survival and low##2##3##(2008-1#1)(2011-2#1)
survival and maintenance##2##3##(1993-11#1)(2012-3#1)
survival and migration##2##3##(2005-8#1)(2010-12#1)
survival and mortality##2##3##(2004-2#1)(2007-8#1)
survival and overall survival##5##4##(2007-11#1)(2008-5#2)(2008-6#2)
survival and progression##2##3##(2008-10#1)(2012-12#1)
survival and proliferation of##4##4##(1992-8#1)(2008-5#1)(2008-9#1)(2011-2#1)
survival and proliferation##8##3##(1992-8#1)(2008-1#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-3#1)(2011-2#1)
survival and quality of life of the##2##7##(2007-11#1)(2011-3#1)
survival and quality of life of##4##6##(1990-10#1)(2007-11#1)(2008-7#1)(2011-3#1)
survival and quality of life##7##5##(1990-10#1)(2005-10#1)(2006-10#2)(2007-11#1)(2008-7#1)(2011-3#1)
survival and recurrence##3##3##(2006-9#1)(2007-2#1)(2008-8#1)
survival and renal##2##3##(1991-11#1)(2006-10#1)
survival and response##2##3##(2005-8#1)(2009-8#1)
survival and the##9##3##(1991-4#1)(1996-11#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-5#1)(2012-3#2)(2013-1#1)
survival and time to##2##4##(2008-10#1)(2008-8#1)
survival and to reduce##2##4##(1994-6#1)(2007-8#1)
survival and to##5##3##(1991-9#1)(1994-6#1)(2007-8#1)(2010-5#1)(2012-2#1)
survival and##222##2##(1990-10#1)(1990-12#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-4#1)(1992-8#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-9#3)(1994-2#1)(1994-5#3)(1994-6#2)(1995-11#1)(1995-2#1)(1995-7#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#1)(1996-6#1)(1997-6#2)(1997-7#1)(2004-11#2)(2004-2#3)(2004-4#2)(2005-10#1)(2005-8#3)(2006-10#4)(2006-6#3)(2006-7#2)(2006-9#1)(2007-10#4)(2007-11#5)(2007-12#1)(2007-2#1)(2007-3#2)(2007-5#4)(2007-8#4)(2008-1#4)(2008-10#14)(2008-11#5)(2008-4#3)(2008-5#8)(2008-6#6)(2008-7#6)(2008-8#7)(2008-9#3)(2009-10#3)(2009-3#2)(2009-8#2)(2010-1#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#3)(2010-7#4)(2010-8#3)(2010-9#2)(2011-1#4)(2011-12#2)(2011-2#11)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#3)(2012-3#4)(2013-1#5)(2013-7#6)(2013-8#3)
survival and/or##3##2##(1994-12#1)(1996-12#1)(2010-4#1)
survival are##8##2##(1993-4#1)(1997-2#1)(2007-6#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-3#1)(2011-1#1)
survival as##4##2##(1990-6#1)(1991-9#1)(2008-1#1)(2008-5#1)
survival at 1 year##2##4##(2007-10#1)(2007-11#1)
survival at 1##4##3##(2007-10#1)(2007-11#1)(2007-8#1)(2011-2#1)
survival at 36##2##3##(1995-8#1)(2008-6#1)
survival at 5 years of##2##5##(1991-2#1)(1994-6#1)
survival at 5 years was##2##5##(1990-2#1)(2008-6#1)
survival at 5 years##4##4##(1990-2#1)(1991-2#1)(1994-6#1)(2008-6#1)
survival at 5##5##3##(1990-2#1)(1991-2#1)(1994-6#1)(2006-10#1)(2008-6#1)
survival at different##2##3##(2004-11#1)(2008-11#1)
survival at the end of##3##5##(2008-10#1)(2008-7#1)(2011-2#1)
survival at three years##2##4##(1991-4#1)(2007-8#1)
survival at##30##2##(1990-2#1)(1990-5#1)(1991-2#1)(1991-4#2)(1993-4#1)(1994-6#1)(1995-8#1)(1995-9#1)(1996-3#1)(2004-11#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-8#4)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#2)(2008-7#1)(2008-9#1)(2011-2#3)
survival benefit for##2##3##(2006-7#1)(2008-10#1)
survival benefit in##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
survival benefit of##3##3##(1990-4#1)(2006-10#1)(2007-11#1)
survival benefit to##2##3##(2007-8#2)
survival benefit##22##2##(1990-4#1)(1993-1#1)(1995-10#1)(2004-2#1)(2006-10#2)(2006-7#1)(2007-11#1)(2007-8#2)(2008-10#3)(2008-3#1)(2010-12#1)(2010-8#1)(2011-3#1)(2012-3#1)(2013-1#4)
survival benefits##4##2##(2004-1#1)(2007-1#1)(2008-11#1)(2011-2#1)
survival between groups##2##3##(2008-6#1)(2011-1#1)
survival between the##4##3##(1996-9#1)(2007-8#1)(2010-3#1)(2011-2#1)
survival between##11##2##(1993-8#1)(1993-9#1)(1996-12#1)(1996-9#1)(2007-8#1)(2008-6#3)(2010-3#1)(2011-1#1)(2011-2#1)
survival beyond##3##2##(1995-12#1)(1997-4#1)(2009-12#1)
survival but also##2##3##(2007-11#1)(2011-2#1)
survival but##5##2##(2007-11#1)(2008-10#1)(2008-3#1)(2010-12#1)(2011-2#1)
survival by providing##2##3##(1994-10#1)(2008-11#1)
survival by##17##2##(1993-11#1)(1993-9#1)(1994-10#1)(1994-5#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-8#1)(2003-11#1)(2004-10#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-9#2)(2009-5#1)
survival can be achieved##2##4##(2007-12#1)(2007-3#1)
survival can be##5##3##(1995-5#1)(1997-3#1)(2007-12#1)(2007-3#1)(2013-1#1)
survival compared to##5##3##(1997-4#1)(2006-2#1)(2007-2#1)(2008-7#1)(2010-7#1)
survival compared with##3##3##(2008-3#1)(2008-7#1)(2010-3#1)
survival compared##8##2##(1997-4#1)(2006-2#1)(2007-2#1)(2008-3#1)(2008-7#2)(2010-3#1)(2010-7#1)
survival could be##2##3##(1990-6#1)(2010-11#1)
survival curve##9##2##(1995-3#4)(1996-1#2)(1997-4#1)(2008-8#2)
survival curves and##2##3##(2007-7#1)(2013-8#1)
survival curves associated with##2##4##(1992-2#2)
survival curves for##3##3##(1993-5#1)(2007-8#1)(2008-12#1)
survival curves of##2##3##(1995-1#1)(2012-2#1)
survival curves were##5##3##(1992-5#1)(2007-7#1)(2007-8#1)(2008-6#1)(2013-1#1)
survival curves with##2##3##(1995-3#1)(1995-8#1)
survival curves##29##2##(1991-4#2)(1992-2#2)(1992-5#1)(1993-5#2)(1995-1#2)(1995-3#3)(1995-8#2)(2007-7#2)(2007-8#2)(2008-12#2)(2008-6#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
survival data in##3##3##(1997-3#1)(2012-2#1)(2012-3#1)
survival data of##2##3##(1992-2#1)(2009-5#1)
survival data##26##2##(1990-2#1)(1990-4#1)(1992-2#2)(1994-4#1)(1994-6#2)(1995-12#1)(1995-4#1)(1995-8#3)(1997-3#2)(1997-7#1)(2005-7#1)(2009-5#1)(2010-10#1)(2010-4#1)(2010-7#1)(2010-8#1)(2012-2#4)(2012-3#1)
survival declined##2##2##(2004-11#1)(2008-10#1)
survival depends on##2##3##(2008-8#1)(2011-3#1)
survival depends##3##2##(1996-12#1)(2008-8#1)(2011-3#1)
survival difference between##2##3##(2007-7#1)(2008-6#1)
survival difference##3##2##(2007-7#1)(2008-6#1)(2011-12#1)
survival distribution##5##2##(1995-12#1)(1995-9#3)(2012-2#1)
survival due to##2##3##(1991-12#1)(2012-3#1)
survival during development##2##3##(1996-3#2)
survival during the##6##3##(1994-2#1)(2008-6#1)(2009-10#1)(2010-11#1)(2010-8#1)(2013-1#1)
survival during##19##2##(1994-2#1)(1995-12#1)(1995-2#1)(1996-3#2)(1997-6#1)(2008-11#1)(2008-6#2)(2008-7#1)(2008-8#3)(2009-10#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
survival dynamics##2##2##(2012-2#2)
survival effects##2##2##(2008-7#1)(2009-8#1)
survival estimates##3##2##(1992-10#1)(2008-7#1)(2010-3#1)
survival expectancies##2##2##(2010-3#1)(2011-2#1)
survival factor##4##2##(1993-11#1)(2008-11#1)(2009-8#1)(2010-11#1)
survival factors for##2##3##(1996-3#2)
survival factors##5##2##(1996-3#3)(2008-6#1)(2009-3#1)
survival following surgical resection##2##4##(2004-1#2)
survival following##11##2##(1994-5#1)(1995-4#1)(2004-1#2)(2005-8#1)(2006-7#1)(2007-1#1)(2008-10#1)(2009-5#1)(2011-2#1)(2013-1#1)
survival for men##2##3##(2006-7#2)
survival for patients in##2##4##(1990-8#1)(2006-8#1)
survival for patients with metastatic##2##5##(2006-9#1)(2009-2#1)
survival for patients with##8##4##(1996-4#2)(2006-9#1)(2007-10#1)(2008-3#2)(2009-2#1)(2011-2#1)
survival for patients##15##3##(1990-8#1)(1996-4#2)(2006-10#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-6#1)(2009-2#1)(2010-12#1)(2011-2#1)
survival for selected patients##2##4##(2006-10#1)(2010-12#1)
survival for the entire##2##4##(2008-6#2)
survival for the##4##3##(2008-1#1)(2008-6#2)(2008-8#1)
survival for those##2##3##(1992-2#1)(2011-2#1)
survival for##44##2##(1990-6#1)(1990-8#2)(1992-2#1)(1993-5#1)(1996-4#2)(2004-1#1)(2005-1#2)(2006-10#3)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2010-12#3)(2010-3#2)(2011-2#4)(2012-2#1)(2013-1#1)
survival free of##4##3##(1994-7#1)(2004-11#1)(2007-10#1)(2013-8#1)
survival from the##3##3##(2005-7#1)(2008-7#1)(2013-1#1)
survival from##9##2##(1992-2#1)(1993-1#1)(2005-7#1)(2006-10#2)(2007-11#1)(2008-7#2)(2013-1#1)
survival function in##2##3##(2008-10#1)(2010-2#1)
survival function of##2##3##(1995-12#1)(2008-3#1)
survival function##11##2##(1995-12#1)(1996-1#1)(2008-10#2)(2008-3#2)(2010-2#1)(2010-8#1)(2012-2#2)(2013-1#1)
survival has been##4##3##(1992-10#1)(2006-10#1)(2009-11#1)(2010-3#1)
survival has improved##2##3##(2006-10#1)(2007-7#1)
survival has increased to##2##4##(2006-10#1)(2009-3#1)
survival has##12##2##(1992-10#1)(1997-6#1)(2006-10#4)(2007-7#1)(2008-5#1)(2009-11#1)(2009-3#1)(2010-12#1)(2010-3#1)
survival have##3##2##(1991-1#1)(2007-11#1)(2008-1#1)
survival improvement##3##2##(2007-11#1)(2010-3#1)(2013-1#1)
survival in a##7##3##(1994-12#1)(1995-2#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-5#1)(2013-1#1)
survival in an##2##3##(1990-12#1)(2008-5#1)
survival in both##4##3##(1997-4#1)(2008-5#1)(2011-1#1)(2012-2#1)
survival in children##2##3##(2006-8#2)
survival in chronic##3##3##(2009-3#1)(2010-12#1)(2013-1#1)
survival in comparison with##2##4##(2008-3#1)(2011-3#1)
survival in each##2##3##(2007-8#1)(2010-7#1)
survival in metastatic##2##3##(1991-4#1)(2008-3#1)
survival in mice following##2##4##(1995-2#1)(2007-11#1)
survival in mice##3##3##(1995-2#1)(2007-11#1)(2008-4#1)
survival in our##3##3##(1990-8#1)(1991-10#1)(2008-9#1)
survival in patients treated##2##4##(2007-8#1)(2008-1#1)
survival in patients who##2##4##(2007-8#1)(2011-1#1)
survival in patients with advanced##2##5##(2008-7#1)(2009-8#1)
survival in patients with both##2##5##(2009-12#1)(2010-12#1)
survival in patients with##23##4##(1996-4#1)(1997-3#1)(1997-5#1)(1997-7#1)(2004-1#2)(2006-10#2)(2006-2#1)(2006-8#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-6#1)(2011-2#3)(2013-7#1)
survival in patients##32##3##(1994-7#1)(1996-4#1)(1997-3#1)(1997-5#1)(1997-7#1)(2004-1#2)(2005-12#2)(2006-10#2)(2006-2#1)(2006-8#1)(2007-8#2)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-6#1)(2011-1#1)(2011-2#4)(2013-7#1)
survival in rat##2##3##(1995-12#1)(2012-1#1)
survival in rats##2##3##(1991-3#1)(1995-2#1)
survival in the developing##2##4##(1996-1#1)(1996-3#1)
survival in the group##2##4##(2004-10#1)(2010-12#1)
survival in the##23##3##(1994-6#1)(1996-1#1)(1996-3#1)(2004-1#1)(2004-10#1)(2004-11#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2009-6#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-1#2)(2012-2#1)(2013-1#2)
survival in these##3##3##(1996-3#1)(2004-10#1)(2008-10#1)
survival in this disease##2##4##(1996-12#1)(2010-5#1)
survival in this##4##3##(1991-11#1)(1996-12#1)(2008-1#1)(2010-5#1)
survival in vitro##4##3##(2008-10#1)(2008-5#1)(2012-2#2)
survival in vivo##2##3##(1991-3#1)(2010-12#1)
survival in##193##2##(1990-12#1)(1990-3#1)(1990-8#2)(1991-10#1)(1991-11#1)(1991-3#4)(1991-4#2)(1991-7#1)(1992-8#1)(1993-4#1)(1994-12#2)(1994-4#1)(1994-6#1)(1994-7#2)(1995-10#1)(1995-12#2)(1995-2#6)(1996-1#3)(1996-12#5)(1996-3#2)(1996-4#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(2004-1#4)(2004-10#3)(2004-11#1)(2004-2#1)(2005-12#2)(2006-10#5)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-10#2)(2007-11#5)(2007-4#1)(2007-5#1)(2007-6#3)(2007-8#9)(2007-9#1)(2008-1#5)(2008-10#3)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#6)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-11#2)(2010-12#7)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#11)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#7)(2013-7#1)
survival included##2##2##(2007-9#1)(2011-2#1)
survival index##5##2##(2008-10#5)
survival information for##2##3##(1995-8#2)
survival inside##2##2##(2008-10#1)(2011-1#1)
survival is less than##2##4##(2008-5#1)(2008-7#1)
survival is not##2##3##(1990-6#1)(2008-6#1)
survival is only##2##3##(2009-5#1)(2010-10#1)
survival is still##3##3##(1993-2#1)(2007-5#1)(2011-3#1)
survival is the##2##3##(1990-10#1)(1995-6#1)
survival is usually##2##3##(1997-6#1)(2007-2#1)
survival is##53##2##(1990-10#1)(1990-6#1)(1990-9#1)(1991-1#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-5#1)(1994-12#2)(1994-2#2)(1994-5#2)(1995-6#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-6#1)(2004-11#1)(2006-10#5)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2011-3#3)(2012-2#1)
survival kinetics##2##2##(1992-12#1)(1994-6#1)
survival level at the end of irradiation##2##7##(2008-9#2)
survival may##3##2##(2007-1#1)(2008-1#1)(2010-4#1)
survival mechanism##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
survival mechanisms that##2##3##(2008-1#1)(2010-12#1)
survival model##9##2##(1992-6#1)(1994-2#1)(1995-6#1)(1996-12#2)(1997-2#1)(1997-8#1)(2010-8#1)(2013-1#1)
survival models##8##2##(1992-9#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-8#1)(2008-9#1)(2012-3#1)(2013-8#1)
survival motor##2##2##(2009-10#2)
survival observed in##2##3##(2007-8#1)(2013-8#1)
survival observed##3##2##(2007-8#1)(2008-6#1)(2013-8#1)
survival of 3 to##2##4##(2012-12#2)
survival of ELBW infants##2##4##(2006-7#1)(2006-8#1)
survival of Fusarium##2##3##(2008-10#2)
survival of P##4##3##(2004-11#1)(2008-10#3)
survival of Verticillium dahliae##2##4##(2008-12#2)
survival of a##4##3##(2007-9#1)(2008-10#2)(2009-2#1)
survival of all##2##3##(1995-3#1)(2011-2#1)
survival of an##2##3##(2007-2#1)(2010-10#1)
survival of approximately##2##3##(2007-10#1)(2008-5#1)
survival of both##4##3##(1996-3#1)(1997-7#1)(2010-4#1)(2012-12#1)
survival of catheters##2##3##(2007-7#2)
survival of cells##2##3##(1993-8#1)(2008-9#1)
survival of certain populations of neurons##2##6##(1996-3#1)(2008-5#1)
survival of children with##2##4##(2008-6#1)(2012-12#1)
survival of cultured neurons and##2##5##(1994-5#1)(1995-5#1)
survival of cultured##5##3##(1994-5#1)(1995-5#1)(1996-3#1)(1996-5#1)(2013-7#1)
survival of developing##2##3##(1995-12#1)(1996-3#1)
survival of dogs##2##3##(2012-1#1)(2012-3#1)
survival of elderly##3##3##(2012-2#3)
survival of experimental animals##2##4##(2006-8#1)(2010-12#1)
survival of exposed##5##3##(2008-9#5)
survival of fish##3##3##(2010-8#3)
survival of free##2##3##(2008-9#1)(2013-8#1)
survival of inoculated##2##3##(2008-10#1)(2008-5#1)
survival of lethally irradiated mice##2##5##(2008-5#2)
survival of living##2##3##(2006-10#1)(2009-8#1)
survival of mice fed##3##4##(2006-10#1)(2006-8#2)
survival of mice##6##3##(2006-10#1)(2006-8#4)(2007-12#1)
survival of microsclerotia##2##3##(2008-10#2)
survival of more than##2##4##(1990-10#1)(1996-11#1)
survival of neurons and##2##4##(1996-2#2)
survival of neurons##9##3##(1991-11#1)(1991-3#1)(1992-8#1)(1993-3#1)(1995-3#1)(1996-2#2)(2008-4#1)(2013-8#1)
survival of patients with a##2##5##(2007-8#1)(2008-6#1)
survival of patients with chronic##2##5##(2006-10#1)(2008-5#1)
survival of patients with glioblastoma##2##5##(1994-4#1)(2008-11#1)
survival of patients with multiple##2##5##(1990-9#1)(2005-1#1)
survival of patients with##28##4##(1990-9#1)(1994-4#2)(1994-6#1)(2004-1#2)(2005-1#1)(2006-10#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-4#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
survival of patients##36##3##(1990-9#1)(1993-8#1)(1994-4#2)(1994-6#1)(2004-1#2)(2005-1#1)(2006-10#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-4#1)(2010-12#3)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
survival of rat##4##3##(1993-11#1)(1993-4#1)(1994-5#1)(1995-3#1)
survival of responders##2##3##(1990-10#1)(1990-2#1)
survival of selected pathogenic bacteria in##3##6##(1997-4#3)
survival of the baby##2##4##(1993-5#1)(2006-2#1)
survival of the cells##3##4##(2008-11#3)
survival of the microorganism##2##4##(1993-3#1)(2011-1#1)
survival of the pathogen##3##4##(2008-10#1)(2011-2#1)(2013-7#1)
survival of the patient##2##4##(1991-9#1)(1992-6#1)
survival of the patients was##2##5##(1993-9#1)(2008-7#1)
survival of the patients##5##4##(1993-9#1)(2006-8#2)(2008-1#1)(2008-7#1)
survival of the whole##2##4##(2008-6#1)(2008-8#1)
survival of the##62##3##(1990-2#1)(1990-8#1)(1991-9#1)(1992-4#1)(1992-6#1)(1993-10#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-12#1)(1995-12#1)(1996-11#1)(1996-12#1)(1997-3#1)(2004-4#2)(2006-10#1)(2006-2#1)(2006-8#5)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
survival of these patients##3##4##(1993-2#1)(2008-10#1)(2012-2#1)
survival of these##5##3##(1993-2#1)(2005-12#1)(2007-10#1)(2008-10#1)(2012-2#1)
survival of this##3##3##(1994-12#1)(1995-8#1)(2011-1#1)
survival of those##3##3##(2008-1#1)(2008-5#1)(2010-5#1)
survival of tumor-bearing mice##2##4##(1992-7#1)(2008-3#1)
survival of two##3##3##(1991-5#1)(2004-4#1)(2008-10#1)
survival of up to##3##4##(1992-6#2)(1996-1#1)
survival of##414##2##(1990-10#2)(1990-12#1)(1990-2#3)(1990-3#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#8)(1991-4#3)(1991-5#1)(1991-6#1)(1991-9#1)(1992-3#2)(1992-4#2)(1992-6#4)(1992-7#1)(1992-8#5)(1992-9#2)(1993-10#1)(1993-11#7)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#3)(1993-9#3)(1994-10#1)(1994-12#2)(1994-2#1)(1994-4#2)(1994-5#4)(1994-6#2)(1995-1#1)(1995-12#4)(1995-2#4)(1995-3#3)(1995-5#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-11#3)(1996-12#2)(1996-2#3)(1996-3#4)(1996-5#2)(1997-3#2)(1997-4#3)(1997-6#2)(1997-7#1)(2004-1#5)(2004-11#1)(2004-2#2)(2004-4#3)(2005-1#1)(2005-11#2)(2005-12#2)(2006-10#7)(2006-12#1)(2006-2#2)(2006-5#2)(2006-6#3)(2006-7#4)(2006-8#12)(2007-10#2)(2007-11#5)(2007-12#6)(2007-2#3)(2007-3#3)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#4)(2007-9#3)(2008-1#6)(2008-10#38)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#17)(2008-6#7)(2008-7#3)(2008-8#7)(2008-9#15)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-8#5)(2010-10#2)(2010-11#1)(2010-12#10)(2010-3#3)(2010-4#1)(2010-5#2)(2010-8#6)(2011-1#6)(2011-12#4)(2011-2#16)(2012-1#2)(2012-12#8)(2012-2#10)(2012-3#5)(2012-5#1)(2013-1#8)(2013-7#2)(2013-8#9)
survival on a##2##3##(1996-3#1)(2010-2#1)
survival on bone slices##2##4##(1993-9#1)(1994-3#1)
survival on##8##2##(1993-9#1)(1994-3#1)(1994-4#1)(1996-3#1)(2007-6#1)(2010-2#1)(2010-8#1)(2012-2#1)
survival only##2##2##(2007-11#1)(2008-5#1)
survival or function##2##3##(1995-2#2)
survival or the##2##3##(1990-11#1)(2008-8#1)
survival or##19##2##(1990-11#1)(1990-8#1)(1992-2#1)(1995-2#3)(2004-1#1)(2004-2#1)(2006-12#1)(2007-5#1)(2008-1#1)(2008-8#4)(2008-9#3)(2009-3#1)
survival outcome##2##2##(2007-11#1)(2012-12#1)
survival outcomes##5##2##(2006-6#1)(2009-3#1)(2010-1#1)(2012-3#1)(2013-1#1)
survival over##2##2##(2008-10#1)(2008-6#1)
survival overall##3##2##(1992-10#1)(2011-2#2)
survival pathway##5##2##(2009-7#2)(2011-2#3)
survival pathways##2##2##(2006-9#1)(2008-1#1)
survival period of##4##3##(2006-6#1)(2008-6#2)(2008-7#1)
survival period was##2##3##(2007-11#2)
survival period##9##2##(2005-2#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-6#2)(2008-7#1)(2012-3#1)
survival periods##3##2##(1995-4#1)(1997-8#1)(2011-2#1)
survival predictions##2##2##(1992-9#2)
survival probabilities##6##2##(1996-2#1)(2007-9#1)(2009-10#3)(2012-3#1)
survival probability and##2##3##(2007-9#2)
survival probability in##2##3##(1994-10#1)(2011-2#1)
survival probability of##2##3##(2008-6#2)
survival probability##14##2##(1994-10#3)(1995-9#1)(2007-9#6)(2008-6#2)(2011-2#1)(2013-1#1)
survival rate after##5##3##(1990-12#1)(1993-8#1)(2007-9#1)(2010-12#1)(2010-3#1)
survival rate and the##2##4##(1995-10#1)(2007-12#1)
survival rate and##7##3##(1995-10#1)(1997-7#1)(2004-1#1)(2006-10#1)(2007-12#1)(2012-12#1)(2013-1#1)
survival rate at##5##3##(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-11#1)
survival rate between the##2##4##(1995-10#1)(1996-3#1)
survival rate between##3##3##(1990-6#1)(1995-10#1)(1996-3#1)
survival rate following##2##3##(2006-6#1)(2008-6#1)
survival rate for all##2##4##(2005-5#1)(2012-1#1)
survival rate for##13##3##(1990-3#1)(2004-1#1)(2005-5#1)(2005-9#1)(2007-9#2)(2008-6#2)(2008-9#1)(2009-10#1)(2010-3#1)(2012-1#1)(2012-2#1)
survival rate in##6##3##(1991-10#1)(1994-7#1)(1995-2#1)(2008-10#1)(2011-2#1)(2013-1#1)
survival rate is##5##3##(1991-6#1)(1996-6#1)(2004-1#1)(2007-11#1)(2013-8#1)
survival rate nor##3##3##(1990-8#1)(1997-7#2)
survival rate of the##5##4##(2006-7#1)(2007-11#1)(2007-7#1)(2008-11#1)(2012-3#1)
survival rate of##29##3##(1990-12#1)(1991-12#1)(1994-6#1)(2004-1#2)(2006-6#1)(2006-7#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-5#1)(2008-6#2)(2008-9#1)(2009-3#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-11#2)(2012-3#1)(2013-1#1)
survival rate using##2##3##(2008-8#2)
survival rate was 59##2##4##(1995-10#1)(1997-7#1)
survival rate was 88%##2##4##(1991-2#1)(1991-6#1)
survival rate was##36##3##(1990-12#1)(1990-6#1)(1990-9#1)(1991-2#2)(1991-6#1)(1992-10#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-9#1)(1995-10#1)(1997-7#4)(2007-1#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#4)(2008-10#1)(2008-6#2)(2008-7#1)(2008-8#1)(2011-2#4)(2013-1#2)
survival rate##161##2##(1990-12#3)(1990-3#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#3)(1991-6#2)(1992-10#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-7#2)(1995-10#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-3#1)(1996-6#2)(1997-7#9)(1997-8#1)(2004-1#5)(2005-5#1)(2005-9#1)(2006-10#3)(2006-6#3)(2006-7#3)(2007-1#1)(2007-11#6)(2007-12#4)(2007-2#3)(2007-3#2)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#7)(2007-9#3)(2008-1#1)(2008-10#5)(2008-11#6)(2008-5#3)(2008-6#8)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-3#1)(2010-12#3)(2010-2#1)(2010-3#3)(2010-8#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
survival rates after##3##3##(2006-10#1)(2007-11#1)(2010-3#1)
survival rates and##2##3##(2011-12#1)(2011-2#1)
survival rates are##7##3##(2007-11#1)(2008-1#1)(2008-9#1)(2011-2#3)(2012-2#1)
survival rates as##3##3##(1994-7#1)(2006-5#1)(2012-3#1)
survival rates at 5##2##4##(1994-12#1)(2007-8#1)
survival rates between the two##2##5##(1995-4#1)(1996-3#1)
survival rates between the##3##4##(1995-4#1)(1996-3#1)(2007-8#1)
survival rates between##5##3##(1995-10#1)(1995-4#1)(1996-3#1)(2006-10#1)(2007-8#1)
survival rates following##2##3##(1993-3#1)(2007-5#1)
survival rates for patients with##3##5##(2007-7#1)(2010-11#1)(2011-2#1)
survival rates for patients##4##4##(2007-7#1)(2009-2#1)(2010-11#1)(2011-2#1)
survival rates for##12##3##(2004-1#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-2#1)(2010-11#2)(2011-2#3)
survival rates from##3##3##(2008-12#1)(2011-2#2)
survival rates have been##2##4##(1997-6#1)(2008-6#1)
survival rates have##4##3##(1997-6#1)(2008-6#1)(2010-7#1)(2011-2#1)
survival rates in##6##3##(1990-9#1)(1997-7#1)(2008-10#1)(2011-2#2)(2013-1#1)
survival rates of patients##2##4##(2006-10#1)(2007-11#1)
survival rates of##12##3##(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#4)(2012-2#1)
survival rates were 86##2##4##(2006-6#2)
survival rates were##12##3##(1990-8#1)(1991-8#1)(2005-11#1)(2006-6#2)(2008-1#2)(2008-3#1)(2009-2#1)(2011-2#2)(2012-1#1)
survival rates##113##2##(1990-10#1)(1990-8#1)(1990-9#3)(1991-8#1)(1993-3#1)(1994-12#2)(1994-7#1)(1994-9#3)(1995-10#1)(1995-4#1)(1996-3#1)(1996-6#1)(1997-6#2)(1997-7#1)(2004-1#1)(2005-11#1)(2006-10#7)(2006-5#1)(2006-6#2)(2007-11#3)(2007-5#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#5)(2009-10#2)(2009-2#2)(2010-11#2)(2010-3#2)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#21)(2012-1#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
survival remain##2##2##(2008-8#1)(2010-11#1)
survival remains to be##2##4##(2006-11#1)(2007-8#1)
survival results##3##2##(1991-4#1)(1997-6#1)(2007-8#1)
survival setting##2##2##(1997-2#1)(2013-1#1)
survival sex work##3##3##(2008-12#3)
survival should persuade the anaesthetist to proceed with general anaesthesia for caesarean section after failed intubation##2##16##(1993-4#2)
survival should##4##2##(1993-4#2)(2005-10#1)(2006-7#1)
survival showed##3##2##(1994-7#1)(1996-12#1)(2007-8#1)
survival signal##4##2##(1994-3#1)(2009-3#3)
survival signals##5##2##(1996-1#3)(2010-12#1)(2013-7#1)
survival significantly##4##2##(2006-12#1)(2008-10#2)(2013-8#1)
survival status##3##2##(1993-1#1)(2007-2#1)(2011-12#1)
survival strategies##6##2##(1990-12#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-12#1)(2012-2#1)
survival strategy##3##2##(2007-3#1)(2009-10#1)(2013-8#1)
survival studies##4##2##(1994-12#1)(1994-2#2)(1996-2#1)
survival study##2##2##(1993-1#1)(2013-1#1)
survival substantially##2##2##(2008-8#1)(2009-10#1)
survival than those with##2##4##(2007-8#1)(2013-1#1)
survival than those##3##3##(2007-8#1)(2010-12#1)(2013-1#1)
survival than##13##2##(1990-2#1)(1991-11#1)(1995-9#1)(2004-1#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-10#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
survival that##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
survival through##3##2##(1994-5#1)(2008-11#1)(2010-12#1)
survival time after surgery was##2##5##(2007-11#1)(2007-12#1)
survival time after##6##3##(1990-9#1)(2007-11#1)(2007-12#1)(2010-12#1)(2012-3#2)
survival time and##2##3##(1996-12#1)(2008-7#1)
survival time data##2##3##(1996-12#1)(1996-2#1)
survival time for##2##3##(1997-4#2)
survival time from##2##3##(1990-10#1)(1992-4#1)
survival time in the##2##4##(2006-12#1)(2007-11#1)
survival time is##4##3##(1992-9#1)(1994-2#1)(2007-11#1)(2007-8#1)
survival time of patients irradiated due to bone metastases##2##9##(2007-11#2)
survival time of patients##4##4##(2007-11#3)(2008-7#1)
survival time of the##2##4##(1995-11#1)(1997-5#1)
survival time of two##2##4##(2013-1#2)
survival time of##19##3##(1990-9#1)(1991-10#1)(1992-3#1)(1995-11#1)(1996-1#1)(1997-5#1)(2007-11#4)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-12#2)(2013-1#2)
survival time or##4##3##(1990-10#1)(1991-11#1)(2006-12#1)(2009-9#1)
survival time was 17##2##4##(2007-7#1)(2008-10#1)
survival time was 30 months##2##5##(1992-10#1)(2008-8#1)
survival time was 7##2##4##(1991-2#1)(1994-8#1)
survival time was##18##3##(1990-10#1)(1990-9#1)(1991-2#1)(1992-10#1)(1994-8#1)(2006-12#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-10#1)(2008-8#2)(2009-10#1)(2012-1#1)(2013-1#1)(2013-8#1)
survival time##87##2##(1990-10#3)(1990-12#1)(1990-9#3)(1991-10#1)(1991-11#1)(1991-2#2)(1992-10#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#1)(1994-2#2)(1994-8#1)(1995-11#1)(1995-12#4)(1996-1#2)(1996-12#3)(1996-2#1)(1997-4#2)(1997-5#1)(2004-1#1)(2006-12#7)(2007-11#12)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-3#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-4#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-12#2)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#4)(2013-8#1)
survival times for patients with##2##5##(2006-2#1)(2013-8#1)
survival times for##3##3##(2006-2#1)(2007-9#1)(2013-8#1)
survival times in##2##3##(2008-8#1)(2012-12#1)
survival times##21##2##(1991-9#1)(1992-8#1)(1994-2#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(2006-2#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-8#2)
survival tips##2##2##(1997-1#1)(2010-3#1)
survival to the##2##3##(1991-12#1)(2007-5#1)
survival to##23##2##(1991-12#1)(1992-2#1)(1993-11#1)(1993-8#1)(1995-2#2)(2004-10#1)(2005-7#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-8#2)(2008-9#1)(2010-3#1)(2010-7#2)(2011-12#1)(2011-2#1)(2011-9#1)(2012-2#1)(2012-3#1)
survival trends##2##2##(2008-7#1)(2010-8#1)
survival under adverse conditions##2##4##(2007-12#1)(2008-11#1)
survival under##8##2##(1994-3#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-7#1)(2012-3#1)
survival up to##2##3##(2008-5#2)
survival using##2##2##(2007-7#1)(2007-8#1)
survival was 10 months##2##4##(1990-8#1)(2008-6#1)
survival was 11 months##4##4##(1991-12#1)(1991-6#1)(1993-2#1)(2008-6#1)
survival was 12##2##3##(2006-6#1)(2010-12#1)
survival was 14 months##2##4##(2008-6#1)(2010-12#1)
survival was 14##3##3##(2006-6#1)(2008-6#1)(2010-12#1)
survival was 15 months##2##4##(1992-4#1)(2008-6#1)
survival was 17##2##3##(2007-8#1)(2008-10#1)
survival was 19##2##3##(1997-3#1)(2011-2#1)
survival was 21##2##3##(2008-5#1)(2008-6#1)
survival was 22##2##3##(1995-8#1)(2006-6#1)
survival was 30%##2##3##(1991-6#1)(2006-8#1)
survival was 36##2##3##(1990-10#1)(2011-2#1)
survival was 4##3##3##(1990-10#1)(1991-12#1)(2008-6#1)
survival was 6##3##3##(1993-6#1)(1997-7#1)(2012-2#1)
survival was 8 months##2##4##(1990-2#1)(2006-6#1)
survival was 8##3##3##(1990-2#1)(2006-6#1)(2013-1#1)
survival was detected##3##3##(1993-1#1)(2008-9#1)(2011-2#1)
survival was estimated##2##3##(2007-8#1)(2008-5#1)
survival was greater##2##3##(2005-2#1)(2008-10#1)
survival was investigated in##2##4##(1993-4#1)(2008-7#1)
survival was investigated##3##3##(1992-12#1)(1993-4#1)(2008-7#1)
survival was monitored##2##3##(2006-8#2)
survival was not##2##3##(2004-2#1)(2006-6#1)
survival was reduced##3##3##(1992-6#1)(2008-6#1)(2008-7#1)
survival was seen in##3##4##(1992-4#1)(2007-6#1)(2012-3#1)
survival was seen##4##3##(1992-12#1)(1992-4#1)(2007-6#1)(2012-3#1)
survival was significantly##6##3##(1990-10#1)(1990-4#1)(2006-8#1)(2007-8#1)(2008-6#1)(2008-7#1)
survival was##141##2##(1990-10#4)(1990-12#2)(1990-2#1)(1990-4#1)(1990-8#2)(1991-12#2)(1991-2#1)(1991-6#5)(1991-8#3)(1992-10#1)(1992-12#6)(1992-4#2)(1992-5#2)(1992-6#1)(1993-1#2)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-11#1)(2004-2#1)(2005-1#1)(2005-2#1)(2006-10#1)(2006-6#7)(2006-7#3)(2006-8#4)(2007-11#1)(2007-6#2)(2007-7#1)(2007-8#9)(2008-1#5)(2008-10#4)(2008-5#3)(2008-6#17)(2008-7#3)(2008-9#6)(2010-12#3)(2010-3#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#2)
survival were also##2##3##(2012-2#1)(2013-1#1)
survival were lower##2##3##(2006-7#1)(2011-2#1)
survival were##30##2##(1990-12#1)(1990-6#2)(1991-4#1)(1996-12#1)(2006-10#1)(2006-6#3)(2006-7#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-6#3)(2010-3#1)(2010-7#1)(2011-1#1)(2011-11#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
survival when##6##2##(1995-6#1)(2008-10#1)(2008-5#3)(2011-12#1)
survival which##3##2##(2004-10#1)(2008-8#1)(2012-1#1)
survival with an##2##3##(1992-9#1)(2006-10#1)
survival with the##2##3##(2008-5#1)(2013-8#1)
survival with##17##2##(1990-8#1)(1992-2#1)(1992-9#1)(1993-2#1)(2005-12#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-12#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-8#1)
survival without brain damage##2##4##(2006-10#2)
survival without recurrence##2##3##(1996-6#1)(2007-8#1)
survival without##5##2##(1996-6#1)(2006-10#2)(2006-2#1)(2007-8#1)
survival##2963##1##(1990-10#14)(1990-11#1)(1990-12#14)(1990-2#10)(1990-3#3)(1990-4#4)(1990-5#2)(1990-6#11)(1990-8#15)(1990-9#12)(1991-1#3)(1991-10#7)(1991-11#7)(1991-12#11)(1991-2#10)(1991-3#14)(1991-4#14)(1991-5#3)(1991-6#11)(1991-7#4)(1991-8#11)(1991-9#5)(1992-10#8)(1992-12#8)(1992-2#12)(1992-3#4)(1992-4#6)(1992-5#5)(1992-6#7)(1992-7#3)(1992-8#12)(1992-9#10)(1993-1#14)(1993-10#5)(1993-11#17)(1993-12#1)(1993-2#9)(1993-3#5)(1993-4#11)(1993-5#12)(1993-6#1)(1993-7#3)(1993-8#8)(1993-9#14)(1994-1#1)(1994-10#5)(1994-12#16)(1994-2#11)(1994-3#5)(1994-4#6)(1994-5#19)(1994-6#14)(1994-7#8)(1994-8#1)(1994-9#4)(1995-1#6)(1995-10#8)(1995-11#4)(1995-12#27)(1995-2#26)(1995-3#12)(1995-4#6)(1995-5#2)(1995-6#4)(1995-7#3)(1995-8#18)(1995-9#12)(1996-1#14)(1996-11#9)(1996-12#27)(1996-2#11)(1996-3#28)(1996-4#4)(1996-5#9)(1996-6#6)(1996-8#1)(1996-9#5)(1997-1#2)(1997-2#8)(1997-3#11)(1997-4#15)(1997-5#7)(1997-6#14)(1997-7#20)(1997-8#6)(1997-9#1)(2003-11#1)(2004-1#26)(2004-10#7)(2004-11#11)(2004-2#10)(2004-4#5)(2005-1#4)(2005-10#3)(2005-11#3)(2005-12#8)(2005-2#2)(2005-5#1)(2005-7#5)(2005-8#8)(2005-9#2)(2006-1#3)(2006-10#70)(2006-11#1)(2006-12#14)(2006-2#11)(2006-4#2)(2006-5#6)(2006-6#45)(2006-7#27)(2006-8#28)(2006-9#8)(2007-1#6)(2007-10#19)(2007-11#78)(2007-12#22)(2007-2#18)(2007-3#14)(2007-4#4)(2007-5#21)(2007-6#17)(2007-7#22)(2007-8#86)(2007-9#30)(2008-1#47)(2008-10#134)(2008-11#42)(2008-12#12)(2008-2#6)(2008-3#26)(2008-4#23)(2008-5#80)(2008-6#107)(2008-7#86)(2008-8#61)(2008-9#56)(2009-1#2)(2009-10#25)(2009-11#5)(2009-12#5)(2009-2#9)(2009-3#23)(2009-4#12)(2009-5#12)(2009-6#5)(2009-7#5)(2009-8#20)(2009-9#3)(2010-1#4)(2010-10#10)(2010-11#16)(2010-12#49)(2010-2#9)(2010-3#34)(2010-4#8)(2010-5#10)(2010-6#3)(2010-7#19)(2010-8#24)(2010-9#2)(2011-1#32)(2011-11#3)(2011-12#18)(2011-2#156)(2011-3#11)(2011-9#2)(2012-1#18)(2012-11#3)(2012-12#35)(2012-2#70)(2012-3#48)(2012-5#2)(2012-7#1)(2013-1#84)(2013-7#20)(2013-8#41)
survival&quot##4##1##(2007-8#1)(2008-8#3)
survival)##6##1##(1992-6#1)(2007-11#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-2#1)
survival-adjusted##2##1##(2008-7#2)
survival/proliferation##2##1##(2009-10#1)(2009-3#1)
survival?##6##1##(1995-3#1)(1995-9#1)(2007-7#1)(2007-8#1)(2008-7#1)(2010-9#1)
survival]##2##1##(1995-5#1)(2008-5#1)
survivals for IgAN RTX were##2##5##(2008-8#2)
survivals for##4##2##(1993-4#1)(2008-8#2)(2011-2#1)
survivals were##2##2##(2006-6#1)(2008-8#1)
survivals##8##1##(1993-4#1)(2006-6#1)(2008-8#3)(2011-2#2)(2013-1#1)
survive acute##2##2##(1994-8#1)(2013-7#1)
survive an##2##2##(2007-10#1)(2007-2#1)
survive and thrive##2##3##(1994-12#1)(1997-1#1)
survive and##13##2##(1990-2#1)(1992-3#1)(1994-12#1)(1995-12#1)(1997-1#1)(1997-4#1)(2004-4#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-5#1)(2013-1#2)
survive as##3##2##(1996-3#1)(2008-10#2)
survive at##3##2##(1991-4#1)(1995-1#1)(2008-10#1)
survive beyond##2##2##(1991-11#1)(2008-7#1)
survive exposure##2##2##(2006-10#1)(2008-10#1)
survive for extended periods##2##4##(1995-8#1)(2008-8#1)
survive for##9##2##(1995-8#1)(1996-5#1)(2007-12#1)(2008-7#2)(2008-8#2)(2009-6#1)(2013-1#1)
survive in the##6##3##(2008-10#2)(2009-3#1)(2011-2#1)(2012-11#1)(2012-12#1)
survive in today's##2##3##(1992-12#1)(1993-2#1)
survive in##18##2##(1992-12#1)(1993-2#1)(1996-12#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-7#1)(2009-12#2)(2009-3#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-8#1)
survive into##2##2##(2006-4#1)(2008-7#1)
survive longer##4##2##(1991-3#1)(2004-1#1)(2008-10#2)
survive on##2##2##(2007-6#1)(2012-12#1)
survive the##10##2##(2007-9#2)(2009-6#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#2)
survive their##3##2##(2008-3#1)(2010-12#1)(2010-8#1)
survive this##4##2##(1991-11#1)(2005-12#1)(2006-8#1)(2008-7#1)
survive to##6##2##(1991-5#1)(1997-4#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-1#1)
survive under these##2##3##(1995-3#1)(2007-9#1)
survive under##5##2##(1995-3#1)(2006-12#1)(2007-9#1)(2011-1#1)(2013-1#1)
survive when##4##2##(2007-6#1)(2008-10#1)(2008-11#1)(2012-1#1)
survive with##2##2##(1993-7#1)(2011-2#1)
survive##177##1##(1990-2#2)(1991-11#2)(1991-12#1)(1991-3#4)(1991-4#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#3)(1996-4#1)(1996-5#2)(1997-1#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(2004-1#1)(2004-11#1)(2004-4#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#3)(2007-3#1)(2007-5#1)(2007-6#3)(2007-8#3)(2007-9#4)(2008-1#1)(2008-10#16)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#8)(2008-8#5)(2008-9#4)(2009-12#2)(2009-3#1)(2009-5#2)(2009-6#4)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#11)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
survive&quot##2##1##(2008-10#1)(2009-3#1)
survived (14%)##2##2##(1993-8#2)
survived MIR604 in the field the previous##2##7##(2011-2#2)
survived a##5##2##(1990-5#1)(1996-12#1)(2007-12#1)(2008-10#1)(2011-12#1)
survived after##9##2##(1994-6#1)(2006-4#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-12#1)(2011-2#1)(2013-1#1)
survived and##7##2##(1993-2#1)(2005-7#1)(2006-11#1)(2008-10#2)(2011-2#1)(2012-12#1)
survived at##7##2##(1995-2#1)(1996-12#1)(2006-8#1)(2008-10#2)(2008-11#1)(2012-12#1)
survived beyond##2##2##(1993-7#1)(2009-3#1)
survived for 5 years after##2##5##(2007-8#1)(2008-7#1)
survived for 5 years##4##4##(2007-8#1)(2008-6#1)(2008-7#1)(2010-12#1)
survived for at least 10##2##5##(2007-6#2)
survived for more than 1##2##5##(2008-10#1)(2011-2#1)
survived for more than three months##2##6##(1990-12#2)
survived for more than##5##4##(1990-12#2)(1991-8#1)(2008-10#1)(2011-2#1)
survived for##16##2##(1990-12#2)(1991-8#1)(1996-4#1)(2007-6#2)(2007-8#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2010-12#1)(2011-2#1)
survived in the##6##3##(1991-9#1)(2006-7#1)(2008-10#2)(2012-12#2)
survived in##9##2##(1991-9#1)(2006-7#1)(2008-10#3)(2012-12#3)(2013-1#1)
survived more than 1 year##2##5##(2008-11#1)(2010-8#1)
survived more than 5 years##2##5##(1990-6#1)(2008-6#1)
survived more than##5##3##(1990-6#1)(1995-12#1)(2008-11#1)(2008-6#1)(2010-8#1)
survived partialling for##2##3##(2009-4#2)
survived the operation##3##3##(1990-2#1)(1993-2#1)(2007-8#1)
survived the##14##2##(1990-2#1)(1992-9#1)(1993-2#1)(1995-1#1)(2004-11#1)(2006-8#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2013-1#1)
survived to discharge##2##3##(2007-10#1)(2008-11#1)
survived to the end of the study##8##7##(2008-9#8)
survived to##11##2##(2006-10#1)(2007-10#1)(2008-11#1)(2008-9#8)
survived until##3##2##(1995-2#1)(2007-2#1)(2008-9#1)
survived well in##2##3##(1996-12#1)(2008-8#1)
survived with##6##2##(1990-12#1)(1990-9#2)(2008-4#1)(2013-1#2)
survived without major##2##3##(1992-5#1)(2007-8#1)
survived without##5##2##(1992-5#1)(1993-2#1)(1994-9#1)(2007-8#1)(2009-4#1)
survived##179##1##(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#4)(1991-9#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-2#3)(1993-3#1)(1993-7#3)(1993-8#4)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-9#1)(1996-12#4)(1996-4#1)(1997-3#1)(2004-11#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-4#1)(2006-7#2)(2006-8#4)(2007-10#1)(2007-12#1)(2007-2#2)(2007-3#2)(2007-6#3)(2007-8#8)(2007-9#1)(2008-1#1)(2008-10#21)(2008-11#4)(2008-2#1)(2008-4#3)(2008-5#2)(2008-6#5)(2008-7#2)(2008-8#4)(2008-9#9)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-12#3)(2011-2#11)(2011-3#1)(2012-12#6)(2012-2#1)(2012-3#1)(2013-1#6)
survives in##3##2##(1991-12#1)(2008-3#1)(2012-12#1)
survives##9##1##(1991-12#1)(1992-6#1)(1995-3#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2012-12#1)
survivin and##4##2##(2008-4#1)(2010-12#1)(2011-2#2)
survivin in##8##2##(2007-7#1)(2008-4#1)(2009-3#1)(2010-1#1)(2011-2#4)
survivin protein##3##2##(2011-2#3)
survivin##36##1##(2007-7#1)(2008-4#7)(2009-3#8)(2010-1#3)(2010-12#1)(2011-2#16)
surviving and##3##2##(1994-12#1)(2008-7#1)(2009-6#1)
surviving at##2##2##(1997-3#1)(2007-10#1)
surviving birds of groups##2##4##(2010-4#2)
surviving birds##3##2##(2008-5#1)(2010-4#2)
surviving by##2##2##(1990-7#1)(2013-8#1)
surviving cell##2##2##(2008-6#1)(2008-9#1)
surviving cells##2##2##(2008-11#1)(2008-5#1)
surviving chickens##2##2##(2008-5#2)
surviving children##2##2##(1994-3#2)
surviving grafts##2##2##(1993-12#1)(1995-2#1)
surviving in##3##2##(1996-8#1)(2008-10#1)(2008-7#1)
surviving infants##2##2##(1995-5#1)(2006-10#1)
surviving neurons##4##2##(1991-11#1)(1994-5#1)(2007-11#1)(2008-7#1)
surviving patients##5##2##(1991-3#1)(1991-9#1)(1993-1#1)(2008-6#1)(2012-3#1)
surviving rats##2##2##(1993-7#1)(1997-3#1)
surviving the##4##2##(1996-12#1)(2006-10#1)(2008-5#1)(2010-4#1)
surviving to##2##2##(1995-12#1)(2008-9#1)
surviving with##2##2##(1996-3#1)(2008-11#1)
surviving##120##1##(1990-7#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1995-1#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-7#2)(1996-12#1)(1996-3#3)(1996-6#1)(1996-8#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(2004-11#1)(2005-1#1)(2006-1#1)(2006-10#4)(2006-5#1)(2006-8#2)(2007-10#2)(2007-11#2)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#6)(2008-11#2)(2008-5#6)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#10)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-8#2)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#2)(2013-8#1)
survivor##22##1##(1991-12#1)(1997-3#2)(2006-2#1)(2006-6#1)(2008-10#1)(2008-6#1)(2008-7#4)(2010-3#2)(2011-2#2)(2012-3#2)(2013-1#5)
survivors (survival##2##2##(2011-12#2)
survivors 1 to 5 years after rehabilitation##2##7##(2007-9#2)
survivors after##4##2##(2004-11#1)(2007-10#1)(2011-2#1)(2013-1#1)
survivors also##2##2##(2008-7#1)(2010-3#1)
survivors and their##2##3##(2007-10#1)(2008-11#1)
survivors and##10##2##(1991-4#1)(1991-6#2)(2006-6#1)(2007-10#2)(2008-11#2)(2008-7#1)(2010-7#1)
survivors are##4##2##(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
survivors at##5##2##(2007-10#2)(2008-6#1)(2011-2#1)(2011-3#1)
survivors born##2##2##(2006-7#1)(2009-9#1)
survivors had##2##2##(1993-5#1)(2012-2#1)
survivors in the##2##3##(2007-10#1)(2012-3#1)
survivors in##7##2##(2007-10#1)(2008-7#2)(2012-2#1)(2012-3#2)(2013-1#1)
survivors increases##2##2##(2010-3#1)(2010-9#1)
survivors is##4##2##(2007-10#2)(2008-6#1)(2010-12#1)
survivors of ICSA##2##3##(2007-3#2)
survivors of a##4##3##(1990-5#1)(1991-6#1)(2008-6#2)
survivors of cancer##2##3##(2008-7#1)(2010-7#1)
survivors of childhood abuse##3##4##(1995-11#3)
survivors of childhood##7##3##(1995-11#4)(2008-6#1)(2008-7#2)
survivors of pediatric brain tumors##2##5##(2005-10#2)
survivors of pediatric##3##3##(1996-1#1)(2005-10#2)
survivors of prostate cancer##2##4##(2008-7#2)
survivors of severe##3##3##(1995-11#1)(2005-10#1)(2006-4#1)
survivors of the##2##3##(2004-11#1)(2011-1#1)
survivors of violence##4##3##(2008-11#4)
survivors of##51##2##(1990-5#3)(1991-6#1)(1995-11#6)(1995-6#1)(1996-1#1)(1997-2#1)(2004-11#1)(2005-10#4)(2005-12#1)(2005-8#1)(2006-10#1)(2006-4#1)(2007-3#3)(2007-7#1)(2008-11#7)(2008-12#1)(2008-6#4)(2008-7#7)(2009-10#1)(2010-3#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-3#1)
survivors than in the controls##2##5##(2004-11#2)
survivors to##2##2##(1993-1#1)(2012-1#1)
survivors was##4##2##(2007-8#1)(2008-6#2)(2008-7#1)
survivors were##2##2##(1993-11#1)(2008-9#1)
survivors who##3##2##(2007-10#1)(2007-9#1)(2010-12#1)
survivors with##4##2##(1990-11#1)(2008-7#1)(2010-9#1)(2012-1#1)
survivors##244##1##(1990-11#1)(1990-5#4)(1990-9#1)(1991-12#2)(1991-4#1)(1991-6#3)(1991-9#2)(1992-2#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-5#2)(1993-8#1)(1994-3#2)(1994-6#1)(1994-7#2)(1995-11#6)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2004-10#2)(2004-11#5)(2005-10#4)(2005-12#1)(2005-8#2)(2005-9#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-10#15)(2007-11#1)(2007-12#2)(2007-3#3)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#8)(2008-11#9)(2008-12#1)(2008-4#5)(2008-5#2)(2008-6#12)(2008-7#32)(2008-8#3)(2008-9#1)(2009-10#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#2)(2010-12#7)(2010-2#2)(2010-3#6)(2010-4#1)(2010-7#2)(2010-8#1)(2010-9#4)(2011-1#4)(2011-12#2)(2011-2#7)(2011-3#1)(2012-1#14)(2012-12#5)(2012-2#2)(2012-3#8)(2013-1#4)(2013-8#2)
survivors'##7##1##(2009-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2012-3#1)(2013-1#2)
survivors)##2##1##(1994-6#1)(2008-10#1)
survivorship and##13##2##(2007-7#1)(2008-7#1)(2008-9#2)(2011-12#2)(2011-2#1)(2012-12#6)
survivorship at##2##2##(2009-4#1)(2013-1#1)
survivorship care##3##2##(2012-11#1)(2012-3#2)
survivorship for##3##2##(2008-3#1)(2013-1#2)
survivorship in##4##2##(2011-12#2)(2011-2#1)(2013-1#1)
survivorship of##11##2##(1991-6#1)(2007-5#1)(2007-7#1)(2008-9#4)(2011-2#1)(2013-1#3)
survivorship on MIR604 in the##2##5##(2011-2#2)
survivorship on MIR604 in##3##4##(2011-2#3)
survivorship on##4##2##(2011-2#4)
survivorship to the##2##3##(2011-12#2)
survivorship to##3##2##(2008-7#1)(2011-12#2)
survivorship was##5##2##(2009-4#1)(2011-2#2)(2013-1#2)
survivorship##89##1##(1991-6#1)(1992-2#1)(2004-11#3)(2007-5#2)(2007-7#2)(2008-11#1)(2008-3#1)(2008-7#15)(2008-8#2)(2008-9#12)(2009-4#2)(2010-8#1)(2011-12#8)(2011-2#11)(2012-11#1)(2012-12#6)(2012-2#1)(2012-3#6)(2013-1#13)
susceptibilities of##10##2##(1991-8#1)(2006-8#3)(2007-12#3)(2007-9#1)(2008-7#2)
susceptibilities to##7##2##(1990-3#1)(1994-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-2#1)
susceptibilities##33##1##(1990-3#1)(1991-8#1)(1992-6#1)(1994-2#1)(1996-2#1)(1997-3#1)(1997-7#1)(2006-8#4)(2007-12#14)(2007-9#1)(2008-10#2)(2008-11#1)(2008-7#2)(2012-2#1)(2013-8#1)
susceptibility among##2##2##(2008-3#1)(2012-3#1)
susceptibility and a##2##3##(2008-10#2)
susceptibility and exposure to##2##4##(1994-2#1)(2011-12#1)
susceptibility and prognosis##2##3##(2007-11#1)(2011-2#1)
susceptibility and resistance##2##3##(2006-10#1)(2008-10#1)
susceptibility and##25##2##(1990-8#1)(1994-2#1)(2006-10#1)(2006-2#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
susceptibility and/or##2##2##(2007-10#1)(2008-7#1)
susceptibility are##2##2##(2008-9#1)(2013-1#1)
susceptibility at##2##2##(2008-7#1)(2012-2#1)
susceptibility behavior##2##2##(1991-7#2)
susceptibility between the##2##3##(2008-10#2)
susceptibility between##5##2##(2008-10#2)(2008-4#1)(2008-9#1)(2011-3#1)
susceptibility can be##2##3##(1993-6#1)(2007-11#1)
susceptibility changes##2##2##(2007-6#1)(2008-10#1)
susceptibility chi((2))##2##2##(2007-12#1)(2008-1#1)
susceptibility data##3##2##(1997-7#1)(2007-8#1)(2008-5#1)
susceptibility effects##2##2##(2012-2#2)
susceptibility factors##2##2##(2006-10#1)(2010-9#1)
susceptibility for##6##2##(1994-5#1)(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#2)
susceptibility from##4##2##(2007-12#2)(2008-10#2)
susceptibility gene for##3##3##(1994-6#1)(2009-12#1)(2010-2#1)
susceptibility gene##14##2##(1990-6#1)(1991-8#1)(1994-6#2)(1994-9#1)(1995-12#1)(1996-11#1)(1996-2#2)(1997-8#1)(2006-10#1)(2008-4#1)(2009-12#1)(2010-2#1)
susceptibility genes are##2##3##(1995-11#1)(2012-12#1)
susceptibility genes##18##2##(1994-9#1)(1995-11#1)(1995-8#1)(1996-5#2)(1997-7#1)(2006-10#1)(2006-9#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-3#1)(2012-12#1)(2012-2#1)
susceptibility has##2##2##(2007-12#1)(2008-4#1)
susceptibility in a##3##3##(2007-12#2)(2013-1#1)
susceptibility in malignant melanoma##2##4##(2011-2#2)
susceptibility in the##3##3##(1990-7#1)(1994-6#1)(2011-2#1)
susceptibility in vitro##3##3##(1997-4#1)(2008-5#1)(2012-2#1)
susceptibility in##32##2##(1990-7#1)(1991-9#1)(1994-6#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-12#6)(2007-7#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-9#1)(2011-2#4)(2012-2#3)(2013-1#1)
susceptibility is##7##2##(1990-8#1)(2006-2#1)(2008-7#1)(2010-2#1)(2011-2#2)(2013-1#1)
susceptibility levels of the##2##4##(2008-12#1)(2013-1#1)
susceptibility levels##4##2##(2007-6#1)(2008-12#1)(2012-12#1)(2013-1#1)
susceptibility loci for##2##3##(1997-5#1)(2006-10#1)
susceptibility loci##7##2##(1997-5#1)(2006-10#1)(2009-4#1)(2011-1#1)(2012-12#1)(2012-3#2)
susceptibility locus##10##2##(1994-12#1)(1994-9#1)(1996-2#1)(1997-4#1)(1997-5#5)(2011-2#1)
susceptibility may be##2##3##(2008-10#1)(2008-9#1)
susceptibility may##4##2##(2008-1#2)(2008-10#1)(2008-9#1)
susceptibility measurements##4##2##(1997-7#1)(2007-11#1)(2008-3#1)(2008-5#1)
susceptibility of 2##2##3##(2006-8#1)(2007-12#1)
susceptibility of 20##2##3##(2008-5#1)(2011-2#1)
susceptibility of Candida##3##3##(2006-11#1)(2007-7#2)
susceptibility of H##2##3##(2006-8#1)(2012-12#1)
susceptibility of LDL to oxidation##2##5##(1995-12#1)(2004-11#1)
susceptibility of LDL to##3##4##(1995-12#2)(2004-11#1)
susceptibility of M##2##3##(2007-7#1)(2011-12#1)
susceptibility of P##2##3##(2008-10#1)(2009-5#1)
susceptibility of a##2##3##(1993-11#1)(2007-7#1)
susceptibility of an##2##3##(2009-7#1)(2012-12#1)
susceptibility of biofilm##2##3##(1995-12#1)(2008-9#1)
susceptibility of diabetic##2##3##(2012-1#1)(2012-2#1)
susceptibility of isolates##2##3##(2011-1#1)(2011-2#1)
susceptibility of peach to##2##4##(2008-10#2)
susceptibility of the chickpea cultivar##2##5##(2008-10#2)
susceptibility of the host##2##4##(2008-10#1)(2012-1#1)
susceptibility of the##33##3##(1990-8#1)(1991-2#1)(1992-10#2)(1992-9#1)(1995-2#1)(1997-2#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#2)(2008-10#6)(2008-3#1)(2008-5#2)(2008-8#1)(2009-8#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)
susceptibility of these##8##3##(1991-12#1)(1992-10#1)(1993-4#1)(1994-5#1)(1994-6#1)(1996-12#2)(1996-8#1)
susceptibility of##175##2##(1990-11#2)(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-7#1)(1991-8#1)(1992-10#4)(1992-6#1)(1992-9#2)(1993-11#4)(1993-4#1)(1994-11#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#2)(1995-12#4)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-12#3)(1996-4#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2004-11#2)(2005-10#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-8#6)(2006-9#1)(2007-10#3)(2007-11#3)(2007-12#5)(2007-6#4)(2007-7#7)(2007-9#1)(2008-10#22)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#7)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#4)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#2)(2010-12#1)(2010-2#1)(2011-1#1)(2011-12#2)(2011-2#8)(2012-1#3)(2012-12#8)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
susceptibility on##3##2##(2007-8#1)(2011-1#2)
susceptibility or resistance to##7##4##(1996-10#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#2)
susceptibility or resistance##9##3##(1996-10#1)(2006-10#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-12#1)
susceptibility or##12##2##(1993-7#1)(1996-10#1)(1997-8#1)(2006-10#1)(2007-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-12#1)
susceptibility pattern in Mulago Hospital##2##5##(2010-8#2)
susceptibility pattern in##4##3##(2007-7#1)(2010-8#2)(2012-3#1)
susceptibility pattern of##6##3##(2006-8#2)(2007-7#2)(2010-8#1)(2012-3#1)
susceptibility pattern##14##2##(1995-11#1)(2006-8#3)(2007-7#3)(2007-8#1)(2010-8#3)(2011-1#1)(2012-3#2)
susceptibility patterns of##7##3##(2006-10#1)(2007-7#1)(2008-12#1)(2008-5#1)(2009-5#1)(2010-11#1)(2013-8#1)
susceptibility patterns##16##2##(2006-10#3)(2006-8#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-7#2)(2009-5#2)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
susceptibility period of##2##3##(2008-10#2)
susceptibility period##3##2##(2008-10#3)
susceptibility profile of##2##3##(2005-8#1)(2006-8#1)
susceptibility profile##4##2##(2005-8#1)(2006-8#1)(2008-5#1)(2009-2#1)
susceptibility profiles##4##2##(1995-1#2)(2007-7#2)
susceptibility results##2##2##(2007-7#1)(2011-2#1)
susceptibility should be##2##3##(1991-12#1)(2011-2#1)
susceptibility should##3##2##(1991-12#1)(2008-10#1)(2011-2#1)
susceptibility tensors##2##2##(1997-4#1)(2008-2#1)
susceptibility test##8##2##(1993-9#1)(2005-8#1)(2007-12#1)(2007-8#2)(2008-12#1)(2008-8#1)(2011-1#1)
susceptibility testing and the##2##4##(2008-8#1)(2013-8#1)
susceptibility testing and##3##3##(2008-8#1)(2008-9#1)(2013-8#1)
susceptibility testing by flow cytometry##2##5##(2008-9#2)
susceptibility testing for##2##3##(2007-7#1)(2008-9#1)
susceptibility testing in##2##3##(2007-8#1)(2008-5#1)
susceptibility testing of##3##3##(2007-7#1)(2008-7#1)(2011-2#1)
susceptibility testing was performed by##2##5##(2007-12#1)(2012-3#1)
susceptibility testing was##4##3##(2007-12#1)(2007-7#1)(2008-7#1)(2012-3#1)
susceptibility testing with##2##3##(2008-7#1)(2010-2#1)
susceptibility testing##39##2##(1992-5#1)(1996-10#1)(2005-8#1)(2007-12#2)(2007-7#7)(2007-8#1)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#4)(2009-5#1)(2010-2#1)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
susceptibility tests on##2##3##(1992-5#1)(2006-8#1)
susceptibility tests were##2##3##(2006-8#1)(2013-1#1)
susceptibility tests##12##2##(1992-5#2)(2006-8#2)(2007-7#1)(2008-11#1)(2008-12#1)(2008-5#2)(2013-1#2)(2013-7#1)
susceptibility to H##3##3##(2008-10#1)(2009-3#1)(2011-10#1)
susceptibility to S##3##3##(2006-10#1)(2008-10#1)(2009-3#1)
susceptibility to a##3##3##(2006-10#1)(2009-5#1)(2011-2#1)
susceptibility to alcoholism##3##3##(1997-5#2)(2006-9#1)
susceptibility to antibiotics##4##3##(1990-6#1)(1997-4#1)(2009-6#1)(2010-4#1)
susceptibility to autoimmune##2##3##(2006-5#1)(2011-2#1)
susceptibility to azoles##2##3##(2005-8#1)(2008-5#1)
susceptibility to bacterial canker##4##4##(2008-10#4)
susceptibility to benznidazole##2##3##(2012-12#2)
susceptibility to certain##2##3##(2005-11#1)(2012-3#1)
susceptibility to chronic##2##3##(1994-5#1)(2009-10#1)
susceptibility to chymotrypsin digestion##2##4##(1995-3#2)
susceptibility to colitis-associated##2##3##(2011-2#2)
susceptibility to common##2##3##(1997-8#1)(2006-10#1)
susceptibility to different##2##3##(2008-10#1)(2011-2#1)
susceptibility to disease and##2##4##(2008-10#1)(2010-7#1)
susceptibility to disease##3##3##(2008-10#1)(2008-9#1)(2010-7#1)
susceptibility to distraction by##2##4##(2012-3#2)
susceptibility to essential hypertension in Han Chinese##2##7##(2008-9#2)
susceptibility to human##4##3##(1990-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
susceptibility to hydrolysis##2##3##(1995-4#1)(2008-5#1)
susceptibility to infection and##2##4##(1997-4#1)(2006-10#1)
susceptibility to infection by##3##4##(2008-10#1)(2009-5#2)
susceptibility to infection##14##3##(1995-5#1)(1997-4#1)(1997-7#1)(2006-10#3)(2007-11#1)(2007-7#1)(2008-10#3)(2009-12#1)(2009-5#2)
susceptibility to infections and##2##4##(2007-2#1)(2012-3#1)
susceptibility to infections##10##3##(1991-6#1)(1991-9#1)(2007-2#4)(2007-8#1)(2008-10#1)(2012-3#1)(2013-1#1)
susceptibility to infectious##2##3##(2007-7#1)(2008-10#1)
susceptibility to inflammatory disease##2##4##(1995-12#2)
susceptibility to inhibition by##2##4##(1997-2#1)(2008-5#1)
susceptibility to inhibition##3##3##(1992-6#1)(1997-2#1)(2008-5#1)
susceptibility to inhibitors##2##3##(1993-11#1)(2006-11#1)
susceptibility to killing by##2##4##(1991-9#1)(1995-8#1)
susceptibility to lung cancer##2##4##(2010-12#1)(2011-1#1)
susceptibility to lung##3##3##(2008-10#1)(2010-12#1)(2011-1#1)
susceptibility to lysis by##2##4##(1992-2#1)(2008-9#1)
susceptibility to oxidation##2##3##(2004-11#1)(2008-10#1)
susceptibility to proteolysis##2##3##(1991-2#1)(1997-7#1)
susceptibility to proteolytic##2##3##(1993-8#1)(1997-4#1)
susceptibility to provoked##2##3##(2004-12#2)
susceptibility to pulmonary tuberculosis##2##4##(2011-1#2)
susceptibility to scrapie infection##3##4##(2006-8#3)
susceptibility to seizures induced by##2##5##(1996-10#2)
susceptibility to the virus##3##4##(2008-9#3)
susceptibility to the##18##3##(1990-2#1)(1993-3#1)(1994-2#1)(1997-8#1)(2005-9#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#3)(2011-2#1)(2012-12#1)
susceptibility to these##3##3##(1992-2#1)(2007-9#1)(2009-11#1)
susceptibility to this disease##2##4##(2008-5#1)(2013-1#1)
susceptibility to this##5##3##(2007-7#1)(2008-5#1)(2009-5#1)(2010-12#1)(2013-1#1)
susceptibility to tuberculosis in Chinese##2##5##(2011-1#1)(2012-2#1)
susceptibility to tuberculosis##6##3##(2006-12#1)(2011-1#2)(2012-2#1)(2013-1#2)
susceptibility to two##2##3##(2004-11#1)(2007-12#1)
susceptibility to type 1 diabetes##2##5##(2007-5#1)(2008-1#1)
susceptibility to type 1##3##4##(2006-10#1)(2007-5#1)(2008-1#1)
susceptibility to type##4##3##(2006-10#1)(2007-5#1)(2008-1#1)(2011-1#1)
susceptibility to vancomycin##2##3##(2008-5#1)(2012-12#1)
susceptibility to##331##2##(1990-2#2)(1990-4#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#3)(1992-12#1)(1992-2#2)(1992-6#1)(1993-11#2)(1993-3#2)(1993-7#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-8#1)(1995-12#4)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-10#2)(1996-2#1)(1996-4#1)(1996-5#3)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#5)(1997-5#4)(1997-6#1)(1997-7#2)(1997-8#10)(2004-11#2)(2004-12#3)(2005-10#2)(2005-11#1)(2005-7#3)(2005-8#2)(2005-9#1)(2006-10#11)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#2)(2006-5#1)(2006-8#4)(2006-9#2)(2007-11#2)(2007-12#6)(2007-2#7)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#8)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#47)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#12)(2008-7#5)(2008-8#3)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#3)(2009-5#7)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#6)(2010-2#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#9)(2011-10#1)(2011-12#1)(2011-2#14)(2012-1#3)(2012-12#6)(2012-2#6)(2012-3#10)(2013-1#7)(2013-7#1)(2013-8#3)
susceptibility was observed##2##3##(2007-9#1)(2008-10#1)
susceptibility was##11##2##(1991-7#1)(1992-2#1)(2007-9#1)(2008-10#2)(2011-2#2)(2012-12#4)
susceptibility were##4##2##(1996-7#1)(2008-10#2)(2012-2#1)
susceptibility with##5##2##(1991-12#1)(1994-6#1)(2008-10#1)(2013-1#1)(2013-8#1)
susceptibility x((3))##2##2##(2007-12#2)
susceptibility##982##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#2)(1990-6#3)(1990-7#3)(1990-8#4)(1990-9#2)(1991-12#8)(1991-2#3)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#4)(1991-8#2)(1991-9#4)(1992-10#4)(1992-12#2)(1992-2#3)(1992-5#3)(1992-6#2)(1992-9#3)(1993-11#6)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#4)(1994-5#4)(1994-6#6)(1994-8#3)(1994-9#3)(1995-1#4)(1995-11#2)(1995-12#9)(1995-2#5)(1995-3#4)(1995-4#2)(1995-5#1)(1995-6#3)(1995-8#3)(1995-9#1)(1996-10#5)(1996-11#2)(1996-12#3)(1996-2#4)(1996-4#2)(1996-5#5)(1996-7#1)(1996-8#4)(1997-2#3)(1997-3#2)(1997-4#10)(1997-5#11)(1997-6#2)(1997-7#8)(1997-8#16)(2004-11#4)(2004-12#3)(2005-10#4)(2005-11#1)(2005-7#3)(2005-8#6)(2005-9#2)(2006-10#30)(2006-11#3)(2006-12#3)(2006-2#4)(2006-4#3)(2006-5#3)(2006-8#22)(2006-9#4)(2007-10#6)(2007-11#14)(2007-12#37)(2007-2#7)(2007-4#3)(2007-5#1)(2007-6#7)(2007-7#31)(2007-8#9)(2007-9#4)(2008-1#11)(2008-10#128)(2008-11#6)(2008-12#6)(2008-2#2)(2008-3#9)(2008-4#12)(2008-5#40)(2008-6#3)(2008-7#22)(2008-8#13)(2008-9#21)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#6)(2009-3#4)(2009-4#3)(2009-5#16)(2009-6#3)(2009-7#5)(2009-8#5)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#12)(2010-2#6)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#5)(2010-9#3)(2011-1#18)(2011-10#1)(2011-12#4)(2011-2#56)(2011-3#1)(2012-1#8)(2012-12#27)(2012-2#24)(2012-3#21)(2013-1#22)(2013-7#4)(2013-8#9)
susceptibility)##2##1##(2005-7#1)(2006-10#1)
susceptible (MIC =##2##3##(2006-10#2)
susceptible (S)##2##2##(1992-11#2)
susceptible B##2##2##(2008-10#2)
susceptible accessions##4##2##(2008-10#2)(2009-3#2)
susceptible and a resistant##3##4##(2006-10#1)(2008-10#2)
susceptible and partially resistant cultivars##2##5##(2008-10#2)
susceptible and protected hosts##2##4##(1996-5#2)
susceptible and resistant cultivars##7##4##(2008-10#7)
susceptible and resistant genotypes##3##4##(2008-10#3)
susceptible and resistant roots##2##4##(2008-10#2)
susceptible and resistant to##3##4##(1992-2#1)(2008-11#1)(2011-10#1)
susceptible and resistant##23##3##(1992-2#1)(1996-12#1)(2008-10#18)(2008-11#1)(2011-10#1)(2013-8#1)
susceptible and three##2##3##(2008-10#2)
susceptible and##47##2##(1992-2#1)(1996-12#3)(1996-5#2)(2005-9#1)(2006-10#1)(2006-8#1)(2007-5#1)(2008-10#33)(2008-11#1)(2011-10#1)(2011-2#1)(2013-8#1)
susceptible animals##3##2##(2007-6#1)(2011-2#1)(2013-1#1)
susceptible as compared with protected##2##5##(1996-5#2)
susceptible as##5##2##(1996-5#2)(2007-10#1)(2008-10#1)(2010-4#1)
susceptible at##4##2##(1990-11#1)(2008-10#3)
susceptible barley cultivars##2##3##(2008-10#2)
susceptible barley##3##2##(2008-10#3)
susceptible beetles##2##2##(2011-2#2)
susceptible berries than##2##3##(2008-10#2)
susceptible berries##6##2##(2008-10#6)
susceptible birds##2##2##(2008-5#1)(2008-8#1)
susceptible cells##4##2##(1991-12#1)(1996-10#1)(1996-5#1)(2008-10#1)
susceptible children##4##2##(1997-2#1)(2007-2#1)(2010-12#1)(2013-1#1)
susceptible control##3##2##(2008-10#3)
susceptible controls##5##2##(2008-10#4)(2011-2#1)
susceptible crops##9##2##(2008-10#9)
susceptible cultivar was##4##3##(2008-10#4)
susceptible cultivar were##2##3##(2008-10#2)
susceptible cultivar##35##2##(2008-10#32)(2009-8#1)(2012-11#2)
susceptible cultivars and##4##3##(2008-10#4)
susceptible cultivars##27##2##(2008-10#25)(2011-10#2)
susceptible cv##20##2##(2008-10#20)
susceptible cvs##5##2##(2008-10#5)
susceptible ecotype N913##3##3##(2008-10#3)
susceptible families##3##2##(2008-10#2)(2011-10#1)
susceptible flag leaves##2##3##(2008-10#2)
susceptible for##2##2##(2008-1#1)(2008-10#1)
susceptible gene##2##2##(1994-12#1)(2013-7#1)
susceptible genotypes##15##2##(2008-10#15)
susceptible host tissue##4##3##(2008-10#4)
susceptible host##12##2##(2008-10#10)(2008-8#1)(2013-8#1)
susceptible hosts as##2##3##(2008-10#2)
susceptible hosts##8##2##(1996-5#1)(2006-10#2)(2006-8#1)(2008-10#4)
susceptible in##4##2##(2008-10#1)(2008-5#1)(2011-2#2)
susceptible inbred##7##2##(2006-2#2)(2008-10#5)
susceptible individuals##16##2##(2005-7#1)(2006-1#1)(2006-11#1)(2007-3#1)(2007-4#1)(2007-5#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-8#1)(2010-12#1)(2011-1#1)(2013-7#1)(2013-8#1)
susceptible isolates##4##2##(1993-10#3)(2008-5#1)
susceptible leaves##3##2##(2008-10#3)
susceptible line##6##2##(1997-6#1)(2008-10#5)
susceptible lines##4##2##(2008-10#4)
susceptible maize genotypes##2##3##(2008-10#1)(2011-2#1)
susceptible maize##3##2##(2008-10#2)(2011-2#1)
susceptible mice##2##2##(1996-12#1)(2008-4#1)
susceptible nematodes##2##2##(1993-10#1)(1996-12#1)
susceptible oat##2##2##(2008-10#2)
susceptible of##3##2##(2007-3#1)(2008-2#1)(2012-2#1)
susceptible ones##7##2##(1991-7#1)(2008-10#5)(2008-12#1)
susceptible only##2##2##(2008-10#1)(2008-5#1)
susceptible or resistant##3##3##(1996-12#1)(2008-10#2)
susceptible or##5##2##(1996-12#1)(2008-10#3)(2011-2#1)
susceptible parent##10##2##(2008-10#10)
susceptible patients##5##2##(2006-10#1)(2006-2#1)(2006-5#1)(2007-11#1)(2008-8#1)
susceptible phenotype##2##2##(2007-7#1)(2008-10#1)
susceptible plant##2##2##(2008-10#1)(2008-12#1)
susceptible plants##13##2##(2008-10#11)(2009-8#2)
susceptible population##2##2##(2008-10#2)
susceptible populations##3##2##(2008-10#2)(2008-8#1)
susceptible potato cv##4##3##(2008-10#4)
susceptible potato##6##2##(2008-10#6)
susceptible reactions##2##2##(2008-10#2)
susceptible roots##5##2##(2008-10#5)
susceptible sorghum cultivar##2##3##(2008-10#2)
susceptible sorghum##3##2##(2008-10#3)
susceptible soybean##2##2##(2008-10#2)
susceptible strain##3##2##(2008-12#1)(2008-5#1)(2011-2#1)
susceptible strains (MIC##2##3##(2006-10#2)
susceptible strains of##3##3##(1994-5#1)(2008-4#1)(2012-3#1)
susceptible strains##8##2##(1991-4#1)(1994-5#1)(1996-12#1)(2006-10#2)(2006-2#1)(2008-4#1)(2012-3#1)
susceptible subgroups##2##2##(1997-1#1)(2011-1#1)
susceptible substrate##2##2##(1990-9#1)(1994-8#1)
susceptible than##9##2##(1991-10#1)(1994-12#1)(2007-6#1)(2008-10#3)(2008-5#2)(2012-2#1)
susceptible to A##3##3##(2008-10#3)
susceptible to Al##2##3##(1996-8#2)
susceptible to S##4##3##(2008-10#4)
susceptible to a variety of##2##5##(2007-12#1)(2012-2#1)
susceptible to a##4##3##(1990-11#1)(2007-12#1)(2007-8#1)(2012-2#1)
susceptible to all races##3##4##(2008-10#3)
susceptible to all##6##3##(2008-10#5)(2008-5#1)
susceptible to ampicillin##2##3##(2007-12#1)(2008-11#1)
susceptible to apoptosis##3##3##(1995-2#1)(1995-8#1)(2008-11#1)
susceptible to bacterial##3##3##(1991-3#1)(2008-10#1)(2008-5#1)
susceptible to both pathogens##3##4##(2008-10#3)
susceptible to both##14##3##(1991-8#1)(1993-6#1)(2004-11#1)(2008-10#6)(2008-11#2)(2009-5#1)(2011-2#2)
susceptible to carbapenems##2##3##(2009-2#1)(2012-12#1)
susceptible to change##2##3##(2008-10#1)(2009-4#1)
susceptible to damage##4##3##(1994-2#1)(1996-6#1)(2008-3#1)(2011-2#1)
susceptible to degradation##2##3##(1993-7#1)(2008-10#1)
susceptible to diabetes##2##3##(2008-1#1)(2009-5#1)
susceptible to enzymatic hydrolysis in mice##2##6##(1994-9#2)
susceptible to enzymatic##3##3##(1994-9#2)(2008-5#1)
susceptible to erythromycin##2##3##(2006-8#1)(2011-2#1)
susceptible to in vitro##2##4##(1993-6#1)(2007-12#1)
susceptible to infection by##5##4##(2007-7#1)(2008-10#3)(2009-5#1)
susceptible to infection with pathogenic##2##5##(2006-8#1)(2008-9#1)
susceptible to infection with##5##4##(2005-9#1)(2006-8#1)(2007-9#1)(2008-12#1)(2008-9#1)
susceptible to infection##26##3##(2005-9#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#15)(2008-12#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
susceptible to inhibition by##2##4##(1994-5#1)(2008-4#1)
susceptible to inhibition##4##3##(1990-11#1)(1994-5#1)(1994-6#1)(2008-4#1)
susceptible to injury from##2##4##(1995-11#2)
susceptible to injury##5##3##(1995-11#2)(2006-11#1)(2006-8#1)(2008-9#1)
susceptible to ischemic##2##3##(2008-4#1)(2009-10#1)
susceptible to isolates##2##3##(2008-10#2)
susceptible to killing by##4##4##(1997-2#1)(2006-8#1)(2008-5#1)(2012-2#1)
susceptible to leaf##3##3##(2008-10#3)
susceptible to malathion##2##3##(2012-2#1)(2013-1#1)
susceptible to many##2##3##(2007-12#1)(2008-10#1)
susceptible to microbial##2##3##(2008-5#1)(2012-2#1)
susceptible to most##2##3##(2006-8#1)(2008-10#1)
susceptible to nystatin and##2##4##(2007-7#1)(2008-5#1)
susceptible to opportunistic##2##3##(2007-10#1)(2007-2#1)
susceptible to other##2##3##(1997-3#1)(2012-2#1)
susceptible to oxidation##3##3##(2007-8#1)(2008-3#1)(2008-5#1)
susceptible to oxidative##3##3##(1991-2#1)(2005-8#1)(2009-3#1)
susceptible to powdery mildew##2##4##(2008-10#2)
susceptible to proteolysis##4##3##(1992-11#2)(1994-5#2)
susceptible to proteolytic degradation in##2##5##(2006-12#2)
susceptible to proteolytic degradation##4##4##(2006-12#4)
susceptible to proteolytic##5##3##(2006-12#4)(2007-11#1)
susceptible to several##2##3##(2008-10#2)
susceptible to such##2##3##(2005-7#1)(2010-12#1)
susceptible to temperature##2##3##(1994-8#1)(2006-1#1)
susceptible to the effects of##2##5##(1992-1#1)(1992-11#1)
susceptible to the pathogen##2##4##(2008-10#2)
susceptible to the##30##3##(1990-3#1)(1990-9#1)(1991-10#2)(1992-1#1)(1992-11#1)(1992-9#1)(1993-2#1)(1996-12#1)(1996-8#1)(1997-6#1)(2004-11#1)(2006-12#1)(2006-2#1)(2006-8#1)(2008-10#7)(2008-5#3)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)
susceptible to these##2##3##(1995-2#1)(2007-12#1)
susceptible to this##2##3##(2006-10#1)(2011-10#1)
susceptible to transformation by##2##4##(2008-10#1)(2008-6#1)
susceptible to##397##2##(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#2)(1990-7#1)(1990-9#3)(1991-10#2)(1991-12#4)(1991-2#2)(1991-3#2)(1991-8#4)(1992-1#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#4)(1993-2#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-5#6)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-8#1)(1995-9#2)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#3)(1996-9#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#3)(2005-11#2)(2005-7#1)(2005-8#2)(2005-9#2)(2006-1#2)(2006-10#3)(2006-11#1)(2006-12#6)(2006-2#3)(2006-3#2)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#10)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#7)(2007-2#6)(2007-3#1)(2007-4#4)(2007-5#1)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#97)(2008-11#9)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#13)(2008-6#3)(2008-7#1)(2008-8#5)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#4)(2009-3#2)(2009-4#2)(2009-5#4)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#11)(2011-10#2)(2011-2#15)(2012-1#1)(2012-11#2)(2012-12#5)(2012-2#12)(2012-3#2)(2013-1#7)(2013-8#2)
susceptible tomato##4##2##(2008-10#4)
susceptible wheat##4##2##(2008-10#4)
susceptible when##2##2##(2008-10#2)
susceptible winter wheat##2##3##(2008-10#2)
susceptible zucchini##2##2##(2008-10#2)
susceptible##992##1##(1990-11#4)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#2)(1990-6#1)(1990-7#1)(1990-9#4)(1991-10#3)(1991-12#5)(1991-2#2)(1991-3#2)(1991-4#1)(1991-7#2)(1991-8#4)(1992-1#1)(1992-11#6)(1992-12#1)(1992-2#2)(1992-3#1)(1992-9#1)(1993-1#1)(1993-10#4)(1993-12#4)(1993-2#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#5)(1994-2#2)(1994-3#1)(1994-5#7)(1994-6#2)(1994-8#4)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#2)(1996-10#2)(1996-12#10)(1996-3#1)(1996-4#1)(1996-5#7)(1996-6#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#3)(2004-4#1)(2005-11#2)(2005-7#4)(2005-8#2)(2005-9#3)(2006-1#3)(2006-10#11)(2006-11#2)(2006-12#6)(2006-2#7)(2006-3#2)(2006-4#2)(2006-5#2)(2006-7#1)(2006-8#12)(2006-9#2)(2007-10#4)(2007-11#4)(2007-12#7)(2007-2#9)(2007-3#3)(2007-4#5)(2007-5#4)(2007-6#4)(2007-7#5)(2007-8#4)(2007-9#3)(2008-1#3)(2008-10#492)(2008-11#10)(2008-12#7)(2008-2#4)(2008-3#7)(2008-4#6)(2008-5#25)(2008-6#4)(2008-7#3)(2008-8#12)(2008-9#3)(2009-10#2)(2009-12#1)(2009-2#5)(2009-3#7)(2009-4#2)(2009-5#5)(2009-6#1)(2009-8#5)(2009-9#2)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#3)(2010-7#1)(2011-1#13)(2011-10#8)(2011-12#2)(2011-2#32)(2012-1#1)(2012-11#4)(2012-12#7)(2012-2#14)(2012-3#5)(2013-1#14)(2013-7#4)(2013-8#6)
suspect a##4##2##(1996-1#1)(2008-10#1)(2011-2#1)(2012-11#1)
suspect cases##3##2##(2007-12#1)(2007-4#1)(2012-2#1)
suspect in##3##2##(2008-11#1)(2009-2#1)(2012-12#1)
suspect that the##4##3##(2006-10#1)(2006-12#1)(2007-8#1)(2010-4#1)
suspect that##10##2##(1990-10#1)(1992-12#1)(2006-10#1)(2006-12#1)(2007-3#1)(2007-8#1)(2008-4#1)(2009-8#1)(2010-4#1)(2012-2#1)
suspect the##3##2##(1991-4#1)(1995-4#1)(2010-5#1)
suspect this##2##2##(2006-12#1)(2010-7#1)
suspect to##2##2##(1996-11#1)(2008-6#1)
suspect##64##1##(1990-10#1)(1991-4#1)(1992-12#1)(1993-1#1)(1993-10#1)(1993-3#1)(1994-7#1)(1995-11#1)(1995-4#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-8#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#3)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
suspected MI##2##2##(1997-1#2)
suspected NAFLD##3##2##(2011-2#3)
suspected ROM based on history##2##5##(1996-9#2)
suspected a##2##2##(1992-4#1)(2013-8#1)
suspected acute PE##2##3##(2011-2#2)
suspected acute appendicitis##2##3##(1991-12#1)(2007-7#1)
suspected acute coronary##3##3##(1990-3#1)(2008-3#1)(2010-9#1)
suspected acute myocardial infarction##2##4##(1990-3#1)(1997-1#1)
suspected acute##16##2##(1990-3#2)(1991-12#1)(1995-11#2)(1996-11#1)(1997-1#1)(2007-7#1)(2008-3#3)(2010-8#1)(2010-9#1)(2011-2#3)
suspected adverse##2##2##(1993-8#1)(2006-3#1)
suspected after##2##2##(2008-12#1)(2009-3#1)
suspected and a##2##3##(1996-1#1)(2007-8#1)
suspected and##10##2##(1996-1#1)(2006-12#1)(2006-8#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#1)(2013-1#1)(2013-8#1)
suspected appendicitis##2##2##(1993-1#1)(1997-8#1)
suspected as a##2##3##(2006-4#1)(2010-4#1)
suspected as##10##2##(1990-2#1)(1993-5#1)(1995-6#1)(1996-6#1)(2006-4#2)(2006-9#1)(2010-4#1)(2013-1#2)
suspected at##2##2##(1992-2#1)(2013-1#1)
suspected by##5##2##(1991-12#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-9#1)
suspected cardiac##2##2##(2008-10#1)(2012-2#1)
suspected case of##2##3##(2007-3#1)(2010-4#1)
suspected case##3##2##(2007-3#1)(2010-4#1)(2013-1#1)
suspected cases of typhoid##2##4##(2007-2#2)
suspected cases of##8##3##(1996-2#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#1)(2013-8#2)
suspected cases##21##2##(1990-12#1)(1994-6#1)(1996-2#1)(2006-10#1)(2006-12#1)(2007-2#3)(2007-3#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-4#1)(2009-7#1)(2010-10#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#3)
suspected cerebral toxoplasmosis##2##3##(2007-2#2)
suspected cerebral##3##2##(2007-2#2)(2007-9#1)
suspected clinically##4##2##(2007-12#1)(2008-5#1)(2008-7#1)(2012-2#1)
suspected complication##2##2##(2006-4#1)(2009-1#1)
suspected coronary##4##2##(1991-9#1)(2009-10#1)(2012-2#1)(2013-8#1)
suspected cutaneous leishmaniasis##2##3##(2008-12#1)(2012-12#1)
suspected cutaneous##3##2##(2007-8#1)(2008-12#1)(2012-12#1)
suspected diagnosis of##2##3##(2005-11#1)(2011-1#1)
suspected drug##3##2##(2011-1#1)(2013-7#2)
suspected due to the absence of testicles in the scrotum and difficulty of penis visualization##2##15##(2013-1#2)
suspected following##2##2##(1990-6#1)(2005-10#1)
suspected from the##2##3##(2010-2#1)(2011-1#1)
suspected from##4##2##(2008-7#2)(2010-2#1)(2011-1#1)
suspected hip##2##2##(1990-2#1)(2008-12#1)
suspected if the##3##3##(1997-4#1)(2006-9#1)(2009-6#1)
suspected if##6##2##(1997-4#1)(2005-11#1)(2006-9#1)(2009-2#1)(2009-6#1)(2012-2#1)
suspected in a patient##2##4##(1991-4#1)(2007-11#1)
suspected in a##6##3##(1991-4#1)(1996-12#1)(2007-11#1)(2007-2#1)(2009-8#1)(2012-12#1)
suspected in the##2##3##(2008-10#1)(2012-12#1)
suspected in##26##2##(1990-2#1)(1990-3#1)(1991-4#1)(1992-12#1)(1995-7#1)(1996-12#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-2#2)(2008-1#1)(2008-10#1)(2008-4#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-10#1)(2012-12#3)(2012-2#2)(2013-1#1)
suspected infections##3##2##(1993-2#1)(2007-2#1)(2007-7#1)
suspected lesions##2##2##(1990-6#1)(2008-9#1)
suspected malignancy##3##2##(1995-11#1)(2008-1#1)(2008-5#1)
suspected of an infectious##2##4##(1990-12#1)(2008-8#1)
suspected of being infected##2##4##(2006-10#1)(2007-6#1)
suspected of being##6##3##(1996-1#1)(1996-9#1)(2006-10#1)(2007-6#2)(2008-10#1)
suspected of having a##3##4##(1992-3#1)(2009-3#1)(2010-12#1)
suspected of having##11##3##(1992-3#1)(1992-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2009-3#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-12#2)
suspected of##41##2##(1990-10#1)(1990-12#1)(1990-3#1)(1992-3#1)(1992-8#1)(1993-12#1)(1995-11#1)(1995-7#1)(1996-1#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-8#2)(2006-10#1)(2006-4#1)(2007-2#1)(2007-6#2)(2007-7#2)(2007-8#1)(2008-10#4)(2008-5#1)(2008-8#2)(2009-3#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#1)
suspected on the basis of##3##5##(1990-3#1)(2008-4#1)(2008-7#1)
suspected on the##4##3##(1990-3#1)(2008-4#1)(2008-7#1)(2009-9#1)
suspected on##10##2##(1990-3#2)(1991-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-9#1)(2012-2#2)(2013-1#1)
suspected only##2##2##(1992-8#1)(2013-8#1)
suspected or confirmed##2##3##(2011-2#1)(2012-3#1)
suspected or documented##2##3##(2007-11#1)(2008-3#1)
suspected or known##4##3##(2006-10#2)(2006-12#1)(2010-7#1)
suspected or##11##2##(2006-10#2)(2006-12#1)(2007-11#1)(2008-3#1)(2008-9#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
suspected ovarian##2##2##(1991-3#1)(2013-8#1)
suspected patients##2##2##(2012-12#1)(2012-3#1)
suspected periodontal##2##2##(1991-1#1)(2006-8#1)
suspected plague##2##2##(2004-11#2)
suspected preoperatively##3##2##(2007-7#1)(2008-12#1)(2009-7#1)
suspected presence of##2##3##(2005-10#1)(2008-5#1)
suspected previously##2##2##(2008-10#1)(2008-4#1)
suspected pulmonary embolism##3##3##(1991-11#1)(2005-10#1)(2011-1#1)
suspected pulmonary##5##2##(1991-11#1)(1991-3#1)(2005-10#1)(2005-11#1)(2011-1#1)
suspected risk##2##2##(1992-12#1)(1996-6#1)
suspected scaphoid fractures##5##3##(2008-9#5)
suspected scaphoid##7##2##(2006-3#1)(2008-9#6)
suspected secondary hypertension##2##3##(2008-1#2)
suspected secondary##3##2##(1993-9#1)(2008-1#2)
suspected skeletal dysplasia##3##3##(2011-1#3)
suspected small bowel##2##3##(2007-8#1)(2012-2#1)
suspected that the##2##3##(2012-2#1)(2013-8#1)
suspected that##8##2##(1990-9#1)(1997-4#1)(2007-12#1)(2007-3#1)(2008-4#1)(2012-1#1)(2012-2#1)(2013-8#1)
suspected to be a##5##4##(1991-12#2)(2008-5#1)(2010-6#1)(2010-8#1)
suspected to be associated with##2##5##(1997-4#1)(2006-10#1)
suspected to be related to##2##5##(2007-2#1)(2008-10#1)
suspected to be the cause##3##5##(1995-9#1)(2008-10#1)(2008-6#1)
suspected to be##16##3##(1991-12#2)(1992-8#1)(1992-9#1)(1995-9#1)(1997-4#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-6#1)(2010-8#1)(2013-8#1)
suspected to have asthma##2##4##(2007-2#2)
suspected to have##10##3##(1990-2#2)(1997-4#1)(2006-10#1)(2007-2#3)(2007-7#1)(2011-2#1)(2012-12#1)
suspected to produce extended spectrum beta-lactamases by the##2##8##(2008-11#2)
suspected to##38##2##(1990-2#2)(1990-3#1)(1991-10#1)(1991-12#2)(1992-4#1)(1992-8#1)(1992-9#1)(1994-5#1)(1995-9#1)(1996-10#1)(1997-4#2)(2005-11#1)(2005-7#1)(2006-10#2)(2006-6#1)(2007-2#4)(2007-7#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-8#2)
suspected upon##2##2##(1993-1#1)(2013-7#1)
suspected when##6##2##(1997-8#1)(2007-7#1)(2011-1#1)(2011-11#1)(2013-1#2)
suspected work-related##2##2##(1996-2#1)(2008-12#1)
suspected##567##1##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#6)(1990-3#8)(1990-4#2)(1990-6#7)(1990-7#1)(1990-8#1)(1990-9#3)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#6)(1991-2#1)(1991-3#7)(1991-4#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#3)(1992-12#3)(1992-2#3)(1992-3#4)(1992-4#4)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-1#2)(1993-10#2)(1993-12#2)(1993-2#2)(1993-5#2)(1993-7#1)(1993-8#1)(1993-9#3)(1994-2#1)(1994-5#3)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#6)(1995-2#1)(1995-5#1)(1995-6#5)(1995-7#2)(1995-9#2)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-6#2)(1996-8#2)(1996-9#5)(1997-1#5)(1997-2#5)(1997-3#1)(1997-4#5)(1997-5#1)(1997-6#1)(1997-8#5)(2004-11#2)(2004-3#1)(2005-1#1)(2005-10#6)(2005-11#4)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#15)(2006-12#7)(2006-2#5)(2006-3#2)(2006-4#5)(2006-5#1)(2006-6#2)(2006-8#5)(2006-9#3)(2007-10#1)(2007-11#2)(2007-12#6)(2007-2#22)(2007-3#6)(2007-4#4)(2007-5#2)(2007-6#2)(2007-7#15)(2007-8#9)(2007-9#4)(2008-1#10)(2008-10#15)(2008-11#6)(2008-12#7)(2008-2#2)(2008-3#8)(2008-4#12)(2008-5#11)(2008-6#4)(2008-7#7)(2008-8#5)(2008-9#13)(2009-1#1)(2009-10#3)(2009-2#3)(2009-3#4)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#7)(2010-2#2)(2010-4#6)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#4)(2010-9#4)(2011-1#12)(2011-11#1)(2011-12#2)(2011-2#21)(2012-1#2)(2012-12#14)(2012-2#19)(2012-3#9)(2013-1#16)(2013-7#5)(2013-8#13)
suspected)##2##1##(1990-12#1)(2011-2#1)
suspecting##5##1##(2005-10#1)(2007-10#1)(2007-3#1)(2010-11#1)(2011-2#1)
suspects##8##1##(1990-8#1)(1996-6#1)(2007-1#1)(2008-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
suspend##4##1##(1993-3#1)(1997-2#1)(2005-3#1)(2008-7#1)
suspended and##2##2##(2006-2#1)(2008-2#1)
suspended axial##3##2##(2007-8#3)
suspended by##2##2##(2008-2#1)(2008-3#1)
suspended carriers in##2##3##(2008-7#2)
suspended carriers##4##2##(1994-5#1)(2008-7#3)
suspended cells##4##2##(1994-3#1)(2008-11#2)(2013-1#1)
suspended colloidal##2##2##(2007-9#1)(2009-6#1)
suspended for##4##2##(2006-10#1)(2007-11#1)(2011-2#1)(2012-2#1)
suspended from the##2##3##(2008-10#1)(2011-2#1)
suspended from##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
suspended in a##5##3##(1991-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#1)
suspended in an aqueous##2##4##(1992-12#1)(2005-11#1)
suspended in aqueous##2##3##(2006-2#1)(2008-5#1)
suspended in distilled water##2##4##(2007-12#1)(2008-5#1)
suspended in non-alcoholic beer##2##4##(2012-2#2)
suspended in organic media##2##4##(2006-12#1)(2008-7#1)
suspended in organic##3##3##(2006-12#1)(2007-6#1)(2008-7#1)
suspended in solution##3##3##(1994-6#1)(2008-10#2)
suspended in solvent##2##3##(2008-10#1)(2012-1#1)
suspended in the##4##3##(2008-1#1)(2008-10#1)(2008-11#1)(2013-8#1)
suspended in water##4##3##(1995-5#1)(2005-11#1)(2008-10#1)(2008-2#1)
suspended in##51##2##(1991-5#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-5#1)(1996-1#1)(2005-11#2)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#2)(2009-5#1)(2010-12#1)(2010-8#1)(2012-1#1)(2012-2#4)(2013-8#1)
suspended matter##8##2##(2008-10#3)(2008-2#1)(2008-5#4)
suspended membrane##2##2##(2006-5#2)
suspended mirrors##4##2##(2008-3#4)
suspended on##2##2##(2008-10#2)
suspended particles##6##2##(2008-10#3)(2008-2#3)
suspended particulate matter (SPM)##2##4##(2008-10#1)(2009-6#1)
suspended particulate matter##4##3##(2008-10#2)(2008-3#1)(2009-6#1)
suspended particulate##7##2##(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2009-6#1)
suspended sediment##3##2##(1992-6#1)(1997-4#1)(2007-5#1)
suspended sediments##2##2##(2008-3#1)(2013-8#1)
suspended solid##3##2##(2011-2#2)(2013-8#1)
suspended solids##13##2##(2006-8#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-5#1)(2010-5#2)(2013-1#1)(2013-8#1)
suspended##167##1##(1990-8#1)(1991-2#1)(1991-5#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#3)(1992-7#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-5#1)(1996-1#2)(1996-6#1)(1997-4#1)(2004-1#1)(2005-11#3)(2005-4#1)(2006-10#1)(2006-12#1)(2006-2#3)(2006-5#2)(2006-8#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#27)(2008-11#6)(2008-2#11)(2008-3#14)(2008-4#1)(2008-5#9)(2008-7#8)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-12#1)(2010-4#3)(2010-5#2)(2010-8#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#5)(2012-4#1)(2013-1#4)(2013-8#4)
suspending agents##2##2##(1992-3#2)
suspending medium##4##2##(1997-1#3)(2008-8#1)
suspending##17##1##(1992-3#2)(1993-3#1)(1994-9#1)(1996-11#1)(1997-1#3)(2005-11#3)(2008-10#2)(2008-5#2)(2008-8#1)(2012-3#1)
suspends the##2##2##(2007-9#1)(2012-1#1)
suspensa##8##1##(2007-12#3)(2011-2#5)
suspension (1##2##2##(2005-11#1)(2008-10#1)
suspension and adherent##2##3##(2008-11#1)(2008-4#1)
suspension and monolayer##3##3##(2008-11#3)
suspension and##25##2##(1994-11#1)(1994-2#1)(2005-11#1)(2007-8#2)(2008-10#5)(2008-11#9)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#2)(2013-1#1)
suspension are##4##2##(1994-11#1)(2005-11#1)(2008-7#1)(2010-7#1)
suspension as##2##2##(2007-12#1)(2008-2#1)
suspension bioreactor##2##2##(2008-11#2)
suspension cell culture##5##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2012-3#1)
suspension cell##8##2##(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2012-11#1)(2012-3#1)
suspension cells and##2##3##(2008-8#2)
suspension cells using##2##3##(2008-11#1)(2008-8#1)
suspension cells##20##2##(1991-5#1)(1992-11#1)(2006-12#1)(2008-1#3)(2008-11#5)(2008-2#1)(2008-4#2)(2008-8#4)(2008-9#1)(2012-3#1)
suspension culture of##3##3##(2008-11#2)(2008-9#1)
suspension culture was##3##3##(2008-11#3)
suspension culture##36##2##(1992-9#1)(1994-11#1)(1997-1#1)(2008-11#28)(2008-2#1)(2008-9#3)(2009-6#1)
suspension cultured##2##2##(2008-11#1)(2008-8#1)
suspension cultures in##3##3##(2008-11#2)(2008-7#1)
suspension cultures of##11##3##(1991-1#1)(1992-8#1)(1996-10#1)(1997-8#1)(2007-1#2)(2008-11#5)
suspension cultures##38##2##(1991-1#1)(1992-8#1)(1993-3#1)(1994-5#1)(1996-10#1)(1997-4#1)(1997-8#1)(2006-12#1)(2007-1#2)(2007-11#1)(2008-11#14)(2008-2#2)(2008-4#3)(2008-7#3)(2008-9#2)(2012-11#3)
suspension for##4##2##(1995-2#1)(2005-11#1)(2008-11#1)(2010-2#1)
suspension galvanic cells##2##3##(2008-10#2)
suspension growth##3##2##(2008-11#3)
suspension in a##4##3##(2005-11#1)(2008-10#1)(2008-11#2)
suspension in the presence##2##4##(1993-12#1)(2005-11#1)
suspension in the same##2##4##(2006-6#1)(2008-11#1)
suspension in the##8##3##(1993-12#1)(2005-11#2)(2006-6#2)(2007-12#1)(2008-10#1)(2008-11#1)
suspension in water##2##3##(2005-11#1)(2008-10#1)
suspension in##20##2##(1993-12#1)(1995-2#1)(1996-1#1)(2005-11#4)(2006-6#2)(2007-1#1)(2007-12#1)(2008-10#3)(2008-11#5)(2010-12#1)
suspension into##3##2##(2008-10#2)(2008-11#1)
suspension is then##2##3##(2004-9#1)(2008-11#1)
suspension is##11##2##(1991-8#1)(2004-9#2)(2008-11#4)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)
suspension medium##2##2##(1997-1#1)(2008-11#1)
suspension of P##3##3##(2008-10#3)
suspension of an##3##3##(2008-10#2)(2008-4#1)
suspension of polystyrene microspheres##2##4##(2008-2#1)(2008-3#1)
suspension of polystyrene##3##3##(2008-2#2)(2008-3#1)
suspension of the##2##3##(2008-8#1)(2012-1#1)
suspension of these##2##3##(2006-12#1)(2008-7#1)
suspension of##57##2##(1990-11#1)(1990-7#1)(1991-1#1)(1993-3#1)(1994-3#1)(1996-1#1)(1996-5#1)(1996-8#1)(1997-3#1)(2005-11#1)(2005-9#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#3)(2007-12#3)(2008-1#1)(2008-10#12)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-12#1)(2012-1#1)(2012-12#1)(2013-1#1)
suspension on the##2##3##(2008-10#1)(2008-11#1)
suspension on##3##2##(2008-10#1)(2008-11#1)(2011-12#1)
suspension or adherent##4##3##(2008-4#4)
suspension or dry##2##3##(2008-6#2)
suspension or##12##2##(1994-5#1)(1995-7#1)(2008-10#1)(2008-11#2)(2008-4#4)(2008-6#2)(2008-9#1)
suspension to##3##2##(1990-12#1)(2008-10#1)(2009-8#1)
suspension was increased##2##3##(1992-9#1)(2011-12#1)
suspension was##11##2##(1990-10#1)(1992-9#1)(1996-5#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#2)(2011-12#1)
suspension with##5##2##(1993-11#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
suspension##457##1##(1990-10#3)(1990-11#1)(1990-12#3)(1990-7#1)(1990-8#1)(1991-1#2)(1991-12#1)(1991-5#1)(1991-8#2)(1992-11#1)(1992-2#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#3)(1993-3#2)(1994-11#6)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-2#2)(1995-3#1)(1995-7#1)(1995-8#1)(1996-1#5)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#4)(1997-3#1)(1997-4#1)(1997-8#1)(2004-12#1)(2004-9#7)(2005-11#19)(2005-9#1)(2006-10#3)(2006-12#3)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#7)(2007-1#3)(2007-11#1)(2007-12#8)(2007-4#1)(2007-8#5)(2007-9#2)(2008-1#6)(2008-10#59)(2008-11#113)(2008-12#2)(2008-2#12)(2008-3#11)(2008-4#24)(2008-5#11)(2008-6#6)(2008-7#9)(2008-8#11)(2008-9#11)(2009-11#3)(2009-3#1)(2009-4#2)(2009-6#2)(2009-7#1)(2009-8#4)(2010-1#1)(2010-12#2)(2010-2#2)(2010-4#3)(2010-7#2)(2010-8#1)(2011-12#6)(2012-1#4)(2012-11#5)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#2)
suspension)##3##1##(1994-9#1)(2008-10#2)
suspension-cultured cells of##2##3##(1990-7#1)(1996-10#1)
suspension-cultured cells##3##2##(1990-7#1)(1994-11#1)(1996-10#1)
suspension-cultured##4##1##(1990-7#1)(1992-11#1)(1994-11#1)(1996-10#1)
suspensions and##10##2##(1994-11#1)(2005-12#1)(2007-12#2)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)
suspensions are prepared by weighing##2##5##(2008-10#2)
suspensions are##12##2##(1992-2#1)(2004-9#1)(2005-11#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#1)
suspensions as##2##2##(1990-10#1)(2008-5#1)
suspensions by use of##2##4##(2007-12#1)(2008-2#1)
suspensions by##3##2##(2005-11#1)(2007-12#1)(2008-2#1)
suspensions containing##5##2##(1990-12#1)(2006-6#1)(2007-9#2)(2008-5#1)
suspensions for##2##2##(2008-10#1)(2008-2#1)
suspensions from##4##2##(1990-12#2)(2007-12#1)(2008-11#1)
suspensions in the##3##3##(1994-11#1)(2005-11#1)(2007-12#1)
suspensions in water##2##3##(2007-12#1)(2008-10#1)
suspensions in##13##2##(1993-3#1)(1994-11#1)(1995-2#1)(2005-11#1)(2006-12#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-4#1)
suspensions is also##2##3##(2008-4#2)
suspensions is##5##2##(2007-11#1)(2007-12#1)(2008-4#3)
suspensions of polystyrene latex spheres##2##5##(2008-3#2)
suspensions of polystyrene##3##3##(2007-12#1)(2008-3#2)
suspensions of small##2##3##(1991-8#1)(2006-10#1)
suspensions of the##2##3##(1994-11#1)(2008-10#1)
suspensions of##66##2##(1990-3#1)(1990-4#1)(1991-8#1)(1991-9#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-7#1)(2005-11#7)(2005-3#1)(2006-10#1)(2007-12#3)(2007-7#1)(2008-10#19)(2008-11#2)(2008-2#5)(2008-3#4)(2008-4#4)(2008-5#2)(2008-9#1)(2009-2#2)(2009-4#1)(2010-12#1)(2010-8#1)(2013-1#1)
suspensions prior to##3##3##(1992-6#2)(2008-4#1)
suspensions that##2##2##(2006-6#1)(2008-3#1)
suspensions to##6##2##(1994-2#2)(1996-8#1)(2008-10#2)(2008-2#1)
suspensions was##3##2##(2005-11#1)(2008-10#1)(2008-3#1)
suspensions were incubated with##2##4##(1994-11#1)(2006-5#1)
suspensions were##10##2##(1990-12#1)(1993-8#1)(1994-11#1)(2004-11#1)(2006-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-2#2)
suspensions with##5##2##(2007-12#1)(2008-10#2)(2008-3#1)(2011-2#1)
suspensions##236##1##(1990-10#1)(1990-12#6)(1990-2#1)(1990-3#1)(1990-4#3)(1990-7#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-4#2)(1992-5#1)(1992-6#2)(1992-9#1)(1993-3#2)(1993-8#1)(1994-11#5)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1995-2#1)(1995-7#3)(1996-11#1)(1996-8#1)(1997-1#1)(1997-6#1)(2004-11#1)(2004-9#1)(2005-11#19)(2005-12#2)(2005-3#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#3)(2007-11#3)(2007-12#15)(2007-7#2)(2007-9#2)(2008-1#2)(2008-10#43)(2008-11#4)(2008-12#1)(2008-2#15)(2008-3#23)(2008-4#15)(2008-5#8)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#6)(2009-2#3)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
suspensor cells##2##2##(2009-8#2)
suspensor##4##1##(2009-8#4)
suspensory fixation##2##2##(2013-1#2)
suspensory##3##1##(2011-2#1)(2013-1#2)
suspicion and the##2##3##(1991-6#1)(2010-7#1)
suspicion and##9##2##(1991-6#1)(2005-10#1)(2008-1#1)(2009-11#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
suspicion for the presence##3##4##(2006-9#1)(2013-1#2)
suspicion for##15##2##(2005-10#2)(2006-10#1)(2006-11#1)(2006-9#1)(2007-9#1)(2008-11#1)(2008-3#1)(2011-1#1)(2011-2#2)(2013-1#3)(2013-8#1)
suspicion in##9##2##(2005-12#1)(2007-7#1)(2008-4#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-12#1)(2012-12#1)(2013-1#1)
suspicion is the##2##3##(2011-2#1)(2012-1#1)
suspicion is##21##2##(1993-6#1)(1995-10#1)(2006-4#2)(2007-7#3)(2008-1#1)(2009-3#2)(2009-4#1)(2009-6#1)(2010-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
suspicion of Sjögren's syndrome##2##4##(2006-10#1)(2007-3#1)
suspicion of a##3##3##(1992-12#1)(1992-2#1)(2012-12#1)
suspicion of an##4##3##(2008-12#1)(2008-7#1)(2010-12#1)(2010-2#1)
suspicion of malignancy##2##3##(1991-2#1)(1994-12#1)
suspicion of##68##2##(1990-12#1)(1990-2#1)(1991-10#1)(1991-2#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-8#1)(1993-10#1)(1993-8#1)(1994-12#2)(1994-7#1)(1995-5#1)(1995-7#1)(2006-10#4)(2006-12#1)(2007-10#1)(2007-11#3)(2007-3#3)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#3)(2008-1#1)(2008-12#3)(2008-3#4)(2008-5#1)(2008-7#1)(2009-8#2)(2010-10#1)(2010-12#3)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)
suspicion when evaluating##2##3##(2008-7#1)(2013-8#1)
suspicion##166##1##(1990-12#2)(1990-2#1)(1990-3#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-8#2)(1993-10#1)(1993-2#2)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-7#1)(1995-10#1)(1995-5#2)(1995-7#1)(1997-2#2)(2004-11#1)(2005-10#3)(2005-11#1)(2005-12#1)(2005-2#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-4#3)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-3#3)(2007-5#1)(2007-6#2)(2007-7#6)(2007-8#3)(2007-9#1)(2008-1#4)(2008-11#1)(2008-12#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#3)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#13)(2012-1#2)(2012-12#8)(2012-2#4)(2012-3#3)(2013-1#10)(2013-8#5)
suspicions that##2##2##(1995-6#1)(2008-7#1)
suspicions##5##1##(1995-6#1)(2006-12#1)(2006-4#2)(2008-7#1)
suspicious breast##2##2##(2008-4#1)(2012-2#1)
suspicious cases##2##2##(1990-6#1)(2012-12#1)
suspicious entries##2##2##(2012-11#2)
suspicious for##2##2##(2010-1#1)(2011-1#1)
suspicious in##2##2##(1995-4#1)(2011-1#1)
suspicious lesions in##2##3##(1996-12#1)(2009-3#1)
suspicious lesions##3##2##(1996-12#1)(2006-10#1)(2009-3#1)
suspicious of malignancy##2##3##(1997-2#1)(2012-2#1)
suspicious of##8##2##(1991-6#1)(1993-1#1)(1995-5#1)(1997-2#1)(2007-8#1)(2010-12#1)(2012-2#1)(2013-8#1)
suspicious##42##1##(1990-6#1)(1991-6#2)(1992-4#2)(1993-1#1)(1993-2#1)(1994-1#1)(1995-4#2)(1995-5#1)(1996-12#1)(1997-2#1)(2005-9#1)(2006-10#1)(2007-4#2)(2007-6#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-3#1)(2010-1#1)(2010-12#1)(2011-1#2)(2012-11#3)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#4)
suspiciousness/feelings of persecution##2##3##(2008-6#2)
suspiciousof##2##1##(2009-8#2)
sustain a healthy##2##3##(2012-2#1)(2013-7#1)
sustain a##9##2##(1993-1#1)(1994-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-7#1)
sustain an##5##2##(2007-1#2)(2008-1#1)(2008-2#1)(2009-5#1)
sustain life##2##2##(1991-2#1)(2013-8#1)
sustain long-lasting in vitro hematopoiesis##2##5##(2009-12#2)
sustain severe##2##2##(2007-4#2)
sustain that##4##2##(2008-2#1)(2012-12#1)(2013-1#2)
sustain the##16##2##(1990-2#1)(1992-10#1)(1992-8#1)(1995-12#1)(1996-2#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-5#1)(2009-5#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
sustain their##4##2##(2007-4#2)(2008-1#1)(2010-5#1)
sustain this##2##2##(1995-9#1)(2007-1#1)
sustain##96##1##(1990-11#1)(1990-2#1)(1990-4#1)(1991-2#2)(1991-3#1)(1992-10#1)(1992-8#1)(1993-1#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-2#1)(1997-5#1)(2005-7#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-1#3)(2007-11#1)(2007-4#6)(2007-8#1)(2008-1#4)(2008-10#3)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#2)(2009-4#1)(2009-5#2)(2009-8#1)(2010-10#3)(2010-12#1)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#2)
sustainability and the##2##3##(2009-5#1)(2013-7#1)
sustainability and##6##2##(2008-12#1)(2009-5#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-7#1)
sustainability in##3##2##(2009-8#1)(2010-8#1)(2013-8#1)
sustainability is##2##2##(2006-4#1)(2013-1#1)
sustainability of the##7##3##(2007-4#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#2)
sustainability of these##2##3##(1997-7#1)(2007-8#1)
sustainability of##19##2##(1997-3#1)(1997-7#2)(2004-4#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-8#1)(2011-2#2)(2012-2#4)
sustainability will##2##2##(2011-1#1)(2012-2#1)
sustainability##52##1##(1997-3#1)(1997-7#3)(2004-4#2)(2006-4#2)(2006-7#1)(2007-10#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#2)(2009-4#2)(2009-5#4)(2009-8#2)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#3)(2012-2#5)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
sustainable agriculture##3##2##(2008-4#1)(2009-8#1)(2012-1#1)
sustainable and##6##2##(1995-3#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-8#1)(2011-2#1)
sustainable approach to##2##3##(2007-6#1)(2008-10#1)
sustainable chemistry##2##2##(2007-11#1)(2008-11#1)
sustainable development##15##2##(1992-5#2)(1996-5#1)(2006-12#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-8#1)(2011-12#1)(2012-3#1)(2013-8#2)
sustainable environmental##2##2##(2008-10#1)(2008-11#1)
sustainable forest##2##2##(2006-5#1)(2008-10#1)
sustainable fortification##2##2##(2006-10#2)
sustainable growth rate##3##3##(2007-4#1)(2008-4#2)
sustainable in the##2##3##(2007-10#1)(2013-8#1)
sustainable interventions##2##2##(2006-10#1)(2008-11#1)
sustainable management##2##2##(2008-10#2)
sustainable production##3##2##(2008-5#1)(2009-3#1)(2012-11#1)
sustainable program##2##2##(1995-12#1)(2007-12#1)
sustainable use of##3##3##(2006-7#1)(2007-3#1)(2009-8#1)
sustainable##128##1##(1992-5#4)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-5#1)(1997-7#4)(2005-11#1)(2006-10#4)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-4#2)(2007-5#3)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#7)(2008-12#6)(2008-4#5)(2008-5#4)(2008-7#3)(2008-8#3)(2009-3#1)(2009-6#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-3#2)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#3)(2012-1#4)(2012-11#1)(2012-12#1)(2012-3#2)(2012-9#1)(2013-1#4)(2013-7#1)(2013-8#9)
sustainably##2##1##(2007-5#1)(2012-12#1)
sustained Ca2+ oscillations##2##3##(1991-1#2)
sustained Ca2+##3##2##(1991-1#2)(1994-2#1)
sustained a##25##2##(1991-5#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-8#3)(2007-10#2)(2007-2#1)(2008-12#1)(2008-7#2)(2009-10#1)(2009-3#1)(2010-1#1)(2012-12#2)(2012-3#2)(2013-1#5)
sustained activation of the##2##4##(1997-7#1)(2008-8#1)
sustained activation of##7##3##(1994-6#1)(1995-3#3)(1997-7#1)(2008-8#1)(2012-2#1)
sustained activation##10##2##(1994-6#1)(1995-3#3)(1997-7#1)(2008-10#1)(2008-8#1)(2010-4#1)(2012-12#1)(2012-2#1)
sustained an injury##2##3##(2008-12#1)(2009-6#1)
sustained an##10##2##(1991-6#1)(2006-4#1)(2007-8#1)(2007-9#1)(2008-12#1)(2009-6#2)(2010-3#1)(2012-2#1)(2013-1#1)
sustained and controlled##3##3##(2008-5#2)(2010-5#1)
sustained and transient ON signals of##2##6##(2008-9#2)
sustained and transient##4##3##(2008-2#1)(2008-9#3)
sustained and##20##2##(1991-10#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-3#1)(2005-8#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-9#3)(2010-5#2)(2011-2#1)(2012-12#1)(2012-2#1)
sustained arterial##2##2##(1991-3#1)(1992-8#1)
sustained at##4##2##(1993-8#1)(1996-5#1)(2007-8#1)(2013-1#1)
sustained attention and attentional##2##4##(2005-10#1)(2008-10#1)
sustained attention and##4##3##(1997-2#1)(2005-10#1)(2008-10#1)(2008-2#1)
sustained attention##13##2##(1996-3#1)(1997-1#3)(1997-2#2)(2005-10#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-2#2)(2011-2#1)
sustained attentional##2##2##(2008-2#1)(2012-1#1)
sustained blockade of##2##3##(1995-2#2)
sustained by the##2##3##(1994-9#1)(1996-11#1)
sustained by##17##2##(1992-8#1)(1993-2#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-5#1)(1996-11#1)(2005-8#1)(2006-11#1)(2007-11#1)(2007-6#4)(2008-10#1)(2012-12#1)(2012-2#1)
sustained cardiac##3##2##(2008-1#1)(2008-3#1)(2009-4#1)
sustained contraction induced by bombesin or##2##6##(1991-12#2)
sustained contractions##3##2##(1997-7#1)(2013-8#2)
sustained currents were##2##3##(2008-4#2)
sustained decrease in##3##3##(1994-11#1)(2009-10#1)(2010-7#1)
sustained decrease##4##2##(1994-11#1)(1994-8#1)(2009-10#1)(2010-7#1)
sustained delivery of##4##3##(2008-5#1)(2009-11#1)(2011-2#2)
sustained drug##2##2##(2005-8#1)(2011-2#1)
sustained during##6##2##(1991-7#1)(1997-6#1)(2007-11#1)(2007-8#1)(2010-1#1)(2013-1#1)
sustained efficacy##2##2##(2008-3#1)(2010-4#1)
sustained either##2##2##(1996-3#1)(2008-9#1)
sustained elevation in##3##3##(1995-3#1)(2005-10#1)(2011-1#1)
sustained elevation of##2##3##(1995-3#1)(1996-6#1)
sustained elevation##6##2##(1991-1#1)(1995-3#2)(1996-6#1)(2005-10#1)(2011-1#1)
sustained even##3##2##(2007-10#1)(2008-6#1)(2009-9#1)
sustained exposure to##2##3##(1996-12#1)(1997-7#1)
sustained exposure##3##2##(1996-12#1)(1997-7#1)(2008-11#1)
sustained expression of##3##3##(1993-2#1)(1995-2#1)(2008-5#1)
sustained expression##4##2##(1993-2#1)(1995-2#1)(2007-3#1)(2008-5#1)
sustained for 6##3##3##(1997-6#1)(2006-5#1)(2010-5#1)
sustained for up to##2##4##(1994-11#1)(2008-10#1)
sustained for##14##2##(1990-10#1)(1993-11#1)(1994-11#1)(1995-9#1)(1997-6#2)(1997-7#1)(2006-5#1)(2008-1#2)(2008-10#1)(2008-7#1)(2010-5#1)(2013-8#1)
sustained from##2##2##(1990-11#1)(2013-1#1)
sustained growth##3##2##(1994-8#1)(1995-8#1)(2008-11#1)
sustained high##3##2##(2007-7#1)(2008-11#1)(2008-5#1)
sustained hyperglycemia##4##2##(2008-1#2)(2009-11#1)(2012-4#1)
sustained improvement in##2##3##(2011-2#1)(2012-3#1)
sustained improvement##3##2##(1994-12#1)(2011-2#1)(2012-3#1)
sustained in##9##2##(1991-1#1)(2004-4#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#2)(2013-1#2)
sustained increase in [Ca2+]i##2##4##(1992-6#1)(1994-10#1)
sustained increase in inositol##2##4##(1994-9#2)
sustained increase in the##3##4##(1997-1#1)(2006-6#1)(2013-8#1)
sustained increase in##15##3##(1991-6#1)(1991-9#1)(1992-6#1)(1994-10#1)(1994-9#2)(1996-2#1)(1997-1#1)(1997-2#1)(2006-6#1)(2008-4#2)(2012-12#1)(2013-8#2)
sustained increase of##4##3##(1992-1#1)(1992-6#1)(1994-10#1)(2008-3#1)
sustained increase##20##2##(1991-6#1)(1991-9#1)(1992-1#1)(1992-6#3)(1994-10#2)(1994-9#2)(1996-2#1)(1997-1#1)(1997-2#1)(2006-6#1)(2008-3#1)(2008-4#2)(2012-12#1)(2013-8#2)
sustained inhibition of##3##3##(1994-11#2)(2006-10#1)
sustained inhibition##4##2##(1991-6#1)(1994-11#2)(2006-10#1)
sustained injury##3##2##(2006-11#1)(2009-8#1)(2013-1#1)
sustained levels of##2##3##(2008-10#1)(2012-12#1)
sustained metabolic##2##2##(1996-11#1)(2008-1#1)
sustained neural activity##2##3##(1996-5#2)
sustained neurological##2##2##(2006-12#1)(2007-11#1)
sustained oscillations##7##2##(1995-8#1)(1996-6#1)(2006-10#3)(2007-9#1)(2010-10#1)
sustained over a##2##3##(1994-3#1)(1997-8#1)
sustained over##6##2##(1994-3#1)(1997-8#1)(2007-10#1)(2008-3#1)(2008-4#1)(2013-1#1)
sustained phase##13##2##(1990-10#1)(1990-3#2)(1991-10#3)(1991-12#1)(1991-5#2)(1992-4#1)(1992-7#2)(1994-2#1)
sustained phosphorylation and activation of##2##5##(1995-3#1)(1996-5#1)
sustained phosphorylation##3##2##(1994-12#1)(1995-3#1)(1996-5#1)
sustained physical##2##2##(1990-12#1)(2011-2#1)
sustained power##2##2##(2008-3#2)
sustained progression##2##2##(2007-11#2)
sustained reduction in the##3##4##(1990-12#1)(2012-2#1)(2013-1#1)
sustained reduction in##5##3##(1990-12#1)(1995-12#1)(1995-5#1)(2012-2#1)(2013-1#1)
sustained release formulation##2##3##(2005-8#1)(2007-10#1)
sustained release of the##2##4##(2011-1#1)(2011-2#1)
sustained release of##5##3##(1994-6#1)(2011-1#1)(2011-2#1)(2013-1#2)
sustained release##26##2##(1992-4#2)(1994-6#1)(1996-11#1)(1997-4#1)(2004-3#1)(2005-8#1)(2007-10#1)(2007-11#1)(2008-11#4)(2009-2#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#5)(2012-2#2)(2013-1#2)
sustained remission##3##2##(2008-1#1)(2010-12#1)(2011-2#1)
sustained response##4##2##(2006-10#1)(2007-11#1)(2008-2#1)(2008-9#1)
sustained responses##2##2##(2007-11#1)(2012-2#1)
sustained severe##2##2##(1991-11#1)(2006-7#1)
sustained suppression of##2##3##(2007-11#1)(2013-1#1)
sustained suppression##3##2##(2007-11#1)(2009-8#1)(2013-1#1)
sustained than##2##2##(1997-1#1)(2008-12#1)
sustained the diagnosis of##2##4##(2013-7#2)
sustained the##7##2##(1995-12#1)(2008-8#1)(2012-2#1)(2013-1#2)(2013-7#2)
sustained therapeutic##2##2##(2007-11#1)(2013-7#1)
sustained this##2##2##(2008-7#2)
sustained through the##2##3##(1991-12#1)(1995-2#1)
sustained through##3##2##(1991-12#1)(1995-2#1)(2008-1#1)
sustained until##3##2##(1992-3#1)(2008-3#1)(2008-9#1)
sustained ventricular tachycardia##7##3##(1990-3#4)(1996-4#1)(2006-4#1)(2008-10#1)
sustained ventricular##9##2##(1990-3#4)(1996-4#2)(2006-4#1)(2007-9#1)(2008-10#1)
sustained viral##2##2##(1995-9#1)(2007-11#1)
sustained virologic response (SVR)##2##4##(2013-1#2)
sustained virologic response##4##3##(2010-12#2)(2013-1#2)
sustained virological response##5##3##(2005-6#1)(2009-7#1)(2012-1#2)(2012-2#1)
sustained visual##3##2##(1997-1#1)(1997-6#2)
sustained with##2##2##(2007-11#2)
sustained##589##1##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#7)(1990-4#1)(1990-5#3)(1990-6#1)(1990-9#1)(1991-1#4)(1991-10#5)(1991-11#2)(1991-12#6)(1991-2#1)(1991-3#3)(1991-5#3)(1991-6#3)(1991-7#2)(1991-8#1)(1991-9#4)(1992-1#1)(1992-2#1)(1992-3#2)(1992-4#3)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#5)(1993-11#3)(1993-12#2)(1993-2#3)(1993-4#1)(1993-5#1)(1993-8#1)(1994-10#2)(1994-11#4)(1994-12#2)(1994-2#5)(1994-3#1)(1994-5#1)(1994-6#6)(1994-8#2)(1994-9#4)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#6)(1995-3#8)(1995-5#3)(1995-6#1)(1995-7#2)(1995-8#4)(1995-9#2)(1996-1#2)(1996-11#5)(1996-12#5)(1996-2#2)(1996-3#4)(1996-4#2)(1996-5#5)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#8)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#5)(1997-7#4)(1997-8#4)(2004-12#1)(2004-3#1)(2004-4#1)(2005-10#3)(2005-12#1)(2005-6#1)(2005-7#1)(2005-8#5)(2005-9#2)(2006-1#1)(2006-10#11)(2006-11#8)(2006-12#2)(2006-3#2)(2006-4#8)(2006-5#4)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#3)(2007-1#3)(2007-10#8)(2007-11#19)(2007-12#4)(2007-2#1)(2007-3#5)(2007-6#4)(2007-7#5)(2007-8#6)(2007-9#5)(2008-1#13)(2008-10#12)(2008-11#12)(2008-12#4)(2008-2#7)(2008-3#10)(2008-4#14)(2008-5#10)(2008-6#2)(2008-7#11)(2008-8#7)(2008-9#8)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#6)(2009-9#1)(2010-1#5)(2010-10#1)(2010-11#3)(2010-12#7)(2010-3#4)(2010-4#3)(2010-5#5)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#15)(2012-1#4)(2012-10#1)(2012-11#2)(2012-12#14)(2012-2#15)(2012-3#5)(2012-4#1)(2013-1#27)(2013-7#3)(2013-8#9)
sustained-release (SR)##2##2##(1992-4#2)
sustained-release form of bFGF##2##4##(2007-8#2)
sustained-release form of##4##3##(1993-10#1)(2007-8#3)
sustained-release form##5##2##(1993-10#1)(2007-8#3)(2009-11#1)
sustained-release formulation of##2##3##(2009-11#1)(2011-2#1)
sustained-release formulation##3##2##(2009-11#2)(2011-2#1)
sustained-release tablets of##2##3##(2011-1#1)(2012-2#1)
sustained-release theophylline pellets formulation for once-daily evening administration##2##8##(2005-10#2)
sustained-release##31##1##(1992-4#3)(1992-8#1)(1993-1#1)(1993-10#3)(1997-3#1)(2004-12#1)(2005-1#1)(2005-10#2)(2005-9#1)(2007-4#1)(2007-8#4)(2008-5#2)(2009-11#3)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#3)
sustaining a##6##2##(1993-1#1)(2006-8#1)(2007-10#1)(2008-4#1)(2009-8#2)
sustaining and##2##2##(2005-8#1)(2008-8#1)
sustaining of##2##2##(2005-8#1)(2010-4#1)
sustaining the##9##2##(1991-7#1)(1994-6#1)(1995-3#2)(2004-11#1)(2006-11#1)(2008-11#1)(2008-7#1)(2013-8#1)
sustaining their##2##2##(1995-10#1)(1996-1#1)
sustaining this##2##2##(2008-11#1)(2009-4#1)
sustaining##59##1##(1990-11#1)(1991-2#1)(1991-7#1)(1992-3#1)(1993-1#1)(1993-5#1)(1994-6#2)(1995-10#1)(1995-3#2)(1996-1#1)(1996-2#1)(1996-6#1)(1997-1#1)(2004-11#1)(2005-8#2)(2006-1#2)(2006-10#2)(2006-11#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
sustains an##2##2##(2008-12#1)(2008-2#1)
sustains its##2##2##(2006-8#1)(2008-10#1)
sustains the##3##2##(2007-4#1)(2008-10#1)(2009-12#1)
sustains##16##1##(2006-8#1)(2007-11#2)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-11#1)(2009-12#1)(2009-9#1)
suture anchor##4##2##(2006-3#1)(2013-7#3)
suture anchors##4##2##(2006-3#1)(2006-4#1)(2007-12#1)(2010-7#1)
suture and##5##2##(1993-9#1)(1996-9#1)(2007-11#2)(2007-8#1)
suture as##3##2##(2007-5#1)(2012-3#2)
suture at##2##2##(1993-11#1)(2013-7#1)
suture closure of the##2##4##(1991-12#1)(1996-11#1)
suture closure##5##2##(1991-12#1)(1996-11#1)(2007-8#2)(2011-2#1)
suture fixation of the##2##4##(2008-10#1)(2010-3#1)
suture for##2##2##(2008-11#1)(2011-2#1)
suture in the##2##3##(2007-7#1)(2010-11#1)
suture in##5##2##(1990-3#1)(2007-7#1)(2007-8#1)(2010-1#1)(2010-11#1)
suture is##2##2##(2006-6#1)(2007-5#1)
suture line##2##2##(2006-9#1)(2011-2#1)
suture management##3##2##(2006-6#2)(2007-7#1)
suture material##4##2##(1995-1#1)(2006-10#1)(2007-5#1)(2007-8#1)
suture materials##5##2##(1991-1#2)(2009-5#2)(2010-10#1)
suture method##2##2##(1991-12#1)(2007-10#1)
suture needle##2##2##(2007-8#1)(2008-9#1)
suture of the blue crab##2##5##(2007-5#2)
suture of the##7##3##(1990-6#1)(1992-3#1)(1993-10#1)(2007-5#2)(2007-8#1)(2008-8#1)
suture of##10##2##(1990-6#1)(1992-3#1)(1993-10#1)(2007-5#2)(2007-8#1)(2008-8#3)(2011-3#1)
suture on the##3##3##(2004-9#2)(2007-8#1)
suture placement##2##2##(2007-7#1)(2008-9#1)
suture repair##3##2##(2008-7#1)(2011-2#2)
suture retention##2##2##(2008-5#2)
suture technique for##3##3##(1991-2#2)(2006-3#1)
suture technique##10##2##(1991-2#2)(2006-3#4)(2006-6#1)(2007-8#3)
suture techniques##5##2##(1992-1#1)(1993-12#1)(2006-3#2)(2013-8#1)
suture the##3##2##(2007-8#1)(2008-11#2)
suture thread)##2##2##(2004-9#2)
suture was##3##2##(2007-5#1)(2007-7#1)(2011-2#1)
suture which##2##2##(2006-3#1)(2006-4#1)
suture##166##1##(1990-3#1)(1990-6#2)(1991-1#4)(1991-12#2)(1991-2#2)(1992-1#3)(1992-2#4)(1992-3#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-9#1)(1995-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-9#2)(2004-9#4)(2005-10#1)(2006-10#1)(2006-2#1)(2006-3#16)(2006-4#2)(2006-6#9)(2006-7#2)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#6)(2007-5#12)(2007-7#5)(2007-8#18)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-5#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-7#1)(2011-1#2)(2011-2#8)(2011-3#1)(2012-1#1)(2012-2#3)(2012-3#5)(2013-1#1)(2013-7#6)(2013-8#1)
suture-anchor##3##1##(2012-12#2)(2013-7#1)
sutured and stapled##2##3##(2008-11#1)(2013-1#1)
sutured and##4##2##(1992-3#1)(2004-9#1)(2008-11#1)(2013-1#1)
sutured to the##3##3##(2006-3#1)(2007-8#2)
sutured##23##1##(1992-3#1)(1993-11#1)(1994-3#1)(1994-8#1)(2004-9#3)(2006-3#1)(2006-6#1)(2007-8#4)(2008-11#1)(2008-12#1)(2008-5#1)(2013-1#6)(2013-7#1)
sutureless anastomotic##2##2##(2007-8#2)
sutureless distal coronary anastomosis##2##4##(2007-8#2)
sutureless distal coronary##3##3##(2007-8#3)
sutureless##10##1##(2007-8#8)(2008-10#1)(2011-1#1)
sutures and##2##2##(2012-2#1)(2013-1#1)
sutures applied##3##2##(1994-2#1)(2010-10#1)(2010-11#1)
sutures are##7##2##(2007-12#1)(2008-11#3)(2010-10#2)(2013-1#1)
sutures in##5##2##(1992-2#1)(2008-11#2)(2008-7#1)(2008-9#1)
sutures insufficiency##2##2##(2011-2#2)
sutures of##2##2##(2007-8#1)(2009-2#1)
sutures or##2##2##(1991-11#1)(2006-6#1)
sutures were##4##2##(2007-7#3)(2012-2#1)
sutures with##2##2##(2007-12#1)(2007-8#1)
sutures##66##1##(1990-12#1)(1991-11#1)(1992-2#2)(1994-2#1)(1994-9#1)(1995-1#1)(1996-6#1)(2006-11#2)(2006-6#2)(2007-12#6)(2007-7#3)(2007-8#5)(2008-10#1)(2008-11#13)(2008-7#1)(2008-9#1)(2009-2#1)(2009-7#1)(2010-10#5)(2010-11#1)(2011-1#3)(2011-2#4)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)
suturing a##2##2##(1996-6#1)(2007-8#1)
suturing and##2##2##(2008-10#1)(2010-8#1)
suturing devices##2##2##(2006-2#1)(2006-5#1)
suturing of##5##2##(1996-12#1)(2006-12#1)(2007-8#2)(2008-10#1)
suturing together##2##2##(1996-3#1)(2007-8#1)
suturing was##2##2##(2007-8#1)(2010-8#1)
suturing##37##1##(1990-4#1)(1990-6#1)(1991-11#1)(1992-3#1)(1995-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#6)(2007-12#1)(2007-8#6)(2008-10#3)(2008-6#2)(2010-11#1)(2010-8#3)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
suxamethonium##7##1##(1996-8#1)(2009-10#1)(2012-2#5)
sw/B/98##2##1##(2011-2#2)
sw/IA/04##4##1##(2011-2#4)
swab and the##2##3##(2013-1#1)(2013-7#1)
swab and##5##2##(2006-8#1)(2013-1#3)(2013-7#1)
swab eluates##2##2##(1996-12#2)
swab in##2##2##(2006-8#1)(2011-2#1)
swab samples##5##2##(2007-8#3)(2011-2#1)(2012-3#1)
swab specimens##3##2##(1993-1#1)(1997-3#1)(2008-3#1)
swab was##7##2##(1994-4#1)(2006-8#1)(2008-10#2)(2008-5#1)(2010-2#1)(2011-2#1)
swab##49##1##(1993-1#1)(1994-4#1)(1996-12#4)(1997-3#1)(2006-8#10)(2007-7#1)(2007-8#4)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#5)(2012-3#1)(2013-1#5)(2013-7#3)
swabbed##4##1##(2007-8#1)(2010-4#2)(2012-2#1)
swabbing##5##1##(1997-4#1)(2006-8#1)(2008-11#1)(2008-12#1)(2008-3#1)
swabs and##5##2##(2008-5#1)(2011-2#2)(2013-1#2)
swabs are##2##2##(1997-7#1)(2007-6#1)
swabs for##2##2##(1991-9#1)(2005-9#1)
swabs from the##5##3##(2010-5#1)(2012-12#1)(2013-8#3)
swabs from##11##2##(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#3)
swabs taken from the##2##4##(2008-12#1)(2009-6#1)
swabs taken from##4##3##(2008-12#1)(2008-5#2)(2009-6#1)
swabs taken##5##2##(2008-12#2)(2008-5#2)(2009-6#1)
swabs were collected from##6##4##(2008-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#2)
swabs were collected##8##3##(1997-6#1)(2007-2#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#2)
swabs were taken from##2##4##(2007-7#1)(2008-5#1)
swabs were##16##2##(1990-9#1)(1997-6#1)(2006-8#1)(2007-2#1)(2007-7#2)(2008-5#4)(2010-8#1)(2011-2#2)(2012-2#1)(2013-8#2)
swabs##78##1##(1990-9#2)(1991-9#1)(1996-12#2)(1997-3#1)(1997-6#3)(1997-7#3)(2005-11#1)(2005-9#3)(2006-10#1)(2006-8#4)(2007-1#1)(2007-2#1)(2007-6#1)(2007-7#5)(2008-10#2)(2008-12#2)(2008-5#15)(2008-9#1)(2009-6#1)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-2#10)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#6)
swainsoni##5##1##(2008-5#1)(2013-8#4)
swainsonine##6##1##(1990-2#1)(1995-2#1)(1997-8#1)(2008-11#3)
swallow##14##1##(1990-6#1)(1994-9#1)(1997-4#1)(2007-5#1)(2007-8#1)(2008-7#1)(2008-9#1)(2009-8#3)(2010-12#1)(2011-12#1)(2011-2#1)(2012-2#1)
swallowed by the##2##3##(2008-5#2)
swallowed##16##1##(1990-6#1)(1990-8#1)(1995-11#1)(2005-11#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-5#3)(2009-10#1)(2012-12#1)(2012-2#1)(2013-8#2)
swallowing ability##2##2##(2007-3#1)(2008-5#1)
swallowing and speech##2##3##(1992-2#1)(2012-2#1)
swallowing and##5##2##(1992-2#1)(1996-3#1)(2005-8#1)(2009-8#1)(2012-2#1)
swallowing exercises##4##2##(2013-8#4)
swallowing in##3##2##(2007-10#1)(2008-10#1)(2013-1#1)
swallowing is##2##2##(2007-10#1)(2012-3#1)
swallowing problems##2##2##(2008-7#1)(2012-2#1)
swallowing##56##1##(1991-3#1)(1992-2#1)(1993-12#6)(1996-3#2)(2005-8#1)(2006-8#1)(2007-10#4)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#6)(2008-5#1)(2008-7#1)(2009-8#1)(2010-2#6)(2011-1#1)(2011-12#2)(2011-2#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#3)(2013-8#7)
swallows and##3##2##(2008-8#2)(2011-12#1)
swallows##9##1##(2008-8#2)(2008-9#1)(2009-10#3)(2011-12#1)(2013-7#1)(2013-8#1)
swam in##2##2##(1995-6#1)(1996-8#1)
swam##5##1##(1995-6#2)(1996-8#1)(2008-5#1)(2013-1#1)
swamp##9##1##(2006-12#2)(2006-5#2)(2007-3#1)(2007-5#4)
swan neck##2##2##(1993-3#1)(2006-4#1)
swan##3##1##(1991-9#1)(1993-3#1)(2006-4#1)
swap##8##1##(1993-5#1)(1994-11#1)(1995-3#2)(1996-5#1)(2008-3#3)
swapped##2##1##(1995-11#1)(2008-3#1)
swapped-out pages##2##2##(2008-3#2)
swapping##4##1##(2006-12#1)(2011-1#2)(2012-1#1)
swarm optimization##5##2##(2007-9#1)(2013-1#4)
swarm rings##2##2##(1993-8#2)
swarm size##5##2##(2013-8#5)
swarm##19##1##(1993-8#2)(1994-2#1)(2005-11#1)(2007-12#1)(2007-2#1)(2007-9#3)(2013-1#4)(2013-8#6)
swarmer cells##2##2##(1994-8#2)
swarming behaviour of##2##3##(2005-8#2)
swarming motility##2##2##(1994-8#2)
swarming##13##1##(1991-2#2)(1994-8#2)(2005-8#3)(2009-5#1)(2009-6#5)
swarms of##2##2##(2005-11#1)(2013-8#1)
swarms were##3##2##(2005-8#1)(2013-8#2)
swarms##19##1##(1991-2#1)(2005-11#1)(2005-8#6)(2012-2#1)(2013-8#10)
sway and##3##2##(1994-1#2)(2005-9#1)
sway in##3##2##(1990-10#1)(2005-6#1)(2007-4#1)
sway of##2##2##(1994-1#1)(2012-3#1)
sway##16##1##(1990-10#2)(1994-1#4)(1995-12#1)(1995-5#1)(2005-6#1)(2005-9#1)(2007-4#2)(2010-10#1)(2010-8#1)(2012-3#2)
swaying##2##1##(1991-11#1)(2008-9#1)
sweat and sebum##2##3##(2008-5#2)
sweat and##7##2##(2006-12#1)(2008-5#6)
sweat components##2##2##(2008-10#2)
sweat from##2##2##(1995-7#1)(2008-5#1)
sweat gland##11##2##(1991-5#3)(1991-6#2)(1995-12#1)(2007-11#1)(2007-7#1)(2008-5#1)(2013-7#2)
sweat glands##13##2##(1991-11#1)(1991-6#1)(1995-12#1)(1996-6#1)(2008-5#6)(2013-7#2)(2013-8#1)
sweat pH of##3##3##(2008-5#3)
sweat pH##5##2##(2008-5#5)
sweat rate##6##2##(1992-3#1)(2008-5#3)(2009-5#1)(2013-7#1)
sweat rates##2##2##(2013-7#2)
sweat the##2##2##(2013-8#2)
sweat##87##1##(1991-11#1)(1991-12#1)(1991-5#3)(1991-6#3)(1992-3#2)(1995-12#4)(1995-7#1)(1996-6#1)(2006-12#11)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-5#30)(2009-12#5)(2009-4#1)(2009-5#1)(2010-4#1)(2013-7#11)(2013-8#3)
sweating and##3##2##(2008-5#1)(2010-5#1)(2012-12#1)
sweating was##7##2##(2008-5#7)
sweating##34##1##(1992-1#1)(1992-3#1)(1993-7#1)(1994-3#1)(2004-3#1)(2006-10#1)(2006-12#2)(2006-2#1)(2007-7#1)(2008-5#15)(2008-7#1)(2009-12#3)(2009-5#1)(2010-5#1)(2012-12#1)(2013-1#1)(2013-7#1)
sweats##9##1##(1991-12#1)(1993-9#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-11#1)(2010-12#1)(2012-12#1)(2012-2#1)
sweep and##3##2##(2008-10#2)(2010-11#1)
sweep rate##4##2##(2008-10#4)
sweep voltammetric##3##2##(2008-10#3)
sweep voltammetry##14##2##(2008-10#14)
sweep##51##1##(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#41)(2008-3#2)(2010-11#1)(2011-2#1)
sweeping legislation##2##2##(1991-12#1)(1992-1#1)
sweeping technique##2##2##(2008-10#1)(2008-3#1)
sweeping##25##1##(1991-12#1)(1992-1#2)(1993-5#1)(1995-9#1)(2005-10#3)(2005-11#1)(2005-2#1)(2007-1#2)(2007-12#1)(2007-8#3)(2007-9#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2010-7#1)(2011-2#1)
sweeps were##2##2##(2008-5#2)
sweeps##7##1##(2005-10#1)(2008-10#1)(2008-5#3)(2008-9#1)(2009-5#1)
sweet Spanish onions we studied had##2##6##(1993-12#2)
sweet and##2##2##(2008-5#1)(2013-1#1)
sweet basil oil##2##3##(2008-5#2)
sweet basil##5##2##(2008-5#4)(2012-12#1)
sweet cherry fruit##6##3##(2008-10#6)
sweet cherry##8##2##(2008-10#8)
sweet corn##10##2##(2008-10#10)
sweet orange grafted on Rangpur lime##2##6##(2008-10#2)
sweet orange##13##2##(2008-10#13)
sweet pepper ferredoxin-I protein##2##4##(2008-10#2)
sweet pepper##8##2##(1997-1#1)(2007-6#1)(2008-10#3)(2011-2#3)
sweet potato (Ipomoea batatas)##2##4##(2008-10#2)
sweet potato (Ipomoea##3##3##(2008-10#3)
sweet potato feathery mottle##3##4##(2008-10#3)
sweet potato root##3##3##(2008-10#2)(2008-6#1)
sweet potato##20##2##(2007-3#1)(2008-10#12)(2008-6#2)(2010-12#1)(2011-2#4)
sweet substances and##2##3##(2008-10#1)(2008-9#1)
sweet taste##4##2##(1991-5#1)(1996-1#1)(2008-2#2)
sweet tastes that##2##3##(2012-1#2)
sweet tastes##3##2##(1991-11#1)(2012-1#2)
sweet wine##2##2##(2008-10#2)
sweet wines##4##2##(1992-1#2)(2008-10#2)
sweet##105##1##(1991-11#1)(1991-5#1)(1992-1#2)(1993-12#2)(1993-5#1)(1995-10#1)(1996-1#4)(1997-1#1)(2006-4#1)(2007-3#1)(2007-6#1)(2007-9#1)(2008-10#58)(2008-11#1)(2008-2#3)(2008-5#6)(2008-6#3)(2008-9#3)(2010-12#2)(2011-1#1)(2011-2#7)(2012-1#2)(2012-12#1)(2013-1#1)
sweetened beverages##3##2##(2012-1#1)(2012-2#2)
sweetened##4##1##(2008-10#1)(2012-1#1)(2012-2#2)
sweetener for##2##2##(2008-5#1)(2012-12#1)
sweetener with##2##2##(2008-5#1)(2008-6#1)
sweetener##14##1##(2008-2#3)(2008-5#5)(2008-6#1)(2008-8#1)(2008-9#1)(2012-1#1)(2012-12#1)(2013-1#1)
sweetener-preferring strain##2##2##(2008-2#2)
sweeteners##15##1##(1992-11#1)(2008-10#2)(2008-2#3)(2011-1#3)(2012-1#3)(2013-7#3)
sweetie##2##1##(2009-8#2)
sweetness##14##1##(2008-10#1)(2008-2#1)(2008-5#5)(2010-4#1)(2011-2#2)(2012-1#2)(2012-2#2)
sweetpotato weevil##3##2##(2011-2#3)
sweetpotato##10##1##(2008-10#6)(2011-12#1)(2011-2#3)
sweets##4##1##(2006-12#3)(2012-2#1)
swell in##4##2##(2005-11#1)(2008-5#1)(2008-9#1)(2010-6#1)
swell##12##1##(1992-12#1)(1993-12#1)(2005-11#2)(2006-10#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-2#1)(2010-6#1)(2012-1#1)(2013-1#1)
swelled vallate papillae##2##3##(2011-2#2)
swelled##7##1##(1992-3#1)(1992-8#1)(1995-1#1)(2008-10#1)(2008-8#1)(2011-2#2)
swelling (HOS)##2##2##(2009-6#1)(2010-7#1)
swelling after##3##2##(2010-12#1)(2013-1#2)
swelling and pain in##2##4##(2010-9#1)(2012-12#1)
swelling and pain##4##3##(2008-5#1)(2010-9#1)(2012-12#2)
swelling and##47##2##(1990-2#1)(1990-3#1)(1991-1#1)(1991-3#1)(1992-10#1)(1992-11#1)(1992-2#1)(1993-2#1)(1995-7#1)(1996-4#1)(1996-5#1)(2004-12#1)(2005-10#1)(2005-8#2)(2006-1#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-7#2)(2008-10#7)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-9#1)(2011-1#1)(2012-12#3)(2013-1#2)
swelling and/or##2##2##(1997-3#1)(2013-1#1)
swelling are##2##2##(2007-11#1)(2011-2#1)
swelling around##3##2##(2009-3#2)(2012-12#1)
swelling at the##3##3##(2008-10#1)(2008-12#1)(2008-7#1)
swelling at##4##2##(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)
swelling behavior##3##2##(2004-9#1)(2008-5#1)(2010-4#1)
swelling degree##2##2##(2008-5#1)(2013-8#1)
swelling for##2##2##(1992-2#1)(2006-9#1)
swelling in patients with##2##4##(2007-10#1)(2008-6#1)
swelling in patients##3##3##(2007-10#1)(2008-1#1)(2008-6#1)
swelling in the maxillary right##2##5##(2007-7#1)(2012-12#1)
swelling in the right##3##4##(1991-10#1)(2006-10#1)(2008-7#1)
swelling in the##15##3##(1991-10#1)(1993-12#1)(2005-12#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-2#1)(2009-9#1)(2010-11#1)(2012-12#1)(2012-2#1)
swelling in##30##2##(1991-10#1)(1993-12#1)(1994-12#1)(2005-12#1)(2005-8#2)(2006-10#1)(2007-10#3)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-4#1)(2009-9#1)(2010-11#1)(2012-12#3)(2012-2#1)(2013-7#1)
swelling is##5##2##(1991-11#1)(1997-5#1)(2008-5#1)(2008-6#1)(2008-8#1)
swelling of a##2##3##(1997-5#1)(1997-8#1)
swelling of his##2##3##(2008-6#1)(2011-2#1)
swelling of left##2##3##(2007-7#1)(2012-2#1)
swelling of mitochondria##3##3##(2005-8#2)(2008-7#1)
swelling of the ankle and##2##5##(2006-4#2)
swelling of the ankle##3##4##(2006-4#3)
swelling of the cells##2##4##(1992-3#1)(2008-6#1)
swelling of the gland##2##4##(1992-5#1)(2011-1#1)
swelling of the left thigh##2##5##(2007-7#1)(2008-6#1)
swelling of the left##4##4##(1991-3#1)(2005-11#1)(2007-7#1)(2008-6#1)
swelling of the right side of the##2##7##(2009-9#1)(2013-7#1)
swelling of the right##4##4##(2007-6#1)(2009-9#1)(2012-12#1)(2013-7#1)
swelling of the##40##3##(1990-11#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-5#1)(1993-8#1)(1996-1#1)(2005-11#1)(2006-4#3)(2007-2#2)(2007-5#2)(2007-6#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-2#2)(2009-5#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#3)(2013-1#2)(2013-7#1)
swelling of##62##2##(1990-11#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-5#1)(1993-8#1)(1995-7#1)(1996-1#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-8#2)(2006-10#2)(2006-4#3)(2007-11#1)(2007-2#2)(2007-5#2)(2007-6#1)(2007-7#4)(2008-1#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#2)(2009-2#2)(2009-5#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
swelling on the##7##3##(2005-11#1)(2007-7#1)(2010-3#1)(2011-12#1)(2011-2#1)(2013-1#2)
swelling on##9##2##(2005-11#1)(2007-2#1)(2007-7#1)(2008-8#1)(2010-3#1)(2011-12#1)(2011-2#1)(2013-1#2)
swelling or##6##2##(1992-7#1)(1996-2#1)(1997-3#1)(2007-10#1)(2007-11#1)(2008-2#1)
swelling over the left##2##4##(2007-7#1)(2012-3#1)
swelling over the##4##3##(2006-8#1)(2007-7#1)(2012-2#1)(2012-3#1)
swelling over##6##2##(2006-8#1)(2007-7#1)(2008-7#1)(2011-12#1)(2012-2#1)(2012-3#1)
swelling pressure##2##2##(2007-10#2)
swelling ratio##5##2##(2005-11#1)(2007-10#1)(2008-10#1)(2009-7#1)(2013-1#1)
swelling test (HOS)##2##3##(2006-5#1)(2009-6#1)
swelling test##4##2##(2006-5#1)(2008-9#2)(2009-6#1)
swelling that##2##2##(2006-2#1)(2010-3#1)
swelling was##10##2##(1991-10#2)(1993-12#1)(2008-12#1)(2008-5#1)(2008-6#2)(2009-4#1)(2010-11#1)(2011-1#1)
swelling with##4##2##(2006-4#2)(2011-1#1)(2013-1#1)
swelling##330##1##(1990-11#1)(1990-2#3)(1990-3#1)(1990-7#1)(1991-1#2)(1991-10#3)(1991-11#1)(1991-3#2)(1991-5#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-7#1)(1993-12#3)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-6#1)(1995-7#2)(1996-1#2)(1996-2#1)(1996-4#2)(1996-5#3)(1997-1#1)(1997-3#4)(1997-4#1)(1997-5#3)(1997-6#2)(1997-8#1)(2004-10#1)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#5)(2005-12#1)(2005-8#8)(2006-1#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-4#7)(2006-5#1)(2006-8#1)(2006-9#3)(2007-10#15)(2007-11#5)(2007-12#2)(2007-2#3)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#11)(2007-8#2)(2008-1#5)(2008-10#18)(2008-11#1)(2008-12#5)(2008-2#1)(2008-4#4)(2008-5#21)(2008-6#10)(2008-7#9)(2008-8#9)(2008-9#3)(2009-2#5)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#3)(2010-4#3)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#6)(2011-12#3)(2011-2#11)(2012-11#1)(2012-12#12)(2012-2#4)(2012-3#3)(2012-8#1)(2013-1#20)(2013-7#5)(2013-8#3)
swelling-induced##3##1##(1992-7#1)(2008-8#2)
swelling]##3##1##(1997-8#1)(2011-12#1)(2011-2#1)
swellings along##2##2##(2007-10#1)(2007-12#1)
swellings of the##2##3##(2005-7#1)(2007-7#1)
swellings were##3##2##(1995-12#1)(2005-7#1)(2008-10#1)
swellings##23##1##(1992-1#2)(1995-12#1)(2005-7#4)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#3)(2008-10#2)(2008-4#1)(2008-5#1)(2009-7#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
swells##5##1##(2007-10#1)(2008-10#1)(2008-5#2)(2009-12#1)
swept by##2##2##(2008-10#2)
swept into a##3##3##(2008-10#3)
swept over the##2##3##(2007-8#1)(2008-3#1)
swept##19##1##(1992-1#1)(1994-2#1)(1996-8#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-3#1)(2008-5#1)(2010-8#1)
swift and##3##2##(1995-12#1)(1996-1#1)(2006-6#1)
swift##10##1##(1995-12#1)(1996-1#1)(2005-8#1)(2006-10#1)(2006-6#2)(2007-8#1)(2007-9#1)(2010-11#1)(2013-1#1)
swiftly##3##1##(1990-12#1)(1993-5#1)(2008-10#1)
swim speed in the##3##4##(1993-12#1)(2008-12#2)
swim speed##11##2##(1992-9#1)(1993-12#6)(2008-12#4)
swim stress##5##2##(1995-12#3)(1997-4#2)
swim training##3##2##(2012-3#3)
swim##38##1##(1990-8#1)(1992-9#1)(1993-12#6)(1993-7#1)(1995-12#3)(1997-4#2)(2007-7#1)(2008-11#5)(2008-12#4)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#2)(2012-12#2)(2012-3#3)(2013-7#2)(2013-8#2)
swim-to-platform##2##1##(1992-12#2)
swimbladder volume##2##2##(2010-8#2)
swimbladder##4##1##(1993-12#1)(2010-8#3)
swimmer##2##1##(2006-3#1)(2009-6#1)
swimmer's itch in Iceland##2##4##(2006-8#2)
swimmers##7##1##(1995-6#2)(1996-8#1)(2007-11#2)(2009-1#1)(2011-2#1)
swimming ability##5##2##(2010-8#1)(2012-3#4)
swimming and##4##2##(1991-3#1)(2008-11#1)(2008-5#1)(2010-8#1)
swimming behavior of##2##3##(2008-5#2)
swimming behavior##4##2##(1992-6#1)(2008-4#1)(2008-5#2)
swimming exercise##2##2##(1995-6#1)(2013-1#1)
swimming in a##2##3##(2007-10#1)(2008-5#1)
swimming in the##2##3##(1990-11#1)(2012-3#1)
swimming in##6##2##(1990-11#1)(2007-10#1)(2008-5#2)(2012-2#1)(2012-3#1)
swimming motility##2##2##(1994-8#1)(2013-8#1)
swimming of##2##2##(1991-2#1)(2008-4#1)
swimming on##2##2##(2007-7#1)(2009-1#1)
swimming performance was##2##3##(1995-6#1)(2010-8#1)
swimming performance##5##2##(1995-6#1)(2008-10#1)(2010-8#2)(2012-3#1)
swimming pool##6##2##(1992-11#1)(1995-6#1)(2007-7#1)(2008-10#3)
swimming pools and##2##3##(2009-6#2)
swimming pools##3##2##(2008-10#1)(2009-6#2)
swimming protocol##2##2##(2008-10#2)
swimming speed##6##2##(1992-6#2)(1993-11#1)(1994-2#1)(2008-10#1)(2010-8#1)
swimming test##11##2##(1990-5#1)(1991-12#1)(1991-3#1)(1996-12#7)(2012-12#1)
swimming were##2##2##(2010-8#2)
swimming##112##1##(1990-11#2)(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#10)(1992-11#1)(1992-6#3)(1992-8#3)(1993-11#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-6#5)(1996-12#7)(1996-6#1)(1997-4#1)(1997-8#2)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#4)(2008-10#10)(2008-11#4)(2008-2#1)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#3)(2009-1#4)(2009-6#2)(2009-9#1)(2010-12#1)(2010-8#8)(2012-12#1)(2012-2#1)(2012-3#8)(2013-1#2)(2013-8#2)
swimsuit##2##1##(2007-12#2)
swine and human##2##3##(2011-1#1)(2013-1#1)
swine and poultry sheds##2##4##(2006-12#2)
swine and##6##2##(2006-12#2)(2007-12#1)(2007-4#1)(2011-1#1)(2013-1#1)
swine farms##3##2##(1996-12#1)(2013-1#2)
swine fecal and manure storage pit samples##4##7##(2006-5#4)
swine fever##4##2##(2005-5#1)(2007-6#1)(2011-2#2)
swine flu##11##2##(2011-1#9)(2013-1#2)
swine herds##4##2##(2013-1#4)
swine influenza viruses##3##3##(2011-2#2)(2013-1#1)
swine influenza##7##2##(1997-6#1)(2010-4#1)(2011-2#3)(2013-1#1)(2013-8#1)
swine manure##9##2##(2008-10#9)
swine origin##4##2##(2008-5#1)(2011-1#1)(2012-1#1)(2013-1#1)
swine waste application sites in##2##5##(2008-10#2)
swine waste##3##2##(2008-10#3)
swine##105##1##(1991-11#1)(1991-8#3)(1992-1#1)(1992-12#4)(1992-5#1)(1995-7#1)(1996-12#1)(1996-5#3)(1997-6#3)(2005-11#3)(2005-5#1)(2006-12#3)(2006-5#5)(2007-12#2)(2007-4#1)(2007-6#1)(2007-7#1)(2008-10#13)(2008-11#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-4#1)(2010-5#1)(2011-1#12)(2011-2#12)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#16)(2013-8#3)
swine-origin influenza##3##2##(2011-1#2)(2011-2#1)
swine-origin##4##1##(2011-1#3)(2011-2#1)
swing beds##4##2##(1991-1#2)(1994-2#2)
swing phase##6##2##(1990-4#1)(1995-5#1)(2007-10#1)(2010-3#1)(2012-1#2)
swing shift workers##2##3##(2011-2#2)
swing##27##1##(1990-4#1)(1991-1#2)(1993-3#2)(1994-2#2)(1995-5#1)(2007-10#2)(2007-12#2)(2008-10#1)(2008-3#1)(2009-4#1)(2010-3#1)(2010-7#1)(2011-2#6)(2012-1#4)
swing-bed program##2##2##(1991-1#1)(1994-2#1)
swing-bed##3##1##(1991-1#2)(1994-2#1)
swinging##6##1##(1996-4#3)(2007-11#1)(2008-3#1)(2009-3#1)
swings##5##1##(1993-5#1)(2007-2#1)(2009-11#1)(2009-6#1)(2012-2#1)
swirl of##2##2##(2008-1#1)(2010-10#1)
swirl##3##1##(2007-9#1)(2008-1#1)(2010-10#1)
swiss needle cast##2##3##(2008-10#2)
swiss##5##1##(1992-6#1)(2008-10#2)(2008-12#1)(2010-1#1)
switch and##6##2##(2008-10#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#1)
switch are also##2##3##(2008-2#1)(2008-3#1)
switch are##4##2##(1990-5#1)(2008-2#1)(2008-3#2)
switch at##2##2##(2008-10#1)(2013-1#1)
switch based on##4##3##(2007-11#1)(2007-12#2)(2009-7#1)
switch between##13##2##(1990-11#1)(1995-11#2)(1996-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2009-8#1)(2012-1#1)(2013-7#1)
switch by##4##2##(1995-2#1)(2008-2#1)(2008-3#2)
switch core##4##2##(2008-3#4)
switch effects##5##2##(2012-3#5)
switch for the##2##3##(1995-6#1)(2008-7#1)
switch for##12##2##(1995-6#1)(2005-11#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2009-6#1)
switch from the##2##3##(1997-6#1)(2011-1#1)
switch from##17##2##(1992-3#1)(1992-9#1)(1995-4#1)(1996-11#1)(1996-6#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2011-1#2)(2012-2#1)(2013-8#1)
switch has##2##2##(1995-12#1)(2008-3#1)
switch in the##4##3##(1992-11#1)(1992-12#1)(1997-7#1)(2009-8#1)
switch in##20##2##(1990-11#1)(1992-11#1)(1992-12#2)(1993-9#1)(1995-12#2)(1996-5#1)(1997-2#1)(1997-4#2)(1997-7#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#1)(2009-6#1)(2009-8#1)(2013-1#1)(2013-8#1)
switch involves##2##2##(2008-1#1)(2012-12#1)
switch is##12##2##(1990-11#1)(2007-12#1)(2008-10#2)(2008-3#6)(2008-4#1)(2010-12#1)
switch of##7##2##(1994-2#2)(1994-9#1)(2008-5#1)(2008-8#1)(2011-1#1)(2012-2#1)
switch on the##2##3##(2009-11#1)(2012-1#1)
switch on##5##2##(2008-9#1)(2009-11#1)(2009-8#1)(2011-2#1)(2012-1#1)
switch operation for##4##3##(2007-8#2)(2009-4#1)(2010-6#1)
switch operation##7##2##(2007-12#1)(2007-8#4)(2009-4#1)(2010-6#1)
switch rearrangement##3##2##(1990-5#2)(2008-4#1)
switch regions##3##2##(1990-5#2)(1994-8#1)
switch technique##2##2##(2007-8#2)
switch that##8##2##(2006-2#1)(2007-11#1)(2008-2#2)(2008-3#2)(2011-1#1)(2012-2#1)
switch the##6##2##(1993-12#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)
switch to a##5##3##(2004-3#1)(2006-10#1)(2007-9#1)(2008-11#1)(2011-1#1)
switch to the##2##3##(2006-10#2)
switch to##20##2##(1992-9#1)(1994-11#1)(2004-3#1)(2006-10#3)(2007-12#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
switch was##2##2##(2008-10#1)(2012-12#1)
switch##284##1##(1990-11#3)(1990-5#6)(1991-11#1)(1991-5#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-9#2)(1993-12#3)(1993-3#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#4)(1994-8#3)(1994-9#1)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#2)(1995-4#1)(1995-5#1)(1995-6#1)(1996-11#2)(1996-5#1)(1996-6#1)(1996-7#2)(1997-2#2)(1997-4#3)(1997-6#1)(1997-7#2)(2004-3#1)(2005-11#1)(2006-10#5)(2006-2#2)(2006-4#1)(2006-8#1)(2007-11#5)(2007-12#16)(2007-7#1)(2007-8#8)(2007-9#3)(2008-1#5)(2008-10#12)(2008-11#4)(2008-2#24)(2008-3#41)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#10)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#3)(2009-4#2)(2009-6#4)(2009-7#1)(2009-8#5)(2010-10#1)(2010-11#1)(2010-12#3)(2010-6#1)(2011-1#6)(2011-12#1)(2011-2#5)(2012-1#4)(2012-12#3)(2012-2#3)(2012-3#8)(2013-1#6)(2013-7#1)(2013-8#5)
switch&quot##3##1##(1995-1#1)(2006-10#1)(2007-12#1)
switch'##3##1##(1990-12#1)(2008-10#2)
switch-on##4##1##(1994-5#1)(2008-9#1)(2009-8#1)(2012-2#1)
switchable##8##1##(2006-12#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-7#1)
switched between##4##2##(2007-11#1)(2008-3#1)(2008-7#1)(2010-12#1)
switched by##3##2##(2008-3#2)(2010-12#1)
switched from##12##2##(1993-12#1)(1995-9#2)(2004-11#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-10#1)(2009-9#1)(2011-2#1)
switched magnetic fields##2##3##(1992-3#2)
switched off plate##3##3##(1994-2#3)
switched off##8##2##(1990-5#1)(1992-11#1)(1992-3#1)(1994-2#3)(2008-10#1)(2008-4#1)
switched on and##2##3##(1994-2#1)(2007-12#1)
switched on##6##2##(1994-2#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-9#1)(2012-2#1)
switched to##12##2##(1991-8#1)(1994-12#1)(1995-9#1)(1997-3#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-8#1)(2010-9#1)(2012-1#1)(2013-1#1)
switched with a##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
switched with##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
switched##72##1##(1990-3#1)(1990-5#1)(1991-8#1)(1992-11#1)(1992-3#4)(1993-12#1)(1994-12#1)(1994-2#4)(1994-5#1)(1995-9#3)(1996-5#1)(1997-3#1)(1997-7#1)(2004-11#1)(2006-10#1)(2007-11#4)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#8)(2008-3#6)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-9#2)(2010-12#3)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
switchers##3##1##(2008-7#3)
switches and##5##2##(2007-9#1)(2008-3#2)(2008-7#1)(2010-12#1)
switches are##2##2##(2006-4#1)(2011-1#1)
switches between a##2##3##(1990-8#1)(2006-10#1)
switches between##4##2##(1990-8#1)(1997-6#1)(2006-10#1)(2008-2#1)
switches for##6##2##(2007-12#1)(2008-2#2)(2008-3#2)(2012-12#1)
switches from##4##2##(1990-5#1)(1990-8#1)(1992-5#1)(2008-10#1)
switches in the##2##3##(1997-7#1)(2009-10#1)
switches in##4##2##(1997-7#1)(2008-3#1)(2009-10#1)(2011-1#1)
switches on##2##2##(2007-11#1)(2012-11#1)
switches sickness##2##2##(2008-7#2)
switches target##2##2##(2011-1#2)
switches that##3##2##(2008-2#1)(2012-12#2)
switches the##3##2##(1990-5#1)(2006-10#1)(2008-3#1)
switches to##6##2##(1994-9#1)(1995-1#1)(1996-8#1)(2007-12#1)(2007-9#1)(2009-4#1)
switches with##2##2##(2007-12#1)(2013-8#1)
switches##84##1##(1990-11#1)(1990-5#2)(1990-8#2)(1992-5#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-8#1)(1997-6#1)(1997-7#1)(2006-10#3)(2006-4#3)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#7)(2007-9#2)(2008-1#1)(2008-10#2)(2008-2#8)(2008-3#13)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-4#1)(2011-1#9)(2012-11#1)(2012-12#3)(2012-2#1)(2013-8#3)
switchgrass##6##1##(2009-3#1)(2011-2#5)
switching and image storage##2##4##(1995-6#2)
switching and##14##2##(1995-6#2)(2007-12#6)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#2)
switching applications##2##2##(2007-12#2)
switching as##3##2##(1996-10#1)(2007-12#1)(2010-12#1)
switching behaviors##2##2##(2007-12#1)(2008-3#1)
switching between a##3##3##(2007-11#1)(2007-12#1)(2008-11#1)
switching between the##2##3##(2007-12#1)(2008-2#1)
switching between##15##2##(1997-1#1)(2006-10#1)(2007-11#3)(2007-12#4)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)
switching by##6##2##(2007-12#2)(2008-1#2)(2008-3#1)(2012-3#1)
switching characteristics##2##2##(2007-11#1)(2007-12#1)
switching device##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
switching efficiency of##2##3##(2007-12#1)(2008-3#1)
switching efficiency##3##2##(2007-12#2)(2008-3#1)
switching element##2##2##(2008-1#1)(2008-2#1)
switching elements##2##2##(2006-4#1)(2008-2#1)
switching energy##3##2##(2007-12#3)
switching for##3##2##(2007-12#1)(2008-3#1)(2012-2#1)
switching from##15##2##(1992-11#1)(2007-12#5)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-6#1)(2011-1#1)(2013-1#1)
switching in a bulk##2##4##(2007-11#1)(2007-12#1)
switching in a##10##3##(2007-11#1)(2007-12#2)(2008-1#1)(2008-3#6)
switching in the##2##3##(2008-1#1)(2010-12#1)
switching in##23##2##(1993-2#1)(2007-11#4)(2007-12#6)(2008-1#2)(2008-3#6)(2009-9#1)(2010-12#2)(2012-3#1)
switching is##11##2##(2007-11#1)(2007-12#3)(2008-3#4)(2008-7#2)(2010-4#1)
switching mechanism##2##2##(2007-12#1)(2008-8#1)
switching network##2##2##(2008-3#2)
switching of a##11##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#7)
switching of the##6##3##(1994-12#1)(1997-2#1)(2007-12#2)(2008-3#1)(2010-5#1)
switching of##29##2##(1994-12#1)(1994-8#1)(1997-2#1)(2007-11#2)(2007-12#7)(2008-1#2)(2008-11#2)(2008-2#1)(2008-3#11)(2010-5#1)
switching off the##3##3##(1990-4#1)(2006-10#1)(2009-11#1)
switching operation of##2##3##(2007-11#1)(2008-1#1)
switching operations##2##2##(2008-3#2)
switching or##2##2##(2011-1#1)(2013-7#1)
switching point##2##2##(2008-1#1)(2009-3#1)
switching power##2##2##(2008-3#2)
switching powers of##2##3##(2007-12#2)
switching rate##2##2##(2008-7#2)
switching speed##3##2##(2007-12#1)(2008-3#1)(2008-7#1)
switching system##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
switching systems##2##2##(2008-2#1)(2008-3#1)
switching the##11##2##(1992-11#1)(1993-2#1)(1994-9#1)(1995-11#2)(2007-8#1)(2008-10#2)(2008-3#2)(2009-6#1)
switching time of##2##3##(2007-11#1)(2007-12#1)
switching time##3##2##(2007-11#1)(2007-12#2)
switching to alternative food##2##4##(2008-8#2)
switching to an alternative##2##4##(2008-10#1)(2008-3#1)
switching to##13##2##(1992-9#1)(1995-2#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#3)(2009-11#1)(2010-12#2)
switching valve##5##2##(1997-3#1)(2008-10#4)
switching voltage##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-7#1)
switching was##3##2##(1990-12#1)(2007-12#1)(2008-3#1)
switching with##5##2##(2007-12#2)(2008-3#2)(2008-7#1)
switching##318##1##(1990-11#1)(1990-12#1)(1990-4#1)(1990-6#3)(1990-8#1)(1992-11#3)(1992-9#1)(1993-2#3)(1993-3#1)(1994-11#1)(1994-12#3)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(2006-10#3)(2006-4#2)(2006-5#1)(2007-11#23)(2007-12#77)(2007-7#1)(2007-8#2)(2008-1#15)(2008-10#14)(2008-11#6)(2008-2#19)(2008-3#65)(2008-4#4)(2008-7#14)(2008-8#7)(2008-9#2)(2009-11#2)(2009-3#1)(2009-6#3)(2009-9#2)(2010-1#1)(2010-12#5)(2010-4#1)(2010-5#1)(2011-1#2)(2011-12#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#1)
swollen connective tissue##4##3##(2012-12#4)
swollen head syndrome (SHS)##3##4##(1997-3#1)(1997-6#1)(2008-5#1)
swollen head syndrome##7##3##(1997-3#1)(1997-6#1)(2008-5#5)
swollen hydrophilic##2##2##(2005-11#1)(2010-7#1)
swollen lamellar gel network phase##2##5##(2008-5#2)
swollen lamellar##3##2##(2008-5#3)
swollen livers##2##2##(1997-6#1)(2008-5#1)
swollen##63##1##(1990-8#1)(1992-11#1)(1992-9#1)(1994-6#1)(1995-9#1)(1997-3#1)(1997-5#3)(1997-6#2)(1997-7#1)(2005-11#4)(2005-8#1)(2006-10#3)(2007-12#3)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#10)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#2)(2009-5#2)(2010-7#1)(2011-2#2)(2012-12#6)(2012-2#2)(2013-1#2)
sword in##2##2##(2008-10#1)(2010-5#1)
sword of##2##2##(1994-2#1)(1997-5#1)
sword##8##1##(1994-2#1)(1997-5#1)(2007-4#1)(2008-10#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-2#1)
sword'##2##1##(2007-5#1)(2011-1#1)
swords##4##1##(1995-12#1)(2008-8#2)(2009-8#1)
swordtail fish##4##2##(2008-7#4)
swordtail##5##1##(2008-7#4)(2008-8#1)
swordtails##6##1##(2008-8#2)(2009-9#4)
sxi-3##3##1##(1995-1#3)
sycamore##6##1##(1996-10#1)(2007-2#2)(2008-10#3)
syllabi##2##1##(2008-12#1)(2008-5#1)
syllable structure##2##2##(2008-8#1)(2008-9#1)
syllable type##2##2##(2010-2#2)
syllable##13##1##(2008-8#1)(2008-9#2)(2010-2#3)(2012-1#2)(2013-8#5)
syllables of the##2##3##(1993-9#1)(2008-4#1)
syllables##12##1##(1993-9#4)(2008-4#1)(2008-9#3)(2012-1#1)(2012-12#1)(2013-8#2)
syllabus##6##1##(2007-6#1)(2008-11#1)(2008-5#4)
syllogisms##2##1##(2009-11#2)
sylvatic##3##1##(2009-7#2)(2012-12#1)
sylvatica L##2##2##(2005-11#1)(2013-8#1)
sylvatica##5##1##(2005-11#1)(2007-7#1)(2008-10#1)(2008-4#1)(2013-8#1)
sylvaticum##4##1##(2008-10#4)
sylvestrene##3##1##(2008-11#3)
sylvestris L##2##2##(1997-2#1)(2004-4#1)
sylvestris and##3##2##(2008-11#1)(2008-7#1)(2011-10#1)
sylvestris##8##1##(1996-4#1)(1997-2#2)(2004-4#1)(2008-11#1)(2008-7#1)(2011-10#2)
sylvestris)##3##1##(2004-4#2)(2008-10#1)
sylvian fissure##4##2##(1995-12#2)(2008-12#1)(2011-1#1)
sylvian##5##1##(1995-12#3)(2008-12#1)(2011-1#1)
symbiogenetic events##2##2##(2007-12#2)
symbiont population##2##2##(2007-12#2)
symbiont##11##1##(2007-12#2)(2008-10#1)(2008-11#1)(2008-8#1)(2010-10#1)(2011-2#3)(2012-12#1)(2013-8#1)
symbionts of##3##2##(2010-8#1)(2012-12#1)(2013-1#1)
symbionts##15##1##(1994-3#1)(1997-4#1)(2006-3#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-7#1)(2010-6#2)(2010-8#2)(2012-12#1)(2013-1#1)
symbioses in##2##2##(2009-8#1)(2010-10#1)
symbioses with##2##2##(2008-8#1)(2011-2#1)
symbioses##11##1##(2006-3#1)(2008-10#1)(2008-7#1)(2008-8#2)(2009-8#2)(2010-10#1)(2011-2#1)(2012-8#1)(2013-1#1)
symbiosis and##4##2##(2006-3#1)(2008-11#1)(2008-8#1)(2009-8#1)
symbiosis between##2##2##(2009-10#1)(2012-12#1)
symbiosis of##3##2##(1996-2#1)(2009-6#1)(2009-8#1)
symbiosis with##4##2##(2006-3#1)(2008-11#1)(2008-5#1)(2008-8#1)
symbiosis##35##1##(1996-2#1)(2006-3#2)(2007-12#1)(2007-7#1)(2008-11#6)(2008-5#1)(2008-8#5)(2009-10#2)(2009-6#1)(2009-8#2)(2010-10#2)(2010-6#1)(2011-1#3)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-8#2)
symbiotic and##2##2##(2006-3#2)
symbiotic bacteria##5##2##(2006-10#1)(2007-12#3)(2008-11#1)
symbiotic cyanobacteria##2##2##(2006-3#2)
symbiotic events##2##2##(2011-2#2)
symbiotic microbes##2##2##(2009-6#2)
symbiotic plasmid##2##2##(1996-7#2)
symbiotic relationship##3##2##(2008-11#1)(2010-5#1)(2012-1#1)
symbiotic solitary waves in##2##4##(2007-12#2)
symbiotic##51##1##(1991-9#1)(1996-7#2)(2006-10#1)(2006-3#6)(2007-12#8)(2008-1#1)(2008-10#3)(2008-11#7)(2008-5#1)(2008-7#1)(2008-8#2)(2009-6#3)(2009-8#2)(2010-4#1)(2010-5#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#2)(2012-8#2)(2013-1#1)
symbiotically##2##1##(1997-2#1)(2010-5#1)
symbiotrophic##2##1##(2010-6#2)
symbiotrophy##2##1##(2010-6#2)
symbiotum##2##1##(2009-8#2)
symblepharon##2##1##(2011-1#1)(2012-2#1)
symbol Rpc1##2##2##(2008-10#2)
symbol of WAIS##2##3##(1994-6#2)
symbol of##4##2##(1994-6#2)(2006-7#1)(2009-7#1)
symbol##16##1##(1994-6#2)(2004-3#1)(2006-7#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-7#1)(2010-4#2)(2010-5#1)(2011-2#1)
symbolic substitution##3##2##(2008-2#2)(2008-3#1)
symbolic##32##1##(1991-12#1)(1993-2#2)(1994-3#1)(2004-3#1)(2006-10#3)(2007-9#1)(2008-11#1)(2008-2#5)(2008-3#2)(2008-7#1)(2009-10#1)(2009-4#1)(2009-7#3)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-1#1)(2012-11#1)(2013-8#2)
symbolic-substitution-based##2##1##(2008-2#2)
symbolism of##3##2##(2007-10#1)(2009-10#2)
symbolism##4##1##(2007-10#1)(2009-10#3)
symbolizing##2##1##(2009-10#1)(2012-12#1)
symbols##4##1##(1992-2#1)(1994-5#1)(1996-1#1)(2008-4#1)
symm##2##1##(2005-10#2)
symmetric about the##2##3##(2008-10#1)(2008-7#1)
symmetric about##4##2##(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)
symmetric and asymmetric fusion##3##4##(2008-8#3)
symmetric and asymmetric##11##3##(1990-4#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-7#1)(2008-8#4)
symmetric and##21##2##(1990-4#1)(2005-4#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-7#1)(2008-8#6)(2012-2#1)
symmetric aspheres##3##2##(2008-2#1)(2008-3#2)
symmetric beam##4##2##(2007-11#1)(2007-12#3)
symmetric emission##2##2##(2008-3#1)(2008-5#1)
symmetric intervals##2##2##(2008-10#2)
symmetric linear##3##2##(2007-12#2)(2008-9#1)
symmetric mean filter##2##3##(2008-3#2)
symmetric modified Daubechie##2##3##(2010-4#2)
symmetric multiprocessors##2##2##(2008-3#2)
symmetric operator##2##2##(1990-4#2)
symmetric stretching band##2##3##(2008-10#2)
symmetric stretching mode of the##2##5##(1995-5#1)(2008-10#1)
symmetric stretching##6##2##(1994-11#1)(1995-5#1)(2008-10#4)
symmetric structures##2##2##(2008-3#2)
symmetric systems##2##2##(2007-12#1)(2008-3#1)
symmetric to##2##2##(1992-2#1)(2008-10#1)
symmetric white matter##2##3##(2012-12#1)(2012-2#1)
symmetric##192##1##(1990-11#1)(1990-4#5)(1990-5#1)(1991-2#1)(1991-3#1)(1991-5#2)(1992-1#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-12#3)(1993-8#4)(1994-11#1)(1994-2#1)(1994-8#1)(1995-11#2)(1995-3#1)(1995-4#2)(1995-5#1)(1995-6#1)(1997-2#1)(1997-6#1)(1997-7#3)(2005-11#1)(2005-4#2)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#11)(2007-12#24)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#14)(2008-3#32)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#3)(2013-1#3)(2013-8#1)
symmetrical and unsymmetrical##3##3##(1994-9#1)(2008-10#2)
symmetrical and##6##2##(1994-9#1)(2005-5#1)(2007-7#1)(2008-10#2)(2010-3#1)
symmetrical arrangement of##2##3##(1990-8#1)(1997-3#1)
symmetrical arthritis##2##2##(1990-3#1)(2012-3#1)
symmetrical copolymerizing##2##2##(2013-8#2)
symmetrical dual-coupling##2##2##(2007-12#2)
symmetrical for##2##2##(2005-11#1)(2008-3#1)
symmetrical in##2##2##(2010-3#1)(2013-8#1)
symmetrical peak and with##2##4##(2008-10#2)
symmetrical peak and##3##3##(2008-10#3)
symmetrical peaks##2##2##(1993-1#1)(2008-6#1)
symmetrical with##2##2##(2008-10#1)(2010-12#1)
symmetrical##119##1##(1990-3#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-3#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-7#3)(1997-3#1)(1997-4#3)(1997-5#3)(1997-7#1)(1997-8#1)(2005-11#1)(2005-5#1)(2006-10#2)(2006-12#1)(2007-11#2)(2007-12#7)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#3)(2008-3#9)(2008-4#2)(2008-5#5)(2008-6#1)(2008-8#1)(2008-9#2)(2009-11#2)(2009-2#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#3)
symmetrically##14##1##(1990-11#1)(1993-11#1)(1993-3#1)(1995-3#1)(1997-4#1)(2005-4#1)(2006-11#1)(2007-8#1)(2008-10#1)(2008-3#3)(2009-2#1)(2012-3#1)
symmetries are##3##2##(2008-3#1)(2010-8#2)
symmetries in the##2##3##(1993-6#1)(2013-1#1)
symmetries in##5##2##(1993-6#1)(2008-3#1)(2010-8#2)(2013-1#1)
symmetries of the##2##3##(2008-2#1)(2009-8#1)
symmetries##22##1##(1993-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#6)(2008-6#1)(2009-8#1)(2010-5#1)(2010-8#5)(2012-2#1)(2013-1#1)
symmetrized##2##1##(2008-3#1)(2009-2#1)
symmetry about##2##2##(1990-8#1)(2008-4#1)
symmetry and the##2##3##(2008-2#1)(2008-5#1)
symmetry and##17##2##(1992-2#1)(1992-9#1)(1994-10#1)(1994-3#1)(1996-2#2)(2007-12#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2012-1#2)(2013-1#1)
symmetry are##2##2##(2006-12#1)(2013-8#1)
symmetry averaging##2##2##(1991-4#1)(1994-6#1)
symmetry axis##3##2##(1997-7#1)(2008-2#1)(2008-3#1)
symmetry between##2##2##(1995-8#1)(1997-2#1)
symmetry breaking##4##2##(2007-12#2)(2010-12#2)
symmetry conservation##2##2##(1990-8#2)
symmetry constraints##2##2##(2007-11#1)(2010-4#1)
symmetry differences in##2##3##(2008-8#2)
symmetry differences##3##2##(2008-8#3)
symmetry filtering##2##2##(2008-3#2)
symmetry for##2##2##(1994-3#1)(1995-11#1)
symmetry from##3##2##(2008-1#1)(2008-10#1)(2008-8#1)
symmetry in the##8##3##(2006-5#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-3#1)(2012-12#2)
symmetry in##18##2##(1990-2#1)(1990-8#1)(1992-11#1)(1995-11#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-3#2)(2008-7#1)(2012-1#1)(2012-12#4)(2013-1#1)
symmetry is##8##2##(2007-11#2)(2007-12#1)(2008-3#2)(2008-6#1)(2012-12#2)
symmetry modes##2##2##(2012-1#2)
symmetry of the##17##3##(1990-8#1)(1993-11#1)(1996-2#1)(1997-7#2)(2007-11#1)(2007-7#1)(2008-2#3)(2008-3#3)(2008-6#1)(2008-7#1)(2009-12#1)(2010-12#1)
symmetry of##33##2##(1990-8#1)(1993-11#1)(1993-2#1)(1996-2#1)(1997-7#2)(2006-11#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#6)(2008-3#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#2)(2010-12#1)(2013-8#1)
symmetry or##4##2##(1990-8#1)(2007-11#1)(2008-2#1)(2008-8#1)
symmetry properties of##2##3##(2007-12#1)(2008-1#1)
symmetry properties##4##2##(2007-12#1)(2008-1#1)(2008-2#1)(2012-1#1)
symmetry related##4##2##(1994-9#3)(1997-5#1)
symmetry rule##2##2##(1994-8#1)(1997-2#1)
symmetry to##2##2##(1995-4#1)(1996-7#1)
symmetry was##3##2##(2007-12#1)(2009-2#1)(2012-1#1)
symmetry with##2##2##(1992-9#1)(2007-11#1)
symmetry##235##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#6)(1991-4#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-8#2)(1992-9#3)(1993-11#1)(1993-2#2)(1993-4#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#3)(1995-11#3)(1995-3#1)(1995-4#1)(1995-7#1)(1995-8#1)(1996-2#8)(1996-5#1)(1996-7#1)(1997-2#2)(1997-5#1)(1997-6#1)(1997-7#3)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-4#1)(2006-5#3)(2007-10#1)(2007-11#16)(2007-12#16)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#7)(2008-2#20)(2008-3#21)(2008-4#1)(2008-5#5)(2008-6#5)(2008-7#4)(2008-8#14)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#4)(2009-3#2)(2009-4#1)(2009-7#2)(2010-12#3)(2010-4#2)(2010-6#1)(2012-1#11)(2012-11#2)(2012-12#9)(2013-1#2)(2013-8#4)
symmetry-breaking##2##1##(2007-11#1)(2012-2#1)
symmetry-related##6##1##(1992-9#2)(1996-2#1)(1997-1#1)(1997-7#2)
sympathectomized rats##3##2##(2008-4#3)
sympathectomy did not##2##3##(1994-10#1)(2011-2#1)
sympathectomy for palmar hyperhidrosis##2##4##(2007-8#2)
sympathectomy for##3##2##(2007-8#3)
sympathectomy is a minimally invasive procedure##2##6##(2007-1#1)(2007-8#1)
sympathectomy is##3##2##(2007-1#2)(2007-8#1)
sympathectomy was##2##2##(2007-8#1)(2011-2#1)
sympathectomy##32##1##(1990-7#1)(1993-7#1)(1994-10#1)(1995-12#1)(2006-7#1)(2007-1#4)(2007-8#13)(2009-4#1)(2011-2#8)(2012-12#1)
sympathetic activation and##2##3##(1992-8#1)(1997-5#1)
sympathetic activation in heart failure##2##5##(2005-10#2)
sympathetic activation in##3##3##(2005-10#3)
sympathetic activation##14##2##(1992-8#1)(1995-12#1)(1997-5#1)(2005-10#5)(2006-10#1)(2008-10#3)(2010-5#1)(2013-8#1)
sympathetic activity in##3##3##(2009-10#1)(2012-2#2)
sympathetic activity with##2##3##(1995-12#1)(2005-10#1)
sympathetic activity##9##2##(1992-7#1)(1995-12#1)(2005-10#2)(2008-7#1)(2009-10#1)(2009-6#1)(2012-2#2)
sympathetic afferent##6##2##(2005-10#5)(2008-5#1)
sympathetic and parasympathetic##10##3##(1991-4#1)(1994-3#2)(2008-10#1)(2009-10#1)(2010-5#1)(2012-2#2)(2013-8#2)
sympathetic and sensory neurons##2##4##(1990-7#1)(1991-1#1)
sympathetic and##17##2##(1990-7#1)(1991-1#1)(1991-4#1)(1991-8#1)(1994-3#2)(1996-12#1)(1996-3#1)(2006-7#1)(2007-8#1)(2008-10#1)(2009-10#1)(2010-5#1)(2012-2#2)(2013-8#2)
sympathetic chain##4##2##(1995-12#1)(1996-3#1)(2006-9#1)(2008-8#1)
sympathetic contraction##2##2##(1996-12#2)
sympathetic denervation##4##2##(2011-2#1)(2013-1#1)(2013-8#2)
sympathetic drive to the bladder and related organs##2##8##(1995-12#2)
sympathetic drive##6##2##(1995-12#2)(2005-10#1)(2006-1#1)(2006-10#1)(2008-12#1)
sympathetic dystrophy syndrome##5##3##(1992-11#2)(1992-3#1)(2006-10#1)(2008-4#1)
sympathetic dystrophy##24##2##(1992-11#12)(1992-3#1)(1995-6#1)(2006-10#2)(2007-11#2)(2008-10#1)(2008-4#1)(2008-7#4)
sympathetic efferent activity##3##3##(1991-3#1)(1991-8#1)(1994-2#1)
sympathetic fibers##3##2##(1993-4#1)(1993-5#1)(2006-12#1)
sympathetic function##3##2##(2005-10#1)(2008-11#1)(2011-12#1)
sympathetic ganglia##4##2##(1996-3#3)(2007-1#1)
sympathetic ganglion##4##2##(1991-3#1)(1994-3#1)(2009-2#1)(2011-12#1)
sympathetic hyperactivity##3##2##(2006-10#1)(2009-11#1)(2010-12#1)
sympathetic innervation##8##2##(1994-10#1)(1994-5#3)(1995-3#1)(1996-9#1)(2010-11#1)(2012-2#1)
sympathetic modulation##2##2##(2012-2#2)
sympathetic nerve activity in##3##4##(1996-1#1)(2005-10#2)
sympathetic nerve activity##10##3##(1990-12#1)(1991-5#1)(1992-3#1)(1994-10#1)(1996-1#1)(2005-10#4)(2008-7#1)
sympathetic nerve function in##3##4##(1995-6#1)(2008-7#2)
sympathetic nerve function##6##3##(1995-6#2)(2008-7#4)
sympathetic nerve stimulation##3##3##(1992-8#2)(1996-6#1)
sympathetic nerve terminals##2##3##(1991-2#1)(1997-5#1)
sympathetic nerve##34##2##(1990-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-8#2)(1993-1#1)(1994-10#1)(1994-5#1)(1995-6#2)(1996-1#1)(1996-6#1)(1997-5#1)(2005-10#6)(2007-8#2)(2008-7#5)(2008-9#4)(2009-12#1)(2009-3#1)(2012-2#1)
sympathetic nerves##8##2##(1990-12#1)(1992-8#1)(1994-10#2)(1995-12#1)(1997-1#1)(2005-10#2)
sympathetic nervous system activity##4##4##(2005-10#1)(2008-7#2)(2011-2#1)
sympathetic nervous system and##2##4##(2005-10#1)(2013-1#1)
sympathetic nervous system##28##3##(1990-4#1)(1990-5#1)(1991-2#1)(1991-3#1)(1995-12#2)(1997-2#1)(2005-10#5)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#3)(2008-4#1)(2008-7#2)(2009-10#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
sympathetic nervous##31##2##(1990-4#1)(1990-5#1)(1991-2#1)(1991-3#1)(1995-12#2)(1997-2#1)(2005-10#7)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#3)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
sympathetic neuronal##3##2##(1990-8#1)(1995-12#2)
sympathetic neurones##5##2##(1995-12#3)(1996-8#2)
sympathetic neurons also##2##3##(1992-3#1)(1994-3#1)
sympathetic neurons##12##2##(1991-1#1)(1991-3#1)(1991-7#2)(1992-3#1)(1994-3#2)(1995-1#1)(1995-12#1)(1996-3#2)(1997-6#1)
sympathetic outflow in heart failure##3##5##(2005-10#3)
sympathetic outflow in##4##3##(2005-10#4)
sympathetic outflow##19##2##(1991-6#1)(1992-6#1)(1995-3#1)(2005-10#14)(2006-10#1)(2008-1#1)
sympathetic overactivity##3##2##(2008-1#1)(2008-10#1)(2012-2#1)
sympathetic plexus##2##2##(2006-12#1)(2006-8#1)
sympathetic preganglionic neurons in the##2##5##(1992-1#2)
sympathetic preganglionic neurons##6##3##(1991-6#1)(1992-1#3)(1995-7#2)
sympathetic preganglionic##12##2##(1991-6#1)(1992-1#7)(1995-12#2)(1995-7#2)
sympathetic radiofrequency##3##2##(2006-12#1)(2006-7#2)
sympathetic response##4##2##(1994-3#3)(2005-10#1)
sympathetic sprouting in the DRG and##2##6##(2008-9#2)
sympathetic sprouting in the##3##4##(2008-9#3)
sympathetic sprouting in##5##3##(2008-9#5)
sympathetic sprouting##9##2##(1997-5#4)(2008-9#5)
sympathetic stimulation##5##2##(1991-3#1)(2006-10#2)(2007-10#1)(2010-7#1)
sympathetic stress##2##2##(1995-12#1)(2012-2#1)
sympathetic to##2##2##(1996-11#1)(2012-1#1)
sympathetic tone##8##2##(1991-2#1)(1995-12#1)(1997-5#1)(2005-10#4)(2010-12#1)
sympathetic trunk##8##2##(1991-3#1)(1994-2#1)(2006-7#6)
sympathetic vasoconstriction in##2##3##(1995-12#2)
sympathetic vasoconstriction##3##2##(1995-12#2)(2005-10#1)
sympathetic##352##1##(1990-12#2)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-2#4)(1991-3#6)(1991-4#1)(1991-5#2)(1991-6#3)(1991-7#2)(1991-8#4)(1992-1#7)(1992-11#12)(1992-12#1)(1992-3#3)(1992-6#1)(1992-7#1)(1992-8#5)(1993-1#1)(1993-4#1)(1993-5#5)(1994-10#4)(1994-2#3)(1994-3#8)(1994-5#4)(1994-9#1)(1995-1#1)(1995-12#24)(1995-3#2)(1995-5#1)(1995-6#3)(1995-7#3)(1996-1#1)(1996-11#1)(1996-12#7)(1996-3#7)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#8)(1997-6#2)(1997-8#1)(2005-10#53)(2006-1#2)(2006-10#12)(2006-11#1)(2006-12#9)(2006-7#11)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#3)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#4)(2008-5#2)(2008-7#12)(2008-8#1)(2008-9#10)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-12#3)(2010-5#3)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#4)(2012-1#1)(2012-2#14)(2013-1#4)(2013-8#5)
sympathetic-related##2##1##(1992-7#1)(1995-3#1)
sympathetically maintained pain##9##3##(2006-12#9)
sympathetically maintained##10##2##(1991-11#1)(2006-12#9)
sympathetically##13##1##(1991-11#1)(2006-12#9)(2007-1#1)(2011-2#1)(2013-8#1)
sympatho-adrenal##2##1##(1995-12#1)(2008-12#1)
sympatho-excitation##3##1##(2005-10#3)
sympatho-excitatory##2##1##(1997-2#1)(2005-10#1)
sympatho-inhibitory##3##1##(1997-6#1)(2005-10#2)
sympathoadrenal##5##1##(1993-2#1)(1994-3#1)(1995-12#3)
sympathoexcitation##2##1##(2005-10#1)(2013-8#1)
sympathoexcitatory neurons##3##2##(1992-3#1)(1992-7#2)
sympathoexcitatory##5##1##(1992-3#1)(1992-7#3)(2009-9#1)
sympathoinhibitory action of 8-OH-DPAT##2##4##(1992-7#2)
sympathoinhibitory neurons##2##2##(1992-7#2)
sympathoinhibitory##5##1##(1992-7#5)
sympatholytic##4##1##(1991-11#1)(2006-10#1)(2006-12#1)(2011-2#1)
sympathomimetic amines##2##2##(2008-10#2)
sympathomimetic drug##5##2##(1993-4#2)(1997-8#2)(2007-8#1)
sympathomimetic##15##1##(1993-4#2)(1995-2#1)(1997-8#2)(2006-10#1)(2006-11#1)(2007-10#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-5#1)(2011-2#1)
sympathoneural##2##1##(1995-12#2)
sympathovagal balance##5##2##(2009-11#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
sympathovagal imbalance in##2##3##(2012-2#2)
sympathovagal imbalance##3##2##(2012-2#3)
sympathovagal##11##1##(2009-11#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#4)(2013-8#3)
sympathy##14##1##(1991-3#1)(2007-11#1)(2008-10#7)(2011-2#1)(2012-2#4)
sympatric divergence of host races##2##5##(2008-10#2)
sympatric locations##3##2##(2008-8#3)
sympatric species##7##2##(2008-10#1)(2008-8#2)(2008-9#2)(2012-3#1)(2013-1#1)
sympatric##30##1##(1991-11#2)(2008-10#9)(2008-6#1)(2008-8#7)(2008-9#2)(2010-8#4)(2011-1#1)(2012-3#3)(2013-1#1)
sympatry and allopatry##2##3##(2008-10#2)
sympatry and##3##2##(2008-10#3)
sympatry##19##1##(2005-8#2)(2006-5#1)(2008-10#8)(2008-8#6)(2011-12#1)(2012-3#1)
symphony##3##1##(2011-1#3)
symphyseal##2##1##(1995-6#1)(2013-1#1)
symphysis pubis diastasis##2##3##(2012-1#2)
symphysis pubis##5##2##(1994-3#1)(2012-1#2)(2012-12#2)
symphysis reconstruction##2##2##(2008-10#2)
symphysis##18##1##(1990-3#1)(1990-6#1)(1994-3#1)(1997-7#3)(2006-10#1)(2007-2#1)(2008-10#2)(2011-1#1)(2012-1#2)(2012-12#3)(2012-3#1)(2013-1#1)
symplastic domains##3##2##(2009-8#3)
symplastic##6##1##(1992-12#1)(2008-11#1)(2009-8#4)
sympodialis##4##1##(2007-7#2)(2008-5#2)
symport activity##2##2##(1995-1#1)(1996-9#1)
symport##13##1##(1991-9#1)(1995-1#4)(1996-9#5)(2008-6#1)(2008-7#2)
symporter (NIS)##2##2##(2007-8#1)(2010-11#1)
symporter##4##1##(1997-7#1)(2007-8#1)(2008-6#1)(2010-11#1)
symposia and poster##2##3##(2005-8#1)(2008-5#1)
symposia and##7##2##(2005-8#3)(2008-5#3)(2008-7#1)
symposia covered##2##2##(2005-8#2)
symposia on##2##2##(2006-11#1)(2008-5#1)
symposia##30##1##(2005-8#15)(2005-9#2)(2006-11#1)(2008-11#1)(2008-5#7)(2008-7#3)(2010-5#1)
symposium entitled##3##2##(2005-7#1)(2005-8#1)(2008-5#1)
symposium focused on##2##3##(2005-8#2)
symposium held##2##2##(2006-11#1)(2010-6#1)
symposium of the##2##3##(2006-11#1)(2008-5#1)
symposium of##3##2##(2005-7#1)(2006-11#1)(2008-5#1)
symposium on &quot##2##3##(2006-6#1)(2008-5#1)
symposium on metal ions in biology and medicine##3##8##(2008-5#3)
symposium on new##2##3##(2005-8#1)(2008-5#1)
symposium on##21##2##(2005-8#2)(2006-11#6)(2006-6#1)(2008-10#1)(2008-5#9)(2009-9#1)(2013-1#1)
symposium to##3##2##(2007-9#1)(2008-5#1)(2012-1#1)
symposium was organized##2##3##(2005-8#1)(2008-5#1)
symposium was the##2##3##(2008-5#2)
symposium was##10##2##(2005-8#3)(2005-9#1)(2008-5#6)
symposium##109##1##(1990-12#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#2)(1994-3#2)(1995-12#1)(2005-7#7)(2005-8#20)(2005-9#1)(2006-11#8)(2006-6#1)(2006-9#1)(2007-12#3)(2007-8#2)(2007-9#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#31)(2008-8#2)(2009-8#1)(2009-9#2)(2010-12#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#3)
symptom after##4##2##(2006-10#1)(2007-8#1)(2008-12#1)(2013-7#1)
symptom and treatment concepts to inform hypotheses generation and clinical decision-making##2##11##(2013-1#2)
symptom and##8##2##(2006-9#1)(2008-10#1)(2011-1#1)(2011-2#3)(2013-1#2)
symptom area##2##2##(2008-10#2)
symptom assessment##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
symptom at##3##2##(1990-3#1)(1997-3#1)(2006-9#1)
symptom burden and##6##3##(1994-3#1)(2008-7#5)
symptom burden in##3##3##(2008-7#3)
symptom burden##18##2##(1994-3#1)(2005-9#1)(2008-7#14)(2012-2#1)(2013-1#1)
symptom clusters##4##2##(2005-7#1)(2008-1#1)(2008-7#2)
symptom complex##6##2##(1991-11#1)(1996-1#1)(1997-2#1)(2006-8#1)(2008-7#1)(2012-3#1)
symptom control and##4##3##(1990-12#1)(2009-7#1)(2012-2#2)
symptom control##8##2##(1990-12#1)(2008-3#1)(2009-7#1)(2010-12#2)(2011-2#1)(2012-2#2)
symptom criteria##2##2##(1991-1#1)(2011-2#1)
symptom descriptors##2##2##(2008-10#2)
symptom development by##2##3##(2008-10#2)
symptom development of##2##3##(2008-10#2)
symptom development on##2##3##(2008-10#2)
symptom development was##3##3##(2008-10#2)(2008-9#1)
symptom development##24##2##(2008-10#22)(2008-9#1)(2012-9#1)
symptom diagnoses##3##2##(1997-6#3)
symptom dimensions##6##2##(2006-3#1)(2006-9#4)(2010-1#1)
symptom duration##3##2##(2006-8#1)(2007-10#1)(2008-7#1)
symptom expression and##6##3##(2008-10#5)(2010-10#1)
symptom expression of##2##3##(2008-10#2)
symptom expression was##2##3##(2008-10#2)
symptom expression##23##2##(2008-10#22)(2010-10#1)
symptom for##3##2##(1996-6#1)(2007-11#1)(2010-12#1)
symptom free##12##2##(1993-10#1)(1995-7#1)(2006-10#3)(2006-8#1)(2007-7#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#2)
symptom in the##2##3##(2009-4#1)(2013-1#1)
symptom in##21##2##(1991-2#1)(1991-4#1)(1996-1#1)(1997-6#1)(2006-1#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2013-1#2)
symptom intensity and##3##3##(1996-8#1)(2006-10#1)(2007-1#1)
symptom intensity##5##2##(1996-8#1)(2006-10#1)(2007-1#1)(2008-6#1)(2008-9#1)
symptom is a##2##3##(2008-3#1)(2009-4#1)
symptom is##8##2##(1996-3#1)(1996-9#1)(2006-2#2)(2007-11#1)(2008-3#1)(2008-7#1)(2009-4#1)
symptom leading to##2##3##(1990-4#1)(2006-8#1)
symptom levels of##2##3##(2006-6#1)(2006-7#1)
symptom levels##4##2##(1996-2#1)(2006-6#1)(2006-7#1)(2008-8#1)
symptom management in##3##3##(2005-10#1)(2007-12#1)(2010-11#1)
symptom management to##2##3##(2007-12#1)(2009-9#1)
symptom management##13##2##(2005-10#2)(2005-9#1)(2007-12#3)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#2)
symptom of malaria##2##3##(2006-4#1)(2007-2#1)
symptom of the disease##2##4##(2008-10#1)(2012-1#1)
symptom of the##5##3##(2007-9#1)(2008-10#1)(2012-1#1)(2013-7#1)(2013-8#1)
symptom of##45##2##(1990-12#1)(1991-8#1)(1994-2#1)(1994-7#1)(1995-11#1)(1996-2#1)(2004-3#1)(2005-1#1)(2005-11#1)(2006-1#1)(2006-4#2)(2007-10#1)(2007-11#1)(2007-2#2)(2007-5#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2009-7#1)(2010-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#6)(2013-8#3)
symptom onset##21##2##(1994-3#1)(1997-8#1)(2006-12#1)(2007-10#3)(2007-6#1)(2007-9#4)(2008-11#1)(2008-3#3)(2008-9#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
symptom or sign##4##3##(1991-8#2)(1993-5#1)(2006-8#1)
symptom or##10##2##(1991-8#2)(1992-8#1)(1993-5#1)(1995-9#1)(2006-6#1)(2006-8#1)(2007-3#1)(2008-10#1)(2008-7#1)
symptom overreporting##2##2##(2008-9#2)
symptom phenotype##3##2##(2008-10#3)
symptom production##2##2##(2006-10#1)(2008-10#1)
symptom recurrence after##3##3##(1993-12#1)(2010-6#2)
symptom recurrence##6##2##(1993-12#1)(2006-8#1)(2007-11#1)(2010-6#3)
symptom reduction##3##2##(2009-1#2)(2009-11#1)
symptom relief and##2##3##(2006-10#1)(2006-6#1)
symptom relief##6##2##(2006-10#1)(2006-6#1)(2008-3#1)(2009-6#1)(2009-9#1)(2012-2#1)
symptom resolution##3##2##(2004-3#1)(2006-10#1)(2011-2#1)
symptom score and##3##3##(2007-2#1)(2007-9#1)(2012-3#1)
symptom score for##2##3##(2005-10#2)
symptom score##17##2##(1994-7#2)(1997-8#1)(2005-10#2)(2007-2#4)(2007-7#2)(2007-9#1)(2008-11#1)(2008-3#2)(2008-7#1)(2012-3#1)
symptom scores##5##2##(2006-7#1)(2008-10#1)(2008-3#1)(2011-2#2)
symptom severity and##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
symptom severity for##2##3##(2008-10#2)
symptom severity in##6##3##(2008-10#4)(2008-9#1)(2013-7#1)
symptom severity score##2##3##(2008-10#2)
symptom severity scores##2##3##(2008-3#1)(2010-2#1)
symptom severity##42##2##(1996-12#1)(1996-2#1)(2004-11#1)(2006-10#1)(2007-12#1)(2008-10#19)(2008-3#2)(2008-6#1)(2008-8#1)(2008-9#3)(2009-8#2)(2009-9#1)(2010-2#3)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#1)
symptom structures##3##2##(1996-5#3)
symptom that##4##2##(2006-8#1)(2007-11#1)(2007-7#1)(2011-2#1)
symptom type##2##2##(2008-10#2)
symptom was a##3##3##(1996-2#1)(2008-10#1)(2012-12#1)
symptom was##16##2##(1990-9#2)(1992-8#2)(1996-2#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#2)(2012-12#1)
symptom##525##1##(1990-12#5)(1990-3#1)(1990-4#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#3)(1991-8#3)(1991-9#1)(1992-8#4)(1993-10#2)(1993-12#1)(1993-5#2)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-7#4)(1995-10#1)(1995-11#3)(1995-2#2)(1995-7#1)(1995-9#3)(1996-1#3)(1996-12#1)(1996-2#4)(1996-3#1)(1996-5#6)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#4)(1997-3#1)(1997-6#5)(1997-8#3)(2004-11#2)(2004-3#3)(2005-1#1)(2005-10#6)(2005-11#1)(2005-7#1)(2005-9#2)(2006-1#2)(2006-10#18)(2006-12#3)(2006-2#2)(2006-3#2)(2006-4#2)(2006-6#4)(2006-7#4)(2006-8#8)(2006-9#10)(2007-1#1)(2007-10#6)(2007-11#10)(2007-12#4)(2007-2#8)(2007-3#2)(2007-5#2)(2007-6#1)(2007-7#10)(2007-8#9)(2007-9#8)(2008-1#5)(2008-10#93)(2008-11#7)(2008-12#4)(2008-3#17)(2008-4#3)(2008-5#5)(2008-6#4)(2008-7#35)(2008-8#4)(2008-9#12)(2009-1#2)(2009-10#1)(2009-11#2)(2009-4#3)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#6)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#7)(2010-2#3)(2010-5#3)(2010-6#3)(2010-7#1)(2011-1#5)(2011-10#1)(2011-2#25)(2011-8#1)(2012-1#3)(2012-12#5)(2012-2#12)(2012-3#3)(2012-9#1)(2013-1#14)(2013-7#9)(2013-8#5)
symptom)##3##1##(2008-7#1)(2010-12#1)(2010-9#1)
symptom-based##3##1##(2007-10#1)(2008-8#1)(2010-9#1)
symptom-days##3##1##(2013-1#3)
symptom-free after##2##2##(1997-8#1)(2012-3#1)
symptom-free and##3##2##(1992-2#1)(2007-7#1)(2011-2#1)
symptom-free##28##1##(1990-6#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-7#1)(1993-10#1)(1993-7#2)(1994-5#1)(1996-11#1)(1996-12#1)(1997-8#1)(2005-1#1)(2006-10#1)(2006-9#1)(2007-2#1)(2007-7#2)(2008-10#1)(2008-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#2)
symptomatic ASD##3##2##(1996-6#1)(2012-12#1)(2012-3#1)
symptomatic HIV##2##2##(2007-12#1)(2007-7#1)
symptomatic and asymptomatic##13##3##(1993-2#1)(1993-8#1)(2006-11#2)(2006-8#1)(2008-10#3)(2008-3#2)(2008-5#1)(2010-8#2)
symptomatic and had##2##3##(2008-4#1)(2008-7#1)
symptomatic and##33##2##(1991-4#1)(1993-10#1)(1993-2#1)(1993-8#1)(1996-8#1)(2006-10#1)(2006-11#2)(2006-2#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-7#1)(2008-10#5)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-8#1)(2010-8#3)(2011-2#1)
symptomatic and/or##2##2##(2010-12#1)(2012-12#1)
symptomatic arrhythmias##2##2##(1993-2#1)(2008-10#1)
symptomatic as well as asymptomatic left ventricular dysfunction##2##8##(1990-1#1)(1993-2#1)
symptomatic at##3##2##(2009-10#1)(2012-2#1)(2012-3#1)
symptomatic bacteriuria##3##2##(2008-5#3)
symptomatic benefit##3##2##(1997-6#1)(2010-12#2)
symptomatic benign##3##2##(1994-5#1)(2007-11#1)(2013-1#1)
symptomatic berries##2##2##(2008-10#2)
symptomatic bone metastases##3##3##(2008-7#3)
symptomatic cancer##2##2##(2007-11#1)(2007-6#1)
symptomatic carotid artery##2##3##(2007-10#1)(2008-8#1)
symptomatic carotid stenosis##3##3##(1993-1#1)(2008-8#2)
symptomatic carotid##5##2##(1993-1#1)(2007-10#1)(2008-8#3)
symptomatic cases##2##2##(2005-12#1)(2008-10#1)
symptomatic cerebral##3##2##(2006-11#2)(2007-10#1)
symptomatic cervical##2##2##(2006-7#1)(2009-2#1)
symptomatic cholelithiasis##4##2##(1993-9#1)(2007-3#1)(2009-3#1)(2011-1#1)
symptomatic control##3##2##(2007-8#1)(2008-7#1)(2010-7#1)
symptomatic controls##2##2##(2007-3#2)
symptomatic disease##5##2##(1997-6#1)(2004-11#1)(2006-11#2)(2007-2#1)
symptomatic effects##2##2##(2006-10#1)(2012-2#1)
symptomatic for##5##2##(1991-3#1)(1992-5#1)(2010-3#2)(2012-3#1)
symptomatic heart failure##2##3##(1991-2#1)(2008-10#1)
symptomatic hydronephrosis##2##2##(1992-3#2)
symptomatic hypoglycemia##2##2##(2007-5#1)(2012-12#1)
symptomatic improvement in##2##3##(2005-5#1)(2012-12#1)
symptomatic improvement of##3##3##(1990-1#2)(2008-7#1)
symptomatic improvement##13##2##(1990-1#2)(1993-1#1)(2005-5#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2011-2#2)(2012-12#1)
symptomatic improvements##2##2##(2008-10#1)(2010-12#1)
symptomatic infection##2##2##(1995-2#1)(2007-12#1)
symptomatic internal carotid artery##3##4##(2007-10#1)(2008-7#1)(2008-8#1)
symptomatic internal carotid##5##3##(2007-10#3)(2008-7#1)(2008-8#1)
symptomatic intracranial haemorrhage##2##3##(2007-10#2)
symptomatic intracranial##4##2##(2007-10#2)(2008-8#2)
symptomatic leaves##3##2##(2008-10#3)
symptomatic left##2##2##(1993-2#1)(2007-8#1)
symptomatic measures##2##2##(2007-8#1)(2011-2#1)
symptomatic metastasis##2##2##(2013-1#2)
symptomatic mitral valve##2##3##(2008-4#1)(2013-1#1)
symptomatic multiple##2##2##(2008-1#1)(2013-7#1)
symptomatic of##2##2##(2006-9#1)(2008-1#1)
symptomatic or##6##2##(1993-3#1)(2007-12#1)(2008-10#1)(2008-3#2)(2013-7#1)
symptomatic osteoarthritis##2##2##(2006-10#2)
symptomatic patient##5##2##(2007-1#1)(2008-10#1)(2008-5#1)(2011-2#2)
symptomatic patients referred for upper##2##5##(2006-10#2)
symptomatic patients with##11##3##(1991-11#1)(2005-10#1)(2005-5#1)(2005-9#1)(2006-9#2)(2007-10#1)(2007-5#1)(2007-8#1)(2009-5#2)
symptomatic patients##30##2##(1990-8#1)(1991-11#1)(1991-3#1)(1993-11#1)(2005-10#1)(2005-5#2)(2005-9#1)(2006-10#2)(2006-8#2)(2006-9#3)(2007-10#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-5#1)(2009-10#1)(2009-4#1)(2009-5#2)(2010-6#1)(2010-7#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-7#1)
symptomatic plants##9##2##(2008-10#9)
symptomatic pulmonary##2##2##(2008-4#1)(2008-7#1)
symptomatic relapse##3##2##(2006-2#1)(2008-5#1)(2012-3#1)
symptomatic relief for##2##3##(2007-6#1)(2007-8#1)
symptomatic relief##16##2##(1991-3#1)(1994-4#1)(1994-6#1)(1995-10#1)(1997-8#1)(2005-10#1)(2005-4#1)(2007-11#2)(2007-6#1)(2007-8#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-12#1)
symptomatic response##2##2##(2009-12#1)(2012-2#1)
symptomatic samples##4##2##(2008-10#4)
symptomatic seizures##3##2##(2010-12#1)(2012-2#2)
symptomatic side##2##2##(2009-8#2)
symptomatic solitary##2##2##(1992-5#1)(1993-9#1)
symptomatic stenosis of the internal carotid artery##2##7##(2006-11#1)(2007-10#1)
symptomatic stenosis##4##2##(2006-11#1)(2007-10#1)(2007-9#1)(2008-8#1)
symptomatic sternal nonunion##2##3##(2012-2#2)
symptomatic therapy##3##2##(1990-6#1)(1996-3#1)(2007-9#1)
symptomatic third molars##2##3##(2007-12#2)
symptomatic thoraco-abdominal aneurysm##3##3##(2012-12#3)
symptomatic treatment and##3##3##(1993-7#1)(1996-11#1)(2007-1#1)
symptomatic treatment of##8##3##(1996-11#1)(2005-8#1)(2006-10#1)(2007-8#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#1)
symptomatic treatment##23##2##(1990-8#1)(1991-2#1)(1993-7#1)(1996-11#2)(1996-9#1)(1997-4#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-6#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
symptomatic treatments##4##2##(2008-11#2)(2011-2#2)
symptomatic trees were##2##3##(2008-10#2)
symptomatic trees##7##2##(2008-10#7)
symptomatic unilateral##2##2##(2007-10#1)(2008-10#1)
symptomatic uterine fibroids##2##3##(1993-12#2)
symptomatic venous thromboembolism##2##3##(2007-10#2)
symptomatic vertebrobasilar artery stenosis##2##4##(2012-3#2)
symptomatic vines##2##2##(2008-10#2)
symptomatic with##2##2##(2007-8#1)(2013-7#1)
symptomatic##524##1##(1990-1#3)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#3)(1990-8#3)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#5)(1991-4#5)(1991-6#3)(1991-7#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-8#2)(1992-9#1)(1993-1#3)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#5)(1993-3#2)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#2)(1994-2#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#2)(1995-10#1)(1995-12#1)(1995-2#2)(1995-4#2)(1996-11#2)(1996-3#1)(1996-4#1)(1996-6#3)(1996-8#1)(1996-9#2)(1997-4#1)(1997-6#2)(1997-8#1)(2004-11#1)(2005-1#1)(2005-10#4)(2005-11#1)(2005-12#2)(2005-2#1)(2005-4#1)(2005-5#3)(2005-7#1)(2005-8#3)(2005-9#2)(2006-10#10)(2006-11#11)(2006-12#1)(2006-2#7)(2006-4#2)(2006-5#3)(2006-6#2)(2006-7#2)(2006-8#10)(2006-9#10)(2007-1#2)(2007-10#13)(2007-11#6)(2007-12#6)(2007-2#6)(2007-3#5)(2007-4#1)(2007-5#2)(2007-6#5)(2007-7#12)(2007-8#16)(2007-9#3)(2008-1#3)(2008-10#63)(2008-11#6)(2008-2#3)(2008-3#9)(2008-4#7)(2008-5#11)(2008-6#3)(2008-7#19)(2008-8#12)(2008-9#2)(2009-1#1)(2009-10#3)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#4)(2010-1#1)(2010-12#11)(2010-2#1)(2010-3#3)(2010-6#1)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#23)(2011-3#2)(2012-11#1)(2012-12#16)(2012-2#15)(2012-3#10)(2013-1#16)(2013-7#5)(2013-8#1)
symptomatics among patients##2##3##(2011-1#2)
symptomatics##3##1##(2011-1#2)(2013-7#1)
symptomatological##3##1##(1990-6#1)(1990-9#1)(2013-1#1)
symptomatologie clinique##2##2##(2012-2#1)(2013-1#1)
symptomatology and##10##2##(1990-5#1)(1993-5#1)(1994-8#1)(1997-3#1)(2007-12#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-3#1)
symptomatology by##2##2##(1993-3#1)(2008-7#1)
symptomatology has##2##2##(1990-5#1)(2011-2#1)
symptomatology in the##2##3##(1991-5#1)(2006-6#1)
symptomatology in##8##2##(1991-5#1)(1996-5#1)(1996-9#1)(2006-12#1)(2006-6#1)(2006-8#1)(2008-10#1)(2009-10#1)
symptomatology is##5##2##(1990-6#1)(1991-4#1)(1991-8#1)(1992-9#1)(2006-9#1)
symptomatology of the##2##3##(2007-11#1)(2008-10#1)
symptomatology of##16##2##(1990-8#1)(1994-3#1)(1997-3#1)(1997-8#1)(2005-11#1)(2006-1#1)(2006-10#2)(2006-6#1)(2006-9#1)(2007-11#1)(2008-10#2)(2009-10#1)(2010-12#1)(2013-1#1)
symptomatology was##7##2##(1991-6#1)(1992-2#1)(1996-9#2)(2008-7#1)(2012-2#1)(2013-8#1)
symptomatology were##3##2##(1990-9#1)(2008-10#1)(2013-1#1)
symptomatology with##2##2##(2008-1#1)(2012-3#1)
symptomatology##136##1##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#4)(1990-6#1)(1990-8#1)(1990-9#4)(1991-1#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-9#1)(1993-3#2)(1993-4#1)(1993-5#1)(1994-3#1)(1994-6#1)(1994-8#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-9#3)(1997-3#2)(1997-8#1)(2005-11#2)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#2)(2006-8#3)(2006-9#2)(2007-10#2)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#9)(2008-11#2)(2008-2#5)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#5)(2008-9#1)(2009-10#5)(2009-2#2)(2009-5#1)(2009-9#1)(2010-12#1)(2010-4#3)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#4)
symptomless Austrian##2##2##(2008-10#2)
symptomless and##2##2##(2008-10#2)
symptomless infection##2##2##(2006-10#1)(2008-10#1)
symptomless infections##2##2##(2008-10#2)
symptomless pear fruit##2##3##(2008-10#2)
symptomless pine shoots##3##3##(2008-10#3)
symptomless plants from##2##3##(2008-10#2)
symptomless plants##6##2##(2008-10#6)
symptomless##36##1##(1990-6#1)(2006-10#1)(2008-10#34)
symptomology and##2##2##(2006-12#1)(2006-6#1)
symptomology##7##1##(2006-12#1)(2006-6#1)(2008-10#4)(2009-4#1)
symptoms (P&lt##2##2##(2006-10#2)
symptoms (cough##2##2##(2005-8#1)(2007-8#1)
symptoms (e##3##2##(1993-8#1)(1997-2#1)(2010-6#1)
symptoms (i##2##2##(1991-4#1)(2012-1#1)
symptoms (including##2##2##(1992-2#1)(2008-3#1)
symptoms 6##3##2##(1991-8#1)(2005-10#1)(2008-10#1)
symptoms according to the##2##4##(2008-10#1)(2011-2#1)
symptoms according to##3##3##(2008-10#2)(2011-2#1)
symptoms after a##4##3##(1992-6#1)(1996-12#1)(2007-8#1)(2013-1#1)
symptoms after surgical##2##3##(2004-1#1)(2008-7#1)
symptoms after treatment with##2##4##(2008-2#2)
symptoms after treatment##3##3##(2008-2#2)(2013-1#1)
symptoms after##36##2##(1991-10#1)(1992-6#1)(1992-8#1)(1993-1#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-6#1)(2004-1#1)(2005-8#1)(2006-10#2)(2006-12#2)(2007-11#1)(2007-2#1)(2007-8#2)(2008-10#2)(2008-2#3)(2008-7#1)(2008-8#1)(2010-12#1)(2010-6#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#3)
symptoms alone and PEFR alone##2##5##(2007-2#2)
symptoms alone##6##2##(2007-2#6)
symptoms among female##2##3##(2006-10#1)(2007-1#1)
symptoms among the##2##3##(1992-6#1)(2006-10#1)
symptoms among##21##2##(1992-6#1)(1995-8#2)(2006-10#4)(2006-7#2)(2006-9#1)(2007-1#2)(2007-12#1)(2007-2#1)(2008-6#1)(2008-7#2)(2009-7#1)(2011-1#3)
symptoms and 82%##2##3##(2006-2#1)(2006-8#1)
symptoms and a##4##3##(1993-12#1)(1995-11#1)(2010-12#1)(2010-9#1)
symptoms and also##3##3##(2007-10#1)(2008-11#1)(2010-12#1)
symptoms and clinical findings##2##4##(2005-12#1)(2012-2#1)
symptoms and clinical##8##3##(1996-3#1)(2004-10#1)(2005-12#1)(2006-4#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-7#1)
symptoms and cognitive dysfunction##3##4##(2006-3#1)(2006-9#1)(2011-2#1)
symptoms and cognitive##4##3##(2006-3#1)(2006-9#2)(2011-2#1)
symptoms and complications##2##3##(2006-2#1)(2008-7#1)
symptoms and degree of##2##4##(2004-3#1)(2012-12#1)
symptoms and diagnosis##4##3##(1992-5#1)(2008-1#1)(2012-12#2)
symptoms and diagnostic##3##3##(2007-7#1)(2011-2#1)(2012-2#1)
symptoms and disability##2##3##(2008-8#2)
symptoms and disease##2##3##(2008-5#1)(2008-6#1)
symptoms and disorders##2##3##(1991-4#1)(2006-10#1)
symptoms and fever##2##3##(1993-8#1)(2010-12#1)
symptoms and findings in systemic lupus##2##6##(1990-8#1)(1997-5#1)
symptoms and findings in##3##4##(1990-8#2)(1997-5#1)
symptoms and findings##5##3##(1990-8#2)(1997-5#1)(2008-12#1)(2009-2#1)
symptoms and for##2##3##(2007-11#1)(2007-8#1)
symptoms and frequent##2##3##(1992-2#1)(2010-5#1)
symptoms and functional##2##3##(2008-7#1)(2011-8#1)
symptoms and functioning##2##3##(1992-9#1)(2009-8#1)
symptoms and had##2##3##(1991-3#1)(2008-10#1)
symptoms and has##2##3##(1997-1#1)(2008-7#1)
symptoms and have a##2##4##(1990-7#1)(2010-12#1)
symptoms and histological##2##3##(2008-5#1)(2011-3#1)
symptoms and improves##2##3##(2012-2#1)(2013-8#1)
symptoms and improving##2##3##(2006-10#1)(2008-7#1)
symptoms and in##3##3##(1990-3#1)(1991-9#1)(2006-2#1)
symptoms and internal##2##3##(2011-2#2)
symptoms and its##2##3##(2006-10#1)(2011-2#1)
symptoms and laboratory findings##2##4##(2007-1#1)(2011-1#1)
symptoms and laboratory##6##3##(2006-8#1)(2007-1#1)(2007-2#1)(2011-1#1)(2012-12#1)(2012-2#1)
symptoms and life##3##3##(1991-8#1)(2008-10#1)(2012-11#1)
symptoms and normal##2##3##(1997-8#1)(2008-4#1)
symptoms and on##2##3##(2008-9#1)(2013-7#1)
symptoms and pain##2##3##(2008-8#1)(2011-1#1)
symptoms and peak expiratory flow rate##2##6##(2007-2#2)
symptoms and physical findings##2##4##(1991-12#1)(2008-8#1)
symptoms and physical##5##3##(1991-12#1)(1992-9#1)(2008-6#1)(2008-8#1)(2011-12#1)
symptoms and quality of life in##2##6##(2008-4#1)(2010-6#1)
symptoms and quality of life##4##5##(2008-4#1)(2010-6#1)(2011-2#2)
symptoms and reduce the##2##4##(2010-12#2)
symptoms and reduce##4##3##(1997-5#1)(2008-6#1)(2010-12#2)
symptoms and results##2##3##(1996-1#1)(2008-9#1)
symptoms and school##2##3##(2009-7#1)(2009-9#1)
symptoms and signs are##2##4##(1992-8#1)(2008-11#1)
symptoms and signs of primary##2##5##(1990-2#1)(1993-8#1)
symptoms and signs of the##2##5##(2011-3#1)(2012-12#1)
symptoms and signs of##20##4##(1990-2#1)(1990-5#1)(1990-8#1)(1993-8#1)(1994-5#1)(1995-2#1)(1996-2#1)(2006-10#1)(2006-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2009-3#1)(2010-12#2)(2010-5#1)(2011-2#1)(2011-3#1)(2012-12#1)
symptoms and signs similar to##2##5##(1992-4#1)(2008-3#1)
symptoms and signs that##2##4##(2007-10#1)(2007-7#1)
symptoms and signs##48##3##(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-4#1)(1992-4#1)(1992-8#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-2#2)(1995-9#1)(1996-2#1)(1996-9#1)(1997-8#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#3)(2008-10#3)(2008-11#3)(2008-3#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-12#3)(2010-5#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)
symptoms and sometimes##2##3##(2008-7#2)
symptoms and that##2##3##(2008-10#1)(2008-2#1)
symptoms and the diagnosis##2##4##(2006-10#1)(2006-12#1)
symptoms and the need for##3##5##(1994-6#1)(2010-10#1)(2011-2#1)
symptoms and the risk of##2##5##(2007-11#1)(2008-3#1)
symptoms and the##34##3##(1990-11#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-9#1)(1994-6#3)(1996-1#1)(1996-11#1)(2006-10#2)(2006-12#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-9#2)(2010-10#1)(2010-9#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
symptoms and their##7##3##(1991-2#1)(1993-5#1)(1996-3#1)(2006-11#1)(2008-3#1)(2008-4#1)(2012-2#1)
symptoms and to##2##3##(2010-6#1)(2012-2#1)
symptoms and treatment##6##3##(1990-8#1)(1996-9#1)(2008-10#1)(2008-7#1)(2010-3#1)(2012-12#1)
symptoms and wall motion abnormalities##2##5##(2007-8#2)
symptoms and was##3##3##(2005-11#1)(2008-10#2)
symptoms and with##2##3##(2007-3#1)(2013-1#1)
symptoms and without##2##3##(1992-4#1)(2008-12#1)
symptoms and##408##2##(1990-11#1)(1990-2#1)(1990-3#4)(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#1)(1990-8#5)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#3)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#2)(1992-2#2)(1992-4#3)(1992-5#3)(1992-8#1)(1992-9#2)(1993-10#1)(1993-12#1)(1993-5#1)(1993-8#3)(1994-2#1)(1994-5#1)(1994-6#3)(1995-11#1)(1995-2#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-8#2)(1996-9#2)(1997-1#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-8#4)(2004-10#1)(2004-11#1)(2004-3#1)(2005-10#2)(2005-11#1)(2005-12#2)(2005-7#1)(2006-10#14)(2006-11#2)(2006-12#4)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#6)(2006-9#6)(2007-1#2)(2007-10#6)(2007-11#8)(2007-12#2)(2007-2#5)(2007-3#2)(2007-5#2)(2007-7#6)(2007-8#6)(2007-9#1)(2008-1#5)(2008-10#34)(2008-11#4)(2008-12#5)(2008-2#3)(2008-3#5)(2008-4#4)(2008-5#2)(2008-6#8)(2008-7#17)(2008-8#5)(2008-9#5)(2009-10#3)(2009-11#4)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#2)(2009-6#4)(2009-7#9)(2009-8#1)(2009-9#2)(2010-10#4)(2010-12#11)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#2)(2010-9#3)(2011-1#5)(2011-12#1)(2011-2#13)(2011-3#2)(2011-8#1)(2012-1#2)(2012-11#3)(2012-12#15)(2012-2#13)(2012-3#2)(2013-1#11)(2013-7#4)(2013-8#5)
symptoms and/or##4##2##(1996-1#1)(2006-5#1)(2006-8#1)(2007-11#1)
symptoms appear to##2##3##(2004-3#1)(2009-9#1)
symptoms appear##6##2##(1993-3#1)(2004-3#1)(2007-6#1)(2009-9#1)(2012-12#1)(2013-8#1)
symptoms appeared##5##2##(1990-3#1)(2008-10#4)
symptoms appearing##2##2##(1997-8#1)(2008-10#1)
symptoms are a##2##3##(1993-6#1)(2008-4#1)
symptoms are caused by##2##4##(2005-7#1)(2008-10#1)
symptoms are common##2##3##(1990-4#1)(2009-7#1)
symptoms are described##2##3##(2006-3#1)(2007-11#1)
symptoms are discussed##2##3##(2007-12#1)(2008-1#1)
symptoms are frequently##2##3##(2013-1#2)
symptoms are not##5##3##(1991-12#1)(1994-5#1)(2005-7#1)(2006-2#1)(2010-9#1)
symptoms are often##7##3##(1996-11#1)(2006-7#1)(2008-11#1)(2008-2#1)(2011-2#1)(2012-2#1)(2013-8#1)
symptoms are present##2##3##(1993-10#1)(2012-2#1)
symptoms are related to##2##4##(2008-11#1)(2010-10#1)
symptoms are reported##2##3##(1990-12#1)(1991-6#1)
symptoms are similar to##2##4##(2008-10#1)(2010-8#1)
symptoms are the##2##3##(1997-3#1)(2013-8#1)
symptoms are usually##4##3##(1991-12#1)(2007-11#1)(2008-11#1)(2012-3#1)
symptoms are##84##2##(1990-12#2)(1990-4#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-6#1)(1993-8#1)(1994-5#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-3#1)(2005-1#1)(2005-10#1)(2005-7#2)(2006-10#2)(2006-2#3)(2006-3#2)(2006-7#1)(2006-9#2)(2007-11#3)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#2)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#3)
symptoms as a##4##3##(1991-8#1)(1997-8#1)(2006-11#1)(2007-3#1)
symptoms as compared to##3##4##(2006-10#1)(2007-7#1)(2009-9#1)
symptoms as well as the##2##5##(2011-1#1)(2012-1#1)
symptoms as well as##8##4##(1994-7#1)(2006-7#1)(2006-8#1)(2007-11#1)(2009-8#1)(2009-9#1)(2011-1#1)(2012-1#1)
symptoms as##30##2##(1991-8#1)(1994-12#1)(1994-7#1)(1997-8#1)(2004-3#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-11#3)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-3#1)(2009-8#1)(2009-9#2)(2010-4#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
symptoms associated with smoking##2##4##(2006-8#1)(2008-8#1)
symptoms associated with the##2##4##(2006-10#1)(2012-3#1)
symptoms associated with##19##3##(1992-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#1)
symptoms associated##20##2##(1990-9#1)(1992-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#1)
symptoms at all##2##3##(1997-6#1)(2008-12#1)
symptoms at discharge##3##3##(2011-2#3)
symptoms at presentation##3##3##(2008-8#1)(2011-1#1)(2012-2#1)
symptoms at the##5##3##(1997-2#1)(1997-8#1)(2007-2#1)(2008-10#1)(2008-4#1)
symptoms at##22##2##(1994-5#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-8#1)
symptoms attributable to the##2##4##(2008-7#1)(2009-5#1)
symptoms become##2##2##(2006-9#1)(2007-8#1)
symptoms began##2##2##(2008-10#1)(2012-12#1)
symptoms being##3##2##(2006-2#1)(2008-1#1)(2013-8#1)
symptoms but##11##2##(1995-5#1)(2006-10#1)(2006-8#1)(2007-3#1)(2008-10#3)(2008-7#2)(2011-2#1)(2013-1#1)
symptoms by##11##2##(1991-8#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2011-1#1)(2012-2#1)(2013-1#1)
symptoms can be##5##3##(2008-11#1)(2008-12#1)(2008-7#1)(2009-7#1)(2011-2#1)
symptoms can##10##2##(2005-10#1)(2005-9#1)(2006-3#1)(2006-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-7#1)(2009-9#1)(2011-2#1)
symptoms caused by the##3##4##(1991-3#1)(2008-10#2)
symptoms caused by##19##3##(1990-6#1)(1991-3#1)(1994-5#1)(2006-10#1)(2006-5#1)(2006-8#1)(2006-9#1)(2008-10#7)(2009-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
symptoms characteristic##2##2##(1994-3#1)(2011-2#1)
symptoms compared with##2##3##(2006-10#1)(2008-10#1)
symptoms compared##3##2##(2006-10#1)(2008-10#1)(2011-2#1)
symptoms compatible with##2##3##(2006-10#1)(2007-7#1)
symptoms compatible##3##2##(2006-10#1)(2007-7#1)(2010-1#1)
symptoms completely##3##2##(2005-10#1)(2011-2#1)(2013-8#1)
symptoms consistent with##4##3##(2006-7#1)(2008-12#1)(2013-1#1)(2013-8#1)
symptoms correlated##3##2##(1997-2#1)(2010-2#1)(2012-11#1)
symptoms could be##2##3##(2009-9#1)(2012-12#1)
symptoms could##3##2##(2008-10#1)(2009-9#1)(2012-12#1)
symptoms described##2##2##(1994-3#1)(2008-12#1)
symptoms despite##5##2##(1992-9#1)(2006-10#1)(2006-4#1)(2008-3#1)(2010-9#1)
symptoms develop##4##2##(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)
symptoms developed in##2##3##(2008-10#1)(2008-5#1)
symptoms developed##8##2##(2008-10#6)(2008-5#1)(2012-3#1)
symptoms did not improve##2##4##(1992-4#1)(2008-7#1)
symptoms did not##6##3##(1990-11#1)(1992-4#1)(2008-7#1)(2011-2#1)(2012-11#1)(2012-2#1)
symptoms disappeared##11##2##(1991-2#1)(1992-12#1)(1997-6#2)(2007-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-12#1)
symptoms do not appear##2##4##(2008-10#1)(2011-1#1)
symptoms do not##5##3##(1991-3#1)(1995-11#1)(2007-11#1)(2008-10#1)(2011-1#1)
symptoms due to##6##3##(2006-8#1)(2007-11#2)(2007-7#1)(2008-7#1)(2012-2#1)
symptoms during the##8##3##(1995-11#1)(2006-10#3)(2006-8#1)(2008-3#1)(2011-1#1)(2012-12#1)
symptoms during##17##2##(1990-6#1)(1991-3#1)(1995-11#1)(1995-4#1)(1996-2#1)(2006-10#3)(2006-8#1)(2007-10#1)(2008-3#1)(2009-5#1)(2011-1#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
symptoms even though##2##3##(2008-10#1)(2012-2#1)
symptoms even##3##2##(1997-4#1)(2008-10#1)(2012-2#1)
symptoms experienced by patients##2##4##(2008-10#1)(2008-6#1)
symptoms experienced by##4##3##(2006-2#1)(2007-2#1)(2008-10#1)(2008-6#1)
symptoms experienced##5##2##(2006-2#1)(2007-2#1)(2008-10#1)(2008-6#1)(2010-4#1)
symptoms five years later##2##4##(2012-2#2)
symptoms following##11##2##(1990-12#1)(1991-2#1)(2004-1#1)(2007-12#1)(2008-10#1)(2008-4#1)(2011-2#2)(2012-2#2)(2013-1#1)
symptoms for##7##2##(1992-5#1)(2006-12#1)(2006-9#1)(2007-8#2)(2008-3#1)(2008-7#1)
symptoms free##2##2##(2007-11#1)(2007-8#1)
symptoms from a##2##3##(2008-3#1)(2008-6#1)
symptoms from the upper gastrointestinal tract##2##6##(2006-10#2)
symptoms from the##4##3##(1990-7#1)(1992-12#1)(2006-10#2)
symptoms from##17##2##(1990-2#1)(1990-7#1)(1991-8#1)(1992-12#1)(1995-6#1)(2005-10#1)(2006-10#2)(2006-9#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#1)(2011-2#1)
symptoms further##2##2##(1991-10#1)(2012-2#1)
symptoms had been##2##3##(1992-2#1)(2008-6#1)
symptoms had resolved##2##3##(2006-6#1)(2011-2#1)
symptoms had##11##2##(1991-4#1)(1992-2#1)(2005-10#1)(2006-10#1)(2006-4#1)(2006-6#1)(2008-3#1)(2008-6#1)(2010-2#1)(2011-2#1)(2013-1#1)
symptoms has been##5##3##(1992-4#1)(1997-6#1)(2005-7#1)(2006-9#1)(2011-2#1)
symptoms has##10##2##(1992-4#1)(1997-6#1)(2005-7#1)(2006-8#2)(2006-9#2)(2007-2#1)(2008-11#1)(2011-2#1)
symptoms have been##6##3##(1991-4#1)(1992-10#1)(2006-3#1)(2010-10#1)(2011-1#1)(2012-1#1)
symptoms have##11##2##(1991-4#2)(1992-10#1)(2005-10#2)(2006-3#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-1#2)
symptoms improved after##2##3##(2006-12#1)(2009-3#1)
symptoms improved in##3##3##(2005-5#1)(2006-2#2)
symptoms improved significantly##3##3##(1997-2#1)(2008-1#1)(2009-3#1)
symptoms improved##18##2##(1995-12#1)(1997-2#1)(2005-12#1)(2005-5#2)(2006-10#1)(2006-12#1)(2006-2#2)(2006-7#1)(2008-1#1)(2008-6#1)(2008-7#1)(2009-3#2)(2013-1#2)(2013-8#1)
symptoms in Parkinson's disease (PD)##3##5##(2008-11#1)(2010-12#1)(2013-8#1)
symptoms in a sample of##2##5##(2012-1#1)(2012-12#1)
symptoms in a##13##3##(1995-4#1)(1995-8#1)(2005-8#1)(2008-10#4)(2008-8#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)
symptoms in bean##2##3##(2008-10#2)
symptoms in both##2##3##(2008-10#2)
symptoms in children and##2##4##(2008-4#1)(2009-12#1)
symptoms in children##3##3##(2008-4#1)(2009-12#1)(2011-12#1)
symptoms in healthy##2##3##(2008-10#1)(2013-1#1)
symptoms in individuals with##2##4##(2008-6#1)(2009-11#1)
symptoms in patients suffering from##2##5##(2007-7#1)(2007-9#1)
symptoms in patients with chronic##2##5##(2005-10#1)(2007-11#1)
symptoms in patients with schizophrenia##2##5##(2009-12#1)(2013-8#1)
symptoms in patients with##13##4##(1997-8#1)(2005-10#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-5#1)(2012-1#2)(2012-2#1)(2013-8#1)
symptoms in patients##20##3##(1997-8#1)(2005-10#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-9#1)(2009-12#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-1#2)(2012-2#2)(2013-8#1)
symptoms in response to##4##4##(2008-10#3)(2012-2#1)
symptoms in rheumatoid arthritis patients##2##5##(2008-4#1)(2013-7#1)
symptoms in schizophrenia##3##3##(1995-8#1)(1997-8#1)(2006-3#1)
symptoms in school##2##3##(2006-3#1)(2008-1#1)
symptoms in seasonal##2##3##(2008-8#1)(2011-2#1)
symptoms in several##2##3##(2008-10#2)
symptoms in some##2##3##(1996-7#1)(1997-3#1)
symptoms in susceptible##4##3##(1995-6#1)(2008-10#3)
symptoms in the##22##3##(1992-8#1)(1993-12#1)(1996-2#1)(2006-10#1)(2007-1#1)(2007-7#1)(2008-10#7)(2008-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-8#1)
symptoms in their##2##3##(2006-7#1)(2008-12#1)
symptoms in these##3##3##(1992-10#1)(1992-8#1)(2008-6#1)
symptoms in this##4##3##(1996-3#1)(2007-6#1)(2007-8#1)(2009-8#1)
symptoms in tobacco##2##3##(2008-10#2)
symptoms in tomato##5##3##(2008-10#5)
symptoms in two cases##2##4##(1997-8#1)(2007-12#1)
symptoms in two##4##3##(1997-8#1)(2007-12#1)(2008-10#1)(2008-7#1)
symptoms in various tests##2##4##(2007-11#2)
symptoms in women with##2##4##(2011-8#1)(2013-1#1)
symptoms in women##5##3##(2004-10#1)(2007-12#1)(2008-3#1)(2011-8#1)(2013-1#1)
symptoms in young##4##3##(1997-1#1)(2011-1#1)(2012-1#2)
symptoms in##231##2##(1990-2#2)(1991-1#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-8#3)(1993-1#1)(1993-10#2)(1993-12#1)(1994-11#1)(1995-1#1)(1995-2#1)(1995-4#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-2#1)(1996-3#3)(1996-7#1)(1997-1#1)(1997-3#1)(1997-6#2)(1997-8#3)(2004-10#1)(2005-10#1)(2005-6#1)(2005-8#1)(2006-10#5)(2006-3#2)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#5)(2007-12#2)(2007-2#2)(2007-6#1)(2007-7#11)(2007-8#4)(2007-9#3)(2008-1#2)(2008-10#55)(2008-11#1)(2008-12#4)(2008-3#1)(2008-4#2)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#5)(2010-3#1)(2010-5#3)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#16)(2011-8#1)(2012-1#7)(2012-11#2)(2012-12#5)(2012-2#8)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#7)
symptoms include a##2##3##(2005-11#1)(2008-10#1)
symptoms include##9##2##(1992-4#1)(2004-3#1)(2005-11#1)(2006-2#1)(2008-10#2)(2008-7#1)(2009-6#1)(2012-3#1)
symptoms included##5##2##(2006-7#1)(2006-9#1)(2008-10#1)(2008-7#1)(2012-3#1)
symptoms including##7##2##(1991-4#1)(2007-2#1)(2008-10#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-1#1)
symptoms induced by##5##3##(2008-10#4)(2008-3#1)
symptoms induced##7##2##(2008-10#6)(2008-3#1)
symptoms initially##2##2##(2008-10#2)
symptoms into##2##2##(2007-9#1)(2008-1#1)
symptoms is##11##2##(2006-10#1)(2006-12#1)(2007-11#2)(2008-10#2)(2008-2#1)(2009-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
symptoms lasting##2##2##(1995-7#1)(2007-11#1)
symptoms leads##2##2##(1996-3#1)(2011-2#1)
symptoms like##3##2##(2006-12#1)(2011-1#1)(2012-2#1)
symptoms mainly##2##2##(2008-10#1)(2008-6#1)
symptoms may appear##2##3##(2008-11#1)(2010-8#1)
symptoms may be##9##3##(1991-10#1)(2006-12#1)(2006-4#1)(2006-9#2)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#1)
symptoms may not##2##3##(2006-10#1)(2011-2#1)
symptoms may##30##2##(1990-5#1)(1991-10#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-9#2)(2007-11#2)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
symptoms measured##2##2##(1996-3#1)(2008-10#1)
symptoms mimicking##2##2##(2010-2#1)(2011-1#1)
symptoms must be##2##3##(1990-10#1)(2008-10#1)
symptoms must##3##2##(1990-10#1)(2008-10#1)(2008-8#1)
symptoms observed in##4##3##(1993-10#1)(2007-12#1)(2008-10#2)
symptoms observed##6##2##(1993-10#1)(2007-12#1)(2008-10#3)(2008-3#1)
symptoms occur##3##2##(2004-11#1)(2008-10#1)(2008-7#1)
symptoms occurred##4##2##(1991-2#1)(2006-10#1)(2008-10#1)(2011-2#1)
symptoms of &quot##2##3##(1995-11#1)(1997-6#1)
symptoms of ASPD##2##3##(1994-2#2)
symptoms of BPH##2##3##(2006-9#2)
symptoms of Darier's disease##2##4##(2005-11#2)
symptoms of Eutypa dieback##2##4##(2008-10#2)
symptoms of KLS##2##3##(2012-2#2)
symptoms of PD##3##3##(2008-11#1)(2010-8#1)(2012-12#1)
symptoms of PTSD##2##3##(2005-10#1)(2006-8#1)
symptoms of Parkinson's disease##2##4##(1994-6#1)(2008-7#1)
symptoms of Parkinson's##3##3##(1994-6#1)(2008-11#1)(2008-7#1)
symptoms of Sjoegren' syndrome##2##4##(2006-10#2)
symptoms of a##10##3##(1992-9#1)(1995-6#1)(1996-6#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-8#1)(2007-9#1)(2012-11#1)(2012-12#1)
symptoms of acute abdomen##3##4##(1993-10#1)(1993-5#1)(2011-1#1)
symptoms of acute##7##3##(1993-10#1)(1993-5#1)(2007-8#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
symptoms of allergic rhinitis##4##4##(2007-2#2)(2012-12#1)(2013-8#1)
symptoms of an##2##3##(1996-4#1)(2008-9#1)
symptoms of anthracnose##2##3##(2008-10#2)
symptoms of anxiety and##5##4##(2008-6#1)(2010-8#2)(2012-1#2)
symptoms of anxiety##8##3##(2008-6#1)(2008-7#1)(2009-12#1)(2010-8#2)(2011-12#1)(2012-1#2)
symptoms of asthma##2##3##(2007-11#2)
symptoms of autonomic neuropathy##2##4##(2006-11#1)(2008-6#1)
symptoms of autonomic##3##3##(2006-11#1)(2008-6#1)(2013-1#1)
symptoms of bacterial meningitis##2##4##(2006-8#1)(2009-3#1)
symptoms of bacterial##3##3##(2006-8#1)(2008-10#1)(2009-3#1)
symptoms of benign prostatic hyperplasia##2##5##(2006-9#2)
symptoms of both##4##3##(2005-8#1)(2006-12#1)(2009-8#1)(2012-12#1)
symptoms of cervical##2##3##(2005-10#1)(2006-10#1)
symptoms of chronic fatigue##2##4##(2008-10#2)
symptoms of citrus variegated chlorosis##2##5##(2008-10#2)
symptoms of citrus##3##3##(2008-10#3)
symptoms of congestive heart failure##2##5##(1993-8#1)(2010-8#1)
symptoms of constipation##2##3##(2010-12#2)
symptoms of dementia##6##3##(1993-11#1)(2005-8#1)(2006-3#1)(2008-5#1)(2011-2#1)(2012-2#1)
symptoms of depression and anxiety##2##5##(2010-8#1)(2012-1#1)
symptoms of depression and##3##4##(2010-7#1)(2010-8#1)(2012-1#1)
symptoms of depression##9##3##(2007-2#1)(2008-4#1)(2010-12#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
symptoms of diabetic neuropathy##3##4##(2008-1#1)(2013-1#2)
symptoms of disease##4##3##(1997-7#1)(2006-2#1)(2008-10#2)
symptoms of dry eye##2##4##(2006-10#1)(2007-1#1)
symptoms of dry##4##3##(2006-10#3)(2007-1#1)
symptoms of dysphagia##3##3##(2007-8#1)(2011-1#1)(2013-8#1)
symptoms of eating disorders##3##4##(2006-7#2)(2007-7#1)
symptoms of eating##4##3##(2006-6#1)(2006-7#2)(2007-7#1)
symptoms of fatigue and##3##4##(2007-12#1)(2011-1#1)(2012-3#1)
symptoms of fatigue##4##3##(2007-11#1)(2007-12#1)(2011-1#1)(2012-3#1)
symptoms of gastroesophageal reflux##2##4##(2006-10#1)(2013-8#1)
symptoms of grief##2##3##(1990-10#1)(1995-11#1)
symptoms of heart failure##3##4##(2008-4#1)(2013-1#1)(2013-8#1)
symptoms of hyperthyroidism##3##3##(2007-8#2)(2012-12#1)
symptoms of hypoglycemia##3##3##(1991-10#2)(2011-1#1)
symptoms of increased##3##3##(2005-10#1)(2008-1#1)(2008-5#1)
symptoms of infection by##2##4##(2008-10#2)
symptoms of infection##4##3##(1995-2#1)(2005-12#1)(2008-10#2)
symptoms of menopause##2##3##(2013-8#2)
symptoms of mental##2##3##(2012-12#1)(2013-7#1)
symptoms of mucosal##2##3##(1996-12#1)(2006-10#1)
symptoms of neuroticism##4##3##(2008-6#4)
symptoms of pain and##2##4##(2012-2#1)(2013-1#1)
symptoms of pain##4##3##(2004-12#1)(2006-7#1)(2012-2#1)(2013-1#1)
symptoms of poisoning##2##3##(2005-11#1)(2008-3#1)
symptoms of post-traumatic stress##2##4##(2012-1#1)(2013-8#1)
symptoms of preeclampsia##2##3##(2006-10#1)(2008-4#1)
symptoms of psychosis##5##3##(2007-6#3)(2007-7#1)(2012-11#1)
symptoms of relapse##2##3##(1997-8#1)(2009-7#1)
symptoms of restenosis##2##3##(2009-6#2)
symptoms of schizophrenia##16##3##(1995-3#1)(1995-5#1)(2004-3#2)(2005-10#1)(2005-7#2)(2006-3#1)(2008-1#1)(2008-2#2)(2008-4#2)(2010-6#1)(2012-12#1)(2012-2#1)
symptoms of seasonal AR##2##4##(2007-2#1)(2012-12#1)
symptoms of seasonal##4##3##(1996-1#1)(2007-11#1)(2007-2#1)(2012-12#1)
symptoms of severe heart failure##2##5##(2007-8#1)(2008-4#1)
symptoms of severe##5##3##(2007-8#1)(2008-2#2)(2008-4#1)(2012-1#1)
symptoms of skin##2##3##(2009-9#1)(2010-8#1)
symptoms of sleep##2##3##(2009-4#1)(2013-1#1)
symptoms of social phobia##2##4##(2007-7#1)(2010-2#1)
symptoms of spinal cord compression##2##5##(1992-12#1)(2007-11#1)
symptoms of spinal##3##3##(1991-8#1)(1992-12#1)(2007-11#1)
symptoms of testicular cancer##2##4##(1994-7#1)(2009-5#1)
symptoms of the common cold##2##5##(2008-10#2)
symptoms of the common##3##4##(2008-10#3)
symptoms of the disease and the##2##6##(2008-10#1)(2013-7#1)
symptoms of the disease are##2##5##(1991-4#1)(2009-11#1)
symptoms of the disease##15##4##(1990-6#1)(1991-4#1)(1993-1#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-7#2)(2008-8#1)(2009-11#1)(2013-7#1)
symptoms of the disorder##2##4##(1994-11#1)(2013-7#1)
symptoms of the underlying##2##4##(2005-10#1)(2007-7#1)
symptoms of the##37##3##(1990-10#1)(1990-6#1)(1991-4#1)(1992-2#1)(1993-1#1)(1994-11#1)(1995-5#1)(1997-3#2)(1997-7#1)(2005-10#1)(2006-10#4)(2006-6#1)(2007-11#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#8)(2008-7#2)(2008-8#1)(2009-11#1)(2013-1#2)(2013-7#2)
symptoms of these##3##3##(2010-2#1)(2012-2#1)(2013-8#1)
symptoms of this##9##3##(1990-9#1)(1993-3#1)(1997-3#1)(2006-11#1)(2006-2#1)(2007-8#1)(2008-7#1)(2008-9#1)(2012-1#1)
symptoms of toxicity##2##3##(2011-12#1)(2012-7#1)
symptoms of urinary tract disorder##2##5##(1991-5#2)
symptoms of urinary tract##3##4##(1991-5#2)(1996-12#1)
symptoms of venous##2##3##(2005-10#1)(2007-10#1)
symptoms of vertebrobasilar##2##3##(2006-11#1)(2007-11#1)
symptoms of which##2##3##(1990-12#1)(2005-10#1)
symptoms of withdrawal##2##3##(1995-12#1)(2005-9#1)
symptoms of##537##2##(1990-10#2)(1990-12#1)(1990-6#2)(1990-9#2)(1991-10#2)(1991-11#1)(1991-2#2)(1991-4#1)(1991-5#3)(1991-8#4)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-9#1)(1993-1#1)(1993-10#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#2)(1994-7#2)(1995-11#4)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#3)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#2)(1996-4#3)(1996-6#2)(1996-7#1)(1997-1#2)(1997-3#4)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#2)(2004-11#1)(2004-12#1)(2004-3#3)(2004-7#1)(2005-10#11)(2005-11#5)(2005-12#1)(2005-5#1)(2005-6#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#22)(2006-11#3)(2006-12#3)(2006-2#3)(2006-3#4)(2006-6#3)(2006-7#4)(2006-8#8)(2006-9#5)(2007-1#3)(2007-10#2)(2007-11#17)(2007-12#1)(2007-2#6)(2007-3#2)(2007-4#2)(2007-5#2)(2007-6#4)(2007-7#14)(2007-8#17)(2007-9#5)(2008-1#12)(2008-10#47)(2008-11#5)(2008-12#3)(2008-2#8)(2008-3#7)(2008-4#11)(2008-5#8)(2008-6#9)(2008-7#15)(2008-8#5)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#4)(2009-4#4)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#3)(2009-9#3)(2010-10#1)(2010-12#7)(2010-2#4)(2010-3#1)(2010-6#1)(2010-7#2)(2010-8#8)(2010-9#1)(2011-1#10)(2011-12#5)(2011-2#17)(2011-3#1)(2012-1#9)(2012-11#2)(2012-12#14)(2012-2#13)(2012-3#1)(2012-7#1)(2013-1#20)(2013-7#3)(2013-8#13)
symptoms often associated with##3##4##(1992-4#1)(2007-12#1)(2009-7#1)
symptoms often##8##2##(1990-4#1)(1991-6#1)(1992-4#1)(2006-8#1)(2007-12#1)(2008-2#1)(2008-8#1)(2009-7#1)
symptoms on soybean##3##3##(2008-10#3)
symptoms on the##6##3##(2007-7#1)(2007-8#1)(2008-10#4)
symptoms on##37##2##(2006-3#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#26)(2008-12#1)(2008-9#1)(2009-12#1)(2010-2#1)(2012-2#1)(2013-1#2)
symptoms only##2##2##(2006-8#1)(2008-10#1)
symptoms onset##3##2##(2007-10#1)(2008-3#1)(2008-7#1)
symptoms or are##2##3##(2006-4#1)(2010-5#1)
symptoms or conditions##2##3##(1995-9#1)(2009-7#1)
symptoms or signs of##2##4##(1991-8#1)(1996-11#1)
symptoms or signs##4##3##(1991-4#1)(1991-8#1)(1996-11#1)(1997-6#1)
symptoms or with##2##3##(2006-2#1)(2008-10#1)
symptoms or##35##2##(1991-4#1)(1991-8#1)(1991-9#1)(1993-10#1)(1995-2#1)(1995-9#1)(1996-11#1)(1997-6#1)(2005-6#1)(2006-12#1)(2006-2#2)(2006-4#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#5)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-7#1)(2010-5#1)(2012-1#1)(2012-2#3)(2013-1#3)
symptoms over time##3##3##(2008-10#1)(2008-6#1)(2010-5#1)
symptoms perceived##2##2##(2009-7#2)
symptoms persist##5##2##(1990-12#1)(2005-11#1)(2006-11#1)(2009-9#1)(2011-2#1)
symptoms persisted##2##2##(2010-12#1)(2011-2#1)
symptoms potentially indicative of##2##4##(2008-12#2)
symptoms predict##2##2##(2009-9#1)(2012-1#1)
symptoms predicted##2##2##(2006-7#1)(2009-7#1)
symptoms predominate##2##2##(2005-10#1)(2013-1#1)
symptoms preoperatively##2##2##(2006-8#1)(2008-5#1)
symptoms present##2##2##(1992-4#1)(1997-2#1)
symptoms presented##2##2##(2012-12#1)(2013-1#1)
symptoms prevail##2##2##(1994-7#1)(2011-2#1)
symptoms prior to##5##3##(1990-6#1)(1997-2#1)(2005-10#1)(2005-8#1)(2007-12#1)
symptoms produced by##2##3##(2008-10#2)
symptoms ranged from##2##3##(2007-10#1)(2012-2#1)
symptoms ranging from##2##3##(2008-7#1)(2011-2#1)
symptoms rather than##2##3##(2008-6#1)(2011-1#1)
symptoms recurred##3##2##(1991-2#1)(1997-6#1)(2012-2#1)
symptoms regressed and##2##3##(1990-11#1)(1992-4#1)
symptoms regressed##3##2##(1990-11#1)(1992-4#1)(2012-2#1)
symptoms related to the##4##4##(2006-10#1)(2006-11#1)(2007-11#1)(2008-5#1)
symptoms related to##16##3##(1990-7#1)(1997-5#1)(2006-10#2)(2006-11#2)(2006-7#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-12#1)(2012-12#1)(2012-2#1)
symptoms related##17##2##(1990-7#1)(1997-5#1)(2006-10#2)(2006-11#2)(2006-7#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
symptoms relevant to##2##3##(1997-7#1)(2006-9#1)
symptoms remained##2##2##(2008-11#1)(2008-6#1)
symptoms remains##3##2##(2006-10#1)(2007-9#1)(2008-4#1)
symptoms remitted after##2##3##(1995-1#1)(2010-7#1)
symptoms reported by##2##3##(2004-7#1)(2007-10#1)
symptoms reported##7##2##(2004-7#1)(2004-9#1)(2006-10#1)(2007-10#1)(2011-1#1)(2011-2#1)(2012-1#1)
symptoms require##3##2##(2007-6#1)(2008-10#1)(2013-8#1)
symptoms resolved in##2##3##(2006-11#1)(2006-5#1)
symptoms resolved##13##2##(1992-11#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-5#2)(2008-4#1)(2008-7#2)(2009-6#1)(2010-12#1)(2011-2#1)(2012-3#1)
symptoms result from##2##3##(1993-3#1)(2006-10#1)
symptoms resulting from##2##3##(2013-1#2)
symptoms revealed##3##2##(1991-4#1)(2008-4#1)(2012-2#1)
symptoms score##2##2##(2007-9#1)(2012-12#1)
symptoms secondary to##3##3##(2004-3#1)(2007-12#1)(2013-1#1)
symptoms seen##2##2##(1995-1#1)(2008-10#1)
symptoms should be##5##3##(2006-10#1)(2008-10#1)(2009-7#1)(2010-5#1)(2013-8#1)
symptoms should##8##2##(1990-7#1)(1994-4#1)(2006-10#1)(2008-10#1)(2009-7#1)(2010-4#1)(2010-5#1)(2013-8#1)
symptoms showed a##2##3##(2008-3#1)(2012-12#1)
symptoms showed##6##2##(2006-8#1)(2007-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)
symptoms significantly##2##2##(2007-2#1)(2011-12#1)
symptoms similar to those observed in##2##6##(2008-10#2)
symptoms similar to those##6##4##(2008-10#6)
symptoms similar to##11##3##(1991-3#1)(1991-7#1)(2007-2#1)(2008-10#8)
symptoms so##4##2##(2008-5#1)(2012-12#1)(2013-1#2)
symptoms spontaneously resolved##2##3##(2007-8#1)(2008-10#1)
symptoms spontaneously##3##2##(2007-11#1)(2007-8#1)(2008-10#1)
symptoms such as fever##2##4##(2010-2#1)(2012-2#1)
symptoms such as headache##2##4##(2006-8#1)(2008-7#1)
symptoms such as##31##3##(1993-9#1)(2005-1#1)(2005-12#2)(2005-3#1)(2006-10#2)(2006-3#1)(2006-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#2)(2010-1#1)(2010-12#2)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
symptoms suggesting##5##2##(2007-7#1)(2007-9#2)(2011-1#1)(2011-12#1)
symptoms suggestive of##13##3##(1991-11#1)(1993-12#2)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-10#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#1)
symptoms than##13##2##(1996-2#2)(1996-7#1)(1997-8#1)(2006-12#1)(2007-8#1)(2008-10#3)(2008-9#1)(2009-11#1)(2009-7#1)(2011-2#1)
symptoms that are##3##3##(2007-11#1)(2007-4#1)(2011-2#1)
symptoms that can##3##3##(2007-11#1)(2012-2#1)(2013-1#1)
symptoms that may##2##3##(1991-6#1)(2012-2#1)
symptoms that##27##2##(1991-6#1)(1993-10#1)(1995-11#1)(1995-8#1)(1996-6#1)(2006-8#1)(2006-9#1)(2007-11#5)(2007-4#1)(2008-10#2)(2010-12#2)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
symptoms they##2##2##(2008-10#1)(2008-6#1)
symptoms to disappear##2##3##(1990-10#1)(1993-2#1)
symptoms to the##3##3##(2009-5#1)(2010-2#1)(2011-1#1)
symptoms to##24##2##(1990-10#1)(1990-4#1)(1993-2#1)(1994-6#1)(1996-2#1)(2004-7#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#1)(2013-1#2)
symptoms typical of##5##3##(1995-1#1)(2004-11#1)(2008-10#2)(2008-12#1)
symptoms under##2##2##(2008-10#1)(2012-3#1)
symptoms until##3##2##(1997-2#1)(2008-10#1)(2008-4#1)
symptoms using the##2##3##(1997-8#1)(2008-10#1)
symptoms using##3##2##(1997-8#1)(2008-10#1)(2013-1#1)
symptoms usually##2##2##(2006-10#1)(2008-10#1)
symptoms was 4##2##3##(1994-2#1)(2007-2#1)
symptoms was assessed##2##3##(2006-10#2)
symptoms was evaluated##2##3##(2007-9#1)(2012-12#1)
symptoms was noted##2##3##(2006-10#1)(2009-3#1)
symptoms was the##2##3##(2008-10#1)(2012-12#1)
symptoms was##46##2##(1990-10#1)(1992-8#2)(1994-2#1)(1995-8#1)(1997-6#1)(1997-8#1)(2005-1#1)(2006-10#3)(2006-6#1)(2006-8#1)(2007-11#1)(2007-2#2)(2007-7#1)(2007-8#1)(2007-9#3)(2008-10#8)(2008-5#1)(2008-7#4)(2009-3#1)(2010-10#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#2)(2013-8#1)
symptoms were absent##3##3##(1996-1#1)(1996-12#1)(2008-10#1)
symptoms were also##2##3##(2007-1#1)(2008-7#1)
symptoms were assessed##5##3##(1997-2#1)(2008-10#1)(2009-10#1)(2009-5#1)(2013-8#1)
symptoms were associated with##4##4##(1994-6#1)(2008-10#1)(2009-10#1)(2010-2#1)
symptoms were compared##2##3##(1990-8#1)(2005-10#1)
symptoms were completely relieved##2##4##(1995-11#1)(2008-7#1)
symptoms were fever##2##3##(2007-2#1)(2012-3#1)
symptoms were found##2##3##(2008-10#1)(2013-1#1)
symptoms were in##2##3##(1990-8#1)(1991-4#1)
symptoms were measured##2##3##(2009-9#1)(2010-5#1)
symptoms were monitored##2##3##(2012-1#1)(2013-8#1)
symptoms were not##6##3##(1992-2#1)(2008-1#1)(2008-10#2)(2011-2#2)
symptoms were observed in##2##4##(1990-10#1)(1990-2#1)
symptoms were observed on##2##4##(2008-10#2)
symptoms were observed##8##3##(1990-10#1)(1990-2#1)(2008-10#3)(2008-5#1)(2011-2#1)(2013-1#1)
symptoms were only##2##3##(2008-12#1)(2008-7#1)
symptoms were present in##3##4##(2008-6#1)(2013-1#2)
symptoms were relieved##4##3##(2007-12#1)(2007-8#1)(2008-1#2)
symptoms were reported by##3##4##(1991-8#1)(2010-7#1)(2013-1#1)
symptoms were reported##4##3##(1991-7#1)(1991-8#1)(2010-7#1)(2013-1#1)
symptoms were significantly higher##2##4##(2012-11#1)(2013-1#1)
symptoms were significantly##6##3##(1997-8#1)(2007-1#1)(2008-6#1)(2009-11#1)(2012-11#1)(2013-1#1)
symptoms were visible by 3 days after inoculation with the pathogen##2##11##(2008-10#2)
symptoms were##137##2##(1990-10#2)(1990-12#1)(1990-2#2)(1990-5#1)(1990-8#2)(1990-9#2)(1991-3#1)(1991-4#2)(1991-7#1)(1991-8#1)(1992-2#3)(1992-9#1)(1994-2#1)(1994-6#1)(1995-11#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-8#1)(2004-10#2)(2005-1#1)(2005-10#2)(2006-10#3)(2006-4#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#23)(2008-12#1)(2008-5#2)(2008-6#5)(2008-7#8)(2009-10#2)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#10)(2013-8#3)
symptoms when the##2##3##(1995-6#1)(2009-11#1)
symptoms when they##2##3##(1995-6#1)(1996-6#1)
symptoms when##15##2##(1991-8#1)(1995-6#2)(1996-6#1)(2008-10#5)(2009-11#1)(2011-10#1)(2012-1#1)(2013-1#3)
symptoms which##6##2##(2008-6#1)(2009-2#1)(2009-7#1)(2010-2#1)(2011-2#1)(2013-8#1)
symptoms who##4##2##(2008-1#1)(2009-6#1)(2010-10#1)(2012-12#1)
symptoms will##2##2##(2005-10#1)(2012-1#1)
symptoms with no##2##3##(2006-10#1)(2008-10#1)
symptoms with##28##2##(1990-6#1)(1991-7#1)(1992-4#1)(1994-5#1)(1996-2#1)(2004-3#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-7#2)(2008-1#2)(2008-10#2)(2008-12#1)(2008-6#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
symptoms within the##3##3##(1990-6#1)(1991-9#1)(2005-10#1)
symptoms within##5##2##(1990-6#1)(1991-4#1)(1991-9#1)(2005-10#1)(2013-8#1)
symptoms without##3##2##(1994-2#1)(2006-10#1)(2008-11#1)
symptoms##3629##1##(1990-10#11)(1990-11#4)(1990-12#8)(1990-2#7)(1990-3#6)(1990-4#7)(1990-5#3)(1990-6#18)(1990-7#6)(1990-8#9)(1990-9#10)(1991-1#4)(1991-10#8)(1991-11#7)(1991-12#7)(1991-2#14)(1991-3#8)(1991-4#14)(1991-5#6)(1991-6#10)(1991-7#6)(1991-8#19)(1991-9#7)(1992-1#3)(1992-10#2)(1992-11#4)(1992-12#9)(1992-2#12)(1992-3#4)(1992-4#15)(1992-5#11)(1992-6#3)(1992-8#11)(1992-9#9)(1993-1#3)(1993-10#12)(1993-11#3)(1993-12#10)(1993-2#2)(1993-3#6)(1993-5#6)(1993-6#3)(1993-7#1)(1993-8#10)(1993-9#4)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#11)(1994-3#3)(1994-4#2)(1994-5#8)(1994-6#10)(1994-7#5)(1994-9#1)(1995-1#6)(1995-11#12)(1995-12#4)(1995-2#5)(1995-3#3)(1995-4#2)(1995-5#4)(1995-6#11)(1995-7#3)(1995-8#13)(1995-9#4)(1996-1#10)(1996-11#5)(1996-12#9)(1996-2#13)(1996-3#8)(1996-4#4)(1996-5#2)(1996-6#6)(1996-7#3)(1996-8#5)(1996-9#7)(1997-1#9)(1997-2#13)(1997-3#13)(1997-4#3)(1997-5#9)(1997-6#13)(1997-7#4)(1997-8#21)(2004-1#3)(2004-10#8)(2004-11#8)(2004-12#2)(2004-2#1)(2004-3#14)(2004-7#3)(2004-9#1)(2005-1#5)(2005-10#40)(2005-11#14)(2005-12#8)(2005-3#2)(2005-4#1)(2005-5#3)(2005-6#3)(2005-7#13)(2005-8#7)(2005-9#2)(2006-10#140)(2006-11#15)(2006-12#24)(2006-2#29)(2006-3#26)(2006-4#13)(2006-5#8)(2006-6#19)(2006-7#22)(2006-8#55)(2006-9#39)(2007-1#16)(2007-10#34)(2007-11#103)(2007-12#37)(2007-2#43)(2007-3#8)(2007-4#4)(2007-5#5)(2007-6#13)(2007-7#61)(2007-8#72)(2007-9#42)(2008-1#52)(2008-10#412)(2008-11#41)(2008-12#30)(2008-2#25)(2008-3#62)(2008-4#36)(2008-5#34)(2008-6#64)(2008-7#106)(2008-8#29)(2008-9#22)(2009-1#3)(2009-10#17)(2009-11#19)(2009-12#11)(2009-2#8)(2009-3#12)(2009-4#11)(2009-5#20)(2009-6#17)(2009-7#36)(2009-8#16)(2009-9#31)(2010-1#9)(2010-10#18)(2010-11#5)(2010-12#65)(2010-2#22)(2010-3#5)(2010-4#12)(2010-5#13)(2010-6#8)(2010-7#10)(2010-8#19)(2010-9#12)(2011-1#59)(2011-10#3)(2011-12#15)(2011-2#146)(2011-3#4)(2011-8#2)(2012-1#44)(2012-11#17)(2012-12#84)(2012-2#105)(2012-3#25)(2012-7#1)(2013-1#146)(2013-7#18)(2013-8#71)
symptoms&quot##4##1##(1991-8#1)(1996-3#1)(2011-2#2)
symptoms) was##2##2##(2007-9#1)(2008-10#1)
symptoms)##17##1##(1990-8#1)(1991-6#1)(1992-4#1)(2006-10#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-9#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
symptoms/diseases##2##1##(2008-11#2)
symptoms?##2##1##(2010-12#1)(2010-3#1)
symptoms]##14##1##(1990-5#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-5#1)(1993-8#1)(1994-8#1)(1995-11#1)(1996-9#2)(2006-8#1)(2009-2#1)(2013-8#2)
symtomatology##2##1##(1997-8#1)(2010-4#1)
syn and anti##3##3##(1996-5#1)(1996-6#1)(1997-4#1)
syn conformation##6##2##(1992-3#1)(1994-8#1)(1996-6#1)(1997-4#1)(2007-11#2)
syn isomers)##2##2##(1996-6#2)
syn##16##1##(1992-3#1)(1994-8#1)(1996-5#2)(1996-6#4)(1997-4#2)(2007-11#3)(2008-10#2)(2011-2#1)
syn-##3##1##(1991-4#2)(2006-11#1)
synaesthesia is##4##2##(2008-9#1)(2012-1#3)
synaesthesia##17##1##(2008-9#7)(2012-1#10)
synaesthetic associations##2##2##(2012-1#2)
synaesthetic##5##1##(2008-9#3)(2012-1#2)
synaphins##3##1##(1997-8#3)
synapomorphic characters for##2##3##(2008-5#2)
synapomorphic characters##3##2##(2008-5#2)(2008-7#1)
synapomorphic##4##1##(2008-10#1)(2008-5#2)(2008-7#1)
synapomorphies of##2##2##(2007-12#1)(2011-2#1)
synapomorphies##6##1##(2007-12#2)(2008-5#1)(2008-7#1)(2011-2#2)
synapomorphy##3##1##(2008-5#2)(2008-7#1)
synapse and##3##2##(1995-1#1)(2008-2#1)(2008-7#1)
synapse between##2##2##(1996-7#1)(2013-8#1)
synapse circuits##2##2##(2008-2#2)
synapse development and##2##3##(2009-11#1)(2009-4#1)
synapse elimination##2##2##(2007-10#2)
synapse formation and##5##3##(1992-12#1)(1996-4#1)(2007-10#1)(2009-11#1)(2009-9#1)
synapse formation##14##2##(1991-11#1)(1992-12#1)(1992-4#1)(1995-12#2)(1996-4#1)(1996-8#1)(1996-9#1)(1997-6#2)(2005-9#1)(2007-10#1)(2009-11#1)(2009-9#1)
synapse function##2##2##(2008-4#1)(2010-2#1)
synapse is##2##2##(2008-11#1)(2009-8#1)
synapse maturation##2##2##(2007-10#2)
synapse number##2##2##(1997-5#1)(2006-8#1)
synapse remodeling##2##2##(2009-11#2)
synapse to##2##2##(2008-2#1)(2013-1#1)
synapse with##2##2##(1994-2#1)(2007-11#1)
synapse##90##1##(1991-11#1)(1991-12#1)(1992-12#1)(1992-4#1)(1992-6#2)(1994-2#2)(1995-1#2)(1995-12#3)(1996-1#1)(1996-2#1)(1996-4#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-6#2)(1997-7#1)(2005-9#1)(2006-10#2)(2006-8#2)(2007-10#7)(2007-11#3)(2007-9#2)(2008-11#2)(2008-2#11)(2008-3#3)(2008-4#4)(2008-6#3)(2008-7#2)(2009-11#6)(2009-12#1)(2009-4#1)(2009-8#6)(2009-9#2)(2010-12#1)(2010-2#1)(2012-2#2)(2013-1#1)(2013-8#2)
synapse-associated protein##5##2##(1996-8#4)(2013-7#1)
synapse-specific##2##1##(1993-6#1)(1997-7#1)
synapsed##3##1##(1995-8#1)(1996-6#1)(2008-5#1)
synapses and the##2##3##(1995-11#1)(2013-1#1)
synapses and##8##2##(1995-11#2)(2007-10#1)(2008-8#1)(2009-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
synapses are##3##2##(2007-12#1)(2008-3#1)(2008-4#1)
synapses between##3##2##(1996-9#1)(1997-8#1)(2007-12#1)
synapses formed with##2##3##(1997-3#2)
synapses formed##5##2##(1992-1#1)(1997-3#2)(1997-7#1)(2009-8#1)
synapses from##2##2##(1995-11#1)(1996-2#1)
synapses in the network##2##4##(1991-6#2)
synapses in the##16##3##(1990-11#1)(1990-4#1)(1991-6#3)(1993-2#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-7#1)(2007-12#1)(2008-5#1)(2008-7#2)(2013-8#1)
synapses in##26##2##(1990-11#1)(1990-4#1)(1991-6#4)(1992-3#1)(1993-2#1)(1995-2#1)(1996-6#4)(1996-7#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-5#1)(2008-7#2)(2013-8#1)
synapses is##3##2##(1996-2#1)(1997-7#1)(2008-2#1)
synapses may##3##2##(1991-6#1)(2007-11#1)(2008-7#1)
synapses of##2##2##(1990-4#1)(2007-12#1)
synapses on the##3##3##(1995-11#1)(1997-7#1)(2008-4#1)
synapses on##9##2##(1993-9#1)(1994-2#1)(1995-11#1)(1997-2#2)(1997-7#2)(2008-4#1)(2012-2#1)
synapses onto##4##2##(1992-12#1)(1995-11#2)(1997-2#1)
synapses that##4##2##(2007-12#1)(2008-4#2)(2008-7#1)
synapses to##6##2##(1995-2#1)(1996-1#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#1)
synapses was##3##2##(1991-6#2)(1997-7#1)
synapses were##3##2##(1997-2#1)(1997-3#1)(2007-11#1)
synapses which##3##2##(1990-2#2)(2008-2#1)
synapses with##10##2##(1995-11#1)(1995-6#1)(1997-3#1)(1997-8#1)(2008-2#1)(2008-7#1)(2011-2#4)
synapses within##2##2##(2008-7#2)
synapses##195##1##(1990-11#1)(1990-2#2)(1990-4#3)(1991-11#2)(1991-5#1)(1991-6#14)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-2#2)(1994-8#2)(1995-1#1)(1995-11#8)(1995-12#4)(1995-2#2)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#3)(1996-4#1)(1996-5#1)(1996-6#5)(1996-7#2)(1996-8#3)(1996-9#3)(1997-2#6)(1997-3#9)(1997-4#2)(1997-7#13)(1997-8#2)(2006-3#1)(2007-10#5)(2007-11#5)(2007-12#7)(2007-9#1)(2008-1#3)(2008-11#4)(2008-2#6)(2008-3#3)(2008-4#6)(2008-5#3)(2008-7#14)(2008-8#1)(2009-3#1)(2009-8#6)(2009-9#2)(2010-2#1)(2011-2#4)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
synapsin I##10##2##(1993-8#4)(2007-10#6)
synapsin IIa##3##2##(2007-10#3)
synapsin##20##1##(1993-8#4)(1994-8#3)(1994-9#1)(1996-12#1)(2007-10#11)
synapsins##11##1##(1990-12#1)(1994-8#4)(2007-10#6)
synapsis and##2##2##(2008-7#1)(2013-8#1)
synapsis##3##1##(2008-5#1)(2008-7#1)(2013-8#1)
synaptic activation of granule##2##4##(1993-2#1)(1995-5#1)
synaptic activation##3##2##(1993-2#1)(1995-5#1)(1996-12#1)
synaptic activities##2##2##(2008-3#2)
synaptic activity##12##2##(1992-7#1)(1992-9#1)(1995-2#1)(1996-12#2)(2007-12#1)(2008-11#1)(2008-7#1)(2009-3#1)(2010-4#2)(2013-8#1)
synaptic and non-synaptic mitochondria from##2##5##(1990-3#1)(1991-4#1)
synaptic and non-synaptic##6##3##(1990-3#3)(1991-4#1)(1992-3#1)(2008-7#1)
synaptic and##10##2##(1990-3#3)(1991-4#1)(1992-3#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-2#1)(2010-4#1)
synaptic blockade##2##2##(1992-8#1)(1995-7#1)
synaptic boutons##2##2##(1995-5#1)(2007-10#1)
synaptic changes##4##2##(1995-11#1)(2007-11#1)(2008-11#1)(2013-1#1)
synaptic circuitry##2##2##(1991-3#1)(2008-7#1)
synaptic circuits##3##2##(1995-11#1)(2008-3#1)(2009-6#1)
synaptic complex##3##2##(1995-8#2)(2009-11#1)
synaptic connections in the developing##2##5##(1995-9#1)(1996-1#1)
synaptic connections with##2##3##(1991-3#1)(1996-3#1)
synaptic connections##14##2##(1991-3#1)(1995-9#1)(1996-1#1)(1996-3#1)(1996-9#2)(1997-2#1)(2007-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2009-8#2)
synaptic connectivity##4##2##(1995-11#1)(2008-1#2)(2008-7#1)
synaptic contact with dendritic##3##4##(1995-12#1)(1997-2#2)
synaptic contact with##7##3##(1990-11#1)(1994-2#1)(1995-12#1)(1996-3#1)(1997-2#3)
synaptic contact##9##2##(1990-11#1)(1991-5#1)(1994-2#1)(1995-12#1)(1996-3#1)(1997-2#3)(1997-5#1)
synaptic contacts in lamina II##2##5##(1996-3#2)
synaptic contacts in the##2##4##(1991-6#1)(1991-9#1)
synaptic contacts in##4##3##(1991-6#1)(1991-9#1)(1996-3#2)
synaptic contacts##12##2##(1990-7#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-8#1)(1993-12#1)(1995-8#1)(1996-3#2)(1996-9#1)(1997-5#1)(2008-4#1)
synaptic currents##5##2##(1994-2#1)(1995-11#1)(1995-2#2)(1995-7#1)
synaptic densities##3##2##(1995-11#2)(1996-1#1)
synaptic depression in##2##3##(1996-1#1)(1997-7#1)
synaptic depression##4##2##(1996-1#1)(1997-7#1)(2007-10#1)(2008-11#1)
synaptic distribution in the##2##4##(1996-3#2)
synaptic drive##3##2##(1996-2#1)(1997-5#1)(2008-11#1)
synaptic efficacy at##2##3##(1990-11#1)(2008-7#1)
synaptic efficacy##8##2##(1990-11#1)(1991-3#1)(1993-12#1)(1994-8#1)(1996-2#1)(2008-2#1)(2008-6#1)(2008-7#1)
synaptic efficiency##3##2##(1993-9#1)(1996-2#1)(1997-2#1)
synaptic events##3##2##(1990-9#1)(2008-7#1)(2012-2#1)
synaptic excitation##2##2##(1992-7#2)
synaptic expression of##2##3##(2008-7#2)
synaptic facilitation in##2##3##(1995-5#1)(2007-11#1)
synaptic facilitation##6##2##(1995-5#1)(2007-11#4)(2008-6#1)
synaptic function in##2##3##(2006-3#1)(2007-12#1)
synaptic function##9##2##(1996-5#1)(2006-3#1)(2007-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-8#2)
synaptic functions##3##2##(2008-3#1)(2009-9#2)
synaptic glutamate release##2##3##(1997-5#2)
synaptic glutamate##3##2##(1993-11#1)(1997-5#2)
synaptic homeostasis##6##2##(2009-9#6)
synaptic impairment##2##2##(2012-3#1)(2013-8#1)
synaptic information##2##2##(2009-3#2)
synaptic inhibition was##2##3##(1995-6#1)(1997-5#1)
synaptic inhibition##10##2##(1991-10#1)(1995-6#1)(1996-5#1)(1997-5#1)(2008-4#4)(2008-7#2)
synaptic input from##2##3##(1992-7#1)(1995-11#1)
synaptic input##6##2##(1992-7#1)(1994-2#1)(1995-11#1)(2008-11#1)(2008-4#2)
synaptic inputs##8##2##(1990-12#1)(1990-4#1)(1993-2#1)(1994-2#1)(1995-11#2)(1995-2#1)(2009-3#1)
synaptic integration##2##2##(1992-7#1)(2012-2#1)
synaptic interactions##2##2##(1994-10#1)(2009-8#1)
synaptic junctions##2##2##(1993-2#1)(1996-12#1)
synaptic learning rule##2##3##(1992-9#2)
synaptic learning##3##2##(1992-9#2)(2013-8#1)
synaptic localization of##3##3##(1997-2#1)(1997-7#1)(2009-8#1)
synaptic mechanisms##2##2##(2008-11#1)(2008-2#1)
synaptic membrane proteins##3##3##(1991-4#1)(1991-9#1)(1994-2#1)
synaptic membrane##8##2##(1990-2#2)(1991-4#1)(1991-9#3)(1993-12#1)(1994-2#1)
synaptic membranes were##2##3##(1990-2#1)(1991-4#1)
synaptic membranes##10##2##(1990-2#3)(1991-4#2)(1991-6#1)(1994-2#2)(1995-12#2)
synaptic mitochondria##5##2##(1990-3#3)(1994-6#1)(1997-6#1)
synaptic modification and##2##3##(1994-8#1)(2009-8#1)
synaptic modification is##2##3##(1997-7#1)(2008-11#1)
synaptic modification##5##2##(1994-8#1)(1997-7#1)(2008-11#1)(2009-10#1)(2009-8#1)
synaptic pathways in the##2##4##(2007-11#1)(2008-4#1)
synaptic patterns##2##2##(1990-12#2)
synaptic physiology##2##2##(2008-7#1)(2008-9#1)
synaptic plasma membrane##2##3##(1991-1#1)(1995-12#1)
synaptic plasma membranes##7##3##(1994-9#1)(1995-6#2)(1996-8#1)(1997-1#3)
synaptic plasma##9##2##(1991-1#1)(1994-9#1)(1995-12#1)(1995-6#2)(1996-8#1)(1997-1#3)
synaptic plasticity and##12##3##(1996-2#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#3)(2011-2#1)(2013-8#2)
synaptic plasticity are##2##3##(1996-6#1)(2009-9#1)
synaptic plasticity in the hippocampal##2##5##(1997-7#1)(2008-7#1)
synaptic plasticity in the nervous system##2##6##(1996-12#1)(2008-7#1)
synaptic plasticity in the##6##4##(1993-12#1)(1996-12#1)(1997-7#1)(2008-7#3)
synaptic plasticity in##12##3##(1993-12#1)(1995-12#1)(1996-12#1)(1997-7#2)(2008-11#1)(2008-4#2)(2008-7#3)(2013-1#1)
synaptic plasticity is##2##3##(1995-7#1)(2011-2#1)
synaptic plasticity might##3##3##(2008-7#2)(2012-2#1)
synaptic plasticity##76##2##(1990-9#1)(1993-12#4)(1995-12#2)(1995-2#1)(1995-3#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#3)(1997-4#1)(1997-5#2)(1997-7#5)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#5)(2008-2#1)(2008-4#4)(2008-7#12)(2008-8#1)(2008-9#1)(2009-8#10)(2009-9#1)(2011-2#4)(2012-2#5)(2013-1#1)(2013-8#3)
synaptic potentials in the##2##4##(1995-7#1)(2008-7#1)
synaptic potentials##12##2##(1991-1#2)(1991-12#2)(1995-7#1)(1996-8#1)(1997-5#1)(2005-10#1)(2008-7#4)
synaptic protein##2##2##(1997-7#1)(2007-12#1)
synaptic proteins##7##2##(1994-2#1)(1996-12#2)(2007-12#3)(2008-8#1)
synaptic receptors##2##2##(2008-3#2)
synaptic release##2##2##(2008-6#2)
synaptic remodelling##2##2##(1997-5#1)(2008-7#1)
synaptic responses##3##2##(1994-2#1)(1995-6#1)(1995-7#1)
synaptic responsiveness##2##2##(1997-7#2)
synaptic sites##6##2##(1995-8#1)(1996-1#1)(1996-2#1)(1996-8#3)
synaptic stimulation##3##2##(1995-6#1)(2008-4#2)
synaptic strength and learning rules##2##5##(2008-11#2)
synaptic strength and##3##3##(2008-1#1)(2008-11#2)
synaptic strength##10##2##(1995-2#1)(2006-3#1)(2008-1#1)(2008-11#2)(2008-7#1)(2008-9#2)(2009-5#1)(2009-9#1)
synaptic tagging##2##2##(2013-8#2)
synaptic terminals and##5##3##(1991-9#1)(1997-3#2)(1997-4#2)
synaptic terminals##12##2##(1991-9#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#1)(2013-1#1)
synaptic transmission and on##2##4##(1993-12#1)(2008-7#1)
synaptic transmission and plasticity##6##4##(2008-11#1)(2008-7#1)(2009-3#1)(2009-8#2)(2009-9#1)
synaptic transmission and##15##3##(1993-12#1)(1994-12#1)(1994-5#1)(2006-4#1)(2008-11#1)(2008-7#3)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#3)(2009-9#1)
synaptic transmission by##2##3##(1993-3#1)(1994-2#1)
synaptic transmission during##2##3##(1996-5#1)(2008-8#1)
synaptic transmission in the hippocampus##5##5##(1990-7#1)(1993-12#1)(1993-2#1)(1995-12#1)(1997-2#1)
synaptic transmission in the##14##4##(1990-7#1)(1993-12#1)(1993-2#1)(1995-11#1)(1995-12#2)(1997-2#2)(1997-5#2)(1997-7#1)(2008-5#1)(2008-8#1)(2013-8#1)
synaptic transmission in##21##3##(1990-7#1)(1992-8#1)(1993-12#1)(1993-2#1)(1995-11#2)(1995-12#2)(1995-2#1)(1996-5#1)(1997-2#2)(1997-5#2)(1997-7#1)(2007-11#1)(2008-4#2)(2008-5#1)(2008-8#1)(2013-8#1)
synaptic transmission mediated by##3##4##(1992-8#1)(1995-11#1)(1996-2#1)
synaptic transmission or##2##3##(1995-12#1)(2006-4#1)
synaptic transmission was##3##3##(1991-5#1)(2009-12#1)(2009-2#1)
synaptic transmission were investigated##3##4##(1990-7#1)(1993-12#1)(1997-5#1)
synaptic transmission were##6##3##(1990-7#1)(1993-12#1)(1995-3#1)(1996-5#1)(1997-5#2)
synaptic transmission##98##2##(1990-7#4)(1991-5#2)(1992-8#2)(1993-12#4)(1993-2#1)(1993-3#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#2)(1995-11#3)(1995-12#6)(1995-2#1)(1995-3#2)(1995-6#1)(1995-7#1)(1996-1#1)(1996-2#3)(1996-5#5)(1997-2#3)(1997-5#4)(1997-7#3)(1997-8#1)(2005-8#1)(2006-4#2)(2007-10#2)(2007-11#2)(2008-11#3)(2008-3#1)(2008-4#6)(2008-5#3)(2008-7#6)(2008-8#5)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#4)(2009-9#2)(2013-8#1)
synaptic vesicle clusters##2##3##(2007-10#2)
synaptic vesicle exocytosis##2##3##(2008-4#2)
synaptic vesicle fusion##2##3##(1995-12#1)(1997-1#1)
synaptic vesicle isolation procedures##2##4##(2008-1#2)
synaptic vesicle membrane proteins##2##4##(1997-6#1)(2008-4#1)
synaptic vesicle membrane##3##3##(1993-6#1)(1997-6#1)(2008-4#1)
synaptic vesicle protein##2##3##(1996-12#1)(1996-3#1)
synaptic vesicle proteins in##2##4##(2008-4#2)
synaptic vesicle proteins##6##3##(2007-10#1)(2008-4#5)
synaptic vesicle proteoglycan##2##3##(1992-6#2)
synaptic vesicle##27##2##(1992-6#2)(1993-6#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-6#1)(2007-10#4)(2007-12#1)(2008-1#3)(2008-4#8)(2008-7#1)(2012-3#1)(2013-8#1)
synaptic vesicle-associated##3##2##(1990-12#1)(1997-6#1)(2007-12#1)
synaptic vesicles and##7##3##(1991-5#1)(1993-12#1)(1993-8#1)(1995-12#2)(1996-8#1)(1997-2#1)
synaptic vesicles from##3##3##(1990-12#1)(2007-10#1)(2008-4#1)
synaptic vesicles in##5##3##(1990-12#2)(1991-5#1)(1997-7#1)(2012-2#1)
synaptic vesicles isolated from the electric organ of Torpedo was##2##10##(1992-6#2)
synaptic vesicles isolated from##3##4##(1992-6#2)(1994-12#1)
synaptic vesicles to##2##3##(1993-6#1)(2007-10#1)
synaptic vesicles##56##2##(1990-11#3)(1990-12#4)(1990-2#1)(1990-4#3)(1991-5#3)(1992-6#7)(1992-8#1)(1993-12#2)(1993-6#1)(1993-8#2)(1994-12#5)(1994-9#1)(1995-12#2)(1995-8#1)(1996-8#3)(1996-9#2)(1997-2#2)(1997-6#1)(1997-7#2)(2007-10#3)(2008-1#2)(2008-4#1)(2008-5#1)(2008-8#1)(2012-2#1)(2013-1#1)
synaptic weights##4##2##(1996-2#1)(2008-1#1)(2008-11#1)(2008-2#1)
synaptic##663##1##(1990-11#5)(1990-12#9)(1990-2#7)(1990-3#7)(1990-4#5)(1990-7#6)(1990-9#2)(1991-1#5)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#5)(1991-4#4)(1991-5#6)(1991-6#3)(1991-8#1)(1991-9#5)(1992-1#1)(1992-12#1)(1992-3#2)(1992-6#10)(1992-7#7)(1992-8#5)(1992-9#3)(1993-11#1)(1993-12#14)(1993-2#4)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-10#4)(1994-12#6)(1994-2#13)(1994-5#1)(1994-6#1)(1994-8#5)(1994-9#2)(1995-11#15)(1995-12#16)(1995-2#8)(1995-3#5)(1995-5#5)(1995-6#6)(1995-7#8)(1995-8#5)(1995-9#1)(1996-1#6)(1996-12#11)(1996-2#10)(1996-3#9)(1996-4#1)(1996-5#9)(1996-6#3)(1996-7#1)(1996-8#8)(1996-9#6)(1997-1#4)(1997-2#12)(1997-3#6)(1997-4#3)(1997-5#16)(1997-6#4)(1997-7#19)(1997-8#2)(2005-10#1)(2005-8#1)(2006-10#1)(2006-3#3)(2006-4#2)(2007-10#16)(2007-11#13)(2007-12#11)(2007-8#2)(2007-9#1)(2008-1#10)(2008-10#1)(2008-11#27)(2008-2#10)(2008-3#11)(2008-4#32)(2008-5#5)(2008-6#6)(2008-7#41)(2008-8#8)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#5)(2009-5#1)(2009-6#2)(2009-8#24)(2009-9#13)(2010-2#1)(2010-4#4)(2011-2#4)(2012-11#1)(2012-12#4)(2012-2#8)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#11)
synaptically evoked##2##2##(1991-8#1)(2009-3#1)
synaptically##5##1##(1991-8#1)(1995-3#1)(1996-12#1)(2008-11#1)(2009-3#1)
synaptobrevin II and##2##3##(1997-6#1)(2008-7#1)
synaptobrevin II##3##2##(1997-6#2)(2008-7#1)
synaptobrevin##5##1##(1994-9#1)(1996-9#1)(1997-6#2)(2008-7#1)
synaptogenesis and##2##2##(2008-11#1)(2008-7#1)
synaptogenesis of##2##2##(1996-2#2)
synaptogenesis##11##1##(1991-3#1)(1996-2#2)(1996-4#1)(1997-6#1)(2008-11#1)(2008-4#1)(2008-7#3)(2012-12#1)
synaptonemal complex (SC)##2##3##(2006-5#1)(2008-5#1)
synaptonemal complex##7##2##(1995-8#2)(2006-5#2)(2008-5#2)(2008-9#1)
synaptonemal complexes##3##2##(2006-5#2)(2008-5#1)
synaptonemal##11##1##(1995-8#2)(2006-5#4)(2008-5#3)(2008-7#1)(2008-9#1)
synaptoneurosomes##5##1##(1990-2#1)(1994-10#1)(1996-5#3)
synaptophysin and##4##2##(1992-2#1)(1997-5#1)(2006-12#1)(2013-1#1)
synaptophysin may be##2##3##(1996-3#1)(2013-1#1)
synaptophysin was##4##2##(1990-12#4)
synaptophysin##30##1##(1990-12#5)(1991-6#1)(1991-8#1)(1992-2#1)(1994-12#1)(1996-3#3)(1996-5#2)(1997-5#3)(1997-6#2)(2006-12#1)(2007-12#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#4)
synaptosomal and##2##2##(1993-8#2)
synaptosomal aspartate##2##2##(1990-7#2)
synaptosomal fraction##4##2##(1992-3#1)(1994-2#1)(1995-1#2)
synaptosomal membrane##2##2##(1991-3#1)(1995-12#1)
synaptosomal membranes##6##2##(1990-7#1)(1991-7#1)(1992-3#1)(1993-7#2)(1995-12#1)
synaptosomal preparations##3##2##(1995-1#2)(2008-4#1)
synaptosomal##28##1##(1990-7#3)(1991-1#1)(1991-3#1)(1991-7#1)(1992-3#3)(1993-7#2)(1993-8#2)(1994-12#2)(1994-2#1)(1995-1#5)(1995-11#3)(1995-12#2)(1995-9#1)(2008-4#1)
synaptosome##6##1##(1991-1#2)(1991-2#2)(1995-6#1)(1997-2#1)
synaptosome-associated##2##1##(1996-5#1)(2010-2#1)
synaptosomes and##8##2##(1990-2#4)(1990-7#1)(1995-11#1)(1995-6#1)(1995-9#1)
synaptosomes but not##2##3##(1990-2#1)(1995-5#1)
synaptosomes but##3##2##(1990-2#1)(1990-7#1)(1995-5#1)
synaptosomes from aged mice but not##2##6##(1995-9#2)
synaptosomes from aged mice##3##4##(1995-9#3)
synaptosomes from##4##2##(1995-9#4)
synaptosomes of##2##2##(1995-10#1)(1995-11#1)
synaptosomes was##2##2##(1992-3#1)(1995-5#1)
synaptosomes with arachidonic acid##2##4##(1995-11#2)
synaptosomes with##5##2##(1990-2#1)(1995-11#3)(1995-3#1)
synaptosomes##55##1##(1990-2#7)(1990-5#1)(1990-7#3)(1991-9#1)(1992-3#3)(1993-4#3)(1994-12#4)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#8)(1995-3#1)(1995-5#5)(1995-6#4)(1995-9#7)(1996-2#4)(2013-1#1)
synbiotics##5##1##(2006-8#2)(2009-3#1)(2010-4#2)
synchronicity##3##1##(2008-8#1)(2010-3#1)(2013-7#1)
synchronisation and##2##2##(2005-7#1)(2006-6#1)
synchronisation of the##2##3##(2005-8#1)(2007-12#1)
synchronisation of##3##2##(2005-8#1)(2007-12#2)
synchronisation##7##1##(2005-7#1)(2005-8#1)(2006-6#2)(2007-12#2)(2008-11#1)
synchronised##6##1##(1992-5#1)(1994-12#1)(1994-7#1)(2008-11#3)
synchronism##6##1##(2008-2#3)(2008-3#3)
synchronization and##5##2##(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)
synchronization between##7##2##(1994-2#1)(2007-12#2)(2007-9#1)(2008-2#1)(2011-2#1)(2013-8#1)
synchronization can be##2##3##(2007-12#1)(2009-8#1)
synchronization in a##2##3##(2007-12#1)(2008-2#1)
synchronization in coupled Nd##2##4##(2007-12#2)
synchronization in the##3##3##(2008-11#1)(2012-1#1)(2013-7#1)
synchronization in##20##2##(1994-5#1)(2006-10#1)(2007-11#2)(2007-12#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-1#2)(2012-2#2)(2013-7#1)
synchronization is##4##2##(2007-11#1)(2007-12#2)(2009-8#1)
synchronization of a##4##3##(2007-11#1)(2010-2#1)(2012-3#1)(2013-7#1)
synchronization of chaos##4##3##(2007-11#2)(2007-12#1)(2008-2#1)
synchronization of chaotic##5##3##(2007-12#5)
synchronization of the##3##3##(1996-2#1)(2007-11#1)(2008-7#1)
synchronization of two different##2##4##(2007-12#1)(2008-1#1)
synchronization of two##4##3##(2007-11#1)(2007-12#2)(2008-1#1)
synchronization of##36##2##(1991-10#1)(1992-3#1)(1995-11#1)(1996-2#2)(2006-9#1)(2007-11#6)(2007-12#8)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
synchronization to##2##2##(2007-11#1)(2009-8#1)
synchronization was##2##2##(2012-1#1)(2013-1#1)
synchronization with##4##2##(2006-5#1)(2008-4#1)(2008-9#1)(2010-5#1)
synchronization without##2##2##(2006-5#1)(2008-11#1)
synchronization##118##1##(1991-10#1)(1992-3#1)(1993-2#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-9#1)(1996-2#3)(2006-10#3)(2006-5#2)(2006-9#1)(2007-11#13)(2007-12#18)(2007-9#5)(2008-1#1)(2008-10#2)(2008-11#10)(2008-12#1)(2008-2#13)(2008-3#7)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#5)(2010-2#1)(2010-5#1)(2011-2#2)(2012-1#4)(2012-2#5)(2012-3#2)(2013-1#1)(2013-7#3)(2013-8#1)
synchronization-1st derivative fluorescence##2##3##(2008-10#2)
synchronize the##4##2##(2007-12#1)(2008-11#1)(2008-3#1)(2009-10#1)
synchronize their##2##2##(1995-11#1)(2011-1#1)
synchronize##14##1##(1995-11#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#1)(2009-10#1)(2009-8#2)(2010-8#1)(2011-1#1)
synchronized Ti##2##2##(2007-11#1)(2007-12#1)
synchronized by##2##2##(1993-9#1)(1995-2#1)
synchronized cardioversion##2##2##(2008-4#2)
synchronized chaotic##4##2##(2007-12#4)
synchronized cultures##2##2##(1994-9#1)(1997-7#1)
synchronized dual wavelength modulation##2##4##(2008-10#2)
synchronized femtosecond##2##2##(2007-11#1)(2008-3#1)
synchronized in##6##2##(1997-6#1)(2006-12#1)(2007-12#1)(2008-2#1)(2008-4#1)(2010-4#1)
synchronized picosecond##3##2##(2007-11#3)
synchronized states##2##2##(2008-11#1)(2012-2#1)
synchronized to the##2##3##(2008-3#1)(2010-8#1)
synchronized to##5##2##(2007-11#1)(2008-3#2)(2010-8#1)(2013-1#1)
synchronized with the##2##3##(2006-10#1)(2007-10#1)
synchronized with##11##2##(1993-2#2)(2006-10#1)(2006-5#3)(2007-10#1)(2007-12#1)(2008-2#1)(2008-5#1)(2013-8#1)
synchronized##90##1##(1991-12#1)(1991-5#1)(1992-4#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#3)(1993-9#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-7#2)(2006-10#1)(2006-12#1)(2006-5#6)(2007-10#1)(2007-11#10)(2007-12#10)(2008-10#3)(2008-11#4)(2008-2#3)(2008-3#5)(2008-4#4)(2008-5#4)(2008-8#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#4)(2013-8#3)
synchronizers##3##1##(2008-5#2)(2008-8#1)
synchronizes##4##1##(2008-1#1)(2008-8#1)(2009-2#1)(2011-1#1)
synchronizing the pulses##2##3##(2007-12#1)(2010-11#1)
synchronizing the##5##2##(2006-5#1)(2007-12#1)(2008-5#1)(2010-11#1)(2010-9#1)
synchronizing##9##1##(1992-9#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-2#1)(2008-5#1)(2009-8#1)(2010-11#1)(2010-9#1)
synchronous activity##2##2##(2013-8#2)
synchronous adenocarcinoma##2##2##(2008-5#1)(2013-8#1)
synchronous and metachronous##3##3##(1992-8#1)(2007-7#1)(2010-3#1)
synchronous and##8##2##(1992-8#1)(1997-3#1)(2005-4#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-3#1)
synchronous cancers##2##2##(2008-1#1)(2009-10#1)
synchronous derivative fluorimetry##2##3##(2008-10#2)
synchronous detection##6##2##(2007-11#1)(2008-2#2)(2008-3#3)
synchronous fluorescence spectra of##2##4##(2005-4#1)(2008-10#1)
synchronous fluorescence spectra##3##3##(2005-4#1)(2008-10#2)
synchronous fluorescence spectrometry##5##3##(2008-10#5)
synchronous fluorescence spectroscopy##4##3##(2008-10#4)
synchronous fluorescence##20##2##(2005-4#1)(2008-10#18)(2010-5#1)
synchronous growth##2##2##(1997-2#1)(2004-4#1)
synchronous in##2##2##(2007-9#1)(2008-9#1)
synchronous liver##2##2##(2010-1#1)(2013-7#1)
synchronous luminescence analysis##2##3##(2008-10#2)
synchronous luminescence##5##2##(2008-10#5)
synchronous malignant neoplasms##2##3##(2006-10#1)(2008-11#1)
synchronous metastases##6##2##(2007-7#1)(2008-6#5)
synchronous modulation##2##2##(2007-12#2)
synchronous occurrence of##2##3##(2006-10#1)(2009-1#1)
synchronous or metachronous##5##3##(1992-8#1)(1993-5#1)(2007-7#1)(2009-10#1)(2013-1#1)
synchronous oscillations in##2##3##(1996-2#1)(2008-11#1)
synchronous oscillations##3##2##(1996-2#1)(2008-11#1)(2008-2#1)
synchronous polarimeter##2##2##(2008-3#2)
synchronous scan fluorescence spectroscopy##2##4##(2013-8#2)
synchronous scan##4##2##(2008-10#1)(2013-8#3)
synchronous scanning##2##2##(1993-8#2)
synchronous spectrofluorimetry##5##2##(2008-10#5)
synchronous with the##3##3##(1990-5#1)(1991-5#1)(1995-6#1)
synchronous##165##1##(1990-5#1)(1990-6#4)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#2)(1992-3#1)(1992-8#2)(1993-1#1)(1993-12#1)(1993-5#2)(1993-8#3)(1994-12#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#1)(2004-4#1)(2005-4#3)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#7)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#41)(2008-11#5)(2008-2#8)(2008-3#11)(2008-5#3)(2008-6#7)(2008-7#3)(2008-9#2)(2009-1#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#7)
synchronously in##2##2##(2008-4#1)(2011-2#1)
synchronously pump an optical parametric oscillator##2##6##(2007-11#1)(2007-12#1)
synchronously pumped by##2##3##(2007-11#1)(2007-12#1)
synchronously pumped optical parametric oscillator##4##5##(2007-11#2)(2007-12#1)(2008-3#1)
synchronously pumped optical parametric##5##4##(2007-11#3)(2007-12#1)(2008-3#1)
synchronously pumped##14##2##(2007-11#7)(2007-12#6)(2008-3#1)
synchronously with the##3##3##(2007-12#2)(2008-3#1)
synchronously##43##1##(1992-5#1)(1993-7#1)(1995-11#1)(2006-10#1)(2007-11#9)(2007-12#14)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#1)(2008-9#1)(2009-12#1)(2010-5#2)(2010-7#1)(2011-2#1)(2012-1#1)
synchrony (0##2##2##(2008-5#2)
synchrony and##2##2##(2007-10#1)(2008-5#1)
synchrony between the##3##3##(2013-8#3)
synchrony between##4##2##(2013-8#4)
synchrony in the##2##3##(2008-11#1)(2013-8#1)
synchrony in##6##2##(2008-11#2)(2009-8#3)(2013-8#1)
synchrony of##5##2##(2007-2#1)(2010-9#1)(2011-2#1)(2013-1#2)
synchrony with##2##2##(1995-6#1)(2010-8#1)
synchrony##36##1##(1995-11#1)(1995-6#1)(2007-10#1)(2007-2#1)(2008-11#9)(2008-2#2)(2008-5#3)(2008-8#1)(2009-8#4)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#2)(2013-8#7)
synchrotron X-ray beam##2##3##(2006-4#1)(2008-4#1)
synchrotron X-ray diffraction##2##3##(2006-10#1)(2006-4#1)
synchrotron X-ray##6##2##(2006-10#1)(2006-4#3)(2008-4#1)(2012-2#1)
synchrotron beamline##2##2##(2008-3#1)(2008-4#1)
synchrotron microangiography##3##2##(2006-4#3)
synchrotron radiation and##4##3##(2006-5#1)(2008-10#1)(2008-2#2)
synchrotron radiation at the##2##4##(2006-5#2)
synchrotron radiation at##8##3##(1997-7#1)(2006-4#1)(2006-5#4)(2007-9#1)(2008-2#1)
synchrotron radiation beam##3##3##(2006-4#1)(2008-2#1)(2008-3#1)
synchrotron radiation facilities##3##3##(2006-4#2)(2006-5#1)
synchrotron radiation facility##3##3##(2006-4#1)(2012-12#2)
synchrotron radiation from##2##3##(2006-4#1)(2006-5#1)
synchrotron radiation have been##2##4##(2006-4#1)(2006-5#1)
synchrotron radiation have##3##3##(2006-4#1)(2006-5#2)
synchrotron radiation in the##3##4##(2006-5#1)(2008-2#1)(2008-3#1)
synchrotron radiation in##5##3##(2006-5#1)(2008-10#2)(2008-2#1)(2008-3#1)
synchrotron radiation is##2##3##(2006-5#1)(2008-3#1)
synchrotron radiation research##3##3##(2006-5#3)
synchrotron radiation source##3##3##(2006-4#1)(2006-5#1)(2008-3#1)
synchrotron radiation sources##3##3##(2006-4#3)
synchrotron radiation was carried out##2##5##(2006-5#2)
synchrotron radiation##87##2##(1995-6#1)(1997-7#1)(2006-4#15)(2006-5#35)(2007-11#2)(2007-9#1)(2008-10#5)(2008-2#10)(2008-3#11)(2008-5#2)(2010-5#2)(2012-12#2)
synchrotron sources##4##2##(2006-5#1)(2008-10#1)(2008-11#1)(2008-2#1)
synchrotron##129##1##(1990-3#1)(1991-12#1)(1992-11#1)(1992-7#1)(1995-5#1)(1995-6#1)(1997-7#1)(2006-10#1)(2006-4#25)(2006-5#39)(2007-11#3)(2007-9#5)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#13)(2008-3#14)(2008-4#2)(2008-5#6)(2010-5#2)(2012-12#2)(2012-2#1)
synchrotron-based##2##1##(2006-4#1)(2008-3#1)
synchrotron-radiation-stimulated processes##3##2##(2006-5#3)
syncopal attacks##2##2##(2008-11#1)(2012-2#1)
syncopal episodes##2##2##(1992-4#1)(2008-12#1)
syncopal##7##1##(1992-4#1)(2006-9#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2012-2#1)
syncope and sudden cardiac death##2##5##(2008-12#1)(2013-7#1)
syncope and the##2##3##(2006-9#1)(2008-11#1)
syncope and##8##2##(2006-12#3)(2006-9#1)(2008-11#1)(2008-12#2)(2013-7#1)
syncope is##2##2##(2006-9#2)
syncope or##3##2##(2005-6#1)(2008-4#1)(2008-7#1)
syncope with##2##2##(2006-9#1)(2008-7#1)
syncope##45##1##(1990-8#2)(1991-8#1)(1992-9#1)(1994-3#1)(1995-6#1)(1997-1#2)(2005-6#1)(2006-12#3)(2006-9#10)(2007-9#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#3)(2009-4#1)(2010-12#3)(2010-2#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
syncopes##2##1##(1990-8#1)(1992-5#1)
syncytia and##2##2##(2005-11#1)(2008-12#1)
syncytia formation##6##2##(1990-8#3)(1991-5#1)(1993-3#1)(2008-4#1)
syncytia##10##1##(1990-8#3)(1991-5#1)(1993-3#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)
syncytial connections between##2##3##(2009-2#2)
syncytial connections##3##2##(2009-2#3)
syncytial development##2##2##(2008-9#2)
syncytial virus (RSV) infection##2##4##(2010-10#1)(2012-2#1)
syncytial virus (RSV)##13##3##(1992-10#1)(1996-3#1)(2005-8#1)(2007-11#1)(2008-11#1)(2009-8#2)(2010-10#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
syncytial virus##29##2##(1992-10#3)(1994-6#3)(1995-5#1)(1996-11#1)(1996-12#1)(1996-3#1)(2005-8#1)(2006-8#2)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#1)(2009-8#2)(2010-10#2)(2010-4#1)(2010-5#1)(2011-2#3)(2012-2#1)(2013-1#1)
syncytial##46##1##(1992-10#3)(1994-6#3)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-11#1)(2007-12#2)(2007-3#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#2)(2009-2#4)(2009-8#2)(2010-1#1)(2010-10#2)(2010-4#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)
syncytiotrophoblast and##2##2##(1990-12#1)(2007-6#1)
syncytiotrophoblast in##8##2##(2007-6#1)(2009-2#1)(2011-1#6)
syncytiotrophoblast##19##1##(1990-12#2)(1990-9#3)(2007-6#3)(2009-2#3)(2011-1#7)(2013-1#1)
syncytium formation induced##2##3##(1991-2#1)(1992-9#1)
syncytium formation##9##2##(1991-10#3)(1991-2#1)(1992-9#1)(1993-6#1)(1993-9#1)(1997-6#1)(2008-4#1)
syncytium##14##1##(1991-10#3)(1991-2#1)(1992-9#1)(1993-6#1)(1993-9#1)(1995-8#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-4#1)(2008-7#1)(2010-11#1)
syncytium-inducing##2##1##(1997-4#1)(2006-10#1)
syndactyly of the##3##3##(1997-1#1)(1997-3#1)(2011-2#1)
syndactyly of##4##2##(1997-1#1)(1997-3#1)(2011-2#2)
syndactyly##6##1##(1997-1#1)(1997-3#1)(2006-6#1)(2007-7#1)(2011-2#2)
syndecan##3##1##(1995-5#3)
syndecan-1 is expressed in##2##4##(2008-5#2)
syndecan-1##5##1##(1995-5#3)(2008-5#2)
syndecan-2##3##1##(2009-4#2)(2013-1#1)
syndesmosis##3##1##(2009-1#1)(2012-12#2)
syndesmotic##3##1##(2009-3#2)(2012-3#1)
syndet surfactants##2##2##(2008-5#2)
syndicate learning##4##2##(2012-1#4)
syndicate##6##1##(2012-1#6)
syndrom##2##1##(2007-11#1)(2011-2#1)
syndromal##3##1##(1997-8#1)(2007-12#1)(2008-6#1)
syndrome (0##2##2##(2006-10#1)(2010-4#1)
syndrome (8##3##2##(2008-3#1)(2008-7#1)(2008-8#1)
syndrome (AES)##2##2##(2012-12#1)(2013-1#1)
syndrome (AIDS)##47##2##(1990-10#1)(1990-6#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#2)(1991-9#3)(1992-12#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-8#1)(2005-10#2)(2005-4#1)(2007-11#2)(2007-2#1)(2008-1#1)(2008-3#1)(2009-8#1)(2011-2#1)(2011-3#1)(2013-7#1)
syndrome (AIDS)-related##2##2##(1995-1#1)(2006-7#1)
syndrome (APS)##5##2##(2006-1#1)(2006-10#3)(2013-8#1)
syndrome (AS) is##2##3##(2006-8#1)(2007-7#1)
syndrome (AS)##6##2##(1996-3#1)(2006-8#1)(2007-7#1)(2008-9#1)(2009-4#1)(2010-12#1)
syndrome (BWS)##2##2##(2010-12#2)
syndrome (CBS) is##2##3##(2008-11#1)(2011-2#1)
syndrome (CBS)##3##2##(2008-11#1)(2011-2#2)
syndrome (CHS)##2##2##(2007-3#1)(2009-8#1)
syndrome (CS)##4##2##(1997-4#1)(2008-9#1)(2011-2#2)
syndrome (DS)##9##2##(1991-1#1)(1993-5#1)(1995-6#2)(1996-1#1)(1996-2#1)(1996-6#1)(2011-1#1)(2012-2#1)
syndrome (FMS) is##4##3##(1990-6#1)(2009-7#1)(2011-1#1)(2011-2#1)
syndrome (FMS)##5##2##(1990-6#1)(2009-7#1)(2011-1#2)(2011-2#1)
syndrome (FSS)##2##2##(1996-3#1)(2012-3#1)
syndrome (FXTAS)##3##2##(2006-12#2)(2008-8#1)
syndrome (GBS)##4##2##(2006-10#1)(2007-11#1)(2008-6#1)(2008-7#1)
syndrome (HES)##3##2##(2006-6#1)(2007-7#1)(2010-12#1)
syndrome (HIV/AIDS)##2##2##(2007-2#1)(2009-12#1)
syndrome (HPS)##2##2##(2006-4#1)(2011-1#1)
syndrome (HS)##2##2##(2011-2#2)
syndrome (INS)##2##2##(2009-8#1)(2010-4#1)
syndrome (KS)##3##2##(1995-5#1)(2013-1#2)
syndrome (LRS)##2##2##(1996-12#1)(2011-2#1)
syndrome (MAS) is a rare##2##5##(2006-10#1)(2012-2#1)
syndrome (MDS)##5##2##(1997-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
syndrome (MFS)##2##2##(2008-7#1)(2012-1#1)
syndrome (MPS)##2##2##(2006-8#1)(2007-8#1)
syndrome (MS) is a##2##4##(2008-10#1)(2008-3#1)
syndrome (MS) is##3##3##(2008-10#1)(2008-3#2)
syndrome (MS)##16##2##(1993-5#1)(2008-10#1)(2008-3#9)(2008-7#1)(2011-1#2)(2011-2#1)(2013-8#1)
syndrome (MetS) is##4##3##(2008-3#1)(2010-10#1)(2012-2#1)(2013-1#1)
syndrome (MetS)##10##2##(2008-3#2)(2010-10#1)(2010-9#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#2)
syndrome (NPS)##2##2##(2008-7#1)(2013-1#1)
syndrome (PCOS) is the most##2##5##(2008-3#1)(2013-8#1)
syndrome (PCOS) is##7##3##(2008-3#1)(2008-4#3)(2012-11#1)(2013-1#1)(2013-8#1)
syndrome (PCOS)##26##2##(2006-2#1)(2008-1#1)(2008-3#5)(2008-4#8)(2009-3#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#4)
syndrome (PDS)##2##2##(2010-12#1)(2011-1#1)
syndrome (SLOS)##10##2##(1995-4#1)(1997-1#8)(2010-7#1)
syndrome (SS)##9##2##(2006-10#2)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-5#1)(2011-2#1)
syndrome (TS)##3##2##(1996-2#1)(1996-5#1)(2006-3#1)
syndrome (Takotsubo##2##2##(2011-2#1)(2013-7#1)
syndrome (VCFS)##2##2##(2012-12#2)
syndrome (WS)##4##2##(2008-8#1)(2009-4#1)(2010-2#2)
syndrome (group##2##2##(2007-9#2)
syndrome (multiple##2##2##(2008-8#1)(2013-8#1)
syndrome (n = 3)##2##4##(1994-6#1)(2012-12#1)
syndrome (n =##6##3##(1994-6#1)(1997-8#1)(2008-11#1)(2008-3#1)(2012-12#2)
syndrome - a##3##3##(2008-11#1)(2012-2#1)(2013-7#1)
syndrome -##8##2##(2007-4#1)(2008-11#1)(2009-9#2)(2012-2#1)(2013-1#2)(2013-7#1)
syndrome X patients##2##3##(2008-12#2)
syndrome X##9##2##(2008-1#1)(2008-12#5)(2008-3#2)(2011-2#1)
syndrome according to the##2##4##(1991-11#1)(2008-3#1)
syndrome according to##5##3##(1991-11#1)(1994-8#1)(2008-3#3)
syndrome admitted##2##2##(2008-3#1)(2009-1#1)
syndrome affect##2##2##(2007-8#1)(2011-2#1)
syndrome affecting##3##2##(1994-11#1)(2008-10#1)(2011-1#1)
syndrome affects##3##2##(2011-2#1)(2013-1#2)
syndrome after a##2##3##(2008-7#1)(2012-3#1)
syndrome after##21##2##(1990-2#2)(1990-9#1)(1995-12#1)(2005-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-2#1)(2009-4#1)(2012-12#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#2)
syndrome also has##2##3##(2008-7#1)(2009-3#1)
syndrome also##6##2##(2006-10#1)(2007-10#1)(2008-3#1)(2008-7#1)(2009-3#1)(2013-1#1)
syndrome among##7##2##(2006-7#1)(2008-3#1)(2009-4#1)(2010-10#1)(2010-7#1)(2012-2#1)(2013-8#1)
syndrome and a##4##3##(1991-8#1)(1994-4#1)(2007-8#1)(2009-3#1)
syndrome and acute##4##3##(2008-7#1)(2009-8#1)(2011-2#1)(2013-8#1)
syndrome and an##3##3##(1996-6#1)(2007-11#1)(2009-4#1)
syndrome and autism##2##3##(2006-8#1)(2009-4#1)
syndrome and cardiac##2##3##(2008-10#1)(2008-8#1)
syndrome and chronic##6##3##(1992-11#1)(1992-2#1)(2007-7#1)(2010-10#1)(2012-3#1)(2013-1#1)
syndrome and diabetes##4##3##(2008-1#1)(2008-3#2)(2011-2#1)
syndrome and discuss##2##3##(2007-11#1)(2008-1#1)
syndrome and idiopathic##2##3##(2008-11#1)(2012-2#1)
syndrome and impaired##2##3##(2008-3#1)(2013-8#1)
syndrome and in##7##3##(1990-2#1)(1994-7#1)(1996-12#1)(1997-7#1)(2008-1#1)(2008-3#1)(2013-1#1)
syndrome and insulin resistance##2##4##(2008-3#1)(2011-2#1)
syndrome and is##3##3##(2009-11#1)(2009-2#1)(2012-2#1)
syndrome and its##12##3##(1990-2#2)(1993-5#1)(2007-5#1)(2008-1#1)(2008-3#4)(2008-7#1)(2013-1#1)(2013-7#1)
syndrome and may be##2##4##(2008-12#1)(2008-3#1)
syndrome and may##4##3##(2006-11#1)(2007-11#1)(2008-12#1)(2008-3#1)
syndrome and most##2##3##(1996-5#1)(2007-11#1)
syndrome and multiple##2##3##(1997-1#1)(2008-12#1)
syndrome and other##6##3##(1990-3#3)(1997-8#1)(2010-12#1)(2010-4#1)
syndrome and performed##2##3##(2009-1#1)(2012-2#1)
syndrome and quality of life##2##5##(2011-2#2)
syndrome and recurrent##2##3##(2007-8#1)(2013-1#1)
syndrome and related disorders##2##4##(2008-3#1)(2009-7#1)
syndrome and related##3##3##(2008-3#2)(2009-7#1)
syndrome and severe##2##3##(2007-8#2)
syndrome and small cell lung##2##5##(1994-3#1)(1996-1#1)
syndrome and suggest that##2##4##(2006-9#1)(2008-5#1)
syndrome and supraventricular arrhythmias##2##4##(1993-10#1)(1995-6#1)
syndrome and the##18##3##(1990-5#1)(1994-5#1)(1995-2#1)(1996-3#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-3#2)(2010-12#2)(2010-2#2)(2012-12#3)(2012-2#1)
syndrome and their##3##3##(2012-12#3)
syndrome and to##2##3##(2008-9#1)(2011-12#1)
syndrome and type 2 diabetes mellitus##6##6##(2008-1#2)(2009-11#4)
syndrome and type 2 diabetes##9##5##(2008-1#4)(2009-11#4)(2009-3#1)
syndrome and unilateral##2##3##(2007-7#1)(2010-5#1)
syndrome and##315##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#4)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-8#1)(1992-1#1)(1992-11#2)(1992-2#2)(1992-5#2)(1993-10#1)(1993-12#2)(1993-4#1)(1993-5#2)(1993-8#2)(1994-3#1)(1994-4#1)(1994-5#2)(1994-7#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#5)(1996-3#4)(1996-5#2)(1996-6#2)(1997-1#4)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#3)(2004-11#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#8)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#3)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#8)(2007-12#1)(2007-2#1)(2007-4#3)(2007-5#1)(2007-7#7)(2007-8#12)(2007-9#5)(2008-1#11)(2008-10#6)(2008-11#3)(2008-12#6)(2008-3#26)(2008-4#6)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#5)(2009-1#2)(2009-10#1)(2009-11#5)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#2)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#9)(2011-12#2)(2011-2#17)(2012-1#1)(2012-12#9)(2012-2#9)(2012-3#3)(2013-1#13)(2013-7#1)(2013-8#6)
syndrome are associated with##3##4##(1997-5#1)(2007-8#1)(2013-1#1)
syndrome are common##2##3##(1993-10#1)(2007-2#1)
syndrome are described##2##3##(1991-5#1)(2012-2#1)
syndrome are discussed##6##3##(1990-2#1)(1991-4#1)(2007-7#1)(2007-8#1)(2010-2#1)(2013-1#1)
syndrome are less##2##3##(1995-2#1)(2009-2#1)
syndrome are reported##2##3##(1996-5#1)(2011-1#1)
syndrome are used##2##3##(2008-11#1)(2008-3#1)
syndrome are##50##2##(1990-2#1)(1991-12#1)(1991-4#2)(1991-5#2)(1993-10#1)(1994-4#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-5#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#5)(2008-3#4)(2008-4#1)(2009-10#1)(2009-12#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#2)
syndrome as a clinical##2##4##(1993-1#1)(2006-10#1)
syndrome as a result of##4##5##(1991-3#1)(2007-10#1)(2009-9#1)(2011-1#1)
syndrome as a##12##3##(1991-3#1)(1991-5#1)(1993-1#1)(1995-2#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-3#1)(2009-9#1)(2011-1#1)(2012-3#1)
syndrome as an##2##3##(2007-11#1)(2008-5#1)
syndrome as the##2##3##(1991-2#1)(2008-3#1)
syndrome as well as##4##4##(1990-3#1)(1991-6#1)(2008-7#1)(2011-2#1)
syndrome as well##5##3##(1990-3#1)(1991-6#1)(2008-4#1)(2008-7#1)(2011-2#1)
syndrome as##29##2##(1990-3#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1993-1#1)(1995-2#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-1#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2009-9#1)(2011-1#1)(2011-2#2)(2012-3#1)
syndrome associated with a##4##4##(2005-1#1)(2006-9#1)(2011-1#2)
syndrome associated with##30##3##(1990-8#1)(1996-12#1)(1996-3#2)(1997-3#1)(1997-7#1)(2005-1#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-7#4)(2007-9#1)(2008-11#1)(2009-6#1)(2009-7#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-12#1)(2013-7#1)
syndrome at the##4##3##(1990-12#1)(1991-9#1)(2008-11#1)(2008-9#1)
syndrome at##13##2##(1990-12#1)(1990-5#1)(1991-9#1)(1995-6#1)(2006-10#2)(2007-8#1)(2008-11#1)(2008-3#2)(2008-9#1)(2010-4#1)(2011-2#1)
syndrome based on##3##3##(2010-6#1)(2011-2#1)(2013-1#1)
syndrome because of##2##3##(2011-1#1)(2012-12#1)
syndrome because##5##2##(1991-12#1)(2006-10#1)(2007-3#1)(2011-1#1)(2012-12#1)
syndrome between##2##2##(1992-11#1)(2010-12#1)
syndrome but not##2##3##(1994-4#2)
syndrome but##5##2##(1994-4#2)(1997-5#1)(2006-3#1)(2008-3#1)
syndrome by proxy##6##3##(1995-5#2)(1996-2#1)(2007-3#1)(2010-12#1)(2010-4#1)
syndrome by##25##2##(1990-6#1)(1993-9#1)(1995-4#1)(1995-5#2)(1996-2#1)(1996-3#1)(2005-12#1)(2006-4#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#1)(2013-8#3)
syndrome can be made##3##4##(1993-10#1)(2008-3#1)(2011-2#1)
syndrome can be##6##3##(1993-10#1)(2006-10#1)(2007-7#1)(2008-3#1)(2008-9#1)(2011-2#1)
syndrome can##16##2##(1993-10#1)(1997-1#2)(2006-10#1)(2007-1#1)(2007-7#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#2)
syndrome care##2##2##(2008-7#1)(2008-9#1)
syndrome cases##2##2##(2008-8#1)(2012-2#1)
syndrome caused by a##7##4##(1997-1#1)(2007-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-4#1)(2012-2#1)
syndrome caused by mutations in the##2##6##(2007-7#1)(2008-1#1)
syndrome caused by##18##3##(1995-1#1)(1996-9#1)(1997-1#1)(1997-5#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2012-2#1)(2012-3#1)
syndrome characterised by##3##3##(2006-10#1)(2008-10#1)(2009-11#1)
syndrome characterized by##19##3##(1990-10#1)(1991-2#1)(1993-3#1)(1994-3#1)(1997-4#2)(2008-11#1)(2008-4#2)(2009-11#1)(2009-3#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
syndrome combined with##2##3##(2007-4#1)(2008-10#1)
syndrome complicated by##4##3##(1992-11#1)(1995-6#1)(2007-7#1)(2013-8#1)
syndrome complicated with##2##3##(1995-6#1)(2007-10#1)
syndrome complicated##6##2##(1992-11#1)(1995-6#2)(2007-10#1)(2007-7#1)(2013-8#1)
syndrome complicating##3##2##(1992-4#1)(1996-6#2)
syndrome comprising##3##2##(1996-3#1)(1997-1#1)(2008-4#1)
syndrome confirmed by##2##3##(2011-2#1)(2012-12#1)
syndrome consists of##4##3##(2006-10#1)(2006-6#1)(2007-4#1)(2013-1#1)
syndrome could##3##2##(1995-6#1)(2007-10#1)(2007-8#1)
syndrome critical##2##2##(1997-2#1)(2008-3#1)
syndrome de glissement&quot##2##3##(2010-6#2)
syndrome de sevrage à la nicotine##2##6##(2013-1#2)
syndrome de sevrage##3##3##(2013-1#3)
syndrome de##5##2##(2010-6#2)(2013-1#3)
syndrome despite##2##2##(2009-9#1)(2013-1#1)
syndrome developed##2##2##(1997-1#1)(2011-2#1)
syndrome diagnosed##4##2##(1997-1#1)(2006-10#1)(2008-8#1)(2011-2#1)
syndrome due to##8##3##(1991-2#2)(1992-10#1)(2007-7#1)(2007-8#1)(2008-12#1)(2011-2#2)
syndrome during pregnancy##2##3##(1996-12#1)(2006-10#1)
syndrome during the##3##3##(2007-11#1)(2011-2#1)(2012-3#1)
syndrome during##13##2##(1996-12#1)(2006-10#3)(2007-11#1)(2007-8#1)(2008-12#2)(2008-3#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-3#1)
syndrome exhibit##2##2##(2008-3#1)(2012-8#1)
syndrome exists##3##2##(2007-10#1)(2007-11#1)(2009-6#1)
syndrome express##2##2##(1994-12#1)(2012-12#1)
syndrome fibroblasts##2##2##(1990-3#1)(2008-7#1)
syndrome following##11##2##(1996-2#1)(1997-7#1)(2007-7#1)(2008-4#1)(2008-7#1)(2009-1#2)(2009-3#1)(2010-11#1)(2010-9#1)(2011-2#1)
syndrome for##2##2##(1996-3#1)(2011-2#1)
syndrome from##5##2##(1996-2#1)(2006-9#1)(2008-3#1)(2011-1#1)(2012-2#1)
syndrome gives##2##2##(2007-7#1)(2007-8#1)
syndrome group##6##2##(1995-1#1)(1997-4#1)(2008-3#3)(2008-7#1)
syndrome groups##4##2##(1990-3#3)(2007-12#1)
syndrome had##6##2##(1990-9#1)(1994-3#1)(1994-5#1)(2008-11#1)(2013-8#2)
syndrome has a##3##3##(1992-3#1)(2005-1#1)(2006-10#1)
syndrome has become##3##3##(2006-10#1)(2006-9#1)(2007-8#1)
syndrome has been described##2##4##(2008-3#1)(2012-2#1)
syndrome has been extensively studied##2##5##(2007-7#1)(2008-10#1)
syndrome has been reported##3##4##(2011-2#1)(2013-1#2)
syndrome has been##16##3##(1992-2#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-4#1)(2007-7#2)(2008-10#1)(2008-3#2)(2008-6#1)(2011-2#1)(2012-2#1)(2013-1#2)
syndrome has not been##2##4##(2006-8#1)(2011-2#1)
syndrome has not##3##3##(2006-8#1)(2008-3#1)(2011-2#1)
syndrome has recently##2##3##(2008-11#1)(2011-2#1)
syndrome has to be##2##4##(1990-9#1)(2011-2#1)
syndrome has##37##2##(1990-9#1)(1991-9#1)(1992-2#1)(1992-3#1)(1997-3#1)(2005-1#1)(2005-10#1)(2005-7#1)(2006-10#4)(2006-11#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-6#1)(2010-12#1)(2011-2#5)(2012-2#1)(2013-1#4)
syndrome have a##3##3##(1997-3#1)(1997-6#1)(2010-5#1)
syndrome have been##7##3##(1992-11#1)(1994-3#1)(1996-3#1)(1997-1#1)(2008-3#1)(2009-6#1)(2013-7#1)
syndrome have##21##2##(1992-11#1)(1992-4#1)(1993-12#1)(1994-3#1)(1996-3#2)(1997-1#1)(1997-3#2)(1997-6#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-3#2)(2009-6#1)(2010-12#1)(2010-5#1)(2011-2#2)(2013-7#1)
syndrome in India##2##3##(2008-3#1)(2013-1#1)
syndrome in Jamaican##2##3##(2011-2#2)
syndrome in Parkinson's disease##2##4##(2009-11#2)
syndrome in Saudi##2##3##(2007-2#1)(2008-3#1)
syndrome in a child##3##4##(2007-2#1)(2007-3#1)(2007-7#1)
syndrome in a patient with renal##2##6##(1997-3#1)(2006-9#1)
syndrome in a patient with##10##5##(1997-3#1)(2005-12#2)(2006-10#3)(2006-9#1)(2009-4#1)(2011-1#1)(2013-7#1)
syndrome in a young##2##4##(1993-3#1)(2011-2#1)
syndrome in a##37##3##(1991-4#1)(1992-4#1)(1993-10#1)(1993-3#1)(1997-3#1)(2005-12#2)(2005-7#2)(2006-10#3)(2006-7#1)(2006-9#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-12#1)(2008-3#3)(2009-3#1)(2009-4#1)(2011-1#3)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
syndrome in about##2##3##(2007-11#1)(2008-9#1)
syndrome in adults is##2##4##(1996-11#1)(2006-10#1)
syndrome in adults with##3##4##(2008-7#2)(2012-2#1)
syndrome in adults##7##3##(1992-8#1)(1996-11#1)(2006-10#1)(2008-7#2)(2012-2#1)(2012-3#1)
syndrome in an adult##3##4##(2006-10#1)(2007-8#1)(2012-2#1)
syndrome in an##7##3##(2006-10#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#1)(2012-2#1)
syndrome in children with##2##4##(2011-2#2)
syndrome in children##9##3##(1997-2#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-4#1)(2009-5#1)(2011-2#2)
syndrome in infants##2##3##(1990-3#1)(2006-10#1)
syndrome in newborn##2##3##(1993-10#1)(1993-5#1)
syndrome in our##2##3##(1995-2#1)(2008-1#1)
syndrome in patients with##6##4##(1992-8#1)(2006-8#1)(2008-1#1)(2008-3#2)(2012-2#1)
syndrome in pregnancy##2##3##(1993-7#1)(2006-12#1)
syndrome in schizophrenia##3##3##(1997-8#2)(2006-3#1)
syndrome in the Chinese Han population##2##6##(2012-2#1)(2013-7#1)
syndrome in the course of##2##5##(1990-12#1)(2007-7#1)
syndrome in the first##2##4##(1990-12#1)(2008-1#1)
syndrome in the##23##3##(1990-12#2)(1990-2#2)(1995-7#1)(1995-8#1)(1996-9#1)(2004-10#1)(2007-7#1)(2008-1#1)(2008-3#5)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
syndrome in two##6##3##(1994-8#1)(1997-1#1)(1997-5#1)(2007-7#1)(2008-1#1)(2010-10#1)
syndrome in type 2##2##4##(2007-5#1)(2011-12#1)
syndrome in which the##2##4##(1994-6#1)(2008-10#1)
syndrome in which##6##3##(1994-6#1)(1996-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2009-10#1)
syndrome in whom##3##3##(1996-3#1)(2006-4#1)(2008-7#1)
syndrome in women##2##3##(2008-3#1)(2012-3#1)
syndrome in##242##2##(1990-12#2)(1990-2#2)(1990-3#1)(1991-1#1)(1991-4#1)(1991-6#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-8#3)(1993-10#2)(1993-11#1)(1993-3#1)(1993-5#1)(1993-7#1)(1994-3#1)(1994-6#2)(1994-8#2)(1995-2#1)(1995-7#1)(1995-8#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-5#1)(1997-8#2)(2004-10#1)(2005-10#3)(2005-12#2)(2005-7#2)(2006-10#9)(2006-12#3)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#3)(2007-3#2)(2007-5#2)(2007-7#3)(2007-8#8)(2007-9#1)(2008-1#8)(2008-10#7)(2008-11#1)(2008-12#4)(2008-3#27)(2008-5#5)(2008-7#7)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#18)(2012-12#10)(2012-2#9)(2012-3#6)(2013-1#10)(2013-7#4)(2013-8#1)
syndrome include##2##2##(1996-12#1)(2011-2#1)
syndrome includes##3##2##(2006-10#1)(2007-11#1)(2008-3#1)
syndrome including##6##2##(1996-3#1)(1996-8#2)(2008-1#1)(2008-3#2)
syndrome individuals##3##2##(1996-7#1)(2012-12#2)
syndrome induced by##4##3##(1996-10#1)(2007-8#1)(2008-4#1)(2009-6#1)
syndrome involves##3##2##(2008-12#1)(2009-5#1)(2013-8#1)
syndrome involving##3##2##(1996-3#2)(2012-2#1)
syndrome is a cluster of##3##5##(2008-3#3)
syndrome is a common##2##4##(1997-1#1)(2009-10#1)
syndrome is a condition##3##4##(1990-2#1)(2009-4#1)(2013-8#1)
syndrome is a disorder##2##4##(1995-8#1)(2007-7#1)
syndrome is a dominantly inherited##3##5##(1996-3#1)(2013-1#2)
syndrome is a potentially##2##4##(2008-10#1)(2009-11#1)
syndrome is a rare X-linked##2##5##(2007-8#1)(2012-3#1)
syndrome is a rare autosomal recessive##3##6##(1997-8#1)(2009-9#1)(2011-1#1)
syndrome is a rare autosomal##4##5##(1997-8#1)(2009-9#1)(2011-1#1)(2011-2#1)
syndrome is a rare cause of##2##6##(2009-6#1)(2012-2#1)
syndrome is a rare complication of##2##6##(1991-4#1)(2011-2#1)
syndrome is a rare complication##3##5##(1991-4#1)(2009-11#1)(2011-2#1)
syndrome is a rare congenital##2##5##(2009-9#1)(2010-7#1)
syndrome is a rare disorder of##2##6##(1990-5#1)(2010-2#1)
syndrome is a rare disorder##4##5##(1990-5#1)(2009-9#1)(2010-2#1)(2011-2#1)
syndrome is a rare##28##4##(1990-5#1)(1991-4#1)(1997-8#1)(2007-8#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#3)(2010-2#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
syndrome is a spectrum of##2##5##(1991-4#1)(2005-12#1)
syndrome is a very rare##2##5##(2005-12#1)(2011-12#1)
syndrome is a##82##3##(1990-2#1)(1990-5#1)(1991-4#2)(1993-5#1)(1993-6#1)(1993-9#1)(1995-8#1)(1996-3#1)(1996-6#2)(1997-1#1)(1997-8#1)(2005-1#1)(2005-12#2)(2006-2#2)(2006-8#2)(2007-11#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#4)(2010-2#2)(2010-6#1)(2010-7#2)(2011-1#3)(2011-12#1)(2011-2#7)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
syndrome is also##5##3##(1992-8#1)(1993-10#1)(1995-12#1)(2008-1#1)(2012-2#1)
syndrome is an autosomal dominant disorder characterized by##2##8##(2008-8#1)(2010-3#1)
syndrome is an autosomal dominant##7##5##(2008-12#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#2)
syndrome is an autosomal recessive##2##5##(1997-1#1)(2010-3#1)
syndrome is an autosomal##9##4##(1997-1#1)(2008-12#1)(2008-8#1)(2010-3#2)(2010-8#1)(2011-2#1)(2013-1#2)
syndrome is an important##2##4##(2006-4#1)(2007-7#1)
syndrome is an uncommon##3##4##(2006-3#1)(2007-3#1)(2009-9#1)
syndrome is an##20##3##(1990-5#1)(1993-11#1)(1997-1#1)(2006-10#2)(2006-3#1)(2006-4#1)(2007-3#1)(2007-7#1)(2008-12#1)(2008-8#1)(2009-9#1)(2010-3#2)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#2)
syndrome is associated with##2##4##(1992-3#1)(2008-12#1)
syndrome is caused by a##3##5##(2008-10#1)(2008-3#1)(2010-4#1)
syndrome is caused##4##3##(2007-3#1)(2008-10#1)(2008-3#1)(2010-4#1)
syndrome is characterized by a##3##5##(1995-8#1)(2008-7#1)(2012-12#1)
syndrome is characterized by##14##4##(1991-3#1)(1994-12#1)(1995-8#1)(2005-12#1)(2005-8#1)(2006-10#1)(2007-8#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)
syndrome is difficult##2##3##(2007-11#1)(2008-12#1)
syndrome is discussed##2##3##(2007-7#1)(2013-1#1)
syndrome is due to##2##4##(1993-11#1)(2008-1#1)
syndrome is even##2##3##(2010-3#1)(2012-2#1)
syndrome is high##2##3##(2007-8#1)(2008-3#1)
syndrome is likely##2##3##(1997-1#1)(1997-6#1)
syndrome is not##4##3##(1990-2#1)(2007-10#1)(2008-4#1)(2011-12#1)
syndrome is often associated with##2##5##(1991-12#1)(2006-10#1)
syndrome is often##5##3##(1991-12#1)(2006-10#1)(2007-11#2)(2008-8#1)
syndrome is one of##2##4##(2006-10#2)
syndrome is presented##5##3##(1993-5#1)(2008-9#1)(2009-9#1)(2011-1#1)(2012-12#1)
syndrome is proposed for##2##4##(1997-1#1)(2010-11#1)
syndrome is related to##2##4##(2007-11#1)(2008-9#1)
syndrome is reported##6##3##(1991-4#1)(1992-6#1)(2007-7#1)(2008-4#1)(2009-5#1)(2010-2#1)
syndrome is still##2##3##(2008-12#1)(2011-2#1)
syndrome is that the##2##4##(2007-7#1)(2012-2#1)
syndrome is the most common##6##5##(1992-2#1)(1992-5#1)(2009-12#1)(2009-9#1)(2010-11#1)(2012-1#1)
syndrome is the most##7##4##(1991-5#1)(1992-2#1)(1992-5#1)(2009-12#1)(2009-9#1)(2010-11#1)(2012-1#1)
syndrome is the##13##3##(1991-5#1)(1992-2#1)(1992-5#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-9#1)(2010-11#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-2#1)
syndrome is##235##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-5#2)(1990-9#1)(1991-12#2)(1991-3#1)(1991-4#3)(1991-5#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-11#3)(1993-5#5)(1993-6#1)(1993-9#1)(1994-12#2)(1995-12#1)(1995-2#1)(1995-8#2)(1996-1#1)(1996-3#2)(1996-6#2)(1997-1#4)(1997-3#1)(1997-6#2)(1997-8#1)(2005-1#1)(2005-10#2)(2005-12#3)(2005-8#1)(2006-10#10)(2006-11#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-8#2)(2007-10#1)(2007-11#7)(2007-2#1)(2007-3#2)(2007-7#7)(2007-8#5)(2008-1#5)(2008-10#4)(2008-11#1)(2008-12#5)(2008-3#10)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#7)(2010-11#2)(2010-2#3)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#6)(2011-12#2)(2011-2#14)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#10)(2012-3#2)(2013-1#12)(2013-7#2)(2013-8#3)
syndrome may also##2##3##(2005-10#2)
syndrome may be associated##2##4##(1992-10#1)(2006-3#1)
syndrome may be##8##3##(1992-10#1)(1996-1#1)(1996-3#1)(2006-3#1)(2006-8#1)(2007-9#1)(2008-1#2)
syndrome may##17##2##(1992-10#1)(1996-1#1)(1996-10#1)(1996-3#1)(2005-10#2)(2006-10#2)(2006-3#1)(2006-8#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-7#1)(2009-6#1)(2010-11#1)
syndrome mosaic##3##2##(2008-6#3)
syndrome mutation##2##2##(2011-2#1)(2012-3#1)
syndrome not previously described##2##4##(1997-5#1)(2008-6#1)
syndrome not##3##2##(1995-1#1)(1997-5#1)(2008-6#1)
syndrome occurring##2##2##(2008-6#1)(2008-7#1)
syndrome occurs in##3##3##(2007-3#1)(2007-8#1)(2008-7#1)
syndrome occurs##8##2##(1990-6#1)(2005-10#1)(2006-10#2)(2007-3#1)(2007-8#1)(2008-7#1)(2010-6#1)
syndrome of Zellweger##2##3##(1990-10#1)(1993-8#1)
syndrome of inappropriate antidiuretic hormone##2##5##(2006-4#1)(2009-8#1)
syndrome of inappropriate secretion of antidiuretic hormone (SIADH)##2##8##(2008-1#1)(2009-10#1)
syndrome of inappropriate##7##3##(1991-5#1)(2005-11#1)(2005-7#1)(2006-4#1)(2008-1#1)(2009-10#1)(2009-8#1)
syndrome of right bundle branch block##2##6##(2006-9#1)(2008-12#1)
syndrome of schizophrenia##2##3##(1997-2#1)(2008-4#1)
syndrome of sustained##2##3##(1996-3#1)(2006-8#1)
syndrome of the battered##2##4##(1995-5#2)
syndrome of the##7##3##(1995-10#1)(1995-5#2)(2006-7#1)(2008-12#1)(2009-3#1)(2009-9#1)
syndrome of unknown etiology##3##4##(2006-2#1)(2011-2#1)(2012-2#1)
syndrome of unknown##4##3##(1995-2#1)(2006-2#1)(2011-2#1)(2012-2#1)
syndrome of##91##2##(1990-10#1)(1990-12#1)(1990-4#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-9#1)(1993-11#1)(1993-7#1)(1993-8#1)(1994-12#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-10#3)(2005-11#1)(2005-7#2)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#3)(2008-4#2)(2008-6#3)(2008-7#1)(2008-9#2)(2009-10#2)(2009-3#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#1)
syndrome on the basis of##2##5##(1990-6#1)(2008-5#1)
syndrome on the##3##3##(1990-6#1)(1995-2#1)(2008-5#1)
syndrome on##11##2##(1990-6#1)(1995-2#1)(2004-10#1)(2007-10#1)(2008-10#1)(2008-3#3)(2008-5#1)(2008-7#1)(2013-1#1)
syndrome only##2##2##(2007-10#1)(2012-12#1)
syndrome or mirror##2##3##(2011-2#2)
syndrome or##32##2##(1990-8#1)(1994-3#1)(1995-8#1)(1996-3#1)(1997-1#1)(1997-3#1)(2006-10#2)(2006-7#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
syndrome patient##5##2##(1996-2#1)(1997-5#1)(2006-10#1)(2009-5#1)(2012-2#1)
syndrome patients##15##2##(1993-11#1)(1995-1#1)(2006-8#2)(2007-10#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#2)(2013-8#2)
syndrome per se##2##3##(2007-7#1)(2008-6#1)
syndrome phenotype##2##2##(2008-3#1)(2012-2#1)
syndrome presented##2##2##(2006-6#1)(2011-1#1)
syndrome presenting as##3##3##(2007-3#1)(2008-8#1)(2009-9#1)
syndrome presenting with##2##3##(2007-3#2)
syndrome presenting##7##2##(2007-3#3)(2007-7#2)(2008-8#1)(2009-9#1)
syndrome presents with##2##3##(2008-9#1)(2012-12#1)
syndrome presents##4##2##(1991-12#1)(2006-10#1)(2008-9#1)(2012-12#1)
syndrome reactions##2##2##(2008-8#2)
syndrome received##2##2##(2007-8#1)(2008-9#1)
syndrome region##2##2##(1996-2#1)(1997-3#1)
syndrome related to##2##3##(2007-8#1)(2010-9#1)
syndrome remains##3##2##(1995-12#1)(2006-10#1)(2008-1#1)
syndrome reported##2##2##(1991-2#1)(2008-1#1)
syndrome represents the##2##3##(2006-10#1)(2013-1#1)
syndrome resulting from##2##3##(1994-12#1)(2006-12#1)
syndrome results from##3##3##(1991-12#1)(2006-10#1)(2007-8#1)
syndrome results##4##2##(1991-12#1)(1997-1#1)(2006-10#1)(2007-8#1)
syndrome revisited##2##2##(2006-4#1)(2008-3#1)
syndrome screening##5##2##(1996-12#3)(1996-3#2)
syndrome secondary to##6##3##(1993-4#1)(2006-10#1)(2007-7#2)(2011-2#1)(2013-8#1)
syndrome seems to be##2##4##(1993-11#1)(2008-3#1)
syndrome seems to##3##3##(1992-5#1)(1993-11#1)(2008-3#1)
syndrome seen##2##2##(2007-8#1)(2007-9#1)
syndrome should be considered##3##4##(1994-5#1)(2011-2#1)(2012-2#1)
syndrome should be##5##3##(1994-5#1)(2006-10#2)(2011-2#1)(2012-2#1)
syndrome should##8##2##(1994-5#1)(1996-3#1)(2006-10#2)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
syndrome showed##2##2##(1990-7#1)(2008-3#1)
syndrome some##2##2##(2007-11#1)(2007-7#1)
syndrome still##2##2##(2006-10#1)(2010-10#1)
syndrome study##2##2##(2007-8#1)(2008-10#1)
syndrome than##4##2##(1991-12#1)(2006-6#1)(2008-4#1)(2009-6#1)
syndrome that have been##2##4##(2008-1#1)(2008-7#1)
syndrome that is##3##3##(2007-10#1)(2008-10#1)(2013-1#1)
syndrome that may occur in##2##5##(2005-8#1)(2007-11#1)
syndrome that may##3##3##(2005-8#1)(2006-10#1)(2007-11#1)
syndrome that occurs##2##3##(2008-4#1)(2008-8#1)
syndrome that was##2##3##(2006-10#1)(2012-3#1)
syndrome that##27##2##(1992-2#1)(1993-10#1)(1995-10#1)(1995-12#1)(1996-11#1)(2004-10#1)(2005-8#1)(2006-10#3)(2007-10#2)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
syndrome the##3##2##(1990-2#1)(2007-11#1)(2007-7#1)
syndrome to##8##2##(1994-6#1)(1995-6#1)(1997-1#1)(2006-8#1)(2008-11#1)(2008-3#2)(2012-2#1)
syndrome type 1##5##3##(2006-12#1)(2006-7#2)(2007-11#1)(2012-3#1)
syndrome type I##4##3##(1997-8#1)(2006-10#2)(2006-7#1)
syndrome type II##3##3##(1992-6#1)(1993-12#1)(2008-4#1)
syndrome type##21##2##(1992-6#1)(1993-12#1)(1997-8#1)(2006-10#2)(2006-12#1)(2006-6#2)(2006-7#3)(2007-11#1)(2007-2#1)(2008-4#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#4)
syndrome using##8##2##(1996-12#1)(1997-1#1)(2007-8#1)(2008-1#1)(2008-3#2)(2010-4#1)(2010-8#1)
syndrome usually##3##2##(1991-5#1)(1997-1#1)(2007-7#1)
syndrome virus##6##2##(1997-6#2)(2005-11#2)(2008-8#2)
syndrome was a##2##3##(1991-2#1)(2008-10#1)
syndrome was diagnosed in##3##4##(1992-5#1)(1997-8#1)(2011-2#1)
syndrome was diagnosed on##2##4##(1992-8#1)(2008-11#1)
syndrome was diagnosed##9##3##(1990-2#1)(1992-5#1)(1992-8#1)(1997-8#1)(2008-11#1)(2011-2#2)(2013-8#2)
syndrome was established##2##3##(1992-11#1)(2012-2#1)
syndrome was first described##2##4##(2008-3#1)(2011-1#1)
syndrome was first##3##3##(1996-3#1)(2008-3#1)(2011-1#1)
syndrome was found##2##3##(2007-3#1)(2008-3#1)
syndrome was the##6##3##(2005-7#1)(2008-1#4)(2010-4#1)
syndrome was##60##2##(1990-10#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-4#1)(1992-11#1)(1992-5#1)(1992-8#1)(1994-11#1)(1995-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-10#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-4#2)(2006-6#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-1#4)(2008-10#1)(2008-11#2)(2008-3#11)(2008-7#1)(2010-2#1)(2010-4#3)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
syndrome were treated with##2##4##(2007-8#1)(2008-3#1)
syndrome were treated##3##3##(2007-8#1)(2008-3#1)(2012-3#1)
syndrome were##14##2##(1990-10#1)(1990-12#1)(1990-3#1)(1991-6#1)(1992-5#1)(1993-1#1)(2007-8#2)(2008-3#2)(2008-5#1)(2008-7#1)(2012-12#1)(2012-3#1)
syndrome where##2##2##(2009-6#1)(2012-2#1)
syndrome which can##2##3##(2008-7#1)(2011-2#1)
syndrome which is##2##3##(2007-7#1)(2008-10#1)
syndrome which##12##2##(1991-12#1)(1997-6#1)(2005-12#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#2)
syndrome who had##3##3##(2010-8#1)(2013-1#2)
syndrome who presented##2##3##(2007-7#1)(2009-6#1)
syndrome who##11##2##(1991-6#1)(2006-10#1)(2007-7#1)(2008-1#2)(2008-4#1)(2009-6#1)(2010-8#1)(2012-2#1)(2013-1#2)
syndrome will##3##2##(1995-1#1)(1997-3#1)(2006-10#1)
syndrome with ST##2##3##(2006-9#1)(2008-10#1)
syndrome with a##6##3##(1995-1#1)(1996-8#1)(2007-3#1)(2008-9#1)(2009-1#1)(2010-5#1)
syndrome with anomalous connection of##2##5##(2007-8#2)
syndrome with bilateral##4##3##(2007-7#1)(2008-1#1)(2008-10#1)(2011-1#1)
syndrome with features##2##3##(2005-8#1)(2011-1#1)
syndrome with generalized##2##3##(1997-1#1)(2010-8#1)
syndrome with hypokalaemic paralysis##2##4##(2013-8#2)
syndrome with lactic acidosis and cerebral##2##6##(1990-3#2)
syndrome with minimal##2##3##(1996-6#1)(2012-3#1)
syndrome with multiple##4##3##(2005-12#1)(2008-5#1)(2013-1#2)
syndrome with pulmonary##2##3##(1993-12#1)(2007-8#1)
syndrome with reflex sympathetic dystrophy##2##5##(1992-11#1)(2007-11#1)
syndrome with spontaneous##2##3##(1991-4#1)(2009-4#1)
syndrome with the##2##3##(2006-4#1)(2008-7#1)
syndrome with##95##2##(1990-3#3)(1990-5#1)(1991-4#2)(1992-11#3)(1992-2#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-7#1)(1995-1#1)(1995-8#1)(1996-6#4)(1996-8#2)(1997-1#3)(1997-3#1)(1997-6#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-3#2)(2006-4#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-2#2)(2007-3#1)(2007-7#3)(2007-8#6)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#5)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#2)
syndrome within##2##2##(1996-6#1)(2011-2#1)
syndrome without##5##2##(1996-6#1)(2008-10#1)(2008-11#1)(2013-1#2)
syndrome would##4##2##(1995-4#1)(1996-6#1)(2008-11#1)(2008-7#1)
syndrome##4211##1##(1990-1#2)(1990-10#11)(1990-11#4)(1990-12#10)(1990-2#25)(1990-3#23)(1990-4#2)(1990-5#14)(1990-6#17)(1990-7#4)(1990-8#8)(1990-9#20)(1991-1#5)(1991-10#2)(1991-11#11)(1991-12#20)(1991-2#11)(1991-3#11)(1991-4#12)(1991-5#14)(1991-6#7)(1991-7#2)(1991-8#12)(1991-9#15)(1992-1#2)(1992-10#3)(1992-11#17)(1992-12#9)(1992-2#19)(1992-3#8)(1992-4#11)(1992-5#12)(1992-6#3)(1992-8#9)(1992-9#6)(1993-1#7)(1993-10#12)(1993-11#11)(1993-12#10)(1993-2#7)(1993-3#4)(1993-4#2)(1993-5#14)(1993-6#5)(1993-7#8)(1993-8#4)(1993-9#11)(1994-10#5)(1994-11#6)(1994-12#12)(1994-2#2)(1994-3#18)(1994-4#10)(1994-5#6)(1994-6#8)(1994-7#3)(1994-8#5)(1994-9#1)(1995-1#13)(1995-10#4)(1995-11#2)(1995-12#13)(1995-2#14)(1995-3#1)(1995-4#5)(1995-5#11)(1995-6#14)(1995-7#1)(1995-8#10)(1995-9#4)(1996-1#7)(1996-10#5)(1996-11#7)(1996-12#44)(1996-2#12)(1996-3#57)(1996-4#2)(1996-5#9)(1996-6#29)(1996-7#1)(1996-8#12)(1996-9#9)(1997-1#61)(1997-2#16)(1997-3#33)(1997-4#8)(1997-5#14)(1997-6#16)(1997-7#8)(1997-8#15)(2004-10#6)(2004-11#4)(2004-3#1)(2005-1#5)(2005-10#35)(2005-11#7)(2005-12#15)(2005-4#1)(2005-7#9)(2005-8#21)(2005-9#4)(2006-1#4)(2006-10#189)(2006-11#12)(2006-12#23)(2006-2#20)(2006-3#14)(2006-4#30)(2006-5#2)(2006-6#20)(2006-7#16)(2006-8#41)(2006-9#28)(2007-1#10)(2007-10#44)(2007-11#62)(2007-12#30)(2007-2#34)(2007-3#29)(2007-4#10)(2007-5#5)(2007-6#4)(2007-7#108)(2007-8#103)(2007-9#26)(2008-1#101)(2008-10#74)(2008-11#52)(2008-12#56)(2008-2#4)(2008-3#283)(2008-4#74)(2008-5#45)(2008-6#33)(2008-7#115)(2008-8#52)(2008-9#52)(2009-1#9)(2009-10#28)(2009-11#28)(2009-12#9)(2009-2#20)(2009-3#19)(2009-4#19)(2009-5#12)(2009-6#30)(2009-7#24)(2009-8#25)(2009-9#30)(2010-1#6)(2010-10#11)(2010-11#10)(2010-12#46)(2010-2#16)(2010-3#13)(2010-4#33)(2010-5#16)(2010-6#17)(2010-7#10)(2010-8#15)(2010-9#8)(2011-1#95)(2011-11#1)(2011-12#17)(2011-2#186)(2011-3#5)(2011-8#1)(2011-9#1)(2012-1#16)(2012-10#1)(2012-11#9)(2012-12#89)(2012-2#107)(2012-3#58)(2012-5#1)(2012-8#1)(2013-1#172)(2013-7#27)(2013-8#68)
syndrome&quot##26##1##(1990-6#1)(1993-10#1)(1993-3#1)(1995-6#1)(1996-12#1)(1996-4#1)(1996-9#1)(1997-6#2)(2006-4#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-6#1)(2008-7#1)(2009-7#2)(2010-5#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
syndrome'##11##1##(1996-2#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2010-5#2)(2012-2#1)(2013-8#1)
syndrome) and##8##2##(1991-10#1)(1995-5#1)(1995-6#1)(2007-2#1)(2007-9#1)(2008-11#1)(2011-2#1)(2012-12#1)
syndrome) are##2##2##(1993-8#1)(2012-1#1)
syndrome) associated with##4##3##(1996-3#1)(1997-7#1)(2006-10#1)(2008-8#1)
syndrome) in a##2##3##(2007-2#1)(2012-12#1)
syndrome) in##6##2##(1995-3#1)(1997-8#1)(2006-12#1)(2007-2#1)(2007-8#1)(2012-12#1)
syndrome) is a rare##3##4##(1996-3#1)(2011-2#1)(2012-12#1)
syndrome) is a##4##3##(1996-3#1)(2010-5#1)(2011-2#1)(2012-12#1)
syndrome) is##7##2##(1995-5#1)(1996-3#1)(2007-7#1)(2008-6#1)(2010-5#1)(2011-2#1)(2012-12#1)
syndrome) or##2##2##(2007-9#1)(2011-2#1)
syndrome)##69##1##(1990-11#1)(1990-3#1)(1990-9#1)(1991-10#1)(1991-4#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-3#1)(1995-1#1)(1995-3#2)(1995-5#3)(1995-6#3)(1996-12#1)(1996-2#1)(1996-3#3)(1996-6#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-2#3)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2010-11#1)(2010-12#3)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#5)(2012-3#1)(2013-7#1)(2013-8#1)
syndrome)]##3##1##(1990-11#1)(1992-12#1)(2012-3#1)
syndrome-##2##1##(2012-2#1)(2012-3#1)
syndrome--a case report##3##3##(2006-4#1)(2007-8#1)(2012-2#1)
syndrome--a case report]##4##3##(2008-11#1)(2008-4#1)(2008-9#1)(2012-3#1)
syndrome--a case##7##2##(2006-4#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-9#1)(2012-2#1)(2012-3#1)
syndrome--a##9##1##(1990-2#1)(1993-5#1)(2006-4#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-9#1)(2012-2#1)(2012-3#1)
syndrome--an##2##1##(2006-4#1)(2008-11#1)
syndrome-associated##3##1##(2007-12#1)(2008-11#1)(2008-7#1)
syndrome-like##3##1##(1996-12#1)(2012-1#2)
syndrome?##23##1##(1996-12#1)(1996-6#1)(1997-3#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#2)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
syndrome?]##4##1##(1996-12#1)(2008-4#1)(2009-5#1)(2011-2#1)
syndrome]##130##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#4)(1990-3#2)(1990-6#3)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#3)(1992-5#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-3#29)(1994-4#1)(1994-5#1)(1995-5#4)(1995-8#2)(1995-9#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#1)(2005-11#1)(2005-8#1)(2006-2#1)(2006-4#1)(2006-6#3)(2006-8#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2010-12#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#5)
syndromes (MDS)##6##2##(2008-11#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-1#1)(2012-12#1)
syndromes (e##2##2##(1995-9#1)(2008-4#1)
syndromes after##2##2##(2006-4#1)(2008-3#1)
syndromes and the##3##3##(2008-6#1)(2010-11#1)(2013-1#1)
syndromes and to##2##3##(2008-3#1)(2010-8#1)
syndromes and##36##2##(1992-12#2)(1994-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(2003-11#1)(2006-10#1)(2006-7#1)(2007-3#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-11#2)(2008-3#4)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
syndromes are also##2##3##(2008-1#1)(2009-12#1)
syndromes are characterized by##2##4##(2007-7#1)(2011-2#1)
syndromes are##25##2##(1993-12#1)(1995-5#1)(1996-1#1)(1996-11#1)(2006-10#1)(2006-3#1)(2007-1#1)(2007-11#1)(2007-7#2)(2008-1#2)(2008-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-7#1)(2011-2#5)(2012-2#3)
syndromes as well as##3##4##(2008-3#1)(2009-7#1)(2012-1#1)
syndromes as##6##2##(1995-1#1)(2006-10#1)(2008-3#1)(2009-7#1)(2010-9#1)(2012-1#1)
syndromes associated with##8##3##(2006-12#1)(2006-9#3)(2009-12#1)(2009-3#1)(2010-7#1)(2012-2#1)
syndromes associated##9##2##(1995-12#1)(2006-12#1)(2006-9#3)(2009-12#1)(2009-3#1)(2010-7#1)(2012-2#1)
syndromes at the##2##3##(1996-4#1)(2008-9#1)
syndromes at##3##2##(1996-4#1)(2008-11#1)(2008-9#1)
syndromes based on##2##3##(2008-9#1)(2013-1#1)
syndromes being##2##2##(1996-11#1)(2010-4#1)
syndromes but##2##2##(2007-1#1)(2008-8#1)
syndromes can##2##2##(2008-4#1)(2009-12#1)
syndromes caused by##3##3##(2006-10#1)(2008-10#1)(2011-12#1)
syndromes characterized by##2##3##(2006-10#1)(2006-2#1)
syndromes could be##2##3##(1991-3#1)(2006-2#1)
syndromes for##2##2##(2008-11#1)(2010-12#1)
syndromes frequently##2##2##(2010-11#1)(2010-12#1)
syndromes has##2##2##(2008-1#1)(2010-12#1)
syndromes have been##3##3##(2006-9#1)(2007-12#1)(2008-7#1)
syndromes have##7##2##(1990-12#1)(1990-4#1)(2006-9#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-5#1)
syndromes in a##3##3##(2008-3#1)(2008-4#1)(2008-7#1)
syndromes in the##4##3##(1990-3#1)(2006-12#1)(2006-8#1)(2009-9#1)
syndromes in##18##2##(1990-3#1)(1993-7#1)(1996-11#1)(1996-5#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2006-9#2)(2007-1#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-9#1)(2010-12#1)(2013-1#1)
syndromes include the##2##3##(2008-3#1)(2009-5#1)
syndromes include##4##2##(1996-6#1)(2007-10#1)(2008-3#1)(2009-5#1)
syndromes including##6##2##(1993-8#1)(1993-9#1)(2006-8#2)(2008-4#1)(2012-11#1)
syndromes involving##2##2##(2007-7#1)(2009-3#1)
syndromes is of##2##3##(1995-12#1)(2008-3#1)
syndromes is##7##2##(1995-12#1)(2006-8#1)(2008-3#2)(2008-8#1)(2010-7#1)(2011-2#1)
syndromes may be##5##3##(1996-4#1)(1997-5#1)(2007-6#1)(2008-11#1)(2011-2#1)
syndromes may##9##2##(1992-6#1)(1993-10#1)(1996-4#1)(1997-5#1)(2006-9#1)(2007-6#1)(2008-11#1)(2011-2#1)(2012-3#1)
syndromes observed in##2##3##(1997-7#1)(2010-12#1)
syndromes observed##3##2##(1996-11#1)(1997-7#1)(2010-12#1)
syndromes of hereditary##2##3##(1995-12#1)(2009-2#1)
syndromes of schizotypal personality##2##4##(1995-1#1)(1997-8#1)
syndromes of##25##2##(1990-3#1)(1992-8#1)(1993-12#1)(1995-1#2)(1995-12#2)(1995-6#1)(1997-8#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-2#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-2#1)
syndromes or##6##2##(2006-1#1)(2006-2#1)(2007-8#1)(2008-11#1)(2008-7#1)(2012-3#1)
syndromes remains##3##2##(1996-11#1)(2006-5#1)(2008-11#1)
syndromes should##2##2##(2008-1#1)(2009-7#1)
syndromes such as##3##3##(1990-12#2)(2011-2#1)
syndromes that##6##2##(2006-3#1)(2007-7#1)(2008-9#1)(2009-12#1)(2012-1#1)(2012-2#1)
syndromes was##3##2##(1997-7#1)(2008-12#1)(2012-2#1)
syndromes were seen##2##3##(1996-11#1)(2006-8#1)
syndromes were##9##2##(1990-8#1)(1996-11#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-9#2)(2008-3#1)
syndromes which##5##2##(2008-12#2)(2011-2#1)(2012-2#2)
syndromes will be##2##3##(2006-2#1)(2007-6#1)
syndromes with##11##2##(1996-12#2)(2005-9#1)(2006-8#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-12#1)(2009-10#1)(2009-8#1)(2010-12#1)
syndromes without##3##2##(2006-6#1)(2008-10#2)
syndromes##610##1##(1990-12#4)(1990-3#4)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#2)(1992-1#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-6#1)(1992-8#2)(1993-10#4)(1993-11#2)(1993-12#3)(1993-7#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-3#1)(1994-9#1)(1995-1#5)(1995-11#1)(1995-12#5)(1995-5#2)(1995-6#2)(1995-9#1)(1996-1#2)(1996-11#10)(1996-12#9)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#2)(1997-1#1)(1997-3#2)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#3)(2003-11#2)(2004-11#1)(2004-3#1)(2005-11#1)(2005-12#2)(2005-6#1)(2005-7#11)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#25)(2006-12#9)(2006-2#7)(2006-3#3)(2006-4#2)(2006-5#4)(2006-6#4)(2006-7#1)(2006-8#13)(2006-9#9)(2007-1#6)(2007-10#8)(2007-11#14)(2007-12#8)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#8)(2007-7#12)(2007-8#7)(2007-9#5)(2008-1#7)(2008-10#13)(2008-11#15)(2008-12#12)(2008-2#4)(2008-3#46)(2008-4#17)(2008-5#4)(2008-6#2)(2008-7#13)(2008-8#9)(2008-9#7)(2009-10#5)(2009-12#17)(2009-2#3)(2009-3#3)(2009-4#4)(2009-5#7)(2009-7#8)(2009-8#4)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#11)(2010-12#12)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#6)(2010-8#6)(2010-9#1)(2011-1#9)(2011-12#1)(2011-2#26)(2012-1#4)(2012-11#2)(2012-12#3)(2012-2#20)(2012-3#8)(2013-1#10)(2013-7#2)(2013-8#4)
syndromes'##2##1##(2007-7#1)(2010-4#1)
syndromes)##5##1##(2005-8#1)(2007-11#2)(2008-10#1)(2008-5#1)
syndromes]##19##1##(1990-11#1)(1991-5#1)(1994-3#1)(1996-11#2)(2006-6#1)(2007-5#1)(2008-10#8)(2008-5#1)(2010-12#2)(2012-2#1)
syndromic case management##2##3##(2007-7#2)
syndromic conditions##2##2##(2011-1#1)(2013-1#1)
syndromic retinal dystrophies##2##3##(2012-12#2)
syndromic surveillance##4##2##(2010-12#2)(2013-1#2)
syndromic##28##1##(1994-10#1)(1996-12#1)(2007-10#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-6#1)(2009-10#2)(2009-6#1)(2010-12#2)(2010-3#1)(2011-1#2)(2011-12#1)(2011-2#1)(2011-9#1)(2012-12#2)(2012-2#1)(2013-1#4)
syneresis##4##1##(2012-11#4)
synergetic effect of##2##3##(2008-10#1)(2008-12#1)
synergetic effect##5##2##(1990-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2013-1#1)
synergetic##9##1##(1990-12#1)(1994-2#1)(1994-6#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2013-1#1)
synergic effect of##2##3##(1994-10#1)(2008-10#1)
synergic effect##5##2##(1994-10#1)(2006-8#1)(2008-10#2)(2008-11#1)
synergic##10##1##(1994-10#1)(2006-6#1)(2006-8#1)(2008-10#3)(2008-11#1)(2009-3#1)(2011-3#1)(2012-1#1)
synergid##3##1##(2008-11#2)(2009-8#1)
synergies and##2##2##(2007-4#1)(2010-10#1)
synergies between##3##2##(2008-5#1)(2009-5#1)(2010-10#1)
synergies##11##1##(1992-9#1)(2007-4#1)(2007-8#3)(2008-5#2)(2009-5#1)(2010-10#2)(2010-2#1)
synergism and##2##2##(2010-1#1)(2011-1#1)
synergism between##10##2##(1993-11#1)(1994-12#1)(1996-10#1)(2008-2#1)(2009-4#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#2)
synergism in surface tension reduction##2##5##(2005-11#2)
synergism in##4##2##(2005-11#2)(2007-9#1)(2012-2#1)
synergism of##6##2##(1994-6#1)(1996-7#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-4#1)
synergism was observed##3##3##(1995-12#1)(2004-11#1)(2008-10#1)
synergism was##4##2##(1995-12#1)(2004-11#1)(2008-10#2)
synergism with##5##2##(1990-2#1)(1994-11#1)(1994-9#1)(2008-4#2)
synergism##53##1##(1990-10#1)(1990-2#1)(1992-1#1)(1993-11#1)(1994-11#2)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#3)(1996-1#1)(1996-10#4)(1996-7#1)(2004-11#1)(2004-2#1)(2005-11#2)(2006-10#1)(2007-1#1)(2007-9#1)(2008-10#9)(2008-2#1)(2008-4#2)(2008-8#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#3)(2013-1#2)
synergist with##2##2##(2008-8#2)
synergist##5##1##(2007-10#1)(2008-10#2)(2008-8#2)
synergistic action of##4##3##(1992-9#1)(2006-5#1)(2008-11#1)(2008-4#1)
synergistic activation of##3##3##(1991-9#1)(1995-2#1)(1996-4#1)
synergistic activation##5##2##(1991-9#1)(1993-9#1)(1995-2#1)(1996-4#1)(1996-8#1)
synergistic activity with##3##3##(1996-9#1)(2008-3#1)(2011-3#1)
synergistic activity##6##2##(1996-9#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-3#1)
synergistic and##4##2##(2006-2#1)(2008-10#1)(2008-6#1)(2010-2#1)
synergistic combination of##2##3##(2009-7#1)(2012-12#1)
synergistic effect between the##2##4##(1992-1#1)(1993-3#1)
synergistic effect between##3##3##(1992-1#1)(1993-3#1)(2009-3#1)
synergistic effect in combination with##2##5##(2008-3#1)(2008-5#1)
synergistic effect in##3##3##(2008-3#1)(2008-5#1)(2009-3#1)
synergistic effect of the##2##4##(2008-10#1)(2013-1#1)
synergistic effect of##15##3##(1993-6#1)(1997-1#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-8#1)(2009-8#1)(2010-4#1)(2012-2#1)(2012-6#1)(2013-1#2)
synergistic effect on the##4##4##(1991-6#1)(1997-8#1)(2008-10#1)(2008-11#1)
synergistic effect on##16##3##(1991-6#1)(1992-2#2)(1992-7#1)(1993-6#1)(1996-9#1)(1997-8#1)(2005-10#2)(2007-2#2)(2008-10#1)(2008-11#2)(2010-10#1)(2011-2#1)
synergistic effect##54##2##(1990-12#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-2#2)(1992-6#1)(1992-7#1)(1993-3#1)(1993-6#2)(1996-9#1)(1997-1#2)(1997-4#1)(1997-7#1)(1997-8#1)(2005-10#2)(2006-10#1)(2006-12#1)(2007-11#1)(2007-2#2)(2008-10#9)(2008-11#5)(2008-3#1)(2008-5#2)(2008-8#2)(2009-3#2)(2009-8#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-6#1)(2013-1#2)
synergistic effects of##5##3##(1996-12#1)(2007-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
synergistic effects with##2##3##(1996-5#1)(2008-7#1)
synergistic effects##23##2##(1995-5#1)(1995-8#1)(1996-12#2)(1996-5#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-10#1)(2010-4#1)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#1)(2013-8#2)
synergistic extraction##3##2##(2008-10#3)
synergistic formula##2##2##(1995-12#2)
synergistic in##4##2##(2008-10#1)(2008-4#1)(2008-8#1)(2011-1#1)
synergistic induction##2##2##(1991-2#1)(1996-11#1)
synergistic inhibitory effect##2##3##(1996-2#1)(2013-7#1)
synergistic inhibitory##3##2##(1996-2#1)(2010-8#1)(2013-7#1)
synergistic interaction between##6##3##(1993-6#1)(1993-8#1)(1994-12#1)(1995-12#1)(1996-10#1)(2008-10#1)
synergistic interaction is not##2##4##(2008-10#1)(2008-4#1)
synergistic interaction on##2##3##(2006-10#1)(2008-10#1)
synergistic interaction##14##2##(1993-6#1)(1993-8#1)(1994-12#1)(1995-12#1)(1996-1#1)(1996-10#1)(1996-7#1)(2006-10#1)(2008-10#4)(2008-4#1)(2008-8#1)
synergistic interactions between##3##3##(1997-4#1)(2007-7#1)(2012-2#1)
synergistic interactions of##3##3##(1995-5#1)(1996-7#1)(2009-3#1)
synergistic interactions##10##2##(1995-5#1)(1996-7#1)(1997-4#1)(2004-4#1)(2007-7#1)(2008-10#1)(2008-9#1)(2009-3#1)(2009-7#1)(2012-2#1)
synergistic manner with##2##3##(1996-5#1)(2008-11#1)
synergistic manner##4##2##(1991-9#1)(1992-10#1)(1996-5#1)(2008-11#1)
synergistic movement patterns##5##3##(2012-1#5)
synergistic or antagonistic##2##3##(2008-10#2)
synergistic or##4##2##(1991-7#1)(2008-10#2)(2008-8#1)
synergistic relationship between##2##3##(2008-10#1)(2011-2#1)
synergistic relationships between##2##3##(2008-10#1)(2008-11#1)
synergistic with phorbol##2##3##(1994-2#1)(1996-8#1)
synergistic with##9##2##(1991-3#1)(1993-11#1)(1994-2#1)(1995-10#1)(1996-8#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-2#1)
synergistic##232##1##(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-6#4)(1993-8#2)(1993-9#2)(1994-10#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-10#1)(1995-12#4)(1995-2#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-4#1)(1996-5#3)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#2)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2004-4#1)(2005-10#3)(2005-4#2)(2006-10#2)(2006-12#1)(2006-2#2)(2006-5#1)(2006-8#2)(2007-11#5)(2007-12#3)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#38)(2008-11#9)(2008-2#2)(2008-3#3)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#2)(2009-3#3)(2009-4#2)(2009-7#2)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#2)(2010-2#2)(2010-4#3)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#6)(2012-12#3)(2012-2#3)(2012-3#1)(2012-6#2)(2013-1#5)(2013-7#1)(2013-8#3)
synergistically and##2##2##(2010-3#1)(2013-1#1)
synergistically enhance##2##2##(1992-12#1)(2007-11#1)
synergistically enhanced##3##2##(2009-4#3)
synergistically in##3##2##(1993-6#1)(1996-8#1)(2010-4#1)
synergistically increased by the##2##4##(1995-6#1)(1996-5#1)
synergistically increased by##4##3##(1995-6#1)(1996-5#1)(1997-1#2)
synergistically increased##5##2##(1995-6#1)(1996-5#1)(1997-1#2)(2009-9#1)
synergistically induce##2##2##(1994-11#1)(2009-9#1)
synergistically mediate the gene transfer into primary rat hepatocytes##2##9##(2008-9#2)
synergistically stimulate##2##2##(1991-10#1)(1995-8#1)
synergistically to enhance##4##3##(2005-11#1)(2008-5#1)(2009-4#1)(2009-7#1)
synergistically to increase##2##3##(1993-6#1)(2008-10#1)
synergistically to##12##2##(1991-12#1)(1991-9#1)(1993-6#1)(1994-12#1)(1995-3#1)(2005-11#1)(2008-10#2)(2008-5#1)(2009-4#1)(2009-7#1)(2011-2#1)
synergistically with the##3##3##(1991-5#1)(1993-2#1)(2008-8#1)
synergistically with##12##2##(1991-5#1)(1993-2#1)(1993-6#1)(1994-12#1)(1996-8#1)(2006-6#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-8#1)(2013-7#1)
synergistically##70##1##(1991-10#1)(1991-12#1)(1991-3#2)(1991-5#2)(1991-9#1)(1992-12#1)(1993-2#1)(1993-6#3)(1994-11#2)(1994-12#2)(1994-6#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-5#1)(1996-8#3)(1997-1#2)(1997-2#1)(1997-5#1)(2005-11#1)(2005-7#1)(2006-6#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-4#4)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-4#4)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-3#1)(2010-4#1)(2011-2#2)(2012-12#4)(2013-1#1)(2013-7#2)
synergize with##10##2##(1993-12#2)(1995-8#1)(1996-10#3)(2007-11#1)(2009-12#3)
synergize##15##1##(1992-1#1)(1993-12#2)(1994-12#1)(1995-3#1)(1995-8#1)(1996-10#3)(1996-11#1)(2004-11#1)(2007-11#1)(2009-12#3)
synergized##2##1##(1994-8#1)(1995-8#1)
synergizes with##3##2##(1991-9#1)(2012-12#2)
synergizing with##2##2##(2009-5#1)(2012-12#1)
synergy among##3##2##(1992-4#1)(2011-2#1)(2012-3#1)
synergy and##6##2##(1993-9#1)(2006-12#1)(2012-1#3)(2012-3#1)
synergy between##15##2##(1991-9#1)(1992-4#1)(1995-3#1)(1996-7#1)(2005-8#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-5#2)(2010-3#1)(2011-3#1)
synergy has been##2##3##(1995-3#1)(1997-2#1)
synergy in##2##2##(2008-10#1)(2008-7#1)
synergy is##2##2##(1994-3#1)(2012-1#1)
synergy or antagonism##2##3##(1994-11#1)(2008-7#1)
synergy with other##2##3##(2007-11#1)(2013-7#1)
synergy with##16##2##(1992-8#1)(1994-3#1)(1995-12#1)(1996-10#1)(1996-8#1)(1997-4#1)(2005-7#1)(2005-9#1)(2007-11#2)(2008-12#1)(2008-5#1)(2009-6#1)(2010-2#1)(2011-2#1)(2013-7#1)
synergy##72##1##(1991-9#1)(1992-4#2)(1992-8#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#2)(1995-12#1)(1995-3#2)(1996-10#1)(1996-7#1)(1996-8#2)(1997-2#2)(1997-4#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-12#2)(2007-11#3)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-2#2)(2011-3#2)(2012-1#7)(2012-12#1)(2012-3#2)(2013-7#1)
syngamosis##2##1##(2007-2#2)
syngeneic and allogeneic##2##3##(1992-9#1)(1994-6#1)
syngeneic animals##2##2##(1992-1#1)(1997-4#1)
syngeneic bone##2##2##(1996-10#1)(1997-7#1)
syngeneic hamsters##2##2##(1996-11#2)
syngeneic lymphocytes##2##2##(1990-12#2)
syngeneic mice##6##2##(1990-8#1)(1991-5#1)(1997-4#2)(2008-4#2)
syngeneic mouse##2##2##(2010-11#1)(2013-1#1)
syngeneic or allogeneic##2##3##(1993-4#1)(1997-4#1)
syngeneic recipients##4##2##(1991-12#3)(1995-8#1)
syngeneic splenocytes##3##2##(1991-12#2)(1995-2#1)
syngeneic##55##1##(1990-11#1)(1990-12#2)(1990-8#1)(1991-12#9)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-7#1)(1992-9#3)(1993-4#1)(1994-5#1)(1994-6#1)(1995-12#2)(1995-2#5)(1995-8#1)(1996-10#1)(1996-11#2)(1997-4#4)(1997-7#1)(2008-4#6)(2008-8#1)(2009-10#1)(2010-11#1)(2011-1#1)(2013-1#3)
syngraft##2##1##(1995-2#2)
synonym##6##1##(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#2)(2013-7#1)
synonymized##7##1##(2007-3#2)(2011-2#2)(2013-7#2)(2013-8#1)
synonymous and nonsynonymous##4##3##(1990-4#2)(1994-8#1)(2012-3#1)
synonymous and##5##2##(1990-4#2)(1994-8#1)(2012-3#1)(2012-5#1)
synonymous codon##2##2##(1993-11#1)(2008-4#1)
synonymous substitutions##2##2##(1990-4#1)(1991-10#1)
synonymous with##11##2##(1997-8#1)(2005-8#3)(2006-11#1)(2008-1#1)(2008-7#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-7#1)
synonymous##32##1##(1990-4#4)(1991-10#1)(1993-11#3)(1994-8#3)(1997-8#1)(2005-8#4)(2006-11#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-7#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-7#1)(2012-2#1)(2012-3#2)(2012-5#1)
synonymously##3##1##(2005-8#1)(2006-12#1)(2009-10#1)
synonyms##8##1##(2006-10#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-7#1)(2011-2#1)
synonymy of##4##2##(2008-10#2)(2013-1#2)
synonymy##8##1##(2008-10#2)(2013-1#6)
synopsis of the##4##3##(1990-12#1)(1992-1#1)(2008-10#1)(2010-12#1)
synopsis of##12##2##(1990-12#1)(1992-1#1)(2005-1#1)(2007-4#1)(2008-10#2)(2008-11#2)(2008-8#1)(2010-12#1)(2013-1#1)(2013-8#1)
synopsis##16##1##(1990-12#1)(1991-3#1)(1992-1#1)(2005-1#1)(2007-10#1)(2007-4#2)(2008-10#2)(2008-11#2)(2008-8#1)(2010-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
synoptic##5##1##(1994-2#1)(1996-12#2)(2008-10#1)(2008-2#1)
synostosis##13##1##(1993-8#1)(1996-3#4)(2006-7#4)(2007-12#1)(2009-8#1)(2013-1#2)
synovectomy is##2##2##(2007-7#1)(2010-7#1)
synovectomy of the knee joint##2##5##(2007-11#1)(2007-7#1)
synovectomy of the knee##3##4##(2007-11#1)(2007-7#2)
synovectomy of##5##2##(2006-7#1)(2007-11#1)(2007-7#2)(2011-2#1)
synovectomy##23##1##(2006-7#1)(2007-11#5)(2007-7#10)(2008-8#1)(2009-3#1)(2010-7#1)(2011-2#2)(2013-1#2)
synovia##3##1##(2006-7#1)(2007-11#1)(2008-4#1)
synoviae##4##1##(1997-3#2)(2008-5#2)
synovial TNF-α##2##2##(2013-1#2)
synovial bursae##3##2##(2007-11#3)
synovial cells##9##2##(1990-12#1)(1991-1#4)(1992-1#1)(2007-11#1)(2008-5#1)(2011-2#1)
synovial chondromatosis and##2##3##(2008-6#2)
synovial chondromatosis of the knee##3##5##(2007-7#3)
synovial chondromatosis##9##2##(1992-4#1)(2007-7#3)(2008-6#4)(2008-8#1)
synovial deposits##2##2##(2008-8#2)
synovial estradiol and##2##3##(1992-3#2)
synovial estradiol level was##2##4##(1992-3#2)
synovial estradiol##4##2##(1992-3#4)
synovial fibroblasts##7##2##(1990-12#2)(1991-10#1)(1992-1#1)(1992-4#2)(2007-11#1)
synovial fluid (SF)##2##3##(1994-8#1)(2006-10#1)
synovial fluid studies##2##3##(2006-10#2)
synovial fluid white blood cell counts##2##6##(2006-10#2)
synovial fluid white cell counts##2##5##(2006-10#2)
synovial fluid white##4##3##(2006-10#4)
synovial fluid##36##2##(1990-2#1)(1990-6#2)(1991-7#1)(1992-11#1)(1992-8#1)(1993-6#1)(1994-8#2)(2005-8#1)(2006-1#1)(2006-10#15)(2007-11#2)(2008-10#1)(2008-12#1)(2009-6#1)(2010-10#1)(2011-1#3)(2013-8#1)
synovial fluids of##2##3##(1994-3#1)(1995-3#1)
synovial fluids##5##2##(1993-2#1)(1994-3#2)(1995-3#1)(1996-1#1)
synovial inflammation##3##2##(2012-3#2)(2013-1#1)
synovial joints##4##2##(2007-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
synovial membrane of a knee joint##2##6##(2013-1#2)
synovial membrane of##3##3##(2010-12#1)(2013-1#2)
synovial membrane##12##2##(1990-6#1)(1992-4#1)(1996-6#1)(2007-11#1)(2009-3#1)(2010-12#4)(2013-1#3)
synovial membranes##3##2##(2005-7#1)(2010-12#2)
synovial mononuclear cells and synovial tissue from patients affected by##2##10##(1991-5#2)
synovial osteochondromatosis##2##2##(2010-5#2)
synovial plica##2##2##(2007-7#2)
synovial proliferation##2##2##(2006-10#1)(2008-7#1)
synovial reaction##2##2##(2011-2#2)
synovial sarcoma of the thyroid##3##5##(2012-1#3)
synovial sarcoma of the##7##4##(2008-7#1)(2009-3#1)(2012-1#3)(2013-1#2)
synovial sarcoma of##8##3##(2008-7#1)(2009-3#1)(2012-1#3)(2013-1#3)
synovial sarcoma was##2##3##(2008-6#2)
synovial sarcoma##30##2##(1990-12#1)(1993-12#1)(2008-6#13)(2008-7#1)(2009-3#1)(2010-3#1)(2012-1#5)(2013-1#5)(2013-7#2)
synovial sarcomas##7##2##(2008-6#7)
synovial septum was##2##3##(2013-1#2)
synovial sheath effusion##2##3##(2006-10#2)
synovial sheath##3##2##(2006-10#2)(2007-11#1)
synovial specimens##2##2##(1990-6#2)
synovial tissue from patients##3##4##(1991-5#2)(1994-8#1)
synovial tissue from##4##3##(1991-5#3)(1994-8#1)
synovial tissue##9##2##(1991-5#3)(1994-8#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#2)
synovial tissues##3##2##(1994-8#1)(2005-7#1)(2013-1#1)
synovial##192##1##(1990-12#4)(1990-2#1)(1990-6#5)(1991-1#4)(1991-10#3)(1991-5#5)(1991-7#1)(1992-1#2)(1992-11#1)(1992-3#6)(1992-4#4)(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-3#2)(1994-8#5)(1995-3#1)(1996-1#1)(1996-4#1)(1996-6#1)(1996-9#1)(2005-7#3)(2005-8#1)(2006-1#1)(2006-10#18)(2007-11#12)(2007-7#6)(2008-10#1)(2008-12#2)(2008-5#2)(2008-6#26)(2008-7#2)(2008-8#5)(2009-3#4)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#6)(2010-3#2)(2010-5#2)(2010-9#1)(2011-1#3)(2011-2#4)(2012-1#5)(2012-2#4)(2012-3#4)(2013-1#18)(2013-7#2)(2013-8#3)
synoviocytes##11##1##(1991-10#1)(2006-4#4)(2007-11#1)(2008-10#3)(2012-3#1)(2013-8#1)
synovitis and##7##2##(1990-6#1)(1991-6#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-11#1)(2013-1#1)
synovitis in##3##2##(2006-8#1)(2009-2#1)(2010-12#1)
synovitis of the##3##3##(2006-10#1)(2010-3#1)(2013-1#1)
synovitis of##4##2##(2006-10#2)(2010-3#1)(2013-1#1)
synovitis with##2##2##(2008-8#1)(2009-2#1)
synovitis##36##1##(1990-6#1)(1991-6#1)(2005-7#2)(2006-10#8)(2006-11#1)(2006-12#1)(2006-3#1)(2006-8#4)(2007-11#1)(2007-7#1)(2008-5#1)(2008-8#1)(2009-2#2)(2010-12#1)(2010-3#2)(2011-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
synovium in 2 patients and##2##5##(2006-10#2)
synovium in##3##2##(2006-10#2)(2007-7#1)
synovium##10##1##(2006-10#2)(2006-11#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-4#1)
synspermia##3##1##(2007-12#3)
syntactic and discourse##2##3##(2007-3#1)(2008-9#1)
syntactic and##4##2##(2006-2#1)(2007-3#1)(2008-7#1)(2008-9#1)
syntactic categories in##2##3##(2008-2#2)
syntactic categories##5##2##(2008-2#5)
syntactic complexity##2##2##(2006-3#1)(2008-4#1)
syntactic constructions##2##2##(2008-2#2)
syntactic structure##4##2##(2008-11#1)(2008-4#1)(2011-1#1)(2013-7#1)
syntactic##34##1##(2006-2#1)(2006-3#1)(2007-3#6)(2007-4#2)(2007-8#2)(2008-11#2)(2008-2#7)(2008-4#3)(2008-7#1)(2008-9#1)(2009-11#1)(2011-1#1)(2012-1#1)(2013-1#2)(2013-7#2)(2013-8#1)
syntactically complex sentences##2##3##(2008-4#2)
syntactically##4##1##(2007-3#1)(2008-4#3)
syntax##14##1##(1997-3#1)(2006-3#2)(2008-12#2)(2008-2#3)(2008-4#2)(2008-9#1)(2010-4#2)(2013-8#1)
syntax)##2##1##(2013-8#2)
syntaxin 1##2##2##(1996-5#1)(2008-4#1)
syntaxin##5##1##(1995-12#2)(1996-5#1)(1997-8#1)(2008-4#1)
syntenic region##4##2##(1996-10#1)(2008-10#1)(2008-7#1)(2012-3#1)
syntenic##10##1##(1993-2#1)(1996-10#1)(2008-10#3)(2008-7#3)(2012-2#1)(2012-3#1)
synteny with##3##2##(1993-2#1)(1996-10#1)(2008-7#1)
synteny##8##1##(1992-7#1)(1993-2#1)(1996-10#1)(2006-12#1)(2008-7#1)(2008-8#3)
synthase (CS)##5##2##(1991-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(2013-1#1)
synthase (EC 1##3##3##(1992-3#1)(1992-9#1)(2008-8#1)
synthase (EC 4##2##3##(1993-12#1)(1994-3#1)
synthase (EC##5##2##(1992-3#1)(1992-9#1)(1993-12#1)(1994-3#1)(2008-8#1)
synthase (NOS) activity##3##3##(1994-11#1)(1995-6#1)(2011-1#1)
synthase (NOS) in##4##3##(1992-8#1)(1993-6#2)(1997-6#1)
synthase (NOS)##32##2##(1992-12#1)(1992-8#2)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-2#2)(1995-12#2)(1995-5#2)(1995-6#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-6#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-10#2)(2009-7#1)(2009-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)
synthase (PGH synthase)##2##3##(1992-8#1)(1993-4#1)
synthase (PGHS)##2##2##(1991-4#1)(1994-8#1)
synthase (PGIS)##2##2##(1993-12#1)(1994-8#1)
synthase (SS##2##2##(1997-6#1)(2011-2#1)
synthase (TS)##9##2##(1990-7#2)(1992-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1997-2#1)
synthase (cNOS)##2##2##(1994-11#1)(1996-6#1)
synthase (eNOS)##4##2##(1997-6#1)(2005-1#1)(2008-8#1)(2010-4#1)
synthase (iNOS) activity##2##3##(1993-3#1)(2008-8#1)
synthase (iNOS)##20##2##(1993-3#1)(1993-8#1)(1994-3#1)(1995-12#1)(1996-10#1)(1996-12#1)(1996-6#1)(1997-6#1)(1997-7#1)(2005-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)(2013-1#1)
synthase (nos)##2##2##(1997-2#2)
synthase 2 gene##2##3##(2007-12#1)(2008-11#1)
synthase 2##5##2##(1996-8#1)(2007-12#2)(2008-11#1)(2009-8#1)
synthase A##2##2##(2008-9#2)
synthase I##5##2##(1993-9#3)(1997-6#2)
synthase II##2##2##(1992-4#1)(2008-9#1)
synthase III##2##2##(1992-4#1)(1993-9#1)
synthase activities in##2##3##(1991-8#1)(1992-9#1)
synthase activities##3##2##(1991-8#1)(1992-9#1)(1997-6#1)
synthase activity and##6##3##(1992-11#2)(1994-10#1)(2008-1#2)(2012-12#1)
synthase activity by##3##3##(1991-1#1)(1992-11#1)(1993-11#1)
synthase activity in the##2##4##(1995-5#1)(2007-3#1)
synthase activity in##9##3##(1990-9#1)(1993-3#1)(1993-6#1)(1995-12#1)(1995-4#1)(1995-5#1)(1996-9#1)(2007-3#1)(2013-1#1)
synthase activity is##2##3##(1994-11#1)(1996-2#1)
synthase activity was significantly##2##4##(1990-9#1)(2008-3#1)
synthase activity was##4##3##(1990-9#1)(1992-11#1)(2008-3#1)(2008-4#1)
synthase activity##45##2##(1990-9#2)(1991-1#4)(1992-11#7)(1992-4#2)(1992-6#3)(1993-11#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-3#2)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-6#1)(1996-7#1)(1996-9#1)(2007-3#1)(2008-1#2)(2008-3#1)(2008-4#1)(2012-12#1)(2013-1#1)
synthase and a##2##3##(1992-12#1)(1995-2#1)
synthase and##31##2##(1990-8#1)(1991-1#2)(1991-10#1)(1991-4#3)(1992-1#1)(1992-10#1)(1992-12#1)(1992-8#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-8#4)(2008-1#1)(2008-5#1)(2009-10#1)(2009-11#1)(2010-10#2)
synthase are##3##2##(1994-3#1)(1994-9#1)(1996-5#1)
synthase but##2##2##(1992-1#1)(1992-10#1)
synthase by##9##2##(1990-9#1)(1991-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1994-10#1)(1996-10#1)(1997-6#1)(2008-3#1)
synthase cDNA##4##2##(1991-5#1)(1994-8#2)(1995-2#1)
synthase catalyzes the##2##3##(1991-5#1)(1997-8#1)
synthase catalyzes##3##2##(1991-5#1)(1994-5#1)(1997-8#1)
synthase compared to##2##3##(1993-9#1)(1995-11#1)
synthase complex##5##2##(1991-6#1)(1992-3#1)(1996-7#2)(2005-8#1)
synthase enzyme and##2##3##(1992-12#1)(1993-4#1)
synthase enzyme##6##2##(1992-12#3)(1993-4#1)(1995-3#1)(2008-6#1)
synthase expression in##2##3##(1991-3#1)(1995-2#1)
synthase expression##4##2##(1991-3#1)(1993-5#1)(1995-2#1)(2007-3#1)
synthase for##2##2##(1993-12#1)(1996-7#1)
synthase from rat cerebellum##3##4##(1992-11#1)(1992-6#2)
synthase from rat##5##3##(1990-5#1)(1990-9#1)(1992-11#1)(1992-6#2)
synthase from the##3##3##(1990-12#2)(2012-2#1)
synthase from##28##2##(1990-12#2)(1990-2#1)(1990-5#1)(1990-9#1)(1991-12#1)(1992-1#1)(1992-11#2)(1992-6#3)(1993-3#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-8#2)(1994-9#1)(1995-3#1)(1996-10#1)(1996-6#1)(1996-7#1)(1997-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
synthase gene and##2##3##(1995-12#1)(2008-9#1)
synthase gene in##3##3##(1993-8#1)(1995-2#1)(1997-7#1)
synthase gene is##2##3##(1994-3#1)(2008-7#1)
synthase gene was##2##3##(1995-3#1)(2008-9#1)
synthase gene##42##2##(1991-6#1)(1992-5#3)(1993-12#1)(1993-3#1)(1993-8#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-2#3)(1995-3#1)(1996-12#1)(1996-2#2)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#2)(2007-10#1)(2008-10#4)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)
synthase had##2##2##(2008-6#1)(2008-7#1)
synthase has been##5##3##(1990-2#1)(1990-5#1)(1990-9#1)(1991-7#1)(2008-4#1)
synthase has##6##2##(1990-2#1)(1990-5#1)(1990-9#1)(1991-7#1)(1995-5#1)(2008-4#1)
synthase have been##2##3##(1992-12#1)(1995-11#1)
synthase identifies a##2##3##(1992-3#1)(1997-4#1)
synthase in rat peritoneal neutrophils##2##5##(1992-7#2)
synthase in rat##3##3##(1992-7#2)(1994-11#1)
synthase in the##5##3##(1992-8#1)(1994-2#1)(1995-11#1)(2006-8#1)(2008-10#1)
synthase in vitro##3##3##(1992-1#1)(1993-12#1)(1995-11#1)
synthase in##39##2##(1991-1#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-7#3)(1992-8#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-11#3)(1995-12#1)(1995-4#1)(1995-8#1)(1996-12#1)(1997-2#2)(1997-3#1)(1997-6#2)(1997-8#1)(2005-12#1)(2006-8#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-2#2)(2013-1#1)
synthase increased##2##2##(1990-3#1)(2008-10#1)
synthase induction##2##2##(1991-10#1)(1995-10#1)
synthase inhibitor L-NG-nitroarginine methyl ester##2##5##(1994-2#1)(1996-6#1)
synthase inhibitor##27##2##(1993-12#1)(1993-3#2)(1993-4#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-5#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#3)(1996-6#1)(1997-2#1)(1997-4#1)(2004-11#2)(2006-10#1)(2007-1#1)(2007-11#1)
synthase inhibitors##6##2##(1992-3#1)(1992-6#1)(1995-11#1)(2006-11#1)(2008-5#1)(2009-4#1)
synthase is a##3##3##(1992-11#1)(1997-2#1)(2008-10#1)
synthase is##12##2##(1991-10#1)(1992-11#1)(1992-3#1)(1993-12#1)(1994-11#1)(1994-2#1)(1995-12#1)(1996-7#1)(1997-2#1)(2008-10#1)(2008-6#1)(2008-8#1)
synthase kinase 3 beta (GSK-3 beta)##3##6##(1995-12#1)(1995-8#1)(2007-11#1)
synthase kinase 3 beta##5##4##(1995-12#1)(1995-8#2)(2007-11#2)
synthase kinase##6##2##(1995-12#1)(1995-8#2)(2007-11#2)(2008-7#1)
synthase kinase-3 (GSK-3)##2##3##(1993-11#1)(1997-6#1)
synthase kinase-3##5##2##(1993-11#2)(1997-1#1)(1997-6#1)(2011-1#1)
synthase levels##2##2##(1992-8#1)(2009-2#1)
synthase mRNA##6##2##(1992-5#1)(1993-6#1)(1994-11#1)(1995-12#2)(1997-6#1)
synthase of##10##2##(1990-9#1)(1992-7#1)(1993-12#1)(1993-9#2)(1996-9#1)(1997-4#2)(1997-8#1)(2008-4#1)
synthase on##2##2##(1990-7#1)(2010-12#1)
synthase pathway##3##2##(1994-5#1)(1997-1#1)(1997-3#1)
synthase protein was##2##3##(1993-12#1)(2008-4#1)
synthase protein##4##2##(1993-12#1)(2008-4#1)(2009-10#1)(2011-1#1)
synthase purified from##4##3##(1992-9#1)(1993-9#1)(1995-8#2)
synthase reaction##5##2##(1991-2#1)(1992-11#1)(1992-8#1)(1996-7#1)(2005-12#1)
synthase revealed that##2##3##(1997-2#1)(1997-8#1)
synthase revealed##3##2##(1992-8#1)(1997-2#1)(1997-8#1)
synthase sequence##2##2##(1995-3#1)(1997-8#1)
synthase subunit##6##2##(1992-11#1)(1994-9#2)(1997-6#1)(2012-2#2)
synthase that##4##2##(1993-4#1)(1996-6#1)(2006-2#1)(2008-10#1)
synthase to##2##2##(1994-2#1)(1997-1#1)
synthase was isolated##2##3##(1990-9#1)(1996-10#1)
synthase was##9##2##(1990-5#1)(1990-9#1)(1992-1#1)(1992-6#1)(1993-11#1)(1995-11#1)(1995-2#1)(1996-10#1)(1997-4#1)
synthase were##5##2##(1990-5#1)(1994-5#1)(1995-4#1)(2004-11#1)(2008-10#1)
synthase with##12##2##(1991-4#1)(1991-8#1)(1992-5#1)(1993-12#1)(1994-5#1)(1995-2#2)(1996-12#1)(1996-7#1)(1997-1#1)(2008-6#1)(2009-9#1)
synthase##765##1##(1990-11#2)(1990-12#4)(1990-2#3)(1990-3#1)(1990-5#5)(1990-7#5)(1990-8#1)(1990-9#12)(1991-1#8)(1991-10#4)(1991-12#5)(1991-2#2)(1991-3#2)(1991-4#9)(1991-5#4)(1991-6#2)(1991-7#3)(1991-8#2)(1992-1#11)(1992-10#5)(1992-11#18)(1992-12#11)(1992-2#2)(1992-3#12)(1992-4#4)(1992-5#8)(1992-6#11)(1992-7#8)(1992-8#16)(1992-9#4)(1993-11#8)(1993-12#15)(1993-2#5)(1993-3#10)(1993-4#7)(1993-5#3)(1993-6#8)(1993-8#4)(1993-9#16)(1994-10#5)(1994-11#10)(1994-12#4)(1994-2#12)(1994-3#8)(1994-5#9)(1994-8#16)(1994-9#10)(1995-10#1)(1995-11#13)(1995-12#15)(1995-2#24)(1995-3#10)(1995-4#3)(1995-5#10)(1995-6#3)(1995-7#4)(1995-8#11)(1995-9#2)(1996-1#1)(1996-10#6)(1996-12#8)(1996-2#6)(1996-3#2)(1996-4#2)(1996-5#5)(1996-6#8)(1996-7#13)(1996-8#3)(1996-9#2)(1997-1#7)(1997-2#15)(1997-3#4)(1997-4#11)(1997-5#1)(1997-6#20)(1997-7#7)(1997-8#15)(2004-11#3)(2004-12#1)(2005-1#2)(2005-10#1)(2005-12#3)(2005-7#2)(2005-8#7)(2006-10#2)(2006-11#2)(2006-12#2)(2006-2#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-2#1)(2007-3#2)(2008-1#6)(2008-10#17)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#10)(2008-5#9)(2008-6#5)(2008-7#6)(2008-8#16)(2008-9#10)(2009-10#10)(2009-11#2)(2009-2#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#4)(2010-10#2)(2010-12#5)(2010-4#3)(2011-1#7)(2011-12#2)(2011-2#7)(2012-12#1)(2012-2#13)(2013-1#8)(2013-8#2)
synthase) in##2##2##(1997-8#1)(2008-6#1)
synthase)##12##1##(1991-12#1)(1992-8#1)(1993-4#1)(1994-8#2)(1995-1#1)(1995-12#2)(1997-8#1)(2008-10#1)(2008-6#1)(2008-9#1)
synthase-1 in##2##2##(1992-3#1)(2012-2#1)
synthase-1 mRNA##2##2##(1993-4#1)(2008-4#1)
synthase-1##13##1##(1992-3#4)(1993-4#4)(1995-5#1)(2008-4#3)(2012-2#1)
synthase-2 mRNA##2##2##(1993-3#1)(1993-4#1)
synthase-2##15##1##(1992-8#1)(1993-3#5)(1993-4#1)(1994-5#1)(1994-8#1)(2008-1#1)(2008-4#3)(2008-7#1)(2011-1#1)
synthases from##2##2##(1990-12#1)(1995-4#1)
synthases in##4##2##(1990-8#1)(1990-9#1)(1995-6#1)(2008-6#1)
synthases were##2##2##(1995-6#1)(2009-8#1)
synthases##40##1##(1990-12#1)(1990-8#1)(1990-9#2)(1991-1#1)(1992-10#1)(1993-2#2)(1993-4#2)(1993-9#5)(1994-2#1)(1995-11#1)(1995-4#1)(1995-6#4)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(2005-7#1)(2005-8#1)(2008-10#4)(2008-4#1)(2008-6#1)(2009-4#1)(2009-8#1)(2013-1#3)(2013-8#1)
syntheses and##6##2##(1991-12#1)(1992-2#1)(1992-9#1)(2005-8#1)(2006-12#1)(2010-5#1)
syntheses are##5##2##(1992-12#2)(1992-2#1)(2006-12#1)(2009-10#1)
syntheses for##2##2##(1997-2#1)(2012-2#1)
syntheses in good yields of##2##5##(2007-11#2)
syntheses in##3##2##(2007-11#2)(2010-7#1)
syntheses of the##8##3##(1996-2#1)(1996-4#1)(1997-4#1)(2007-10#1)(2008-10#1)(2009-5#1)(2009-7#1)(2013-8#1)
syntheses of these##2##3##(1992-6#1)(2009-7#1)
syntheses of##42##2##(1991-6#1)(1992-6#2)(1996-2#2)(1996-4#1)(1997-2#1)(1997-4#1)(2005-10#1)(2006-12#2)(2006-7#1)(2007-10#2)(2007-11#4)(2008-10#1)(2008-12#1)(2008-4#3)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-12#2)(2010-6#2)(2012-12#1)(2013-1#1)(2013-8#2)
syntheses##81##1##(1990-12#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-6#3)(1992-9#1)(1993-4#1)(1996-2#3)(1996-4#1)(1996-6#2)(1997-2#2)(1997-4#1)(2005-10#1)(2005-8#1)(2006-12#4)(2006-7#1)(2007-10#3)(2007-11#7)(2008-10#1)(2008-12#1)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#2)(2009-12#3)(2009-3#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-12#2)(2010-2#1)(2010-5#2)(2010-6#2)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
synthesis (in##2##2##(1991-5#1)(1996-11#1)
synthesis after##3##2##(1991-4#1)(1994-2#1)(2008-4#1)
synthesis and GTP hydrolysis##2##4##(1995-5#2)
synthesis and a##8##3##(1993-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(2009-2#1)(2009-7#1)(2010-12#1)
synthesis and absorption##3##3##(2005-4#1)(2009-4#2)
synthesis and accumulation of##3##4##(1994-3#1)(1995-11#1)(2008-8#1)
synthesis and action##3##3##(1992-9#1)(2005-1#1)(2008-7#1)
synthesis and activity of##2##4##(1991-6#1)(2008-8#1)
synthesis and activity##3##3##(1991-6#1)(1991-9#1)(2008-8#1)
synthesis and analysis of##2##4##(1994-6#1)(2008-10#1)
synthesis and analysis##3##3##(1994-6#1)(2008-10#1)(2008-3#1)
synthesis and antimicrobial evaluation of##2##5##(2012-3#2)
synthesis and antimicrobial##3##3##(2007-11#1)(2012-3#2)
synthesis and application##2##3##(2008-10#1)(2008-4#1)
synthesis and applications as##2##4##(2008-10#2)
synthesis and biological activities of##2##5##(1994-12#1)(2011-2#1)
synthesis and biological activities##3##4##(1994-12#1)(2010-6#1)(2011-2#1)
synthesis and biological activity##2##4##(2007-11#1)(2010-12#1)
synthesis and biological evaluation of##3##5##(1994-9#1)(2006-12#1)(2013-1#1)
synthesis and biological evaluation##5##4##(1994-9#1)(1997-1#1)(2006-12#1)(2007-10#1)(2013-1#1)
synthesis and biological##10##3##(1994-12#1)(1994-9#1)(1997-1#1)(2006-12#1)(2007-10#1)(2007-11#1)(2010-12#1)(2010-6#1)(2011-2#1)(2013-1#1)
synthesis and breakdown of##2##4##(1993-8#1)(2011-2#1)
synthesis and breakdown##4##3##(1991-7#1)(1993-8#1)(2008-5#1)(2011-2#1)
synthesis and catabolism##3##3##(1991-12#1)(1994-3#2)
synthesis and cell growth##4##4##(1990-10#1)(1995-5#1)(1996-2#1)(2008-2#1)
synthesis and cell##16##3##(1990-10#1)(1990-12#1)(1990-2#1)(1991-2#1)(1992-8#1)(1993-6#1)(1993-8#2)(1994-8#1)(1995-11#2)(1995-5#1)(1996-2#1)(1997-2#1)(2008-2#1)(2008-4#1)
synthesis and characterization of the##3##5##(1990-8#1)(2006-12#1)(2008-3#1)
synthesis and characterization of##20##4##(1990-8#1)(1994-8#1)(2005-11#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#3)(2008-5#2)(2009-11#1)(2009-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2012-11#1)(2013-7#1)
synthesis and degradation in##4##4##(1991-1#2)(1991-6#1)(1997-8#1)
synthesis and degradation of##6##4##(1991-11#1)(2007-4#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
synthesis and degradation##13##3##(1991-1#2)(1991-11#1)(1991-6#3)(1997-8#1)(2007-4#1)(2008-1#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
synthesis and deposition##2##3##(2009-8#2)
synthesis and detection##2##3##(1995-2#1)(2012-2#1)
synthesis and distribution##2##3##(1992-6#1)(1994-12#1)
synthesis and evaluation of##4##4##(1994-9#1)(2007-11#1)(2008-10#1)(2012-3#1)
synthesis and evaluation##5##3##(1994-9#1)(2007-11#1)(2008-10#2)(2012-3#1)
synthesis and expression of##2##4##(1992-5#1)(1997-2#1)
synthesis and expression##3##3##(1992-5#1)(1993-12#1)(1997-2#1)
synthesis and hydrolysis of##3##4##(1991-12#1)(1994-11#1)(1994-12#1)
synthesis and hydrolysis##4##3##(1990-5#1)(1991-12#1)(1994-11#1)(1994-12#1)
synthesis and in##2##3##(1995-7#1)(2010-12#1)
synthesis and increased##2##3##(2008-1#1)(2008-3#1)
synthesis and inhibitors of##2##4##(1997-4#1)(2009-4#1)
synthesis and is##3##3##(1991-7#1)(2006-8#1)(2007-12#1)
synthesis and it##2##3##(1990-2#1)(1992-8#1)
synthesis and knowledge##2##3##(2009-4#1)(2012-2#1)
synthesis and mRNA levels##2##4##(1996-3#2)
synthesis and pharmacological##2##3##(1994-9#1)(2010-6#1)
synthesis and phosphorylation##2##3##(1993-9#1)(1994-8#1)
synthesis and potent##2##3##(2008-8#1)(2011-2#1)
synthesis and production of##2##4##(1991-12#1)(2011-1#1)
synthesis and release of##11##4##(1991-10#1)(1994-2#1)(1994-9#1)(1995-11#1)(1996-2#1)(1997-1#1)(1997-5#1)(2007-9#1)(2008-5#1)(2008-9#1)(2013-7#1)
synthesis and release##17##3##(1990-7#1)(1991-10#1)(1994-10#1)(1994-2#1)(1994-9#1)(1995-11#1)(1996-2#1)(1997-1#1)(1997-5#2)(2007-7#1)(2007-9#1)(2008-5#1)(2008-9#1)(2011-1#1)(2013-7#2)
synthesis and rendering##2##3##(2008-6#2)
synthesis and screening##3##3##(2008-1#1)(2008-4#1)(2012-12#1)
synthesis and secretion in##2##4##(1990-11#1)(1990-4#1)
synthesis and secretion of##13##4##(1990-4#1)(1990-9#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1997-4#3)(2004-11#1)(2007-12#1)
synthesis and secretion##20##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#2)(1990-9#1)(1991-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1996-1#1)(1997-4#3)(2004-11#1)(2007-12#1)(2008-11#1)
synthesis and structure##2##3##(1992-6#1)(2010-5#1)
synthesis and structure-activity relationships of##2##5##(1996-8#1)(2008-10#1)
synthesis and the##10##3##(1992-6#1)(1992-8#1)(1994-8#1)(1995-11#1)(1995-6#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-12#1)(2012-2#1)
synthesis and to##2##3##(1996-10#1)(2007-11#1)
synthesis and##375##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#4)(1990-3#1)(1990-4#2)(1990-5#2)(1990-7#6)(1990-8#2)(1990-9#1)(1991-1#5)(1991-10#1)(1991-11#1)(1991-12#7)(1991-2#1)(1991-6#5)(1991-7#3)(1991-9#3)(1992-11#4)(1992-3#1)(1992-5#2)(1992-6#3)(1992-7#2)(1992-8#4)(1992-9#1)(1993-11#2)(1993-12#4)(1993-4#2)(1993-6#3)(1993-8#4)(1993-9#2)(1994-10#2)(1994-11#3)(1994-12#8)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#5)(1994-7#1)(1994-8#11)(1994-9#5)(1995-10#1)(1995-11#9)(1995-2#2)(1995-3#4)(1995-5#4)(1995-6#4)(1995-7#1)(1996-1#1)(1996-10#3)(1996-2#7)(1996-3#2)(1996-5#2)(1996-6#1)(1996-7#4)(1996-8#2)(1997-1#3)(1997-2#3)(1997-3#1)(1997-4#10)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#2)(2004-11#2)(2005-1#1)(2005-11#2)(2005-4#1)(2005-8#1)(2006-1#1)(2006-11#1)(2006-12#5)(2006-2#1)(2006-5#2)(2006-8#2)(2007-10#1)(2007-11#7)(2007-12#2)(2007-4#1)(2007-5#2)(2007-7#1)(2007-9#2)(2008-1#4)(2008-10#20)(2008-11#5)(2008-2#2)(2008-3#4)(2008-4#10)(2008-5#14)(2008-6#4)(2008-7#5)(2008-8#7)(2008-9#1)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#2)(2009-7#1)(2009-8#5)(2010-12#9)(2010-2#1)(2010-4#4)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-11#1)(2012-12#2)(2012-2#7)(2012-3#3)(2013-1#3)(2013-7#3)(2013-8#2)
synthesis and/or##5##2##(1992-3#1)(1993-6#1)(1994-11#1)(2005-7#1)(2008-10#1)
synthesis andin vitro##2##3##(2008-11#1)(2008-7#1)
synthesis applications##2##2##(1997-4#1)(2008-4#1)
synthesis are described##3##3##(1995-6#1)(1997-4#1)(2008-4#1)
synthesis are##19##2##(1991-4#1)(1994-6#1)(1995-12#1)(1995-6#2)(1997-1#1)(1997-4#3)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2009-11#1)(2009-3#2)(2011-1#1)
synthesis as a##2##3##(1992-1#1)(2009-12#1)
synthesis as measured by##2##4##(1993-12#1)(1997-7#1)
synthesis as well as##7##4##(1990-7#2)(1993-4#1)(1995-2#1)(2006-12#1)(2008-5#2)
synthesis as##17##2##(1990-7#2)(1991-3#1)(1991-6#1)(1992-1#1)(1992-10#1)(1993-12#1)(1993-4#1)(1995-2#2)(1997-7#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-5#2)(2009-12#1)
synthesis at 37 degrees C##2##5##(1990-5#1)(1991-2#1)
synthesis at the centre of##2##5##(1997-2#2)
synthesis at the##9##3##(1992-2#1)(1992-3#1)(1995-3#2)(1997-2#2)(1997-4#1)(2008-10#1)(2008-5#1)
synthesis at##18##2##(1990-11#1)(1990-5#1)(1990-9#1)(1991-2#1)(1992-2#1)(1992-3#1)(1993-4#1)(1994-11#1)(1995-2#2)(1995-3#2)(1997-2#2)(1997-4#1)(2008-10#1)(2008-4#1)(2008-5#1)
synthesis but##7##2##(1990-10#1)(1992-6#1)(1993-6#2)(1994-2#1)(1994-5#1)(1995-5#1)
synthesis by a##3##3##(1990-11#1)(1991-7#1)(2007-2#1)
synthesis by cycloheximide or##2##4##(1991-10#1)(1997-7#1)
synthesis by cycloheximide##4##3##(1991-10#1)(1992-8#1)(1995-8#1)(1997-7#1)
synthesis by human##2##3##(1990-2#1)(1996-6#1)
synthesis by mouse##2##3##(1990-7#1)(1996-9#1)
synthesis by the##14##3##(1991-12#1)(1992-3#1)(1993-12#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-8#1)(1997-8#1)(2008-4#2)(2008-5#1)(2008-6#1)(2010-2#1)(2013-1#1)
synthesis by use of##2##4##(2007-12#1)(2008-3#1)
synthesis by##94##2##(1990-11#3)(1990-2#2)(1990-3#1)(1990-4#1)(1990-7#2)(1990-9#1)(1991-1#4)(1991-10#1)(1991-11#1)(1991-12#2)(1991-4#1)(1991-7#1)(1992-11#2)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#2)(1993-12#1)(1993-6#1)(1993-8#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#2)(1997-1#4)(1997-3#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-9#1)(2009-8#1)(2010-2#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
synthesis can be##2##3##(1995-10#1)(2008-4#1)
synthesis can##3##2##(1990-5#1)(1995-10#1)(2008-4#1)
synthesis compared with##2##3##(1991-7#1)(1992-9#1)
synthesis compared##3##2##(1990-11#1)(1991-7#1)(1992-9#1)
synthesis conditions and##4##3##(2008-1#1)(2008-10#1)(2008-5#1)(2010-4#1)
synthesis conditions##6##2##(2008-1#2)(2008-10#1)(2008-5#1)(2009-10#1)(2010-4#1)
synthesis consists of##3##3##(1990-5#1)(2008-10#1)(2008-4#1)
synthesis could be##2##3##(1993-9#1)(1994-2#1)
synthesis could##3##2##(1993-9#1)(1994-2#1)(1996-11#1)
synthesis decrease##2##2##(1990-7#1)(1993-11#1)
synthesis did not differ##2##4##(1992-1#1)(2008-10#1)
synthesis directly##2##2##(1991-5#1)(1992-4#1)
synthesis during##11##2##(1991-3#1)(1991-6#1)(1992-11#1)(1992-2#1)(1993-12#1)(1993-3#1)(1993-9#1)(1995-6#1)(1995-8#1)(2008-9#1)(2009-12#1)
synthesis enzymes##3##2##(1991-4#1)(2011-2#2)
synthesis followed by##2##3##(1995-11#1)(1997-2#1)
synthesis following##3##2##(1994-11#1)(1996-11#1)(2010-10#1)
synthesis for##9##2##(1991-7#1)(1991-8#1)(1993-9#1)(1996-2#1)(2004-11#1)(2007-12#1)(2008-3#1)(2008-5#1)(2013-1#1)
synthesis from glucose##4##3##(1991-10#1)(1992-1#1)(1995-8#1)(1997-8#1)
synthesis from the##3##3##(1994-2#1)(2007-11#2)
synthesis from##18##2##(1990-3#1)(1991-1#1)(1991-10#1)(1992-1#1)(1992-7#1)(1994-2#1)(1994-8#1)(1995-11#2)(1995-5#1)(1995-8#1)(1996-11#1)(1996-5#1)(1997-8#1)(2007-11#2)(2011-1#1)(2013-1#1)
synthesis gene##4##2##(1992-10#1)(1995-3#2)(2008-4#1)
synthesis genes##3##2##(2011-2#2)(2012-3#1)
synthesis had been##2##3##(1993-6#1)(1997-3#1)
synthesis has been##2##3##(2008-4#1)(2008-9#1)
synthesis has##8##2##(2005-8#1)(2008-2#1)(2008-4#2)(2008-9#2)(2009-8#1)(2010-12#1)
synthesis have been##4##3##(1994-9#1)(2006-2#1)(2007-11#1)(2008-10#1)
synthesis have##5##2##(1994-9#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-7#1)
synthesis in Escherichia coli##2##4##(1992-1#1)(1997-7#1)
synthesis in HepG2 cells##2##4##(1991-9#1)(1996-8#1)
synthesis in a rabbit reticulocyte##2##5##(1990-10#1)(1993-3#1)
synthesis in a##12##3##(1990-10#1)(1990-7#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-8#1)(1993-3#1)(1995-11#1)(1995-12#1)(2006-8#1)(2008-10#1)(2008-8#1)
synthesis in cells##4##3##(1990-9#1)(1995-12#1)(1997-7#1)(2010-12#1)
synthesis in cultured##3##3##(1990-9#1)(1991-2#1)(1996-11#1)
synthesis in fibroblasts##3##3##(1995-1#1)(1995-11#1)(2008-5#1)
synthesis in healthy##2##3##(2004-11#1)(2010-4#1)
synthesis in hepatocytes##3##3##(1993-3#2)(1995-8#1)
synthesis in human##7##3##(1992-5#1)(1992-9#1)(1997-1#1)(1997-2#3)(2008-9#1)
synthesis in isolated##3##3##(1991-4#1)(1994-3#1)(2012-12#1)
synthesis in mouse##3##3##(1990-4#1)(1991-2#1)(1993-11#1)
synthesis in normal##5##3##(1991-3#1)(1992-7#1)(1992-9#1)(1993-9#1)(1997-1#1)
synthesis in our##2##3##(1990-7#1)(2008-10#1)
synthesis in primary##2##3##(1990-7#1)(1992-3#1)
synthesis in rat liver##2##4##(1991-6#1)(1991-7#1)
synthesis in rat##10##3##(1990-10#2)(1990-8#1)(1991-10#1)(1991-6#1)(1991-7#1)(1992-3#1)(1993-9#1)(1994-9#1)(2010-10#1)
synthesis in response to##8##4##(1990-2#2)(1993-12#1)(1994-5#1)(1996-12#1)(1996-7#2)(2008-1#1)
synthesis in skeletal muscle##2##4##(1992-1#1)(1992-6#1)
synthesis in the heart##2##4##(1995-6#1)(2013-1#1)
synthesis in the liver##2##4##(1995-3#1)(1997-3#1)
synthesis in the presence of##3##5##(1994-5#1)(1995-11#1)(2008-3#1)
synthesis in the rat##2##4##(1991-7#1)(1993-12#1)
synthesis in the recombinant##2##4##(1994-6#1)(2008-9#1)
synthesis in the retina##2##4##(2008-5#2)
synthesis in the##42##3##(1990-12#1)(1990-2#1)(1991-5#1)(1991-7#1)(1992-4#1)(1992-9#1)(1993-12#2)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-3#2)(2005-10#1)(2005-12#1)(2006-8#3)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#3)(2008-9#1)(2009-4#1)(2009-6#1)(2011-2#1)(2013-1#1)
synthesis in these cells##2##4##(1991-10#1)(1994-11#1)
synthesis in these##5##3##(1991-10#1)(1993-11#1)(1993-9#1)(1994-11#1)(1996-8#1)
synthesis in this##3##3##(1992-9#1)(1994-8#1)(2008-10#1)
synthesis in two##2##3##(1992-7#1)(2007-11#1)
synthesis in vitro and in vivo##2##6##(2008-5#2)
synthesis in vitro by##2##4##(1992-8#1)(1994-8#1)
synthesis in vitro##8##3##(1992-8#1)(1994-7#1)(1994-8#1)(1996-2#1)(1997-5#1)(2005-8#1)(2008-5#2)
synthesis in vivo##6##3##(1992-10#1)(1992-11#1)(1995-3#1)(1997-1#2)(1997-5#1)
synthesis in yeast##2##3##(2011-1#1)(2011-2#1)
synthesis in##250##2##(1990-10#4)(1990-11#1)(1990-12#2)(1990-2#4)(1990-3#2)(1990-4#2)(1990-5#1)(1990-7#5)(1990-8#1)(1990-9#4)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#3)(1991-7#3)(1991-8#1)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#1)(1992-3#5)(1992-4#2)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#4)(1992-9#4)(1993-11#3)(1993-12#5)(1993-2#1)(1993-3#3)(1993-9#5)(1994-10#3)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#3)(1994-5#8)(1994-6#2)(1994-7#1)(1994-8#6)(1994-9#3)(1995-1#1)(1995-11#8)(1995-12#5)(1995-2#1)(1995-3#2)(1995-6#1)(1995-7#1)(1995-8#2)(1996-11#4)(1996-12#3)(1996-2#1)(1996-4#1)(1996-7#2)(1996-8#2)(1997-1#8)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#3)(1997-7#3)(1997-8#1)(2004-11#4)(2005-10#1)(2005-12#1)(2005-8#1)(2006-12#1)(2006-8#4)(2007-11#1)(2008-1#2)(2008-10#6)(2008-11#9)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#8)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#3)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
synthesis induced both by##2##4##(1991-5#1)(2008-4#1)
synthesis induced by##5##3##(1990-9#2)(1994-5#1)(1997-2#1)(2008-4#1)
synthesis induced##7##2##(1990-9#2)(1991-5#1)(1994-5#1)(1997-2#1)(2008-4#2)
synthesis inhibition##5##2##(1992-11#1)(1994-8#1)(1994-9#1)(1997-2#1)(2013-7#1)
synthesis inhibitor cycloheximide##3##3##(1993-3#1)(1995-3#1)(2013-7#1)
synthesis inhibitor##23##2##(1992-11#1)(1993-12#1)(1993-3#3)(1993-9#3)(1994-12#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-3#1)(1996-6#1)(1996-9#1)(1997-7#1)(2005-8#2)(2006-5#1)(2007-11#1)(2008-4#1)(2008-9#1)(2013-7#1)
synthesis inhibitor)##3##2##(1994-5#2)(2008-7#1)
synthesis inhibitors##15##2##(1991-1#1)(1991-2#1)(1991-5#3)(1992-5#1)(1993-5#1)(1994-11#1)(1994-9#1)(1997-2#1)(1997-7#1)(2005-7#1)(2007-11#1)(2008-11#1)(2013-7#1)
synthesis inhibitory activity##2##3##(1996-4#1)(1997-6#1)
synthesis inhibitory##4##2##(1993-4#2)(1996-4#1)(1997-6#1)
synthesis involves##4##2##(1990-6#1)(2007-11#2)(2008-10#1)
synthesis involving##2##2##(2006-12#1)(2007-12#1)
synthesis is an##2##3##(2004-11#1)(2006-12#1)
synthesis is dependent on##2##4##(2006-11#1)(2009-8#1)
synthesis is dependent##3##3##(1995-11#1)(2006-11#1)(2009-8#1)
synthesis is reported##2##3##(2006-12#1)(2007-11#1)
synthesis is required##2##3##(1995-3#1)(2011-2#1)
synthesis is the##3##3##(2008-10#1)(2010-12#1)(2010-6#1)
synthesis is##52##2##(1990-12#2)(1990-9#1)(1991-3#1)(1992-11#1)(1992-2#1)(1993-3#1)(1993-6#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-4#4)(2004-11#1)(2004-3#1)(2006-11#1)(2006-12#3)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#4)(2008-5#2)(2008-6#2)(2008-9#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-8#1)
synthesis like##2##2##(1994-6#1)(2011-1#1)
synthesis may be##3##3##(1994-2#1)(1995-5#1)(1997-1#1)
synthesis may##9##2##(1990-12#1)(1991-5#1)(1993-9#1)(1994-2#1)(1995-2#1)(1995-5#1)(1996-11#2)(1997-1#1)
synthesis method is##2##3##(2008-2#1)(2008-6#1)
synthesis method##6##2##(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-11#1)(2010-4#1)
synthesis methods##2##2##(2008-4#2)
synthesis occurs##3##2##(1990-5#1)(1991-2#1)(1992-2#1)
synthesis of 1##4##3##(1992-5#1)(1996-5#1)(2007-11#2)
synthesis of 1-deoxycastanospermine##2##3##(2007-11#2)
synthesis of 16##2##3##(2012-12#2)
synthesis of 2##6##3##(1991-12#1)(1995-2#1)(2004-3#1)(2007-11#3)
synthesis of 3##6##3##(1994-5#1)(2007-11#4)(2008-2#1)
synthesis of 5##2##3##(1996-5#1)(2007-11#1)
synthesis of 5-arylidene-2-imino-4-thiazolidinones##2##3##(2007-11#2)
synthesis of 9##3##3##(2007-11#2)(2007-12#1)
synthesis of ATP in##2##4##(1992-1#1)(1997-4#1)
synthesis of DHA##2##3##(2005-11#1)(2012-1#1)
synthesis of DNA in##2##4##(1995-8#1)(2011-2#1)
synthesis of DNA##9##3##(1990-2#1)(1994-8#1)(1995-8#1)(1996-7#1)(2008-4#4)(2011-2#1)
synthesis of LH beta##3##4##(1997-2#3)
synthesis of PI##4##3##(1991-7#4)
synthesis of RNA##2##3##(2008-4#1)(2010-12#1)
synthesis of a hippocampal##2##4##(1994-11#2)
synthesis of a model##2##4##(1990-10#1)(1994-12#1)
synthesis of a new##6##4##(1991-1#1)(2007-11#4)(2012-2#1)
synthesis of a novel##5##4##(1996-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-2#1)
synthesis of a series of##4##5##(1993-4#1)(2008-12#1)(2008-4#1)(2009-12#1)
synthesis of a variety of##2##5##(2008-4#1)(2012-2#1)
synthesis of a##69##3##(1990-10#1)(1990-3#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-8#1)(1992-11#2)(1992-3#1)(1992-4#1)(1992-6#1)(1993-4#1)(1993-6#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-2#2)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(2004-12#1)(2006-10#1)(2006-12#2)(2006-9#1)(2007-10#2)(2007-11#5)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-9#1)(2010-5#1)(2011-12#1)(2012-2#2)
synthesis of activated##2##3##(1992-11#1)(2009-10#1)
synthesis of active##3##3##(1991-7#1)(1993-5#1)(2005-1#1)
synthesis of all the##2##4##(1990-8#1)(1996-9#1)
synthesis of all##4##3##(1990-8#1)(1994-12#1)(1996-9#1)(2008-7#1)
synthesis of amino##2##3##(2008-11#1)(2008-7#1)
synthesis of an##16##3##(1991-10#1)(1992-7#1)(1995-3#1)(1996-10#1)(1996-11#1)(1996-5#1)(1997-5#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-6#1)
synthesis of angiogenic factors##2##4##(2008-1#1)(2010-9#1)
synthesis of angiotensin##2##3##(2007-1#1)(2009-10#1)
synthesis of anisotropic##2##3##(2006-12#1)(2010-4#1)
synthesis of bioactive heterocycles including natural products##2##7##(2005-8#2)
synthesis of bioactive##3##3##(2005-8#2)(2008-5#1)
synthesis of both subunits##2##4##(1996-2#2)
synthesis of both##8##3##(1990-11#1)(1992-5#1)(1996-2#2)(2006-12#1)(2007-12#1)(2008-5#1)(2010-3#1)
synthesis of branched##2##3##(2008-4#2)
synthesis of chiral##5##3##(1992-11#1)(2007-11#2)(2007-12#1)(2009-10#1)
synthesis of cholesterol##6##3##(1991-2#1)(1993-9#1)(1994-8#1)(2006-2#1)(2008-3#1)(2008-5#1)
synthesis of cinnamic##2##3##(2007-11#1)(2008-5#1)
synthesis of clinical##3##3##(1996-8#1)(2013-1#2)
synthesis of collagen##3##3##(2007-11#1)(2008-10#1)(2008-5#1)
synthesis of cyclooxygenase##3##3##(1994-9#3)
synthesis of cys-tRNA(Cys)##2##3##(2006-12#2)
synthesis of di- and##2##4##(2007-11#1)(2008-4#1)
synthesis of endomorphin-2##2##3##(2013-1#2)
synthesis of ethylene##2##3##(2008-10#1)(2009-8#1)
synthesis of extracellular##2##3##(1997-5#1)(2008-9#1)
synthesis of gold##2##3##(2010-4#1)(2013-1#1)
synthesis of highly sulfated##2##4##(2008-9#2)
synthesis of highly##5##3##(2006-12#1)(2008-9#2)(2009-10#1)(2009-2#1)
synthesis of hybrid##3##3##(1990-5#1)(1991-4#1)(1991-5#1)
synthesis of large quantities of##2##5##(1991-10#1)(1997-4#1)
synthesis of large##5##3##(1991-10#1)(1997-4#1)(2007-11#1)(2008-4#1)(2010-12#1)
synthesis of long##2##3##(1994-8#1)(1997-5#1)
synthesis of melatonin##2##3##(1995-11#1)(1995-3#1)
synthesis of modified##4##3##(2006-12#1)(2008-2#1)(2008-4#1)(2012-2#1)
synthesis of nascent##2##3##(2008-10#1)(2008-9#1)
synthesis of natural products and##2##5##(2009-10#1)(2010-12#1)
synthesis of natural products##3##4##(2009-10#1)(2010-12#2)
synthesis of natural##5##3##(1992-11#2)(2009-10#1)(2010-12#2)
synthesis of new##18##3##(1992-2#1)(1992-6#1)(1992-7#1)(1996-2#1)(2005-10#1)(2006-12#1)(2006-4#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#3)(2010-4#1)(2010-5#1)
synthesis of nitric oxide (NO)##2##5##(1992-12#1)(2011-1#1)
synthesis of nitric oxide##4##4##(1992-12#1)(1994-7#1)(1996-11#1)(2011-1#1)
synthesis of novel##6##3##(1992-9#1)(2007-11#2)(2009-9#1)(2010-12#1)(2011-2#1)
synthesis of nucleic acid##2##4##(2008-10#1)(2008-4#1)
synthesis of oligodeoxyribonucleotides##3##3##(2008-4#3)
synthesis of oligonucleotide##2##3##(1995-7#1)(2008-10#1)
synthesis of oligonucleotides##2##3##(2008-4#2)
synthesis of oligosaccharide-lipid##2##3##(1991-1#2)
synthesis of osteocalcin##3##3##(1990-2#2)(1994-2#1)
synthesis of other##6##3##(1992-6#1)(1994-11#1)(2006-12#1)(2007-11#1)(2008-7#1)(2009-8#1)
synthesis of p58-M2 was##2##4##(1992-11#2)
synthesis of p58-M2##8##3##(1992-11#8)
synthesis of phosphatidylcholine##2##3##(1992-4#1)(1993-9#1)
synthesis of phosphatidylinositol##3##3##(1992-6#1)(1997-1#1)(1997-8#1)
synthesis of phosphoramidite##2##3##(2008-4#2)
synthesis of polysubstituted##2##3##(2007-11#1)(2008-3#1)
synthesis of prostaglandin E2 (PGE2)##2##5##(1990-2#1)(2007-11#1)
synthesis of prostaglandin E2##3##4##(1990-2#1)(1994-12#1)(2007-11#1)
synthesis of prostaglandins in the central nervous system##2##8##(2006-10#2)
synthesis of prostaglandins##4##3##(1997-1#1)(2006-10#3)
synthesis of prostanoids##3##3##(1992-8#3)
synthesis of protein##3##3##(1993-12#1)(1993-5#1)(1995-6#1)
synthesis of proteins##5##3##(1990-7#1)(1991-9#1)(1995-7#1)(1997-2#1)(2006-5#1)
synthesis of radiolabeled##2##3##(2008-4#2)
synthesis of ribose##2##3##(1995-8#2)
synthesis of salinosporamide A##2##4##(2010-7#2)
synthesis of several##15##3##(1991-4#1)(1991-9#1)(1992-8#1)(1993-8#1)(1995-11#1)(1997-8#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-11#3)(2008-11#1)(2008-4#1)(2010-12#1)
synthesis of sex##2##3##(2008-11#1)(2009-7#1)
synthesis of soluble##2##3##(2006-12#1)(2010-9#1)
synthesis of some new##2##4##(2007-11#2)
synthesis of some##11##3##(1992-7#1)(1994-9#1)(1996-5#1)(2007-11#4)(2008-10#1)(2008-4#1)(2008-5#2)
synthesis of specific##2##3##(2004-2#1)(2008-11#1)
synthesis of substituted##4##3##(2007-10#1)(2007-11#2)(2009-3#1)
synthesis of sulfated##2##3##(1993-12#1)(1995-4#1)
synthesis of the corresponding##6##4##(1990-11#1)(1993-5#1)(1995-2#1)(2007-11#2)(2010-5#1)
synthesis of the cortistatin core##2##5##(2009-11#2)
synthesis of the first##2##4##(1994-8#1)(2008-1#1)
synthesis of the fungal##2##4##(2007-11#1)(2008-7#1)
synthesis of the major##2##4##(1992-8#1)(1995-1#1)
synthesis of the novel##2##4##(1996-2#1)(2008-3#1)
synthesis of the protein##2##4##(1994-11#1)(2008-11#1)
synthesis of the title##2##4##(1997-4#1)(2007-10#1)
synthesis of the##104##3##(1990-11#4)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-10#3)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-9#2)(1992-12#2)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-6#2)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-10#2)(2007-11#9)(2007-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-11#4)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-6#1)(2011-1#3)(2012-1#1)(2013-8#1)
synthesis of these compounds##2##4##(1994-9#1)(2007-12#1)
synthesis of these##8##3##(1990-5#1)(1991-10#1)(1993-12#1)(1994-10#1)(1994-9#1)(2007-12#1)(2008-12#1)(2011-2#1)
synthesis of this##4##3##(1993-3#1)(1994-11#1)(2006-12#1)(2008-10#1)
synthesis of those##2##3##(1995-7#1)(2008-7#1)
synthesis of three##5##3##(1995-3#1)(1997-5#1)(2005-11#1)(2007-10#1)(2009-9#1)
synthesis of three-dimensional##2##3##(2007-12#2)
synthesis of tricycloillicinone##2##3##(2009-11#2)
synthesis of two##4##3##(1993-4#1)(1994-8#1)(2007-10#1)(2009-2#1)
synthesis of##1074##2##(1990-10#1)(1990-11#9)(1990-12#2)(1990-2#9)(1990-3#3)(1990-4#3)(1990-5#11)(1990-7#7)(1990-8#6)(1990-9#2)(1991-1#5)(1991-10#10)(1991-11#3)(1991-12#5)(1991-2#4)(1991-3#5)(1991-4#4)(1991-5#3)(1991-6#3)(1991-7#7)(1991-8#6)(1991-9#10)(1992-1#5)(1992-11#16)(1992-12#8)(1992-2#3)(1992-3#5)(1992-4#2)(1992-5#2)(1992-6#9)(1992-7#6)(1992-8#8)(1992-9#9)(1993-1#1)(1993-11#3)(1993-12#6)(1993-2#1)(1993-3#3)(1993-4#4)(1993-5#3)(1993-6#7)(1993-7#1)(1993-8#4)(1993-9#6)(1994-10#2)(1994-11#8)(1994-12#8)(1994-2#4)(1994-3#7)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#7)(1994-9#7)(1995-1#2)(1995-11#5)(1995-12#2)(1995-2#6)(1995-3#17)(1995-4#4)(1995-6#5)(1995-7#4)(1995-8#9)(1996-10#1)(1996-11#4)(1996-12#3)(1996-2#8)(1996-4#5)(1996-5#16)(1996-6#1)(1996-7#5)(1996-8#6)(1996-9#2)(1997-1#6)(1997-2#10)(1997-3#5)(1997-4#9)(1997-5#5)(1997-6#2)(1997-7#2)(1997-8#4)(2004-11#1)(2004-12#1)(2004-2#1)(2004-3#1)(2004-9#3)(2005-1#1)(2005-10#2)(2005-11#10)(2005-12#1)(2005-7#1)(2005-8#10)(2006-1#1)(2006-10#9)(2006-12#34)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#1)(2006-7#1)(2006-9#3)(2007-1#1)(2007-10#15)(2007-11#105)(2007-12#12)(2007-3#1)(2007-5#1)(2007-6#3)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#7)(2008-10#39)(2008-11#13)(2008-12#6)(2008-2#12)(2008-3#13)(2008-4#66)(2008-5#32)(2008-6#13)(2008-7#16)(2008-8#8)(2008-9#12)(2009-10#10)(2009-11#8)(2009-12#4)(2009-2#5)(2009-3#5)(2009-4#1)(2009-5#4)(2009-6#3)(2009-7#6)(2009-8#6)(2009-9#7)(2010-10#1)(2010-11#3)(2010-12#12)(2010-2#5)(2010-3#1)(2010-4#8)(2010-5#5)(2010-6#7)(2010-7#5)(2010-9#2)(2011-1#10)(2011-12#1)(2011-2#13)(2011-3#2)(2012-1#4)(2012-11#4)(2012-12#5)(2012-2#11)(2012-3#7)(2012-7#2)(2013-1#11)(2013-7#2)(2013-8#3)
synthesis on a##2##3##(1996-9#2)
synthesis on the##2##3##(1995-4#1)(2010-12#1)
synthesis on##9##2##(1991-1#1)(1991-7#2)(1994-3#1)(1995-1#1)(1995-4#1)(1996-9#2)(2010-12#1)
synthesis or a##2##3##(1993-8#1)(2008-7#1)
synthesis or##16##2##(1990-12#1)(1990-5#1)(1993-8#1)(1994-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-4#1)(1997-7#1)(2005-11#1)(2006-12#1)(2006-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-2#1)
synthesis per##2##2##(1991-2#1)(2004-11#1)
synthesis procedure##2##2##(2008-10#1)(2010-12#1)
synthesis proceeds via##2##3##(1997-2#1)(2011-1#1)
synthesis proceeds##3##2##(1997-2#1)(2009-7#1)(2011-1#1)
synthesis process##6##2##(2008-10#4)(2008-6#1)(2011-2#1)
synthesis rate##7##2##(1991-4#1)(1992-8#1)(1994-5#1)(1995-12#1)(1996-3#1)(1997-4#1)(2007-3#1)
synthesis rates##8##2##(1991-2#1)(1991-6#3)(1996-3#3)(2006-5#1)
synthesis reaction##2##2##(1997-2#1)(2008-5#1)
synthesis reactions##5##2##(1990-4#1)(1994-12#1)(1995-3#1)(2007-11#1)(2008-6#1)
synthesis regulation##2##2##(2004-11#1)(2012-3#1)
synthesis requires##3##2##(1990-8#1)(2008-7#1)(2010-12#1)
synthesis results##2##2##(1995-2#1)(1996-2#1)
synthesis seen##2##2##(1990-9#1)(1995-6#1)
synthesis studies##2##2##(1994-8#1)(2008-9#1)
synthesis such as##2##3##(2004-11#1)(2011-1#1)
synthesis suggests##2##2##(1990-6#1)(1993-6#1)
synthesis suppression##2##2##(2010-2#1)(2013-1#1)
synthesis system##2##2##(1995-6#1)(2011-2#1)
synthesis technique##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
synthesis techniques##4##2##(1995-7#1)(2008-2#1)(2008-3#1)(2008-4#1)
synthesis technology##2##2##(2006-10#1)(2011-1#1)
synthesis temperature##2##2##(2008-10#1)(2010-2#1)
synthesis than##2##2##(1995-3#1)(2008-5#1)
synthesis that may##2##3##(1993-9#1)(2006-12#1)
synthesis that##5##2##(1992-3#1)(1993-9#1)(1995-3#1)(1997-7#1)(2006-12#1)
synthesis the##2##2##(1991-7#1)(2008-5#1)
synthesis through##5##2##(1993-4#1)(1994-11#1)(1994-8#1)(1997-8#1)(2006-10#1)
synthesis to a##4##3##(1992-8#1)(1994-12#1)(1997-4#1)(2008-5#1)
synthesis to the##2##3##(1994-9#1)(2008-4#1)
synthesis to##16##2##(1991-12#1)(1992-8#1)(1994-12#1)(1994-8#1)(1994-9#1)(1996-5#1)(1996-6#1)(1997-4#2)(1997-5#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-7#1)
synthesis under##2##2##(2007-9#1)(2010-5#1)
synthesis upon##2##2##(2008-7#1)(2010-12#1)
synthesis using##9##2##(1994-3#1)(1995-7#1)(2007-11#1)(2007-12#1)(2008-4#4)(2008-6#1)
synthesis via the##2##3##(1991-2#1)(1997-1#1)
synthesis via##7##2##(1991-2#1)(1991-9#1)(1992-10#1)(1995-1#1)(1997-1#1)(2008-3#1)(2011-1#1)
synthesis was also##3##3##(1990-7#1)(2008-4#1)(2008-5#1)
synthesis was developed##2##3##(2008-4#1)(2012-3#1)
synthesis was induced in##2##4##(1990-10#1)(2008-10#1)
synthesis was induced##5##3##(1990-10#1)(1993-9#1)(1994-6#1)(1996-1#1)(2008-10#1)
synthesis was inhibited by##3##4##(1993-12#1)(1993-6#1)(1995-3#1)
synthesis was inhibited##6##3##(1990-10#1)(1993-12#1)(1993-6#1)(1994-11#1)(1995-3#1)(2008-2#1)
synthesis was initiated##2##3##(1990-5#1)(1994-12#1)
synthesis was investigated in the##2##5##(1991-2#1)(2008-7#1)
synthesis was investigated##3##3##(1991-2#1)(1997-1#1)(2008-7#1)
synthesis was measured##3##3##(1990-3#1)(1991-2#1)(2004-11#1)
synthesis was not inhibited##2##4##(1992-9#1)(1996-12#1)
synthesis was not##5##3##(1992-9#1)(1994-12#1)(1994-8#1)(1996-12#1)(1996-8#1)
synthesis was observed##2##3##(1994-8#1)(1996-10#1)
synthesis was performed##2##3##(1997-2#1)(2012-11#1)
synthesis was significantly##3##3##(1992-1#1)(1993-9#1)(1994-2#1)
synthesis was##74##2##(1990-10#3)(1990-11#1)(1990-3#2)(1990-5#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#2)(1992-1#1)(1992-11#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#3)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-12#2)(1995-3#2)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#3)(1997-4#1)(1997-7#1)(2004-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#1)(2010-11#1)(2010-8#1)(2012-11#1)(2012-3#1)
synthesis were examined##2##3##(1991-9#1)(1996-11#1)
synthesis were studied in##4##4##(1994-12#1)(1994-2#1)(2008-11#2)
synthesis were studied##5##3##(1991-2#1)(1994-12#1)(1994-2#1)(2008-11#2)
synthesis were##13##2##(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-9#1)(1994-12#1)(1994-2#1)(1996-11#1)(1996-12#1)(2008-11#2)(2012-12#1)(2013-1#1)
synthesis when compared to##2##4##(2006-11#1)(2009-11#1)
synthesis when##6##2##(1995-11#1)(1996-8#1)(1997-2#1)(2006-11#1)(2009-11#1)(2010-10#1)
synthesis which##4##2##(1990-4#1)(1990-5#1)(1996-8#1)(2009-8#1)
synthesis while##2##2##(1990-12#1)(2008-5#1)
synthesis with the##2##3##(1990-5#1)(1991-12#1)
synthesis with##12##2##(1990-5#2)(1991-12#1)(1991-5#1)(1992-7#1)(1993-9#1)(1994-3#1)(1994-8#1)(2007-11#1)(2009-5#1)(2009-8#1)(2012-2#1)
synthesis without##5##2##(2008-4#4)(2008-9#1)
synthesis##3219##1##(1990-10#14)(1990-11#25)(1990-12#16)(1990-2#24)(1990-3#12)(1990-4#12)(1990-5#32)(1990-6#3)(1990-7#26)(1990-8#16)(1990-9#22)(1991-1#23)(1991-10#18)(1991-11#8)(1991-12#20)(1991-2#31)(1991-3#12)(1991-4#13)(1991-5#20)(1991-6#26)(1991-7#26)(1991-8#13)(1991-9#19)(1992-1#13)(1992-10#5)(1992-11#36)(1992-12#15)(1992-2#8)(1992-3#25)(1992-4#8)(1992-5#11)(1992-6#22)(1992-7#13)(1992-8#26)(1992-9#29)(1993-1#1)(1993-11#17)(1993-12#32)(1993-2#3)(1993-3#15)(1993-4#14)(1993-5#6)(1993-6#24)(1993-7#1)(1993-8#16)(1993-9#31)(1994-10#12)(1994-11#26)(1994-12#39)(1994-2#26)(1994-3#24)(1994-5#27)(1994-6#19)(1994-7#3)(1994-8#44)(1994-9#36)(1995-1#9)(1995-10#6)(1995-11#38)(1995-12#24)(1995-2#26)(1995-3#49)(1995-4#7)(1995-5#14)(1995-6#25)(1995-7#10)(1995-8#18)(1995-9#1)(1996-1#2)(1996-10#9)(1996-11#17)(1996-12#12)(1996-2#26)(1996-3#6)(1996-4#10)(1996-5#31)(1996-6#8)(1996-7#14)(1996-8#31)(1996-9#13)(1997-1#31)(1997-2#41)(1997-3#13)(1997-4#46)(1997-5#15)(1997-6#8)(1997-7#20)(1997-8#14)(2004-11#17)(2004-12#1)(2004-2#1)(2004-3#2)(2004-8#1)(2004-9#6)(2005-1#2)(2005-10#6)(2005-11#16)(2005-12#3)(2005-4#1)(2005-6#1)(2005-7#6)(2005-8#19)(2006-1#3)(2006-10#15)(2006-11#6)(2006-12#68)(2006-2#3)(2006-3#2)(2006-4#1)(2006-5#8)(2006-7#3)(2006-8#9)(2006-9#3)(2007-1#3)(2007-10#18)(2007-11#143)(2007-12#27)(2007-2#2)(2007-3#3)(2007-4#1)(2007-5#3)(2007-6#5)(2007-7#2)(2007-8#9)(2007-9#6)(2008-1#19)(2008-10#120)(2008-11#57)(2008-12#8)(2008-2#29)(2008-3#38)(2008-4#154)(2008-5#95)(2008-6#30)(2008-7#52)(2008-8#20)(2008-9#33)(2009-1#1)(2009-10#15)(2009-11#15)(2009-12#10)(2009-2#9)(2009-3#10)(2009-4#8)(2009-5#8)(2009-6#6)(2009-7#9)(2009-8#22)(2009-9#12)(2010-1#1)(2010-10#7)(2010-11#7)(2010-12#45)(2010-2#13)(2010-3#2)(2010-4#21)(2010-5#13)(2010-6#13)(2010-7#9)(2010-8#7)(2010-9#4)(2011-1#38)(2011-12#5)(2011-2#39)(2011-3#3)(2012-1#7)(2012-11#7)(2012-12#13)(2012-2#35)(2012-3#19)(2012-7#2)(2013-1#29)(2013-7#12)(2013-8#11)
synthesis(0##2##1##(2005-6#2)
synthesis) and##3##2##(1991-12#2)(2004-11#1)
synthesis)##10##1##(1990-12#1)(1991-12#2)(1994-8#1)(1995-12#1)(1997-4#1)(2004-11#2)(2010-2#1)(2012-4#1)
synthesise##12##1##(1992-11#1)(1994-10#1)(1995-6#1)(1997-1#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-4#1)(2010-12#1)(2012-12#2)
synthesised and tested for their##2##5##(2006-9#1)(2011-2#1)
synthesised and tested##3##3##(2006-9#1)(2008-10#1)(2011-2#1)
synthesised and##8##2##(1990-2#1)(1997-3#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-4#2)(2011-2#1)
synthesised as##2##2##(1995-1#1)(2011-1#1)
synthesised by the##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
synthesised by##7##2##(1991-5#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2013-7#1)
synthesised for##3##2##(2008-10#2)(2008-5#1)
synthesised from##4##2##(2006-12#1)(2008-10#1)(2008-5#1)(2012-12#1)
synthesised in our##2##3##(2008-10#2)
synthesised in##6##2##(1991-3#1)(1992-8#1)(1996-8#1)(2008-10#2)(2008-5#1)
synthesised##55##1##(1990-11#1)(1990-2#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#3)(1992-3#2)(1992-8#1)(1993-6#1)(1995-1#1)(1996-8#1)(1997-3#1)(2005-7#1)(2006-12#1)(2006-9#1)(2007-11#2)(2008-10#12)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#9)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)
synthesize IGF-I##2##2##(1994-2#1)(1996-2#1)
synthesize a##14##2##(1990-3#1)(1990-7#1)(1991-2#1)(1991-7#1)(1992-5#1)(1993-3#1)(1993-4#1)(2006-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-3#1)(2010-2#1)(2011-2#1)
synthesize and secrete reelin in##2##5##(2009-8#2)
synthesize and secrete##10##3##(1991-8#1)(1993-3#1)(1994-5#1)(1994-6#1)(1996-2#1)(1997-8#1)(2008-7#1)(2009-8#2)(2013-1#1)
synthesize and##23##2##(1991-4#1)(1991-8#2)(1993-3#1)(1994-5#1)(1994-6#1)(1995-6#1)(1996-2#1)(1997-8#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-8#2)(2010-4#1)(2012-1#1)(2012-11#2)(2013-1#1)(2013-8#1)
synthesize both##3##2##(1991-9#1)(1992-8#1)(2012-12#1)
synthesize cDNA##2##2##(2008-9#1)(2011-2#1)
synthesize several##2##2##(1997-2#1)(2008-7#1)
synthesize the##16##2##(1990-5#1)(1992-11#1)(1993-3#1)(1996-6#1)(1997-5#1)(2006-12#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-1#1)(2009-10#1)(2010-2#1)(2011-1#1)
synthesize##164##1##(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#3)(1990-7#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#3)(1992-11#1)(1992-12#4)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#5)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#2)(1995-7#2)(1996-1#1)(1996-11#1)(1996-2#3)(1996-6#1)(1997-1#2)(1997-2#2)(1997-5#1)(1997-6#1)(1997-8#1)(2005-4#1)(2006-11#1)(2006-12#3)(2006-5#1)(2006-8#1)(2007-11#5)(2007-12#3)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#5)(2008-5#4)(2008-6#7)(2008-7#5)(2008-8#1)(2008-9#5)(2009-1#1)(2009-10#2)(2009-3#2)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#3)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
synthesized 9##2##2##(2008-10#1)(2008-5#1)
synthesized ATP##2##2##(1992-1#2)
synthesized DNA##5##2##(1995-2#1)(1996-5#1)(1996-6#2)(2012-2#1)
synthesized GM3 and##2##3##(1994-3#1)(1995-1#1)
synthesized GlcCer##3##2##(1994-3#3)
synthesized HA##2##2##(2004-9#2)
synthesized PI is##2##3##(1991-7#2)
synthesized PI##3##2##(1991-7#3)
synthesized RNA hairpin##2##3##(1994-8#2)
synthesized RNA##6##2##(1993-3#1)(1994-8#2)(1995-1#1)(1996-9#1)(2006-12#1)
synthesized a series of##5##4##(1993-6#1)(1994-9#1)(1995-10#1)(2007-11#1)(2012-2#1)
synthesized a##18##2##(1992-10#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-10#2)(1995-11#1)(1995-2#1)(1996-1#1)(1996-8#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-4#1)(2010-6#1)(2012-2#1)
synthesized analogs##2##2##(1992-11#1)(2009-2#1)
synthesized and characterized by elemental analysis##4##6##(1996-2#1)(2007-8#1)(2008-3#2)
synthesized and characterized by single crystal X-ray##2##7##(2007-11#1)(2008-5#1)
synthesized and characterized by spectroscopic and electrochemical##2##7##(1996-2#1)(2008-5#1)
synthesized and characterized by spectroscopy and##2##6##(2008-4#1)(2008-5#1)
synthesized and characterized by standard##2##5##(2008-5#2)
synthesized and characterized by##23##4##(1996-2#3)(1997-7#1)(2005-11#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#9)(2010-5#1)(2011-1#1)
synthesized and characterized with##3##4##(1995-3#1)(2008-10#1)(2008-5#1)
synthesized and characterized##44##3##(1993-8#1)(1994-8#1)(1995-3#2)(1996-2#3)(1997-7#1)(2005-11#1)(2005-4#1)(2007-11#2)(2007-8#2)(2008-10#6)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#15)(2009-3#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#1)
synthesized and employed as##3##4##(2010-7#1)(2012-11#2)
synthesized and evaluated against##2##4##(1992-5#1)(2009-3#1)
synthesized and evaluated as potential##2##5##(1993-4#1)(1995-3#1)
synthesized and evaluated as##9##4##(1992-3#1)(1993-1#1)(1993-4#1)(1994-9#2)(1995-3#1)(1997-2#1)(2008-10#1)(2010-6#1)
synthesized and evaluated for##8##4##(1992-12#1)(1992-5#1)(1996-8#1)(1997-1#2)(2007-11#1)(2007-2#1)(2012-1#1)
synthesized and evaluated in vitro for##2##6##(1997-2#1)(2007-11#1)
synthesized and evaluated in vitro##3##5##(1997-2#1)(2006-12#1)(2007-11#1)
synthesized and evaluated in##5##4##(1995-3#1)(1997-2#1)(2006-12#2)(2007-11#1)
synthesized and evaluated##25##3##(1992-12#1)(1992-3#1)(1992-5#2)(1993-1#1)(1993-4#1)(1994-9#2)(1995-3#2)(1996-8#1)(1997-1#2)(1997-2#2)(2006-12#2)(2007-11#3)(2007-2#1)(2008-10#1)(2009-3#1)(2010-6#1)(2012-1#1)
synthesized and examined for##4##4##(1991-4#1)(1994-8#1)(1996-8#1)(2009-7#1)
synthesized and examined##5##3##(1991-4#1)(1994-8#1)(1996-8#1)(2008-10#1)(2009-7#1)
synthesized and found to be##2##5##(1991-4#1)(1992-8#1)
synthesized and found to##3##4##(1991-4#1)(1992-1#1)(1992-8#1)
synthesized and incorporated##2##3##(1996-7#1)(2005-11#1)
synthesized and investigated##7##3##(1993-4#1)(1994-11#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-2#1)
synthesized and its##7##3##(1997-7#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#3)
synthesized and released##2##3##(1992-6#1)(2009-10#1)
synthesized and secreted by##6##4##(1990-11#1)(1993-3#1)(1993-8#1)(1996-2#1)(2008-1#1)(2009-6#1)
synthesized and secreted##10##3##(1990-11#1)(1991-2#1)(1991-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1996-2#1)(2008-1#1)(2009-3#1)(2009-6#1)
synthesized and shown to##2##4##(1991-12#1)(2010-6#1)
synthesized and studied as##2##4##(1991-2#1)(1992-8#1)
synthesized and studied##6##3##(1991-2#1)(1992-8#1)(1995-3#1)(1997-6#1)(2008-10#1)(2013-7#1)
synthesized and tested as inhibitors of##2##6##(1990-7#1)(1992-8#1)
synthesized and tested as##4##4##(1990-7#1)(1992-8#1)(1997-8#1)(2008-11#1)
synthesized and tested for##7##4##(1992-5#1)(1993-3#1)(1995-1#1)(1996-5#1)(1996-8#1)(1997-2#1)(2010-2#1)
synthesized and tested in##2##4##(2008-8#1)(2011-2#1)
synthesized and tested##15##3##(1990-7#1)(1992-5#1)(1992-8#1)(1993-3#1)(1995-1#1)(1996-5#1)(1996-8#2)(1997-2#1)(1997-8#1)(2008-11#1)(2008-8#1)(2010-2#1)(2010-4#1)(2011-2#1)
synthesized and the##6##3##(1992-7#1)(1992-8#1)(2007-11#1)(2008-10#2)(2012-2#1)
synthesized and their conformational preferences##2##5##(1993-6#2)
synthesized and their spectral##2##4##(2007-8#1)(2008-10#1)
synthesized and their##17##3##(1990-2#1)(1990-6#1)(1991-7#1)(1993-11#1)(1993-6#2)(1994-9#1)(1995-2#1)(1995-7#1)(2005-11#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-4#1)
synthesized and thoroughly characterized##2##4##(2013-1#2)
synthesized and used as##4##4##(2007-8#1)(2008-10#3)
synthesized and used for the##2##5##(1990-2#1)(2008-10#1)
synthesized and used for##3##4##(1990-2#1)(1996-7#1)(2008-10#1)
synthesized and used in the##2##5##(2007-11#1)(2008-10#1)
synthesized and used to##3##4##(1991-6#1)(1991-8#1)(2008-10#1)
synthesized and used##12##3##(1990-2#1)(1991-6#1)(1991-8#1)(1996-7#1)(2007-11#1)(2007-8#1)(2008-10#6)
synthesized and##214##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-6#1)(1990-7#1)(1991-1#2)(1991-12#2)(1991-2#2)(1991-4#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#3)(1992-6#2)(1992-7#1)(1992-8#4)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#3)(1994-8#3)(1994-9#3)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#6)(1995-7#1)(1995-8#1)(1996-2#6)(1996-5#1)(1996-7#2)(1996-8#5)(1997-1#2)(1997-2#4)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#3)(2005-11#7)(2005-4#1)(2005-7#1)(2006-12#3)(2007-11#11)(2007-2#1)(2007-8#6)(2008-1#1)(2008-10#27)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#16)(2008-6#1)(2008-8#3)(2009-10#1)(2009-2#1)(2009-3#4)(2009-6#1)(2009-7#1)(2009-9#2)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#3)(2012-12#2)(2012-2#1)(2013-1#4)(2013-7#1)
synthesized antimicrobial##2##2##(2008-1#2)
synthesized as a precursor##5##4##(1990-8#1)(1991-2#1)(1994-12#2)(1995-8#1)
synthesized as a##19##3##(1990-12#2)(1990-5#1)(1990-8#1)(1991-11#2)(1991-2#1)(1991-3#1)(1992-11#1)(1993-3#1)(1994-12#3)(1994-9#1)(1995-8#1)(1996-2#1)(2008-10#2)(2012-12#1)
synthesized as models for##2##4##(2007-11#1)(2010-5#1)
synthesized as##40##2##(1990-12#2)(1990-5#1)(1990-8#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-5#1)(1992-11#1)(1993-3#1)(1994-12#4)(1994-9#2)(1995-1#1)(1995-6#1)(1995-8#2)(1996-2#1)(1996-5#1)(1996-8#1)(1997-6#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)(2010-3#1)(2010-5#2)(2011-1#1)(2012-12#1)(2013-8#1)
synthesized at a##4##3##(1993-6#1)(1994-12#1)(2007-3#1)(2008-10#1)
synthesized at the##4##3##(2008-10#1)(2008-12#1)(2013-1#2)
synthesized at##16##2##(1991-11#1)(1991-7#1)(1993-6#1)(1994-12#2)(2004-9#1)(2006-12#1)(2007-3#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2013-1#2)
synthesized biotin##2##2##(2006-10#1)(2008-10#1)
synthesized brood food proteins##2##4##(2008-6#2)
synthesized by a simple##2##4##(2006-12#1)(2013-8#1)
synthesized by a##15##3##(1991-5#1)(1992-3#1)(1997-2#1)(2004-9#1)(2005-11#1)(2006-12#1)(2008-10#4)(2010-3#1)(2010-4#1)(2010-7#1)(2013-8#2)
synthesized by addition of##2##4##(2006-4#1)(2007-11#1)
synthesized by automated solid-phase##2##4##(1992-6#2)
synthesized by coupling##4##3##(2007-11#1)(2008-10#1)(2009-11#1)(2011-2#1)
synthesized by means of the beta-lactam synthon method##2##8##(1997-1#2)
synthesized by nitric oxide##3##4##(1993-9#1)(2009-10#2)
synthesized by osteoblasts##2##3##(1997-1#2)
synthesized by reacting##6##3##(1994-2#1)(1995-3#1)(2007-10#1)(2007-11#1)(2008-5#1)(2010-12#1)
synthesized by solid-phase##4##3##(1990-12#1)(1992-3#1)(2005-8#1)(2008-9#1)
synthesized by standard##2##3##(1993-6#1)(2008-5#1)
synthesized by suspension polymerization##2##4##(2008-10#2)
synthesized by the reaction of##6##5##(2005-4#1)(2008-5#2)(2009-3#1)(2011-1#1)(2012-11#1)
synthesized by the solution procedure##2##5##(1990-7#1)(1992-6#1)
synthesized by the##33##3##(1990-7#2)(1991-2#1)(1991-4#1)(1991-5#1)(1992-12#1)(1992-6#1)(1994-12#1)(1994-9#2)(1995-2#1)(1996-2#1)(1996-8#1)(2005-4#1)(2005-7#1)(2007-12#2)(2008-10#4)(2008-3#2)(2008-5#4)(2008-6#1)(2009-12#1)(2009-3#1)(2010-10#1)(2011-1#1)(2012-11#1)
synthesized by this##2##3##(1990-9#1)(2005-8#1)
synthesized by us##3##3##(1991-12#1)(1995-3#1)(1996-4#1)
synthesized by using##4##3##(1991-3#1)(2008-10#3)
synthesized by##174##2##(1990-12#1)(1990-2#2)(1990-7#2)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-6#3)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#4)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#4)(1995-5#1)(1996-2#1)(1996-4#2)(1996-6#1)(1996-8#1)(1997-1#5)(1997-2#1)(2004-9#2)(2005-11#4)(2005-4#1)(2005-7#1)(2005-8#3)(2006-12#3)(2006-4#1)(2007-1#1)(2007-10#4)(2007-11#8)(2007-12#2)(2007-8#1)(2008-10#24)(2008-11#2)(2008-3#4)(2008-4#5)(2008-5#8)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-11#2)(2012-3#1)(2013-1#2)(2013-8#3)
synthesized cell wall materials##2##4##(2008-10#2)
synthesized chemically and##2##3##(1992-12#1)(2008-8#1)
synthesized chemically##3##2##(1992-12#1)(1994-8#1)(2008-8#1)
synthesized collagen##4##2##(2013-8#4)
synthesized complexes##2##2##(2008-5#2)
synthesized compound##3##2##(2006-12#1)(2012-11#1)(2013-1#1)
synthesized compounds have been tested##2##5##(2007-11#1)(2010-2#1)
synthesized compounds have been##4##4##(2007-11#1)(2008-6#1)(2010-2#1)(2012-2#1)
synthesized compounds have##5##3##(2007-11#1)(2008-6#1)(2010-2#1)(2012-2#1)(2012-3#1)
synthesized compounds was##4##3##(2007-9#1)(2008-5#2)(2012-11#1)
synthesized compounds were confirmed by elemental analyses##3##7##(2007-11#3)
synthesized compounds were confirmed by##4##5##(2007-11#4)
synthesized compounds were screened for##2##5##(2007-11#1)(2010-5#1)
synthesized compounds were##16##3##(2007-11#9)(2008-11#1)(2008-4#1)(2008-5#2)(2010-3#1)(2010-5#1)(2013-7#1)
synthesized compounds##37##2##(1994-12#1)(1995-6#1)(2007-10#1)(2007-11#11)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#5)(2008-6#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-5#1)(2011-2#1)(2012-11#2)(2012-2#2)(2012-3#1)(2013-7#1)
synthesized data##5##2##(2008-2#5)
synthesized derivatives##2##2##(2007-11#1)(2008-5#1)
synthesized directly##2##2##(2010-12#1)(2011-3#1)
synthesized during##2##2##(2007-8#1)(2010-2#1)
synthesized for the##5##3##(1996-5#1)(2006-12#1)(2008-3#2)(2008-6#1)
synthesized for##14##2##(1993-4#1)(1995-2#1)(1996-5#1)(2005-11#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-3#3)(2008-6#1)(2012-12#1)
synthesized from a##5##3##(1993-11#1)(2005-11#1)(2007-12#1)(2008-4#1)(2008-9#1)
synthesized from an##2##3##(2008-10#2)
synthesized from glutamate##2##3##(1995-3#1)(1997-6#1)
synthesized from the corresponding##3##4##(1997-2#2)(2006-12#1)
synthesized from the##11##3##(1996-10#1)(1996-5#1)(1997-2#3)(2006-12#1)(2006-9#1)(2008-4#1)(2008-5#1)(2008-6#1)(2012-11#1)
synthesized from##60##2##(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-6#1)(1991-7#2)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-3#1)(1995-4#1)(1996-10#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-2#3)(1997-6#1)(1997-8#2)(2005-11#3)(2006-12#2)(2006-2#1)(2006-3#1)(2006-9#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#2)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-11#3)(2012-2#1)
synthesized in E##5##3##(1990-11#1)(1991-1#1)(1997-2#2)(2008-11#1)
synthesized in Escherichia coli##4##4##(1992-6#1)(1993-12#1)(1994-3#1)(1995-3#1)
synthesized in a##10##3##(1990-3#1)(1990-8#1)(1994-5#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-3#1)(2005-4#1)(2009-10#1)(2010-7#1)
synthesized in an##2##3##(2005-11#1)(2008-6#1)
synthesized in good##4##3##(1991-9#1)(2007-11#1)(2008-12#1)(2008-3#1)
synthesized in large##2##3##(1990-9#1)(2008-2#1)
synthesized in order to##2##4##(1992-12#1)(2009-2#1)
synthesized in our laboratory##3##4##(1993-1#1)(2008-10#2)
synthesized in the endoplasmic##2##4##(1994-11#1)(1996-9#1)
synthesized in the presence of warfarin##2##6##(1995-1#2)
synthesized in the##26##3##(1990-11#2)(1992-1#1)(1992-10#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-11#2)(1994-12#2)(1995-1#2)(1996-9#1)(1997-4#1)(1997-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-1#1)
synthesized in this work##2##4##(2007-11#1)(2008-5#1)
synthesized in this##4##3##(1993-11#1)(2007-11#1)(2008-5#1)(2011-1#1)
synthesized in two steps from##2##5##(1991-10#1)(2008-8#1)
synthesized in two##4##3##(1991-10#1)(2007-2#1)(2008-7#1)(2008-8#1)
synthesized in vitro and##3##4##(1990-11#1)(1994-6#1)(1994-8#1)
synthesized in vitro in##2##4##(1995-6#1)(1996-9#1)
synthesized in vitro##9##3##(1990-11#1)(1994-11#1)(1994-6#1)(1994-8#2)(1995-6#2)(1996-9#1)(1997-5#1)
synthesized in##124##2##(1990-11#4)(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#3)(1993-7#1)(1994-11#3)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#2)(1995-3#2)(1995-4#1)(1995-6#5)(1996-10#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-9#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#3)(2005-11#3)(2005-4#1)(2005-8#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-11#5)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2009-10#2)(2009-2#2)(2009-7#2)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#3)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
synthesized into a##2##3##(2007-12#1)(2008-8#1)
synthesized into##3##2##(1994-3#1)(2007-12#1)(2008-8#1)
synthesized macrocyclic##2##2##(2008-10#2)
synthesized on a##2##3##(2005-11#1)(2008-11#1)
synthesized on the basis##2##4##(1997-2#1)(2012-1#1)
synthesized on##10##2##(1992-6#1)(1997-2#1)(1997-3#2)(2005-11#1)(2006-12#1)(2008-10#1)(2008-11#1)(2012-1#1)(2012-11#1)
synthesized only##2##2##(1990-11#1)(1996-6#1)
synthesized optical##2##2##(2007-12#1)(2013-8#1)
synthesized painting##3##2##(2008-6#3)
synthesized peptides##3##2##(1994-8#1)(1996-11#1)(2008-4#1)
synthesized populations##2##2##(2010-5#2)
synthesized products were##2##3##(2006-12#1)(2008-10#1)
synthesized products##3##2##(2006-12#1)(2008-10#1)(2008-3#1)
synthesized protein##3##2##(1990-11#1)(1993-12#1)(1994-8#1)
synthesized proteins##7##2##(1993-2#1)(1996-4#1)(2005-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2012-2#1)
synthesized separately and##2##3##(1991-3#1)(2008-4#1)
synthesized several##2##2##(1994-9#1)(2008-5#1)
synthesized silver nanoparticles##2##3##(2010-1#1)(2011-2#1)
synthesized the##7##2##(1990-3#1)(1991-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-8#1)(2012-11#1)
synthesized through##6##2##(1992-6#1)(2004-2#1)(2008-10#1)(2008-4#1)(2009-11#1)(2010-7#1)
synthesized to##8##2##(1991-6#1)(1993-6#1)(1995-3#1)(1996-4#1)(2005-11#1)(2007-8#1)(2008-10#1)(2012-2#1)
synthesized two##5##2##(1991-12#1)(1992-9#1)(1994-11#1)(1994-8#1)(1994-9#1)
synthesized under##5##2##(1994-10#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-7#1)
synthesized using a##5##3##(2007-12#1)(2008-10#2)(2008-8#1)(2009-3#1)
synthesized using the##3##3##(2004-9#1)(2008-10#1)(2010-2#1)
synthesized using##28##2##(1995-1#1)(1995-3#1)(1996-11#1)(2004-9#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#2)(2010-12#1)(2010-2#2)(2010-5#1)(2012-3#1)
synthesized via a simple##2##4##(1997-8#1)(2010-7#1)
synthesized via a##4##3##(1996-5#1)(1997-8#1)(2009-2#1)(2010-7#1)
synthesized via an##2##3##(2009-7#1)(2012-2#1)
synthesized via the##3##3##(1994-5#1)(2008-6#1)(2008-8#1)
synthesized via##16##2##(1994-5#1)(1996-5#1)(1997-1#1)(1997-8#1)(2006-12#1)(2007-11#2)(2008-11#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-7#1)(2010-5#1)(2010-7#1)(2012-2#1)(2013-8#1)
synthesized were##4##2##(1994-12#1)(1995-9#1)(2005-12#1)(2007-11#1)
synthesized which##3##2##(1992-1#1)(1994-3#1)(2008-5#1)
synthesized with a##9##3##(1990-3#1)(1990-5#1)(1993-11#1)(1996-5#1)(2008-4#1)(2008-5#1)(2010-10#1)(2013-1#2)
synthesized with the##4##3##(1991-7#1)(1994-5#1)(2005-11#1)(2009-5#1)
synthesized with##22##2##(1990-3#1)(1990-5#1)(1991-7#1)(1992-2#1)(1993-11#1)(1994-5#1)(1995-3#1)(1996-5#1)(2005-11#1)(2005-4#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#2)(2009-4#1)(2009-5#2)(2010-10#1)(2013-1#2)
synthesized within the##2##3##(1994-7#1)(1997-2#1)
synthesized without##3##2##(1991-7#1)(1995-6#1)(2008-4#1)
synthesized##1353##1##(1990-11#14)(1990-12#6)(1990-2#10)(1990-3#6)(1990-4#4)(1990-5#10)(1990-6#2)(1990-7#5)(1990-8#5)(1990-9#3)(1991-1#4)(1991-10#1)(1991-11#3)(1991-12#9)(1991-2#8)(1991-3#7)(1991-4#6)(1991-5#5)(1991-6#4)(1991-7#17)(1991-8#3)(1991-9#4)(1992-1#5)(1992-10#2)(1992-11#2)(1992-12#8)(1992-2#1)(1992-3#6)(1992-4#2)(1992-5#5)(1992-6#14)(1992-7#2)(1992-8#8)(1992-9#9)(1993-1#2)(1993-11#11)(1993-12#5)(1993-2#1)(1993-3#8)(1993-4#4)(1993-6#10)(1993-7#1)(1993-8#7)(1993-9#8)(1994-10#1)(1994-11#10)(1994-12#17)(1994-2#3)(1994-3#10)(1994-5#6)(1994-6#3)(1994-7#1)(1994-8#17)(1994-9#27)(1995-1#13)(1995-10#2)(1995-11#12)(1995-12#3)(1995-2#7)(1995-3#18)(1995-4#4)(1995-5#1)(1995-6#10)(1995-7#2)(1995-8#9)(1995-9#1)(1996-1#1)(1996-10#2)(1996-11#7)(1996-2#14)(1996-3#2)(1996-4#8)(1996-5#10)(1996-6#4)(1996-7#4)(1996-8#17)(1996-9#5)(1997-1#17)(1997-2#20)(1997-3#3)(1997-4#5)(1997-5#5)(1997-6#5)(1997-7#2)(1997-8#7)(2004-11#2)(2004-2#2)(2004-9#6)(2005-10#1)(2005-11#26)(2005-12#1)(2005-4#6)(2005-7#2)(2005-8#6)(2006-10#2)(2006-12#25)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-7#1)(2006-9#3)(2007-1#2)(2007-10#6)(2007-11#53)(2007-12#11)(2007-2#3)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#13)(2007-9#2)(2008-1#8)(2008-10#160)(2008-11#19)(2008-12#5)(2008-2#14)(2008-3#19)(2008-4#30)(2008-5#66)(2008-6#20)(2008-7#9)(2008-8#17)(2008-9#6)(2009-10#11)(2009-11#4)(2009-12#2)(2009-2#8)(2009-3#14)(2009-4#3)(2009-5#3)(2009-6#3)(2009-7#7)(2009-8#2)(2009-9#3)(2010-1#5)(2010-10#2)(2010-12#10)(2010-2#11)(2010-3#4)(2010-4#6)(2010-5#18)(2010-6#5)(2010-7#7)(2011-1#9)(2011-2#9)(2011-3#3)(2012-1#2)(2012-11#14)(2012-12#5)(2012-2#14)(2012-3#7)(2013-1#18)(2013-7#6)(2013-8#12)
synthesizer##10##1##(1990-5#1)(1997-3#1)(2006-12#1)(2007-12#2)(2008-1#1)(2008-3#2)(2008-4#1)(2009-10#1)
synthesizers##2##1##(2008-3#1)(2008-4#1)
synthesizes a##4##2##(1994-9#1)(1997-4#1)(2007-12#1)(2008-9#1)
synthesizes information##2##2##(1995-8#1)(1996-2#1)
synthesizes the##3##2##(1992-6#1)(1994-9#1)(2012-3#1)
synthesizes##24##1##(1992-6#1)(1993-12#1)(1993-3#1)(1994-9#2)(1995-5#1)(1995-8#1)(1996-2#1)(1997-4#1)(2006-10#2)(2006-12#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-9#1)(2009-2#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-3#1)
synthesizing DNA##2##2##(1993-11#1)(1994-9#1)
synthesizing a##8##2##(2007-12#2)(2008-1#1)(2008-3#2)(2008-4#1)(2008-6#1)(2011-2#1)
synthesizing ability##2##2##(1997-4#2)
synthesizing and##4##2##(2005-9#1)(2008-4#1)(2008-6#1)(2013-7#1)
synthesizing complex##2##2##(2008-3#1)(2010-12#1)
synthesizing enzyme##4##2##(1994-2#1)(1996-12#1)(1996-5#2)
synthesizing enzymes##2##2##(1996-12#2)
synthesizing research results##2##3##(2008-10#2)
synthesizing the##7##2##(2008-2#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-9#1)(2013-8#1)
synthesizing##79##1##(1990-11#1)(1990-5#1)(1992-8#2)(1993-11#1)(1994-11#2)(1994-2#2)(1994-8#1)(1994-9#1)(1995-7#1)(1996-1#1)(1996-12#3)(1996-4#1)(1996-5#3)(1997-2#1)(1997-4#3)(1997-5#1)(1997-8#1)(2004-3#2)(2005-9#1)(2006-11#1)(2007-1#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#8)(2008-4#11)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-6#1)(2011-1#2)(2011-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
synthetase (CPS)##3##2##(1990-7#2)(1992-3#1)
synthetase (EC 6##2##3##(1990-7#1)(1995-3#1)
synthetase 2##3##2##(1994-2#2)(2012-2#1)
synthetase activity##3##2##(1990-2#1)(1995-6#1)(2008-11#1)
synthetase and the##2##3##(1990-2#1)(2012-2#1)
synthetase and##9##2##(1990-2#2)(1991-10#1)(1994-11#1)(1996-5#1)(2008-11#1)(2008-5#2)(2012-2#1)
synthetase by##3##2##(1990-6#2)(1993-6#1)
synthetase complex##2##2##(1991-10#1)(1994-12#1)
synthetase from Escherichia coli##2##4##(1994-6#1)(1994-9#1)
synthetase from##10##2##(1990-6#1)(1991-4#2)(1993-2#1)(1994-6#1)(1994-9#3)(1995-3#1)(1996-2#1)
synthetase gene##4##2##(1992-2#1)(1996-12#1)(2008-10#1)(2008-11#1)
synthetase has a##2##3##(1992-9#1)(1994-11#1)
synthetase has been##2##3##(1990-2#1)(1991-6#1)
synthetase has##4##2##(1990-2#1)(1991-6#1)(1992-9#1)(1994-11#1)
synthetase in a##2##3##(1994-6#1)(1997-2#1)
synthetase in the##4##3##(1992-12#1)(1993-6#1)(1995-9#1)(1996-12#1)
synthetase in##15##2##(1990-9#1)(1992-11#1)(1992-12#2)(1993-6#2)(1994-11#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-11#1)
synthetase is##4##2##(1991-10#2)(1994-11#1)(1994-9#1)
synthetase with##3##2##(1994-9#1)(1995-3#1)(1997-1#1)
synthetase##206##1##(1990-12#6)(1990-2#9)(1990-3#2)(1990-5#1)(1990-6#4)(1990-7#6)(1990-9#1)(1991-10#5)(1991-12#2)(1991-2#1)(1991-4#7)(1991-6#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-7#3)(1992-8#2)(1992-9#4)(1993-12#3)(1993-2#1)(1993-6#6)(1993-8#2)(1994-11#10)(1994-12#7)(1994-2#3)(1994-3#3)(1994-6#5)(1994-8#3)(1994-9#13)(1995-1#2)(1995-12#2)(1995-3#13)(1995-6#4)(1995-7#1)(1995-8#1)(1995-9#2)(1996-10#5)(1996-12#6)(1996-2#3)(1996-5#2)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#3)(2006-10#1)(2006-12#3)(2006-4#1)(2008-10#1)(2008-11#11)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-10#1)(2009-8#1)(2009-9#1)(2011-2#3)(2012-2#4)
synthetase)##2##1##(1992-8#1)(2007-7#1)
synthetases and their cognate tRNAs##2##5##(1995-3#1)(2006-5#1)
synthetases are##2##2##(1994-11#1)(2012-2#1)
synthetases from##2##2##(1990-6#1)(1992-9#1)
synthetases with##3##2##(1990-12#1)(1993-2#1)(1995-3#1)
synthetases##41##1##(1990-12#3)(1990-6#1)(1990-7#2)(1991-10#1)(1991-12#1)(1991-4#3)(1992-2#1)(1992-9#1)(1993-2#2)(1993-8#1)(1994-11#3)(1994-8#1)(1994-9#5)(1995-3#3)(1997-2#1)(1997-5#2)(2005-10#1)(2006-12#2)(2006-5#1)(2008-8#1)(2009-3#2)(2012-2#3)
synthetic D-erythro-sphingosine##2##2##(1990-10#2)
synthetic DI RNA##2##3##(1997-3#2)
synthetic DNA##7##2##(1990-10#1)(1990-5#1)(1993-3#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-4#1)
synthetic DNAs##2##2##(1995-2#1)(1996-4#1)
synthetic HA##2##2##(2008-10#2)
synthetic PPT-B(50-79)##2##2##(1995-5#2)
synthetic PRP##2##2##(2008-4#2)
synthetic RNA##5##2##(1996-8#1)(2008-10#1)(2008-2#1)(2008-4#2)
synthetic SAMDC mRNAs##2##3##(1993-4#2)
synthetic SIV protease##2##3##(1992-6#2)
synthetic activity of##4##3##(1993-12#1)(1994-11#1)(1994-8#1)(2012-1#1)
synthetic activity##9##2##(1993-12#1)(1994-11#1)(1994-8#2)(1996-4#2)(2010-12#1)(2011-2#1)(2012-1#1)
synthetic agonists##3##2##(2008-4#1)(2009-3#1)(2012-12#1)
synthetic aminosuccinimide peptide##2##3##(1995-8#2)
synthetic amyloid##2##2##(1996-6#2)
synthetic analog of##3##3##(1993-12#1)(1994-11#1)(1995-8#1)
synthetic analog##8##2##(1990-2#1)(1991-4#2)(1993-12#1)(1993-6#1)(1994-11#1)(1995-8#1)(2009-9#1)
synthetic analogs##8##2##(1990-11#1)(1994-6#1)(1994-9#3)(1996-2#1)(2012-12#2)
synthetic analogue of the##3##4##(1990-5#1)(1993-7#1)(2008-8#1)
synthetic analogue of##5##3##(1990-5#1)(1993-7#1)(1995-9#1)(2008-8#1)(2009-6#1)
synthetic analogue##8##2##(1990-5#1)(1990-7#1)(1993-7#1)(1995-9#3)(2008-8#1)(2009-6#1)
synthetic analogues##3##2##(1994-11#2)(1997-3#1)
synthetic and actual##2##3##(2008-10#1)(2008-2#1)
synthetic and animal##2##3##(2010-4#2)
synthetic and biologic##2##3##(2011-2#2)
synthetic and biological##2##3##(2005-10#1)(2008-6#1)
synthetic and natural photosensitising agents##2##5##(2008-11#2)
synthetic and natural##9##3##(1995-4#1)(1997-8#1)(2008-10#3)(2008-11#2)(2010-10#1)(2012-1#1)
synthetic and real data##3##4##(2008-10#1)(2008-2#1)(2013-1#1)
synthetic and real samples##6##4##(2007-8#1)(2008-10#5)
synthetic and real##17##3##(2007-8#1)(2008-10#8)(2008-2#6)(2008-3#1)(2013-1#1)
synthetic and water samples##2##4##(2008-10#2)
synthetic and##56##2##(1990-10#1)(1990-3#1)(1991-5#1)(1992-5#1)(1994-11#1)(1995-4#1)(1997-3#1)(1997-8#1)(2005-10#1)(2005-11#2)(2006-10#1)(2006-9#1)(2007-8#1)(2008-10#18)(2008-11#2)(2008-2#7)(2008-3#2)(2008-5#1)(2008-6#1)(2010-10#1)(2010-2#1)(2010-4#2)(2011-2#2)(2012-1#2)(2012-2#2)(2013-1#1)
synthetic antigen##4##2##(1992-7#1)(1996-2#1)(2007-11#1)(2008-4#1)
synthetic antioxidant##5##2##(2007-1#1)(2007-3#1)(2008-10#2)(2009-3#1)
synthetic antioxidants##7##2##(2008-10#1)(2008-3#1)(2008-4#1)(2010-4#2)(2010-8#1)(2012-1#1)
synthetic aperture imaging##2##3##(2007-11#2)
synthetic aperture infrared laser radar##4##5##(2008-2#2)(2008-3#2)
synthetic aperture integral imaging##2##4##(2007-11#2)
synthetic aperture radar (SAR)##4##4##(2008-2#3)(2008-3#1)
synthetic aperture radar images##2##4##(2007-12#1)(2008-3#1)
synthetic aperture radar##13##3##(2007-12#1)(2007-8#1)(2008-2#4)(2008-3#6)(2008-6#1)
synthetic aperture##30##2##(2007-11#7)(2007-12#1)(2007-8#1)(2008-2#8)(2008-3#11)(2008-6#1)(2011-2#1)
synthetic applications##2##2##(1996-2#1)(2007-11#1)
synthetic approach##3##2##(2008-8#1)(2009-2#1)(2010-5#1)
synthetic approaches##4##2##(2008-4#2)(2009-12#1)(2010-10#1)
synthetic arteriovenous grafts##2##3##(2007-7#2)
synthetic association##4##2##(2012-3#4)
synthetic beta-carotene##2##2##(2004-11#2)
synthetic biology##11##2##(2009-5#5)(2011-1#1)(2012-2#4)(2013-7#1)
synthetic biomaterials##3##2##(2008-5#1)(2009-12#1)(2011-1#1)
synthetic bone graft substitutes##2##4##(2008-8#2)
synthetic bone graft##4##3##(2008-8#3)(2009-3#1)
synthetic bone##6##2##(2008-8#3)(2008-9#1)(2009-3#1)(2009-7#1)
synthetic cDNA##3##2##(1994-3#3)
synthetic calbindin-D9k##2##2##(1990-7#2)
synthetic calcium##2##2##(2005-11#1)(2008-10#1)
synthetic cannabinoid##2##2##(1997-8#1)(2013-7#1)
synthetic cannabinoids##7##2##(2005-10#2)(2008-7#1)(2013-7#4)
synthetic capacity##2##2##(1997-1#1)(2008-10#1)
synthetic cationic##2##2##(2007-11#1)(2008-5#1)
synthetic cellular systems##2##3##(2010-7#2)
synthetic ceramides##2##2##(1995-12#2)
synthetic chemical##3##2##(2008-1#1)(2008-10#1)(2009-11#1)
synthetic chemicals##3##2##(2008-11#1)(2012-2#2)
synthetic chemistry##2##2##(2007-6#1)(2008-11#1)
synthetic chromone derivatives was##2##4##(2009-3#2)
synthetic circuits##2##2##(2013-7#2)
synthetic complexity##2##2##(2006-12#2)
synthetic compound##8##2##(1992-12#1)(1997-6#1)(2005-11#2)(2005-8#1)(2008-10#1)(2008-2#1)(2012-2#1)
synthetic compounds that##2##3##(1993-11#1)(2005-8#1)
synthetic compounds to##2##3##(2008-11#1)(2013-1#1)
synthetic compounds##9##2##(1993-11#1)(1993-8#1)(2004-12#1)(2004-2#1)(2005-8#1)(2008-11#2)(2012-11#1)(2013-1#1)
synthetic constructs##2##2##(1991-7#1)(2013-7#1)
synthetic counterparts##2##2##(1994-3#1)(2008-5#1)
synthetic data##9##2##(2006-10#1)(2008-2#4)(2008-3#3)(2012-12#1)
synthetic decapeptide##2##2##(1992-11#1)(1994-12#1)
synthetic derivatives##5##2##(1991-9#1)(2006-12#2)(2008-1#1)(2009-4#1)
synthetic devices##3##2##(2010-12#1)(2012-11#2)
synthetic diamond##4##2##(2006-4#1)(2006-5#1)(2008-10#2)
synthetic discriminant function filter##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
synthetic discriminant function filters##2##4##(2007-12#2)
synthetic discriminant function is##2##4##(2008-2#1)(2008-3#1)
synthetic discriminant function##9##3##(2007-12#4)(2008-2#3)(2008-3#2)
synthetic discriminant##10##2##(2007-12#4)(2008-2#3)(2008-3#3)
synthetic dodecapeptide##4##2##(1990-12#1)(1991-1#2)(1994-12#1)
synthetic double-stranded##2##2##(1991-2#1)(1995-3#1)
synthetic drug##2##2##(2005-7#1)(2007-4#1)
synthetic drugs##3##2##(2008-10#1)(2012-2#1)(2013-8#1)
synthetic efforts##3##2##(2006-12#1)(2009-12#1)(2009-3#1)
synthetic emergence inhibitors##2##3##(2008-10#2)
synthetic endoprosthesis##2##2##(1992-1#1)(1992-5#1)
synthetic enzyme##5##2##(1992-8#1)(1993-9#1)(1996-2#1)(2008-10#1)(2009-3#1)
synthetic enzymes##4##2##(1990-5#1)(1992-8#1)(1997-3#1)(2009-10#1)
synthetic estrogen##4##2##(1992-10#1)(2013-1#3)
synthetic extensions of##2##3##(1994-11#2)
synthetic fertilizers##4##2##(2008-10#4)
synthetic fiber##2##2##(2008-2#2)
synthetic filler##2##2##(2006-12#2)
synthetic folic acid##2##3##(2012-1#2)
synthetic fragments of ACTH##2##4##(1991-5#2)
synthetic fragments of##4##3##(1991-5#3)(1992-2#1)
synthetic fragments##5##2##(1991-5#3)(1992-2#2)
synthetic gene was##2##3##(1990-11#1)(1995-2#1)
synthetic gene##9##2##(1990-11#1)(1991-5#1)(1994-5#1)(1995-2#3)(2006-12#1)(2008-11#2)
synthetic genes##2##2##(1990-10#1)(1995-8#1)
synthetic glucocorticoid dexamethasone##3##3##(1992-12#1)(1993-7#1)(1995-11#1)
synthetic glucocorticoid##6##2##(1991-5#1)(1992-12#1)(1993-7#1)(1995-11#1)(1995-8#1)(2011-2#1)
synthetic grafts are the##2##4##(2007-7#1)(2008-4#1)
synthetic grafts##7##2##(2007-7#5)(2008-4#1)(2009-4#1)
synthetic hexaploid wheat##2##3##(2008-10#2)
synthetic high##2##2##(2008-10#1)(2013-8#1)
synthetic holograms##2##2##(2008-2#2)
synthetic homopolymers##3##2##(1990-10#1)(1997-2#2)
synthetic human##6##2##(1991-8#1)(1993-3#1)(1993-6#1)(1993-9#1)(2004-11#1)(2012-3#1)
synthetic hydroxyapatite (HA)##2##3##(2004-9#1)(2006-7#1)
synthetic hydroxyapatite##4##2##(2004-9#1)(2006-7#2)(2010-2#1)
synthetic image##2##2##(2008-2#2)
synthetic images##5##2##(2008-2#2)(2008-3#3)
synthetic impurities##2##2##(1992-2#1)(2007-8#1)
synthetic inhibitor of##2##3##(1990-7#1)(1992-1#1)
synthetic inhibitor##4##2##(1990-7#1)(1992-1#1)(1994-5#2)
synthetic inhibitors of##2##3##(2005-7#1)(2007-11#1)
synthetic inhibitors##4##2##(1994-5#1)(1994-8#1)(2005-7#1)(2007-11#1)
synthetic insecticides##2##2##(2011-2#1)(2013-7#1)
synthetic insulin##2##2##(2008-4#1)(2010-4#1)
synthetic intermediates for the preparation of##2##6##(1996-5#1)(2011-1#1)
synthetic intermediates##5##2##(1992-2#1)(1996-2#1)(1996-5#1)(2008-5#1)(2011-1#1)
synthetic iron hydroxide##2##3##(2008-10#2)
synthetic iron##3##2##(2008-10#2)(2009-10#1)
synthetic kitchen waste (KW)##2##4##(2013-1#2)
synthetic latex##2##2##(2008-10#1)(2011-2#1)
synthetic lidar signals##2##3##(2008-3#2)
synthetic ligands##5##2##(2008-10#3)(2008-9#1)(2009-6#1)
synthetic lipids##2##2##(1995-2#1)(2008-5#1)
synthetic mRNA##3##2##(1992-6#2)(1994-9#1)
synthetic mRNAs##2##2##(1992-2#1)(1997-2#1)
synthetic material##3##2##(1993-9#1)(2008-5#1)(2010-12#1)
synthetic materials##10##2##(1991-3#1)(1992-4#2)(2005-10#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-1#1)(2009-3#1)(2011-2#1)
synthetic media##4##2##(1990-3#1)(2007-7#1)(2008-10#1)(2008-8#1)
synthetic medium containing##4##3##(1997-1#1)(2008-10#2)(2008-6#1)
synthetic medium##7##2##(1997-1#1)(2008-10#3)(2008-5#1)(2008-6#2)
synthetic membranes##2##2##(2008-1#1)(2008-5#1)
synthetic mesh##2##2##(2010-4#1)(2012-2#1)
synthetic metal-doped##2##2##(2008-10#2)
synthetic method for the##2##4##(2008-12#1)(2010-6#1)
synthetic method for##3##3##(2008-12#1)(2009-3#1)(2010-6#1)
synthetic method##6##2##(2008-10#1)(2008-12#1)(2008-5#1)(2009-3#1)(2010-6#1)(2012-12#1)
synthetic methodologies##3##2##(2005-9#1)(2007-11#1)(2009-12#1)
synthetic methodology for##2##3##(2007-12#1)(2009-12#1)
synthetic methodology##6##2##(2006-12#1)(2007-11#1)(2007-12#1)(2008-4#1)(2009-12#2)
synthetic methods##5##2##(1995-1#1)(2005-8#1)(2007-11#1)(2008-4#1)(2010-10#1)
synthetic minimal cell##2##3##(2011-1#2)
synthetic minimal##3##2##(2011-1#3)
synthetic mitochondrial##2##2##(1992-6#1)(1997-2#1)
synthetic mixture##8##2##(2008-10#7)(2008-6#1)
synthetic mixtures and mineral sample##2##5##(2008-10#2)
synthetic mixtures and##11##3##(2008-10#11)
synthetic mixtures containing##4##3##(2008-10#4)
synthetic mixtures of the##2##4##(2008-10#2)
synthetic mixtures of##8##3##(2008-10#8)
synthetic mixtures##36##2##(2006-12#1)(2008-10#34)(2008-6#1)
synthetic model peptides for the amphipathic helices of the plasma apolipoproteins##2##11##(1993-9#2)
synthetic model peptides for##3##4##(1993-9#3)
synthetic model##5##2##(1993-9#3)(1996-2#1)(2009-3#1)
synthetic models##2##2##(1997-7#1)(2008-3#1)
synthetic modules##2##2##(1990-9#1)(2013-7#1)
synthetic molecular machines##2##3##(2008-7#2)
synthetic molecular##4##2##(2008-7#4)
synthetic molecules##3##2##(2006-10#1)(2008-5#1)(2008-9#1)
synthetic mutant##2##2##(1990-7#1)(1995-1#1)
synthetic near-field##2##2##(2008-3#2)
synthetic nectar##2##2##(2008-10#2)
synthetic oligo##2##2##(1992-11#1)(1996-5#1)
synthetic oligodeoxynucleotides##4##2##(1990-2#1)(1995-1#1)(2008-4#1)(2009-3#1)
synthetic oligodeoxyribonucleotide##3##2##(1990-11#1)(1995-3#1)(1997-7#1)
synthetic oligodeoxyribonucleotides##4##2##(1990-3#1)(1991-7#1)(1994-12#1)(2008-4#1)
synthetic oligonucleotide##5##2##(1994-12#1)(1997-1#1)(2007-8#1)(2008-1#1)(2008-4#1)
synthetic oligonucleotides by##2##3##(2006-12#1)(2008-4#1)
synthetic oligonucleotides##11##2##(1990-5#1)(1991-7#1)(1992-3#1)(1995-12#1)(1995-5#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-4#3)
synthetic oligopeptides##2##2##(1993-6#1)(1994-11#1)
synthetic or natural##3##3##(2008-10#1)(2010-10#1)(2010-7#1)
synthetic or##5##2##(2007-8#1)(2008-10#1)(2008-3#1)(2010-10#1)(2010-7#1)
synthetic organic chemistry##3##3##(2007-10#1)(2007-11#1)(2010-6#1)
synthetic organic##5##2##(1994-8#1)(2007-10#1)(2007-11#1)(2010-6#2)
synthetic origin##2##2##(2008-11#1)(2009-12#1)
synthetic oviduct fluid medium containing##2##5##(2006-5#2)
synthetic pathway of##2##3##(2007-11#1)(2013-1#1)
synthetic pathway##4##2##(1992-8#1)(2006-11#1)(2007-11#1)(2013-1#1)
synthetic peptide analogs of the##2##5##(1990-4#1)(1992-9#1)
synthetic peptide analogs##6##3##(1990-4#2)(1991-3#1)(1992-9#1)(1993-9#1)(1995-5#1)
synthetic peptide and##2##3##(1991-2#1)(2005-7#1)
synthetic peptide combinatorial libraries##2##4##(1997-3#1)(2008-4#1)
synthetic peptide corresponding to residues##6##5##(1990-9#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-5#2)
synthetic peptide corresponding to the N-terminal##2##6##(1991-7#1)(1993-11#1)
synthetic peptide corresponding to the##7##5##(1990-11#1)(1990-2#1)(1991-7#1)(1992-12#2)(1993-11#1)(1997-5#1)
synthetic peptide corresponding to##17##4##(1990-11#1)(1990-2#1)(1990-9#2)(1991-7#1)(1992-12#2)(1993-11#1)(1994-12#1)(1994-6#2)(1994-8#1)(1995-10#1)(1995-2#1)(1996-5#2)(1997-5#1)
synthetic peptide derived from the##5##5##(1991-2#3)(1993-3#1)(1994-9#1)
synthetic peptide derived from##6##4##(1991-2#3)(1993-3#2)(1994-9#1)
synthetic peptide of 15 amino acids##2##6##(1991-3#1)(1992-4#1)
synthetic peptide of this##2##4##(1993-2#1)(1994-3#1)
synthetic peptide of##9##3##(1990-10#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-4#1)(1993-2#1)(1994-3#1)(1995-6#1)(2008-11#1)
synthetic peptide substrate##3##3##(1990-7#1)(1991-12#1)(1991-7#1)
synthetic peptide substrates##2##3##(1990-12#1)(1994-2#1)
synthetic peptide to##4##3##(1990-10#1)(2008-2#1)(2008-4#2)
synthetic peptide was##2##3##(1995-11#1)(2011-1#1)
synthetic peptide with##3##3##(1990-7#1)(1996-8#1)(2007-11#1)
synthetic peptide##110##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#3)(1990-4#2)(1990-6#2)(1990-7#3)(1990-9#2)(1991-10#2)(1991-12#2)(1991-2#6)(1991-3#4)(1991-5#1)(1991-6#1)(1991-7#4)(1991-9#2)(1992-1#1)(1992-12#2)(1992-4#2)(1992-7#3)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#4)(1995-10#3)(1995-11#2)(1995-2#3)(1995-3#2)(1995-5#3)(1995-6#3)(1996-2#1)(1996-5#4)(1996-8#1)(1997-3#1)(1997-5#1)(1997-8#1)(2004-2#1)(2005-7#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#5)(2008-7#1)(2008-8#1)(2010-4#1)(2011-1#1)(2013-1#1)
synthetic peptides and##5##3##(1990-7#1)(1994-9#1)(1995-10#1)(2008-4#2)
synthetic peptides are##5##3##(1993-3#2)(2008-2#1)(2008-4#2)
synthetic peptides based on##4##4##(2008-2#1)(2008-4#2)(2013-7#1)
synthetic peptides corresponding to the calmodulin binding##2##7##(1992-12#1)(1992-3#1)
synthetic peptides corresponding to the##6##5##(1990-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1995-11#1)(2006-10#1)
synthetic peptides corresponding to##9##4##(1990-7#1)(1991-10#1)(1991-9#1)(1992-12#1)(1992-3#1)(1995-10#1)(1995-11#1)(2006-10#1)(2010-11#1)
synthetic peptides derived from##8##4##(1991-8#1)(1992-8#1)(1994-12#1)(1994-3#2)(1995-2#1)(1996-8#1)(2008-4#1)
synthetic peptides encompassing##2##3##(1993-6#1)(1994-12#1)
synthetic peptides in##3##3##(1991-5#1)(1992-6#1)(2008-4#1)
synthetic peptides of##3##3##(1990-10#1)(1996-11#1)(2008-10#1)
synthetic peptides on the##2##4##(1997-8#1)(2012-1#1)
synthetic peptides representing##3##3##(1991-12#1)(1993-8#1)(2008-10#1)
synthetic peptides reproducing the##2##4##(1992-11#2)
synthetic peptides to##3##3##(1996-11#1)(2008-2#1)(2008-4#1)
synthetic peptides were##2##3##(1993-11#1)(1994-3#1)
synthetic peptides with##5##3##(1990-7#1)(1991-5#1)(1995-10#1)(1995-7#1)(2005-7#1)
synthetic peptides##112##2##(1990-10#1)(1990-12#4)(1990-2#2)(1990-3#1)(1990-4#2)(1990-6#1)(1990-7#6)(1991-10#1)(1991-12#2)(1991-5#2)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#4)(1992-3#1)(1992-6#1)(1992-8#6)(1993-11#1)(1993-3#4)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#2)(1994-9#5)(1995-1#1)(1995-10#3)(1995-11#2)(1995-2#1)(1995-3#2)(1995-7#1)(1995-8#1)(1996-11#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-2#1)(2008-10#2)(2008-2#4)(2008-4#14)(2010-11#1)(2012-1#1)(2013-7#1)
synthetic phase##2##2##(1993-8#1)(2007-12#1)
synthetic phosphopeptides##2##2##(1991-3#1)(1994-12#1)
synthetic playing surfaces##3##3##(2013-1#3)
synthetic polymer##2##2##(2010-10#1)(2012-12#1)
synthetic polymers##8##2##(2007-12#2)(2008-1#1)(2008-11#1)(2008-5#1)(2009-12#1)(2010-6#1)(2011-1#1)
synthetic polynucleotides##2##2##(1994-8#1)(2008-10#1)
synthetic polypeptide##2##2##(1992-7#1)(2008-9#1)
synthetic polypeptides##2##2##(1991-2#1)(1991-3#1)
synthetic procedure##3##2##(1993-11#1)(2008-10#1)(2010-4#1)
synthetic procedures for##2##3##(2008-4#2)
synthetic procedures##4##2##(2008-4#2)(2008-5#1)(2012-3#1)
synthetic process##3##2##(2005-11#1)(2008-10#1)(2008-11#1)
synthetic processes##2##2##(1991-6#1)(2010-12#1)
synthetic products##2##2##(1996-5#1)(2012-2#1)
synthetic prostaglandin##2##2##(2006-10#1)(2007-2#1)
synthetic protocols##3##2##(2005-11#1)(2008-10#1)(2008-4#1)
synthetic psoralen##2##2##(2008-11#2)
synthetic pterin##2##2##(2010-5#2)
synthetic pyrethroid insecticides##3##3##(1995-1#1)(2008-10#1)(2008-5#1)
synthetic pyrethroid##5##2##(1995-1#1)(1996-4#1)(2008-10#2)(2008-5#1)
synthetic pyrethroids##3##2##(2008-10#3)
synthetic rat##4##2##(1990-3#1)(1994-12#1)(1994-6#1)(1994-8#1)
synthetic rate##2##2##(1991-1#1)(1995-1#1)
synthetic reactions##2##2##(2008-4#1)(2013-1#1)
synthetic replicators##2##2##(1992-6#2)
synthetic retinoid##5##2##(1991-12#1)(1992-9#2)(2012-12#2)
synthetic route also##2##3##(1996-5#1)(2009-11#1)
synthetic route for##2##3##(1992-2#1)(2008-10#1)
synthetic route to##3##3##(2006-12#1)(2007-10#1)(2007-11#1)
synthetic route##13##2##(1992-2#2)(1996-5#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-11#2)(2008-10#1)(2008-11#1)(2009-11#2)(2010-2#1)
synthetic routes to##3##3##(2007-11#1)(2010-12#1)(2010-8#1)
synthetic routes##6##2##(1992-5#1)(2007-11#2)(2010-12#1)(2010-4#1)(2010-8#1)
synthetic saliva##3##2##(2008-10#3)
synthetic sample solutions by##2##4##(2008-10#2)
synthetic sample##7##2##(1995-6#1)(2008-10#6)
synthetic samples in##2##3##(2008-10#2)
synthetic samples prepared with##3##4##(2008-10#3)
synthetic samples prepared##5##3##(2008-10#5)
synthetic samples were##3##3##(2008-10#3)
synthetic samples with##4##3##(2008-10#4)
synthetic samples##40##2##(2005-4#1)(2007-8#1)(2008-10#38)
synthetic sea water##2##3##(2008-10#2)
synthetic seawater##3##2##(2008-10#2)(2008-2#1)
synthetic serum and pharmaceutical##2##4##(2008-10#2)
synthetic serum and##3##3##(2008-10#3)
synthetic serum samples##3##3##(2007-8#1)(2008-10#2)
synthetic serum##6##2##(2007-8#1)(2008-10#5)
synthetic slit##2##2##(2008-3#2)
synthetic solution##4##2##(1992-1#1)(2008-10#3)
synthetic solutions##5##2##(2007-11#1)(2008-10#3)(2013-1#1)
synthetic spectra##2##2##(2008-2#1)(2008-3#1)
synthetic spider silks##2##3##(1995-8#2)
synthetic standard##3##2##(1992-2#1)(2008-10#1)(2013-8#1)
synthetic standards##2##2##(1990-10#1)(2007-8#1)
synthetic strategies for##3##3##(2009-10#3)
synthetic strategies##5##2##(2008-4#1)(2009-10#3)(2012-3#1)
synthetic strategy for##3##3##(1994-9#1)(2007-8#1)(2010-12#1)
synthetic strategy##6##2##(1994-9#1)(1997-7#1)(2007-11#1)(2007-8#1)(2009-12#1)(2010-12#1)
synthetic substrate##5##2##(1990-2#1)(1994-5#1)(1995-6#1)(2008-4#1)(2013-8#1)
synthetic substrates and##2##3##(1991-12#1)(1995-7#1)
synthetic substrates##11##2##(1990-11#1)(1990-5#1)(1991-12#2)(1991-5#1)(1993-12#2)(1993-3#2)(1995-7#1)(2008-4#1)
synthetic sunscreen##6##2##(2008-5#6)
synthetic sweeteners##3##2##(2011-1#3)
synthetic systems##2##2##(2008-3#1)(2012-2#1)
synthetic target##2##2##(2008-10#2)
synthetic tear##2##2##(2009-4#2)
synthetic telomeres##2##2##(1991-7#2)
synthetic test##2##2##(1995-6#1)(2008-2#1)
synthetic tetradecapeptide##2##2##(1990-8#2)
synthetic thrombin##2##2##(1991-9#1)(1994-3#1)
synthetic tissue adhesives##2##3##(2009-2#2)
synthetic vascular##2##2##(2009-11#1)(2011-3#1)
synthetic version of the human D4##2##6##(1994-5#2)
synthetic wastewater##2##2##(2008-10#1)(2011-2#1)
synthetic water##3##2##(2008-10#1)(2008-5#1)(2011-12#1)
synthetic wavelength##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
synthetic##1514##1##(1990-10#13)(1990-11#6)(1990-12#11)(1990-2#12)(1990-3#8)(1990-4#4)(1990-5#10)(1990-6#5)(1990-7#19)(1990-8#6)(1990-9#7)(1991-1#4)(1991-10#3)(1991-11#2)(1991-12#7)(1991-2#12)(1991-3#10)(1991-4#5)(1991-5#13)(1991-6#2)(1991-7#14)(1991-8#5)(1991-9#11)(1992-1#7)(1992-10#1)(1992-11#9)(1992-12#9)(1992-2#10)(1992-3#3)(1992-4#5)(1992-5#5)(1992-6#11)(1992-7#8)(1992-8#11)(1992-9#4)(1993-11#6)(1993-12#7)(1993-2#2)(1993-3#11)(1993-4#4)(1993-6#5)(1993-7#4)(1993-8#4)(1993-9#11)(1994-11#9)(1994-12#14)(1994-2#7)(1994-3#9)(1994-5#14)(1994-6#9)(1994-8#10)(1994-9#22)(1995-1#9)(1995-10#6)(1995-11#7)(1995-12#5)(1995-2#12)(1995-3#8)(1995-4#1)(1995-5#7)(1995-6#7)(1995-7#4)(1995-8#13)(1995-9#3)(1996-1#2)(1996-11#4)(1996-12#2)(1996-2#8)(1996-4#5)(1996-5#11)(1996-6#2)(1996-7#4)(1996-8#3)(1996-9#2)(1997-1#6)(1997-2#6)(1997-3#6)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#7)(2004-11#4)(2004-12#1)(2004-2#3)(2004-4#1)(2004-7#2)(2004-9#1)(2005-10#6)(2005-11#11)(2005-12#1)(2005-4#2)(2005-7#14)(2005-8#6)(2005-9#1)(2006-10#13)(2006-11#1)(2006-12#21)(2006-2#1)(2006-4#1)(2006-5#4)(2006-7#2)(2006-9#2)(2007-1#2)(2007-10#4)(2007-11#41)(2007-12#16)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#13)(2007-8#12)(2007-9#1)(2008-1#10)(2008-10#233)(2008-11#22)(2008-12#3)(2008-2#51)(2008-3#43)(2008-4#56)(2008-5#37)(2008-6#13)(2008-7#12)(2008-8#10)(2008-9#6)(2009-10#5)(2009-11#4)(2009-12#10)(2009-2#3)(2009-3#13)(2009-4#4)(2009-5#5)(2009-6#4)(2009-7#2)(2009-8#1)(2009-9#5)(2010-1#2)(2010-10#5)(2010-11#1)(2010-12#8)(2010-2#4)(2010-4#12)(2010-5#5)(2010-6#4)(2010-7#6)(2010-8#5)(2011-1#15)(2011-12#2)(2011-2#16)(2011-3#2)(2012-1#9)(2012-11#14)(2012-12#11)(2012-2#19)(2012-3#10)(2013-1#19)(2013-7#15)(2013-8#7)
synthetic)##2##1##(2008-10#2)
synthetic-imaging technique##2##2##(2007-12#2)
synthetic-peptide strategy was used##2##4##(1990-2#1)(1990-6#1)
synthetically prepared##3##2##(1996-7#1)(2008-10#1)(2012-12#1)
synthetically##9##1##(1991-4#1)(1992-1#1)(1996-7#1)(2008-10#1)(2009-7#1)(2011-2#1)(2012-11#2)(2012-12#1)
synthetics##2##1##(2008-11#2)
synthetized##4##1##(1991-3#1)(1992-3#1)(1995-6#1)(2008-7#1)
synthon##8##1##(1995-3#1)(1997-1#2)(2005-8#1)(2008-4#3)(2009-9#1)
synthons in##2##2##(1995-6#1)(2012-3#1)
synthons##9##1##(1995-6#1)(1997-3#1)(2006-12#1)(2008-2#1)(2008-4#2)(2009-9#1)(2010-5#1)(2012-3#1)
syntocinon##2##1##(2004-10#2)
syphilis (leus maligna)##2##3##(2007-8#2)
syphilis and HIV##3##3##(1993-3#1)(2011-2#1)(2012-3#1)
syphilis and gonorrhea##2##3##(1991-6#1)(2005-11#1)
syphilis and##15##2##(1991-6#1)(1993-3#3)(2005-11#1)(2008-3#1)(2009-2#1)(2011-2#4)(2012-3#3)(2013-8#1)
syphilis by##2##2##(2007-12#1)(2007-7#1)
syphilis can##2##2##(2009-8#2)
syphilis in patients with##2##4##(1993-3#1)(1997-7#1)
syphilis in the##4##3##(2006-10#1)(2007-7#1)(2009-9#2)
syphilis in##15##2##(1993-3#2)(1997-5#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-7#2)(2009-2#1)(2009-8#2)(2009-9#2)(2011-1#1)(2012-3#1)
syphilis infections##4##2##(1997-6#1)(2008-12#3)
syphilis is##4##2##(1997-2#1)(2009-9#1)(2010-7#1)(2011-2#1)
syphilis patients##2##2##(1993-3#1)(2008-10#1)
syphilis serology in##2##3##(1993-3#1)(2006-10#1)
syphilis serology##5##2##(1993-3#2)(2006-10#1)(2012-3#2)
syphilis was##3##2##(1997-5#1)(2007-7#1)(2012-3#1)
syphilis were##2##2##(1993-3#1)(2007-7#1)
syphilis with##3##2##(1997-5#1)(2013-1#2)
syphilis##123##1##(1991-6#1)(1992-5#1)(1993-3#16)(1994-3#1)(1994-9#1)(1995-2#1)(1996-11#1)(1997-2#2)(1997-5#4)(1997-6#1)(1997-7#2)(2005-11#3)(2006-10#4)(2007-10#1)(2007-12#2)(2007-2#2)(2007-7#12)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#4)(2008-3#1)(2008-9#1)(2009-10#3)(2009-2#3)(2009-8#9)(2009-9#4)(2010-7#3)(2011-1#1)(2011-2#9)(2012-2#1)(2012-3#12)(2013-1#8)(2013-8#1)
syphilitic##3##1##(1997-5#1)(2009-10#1)(2010-3#1)
syrB gene##5##2##(2008-10#5)
syrB##8##1##(2008-10#8)
syringae B728a##2##2##(2008-10#2)
syringae Cit7 was the most effective##2##6##(2008-10#2)
syringae Cit7##3##2##(2008-10#3)
syringae and C##2##3##(2008-10#2)
syringae and##8##2##(2007-12#1)(2008-10#7)
syringae in the##2##3##(2008-10#2)
syringae in##3##2##(2006-3#1)(2008-10#2)
syringae pathovars##5##2##(2008-10#5)
syringae pv##97##2##(2006-3#4)(2007-12#2)(2008-10#87)(2009-6#1)(2011-1#3)
syringae pvs##9##2##(2008-10#9)
syringae strain##3##2##(2008-10#2)(2009-8#1)
syringae strains##4##2##(2008-10#4)
syringae subsp##5##2##(2008-10#5)
syringae was##2##2##(2008-10#2)
syringae were##2##2##(2008-10#2)
syringae##202##1##(1996-4#1)(2006-3#8)(2007-12#3)(2008-10#180)(2009-6#2)(2009-8#3)(2011-1#5)
syringae)##2##1##(2008-10#2)
syringaldazine##5##1##(2008-10#5)
syringe and##3##2##(2008-10#3)
syringe filled with##2##3##(2008-10#2)
syringe needle##3##2##(2008-10#2)(2008-11#1)
syringe pump##13##2##(2007-8#2)(2008-10#8)(2009-6#1)(2011-2#1)(2013-1#1)
syringe pumps##5##2##(1996-8#1)(2007-8#1)(2008-10#1)(2010-8#1)(2011-2#1)
syringe to##2##2##(2007-8#1)(2008-10#1)
syringe##61##1##(1990-8#1)(1995-5#1)(1996-8#1)(2007-1#1)(2007-7#2)(2007-8#4)(2008-10#28)(2008-11#8)(2008-3#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-8#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#4)
syringes and##3##2##(2008-10#1)(2012-2#1)(2013-8#1)
syringes or##2##2##(2007-11#1)(2010-4#1)
syringes##17##1##(1991-2#1)(1991-6#1)(1994-4#1)(1996-11#1)(2007-11#1)(2008-1#1)(2008-10#2)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
syringic acid##7##2##(2008-10#1)(2008-11#1)(2008-6#2)(2011-1#3)
syringic and vanillic##2##3##(2007-8#2)
syringic##11##1##(2004-2#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-6#2)(2011-1#3)(2011-2#1)
syringoma##2##1##(1990-6#1)(2007-7#1)
syringomatous features##2##2##(1990-6#2)
syringomycin##3##1##(2006-3#1)(2008-10#2)
syringomyelia in##2##2##(2006-5#2)
syringomyelia is##3##2##(2006-5#3)
syringomyelia was##2##2##(2005-8#1)(2010-2#1)
syringomyelia##41##1##(2005-8#2)(2006-5#34)(2007-8#3)(2010-2#1)(2011-2#1)
syringyl lignin##3##2##(2008-5#1)(2009-8#2)
syringyl##4##1##(2006-12#1)(2008-5#1)(2009-8#2)
syrinx cavity##3##2##(2006-5#3)
syrinx formation##5##2##(2006-5#5)
syrinx in##3##2##(2006-5#2)(2006-9#1)
syrinx##22##1##(2005-5#2)(2006-5#17)(2006-9#1)(2008-7#1)(2008-8#1)
syrup which##2##2##(1992-3#1)(2013-7#1)
syrup##32##1##(1990-10#1)(1990-6#1)(1991-1#1)(1992-3#1)(1995-11#1)(1997-4#1)(2007-2#2)(2007-9#1)(2008-10#5)(2008-5#3)(2008-7#2)(2012-1#4)(2012-12#4)(2012-2#2)(2013-7#3)
syrups by##2##2##(2008-10#2)
syrups##10##1##(2006-10#1)(2008-10#7)(2012-1#1)(2012-12#1)
system (AOS)##3##2##(1995-11#1)(2006-6#1)(2008-2#1)
system (EMR)##2##2##(2008-8#1)(2010-8#1)
system (IL-1##2##2##(1996-12#2)
system (QMS)##2##2##(1996-2#1)(2007-8#1)
system (RAAS) is##2##3##(2005-7#1)(2008-1#1)
system (RAAS)##7##2##(2005-7#1)(2007-1#3)(2008-1#2)(2013-1#1)
system (RAS)##12##2##(1991-5#1)(1992-8#1)(1993-12#1)(1995-10#1)(2005-7#2)(2008-7#1)(2009-10#1)(2009-4#1)(2012-3#1)(2013-1#2)
system (e##5##2##(1997-2#1)(2007-6#1)(2008-2#1)(2009-5#1)(2011-2#1)
system (elevated##2##2##(1990-11#2)
system (i##3##2##(1995-3#1)(2007-6#1)(2010-9#1)
system (in##2##2##(1992-8#1)(2010-6#1)
system (r##2##2##(1996-4#1)(2008-9#1)
system (the##5##2##(2008-10#2)(2009-7#1)(2013-1#2)
system A##3##2##(1992-1#1)(1992-11#1)(2008-1#1)
system BqsS-BqsR##2##2##(2009-6#2)
system FXIIIB##2##2##(1996-7#2)
system XAG-##2##2##(1990-12#2)
system ZEUS##2##2##(2006-6#2)
system a##12##2##(1995-7#1)(1996-6#1)(2006-10#2)(2007-4#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)
system aberrations##3##2##(1990-8#1)(2008-2#1)(2008-3#1)
system abnormalities##4##2##(1996-6#1)(2007-9#1)(2010-8#1)(2011-1#1)
system according to##3##3##(2007-8#1)(2008-2#1)(2012-11#1)
system accuracy##3##2##(2008-10#1)(2013-1#2)
system achieved##3##2##(2008-10#2)(2010-3#1)
system achieves##4##2##(2008-10#1)(2013-1#2)(2013-7#1)
system activation##5##2##(2006-10#1)(2007-12#1)(2007-2#1)(2009-4#1)(2010-2#1)
system activities##2##2##(2008-10#1)(2013-8#1)
system activity in##3##3##(1991-5#1)(2005-10#1)(2006-1#1)
system activity##13##2##(1991-5#3)(2005-10#1)(2006-1#1)(2008-3#2)(2008-4#1)(2008-7#3)(2009-10#1)(2011-2#1)
system acts as a##2##4##(2008-3#2)
system adapted to##2##3##(2008-10#2)
system adapted##3##2##(2008-10#2)(2012-2#1)
system adjusts##2##2##(1991-8#1)(2012-1#1)
system after##14##2##(1990-7#1)(1993-3#1)(1994-2#1)(1994-3#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-1#1)
system against##3##2##(1990-4#1)(1994-6#1)(2011-1#1)
system aimed at##2##3##(1996-1#1)(2008-7#1)
system all patients##2##3##(1995-7#1)(2012-2#1)
system all##3##2##(1995-7#1)(2008-3#1)(2012-2#1)
system allow##3##2##(2006-10#1)(2008-10#1)(2008-12#1)
system allowed determination of##2##4##(2008-10#2)
system allowed for##2##3##(2008-10#1)(2009-9#1)
system allowed the##4##3##(2006-4#1)(2008-10#3)
system allowed##11##2##(2006-4#1)(2007-8#1)(2008-10#8)(2009-9#1)
system allowing##7##2##(1993-2#1)(2005-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)
system allows for the##4##4##(2007-11#1)(2008-11#1)(2008-2#2)
system allows for##6##3##(1992-3#1)(2007-11#1)(2008-11#1)(2008-2#2)(2011-1#1)
system allows the##3##3##(1992-10#1)(2007-5#1)(2007-8#1)
system allows to##2##3##(2005-8#1)(2012-1#1)
system allows us to##2##4##(2008-10#1)(2008-3#1)
system allows##27##2##(1990-5#1)(1992-10#1)(1992-3#1)(2005-8#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#4)(2008-3#2)(2011-1#1)(2012-1#1)(2013-1#2)
system alone##3##2##(1992-8#1)(2008-11#1)(2009-12#1)
system along with##2##3##(1991-1#1)(2008-11#1)
system along##3##2##(1991-1#1)(2008-11#1)(2008-2#1)
system already##2##2##(2007-9#1)(2008-3#1)
system also contains##2##3##(1993-6#1)(2005-4#1)
system also##14##2##(1991-2#1)(1991-9#1)(1993-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(2005-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-4#1)
system always##2##2##(1997-2#1)(2008-8#1)
system an##2##2##(2008-2#1)(2010-9#1)
system analysis and##3##3##(2006-10#1)(2006-12#1)(2008-3#1)
system analysis##7##2##(2006-10#1)(2006-12#1)(2008-3#3)(2011-1#2)
system and (3)##2##3##(1991-5#1)(2009-5#1)
system and 0##3##3##(2008-10#2)(2010-4#1)
system and X-ray##2##3##(2005-1#1)(2006-4#1)
system and a computer##2##4##(2007-10#1)(2009-10#1)
system and a##20##3##(1990-5#1)(1991-3#1)(1992-5#1)(1995-3#1)(1996-3#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-12#4)(2008-10#3)(2008-3#1)(2009-10#1)(2010-9#1)(2011-12#1)(2012-2#1)
system and achieved##2##3##(2008-10#1)(2008-2#1)
system and an##7##3##(1996-11#1)(2006-10#2)(2007-12#2)(2007-8#1)(2009-12#1)
system and applied##2##3##(2007-11#1)(2008-10#1)
system and are##5##3##(1996-10#1)(2007-6#1)(2010-12#1)(2011-2#1)(2013-7#1)
system and can##3##3##(2007-12#1)(2007-8#1)(2010-7#1)
system and data##2##3##(2008-12#1)(2008-2#1)
system and for##6##3##(1995-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)
system and functional##2##3##(2008-9#1)(2009-10#1)
system and have##5##3##(1990-5#1)(1991-6#1)(2007-11#2)(2007-9#1)
system and how##3##3##(2006-10#1)(2008-9#1)(2010-12#1)
system and illustrates the##2##4##(1993-11#1)(2006-11#1)
system and immune##2##3##(2006-1#1)(2008-7#1)
system and in the##3##4##(1996-7#1)(2006-10#1)(2008-10#1)
system and in##9##3##(1990-7#1)(1992-12#1)(1996-11#1)(1996-7#1)(2006-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-9#1)
system and increase##2##3##(2008-10#1)(2011-1#1)
system and is##3##3##(2008-10#1)(2010-12#1)(2011-2#1)
system and it##2##3##(1990-2#1)(2013-1#1)
system and its application to the##2##6##(2008-10#1)(2008-2#1)
system and its application to##4##5##(2008-10#3)(2008-2#1)
system and its application##5##4##(2008-10#4)(2008-2#1)
system and its##21##3##(1993-3#1)(1993-4#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-8#1)(2005-11#1)(2006-3#1)(2006-6#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-7#1)(2012-3#2)
system and lead to##2##4##(1996-11#1)(2010-4#1)
system and lower##2##3##(2005-4#1)(2006-10#1)
system and may##4##3##(1995-1#1)(2008-10#2)(2008-4#1)
system and mixed##2##3##(2008-10#1)(2010-8#1)
system and more##2##3##(2007-12#1)(2008-7#1)
system and obtained##3##3##(1992-6#1)(1997-7#1)(2008-8#1)
system and of the##3##4##(1994-12#1)(2007-9#1)(2013-8#1)
system and of##5##3##(1994-12#1)(2007-9#1)(2011-1#2)(2013-8#1)
system and other##6##3##(1990-12#2)(1991-7#1)(2007-6#1)(2008-9#1)(2011-1#1)
system and others##2##3##(2008-2#1)(2011-2#1)
system and possible##3##3##(1991-11#1)(2007-10#1)(2011-2#1)
system and proper##2##3##(2008-4#1)(2013-1#1)
system and provide a##2##4##(2010-4#1)(2013-8#1)
system and provide##3##3##(1995-5#1)(2010-4#1)(2013-8#1)
system and provides##3##3##(1990-12#1)(2012-12#2)
system and show that##3##4##(2007-12#2)(2008-2#1)
system and show##4##3##(2007-12#2)(2008-2#2)
system and suggest##2##3##(1994-8#1)(1995-12#1)
system and that##3##3##(1995-5#1)(2007-2#1)(2008-5#1)
system and the amounts of##2##5##(2008-10#2)
system and the presence of##2##5##(1993-6#1)(2012-3#1)
system and the##86##3##(1990-10#1)(1990-3#1)(1990-4#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-6#1)(1993-11#1)(1993-12#3)(1993-6#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-12#2)(1995-9#1)(1996-1#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-8#3)(2008-1#2)(2008-10#18)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-4#2)(2010-8#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-3#2)(2013-1#4)
system and their##4##3##(1993-11#1)(2005-8#1)(2006-10#1)(2008-10#1)
system and then##3##3##(1992-1#1)(2007-12#1)(2008-10#1)
system and those obtained##2##4##(2008-10#2)
system and those##3##3##(2008-10#2)(2009-11#1)
system and thus##6##3##(1991-2#1)(1996-2#1)(1997-3#1)(2009-8#1)(2011-12#1)(2012-3#1)
system and to determine the##2##5##(2006-1#1)(2008-2#1)
system and to determine##4##4##(2005-8#1)(2006-1#1)(2008-10#1)(2008-2#1)
system and to##17##3##(1996-2#1)(2005-8#1)(2006-1#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#1)(2009-6#1)(2010-8#1)
system and transported to##2##4##(1994-11#1)(1995-4#1)
system and was##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
system and were##2##3##(2008-10#1)(2012-2#1)
system and with##2##3##(1990-9#1)(2008-11#1)
system and##556##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#3)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#4)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#3)(1992-4#2)(1992-5#1)(1992-6#3)(1992-8#1)(1993-11#5)(1993-12#5)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#2)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#1)(1994-8#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#6)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#3)(1995-9#3)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#4)(1996-2#3)(1996-3#2)(1996-4#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#1)(2004-12#1)(2005-1#1)(2005-10#1)(2005-11#5)(2005-12#1)(2005-4#1)(2005-8#5)(2006-1#3)(2006-10#15)(2006-11#2)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#6)(2006-8#1)(2007-1#2)(2007-10#3)(2007-11#9)(2007-12#23)(2007-2#2)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#10)(2007-9#4)(2008-1#10)(2008-10#86)(2008-11#15)(2008-12#5)(2008-2#19)(2008-3#16)(2008-4#7)(2008-5#8)(2008-7#13)(2008-8#7)(2008-9#9)(2009-10#3)(2009-11#1)(2009-12#4)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#3)(2010-12#9)(2010-2#1)(2010-4#9)(2010-5#1)(2010-7#1)(2010-8#8)(2010-9#1)(2011-1#7)(2011-12#4)(2011-2#20)(2012-1#4)(2012-11#4)(2012-12#6)(2012-2#5)(2012-3#8)(2013-1#15)(2013-7#2)(2013-8#8)
system anomalies##2##2##(1992-12#1)(1996-1#1)
system appears to##7##3##(1991-3#1)(1991-8#1)(1991-9#1)(1993-6#1)(1995-12#1)(2005-9#1)(2007-11#1)
system applicable to##2##3##(2006-6#1)(2008-11#1)
system applications##4##2##(2007-12#2)(2008-3#2)
system applied to##2##3##(2008-10#1)(2008-7#1)
system applied##3##2##(2006-8#1)(2008-10#1)(2008-7#1)
system approach##6##2##(2006-5#1)(2008-2#1)(2009-9#1)(2010-12#2)(2012-3#1)
system architecture##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
system architectures##2##2##(2007-5#1)(2008-3#1)
system are also presented##2##4##(2007-12#1)(2008-2#1)
system are also##5##3##(2006-12#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-5#1)
system are analyzed##3##3##(1990-12#1)(2008-3#1)(2012-12#1)
system are compared with##2##4##(2008-2#2)
system are connected##2##3##(2007-12#1)(2007-8#1)
system are considered##2##3##(1991-3#1)(2008-2#1)
system are derived and##2##4##(2008-2#1)(2008-3#1)
system are described##8##3##(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2010-2#1)(2012-1#2)
system are discussed in detail##2##5##(2008-10#1)(2008-3#1)
system are discussed in##3##4##(2008-10#1)(2008-3#1)(2009-2#1)
system are discussed##8##3##(2008-10#3)(2008-2#1)(2008-3#1)(2009-2#1)(2010-12#1)(2011-2#1)
system are involved in##2##4##(2008-1#1)(2008-10#1)
system are measured##2##3##(2007-12#2)
system are presented##11##3##(2007-11#4)(2007-12#1)(2008-2#3)(2008-3#2)(2012-1#1)
system are reviewed##2##3##(2006-5#1)(2013-1#1)
system are shown##3##3##(2007-11#1)(2007-12#1)(2008-1#1)
system are the##4##3##(1990-11#1)(2006-10#1)(2007-5#1)(2013-1#1)
system are used##3##3##(2008-3#1)(2012-12#2)
system are##139##2##(1990-11#2)(1990-12#1)(1991-3#1)(1991-9#1)(1993-3#2)(1994-10#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#2)(1996-5#1)(1997-2#1)(2005-10#1)(2005-11#4)(2006-10#2)(2006-12#2)(2006-3#1)(2006-5#1)(2007-11#8)(2007-12#12)(2007-5#2)(2007-8#3)(2008-1#4)(2008-10#11)(2008-11#1)(2008-2#18)(2008-3#10)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#2)(2009-2#1)(2009-8#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#3)(2012-12#5)(2012-2#3)(2013-1#2)(2013-8#1)
system around##2##2##(1997-2#1)(2008-5#1)
system as a function of##2##5##(2008-10#1)(2008-2#1)
system as a method to##2##5##(2007-11#1)(2007-8#1)
system as a novel##2##4##(1996-11#1)(2009-9#1)
system as a whole##2##4##(1996-3#1)(2012-2#1)
system as a##28##3##(1990-3#1)(1990-4#1)(1993-11#1)(1993-6#1)(1994-11#1)(1995-12#1)(1996-11#1)(1996-3#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-5#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-4#1)(2012-2#1)
system as an example##2##4##(2007-12#1)(2008-9#1)
system as an##5##3##(2006-12#1)(2007-12#1)(2008-2#1)(2008-9#1)(2010-7#1)
system as it##3##3##(1994-1#1)(2012-12#1)(2012-3#1)
system as the##4##3##(2008-2#1)(2009-3#1)(2012-3#1)(2013-1#1)
system as well as its##2##5##(1993-12#1)(2006-10#1)
system as well as the##6##5##(1993-12#1)(1995-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
system as well as##17##4##(1991-12#1)(1993-12#2)(1995-9#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
system as well##18##3##(1991-12#1)(1993-12#2)(1995-9#1)(2006-10#1)(2007-11#3)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
system as##79##2##(1990-3#1)(1990-4#1)(1991-12#1)(1991-2#1)(1991-9#1)(1993-11#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1995-11#1)(1995-12#2)(1995-9#1)(1996-11#1)(1996-3#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-5#1)(2007-11#4)(2007-12#4)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-7#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#6)
system assembly##2##2##(2008-2#2)
system associated with##5##3##(1995-12#1)(2006-12#1)(2008-10#1)(2008-5#1)(2012-3#1)
system at 1##2##3##(2007-12#2)
system at 25 degrees C##2##5##(1990-12#1)(2008-10#1)
system at a##4##3##(1992-5#1)(1995-2#1)(2007-11#1)(2008-10#1)
system at different##2##3##(2006-10#1)(2008-3#1)
system at equilibrium##2##3##(1990-8#1)(2008-10#1)
system at the##12##3##(1993-12#1)(1996-12#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-2#1)(2010-6#1)
system at##46##2##(1990-12#2)(1990-8#1)(1991-8#1)(1992-5#1)(1993-12#1)(1995-2#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#1)(1997-2#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-4#1)(2007-11#2)(2007-12#3)(2007-2#1)(2008-1#1)(2008-10#5)(2008-2#4)(2008-3#4)(2008-4#1)(2008-8#1)(2009-2#1)(2010-4#1)(2010-6#1)(2012-1#1)(2013-1#3)
system atrophy (MSA)##3##3##(2008-11#1)(2008-7#2)
system atrophy with predominant parkinsonism##2##5##(2013-8#2)
system atrophy##15##2##(2008-11#4)(2008-7#8)(2009-11#1)(2013-8#2)
system attractive##2##2##(2008-11#1)(2008-2#1)
system automatically##3##2##(1995-12#1)(2008-11#1)(2010-8#1)
system back##2##2##(2008-3#2)
system bandwidth is##2##3##(2008-3#2)
system bandwidth##4##2##(2008-2#1)(2008-3#3)
system based on a##17##4##(2005-11#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-7#1)(2009-4#1)(2012-1#1)
system based on an array of##2##6##(2008-10#2)
system based on an##4##4##(2007-12#1)(2008-10#2)(2008-2#1)
system based on multicommutation##2##4##(2007-10#1)(2008-10#1)
system based on optical##3##4##(2007-11#2)(2007-12#1)
system based on the##20##4##(1991-3#1)(1991-7#1)(1992-2#1)(1994-3#1)(1997-2#1)(2007-12#1)(2008-10#5)(2008-2#3)(2008-3#3)(2008-6#1)(2010-8#1)(2013-8#1)
system based on##96##3##(1991-3#1)(1991-7#1)(1992-1#1)(1992-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-6#1)(1997-2#1)(1997-6#1)(2004-2#1)(2005-11#1)(2006-6#1)(2007-10#1)(2007-11#6)(2007-12#9)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#21)(2008-11#1)(2008-2#14)(2008-3#10)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-4#2)(2010-8#2)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
system based##99##2##(1991-3#1)(1991-7#1)(1992-1#1)(1992-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-6#1)(1997-2#1)(1997-6#1)(2004-2#1)(2005-11#1)(2006-6#1)(2007-10#1)(2007-11#6)(2007-12#9)(2007-5#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#21)(2008-11#1)(2008-2#14)(2008-3#10)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-4#2)(2010-8#2)(2011-2#1)(2011-3#1)(2012-1#1)(2013-1#1)(2013-8#1)
system became##2##2##(2008-3#1)(2010-1#1)
system because of the##2##4##(2007-10#1)(2007-12#1)
system because of##3##3##(1996-6#1)(2007-10#1)(2007-12#1)
system because##6##2##(1996-6#1)(2007-10#1)(2007-12#1)(2008-3#1)(2008-5#1)(2009-6#1)
system becomes##2##2##(2007-9#1)(2008-5#1)
system before##2##2##(1995-3#1)(2012-1#1)
system being##3##2##(2007-9#1)(2008-10#1)(2008-5#1)
system between##3##2##(1995-11#1)(2006-10#1)(2008-3#1)
system biology##3##2##(2011-2#1)(2013-1#2)
system both in##2##3##(2005-11#1)(2010-5#1)
system both##5##2##(2005-11#1)(2006-8#1)(2008-11#1)(2010-5#1)(2010-9#1)
system built##5##2##(1995-1#1)(2007-12#1)(2008-7#1)(2012-1#1)(2012-12#1)
system but also##5##3##(1994-9#1)(1995-8#1)(1997-7#1)(2006-6#1)(2012-6#1)
system but##13##2##(1994-6#1)(1994-9#1)(1995-8#1)(1997-7#1)(2006-10#1)(2006-6#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-2#1)(2012-6#1)(2013-1#2)
system by a##2##3##(1991-2#1)(2010-8#1)
system by acting as##2##4##(2007-12#2)
system by adding##2##3##(2004-9#1)(2011-12#1)
system by an##2##3##(2006-6#1)(2008-4#1)
system by means of a##2##5##(1992-2#1)(2008-10#1)
system by the##13##3##(1991-7#1)(1992-11#1)(1996-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-7#2)(2011-2#1)(2012-1#1)
system by use of a##2##5##(2007-11#1)(2008-3#1)
system by use of##4##4##(2007-11#1)(2008-2#1)(2008-3#2)
system by using##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
system by##90##2##(1990-11#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-7#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-10#1)(1996-1#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-7#1)(2004-9#1)(2005-8#1)(2006-12#1)(2006-6#1)(2007-11#3)(2007-12#4)(2007-7#1)(2008-1#2)(2008-10#9)(2008-11#5)(2008-2#5)(2008-3#11)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#3)(2009-2#1)(2010-2#2)(2010-8#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#2)(2013-1#2)
system called##6##2##(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-1#1)
system can also be used##2##5##(2010-8#1)(2011-1#1)
system can also be##5##4##(1995-2#1)(2006-6#1)(2008-10#1)(2010-8#1)(2011-1#1)
system can also##9##3##(1992-12#1)(1995-2#1)(2006-6#1)(2008-10#1)(2008-3#1)(2010-12#1)(2010-8#1)(2011-1#2)
system can be a##3##4##(1992-12#1)(2008-10#1)(2008-7#1)
system can be activated by##2##5##(1994-11#1)(1997-3#1)
system can be controlled##2##4##(2008-2#1)(2008-4#1)
system can be easily##2##4##(2008-10#1)(2008-3#1)
system can be enhanced by##2##5##(2008-10#2)
system can be readily applied to the##2##7##(1992-11#1)(2008-10#1)
system can be used for##4##5##(2007-12#1)(2008-3#2)(2010-1#1)
system can be used to study##2##6##(2008-10#1)(2010-11#1)
system can be used to##8##5##(1996-12#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-11#1)(2011-2#1)
system can be used##15##4##(1990-4#1)(1996-12#1)(2006-12#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-7#1)(2010-1#1)(2010-11#1)(2011-2#1)
system can be##69##3##(1990-2#1)(1990-4#1)(1992-11#1)(1992-12#1)(1994-11#1)(1994-2#1)(1995-2#1)(1996-1#1)(1996-12#1)(1997-3#1)(2006-12#2)(2006-5#2)(2006-6#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#14)(2008-11#2)(2008-2#5)(2008-3#11)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-9#1)(2010-1#1)(2010-11#1)(2011-2#3)(2013-8#1)
system can contribute##2##3##(2008-3#1)(2010-6#1)
system can detect##2##3##(2007-12#1)(2010-8#1)
system can improve##3##3##(2007-10#1)(2013-1#2)
system can perform##3##3##(2008-10#1)(2008-3#2)
system can provide a##2##4##(2008-10#1)(2008-2#1)
system can provide##5##3##(1993-2#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
system can recognize##3##3##(2008-2#1)(2008-3#1)(2008-4#1)
system can result in##3##4##(2008-2#1)(2008-9#1)(2010-9#1)
system can##139##2##(1990-2#1)(1990-4#1)(1992-11#1)(1992-12#2)(1992-3#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-2#3)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#2)(1997-3#2)(1997-4#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-5#2)(2006-6#3)(2007-10#1)(2007-11#1)(2007-12#8)(2007-5#1)(2007-8#1)(2008-1#4)(2008-10#21)(2008-11#2)(2008-2#11)(2008-3#19)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#4)(2011-2#4)(2012-2#1)(2013-1#3)(2013-8#1)
system cannot##2##2##(1992-12#1)(2007-12#1)
system capabilities##2##2##(1991-12#1)(2011-1#1)
system capable of##8##3##(1993-9#1)(1994-2#1)(1996-1#1)(1996-12#1)(2005-10#1)(2006-6#1)(2008-10#1)(2009-8#1)
system capable##9##2##(1993-9#1)(1994-2#1)(1996-1#1)(1996-12#1)(2005-10#1)(2006-6#1)(2008-10#2)(2009-8#1)
system capacity##3##2##(1996-11#1)(2011-2#1)(2012-12#1)
system caused by##4##3##(1996-1#1)(2007-11#1)(2008-2#1)(2008-7#1)
system caused##6##2##(1996-1#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-2#1)(2008-7#1)
system causes##3##2##(2007-9#1)(2008-10#1)(2010-2#1)
system cells##3##2##(1996-12#1)(2007-3#1)(2012-1#1)
system changes##2##2##(1996-2#1)(2007-8#1)
system characteristics to mitigate##2##4##(2008-2#1)(2008-3#1)
system characteristics##4##2##(2008-2#1)(2008-3#2)(2009-4#1)
system collects##2##2##(2008-3#1)(2010-5#1)
system combined with a##2##4##(2007-8#1)(2008-10#1)
system combined with##7##3##(2007-10#1)(2007-8#1)(2008-10#3)(2008-3#1)(2009-4#1)
system combined##9##2##(2007-10#1)(2007-8#1)(2008-10#5)(2008-3#1)(2009-4#1)
system combines##5##2##(1997-4#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-3#1)
system combining a##2##3##(2008-10#1)(2008-5#1)
system combining##3##2##(2007-12#1)(2008-10#1)(2008-5#1)
system compared to other##2##4##(1997-8#1)(2008-9#1)
system compared to##3##3##(1997-8#1)(2008-9#1)(2010-8#1)
system compared with that of##2##5##(2008-3#1)(2012-2#1)
system compared with that##3##4##(2008-10#1)(2008-3#1)(2012-2#1)
system compared with##5##3##(1994-9#1)(2006-10#1)(2008-10#1)(2008-3#1)(2012-2#1)
system compared##8##2##(1994-9#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-8#1)(2012-2#1)
system complexity##3##2##(2008-2#2)(2008-3#1)
system components and##3##3##(2008-3#1)(2012-1#1)(2013-1#1)
system components in##3##3##(2010-8#2)(2012-1#1)
system components##17##2##(1994-6#1)(1996-12#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-9#1)(2010-8#2)(2011-1#1)(2012-1#3)(2013-1#1)
system composed of a##4##4##(2008-10#1)(2008-3#2)(2010-10#1)
system composed of the##3##4##(1990-5#1)(2008-5#1)(2010-5#1)
system composed of##17##3##(1990-5#1)(1992-7#1)(2005-12#1)(2007-8#1)(2008-10#1)(2008-3#3)(2008-5#1)(2010-10#1)(2010-5#1)(2011-1#3)(2012-1#2)(2012-2#1)
system composed##18##2##(1990-5#1)(1992-7#1)(2005-12#1)(2007-8#1)(2008-10#1)(2008-3#3)(2008-5#1)(2008-7#1)(2010-10#1)(2010-5#1)(2011-1#3)(2012-1#2)(2012-2#1)
system comprised of a##2##4##(2007-8#1)(2008-10#1)
system comprised of##3##3##(1993-4#1)(2007-8#1)(2008-10#1)
system comprised##5##2##(1993-4#1)(2007-10#1)(2007-8#1)(2008-10#2)
system comprises a##2##3##(2007-11#1)(2007-12#1)
system comprises two##2##3##(1994-12#1)(2008-7#1)
system comprises##6##2##(1994-12#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)
system comprising high performance liquid chromatography##2##6##(2008-10#1)(2012-1#1)
system comprising##5##2##(1992-8#1)(1994-9#1)(2008-10#1)(2009-8#1)(2012-1#1)
system configuration##6##2##(2008-2#3)(2008-3#1)(2009-2#1)(2010-2#1)
system conforms to##2##3##(2008-10#2)
system connected to a flow##2##5##(2008-10#2)
system connected to##3##3##(2008-10#2)(2009-10#1)
system consisted of a##3##4##(2007-8#1)(2008-10#1)(2010-2#1)
system consisted of##10##3##(1991-9#1)(1996-5#1)(2007-8#2)(2008-10#4)(2008-5#1)(2010-2#1)
system consisting of a##9##4##(2007-11#2)(2007-12#3)(2008-10#2)(2008-3#2)
system consisting of two##5##4##(1994-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
system consisting of##35##3##(1990-11#1)(1990-5#1)(1991-2#1)(1991-5#1)(1993-2#1)(1993-8#1)(1994-2#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-9#1)(2004-12#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-11#2)(2007-12#4)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#4)(2009-4#1)(2009-8#1)(2010-1#1)(2010-4#1)
system consists of a##16##4##(2006-12#1)(2007-11#1)(2007-12#4)(2008-10#4)(2008-11#1)(2008-2#3)(2009-5#1)(2010-9#1)
system consists of an##2##4##(2007-12#1)(2012-1#1)
system consists of three##2##4##(2006-6#2)
system consists of two##5##4##(2006-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-12#1)
system consists of##38##3##(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#3)(2007-11#1)(2007-12#5)(2008-10#7)(2008-11#1)(2008-2#6)(2008-3#4)(2008-4#1)(2009-5#1)(2010-9#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
system consists##40##2##(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#3)(2007-11#1)(2007-12#5)(2008-10#8)(2008-11#1)(2008-2#6)(2008-3#4)(2008-4#1)(2009-5#1)(2010-9#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#2)(2013-8#1)
system containing a##4##3##(1993-9#1)(2008-10#2)(2010-8#1)
system containing both##2##3##(1996-3#1)(2008-5#1)
system containing purified##2##3##(1990-7#1)(1993-4#1)
system containing the##2##3##(2008-10#1)(2009-2#1)
system containing##31##2##(1990-7#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-3#1)(1995-6#2)(1995-7#1)(1996-3#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#11)(2008-5#3)(2009-2#2)(2010-8#1)(2012-12#1)
system contains a##2##3##(1994-8#1)(2008-10#1)
system contains##6##2##(1992-7#1)(1994-8#1)(2005-4#1)(2008-10#1)(2008-3#1)(2009-8#1)
system contributes to##2##3##(2008-3#1)(2011-1#1)
system control and##2##3##(1991-5#1)(2012-3#1)
system control##3##2##(1991-5#1)(2008-10#1)(2012-3#1)
system controls##2##2##(1992-10#1)(2011-2#1)
system correlates##2##2##(2008-11#1)(2013-8#1)
system cost##3##2##(1993-3#1)(2007-12#1)(2013-8#1)
system could be used##3##4##(2006-2#1)(2011-2#1)(2013-1#1)
system could be##18##3##(1990-4#1)(1994-11#1)(1996-8#1)(2006-2#1)(2006-6#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-7#1)(2009-6#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-1#2)
system could##33##2##(1990-4#1)(1992-3#1)(1992-4#1)(1994-11#1)(1995-1#1)(1996-8#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#2)(2008-10#7)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-1#3)
system coupled to a flame atomic absorption spectrometer##2##8##(2008-10#2)
system coupled to a##4##4##(2004-8#1)(2008-10#3)
system coupled to##12##3##(1995-3#1)(2004-8#1)(2007-8#1)(2008-10#9)
system coupled with a##3##4##(2008-10#3)
system coupled with##4##3##(2008-10#4)
system coupled##16##2##(1995-3#1)(2004-8#1)(2007-8#1)(2008-10#13)
system coupling##2##2##(2008-10#2)
system covering##2##2##(2008-10#1)(2012-12#1)
system critical for##2##3##(2005-8#1)(2008-11#1)
system damage##9##2##(1991-3#1)(1992-5#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(2007-11#1)(2010-12#1)(2012-1#1)
system data##3##2##(1995-5#1)(2009-3#1)(2012-5#1)
system decreased##2##2##(2009-11#1)(2009-4#1)
system decreases with##2##3##(2008-10#1)(2008-3#1)
system decreases##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
system delivers##3##2##(1997-4#1)(2007-12#1)(2008-1#1)
system demonstrated the##2##3##(1990-12#1)(1996-5#1)
system demonstrated##5##2##(1990-12#1)(1996-5#1)(2008-10#1)(2008-6#1)(2010-8#1)
system demonstration##2##2##(2008-2#1)(2008-3#1)
system depended on##2##3##(2012-1#1)(2012-10#1)
system depended##3##2##(1996-9#1)(2012-1#1)(2012-10#1)
system depending##2##2##(2006-6#1)(2008-8#1)
system depends on the##4##4##(1990-9#1)(2004-4#1)(2008-10#1)(2008-3#1)
system depends on##7##3##(1990-9#1)(1993-3#1)(2004-4#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-10#1)
system depends##8##2##(1990-9#1)(1991-3#1)(1993-3#1)(2004-4#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-10#1)
system derived from##2##3##(1996-1#1)(2004-8#1)
system described here##4##3##(1994-2#1)(2008-2#1)(2008-5#1)(2011-1#1)
system described in this unit##2##5##(2008-2#1)(2008-4#1)
system described in this##4##4##(2008-10#1)(2008-2#1)(2008-4#1)(2012-1#1)
system described##12##2##(1990-12#1)(1994-2#1)(1995-7#1)(1996-3#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-1#1)
system design and##4##3##(2008-2#3)(2008-9#1)
system design are discussed##2##4##(2008-1#1)(2008-2#1)
system design for a##2##4##(2008-3#2)
system design for##4##3##(2008-10#2)(2008-3#2)
system design is##2##3##(2008-2#1)(2008-3#1)
system design##28##2##(1992-4#1)(1994-1#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-2#10)(2008-3#6)(2008-9#1)(2010-2#1)(2013-1#2)
system designed for##2##3##(2008-2#1)(2008-7#1)
system designed to##5##3##(1993-2#1)(1995-2#1)(2008-3#1)(2008-5#1)(2010-8#1)
system designed##12##2##(1993-2#1)(1995-2#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-8#1)(2013-7#1)
system designers and##2##3##(2008-2#2)
system designers##3##2##(2008-2#3)
system designs##4##2##(1993-2#1)(2007-1#1)(2008-3#2)
system detects##2##2##(2008-10#2)
system determines##2##2##(2006-10#1)(2008-2#1)
system developed and implemented by##2##5##(1996-12#1)(2013-1#1)
system developed at##2##3##(2007-12#1)(2008-2#1)
system developed by the##2##4##(1996-3#1)(2008-10#1)
system developed for##3##3##(1997-1#1)(2005-10#1)(2008-10#1)
system developed in##3##3##(2008-10#2)(2013-1#1)
system developed is##2##3##(2008-10#2)
system developed##21##2##(1995-1#1)(1996-12#1)(1996-3#1)(1997-1#1)(2005-10#1)(2006-2#2)(2007-12#2)(2008-10#8)(2008-11#1)(2008-2#1)(2013-1#2)
system development and##3##3##(2006-1#1)(2008-7#2)
system development in##2##3##(2007-12#1)(2008-7#1)
system development##18##2##(1992-12#1)(1993-6#1)(1994-2#1)(1994-3#1)(1996-4#1)(1997-6#1)(2006-1#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#4)(2008-8#1)(2013-1#1)
system did not##6##3##(1995-3#1)(1997-2#1)(2006-10#1)(2008-8#1)(2009-5#1)(2009-6#1)
system differs from##2##3##(2008-2#1)(2008-5#1)
system differs##3##2##(2008-2#1)(2008-5#1)(2008-9#1)
system diseases are##2##3##(2009-5#1)(2010-12#1)
system diseases##9##2##(1990-11#1)(1993-5#1)(1994-9#1)(2005-11#1)(2009-5#1)(2010-12#1)(2013-1#3)
system disorders in##3##3##(2004-12#1)(2006-6#1)(2013-1#1)
system disorders##9##2##(1993-11#1)(2004-12#1)(2006-6#1)(2008-4#1)(2008-9#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-1#1)
system displays##2##2##(2008-10#1)(2010-5#1)
system disturbances##4##2##(1997-8#1)(2008-12#2)(2008-3#1)
system does not require##3##4##(2008-3#1)(2013-1#2)
system does not##12##3##(1994-3#1)(2006-2#1)(2006-5#1)(2008-3#3)(2008-8#2)(2009-4#1)(2011-2#1)(2013-1#2)
system does##13##2##(1994-3#1)(2006-2#1)(2006-5#1)(2007-4#1)(2008-3#3)(2008-8#2)(2009-4#1)(2011-2#1)(2013-1#2)
system driven by##3##3##(2007-12#2)(2009-2#1)
system drugs##4##2##(2008-11#1)(2010-12#2)(2010-5#1)
system due to##4##3##(1992-1#1)(2008-10#1)(2008-7#1)(2012-3#1)
system during the##7##3##(1994-12#1)(1996-10#1)(2006-11#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-5#1)
system during##22##2##(1994-12#1)(1995-4#1)(1995-5#1)(1996-10#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-11#1)(2007-6#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-4#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#1)(2013-8#1)
system dynamics##3##2##(1996-4#1)(2008-9#1)(2010-8#1)
system dysfunction##8##2##(1996-12#1)(2006-3#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-4#1)(2010-12#1)
system effects##10##2##(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#3)(2009-12#1)(2010-8#1)(2012-3#1)
system efficiency##3##2##(1991-5#1)(2008-11#1)(2008-3#1)
system emitting##2##2##(2007-12#2)
system employed##2##2##(1990-8#1)(1996-4#1)
system employing a##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
system employing the##3##3##(2006-12#1)(2007-12#1)(2008-10#1)
system employing##11##2##(1991-4#1)(1991-9#1)(2006-12#1)(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#1)
system employs a##2##3##(2007-11#1)(2008-10#1)
system employs##9##2##(2007-11#2)(2008-10#4)(2008-3#1)(2008-4#1)(2008-9#1)
system enabled##2##2##(1995-11#1)(2007-8#1)
system enables a##2##3##(2008-10#1)(2008-11#1)
system enables the##3##3##(2008-10#2)(2008-11#1)
system enables##13##2##(1991-9#1)(1996-12#1)(2006-5#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-7#1)(2009-10#1)
system enhances##2##2##(2008-10#1)(2013-8#1)
system equipped with a##4##4##(1993-7#1)(2006-12#1)(2008-10#2)
system equipped with##8##3##(1993-7#1)(2006-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-8#1)
system errors##2##2##(2008-3#1)(2013-8#1)
system especially##2##2##(1991-11#1)(2008-3#1)
system established##2##2##(1993-12#1)(1996-6#1)
system evaluation##3##2##(2007-10#1)(2007-4#1)(2008-10#1)
system evolution##2##2##(1997-3#1)(2008-9#1)
system evolved from##2##3##(1994-12#1)(2008-11#1)
system evolved to##2##3##(2008-11#1)(2008-7#1)
system evolved##5##2##(1994-12#1)(2008-11#3)(2008-7#1)
system excitations for each##2##4##(2008-2#2)
system exhibited##6##2##(1995-2#1)(2008-10#3)(2010-4#1)(2013-7#1)
system exhibits a##2##3##(1996-8#1)(2008-10#1)
system exhibits##10##2##(1991-3#1)(1996-8#1)(2006-10#2)(2007-12#3)(2008-10#1)(2008-2#1)(2010-5#1)
system exists##3##2##(1992-3#1)(1994-9#1)(2012-2#1)
system exploiting multicommutation##2##3##(2008-10#2)
system exploiting##3##2##(2008-10#2)(2008-2#1)
system expressing##2##2##(2008-11#1)(2008-8#1)
system facilitates##5##2##(1995-6#1)(2008-11#1)(2008-2#1)(2012-1#1)(2012-12#1)
system factors##2##2##(2010-12#1)(2010-8#1)
system failed##2##2##(1991-4#1)(2010-2#1)
system failure##5##2##(2006-10#4)(2012-3#1)
system features##2##2##(2008-10#1)(2008-3#1)
system following##6##2##(1995-12#1)(2005-5#1)(2007-9#1)(2008-10#1)(2012-1#1)(2013-1#1)
system for DNA##3##3##(2006-6#1)(2007-8#1)(2011-2#1)
system for a##16##3##(1992-11#1)(1996-3#1)(1997-2#1)(2006-2#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#2)(2010-7#1)(2010-8#1)(2012-1#1)
system for acute##2##3##(2006-12#1)(2008-1#1)
system for all##5##3##(1996-2#1)(2007-11#1)(2008-2#1)(2008-4#2)
system for ambulatory care##3##4##(1993-12#1)(1994-3#2)
system for ambulatory##5##3##(1991-1#2)(1993-12#1)(1994-3#2)
system for an##5##3##(2006-5#1)(2008-3#2)(2012-1#2)
system for analysis of the##2##5##(1990-8#1)(2008-5#1)
system for analysis of##5##4##(1990-8#2)(1995-1#1)(2008-5#1)(2009-8#1)
system for analyzing##3##3##(1990-6#1)(2008-2#1)(2012-1#1)
system for assessing the##2##4##(2008-5#1)(2010-9#1)
system for assessing##3##3##(2008-11#1)(2008-5#1)(2010-9#1)
system for automated dissolution testing##2##5##(2008-10#2)
system for automated##4##3##(2008-10#4)
system for automatic determination of chemical oxygen demand##2##8##(2008-10#2)
system for automatic##4##3##(2008-10#2)(2008-2#1)(2011-1#1)
system for bidirectional##2##3##(2008-1#1)(2008-3#1)
system for biomedical##3##3##(2008-11#1)(2013-7#2)
system for broadband##3##3##(2007-12#2)(2008-3#1)
system for cardiac##2##3##(2007-8#2)
system for copper##3##3##(2008-10#3)
system for data##3##3##(1996-8#1)(2013-1#2)
system for detecting the##2##4##(2010-8#1)(2013-1#1)
system for detecting##4##3##(2007-12#1)(2008-4#1)(2010-8#1)(2013-1#1)
system for detection of##3##4##(2008-10#1)(2008-3#1)(2010-8#1)
system for determination of ascorbic acid##2##6##(2008-10#2)
system for determination of##7##4##(2008-10#7)
system for determination##9##3##(2008-10#8)(2010-8#1)
system for determining##4##3##(2007-8#1)(2008-10#2)(2010-8#1)
system for digital##2##3##(2007-12#1)(2008-3#1)
system for dynamic##2##3##(2006-5#1)(2008-10#1)
system for early detection of##2##5##(2007-11#1)(2008-5#1)
system for early##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)
system for efficient##3##3##(2008-11#2)(2011-1#1)
system for evaluating##2##3##(2007-8#1)(2008-10#1)
system for evaluation of##2##4##(2007-11#1)(2008-5#1)
system for expanding##2##3##(1992-2#1)(2005-8#1)
system for generating##3##3##(1994-12#1)(2006-12#1)(2012-12#1)
system for health care##2##4##(1993-2#1)(1993-3#1)
system for high##4##3##(2005-8#1)(2008-2#1)(2008-3#1)(2008-7#1)
system for human##5##3##(1990-3#1)(1990-8#1)(1996-1#2)(1996-6#1)
system for identifying named entities##2##5##(2008-7#2)
system for imaging through##2##4##(2008-1#1)(2008-2#1)
system for imaging##4##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
system for in##3##3##(2008-11#1)(2008-2#1)(2009-8#1)
system for lead##2##3##(2008-10#2)
system for making##2##3##(2008-10#1)(2010-12#1)
system for many##2##3##(1993-3#1)(2007-12#1)
system for measurement of the##2##5##(2008-2#1)(2008-3#1)
system for measurement of##3##4##(2008-2#1)(2008-3#2)
system for measuring the##4##4##(2008-10#1)(2008-3#1)(2008-5#1)(2013-8#1)
system for measuring##7##3##(1996-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-1#1)(2013-8#1)
system for medical##4##3##(2007-4#1)(2008-3#1)(2013-1#2)
system for monitoring##4##3##(1997-1#1)(1997-2#1)(2008-10#1)(2010-8#1)
system for on-line preconcentration and determination of##2##7##(2008-10#2)
system for on-line##6##3##(2008-10#5)(2008-3#1)
system for optical##2##3##(2007-12#1)(2008-2#1)
system for physician##3##3##(1992-1#1)(1992-12#1)(2013-1#1)
system for plant##2##3##(1994-11#1)(2010-2#1)
system for preclinical##2##3##(2008-11#1)(2012-11#1)
system for preconcentration and determination of##3##6##(2007-8#1)(2008-10#2)
system for primary##3##3##(1991-9#1)(1996-4#2)
system for producing##2##3##(1993-3#1)(2008-8#1)
system for protein##4##3##(1991-5#1)(1993-6#1)(2008-4#2)
system for rapid##3##3##(2008-10#2)(2008-2#1)
system for real-time##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
system for recombinant##2##3##(2008-11#1)(2008-9#1)
system for sampling##2##3##(2010-12#2)
system for selective##2##3##(1995-2#1)(2008-8#1)
system for separation of##2##4##(2008-10#1)(2008-7#1)
system for separation##3##3##(2008-10#2)(2008-7#1)
system for several##2##3##(2007-12#1)(2008-4#1)
system for simultaneous determination of##3##5##(2008-10#2)(2008-3#1)
system for simultaneous##7##3##(2007-12#1)(2008-10#4)(2008-3#1)(2011-1#1)
system for small##2##3##(1990-11#1)(2012-11#1)
system for spectrophotometric determination of##3##5##(2008-10#3)
system for studies of##3##4##(1990-7#1)(2008-2#1)(2010-2#1)
system for studies##4##3##(1990-7#1)(2008-11#1)(2008-2#1)(2010-2#1)
system for study on adaptive mutations##2##6##(2008-9#2)
system for studying the##4##4##(1991-4#1)(2008-11#1)(2008-2#1)(2009-12#1)
system for studying##15##3##(1990-5#1)(1991-3#1)(1991-4#2)(1993-4#1)(1995-3#2)(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-12#1)(2009-2#1)(2009-8#1)
system for superresolution of temporally restricted objects##3##7##(2007-12#3)
system for surveillance##2##3##(2008-10#1)(2011-2#1)
system for synthesizing##2##3##(2007-12#1)(2008-3#1)
system for testing##4##3##(2006-5#1)(2008-3#1)(2008-5#1)(2008-9#1)
system for the analysis of##3##5##(1994-12#1)(1995-4#1)(2008-10#1)
system for the automated##2##4##(2008-10#1)(2008-9#1)
system for the construction of##2##5##(1993-11#1)(2010-7#1)
system for the continuous##2##4##(2007-8#1)(2008-10#1)
system for the detection of##5##5##(2008-10#1)(2008-3#2)(2008-5#1)(2013-8#1)
system for the detection##6##4##(2008-10#2)(2008-3#2)(2008-5#1)(2013-8#1)
system for the determination of copper##2##6##(2008-10#2)
system for the determination of fish freshness##2##7##(2008-10#2)
system for the determination of mercury by##2##7##(2008-10#2)
system for the determination of the##2##6##(2008-10#2)
system for the determination of total##2##6##(2008-10#2)
system for the determination of trace boron in iron and##2##10##(2008-10#2)
system for the determination of trace##4##6##(2008-10#4)
system for the determination of##35##5##(1992-1#1)(2007-8#1)(2008-10#31)(2008-3#1)(2010-4#1)
system for the determination##36##4##(1992-1#1)(2007-8#1)(2008-10#32)(2008-3#1)(2010-4#1)
system for the development of##2##5##(2006-6#1)(2008-10#1)
system for the evaluation of##3##5##(2008-5#1)(2009-11#1)(2010-3#1)
system for the expression of##2##5##(1990-9#1)(2008-11#1)
system for the generation of##4##5##(2006-12#1)(2007-12#1)(2008-11#1)(2008-3#1)
system for the genetic and##2##5##(2008-9#1)(2012-12#1)
system for the management of##4##5##(2007-8#2)(2008-12#1)(2011-2#1)
system for the on-line##3##4##(2008-10#3)
system for the preparation of##2##5##(2005-11#1)(2006-9#1)
system for the production of##7##5##(1991-4#1)(1993-11#1)(1994-10#1)(1994-11#1)(1997-4#1)(2008-11#1)(2011-2#1)
system for the quality##2##4##(2007-5#1)(2008-10#1)
system for the quantification of##2##5##(2004-9#1)(2008-10#1)
system for the quantitative##3##4##(1991-8#1)(1997-6#1)(2008-2#1)
system for the selective##2##4##(2008-10#2)
system for the separation##2##4##(1990-8#1)(2008-10#1)
system for the simultaneous detection##2##5##(2008-10#1)(2008-2#1)
system for the simultaneous determination of##4##6##(1997-8#1)(2008-10#3)
system for the simultaneous##7##4##(1997-8#1)(2008-10#5)(2008-2#1)
system for the spectrophotometric determination of##7##6##(2008-10#7)
system for the study of##10##5##(1990-4#1)(1990-5#1)(1995-6#1)(2005-11#1)(2006-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2012-3#1)
system for the synthesis of##2##5##(1990-5#1)(2006-9#1)
system for the treatment of##3##5##(2005-7#1)(2007-8#1)(2008-6#1)
system for the##203##3##(1990-2#1)(1990-4#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-4#1)(1991-8#1)(1992-1#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#1)(1994-10#1)(1994-11#2)(1994-12#2)(1995-3#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-12#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#2)(2004-4#1)(2004-9#1)(2005-11#2)(2005-7#1)(2006-10#3)(2006-12#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#2)(2007-12#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#6)(2008-1#1)(2008-10#76)(2008-11#6)(2008-12#2)(2008-2#7)(2008-3#10)(2008-4#1)(2008-5#5)(2008-6#5)(2008-9#4)(2009-11#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-12#3)(2012-2#1)(2012-3#2)(2013-8#1)
system for their##2##3##(1994-12#1)(2012-2#1)
system for three-dimensional##2##3##(2007-12#1)(2008-3#1)
system for two##2##3##(1993-3#1)(2008-5#1)
system for use in##4##4##(1994-5#1)(1996-2#1)(2006-2#1)(2006-6#1)
system for use##5##3##(1994-5#1)(1996-2#1)(1996-4#1)(2006-2#1)(2006-6#1)
system for your##2##3##(1992-2#1)(2007-4#1)
system for zinc determination in##3##5##(2008-10#3)
system for##857##2##(1990-11#4)(1990-12#4)(1990-2#4)(1990-3#3)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#5)(1990-9#2)(1991-1#2)(1991-10#1)(1991-2#3)(1991-3#5)(1991-4#3)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#6)(1992-1#3)(1992-11#1)(1992-12#2)(1992-2#9)(1992-3#5)(1992-4#4)(1992-6#3)(1992-7#1)(1992-8#4)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#5)(1993-4#2)(1993-6#3)(1993-8#1)(1994-10#1)(1994-11#3)(1994-12#4)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#4)(1994-9#2)(1995-1#1)(1995-12#2)(1995-2#3)(1995-3#5)(1995-4#1)(1995-5#1)(1995-6#1)(1995-9#3)(1996-1#3)(1996-10#1)(1996-12#3)(1996-2#4)(1996-3#2)(1996-4#3)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#4)(1997-2#6)(1997-3#3)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#2)(2004-3#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-4#3)(2005-7#2)(2005-8#2)(2006-10#5)(2006-11#1)(2006-12#5)(2006-2#3)(2006-3#4)(2006-4#1)(2006-5#4)(2006-6#6)(2006-8#3)(2006-9#2)(2007-11#12)(2007-12#28)(2007-2#1)(2007-3#1)(2007-4#6)(2007-5#10)(2007-6#3)(2007-7#1)(2007-8#18)(2008-1#8)(2008-10#200)(2008-11#27)(2008-12#3)(2008-2#41)(2008-3#49)(2008-4#13)(2008-5#21)(2008-6#6)(2008-7#12)(2008-8#6)(2008-9#15)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#3)(2009-5#1)(2009-6#1)(2009-8#4)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#1)(2010-7#3)(2010-8#14)(2010-9#2)(2011-1#11)(2011-2#10)(2011-3#1)(2012-1#15)(2012-11#3)(2012-12#10)(2012-2#5)(2012-3#11)(2013-1#25)(2013-7#5)(2013-8#4)
system formation##2##2##(1992-12#1)(2010-1#1)
system from Staphylococcus aureus##2##4##(1991-12#1)(1991-9#1)
system from a##3##3##(1995-1#1)(2008-10#1)(2008-4#1)
system from the##7##3##(1990-5#1)(1995-7#2)(2007-12#1)(2008-2#1)(2008-5#1)(2011-2#1)
system from which the##2##4##(2007-12#1)(2008-10#1)
system from which##4##3##(1993-12#1)(1997-3#1)(2007-12#1)(2008-10#1)
system from##37##2##(1990-5#1)(1990-6#1)(1991-12#1)(1991-9#1)(1993-12#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-7#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(2006-10#2)(2006-11#1)(2006-6#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-2#1)
system function in##2##3##(2008-10#1)(2009-8#1)
system function##11##2##(1990-7#1)(1994-8#1)(1996-5#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-5#1)(2009-8#1)(2010-5#1)(2011-2#1)
system functions##6##2##(1991-2#1)(1997-3#1)(2005-7#1)(2008-10#1)(2010-12#1)(2012-2#1)
system gave##4##2##(1992-11#1)(1997-7#1)(2008-10#1)(2008-11#1)
system generated##2##2##(1990-3#1)(1992-7#1)
system generates##3##2##(2007-12#1)(2008-2#1)(2008-4#1)
system generating##2##2##(2007-12#1)(2008-10#1)
system geometry##4##2##(2005-11#1)(2007-12#1)(2008-2#1)(2008-7#1)
system gives a##2##3##(2008-8#1)(2013-8#1)
system gives##4##2##(2008-10#1)(2008-3#1)(2008-8#1)(2013-8#1)
system governance##2##2##(1996-1#1)(2006-7#1)
system greatly##2##2##(2008-10#1)(2008-9#1)
system had a##5##3##(2008-10#3)(2008-11#1)(2009-10#1)
system had been##2##3##(1994-10#1)(2008-10#1)
system had##11##2##(1990-9#2)(1992-12#1)(1994-10#1)(2008-10#5)(2008-11#1)(2009-10#1)
system handles about 65 samples per hour##2##7##(2008-10#2)
system handles about##4##3##(2008-10#4)
system handles##5##2##(2008-10#5)
system has a detection limit of 0##2##7##(2008-10#2)
system has a##14##3##(1992-12#1)(2005-11#1)(2006-12#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#2)(2010-8#1)
system has also been investigated##2##5##(2008-10#2)
system has also been##4##4##(1995-5#1)(2008-10#2)(2012-12#1)
system has become##2##3##(1990-11#1)(2007-8#1)
system has been applied to the analysis of##2##8##(2008-10#2)
system has been applied to the##3##6##(1994-12#1)(2008-10#2)
system has been applied to##4##5##(1994-12#1)(2008-10#2)(2010-5#1)
system has been applied##6##4##(1994-12#1)(2008-10#4)(2010-5#1)
system has been demonstrated by##2##5##(2007-12#1)(2008-2#1)
system has been demonstrated##4##4##(1994-8#1)(2007-12#1)(2007-5#1)(2008-2#1)
system has been described##2##4##(2006-6#1)(2008-9#1)
system has been designed##2##4##(2006-11#1)(2008-3#1)
system has been developed for the##5##6##(1994-11#1)(1997-3#1)(2008-10#3)
system has been developed for##11##5##(1992-6#1)(1994-11#1)(1997-3#1)(2008-10#5)(2008-2#1)(2010-6#1)(2013-1#1)
system has been developed in##2##5##(2006-10#1)(2008-10#1)
system has been developed to measure the##2##7##(2008-2#2)
system has been developed using##3##5##(1990-3#1)(1996-2#1)(2008-10#1)
system has been developed##28##4##(1990-3#1)(1992-6#1)(1994-11#1)(1996-2#1)(1997-3#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-2#5)(2008-3#2)(2010-6#1)(2012-1#1)(2013-1#1)
system has been employed##2##4##(1992-6#1)(1994-2#1)
system has been established##3##4##(2008-10#1)(2010-2#1)(2010-6#1)
system has been evaluated##4##4##(2008-10#2)(2008-2#1)(2012-1#1)
system has been examined##2##4##(1994-5#1)(2006-10#1)
system has been explored for##2##5##(2008-10#2)
system has been explored##3##4##(2006-10#1)(2008-10#2)
system has been identified as an##2##6##(2008-2#1)(2012-2#1)
system has been identified##4##4##(1991-1#1)(2008-2#1)(2010-12#1)(2012-2#1)
system has been implemented in##2##5##(2007-12#1)(2008-3#1)
system has been implemented##4##4##(2007-12#2)(2008-2#1)(2008-3#1)
system has been investigated##2##4##(2008-11#1)(2008-2#1)
system has been proposed##3##4##(2008-10#2)(2012-12#1)
system has been shown##2##4##(1990-4#1)(1993-12#1)
system has been studied##3##4##(1992-9#1)(2008-10#1)(2012-7#1)
system has been successfully applied##2##5##(1991-12#1)(2008-10#1)
system has been successfully used##2##5##(2007-12#1)(2008-10#1)
system has been successfully##4##4##(1991-12#1)(2007-12#1)(2008-10#2)
system has been suggested##2##4##(1994-6#1)(2009-9#1)
system has been tested##11##4##(2006-5#1)(2007-8#1)(2008-10#4)(2008-3#1)(2013-1#4)
system has been used as##2##5##(1992-4#1)(1993-3#1)
system has been used for##4##5##(2008-10#2)(2008-11#1)(2011-1#1)
system has been used to##4##5##(1993-6#1)(2006-11#1)(2008-2#1)(2008-8#1)
system has been used##11##4##(1992-4#1)(1993-3#1)(1993-6#1)(2006-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2011-1#1)(2012-3#1)
system has been##146##3##(1990-3#1)(1990-4#1)(1991-1#1)(1991-12#1)(1991-4#1)(1992-12#1)(1992-4#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-3#2)(1997-5#1)(2006-10#4)(2006-11#2)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#6)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#31)(2008-11#4)(2008-2#16)(2008-3#9)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#2)(2009-6#1)(2009-9#2)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#4)(2011-1#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#9)(2013-7#1)
system has emerged as the##5##5##(1997-4#1)(2013-8#4)
system has failed to##2##4##(1994-2#1)(1995-3#1)
system has found##2##3##(1991-9#1)(2008-11#1)
system has good##2##3##(2004-4#1)(2008-10#1)
system has made it possible##2##5##(2008-7#1)(2010-12#1)
system has made it##3##4##(2007-12#1)(2008-7#1)(2010-12#1)
system has not##3##3##(2008-11#1)(2011-2#1)(2012-1#1)
system has potential##2##3##(2008-5#1)(2008-8#1)
system has supported##2##3##(1997-3#1)(2008-10#1)
system has the advantage##3##4##(1994-8#1)(2008-1#1)(2008-4#1)
system has the##13##3##(1993-12#1)(1994-8#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-4#1)(2010-12#1)
system has##250##2##(1990-11#1)(1990-3#1)(1990-4#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-12#2)(1992-4#1)(1992-6#2)(1992-9#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-5#2)(1994-6#2)(1994-8#2)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#2)(1996-1#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-3#4)(1997-4#2)(1997-5#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-6#1)(2006-10#5)(2006-11#3)(2006-12#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#5)(2007-12#9)(2007-5#1)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#50)(2008-11#8)(2008-12#1)(2008-2#23)(2008-3#16)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#2)(2009-11#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-12#4)(2010-2#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#6)(2011-1#1)(2011-2#1)(2012-1#3)(2012-12#4)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#9)(2013-7#1)(2013-8#6)
system have been studied##3##4##(1991-11#1)(2008-10#1)(2009-4#1)
system have been##13##3##(1990-12#1)(1991-11#1)(1991-6#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-4#1)(2010-12#1)(2013-8#1)
system have##31##2##(1990-12#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-8#1)(1996-3#1)(1997-1#1)(2005-7#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-3#1)(2012-1#1)(2013-8#2)
system having a##2##3##(2008-3#2)
system having##3##2##(2008-2#1)(2008-3#2)
system identification##6##2##(1997-6#1)(2007-9#2)(2008-2#2)(2012-1#1)
system if##3##2##(1997-2#1)(2008-2#2)
system impairment##2##2##(1990-4#1)(2010-4#1)
system implementation##4##2##(1992-12#1)(1993-2#1)(1996-2#1)(2006-4#1)
system improves##2##2##(2008-10#1)(2009-4#1)
system in Brazil##2##3##(2009-4#1)(2011-2#1)
system in E##2##3##(2007-12#1)(2009-3#1)
system in Escherichia coli##3##4##(1990-11#1)(1990-5#1)(1997-1#1)
system in P##2##3##(2009-9#1)(2011-2#1)
system in a##26##3##(1990-9#1)(1992-10#2)(1994-2#1)(1996-4#1)(1996-5#1)(1997-2#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-6#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
system in an##5##3##(1996-2#1)(2004-9#1)(2007-5#1)(2008-3#1)(2011-2#1)
system in both##5##3##(1997-8#1)(2006-10#1)(2008-10#2)(2008-7#1)
system in cancer cells##2##4##(1994-11#1)(2008-4#1)
system in cancer##3##3##(1994-11#1)(2008-4#1)(2013-1#1)
system in cesium##2##3##(2007-12#2)
system in chronic##2##3##(1991-12#1)(2005-7#1)
system in comparison with that##2##5##(1994-10#1)(2008-10#1)
system in comparison with##3##4##(1994-10#1)(1996-6#1)(2008-10#1)
system in detail##2##3##(2008-2#1)(2008-7#1)
system in diabetic##2##3##(1993-12#1)(2010-10#1)
system in general##3##3##(1994-2#1)(2010-12#1)(2012-12#1)
system in heart failure##2##4##(2008-7#1)(2012-2#1)
system in human##4##3##(1991-8#1)(1994-3#1)(1997-1#1)(2011-2#1)
system in humans##2##3##(2006-10#1)(2008-7#1)
system in many diseases##2##4##(2008-10#1)(2008-5#1)
system in many##3##3##(1994-11#1)(2008-10#1)(2008-5#1)
system in mice##4##3##(1991-12#1)(1997-6#1)(2006-10#1)(2006-11#1)
system in modulating##2##3##(1995-1#1)(2006-10#1)
system in one##2##3##(1996-2#1)(2007-3#1)
system in order to##6##4##(1993-6#1)(1995-3#1)(1997-4#1)(2006-10#1)(2011-1#1)(2012-2#1)
system in other##3##3##(2008-1#1)(2012-12#2)
system in patients with##4##4##(1993-11#1)(1997-1#1)(1997-7#1)(2013-1#1)
system in patients##5##3##(1993-11#1)(1997-1#1)(1997-7#1)(2008-10#1)(2013-1#1)
system in phagocytes##2##3##(1993-8#1)(1994-3#1)
system in place##2##3##(1991-3#1)(2012-1#1)
system in plants##2##3##(1991-8#1)(2008-9#1)
system in pulmonary##3##3##(2005-11#1)(2008-11#1)(2010-10#1)
system in rat##5##3##(1990-4#1)(1992-3#1)(1994-6#1)(1995-9#1)(2013-1#1)
system in regulating##2##3##(2008-11#1)(2011-2#1)
system in relation to##2##4##(2008-8#1)(2011-2#1)
system in such a##2##4##(1991-9#1)(2008-10#1)
system in terms of##5##4##(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)
system in the brain and##2##5##(2008-11#1)(2012-11#1)
system in the brain##5##4##(2007-11#1)(2008-11#1)(2010-4#1)(2010-8#1)(2012-11#1)
system in the context of##2##5##(2012-1#1)(2013-1#1)
system in the diagnosis of##2##5##(2007-7#1)(2008-5#1)
system in the early##2##4##(1995-4#1)(2008-11#1)
system in the form of##2##5##(2012-2#1)(2013-8#1)
system in the gastrointestinal tract##2##5##(2008-5#1)(2010-12#1)
system in the management of##2##5##(2007-8#1)(2008-9#1)
system in the pathogenesis of##2##5##(2009-9#1)(2011-2#1)
system in the pathogenesis##3##4##(2008-5#1)(2009-9#1)(2011-2#1)
system in the presence of##7##5##(1994-12#1)(1996-1#1)(1996-8#1)(2008-10#4)
system in the rat##3##4##(1991-2#1)(1993-1#1)(1995-12#1)
system in the regulation##2##4##(1993-12#1)(2010-11#1)
system in the sense##2##4##(2008-2#1)(2008-3#1)
system in the squid##2##4##(1995-5#1)(2008-7#1)
system in the study of##2##5##(1994-9#1)(2005-11#1)
system in the##100##3##(1990-12#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#2)(1992-12#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-4#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#3)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#2)(2005-10#1)(2005-11#2)(2005-9#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-2#4)(2008-3#3)(2008-5#4)(2008-7#4)(2008-9#2)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-8#2)(2011-1#2)(2011-12#2)(2011-2#2)(2012-1#2)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
system in this##5##3##(1996-6#1)(2005-10#1)(2007-7#1)(2008-7#1)(2008-8#1)
system in vitro##2##3##(2006-1#1)(2006-8#1)
system in vivo##3##3##(1990-5#1)(1995-2#1)(1997-4#1)
system in which a##4##4##(1992-10#1)(2007-12#1)(2008-3#1)(2008-7#1)
system in which the##14##4##(1991-5#1)(1991-9#1)(1992-12#1)(1993-3#2)(1994-12#1)(1995-1#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
system in which they##2##4##(1996-3#1)(2008-2#1)
system in which to study the##3##6##(1995-2#1)(1997-3#1)(2009-6#1)
system in which to study##5##5##(1993-4#1)(1995-2#1)(1997-3#1)(2008-11#1)(2009-6#1)
system in which to##7##4##(1993-4#1)(1995-2#1)(1997-3#1)(2008-11#1)(2009-6#1)(2009-8#1)(2012-3#1)
system in which##48##3##(1990-3#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-12#2)(1992-2#1)(1993-3#2)(1993-4#1)(1994-12#2)(1995-1#1)(1995-2#1)(1996-3#1)(1997-3#1)(1997-4#1)(2006-8#2)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-10#1)(2012-3#1)
system in##504##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#1)(1990-8#1)(1990-9#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#4)(1991-9#2)(1992-1#4)(1992-10#4)(1992-12#5)(1992-2#3)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#4)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#3)(1994-6#3)(1994-8#3)(1994-9#2)(1995-1#2)(1995-11#4)(1995-12#7)(1995-2#3)(1995-3#3)(1995-4#2)(1995-5#2)(1995-6#1)(1995-8#2)(1995-9#3)(1996-1#2)(1996-10#1)(1996-12#7)(1996-2#4)(1996-3#1)(1996-4#2)(1996-5#4)(1996-6#3)(1996-8#2)(1996-9#1)(1997-1#5)(1997-2#5)(1997-3#3)(1997-4#3)(1997-6#1)(1997-7#3)(1997-8#2)(2004-9#2)(2005-10#4)(2005-11#5)(2005-7#2)(2005-9#1)(2006-1#1)(2006-10#8)(2006-11#1)(2006-2#2)(2006-5#2)(2006-6#3)(2006-8#5)(2006-9#2)(2007-10#4)(2007-11#8)(2007-12#20)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#4)(2007-6#2)(2007-7#3)(2007-8#9)(2007-9#3)(2008-1#8)(2008-10#36)(2008-11#18)(2008-12#7)(2008-2#12)(2008-3#13)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#15)(2008-8#10)(2008-9#8)(2009-2#2)(2009-3#1)(2009-4#4)(2009-6#2)(2009-8#2)(2009-9#4)(2010-10#4)(2010-11#1)(2010-12#6)(2010-4#1)(2010-5#2)(2010-8#6)(2010-9#1)(2011-1#7)(2011-12#3)(2011-2#16)(2012-1#9)(2012-11#1)(2012-12#5)(2012-2#6)(2012-3#6)(2013-1#12)(2013-2#1)(2013-8#2)
system include##12##2##(1994-12#1)(1995-7#1)(1997-4#1)(2004-1#1)(2006-1#1)(2007-12#2)(2007-8#1)(2008-2#1)(2008-4#1)(2011-1#1)(2011-2#1)
system includes a##4##3##(2008-10#3)(2008-2#1)
system includes the##2##3##(2008-1#1)(2008-10#1)
system includes##10##2##(1995-5#1)(2005-11#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2011-1#1)
system including the##3##3##(1993-6#1)(1996-9#1)(2009-10#1)
system including##16##2##(1990-5#1)(1993-6#1)(1994-8#1)(1996-9#1)(2004-12#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2009-10#1)(2010-9#1)(2011-2#1)(2013-8#1)
system incorporated##2##2##(2009-4#1)(2013-1#1)
system incorporates##3##2##(2008-10#1)(2008-2#2)
system incorporating a##3##3##(2007-12#2)(2008-10#1)
system incorporating the##2##3##(2006-5#1)(2008-10#1)
system incorporating##10##2##(2006-5#1)(2007-12#2)(2008-1#2)(2008-10#4)(2011-2#1)
system increased the##2##3##(2007-11#1)(2008-7#1)
system increased##4##2##(2005-11#1)(2007-11#1)(2008-7#1)(2010-12#1)
system increases##2##2##(1993-11#1)(2010-12#1)
system indicate that##3##3##(2008-11#1)(2010-12#1)(2012-2#1)
system induced by##2##3##(1994-6#1)(1997-1#1)
system injury##7##2##(1993-7#2)(2005-7#2)(2006-10#1)(2007-8#1)(2011-2#1)
system integrates##3##2##(2007-5#1)(2008-10#1)(2012-1#1)
system integrating##2##2##(2007-8#1)(2011-12#1)
system integration##3##2##(2008-7#1)(2010-8#2)
system interacting with##2##3##(1993-8#1)(2010-7#1)
system interactions##2##2##(1995-12#1)(2013-8#1)
system interacts##2##2##(1991-11#1)(2012-2#1)
system interface##2##2##(2004-9#1)(2013-1#1)
system interventions##2##2##(2009-4#1)(2009-9#1)
system into a##5##3##(2006-1#1)(2006-10#1)(2007-11#1)(2008-10#1)(2010-4#1)
system into the##2##3##(2007-11#1)(2010-8#1)
system into##9##2##(1992-6#1)(2005-10#1)(2006-1#1)(2006-10#1)(2007-11#2)(2008-10#1)(2010-4#1)(2010-8#1)
system involved in##4##3##(1992-8#1)(1993-2#1)(1993-6#1)(2008-10#1)
system involvement in##4##3##(1993-12#1)(2006-10#2)(2008-3#1)
system involvement##14##2##(1990-11#1)(1993-12#1)(2006-10#2)(2007-3#4)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
system involves the##2##3##(2006-10#1)(2008-10#1)
system involves##5##2##(2006-10#1)(2008-10#2)(2008-2#1)(2010-8#1)
system involving a##2##3##(2006-7#1)(2008-10#1)
system involving the##5##3##(1990-12#1)(2008-10#2)(2008-4#1)(2009-8#1)
system involving##11##2##(1990-12#1)(1990-2#1)(1991-12#1)(2006-7#1)(2008-10#5)(2008-4#1)(2009-8#1)
system is 0##3##3##(2008-10#2)(2008-3#1)
system is 1##3##3##(2008-2#3)
system is a good##2##4##(2008-11#1)(2009-2#1)
system is a new##2##4##(2008-3#1)(2012-2#1)
system is a useful##2##4##(2008-10#1)(2012-2#1)
system is a##39##3##(1991-8#1)(1992-12#1)(1994-11#1)(1994-2#1)(1995-2#1)(1995-9#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#1)(2006-7#1)(2007-8#2)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-2#1)(2009-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-2#2)(2013-8#1)
system is able to detect##2##5##(2008-11#1)(2008-3#1)
system is able to##14##4##(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-6#1)(2008-8#1)(2009-8#1)(2010-8#1)(2012-1#1)(2013-1#1)
system is affected by##2##4##(1993-7#1)(2013-1#1)
system is affected##4##3##(1993-7#1)(1996-6#1)(2009-10#1)(2013-1#1)
system is allowed##2##3##(1992-1#1)(2008-10#1)
system is also essential##2##4##(2005-5#1)(2007-8#1)
system is also##14##3##(2005-5#1)(2007-12#2)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2011-1#2)
system is an important##2##4##(2008-8#1)(2013-8#1)
system is an##11##3##(1990-11#1)(1996-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-8#1)
system is analyzed##2##3##(2008-2#2)
system is applicable##2##3##(2007-12#1)(2008-2#1)
system is applied to##2##4##(2008-2#2)
system is applied##5##3##(1990-6#1)(2008-2#3)(2008-3#1)
system is approximately##2##3##(2008-3#1)(2008-6#1)
system is assumed to##2##4##(2006-3#1)(2008-2#1)
system is available##3##3##(2008-9#1)(2013-1#2)
system is based on a Nd##2##6##(2008-3#2)
system is based on a##16##5##(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#1)(2009-8#1)
system is based on an##2##5##(1994-2#1)(2008-10#1)
system is based on the ability of##2##7##(1993-11#1)(1995-5#1)
system is based on the##9##5##(1992-6#1)(1993-11#1)(1995-5#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-9#1)(2010-2#1)
system is based on##41##4##(1990-3#1)(1991-1#1)(1992-4#1)(1992-6#1)(1993-11#1)(1994-2#1)(1995-5#1)(2007-11#2)(2007-12#5)(2008-10#6)(2008-11#1)(2008-2#6)(2008-3#7)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-2#1)(2013-1#2)
system is based##42##3##(1990-3#1)(1991-1#1)(1992-4#1)(1992-6#1)(1993-11#1)(1994-2#1)(1995-5#1)(2007-11#2)(2007-12#5)(2008-10#6)(2008-11#1)(2008-2#6)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-2#1)(2013-1#2)
system is being developed##2##4##(2006-11#1)(2006-2#1)
system is being##6##3##(1994-2#1)(2006-10#1)(2006-11#1)(2006-2#1)(2008-4#1)(2008-7#1)
system is believed to##2##4##(1993-2#1)(2007-8#1)
system is both##2##3##(1992-3#1)(1996-5#1)
system is built##2##3##(2008-2#1)(2008-7#1)
system is called##2##3##(2010-8#2)
system is capable of a##2##5##(2007-12#1)(2008-2#1)
system is capable of##11##4##(1990-8#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-6#1)(2010-2#1)
system is characterized by##2##4##(2005-11#1)(2008-3#1)
system is characterized##4##3##(2005-11#1)(2008-2#2)(2008-3#1)
system is composed of##4##4##(2008-10#2)(2008-4#1)(2008-6#1)
system is considered to originate from intramolecular and intermolecular energy transfers##2##11##(2008-10#2)
system is considered##5##3##(2008-10#3)(2008-2#1)(2008-3#1)
system is constructed##2##3##(2008-2#1)(2013-1#1)
system is controlled by##2##4##(2008-10#1)(2008-2#1)
system is critical##2##3##(2008-3#1)(2011-1#1)
system is currently##3##3##(1992-3#1)(2008-3#1)(2010-5#1)
system is demonstrated with##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
system is demonstrated##7##3##(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#1)
system is described for the determination of##3##7##(1993-2#1)(2008-10#2)
system is described for##4##4##(1993-2#1)(2008-10#2)(2008-4#1)
system is described in this paper##3##6##(2007-12#1)(2008-10#2)
system is described in##4##4##(1994-5#1)(2007-12#1)(2008-10#2)
system is described##25##3##(1991-12#1)(1993-2#1)(1994-5#1)(2005-4#1)(2007-12#1)(2007-2#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2009-11#1)
system is designed for the##2##5##(1991-1#1)(2008-10#1)
system is designed for##3##4##(1991-1#1)(2008-10#1)(2008-2#1)
system is designed to##7##4##(1991-12#1)(2007-12#2)(2008-2#1)(2008-3#2)(2011-2#1)
system is designed##13##3##(1991-1#1)(1991-12#1)(1993-3#1)(2007-12#3)(2008-10#2)(2008-2#2)(2008-3#2)(2011-2#1)
system is determined by the##2##5##(1990-6#1)(2008-8#1)
system is determined by##3##4##(1990-6#1)(2008-3#1)(2008-8#1)
system is developed##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2012-1#1)
system is discussed##8##3##(2006-6#1)(2006-8#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)
system is due##2##3##(1994-8#1)(2008-7#1)
system is essential for##2##4##(1994-8#1)(2008-10#1)
system is evaluated##2##3##(2008-3#2)
system is examined##2##3##(2008-10#1)(2008-2#1)
system is expected to##2##4##(2006-10#1)(2008-7#1)
system is feasible##2##3##(1995-12#1)(2008-2#1)
system is formed by##2##4##(1990-11#1)(2007-12#1)
system is found to be##3##5##(2008-10#1)(2008-2#2)
system is found to##4##4##(2008-10#1)(2008-2#2)(2008-7#1)
system is found##5##3##(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)
system is fully##2##3##(2008-2#1)(2008-3#1)
system is given##2##3##(2008-10#1)(2008-2#1)
system is highly##6##3##(1992-12#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-10#1)
system is important in the##3##5##(2005-7#1)(2008-10#1)(2011-2#1)
system is important in##4##4##(2005-7#1)(2008-10#1)(2008-2#1)(2011-2#1)
system is important##6##3##(1993-2#1)(1994-6#1)(2005-7#1)(2008-10#1)(2008-2#1)(2011-2#1)
system is in a##2##4##(2008-5#1)(2009-12#1)
system is in place##2##4##(2008-9#1)(2012-2#1)
system is in the##2##4##(1996-12#1)(2008-3#1)
system is in##8##3##(1996-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-12#1)(2012-2#1)
system is increased##2##3##(1994-11#1)(2007-11#1)
system is installed##2##3##(2006-6#1)(2007-12#1)
system is integral to the##3##5##(1994-6#1)(2013-1#2)
system is introduced##3##3##(2008-10#1)(2008-2#2)
system is investigated##2##3##(2008-2#2)
system is involved in the##4##5##(1993-3#1)(1996-2#1)(2006-9#1)(2008-7#1)
system is involved in##7##4##(1993-3#1)(1996-2#1)(2006-9#1)(2008-10#1)(2008-7#1)(2011-1#1)(2013-7#1)
system is involved##8##3##(1993-3#1)(1996-2#1)(2006-10#1)(2006-9#1)(2008-10#1)(2008-7#1)(2011-1#1)(2013-7#1)
system is known to be involved##2##6##(1991-3#1)(2009-8#1)
system is largely##2##3##(1997-3#1)(2008-7#1)
system is likely to be##2##5##(2008-8#1)(2009-6#1)
system is likely##3##3##(2008-8#1)(2009-6#1)(2009-8#1)
system is located in##2##4##(1992-8#1)(2008-5#1)
system is located##3##3##(1992-8#2)(2008-5#1)
system is measured##2##3##(2005-11#1)(2008-3#1)
system is modified##2##3##(2008-3#1)(2008-5#1)
system is more##5##3##(1993-5#1)(2006-8#1)(2007-12#1)(2008-10#1)(2013-1#1)
system is necessary to##2##4##(2009-9#1)(2013-8#1)
system is necessary##4##3##(1997-4#1)(2005-3#1)(2009-9#1)(2013-8#1)
system is needed for##2##4##(2006-2#1)(2010-5#1)
system is needed##4##3##(2006-2#1)(2010-11#1)(2010-5#1)(2012-12#1)
system is not the##2##4##(1991-12#1)(2006-6#1)
system is not##11##3##(1991-12#1)(1992-3#1)(1993-12#1)(1994-2#1)(2006-6#1)(2007-4#2)(2008-2#1)(2009-6#1)(2012-1#1)(2013-7#1)
system is often##2##3##(1997-5#1)(2004-10#1)
system is one of##3##4##(1995-5#1)(1996-10#1)(2012-2#1)
system is one##4##3##(1995-5#1)(1996-10#1)(2008-2#1)(2012-2#1)
system is particularly##2##3##(2008-3#1)(2008-4#1)
system is performed##2##3##(2008-2#2)
system is prepared##2##3##(2008-10#2)
system is present in##4##4##(1991-8#1)(1994-3#1)(1995-8#1)(2009-8#1)
system is presented for##3##4##(2006-2#1)(2008-11#1)(2012-1#1)
system is presented that##4##4##(2008-2#1)(2008-3#3)
system is presented##19##3##(2006-10#1)(2006-2#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#1)(2009-10#1)(2012-1#1)(2013-1#1)
system is probably##2##3##(2006-8#1)(2008-2#1)
system is promising for##3##4##(2007-12#1)(2012-11#2)
system is proposed for the determination of##5##7##(2008-10#5)
system is proposed for the##8##5##(2008-10#8)
system is proposed for##11##4##(2008-10#11)
system is proposed to##3##4##(2007-7#1)(2007-8#1)(2013-7#1)
system is proposed##26##3##(1991-5#1)(1996-2#1)(2006-6#2)(2007-7#1)(2007-8#1)(2008-10#15)(2008-3#1)(2012-11#2)(2013-1#1)(2013-7#1)
system is provided##2##3##(2007-5#1)(2008-3#1)
system is quite##3##3##(1994-2#1)(2007-12#1)(2008-10#1)
system is rapid##2##3##(2006-10#1)(2008-10#1)
system is recommended##2##3##(1993-8#1)(2008-10#1)
system is reported##2##3##(2008-10#1)(2008-2#1)
system is required##3##3##(1991-8#1)(2008-11#1)(2008-2#1)
system is robust##2##3##(2008-2#1)(2008-7#1)
system is safe and effective##2##5##(2006-8#1)(2008-11#1)
system is shown to be##2##5##(2008-2#1)(2008-3#1)
system is shown to##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
system is shown##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
system is simple and##2##4##(2006-5#1)(2007-12#1)
system is simple##3##3##(2006-5#1)(2007-12#1)(2008-10#1)
system is stable##2##3##(2008-10#1)(2008-2#1)
system is studied##3##3##(2007-12#1)(2007-8#1)(2008-10#1)
system is subjected to##2##4##(1995-1#1)(1995-6#1)
system is suitable for##7##4##(1993-12#1)(2008-10#4)(2008-3#1)(2008-4#1)
system is tested##2##3##(2008-10#1)(2008-2#1)
system is the best##2##4##(2006-10#1)(2008-10#1)
system is the key##2##4##(2005-5#1)(2012-1#1)
system is the most##2##4##(2008-10#1)(2013-1#1)
system is the##22##3##(1991-6#1)(1997-6#1)(2005-5#1)(2006-10#1)(2006-12#1)(2007-5#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-9#1)(2012-1#1)(2013-1#1)(2013-7#1)
system is then##2##3##(1991-8#1)(2008-6#1)
system is to##5##3##(1994-2#1)(2006-6#1)(2007-8#1)(2010-10#1)(2013-8#1)
system is unaffected by##2##4##(1993-11#1)(2008-10#1)
system is under development##2##4##(2006-6#1)(2010-8#1)
system is under##3##3##(2006-6#1)(2007-2#1)(2010-8#1)
system is unique in##2##4##(1997-2#1)(2006-10#1)
system is used to measure##2##5##(2008-2#1)(2009-4#1)
system is used to##15##4##(1997-2#1)(2007-12#2)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#3)(2008-5#1)(2009-4#1)
system is used##25##3##(1991-2#1)(1996-1#1)(1997-2#1)(2007-12#3)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#1)(2009-4#1)(2009-8#1)(2010-6#1)(2011-1#1)
system is useful for##4##4##(2007-11#1)(2008-11#2)(2008-3#1)
system is useful##5##3##(2007-11#1)(2008-11#2)(2008-3#1)(2008-5#1)
system is validated##2##3##(2006-10#1)(2008-3#1)
system is very##7##3##(1990-3#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)
system is warranted##2##3##(2008-7#1)(2010-2#1)
system is well##2##3##(1995-12#1)(2006-10#1)
system is##728##2##(1990-11#3)(1990-2#1)(1990-3#2)(1990-6#2)(1990-7#2)(1990-8#3)(1991-1#2)(1991-12#3)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#4)(1992-1#1)(1992-12#2)(1992-3#5)(1992-4#2)(1992-6#1)(1992-8#2)(1993-11#2)(1993-12#2)(1993-2#3)(1993-3#2)(1993-5#1)(1993-7#2)(1993-8#3)(1993-9#2)(1994-1#1)(1994-11#2)(1994-2#6)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#4)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#3)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#5)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#1)(1997-8#2)(2004-10#1)(2004-2#2)(2004-9#1)(2005-10#1)(2005-11#4)(2005-3#1)(2005-4#2)(2005-5#3)(2005-7#1)(2006-10#12)(2006-11#2)(2006-12#1)(2006-2#3)(2006-3#1)(2006-5#1)(2006-6#10)(2006-7#1)(2006-8#5)(2006-9#1)(2007-11#12)(2007-12#44)(2007-2#3)(2007-4#2)(2007-5#5)(2007-7#2)(2007-8#11)(2007-9#1)(2008-1#5)(2008-10#116)(2008-11#19)(2008-12#1)(2008-2#88)(2008-3#78)(2008-4#11)(2008-5#10)(2008-6#8)(2008-7#12)(2008-8#5)(2008-9#12)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-6#4)(2009-7#1)(2009-8#9)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#7)(2010-9#3)(2011-1#6)(2011-2#6)(2012-1#7)(2012-11#5)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#16)(2013-7#6)(2013-8#6)
system it is##3##3##(1990-9#1)(2008-3#2)
system it##4##2##(1990-9#1)(2005-1#1)(2008-3#2)
system itself##3##2##(1991-12#1)(2008-2#1)(2008-3#1)
system leading to the##4##4##(1992-1#1)(1992-3#1)(2008-1#1)(2010-9#1)
system leading to##7##3##(1992-1#1)(1992-3#1)(2006-4#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-9#1)
system lesions##8##2##(1993-11#1)(1994-7#1)(2005-9#1)(2007-8#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
system level##11##2##(1993-2#1)(1994-12#1)(2008-2#2)(2008-3#2)(2009-3#1)(2013-1#4)
system levels##3##2##(2007-6#1)(2010-11#1)(2011-2#1)
system linearity##2##2##(2008-9#2)
system located in the##2##4##(1992-5#1)(2012-12#1)
system lymphomas##2##2##(1994-7#1)(2007-12#1)
system made up##3##3##(2008-10#3)
system made##4##2##(2008-10#4)
system maintained##2##2##(2008-10#1)(2008-11#1)
system makes it possible to##2##5##(2007-12#1)(2008-4#1)
system makes it possible##3##4##(2007-12#2)(2008-4#1)
system makes##7##2##(2007-12#2)(2008-1#1)(2008-2#1)(2008-4#1)(2013-1#2)
system making##2##2##(2008-5#1)(2010-6#1)
system matures##2##2##(1993-2#1)(2008-9#1)
system may also be##2##4##(2008-10#1)(2009-4#1)
system may also##3##3##(2008-1#1)(2008-10#1)(2009-4#1)
system may be a valuable##2##5##(1996-8#1)(2010-7#1)
system may be a##4##4##(1996-1#1)(1996-8#1)(2008-7#1)(2010-7#1)
system may be the##4##4##(1995-12#1)(1996-2#1)(2007-7#1)(2012-2#1)
system may be used##2##4##(2008-10#1)(2008-7#1)
system may be utilized##2##4##(1990-7#1)(2008-11#1)
system may be##31##3##(1990-3#1)(1990-7#1)(1992-12#1)(1995-12#2)(1996-1#1)(1996-2#1)(1996-8#1)(1997-2#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-7#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
system may have##2##3##(2008-1#1)(2012-12#1)
system may help##2##3##(1996-11#1)(2012-2#1)
system may lead to##2##4##(1997-4#1)(2004-4#1)
system may not##2##3##(1997-2#1)(2011-1#1)
system may provide a##3##4##(1993-7#1)(1994-9#1)(2007-11#1)
system may provide##4##3##(1993-7#1)(1994-9#1)(2007-11#1)(2007-3#1)
system may##57##2##(1990-3#1)(1990-7#1)(1992-12#1)(1993-12#1)(1993-7#1)(1994-9#1)(1995-12#3)(1996-1#1)(1996-11#1)(1996-2#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-8#1)(2004-4#1)(2005-8#1)(2006-10#2)(2006-5#1)(2007-11#2)(2007-3#1)(2007-4#1)(2007-7#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-4#1)(2009-9#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
system mediated by##4##3##(1992-8#1)(1994-3#1)(2007-11#1)(2011-2#1)
system might be##2##3##(2008-11#1)(2008-4#1)
system might##6##2##(2006-6#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-6#1)
system model##2##2##(2008-2#1)(2009-5#1)
system modelling##2##2##(2008-11#1)(2010-10#1)
system models##3##2##(1997-2#1)(2007-11#1)(2012-1#1)
system modulation##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
system more than##2##3##(2008-11#1)(2013-1#1)
system more##5##2##(1991-3#1)(2005-4#1)(2008-10#1)(2008-11#1)(2013-1#1)
system must be##3##3##(1990-10#1)(1996-3#1)(1997-1#1)
system must overcome##2##3##(1993-12#1)(1997-8#1)
system must##8##2##(1990-10#1)(1990-12#1)(1993-12#1)(1996-3#1)(1997-1#1)(1997-8#1)(2006-2#1)(2008-12#1)
system near##3##2##(1992-6#1)(2008-2#1)(2008-3#1)
system needs to##2##3##(1997-8#1)(2009-12#1)
system needs##3##2##(1997-8#1)(2009-12#1)(2013-8#1)
system no##2##2##(1995-8#1)(2008-5#1)
system noise##3##2##(2008-1#1)(2008-2#2)
system nonuniformity that results from the system components##2##8##(2008-3#2)
system nonuniformity##5##2##(2008-3#5)
system not only##5##3##(2007-12#1)(2008-10#2)(2009-2#1)(2010-8#1)
system not##7##2##(1996-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2009-2#1)(2010-8#1)
system obeys Beer's law in the range##3##7##(2008-10#3)
system obeys Beer's law##6##4##(2008-10#6)
system obeys##7##2##(1992-7#1)(2008-10#6)
system occur##3##2##(1992-3#1)(1992-5#1)(2008-1#1)
system occurred##3##2##(1996-6#1)(2006-8#1)(2013-8#1)
system occurs at##2##3##(1991-2#1)(2007-4#1)
system occurs in##2##3##(1991-2#1)(2008-11#1)
system occurs##5##2##(1991-2#2)(2007-11#1)(2007-4#1)(2008-11#1)
system of 0##3##3##(2008-10#1)(2008-3#1)(2012-3#1)
system of 1##2##3##(2009-5#1)(2010-2#1)
system of 7##2##3##(2008-1#1)(2008-10#1)
system of Aplysia##2##3##(1991-6#1)(2008-6#1)
system of Drosophila##4##3##(1994-3#1)(1995-6#1)(1997-4#1)(2008-3#1)
system of Neisseria gonorrhoeae##2##4##(1993-9#2)
system of P##3##3##(2006-8#1)(2008-10#1)(2011-2#1)
system of Tb-TMA-beta-CD##2##3##(2008-10#2)
system of a##12##3##(1996-6#2)(2008-10#5)(2008-2#1)(2008-3#1)(2009-2#1)(2012-12#1)(2013-7#1)
system of adult##3##3##(1991-3#1)(1993-7#1)(2013-8#1)
system of an##3##3##(2007-8#1)(2008-10#1)(2012-2#1)
system of care in##2##4##(1997-1#1)(2006-5#1)
system of care##7##3##(1996-1#1)(1997-1#1)(2006-5#2)(2009-10#1)(2010-12#1)(2013-1#1)
system of choice for the##2##5##(1996-2#1)(1997-4#1)
system of choice in##2##4##(1990-7#1)(1996-1#1)
system of choice##5##3##(1990-7#1)(1996-1#1)(1996-2#1)(1997-4#1)(2008-11#1)
system of classification##2##3##(2007-7#1)(2008-10#1)
system of coupled differential##2##4##(2006-10#1)(2008-3#1)
system of coupled##3##3##(2006-10#1)(2008-2#1)(2008-3#1)
system of defense##2##3##(2006-10#2)
system of differential equations##4##4##(2005-11#1)(2010-11#1)(2011-1#1)(2013-8#1)
system of each##2##3##(1991-11#1)(1994-1#1)
system of equations##3##3##(2007-12#2)(2008-2#1)
system of free##2##3##(2008-10#1)(2008-5#1)
system of health care##2##4##(2007-4#1)(2011-1#1)
system of health##4##3##(2007-4#1)(2011-1#1)(2013-1#2)
system of local##2##3##(2008-3#1)(2008-8#1)
system of medical##2##3##(2008-6#1)(2012-3#1)
system of medicine in India##2##5##(2008-10#2)
system of medicine is##2##4##(2008-7#1)(2013-1#1)
system of medicine##8##3##(2008-10#3)(2008-7#1)(2010-3#1)(2010-5#1)(2012-2#1)(2013-1#1)
system of operation##2##3##(2010-1#2)
system of oxidase activation##2##4##(1991-2#1)(1992-7#1)
system of partial differential equations##2##5##(2013-8#2)
system of performance intervention zones##2##5##(2008-12#2)
system of primary##2##3##(2006-8#1)(2007-10#1)
system of rabbit##2##3##(1992-6#1)(1996-5#1)
system of radiation protection##3##4##(2008-12#2)(2008-7#1)
system of rats##3##3##(1991-10#1)(1997-8#1)(2008-11#1)
system of schistosomiasis in##2##4##(2011-12#2)
system of service##11##3##(2013-8#11)
system of that##2##3##(1994-4#1)(2005-5#1)
system of the fruit fly##2##5##(2007-12#1)(2008-7#1)
system of the fruit##3##4##(2007-12#1)(2008-10#1)(2008-7#1)
system of the lamprey##2##4##(1997-3#2)
system of the plant##2##4##(2008-10#1)(2011-1#1)
system of the rat##3##4##(1990-9#1)(1992-6#1)(1995-5#1)
system of the##74##3##(1990-10#1)(1990-6#1)(1990-9#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-10#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-3#2)(1997-6#1)(2005-1#2)(2005-12#1)(2005-5#1)(2005-8#1)(2005-9#1)(2006-6#1)(2006-8#1)(2007-12#11)(2008-10#7)(2008-11#2)(2008-2#1)(2008-4#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#2)(2009-6#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
system of this region##2##4##(2007-3#1)(2008-9#1)
system of this##3##3##(2007-3#1)(2008-2#1)(2008-9#1)
system of two##10##3##(2005-11#1)(2007-12#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)
system of##518##2##(1990-1#1)(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#4)(1990-4#1)(1990-5#5)(1990-6#1)(1990-7#3)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#3)(1992-7#3)(1992-9#3)(1993-11#1)(1993-12#4)(1993-2#2)(1993-3#3)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#6)(1995-2#5)(1995-3#1)(1995-5#3)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#5)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#4)(1996-4#2)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#4)(1997-2#5)(1997-3#2)(1997-4#7)(1997-5#1)(1997-6#3)(1997-8#2)(2005-1#2)(2005-10#2)(2005-11#4)(2005-12#1)(2005-5#2)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#10)(2006-12#3)(2006-5#3)(2006-6#1)(2006-8#4)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#32)(2007-3#2)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#5)(2008-1#2)(2008-10#55)(2008-11#15)(2008-12#9)(2008-2#18)(2008-3#12)(2008-4#5)(2008-5#3)(2008-6#5)(2008-7#15)(2008-8#8)(2008-9#12)(2009-10#2)(2009-12#1)(2009-2#4)(2009-3#4)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#4)(2010-11#2)(2010-12#2)(2010-2#3)(2010-3#2)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#7)(2011-12#2)(2011-2#7)(2011-7#1)(2012-11#3)(2012-12#5)(2012-2#6)(2012-3#7)(2013-1#7)(2013-7#1)(2013-8#31)
system offer##2##2##(2004-2#1)(2008-7#1)
system offered improved##2##3##(2008-10#2)
system offered##4##2##(2008-10#4)
system offers a##3##3##(1995-3#1)(2008-10#1)(2008-2#1)
system offers several##2##3##(1991-9#1)(2008-10#1)
system offers the##5##3##(2007-6#1)(2008-11#1)(2008-7#1)(2010-7#1)(2012-2#1)
system offers##16##2##(1991-9#1)(1993-3#1)(1994-2#1)(1995-2#1)(1995-3#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2010-7#1)(2012-2#1)
system on a##9##3##(2007-9#1)(2008-10#2)(2008-4#1)(2012-2#1)(2013-1#4)
system on chip##3##3##(2009-10#1)(2010-8#2)
system on the##16##3##(1990-2#1)(1996-2#2)(2005-11#1)(2006-10#1)(2006-6#1)(2007-4#1)(2007-9#1)(2008-10#3)(2008-3#1)(2010-6#2)(2013-1#2)
system on##58##2##(1990-2#1)(1990-7#2)(1990-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-8#1)(1995-11#1)(1996-2#2)(1996-5#1)(1996-8#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-6#1)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-10#5)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-6#2)(2010-8#3)(2011-1#2)(2012-1#1)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#7)(2013-8#1)
system onto##2##2##(2005-11#1)(2008-2#1)
system operated##2##2##(2008-2#1)(2008-3#1)
system operates in the##2##4##(2007-12#1)(2008-2#1)
system operates##3##2##(2007-12#2)(2008-2#1)
system operating at##3##3##(2007-12#1)(2008-2#2)
system operating in the##2##4##(1990-5#1)(2008-3#1)
system operating with##2##3##(2007-12#2)
system operating##11##2##(1990-5#1)(2007-12#5)(2008-2#3)(2008-3#2)
system operation##2##2##(2008-2#1)(2011-1#1)
system or a##4##3##(1990-12#1)(2007-8#1)(2008-2#1)(2008-4#1)
system or the##2##3##(1993-12#1)(2008-9#1)
system or##27##2##(1990-12#1)(1990-3#1)(1991-12#1)(1991-2#1)(1993-1#1)(1993-12#1)(1993-5#2)(1994-3#1)(1996-3#1)(2006-3#1)(2007-12#1)(2007-4#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-7#1)
system originate from##2##3##(1991-11#1)(2008-1#1)
system output##4##2##(2007-11#1)(2008-2#1)(2008-9#1)(2009-8#1)
system outputs##2##2##(2006-1#1)(2009-8#1)
system over the##6##3##(1993-12#1)(1993-3#1)(2008-10#3)(2008-11#1)
system over##12##2##(1993-12#1)(1993-3#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-7#1)(2011-2#1)
system owing to the##2##4##(1990-9#1)(2008-10#1)
system parameters are##2##3##(2008-3#2)
system parameters by using##2##4##(2008-2#1)(2008-3#1)
system parameters##22##2##(2006-10#1)(2007-11#1)(2007-12#4)(2008-2#5)(2008-3#9)(2008-7#1)(2011-1#1)
system pathways##4##2##(1993-12#1)(2008-1#1)(2010-12#1)(2010-2#1)
system performance for##3##3##(2008-2#1)(2008-3#1)(2011-1#1)
system performance is##4##3##(1996-12#1)(2008-3#3)
system performance results##2##3##(2008-2#1)(2008-3#1)
system performance was evaluated##2##4##(2008-3#1)(2013-1#1)
system performance was##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
system performance with##4##3##(2007-4#1)(2008-3#2)(2012-1#1)
system performance##54##2##(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(2007-1#2)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-2#11)(2008-3#18)(2008-7#1)(2009-4#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#2)
system performances##2##2##(2008-2#2)
system performs##3##2##(2008-1#1)(2008-10#1)(2008-3#1)
system permits the##2##3##(1994-3#1)(2007-12#1)
system permits##9##2##(1994-3#1)(1997-2#1)(2005-12#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-9#1)
system permitted##2##2##(2008-10#1)(2008-11#1)
system play##3##2##(2007-2#2)(2008-7#1)
system plays a key role in the##2##7##(2005-8#1)(2009-7#1)
system plays a##10##3##(1997-7#1)(2005-8#1)(2006-8#1)(2008-1#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-7#1)(2013-7#1)
system plays an important role in the##2##7##(1993-12#1)(2006-11#1)
system plays an important role in##4##6##(1993-12#1)(2006-11#1)(2010-3#1)(2012-12#1)
system plays##16##2##(1993-12#2)(1997-7#1)(2005-8#1)(2006-11#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-7#1)(2010-3#1)(2012-12#1)(2013-7#1)
system possibly##2##2##(1990-10#1)(1993-2#1)
system power##2##2##(2007-11#1)(2008-2#1)
system powered by##2##3##(2012-1#2)
system presented an analytical##2##4##(2008-10#2)
system presented##6##2##(2008-10#4)(2008-11#1)(2008-4#1)
system presents##4##2##(1990-2#1)(1997-2#1)(2008-11#1)(2012-3#1)
system primarily##2##2##(2008-10#1)(2008-3#1)
system processes##5##2##(1990-11#1)(2007-11#1)(2008-10#1)(2008-4#1)(2010-4#1)
system produced##8##2##(1991-1#1)(1995-2#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)
system produces a##3##3##(2005-11#1)(2007-11#1)(2008-10#1)
system produces an##2##3##(1996-2#1)(2008-10#1)
system produces##9##2##(1996-2#1)(2005-11#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-3#1)
system producing##2##2##(2008-1#1)(2008-3#1)
system proposed by##3##3##(1990-8#1)(2007-11#1)(2011-1#1)
system proposed##4##2##(1990-8#1)(2007-11#1)(2010-8#1)(2011-1#1)
system proved to be##4##4##(1995-11#1)(2007-8#1)(2008-10#2)
system proved##5##2##(1995-11#1)(2006-5#1)(2007-8#1)(2008-10#2)
system provided a##3##3##(2008-10#2)(2008-9#1)
system provided excellent##2##3##(1995-12#1)(2008-3#1)
system provided##10##2##(1990-11#1)(1995-12#1)(2006-10#1)(2008-10#4)(2008-3#1)(2008-9#1)(2010-2#1)
system provides a##12##3##(1990-7#1)(1991-6#1)(1994-3#2)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-7#1)(2011-2#1)(2013-1#1)
system provides an##3##3##(1994-12#1)(2006-8#1)(2008-10#1)
system provides high##2##3##(2007-11#1)(2008-3#1)
system provides information##2##3##(2008-10#1)(2010-5#1)
system provides the##4##3##(1990-4#1)(2007-12#1)(2008-1#1)(2008-3#1)
system provides##36##2##(1990-4#1)(1990-7#1)(1991-6#1)(1992-2#1)(1993-3#1)(1994-12#1)(1994-3#2)(2006-10#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-4#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-7#1)
system pumped by a##3##4##(2007-12#1)(2008-3#1)(2008-5#1)
system puts##2##2##(1992-3#1)(2006-10#1)
system rather than the##3##4##(1990-8#1)(1994-12#1)(2008-7#1)
system rather##4##2##(1990-8#1)(1994-12#1)(1995-1#1)(2008-7#1)
system reached##5##2##(1996-3#1)(1997-8#1)(2008-6#2)(2011-2#1)
system reconstituted with##2##3##(1991-9#1)(1995-2#1)
system records##2##2##(2008-10#1)(2008-2#1)
system reduced##4##2##(1992-5#1)(2008-10#1)(2008-5#1)(2010-3#1)
system reduces##2##2##(2008-10#1)(2009-5#1)
system reform##18##2##(1993-12#4)(1993-3#2)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#3)(1996-12#2)(2007-5#1)(2009-3#1)(2012-12#1)
system regulated by##2##3##(2008-4#1)(2011-1#1)
system regulates##2##2##(1992-11#1)(2009-10#1)
system related to##2##3##(2007-11#1)(2007-3#1)
system related##4##2##(2007-11#1)(2007-3#1)(2010-12#1)(2010-3#1)
system reliability##2##2##(2008-3#2)
system relies on##3##3##(2005-10#1)(2008-10#1)(2008-3#1)
system remains##4##2##(1991-2#1)(1992-12#1)(2007-11#1)(2008-7#1)
system represents an##2##3##(2008-10#2)
system represents the##2##3##(1996-9#1)(2008-1#1)
system represents##5##2##(1996-9#1)(2008-1#1)(2008-10#2)(2008-11#1)
system required##2##2##(2008-10#1)(2008-11#1)
system requirements##5##2##(1991-1#1)(1996-3#1)(2010-12#1)(2010-8#2)
system requires only##2##3##(2008-11#1)(2010-6#1)
system requires##8##2##(1993-12#1)(1994-1#1)(1997-8#1)(2007-2#1)(2008-11#2)(2008-4#1)(2010-6#1)
system research##2##2##(2007-3#1)(2011-2#1)
system resistance##2##2##(2005-11#1)(2012-2#1)
system resolution##2##2##(2007-12#1)(2010-9#1)
system response##9##2##(2007-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2010-2#1)(2012-2#1)(2012-6#1)(2013-1#1)
system responses to##2##3##(1993-2#1)(1994-11#1)
system responses##4##2##(1993-2#1)(1994-11#1)(2008-2#2)
system resulted in##7##3##(1992-8#1)(1993-3#1)(1995-6#1)(2004-12#1)(2007-1#1)(2008-10#1)(2008-7#1)
system results in an##2##4##(2007-11#1)(2008-10#1)
system results in##6##3##(2007-11#1)(2007-9#1)(2008-10#1)(2008-8#1)(2011-1#1)(2013-1#1)
system revealed##6##2##(1995-6#1)(1996-2#1)(2007-11#1)(2007-8#1)(2008-11#1)(2013-1#1)
system reveals##2##2##(2007-12#1)(2013-1#1)
system review##5##2##(2011-1#2)(2012-1#1)(2013-1#1)(2013-8#1)
system safety##2##2##(1990-11#2)
system scalability and##2##3##(2008-2#1)(2010-8#1)
system scalability##4##2##(2008-2#1)(2010-8#3)
system seems to be##4##4##(1990-5#1)(1993-8#1)(2005-7#1)(2007-3#1)
system seems to##5##3##(1990-5#1)(1993-8#1)(2005-7#1)(2007-3#1)(2009-4#1)
system sends##2##2##(2007-12#1)(2009-10#1)
system serves as##2##3##(2010-12#1)(2010-2#1)
system serves##5##2##(1990-4#1)(1995-12#1)(2008-8#1)(2010-12#1)(2010-2#1)
system settings##2##2##(2008-2#2)
system setup##2##2##(2007-3#1)(2009-3#1)
system should allow##2##3##(1997-7#1)(2006-6#1)
system should be useful for##3##5##(1992-1#1)(1995-2#1)(2008-11#1)
system should be useful##4##4##(1992-1#1)(1995-2#1)(2008-11#1)(2008-5#1)
system should be##17##3##(1992-1#1)(1992-6#1)(1995-2#1)(1997-5#1)(2007-3#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)
system should not be##2##4##(2008-10#1)(2013-8#1)
system should##31##2##(1991-7#1)(1992-1#1)(1992-6#1)(1993-7#1)(1994-3#2)(1994-8#1)(1995-2#1)(1996-2#1)(1997-5#1)(1997-7#1)(2006-6#1)(2007-12#1)(2007-3#2)(2007-7#2)(2008-10#5)(2008-11#2)(2008-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-8#1)
system show that the##2##4##(2005-10#1)(2008-3#1)
system showed good##4##3##(2008-10#4)
system showed that##6##3##(1993-11#1)(1997-2#1)(2008-10#1)(2008-11#1)(2009-12#1)(2011-2#1)
system showed##12##2##(1993-11#1)(1997-2#1)(2008-10#5)(2008-11#1)(2008-3#1)(2009-12#1)(2011-2#1)(2012-2#1)
system shows greater##2##3##(2007-7#2)
system shows that the##2##4##(2007-11#1)(2008-10#1)
system shows that##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
system shows the##2##3##(1996-4#1)(2010-8#1)
system shows##12##2##(1996-4#1)(2006-10#1)(2007-11#1)(2007-7#3)(2008-10#1)(2008-2#1)(2008-3#2)(2010-4#1)(2010-8#1)
system similar to##2##3##(1996-4#1)(2007-2#1)
system simulation##3##2##(2007-12#1)(2008-2#2)
system since it##2##3##(2008-10#1)(2010-5#1)
system since##5##2##(1994-1#1)(1996-4#1)(2008-10#1)(2010-5#1)(2011-1#1)
system size##5##2##(2008-2#3)(2012-2#1)(2013-8#1)
system so that##4##3##(2008-10#1)(2008-3#2)(2010-5#1)
system specific to##2##3##(1994-8#1)(2007-3#1)
system specific##3##2##(1994-8#1)(2006-10#1)(2007-3#1)
system specifically##2##2##(2007-11#1)(2009-11#1)
system stability##3##2##(2008-1#1)(2008-3#1)(2008-5#1)
system states##2##2##(2008-11#1)(2009-10#1)
system still##3##2##(1991-10#1)(2005-11#1)(2010-5#1)
system structure and##2##3##(1991-11#1)(2008-2#1)
system studied##2##2##(2005-8#1)(2008-10#1)
system successfully##3##2##(2007-8#1)(2008-2#1)(2008-3#1)
system such as a##2##4##(2007-12#1)(2008-3#1)
system such as##12##3##(1995-2#1)(1995-5#1)(1996-8#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)
system such that the##2##4##(1995-3#1)(2008-3#1)
system such that##3##3##(1995-3#1)(2008-3#2)
system such##15##2##(1995-2#1)(1995-3#1)(1995-5#1)(1996-8#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-7#1)(2011-1#1)(2011-2#1)
system suffers from##3##3##(1996-2#1)(2005-11#1)(2010-5#1)
system suggests that##2##3##(1996-12#1)(2009-10#1)
system suggests##3##2##(1995-8#1)(1996-12#1)(2009-10#1)
system suitability##6##2##(1996-3#1)(2008-10#1)(2008-3#1)(2010-4#1)(2012-12#1)(2012-2#1)
system takes##5##2##(1995-1#1)(1997-7#1)(2007-11#1)(2008-10#2)
system targeting##2##2##(1995-1#1)(2011-1#1)
system technology##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
system than in##3##3##(1996-9#1)(2006-10#1)(2008-10#1)
system than the##3##3##(1997-4#1)(2008-10#1)(2008-2#1)
system than##11##2##(1991-5#1)(1996-9#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-4#1)
system that allows for##2##4##(2006-5#1)(2013-8#1)
system that allows us to##3##5##(2008-2#1)(2010-5#2)
system that allows##9##3##(2006-5#1)(2008-12#1)(2008-2#1)(2010-5#2)(2011-2#1)(2013-1#2)(2013-8#1)
system that are##2##3##(2008-3#1)(2008-9#1)
system that assembles##2##3##(1996-5#1)(2008-4#1)
system that can be used for##2##6##(2008-10#1)(2011-1#1)
system that can be used in##3##6##(2009-6#1)(2013-1#2)
system that can be used to##3##6##(1991-2#1)(1997-4#1)(2009-4#1)
system that can be used##9##5##(1991-2#1)(1997-4#1)(2008-10#1)(2008-2#1)(2009-4#1)(2009-6#1)(2011-1#1)(2013-1#2)
system that can simultaneously##2##4##(2007-11#1)(2008-11#1)
system that can##19##3##(1991-2#1)(1996-3#1)(1997-4#1)(2006-2#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-4#1)(2009-6#1)(2011-1#2)(2013-1#2)
system that combines the##3##4##(1993-3#1)(2008-12#1)(2008-2#1)
system that combines##6##3##(1993-3#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-2#1)
system that consists of##2##4##(2008-2#1)(2008-4#1)
system that contains a##2##4##(2007-12#1)(2008-3#1)
system that controls##3##3##(1995-12#1)(1995-9#1)(2009-8#1)
system that could be used##3##5##(1995-2#1)(2009-10#1)(2012-1#1)
system that could be##4##4##(1995-2#1)(2008-7#1)(2009-10#1)(2012-1#1)
system that could##5##3##(1995-2#1)(2007-12#1)(2008-7#1)(2009-10#1)(2012-1#1)
system that determines##2##3##(1994-2#1)(2010-2#1)
system that does not##3##4##(1996-2#1)(2008-10#1)(2008-9#1)
system that employs##5##3##(2008-10#1)(2008-2#3)(2008-3#1)
system that exhibits##2##3##(2007-11#1)(2007-12#1)
system that groups##2##3##(1996-1#1)(2006-3#1)
system that has a##2##4##(2007-2#1)(2009-10#1)
system that has been developed##2##5##(2008-10#1)(2008-2#1)
system that has been##9##4##(1996-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-12#1)
system that has##14##3##(1996-6#1)(1997-3#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#1)(2009-10#1)(2010-12#1)(2012-1#1)
system that includes##3##3##(1993-6#1)(2008-1#1)(2008-3#1)
system that incorporates##2##3##(2008-3#2)
system that integrates##3##3##(2008-10#1)(2008-3#1)(2009-4#1)
system that is able to##5##5##(1995-11#1)(2008-5#1)(2011-1#1)(2013-8#2)
system that is based on##2##5##(2006-4#1)(2008-2#1)
system that is capable of##2##5##(1991-9#1)(2007-12#1)
system that is##29##3##(1991-9#1)(1995-11#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
system that makes##2##3##(2006-8#1)(2008-3#1)
system that may##2##3##(2007-11#1)(2010-1#1)
system that measures##2##3##(2008-2#1)(2008-3#1)
system that operates##2##3##(2007-11#1)(2008-3#1)
system that permits##2##3##(2007-11#1)(2008-2#1)
system that produces##6##3##(2007-11#1)(2007-12#4)(2008-10#1)
system that provides a##2##4##(2008-2#1)(2008-3#1)
system that provides##9##3##(1991-4#1)(1992-1#1)(1994-3#1)(2007-4#1)(2008-2#1)(2008-3#1)(2013-1#2)(2013-8#1)
system that regulates##3##3##(1995-12#1)(1995-8#1)(2009-6#1)
system that relies##2##3##(1996-1#1)(2007-12#1)
system that responds to##2##4##(1994-9#1)(1995-12#1)
system that responds##3##3##(1990-12#1)(1994-9#1)(1995-12#1)
system that targeted##2##3##(2009-7#1)(2013-1#1)
system that uses a##13##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#8)(2013-1#2)
system that uses the##2##4##(2008-2#1)(2008-3#1)
system that uses##26##3##(1994-12#1)(2007-11#2)(2007-12#1)(2008-2#6)(2008-3#13)(2008-4#1)(2013-1#2)
system that utilizes##2##3##(2007-11#1)(2008-3#1)
system that was developed for##2##5##(2008-10#1)(2008-2#1)
system that was developed##4##4##(1994-3#1)(1995-2#1)(2008-10#1)(2008-2#1)
system that was##5##3##(1990-10#1)(1994-3#1)(1995-2#1)(2008-10#1)(2008-2#1)
system that we##3##3##(2008-11#1)(2008-5#1)(2012-12#1)
system that will##5##3##(1994-12#1)(2007-7#1)(2008-2#1)(2008-3#1)(2012-1#1)
system that would##6##3##(1995-2#1)(2008-10#1)(2008-6#1)(2009-8#1)(2013-1#2)
system that##286##2##(1990-10#1)(1990-12#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-1#2)(1992-3#1)(1993-12#1)(1993-3#2)(1993-6#2)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#3)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-12#1)(2006-1#1)(2006-10#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#11)(2007-12#19)(2007-2#2)(2007-3#1)(2007-4#3)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#15)(2008-11#5)(2008-12#3)(2008-2#25)(2008-3#45)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#5)(2009-10#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-5#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#4)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#27)(2013-7#1)(2013-8#4)
system the##14##2##(1990-3#1)(1991-10#1)(1991-3#1)(1993-8#2)(1994-12#1)(1997-2#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-3#2)
system theory##3##2##(1990-12#1)(2006-10#1)(2008-9#1)
system there are##2##3##(2008-10#1)(2010-5#1)
system there##3##2##(2008-10#1)(2008-5#1)(2010-5#1)
system through a##4##3##(1993-8#2)(2008-10#1)(2008-2#1)
system through the##5##3##(1997-7#1)(2008-5#1)(2008-9#2)(2013-8#1)
system through##17##2##(1993-12#1)(1993-8#2)(1997-7#2)(2006-3#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#2)(2010-12#1)(2010-8#1)(2011-1#1)(2013-8#1)
system throughput##2##2##(2008-3#1)(2008-5#1)
system thus##6##2##(1994-9#1)(1995-12#1)(1997-2#1)(2005-8#1)(2008-10#1)(2008-11#1)
system time##2##2##(2008-3#1)(2008-6#1)
system to a##5##3##(1995-11#1)(1996-1#1)(2007-12#1)(2008-10#1)(2008-3#1)
system to achieve##2##3##(1992-12#1)(2008-1#1)
system to an##2##3##(1996-2#1)(2007-3#1)
system to analyze##4##3##(1996-12#1)(2007-12#1)(2008-10#1)(2011-2#1)
system to assess the##3##4##(1993-7#1)(2008-4#1)(2012-2#1)
system to assess##7##3##(1993-7#1)(1994-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
system to automatically##3##3##(2012-1#1)(2013-1#2)
system to avoid##3##3##(2008-10#2)(2012-1#1)
system to be used in##4##5##(1990-3#1)(2008-10#1)(2008-3#1)(2010-11#1)
system to be used to##2##5##(2008-2#1)(2009-12#1)
system to be used##7##4##(1990-3#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-12#1)(2010-11#1)
system to be##16##3##(1990-3#1)(1997-1#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)(2009-12#1)(2009-8#1)(2010-11#2)(2010-5#1)(2013-1#1)
system to characterize the##2##4##(1997-3#1)(2008-10#1)
system to characterize##6##3##(1991-5#1)(1997-3#1)(2008-10#1)(2009-8#1)(2013-1#2)
system to compensate for##2##4##(2007-11#1)(2008-2#1)
system to control##2##3##(2008-11#1)(2011-2#1)
system to define##2##3##(1991-12#1)(2007-12#1)
system to demonstrate the##4##4##(2006-10#1)(2007-11#1)(2008-2#1)(2008-3#1)
system to demonstrate##5##3##(1991-10#1)(2006-10#1)(2007-11#1)(2008-2#1)(2008-3#1)
system to detect##7##3##(1992-8#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-4#1)
system to determine##2##3##(2008-10#2)
system to develop##2##3##(2008-10#1)(2008-11#1)
system to evaluate the##4##4##(2008-10#1)(2008-5#1)(2009-3#1)(2013-8#1)
system to evaluate##7##3##(1990-12#1)(1996-3#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-3#1)(2013-8#1)
system to examine the##3##4##(1997-6#1)(2006-6#1)(2007-11#1)
system to examine##4##3##(1997-6#1)(2006-6#1)(2007-11#1)(2008-9#1)
system to experimentally##2##3##(2009-2#1)(2010-2#1)
system to express##5##3##(1992-10#1)(1995-10#1)(1997-4#1)(2008-10#1)(2008-11#1)
system to facilitate##5##3##(1997-2#1)(2008-2#1)(2013-1#3)
system to generate##3##3##(2008-2#1)(2008-9#1)(2012-3#1)
system to guide##2##3##(2005-5#1)(2007-8#1)
system to identify##8##3##(1994-8#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-6#1)(2012-12#1)(2013-8#2)
system to improve the##2##4##(2007-2#1)(2013-8#1)
system to improve##4##3##(2007-12#1)(2007-2#1)(2007-8#1)(2013-8#1)
system to increase the##2##4##(2008-10#1)(2008-4#1)
system to increase##3##3##(1997-8#1)(2008-10#1)(2008-4#1)
system to induce##2##3##(2007-10#1)(2008-9#1)
system to investigate the##5##4##(1993-6#1)(2007-11#1)(2008-9#2)(2009-2#1)
system to investigate##7##3##(1993-6#1)(1994-6#1)(2007-11#1)(2008-11#1)(2008-9#2)(2009-2#1)
system to maintain##3##3##(1996-8#1)(2004-12#1)(2007-11#1)
system to measure the##3##4##(2007-12#1)(2008-3#1)(2009-9#1)
system to measure##8##3##(1991-9#1)(2007-12#1)(2008-10#1)(2008-3#2)(2009-4#1)(2009-9#1)(2012-12#1)
system to meet##3##3##(1990-5#1)(1992-1#1)(1994-1#1)
system to monitor the##2##4##(2008-10#1)(2011-1#1)
system to monitor##3##3##(2008-10#1)(2008-2#1)(2011-1#1)
system to obtain##2##3##(1997-4#1)(2008-3#1)
system to perform##4##3##(2008-10#3)(2008-2#1)
system to predict##2##3##(2007-8#1)(2010-12#1)
system to produce##6##3##(1992-4#1)(1993-5#1)(1996-3#1)(1996-5#1)(2008-10#1)(2008-6#1)
system to provide##4##3##(1992-3#1)(1996-2#1)(2006-10#1)(2013-8#1)
system to realize##3##3##(2012-1#1)(2012-11#2)
system to reduce##3##3##(2007-8#1)(2008-10#1)(2010-3#1)
system to study##18##3##(1990-3#1)(1995-11#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-8#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-9#1)(2010-9#1)(2012-2#1)
system to support##6##3##(1996-2#1)(1997-1#1)(2010-11#2)(2013-1#2)
system to test##4##3##(1995-8#1)(2008-10#1)(2008-11#1)(2011-1#1)
system to the##10##3##(1994-3#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-3#1)(2009-5#1)(2013-1#1)
system to work##2##3##(1996-2#1)(2013-1#1)
system to##330##2##(1990-12#1)(1990-3#3)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-5#3)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-8#2)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-7#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#2)(1995-11#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#3)(1996-10#1)(1996-12#2)(1996-2#5)(1996-3#4)(1996-5#2)(1996-8#1)(1997-1#3)(1997-2#2)(1997-3#3)(1997-4#2)(1997-6#1)(1997-8#2)(2004-1#1)(2004-12#1)(2004-9#1)(2005-5#1)(2006-10#6)(2006-12#3)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#8)(2007-12#12)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-8#5)(2008-1#5)(2008-10#42)(2008-11#14)(2008-12#1)(2008-2#16)(2008-3#15)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#8)(2009-10#1)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#5)(2012-11#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#18)(2013-7#2)(2013-8#8)
system together##2##2##(1992-11#1)(2008-10#1)
system transfer function##2##3##(2007-12#1)(2008-3#1)
system transfer##3##2##(2007-12#1)(2008-3#2)
system transforms##2##2##(2008-10#1)(2008-9#1)
system under low##2##3##(2007-12#1)(2009-4#1)
system under the##3##3##(2007-12#1)(2010-12#1)(2010-8#1)
system under##17##2##(1994-12#1)(1995-2#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#2)(2009-4#1)(2010-12#1)(2010-4#1)(2010-8#1)
system underlying the##2##3##(2010-8#1)(2012-1#1)
system until##2##2##(2008-6#1)(2011-12#1)
system use##5##2##(2011-1#1)(2013-1#4)
system used for##5##3##(2006-3#1)(2007-12#1)(2011-2#1)(2012-11#2)
system used in##5##3##(1996-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-6#1)
system used to##3##3##(2007-5#1)(2008-5#1)(2009-7#1)
system used was##2##3##(2008-7#2)
system used##25##2##(1990-11#1)(1993-3#1)(1996-12#2)(2006-3#1)(2006-6#1)(2007-12#2)(2007-5#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-7#1)(2010-6#1)(2011-2#2)(2012-11#2)
system uses a##10##3##(1993-12#1)(1994-12#1)(1997-3#1)(2008-10#1)(2008-2#2)(2008-3#2)(2012-1#1)(2013-1#1)
system uses only##2##3##(2007-12#1)(2008-3#1)
system uses##26##2##(1993-12#1)(1994-12#1)(1997-3#1)(2006-11#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#6)(2008-4#1)(2008-6#1)(2008-9#1)(2012-1#1)(2013-1#2)
system using a flow cytometer to##2##6##(1994-2#2)
system using a##23##3##(1994-2#2)(2008-10#13)(2008-2#2)(2008-3#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
system using an##4##3##(2008-10#2)(2008-11#1)(2008-8#1)
system using human##2##3##(1993-3#1)(2008-11#1)
system using purified##2##3##(1993-11#1)(1996-10#1)
system using the##13##3##(1991-9#1)(1996-7#1)(1997-4#1)(2005-11#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-5#2)(2012-12#2)
system using##118##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-11#1)(1991-3#1)(1991-9#1)(1992-2#1)(1993-11#1)(1993-3#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-2#2)(1994-9#1)(1995-1#1)(1996-10#1)(1996-12#2)(1996-4#1)(1996-5#1)(1996-7#1)(1997-2#2)(1997-4#3)(2005-11#2)(2006-6#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-1#2)(2008-10#40)(2008-11#6)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#3)(2012-12#2)
system utilization##3##2##(1994-12#1)(2008-2#2)
system utilized##3##2##(1996-11#1)(2008-10#1)(2008-2#1)
system utilizes the##2##3##(1997-4#1)(2008-10#1)
system utilizes##7##2##(1997-4#1)(2008-10#3)(2008-2#1)(2008-3#2)
system utilizing##8##2##(1995-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-7#1)(2012-1#1)
system variables##4##2##(1990-7#1)(2008-10#1)(2008-2#2)
system velocity##2##2##(2008-2#2)
system via a##2##3##(1997-1#1)(2008-10#1)
system via##6##2##(1992-8#1)(1997-1#1)(2007-11#1)(2008-10#1)(2009-9#1)(2012-12#1)
system volume##4##2##(1996-3#2)(2008-2#2)
system was 0##3##3##(1994-9#1)(1995-8#1)(1996-1#1)
system was able to##4##4##(2007-5#1)(2008-10#2)(2012-12#1)
system was about##2##3##(1990-10#1)(2013-8#1)
system was achieved##3##3##(1995-1#1)(2008-10#2)
system was also applied to##2##5##(2008-10#1)(2008-5#1)
system was also used##3##4##(1995-1#1)(2006-5#1)(2008-10#1)
system was also##11##3##(1991-8#1)(1991-9#1)(1995-1#1)(2006-5#1)(2008-10#5)(2008-3#1)(2008-5#1)
system was an##2##3##(1992-3#1)(2012-1#1)
system was applied for the determination of##2##7##(2008-10#2)
system was applied to measure##2##5##(2006-6#1)(2008-5#1)
system was applied to the determination of##5##7##(2007-8#1)(2008-10#4)
system was applied to the##11##5##(2007-8#2)(2008-10#9)
system was applied to##20##4##(2006-12#1)(2006-6#1)(2007-8#2)(2008-10#12)(2008-3#1)(2008-5#1)(2011-3#1)(2013-8#1)
system was applied##24##3##(1997-4#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-8#2)(2008-10#14)(2008-3#1)(2008-5#1)(2011-3#1)(2013-8#1)
system was approximately##2##3##(2008-10#1)(2008-2#1)
system was ascertained by analyzing a set of##3##8##(2008-10#3)
system was assembled with a##2##5##(2008-10#2)
system was assembled##4##3##(2008-10#4)
system was based on the##3##5##(2006-12#1)(2008-10#1)(2013-1#1)
system was built and##2##4##(2008-2#1)(2008-3#1)
system was built##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
system was calculated##3##3##(2008-2#1)(2008-3#1)(2013-8#1)
system was calibrated in the range##2##6##(2008-10#2)
system was calibrated in##3##4##(2008-10#2)(2008-2#1)
system was calibrated##7##3##(2006-6#1)(2007-11#1)(2008-10#4)(2008-2#1)
system was capable of##3##4##(2008-10#1)(2008-11#1)(2011-1#1)
system was carried out by##2##5##(2008-10#2)
system was carried out##5##4##(2007-8#1)(2008-10#4)
system was chosen##2##3##(1994-12#1)(2008-11#1)
system was compared with##3##4##(2008-10#1)(2008-2#1)(2008-5#1)
system was composed of##2##4##(1990-2#1)(2007-8#1)
system was constructed and##2##4##(2008-10#1)(2008-3#1)
system was constructed by using##2##5##(2008-11#1)(2011-3#1)
system was constructed##11##3##(1997-6#1)(2007-10#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2011-3#1)
system was controlled by##2##4##(2008-10#2)
system was controlled##3##3##(2008-10#3)
system was demonstrated by##2##4##(1997-8#1)(2008-10#1)
system was demonstrated to be##2##5##(2008-10#1)(2009-5#1)
system was demonstrated##8##3##(1997-8#1)(2007-8#1)(2008-10#5)(2009-5#1)
system was designed and##3##4##(2007-11#1)(2008-11#1)(2008-8#1)
system was designed to##2##4##(2007-12#1)(2008-10#1)
system was designed##9##3##(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-1#1)
system was detected##2##3##(1995-8#1)(2008-10#1)
system was determined##2##3##(2007-11#1)(2007-7#1)
system was developed and##2##4##(2007-8#1)(2008-7#1)
system was developed for the determination of##3##7##(2008-10#3)
system was developed for the##7##5##(1992-11#1)(1997-3#1)(2008-10#5)
system was developed for##12##4##(1992-11#1)(1997-3#1)(2007-8#1)(2008-10#8)(2012-1#1)
system was developed that##2##4##(1990-3#1)(2008-7#1)
system was developed to##8##4##(1992-7#1)(1995-3#1)(1996-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2011-1#1)
system was developed using##3##4##(2008-10#3)
system was developed##37##3##(1990-3#1)(1992-11#1)(1992-7#1)(1993-4#1)(1993-8#1)(1995-3#1)(1996-8#1)(1997-3#2)(2006-5#1)(2007-12#1)(2007-8#2)(2008-10#16)(2008-11#1)(2008-2#1)(2008-7#2)(2010-5#1)(2011-1#1)(2012-1#1)(2012-11#1)
system was done##2##3##(2007-8#1)(2008-5#1)
system was employed to##4##4##(2008-10#3)(2008-3#1)
system was employed##7##3##(1997-4#1)(1997-8#1)(2008-10#4)(2008-3#1)
system was established##4##3##(1990-9#1)(1991-12#1)(2008-8#2)
system was evaluated by##3##4##(1993-1#1)(2008-10#2)
system was evaluated for the##2##5##(2008-10#2)
system was evaluated for##5##4##(2007-8#1)(2008-10#3)(2008-7#1)
system was evaluated in##3##4##(2008-2#1)(2008-5#1)(2008-6#1)
system was evaluated through##2##4##(2008-10#1)(2012-1#1)
system was evaluated using##3##4##(2010-2#1)(2013-1#2)
system was evaluated##18##3##(1993-1#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-2#1)(2012-1#1)(2013-1#4)
system was found to be##4##5##(2008-10#1)(2008-5#1)(2009-5#1)(2013-1#1)
system was found to##13##4##(1991-9#1)(2005-11#1)(2007-11#2)(2007-8#1)(2008-10#4)(2008-5#2)(2009-5#1)(2013-1#1)
system was found##15##3##(1991-9#1)(2005-11#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#5)(2008-5#2)(2009-5#1)(2013-1#1)
system was further##3##3##(1996-5#1)(2008-10#2)
system was higher than##2##4##(2008-11#1)(2008-9#1)
system was illustrated##3##3##(1991-9#1)(2008-10#1)(2012-3#1)
system was implemented to##2##4##(1997-1#1)(2008-10#1)
system was implemented##5##3##(1992-4#1)(1997-1#1)(2008-10#1)(2008-2#1)(2010-2#1)
system was improved##2##3##(2004-8#1)(2008-10#1)
system was intended##2##3##(1990-11#1)(2007-2#1)
system was introduced##4##3##(1995-6#1)(2005-12#1)(2008-11#1)(2008-7#1)
system was investigated by##3##4##(1993-5#1)(2008-10#1)(2008-11#1)
system was investigated in##3##4##(1997-4#1)(2008-10#1)(2011-2#1)
system was investigated##10##3##(1993-5#1)(1997-4#1)(2008-10#6)(2008-11#1)(2011-2#1)
system was linear##2##3##(2008-10#2)
system was measured##2##3##(1990-12#1)(2008-10#1)
system was more active in##2##5##(1994-12#1)(2010-8#1)
system was more##4##3##(1993-12#1)(1994-12#1)(2008-10#1)(2010-8#1)
system was not##5##3##(1996-12#1)(1997-8#1)(2007-11#1)(2007-4#1)(2008-10#1)
system was obtained##2##3##(2008-10#2)
system was operated##3##3##(2005-11#1)(2008-10#1)(2008-2#1)
system was optimised##3##3##(2007-8#1)(2008-10#2)
system was optimized and##3##4##(2008-10#3)
system was optimized##7##3##(2007-8#1)(2008-10#4)(2008-11#1)(2012-3#1)
system was performed##2##3##(1991-8#1)(2008-10#1)
system was proposed##2##3##(2007-12#1)(2008-10#1)
system was proved##2##3##(2007-8#1)(2008-10#1)
system was reported##2##3##(2008-12#1)(2008-2#1)
system was shown##3##3##(1991-7#1)(1994-12#1)(2006-6#1)
system was significantly##2##3##(1990-4#1)(2008-10#1)
system was studied##5##3##(1994-12#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-5#1)
system was successfully applied to##5##5##(1994-9#1)(2007-12#1)(2008-10#3)
system was successfully applied##6##4##(1994-9#1)(2007-12#1)(2008-10#4)
system was successfully##9##3##(1994-9#1)(2007-12#2)(2007-7#1)(2008-10#5)
system was tested by##2##4##(2008-10#1)(2013-8#1)
system was tested in##2##4##(1990-9#1)(2012-1#1)
system was tested##9##3##(1990-9#1)(2008-10#3)(2008-3#1)(2012-1#2)(2012-12#1)(2013-8#1)
system was the##3##3##(2008-10#2)(2011-1#1)
system was to##2##3##(1990-12#1)(1997-1#1)
system was used as a##3##5##(2007-11#1)(2008-10#2)
system was used as##6##4##(2007-11#1)(2008-10#4)(2008-8#1)
system was used for the##5##5##(1991-2#1)(2008-10#3)(2009-8#1)
system was used for##11##4##(1991-2#1)(2007-12#1)(2008-10#5)(2008-12#1)(2009-8#1)(2010-12#1)(2013-1#1)
system was used in##2##4##(1990-12#1)(2008-10#1)
system was used to determine the##2##6##(1993-8#1)(2008-10#1)
system was used to determine##3##5##(1990-11#1)(1993-8#1)(2008-10#1)
system was used to evaluate##2##5##(2007-8#1)(2008-10#1)
system was used to measure##2##5##(2008-3#1)(2008-8#1)
system was used to record the##2##6##(2007-1#1)(2007-10#1)
system was used to record##3##5##(2007-1#1)(2007-10#1)(2009-11#1)
system was used to##25##4##(1990-11#1)(1993-8#2)(1994-5#1)(1994-8#1)(1995-8#1)(1997-4#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-11#1)(2009-4#1)(2013-8#1)
system was used##51##3##(1990-11#1)(1990-12#1)(1991-2#1)(1993-8#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-8#1)(1997-4#1)(2004-8#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#16)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-8#2)(2009-11#2)(2009-4#1)(2009-8#1)(2010-12#1)(2013-1#1)(2013-8#1)
system was validated with##2##4##(2008-10#1)(2011-1#1)
system was validated##3##3##(2008-10#2)(2011-1#1)
system was##455##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-9#2)(1991-12#1)(1991-2#4)(1991-7#1)(1991-8#2)(1991-9#3)(1992-11#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-4#1)(1993-5#1)(1993-8#4)(1993-9#1)(1994-1#1)(1994-12#4)(1994-5#1)(1994-8#1)(1994-9#3)(1995-1#2)(1995-12#1)(1995-3#2)(1995-6#1)(1995-8#3)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-8#3)(1997-1#2)(1997-3#3)(1997-4#4)(1997-6#1)(1997-7#1)(1997-8#4)(2004-8#2)(2005-11#2)(2005-12#1)(2006-12#4)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#3)(2007-11#11)(2007-12#9)(2007-2#2)(2007-4#1)(2007-5#3)(2007-7#2)(2007-8#17)(2008-10#174)(2008-11#11)(2008-12#4)(2008-2#15)(2008-3#16)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#6)(2008-8#7)(2008-9#3)(2009-10#1)(2009-11#2)(2009-2#1)(2009-4#2)(2009-5#2)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#2)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#6)(2011-2#1)(2011-3#2)(2012-1#5)(2012-11#1)(2012-12#6)(2012-2#1)(2012-3#2)(2013-1#9)(2013-8#9)
system we have##5##3##(1992-7#1)(1994-11#1)(1996-3#1)(2008-11#2)
system we used##3##3##(1990-12#1)(1994-10#1)(1996-2#1)
system we##19##2##(1990-12#1)(1992-7#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1995-4#1)(1996-2#1)(1996-3#1)(1997-4#1)(1997-8#1)(2006-8#1)(2008-11#2)(2008-3#2)(2008-8#1)(2011-1#1)
system were also evaluated##2##4##(2008-10#2)
system were also##4##3##(1991-2#1)(2008-10#3)
system were analyzed##2##3##(1996-3#1)(2006-12#1)
system were assessed##3##3##(1992-2#1)(2008-3#1)(2008-4#1)
system were compared##2##3##(2008-10#2)
system were determined##2##3##(2008-5#1)(2012-1#1)
system were discussed##2##3##(2008-10#1)(2008-6#1)
system were evaluated##6##3##(1997-8#1)(2007-8#1)(2008-10#4)
system were examined in##2##4##(1993-12#1)(2008-5#1)
system were examined##4##3##(1992-3#1)(1993-12#1)(1997-3#1)(2008-5#1)
system were found to be##2##5##(2008-10#2)
system were found##3##3##(1992-1#1)(2008-10#2)
system were improved##2##3##(2005-11#1)(2008-11#1)
system were in##2##3##(1990-12#1)(2008-10#1)
system were investigated##7##3##(1991-10#1)(2008-10#3)(2008-3#1)(2008-4#1)(2011-1#1)
system were measured##2##3##(2008-10#1)(2008-3#1)
system were not##2##3##(2008-10#2)
system were observed##2##3##(2007-10#1)(2011-2#1)
system were obtained from##2##4##(2007-11#1)(2008-12#1)
system were optimized and##2##4##(2008-10#2)
system were optimized##7##3##(2008-10#5)(2010-5#1)(2013-8#1)
system were studied in##2##4##(1992-10#1)(2010-12#1)
system were studied##6##3##(1992-10#1)(2005-9#1)(2008-10#2)(2010-12#1)(2012-2#1)
system were the##2##3##(2008-10#1)(2008-7#1)
system were used to##2##4##(2007-8#1)(2010-12#1)
system were used##3##3##(2006-8#1)(2007-8#1)(2010-12#1)
system were##89##2##(1990-12#1)(1991-10#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-9#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#37)(2008-11#3)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#2)
system when##6##2##(1996-1#1)(2006-4#1)(2008-10#1)(2008-3#2)(2008-7#1)
system where a##2##3##(1990-12#1)(2008-10#1)
system where it##2##3##(1991-6#1)(1996-8#1)
system where the##4##3##(2007-10#1)(2008-3#1)(2008-8#1)(2009-12#1)
system where##20##2##(1990-12#1)(1991-6#1)(1992-10#1)(1995-3#1)(1996-8#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-9#1)(2013-8#1)
system wherein##2##2##(2007-2#1)(2008-11#1)
system which can##3##3##(2010-3#1)(2011-1#1)(2011-2#1)
system which has##2##3##(1996-12#1)(2009-2#1)
system which includes##2##3##(1993-12#1)(2006-10#1)
system which is not##2##4##(1990-4#1)(1997-8#1)
system which is##10##3##(1990-4#1)(1994-5#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-4#1)(2012-3#1)(2013-8#1)
system which uses##5##3##(1996-12#1)(1996-4#1)(2008-10#1)(2010-8#1)(2012-1#1)
system which utilizes the##2##4##(1990-11#1)(1990-4#1)
system which would##2##3##(1992-8#1)(1996-2#1)
system which##56##2##(1990-11#1)(1990-12#2)(1990-4#3)(1990-6#1)(1991-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-12#3)(1996-2#1)(1996-4#2)(1996-6#1)(1997-3#1)(1997-8#1)(2005-5#1)(2006-10#1)(2006-11#1)(2007-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#2)(2012-3#2)(2013-1#2)(2013-8#1)
system while the##3##3##(1991-11#1)(2008-10#1)(2008-2#1)
system while##9##2##(1991-11#1)(1996-2#1)(2005-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-4#1)(2012-2#1)
system whose##5##2##(2006-6#1)(2007-11#1)(2008-5#1)(2013-1#2)
system wide##3##2##(1992-9#1)(2013-1#2)
system will allow##2##3##(2012-12#1)(2013-8#1)
system will be discussed##3##4##(2008-1#1)(2008-10#1)(2008-2#1)
system will be useful##2##4##(2007-8#1)(2008-11#1)
system will be##18##3##(1991-6#1)(1992-12#1)(1994-3#1)(1995-8#1)(1996-3#1)(1997-1#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-2#1)(2010-2#1)(2012-1#1)
system will have a##3##4##(1994-12#1)(2008-2#1)(2008-3#1)
system will not be##2##4##(1992-11#1)(1992-3#1)
system will provide a##2##4##(1994-8#1)(2008-8#1)
system will##46##2##(1990-12#1)(1991-6#1)(1992-11#1)(1992-12#2)(1992-3#1)(1994-12#2)(1994-3#2)(1994-8#1)(1995-8#1)(1996-3#1)(1997-1#1)(2006-2#1)(2006-3#1)(2006-6#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-9#1)(2010-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#2)
system with a carbon##2##4##(2008-10#2)
system with a conventional##2##4##(2008-10#1)(2008-5#1)
system with a dual##2##4##(2008-10#1)(2008-3#1)
system with a set of##2##5##(2007-11#1)(2012-2#1)
system with a##61##3##(1996-5#1)(1996-9#1)(1997-3#1)(2006-6#1)(2007-11#5)(2007-12#5)(2007-3#1)(2007-5#1)(2007-8#2)(2008-10#18)(2008-11#1)(2008-2#9)(2008-3#7)(2008-5#1)(2009-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2012-2#1)
system with an on-line##2##4##(1997-8#1)(2008-10#1)
system with an##17##3##(1993-3#1)(1994-2#1)(1997-8#1)(2005-10#1)(2005-11#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#2)(2011-3#1)(2013-1#2)
system with bead injection##3##4##(2008-10#3)
system with both##2##3##(1993-12#1)(1993-6#1)
system with dispersion##2##3##(2008-1#2)
system with extracorporeal ultrafiltration by##2##5##(2007-12#2)
system with fluorimetric detection##2##4##(1990-8#1)(2008-10#1)
system with fluorimetric##3##3##(1990-8#1)(2008-10#2)
system with highly##2##3##(1996-9#1)(2008-3#1)
system with hydride##2##3##(2008-10#2)
system with microwave irradiation##2##4##(2008-10#2)
system with microwave-assisted sample digestion##3##5##(2008-10#3)
system with on-line##4##3##(1993-7#1)(2006-5#1)(2008-10#2)
system with respect to##4##4##(1990-12#1)(2008-10#1)(2008-2#1)(2010-2#1)
system with special##2##3##(1992-3#1)(2007-11#1)
system with spectrophotometric detection##2##4##(2008-10#2)
system with spectrophotometric##3##3##(2008-10#3)
system with strong dispersion management##3##5##(2007-12#3)
system with strong##7##3##(2007-11#1)(2007-12#5)(2010-5#1)
system with the##26##3##(1990-5#1)(1992-3#1)(1995-5#1)(1996-12#1)(2006-8#1)(2008-10#6)(2008-2#2)(2008-4#1)(2008-5#1)(2009-11#1)(2009-2#1)(2009-6#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
system with three##3##3##(1991-9#1)(2008-3#2)
system with time##2##3##(2006-10#1)(2008-3#1)
system with two##5##3##(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#1)
system with##308##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#2)(1990-8#1)(1991-11#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-5#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-1#1)(1994-12#1)(1994-2#2)(1995-5#1)(1996-12#1)(1996-5#1)(1996-9#2)(1997-3#3)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#9)(2007-12#24)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#6)(2008-1#4)(2008-10#87)(2008-11#3)(2008-12#1)(2008-2#26)(2008-3#32)(2008-4#1)(2008-5#5)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-6#3)(2010-1#1)(2010-12#5)(2010-2#2)(2010-5#4)(2010-8#2)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#3)(2012-2#4)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#4)
system within the##5##3##(1993-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2009-2#1)
system within##10##2##(1993-11#1)(1995-9#1)(2007-12#1)(2007-7#1)(2008-10#3)(2009-2#1)(2013-1#2)
system without##12##2##(1990-8#1)(2005-11#1)(2008-10#7)(2008-3#1)(2010-4#1)(2011-2#1)
system working##2##2##(2008-2#1)(2008-3#1)
system works##5##2##(1994-1#1)(2006-10#1)(2008-3#2)(2010-12#1)
system would be##4##3##(1990-3#1)(2008-10#1)(2010-8#1)(2013-8#1)
system would have##2##3##(1990-3#2)
system would##13##2##(1990-3#4)(1996-1#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-8#1)(2013-8#1)
system xc-##2##2##(1992-6#2)
system yielded##2##2##(2006-6#1)(2008-10#1)
system yields##2##2##(1997-2#1)(2007-12#1)
system##13349##1##(1990-1#2)(1990-10#20)(1990-11#42)(1990-12#63)(1990-2#24)(1990-3#40)(1990-4#30)(1990-5#48)(1990-6#14)(1990-7#26)(1990-8#36)(1990-9#25)(1991-1#22)(1991-10#20)(1991-11#23)(1991-12#45)(1991-2#52)(1991-3#47)(1991-4#14)(1991-5#31)(1991-6#17)(1991-7#14)(1991-8#34)(1991-9#42)(1992-1#35)(1992-10#16)(1992-11#32)(1992-12#76)(1992-2#40)(1992-3#50)(1992-4#17)(1992-5#12)(1992-6#35)(1992-7#21)(1992-8#40)(1992-9#16)(1993-1#12)(1993-10#1)(1993-11#35)(1993-12#77)(1993-2#34)(1993-3#67)(1993-4#19)(1993-5#19)(1993-6#40)(1993-7#18)(1993-8#29)(1993-9#20)(1994-1#27)(1994-10#18)(1994-11#33)(1994-12#74)(1994-2#74)(1994-3#54)(1994-4#3)(1994-5#25)(1994-6#37)(1994-7#7)(1994-8#43)(1994-9#44)(1995-1#35)(1995-10#11)(1995-11#35)(1995-12#94)(1995-2#70)(1995-3#58)(1995-4#10)(1995-5#43)(1995-6#27)(1995-7#14)(1995-8#35)(1995-9#21)(1996-1#60)(1996-10#18)(1996-11#14)(1996-12#77)(1996-2#68)(1996-3#62)(1996-4#40)(1996-5#52)(1996-6#32)(1996-7#14)(1996-8#34)(1996-9#26)(1997-1#38)(1997-2#81)(1997-3#66)(1997-4#66)(1997-5#20)(1997-6#27)(1997-7#44)(1997-8#43)(1997-9#1)(2004-1#2)(2004-10#1)(2004-11#4)(2004-12#11)(2004-2#7)(2004-3#2)(2004-4#4)(2004-7#1)(2004-8#6)(2004-9#13)(2005-1#7)(2005-10#45)(2005-11#95)(2005-12#10)(2005-3#1)(2005-4#17)(2005-5#10)(2005-6#2)(2005-7#24)(2005-8#31)(2005-9#7)(2006-1#23)(2006-10#207)(2006-11#34)(2006-12#59)(2006-2#21)(2006-3#19)(2006-4#19)(2006-5#38)(2006-6#82)(2006-7#20)(2006-8#46)(2006-9#13)(2007-1#29)(2007-10#45)(2007-11#289)(2007-12#511)(2007-2#38)(2007-3#36)(2007-4#59)(2007-5#66)(2007-6#23)(2007-7#53)(2007-8#197)(2007-9#61)(2008-1#148)(2008-10#1951)(2008-11#367)(2008-12#75)(2008-2#712)(2008-3#796)(2008-4#198)(2008-5#232)(2008-6#85)(2008-7#276)(2008-8#174)(2008-9#190)(2009-1#3)(2009-10#55)(2009-11#21)(2009-12#33)(2009-2#41)(2009-3#22)(2009-4#54)(2009-5#32)(2009-6#35)(2009-7#23)(2009-8#59)(2009-9#37)(2010-1#22)(2010-10#19)(2010-11#24)(2010-12#117)(2010-2#56)(2010-3#25)(2010-4#47)(2010-5#54)(2010-6#17)(2010-7#32)(2010-8#128)(2010-9#39)(2011-1#177)(2011-12#24)(2011-2#220)(2011-3#11)(2011-7#3)(2012-1#165)(2012-10#1)(2012-11#32)(2012-12#126)(2012-2#122)(2012-3#102)(2012-4#1)(2012-5#2)(2012-6#3)(2012-7#1)(2012-8#2)(2013-1#363)(2013-2#2)(2013-7#48)(2013-8#190)
system&quot##8##1##(1990-12#1)(1996-3#1)(2005-7#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#2)
system'##8##1##(1990-5#1)(2006-11#2)(2006-6#1)(2007-8#2)(2008-11#1)(2008-12#1)
system's ability to##7##3##(2007-9#1)(2008-2#2)(2008-3#1)(2012-1#1)(2013-7#1)(2013-8#1)
system's efficacy in identifying##2##4##(2012-2#2)
system's performance is##2##3##(2008-2#2)
system's performance##5##2##(1997-2#1)(2008-10#1)(2008-2#2)(2008-3#1)
system's##63##1##(1990-12#2)(1990-5#1)(1991-1#1)(1991-12#1)(1991-8#1)(1992-9#1)(1993-2#1)(1994-1#2)(1995-1#1)(1995-2#2)(1996-1#1)(1997-2#1)(1997-5#1)(2007-1#2)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#12)(2008-3#7)(2008-9#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-7#2)(2013-8#3)
system(s)##2##1##(1993-2#1)(1996-2#1)
system) and##7##2##(1990-10#1)(1994-10#1)(2004-9#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)
system) in the##2##3##(1993-8#1)(2008-5#1)
system) in##4##2##(1993-8#1)(1996-3#1)(2005-8#1)(2008-5#1)
system) that##2##2##(2007-4#1)(2008-1#1)
system) was##2##2##(2008-10#1)(2008-11#1)
system)##61##1##(1990-10#1)(1990-12#1)(1991-4#1)(1991-6#1)(1992-10#1)(1992-8#5)(1993-2#1)(1993-8#2)(1994-10#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-4#1)(2004-9#2)(2005-8#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-4#2)(2007-6#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#3)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2012-6#1)
system--a##2##1##(1991-2#1)(2008-1#1)
system-based##7##1##(1996-12#1)(2010-4#1)(2012-2#2)(2012-3#3)
system-level parameters##2##2##(2008-3#2)
system-level##8##1##(2007-12#1)(2008-3#4)(2009-3#1)(2011-2#1)(2012-11#1)
system-mediated##2##1##(2007-7#1)(2008-10#1)
system-performance##3##1##(2008-2#1)(2008-3#2)
system-related##3##1##(2008-1#1)(2008-5#1)(2008-7#1)
system-specific##2##1##(2007-12#1)(2009-8#1)
system-wide state##2##2##(2008-2#2)
system-wide##6##1##(1994-1#1)(1996-1#1)(2007-11#1)(2008-2#2)(2009-1#1)
system? The##2##2##(1991-2#1)(2008-8#1)
system? This article##2##3##(1993-12#1)(1994-9#1)
system?##17##1##(1991-2#1)(1991-3#1)(1992-2#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-12#1)(2007-12#1)(2007-6#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-5#1)(2012-3#1)
system]##49##1##(1990-3#1)(1991-11#1)(1992-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-4#1)(1994-6#1)(1995-2#1)(1997-3#1)(1997-4#1)(2005-10#1)(2005-11#4)(2005-4#3)(2006-6#2)(2007-11#1)(2007-9#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-2#1)(2011-12#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#7)(2013-8#1)
systematic adverse##2##2##(2009-5#1)(2013-1#1)
systematic advice##2##2##(2011-1#2)
systematic analysis of the##4##4##(1992-7#1)(2007-9#1)(2008-10#1)(2008-4#1)
systematic analysis of##12##3##(1992-7#1)(1993-3#1)(1996-9#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-1#2)
systematic analysis##16##2##(1992-7#1)(1993-3#1)(1995-12#1)(1996-2#1)(1996-9#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-1#2)
systematic and random errors##3##4##(2008-3#1)(2011-2#1)(2012-12#1)
systematic and random##4##3##(2008-3#2)(2011-2#1)(2012-12#1)
systematic and##20##2##(1996-3#1)(2006-10#1)(2006-12#1)(2006-3#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#2)(2009-2#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
systematic approach for##4##3##(2006-2#1)(2008-10#1)(2008-2#1)(2008-6#1)
systematic approach in##3##3##(2008-8#1)(2010-10#1)(2011-2#1)
systematic approach to drug##2##4##(2005-8#1)(2011-2#1)
systematic approach to item reduction based on results of##2##9##(2012-2#2)
systematic approach to optimizing##2##4##(2008-1#1)(2012-1#1)
systematic approach to planning##2##4##(1994-2#2)
systematic approach to the##3##4##(2006-5#1)(2008-3#1)(2009-9#1)
systematic approach to##25##3##(1993-3#1)(1994-2#2)(1995-12#1)(1996-12#2)(2005-8#2)(2006-5#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#3)(2008-5#1)(2009-10#1)(2009-6#2)(2009-9#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
systematic approach##39##2##(1991-12#1)(1993-3#1)(1994-2#2)(1995-12#1)(1996-12#2)(1996-2#1)(2005-5#1)(2005-8#2)(2006-2#2)(2006-5#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-10#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)
systematic approaches to##3##3##(2006-10#1)(2008-7#1)(2010-1#1)
systematic approaches##4##2##(2006-10#1)(2008-2#1)(2008-7#1)(2010-1#1)
systematic assessment##2##2##(2007-6#1)(2007-7#1)
systematic assessments##2##2##(2007-6#1)(2009-6#1)
systematic bias##4##2##(2006-12#1)(2008-11#1)(2009-1#1)(2013-1#1)
systematic biases##2##2##(2008-3#1)(2008-7#1)
systematic catatonia##5##2##(1996-5#5)
systematic chemical##2##2##(2006-12#1)(2013-8#1)
systematic clinical##3##2##(2007-12#1)(2008-11#1)(2009-7#1)
systematic collection##2##2##(2011-3#1)(2013-1#1)
systematic comparison of the##2##4##(1996-6#1)(2011-2#1)
systematic comparison of##5##3##(1994-9#1)(1996-6#1)(2008-10#1)(2008-9#1)(2011-2#1)
systematic decrease##2##2##(2010-4#1)(2011-2#1)
systematic description of the##2##4##(1992-3#1)(2006-11#1)
systematic design and##2##3##(2008-2#1)(2013-7#1)
systematic diagnostic##3##2##(2008-3#2)(2010-2#1)
systematic difference between the##2##4##(2007-11#1)(2008-3#1)
systematic difference between##3##3##(2007-11#1)(2008-3#1)(2008-7#1)
systematic difference##6##2##(2006-1#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-7#1)
systematic differences in##3##3##(1995-3#1)(2010-12#1)(2012-1#1)
systematic differences##6##2##(1992-3#1)(1994-2#1)(1995-3#1)(2008-11#1)(2010-12#1)(2012-1#1)
systematic discussion of##2##3##(2011-2#1)(2013-8#1)
systematic effect on##3##3##(1993-2#1)(2008-1#1)(2010-8#1)
systematic effect##4##2##(1993-2#1)(2008-1#1)(2008-10#1)(2010-8#1)
systematic effects##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
systematic effort to##2##3##(1991-1#1)(1995-12#1)
systematic effort##4##2##(1991-1#1)(1995-12#1)(2006-12#1)(2008-8#1)
systematic error in##3##3##(1993-2#1)(2008-10#1)(2008-2#1)
systematic error of##3##3##(2008-2#1)(2008-3#1)(2012-12#1)
systematic error that##2##3##(2008-2#1)(2008-3#1)
systematic error##19##2##(1993-2#1)(2007-12#1)(2008-10#5)(2008-2#5)(2008-3#3)(2009-5#1)(2012-12#3)
systematic errors and##2##3##(1992-11#1)(2008-2#1)
systematic errors can##2##3##(2008-2#1)(2008-3#1)
systematic errors in##6##3##(2007-11#1)(2007-12#1)(2008-3#3)(2008-6#1)
systematic errors is##2##3##(2008-3#2)
systematic errors##30##2##(1990-8#1)(1992-11#2)(1996-5#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-2#6)(2008-3#11)(2008-6#1)(2010-2#1)
systematic evaluation of the##2##4##(1996-4#1)(2008-2#1)
systematic evaluation of##9##3##(1996-4#1)(2006-6#1)(2008-10#1)(2008-2#1)(2009-2#1)(2010-12#1)(2011-1#1)(2013-1#2)
systematic evaluation##11##2##(1996-4#1)(2006-6#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-2#1)(2010-12#1)(2011-1#1)(2013-1#2)
systematic evolution of ligands by exponential enrichment (SELEX)##3##8##(2007-8#1)(2008-4#1)(2008-9#1)
systematic evolution of ligands by exponential enrichment##5##7##(1996-4#1)(2007-8#2)(2008-4#1)(2008-9#1)
systematic examination of##4##3##(2006-2#1)(2007-9#1)(2009-1#1)(2013-1#1)
systematic examination##5##2##(2006-2#1)(2007-9#1)(2009-1#1)(2009-2#1)(2013-1#1)
systematic exclusion##2##2##(2012-2#1)(2013-1#1)
systematic experimental##5##2##(1992-4#1)(2007-12#1)(2008-2#2)(2010-8#1)
systematic exploration of##3##3##(2008-7#1)(2011-1#1)(2013-1#1)
systematic follow-up##2##2##(2008-1#1)(2010-12#1)
systematic functional analysis##3##3##(2008-7#1)(2012-12#2)
systematic functional##4##2##(2008-7#1)(2008-8#1)(2012-12#2)
systematic inpatient delirium screening##2##4##(2013-1#2)
systematic investigation of the##6##4##(2008-1#1)(2010-2#2)(2010-5#1)(2012-2#1)(2013-1#1)
systematic investigation of##14##3##(2007-12#1)(2008-1#1)(2008-3#1)(2008-5#2)(2010-2#3)(2010-5#1)(2011-2#1)(2012-11#2)(2012-2#1)(2013-1#1)
systematic investigation##16##2##(2007-12#1)(2008-1#1)(2008-3#1)(2008-5#2)(2008-8#1)(2010-2#3)(2010-5#1)(2011-2#2)(2012-11#2)(2012-2#1)(2013-1#1)
systematic list of the echinoderms##3##5##(2007-5#3)
systematic list of##4##3##(2007-5#3)(2011-2#1)
systematic literature review comparing##2##4##(2012-12#1)(2013-1#1)
systematic literature review##9##3##(1996-11#1)(2007-10#1)(2007-7#1)(2008-11#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
systematic literature search is##2##4##(2011-2#2)
systematic literature search##6##3##(2011-1#1)(2011-2#3)(2013-1#2)
systematic literature##16##2##(1996-11#1)(2007-10#1)(2007-7#1)(2008-11#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
systematic measurement##2##2##(1993-6#1)(2007-12#1)
systematic method for##5##3##(2007-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2013-1#1)
systematic method##8##2##(1996-2#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-12#1)(2013-1#1)
systematic methods##2##2##(1994-1#1)(2013-8#1)
systematic monitoring and feedback of##2##5##(2012-2#2)
systematic names##2##2##(1996-2#1)(2007-11#1)
systematic observations of##2##3##(2008-2#1)(2013-7#1)
systematic onset of JRA##2##4##(2012-2#2)
systematic or##2##2##(1996-3#2)
systematic phase errors##2##3##(2008-3#2)
systematic phase##3##2##(2008-3#2)(2008-7#1)
systematic process##3##2##(1992-3#1)(2009-4#1)(2012-3#1)
systematic quantitative##2##2##(2006-10#1)(2008-7#1)
systematic random sampling##2##3##(2006-8#1)(2013-1#1)
systematic research##3##2##(1992-1#1)(1993-1#1)(1997-8#1)
systematic review and meta-analysis of##5##5##(2008-3#1)(2010-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
systematic review and meta-analysis##12##4##(2008-3#2)(2009-11#1)(2010-10#1)(2010-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
systematic review and##19##3##(2008-3#2)(2008-6#1)(2009-11#1)(2010-10#1)(2010-2#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#4)
systematic review in##2##3##(2011-2#1)(2013-8#1)
systematic review is##4##3##(2006-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
systematic review of published##3##4##(1995-9#1)(2012-3#1)(2013-1#1)
systematic review of the evidence##6##5##(2005-10#1)(2006-8#2)(2008-12#1)(2008-8#1)(2011-12#1)
systematic review of the literature and##2##6##(2007-8#1)(2012-3#1)
systematic review of the literature was undertaken##2##7##(2012-12#1)(2012-2#1)
systematic review of the literature##10##5##(2007-8#1)(2008-10#1)(2008-11#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
systematic review of the##29##4##(2005-10#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-8#1)(2011-12#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)
systematic review of##51##3##(1995-9#1)(2005-10#1)(2005-11#1)(2006-4#1)(2006-8#3)(2007-10#2)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-6#1)(2008-8#2)(2009-2#1)(2009-3#1)(2009-9#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#1)
systematic review on the##2##4##(2010-11#1)(2012-12#1)
systematic review on##3##3##(2010-11#1)(2012-12#2)
systematic review was conducted##3##4##(2007-11#1)(2009-11#1)(2011-2#1)
systematic review was to assess##2##5##(2012-2#1)(2013-1#1)
systematic review was to##5##4##(2005-8#1)(2008-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
systematic review was##13##3##(2005-8#1)(2007-11#1)(2008-10#1)(2009-11#1)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
systematic review##158##2##(1992-2#1)(1995-9#1)(1997-1#1)(2005-10#2)(2005-11#1)(2005-7#1)(2005-8#2)(2006-4#1)(2006-8#5)(2007-10#5)(2007-11#6)(2007-4#1)(2007-7#2)(2007-8#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#2)(2008-6#4)(2008-7#3)(2008-8#2)(2009-1#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#9)(2011-12#1)(2011-2#14)(2011-7#1)(2012-1#6)(2012-12#16)(2012-2#5)(2012-3#7)(2013-1#18)(2013-7#5)(2013-8#9)
systematic reviews and##4##3##(2007-5#1)(2010-5#1)(2012-2#1)(2013-8#1)
systematic reviews of the##3##4##(1993-12#1)(2012-2#1)(2013-1#1)
systematic reviews of##8##3##(1993-12#2)(1996-11#1)(2006-9#1)(2011-2#2)(2012-2#1)(2013-1#1)
systematic reviews##25##2##(1993-12#2)(1993-2#1)(1996-11#1)(2006-8#1)(2006-9#1)(2007-5#3)(2008-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#4)(2012-2#2)(2013-1#4)(2013-8#1)
systematic sample##2##2##(1991-8#1)(2009-10#1)
systematic sampling##3##2##(2011-1#1)(2012-12#1)(2013-8#1)
systematic screening for##3##3##(1996-2#1)(2009-3#1)(2013-1#1)
systematic screening of##3##3##(1994-12#1)(2008-4#1)(2013-8#1)
systematic screening##8##2##(1991-3#1)(1994-12#1)(1996-2#1)(2008-4#2)(2009-3#1)(2013-1#1)(2013-8#1)
systematic search of##6##3##(2008-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
systematic search##9##2##(1996-12#1)(2008-6#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#3)
systematic sequencing##2##2##(1996-3#1)(2008-7#1)
systematic series of##2##3##(1990-6#1)(2010-9#1)
systematic strategies##2##2##(2008-10#2)
systematic studies##5##2##(1992-6#1)(1996-2#1)(2010-10#1)(2011-2#1)(2013-7#1)
systematic study of the##9##4##(1994-10#1)(1994-3#1)(2003-11#1)(2007-11#1)(2008-10#3)(2008-2#2)
systematic study of##15##3##(1992-11#1)(1994-10#1)(1994-3#1)(1997-2#1)(2003-11#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2009-10#1)(2010-6#1)
systematic study##22##2##(1990-8#1)(1992-11#1)(1994-10#1)(1994-3#1)(1997-2#1)(2003-11#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-12#2)(2008-2#3)(2008-3#1)(2008-5#1)(2009-10#1)(2009-5#1)(2010-6#1)
systematic survey of##4##3##(1997-7#1)(2004-11#1)(2008-10#1)(2010-9#1)
systematic training##3##2##(1990-4#1)(1991-9#1)(1995-5#1)
systematic uncertainties##2##2##(2006-7#1)(2008-3#1)
systematic use of##5##3##(1990-10#1)(1993-10#1)(1997-1#1)(2007-8#1)(2010-8#1)
systematic utilization of##2##3##(2006-8#1)(2012-11#1)
systematic variation of##2##3##(2010-1#1)(2012-2#1)
systematic variation##4##2##(1993-1#1)(2008-10#1)(2010-1#1)(2012-2#1)
systematic variations in the##2##4##(1991-7#1)(2007-11#1)
systematic variations##3##2##(1991-7#1)(2007-11#2)
systematic way of##3##3##(1994-12#1)(2007-12#1)(2008-11#1)
systematic way to##2##3##(2008-7#1)(2011-2#1)
systematic way##9##2##(1994-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-1#1)
systematic##774##1##(1990-10#1)(1990-4#2)(1990-6#2)(1990-8#4)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#2)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#3)(1992-2#3)(1992-3#5)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#3)(1993-10#1)(1993-12#4)(1993-2#4)(1993-3#2)(1993-6#1)(1994-1#1)(1994-10#1)(1994-12#3)(1994-2#3)(1994-3#2)(1994-6#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#3)(1995-5#4)(1995-6#2)(1995-9#2)(1996-1#2)(1996-11#3)(1996-12#4)(1996-2#7)(1996-3#6)(1996-4#2)(1996-5#6)(1996-6#2)(1996-7#1)(1996-9#2)(1997-1#2)(1997-2#4)(1997-7#1)(1997-8#2)(1997-9#1)(2003-11#1)(2004-10#1)(2004-11#1)(2005-10#4)(2005-11#4)(2005-5#1)(2005-7#1)(2005-8#4)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#6)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#3)(2006-7#2)(2006-8#10)(2006-9#3)(2007-1#3)(2007-10#9)(2007-11#19)(2007-12#14)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#8)(2007-6#4)(2007-7#7)(2007-8#8)(2007-9#2)(2008-1#6)(2008-10#35)(2008-11#16)(2008-12#6)(2008-2#29)(2008-3#46)(2008-4#9)(2008-5#11)(2008-6#10)(2008-7#18)(2008-8#9)(2008-9#2)(2009-1#4)(2009-10#6)(2009-11#4)(2009-12#4)(2009-2#5)(2009-3#3)(2009-4#2)(2009-5#4)(2009-6#3)(2009-7#3)(2009-8#5)(2009-9#4)(2010-1#4)(2010-10#5)(2010-11#3)(2010-12#7)(2010-2#8)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#3)(2011-1#19)(2011-12#2)(2011-2#37)(2011-3#1)(2011-7#1)(2012-1#14)(2012-11#3)(2012-12#30)(2012-2#24)(2012-3#14)(2013-1#48)(2013-7#10)(2013-8#22)
systematically analyze##3##2##(2008-6#1)(2009-5#1)(2010-10#1)
systematically and##4##2##(1993-5#1)(2008-11#2)(2012-1#1)
systematically assessed##2##2##(2013-1#1)(2013-8#1)
systematically by using##2##3##(2005-5#1)(2010-4#1)
systematically collected in##2##3##(2008-10#2)
systematically collected##3##2##(1996-3#1)(2008-10#2)
systematically compared##3##2##(2008-11#1)(2008-5#1)(2009-8#1)
systematically correlated with##2##3##(2008-7#1)(2009-12#1)
systematically decreased##2##2##(1994-9#1)(2008-10#1)
systematically determined##3##2##(2008-3#1)(2009-5#1)(2011-2#1)
systematically developed##2##2##(2005-11#1)(2006-8#1)
systematically discussed##2##2##(2008-10#1)(2009-5#1)
systematically evaluate the##3##3##(2008-4#1)(2009-3#1)(2011-2#1)
systematically evaluate these##2##3##(2006-2#1)(2009-3#1)
systematically evaluate##7##2##(2006-2#1)(2008-4#1)(2009-3#2)(2009-4#1)(2011-2#2)
systematically evaluated##7##2##(1990-12#1)(1991-2#1)(2006-7#1)(2007-8#1)(2008-2#1)(2008-3#1)(2009-4#1)
systematically examine##2##2##(2008-3#1)(2008-4#1)
systematically examined the##2##3##(1992-3#1)(1993-6#1)
systematically examined##9##2##(1992-3#1)(1992-6#1)(1993-6#1)(1994-11#1)(2008-10#2)(2009-4#1)(2011-12#1)(2013-8#1)
systematically explored##2##2##(2011-1#1)(2012-12#1)
systematically for##2##2##(1990-5#1)(1994-2#1)
systematically from##2##2##(2008-10#2)
systematically in##3##2##(2008-10#1)(2009-2#1)(2011-2#1)
systematically increased##2##2##(1993-3#1)(2009-6#1)
systematically investigated##11##2##(2008-10#7)(2008-2#1)(2008-3#1)(2009-4#1)(2010-11#1)
systematically modified##3##2##(1995-2#1)(1997-5#1)(2010-2#1)
systematically optimized##3##2##(2010-12#1)(2013-7#1)(2013-8#1)
systematically over##2##2##(1991-4#1)(1991-8#1)
systematically performed##2##2##(1994-9#1)(2008-5#1)
systematically relate##2##2##(2008-5#1)(2008-7#1)
systematically replaced with##3##3##(1994-11#1)(1995-10#1)(1995-5#1)
systematically replaced##5##2##(1990-3#1)(1994-11#1)(1995-10#1)(1995-5#1)(1995-6#1)
systematically review and##2##3##(2013-1#1)(2013-8#1)
systematically review the##3##3##(2011-12#1)(2011-2#1)(2013-1#1)
systematically review##6##2##(2005-10#1)(2011-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
systematically reviewed##4##2##(2005-10#1)(2010-5#1)(2012-12#2)
systematically sampled##2##2##(2009-11#1)(2013-8#1)
systematically searched##2##2##(2008-7#1)(2011-2#1)
systematically selected##2##2##(1996-9#1)(2007-2#1)
systematically studied and##2##3##(1991-12#1)(2008-10#1)
systematically studied with##2##3##(2008-10#1)(2012-12#1)
systematically studied##16##2##(1991-12#1)(2006-12#2)(2007-12#1)(2008-10#5)(2008-3#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
systematically tested##2##2##(2008-5#1)(2010-12#1)
systematically the##4##2##(1991-11#1)(2008-11#1)(2008-3#1)(2012-1#1)
systematically to##3##2##(1993-12#1)(1994-9#1)(2013-8#1)
systematically varied to##2##3##(1991-11#1)(2008-2#1)
systematically varied##5##2##(1991-11#1)(1997-7#1)(2005-11#1)(2008-2#1)(2013-8#1)
systematically with##2##2##(1996-8#1)(2005-11#1)
systematically##259##1##(1990-12#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-11#3)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1994-1#1)(1994-11#2)(1994-2#3)(1994-7#2)(1994-9#3)(1995-10#1)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-10#2)(2005-11#6)(2005-5#2)(2006-10#2)(2006-12#4)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#2)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#29)(2008-11#6)(2008-2#8)(2008-3#10)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#2)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#5)(2009-5#5)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#3)(2010-4#4)(2010-5#3)(2010-9#2)(2011-1#2)(2011-12#2)(2011-2#10)(2012-1#4)(2012-12#4)(2012-2#5)(2012-3#3)(2012-4#1)(2013-1#6)(2013-7#1)(2013-8#13)
systematics and##5##2##(1996-11#1)(2006-5#1)(2008-8#1)(2011-2#1)(2013-7#1)
systematics of##5##2##(1996-3#1)(2008-8#1)(2010-3#1)(2010-4#1)(2010-6#1)
systematics##21##1##(1990-6#1)(1991-5#1)(1991-9#1)(1996-11#1)(1996-3#1)(2006-5#2)(2007-6#1)(2008-10#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-1#1)(2010-3#2)(2010-4#1)(2010-6#2)(2011-2#1)(2013-7#1)
systematization of##3##2##(2008-9#1)(2012-3#1)(2013-1#1)
systematization##5##1##(2008-9#2)(2012-3#2)(2013-1#1)
systematize##4##1##(2007-7#1)(2008-10#1)(2009-4#2)
systematized##4##1##(1996-12#1)(2009-5#1)(2011-2#1)(2012-12#1)
systemic (0##2##2##(1993-6#2)
systemic D-amphetamine treatment##4##3##(1994-10#4)
systemic T cell##3##3##(1997-4#1)(2008-11#2)
systemic abnormalities##2##2##(2005-10#1)(2011-2#1)
systemic abnormality##2##2##(2010-7#1)(2011-1#1)
systemic absorption##4##2##(2005-8#1)(2006-10#1)(2007-11#1)(2008-4#1)
systemic acquired resistance (SAR)##7##4##(2007-11#1)(2008-10#5)(2011-10#1)
systemic acquired resistance in##2##4##(2008-10#2)
systemic acquired resistance##16##3##(1992-11#1)(2007-11#1)(2008-10#12)(2011-10#1)(2011-2#1)
systemic acquired resistance-inducing##2##3##(2008-10#2)
systemic acquired##19##2##(1992-11#1)(2007-11#1)(2008-10#14)(2008-5#1)(2011-10#1)(2011-2#1)
systemic active##2##2##(2007-11#1)(2007-8#1)
systemic activity##2##2##(1992-3#1)(2010-9#1)
systemic administration of ETOH##2##4##(1995-7#2)
systemic administration of kainic acid##2##5##(1990-4#2)
systemic administration of recombinant##2##4##(1996-10#1)(2007-11#1)
systemic administration of the##2##4##(1996-9#1)(2008-2#1)
systemic administration of##31##3##(1990-11#1)(1990-4#2)(1991-3#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-3#1)(1995-12#1)(1995-7#2)(1996-10#2)(1996-12#2)(1996-2#2)(1996-9#1)(2005-8#1)(2007-10#1)(2007-11#2)(2008-1#2)(2008-2#1)(2009-10#1)(2009-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
systemic administration##37##2##(1990-11#1)(1990-4#2)(1991-3#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-3#1)(1995-1#1)(1995-12#2)(1995-7#2)(1996-10#2)(1996-12#3)(1996-2#2)(1996-9#1)(1997-8#1)(2005-8#1)(2007-10#1)(2007-11#2)(2008-1#2)(2008-2#1)(2008-4#1)(2009-10#2)(2009-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
systemic adverse effects##7##3##(2007-11#3)(2007-2#1)(2008-4#1)(2009-11#1)(2013-1#1)
systemic adverse reactions##3##3##(2007-11#3)
systemic adverse##12##2##(2007-11#7)(2007-2#1)(2008-1#1)(2008-4#1)(2009-11#1)(2013-1#1)
systemic agents##2##2##(2011-2#1)(2012-1#1)
systemic allergic reactions##3##3##(1990-8#2)(2007-11#1)
systemic allergic##4##2##(1990-8#2)(2007-11#1)(2008-6#1)
systemic amyloidosis associated with##2##4##(2008-7#1)(2011-2#1)
systemic amyloidosis with##2##3##(1990-3#1)(2012-12#1)
systemic amyloidosis##12##2##(1990-3#1)(1991-3#1)(1993-11#1)(2006-10#1)(2008-7#1)(2009-8#2)(2011-2#4)(2012-12#1)
systemic analysis of the##2##4##(2009-10#2)
systemic analysis##3##2##(2009-10#3)
systemic anaphylactic##2##2##(2008-10#1)(2009-6#1)
systemic anaphylaxis##4##2##(2006-8#1)(2011-2#3)
systemic and intrapleural##2##3##(2007-8#2)
systemic and local##10##3##(1992-8#1)(1992-9#1)(1995-7#2)(2007-11#1)(2008-10#1)(2009-2#2)(2011-2#2)
systemic and oropharyngeal##2##3##(2008-8#2)
systemic and##37##2##(1992-8#2)(1992-9#1)(1993-12#1)(1994-12#1)(1995-1#1)(1995-7#2)(1996-12#1)(1996-9#1)(1997-3#1)(2005-1#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-6#2)(2007-11#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-2#2)(2009-6#1)(2011-2#2)(2013-1#1)(2013-7#1)
systemic antibiotic therapy##4##3##(1994-7#1)(2007-7#1)(2008-8#1)(2013-7#1)
systemic antibiotic##5##2##(1994-7#1)(2007-7#1)(2008-8#1)(2010-5#1)(2013-7#1)
systemic antibiotics##4##2##(1994-12#2)(2012-11#1)(2013-8#1)
systemic approach to##2##3##(1990-6#1)(2009-6#1)
systemic approach##3##2##(1990-6#1)(2009-6#1)(2013-7#1)
systemic approaches to##2##3##(2010-12#2)
systemic arterial pressure##2##3##(1991-5#1)(1996-3#1)
systemic arterial resistance##2##3##(1997-5#2)
systemic arterial##8##2##(1991-5#1)(1996-3#1)(1997-5#2)(2008-11#1)(2009-2#1)(2012-3#1)(2013-8#1)
systemic arteries##4##2##(1997-2#1)(2007-8#2)(2010-12#1)
systemic associations##2##2##(2008-12#1)(2009-10#1)
systemic autoimmune disease##4##3##(2007-7#1)(2008-10#2)(2008-5#1)
systemic autoimmune diseases##7##3##(2008-10#1)(2010-4#1)(2011-1#2)(2012-3#1)(2013-1#2)
systemic autoimmune disorders##2##3##(1995-1#1)(1996-11#1)
systemic autoimmune##14##2##(1995-1#1)(1996-11#1)(2006-10#1)(2007-7#1)(2008-10#3)(2008-5#1)(2010-4#1)(2011-1#2)(2012-3#1)(2013-1#2)
systemic autoimmunity##4##2##(2010-4#1)(2012-1#3)
systemic bacterial infection##2##3##(2005-7#1)(2008-5#1)
systemic bacterial##3##2##(1991-8#1)(2005-7#1)(2008-5#1)
systemic behavior##2##2##(2007-6#1)(2007-9#1)
systemic blood pressure##3##3##(1992-8#1)(2005-10#1)(2006-10#1)
systemic blood##7##2##(1990-12#1)(1992-8#1)(1993-12#1)(2005-10#1)(2005-11#1)(2006-10#1)(2012-2#1)
systemic candidiasis##5##2##(1997-1#1)(2008-5#4)
systemic causes##4##2##(2009-6#1)(2010-2#1)(2010-8#1)(2011-1#1)
systemic changes##2##2##(2007-11#1)(2008-10#1)
systemic chemotherapeutic regimen is##2##4##(2006-6#2)
systemic chemotherapy and postoperative##2##4##(2007-11#2)
systemic chemotherapy and##5##3##(2005-11#1)(2006-2#1)(2006-6#1)(2007-11#2)
systemic chemotherapy was##2##3##(1997-3#1)(2008-5#1)
systemic chemotherapy##32##2##(1992-12#1)(1992-2#1)(1994-12#2)(1997-3#1)(2005-11#1)(2006-2#1)(2006-6#8)(2006-8#1)(2006-9#1)(2007-11#2)(2007-5#1)(2007-7#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-3#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-3#1)(2012-1#1)
systemic circulation and##2##3##(1994-8#1)(2010-6#1)
systemic circulation##12##2##(1990-3#1)(1990-5#1)(1994-8#1)(1995-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-12#1)(2010-6#2)(2011-2#1)(2012-2#1)
systemic clearance##2##2##(2008-8#1)(2009-8#1)
systemic complaints##3##2##(2006-10#1)(2007-7#1)(2008-11#1)
systemic complications##7##2##(2006-10#1)(2007-7#1)(2007-8#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
systemic conditions##4##2##(2010-11#1)(2010-3#1)(2011-1#1)(2013-1#1)
systemic consequences##2##2##(2005-8#1)(2006-10#1)
systemic contact##2##2##(2005-11#1)(2007-12#1)
systemic corticosteroid##3##2##(1991-8#1)(2006-8#1)(2011-2#1)
systemic corticosteroids for##2##3##(2007-11#1)(2007-8#1)
systemic corticosteroids##7##2##(2006-10#1)(2007-11#1)(2007-8#1)(2008-5#2)(2012-3#1)(2013-1#1)
systemic disease characterized by##2##4##(2005-11#1)(2013-8#1)
systemic disease control##2##3##(2008-10#2)
systemic disease in##5##3##(1997-8#1)(2006-10#2)(2010-11#1)(2011-1#1)
systemic disease or##3##3##(1997-6#1)(2005-5#1)(2006-10#1)
systemic disease that##3##3##(1992-9#1)(2009-7#1)(2011-2#1)
systemic disease##53##2##(1990-8#1)(1991-12#1)(1991-2#1)(1992-3#2)(1992-9#1)(1995-1#1)(1995-10#1)(1996-2#1)(1997-6#1)(1997-8#2)(2004-1#1)(2005-11#1)(2005-5#1)(2005-8#1)(2006-10#5)(2006-12#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-6#2)(2008-8#1)(2009-2#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#4)
systemic diseases and##2##3##(2008-4#1)(2009-2#1)
systemic diseases or##2##3##(2006-10#1)(2007-7#1)
systemic diseases such as##2##4##(2008-5#1)(2011-2#1)
systemic diseases##31##2##(1993-2#2)(1994-6#1)(1997-1#1)(2005-11#1)(2006-10#3)(2007-10#1)(2007-11#2)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-2#4)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
systemic diseases]##2##2##(2009-2#2)
systemic disorder of the##3##4##(2011-2#1)(2013-1#2)
systemic disorder##10##2##(1993-1#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-6#1)(2011-2#2)(2012-12#1)(2013-1#2)
systemic disorders##8##2##(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2009-2#1)(2012-12#1)
systemic dissemination following##2##3##(2008-9#2)
systemic dissemination of##2##3##(2006-10#1)(2009-3#1)
systemic dissemination##6##2##(2006-10#1)(2008-5#1)(2008-9#2)(2009-3#1)(2009-4#1)
systemic distribution##3##2##(1994-9#1)(2008-10#1)(2009-7#1)
systemic drug##2##2##(2005-8#2)
systemic drugs##3##2##(1997-1#1)(2008-1#1)(2011-2#1)
systemic effect##4##2##(1994-9#1)(2005-10#1)(2005-8#1)(2008-10#1)
systemic effects of##4##3##(2006-10#1)(2008-4#1)(2009-6#1)(2010-12#1)
systemic effects##20##2##(1996-8#1)(1996-9#1)(1997-1#1)(1997-5#1)(2006-10#2)(2006-6#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-2#3)(2012-1#1)(2013-1#1)
systemic embolism##2##2##(1996-6#1)(2010-7#1)
systemic embolization##4##2##(2009-10#1)(2012-3#3)
systemic endothelial##4##2##(1994-12#2)(1997-2#1)(2012-12#1)
systemic enzymotherapy##2##2##(2006-6#2)
systemic ethanol##3##2##(1992-3#3)
systemic exposure to##2##3##(2008-10#1)(2010-5#1)
systemic exposure##5##2##(1992-3#1)(2008-10#1)(2010-11#2)(2010-5#1)
systemic factors##4##2##(1990-12#1)(2007-12#2)(2009-4#1)
systemic features##4##2##(2006-10#1)(2007-10#1)(2007-7#1)(2011-12#1)
systemic florigen signalling##2##3##(2012-2#2)
systemic flow by prostaglandin E1 infusion or a main pulmonary artery to the descending aorta shunt##2##16##(2007-8#2)
systemic flow##4##2##(2007-8#3)(2010-6#1)
systemic fungal infections and##2##4##(2007-7#1)(2009-9#1)
systemic fungal infections##4##3##(1997-2#1)(2005-8#1)(2007-7#1)(2009-9#1)
systemic fungal##6##2##(1997-1#1)(1997-2#1)(2005-8#1)(2007-7#1)(2008-7#1)(2009-9#1)
systemic glucocorticoids##2##2##(1996-12#1)(2005-8#1)
systemic glucose concentration##3##3##(1994-2#3)
systemic haemorrhages##2##2##(1996-11#2)
systemic health##8##2##(2005-11#2)(2007-12#1)(2010-3#1)(2012-3#1)(2013-8#3)
systemic hemodynamic measures in##2##4##(2007-10#2)
systemic hosts##3##2##(2008-10#3)
systemic hypertension and##2##3##(2006-2#1)(2011-2#1)
systemic hypertension##11##2##(1992-4#2)(1997-3#1)(2006-2#3)(2007-11#1)(2008-2#1)(2009-4#1)(2011-2#2)
systemic hypotension##4##2##(1995-4#1)(1995-6#1)(2008-12#1)(2009-5#1)
systemic illness##5##2##(2005-11#1)(2006-10#1)(2007-12#1)(2007-7#1)(2010-9#1)
systemic illnesses and##2##3##(2007-12#1)(2008-7#1)
systemic illnesses##3##2##(2006-2#1)(2007-12#1)(2008-7#1)
systemic immune activation##2##3##(2008-10#1)(2012-1#1)
systemic immune##6##2##(2007-11#1)(2008-10#3)(2009-11#1)(2012-1#1)
systemic immunization##2##2##(2007-12#2)
systemic immunosuppressive response##2##3##(2011-2#2)
systemic immunosuppressive##3##2##(2011-2#2)(2012-1#1)
systemic immunotherapy##2##2##(2006-10#1)(2006-9#1)
systemic in nature##2##3##(2005-8#1)(2008-5#1)
systemic in##4##2##(2005-8#1)(2006-10#2)(2008-5#1)
systemic induced resistance##2##3##(2008-10#1)(2009-8#1)
systemic infection and##3##3##(1993-12#1)(2008-4#1)(2011-2#1)
systemic infection by the virus##2##5##(2008-10#1)(2011-1#1)
systemic infection of##4##3##(2008-10#4)
systemic infection with##3##3##(1995-5#1)(2007-12#1)(2007-7#1)
systemic infection##35##2##(1992-3#1)(1993-12#2)(1995-5#1)(1995-9#1)(2005-12#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-4#1)(2009-10#1)(2009-11#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#1)
systemic infections in##3##3##(2008-10#3)
systemic infections of##2##3##(1997-6#1)(2007-2#1)
systemic infections##14##2##(1995-5#1)(1997-6#1)(2007-2#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-7#1)(2013-1#1)
systemic infectious##2##2##(2008-7#1)(2009-2#1)
systemic inflammation and##3##3##(2007-8#1)(2013-1#2)
systemic inflammation##19##2##(1995-3#1)(2005-10#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-1#1)(2010-10#2)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#3)(2013-7#3)
systemic inflammatory diseases##2##3##(2006-10#1)(2012-3#1)
systemic inflammatory disorder##3##3##(2008-3#1)(2011-2#1)(2012-3#1)
systemic inflammatory response and##3##4##(2006-10#2)(2007-8#1)
systemic inflammatory response syndrome (SIRS)##4##5##(2007-11#1)(2008-5#2)(2011-2#1)
systemic inflammatory response syndrome##9##4##(2006-10#1)(2007-11#1)(2008-5#2)(2008-7#2)(2010-5#2)(2011-2#1)
systemic inflammatory response that##3##4##(2006-10#1)(2009-6#1)(2012-2#1)
systemic inflammatory response##22##3##(1997-7#1)(2006-10#5)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-7#2)(2009-6#1)(2010-5#2)(2011-2#1)(2012-2#1)(2012-3#2)
systemic inflammatory##40##2##(1997-7#1)(2006-10#6)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-6#1)(2010-5#2)(2010-9#1)(2011-2#4)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#1)
systemic injection of##2##3##(1995-12#1)(1997-2#1)
systemic injection##4##2##(1994-5#1)(1995-12#1)(1997-2#1)(2010-2#1)
systemic injections of##2##3##(1995-10#1)(1995-12#1)
systemic involvement##4##2##(2005-11#1)(2007-7#1)(2013-1#2)
systemic level work was##2##4##(2008-12#2)
systemic level work##7##3##(2008-12#7)
systemic level##11##2##(1994-12#1)(1996-12#1)(2006-10#1)(2007-11#1)(2008-12#7)
systemic levels##3##2##(2009-4#1)(2010-10#1)(2010-9#1)
systemic lupus erythematosis##2##3##(2005-11#1)(2007-7#1)
systemic lupus erythematosus (SLE) and##8##5##(1994-6#1)(1995-2#1)(2006-10#3)(2008-1#1)(2010-12#1)(2011-1#1)
systemic lupus erythematosus (SLE) is##2##5##(2006-10#1)(2011-2#1)
systemic lupus erythematosus (SLE) may##2##5##(2006-10#2)
systemic lupus erythematosus (SLE) patients##4##5##(2006-10#1)(2008-10#1)(2012-2#1)(2013-1#1)
systemic lupus erythematosus (SLE) was##3##5##(2007-3#2)(2008-1#1)
systemic lupus erythematosus (SLE) with##2##5##(2006-10#1)(2012-12#1)
systemic lupus erythematosus (SLE)##49##4##(1990-12#1)(1990-6#1)(1992-11#1)(1994-3#1)(1994-6#1)(1995-2#1)(1997-4#1)(2006-10#16)(2007-3#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#2)(2010-12#3)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#1)
systemic lupus erythematosus and antiphospholipid##3##5##(2006-10#2)(2012-12#1)
systemic lupus erythematosus and##9##4##(2006-10#6)(2008-8#1)(2009-3#1)(2012-12#1)
systemic lupus erythematosus developed##3##4##(1993-11#1)(2013-1#2)
systemic lupus erythematosus in remission##2##5##(1992-5#2)
systemic lupus erythematosus in##5##4##(1990-9#1)(1992-5#2)(2006-10#1)(2007-3#1)
systemic lupus erythematosus is##2##4##(2007-7#1)(2012-2#1)
systemic lupus erythematosus patients##5##4##(1991-5#1)(2006-10#1)(2010-4#1)(2012-2#1)(2013-7#1)
systemic lupus erythematosus was##3##4##(1991-5#1)(1994-2#1)(2006-10#1)
systemic lupus erythematosus with##3##4##(1997-4#1)(1997-8#1)(2012-2#1)
systemic lupus erythematosus##168##3##(1990-10#1)(1990-12#1)(1990-6#2)(1990-9#2)(1991-5#3)(1992-11#1)(1992-2#1)(1992-5#2)(1993-11#1)(1993-2#1)(1994-2#4)(1994-3#1)(1994-6#1)(1994-9#2)(1995-2#1)(1995-5#1)(1997-4#2)(1997-5#1)(1997-8#2)(2006-10#44)(2007-11#4)(2007-12#2)(2007-3#7)(2007-7#4)(2007-8#2)(2007-9#3)(2008-1#6)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#2)(2010-11#1)(2010-12#9)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#7)(2012-1#1)(2012-12#5)(2012-2#10)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#3)
systemic lupus erythematosus)##2##3##(1991-12#1)(2012-2#1)
systemic lupus erythematosus]##4##3##(1990-8#2)(1993-10#1)(2007-9#1)
systemic lupus##184##2##(1990-10#1)(1990-12#1)(1990-6#2)(1990-8#3)(1990-9#2)(1991-12#1)(1991-5#3)(1992-11#1)(1992-2#1)(1992-5#2)(1993-10#1)(1993-11#1)(1993-2#1)(1994-2#4)(1994-3#1)(1994-6#1)(1994-9#2)(1995-2#1)(1995-5#1)(1996-9#1)(1997-4#2)(1997-5#1)(1997-8#2)(2005-11#1)(2006-10#45)(2007-11#5)(2007-12#2)(2007-3#7)(2007-7#5)(2007-8#2)(2007-9#4)(2008-1#6)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#2)(2010-11#1)(2010-12#9)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#7)(2012-1#1)(2012-12#5)(2012-2#11)(2012-3#4)(2013-1#11)(2013-7#2)(2013-8#3)
systemic management##3##2##(1990-11#1)(2007-10#1)(2007-11#1)
systemic manifestation##2##2##(2007-7#1)(2008-7#1)
systemic manifestations of##2##3##(2005-11#1)(2006-10#1)
systemic manifestations##9##2##(1997-5#1)(2005-11#1)(2006-10#2)(2007-11#1)(2009-6#1)(2011-2#2)(2012-3#1)
systemic mastocytosis and##2##3##(1991-11#1)(2010-1#1)
systemic mastocytosis##9##2##(1991-11#2)(2010-1#1)(2011-12#1)(2011-2#1)(2013-8#4)
systemic medications##2##2##(2006-10#1)(2008-11#1)
systemic metastases##2##2##(2007-6#1)(2010-3#1)
systemic methotrexate##3##2##(1996-12#1)(2004-10#1)(2011-2#1)
systemic mitochondrial##2##2##(1994-11#2)
systemic movement of##2##3##(2008-10#2)
systemic movement##4##2##(2008-10#4)
systemic neutrophil activation##2##3##(1991-10#2)
systemic onset juvenile##2##3##(2006-10#1)(2008-5#1)
systemic onset##4##2##(2006-10#3)(2008-5#1)
systemic or local##3##3##(1990-9#1)(1995-7#1)(2011-2#1)
systemic or##14##2##(1990-9#1)(1994-2#1)(1995-7#2)(2006-10#1)(2006-6#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-2#1)(2011-2#1)
systemic organ dysfunction##2##3##(2013-1#2)
systemic oxalosis##2##2##(1991-1#1)(2007-7#1)
systemic oxidative stress and##2##4##(2011-1#1)(2012-2#1)
systemic oxidative stress##3##3##(2007-8#1)(2011-1#1)(2012-2#1)
systemic oxygen saturation##2##3##(2010-10#1)(2010-5#1)
systemic oxygen##3##2##(2006-10#1)(2010-10#1)(2010-5#1)
systemic oxygenation##2##2##(1994-7#2)
systemic perfusion##2##2##(2008-10#1)(2011-2#1)
systemic peripheral gangrene##4##3##(2013-1#4)
systemic peripheral##5##2##(2007-10#1)(2013-1#4)
systemic pneumococcal disease##3##3##(1994-9#3)
systemic production of##2##3##(1995-2#1)(1995-9#1)
systemic protection against##2##3##(2008-10#2)
systemic protection##7##2##(2008-10#7)
systemic psychological responses##2##3##(1992-4#2)
systemic rather than##2##3##(2007-6#1)(2010-12#1)
systemic reaction of the##2##4##(1991-11#1)(2011-2#1)
systemic reaction##3##2##(1991-11#1)(1993-5#1)(2011-2#1)
systemic reactions##4##2##(2005-7#1)(2007-11#2)(2007-2#1)
systemic resistance against##5##3##(2007-12#2)(2008-10#3)
systemic resistance and##3##3##(2008-10#2)(2013-8#1)
systemic resistance in apple fruit##2##5##(2008-10#2)
systemic resistance in plants##4##4##(2008-10#4)
systemic resistance in##14##3##(2008-10#14)
systemic resistance to##6##3##(2008-10#4)(2009-8#1)(2013-8#1)
systemic resistance##50##2##(2007-12#2)(2008-10#44)(2009-8#2)(2013-8#2)
systemic response##5##2##(2006-2#1)(2007-11#1)(2008-3#2)(2008-9#1)
systemic responses to##2##3##(1994-2#1)(2008-10#1)
systemic responses##5##2##(1992-4#1)(1994-2#1)(1996-9#1)(2008-10#1)(2008-9#1)
systemic retinoids##3##2##(2007-10#1)(2007-11#1)(2008-5#1)
systemic rheumatic##2##2##(1991-2#1)(2006-10#1)
systemic scleroderma##2##2##(2012-2#2)
systemic sclerosis (SSc)##6##3##(2006-10#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-12#2)
systemic sclerosis and##6##3##(2006-10#1)(2006-2#1)(2007-7#1)(2009-8#3)
systemic sclerosis bind##2##3##(2009-8#2)
systemic sclerosis in a##3##4##(1995-11#1)(2006-10#1)(2008-8#1)
systemic sclerosis in##5##3##(1995-11#1)(2006-10#1)(2007-7#1)(2008-8#1)(2012-2#1)
systemic sclerosis is##2##3##(2007-7#2)
systemic sclerosis patients##2##3##(2009-8#1)(2012-3#1)
systemic sclerosis##61##2##(1991-12#3)(1991-3#1)(1992-8#1)(1995-11#1)(2006-10#11)(2006-2#2)(2007-11#1)(2007-7#10)(2007-8#1)(2008-12#1)(2008-8#2)(2009-8#8)(2009-9#1)(2010-10#3)(2010-11#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#2)
systemic sclerosis]##2##2##(1991-3#1)(1994-3#1)
systemic sequelae##2##2##(2006-9#1)(2008-5#1)
systemic side effects and##2##4##(1992-3#1)(2010-1#1)
systemic side effects##8##3##(1992-3#1)(1994-4#1)(1995-5#1)(1997-1#1)(2007-11#1)(2007-8#1)(2010-1#1)(2013-1#1)
systemic side##9##2##(1990-4#1)(1992-3#1)(1994-4#1)(1995-5#1)(1997-1#1)(2007-11#1)(2007-8#1)(2010-1#1)(2013-1#1)
systemic side-effects##3##2##(2006-10#1)(2008-9#2)
systemic signs and symptoms##2##4##(2007-12#1)(2012-2#1)
systemic signs##3##2##(2007-12#1)(2009-8#1)(2012-2#1)
systemic spread of##2##3##(2008-10#2)
systemic spread##4##2##(2008-10#4)
systemic steroid therapy##2##3##(2011-2#2)
systemic steroid##4##2##(2007-7#2)(2011-2#2)
systemic steroids##2##2##(1993-5#1)(2008-4#1)
systemic symptoms##9##2##(1991-4#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-10#3)(2010-2#2)
systemic testosterone##2##2##(1994-2#2)
systemic therapies##6##2##(1995-10#1)(2008-3#2)(2011-2#1)(2012-12#1)(2013-1#1)
systemic therapy and##2##3##(1995-4#1)(2012-1#1)
systemic therapy for##5##3##(2007-11#1)(2008-6#1)(2010-11#1)(2011-12#1)(2013-1#1)
systemic therapy of##2##3##(2008-5#1)(2010-11#1)
systemic therapy with##2##3##(2010-12#1)(2012-2#1)
systemic therapy##44##2##(1990-6#1)(1991-8#2)(1994-8#1)(1995-4#2)(1995-8#1)(1996-11#1)(1997-8#1)(2004-1#1)(2005-11#1)(2005-7#1)(2006-10#3)(2007-11#1)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-6#3)(2009-12#1)(2009-2#2)(2009-6#2)(2010-11#3)(2010-12#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
systemic thrombolytic treatment##2##3##(1990-6#2)
systemic tissue##3##2##(2008-10#1)(2009-8#2)
systemic toxicity was##3##3##(1993-3#1)(2006-6#2)
systemic toxicity##15##2##(1992-2#1)(1992-6#1)(1993-3#1)(1997-1#1)(2005-10#1)(2005-7#1)(2006-6#3)(2007-11#1)(2008-10#1)(2010-2#1)(2012-2#1)(2013-1#2)
systemic treatment of the##2##4##(2005-11#1)(2009-2#1)
systemic treatment of##6##3##(2005-11#2)(2007-11#1)(2009-11#1)(2009-2#1)(2013-1#1)
systemic treatment##19##2##(1990-5#1)(1993-1#1)(1996-1#1)(1997-5#1)(1997-8#1)(2005-11#2)(2007-11#3)(2007-5#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-2#1)(2009-3#1)(2011-12#1)(2011-2#1)(2013-1#1)
systemic treatments for##3##3##(2008-5#1)(2009-10#1)(2013-8#1)
systemic treatments##6##2##(2008-5#1)(2009-10#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
systemic vascular resistance and##2##4##(1993-12#1)(1995-4#1)
systemic vascular resistance of##2##4##(2007-9#1)(2009-5#1)
systemic vascular resistance##15##3##(1991-3#1)(1993-12#3)(1995-4#1)(2007-8#3)(2007-9#2)(2008-12#1)(2008-7#1)(2009-5#1)(2010-8#1)(2011-2#1)
systemic vascular##17##2##(1991-3#1)(1993-12#3)(1995-12#1)(1995-4#1)(2007-8#3)(2007-9#2)(2008-12#1)(2008-7#1)(2009-5#2)(2010-8#1)(2011-2#1)
systemic vasculitides##5##2##(2005-8#1)(2008-7#1)(2010-4#1)(2012-1#1)(2012-3#1)
systemic vasculitis##14##2##(1995-5#1)(1996-8#1)(2006-10#3)(2007-2#1)(2008-1#2)(2008-3#1)(2008-5#1)(2009-2#1)(2010-12#1)(2012-3#2)
systemic veins##2##2##(1997-1#1)(2007-8#1)
systemic venous pressure##2##3##(1993-2#2)
systemic venous##3##2##(1993-2#2)(2007-8#1)
systemic virus##2##2##(2008-10#2)
systemic viruses##2##2##(2008-10#1)(2009-7#1)
systemic##1562##1##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#3)(1990-4#5)(1990-5#2)(1990-6#8)(1990-7#2)(1990-8#7)(1990-9#4)(1991-1#2)(1991-10#3)(1991-11#5)(1991-12#5)(1991-2#3)(1991-3#6)(1991-4#1)(1991-5#4)(1991-8#4)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#4)(1992-3#10)(1992-4#5)(1992-5#3)(1992-6#1)(1992-8#6)(1992-9#2)(1993-1#4)(1993-10#2)(1993-11#3)(1993-12#9)(1993-2#6)(1993-3#3)(1993-5#3)(1993-6#3)(1994-10#6)(1994-11#3)(1994-12#9)(1994-2#12)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#3)(1994-7#4)(1994-8#2)(1994-9#8)(1995-1#5)(1995-10#3)(1995-11#3)(1995-12#6)(1995-2#4)(1995-3#4)(1995-4#4)(1995-5#6)(1995-6#2)(1995-7#9)(1995-8#1)(1995-9#3)(1996-1#3)(1996-10#3)(1996-11#5)(1996-12#8)(1996-2#4)(1996-3#4)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#6)(1996-9#5)(1997-1#8)(1997-2#4)(1997-3#4)(1997-4#4)(1997-5#7)(1997-6#3)(1997-7#1)(1997-8#10)(2004-1#4)(2004-10#1)(2005-1#1)(2005-10#8)(2005-11#15)(2005-12#2)(2005-5#1)(2005-7#4)(2005-8#14)(2006-1#1)(2006-10#116)(2006-11#2)(2006-12#1)(2006-2#12)(2006-4#1)(2006-5#1)(2006-6#21)(2006-7#2)(2006-8#10)(2006-9#5)(2007-1#1)(2007-10#12)(2007-11#58)(2007-12#18)(2007-2#6)(2007-3#10)(2007-5#4)(2007-6#4)(2007-7#39)(2007-8#33)(2007-9#13)(2008-1#18)(2008-10#152)(2008-11#12)(2008-12#16)(2008-2#2)(2008-3#11)(2008-4#16)(2008-5#31)(2008-6#11)(2008-7#28)(2008-8#15)(2008-9#12)(2009-10#13)(2009-11#4)(2009-12#2)(2009-2#21)(2009-3#4)(2009-4#7)(2009-5#3)(2009-6#11)(2009-7#5)(2009-8#27)(2009-9#4)(2010-1#3)(2010-10#7)(2010-11#11)(2010-12#19)(2010-2#6)(2010-3#9)(2010-4#4)(2010-5#8)(2010-6#5)(2010-7#3)(2010-8#2)(2010-9#7)(2011-1#20)(2011-10#1)(2011-12#5)(2011-2#67)(2011-3#1)(2012-1#16)(2012-11#2)(2012-12#24)(2012-2#37)(2012-3#31)(2013-1#62)(2013-7#10)(2013-8#30)
systemic)##2##1##(2006-10#1)(2008-9#1)
systemic-pulmonary##2##1##(1990-11#1)(2009-4#1)
systemically active##2##2##(1996-12#1)(1997-2#1)
systemically administered CDP##2##3##(1993-12#2)
systemically administered drugs##2##3##(2007-11#1)(2008-10#1)
systemically administered##15##2##(1993-11#1)(1993-12#6)(1994-10#1)(1995-7#1)(1996-12#1)(1997-3#1)(2007-11#2)(2008-10#1)(2010-12#1)
systemically and##3##2##(1993-12#1)(2007-11#1)(2013-1#1)
systemically in##5##2##(1990-11#1)(1997-5#1)(2008-10#1)(2008-8#1)(2009-10#1)
systemically infect##2##2##(2008-10#2)
systemically infected leaves##2##3##(2008-10#2)
systemically infected wheat##2##3##(2008-10#2)
systemically infected##11##2##(1995-2#1)(2008-10#10)
systemically to##2##2##(2006-9#1)(2010-12#1)
systemically##76##1##(1990-11#1)(1991-5#1)(1992-9#1)(1993-11#1)(1993-12#10)(1994-10#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-1#1)(1996-12#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2005-7#1)(2005-9#1)(2006-6#1)(2006-9#1)(2007-11#5)(2007-7#1)(2008-10#26)(2008-5#1)(2008-8#1)(2009-10#2)(2010-12#4)(2011-1#2)(2012-2#2)(2013-1#2)(2013-8#1)
systems (MEMS) technology##3##3##(2007-2#1)(2008-2#1)(2010-9#1)
systems (MEMS)##6##2##(2007-12#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-9#1)
systems (PACS)##3##2##(1996-2#2)(1997-8#1)
systems (Wistar rats)##2##3##(2012-3#2)
systems (e##2##2##(2008-2#1)(2012-11#1)
systems (eg##3##2##(1992-10#1)(2007-10#2)
systems (i##4##2##(1997-8#1)(2008-3#1)(2008-7#1)(2008-8#1)
systems (including##5##2##(1996-5#1)(2012-11#4)
systems -##2##2##(2006-6#1)(2007-12#1)
systems a##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
systems above##2##2##(2006-5#1)(2012-3#1)
systems affected by##2##3##(2009-10#1)(2011-2#1)
systems affected##3##2##(2009-10#1)(2011-2#1)(2013-1#1)
systems against##3##2##(2006-10#1)(2008-10#1)(2008-5#1)
systems all##2##2##(1993-11#1)(2006-10#1)
systems allow for##2##3##(1994-3#1)(2008-7#1)
systems allow the##2##3##(2007-5#1)(2008-7#1)
systems allow us to##2##4##(2008-2#1)(2008-3#1)
systems allow##13##2##(1992-8#1)(1994-2#1)(1994-3#1)(2006-10#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#2)
systems allowing##3##2##(2012-12#1)(2013-1#2)
systems allows for##2##3##(2006-11#1)(2008-2#1)
systems allows##5##2##(2006-11#1)(2007-12#1)(2008-2#1)(2009-12#1)(2012-12#1)
systems also differ in##2##4##(1995-10#1)(2007-10#1)
systems also##4##2##(1991-11#1)(1994-2#1)(1995-10#1)(2007-10#1)
systems analysis of##4##3##(2010-5#1)(2011-1#1)(2012-2#2)
systems analysis##8##2##(1990-12#1)(1993-2#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-2#3)
systems and a##2##3##(2008-10#1)(2008-7#1)
systems and all##2##3##(2008-3#1)(2013-8#1)
systems and describes##2##3##(2008-4#1)(2010-11#1)
systems and for##4##3##(1993-12#1)(1994-2#1)(2005-11#1)(2008-2#1)
systems and have##2##3##(2008-3#1)(2011-2#1)
systems and health##2##3##(1997-2#1)(2012-12#1)
systems and how##2##3##(2005-8#1)(2008-4#1)
systems and improving##2##3##(2009-7#1)(2010-8#1)
systems and in##8##3##(1991-5#1)(1991-9#1)(1994-5#1)(2005-11#1)(2008-2#1)(2008-7#1)(2012-11#2)
systems and influence##2##3##(2007-10#1)(2010-4#1)
systems and is##5##3##(2006-12#1)(2007-11#1)(2008-11#1)(2008-2#1)(2013-1#1)
systems and measurement##2##3##(1992-3#1)(2008-10#1)
systems and other##2##3##(2007-5#1)(2011-2#1)
systems and plays##2##3##(2007-1#1)(2008-10#1)
systems and suggest##2##3##(1990-2#1)(2008-8#1)
systems and that##2##3##(2007-1#1)(2007-12#1)
systems and the separation##2##4##(2005-11#1)(2008-10#1)
systems and the##27##3##(1990-11#1)(1991-3#1)(1994-12#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-3#2)(2005-11#1)(2005-5#1)(2006-10#2)(2006-3#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-7#3)(2008-9#1)(2010-2#2)(2011-2#2)(2012-3#1)
systems and their applications##3##4##(2008-3#1)(2008-4#1)(2008-9#1)
systems and their##11##3##(1995-4#1)(2005-11#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2013-1#3)
systems and to##4##3##(1992-3#1)(2007-12#1)(2008-5#1)(2011-2#1)
systems and will##3##3##(2007-12#1)(2008-10#2)
systems and##253##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-7#5)(1993-8#1)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#2)(1995-1#1)(1995-10#1)(1995-12#2)(1995-4#1)(1995-5#1)(1996-1#3)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#2)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-5#1)(1997-8#1)(2004-9#2)(2005-11#5)(2005-5#1)(2005-7#1)(2005-8#4)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#3)(2006-2#2)(2006-3#1)(2006-6#2)(2007-1#3)(2007-10#1)(2007-11#4)(2007-12#4)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#18)(2008-11#6)(2008-12#1)(2008-2#9)(2008-3#10)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#10)(2008-8#8)(2008-9#2)(2009-10#3)(2009-11#1)(2009-3#2)(2009-7#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#4)(2010-8#6)(2011-1#4)(2011-12#1)(2011-2#10)(2011-7#1)(2011-9#1)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#12)(2013-7#1)(2013-8#4)
systems appear to##2##3##(2007-12#1)(2008-8#1)
systems applied to##3##3##(2008-12#1)(2008-2#1)(2011-1#1)
systems approach to asthma care##2##5##(1997-2#2)
systems approach to##12##3##(1992-2#1)(1994-2#1)(1995-12#1)(1995-2#1)(1997-2#2)(2006-10#2)(2006-5#1)(2006-6#1)(2008-2#1)(2008-3#1)
systems approach##18##2##(1992-2#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1997-2#2)(2006-10#2)(2006-5#1)(2006-6#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-5#1)
systems are a##2##3##(1994-2#1)(2010-4#1)
systems are also addressed##2##4##(2008-2#1)(2010-8#1)
systems are also present##2##4##(1994-3#1)(2012-3#1)
systems are also##7##3##(1990-12#1)(1994-3#1)(2008-2#1)(2008-5#1)(2010-5#1)(2010-8#1)(2012-3#1)
systems are an##3##3##(2007-8#1)(2008-10#1)(2008-3#1)
systems are analyzed by use of##2##6##(2008-3#2)
systems are based on##3##4##(2005-8#1)(2013-1#2)
systems are based##4##3##(1996-12#1)(2005-8#1)(2013-1#2)
systems are being##7##3##(1991-11#1)(1994-5#1)(1996-12#1)(1997-3#1)(2005-8#1)(2007-7#1)(2008-3#1)
systems are capable of##2##4##(2008-3#1)(2010-8#1)
systems are characterized by##3##4##(1997-1#1)(2007-12#1)(2008-10#1)
systems are compared##4##3##(1991-2#1)(2008-10#1)(2008-3#1)(2011-2#1)
systems are described##4##3##(2008-10#1)(2008-2#1)(2008-4#1)(2010-12#1)
systems are discussed##12##3##(1991-3#1)(2005-7#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-7#1)
systems are examined##4##3##(1992-12#1)(1994-2#1)(2006-10#1)(2008-2#1)
systems are expected to become##2##5##(1994-2#1)(2010-7#1)
systems are expected to##4##4##(1994-2#1)(1996-2#1)(2009-3#1)(2010-7#1)
systems are highly##3##3##(1994-12#1)(2008-4#1)(2010-1#1)
systems are increasingly##2##3##(2006-4#1)(2007-5#1)
systems are needed##2##3##(2010-5#1)(2010-7#1)
systems are not##6##3##(2006-10#1)(2006-6#1)(2006-9#1)(2008-3#1)(2008-7#2)
systems are now##2##3##(2008-9#1)(2011-2#1)
systems are only##3##3##(2006-6#1)(2007-12#1)(2008-9#1)
systems are presented##6##3##(1990-8#1)(2007-12#1)(2008-10#2)(2008-2#1)(2009-9#1)
systems are prone to##2##4##(1997-6#1)(2006-9#1)
systems are required##2##3##(1993-8#1)(1994-5#1)
systems are reviewed##2##3##(2006-6#1)(2010-12#1)
systems are subject to##2##4##(2008-2#1)(2008-3#1)
systems are the##4##3##(2006-8#1)(2008-10#1)(2008-3#1)(2008-7#1)
systems are under##2##3##(2007-5#1)(2008-3#1)
systems are used in##2##4##(2008-9#1)(2010-8#1)
systems are used##5##3##(1995-2#1)(2008-9#1)(2010-8#1)(2013-1#2)
systems are usually##2##3##(2008-10#1)(2010-7#1)
systems are##207##2##(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-8#2)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-12#2)(1996-2#2)(1997-1#3)(1997-2#1)(1997-3#2)(1997-6#2)(1997-7#1)(2005-10#1)(2005-5#1)(2005-7#1)(2005-8#2)(2006-10#11)(2006-4#1)(2006-6#4)(2006-7#1)(2006-8#1)(2006-9#2)(2007-11#1)(2007-12#10)(2007-5#3)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#16)(2008-11#3)(2008-2#11)(2008-3#18)(2008-4#5)(2008-5#5)(2008-7#4)(2008-8#1)(2008-9#4)(2009-10#2)(2009-2#1)(2009-3#2)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#6)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
systems as a function of##2##5##(2005-11#1)(2013-1#1)
systems as a##6##3##(1992-4#1)(2005-11#1)(2008-11#1)(2010-4#1)(2012-2#1)(2013-1#1)
systems as an##2##3##(2006-10#1)(2012-3#1)
systems as well as the##2##5##(2006-6#1)(2008-10#1)
systems as well as##6##4##(2006-6#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-9#1)(2010-4#1)
systems as well##8##3##(1995-8#1)(1996-12#1)(2006-6#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-9#1)(2010-4#1)
systems as##28##2##(1990-11#1)(1992-4#1)(1993-2#1)(1995-8#1)(1996-12#1)(2005-11#1)(2006-10#3)(2006-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-8#1)(2008-9#1)(2010-1#1)(2010-4#2)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
systems at the##5##3##(2008-3#1)(2008-5#1)(2009-5#1)(2012-1#2)
systems at##19##2##(1990-10#1)(1993-7#1)(2005-11#1)(2005-5#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2009-5#2)(2010-4#1)(2012-1#2)
systems available##4##2##(1993-3#1)(2005-8#1)(2007-8#1)(2008-9#1)
systems based on the##10##4##(1991-9#1)(1996-12#1)(2006-8#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2012-2#1)
systems based on these##2##4##(1994-12#1)(2008-1#1)
systems based on##35##3##(1991-9#1)(1994-12#1)(1996-12#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#6)(2008-1#1)(2008-10#6)(2008-2#8)(2008-3#5)(2008-7#1)(2012-2#1)
systems based##36##2##(1991-9#1)(1994-12#1)(1996-12#1)(1997-3#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#6)(2008-1#1)(2008-10#6)(2008-2#8)(2008-3#5)(2008-7#1)(2012-2#1)
systems because of##3##3##(2007-11#1)(2007-12#1)(2010-4#1)
systems because##5##2##(2007-11#1)(2007-12#1)(2008-5#1)(2010-4#1)(2010-7#1)
systems between##2##2##(1992-8#1)(1997-2#1)
systems biology and##2##3##(2013-8#2)
systems biology approach##7##3##(2006-10#1)(2008-7#1)(2010-5#1)(2010-9#2)(2011-2#1)(2012-3#1)
systems biology approaches##3##3##(2010-9#2)(2012-2#1)
systems biology in##2##3##(2009-5#1)(2010-9#1)
systems biology research##2##3##(2006-10#1)(2012-2#1)
systems biology##61##2##(2006-10#12)(2008-11#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#2)(2009-5#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#4)(2010-7#1)(2010-9#10)(2011-2#5)(2012-2#4)(2012-3#3)(2013-1#1)(2013-8#2)
systems biology-level##2##2##(2010-9#2)
systems but##3##2##(1997-1#2)(2008-11#1)
systems by use of##4##4##(2007-11#3)(2008-2#1)
systems by using##3##3##(2007-12#1)(2008-3#1)(2010-8#1)
systems by##23##2##(1991-2#2)(1991-5#1)(1992-3#1)(1995-12#1)(2007-11#4)(2007-12#2)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#1)(2010-8#1)(2013-8#1)
systems can also##2##3##(2008-7#1)(2010-4#1)
systems can be obtained##2##4##(2008-10#1)(2008-2#1)
systems can be readily##2##4##(1994-3#1)(2007-12#1)
systems can be##15##3##(1991-2#1)(1994-3#1)(2005-12#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-4#1)(2009-12#1)(2011-1#1)(2011-2#1)
systems can have##2##3##(1995-5#1)(2008-3#1)
systems can occur##2##3##(1995-2#1)(2012-12#1)
systems can##36##2##(1991-2#1)(1991-5#1)(1994-3#2)(1995-2#1)(1995-5#1)(1996-2#1)(1997-6#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)
systems cannot be##4##3##(1995-5#1)(2008-10#1)(2008-2#1)(2012-2#1)
systems cannot##5##2##(1995-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2012-2#1)
systems capable of##7##3##(2005-8#1)(2008-2#2)(2008-7#1)(2008-9#1)(2010-2#1)(2011-2#1)
systems change##2##2##(1996-3#1)(2012-2#1)
systems changes##2##2##(2010-8#1)(2012-1#1)
systems characterized by##2##3##(1990-3#1)(2008-5#1)
systems considered##2##2##(2008-10#1)(2010-4#1)
systems consisted of##2##3##(1992-3#1)(1993-3#1)
systems consisting of##3##3##(2008-2#2)(2008-3#1)
systems containing##17##2##(1990-7#3)(1995-1#1)(2005-11#3)(2006-10#1)(2007-12#2)(2007-6#1)(2008-3#1)(2008-5#1)(2009-3#1)(2010-4#1)(2010-9#1)(2012-12#1)
systems could be##6##3##(1995-8#1)(2007-12#1)(2008-10#2)(2008-7#1)(2010-4#1)
systems could##11##2##(1991-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)
systems currently under##2##3##(2007-5#1)(2012-2#1)
systems currently##5##2##(2006-7#1)(2007-5#1)(2008-4#1)(2012-2#2)
systems demonstrate##2##2##(2008-11#1)(2012-2#1)
systems depend on##2##3##(1994-5#1)(2008-7#1)
systems derived from##2##3##(2008-1#1)(2008-11#1)
systems described##3##2##(2004-11#1)(2007-12#1)(2008-5#1)
systems designed for##5##3##(2007-12#1)(2008-2#1)(2008-4#1)(2013-1#2)
systems designed to##3##3##(1996-2#1)(2008-4#1)(2009-3#1)
systems designed##9##2##(1996-2#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2009-3#1)(2013-1#2)
systems developed by##2##3##(1997-8#1)(2011-2#1)
systems developed to date have##2##5##(1995-2#1)(2008-12#1)
systems developed##5##2##(1992-3#1)(1995-2#1)(1997-8#1)(2008-12#1)(2011-2#1)
systems development##3##2##(1993-2#2)(1995-12#1)
systems did##2##2##(2008-11#1)(2008-8#1)
systems differ##3##2##(2006-10#1)(2008-7#1)(2013-1#1)
systems do not##2##3##(1995-2#1)(2006-6#1)
systems do##4##2##(1993-11#1)(1995-2#1)(2006-6#1)(2008-8#1)
systems during the##3##3##(1990-8#1)(1996-12#1)(2008-7#1)
systems during##10##2##(1990-8#1)(1992-3#1)(1996-12#1)(2008-7#1)(2011-12#1)(2012-1#1)(2012-3#2)(2013-1#2)
systems employed##3##2##(1991-3#1)(2008-4#1)(2008-6#1)
systems employing a##2##3##(2007-12#2)
systems employing##5##2##(1995-3#1)(2007-12#2)(2007-3#1)(2008-10#1)
systems enable##4##2##(2006-6#1)(2007-1#1)(2010-5#1)(2012-11#1)
systems engineering##2##2##(2007-12#2)
systems environment##2##2##(1993-2#1)(1996-3#1)
systems established##2##2##(2008-10#1)(2008-11#1)
systems everywhere##2##2##(2010-11#1)(2011-12#1)
systems exhibit a high degree of##2##6##(2008-10#1)(2009-4#1)
systems exhibit##3##2##(2008-10#1)(2008-9#1)(2009-4#1)
systems experience##3##2##(2007-12#1)(2008-11#1)(2008-3#1)
systems exploiting##2##2##(2008-10#2)
systems for an##3##3##(1997-3#1)(2008-2#1)(2010-12#1)
systems for analysis##3##3##(2008-2#1)(2010-9#1)(2011-2#1)
systems for cancer##2##3##(2008-11#1)(2012-2#1)
systems for clinical##3##3##(1992-3#1)(1997-3#1)(2008-5#1)
systems for evaluating##2##3##(2008-10#1)(2008-4#1)
systems for gene##2##3##(2008-11#1)(2008-2#1)
systems for human##2##3##(1995-1#1)(2008-9#1)
systems for long-term##2##3##(1997-1#1)(2012-2#1)
systems for managed care##2##4##(1994-2#1)(1996-12#1)
systems for measuring##2##3##(2008-2#2)
systems for medical##2##3##(1992-5#1)(2010-6#1)
systems for more##2##3##(2007-12#1)(2008-7#1)
systems for new##3##3##(1994-3#1)(2007-3#1)(2008-9#1)
systems for nursing##2##3##(1991-2#2)
systems for optical##2##3##(2008-2#2)
systems for public health##2##4##(1997-3#1)(2010-8#1)
systems for rapid##2##3##(2007-12#1)(2008-11#1)
systems for the analysis of##2##5##(2008-10#1)(2008-4#1)
systems for the detection of##2##5##(2008-2#1)(2008-4#1)
systems for the detection##3##4##(2008-10#1)(2008-2#1)(2008-4#1)
systems for the determination of##2##5##(2008-10#2)
systems for the evaluation of##2##5##(2008-8#1)(2011-1#1)
systems for the study of##2##5##(2008-4#1)(2008-9#1)
systems for the##37##3##(1990-5#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-2#1)(1995-5#1)(1995-6#1)(1995-7#1)(1997-1#2)(1997-8#1)(2004-9#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
systems for their##3##3##(1990-4#1)(2008-11#1)(2008-7#1)
systems for three-plane correction and fixation of##2##7##(2007-11#2)
systems for treatment and care of persons with alcohol-related problems##2##10##(1990-5#2)
systems for which##2##3##(1995-8#1)(2007-12#1)
systems for##209##2##(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#5)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-5#1)(1992-8#1)(1993-12#3)(1993-3#2)(1993-5#1)(1993-6#1)(1994-1#2)(1994-2#2)(1994-3#2)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-12#2)(1996-2#2)(1996-4#1)(1996-5#2)(1997-1#5)(1997-3#4)(1997-4#3)(1997-8#1)(2004-9#2)(2006-10#3)(2007-10#1)(2007-11#3)(2007-12#7)(2007-3#2)(2007-8#4)(2008-10#21)(2008-11#9)(2008-12#3)(2008-2#14)(2008-3#9)(2008-4#7)(2008-5#1)(2008-7#8)(2008-8#2)(2008-9#7)(2009-10#1)(2009-3#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#9)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#3)(2013-1#4)(2013-7#3)(2013-8#2)
systems form a##3##3##(2007-12#1)(2008-7#1)(2013-1#1)
systems found##2##2##(1997-3#1)(2010-7#1)
systems from the##3##3##(1990-7#1)(1996-3#1)(2008-4#1)
systems from##20##2##(1990-7#1)(1991-7#1)(1994-8#1)(1996-3#1)(2006-11#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-6#1)
systems generally##4##2##(2008-10#1)(2011-1#1)(2012-2#1)(2013-7#1)
systems give##2##2##(1994-5#1)(2008-11#1)
systems has been developed##2##4##(2007-8#1)(2008-7#1)
systems has been##12##3##(1990-3#1)(1991-1#1)(1992-8#1)(1993-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-7#1)(2012-2#1)
systems has##24##2##(1990-3#1)(1991-1#1)(1991-3#1)(1992-8#1)(1993-6#1)(1993-9#1)(1995-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-7#1)(2010-4#1)(2012-2#2)
systems have also been##2##4##(2005-12#1)(2008-2#1)
systems have become##2##3##(1992-12#1)(1996-3#1)
systems have been an active##2##5##(2008-3#1)(2012-1#1)
systems have been described##2##4##(2007-11#1)(2012-12#1)
systems have been developed for##4##5##(2008-10#2)(2013-1#2)
systems have been developed to##4##5##(1994-6#1)(2006-6#1)(2010-7#1)(2012-2#1)
systems have been developed##16##4##(1992-3#1)(1994-6#1)(2006-6#1)(2008-10#2)(2008-5#1)(2009-11#1)(2010-7#1)(2012-2#1)(2013-1#2)(2013-8#5)
systems have been identified##2##4##(1997-4#1)(2008-3#1)
systems have been implicated in the##2##6##(1993-3#1)(1996-7#1)
systems have been implicated in##3##5##(1993-3#1)(1994-12#1)(1996-7#1)
systems have been implicated##4##4##(1993-3#1)(1994-12#1)(1996-7#1)(2009-7#1)
systems have been introduced##3##4##(2006-10#1)(2006-6#1)(2008-9#1)
systems have been proposed##2##4##(1997-1#1)(2007-9#1)
systems have been used to##2##5##(2008-5#1)(2008-7#1)
systems have been used##4##4##(1992-8#1)(2008-3#1)(2008-5#1)(2008-7#1)
systems have been##57##3##(1990-3#1)(1992-3#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-6#1)(1996-12#1)(1996-7#1)(1997-1#3)(1997-4#1)(2005-11#3)(2006-10#1)(2006-6#2)(2007-11#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#2)(2008-7#2)(2008-9#2)(2009-10#1)(2009-11#2)(2009-7#1)(2009-9#2)(2010-11#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#5)
systems have begun to##2##4##(1996-1#1)(2010-10#1)
systems have evolved##4##3##(2008-8#1)(2010-9#1)(2012-11#2)
systems have not been##2##4##(1997-5#1)(2010-8#1)
systems have shown##2##3##(2006-10#1)(2008-11#1)
systems have the##3##3##(2008-4#1)(2009-11#1)(2012-2#1)
systems have their##2##3##(1996-2#1)(2007-5#1)
systems have##100##2##(1990-3#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-12#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-7#1)(1997-1#3)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#3)(2005-12#1)(2006-10#3)(2006-6#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#3)(2009-5#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#4)(2013-1#4)(2013-8#5)
systems having##3##2##(2008-10#1)(2008-2#1)(2010-4#1)
systems implementation##3##2##(2008-3#1)(2013-1#2)
systems implemented##3##2##(1996-1#1)(2005-5#1)(2008-7#1)
systems improve##2##2##(1996-2#1)(2008-9#1)
systems in ENT surgery##2##4##(2005-5#1)(2006-6#1)
systems in a##8##3##(1994-11#1)(2005-11#1)(2008-2#3)(2008-3#2)(2013-8#1)
systems in an##3##3##(1996-3#1)(2010-8#1)(2013-8#1)
systems in animals##2##3##(2006-12#1)(2006-6#1)
systems in biology##2##3##(2008-4#1)(2008-7#1)
systems in both##3##3##(1996-12#1)(2005-11#1)(2006-8#1)
systems in developed##2##3##(2006-10#2)
systems in general##3##3##(2008-5#1)(2008-8#1)(2013-8#1)
systems in health care##3##4##(1992-1#2)(2007-4#1)
systems in health##7##3##(1990-12#1)(1992-1#2)(1997-3#1)(2007-4#1)(2008-7#1)(2008-8#1)
systems in hospitals##2##3##(1995-12#1)(2007-12#1)
systems in many##2##3##(2008-9#1)(2012-12#1)
systems in order to##5##4##(2008-1#1)(2008-8#2)(2010-3#2)
systems in other##2##3##(1995-1#1)(2008-9#1)
systems in patients##2##3##(2007-12#1)(2012-3#1)
systems in place##3##3##(1995-12#1)(2008-5#1)(2012-12#1)
systems in response to##2##4##(2006-10#1)(2012-2#1)
systems in the Pacific##4##4##(2008-1#1)(2012-12#3)
systems in the brain##6##4##(1991-5#1)(1991-6#1)(1993-5#1)(1994-8#1)(2008-1#1)(2010-4#1)
systems in the health##2##4##(1990-12#1)(1996-2#1)
systems in the human##2##4##(1992-11#1)(2012-11#1)
systems in the near future##2##5##(2006-10#1)(2010-11#1)
systems in the past##2##4##(1994-1#1)(1994-12#1)
systems in the presence of##5##5##(1997-2#1)(2005-11#2)(2008-1#1)(2009-8#1)
systems in the rat##2##4##(1994-11#1)(1997-7#1)
systems in the##64##3##(1990-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1993-2#2)(1993-5#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-2#2)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#3)(2006-10#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#3)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2013-8#1)
systems in their##2##3##(2008-10#1)(2008-2#1)
systems in these##2##3##(2006-8#1)(2009-3#1)
systems in this##2##3##(2006-9#1)(2008-2#1)
systems in total hip##2##4##(2007-5#2)
systems in which the##3##4##(1991-3#1)(2008-10#1)(2008-3#1)
systems in which##15##3##(1990-12#1)(1990-2#1)(1991-2#1)(1991-3#1)(1994-5#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2012-3#1)
systems in##257##2##(1990-11#1)(1990-12#4)(1990-2#2)(1990-5#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#3)(1993-5#2)(1993-6#2)(1994-1#2)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#2)(1995-10#1)(1995-12#3)(1995-2#2)(1995-3#2)(1995-7#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-4#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-4#1)(2005-11#7)(2005-5#2)(2005-7#1)(2005-8#2)(2006-10#8)(2006-11#1)(2006-12#5)(2006-4#1)(2006-6#5)(2006-8#3)(2006-9#2)(2007-10#1)(2007-11#3)(2007-12#4)(2007-4#1)(2007-5#2)(2007-6#1)(2007-8#3)(2008-1#8)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#10)(2008-3#5)(2008-4#2)(2008-5#3)(2008-7#6)(2008-8#6)(2008-9#4)(2009-10#2)(2009-3#2)(2009-8#4)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#6)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#11)
systems include##7##2##(2006-12#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-11#1)(2010-11#1)
systems including the##5##3##(1993-10#1)(2008-10#1)(2008-8#1)(2010-4#1)(2011-1#1)
systems including their##3##3##(2008-1#1)(2008-10#1)(2013-8#1)
systems including##14##2##(1990-10#1)(1993-10#1)(1996-5#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-4#1)(2011-1#1)(2011-12#1)(2012-3#1)(2013-8#1)
systems increases##2##2##(1991-2#1)(2006-5#1)
systems indicated that##2##3##(1992-6#1)(2008-5#1)
systems into##8##2##(1991-5#1)(1992-12#1)(1996-3#1)(1997-3#3)(2005-11#1)(2007-5#1)
systems investigated##3##2##(2005-11#1)(2008-2#1)(2009-8#1)
systems involved in the##2##4##(1993-12#1)(1996-12#1)
systems involved in##5##3##(1992-8#1)(1993-12#1)(1996-12#1)(2010-8#1)(2012-2#1)
systems involved##7##2##(1992-8#1)(1993-12#1)(1996-12#1)(1996-6#1)(2007-4#1)(2010-8#1)(2012-2#1)
systems involving##5##2##(1991-12#1)(2008-10#1)(2008-3#1)(2009-6#1)(2010-10#1)
systems is a##3##3##(1994-11#1)(2006-10#1)(2008-7#1)
systems is also##5##3##(1996-1#1)(2007-11#1)(2008-10#1)(2008-12#1)(2010-8#1)
systems is described##6##3##(1992-9#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-4#1)
systems is developed##3##3##(2005-11#1)(2007-11#1)(2008-2#1)
systems is discussed##9##3##(1994-6#1)(1995-12#1)(1996-5#1)(1997-4#1)(2006-10#1)(2007-12#2)(2008-3#1)(2008-4#1)
systems is essential##2##3##(1992-8#1)(2008-1#1)
systems is examined##3##3##(2008-2#2)(2008-3#1)
systems is given##2##3##(2007-12#1)(2008-10#1)
systems is limited##2##3##(2007-12#1)(2008-3#1)
systems is needed##2##3##(2006-2#1)(2010-11#1)
systems is not##4##3##(1994-1#1)(2008-10#1)(2010-2#2)
systems is of##2##3##(2008-10#1)(2008-11#1)
systems is presented in##2##4##(2008-10#1)(2008-4#1)
systems is presented##12##3##(1994-6#1)(2008-10#1)(2008-2#2)(2008-3#5)(2008-4#1)(2009-11#1)(2010-5#1)
systems is proposed##2##3##(2008-2#1)(2012-12#1)
systems is shown##4##3##(2007-8#1)(2008-2#1)(2008-3#1)(2012-1#1)
systems is studied##2##3##(2008-2#1)(2013-8#1)
systems is that##2##3##(2006-12#1)(2008-9#1)
systems is the##6##3##(2007-11#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)
systems is their##2##3##(2008-2#1)(2012-2#1)
systems is to ensure that##2##5##(2008-7#1)(2012-12#1)
systems is to##5##3##(2006-7#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-12#1)
systems is##118##2##(1990-8#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-6#2)(1995-1#1)(1995-12#1)(1996-1#1)(1996-4#1)(1996-5#1)(1997-4#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2007-11#3)(2007-12#7)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#15)(2008-3#11)(2008-4#5)(2008-7#4)(2008-8#3)(2008-9#3)(2009-11#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-2#2)(2010-5#1)(2010-8#1)(2011-1#3)(2011-7#1)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#3)
systems issues##2##2##(2007-1#1)(2010-5#1)
systems it is##2##3##(1997-1#1)(2008-2#1)
systems it##4##2##(1997-1#1)(2006-5#1)(2008-2#1)(2010-5#1)
systems like##8##2##(1994-12#1)(2007-12#1)(2008-10#3)(2008-11#1)(2013-1#2)
systems made##3##2##(2008-1#1)(2008-5#1)(2010-4#1)
systems management under pressure##2##4##(1992-12#2)
systems management##6##2##(1992-12#4)(1993-1#2)
systems managers##2##2##(1993-2#1)(1994-3#1)
systems may also##2##3##(1990-4#1)(1991-5#1)
systems may be##9##3##(1992-1#1)(1993-1#1)(1995-11#1)(1995-8#1)(1996-7#1)(2006-9#1)(2007-11#1)(2008-11#1)(2008-6#1)
systems may have##3##3##(1994-6#1)(2008-11#1)(2008-3#1)
systems may##29##2##(1990-4#1)(1991-5#1)(1992-1#1)(1992-4#1)(1993-1#1)(1993-12#1)(1994-2#2)(1994-6#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-7#1)(2006-2#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-3#1)(2011-12#1)
systems mediate##2##2##(1990-8#1)(2009-7#1)
systems medicine##3##2##(2013-8#3)
systems might##2##2##(1990-3#1)(2007-12#1)
systems more##4##2##(1991-1#1)(1993-2#1)(2008-11#1)(2008-3#1)
systems must be##4##3##(1994-3#1)(1997-3#1)(2006-3#1)(2007-11#1)
systems must##7##2##(1994-3#1)(1996-3#1)(1996-8#1)(1997-3#1)(2006-12#1)(2006-3#1)(2007-11#1)
systems need to be##2##4##(1996-3#1)(2010-11#1)
systems need to##4##3##(1996-3#1)(1997-1#1)(1997-3#1)(2010-11#1)
systems need##5##2##(1996-3#1)(1997-1#1)(1997-3#1)(2007-4#1)(2010-11#1)
systems needed##2##2##(1997-1#1)(2005-7#1)
systems neuroscience##2##2##(2008-6#1)(2012-2#1)
systems nonlinear##2##2##(2007-12#1)(2012-1#1)
systems not only##3##3##(2008-3#1)(2011-12#1)(2012-1#1)
systems not##4##2##(2008-3#1)(2008-5#1)(2011-12#1)(2012-1#1)
systems of a##5##3##(1990-11#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-9#1)
systems of care##11##3##(1992-4#2)(1994-2#1)(1996-1#1)(1997-2#1)(1997-3#1)(2006-10#1)(2010-12#3)(2012-11#1)
systems of four##2##3##(2007-12#1)(2008-3#1)
systems of healthcare##2##3##(2008-10#1)(2009-4#1)
systems of interest##3##3##(2008-10#1)(2009-12#1)(2011-1#1)
systems of many##2##3##(2007-12#1)(2011-2#1)
systems of most##2##3##(2004-4#1)(2008-10#1)
systems of public health##2##4##(1996-1#1)(1997-3#1)
systems of social##2##3##(1996-1#1)(2008-11#1)
systems of southern Baffin Island##2##5##(2010-8#2)
systems of the 1980s##2##4##(1993-3#1)(1997-3#1)
systems of the two##2##4##(1996-4#1)(2008-5#1)
systems of the##26##3##(1992-10#1)(1992-9#1)(1993-2#1)(1993-3#1)(1995-3#1)(1995-5#1)(1996-4#1)(1996-6#1)(1997-3#1)(1997-4#1)(2006-11#1)(2007-11#1)(2007-5#1)(2007-8#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-9#1)(2012-1#1)(2012-3#2)
systems of this##2##3##(1996-12#1)(2008-2#1)
systems of three##2##3##(2008-10#1)(2008-3#1)
systems of tumor-immune##2##3##(2013-8#2)
systems of two##2##3##(1997-6#1)(2008-9#1)
systems of##143##2##(1990-11#1)(1990-4#1)(1990-5#1)(1991-9#1)(1992-10#1)(1992-4#2)(1992-9#1)(1993-2#1)(1993-3#1)(1994-2#2)(1995-1#2)(1995-12#1)(1995-3#1)(1995-5#2)(1996-1#5)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#2)(2004-12#1)(2004-4#1)(2005-11#1)(2006-10#3)(2006-11#1)(2007-11#4)(2007-12#5)(2007-2#1)(2007-5#3)(2007-8#3)(2008-1#2)(2008-10#16)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#3)(2009-12#1)(2009-4#1)(2010-12#4)(2010-5#1)(2010-8#3)(2010-9#2)(2011-1#3)(2011-2#2)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#6)(2013-8#4)
systems offer##4##2##(1996-3#1)(2008-1#1)(2008-11#1)(2009-12#1)
systems often##4##2##(2007-12#1)(2009-9#1)(2012-2#1)(2013-8#1)
systems on the##6##3##(2006-10#1)(2008-10#2)(2011-1#1)(2012-1#1)(2012-3#1)
systems on##25##2##(1990-12#1)(1993-12#1)(1993-2#1)(1994-2#1)(1996-1#1)(2004-12#1)(2006-10#1)(2006-4#1)(2007-12#1)(2008-10#3)(2008-2#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-12#2)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#3)
systems operating##2##2##(2007-12#1)(2010-8#1)
systems or##14##2##(1990-2#1)(1991-12#1)(1992-3#1)(1993-7#1)(2005-5#1)(2006-12#1)(2006-6#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-2#1)(2010-4#1)
systems other than##2##3##(1993-2#1)(2007-12#1)
systems over a wide##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
systems over the##2##3##(1994-6#1)(2011-2#1)
systems over##9##2##(1994-6#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#1)(2012-1#1)
systems perform##2##2##(2008-3#1)(2008-7#1)
systems permit##2##2##(2008-3#1)(2008-7#1)
systems permitting##2##2##(2008-10#1)(2008-2#1)
systems perspective##14##2##(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#10)
systems physiology##2##2##(2010-9#2)
systems play an important role in##3##6##(1992-8#1)(1996-1#1)(2007-11#1)
systems play an important##4##4##(1992-8#1)(1993-12#1)(1996-1#1)(2007-11#1)
systems play##6##2##(1992-8#1)(1993-12#1)(1994-12#1)(1996-1#1)(1997-7#1)(2007-11#1)
systems presented##2##2##(2005-7#1)(2012-1#1)
systems produce##2##2##(2008-2#1)(2008-5#1)
systems profilometry##2##2##(2008-3#2)
systems promise to##2##3##(1997-1#1)(2007-8#1)
systems proposed by##2##3##(2008-2#1)(2009-7#1)
systems provide a##2##3##(2008-2#1)(2008-5#1)
systems provide the##3##3##(1993-6#1)(2006-10#1)(2006-6#1)
systems provide##11##2##(1993-12#1)(1993-6#1)(1997-1#1)(1997-7#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-8#1)
systems providing##2##2##(1995-1#1)(2008-8#1)
systems pumped by##2##3##(2007-12#1)(2008-2#1)
systems pumped##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
systems rather than##3##3##(2007-4#1)(2008-10#1)(2009-12#1)
systems reconstituted##2##2##(1990-12#1)(1990-3#1)
systems reduce##2##2##(2006-10#1)(2006-11#1)
systems reform##2##2##(2012-12#2)
systems regulating##2##2##(1993-9#1)(2008-10#1)
systems related to##2##3##(2006-12#1)(2012-11#1)
systems rely on the##2##4##(2008-10#1)(2013-8#1)
systems rely on##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
systems rely##4##2##(1997-2#1)(2008-10#1)(2011-2#1)(2013-8#1)
systems remains##2##2##(2008-8#1)(2012-2#1)
systems reported##3##2##(2008-10#1)(2008-2#1)(2010-8#1)
systems represent##2##2##(1994-12#1)(1997-3#1)
systems require##4##2##(2008-3#1)(2008-9#1)(2009-11#1)(2012-12#1)
systems requires##4##2##(2007-11#1)(2007-12#1)(2008-7#1)(2009-8#1)
systems resulted in a##2##4##(2008-10#1)(2008-12#1)
systems resulted in##4##3##(1996-1#1)(2008-10#1)(2008-12#1)(2013-1#1)
systems science methods##2##3##(2012-1#2)
systems science##4##2##(2012-1#4)
systems separately##2##2##(2008-10#2)
systems should be##7##3##(1991-9#1)(1996-1#1)(1997-1#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-7#1)
systems should##15##2##(1991-9#1)(1993-3#1)(1996-1#1)(1997-1#1)(1997-3#2)(1997-6#1)(2006-10#1)(2006-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2012-12#1)(2012-2#1)(2013-8#1)
systems show##2##2##(1996-12#1)(2008-2#1)
systems showed##3##2##(2005-11#1)(2010-8#1)(2010-9#1)
systems shows that##2##3##(1997-8#1)(2008-7#1)
systems since##3##2##(2005-11#1)(2008-1#1)(2008-10#1)
systems studied were##2##3##(1990-2#1)(1991-4#1)
systems studied##8##2##(1990-2#1)(1991-4#1)(2005-11#2)(2007-10#1)(2007-8#1)(2008-10#1)(2008-4#1)
systems such as the##6##4##(2007-12#1)(2008-10#2)(2008-3#1)(2010-11#1)(2010-8#1)
systems such as##22##3##(1992-9#1)(1993-11#1)(1994-2#1)(1994-3#1)(1995-8#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-12#1)(2010-11#1)(2010-2#1)(2010-8#1)
systems such##24##2##(1992-9#1)(1993-11#1)(1994-2#1)(1994-3#1)(1995-8#1)(2006-6#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-12#1)(2010-11#1)(2010-2#1)(2010-8#1)
systems suffer##2##2##(2008-6#1)(2011-1#1)
systems suitable for##2##3##(2005-8#1)(2008-2#1)
systems suitable##3##2##(2005-8#1)(2008-2#2)
systems supporting##3##2##(1995-1#1)(2008-11#1)(2012-11#1)
systems tested##4##2##(1993-11#1)(2008-11#1)(2008-2#1)(2013-8#1)
systems than in the##2##4##(2008-10#1)(2008-6#1)
systems than in##3##3##(2008-10#2)(2008-6#1)
systems that allow##2##3##(2008-11#1)(2010-4#1)
systems that are##19##3##(1992-3#1)(1994-2#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-5#2)(2012-2#1)(2013-8#2)
systems that can be##2##4##(1993-2#1)(2008-11#1)
systems that can##4##3##(1993-2#1)(2007-8#1)(2008-11#1)(2008-9#1)
systems that combine##2##3##(2007-4#1)(2011-1#1)
systems that consist of##2##4##(2008-2#1)(2008-3#1)
systems that do not##2##4##(2008-2#1)(2010-7#1)
systems that employ##3##3##(2007-8#1)(2008-11#1)(2008-2#1)
systems that have been implemented##2##5##(1997-1#1)(2007-12#1)
systems that have been##6##4##(1991-9#1)(1992-12#1)(1997-1#1)(2007-12#1)(2008-11#1)(2013-8#1)
systems that have##8##3##(1991-9#1)(1992-12#1)(1992-9#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-11#1)(2013-8#1)
systems that include##2##3##(2008-3#1)(2011-2#1)
systems that incorporate##3##3##(2008-2#2)(2010-7#1)
systems that is##2##3##(2007-12#1)(2007-2#1)
systems that may##2##3##(2008-7#1)(2008-9#1)
systems that meet##2##3##(1993-12#1)(1996-3#1)
systems that provide##2##3##(2008-2#1)(2012-1#1)
systems that regulate##2##3##(1996-12#1)(1996-6#1)
systems that rely on##2##4##(1995-12#1)(2008-10#1)
systems that support##2##3##(1996-3#1)(2012-12#1)
systems that use chirped##2##4##(2007-11#1)(2007-12#1)
systems that use##10##3##(2007-11#1)(2007-12#3)(2008-2#5)(2008-3#1)
systems that will##4##3##(2006-2#1)(2008-1#1)(2008-10#1)(2008-2#1)
systems that##135##2##(1990-9#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-2#4)(1993-3#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#4)(1995-3#1)(1995-5#1)(1996-12#2)(1996-3#3)(1996-6#1)(1997-1#1)(1997-3#1)(1997-8#2)(2005-8#2)(2005-9#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#1)(2007-11#3)(2007-12#6)(2007-2#2)(2007-4#1)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#5)(2008-11#6)(2008-12#2)(2008-2#18)(2008-3#9)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#3)
systems the##13##2##(1990-4#1)(2006-12#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#5)(2009-9#1)(2010-10#1)
systems theory##12##2##(1990-12#1)(1993-12#2)(1993-9#1)(1996-2#1)(2006-10#1)(2009-12#1)(2009-8#1)(2011-1#2)(2012-12#2)
systems they##2##2##(1994-1#1)(2008-8#1)
systems thinking##2##2##(1994-2#1)(1997-3#1)
systems this##2##2##(1990-12#1)(2008-3#1)
systems through a##2##3##(2010-12#1)(2011-1#1)
systems through##9##2##(1995-12#1)(1996-1#1)(1996-5#1)(2008-10#2)(2009-2#1)(2009-5#1)(2010-12#1)(2011-1#1)
systems throughout the world##2##4##(2005-6#1)(2007-10#1)
systems throughout the##3##3##(2005-6#1)(2007-10#1)(2008-5#1)
systems to achieve##2##3##(2004-4#1)(2006-6#1)
systems to address##3##3##(2008-8#1)(2009-12#1)(2013-8#1)
systems to assess##3##3##(2008-9#1)(2009-11#1)(2011-1#1)
systems to be##5##3##(1997-2#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-3#1)
systems to detect##2##3##(2008-10#1)(2008-3#1)
systems to enhance##4##3##(1994-3#1)(1997-3#1)(2010-11#2)
systems to evaluate the##2##4##(2008-10#1)(2008-6#1)
systems to evaluate##4##3##(2008-10#1)(2008-6#1)(2013-1#2)
systems to manage##2##3##(1997-1#1)(2008-1#1)
systems to monitor##3##3##(1997-2#1)(2008-2#1)(2008-9#1)
systems to predict##2##3##(1992-11#1)(2008-10#1)
systems to provide a##2##4##(1993-12#1)(2008-10#1)
systems to provide##4##3##(1992-12#1)(1993-12#1)(2008-10#2)
systems to reduce##2##3##(1990-4#1)(2008-11#1)
systems to study the##2##4##(2008-10#1)(2008-4#1)
systems to study##3##3##(2008-10#2)(2008-4#1)
systems to support a##3##4##(1994-1#2)(2010-8#1)
systems to support##9##3##(1993-3#1)(1994-1#2)(1994-12#1)(1996-12#1)(2010-11#1)(2010-8#1)(2013-1#2)
systems to the##2##3##(1992-3#1)(1996-2#1)
systems to##110##2##(1990-4#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-1#2)(1994-12#2)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-4#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#2)(2004-4#1)(2005-10#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-12#4)(2007-2#2)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#2)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-11#1)(2009-12#1)(2009-8#1)(2010-11#3)(2010-4#2)(2010-5#1)(2010-8#2)(2011-1#1)(2011-9#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#1)
systems under investigation##2##3##(1997-6#1)(2006-6#1)
systems under##10##2##(1991-1#1)(1992-12#1)(1992-3#1)(1996-12#1)(1997-6#1)(2006-6#1)(2007-8#1)(2008-10#2)(2008-11#1)
systems upside down##2##3##(1994-12#2)
systems use##2##2##(2008-11#1)(2008-2#1)
systems used for##2##3##(1994-7#1)(2007-8#1)
systems used in the##2##4##(2007-8#1)(2008-10#1)
systems used in##5##3##(2005-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2010-8#1)
systems used##10##2##(1994-7#1)(1996-2#1)(2005-10#1)(2006-6#1)(2007-7#1)(2007-8#2)(2008-10#1)(2010-8#1)(2011-1#1)
systems using a##3##3##(2008-11#1)(2008-3#1)(2012-1#1)
systems using the##5##3##(1996-2#1)(2008-10#1)(2008-2#2)(2010-12#1)
systems using##23##2##(1992-11#1)(1993-9#1)(1996-2#1)(1997-6#1)(2006-12#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#2)(2012-1#1)(2012-2#1)(2013-7#1)
systems usually##3##2##(2008-10#1)(2008-2#1)(2013-1#1)
systems was evaluated##2##3##(1992-12#1)(1997-8#1)
systems was investigated by##2##4##(1990-3#1)(2008-10#1)
systems was investigated##5##3##(1990-10#1)(1990-3#1)(2008-10#1)(2008-11#1)(2008-2#1)
systems was##29##2##(1990-10#1)(1990-3#1)(1992-12#2)(1992-2#1)(1992-8#1)(1995-7#1)(1997-6#1)(1997-8#1)(2005-11#2)(2007-11#1)(2008-10#7)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2012-1#1)(2013-1#1)
systems were also##2##3##(2008-10#1)(2010-5#1)
systems were assessed##2##3##(2008-5#1)(2008-8#1)
systems were calculated##2##3##(1996-7#1)(2008-10#1)
systems were compared##2##3##(2007-1#1)(2013-1#1)
systems were created##2##3##(1997-3#1)(2008-11#1)
systems were designed##2##3##(2008-10#2)
systems were developed to##2##4##(1992-5#1)(2008-5#1)
systems were developed##4##3##(1992-5#1)(1993-11#1)(1996-3#1)(2008-5#1)
systems were established##2##3##(1994-9#1)(2008-8#1)
systems were evaluated##2##3##(2008-10#1)(2011-2#1)
systems were identified##4##3##(2007-8#1)(2013-8#3)
systems were investigated##3##3##(2008-10#1)(2008-7#1)(2011-1#1)
systems were not##4##3##(1996-1#1)(2008-10#1)(2011-2#2)
systems were studied##4##3##(1991-9#1)(2008-10#3)
systems were tested##4##3##(1993-11#1)(2008-10#2)(2008-9#1)
systems were the##2##3##(1992-8#1)(2007-3#1)
systems were used##4##3##(2006-8#1)(2007-7#2)(2008-10#1)
systems were useful##2##3##(2011-2#2)
systems were##89##2##(1990-11#1)(1990-2#1)(1991-9#2)(1992-5#1)(1992-8#2)(1993-11#2)(1994-12#1)(1994-9#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-3#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#22)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
systems where high##2##3##(2007-5#1)(2013-1#1)
systems where the##2##3##(2006-4#1)(2008-9#1)
systems where##13##2##(1990-11#1)(2005-11#2)(2006-10#1)(2006-4#1)(2007-5#1)(2008-2#1)(2008-3#1)(2008-9#2)(2011-1#1)(2013-1#1)(2013-8#1)
systems which##9##2##(1990-11#1)(1993-12#1)(1995-6#1)(1997-2#1)(2005-8#1)(2007-11#1)(2007-9#1)(2008-3#1)(2012-11#1)
systems while##3##2##(1994-8#1)(1996-2#1)(2013-1#1)
systems will be##5##3##(1993-12#1)(1994-2#1)(1995-12#1)(2006-6#1)(2011-2#1)
systems will have to##2##4##(1994-12#1)(2008-6#1)
systems will have##3##3##(1994-12#1)(1995-9#1)(2008-6#1)
systems will##23##2##(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-9#1)(1996-3#1)(1997-3#4)(2006-11#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-10#1)(2010-3#1)(2011-2#1)
systems with a mean##2##4##(2008-10#1)(2008-8#1)
systems with a##14##3##(1990-3#1)(1997-2#2)(2005-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-8#1)(2010-4#1)
systems with an##2##3##(1995-5#1)(2008-3#1)
systems with complete##2##3##(1997-2#1)(2009-12#1)
systems with different##5##3##(1996-3#1)(2008-10#1)(2008-9#1)(2012-11#2)
systems with either##2##3##(2007-11#1)(2008-3#1)
systems with free##2##3##(2008-8#1)(2011-1#1)
systems with higher##2##3##(2008-10#1)(2008-2#1)
systems with large##3##3##(2007-12#1)(2008-3#1)(2011-1#1)
systems with optical amplifiers##2##4##(2008-2#1)(2008-3#1)
systems with strong dispersion management##4##5##(2007-12#2)(2008-1#2)
systems with strong##5##3##(2007-12#3)(2008-1#2)
systems with the##5##3##(2005-11#1)(2007-5#1)(2008-3#2)(2008-6#1)
systems with##117##2##(1990-12#1)(1990-3#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-7#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-3#1)(1996-5#1)(1997-2#3)(1997-6#1)(2005-11#5)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#18)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#12)(2008-11#1)(2008-2#10)(2008-3#15)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#3)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-4#4)(2011-1#3)(2012-11#3)(2012-2#1)
systems within the##3##3##(1992-7#1)(1994-2#1)(2010-8#1)
systems within##7##2##(1990-8#1)(1992-7#1)(1994-2#1)(2010-8#1)(2011-2#1)(2013-1#2)
systems without##6##2##(1990-8#1)(1992-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)
systems would be##2##3##(2008-10#1)(2009-6#1)
systems would##4##2##(2007-1#1)(2008-10#1)(2008-11#1)(2009-6#1)
systems##5184##1##(1990-10#8)(1990-11#18)(1990-12#32)(1990-2#13)(1990-3#15)(1990-4#8)(1990-5#17)(1990-6#1)(1990-7#7)(1990-8#19)(1990-9#3)(1991-1#10)(1991-10#2)(1991-11#7)(1991-12#7)(1991-2#16)(1991-3#13)(1991-4#3)(1991-5#13)(1991-6#8)(1991-7#4)(1991-8#7)(1991-9#14)(1992-1#12)(1992-10#5)(1992-11#9)(1992-12#33)(1992-2#8)(1992-3#36)(1992-4#6)(1992-5#8)(1992-6#8)(1992-7#6)(1992-8#14)(1992-9#12)(1993-1#7)(1993-10#1)(1993-11#9)(1993-12#35)(1993-2#27)(1993-3#26)(1993-4#3)(1993-5#5)(1993-6#11)(1993-7#9)(1993-8#8)(1993-9#6)(1994-1#11)(1994-10#7)(1994-11#6)(1994-12#26)(1994-2#37)(1994-3#36)(1994-4#1)(1994-5#13)(1994-6#13)(1994-7#2)(1994-8#10)(1994-9#9)(1995-1#27)(1995-10#6)(1995-11#8)(1995-12#37)(1995-2#19)(1995-3#12)(1995-4#3)(1995-5#17)(1995-6#5)(1995-7#6)(1995-8#8)(1995-9#4)(1996-1#36)(1996-10#8)(1996-11#5)(1996-12#41)(1996-2#33)(1996-3#30)(1996-4#9)(1996-5#15)(1996-6#5)(1996-7#6)(1996-8#9)(1996-9#2)(1997-1#44)(1997-2#37)(1997-3#56)(1997-4#14)(1997-5#3)(1997-6#20)(1997-7#10)(1997-8#20)(2003-11#1)(2004-11#2)(2004-12#5)(2004-4#5)(2004-7#1)(2004-9#11)(2005-10#9)(2005-11#64)(2005-12#5)(2005-4#2)(2005-5#17)(2005-6#1)(2005-7#9)(2005-8#22)(2005-9#3)(2006-1#2)(2006-10#129)(2006-11#18)(2006-12#36)(2006-2#8)(2006-3#5)(2006-4#11)(2006-5#14)(2006-6#52)(2006-7#5)(2006-8#19)(2006-9#8)(2007-1#16)(2007-10#16)(2007-11#102)(2007-12#186)(2007-2#10)(2007-3#11)(2007-4#13)(2007-5#26)(2007-6#4)(2007-7#15)(2007-8#54)(2007-9#19)(2008-1#79)(2008-10#459)(2008-11#140)(2008-12#31)(2008-2#302)(2008-3#266)(2008-4#81)(2008-5#93)(2008-6#28)(2008-7#141)(2008-8#84)(2008-9#80)(2009-10#23)(2009-11#17)(2009-12#24)(2009-2#6)(2009-3#23)(2009-4#8)(2009-5#19)(2009-6#10)(2009-7#10)(2009-8#31)(2009-9#13)(2010-1#5)(2010-10#20)(2010-11#25)(2010-12#30)(2010-2#23)(2010-3#9)(2010-4#62)(2010-5#31)(2010-6#4)(2010-7#21)(2010-8#52)(2010-9#30)(2011-1#54)(2011-12#12)(2011-2#79)(2011-3#1)(2011-7#3)(2011-9#2)(2012-1#46)(2012-11#29)(2012-12#79)(2012-2#96)(2012-3#35)(2012-5#1)(2013-1#164)(2013-7#15)(2013-8#77)
systems&quot##2##1##(1994-1#1)(2013-8#1)
systems'##7##1##(1992-9#1)(1997-1#2)(2007-8#1)(2008-10#1)(2008-11#2)
systems) and##2##2##(1996-5#1)(2008-10#1)
systems) were##2##2##(2006-5#1)(2008-10#1)
systems)##18##1##(1991-4#1)(1992-12#1)(1992-2#1)(1994-12#1)(1996-12#1)(1996-5#2)(1997-7#1)(2006-5#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2012-12#2)
systems-based##2##1##(2009-11#1)(2012-1#1)
systems-level##8##1##(1993-2#1)(1995-11#1)(2009-12#1)(2010-2#1)(2010-9#1)(2012-1#2)(2012-2#1)
systems?##5##1##(1992-12#1)(1996-1#2)(2008-7#1)(2012-1#1)
systems]##7##1##(1990-8#1)(1994-2#1)(2005-4#1)(2006-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
systemwide##5##1##(1993-3#1)(1995-3#1)(1996-1#1)(1997-2#1)(2008-3#1)
systole and##3##2##(1992-9#1)(2007-8#2)
systole##6##1##(1992-9#2)(2005-1#1)(2005-9#1)(2007-8#2)
systolic BP was##2##3##(2008-5#1)(2010-12#1)
systolic BP##14##2##(1991-3#1)(1992-6#1)(2007-10#2)(2007-8#5)(2008-10#1)(2008-5#1)(2010-12#1)(2011-1#1)(2012-2#1)
systolic HF##5##2##(2010-12#5)
systolic and diastolic BP##3##4##(1991-3#1)(2010-7#2)
systolic and diastolic blood pressure and##2##6##(1997-8#1)(2013-1#1)
systolic and diastolic blood pressure in##2##6##(1992-8#2)
systolic and diastolic blood pressure to##2##6##(2007-9#1)(2008-1#1)
systolic and diastolic blood pressure were##2##6##(1992-8#1)(2013-1#1)
systolic and diastolic blood pressure##24##5##(1990-12#1)(1992-8#4)(1996-9#1)(1997-8#1)(2005-11#2)(2006-4#1)(2006-6#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#2)
systolic and diastolic blood pressures were##3##6##(2006-8#1)(2008-10#1)(2008-3#1)
systolic and diastolic blood pressures##6##5##(2005-8#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-4#2)
systolic and diastolic blood##32##4##(1990-12#1)(1992-8#4)(1996-9#1)(1997-8#1)(2005-11#2)(2005-8#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#5)(2008-4#2)(2008-7#1)(2010-7#2)(2011-1#1)(2012-3#1)(2013-1#2)
systolic and diastolic function in##2##5##(2006-10#1)(2012-2#1)
systolic and diastolic function##3##4##(1991-2#1)(2006-10#1)(2012-2#1)
systolic and diastolic hypertension##2##4##(1995-10#1)(2012-12#1)
systolic and diastolic left##2##4##(2005-1#1)(2010-12#1)
systolic and diastolic pressures##3##4##(1990-8#1)(1991-8#1)(2010-4#1)
systolic and diastolic##59##3##(1990-12#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-8#2)(1992-8#4)(1994-11#1)(1995-10#1)(1996-1#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-8#1)(2005-1#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-4#1)(2006-6#2)(2006-8#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#5)(2008-4#2)(2008-7#1)(2009-10#1)(2010-12#1)(2010-4#1)(2010-5#3)(2010-7#4)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
systolic and##71##2##(1990-12#1)(1990-8#2)(1991-2#1)(1991-3#1)(1991-8#2)(1992-8#4)(1994-11#1)(1994-6#1)(1995-10#1)(1996-1#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-8#1)(2005-1#2)(2005-11#2)(2005-8#1)(2006-10#1)(2006-4#2)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#5)(2008-4#2)(2008-7#2)(2008-8#1)(2009-10#1)(2010-12#1)(2010-4#1)(2010-5#3)(2010-7#4)(2011-1#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
systolic anterior motion##4##3##(2007-8#4)
systolic arterial blood pressure (SABP)##2##5##(1997-6#1)(2007-8#1)
systolic arterial blood pressure##3##4##(1997-6#1)(2007-8#1)(2008-5#1)
systolic arterial##4##2##(1997-6#1)(2007-8#1)(2008-3#1)(2008-5#1)
systolic blood pressure (SBP) and##2##5##(1991-10#1)(2012-12#1)
systolic blood pressure (SBP)##9##4##(1990-7#1)(1991-10#1)(1992-12#1)(2007-8#1)(2008-4#1)(2009-9#1)(2010-4#1)(2012-12#1)(2013-8#1)
systolic blood pressure (r##2##4##(2006-6#1)(2008-3#1)
systolic blood pressure and heart rate##2##6##(1996-2#1)(2012-12#1)
systolic blood pressure and##6##4##(1995-8#1)(1995-9#1)(1996-2#1)(2006-4#1)(2011-1#1)(2012-12#1)
systolic blood pressure decreased##2##4##(1990-11#1)(1992-8#1)
systolic blood pressure in men##3##5##(1991-6#1)(1997-8#2)
systolic blood pressure should##2##4##(1992-6#1)(2013-1#1)
systolic blood pressure was##3##4##(1990-5#1)(1993-10#1)(2007-10#1)
systolic blood pressure were##4##4##(1990-4#1)(2008-5#1)(2010-7#1)(2012-3#1)
systolic blood pressure##74##3##(1990-11#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-6#2)(1992-12#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-12#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-8#3)(2005-10#1)(2006-4#1)(2006-6#3)(2007-1#2)(2007-10#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#4)(2009-1#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#3)(2010-7#2)(2011-1#3)(2011-2#1)(2012-1#2)(2012-12#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
systolic blood pressures##3##3##(2008-4#2)(2012-3#1)
systolic blood##80##2##(1990-11#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-6#2)(1992-12#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-12#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-8#3)(2005-10#1)(2006-4#1)(2006-6#3)(2007-1#2)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#1)(2008-3#3)(2008-4#4)(2008-5#2)(2008-7#4)(2009-1#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-4#3)(2010-7#2)(2011-1#3)(2011-2#1)(2012-1#2)(2012-12#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
systolic dysfunction and##2##3##(2010-12#1)(2013-7#1)
systolic dysfunction##16##2##(1997-3#1)(2005-12#3)(2006-2#1)(2007-10#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-7#1)(2013-1#3)(2013-7#1)
systolic flow may##2##3##(2006-5#2)
systolic flow##4##2##(1994-4#1)(2006-5#3)
systolic function and lowering of##2##5##(2006-6#1)(2007-11#1)
systolic function and##4##3##(2006-6#1)(2007-11#1)(2009-9#1)(2012-1#1)
systolic function following##3##3##(2008-11#1)(2010-6#2)
systolic function in##2##3##(2008-12#1)(2009-4#1)
systolic function##29##2##(1997-1#1)(1997-8#2)(2006-10#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#2)(2009-4#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-6#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
systolic gradient##3##2##(1990-8#2)(2007-8#1)
systolic heart failure##6##3##(1990-9#1)(2008-3#2)(2008-8#1)(2010-10#1)(2011-2#1)
systolic hypertension by##2##3##(1995-10#1)(2011-1#1)
systolic hypertension##19##2##(1991-12#1)(1992-6#1)(1993-1#1)(1993-12#1)(1995-10#2)(1996-1#1)(2007-3#2)(2008-1#1)(2008-4#2)(2010-12#1)(2011-1#5)(2012-12#1)
systolic hypertension]##2##2##(1992-2#1)(2011-1#1)
systolic left ventricular function##2##4##(2006-6#1)(2010-4#1)
systolic mitral##2##2##(1995-6#1)(2013-7#1)
systolic murmur##2##2##(2008-10#1)(2011-1#1)
systolic peak##2##2##(1991-12#1)(2008-1#1)
systolic pressure and##3##3##(1993-4#1)(1997-8#1)(2006-4#1)
systolic pressure by##2##3##(1993-12#1)(2011-11#1)
systolic pressure in##2##3##(2009-12#1)(2009-4#1)
systolic pressure is##2##3##(1995-10#1)(2013-7#1)
systolic pressure##16##2##(1993-12#2)(1993-4#1)(1995-10#1)(1997-8#2)(2006-4#2)(2007-8#1)(2008-1#2)(2009-12#1)(2009-4#1)(2011-11#1)(2012-2#1)(2013-7#1)
systolic tension##2##2##(2011-1#2)
systolic velocity##7##2##(2007-10#3)(2008-1#1)(2008-7#1)(2011-2#1)(2013-8#1)
systolic##322##1##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#5)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-6#2)(1991-8#3)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#3)(1992-8#5)(1993-1#1)(1993-10#1)(1993-12#4)(1993-4#3)(1994-11#1)(1994-4#1)(1994-6#1)(1995-10#4)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#2)(1996-2#1)(1996-3#2)(1996-6#2)(1996-9#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#8)(2005-1#2)(2005-10#3)(2005-11#2)(2005-12#3)(2005-8#1)(2006-10#2)(2006-2#1)(2006-4#6)(2006-5#4)(2006-6#7)(2006-8#1)(2006-9#1)(2007-1#5)(2007-10#8)(2007-11#2)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#21)(2007-9#4)(2008-1#6)(2008-10#6)(2008-11#2)(2008-12#4)(2008-3#11)(2008-4#11)(2008-5#5)(2008-7#10)(2008-8#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#4)(2010-11#3)(2010-12#9)(2010-2#1)(2010-4#5)(2010-5#6)(2010-6#3)(2010-7#7)(2010-8#1)(2011-1#16)(2011-11#1)(2011-2#8)(2012-1#4)(2012-12#7)(2012-2#6)(2012-3#3)(2013-1#10)(2013-7#4)(2013-8#5)
systolic/diastolic blood pressure##2##3##(1997-3#1)(2011-2#1)
systolic/diastolic ratios##4##2##(1992-2#4)
systolic/diastolic##10##1##(1992-2#7)(1997-3#1)(2008-7#1)(2011-2#1)
système de##2##2##(2012-2#2)
système##3##1##(2012-2#3)
systématiquement##2##1##(2011-2#1)(2012-2#1)
sévère et##2##2##(2013-1#2)
sévère##4##1##(2012-2#1)(2013-1#3)
t (max)##2##2##(2011-2#2)
t -test##3##2##(2008-11#2)(2011-2#1)
t 1/2##2##2##(2004-12#1)(2013-7#1)
t =##7##2##(1994-3#3)(1996-12#1)(2008-10#2)(2012-1#1)
t and Wilcoxon##2##3##(1992-2#2)
t and##7##2##(1992-2#4)(1996-7#2)(2012-2#1)
t dry##2##2##(2007-5#1)(2008-2#1)
t gypsum ha(-1)##3##3##(2008-12#3)
t ha(-1)##2##2##(2008-12#2)
t ha(-1))##3##2##(2008-12#3)
t he##2##2##(1995-1#1)(2008-11#1)
t km-2##3##2##(2013-8#3)
t protein was##2##3##(1992-5#2)
t protein##5##2##(1992-5#5)
t test and##3##3##(2010-1#1)(2013-1#1)(2013-8#1)
t test for##2##3##(2005-10#1)(2008-10#1)
t test was used to##2##5##(2008-8#1)(2011-2#1)
t test##25##2##(1990-12#1)(1995-1#1)(1996-12#1)(2005-10#1)(2006-10#1)(2007-8#2)(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#2)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
t test)##5##2##(1990-4#1)(1993-2#1)(1996-9#1)(2005-10#1)(2008-7#1)
t tests were used##2##4##(2006-10#1)(2012-12#1)
t tests##8##2##(1992-3#1)(1995-1#1)(2006-10#2)(2008-7#1)(2009-5#1)(2012-12#1)(2012-2#1)
t##166##1##(1990-12#2)(1990-2#3)(1990-4#1)(1990-5#1)(1991-2#2)(1991-3#1)(1991-9#2)(1992-2#4)(1992-3#4)(1992-5#5)(1992-8#2)(1992-9#2)(1993-1#1)(1993-2#1)(1994-3#4)(1995-1#3)(1995-12#1)(1995-7#1)(1996-1#2)(1996-10#2)(1996-11#2)(1996-12#3)(1996-7#8)(1996-8#3)(1996-9#1)(1997-2#5)(1997-4#1)(1997-8#4)(2004-12#3)(2005-10#2)(2006-10#3)(2006-6#1)(2006-8#1)(2007-12#3)(2007-4#1)(2007-5#2)(2007-8#2)(2008-10#10)(2008-11#5)(2008-12#8)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#8)(2012-1#3)(2012-12#3)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#4)
t((1/2)) and Vd##2##3##(2009-4#2)
t((1/2))##4##1##(2009-4#4)
t(0)##3##1##(2008-10#3)
t(1)##5##1##(2008-10#4)(2012-2#1)
t(1/2) of##2##2##(2008-10#1)(2010-12#1)
t(1/2) values##4##2##(2008-10#4)
t(1/2)##12##1##(2005-11#1)(2008-10#7)(2010-12#1)(2012-2#3)
t(10##2##1##(2011-3#1)(2012-12#1)
t(11##10##1##(2005-11#1)(2007-12#4)(2008-6#1)(2009-8#1)(2010-11#1)(2011-3#1)(2012-12#1)
t(14##8##1##(1994-10#1)(1996-10#1)(2009-8#5)(2010-11#1)
t(15##9##1##(1990-9#1)(1991-11#2)(1991-9#2)(1994-8#1)(2007-4#1)(2012-2#2)
t(2##7##1##(1993-2#2)(2009-2#5)
t(2)##2##1##(2008-10#2)
t(8##3##1##(2007-12#1)(2010-1#2)
t(9##10##1##(2007-11#1)(2007-12#5)(2011-3#1)(2012-12#1)(2013-8#2)
t(a) =##2##2##(2007-12#2)
t(ip) and##2##2##(2008-10#2)
t(ip)##3##1##(2008-10#3)
t(m)##2##1##(2007-11#1)(2008-10#1)
t(max)##3##1##(2008-12#1)(2009-4#1)(2010-8#1)
t(o)##2##1##(1994-12#2)
t)##6##1##(1991-5#1)(1995-2#2)(1996-7#1)(2008-3#1)(2011-2#1)
t- and##2##2##(1990-8#1)(2008-10#1)
t-##6##1##(1990-2#1)(1990-8#2)(1991-4#1)(2008-10#1)(2009-6#1)
t-18##3##1##(2007-8#3)
t-4-dienoyl-CoA isomerase##2##2##(1994-8#2)
t-ACPD##4##1##(1992-12#4)
t-BuOH and##2##2##(2008-11#1)(2008-9#1)
t-BuOH##3##1##(2008-11#1)(2008-9#1)(2012-3#1)
t-BuOOH##9##1##(1990-4#7)(1995-5#2)
t-BuOOH-induced##2##1##(1990-4#2)
t-J##3##1##(1992-3#1)(1995-7#1)(1996-7#1)
t-PA and u-PA##3##3##(1990-11#1)(1991-1#1)(1994-3#1)
t-PA and##9##2##(1990-11#3)(1990-5#1)(1991-1#1)(1994-3#1)(1995-3#2)(1997-2#1)
t-PA antigen is##2##3##(2007-9#2)
t-PA antigen was##4##3##(2007-9#4)
t-PA antigen##12##2##(1994-6#3)(2007-9#9)
t-PA but##2##2##(1990-11#1)(2007-9#1)
t-PA during##2##2##(1990-11#2)
t-PA expression levels##2##3##(2008-7#2)
t-PA for##7##2##(1990-5#2)(1995-3#3)(2007-10#1)(2007-9#1)
t-PA in the##2##3##(2007-9#2)
t-PA in##6##2##(1990-11#1)(2007-9#5)
t-PA increased##2##2##(1990-11#2)
t-PA infusion##2##2##(2010-12#2)
t-PA is##3##2##(1995-3#1)(2007-10#2)
t-PA production##2##2##(2008-11#2)
t-PA treated##2##2##(1990-11#1)(2007-9#1)
t-PA treatment##2##2##(2007-9#2)
t-PA was##6##2##(1990-11#1)(1992-2#1)(2007-9#2)(2008-11#2)
t-PA##112##1##(1990-11#23)(1990-12#6)(1990-5#5)(1991-1#3)(1992-2#4)(1994-3#2)(1994-6#3)(1995-3#10)(1995-8#1)(1997-2#4)(2007-10#9)(2007-9#27)(2008-11#10)(2008-7#2)(2010-12#3)
t-PA-ag##2##1##(1990-11#2)
t-PA-induced fibrinolysis in PAI-1 enriched plasma##2##6##(1992-2#2)
t-PA-induced thrombolysis##2##2##(1990-11#1)(1990-12#1)
t-PA-induced##5##1##(1990-11#1)(1990-12#1)(1990-5#1)(1992-2#2)
t-PA/DR5##2##1##(1995-3#2)
t-PA/PAI-1 complexes are##2##3##(1995-8#2)
t-PA/PAI-1 complexes##5##2##(1995-8#5)
t-PA/PAI-1##6##1##(1995-8#6)
t-RNA##4##1##(2008-11#1)(2008-5#2)(2008-8#1)
t-SNARE##2##1##(1997-6#2)
t-SNAREs##5##1##(1997-3#1)(1997-6#4)
t-butyl ester##2##2##(2008-10#1)(2012-12#1)
t-butyl hydroperoxide##8##2##(1990-6#3)(1992-1#1)(1996-2#1)(1997-8#2)(2004-12#1)
t-butyl##11##1##(1990-6#3)(1992-1#1)(1992-5#1)(1996-2#1)(1997-8#2)(2004-12#1)(2008-10#1)(2012-12#1)
t-statistic##3##1##(1994-8#2)(2009-9#1)
t-test and ANOVA##2##3##(1990-8#1)(1991-2#1)
t-test and##11##2##(1990-12#1)(1990-8#1)(1991-2#1)(2008-10#1)(2008-11#1)(2010-2#2)(2011-2#2)(2012-12#2)
t-test at the 95% confidence level##2##6##(2008-10#2)
t-test at the 95%##3##4##(2008-10#3)
t-test for##3##2##(1994-2#1)(2011-2#1)(2013-8#1)
t-test or##2##2##(2010-2#1)(2011-12#1)
t-test shows##2##2##(2008-10#2)
t-test to##2##2##(2008-10#1)(2011-2#1)
t-test was used to compare##2##5##(2010-9#1)(2011-1#1)
t-test was used to##4##4##(2006-2#1)(2009-6#1)(2010-9#1)(2011-1#1)
t-test was used##6##3##(2006-2#1)(2009-6#1)(2010-9#1)(2011-1#1)(2013-1#2)
t-test##82##1##(1990-12#1)(1990-2#1)(1990-8#1)(1991-2#1)(1994-2#1)(1994-4#1)(1996-12#1)(1997-8#1)(2004-1#1)(2004-11#1)(2005-12#1)(2006-1#1)(2006-2#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#21)(2008-11#1)(2008-12#3)(2008-5#2)(2008-7#3)(2009-6#1)(2009-9#4)(2010-12#1)(2010-2#3)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-12#4)(2012-2#1)(2013-1#4)(2013-8#4)
t-test)##10##1##(1992-7#1)(1993-12#1)(1997-8#1)(2006-10#1)(2007-1#1)(2008-10#3)(2008-3#1)(2008-5#1)
t-tests showed##2##2##(2009-4#1)(2010-6#1)
t-tests##19##1##(1992-2#1)(1996-12#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#2)(2009-12#1)(2009-2#1)(2009-4#1)(2010-6#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
t-tests)##3##1##(1990-9#1)(2006-9#1)(2008-3#1)
t/NH3##2##1##(1995-11#2)
t/ha##3##1##(2008-10#3)
t/km2/year)##3##1##(2008-5#3)
t0=0##2##1##(2010-8#2)
t1/2 of##6##2##(1990-2#1)(1990-3#1)(1990-5#1)(1992-6#1)(1995-10#1)(1995-6#1)
t1/2##16##1##(1990-2#2)(1990-3#1)(1990-5#1)(1992-10#1)(1992-5#2)(1992-6#1)(1995-10#1)(1995-5#3)(1995-6#1)(1995-8#1)(2008-5#2)
t11-18##2##1##(2007-8#2)
t11-CLA##3##1##(2012-2#3)
t=-5##2##1##(2010-6#1)(2013-7#1)
t=1##2##1##(2006-9#1)(2013-7#1)
tADA##3##1##(1995-11#3)
tBRD-1 is##2##2##(2012-12#2)
tBRD-1##6##1##(2012-12#6)
tBuBHQ caused O2- production##2##4##(1996-2#2)
tBuBHQ##6##1##(1996-2#6)
tDCS##11##1##(2009-10#3)(2010-6#2)(2010-7#1)(2012-2#5)
tDCS)##2##1##(2010-6#1)(2010-7#1)
tDNA and##2##2##(1990-4#2)
tDNA##3##1##(1990-4#3)
tHcy and mSGA##2##3##(2010-12#2)
tHcy and##3##2##(2010-12#3)
tHcy##4##1##(2010-12#4)
tMCAO##3##1##(2011-2#3)
tNOX activity##2##2##(2009-9#2)
tNOX expression##2##2##(2009-9#2)
tNOX##11##1##(2008-7#2)(2009-9#9)
tPA activity##4##2##(1990-11#2)(2008-8#2)
tPA antigen##2##2##(1990-11#2)
tPA in the##3##3##(1990-11#1)(2008-8#1)(2010-3#1)
tPA in##5##2##(1990-11#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-3#1)
tPA production##4##2##(1990-11#2)(2008-11#1)(2008-8#1)
tPA##41##1##(1990-11#13)(1990-9#3)(1992-12#3)(2007-7#2)(2008-11#5)(2008-5#5)(2008-8#6)(2008-9#1)(2010-3#2)(2011-2#1)
tPA/PAI-1 complexes##3##2##(1990-11#3)
tPA/PAI-1##4##1##(1990-11#4)
tPMET##2##1##(2009-9#2)
tPSA##2##1##(2006-9#2)
tRAUDPC##2##1##(2008-10#2)
tRNA (1) (Leu)##2##3##(2008-4#2)
tRNA (2) (Leu)##2##3##(2008-4#2)
tRNA and##7##2##(1990-2#1)(1993-3#1)(1996-4#1)(1996-8#2)(2006-12#1)(2012-2#1)
tRNA as a##2##3##(1993-9#1)(1997-1#1)
tRNA by##2##2##(1996-11#1)(2009-3#1)
tRNA found in##2##3##(1992-6#2)
tRNA from##4##2##(1997-5#1)(2008-4#2)(2009-3#1)
tRNA gene of##2##3##(1991-1#2)
tRNA gene##19##2##(1990-10#2)(1990-9#1)(1991-1#2)(1991-4#3)(1995-12#1)(1996-6#1)(1997-4#2)(1997-5#3)(1997-7#3)(2008-9#1)
tRNA genes and one##2##4##(1995-4#1)(2008-9#1)
tRNA genes and##5##3##(1995-4#1)(1995-6#1)(2008-9#3)
tRNA genes have been##2##4##(1996-7#1)(2006-11#1)
tRNA genes is##2##3##(2008-9#2)
tRNA genes were##2##3##(1995-6#1)(1995-8#1)
tRNA genes##23##2##(1995-1#1)(1995-4#1)(1995-6#2)(1995-8#3)(1996-6#1)(1996-7#1)(1997-2#2)(1997-7#2)(2006-11#1)(2008-9#8)(2012-3#1)
tRNA import##2##2##(2006-12#2)
tRNA is##3##2##(1992-11#1)(1992-3#1)(1995-3#1)
tRNA ligase##3##2##(2008-8#3)
tRNA molecules##3##2##(1990-12#1)(1991-11#2)
tRNA nucleotidyltransferase##2##2##(1991-10#2)
tRNA of##3##2##(1992-6#2)(1993-9#1)
tRNA or##2##2##(1997-1#1)(2005-8#1)
tRNA recognition##3##2##(1992-2#1)(1997-5#2)
tRNA sequence##2##2##(1992-2#2)
tRNA sequences##2##2##(1997-5#1)(1997-6#1)
tRNA species##7##2##(1992-6#5)(1995-6#1)(1995-8#1)
tRNA synthetase##6##2##(1994-11#1)(1997-3#1)(1997-5#2)(1997-6#1)(2006-10#1)
tRNA synthetases##5##2##(1994-11#1)(1995-3#1)(1997-2#1)(1997-5#1)(2005-10#1)
tRNA was##3##2##(1994-12#2)(2008-8#1)
tRNA##193##1##(1990-10#2)(1990-12#2)(1990-2#1)(1990-4#4)(1990-5#2)(1990-9#1)(1991-1#3)(1991-10#4)(1991-11#3)(1991-4#5)(1992-11#4)(1992-2#5)(1992-3#3)(1992-6#14)(1992-7#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#2)(1993-9#6)(1994-11#3)(1994-12#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#4)(1995-4#1)(1995-6#4)(1995-8#4)(1996-11#5)(1996-4#4)(1996-6#2)(1996-7#2)(1996-8#3)(1997-1#7)(1997-2#5)(1997-3#1)(1997-4#3)(1997-5#14)(1997-6#2)(1997-7#5)(2005-10#1)(2005-8#1)(2006-10#1)(2006-11#2)(2006-12#6)(2008-2#1)(2008-4#7)(2008-7#1)(2008-8#7)(2008-9#9)(2009-3#4)(2009-5#1)(2012-2#4)(2012-3#1)
tRNA(Ala)##6##1##(1990-5#1)(2008-8#5)
tRNA(Asp)##4##1##(1992-7#3)(1993-9#1)
tRNA(Gln)##2##1##(1993-9#1)(1994-8#1)
tRNA(Glu)##3##1##(1993-9#1)(1994-10#1)(1995-3#1)
tRNA(Gly)##3##1##(1993-9#2)(2009-5#1)
tRNA(Gly)1##4##1##(1997-7#4)
tRNA(Leu(UUR))##4##1##(2006-11#2)(2008-8#2)
tRNA(Leu)##7##1##(1990-12#1)(1991-1#1)(2008-4#2)(2008-8#3)
tRNA(Leu)(UUR) gene##2##2##(1990-12#1)(1993-12#1)
tRNA(Leu)(UUR)##3##1##(1990-12#1)(1993-12#2)
tRNA(Lys##10##1##(1991-10#2)(1992-6#8)
tRNA(Lys)##6##1##(1992-2#3)(1997-1#1)(2006-11#2)
tRNA(Lys1##2##1##(1996-11#1)(1997-1#1)
tRNA(Lys3) and##4##2##(1997-1#4)
tRNA(Lys3) incorporation is##2##3##(1997-1#2)
tRNA(Lys3) incorporation##3##2##(1997-1#3)
tRNA(Lys3) primer##2##2##(1996-11#2)
tRNA(Lys3)##13##1##(1996-11#3)(1997-1#10)
tRNA(Met)##4##1##(1990-12#1)(1990-4#2)(1994-12#1)
tRNA(Phe) affinity for pdTpdTpdT##2##4##(1992-2#2)
tRNA(Phe)##12##1##(1990-8#1)(1991-11#2)(1991-4#3)(1992-2#2)(1996-11#1)(2006-11#1)(2008-11#1)(2008-8#1)
tRNA(Phe)U39##3##1##(1991-4#3)
tRNA(Pro)##2##1##(1996-11#1)(2008-11#1)
tRNA(Ser(AGY)GCU##4##1##(1997-1#4)
tRNA(Ser)##3##1##(1990-5#3)
tRNA(TGASer)##3##1##(1991-6#3)
tRNA(Thr) (AGU)##2##2##(1997-2#2)
tRNA(Thr)##7##1##(1997-2#6)(2008-11#1)
tRNA(Trp)##7##1##(1993-11#5)(1994-3#1)(1996-11#1)
tRNA(Tyr)##3##1##(1995-6#1)(1996-7#1)(1997-5#1)
tRNA(Val)##4##1##(1990-12#1)(1990-2#1)(1990-8#1)(1992-12#1)
tRNA(fMet)##8##1##(1991-12#1)(1995-6#7)
tRNA(lys)##2##1##(2006-12#2)
tRNA(phe)##5##1##(1993-3#2)(1995-9#1)(2008-3#2)
tRNA-dependent##2##1##(2006-12#2)
tRNA-encoding genes##2##2##(1993-9#2)
tRNA-encoding##3##1##(1993-9#3)
tRNA-guanine transglycosylase##2##2##(1995-11#2)
tRNA-like##3##1##(1990-2#2)(1992-9#1)
tRNA-specific##2##1##(1992-11#2)
tRNA2(fMet)##6##1##(1993-11#6)
tRNAIle##5##1##(1996-7#5)
tRNAThr##2##1##(1997-3#2)
tRNA[Ser]Sec TATA element##2##3##(1997-2#2)
tRNA[Ser]Sec gene transcription##2##3##(1995-8#2)
tRNA[Ser]Sec gene##6##2##(1995-8#3)(1997-2#3)
tRNA[Ser]Sec promoter##2##2##(1995-8#1)(1997-2#1)
tRNA[Ser]Sec##11##1##(1995-8#5)(1997-2#6)
tRNAa##3##1##(2008-8#3)
tRNAb##3##1##(2008-8#3)
tRNAs and##5##2##(1997-2#1)(1997-3#1)(2005-10#2)(2011-2#1)
tRNAs are##2##2##(1996-4#1)(2006-5#1)
tRNAs by##2##2##(1994-8#1)(1997-2#1)
tRNAs for##2##2##(1997-2#1)(1997-3#1)
tRNAs from##3##2##(1991-10#2)(1993-11#1)
tRNAs have been shown to have pro-proliferative and anti-apoptotic roles##2##10##(2012-12#2)
tRNAs in##2##2##(1991-10#1)(2010-11#1)
tRNAs were##4##2##(1991-10#2)(1991-11#1)(2008-8#1)
tRNAs##55##1##(1990-12#1)(1990-8#3)(1991-10#7)(1991-11#1)(1991-6#1)(1992-11#1)(1992-2#2)(1993-11#1)(1994-8#1)(1995-2#2)(1995-3#2)(1995-8#1)(1996-4#2)(1997-1#2)(1997-2#3)(1997-3#3)(1997-5#1)(1997-7#1)(2005-10#3)(2006-11#2)(2006-12#3)(2006-5#1)(2008-4#2)(2008-8#1)(2010-11#1)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#1)
tSAH##4##1##(2008-7#4)
tSSEP##2##1##(2007-8#2)
ta##2##1##(2008-4#1)(2011-2#1)
tabaci and##2##2##(2008-10#2)
tabaci biotype B##3##3##(2008-10#1)(2011-12#2)
tabaci biotype##4##2##(2008-10#2)(2011-12#2)
tabaci in the New World##2##5##(2011-2#2)
tabaci in the##3##3##(2011-2#3)
tabaci in##5##2##(2008-10#2)(2011-2#3)
tabaci population##2##2##(2008-10#2)
tabaci were measured##2##3##(2007-6#2)
tabaci were##3##2##(2007-6#2)(2011-12#1)
tabaci##64##1##(2007-6#8)(2008-10#32)(2008-12#3)(2011-12#16)(2011-2#5)
tabacina DNA##2##2##(2008-10#2)
tabacina##29##1##(2008-10#29)
tabacum cv##10##2##(1993-5#1)(1994-2#2)(2006-12#1)(2008-10#4)(2008-9#2)
tabacum##31##1##(1993-5#2)(1994-2#2)(1994-9#1)(1997-2#1)(2006-12#2)(2008-10#14)(2008-7#1)(2008-9#2)(2009-3#4)(2009-8#1)(2012-2#1)
tabes dorsalis##2##2##(1991-11#2)
tabes##3##1##(1991-11#3)
tabira population##2##2##(2010-8#2)
tabira##6##1##(2010-8#6)
table analysis of##2##3##(1991-12#1)(2008-10#1)
table analysis##6##2##(1991-10#1)(1991-12#1)(1991-3#1)(1993-2#1)(2008-10#1)(2008-9#1)
table and a##2##3##(2007-1#1)(2007-4#1)
table and##6##2##(2006-6#1)(2007-1#1)(2007-4#1)(2008-10#1)(2008-5#1)(2013-1#1)
table are##3##2##(2008-2#2)(2008-6#1)
table comparing##2##2##(1994-2#1)(1995-9#1)
table discussion##3##2##(1991-6#1)(1994-6#2)
table for##4##2##(2007-3#1)(2009-12#1)(2010-12#1)(2011-1#1)
table have##2##2##(2008-10#1)(2008-4#1)
table is##4##2##(1995-9#1)(2008-10#2)(2009-3#1)
table method##2##2##(2008-2#2)
table of the##4##3##(2008-3#1)(2008-4#1)(2008-5#1)(2013-8#1)
table of##18##2##(1992-6#1)(1996-1#1)(1996-5#1)(2007-11#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
table salt by##2##3##(1990-9#1)(2008-10#1)
table salt samples##5##3##(2008-10#5)
table salt##15##2##(1990-9#1)(2006-4#1)(2007-2#1)(2007-8#1)(2008-10#11)
table salts##3##2##(2008-10#3)
table that##4##2##(1996-3#1)(2006-2#1)(2008-4#1)(2008-6#1)
table to##6##2##(1993-1#1)(2006-8#2)(2008-12#1)(2009-12#1)(2011-2#1)
table were##2##2##(2007-2#1)(2008-2#1)
table with##3##2##(2007-3#1)(2007-4#2)
table##167##1##(1990-5#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-3#1)(1991-5#2)(1991-6#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-2#3)(1993-9#1)(1994-2#1)(1994-6#2)(1995-2#1)(1995-3#2)(1995-9#3)(1996-1#2)(1996-12#2)(1996-3#1)(1996-5#1)(1997-3#2)(1997-6#2)(1997-8#2)(2005-4#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#3)(2007-3#3)(2007-4#3)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#25)(2008-12#4)(2008-2#10)(2008-3#2)(2008-4#6)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#3)(2009-3#3)(2009-5#2)(2010-11#1)(2010-12#2)(2011-1#1)(2011-2#10)(2012-1#3)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#3)
tables and##9##2##(1993-2#2)(1995-9#1)(1996-2#1)(2007-3#1)(2007-7#1)(2008-2#1)(2008-4#1)(2012-3#1)
tables are provided##2##3##(1994-6#1)(1997-4#1)
tables are##3##2##(1994-6#1)(1995-2#1)(1997-4#1)
tables can be##2##3##(2006-10#1)(2008-1#1)
tables for##3##2##(1993-1#1)(1994-11#1)(1996-1#1)
tables from##2##2##(1993-4#1)(2008-1#1)
tables generated##2##2##(2008-2#1)(2008-3#1)
tables in##2##2##(2009-3#1)(2011-2#1)
tables of data##2##3##(1993-2#1)(2011-1#1)
tables of##15##2##(1993-1#1)(1993-11#1)(1993-2#1)(1995-12#1)(1996-5#1)(2004-11#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
tables on##2##2##(1994-2#1)(2009-3#1)
tables to##2##2##(1995-1#1)(2008-2#1)
tables with little##2##3##(2012-12#2)
tables with##3##2##(2010-1#1)(2012-12#2)
tables##86##1##(1991-11#2)(1992-8#1)(1993-1#2)(1993-11#1)(1993-2#5)(1993-4#1)(1994-11#1)(1994-2#2)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-9#1)(1996-1#2)(1996-2#1)(1996-5#1)(1996-7#1)(1997-4#1)(2004-11#1)(2006-10#1)(2006-4#1)(2006-5#2)(2007-3#1)(2007-7#2)(2008-1#4)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#8)(2008-7#1)(2008-9#2)(2009-3#7)(2009-4#1)(2010-1#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#2)(2013-7#1)
tablet and##4##2##(1990-10#1)(2008-10#2)(2008-7#1)
tablet as##2##2##(2008-6#1)(2010-5#1)
tablet by##3##2##(2005-9#1)(2012-11#1)(2012-2#1)
tablet coatings##2##2##(2010-5#2)
tablet containing##4##2##(1993-11#1)(1995-7#1)(2008-10#2)
tablet dosage form and##2##4##(2008-10#1)(2010-5#1)
tablet dosage form##11##3##(2008-10#2)(2010-2#1)(2010-5#6)(2012-12#2)
tablet dosage forms##3##3##(2008-10#1)(2010-2#2)
tablet dosage##14##2##(2008-10#3)(2010-2#3)(2010-5#6)(2012-12#2)
tablet excipients##3##2##(2008-10#1)(2010-12#1)(2010-2#1)
tablet formulation##12##2##(2008-10#2)(2008-5#1)(2010-12#2)(2010-2#4)(2010-3#2)(2012-2#1)
tablet formulations##6##2##(2008-10#3)(2010-2#1)(2011-2#1)(2012-2#1)
tablet in##2##2##(2004-12#1)(2012-3#1)
tablet matrix##2##2##(2010-5#2)
tablet of##6##2##(1990-10#1)(1990-7#1)(1990-8#1)(1996-5#1)(2008-5#1)(2010-5#1)
tablet preparations##2##2##(2008-10#2)
tablet samples##3##2##(2008-10#3)
tablet three times##2##3##(2007-11#1)(2008-7#1)
tablet twice a##2##3##(1990-11#1)(2006-7#1)
tablet twice##3##2##(1990-11#1)(1990-8#1)(2006-7#1)
tablet was##5##2##(2008-10#1)(2008-5#1)(2010-5#3)
tablet##124##1##(1990-10#2)(1990-11#2)(1990-12#1)(1990-7#1)(1990-8#2)(1992-4#1)(1993-11#2)(1995-7#1)(1996-5#1)(1997-2#1)(2004-12#3)(2005-9#1)(2006-1#2)(2006-7#1)(2007-11#4)(2007-8#1)(2008-10#30)(2008-3#1)(2008-5#9)(2008-6#1)(2008-7#5)(2009-9#3)(2010-12#3)(2010-2#10)(2010-3#2)(2010-5#21)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-8#1)
tablet) were##2##2##(2008-10#2)
tablet)##7##1##(2006-1#2)(2008-10#5)
tableting##3##1##(2010-12#3)
tabletop laser is##2##3##(2007-12#2)
tabletop laser##6##2##(2007-12#5)(2008-3#1)
tabletop soft-x-ray##3##2##(2007-12#2)(2008-3#1)
tabletop##16##1##(2007-12#9)(2008-2#1)(2008-3#3)(2011-1#2)(2011-7#1)
tablets and human serum##3##4##(2008-10#3)
tablets and##27##2##(1996-4#1)(2007-2#2)(2008-10#21)(2008-5#1)(2010-12#1)(2012-2#1)
tablets are##2##2##(2005-12#1)(2012-2#1)
tablets based on##2##3##(2010-2#1)(2013-8#1)
tablets by##8##2##(2008-10#3)(2008-5#1)(2010-12#1)(2010-2#1)(2012-2#1)(2013-7#1)
tablets containing##5##2##(1991-3#1)(2004-12#2)(2008-10#1)(2010-12#1)
tablets for the##2##3##(2008-5#1)(2010-12#1)
tablets for##6##2##(2008-10#2)(2008-5#1)(2010-1#1)(2010-12#1)(2012-2#1)
tablets in##6##2##(1996-4#1)(2005-10#1)(2006-9#1)(2010-12#1)(2011-2#1)(2012-3#1)
tablets is##2##2##(2008-10#2)
tablets of miconazole##2##3##(2010-5#2)
tablets of##17##2##(1990-2#1)(2006-1#1)(2008-10#1)(2010-12#1)(2010-2#3)(2010-3#3)(2010-5#4)(2011-1#1)(2012-2#2)
tablets or##4##2##(1996-1#1)(2006-9#1)(2008-10#1)(2013-1#1)
tablets prepared##2##2##(2010-12#1)(2010-5#1)
tablets remained in the stomach for##2##6##(2012-2#2)
tablets remained##3##2##(2012-2#3)
tablets showed##2##2##(2012-12#1)(2012-2#1)
tablets using##2##2##(2008-10#1)(2010-5#1)
tablets was developed##2##3##(2007-8#1)(2008-10#1)
tablets was##6##2##(2007-8#1)(2008-10#3)(2010-4#1)(2010-5#1)
tablets were also##2##3##(2010-5#1)(2011-2#1)
tablets were evaluated for##5##4##(2010-12#1)(2010-2#2)(2010-3#2)
tablets were prepared by##3##4##(2010-2#1)(2010-5#1)(2012-2#1)
tablets were prepared##4##3##(2010-12#1)(2010-2#1)(2010-5#1)(2012-2#1)
tablets were##23##2##(2004-12#1)(2008-10#5)(2008-5#1)(2010-12#2)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#3)(2011-2#1)(2012-2#4)
tablets with##7##2##(2006-1#1)(2008-10#5)(2008-5#1)
tablets##235##1##(1990-2#1)(1990-7#1)(1991-3#1)(1991-8#1)(1996-1#2)(1996-4#2)(2004-12#5)(2005-10#1)(2005-12#1)(2006-1#2)(2006-12#1)(2006-9#2)(2007-10#2)(2007-11#1)(2007-2#5)(2007-7#1)(2007-8#8)(2008-10#93)(2008-5#13)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-1#2)(2010-12#14)(2010-2#10)(2010-3#6)(2010-4#2)(2010-5#15)(2011-1#3)(2011-2#5)(2011-3#2)(2012-12#3)(2012-2#18)(2012-3#3)(2013-1#1)(2013-7#3)(2013-8#1)
tablets)##3##1##(2008-10#2)(2009-11#1)
taboo search##2##2##(2008-10#2)
taboo##7##1##(1993-6#1)(1996-6#1)(1997-5#1)(2008-10#2)(2008-3#1)(2012-12#1)
taboos##3##1##(1994-4#1)(2007-2#1)(2010-3#1)
tabs on##3##2##(1991-11#1)(1991-5#2)
tabs##5##1##(1991-11#1)(1991-5#2)(2010-8#1)(2013-8#1)
tabular data##2##2##(2008-12#1)(2012-3#1)
tabular##5##1##(1990-4#1)(2005-4#1)(2007-7#1)(2008-12#1)(2012-3#1)
tabulare##2##1##(2013-7#2)
tabulated and##5##2##(1994-1#1)(1996-1#1)(2008-10#1)(2010-8#1)(2013-8#1)
tabulated values##2##2##(1994-6#1)(2008-2#1)
tabulated##83##1##(1991-3#1)(1994-1#1)(1994-5#1)(1994-6#2)(1996-1#1)(2007-12#1)(2007-8#62)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#2)(2008-8#2)(2010-8#1)(2011-2#1)(2013-8#1)
tabulating##3##1##(1994-2#1)(1997-2#1)(1997-8#1)
tabulation of##2##2##(2006-12#1)(2008-8#1)
tabulation standards##2##2##(1997-8#2)
tabulation##5##1##(1997-8#3)(2006-12#1)(2008-8#1)
tac promoter##5##2##(1990-5#1)(1994-8#1)(1995-1#2)(1997-4#1)
tac##9##1##(1990-5#2)(1994-8#1)(1995-1#2)(1995-2#1)(1995-8#1)(1997-4#1)(2013-8#1)
tachistoscopically presented##2##2##(1993-2#1)(2008-4#1)
tachyarrhythmia##9##1##(1992-6#1)(2005-1#2)(2006-9#1)(2008-3#1)(2010-11#1)(2010-2#1)(2010-7#1)(2011-2#1)
tachyarrhythmias in##5##2##(1996-4#1)(2006-9#2)(2010-4#1)(2012-2#1)
tachyarrhythmias##16##1##(1991-6#1)(1993-2#1)(1996-4#2)(2006-9#6)(2008-1#1)(2010-12#1)(2010-4#3)(2012-2#1)
tachycardia (1 patient)##3##3##(1995-6#3)
tachycardia after##4##2##(2006-4#1)(2008-10#1)(2010-5#1)(2013-8#1)
tachycardia and an##2##3##(1990-9#1)(2008-12#1)
tachycardia and hypertension##2##3##(2005-1#2)
tachycardia and ventricular fibrillation##3##4##(1995-12#1)(1996-3#1)(2006-4#1)
tachycardia and##24##2##(1990-9#1)(1991-5#1)(1993-2#1)(1995-12#4)(1995-6#2)(1996-3#1)(2004-11#1)(2005-1#2)(2006-4#1)(2006-8#1)(2006-9#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-4#2)(2013-1#1)
tachycardia at##2##2##(2008-4#1)(2012-3#1)
tachycardia can##2##2##(1990-3#1)(2006-9#1)
tachycardia during##2##2##(2006-9#1)(2008-7#1)
tachycardia have##2##2##(2006-8#1)(2008-4#1)
tachycardia in##6##2##(1993-12#1)(1995-6#1)(1996-4#1)(2005-1#1)(2008-4#1)(2011-12#1)
tachycardia induced by##2##3##(1991-2#1)(2005-9#1)
tachycardia of##5##2##(1993-8#2)(2008-7#2)(2009-7#1)
tachycardia was induced##2##3##(1990-3#2)
tachycardia was##10##2##(1990-3#2)(1991-12#1)(1993-2#1)(1993-8#1)(1995-12#2)(2006-9#1)(2007-8#1)(2008-4#1)
tachycardia with##5##2##(2006-9#1)(2007-8#1)(2009-11#2)(2012-3#1)
tachycardia##183##1##(1990-3#8)(1990-5#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-5#2)(1991-9#1)(1992-4#1)(1993-10#1)(1993-12#3)(1993-2#5)(1993-7#1)(1993-8#5)(1994-11#1)(1995-12#6)(1995-6#15)(1996-3#1)(1996-4#1)(1996-6#1)(1997-1#2)(2004-10#1)(2004-11#1)(2005-1#4)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#4)(2006-11#1)(2006-4#7)(2006-8#5)(2006-9#20)(2007-4#1)(2007-7#1)(2007-8#5)(2008-1#4)(2008-10#4)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#9)(2008-7#5)(2008-8#1)(2009-10#3)(2009-11#5)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#2)(2010-5#6)(2011-1#1)(2011-12#3)(2011-2#5)(2012-3#2)(2013-1#4)(2013-8#3)
tachycardia)##3##1##(1995-12#1)(1996-3#1)(2007-9#1)
tachycardia?##2##1##(2009-10#1)(2010-3#1)
tachycardia]##4##1##(1990-5#1)(1995-11#1)(1995-2#1)(2013-1#1)
tachycardiac effects of##3##3##(1993-11#3)
tachycardiac response##2##2##(1996-12#2)
tachycardiac##7##1##(1993-11#3)(1995-12#1)(1996-12#3)
tachycardias in##2##2##(2006-8#1)(2006-9#1)
tachycardias##14##1##(1991-3#1)(1996-4#2)(2006-4#2)(2006-8#1)(2006-9#5)(2008-10#1)(2009-10#1)(2010-11#1)
tachycardic arrhythmias##2##2##(1991-8#1)(1995-2#1)
tachycardic##3##1##(1991-8#1)(1995-2#1)(2012-2#1)
tachykinin NK1 and NK2 receptor antagonists##3##6##(1995-12#1)(1997-4#2)
tachykinin NK1 and NK2 receptor##4##5##(1995-12#2)(1997-4#2)
tachykinin NK1 and NK2##5##4##(1995-12#3)(1997-4#2)
tachykinin NK1 receptor antagonists##4##4##(1993-11#2)(1996-12#2)
tachykinin NK1 receptor##10##3##(1993-11#5)(1995-12#1)(1996-12#4)
tachykinin NK1 receptors##2##3##(1993-11#2)
tachykinin NK1##17##2##(1993-11#7)(1995-12#4)(1996-12#4)(1997-4#2)
tachykinin NK2 receptor antagonist##5##4##(1993-11#4)(1993-3#1)
tachykinin NK2 receptor##11##3##(1993-11#4)(1993-3#2)(1996-12#5)
tachykinin NK2 receptors##3##3##(1993-11#1)(1993-3#2)
tachykinin NK2##14##2##(1993-11#5)(1993-3#4)(1996-12#5)
tachykinin agonists in midbrain dopamine##2##5##(1991-11#2)
tachykinin agonists##4##2##(1991-11#3)(1993-12#1)
tachykinin family##6##2##(1990-12#1)(1990-2#2)(1991-5#2)(1994-10#1)
tachykinin peptides##3##2##(1990-5#1)(1991-5#1)(1991-9#1)
tachykinin receptor##3##2##(1993-12#2)(1995-12#1)
tachykinin receptors##6##2##(1991-11#1)(1993-12#1)(1995-5#1)(1996-12#1)(2008-8#2)
tachykinin##65##1##(1990-12#1)(1990-2#3)(1990-5#1)(1991-11#5)(1991-5#3)(1991-9#1)(1993-11#12)(1993-12#8)(1993-3#4)(1993-8#1)(1994-10#3)(1995-12#5)(1995-5#1)(1996-12#11)(1997-4#2)(1997-6#1)(2008-8#3)
tachykinin-induced##3##1##(1991-11#1)(1993-12#1)(1996-12#1)
tachykinins and##2##2##(1994-10#1)(2006-6#1)
tachykinins on##2##2##(1993-12#1)(1997-6#1)
tachykinins##21##1##(1990-11#1)(1990-2#5)(1991-5#3)(1993-12#1)(1994-10#2)(1995-12#3)(1997-4#1)(1997-6#2)(2006-2#1)(2006-6#2)
tachyphylaxis##4##1##(1993-2#1)(1996-10#1)(2007-11#1)(2010-1#1)
tachypnea##8##1##(2006-10#1)(2007-11#1)(2007-2#1)(2007-6#2)(2011-2#1)(2012-2#1)(2012-3#1)
tachypnoea##3##1##(2005-11#2)(2013-1#1)
tachyzoites##4##1##(1997-3#1)(2005-7#1)(2006-10#1)(2008-4#1)
tacit knowledge##2##2##(2008-10#1)(2013-8#1)
tacit##4##1##(2008-10#1)(2010-9#1)(2012-1#1)(2013-8#1)
tacking##2##1##(2008-12#1)(2010-2#1)
tackle the problem##2##3##(2008-2#1)(2010-11#1)
tackle the##7##2##(2007-12#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-4#1)(2010-11#1)(2012-3#1)
tackle these##2##2##(2009-4#1)(2013-1#1)
tackle this issue##2##3##(2009-5#1)(2013-8#1)
tackle this##7##2##(1994-6#1)(1995-5#1)(2007-7#1)(2009-10#1)(2009-5#1)(2011-2#1)(2013-8#1)
tackle##38##1##(1991-11#1)(1994-3#1)(1994-6#1)(1995-5#1)(2005-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
tackled at the##2##3##(2007-1#1)(2013-1#1)
tackled at##3##2##(2007-1#1)(2010-8#1)(2013-1#1)
tackled##13##1##(1997-8#1)(2005-11#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-10#1)(2010-8#1)(2012-3#1)(2013-1#1)
tackles##7##1##(1992-1#1)(1994-2#1)(1997-3#1)(2007-10#1)(2009-5#1)(2010-9#1)(2012-3#1)
tackling questions##2##2##(2007-12#1)(2008-9#1)
tackling the##3##2##(2007-9#1)(2008-11#1)(2012-3#1)
tackling this##2##2##(2008-7#1)(2012-12#1)
tackling##24##1##(1990-4#1)(1993-6#1)(1996-2#1)(2003-11#1)(2005-11#1)(2006-4#1)(2007-12#1)(2007-9#2)(2008-11#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-3#3)
tacrine and NIK-247##3##3##(1993-11#3)
tacrine can##2##2##(2011-12#2)
tacrine##18##1##(1993-11#9)(1996-9#4)(2004-12#1)(2011-12#2)(2011-3#1)(2012-3#1)
tacrolimus and pimecrolimus##3##3##(2006-12#1)(2008-3#1)(2011-2#1)
tacrolimus and##9##2##(2006-10#1)(2006-12#1)(2007-11#2)(2008-3#1)(2011-2#2)(2012-11#1)(2012-2#1)
tacrolimus but##2##2##(2007-11#1)(2007-8#1)
tacrolimus for##3##2##(2006-10#1)(2007-11#2)
tacrolimus in the##2##3##(2007-11#2)
tacrolimus in##6##2##(2007-11#3)(2008-1#1)(2008-10#1)(2012-2#1)
tacrolimus is##2##2##(2007-11#2)
tacrolimus recipients##2##2##(2007-11#2)
tacrolimus to##2##2##(2011-2#1)(2012-2#1)
tacrolimus was##3##2##(2007-11#2)(2011-2#1)
tacrolimus##80##1##(1997-3#1)(2004-11#1)(2004-12#3)(2005-11#1)(2005-7#3)(2005-8#2)(2006-10#7)(2006-12#1)(2006-5#3)(2006-8#1)(2007-11#27)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-3#3)(2008-8#1)(2011-1#1)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#7)(2013-8#3)
tacrolimus) and##2##2##(2007-12#1)(2008-1#1)
tacrolimus)##4##1##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)
tacrolimus-based immunosuppression##2##2##(2007-11#1)(2008-11#1)
tacrolimus-based##3##1##(2007-11#2)(2008-11#1)
tacrolimus-induced##2##1##(2008-8#1)(2013-8#1)
tactic for##2##2##(2008-10#1)(2008-8#1)
tactic of##2##2##(2010-8#1)(2011-2#1)
tactic##22##1##(1991-1#2)(1993-12#1)(1993-9#1)(2006-10#1)(2007-7#1)(2008-10#3)(2008-8#4)(2009-3#1)(2010-8#1)(2011-2#4)(2013-8#3)
tactical##8##1##(1990-3#1)(1997-1#1)(2008-12#1)(2008-2#1)(2008-3#2)(2013-1#2)
tactics and##4##2##(1992-8#1)(1996-3#1)(2008-10#1)(2010-8#1)
tactics are##2##2##(1991-5#1)(2008-10#1)
tactics for the##2##3##(1991-3#1)(1993-12#1)
tactics for##6##2##(1991-3#1)(1993-12#1)(2007-6#1)(2007-8#1)(2008-9#1)(2013-8#1)
tactics including##2##2##(2008-10#2)
tactics of##7##2##(1992-3#1)(2005-1#2)(2006-6#1)(2008-5#1)(2008-6#1)(2011-1#1)
tactics to##4##2##(1992-12#1)(1994-12#1)(2010-1#1)(2013-1#1)
tactics##48##1##(1990-3#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-12#1)(1996-3#1)(2004-12#1)(2005-1#2)(2006-10#2)(2006-6#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-1#6)(2010-8#2)(2011-1#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
tactile allodynia##4##2##(1996-8#1)(1997-2#2)(2006-8#1)
tactile and##2##2##(2008-4#1)(2010-12#1)
tactile events##2##2##(2009-8#2)
tactile feedback##2##2##(2006-6#1)(2006-9#1)
tactile hypersensitivity##3##2##(1997-2#3)
tactile imaging##2##2##(2009-7#2)
tactile perception##5##2##(1995-8#1)(2007-5#2)(2008-5#2)
tactile placing##2##2##(1992-12#2)
tactile properties##2##2##(2006-6#1)(2007-5#1)
tactile responses##2##2##(1993-12#2)
tactile sensation##3##2##(2004-3#1)(2008-5#1)(2009-8#1)
tactile sensor##4##2##(2006-6#2)(2007-5#1)(2008-3#1)
tactile sensors##2##2##(2007-5#1)(2008-3#1)
tactile stimulation of the##2##4##(1991-3#1)(1993-12#1)
tactile stimulation of##4##3##(1991-3#1)(1993-12#1)(1995-12#1)(2010-12#1)
tactile stimulation##8##2##(1991-3#1)(1993-12#2)(1995-12#1)(1997-2#1)(2008-5#2)(2010-12#1)
tactile stimuli##2##2##(1993-12#1)(1996-12#1)
tactile##68##1##(1991-3#1)(1992-12#2)(1992-9#1)(1993-12#6)(1994-2#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-2#7)(2004-3#1)(2006-6#4)(2006-8#1)(2006-9#1)(2007-5#9)(2008-3#4)(2008-4#2)(2008-5#7)(2008-9#1)(2009-10#2)(2009-7#2)(2009-8#5)(2010-12#2)(2013-1#1)(2013-7#1)
tactoids##2##1##(2005-11#2)
tadalafil##10##1##(2007-10#3)(2008-10#5)(2008-11#1)(2010-12#1)
tadpole pupil##2##2##(2011-1#2)
tadpole##9##1##(1997-7#1)(2007-3#1)(2008-8#5)(2011-1#2)
tadpoles and##2##2##(1991-5#1)(1994-9#1)
tadpoles have##3##2##(2008-7#1)(2012-12#2)
tadpoles of##3##2##(2007-3#1)(2011-2#2)
tadpoles##37##1##(1991-5#4)(1994-12#1)(1994-9#2)(1995-12#1)(2007-3#2)(2008-5#4)(2008-7#1)(2008-8#1)(2011-2#3)(2012-12#18)
taeda L##2##2##(2006-12#1)(2010-3#1)
taeda##6##1##(2006-12#1)(2008-7#4)(2010-3#1)
taenia coli##3##2##(1994-5#1)(1995-5#2)
taenia##5##1##(1990-7#2)(1994-5#1)(1995-5#2)
taeniosis prevalence##2##2##(2011-2#2)
taeniosis##4##1##(2011-2#4)
tag (EST)##6##2##(1997-6#1)(2006-11#1)(2008-10#2)(2008-11#1)(2008-9#1)
tag SNP##2##2##(2008-6#1)(2012-3#1)
tag SNPs##5##2##(2008-6#1)(2010-12#1)(2012-3#3)
tag and##5##2##(1995-10#1)(2008-10#1)(2008-4#1)(2012-3#2)
tag at##3##2##(1994-3#1)(2008-11#2)
tag for##3##2##(1995-8#1)(1997-3#1)(2008-4#1)
tag fused to##2##3##(1997-2#1)(2008-11#1)
tag gene##3##2##(1992-5#3)
tag genes##2##2##(1997-8#1)(2008-10#1)
tag in the##2##3##(1997-3#1)(1997-4#1)
tag in##3##2##(1997-3#1)(1997-4#1)(2008-7#1)
tag is##2##2##(2008-4#2)
tag line##3##2##(2008-3#3)
tag lines##2##2##(2007-1#1)(2008-3#1)
tag sequences are##2##3##(1997-3#2)
tag sequences##5##2##(1997-3#4)(2008-2#1)
tag single-nucleotide polymorphisms##2##3##(2012-3#2)
tag the##2##2##(2007-9#1)(2012-3#1)
tag type##2##2##(2010-8#1)(2011-12#1)
tag was##2##2##(2008-10#1)(2008-11#1)
tag when##2##2##(2008-4#1)(2008-7#1)
tag with##2##2##(1994-12#1)(2008-11#1)
tag##128##1##(1992-5#3)(1993-4#1)(1994-12#4)(1994-3#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-3#1)(1996-5#1)(1997-2#3)(1997-3#6)(1997-4#2)(1997-6#2)(1997-8#1)(2004-4#1)(2006-11#1)(2006-12#2)(2007-1#1)(2007-9#2)(2008-10#9)(2008-11#9)(2008-2#3)(2008-3#5)(2008-4#16)(2008-6#2)(2008-7#7)(2008-9#3)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-5#2)(2010-8#6)(2011-1#1)(2011-12#4)(2011-2#1)(2012-2#1)(2012-3#10)(2013-8#2)
tag) and##2##2##(1995-1#1)(1996-6#1)
tag)##4##1##(1995-1#1)(1996-6#1)(1997-2#1)(2008-10#1)
tagged and##3##2##(2010-8#3)
tagged by the##2##3##(1990-11#1)(2008-10#1)
tagged by##3##2##(1990-11#1)(2006-12#1)(2008-10#1)
tagged fish##2##2##(2008-8#1)(2010-8#1)
tagged proteins##8##2##(2008-1#1)(2008-2#1)(2008-4#4)(2008-7#1)(2010-7#1)
tagged site##3##2##(1994-12#1)(2008-10#2)
tagged with##10##2##(1993-6#1)(1996-6#1)(1997-1#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-6#1)(2010-9#1)
tagged##65##1##(1990-11#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-6#1)(1997-1#1)(1997-8#3)(2006-12#3)(2007-11#1)(2007-12#4)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-2#2)(2008-4#9)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-9#1)(2010-7#1)(2010-8#5)(2010-9#1)(2011-12#2)(2011-2#1)(2012-11#1)(2012-3#2)
tagging and##4##2##(1997-8#1)(2006-12#1)(2008-2#1)(2013-8#1)
tagging method##3##2##(2008-3#1)(2008-7#1)(2010-8#1)
tagging of##11##2##(1995-9#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-4#2)(2009-9#1)(2012-1#1)(2012-2#1)(2013-1#1)
tagging studies##2##2##(2013-1#2)
tagging the##3##2##(1995-6#1)(1997-2#1)(2007-11#1)
tagging using##2##2##(2007-9#1)(2008-4#1)
tagging velocimetry##2##2##(2008-3#2)
tagging with GFP##2##3##(2008-7#2)
tagging##59##1##(1991-5#3)(1995-2#1)(1995-6#1)(1995-9#1)(1997-2#2)(1997-8#2)(2006-12#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-9#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-7#6)(2008-9#1)(2009-9#1)(2010-8#8)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#3)
tagitinin C##4##2##(2008-10#4)
tagless##2##1##(2006-4#1)(2009-12#1)
tagma##2##1##(1994-8#1)(2007-12#1)
tagmosis of the##2##3##(2007-12#2)
tags and##4##2##(2007-2#1)(2008-12#1)(2008-7#1)(2011-2#1)
tags are##2##2##(2008-2#1)(2010-8#1)
tags for relative and absolute quantification (iTRAQ)##2##7##(2008-4#2)
tags for##6##2##(1996-6#1)(2008-4#3)(2008-7#1)(2009-10#1)
tags from recombinant proteins##2##4##(2008-11#1)(2010-2#1)
tags from##6##2##(2008-11#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-4#2)
tags is##2##2##(2008-5#1)(2008-7#1)
tags that##2##2##(1994-3#1)(2008-4#1)
tags to##3##2##(1997-3#1)(2008-4#1)(2011-12#1)
tags were##3##2##(2006-12#1)(2010-8#2)
tags##88##1##(1992-11#1)(1992-5#1)(1994-3#2)(1994-6#1)(1995-8#3)(1995-9#1)(1996-6#1)(1997-2#2)(1997-3#2)(1997-6#1)(1997-7#2)(2006-12#5)(2006-3#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#2)(2008-4#10)(2008-5#1)(2008-7#13)(2008-8#1)(2009-10#3)(2009-12#1)(2010-10#1)(2010-2#1)(2010-4#5)(2010-5#1)(2010-8#9)(2011-12#5)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
tai chi group##2##3##(2008-10#2)
tai chi##12##2##(2007-12#1)(2008-10#7)(2010-12#1)(2011-12#3)
taiga##3##1##(2011-2#3)
taiji quan training on##2##4##(2009-3#2)
taiji quan##5##2##(2009-3#5)
taiji##6##1##(2009-3#6)
tail DNA##6##2##(1997-4#3)(2010-5#3)
tail amputation##2##2##(1994-4#2)
tail and##5##2##(1991-10#1)(1994-9#1)(2008-7#1)(2008-8#1)(2011-2#1)
tail arteries##4##2##(1996-10#4)
tail assemblies##3##2##(2011-12#3)
tail at the 3' end##2##5##(1991-5#1)(2008-10#1)
tail at the##3##3##(1991-5#1)(2006-5#1)(2008-10#1)
tail at##5##2##(1991-5#1)(1993-8#1)(2006-5#1)(2008-10#1)(2008-2#1)
tail attached##2##2##(1994-5#1)(2008-4#1)
tail base##3##2##(1995-12#1)(2005-7#2)
tail collagen breaktime##2##3##(1995-3#2)
tail coverage##3##2##(1993-1#3)
tail current##2##2##(1991-9#1)(1993-12#1)
tail currents evoked at potentials more##2##6##(1997-2#2)
tail currents##3##2##(1991-9#1)(1997-2#2)
tail docking##4##2##(1994-4#4)
tail domain of vinculin##2##4##(2009-7#2)
tail domain of##6##3##(1990-11#2)(1997-6#1)(2009-7#2)(2011-2#1)
tail domain##7##2##(1990-11#3)(1997-6#1)(2009-7#2)(2011-2#1)
tail flick##6##2##(1990-2#2)(1990-4#1)(1996-10#1)(2010-5#1)(2011-1#1)
tail in##6##2##(1995-12#1)(1997-5#2)(1997-7#1)(2008-3#1)(2008-5#1)
tail is##12##2##(1991-4#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-9#1)(1997-2#1)(1997-7#1)(2005-11#1)(2007-11#1)(2010-6#2)(2011-1#1)
tail length and cloacal distance##2##5##(2007-3#2)
tail length and##6##3##(2005-11#1)(2007-3#2)(2008-8#1)(2008-9#1)(2010-5#1)
tail length##11##2##(2005-11#2)(2007-3#2)(2008-8#3)(2008-9#1)(2010-5#3)
tail markings as##2##3##(2008-9#2)
tail markings##5##2##(2008-9#5)
tail moment##3##2##(1997-4#1)(2008-10#2)
tail of pancreas##2##3##(2008-7#2)
tail of the pancreas##2##4##(2010-12#1)(2013-1#1)
tail of the##15##3##(1991-10#1)(1991-11#1)(1992-8#1)(1993-9#1)(1996-2#1)(1996-8#1)(1997-4#2)(2007-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-1#1)(2013-1#1)
tail of##36##2##(1990-6#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-8#1)(1993-1#1)(1993-9#1)(1994-4#1)(1994-8#1)(1994-9#1)(1995-3#3)(1996-2#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-7#1)(2006-10#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#2)(2010-12#1)(2011-1#2)(2012-2#1)(2013-1#1)
tail or##4##2##(1997-5#2)(2008-6#1)(2008-7#1)
tail part##2##2##(1997-2#1)(2011-2#1)
tail pinch##3##2##(1993-2#3)
tail region##4##2##(1993-12#1)(1995-3#1)(2011-1#2)
tail sheath protein##5##3##(1990-5#5)
tail sheath##10##2##(1990-5#10)
tail skin temperature##2##3##(1997-7#2)
tail skin##5##2##(1993-3#1)(1995-2#1)(1997-7#2)(2008-4#1)
tail tendon##4##2##(1995-1#2)(2008-3#2)
tail that##5##2##(1990-5#1)(1993-5#1)(2005-5#1)(2008-2#1)(2011-2#1)
tail tip##2##2##(1995-3#1)(2007-12#1)
tail to##2##2##(1993-9#1)(1997-6#1)
tail traits in##2##3##(2008-9#2)
tail traits##3##2##(2008-9#3)
tail vein##13##2##(1991-6#1)(1994-9#1)(1995-8#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)(2010-12#2)(2011-1#1)(2011-2#1)
tail veins##3##2##(1990-12#1)(1991-5#1)(2008-11#1)
tail was##4##2##(1993-9#1)(2004-11#1)(2011-12#1)(2011-2#1)
tail were##3##2##(1992-12#1)(2007-5#1)(2007-8#1)
tail with##3##2##(1997-7#1)(2007-12#2)
tail withdrawal##2##2##(1990-5#1)(1995-12#1)
tail##345##1##(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#4)(1990-5#12)(1990-6#2)(1991-10#2)(1991-11#1)(1991-2#1)(1991-4#4)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#4)(1992-11#1)(1992-12#1)(1992-4#2)(1992-5#2)(1992-7#1)(1992-8#3)(1992-9#5)(1993-1#5)(1993-12#2)(1993-2#3)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#8)(1994-11#2)(1994-12#1)(1994-3#4)(1994-4#7)(1994-5#2)(1994-8#1)(1994-9#8)(1995-1#2)(1995-12#4)(1995-2#1)(1995-3#12)(1995-5#1)(1995-8#2)(1996-1#1)(1996-10#6)(1996-2#1)(1996-5#1)(1996-8#2)(1997-2#10)(1997-4#11)(1997-5#5)(1997-6#2)(1997-7#11)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#3)(2005-5#1)(2005-7#2)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#2)(2007-12#9)(2007-2#1)(2007-3#3)(2007-5#1)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#8)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#10)(2008-9#21)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#2)(2009-7#2)(2010-1#1)(2010-11#1)(2010-12#4)(2010-5#7)(2010-6#4)(2010-8#1)(2011-1#9)(2011-12#8)(2011-2#14)(2012-2#3)(2013-1#1)
tail&quot##2##1##(1991-3#1)(1993-1#1)
tail)##12##1##(1991-4#2)(1994-11#2)(1995-10#1)(2007-2#1)(2008-3#1)(2008-8#2)(2010-12#1)(2012-2#1)(2013-8#1)
tail-flick (TF) reflex##3##3##(1990-7#1)(1991-5#1)(1992-7#1)
tail-flick (TF)##4##2##(1990-7#1)(1991-5#1)(1992-7#1)(1993-11#1)
tail-flick and##3##2##(1990-2#1)(1991-5#1)(1992-3#1)
tail-flick response##8##2##(1992-3#5)(1997-8#3)
tail-flick test##9##2##(1991-1#3)(1992-8#1)(1993-5#2)(1997-8#2)(2008-2#1)
tail-flick##29##1##(1990-2#1)(1990-7#1)(1991-1#3)(1991-5#3)(1992-3#6)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-5#2)(1994-9#2)(1997-8#5)(2008-2#1)(2011-2#1)
tail-skin graft##2##2##(2008-4#2)
tail-skin##4##1##(1994-2#1)(2008-4#3)
tail-vein-injected##2##1##(1991-5#1)(1992-9#1)
tail-withdrawal##2##1##(1996-2#2)
tailbud stage##3##2##(1996-7#1)(2008-5#1)(2008-6#1)
tailbud##4##1##(1996-7#2)(2008-5#1)(2008-6#1)
tailed##5##1##(1992-3#1)(1996-12#1)(2007-12#1)(2008-12#1)(2011-12#1)
tailflick##2##1##(1991-3#1)(1997-5#1)
tailflip##2##1##(2007-12#2)
tailflipping##3##1##(2007-12#3)
tailflips##2##1##(2007-12#2)
tailing factor##2##2##(2013-7#1)(2013-8#1)
tailing in##2##2##(2010-4#1)(2012-2#1)
tailing##7##1##(1997-3#1)(1997-4#1)(2008-10#1)(2010-4#1)(2012-2#1)(2013-7#1)(2013-8#1)
tailor the##9##2##(2006-10#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2013-1#1)
tailor their##3##2##(1994-3#1)(2006-10#1)(2006-12#1)
tailor##23##1##(1993-2#1)(1994-3#1)(2006-10#4)(2006-12#1)(2007-11#2)(2007-12#2)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#1)(2010-4#1)(2011-2#1)(2013-1#3)
tailor-made##11##1##(1996-6#1)(2008-11#2)(2008-4#1)(2008-5#1)(2010-3#1)(2010-6#1)(2010-8#3)(2011-2#1)
tailorable##3##1##(2007-12#1)(2008-12#1)(2008-3#1)
tailored according to##2##3##(1990-12#1)(2010-10#1)
tailored and##4##2##(1991-7#1)(2008-10#1)(2011-2#1)(2013-1#1)
tailored approach##2##2##(2008-8#1)(2013-1#1)
tailored by##6##2##(2005-11#1)(2006-10#1)(2007-11#1)(2009-11#1)(2011-2#1)(2012-2#1)
tailored counseling##2##2##(2010-12#1)(2013-1#1)
tailored design##2##2##(2010-10#1)(2012-3#1)
tailored for the##2##3##(2007-12#1)(2010-2#1)
tailored for##11##2##(2007-12#1)(2007-8#1)(2008-3#2)(2008-5#2)(2008-9#1)(2010-2#1)(2012-10#1)(2012-12#2)
tailored in##3##2##(2007-12#1)(2008-1#1)(2008-8#1)
tailored program##2##2##(1990-3#1)(2007-10#1)
tailored smoking cessation##2##3##(2008-8#1)(2011-2#1)
tailored to each##3##3##(1992-6#1)(2008-10#1)(2008-9#1)
tailored to individual##2##3##(2008-11#1)(2008-5#1)
tailored to specific##2##3##(1996-3#1)(2007-5#1)
tailored to the individual patient##5##5##(2006-10#1)(2006-7#1)(2007-10#1)(2007-4#1)(2010-12#1)
tailored to the individual##7##4##(2006-10#1)(2006-7#1)(2007-10#1)(2007-4#1)(2010-1#1)(2010-12#1)(2013-8#1)
tailored to the needs of the##2##6##(2006-10#1)(2008-8#1)
tailored to the needs of##4##5##(2006-10#1)(2007-7#1)(2008-8#1)(2010-8#1)
tailored to the purposes of##2##5##(1996-9#1)(2008-9#1)
tailored to the##25##3##(1994-6#1)(1994-7#1)(1996-9#1)(2005-9#1)(2006-10#3)(2006-7#1)(2007-10#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-11#2)(2008-4#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-8#1)
tailored to their##3##3##(1992-2#1)(2010-8#1)(2012-12#1)
tailored to##55##2##(1991-7#1)(1992-2#1)(1992-6#1)(1994-6#1)(1994-7#1)(1995-1#1)(1996-3#1)(1996-9#1)(1997-1#1)(2005-9#1)(2006-10#3)(2006-7#1)(2007-10#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#2)
tailored treatment##5##2##(2006-10#2)(2009-2#1)(2010-12#1)(2013-8#1)
tailored treatments##3##2##(2007-5#1)(2009-11#1)(2012-2#1)
tailored use of##2##3##(2007-10#1)(2008-9#1)
tailored##143##1##(1990-12#1)(1990-3#1)(1991-7#2)(1992-2#2)(1992-6#1)(1994-6#1)(1994-7#1)(1995-1#1)(1996-1#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#2)(1997-8#1)(2005-11#2)(2005-9#1)(2006-10#7)(2006-7#1)(2007-10#6)(2007-11#3)(2007-12#5)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#4)(2008-7#2)(2008-8#4)(2008-9#4)(2009-11#2)(2009-2#1)(2009-5#1)(2009-6#3)(2009-7#2)(2009-9#3)(2010-1#1)(2010-10#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-8#6)(2011-1#1)(2011-2#6)(2012-1#4)(2012-10#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#10)(2013-8#5)
tailoring interventions##2##2##(2010-2#1)(2012-1#1)
tailoring of##4##2##(2006-12#1)(2008-3#2)(2008-4#1)
tailoring the##6##2##(2007-11#1)(2007-9#1)(2008-10#2)(2008-5#1)(2010-1#1)
tailoring##31##1##(1993-12#1)(1994-3#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2009-1#1)(2009-5#2)(2010-1#1)(2010-12#2)(2010-2#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
tails and##4##2##(2005-11#1)(2008-8#2)(2011-2#1)
tails are##3##2##(2008-1#1)(2011-12#1)(2011-2#1)
tails in##3##2##(1992-11#2)(2005-11#1)
tails of a##2##3##(2007-12#2)
tails of the##6##3##(1992-9#1)(1995-6#1)(2007-12#2)(2011-12#1)(2012-3#1)
tails of##12##2##(1991-5#1)(1992-9#1)(1995-6#1)(1997-4#1)(2007-12#4)(2008-7#1)(2011-1#1)(2011-12#1)(2012-3#1)
tails that##2##2##(2008-8#1)(2012-2#1)
tails were##2##2##(1997-4#1)(2008-11#1)
tails with##2##2##(1991-5#1)(2012-2#1)
tails##68##1##(1990-2#1)(1991-10#1)(1991-5#2)(1992-11#2)(1992-9#1)(1993-9#1)(1994-3#3)(1994-5#1)(1994-9#1)(1995-12#1)(1995-6#1)(1995-9#4)(1997-2#1)(1997-4#3)(2005-11#4)(2006-12#1)(2006-5#1)(2007-12#7)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2010-4#1)(2010-7#2)(2011-1#1)(2011-12#3)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#1)
tails)##2##1##(2008-2#1)(2011-2#1)
taimen larvae##3##2##(2013-8#3)
taimen##4##1##(2013-8#4)
taint is##2##2##(2010-4#2)
taint##3##1##(2010-4#3)
tainted blood##3##2##(1992-10#1)(1992-7#1)(1995-6#1)
tainted##5##1##(1992-10#1)(1992-7#1)(1995-6#1)(1996-8#1)(1997-5#1)
taiwanin C and##2##3##(1996-5#2)
taiwanin##3##1##(1996-5#3)
take 20##2##2##(2006-2#1)(2008-7#1)
take HIV test##2##3##(1996-12#1)(1996-5#1)
take HIV##3##2##(1991-10#1)(1996-12#1)(1996-5#1)
take a more##2##3##(1993-1#1)(2007-10#1)
take a stand##3##3##(1990-8#1)(1991-2#1)(2011-3#1)
take a##40##2##(1990-6#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-3#3)(1993-1#1)(1993-2#2)(1993-6#1)(1994-10#1)(1994-12#1)(1996-9#1)(1997-4#1)(1997-7#1)(2004-12#1)(2005-10#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#1)(2011-3#1)
take account of such##2##4##(1993-5#1)(1994-8#1)
take account of the##8##4##(1990-3#1)(1992-3#1)(1994-4#2)(2008-11#1)(2008-3#2)(2012-3#1)
take account of##16##3##(1990-3#1)(1992-3#1)(1993-5#1)(1994-4#2)(1994-8#1)(1996-11#1)(1997-8#1)(2005-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2010-10#1)(2012-1#1)(2012-3#1)
take account##17##2##(1990-3#1)(1992-3#1)(1993-5#1)(1994-4#2)(1994-8#1)(1996-11#1)(1997-8#1)(2005-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2010-10#1)(2012-1#1)(2012-3#1)(2013-8#1)
take action and##2##3##(2005-11#1)(2008-11#1)
take action##9##2##(1991-7#1)(1995-3#1)(2005-11#1)(2006-2#1)(2008-11#1)(2008-6#1)(2011-1#1)(2012-2#1)(2012-3#1)
take advantage of a##4##4##(2007-11#1)(2008-10#1)(2008-3#1)(2012-3#1)
take advantage of the##18##4##(1992-11#1)(1992-12#1)(1994-3#2)(1996-3#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2009-2#1)(2009-5#1)(2011-1#1)(2012-2#1)(2013-7#1)
take advantage of this##5##4##(1993-12#2)(2006-5#1)(2008-7#1)(2008-9#1)
take advantage of those##2##4##(1990-11#1)(1990-12#1)
take advantage of##54##3##(1990-11#1)(1990-12#1)(1991-10#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-7#1)(1993-12#2)(1994-3#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-3#1)(2004-10#1)(2004-2#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-7#1)(2008-9#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
take advantage##56##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-10#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-7#1)(1993-12#2)(1994-3#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-3#1)(2004-10#1)(2004-2#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
take an active role in##3##5##(1994-1#1)(1995-3#1)(2006-1#1)
take an active role##4##4##(1994-1#1)(1995-3#1)(2006-1#1)(2010-12#1)
take an active##5##3##(1994-1#1)(1995-3#1)(2006-1#1)(2007-7#1)(2010-12#1)
take an##14##2##(1994-1#1)(1995-3#1)(1996-11#1)(2006-1#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-10#1)(2010-12#1)(2012-3#1)
take approximately##3##2##(2008-1#1)(2010-6#2)
take as a##2##3##(2008-1#1)(2013-7#1)
take as##6##2##(2006-3#1)(2006-7#1)(2008-1#1)(2013-1#2)(2013-7#1)
take at##2##2##(1993-7#1)(2008-5#1)
take between##2##2##(2008-11#1)(2008-5#1)
take care of their##2##4##(1992-12#1)(2008-6#1)
take care of##11##3##(1990-10#1)(1992-10#1)(1992-12#1)(1995-12#1)(2004-9#1)(2006-6#1)(2008-10#1)(2008-6#1)(2009-12#1)(2012-2#2)
take care##16##2##(1990-10#1)(1992-10#1)(1992-12#1)(1995-12#1)(2004-9#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-12#1)(2011-2#4)(2012-2#2)
take charge##2##2##(1991-3#1)(2005-5#1)
take control of their##3##4##(1997-3#1)(2007-7#1)(2011-2#1)
take days to complete##2##4##(2008-4#1)(2009-12#1)
take decisions##2##2##(2007-9#1)(2008-9#1)
take full advantage of the##5##5##(1996-4#1)(2006-4#1)(2006-5#1)(2008-7#2)
take full advantage of##8##4##(1994-2#1)(1996-4#1)(2006-4#1)(2006-5#1)(2008-2#2)(2008-7#2)
take in the##2##3##(2006-10#1)(2009-9#1)
take in##5##2##(1994-1#1)(1996-2#1)(2006-10#1)(2009-10#1)(2009-9#1)
take into account a##2##4##(1993-4#1)(2008-3#1)
take into account all##3##4##(2008-2#1)(2013-1#2)
take into account in the##2##5##(1996-7#1)(2006-10#1)
take into account many##3##4##(1994-1#2)(2009-12#1)
take into account possible##2##4##(2012-11#1)(2012-12#1)
take into account the possible##2##5##(2006-10#1)(2008-10#1)
take into account the##54##4##(1992-12#1)(1992-2#1)(1992-7#1)(1993-2#1)(1993-3#1)(1994-2#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#2)(1996-6#1)(1997-2#1)(2005-5#1)(2006-10#1)(2006-2#2)(2006-4#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-9#1)(2008-10#6)(2008-11#2)(2008-3#3)(2008-4#1)(2008-7#3)(2009-12#1)(2009-5#1)(2010-12#2)(2010-2#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#2)
take into account##90##3##(1990-7#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-1#2)(1994-2#3)(1994-6#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(2005-5#1)(2006-10#2)(2006-2#2)(2006-4#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-3#1)(2007-5#1)(2007-9#1)(2008-10#6)(2008-11#3)(2008-2#4)(2008-3#4)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#2)(2009-2#1)(2009-4#2)(2009-5#1)(2010-12#2)(2010-2#2)(2010-5#1)(2010-6#1)(2010-9#2)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#1)
take into consideration that the##2##5##(1993-7#1)(2008-6#1)
take into consideration the##9##4##(1996-3#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-3#1)(2012-2#1)(2012-3#1)
take into consideration##16##3##(1993-7#1)(1995-12#1)(1996-3#1)(1996-6#1)(2006-10#1)(2006-5#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-3#2)(2012-2#1)(2012-3#1)
take into##106##2##(1990-7#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-1#2)(1994-2#3)(1994-6#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-5#2)(1996-3#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-2#1)(2005-5#1)(2006-10#3)(2006-2#2)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-3#1)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#4)(2008-2#4)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2010-12#2)(2010-2#2)(2010-5#1)(2010-6#1)(2010-9#2)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#4)(2013-8#1)
take it##5##2##(1992-9#1)(1993-11#1)(1995-9#1)(2007-11#1)(2008-2#1)
take longer to##2##3##(1994-9#1)(2012-2#1)
take longer##5##2##(1994-9#1)(2008-11#1)(2010-9#1)(2012-2#2)
take many forms##3##3##(2008-1#1)(2012-12#2)
take many years to##2##4##(2005-7#1)(2008-10#1)
take many##9##2##(1992-1#1)(2005-7#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-5#1)(2012-12#2)
take more##3##2##(1993-12#1)(2008-11#1)(2010-4#1)
take on a##3##3##(1993-12#1)(2006-10#1)(2008-9#1)
take on these##2##3##(1992-3#1)(1996-2#1)
take on##13##2##(1990-4#1)(1992-3#2)(1993-12#1)(1996-2#1)(1996-3#1)(1997-6#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-9#1)
take over##6##2##(1991-5#1)(1997-4#1)(2007-4#1)(2007-8#1)(2007-9#1)(2009-4#1)
take part in research##4##4##(1992-3#2)(2009-6#2)
take part in the##11##4##(1991-5#1)(1991-7#1)(1993-3#1)(1994-6#1)(1997-3#1)(1997-6#1)(2004-4#1)(2007-11#1)(2008-10#1)(2008-5#1)(2011-1#1)
take part in##31##3##(1990-11#1)(1991-5#1)(1991-7#1)(1992-3#2)(1993-3#1)(1994-6#1)(1996-1#1)(1996-11#1)(1997-3#1)(1997-6#1)(2004-4#1)(2006-3#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-5#2)(2008-9#1)(2009-6#6)(2011-1#1)(2013-1#1)(2013-8#1)
take part##36##2##(1990-10#1)(1990-11#1)(1991-5#1)(1991-7#1)(1992-3#2)(1993-3#1)(1994-6#1)(1996-1#1)(1996-11#1)(1997-3#1)(1997-6#1)(2004-4#1)(2006-3#1)(2007-11#2)(2008-10#4)(2008-11#3)(2008-5#2)(2008-9#1)(2009-6#6)(2011-1#1)(2013-1#2)(2013-8#1)
take place around##2##3##(2008-11#1)(2012-2#1)
take place as##2##3##(1991-9#1)(2008-9#1)
take place at the##4##4##(1991-2#1)(2007-5#1)(2008-10#1)(2008-8#1)
take place at##10##3##(1991-2#1)(1992-2#1)(1995-1#1)(1996-2#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-1#1)
take place between##4##3##(1997-2#1)(2006-8#1)(2007-12#1)(2008-8#1)
take place during the##4##4##(1990-2#1)(1997-8#1)(2008-10#1)(2009-9#1)
take place during##7##3##(1990-2#1)(1995-4#1)(1997-8#1)(2008-10#1)(2009-9#1)(2012-12#2)
take place for##3##3##(1992-1#1)(2008-10#1)(2008-9#1)
take place in a##10##4##(1992-9#1)(1993-12#1)(1996-11#1)(2008-10#2)(2008-11#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-8#1)
take place in the##17##4##(1992-3#1)(1994-10#1)(1995-2#1)(2005-11#1)(2006-7#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#2)(2009-12#1)(2009-3#1)(2012-1#1)(2012-3#1)
take place in##41##3##(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-10#1)(1995-2#1)(1996-11#1)(2005-11#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-7#2)(2009-12#1)(2009-3#1)(2009-6#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#2)
take place simultaneously##2##3##(2007-12#1)(2012-2#1)
take place through the##2##4##(2007-12#1)(2008-5#1)
take place to##2##3##(2009-8#1)(2012-12#1)
take place under##2##3##(1994-6#1)(2008-10#1)
take place via##3##3##(1996-2#1)(1996-8#1)(2010-4#1)
take place when##2##3##(2008-2#1)(2008-7#1)
take place with the##2##4##(1997-1#1)(2011-1#1)
take place with##3##3##(1990-5#1)(1997-1#1)(2011-1#1)
take place##128##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-2#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#2)(1994-10#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-4#1)(1996-11#1)(1996-2#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-8#1)(2004-3#1)(2005-11#1)(2005-8#1)(2005-9#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#5)(2007-3#2)(2007-5#2)(2008-1#3)(2008-10#11)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#4)(2008-7#5)(2008-8#2)(2008-9#3)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#1)(2013-8#2)
take responsibility for##8##3##(1995-1#1)(1995-3#1)(1997-3#1)(2008-12#1)(2008-3#1)(2009-5#2)(2010-2#1)
take several##6##2##(1992-12#1)(1996-8#1)(1997-3#1)(2007-5#1)(2007-7#1)(2012-2#1)
take some##3##2##(1993-11#1)(2006-9#1)(2007-6#1)
take special care in##2##4##(2006-10#1)(2011-1#1)
take special##3##2##(2006-10#1)(2010-8#1)(2011-1#1)
take steps to prevent##2##4##(1993-1#1)(2007-12#1)
take steps to##5##3##(1993-1#1)(2007-11#1)(2007-12#1)(2008-11#1)(2012-2#1)
take steps##7##2##(1993-1#1)(2007-11#2)(2007-12#1)(2008-11#1)(2010-9#1)(2012-2#1)
take that##4##2##(2007-4#1)(2008-12#1)(2009-10#1)(2013-8#1)
take the following steps##2##4##(1996-3#1)(2010-1#1)
take the form of##6##4##(1990-8#1)(1992-5#1)(1996-8#1)(2004-12#1)(2008-1#1)(2008-10#1)
take the lead in##3##4##(1995-2#1)(1995-3#1)(1997-7#1)
take the lead##7##3##(1995-12#2)(1995-2#1)(1995-3#1)(1997-7#1)(2008-8#1)(2012-2#1)
take the place of the##2##5##(1990-6#1)(2007-10#1)
take the place of##4##4##(1990-6#1)(2007-10#1)(2007-3#1)(2008-11#1)
take the risk##2##3##(2005-11#1)(2007-2#1)
take the##47##2##(1990-6#1)(1990-8#1)(1992-11#1)(1992-5#1)(1992-9#1)(1994-3#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-3#2)(1996-8#2)(1997-6#1)(1997-7#1)(2004-12#1)(2005-11#1)(2005-9#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2010-1#1)(2011-2#3)(2012-2#1)(2013-7#1)(2013-8#2)
take their medication##3##3##(1990-8#1)(1993-11#1)(2011-1#1)
take their own##2##3##(1990-8#1)(1995-9#1)
take their place in##2##4##(2005-8#1)(2012-12#1)
take their##8##2##(1990-8#2)(1993-11#1)(1995-9#1)(2005-8#1)(2008-7#1)(2011-1#1)(2012-12#1)
take them##4##2##(1994-1#1)(1994-12#1)(2011-1#1)(2012-2#1)
take these##2##2##(2008-3#1)(2009-12#1)
take this into consideration##2##4##(2009-9#1)(2012-2#1)
take this into##3##3##(2009-9#1)(2011-2#1)(2012-2#1)
take this opportunity##2##3##(1992-1#1)(2012-2#1)
take this##12##2##(1992-1#1)(1992-6#1)(1995-6#1)(1996-3#1)(2007-9#1)(2008-2#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#2)
take three##2##2##(2007-12#1)(2008-2#1)
take time##4##2##(1996-3#1)(1997-2#1)(2007-12#1)(2007-7#1)
take to deal with##2##4##(1996-2#1)(2008-11#1)
take to##18##2##(1991-12#1)(1992-2#1)(1993-2#2)(1995-1#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-3#1)
take two##2##2##(1991-9#1)(1994-12#1)
take up glucose from##2##4##(2008-7#1)(2011-1#1)
take up the##2##3##(1996-2#1)(2008-3#1)
take up##26##2##(1990-2#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-7#1)(1992-8#1)(1995-12#1)(1995-2#1)(1996-2#1)(2006-10#2)(2006-6#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2011-1#1)(2012-2#1)
take##804##1##(1990-10#3)(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#5)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#3)(1991-9#4)(1992-1#3)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#5)(1992-3#9)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#5)(1993-1#2)(1993-11#4)(1993-12#5)(1993-2#9)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#2)(1993-8#1)(1994-1#5)(1994-10#2)(1994-12#6)(1994-2#4)(1994-3#3)(1994-4#2)(1994-6#3)(1994-8#2)(1994-9#1)(1995-1#5)(1995-10#1)(1995-11#1)(1995-12#8)(1995-2#4)(1995-3#5)(1995-4#1)(1995-5#4)(1995-6#3)(1995-9#4)(1996-1#5)(1996-11#6)(1996-12#1)(1996-2#6)(1996-3#8)(1996-4#2)(1996-5#3)(1996-6#3)(1996-7#1)(1996-8#5)(1996-9#1)(1997-1#1)(1997-2#7)(1997-3#7)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#4)(2004-10#1)(2004-12#2)(2004-2#1)(2004-3#1)(2004-4#1)(2004-7#2)(2004-9#1)(2005-10#2)(2005-11#3)(2005-5#2)(2005-7#1)(2005-8#2)(2005-9#4)(2006-1#1)(2006-10#12)(2006-12#1)(2006-2#5)(2006-3#4)(2006-4#2)(2006-5#4)(2006-6#3)(2006-7#2)(2006-8#3)(2006-9#3)(2007-1#2)(2007-10#6)(2007-11#13)(2007-12#15)(2007-2#6)(2007-3#5)(2007-4#4)(2007-5#4)(2007-6#2)(2007-7#8)(2007-8#6)(2007-9#8)(2008-1#18)(2008-10#33)(2008-11#27)(2008-12#5)(2008-2#18)(2008-3#21)(2008-4#9)(2008-5#16)(2008-6#12)(2008-7#18)(2008-8#11)(2008-9#14)(2009-10#4)(2009-11#1)(2009-12#8)(2009-2#4)(2009-3#5)(2009-4#4)(2009-5#6)(2009-6#7)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#2)(2010-10#2)(2010-12#6)(2010-2#5)(2010-3#2)(2010-4#7)(2010-5#2)(2010-6#5)(2010-7#3)(2010-8#4)(2010-9#6)(2011-1#12)(2011-12#1)(2011-2#21)(2011-3#1)(2012-1#8)(2012-11#1)(2012-12#10)(2012-2#22)(2012-3#14)(2013-1#15)(2013-7#4)(2013-8#10)
take-all conducive soil##2##3##(2008-10#2)
take-all decline##3##2##(2008-10#3)
take-all disease##3##2##(2008-10#3)
take-all epidemics##4##2##(2008-10#4)
take-all incidence##2##2##(2008-10#2)
take-all of wheat##3##3##(2008-10#3)
take-all##32##1##(2008-10#32)
take-all-suppressive##2##1##(2008-10#2)
take-off##3##1##(2005-11#1)(2006-8#1)(2010-7#1)
take-up##7##1##(1990-6#1)(1993-8#1)(2007-7#3)(2008-10#1)(2008-9#1)
take?##2##1##(2008-4#1)(2008-7#1)
taken 1##2##2##(2010-12#2)
taken 2##2##2##(1995-11#1)(2013-8#1)
taken 5##3##2##(1994-6#1)(1996-9#1)(2008-4#1)
taken 6 weeks##2##3##(2007-11#1)(2008-9#1)
taken a##11##2##(1991-1#1)(1991-10#1)(1994-3#1)(1997-3#1)(1997-6#2)(2006-4#1)(2008-1#1)(2008-12#1)(2012-2#2)
taken advantage of##2##3##(1997-3#1)(2010-8#1)
taken after the##3##3##(1994-4#1)(2007-11#1)(2008-11#1)
taken after##12##2##(1990-4#1)(1994-4#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-5#3)(2013-1#2)
taken along the##2##3##(2008-3#2)
taken an##4##2##(2008-11#1)(2008-12#1)(2009-4#1)(2013-1#1)
taken and the##4##3##(2007-2#1)(2008-11#1)(2010-8#1)(2013-1#1)
taken and##17##2##(1995-6#1)(1996-12#1)(1997-6#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
taken any##3##2##(2008-3#1)(2013-1#2)
taken as a model##2##4##(1997-7#1)(2007-6#1)
taken as a reference##3##4##(2005-10#2)(2006-7#1)
taken as a##12##3##(1990-7#1)(1992-6#1)(1997-7#1)(2005-10#2)(2006-7#1)(2007-6#1)(2007-7#1)(2008-2#2)(2008-8#1)(2012-2#1)
taken as an indication of the##2##6##(1997-4#1)(2008-5#1)
taken as an indication##3##4##(1997-4#1)(2005-11#1)(2008-5#1)
taken as an##10##3##(1996-5#1)(1997-4#1)(2005-11#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-5#1)
taken as control##4##3##(2006-4#1)(2007-1#1)(2008-5#1)(2012-3#1)
taken as evidence of##2##4##(2005-7#1)(2008-10#1)
taken as evidence that the##2##5##(2006-2#1)(2007-12#1)
taken as evidence that##4##4##(2004-12#1)(2006-2#1)(2007-12#1)(2008-11#1)
taken as evidence##7##3##(2004-12#1)(2005-7#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
taken as the##12##3##(1992-12#1)(1996-7#1)(2006-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#2)(2011-1#1)(2011-2#1)(2013-8#1)
taken as##74##2##(1990-12#1)(1990-7#1)(1990-8#1)(1992-11#1)(1992-12#2)(1992-6#1)(1993-2#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-12#1)(2005-10#2)(2005-11#1)(2005-7#1)(2006-2#1)(2006-4#3)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#4)(2007-8#3)(2008-1#1)(2008-10#10)(2008-11#3)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#5)(2008-8#2)(2009-4#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
taken at 0##2##3##(2006-8#1)(2011-2#1)
taken at 23##2##3##(2006-7#2)
taken at a##3##3##(2008-12#1)(2008-2#1)(2008-3#1)
taken at days##2##3##(2008-7#2)
taken at different##2##3##(2007-12#1)(2008-3#1)
taken at the end of round##3##6##(1997-4#3)
taken at the end of##5##5##(1997-4#5)
taken at the greatest diameter of the femoral head##2##9##(2007-7#2)
taken at the time of##2##5##(2009-1#1)(2011-2#1)
taken at the##19##3##(1991-12#1)(1991-7#1)(1994-3#1)(1997-4#5)(2006-10#1)(2007-12#1)(2007-7#2)(2008-10#1)(2009-1#1)(2011-2#1)(2012-12#3)(2013-1#1)
taken at three##2##3##(2005-11#1)(2008-1#1)
taken at##60##2##(1990-3#1)(1991-12#1)(1991-7#1)(1991-9#1)(1994-2#1)(1994-3#1)(1995-9#1)(1997-4#5)(2005-11#1)(2006-10#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-10#1)(2007-12#2)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-2#2)(2008-3#5)(2008-5#3)(2008-7#2)(2009-1#1)(2009-10#1)(2010-2#2)(2010-3#1)(2011-2#3)(2012-12#4)(2013-1#3)(2013-8#1)
taken away##3##2##(1992-5#1)(1997-1#1)(2008-3#1)
taken based on##2##3##(1996-9#1)(2012-2#1)
taken before and after##6##4##(1990-12#1)(2007-7#1)(2007-8#1)(2008-2#1)(2012-1#1)(2013-8#1)
taken before and##10##3##(1990-12#1)(1995-1#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-2#1)(2011-2#1)(2012-1#1)(2013-8#1)
taken before the##3##3##(1992-1#1)(2008-5#1)(2010-12#1)
taken before##23##2##(1990-12#1)(1990-3#1)(1991-3#1)(1992-1#1)(1992-3#1)(1995-1#1)(2006-3#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
taken between##4##2##(2007-12#1)(2007-2#1)(2007-5#1)(2008-3#1)
taken by a##3##3##(2007-7#1)(2008-2#1)(2010-7#1)
taken by the government##3##4##(2007-7#1)(2008-9#1)(2010-1#1)
taken by the nurse##2##4##(2010-7#2)
taken by the##22##3##(1990-8#1)(1991-3#1)(1995-12#1)(2006-2#1)(2006-4#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-3#1)(2008-4#1)(2008-9#1)(2010-1#1)(2010-7#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
taken by##45##2##(1990-8#1)(1991-3#1)(1993-3#1)(1995-12#1)(1996-7#1)(2006-2#1)(2006-4#2)(2007-1#1)(2007-10#3)(2007-12#1)(2007-4#3)(2007-7#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-1#1)(2010-4#1)(2010-7#4)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
taken care of##4##3##(1992-6#1)(1997-5#1)(2011-1#1)(2011-3#1)
taken during a##2##3##(2008-8#1)(2012-12#1)
taken during the##6##3##(1990-8#1)(2004-11#1)(2007-5#1)(2008-2#1)(2011-1#1)(2011-2#1)
taken during##16##2##(1990-8#1)(1990-9#1)(1991-3#1)(1993-12#1)(1993-4#1)(1995-7#1)(1996-7#1)(2004-11#1)(2007-5#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
taken early##3##2##(2004-9#1)(2006-8#1)(2007-9#1)
taken every 2##3##3##(1991-3#1)(2006-2#1)(2010-12#1)
taken every##4##2##(1991-3#1)(2006-2#1)(2007-3#1)(2010-12#1)
taken for a##2##3##(2008-4#1)(2010-12#1)
taken for analysis##4##3##(2007-8#1)(2008-10#2)(2012-12#1)
taken for each##4##3##(2007-7#2)(2008-10#1)(2008-3#1)
taken for granted that##2##4##(1997-4#1)(2008-11#1)
taken for granted##6##3##(1993-10#1)(1997-4#1)(2007-12#1)(2008-11#1)(2008-6#1)(2012-12#1)
taken for the##7##3##(1993-2#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-8#1)(2013-1#2)
taken for##56##2##(1990-10#2)(1990-12#1)(1990-9#1)(1991-3#1)(1991-8#1)(1992-12#1)(1993-10#1)(1993-2#1)(1994-12#1)(1994-7#1)(1995-3#1)(1996-2#1)(1997-4#1)(2005-1#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-8#1)(2010-1#1)(2010-12#3)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
taken four##3##2##(1997-3#1)(2008-3#1)(2010-4#1)
taken from 10##2##3##(1997-3#1)(2009-8#1)
taken from a control##2##4##(1992-7#1)(2004-4#1)
taken from a##11##3##(1992-7#1)(2004-4#1)(2007-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-8#1)(2011-1#1)(2012-12#1)
taken from all##3##3##(2006-8#1)(2008-5#1)(2011-1#1)
taken from an##6##3##(2008-10#4)(2010-3#1)(2010-8#1)
taken from blood##2##3##(2008-7#1)(2010-6#1)
taken from depths of##2##4##(2006-12#1)(2008-10#1)
taken from different##4##3##(1993-6#1)(1995-6#2)(2008-10#1)
taken from each##6##3##(1993-3#1)(2006-12#1)(2008-10#2)(2008-5#1)(2012-12#1)
taken from eight##2##3##(2008-5#1)(2010-5#1)
taken from patients with##3##4##(2007-7#1)(2007-9#1)(2008-7#1)
taken from patients##4##3##(2007-7#2)(2007-9#1)(2008-7#1)
taken from rats##2##3##(1997-2#1)(2008-3#1)
taken from several##2##3##(2007-2#1)(2010-5#1)
taken from the iliac crest##2##5##(2007-11#1)(2007-7#1)
taken from the literature##5##4##(1995-6#1)(2007-4#1)(2008-10#2)(2008-2#1)
taken from the same##2##4##(2007-5#1)(2008-5#1)
taken from the##62##3##(1991-2#1)(1992-7#1)(1995-12#1)(1995-5#2)(1995-6#1)(1996-12#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-10#1)(2006-4#1)(2006-5#1)(2007-11#3)(2007-12#3)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#2)(2010-10#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#8)(2013-8#3)
taken from these##2##3##(2008-10#1)(2010-4#1)
taken from two##2##3##(2007-12#1)(2008-10#1)
taken from##195##2##(1990-12#1)(1990-8#1)(1990-9#1)(1991-2#1)(1992-7#2)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#1)(1995-11#1)(1995-12#1)(1995-5#2)(1995-6#5)(1995-7#1)(1996-1#1)(1996-11#3)(1996-12#2)(1996-6#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#2)(2004-10#1)(2004-11#1)(2004-4#1)(2005-11#1)(2006-10#4)(2006-11#2)(2006-12#4)(2006-4#1)(2006-5#1)(2006-7#3)(2006-8#1)(2007-11#3)(2007-12#5)(2007-2#2)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-10#29)(2008-11#4)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#15)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#3)(2011-1#5)(2011-12#1)(2011-2#6)(2012-12#4)(2012-2#4)(2013-1#10)(2013-8#5)
taken in 1984##2##3##(1990-12#1)(1993-1#1)
taken in a##4##3##(1997-4#2)(2008-10#1)(2008-3#1)
taken in instrument##2##3##(2006-6#2)
taken in the same##3##4##(2007-7#1)(2010-3#1)(2012-1#1)
taken in the##19##3##(1990-7#1)(1990-8#1)(1992-11#1)(1992-4#1)(1996-7#1)(1997-3#1)(2005-4#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-3#1)(2010-4#1)(2011-12#1)(2012-1#1)(2013-7#2)
taken in##61##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-4#1)(1992-11#1)(1992-4#1)(1993-1#1)(1994-11#1)(1995-11#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-4#2)(2005-4#1)(2006-2#1)(2006-4#4)(2006-6#2)(2006-9#1)(2007-12#1)(2007-7#3)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-12#1)(2010-3#1)(2010-4#2)(2011-12#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#3)
taken into account and##3##4##(1994-4#1)(2007-11#1)(2008-7#1)
taken into account by means of##2##6##(1991-9#1)(2008-2#1)
taken into account by the##3##5##(2006-7#1)(2011-3#1)(2012-1#1)
taken into account by##13##4##(1991-9#1)(1993-1#1)(1993-12#1)(2006-7#1)(2008-10#3)(2008-2#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#1)
taken into account for the##4##5##(2006-4#1)(2007-5#1)(2008-3#1)(2008-5#1)
taken into account for##11##4##(1995-2#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-5#1)(2013-7#1)
taken into account in a##3##5##(2008-2#2)(2013-1#1)
taken into account in order to##3##6##(2007-8#1)(2008-10#1)(2011-2#1)
taken into account in order##4##5##(1992-3#1)(2007-8#1)(2008-10#1)(2011-2#1)
taken into account in the##19##5##(1990-3#1)(1994-12#1)(1994-3#1)(1995-3#1)(1997-1#1)(2004-4#1)(2006-1#1)(2006-11#1)(2007-12#2)(2008-10#2)(2008-2#4)(2008-3#1)(2009-5#1)(2011-2#1)
taken into account in##43##4##(1990-3#1)(1992-2#1)(1992-3#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-3#1)(1997-1#1)(2004-4#1)(2005-11#1)(2006-1#1)(2006-11#1)(2006-12#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-10#5)(2008-2#10)(2008-3#1)(2008-5#1)(2009-5#1)(2011-2#2)(2012-12#1)(2013-1#3)
taken into account the##3##4##(1994-11#1)(2007-9#1)(2008-10#1)
taken into account to##7##4##(1991-3#1)(2008-10#1)(2009-8#1)(2010-4#2)(2011-2#1)(2012-2#1)
taken into account##195##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#2)(1993-1#1)(1993-11#2)(1993-12#2)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#2)(1994-9#1)(1995-1#2)(1995-2#1)(1995-3#1)(1996-3#3)(1996-9#1)(1997-1#2)(1997-6#1)(2004-4#1)(2005-1#1)(2005-10#1)(2005-11#3)(2005-5#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-4#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#16)(2008-11#3)(2008-2#21)(2008-3#17)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#3)(2009-2#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#7)(2013-7#3)(2013-8#1)
taken into consideration and##3##4##(1992-6#1)(2006-10#1)(2008-7#1)
taken into consideration by the##2##5##(2005-11#1)(2008-11#1)
taken into consideration for##3##4##(2008-10#1)(2010-11#1)(2010-12#1)
taken into consideration in##10##4##(1991-11#1)(1994-3#1)(2006-8#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2013-8#1)
taken into consideration##56##3##(1990-6#1)(1991-11#1)(1992-4#1)(1992-6#1)(1992-7#1)(1994-3#1)(1994-4#1)(1995-5#2)(2005-11#2)(2006-10#3)(2006-3#1)(2006-8#1)(2007-11#4)(2007-12#3)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#5)(2008-6#1)(2008-7#2)(2009-4#3)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
taken into##256##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-6#2)(1992-7#3)(1993-1#1)(1993-11#2)(1993-12#2)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-4#3)(1994-9#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-5#2)(1996-3#3)(1996-9#1)(1997-1#2)(1997-6#1)(2004-4#1)(2005-1#1)(2005-10#1)(2005-11#5)(2005-5#1)(2005-7#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-7#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#10)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#19)(2008-11#4)(2008-12#1)(2008-2#24)(2008-3#22)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#4)(2009-2#1)(2009-4#5)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#9)(2013-7#4)(2013-8#2)
taken is##2##2##(1990-12#1)(1995-2#1)
taken not##2##2##(2008-7#1)(2008-8#1)
taken of each##2##3##(2006-11#1)(2012-3#1)
taken of the##6##3##(1991-4#1)(1991-8#1)(1993-11#1)(1996-7#1)(2007-12#1)(2013-1#1)
taken of##13##2##(1991-4#2)(1991-8#1)(1993-11#1)(1995-6#1)(1996-7#1)(2006-11#1)(2006-12#1)(2007-12#1)(2008-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
taken off##3##2##(1995-12#1)(2006-10#1)(2008-10#1)
taken on a##2##3##(2008-1#1)(2008-2#1)
taken on admission##2##3##(2005-6#1)(2008-10#1)
taken on the##3##3##(2006-2#1)(2009-10#1)(2010-12#1)
taken on##21##2##(1992-9#1)(1993-1#1)(1993-2#1)(1995-2#1)(1996-12#1)(1996-3#1)(2004-2#1)(2005-6#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-6#1)(2011-2#1)
taken one##3##2##(2007-5#1)(2007-7#1)(2008-10#1)
taken orally##3##2##(1990-4#1)(2008-1#1)(2009-6#1)
taken out from the##3##4##(2005-11#1)(2006-7#1)(2008-10#1)
taken out of the##2##4##(1990-9#1)(1997-6#1)
taken out##6##2##(1990-9#1)(1997-6#1)(2005-11#1)(2006-7#1)(2007-8#1)(2008-10#1)
taken over by##3##3##(2005-7#1)(2010-8#1)(2011-2#1)
taken over the##3##3##(1994-6#1)(2008-3#2)
taken over##10##2##(1992-10#1)(1992-9#1)(1994-5#1)(1994-6#1)(1995-12#1)(2005-7#1)(2008-3#2)(2010-8#1)(2011-2#1)
taken part in##2##3##(1992-7#1)(2010-9#1)
taken part##3##2##(1992-7#1)(2004-2#1)(2010-9#1)
taken place during the##2##4##(2006-10#1)(2006-6#1)
taken place during##4##3##(2006-10#1)(2006-6#1)(2008-12#1)(2012-2#1)
taken place in##8##3##(1991-2#1)(1991-3#1)(1993-8#1)(1995-3#1)(2005-11#1)(2006-10#1)(2008-2#1)(2011-1#1)
taken place##26##2##(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-7#1)(1993-8#1)(1994-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-1#1)(1997-2#1)(2004-4#1)(2005-11#1)(2006-10#2)(2006-6#1)(2008-12#1)(2008-2#1)(2009-4#1)(2011-1#1)(2012-2#2)
taken preoperatively##2##2##(1993-1#1)(2009-6#1)
taken sdNVP##2##2##(2011-1#2)
taken seriously##6##2##(1993-5#1)(1996-12#1)(1996-6#1)(2005-10#1)(2008-10#1)(2008-4#1)
taken simultaneously##3##2##(1993-1#1)(2008-3#1)(2009-10#1)
taken so far##3##3##(1993-8#1)(2008-11#2)
taken so##5##2##(1993-8#1)(1996-12#1)(2008-10#1)(2008-11#2)
taken the##10##2##(1990-4#1)(1992-11#1)(1994-3#2)(1997-6#1)(2007-12#1)(2007-7#1)(2010-12#1)(2011-2#1)(2013-7#1)
taken through a##3##3##(1996-11#1)(2008-5#1)(2011-1#1)
taken through##4##2##(1993-12#1)(1996-11#1)(2008-5#1)(2011-1#1)
taken to a##3##3##(2008-10#2)(2009-3#1)
taken to address##2##3##(2008-4#1)(2012-12#1)
taken to an extreme##2##4##(1990-12#1)(2006-7#1)
taken to avoid##6##3##(2008-10#2)(2008-3#1)(2009-1#1)(2009-11#1)(2013-8#1)
taken to be the##3##4##(2008-10#1)(2008-3#1)(2010-4#1)
taken to be##9##3##(1992-6#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-4#1)
taken to determine the##2##4##(2007-11#1)(2007-3#1)
taken to determine##4##3##(2007-11#1)(2007-3#1)(2010-8#1)(2013-1#1)
taken to develop a##2##4##(1993-1#1)(2007-5#1)
taken to develop##4##3##(1993-1#1)(2007-5#1)(2007-9#1)(2010-11#1)
taken to improve##4##3##(1996-2#1)(2009-4#1)(2010-2#1)(2010-8#1)
taken to indicate##2##3##(1994-8#1)(2008-10#1)
taken to initiate##2##3##(1990-11#1)(2008-11#1)
taken to minimize the##2##4##(1995-12#1)(2008-8#1)
taken to minimize##3##3##(1995-12#1)(2008-8#1)(2010-2#1)
taken to overcome this##2##4##(2008-10#1)(2009-11#1)
taken to overcome##3##3##(2008-10#1)(2009-11#1)(2012-1#1)
taken to prevent the##2##4##(1997-6#1)(2008-10#1)
taken to prevent##4##3##(1994-7#1)(1997-6#1)(2008-10#2)
taken to prioritize##2##3##(2008-12#1)(2012-3#1)
taken to protect##4##3##(1992-3#1)(1996-6#1)(2006-6#1)(2011-2#1)
taken to provide##2##3##(2007-2#1)(2008-5#1)
taken to reduce the##2##4##(2005-7#1)(2008-5#1)
taken to reduce##6##3##(1992-2#1)(1993-1#1)(2005-7#1)(2006-6#1)(2007-10#1)(2008-5#1)
taken to the management of##2##5##(1996-3#1)(1997-3#1)
taken to the##5##3##(1996-3#1)(1997-3#1)(2010-12#1)(2011-12#1)(2013-1#1)
taken to##122##2##(1990-11#1)(1990-12#2)(1990-6#1)(1990-8#1)(1991-2#2)(1992-1#2)(1992-2#2)(1992-3#1)(1992-6#1)(1993-1#2)(1993-12#2)(1993-9#1)(1994-3#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(2004-9#1)(2005-7#1)(2006-2#2)(2006-4#1)(2006-6#2)(2006-7#2)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#4)(2008-8#3)(2008-9#3)(2009-1#1)(2009-11#3)(2009-3#2)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#5)(2012-3#2)(2013-1#3)(2013-8#1)
taken together indicate that##2##4##(1990-7#1)(1996-12#1)
taken together suggest that##3##4##(1990-12#1)(1994-5#1)(2008-5#1)
taken together suggest##4##3##(1990-12#1)(1994-5#1)(1995-6#1)(2008-5#1)
taken together with previous##3##4##(1991-10#1)(1993-12#1)(1994-12#1)
taken together with previously published##2##5##(1996-3#1)(1996-5#1)
taken together with##9##3##(1991-10#1)(1993-12#2)(1993-3#1)(1994-12#1)(1996-3#1)(1996-5#1)(1997-5#1)(2007-1#1)
taken together##23##2##(1990-12#1)(1990-7#1)(1991-10#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-12#2)(1994-5#1)(1995-6#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-5#2)(1997-8#1)(2007-1#1)(2008-11#1)(2008-5#1)
taken towards##2##2##(2008-1#1)(2009-6#1)
taken under the##3##3##(2004-12#1)(2008-11#1)(2012-2#1)
taken under##12##2##(1997-8#1)(2004-12#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-12#1)(2012-2#1)
taken up and degraded##2##4##(1992-5#1)(1995-6#1)
taken up and metabolized by##2##5##(2008-12#1)(2008-5#1)
taken up and##9##3##(1992-5#1)(1992-8#1)(1993-6#1)(1995-6#1)(1996-12#1)(1996-2#1)(2008-12#1)(2008-5#1)(2008-9#1)
taken up by all##3##4##(2010-12#1)(2012-11#2)
taken up by cells##2##4##(1992-2#1)(2008-7#1)
taken up by the cells##3##5##(1992-1#1)(1994-8#1)(2008-10#1)
taken up by the liver##2##5##(1992-4#2)
taken up by the##18##4##(1991-2#1)(1992-1#1)(1992-11#1)(1992-4#2)(1994-12#1)(1994-5#1)(1994-8#1)(1996-9#1)(1997-3#1)(2006-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#1)
taken up by##39##3##(1990-2#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-4#2)(1994-12#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-4#1)(1995-6#2)(1996-9#1)(1997-3#1)(2006-3#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-5#1)(2012-11#2)(2012-2#1)
taken up from the##2##4##(1996-1#1)(2008-11#1)
taken up from##3##3##(1990-2#1)(1996-1#1)(2008-11#1)
taken up in##2##3##(1992-8#1)(2012-2#1)
taken up into the##3##4##(1994-8#1)(1997-4#1)(2007-10#1)
taken up into##6##3##(1992-12#1)(1992-3#1)(1994-8#1)(1997-4#1)(2005-11#1)(2007-10#1)
taken up##76##2##(1990-2#2)(1991-12#1)(1991-2#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#2)(1992-8#2)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-12#2)(1994-5#1)(1994-6#2)(1994-8#2)(1995-11#1)(1995-4#1)(1995-6#3)(1996-1#1)(1996-12#2)(1996-2#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-3#1)(2007-10#1)(2007-12#1)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2010-12#1)(2010-5#1)(2012-11#2)(2012-12#1)(2012-2#3)
taken using##4##2##(1991-4#1)(1993-11#1)(2010-7#1)(2013-8#1)
taken via##2##2##(2008-12#1)(2011-1#1)
taken were##4##2##(1990-11#1)(1996-12#1)(2006-11#1)(2007-6#1)
taken when##9##2##(1995-1#1)(2006-10#1)(2007-2#1)(2008-6#1)(2008-9#1)(2009-6#1)(2009-9#1)(2011-1#1)(2013-8#1)
taken with a##7##3##(2008-2#3)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#1)
taken with food##2##3##(2005-8#1)(2012-12#1)
taken with the##4##3##(1992-11#1)(2007-1#1)(2007-12#1)(2012-3#1)
taken with##26##2##(1992-11#1)(2005-8#1)(2006-3#1)(2007-1#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#5)(2008-5#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)
taken within##3##2##(2007-10#1)(2007-4#1)(2012-12#1)
taken##1464##1##(1990-10#3)(1990-11#3)(1990-12#10)(1990-2#3)(1990-3#5)(1990-4#4)(1990-6#3)(1990-7#3)(1990-8#6)(1990-9#6)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#4)(1991-2#7)(1991-3#9)(1991-4#4)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#5)(1991-9#5)(1992-1#5)(1992-10#1)(1992-11#5)(1992-12#4)(1992-2#4)(1992-3#5)(1992-4#6)(1992-5#3)(1992-6#5)(1992-7#6)(1992-8#3)(1992-9#2)(1993-1#7)(1993-10#1)(1993-11#5)(1993-12#10)(1993-2#3)(1993-3#6)(1993-4#2)(1993-5#3)(1993-6#3)(1993-7#2)(1993-8#2)(1993-9#3)(1994-1#1)(1994-11#2)(1994-12#9)(1994-2#3)(1994-3#10)(1994-4#4)(1994-5#3)(1994-6#5)(1994-7#2)(1994-8#3)(1994-9#3)(1995-1#5)(1995-10#1)(1995-11#6)(1995-12#5)(1995-2#4)(1995-3#4)(1995-4#2)(1995-5#5)(1995-6#13)(1995-7#3)(1995-8#1)(1995-9#2)(1996-1#3)(1996-11#4)(1996-12#11)(1996-2#4)(1996-3#6)(1996-5#3)(1996-6#5)(1996-7#5)(1996-8#1)(1996-9#5)(1997-1#5)(1997-2#4)(1997-3#9)(1997-4#11)(1997-5#5)(1997-6#8)(1997-7#1)(1997-8#2)(2004-10#1)(2004-11#2)(2004-12#2)(2004-2#2)(2004-4#3)(2004-9#3)(2005-1#2)(2005-10#4)(2005-11#11)(2005-4#1)(2005-5#1)(2005-6#1)(2005-7#4)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#19)(2006-11#5)(2006-12#8)(2006-2#8)(2006-3#4)(2006-4#16)(2006-5#2)(2006-6#8)(2006-7#11)(2006-8#11)(2006-9#1)(2007-1#7)(2007-10#14)(2007-11#22)(2007-12#34)(2007-2#8)(2007-3#2)(2007-4#10)(2007-5#11)(2007-6#8)(2007-7#25)(2007-8#22)(2007-9#8)(2008-1#12)(2008-10#113)(2008-11#35)(2008-12#19)(2008-2#49)(2008-3#66)(2008-4#16)(2008-5#50)(2008-6#7)(2008-7#27)(2008-8#18)(2008-9#15)(2009-1#2)(2009-10#5)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#10)(2009-5#3)(2009-6#8)(2009-7#4)(2009-8#3)(2009-9#1)(2010-1#4)(2010-10#1)(2010-11#2)(2010-12#18)(2010-2#7)(2010-3#8)(2010-4#11)(2010-5#9)(2010-6#4)(2010-7#7)(2010-8#17)(2010-9#3)(2011-1#21)(2011-12#4)(2011-2#40)(2011-3#2)(2012-1#6)(2012-11#6)(2012-12#32)(2012-2#30)(2012-3#10)(2013-1#42)(2013-7#12)(2013-8#16)
takeover##2##1##(1995-9#1)(1996-12#1)
takers##6##1##(1994-6#1)(2009-12#3)(2010-4#1)(2012-3#1)
takes a long time##2##4##(2008-3#1)(2010-9#1)
takes a village##2##3##(2008-10#1)(2009-7#1)
takes a##33##2##(1991-1#1)(1992-1#2)(1993-1#2)(1994-1#1)(1995-9#1)(1997-3#1)(1997-5#1)(1997-8#1)(2005-11#2)(2005-9#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-7#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
takes about##4##2##(1990-8#1)(1995-2#1)(2008-10#2)
takes account of the##6##4##(1990-3#1)(1995-2#1)(1996-12#1)(1996-3#1)(2008-10#1)(2013-1#1)
takes account of##9##3##(1990-3#1)(1995-2#1)(1996-12#1)(1996-3#1)(2005-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2013-1#1)
takes advantage of a##4##4##(1996-8#1)(2008-7#1)(2009-5#1)(2011-1#1)
takes advantage of the known##2##5##(2008-2#1)(2008-3#1)
takes advantage of the##20##4##(1991-9#1)(1993-8#1)(1996-12#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#4)(2008-3#2)(2008-4#3)(2008-8#1)(2011-1#1)(2012-3#1)
takes advantage of##34##3##(1991-9#1)(1993-8#1)(1994-3#1)(1996-12#1)(1996-2#1)(1996-8#1)(2006-4#1)(2007-12#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#7)(2008-3#2)(2008-4#5)(2008-7#1)(2008-8#1)(2009-5#1)(2011-1#2)(2012-3#1)
takes aim at##2##3##(1990-3#1)(1994-1#1)
takes an average##2##3##(1994-12#1)(2008-3#1)
takes an##4##2##(1994-12#1)(2008-3#1)(2009-9#1)(2013-1#1)
takes approximately##2##2##(1996-3#1)(2010-12#1)
takes care of##3##3##(1995-6#1)(2008-10#1)(2012-3#1)
takes into account all possible##2##5##(1997-8#1)(2010-2#1)
takes into account all##3##4##(1996-5#1)(1997-8#1)(2010-2#1)
takes into account the##25##4##(1990-5#1)(1990-8#1)(1992-4#1)(1995-4#1)(2005-11#1)(2006-10#1)(2007-11#3)(2007-2#1)(2007-9#2)(2008-10#1)(2008-2#2)(2008-3#5)(2008-5#1)(2009-2#1)(2009-6#1)(2010-5#1)(2010-8#1)
takes into account##48##3##(1990-5#1)(1990-8#1)(1992-4#1)(1994-5#1)(1995-4#1)(1996-5#1)(1997-8#1)(2005-11#3)(2006-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#7)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#2)(2009-6#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2012-2#1)(2012-3#1)
takes into consideration the##3##4##(1990-8#1)(2006-5#1)(2008-10#1)
takes into consideration##5##3##(1990-8#1)(2006-5#1)(2008-10#1)(2008-4#1)(2009-5#1)
takes into##53##2##(1990-5#1)(1990-8#2)(1992-4#1)(1994-5#1)(1995-4#1)(1996-5#1)(1997-8#1)(2005-11#3)(2006-10#1)(2006-5#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-9#2)(2008-10#2)(2008-11#1)(2008-2#6)(2008-3#7)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#2)(2009-5#1)(2009-6#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2012-2#1)(2012-3#1)
takes issue with##2##3##(2012-1#1)(2012-3#1)
takes its##2##2##(1995-1#1)(2008-4#1)
takes less than##5##3##(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#1)
takes less time##2##3##(2006-6#1)(2008-4#1)
takes less##7##2##(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)
takes longer than##2##3##(1997-3#1)(2008-5#1)
takes longer##4##2##(1992-12#1)(1995-2#1)(1997-3#1)(2008-5#1)
takes many forms##3##3##(1996-8#1)(2008-11#1)(2009-4#1)
takes more##2##2##(1996-8#1)(2010-12#1)
takes much time##2##3##(2008-7#1)(2012-3#1)
takes on a##2##3##(1996-11#1)(2010-12#1)
takes on##8##2##(1992-2#1)(1996-11#1)(1997-6#1)(2007-11#1)(2008-11#1)(2008-4#2)(2010-12#1)
takes only##4##2##(1990-4#1)(2007-12#2)(2009-2#1)
takes part in the##2##4##(1992-3#1)(2010-10#1)
takes part in##5##3##(1991-3#1)(1992-3#1)(1995-5#1)(1997-7#1)(2010-10#1)
takes place after##2##3##(1990-8#1)(2006-12#1)
takes place and##2##3##(1990-8#1)(2013-8#1)
takes place as##2##3##(2006-12#1)(2008-10#1)
takes place at a##2##4##(2006-8#1)(2008-10#1)
takes place at the##3##4##(2006-10#1)(2007-8#1)(2008-10#1)
takes place at##8##3##(1990-11#1)(1993-12#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#3)
takes place between##2##3##(2008-2#1)(2009-3#1)
takes place during the##2##4##(1991-2#1)(2008-10#1)
takes place during##3##3##(1991-2#1)(1995-12#1)(2008-10#1)
takes place from the##2##4##(2008-1#1)(2008-10#1)
takes place from##5##3##(2008-1#1)(2008-10#2)(2012-12#2)
takes place in a##2##4##(2008-10#1)(2009-10#1)
takes place in the##14##4##(1991-11#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-8#1)(2012-12#2)
takes place in##26##3##(1991-11#1)(1991-2#1)(1992-6#1)(1993-5#1)(1993-8#1)(1996-11#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2009-10#2)(2009-8#1)(2010-12#1)(2012-12#2)(2012-2#1)(2012-8#1)(2013-8#1)
takes place is##2##3##(2008-9#1)(2009-10#1)
takes place through##4##3##(1990-11#1)(2005-11#1)(2008-5#1)(2009-6#1)
takes place to##2##3##(1995-8#1)(2008-10#1)
takes place when##2##3##(1997-1#1)(2008-10#1)
takes place within##5##3##(1990-3#1)(1992-1#1)(2005-11#1)(2012-12#1)(2012-2#1)
takes place##109##2##(1990-11#2)(1990-3#1)(1990-7#1)(1990-8#2)(1991-11#2)(1991-2#2)(1991-3#1)(1992-1#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-4#2)(1997-1#1)(1997-4#1)(1997-8#1)(2005-11#3)(2006-10#2)(2006-12#3)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#4)(2008-8#1)(2008-9#2)(2009-10#4)(2009-11#2)(2009-3#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-7#1)(2012-12#5)(2012-2#2)(2012-3#1)(2012-8#1)(2013-8#2)
takes shape##3##2##(1996-3#1)(1997-7#1)(2008-2#1)
takes the form of##7##4##(1992-6#1)(1993-2#1)(2007-9#1)(2008-2#1)(2008-3#2)(2011-12#1)
takes the##25##2##(1992-12#1)(1992-6#1)(1993-2#1)(1994-3#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#5)(2008-9#1)(2009-4#1)(2009-6#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-12#1)(2012-9#1)
takes this approach##2##3##(2008-6#1)(2012-2#1)
takes this##3##2##(1991-3#1)(2008-6#1)(2012-2#1)
takes time and##2##3##(2009-4#1)(2010-4#1)
takes time##3##2##(2005-9#1)(2009-4#1)(2010-4#1)
takes to##9##2##(1992-1#1)(1993-12#1)(1993-3#1)(1997-3#1)(2008-1#1)(2008-7#1)(2010-5#1)(2010-9#1)(2012-3#1)
takes toll in##2##3##(1997-6#2)
takes toll##3##2##(1994-9#1)(1997-6#2)
takes up##5##2##(1990-12#1)(1992-3#1)(1994-11#1)(1995-2#1)(2005-11#1)
takes us##2##2##(2008-11#1)(2010-3#1)
takes##411##1##(1990-11#2)(1990-12#1)(1990-3#3)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#6)(1991-1#1)(1991-11#2)(1991-2#2)(1991-3#3)(1991-9#1)(1992-1#4)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#2)(1993-8#2)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#4)(1995-4#1)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#1)(1995-9#1)(1996-11#2)(1996-12#2)(1996-2#4)(1996-3#4)(1996-4#2)(1996-5#1)(1996-8#3)(1997-1#1)(1997-3#4)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#3)(2005-10#1)(2005-11#10)(2005-12#2)(2005-2#1)(2005-9#2)(2006-10#6)(2006-12#4)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#2)(2007-11#7)(2007-12#10)(2007-2#4)(2007-3#2)(2007-6#1)(2007-8#3)(2007-9#7)(2008-1#5)(2008-10#36)(2008-11#13)(2008-12#3)(2008-2#20)(2008-3#23)(2008-4#13)(2008-5#7)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#4)(2009-10#5)(2009-11#3)(2009-2#3)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#4)(2010-12#7)(2010-2#2)(2010-3#5)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#5)(2012-2#6)(2012-3#10)(2012-8#1)(2012-9#1)(2013-1#2)(2013-8#5)
taking ASA##2##2##(2007-9#2)
taking COX-2 selective##2##3##(2006-10#1)(2011-2#1)
taking NSAIDs##2##2##(1995-3#1)(2011-2#1)
taking OC##3##2##(1990-11#2)(2008-11#1)
taking OCs##3##2##(1990-11#3)
taking SSRIs##2##2##(2011-1#1)(2011-2#1)
taking a hard look at##2##5##(1990-4#1)(1993-3#1)
taking a more##2##3##(2008-8#1)(2012-12#1)
taking a##28##2##(1990-10#1)(1990-4#1)(1991-2#1)(1992-3#1)(1993-3#1)(1993-9#1)(1994-6#1)(1995-6#1)(1997-8#1)(2005-11#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-2#1)(2010-7#1)(2012-12#2)(2012-2#2)(2013-1#1)
taking account of the##2##4##(2006-10#1)(2008-3#1)
taking account of##4##3##(1997-1#1)(2006-10#1)(2008-11#1)(2008-3#1)
taking action##3##2##(1993-3#1)(2010-10#1)(2010-2#1)
taking advantage of its##2##4##(2008-2#1)(2009-10#1)
taking advantage of the rapid##2##5##(2009-12#1)(2010-7#1)
taking advantage of the##24##4##(1990-10#1)(1993-9#1)(1995-3#2)(1996-12#1)(1997-3#1)(2007-12#2)(2008-10#3)(2008-2#2)(2008-4#2)(2008-6#1)(2008-7#1)(2009-12#1)(2009-2#1)(2010-7#1)(2012-11#3)(2012-3#1)
taking advantage of##38##3##(1990-10#1)(1991-9#1)(1993-3#1)(1993-9#1)(1995-3#2)(1996-1#1)(1996-12#1)(1997-3#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#5)(2008-4#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-5#1)(2010-7#1)(2012-11#5)(2012-3#1)
taking all##3##2##(2008-2#1)(2008-7#1)(2013-7#1)
taking an active##3##3##(1992-12#1)(1992-3#1)(2008-5#1)
taking an##12##2##(1992-12#1)(1992-3#1)(1995-6#2)(1997-7#1)(2007-12#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-5#2)
taking and##7##2##(1995-2#1)(1997-3#1)(2006-10#1)(2008-6#1)(2009-5#1)(2011-1#1)(2011-2#1)
taking anticoagulation medication##2##3##(2006-10#1)(2007-12#1)
taking antihypertensive##2##2##(2008-8#2)
taking antiretroviral##2##2##(2009-4#1)(2012-2#1)
taking any##2##2##(1992-2#1)(2007-8#1)
taking as an example the##2##5##(1994-6#1)(2007-5#1)
taking as an example##3##4##(1994-6#1)(2007-5#2)
taking as its##3##3##(1993-6#1)(2009-4#1)(2012-12#1)
taking as##8##2##(1991-9#1)(1993-6#1)(1994-6#1)(2007-5#2)(2008-11#1)(2009-4#1)(2012-12#1)
taking aspirin##3##2##(2006-8#1)(2007-9#1)(2008-8#1)
taking aspirin/clopidogrel and/or##2##3##(2007-8#2)
taking care of patients##2##4##(1991-6#1)(2007-10#1)
taking care of the##2##4##(1990-10#1)(2008-10#1)
taking care of##6##3##(1990-10#1)(1991-6#1)(2005-10#1)(2006-1#1)(2007-10#1)(2008-10#1)
taking care##7##2##(1990-10#1)(1991-6#1)(2005-10#1)(2006-1#1)(2007-10#1)(2008-10#1)(2008-11#1)
taking clopidogrel##3##2##(2008-3#2)(2008-8#1)
taking drugs##3##2##(2008-7#3)
taking during##2##2##(2008-11#1)(2010-8#1)
taking from##2##2##(1994-12#1)(2009-9#1)
taking full advantage of##2##4##(2008-3#1)(2012-2#1)
taking high##2##2##(2007-10#1)(2013-1#1)
taking in##3##2##(1993-11#1)(1995-5#1)(2008-10#1)
taking into account a##3##4##(1997-6#1)(2007-12#1)(2008-8#1)
taking into account all the##2##5##(2006-5#1)(2008-9#1)
taking into account all##4##4##(2006-5#1)(2008-10#1)(2008-3#1)(2008-9#1)
taking into account an individual patient's medical condition##2##8##(2006-8#2)
taking into account an##3##4##(2005-11#1)(2006-8#2)
taking into account both the##3##5##(1996-8#1)(2007-12#1)(2012-12#1)
taking into account both##7##4##(1995-1#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-6#1)(2012-12#1)
taking into account data##2##4##(2008-2#2)
taking into account different##2##4##(2008-10#1)(2009-12#1)
taking into account of##2##4##(2008-10#1)(2008-2#1)
taking into account that##2##4##(1992-8#1)(1996-8#1)
taking into account the different##2##5##(1994-2#1)(2006-11#1)
taking into account the effects of##2##6##(2007-4#1)(2008-10#1)
taking into account the effects##3##5##(1990-8#1)(2007-4#1)(2008-10#1)
taking into account the influence of##2##6##(2005-11#1)(2008-2#1)
taking into account the type of##2##6##(2007-6#1)(2011-2#1)
taking into account the##73##4##(1990-10#2)(1990-3#2)(1990-8#1)(1991-4#1)(1991-7#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#1)(1994-2#1)(1995-1#1)(1996-1#1)(2005-11#3)(2005-5#1)(2005-8#1)(2006-11#1)(2006-2#1)(2006-6#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#9)(2008-3#9)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
taking into account this##2##4##(2008-11#1)(2008-7#1)
taking into account##136##3##(1990-10#2)(1990-11#1)(1990-3#2)(1990-8#1)(1991-4#1)(1991-7#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-4#1)(1996-1#1)(1996-8#2)(1997-6#1)(2005-11#6)(2005-12#1)(2005-5#1)(2005-8#1)(2005-9#1)(2006-11#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-12#6)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#16)(2008-3#11)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-1#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-4#2)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#4)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
taking into consideration the##12##4##(1995-9#1)(1996-4#1)(2005-11#1)(2006-8#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-2#2)(2008-8#1)(2008-9#1)(2013-7#1)
taking into consideration##15##3##(1993-3#1)(1995-9#1)(1996-2#1)(1996-4#1)(2005-11#1)(2006-8#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-2#2)(2008-8#1)(2008-9#1)(2009-4#1)(2013-7#1)
taking into##151##2##(1990-10#2)(1990-11#1)(1990-3#2)(1990-8#1)(1991-4#1)(1991-7#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-4#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-8#2)(1997-6#1)(2005-11#7)(2005-12#1)(2005-5#1)(2005-8#1)(2005-9#1)(2006-11#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#3)(2007-10#1)(2007-11#1)(2007-12#6)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#18)(2008-3#11)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#3)(2009-1#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-4#2)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#4)(2012-3#1)(2013-1#2)(2013-7#3)(2013-8#1)
taking it##3##2##(2008-5#1)(2009-7#1)(2010-1#1)
taking less##2##2##(2007-2#1)(2008-10#1)
taking medication##5##2##(2005-9#1)(2008-7#2)(2009-7#1)(2010-1#1)
taking medications and##2##3##(2008-9#2)
taking medications##4##2##(2005-6#1)(2006-7#1)(2008-9#2)
taking non-steroidal##3##2##(1995-3#1)(1996-3#2)
taking nonsteroidal##2##2##(2007-7#1)(2008-11#1)
taking on the##2##3##(2008-8#1)(2013-8#1)
taking on##8##2##(1992-1#1)(2008-1#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-12#1)(2012-2#1)(2013-8#1)
taking one##3##2##(2004-11#1)(2006-12#1)(2008-3#1)
taking oral contraceptives##4##3##(1990-11#1)(2004-3#1)(2007-8#1)(2009-8#1)
taking other##4##2##(1993-12#1)(2006-7#1)(2008-9#1)(2011-1#1)
taking part in##5##3##(2007-11#1)(2007-7#1)(2008-11#1)(2008-8#1)(2009-11#1)
taking place after##2##3##(1993-10#1)(1993-5#1)
taking place at home##2##4##(2008-3#1)(2012-12#1)
taking place at##6##3##(2007-11#1)(2008-10#2)(2008-3#1)(2010-7#1)(2012-12#1)
taking place both in##2##4##(1994-2#1)(1995-3#1)
taking place during##5##3##(1991-12#1)(1996-4#1)(2006-12#1)(2007-5#1)(2008-10#1)
taking place in the##8##4##(2006-10#1)(2007-11#3)(2008-10#1)(2008-12#1)(2012-12#1)(2013-1#1)
taking place in##19##3##(1991-11#1)(1996-2#1)(2005-7#1)(2006-10#2)(2007-11#5)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2010-11#1)(2010-12#1)(2012-12#1)(2013-1#1)
taking place on the##4##4##(2005-11#1)(2007-11#1)(2008-10#1)(2008-8#1)
taking place within the##2##4##(2008-11#1)(2010-10#1)
taking place##60##2##(1990-2#1)(1991-11#1)(1991-12#1)(1992-2#1)(1993-10#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-2#1)(1996-4#2)(1997-4#1)(2005-11#2)(2005-7#1)(2006-10#2)(2006-12#1)(2007-11#7)(2007-2#2)(2007-5#2)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#3)
taking placebo##2##2##(1991-11#1)(2008-5#1)
taking preventative##2##2##(2007-2#1)(2012-3#1)
taking special##2##2##(1991-11#1)(2008-10#1)
taking statins##4##2##(2007-8#1)(2013-1#3)
taking steps##2##2##(1994-1#1)(1997-6#1)
taking stock of##2##3##(1997-2#1)(2006-5#1)
taking stock##5##2##(1994-2#1)(1997-2#1)(2006-5#1)(2008-12#1)(2010-12#1)
taking the drugs##3##3##(2007-7#1)(2008-11#2)
taking the form of##2##4##(1992-11#1)(2007-12#1)
taking the sample##2##3##(2008-10#2)
taking the##41##2##(1991-2#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-7#1)(1996-12#1)(1997-3#2)(2005-12#1)(2005-7#1)(2006-10#1)(2006-7#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)
taking their children to HIV care##2##6##(2012-12#2)
taking their##7##2##(1995-12#1)(1996-3#1)(2010-1#2)(2011-1#1)(2012-12#2)
taking these##4##2##(1990-8#1)(2006-12#1)(2007-6#1)(2008-7#1)
taking to##2##2##(1997-2#1)(2005-8#1)
taking treatment in##3##3##(2007-7#2)(2010-4#1)
taking treatment##5##2##(2007-7#2)(2010-4#3)
taking up the##2##3##(1994-9#1)(2008-11#1)
taking up##6##2##(1991-8#1)(1994-9#1)(2007-8#1)(2008-11#1)(2011-1#2)
taking warfarin##4##2##(2006-8#4)
taking##658##1##(1990-10#5)(1990-11#12)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#1)(1990-8#2)(1991-10#1)(1991-11#4)(1991-12#1)(1991-2#4)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#3)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-10#2)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#5)(1993-4#1)(1993-5#2)(1993-6#2)(1993-7#1)(1993-9#4)(1994-1#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-6#3)(1994-7#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#5)(1995-4#1)(1995-5#1)(1995-6#4)(1995-7#1)(1995-9#1)(1996-1#5)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#4)(1996-4#3)(1996-5#1)(1996-8#2)(1997-1#2)(1997-2#2)(1997-3#6)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#1)(2004-11#1)(2004-3#1)(2004-4#1)(2005-10#1)(2005-11#10)(2005-12#2)(2005-3#1)(2005-5#2)(2005-6#1)(2005-7#2)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#13)(2006-11#1)(2006-12#4)(2006-2#2)(2006-3#1)(2006-5#3)(2006-6#1)(2006-7#7)(2006-8#9)(2006-9#1)(2007-10#6)(2007-11#14)(2007-12#17)(2007-2#6)(2007-4#1)(2007-5#5)(2007-6#2)(2007-7#13)(2007-8#11)(2007-9#8)(2008-1#5)(2008-10#37)(2008-11#30)(2008-12#5)(2008-2#29)(2008-3#23)(2008-4#5)(2008-5#7)(2008-6#6)(2008-7#14)(2008-8#14)(2008-9#10)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#4)(2009-3#4)(2009-4#4)(2009-5#5)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#4)(2010-10#3)(2010-11#1)(2010-12#4)(2010-2#4)(2010-3#2)(2010-4#9)(2010-5#1)(2010-6#3)(2010-7#4)(2010-8#4)(2011-1#16)(2011-12#3)(2011-2#14)(2011-3#1)(2012-1#1)(2012-11#5)(2012-12#14)(2012-2#9)(2012-3#3)(2012-4#1)(2013-1#16)(2013-7#4)(2013-8#5)
talar body fracture##3##3##(2007-4#1)(2010-5#2)
talar body##4##2##(2007-4#1)(2010-3#1)(2010-5#2)
talar cartilage##2##2##(1991-10#2)
talar dome##2##2##(2006-3#1)(2011-2#1)
talar neck##3##2##(2007-1#1)(2007-4#1)(2008-12#1)
talar osteitis##2##2##(2009-3#2)
talar##15##1##(1991-10#2)(2006-3#1)(2007-1#1)(2007-4#2)(2007-9#1)(2008-12#1)(2009-1#1)(2009-3#2)(2010-3#1)(2010-5#2)(2011-2#1)
talbot array illuminators##2##3##(2008-2#2)
talbot array##3##2##(2008-2#2)(2008-3#1)
talbot##6##1##(2008-2#3)(2008-3#3)
talc pleurodesis##6##2##(2006-10#1)(2007-3#1)(2007-8#1)(2008-1#3)
talc##16##1##(1993-9#3)(2005-11#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-1#4)(2008-10#2)(2008-5#2)(2011-2#1)
tale of two##8##3##(1993-6#1)(1993-9#1)(2007-7#1)(2007-9#1)(2009-3#1)(2009-5#1)(2011-1#1)(2013-1#1)
tale of##13##2##(1993-6#1)(1993-9#1)(1996-1#1)(2006-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2009-3#1)(2009-5#1)(2010-6#1)(2011-1#1)(2013-1#2)
tale##25##1##(1993-6#1)(1993-9#1)(1994-2#1)(1995-2#1)(1996-1#1)(2005-8#1)(2006-12#2)(2007-12#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-11#1)(2008-4#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
talent identification##2##2##(2013-7#2)
talent##12##1##(1994-2#1)(1995-1#1)(2007-8#3)(2007-9#1)(2008-12#2)(2008-7#1)(2012-3#1)(2013-7#2)
talented##4##1##(1990-4#1)(2004-3#1)(2007-3#1)(2010-9#1)
talents to##2##2##(1991-12#1)(2008-10#1)
talents##4##1##(1991-12#1)(2006-9#1)(2008-1#1)(2008-10#1)
tales from##2##2##(1995-1#1)(1995-12#1)
tales of##3##2##(2004-12#1)(2007-8#1)(2013-1#1)
tales##7##1##(1995-1#1)(1995-12#1)(2004-12#1)(2007-8#1)(2007-9#1)(2013-1#1)(2013-8#1)
talin and actin##2##3##(1990-9#1)(1993-4#1)
talin and##6##2##(1990-9#3)(1991-7#2)(1993-4#1)
talin##22##1##(1990-9#8)(1991-7#4)(1993-4#4)(1994-8#1)(2006-10#3)(2009-7#1)(2012-2#1)
talipes##3##1##(1990-9#1)(2008-7#1)(2009-7#1)
talk about emotions##2##3##(2012-12#2)
talk about the##3##3##(1995-2#1)(1995-7#1)(2011-2#1)
talk about##10##2##(1995-2#1)(1995-7#1)(2008-6#2)(2011-2#1)(2012-12#2)(2012-3#3)
talk and##10##2##(2007-12#1)(2008-2#4)(2008-3#3)(2008-8#1)(2012-12#1)
talk at##3##2##(2006-12#2)(2008-2#1)
talk begins##2##2##(1994-3#1)(2011-2#1)
talk between the##3##3##(1994-8#1)(2008-2#1)(2008-3#1)
talk between##18##2##(1994-8#1)(1996-4#2)(1997-6#1)(2007-10#1)(2007-12#1)(2008-2#3)(2008-3#5)(2009-8#1)(2012-12#1)(2013-1#2)
talk by##2##2##(2008-3#1)(2010-4#1)
talk for##2##2##(2008-5#1)(2012-2#1)
talk in##10##2##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#4)
talk of wavelength-multiplexed quasi-infinite##2##4##(2007-12#2)
talk of##14##2##(1993-6#1)(1995-12#1)(2007-12#2)(2008-2#4)(2008-3#5)(2008-8#1)
talk on##2##2##(1994-2#1)(2008-2#1)
talk to each other##2##4##(1997-1#1)(2010-9#1)
talk to their##2##3##(2012-12#1)(2013-1#1)
talk to##7##2##(1997-1#1)(2007-7#1)(2009-7#1)(2010-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
talk will##4##2##(2007-11#1)(2008-3#1)(2008-7#1)(2009-4#1)
talk with##2##2##(2009-11#1)(2009-12#1)
talk##141##1##(1990-5#1)(1993-5#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-8#3)(1995-12#1)(1995-2#1)(1995-7#1)(1996-4#2)(1997-1#1)(1997-4#1)(1997-6#1)(2006-12#3)(2006-8#1)(2007-10#1)(2007-11#6)(2007-12#15)(2007-7#1)(2007-9#2)(2008-2#31)(2008-3#27)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#6)(2012-2#1)(2012-3#5)(2013-1#4)
talked about##5##2##(1994-3#1)(1996-11#1)(2007-7#1)(2013-1#2)
talked to##3##2##(1996-2#1)(1996-8#1)(2007-8#1)
talked##8##1##(1994-3#1)(1996-11#1)(1996-2#1)(1996-8#1)(2007-7#1)(2007-8#1)(2013-1#2)
talking about the##3##3##(1996-5#1)(2007-8#1)(2008-12#1)
talking about##8##2##(1992-3#1)(1994-3#1)(1996-5#1)(2007-8#1)(2008-12#1)(2008-5#1)(2009-5#1)(2011-2#1)
talking and##2##2##(2010-8#1)(2012-12#1)
talking to##2##2##(1992-3#2)
talking##14##1##(1992-3#3)(1994-3#1)(1996-5#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)
talks and##2##2##(2008-7#1)(2010-12#1)
talks from##2##2##(2006-12#1)(2008-7#1)
talks on##2##2##(1994-6#1)(2005-9#1)
talks to##2##2##(2008-7#1)(2011-2#1)
talks with##5##2##(1990-6#1)(1991-2#1)(1993-8#1)(1995-5#1)(2008-7#1)
talks##29##1##(1990-6#1)(1991-2#1)(1992-9#1)(1993-8#1)(1994-6#1)(1995-5#1)(2005-8#2)(2005-9#1)(2006-12#1)(2007-5#1)(2007-7#2)(2008-2#1)(2008-7#10)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
tall and##2##2##(2006-9#1)(2012-2#1)
tall fescue (Festuca arundinacea)##6##4##(1994-3#1)(2006-12#1)(2008-10#4)
tall fescue (Festuca##7##3##(1994-3#1)(2006-12#2)(2008-10#4)
tall fescue and##2##3##(2008-10#2)
tall fescue endophytes##4##3##(1994-3#4)
tall fescue leaves##2##3##(2008-10#2)
tall fescue was##2##3##(2008-10#2)
tall fescue##37##2##(1994-3#8)(2006-12#4)(2008-10#22)(2008-2#2)(2008-8#1)
tall stature##5##2##(2004-11#1)(2008-10#2)(2013-1#2)
tall##58##1##(1994-3#9)(2004-11#1)(2006-1#1)(2006-12#4)(2006-6#1)(2006-9#1)(2007-1#1)(2007-5#1)(2008-10#25)(2008-11#1)(2008-2#2)(2008-5#4)(2008-8#1)(2009-2#1)(2009-5#1)(2012-2#1)(2013-1#3)
taller and##2##2##(2007-8#1)(2008-10#1)
taller in##6##2##(2006-10#1)(2008-8#5)
taller stacks##2##2##(2004-4#2)
taller than the##2##3##(2004-2#1)(2010-10#1)
taller than##3##2##(2004-2#1)(2008-10#1)(2010-10#1)
taller##19##1##(2004-2#1)(2004-4#2)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-8#5)(2010-10#1)(2010-2#1)(2013-8#1)
tallied##2##1##(2008-10#1)(2012-2#1)
tallies##2##1##(1992-8#1)(1996-9#1)
tally##3##1##(1996-11#1)(2007-3#1)(2009-3#1)
talo-crural joint##4##2##(2007-11#3)(2007-8#1)
talocalcaneal coalition##3##2##(2010-5#3)
talocalcaneal##8##1##(2007-9#2)(2008-12#1)(2009-10#2)(2010-5#3)
talon cusp##6##2##(2012-2#6)
talonavicular##6##1##(2008-12#1)(2009-10#1)(2010-3#3)(2012-2#1)
talpid3##11##1##(2003-11#11)
taltirelin##4##1##(2005-8#4)
talus and tibia##2##3##(2008-4#2)
talus is##3##2##(2009-10#1)(2010-5#2)
talus##24##1##(1991-10#3)(2006-11#2)(2007-7#1)(2008-12#1)(2008-4#3)(2008-6#1)(2008-8#1)(2009-1#1)(2009-10#2)(2009-5#1)(2010-3#3)(2010-5#4)(2012-2#1)
tamarillo isolates as C##2##4##(2008-10#2)
tamarillo isolates##4##2##(2008-10#4)
tamarillo##9##1##(2008-10#9)
tamarin##4##1##(1994-2#2)(2007-2#2)
tamarind fruit##3##2##(2008-5#3)
tamarind seed xyloglucan##2##3##(1996-2#1)(1996-4#1)
tamarind seed##3##2##(1991-7#1)(1996-2#1)(1996-4#1)
tamarind##8##1##(1991-7#1)(1996-2#1)(1996-4#1)(2008-5#5)
tamarind's fruit pulp##2##3##(2008-5#2)
tamarins##5##1##(1994-2#3)(2006-6#1)(2007-2#1)
tame##3##1##(1997-1#1)(2008-10#1)(2008-7#1)
taming the##2##2##(2005-11#1)(2006-10#1)
taming##3##1##(2005-11#1)(2006-10#1)(2008-2#1)
tammar wallaby##4##2##(1992-8#2)(1996-5#2)
tamoxifen (TAM)##7##2##(1993-1#2)(1993-7#1)(1994-7#2)(1995-10#1)(1996-3#1)
tamoxifen and progestin##3##3##(1992-2#3)
tamoxifen and tamoxifen metabolites##2##4##(2007-11#2)
tamoxifen and##16##2##(1990-8#1)(1992-2#3)(1993-10#1)(1993-4#1)(1994-7#1)(1995-10#1)(1996-4#1)(1996-9#1)(2007-11#4)(2008-10#2)
tamoxifen as a##2##3##(1991-5#1)(1995-9#1)
tamoxifen as##3##2##(1991-5#1)(1995-9#1)(2008-10#1)
tamoxifen citrate##2##2##(1993-9#1)(1997-7#1)
tamoxifen for##4##2##(1992-1#1)(2008-5#3)
tamoxifen in##6##2##(1990-8#1)(1993-11#1)(1993-7#1)(2008-10#1)(2008-5#1)(2008-7#1)
tamoxifen is##4##2##(2007-11#1)(2008-10#1)(2008-7#2)
tamoxifen metabolites in breast cancer##2##5##(2007-11#2)
tamoxifen metabolites##3##2##(2007-11#3)
tamoxifen resistance##4##2##(1994-6#1)(2008-7#3)
tamoxifen therapy##6##2##(1993-10#1)(1993-11#1)(1994-6#2)(2008-10#2)
tamoxifen treatment##3##2##(1993-10#2)(2004-2#1)
tamoxifen was##2##2##(1993-12#1)(1997-3#1)
tamoxifen were##2##2##(2008-5#1)(2011-2#1)
tamoxifen##141##1##(1990-2#2)(1990-4#1)(1990-8#3)(1991-10#1)(1991-4#1)(1991-5#1)(1991-8#3)(1992-1#1)(1992-2#4)(1992-4#2)(1992-8#1)(1993-1#3)(1993-10#5)(1993-11#4)(1993-12#6)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#2)(1993-9#1)(1994-6#4)(1994-7#3)(1994-8#3)(1995-10#2)(1995-2#1)(1995-9#1)(1996-1#1)(1996-3#2)(1996-4#3)(1996-9#5)(1997-3#1)(1997-7#1)(2004-1#4)(2004-2#3)(2006-10#1)(2007-11#10)(2008-10#14)(2008-11#3)(2008-4#1)(2008-5#15)(2008-6#1)(2008-7#10)(2009-2#3)(2011-2#2)(2012-2#2)(2012-3#1)
tamoxifen&gt##2##1##(2008-11#2)
tamoxifen)##3##1##(1993-10#1)(2011-2#1)(2012-2#1)
tamoxifen]##2##1##(1990-5#1)(2009-2#1)
tamoxifene##2##1##(2013-1#2)
tampering##3##1##(1991-2#1)(2007-2#1)(2013-7#1)
tamponade and##8##2##(2006-10#1)(2007-5#1)(2007-7#2)(2007-8#3)(2010-4#1)
tamponade as a##3##3##(2007-8#1)(2008-2#1)(2011-2#1)
tamponade as##4##2##(1991-6#1)(2007-8#1)(2008-2#1)(2011-2#1)
tamponade during##2##2##(2007-8#1)(2008-11#1)
tamponade is a##3##3##(2007-3#1)(2007-8#2)
tamponade is##6##2##(2006-10#2)(2007-3#1)(2007-5#1)(2007-8#2)
tamponade##63##1##(1990-3#1)(1991-6#2)(1992-2#1)(1996-6#1)(2006-10#12)(2006-7#1)(2007-10#1)(2007-3#3)(2007-4#2)(2007-5#3)(2007-7#3)(2007-8#14)(2007-9#3)(2008-1#2)(2008-11#1)(2008-2#1)(2010-4#2)(2010-5#2)(2011-2#7)(2013-1#1)
tamsulosin##2##1##(2009-2#1)(2009-5#1)
tan necrosis##2##2##(2008-10#2)
tan psi##2##2##(2008-3#2)
tan spot and leaf rust##3##5##(2008-10#3)
tan spot and##5##3##(2008-10#5)
tan spot##32##2##(2008-10#32)
tan theta(nu))##2##2##(2008-2#2)
tan##48##1##(2007-10#1)(2007-12#1)(2008-10#36)(2008-2#2)(2008-3#3)(2008-5#1)(2011-1#1)(2012-11#1)(2012-3#1)(2013-8#1)
tanager##2##1##(2007-2#2)
tanagers##4##1##(2007-2#4)
tandem G x A##2##4##(1993-11#2)
tandem GA##2##2##(1996-7#2)
tandem H-DNA##2##2##(1992-5#2)
tandem MS##5##2##(2008-4#1)(2008-9#2)(2012-12#2)
tandem Michael##2##2##(1996-5#1)(2009-3#1)
tandem array of##2##3##(1995-1#1)(1997-2#1)
tandem arrays of##2##3##(1995-1#1)(2012-1#1)
tandem arrays##6##2##(1991-5#1)(1995-1#1)(1997-2#1)(2008-11#1)(2008-9#1)(2012-1#1)
tandem conjugate##2##2##(1996-5#1)(2008-9#1)
tandem copies##2##2##(1995-1#1)(1995-3#1)
tandem duplication of##2##3##(1990-10#1)(1996-3#1)
tandem duplication##5##2##(1990-10#1)(1996-3#1)(2008-7#1)(2012-12#1)(2012-3#1)
tandem duplications in the##2##4##(1994-10#2)
tandem duplications in##3##3##(1994-10#2)(2010-4#1)
tandem duplications##8##2##(1994-10#3)(2008-5#1)(2010-3#1)(2010-4#1)(2011-3#1)(2012-3#1)
tandem lesions##3##2##(1997-2#1)(2010-11#1)(2013-8#1)
tandem linked##2##2##(2008-8#2)
tandem mass spectra##4##3##(2008-4#1)(2011-2#1)(2012-3#2)
tandem mass spectral detection##2##4##(2010-4#2)
tandem mass spectrometer##4##3##(1997-3#1)(2010-5#1)(2011-1#1)(2011-3#1)
tandem mass spectrometric detection##4##4##(1996-6#1)(2008-10#1)(2010-4#1)(2012-1#1)
tandem mass spectrometric method##3##4##(2007-8#1)(2008-10#1)(2011-1#1)
tandem mass spectrometric##10##3##(1993-2#1)(1996-6#1)(1997-3#1)(2007-8#2)(2008-10#2)(2010-4#1)(2011-1#1)(2012-1#1)
tandem mass spectrometry (LC-MS/MS)##4##4##(2007-8#1)(2008-10#1)(2011-1#2)
tandem mass spectrometry (MS-MS)##2##4##(1996-8#1)(2008-10#1)
tandem mass spectrometry (MS/MS)##6##4##(2008-4#3)(2008-7#1)(2008-8#1)(2012-3#1)
tandem mass spectrometry and##2##4##(1990-1#1)(2010-2#1)
tandem mass spectrometry data##3##4##(2008-7#2)(2009-11#1)
tandem mass spectrometry for the analysis##2##6##(1996-8#1)(2008-10#1)
tandem mass spectrometry in##2##4##(1996-8#1)(2008-10#1)
tandem mass spectrometry with##2##4##(2010-9#1)(2011-2#1)
tandem mass spectrometry##69##3##(1990-1#2)(1990-7#2)(1992-1#2)(1992-4#1)(1993-2#1)(1994-12#1)(1996-8#5)(1997-3#1)(2007-1#4)(2007-12#1)(2007-3#2)(2007-8#5)(2008-10#11)(2008-4#6)(2008-7#4)(2008-8#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#3)(2012-1#1)(2012-3#2)
tandem mass##94##2##(1990-1#2)(1990-7#2)(1992-1#2)(1992-4#1)(1993-2#3)(1994-12#1)(1996-6#1)(1996-8#5)(1997-3#3)(2007-1#4)(2007-12#1)(2007-3#3)(2007-8#9)(2008-10#13)(2008-4#7)(2008-7#4)(2008-8#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-2#1)(2010-4#3)(2010-5#2)(2010-9#2)(2011-1#8)(2011-12#1)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#1)(2012-3#4)
tandem mirror##2##2##(1990-12#1)(1993-6#1)
tandem optical parametric oscillator (OPO)##2##5##(2007-12#2)
tandem optical parametric oscillator##3##4##(2007-12#2)(2008-2#1)
tandem pairs##5##2##(2009-5#5)
tandem process##3##2##(2008-3#1)(2009-12#1)(2013-8#1)
tandem quadrupole##2##2##(2007-8#1)(2012-12#1)
tandem reactions with##2##3##(2012-3#2)
tandem repeat (STR)##8##3##(1995-11#1)(1996-12#1)(2008-12#5)(2008-4#1)
tandem repeat (VNTR) in##2##4##(1997-5#1)(2010-12#1)
tandem repeat (VNTR)##4##3##(1997-5#1)(2008-10#2)(2010-12#1)
tandem repeat and a##2##4##(2007-10#1)(2008-11#1)
tandem repeat of##2##3##(1996-10#1)(2006-12#1)
tandem repeat region of the##2##5##(1990-12#1)(1992-5#1)
tandem repeat units and##2##4##(1997-7#2)
tandem repeat##42##2##(1990-12#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-5#1)(1994-9#2)(1995-11#1)(1996-10#1)(1996-12#2)(1996-7#1)(1997-2#1)(1997-5#1)(1997-7#6)(2006-12#1)(2007-10#1)(2008-10#2)(2008-11#2)(2008-12#7)(2008-4#3)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-9#1)(2011-12#1)
tandem repeated##2##2##(1991-10#1)(2008-8#1)
tandem repeats (VNTR)##3##3##(1991-7#1)(1994-8#1)(2008-4#1)
tandem repeats and##3##3##(1992-5#1)(1993-8#1)(1995-12#1)
tandem repeats in the##2##4##(1991-2#1)(2008-7#1)
tandem repeats in##5##3##(1990-12#1)(1991-2#1)(2008-7#1)(2009-3#1)(2013-1#1)
tandem repeats of the##3##4##(1991-7#1)(1993-9#1)(2008-10#1)
tandem repeats of##6##3##(1991-7#1)(1993-9#1)(1994-12#1)(1996-4#1)(2008-10#2)
tandem repeats##37##2##(1990-12#2)(1990-8#1)(1991-12#1)(1991-2#2)(1991-7#2)(1992-1#2)(1992-11#1)(1992-5#1)(1993-11#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-12#2)(1996-10#1)(1996-4#1)(2004-10#1)(2006-10#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#1)(2009-3#2)(2013-1#1)
tandem running##3##2##(2009-5#3)
tandem technique for the##2##4##(2008-10#2)
tandem technique##3##2##(2007-8#1)(2008-10#2)
tandem use##2##2##(2008-11#1)(2008-5#1)
tandem with##13##2##(1995-2#1)(1996-9#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-7#1)
tandem##353##1##(1990-1#3)(1990-10#2)(1990-12#4)(1990-3#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-1#4)(1992-11#5)(1992-4#2)(1992-5#4)(1993-11#5)(1993-12#2)(1993-2#3)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#3)(1994-12#3)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#5)(1995-1#7)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-10#2)(1996-12#2)(1996-3#1)(1996-4#2)(1996-5#6)(1996-6#1)(1996-7#6)(1996-8#6)(1996-9#1)(1997-2#5)(1997-3#3)(1997-5#1)(1997-7#6)(2004-10#1)(2006-10#1)(2006-12#2)(2007-1#4)(2007-10#2)(2007-11#3)(2007-12#5)(2007-2#1)(2007-3#3)(2007-5#1)(2007-8#12)(2007-9#1)(2008-10#32)(2008-11#7)(2008-12#9)(2008-2#3)(2008-3#6)(2008-4#15)(2008-5#4)(2008-7#15)(2008-8#8)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#4)(2009-4#1)(2009-5#10)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#3)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#8)(2011-12#2)(2011-2#5)(2011-3#3)(2012-1#4)(2012-12#5)(2012-2#1)(2012-3#9)(2013-1#1)(2013-7#1)(2013-8#4)
tandem-flow##2##1##(2008-10#2)
tandemly arranged##4##2##(1990-12#1)(1991-8#1)(1993-12#1)(1997-4#1)
tandemly arrayed##3##2##(1990-5#2)(1993-2#1)
tandemly repeated##6##2##(1990-8#1)(1995-8#1)(1997-6#1)(2008-4#1)(2008-5#1)(2008-9#1)
tandemly##17##1##(1990-12#1)(1990-5#2)(1990-8#1)(1991-7#1)(1991-8#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-8#2)(1996-7#1)(1997-4#1)(1997-6#1)(2008-4#1)(2008-5#1)(2008-9#1)
tandutinib##2##1##(2007-10#2)
tangelo##4##1##(2008-10#4)
tangent modulus##2##2##(2009-7#1)(2012-2#1)
tangent##10##1##(2006-4#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#3)(2009-7#1)(2012-2#1)
tangential cells##3##2##(2008-11#3)
tangential field##2##2##(2009-2#2)
tangential fields##2##2##(2007-10#1)(2009-2#1)
tangential flow filtration##5##3##(2008-10#2)(2008-7#3)
tangential plane##4##2##(2007-12#1)(2008-10#1)(2008-3#2)
tangential planes##3##2##(2008-3#3)
tangential streaming potential##2##3##(2005-11#2)
tangential to##2##2##(1995-5#1)(2010-2#1)
tangential ultrafiltration##3##2##(2008-10#2)(2008-6#1)
tangential##46##1##(1992-5#1)(1992-7#1)(1995-5#1)(2005-11#4)(2005-7#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#7)(2008-11#4)(2008-2#3)(2008-3#6)(2008-6#1)(2008-7#3)(2009-2#4)(2009-3#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#1)
tangential-flow##2##1##(2008-10#2)
tangentially cut##2##2##(1993-7#1)(2006-12#1)
tangentially##5##1##(1993-7#1)(1995-12#1)(2006-12#1)(2008-2#1)(2008-3#1)
tangerine pathotype of##2##3##(2008-10#2)
tangerine pathotype##3##2##(2008-10#3)
tangerine##8##1##(2008-10#7)(2012-12#1)
tangerines and##3##2##(2008-10#3)
tangerines##4##1##(1992-10#1)(2008-10#3)
tangible benefits##2##2##(1991-3#1)(2008-11#1)
tangible results##2##2##(1991-3#1)(1994-1#1)
tangible##20##1##(1991-3#2)(1992-12#1)(1994-1#1)(1996-3#1)(1997-1#1)(2007-4#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-8#2)(2009-10#1)(2009-9#1)(2012-2#1)(2013-1#2)(2013-7#1)
tangle formation##4##2##(1995-10#1)(1996-1#2)(2008-7#1)
tangle##8##1##(1991-8#1)(1995-10#1)(1996-1#2)(1997-3#1)(2005-7#1)(2008-7#2)
tangles and abnormal##2##3##(1991-1#1)(1995-3#1)
tangles and##5##2##(1991-1#1)(1993-11#1)(1995-3#1)(1996-9#1)(2008-7#1)
tangles with##2##2##(1992-1#1)(1992-8#1)
tangles##27##1##(1991-1#5)(1991-3#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-11#3)(1995-3#1)(1995-8#1)(1996-11#1)(1996-8#2)(1996-9#1)(2004-11#1)(2004-12#1)(2008-5#1)(2008-7#3)(2009-11#1)
tangor##3##1##(2008-10#3)
tank and##2##2##(1996-9#1)(2007-12#1)
tank in the##2##3##(2008-3#1)(2009-9#1)
tank in##4##2##(2008-1#1)(2008-3#1)(2009-9#2)
tank of##2##2##(2008-2#1)(2008-5#1)
tank reactor where##2##3##(2008-10#1)(2008-11#1)
tank reactor##10##2##(1997-2#1)(2006-10#1)(2008-10#2)(2008-11#2)(2008-7#4)
tank test##2##2##(2008-8#2)
tank##54##1##(1994-1#1)(1996-1#1)(1996-9#2)(1997-2#1)(2004-4#1)(2006-10#1)(2007-10#4)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#15)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#5)(2008-8#2)(2009-9#3)(2010-8#1)(2011-2#2)(2012-3#1)
tank-treading##3##1##(1992-1#2)(2013-1#1)
tanker##2##1##(2008-10#1)(2008-11#1)
tanks and##3##2##(2008-7#1)(2009-6#1)(2011-2#1)
tanks of##2##2##(2008-7#1)(2013-7#1)
tanks##24##1##(1994-6#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-10#1)(2009-6#1)(2010-8#4)(2011-1#1)(2011-2#4)(2012-1#1)(2013-7#1)
tankships have##2##2##(2008-11#2)
tankships##5##1##(2008-11#5)
tannase##4##1##(2008-5#4)
tanned leather##2##2##(2008-10#2)
tanned##4##1##(2006-12#1)(2008-10#2)(2008-5#1)
tanneries at##2##2##(2007-10#1)(2009-12#1)
tanneries##6##1##(1993-9#1)(2007-10#1)(2008-10#1)(2009-12#3)
tanners##6##1##(2007-10#1)(2007-12#2)(2008-5#3)
tannery effluents##2##2##(2008-10#2)
tannery wastewater##2##2##(2008-10#2)
tannery##10##1##(2008-10#10)
tannic acid (TA)##2##3##(2004-9#1)(2008-10#1)
tannic acid##18##2##(1993-9#1)(1996-1#2)(2004-9#3)(2007-8#1)(2008-10#8)(2008-5#2)(2008-8#1)
tannic##19##1##(1993-9#1)(1996-1#2)(2004-9#3)(2007-8#1)(2008-10#8)(2008-5#2)(2008-8#1)(2012-2#1)
tannin and##2##2##(2007-10#2)
tannin present in##2##3##(2008-10#2)
tannin##20##1##(2007-1#1)(2007-10#5)(2008-10#12)(2010-2#1)(2011-2#1)
tanning ability and##2##3##(1991-6#1)(2008-5#1)
tanning products##2##2##(2007-3#1)(2008-5#1)
tanning residue##4##2##(2007-10#4)
tanning##23##1##(1991-6#1)(1993-5#1)(2007-10#6)(2007-12#2)(2007-3#1)(2008-10#5)(2008-5#5)(2008-9#2)
tannins and##2##2##(2008-12#1)(2009-8#1)
tannins were##2##2##(2008-10#1)(2013-8#1)
tannins##20##1##(1993-8#1)(2006-12#1)(2008-10#3)(2008-12#3)(2008-4#1)(2008-5#1)(2009-8#2)(2010-12#2)(2011-3#1)(2013-7#1)(2013-8#4)
tannophilus##2##1##(2008-6#2)
tanoak (Lithocarpus densiflorus)##2##3##(2008-10#2)
tanoak##3##1##(2008-10#3)
tanshinones##4##1##(2008-10#4)
tansy##3##1##(2008-10#3)
tantalizing##7##1##(2007-7#1)(2007-9#2)(2008-5#1)(2008-8#1)(2009-8#1)(2012-2#1)
tantalum and##2##2##(1994-6#1)(2008-3#1)
tantalum oxide##4##2##(1994-2#1)(2008-2#2)(2008-3#1)
tantalum##18##1##(1994-2#2)(1994-6#2)(2007-5#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#2)(2009-7#1)
tanycytes##7##1##(1997-5#3)(2012-1#4)
tap and industrial wastewater)##2##4##(2008-10#2)
tap and mineral water##2##4##(2007-8#1)(2008-10#1)
tap and mineral##3##3##(2007-8#1)(2008-10#2)
tap and river water samples##4##5##(2008-10#4)
tap and river##5##3##(1996-11#1)(2008-10#4)
tap and##18##2##(1996-11#1)(2007-8#1)(2008-10#16)
tap into##3##2##(2008-8#1)(2009-12#1)(2010-8#1)
tap test##3##2##(2006-2#3)
tap water ad libitum for 60 days##2##7##(2007-1#2)
tap water and river water##2##5##(2008-10#2)
tap water and wastewater samples##2##5##(2008-10#2)
tap water and wastewater##3##4##(2008-10#3)
tap water and##24##3##(2007-8#1)(2008-10#20)(2008-3#1)(2008-8#1)(2009-5#1)
tap water as##2##3##(1992-7#1)(2011-12#1)
tap water sample##2##3##(2008-10#2)
tap water samples and##2##4##(2008-10#2)
tap water samples##15##3##(2007-8#1)(2008-10#13)(2012-2#1)
tap water was##3##3##(2007-1#1)(2008-10#2)
tap water##98##2##(1990-4#1)(1992-7#1)(1993-5#2)(2005-8#1)(2006-2#1)(2007-1#3)(2007-8#5)(2007-9#1)(2008-10#64)(2008-12#2)(2008-3#1)(2008-5#7)(2008-8#1)(2009-5#4)(2011-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
tap waters##4##2##(2007-8#1)(2008-10#3)
tap##149##1##(1990-4#1)(1990-8#1)(1992-7#1)(1993-10#2)(1993-5#2)(1994-11#1)(1996-11#1)(2005-8#1)(2006-2#5)(2006-4#3)(2007-1#3)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#95)(2008-12#2)(2008-3#1)(2008-5#7)(2008-8#3)(2009-12#1)(2009-5#4)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-8#1)
tap*&quot##2##1##(2013-1#2)
tape backings##3##2##(2012-2#3)
tape recorded and##2##3##(2007-10#1)(2008-10#1)
tape recorded##4##2##(1991-12#1)(2007-10#1)(2008-10#1)(2008-12#1)
tape recordings##2##2##(1993-8#1)(2008-11#1)
tape samples##3##2##(2012-2#3)
tape stripping##5##2##(2005-11#1)(2008-5#4)
tape strippings##2##2##(2008-5#2)
tape to##2##2##(2004-9#1)(2013-8#1)
tape##58##1##(1991-12#1)(1993-12#1)(1993-8#1)(2004-9#1)(2005-11#1)(2006-3#1)(2007-10#1)(2007-11#2)(2007-7#3)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#1)(2008-5#9)(2008-7#1)(2009-4#1)(2011-2#1)(2012-2#16)(2013-7#4)(2013-8#1)
tape-recorded and##2##2##(2006-2#1)(2007-10#1)
tape-recorded lung sounds##3##3##(1993-12#3)
tape-recorded##5##1##(1993-12#3)(2006-2#1)(2007-10#1)
taped interviews##3##2##(2008-11#2)(2011-1#1)
taped##7##1##(1996-3#1)(2008-11#3)(2008-4#1)(2011-1#1)(2012-12#1)
tapentadol may##2##2##(2011-1#2)
tapentadol##5##1##(2011-1#5)
taper and##2##2##(2007-12#1)(2008-3#1)
taper as##3##2##(2008-3#2)(2013-1#1)
taper is##5##2##(2007-11#2)(2007-12#2)(2008-3#1)
taper structure##2##2##(2007-11#2)
taper waist##2##2##(2008-3#2)
taper##40##1##(2006-10#1)(2007-11#7)(2007-12#11)(2008-1#1)(2008-2#7)(2008-3#9)(2009-10#1)(2011-1#1)(2013-1#2)
tapered PWG##3##2##(2008-2#1)(2008-3#2)
tapered PWG's##2##2##(2008-3#2)
tapered air-silica microstructure fiber##2##4##(2007-11#2)
tapered amplifier##6##2##(2007-12#1)(2008-1#1)(2008-2#4)
tapered and##3##2##(2008-7#1)(2010-12#1)(2011-12#1)
tapered directional coupler##2##3##(2008-3#2)
tapered ends##2##2##(1990-7#1)(2007-12#1)
tapered fiber##7##2##(2007-11#4)(2007-12#3)
tapered fibers##2##2##(2007-12#2)
tapered hollow##2##2##(2008-2#2)
tapered optical fiber##3##3##(2007-12#2)(2008-3#1)
tapered optical##6##2##(2007-11#2)(2007-12#3)(2008-3#1)
tapered over##2##2##(2006-10#1)(2007-7#1)
tapered structure##2##2##(2007-11#1)(2007-12#1)
tapered thin-film planar waveguide##2##4##(2008-2#1)(2008-3#1)
tapered waveguide##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
tapered##82##1##(1990-7#1)(1996-2#1)(2005-12#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-11#14)(2007-12#18)(2007-7#1)(2008-1#2)(2008-10#2)(2008-2#12)(2008-3#19)(2008-4#1)(2008-7#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-12#1)(2011-2#2)
tapered-waveguide laser##2##2##(2007-12#2)
taperin##5##1##(2012-12#5)
tapering of the##3##3##(2006-9#1)(2008-7#1)(2013-7#1)
tapering##9##1##(1997-8#1)(2006-9#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2013-7#1)
tapers##14##1##(2007-11#1)(2007-12#6)(2008-1#1)(2008-10#1)(2008-3#2)(2008-7#1)(2013-1#2)
tapes with##2##2##(1993-12#1)(2012-2#1)
tapes##10##1##(1993-12#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-8#1)(2012-2#5)
tapetum##3##1##(2007-12#2)(2011-2#1)
tapeworm##6##1##(1993-6#2)(1993-9#1)(1995-12#1)(2008-7#1)(2011-2#1)
tapeworms##2##1##(2007-12#1)(2012-2#1)
taping for##3##2##(2006-3#2)(2013-1#1)
taping on##2##2##(2007-11#1)(2010-9#1)
taping##10##1##(1995-12#1)(2006-3#2)(2007-11#2)(2008-10#1)(2008-9#1)(2010-9#1)(2013-1#2)
tapioca starch##3##2##(2008-5#3)
tapioca##4##1##(2008-5#4)
tapir##3##1##(2008-5#3)
tapirs (Tapirus bairdii)##2##3##(2007-2#2)
tapirs##4##1##(2007-2#4)
tapped delay lines##2##3##(2008-3#2)
tapped##9##1##(1994-12#1)(1994-2#1)(2007-6#1)(2008-2#1)(2008-3#2)(2009-11#1)(2010-11#1)(2012-12#1)
tapping into##3##2##(2009-5#1)(2011-1#1)(2012-12#1)
tapping mode atomic force##2##4##(2008-12#1)(2012-2#1)
tapping mode##3##2##(2008-10#1)(2008-12#1)(2012-2#1)
tapping tasks##2##2##(1994-3#1)(2012-2#1)
tapping time##2##2##(2008-3#2)
tapping##24##1##(1991-12#2)(1994-12#3)(1994-2#1)(1994-3#5)(2008-10#2)(2008-12#1)(2008-3#2)(2008-7#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#1)
taproots##4##1##(2008-10#4)
taps##7##1##(1995-8#1)(1997-1#1)(1997-8#1)(2007-12#1)(2008-3#1)(2010-6#1)(2012-1#1)
tapwater and upland soil extracts##2##5##(2008-10#2)
tapwater and##4##2##(2008-10#4)
tapwater##6##1##(2008-10#6)
tar and nicotine##3##3##(2007-3#1)(2009-7#2)
tar in##2##2##(2007-8#2)
tar##16##1##(1995-5#1)(1997-4#1)(2007-3#2)(2007-7#3)(2007-8#3)(2008-10#1)(2008-8#1)(2009-7#2)(2010-4#1)(2012-2#1)
tarabine PFS and##5##3##(2008-10#5)
tarabine PFS##6##2##(2008-10#6)
tarantula (Brachypelma##2##2##(2009-4#2)
tarantula##4##1##(1990-8#1)(2009-4#3)
taraxasteryl acetate##2##2##(2007-1#2)
tarda##13##1##(1990-1#1)(1991-10#2)(2006-10#1)(2011-2#3)(2012-12#1)(2012-2#5)
tardive dyskinesia and##2##3##(1993-6#1)(1997-8#1)
tardive dyskinesia combined with##3##4##(1997-8#3)
tardive dyskinesia##19##2##(1991-8#1)(1993-6#1)(1995-1#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-7#1)(1997-8#6)(2007-6#1)(2010-12#1)(2010-6#2)(2012-1#1)(2012-3#1)
tardive dystonia##6##2##(1997-8#5)(2008-7#1)
tardive syndromes##2##2##(2008-7#2)
tardive##29##1##(1991-8#1)(1993-6#1)(1995-1#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-7#1)(1997-8#11)(2007-6#1)(2008-7#3)(2008-8#1)(2010-12#1)(2010-6#2)(2012-1#1)(2012-2#1)(2012-3#1)
tardy diagnosis##2##2##(1995-6#1)(2008-7#1)
tarentolae##2##1##(1994-11#2)
target DNA and##3##3##(1992-3#1)(1995-10#1)(2008-10#1)
target DNA fragment##2##3##(1995-8#1)(2008-10#1)
target DNA in##4##3##(1990-9#1)(2008-8#2)(2013-1#1)
target DNA is##2##3##(1994-6#1)(2008-10#1)
target DNA sequence##3##3##(2008-10#2)(2008-4#1)
target DNA that##2##3##(1993-12#1)(2008-4#1)
target DNA to##2##3##(2008-1#1)(2008-10#1)
target DNA##41##2##(1990-9#2)(1991-8#1)(1991-9#1)(1992-3#1)(1993-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-8#1)(1996-10#1)(1997-3#1)(2007-8#1)(2008-1#2)(2008-10#14)(2008-4#3)(2008-5#1)(2008-8#2)(2008-9#1)(2011-1#2)(2013-1#1)
target DNAs##3##2##(1993-11#1)(1993-12#1)(2008-10#1)
target Hb level##3##3##(2005-10#1)(2008-7#2)
target Hb##4##2##(2005-10#1)(2007-7#1)(2008-7#2)
target LDL-C##4##2##(2011-2#1)(2013-1#3)
target LDL-cholesterol levels##2##3##(2010-4#2)
target ODN##2##2##(2008-10#2)
target RNA##5##2##(2004-1#2)(2008-10#1)(2009-10#1)(2011-1#1)
target RNAs##2##2##(1996-9#1)(2011-1#1)
target RPEs that##2##3##(2013-8#2)
target a##6##2##(1991-12#1)(2009-4#1)(2010-5#1)(2011-12#1)(2011-2#1)(2013-1#1)
target acquisition##5##2##(1991-6#1)(2008-3#2)(2008-7#1)(2010-2#1)
target against##2##2##(2011-1#1)(2012-2#1)
target amplification##2##2##(2008-7#2)
target an##2##2##(2005-7#1)(2008-11#1)
target analyte##12##2##(2006-12#1)(2007-8#1)(2008-10#6)(2008-7#1)(2009-11#1)(2010-4#1)(2011-1#1)
target analytes##18##2##(2007-8#2)(2008-10#8)(2008-7#1)(2008-8#1)(2010-4#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
target and a##2##3##(2007-12#1)(2008-3#1)
target and distractors##2##3##(2008-1#2)
target and non-target##2##3##(1995-9#1)(2006-5#1)
target and the##6##3##(1995-1#1)(2008-1#1)(2008-7#1)(2010-3#1)(2010-5#1)(2010-7#1)
target and##48##2##(1990-12#1)(1991-9#1)(1993-12#1)(1993-4#1)(1995-1#1)(1995-12#1)(1995-6#1)(1995-9#1)(1997-4#1)(2005-7#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-12#3)(2008-1#6)(2008-10#3)(2008-2#4)(2008-3#4)(2008-4#1)(2008-7#1)(2009-12#1)(2010-3#1)(2010-5#2)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
target angle##2##2##(2012-1#2)
target antigen##8##2##(1990-12#1)(1991-2#1)(2005-10#1)(2008-10#1)(2008-11#1)(2008-9#3)
target antigens of##2##3##(2005-11#1)(2008-9#1)
target antigens##13##2##(1996-4#1)(2005-11#1)(2006-12#1)(2006-2#1)(2007-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2012-12#4)
target are##5##2##(1994-3#1)(2007-11#1)(2008-1#1)(2008-3#1)(2012-12#1)
target area of##2##3##(1994-2#1)(2008-5#1)
target area##6##2##(1994-2#1)(1994-8#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
target areas and##2##3##(2006-8#1)(2008-7#1)
target areas##9##2##(1991-3#1)(1991-5#1)(1995-8#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-7#2)(2012-12#1)
target as##3##2##(2008-11#1)(2008-5#1)(2011-1#1)
target at the##2##3##(2008-9#1)(2011-2#1)
target at##4##2##(2008-4#1)(2008-9#1)(2009-8#1)(2011-2#1)
target attainment of AUC/MIC##2##4##(2011-2#2)
target attainment##3##2##(2011-2#3)
target audience##4##2##(1996-2#1)(2008-7#1)(2010-11#1)(2013-1#1)
target binding##4##2##(2010-5#2)(2011-1#1)(2013-1#1)
target blood pressure##2##3##(2008-1#1)(2010-4#1)
target both##4##2##(2006-10#1)(2007-8#1)(2008-1#1)(2008-12#1)
target by##4##2##(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#1)
target can be##2##3##(1991-2#1)(2009-11#1)
target cancer cell##2##3##(1994-12#1)(2010-12#1)
target cancer##3##2##(1994-12#1)(2010-12#1)(2010-5#1)
target cell for##2##3##(2008-1#1)(2012-2#1)
target cell lysis##2##3##(2008-4#2)
target cell populations##2##3##(2008-1#1)(2008-8#1)
target cell type##2##3##(1992-11#1)(1993-6#1)
target cell types##3##3##(1991-2#1)(1997-7#1)(2008-12#1)
target cell##36##2##(1990-12#1)(1991-2#1)(1992-11#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-2#2)(1994-3#1)(1994-9#1)(1996-8#2)(1996-9#1)(1997-7#2)(2006-10#2)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#4)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-2#1)
target cells and their##2##4##(1996-2#1)(2010-12#1)
target cells and##6##3##(1996-2#1)(2005-8#1)(2008-4#1)(2010-10#1)(2010-12#1)(2011-1#1)
target cells as##2##3##(2007-11#1)(2011-2#1)
target cells by##4##3##(1993-3#1)(2006-10#1)(2008-11#1)(2013-1#1)
target cells can##2##3##(1991-9#1)(2008-4#1)
target cells expressing##2##3##(1990-11#1)(2008-1#1)
target cells for##3##3##(1995-8#1)(2008-4#1)(2008-7#1)
target cells from##2##3##(2008-10#1)(2008-4#1)
target cells in the##3##4##(2008-4#1)(2008-5#1)(2008-7#1)
target cells in##6##3##(1991-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2011-2#1)
target cells is##2##3##(1990-12#1)(2008-4#1)
target cells of##7##3##(1993-3#1)(1994-3#1)(1995-3#1)(2008-11#3)(2008-5#1)
target cells or##2##3##(1997-8#1)(2008-4#1)
target cells that##4##3##(2007-8#1)(2008-4#2)(2008-8#1)
target cells through##2##3##(1991-3#1)(2011-3#1)
target cells to##4##3##(1992-1#1)(2008-11#1)(2008-4#2)
target cells was##6##3##(1991-12#1)(1991-9#1)(1993-12#1)(1995-3#1)(2008-11#1)(2008-5#1)
target cells##143##2##(1990-11#2)(1990-12#5)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#2)(1991-3#3)(1991-5#1)(1991-8#1)(1991-9#5)(1992-1#1)(1992-4#1)(1992-8#2)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-2#5)(1995-3#2)(1995-5#1)(1995-8#1)(1996-2#1)(1997-4#2)(1997-8#4)(2005-7#2)(2005-8#1)(2006-10#2)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#12)(2008-12#1)(2008-2#1)(2008-4#24)(2008-5#7)(2008-6#3)(2008-7#2)(2008-8#4)(2008-9#2)(2009-2#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
target classification##2##2##(2008-11#1)(2013-1#1)
target compounds in##3##3##(2007-11#1)(2007-8#1)(2013-1#1)
target compounds were##6##3##(2007-11#1)(2008-10#2)(2011-3#1)(2012-3#1)(2013-8#1)
target compounds##17##2##(2007-11#3)(2007-8#2)(2008-10#7)(2010-8#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
target contour##2##2##(1993-4#1)(2009-8#1)
target contrast##2##2##(2008-3#1)(2012-2#1)
target controlled infusion##2##3##(2006-10#1)(2010-8#1)
target cytokines##2##2##(2007-11#1)(2007-6#1)
target date for##2##3##(1996-1#1)(2005-7#1)
target date of##2##3##(2008-1#1)(2009-6#1)
target date##4##2##(1996-1#1)(2005-7#1)(2008-1#1)(2009-6#1)
target detection and##2##3##(2008-2#1)(2008-3#1)
target detection in##3##3##(1995-12#1)(2008-2#1)(2008-3#1)
target detection##12##2##(1994-2#1)(1995-12#1)(2008-1#2)(2008-11#1)(2008-2#3)(2008-3#3)(2011-1#1)
target different##7##2##(1993-2#1)(1997-4#1)(2005-7#1)(2009-7#1)(2009-8#1)(2012-3#2)
target discrimination##2##2##(2008-1#2)
target displacement##2##2##(2008-2#1)(2010-12#1)
target distance##9##2##(1991-3#2)(1992-7#3)(1997-2#1)(2008-2#1)(2012-1#2)
target dose of##2##3##(2007-9#2)
target dose##3##2##(2007-9#2)(2008-6#1)
target duplication##3##2##(1995-8#3)
target during the##2##3##(2006-2#1)(2009-8#1)
target during##4##2##(1992-9#1)(2006-2#1)(2009-8#1)(2011-2#1)
target eccentricity##5##2##(1993-7#2)(2008-1#3)
target elements composed of##2##4##(1995-8#2)
target embedded in##2##3##(2007-12#1)(2008-2#1)
target enzyme##5##2##(1990-7#1)(1991-4#1)(1996-8#1)(1997-4#1)(2008-5#1)
target enzymes##6##2##(1990-12#1)(1992-11#1)(1995-6#1)(2006-12#1)(2007-11#1)(2009-9#1)
target epitope##2##2##(1996-5#1)(2007-11#1)
target events##3##2##(1994-8#1)(1995-12#2)
target factor analysis##4##3##(2008-10#4)
target factor##6##2##(2008-10#5)(2009-8#1)
target female##2##2##(2007-12#2)
target field##4##2##(1991-3#1)(1996-3#2)(2008-7#1)
target fields##5##2##(1996-3#5)
target for PD##2##3##(2008-11#2)
target for a##4##3##(1992-9#1)(1993-11#1)(1995-2#1)(2006-10#1)
target for anti-HIV##2##3##(2008-1#1)(2011-3#1)
target for anti-cancer therapy##2##4##(1997-1#1)(2013-1#1)
target for anti-cancer##4##3##(1997-1#1)(2008-9#1)(2011-2#1)(2013-1#1)
target for anticancer drug##3##4##(2008-5#1)(2010-7#1)(2012-2#1)
target for antiretroviral therapy##2##4##(1995-8#1)(2005-7#1)
target for both##3##3##(1997-4#1)(2011-1#1)(2012-3#1)
target for breast cancer##2##4##(2011-2#1)(2013-8#1)
target for cancer immunotherapy##2##4##(2008-11#2)
target for cancer therapy##6##4##(2008-11#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
target for cancer treatment##2##4##(2007-11#1)(2013-8#1)
target for cancer##14##3##(1995-2#1)(2007-11#1)(2007-4#1)(2008-11#3)(2011-2#3)(2012-2#2)(2012-3#1)(2013-8#2)
target for drug discovery##3##4##(2005-7#1)(2007-3#2)
target for drug##5##3##(1994-8#1)(1996-11#1)(2005-7#1)(2007-3#2)
target for future therapeutic##2##4##(2006-10#1)(2007-11#1)
target for future##5##3##(2005-8#1)(2006-10#1)(2006-9#1)(2007-11#1)(2012-12#1)
target for human##2##3##(2005-7#1)(2012-3#1)
target for multiple##2##3##(2010-11#1)(2012-2#1)
target for novel##6##3##(1997-4#1)(2005-7#1)(2008-5#3)(2010-2#1)
target for oestrogens##2##3##(2005-12#2)
target for orotic##2##3##(1993-9#2)
target for the development of novel##2##6##(2012-12#1)(2012-2#1)
target for the development of##8##5##(1991-10#1)(2008-4#1)(2009-12#1)(2009-7#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
target for the development##9##4##(1991-10#1)(2008-1#1)(2008-4#1)(2009-12#1)(2009-7#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
target for the treatment of##9##5##(2008-1#2)(2010-6#1)(2011-1#1)(2012-2#3)(2013-1#2)
target for the##35##3##(1990-3#1)(1990-9#1)(1991-10#1)(1993-8#1)(1995-5#1)(1996-10#1)(1996-8#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-7#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2012-12#1)(2012-2#4)(2013-1#3)
target for therapeutic intervention because##2##5##(2007-11#1)(2009-10#1)
target for therapeutic intervention##9##4##(2005-6#1)(2007-10#1)(2007-11#2)(2009-10#1)(2009-4#1)(2010-12#1)(2010-3#1)(2011-1#1)
target for therapeutic##14##3##(1995-11#1)(2005-6#1)(2005-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-8#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-3#1)(2011-1#1)
target for therapy of##2##4##(2010-3#1)(2011-3#1)
target for therapy##5##3##(2006-10#1)(2008-11#1)(2010-12#1)(2010-3#1)(2011-3#1)
target for these##2##3##(2008-1#1)(2011-2#1)
target for tumor##2##3##(2011-1#1)(2011-2#1)
target for type##2##3##(2010-7#1)(2012-2#1)
target for##239##2##(1990-3#1)(1990-9#2)(1991-10#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-4#1)(1993-8#1)(1993-9#3)(1994-5#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#4)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#2)(1996-7#1)(1996-8#2)(1997-1#2)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#3)(2004-12#2)(2005-11#1)(2005-12#2)(2005-6#1)(2005-7#8)(2005-8#2)(2006-10#5)(2006-12#3)(2006-2#1)(2006-5#1)(2006-9#2)(2007-10#1)(2007-11#6)(2007-12#1)(2007-3#2)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#14)(2008-10#3)(2008-11#7)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#2)(2010-10#2)(2010-11#3)(2010-12#3)(2010-2#2)(2010-3#3)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#9)(2011-2#14)(2011-3#2)(2012-12#5)(2012-2#14)(2012-3#5)(2013-1#10)(2013-7#1)(2013-8#5)
target frequency##3##2##(1993-2#1)(2007-7#2)
target from a##2##3##(2008-2#1)(2008-4#1)
target from##4##2##(2007-12#1)(2007-8#1)(2008-2#1)(2008-4#1)
target function##2##2##(2008-2#1)(2008-8#1)
target fungal species##2##3##(2005-11#2)
target gene expression##4##3##(1996-12#1)(2008-5#1)(2009-8#1)(2011-1#1)
target gene##28##2##(1991-9#1)(1993-5#2)(1995-12#1)(1995-8#1)(1996-12#1)(1996-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-4#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-12#1)(2012-11#1)
target gene(s)##5##2##(1994-12#1)(2008-1#2)(2008-2#2)
target generated##2##2##(2008-2#2)
target genes and##4##3##(1995-1#1)(1997-4#1)(2008-4#1)(2011-2#1)
target genes have been##2##4##(1995-11#1)(2011-2#1)
target genes have##3##3##(1995-11#1)(1997-7#1)(2011-2#1)
target genes in a##2##4##(2008-9#1)(2009-8#1)
target genes in##4##3##(1996-12#1)(2008-9#1)(2009-8#2)
target genes involved in##2##4##(1996-4#1)(2011-1#1)
target genes of##4##3##(2008-9#1)(2012-12#2)(2013-8#1)
target genes such as##2##4##(2009-3#1)(2010-7#1)
target genes##61##2##(1991-2#1)(1993-2#1)(1994-12#1)(1994-8#1)(1995-1#2)(1995-11#1)(1996-12#2)(1996-4#2)(1996-9#1)(1997-4#2)(1997-7#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#6)(2009-3#1)(2009-4#1)(2009-8#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-12#7)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
target gland##2##2##(2006-1#1)(2008-6#1)
target group for##2##3##(2007-2#1)(2010-12#1)
target group##17##2##(1991-4#1)(1996-12#1)(1997-7#1)(2004-2#2)(2006-2#3)(2007-2#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)
target groups##10##2##(1990-5#1)(1992-12#1)(1996-1#2)(1997-7#2)(2008-1#1)(2008-12#1)(2009-2#1)(2012-3#1)
target has been##5##3##(1993-7#1)(2007-11#1)(2008-1#2)(2008-3#1)
target have##2##2##(2007-11#1)(2008-11#1)
target hemoglobin##4##2##(2006-5#1)(2008-1#1)(2008-5#1)(2008-7#1)
target host factors required for##2##5##(2008-10#1)(2012-2#1)
target identification##5##2##(2006-2#1)(2008-5#3)(2012-2#1)
target image##5##2##(2008-1#1)(2008-2#1)(2008-3#2)(2012-1#1)
target images##2##2##(2008-2#2)
target in a scattering##2##4##(2008-3#2)
target in a##6##3##(2005-11#1)(2008-10#1)(2008-3#3)(2010-2#1)
target in liver##2##3##(2005-10#1)(2009-2#1)
target in the##13##3##(1990-5#1)(1992-12#1)(1996-4#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2009-10#1)(2009-8#1)(2013-1#1)
target in##49##2##(1990-4#1)(1990-5#1)(1992-12#1)(1994-10#1)(1996-11#1)(1996-4#1)(1997-2#1)(2005-10#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-1#3)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#5)(2008-5#2)(2008-8#1)(2009-10#1)(2009-2#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-2#1)(2011-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
target innervation##2##2##(1995-11#1)(1996-3#1)
target intensity of the##2##4##(2006-5#2)
target ions##2##2##(2008-10#1)(2013-1#1)
target is a##2##3##(1993-3#1)(2007-11#1)
target is also##2##3##(1993-4#1)(2008-4#1)
target is##23##2##(1991-2#1)(1991-7#1)(1993-3#1)(1993-4#1)(1995-5#1)(1996-12#1)(1997-1#2)(1997-6#1)(2005-8#1)(2007-11#1)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#1)(2009-11#1)(2009-4#1)(2010-12#1)(2011-2#1)
target key##4##2##(1996-2#1)(2007-12#1)(2008-11#1)(2013-1#1)
target lamp##2##2##(2012-1#2)
target lesion##5##2##(2006-11#2)(2006-6#1)(2008-11#1)(2010-8#1)
target lesions of##2##3##(1990-11#2)
target lesions##5##2##(1990-11#2)(2010-8#2)(2012-2#1)
target level##3##2##(2007-10#1)(2008-8#1)(2013-1#1)
target levels##3##2##(2007-8#1)(2008-3#1)(2010-5#1)
target localization in##2##3##(1997-1#1)(2008-7#1)
target location in##2##3##(2007-12#1)(2008-3#1)
target location##8##2##(1992-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#2)(2012-1#2)
target mRNA##9##2##(1996-12#2)(2006-12#1)(2008-1#1)(2008-10#1)(2008-4#3)(2013-1#1)
target mRNAs##5##2##(2008-1#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
target macromolecules##2##2##(2010-4#1)(2011-12#1)
target may##2##2##(1994-2#1)(1995-1#1)
target mediating the##2##3##(1995-2#1)(1996-12#1)
target membrane##4##2##(1992-6#1)(1994-2#1)(1997-6#1)(2007-8#1)
target membranes##2##2##(1993-6#1)(1997-6#1)
target molecule for##2##3##(1994-2#1)(2008-3#1)
target molecule##8##2##(1992-3#1)(1994-2#1)(2005-11#1)(2007-11#1)(2008-3#1)(2008-6#1)(2009-10#1)(2010-12#1)
target molecules were##2##3##(2008-2#1)(2012-11#1)
target molecules##16##2##(2007-11#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-6#1)(2009-12#1)(2009-4#2)(2011-1#1)(2012-11#2)(2013-1#1)
target motion##9##2##(1993-2#1)(1996-1#6)(2009-8#2)
target movement##4##2##(2009-8#4)
target multiple##4##2##(1996-9#1)(2009-12#1)(2009-8#1)(2013-1#1)
target muscle##3##2##(2007-11#1)(2008-12#1)(2008-6#1)
target neural##2##2##(2006-12#1)(2012-1#1)
target neuron##2##2##(2008-11#2)
target neurons##2##2##(1991-3#1)(2007-12#1)
target not only the##2##4##(2007-3#1)(2013-1#1)
target nucleic##4##2##(2007-8#2)(2008-10#1)(2008-9#1)
target nucleobases##2##2##(2008-10#2)
target nucleotides##2##2##(2007-8#2)
target number of##2##3##(2008-10#1)(2008-8#1)
target object##10##2##(1994-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-2#1)(2012-2#1)
target of 1##2##3##(2005-4#1)(2007-12#1)
target of a##3##3##(1995-6#1)(2010-12#1)(2010-7#1)
target of interest##4##3##(1994-8#1)(2006-10#1)(2008-1#1)(2008-9#1)
target of rapamycin (mTOR) and##2##5##(2008-5#1)(2011-2#1)
target of rapamycin (mTOR) is##3##5##(2009-12#1)(2009-7#1)(2010-7#1)
target of rapamycin (mTOR) signaling pathway##2##6##(2013-1#2)
target of rapamycin (mTOR)##18##4##(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-12#2)(2010-7#1)(2011-2#1)(2013-1#5)
target of rapamycin##23##3##(2006-10#1)(2006-5#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-12#3)(2010-7#1)(2011-2#2)(2013-1#5)(2013-7#1)
target of the protein##2##4##(1995-2#1)(2011-2#1)
target of the##11##3##(1992-4#1)(1995-2#1)(1995-3#1)(1996-7#1)(1996-9#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#1)
target of these##4##3##(1995-2#1)(1997-8#1)(2009-4#1)(2011-2#1)
target of this##4##3##(2005-8#1)(2008-10#1)(2009-6#1)(2010-12#1)
target of##120##2##(1991-11#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#3)(1993-8#1)(1994-7#1)(1994-8#2)(1995-1#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-7#1)(1996-2#1)(1996-5#3)(1996-7#2)(1996-9#1)(1997-8#3)(2004-12#1)(2005-4#1)(2005-8#2)(2006-10#3)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#4)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#8)(2008-7#2)(2008-8#3)(2008-9#3)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-7#2)(2011-1#4)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#8)(2013-7#2)(2013-8#1)
target oligonucleotide##3##2##(1997-2#1)(2008-10#2)
target on the##3##3##(1992-2#1)(1993-3#1)(2008-8#1)
target on##7##2##(1992-2#1)(1993-3#1)(2007-4#1)(2008-2#1)(2008-8#1)(2011-2#1)(2013-1#1)
target or##4##2##(1996-1#1)(2008-4#1)(2008-8#1)(2012-1#1)
target organ damage##6##3##(1995-12#1)(2007-8#2)(2009-1#3)
target organ for##3##3##(1992-12#1)(1994-11#1)(2012-2#1)
target organ is the##2##4##(1997-3#1)(2008-11#1)
target organ of##4##3##(1990-5#1)(1992-9#1)(2008-5#1)(2011-1#1)
target organ responses##2##3##(2008-7#2)
target organ##32##2##(1990-4#1)(1990-5#1)(1990-8#1)(1992-12#1)(1992-6#1)(1992-9#1)(1994-11#2)(1994-6#1)(1995-12#1)(1997-3#1)(1997-4#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#3)(2009-1#3)(2010-1#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
target organisms##2##2##(2007-5#1)(2008-10#1)
target organs and tissues##2##4##(1994-3#1)(1996-2#1)
target organs of##2##3##(1997-3#1)(2008-5#1)
target organs##17##2##(1992-6#1)(1994-3#1)(1994-6#1)(1995-5#1)(1996-2#1)(1997-3#1)(2005-7#1)(2008-1#1)(2008-4#3)(2008-5#1)(2008-8#1)(2009-2#1)(2011-2#1)(2012-1#1)(2012-2#1)
target parameters##2##2##(2007-11#1)(2008-3#1)
target patterns##2##2##(1995-8#1)(2010-2#1)
target plant##3##2##(2008-10#2)(2008-7#1)
target plasma##2##2##(1991-12#1)(2007-9#1)
target points##2##2##(2012-1#2)
target population of##3##3##(2006-8#1)(2008-9#1)(2011-1#1)
target population size##2##3##(2012-3#2)
target population##28##2##(1990-10#1)(1991-12#1)(1996-12#1)(1997-1#1)(1997-2#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#3)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
target populations##5##2##(1995-5#1)(2005-4#1)(2008-8#1)(2012-2#1)(2012-3#1)
target position in relation to the body##2##7##(1995-5#2)
target position in##3##3##(1995-5#2)(1997-1#1)
target precision##2##2##(2008-2#1)(2013-7#1)
target prediction##2##2##(2008-11#1)(2013-8#1)
target processing##2##2##(1995-12#1)(2008-1#1)
target promoters##4##2##(1994-6#1)(2007-12#1)(2012-12#2)
target protein and##5##3##(1990-12#1)(2006-11#1)(2008-4#2)(2010-7#1)
target protein for##6##3##(1991-5#1)(1994-11#1)(1994-12#2)(1994-9#2)
target protein in the##2##4##(1991-4#1)(2008-7#1)
target protein in##4##3##(1991-4#1)(1997-1#1)(2008-4#1)(2008-7#1)
target protein is##2##3##(2008-11#2)
target protein##49##2##(1990-11#1)(1990-12#4)(1991-12#1)(1991-4#3)(1991-5#1)(1994-11#1)(1994-12#2)(1994-9#2)(1995-6#1)(1997-1#1)(1997-2#1)(1997-6#2)(2006-11#5)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#5)(2008-2#2)(2008-4#5)(2008-7#1)(2009-9#1)(2010-7#1)
target proteins and##4##3##(2006-12#1)(2007-8#1)(2009-4#1)(2011-2#1)
target proteins by##2##3##(2008-11#1)(2008-8#1)
target proteins for##2##3##(2008-11#1)(2008-4#1)
target proteins into##2##3##(1992-6#1)(2006-11#1)
target proteins of##2##3##(1990-11#1)(2012-3#1)
target proteins##30##2##(1990-11#1)(1992-6#1)(1995-1#1)(1997-4#2)(2006-11#1)(2006-12#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-11#3)(2008-4#3)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-4#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)
target range##2##2##(2008-2#1)(2008-3#1)
target receptor##3##2##(2008-8#2)(2009-12#1)
target recognition##12##2##(1995-3#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)(2008-6#1)(2010-8#1)(2012-2#1)
target region of##2##3##(2007-12#1)(2008-10#1)
target region##7##2##(1995-12#1)(1995-9#1)(2007-12#1)(2008-10#1)(2010-2#1)(2011-2#1)(2012-1#1)
target regions##2##2##(1994-12#1)(1996-12#1)
target release##2##2##(2012-3#1)(2013-7#1)
target rocks and##2##3##(1993-7#2)
target rocks##3##2##(1993-7#3)
target selection##6##2##(2006-5#2)(2008-6#1)(2008-7#1)(2012-2#2)
target sequence and##2##3##(1990-8#1)(2008-10#1)
target sequence in##3##3##(1996-10#1)(2008-10#1)(2008-9#1)
target sequence of##2##3##(1994-12#1)(2009-8#1)
target sequence##26##2##(1990-8#1)(1991-11#1)(1993-11#2)(1994-12#2)(1994-9#1)(1996-10#1)(2006-12#1)(2008-10#5)(2008-12#4)(2008-2#2)(2008-4#2)(2008-9#2)(2009-8#1)(2011-1#1)
target sequences and##2##3##(1995-5#1)(1997-6#1)
target sequences in solution##2##4##(2009-2#1)(2010-4#1)
target sequences in##5##3##(2006-12#1)(2008-4#1)(2008-9#1)(2009-2#1)(2010-4#1)
target sequences##20##2##(1995-5#1)(1996-4#1)(1997-6#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-4#3)(2008-9#3)(2009-2#1)(2009-8#1)(2010-4#1)(2012-2#1)(2013-8#1)
target several##2##2##(1996-9#1)(2008-11#1)
target signature##2##2##(2008-3#2)
target site and a##2##4##(1995-1#1)(2007-6#1)
target site duplication##2##3##(2012-3#2)
target site for##6##3##(1991-2#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-9#1)(2008-10#1)
target site of the##2##4##(1994-11#1)(1996-7#1)
target site of##5##3##(1994-11#1)(1994-8#1)(1996-7#2)(2007-8#1)
target site##29##2##(1990-11#2)(1991-2#4)(1991-4#1)(1991-5#1)(1993-11#2)(1993-12#1)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-7#4)(1997-2#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-12#1)(2012-3#2)
target sites##26##2##(1990-11#1)(1991-4#1)(1991-8#1)(1994-8#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-9#2)(1997-2#1)(2006-11#2)(2006-12#2)(2007-10#1)(2008-1#1)(2008-11#1)(2008-4#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
target size and##2##3##(2008-3#1)(2008-8#1)
target size##4##2##(1997-2#1)(2008-2#1)(2008-3#1)(2008-8#1)
target species##8##2##(1997-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)
target specific##8##2##(2005-8#1)(2006-10#1)(2007-11#1)(2008-11#1)(2010-12#2)(2012-2#1)(2013-1#1)
target specificity and##2##3##(2006-8#1)(2008-10#1)
target specificity##4##2##(1997-4#1)(2006-8#1)(2008-10#2)
target ssDNA##2##2##(2008-10#2)
target ssDNA(I)##2##2##(2008-10#2)
target stimuli##6##2##(1996-5#1)(1996-6#1)(2008-6#1)(2009-4#1)(2010-7#1)(2012-12#1)
target stimulus##4##2##(1996-1#1)(2008-6#1)(2013-7#2)
target strain##2##2##(1993-11#1)(2006-11#1)
target structures##2##2##(2005-9#1)(2008-3#1)
target substrate##2##2##(1990-12#1)(2008-3#1)
target surface##6##2##(2008-2#1)(2008-3#2)(2010-4#1)(2013-1#2)
target symptoms##2##2##(2005-7#1)(2008-7#1)
target territory##2##2##(1996-1#2)
target that is##2##3##(2008-2#1)(2008-3#1)
target that##5##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
target the expression##2##3##(2008-11#1)(2009-8#1)
target the perceptual##2##3##(2009-9#1)(2010-8#1)
target the underlying##2##3##(2006-10#1)(2008-5#1)
target the##51##2##(1993-2#1)(1993-7#1)(1994-12#1)(1994-5#1)(1994-9#1)(1997-1#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#1)(2007-11#2)(2007-6#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-12#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#2)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#5)(2013-8#2)
target therapy##4##2##(2008-5#1)(2010-8#1)(2011-2#1)(2012-3#1)
target these mechanisms##2##3##(2006-10#1)(2011-2#1)
target these##7##2##(2006-10#1)(2006-7#1)(2007-1#1)(2008-1#1)(2011-2#2)(2012-2#1)
target this##4##2##(1997-6#1)(2007-11#1)(2009-7#1)(2011-2#1)
target tissue by##2##3##(1996-3#1)(2013-7#1)
target tissue for##2##3##(1994-3#1)(1994-6#1)
target tissue of##2##3##(1990-7#1)(2009-11#1)
target tissue##20##2##(1990-7#1)(1991-10#1)(1992-6#1)(1993-4#1)(1994-3#1)(1994-6#1)(1995-9#1)(1996-3#2)(1997-2#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2009-11#1)(2009-7#1)(2011-2#1)(2012-12#2)(2013-7#1)
target tissues and##4##3##(1993-3#1)(1995-12#1)(2008-3#1)(2009-4#1)
target tissues of the##2##4##(1997-4#1)(2006-10#1)
target tissues of##3##3##(1993-11#1)(1997-4#1)(2006-10#1)
target tissues##31##2##(1991-12#1)(1991-3#1)(1991-5#2)(1993-11#1)(1993-3#1)(1994-11#3)(1995-12#1)(1995-2#2)(1996-2#1)(1997-4#3)(1997-7#1)(2006-1#2)(2006-10#1)(2006-6#2)(2008-1#1)(2008-3#1)(2008-4#1)(2009-4#1)(2010-3#1)(2010-8#2)(2012-2#1)(2012-3#1)
target to##15##2##(1993-2#1)(1995-12#1)(2005-7#1)(2006-3#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2009-5#1)(2009-6#1)(2010-1#1)(2012-12#1)(2013-8#1)
target tumor##6##2##(1990-11#1)(1995-1#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-11#1)
target using##3##2##(2008-10#1)(2008-11#1)(2012-1#1)
target validation and gene function##2##5##(2005-8#2)
target validation and##3##3##(2005-7#1)(2005-8#2)
target validation##6##2##(2005-7#1)(2005-8#2)(2008-11#1)(2008-4#1)(2013-1#1)
target value of##2##3##(2008-10#2)
target value##5##2##(1990-12#1)(1993-9#1)(2008-10#2)(2011-2#1)
target values##5##2##(1990-12#1)(1993-9#2)(2008-2#1)(2012-2#1)
target variable##3##2##(2007-6#1)(2008-12#1)(2008-3#1)
target vessel##3##2##(2007-8#1)(2008-11#1)(2009-5#1)
target vessels##2##2##(2007-8#2)
target viral##2##2##(2011-1#2)
target volume of##2##3##(2008-6#1)(2009-11#1)
target volume##27##2##(1993-4#2)(1993-9#2)(2006-6#1)(2008-2#5)(2008-3#3)(2008-6#3)(2009-10#1)(2009-11#2)(2009-5#2)(2009-8#1)(2010-9#3)(2012-12#2)
target volumes defined##2##3##(2012-12#2)
target volumes for##3##3##(2008-2#2)(2012-12#1)
target volumes##8##2##(2008-2#2)(2008-3#1)(2012-12#5)
target vowel##4##2##(2010-12#4)
target vs##2##2##(2007-1#1)(2009-12#1)
target was an##2##3##(2009-4#1)(2010-2#1)
target was##17##2##(1992-12#1)(1994-2#2)(1996-6#2)(1997-1#1)(2006-12#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-4#1)(2010-2#1)(2012-1#1)(2012-2#1)
target weight##6##2##(2013-1#6)
target were##4##2##(1996-6#1)(2007-12#1)(2008-10#1)(2008-3#1)
target with a##6##3##(1996-1#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#1)
target with##14##2##(1996-1#1)(1996-6#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#3)(2013-1#1)
target word##3##2##(1997-7#1)(2009-8#2)
target words##7##2##(2007-12#1)(2007-4#2)(2009-10#1)(2009-8#1)(2012-1#1)(2012-12#1)
target##2603##1##(1990-10#1)(1990-11#10)(1990-12#16)(1990-3#3)(1990-4#3)(1990-5#5)(1990-6#2)(1990-7#3)(1990-8#3)(1990-9#6)(1991-1#1)(1991-10#4)(1991-11#4)(1991-12#7)(1991-2#11)(1991-3#9)(1991-4#7)(1991-5#10)(1991-6#5)(1991-7#2)(1991-8#4)(1991-9#12)(1992-1#1)(1992-10#3)(1992-11#5)(1992-12#6)(1992-2#3)(1992-3#3)(1992-4#4)(1992-5#3)(1992-6#7)(1992-7#3)(1992-8#5)(1992-9#4)(1993-1#1)(1993-11#11)(1993-12#13)(1993-2#10)(1993-3#10)(1993-4#9)(1993-5#2)(1993-6#3)(1993-7#8)(1993-8#2)(1993-9#12)(1994-10#1)(1994-11#9)(1994-12#10)(1994-2#17)(1994-3#8)(1994-5#5)(1994-6#7)(1994-7#2)(1994-8#11)(1994-9#9)(1995-1#13)(1995-10#2)(1995-11#4)(1995-12#12)(1995-2#17)(1995-3#10)(1995-4#1)(1995-5#12)(1995-6#6)(1995-7#1)(1995-8#15)(1995-9#6)(1996-1#21)(1996-10#3)(1996-11#3)(1996-12#12)(1996-2#8)(1996-3#13)(1996-4#9)(1996-5#5)(1996-6#8)(1996-7#7)(1996-8#6)(1996-9#9)(1997-1#15)(1997-2#14)(1997-3#6)(1997-4#21)(1997-5#2)(1997-6#10)(1997-7#13)(1997-8#8)(2004-1#3)(2004-11#1)(2004-12#3)(2004-2#2)(2004-4#2)(2005-10#5)(2005-11#11)(2005-12#2)(2005-4#2)(2005-6#1)(2005-7#26)(2005-8#12)(2005-9#4)(2006-1#3)(2006-10#28)(2006-11#11)(2006-12#26)(2006-2#9)(2006-3#2)(2006-5#10)(2006-6#9)(2006-7#2)(2006-8#4)(2006-9#4)(2007-1#4)(2007-10#4)(2007-11#57)(2007-12#42)(2007-2#5)(2007-3#3)(2007-4#9)(2007-5#1)(2007-6#7)(2007-7#7)(2007-8#44)(2007-9#6)(2008-1#88)(2008-10#175)(2008-11#83)(2008-12#13)(2008-2#91)(2008-3#94)(2008-4#92)(2008-5#52)(2008-6#24)(2008-7#48)(2008-8#43)(2008-9#35)(2009-1#4)(2009-10#10)(2009-11#13)(2009-12#12)(2009-2#9)(2009-3#5)(2009-4#18)(2009-5#12)(2009-6#10)(2009-7#10)(2009-8#35)(2009-9#9)(2010-1#5)(2010-10#9)(2010-11#10)(2010-12#32)(2010-2#18)(2010-3#8)(2010-4#16)(2010-5#19)(2010-6#4)(2010-7#15)(2010-8#18)(2010-9#4)(2011-1#56)(2011-12#5)(2011-2#77)(2011-3#5)(2012-1#31)(2012-11#6)(2012-12#60)(2012-2#62)(2012-3#35)(2013-1#80)(2013-7#15)(2013-8#30)
target(s)##4##1##(1997-3#1)(1997-4#1)(2008-1#1)(2012-2#1)
target) and##2##2##(1993-4#1)(2006-4#1)
target)##4##1##(1993-4#2)(2006-4#1)(2008-4#1)
target-based screening##2##2##(1997-4#2)
target-based##4##1##(1997-4#3)(2009-6#1)
target-cell##3##1##(1993-9#1)(2008-4#2)
target-controlled##3##1##(2006-10#1)(2009-4#1)(2009-6#1)
target-date funds##3##2##(2011-2#3)
target-derived factors##2##2##(1996-12#1)(1996-3#1)
target-derived neurotrophic##2##2##(1990-5#1)(1996-3#1)
target-derived##11##1##(1990-5#1)(1995-8#2)(1996-12#1)(1996-3#7)
target-distractor##2##1##(2008-1#2)
target-like##2##1##(1997-3#1)(2012-12#1)
target-mediated##2##1##(2008-5#2)
target-object light levels##2##3##(2008-2#2)
target-oriented##3##1##(2008-10#2)(2008-2#1)
target-site##4##1##(1995-8#1)(1996-11#1)(2008-10#2)
target-specific oligonucleotide##2##2##(2007-2#1)(2008-10#1)
target-specific##7##1##(1994-6#1)(1996-3#1)(2007-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#1)
target-to-nontarget ratios##2##2##(2005-9#1)(2011-1#1)
target?##2##1##(1995-3#1)(2011-2#1)
targeted ES cell##2##3##(2008-11#1)(2008-9#1)
targeted ES cells using##2##4##(2008-8#2)
targeted ES cells##3##3##(2008-11#1)(2008-8#2)
targeted ES##5##2##(2008-11#2)(2008-8#2)(2008-9#1)
targeted HIV##2##2##(2012-3#2)
targeted RNA##2##2##(1997-3#1)(1997-4#1)
targeted aerosol delivery to##2##4##(2008-7#2)
targeted against a specific##2##4##(1997-1#2)
targeted against a##4##3##(1997-1#2)(2006-10#1)(2007-11#1)
targeted against##10##2##(1997-1#2)(2006-10#1)(2007-11#1)(2008-10#3)(2008-4#1)(2010-1#1)(2011-12#1)
targeted agent for##2##3##(2012-12#1)(2013-8#1)
targeted agent##3##2##(2012-12#1)(2013-8#2)
targeted agents are##2##3##(2005-11#1)(2010-12#1)
targeted agents##16##2##(2005-11#1)(2008-7#1)(2009-11#3)(2009-3#1)(2010-10#1)(2010-12#5)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
targeted and controlled##2##3##(2008-11#1)(2008-5#1)
targeted and##13##2##(1994-9#1)(1997-1#1)(2007-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-3#1)(2010-10#1)(2012-2#1)(2013-7#1)
targeted antibiotic therapy and##2##4##(2007-8#1)(2011-2#1)
targeted approach to##4##3##(1991-2#1)(1993-9#1)(1997-8#1)(2008-7#1)
targeted approach##5##2##(1991-2#1)(1993-9#1)(1997-8#1)(2008-7#1)(2009-12#1)
targeted approaches##3##2##(2006-12#1)(2007-11#1)(2010-2#1)
targeted at the various##2##4##(2008-3#1)(2009-10#1)
targeted at the##8##3##(1997-3#1)(1997-4#1)(2008-10#1)(2008-3#1)(2009-10#1)(2009-12#1)(2010-12#1)(2012-1#1)
targeted at##21##2##(1991-7#1)(1993-11#1)(1995-1#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-12#1)(2005-8#1)(2006-5#1)(2008-10#1)(2008-3#3)(2009-10#1)(2009-12#1)(2010-12#1)(2010-3#1)(2012-1#1)(2012-12#1)(2012-2#1)
targeted behaviors##2##2##(2008-11#1)(2010-8#1)
targeted bioimmune##2##2##(2005-10#2)
targeted biopsy##2##2##(2008-1#2)
targeted by small molecules##2##4##(2010-12#1)(2011-2#1)
targeted by the##4##3##(2008-4#1)(2009-4#1)(2012-2#1)(2012-3#1)
targeted by##27##2##(1990-4#1)(1994-3#1)(1994-6#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#2)(2009-8#3)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
targeted cancer therapy##5##3##(1993-9#1)(2008-7#1)(2011-1#2)(2011-2#1)
targeted cancer##6##2##(1993-9#1)(2008-7#1)(2010-12#1)(2011-1#2)(2011-2#1)
targeted cells##2##2##(1996-10#1)(2008-2#1)
targeted clones##2##2##(2008-11#2)
targeted communities##3##2##(1995-2#1)(2010-8#1)(2013-1#1)
targeted compounds##2##2##(2008-5#1)(2012-12#1)
targeted contrast agents##3##3##(2010-12#1)(2010-9#2)
targeted contrast##4##2##(2008-8#1)(2010-12#1)(2010-9#2)
targeted degradation##2##2##(1995-2#1)(2010-4#1)
targeted delivery of##8##3##(1996-4#2)(2008-7#1)(2010-5#2)(2011-2#1)(2012-11#2)
targeted delivery##10##2##(1996-4#2)(2008-7#1)(2010-5#2)(2011-2#1)(2012-11#2)(2012-2#1)(2012-3#1)
targeted disruption of the mouse##3##5##(1994-12#2)(1995-3#1)
targeted disruption of the##4##4##(1994-12#2)(1995-3#1)(1996-4#1)
targeted disruption of##6##3##(1994-12#2)(1995-3#1)(1996-4#1)(2008-7#1)(2010-11#1)
targeted disruption##8##2##(1994-12#3)(1995-3#1)(1996-4#1)(1997-4#1)(2008-7#1)(2010-11#1)
targeted drug delivery##5##3##(2005-11#1)(2007-11#1)(2008-8#1)(2011-1#1)(2012-3#1)
targeted drugs##8##2##(2007-2#1)(2008-1#2)(2008-3#1)(2008-5#1)(2010-12#1)(2010-4#1)(2010-5#1)
targeted efforts##2##2##(2007-5#1)(2012-2#1)
targeted expression of##3##3##(1994-2#1)(1995-2#1)(2006-12#1)
targeted for intervention##2##3##(2008-4#1)(2010-12#1)
targeted for the##2##3##(2011-1#1)(2012-2#1)
targeted for treatment##2##3##(2005-10#1)(2010-5#1)
targeted for##28##2##(1991-5#1)(1994-3#1)(1994-4#1)(1995-3#1)(1995-7#1)(1996-11#2)(1996-2#1)(2004-11#1)(2005-10#1)(2005-8#1)(2006-8#1)(2007-3#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-4#1)(2010-12#3)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-2#1)
targeted gene disruption##3##3##(1991-6#1)(1992-5#1)(2007-7#1)
targeted gene##10##2##(1991-6#1)(1992-5#1)(2005-9#1)(2006-12#1)(2007-11#1)(2007-7#1)(2010-1#2)(2011-1#1)(2013-1#1)
targeted genes##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
targeted health##2##2##(2008-4#1)(2010-2#1)
targeted homologous##2##2##(1995-1#1)(2008-6#1)
targeted in##8##2##(1994-2#1)(1995-11#1)(1997-2#1)(2007-9#1)(2008-12#1)(2010-12#1)(2012-3#1)(2013-8#1)
targeted intervention##7##2##(1996-11#1)(2006-10#1)(2007-1#1)(2011-2#1)(2013-1#3)
targeted interventions##8##2##(2008-10#1)(2009-7#1)(2009-8#1)(2012-3#4)(2013-1#1)
targeted magnetic##2##2##(2012-2#1)(2012-3#1)
targeted molecular##3##2##(2009-10#1)(2009-4#1)(2010-5#1)
targeted mutagenesis##3##2##(1993-2#1)(1995-6#1)(2008-9#1)
targeted mutation into##2##3##(1995-1#1)(2008-4#1)
targeted mutation of##4##3##(1993-12#1)(1995-11#2)(1995-5#1)
targeted mutation##8##2##(1993-12#1)(1995-1#2)(1995-11#2)(1995-5#1)(2008-10#1)(2008-4#1)
targeted mutations##3##2##(2008-10#1)(2008-4#2)
targeted on the##2##3##(1994-2#1)(2008-5#1)
targeted on##3##2##(1992-6#1)(1994-2#1)(2008-5#1)
targeted prevention##3##2##(2006-7#1)(2007-1#1)(2009-9#1)
targeted programs##2##2##(1995-2#1)(2007-9#1)
targeted quantitative##2##2##(2008-9#2)
targeted reduction of##2##3##(2006-6#1)(2010-7#1)
targeted regions##3##2##(2012-1#1)(2012-3#2)
targeted rotation##2##2##(2008-11#2)
targeted sequencing##2##2##(2008-7#1)(2012-3#1)
targeted specifically to the##3##4##(2006-10#1)(2007-12#1)(2012-12#1)
targeted strategies##2##2##(2008-5#1)(2012-11#1)
targeted surveillance##3##2##(1995-10#1)(2011-2#1)(2012-3#1)
targeted the##7##2##(1994-9#1)(1995-1#1)(1995-3#1)(2008-10#1)(2008-6#1)(2012-3#1)(2013-7#1)
targeted therapeutic strategies##2##3##(2006-10#1)(2010-12#1)
targeted therapeutic##7##2##(2006-10#1)(2008-6#1)(2010-12#1)(2010-4#1)(2012-1#1)(2012-12#2)
targeted therapeutics##2##2##(2005-10#1)(2012-12#1)
targeted therapies are##2##3##(2006-10#1)(2010-10#1)
targeted therapies for##6##3##(2005-11#1)(2009-1#1)(2010-10#1)(2010-12#1)(2012-1#2)
targeted therapies in##8##3##(2009-10#1)(2009-11#1)(2011-2#1)(2012-1#1)(2013-8#4)
targeted therapies is##2##3##(2008-6#1)(2011-2#1)
targeted therapies##32##2##(2005-11#1)(2006-10#1)(2007-4#1)(2008-1#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-7#1)(2010-10#2)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#4)(2012-12#2)(2012-2#1)(2013-8#4)
targeted therapy can##2##3##(2006-10#1)(2012-2#1)
targeted therapy for the treatment of##2##6##(2006-7#1)(2013-8#1)
targeted therapy for##3##3##(2006-7#1)(2010-12#1)(2013-8#1)
targeted therapy in##4##3##(2008-2#1)(2009-8#2)(2011-3#1)
targeted therapy##22##2##(2006-10#1)(2006-7#1)(2007-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-3#1)(2009-8#2)(2010-11#1)(2010-12#2)(2010-7#1)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
targeted to high-risk##3##3##(2006-10#1)(2009-2#1)(2012-3#1)
targeted to the##16##3##(1990-11#1)(1992-11#1)(1997-6#1)(1997-7#1)(2005-10#1)(2006-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-5#2)(2011-1#1)(2011-2#1)
targeted to viral proteins##2##4##(2009-8#1)(2012-2#1)
targeted to##58##2##(1990-11#1)(1990-12#1)(1991-12#1)(1992-11#1)(1992-7#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(2005-10#2)(2005-7#4)(2005-8#1)(2006-10#2)(2006-11#1)(2007-1#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-9#2)(2009-12#2)(2009-2#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-5#2)(2011-1#1)(2011-2#3)(2012-11#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
targeted toward the##3##3##(1997-2#1)(1997-5#1)(2010-2#1)
targeted toward##6##2##(1997-2#1)(1997-5#1)(2006-10#1)(2006-7#1)(2010-10#1)(2010-2#1)
targeted towards##4##2##(1991-9#1)(1993-11#1)(2007-12#1)(2007-7#1)
targeted toxins for##2##3##(2008-5#2)
targeted toxins##5##2##(2008-5#5)
targeted treatment##5##2##(1990-6#1)(2005-10#1)(2008-7#1)(2012-12#1)(2013-8#1)
targeted use of a##2##4##(2006-12#1)(2008-10#1)
targeted use of##4##3##(2006-12#1)(2007-6#1)(2008-10#1)(2008-7#1)
targeted vaccination##2##2##(2006-10#1)(2012-2#1)
targeted with##3##2##(1991-12#1)(1993-9#1)(2013-1#1)
targeted##652##1##(1990-11#1)(1990-12#6)(1990-4#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#3)(1993-11#2)(1993-12#1)(1993-2#1)(1993-9#8)(1994-12#5)(1994-2#4)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#1)(1994-9#3)(1995-1#5)(1995-10#2)(1995-11#4)(1995-12#1)(1995-2#4)(1995-3#5)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#1)(1996-10#2)(1996-11#3)(1996-2#4)(1996-3#1)(1996-4#4)(1996-8#1)(1997-1#4)(1997-2#4)(1997-3#3)(1997-4#6)(1997-5#1)(1997-6#1)(1997-7#5)(1997-8#1)(2004-11#1)(2004-12#1)(2005-10#9)(2005-11#3)(2005-12#1)(2005-7#4)(2005-8#3)(2005-9#2)(2006-10#16)(2006-11#2)(2006-12#4)(2006-5#2)(2006-6#1)(2006-7#3)(2006-8#3)(2006-9#1)(2007-1#4)(2007-10#4)(2007-11#6)(2007-12#9)(2007-2#2)(2007-3#2)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#9)(2007-9#2)(2008-1#12)(2008-10#23)(2008-11#16)(2008-12#5)(2008-2#5)(2008-3#7)(2008-4#13)(2008-5#15)(2008-6#7)(2008-7#20)(2008-8#8)(2008-9#14)(2009-1#1)(2009-10#4)(2009-11#5)(2009-12#5)(2009-2#1)(2009-3#6)(2009-4#4)(2009-5#1)(2009-7#6)(2009-8#10)(2009-9#2)(2010-1#3)(2010-10#6)(2010-11#3)(2010-12#24)(2010-2#5)(2010-3#4)(2010-4#5)(2010-5#10)(2010-7#4)(2010-8#2)(2010-9#3)(2011-1#15)(2011-12#1)(2011-2#19)(2011-3#5)(2012-1#10)(2012-11#6)(2012-12#24)(2012-2#26)(2012-3#22)(2013-1#21)(2013-7#8)(2013-8#10)
targeting Black men##2##3##(2009-5#2)
targeting GSCs located in such a hypoxic environment may be critical to improving the therapeutic outcome for GBM patients##2##19##(2012-12#2)
targeting a novel##2##3##(2012-2#2)
targeting a specific##3##3##(2008-6#1)(2012-11#1)(2013-1#1)
targeting a##13##2##(1993-2#1)(1995-6#1)(1996-12#1)(1997-6#1)(2005-7#1)(2007-8#1)(2008-2#1)(2008-6#1)(2010-5#1)(2012-11#1)(2012-2#2)(2013-1#1)
targeting and imaging in live animals##2##6##(2010-2#2)
targeting and transcytosis##2##3##(2009-10#2)
targeting and##20##2##(1995-3#1)(1996-8#1)(1997-3#1)(2005-6#2)(2005-7#1)(2005-8#1)(2008-1#2)(2008-2#1)(2009-10#2)(2009-11#1)(2010-10#1)(2010-2#2)(2012-12#2)(2012-2#1)(2013-7#1)
targeting antibody##2##2##(1993-9#1)(2009-8#1)
targeting at##2##2##(2008-11#1)(2011-1#1)
targeting both##2##2##(2008-11#1)(2009-4#1)
targeting by##2##2##(2008-4#1)(2009-4#1)
targeting c-raf##2##2##(2005-11#2)
targeting construct##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
targeting defect##2##2##(1992-12#1)(1993-6#1)
targeting different##2##2##(2008-1#2)
targeting each of##2##3##(1992-7#1)(2005-7#1)
targeting for##6##2##(1994-5#1)(2008-1#1)(2009-5#1)(2009-9#1)(2011-1#1)(2012-2#1)
targeting fungal##2##2##(2008-10#1)(2011-2#1)
targeting gene delivery system##2##4##(2008-8#2)
targeting genes##3##2##(2012-12#2)(2012-2#1)
targeting in the##2##3##(2005-11#1)(2008-7#1)
targeting in##15##2##(1990-7#1)(1993-11#1)(1995-1#1)(1995-2#2)(1997-6#2)(2005-11#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-7#1)(2009-7#1)(2010-6#1)
targeting individual##3##2##(2006-10#1)(2008-1#1)(2012-3#1)
targeting interventions##2##2##(2006-10#1)(2013-1#1)
targeting is##5##2##(1997-6#1)(2008-2#1)(2008-8#1)(2009-8#1)(2012-2#1)
targeting key##2##2##(2008-1#1)(2009-12#1)
targeting lesbian##2##2##(2008-12#2)
targeting mechanisms##3##2##(2008-5#1)(2009-3#1)(2010-12#1)
targeting methods##2##2##(2009-12#2)
targeting multiple##2##2##(2011-2#1)(2013-1#1)
targeting of drugs##2##3##(1996-4#1)(2006-5#1)
targeting of endothelial##2##3##(1997-6#1)(2008-1#1)
targeting of its##2##3##(2008-11#1)(2012-3#1)
targeting of the##14##3##(1991-11#1)(1991-6#1)(1994-12#1)(1995-2#1)(1996-7#1)(2006-12#2)(2007-1#1)(2007-10#1)(2007-12#1)(2007-5#1)(2009-1#1)(2010-3#1)(2012-2#1)
targeting of these##2##3##(1990-12#1)(2009-8#1)
targeting of this##2##3##(2005-8#1)(2010-12#1)
targeting of##74##2##(1990-12#1)(1991-11#1)(1991-6#1)(1992-7#1)(1993-6#1)(1994-12#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-7#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(2005-6#1)(2005-8#2)(2006-10#1)(2006-12#2)(2006-5#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-5#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)
targeting one##2##2##(1992-3#1)(2009-4#1)
targeting pathways##2##2##(2008-7#1)(2012-12#1)
targeting potential of the##2##4##(1993-11#1)(1996-11#1)
targeting potential##3##2##(1993-11#2)(1996-11#1)
targeting sequence##6##2##(1990-11#1)(1991-1#1)(1994-2#1)(1994-8#1)(1994-9#1)(2009-10#1)
targeting sequences##5##2##(1991-10#1)(1991-7#1)(1994-8#1)(1996-4#1)(2008-1#1)
targeting signal of##2##3##(1994-9#1)(1997-4#1)
targeting signal##10##2##(1992-6#2)(1992-7#1)(1994-12#1)(1994-2#2)(1994-9#1)(1995-3#2)(1997-4#1)
targeting signals of##2##3##(1994-12#1)(2005-8#1)
targeting specific##5##2##(1990-7#1)(1995-5#1)(2005-11#1)(2010-8#1)(2012-3#1)
targeting strategies##6##2##(2010-2#2)(2011-2#2)(2012-2#1)(2013-7#1)
targeting subunits##2##2##(2012-12#2)
targeting telomerase##2##2##(2007-11#1)(2008-9#1)
targeting the conserved##4##3##(1997-6#1)(2008-10#2)(2008-3#1)
targeting the epigenome##2##3##(2007-10#1)(2012-2#1)
targeting the specific##2##3##(2008-3#1)(2012-11#1)
targeting the underlying##2##3##(2008-7#1)(2013-8#1)
targeting the viral##3##3##(2006-10#1)(2011-1#1)(2012-3#1)
targeting the##67##2##(1990-5#1)(1991-12#1)(1994-11#1)(1997-2#1)(1997-6#1)(2005-7#2)(2006-1#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#4)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2011-3#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#3)
targeting them to##2##3##(2007-8#1)(2009-2#1)
targeting therapeutics to##2##3##(2005-7#1)(2007-11#1)
targeting therapy##2##2##(2008-12#1)(2010-3#1)
targeting these##9##2##(2005-8#1)(2006-10#2)(2008-11#1)(2010-1#1)(2010-6#1)(2011-1#1)(2011-2#2)
targeting this##4##2##(2008-5#1)(2010-3#1)(2011-2#1)(2013-8#1)
targeting to the endoplasmic reticulum##2##5##(1993-6#1)(1995-6#1)
targeting to the##5##3##(1993-6#1)(1994-2#1)(1994-8#1)(1995-6#1)(2009-8#1)
targeting to##13##2##(1991-7#1)(1991-8#1)(1992-9#1)(1993-6#1)(1994-10#1)(1994-2#1)(1994-8#1)(1995-6#1)(1996-4#1)(1997-6#1)(2005-10#1)(2009-10#1)(2009-8#1)
targeting tumor##4##2##(2007-8#1)(2008-1#2)(2008-5#1)
targeting using##2##2##(1996-10#1)(2012-12#1)
targeting vector##5##2##(1996-10#2)(2008-10#1)(2008-9#2)
targeting via##2##2##(2010-12#1)(2012-12#1)
targeting was##2##2##(1997-6#1)(2010-1#1)
targeting were##2##2##(2009-10#1)(2013-1#1)
targeting with##3##2##(2008-8#1)(2009-9#1)(2011-2#1)
targeting youth##2##2##(2011-1#1)(2012-12#1)
targeting##611##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-7#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#3)(1991-12#4)(1991-6#2)(1991-7#2)(1991-8#4)(1992-12#3)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#6)(1992-9#1)(1993-11#4)(1993-2#3)(1993-3#1)(1993-6#4)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#5)(1994-5#1)(1994-6#1)(1994-8#7)(1994-9#3)(1995-1#7)(1995-11#2)(1995-12#2)(1995-2#5)(1995-3#3)(1995-5#3)(1995-6#5)(1996-10#4)(1996-11#2)(1996-12#1)(1996-2#1)(1996-4#3)(1996-5#1)(1996-7#2)(1996-8#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#12)(1997-7#3)(2004-1#1)(2004-12#3)(2005-10#1)(2005-11#6)(2005-6#10)(2005-7#11)(2005-8#13)(2006-1#1)(2006-10#8)(2006-12#5)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#5)(2007-11#12)(2007-12#7)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#19)(2008-10#8)(2008-11#17)(2008-12#5)(2008-2#8)(2008-3#3)(2008-4#8)(2008-5#8)(2008-6#3)(2008-7#12)(2008-8#8)(2008-9#10)(2009-1#1)(2009-10#13)(2009-11#2)(2009-12#8)(2009-2#1)(2009-3#7)(2009-4#3)(2009-5#4)(2009-6#1)(2009-7#2)(2009-8#7)(2009-9#5)(2010-1#3)(2010-10#2)(2010-11#2)(2010-12#11)(2010-2#9)(2010-3#3)(2010-4#4)(2010-5#4)(2010-6#4)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#10)(2011-12#2)(2011-2#22)(2011-3#4)(2012-1#3)(2012-11#7)(2012-12#33)(2012-2#20)(2012-3#11)(2013-1#29)(2013-7#6)(2013-8#7)
targeting&quot##2##1##(1997-1#1)(2008-3#1)
targeting)##3##1##(2008-2#1)(2008-4#1)(2012-12#1)
targets (e##2##2##(2007-12#1)(2009-9#1)
targets a##2##2##(2009-3#1)(2013-1#1)
targets according to##2##3##(2007-8#1)(2008-7#1)
targets and biomarkers##3##3##(2013-1#3)
targets and pathways##2##3##(2010-6#1)(2012-2#1)
targets and strategies##2##3##(2008-5#1)(2009-12#1)
targets and the##2##3##(2006-5#1)(2008-7#1)
targets and therapy##2##3##(2009-8#2)
targets and##58##2##(1992-1#1)(1995-6#1)(1997-6#1)(1997-7#1)(2005-7#2)(2005-8#2)(2006-5#1)(2006-9#1)(2007-11#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#4)(2009-11#1)(2009-12#3)(2009-5#1)(2009-8#2)(2010-12#3)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#3)(2013-1#5)(2013-7#1)
targets are known##2##3##(1990-8#1)(2007-12#1)
targets are present##2##3##(1992-12#1)(2008-3#1)
targets are##15##2##(1990-8#1)(1992-12#1)(1992-9#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-3#4)(2008-4#1)(2009-8#1)(2011-1#1)(2012-12#1)
targets as well as##2##4##(2008-8#1)(2009-12#1)
targets as##7##2##(2008-1#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-12#1)(2012-3#1)
targets at the##3##3##(1995-1#1)(2007-4#1)(2007-7#1)
targets at##8##2##(1995-1#1)(1996-10#1)(1997-4#1)(2007-4#1)(2007-7#1)(2008-3#1)(2009-9#1)(2011-2#1)
targets by the##2##3##(2007-12#1)(2008-10#1)
targets by##9##2##(1996-11#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#1)(2013-7#1)
targets can be##4##3##(1996-12#1)(2008-3#1)(2009-3#1)(2010-11#1)
targets compared to##2##3##(1997-7#1)(2010-7#1)
targets during##3##2##(2008-10#1)(2008-2#1)(2011-12#1)
targets elicited##2##2##(2008-11#2)
targets embedded in a##2##4##(2007-11#1)(2008-11#1)
targets embedded in##3##3##(2007-11#1)(2007-4#1)(2008-11#1)
targets for a##2##3##(2006-10#1)(2008-7#1)
targets for action##2##3##(1991-2#1)(2008-11#1)
targets for cancer therapy##4##4##(2007-11#1)(2008-1#1)(2009-12#1)(2012-12#1)
targets for cancer##6##3##(2007-11#1)(2008-1#1)(2009-12#1)(2010-12#1)(2012-12#1)(2013-1#1)
targets for chemoprevention##2##3##(2011-2#2)
targets for chemotherapy##2##3##(1991-5#1)(1997-7#1)
targets for drug development##2##4##(2005-8#1)(2007-11#1)
targets for drug discovery##3##4##(2005-8#1)(2008-1#1)(2011-3#1)
targets for drug##6##3##(2005-8#2)(2007-11#1)(2008-1#1)(2008-9#1)(2011-3#1)
targets for future##3##3##(1995-6#1)(2012-12#1)(2012-3#1)
targets for immunotherapy##3##3##(2008-6#1)(2009-8#1)(2010-12#1)
targets for intervention##2##3##(1995-12#1)(1995-6#1)
targets for new##3##3##(2008-1#1)(2008-11#1)(2008-5#1)
targets for novel therapeutic##2##4##(2006-10#1)(2009-11#1)
targets for novel##4##3##(2006-10#1)(2006-11#1)(2007-11#1)(2009-11#1)
targets for pharmacological##3##3##(2005-7#1)(2008-1#1)(2010-3#1)
targets for prevention##3##3##(1997-2#1)(2008-1#1)(2008-7#1)
targets for protein kinase##2##4##(1994-2#1)(1994-9#1)
targets for reducing##2##3##(2008-8#1)(2012-2#1)
targets for structure-based##2##3##(2011-1#2)
targets for the development of new##2##6##(1994-4#1)(2008-10#1)
targets for the development of novel##2##6##(2009-10#1)(2011-2#1)
targets for the development of##5##5##(1994-4#1)(2008-10#1)(2009-10#1)(2011-2#2)
targets for the treatment of##5##5##(2005-8#2)(2008-1#1)(2008-5#1)(2011-1#1)
targets for the year 2015##2##5##(2008-8#2)
targets for the##22##3##(1994-4#1)(1995-10#1)(1996-1#1)(1996-3#1)(2005-7#1)(2005-8#3)(2006-10#1)(2007-4#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-8#2)(2009-10#1)(2011-1#1)(2011-2#3)(2013-7#1)
targets for therapeutic intervention##5##4##(2007-6#1)(2008-11#1)(2008-8#1)(2010-3#1)(2012-12#1)
targets for therapeutic##7##3##(2007-6#1)(2008-11#1)(2008-8#1)(2010-3#1)(2011-2#2)(2012-12#1)
targets for therapy##9##3##(1996-11#1)(2006-10#2)(2008-4#1)(2009-6#1)(2011-2#2)(2012-12#1)(2012-2#1)
targets for this##3##3##(2008-5#1)(2009-11#1)(2010-11#1)
targets for treatment##2##3##(2010-2#1)(2010-3#1)
targets for##176##2##(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-6#1)(1994-9#2)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#2)(2005-12#1)(2005-7#4)(2005-8#5)(2006-10#9)(2006-11#1)(2006-12#2)(2006-2#1)(2007-10#1)(2007-11#8)(2007-4#1)(2007-6#2)(2007-8#1)(2007-9#1)(2008-1#12)(2008-10#2)(2008-11#3)(2008-4#9)(2008-5#5)(2008-6#2)(2008-7#8)(2008-8#5)(2008-9#1)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#1)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-5#1)(2011-1#6)(2011-2#9)(2011-3#1)(2012-12#7)(2012-2#7)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#4)
targets from##4##2##(1995-6#1)(2007-12#1)(2008-10#1)(2008-4#1)
targets has been##2##3##(2005-7#1)(2008-5#1)
targets have been identified##4##4##(2008-1#1)(2008-11#1)(2012-12#2)
targets have been##10##3##(2005-7#1)(2007-12#1)(2008-1#2)(2008-11#1)(2009-12#1)(2009-8#1)(2010-8#1)(2012-12#2)
targets have##12##2##(2005-7#1)(2007-12#1)(2008-1#2)(2008-11#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-8#1)(2012-12#2)
targets if##2##2##(2008-2#1)(2008-3#1)
targets in a##5##3##(1994-2#1)(2005-8#1)(2008-3#1)(2008-8#1)(2010-5#1)
targets in the##23##3##(1990-5#1)(1991-3#1)(1996-10#1)(1996-12#1)(1996-9#1)(2005-9#2)(2006-10#2)(2007-4#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-8#1)
targets in these##2##3##(2009-1#1)(2012-12#1)
targets in various##2##3##(1994-3#1)(2009-8#1)
targets in##69##2##(1990-5#1)(1991-3#1)(1992-6#1)(1993-7#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-9#1)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#4)(2006-2#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-4#2)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-1#1)(2010-12#3)(2010-5#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#3)
targets include##2##2##(1994-8#1)(2009-9#1)
targets involved##3##2##(2008-7#1)(2009-3#1)(2012-1#1)
targets is##9##2##(2005-8#1)(2007-2#1)(2007-8#1)(2009-12#1)(2009-8#1)(2010-10#1)(2011-1#2)(2012-3#1)
targets led to##2##3##(2010-8#1)(2012-2#1)
targets located##2##2##(2009-2#1)(2010-2#1)
targets may##3##2##(2008-1#1)(2011-1#1)(2012-2#1)
targets more##3##2##(2010-2#1)(2012-2#2)
targets of DNA##2##3##(1991-5#1)(2007-11#1)
targets of DNA-binding proteins##3##4##(2008-2#3)
targets of Hox protein Ultrabithorax##2##5##(2012-2#2)
targets of Internet aggression##2##4##(2010-4#2)
targets of Notch signaling in##2##5##(2007-12#2)
targets of a##2##3##(1992-3#1)(2008-1#1)
targets of individual##3##3##(2008-2#2)(2008-4#1)
targets of the##11##3##(1991-4#1)(1993-11#1)(1995-2#1)(1995-5#1)(1996-4#1)(1997-4#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-8#1)
targets of this##5##3##(2008-10#1)(2008-11#2)(2008-7#1)(2009-10#1)
targets of##83##2##(1990-12#1)(1991-4#1)(1991-5#2)(1992-12#1)(1992-3#2)(1992-9#1)(1993-11#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-7#1)(1996-4#2)(1997-2#1)(1997-4#1)(2005-11#1)(2005-8#1)(2007-11#1)(2007-12#3)(2008-1#3)(2008-10#5)(2008-11#5)(2008-2#7)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#3)
targets on the##2##3##(1992-8#1)(2008-3#1)
targets on##3##2##(1992-8#1)(2008-3#1)(2012-2#1)
targets or##5##2##(2005-7#1)(2006-10#1)(2008-3#1)(2009-9#1)(2012-3#1)
targets presented##5##2##(1992-10#1)(1995-8#1)(1996-6#2)(2008-4#1)
targets regulating##2##2##(1997-7#1)(2009-9#1)
targets should##2##2##(1991-3#1)(2008-1#1)
targets simultaneously##2##2##(2008-2#1)(2011-1#1)
targets such as##8##3##(2004-12#1)(2008-3#3)(2008-5#1)(2008-7#1)(2010-12#1)(2010-5#1)
targets than##5##2##(2006-12#1)(2008-11#1)(2013-1#2)(2013-8#1)
targets that are##3##3##(2008-3#1)(2011-1#1)(2012-2#1)
targets that can##2##3##(2010-12#1)(2010-3#1)
targets that have been##2##4##(2006-10#1)(2012-12#1)
targets that is##2##3##(2008-2#1)(2008-5#1)
targets that##21##2##(1994-2#1)(1995-1#1)(1996-3#1)(2004-12#1)(2006-10#2)(2006-9#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
targets the##13##2##(1992-2#1)(1993-11#1)(1993-2#1)(1993-7#1)(2007-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-12#2)(2011-2#1)(2013-8#1)
targets thrombin##2##2##(2004-11#2)
targets through##2##2##(1991-2#1)(1994-8#1)
targets to prevent##2##3##(2012-12#1)(2013-8#1)
targets to promote bacterial killing##2##5##(2008-3#2)
targets to promote##3##3##(2008-3#2)(2013-7#1)
targets to##17##2##(1994-8#1)(2006-9#1)(2008-1#1)(2008-3#2)(2008-4#1)(2009-3#1)(2011-1#1)(2012-12#3)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
targets using##3##2##(2005-8#1)(2008-7#1)(2013-7#1)
targets was##4##2##(1993-7#1)(2007-12#1)(2007-8#1)(2008-1#1)
targets were##13##2##(1996-5#1)(2005-6#1)(2005-9#2)(2008-10#2)(2008-7#1)(2010-1#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-7#1)
targets when##2##2##(1991-3#1)(2008-3#1)
targets where##2##2##(2007-8#1)(2013-8#1)
targets whose##2##2##(2009-12#1)(2012-12#1)
targets will be##2##3##(2005-8#1)(2013-1#1)
targets will##4##2##(2005-8#1)(2009-8#1)(2013-1#2)
targets with high##2##3##(2007-8#1)(2008-2#1)
targets with which##2##3##(1991-3#1)(1994-8#1)
targets with##14##2##(1991-3#1)(1993-2#1)(1994-12#1)(1994-8#1)(1997-1#1)(2004-1#1)(2005-9#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2010-8#1)(2013-8#1)
targets within the##4##3##(2005-7#2)(2007-11#1)(2013-7#1)
targets##1018##1##(1990-10#2)(1990-12#1)(1990-5#2)(1990-7#2)(1990-8#1)(1991-10#4)(1991-12#2)(1991-2#2)(1991-3#14)(1991-4#1)(1991-5#3)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#3)(1992-12#3)(1992-2#1)(1992-3#2)(1992-6#1)(1992-7#2)(1992-8#4)(1992-9#3)(1993-1#1)(1993-11#4)(1993-2#5)(1993-6#1)(1993-7#4)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#6)(1994-3#5)(1994-4#1)(1994-6#1)(1994-8#6)(1994-9#3)(1995-1#5)(1995-10#2)(1995-11#3)(1995-12#4)(1995-2#2)(1995-3#2)(1995-5#3)(1995-6#5)(1995-7#2)(1995-8#5)(1996-1#1)(1996-10#2)(1996-11#4)(1996-12#2)(1996-2#3)(1996-3#5)(1996-4#3)(1996-5#1)(1996-6#3)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#4)(1997-3#1)(1997-4#2)(1997-6#5)(1997-7#8)(2004-1#1)(2004-11#2)(2004-12#2)(2005-11#2)(2005-12#4)(2005-6#1)(2005-7#19)(2005-8#28)(2005-9#8)(2006-10#21)(2006-11#3)(2006-12#8)(2006-2#2)(2006-4#1)(2006-5#1)(2006-9#3)(2007-1#3)(2007-10#4)(2007-11#25)(2007-12#28)(2007-2#1)(2007-3#1)(2007-4#7)(2007-6#2)(2007-7#1)(2007-8#13)(2007-9#3)(2008-1#37)(2008-10#26)(2008-11#29)(2008-12#4)(2008-2#31)(2008-3#37)(2008-4#30)(2008-5#23)(2008-6#4)(2008-7#41)(2008-8#12)(2008-9#17)(2009-1#1)(2009-10#4)(2009-11#4)(2009-12#17)(2009-2#4)(2009-3#7)(2009-4#2)(2009-5#4)(2009-6#3)(2009-8#16)(2009-9#9)(2010-1#3)(2010-10#3)(2010-11#2)(2010-12#22)(2010-2#4)(2010-3#5)(2010-4#7)(2010-5#9)(2010-6#2)(2010-7#8)(2010-8#6)(2011-1#22)(2011-12#2)(2011-2#26)(2011-3#5)(2012-1#7)(2012-12#36)(2012-2#37)(2012-3#10)(2013-1#31)(2013-7#13)(2013-8#21)
targets'##2##1##(2008-11#1)(2010-7#1)
targetting##9##1##(1991-2#2)(1991-6#1)(1992-9#1)(1993-11#1)(2006-11#1)(2007-1#1)(2007-7#1)(2008-8#1)
tarnished##5##1##(1997-7#1)(2007-12#2)(2008-3#1)(2009-12#1)
taro##2##1##(2006-12#1)(2008-10#1)
tarred##2##1##(1997-4#2)
tarsal coalition##4##2##(2008-7#1)(2009-10#3)
tarsal##11##1##(2007-11#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-7#1)(2009-10#4)(2010-12#1)
tarsi##3##1##(1995-2#1)(2005-7#1)(2008-8#1)
tarsus length##2##2##(2008-8#2)
tartarate##5##1##(1992-2#1)(2006-12#2)(2008-10#2)
tartaric acid in##3##3##(2007-8#1)(2008-10#2)
tartaric acid with##3##3##(2005-11#1)(2008-10#2)
tartaric acid##26##2##(1996-11#1)(2005-11#1)(2007-8#1)(2008-10#14)(2008-5#6)(2010-12#1)(2010-3#2)
tartaric##34##1##(1996-11#1)(2005-11#1)(2007-8#1)(2008-10#20)(2008-5#7)(2010-12#2)(2010-3#2)
tartaricus##4##1##(1993-12#2)(2008-4#2)
tartrate and##4##2##(2008-10#2)(2011-1#2)
tartrate or##2##2##(2007-10#1)(2008-10#1)
tartrate resistant acid phosphatase (TRAP)##2##5##(1994-12#1)(1996-9#1)
tartrate##32##1##(1990-8#1)(1994-12#1)(1994-9#1)(1996-9#1)(1997-7#2)(2007-10#1)(2007-2#1)(2008-10#13)(2008-5#1)(2008-6#2)(2009-8#1)(2011-1#3)(2012-2#2)(2012-3#2)
tartrate-resistant acid phosphatase##4##3##(1990-4#2)(1993-8#1)(2008-7#1)
tartrate-resistant acid##5##2##(1990-4#3)(1993-8#1)(2008-7#1)
tartrate-resistant##7##1##(1990-4#3)(1992-7#1)(1993-8#1)(2008-7#2)
tartrazine and##3##2##(2008-10#3)
tartrazine##7##1##(2008-10#7)
task (dis)engagement##2##2##(2011-1#2)
task (i##2##2##(2008-11#1)(2013-8#1)
task analysis and##2##3##(2009-10#1)(2012-2#1)
task analysis##3##2##(2009-10#1)(2010-7#1)(2012-2#1)
task and a##5##3##(1994-5#1)(2008-11#1)(2009-4#1)(2009-7#1)(2011-1#1)
task and on##3##3##(2006-4#1)(2008-10#1)(2008-4#1)
task and the##6##3##(2006-10#1)(2007-7#1)(2008-4#2)(2009-11#1)(2013-8#1)
task and to##2##3##(1996-2#1)(2008-11#1)
task and##48##2##(1991-2#1)(1991-3#1)(1992-11#2)(1992-9#1)(1993-2#1)(1993-5#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1996-2#1)(2005-8#1)(2006-10#2)(2006-4#2)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#3)(2008-9#1)(2009-10#1)(2009-11#2)(2009-4#1)(2009-7#1)(2011-1#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#2)
task as the##2##3##(1995-3#1)(2009-11#1)
task as well##2##3##(1991-5#1)(1993-2#1)
task as##7##2##(1991-5#1)(1993-2#2)(1995-3#1)(2007-1#1)(2008-4#1)(2009-11#1)
task at##7##2##(1994-8#3)(1997-2#1)(2009-4#1)(2011-2#1)(2013-1#1)
task but not##2##3##(1997-8#1)(2013-8#1)
task but##3##2##(1997-8#1)(2007-8#1)(2013-8#1)
task by##5##2##(1994-8#1)(2008-7#2)(2009-11#1)(2012-2#1)
task can be##2##3##(1991-3#1)(2008-4#1)
task can##3##2##(1991-3#1)(2007-12#1)(2008-4#1)
task cannot be##2##3##(1995-8#1)(2007-12#1)
task compared with##2##3##(1996-3#1)(1997-7#1)
task compared##3##2##(1996-3#1)(1997-7#1)(2013-1#1)
task comparison##2##2##(2011-12#2)
task completion##2##2##(1994-8#1)(2012-2#1)
task conditions##2##2##(1992-8#1)(1995-12#1)
task could be##2##3##(1997-8#1)(2011-2#1)
task decomposition##2##2##(2011-2#2)
task demands##5##2##(1991-1#1)(2006-10#2)(2008-7#1)(2012-1#1)
task depends on the##2##4##(2008-10#1)(2010-2#1)
task difficulty and response correctness##2##5##(2008-11#2)
task difficulty and##5##3##(2008-11#3)(2012-1#2)
task difficulty##9##2##(1995-12#1)(2008-11#5)(2012-1#2)(2013-8#1)
task disengagement##2##2##(2011-1#1)(2012-12#1)
task during which##2##3##(1997-5#1)(2011-2#1)
task during##5##2##(1991-2#1)(1997-5#1)(2009-1#1)(2009-8#1)(2011-2#1)
task faster than##2##3##(1994-8#1)(2012-2#1)
task for many##4##3##(2007-12#1)(2010-8#1)(2013-1#2)
task for the##5##3##(1990-9#1)(1993-11#1)(2008-3#1)(2013-1#1)(2013-8#1)
task for which##3##3##(2007-8#1)(2009-5#1)(2012-12#1)
task for##31##2##(1990-9#1)(1991-6#1)(1992-9#2)(1993-11#1)(1994-5#1)(1996-3#1)(1997-1#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-5#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-2#1)(2010-8#1)(2012-12#2)(2013-1#3)(2013-8#1)
task force on##4##3##(1994-12#1)(2007-4#3)
task force to promote##2##4##(2008-6#1)(2011-1#1)
task force to##3##3##(2007-4#1)(2008-6#1)(2011-1#1)
task force was##3##3##(1994-1#1)(2007-4#1)(2013-1#1)
task force##27##2##(1994-1#2)(1994-12#2)(1994-3#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-3#1)(2007-4#7)(2008-6#1)(2008-8#1)(2010-8#3)(2011-1#3)(2011-2#1)(2013-1#2)
task forces##3##2##(1992-1#1)(1995-2#1)(2008-10#1)
task from##2##2##(1995-11#1)(2010-12#1)
task has been##3##3##(1995-1#1)(2008-10#1)(2009-4#1)
task has##5##2##(1995-1#1)(2006-4#1)(2008-10#1)(2008-4#1)(2009-4#1)
task impersistence##3##2##(1994-2#3)
task in a T-maze##3##4##(1991-1#1)(1993-3#2)
task in a##6##3##(1991-1#1)(1993-3#2)(1993-5#1)(2013-8#2)
task in healthy##2##3##(2006-10#1)(2012-2#1)
task in mice##2##3##(1993-5#1)(2008-4#1)
task in the Morris water maze##2##6##(1993-12#1)(1993-3#1)
task in the##12##3##(1993-12#1)(1993-2#1)(1993-3#1)(1995-9#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#2)
task in which participants##3##4##(2008-5#2)(2012-12#1)
task in which they##2##4##(1994-3#1)(2006-3#1)
task in which##8##3##(1990-10#1)(1994-3#2)(1994-6#1)(2006-3#1)(2008-5#2)(2012-12#1)
task in##50##2##(1990-10#1)(1991-1#1)(1993-12#1)(1993-2#2)(1993-3#3)(1993-5#2)(1994-3#2)(1994-6#2)(1995-12#1)(1995-5#1)(1995-9#1)(1996-3#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-2#3)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#3)
task induced by##2##3##(1993-3#1)(2008-11#1)
task is not##2##3##(2008-11#1)(2009-4#1)
task is to##2##3##(1993-9#1)(2008-10#1)
task is##27##2##(1990-12#1)(1991-1#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-9#1)(1995-5#1)(1997-8#1)(2006-4#1)(2006-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2009-11#1)(2009-4#1)(2012-1#2)(2013-1#1)(2013-8#1)
task measuring##2##2##(1992-11#1)(2008-1#1)
task more##2##2##(1994-8#2)
task of generating##2##3##(2008-7#1)(2012-1#1)
task of the##6##3##(1995-11#1)(1996-2#1)(2005-11#1)(2011-4#1)(2013-1#2)
task of##57##2##(1992-2#1)(1992-7#1)(1993-11#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-1#1)(2006-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#2)(2009-6#2)(2010-2#1)(2010-8#1)(2011-2#1)(2011-4#1)(2012-1#2)(2012-12#3)(2012-3#1)(2013-1#9)(2013-8#1)
task on##5##2##(1994-2#1)(1994-8#1)(1995-5#1)(1996-1#1)(2006-7#1)
task only##2##2##(1991-2#1)(2009-10#1)
task or##2##2##(1994-3#1)(2013-7#1)
task parameters##3##2##(2007-8#2)(2008-4#1)
task performance and##2##3##(1992-11#1)(1997-5#1)
task performance in##2##3##(1991-1#1)(1996-5#1)
task performance##20##2##(1991-1#3)(1992-11#1)(1993-9#1)(1994-8#1)(1995-12#1)(1996-5#1)(1997-5#1)(2006-4#1)(2006-6#1)(2008-11#1)(2009-10#1)(2009-5#1)(2010-8#2)(2012-1#1)(2013-1#3)
task performed by##2##3##(1996-1#1)(2006-7#1)
task performed##3##2##(1996-1#1)(2006-6#1)(2006-7#1)
task requiring##4##2##(1993-9#1)(1995-5#1)(2006-3#1)(2012-2#1)
task specific##2##2##(1997-8#1)(2012-1#1)
task switching##3##2##(2008-10#2)(2012-3#1)
task than any other group##2##5##(1991-2#2)
task than##4##2##(1991-2#2)(2012-1#1)(2012-2#1)
task that involved##2##3##(2008-10#1)(2008-11#1)
task that required the##2##4##(2008-6#1)(2013-8#1)
task that requires##3##3##(1993-2#1)(2008-10#1)(2012-2#1)
task that##16##2##(1992-9#1)(1993-11#1)(1993-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-5#1)(2012-1#1)(2012-2#1)(2013-8#1)
task to the##2##3##(1995-1#1)(2008-11#1)
task to##16##2##(1991-1#1)(1991-10#1)(1993-2#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-1#1)(2007-9#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-3#1)
task training##2##2##(2012-2#2)
task using a##2##3##(1992-10#1)(1994-2#1)
task using##10##2##(1991-3#1)(1992-10#1)(1993-3#1)(1994-2#2)(1994-3#1)(1996-2#1)(2009-11#1)(2010-7#1)(2013-7#1)
task variables##2##2##(1990-11#1)(2009-2#1)
task was examined in##2##4##(1991-2#1)(2008-11#1)
task was to##3##3##(1994-8#1)(2008-6#1)(2009-11#1)
task was##20##2##(1991-2#1)(1993-3#1)(1994-3#1)(1994-8#1)(1996-5#1)(1997-8#1)(2008-11#3)(2008-4#1)(2008-6#2)(2008-8#1)(2009-10#1)(2009-11#1)(2010-5#1)(2012-1#1)(2013-1#1)(2013-7#2)
task we##2##2##(1996-8#1)(2009-2#1)
task were##11##2##(1991-3#1)(1992-7#1)(1993-4#1)(1993-6#1)(1994-3#1)(1996-2#1)(2008-8#1)(2010-5#1)(2012-12#2)(2013-8#1)
task where##3##2##(2008-11#1)(2011-2#1)(2012-1#1)
task which##4##2##(1991-1#1)(1992-11#1)(1994-5#1)(2008-12#1)
task with a##3##3##(1996-12#1)(2007-1#1)(2011-1#1)
task with the##2##3##(1994-3#1)(1995-11#1)
task with##23##2##(1993-12#1)(1993-7#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-12#1)(2006-2#1)(2007-1#1)(2007-12#1)(2007-9#1)(2008-1#1)(2009-10#3)(2009-11#1)(2009-4#1)(2010-3#1)(2011-1#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-8#1)
task##999##1##(1990-10#6)(1990-11#4)(1990-12#1)(1990-2#1)(1990-7#3)(1990-9#1)(1991-1#15)(1991-10#1)(1991-12#1)(1991-2#12)(1991-3#10)(1991-4#4)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#3)(1992-11#11)(1992-12#1)(1992-2#2)(1992-7#4)(1992-8#3)(1992-9#14)(1993-11#4)(1993-12#9)(1993-2#13)(1993-3#12)(1993-4#1)(1993-5#10)(1993-6#5)(1993-7#3)(1993-9#9)(1994-1#2)(1994-11#2)(1994-12#2)(1994-2#13)(1994-3#19)(1994-4#1)(1994-5#4)(1994-6#5)(1994-8#25)(1995-1#5)(1995-11#6)(1995-12#14)(1995-2#4)(1995-3#2)(1995-5#7)(1995-8#1)(1995-9#1)(1996-1#7)(1996-10#1)(1996-12#2)(1996-2#6)(1996-3#5)(1996-5#6)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#3)(1997-5#3)(1997-6#2)(1997-7#5)(1997-8#14)(2005-10#4)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#7)(2006-11#3)(2006-2#2)(2006-3#5)(2006-4#7)(2006-6#6)(2006-7#4)(2006-8#2)(2006-9#2)(2007-1#2)(2007-10#2)(2007-12#16)(2007-2#2)(2007-3#1)(2007-4#13)(2007-5#4)(2007-6#3)(2007-7#3)(2007-8#11)(2007-9#6)(2008-1#7)(2008-10#28)(2008-11#39)(2008-12#7)(2008-2#10)(2008-3#12)(2008-4#34)(2008-5#9)(2008-6#7)(2008-7#13)(2008-8#7)(2008-9#17)(2009-1#3)(2009-10#17)(2009-11#11)(2009-12#1)(2009-2#6)(2009-4#9)(2009-5#9)(2009-6#6)(2009-7#4)(2009-8#4)(2009-9#3)(2010-12#3)(2010-2#13)(2010-3#1)(2010-5#4)(2010-6#1)(2010-7#4)(2010-8#12)(2010-9#2)(2011-1#11)(2011-12#5)(2011-2#20)(2011-4#1)(2012-1#54)(2012-12#14)(2012-2#32)(2012-3#23)(2013-1#57)(2013-7#4)(2013-8#26)
task) and##2##2##(1994-3#1)(2012-1#1)
task)##10##1##(1993-9#1)(1994-3#4)(1997-2#1)(2008-11#1)(2012-1#1)(2013-1#1)(2013-8#1)
task-based measure##2##2##(2010-12#2)
task-based##3##1##(2010-12#3)
task-directed##2##1##(1997-1#2)
task-irrelevant perceptual learning##4##3##(2010-5#2)(2012-2#2)
task-irrelevant##12##1##(1995-1#1)(1996-6#1)(2008-11#2)(2009-1#1)(2010-5#3)(2010-7#1)(2012-2#3)
task-oriented##2##1##(1993-2#1)(2012-1#1)
task-related##5##1##(1991-6#1)(1993-2#1)(1995-12#1)(1995-2#1)(2009-6#1)
task-relevant and task-irrelevant##2##3##(2010-5#2)
task-relevant##7##1##(1996-6#1)(2007-8#1)(2008-11#2)(2010-5#2)(2010-7#1)
task-shifting##3##1##(2010-11#2)(2010-12#1)
task-specific information##3##2##(2006-10#3)
task-specific##4##1##(2006-10#4)
task?##2##1##(1996-3#1)(1997-8#1)
task]##3##1##(1990-4#1)(2013-8#2)
tasked with##3##2##(2011-2#1)(2012-3#1)(2013-1#1)
tasks (passive##2##2##(1993-12#1)(2008-11#1)
tasks and care team notifications##2##5##(2013-1#2)
tasks and##29##2##(1991-6#2)(1992-12#1)(1994-1#1)(1997-2#1)(2006-6#1)(2008-10#2)(2008-11#3)(2008-7#2)(2009-8#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#5)
tasks are##11##2##(1993-11#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-10#1)(2012-1#1)(2012-2#1)
tasks as well as the##2##5##(2009-5#1)(2012-3#1)
tasks as##7##2##(1992-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-5#1)(2012-3#1)
tasks assigned##2##2##(2008-9#1)(2011-2#1)
tasks associated with the##2##4##(2005-10#1)(2008-10#1)
tasks associated with##4##3##(2005-10#1)(2008-10#2)(2010-7#1)
tasks at##3##2##(1990-12#1)(1997-8#1)(2007-2#1)
tasks by##2##2##(1990-10#1)(1993-12#1)
tasks can##2##2##(2013-1#1)(2013-8#1)
tasks designed to##2##3##(1991-1#1)(2011-1#1)
tasks did not##2##3##(2010-3#1)(2013-8#1)
tasks during##3##2##(2008-11#1)(2010-2#1)(2012-12#1)
tasks for which##2##3##(2007-3#1)(2013-7#1)
tasks for##8##2##(1992-1#1)(1996-12#1)(2007-2#1)(2007-3#1)(2008-2#1)(2012-1#1)(2012-2#1)(2013-7#1)
tasks from##4##2##(1995-11#1)(2005-11#1)(2006-6#1)(2008-4#1)
tasks have been used with##2##5##(2012-1#2)
tasks have been##4##3##(2007-9#1)(2009-11#1)(2012-1#2)
tasks have##7##2##(2007-9#1)(2008-5#1)(2009-11#1)(2010-2#1)(2012-1#3)
tasks in a##5##3##(1991-5#1)(2008-2#1)(2009-11#1)(2010-12#1)(2012-1#1)
tasks in mice##2##3##(1993-7#1)(1993-9#1)
tasks in the##6##3##(2008-11#1)(2008-2#1)(2008-3#1)(2012-12#1)(2013-8#2)
tasks in##31##2##(1991-5#1)(1993-7#1)(1993-9#2)(1997-6#1)(2006-4#1)(2008-11#3)(2008-2#3)(2008-3#2)(2008-6#1)(2009-10#2)(2009-11#1)(2009-2#1)(2010-12#2)(2010-2#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#1)(2013-8#3)
tasks including##3##2##(2009-12#1)(2009-4#1)(2012-1#1)
tasks involving##3##2##(2012-1#1)(2013-1#1)(2013-8#1)
tasks is##2##2##(2008-1#1)(2008-11#1)
tasks may help##2##3##(1996-1#1)(2006-4#1)
tasks may##3##2##(1996-1#1)(2006-4#1)(2011-2#1)
tasks of the##3##3##(1990-3#1)(1995-4#1)(2005-5#1)
tasks of##19##2##(1990-3#1)(1994-11#1)(1995-4#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-2#1)(2005-5#1)(2007-11#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-2#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
tasks on the##3##3##(1997-2#2)(2008-11#1)
tasks on##8##2##(1997-2#2)(2006-10#2)(2006-8#1)(2008-11#1)(2010-3#1)(2012-1#1)
tasks performed##3##2##(2007-12#1)(2008-6#1)(2010-2#1)
tasks related to the##2##4##(2009-7#1)(2013-8#1)
tasks requiring##7##2##(1990-10#1)(2005-10#1)(2008-11#2)(2008-4#1)(2012-1#2)
tasks should##2##2##(1992-12#1)(2006-4#1)
tasks such as##4##3##(2008-2#1)(2008-3#1)(2008-4#1)(2010-12#1)
tasks that are##4##3##(1993-11#1)(2008-11#1)(2008-7#1)(2008-9#1)
tasks that require##3##3##(1991-6#1)(2013-1#2)
tasks that required##2##3##(1991-11#1)(2012-12#1)
tasks that##18##2##(1990-4#1)(1991-11#1)(1991-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(2008-11#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-9#1)(2012-1#1)(2012-12#1)(2013-1#4)
tasks the##2##2##(1992-8#1)(2012-1#1)
tasks to be##2##3##(2006-6#1)(2008-11#1)
tasks to##6##2##(2006-2#1)(2006-6#1)(2007-9#1)(2008-11#1)(2008-9#1)(2009-4#1)
tasks using##2##2##(2008-11#1)(2009-7#1)
tasks was##8##2##(1990-10#1)(1991-2#1)(1993-12#1)(1993-3#1)(1996-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
tasks were compared to##2##4##(1991-6#1)(2013-1#1)
tasks were performed##3##3##(1997-7#1)(2007-4#1)(2008-10#1)
tasks were similar##2##3##(1994-8#1)(2012-2#1)
tasks were##22##2##(1991-6#1)(1994-8#1)(1996-3#1)(1997-7#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-2#1)(2011-1#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
tasks when##2##2##(1993-2#1)(2008-3#1)
tasks which##4##2##(1993-5#1)(1993-7#1)(2012-1#2)
tasks with##6##2##(2008-11#1)(2008-2#1)(2008-9#1)(2012-1#1)(2013-8#2)
tasks##535##1##(1990-10#5)(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#5)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-8#1)(1992-9#8)(1993-10#1)(1993-11#5)(1993-12#6)(1993-2#4)(1993-3#4)(1993-5#1)(1993-6#1)(1993-7#2)(1993-9#5)(1994-1#2)(1994-11#1)(1994-2#6)(1994-3#5)(1994-6#3)(1994-8#7)(1995-1#2)(1995-11#1)(1995-12#4)(1995-2#1)(1995-4#2)(1996-1#5)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#5)(1996-7#1)(1997-2#4)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#6)(2003-11#1)(2004-9#1)(2005-10#3)(2005-11#1)(2005-5#2)(2005-9#1)(2006-10#6)(2006-2#3)(2006-3#1)(2006-4#7)(2006-5#1)(2006-6#3)(2006-8#1)(2006-9#3)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#2)(2007-4#3)(2007-7#1)(2007-8#2)(2007-9#13)(2008-1#5)(2008-10#9)(2008-11#36)(2008-12#3)(2008-2#12)(2008-3#8)(2008-4#12)(2008-5#3)(2008-6#3)(2008-7#11)(2008-8#2)(2008-9#9)(2009-1#3)(2009-10#9)(2009-11#6)(2009-12#1)(2009-2#5)(2009-4#9)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#6)(2010-1#1)(2010-12#7)(2010-2#5)(2010-3#3)(2010-5#4)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#10)(2012-1#42)(2012-12#12)(2012-2#15)(2012-3#12)(2013-1#38)(2013-7#7)(2013-8#20)
tasks) to##2##2##(2008-7#1)(2009-11#1)
tasks]##2##1##(1992-3#1)(1994-4#1)
tassels##3##1##(2008-8#3)
tastant delivery##4##2##(2008-11#4)
tastant##7##1##(2008-11#7)
tastants in a single lick##2##5##(2008-11#2)
tastants##8##1##(1993-12#1)(2008-11#6)(2009-10#1)
taste analyzing system##3##3##(2008-10#3)
taste analyzing##4##2##(2008-10#4)
taste and##8##2##(1993-12#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#1)(2010-5#1)(2012-12#1)(2013-7#1)
taste aversion learning##4##3##(1991-1#1)(1993-12#1)(1996-7#2)
taste aversion##18##2##(1991-1#2)(1992-11#2)(1993-12#2)(1995-11#2)(1995-12#1)(1996-10#1)(1996-7#5)(2008-5#3)
taste behavior##2##2##(2008-11#2)
taste buds##4##2##(2010-5#1)(2013-1#3)
taste center##2##2##(2008-9#2)
taste for sugar##2##3##(1993-9#2)
taste for##3##2##(1993-9#2)(2008-9#1)
taste function##2##2##(1993-12#2)
taste learning##2##2##(1996-5#2)
taste masking and enteric-coated clarithromycin granules##2##6##(2012-3#2)
taste masking##4##2##(2012-3#4)
taste neurons##2##2##(2008-11#1)(2009-10#1)
taste of the##2##3##(2006-10#2)
taste of##5##2##(1990-10#1)(2006-10#2)(2008-9#1)(2010-5#1)
taste panel##5##2##(2008-10#2)(2010-4#3)
taste perception##3##2##(1996-1#1)(2006-12#1)(2010-5#1)
taste qualities##3##2##(1990-9#1)(2013-1#2)
taste quality of##2##3##(2008-12#1)(2012-1#1)
taste quality##4##2##(2008-12#1)(2012-1#3)
taste receptor cells##2##3##(2013-1#2)
taste receptor##5##2##(1994-5#1)(2008-2#2)(2013-1#2)
taste receptors##2##2##(1993-12#1)(2008-2#1)
taste sensation##2##2##(1991-3#1)(1996-1#1)
taste sensitivity##4##2##(2008-7#1)(2011-2#3)
taste sensor##4##2##(2008-10#2)(2013-1#2)
taste stimuli in##2##3##(2008-7#2)
taste stimuli were##2##3##(1993-12#1)(2010-12#1)
taste stimuli##19##2##(1993-12#2)(1994-5#1)(1995-11#2)(1996-5#1)(1996-8#2)(2008-7#3)(2010-12#1)(2012-12#5)(2013-1#2)
taste substances##4##2##(1996-8#1)(2008-10#3)
taste##170##1##(1990-10#1)(1990-9#3)(1991-1#2)(1991-3#3)(1991-5#1)(1992-11#3)(1993-12#10)(1993-7#1)(1993-8#1)(1993-9#2)(1994-5#3)(1995-11#4)(1995-12#1)(1996-1#5)(1996-10#5)(1996-2#1)(1996-5#6)(1996-7#6)(1996-8#3)(2006-10#4)(2006-12#1)(2007-12#4)(2007-9#5)(2008-1#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#6)(2008-8#1)(2008-9#9)(2009-10#2)(2010-12#3)(2010-2#1)(2010-4#6)(2010-5#4)(2011-2#4)(2012-1#3)(2012-12#6)(2012-3#5)(2013-1#12)(2013-7#1)
taste-elicited oral motor##2##3##(1993-12#2)
taster##2##1##(2011-2#1)(2013-8#1)
tastes and##5##2##(1993-12#1)(1996-3#1)(2008-10#1)(2008-7#1)(2012-2#1)
tastes##15##1##(1991-11#1)(1993-12#2)(1996-3#1)(2008-10#4)(2008-7#1)(2012-1#3)(2012-2#1)(2013-1#2)
tasting##3##1##(2008-10#1)(2008-6#1)(2008-7#1)
tat##14##1##(1990-6#1)(1991-10#1)(1991-9#1)(1994-11#6)(1996-4#1)(1996-8#1)(1997-4#1)(2008-8#2)
tattoo removal by##2##3##(1992-10#2)
tattoo removal##5##2##(1992-10#5)
tattoo##11##1##(1992-10#5)(2006-12#1)(2007-12#1)(2008-6#1)(2010-9#1)(2012-3#1)(2013-8#1)
tattooed##6##1##(1992-9#1)(2007-12#1)(2007-4#1)(2010-6#3)
tattooing and##2##2##(2007-1#2)
tattooing##8##1##(2007-1#3)(2007-12#2)(2007-7#2)(2008-8#1)
tattoos are##3##2##(2006-12#3)
tattoos for mouse##2##3##(2008-4#2)
tattoos have##2##2##(2006-12#1)(2010-6#1)
tattoos##19##1##(1991-11#1)(1992-10#1)(2006-12#7)(2006-3#1)(2007-12#1)(2007-2#2)(2008-4#2)(2010-6#2)(2012-12#1)(2013-8#1)
tau (Walker)##2##2##(2011-2#1)(2013-8#1)
tau 1 core##5##3##(1995-2#5)
tau 1##8##2##(1991-9#1)(1992-11#1)(1995-2#6)
tau 2 =##2##3##(1992-11#2)
tau 2##4##2##(1992-11#2)(1996-8#2)
tau = 0##2##3##(2007-12#1)(2008-3#1)
tau =##5##2##(1992-11#1)(1995-9#1)(2006-7#1)(2007-12#1)(2008-3#1)
tau and##6##2##(1991-1#1)(1993-6#1)(1995-11#1)(1997-4#1)(2003-11#1)(2008-3#1)
tau are##2##2##(1996-3#1)(2007-12#1)
tau at##3##2##(1995-3#1)(2003-11#1)(2008-3#1)
tau b##3##2##(1995-2#3)
tau h##2##2##(1992-9#2)
tau has##2##2##(1995-10#1)(1995-11#1)
tau in a##2##3##(1995-11#1)(1995-8#1)
tau in##6##2##(1995-11#2)(1995-2#1)(1995-8#1)(2007-9#2)
tau is##5##2##(1992-9#1)(1995-2#1)(1995-3#2)(2003-11#1)
tau kinase##3##2##(1993-6#1)(1997-1#1)(2013-1#1)
tau m##5##2##(1991-12#1)(1991-2#1)(1994-9#2)(1996-7#1)
tau may##2##2##(1995-10#1)(2006-10#1)
tau mutation##3##2##(1996-9#3)
tau of the##2##3##(2007-9#1)(2008-2#1)
tau pathology##2##2##(2008-11#2)
tau phosphatase##2##2##(1993-6#2)
tau phosphatases##2##2##(2004-12#2)
tau phosphorylation in##2##3##(1997-1#1)(2003-11#1)
tau phosphorylation##5##2##(1995-11#1)(1997-1#3)(2003-11#1)
tau protein and##3##3##(1994-9#2)(1995-8#1)
tau protein##23##2##(1992-12#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-8#2)(1996-8#1)(2003-11#2)(2005-7#1)(2008-1#1)(2008-3#4)(2008-9#1)(2011-2#2)
tau proteins##4##2##(1995-10#3)(1995-11#1)
tau showed##2##2##(1995-2#1)(2010-8#1)
tau synthetic peptides##2##3##(1995-10#2)
tau was##4##2##(1995-2#2)(1997-4#1)(2008-3#1)
tau##190##1##(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-11#7)(1992-12#1)(1992-3#4)(1992-6#2)(1992-8#1)(1992-9#6)(1993-2#3)(1993-6#8)(1994-12#1)(1994-5#1)(1994-9#5)(1995-10#15)(1995-11#10)(1995-12#5)(1995-2#19)(1995-3#4)(1995-6#2)(1995-8#7)(1995-9#1)(1996-3#3)(1996-7#4)(1996-8#4)(1996-9#3)(1997-1#5)(1997-4#7)(2003-11#6)(2004-12#4)(2005-7#1)(2006-10#4)(2006-7#1)(2007-11#1)(2007-12#3)(2007-9#5)(2008-1#1)(2008-11#5)(2008-2#1)(2008-3#12)(2008-7#1)(2008-9#1)(2010-5#2)(2010-8#2)(2011-2#4)(2013-1#1)(2013-8#1)
tau(B)##2##1##(2008-7#2)
tau(c)##2##1##(1996-5#1)(2008-3#1)
tau(w##4##1##(2009-4#4)
tau-mutant hamsters##2##2##(1996-9#2)
tau441##3##1##(1995-2#3)
taught a##4##2##(1993-5#1)(2008-1#1)(2008-10#1)(2008-2#1)
taught and##2##2##(1994-2#1)(2005-12#1)
taught by the##2##3##(2008-1#1)(2011-2#1)
taught by##7##2##(1991-12#1)(1994-12#1)(2006-12#1)(2007-5#1)(2008-1#1)(2010-2#1)(2011-2#1)
taught in##9##2##(1991-12#1)(1994-12#1)(2004-10#1)(2007-6#1)(2007-7#1)(2008-12#1)(2008-7#1)(2008-9#1)(2012-2#1)
taught through##2##2##(1993-12#1)(2005-12#1)
taught to measure their blood glucose##2##6##(1997-3#2)
taught to measure##3##3##(1997-3#2)(2008-1#1)
taught to##7##2##(1997-3#2)(2006-5#1)(2008-1#1)(2010-2#1)(2010-9#1)(2013-8#1)
taught##62##1##(1991-12#3)(1992-6#1)(1993-12#2)(1993-5#1)(1994-12#3)(1994-2#1)(1995-1#1)(1996-3#1)(1997-3#2)(2004-10#1)(2005-12#3)(2006-10#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-5#3)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#3)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#2)(2008-7#1)(2008-9#1)(2009-2#1)(2010-2#2)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
tauopathies##2##1##(2008-7#1)(2008-9#1)
taurica##2##1##(2008-10#2)
taurine (100##2##2##(2009-10#2)
taurine (2-aminoethanesulfonic acid)##2##3##(2007-1#1)(2012-12#1)
taurine and phosphoethanolamine##2##3##(1997-5#2)
taurine and vitamin E##3##4##(1994-2#3)
taurine and##16##2##(1990-4#1)(1990-7#1)(1994-2#3)(1995-1#1)(1996-9#1)(1997-5#3)(2007-12#1)(2008-7#1)(2009-10#1)(2012-12#3)
taurine appeared to be##2##4##(1997-3#2)
taurine as a non-invasive##2##4##(1997-3#2)
taurine as a##3##3##(1997-3#2)(2008-10#1)
taurine breeds##2##2##(1994-3#1)(2013-1#1)
taurine efflux##3##2##(1994-12#3)
taurine had increased by##2##4##(1996-9#2)
taurine in##8##2##(1992-9#1)(1994-12#1)(2007-1#1)(2008-10#4)(2012-1#1)
taurine increased by##2##3##(1996-9#2)
taurine on##2##2##(2008-5#1)(2011-2#1)
taurine or##2##2##(1990-4#1)(1992-1#1)
taurine structural##2##2##(1995-1#2)
taurine uptake by##3##3##(1995-1#2)(2008-5#1)
taurine uptake in##2##3##(1995-1#2)
taurine uptake##8##2##(1995-1#7)(2008-5#1)
taurine was##2##2##(1997-3#1)(2008-5#1)
taurine were##4##2##(1992-1#1)(1995-5#2)(1997-3#1)
taurine##114##1##(1990-2#1)(1990-4#2)(1990-7#1)(1990-8#2)(1991-5#1)(1992-1#7)(1992-9#1)(1994-12#8)(1994-2#3)(1994-3#2)(1995-1#11)(1995-5#3)(1996-12#2)(1996-9#6)(1997-3#9)(1997-5#6)(2007-1#3)(2007-12#2)(2008-10#14)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-10#7)(2010-12#1)(2011-2#5)(2012-1#1)(2012-12#7)(2012-3#2)(2013-1#1)
taurocholate##12##1##(1991-9#1)(1992-3#6)(1993-9#1)(1994-11#1)(1994-12#2)(2005-11#1)
taurocholate/phosphatidylcholine mixed micelles##2##3##(1993-11#2)
taurocholic acid##4##2##(1991-7#3)(1991-9#1)
taurus##7##1##(1993-12#1)(1993-2#4)(1994-3#1)(2011-2#1)
taurus)##3##1##(1994-3#1)(2010-2#1)(2010-4#1)
tautomer of##2##2##(1990-12#1)(2007-12#1)
tautomer##8##1##(1990-12#1)(1994-8#1)(1995-7#1)(2007-10#1)(2007-12#2)(2008-3#2)
tautomeric equilibrium##3##2##(2007-11#1)(2008-3#2)
tautomeric forms##3##2##(1996-8#1)(2007-10#2)
tautomeric or hydrated forms of##2##5##(2006-12#2)
tautomeric##15##1##(1990-9#1)(1995-11#1)(1996-8#1)(2006-12#3)(2007-10#2)(2007-11#2)(2008-10#2)(2008-3#3)
tautomerisation of the##2##3##(2010-5#1)(2011-1#1)
tautomerism of##2##2##(1997-7#1)(2007-10#1)
tautomerism##5##1##(1997-7#1)(2007-10#1)(2007-11#3)
taux de##2##2##(2008-11#1)(2013-1#1)
taux##4##1##(2008-11#2)(2013-1#2)
tax and##4##2##(1993-1#1)(1993-12#2)(1996-1#1)
tax dollars in##2##3##(2008-6#2)
tax exemption##15##2##(1991-3#1)(1992-6#2)(1992-8#1)(1993-2#1)(1995-12#1)(1995-2#2)(1995-7#1)(1996-2#1)(2005-11#1)(2008-11#4)
tax exemptions##3##2##(1990-5#1)(1993-2#1)(1996-2#1)
tax incentives##2##2##(1993-12#1)(2009-10#1)
tax laws##2##2##(1992-12#1)(1994-3#1)
tax mRNA and protein##2##4##(2008-8#2)
tax planning##4##2##(1993-2#2)(2008-11#2)
tax##71##1##(1990-12#1)(1990-5#1)(1991-1#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-12#3)(1993-2#5)(1993-3#2)(1993-6#1)(1993-8#1)(1994-3#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-7#1)(1996-1#1)(1996-2#3)(1997-1#1)(1997-4#1)(2005-11#1)(2007-2#1)(2007-4#1)(2008-11#8)(2008-12#1)(2008-6#2)(2008-7#2)(2008-8#8)(2008-9#1)(2009-10#1)(2009-12#2)(2009-5#1)(2010-12#1)(2010-8#1)
tax-based##2##1##(1993-2#1)(2008-7#1)
tax-exempt bonds##2##2##(1992-8#2)
tax-exempt hospitals##3##2##(1994-1#1)(1994-3#1)(1996-2#1)
tax-exempt organizations##2##2##(2007-2#2)
tax-exempt status##3##2##(1991-2#1)(1991-4#1)(1993-2#1)
tax-exempt##16##1##(1990-12#1)(1991-2#1)(1991-4#1)(1992-8#2)(1993-2#2)(1994-1#1)(1994-3#1)(1996-2#1)(1996-3#2)(2007-2#2)(2008-11#2)
tax-exemption##9##1##(1990-5#1)(1991-4#1)(1993-1#1)(1995-2#1)(1996-2#1)(2008-11#4)
tax-financed##2##1##(1995-2#1)(2008-7#1)
taxa (e##2##2##(2008-7#1)(2011-2#1)
taxa and##5##2##(1991-11#1)(2006-5#1)(2008-10#1)(2011-2#1)(2012-3#1)
taxa are##7##2##(1997-4#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2013-1#1)
taxa as well as##3##4##(2006-8#1)(2007-3#1)(2008-9#1)
taxa as##4##2##(2006-8#2)(2007-3#1)(2008-9#1)
taxa at the##3##3##(2008-10#1)(2008-8#1)(2010-3#1)
taxa at##4##2##(2008-1#1)(2008-10#1)(2008-8#1)(2010-3#1)
taxa based on##3##3##(2006-12#1)(2008-10#1)(2011-2#1)
taxa based##4##2##(2006-12#1)(2007-3#1)(2008-10#1)(2011-2#1)
taxa by##2##2##(2011-2#2)
taxa from##2##2##(2010-8#1)(2012-2#1)
taxa have##5##2##(2008-10#1)(2008-11#2)(2010-6#1)(2012-12#1)
taxa in the##6##3##(2008-10#4)(2010-6#1)(2012-2#1)
taxa in##12##2##(2006-7#1)(2008-10#4)(2008-8#2)(2008-9#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-7#1)
taxa is##2##2##(2008-5#1)(2009-2#1)
taxa may##3##2##(2008-1#1)(2008-9#1)(2013-7#1)
taxa of##6##2##(2007-12#1)(2008-10#2)(2012-2#2)(2013-7#1)
taxa than##4##2##(2004-11#1)(2007-12#1)(2008-11#1)(2008-9#1)
taxa that are##2##3##(1997-4#1)(2006-5#1)
taxa that had##2##3##(2008-8#2)
taxa that##6##2##(1997-4#1)(2006-5#1)(2008-8#2)(2010-6#1)(2012-2#1)
taxa were##4##2##(1997-4#1)(2008-5#2)(2011-2#1)
taxa with##4##2##(2008-8#2)(2008-9#2)
taxa would##2##2##(2007-12#1)(2010-3#1)
taxa##178##1##(1991-11#1)(1991-6#2)(1993-4#1)(1995-8#1)(1996-3#1)(1996-4#1)(1997-4#9)(1997-5#1)(2004-11#1)(2006-12#3)(2006-5#3)(2006-7#1)(2006-8#4)(2007-12#11)(2007-3#4)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#23)(2008-11#6)(2008-12#2)(2008-3#1)(2008-5#9)(2008-7#4)(2008-8#16)(2008-9#9)(2009-2#3)(2009-4#2)(2009-5#1)(2009-8#1)(2010-3#14)(2010-6#7)(2010-8#1)(2011-2#11)(2012-12#3)(2012-2#10)(2012-3#1)(2013-1#2)(2013-7#4)
taxa)##2##1##(2007-5#1)(2008-8#1)
taxane##10##1##(2007-1#3)(2008-1#1)(2008-4#1)(2008-9#3)(2009-9#1)(2011-1#1)
taxanes and##3##2##(2004-1#1)(2007-1#1)(2010-12#1)
taxanes##17##1##(1996-11#1)(2004-1#1)(2005-7#1)(2007-1#2)(2007-3#1)(2007-5#2)(2009-8#2)(2010-12#4)(2011-1#1)(2011-2#1)(2012-11#1)
taxation##6##1##(1990-12#1)(1993-2#1)(2008-1#1)(2011-1#1)(2012-1#1)(2013-7#1)
taxenes##2##1##(2008-8#2)
taxes and##2##2##(1995-3#1)(1996-3#1)
taxes for##2##2##(1993-6#1)(2007-2#1)
taxes##13##1##(1990-12#1)(1992-3#1)(1993-6#1)(1994-1#1)(1995-3#1)(1996-1#1)(1996-3#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-7#1)
taxine B and isotaxine B##4##5##(2010-9#4)
taxines##3##1##(2010-9#3)
taxing and##2##2##(2010-8#1)(2012-1#1)
taxing##7##1##(1992-3#1)(1994-1#1)(1994-2#1)(1997-8#1)(2009-9#1)(2010-8#1)(2012-1#1)
taxis##2##1##(1996-8#1)(2007-2#1)
taxoid##5##1##(1994-5#3)(2005-7#1)(2007-1#1)
taxoids derived from 14 beta-hydroxy-10-deacetylbaccatin III##2##6##(1997-1#2)
taxoids with##2##2##(1997-1#2)
taxoids##14##1##(1997-1#11)(2007-1#3)
taxol and diamide##2##3##(1994-11#2)
taxol and taxotere##3##3##(1994-9#3)
taxol and##9##2##(1994-11#2)(1994-8#1)(1994-9#3)(2005-11#1)(2006-12#1)(2008-5#1)
taxol for##2##2##(1992-8#1)(2011-2#1)
taxol##48##1##(1992-8#6)(1993-11#1)(1993-8#1)(1994-11#8)(1994-5#1)(1994-8#3)(1994-9#8)(1995-3#1)(1996-4#2)(1997-6#2)(2005-11#1)(2006-12#1)(2008-11#2)(2008-3#1)(2008-5#4)(2008-8#3)(2009-10#1)(2011-2#2)
taxometric procedures##2##2##(2007-12#2)
taxometric##4##1##(2007-12#3)(2009-2#1)
taxon groups##2##2##(2008-10#2)
taxon sampling##5##2##(2010-6#3)(2012-2#2)
taxon##32##1##(2006-5#1)(2006-7#1)(2007-12#3)(2007-3#1)(2008-10#8)(2008-3#1)(2008-5#2)(2008-8#2)(2010-6#6)(2011-2#3)(2012-2#2)(2013-7#1)(2013-8#1)
taxon-specific definitions##2##2##(2006-5#1)(2011-12#1)
taxon-specific##5##1##(2006-5#1)(2008-10#1)(2011-12#1)(2011-2#1)(2013-8#1)
taxonomic and##3##2##(2007-3#1)(2008-12#1)(2008-8#1)
taxonomic breadth##2##2##(1991-9#1)(2006-5#1)
taxonomic characters##3##2##(2007-3#1)(2008-12#2)
taxonomic classification##6##2##(1997-4#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
taxonomic group number##3##3##(2013-8#3)
taxonomic group##8##2##(2007-3#1)(2008-10#2)(2008-9#1)(2009-5#1)(2013-8#3)
taxonomic groups and##2##3##(2007-12#1)(2008-8#1)
taxonomic groups##4##2##(2007-12#1)(2008-8#1)(2010-1#1)(2010-10#1)
taxonomic implications##2##2##(1994-3#1)(2008-6#1)
taxonomic issues##2##2##(2008-10#1)(2010-10#1)
taxonomic key##2##2##(2007-3#1)(2013-7#1)
taxonomic levels##2##2##(2008-12#1)(2008-8#1)
taxonomic orders##4##2##(1992-5#1)(2007-2#1)(2008-8#1)(2011-2#1)
taxonomic position##4##2##(1995-12#1)(2008-5#1)(2012-11#1)(2013-1#1)
taxonomic revision of the##2##4##(2007-7#1)(2013-8#1)
taxonomic revision##5##2##(1993-6#1)(2007-7#1)(2008-5#1)(2013-7#1)(2013-8#1)
taxonomic status of##6##3##(1994-3#1)(2007-3#1)(2008-5#2)(2010-8#2)
taxonomic status##9##2##(1994-3#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-5#2)(2010-8#3)
taxonomic studies##2##2##(1996-12#1)(2007-11#1)
taxonomic study##3##2##(2008-12#1)(2012-2#1)(2013-7#1)
taxonomic units##3##2##(2005-11#1)(2010-10#1)(2012-2#1)
taxonomic value##5##2##(2007-3#3)(2008-10#1)(2008-5#1)
taxonomic##125##1##(1991-6#1)(1991-9#1)(1992-5#1)(1993-6#1)(1994-3#3)(1995-12#1)(1996-12#1)(1996-2#1)(1997-4#2)(2005-11#1)(2006-5#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#8)(2007-5#3)(2007-7#1)(2008-10#18)(2008-12#6)(2008-5#10)(2008-6#2)(2008-7#1)(2008-8#11)(2008-9#4)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#4)(2010-3#1)(2010-6#1)(2010-8#3)(2011-2#9)(2012-11#1)(2012-2#4)(2013-1#3)(2013-7#7)(2013-8#6)
taxonomically related##2##2##(1994-6#1)(1996-12#1)
taxonomically##9##1##(1991-9#1)(1994-6#1)(1996-12#1)(1996-6#1)(2008-10#2)(2008-12#1)(2011-2#1)(2012-3#1)
taxonomies and##3##2##(2013-1#2)(2013-7#1)
taxonomies##10##1##(1995-8#1)(2008-12#2)(2009-7#1)(2009-8#1)(2013-1#4)(2013-7#1)
taxonomy and evolutionary biology##2##4##(2007-12#1)(2010-8#1)
taxonomy and the##2##3##(2006-6#1)(2013-8#1)
taxonomy and##11##2##(2006-6#1)(2007-12#1)(2007-5#2)(2008-10#1)(2008-5#1)(2010-10#1)(2010-8#2)(2011-12#1)(2013-8#1)
taxonomy for##5##2##(2006-8#1)(2008-7#1)(2012-1#1)(2013-1#2)
taxonomy has##2##2##(1991-9#1)(2013-7#1)
taxonomy in##3##2##(1995-6#1)(2011-2#1)(2013-1#1)
taxonomy is##3##2##(2008-11#1)(2013-1#2)
taxonomy of the genus##3##4##(1996-3#1)(2008-10#1)(2008-5#1)
taxonomy of the##9##3##(1996-3#2)(1996-6#1)(2008-10#2)(2008-5#2)(2010-3#1)(2013-7#1)
taxonomy of##19##2##(1993-7#1)(1996-3#2)(1996-6#1)(2006-8#1)(2007-8#1)(2008-10#4)(2008-5#3)(2008-6#1)(2008-7#1)(2010-10#1)(2010-3#1)(2013-1#1)(2013-7#1)
taxonomy that##2##2##(2008-12#1)(2011-12#1)
taxonomy##84##1##(1991-9#1)(1993-7#2)(1995-6#2)(1996-3#2)(1996-6#1)(1997-4#1)(2006-6#1)(2006-8#3)(2007-12#1)(2007-5#2)(2007-8#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-7#1)(2009-8#1)(2010-10#2)(2010-3#1)(2010-8#5)(2011-12#2)(2011-2#2)(2012-1#4)(2013-1#14)(2013-7#7)(2013-8#1)
taxotere##9##1##(1994-9#3)(2012-1#6)
taxpayer##3##1##(1995-1#1)(1996-1#1)(2009-11#1)
taxpayers funding holistic healthcare and the first amendment requirement for separation of church and state##2##15##(2009-11#2)
taxpayers##5##1##(1996-1#2)(2007-4#1)(2009-11#2)
tazarotene##6##1##(2007-10#1)(2007-11#3)(2007-7#1)(2010-3#1)
tazobactam and##4##2##(1996-6#4)
tazobactam##6##1##(1996-6#6)
tbRAP1##2##1##(2011-2#2)
tbcrk##2##1##(1995-8#2)
tbd1##5##1##(1996-2#3)(1997-7#2)
tcu-PA##3##1##(1990-11#3)
te##5##1##(2008-1#1)(2008-11#2)(2012-12#2)
tea (Camellia##2##2##(2008-10#1)(2008-11#1)
tea and drug##3##3##(2008-10#3)
tea and soil##5##3##(2011-1#5)
tea and##17##2##(1990-2#1)(1996-1#1)(1997-8#2)(2007-1#1)(2008-10#5)(2008-11#1)(2009-9#1)(2011-1#5)
tea as##3##2##(1993-9#1)(2008-11#1)(2013-8#1)
tea bag##2##2##(1990-5#1)(2008-10#1)
tea by##2##2##(2005-4#1)(2008-10#1)
tea catechins##5##2##(1997-8#1)(2008-10#1)(2008-11#2)(2013-7#1)
tea components##2##2##(2008-11#2)
tea consumption and##2##3##(1990-7#1)(2010-12#1)
tea consumption do not##2##4##(1990-5#1)(1990-6#1)
tea consumption##6##2##(1990-5#1)(1990-6#1)(1990-7#2)(2009-9#1)(2010-12#1)
tea extract was##3##3##(2008-10#1)(2008-11#1)(2009-11#1)
tea extract##10##2##(1994-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-11#3)(2009-5#1)(2013-7#1)
tea extracts##2##2##(2008-10#1)(2008-11#1)
tea in the##3##3##(1993-10#1)(1993-6#1)(2009-8#1)
tea in##5##2##(1993-10#1)(1993-6#1)(1993-9#1)(2008-11#1)(2009-8#1)
tea infusions##4##2##(1993-9#1)(2007-8#1)(2008-10#2)
tea leaves##6##2##(1993-9#3)(2008-10#3)
tea polyphenol##4##2##(1995-9#2)(2007-8#2)
tea polyphenolic compounds##2##3##(2008-5#2)
tea produced##2##2##(2007-1#1)(2008-10#1)
tea products##3##2##(2008-10#1)(2012-2#2)
tea samples##8##2##(2008-10#8)
tea to##2##2##(2009-11#1)(2009-8#1)
tea tree##3##2##(2005-11#1)(2007-11#2)
tea varieties##2##2##(2008-10#2)
tea was##4##2##(2007-1#1)(2008-10#1)(2008-11#1)(2009-8#1)
tea were##3##2##(2005-4#1)(2007-1#1)(2008-11#1)
tea with##2##2##(1993-9#1)(2009-8#1)
tea##163##1##(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#2)(1992-7#2)(1993-10#1)(1993-5#1)(1993-6#1)(1993-9#12)(1994-2#3)(1995-9#2)(1996-1#1)(1997-8#3)(2005-11#1)(2005-4#2)(2007-1#5)(2007-11#2)(2007-8#3)(2008-1#1)(2008-10#54)(2008-11#17)(2008-3#1)(2008-5#3)(2008-7#2)(2009-11#5)(2009-3#1)(2009-5#4)(2009-8#8)(2009-9#3)(2010-1#1)(2010-12#1)(2011-1#5)(2011-2#1)(2012-12#1)(2012-2#3)(2012-8#1)(2013-7#3)(2013-8#3)
teach and##5##2##(2008-11#1)(2008-12#2)(2009-3#1)(2012-1#1)
teach students##3##2##(1990-2#1)(1995-12#1)(2010-3#1)
teach the##6##2##(1995-3#1)(1996-1#1)(2009-2#1)(2009-4#1)(2012-1#1)(2012-3#1)
teach this##2##2##(2008-1#1)(2008-10#1)
teach##67##1##(1990-2#1)(1991-2#1)(1992-2#1)(1992-4#1)(1993-12#2)(1994-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#1)(2004-5#1)(2005-10#1)(2005-12#3)(2006-12#1)(2006-5#2)(2006-7#1)(2006-9#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#4)(2008-3#2)(2008-7#2)(2009-11#2)(2009-2#2)(2009-3#1)(2009-4#2)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-8#1)
teacher and##4##2##(1990-10#1)(2007-2#1)(2008-12#1)(2009-7#1)
teacher expectations of##2##3##(2008-12#2)
teacher expectations##4##2##(2008-12#4)
teacher in##4##2##(1992-1#1)(1992-9#1)(2008-11#1)(2008-12#1)
teacher practices##4##2##(2008-12#4)
teacher preparation##2##2##(2007-12#1)(2007-9#1)
teacher ratings##6##2##(2008-2#2)(2013-7#4)
teacher reports##3##2##(2008-12#1)(2010-4#1)(2012-2#1)
teacher support##3##2##(2008-6#1)(2009-7#2)
teacher training##3##2##(1994-6#1)(2008-12#1)(2012-1#1)
teacher##90##1##(1990-10#1)(1991-12#1)(1992-1#1)(1992-9#1)(1994-1#1)(1994-2#1)(1994-6#1)(1995-3#1)(2005-10#1)(2006-2#1)(2006-3#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-9#3)(2008-10#3)(2008-11#2)(2008-12#19)(2008-2#2)(2008-4#7)(2008-6#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#4)(2009-8#1)(2010-1#1)(2010-2#3)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#7)(2012-2#5)(2012-3#2)(2013-1#1)(2013-7#4)
teacher's##5##1##(1991-12#1)(2008-11#2)(2008-12#1)(2011-2#1)
teacher-child relationships##2##2##(2006-3#1)(2008-12#1)
teacher-rated##3##1##(2007-12#2)(2012-2#1)
teacher-student relationships##2##2##(2008-12#1)(2011-2#1)
teacher-student##3##1##(2008-12#2)(2011-2#1)
teachers and learners##3##3##(2007-7#2)(2008-11#1)
teachers and other educators##2##4##(2006-7#2)
teachers and other##3##3##(2006-7#3)
teachers and parents##2##3##(2009-7#1)(2010-4#1)
teachers and##28##2##(1991-9#1)(1992-5#1)(2006-5#1)(2006-7#4)(2007-7#4)(2007-9#1)(2008-11#5)(2008-12#1)(2009-7#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#2)
teachers are##2##2##(2005-12#1)(2012-2#1)
teachers at##2##2##(1994-6#1)(2008-2#1)
teachers for##2##2##(2005-10#1)(2008-12#1)
teachers from a##2##3##(2008-12#1)(2011-2#1)
teachers from##3##2##(1991-9#1)(2008-12#1)(2011-2#1)
teachers had##2##2##(1991-12#1)(2012-2#1)
teachers have##3##2##(1991-9#1)(2013-1#2)
teachers held##2##2##(2008-12#2)
teachers in the##2##3##(2006-2#1)(2007-12#1)
teachers in##7##2##(1993-6#1)(2006-2#1)(2007-12#1)(2007-9#1)(2008-12#1)(2012-1#1)(2012-12#1)
teachers of physical exercise##2##4##(1993-6#2)
teachers of##5##2##(1991-9#1)(1993-6#2)(2007-4#1)(2012-3#1)
teachers reported##2##2##(2010-2#1)(2010-6#1)
teachers to##5##2##(2005-12#1)(2008-12#1)(2011-1#1)(2011-2#2)
teachers was##2##2##(2008-12#1)(2009-7#1)
teachers were not##2##3##(2008-10#1)(2008-12#1)
teachers were##6##2##(1991-12#1)(1993-1#1)(2008-10#1)(2008-12#1)(2012-1#1)(2012-2#1)
teachers who##2##2##(2008-11#1)(2011-2#1)
teachers##165##1##(1990-8#1)(1991-12#6)(1991-9#4)(1992-5#1)(1993-1#1)(1993-6#5)(1994-6#1)(1995-3#1)(1997-5#1)(2005-10#2)(2005-12#2)(2005-8#1)(2005-9#2)(2006-2#2)(2006-5#3)(2006-7#8)(2007-1#1)(2007-12#3)(2007-3#1)(2007-4#3)(2007-7#7)(2007-8#1)(2007-9#4)(2008-1#1)(2008-10#5)(2008-11#11)(2008-12#23)(2008-2#1)(2008-4#1)(2008-9#2)(2009-11#1)(2009-4#2)(2009-5#1)(2009-7#3)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#10)(2012-1#7)(2012-12#6)(2012-2#9)(2012-3#3)(2013-1#6)(2013-8#1)
teachers' knowledge##2##2##(2007-9#1)(2012-2#1)
teachers'##24##1##(1993-1#1)(2007-12#1)(2007-9#3)(2008-12#5)(2009-7#3)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#2)
teachers]##5##1##(1991-9#1)(2010-12#3)(2010-6#1)
teaches##8##1##(1995-2#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-5#1)(2008-2#1)(2010-2#1)(2013-1#1)
teaching about##3##2##(2007-10#1)(2008-10#1)(2009-9#1)
teaching aid for##2##3##(1992-12#1)(2006-10#1)
teaching and assessing##3##3##(2008-11#3)
teaching and community hospitals##2##4##(1995-2#1)(2006-10#1)
teaching and evaluation##2##3##(2008-12#2)
teaching and feeding##2##3##(1990-12#2)
teaching and learning approaches##2##4##(2008-11#1)(2008-12#1)
teaching and learning strategies##4##4##(2008-11#3)(2008-12#1)
teaching and learning strategy##4##4##(2008-11#4)
teaching and learning##36##3##(1996-1#1)(2005-12#2)(2006-5#1)(2007-8#1)(2008-11#18)(2008-12#7)(2010-3#1)(2010-6#1)(2012-1#2)(2013-8#2)
teaching and research##8##3##(1990-8#1)(1993-3#1)(1994-3#2)(1996-9#1)(2007-8#1)(2008-11#1)(2009-2#1)
teaching and the##2##3##(2013-1#2)
teaching and training##5##3##(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-7#1)
teaching and##75##2##(1990-12#2)(1990-8#1)(1992-12#1)(1993-3#1)(1994-3#2)(1995-2#1)(1995-3#1)(1996-1#1)(1996-9#1)(1997-7#1)(2005-12#2)(2006-10#1)(2006-5#2)(2007-2#2)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#26)(2008-12#10)(2008-4#1)(2009-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#2)(2013-1#2)(2013-8#2)
teaching are##5##2##(1994-2#1)(1997-5#1)(2009-4#1)(2012-1#1)(2012-2#1)
teaching assistants##2##2##(2006-5#1)(2007-9#1)
teaching at the##2##3##(2010-1#1)(2013-8#1)
teaching at##4##2##(1990-3#1)(2008-12#1)(2010-1#1)(2013-8#1)
teaching breast##2##2##(2007-10#2)
teaching by##5##2##(1990-2#1)(2005-12#1)(2008-1#1)(2011-2#2)
teaching centers##2##2##(1996-2#1)(2007-12#1)
teaching clinical skills##2##3##(2006-10#1)(2008-11#1)
teaching clinical##6##2##(1993-3#1)(1994-12#2)(2006-10#1)(2008-11#2)
teaching excellence and##2##3##(1991-2#1)(2011-2#1)
teaching excellence##5##2##(1991-2#1)(2011-2#4)
teaching facilities##2##2##(1995-8#1)(2007-12#1)
teaching for critical thinking##2##4##(2005-12#2)
teaching for##3##2##(2005-12#2)(2012-2#1)
teaching has##3##2##(2007-4#1)(2011-7#1)(2013-1#1)
teaching health##4##2##(1993-4#1)(1995-1#1)(2007-8#1)(2008-11#1)
teaching hospital and##4##3##(1993-2#1)(1995-1#1)(2008-5#1)(2012-3#1)
teaching hospital in the##2##4##(2007-2#2)
teaching hospital in##15##3##(2007-10#2)(2007-2#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
teaching hospital of##5##3##(2008-7#2)(2009-10#2)(2012-3#1)
teaching hospital to##3##3##(1992-2#1)(1992-3#1)(2007-7#1)
teaching hospital were##4##3##(1992-5#1)(1993-12#1)(1997-2#1)(2007-3#1)
teaching hospital##75##2##(1992-2#1)(1992-3#2)(1992-5#1)(1993-12#1)(1993-2#1)(1994-2#2)(1994-3#1)(1995-1#2)(1997-2#2)(2005-7#2)(2005-9#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-2#5)(2007-3#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2009-1#1)(2009-10#2)(2009-5#1)(2010-12#2)(2010-3#4)(2010-8#1)(2010-9#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#4)
teaching hospitals affiliated to##2##4##(2007-2#1)(2011-2#1)
teaching hospitals are##2##3##(1992-12#1)(1995-1#1)
teaching hospitals in##4##3##(2007-4#1)(2008-11#1)(2010-3#1)(2012-11#1)
teaching hospitals to##2##3##(1997-1#1)(2008-11#1)
teaching hospitals##31##2##(1990-12#1)(1991-3#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-3#1)(1995-1#3)(1996-3#1)(1997-1#1)(2007-2#1)(2007-4#2)(2007-8#1)(2008-11#8)(2008-12#1)(2008-7#1)(2010-3#2)(2011-2#2)(2012-11#1)(2012-12#1)
teaching in a busy##2##4##(2007-7#2)
teaching in medical##2##3##(2008-12#1)(2012-2#1)
teaching in order##2##3##(2008-11#1)(2010-7#1)
teaching in the field of##2##5##(2009-4#1)(2011-2#1)
teaching in the##5##3##(2008-11#1)(2008-12#1)(2009-4#1)(2011-2#1)(2012-3#1)
teaching in##24##2##(1992-2#1)(1994-4#1)(1997-2#1)(2005-12#1)(2006-8#1)(2007-7#2)(2008-11#5)(2008-12#2)(2008-7#1)(2009-2#1)(2009-4#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
teaching intensity##2##2##(1992-12#2)
teaching into##2##2##(2008-11#1)(2013-8#1)
teaching is an##2##3##(2007-7#1)(2008-11#1)
teaching is##8##2##(1994-12#1)(2007-10#1)(2007-7#1)(2008-11#2)(2012-2#1)(2013-1#1)(2013-8#1)
teaching method##13##2##(2005-11#1)(2008-11#6)(2008-12#1)(2008-4#1)(2011-2#2)(2013-8#2)
teaching methodologies##2##2##(2012-2#1)(2013-8#1)
teaching methodology##3##2##(2008-11#1)(2008-12#1)(2013-8#1)
teaching methods and##2##3##(2008-11#1)(2012-2#1)
teaching methods##9##2##(1996-2#1)(2006-8#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-9#1)(2012-2#1)
teaching model##3##2##(2005-10#2)(2008-11#1)
teaching nursing home##2##3##(2008-12#2)
teaching nursing##5##2##(1996-2#2)(2006-5#1)(2008-12#2)
teaching of basic##2##3##(2013-1#2)
teaching of posterior composites##4##4##(2009-2#4)
teaching of the##2##3##(1991-6#1)(2006-7#1)
teaching of##31##2##(1991-6#1)(1995-3#1)(2006-10#1)(2006-7#2)(2007-1#1)(2007-7#2)(2008-11#3)(2008-12#1)(2008-4#1)(2009-2#7)(2010-1#1)(2010-11#1)(2011-2#3)(2012-12#2)(2013-1#3)(2013-8#1)
teaching on##3##2##(2008-5#1)(2008-6#1)(2010-8#1)
teaching or##2##2##(2008-11#1)(2011-1#1)
teaching practice##2##2##(2009-2#1)(2012-3#1)
teaching program##3##2##(1995-1#3)
teaching programs##7##2##(1992-12#1)(1992-2#1)(1995-1#4)(2010-9#1)
teaching recognition##2##2##(2010-10#1)(2011-2#1)
teaching sessions##3##2##(2008-1#1)(2008-11#2)
teaching spirometry##2##2##(2005-10#2)
teaching staff##3##2##(2006-5#1)(2007-6#1)(2008-12#1)
teaching strategies have been##2##4##(2006-5#1)(2008-12#1)
teaching strategies##12##2##(2005-12#2)(2006-5#3)(2007-2#2)(2008-11#2)(2008-12#3)
teaching strategy for##2##3##(2008-11#1)(2008-12#1)
teaching strategy is##2##3##(2008-11#2)
teaching strategy that##2##3##(2008-12#2)
teaching strategy to##2##3##(2005-12#1)(2008-12#1)
teaching strategy##17##2##(2005-12#1)(2006-5#3)(2008-11#5)(2008-12#5)(2010-3#1)(2012-3#2)
teaching students about##2##3##(1995-12#1)(2009-8#1)
teaching students##3##2##(1995-12#1)(1997-2#1)(2009-8#1)
teaching techniques##2##2##(2012-2#1)(2013-8#1)
teaching the##4##2##(1994-12#1)(2006-10#2)(2008-12#1)
teaching them##2##2##(1994-3#1)(2007-2#1)
teaching to##7##2##(1995-1#1)(1995-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2010-9#1)(2013-8#1)
teaching tool##2##2##(1995-12#1)(2008-8#1)
teaching tools##2##2##(2008-11#1)(2010-9#1)
teaching##604##1##(1990-12#8)(1990-2#3)(1990-3#1)(1990-8#2)(1991-2#1)(1991-3#4)(1991-6#1)(1992-1#1)(1992-12#7)(1992-2#6)(1992-3#2)(1992-5#1)(1992-6#1)(1993-1#1)(1993-12#5)(1993-2#1)(1993-3#5)(1993-4#1)(1993-6#1)(1994-12#7)(1994-2#6)(1994-3#6)(1994-4#3)(1994-6#1)(1995-1#17)(1995-12#3)(1995-2#3)(1995-3#3)(1995-8#1)(1996-1#8)(1996-11#1)(1996-2#4)(1996-3#3)(1996-9#1)(1997-1#1)(1997-2#5)(1997-5#1)(1997-7#1)(2005-10#7)(2005-11#1)(2005-12#10)(2005-4#1)(2005-7#2)(2005-9#1)(2006-10#7)(2006-2#1)(2006-5#12)(2006-6#2)(2006-7#2)(2006-8#3)(2007-1#2)(2007-10#8)(2007-11#2)(2007-12#4)(2007-2#16)(2007-3#4)(2007-4#11)(2007-5#2)(2007-6#1)(2007-7#7)(2007-8#6)(2007-9#5)(2008-1#5)(2008-10#8)(2008-11#92)(2008-12#42)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#10)(2008-8#4)(2008-9#2)(2009-1#2)(2009-10#2)(2009-2#13)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#2)(2010-3#9)(2010-6#2)(2010-7#3)(2010-8#8)(2010-9#6)(2011-1#3)(2011-2#34)(2011-7#1)(2012-1#9)(2012-11#1)(2012-12#9)(2012-2#17)(2012-3#7)(2013-1#17)(2013-7#1)(2013-8#22)
teaching-learning strategies##2##2##(2005-12#1)(2013-8#1)
teaching-learning##5##1##(2005-12#1)(2010-6#1)(2012-3#1)(2013-8#2)
teaching/administrative##2##1##(2011-1#2)
teaching/learning##4##1##(2005-12#1)(2008-11#2)(2012-12#1)
teachings and##2##2##(2008-11#1)(2009-4#1)
teachings##8##1##(1997-3#1)(2007-10#2)(2007-12#2)(2008-1#1)(2008-11#1)(2009-4#1)
teal##4##1##(2013-1#4)
team allows##2##2##(2006-6#1)(2007-12#1)
team and the##8##3##(2005-10#1)(2005-7#1)(2006-4#1)(2008-2#1)(2008-3#1)(2009-6#1)(2010-1#1)(2012-2#1)
team and##20##2##(1993-3#1)(2005-10#1)(2005-5#1)(2005-7#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-6#1)(2010-1#1)(2010-11#1)(2011-1#1)(2012-1#1)(2012-2#1)
team approach for##2##3##(2011-2#1)(2013-8#1)
team approach is##2##3##(2005-8#1)(2011-2#1)
team approach to##7##3##(1994-12#1)(1994-2#2)(1996-3#1)(2008-6#1)(2009-3#1)(2012-2#1)
team approach##22##2##(1994-12#2)(1994-2#2)(1996-1#1)(1996-2#1)(1996-3#1)(2005-8#1)(2007-10#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-6#1)(2009-3#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-8#1)
team approach]##2##2##(2006-2#1)(2012-3#1)
team are##2##2##(1995-3#1)(2012-12#1)
team assessed##2##2##(2012-3#1)(2013-1#1)
team at the##5##3##(1995-2#1)(2007-9#1)(2008-10#1)(2010-10#1)(2011-1#1)
team at##8##2##(1995-2#1)(1997-2#1)(2007-9#1)(2008-10#1)(2010-10#1)(2010-8#1)(2011-1#1)(2013-8#1)
team can##5##2##(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(2008-7#1)
team concept##3##2##(1993-3#1)(2008-10#2)
team conducted a##2##3##(2008-1#1)(2010-11#1)
team conducted##4##2##(2008-1#1)(2010-11#1)(2013-1#2)
team consisting of##3##3##(1996-3#1)(2006-7#1)(2007-7#1)
team during##2##2##(2007-12#1)(2008-7#1)
team effectiveness##2##2##(1993-12#1)(2011-1#1)
team effort##3##2##(1994-12#1)(2008-10#1)(2011-2#1)
team established##2##2##(1996-1#1)(2013-1#1)
team for##5##2##(1995-3#1)(2006-8#1)(2008-11#1)(2009-9#1)(2013-1#1)
team from the##2##3##(2008-2#1)(2013-8#1)
team has the##2##3##(2008-11#2)
team has##10##2##(1990-3#1)(1994-12#1)(1995-3#1)(2006-10#1)(2007-8#1)(2008-11#2)(2008-9#1)(2012-2#1)(2013-8#1)
team identified##2##2##(1996-1#1)(2013-1#1)
team in the year 2000##2##5##(2006-8#2)
team in the##7##3##(1992-2#1)(1996-2#1)(2006-8#2)(2007-11#1)(2011-2#1)(2012-2#1)
team in their##3##3##(2006-10#1)(2013-1#2)
team in##11##2##(1992-2#1)(1996-2#1)(2006-10#1)(2006-8#2)(2007-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
team including##2##2##(2009-4#1)(2010-12#1)
team involved in##2##3##(2007-11#1)(2010-3#1)
team is the##2##3##(1996-7#1)(2011-1#1)
team is to##3##3##(2008-1#1)(2008-10#1)(2012-1#1)
team is##9##2##(1996-7#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2011-1#1)(2012-1#2)(2013-1#1)
team leader##4##2##(1993-12#1)(2007-8#1)(2011-12#1)(2012-2#1)
team leadership##5##2##(1992-5#1)(2008-6#3)(2011-1#1)
team member##3##2##(1996-7#1)(2010-4#1)(2012-12#1)
team members in##3##3##(1994-2#1)(2009-4#1)(2011-2#1)
team members who##3##3##(2007-11#1)(2008-8#1)(2011-1#1)
team members##24##2##(1993-12#2)(1994-12#1)(1994-2#1)(1996-3#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-4#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#1)
team must##3##2##(1995-3#1)(2008-11#1)(2008-7#1)
team of experts##3##3##(2011-2#1)(2013-1#2)
team of health care##2##4##(1994-12#1)(2010-10#1)
team of health##6##3##(1990-3#1)(1994-12#1)(2006-9#1)(2007-12#1)(2008-1#1)(2010-10#1)
team of nurses##2##3##(2008-10#1)(2009-6#1)
team of physicians##2##3##(1996-1#1)(2009-3#1)
team of physicists##2##3##(2007-9#2)
team of professionals##2##3##(2006-5#1)(2008-12#1)
team of specialists##3##3##(2007-11#1)(2007-8#2)
team of##53##2##(1990-3#1)(1990-6#1)(1993-1#1)(1994-12#1)(1994-3#1)(1995-5#1)(1996-1#2)(2006-5#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-8#3)(2007-9#7)(2008-1#3)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-5#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#6)
team performance##3##2##(1995-2#2)(2011-1#1)
team should be##4##3##(2007-11#1)(2007-12#1)(2010-7#2)
team should##7##2##(1995-3#2)(2007-11#2)(2007-12#1)(2010-7#2)
team spirit##2##2##(2008-12#1)(2009-8#1)
team that##4##2##(1997-1#1)(2007-12#1)(2011-12#1)(2011-2#1)
team to determine##2##3##(1995-2#1)(2010-3#1)
team to develop##4##3##(1997-3#1)(2006-1#1)(2013-1#2)
team to identify##2##3##(1995-12#1)(2007-8#1)
team to improve##2##3##(1996-1#1)(2007-9#1)
team to make##2##3##(1995-9#1)(2012-2#1)
team to##26##2##(1993-12#1)(1993-5#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-1#1)(1997-2#1)(1997-3#1)(2006-1#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-7#1)(2010-11#1)(2010-3#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
team training##3##2##(1993-12#1)(2011-1#2)
team up##2##2##(1995-10#1)(1995-7#1)
team using##2##2##(2009-2#1)(2011-2#1)
team was formed to##2##4##(1994-12#1)(2013-1#1)
team was formed##3##3##(1994-12#2)(2013-1#1)
team was##10##2##(1994-12#2)(1995-1#1)(1996-1#1)(2007-9#2)(2008-12#1)(2011-12#1)(2012-8#1)(2013-1#1)
team with##10##2##(1993-3#1)(1994-3#1)(1995-2#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-8#1)
team work##5##2##(1991-2#1)(1997-4#1)(2005-1#1)(2007-1#1)(2010-3#1)
team##546##1##(1990-12#2)(1990-3#2)(1990-6#2)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#2)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#5)(1992-6#1)(1993-1#5)(1993-12#10)(1993-2#2)(1993-3#7)(1993-5#1)(1994-1#2)(1994-12#10)(1994-2#10)(1994-3#6)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#8)(1995-3#8)(1995-5#2)(1995-7#1)(1995-9#3)(1996-1#13)(1996-11#1)(1996-12#2)(1996-2#5)(1996-3#5)(1996-5#1)(1996-7#3)(1997-1#3)(1997-2#6)(1997-3#4)(1997-4#2)(1997-6#1)(2005-1#1)(2005-10#1)(2005-11#2)(2005-5#2)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#6)(2006-7#3)(2006-8#9)(2006-9#2)(2007-1#2)(2007-10#5)(2007-11#12)(2007-12#12)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#6)(2007-6#3)(2007-7#2)(2007-8#15)(2007-9#19)(2008-1#14)(2008-10#16)(2008-11#17)(2008-12#6)(2008-2#6)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#8)(2008-7#8)(2008-8#3)(2008-9#2)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#3)(2009-8#3)(2009-9#4)(2010-1#1)(2010-10#5)(2010-11#3)(2010-12#5)(2010-2#1)(2010-3#7)(2010-4#1)(2010-5#4)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#14)(2011-12#4)(2011-2#19)(2011-3#2)(2011-8#1)(2012-1#5)(2012-12#11)(2012-2#25)(2012-3#6)(2012-8#1)(2013-1#35)(2013-7#5)(2013-8#8)
team's##14##1##(1990-4#1)(1993-12#2)(1994-1#1)(1995-12#1)(1997-2#2)(2006-4#1)(2007-8#1)(2009-6#1)(2009-9#1)(2011-2#1)(2013-7#1)(2013-8#1)
team-based approach to##2##3##(2008-11#1)(2009-2#1)
team-based structures##2##2##(1993-12#1)(1997-1#1)
team-based##13##1##(1993-12#2)(1997-1#1)(1997-2#1)(2007-8#1)(2008-11#1)(2008-12#1)(2009-2#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#1)
team-building##2##1##(1990-12#1)(1992-3#1)
team-work##2##1##(2008-11#1)(2012-12#1)
team-working##2##1##(2006-10#1)(2008-11#1)
team]##2##1##(1996-4#1)(2009-8#1)
teamed##2##1##(2013-8#2)
teams and##14##2##(1993-10#1)(1993-2#1)(1995-12#1)(1995-6#1)(1996-2#1)(2006-2#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)(2011-3#1)
teams are##9##2##(1993-12#2)(1993-2#1)(1994-2#1)(2007-8#1)(2007-9#2)(2011-1#2)
teams at##3##2##(2006-2#1)(2008-10#1)(2013-7#1)
teams can##3##2##(1993-12#1)(1994-2#1)(1997-1#1)
teams caring for clients with chronic conditions##2##7##(2011-1#2)
teams for##5##2##(1997-2#1)(2006-9#1)(2007-4#1)(2007-8#1)(2008-3#1)
teams from rural cancer coalitions and hospitals##2##7##(2008-7#2)
teams function##2##2##(1993-12#1)(2008-2#1)
teams have##6##2##(1993-3#1)(1994-2#1)(1995-9#1)(2008-8#1)(2009-8#1)(2010-5#1)
teams in the##7##3##(1993-11#1)(1994-1#1)(1994-2#1)(1996-3#1)(2008-2#2)(2012-12#1)
teams in##19##2##(1992-2#1)(1993-11#1)(1993-12#1)(1994-1#2)(1994-2#1)(1995-5#1)(1996-3#2)(2005-8#1)(2007-4#1)(2008-2#2)(2010-2#1)(2011-2#2)(2012-12#1)(2012-3#2)
teams involved in the##2##4##(2008-3#1)(2011-2#1)
teams involved in##3##3##(2008-3#2)(2011-2#1)
teams is##3##2##(1993-12#1)(2011-1#1)(2011-2#1)
teams of researchers##2##3##(2006-10#1)(2011-2#1)
teams of##12##2##(1993-1#1)(1994-2#1)(1996-2#1)(2004-3#1)(2006-10#2)(2007-9#1)(2008-2#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
teams should##2##2##(2006-5#1)(2007-12#1)
teams that##4##2##(1995-2#1)(1996-1#1)(1997-3#1)(2011-2#1)
teams to##3##2##(1990-4#1)(1994-3#1)(2008-9#1)
teams visited##2##2##(2012-3#2)
teams with##2##2##(2011-2#1)(2012-12#1)
teams##211##1##(1990-4#1)(1991-3#1)(1992-12#1)(1992-2#2)(1992-5#2)(1992-6#1)(1993-1#1)(1993-10#2)(1993-11#1)(1993-12#15)(1993-2#3)(1993-3#1)(1993-5#1)(1994-1#7)(1994-12#1)(1994-2#11)(1994-3#3)(1995-12#1)(1995-2#3)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#2)(1996-3#3)(1996-7#1)(1997-1#1)(1997-2#6)(1997-3#1)(2004-3#1)(2005-8#1)(2006-10#4)(2006-2#3)(2006-5#2)(2006-9#1)(2007-10#1)(2007-12#3)(2007-4#4)(2007-6#1)(2007-8#3)(2007-9#6)(2008-1#4)(2008-10#2)(2008-11#4)(2008-12#2)(2008-2#6)(2008-3#5)(2008-4#1)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#4)(2009-3#1)(2009-4#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#3)(2010-5#3)(2010-7#1)(2011-1#12)(2011-2#11)(2011-3#1)(2012-12#4)(2012-2#2)(2012-3#12)(2013-1#5)(2013-7#1)(2013-8#1)
teamwork and##3##2##(1993-3#1)(1994-1#1)(2010-5#1)
teamwork in##3##2##(1995-1#1)(2007-8#1)(2013-1#1)
teamwork is##2##2##(1996-1#1)(2006-2#1)
teamwork##25##1##(1991-12#2)(1992-1#1)(1993-3#2)(1994-1#1)(1994-2#1)(1995-1#1)(1996-1#2)(1996-2#1)(1996-3#1)(2005-9#1)(2006-2#1)(2007-11#1)(2007-8#2)(2008-1#1)(2010-10#1)(2010-5#1)(2010-7#1)(2010-9#1)(2012-3#1)(2013-1#2)
tear amount##4##2##(2013-8#4)
tear and##7##2##(1996-11#1)(2007-10#1)(2008-12#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-2#1)
tear at the##2##3##(2011-3#1)(2013-7#1)
tear at##3##2##(2009-9#1)(2011-3#1)(2013-7#1)
tear composition##2##2##(2007-1#2)
tear deficiency##4##2##(2005-11#2)(2007-1#2)
tear film and##5##3##(2006-11#3)(2007-1#1)(2011-2#1)
tear film##18##2##(2005-11#1)(2006-10#1)(2006-11#7)(2007-1#3)(2009-4#4)(2009-6#1)(2011-2#1)
tear fluid##4##2##(2006-11#3)(2012-2#1)
tear of the##9##3##(1996-11#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-7#1)(2009-4#1)(2009-9#1)(2013-1#1)
tear of##11##2##(1996-11#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-7#2)(2009-4#1)(2009-9#1)(2013-1#1)(2013-8#1)
tear secretion##3##2##(2007-1#1)(2012-2#2)
tear was##2##2##(2009-4#1)(2011-2#1)
tear##119##1##(1992-3#1)(1992-8#1)(1996-11#2)(2004-10#1)(2005-11#5)(2006-10#2)(2006-11#21)(2006-12#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#10)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#4)(2008-9#1)(2009-3#3)(2009-4#8)(2009-6#1)(2009-9#14)(2010-4#1)(2011-2#4)(2011-3#1)(2011-7#1)(2012-11#2)(2012-2#8)(2013-1#1)(2013-7#4)(2013-8#6)
tearing of the##2##3##(2007-4#1)(2013-7#1)
tearing of##4##2##(2007-4#1)(2008-5#1)(2012-2#1)(2013-7#1)
tearing##12##1##(2005-11#1)(2007-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-8#2)(2010-4#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-7#1)
tears and##4##2##(1996-11#1)(2006-3#1)(2009-3#1)(2012-3#1)
tears are##4##2##(1994-2#1)(2007-1#1)(2007-11#1)(2013-7#1)
tears at##2##2##(2007-1#1)(2009-10#1)
tears in the##2##3##(2008-11#1)(2013-7#1)
tears of##3##2##(1995-8#1)(2009-8#1)(2013-7#1)
tears was##3##2##(2009-9#2)(2012-2#1)
tears were identified##2##3##(1994-2#1)(2009-9#1)
tears were##3##2##(1994-2#1)(2007-4#1)(2009-9#1)
tears##65##1##(1992-6#1)(1992-8#1)(1993-11#2)(1994-2#3)(1995-8#1)(1996-11#4)(2005-11#1)(2006-11#4)(2006-12#1)(2006-3#1)(2006-4#1)(2007-1#4)(2007-11#2)(2007-4#1)(2007-7#1)(2007-8#3)(2008-11#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#6)(2010-4#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-11#1)(2012-2#7)(2012-3#1)(2013-7#7)
tears)##2##1##(2008-2#1)(2012-2#1)
teas and related components on the proliferation and invasion of##2##10##(2008-11#2)
teas and related components##3##4##(2008-11#3)
teas and##4##2##(2008-11#4)
teas were##2##2##(2008-10#2)
teas##26##1##(2005-11#4)(2008-10#10)(2008-11#6)(2009-12#1)(2009-8#1)(2012-2#4)
tease out##2##2##(1994-9#1)(2008-11#1)
teased##3##1##(2005-9#2)(2009-10#1)
teasing was associated with##2##4##(2007-12#2)
teasing##14##1##(2005-9#1)(2007-12#7)(2007-2#1)(2007-8#1)(2008-2#1)(2008-4#2)(2009-4#1)
teat dip##4##2##(1990-6#4)
teat##10##1##(1990-6#6)(1992-2#2)(2005-7#1)(2011-2#1)
tebuconazole effect on##3##3##(2008-10#3)
tebuconazole##13##1##(2008-10#11)(2008-6#1)(2011-12#1)
tech VR helmet##2##3##(2010-4#2)
tech##9##1##(2007-10#1)(2008-12#3)(2008-7#1)(2009-9#1)(2010-4#2)(2013-8#1)
technetium##6##1##(1992-2#1)(1994-9#1)(1996-3#1)(2008-5#3)
technetium-99m complexes##2##2##(1994-9#2)
technetium-99m hexamethylpropyleneamine oxime##2##3##(1996-5#1)(2006-8#1)
technetium-99m##11##1##(1990-12#1)(1991-11#1)(1994-9#2)(1995-8#2)(1996-5#1)(2006-8#1)(2008-5#2)(2012-12#1)
technic##6##1##(1990-2#1)(1990-3#1)(1990-6#1)(1993-9#1)(2007-11#1)(2011-3#1)
technic]##3##1##(1990-2#1)(1990-3#2)
technical adaptations##2##2##(2006-2#1)(2009-1#1)
technical advances have##2##3##(2006-5#1)(2006-7#1)
technical advances##8##2##(2006-10#1)(2006-5#1)(2006-7#1)(2008-12#1)(2008-6#1)(2010-9#1)(2011-2#1)(2012-2#1)
technical and administrative##2##3##(1991-1#1)(2005-5#1)
technical and medical##6##3##(1990-11#1)(1990-12#1)(1997-6#1)(2007-11#1)(2008-3#1)(2013-1#1)
technical and therapeutic##2##3##(2007-5#1)(2012-3#1)
technical and##32##2##(1990-11#1)(1990-12#1)(1991-1#1)(1992-9#1)(1993-1#1)(1993-6#1)(1996-2#1)(1997-6#1)(2005-12#1)(2005-5#2)(2006-6#1)(2007-11#2)(2007-12#1)(2007-4#3)(2007-5#1)(2008-11#2)(2008-3#3)(2008-5#2)(2009-11#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
technical approaches##4##2##(2008-11#1)(2010-4#1)(2011-2#1)(2012-1#1)
technical aspects and##4##3##(2006-10#1)(2007-7#1)(2009-5#1)(2013-1#1)
technical aspects of the procedure and##2##6##(2006-8#1)(2007-8#1)
technical aspects of the##5##4##(2006-8#2)(2007-8#1)(2008-11#1)(2008-9#1)
technical aspects of their##2##4##(1991-4#1)(2006-10#1)
technical aspects of##20##3##(1991-4#1)(1993-12#1)(1997-5#1)(1997-8#1)(2005-10#1)(2006-10#2)(2006-6#1)(2006-7#1)(2006-8#2)(2007-5#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-12#1)(2012-2#1)(2013-8#1)
technical aspects##30##2##(1990-8#1)(1991-4#1)(1993-12#1)(1996-3#1)(1997-5#1)(1997-8#1)(2005-10#1)(2006-10#3)(2006-6#1)(2006-7#1)(2006-8#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
technical assistance##9##2##(1993-8#1)(1994-3#1)(2008-1#2)(2008-8#1)(2012-12#1)(2012-3#1)(2013-1#2)
technical basis and##2##3##(2012-1#2)
technical capabilities##2##2##(2007-11#1)(2008-7#1)
technical care and##2##3##(2008-12#1)(2011-1#1)
technical care##4##2##(2008-12#2)(2011-1#1)(2011-2#1)
technical challenges in##3##3##(2008-7#1)(2011-2#2)
technical challenges##11##2##(2007-11#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)
technical change##3##2##(1992-1#3)
technical characteristics of the##2##4##(2007-8#1)(2011-1#1)
technical characteristics of##3##3##(2007-1#1)(2007-8#1)(2011-1#1)
technical characteristics##4##2##(1996-1#1)(2007-1#1)(2007-8#1)(2011-1#1)
technical competence as##2##3##(1990-12#1)(1995-9#1)
technical competence##6##2##(1990-12#3)(1995-9#1)(1996-4#1)(2008-12#1)
technical complications##2##2##(1997-3#1)(2007-5#1)
technical concept##2##2##(2007-5#1)(2008-5#1)
technical conditions##4##2##(2007-8#1)(2008-10#1)(2012-1#1)(2012-2#1)
technical considerations##4##2##(2006-3#1)(2010-8#1)(2011-2#2)
technical control##2##2##(1994-6#2)
technical cooperation##2##2##(2011-2#2)
technical details of##4##3##(1994-9#1)(2007-12#1)(2008-10#1)(2012-3#1)
technical details##11##2##(1994-9#1)(1996-2#1)(2007-12#1)(2007-5#2)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-8#1)(2012-3#1)
technical development##4##2##(1990-4#1)(1993-10#1)(2006-6#1)(2013-1#1)
technical developments of##2##3##(2008-1#1)(2012-2#1)
technical developments##7##2##(2006-6#2)(2007-7#1)(2008-1#1)(2008-4#1)(2010-2#1)(2012-2#1)
technical difficulties and##4##3##(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#1)
technical difficulties##12##2##(1991-12#1)(1993-10#1)(2007-11#1)(2007-8#3)(2008-6#2)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#1)
technical difficulty of##2##3##(2008-3#1)(2009-6#1)
technical difficulty##3##2##(2008-3#1)(2009-6#1)(2012-3#1)
technical ease##2##2##(2007-12#1)(2008-1#1)
technical efficiency##4##2##(2013-8#4)
technical error##3##2##(1991-12#1)(2007-7#1)(2008-9#1)
technical errors##2##2##(2010-8#1)(2012-2#1)
technical expertise##5##2##(1996-2#1)(2008-4#1)(2009-2#1)(2010-4#1)(2013-1#1)
technical experts and##2##3##(1996-1#1)(2010-10#1)
technical experts##6##2##(1994-12#1)(1996-1#1)(2006-7#2)(2008-1#1)(2010-10#1)
technical factors##4##2##(2006-10#1)(2008-1#1)(2010-4#1)(2012-12#1)
technical failure##3##2##(1995-2#1)(2008-10#1)(2012-2#1)
technical feasibility of##3##3##(2007-3#1)(2008-2#1)(2008-5#1)
technical feasibility##4##2##(2007-3#1)(2008-2#1)(2008-5#1)(2011-2#1)
technical features##5##2##(2006-10#1)(2006-8#1)(2008-3#1)(2008-8#1)(2011-2#1)
technical formulations##4##2##(2007-10#1)(2008-10#3)
technical grade##8##2##(2008-10#3)(2008-9#4)(2012-12#1)
technical hurdles##2##2##(2008-4#1)(2011-2#1)
technical hygienic##2##2##(1992-11#1)(1993-8#1)
technical improvement##2##2##(2007-11#1)(2008-7#1)
technical improvements##6##2##(1994-6#2)(2007-8#1)(2008-11#1)(2008-7#1)(2011-1#1)
technical indicators and user##2##4##(2011-2#2)
technical innovation##2##2##(2007-4#1)(2009-3#1)
technical innovations for##2##3##(2006-10#1)(2008-4#1)
technical innovations##3##2##(2006-10#1)(2006-5#1)(2008-4#1)
technical issues##13##2##(2006-10#1)(2007-10#2)(2007-2#1)(2008-3#2)(2008-6#1)(2009-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#2)
technical knowledge and skill##2##4##(1990-12#2)
technical knowledge and##3##3##(1990-12#2)(1994-6#1)
technical knowledge##7##2##(1990-12#3)(1994-6#1)(2008-11#1)(2011-2#2)
technical limitations##8##2##(2006-10#2)(2006-5#2)(2008-7#1)(2009-12#1)(2009-8#1)(2012-1#1)
technical literature##2##2##(2008-2#1)(2008-3#1)
technical managerial/clinical##2##2##(2008-1#2)
technical note##13##2##(2006-12#1)(2007-7#1)(2008-10#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)
technical obstacles##2##2##(1997-8#1)(2010-9#1)
technical oil##2##2##(2008-10#2)
technical or##2##2##(1997-6#1)(2012-2#1)
technical paper##2##2##(2006-11#2)
technical parameters were##2##3##(2004-11#1)(2011-2#1)
technical parameters##4##2##(2004-11#1)(2005-11#1)(2008-2#1)(2011-2#1)
technical performance##2##2##(2008-3#1)(2012-2#1)
technical personnel##3##2##(2007-7#1)(2007-9#1)(2013-1#1)
technical pitfalls##2##2##(2008-1#1)(2009-8#1)
technical possibilities##2##2##(1990-9#1)(2007-4#1)
technical principles##4##2##(2005-5#1)(2007-11#1)(2008-7#1)(2008-9#1)
technical problem##3##2##(1997-8#1)(2007-7#1)(2008-5#1)
technical problems involved##2##3##(1996-12#1)(2007-11#1)
technical problems##15##2##(1991-12#1)(1994-6#1)(1996-12#1)(1997-2#1)(2007-11#3)(2007-5#2)(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-2#1)
technical procedures##2##2##(1990-2#1)(2010-8#1)
technical progress##2##2##(1996-4#1)(2008-8#1)
technical properties##2##2##(2006-12#1)(2008-10#1)
technical quality and##2##3##(2009-3#1)(2012-12#1)
technical reasons##5##2##(1993-11#1)(2007-3#1)(2008-3#1)(2009-7#1)(2009-9#1)
technical report##4##2##(2007-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
technical requirements##3##2##(1996-1#1)(2008-12#1)(2010-7#1)
technical resources##3##2##(1991-3#1)(2007-11#1)(2009-10#1)
technical simplicity##5##2##(1995-5#1)(2006-12#1)(2006-5#1)(2009-5#2)
technical skills and##3##3##(1995-10#1)(1997-2#1)(2011-2#1)
technical skills of the##2##4##(1993-5#1)(2008-11#1)
technical skills of##3##3##(1993-5#1)(1994-2#1)(2008-11#1)
technical skills##15##2##(1992-2#1)(1993-12#2)(1993-5#1)(1994-2#1)(1995-10#1)(1997-2#1)(2006-10#1)(2006-8#1)(2007-2#1)(2008-11#2)(2008-6#1)(2011-2#1)(2012-2#1)
technical solutions##6##2##(1990-11#1)(1990-12#1)(1990-3#1)(1994-6#1)(2007-4#1)(2010-9#1)
technical specifications##5##2##(2006-10#1)(2008-3#2)(2013-1#2)
technical staff##2##2##(2009-4#2)
technical standards##2##2##(2007-4#1)(2012-12#1)
technical study##2##2##(2006-6#1)(2007-8#1)
technical success rate##2##3##(2006-10#1)(2012-2#1)
technical success##6##2##(2006-10#1)(2007-7#1)(2008-1#2)(2011-2#1)(2012-2#1)
technical support from##2##3##(2008-1#1)(2012-2#1)
technical support##4##2##(2004-9#1)(2008-1#1)(2008-9#1)(2012-2#1)
technical systems##2##2##(2005-11#1)(2010-8#1)
technical tasks##3##2##(2010-2#3)
technical training##2##2##(2008-1#1)(2010-12#1)
technical variables##2##2##(2008-5#1)(2013-1#1)
technical versus##2##2##(1990-12#1)(1993-8#1)
technical waste plastics##2##3##(2008-10#2)
technical waste##3##2##(2008-10#3)
technical##573##1##(1990-10#2)(1990-11#2)(1990-12#9)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#3)(1991-3#3)(1991-4#1)(1991-9#1)(1992-1#4)(1992-11#1)(1992-2#2)(1992-3#3)(1992-5#1)(1992-9#2)(1993-1#2)(1993-10#4)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#3)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#7)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-12#1)(1996-2#4)(1996-3#1)(1996-4#3)(1996-9#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-6#3)(1997-8#3)(2004-11#1)(2004-3#1)(2004-9#2)(2005-10#1)(2005-11#3)(2005-12#1)(2005-4#1)(2005-5#6)(2006-10#18)(2006-11#2)(2006-12#5)(2006-2#1)(2006-3#1)(2006-5#6)(2006-6#7)(2006-7#4)(2006-8#6)(2007-1#2)(2007-10#5)(2007-11#15)(2007-12#8)(2007-2#4)(2007-3#2)(2007-4#9)(2007-5#10)(2007-7#11)(2007-8#15)(2007-9#1)(2008-1#16)(2008-10#24)(2008-11#17)(2008-12#8)(2008-2#6)(2008-3#19)(2008-4#10)(2008-5#11)(2008-6#6)(2008-7#9)(2008-8#4)(2008-9#17)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#4)(2010-4#6)(2010-5#1)(2010-7#1)(2010-8#6)(2010-9#3)(2011-1#6)(2011-12#1)(2011-2#37)(2012-1#6)(2012-11#2)(2012-12#11)(2012-2#18)(2012-3#8)(2013-1#17)(2013-7#4)(2013-8#9)
technically and##2##2##(1996-11#1)(2010-12#1)
technically challenging and##2##3##(2008-4#1)(2011-2#1)
technically challenging procedure##2##3##(2005-10#1)(2011-2#1)
technically challenging##12##2##(2005-10#1)(2006-9#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-4#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)
technically demanding and##4##3##(1996-9#1)(2007-5#1)(2008-12#1)(2011-1#1)
technically demanding##9##2##(1993-11#1)(1996-9#1)(2007-11#1)(2007-5#1)(2008-12#1)(2009-2#1)(2011-1#1)(2012-12#1)(2013-1#1)
technically difficult and##2##3##(1990-5#1)(2010-7#1)
technically difficult##6##2##(1990-5#1)(2008-4#2)(2009-10#1)(2009-6#1)(2010-7#1)
technically easier and##2##3##(1990-4#1)(2012-12#1)
technically easy and##2##3##(1997-5#1)(2006-12#1)
technically easy##4##2##(1997-5#1)(2006-12#1)(2007-7#1)(2009-6#1)
technically efficient##2##2##(2007-7#1)(2010-12#1)
technically feasible and##3##3##(2006-8#1)(2007-8#1)(2009-8#1)
technically feasible##13##2##(2006-6#1)(2006-8#1)(2007-8#4)(2008-12#1)(2008-7#2)(2009-8#1)(2010-12#1)(2010-4#1)(2012-3#1)
technically more demanding##3##3##(2007-12#1)(2008-4#1)(2013-1#1)
technically more##4##2##(2007-12#1)(2008-11#1)(2008-4#1)(2013-1#1)
technically possible##3##2##(1993-11#1)(2008-5#1)(2008-6#1)
technically simple##5##2##(1993-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2010-3#1)
technically simpler##2##2##(2008-10#1)(2008-4#1)
technically##92##1##(1990-4#1)(1990-5#1)(1991-12#1)(1993-11#3)(1993-3#1)(1993-8#2)(1994-4#1)(1994-9#1)(1995-12#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-5#2)(2004-9#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#2)(2009-8#2)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)
technician and##3##2##(2006-5#1)(2012-1#1)(2012-3#1)
technician to##2##2##(2008-10#1)(2009-8#1)
technician##22##1##(1990-12#1)(1993-7#1)(1994-8#1)(1996-2#1)(2006-10#2)(2006-5#1)(2007-1#1)(2007-10#2)(2007-11#1)(2008-1#2)(2008-10#3)(2008-9#1)(2009-11#1)(2009-8#1)(2010-2#1)(2012-1#1)(2012-3#1)
technicians##18##1##(1991-7#1)(1992-5#1)(1992-8#1)(1994-12#1)(1994-6#1)(1997-4#1)(2005-12#2)(2006-10#1)(2006-5#4)(2007-11#1)(2009-11#1)(2010-8#1)(2012-12#1)(2012-2#1)
technics##5##1##(1994-3#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#1)
technics]##2##1##(1990-4#1)(1993-6#1)
technique (DGT)##2##2##(2008-10#2)
technique (DMT)##2##2##(2007-10#1)(2007-8#1)
technique (Group II)##2##3##(2007-7#1)(2007-8#1)
technique (Group##3##2##(2007-7#2)(2007-8#1)
technique (a##4##2##(1997-4#1)(2008-10#1)(2008-3#1)(2008-5#1)
technique EC-ECG##2##2##(2007-7#2)
technique a##7##2##(2005-1#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-8#1)
technique able to##3##3##(1995-11#1)(2006-10#1)(2008-7#1)
technique after##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
technique allow##2##2##(2006-10#1)(2008-10#1)
technique allowed the##2##3##(1997-3#1)(2010-12#1)
technique allowed to##2##3##(2007-11#1)(2007-12#1)
technique allowed##11##2##(1990-11#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2010-12#1)
technique allowing##2##2##(1995-4#1)(1997-3#1)
technique allows a##3##3##(2004-9#1)(2007-12#1)(2008-10#1)
technique allows for##5##3##(2006-5#1)(2007-12#2)(2008-2#1)(2008-3#1)
technique allows one to##3##4##(2007-11#1)(2008-10#1)(2008-2#1)
technique allows the##7##3##(2005-11#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)
technique allows##39##2##(2004-9#1)(2005-11#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#3)(2007-12#6)(2007-8#1)(2008-10#10)(2008-11#2)(2008-2#2)(2008-3#4)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#2)(2013-8#1)
technique also provides a##2##4##(2008-10#1)(2008-3#1)
technique also##12##2##(1997-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#3)
technique and a joint##2##4##(1994-4#1)(2008-2#1)
technique and a##9##3##(1994-4#1)(1995-5#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#1)
technique and an##4##3##(1994-12#1)(2008-2#2)(2008-3#1)
technique and by##2##3##(2008-10#2)
technique and can be##2##4##(2007-12#1)(2008-10#1)
technique and clinical##4##3##(1992-6#1)(2007-8#1)(2008-7#1)(2012-2#1)
technique and cyclic##2##3##(2008-10#2)
technique and discuss##2##3##(2006-3#1)(2008-7#1)
technique and early##2##3##(2007-8#1)(2012-2#1)
technique and have##2##3##(2006-12#1)(2008-11#1)
technique and indications##2##3##(2006-12#1)(2006-4#1)
technique and its application##2##4##(2008-10#1)(2008-7#1)
technique and its applications in##2##5##(2008-3#1)(2008-7#1)
technique and its##10##3##(1992-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-7#2)(2013-1#1)
technique and outcomes##6##3##(2005-10#1)(2007-7#1)(2008-9#1)(2009-10#1)(2011-2#2)
technique and preliminary results##3##4##(1994-4#1)(2007-8#1)(2012-12#1)
technique and results##5##3##(1990-11#1)(1994-11#1)(1995-12#1)(2006-5#1)(2010-11#1)
technique and some##2##3##(2008-3#1)(2010-7#1)
technique and that##2##3##(1991-12#1)(2007-8#1)
technique and the correct##2##4##(2007-7#2)
technique and the results##3##4##(1997-2#1)(2008-10#1)(2013-7#1)
technique and the##24##3##(1990-10#1)(1993-12#1)(1994-2#1)(1997-2#1)(1997-6#2)(2006-10#2)(2006-6#1)(2007-11#1)(2007-7#2)(2008-10#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-8#2)(2009-5#1)(2013-7#1)
technique and their##2##3##(2006-10#1)(2006-5#1)
technique and then##2##3##(2006-3#1)(2007-11#1)
technique and to##2##3##(2010-7#1)(2011-2#1)
technique and two##2##3##(2007-1#1)(2008-2#1)
technique and##220##2##(1990-10#1)(1990-11#1)(1990-3#1)(1991-12#1)(1991-4#1)(1992-12#1)(1992-6#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-4#2)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-6#3)(1997-7#1)(2005-10#2)(2005-11#2)(2005-9#1)(2006-10#4)(2006-12#4)(2006-2#1)(2006-3#3)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#1)(2007-1#1)(2007-11#5)(2007-12#6)(2007-2#1)(2007-5#1)(2007-7#4)(2007-8#7)(2008-1#2)(2008-10#27)(2008-11#6)(2008-2#14)(2008-3#21)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#3)(2009-10#2)(2009-5#4)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#2)(2010-4#1)(2010-7#4)(2011-12#1)(2011-2#8)(2012-11#2)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#8)(2013-7#2)(2013-8#2)
technique appears to be##4##4##(1992-2#1)(1993-11#1)(2007-7#1)(2008-5#1)
technique applied to##2##3##(1992-6#1)(2008-5#1)
technique applied##5##2##(1992-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)
technique applies##2##2##(2008-2#1)(2010-4#1)
technique are compared with##3##4##(2005-11#1)(2007-12#1)(2008-3#1)
technique are compared##4##3##(2005-11#1)(2006-12#1)(2007-12#1)(2008-3#1)
technique are demonstrated##2##3##(2007-1#1)(2008-2#1)
technique are described##2##3##(2006-9#1)(2008-2#1)
technique are discussed##7##3##(1993-10#1)(1994-9#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)
technique are investigated##2##3##(2008-3#2)
technique are its##2##3##(2008-1#1)(2008-11#1)
technique are presented##3##3##(2006-12#1)(2008-10#1)(2008-2#1)
technique are proposed##2##3##(2005-4#1)(2008-2#1)
technique are##50##2##(1990-4#1)(1990-9#1)(1991-3#1)(1992-7#1)(1993-10#1)(1994-9#1)(1995-11#1)(1996-5#1)(1997-3#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-12#2)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#7)(2008-3#9)(2009-1#1)(2010-5#1)
technique as a tool##2##4##(2008-3#1)(2008-5#1)
technique as a##12##3##(1994-5#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#1)
technique as well as##3##4##(2007-7#1)(2008-6#1)(2011-1#1)
technique as well##4##3##(2007-7#1)(2008-10#1)(2008-6#1)(2011-1#1)
technique as##21##2##(1994-5#1)(2005-9#1)(2007-11#1)(2007-12#4)(2007-7#2)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2010-11#1)(2011-1#1)
technique associated with the##2##4##(2008-5#2)
technique associated with##4##3##(2008-5#4)
technique at different##2##3##(1991-6#1)(2008-10#1)
technique at##13##2##(1991-6#1)(1994-3#1)(1996-12#1)(2005-11#1)(2006-6#1)(2008-10#5)(2010-5#1)(2011-2#1)(2012-3#1)
technique based on a regularized phase-tracking (RPT) system##2##8##(2008-3#2)
technique based on a##10##4##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#5)
technique based on an##2##4##(2007-12#1)(2008-2#1)
technique based on photolysis of H2O2##2##6##(2013-8#2)
technique based on the##15##4##(2005-11#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#4)(2008-6#1)(2008-7#1)
technique based on##55##3##(1995-5#1)(1996-2#1)(2005-11#1)(2006-10#1)(2007-11#4)(2007-12#10)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#8)(2008-3#13)(2008-6#1)(2008-7#1)(2009-3#1)(2010-3#1)(2012-1#1)(2013-8#2)
technique based##56##2##(1995-5#1)(1996-2#1)(2005-11#1)(2006-10#1)(2007-11#4)(2007-12#10)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#8)(2008-3#13)(2008-6#1)(2008-7#1)(2009-3#1)(2010-3#1)(2012-1#1)(2013-8#2)
technique because of##3##3##(1991-12#1)(2008-10#1)(2013-8#1)
technique because##5##2##(1991-12#1)(2008-10#2)(2008-3#1)(2013-8#1)
technique before##3##2##(1996-11#1)(2007-8#1)(2008-3#1)
technique between##2##2##(2008-10#1)(2013-7#1)
technique but##2##2##(1991-5#1)(2007-12#1)
technique by measuring the##4##4##(2007-12#2)(2008-10#1)(2008-3#1)
technique by use of either molecular or aerosol atmospheric backscatter##2##10##(2008-2#2)
technique by use of##3##4##(2008-2#2)(2008-6#1)
technique by which##3##3##(1990-10#1)(1991-12#1)(2007-12#1)
technique by##30##2##(1990-10#1)(1990-12#1)(1991-12#1)(2007-12#10)(2007-7#1)(2008-1#1)(2008-10#4)(2008-2#4)(2008-3#4)(2008-6#1)(2011-2#2)
technique called##13##2##(2007-11#1)(2007-12#3)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)
technique can also be used to##3##6##(2007-12#1)(2008-3#1)(2013-8#1)
technique can also be used##4##5##(2007-12#1)(2008-3#1)(2013-1#1)(2013-8#1)
technique can also be##7##4##(2007-12#2)(2008-3#2)(2008-4#1)(2013-1#1)(2013-8#1)
technique can also##10##3##(2006-7#1)(2007-12#2)(2008-3#3)(2008-4#1)(2009-2#1)(2013-1#1)(2013-8#1)
technique can be adapted to##2##5##(2007-12#1)(2008-3#1)
technique can be applied to##5##5##(1994-3#1)(1996-8#1)(2007-12#1)(2008-2#1)(2012-2#1)
technique can be applied##6##4##(1994-3#1)(1996-8#1)(2007-12#1)(2008-11#1)(2008-2#1)(2012-2#1)
technique can be implemented in##2##5##(2008-3#1)(2010-8#1)
technique can be used for##6##5##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#3)
technique can be used in##2##5##(2007-12#1)(2007-8#1)
technique can be used over a##2##6##(2007-11#1)(2008-3#1)
technique can be used to##6##5##(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)
technique can be used##19##4##(2007-11#2)(2007-12#3)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#5)(2008-5#1)(2008-9#1)(2009-3#1)
technique can be##44##3##(1990-4#1)(1993-2#1)(1994-3#1)(1996-8#1)(2006-10#1)(2006-3#2)(2007-1#1)(2007-11#3)(2007-12#6)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-2#1)
technique can effectively##2##3##(2008-5#1)(2012-3#1)
technique can give##2##3##(2008-10#1)(2008-5#1)
technique can help to##2##4##(2006-10#1)(2013-7#1)
technique can help##3##3##(2006-10#1)(2008-4#1)(2013-7#1)
technique can improve##2##3##(2007-7#1)(2008-3#1)
technique can provide##3##3##(2007-11#1)(2007-12#1)(2008-1#1)
technique can##82##2##(1990-4#1)(1992-10#1)(1993-2#1)(1994-3#1)(1996-8#1)(2006-10#2)(2006-3#2)(2006-7#1)(2007-1#1)(2007-11#6)(2007-12#12)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#5)(2008-3#13)(2008-4#3)(2008-5#4)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
technique capable of##2##3##(2007-11#1)(2010-2#1)
technique combined with a##2##4##(1992-8#1)(2009-9#1)
technique combined with##9##3##(1992-8#1)(1993-9#1)(1994-5#1)(2006-7#1)(2007-7#1)(2008-2#1)(2008-3#2)(2009-9#1)
technique combines the##2##3##(2008-2#1)(2008-7#1)
technique combines##5##2##(2006-5#1)(2007-11#1)(2008-2#1)(2008-7#1)(2009-12#1)
technique combining##3##2##(2006-10#1)(2008-10#1)(2012-2#1)
technique compared with the##3##4##(2006-8#1)(2008-2#1)(2008-3#1)
technique compared with##6##3##(2006-8#1)(2008-2#2)(2008-3#1)(2011-2#2)
technique consisted of##3##3##(2011-2#1)(2012-12#2)
technique consists of##5##3##(1990-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-6#1)
technique could be applied##3##4##(1993-11#1)(2007-11#1)(2008-10#1)
technique could be used##3##4##(2007-8#1)(2010-2#1)(2013-8#1)
technique could be useful for##2##5##(1996-12#1)(2008-10#1)
technique could be useful##3##4##(1996-12#1)(2008-10#1)(2008-3#1)
technique could be##16##3##(1992-8#1)(1993-11#1)(1996-12#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#4)(2010-2#1)(2013-7#1)(2013-8#1)
technique could##27##2##(1992-8#1)(1993-11#1)(1996-12#1)(2007-11#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#6)(2008-5#1)(2008-7#1)(2010-2#1)(2012-2#2)(2013-7#2)(2013-8#1)
technique coupled with##3##3##(2008-10#2)(2008-5#1)
technique coupled##4##2##(1996-9#1)(2008-10#2)(2008-5#1)
technique described by##2##3##(1996-12#1)(2008-10#1)
technique described here is a##2##5##(2008-7#1)(2011-2#1)
technique described here is##3##4##(2007-12#1)(2008-7#1)(2011-2#1)
technique described here##5##3##(2006-3#1)(2007-12#1)(2008-7#1)(2010-4#1)(2011-2#1)
technique described in this unit##2##5##(2008-9#2)
technique described in this##4##4##(2008-10#1)(2008-11#1)(2008-9#2)
technique described in##5##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#2)
technique described##15##2##(1996-12#1)(2005-11#1)(2006-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#2)(2010-4#1)(2011-2#1)(2013-7#1)
technique developed by##2##3##(2008-1#1)(2008-11#1)
technique developed for##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
technique developed in this##2##4##(2008-10#1)(2008-7#1)
technique developed in##4##3##(2007-6#1)(2008-10#1)(2008-5#1)(2008-7#1)
technique developed##14##2##(1995-2#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
technique does not require##2##4##(1996-2#1)(2008-3#1)
technique does not##4##3##(1996-2#1)(2006-6#1)(2008-3#1)(2008-7#1)
technique due to##2##3##(2007-8#1)(2008-10#1)
technique during the##2##3##(2007-8#1)(2008-10#1)
technique during##6##2##(1992-9#1)(2006-8#1)(2007-8#1)(2008-10#2)(2011-2#1)
technique eliminates##2##2##(2006-3#1)(2008-10#1)
technique employed##6##2##(2005-7#1)(2007-7#1)(2008-10#2)(2008-7#1)(2010-4#1)
technique employs##4##2##(2007-12#1)(2008-2#2)(2013-7#1)
technique enables the##2##3##(2008-10#1)(2008-3#1)
technique enables us to##5##4##(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)
technique enables##10##2##(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-3#2)(2009-2#1)(2011-1#1)
technique especially useful##2##3##(1991-12#1)(2007-8#1)
technique facilitates##6##2##(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-12#1)(2013-1#1)
technique failure##3##2##(2011-2#3)
technique following##2##2##(1996-9#1)(2008-10#1)
technique for Doppler lidar wind measurement##2##6##(2008-2#2)
technique for Doppler lidar wind##3##5##(2008-2#2)(2008-3#1)
technique for Doppler##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
technique for a##3##3##(2007-12#2)(2008-3#1)
technique for accurate##2##3##(2007-12#1)(2008-3#1)
technique for acquiring##2##3##(2006-12#1)(2008-3#1)
technique for analysis of##2##4##(2008-10#2)
technique for analyzing##2##3##(2008-2#2)
technique for assessing the##2##4##(1993-12#1)(2008-3#1)
technique for assessing##5##3##(1993-12#2)(2008-10#1)(2008-3#1)(2009-5#1)
technique for calculating the##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
technique for calculating##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2011-2#1)
technique for central venous catheterization##2##5##(2007-7#1)(2012-12#1)
technique for central venous##3##4##(2007-7#2)(2012-12#1)
technique for characterizing the##2##4##(2008-1#1)(2008-3#1)
technique for characterizing##4##3##(2007-12#2)(2008-1#1)(2008-3#1)
technique for clinical##2##3##(1994-3#1)(2013-1#1)
technique for closing##2##3##(2007-8#1)(2012-1#1)
technique for closure##3##3##(2007-8#2)(2011-2#1)
technique for controlling##2##3##(2008-2#1)(2008-5#1)
technique for detecting##8##3##(1995-6#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-8#1)(2012-2#1)
technique for detection of##5##4##(1995-2#1)(2008-10#4)
technique for determination of##2##4##(2008-10#1)(2008-2#1)
technique for determining the##5##4##(2008-2#2)(2008-3#3)
technique for determining##9##3##(1995-10#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-4#1)(2010-3#1)
technique for diagnosis of##3##4##(2006-10#1)(2008-10#1)(2008-2#1)
technique for differentiating##2##3##(2006-10#2)
technique for encoding##2##3##(2008-3#2)
technique for enhancing##2##3##(2008-3#1)(2012-2#1)
technique for environmental##2##3##(1994-9#1)(2008-3#1)
technique for estimating##2##3##(1994-8#1)(2008-3#1)
technique for evaluating##3##3##(1996-6#1)(2008-10#1)(2008-5#1)
technique for extracting the##2##4##(2008-2#1)(2009-2#1)
technique for extracting##3##3##(2008-10#1)(2008-2#1)(2009-2#1)
technique for fabricating##3##3##(2007-11#1)(2008-10#1)(2010-4#1)
technique for fascial closure##3##4##(1991-2#2)(1992-1#1)
technique for fiber##2##3##(2008-3#2)
technique for identification of##2##4##(2008-1#1)(2011-2#1)
technique for identifying##2##3##(1990-8#1)(1997-6#1)
technique for imaging##3##3##(1997-8#1)(2007-10#1)(2007-12#1)
technique for increasing the##2##4##(2007-12#1)(2013-7#1)
technique for increasing##3##3##(2007-12#1)(2008-3#1)(2013-7#1)
technique for investigating##4##3##(1997-7#1)(2007-11#1)(2008-2#1)(2008-7#1)
technique for measurement of the##2##5##(2007-11#2)
technique for measurement of##5##4##(1996-2#1)(2007-11#2)(2008-1#1)(2008-2#1)
technique for measuring small angles##2##5##(2008-2#2)
technique for measuring the##22##4##(1991-5#1)(2007-11#2)(2007-12#3)(2008-1#2)(2008-2#9)(2008-3#4)(2008-5#1)
technique for measuring##41##3##(1991-5#1)(1992-3#1)(2006-8#1)(2007-11#6)(2007-12#4)(2008-1#2)(2008-10#1)(2008-2#14)(2008-3#8)(2008-5#1)(2011-2#1)(2012-12#1)
technique for modeling##2##3##(2008-3#2)
technique for monitoring the##3##4##(2008-10#2)(2008-3#1)
technique for monitoring##6##3##(2007-12#1)(2008-10#3)(2008-3#2)
technique for myocardial##2##3##(1991-3#1)(2013-8#1)
technique for nonlinear##2##3##(2007-12#1)(2008-3#1)
technique for obtaining##2##3##(1994-11#1)(2008-3#1)
technique for optical##2##3##(2006-12#1)(2008-3#1)
technique for percutaneous##4##3##(1992-10#1)(2007-7#1)(2011-2#2)
technique for performing a##2##4##(2008-3#1)(2012-2#1)
technique for performing##11##3##(1994-2#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-5#1)(2008-10#1)(2008-3#2)(2012-2#1)
technique for placement of##2##4##(2007-8#1)(2010-3#1)
technique for preparation of the##2##5##(2007-12#1)(2009-5#1)
technique for producing a##2##4##(2007-11#1)(2008-3#1)
technique for producing##4##3##(2004-9#1)(2007-11#1)(2008-2#1)(2008-3#1)
technique for quantitative##2##3##(2009-5#1)(2013-1#1)
technique for rapid##3##3##(2007-12#1)(2008-10#1)(2012-3#1)
technique for real-time##2##3##(2007-12#1)(2008-10#1)
technique for reconstruction of an##2##5##(2006-3#1)(2010-7#1)
technique for reconstruction of##3##4##(2006-3#1)(2010-7#2)
technique for reducing the##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
technique for removing##2##3##(2007-8#1)(2008-5#1)
technique for retrieving the##2##4##(2007-12#1)(2008-3#1)
technique for routine##5##3##(2008-10#3)(2008-2#1)(2008-9#1)
technique for sample##3##3##(2008-10#2)(2013-1#1)
technique for scatter##2##3##(2008-5#2)
technique for screening##2##3##(1996-2#1)(2008-10#1)
technique for significantly##2##3##(2007-12#1)(2008-2#1)
technique for simultaneous measurement of##2##5##(2007-12#1)(2008-3#1)
technique for simultaneous##5##3##(2007-11#1)(2007-12#2)(2008-3#2)
technique for simultaneously##2##3##(2007-12#1)(2008-3#1)
technique for single##4##3##(2008-2#2)(2009-12#2)
technique for studying the##4##4##(1995-8#1)(2006-5#1)(2007-11#1)(2008-4#1)
technique for studying##7##3##(1995-8#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#2)
technique for suppressing##2##3##(2007-11#1)(2007-12#1)
technique for surgical##2##3##(1990-9#1)(2006-7#1)
technique for testing##3##3##(2007-7#1)(2008-3#1)(2010-1#1)
technique for the accurate##2##4##(2007-5#1)(2008-3#1)
technique for the analysis of##6##5##(2008-10#5)(2008-3#1)
technique for the assay of##4##5##(1990-2#1)(1990-6#1)(1996-3#1)(2008-10#1)
technique for the assessment of##5##5##(1991-12#1)(1997-8#1)(2006-5#1)(2008-4#1)(2008-7#1)
technique for the automatic detection##2##5##(2008-3#2)
technique for the construction of##2##5##(1994-12#1)(2008-2#1)
technique for the design of##2##5##(2007-11#1)(2008-3#1)
technique for the detection of##7##5##(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)
technique for the detection##8##4##(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#3)
technique for the determination of##12##5##(2008-10#8)(2008-11#1)(2009-8#1)(2010-5#1)(2012-1#1)
technique for the direct##5##4##(2007-11#1)(2008-10#2)(2008-2#1)(2008-4#1)
technique for the early detection of##2##6##(1991-6#1)(2007-11#1)
technique for the evaluation of##2##5##(1990-11#1)(2010-11#1)
technique for the fabrication of##2##5##(2007-11#1)(2007-12#1)
technique for the management of##4##5##(2006-8#1)(2008-12#1)(2011-2#2)
technique for the measurement of##4##5##(2007-11#2)(2007-8#1)(2008-3#1)
technique for the quantitative##2##4##(2007-11#1)(2008-10#1)
technique for the rapid##3##4##(1994-3#1)(2010-12#1)(2011-1#1)
technique for the separation of##2##5##(1996-8#1)(2008-10#1)
technique for the simultaneous determination of##2##6##(2008-10#2)
technique for the simultaneous##3##4##(2008-10#3)
technique for the study of##6##5##(1990-10#1)(2008-2#1)(2008-8#1)(2011-2#1)(2013-1#2)
technique for the treatment of##4##5##(1992-10#1)(2006-10#1)(2007-8#1)(2010-12#1)
technique for the##132##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-6#1)(1992-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-3#1)(1996-8#1)(1997-8#1)(2004-9#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-8#2)(2007-11#8)(2007-12#6)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#34)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#9)(2008-4#6)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-5#2)(2010-9#2)(2011-1#3)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#1)
technique for this##2##3##(2008-11#1)(2010-8#1)
technique for treatment of##5##4##(1991-9#2)(2010-12#1)(2011-1#1)(2013-7#1)
technique for use in##2##4##(2007-8#1)(2008-3#1)
technique for visualizing##2##3##(2007-12#1)(2008-3#1)
technique for##706##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-1#1)(1992-10#2)(1992-12#1)(1992-3#1)(1993-12#3)(1993-3#2)(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-8#1)(1994-9#3)(1995-10#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-2#2)(1996-3#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-2#1)(2004-9#2)(2005-10#1)(2005-11#2)(2005-5#1)(2005-7#1)(2006-10#11)(2006-12#4)(2006-2#1)(2006-3#6)(2006-4#5)(2006-5#3)(2006-6#3)(2006-7#3)(2006-8#5)(2007-1#2)(2007-10#1)(2007-11#40)(2007-12#67)(2007-5#2)(2007-7#9)(2007-8#18)(2007-9#1)(2008-1#12)(2008-10#92)(2008-11#13)(2008-12#1)(2008-2#64)(2008-3#96)(2008-4#13)(2008-5#12)(2008-6#4)(2008-7#8)(2008-8#5)(2008-9#8)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#8)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#3)(2010-11#2)(2010-12#5)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#4)(2010-9#4)(2011-1#7)(2011-12#2)(2011-2#16)(2012-1#5)(2012-12#7)(2012-2#7)(2012-3#2)(2012-4#1)(2013-1#12)(2013-7#8)(2013-8#6)
technique from a##3##3##(1995-12#1)(2006-8#1)(2008-11#1)
technique from the##3##3##(1991-5#1)(2008-3#1)(2010-7#1)
technique from##8##2##(1991-1#1)(1991-5#1)(1995-12#1)(2006-8#1)(2008-11#1)(2008-3#1)(2010-7#1)(2012-2#1)
technique gave a##2##3##(2008-10#1)(2008-7#1)
technique gave##6##2##(1990-12#1)(2008-10#4)(2008-7#1)
technique gives##4##2##(2007-11#1)(2007-6#1)(2007-7#1)(2008-1#1)
technique giving##2##2##(2008-10#1)(2008-8#1)
technique had a##4##3##(1993-12#1)(1993-9#1)(2007-8#1)(2012-12#1)
technique had##9##2##(1991-12#1)(1993-12#1)(1993-9#1)(2007-8#2)(2008-3#1)(2011-12#1)(2012-12#2)
technique has a higher##2##4##(2006-5#1)(2007-12#1)
technique has a number of advantages over##2##7##(2008-2#1)(2008-9#1)
technique has a number of##3##5##(2008-2#1)(2008-9#2)
technique has a##7##3##(1992-8#1)(2006-5#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#2)
technique has become##3##3##(2007-2#1)(2007-8#1)(2008-3#1)
technique has been applied to the##2##6##(2008-10#1)(2008-3#1)
technique has been applied to##6##5##(1991-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)
technique has been applied##10##4##(1991-3#1)(1992-8#1)(1996-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)
technique has been developed for the##2##6##(2007-8#1)(2008-10#1)
technique has been developed for##6##5##(2006-4#1)(2006-8#1)(2007-8#1)(2008-10#3)
technique has been developed to##2##5##(1991-10#1)(2008-3#1)
technique has been developed##18##4##(1991-10#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-8#3)(2008-10#7)(2008-2#1)(2008-3#2)(2010-12#1)
technique has been evaluated in##2##5##(1990-12#1)(1992-8#1)
technique has been implemented##2##4##(2007-12#1)(2008-2#1)
technique has been successfully applied for the##2##7##(2007-12#1)(2008-10#1)
technique has been successfully applied to##2##6##(1991-3#1)(2012-12#1)
technique has been successfully applied##4##5##(1991-3#1)(2007-12#1)(2008-10#1)(2012-12#1)
technique has been successfully used##2##5##(2005-4#1)(2006-7#1)
technique has been successfully##6##4##(1991-3#1)(2005-4#1)(2006-7#1)(2007-12#1)(2008-10#1)(2012-12#1)
technique has been used for##2##5##(2007-12#1)(2008-10#1)
technique has been used in##5##5##(1991-11#1)(1995-4#1)(2007-2#1)(2007-9#1)(2009-2#1)
technique has been used to assess the##2##7##(2008-5#2)
technique has been used to study the##2##7##(1994-5#1)(2008-10#1)
technique has been used to##12##5##(1991-7#1)(1994-5#1)(1996-11#1)(2004-2#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-5#2)
technique has been used##20##4##(1991-11#1)(1991-7#1)(1994-5#1)(1995-4#1)(1996-11#1)(2004-2#1)(2005-11#1)(2006-10#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-5#2)(2009-2#1)
technique has been##81##3##(1990-12#1)(1990-4#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-7#1)(1992-8#3)(1994-5#1)(1995-4#1)(1996-11#1)(1996-8#1)(1997-4#1)(2004-2#1)(2005-11#2)(2005-4#1)(2006-10#1)(2006-4#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#8)(2007-2#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-10#17)(2008-2#5)(2008-3#8)(2008-4#1)(2008-5#3)(2009-2#1)(2010-12#1)(2012-12#1)
technique has great##2##3##(2008-1#1)(2008-3#1)
technique has its advantages##2##4##(2007-8#1)(2008-11#1)
technique has its##3##3##(2007-8#1)(2008-11#1)(2008-4#1)
technique has made##2##3##(1991-8#1)(2009-10#1)
technique has potential##2##3##(1993-5#1)(2007-12#1)
technique has provided##2##3##(2006-12#1)(2006-3#1)
technique has resulted in##2##4##(2007-8#1)(2011-2#1)
technique has the potential to##3##5##(2008-1#1)(2008-2#1)(2008-3#1)
technique has the##6##3##(2007-11#1)(2008-1#1)(2008-2#2)(2008-3#1)(2012-2#1)
technique has##138##2##(1990-12#1)(1990-4#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-7#1)(1991-8#1)(1992-8#4)(1993-5#1)(1994-11#1)(1994-5#1)(1995-4#1)(1995-9#1)(1996-11#1)(1996-8#1)(1997-4#1)(2004-2#1)(2005-11#2)(2005-4#1)(2005-5#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#11)(2007-2#2)(2007-7#4)(2007-8#8)(2007-9#1)(2008-1#3)(2008-10#19)(2008-11#2)(2008-2#9)(2008-3#14)(2008-4#4)(2008-5#4)(2008-7#2)(2008-9#2)(2009-10#1)(2009-2#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#1)
technique have##8##2##(1995-2#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-6#1)(2008-8#1)(2010-3#1)
technique improved##2##2##(2008-10#1)(2013-1#1)
technique improves the##2##3##(2008-3#1)(2009-5#1)
technique improves##6##2##(2007-12#2)(2007-7#1)(2008-2#1)(2008-3#1)(2009-5#1)
technique in a##10##3##(1992-12#1)(1993-11#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#1)(2008-3#1)(2013-7#1)
technique in an##5##3##(1993-11#1)(2004-9#1)(2008-2#1)(2008-3#1)(2012-2#1)
technique in both##4##3##(1995-2#1)(2007-12#1)(2008-10#2)
technique in combination with a##2##5##(2008-3#1)(2010-5#1)
technique in combination with the##2##5##(1990-7#1)(1996-7#1)
technique in combination with##5##4##(1990-7#1)(1996-7#1)(2008-3#1)(2008-7#1)(2010-5#1)
technique in evaluating the##2##4##(2008-10#1)(2008-6#1)
technique in image##2##3##(2008-2#1)(2011-7#1)
technique in molecular##2##3##(1997-6#1)(2009-11#1)
technique in order to##2##4##(1992-2#1)(2008-10#1)
technique in our##2##3##(2007-6#1)(2011-2#1)
technique in patients##3##3##(1993-8#1)(2007-9#1)(2013-1#1)
technique in terms of##3##4##(2010-1#1)(2012-3#1)(2013-1#1)
technique in the clinical setting##2##5##(2008-8#1)(2009-9#1)
technique in the clinical##3##4##(2008-6#1)(2008-8#1)(2009-9#1)
technique in the field of##2##5##(2008-3#1)(2013-8#1)
technique in the surgery of arteriovenous malformations of the brain##2##10##(2008-7#2)
technique in the treatment of##3##5##(2007-8#1)(2010-3#1)(2012-3#1)
technique in the##35##3##(1991-3#1)(1993-5#1)(1994-6#1)(1995-5#1)(2006-10#2)(2006-12#1)(2007-12#2)(2007-8#2)(2008-10#1)(2008-2#3)(2008-3#3)(2008-6#1)(2008-7#4)(2008-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
technique in these##2##3##(2008-1#1)(2011-2#1)
technique in treating##2##3##(2010-4#1)(2013-1#1)
technique in two##3##3##(2012-12#2)(2013-8#1)
technique in which a##4##4##(2007-7#1)(2008-2#1)(2008-3#2)
technique in which the##3##4##(2008-3#1)(2009-8#1)(2011-2#1)
technique in which##15##3##(1992-9#1)(1994-2#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-9#1)(2009-7#1)(2009-8#1)(2011-2#1)
technique in##188##2##(1990-7#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#3)(1993-5#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-2#1)(1995-5#2)(1996-1#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-6#1)(2004-3#1)(2004-9#1)(2005-10#1)(2006-10#6)(2006-12#1)(2006-3#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#6)(2007-12#6)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#5)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#11)(2008-3#13)(2008-4#4)(2008-5#1)(2008-6#4)(2008-7#10)(2008-8#2)(2008-9#1)(2009-11#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-2#9)(2011-7#2)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#4)(2013-8#4)
technique include##7##2##(1991-12#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-4#1)(2010-7#1)
technique includes##3##2##(2007-12#1)(2007-8#1)(2008-10#1)
technique including##3##2##(2008-11#1)(2008-4#1)(2009-5#1)
technique into the##2##3##(2007-8#1)(2008-2#1)
technique into##3##2##(2007-8#1)(2008-2#1)(2013-1#1)
technique involved##3##2##(1996-3#1)(2007-12#1)(2012-2#1)
technique involves the elution of a single protein from an immunoaffinity column after prior elution of nonspecifically adsorbed proteins##2##19##(2008-4#2)
technique involves the##3##3##(2008-10#1)(2008-4#2)
technique involves##15##2##(1990-12#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#1)(2011-2#1)
technique involving##3##2##(2009-4#1)(2009-5#1)(2012-2#1)
technique is a powerful##2##4##(2008-3#1)(2008-4#1)
technique is a promising method##2##5##(2008-10#1)(2008-5#1)
technique is a promising##3##4##(2008-10#2)(2008-5#1)
technique is a safe and##2##5##(2007-8#1)(2011-2#1)
technique is a useful##2##4##(2006-10#1)(2006-8#1)
technique is a very##2##4##(2006-9#1)(2008-4#1)
technique is a##23##3##(1992-7#1)(1992-8#1)(2006-10#2)(2006-8#1)(2006-9#1)(2007-7#1)(2007-8#3)(2008-10#3)(2008-3#3)(2008-4#2)(2008-5#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-12#1)
technique is able to##6##4##(2007-11#1)(2007-12#1)(2008-3#1)(2010-6#1)(2012-11#2)
technique is advantageous##2##3##(2008-4#1)(2009-10#1)
technique is also##9##3##(2004-2#1)(2006-3#1)(2007-5#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-6#1)
technique is an alternative to##2##5##(2007-7#1)(2013-1#1)
technique is an##5##3##(2007-7#1)(2008-10#1)(2008-8#1)(2008-9#1)(2013-1#1)
technique is analyzed##3##3##(2007-12#1)(2008-1#1)(2008-2#1)
technique is another##2##3##(1997-3#1)(2007-9#1)
technique is applicable to##6##4##(1995-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#1)
technique is applicable##7##3##(1995-8#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#1)
technique is applied to##10##4##(2006-5#1)(2007-12#4)(2008-2#3)(2008-3#2)
technique is available##2##3##(2007-12#2)
technique is based on a##2##5##(2007-12#1)(2008-6#1)
technique is based on the use of##2##7##(2007-12#1)(2010-5#1)
technique is based on the##17##5##(2007-11#4)(2007-12#4)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2010-5#1)
technique is based on##38##4##(2007-1#1)(2007-11#5)(2007-12#8)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)
technique is based upon##2##4##(2008-5#1)(2008-9#1)
technique is based##41##3##(2007-1#1)(2007-11#5)(2007-12#8)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#2)(2009-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)
technique is being used##2##4##(2008-11#2)
technique is being##3##3##(2008-10#1)(2008-11#2)
technique is capable of##5##4##(1991-12#1)(2007-12#1)(2008-4#1)(2008-9#1)(2011-2#1)
technique is compared with##4##4##(2006-8#1)(2007-12#2)(2008-2#1)
technique is conceptually simple and##2##5##(2007-12#1)(2008-3#1)
technique is demonstrated in a##2##5##(2008-2#1)(2008-3#1)
technique is demonstrated to##2##4##(2007-11#1)(2007-12#1)
technique is demonstrated##12##3##(2007-11#1)(2007-12#4)(2008-2#4)(2008-3#2)(2008-6#1)
technique is derived##2##3##(2008-3#1)(2012-3#1)
technique is described and##2##4##(1992-8#1)(2007-8#1)
technique is described by##2##4##(2006-3#1)(2008-2#1)
technique is described for the##3##5##(1996-8#1)(2008-10#1)(2010-4#1)
technique is described for##8##4##(1996-8#1)(2006-3#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-4#1)
technique is described to##2##4##(2006-8#1)(2008-2#1)
technique is described##22##3##(1990-9#1)(1992-8#1)(1996-8#1)(2006-3#2)(2006-7#1)(2006-8#1)(2007-12#2)(2007-8#2)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#1)(2010-4#1)
technique is developed to##3##4##(1997-4#1)(2008-2#1)(2008-3#1)
technique is developed##7##3##(1997-4#1)(2008-10#1)(2008-2#3)(2008-3#2)
technique is discussed##6##3##(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)
technique is easy to##2##4##(2008-4#1)(2011-2#1)
technique is effective##2##3##(2008-3#1)(2011-2#1)
technique is employed to##3##4##(2006-5#1)(2008-3#1)(2010-4#1)
technique is employed##4##3##(2006-5#1)(2008-10#1)(2008-3#1)(2010-4#1)
technique is essential to##2##4##(2007-11#1)(2008-2#1)
technique is essential##3##3##(1991-9#1)(2007-11#1)(2008-2#1)
technique is examined##2##3##(2008-3#2)
technique is extended##2##3##(1995-6#1)(2008-2#1)
technique is fast and##2##4##(2008-10#1)(2010-4#1)
technique is found to be##2##5##(2007-11#1)(2008-10#1)
technique is found to##3##4##(2007-11#1)(2008-10#1)(2008-2#1)
technique is generally##2##3##(2008-10#1)(2010-7#1)
technique is given##3##3##(2006-4#1)(2006-5#1)(2008-3#1)
technique is highly##3##3##(2008-10#1)(2008-2#1)(2012-2#1)
technique is illustrated with##2##4##(2006-4#1)(2008-3#1)
technique is illustrated##3##3##(2006-4#1)(2008-10#1)(2008-3#1)
technique is introduced for##2##4##(2008-2#1)(2008-3#1)
technique is introduced##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
technique is limited##3##3##(2007-12#1)(2008-3#1)(2008-7#1)
technique is more##2##3##(2008-3#1)(2008-8#1)
technique is not limited to##2##5##(1996-7#1)(2008-2#1)
technique is not##7##3##(1992-6#1)(1996-7#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-2#1)
technique is now##4##3##(1994-5#1)(1997-8#1)(2008-11#2)
technique is of great##2##4##(2007-12#1)(2008-7#1)
technique is of##5##3##(2006-9#1)(2007-12#1)(2008-11#1)(2008-7#1)(2009-8#1)
technique is one##2##3##(1994-12#1)(2008-3#1)
technique is particularly##2##3##(1992-6#1)(2008-4#1)
technique is performed##4##3##(2006-3#1)(2007-8#1)(2008-11#1)(2010-9#1)
technique is presented by which##2##5##(2007-12#1)(2008-3#1)
technique is presented for##6##4##(2007-12#1)(2008-10#1)(2008-2#2)(2008-4#1)(2009-5#1)
technique is presented in##2##4##(2008-2#1)(2008-4#1)
technique is presented to##3##4##(2008-10#1)(2008-2#2)
technique is presented##22##3##(2007-11#1)(2007-12#4)(2008-10#3)(2008-2#7)(2008-3#3)(2008-4#2)(2009-5#1)(2012-11#1)
technique is proposed and##2##4##(2007-12#1)(2008-2#1)
technique is proposed for##6##4##(2007-11#1)(2008-2#2)(2008-3#3)
technique is proposed to##2##4##(2008-3#2)
technique is proposed##20##3##(2006-7#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#10)(2010-2#1)
technique is rapid##3##3##(1994-11#1)(1997-4#1)(2005-11#1)
technique is safe##3##3##(2006-10#1)(2006-6#1)(2007-8#1)
technique is sensitive to small##2##5##(2007-11#1)(2008-2#1)
technique is sensitive to##3##4##(2007-11#1)(2008-2#1)(2011-1#1)
technique is shown to##3##4##(2006-12#1)(2008-2#1)(2013-1#1)
technique is shown##4##3##(2006-12#1)(2008-2#2)(2013-1#1)
technique is simple and##2##4##(2010-5#1)(2010-7#1)
technique is simple##5##3##(2004-10#1)(2008-10#1)(2008-4#1)(2010-5#1)(2010-7#1)
technique is still##3##3##(1997-7#1)(2008-12#1)(2009-6#1)
technique is straightforward##2##3##(2006-3#1)(2007-11#1)
technique is suitable for the determination of##2##7##(2008-10#2)
technique is suitable for##7##4##(2008-10#3)(2008-2#2)(2008-3#2)
technique is superior to##2##4##(2006-10#1)(2007-8#1)
technique is tested##3##3##(2008-2#2)(2008-3#1)
technique is that##5##3##(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#2)
technique is the##7##3##(1995-4#1)(1997-3#1)(1997-6#1)(2008-2#1)(2008-4#1)(2008-6#1)(2013-8#1)
technique is then##2##3##(2005-11#1)(2008-2#1)
technique is to##4##3##(1991-10#1)(1995-4#1)(2007-11#1)(2008-1#1)
technique is used in##3##4##(2008-2#1)(2008-3#2)
technique is used to calculate##2##5##(2008-2#2)
technique is used to measure the##2##6##(2008-3#2)
technique is used to measure##3##5##(2007-12#1)(2008-3#2)
technique is used to##18##4##(2007-12#2)(2008-1#1)(2008-2#4)(2008-3#8)(2008-8#1)(2010-8#1)(2013-7#1)
technique is used##26##3##(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#12)(2008-5#1)(2008-8#1)(2010-8#1)(2013-7#1)
technique is useful for##5##4##(2007-12#1)(2008-2#1)(2008-3#2)(2012-3#1)
technique is useful in##2##4##(2006-3#1)(2007-9#1)
technique is useful##7##3##(2006-3#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-3#2)(2012-3#1)
technique is validated by##3##4##(2007-11#1)(2008-3#1)(2010-7#1)
technique is very##2##3##(2005-4#1)(2010-3#1)
technique is well suited for##2##5##(2007-12#1)(2008-3#1)
technique is##459##2##(1990-12#1)(1990-9#2)(1991-10#2)(1991-12#3)(1991-7#1)(1991-9#1)(1992-12#1)(1992-6#2)(1992-7#2)(1992-8#2)(1994-11#1)(1994-12#1)(1994-5#1)(1995-4#2)(1995-6#1)(1995-8#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-10#1)(2004-2#1)(2005-11#3)(2005-4#2)(2005-9#1)(2006-10#4)(2006-12#1)(2006-3#7)(2006-4#2)(2006-5#4)(2006-6#1)(2006-7#2)(2006-8#3)(2006-9#3)(2007-1#1)(2007-11#20)(2007-12#48)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#11)(2007-9#3)(2008-1#5)(2008-10#38)(2008-11#10)(2008-12#1)(2008-2#64)(2008-3#83)(2008-4#14)(2008-5#5)(2008-6#6)(2008-7#4)(2008-8#6)(2008-9#8)(2009-1#2)(2009-10#2)(2009-2#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#8)(2011-3#1)(2012-1#2)(2012-11#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
technique it was possible to##2##5##(1996-12#1)(2008-5#1)
technique it was##3##3##(1990-8#1)(1996-12#1)(2008-5#1)
technique it##6##2##(1990-8#1)(1992-11#1)(1996-12#1)(2007-12#1)(2008-3#1)(2008-5#1)
technique known as##4##3##(2008-10#1)(2008-2#1)(2008-7#1)(2011-1#1)
technique leads to a##2##4##(2007-12#1)(2008-3#1)
technique leads to significant##2##4##(2009-3#1)(2011-1#1)
technique leads to##5##3##(2007-11#1)(2007-12#1)(2008-3#1)(2009-3#1)(2011-1#1)
technique like##3##2##(2008-10#1)(2009-6#1)(2010-5#1)
technique makes it possible to##3##5##(1996-5#1)(2008-11#1)(2008-2#1)
technique makes use of##2##4##(2007-12#1)(2008-3#1)
technique makes##10##2##(1991-5#1)(1996-5#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-4#1)
technique may be used##4##4##(2006-8#1)(2008-3#1)(2008-7#1)(2010-12#1)
technique may be useful##2##4##(2007-11#1)(2008-10#1)
technique may be##14##3##(1992-2#1)(2006-6#2)(2006-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-7#1)
technique may have##2##3##(2006-10#1)(2006-6#1)
technique may therefore be a##2##5##(1990-10#1)(2012-12#1)
technique may##28##2##(1990-10#1)(1990-12#1)(1992-2#1)(1994-2#1)(1995-1#1)(2006-10#1)(2006-6#3)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#2)(2010-10#1)(2010-12#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-12#1)(2013-7#1)
technique measures##3##2##(2008-2#1)(2008-3#2)
technique might##2##2##(2010-12#1)(2011-12#1)
technique not only##2##3##(2008-11#1)(2008-2#1)
technique not##4##2##(2007-1#1)(2008-10#1)(2008-11#1)(2008-2#1)
technique of &quot##2##3##(1996-4#1)(2007-4#1)
technique of a##5##3##(1992-9#1)(2010-11#1)(2012-12#2)(2013-1#1)
technique of capillary##2##3##(1997-5#1)(2008-10#1)
technique of choice in##4##4##(1995-11#1)(2007-11#2)(2010-2#1)
technique of choice is##2##4##(2005-11#1)(2007-7#1)
technique of choice##15##3##(1991-5#1)(1992-8#1)(1992-9#1)(1995-11#1)(2005-11#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-4#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-2#2)
technique of chromosome microdissection and microcloning##2##6##(2008-7#2)
technique of craniospinal irradiation in the##2##6##(2007-6#2)
technique of craniospinal irradiation##3##4##(2007-6#3)
technique of harvesting##2##3##(2007-8#1)(2013-1#1)
technique of interspecific hybridization##2##4##(2008-9#2)
technique of ion chromatography##2##4##(2007-8#1)(2008-10#1)
technique of laparoscopic##3##3##(1994-2#1)(2006-6#1)(2011-2#1)
technique of molecular##2##3##(2007-12#1)(2008-11#1)
technique of optical##4##3##(2006-12#1)(2007-12#2)(2008-2#1)
technique of photoacoustic##2##3##(2008-2#1)(2008-3#1)
technique of pulsed##2##3##(2008-3#1)(2011-2#1)
technique of radiofrequency##3##3##(2006-12#1)(2006-6#1)(2011-2#1)
technique of reconstruction after pancreaticoduodenectomy##2##5##(2006-6#2)
technique of reconstruction##3##3##(2006-6#2)(2012-2#1)
technique of resternotomy##3##3##(2007-8#3)
technique of retrograde##2##3##(1993-12#1)(2006-12#1)
technique of superficially##2##3##(2007-8#2)
technique of the##17##3##(1990-3#1)(1995-4#1)(1996-10#1)(1996-9#1)(2005-11#1)(2006-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-8#1)(2009-2#1)(2009-8#1)(2012-12#1)
technique of using##3##3##(2006-3#1)(2008-2#1)(2008-3#1)
technique of wound dressing##2##4##(2011-2#2)
technique of##263##2##(1990-10#1)(1990-3#1)(1990-4#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-9#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-11#2)(1995-12#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#2)(2005-11#2)(2005-4#1)(2006-10#5)(2006-12#4)(2006-2#1)(2006-3#6)(2006-4#3)(2006-5#1)(2006-6#4)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#17)(2007-4#1)(2007-5#3)(2007-6#3)(2007-7#5)(2007-8#20)(2007-9#3)(2008-1#3)(2008-10#17)(2008-11#6)(2008-2#16)(2008-3#10)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#3)(2009-10#1)(2009-2#2)(2009-3#1)(2009-8#5)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#4)(2011-12#1)(2011-2#15)(2012-1#1)(2012-12#7)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
technique offered##2##2##(2007-8#1)(2008-7#1)
technique offers a##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-4#1)
technique offers many advantages##2##4##(2007-12#1)(2008-8#1)
technique offers the##2##3##(2007-7#1)(2010-8#1)
technique offers##13##2##(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-8#1)(2013-7#1)
technique on a##2##3##(1997-4#1)(2008-2#1)
technique on the##7##3##(2005-11#1)(2005-12#1)(2008-10#1)(2009-2#1)(2011-12#1)(2012-3#1)(2013-7#1)
technique on##30##2##(1990-6#1)(1991-4#1)(1995-1#1)(1997-4#1)(2005-11#1)(2005-12#1)(2005-4#1)(2006-10#2)(2006-3#1)(2007-11#3)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-3#1)(2010-5#1)(2011-12#1)(2012-3#1)(2013-7#1)
technique onto a##2##3##(2007-11#2)
technique or##10##2##(1990-3#1)(1991-7#1)(1996-2#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-3#2)(2010-9#1)
technique over the##2##3##(1990-6#1)(1991-12#1)
technique parameters##2##2##(2008-10#1)(2010-1#1)
technique particularly##3##2##(1991-5#1)(2008-3#1)(2010-7#1)
technique performed##2##2##(2009-8#1)(2011-2#1)
technique permits the##4##3##(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
technique permits##18##2##(2007-11#3)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#4)(2008-3#3)
technique presented here##3##3##(2008-11#1)(2008-3#1)(2008-6#1)
technique presented is##2##3##(2007-8#1)(2008-5#1)
technique presented##9##2##(2006-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-3#1)
technique presents##4##2##(1991-4#1)(2006-8#1)(2008-11#1)(2008-3#1)
technique previously##2##2##(2007-12#1)(2008-10#1)
technique produced##4##2##(2007-7#1)(2007-9#1)(2008-6#1)(2008-8#1)
technique produces##6##2##(1991-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
technique proposed##6##2##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)
technique proved to be##2##4##(2008-3#1)(2008-5#1)
technique proved##4##2##(1991-12#1)(1991-4#1)(2008-3#1)(2008-5#1)
technique provided##2##2##(2006-6#1)(2007-8#1)
technique provides a##9##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-4#1)
technique provides the##2##3##(2007-10#1)(2011-2#1)
technique provides##23##2##(1990-8#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-5#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
technique ranged from##2##3##(1992-11#1)(2008-10#1)
technique reduces##4##2##(2006-2#1)(2007-8#1)(2011-2#1)(2012-2#1)
technique relaxes the strict##2##4##(2007-12#1)(2008-3#1)
technique relies on a##2##4##(2007-12#1)(2008-2#1)
technique relies on the##4##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
technique relies on##8##3##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)
technique remains##5##2##(2007-8#1)(2008-3#1)(2009-5#1)(2010-12#1)(2011-1#1)
technique represents a##3##3##(1990-2#1)(1991-3#1)(1992-6#1)
technique represents##5##2##(1990-2#1)(1991-3#1)(1992-6#1)(2006-2#1)(2008-6#1)
technique requires no##3##3##(2006-5#1)(2007-11#1)(2008-3#1)
technique requires only##2##3##(1995-9#1)(2008-3#1)
technique requires##12##2##(1995-9#1)(1996-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-3#3)(2009-5#1)(2011-2#2)
technique resulted in##4##3##(2009-2#1)(2011-2#2)(2013-8#1)
technique results##2##2##(2008-10#1)(2010-10#1)
technique revealed a##2##3##(1996-2#1)(2009-2#1)
technique revealed##3##2##(1991-9#1)(1996-2#1)(2009-2#1)
technique reveals##2##2##(1994-9#1)(2012-12#1)
technique seems to be##2##4##(2008-9#1)(2009-2#1)
technique seems##3##2##(1997-3#1)(2008-9#1)(2009-2#1)
technique separates the##2##3##(2007-12#1)(2008-2#1)
technique separates##3##2##(1990-11#1)(2007-12#1)(2008-2#1)
technique should be##6##3##(1990-10#1)(2007-12#1)(2008-2#1)(2009-3#1)(2009-5#1)(2012-2#1)
technique should not be##2##4##(1996-8#1)(2006-12#1)
technique should##13##2##(1990-10#1)(1993-12#1)(1996-8#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-2#1)(2009-3#1)(2009-5#1)(2012-2#1)
technique showed a##2##3##(2007-10#1)(2008-6#1)
technique showed high##2##3##(2007-1#1)(2008-10#1)
technique showed that the##2##4##(2006-10#1)(2008-8#1)
technique showed that##3##3##(2006-10#1)(2008-8#1)(2008-9#1)
technique showed##7##2##(2006-10#1)(2007-1#1)(2007-10#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)
technique shows a##2##3##(2008-2#1)(2012-2#1)
technique shows##7##2##(1991-3#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2012-2#1)
technique significantly reduces the##2##4##(2007-1#1)(2007-12#1)
technique significantly##3##2##(2007-1#1)(2007-12#1)(2008-10#1)
technique simplifies##2##2##(2007-8#1)(2008-10#1)
technique simultaneously##2##2##(2012-2#1)(2013-7#1)
technique since##4##2##(1995-4#1)(2008-4#1)(2009-4#1)(2013-7#1)
technique such as##2##3##(2007-8#1)(2013-1#1)
technique suitable for##3##3##(1990-5#1)(1996-2#1)(2011-2#1)
technique survival in##2##3##(2011-2#2)
technique survival overall and in anuric patients##2##7##(2011-2#2)
technique survival##10##2##(2007-12#2)(2008-1#1)(2011-2#7)
technique takes advantage of the##2##5##(2008-2#1)(2008-4#1)
technique than it is on the##2##6##(1997-6#2)
technique than##3##2##(1997-6#2)(2005-8#1)
technique that allows the##2##4##(2010-6#1)(2012-2#1)
technique that allows##12##3##(1993-12#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-2#2)(2008-3#2)(2009-4#1)(2010-6#1)(2011-2#1)(2012-2#1)
technique that can be used to improve the##2##8##(2007-12#1)(2012-2#1)
technique that can be used to##6##6##(2006-12#1)(2006-7#1)(2007-12#1)(2008-4#1)(2011-1#1)(2012-2#1)
technique that can be used##8##5##(2006-12#1)(2006-7#1)(2007-12#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
technique that can be##9##4##(2006-12#1)(2006-7#1)(2007-12#2)(2008-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
technique that can##11##3##(2006-12#1)(2006-7#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
technique that combines the##2##4##(2008-10#1)(2008-9#1)
technique that combines##5##3##(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)
technique that does not require##2##5##(1995-12#1)(2008-10#1)
technique that enables##4##3##(2008-3#1)(2008-6#1)(2010-9#1)(2012-2#1)
technique that has been##2##4##(2007-12#1)(2008-8#1)
technique that has##12##3##(1997-4#1)(2006-9#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#1)(2011-1#1)
technique that involves##4##3##(1993-8#1)(2007-10#1)(2008-2#1)(2012-2#1)
technique that is able to##3##5##(2007-11#1)(2008-1#1)(2008-2#1)
technique that is used to##2##5##(2008-3#1)(2008-8#1)
technique that is##16##3##(1997-2#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#4)(2008-3#2)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)
technique that may##3##3##(2006-10#1)(2007-12#1)(2011-2#1)
technique that permits the##3##4##(2008-3#2)(2009-4#1)
technique that permits##7##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)(2009-4#1)
technique that produces##2##3##(1996-3#1)(2008-1#1)
technique that provides##5##3##(2006-5#1)(2008-2#1)(2008-3#2)(2010-9#1)
technique that quantifies##2##3##(2006-10#1)(2007-11#1)
technique that uses a##4##4##(1993-11#1)(2007-11#2)(2007-12#1)
technique that uses##20##3##(1993-11#1)(2007-11#3)(2007-12#4)(2008-1#1)(2008-2#2)(2008-3#5)(2008-5#2)(2009-10#1)(2011-2#1)
technique that was##2##3##(2006-10#1)(2008-5#1)
technique that we##2##3##(2008-2#1)(2008-3#1)
technique that##155##2##(1990-4#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-7#1)(1993-8#1)(1994-3#1)(1995-12#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-10#5)(2006-12#1)(2006-3#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#9)(2007-12#16)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#7)(2008-11#2)(2008-2#15)(2008-3#26)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-4#2)(2009-9#1)(2010-11#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#6)(2012-3#1)
technique the##14##2##(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)(2010-7#2)(2012-2#1)(2013-1#1)
technique through##4##2##(2007-12#1)(2007-7#1)(2008-4#1)(2009-6#1)
technique to a##6##3##(1990-5#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)
technique to analyze##5##3##(2008-10#2)(2008-2#1)(2008-4#1)(2012-1#1)
technique to assess the##4##4##(2008-4#1)(2008-5#1)(2011-1#1)(2012-3#1)
technique to assess##5##3##(2008-10#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-3#1)
technique to be##2##3##(1996-8#1)(2007-9#1)
technique to calculate the##2##4##(2007-12#1)(2008-5#1)
technique to characterize##6##3##(2007-12#3)(2008-1#1)(2008-10#1)(2010-4#1)
technique to control##2##3##(1997-4#1)(2009-9#1)
technique to create##2##3##(2006-8#1)(2007-12#1)
technique to demonstrate##2##3##(1991-1#1)(2008-5#1)
technique to detect##8##3##(1992-4#1)(1992-8#1)(1994-10#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2012-12#1)
technique to determine the##5##4##(1995-3#1)(2008-1#1)(2008-2#2)(2008-3#1)
technique to determine##11##3##(1992-6#1)(1993-9#1)(1995-3#1)(2004-1#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2011-2#1)
technique to develop##2##3##(2009-11#1)(2010-2#1)
technique to diagnose##2##3##(2007-12#1)(2008-5#1)
technique to evaluate the##3##4##(1997-6#1)(1997-8#1)(2006-10#1)
technique to evaluate##4##3##(1997-6#1)(1997-8#1)(2006-10#1)(2011-1#1)
technique to examine the##2##4##(2008-3#2)
technique to examine##4##3##(2007-12#1)(2008-3#2)(2008-9#1)
technique to frequency lock##2##4##(2007-12#2)
technique to have##2##3##(2006-6#1)(2007-12#1)
technique to image##2##3##(2011-1#2)
technique to improve the##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
technique to improve##7##3##(2007-12#2)(2007-8#1)(2008-2#1)(2008-3#1)(2008-6#1)(2011-2#1)
technique to increase##2##3##(2007-12#1)(2008-2#1)
technique to investigate the##4##4##(2005-11#1)(2008-2#1)(2010-9#1)(2011-3#1)
technique to investigate##6##3##(1994-8#1)(2005-11#1)(2008-2#1)(2009-11#1)(2010-9#1)(2011-3#1)
technique to isolate##3##3##(1990-12#1)(1991-5#1)(1997-7#1)
technique to make##3##3##(2007-12#2)(2010-8#1)
technique to measure simultaneously##2##4##(2007-12#1)(2008-3#1)
technique to measure the thermal##2##5##(2008-3#2)
technique to measure the##9##4##(2005-11#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#2)
technique to measure##21##3##(2005-11#1)(2007-11#2)(2007-12#6)(2008-1#1)(2008-2#3)(2008-3#7)(2008-6#1)
technique to model##3##3##(2008-3#1)(2013-1#2)
technique to monitor##2##3##(1991-8#1)(2008-3#1)
technique to obtain##3##3##(2007-2#1)(2008-2#1)(2013-1#1)
technique to perform##2##3##(1991-2#1)(2008-10#1)
technique to quantify the##2##4##(2008-10#1)(2010-8#1)
technique to reduce the##5##4##(2007-11#1)(2007-8#1)(2008-2#2)(2008-3#1)
technique to reveal##2##3##(2006-6#1)(2008-10#1)
technique to select##2##3##(1997-4#1)(2008-10#1)
technique to study the##2##4##(2005-12#1)(2008-8#1)
technique to study##7##3##(1996-4#1)(2005-12#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-8#1)
technique to the##18##3##(1990-3#1)(1993-12#1)(1995-2#1)(1996-2#1)(1996-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-7#1)(2010-5#1)(2011-1#1)(2011-12#1)(2013-1#1)
technique to three-dimensional##2##3##(2007-12#1)(2008-3#1)
technique to understand##2##3##(2008-11#1)(2013-8#1)
technique to##264##2##(1990-12#1)(1990-3#2)(1990-5#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-3#1)(1996-2#1)(1996-4#2)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#2)(2004-1#1)(2005-11#3)(2005-12#1)(2006-10#2)(2006-2#1)(2006-3#2)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#6)(2007-12#28)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#8)(2007-9#1)(2008-1#3)(2008-10#23)(2008-11#7)(2008-2#24)(2008-3#33)(2008-4#5)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#3)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-9#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#3)(2010-8#3)(2010-9#3)(2011-1#8)(2011-12#2)(2011-2#2)(2011-3#1)(2012-1#3)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
technique under##5##2##(1993-2#1)(1997-1#1)(2007-11#1)(2007-8#1)(2010-3#1)
technique used at##2##3##(1991-2#1)(2006-3#1)
technique used by the authors##2##5##(2006-2#1)(2007-9#1)
technique used by##4##3##(1990-9#1)(2006-2#1)(2007-9#1)(2012-2#1)
technique used for the##2##4##(1992-7#1)(2008-3#1)
technique used for##7##3##(1992-7#1)(1995-3#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-12#1)
technique used in##4##3##(2007-12#1)(2008-4#1)(2012-2#1)(2013-1#1)
technique used is##3##3##(2008-2#2)(2008-3#1)
technique used to treat##2##4##(2008-8#2)
technique used to##16##3##(1990-8#1)(1994-12#1)(2008-10#3)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2011-1#1)
technique used##48##2##(1990-8#1)(1990-9#1)(1991-2#1)(1991-4#1)(1992-7#1)(1994-12#1)(1995-3#1)(1995-8#1)(1997-5#1)(2006-2#1)(2006-3#1)(2006-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2011-1#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#2)
technique uses a##10##3##(2007-12#5)(2008-2#1)(2008-3#3)(2012-1#1)
technique uses the##2##3##(2007-7#1)(2008-2#1)
technique uses two##2##3##(1993-5#1)(2008-3#1)
technique uses##23##2##(1993-5#1)(2007-12#7)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#8)(2012-1#1)
technique using a##10##3##(1992-12#1)(1993-4#1)(1997-3#1)(2008-10#2)(2011-2#2)(2012-12#2)(2012-3#1)
technique using an##4##3##(1992-12#1)(1996-12#1)(2007-11#1)(2009-5#1)
technique using the##5##3##(1990-8#1)(1991-10#1)(1991-12#1)(1994-9#1)(2008-8#1)
technique using##54##2##(1990-8#1)(1991-10#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-12#2)(1993-4#1)(1993-7#1)(1994-3#1)(1994-9#1)(1995-10#1)(1996-11#1)(1996-12#1)(1997-3#1)(2004-1#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-8#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#1)
technique utilized here##2##3##(2007-11#1)(2008-10#1)
technique utilized##4##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)
technique utilizes the##2##3##(2008-10#1)(2008-5#1)
technique utilizes##6##2##(1991-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)
technique utilizing a##2##3##(1996-4#1)(2008-2#1)
technique versus##2##2##(2007-8#1)(2009-5#1)
technique very##2##2##(2008-6#1)(2010-10#1)
technique was 100%##2##3##(1991-2#1)(2008-8#1)
technique was also used to##3##5##(2008-10#1)(2008-3#1)(2009-9#1)
technique was also##7##3##(2006-10#1)(2008-10#2)(2008-3#1)(2009-9#1)(2013-1#2)
technique was applied for the##2##5##(2007-11#1)(2008-10#1)
technique was applied for##4##4##(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)
technique was applied in##3##4##(2006-9#1)(2008-10#1)(2008-3#1)
technique was applied to a##4##5##(1990-5#1)(2006-5#1)(2008-10#1)(2008-2#1)
technique was applied to the##3##5##(2008-10#3)
technique was applied to##18##4##(1990-5#1)(1993-2#2)(2005-11#1)(2006-5#1)(2007-12#2)(2008-10#6)(2008-2#1)(2008-3#3)(2010-3#1)
technique was applied##27##3##(1990-5#1)(1993-2#2)(2005-11#1)(2006-3#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#8)(2008-2#2)(2008-3#4)(2010-3#1)(2013-1#1)
technique was combined with##2##4##(1994-12#1)(2008-10#1)
technique was confirmed##2##3##(2008-10#2)
technique was demonstrated##2##3##(2007-12#1)(2010-7#1)
technique was described##2##3##(2008-10#1)(2012-3#1)
technique was developed for##2##4##(2008-10#2)
technique was developed to localize##2##5##(2008-10#2)
technique was developed to produce##2##5##(2008-10#1)(2009-5#1)
technique was developed to##10##4##(1995-12#1)(1997-4#1)(2007-12#1)(2008-10#5)(2008-11#1)(2009-5#1)
technique was developed##18##3##(1995-12#1)(1996-3#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-5#1)(2009-5#1)
technique was effective##2##3##(2007-11#1)(2011-2#1)
technique was employed to##7##4##(2005-12#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-12#1)
technique was employed##12##3##(1990-12#1)(1996-9#1)(1997-3#1)(2005-12#1)(2006-8#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-3#1)(2009-12#1)(2011-12#1)
technique was evaluated##2##3##(2008-10#2)
technique was examined##3##3##(2008-10#3)
technique was first##3##3##(2006-10#1)(2008-10#1)(2012-1#1)
technique was found to be##4##5##(2008-10#2)(2008-2#1)(2008-3#1)
technique was found to##5##4##(2008-10#2)(2008-2#1)(2008-3#1)(2011-1#1)
technique was found##7##3##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-3#1)(2011-1#1)
technique was investigated##2##3##(2008-10#1)(2013-8#1)
technique was modified##2##3##(1997-6#1)(1997-8#1)
technique was performed in##3##4##(1991-5#1)(2007-11#2)
technique was performed on##2##4##(2008-10#1)(2008-7#1)
technique was performed##11##3##(1991-5#1)(1997-5#1)(2007-11#2)(2007-8#2)(2008-10#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#1)
technique was shown to be##2##5##(2005-11#1)(2008-5#1)
technique was successfully applied##2##4##(2008-10#2)
technique was tested##2##3##(1993-12#1)(2007-8#1)
technique was used and the##2##5##(2008-10#2)
technique was used for the##2##5##(1996-2#1)(2008-10#1)
technique was used for##9##4##(1994-11#1)(1996-2#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2013-1#1)
technique was used in##5##4##(1996-11#1)(1997-6#1)(2006-5#1)(2007-10#1)(2008-5#1)
technique was used on##2##4##(2007-9#1)(2008-10#1)
technique was used to compute##2##5##(2007-2#1)(2008-3#1)
technique was used to determine##5##5##(1990-2#1)(2007-5#2)(2008-10#1)(2008-2#1)
technique was used to investigate the effect of##2##8##(1994-3#1)(1996-3#1)
technique was used to investigate the##5##6##(1990-11#1)(1991-2#1)(1994-3#1)(1995-12#1)(1996-3#1)
technique was used to investigate##6##5##(1990-11#1)(1991-2#1)(1994-3#1)(1995-12#1)(1996-3#1)(2008-2#1)
technique was used to measure the##3##6##(1990-2#1)(1997-8#1)(2008-3#1)
technique was used to measure##4##5##(1990-12#1)(1990-2#1)(1997-8#1)(2008-3#1)
technique was used to observe##2##5##(1991-9#1)(2007-10#1)
technique was used to select##2##5##(2008-10#1)(2012-12#1)
technique was used to study##3##5##(1990-12#1)(1992-11#1)(2005-11#1)
technique was used to##44##4##(1990-11#1)(1990-12#2)(1990-2#2)(1991-2#1)(1991-9#1)(1992-11#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-3#1)(1995-12#1)(1996-3#1)(1997-1#1)(1997-8#1)(2005-11#2)(2006-12#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#2)(2008-10#5)(2008-2#2)(2008-3#2)(2008-8#1)(2010-10#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)
technique was used with##2##4##(2007-9#1)(2008-5#1)
technique was used##73##3##(1990-11#1)(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-2#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-3#1)(1995-12#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-6#1)(1997-8#1)(2005-11#2)(2006-12#1)(2006-5#1)(2007-10#4)(2007-11#3)(2007-12#1)(2007-2#1)(2007-5#2)(2007-7#1)(2007-9#2)(2008-10#13)(2008-2#4)(2008-3#4)(2008-5#2)(2008-8#1)(2010-10#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
technique was utilized to reconstruct##2##5##(2007-12#1)(2012-1#1)
technique was utilized to##3##4##(1996-1#1)(2007-12#1)(2012-1#1)
technique was verified by##2##4##(1991-5#1)(2008-3#1)
technique was##245##2##(1990-11#1)(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#2)(1991-2#2)(1991-5#3)(1991-9#1)(1992-11#2)(1992-2#1)(1992-8#2)(1993-10#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-6#1)(1993-7#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-12#2)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#2)(2004-2#1)(2005-11#5)(2005-12#1)(2006-10#3)(2006-12#1)(2006-3#2)(2006-5#3)(2006-8#2)(2006-9#1)(2007-10#4)(2007-11#11)(2007-12#8)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#7)(2007-9#2)(2008-10#60)(2008-11#3)(2008-2#12)(2008-3#16)(2008-5#5)(2008-7#2)(2008-8#4)(2009-12#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
technique we have##3##3##(1991-1#1)(1991-5#1)(2008-2#1)
technique we##9##2##(1991-1#1)(1991-5#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-5#1)(2012-3#1)
technique were compared with##2##4##(2008-10#1)(2012-12#1)
technique were compared##3##3##(2008-10#2)(2012-12#1)
technique were developed##2##3##(2007-2#1)(2008-10#1)
technique were used##2##3##(2007-8#1)(2008-10#1)
technique were##29##2##(1994-12#1)(1996-2#1)(2005-11#1)(2006-5#1)(2006-8#1)(2007-2#1)(2007-8#2)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
technique when##4##2##(1997-6#1)(2007-8#1)(2008-2#1)(2008-3#1)
technique where##3##2##(1990-4#1)(2008-10#1)(2009-2#1)
technique which allows##4##3##(1993-11#1)(1994-6#1)(2006-2#1)(2007-11#1)
technique which can be##2##4##(1993-9#1)(1996-3#1)
technique which can##3##3##(1993-9#1)(1996-3#1)(2008-10#1)
technique which is thought##2##4##(2008-5#1)(2010-8#1)
technique which is##5##3##(1994-6#1)(1996-2#1)(1996-9#1)(2008-5#1)(2010-8#1)
technique which may##2##3##(2006-6#1)(2013-1#1)
technique which utilizes the##2##4##(2008-10#1)(2008-6#1)
technique which was##2##3##(2008-5#1)(2008-9#1)
technique which##34##2##(1991-2#1)(1991-5#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-6#2)(1995-7#1)(1996-2#1)(1996-3#1)(1996-9#1)(2005-11#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#2)(2013-1#3)
technique will be discussed##2##4##(2007-11#1)(2009-10#1)
technique will be##7##3##(1992-12#1)(1992-3#1)(2007-11#1)(2007-12#1)(2009-10#1)(2009-2#1)(2011-1#1)
technique will become##2##3##(2008-2#1)(2012-2#1)
technique will##18##2##(1992-12#1)(1992-3#1)(1993-5#1)(2005-11#1)(2006-6#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-7#2)(2009-10#1)(2009-2#1)(2011-1#1)(2012-2#2)
technique with a pulsed##2##4##(2007-12#1)(2008-3#1)
technique with a##19##3##(1991-12#1)(1997-4#1)(2007-12#4)(2008-10#2)(2008-2#1)(2008-3#5)(2008-5#2)(2011-2#3)
technique with an##8##3##(1993-12#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-3#2)(2010-3#1)
technique with high##2##3##(2007-12#1)(2008-2#1)
technique with many##2##3##(1994-3#1)(2008-2#1)
technique with the##10##3##(1995-8#1)(1997-1#1)(2006-10#1)(2006-3#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2012-12#1)
technique with##113##2##(1990-5#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-7#1)(1992-3#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#3)(1995-8#1)(1996-3#1)(1997-1#1)(1997-4#1)(2004-9#1)(2005-11#1)(2006-10#3)(2006-2#1)(2006-3#3)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#10)(2007-5#1)(2007-8#3)(2007-9#1)(2008-10#19)(2008-11#1)(2008-2#8)(2008-3#8)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2009-5#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#2)
technique without the##2##3##(2007-8#1)(2013-1#1)
technique without##7##2##(1996-6#1)(2007-11#1)(2007-8#2)(2008-7#1)(2011-1#1)(2013-1#1)
technique would##2##2##(2008-10#1)(2008-3#1)
technique yields##6##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
technique##5631##1##(1990-10#9)(1990-11#7)(1990-12#18)(1990-2#7)(1990-3#8)(1990-4#12)(1990-5#11)(1990-6#5)(1990-7#5)(1990-8#11)(1990-9#11)(1991-1#6)(1991-10#9)(1991-11#4)(1991-12#23)(1991-2#15)(1991-3#14)(1991-4#10)(1991-5#16)(1991-6#9)(1991-7#8)(1991-8#3)(1991-9#8)(1992-1#4)(1992-10#4)(1992-11#10)(1992-12#8)(1992-2#9)(1992-3#5)(1992-4#3)(1992-5#5)(1992-6#11)(1992-7#6)(1992-8#17)(1992-9#8)(1993-1#1)(1993-10#6)(1993-11#8)(1993-12#24)(1993-2#10)(1993-3#9)(1993-4#3)(1993-5#5)(1993-6#2)(1993-7#5)(1993-8#5)(1993-9#9)(1994-1#3)(1994-10#1)(1994-11#8)(1994-12#11)(1994-2#10)(1994-3#11)(1994-4#3)(1994-5#9)(1994-6#5)(1994-7#3)(1994-8#7)(1994-9#15)(1995-1#5)(1995-10#3)(1995-11#6)(1995-12#13)(1995-2#11)(1995-3#4)(1995-4#8)(1995-5#7)(1995-6#3)(1995-7#5)(1995-8#7)(1995-9#6)(1996-1#4)(1996-10#3)(1996-11#4)(1996-12#15)(1996-2#21)(1996-3#11)(1996-4#5)(1996-5#12)(1996-6#10)(1996-7#3)(1996-8#13)(1996-9#8)(1997-1#10)(1997-2#8)(1997-3#17)(1997-4#20)(1997-5#6)(1997-6#18)(1997-7#6)(1997-8#11)(2004-1#3)(2004-10#1)(2004-11#2)(2004-2#7)(2004-3#1)(2004-9#8)(2005-1#1)(2005-10#5)(2005-11#46)(2005-12#6)(2005-4#12)(2005-5#2)(2005-7#6)(2005-8#3)(2005-9#3)(2006-10#86)(2006-11#2)(2006-12#27)(2006-2#16)(2006-3#50)(2006-4#18)(2006-5#28)(2006-6#36)(2006-7#26)(2006-8#31)(2006-9#11)(2007-1#16)(2007-10#20)(2007-11#204)(2007-12#440)(2007-2#15)(2007-3#1)(2007-4#4)(2007-5#15)(2007-6#12)(2007-7#81)(2007-8#184)(2007-9#29)(2008-1#64)(2008-10#700)(2008-11#97)(2008-12#25)(2008-2#432)(2008-3#609)(2008-4#89)(2008-5#107)(2008-6#45)(2008-7#92)(2008-8#65)(2008-9#62)(2009-1#4)(2009-10#15)(2009-11#12)(2009-12#11)(2009-2#22)(2009-3#13)(2009-4#17)(2009-5#36)(2009-6#7)(2009-7#8)(2009-8#18)(2009-9#12)(2010-1#12)(2010-10#6)(2010-11#8)(2010-12#41)(2010-2#18)(2010-3#14)(2010-4#21)(2010-5#17)(2010-6#8)(2010-7#31)(2010-8#20)(2010-9#11)(2011-1#53)(2011-12#12)(2011-2#156)(2011-3#4)(2011-7#5)(2012-1#27)(2012-11#6)(2012-12#67)(2012-2#82)(2012-3#29)(2012-4#1)(2012-5#1)(2013-1#107)(2013-7#39)(2013-8#40)
technique&quot##4##1##(1990-8#1)(1997-3#1)(2008-8#2)
technique's##6##1##(1997-7#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-3#1)
technique) and##2##2##(1991-4#1)(2013-8#1)
technique) for##2##2##(2007-7#1)(2007-9#1)
technique)##23##1##(1990-3#1)(1990-5#1)(1991-12#1)(1991-4#3)(1996-1#1)(1997-8#1)(2005-11#1)(2006-10#3)(2007-7#2)(2007-9#1)(2008-10#2)(2008-2#1)(2011-1#1)(2011-12#1)(2012-12#1)(2013-8#2)
technique--an##2##1##(1992-1#1)(2009-7#1)
technique?]##3##1##(1991-2#1)(1995-9#1)(2007-6#1)
technique]##13##1##(1990-9#1)(1991-10#1)(1991-2#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-10#1)(1993-6#1)(1993-9#1)(2005-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
techniques (e##2##2##(1997-7#1)(2011-2#1)
techniques (i##3##2##(1996-7#1)(2008-10#1)(2010-5#1)
techniques -##4##2##(2008-10#2)(2010-11#1)(2012-2#1)
techniques a##2##2##(2008-10#2)
techniques adopted##3##2##(1991-9#1)(2008-10#1)(2010-7#1)
techniques allow for##2##3##(2007-10#1)(2013-1#1)
techniques allow##14##2##(1992-10#1)(2006-10#2)(2006-3#1)(2007-10#1)(2007-6#1)(2007-8#1)(2008-2#1)(2008-6#1)(2009-4#1)(2009-8#1)(2011-12#1)(2013-1#1)(2013-8#1)
techniques allowed##2##2##(2006-3#1)(2008-10#1)
techniques allowing the##2##3##(1994-6#1)(2004-9#1)
techniques allowing##3##2##(1994-6#1)(2004-9#1)(2008-11#1)
techniques allows##2##2##(1991-9#1)(2007-8#1)
techniques also##4##2##(1997-5#1)(2008-1#1)(2008-11#1)(2009-10#1)
techniques and X-ray##2##3##(2007-11#1)(2008-10#1)
techniques and a##6##3##(1994-2#1)(2005-9#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-9#1)
techniques and an##2##3##(2008-10#2)
techniques and applications##2##3##(1991-9#1)(2010-11#1)
techniques and approaches##4##3##(1994-6#1)(2012-2#1)(2013-1#2)
techniques and by##2##3##(1994-3#1)(2006-12#1)
techniques and image##2##3##(2006-11#1)(2007-1#1)
techniques and in##2##3##(2008-10#1)(2011-2#1)
techniques and instrumentation##3##3##(2008-10#2)(2008-8#1)
techniques and is##3##3##(2008-1#1)(2008-3#1)(2010-7#1)
techniques and it##2##3##(2008-10#1)(2011-1#1)
techniques and mass spectrometry##2##4##(2008-7#1)(2013-1#1)
techniques and mass##3##3##(2007-10#1)(2008-7#1)(2013-1#1)
techniques and materials##2##3##(2006-12#1)(2012-12#1)
techniques and medical##2##3##(2005-7#1)(2011-3#1)
techniques and methodologies used##2##4##(2008-10#1)(2008-11#1)
techniques and methods##2##3##(2007-8#1)(2008-10#1)
techniques and other##2##3##(1991-3#1)(2008-7#1)
techniques and outcomes##4##3##(2007-1#1)(2008-9#1)(2009-10#1)(2013-8#1)
techniques and procedures##2##3##(1992-7#1)(2006-4#1)
techniques and standard##3##3##(2007-12#1)(2008-10#1)(2010-9#1)
techniques and technologies##2##3##(2006-9#1)(2008-7#1)
techniques and technology##2##3##(2009-4#1)(2011-1#1)
techniques and that##2##3##(2008-7#1)(2011-2#1)
techniques and the development of##2##5##(1994-5#1)(2008-10#1)
techniques and the use of##2##5##(2006-10#1)(2013-8#1)
techniques and the##21##3##(1994-5#1)(2006-10#4)(2006-12#1)(2006-3#2)(2007-11#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-6#1)(2010-11#1)(2010-3#1)(2010-5#1)(2013-8#2)
techniques and their##3##3##(1995-3#1)(2011-12#1)(2011-2#1)
techniques and these##2##3##(2008-10#1)(2013-8#1)
techniques and to##2##3##(2006-10#1)(2010-5#1)
techniques and were##2##3##(2008-11#1)(2012-3#1)
techniques and##234##2##(1990-12#2)(1991-10#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-12#2)(1992-3#2)(1992-7#1)(1992-8#2)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-1#2)(1995-11#1)(1995-3#2)(1995-5#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(2004-12#1)(2004-2#1)(2005-11#2)(2005-7#1)(2005-9#2)(2006-10#12)(2006-11#1)(2006-12#3)(2006-2#2)(2006-3#2)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#6)(2007-12#7)(2007-3#1)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#29)(2008-11#4)(2008-2#4)(2008-3#11)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#7)(2009-10#4)(2009-2#2)(2009-4#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#5)(2010-3#1)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#8)(2011-3#1)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#5)
techniques appear to##2##3##(2004-12#1)(2006-10#1)
techniques appeared to be##2##4##(1996-12#1)(2008-10#1)
techniques applied by##2##3##(2008-10#1)(2010-12#1)
techniques applied in##3##3##(2007-8#1)(2013-1#2)
techniques applied to##2##3##(1993-12#1)(2013-1#1)
techniques applied##8##2##(1993-12#1)(2007-8#1)(2008-10#2)(2010-12#1)(2013-1#3)
techniques are able to##2##4##(2009-10#1)(2009-4#1)
techniques are adapted##2##3##(2008-10#1)(2008-9#1)
techniques are also discussed##2##4##(2008-10#1)(2008-4#1)
techniques are also##6##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-11#1)(2013-1#1)
techniques are applied to##4##4##(2006-8#1)(2008-2#2)(2008-9#1)
techniques are applied##5##3##(2006-8#1)(2008-2#2)(2008-9#1)(2009-7#1)
techniques are available for the##2##5##(1997-6#1)(2008-7#1)
techniques are available for##4##4##(1991-9#1)(1997-6#1)(2006-2#1)(2008-7#1)
techniques are available to##3##4##(2005-9#1)(2008-11#1)(2013-8#1)
techniques are available##11##3##(1991-9#1)(1997-6#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-2#1)(2008-11#2)(2008-7#2)(2013-8#1)
techniques are based on##2##4##(1996-9#1)(2010-8#1)
techniques are becoming##2##3##(2006-10#1)(2007-1#1)
techniques are beginning to##2##4##(2010-2#1)(2011-2#1)
techniques are being developed to##2##5##(2005-8#1)(2013-1#1)
techniques are being developed##3##4##(1994-12#1)(2005-8#1)(2013-1#1)
techniques are being used##2##4##(2006-10#1)(2010-8#1)
techniques are being##7##3##(1994-12#1)(2005-8#1)(2006-10#1)(2009-3#1)(2009-4#1)(2010-8#1)(2013-1#1)
techniques are commonly used in the##2##6##(1997-8#1)(2008-4#1)
techniques are compared##3##3##(1992-2#1)(2008-10#1)(2008-2#1)
techniques are computationally##2##3##(2008-6#1)(2008-7#1)
techniques are currently used##2##4##(2008-1#1)(2010-1#1)
techniques are currently##3##3##(2007-11#1)(2008-1#1)(2010-1#1)
techniques are described and##2##4##(2006-10#1)(2010-12#1)
techniques are described in##2##4##(2008-3#1)(2008-4#1)
techniques are described##8##3##(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-10#1)(2010-12#1)
techniques are discussed in##3##4##(2006-2#1)(2006-8#1)(2008-10#1)
techniques are discussed##13##3##(1990-8#1)(2006-12#1)(2006-2#1)(2006-8#1)(2008-10#4)(2008-3#2)(2008-8#1)(2010-9#1)(2011-2#1)
techniques are employed to##2##4##(1994-2#1)(2008-10#1)
techniques are employed##4##3##(1994-2#1)(1994-9#1)(2007-11#1)(2008-10#1)
techniques are essential in##2##4##(2010-12#1)(2010-9#1)
techniques are feasible##2##3##(2008-3#1)(2009-2#1)
techniques are more##2##3##(2008-10#1)(2009-9#1)
techniques are needed##2##3##(1994-3#1)(2010-7#1)
techniques are not##11##3##(1990-5#1)(1994-12#1)(1995-1#1)(1995-8#1)(2006-12#1)(2006-7#1)(2008-2#1)(2008-7#1)(2009-9#1)(2010-11#1)(2013-1#1)
techniques are of##2##3##(1991-2#1)(2007-12#1)
techniques are often##3##3##(2008-11#1)(2008-7#1)(2010-11#1)
techniques are particularly##2##3##(2006-12#1)(2008-10#1)
techniques are presented to##2##4##(2008-10#1)(2008-2#1)
techniques are presented##8##3##(2007-11#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2012-2#1)
techniques are revolutionizing##2##3##(1992-8#1)(2006-10#1)
techniques are the##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
techniques are then##2##3##(2008-3#1)(2008-7#1)
techniques are used for##2##4##(2008-2#1)(2010-3#1)
techniques are used in##2##4##(2008-2#1)(2009-4#1)
techniques are used to enhance the##2##6##(2008-3#1)(2009-10#1)
techniques are used to##9##4##(1990-8#1)(2007-12#2)(2007-7#1)(2008-3#2)(2009-10#1)(2013-1#2)
techniques are used##19##3##(1990-8#1)(2007-12#3)(2007-7#1)(2008-2#2)(2008-3#4)(2009-10#1)(2009-4#1)(2010-12#1)(2010-3#1)(2011-1#1)(2013-1#3)
techniques are useful in##3##4##(2008-10#1)(2008-2#1)(2010-4#1)
techniques are useful##4##3##(2008-10#1)(2008-2#2)(2010-4#1)
techniques are very##6##3##(1990-12#1)(1991-3#1)(2008-10#2)(2008-9#2)
techniques are##214##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#2)(1991-2#1)(1991-3#1)(1991-9#1)(1992-2#1)(1992-6#1)(1992-8#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-5#1)(1996-9#3)(1997-6#3)(1997-8#1)(2004-2#1)(2005-10#1)(2005-11#1)(2005-8#2)(2005-9#2)(2006-10#9)(2006-11#1)(2006-12#3)(2006-2#3)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#4)(2007-12#10)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#4)(2008-10#24)(2008-11#5)(2008-2#12)(2008-3#22)(2008-4#9)(2008-5#1)(2008-6#3)(2008-7#7)(2008-8#1)(2008-9#6)(2009-10#3)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-7#1)(2009-9#2)(2010-1#1)(2010-11#4)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#8)(2013-8#1)
techniques as a##5##3##(2007-10#1)(2008-10#1)(2008-2#1)(2009-1#1)(2010-2#1)
techniques as well as##5##4##(1991-2#1)(2007-1#1)(2007-8#1)(2008-11#1)(2008-8#1)
techniques as##21##2##(1991-10#1)(1991-2#2)(1994-9#1)(2005-11#1)(2007-1#2)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-1#1)(2010-2#1)(2012-12#1)(2012-3#1)
techniques associated with##4##3##(1996-7#1)(2008-2#1)(2008-7#1)(2008-9#1)
techniques at present##2##3##(2007-8#1)(2011-2#1)
techniques at##6##2##(1997-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)
techniques available for##5##3##(2008-10#1)(2008-11#1)(2010-7#1)(2013-1#1)(2013-7#1)
techniques available is##2##3##(1990-6#1)(1993-11#1)
techniques available to##3##3##(2007-12#1)(2008-4#1)(2009-12#1)
techniques available##17##2##(1990-6#1)(1993-11#1)(2006-7#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#2)(2009-12#1)(2010-7#1)(2010-9#1)(2012-2#1)(2013-1#2)(2013-7#1)
techniques based on the##4##4##(1997-5#1)(2006-3#1)(2008-1#1)(2008-2#1)
techniques based on##19##3##(1990-9#1)(1991-12#1)(1996-12#1)(1997-5#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-8#1)(2009-2#1)(2009-5#1)
techniques based##20##2##(1990-9#1)(1991-12#1)(1996-12#1)(1997-5#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2009-2#1)(2009-5#1)
techniques because##3##2##(1993-2#1)(2008-10#1)(2008-2#1)
techniques become##2##2##(2006-12#1)(2013-7#1)
techniques being##3##2##(2007-1#1)(2008-11#1)(2008-2#1)
techniques both##3##2##(1997-4#1)(2009-5#1)(2011-2#1)
techniques but the##2##3##(2006-4#1)(2010-12#1)
techniques but##6##2##(1997-7#1)(2006-4#1)(2008-10#2)(2008-11#1)(2010-12#1)
techniques by which this##2##4##(2007-8#1)(2008-11#1)
techniques by which##3##3##(2007-8#1)(2008-1#1)(2008-11#1)
techniques by##10##2##(2006-10#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2010-4#1)(2011-2#1)
techniques can also be##2##4##(2006-4#1)(2008-6#1)
techniques can be applied##2##4##(2008-2#1)(2010-8#1)
techniques can be employed##2##4##(2008-2#1)(2010-8#1)
techniques can be used for##3##5##(2006-4#1)(2008-9#1)(2010-12#1)
techniques can be used in the##2##6##(2011-2#2)
techniques can be used in##4##5##(2008-10#1)(2009-2#1)(2011-2#2)
techniques can be used to##10##5##(1990-9#1)(1995-3#1)(1997-8#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#2)(2010-8#1)(2012-2#1)
techniques can be used##18##4##(1990-9#1)(1995-3#1)(1997-8#1)(2006-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-2#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#1)
techniques can be##32##3##(1990-9#1)(1991-5#1)(1994-12#1)(1995-3#2)(1997-7#1)(1997-8#1)(2006-4#1)(2006-6#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-8#3)(2011-2#2)(2012-2#1)
techniques can provide##3##3##(1994-3#1)(1995-4#1)(2007-5#1)
techniques can reduce##2##3##(2007-7#1)(2008-10#1)
techniques can##52##2##(1990-9#1)(1991-5#1)(1994-12#1)(1994-3#1)(1995-3#2)(1995-4#1)(1996-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-4#2)(2006-6#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-8#3)(2011-2#2)(2012-2#2)
techniques cannot##3##2##(2007-12#1)(2008-3#1)(2008-9#1)
techniques combined with##3##3##(1990-4#1)(2006-12#1)(2007-12#1)
techniques could modulate##2##3##(2008-5#1)(2009-10#1)
techniques could##3##2##(2008-5#1)(2009-10#1)(2012-1#1)
techniques coupled##2##2##(1997-4#1)(2008-3#1)
techniques currently##3##2##(2006-10#1)(2008-5#1)(2013-1#1)
techniques described here##2##3##(1990-9#1)(2008-10#1)
techniques described in this##2##4##(2006-10#1)(2008-2#1)
techniques described in##4##3##(2006-10#1)(2008-2#1)(2008-4#1)(2010-2#1)
techniques described##10##2##(1990-9#1)(2006-10#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2010-2#1)
techniques designed to provide##2##4##(2006-10#1)(2006-6#1)
techniques designed to##4##3##(2006-10#1)(2006-5#1)(2006-6#1)(2008-9#1)
techniques designed##5##2##(1992-6#1)(2006-10#1)(2006-5#1)(2006-6#1)(2008-9#1)
techniques detect##2##2##(2008-4#1)(2008-5#1)
techniques developed in##3##3##(1996-8#1)(2008-10#1)(2008-8#1)
techniques developed to##2##3##(2008-10#1)(2008-2#1)
techniques developed##6##2##(1996-8#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)
techniques differ##2##2##(2008-9#1)(2009-1#1)
techniques do not##3##3##(2005-7#1)(2011-2#1)(2012-2#1)
techniques during##3##2##(2006-10#2)(2012-3#1)
techniques employed to generate##2##4##(1995-2#1)(2011-1#1)
techniques employed to##4##3##(1995-2#1)(2007-12#1)(2008-3#1)(2011-1#1)
techniques employed##12##2##(1990-10#1)(1995-2#1)(2004-11#1)(2006-3#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-7#1)(2011-1#1)
techniques employing the##2##3##(1991-8#1)(2008-8#1)
techniques employing##4##2##(1991-8#1)(1995-7#1)(2008-2#1)(2008-8#1)
techniques exist##3##2##(2006-8#1)(2008-4#1)(2013-1#1)
techniques fail to##3##3##(2005-11#1)(2008-3#1)(2008-6#1)
techniques fail##5##2##(1990-4#1)(2005-11#1)(2007-12#1)(2008-3#1)(2008-6#1)
techniques for a##3##3##(2007-4#1)(2008-10#1)(2008-2#1)
techniques for an##3##3##(1997-6#1)(2010-6#1)(2013-8#1)
techniques for ankle arthrodesis##2##4##(2008-12#2)
techniques for applying##2##3##(2006-4#1)(2008-8#1)
techniques for cancer##3##3##(2008-1#1)(2013-1#2)
techniques for characterizing##2##3##(2008-2#1)(2011-1#1)
techniques for children##2##3##(2008-9#1)(2010-6#1)
techniques for computing##2##3##(2008-3#1)(2009-3#1)
techniques for detecting##4##3##(1992-10#1)(2008-10#2)(2013-7#1)
techniques for detection of##3##4##(2008-10#1)(2010-7#1)(2012-3#1)
techniques for determining##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
techniques for diagnosing##2##3##(2006-1#1)(2006-10#1)
techniques for diagnosis##4##3##(1996-12#1)(2004-11#1)(2008-3#1)(2013-1#1)
techniques for drawing blood##2##4##(2008-11#2)
techniques for establishing##2##3##(1991-1#1)(2005-6#1)
techniques for extracting##2##3##(1997-8#1)(2007-3#1)
techniques for fixation of##2##4##(2006-3#1)(2007-7#1)
techniques for fluorescence##2##3##(2008-9#2)
techniques for food##2##3##(2007-9#2)
techniques for handling##2##3##(2008-10#1)(2008-9#1)
techniques for identifying##3##3##(2007-5#1)(2010-12#1)(2010-2#1)
techniques for imaging##2##3##(2008-2#1)(2010-12#1)
techniques for in##2##3##(1997-6#1)(2009-5#1)
techniques for isolation##2##3##(2008-1#1)(2008-4#1)
techniques for long-term##2##3##(2005-10#1)(2006-5#1)
techniques for measurements##2##3##(2008-10#1)(2008-3#1)
techniques for measuring the##2##4##(2008-2#1)(2008-4#1)
techniques for measuring##5##3##(2008-2#3)(2008-4#2)
techniques for monitoring##3##3##(1991-5#1)(2006-7#1)(2008-10#1)
techniques for performing##2##3##(1996-1#1)(2006-10#1)
techniques for preparing##3##3##(2008-11#1)(2008-4#2)
techniques for rapid##2##3##(2007-8#1)(2008-10#1)
techniques for removal of##2##4##(2006-7#1)(2008-11#1)
techniques for screening##5##3##(2008-10#4)(2011-2#1)
techniques for the analysis of##2##5##(1996-3#1)(2008-10#1)
techniques for the analysis##3##4##(1996-3#1)(2008-10#2)
techniques for the detection of##3##5##(1995-12#1)(2008-10#1)(2009-10#1)
techniques for the detection##4##4##(1995-12#1)(2008-10#1)(2008-2#1)(2009-10#1)
techniques for the determination of##2##5##(1992-8#1)(2008-10#1)
techniques for the management of##2##5##(2006-10#1)(2008-11#1)
techniques for the quantification of##2##5##(1994-12#1)(2008-10#1)
techniques for the study of human##2##6##(1991-10#1)(1997-6#1)
techniques for the study of##4##5##(1991-10#1)(1997-6#1)(2008-10#1)(2008-4#1)
techniques for the treatment of##5##5##(1991-2#1)(2007-8#2)(2011-2#1)(2011-3#1)
techniques for the##57##3##(1991-10#1)(1991-2#1)(1992-4#1)(1992-8#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-7#1)(1996-3#1)(1997-6#2)(2006-10#4)(2006-5#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#4)(2008-4#5)(2008-5#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-2#1)(2011-2#4)(2011-3#1)(2012-11#2)(2012-3#1)
techniques for their##2##3##(2012-2#2)
techniques for these##2##3##(2007-12#1)(2010-3#1)
techniques for tissue##3##3##(2008-2#1)(2010-6#1)(2011-1#1)
techniques for visualization and##2##4##(2006-5#1)(2008-9#1)
techniques for##329##2##(1990-11#1)(1990-12#2)(1990-3#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-10#1)(1992-4#1)(1992-6#1)(1992-8#1)(1994-11#2)(1994-12#1)(1994-6#2)(1995-12#2)(1995-5#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-5#1)(1997-6#4)(1997-8#1)(2004-11#1)(2005-10#2)(2005-11#1)(2005-6#1)(2005-9#1)(2006-1#1)(2006-10#17)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#3)(2006-4#3)(2006-5#4)(2006-6#2)(2006-7#2)(2007-11#2)(2007-12#10)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#8)(2007-9#4)(2008-1#4)(2008-10#41)(2008-11#10)(2008-12#2)(2008-2#22)(2008-3#9)(2008-4#19)(2008-5#9)(2008-7#3)(2008-8#4)(2008-9#13)(2009-10#2)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#4)(2009-8#1)(2009-9#1)(2010-12#3)(2010-2#4)(2010-3#2)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#3)(2010-9#4)(2011-1#5)(2011-2#12)(2011-3#1)(2012-11#2)(2012-2#5)(2012-3#3)(2013-1#14)(2013-7#2)(2013-8#2)
techniques from##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
techniques gave##5##2##(1992-3#1)(2008-10#2)(2008-2#1)(2008-7#1)
techniques give##3##2##(1995-7#1)(2008-10#1)(2008-3#1)
techniques has been##9##3##(1996-12#1)(2008-2#1)(2008-5#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)
techniques has improved##2##3##(2008-1#1)(2012-2#1)
techniques has increased##2##3##(2007-11#1)(2012-2#1)
techniques has led to the##3##5##(2008-10#1)(2008-8#1)(2010-3#1)
techniques has provided a##2##4##(2006-3#1)(2009-8#1)
techniques has resulted in##2##4##(2006-6#1)(2008-10#1)
techniques has##31##2##(1992-5#1)(1994-6#1)(1996-12#1)(1997-3#1)(2006-10#3)(2006-3#1)(2006-6#1)(2007-11#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#2)
techniques have advanced##2##3##(2007-9#1)(2010-12#1)
techniques have allowed##2##3##(2006-5#1)(2008-4#1)
techniques have already##2##3##(1990-12#1)(1990-9#1)
techniques have also##3##3##(1994-3#1)(2008-11#1)(2008-9#1)
techniques have become##3##3##(2008-7#1)(2010-7#1)(2010-9#1)
techniques have been able to##2##5##(2008-7#1)(2011-2#1)
techniques have been applied to the problem of##2##8##(2008-2#1)(2009-4#1)
techniques have been applied to##6##5##(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-4#1)(2010-9#1)
techniques have been applied##8##4##(1996-3#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-4#1)(2010-9#1)
techniques have been described and##2##5##(2006-10#1)(2012-2#1)
techniques have been described for##2##5##(2009-10#1)(2012-12#1)
techniques have been described##7##4##(2006-10#1)(2006-11#1)(2007-8#1)(2009-10#1)(2010-3#1)(2012-12#1)(2012-2#1)
techniques have been developed to##5##5##(2007-11#1)(2007-3#1)(2008-1#1)(2011-2#1)(2013-7#1)
techniques have been developed##8##4##(2007-10#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-7#1)
techniques have been employed to##2##5##(2008-4#1)(2008-9#1)
techniques have been employed##5##4##(2008-10#1)(2008-4#1)(2008-9#1)(2010-2#1)(2011-1#1)
techniques have been introduced to##2##5##(2008-5#1)(2009-11#1)
techniques have been modified##2##4##(2010-8#1)(2011-3#1)
techniques have been proposed to##2##5##(2004-8#1)(2008-2#1)
techniques have been proposed##5##4##(1996-12#1)(2004-8#1)(2006-10#1)(2008-2#1)(2008-3#1)
techniques have been significantly modified to##2##6##(2006-10#2)
techniques have been successfully##2##4##(2005-8#1)(2008-1#1)
techniques have been suggested##2##4##(2008-3#1)(2012-12#1)
techniques have been tried##2##4##(2010-7#2)
techniques have been used in##3##5##(2006-10#1)(2007-2#1)(2008-7#1)
techniques have been used to##10##5##(1991-3#1)(1991-4#1)(1992-4#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
techniques have been used##17##4##(1991-3#1)(1991-4#1)(1992-4#1)(2006-10#2)(2007-11#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)
techniques have been##81##3##(1991-3#1)(1991-4#1)(1992-4#1)(1996-12#1)(1996-3#1)(1997-6#1)(2004-8#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#8)(2006-11#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-4#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)
techniques have improved##3##3##(2006-11#1)(2011-1#1)(2012-12#1)
techniques have led to##2##4##(2011-1#1)(2013-8#1)
techniques have limited##2##3##(2008-4#1)(2010-5#1)
techniques have made##3##3##(2005-5#1)(2008-4#1)(2008-8#1)
techniques have reduced##2##3##(1997-1#1)(2007-7#1)
techniques have resulted in##2##4##(2008-10#1)(2012-1#1)
techniques have revolutionized##2##3##(2007-5#1)(2008-4#1)
techniques have##136##2##(1990-12#1)(1990-9#1)(1991-3#1)(1991-4#1)(1992-4#1)(1994-3#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-6#1)(2004-2#1)(2004-8#1)(2005-11#1)(2005-5#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#9)(2006-11#2)(2006-12#1)(2006-5#2)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#3)(2007-9#4)(2008-1#2)(2008-10#8)(2008-11#6)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#6)(2008-5#2)(2008-7#8)(2008-8#2)(2008-9#6)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-5#1)(2010-7#4)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
techniques help##2##2##(2006-9#1)(2007-11#1)
techniques in a##5##3##(1994-11#1)(1994-12#1)(2007-12#1)(2007-8#1)(2008-4#1)
techniques in both##2##3##(2008-3#1)(2012-12#1)
techniques in children##3##3##(2006-10#2)(2011-2#1)
techniques in gene##2##3##(1995-8#1)(2008-8#1)
techniques in infants and children##2##5##(2006-10#2)
techniques in open##2##3##(2007-8#1)(2013-7#1)
techniques in order to##4##4##(1993-2#1)(2009-4#1)(2013-1#2)
techniques in patients##2##3##(2005-8#1)(2007-8#1)
techniques in recent years##2##4##(2008-12#1)(2008-4#1)
techniques in terms of##2##4##(2006-10#1)(2007-7#1)
techniques in the field##2##4##(2008-1#1)(2011-1#1)
techniques in the management of##7##5##(2006-8#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-3#1)
techniques in the study of##2##5##(2008-7#1)(2011-2#1)
techniques in the##38##3##(1990-5#1)(1990-8#1)(2005-8#1)(2006-10#3)(2006-4#1)(2006-8#3)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-8#1)
techniques in various##2##3##(2007-12#1)(2010-5#1)
techniques in which##4##3##(2006-12#1)(2008-3#1)(2009-10#2)
techniques in##159##2##(1990-5#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-9#1)(1993-2#2)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-8#3)(2006-10#15)(2006-12#1)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#5)(2007-9#3)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#8)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#2)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#3)(2013-8#1)
techniques include##8##2##(2006-10#3)(2007-7#1)(2008-10#1)(2008-4#2)(2010-7#1)
techniques including##15##2##(1990-2#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-6#2)(2008-8#1)(2009-10#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#2)
techniques into clinical##2##3##(2006-10#1)(2008-6#1)
techniques into##3##2##(2006-10#1)(2008-6#1)(2012-3#1)
techniques involved in the##2##4##(2008-2#1)(2008-9#1)
techniques involved##3##2##(2008-11#1)(2008-2#1)(2008-9#1)
techniques involving##4##2##(1996-12#1)(2006-10#1)(2008-10#1)(2008-3#1)
techniques is also##2##3##(1995-3#1)(2008-2#1)
techniques is an##2##3##(1996-8#1)(2007-8#1)
techniques is described##4##3##(1996-2#1)(2008-10#2)(2010-11#1)
techniques is discussed##2##3##(1994-11#1)(2006-7#1)
techniques is increasing in popularity because##2##6##(2006-10#2)
techniques is proposed##4##3##(2008-10#1)(2008-2#1)(2008-6#2)
techniques is reported##3##3##(2006-5#1)(2008-10#1)(2008-2#1)
techniques is required##2##3##(1994-2#1)(2008-4#1)
techniques is the##3##3##(2007-8#1)(2008-1#1)(2009-12#1)
techniques is##56##2##(1992-2#1)(1994-11#1)(1994-2#1)(1995-3#1)(1996-2#1)(1996-5#1)(1996-8#1)(2006-10#3)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-4#1)(2007-8#2)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#5)(2008-3#1)(2008-4#4)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-5#1)(2010-11#2)(2010-4#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)
techniques it##2##2##(1993-2#1)(2006-4#1)
techniques lead to the##2##4##(1990-7#1)(2010-7#1)
techniques led##2##2##(2007-9#1)(2009-10#1)
techniques like##8##2##(2006-10#2)(2007-12#1)(2008-10#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-7#1)
techniques may be combined with##2##5##(2006-10#1)(2008-2#1)
techniques may be##9##3##(1991-6#1)(1994-5#1)(2006-10#4)(2008-2#1)(2008-4#1)(2013-7#1)
techniques may facilitate##2##3##(2006-3#1)(2007-11#1)
techniques may identify##2##3##(2006-6#1)(2009-10#1)
techniques may lead to more##2##5##(2006-9#1)(2011-1#1)
techniques may##28##2##(1991-12#1)(1991-6#1)(1994-5#1)(2006-10#8)(2006-11#1)(2006-3#1)(2006-6#1)(2006-9#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#2)(2011-1#1)(2013-1#1)(2013-7#1)
techniques mentioned##2##2##(2006-6#1)(2008-10#1)
techniques might be##3##3##(2006-9#1)(2007-12#1)(2011-2#1)
techniques might##4##2##(2006-9#1)(2007-10#1)(2007-12#1)(2011-2#1)
techniques most commonly used##2##4##(2008-1#1)(2008-5#1)
techniques must be##2##3##(2007-11#1)(2010-11#1)
techniques need to be##2##4##(2007-11#1)(2011-1#1)
techniques needed to##3##3##(1992-11#1)(1993-12#1)(2011-1#1)
techniques of a##2##3##(2006-3#1)(2008-7#1)
techniques of analysis##2##3##(2008-10#1)(2008-9#1)
techniques of diffusion##2##3##(2007-5#1)(2009-7#1)
techniques of donor##2##3##(2006-10#1)(2009-8#1)
techniques of materials##2##3##(2008-10#1)(2011-11#1)
techniques of molecular biology##3##4##(1990-11#1)(1997-7#1)(2011-2#1)
techniques of operative##2##3##(2007-11#1)(2009-2#1)
techniques of spinal anesthesia##3##4##(2007-7#1)(2012-3#2)
techniques of the##5##3##(1990-3#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#1)
techniques of##117##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-11#2)(1991-2#1)(1991-4#1)(1992-6#1)(1994-5#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-9#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-2#1)(2005-10#1)(2005-6#1)(2006-10#7)(2006-11#1)(2006-3#1)(2006-4#1)(2006-5#3)(2006-7#2)(2006-8#2)(2007-1#1)(2007-11#5)(2007-12#4)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#12)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-2#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-11#1)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#2)
techniques offer##3##2##(2009-12#1)(2012-2#1)(2013-1#1)
techniques often##3##2##(2006-10#1)(2007-9#1)(2012-12#1)
techniques on both##2##3##(2008-2#1)(2008-3#1)
techniques on the##6##3##(1992-2#1)(2008-2#1)(2008-6#1)(2009-1#1)(2010-11#1)(2011-2#1)
techniques on##20##2##(1990-4#1)(1991-3#1)(1992-2#1)(2006-10#2)(2008-2#4)(2008-3#2)(2008-6#1)(2009-1#1)(2009-5#1)(2010-11#1)(2010-2#2)(2011-2#1)(2012-7#1)(2013-1#1)
techniques only##2##2##(1992-2#1)(2011-1#1)
techniques or##6##2##(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#1)
techniques over a##2##3##(2006-8#1)(2008-2#1)
techniques over the last##2##4##(2008-4#1)(2009-12#1)
techniques over##5##2##(2004-11#1)(2006-8#1)(2008-2#1)(2008-4#1)(2009-12#1)
techniques presented are##2##3##(2008-4#1)(2008-9#1)
techniques presented##5##2##(2008-10#1)(2008-4#2)(2008-9#1)(2009-9#1)
techniques produced##2##2##(2006-3#1)(2011-2#1)
techniques provide##7##2##(2006-10#1)(2006-11#1)(2006-9#1)(2008-2#1)(2008-3#3)
techniques provided##2##2##(2008-10#1)(2008-8#1)
techniques provides##3##2##(2008-5#1)(2012-12#2)
techniques relying on anatomic##2##4##(2007-7#2)
techniques remains##2##2##(2006-3#1)(2012-2#1)
techniques represent an important##2##4##(2008-3#1)(2009-3#1)
techniques represents##2##2##(2005-5#1)(2008-11#1)
techniques require##3##2##(2005-8#1)(2006-6#1)(2008-11#1)
techniques required for##2##3##(2008-5#1)(2010-9#1)
techniques requires##2##2##(2007-1#1)(2008-10#1)
techniques result in##3##3##(2008-2#2)(2012-3#1)
techniques reveal##2##2##(2009-3#1)(2011-2#1)
techniques revealed##3##2##(1993-6#1)(1995-5#1)(2008-5#1)
techniques should be##8##3##(1991-6#1)(1996-12#1)(2006-3#1)(2006-5#1)(2008-4#1)(2008-9#1)(2010-12#1)(2013-1#1)
techniques should##11##2##(1991-6#1)(1994-2#1)(1996-12#1)(1996-9#1)(2006-12#1)(2006-3#1)(2006-5#1)(2008-4#1)(2008-9#1)(2010-12#1)(2013-1#1)
techniques show that##2##3##(2005-10#1)(2008-2#1)
techniques show##3##2##(2005-10#1)(2006-8#1)(2008-2#1)
techniques showed that the##2##4##(1997-2#1)(2008-10#1)
techniques showed##3##2##(1994-12#1)(1997-2#1)(2008-10#1)
techniques shows##3##2##(1990-3#1)(2005-11#1)(2008-10#1)
techniques such as atomic force microscopy##2##6##(2006-10#1)(2007-12#1)
techniques such as flame atomic absorption spectrometry##2##7##(2008-10#2)
techniques such as fluorescence##2##4##(2010-7#1)(2012-2#1)
techniques such as multiphoton##2##4##(2007-11#1)(2011-1#1)
techniques such as optical##2##4##(1996-12#1)(2008-1#1)
techniques such as the##3##4##(2008-2#2)(2008-4#1)
techniques such as##75##3##(1994-3#1)(1995-1#1)(1996-12#1)(1996-8#1)(2004-9#1)(2006-10#4)(2006-6#1)(2007-11#3)(2007-12#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#14)(2008-12#2)(2008-2#7)(2008-4#4)(2008-5#2)(2008-7#3)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#2)(2010-7#5)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#5)(2013-1#1)
techniques such##76##2##(1994-3#1)(1995-1#1)(1996-12#1)(1996-8#1)(2004-9#1)(2006-10#4)(2006-6#1)(2007-11#3)(2007-12#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#14)(2008-12#2)(2008-2#7)(2008-4#4)(2008-5#3)(2008-7#3)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#2)(2010-7#5)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#5)(2013-1#1)
techniques suitable for##2##3##(2008-1#1)(2008-3#1)
techniques suitable##3##2##(2008-1#1)(2008-3#1)(2008-9#1)
techniques tailored to##2##3##(2008-11#1)(2010-8#1)
techniques than##2##2##(1996-12#1)(2012-12#1)
techniques that allow##5##3##(2007-6#1)(2008-5#1)(2009-12#1)(2010-11#1)(2011-1#1)
techniques that are currently##2##4##(2007-7#1)(2010-10#1)
techniques that are used to##4##5##(2008-2#1)(2008-4#1)(2008-9#2)
techniques that are##17##3##(1992-12#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-2#2)(2008-4#1)(2008-9#2)(2010-10#1)(2010-11#1)(2010-2#1)(2011-2#1)(2013-1#2)
techniques that can be##2##4##(2008-4#1)(2008-9#1)
techniques that can help##2##4##(1995-1#1)(2008-9#1)
techniques that can##5##3##(1995-1#1)(2008-12#1)(2008-4#1)(2008-9#2)
techniques that have been applied##2##5##(1992-3#1)(2012-12#1)
techniques that have been developed for##3##6##(2008-11#1)(2008-4#1)(2010-12#1)
techniques that have been used##3##5##(2006-5#1)(2008-4#2)
techniques that have been##11##4##(1991-12#1)(1992-3#1)(2006-10#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-4#3)(2010-12#1)(2012-12#1)
techniques that have contributed to##2##5##(2010-8#1)(2012-2#1)
techniques that have proved##2##4##(2008-2#1)(2010-12#1)
techniques that have##18##3##(1991-12#1)(1992-3#1)(2006-10#2)(2006-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#3)(2010-12#2)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
techniques that may##2##3##(2006-9#1)(2012-1#1)
techniques that permit##2##3##(2008-4#1)(2009-11#1)
techniques that require##3##3##(2006-10#1)(2008-1#1)(2008-10#1)
techniques that should be##2##4##(1994-1#1)(2010-2#1)
techniques that show##2##3##(2008-2#1)(2008-8#1)
techniques that the##3##3##(1995-3#1)(2006-7#1)(2008-10#1)
techniques that use##3##3##(2007-12#1)(2008-3#1)(2012-2#1)
techniques that will be##2##4##(2008-10#2)
techniques that will##4##3##(2007-7#1)(2008-10#2)(2011-2#1)
techniques that##94##2##(1991-12#1)(1992-12#1)(1992-3#1)(1994-1#1)(1995-1#1)(1995-3#1)(1995-5#1)(1997-6#1)(1997-7#1)(2005-10#1)(2006-10#5)(2006-11#1)(2006-5#1)(2006-7#2)(2006-9#2)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#1)(2008-4#8)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#5)(2009-11#1)(2009-12#2)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#4)
techniques the##5##2##(1993-8#1)(2007-1#1)(2007-11#1)(2009-12#1)(2013-8#1)
techniques to address##2##3##(2006-3#1)(2008-1#1)
techniques to allow##2##3##(2008-1#1)(2008-11#1)
techniques to analyze##3##3##(1996-9#1)(2007-7#1)(2008-1#1)
techniques to assess##2##3##(2009-10#1)(2010-4#1)
techniques to avoid##2##3##(2008-10#1)(2009-3#1)
techniques to be##7##3##(1994-8#1)(1995-7#1)(1996-2#1)(2008-3#2)(2008-8#1)(2012-12#1)
techniques to confirm##2##3##(2007-8#1)(2008-7#1)
techniques to detect##4##3##(2007-12#1)(2007-7#1)(2008-4#1)(2012-12#1)
techniques to determine the##5##4##(1997-4#1)(2008-10#2)(2008-5#1)(2009-2#1)
techniques to develop##2##3##(1994-2#1)(2008-11#1)
techniques to establish the##2##4##(1994-7#1)(2008-5#1)
techniques to establish##3##3##(1994-7#1)(2008-5#1)(2008-9#1)
techniques to estimate##2##3##(2008-11#1)(2010-2#1)
techniques to evaluate##2##3##(2008-8#1)(2008-9#1)
techniques to examine the##3##4##(1993-12#1)(1996-12#1)(2007-8#1)
techniques to examine##4##3##(1993-12#1)(1996-12#1)(2007-8#1)(2008-8#1)
techniques to facilitate the##2##4##(2009-9#1)(2013-1#1)
techniques to generate##3##3##(1997-8#1)(2008-3#1)(2008-9#1)
techniques to help##2##3##(2006-3#1)(2009-10#1)
techniques to identify##8##3##(1996-12#1)(2006-2#1)(2009-4#1)(2012-11#1)(2013-1#4)
techniques to implement##2##3##(2008-2#1)(2010-9#1)
techniques to improve the##4##4##(1996-3#1)(2006-2#1)(2008-2#1)(2010-8#1)
techniques to improve##9##3##(1996-3#1)(2006-10#1)(2006-2#1)(2006-5#1)(2008-10#1)(2008-2#1)(2010-8#1)(2013-1#2)
techniques to investigate the##2##4##(2008-1#1)(2008-11#1)
techniques to investigate##4##3##(1991-9#1)(2007-5#1)(2008-1#1)(2008-11#1)
techniques to measure the##2##4##(2008-3#1)(2009-7#1)
techniques to measure##6##3##(1993-11#1)(2006-7#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#1)
techniques to model##2##3##(1995-8#1)(2010-5#1)
techniques to more##2##3##(2008-4#1)(2010-12#1)
techniques to perform##4##3##(2006-3#1)(2006-8#1)(2008-10#1)(2008-3#1)
techniques to prevent##2##3##(2007-12#1)(2008-3#1)
techniques to produce##2##3##(1992-2#1)(2010-7#1)
techniques to provide a##2##4##(2008-11#1)(2013-8#1)
techniques to provide##3##3##(2008-11#1)(2011-1#1)(2013-8#1)
techniques to reduce the##2##4##(2007-8#1)(2010-7#1)
techniques to reduce##6##3##(2006-10#1)(2006-11#1)(2007-11#1)(2007-8#1)(2008-3#1)(2010-7#1)
techniques to study the##3##4##(1995-8#1)(2007-9#1)(2008-5#1)
techniques to study##6##3##(1995-8#1)(2007-9#1)(2008-5#1)(2009-4#1)(2010-9#1)(2011-1#1)
techniques to test for##2##4##(2006-2#1)(2008-4#1)
techniques to the analysis of##2##5##(1995-5#1)(2008-10#1)
techniques to the study of##2##5##(2006-10#1)(2008-10#1)
techniques to the##10##3##(1995-5#1)(2006-10#1)(2006-6#1)(2007-7#1)(2007-9#2)(2008-10#3)(2008-3#1)
techniques to treat disorders of the##2##6##(2006-4#1)(2006-7#1)
techniques to water analysis Part##2##5##(2008-10#2)
techniques to water analysis##3##4##(2008-10#3)
techniques to yield a potentially low-cost##2##6##(2008-3#2)
techniques to yield##3##3##(2006-7#1)(2008-3#2)
techniques to##197##2##(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-2#1)(1993-11#1)(1993-12#1)(1994-1#1)(1994-2#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-7#1)(2006-10#4)(2006-11#1)(2006-12#4)(2006-2#3)(2006-3#3)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#3)(2006-8#1)(2007-11#3)(2007-12#4)(2007-2#2)(2007-5#2)(2007-7#3)(2007-8#4)(2007-9#3)(2008-1#5)(2008-10#14)(2008-11#6)(2008-2#6)(2008-3#14)(2008-4#6)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#6)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#3)(2010-8#1)(2010-9#3)(2011-1#5)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#12)(2013-7#1)(2013-8#1)
techniques together with##2##3##(2005-11#1)(2008-3#1)
techniques typically##2##2##(2010-12#1)(2011-2#1)
techniques under##2##2##(1997-6#1)(2012-2#1)
techniques use##2##2##(2007-6#1)(2008-3#1)
techniques used during the##2##4##(1994-1#1)(2008-7#1)
techniques used for##11##3##(1992-9#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-6#1)(2008-7#1)(2009-2#1)(2011-2#1)
techniques used here##2##3##(2006-8#1)(2008-10#1)
techniques used in the field of##2##6##(2008-10#1)(2012-3#1)
techniques used in the##8##4##(1990-12#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-7#1)(2008-10#1)(2009-2#1)(2012-3#1)
techniques used in this##2##4##(2006-8#1)(2008-2#1)
techniques used in##15##3##(1990-12#1)(1995-1#1)(2004-2#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-7#1)(2009-2#1)(2012-3#1)
techniques used to treat##4##4##(2006-7#1)(2006-8#1)(2008-7#1)(2009-3#1)
techniques used to##14##3##(2006-7#1)(2006-8#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#3)(2008-9#1)(2009-3#1)(2011-2#1)(2012-3#1)
techniques used were##3##3##(2007-7#1)(2008-10#2)
techniques used##60##2##(1990-12#1)(1991-12#1)(1991-4#1)(1992-9#1)(1993-9#1)(1994-1#1)(1995-1#1)(1997-6#1)(1997-7#1)(2004-2#1)(2006-10#1)(2006-11#1)(2006-7#2)(2006-8#3)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#3)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#4)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-9#1)(2009-10#1)(2009-2#2)(2009-3#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-3#2)
techniques using##21##2##(1990-5#1)(1991-5#1)(1996-2#1)(1996-3#1)(2004-2#1)(2005-11#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-10#1)(2011-1#1)(2012-2#1)
techniques utilized in##3##3##(2006-10#2)(2008-10#1)
techniques utilized##4##2##(2006-10#2)(2008-10#1)(2010-2#1)
techniques utilizing##2##2##(2006-3#1)(2008-2#1)
techniques was applied##2##3##(2007-10#1)(2008-10#1)
techniques was used##2##3##(2005-12#1)(2008-8#1)
techniques was##18##2##(1990-7#1)(1991-12#1)(1995-5#1)(1996-3#1)(1996-7#1)(2005-12#1)(2005-8#1)(2006-10#1)(2007-10#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)
techniques we have##3##3##(1991-2#1)(2008-10#1)(2008-7#1)
techniques we##4##2##(1991-2#1)(2008-10#1)(2008-5#1)(2008-7#1)
techniques were applied to the##3##5##(1990-2#1)(1997-3#1)(2008-11#1)
techniques were applied to##7##4##(1990-2#1)(1993-12#1)(1996-7#1)(1997-3#1)(2008-10#1)(2008-11#1)(2011-2#1)
techniques were applied##13##3##(1990-2#1)(1993-12#1)(1996-7#1)(1997-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2010-5#1)(2011-2#2)(2013-1#2)
techniques were available##2##3##(2006-8#1)(2007-1#1)
techniques were compared##4##3##(2007-7#1)(2008-10#1)(2008-3#1)(2012-1#1)
techniques were employed in##2##4##(1996-8#1)(2004-9#1)
techniques were employed to##4##4##(1990-4#1)(2008-3#1)(2008-7#1)(2008-8#1)
techniques were employed##9##3##(1990-4#1)(1992-3#1)(1996-8#1)(2004-9#1)(2006-6#2)(2008-3#1)(2008-7#1)(2008-8#1)
techniques were implemented##2##3##(2007-8#1)(2008-3#1)
techniques were mainly##2##3##(1991-5#1)(2008-10#1)
techniques were reviewed##2##3##(2011-2#1)(2013-1#1)
techniques were used for##3##4##(2005-11#1)(2008-10#1)(2008-7#1)
techniques were used in##2##4##(1996-2#1)(2008-10#1)
techniques were used to construct##2##5##(1991-4#1)(1997-2#1)
techniques were used to examine##2##5##(1991-3#1)(1993-12#1)
techniques were used to study the##5##6##(1993-12#1)(1996-1#1)(1997-5#1)(2008-10#1)(2010-7#1)
techniques were used to study##8##5##(1990-2#1)(1993-12#1)(1994-10#1)(1996-1#1)(1997-5#1)(2008-10#1)(2009-5#1)(2010-7#1)
techniques were used to##34##4##(1990-2#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-12#1)(1993-12#3)(1994-10#1)(1994-2#1)(1995-7#1)(1996-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2006-3#1)(2006-8#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-5#1)(2009-5#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#2)
techniques were used##44##3##(1990-2#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-12#1)(1993-12#3)(1994-10#1)(1994-2#1)(1995-7#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(2005-11#1)(2006-3#1)(2006-8#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-5#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
techniques were##110##2##(1990-2#2)(1990-4#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-12#1)(1992-3#2)(1993-12#4)(1994-10#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-7#1)(1996-1#1)(1996-2#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#2)(1997-5#1)(2004-9#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-3#1)(2006-6#2)(2006-8#3)(2007-1#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#5)(2008-10#20)(2008-11#2)(2008-3#5)(2008-5#2)(2008-7#3)(2008-8#2)(2009-11#1)(2009-2#1)(2009-5#2)(2009-9#1)(2010-10#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#8)
techniques when used##2##3##(2006-10#1)(2012-3#1)
techniques when##4##2##(1990-9#1)(1997-6#1)(2006-10#1)(2012-3#1)
techniques which are##5##3##(2006-8#1)(2009-5#1)(2010-12#2)(2013-8#1)
techniques which##11##2##(1992-12#1)(1995-3#1)(2005-10#1)(2006-8#1)(2007-6#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-6#1)(2013-8#1)
techniques widely##2##2##(2008-10#1)(2010-7#1)
techniques will be essential to##2##5##(2007-2#1)(2011-1#1)
techniques will be presented##2##4##(2009-10#1)(2010-3#1)
techniques will be##7##3##(2006-11#1)(2007-2#1)(2009-10#1)(2010-3#1)(2010-8#2)(2011-1#1)
techniques will##22##2##(1990-10#1)(1993-11#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-3#2)(2008-7#1)(2009-10#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#2)
techniques with more##2##3##(1991-3#1)(2008-10#1)
techniques with the##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
techniques with##23##2##(1991-3#1)(1996-3#1)(1996-9#1)(2006-10#1)(2007-12#2)(2008-10#7)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-3#1)(2010-11#1)(2010-7#1)(2011-12#1)(2011-2#1)
techniques within the##2##3##(1992-6#1)(2008-9#1)
techniques within##4##2##(1992-6#1)(2007-12#1)(2008-9#1)(2012-2#1)
techniques without##4##2##(2008-10#2)(2008-7#1)(2012-12#1)
techniques##3908##1##(1990-10#6)(1990-11#4)(1990-12#11)(1990-2#5)(1990-3#7)(1990-4#8)(1990-5#5)(1990-6#3)(1990-7#7)(1990-8#7)(1990-9#10)(1991-1#3)(1991-10#4)(1991-11#5)(1991-12#12)(1991-2#16)(1991-3#11)(1991-4#6)(1991-5#9)(1991-6#5)(1991-7#3)(1991-8#5)(1991-9#10)(1992-1#5)(1992-10#3)(1992-11#5)(1992-12#7)(1992-2#8)(1992-3#8)(1992-4#3)(1992-5#3)(1992-6#10)(1992-7#6)(1992-8#7)(1992-9#5)(1993-1#1)(1993-10#1)(1993-11#5)(1993-12#12)(1993-2#9)(1993-3#3)(1993-5#3)(1993-6#5)(1993-7#2)(1993-8#3)(1993-9#8)(1994-1#3)(1994-10#2)(1994-11#11)(1994-12#11)(1994-2#10)(1994-3#12)(1994-5#5)(1994-6#12)(1994-7#1)(1994-8#4)(1994-9#6)(1995-1#14)(1995-10#2)(1995-11#3)(1995-12#6)(1995-2#6)(1995-3#12)(1995-4#4)(1995-5#12)(1995-6#2)(1995-7#7)(1995-8#9)(1995-9#2)(1996-1#6)(1996-10#2)(1996-12#13)(1996-2#10)(1996-3#9)(1996-4#1)(1996-5#12)(1996-6#3)(1996-7#7)(1996-8#7)(1996-9#13)(1997-1#6)(1997-2#6)(1997-3#11)(1997-4#9)(1997-5#9)(1997-6#17)(1997-7#12)(1997-8#12)(2003-11#1)(2004-11#3)(2004-12#2)(2004-2#11)(2004-4#3)(2004-8#1)(2004-9#4)(2005-10#11)(2005-11#29)(2005-12#2)(2005-2#1)(2005-5#2)(2005-6#2)(2005-7#6)(2005-8#12)(2005-9#9)(2006-1#2)(2006-10#167)(2006-11#15)(2006-12#35)(2006-2#16)(2006-3#31)(2006-4#19)(2006-5#26)(2006-6#31)(2006-7#23)(2006-8#31)(2006-9#13)(2007-1#27)(2007-10#13)(2007-11#64)(2007-12#105)(2007-2#15)(2007-3#8)(2007-4#9)(2007-5#16)(2007-6#15)(2007-7#38)(2007-8#79)(2007-9#32)(2008-1#58)(2008-10#458)(2008-11#95)(2008-12#16)(2008-2#172)(2008-3#178)(2008-4#128)(2008-5#72)(2008-6#31)(2008-7#100)(2008-8#57)(2008-9#82)(2009-1#4)(2009-10#28)(2009-11#9)(2009-12#18)(2009-2#19)(2009-3#16)(2009-4#20)(2009-5#29)(2009-6#1)(2009-7#9)(2009-8#11)(2009-9#13)(2010-1#4)(2010-10#4)(2010-11#29)(2010-12#34)(2010-2#27)(2010-3#13)(2010-4#19)(2010-5#19)(2010-6#8)(2010-7#36)(2010-8#31)(2010-9#24)(2011-1#56)(2011-11#1)(2011-12#13)(2011-2#109)(2011-3#3)(2012-1#13)(2012-11#5)(2012-12#52)(2012-2#63)(2012-3#36)(2012-7#1)(2013-1#104)(2013-7#20)(2013-8#26)
techniques) and##3##2##(2006-2#1)(2010-10#1)(2013-1#1)
techniques)##10##1##(2006-2#1)(2006-6#1)(2006-9#1)(2007-2#1)(2008-2#1)(2010-10#1)(2011-2#2)(2012-2#1)(2013-1#1)
techniques--the##2##1##(1994-7#1)(2005-11#1)
techniques]##3##1##(1991-3#1)(1991-5#1)(1996-9#1)
technologic advances and##2##3##(2006-10#1)(2007-12#1)
technologic advances in##2##3##(2006-3#1)(2013-7#1)
technologic advances##6##2##(2006-10#1)(2006-3#1)(2007-12#2)(2013-1#1)(2013-7#1)
technologic##13##1##(1992-3#1)(1993-1#1)(2006-10#1)(2006-2#1)(2006-3#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-7#1)(2013-1#1)(2013-7#1)(2013-8#1)
technological advance##3##2##(1992-2#1)(1992-3#1)(2010-9#1)
technological advancement##5##2##(1994-12#1)(2007-12#1)(2007-4#1)(2008-3#1)(2010-12#1)
technological advancements##2##2##(2007-8#1)(2009-5#1)
technological advances and##2##3##(2008-11#1)(2008-12#1)
technological advances have allowed##2##4##(2008-10#1)(2012-3#1)
technological advances have##5##3##(1995-12#1)(2008-10#1)(2010-12#1)(2012-3#1)(2013-7#1)
technological advances in##7##3##(1993-6#1)(2008-1#1)(2008-3#1)(2008-6#1)(2009-4#1)(2011-2#1)(2013-8#1)
technological advances##25##2##(1993-6#1)(1995-12#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#2)(2009-5#1)(2010-12#2)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
technological and economic##2##3##(1993-1#1)(2007-3#1)
technological and medical##2##3##(1992-5#1)(2009-9#1)
technological and scientific##2##3##(1992-2#1)(2010-12#1)
technological and sensory##3##3##(2010-4#3)
technological and##18##2##(1992-2#1)(1992-5#1)(1993-1#1)(2006-10#1)(2007-3#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-9#1)(2010-12#2)(2010-4#3)(2011-2#1)(2012-2#1)(2012-3#1)
technological application##2##2##(1997-6#1)(2008-7#1)
technological applications##8##2##(1991-11#1)(2006-4#1)(2007-9#1)(2008-3#1)(2008-7#2)(2009-2#2)
technological aspects##2##2##(2008-1#1)(2010-11#1)
technological assistance##2##2##(1993-3#1)(2007-5#1)
technological background##3##2##(1994-6#1)(2006-6#1)(2010-8#1)
technological barriers##2##2##(2008-2#1)(2010-5#1)
technological challenges in##2##3##(2006-12#1)(2011-11#1)
technological challenges##6##2##(2006-12#1)(2007-5#3)(2010-7#1)(2011-11#1)
technological changes##2##2##(2013-1#1)(2013-8#1)
technological competencies##2##2##(1994-2#2)
technological development##8##2##(1996-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-8#1)
technological developments in##3##3##(1997-8#1)(2005-8#1)(2008-1#1)
technological developments##10##2##(1995-1#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-7#1)
technological evolution of##2##3##(1993-12#1)(2006-10#1)
technological evolution##3##2##(1993-12#1)(2006-10#2)
technological hurdles##2##2##(2008-10#1)(2008-7#1)
technological improvement is##2##3##(2006-12#1)(2011-2#1)
technological improvements##3##2##(1994-1#1)(2010-9#1)(2012-12#1)
technological innovation##2##2##(2010-7#1)(2011-1#1)
technological parameters##2##2##(1992-5#1)(2010-4#1)
technological process##2##2##(2007-1#1)(2013-1#1)
technological progress##2##2##(1991-3#1)(1991-5#1)
technological properties##4##2##(2008-11#1)(2008-6#1)(2010-4#1)(2012-2#1)
technological support##2##2##(1992-1#1)(2008-9#1)
technological systems##2##2##(2011-1#2)
technological transformation##2##2##(2008-4#1)(2008-8#1)
technological##190##1##(1991-11#2)(1991-12#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-5#2)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-8#1)(1997-6#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#6)(2006-12#2)(2006-4#1)(2006-5#2)(2006-6#3)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#2)(2007-3#1)(2007-4#4)(2007-5#5)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#7)(2008-10#5)(2008-11#7)(2008-12#3)(2008-2#5)(2008-3#8)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#9)(2008-8#1)(2008-9#4)(2009-11#1)(2009-2#3)(2009-4#2)(2009-5#3)(2009-9#1)(2010-11#1)(2010-12#6)(2010-2#1)(2010-4#5)(2010-5#1)(2010-7#4)(2010-8#4)(2010-9#2)(2011-1#7)(2011-11#1)(2011-12#2)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#3)
technologically important##4##2##(2007-12#2)(2008-3#1)(2010-4#1)
technologically##11##1##(1990-12#1)(1993-12#1)(1996-3#1)(2006-10#1)(2007-12#2)(2008-3#1)(2009-12#1)(2010-4#1)(2011-1#1)(2012-2#1)
technologies (e##2##2##(2007-4#1)(2009-3#1)
technologies (eg##2##2##(2005-8#1)(2011-2#1)
technologies allow##4##2##(2008-2#1)(2008-9#1)(2012-3#2)
technologies allowing##2##2##(2006-12#1)(2008-1#1)
technologies and new applications##2##4##(2009-3#1)(2012-2#1)
technologies and the##8##3##(2006-11#1)(2008-10#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-12#1)(2013-1#1)
technologies and##51##2##(1993-12#2)(1993-2#1)(1996-1#1)(1997-1#1)(1997-4#1)(2005-7#1)(2005-9#2)(2006-10#2)(2006-11#2)(2006-6#2)(2007-12#1)(2007-4#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-9#1)(2012-1#1)(2012-11#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
technologies are being##3##3##(2005-8#1)(2008-2#2)
technologies are discussed##2##3##(2006-10#1)(2008-4#1)
technologies are needed to##3##4##(2009-12#1)(2010-9#2)
technologies are the##3##3##(2007-8#1)(2012-1#1)(2012-3#1)
technologies are##33##2##(2005-8#1)(2006-10#1)(2006-6#2)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#3)(2008-9#3)(2009-12#1)(2009-6#1)(2010-11#1)(2010-3#1)(2010-7#1)(2010-9#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
technologies as they##2##3##(2007-4#1)(2010-7#1)
technologies as##6##2##(1997-1#1)(2007-4#1)(2008-1#1)(2008-9#1)(2009-4#1)(2010-7#1)
technologies at##2##2##(1994-5#1)(2011-12#1)
technologies available for##2##3##(2007-12#1)(2009-6#1)
technologies available##4##2##(2007-12#1)(2008-11#1)(2008-3#1)(2009-6#1)
technologies based on##3##3##(2008-10#2)(2012-11#1)
technologies by##3##2##(2008-11#1)(2008-5#1)(2008-7#1)
technologies can##6##2##(1996-2#1)(2006-10#1)(2008-10#1)(2012-12#1)(2013-1#2)
technologies could be used##2##4##(2010-10#1)(2010-12#1)
technologies could##3##2##(2008-12#1)(2010-10#1)(2010-12#1)
technologies currently##3##2##(2006-10#1)(2008-2#1)(2010-7#1)
technologies developed##2##2##(2010-7#1)(2012-3#1)
technologies enable##2##2##(2012-11#1)(2012-3#1)
technologies exist to##2##3##(2007-11#1)(2013-1#1)
technologies for the##5##3##(1996-3#1)(2006-2#1)(2008-3#1)(2008-6#1)(2013-1#1)
technologies for##38##2##(1996-3#1)(1997-2#1)(1997-4#1)(2005-8#3)(2006-10#1)(2006-2#1)(2006-6#1)(2007-1#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-12#3)(2009-4#1)(2009-7#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-11#1)(2013-1#2)
technologies has##10##2##(2006-11#1)(2008-2#1)(2008-4#1)(2009-11#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-1#1)
technologies have been developed##4##4##(2006-6#1)(2010-7#1)(2013-1#2)
technologies have been##10##3##(2005-7#1)(2006-6#2)(2007-2#1)(2007-5#1)(2010-7#1)(2011-2#1)(2011-3#1)(2013-1#2)
technologies have enabled##4##3##(2007-1#1)(2008-11#1)(2010-5#1)(2012-11#1)
technologies have##25##2##(2005-7#1)(2006-5#1)(2006-6#2)(2007-1#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#2)
technologies in a##2##3##(2008-10#1)(2013-8#1)
technologies in nurse education##2##4##(2008-11#2)
technologies in the treatment of##2##5##(2011-2#1)(2012-3#1)
technologies in the##6##3##(1993-12#1)(2008-7#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
technologies in##30##2##(1992-2#1)(1993-12#1)(1997-1#1)(2006-6#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#4)(2009-3#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#2)(2011-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
technologies include##2##2##(2006-6#1)(2009-7#1)
technologies including##2##2##(2006-10#1)(2010-9#1)
technologies into##2##2##(2008-7#1)(2008-9#1)
technologies is a##2##3##(2007-4#1)(2011-12#1)
technologies is##9##2##(2005-10#1)(2005-9#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2011-12#1)(2013-8#1)
technologies make##2##2##(2010-2#1)(2012-3#1)
technologies may##5##2##(2007-11#1)(2007-9#1)(2009-12#1)(2009-3#1)(2012-2#1)
technologies not##2##2##(2005-7#1)(2008-5#1)
technologies now##3##2##(2009-6#1)(2012-2#1)(2012-3#1)
technologies of##3##2##(2008-2#2)(2008-3#1)
technologies offer##4##2##(2004-10#1)(2006-10#1)(2008-2#1)(2011-1#1)
technologies or##2##2##(1993-12#1)(2008-7#1)
technologies provide##3##2##(2007-5#1)(2008-4#1)(2009-2#1)
technologies requires##2##2##(2012-2#1)(2013-1#1)
technologies such as microarrays##2##4##(2008-10#1)(2010-9#1)
technologies such as##13##3##(1997-5#1)(2008-10#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
technologies that allow##2##3##(2007-12#1)(2013-1#1)
technologies that are##3##3##(2009-3#1)(2010-11#1)(2010-9#1)
technologies that can improve##3##4##(2010-4#1)(2013-1#2)
technologies that can##4##3##(2006-10#1)(2010-4#1)(2013-1#2)
technologies that could##2##3##(2006-10#1)(2008-5#1)
technologies that have been##2##4##(2008-7#1)(2010-10#1)
technologies that have##3##3##(2007-7#1)(2008-7#1)(2010-10#1)
technologies that##22##2##(2006-10#2)(2007-12#3)(2007-7#1)(2007-8#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-3#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-9#1)(2013-1#3)(2013-8#1)
technologies to support##2##3##(2008-12#1)(2008-3#1)
technologies to##27##2##(1995-5#1)(1997-1#1)(2006-1#1)(2007-4#1)(2007-5#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#4)(2009-10#1)(2009-7#1)(2010-12#2)(2010-4#1)(2011-10#1)(2011-2#1)(2012-2#1)(2013-1#2)
technologies under##2##2##(2006-10#1)(2007-10#1)
technologies using##2##2##(2012-2#2)
technologies were##6##2##(2005-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-8#1)(2012-2#1)
technologies will##3##2##(2008-5#1)(2009-5#1)(2012-3#1)
technologies with the##2##3##(2005-11#1)(2009-2#1)
technologies with##4##2##(2005-11#1)(2008-3#1)(2008-7#1)(2009-2#1)
technologies##598##1##(1990-12#3)(1991-10#1)(1992-11#1)(1992-2#3)(1992-3#2)(1992-4#1)(1993-12#4)(1993-2#3)(1994-3#1)(1994-5#1)(1995-1#1)(1995-5#1)(1996-1#3)(1996-12#1)(1996-2#2)(1996-3#2)(1996-8#1)(1997-1#6)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#2)(2004-10#2)(2005-10#1)(2005-11#3)(2005-6#2)(2005-7#7)(2005-8#7)(2005-9#5)(2006-1#2)(2006-10#16)(2006-11#5)(2006-12#1)(2006-2#5)(2006-4#2)(2006-5#2)(2006-6#19)(2006-8#1)(2006-9#2)(2007-1#3)(2007-10#3)(2007-11#2)(2007-12#8)(2007-2#2)(2007-3#2)(2007-4#14)(2007-5#5)(2007-6#2)(2007-7#2)(2007-8#3)(2007-9#3)(2008-1#6)(2008-10#32)(2008-11#31)(2008-12#6)(2008-2#16)(2008-3#11)(2008-4#14)(2008-5#11)(2008-6#4)(2008-7#32)(2008-8#3)(2008-9#9)(2009-10#2)(2009-11#2)(2009-12#9)(2009-2#6)(2009-3#7)(2009-4#7)(2009-5#4)(2009-6#4)(2009-7#4)(2009-8#2)(2009-9#1)(2010-1#3)(2010-10#4)(2010-11#10)(2010-12#10)(2010-2#2)(2010-3#3)(2010-4#3)(2010-5#5)(2010-7#9)(2010-8#10)(2010-9#6)(2011-1#11)(2011-10#1)(2011-12#5)(2011-2#14)(2011-3#2)(2011-9#2)(2012-1#3)(2012-11#10)(2012-12#6)(2012-2#21)(2012-3#18)(2013-1#28)(2013-7#4)(2013-8#9)
technologies)##2##1##(2008-10#1)(2009-3#1)
technologies?##3##1##(1996-8#1)(2013-1#2)
technologist and##2##2##(1991-1#1)(1993-12#1)
technologist shortage##2##2##(1990-12#1)(2007-4#1)
technologist##15##1##(1990-12#1)(1991-1#1)(1991-2#1)(1993-12#1)(1994-1#1)(1994-12#2)(1994-6#1)(1995-3#2)(2006-8#1)(2007-4#1)(2007-6#2)(2008-12#1)
technologist's##3##1##(1994-6#1)(1995-3#1)(1996-3#1)
technologists and##9##2##(1992-3#1)(1993-1#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-2#1)(2007-4#1)(2008-12#1)
technologists in##5##2##(1990-12#1)(1992-1#1)(1995-3#1)(1996-3#1)(2007-4#1)
technologists not##2##2##(1990-12#1)(1992-1#1)
technologists##60##1##(1990-12#2)(1991-2#1)(1992-1#7)(1992-3#1)(1993-1#1)(1993-12#1)(1993-6#3)(1994-1#3)(1994-12#5)(1994-2#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-3#4)(1996-2#2)(1996-3#4)(2006-8#1)(2007-4#14)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-6#1)
technology acquisition in##3##3##(1991-1#1)(1994-12#1)(1996-2#1)
technology acquisition##4##2##(1991-1#1)(1994-12#1)(1996-2#1)(1997-1#1)
technology adoption##5##2##(2006-6#1)(2013-1#4)
technology advances##2##2##(2007-6#1)(2011-2#1)
technology allows for##2##3##(2005-10#1)(2008-9#1)
technology allows##10##2##(1992-5#1)(2005-10#1)(2006-2#1)(2006-7#1)(2008-12#1)(2008-2#2)(2008-6#1)(2008-7#1)(2008-9#1)
technology and a##5##3##(2006-12#1)(2008-10#1)(2008-3#1)(2013-1#2)
technology and adolescent health##2##4##(2008-7#2)
technology and application##2##3##(1995-4#1)(2011-1#1)
technology and clinical##3##3##(2008-3#1)(2008-4#1)(2008-7#1)
technology and its##6##3##(1990-12#1)(2009-2#1)(2011-2#2)(2012-3#1)(2013-8#1)
technology and medical##3##3##(1990-12#1)(1993-11#1)(1993-2#1)
technology and more##2##3##(1994-6#1)(2006-10#1)
technology and new##3##3##(2005-5#1)(2007-3#1)(2013-1#1)
technology and techniques##2##3##(2006-10#1)(2008-12#1)
technology and the##8##3##(2006-5#1)(2006-6#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
technology and to##4##3##(2006-11#1)(2006-12#1)(2008-4#1)(2010-5#1)
technology and##122##2##(1990-12#2)(1991-11#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-11#2)(1993-2#3)(1994-2#1)(1994-6#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-3#1)(1997-3#1)(1997-6#1)(2005-5#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#2)(2006-5#3)(2006-6#6)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#2)(2008-2#5)(2008-3#5)(2008-4#4)(2008-7#9)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#3)(2009-4#3)(2009-6#1)(2009-9#1)(2010-12#1)(2010-5#2)(2011-1#3)(2011-12#1)(2011-2#4)(2011-7#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#3)
technology appears##2##2##(2005-8#1)(2006-5#1)
technology applied to##3##3##(1994-3#1)(2005-11#1)(2005-8#1)
technology are##14##2##(1990-12#1)(1995-11#2)(2006-10#2)(2006-12#1)(2007-11#1)(2008-2#2)(2008-3#1)(2010-8#1)(2011-2#1)(2013-1#2)
technology as a##4##3##(1996-12#1)(1997-2#1)(2006-6#1)(2008-7#1)
technology as##8##2##(1992-6#1)(1996-12#1)(1997-2#1)(2006-10#1)(2006-6#1)(2008-11#1)(2008-7#2)
technology assessment and##2##3##(1993-3#1)(2008-2#1)
technology assessment##17##2##(1990-12#3)(1993-3#1)(1994-12#1)(1996-12#1)(1996-2#1)(2008-2#2)(2008-7#1)(2009-3#1)(2009-6#1)(2011-2#2)(2012-12#2)(2013-1#1)
technology assessments##2##2##(1994-12#1)(2009-3#1)
technology associated with the##2##4##(2008-11#1)(2008-9#1)
technology at##3##2##(2006-6#1)(2006-8#1)(2008-2#1)
technology based on##3##3##(1995-12#1)(2007-12#1)(2008-7#1)
technology but##3##2##(1994-12#1)(2006-8#1)(2009-6#1)
technology by##6##2##(2007-8#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-2#1)
technology called##2##2##(2008-11#1)(2008-9#1)
technology can also##2##3##(2008-7#1)(2010-4#1)
technology can be used to##2##5##(2006-7#1)(2008-4#1)
technology can be used##3##4##(2006-7#1)(2008-4#1)(2008-7#1)
technology can be##8##3##(2006-4#1)(2006-7#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#2)
technology can have a##2##4##(2008-11#2)
technology can provide##3##3##(2008-3#1)(2008-7#1)(2013-1#1)
technology can##22##2##(1990-12#1)(1997-5#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#3)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
technology capable of##2##3##(1997-4#1)(2010-9#1)
technology continue to##2##3##(1990-12#1)(2006-10#1)
technology dependent##3##2##(1992-1#2)(2008-11#1)
technology developed##2##2##(2006-2#1)(2013-7#1)
technology development and##2##3##(2006-10#1)(2006-5#1)
technology development##5##2##(2006-10#1)(2006-5#1)(2009-11#1)(2009-4#1)(2012-3#1)
technology enables##2##2##(2011-2#1)(2012-12#1)
technology for rapid##2##3##(2007-12#1)(2007-7#1)
technology for surgical##2##3##(2006-6#1)(2007-8#1)
technology for the##15##3##(2006-7#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#2)(2010-6#1)(2012-1#1)(2012-2#1)(2012-3#1)
technology for##75##2##(1994-9#1)(1995-12#1)(1995-2#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-11#4)(2007-12#5)(2007-3#2)(2007-4#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#5)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#5)(2008-9#2)(2009-11#1)(2010-12#3)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-7#2)
technology has allowed##4##3##(2006-10#1)(2007-9#1)(2008-11#1)(2008-4#1)
technology has become##3##3##(2008-11#2)(2010-12#1)
technology has been a##3##4##(2007-12#1)(2008-7#1)(2013-1#1)
technology has been applied##2##4##(2006-11#1)(2008-3#1)
technology has been used to##3##5##(1991-8#1)(2008-11#1)(2012-1#1)
technology has been used##4##4##(1991-8#1)(2008-11#1)(2008-6#1)(2012-1#1)
technology has been##15##3##(1991-8#1)(2005-11#1)(2005-2#1)(2006-11#1)(2007-12#1)(2008-11#3)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-12#1)(2012-1#1)(2013-1#1)
technology has emerged as a##2##5##(2008-7#1)(2009-8#1)
technology has enhanced the##2##4##(2008-12#1)(2012-3#1)
technology has had a significant impact on the##2##8##(2007-12#1)(2008-7#1)
technology has improved##2##3##(2007-4#1)(2008-9#1)
technology has made it possible to##2##6##(2007-11#1)(2010-2#1)
technology has made possible the##2##5##(2007-11#1)(2011-2#1)
technology has made##5##3##(2007-11#2)(2008-10#1)(2010-2#1)(2011-2#1)
technology has provided##2##3##(2006-5#1)(2008-2#1)
technology has several##2##3##(2008-1#1)(2008-10#1)
technology has##58##2##(1991-8#1)(1994-12#1)(2005-11#1)(2005-2#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#5)(2007-12#3)(2007-4#1)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-8#1)(2010-12#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
technology have allowed##2##3##(2004-9#1)(2008-7#1)
technology have increased##2##3##(2006-7#1)(2008-7#1)
technology have led to##3##4##(2008-7#1)(2010-6#1)(2012-3#1)
technology have resulted in##2##4##(1996-2#1)(2008-9#1)
technology have##17##2##(1996-2#1)(2004-9#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-7#4)(2008-9#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#2)
technology implications##2##2##(1995-12#1)(2007-9#1)
technology improves##2##2##(2010-12#1)(2012-2#1)
technology in a##6##3##(1996-4#1)(2007-3#1)(2008-10#2)(2008-7#1)(2010-4#1)
technology in an##3##3##(2008-11#1)(2013-1#2)
technology in children##2##3##(2006-10#1)(2013-1#1)
technology in clinical##3##3##(1994-12#1)(2008-8#1)(2011-7#1)
technology in combination with##2##4##(2005-8#1)(2012-11#1)
technology in health care and##3##5##(1990-12#1)(2008-1#1)(2008-10#1)
technology in health care##4##4##(1990-12#1)(2008-1#1)(2008-10#2)
technology in health##6##3##(1990-12#1)(2008-1#1)(2008-10#3)(2012-12#1)
technology in medicine##5##3##(1991-11#1)(2005-10#1)(2006-6#1)(2013-8#2)
technology in rural settings##2##4##(1996-1#1)(2007-12#1)
technology in rural##4##3##(1996-1#1)(2007-12#2)(2012-1#1)
technology in the##17##3##(1991-11#1)(1993-2#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2009-11#1)(2010-4#1)(2010-8#1)(2013-1#2)
technology in this##3##3##(2006-10#1)(2010-11#1)(2010-8#1)
technology in##105##2##(1990-12#3)(1991-11#2)(1993-2#1)(1994-12#2)(1995-2#1)(1996-1#1)(1996-4#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-2#2)(2006-5#1)(2006-6#2)(2006-7#1)(2006-9#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#7)(2008-12#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#5)(2008-8#2)(2009-11#1)(2009-2#1)(2009-6#2)(2009-9#2)(2010-11#1)(2010-4#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#3)
technology including##2##2##(2008-6#1)(2010-8#1)
technology into the##4##3##(2007-5#1)(2008-12#1)(2010-9#1)(2012-1#1)
technology into##9##2##(2005-9#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
technology is a powerful##2##4##(2007-8#1)(2008-5#1)
technology is a##11##3##(1990-12#2)(1995-12#1)(2007-8#2)(2008-10#1)(2008-5#2)(2008-7#1)(2011-12#1)(2013-8#1)
technology is also##2##3##(2008-11#1)(2008-5#1)
technology is based on##3##4##(1996-12#1)(2008-6#1)(2008-7#1)
technology is demonstrated by##3##4##(2012-11#1)(2012-3#1)(2013-7#1)
technology is demonstrated##5##3##(2007-12#1)(2010-2#1)(2012-11#1)(2012-3#1)(2013-7#1)
technology is described##2##3##(2008-3#1)(2013-1#1)
technology is growing##2##3##(1996-2#1)(2012-2#1)
technology is in##2##3##(2006-11#1)(2008-2#1)
technology is introduced##2##3##(1990-12#1)(1992-1#1)
technology is particularly well suited##2##5##(2007-6#1)(2008-3#1)
technology is the##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2010-5#1)
technology is used to##2##4##(1994-12#1)(2008-3#1)
technology is used##3##3##(1994-12#1)(2008-3#2)
technology is##76##2##(1990-12#3)(1992-1#1)(1993-11#1)(1994-12#2)(1994-2#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-3#1)(2005-8#1)(2006-10#2)(2006-11#2)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-6#2)(2007-8#3)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#5)(2009-3#2)(2009-9#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
technology makes##4##2##(2005-7#1)(2007-4#1)(2012-3#1)(2013-8#1)
technology management##2##2##(2011-2#2)
technology may be a##2##4##(2012-1#1)(2013-1#1)
technology may play a##2##4##(2006-6#1)(2008-3#1)
technology may##10##2##(1997-5#1)(2006-6#1)(2006-7#1)(2007-11#1)(2008-11#1)(2008-3#1)(2009-3#1)(2012-1#1)(2013-1#2)
technology must##4##2##(1996-2#1)(2006-11#1)(2008-11#1)(2008-2#1)
technology needs to##2##3##(2011-7#1)(2012-2#1)
technology not##2##2##(2008-7#1)(2011-2#1)
technology now##4##2##(2006-10#1)(2006-12#1)(2008-7#1)(2010-11#1)
technology of the##4##3##(1997-5#1)(2008-10#1)(2008-5#2)
technology of##33##2##(1990-3#1)(1990-8#1)(1991-11#1)(1991-3#1)(1994-1#1)(1996-6#1)(1997-5#1)(2005-6#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-2#2)(2009-6#1)(2010-8#1)(2013-1#1)(2013-8#3)
technology offers an##2##3##(2004-9#1)(2012-12#1)
technology offers new##2##3##(1991-11#1)(2008-2#1)
technology offers##5##2##(1991-11#1)(2004-9#1)(2006-4#1)(2008-2#1)(2012-12#1)
technology on##3##2##(1995-12#1)(2008-4#1)(2013-1#1)
technology or##3##2##(2005-8#1)(2007-4#1)(2007-7#1)
technology platform##2##2##(2006-12#1)(2008-10#1)
technology platforms are##2##3##(2008-4#1)(2008-7#1)
technology platforms##3##2##(2008-4#1)(2008-7#1)(2011-1#1)
technology probe&quot##2##2##(2013-1#2)
technology provides a##2##3##(2008-7#1)(2012-2#1)
technology provides##6##2##(1992-5#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
technology refers to the##2##4##(1996-12#1)(2008-4#1)
technology related##4##2##(1994-6#1)(2010-8#1)(2011-1#2)
technology represents a##2##3##(2006-12#1)(2008-8#1)
technology requires##2##2##(2007-5#1)(2008-3#1)
technology should be##3##3##(1996-2#1)(1996-3#1)(2007-9#1)
technology should##7##2##(1996-2#1)(1996-3#1)(2006-6#1)(2007-9#1)(2008-2#1)(2008-9#1)(2011-2#1)
technology significantly##2##2##(2008-10#1)(2010-2#1)
technology specifically##2##2##(1995-2#1)(2008-10#1)
technology such as##4##3##(2005-7#1)(2005-8#1)(2007-4#1)(2010-3#1)
technology that allows##2##3##(1992-9#1)(2008-1#1)
technology that are##3##3##(1992-1#1)(2008-1#1)(2009-7#1)
technology that can##3##3##(2012-2#2)(2013-7#1)
technology that could##2##3##(2004-9#1)(2008-2#1)
technology that has##4##3##(2006-2#1)(2006-9#1)(2007-8#1)(2008-11#1)
technology that is##3##3##(1997-1#1)(2012-1#1)(2013-1#1)
technology that may be##2##4##(2007-12#1)(2008-12#1)
technology that may##4##3##(2005-7#1)(2007-12#1)(2008-12#1)(2009-5#1)
technology that offers##2##3##(2006-10#1)(2011-7#1)
technology that##35##2##(1992-1#1)(1992-11#1)(1992-9#1)(1994-3#1)(1997-1#1)(2004-9#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-9#1)(2009-5#1)(2009-7#1)(2010-6#1)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
technology through##2##2##(2007-12#1)(2008-2#1)
technology to achieve##2##3##(2008-3#1)(2008-4#1)
technology to be##2##3##(2008-9#1)(2013-8#1)
technology to deliver##3##3##(2008-11#1)(2008-3#1)(2013-1#1)
technology to enhance##4##3##(1990-12#1)(2008-11#1)(2008-7#1)(2008-9#1)
technology to facilitate##3##3##(2008-11#1)(2008-12#1)(2008-9#1)
technology to manage##2##3##(1996-3#1)(2009-11#1)
technology to measure##2##3##(2007-12#1)(2008-4#1)
technology to monitor##2##3##(2008-10#1)(2013-8#1)
technology to produce##2##3##(2006-6#1)(2007-11#1)
technology to teach##2##3##(2005-12#1)(2006-5#1)
technology to the##2##3##(2008-1#1)(2012-3#1)
technology to their##2##3##(2008-4#1)(2009-7#1)
technology to##90##2##(1990-12#1)(1990-4#1)(1992-9#1)(1993-1#1)(1994-11#2)(1994-6#1)(1995-11#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-4#1)(2004-10#1)(2005-12#1)(2006-10#1)(2006-5#2)(2006-6#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#7)(2008-5#3)(2008-7#7)(2008-9#5)(2009-11#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#3)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#2)
technology together with##3##3##(2008-10#2)(2009-2#1)
technology transfer##7##2##(1997-7#1)(2005-10#1)(2007-12#2)(2007-7#1)(2008-3#1)(2012-2#1)
technology under##2##2##(2008-10#1)(2008-5#1)
technology used in##2##3##(2008-5#1)(2013-1#1)
technology used##5##2##(2005-8#1)(2006-6#1)(2008-5#1)(2009-11#1)(2013-1#1)
technology using##2##2##(2008-3#1)(2008-9#1)
technology was used to##2##4##(1994-5#1)(2008-10#1)
technology was used##3##3##(1994-5#1)(2007-6#1)(2008-10#1)
technology was##15##2##(1994-3#1)(1994-5#1)(2004-12#1)(2005-8#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-10#4)(2008-5#2)(2008-6#1)(2013-8#1)
technology we##3##2##(2007-11#1)(2008-11#1)(2013-8#1)
technology were##5##2##(2008-10#2)(2008-12#1)(2008-6#1)(2010-7#1)
technology which##8##2##(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#1)
technology will allow##2##3##(1995-12#1)(1996-1#1)
technology will also##2##3##(1994-12#1)(1997-6#1)
technology will be##4##3##(1995-7#1)(2006-11#1)(2006-6#1)(2007-6#1)
technology will##15##2##(1990-12#1)(1994-12#1)(1995-12#1)(1995-7#1)(1996-1#1)(1997-6#1)(2006-11#2)(2006-6#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-3#1)
technology with##12##2##(1996-12#1)(2006-10#1)(2007-4#1)(2008-11#2)(2008-3#1)(2008-9#2)(2011-2#2)(2013-1#2)
technology within the##2##3##(2007-12#1)(2013-7#1)
technology within##3##2##(2007-12#2)(2013-7#1)
technology##1547##1##(1990-12#22)(1990-3#1)(1990-4#2)(1990-8#2)(1991-1#1)(1991-11#7)(1991-12#5)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-1#8)(1992-11#3)(1992-12#2)(1992-2#5)(1992-3#3)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#3)(1993-12#5)(1993-2#7)(1993-3#3)(1993-5#2)(1993-9#2)(1994-1#6)(1994-11#2)(1994-12#15)(1994-2#5)(1994-3#4)(1994-5#1)(1994-6#3)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#9)(1995-2#5)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#2)(1996-1#7)(1996-11#2)(1996-12#10)(1996-2#7)(1996-3#9)(1996-4#3)(1996-5#2)(1996-6#1)(1997-1#6)(1997-2#3)(1997-3#4)(1997-4#6)(1997-5#4)(1997-6#2)(1997-7#3)(2004-10#2)(2004-11#1)(2004-12#3)(2004-2#1)(2004-4#2)(2004-5#1)(2004-9#3)(2005-10#4)(2005-11#3)(2005-12#1)(2005-2#1)(2005-4#1)(2005-5#1)(2005-6#3)(2005-7#9)(2005-8#10)(2005-9#2)(2006-1#1)(2006-10#34)(2006-11#12)(2006-12#15)(2006-2#15)(2006-4#8)(2006-5#12)(2006-6#28)(2006-7#11)(2006-8#5)(2006-9#6)(2007-1#2)(2007-10#13)(2007-11#28)(2007-12#54)(2007-2#5)(2007-3#8)(2007-4#27)(2007-5#4)(2007-6#9)(2007-7#5)(2007-8#22)(2007-9#10)(2008-1#20)(2008-10#102)(2008-11#76)(2008-12#17)(2008-2#41)(2008-3#46)(2008-4#35)(2008-5#28)(2008-6#13)(2008-7#80)(2008-8#13)(2008-9#35)(2009-10#3)(2009-11#7)(2009-12#3)(2009-2#12)(2009-3#8)(2009-4#10)(2009-5#4)(2009-6#10)(2009-7#3)(2009-8#2)(2009-9#8)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#14)(2010-2#4)(2010-3#4)(2010-4#5)(2010-5#8)(2010-6#5)(2010-7#5)(2010-8#20)(2010-9#7)(2011-1#23)(2011-12#8)(2011-2#44)(2011-7#7)(2012-1#13)(2012-11#2)(2012-12#24)(2012-2#30)(2012-3#29)(2013-1#70)(2013-7#12)(2013-8#21)
technology&quot##5##1##(1996-12#2)(2011-1#1)(2013-1#2)
technology's##4##1##(1994-12#1)(2007-9#1)(2009-2#1)(2010-8#1)
technology)##10##1##(1993-2#2)(1996-7#1)(2005-8#1)(2005-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-1#1)
technology-based##3##1##(1996-3#1)(2013-1#2)
technology]##11##1##(1990-9#1)(1994-11#1)(1996-12#1)(1997-6#1)(2005-4#1)(2006-5#1)(2007-10#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
tecnique##2##1##(2009-10#2)
tectal tumor in##2##3##(2006-5#2)
tectal tumor##3##2##(2006-5#3)
tectal tumors##4##2##(2006-5#4)
tectal##12##1##(1993-9#1)(2006-5#8)(2008-7#3)
tectonic plate##2##2##(2008-9#2)
tectonic##8##1##(1993-7#1)(1994-7#3)(2007-9#1)(2008-9#2)(2009-10#1)
tectonics##4##1##(2006-5#2)(2007-8#1)(2008-3#1)
tectopontine##3##1##(1993-3#3)
tectorial membrane injury##2##3##(2012-12#2)
tectorial membrane##5##2##(1995-5#3)(2012-12#2)
tectum##14##1##(1990-5#1)(1990-7#1)(1993-12#4)(1993-9#1)(1995-11#1)(1995-5#1)(1997-3#1)(1997-6#1)(2006-5#1)(2008-6#2)
ted##2##1##(2008-6#1)(2010-4#1)
tedious and time consuming##4##4##(1990-2#1)(2007-8#1)(2008-10#1)(2008-9#1)
tedious and time-consuming##3##3##(2007-6#1)(2008-10#1)(2008-4#1)
tedious and##11##2##(1990-2#1)(1992-9#1)(1994-6#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-9#1)(2010-8#1)(2012-2#1)
tedious prior separation##2##3##(2008-10#2)
tedious##35##1##(1990-2#1)(1991-5#1)(1992-12#1)(1992-9#1)(1994-6#1)(2005-4#1)(2006-10#1)(2006-2#1)(2007-6#1)(2007-8#3)(2008-10#9)(2008-2#1)(2008-3#1)(2008-4#2)(2008-9#2)(2009-3#1)(2010-12#1)(2010-8#2)(2012-2#2)(2013-1#2)
tedium##2##1##(1996-2#1)(2008-9#1)
teen pregnancy##2##2##(1997-2#1)(2013-1#1)
teen tattoos##2##2##(2007-2#2)
teen##23##1##(1990-12#1)(1994-1#1)(1994-2#1)(1995-2#1)(1997-2#1)(2007-2#4)(2007-3#1)(2007-9#1)(2008-7#2)(2012-12#2)(2012-2#1)(2013-1#6)(2013-7#1)
teenage girl##2##2##(1993-6#1)(2007-7#1)
teenage mother##2##2##(2008-2#1)(2008-9#1)
teenage pregnancy##5##2##(1996-12#1)(2007-1#1)(2008-3#2)(2013-1#1)
teenage years##3##2##(2006-7#2)(2009-7#1)
teenage##24##1##(1993-6#1)(1996-12#1)(2006-7#3)(2006-8#1)(2007-1#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-7#1)(2011-1#2)(2012-2#1)(2013-1#2)
teenagehealthfreak##2##1##(2008-7#2)
teenager##5##1##(2007-4#1)(2007-8#1)(2008-6#1)(2009-4#1)(2012-3#1)
teenagers and adults##2##3##(2006-10#1)(2013-1#1)
teenagers and##4##2##(2006-10#1)(2007-12#1)(2007-3#1)(2013-1#1)
teenagers are##3##2##(2008-11#2)(2008-7#1)
teenagers from##2##2##(2011-1#1)(2013-8#1)
teenagers is##2##2##(1994-3#1)(2008-11#1)
teenagers than##2##2##(2008-11#1)(2008-9#1)
teenagers who were##2##3##(2007-7#2)
teenagers who##4##2##(2007-7#3)(2008-9#1)
teenagers##43##1##(1991-10#1)(1991-2#1)(1994-3#1)(1996-6#1)(1996-9#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-3#1)(2007-7#6)(2008-11#7)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#7)(2009-7#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#5)(2013-8#1)
teenagers]##2##1##(1993-9#1)(2011-1#1)
teens to##2##2##(2008-6#1)(2009-7#1)
teens were##2##2##(2009-7#1)(2013-1#1)
teens with##2##2##(2007-3#1)(2013-1#1)
teens##36##1##(1996-3#1)(2006-8#1)(2007-2#3)(2007-3#1)(2008-2#2)(2008-6#1)(2008-7#2)(2009-7#3)(2009-8#2)(2012-12#1)(2012-2#2)(2013-1#16)(2013-8#1)
teens'##3##1##(1994-2#1)(2009-7#1)(2012-12#1)
teeth after##5##2##(2008-5#1)(2008-9#2)(2013-1#1)(2013-8#1)
teeth and bone##2##3##(1993-11#1)(1995-9#1)
teeth and denture bases##2##4##(2008-6#2)
teeth and periodontium##2##3##(2010-3#1)(2013-1#1)
teeth and##29##2##(1993-11#1)(1995-6#1)(1995-9#2)(2005-11#1)(2006-2#1)(2007-12#2)(2007-2#1)(2008-1#2)(2008-12#1)(2008-6#3)(2008-7#1)(2008-9#3)(2009-10#1)(2009-7#1)(2010-3#1)(2012-12#1)(2013-1#5)(2013-8#1)
teeth are##9##2##(1993-2#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-6#2)(2010-3#2)
teeth as##2##2##(2007-12#1)(2011-2#1)
teeth based on##2##3##(2008-6#1)(2013-8#1)
teeth by##2##2##(2008-5#1)(2012-8#1)
teeth extracted for orthodontic reasons##2##5##(2013-8#2)
teeth extracted##4##2##(1996-6#1)(2010-9#1)(2013-8#2)
teeth for##2##2##(2012-3#1)(2013-1#1)
teeth had##2##2##(2008-12#1)(2013-1#1)
teeth have##2##2##(2008-12#1)(2013-1#1)
teeth in a##2##3##(2008-5#1)(2012-3#1)
teeth in children##5##3##(2007-12#3)(2011-2#1)(2013-1#1)
teeth in the##5##3##(2004-3#1)(2008-5#1)(2008-7#1)(2011-1#2)
teeth in##23##2##(1991-6#2)(1997-5#1)(2004-3#1)(2006-2#1)(2006-8#1)(2007-12#3)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#3)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#3)
teeth into##2##2##(1997-2#1)(2005-9#1)
teeth involved##2##2##(2011-1#1)(2013-1#1)
teeth is##7##2##(1997-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-12#2)(2013-1#1)
teeth loss##2##2##(2009-11#1)(2012-12#1)
teeth marks##2##2##(1995-3#1)(1996-5#1)
teeth of the##2##3##(2008-7#1)(2011-2#1)
teeth of##10##2##(1995-6#1)(1996-3#1)(1997-4#2)(2008-7#1)(2010-5#2)(2011-2#2)(2013-8#1)
teeth restored##3##2##(2005-9#1)(2013-8#2)
teeth show##2##2##(2008-12#1)(2008-7#1)
teeth that##3##2##(2007-12#1)(2008-6#1)(2011-1#1)
teeth the##3##2##(2006-8#1)(2013-1#1)(2013-8#1)
teeth to##4##2##(2007-12#1)(2008-3#1)(2011-2#1)(2013-7#1)
teeth was associated##2##3##(2008-9#1)(2012-2#1)
teeth was##7##2##(1991-6#1)(2008-1#1)(2008-9#2)(2010-5#1)(2012-2#1)(2013-8#1)
teeth were bonded with##2##4##(2009-7#2)
teeth were exposed to a##3##5##(2012-2#3)
teeth were exposed to##4##4##(2012-2#4)
teeth were extracted##2##3##(1990-12#1)(1990-2#1)
teeth were randomly divided into##2##5##(2006-8#1)(2013-8#1)
teeth were randomly##3##3##(2006-8#1)(2008-11#1)(2013-8#1)
teeth were restored using a##2##5##(2009-8#2)
teeth were restored using##3##4##(2009-8#2)(2010-6#1)
teeth were restored##4##3##(2008-5#1)(2009-8#2)(2010-6#1)
teeth were##31##2##(1990-12#1)(1990-2#1)(1991-6#1)(1996-3#1)(1996-5#1)(2006-3#1)(2006-8#3)(2008-11#1)(2008-5#2)(2008-7#1)(2009-7#2)(2009-8#2)(2010-6#1)(2010-8#1)(2012-12#1)(2012-2#6)(2013-1#4)(2013-8#1)
teeth with a##2##3##(2008-6#1)(2012-2#1)
teeth with large##2##3##(2011-2#1)(2012-2#1)
teeth with##10##2##(1991-2#1)(1995-9#1)(2008-6#2)(2008-7#1)(2010-6#1)(2011-2#2)(2012-2#2)
teeth within##2##2##(2008-1#1)(2013-1#1)
teeth##362##1##(1990-1#2)(1990-10#2)(1990-12#1)(1990-2#3)(1990-5#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#5)(1992-4#1)(1992-5#1)(1993-11#3)(1993-2#1)(1993-3#1)(1993-7#1)(1995-3#1)(1995-6#2)(1995-9#5)(1996-3#4)(1996-5#2)(1996-6#3)(1997-2#1)(1997-4#5)(1997-5#1)(2004-3#1)(2005-11#3)(2005-7#1)(2005-9#4)(2006-2#5)(2006-3#1)(2006-7#1)(2006-8#7)(2007-12#19)(2007-2#3)(2007-7#1)(2007-8#1)(2008-1#13)(2008-11#2)(2008-12#11)(2008-3#3)(2008-4#1)(2008-5#21)(2008-6#15)(2008-7#18)(2008-9#14)(2009-10#2)(2009-11#2)(2009-3#1)(2009-4#1)(2009-7#4)(2009-8#6)(2009-9#2)(2010-2#1)(2010-3#6)(2010-5#3)(2010-6#3)(2010-8#5)(2010-9#1)(2011-1#17)(2011-2#15)(2012-12#19)(2012-2#15)(2012-3#4)(2012-8#1)(2013-1#34)(2013-7#3)(2013-8#21)
teeth]##3##1##(1990-1#1)(1991-1#1)(2013-1#1)
tef##4##1##(2008-5#4)
teflon membrane##6##2##(2008-10#6)
teflon##14##1##(1991-11#1)(2004-9#3)(2008-10#10)
tegafur (Futraful##2##2##(1994-7#1)(1997-7#1)
tegafur##5##1##(1994-7#1)(1997-3#3)(1997-7#1)
tegaserod maleate##4##2##(2010-2#4)
tegaserod##18##1##(2008-3#8)(2010-2#4)(2010-6#6)
tegmental area (VTA)##16##3##(1991-8#1)(1993-12#3)(1993-2#1)(1993-6#1)(1994-12#1)(1996-12#2)(1996-5#1)(1997-5#2)(2008-7#2)(2009-2#1)(2009-8#1)
tegmental area##53##2##(1990-4#1)(1991-11#3)(1991-8#1)(1991-9#1)(1992-10#1)(1992-7#1)(1993-12#6)(1993-2#1)(1993-6#2)(1994-12#2)(1994-2#4)(1995-12#1)(1996-10#1)(1996-12#3)(1996-5#1)(1997-2#1)(1997-3#2)(1997-5#3)(1997-7#3)(1997-8#8)(2008-4#1)(2008-7#3)(2009-2#2)(2009-8#1)
tegmental nucleus##16##2##(1991-11#2)(1991-12#3)(1992-1#1)(1994-10#2)(1994-2#2)(1994-3#2)(1995-12#1)(1995-5#2)(2008-7#1)
tegmental##82##1##(1990-4#1)(1991-11#5)(1991-12#3)(1991-8#3)(1991-9#2)(1992-1#2)(1992-10#2)(1992-7#4)(1993-12#8)(1993-2#1)(1993-6#2)(1994-10#2)(1994-12#2)(1994-2#6)(1994-3#2)(1995-12#2)(1995-5#2)(1996-10#1)(1996-12#3)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-5#3)(1997-7#3)(1997-8#8)(2007-10#1)(2008-4#1)(2008-7#4)(2009-2#2)(2009-8#1)(2010-12#1)
tegmenti##3##1##(1991-3#2)(1997-6#1)
tegmentum##11##1##(1991-3#1)(1991-9#2)(1992-1#2)(1993-2#1)(1994-6#1)(1995-12#2)(2008-6#1)(2008-7#1)
tegument##3##1##(1991-12#1)(2006-10#2)
teh##3##1##(1997-7#1)(2007-9#2)
tehran university of medical sciences##2##5##(2011-2#2)
tehran##6##1##(2007-7#1)(2011-2#4)(2013-1#1)
tehsils of##2##2##(2009-6#2)
teicoplanin modified with acetonitrile-based##2##4##(2008-10#2)
teicoplanin modified with##3##3##(2008-10#3)
teicoplanin phase##2##2##(2008-10#2)
teicoplanin stationary phase##2##3##(2008-10#2)
teicoplanin was##2##2##(2008-10#1)(2013-8#1)
teicoplanin##24##1##(1995-2#2)(2007-7#1)(2008-10#19)(2012-12#1)(2013-8#1)
teicoplanin)##2##1##(1993-5#1)(2005-8#1)
teicoplanine##2##1##(2008-10#2)
tektites##3##1##(1993-7#3)
telangiectases##4##1##(1996-2#1)(2007-7#1)(2011-2#2)
telangiectasia and##2##2##(2006-12#1)(2008-7#1)
telangiectasia in##4##2##(1994-12#1)(1995-10#1)(2008-8#1)(2011-2#1)
telangiectasia is##2##2##(2006-12#1)(2011-2#1)
telangiectasia##34##1##(1994-12#1)(1995-10#1)(1995-6#3)(2006-10#1)(2006-12#7)(2007-10#1)(2008-1#1)(2008-7#6)(2008-8#1)(2009-10#2)(2010-6#4)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)
telangiectasia)##2##1##(2007-12#1)(2008-7#1)
telangiectasias##3##1##(2006-10#1)(2010-6#2)
telbivudine##5##1##(2009-11#1)(2009-8#3)(2013-1#1)
tele-methylhistamine##2##1##(1994-12#2)
telecentric##5##1##(2008-2#1)(2008-3#4)
telechelic oligomers##2##2##(2004-9#2)
telechelic##4##1##(2004-9#3)(2009-11#1)
telecom##6##1##(2007-11#4)(2007-12#2)
telecommunication fiber##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
telecommunication technology##4##2##(1996-2#1)(2005-10#1)(2006-4#1)(2010-5#1)
telecommunication wavelength##2##2##(2008-3#2)
telecommunication##17##1##(1996-2#1)(2005-10#2)(2006-4#1)(2007-11#4)(2007-12#1)(2007-9#1)(2008-2#1)(2008-3#5)(2010-5#1)
telecommunications and##2##2##(1995-12#1)(2005-10#1)
telecommunications system##4##2##(1995-2#1)(1997-2#1)(2007-12#1)(2007-9#1)
telecommunications##20##1##(1991-12#1)(1994-3#1)(1995-12#1)(1995-2#3)(1996-1#2)(1996-2#2)(1997-2#1)(2005-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-2#1)(2008-3#1)
teleconferencing##2##1##(2006-6#1)(2008-6#1)
teledermatology##2##1##(1997-2#1)(2008-12#1)
telehealth nursing services##3##3##(2012-3#3)
telehealth nursing##4##2##(2012-3#4)
telehealth technologies##3##2##(2007-10#1)(2013-1#2)
telehealth##19##1##(2007-10#4)(2010-5#3)(2010-9#3)(2012-12#2)(2012-3#4)(2013-1#2)(2013-8#1)
telemanipulation system##3##2##(2007-5#1)(2007-8#2)
telemanipulation##4##1##(2007-5#1)(2007-8#3)
telemanipulator##2##1##(2007-5#2)
telemanipulatory##2##1##(2007-5#2)
telemedicine and##4##2##(1996-11#1)(2006-6#1)(2008-5#1)(2012-2#1)
telemedicine has##3##2##(1996-11#1)(1996-3#1)(2005-10#1)
telemedicine in##3##2##(1996-2#1)(2005-10#1)(2013-1#1)
telemedicine system##2##2##(2005-10#1)(2008-8#1)
telemedicine##47##1##(1996-11#4)(1996-2#5)(1996-3#5)(2004-9#2)(2005-10#4)(2005-12#1)(2006-10#1)(2006-6#1)(2007-10#3)(2007-11#1)(2007-4#1)(2007-9#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#4)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#2)(2012-2#1)(2013-1#1)
telemeter##3##1##(2008-2#2)(2008-3#1)
telemetric##4##1##(1997-5#1)(2007-8#1)(2008-4#1)(2009-3#1)
telemetry monitoring##3##2##(2004-4#1)(2008-3#1)(2013-8#1)
telemetry system for##2##3##(2008-2#1)(2013-7#1)
telemetry system##3##2##(2008-2#1)(2013-7#2)
telemetry##27##1##(1991-3#2)(1992-4#1)(1997-3#1)(2004-4#2)(2007-12#1)(2008-2#1)(2008-3#4)(2008-9#6)(2010-12#1)(2010-6#1)(2010-8#1)(2013-7#3)(2013-8#3)
telemonitoring##3##1##(2009-3#2)(2010-8#1)
telencephali pars##2##2##(2008-6#2)
telencephali##4##1##(1995-7#1)(2008-6#3)
telencephalic regions##2##2##(1996-5#2)
telencephalic synaptoneurosomes##2##2##(1996-5#2)
telencephalic##10##1##(1990-10#2)(1996-5#4)(1996-7#1)(1997-3#1)(1997-6#1)(2009-2#1)
telencephalon in##2##2##(1995-12#2)
telencephalon or##2##2##(1996-5#2)
telencephalon##30##1##(1990-10#1)(1991-9#1)(1992-1#1)(1993-2#2)(1994-3#2)(1995-12#2)(1995-7#1)(1996-4#2)(1996-5#12)(1997-6#2)(2008-11#1)(2008-6#1)(2012-3#1)(2013-8#1)
teleocidin##4##1##(1992-9#1)(1993-7#3)
teleologic processes##2##2##(2008-5#2)
teleological explanation##3##2##(2012-2#3)
teleological reasoning##3##2##(2012-2#3)
teleological##10##1##(2006-1#1)(2012-2#9)
teleology##8##1##(2006-4#1)(2012-2#7)
teleomorph has##2##2##(2008-10#2)
teleomorph stage and##2##3##(2008-10#2)
teleomorph##10##1##(2008-10#9)(2010-3#1)
teleomorphs are##2##2##(2008-10#1)(2010-3#1)
teleomorphs##7##1##(2008-10#3)(2008-5#1)(2010-3#2)(2012-11#1)
teleost fish##14##2##(1991-10#1)(1993-3#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-4#2)(2008-7#2)(2009-2#1)(2012-11#1)(2012-12#1)(2012-3#1)
teleost fishes##3##2##(2008-1#2)(2012-2#1)
teleost pseudobranch##2##2##(2009-4#2)
teleost species##4##2##(1996-11#1)(1997-2#1)(2008-7#1)(2012-12#1)
teleost##50##1##(1991-10#1)(1991-9#1)(1993-3#1)(1993-5#1)(1994-2#1)(1995-12#1)(1995-2#2)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-9#2)(2006-8#2)(2008-1#3)(2008-5#1)(2008-7#6)(2008-8#3)(2009-2#1)(2009-4#3)(2010-4#1)(2010-8#2)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#1)
teleostean##3##1##(1993-5#1)(2008-1#1)(2008-7#1)
teleosts and##2##2##(1991-9#1)(2008-8#1)
teleosts from##2##2##(1995-2#1)(1997-3#1)
teleosts##28##1##(1991-5#1)(1991-9#1)(1992-1#2)(1995-2#2)(1996-5#1)(1997-3#2)(2007-3#2)(2007-7#1)(2007-9#2)(2008-1#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-4#1)(2009-5#1)(2010-2#1)(2010-5#1)(2010-8#3)(2012-11#1)
telephone advice##2##2##(1996-12#1)(2004-7#1)
telephone call was made##2##4##(2007-2#2)
telephone call##8##2##(2007-2#2)(2008-8#5)(2012-3#1)
telephone calls and##2##3##(1992-8#1)(2007-11#1)
telephone calls##6##2##(1992-11#1)(1992-8#1)(2004-7#1)(2007-11#1)(2011-2#1)(2012-3#1)
telephone consultation##2##2##(2004-7#2)
telephone conversations##2##2##(1993-5#1)(1995-12#1)
telephone counseling##2##2##(1996-5#1)(1997-2#1)
telephone interview and##2##3##(2007-10#1)(2007-2#1)
telephone interview##11##2##(1991-9#1)(2004-12#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-7#1)(2008-9#2)(2009-11#1)
telephone interviews were##3##3##(2008-11#1)(2012-11#2)
telephone interviews with##2##3##(2008-9#1)(2013-1#1)
telephone interviews##14##2##(1996-1#1)(2007-10#1)(2008-11#3)(2008-7#1)(2008-9#1)(2009-10#1)(2010-10#1)(2011-1#1)(2012-11#2)(2013-1#2)
telephone survey and crash investigation data##2##6##(2006-11#1)(2007-1#1)
telephone survey of##6##3##(1993-3#1)(1996-8#1)(1997-2#1)(2006-7#1)(2008-11#1)(2013-1#1)
telephone survey was##5##3##(1993-8#1)(1996-3#1)(2006-10#1)(2007-10#1)(2012-12#1)
telephone survey##22##2##(1993-3#1)(1993-8#1)(1995-3#1)(1996-1#2)(1996-3#1)(1996-8#1)(1997-2#1)(2006-10#1)(2006-11#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#2)(2008-11#1)(2008-5#1)(2012-12#2)(2013-1#1)
telephone surveys##3##2##(1995-12#1)(2013-1#2)
telephone systems and##2##3##(1997-2#1)(2010-2#1)
telephone systems##3##2##(1997-2#1)(2008-10#1)(2010-2#1)
telephone using##2##2##(1993-5#1)(2008-1#1)
telephone##138##1##(1991-2#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#2)(1993-8#2)(1994-2#1)(1994-6#2)(1995-1#1)(1995-12#2)(1995-3#1)(1995-6#2)(1995-9#1)(1996-1#4)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#4)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-5#1)(2004-12#1)(2004-7#7)(2004-9#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#4)(2007-11#2)(2007-2#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#6)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#8)(2008-9#5)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-11#3)(2010-2#5)(2010-3#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-11#2)(2012-12#2)(2012-3#2)(2013-1#11)(2013-8#2)
telephone-administered##3##1##(2007-10#3)
telephones##3##1##(1993-7#1)(2010-3#1)(2011-2#1)
telephonic health coaching##2##3##(2011-2#1)(2012-2#1)
telephonic##4##1##(2007-12#1)(2008-11#1)(2011-2#1)(2012-2#1)
teleportation##3##1##(2007-11#1)(2007-12#2)
telepresence##4##1##(2006-6#2)(2007-5#2)
telepsychiatry##3##1##(2004-11#2)(2012-2#1)
teleradiology and##4##2##(1996-2#1)(2007-11#1)(2007-4#2)
teleradiology in the##2##3##(2007-4#1)(2012-2#1)
teleradiology may##2##2##(1997-4#1)(2007-11#1)
teleradiology##34##1##(1996-2#4)(1997-4#3)(1997-8#1)(2004-9#4)(2007-11#4)(2007-4#15)(2012-2#3)
telerehabilitation##2##1##(2010-5#1)(2012-1#1)
telescope II##2##2##(2008-3#2)
telescope alignment##4##2##(2008-3#4)
telescope and a##2##3##(2007-12#1)(2008-3#1)
telescope and##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
telescope aperture##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
telescope are##2##2##(2008-2#1)(2008-3#1)
telescope at##2##2##(2007-12#1)(2008-2#1)
telescope by##2##2##(2007-11#1)(2008-3#1)
telescope diameter##2##2##(2008-3#2)
telescope for astrophysical research from##2##5##(2008-2#2)
telescope for##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
telescope in##2##2##(2007-12#1)(2008-3#1)
telescope is##2##2##(1990-12#1)(2008-2#1)
telescope mirrors##5##2##(2008-2#1)(2008-3#4)
telescope optics##2##2##(2008-2#1)(2008-3#1)
telescope pupil##3##2##(2008-2#1)(2008-3#2)
telescope rod implantation##2##3##(2007-7#2)
telescope rod##3##2##(2007-7#3)
telescope system##2##2##(2008-3#2)
telescope to##2##2##(2008-2#1)(2008-3#1)
telescope was##2##2##(2008-2#1)(2008-3#1)
telescope with a##5##3##(2007-12#1)(2008-3#4)
telescope with##9##2##(2007-12#1)(2008-3#8)
telescope##139##1##(1990-12#1)(1990-3#1)(1991-2#1)(1992-1#2)(2007-11#8)(2007-12#13)(2007-7#4)(2007-9#2)(2008-2#34)(2008-3#73)
telescope's##2##1##(2008-2#1)(2008-3#1)
telescopes and##2##2##(2006-10#1)(2008-2#1)
telescopes are##2##2##(2007-9#1)(2008-3#1)
telescopes can##2##2##(2007-9#1)(2008-2#1)
telescopes of the##2##3##(2008-2#1)(2008-3#1)
telescopes on##2##2##(1990-8#1)(2007-8#1)
telescopes to##3##2##(2008-3#3)
telescopes with##2##2##(2008-2#1)(2008-3#1)
telescopes##47##1##(1990-8#1)(1995-6#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#2)(2007-9#5)(2008-2#13)(2008-3#20)(2012-12#1)
telescopic##4##1##(2007-12#2)(2008-3#1)(2012-1#1)
telescoping##2##1##(2007-12#1)(2008-5#1)
telesurgical##2##1##(2006-6#1)(2006-9#1)
teletherapy##4##1##(2007-10#1)(2011-2#2)(2012-1#1)
telethermography##3##1##(1991-7#3)
television advertising of prescription##2##4##(2008-12#2)
television advertising##3##2##(2008-12#2)(2012-2#1)
television and radio##3##3##(1995-2#1)(1997-1#1)(1997-6#1)
television and##5##2##(1995-2#1)(1997-1#1)(1997-6#1)(2011-1#1)(2012-12#1)
television commercials##3##2##(2007-12#2)(2008-8#1)
television holography##3##2##(2008-3#3)
television news##2##2##(2011-2#2)
television or radio##2##3##(1996-5#1)(2008-2#1)
television viewing##3##2##(2009-7#2)(2012-12#1)
television##53##1##(1990-11#1)(1993-4#1)(1993-7#1)(1995-2#1)(1996-5#1)(1997-1#1)(1997-6#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-11#2)(2008-12#4)(2008-2#3)(2008-3#7)(2008-8#2)(2009-3#1)(2009-4#1)(2009-7#4)(2010-11#2)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)
televisions##4##1##(2008-11#1)(2008-2#3)
telia##6##1##(2008-10#6)
telial hosts##2##2##(2008-10#2)
telial##3##1##(2008-10#3)
teliospore germination##8##2##(2008-10#8)
teliospores of P##2##3##(2008-10#2)
teliospores of##6##2##(2008-10#6)
teliospores on##2##2##(2008-10#2)
teliospores produced##2##2##(2008-10#2)
teliospores##20##1##(2008-10#20)
telithromycin is##2##2##(2008-3#2)
telithromycin##5##1##(2005-7#1)(2008-3#4)
tell a##2##2##(2008-11#1)(2010-2#1)
tell about##2##2##(1990-8#1)(2006-9#1)
tell us about the##2##4##(2011-12#1)(2012-12#1)
tell us about##8##3##(2008-8#1)(2008-9#1)(2009-7#1)(2010-10#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
tell us##12##2##(2006-2#1)(2008-1#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-10#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
tell us?##4##2##(1997-4#1)(2006-9#1)(2009-10#1)(2009-5#1)
tell you##2##2##(2007-9#1)(2011-2#1)
tell##54##1##(1990-6#1)(1990-8#1)(1991-2#1)(1992-3#1)(1993-7#1)(1993-8#1)(1996-5#1)(1997-4#1)(2005-9#1)(2006-2#1)(2006-6#1)(2006-7#3)(2006-9#2)(2007-11#1)(2007-7#1)(2007-9#2)(2008-1#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-12#4)(2013-1#6)(2013-8#2)
telling us about##3##3##(2007-6#1)(2011-1#1)(2011-2#1)
telling##18##1##(1990-6#1)(1992-10#1)(1992-3#1)(1992-6#1)(1995-12#1)(1996-8#1)(1996-9#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-12#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#3)
tells us about##3##3##(2009-7#1)(2012-1#1)(2012-3#1)
tells us##4##2##(2009-7#1)(2012-1#1)(2012-3#1)(2013-7#1)
tells you##3##2##(2005-8#1)(2007-11#1)(2011-12#1)
tells##16##1##(1994-1#1)(1994-6#2)(1995-7#1)(2005-8#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-7#1)(2011-12#1)(2012-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
telluric##2##1##(1996-4#2)
tellurite glass##3##2##(2007-11#1)(2008-3#2)
tellurite##4##1##(2007-11#1)(2007-12#1)(2008-3#2)
tellurium##12##1##(1993-12#1)(2007-12#1)(2008-10#9)(2008-3#1)
telluronium choline##2##2##(1993-12#2)
telluronium##3##1##(1993-12#3)
telmisartan##11##1##(2010-3#5)(2010-9#3)(2011-2#2)(2011-3#1)
teloRZ##6##1##(2008-9#6)
teloblastic##2##1##(2007-12#2)
telogen effluvium was##2##3##(2008-5#2)
telogen effluvium##9##2##(2007-7#1)(2008-5#5)(2008-8#1)(2010-9#1)(2012-3#1)
telogen##11##1##(2007-7#2)(2008-5#6)(2008-8#1)(2010-9#1)(2012-3#1)
telomerase RNA##3##2##(2008-9#2)(2013-8#1)
telomerase activation##3##2##(2008-1#1)(2008-11#2)
telomerase activity and##8##3##(2004-1#1)(2006-10#1)(2007-12#1)(2008-11#4)(2008-9#1)
telomerase activity in##10##3##(2004-1#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-6#3)(2008-9#2)
telomerase activity is##2##3##(2004-1#1)(2008-8#1)
telomerase activity##38##2##(2004-1#5)(2006-10#1)(2006-9#1)(2007-12#1)(2008-1#2)(2008-11#10)(2008-4#2)(2008-6#7)(2008-8#2)(2008-9#4)(2009-5#1)(2010-2#1)(2012-12#1)
telomerase and##3##2##(2006-9#1)(2008-11#2)
telomerase in##5##2##(2007-11#1)(2008-8#2)(2008-9#1)(2012-3#1)
telomerase inhibitors##2##2##(2007-11#2)
telomerase is##3##2##(1990-8#1)(2007-11#1)(2008-11#1)
telomerase may##2##2##(2006-10#1)(2008-6#1)
telomerase reverse transcriptase (hTERT)##4##4##(2008-11#2)(2009-8#1)(2012-3#1)
telomerase reverse transcriptase##6##3##(2007-12#1)(2008-11#3)(2009-8#1)(2012-3#1)
telomerase reverse##7##2##(2007-12#1)(2008-11#4)(2009-8#1)(2012-3#1)
telomerase##114##1##(1990-5#1)(1990-8#2)(1995-6#3)(2004-1#5)(2004-8#1)(2005-8#1)(2006-10#3)(2006-9#2)(2007-11#9)(2007-12#2)(2008-1#5)(2008-11#37)(2008-4#3)(2008-5#3)(2008-6#8)(2008-8#5)(2008-9#8)(2009-5#1)(2009-8#1)(2010-2#1)(2011-1#4)(2012-1#5)(2012-12#1)(2012-3#2)(2013-8#1)
telomere biology##3##2##(2008-1#1)(2008-11#1)(2012-3#1)
telomere dysfunction##3##2##(2008-8#1)(2010-2#1)(2010-3#1)
telomere dysfunctional mice##2##3##(2010-3#2)
telomere dysfunctional##3##2##(2010-3#3)
telomere ends##2##2##(1991-9#1)(2010-2#1)
telomere formation##2##2##(1990-5#2)
telomere length and##5##3##(2006-10#1)(2008-4#2)(2012-12#1)(2013-8#1)
telomere length in##5##3##(2008-11#1)(2008-9#3)(2012-3#1)
telomere length of##2##3##(2008-11#1)(2008-8#1)
telomere length##27##2##(1990-8#2)(2006-10#1)(2008-11#3)(2008-4#3)(2008-8#1)(2008-9#6)(2011-1#2)(2012-12#1)(2012-3#6)(2013-8#2)
telomere lengths from##2##3##(2008-9#1)(2012-3#1)
telomere lengths##4##2##(2008-4#1)(2008-9#2)(2012-3#1)
telomere maintenance##11##2##(2008-1#1)(2008-11#4)(2008-8#1)(2010-12#1)(2011-1#4)
telomere regions of##2##3##(1995-4#1)(2008-8#1)
telomere sequence##4##2##(1991-9#1)(2008-11#3)
telomere shortening and##2##3##(1996-7#1)(2010-2#1)
telomere shortening##13##2##(1996-7#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-2#1)(2010-3#1)(2012-1#1)
telomere##105##1##(1990-5#4)(1990-8#6)(1991-7#1)(1991-9#2)(1993-9#1)(1995-4#1)(1996-7#1)(1997-5#1)(2006-10#1)(2007-11#1)(2008-1#4)(2008-10#1)(2008-11#18)(2008-4#4)(2008-5#1)(2008-8#7)(2008-9#10)(2009-5#1)(2010-12#1)(2010-2#4)(2010-3#6)(2011-1#8)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#11)(2013-1#1)(2013-8#2)
telomere-associated sequences##2##2##(2008-8#2)
telomere-associated##4##1##(2008-8#3)(2010-2#1)
telomere-binding protein##3##2##(1992-12#3)
telomere-controlled senescence##3##2##(2008-11#3)
telomere-independent##2##1##(2010-2#2)
telomere-like##2##1##(1993-12#2)
telomere-specific##2##1##(1996-4#1)(2008-9#1)
telomeres and telomerase##4##3##(2006-10#1)(2008-1#1)(2008-11#1)(2008-8#1)
telomeres and##11##2##(1995-1#2)(1995-4#1)(2006-10#1)(2008-1#1)(2008-11#3)(2008-8#1)(2011-2#1)(2012-3#1)
telomeres are sufficient to##2##4##(1991-9#2)
telomeres are##5##2##(1991-9#2)(2008-9#1)(2010-2#1)(2011-2#1)
telomeres containing##2##2##(1991-7#2)
telomeres in##2##2##(2008-1#1)(2011-2#1)
telomeres of##8##2##(1991-7#1)(1992-12#2)(1995-4#1)(1997-6#2)(2008-5#1)(2011-12#1)
telomeres to##2##2##(2010-2#1)(2011-2#1)
telomeres##57##1##(1990-5#2)(1990-8#1)(1991-7#7)(1991-9#4)(1992-12#2)(1995-1#3)(1995-4#2)(1997-6#2)(2006-10#2)(2006-5#1)(2007-3#1)(2008-1#2)(2008-11#9)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-2#4)(2011-1#1)(2011-12#1)(2011-2#5)(2012-3#1)
telomeric DNA exhibits##2##3##(1993-9#2)
telomeric DNA sequences##2##3##(2008-8#2)
telomeric DNA##17##2##(1990-5#4)(1990-8#2)(1993-9#4)(1995-6#1)(2008-11#2)(2008-8#3)(2010-2#1)
telomeric and##2##2##(1990-5#1)(2008-12#1)
telomeric damage##2##2##(2010-2#2)
telomeric regions##3##2##(2008-12#2)(2008-8#1)
telomeric repeat amplification##2##3##(2008-1#1)(2008-6#1)
telomeric repeat sequences##2##3##(2008-8#1)(2013-8#1)
telomeric repeat##5##2##(1990-8#1)(2008-1#1)(2008-6#1)(2008-8#1)(2013-8#1)
telomeric repeats##3##2##(1995-1#1)(2008-4#1)(2013-8#1)
telomeric sequences##5##2##(1991-9#2)(2008-5#1)(2010-2#1)(2010-3#1)
telomeric to the##2##3##(1990-11#1)(2009-8#1)
telomeric##68##1##(1990-11#1)(1990-5#6)(1990-8#3)(1990-9#1)(1991-9#2)(1993-3#1)(1993-9#5)(1994-11#1)(1995-1#1)(1995-2#2)(1995-6#1)(1996-4#3)(1997-6#1)(2006-12#1)(2008-1#2)(2008-10#1)(2008-11#5)(2008-12#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#5)(2009-5#1)(2009-8#1)(2010-12#2)(2010-2#8)(2010-3#1)(2010-8#1)(2011-2#1)(2013-8#3)
telomerisation##2##1##(2010-5#2)
telomerized fibroblasts##2##2##(2012-1#2)
telomerized##5##1##(1997-1#1)(2008-11#2)(2012-1#2)
telopeptide of type I collagen in##2##6##(1995-6#1)(1996-4#1)
telopeptide of type I collagen##4##5##(1995-6#1)(1996-4#3)
telopeptide##6##1##(1995-6#1)(1996-4#3)(2006-6#1)(2008-7#1)
telophase cells##2##2##(1997-7#2)
telophase##6##1##(1994-3#1)(1997-7#3)(2008-8#2)
teloptosis##2##1##(2008-5#2)
telotrophic##6##1##(2007-12#3)(2008-12#3)
temafloxacin in##2##2##(1991-12#2)
temafloxacin were##2##2##(1991-12#2)
temafloxacin##28##1##(1991-12#28)
temazepam and##2##2##(1995-2#1)(2008-11#1)
temazepam##8##1##(1990-11#1)(1991-11#1)(1995-2#5)(2008-11#1)
temephos##3##1##(2012-2#3)
temozolomide and##2##2##(2006-6#1)(2008-8#1)
temozolomide is##3##2##(2008-8#3)
temozolomide##10##1##(2006-6#1)(2008-8#6)(2011-2#2)(2011-3#1)
temperament and##11##2##(1992-9#1)(2004-2#1)(2005-7#1)(2006-3#2)(2009-10#1)(2009-2#1)(2009-8#1)(2012-12#3)
temperament is##2##2##(1991-1#1)(2013-8#1)
temperament profiles##2##2##(2013-8#2)
temperament##38##1##(1991-1#2)(1992-9#1)(1994-2#4)(1995-12#1)(2004-2#1)(2005-7#1)(2006-3#3)(2008-2#1)(2008-3#1)(2008-6#4)(2008-9#1)(2009-10#5)(2009-2#3)(2009-8#1)(2009-9#1)(2012-12#3)(2012-5#1)(2013-8#4)
temperamental##6##1##(2004-3#1)(2006-3#1)(2008-2#1)(2013-7#1)(2013-8#2)
temperaments in the##2##3##(2008-12#1)(2010-6#1)
temperaments##6##1##(1991-1#1)(2004-3#1)(2008-12#1)(2008-8#1)(2010-6#1)(2011-2#1)
temperate and tropical isolates##8##4##(2008-10#8)
temperate and tropical##11##3##(2007-3#1)(2008-10#10)
temperate and##14##2##(2007-3#1)(2008-10#10)(2008-12#1)(2008-8#1)(2012-12#1)
temperate area##2##2##(2007-7#1)(2008-12#1)
temperate climates##4##2##(2007-5#1)(2008-10#3)
temperate deciduous##3##2##(2008-9#1)(2013-8#2)
temperate forest##4##2##(1995-8#1)(2008-8#1)(2008-9#1)(2011-2#1)
temperate isolates##5##2##(2008-10#5)
temperate regions of the##2##4##(1996-12#1)(2008-10#1)
temperate regions of##4##3##(1996-12#1)(2008-10#3)
temperate regions##8##2##(1996-12#1)(2006-10#1)(2007-2#1)(2008-10#4)(2008-8#1)
temperate zones##3##2##(2008-9#1)(2012-2#1)(2013-1#1)
temperate##75##1##(1993-9#3)(1995-8#2)(1996-12#1)(1997-1#1)(2006-10#2)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#27)(2008-12#2)(2008-5#2)(2008-8#5)(2008-9#4)(2009-8#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#3)(2012-4#1)(2013-1#1)(2013-7#2)(2013-8#3)
temperature &gt##3##2##(1997-7#1)(2006-4#1)(2008-10#1)
temperature &lt##4##2##(1997-7#1)(2008-10#2)(2008-3#1)
temperature ( approximately##2##3##(2008-10#2)
temperature (##3##2##(2008-10#3)
temperature (&gt##3##2##(1995-5#1)(1997-7#2)
temperature (&lt##2##2##(1995-5#1)(2012-2#1)
temperature (-20##2##2##(2005-11#1)(2010-4#1)
temperature (0##2##2##(1990-5#1)(2008-3#1)
temperature (20##3##2##(1996-11#1)(2010-4#1)(2011-2#1)
temperature (22##3##2##(1995-1#1)(2005-10#1)(2005-11#1)
temperature (23 degrees C) and##2##5##(1994-8#1)(1995-1#1)
temperature (23 degrees C)##4##4##(1994-8#2)(1995-1#1)(1996-10#1)
temperature (25 degrees C)##4##4##(1990-11#1)(2008-12#2)(2008-5#1)
temperature (25 degrees##5##3##(1990-11#1)(2008-12#2)(2008-5#1)(2010-4#1)
temperature (25##7##2##(1990-11#1)(1995-1#1)(2008-10#1)(2008-12#2)(2008-5#1)(2010-4#1)
temperature (293 K)##2##3##(1994-8#1)(2008-10#1)
temperature (35 degrees C)##2##4##(1994-8#1)(2007-12#1)
temperature (35##3##2##(1994-8#1)(2007-10#1)(2007-12#1)
temperature (4##2##2##(2008-10#1)(2009-8#1)
temperature (5##3##2##(2008-10#2)(2010-4#1)
temperature (GT)##2##2##(2008-9#1)(2010-5#1)
temperature (SST)##2##2##(1992-7#1)(2008-2#1)
temperature (T(m)) of##2##3##(2008-5#1)(2011-1#1)
temperature (T)##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
temperature (Tb)##2##2##(2008-6#1)(2008-8#1)
temperature (Tc)##3##2##(1994-2#1)(2005-4#1)(2008-8#1)
temperature (Ts)##2##2##(1993-12#1)(2008-3#1)
temperature (i##2##2##(2008-10#1)(2008-4#1)
temperature (less than##2##3##(1990-2#1)(1991-7#1)
temperature (r = 0##3##4##(1997-6#2)(2006-7#1)
temperature (r=0##2##2##(2013-7#2)
temperature 1H NMR##2##3##(1994-11#1)(1994-9#1)
temperature 20##2##2##(2008-10#1)(2013-1#1)
temperature 31##2##2##(2007-3#1)(2008-6#1)
temperature 36##2##2##(2007-11#1)(2008-7#1)
temperature 37##3##2##(2005-8#1)(2008-5#1)(2013-7#1)
temperature DRIFTS##2##2##(2005-11#1)(2008-10#1)
temperature T##2##2##(2005-11#1)(2008-10#1)
temperature T(K)##2##2##(1995-3#1)(2005-11#1)
temperature T(g)##3##2##(1995-3#1)(2007-12#1)(2008-2#1)
temperature above##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
temperature affected##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
temperature affects##2##2##(2008-10#1)(2013-8#1)
temperature afforded the##2##3##(1997-1#1)(2007-11#1)
temperature afforded##3##2##(1997-1#1)(2007-11#1)(2010-5#1)
temperature after##5##2##(2007-12#1)(2008-10#1)(2011-1#1)(2013-7#2)
temperature along##2##2##(2008-3#1)(2012-6#1)
temperature and NaCl concentration##2##4##(1990-7#1)(1997-2#1)
temperature and OH concentration profiles##2##5##(2008-3#2)
temperature and OH##3##3##(2008-3#3)
temperature and RH##3##3##(2008-10#3)
temperature and a##4##3##(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)
temperature and applied##2##3##(2008-10#2)
temperature and at 37##2##4##(2008-10#1)(2008-5#1)
temperature and at##6##3##(1990-12#1)(2008-10#1)(2008-5#3)(2012-2#1)
temperature and atmospheric##2##3##(1996-1#1)(2007-12#1)
temperature and bending##2##3##(2007-12#2)
temperature and build height##2##4##(2008-2#2)
temperature and by##2##3##(1991-4#1)(2008-2#1)
temperature and cations on spermatozoa##2##5##(2011-12#2)
temperature and cations##3##3##(2005-11#1)(2011-12#2)
temperature and concentration##3##3##(2005-11#1)(2008-10#1)(2008-3#1)
temperature and decreasing##3##3##(2008-10#1)(2008-5#2)
temperature and density##3##3##(2008-1#1)(2008-9#2)
temperature and dew period##3##4##(2008-10#3)
temperature and duration##4##3##(2008-10#3)(2011-12#1)
temperature and feeding##2##3##(2008-7#1)(2013-8#1)
temperature and has##3##3##(1990-6#1)(2010-3#1)(2012-2#1)
temperature and heat##2##3##(1996-12#1)(2007-10#1)
temperature and heating##2##3##(2005-11#1)(2013-1#1)
temperature and humidity on##3##4##(2008-10#1)(2011-2#2)
temperature and humidity##12##3##(2008-10#1)(2008-5#1)(2009-3#1)(2011-2#6)(2013-1#1)(2013-7#2)
temperature and in##4##3##(1996-11#1)(2007-11#1)(2008-3#1)(2008-5#1)
temperature and initial##2##3##(2007-10#1)(2008-5#1)
temperature and inoculum density of##2##5##(2008-10#2)
temperature and ionic strength##2##4##(1992-8#1)(2008-10#1)
temperature and larval##2##3##(2007-5#1)(2008-9#1)
temperature and leaf wetness duration##5##5##(2008-10#5)
temperature and leaf wetness##6##4##(2008-10#6)
temperature and modifier concentration on##2##5##(2008-10#2)
temperature and moisture##7##3##(1997-2#1)(2008-10#4)(2008-2#1)(2008-8#1)
temperature and oxygen##2##3##(2005-12#1)(2008-3#1)
temperature and pH for the##2##5##(1990-4#1)(2008-10#1)
temperature and pH for##3##4##(1990-4#1)(2008-10#2)
temperature and pH of##2##4##(2005-11#1)(2008-4#1)
temperature and pH values##2##4##(1996-2#1)(2008-10#1)
temperature and pH##17##3##(1990-4#1)(1993-12#1)(1994-5#1)(1996-2#1)(1997-4#1)(2005-11#1)(2006-8#1)(2007-10#1)(2008-10#6)(2008-4#1)(2008-5#1)(2009-9#1)
temperature and pain##3##3##(1992-5#1)(2008-7#2)
temperature and pressure and##2##4##(2007-12#1)(2010-12#1)
temperature and pressure are##2##4##(2008-3#2)
temperature and pressure conditions##2##4##(2008-10#1)(2008-11#1)
temperature and pressure from##2##4##(2008-3#2)
temperature and pressure##27##3##(2005-12#1)(2005-9#1)(2007-12#4)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#9)(2008-6#1)(2010-12#1)(2012-1#1)(2012-2#1)
temperature and pump##2##3##(2007-12#1)(2008-3#1)
temperature and rain##2##3##(2008-5#2)
temperature and rainfall##3##3##(2008-10#2)(2008-8#1)
temperature and relative humidity (RH)##2##5##(1996-12#1)(2008-10#1)
temperature and relative humidity##10##4##(1995-3#1)(1996-12#1)(2008-10#5)(2008-8#1)(2010-10#1)(2010-12#1)
temperature and relative##15##3##(1995-3#1)(1996-12#1)(2008-10#5)(2008-2#2)(2008-3#3)(2008-8#1)(2010-10#1)(2010-12#1)
temperature and salinity##4##3##(1992-8#1)(2008-5#2)(2013-8#1)
temperature and soil moisture##2##4##(2008-10#2)
temperature and strain coefficients on##2##5##(2007-11#2)
temperature and strain##8##3##(2007-11#4)(2007-12#2)(2008-2#1)(2008-3#1)
temperature and subsequent##2##3##(2007-12#1)(2008-10#1)
temperature and subsequently##2##3##(2008-10#1)(2008-3#1)
temperature and that##3##3##(2007-2#1)(2008-10#1)(2013-8#1)
temperature and the##27##3##(1990-2#1)(1992-2#1)(1996-7#1)(1997-1#1)(2005-11#1)(2006-6#1)(2007-3#1)(2008-10#6)(2008-2#3)(2008-3#5)(2008-5#1)(2008-8#2)(2011-1#1)(2011-2#2)
temperature and then##2##3##(2006-10#1)(2008-10#1)
temperature and time of##5##4##(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-4#1)
temperature and time on the##3##5##(2004-9#1)(2008-3#1)(2011-1#1)
temperature and time on##4##4##(2004-9#1)(2008-3#1)(2011-1#1)(2013-1#1)
temperature and time##12##3##(2004-9#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2011-1#1)(2011-12#1)(2012-4#1)(2013-1#1)
temperature and velocity##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
temperature and viscosity effects##2##4##(2005-11#2)
temperature and viscosity##3##3##(2005-11#3)
temperature and voltage##2##3##(2008-10#2)
temperature and water##7##3##(2005-12#1)(2006-10#1)(2008-10#1)(2009-5#1)(2010-8#2)(2011-2#1)
temperature and wetness duration##2##4##(2008-10#2)
temperature and wetness##6##3##(2008-10#6)
temperature and##414##2##(1990-12#1)(1990-2#3)(1990-3#2)(1990-4#1)(1990-6#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-2#3)(1992-5#2)(1992-6#1)(1992-8#2)(1993-12#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#3)(1995-5#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#4)(1997-4#2)(1997-5#1)(1997-7#2)(2004-9#2)(2005-11#17)(2005-12#3)(2005-7#1)(2005-9#1)(2006-10#5)(2006-12#1)(2006-6#1)(2006-8#2)(2007-10#3)(2007-11#7)(2007-12#20)(2007-2#2)(2007-3#2)(2007-5#2)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#106)(2008-11#3)(2008-12#1)(2008-2#27)(2008-3#37)(2008-4#3)(2008-5#26)(2008-6#4)(2008-7#5)(2008-8#5)(2008-9#3)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#2)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#4)(2011-12#5)(2011-2#13)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#4)(2012-4#2)(2012-6#1)(2013-1#6)(2013-7#3)(2013-8#8)
temperature are##14##2##(2005-11#1)(2005-4#1)(2007-11#1)(2008-10#4)(2008-2#3)(2008-3#1)(2008-5#1)(2012-2#1)(2013-7#1)
temperature around##3##2##(2005-11#1)(2008-7#2)
temperature as a function of##2##5##(2007-12#1)(2008-1#1)
temperature as a##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
temperature as the##4##3##(2006-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
temperature as well as##5##4##(1992-3#1)(2008-10#1)(2008-3#2)(2012-2#1)
temperature as##20##2##(1990-8#1)(1992-3#1)(1994-2#1)(1995-3#1)(2006-1#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-5#1)(2011-1#3)(2012-2#1)
temperature at the##3##3##(2005-11#1)(2008-12#1)(2008-3#1)
temperature at which the##5##4##(1990-5#1)(1995-10#1)(2004-9#1)(2008-10#1)(2008-3#1)
temperature at which##9##3##(1990-5#1)(1994-12#1)(1995-10#1)(1995-2#1)(1996-1#1)(2004-9#2)(2008-10#1)(2008-3#1)
temperature at##27##2##(1990-3#1)(1990-5#1)(1994-12#1)(1995-10#1)(1995-2#1)(1996-1#1)(1996-12#1)(2004-9#2)(2005-11#1)(2005-12#1)(2006-8#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#1)(2012-12#1)(2013-7#1)
temperature behavior##2##2##(1993-3#1)(1997-4#1)
temperature below the##2##3##(2005-11#1)(2009-7#1)
temperature below##6##2##(1993-8#1)(2005-11#1)(2005-8#1)(2008-11#1)(2009-7#1)(2012-2#1)
temperature between##7##2##(2008-10#1)(2008-5#2)(2008-7#1)(2009-3#1)(2011-1#1)(2013-8#1)
temperature both##2##2##(2008-10#1)(2008-3#1)
temperature breaks##2##2##(2012-4#2)
temperature but not##2##3##(1996-2#1)(2007-8#1)
temperature but##3##2##(1990-3#1)(1996-2#1)(2007-8#1)
temperature by use of##5##4##(2007-11#1)(2008-2#1)(2008-3#3)
temperature by##17##2##(1991-5#1)(1993-4#1)(1995-8#1)(1996-7#1)(1997-1#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)
temperature can be##7##3##(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2009-4#1)
temperature can##10##2##(1991-11#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2009-4#1)
temperature caused##2##2##(2005-11#1)(2008-11#1)
temperature change in the##2##4##(1991-2#1)(2010-6#1)
temperature change or strain##2##4##(2008-2#2)
temperature change or##3##3##(2008-10#1)(2008-2#2)
temperature change##13##2##(1991-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2010-6#1)(2010-8#2)(2012-12#1)(2012-6#1)
temperature changes observed##2##3##(1991-8#1)(2008-10#1)
temperature changes on##2##3##(2008-3#1)(2008-8#1)
temperature changes##16##2##(1990-3#1)(1991-8#1)(1993-12#1)(1994-10#1)(1994-3#1)(1994-6#1)(1994-9#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
temperature close to##2##3##(2008-3#1)(2008-5#1)
temperature coefficient of##2##3##(2005-11#1)(2007-12#1)
temperature coefficient##5##2##(1991-5#1)(1997-4#1)(2005-11#1)(2007-12#1)(2008-10#1)
temperature coefficients##5##2##(1991-12#1)(1994-5#1)(2008-10#1)(2008-3#1)(2008-5#1)
temperature compared to##2##3##(2005-11#1)(2010-8#1)
temperature compared with##2##3##(1990-11#1)(2005-4#1)
temperature compared##4##2##(1990-11#1)(2005-11#1)(2005-4#1)(2010-8#1)
temperature compensation of##2##3##(2008-2#1)(2008-3#1)
temperature compensation##7##2##(2006-7#1)(2008-2#3)(2008-3#2)(2013-8#1)
temperature condition##3##2##(2008-12#3)
temperature conditions##21##2##(1991-11#1)(1991-3#1)(1994-10#1)(1997-2#2)(2007-11#1)(2008-10#4)(2008-12#3)(2008-4#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-7#1)(2011-12#1)(2012-12#1)(2013-7#1)
temperature control of##2##3##(2008-2#2)
temperature control##10##2##(2006-4#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#1)(2011-2#1)
temperature could##2##2##(2005-12#1)(2008-10#1)
temperature cultivation##2##2##(2008-11#2)
temperature curves##3##2##(2008-10#2)(2008-11#1)
temperature cycling##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
temperature damage##2##2##(2006-6#1)(2009-2#1)
temperature data##5##2##(2005-11#1)(2006-6#1)(2008-10#1)(2008-3#1)(2008-8#1)
temperature decrease in##2##3##(1992-2#1)(2005-11#1)
temperature decreased##3##2##(2008-10#2)(2011-1#1)
temperature dependence and##2##3##(2007-11#1)(2008-3#1)
temperature dependence of a##2##4##(2007-12#1)(2008-3#1)
temperature dependence of the fluorescence##3##5##(1991-4#1)(2008-2#2)
temperature dependence of the##43##4##(1990-3#2)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-4#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-5#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-11#4)(2006-1#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#8)(2008-3#6)(2008-5#1)
temperature dependence of these##3##4##(1992-7#1)(1995-10#1)(2006-4#1)
temperature dependence of##72##3##(1990-3#2)(1990-7#2)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-4#1)(1992-7#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-2#2)(1995-5#1)(1996-12#2)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(2004-9#1)(2005-11#7)(2006-1#1)(2006-10#3)(2006-4#1)(2006-6#1)(2007-11#2)(2007-12#6)(2007-9#1)(2008-10#3)(2008-2#10)(2008-3#10)(2008-5#1)(2009-12#1)
temperature dependence##92##2##(1990-3#2)(1990-7#2)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#3)(1992-12#1)(1992-3#1)(1992-4#2)(1992-7#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-2#2)(1995-5#2)(1996-12#2)(1996-5#1)(1997-2#1)(1997-4#3)(1997-6#1)(1997-7#1)(2004-9#1)(2005-11#7)(2006-1#1)(2006-10#3)(2006-4#1)(2006-6#1)(2007-11#3)(2007-12#7)(2007-9#1)(2008-10#6)(2008-2#12)(2008-3#15)(2008-5#2)(2009-12#1)
temperature dependences of the##2##4##(2006-10#1)(2008-5#1)
temperature dependencies##2##2##(1993-8#1)(2005-11#1)
temperature dependent and##3##3##(1994-12#1)(1994-8#1)(1996-2#1)
temperature dependent##19##2##(1990-8#1)(1994-12#1)(1994-8#4)(1995-5#1)(1996-2#1)(1996-6#1)(1996-9#2)(1997-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2010-2#1)
temperature depression##2##2##(2008-10#2)
temperature derivative##2##2##(2008-2#1)(2008-3#1)
temperature determination##4##2##(2007-12#1)(2008-2#3)
temperature diagnostics##2##2##(2007-12#1)(2008-2#1)
temperature did not##2##3##(2008-10#1)(2008-2#1)
temperature difference between the##3##4##(1990-7#1)(2008-5#1)(2010-6#1)
temperature difference between##4##3##(1990-7#1)(2007-7#1)(2008-5#1)(2010-6#1)
temperature difference##15##2##(1990-7#1)(2007-7#3)(2008-10#1)(2008-2#3)(2008-3#4)(2008-5#1)(2010-6#2)
temperature differences##4##2##(2005-11#1)(2008-2#1)(2008-3#1)(2009-6#1)
temperature differential in rats##2##4##(2007-12#2)
temperature differential##4##2##(2007-12#3)(2008-2#1)
temperature displayed a##2##3##(2008-11#1)(2010-4#1)
temperature distribution in##2##3##(2008-3#2)
temperature distribution on##2##3##(2008-2#1)(2008-3#1)
temperature distribution##13##2##(2007-11#1)(2008-10#2)(2008-2#3)(2008-3#6)(2008-7#1)
temperature distributions and thermal deformations##2##5##(2008-3#2)
temperature distributions for##2##3##(2007-11#1)(2008-2#1)
temperature distributions##11##2##(2007-11#1)(2008-2#3)(2008-3#7)
temperature drift in##2##3##(2013-8#2)
temperature drift##4##2##(2008-2#1)(2013-8#3)
temperature dropped##2##2##(1995-3#1)(2008-10#1)
temperature during the##6##3##(1994-8#1)(2008-10#3)(2008-12#1)(2011-1#1)
temperature during wetness and during the incubation period##2##8##(2008-10#2)
temperature during##18##2##(1994-8#1)(1996-7#1)(1997-5#1)(2007-4#1)(2008-10#10)(2008-12#1)(2011-1#1)(2011-2#1)(2012-11#1)
temperature effect on##4##3##(2008-10#1)(2008-11#1)(2013-7#2)
temperature effect was##3##3##(2008-10#1)(2010-8#2)
temperature effect##14##2##(1996-2#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-3#1)(2010-8#2)(2012-5#1)(2013-7#2)
temperature effects in##2##3##(2008-2#1)(2008-8#1)
temperature effects##8##2##(2008-10#3)(2008-11#2)(2008-2#1)(2008-8#2)
temperature elevation##2##2##(1990-2#1)(2007-10#1)
temperature error of##3##3##(2007-12#2)(2008-3#1)
temperature etc##2##2##(2005-11#1)(2010-5#1)
temperature expansion##2##2##(1992-9#1)(2008-2#1)
temperature experienced##2##2##(2008-8#1)(2011-2#1)
temperature field database##2##3##(2008-3#2)
temperature field##7##2##(1994-7#1)(2008-2#1)(2008-3#5)
temperature fields##2##2##(2008-3#2)
temperature fluctuation##3##2##(2007-11#1)(2008-2#1)(2013-8#1)
temperature fluctuations and##2##3##(2008-2#1)(2008-3#1)
temperature fluctuations in##2##3##(1990-4#1)(2011-12#1)
temperature fluctuations##5##2##(1990-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-12#1)
temperature fluorescence##2##2##(1992-4#1)(2008-10#1)
temperature for 2##2##3##(2008-10#1)(2008-5#1)
temperature for 3##2##3##(2006-5#1)(2011-2#1)
temperature for a##4##3##(1997-7#1)(2005-11#1)(2008-10#1)(2008-11#1)
temperature for activity##2##3##(1997-4#1)(2008-10#1)
temperature for growth of##2##4##(2008-10#1)(2010-3#1)
temperature for infection##3##3##(2008-10#3)
temperature for surfactants with##2##4##(2005-11#2)
temperature for the reaction##2##4##(1994-11#1)(2008-10#1)
temperature for the##8##3##(1994-11#1)(2008-10#3)(2008-6#2)(2008-9#1)(2012-2#1)
temperature for##58##2##(1990-11#1)(1991-3#1)(1991-8#1)(1991-9#1)(1994-11#1)(1995-2#4)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(2005-11#3)(2006-5#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#15)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#3)(2008-6#2)(2008-9#1)(2009-6#1)(2010-3#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)
temperature from 37 degrees C to##3##6##(1990-11#1)(2008-11#2)
temperature from the##4##3##(2006-10#1)(2007-12#1)(2008-3#1)(2010-7#1)
temperature from##23##2##(1990-11#1)(1992-7#1)(1995-6#1)(2006-10#1)(2006-8#1)(2007-12#3)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2010-7#1)
temperature gradient##5##2##(2005-11#1)(2007-11#1)(2011-2#1)(2012-5#1)(2013-1#1)
temperature gradients##6##2##(2007-11#1)(2008-10#1)(2008-3#3)(2008-9#1)
temperature had##4##2##(2008-10#1)(2008-11#1)(2010-8#1)(2012-12#1)
temperature has##2##2##(2008-10#1)(2011-12#1)
temperature have been##6##3##(2007-12#1)(2008-2#1)(2008-3#2)(2008-9#1)(2011-2#1)
temperature holes##2##2##(2007-7#2)
temperature in a##7##3##(1990-11#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2013-7#1)
temperature in aqueous##4##3##(1991-9#1)(2005-11#2)(2008-10#1)
temperature in the range of##2##5##(1997-8#1)(2008-10#1)
temperature in the range##7##4##(1995-6#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#3)
temperature in the sample chamber of a##2##7##(2008-11#1)(2008-9#1)
temperature in the##25##3##(1990-11#1)(1991-11#1)(1991-8#1)(1995-6#1)(1997-2#1)(1997-8#1)(2004-9#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#3)(2008-9#1)(2010-8#1)(2012-3#1)
temperature in this##2##3##(2007-12#1)(2008-11#1)
temperature in##75##2##(1990-11#2)(1990-5#4)(1991-1#1)(1991-11#1)(1991-2#2)(1991-8#1)(1991-9#1)(1994-12#1)(1995-6#1)(1996-1#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2004-9#2)(2005-10#1)(2005-11#2)(2005-12#1)(2006-10#1)(2006-12#1)(2007-10#3)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#13)(2008-11#3)(2008-2#2)(2008-3#4)(2008-5#1)(2008-8#2)(2008-9#1)(2010-12#1)(2010-8#2)(2011-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-7#2)
temperature increase##9##2##(1992-7#1)(2007-10#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-4#1)(2013-8#2)
temperature increased##12##2##(1992-1#1)(2004-9#1)(2005-12#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-11#1)(2011-12#1)(2013-8#1)
temperature increases##9##2##(1995-1#1)(1996-2#1)(2007-12#2)(2008-10#1)(2008-9#1)(2009-4#1)(2012-2#1)(2013-8#1)
temperature independent##5##2##(1995-2#1)(1996-11#1)(2007-11#1)(2008-7#1)(2009-5#1)
temperature induced by##3##3##(1990-5#2)(2007-12#1)
temperature induced##4##2##(1990-5#2)(2007-12#1)(2008-10#1)
temperature information##2##2##(1990-3#1)(2007-12#1)
temperature inside the##2##3##(2008-10#1)(2008-2#1)
temperature inside##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
temperature instability##2##2##(2006-11#1)(2008-10#1)
temperature inversion##2##2##(2008-3#2)
temperature is accompanied by##2##4##(1990-3#1)(2011-1#1)
temperature is an important##2##4##(2008-10#1)(2008-9#1)
temperature is demonstrated##2##3##(2007-11#1)(2008-3#1)
temperature is determined##2##3##(2007-11#1)(2009-11#1)
temperature is observed##2##3##(2005-11#2)
temperature is raised from 30 to##2##6##(1990-3#1)(2008-6#1)
temperature is raised from##3##4##(1990-3#1)(2008-11#1)(2008-6#1)
temperature is raised##4##3##(1990-3#1)(1995-2#1)(2008-11#1)(2008-6#1)
temperature is##56##2##(1990-3#2)(1990-8#1)(1991-7#1)(1993-11#1)(1995-2#4)(1996-10#1)(1996-12#1)(1997-7#1)(2005-11#5)(2005-8#1)(2006-1#1)(2006-10#1)(2006-9#1)(2007-11#2)(2007-12#3)(2008-10#6)(2008-11#1)(2008-2#7)(2008-3#5)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-12#1)(2013-8#1)
temperature jump##3##2##(1997-7#3)
temperature leads to##2##3##(2008-10#1)(2010-3#1)
temperature level##2##2##(2006-6#2)
temperature levels##3##2##(2008-5#1)(2011-12#1)(2012-2#1)
temperature lidar##2##2##(2008-2#2)
temperature magnetic##2##2##(2007-11#1)(2008-5#1)
temperature management system##2##3##(2007-10#1)(2007-8#1)
temperature management##5##2##(2006-10#2)(2007-10#2)(2007-8#1)
temperature may##2##2##(1996-2#1)(2011-1#1)
temperature measured by the##2##4##(1990-2#1)(2008-3#1)
temperature measured with##2##3##(1990-2#1)(2008-2#1)
temperature measured##6##2##(1990-2#2)(1991-8#2)(2008-2#1)(2008-3#1)
temperature measurement with##3##3##(2007-12#1)(2008-3#2)
temperature measurement##17##2##(1990-2#2)(2007-11#1)(2007-12#2)(2007-7#1)(2008-2#2)(2008-3#8)(2011-2#1)
temperature measurements and##2##3##(2007-11#1)(2008-2#1)
temperature measurements by##2##3##(2007-11#1)(2008-3#1)
temperature measurements in##9##3##(2006-12#1)(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#1)(2009-4#1)
temperature measurements of##2##3##(2008-2#1)(2008-3#1)
temperature measurements with##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
temperature measurements##35##2##(2006-12#2)(2007-11#5)(2007-12#4)(2008-2#9)(2008-3#14)(2009-4#1)
temperature must##2##2##(2006-12#1)(2011-1#1)
temperature near##2##2##(2005-11#1)(2007-11#1)
temperature not only##2##3##(1992-6#1)(2005-11#1)
temperature not##4##2##(1992-6#1)(1996-2#1)(2005-11#1)(2008-9#1)
temperature of 10 degrees C##2##5##(2006-10#1)(2008-10#1)
temperature of 10##3##3##(2006-10#1)(2008-10#1)(2011-12#1)
temperature of 1000 degrees C##2##5##(2007-11#1)(2008-10#1)
temperature of 15 degrees C with an##2##7##(2008-2#2)
temperature of 15 degrees C##4##5##(2007-12#1)(2008-2#3)
temperature of 150##2##3##(2007-12#1)(2008-10#1)
temperature of 1500 degrees C##2##5##(2008-10#1)(2008-2#1)
temperature of 1900 degrees C##2##5##(2008-10#2)
temperature of 24##3##3##(2005-12#1)(2008-10#1)(2013-7#1)
temperature of 25 +/-##2##4##(2008-10#1)(2008-6#1)
temperature of 25 degrees C##5##5##(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)
temperature of 25##7##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)
temperature of 30 degrees C##3##5##(2005-12#1)(2008-5#1)(2012-12#1)
temperature of 30##4##3##(1995-2#1)(2005-12#1)(2008-5#1)(2012-12#1)
temperature of 300##2##3##(1995-6#1)(2007-12#1)
temperature of 35 degrees C##3##5##(2007-10#1)(2008-10#1)(2008-5#1)
temperature of 37 degrees C##3##5##(2006-5#1)(2008-10#2)
temperature of 40##2##3##(2004-9#1)(2008-5#1)
temperature of 50 degrees C##3##5##(2008-10#2)(2008-5#1)
temperature of a##2##3##(1991-7#1)(2008-2#1)
temperature of about##2##3##(1990-9#1)(2008-10#1)
temperature of an##2##3##(1991-7#1)(2008-2#1)
temperature of approximately##2##3##(2008-10#1)(2013-7#1)
temperature of each##2##3##(1996-11#1)(2008-4#1)
temperature of the adhesive##2##4##(2008-3#2)
temperature of the cold##3##4##(2007-12#1)(2011-2#1)(2012-3#1)
temperature of the incoming arterial blood##2##6##(2008-1#2)
temperature of the solution##2##4##(1996-2#1)(2008-10#1)
temperature of the##63##3##(1990-4#3)(1991-5#1)(1991-7#1)(1992-2#1)(1993-3#1)(1993-4#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-3#1)(2005-11#4)(2005-4#1)(2006-3#1)(2007-11#3)(2007-12#4)(2007-6#1)(2008-1#2)(2008-10#12)(2008-2#1)(2008-3#9)(2008-4#1)(2008-7#2)(2009-3#1)(2010-11#1)(2010-5#2)(2010-9#1)(2011-2#2)(2012-3#1)(2013-7#1)
temperature of##211##2##(1990-2#1)(1990-4#3)(1990-8#1)(1990-9#1)(1991-5#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1994-12#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-6#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-9#2)(1997-3#1)(2004-9#2)(2005-11#5)(2005-12#2)(2005-4#1)(2006-10#2)(2006-3#1)(2006-4#1)(2006-5#3)(2006-8#1)(2007-10#2)(2007-11#8)(2007-12#10)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2008-1#2)(2008-10#50)(2008-11#3)(2008-12#2)(2008-2#12)(2008-3#14)(2008-4#2)(2008-5#8)(2008-6#4)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#3)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#3)(2013-8#2)
temperature on infection##2##3##(2008-10#2)
temperature on the##40##3##(1990-11#1)(1990-8#1)(1991-11#2)(1991-5#1)(1992-5#1)(1992-6#2)(1995-8#1)(1996-5#1)(1997-2#1)(2004-9#1)(2005-11#1)(2008-10#14)(2008-3#3)(2008-5#2)(2009-4#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-7#1)(2013-8#2)
temperature on their##2##3##(2008-10#1)(2008-7#1)
temperature on##97##2##(1990-11#2)(1990-8#2)(1991-11#2)(1991-5#2)(1991-6#1)(1992-1#1)(1992-5#1)(1992-6#2)(1993-5#1)(1994-5#2)(1995-8#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-12#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#30)(2008-11#3)(2008-3#4)(2008-5#5)(2008-6#1)(2008-7#4)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-4#2)(2010-8#2)(2011-2#3)(2012-2#2)(2012-6#1)(2013-7#2)(2013-8#3)
temperature optimum of##3##3##(1990-12#1)(2004-8#1)(2008-10#1)
temperature optimum##9##2##(1990-12#1)(1990-5#1)(1991-5#1)(1994-11#1)(1994-9#1)(2004-8#1)(2006-8#1)(2008-10#2)
temperature or at##4##3##(2007-10#1)(2008-10#1)(2008-5#2)
temperature or##18##2##(1990-5#1)(1992-7#1)(1993-3#1)(1995-4#1)(2004-9#2)(2007-10#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-4#1)(2008-5#2)(2010-4#1)(2012-7#1)
temperature over the##3##3##(1991-4#1)(1996-2#2)
temperature over##4##2##(1991-4#1)(1996-2#2)(2008-3#1)
temperature peak##2##2##(1992-10#1)(2011-2#1)
temperature phosphorescence (RTP) emission##2##4##(2008-10#2)
temperature phosphorescence (RTP)##8##3##(2007-8#1)(2008-10#7)
temperature phosphorescence of##3##3##(2008-10#3)
temperature phosphorescence##26##2##(1991-8#1)(2007-8#1)(2008-10#24)
temperature phosphorimetric##2##2##(2005-4#1)(2008-10#1)
temperature phosphorimetry##3##2##(2008-10#3)
temperature plays##2##2##(2006-10#1)(2008-3#1)
temperature preferences##2##2##(2008-10#1)(2010-8#1)
temperature probe##2##2##(2007-12#1)(2008-2#1)
temperature profile##7##2##(2006-6#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#2)
temperature profiles in the##2##4##(2008-3#2)
temperature profiles in##3##3##(2006-10#1)(2008-3#2)
temperature profiles of##2##3##(1993-3#1)(2008-2#1)
temperature profiles##15##2##(1991-2#1)(1993-3#1)(1996-12#1)(2006-10#1)(2008-2#5)(2008-3#4)(2011-2#2)
temperature profiling##4##2##(2008-2#2)(2008-3#2)
temperature program##11##2##(2007-10#1)(2007-8#1)(2008-10#6)(2008-6#1)(2012-1#2)
temperature programme##2##2##(2004-9#1)(2008-10#1)
temperature range and##2##3##(1990-3#1)(1993-11#1)
temperature range for##2##3##(2008-10#2)
temperature range from 10 to##2##5##(2008-10#1)(2008-3#1)
temperature range from##10##3##(2005-11#1)(2006-12#1)(2008-10#2)(2008-2#2)(2008-3#4)
temperature range of##21##3##(1991-2#1)(1993-8#1)(1994-12#1)(1996-1#1)(1996-5#1)(1996-7#1)(1997-8#1)(2005-11#2)(2007-1#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-5#1)(2009-9#1)
temperature range the##2##3##(1995-5#1)(2005-11#1)
temperature range was##2##3##(2008-10#1)(2008-6#1)
temperature range##88##2##(1990-11#1)(1990-2#1)(1990-3#2)(1990-5#1)(1991-2#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-8#2)(1994-12#2)(1994-5#1)(1994-9#1)(1995-2#3)(1995-5#1)(1996-1#2)(1996-2#1)(1996-5#1)(1996-7#1)(1997-4#1)(1997-8#1)(2005-11#6)(2006-10#4)(2006-12#1)(2006-4#1)(2006-6#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-10#14)(2008-2#10)(2008-3#10)(2008-5#1)(2008-6#1)(2008-7#1)(2009-9#1)
temperature ranges##4##2##(1997-2#1)(2008-10#3)
temperature ranging from##4##3##(1990-3#1)(1996-12#1)(2008-10#1)(2010-6#1)
temperature reference##3##2##(2008-2#2)(2008-3#1)
temperature regime##2##2##(2008-10#1)(2011-12#1)
temperature regimes of##2##3##(2008-8#1)(2011-2#1)
temperature regimes##14##2##(2008-10#6)(2008-12#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-8#2)(2011-2#1)(2012-2#1)
temperature region##2##2##(1990-4#1)(2004-9#1)
temperature regions##2##2##(1990-11#1)(2005-11#1)
temperature regulation in##2##3##(1994-4#1)(2008-1#1)
temperature regulation##7##2##(1994-4#1)(1996-2#1)(2008-1#2)(2008-6#1)(2009-5#1)(2010-2#1)
temperature relationships##2##2##(2008-10#2)
temperature resolution of##3##3##(2007-12#1)(2008-3#2)
temperature resolution##4##2##(2007-12#1)(2008-3#3)
temperature response##5##2##(2008-10#1)(2008-2#1)(2009-11#1)(2010-6#1)(2012-6#1)
temperature resulted##2##2##(2010-4#1)(2013-7#1)
temperature results in##4##3##(1990-5#1)(1993-9#1)(2005-11#1)(2013-8#1)
temperature results##5##2##(1990-5#1)(1993-9#1)(2005-11#1)(2007-11#1)(2013-8#1)
temperature rise in the##2##4##(2008-2#1)(2008-3#1)
temperature rise in##6##3##(1990-4#1)(2008-2#1)(2008-3#2)(2008-5#2)
temperature rise##13##2##(1990-4#1)(2008-2#2)(2008-3#4)(2008-5#5)(2009-11#1)
temperature sensitive transient receptor potential##2##5##(2009-3#1)(2011-2#1)
temperature sensitive##9##2##(1993-4#1)(1995-5#1)(1997-6#1)(2006-9#1)(2008-10#2)(2009-3#1)(2009-8#1)(2011-2#1)
temperature sensitivities##3##2##(1995-5#1)(2007-11#2)
temperature sensitivity and##2##3##(2008-3#1)(2010-3#1)
temperature sensitivity for##4##3##(1991-1#4)
temperature sensitivity in##2##3##(1997-6#1)(2008-3#1)
temperature sensitivity of the##2##4##(2008-9#1)(2013-1#1)
temperature sensitivity of##8##3##(2007-12#1)(2008-10#1)(2008-3#2)(2008-8#1)(2008-9#2)(2013-1#1)
temperature sensitivity to##2##3##(2008-2#1)(2008-3#1)
temperature sensitivity##24##2##(1991-1#4)(1994-12#1)(1995-2#1)(1995-8#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-8#1)(2008-9#2)(2010-3#1)(2013-1#1)
temperature sensor based on##2##4##(2007-12#1)(2008-2#1)
temperature sensor using##2##3##(2007-11#1)(2008-1#1)
temperature sensor with##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
temperature sensor##18##2##(2006-6#1)(2007-11#4)(2007-12#4)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#2)(2013-1#1)
temperature sensors##2##2##(2007-12#1)(2010-4#1)
temperature shift##9##2##(1991-2#1)(1994-11#1)(1994-2#1)(1995-6#1)(2007-6#1)(2008-11#3)(2011-12#1)
temperature shifts##3##2##(2008-11#1)(2008-3#1)(2008-7#1)
temperature simultaneously##2##2##(2007-12#1)(2008-8#1)
temperature stability of the##4##4##(1993-6#1)(2007-11#1)(2008-3#2)
temperature stability of##6##3##(1993-6#1)(2007-11#1)(2008-2#1)(2008-3#3)
temperature stability##11##2##(1993-6#1)(1994-8#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#4)
temperature stabilization##2##2##(2008-2#2)
temperature studied##3##2##(1990-2#1)(1994-8#1)(2005-11#1)
temperature studies##4##2##(1990-2#1)(1997-8#1)(2007-12#1)(2008-5#1)
temperature than the##3##3##(1990-12#1)(1991-11#1)(2007-12#1)
temperature than##10##2##(1990-12#1)(1991-11#1)(1992-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-3#1)(2012-2#1)(2013-1#1)
temperature that##4##2##(2006-10#1)(2007-12#1)(2008-2#1)(2013-1#1)
temperature the##8##2##(1994-8#1)(1995-10#1)(1995-11#1)(2006-4#2)(2007-12#3)
temperature threshold##3##2##(1997-6#1)(2008-9#1)(2011-2#1)
temperature thresholds##2##2##(2008-10#2)
temperature through##2##2##(1996-11#1)(2008-10#1)
temperature to allow for##2##4##(2008-12#1)(2011-2#1)
temperature to##33##2##(1994-11#1)(1994-2#1)(1995-1#1)(1995-6#1)(1996-10#1)(1996-11#1)(1997-1#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-6#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-4#1)(2010-9#1)(2011-2#1)
temperature transition##4##2##(1991-7#3)(1996-11#1)
temperature treatment##3##2##(2008-10#1)(2008-9#1)(2013-8#1)
temperature tuned over##2##3##(2007-12#2)
temperature tuned##3##2##(2007-12#3)
temperature tuning of the##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
temperature tuning of##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
temperature tuning##12##2##(2007-11#1)(2007-12#4)(2008-1#1)(2008-2#4)(2008-3#2)
temperature under##4##2##(1997-2#1)(2007-11#1)(2007-12#1)(2007-8#1)
temperature up to##4##3##(1996-12#1)(2008-10#3)
temperature upshift##2##2##(1993-11#2)
temperature used##3##2##(1990-7#1)(2008-5#1)(2012-2#1)
temperature using##4##2##(1992-12#1)(2006-1#1)(2008-10#2)
temperature variability##2##2##(1990-3#1)(2006-7#1)
temperature variation and##2##3##(2005-11#1)(2012-6#1)
temperature variation of##2##3##(1997-2#1)(2008-3#1)
temperature variation##9##2##(1997-2#1)(2005-11#2)(2007-11#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-6#1)(2013-8#1)
temperature variations##13##2##(1990-10#1)(1994-12#1)(2007-8#1)(2008-10#2)(2008-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-7#4)
temperature was &gt##2##3##(2008-10#1)(2009-2#1)
temperature was 1##2##3##(1990-2#1)(2007-11#1)
temperature was 25 degrees C and the##2##7##(2011-1#1)(2012-3#1)
temperature was 37##2##3##(2009-10#1)(2011-1#1)
temperature was also##4##3##(1990-3#1)(2008-10#1)(2008-6#1)(2010-4#1)
temperature was between##3##3##(2008-10#2)(2008-6#1)
temperature was found##2##3##(1991-3#1)(2011-2#1)
temperature was increased##3##3##(2005-11#1)(2007-12#1)(2008-10#1)
temperature was kept at##2##4##(2005-12#1)(2011-1#1)
temperature was kept##3##3##(2005-12#1)(2008-10#1)(2011-1#1)
temperature was measured by##2##4##(1990-2#1)(2008-5#1)
temperature was measured in the##2##5##(1991-8#1)(1996-7#1)
temperature was measured##5##3##(1990-2#1)(1991-8#1)(1996-7#1)(2008-5#1)(2010-7#1)
temperature was not significantly different between the##2##7##(2005-8#1)(2007-4#1)
temperature was observed##5##3##(2005-8#1)(2008-10#3)(2010-4#1)
temperature was raised##2##3##(1990-2#1)(2008-4#1)
temperature was recorded##2##3##(2008-10#1)(2008-3#1)
temperature was reduced##3##3##(1992-2#1)(2006-1#1)(2007-10#1)
temperature was slightly##2##3##(2008-10#1)(2008-3#1)
temperature was##101##2##(1990-2#3)(1990-3#1)(1990-5#1)(1991-3#1)(1991-8#1)(1992-2#1)(1994-3#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-2#2)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-11#3)(2005-12#1)(2005-4#1)(2005-8#3)(2006-1#1)(2007-10#3)(2007-11#2)(2007-12#6)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#27)(2008-11#1)(2008-3#5)(2008-4#1)(2008-5#5)(2008-6#4)(2008-7#1)(2009-10#1)(2009-2#1)(2010-4#2)(2010-7#1)(2011-1#4)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
temperature we##3##2##(2007-12#1)(2008-2#1)(2012-2#1)
temperature were also##2##3##(2009-3#1)(2009-5#1)
temperature were developed##2##3##(2008-10#2)
temperature were investigated##2##3##(2008-10#2)
temperature were not##2##3##(1994-8#1)(2008-5#1)
temperature were optimised##2##3##(2008-10#2)
temperature were optimized##3##3##(2008-10#3)
temperature were recorded##2##3##(1991-9#1)(2008-10#1)
temperature were studied##2##3##(2008-10#2)
temperature were the##2##3##(2004-11#1)(2012-2#1)
temperature were##40##2##(1990-12#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-11#1)(1994-8#1)(2004-11#1)(2005-11#2)(2007-12#1)(2008-10#18)(2008-2#2)(2008-3#1)(2008-5#2)(2008-8#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-4#1)(2012-2#2)
temperature when##3##2##(1994-2#1)(1995-9#1)(2004-9#1)
temperature where##2##2##(1991-2#1)(1994-8#1)
temperature which##2##2##(1990-5#1)(2008-10#1)
temperature while##2##2##(2006-6#1)(2012-2#1)
temperature will##2##2##(1992-3#1)(1995-10#1)
temperature with a##5##3##(1996-6#1)(2008-10#1)(2008-2#1)(2008-3#2)
temperature with##17##2##(1992-3#1)(1996-11#1)(1996-6#1)(1996-7#1)(2007-12#3)(2008-10#3)(2008-2#1)(2008-3#5)(2010-12#1)
temperature would##2##2##(2006-5#1)(2008-8#1)
temperature zone##2##2##(2006-5#1)(2011-2#1)
temperature zones##2##2##(2008-10#1)(2008-9#1)
temperature##3666##1##(1990-10#6)(1990-11#17)(1990-12#9)(1990-2#22)(1990-3#22)(1990-4#9)(1990-5#22)(1990-6#2)(1990-7#8)(1990-8#8)(1990-9#3)(1991-1#6)(1991-10#1)(1991-11#10)(1991-12#4)(1991-2#15)(1991-3#5)(1991-4#3)(1991-5#13)(1991-6#4)(1991-7#15)(1991-8#12)(1991-9#6)(1992-1#9)(1992-10#1)(1992-11#1)(1992-12#6)(1992-2#10)(1992-3#6)(1992-4#6)(1992-5#6)(1992-6#8)(1992-7#6)(1992-8#4)(1992-9#6)(1993-1#1)(1993-11#7)(1993-12#7)(1993-2#1)(1993-3#6)(1993-4#3)(1993-5#2)(1993-6#5)(1993-8#6)(1993-9#5)(1994-10#4)(1994-11#10)(1994-12#11)(1994-2#6)(1994-3#4)(1994-4#1)(1994-5#11)(1994-6#2)(1994-7#4)(1994-8#17)(1994-9#8)(1995-1#9)(1995-10#9)(1995-11#10)(1995-2#22)(1995-3#15)(1995-4#1)(1995-5#14)(1995-6#18)(1995-8#8)(1995-9#1)(1996-1#7)(1996-10#7)(1996-11#10)(1996-12#14)(1996-2#24)(1996-5#7)(1996-6#5)(1996-7#9)(1996-8#5)(1996-9#5)(1997-1#12)(1997-2#22)(1997-3#4)(1997-4#18)(1997-5#5)(1997-6#12)(1997-7#24)(1997-8#8)(2004-11#2)(2004-8#1)(2004-9#22)(2005-10#2)(2005-11#118)(2005-12#17)(2005-4#11)(2005-7#1)(2005-8#8)(2005-9#1)(2006-1#8)(2006-10#43)(2006-11#2)(2006-12#15)(2006-3#2)(2006-4#12)(2006-5#11)(2006-6#20)(2006-7#4)(2006-8#7)(2006-9#4)(2007-1#3)(2007-10#30)(2007-11#77)(2007-12#184)(2007-2#2)(2007-3#11)(2007-4#3)(2007-5#9)(2007-6#9)(2007-7#12)(2007-8#21)(2007-9#5)(2008-1#19)(2008-10#735)(2008-11#63)(2008-12#26)(2008-2#229)(2008-3#292)(2008-4#17)(2008-5#138)(2008-6#34)(2008-7#42)(2008-8#47)(2008-9#37)(2009-10#4)(2009-11#16)(2009-12#4)(2009-2#8)(2009-3#13)(2009-4#10)(2009-5#8)(2009-6#13)(2009-7#7)(2009-8#9)(2009-9#2)(2010-10#3)(2010-11#2)(2010-12#12)(2010-2#7)(2010-3#5)(2010-4#33)(2010-5#14)(2010-6#6)(2010-7#6)(2010-8#23)(2010-9#4)(2011-1#31)(2011-12#22)(2011-2#78)(2012-1#6)(2012-11#10)(2012-12#25)(2012-2#54)(2012-3#8)(2012-4#5)(2012-5#3)(2012-6#10)(2012-7#9)(2012-9#1)(2013-1#35)(2013-7#36)(2013-8#51)
temperature) and##5##2##(1991-4#1)(2008-10#1)(2008-11#1)(2010-4#2)
temperature) was##2##2##(2008-10#1)(2008-11#1)
temperature) were##2##2##(2008-10#1)(2011-2#1)
temperature)##30##1##(1990-8#1)(1991-4#1)(1995-3#1)(1996-2#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#1)(2009-4#1)(2010-4#2)(2011-2#1)(2012-6#1)(2013-1#1)
temperature- and time-dependent##3##3##(1991-4#1)(1993-3#1)(1996-12#1)
temperature- and##5##2##(1991-4#1)(1993-3#1)(1996-12#1)(2007-12#1)(2008-10#1)
temperature-##8##1##(1991-4#1)(1993-3#1)(1996-12#1)(1996-3#1)(2007-12#1)(2008-10#2)(2013-8#1)
temperature-controlled##4##1##(2007-11#1)(2007-8#1)(2008-2#1)(2013-1#1)
temperature-dependence of##3##2##(1992-6#1)(1995-11#1)(1997-1#1)
temperature-dependence##5##1##(1992-6#2)(1995-11#1)(1997-1#2)
temperature-dependent and##2##2##(1994-8#1)(1996-6#1)
temperature-dependent conformational##2##2##(1993-12#1)(1997-1#1)
temperature-dependent sex determination (TSD)##2##4##(1995-11#1)(2010-3#1)
temperature-dependent sex determination##6##3##(1995-11#2)(1997-5#1)(2008-8#2)(2010-3#1)
temperature-dependent##56##1##(1990-11#1)(1990-2#2)(1990-8#1)(1991-3#1)(1991-9#3)(1992-4#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-3#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-4#1)(1997-5#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-5#5)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#6)(2008-8#3)(2010-3#2)(2011-1#1)(2013-7#3)(2013-8#1)
temperature-humidity##2##1##(2007-8#1)(2008-3#1)
temperature-imaging diagnostics##2##2##(2008-2#2)
temperature-induced##12##1##(1990-2#1)(1991-6#2)(1993-11#1)(1994-9#1)(2008-3#4)(2008-7#1)(2011-12#1)(2012-2#1)
temperature-insensitive##3##1##(2008-2#1)(2008-3#2)
temperature-measurement accuracy##2##2##(2008-2#2)
temperature-measurement##3##1##(2008-2#3)
temperature-programmed##3##1##(1996-2#1)(2010-7#2)
temperature-sensitive (ts) mutants##2##3##(1992-4#1)(1995-9#1)
temperature-sensitive (ts)##7##2##(1990-4#1)(1990-5#1)(1992-4#1)(1994-12#1)(1994-2#1)(1995-9#1)(2008-10#1)
temperature-sensitive and##2##2##(2013-1#2)
temperature-sensitive defect##2##2##(1994-9#1)(1996-9#1)
temperature-sensitive for##4##2##(1991-2#2)(1994-12#2)
temperature-sensitive mutant of##3##3##(1994-9#1)(1995-6#1)(2008-1#1)
temperature-sensitive mutant##8##2##(1994-12#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(2008-1#1)(2008-4#2)
temperature-sensitive phenotype of##2##3##(1994-12#1)(1997-8#1)
temperature-sensitive phenotype##3##2##(1994-12#1)(1997-3#1)(1997-8#1)
temperature-sensitive##68##1##(1990-11#1)(1990-4#1)(1990-5#3)(1991-1#1)(1991-2#3)(1991-5#1)(1991-8#2)(1992-3#1)(1992-4#2)(1992-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#6)(1994-2#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#2)(1995-8#3)(1995-9#2)(1996-9#2)(1997-2#1)(1997-3#5)(1997-8#2)(2005-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-8#3)(2013-1#2)
temperature-sensor##2##1##(2008-1#1)(2010-5#1)
temperature-tuned##2##1##(2007-12#1)(2008-3#1)
temperature]##2##1##(1992-4#1)(2006-6#1)
temperatures &gt##7##2##(1995-6#3)(2006-10#1)(2008-10#3)
temperatures (20##6##2##(2008-10#3)(2008-5#1)(2011-2#1)(2012-2#1)
temperatures (22##2##2##(2008-11#1)(2008-5#1)
temperatures (30##2##2##(1997-8#1)(2008-10#1)
temperatures (37##2##2##(1990-2#1)(1994-5#1)
temperatures (4##2##2##(2008-10#1)(2013-8#1)
temperatures (7 to##2##3##(2008-10#2)
temperatures (7##4##2##(2008-10#2)(2010-8#2)
temperatures (Tm)##3##2##(1991-2#1)(1992-3#1)(2005-11#1)
temperatures above the##3##3##(1990-3#1)(2006-10#1)(2011-12#1)
temperatures above##13##2##(1990-2#1)(1990-3#1)(1995-5#2)(1996-11#1)(2006-10#1)(2008-10#3)(2010-4#1)(2010-7#1)(2011-12#1)(2013-1#1)
temperatures also##2##2##(2008-10#1)(2008-2#1)
temperatures and exposure##2##3##(2008-10#2)
temperatures and heating##2##3##(2008-10#2)
temperatures and high##3##3##(1995-5#1)(2008-10#1)(2010-4#1)
temperatures and its##2##3##(2008-10#1)(2008-5#1)
temperatures and leaf wetness##2##4##(2008-10#2)
temperatures and pH values##2##4##(2008-10#1)(2010-4#1)
temperatures and pressures##3##3##(2008-10#1)(2008-3#2)
temperatures and salinities##2##3##(2008-10#1)(2008-5#1)
temperatures and the##6##3##(2005-11#1)(2007-10#1)(2008-10#2)(2008-7#1)(2012-4#1)
temperatures and with##2##3##(2004-9#1)(2005-11#1)
temperatures and##65##2##(1991-4#1)(1992-6#1)(1993-5#1)(1993-8#1)(1995-5#2)(1996-12#1)(1997-7#1)(2004-4#1)(2004-9#2)(2005-11#4)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#19)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-4#2)(2011-2#1)(2012-1#1)(2012-4#1)(2013-1#1)(2013-7#1)
temperatures are##10##2##(1994-12#1)(1996-11#2)(2005-11#1)(2008-10#3)(2008-2#2)(2008-9#1)
temperatures as low as##5##4##(1990-11#1)(1992-6#1)(1997-7#1)(2007-12#1)(2008-2#1)
temperatures as##9##2##(1990-11#1)(1992-6#1)(1994-9#1)(1997-7#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#2)
temperatures at which##2##3##(2005-8#1)(2008-10#1)
temperatures at##8##2##(1997-7#2)(2005-8#1)(2008-10#3)(2008-12#1)(2013-1#1)
temperatures below##6##2##(1990-3#1)(1993-11#1)(1997-6#1)(2005-11#1)(2007-12#1)(2008-10#1)
temperatures between 10##2##3##(2008-10#2)
temperatures between 22##2##3##(2008-10#1)(2008-11#1)
temperatures between 5 and##2##4##(1992-2#1)(1995-11#1)
temperatures between##23##2##(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#1)(1995-10#1)(1995-11#1)(2004-9#2)(2005-11#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#1)(2009-7#1)(2013-1#1)(2013-8#1)
temperatures by##3##2##(2008-10#3)
temperatures close to##4##3##(1995-2#1)(2005-11#1)(2007-8#1)(2008-3#1)
temperatures decreased##2##2##(2004-9#1)(2008-8#1)
temperatures during the##3##3##(1993-4#1)(2012-5#1)(2012-8#1)
temperatures during##7##2##(1993-4#1)(2008-10#3)(2012-4#1)(2012-5#1)(2012-8#1)
temperatures for pyrolysis and atomization##3##5##(2008-10#3)
temperatures for the##5##3##(2008-10#3)(2009-6#1)(2009-7#1)
temperatures for##27##2##(1990-2#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-10#15)(2008-12#1)(2008-4#1)(2009-6#1)(2009-7#1)(2012-12#2)(2012-2#1)(2013-1#1)
temperatures from 2##2##3##(2008-10#1)(2011-2#1)
temperatures from 20 to##3##4##(2008-10#3)
temperatures from 5 to##3##4##(2005-11#1)(2008-10#2)
temperatures from##32##2##(1990-3#1)(1991-8#1)(2005-11#1)(2006-1#1)(2008-10#15)(2008-2#3)(2008-3#3)(2008-5#2)(2008-6#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-8#1)
temperatures had##2##2##(2006-5#1)(2008-6#1)
temperatures has been##4##3##(1995-2#1)(2006-10#2)(2008-10#1)
temperatures have been##3##3##(1990-9#1)(2008-10#1)(2008-2#1)
temperatures have##6##2##(1990-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2011-12#1)
temperatures higher than##2##3##(2008-3#1)(2008-9#1)
temperatures higher##3##2##(2007-4#1)(2008-3#1)(2008-9#1)
temperatures in the range##5##4##(1995-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-4#1)
temperatures in the##12##3##(1994-7#1)(1995-11#1)(1995-6#1)(2006-7#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2010-4#1)
temperatures in##24##2##(1994-7#1)(1995-11#1)(1995-5#1)(1995-6#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#3)(2008-3#3)(2008-5#2)(2008-8#1)(2010-4#1)(2010-5#1)(2011-2#1)
temperatures increased##3##2##(2007-8#1)(2008-10#2)
temperatures inferred from##2##3##(2008-2#2)
temperatures is##2##2##(1990-12#1)(2008-10#1)
temperatures may##2##2##(2008-10#2)
temperatures near##3##2##(1994-7#1)(2008-2#1)(2008-3#1)
temperatures of &lt##3##3##(2008-10#2)(2008-3#1)
temperatures of 15##3##3##(2008-10#3)
temperatures of 20##2##3##(2008-10#2)
temperatures of 5-20##2##3##(2008-10#1)(2012-2#1)
temperatures of the##4##3##(1991-2#1)(2004-9#1)(2006-7#1)(2008-10#1)
temperatures of these materials##2##4##(2008-10#1)(2013-7#1)
temperatures of##58##2##(1991-2#1)(1993-9#1)(1996-5#1)(1997-1#1)(2004-9#1)(2005-11#3)(2005-12#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-12#3)(2007-4#1)(2008-10#24)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#2)(2008-8#1)(2009-8#1)(2010-4#2)(2012-11#1)(2012-2#2)(2013-7#1)
temperatures on the##4##3##(1990-11#1)(2004-9#1)(2008-9#1)(2010-8#1)
temperatures on##12##2##(1990-11#1)(2004-9#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-8#2)
temperatures or##7##2##(1995-8#1)(2006-11#1)(2008-10#3)(2008-3#1)(2008-8#1)
temperatures over##2##2##(1997-2#1)(2008-2#1)
temperatures ranging from##17##3##(1994-11#1)(1995-5#1)(2007-12#1)(2007-3#1)(2008-10#9)(2008-2#1)(2008-7#1)(2010-4#1)(2011-2#1)
temperatures resulted in##2##3##(2008-10#1)(2008-8#1)
temperatures showed##3##2##(2004-9#1)(2008-10#1)(2009-5#1)
temperatures tested##3##2##(2008-10#2)(2008-5#1)
temperatures than##3##2##(1994-12#1)(2007-6#1)(2008-10#1)
temperatures that##7##2##(1997-5#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-9#1)
temperatures the development##2##3##(2008-10#2)
temperatures the##7##2##(1990-11#1)(1995-11#1)(2004-9#1)(2008-10#3)(2008-3#1)
temperatures to the##2##3##(2007-11#1)(2007-5#1)
temperatures to##8##2##(1992-1#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#2)(2009-2#1)
temperatures under##4##2##(2005-11#1)(2008-10#3)
temperatures up to 50 degrees C##2##6##(2008-10#1)(2008-6#1)
temperatures up to##10##3##(1997-7#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-6#2)(2009-7#1)
temperatures was##11##2##(1994-6#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-5#2)(2012-12#2)(2012-2#1)
temperatures were maintained at##2##4##(1996-5#1)(2008-10#1)
temperatures were measured##4##3##(2007-10#1)(2008-10#2)(2013-1#1)
temperatures were##30##2##(1990-3#1)(1996-2#1)(1996-5#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-10#11)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#1)(2010-3#1)(2010-4#1)(2013-1#1)(2013-7#2)(2013-8#2)
temperatures where the##2##3##(2006-10#1)(2008-8#1)
temperatures where##3##2##(2005-11#1)(2006-10#1)(2008-8#1)
temperatures which##2##2##(1996-1#1)(2008-10#1)
temperatures with a##2##3##(2005-11#1)(2008-6#1)
temperatures with an##2##3##(2007-11#1)(2008-3#1)
temperatures with##7##2##(1990-3#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)
temperatures##894##1##(1990-11#6)(1990-12#4)(1990-2#8)(1990-3#6)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#3)(1991-12#1)(1991-2#8)(1991-4#4)(1991-5#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#2)(1993-11#1)(1993-3#2)(1993-4#3)(1993-5#1)(1993-8#2)(1993-9#3)(1994-11#3)(1994-12#4)(1994-3#5)(1994-5#2)(1994-6#1)(1994-7#2)(1994-9#1)(1995-10#3)(1995-11#4)(1995-2#3)(1995-3#6)(1995-5#9)(1995-6#5)(1995-7#2)(1995-8#2)(1996-1#2)(1996-11#5)(1996-12#2)(1996-2#4)(1996-5#6)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#9)(1997-8#1)(2004-4#1)(2004-9#14)(2005-10#1)(2005-11#27)(2005-12#3)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#11)(2006-11#1)(2006-12#4)(2006-4#2)(2006-5#6)(2006-6#3)(2006-7#5)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#12)(2007-12#21)(2007-2#1)(2007-3#3)(2007-4#3)(2007-5#2)(2007-6#5)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#258)(2008-11#8)(2008-12#9)(2008-2#39)(2008-3#49)(2008-4#7)(2008-5#31)(2008-6#11)(2008-7#11)(2008-8#22)(2008-9#12)(2009-2#2)(2009-3#4)(2009-5#2)(2009-6#4)(2009-7#5)(2009-8#1)(2010-12#1)(2010-2#4)(2010-3#2)(2010-4#11)(2010-5#5)(2010-7#3)(2010-8#6)(2011-1#1)(2011-12#5)(2011-2#11)(2012-1#2)(2012-11#3)(2012-12#6)(2012-2#15)(2012-4#2)(2012-5#5)(2012-6#2)(2012-7#2)(2012-8#5)(2013-1#10)(2013-7#5)(2013-8#6)
tempered by the fact that##2##5##(2008-11#1)(2008-9#1)
tempered by the##3##3##(1997-5#1)(2008-11#1)(2008-9#1)
tempered by##4##2##(1997-5#1)(2007-7#1)(2008-11#1)(2008-9#1)
tempered##7##1##(1997-5#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)
tempers##2##1##(1996-1#1)(2007-8#1)
template DNA##9##2##(1992-7#1)(1993-12#1)(1993-3#1)(1994-7#1)(1997-3#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-4#1)
template activity was##2##3##(1995-1#1)(2008-5#1)
template activity##4##2##(1990-7#1)(1995-1#2)(2008-5#1)
template and the actual##2##4##(1995-8#1)(2008-6#1)
template and the##4##3##(1993-12#1)(1995-8#1)(1997-3#1)(2008-6#1)
template and##12##2##(1993-12#1)(1995-8#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#2)
template concentration and##2##3##(1994-12#1)(2008-12#1)
template containing##2##2##(1994-9#1)(2007-8#1)
template extraction##2##2##(2008-2#2)
template for in vitro transcription##2##5##(1996-10#1)(2008-10#1)
template for the development of##3##5##(2007-12#1)(2007-3#1)(2011-2#1)
template for the##6##3##(1991-2#1)(1997-6#1)(2007-12#1)(2007-3#1)(2010-8#1)(2011-2#1)
template for##26##2##(1991-2#1)(1991-3#1)(1991-8#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-11#1)(1997-6#1)(1997-7#1)(2005-10#2)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-7#1)(2010-1#1)(2010-7#1)(2010-8#1)(2011-2#1)
template fragments##2##2##(1996-12#1)(2008-2#1)
template guided##2##2##(2007-11#2)
template images##2##2##(2007-12#1)(2008-3#1)
template in the##2##3##(1995-1#1)(1997-6#1)
template in##9##2##(1991-9#1)(1994-9#1)(1995-1#1)(1997-6#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-4#1)
template is##6##2##(1990-4#1)(1994-9#1)(1997-4#1)(2006-5#1)(2008-2#2)
template model##3##2##(1991-2#1)(1994-12#2)
template molecule##6##2##(2008-10#6)
template protein##2##2##(2013-8#2)
template responses##4##2##(1991-2#4)
template size##2##2##(1996-9#1)(2011-2#1)
template to##4##2##(2008-1#1)(2008-4#1)(2008-8#1)(2008-9#1)
template update##2##2##(2008-6#2)
template used##2##2##(1996-9#1)(2008-12#1)
template using##2##2##(2008-2#1)(2011-1#1)
template was##5##2##(1994-8#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-5#1)
template with##2##2##(1991-2#1)(2006-4#1)
template##272##1##(1990-11#3)(1990-4#3)(1990-5#1)(1990-7#2)(1991-12#2)(1991-2#9)(1991-3#1)(1991-5#1)(1991-7#3)(1991-8#1)(1991-9#4)(1992-3#1)(1992-6#1)(1992-7#3)(1993-11#1)(1993-12#2)(1993-3#3)(1993-4#1)(1993-9#1)(1994-12#9)(1994-7#1)(1994-8#5)(1994-9#7)(1995-1#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#1)(1995-8#3)(1996-1#1)(1996-10#2)(1996-11#3)(1996-12#2)(1996-2#1)(1996-7#1)(1996-9#4)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#4)(1997-7#2)(2005-10#2)(2005-11#9)(2006-12#4)(2006-4#1)(2006-5#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-7#1)(2007-8#7)(2008-1#2)(2008-10#31)(2008-11#4)(2008-12#3)(2008-2#18)(2008-3#1)(2008-4#7)(2008-5#7)(2008-6#5)(2008-7#7)(2008-8#6)(2008-9#6)(2009-10#1)(2009-2#1)(2009-3#1)(2009-6#2)(2009-9#1)(2010-1#1)(2010-12#4)(2010-2#1)(2010-4#4)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#3)(2011-2#2)(2012-3#3)(2013-1#3)(2013-8#4)
template)##2##1##(1996-9#2)
template-directed##4##1##(1990-5#1)(1991-3#1)(1991-7#1)(2010-12#1)
template-independent##2##1##(1990-4#1)(1996-4#1)
template-primer##2##1##(1992-11#1)(1995-5#1)
templated##10##1##(1991-7#1)(1995-10#1)(2006-5#1)(2007-8#2)(2008-10#1)(2008-7#1)(2009-2#1)(2010-4#1)(2010-8#1)
templates and##13##2##(1992-12#2)(1993-3#1)(1997-5#1)(1997-6#1)(2007-6#1)(2007-8#1)(2008-2#1)(2010-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
templates are##4##2##(1991-2#1)(1991-7#1)(2007-12#1)(2010-6#1)
templates by##3##2##(1991-7#1)(2007-1#1)(2010-4#1)
templates containing##3##2##(1991-1#1)(1991-8#1)(1994-8#1)
templates for PCR##3##3##(1994-8#2)(1996-8#1)
templates for the##2##3##(2008-4#1)(2010-12#1)
templates for##12##2##(1994-8#2)(1996-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-9#1)(2010-11#1)(2010-12#1)
templates formed##2##2##(2007-12#1)(2008-11#1)
templates from##4##2##(1992-12#1)(2008-10#3)
templates in vitro##2##3##(1990-11#1)(1991-7#1)
templates in##5##2##(1990-11#1)(1991-7#1)(1996-11#1)(1997-2#1)(2008-2#1)
templates is##4##2##(1990-11#1)(2008-2#1)(2008-4#1)(2013-1#1)
templates of##4##2##(1991-10#1)(2008-7#1)(2009-2#1)(2012-1#1)
templates that##3##2##(1991-2#1)(2008-2#1)(2008-6#1)
templates to##4##2##(2008-10#1)(2009-3#1)(2010-4#1)(2010-6#1)
templates with##2##2##(1994-9#1)(2013-1#1)
templates##121##1##(1990-11#3)(1990-12#1)(1990-7#1)(1991-1#1)(1991-10#2)(1991-2#3)(1991-5#1)(1991-7#3)(1991-8#1)(1992-12#5)(1992-6#1)(1993-3#1)(1994-12#1)(1994-8#4)(1994-9#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-7#1)(1996-11#1)(1996-8#4)(1996-9#2)(1997-2#1)(1997-4#1)(1997-5#3)(1997-6#1)(2005-11#1)(2006-12#3)(2007-1#1)(2007-12#3)(2007-6#1)(2007-8#2)(2008-10#10)(2008-11#1)(2008-2#8)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#6)(2009-11#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#3)(2010-6#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#10)(2013-8#1)
templating##6##1##(2005-11#1)(2008-5#3)(2008-8#1)(2009-2#1)
temple##2##1##(2005-9#1)(2008-5#1)
tempo of extinction##2##3##(2008-8#2)
tempo of##6##2##(1994-9#1)(1996-4#1)(2006-10#2)(2008-8#2)
tempo##11##1##(1994-9#1)(1995-11#1)(1996-4#1)(2006-10#3)(2007-12#1)(2008-8#2)(2013-8#2)
temporal HF##2##2##(1994-12#2)
temporal Talbot effect##5##3##(2007-11#1)(2007-12#3)(2008-3#1)
temporal Talbot##6##2##(2007-11#1)(2007-12#4)(2008-3#1)
temporal activity##3##2##(1995-12#1)(2008-4#2)
temporal analysis##2##2##(2006-5#1)(2009-10#1)
temporal and frontal lobes##2##4##(1994-3#1)(1997-3#1)
temporal and frontal##4##3##(1993-11#1)(1994-3#1)(1997-3#1)(2007-9#1)
temporal and parietal##3##3##(1997-3#1)(2008-2#2)
temporal and rate##2##3##(2008-11#2)
temporal and spatial changes##2##4##(2007-5#1)(2013-7#1)
temporal and spatial distribution patterns of##2##6##(2008-10#1)(2008-5#1)
temporal and spatial distribution##3##4##(2006-11#1)(2008-10#1)(2008-5#1)
temporal and spatial dynamics of##3##5##(2008-10#3)
temporal and spatial expression of##3##5##(1995-8#1)(1997-8#1)(2012-2#1)
temporal and spatial expression##4##4##(1995-8#1)(1996-12#1)(1997-8#1)(2012-2#1)
temporal and spatial information on##2##5##(2008-3#1)(2012-12#1)
temporal and spatial information##3##4##(2008-1#1)(2008-3#1)(2012-12#1)
temporal and spatial patterns of##3##5##(2007-10#1)(2007-12#1)(2008-10#1)
temporal and spatial patterns##5##4##(2007-10#1)(2007-12#1)(2008-10#1)(2008-8#1)(2011-2#1)
temporal and spatial resolution of##2##5##(2007-12#1)(2008-3#1)
temporal and spatial resolution that##2##5##(2008-10#2)
temporal and spatial resolution##11##4##(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#2)(2009-11#1)(2010-12#1)(2011-1#1)(2012-2#1)
temporal and spatial spread of SMV strain##2##7##(2008-10#2)
temporal and spatial##54##3##(1990-11#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-8#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#14)(2008-2#1)(2008-3#5)(2008-5#1)(2008-8#1)(2009-11#2)(2009-6#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-7#1)
temporal and spectral##4##3##(2007-11#3)(2009-8#1)
temporal and##88##2##(1990-11#1)(1990-8#1)(1991-11#1)(1993-11#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-3#2)(1997-8#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-11#4)(2007-12#9)(2007-5#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-2#3)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
temporal approach##2##2##(2008-8#1)(2009-8#1)
temporal areas associated with##2##4##(2009-10#1)(2011-2#1)
temporal areas##6##2##(1991-10#1)(2007-8#1)(2008-11#2)(2009-10#1)(2011-2#1)
temporal arteritis##19##2##(1990-8#1)(1994-10#1)(1994-6#1)(1994-9#3)(1995-4#1)(1996-9#1)(1997-8#6)(2006-10#5)
temporal artery##10##2##(1994-9#1)(1997-8#1)(2006-10#3)(2006-11#1)(2007-9#1)(2008-9#2)(2011-12#1)
temporal artery-superior cerebellar artery bypass##2##5##(2012-3#2)
temporal aspects of BSO##2##4##(1997-2#2)
temporal aspects of##5##3##(1995-12#1)(1997-1#1)(1997-2#2)(2008-2#1)
temporal aspects##6##2##(1995-12#1)(1997-1#1)(1997-2#2)(2008-2#1)(2008-3#1)
temporal association##2##2##(2006-10#1)(2012-2#1)
temporal associations between##2##3##(2009-7#1)(2011-2#1)
temporal bone and##2##3##(2006-12#1)(2008-6#1)
temporal bone changes##2##3##(2008-9#2)
temporal bone computed tomography##2##4##(2008-9#1)(2011-2#1)
temporal bone erosion on##2##4##(2011-2#2)
temporal bone fracture##4##3##(2009-10#4)
temporal bone resection and parotidectomy##2##5##(2011-2#2)
temporal bone resection##3##3##(2011-2#3)
temporal bone##42##2##(1995-5#1)(2005-5#3)(2006-12#9)(2008-6#1)(2008-8#3)(2008-9#8)(2009-10#5)(2011-2#12)
temporal bones were##2##3##(2008-9#1)(2012-2#1)
temporal bones##4##2##(2006-12#1)(2008-9#2)(2012-2#1)
temporal broadening of a pulsed##2##5##(2008-3#2)
temporal broadening of##3##3##(2008-3#3)
temporal broadening##5##2##(2008-2#1)(2008-3#4)
temporal change in##2##3##(1991-4#1)(2012-12#1)
temporal change##3##2##(1991-4#1)(2008-2#1)(2012-12#1)
temporal changes in gene expression in##2##6##(2010-5#2)
temporal changes in the##5##4##(1993-1#1)(2007-12#1)(2008-10#2)(2008-3#1)
temporal changes in##18##3##(1993-1#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2010-12#1)(2010-4#1)(2010-5#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
temporal changes of##3##3##(1994-7#1)(1995-12#1)(2011-1#1)
temporal changes##24##2##(1993-1#1)(1994-7#1)(1995-12#1)(1995-5#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-4#1)(2010-5#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
temporal characteristics of visual perception##2##5##(2008-4#2)
temporal characteristics of##8##3##(2007-12#2)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-8#1)
temporal characteristics##14##2##(1997-2#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-8#3)(2013-1#1)
temporal characterization of##2##3##(2007-11#2)
temporal characterization##3##2##(2007-11#2)(2007-12#1)
temporal coding##4##2##(1996-2#2)(2008-11#1)(2008-2#1)
temporal coherence of##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
temporal coherence properties of##2##4##(2007-11#1)(2008-2#1)
temporal coherence##9##2##(2007-11#3)(2007-12#2)(2008-2#2)(2008-3#2)
temporal compression by##2##3##(2007-11#1)(2007-12#1)
temporal compression##4##2##(2007-11#3)(2007-12#1)
temporal context of##2##3##(1994-6#1)(2012-2#1)
temporal continuity and##2##3##(2008-2#2)
temporal continuity##3##2##(2008-11#1)(2008-2#2)
temporal contrast##3##2##(1991-2#2)(2011-1#1)
temporal control of##2##3##(1994-11#1)(2007-12#1)
temporal control##3##2##(1994-11#1)(2007-12#1)(2008-11#1)
temporal correlation between##2##3##(1996-4#1)(2008-3#1)
temporal correlation##12##2##(1992-3#1)(1994-3#1)(1995-11#1)(1996-4#1)(2005-10#1)(2008-2#1)(2008-3#3)(2008-8#1)(2009-8#1)(2013-8#1)
temporal cortex and##3##3##(1993-11#1)(1995-11#1)(1997-5#1)
temporal cortex or amygdala##2##4##(1993-6#2)
temporal cortex##34##2##(1990-10#2)(1991-11#1)(1991-9#2)(1992-5#1)(1993-11#1)(1993-12#1)(1993-6#2)(1994-10#1)(1995-11#3)(1995-12#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-5#4)(2007-10#1)(2008-11#2)(2008-2#1)(2008-9#3)(2010-3#1)(2012-2#2)
temporal cortices##4##2##(1996-12#1)(1996-5#1)(2008-9#1)(2009-4#1)
temporal course##3##2##(1991-3#1)(1996-7#1)(2009-8#1)
temporal data set##2##3##(2011-2#2)
temporal data##11##2##(2007-12#4)(2008-11#2)(2008-3#1)(2011-2#3)(2012-1#1)
temporal decay##4##2##(2006-3#1)(2007-11#1)(2007-8#1)(2008-3#1)
temporal delay##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
temporal delays##3##2##(1995-2#1)(2007-11#1)(2007-12#1)
temporal dependence of##2##3##(1994-12#1)(2008-2#1)
temporal dependence##3##2##(1994-12#1)(2008-11#1)(2008-2#1)
temporal development of##4##3##(2007-12#1)(2008-10#3)
temporal difference##2##2##(2008-2#1)(2012-12#1)
temporal differentiation##2##2##(2008-8#2)
temporal digital speckle photography##2##4##(2008-3#2)
temporal discrimination##4##2##(2011-2#4)
temporal distance##2##2##(2009-11#1)(2009-6#1)
temporal distribution of##12##3##(2007-11#1)(2007-5#1)(2007-6#2)(2008-10#4)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)
temporal distribution##13##2##(2007-11#1)(2007-5#1)(2007-6#2)(2008-10#5)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)
temporal dynamics of the##2##4##(2008-10#1)(2009-8#1)
temporal dynamics of##11##3##(2007-12#1)(2008-10#4)(2008-2#1)(2008-8#1)(2009-8#2)(2010-11#1)(2012-2#1)
temporal dynamics##16##2##(1995-12#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-11#1)(2012-2#2)
temporal effects##4##2##(2008-10#1)(2010-2#1)(2011-1#2)
temporal evolution of the##10##4##(1991-8#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#5)
temporal evolution of##17##3##(1991-8#1)(1992-6#1)(2006-12#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-2#7)(2008-3#1)(2008-4#1)
temporal evolution##18##2##(1991-8#1)(1992-6#1)(2006-12#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-2#8)(2008-3#1)(2008-4#1)
temporal expression pattern of##3##4##(2006-12#1)(2008-5#1)(2012-3#1)
temporal expression pattern##8##3##(1997-4#1)(2006-12#2)(2008-5#1)(2008-7#1)(2012-12#2)(2012-3#1)
temporal expression patterns##3##3##(1992-9#1)(2008-10#1)(2011-12#1)
temporal expression##20##2##(1991-12#1)(1992-4#1)(1992-9#1)(1995-5#1)(1996-3#1)(1996-6#1)(1997-4#1)(2006-12#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-12#1)(2012-12#2)(2012-3#1)(2013-1#2)
temporal fascia pedicled##2##3##(2011-12#2)
temporal features of the##2##4##(1996-7#1)(2009-8#1)
temporal features of##7##3##(1993-2#1)(1996-7#1)(2008-7#1)(2009-11#1)(2009-3#1)(2009-8#1)(2012-1#1)
temporal features##9##2##(1993-2#1)(1996-7#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-3#1)(2009-8#1)(2012-1#1)
temporal filtering##2##2##(2007-12#2)
temporal fluctuation##2##2##(1997-7#1)(2012-2#1)
temporal frequencies##4##2##(1996-2#2)(2008-2#2)
temporal frequency of the##2##4##(1996-12#1)(2007-12#1)
temporal frequency##4##2##(1996-12#1)(2007-12#2)(2008-1#1)
temporal gyrus and##5##3##(1996-2#1)(1996-9#2)(1997-8#1)(2008-11#1)
temporal gyrus##18##2##(1996-2#3)(1996-7#3)(1996-9#2)(1997-8#1)(2008-11#4)(2008-9#2)(2009-1#1)(2009-2#2)
temporal gyrus)##2##2##(2008-11#1)(2008-9#1)
temporal imaging##3##2##(2007-11#2)(2007-12#1)
temporal increase of##2##3##(2008-10#2)
temporal increase##5##2##(2008-10#5)
temporal information from##5##3##(2008-3#1)(2013-1#4)
temporal information##13##2##(2006-2#1)(2008-2#1)(2008-3#2)(2008-9#3)(2013-1#6)
temporal integrated##2##2##(2008-3#2)
temporal integration##2##2##(1992-4#1)(1997-5#1)
temporal intensity##2##2##(2008-2#2)
temporal jitter##2##2##(2007-11#2)
temporal lesions##3##2##(2004-11#1)(2009-4#1)(2011-1#1)
temporal lobe and##2##3##(1996-7#1)(2009-4#1)
temporal lobe as##2##3##(1996-7#1)(2012-12#1)
temporal lobe damage##2##3##(1992-11#1)(2009-9#1)
temporal lobe epilepsy with medial temporal##2##6##(2004-11#2)
temporal lobe epilepsy##11##3##(1995-7#2)(2004-11#2)(2005-9#1)(2008-1#1)(2008-3#1)(2008-4#2)(2012-2#2)
temporal lobe epileptic##2##3##(2010-8#2)
temporal lobe from##2##3##(1990-7#1)(2011-2#1)
temporal lobe is##2##3##(2007-9#1)(2010-7#1)
temporal lobe lesions##4##3##(1992-11#2)(1992-12#1)(1993-12#1)
temporal lobe structures##2##3##(2009-2#1)(2013-8#1)
temporal lobe##84##2##(1990-7#1)(1991-10#2)(1991-12#2)(1991-2#1)(1991-3#3)(1992-11#4)(1992-12#1)(1993-12#2)(1993-8#1)(1993-9#2)(1994-2#1)(1995-12#5)(1995-7#2)(1996-3#1)(1996-6#1)(1996-7#5)(1996-9#1)(1997-3#2)(1997-7#1)(1997-8#1)(2004-11#5)(2005-9#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#2)(2009-2#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-7#2)(2010-8#2)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#2)(2013-8#1)
temporal lobectomy and##2##3##(1990-9#1)(2008-11#1)
temporal lobectomy subjects##2##3##(1992-12#2)
temporal lobectomy##7##2##(1990-5#1)(1990-9#2)(1992-12#3)(2008-11#1)
temporal lobes##8##2##(1995-12#2)(1996-7#1)(1997-1#1)(2007-8#1)(2008-6#1)(2009-10#1)(2010-7#1)
temporal macular##2##2##(2013-1#2)
temporal measurements##2##2##(2007-12#1)(2008-2#1)
temporal muscle##4##2##(1991-11#2)(2006-11#1)(2008-9#1)
temporal muscles##2##2##(2007-3#1)(2008-9#1)
temporal neurons##2##2##(1990-10#1)(1992-2#1)
temporal nonlinearity of##2##3##(2006-11#2)
temporal optical data##2##3##(2007-12#2)
temporal optical##5##2##(2007-12#2)(2008-2#2)(2008-3#1)
temporal or geographical##2##3##(1997-6#1)(2006-10#1)
temporal or spatial##3##3##(2007-12#1)(2008-2#1)(2009-10#1)
temporal or##6##2##(1994-2#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-2#1)(2009-10#1)
temporal order of##3##3##(1992-11#1)(1992-3#1)(1996-5#1)
temporal order##5##2##(1992-11#2)(1992-3#1)(1996-2#1)(1996-5#1)
temporal organization of##4##3##(1995-12#1)(1997-1#1)(2009-8#2)
temporal orientations##3##2##(2008-6#3)
temporal oscillations of##2##3##(2007-11#1)(2009-8#1)
temporal oscillations##4##2##(2006-10#1)(2007-11#1)(2008-2#1)(2009-8#1)
temporal overlap between##2##3##(1997-1#1)(2009-8#1)
temporal overlap##3##2##(1997-1#1)(1997-5#1)(2009-8#1)
temporal parameters##2##2##(1990-11#1)(2007-10#1)
temporal pattern of the##3##4##(1997-8#1)(2007-12#1)(2011-1#1)
temporal pattern of##12##3##(1992-3#1)(1994-12#1)(1995-5#2)(1997-8#1)(2007-11#1)(2007-12#3)(2010-11#1)(2011-1#1)(2011-12#1)
temporal pattern##15##2##(1992-3#1)(1994-12#1)(1995-12#1)(1995-5#2)(1997-8#1)(2007-11#1)(2007-12#3)(2007-5#1)(2008-1#1)(2010-11#1)(2011-1#1)(2011-12#1)
temporal patterns in##2##3##(2006-7#1)(2007-9#1)
temporal patterns of expression##2##4##(1996-3#1)(2008-5#1)
temporal patterns of the##4##4##(1997-8#1)(2008-11#1)(2008-7#2)
temporal patterns of##15##3##(1993-12#1)(1996-3#1)(1997-8#1)(2007-10#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-8#1)
temporal patterns##21##2##(1993-12#1)(1996-3#1)(1997-8#1)(2003-11#1)(2006-7#1)(2007-10#1)(2007-12#2)(2007-9#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-8#1)(2013-7#1)
temporal phase unwrapping##2##3##(2008-3#2)
temporal phase##10##2##(2007-12#3)(2008-2#2)(2008-3#5)
temporal phase-unwrapping algorithm##2##3##(2008-3#2)
temporal pole##5##2##(1993-9#2)(1996-7#1)(2008-11#1)(2009-4#1)
temporal position of the##2##4##(2007-12#1)(2008-10#1)
temporal position of##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
temporal position##4##2##(2007-11#1)(2007-12#2)(2008-10#1)
temporal power##2##2##(2008-2#1)(2008-3#1)
temporal processing in##2##3##(2006-2#1)(2006-3#1)
temporal processing##6##2##(2006-2#1)(2006-3#1)(2008-9#1)(2009-7#1)(2011-1#2)
temporal profile of the##8##4##(1996-1#1)(2006-3#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2011-1#1)
temporal profile of##9##3##(1996-1#1)(2006-3#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2011-1#1)(2013-8#1)
temporal profile##12##2##(1996-1#1)(2006-3#1)(2007-12#1)(2008-2#2)(2008-3#3)(2008-7#2)(2011-1#1)(2013-8#1)
temporal profiles of##3##3##(2007-11#1)(2008-1#1)(2009-8#1)
temporal profiles##5##2##(1994-3#1)(2007-11#2)(2008-1#1)(2009-8#1)
temporal properties of##2##3##(2007-11#1)(2008-1#1)
temporal properties##3##2##(2007-11#1)(2008-1#1)(2008-8#1)
temporal pulse##3##2##(2007-11#1)(2008-10#2)
temporal range of##2##3##(1994-7#1)(2007-12#1)
temporal region##6##2##(2007-12#1)(2008-9#2)(2009-1#1)(2010-7#1)(2012-12#1)
temporal regions##6##2##(1996-3#1)(1996-5#1)(2008-11#1)(2008-9#1)(2009-4#1)(2010-7#1)
temporal regulation##3##2##(2009-12#1)(2009-8#1)(2012-3#1)
temporal relation between##2##3##(2006-2#1)(2008-7#1)
temporal relations##6##2##(2013-1#6)
temporal relationship between the##4##4##(1996-3#1)(2006-8#1)(2008-7#1)(2008-9#1)
temporal relationship between##11##3##(1994-10#1)(1994-2#1)(1996-3#1)(2006-6#2)(2006-8#1)(2007-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2013-8#1)
temporal relationship##16##2##(1990-7#1)(1991-10#1)(1994-10#1)(1994-2#1)(1996-3#1)(2006-6#2)(2006-8#1)(2007-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#2)(2011-2#1)(2013-8#1)
temporal relationships among##3##3##(1995-2#1)(2013-1#2)
temporal relationships##4##2##(1995-2#1)(1995-5#1)(2013-1#2)
temporal reshaping##3##2##(2007-12#3)
temporal resolution and##7##3##(2006-4#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-11#1)
temporal resolution for the##2##4##(1996-11#1)(2008-2#1)
temporal resolution images##2##3##(2012-1#2)
temporal resolution in##4##3##(2008-11#1)(2008-2#1)(2011-2#1)(2013-8#1)
temporal resolution is##3##3##(1996-12#1)(2007-11#1)(2007-12#1)
temporal resolution of the##3##4##(2007-12#1)(2009-9#1)(2010-9#1)
temporal resolution of##12##3##(1995-2#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-11#1)(2009-9#1)(2010-9#1)(2011-2#2)
temporal resolution to##2##3##(2008-3#1)(2008-6#1)
temporal resolution##57##2##(1991-2#1)(1995-2#1)(1996-11#1)(1996-12#1)(2006-4#1)(2006-6#1)(2007-11#4)(2007-12#10)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-1#2)(2012-2#1)(2013-8#2)
temporal response function##2##3##(2008-2#1)(2008-3#1)
temporal response of##3##3##(2007-11#1)(2007-12#2)
temporal response##7##2##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#1)
temporal scale##3##2##(2011-1#1)(2013-7#1)(2013-8#1)
temporal separation##3##2##(1992-11#1)(2007-12#1)(2008-11#1)
temporal sequence of##4##3##(1995-3#1)(2008-10#1)(2012-12#2)
temporal sequence##6##2##(1995-3#1)(2008-10#1)(2010-9#1)(2012-12#2)(2012-2#1)
temporal sequencing##2##2##(2008-1#1)(2009-3#1)
temporal shape of the##2##4##(2007-12#1)(2008-2#1)
temporal shape##4##2##(2007-12#1)(2008-2#3)
temporal shift##2##2##(2007-12#1)(2008-1#1)
temporal signal##5##2##(2007-12#2)(2008-3#3)
temporal signals##3##2##(2008-2#1)(2008-3#2)
temporal soliton##2##2##(2008-2#1)(2008-3#1)
temporal solitons with##2##3##(2008-3#2)
temporal solitons##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
temporal speckle-pattern interferometry##2##3##(2008-3#2)
temporal spread of SMV##2##4##(2008-10#2)
temporal spread##3##2##(2008-10#3)
temporal stability of##2##3##(2007-11#1)(2008-9#1)
temporal stability##10##2##(1997-8#1)(2007-11#1)(2008-10#1)(2008-9#3)(2012-1#2)(2013-8#2)
temporal structure of##2##3##(2006-5#1)(2012-1#1)
temporal structure##4##2##(1997-8#1)(2006-5#2)(2012-1#1)
temporal structures are##2##3##(1996-1#1)(2008-11#1)
temporal structures##7##2##(1996-1#1)(1997-8#1)(2008-11#3)(2008-6#1)(2012-2#1)
temporal summation##4##2##(2011-1#4)
temporal texture##3##2##(2006-7#1)(2008-2#2)
temporal trends##3##2##(2006-10#1)(2008-7#1)(2012-1#1)
temporal tumor##2##2##(2007-12#2)
temporal validation##2##2##(2007-1#2)
temporal variability in the##2##4##(1991-6#1)(2008-8#1)
temporal variability in##3##3##(1991-6#2)(2008-8#1)
temporal variability##10##2##(1991-6#2)(1992-9#3)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#1)
temporal variables##3##2##(2008-5#1)(2013-7#1)(2013-8#1)
temporal variation in the opportunity for sexual selection##2##8##(2008-8#2)
temporal variation in the##3##4##(2008-8#2)(2013-8#1)
temporal variation in##5##3##(2008-8#3)(2008-9#1)(2013-8#1)
temporal variation of##4##3##(2005-11#1)(2007-3#1)(2010-12#1)(2013-8#1)
temporal variation##14##2##(2005-11#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-8#3)(2008-9#2)(2010-12#1)(2013-1#1)(2013-8#3)
temporal variations in amplitude##2##4##(2012-1#2)
temporal variations in##6##3##(2008-6#1)(2008-9#1)(2011-12#2)(2012-1#2)
temporal variations of##3##3##(2006-7#1)(2008-5#1)(2013-8#1)
temporal variations##13##2##(2006-6#1)(2006-7#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2011-12#2)(2012-1#3)(2013-8#1)
temporal visual##2##2##(1992-2#1)(2009-10#1)
temporal volume##6##2##(1997-8#6)
temporal walk-off##3##2##(2007-11#1)(2007-12#2)
temporal water body of##2##4##(2008-5#2)
temporal water body##3##3##(2008-5#3)
temporal waveform##4##2##(2007-11#1)(2007-12#3)
temporal waveforms of##2##3##(2007-12#2)
temporal waveforms##3##2##(2007-12#3)
temporal wavelet##3##2##(2008-2#3)
temporal width##2##2##(2007-11#1)(2007-12#1)
temporal window##4##2##(2007-12#1)(2008-11#2)(2008-6#1)
temporal##1290##1##(1990-10#3)(1990-11#2)(1990-3#1)(1990-5#2)(1990-7#2)(1990-8#2)(1990-9#2)(1991-10#4)(1991-11#7)(1991-12#3)(1991-2#4)(1991-3#6)(1991-4#1)(1991-6#4)(1991-8#2)(1991-9#2)(1992-11#7)(1992-12#4)(1992-2#2)(1992-3#3)(1992-4#2)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#5)(1993-1#3)(1993-11#3)(1993-12#4)(1993-2#2)(1993-3#2)(1993-5#2)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#6)(1994-10#4)(1994-11#3)(1994-12#4)(1994-2#5)(1994-3#3)(1994-6#2)(1994-7#2)(1994-8#1)(1994-9#4)(1995-11#6)(1995-12#14)(1995-2#4)(1995-3#1)(1995-4#1)(1995-5#6)(1995-7#2)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#5)(1996-2#9)(1996-3#5)(1996-4#1)(1996-5#5)(1996-6#2)(1996-7#17)(1996-9#6)(1997-1#5)(1997-2#8)(1997-3#5)(1997-4#1)(1997-5#7)(1997-6#1)(1997-7#3)(1997-8#23)(2003-11#1)(2004-11#10)(2004-9#1)(2005-10#4)(2005-11#2)(2005-5#3)(2005-8#1)(2005-9#1)(2006-10#15)(2006-11#7)(2006-12#16)(2006-2#4)(2006-3#4)(2006-4#1)(2006-5#3)(2006-6#4)(2006-7#4)(2006-8#2)(2007-1#7)(2007-10#5)(2007-11#46)(2007-12#112)(2007-2#2)(2007-3#5)(2007-4#1)(2007-5#7)(2007-6#3)(2007-8#7)(2007-9#10)(2008-1#13)(2008-10#65)(2008-11#48)(2008-12#4)(2008-2#92)(2008-3#77)(2008-4#14)(2008-5#15)(2008-6#9)(2008-7#19)(2008-8#25)(2008-9#54)(2009-1#2)(2009-10#13)(2009-11#4)(2009-12#2)(2009-2#8)(2009-3#2)(2009-4#10)(2009-5#5)(2009-6#3)(2009-7#3)(2009-8#18)(2009-9#2)(2010-1#1)(2010-11#4)(2010-12#6)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#3)(2010-7#5)(2010-8#3)(2010-9#4)(2011-1#27)(2011-11#1)(2011-12#8)(2011-2#36)(2012-1#15)(2012-12#13)(2012-2#23)(2012-3#7)(2013-1#40)(2013-7#8)(2013-8#16)
temporalis muscle flap in##2##4##(2007-12#2)
temporalis muscle transposition##2##3##(2008-8#2)
temporalis muscle##6##2##(2007-12#2)(2008-8#4)
temporalis##9##1##(1990-4#1)(2007-12#2)(2008-5#2)(2008-8#4)
temporality##5##1##(2008-2#2)(2009-5#1)(2013-1#2)
temporally and spatially##4##3##(1994-3#1)(1994-9#1)(2008-8#1)(2012-3#1)
temporally and##11##2##(1992-7#1)(1994-3#1)(1994-9#1)(1996-5#1)(2005-9#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-8#1)(2012-3#1)
temporally associated with##2##3##(1993-10#1)(2006-5#1)
temporally decorrelated##2##2##(2007-12#2)
temporally distant##3##2##(2009-11#2)(2009-6#1)
temporally distinct##3##2##(1994-5#1)(1995-8#1)(2008-11#1)
temporally limited##3##2##(1997-7#1)(2008-11#1)(2009-4#1)
temporally regulated during##2##3##(1997-4#1)(2009-3#1)
temporally regulated in the##2##4##(1991-11#1)(2009-3#1)
temporally regulated##8##2##(1991-11#1)(1994-2#1)(1996-5#1)(1997-4#1)(2009-3#2)(2009-8#1)(2011-2#1)
temporally related##4##2##(1996-3#1)(2007-11#1)(2013-1#2)
temporally restricted expression##2##3##(1994-8#1)(1997-4#1)
temporally restricted objects##4##3##(2007-12#3)(2008-2#1)
temporally restricted##7##2##(1994-8#1)(1997-4#1)(2007-12#3)(2008-2#2)
temporally separated##3##2##(2009-8#1)(2009-9#2)
temporally variable##3##2##(2006-10#1)(2008-8#1)(2008-9#1)
temporally varying##3##2##(2008-8#1)(2008-9#2)
temporally with##2##2##(1994-5#1)(2010-5#1)
temporally##110##1##(1990-7#1)(1991-11#2)(1991-5#1)(1991-8#1)(1992-7#1)(1993-10#1)(1993-2#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-4#2)(1997-7#1)(2005-9#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#6)(2007-12#16)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-2#8)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#3)(2009-10#1)(2009-11#2)(2009-3#2)(2009-4#2)(2009-6#1)(2009-8#2)(2009-9#3)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)
temporaria##7##1##(1990-9#1)(2008-7#2)(2011-2#3)(2013-1#1)
temporarily and##2##2##(2007-12#1)(2008-11#1)
temporarily for##2##2##(1990-11#1)(1996-1#1)
temporarily in##2##2##(1997-6#1)(2007-11#1)
temporarily occluding##2##2##(1995-3#1)(2009-11#1)
temporarily prior##2##2##(1990-12#1)(2008-8#1)
temporarily suppressed##2##2##(1994-12#1)(1995-2#1)
temporarily##61##1##(1990-11#1)(1990-12#1)(1990-5#2)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-9#1)(1993-11#1)(1993-2#2)(1994-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-9#3)(1996-1#2)(1996-4#1)(1996-5#1)(1997-6#2)(2005-8#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#2)(2007-9#5)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#4)(2008-9#1)(2009-11#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
temporary access##3##2##(2007-7#3)
temporary and reversible##2##3##(1991-7#1)(2006-10#1)
temporary and##6##2##(1991-7#1)(1992-8#1)(2006-10#1)(2007-7#1)(2008-1#1)(2012-2#1)
temporary changes##2##2##(2008-10#1)(2008-2#1)
temporary crown##2##2##(2010-12#1)(2013-1#1)
temporary epicardial pacing##2##3##(2008-4#2)
temporary external##2##2##(2008-4#1)(2009-9#1)
temporary hemodialysis##2##2##(2008-1#1)(2011-2#1)
temporary in##2##2##(2006-6#1)(2007-11#1)
temporary increase in##2##3##(2008-10#1)(2008-5#1)
temporary increase of##2##3##(2008-11#1)(2008-8#1)
temporary increase##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
temporary interruption##2##2##(1992-5#1)(2011-2#1)
temporary occlusion of the##2##4##(1993-3#1)(1997-8#1)
temporary occlusion of##3##3##(1993-3#1)(1997-8#1)(2007-9#1)
temporary or permanent##9##3##(2006-2#1)(2006-5#1)(2007-1#1)(2007-9#1)(2009-3#2)(2010-4#3)
temporary or##14##2##(1992-5#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-7#3)(2007-9#1)(2009-2#1)(2009-3#2)(2010-4#3)
temporary pacemaker##2##2##(1992-1#1)(1996-3#1)
temporary partial##2##2##(1990-4#1)(2008-12#1)
temporary relief##2##2##(2005-12#1)(2008-11#1)
temporary storage##2##2##(1992-1#1)(2008-11#1)
temporary tattoos##3##2##(2006-12#3)
temporary use##2##2##(2007-7#2)
temporary vascular access##3##3##(2007-7#3)
temporary##178##1##(1990-4#1)(1990-5#2)(1990-6#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-5#2)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-3#2)(1997-8#2)(2005-10#1)(2005-12#1)(2005-7#1)(2006-1#1)(2006-10#4)(2006-12#3)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2007-1#3)(2007-10#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#18)(2007-8#2)(2007-9#4)(2008-1#2)(2008-10#8)(2008-11#4)(2008-12#3)(2008-2#1)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#3)(2009-5#1)(2009-7#1)(2009-9#2)(2010-10#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-6#1)(2010-8#2)(2011-2#7)(2012-1#2)(2012-2#2)(2012-5#1)(2013-1#6)(2013-7#4)(2013-8#1)
temporizing graft##2##2##(2009-10#2)
temporo-mandibular joint##5##2##(2011-2#5)
temporo-occipital##4##1##(1993-5#1)(2008-7#2)(2009-3#1)
temporo-parietal junction##2##2##(2008-11#2)
temporo-parietal##6##1##(2006-4#1)(2008-11#4)(2009-1#1)
temporo-parieto-occipital##3##1##(1996-1#1)(1996-5#1)(2008-9#1)
temporo-suboccipital craniotomy##2##2##(2008-7#2)
temporolimbic##2##1##(1996-7#2)
temporomandibular disorder##3##2##(2013-1#3)
temporomandibular disorders##3##2##(2007-12#2)(2008-10#1)
temporomandibular joint (TMJ)##5##3##(2007-12#2)(2010-12#1)(2010-2#1)(2012-3#1)
temporomandibular joint disorder##3##3##(2007-6#3)
temporomandibular joint surgery##3##3##(2007-12#3)
temporomandibular joint##37##2##(1990-10#1)(1991-1#1)(1993-1#1)(1995-10#1)(1996-2#1)(2007-12#13)(2007-6#4)(2007-7#1)(2009-4#2)(2010-12#1)(2010-2#2)(2011-1#1)(2011-12#1)(2012-2#2)(2012-3#2)(2013-1#3)
temporomandibular joints##2##2##(2007-7#2)
temporomandibular##47##1##(1990-10#1)(1991-1#1)(1993-1#1)(1995-10#1)(1996-2#1)(2007-12#15)(2007-6#4)(2007-7#4)(2008-10#1)(2008-9#1)(2009-4#2)(2010-12#1)(2010-2#2)(2011-1#1)(2011-12#1)(2012-2#2)(2012-3#2)(2013-1#6)
temporooccipital##2##1##(2007-12#1)(2008-9#1)
temporoparietal junction##3##2##(2008-11#2)(2010-2#1)
temporoparietal##10##1##(2007-12#2)(2007-4#1)(2008-11#2)(2008-12#1)(2008-9#1)(2010-2#2)(2012-12#1)
temporopolar##2##1##(2007-1#2)
temporospatial##2##1##(1997-8#1)(2008-9#1)
tempos##2##1##(2012-2#2)
temps##2##1##(1993-3#1)(2008-6#1)
temptation to##2##2##(1995-5#1)(2006-7#1)
temptation##3##1##(1993-3#1)(1995-5#1)(2006-7#1)
tempted##5##1##(1994-2#1)(1995-3#1)(2006-6#2)(2011-1#1)
tempting to##3##2##(2006-10#1)(2008-10#1)(2013-8#1)
tempting##6##1##(1991-12#1)(2006-10#1)(2008-10#1)(2008-9#1)(2012-2#1)(2013-8#1)
temsirolimus have##2##2##(2009-11#1)(2010-12#1)
temsirolimus##13##1##(2008-5#1)(2008-6#1)(2009-11#3)(2010-11#2)(2010-12#5)(2011-1#1)
ten CIS services and eight CIS capabilities were identified as being important for enabling scalable##2##15##(2013-1#2)
ten additional##2##2##(1994-8#1)(2012-2#1)
ten and##4##2##(1994-11#1)(2006-6#1)(2008-4#1)(2008-9#1)
ten basic dyes##2##3##(2012-12#2)
ten cases and##2##3##(1997-3#1)(2013-8#1)
ten cases of##5##3##(2007-8#1)(2008-4#1)(2010-7#1)(2012-2#1)(2013-8#1)
ten cases##11##2##(1997-3#1)(2007-8#2)(2008-4#1)(2009-8#1)(2010-7#3)(2012-2#1)(2013-8#2)
ten children with##2##3##(2006-10#1)(2007-7#1)
ten consecutive##4##2##(2007-6#1)(2008-10#2)(2012-1#1)
ten days after the diagnosis##2##5##(1993-3#1)(2009-8#1)
ten days after the##3##4##(1993-3#1)(2007-7#1)(2009-8#1)
ten days after##4##3##(1993-3#1)(2007-7#1)(2008-8#1)(2009-8#1)
ten days##16##2##(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-5#1)(1993-3#1)(1995-4#1)(1997-4#1)(1997-8#1)(2006-5#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-8#1)
ten determinations##5##2##(2008-10#5)
ten different##6##2##(1993-12#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-7#1)
ten dimensions##2##2##(2004-10#1)(2009-10#1)
ten exons##4##2##(1991-6#1)(1992-11#1)(1997-4#2)
ten female##2##2##(2007-12#1)(2008-12#1)
ten gratings##3##2##(2013-8#3)
ten head and neck##2##4##(2008-2#2)
ten healthy subjects##3##3##(2006-7#2)(2013-1#1)
ten healthy volunteers##3##3##(1993-11#1)(2006-7#1)(2012-2#1)
ten healthy##9##2##(1993-11#1)(1996-3#1)(1997-2#1)(2006-7#3)(2010-2#1)(2012-2#1)(2013-1#1)
ten hours##2##2##(2007-3#1)(2008-8#1)
ten in##4##2##(2007-11#1)(2010-10#1)(2012-3#2)
ten individuals##2##2##(2013-1#1)(2013-7#1)
ten known##2##2##(1991-9#1)(2007-1#1)
ten laminin##2##2##(2008-11#2)
ten measurements##2##2##(2008-10#1)(2008-3#1)
ten minutes##7##2##(1990-5#1)(1991-10#1)(1991-6#1)(1993-7#1)(1996-2#1)(2007-8#2)
ten months##8##2##(1990-10#1)(1996-9#1)(2006-4#1)(2007-7#1)(2008-5#1)(2008-9#2)(2012-2#1)
ten most common##2##3##(2008-4#1)(2011-2#1)
ten new##3##2##(2006-12#1)(2008-6#1)(2011-1#1)
ten normal##4##2##(1990-11#1)(2007-2#1)(2008-10#1)(2012-2#1)
ten of the##2##3##(1994-9#1)(2012-3#1)
ten of these##2##3##(1996-4#1)(2007-7#1)
ten of##7##2##(1991-10#1)(1994-9#1)(1996-4#1)(2007-7#1)(2008-12#1)(2008-5#1)(2012-3#1)
ten open surgery and two laparoscopic##2##6##(2012-12#2)
ten or 100 female##2##4##(1996-12#2)
ten or 100##3##3##(1996-12#3)
ten or more##2##3##(2004-1#1)(2013-8#1)
ten or##6##2##(1993-12#1)(1996-12#3)(2004-1#1)(2013-8#1)
ten other##3##2##(1994-5#1)(1996-6#1)(2008-6#1)
ten patients in group##2##4##(2007-9#2)
ten patients in##3##3##(2007-9#2)(2008-6#1)
ten patients who##3##3##(2007-7#1)(2007-8#1)(2008-7#1)
ten patients with##11##3##(1990-10#1)(1990-11#1)(1990-12#1)(1996-9#1)(2007-5#1)(2007-7#1)(2008-3#1)(2008-9#1)(2011-1#1)(2013-1#2)
ten patients##34##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-8#1)(1991-9#1)(1992-3#1)(1993-2#1)(1994-2#1)(1995-3#1)(1996-11#2)(1996-9#1)(2006-7#1)(2007-11#1)(2007-5#2)(2007-7#3)(2007-8#1)(2007-9#2)(2008-3#2)(2008-6#2)(2008-7#2)(2008-9#1)(2009-4#1)(2011-1#1)(2013-1#2)
ten percent of##2##3##(1992-5#1)(1993-12#1)
ten percent##5##2##(1992-5#1)(1993-12#1)(1993-3#1)(2008-10#1)(2010-8#1)
ten putative##2##2##(1991-7#1)(1993-3#1)
ten rats##3##2##(2008-4#1)(2009-5#1)(2010-4#1)
ten replicate##6##2##(2008-10#5)(2013-7#1)
ten sites##2##2##(1996-11#1)(2013-8#1)
ten species##2##2##(1992-12#1)(2007-5#1)
ten standard##2##2##(2006-6#1)(2008-2#1)
ten strains##2##2##(2006-8#1)(2008-5#1)
ten subjects##5##2##(1997-6#1)(2007-4#2)(2008-5#2)
ten substances##2##2##(1996-6#1)(2007-1#1)
ten times as##2##3##(1992-1#1)(2007-8#1)
ten times greater than##2##4##(2008-2#1)(2008-3#1)
ten times higher than the##4##5##(1990-10#1)(2005-8#1)(2007-12#1)(2012-3#1)
ten times higher than##9##4##(1990-10#1)(1990-12#1)(1991-5#1)(1992-2#1)(1992-5#1)(2005-8#1)(2007-12#1)(2010-12#1)(2012-3#1)
ten times higher##13##3##(1990-10#2)(1990-12#1)(1990-6#1)(1991-5#1)(1992-2#1)(1992-5#1)(1993-1#1)(2005-8#1)(2007-12#1)(2008-11#1)(2010-12#1)(2012-3#1)
ten times larger than##2##4##(2006-11#1)(2007-12#1)
ten times lower than##2##4##(1990-6#1)(1992-9#1)
ten times more##6##3##(1990-8#2)(1992-2#1)(1993-3#1)(1994-6#1)(2008-10#1)
ten times that of##2##4##(1994-9#1)(2008-10#1)
ten times that##3##3##(1994-9#1)(1995-1#1)(2008-10#1)
ten times the##6##3##(1990-6#1)(1993-12#1)(2008-10#2)(2008-5#1)(2013-8#1)
ten times##46##2##(1990-10#2)(1990-12#1)(1990-6#3)(1990-8#2)(1991-2#1)(1991-5#1)(1992-1#1)(1992-2#2)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-6#1)(1994-9#2)(1995-1#1)(1996-6#1)(2005-8#1)(2006-11#1)(2007-12#3)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2012-3#1)(2013-8#1)
ten to 16 years##2##4##(2008-3#2)
ten to##7##2##(1992-1#1)(2007-1#1)(2008-3#3)(2008-4#1)(2011-1#1)
ten trials##2##2##(2006-2#1)(2010-8#1)
ten volunteers##2##2##(1990-3#1)(2006-7#1)
ten weeks##4##2##(2007-8#1)(2008-10#1)(2011-1#1)(2013-8#1)
ten were given placebo##2##4##(2007-7#1)(2007-8#1)
ten were##9##2##(1990-12#1)(1990-2#1)(1992-1#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-9#2)(2013-8#1)
ten with##2##2##(2011-2#1)(2012-2#1)
ten women##2##2##(1991-8#1)(1994-12#1)
ten year period##5##3##(1992-9#1)(1994-2#1)(2006-8#2)(2012-2#1)
ten year##13##2##(1992-9#1)(1994-2#1)(2006-8#2)(2008-1#1)(2008-3#1)(2008-5#1)(2008-8#3)(2010-5#1)(2011-1#1)(2012-2#1)
ten years after the##2##4##(2007-2#1)(2008-12#1)
ten years after##5##3##(1997-7#1)(2007-2#1)(2008-12#1)(2010-11#1)(2010-8#1)
ten years ago##5##3##(1990-6#1)(1993-5#1)(2007-1#1)(2008-1#1)(2009-12#1)
ten years and##2##3##(1992-2#1)(2006-4#1)
ten years before##2##3##(1994-9#1)(2008-1#1)
ten years from##2##3##(2008-3#1)(2012-3#1)
ten years have##2##3##(1990-7#1)(2008-8#1)
ten years in##3##3##(2005-9#1)(2008-4#1)(2013-1#1)
ten years is##2##3##(1991-8#1)(1992-6#1)
ten years of clinical experience##2##5##(2008-3#2)
ten years of follow-up##3##4##(1991-8#1)(1995-8#1)(2009-8#1)
ten years of##12##3##(1991-8#1)(1992-1#1)(1992-12#1)(1995-8#1)(2006-4#1)(2006-7#1)(2008-3#2)(2008-9#2)(2009-2#1)(2009-8#1)
ten years previously##2##3##(1990-12#1)(1990-5#1)
ten years##103##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#2)(1990-6#3)(1990-7#2)(1991-12#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#2)(1994-5#2)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-3#2)(1996-4#1)(1996-7#1)(1996-9#1)(1997-7#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-4#2)(2006-6#1)(2006-7#2)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#4)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#6)(2008-9#2)(2009-12#1)(2009-2#1)(2009-8#3)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#5)(2013-1#2)
ten years' experience##2##3##(1990-2#1)(2007-7#1)
ten years'##4##2##(1990-2#1)(2007-7#1)(2011-1#1)(2011-2#1)
ten##652##1##(1990-10#5)(1990-11#4)(1990-12#5)(1990-2#3)(1990-3#1)(1990-4#3)(1990-5#4)(1990-6#6)(1990-7#2)(1990-8#4)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#5)(1991-3#3)(1991-4#1)(1991-5#4)(1991-6#3)(1991-7#3)(1991-8#5)(1991-9#4)(1992-1#7)(1992-11#4)(1992-12#3)(1992-2#3)(1992-3#3)(1992-5#3)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#6)(1993-2#3)(1993-3#5)(1993-5#3)(1993-6#2)(1993-7#3)(1993-8#2)(1993-9#3)(1994-11#2)(1994-12#2)(1994-2#4)(1994-5#4)(1994-6#5)(1994-8#1)(1994-9#5)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-4#1)(1995-6#2)(1995-8#3)(1996-11#5)(1996-12#8)(1996-2#4)(1996-3#5)(1996-4#2)(1996-5#1)(1996-6#3)(1996-7#2)(1996-9#4)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#7)(2004-1#1)(2004-10#1)(2005-12#2)(2005-5#1)(2005-7#2)(2005-8#3)(2005-9#1)(2006-1#2)(2006-10#3)(2006-11#4)(2006-12#6)(2006-2#1)(2006-3#1)(2006-4#5)(2006-5#1)(2006-6#3)(2006-7#7)(2006-8#6)(2006-9#1)(2007-1#4)(2007-10#4)(2007-11#8)(2007-12#8)(2007-2#4)(2007-3#4)(2007-4#4)(2007-5#8)(2007-6#2)(2007-7#14)(2007-8#11)(2007-9#2)(2008-1#9)(2008-10#47)(2008-11#9)(2008-12#7)(2008-2#8)(2008-3#21)(2008-4#10)(2008-5#14)(2008-6#5)(2008-7#8)(2008-8#16)(2008-9#13)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#2)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#6)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#4)(2010-3#2)(2010-4#3)(2010-5#1)(2010-7#5)(2010-8#3)(2010-9#2)(2011-1#11)(2011-12#1)(2011-2#10)(2011-9#1)(2012-1#1)(2012-11#2)(2012-12#11)(2012-2#12)(2012-3#10)(2013-1#20)(2013-7#3)(2013-8#13)
ten- to##2##2##(1990-5#1)(1991-9#1)
ten-channel##2##1##(2008-2#1)(2008-3#1)
ten-fold diluted##2##2##(1991-12#1)(1991-5#1)
ten-fold in##2##2##(1991-1#1)(2008-7#1)
ten-fold increase in the##2##4##(1992-8#1)(2007-12#1)
ten-fold increase in##3##3##(1990-9#1)(1992-8#1)(2007-12#1)
ten-fold increase##5##2##(1990-9#1)(1992-8#1)(1994-6#1)(1995-12#1)(2007-12#1)
ten-fold to##2##2##(1993-9#1)(2009-8#1)
ten-fold##23##1##(1990-2#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-11#2)(1996-12#1)(1997-3#2)(2006-8#1)(2007-12#1)(2008-7#1)(2009-8#1)(2013-1#2)
ten-year experience##2##2##(2006-6#1)(2007-8#1)
ten-year period##5##2##(1991-9#1)(1995-9#1)(2005-9#1)(2008-4#1)(2012-2#1)
ten-year##21##1##(1990-2#1)(1991-9#1)(1993-1#3)(1995-8#1)(1995-9#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-3#2)(2007-8#1)(2008-4#1)(2008-9#1)(2009-11#1)(2009-8#2)(2011-12#1)(2012-2#1)
tenable##2##1##(1993-5#1)(2008-5#1)
tenacious##3##1##(2005-11#1)(2007-7#1)(2008-3#1)
tenacity##2##1##(2004-11#1)(2007-10#1)
tenant##2##1##(1996-5#1)(2013-1#1)
tenants##3##1##(1993-1#2)(1996-5#1)
tenascin and##2##2##(1993-4#1)(2007-11#1)
tenascin or##2##2##(1991-3#1)(2004-9#1)
tenascin##8##1##(1991-3#3)(1993-4#1)(2004-9#1)(2007-11#1)(2009-3#2)
tend not to##2##3##(2007-10#1)(2008-11#1)
tend to adopt##2##3##(1995-4#1)(2006-7#1)
tend to aggregate##2##3##(2005-11#1)(2008-6#1)
tend to agree with##2##4##(1990-10#1)(2008-11#1)
tend to agree##3##3##(1990-10#1)(1992-2#1)(2008-11#1)
tend to avoid##3##3##(2006-10#1)(2012-2#1)(2013-8#1)
tend to be associated with##2##5##(2007-12#1)(2008-5#1)
tend to be higher than##2##5##(2004-11#1)(2013-8#1)
tend to be in##2##4##(1995-2#1)(2009-11#1)
tend to be less##2##4##(2010-3#1)(2011-2#1)
tend to be more##10##4##(1992-9#2)(1993-3#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)(2012-2#1)
tend to be positive##2##4##(2009-9#1)(2011-2#1)
tend to be positively##2##4##(1994-5#1)(2011-12#1)
tend to be##73##3##(1991-12#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#2)(1993-1#1)(1993-3#1)(1993-8#1)(1994-3#2)(1994-5#2)(1994-9#1)(1995-2#1)(1996-7#1)(1997-2#1)(1997-8#1)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-11#3)(2007-12#4)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2009-11#1)(2009-9#1)(2010-12#2)(2010-3#1)(2011-12#1)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#3)
tend to believe##2##3##(2009-11#1)(2011-1#1)
tend to contain##2##3##(2007-12#1)(2008-2#1)
tend to correlate##2##3##(2006-2#1)(2007-3#1)
tend to decrease##4##3##(2008-8#1)(2009-5#1)(2009-6#1)(2013-1#1)
tend to develop##3##3##(1996-12#1)(2008-10#1)(2011-2#1)
tend to diminish##2##3##(2007-9#1)(2010-12#1)
tend to fall into##2##4##(1997-1#1)(2011-2#1)
tend to fall##3##3##(1997-1#1)(2011-2#2)
tend to form##2##3##(2005-4#1)(2006-8#1)
tend to generate##3##3##(2008-5#1)(2008-9#1)(2012-1#1)
tend to have a##3##4##(1993-4#1)(1996-9#1)(2012-2#1)
tend to have been##2##4##(2006-10#1)(2006-12#1)
tend to have higher##2##4##(1994-2#1)(2010-2#1)
tend to have more##2##4##(2006-12#1)(2010-6#1)
tend to have##16##3##(1993-4#1)(1994-2#1)(1996-9#1)(2006-10#1)(2006-12#2)(2008-1#1)(2008-5#1)(2009-5#1)(2010-2#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)
tend to increase in the##2##5##(2008-9#1)(2013-1#1)
tend to increase##8##3##(1991-6#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-4#1)(2012-1#1)(2013-1#2)
tend to live in high density households compared to##2##9##(2011-2#2)
tend to lose##2##3##(2008-5#1)(2008-7#1)
tend to occur##2##3##(1997-8#1)(2008-9#1)
tend to only##2##3##(1994-3#1)(2012-2#1)
tend to perform##3##3##(1996-12#1)(2011-2#1)(2012-3#1)
tend to present##2##3##(2006-1#1)(2008-7#1)
tend to produce##5##3##(2007-11#1)(2007-12#1)(2008-7#1)(2010-3#1)(2012-1#1)
tend to provide##2##3##(2008-5#1)(2008-7#1)
tend to remain##3##3##(1994-4#1)(2008-10#1)(2008-9#1)
tend to show a##2##4##(1997-1#1)(2007-3#1)
tend to show##5##3##(1997-1#1)(1997-7#1)(2007-3#1)(2007-9#1)(2008-5#1)
tend to treat##2##3##(2008-5#1)(2010-12#1)
tend to use##2##3##(2006-5#1)(2008-11#1)
tend to##239##2##(1990-10#1)(1990-11#1)(1990-2#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-2#1)(1994-3#3)(1994-4#2)(1994-5#2)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-3#2)(1996-7#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#2)(2004-11#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#3)(2005-4#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-5#1)(2006-7#3)(2006-8#1)(2007-1#1)(2007-11#5)(2007-12#8)(2007-3#2)(2007-4#2)(2007-8#2)(2007-9#3)(2008-1#3)(2008-10#6)(2008-11#8)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#9)(2008-6#4)(2008-7#7)(2008-8#6)(2008-9#4)(2009-11#4)(2009-12#1)(2009-2#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-9#1)(2010-12#5)(2010-2#1)(2010-3#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#15)(2012-1#3)(2012-12#8)(2012-2#7)(2012-3#2)(2013-1#3)(2013-8#7)
tend##245##1##(1990-10#1)(1990-11#1)(1990-2#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-2#1)(1994-3#3)(1994-4#2)(1994-5#2)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-3#2)(1996-7#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#2)(2004-11#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#3)(2005-4#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-5#1)(2006-7#3)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#8)(2007-3#2)(2007-4#2)(2007-8#2)(2007-9#3)(2008-1#3)(2008-10#6)(2008-11#10)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#9)(2008-6#4)(2008-7#7)(2008-8#6)(2008-9#4)(2009-11#4)(2009-12#1)(2009-2#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-12#5)(2010-2#1)(2010-3#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#15)(2011-3#1)(2012-1#3)(2012-12#8)(2012-2#7)(2012-3#2)(2013-1#3)(2013-8#7)
tended to be associated with##3##5##(2007-9#1)(2008-9#2)
tended to be greater in##3##5##(2004-11#1)(2007-4#2)
tended to be greater##5##4##(2004-11#1)(2007-4#2)(2008-10#1)(2013-1#1)
tended to be higher in non-responders##2##6##(2013-1#2)
tended to be higher in##7##5##(1994-5#1)(1995-10#1)(1995-3#1)(1996-9#1)(2008-3#1)(2013-1#2)
tended to be higher##9##4##(1994-5#1)(1995-10#1)(1995-3#1)(1996-9#1)(2008-2#1)(2008-3#2)(2013-1#2)
tended to be highest (P&lt##2##5##(2009-4#2)
tended to be highest##3##4##(2008-10#1)(2009-4#2)
tended to be increased##3##4##(1996-7#1)(2007-8#2)
tended to be less than##2##5##(1995-5#1)(2008-9#1)
tended to be less##4##4##(1990-12#1)(1995-5#1)(2008-9#1)(2011-2#1)
tended to be longer in patients with##2##7##(2008-5#2)
tended to be lower in the##2##6##(2007-5#1)(2008-7#1)
tended to be lower in##3##5##(2007-4#1)(2007-5#1)(2008-7#1)
tended to be lower than in##2##6##(2006-10#1)(2007-8#1)
tended to be lower than##3##5##(1993-12#1)(2006-10#1)(2007-8#1)
tended to be lower##8##4##(1993-12#1)(2006-10#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-5#1)(2008-7#1)(2013-8#1)
tended to be more##8##4##(1991-12#1)(2007-10#1)(2008-10#1)(2008-5#1)(2010-2#1)(2011-2#1)(2012-7#1)(2013-7#1)
tended to be older##2##4##(1994-12#1)(1995-3#1)
tended to be similar##2##4##(2008-10#1)(2008-9#1)
tended to be slightly more##2##5##(1995-10#1)(1995-5#1)
tended to be slightly##3##4##(1995-10#1)(1995-3#1)(1995-5#1)
tended to be younger (mean age##2##6##(1996-12#1)(2007-9#1)
tended to be younger##5##4##(1993-1#1)(1996-12#1)(1996-2#1)(2007-9#1)(2012-3#1)
tended to be##84##3##(1990-11#1)(1990-12#1)(1991-12#1)(1991-5#1)(1993-1#1)(1993-10#1)(1993-12#1)(1994-12#1)(1994-5#1)(1994-7#1)(1995-10#2)(1995-3#3)(1995-5#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-8#1)(2004-11#1)(2005-10#1)(2006-10#2)(2006-4#1)(2007-10#2)(2007-4#4)(2007-5#1)(2007-8#3)(2007-9#3)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#4)(2009-4#3)(2009-9#1)(2010-2#1)(2010-3#2)(2011-1#1)(2011-2#3)(2012-3#2)(2012-7#1)(2013-1#4)(2013-7#1)(2013-8#1)
tended to cluster##2##3##(2008-10#1)(2008-11#1)
tended to decline##5##3##(1995-12#1)(1995-5#1)(2010-8#1)(2011-12#1)(2011-2#1)
tended to decrease in the##2##5##(2007-1#1)(2011-2#1)
tended to decrease in##4##4##(1994-12#1)(2007-1#1)(2007-8#1)(2011-2#1)
tended to decrease##13##3##(1991-4#1)(1991-9#1)(1993-4#1)(1994-12#1)(1995-6#1)(1997-2#1)(2007-1#1)(2007-8#2)(2008-5#1)(2010-4#1)(2011-2#1)(2012-12#1)
tended to enhance the##2##4##(2008-10#1)(2009-12#1)
tended to focus on the##2##5##(2007-6#1)(2008-11#1)
tended to focus on##3##4##(2004-12#1)(2007-6#1)(2008-11#1)
tended to follow##2##3##(2008-12#1)(2008-9#1)
tended to form##2##3##(1991-3#1)(2008-11#1)
tended to give a##2##4##(1991-2#1)(2008-5#1)
tended to give##3##3##(1991-2#1)(2008-5#2)
tended to have a##2##4##(1995-10#1)(2008-7#1)
tended to have greater##2##4##(2008-10#1)(2012-1#1)
tended to have lower##3##4##(2008-10#1)(2008-9#1)(2010-10#1)
tended to have##16##3##(1990-5#1)(1991-11#1)(1991-9#1)(1994-3#1)(1995-10#1)(2007-2#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-10#1)(2010-8#2)(2011-2#2)(2012-1#1)
tended to hold##2##3##(2006-8#1)(2010-10#1)
tended to improve##6##3##(2010-2#1)(2010-4#1)(2011-2#1)(2013-1#3)
tended to increase in the##2##5##(1990-3#1)(2010-12#1)
tended to increase in##3##4##(1990-3#1)(2010-12#1)(2012-2#1)
tended to increase the##2##4##(1992-10#1)(1995-5#1)
tended to increase with time##2##5##(2008-10#2)
tended to increase with##4##4##(1995-9#1)(2006-4#1)(2008-10#2)
tended to increase##18##3##(1990-10#1)(1990-3#2)(1992-10#1)(1995-5#1)(1995-9#1)(1996-8#1)(2006-4#1)(2007-1#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-8#1)
tended to occur##2##3##(1995-10#1)(2008-9#1)
tended to remain##2##3##(1991-1#1)(1993-1#1)
tended to report##2##3##(2008-5#1)(2013-8#1)
tended to target##2##3##(2010-1#1)(2013-7#1)
tended to underestimate##2##3##(1991-3#1)(2005-10#1)
tended to yield##2##3##(1992-9#1)(2008-10#1)
tended to##248##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#4)(1990-4#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#2)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-7#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-12#2)(1993-4#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#2)(1995-10#5)(1995-12#1)(1995-3#4)(1995-5#4)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#3)(2004-11#1)(2004-12#1)(2005-10#3)(2005-7#1)(2006-10#2)(2006-2#1)(2006-4#3)(2006-6#1)(2006-8#1)(2007-1#2)(2007-10#5)(2007-12#1)(2007-2#2)(2007-4#5)(2007-5#1)(2007-6#3)(2007-7#2)(2007-8#7)(2007-9#3)(2008-10#17)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#13)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#8)(2009-12#1)(2009-4#5)(2009-5#1)(2009-9#3)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#1)(2010-8#5)(2011-1#1)(2011-12#1)(2011-2#11)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#3)(2012-7#1)(2013-1#9)(2013-7#2)(2013-8#4)
tended##253##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#4)(1990-4#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#2)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-7#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-12#2)(1993-4#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#2)(1995-10#5)(1995-12#1)(1995-3#4)(1995-5#4)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-11#1)(2004-12#1)(2005-10#3)(2005-7#1)(2006-10#2)(2006-2#1)(2006-4#3)(2006-6#1)(2006-8#1)(2007-1#2)(2007-10#5)(2007-12#1)(2007-2#2)(2007-4#5)(2007-5#1)(2007-6#3)(2007-7#2)(2007-8#7)(2007-9#3)(2008-10#19)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#13)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#8)(2009-12#1)(2009-4#5)(2009-5#1)(2009-9#3)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#4)(2010-5#1)(2010-8#5)(2011-1#1)(2011-12#1)(2011-2#11)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#3)(2012-7#1)(2013-1#9)(2013-7#2)(2013-8#4)
tendencies and##2##2##(1993-8#1)(2007-12#1)
tendencies in##4##2##(1991-9#1)(1993-5#1)(2012-12#1)(2013-7#1)
tendencies of##6##2##(1990-8#1)(2006-5#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-12#1)
tendencies to##3##2##(1994-2#1)(2007-12#1)(2008-10#1)
tendencies##44##1##(1990-8#1)(1991-9#1)(1992-1#1)(1993-5#2)(1993-8#1)(1994-2#1)(1996-2#1)(2004-3#1)(2005-11#1)(2006-5#1)(2007-12#4)(2007-3#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#2)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-3#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
tendency among##2##2##(1990-8#1)(1992-3#1)
tendency and##4##2##(1997-3#1)(2011-2#1)(2012-12#2)
tendency at##2##2##(2005-10#1)(2008-5#1)
tendency for spontaneous##2##3##(1993-9#1)(2007-8#1)
tendency for the##6##3##(1994-3#2)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)
tendency for##51##2##(1991-2#1)(1992-2#1)(1992-6#1)(1993-9#1)(1994-3#2)(1995-7#2)(1997-4#2)(1997-5#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#3)(2008-8#1)(2009-5#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-7#1)
tendency in the##3##3##(1995-3#1)(2007-4#1)(2008-7#1)
tendency in##6##2##(1991-2#1)(1995-3#1)(1996-12#1)(2007-4#1)(2008-11#1)(2008-7#1)
tendency is##3##2##(1992-5#1)(1997-8#1)(2011-1#1)
tendency of FMN(2-)##2##3##(2006-10#2)
tendency of a##3##3##(1997-6#1)(2008-7#1)(2008-8#1)
tendency of the##10##3##(1991-3#1)(1992-3#1)(1997-2#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-10#1)(2008-5#1)(2012-1#1)(2013-8#1)
tendency of##45##2##(1990-8#1)(1991-3#1)(1991-6#1)(1992-3#1)(1994-2#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-6#3)(1997-7#1)(2005-11#1)(2006-10#4)(2006-3#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#3)(2009-8#1)(2010-2#1)(2011-2#1)(2012-1#2)(2012-12#2)(2013-8#3)
tendency to a##3##3##(1992-8#1)(2008-10#1)(2008-5#1)
tendency to accumulate in the##2##5##(2008-10#1)(2010-2#1)
tendency to accumulate in##3##4##(2008-10#1)(2010-2#1)(2013-8#1)
tendency to accumulate##4##3##(2008-10#2)(2010-2#1)(2013-8#1)
tendency to aggregate##5##3##(1990-12#1)(1991-11#2)(1995-10#1)(2005-11#1)
tendency to be##2##3##(2010-2#1)(2011-2#1)
tendency to decrease##2##3##(2008-10#1)(2013-1#1)
tendency to develop##2##3##(1990-12#1)(1997-8#1)
tendency to form##6##3##(1991-2#2)(1993-4#1)(2005-11#1)(2008-10#1)(2013-1#1)
tendency to have##2##3##(2011-2#1)(2012-2#1)
tendency to produce##2##3##(1997-5#1)(2012-1#1)
tendency to spread##2##3##(1995-5#1)(2013-1#1)
tendency to use##2##3##(2006-10#1)(2012-2#1)
tendency to##105##2##(1990-11#1)(1990-12#2)(1990-4#1)(1990-5#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#3)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-4#2)(1993-5#5)(1993-6#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-5#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-4#1)(2005-10#1)(2005-11#2)(2006-10#3)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#6)(2013-7#1)(2013-8#1)
tendency toward##13##2##(1992-9#1)(1994-3#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-2#1)(2007-9#1)(2008-10#1)(2011-2#2)(2012-12#1)(2013-8#2)
tendency towards higher##2##3##(1990-2#1)(2011-2#1)
tendency towards the##2##3##(2008-2#1)(2008-4#1)
tendency towards##14##2##(1990-10#1)(1990-2#1)(1991-12#1)(1991-2#1)(1992-6#1)(1993-3#2)(1995-11#1)(2007-11#1)(2008-2#1)(2008-4#1)(2011-12#1)(2011-2#1)(2013-8#1)
tendency was found for##2##4##(1996-7#1)(2011-2#1)
tendency was noticed##2##3##(2005-10#1)(2007-11#1)
tendency was observed in##5##4##(1995-7#1)(2008-11#1)(2010-2#1)(2011-1#1)(2012-12#1)
tendency was observed##7##3##(1992-6#1)(1995-7#1)(2008-11#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-7#1)
tendency was##25##2##(1990-4#1)(1991-12#1)(1992-6#1)(1993-3#1)(1993-9#1)(1995-11#1)(1995-7#1)(1996-2#1)(1996-6#1)(1996-7#1)(2005-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-11#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-12#2)(2013-7#1)(2013-8#1)
tendency##308##1##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-4#2)(1990-5#1)(1990-8#2)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#6)(1991-3#1)(1991-5#1)(1991-6#3)(1992-1#2)(1992-11#1)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#3)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#3)(1993-4#2)(1993-5#5)(1993-6#1)(1993-8#1)(1993-9#2)(1994-2#2)(1994-3#4)(1994-6#1)(1995-10#1)(1995-11#2)(1995-3#1)(1995-5#1)(1995-7#3)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#2)(2004-3#1)(2004-4#1)(2005-10#4)(2005-11#5)(2005-8#1)(2006-10#9)(2006-11#1)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#7)(2007-12#7)(2007-2#2)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#18)(2008-11#8)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#10)(2008-6#1)(2008-7#10)(2008-8#6)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#5)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#12)(2012-1#3)(2012-11#1)(2012-12#9)(2012-2#5)(2013-1#9)(2013-7#3)(2013-8#10)
tender and##2##2##(2010-4#2)
tender mass in the##3##4##(1991-10#1)(1993-9#1)(2009-3#1)
tender nodule##2##2##(2006-6#1)(2007-7#1)
tender points##8##2##(1990-6#1)(2006-10#2)(2007-6#3)(2008-12#1)(2009-7#1)
tender##41##1##(1990-2#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-8#1)(1993-8#1)(1993-9#1)(2005-12#1)(2006-10#5)(2006-6#1)(2007-6#3)(2007-7#5)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-4#6)(2011-1#1)(2013-8#3)
tenderness and##10##2##(2007-2#1)(2009-4#1)(2010-2#1)(2010-4#2)(2011-12#1)(2012-12#1)(2013-1#3)
tenderness at the##2##3##(2006-10#1)(2009-3#1)
tenderness can be##2##3##(1991-4#1)(2011-2#1)
tenderness in##2##2##(2008-9#1)(2010-4#1)
tenderness of the##2##3##(1990-6#1)(2010-4#1)
tenderness of##5##2##(1990-6#1)(2007-11#1)(2010-4#3)
tenderness on##3##2##(2006-10#1)(2008-12#1)(2008-3#1)
tenderness or##2##2##(2010-4#1)(2013-8#1)
tenderness over the affected##2##4##(2006-7#1)(2006-8#1)
tenderness over the##5##3##(2006-10#2)(2006-7#1)(2006-8#1)(2013-1#1)
tenderness threshold##2##2##(2010-4#2)
tenderness thresholds##2##2##(2010-4#2)
tenderness to##2##2##(1990-10#1)(2006-7#1)
tenderness with##2##2##(2008-1#1)(2010-4#1)
tenderness##73##1##(1990-10#1)(1990-6#1)(1991-4#1)(1991-6#1)(1992-5#1)(1997-1#1)(1997-8#1)(2006-10#5)(2006-7#2)(2006-8#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#2)(2009-10#2)(2009-11#1)(2009-3#1)(2009-4#1)(2010-2#2)(2010-4#28)(2011-12#2)(2011-2#2)(2012-11#1)(2012-12#2)(2013-1#4)(2013-8#1)
tendinae##2##1##(2007-10#2)
tendineae##3##1##(2008-5#2)(2013-1#1)
tending to##10##2##(1991-12#1)(1991-6#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-4#1)(2008-9#1)(2011-1#1)(2012-4#1)
tending towards##2##2##(2010-7#1)(2012-12#1)
tending##12##1##(1991-12#1)(1991-6#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-4#1)(2008-9#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-4#1)
tendinitis is##2##2##(2009-9#2)
tendinitis of the shoulder##2##4##(1991-4#1)(1997-6#1)
tendinitis of##3##2##(1991-4#1)(1992-11#1)(1997-6#1)
tendinitis##13##1##(1991-4#2)(1992-11#1)(1996-12#2)(1997-6#1)(2006-10#1)(2007-8#2)(2009-9#3)(2013-1#1)
tendinopathies##2##1##(1994-11#1)(2006-10#1)
tendinopathy##8##1##(2006-10#4)(2008-12#1)(2011-2#1)(2013-1#2)
tendinosis##12##1##(1997-6#1)(2007-8#1)(2008-8#1)(2009-10#4)(2010-11#1)(2010-3#4)
tendinous xanthomas##3##2##(1997-8#3)
tendinous##10##1##(1994-4#1)(1997-8#3)(2006-10#1)(2007-8#2)(2008-6#1)(2008-9#1)(2012-12#1)
tendo Achilles##2##2##(2008-12#1)(2010-7#1)
tendo-Achilles lengthening##2##2##(2008-8#1)(2011-2#1)
tendon adhesions##2##2##(2006-3#1)(2008-9#1)
tendon after##2##2##(2013-1#2)
tendon allograft##2##2##(2008-4#1)(2012-2#1)
tendon and##15##2##(1990-11#1)(2006-3#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#3)(2009-4#1)(2009-9#2)(2010-9#1)(2012-11#1)
tendon at the##2##3##(2006-3#1)(2013-7#1)
tendon at##3##2##(2006-3#2)(2013-7#1)
tendon collagen##2##2##(1995-1#1)(2004-9#1)
tendon disorders##2##2##(2009-10#1)(2010-3#1)
tendon fibroblasts##2##2##(1996-8#1)(2006-11#1)
tendon graft##10##2##(2006-3#4)(2009-3#3)(2009-6#2)(2012-2#1)
tendon had##2##2##(2009-10#1)(2009-9#1)
tendon healing##2##2##(2006-3#1)(2013-1#1)
tendon in a##4##3##(2006-3#1)(2007-12#1)(2009-4#1)(2010-7#1)
tendon in the##2##3##(2009-5#2)
tendon in##8##2##(1990-9#1)(2006-3#1)(2007-12#1)(2009-10#1)(2009-4#1)(2009-5#2)(2010-7#1)
tendon injuries##4##2##(2006-3#2)(2006-4#1)(2009-5#1)
tendon injury##3##2##(2008-10#1)(2008-12#1)(2013-7#1)
tendon interposition##4##2##(2006-3#1)(2008-9#1)(2009-3#2)
tendon is##6##2##(1992-7#1)(2006-3#2)(2007-12#1)(2009-4#1)(2009-5#1)
tendon of the long head of##2##6##(2007-11#1)(2007-8#1)
tendon of the##5##3##(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-8#1)
tendon of##6##2##(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-8#1)
tendon or##3##2##(2009-9#2)(2013-1#1)
tendon pathology##3##2##(2010-4#3)
tendon reflex##3##2##(1993-9#1)(2008-4#2)
tendon reflexes##6##2##(1992-8#2)(2007-11#1)(2007-7#1)(2008-6#1)(2008-7#1)
tendon repair##3##2##(2006-3#1)(2006-4#2)
tendon rupture and##2##3##(1996-12#1)(2012-11#1)
tendon rupture following##3##3##(2009-4#1)(2010-3#2)
tendon rupture in##3##3##(1996-12#2)(2010-3#1)
tendon rupture##22##2##(1996-12#4)(2006-3#2)(2006-4#1)(2009-3#1)(2009-4#5)(2010-3#3)(2011-12#1)(2011-2#1)(2012-11#2)(2012-12#2)
tendon ruptures##5##2##(1996-12#2)(2006-4#1)(2010-11#1)(2011-2#1)
tendon sheath fistula formation##2##4##(2008-10#2)
tendon sheath##11##2##(2006-10#2)(2006-3#1)(2006-4#1)(2008-10#3)(2008-9#4)
tendon sheaths##3##2##(2005-7#1)(2006-10#1)(2010-3#1)
tendon to the##2##3##(2009-10#2)
tendon to##5##2##(2006-3#1)(2007-2#1)(2008-9#1)(2009-10#2)
tendon transfer has##2##3##(2006-3#1)(2012-12#1)
tendon transfer##11##2##(2006-3#4)(2007-7#3)(2009-10#2)(2012-12#2)
tendon transfers##5##2##(2006-3#4)(2007-7#1)
tendon transposition##2##2##(2007-2#1)(2009-10#1)
tendon using a##2##3##(2006-3#1)(2006-4#1)
tendon using##3##2##(2006-3#1)(2006-4#1)(2010-3#1)
tendon was sectioned##2##3##(2008-9#1)(2009-4#1)
tendon was##5##2##(2008-9#2)(2009-10#2)(2009-4#1)
tendon with##2##2##(2008-12#1)(2009-9#1)
tendon##290##1##(1990-11#1)(1990-9#2)(1992-7#2)(1992-8#2)(1993-9#2)(1995-1#2)(1995-8#3)(1996-12#6)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-5#1)(2004-9#1)(2005-7#1)(2005-9#1)(2006-10#7)(2006-11#3)(2006-3#40)(2006-4#8)(2006-9#1)(2007-11#2)(2007-12#3)(2007-2#5)(2007-4#1)(2007-7#9)(2007-8#2)(2008-1#5)(2008-10#4)(2008-11#3)(2008-12#7)(2008-3#2)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#24)(2009-10#15)(2009-3#10)(2009-4#9)(2009-5#7)(2009-6#2)(2009-7#1)(2009-9#10)(2010-11#1)(2010-12#1)(2010-3#6)(2010-4#3)(2010-7#3)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#8)(2012-1#1)(2012-11#3)(2012-12#6)(2012-2#4)(2013-1#8)(2013-7#13)
tendon-bone##5##1##(2008-4#1)(2008-6#2)(2009-3#1)(2013-1#1)
tendonitis of the##2##3##(2012-12#2)
tendonitis##9##1##(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#3)(2012-12#3)
tendons and deep peroneal nerve##2##5##(2012-2#2)
tendons and the##3##3##(1997-8#1)(2008-9#2)
tendons and##14##2##(1990-11#1)(1997-8#1)(2006-4#1)(2006-8#1)(2007-12#1)(2008-6#1)(2008-9#2)(2009-7#1)(2010-9#1)(2012-1#1)(2012-2#2)(2013-1#1)
tendons are##5##2##(1993-1#1)(2008-11#2)(2012-1#1)(2013-1#1)
tendons as##2##2##(1993-1#1)(2008-5#1)
tendons can##2##2##(2006-3#1)(2008-11#1)
tendons harvested##2##2##(2009-9#2)
tendons in##3##2##(2006-3#1)(2008-11#1)(2013-1#1)
tendons of##5##2##(1992-7#1)(2007-7#1)(2008-7#3)
tendons showed##2##2##(1997-8#2)
tendons were##4##2##(2006-10#1)(2008-5#1)(2008-7#1)(2009-4#1)
tendons##102##1##(1990-11#1)(1990-4#1)(1990-6#1)(1992-11#1)(1992-7#4)(1992-9#1)(1993-1#4)(1995-8#1)(1996-5#2)(1997-3#1)(1997-8#3)(2004-9#1)(2006-10#3)(2006-11#1)(2006-3#2)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#5)(2007-7#2)(2007-8#2)(2008-11#4)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#6)(2008-9#3)(2009-10#1)(2009-4#3)(2009-5#2)(2009-7#1)(2009-9#3)(2010-9#1)(2011-2#7)(2012-1#8)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#10)(2013-7#1)
tendons/ligaments##2##1##(2008-5#1)(2009-7#1)
tendopathy##2##1##(2006-12#2)
tends to adopt a##2##4##(1994-11#1)(2006-10#1)
tends to be associated with##2##5##(2007-6#1)(2008-7#1)
tends to be greater##2##4##(1994-3#1)(1996-12#1)
tends to be higher##2##4##(2006-11#1)(2013-8#1)
tends to be more##6##4##(1994-4#1)(2007-11#1)(2008-4#2)(2009-8#1)(2013-1#1)
tends to be the##2##4##(2005-11#1)(2006-10#1)
tends to be##37##3##(1992-6#1)(1994-11#1)(1994-3#1)(1994-4#1)(1995-8#1)(1996-12#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#2)(2010-5#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#3)
tends to become##2##3##(2008-2#1)(2009-6#1)
tends to break down##2##4##(2008-3#1)(2008-5#1)
tends to break##3##3##(2008-3#1)(2008-5#1)(2011-2#1)
tends to grow##2##3##(1996-3#1)(2005-11#1)
tends to have##3##3##(2006-12#1)(2007-8#1)(2011-2#1)
tends to increase with##3##4##(1991-2#1)(2008-3#1)(2008-9#1)
tends to increase##5##3##(1991-2#1)(2008-3#1)(2008-8#2)(2008-9#1)
tends to occur##3##3##(1996-4#1)(2008-1#1)(2010-12#1)
tends to result in##2##4##(1994-9#1)(2009-10#1)
tends to take##2##3##(2008-11#1)(2008-2#1)
tends to##104##2##(1990-3#1)(1990-8#1)(1991-2#1)(1992-6#2)(1994-11#2)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-8#1)(2004-11#1)(2005-11#4)(2005-4#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-3#2)(2007-10#3)(2007-11#3)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-2#4)(2008-3#4)(2008-4#4)(2008-5#2)(2008-7#3)(2008-8#6)(2008-9#3)(2009-10#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#2)(2009-8#3)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#3)
tends towards##2##2##(1996-4#1)(2009-6#1)
tends##107##1##(1990-2#1)(1990-3#1)(1990-8#1)(1991-2#1)(1992-6#2)(1994-11#2)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-4#2)(1997-8#1)(2004-11#1)(2005-11#4)(2005-4#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-3#2)(2007-10#3)(2007-11#3)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-2#4)(2008-3#4)(2008-4#4)(2008-5#2)(2008-7#3)(2008-8#6)(2008-9#3)(2009-10#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#3)(2009-8#3)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#3)
tenebrionis insecticidal proteins##2##3##(1990-7#2)
tenebrionis proteins##2##2##(1990-7#2)
tenebrionis##5##1##(1990-7#5)
tenella was##2##2##(2007-6#1)(2008-5#1)
tenella were##2##2##(2008-5#2)
tenella##13##1##(1992-8#2)(2006-10#1)(2007-12#2)(2007-6#1)(2008-10#2)(2008-5#5)
tenellus##6##1##(2008-10#6)
tenesmus##3##1##(2007-11#1)(2010-12#1)(2011-1#1)
tenet is##2##2##(1996-3#1)(2007-11#1)
tenet of##7##2##(1993-12#1)(1995-12#1)(2008-7#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-3#1)
tenet##9##1##(1993-12#1)(1995-12#1)(1996-3#1)(2007-11#1)(2008-7#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-3#1)
tenets of##6##2##(1993-3#1)(1994-12#1)(2009-2#1)(2010-2#1)(2010-4#1)(2011-1#1)
tenets##13##1##(1991-12#1)(1993-3#1)(1994-12#1)(2007-10#1)(2007-4#1)(2008-11#1)(2009-2#2)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)
tenfold by##2##2##(1993-8#1)(1997-1#1)
tenfold higher##3##2##(1993-6#1)(1995-2#1)(1997-3#1)
tenfold improvement##2##2##(2007-11#1)(2008-2#1)
tenfold increase in the##2##4##(2007-11#2)
tenfold increase in##3##3##(1990-12#1)(2007-11#2)
tenfold##22##1##(1990-11#1)(1990-12#1)(1990-3#1)(1991-1#1)(1991-7#1)(1992-11#1)(1992-7#1)(1992-9#1)(1993-6#1)(1993-8#1)(1995-2#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-11#3)(2008-10#1)(2008-2#1)(2008-5#1)(2010-8#1)
teniposide##9##1##(1990-2#1)(1991-4#1)(1991-7#1)(1992-2#1)(1992-6#1)(1994-12#1)(1994-5#1)(2007-1#1)(2008-11#1)
tennis elbow##8##2##(1997-6#1)(2007-11#5)(2008-12#1)(2011-2#1)
tennis players##5##2##(1995-9#1)(2011-2#4)
tennis serve##3##2##(2011-2#3)
tennis##20##1##(1995-9#1)(1997-6#1)(1997-8#1)(2007-11#5)(2007-2#1)(2008-12#1)(2009-1#1)(2011-2#8)(2012-1#1)
tenocyte##2##1##(2013-1#2)
tenocytes##6##1##(2013-1#6)
tenodesis and##2##2##(2013-7#2)
tenodesis##15##1##(2007-8#1)(2013-7#14)
tenofovir and##3##2##(2007-1#2)(2011-2#1)
tenofovir disoproxil fumarate (TDF)##2##4##(2010-12#1)(2013-1#1)
tenofovir disoproxil fumarate##3##3##(2010-12#2)(2013-1#1)
tenofovir resistance##4##2##(2013-1#4)
tenofovir##23##1##(2007-1#6)(2008-8#1)(2009-11#1)(2010-12#5)(2010-2#1)(2011-2#1)(2013-1#8)
tenolysis of the flexor tendon##3##5##(2007-7#3)
tenolysis##6##1##(2006-3#1)(2007-7#5)
tenosynovitis in##2##2##(2006-10#1)(2008-9#1)
tenosynovitis of the hand##2##4##(2006-10#2)
tenosynovitis of##3##2##(2006-10#3)
tenosynovitis##11##1##(2006-10#5)(2007-8#1)(2008-1#1)(2008-9#4)
tenotomy is##2##2##(2013-7#2)
tenotomy##7##1##(2011-1#2)(2013-7#5)
tens of hours##2##3##(1993-3#1)(2007-11#1)
tens of megahertz##2##3##(2008-2#2)
tens of meters##2##3##(2008-3#2)
tens of micrometers##8##3##(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)
tens of milligrams of##2##4##(2008-10#2)
tens of millimeters##3##3##(2007-12#2)(2008-3#1)
tens of millions of##2##4##(1991-2#1)(1993-6#1)
tens of milliseconds##2##3##(2007-12#1)(2008-2#1)
tens of millisieverts in a year##2##6##(2008-7#2)
tens of millisieverts##3##3##(2008-7#3)
tens of milliwatts##2##3##(2007-11#1)(2007-12#1)
tens of nanometers##4##3##(2007-12#1)(2008-3#1)(2010-4#1)(2012-1#1)
tens of nanometres##3##3##(2008-7#2)(2010-8#1)
tens of nanoseconds##3##3##(1991-2#1)(2008-2#1)(2009-2#1)
tens of picoseconds##2##3##(1994-5#1)(2008-3#1)
tens of seconds##2##3##(2007-12#1)(2008-10#1)
tens of thousands of##8##4##(1991-9#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-7#1)(2013-1#1)
tens of##77##2##(1991-2#2)(1991-9#1)(1993-3#2)(1993-6#1)(1994-5#1)(1995-8#1)(1996-12#1)(2005-11#1)(2006-12#1)(2007-11#5)(2007-12#16)(2008-1#1)(2008-10#7)(2008-2#12)(2008-3#10)(2008-4#1)(2008-7#7)(2008-9#1)(2009-10#1)(2009-2#1)(2010-4#1)(2010-8#1)(2012-1#1)(2013-1#1)
tens or##2##2##(1996-12#1)(2006-10#1)
tens to##2##2##(2007-11#1)(2011-2#1)
tens##84##1##(1991-2#2)(1991-9#1)(1993-3#2)(1993-6#1)(1994-5#1)(1995-8#1)(1996-12#2)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#6)(2007-12#16)(2008-1#1)(2008-10#9)(2008-2#12)(2008-3#10)(2008-4#1)(2008-7#7)(2008-9#1)(2009-10#1)(2009-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
tense and agreement morphology##2##4##(2012-1#2)
tense and present tense/agreement##2##4##(2012-1#2)
tense and##7##2##(2008-5#3)(2012-1#4)
tense ascites##2##2##(2007-12#1)(2011-2#1)
tense bullae##2##2##(2011-1#1)(2011-12#1)
tense##24##1##(1996-6#1)(2004-11#1)(2005-7#1)(2007-12#1)(2008-5#4)(2008-6#1)(2009-11#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#8)(2012-12#2)
tense/agreement morphology##3##2##(2009-8#1)(2012-1#2)
tense/agreement##8##1##(2009-8#4)(2012-1#4)
tensed volunteer##3##2##(2006-11#3)
tensed##7##1##(2006-11#7)
tensegrity principle##2##2##(2009-3#2)
tensegrity##3##1##(2008-10#1)(2009-3#2)
tensile and compressive stresses were great##2##6##(2010-2#2)
tensile and compressive stresses##3##4##(2008-2#1)(2010-2#2)
tensile and compressive##7##3##(2005-11#2)(2008-2#1)(2008-3#1)(2009-7#1)(2010-2#2)
tensile and##9##2##(2005-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-2#2)
tensile bond strength and##2##4##(2008-12#1)(2013-1#1)
tensile bond strength of##2##4##(2008-5#1)(2013-1#1)
tensile bond strength##4##3##(2008-12#1)(2008-5#1)(2013-1#2)
tensile failure##2##2##(2006-11#1)(2007-4#1)
tensile forces##3##2##(2007-4#1)(2009-7#1)(2012-1#1)
tensile load##2##2##(2007-4#2)
tensile loading##7##2##(2006-11#2)(2007-4#1)(2009-7#1)(2012-7#3)
tensile modulus##2##2##(2008-5#1)(2010-4#1)
tensile or##2##2##(2006-11#1)(2007-4#1)
tensile properties of the hair##2##5##(2008-5#2)
tensile properties of the##4##4##(1991-10#1)(2008-5#2)(2009-7#1)
tensile properties of##7##3##(1991-10#2)(2008-5#3)(2009-7#2)
tensile properties##15##2##(1991-10#4)(2004-9#1)(2008-5#5)(2009-10#1)(2009-7#3)(2012-2#1)
tensile stiffness at##2##3##(1991-10#2)
tensile stiffness##4##2##(1991-10#2)(2007-4#2)
tensile strain to##2##3##(2008-11#1)(2011-2#1)
tensile strain##5##2##(2008-11#2)(2009-7#1)(2011-2#2)
tensile strength and##2##3##(2006-12#1)(2008-12#1)
tensile strength of##4##3##(2006-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
tensile strength values##2##3##(2008-5#2)
tensile strength was##2##3##(2004-9#1)(2007-8#1)
tensile strength when##2##3##(2008-12#1)(2009-3#1)
tensile strength with##2##3##(2008-12#1)(2012-1#1)
tensile strength##32##2##(1992-9#1)(1997-5#1)(2004-9#3)(2005-11#1)(2006-12#2)(2007-8#1)(2008-12#4)(2008-5#6)(2008-7#2)(2008-8#1)(2009-3#1)(2009-7#2)(2009-9#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#1)
tensile strengths##2##2##(2004-9#1)(2009-7#1)
tensile stress##3##2##(2004-9#1)(2006-12#1)(2008-3#1)
tensile tests##3##2##(2008-5#1)(2012-2#2)
tensile tolerance##3##2##(2006-11#1)(2007-4#2)
tensile##117##1##(1991-10#7)(1992-9#1)(1997-5#1)(2004-9#7)(2005-11#5)(2006-11#7)(2006-12#3)(2007-4#15)(2007-8#1)(2008-11#3)(2008-12#5)(2008-2#1)(2008-3#2)(2008-5#16)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-7#12)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#2)(2011-2#3)(2012-1#2)(2012-2#6)(2012-7#3)(2013-1#2)(2013-8#1)
tensio-actif##2##1##(2008-5#2)
tensioactifs##4##1##(2008-5#4)
tensiometry##3##1##(2005-11#3)
tension (gamma)##2##2##(1992-5#1)(2005-11#1)
tension and cell##2##3##(2008-7#1)(2009-5#1)
tension and extension moment##2##4##(2007-4#2)
tension and pulmonary arterial##2##4##(2008-11#2)
tension and the##5##3##(2005-11#1)(2007-4#1)(2008-2#1)(2008-7#1)(2011-1#1)
tension and##44##2##(1990-11#1)(1991-12#1)(1994-2#2)(1994-4#1)(1995-5#1)(1997-6#1)(2005-11#10)(2006-10#1)(2007-2#1)(2007-4#5)(2008-11#4)(2008-2#2)(2008-3#1)(2008-7#2)(2009-4#2)(2009-5#2)(2010-4#1)(2011-1#3)(2013-1#1)(2013-8#2)
tension and/or##2##2##(2009-7#1)(2010-9#1)
tension at the##5##3##(2005-11#3)(2005-9#1)(2008-10#1)
tension at##8##2##(1991-11#1)(2005-11#3)(2005-9#1)(2006-11#1)(2008-10#1)(2008-7#1)
tension band##2##2##(2008-12#2)
tension between the##7##3##(1996-8#1)(2004-12#1)(2005-11#1)(2005-7#1)(2007-3#1)(2008-11#1)(2012-3#1)
tension between##22##2##(1991-3#1)(1995-12#1)(1996-8#1)(2004-12#2)(2005-11#4)(2005-7#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-11#1)(2012-3#2)(2013-1#1)
tension by##3##2##(2007-8#1)(2009-3#1)(2011-1#1)
tension during##3##2##(1991-12#1)(2006-10#1)(2007-4#1)
tension for##3##2##(1996-1#1)(2008-3#1)(2011-2#1)
tension force##2##2##(2006-11#1)(2013-1#1)
tension forces##3##2##(1997-2#1)(2008-10#1)(2010-3#1)
tension from##3##2##(1991-4#1)(2012-11#2)
tension has##2##2##(2008-8#1)(2012-12#1)
tension in the##5##3##(1991-8#1)(1992-3#1)(2007-8#1)(2008-5#1)(2012-2#1)
tension in##14##2##(1990-12#1)(1991-10#1)(1991-8#1)(1992-3#1)(1993-11#1)(1996-9#1)(1997-2#1)(2005-11#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-5#1)(2009-8#1)(2012-2#1)
tension increased##2##2##(1991-12#1)(1997-2#1)
tension induced by##3##3##(1990-4#1)(1993-11#1)(1993-3#1)
tension is##13##2##(1992-5#1)(1995-5#1)(1996-1#2)(1996-11#1)(1997-2#1)(2005-11#3)(2008-5#1)(2010-2#1)(2011-1#1)(2012-3#1)
tension lowering##6##2##(2005-11#2)(2008-10#4)
tension measurements##9##2##(1996-5#1)(2005-11#5)(2008-10#2)(2011-1#1)
tension of the##12##3##(1991-12#2)(1992-1#1)(1995-3#1)(1996-3#1)(2005-11#4)(2007-2#1)(2008-5#1)(2011-2#1)
tension of##32##2##(1991-10#1)(1991-12#3)(1992-1#1)(1995-11#1)(1995-3#1)(1996-3#1)(2005-11#10)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#3)(2008-6#2)(2009-2#1)(2011-1#1)(2011-2#1)(2012-3#1)
tension on the##6##3##(1994-3#1)(2006-3#1)(2006-9#1)(2007-12#2)(2009-6#1)
tension on##8##2##(1994-3#1)(1995-6#1)(1996-3#1)(2006-3#1)(2006-9#1)(2007-12#2)(2009-6#1)
tension pneumocephalus##3##2##(2006-12#2)(2008-7#1)
tension pneumothoraces##3##2##(2005-8#1)(2011-2#2)
tension results##2##2##(2005-11#1)(2007-12#1)
tension studies##3##2##(2005-11#2)(2011-2#1)
tension to##5##2##(2006-4#1)(2007-12#1)(2007-8#1)(2009-7#1)(2013-1#1)
tension type headache##3##3##(2010-9#2)(2012-2#1)
tension was recorded##2##3##(2007-10#1)(2007-8#1)
tension was##11##2##(1990-4#1)(1992-11#1)(1995-5#1)(1997-2#1)(2005-11#1)(2007-10#1)(2007-8#1)(2008-5#2)(2013-1#2)
tension were##4##2##(2005-11#1)(2006-11#1)(2008-5#1)(2010-12#1)
tension with the##3##3##(2006-4#1)(2008-10#1)(2011-2#1)
tension with##6##2##(1996-11#1)(1996-5#1)(2005-11#1)(2006-4#1)(2008-10#1)(2011-2#1)
tension##425##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#3)(1990-5#1)(1990-8#4)(1991-10#2)(1991-11#2)(1991-12#6)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#2)(1993-10#1)(1993-11#2)(1993-12#1)(1993-3#2)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#5)(1994-4#1)(1994-5#3)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#2)(1995-5#4)(1995-6#3)(1995-9#1)(1996-1#4)(1996-11#4)(1996-3#2)(1996-4#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#9)(1997-3#1)(1997-6#1)(2004-12#4)(2005-11#72)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-11#5)(2006-12#4)(2006-3#1)(2006-4#2)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#8)(2007-2#2)(2007-3#1)(2007-4#10)(2007-7#3)(2007-8#7)(2007-9#1)(2008-1#2)(2008-10#31)(2008-11#10)(2008-12#4)(2008-2#4)(2008-3#8)(2008-4#2)(2008-5#17)(2008-6#2)(2008-7#10)(2008-8#3)(2008-9#2)(2009-1#2)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#7)(2009-6#2)(2009-7#4)(2009-8#2)(2009-9#2)(2010-1#3)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#2)(2010-9#4)(2011-1#8)(2011-12#2)(2011-2#12)(2012-1#1)(2012-11#3)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#10)(2013-8#5)
tension-band##2##1##(2009-3#2)
tension-extension criteria##2##2##(2007-4#2)
tension-free repair##2##2##(1996-9#1)(2010-8#1)
tension-free vaginal tape##2##3##(2012-2#2)
tension-free##8##1##(1996-9#1)(2004-2#1)(2007-8#1)(2010-8#1)(2011-2#2)(2012-2#2)
tension-type headache and##2##3##(2004-3#1)(2012-3#1)
tension-type headache##5##2##(2004-3#2)(2008-4#1)(2012-3#2)
tension-type headaches##2##2##(2004-12#1)(2004-3#1)
tension-type##7##1##(2004-12#1)(2004-3#3)(2008-4#1)(2012-3#2)
tensional##2##1##(2011-1#1)(2013-1#1)
tensions between##4##2##(2008-12#1)(2011-2#1)(2013-1#1)(2013-7#1)
tensions for##3##2##(2008-10#1)(2009-4#1)(2012-3#1)
tensions in##5##2##(2006-4#1)(2007-8#1)(2009-5#1)(2012-12#1)(2012-3#1)
tensions of##4##2##(2005-11#2)(2010-4#1)(2011-2#1)
tensions on##2##2##(1996-8#1)(2007-2#1)
tensions resulting from##2##3##(1991-9#1)(1995-12#1)
tensions that##4##2##(1995-3#1)(2005-7#1)(2008-8#1)(2012-3#1)
tensions within the##2##3##(2004-12#1)(2011-1#1)
tensions##53##1##(1990-12#2)(1990-5#1)(1991-9#1)(1992-3#1)(1994-2#1)(1994-3#2)(1995-12#1)(1995-3#1)(1995-5#1)(1996-8#1)(1997-6#1)(1997-7#1)(2004-12#1)(2005-11#4)(2005-7#1)(2006-10#1)(2006-4#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-4#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#2)(2013-7#1)
tensor ABCD law##2##3##(2007-11#2)
tensor components##2##2##(1996-2#1)(2007-11#1)
tensor elements##2##2##(2008-2#1)(2008-3#1)
tensor fascia lata##3##3##(2013-1#3)
tensor fasciae latae muscles##2##4##(1995-12#1)(2009-3#1)
tensor fasciae##4##2##(1995-12#1)(2009-3#3)
tensor field##2##2##(2008-2#2)
tensor for##3##2##(2007-11#2)(2007-5#1)
tensor imaging (DTI) is##3##4##(2009-9#1)(2012-1#1)(2013-7#1)
tensor imaging (DTI)##7##3##(2009-9#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-7#1)
tensor imaging in##2##3##(2009-4#1)(2011-12#1)
tensor imaging##20##2##(2007-5#1)(2007-8#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#4)(2011-2#1)(2012-1#2)(2012-12#1)(2013-7#2)
tensor is##3##2##(1996-2#1)(2008-2#1)(2008-5#1)
tensor of a##2##3##(2007-11#1)(2008-5#1)
tensor of##5##2##(2007-11#1)(2008-5#3)(2010-9#1)
tensor voting##5##2##(2008-6#5)
tensor##98##1##(1990-3#1)(1991-12#1)(1995-12#1)(1996-2#4)(1997-7#2)(2007-10#1)(2007-11#9)(2007-12#7)(2007-5#4)(2007-8#1)(2008-1#2)(2008-11#1)(2008-2#10)(2008-3#4)(2008-5#7)(2008-6#10)(2008-9#2)(2009-10#2)(2009-3#3)(2009-4#1)(2009-9#1)(2010-12#2)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-12#4)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#5)(2013-7#2)
tensor-based##2##1##(2008-1#1)(2008-6#1)
tensors are##2##2##(2008-6#1)(2013-1#1)
tensors for##3##2##(1997-4#1)(2008-5#1)(2010-7#1)
tensors of the two##2##4##(1996-2#1)(2008-3#1)
tensors of##4##2##(1996-2#1)(2008-3#1)(2013-1#2)
tensors##21##1##(1995-10#2)(1996-2#1)(1997-1#1)(1997-4#1)(2007-10#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2010-5#1)(2010-7#1)(2013-1#7)
tent##6##1##(1990-12#5)(2007-9#1)
tentacled snakes (Erpeton tentaculatum)##2##4##(2007-2#2)
tentacles and##2##2##(2010-8#1)(2012-12#1)
tentacles##8##1##(2010-8#4)(2011-2#2)(2012-12#2)
tentative assignment##2##2##(1991-2#1)(1996-7#1)
tentative cpPKs and##2##3##(2009-5#2)
tentative cpPPs##2##2##(2009-5#2)
tentative diagnosis of##2##3##(1997-3#1)(2006-10#1)
tentative diagnosis##3##2##(1997-3#1)(2006-10#1)(2012-2#1)
tentative evidence for##2##3##(1995-1#1)(1996-7#1)
tentative group mean##2##3##(2011-2#2)
tentative identification of##2##3##(2005-7#1)(2008-10#1)
tentative mechanism which##2##3##(1996-5#2)
tentative##43##1##(1991-2#1)(1992-9#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-1#1)(1996-2#2)(1996-5#3)(1996-7#2)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#2)(2005-11#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-11#2)(2008-10#4)(2008-12#1)(2008-3#2)(2009-12#1)(2009-5#4)(2010-12#1)(2011-2#3)(2012-2#1)(2013-8#1)
tentatively assigned to##2##3##(1993-3#1)(1997-7#1)
tentatively attribute the##2##3##(1996-5#1)(2007-3#1)
tentatively attributed to a##2##4##(1991-7#2)
tentatively attributed to##4##3##(1991-7#2)(1993-3#1)(1996-7#1)
tentatively classified as##4##3##(2007-12#1)(2008-10#2)(2011-12#1)
tentatively concluded that##2##3##(1992-10#1)(2009-6#1)
tentatively designated##3##2##(1996-6#1)(2008-10#1)(2008-7#1)
tentatively explained##2##2##(1994-11#1)(2006-12#1)
tentatively identified as a##2##4##(1993-11#1)(2006-3#1)
tentatively identified as##9##3##(1990-3#1)(1993-11#1)(1993-12#1)(1995-5#1)(1996-2#1)(2006-12#1)(2006-3#1)(2008-10#2)
tentatively identified##13##2##(1990-3#2)(1992-2#1)(1993-11#1)(1993-12#1)(1995-5#1)(1996-2#1)(2006-12#1)(2006-3#1)(2008-10#3)(2008-7#1)
tentatively identify this##2##3##(1991-7#1)(2010-5#1)
tentatively identify##4##2##(1990-7#1)(1991-7#1)(2008-7#1)(2010-5#1)
tentatively named##4##2##(1993-11#1)(1995-3#1)(2008-10#2)
tentatively suggest that the##2##4##(1991-9#1)(1996-10#1)
tentatively to##3##2##(1991-7#1)(1991-8#1)(1991-9#1)
tentatively##65##1##(1990-2#1)(1990-3#3)(1990-7#1)(1991-7#4)(1991-8#1)(1991-9#2)(1992-10#1)(1992-2#1)(1993-11#3)(1993-12#1)(1993-3#2)(1993-5#1)(1993-8#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-7#1)(2006-12#2)(2006-3#1)(2007-12#2)(2007-3#1)(2008-10#12)(2008-7#4)(2008-9#1)(2009-10#1)(2009-2#2)(2009-6#1)(2010-4#1)(2010-5#1)(2011-12#1)(2012-2#1)
tenth for women##2##3##(1996-3#1)(2008-6#1)
tenth of##6##2##(1993-4#1)(1994-11#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-5#1)
tenth##27##1##(1993-4#1)(1994-11#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#2)(2005-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#4)(2008-6#2)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)
tenths##2##1##(2008-2#2)
tentorial##3##1##(2006-12#2)(2008-7#1)
tentorium##5##1##(1991-12#1)(1997-3#1)(2006-11#1)(2007-12#1)(2011-2#1)
tents were inserted##2##3##(1990-12#2)
tents##5##1##(1990-12#2)(1995-5#1)(2008-7#1)(2009-9#1)
tenuiflorum##2##1##(2013-7#2)
tenuis and G##2##3##(2010-8#2)
tenuis and##4##2##(1993-11#1)(2010-8#3)
tenuis in##2##2##(2008-8#1)(2010-8#1)
tenuis##10##1##(1993-11#1)(2004-4#1)(2008-8#2)(2010-8#6)
tenuissima##4##1##(2008-10#4)
tenuous##4##1##(1991-7#1)(1995-5#1)(2010-7#1)(2011-2#1)
tenure and##2##2##(2010-6#2)
tenure of##2##2##(2008-2#1)(2010-6#1)
tenure on##2##2##(2007-6#1)(2010-6#1)
tenure was##2##2##(2010-6#2)
tenure##25##1##(1990-3#1)(1994-1#1)(2006-10#1)(2006-4#1)(2007-6#1)(2008-12#3)(2008-2#4)(2010-6#10)(2011-1#1)(2011-12#1)(2011-2#1)
teosinte##6##1##(1995-8#1)(2008-5#4)(2012-3#1)
tepidum##4##1##(1997-7#2)(2009-10#2)
ter##2##1##(1996-2#2)
terabit##3##1##(2007-8#1)(2008-3#2)
terabits of##2##2##(2008-3#2)
terahertz (THz) frequency##3##3##(2007-12#3)
terahertz (THz) imaging with##2##4##(2007-11#1)(2007-12#1)
terahertz (THz) pulse##2##3##(2007-11#1)(2007-12#1)
terahertz (THz) pulses##3##3##(2007-11#1)(2007-12#2)
terahertz (THz) radiation##7##3##(2007-11#3)(2007-12#3)(2008-3#1)
terahertz (THz) wave##2##3##(2007-11#1)(2007-12#1)
terahertz (THz)##24##2##(2007-11#9)(2007-12#14)(2008-3#1)
terahertz devices##2##2##(2012-2#2)
terahertz dipole antennas##2##3##(2007-12#2)
terahertz dipole##3##2##(2007-12#3)
terahertz electromagnetic##3##2##(2007-12#2)(2012-2#1)
terahertz emission##4##2##(2007-12#4)
terahertz field##2##2##(2007-12#1)(2008-3#1)
terahertz frequency##3##2##(2007-12#1)(2007-9#1)(2012-2#1)
terahertz imaging and spectroscopy for##2##5##(2012-12#2)
terahertz imaging and spectroscopy##3##4##(2012-12#3)
terahertz imaging with a dynamic##2##5##(2007-12#1)(2008-3#1)
terahertz imaging##9##2##(2007-11#1)(2007-12#2)(2008-3#1)(2012-12#5)
terahertz output##2##2##(2007-11#1)(2007-12#1)
terahertz pulses in##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
terahertz pulses##17##2##(2007-11#3)(2007-12#10)(2008-2#4)
terahertz radiation emitter##2##3##(2008-3#2)
terahertz radiation in##2##3##(2007-11#1)(2007-12#1)
terahertz radiation##12##2##(2007-11#5)(2007-12#4)(2008-3#3)
terahertz region##2##2##(2007-12#1)(2012-12#1)
terahertz source##3##2##(2007-11#2)(2010-5#1)
terahertz spectroscopy##4##2##(2007-12#3)(2010-5#1)
terahertz time-domain spectroscopy##6##3##(2007-12#3)(2008-2#1)(2008-3#1)(2010-5#1)
terahertz time-domain##8##2##(2007-12#3)(2008-2#1)(2008-3#2)(2010-5#1)(2013-8#1)
terahertz waves##3##2##(2007-12#1)(2013-8#2)
terahertz##125##1##(2007-11#25)(2007-12#60)(2007-9#1)(2008-2#7)(2008-3#8)(2010-5#6)(2011-1#1)(2012-12#9)(2012-2#5)(2013-8#3)
terahertz- (THz-) wave##2##3##(2007-12#1)(2008-3#1)
terahertz- (THz-)##3##2##(2007-12#2)(2008-3#1)
terahertz-band##3##1##(2013-8#3)
terahertz-wave generation from##2##3##(2007-12#2)
terahertz-wave generation##3##2##(2007-12#3)
terahertz-wave parametric##3##2##(2007-11#2)(2008-3#1)
terahertz-wave##14##1##(2007-11#3)(2007-12#6)(2008-2#2)(2008-3#1)(2013-8#2)
teratocarcinoma cells##12##2##(1991-4#1)(1992-8#1)(1992-9#2)(1994-11#3)(1994-12#2)(1995-10#1)(1996-7#1)(2010-12#1)
teratocarcinoma##18##1##(1991-4#1)(1992-12#1)(1992-8#1)(1992-9#2)(1993-3#1)(1993-8#1)(1994-11#3)(1994-12#3)(1995-10#1)(1995-5#1)(1996-7#1)(2008-10#1)(2010-12#1)
teratocarcinosarcoma##3##1##(2008-11#3)
teratogen##4##1##(1992-2#2)(1996-12#1)(2008-4#1)
teratogenesis or##2##2##(1996-12#1)(2008-1#1)
teratogenesis##5##1##(1996-12#3)(2008-1#1)(2008-7#1)
teratogenic and##2##2##(1994-6#1)(2008-1#1)
teratogenic effect##2##2##(1996-9#1)(2013-1#1)
teratogenic effects of##3##3##(1993-12#1)(1996-10#1)(2010-2#1)
teratogenic factors##4##2##(1993-2#1)(2007-9#3)
teratogenic potential of##2##3##(2013-1#2)
teratogenic potential##3##2##(1995-2#1)(2013-1#2)
teratogenic risk of##3##3##(1991-4#1)(1994-6#1)(2010-2#1)
teratogenic risk##5##2##(1991-4#1)(1994-6#1)(1995-8#1)(2008-7#1)(2010-2#1)
teratogenic##29##1##(1991-4#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-6#2)(1995-2#1)(1995-8#1)(1996-10#1)(1996-8#1)(1996-9#1)(2006-4#1)(2007-9#3)(2008-1#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)(2010-2#3)(2013-1#4)
teratogenicity in##2##2##(1996-12#1)(2007-1#1)
teratogenicity of##6##2##(1990-5#1)(1993-12#1)(1993-3#1)(2013-1#3)
teratogenicity##15##1##(1990-5#1)(1991-12#1)(1993-12#2)(1993-3#2)(1994-11#1)(1995-8#1)(1996-12#1)(2007-1#1)(2007-11#1)(2010-12#1)(2013-1#3)
teratoid/rhabdoid tumor of the spine##2##5##(2011-2#2)
teratoid/rhabdoid tumor of the##3##4##(2011-2#3)
teratologic studies##2##2##(1994-6#2)
teratological##3##1##(1990-8#2)(2013-8#1)
teratoma and##5##2##(2008-7#1)(2012-2#2)(2013-1#2)
teratoma in a 2-month-old boy##2##5##(2007-5#2)
teratoma in a##3##3##(2007-5#2)(2008-8#1)
teratoma in an 11-month-old##2##4##(2008-12#2)
teratoma in##11##2##(2007-5#2)(2008-10#1)(2008-12#2)(2008-8#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-2#2)
teratoma is a##3##3##(2005-11#1)(2008-7#1)(2013-8#1)
teratoma is##6##2##(2005-11#2)(2007-5#1)(2008-10#1)(2008-7#1)(2013-8#1)
teratoma of the##5##3##(2007-3#1)(2008-10#2)(2008-9#1)(2013-8#1)
teratoma of##6##2##(2007-3#1)(2008-10#2)(2008-12#1)(2008-9#1)(2013-8#1)
teratoma or##2##2##(2007-6#1)(2008-9#1)
teratoma was##4##2##(2007-5#1)(2008-10#1)(2011-1#2)
teratoma##65##1##(1990-9#1)(1992-8#1)(1994-9#1)(2005-11#4)(2006-12#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#4)(2007-6#1)(2007-8#3)(2008-10#6)(2008-11#1)(2008-12#3)(2008-7#3)(2008-8#4)(2008-9#4)(2009-4#1)(2009-5#2)(2009-7#1)(2010-1#1)(2010-2#1)(2011-1#4)(2012-12#1)(2012-2#5)(2013-1#3)(2013-8#5)
teratomas are##2##2##(2007-8#1)(2012-12#1)
teratomas##14##1##(1994-12#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-10#3)(2008-9#3)(2010-1#1)(2012-12#1)(2013-1#1)
terawatt laser##4##2##(2007-11#1)(2007-12#3)
terawatt##7##1##(2007-11#2)(2007-12#4)(2008-3#1)
terawatt-class laser system##2##3##(2007-11#1)(2007-12#1)
terazosin in bulk form##2##4##(2008-10#2)
terazosin in##3##2##(2008-10#3)
terazosin##11##1##(1995-12#5)(2008-10#6)
terbinafine##20##1##(1993-8#1)(2005-9#1)(2007-7#1)(2008-10#6)(2008-3#4)(2008-5#7)
terbium (III)##2##2##(2005-4#1)(2008-2#1)
terbium##16##1##(1995-5#2)(2005-4#1)(2008-10#9)(2008-2#2)(2010-3#1)(2012-2#1)
terbium(III) as##2##2##(2007-8#1)(2008-4#1)
terbium(III)##11##1##(2007-8#2)(2008-10#4)(2008-4#5)
terbium-sensitised luminescence##3##2##(2008-10#3)
terbutaline in##3##2##(1997-2#1)(2008-10#2)
terbutaline sulphate and fenoterol hydrobromide in##2##6##(1992-1#2)
terbutaline sulphate##3##2##(1992-1#2)(2004-1#1)
terbutaline##17##1##(1991-12#1)(1992-1#2)(1993-2#1)(1995-11#1)(1995-3#1)(1995-6#1)(1997-2#1)(2004-1#1)(2008-10#7)(2011-1#1)
terbutaline-stimulated cAMP accumulation##2##3##(1995-3#2)
terbutaline-stimulated##3##1##(1995-3#3)
terbuthylazine and##2##2##(2008-10#1)(2008-11#1)
terbuthylazine##6##1##(2008-10#2)(2008-11#3)(2008-7#1)
terbutryn##3##1##(2008-10#3)
terbutylazine##3##1##(2007-8#1)(2008-11#2)
terebate##2##1##(2008-5#2)
terephthalate##5##1##(2008-10#1)(2013-1#4)
terephthalate) (PET)##3##2##(2007-11#1)(2008-10#1)(2010-5#1)
terephthalate)##13##1##(2007-11#4)(2007-12#1)(2008-10#6)(2010-5#1)(2010-8#1)
terephthalic acid##2##2##(2006-12#2)
terephthalic##3##1##(2006-12#2)(2008-10#1)
teres f##8##2##(2008-10#8)
teres##30##1##(2006-3#2)(2008-10#26)(2008-8#1)(2013-1#1)
teres)##2##1##(2008-10#2)
terfenadine in##2##2##(1992-8#1)(2007-11#1)
terfenadine##8##1##(1992-8#4)(2007-11#4)
tergal##4##1##(1994-2#1)(2007-12#2)(2008-9#1)
tergite is##2##2##(2007-12#2)
tergite##4##1##(1997-4#1)(2007-12#3)
tergites##8##1##(2007-12#8)
tergo-tergal mechanism##3##2##(2007-12#3)
tergo-tergal##4##1##(2007-12#4)
tergum and##2##2##(2007-12#2)
teriparatide##2##1##(2008-8#1)(2013-1#1)
terlipressin and##2##2##(2008-12#1)(2008-5#1)
terlipressin##11##1##(1995-9#2)(2008-12#5)(2008-5#1)(2013-8#3)
term &quot##57##2##(1990-11#1)(1990-3#1)(1990-6#1)(1991-12#2)(1992-5#1)(1993-12#1)(1993-9#1)(1994-1#1)(1994-3#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-6#1)(2005-5#1)(2006-10#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-11#1)(2012-12#3)(2012-2#3)(2013-1#5)(2013-7#2)(2013-8#2)
term accounts for##2##3##(2008-2#2)
term acute##2##2##(1993-7#1)(2008-10#1)
term and a##2##3##(2008-2#2)
term and preterm labour##3##4##(1992-2#2)(1994-3#1)
term and preterm neonates##2##4##(2013-1#2)
term and preterm##8##3##(1992-2#2)(1994-3#2)(2011-2#1)(2012-3#1)(2013-1#2)
term and the##4##3##(1994-2#1)(2008-8#1)(2013-1#2)
term and##31##2##(1991-2#1)(1992-2#2)(1992-4#1)(1993-10#1)(1993-11#2)(1994-2#1)(1994-3#3)(1995-3#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-6#1)(2008-11#2)(2008-12#1)(2008-2#4)(2008-4#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#4)
term anticoagulation##2##2##(2005-10#1)(2007-10#1)
term as##3##2##(1996-5#1)(2008-11#1)(2008-7#1)
term birth##2##2##(1991-5#1)(1992-10#1)
term born##4##2##(2011-12#1)(2012-2#3)
term by changes in##2##4##(1994-8#2)
term by##4##2##(1991-4#1)(1994-6#1)(1994-8#2)
term can be##3##3##(2008-2#2)(2008-6#1)
term can##4##2##(2008-1#1)(2008-2#2)(2008-6#1)
term care##32##2##(1990-12#2)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#2)(1993-2#1)(1993-3#2)(1994-12#1)(1994-3#1)(1995-1#1)(1996-2#1)(1996-3#1)(2006-12#1)(2006-7#2)(2007-12#6)(2008-1#1)(2008-12#2)(2008-7#1)(2012-12#1)(2012-2#1)
term children##2##2##(2008-12#1)(2011-2#1)
term clinical##4##2##(1997-4#1)(2007-8#1)(2008-8#1)(2013-8#1)
term coined##2##2##(2008-7#1)(2009-2#1)
term contains##2##2##(2005-3#1)(2008-2#1)
term control##3##2##(1993-1#1)(2007-11#1)(2013-8#1)
term describes the##2##3##(1995-4#2)
term drought##5##2##(2007-1#5)
term effect##2##2##(1994-2#1)(2006-4#1)
term effects of##13##3##(1990-5#1)(1992-8#1)(1995-6#1)(2006-11#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-12#1)(2010-9#2)(2011-2#1)
term effects##15##2##(1990-5#1)(1992-8#1)(1995-6#1)(2004-2#1)(2006-11#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-12#1)(2010-9#2)(2011-2#1)
term ethanol##2##2##(2011-2#2)
term familiarity##6##2##(2013-1#6)
term follow up of##2##4##(1993-2#1)(2013-7#1)
term follow up##6##3##(1993-2#1)(2007-11#1)(2011-2#1)(2013-7#1)(2013-8#2)
term follow-up of##2##3##(2007-11#1)(2007-8#1)
term follow-up##10##2##(2007-11#3)(2007-2#1)(2007-4#1)(2007-8#1)(2010-8#1)(2011-2#2)(2012-12#1)
term for the##2##3##(1997-2#1)(2005-8#1)
term for##9##2##(1991-12#1)(1993-7#1)(1997-2#1)(2005-8#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-11#1)(2013-1#1)
term graft##2##2##(2007-11#1)(2011-2#1)
term has##3##2##(2008-10#1)(2010-12#1)(2011-1#1)
term human##3##2##(1994-2#2)(1995-11#1)
term impact##2##2##(1992-2#1)(2010-4#1)
term in a##2##3##(1993-1#1)(2009-2#1)
term in the##8##3##(1995-1#1)(1995-5#1)(1996-12#1)(1997-8#1)(2008-2#2)(2008-3#1)(2011-2#1)
term in vitro cultures of six##2##6##(1990-4#2)
term in vitro##4##3##(1990-4#2)(1994-3#1)(2008-11#1)
term in##26##2##(1990-4#2)(1991-12#1)(1993-1#1)(1993-2#2)(1994-3#1)(1995-1#1)(1995-5#1)(1996-12#1)(1997-8#1)(2005-11#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-7#1)
term includes##2##2##(2009-2#1)(2011-1#1)
term increase in##2##3##(1995-4#1)(1997-2#1)
term infants##10##2##(1990-11#2)(1994-4#1)(1995-8#1)(2006-8#1)(2007-11#2)(2007-2#1)(2011-2#2)
term is##17##2##(1991-2#1)(1993-2#1)(1997-2#1)(2004-4#1)(2006-10#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-7#1)(2011-2#1)(2013-1#3)(2013-8#2)
term labor##2##2##(2011-2#2)
term management of liver##2##4##(2007-11#2)
term management of##4##3##(2007-11#2)(2009-9#1)(2013-1#1)
term management##5##2##(2007-11#2)(2007-3#1)(2009-9#1)(2013-1#1)
term memory formation##2##3##(2009-8#1)(2013-1#1)
term memory##10##2##(1993-12#1)(2005-9#1)(2008-11#1)(2009-8#1)(2012-2#3)(2013-1#3)
term mortality##3##2##(2007-8#1)(2013-1#2)
term names##2##2##(2008-7#2)
term newborn##2##2##(2008-11#1)(2012-12#1)
term of the##7##3##(1994-1#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)
term of##22##2##(1994-1#1)(2006-10#2)(2006-4#1)(2006-6#2)(2007-11#2)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2009-3#1)(2009-8#1)(2009-9#2)
term on the##2##3##(2008-2#1)(2008-5#1)
term optical##2##2##(2007-12#1)(2012-2#1)
term or##2##2##(2007-7#1)(2012-2#1)
term outcome in##3##3##(2007-11#1)(2009-9#1)(2010-12#1)
term outcome of##2##3##(2006-6#1)(2008-8#1)
term outcome##11##2##(2006-6#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-9#2)(2010-12#1)(2011-2#1)(2013-1#1)
term outcomes##5##2##(2006-2#1)(2007-8#1)(2008-8#1)(2012-2#1)(2013-1#1)
term passive##2##2##(1991-4#1)(2007-11#1)
term placenta##7##2##(1991-4#1)(1995-11#1)(2007-7#1)(2008-10#1)(2008-9#1)(2012-12#2)
term plasticity##2##2##(2008-2#2)
term pregnancies##3##2##(1991-3#1)(1996-12#1)(2007-8#1)
term pregnancy rate##2##3##(1995-7#2)
term pregnancy rates##2##3##(1995-7#2)
term pregnancy##11##2##(1990-12#2)(1992-4#1)(1995-4#1)(1995-7#4)(2011-1#1)(2012-12#1)(2013-1#1)
term pregnant##2##2##(2005-12#1)(2008-11#1)
term prognosis of##2##3##(2007-11#1)(2010-11#1)
term prognosis##6##2##(1996-9#1)(2007-11#1)(2010-11#1)(2010-7#1)(2012-3#1)(2013-8#1)
term registered##2##2##(2008-11#2)
term responses##2##2##(2005-12#1)(2011-12#1)
term results obtained##2##3##(2007-11#1)(2007-8#1)
term results of##4##3##(2007-11#1)(2010-12#1)(2012-1#1)(2012-12#1)
term results##14##2##(1991-10#1)(1991-6#1)(1994-4#1)(1995-9#1)(2007-11#3)(2007-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
term role##2##2##(2007-11#1)(2008-7#1)
term sequelae##2##2##(2007-8#1)(2012-12#1)
term single##2##2##(2010-8#1)(2011-1#1)
term stability##9##2##(2008-10#5)(2008-5#2)(2010-3#1)(2012-12#1)
term studies are##3##3##(1997-8#1)(2007-8#1)(2010-8#1)
term survival in##2##3##(1991-4#1)(2010-1#1)
term survival##12##2##(1990-2#1)(1991-4#1)(1995-8#1)(2006-10#2)(2010-1#1)(2010-12#2)(2010-7#2)(2013-1#2)
term that accounts for##2##4##(2007-12#1)(2009-2#1)
term that has been used to##2##6##(2004-11#1)(2012-2#1)
term that is##3##3##(2008-3#1)(2008-9#1)(2012-11#1)
term that##11##2##(2004-11#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#2)(2008-9#1)(2009-2#1)(2012-11#1)(2012-2#1)
term the##3##2##(1993-11#1)(2008-8#1)(2009-9#1)
term therapy##4##2##(1997-4#1)(2005-12#1)(2007-11#1)(2010-11#1)
term this##6##2##(1991-2#1)(1992-5#1)(1996-11#2)(2007-12#1)(2013-1#1)
term to describe##2##3##(2004-12#1)(2009-8#1)
term to keep the##2##4##(2011-2#2)
term to##10##2##(2004-12#1)(2007-12#1)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#4)(2013-8#1)
term tolerability##3##2##(2007-11#2)(2010-11#1)
term toxicity##2##2##(2007-11#1)(2008-5#1)
term treatment with##6##3##(1992-3#1)(1996-3#1)(2007-11#1)(2008-7#1)(2008-8#1)(2009-4#1)
term treatment##12##2##(1992-3#1)(1996-3#1)(2006-12#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)
term use##5##2##(1996-9#1)(1997-8#1)(2007-11#3)
term used to describe a##3##5##(2008-9#1)(2009-3#1)(2012-1#1)
term used to describe the##2##5##(2006-2#1)(2013-7#1)
term used to describe##9##4##(1996-2#1)(2006-2#1)(2008-9#1)(2009-3#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-7#1)
term used to##10##3##(1996-2#1)(2006-10#1)(2006-2#1)(2008-9#1)(2009-3#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-7#1)
term used##12##2##(1996-2#1)(2005-8#1)(2006-10#1)(2006-2#1)(2008-9#1)(2009-3#1)(2010-12#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-7#1)
term using##2##2##(1990-11#1)(2008-4#1)
term vectors##4##2##(2013-1#4)
term was##5##2##(1995-8#1)(2008-2#1)(2011-1#1)(2011-12#1)(2012-12#1)
term were##4##2##(1993-7#1)(1994-3#1)(2005-11#1)(2009-3#1)
term which##2##2##(1993-8#1)(2008-10#1)
term with##6##2##(1992-2#1)(2007-11#1)(2007-12#1)(2013-1#3)
term without##3##2##(1996-12#1)(2006-12#1)(2011-2#1)
term##1045##1##(1990-10#1)(1990-11#9)(1990-12#4)(1990-2#3)(1990-3#3)(1990-4#3)(1990-5#4)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#7)(1991-2#3)(1991-3#1)(1991-4#4)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#3)(1992-10#5)(1992-11#1)(1992-12#6)(1992-2#6)(1992-3#6)(1992-4#4)(1992-5#4)(1992-6#2)(1992-7#4)(1992-8#3)(1993-1#4)(1993-10#2)(1993-11#5)(1993-12#7)(1993-2#6)(1993-3#5)(1993-6#2)(1993-7#5)(1993-8#4)(1993-9#2)(1994-1#3)(1994-12#3)(1994-2#7)(1994-3#11)(1994-4#4)(1994-6#4)(1994-7#2)(1994-8#3)(1994-9#6)(1995-1#2)(1995-10#3)(1995-11#4)(1995-12#4)(1995-2#1)(1995-3#4)(1995-4#4)(1995-5#2)(1995-6#3)(1995-7#4)(1995-8#6)(1995-9#2)(1996-1#7)(1996-11#6)(1996-12#7)(1996-2#2)(1996-3#3)(1996-4#2)(1996-5#2)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#5)(1997-4#4)(1997-6#3)(1997-8#5)(2004-1#1)(2004-11#3)(2004-12#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-10#2)(2005-11#4)(2005-12#3)(2005-3#1)(2005-5#1)(2005-7#3)(2005-8#10)(2005-9#1)(2006-10#20)(2006-11#2)(2006-12#9)(2006-2#4)(2006-3#1)(2006-4#5)(2006-5#1)(2006-6#5)(2006-7#3)(2006-8#4)(2006-9#4)(2007-1#8)(2007-10#3)(2007-11#69)(2007-12#23)(2007-2#11)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#4)(2007-7#14)(2007-8#18)(2007-9#6)(2008-1#11)(2008-10#45)(2008-11#25)(2008-12#9)(2008-2#24)(2008-3#13)(2008-4#7)(2008-5#12)(2008-6#6)(2008-7#31)(2008-8#16)(2008-9#9)(2009-10#2)(2009-11#4)(2009-12#1)(2009-2#6)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#4)(2009-7#2)(2009-8#4)(2009-9#7)(2010-1#3)(2010-11#5)(2010-12#12)(2010-3#3)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#5)(2010-8#6)(2010-9#3)(2011-1#17)(2011-12#4)(2011-2#41)(2011-3#2)(2012-1#6)(2012-11#6)(2012-12#19)(2012-2#27)(2012-3#7)(2012-8#1)(2013-1#71)(2013-7#8)(2013-8#22)
term)##5##1##(1994-3#1)(1996-11#1)(2007-11#1)(2007-9#1)(2013-1#1)
termed &quot##17##2##(1995-1#1)(1995-2#1)(1996-12#1)(1996-9#1)(2004-7#1)(2005-10#1)(2005-11#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-4#2)(2009-10#1)(2009-12#1)(2009-4#1)(2011-12#1)(2012-2#1)
termed 6##2##2##(2008-11#2)
termed a##8##2##(1997-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-2#1)(2011-2#2)(2013-8#1)
termed acute##2##2##(2005-7#1)(2005-8#1)
termed an##2##2##(2008-10#1)(2013-1#1)
termed apoptosis##2##2##(1991-10#1)(1992-3#1)
termed as the##2##3##(1997-1#1)(2010-7#1)
termed as##3##2##(1997-1#1)(2008-10#1)(2010-7#1)
termed beta##2##2##(1992-9#1)(1995-2#1)
termed diffuse##2##2##(1995-12#1)(2005-11#1)
termed the &quot##5##3##(1997-4#1)(2006-10#1)(2007-11#1)(2008-4#1)(2012-2#1)
termed the##18##2##(1990-8#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-4#2)(2005-8#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2012-2#1)(2013-8#1)
termed##248##1##(1990-11#2)(1990-12#3)(1990-2#1)(1990-4#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#2)(1994-12#6)(1994-2#2)(1994-3#3)(1994-5#1)(1995-1#3)(1995-11#2)(1995-12#4)(1995-2#7)(1995-6#3)(1995-8#4)(1996-10#4)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#6)(1997-5#1)(1997-6#1)(1997-7#5)(2004-7#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#2)(2006-10#5)(2006-11#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#16)(2008-11#6)(2008-2#1)(2008-3#2)(2008-4#9)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#4)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2011-1#3)(2011-12#2)(2011-2#6)(2011-7#1)(2012-1#3)(2012-12#7)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#6)
terminal Araf residues##2##3##(1996-10#2)
terminal Araf##4##2##(1996-10#4)
terminal alkynes##2##2##(2010-6#1)(2013-8#1)
terminal amino acid##2##3##(1991-7#1)(1992-8#1)
terminal amino group##4##3##(1990-12#1)(2005-11#2)(2008-3#1)
terminal amino##8##2##(1990-12#1)(1991-7#1)(1992-8#1)(1992-9#1)(2005-11#2)(2006-10#1)(2008-3#1)
terminal and##6##2##(1991-7#1)(1994-3#1)(1995-3#1)(1996-7#1)(2008-8#1)(2011-2#1)
terminal arbor size##3##3##(2008-4#3)
terminal arborizations##2##2##(1990-4#2)
terminal arbors##2##2##(1990-4#2)
terminal base pairs##2##3##(1995-10#1)(2007-10#1)
terminal boutons##3##2##(1992-1#2)(2008-7#1)
terminal branches of the##4##4##(1997-3#1)(2007-12#1)(2010-12#1)(2012-3#1)
terminal branches##5##2##(1997-3#1)(2007-12#1)(2010-12#2)(2012-3#1)
terminal cancer##8##2##(1990-8#3)(1993-7#1)(1997-5#1)(2006-4#1)(2010-7#1)(2011-2#1)
terminal care##7##2##(1990-3#1)(1990-6#1)(1993-3#2)(1994-12#1)(2005-1#1)(2007-3#1)
terminal cisternae (TC)##2##3##(1993-12#1)(1994-5#1)
terminal cisternae##7##2##(1991-3#1)(1991-7#4)(1993-12#1)(1994-5#1)
terminal complement proteins##2##3##(1994-2#2)
terminal complement##3##2##(1993-11#1)(1994-2#2)
terminal components##3##2##(1996-5#1)(2008-4#2)
terminal condition##2##2##(2007-8#1)(2011-2#1)
terminal cysteine##3##2##(1990-7#1)(2008-10#1)(2009-9#1)
terminal deletions##2##2##(1997-1#1)(1997-3#1)
terminal dendrites##2##2##(1990-7#1)(2007-12#1)
terminal dendritic mass (TDM)##2##4##(2007-12#2)
terminal density##3##2##(1995-12#1)(1996-2#1)(2008-4#1)
terminal deoxynucleotidyl transferase (TdT)##2##4##(1992-6#1)(1997-9#1)
terminal deoxynucleotidyl transferase##5##3##(1992-6#1)(1997-6#1)(1997-9#2)(2008-9#1)
terminal deoxynucleotidyl transferase-mediated##2##3##(2006-11#1)(2008-10#1)
terminal deoxynucleotidyl##10##2##(1992-6#1)(1995-12#1)(1997-6#1)(1997-9#2)(2006-11#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-9#1)
terminal deoxynucleotidyltransferase##3##2##(1995-2#1)(1996-4#2)
terminal deoxyribonucleotidyl##2##2##(1995-12#1)(1997-7#1)
terminal differentiated##3##2##(1990-11#1)(2008-8#1)(2008-9#1)
terminal differentiation and##2##3##(1995-1#1)(2008-8#1)
terminal differentiation by##2##3##(1990-5#1)(1995-1#1)
terminal differentiation of the##2##4##(1990-11#1)(1994-6#1)
terminal differentiation of transformed##2##4##(1991-8#1)(1995-1#1)
terminal differentiation of##14##3##(1990-11#2)(1990-5#1)(1991-4#1)(1991-8#1)(1992-9#2)(1993-6#1)(1994-6#1)(1995-1#2)(1997-4#1)(2008-7#1)(2008-9#1)
terminal differentiation##37##2##(1990-11#2)(1990-5#2)(1991-4#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-12#2)(1992-9#2)(1993-6#2)(1994-11#1)(1994-3#1)(1994-6#1)(1995-1#4)(1996-3#1)(1997-4#1)(1997-6#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#3)(2010-3#1)
terminal direct repeats##2##3##(1991-5#1)(2008-10#1)
terminal disease##3##2##(1992-5#1)(2006-11#1)(2013-1#1)
terminal domain##3##2##(1991-3#1)(1996-12#1)(2008-8#1)
terminal domains##2##2##(1993-8#1)(1997-2#1)
terminal electron accepting##2##3##(2006-8#2)
terminal electron acceptor##5##3##(1990-3#1)(1990-7#2)(1997-6#1)(2009-8#1)
terminal electron##8##2##(1990-3#1)(1990-7#2)(1997-6#1)(2006-8#2)(2009-8#1)(2010-11#1)
terminal elimination half-life##2##3##(1991-12#1)(2006-11#1)
terminal end##4##2##(1995-5#1)(2005-11#2)(2008-10#1)
terminal events##2##2##(1997-4#1)(2009-3#1)
terminal field of the##3##4##(1990-5#1)(1997-3#2)
terminal field of##4##3##(1990-5#2)(1997-3#2)
terminal field##7##2##(1990-5#2)(1991-1#1)(1993-6#1)(1997-3#3)
terminal fields##5##2##(1990-5#1)(1991-3#1)(1993-12#1)(1993-6#1)(1996-9#1)
terminal filament##3##2##(2007-12#3)
terminal filum##2##2##(2005-10#2)
terminal fragment##4##2##(1994-3#3)(2007-11#1)
terminal fragments##2##2##(1995-3#1)(2008-8#1)
terminal galactose residues##2##3##(1993-11#1)(1995-10#1)
terminal galactose##4##2##(1992-1#1)(1993-11#2)(1995-10#1)
terminal groups##3##2##(2005-11#1)(2008-10#2)
terminal hair##2##2##(2010-6#1)(2012-11#1)
terminal half of the##3##4##(1990-12#1)(1992-2#1)(2008-10#1)
terminal half of##4##3##(1990-12#1)(1992-2#1)(1997-2#1)(2008-10#1)
terminal half##6##2##(1990-12#1)(1992-2#1)(1996-11#1)(1997-2#2)(2008-10#1)
terminal ileum##8##2##(1992-5#1)(1993-7#1)(1996-2#1)(1997-1#1)(1997-5#1)(2007-8#2)(2008-12#1)
terminal illness##3##2##(1994-12#1)(2005-2#1)(2010-11#1)
terminal illnesses##2##2##(1996-11#1)(2008-12#1)
terminal inverted##2##2##(1990-3#1)(1991-8#1)
terminal is##2##2##(1996-4#1)(2008-8#1)
terminal methyl groups##3##3##(1990-3#1)(1991-5#1)(2008-10#1)
terminal molars##2##2##(2012-12#2)
terminal nitrogen##2##2##(1994-9#1)(2008-5#1)
terminal of##5##2##(1991-7#1)(1996-8#1)(1997-7#1)(2007-11#1)(2008-9#1)
terminal oxidase##8##2##(1990-11#1)(1990-7#1)(1991-10#1)(1995-6#2)(2006-8#1)(2010-10#1)(2013-8#1)
terminal oxidases##4##2##(1990-7#1)(1994-8#1)(1995-6#1)(2009-9#1)
terminal oxo##2##2##(2008-5#1)(2010-5#1)
terminal part of the##2##4##(1992-6#1)(1993-11#1)
terminal part##3##2##(1992-6#1)(1993-11#1)(2008-8#1)
terminal patients##2##2##(1995-12#1)(2006-12#1)
terminal peptide##3##2##(1992-5#3)
terminal phase of the##2##4##(1996-11#1)(1997-5#1)
terminal phase of##5##3##(1992-9#1)(1994-4#1)(1996-11#1)(1997-5#1)(2010-11#1)
terminal phase##6##2##(1992-9#1)(1994-4#1)(1996-11#1)(1997-5#1)(2010-11#1)(2011-1#1)
terminal placental villi##2##3##(2009-2#2)
terminal pore##3##2##(2007-12#2)(2010-11#1)
terminal protein (TP)##2##3##(1990-3#1)(1997-5#1)
terminal protein##5##2##(1990-3#2)(1995-6#1)(1996-12#1)(1997-5#1)
terminal region of the##8##4##(1992-10#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-11#1)(2008-7#1)(2008-9#1)(2012-3#1)
terminal region of##10##3##(1992-10#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)
terminal region##17##2##(1991-3#1)(1992-10#1)(1993-6#1)(1993-8#1)(1994-11#3)(1995-11#2)(1995-5#1)(1997-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2012-3#1)
terminal regions of the##2##4##(1993-6#1)(2008-10#1)
terminal regions##4##2##(1993-6#1)(2005-9#1)(2008-10#1)(2008-5#1)
terminal renal failure in##2##4##(1990-8#1)(2007-11#1)
terminal renal failure##4##3##(1990-5#1)(1990-8#1)(1992-5#1)(2007-11#1)
terminal repeat (LTR)##15##3##(1991-3#1)(1991-5#2)(1992-12#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-8#1)(1996-5#1)(1997-6#1)(1997-8#1)(2008-11#1)(2009-10#1)(2013-8#1)
terminal repeat from the##2##4##(1992-12#1)(1993-5#1)
terminal repeat of##3##3##(1991-12#1)(1994-12#1)(1996-5#1)
terminal repeat##45##2##(1990-12#2)(1990-6#2)(1991-12#1)(1991-3#1)(1991-5#3)(1992-12#3)(1992-2#1)(1992-8#4)(1993-12#4)(1993-5#1)(1993-8#2)(1994-12#2)(1994-5#1)(1994-8#1)(1995-2#1)(1995-6#2)(1996-5#2)(1997-1#1)(1997-4#1)(1997-6#2)(1997-8#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-10#1)(2012-3#1)(2013-8#2)
terminal repeats##7##2##(1994-8#1)(1995-8#2)(2008-10#1)(2008-5#2)(2008-8#1)
terminal residue##2##2##(1993-3#1)(1995-11#1)
terminal residues##2##2##(1993-8#1)(2009-8#1)
terminal sequence of##5##3##(1990-3#1)(1991-11#1)(1991-2#1)(1991-3#1)(2005-11#1)
terminal sequence##11##2##(1990-3#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#3)(1992-8#1)(2005-11#1)
terminal sequences##3##2##(1990-9#1)(1991-9#1)(2005-11#1)
terminal sialic acid##3##3##(1991-9#1)(1996-8#1)(2008-11#1)
terminal stage##4##2##(2010-12#1)(2011-2#2)(2012-2#1)
terminal structure##2##2##(2008-8#2)
terminal sugar##3##2##(1992-12#3)
terminal sugars##2##2##(1994-3#1)(2011-2#1)
terminal to##2##2##(1991-4#1)(2010-12#1)
terminal transferase##3##2##(1996-3#1)(1996-9#1)(1997-7#1)
terminal ureter##3##2##(2008-10#1)(2009-5#1)(2013-1#1)
terminal values##3##2##(2011-1#3)
terminal velocity and##2##3##(2008-5#2)
terminal velocity##5##2##(2008-5#5)
terminal villi in##2##3##(2009-2#2)
terminal villi##3##2##(2009-2#3)
terminal was##2##2##(1994-2#1)(1996-7#1)
terminal with##2##2##(1991-12#1)(2008-7#1)
terminal zone##2##2##(1991-9#1)(1993-5#1)
terminal##684##1##(1990-10#1)(1990-11#7)(1990-12#4)(1990-2#2)(1990-3#8)(1990-4#6)(1990-5#11)(1990-6#4)(1990-7#8)(1990-8#7)(1990-9#4)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#4)(1991-2#1)(1991-3#9)(1991-4#2)(1991-5#11)(1991-6#1)(1991-7#16)(1991-8#3)(1991-9#7)(1992-1#5)(1992-10#1)(1992-12#8)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#12)(1992-6#3)(1992-8#10)(1992-9#4)(1993-10#1)(1993-11#7)(1993-12#9)(1993-2#4)(1993-3#5)(1993-4#2)(1993-5#2)(1993-6#9)(1993-7#3)(1993-8#6)(1994-11#5)(1994-12#6)(1994-2#4)(1994-3#7)(1994-4#1)(1994-5#9)(1994-6#3)(1994-8#11)(1994-9#2)(1995-1#5)(1995-10#3)(1995-11#4)(1995-12#7)(1995-2#4)(1995-3#5)(1995-4#1)(1995-5#2)(1995-6#8)(1995-7#1)(1995-8#6)(1995-9#3)(1996-1#1)(1996-10#8)(1996-11#5)(1996-12#5)(1996-2#3)(1996-3#5)(1996-4#5)(1996-5#6)(1996-6#4)(1996-7#3)(1996-8#4)(1996-9#4)(1997-1#4)(1997-2#6)(1997-3#10)(1997-4#6)(1997-5#4)(1997-6#5)(1997-7#3)(1997-8#1)(1997-9#2)(2005-1#1)(2005-10#3)(2005-11#10)(2005-2#1)(2005-9#1)(2006-10#3)(2006-11#4)(2006-12#3)(2006-2#1)(2006-4#2)(2006-5#1)(2006-8#3)(2007-1#4)(2007-10#3)(2007-11#6)(2007-12#13)(2007-2#1)(2007-3#4)(2007-4#1)(2007-8#8)(2007-9#1)(2008-1#2)(2008-10#26)(2008-11#11)(2008-12#4)(2008-3#2)(2008-4#15)(2008-5#18)(2008-6#3)(2008-7#12)(2008-8#21)(2008-9#10)(2009-10#1)(2009-2#6)(2009-3#5)(2009-5#2)(2009-8#3)(2009-9#3)(2010-10#1)(2010-11#4)(2010-12#8)(2010-3#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#6)(2011-12#2)(2011-2#10)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#8)(2013-1#2)(2013-7#1)(2013-8#4)
terminal-stream-limitation model##2##2##(2008-8#2)
terminalis (OVLT)##3##2##(1993-2#1)(1993-7#2)
terminalis and##4##2##(1992-8#1)(1994-2#1)(1995-5#1)(2008-4#1)
terminalis##27##1##(1991-8#3)(1992-3#1)(1992-7#3)(1992-8#1)(1993-12#1)(1993-2#1)(1993-7#2)(1994-2#1)(1995-5#2)(1995-6#2)(1997-3#1)(1997-8#3)(2006-5#1)(2007-12#1)(2008-4#1)(2008-5#2)(2008-9#1)
terminally differentiated cells##2##3##(1992-11#1)(1995-1#1)
terminally differentiated##7##2##(1992-11#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(2008-5#1)(2009-10#1)
terminally ill cancer##2##3##(2012-2#1)(2013-8#1)
terminally ill patients and##2##4##(1990-10#1)(2006-10#1)
terminally ill patients##11##3##(1990-10#3)(1994-12#1)(2006-10#2)(2007-11#1)(2007-12#2)(2007-2#2)
terminally ill##28##2##(1990-10#4)(1990-12#1)(1991-2#1)(1992-2#1)(1993-12#1)(1994-12#2)(1996-2#3)(2006-10#2)(2006-4#2)(2007-11#1)(2007-12#2)(2007-2#2)(2008-12#2)(2012-12#1)(2012-2#1)(2013-8#2)
terminally##42##1##(1990-10#4)(1990-12#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-2#1)(1993-12#2)(1993-3#1)(1993-4#1)(1994-12#2)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#3)(2005-11#1)(2006-10#2)(2006-4#2)(2007-11#1)(2007-12#2)(2007-2#2)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-12#1)(2012-2#1)(2013-8#2)
terminally-ill patients##2##2##(2008-7#1)(2012-12#1)
terminally-ill##3##1##(2008-7#1)(2012-12#2)
terminals and##12##2##(1990-12#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-9#1)(1997-3#3)(1997-4#2)(1997-8#1)(2012-3#1)
terminals are##6##2##(1992-8#1)(1993-7#1)(1993-8#1)(1994-8#1)(1995-12#1)(1997-3#1)
terminals as well as##2##4##(1995-12#1)(1995-6#1)
terminals but##2##2##(1997-5#1)(2008-7#1)
terminals containing##2##2##(1990-2#1)(1997-8#1)
terminals forming##2##2##(1995-11#1)(1997-3#1)
terminals from##2##2##(1993-8#1)(2007-12#1)
terminals in the brain##2##4##(1994-2#1)(1997-3#1)
terminals in the rat##2##4##(1995-6#1)(1997-2#1)
terminals in the spinal cord##2##5##(1990-7#1)(1993-4#1)
terminals in the striatum and##2##5##(1996-12#1)(2008-7#1)
terminals in the striatum##3##4##(1996-12#1)(1997-8#1)(2008-7#1)
terminals in the##19##3##(1990-5#1)(1990-7#1)(1992-7#1)(1993-4#1)(1993-7#1)(1994-2#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-7#1)
terminals in##29##2##(1990-2#1)(1990-5#1)(1990-7#1)(1992-7#1)(1993-4#1)(1993-7#1)(1994-2#2)(1995-12#1)(1995-6#3)(1995-7#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-8#1)
terminals innervating the##2##3##(1993-12#1)(1995-3#1)
terminals into##2##2##(1994-5#1)(1997-3#1)
terminals is##2##2##(1995-11#1)(2008-4#1)
terminals made##3##2##(1992-3#1)(1993-12#1)(2013-8#1)
terminals of the neurons##2##4##(1992-12#1)(1997-8#1)
terminals of the##8##3##(1990-5#1)(1991-9#1)(1992-12#1)(1994-2#1)(1995-12#1)(1997-5#1)(1997-8#1)(2008-10#1)
terminals of##29##2##(1990-5#2)(1991-6#1)(1991-9#2)(1992-12#1)(1992-9#2)(1993-12#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-2#2)(1997-3#1)(1997-5#3)(1997-8#2)(2007-10#1)(2007-11#1)(2008-10#1)(2008-8#1)(2013-8#1)
terminals on##3##2##(1995-3#1)(1997-2#2)
terminals or##4##2##(1995-11#1)(1995-7#2)(1996-5#1)
terminals that##2##2##(1993-12#1)(1994-5#1)
terminals to##2##2##(1994-5#1)(1996-1#1)
terminals were also##3##3##(1992-7#1)(1995-8#1)(1997-5#1)
terminals were observed##2##3##(1995-12#1)(1997-6#1)
terminals were seen##2##3##(1996-11#1)(2008-5#1)
terminals were##11##2##(1990-2#1)(1992-7#1)(1994-2#1)(1995-12#2)(1995-3#1)(1995-8#1)(1996-11#1)(1997-5#1)(1997-6#1)(2008-5#1)
terminals which##3##2##(1991-9#1)(1995-3#1)(1997-7#1)
terminals with##5##2##(1992-8#1)(1997-2#3)(2008-11#1)
terminals within##2##2##(1991-9#1)(1992-1#1)
terminals##231##1##(1990-10#1)(1990-12#1)(1990-2#5)(1990-4#1)(1990-5#5)(1990-7#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#3)(1991-9#6)(1992-1#3)(1992-12#1)(1992-3#4)(1992-6#2)(1992-7#2)(1992-8#4)(1992-9#2)(1993-12#7)(1993-3#1)(1993-4#3)(1993-6#1)(1993-7#3)(1993-8#2)(1993-9#2)(1994-10#1)(1994-2#6)(1994-5#3)(1994-8#3)(1995-11#12)(1995-12#11)(1995-3#6)(1995-5#3)(1995-6#5)(1995-7#6)(1995-8#4)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#1)(1997-1#1)(1997-2#12)(1997-3#11)(1997-4#2)(1997-5#6)(1997-6#2)(1997-7#8)(1997-8#6)(2007-10#5)(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2009-8#1)(2010-8#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#5)
terminase##10##1##(1990-11#1)(1996-8#8)(2012-3#1)
terminate at##2##2##(1997-5#2)
terminate in##3##2##(1996-2#1)(1996-7#1)(2007-12#1)
terminate near the##2##3##(1993-9#1)(2010-11#1)
terminate near##3##2##(1993-9#1)(2007-12#1)(2010-11#1)
terminate the##13##2##(1991-3#1)(1991-8#1)(1991-9#1)(1992-6#1)(1994-11#1)(1997-2#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-4#2)(2010-9#1)
terminate transcription##3##2##(1995-4#2)(1996-11#1)
terminate with##2##2##(1992-10#2)
terminate##52##1##(1990-10#1)(1990-3#1)(1990-6#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-2#1)(1992-6#1)(1993-3#2)(1993-9#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-4#2)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#2)(1997-2#1)(1997-5#4)(2005-7#1)(2006-4#2)(2007-12#3)(2007-3#3)(2007-9#2)(2008-10#1)(2008-11#1)(2008-4#2)(2009-8#1)(2010-11#1)(2010-9#1)(2012-3#1)(2013-1#2)
terminated at the##2##3##(1997-2#1)(2008-7#1)
terminated at##3##2##(1992-3#1)(1997-2#1)(2008-7#1)
terminated because of##2##3##(2004-1#1)(2011-1#1)
terminated by a##3##3##(1990-5#1)(2007-11#1)(2008-12#1)
terminated by glycine##3##3##(1991-10#3)
terminated by##10##2##(1990-5#1)(1991-10#4)(1991-4#1)(1992-2#1)(1995-12#1)(2007-11#1)(2008-12#1)
terminated early##2##2##(1997-6#1)(2010-12#1)
terminated in##7##2##(1991-7#1)(1993-1#1)(1993-10#1)(2005-7#1)(2007-12#2)(2008-3#1)
terminated on##3##2##(1993-12#1)(1993-9#1)(1995-3#1)
terminated prematurely##2##2##(2007-8#1)(2008-10#1)
terminated the##4##2##(1991-10#1)(1994-11#1)(1994-7#1)(2008-4#1)
terminated transcripts##2##2##(1996-11#1)(1997-6#1)
terminated##71##1##(1990-3#2)(1990-5#2)(1991-10#5)(1991-3#1)(1991-4#1)(1991-7#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-10#1)(1993-12#3)(1993-9#1)(1994-11#2)(1994-2#1)(1994-5#1)(1994-7#1)(1995-12#2)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1997-2#1)(1997-6#3)(1997-7#1)(2004-1#1)(2005-11#1)(2005-7#1)(2005-8#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-4#1)(2012-11#4)(2012-12#1)(2013-8#1)
terminates in##3##2##(1992-12#1)(2008-7#1)(2010-4#1)
terminates##12##1##(1992-12#1)(1994-3#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-7#1)(2008-2#1)(2008-7#1)(2009-8#1)(2010-11#1)(2010-4#1)(2012-3#1)
terminating in the##4##3##(1994-8#1)(1995-6#1)(1997-5#1)(2008-11#1)
terminating in##9##2##(1990-11#1)(1990-5#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1997-5#1)(2008-11#1)
terminating outcome##3##2##(1997-4#3)
terminating with##2##2##(1992-10#1)(1995-6#1)
terminating##32##1##(1990-1#1)(1990-11#1)(1990-5#1)(1991-2#1)(1991-8#1)(1992-10#1)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-7#1)(1996-6#2)(1997-4#5)(1997-5#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-7#1)(2010-10#1)(2011-1#2)
termination and##6##2##(1992-3#1)(1995-4#1)(1996-7#1)(2005-10#1)(2007-4#1)(2008-4#1)
termination are##2##2##(2008-10#1)(2008-11#1)
termination at##5##2##(1997-2#3)(1997-5#1)(1997-8#1)
termination by the##2##3##(1996-7#1)(2008-2#1)
termination by##5##2##(1991-2#1)(1995-1#1)(1996-7#1)(1997-5#1)(2008-2#1)
termination codon##11##2##(1990-7#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-9#1)(1995-1#1)(1995-8#1)(1997-1#1)(2008-10#1)(2012-1#1)
termination codons##2##2##(1995-3#1)(2006-12#1)
termination factor##2##2##(1993-4#1)(1995-5#1)
termination function##3##2##(1995-2#1)(1995-4#1)(1996-8#1)
termination in##4##2##(1996-2#1)(2008-9#1)(2011-2#1)(2012-11#1)
termination level##2##2##(2008-3#2)
termination occurred##3##2##(1996-8#1)(1997-2#2)
termination of VF##3##3##(2006-9#3)
termination of early pregnancy##2##4##(1995-8#2)
termination of life##3##3##(1991-3#1)(2005-7#1)(2006-7#1)
termination of pregnancy and##2##4##(2013-1#1)(2013-8#1)
termination of pregnancy##15##3##(1990-2#1)(1991-8#1)(1992-2#1)(1993-2#1)(1995-8#3)(2006-10#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
termination of the##16##3##(1990-12#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-12#2)(1996-11#1)(1996-6#1)(1997-2#1)(1997-6#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-4#1)
termination of transcription##4##3##(1996-7#1)(1996-8#1)(1997-1#1)(2008-11#1)
termination of translation##7##3##(1991-11#1)(1991-12#1)(1994-3#1)(2008-11#4)
termination of##94##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-7#1)(1991-8#4)(1992-12#1)(1992-2#2)(1992-6#1)(1993-12#1)(1993-2#3)(1993-6#2)(1994-12#2)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#5)(1996-11#1)(1996-12#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#3)(1997-3#1)(1997-6#1)(1997-8#1)(2004-10#1)(2005-1#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#2)(2006-7#1)(2006-9#4)(2007-11#1)(2007-3#1)(2007-8#1)(2007-9#3)(2008-1#4)(2008-11#5)(2008-3#2)(2008-4#2)(2008-7#1)(2008-9#2)(2009-7#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#2)(2013-1#2)(2013-8#1)
termination or##3##2##(1997-5#1)(2007-4#1)(2009-2#1)
termination reactions##2##2##(1996-5#1)(2006-10#1)
termination signal##3##2##(1990-5#1)(1990-8#1)(1993-9#1)
termination signals##4##2##(1990-5#1)(1990-9#1)(1996-7#1)(1997-5#1)
termination site of##2##3##(1996-3#1)(1997-2#1)
termination site##3##2##(1996-3#1)(1997-2#1)(1997-5#1)
termination sites##4##2##(1994-9#1)(1997-2#1)(1997-5#1)(2008-4#1)
termination was##4##2##(1996-7#1)(1996-8#1)(1997-2#1)(2007-8#1)
termination were##2##2##(1997-2#1)(2012-2#1)
termination##242##1##(1990-1#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#5)(1991-3#2)(1991-7#1)(1991-8#4)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1993-11#3)(1993-12#1)(1993-2#3)(1993-3#1)(1993-4#3)(1993-6#2)(1993-9#2)(1994-12#3)(1994-3#1)(1994-6#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#1)(1995-4#6)(1995-5#2)(1995-8#6)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#3)(1996-7#6)(1996-8#4)(1996-9#1)(1997-1#4)(1997-2#18)(1997-3#3)(1997-4#2)(1997-5#8)(1997-6#2)(1997-8#2)(2004-10#1)(2005-1#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-12#2)(2006-6#2)(2006-7#1)(2006-9#4)(2007-11#1)(2007-3#2)(2007-4#3)(2007-8#2)(2007-9#4)(2008-1#4)(2008-10#4)(2008-11#9)(2008-2#1)(2008-3#6)(2008-4#6)(2008-7#1)(2008-8#1)(2008-9#5)(2009-10#1)(2009-12#4)(2009-2#2)(2009-5#1)(2009-7#1)(2009-9#1)(2011-1#3)(2011-12#2)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#2)
termination)##2##1##(2008-10#1)(2011-12#1)
terminations concentrated in layer##2##4##(1996-9#2)
terminations in##2##2##(1996-12#1)(2013-8#1)
terminations of##3##2##(1994-2#1)(1995-7#1)(2008-9#1)
terminations##13##1##(1990-2#1)(1993-12#1)(1994-2#1)(1995-7#1)(1996-12#1)(1996-9#2)(2007-9#2)(2008-9#2)(2011-1#1)(2013-8#1)
terminator in##5##2##(1996-10#1)(1996-8#1)(1997-5#1)(1997-6#1)(2008-9#1)
terminator of##3##2##(1994-12#1)(2008-8#2)
terminator region##2##2##(1991-7#2)
terminator sequence##2##2##(1990-3#1)(2006-12#1)
terminator was##2##2##(1993-12#1)(1993-9#1)
terminator##41##1##(1990-11#2)(1990-3#1)(1990-5#2)(1991-7#2)(1991-8#1)(1993-11#1)(1993-12#2)(1993-4#2)(1993-9#4)(1994-12#2)(1994-5#1)(1996-10#3)(1996-2#1)(1996-8#3)(1997-2#3)(1997-5#2)(1997-6#1)(2006-12#1)(2008-10#1)(2008-8#4)(2008-9#1)(2011-1#1)
terminators and##3##2##(1990-5#1)(1990-9#1)(1995-2#1)
terminators##19##1##(1990-5#3)(1990-9#2)(1991-7#1)(1991-8#1)(1993-12#1)(1993-4#3)(1993-5#1)(1994-12#1)(1994-5#1)(1995-2#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-7#1)
termini and##4##2##(1996-5#1)(1996-8#1)(1997-4#1)(2013-8#1)
termini are##2##2##(1993-3#1)(2008-8#1)
termini in##3##2##(1991-2#1)(1994-3#1)(2006-10#1)
termini of the##11##3##(1992-6#1)(1992-9#1)(1994-3#1)(1995-10#1)(1996-7#1)(1997-4#2)(2008-10#1)(2008-2#1)(2008-9#1)(2013-8#1)
termini of##25##2##(1990-5#1)(1991-8#1)(1992-1#1)(1992-6#1)(1992-9#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-10#2)(1995-3#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-4#2)(1997-8#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#1)(2013-8#1)
termini were##3##2##(1991-8#1)(1994-8#1)(1995-1#1)
termini##67##1##(1990-1#1)(1990-5#3)(1990-7#1)(1991-10#1)(1991-2#1)(1991-8#2)(1992-1#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-3#2)(1993-9#1)(1994-3#3)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-10#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#3)(1996-7#1)(1996-8#2)(1997-4#4)(1997-8#2)(2005-11#2)(2005-12#1)(2006-10#2)(2006-12#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-8#3)(2008-9#2)(2012-2#1)(2013-8#2)
termino-terminal##2##1##(1993-10#1)(2008-8#1)
terminological resource##2##2##(2008-7#2)
terminological##10##1##(1991-9#1)(2006-3#1)(2008-7#2)(2013-1#6)
terminologies##18##1##(2008-7#2)(2013-1#16)
terminology (CPT) codes##3##3##(2006-8#1)(2013-1#2)
terminology and definitions##2##3##(1995-1#1)(2004-11#1)
terminology and secondly##2##3##(2006-12#1)(2013-1#1)
terminology and##13##2##(1991-3#1)(1995-1#1)(2004-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-4#1)(2011-12#1)(2012-2#1)(2013-1#2)
terminology for medical##3##3##(2007-6#1)(2013-1#2)
terminology for##10##2##(1992-3#1)(1996-2#1)(2007-6#1)(2008-10#1)(2013-1#4)(2013-8#2)
terminology in##5##2##(1997-8#1)(2008-10#1)(2011-2#1)(2013-1#2)
terminology is##5##2##(2008-10#1)(2010-5#1)(2010-9#1)(2013-1#2)
terminology of lean manufacturing and the Toyota Production System##3##9##(2012-2#3)
terminology of the##3##3##(1996-3#1)(2007-12#1)(2011-12#1)
terminology of##14##2##(1990-11#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-12#1)(2012-2#4)(2013-1#2)(2013-7#1)
terminology to##2##2##(2009-7#1)(2012-3#1)
terminology used in##2##3##(2006-8#1)(2008-10#1)
terminology used##4##2##(2006-8#1)(2007-11#1)(2008-10#1)(2008-5#1)
terminology##109##1##(1990-11#1)(1990-3#1)(1991-12#1)(1991-3#1)(1992-1#2)(1992-3#1)(1993-12#1)(1993-7#2)(1994-1#1)(1994-3#1)(1995-1#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-8#2)(2004-11#1)(2005-1#1)(2005-9#2)(2006-10#1)(2006-12#2)(2006-7#1)(2006-8#4)(2007-11#4)(2007-12#4)(2007-6#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#3)(2011-2#2)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#31)(2013-7#1)(2013-8#2)
terminus (residues##2##2##(1991-7#2)
terminus and the##6##3##(1991-5#1)(1993-2#1)(1994-9#1)(1996-10#1)(1996-12#1)(1996-8#1)
terminus and##19##2##(1990-5#1)(1991-5#1)(1992-1#1)(1992-4#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-8#1)(1994-9#3)(1995-4#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(2008-10#2)
terminus are##2##2##(1990-3#1)(1997-4#1)
terminus by##3##2##(1995-2#1)(1995-6#2)
terminus contained a##2##3##(1995-3#1)(2008-10#1)
terminus in a##2##3##(1995-6#2)
terminus in##6##2##(1991-2#1)(1994-12#1)(1994-9#1)(1995-6#2)(1997-4#1)
terminus is first order in [peptide]##2##6##(2006-11#2)
terminus is##7##2##(1992-7#1)(1994-9#2)(1995-8#1)(1996-10#1)(2006-11#2)
terminus of Escherichia coli##2##4##(1990-10#1)(1997-2#1)
terminus of a##4##3##(1990-5#1)(1994-9#1)(1996-8#1)(2012-2#1)
terminus of an##9##3##(1992-6#1)(1994-9#1)(1995-2#1)(1995-4#1)(2008-10#1)(2008-4#4)
terminus of human##2##3##(1991-2#1)(1994-12#1)
terminus of the catalytic##3##4##(1995-2#2)(1997-2#1)
terminus of the deduced##2##4##(1992-8#1)(1994-12#1)
terminus of the peptide##2##4##(2008-5#1)(2010-10#1)
terminus of the protein##4##4##(1990-3#1)(1990-4#1)(1994-12#1)(1994-9#1)
terminus of the##49##3##(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-8#2)(1992-9#1)(1993-6#1)(1994-12#4)(1994-8#2)(1994-9#2)(1995-10#2)(1995-12#1)(1995-2#3)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-5#3)(1997-2#1)(1997-6#1)(2005-11#1)(2008-11#1)(2008-4#3)(2008-5#1)(2010-10#1)(2012-3#1)
terminus of##104##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#3)(1990-7#1)(1991-10#4)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-6#1)(1993-8#1)(1994-12#5)(1994-3#1)(1994-8#3)(1994-9#6)(1995-10#2)(1995-12#1)(1995-2#5)(1995-3#8)(1995-4#2)(1995-5#1)(1995-6#2)(1995-8#2)(1996-10#1)(1996-12#1)(1996-5#6)(1996-8#2)(1997-2#2)(1997-4#1)(1997-6#1)(2005-11#2)(2008-10#2)(2008-11#1)(2008-4#8)(2008-5#1)(2010-10#1)(2010-4#1)(2012-2#1)(2012-3#2)
terminus or##3##2##(1992-3#1)(1995-8#1)(1996-12#1)
terminus region of the chromosome##2##5##(1995-2#1)(1997-2#1)
terminus region##5##2##(1995-2#3)(1996-12#1)(1997-2#1)
terminus that##4##2##(1990-6#1)(1992-7#1)(1994-9#1)(2012-2#1)
terminus was##5##2##(1992-7#1)(1994-9#3)(2008-11#1)
terminus were##5##2##(1992-1#1)(1992-9#1)(1995-6#1)(1997-6#1)(2008-10#1)
terminus with##3##2##(1994-12#1)(1995-8#1)(1997-4#1)
terminus##272##1##(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#4)(1990-4#3)(1990-5#7)(1990-6#2)(1990-7#1)(1991-10#4)(1991-2#4)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#4)(1991-8#4)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#1)(1992-3#3)(1992-4#2)(1992-5#2)(1992-6#1)(1992-7#3)(1992-8#5)(1992-9#6)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#4)(1993-8#2)(1994-12#11)(1994-3#2)(1994-6#1)(1994-8#6)(1994-9#26)(1995-1#2)(1995-10#2)(1995-12#1)(1995-2#11)(1995-3#11)(1995-4#3)(1995-5#1)(1995-6#15)(1995-8#7)(1996-10#4)(1996-12#6)(1996-4#1)(1996-5#10)(1996-6#1)(1996-7#2)(1996-8#5)(1997-2#5)(1997-4#5)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#1)(2005-11#2)(2006-11#2)(2007-11#1)(2008-10#8)(2008-11#7)(2008-4#10)(2008-5#2)(2008-6#1)(2009-3#1)(2009-9#2)(2010-10#1)(2010-4#1)(2012-2#2)(2012-3#2)
termis##4##1##(2008-5#1)(2011-1#3)
termite Prorhinotermes simplex (Isoptera##2##4##(2007-12#2)
termite gut##2##2##(2008-11#2)
termite hills and animal burrows##4##5##(2007-6#4)
termite hills##7##2##(2007-6#7)
termite hindgut##2##2##(2008-11#2)
termite##29##1##(2007-12#2)(2007-6#7)(2008-11#10)(2008-8#1)(2009-5#1)(2010-1#1)(2011-2#7)
termites and##2##2##(2008-8#1)(2011-2#1)
termites were##2##2##(2011-2#1)(2013-7#1)
termites##27##1##(2008-11#2)(2008-8#1)(2009-5#3)(2011-2#7)(2013-7#10)(2013-8#4)
termiticides##3##1##(2011-2#3)
terms &quot##8##2##(1996-9#1)(2006-8#1)(2009-9#1)(2011-12#1)(2011-2#2)(2013-1#2)
terms and a##2##3##(2006-10#1)(2006-7#1)
terms and conditions##4##3##(2006-8#4)
terms and definitions##2##3##(2007-12#1)(2008-4#1)
terms and the##4##3##(1994-1#1)(1995-1#1)(2008-7#1)(2010-9#1)
terms and then##2##3##(1991-10#1)(2011-2#1)
terms and##31##2##(1990-4#1)(1991-10#2)(1993-6#1)(1994-1#2)(1995-1#1)(1996-2#2)(1996-9#1)(2006-10#1)(2006-3#1)(2006-7#1)(2006-8#4)(2007-12#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-7#1)(2010-9#1)(2011-12#1)(2011-2#1)(2013-1#2)
terms are used to##2##4##(2008-3#2)
terms are##19##2##(1990-11#1)(1990-8#1)(1991-6#1)(1993-2#2)(1994-12#1)(2006-7#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#2)(2010-2#2)(2011-2#1)(2012-2#1)
terms as##4##2##(2006-1#1)(2008-5#1)(2010-5#1)(2011-2#1)
terms between##2##2##(2007-12#1)(2008-3#1)
terms but##3##2##(2006-7#1)(2007-9#1)(2008-10#1)
terms by##4##2##(1997-8#1)(2006-7#1)(2007-7#1)(2008-7#1)
terms can be##3##3##(2008-2#1)(2008-4#1)(2008-7#1)
terms can##4##2##(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)
terms for primary##3##3##(2008-10#3)
terms for##22##2##(1996-7#1)(2008-10#4)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-1#1)(2013-1#8)
terms from##4##2##(2013-1#4)
terms have been##4##3##(2007-4#1)(2008-8#1)(2008-9#1)(2012-2#1)
terms in the##11##3##(1994-11#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#3)(2012-2#1)
terms in this context##4##4##(2013-1#4)
terms in##28##2##(1994-11#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#6)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#10)
terms included##3##2##(2006-9#1)(2011-2#1)(2013-1#1)
terms is##5##2##(1990-4#1)(1996-9#1)(2008-2#1)(2011-2#2)
terms of a##60##3##(1990-11#1)(1990-8#1)(1991-8#1)(1993-11#2)(1993-4#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#2)(1994-5#1)(1994-8#2)(1994-9#2)(1995-12#1)(1995-6#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-1#2)(2005-11#4)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2008-10#2)(2008-3#8)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#2)(2009-8#1)(2011-2#1)(2013-7#1)(2013-8#1)
terms of an##11##3##(1990-8#1)(1991-8#1)(1993-3#1)(2006-10#1)(2008-2#3)(2008-3#1)(2008-9#1)(2011-1#1)(2013-1#1)
terms of biological##3##3##(1991-4#1)(2004-2#1)(2013-7#1)
terms of both##32##3##(1992-11#1)(1992-6#1)(1993-9#1)(2006-10#3)(2006-12#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#4)(2008-3#3)(2008-5#3)(2008-7#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#2)
terms of cancer##2##3##(1996-3#1)(2005-8#1)
terms of clinical##7##3##(1993-12#1)(1997-1#1)(2006-2#1)(2006-7#1)(2007-12#1)(2007-5#1)(2008-5#1)
terms of detection##6##3##(1992-4#1)(2005-11#1)(2008-10#2)(2008-3#1)(2010-12#1)
terms of disease##2##3##(2011-2#1)(2012-2#1)
terms of drug##4##3##(2005-7#1)(2008-4#1)(2009-6#1)(2013-7#1)
terms of efficacy##4##3##(1990-6#1)(1991-5#1)(1993-11#1)(2005-9#1)
terms of food##4##3##(2007-12#1)(2008-5#1)(2011-2#1)(2012-1#1)
terms of her##2##3##(1991-6#1)(2012-3#1)
terms of its##26##3##(1990-11#1)(1990-7#1)(1992-1#2)(1994-3#1)(1995-3#1)(1995-8#1)(2005-11#3)(2006-8#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-7#1)(2010-5#1)(2011-2#1)(2012-2#1)
terms of length of stay##2##5##(1993-12#1)(2012-3#1)
terms of length of##3##4##(1993-12#1)(1995-10#1)(2012-3#1)
terms of membrane##3##3##(2008-10#2)(2008-7#1)
terms of mortality##4##3##(1995-3#1)(1996-12#1)(2007-7#1)(2008-7#1)
terms of number of##4##4##(1994-10#1)(2006-9#1)(2007-7#1)(2012-3#1)
terms of production##2##3##(2008-12#1)(2008-4#1)
terms of reference##3##3##(2008-1#1)(2008-12#1)(2010-12#1)
terms of reliability##2##3##(2008-1#1)(2013-1#1)
terms of research##3##3##(2006-5#1)(2007-7#1)(2008-12#1)
terms of risk##4##3##(2007-2#1)(2007-7#1)(2008-11#1)(2010-7#1)
terms of sensitivity##12##3##(1996-11#1)(2007-2#1)(2008-10#8)(2012-2#1)(2012-8#1)
terms of specific##5##3##(1991-5#1)(1991-9#1)(2008-9#1)(2010-3#1)(2013-7#1)
terms of stability##4##3##(2005-4#1)(2008-10#2)(2011-1#1)
terms of surface##3##3##(1997-2#1)(2006-7#1)(2008-10#1)
terms of survival##8##3##(1991-2#1)(1993-2#1)(2005-8#1)(2007-10#1)(2007-8#1)(2008-7#1)(2013-7#2)
terms of symptom expression##2##4##(2008-10#2)
terms of symptom##3##3##(2008-10#2)(2012-2#1)
terms of the distribution of##3##5##(2008-8#1)(2008-9#1)(2013-7#1)
terms of the range of##2##5##(2008-8#1)(2008-9#1)
terms of the settlement##2##4##(1995-12#1)(1997-5#1)
terms of the##270##3##(1990-10#1)(1990-11#2)(1990-12#2)(1990-3#1)(1990-7#3)(1990-8#2)(1990-9#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#1)(1994-12#2)(1994-2#2)(1994-6#1)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#2)(1996-1#2)(1996-11#3)(1996-12#2)(1996-2#3)(1996-3#2)(1996-4#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-5#1)(1997-7#1)(2004-12#1)(2005-11#8)(2005-12#1)(2005-8#2)(2006-10#4)(2006-12#2)(2006-2#2)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#8)(2007-12#6)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#3)(2008-1#4)(2008-10#30)(2008-11#7)(2008-12#5)(2008-2#19)(2008-3#17)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#5)(2009-10#1)(2009-11#3)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-12#3)(2010-2#2)(2010-4#3)(2010-5#3)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
terms of their relationship##2##4##(2009-12#1)(2013-1#1)
terms of their##73##3##(1990-7#1)(1991-2#1)(1991-4#1)(1992-11#2)(1993-2#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-10#1)(1996-5#1)(1997-2#1)(2005-10#1)(2005-11#2)(2005-6#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-4#1)(2013-1#3)
terms of total##5##3##(1992-3#1)(1993-11#1)(2007-8#1)(2008-7#1)(2012-12#1)
terms of tumor##3##3##(1992-12#1)(2006-6#2)
terms of##1560##2##(1990-1#2)(1990-10#2)(1990-11#4)(1990-12#6)(1990-2#4)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#4)(1990-7#8)(1990-8#10)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#6)(1991-3#4)(1991-4#4)(1991-5#5)(1991-6#3)(1991-7#2)(1991-8#5)(1991-9#2)(1992-1#7)(1992-10#1)(1992-11#4)(1992-12#7)(1992-2#5)(1992-3#6)(1992-4#6)(1992-5#3)(1992-6#7)(1992-7#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#7)(1993-12#8)(1993-2#6)(1993-3#3)(1993-4#3)(1993-5#2)(1993-6#3)(1993-7#2)(1993-8#2)(1993-9#4)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#8)(1994-3#5)(1994-5#4)(1994-6#4)(1994-7#1)(1994-8#7)(1994-9#5)(1995-1#4)(1995-10#4)(1995-11#4)(1995-12#6)(1995-2#6)(1995-3#6)(1995-4#1)(1995-5#5)(1995-6#6)(1995-8#6)(1995-9#1)(1996-1#7)(1996-11#7)(1996-12#6)(1996-2#6)(1996-3#5)(1996-4#4)(1996-5#4)(1996-6#2)(1996-8#5)(1996-9#3)(1997-1#7)(1997-2#5)(1997-3#4)(1997-4#3)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#5)(2004-12#1)(2004-2#2)(2004-3#1)(2004-9#2)(2005-10#6)(2005-11#32)(2005-12#1)(2005-4#1)(2005-5#5)(2005-6#1)(2005-7#1)(2005-8#9)(2005-9#2)(2006-10#37)(2006-11#2)(2006-12#11)(2006-2#5)(2006-3#1)(2006-4#5)(2006-5#4)(2006-6#10)(2006-7#5)(2006-8#10)(2006-9#3)(2007-1#1)(2007-10#9)(2007-11#34)(2007-12#39)(2007-2#8)(2007-3#4)(2007-4#6)(2007-5#9)(2007-6#4)(2007-7#17)(2007-8#16)(2007-9#13)(2008-1#28)(2008-10#158)(2008-11#35)(2008-12#19)(2008-2#73)(2008-3#81)(2008-4#17)(2008-5#38)(2008-6#12)(2008-7#33)(2008-8#23)(2008-9#23)(2009-1#1)(2009-10#4)(2009-11#4)(2009-12#6)(2009-2#3)(2009-3#3)(2009-4#12)(2009-5#7)(2009-6#7)(2009-7#10)(2009-8#6)(2009-9#7)(2010-1#1)(2010-10#3)(2010-11#5)(2010-12#16)(2010-2#14)(2010-3#7)(2010-4#7)(2010-5#9)(2010-6#2)(2010-7#5)(2010-8#10)(2010-9#2)(2011-1#21)(2011-12#6)(2011-2#37)(2011-3#1)(2012-1#13)(2012-11#2)(2012-12#20)(2012-2#29)(2012-3#18)(2012-4#2)(2012-8#1)(2013-1#35)(2013-7#11)(2013-8#12)
terms related to##6##3##(2009-4#1)(2010-9#1)(2012-12#2)(2013-1#2)
terms should be##2##3##(2006-7#1)(2008-3#1)
terms such as &quot##3##4##(2008-1#1)(2012-12#1)(2013-1#1)
terms such as##10##3##(1994-9#1)(2007-4#2)(2007-7#1)(2008-1#1)(2008-7#1)(2008-9#1)(2010-4#1)(2012-12#1)(2013-1#1)
terms that are##3##3##(1993-2#1)(1995-1#1)(2007-12#1)
terms that##9##2##(1993-2#1)(1995-1#1)(1995-3#1)(2006-7#1)(2007-12#1)(2007-9#1)(2008-2#2)(2011-2#1)
terms the##4##2##(1991-12#1)(1992-3#1)(2009-7#1)(2012-1#1)
terms to##8##2##(1996-2#1)(2007-4#1)(2008-2#1)(2008-7#2)(2008-9#1)(2010-4#1)(2010-5#1)
terms used in the##2##4##(1996-2#1)(2009-8#1)
terms used in##4##3##(1996-2#1)(2008-4#1)(2008-9#1)(2009-8#1)
terms used##7##2##(1996-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)
terms using##4##2##(2013-1#4)
terms were##4##2##(1990-3#1)(2010-5#1)(2012-11#1)(2013-1#1)
terms with##9##2##(1994-1#1)(1995-1#1)(1995-11#1)(1997-2#1)(2007-12#1)(2008-11#1)(2012-3#1)(2013-1#2)
terms within the##4##3##(2008-7#2)(2013-1#2)
terms within##6##2##(1995-11#1)(2008-7#3)(2013-1#2)
terms##1990##1##(1990-1#2)(1990-10#2)(1990-11#5)(1990-12#6)(1990-2#5)(1990-3#4)(1990-4#3)(1990-5#2)(1990-6#4)(1990-7#8)(1990-8#13)(1990-9#2)(1991-10#3)(1991-11#1)(1991-12#3)(1991-2#8)(1991-3#4)(1991-4#5)(1991-5#5)(1991-6#4)(1991-7#2)(1991-8#5)(1991-9#2)(1992-1#7)(1992-10#1)(1992-11#4)(1992-12#7)(1992-2#5)(1992-3#7)(1992-4#6)(1992-5#3)(1992-6#7)(1992-7#2)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#8)(1993-12#10)(1993-2#12)(1993-3#4)(1993-4#3)(1993-5#3)(1993-6#4)(1993-7#2)(1993-8#2)(1993-9#4)(1994-1#5)(1994-10#1)(1994-11#5)(1994-12#4)(1994-2#10)(1994-3#6)(1994-5#4)(1994-6#4)(1994-7#1)(1994-8#7)(1994-9#6)(1995-1#7)(1995-10#4)(1995-11#6)(1995-12#6)(1995-2#7)(1995-3#7)(1995-4#2)(1995-5#6)(1995-6#6)(1995-8#6)(1995-9#1)(1996-1#7)(1996-11#7)(1996-12#6)(1996-2#12)(1996-3#5)(1996-4#4)(1996-5#4)(1996-6#2)(1996-7#2)(1996-8#5)(1996-9#6)(1997-1#7)(1997-2#6)(1997-3#4)(1997-4#3)(1997-5#3)(1997-6#2)(1997-7#2)(1997-8#9)(2004-12#1)(2004-2#2)(2004-3#2)(2004-7#1)(2004-9#2)(2005-10#6)(2005-11#41)(2005-12#1)(2005-4#1)(2005-5#5)(2005-6#2)(2005-7#1)(2005-8#10)(2005-9#2)(2006-1#1)(2006-10#42)(2006-11#2)(2006-12#12)(2006-2#5)(2006-3#2)(2006-4#5)(2006-5#4)(2006-6#12)(2006-7#13)(2006-8#16)(2006-9#5)(2007-1#1)(2007-10#9)(2007-11#38)(2007-12#51)(2007-2#9)(2007-3#4)(2007-4#14)(2007-5#10)(2007-6#4)(2007-7#23)(2007-8#16)(2007-9#17)(2008-1#33)(2008-10#173)(2008-11#42)(2008-12#19)(2008-2#99)(2008-3#98)(2008-4#24)(2008-5#45)(2008-6#15)(2008-7#68)(2008-8#29)(2008-9#29)(2009-1#1)(2009-10#5)(2009-11#4)(2009-12#6)(2009-2#3)(2009-3#4)(2009-4#13)(2009-5#8)(2009-6#8)(2009-7#15)(2009-8#7)(2009-9#8)(2010-1#1)(2010-10#3)(2010-11#6)(2010-12#18)(2010-2#16)(2010-3#7)(2010-4#12)(2010-5#17)(2010-6#2)(2010-7#6)(2010-8#10)(2010-9#5)(2011-1#26)(2011-12#8)(2011-2#62)(2011-3#1)(2012-1#15)(2012-11#3)(2012-12#26)(2012-2#36)(2012-3#20)(2012-4#2)(2012-8#1)(2013-1#101)(2013-7#11)(2013-8#16)
terms)##2##1##(2007-12#1)(2009-7#1)
ternary SiO(2)##2##2##(2007-12#2)
ternary and##4##2##(2008-10#4)
ternary complex at##2##3##(1994-5#1)(1996-7#1)
ternary complex between##3##3##(1995-5#1)(2008-10#1)(2010-11#1)
ternary complex factors##2##3##(1994-11#1)(1994-6#1)
ternary complex formation##6##3##(1991-2#1)(1994-6#1)(1996-5#1)(2006-12#1)(2008-10#1)(2013-1#1)
ternary complex formed##3##3##(1993-6#1)(1994-5#1)(2008-10#1)
ternary complex in the##2##4##(1994-5#1)(2007-12#1)
ternary complex in which the##2##5##(1994-8#1)(1995-1#1)
ternary complex in##4##3##(1994-5#1)(1994-8#1)(1995-1#1)(2007-12#1)
ternary complex is##2##3##(1994-8#1)(2008-4#1)
ternary complex model##2##3##(2008-3#2)
ternary complex of##2##3##(1994-5#1)(2005-4#1)
ternary complex on##4##3##(2008-10#2)(2012-12#2)
ternary complex was##4##3##(1995-8#1)(1996-5#1)(2006-12#1)(2008-10#1)
ternary complex with##7##3##(1994-8#1)(1995-6#1)(2007-3#1)(2008-10#4)
ternary complex##72##2##(1990-7#1)(1991-2#4)(1992-9#3)(1993-3#1)(1993-6#3)(1993-8#1)(1994-11#1)(1994-5#6)(1994-6#2)(1994-8#4)(1994-9#2)(1995-1#2)(1995-10#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-5#2)(1996-7#1)(2005-11#3)(2005-4#1)(2006-10#2)(2006-12#2)(2007-12#2)(2007-3#1)(2008-10#15)(2008-3#2)(2008-4#1)(2008-5#1)(2010-11#1)(2012-12#2)(2013-1#1)
ternary complexes have been##2##4##(2008-10#1)(2008-5#1)
ternary complexes of Cu(II)##2##4##(2008-10#2)
ternary complexes of##9##3##(1995-11#1)(1997-1#1)(2005-4#1)(2008-10#6)
ternary complexes with##4##3##(1990-7#1)(2006-12#1)(2008-10#2)
ternary complexes##31##2##(1990-7#1)(1992-9#2)(1994-6#1)(1994-9#1)(1995-11#1)(1996-8#1)(1997-1#1)(2005-4#1)(2006-12#2)(2008-10#18)(2008-5#1)(2010-6#1)
ternary composites##2##2##(2009-11#2)
ternary inclusion complex##2##3##(2008-10#2)
ternary ion associate##2##3##(2008-10#2)
ternary ion##3##2##(2008-10#3)
ternary mixture of##5##3##(2008-10#5)
ternary mixture##7##2##(2008-10#7)
ternary mixtures and##2##3##(2004-2#1)(2008-10#1)
ternary mixtures of purified##2##4##(2008-6#2)
ternary mixtures of##10##3##(2008-10#8)(2008-6#2)
ternary mixtures##24##2##(2004-2#1)(2008-10#20)(2008-6#2)(2013-8#1)
ternary porogenic mixture##2##3##(2005-12#2)
ternary solutions##2##2##(2005-11#1)(2009-2#1)
ternary solvent##3##2##(2008-10#3)
ternary system##7##2##(1990-5#1)(1991-2#1)(2008-10#3)(2008-3#1)(2008-6#1)
ternary systems##3##2##(2008-10#1)(2008-6#2)
ternary##214##1##(1990-2#1)(1990-5#1)(1990-7#2)(1991-2#6)(1991-7#3)(1992-9#7)(1993-3#1)(1993-6#4)(1993-8#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#6)(1994-6#3)(1994-8#4)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#1)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#1)(1996-5#4)(1996-7#2)(1996-8#2)(1997-1#1)(1997-7#1)(2004-2#1)(2004-9#1)(2005-11#6)(2005-12#3)(2005-4#2)(2006-10#2)(2006-12#5)(2007-12#4)(2007-3#1)(2007-8#3)(2008-10#85)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#4)(2008-6#5)(2009-11#2)(2009-2#2)(2009-8#1)(2010-11#1)(2010-2#1)(2010-6#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
ternatea##2##1##(2006-12#2)
ternatin C5##3##2##(2006-12#3)
ternatins##4##1##(2006-12#4)
terotoma##3##1##(2012-12#3)
terpene concentration##2##2##(2011-10#2)
terpene content##2##2##(2011-10#2)
terpene emission rates##3##3##(2011-10#3)
terpene emission##4##2##(2011-10#4)
terpene trilactones##4##2##(2008-10#3)(2011-12#1)
terpene##20##1##(1991-2#1)(1995-3#1)(2008-10#3)(2008-11#1)(2008-6#1)(2009-8#1)(2011-10#11)(2011-12#1)
terpenes##11##1##(2008-10#5)(2008-11#1)(2008-5#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-1#1)
terpenoid compounds##2##2##(1994-8#1)(2008-10#1)
terpenoid synthesis##3##2##(2008-10#3)
terpenoid##14##1##(1990-11#1)(1994-8#4)(2007-1#1)(2008-10#7)(2012-2#1)
terpenoids and##3##2##(2006-12#1)(2007-11#1)(2010-12#1)
terpenoids in##3##2##(2008-10#1)(2010-12#1)(2013-8#1)
terpenoids##20##1##(1990-11#2)(2006-12#6)(2007-11#3)(2008-10#3)(2008-4#1)(2009-8#1)(2010-12#2)(2011-3#1)(2013-8#1)
terpolymers##4##1##(2008-5#1)(2008-9#1)(2013-1#2)
terra rossa##6##2##(2005-10#6)
terra-cotta##2##1##(2008-10#2)
terrace of##2##2##(2007-12#1)(2010-12#1)
terrace##4##1##(1991-6#2)(2007-12#1)(2010-12#1)
terraces##3##1##(1991-6#3)
terracotta##5##1##(2007-5#1)(2008-10#4)
terrain of##2##2##(2007-5#2)
terrain##25##1##(1992-1#1)(1996-2#1)(2005-8#1)(2006-4#1)(2007-12#2)(2007-5#3)(2007-9#1)(2008-2#9)(2008-3#1)(2008-7#2)(2009-10#1)(2011-1#1)(2012-1#1)
terrains and##2##2##(2007-12#1)(2008-2#1)
terrains##4##1##(2007-12#1)(2008-2#3)
terrestrial and aquatic##2##3##(2007-12#1)(2009-4#1)
terrestrial and##7##2##(1994-9#1)(1996-6#1)(2007-12#1)(2008-3#2)(2009-4#1)(2012-2#1)
terrestrial animals##4##2##(2007-1#3)(2008-9#1)
terrestrial ecosystems##4##2##(2006-5#2)(2008-6#1)(2012-2#1)
terrestrial environment##2##2##(2008-5#1)(2010-8#1)
terrestrial environments##3##2##(2007-12#1)(2010-10#1)(2012-12#1)
terrestrial impact structures##2##3##(1997-5#2)
terrestrial impact##4##2##(1997-5#4)
terrestrial invertebrate##2##2##(2004-11#1)(2009-4#1)
terrestrial invertebrates##2##2##(2008-11#1)(2009-4#1)
terrestrial mammals##4##2##(1996-7#1)(2004-4#3)
terrestrial mollusc##2##2##(1990-5#2)
terrestrial origin##2##2##(2008-10#1)(2011-2#1)
terrestrial planets##2##2##(1995-6#1)(1997-5#1)
terrestrial plant##2##2##(2008-10#1)(2008-12#1)
terrestrial plants##3##2##(1991-9#1)(2008-10#1)(2008-7#1)
terrestrial slug##2##2##(2008-6#1)(2008-7#1)
terrestrial species##3##2##(2007-12#1)(2008-7#1)(2013-7#1)
terrestrial vegetation##2##2##(1995-8#1)(2008-5#1)
terrestrial##107##1##(1990-5#2)(1990-7#1)(1991-11#1)(1991-6#2)(1991-9#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-5#7)(2004-11#1)(2004-4#5)(2005-11#1)(2006-4#1)(2006-5#3)(2007-1#3)(2007-12#6)(2007-2#1)(2007-3#1)(2007-5#1)(2007-9#3)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#9)(2008-6#2)(2008-7#6)(2008-8#7)(2008-9#2)(2009-10#1)(2009-4#3)(2010-10#2)(2010-5#2)(2010-6#2)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#2)(2013-7#1)
terrestris##6##1##(1996-10#2)(2007-1#1)(2008-5#1)(2011-3#2)
terreus##8##1##(2007-3#1)(2008-3#1)(2008-5#4)(2009-3#1)(2012-2#1)
terrible##4##1##(2006-3#1)(2007-2#1)(2008-11#1)(2009-2#1)
terrified##2##1##(2008-11#1)(2009-10#1)
terrifying##2##1##(2008-10#1)(2010-9#1)
terrigenous##2##1##(2007-5#1)(2008-5#1)
territorial animals##2##2##(2008-8#2)
territorial inheritance##2##2##(2008-8#2)
territorial##19##1##(1992-12#1)(1994-12#1)(1996-8#1)(1997-7#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#8)(2008-9#1)(2011-1#1)(2012-12#1)
territoriality##2##1##(2008-8#1)(2008-9#1)
territories and rCBV in the striatum were##2##7##(2006-11#2)
territories and##10##2##(2006-11#2)(2008-11#1)(2008-8#2)(2008-9#1)(2009-8#2)(2011-1#2)
territories as##2##2##(2007-9#1)(2008-8#1)
territories in##4##2##(2007-10#3)(2008-9#1)
territories of the##3##3##(2008-3#1)(2012-2#2)
territories of##5##2##(1993-9#1)(2008-3#1)(2011-2#1)(2012-2#2)
territories##51##1##(1991-3#1)(1993-9#1)(1995-8#2)(1996-7#1)(1997-1#1)(2005-12#1)(2006-10#1)(2006-11#4)(2006-9#1)(2007-10#3)(2007-9#3)(2008-1#5)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#5)(2008-9#4)(2009-8#3)(2010-11#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-2#2)
territory and##8##2##(1991-12#1)(1993-3#1)(2006-5#1)(2007-9#1)(2008-12#1)(2008-8#1)(2009-2#1)(2013-8#1)
territory as##2##2##(2008-8#1)(2013-8#1)
territory by##3##2##(1991-12#1)(2008-12#1)(2008-7#1)
territory for##3##2##(1994-2#1)(2007-4#1)(2013-7#1)
territory in##3##2##(2008-5#1)(2009-10#1)(2012-3#1)
territory infarction##3##2##(2007-10#1)(2007-9#2)
territory of a##3##3##(2007-10#1)(2008-4#1)(2008-7#1)
territory of the##7##3##(1992-2#1)(1992-7#1)(1993-2#1)(1995-12#1)(1996-3#1)(2007-9#1)(2008-7#1)
territory of##17##2##(1990-7#1)(1992-2#1)(1992-7#1)(1993-2#1)(1995-12#1)(1996-3#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2011-2#1)(2013-8#2)
territory owners##3##2##(2008-8#1)(2008-9#1)(2010-8#1)
territory quality##2##2##(2008-9#1)(2009-10#1)
territory was##4##2##(2007-9#4)
territory##119##1##(1990-7#1)(1991-11#1)(1991-12#2)(1992-2#1)(1992-7#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-5#1)(1995-12#1)(1996-1#2)(1996-2#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-2#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-10#8)(2007-12#1)(2007-2#3)(2007-4#1)(2007-8#4)(2007-9#14)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#3)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#11)(2008-9#6)(2009-10#2)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-8#3)(2011-1#1)(2011-2#5)(2012-12#1)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#6)
territrem B##2##2##(2006-12#2)
terror attacks##2##2##(2009-7#2)
terror##16##1##(1990-6#1)(1990-8#1)(2006-10#1)(2008-1#1)(2009-10#4)(2009-2#2)(2009-3#1)(2009-7#5)
terrorism and##2##2##(2007-2#1)(2008-4#1)
terrorism preparedness##4##2##(2008-2#2)(2008-9#2)
terrorism##20##1##(2006-7#2)(2007-2#1)(2007-3#1)(2007-9#3)(2008-2#2)(2008-4#4)(2008-7#2)(2008-8#2)(2008-9#2)(2013-7#1)
terrorism-preparedness training##3##2##(2008-9#3)
terrorist attack##4##2##(2007-12#2)(2007-3#1)(2008-8#1)
terrorist attacks and##2##3##(2008-9#1)(2013-7#1)
terrorist attacks in the United States##2##6##(2007-12#1)(2008-9#1)
terrorist attacks##10##2##(2007-12#5)(2008-9#2)(2009-4#1)(2011-1#1)(2013-7#1)
terrorist event##3##2##(2008-12#1)(2008-7#1)(2008-9#1)
terrorist threat##3##2##(1996-12#2)(2004-7#1)
terrorist##27##1##(1996-12#2)(2004-7#2)(2005-9#1)(2007-12#8)(2007-2#1)(2007-3#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-4#1)(2011-1#1)(2013-7#1)
terrorists##3##1##(2006-7#1)(2008-11#1)(2008-8#1)
terrylene##2##1##(2007-12#2)
tert##3##1##(1996-5#1)(1996-8#1)(1997-8#1)
tert-amino##3##1##(2007-11#3)
tert-butanol##3##1##(1997-8#1)(2008-10#1)(2013-1#1)
tert-butyl acrylate##3##2##(2008-12#2)(2010-2#1)
tert-butyl alcohol##3##2##(2007-11#2)(2008-10#1)
tert-butyl hydroperoxide##3##2##(1990-4#1)(1995-11#1)(1995-5#1)
tert-butyl##29##1##(1990-4#1)(1992-11#2)(1995-11#1)(1995-5#1)(1996-5#1)(1996-8#1)(1997-2#1)(2004-7#1)(2006-12#2)(2007-11#4)(2008-10#1)(2008-12#4)(2008-5#2)(2009-8#2)(2010-2#1)(2011-1#2)(2011-2#1)(2012-12#1)
tert-butyldimethylsilyl (TBDMS) derivatives##2##3##(1996-6#1)(2009-10#1)
tert-butyldimethylsilyl##5##1##(1996-6#2)(1997-2#1)(2009-10#2)
tert-butylhydroquinone (TBHQ)##2##2##(2008-10#2)
tert-butylhydroquinone##3##1##(2008-10#3)
tertiary Bohr effect##2##3##(1994-8#2)
tertiary Bohr effect&quot##2##3##(1994-8#2)
tertiary Bohr##4##2##(1994-8#4)
tertiary alcohol##3##2##(2008-10#3)
tertiary alkyl halides##2##3##(2011-1#2)
tertiary alkyl##5##2##(2007-11#1)(2009-10#1)(2011-1#3)
tertiary amines##7##2##(1991-9#2)(2008-10#2)(2010-6#1)(2010-8#2)
tertiary and secondary##2##3##(1992-8#1)(1996-11#1)
tertiary and##5##2##(1992-8#2)(1996-11#1)(1997-2#2)
tertiary care center##11##3##(2006-7#1)(2007-10#2)(2007-3#1)(2007-7#2)(2010-4#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
tertiary care centre##8##3##(2009-4#1)(2010-5#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
tertiary care centres##2##3##(1994-2#1)(2007-12#1)
tertiary care facility##2##3##(1995-3#1)(2011-12#1)
tertiary care hospital in##21##4##(2007-2#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-7#1)(2009-4#1)(2009-7#1)(2011-2#2)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#4)
tertiary care hospital of##5##4##(2007-7#3)(2008-7#1)(2013-8#1)
tertiary care hospital##55##3##(1997-3#1)(2006-10#1)(2007-2#2)(2007-3#1)(2007-7#8)(2007-8#2)(2008-11#2)(2008-3#1)(2008-7#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#2)(2010-4#1)(2010-8#1)(2011-12#2)(2011-2#3)(2012-1#2)(2012-2#6)(2012-3#3)(2013-1#4)(2013-8#8)
tertiary care hospitals##2##3##(1994-2#1)(2012-2#1)
tertiary care paediatric##2##3##(2008-11#2)
tertiary care referral##2##3##(2012-2#2)
tertiary care##105##2##(1994-2#2)(1995-1#1)(1995-3#1)(1997-3#1)(2004-10#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-10#2)(2007-12#2)(2007-2#2)(2007-3#2)(2007-7#11)(2007-8#2)(2008-1#1)(2008-11#4)(2008-3#1)(2008-6#1)(2008-7#4)(2009-4#3)(2009-5#1)(2009-7#1)(2010-11#2)(2010-4#2)(2010-5#2)(2010-8#1)(2011-12#3)(2011-2#7)(2012-1#2)(2012-12#1)(2012-2#12)(2012-3#6)(2013-1#6)(2013-8#13)
tertiary center##6##2##(2008-3#1)(2012-12#1)(2012-2#2)(2013-1#2)
tertiary chloride##2##2##(1997-2#2)
tertiary conformational##2##2##(1990-8#1)(1992-8#1)
tertiary education##2##2##(2013-1#1)(2013-7#1)
tertiary health##5##2##(2005-10#1)(2007-3#1)(2009-7#1)(2011-11#1)(2012-2#1)
tertiary hospital##8##2##(1995-9#1)(2006-4#1)(2007-6#1)(2008-4#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
tertiary hospitals in##2##3##(2007-11#1)(2007-3#1)
tertiary hospitals##5##2##(1993-2#1)(2007-11#1)(2007-3#1)(2008-3#1)(2011-2#1)
tertiary hyperparathyroidism##3##2##(2009-4#1)(2012-12#2)
tertiary institutions##3##2##(2007-7#3)
tertiary interaction##3##2##(1993-1#1)(1997-2#2)
tertiary interactions##6##2##(1991-11#1)(1993-11#1)(1997-2#3)(2008-7#1)
tertiary level of##2##3##(2011-2#1)(2012-2#1)
tertiary level##4##2##(2011-2#1)(2012-2#1)(2013-1#2)
tertiary medical center##2##3##(2007-2#1)(2011-2#1)
tertiary medical##5##2##(2005-12#1)(2007-2#1)(2011-2#2)(2012-1#1)
tertiary or quaternary structure##2##4##(2008-4#2)
tertiary or##3##2##(2008-4#3)
tertiary paediatric##3##2##(2008-11#1)(2012-2#1)(2013-7#1)
tertiary phosphine##4##2##(2008-5#3)(2010-5#1)
tertiary rainbow of##2##3##(2008-2#2)
tertiary referral center##4##3##(2011-1#1)(2011-12#1)(2011-2#2)
tertiary referral centers##3##3##(2007-8#1)(2011-2#2)
tertiary referral##15##2##(2005-12#1)(2007-8#1)(2008-1#1)(2008-9#1)(2011-1#3)(2011-12#3)(2011-2#4)(2013-1#1)
tertiary screening##2##2##(1993-11#1)(2008-10#1)
tertiary structural changes##2##3##(1990-7#1)(1997-4#1)
tertiary structural##5##2##(1990-7#1)(1994-5#2)(1995-5#1)(1997-4#1)
tertiary structure and##5##3##(1992-12#1)(1992-8#1)(2006-12#1)(2008-4#2)
tertiary structure as compared to the##2##6##(1995-5#1)(2008-6#1)
tertiary structure as##4##3##(1991-5#1)(1995-5#1)(2008-6#1)(2008-9#1)
tertiary structure changes##3##3##(1991-5#1)(1997-4#1)(2005-4#1)
tertiary structure in##2##3##(1990-7#1)(1994-10#1)
tertiary structure is##5##3##(1991-5#1)(1992-4#1)(1997-4#1)(2008-4#2)
tertiary structure of a##2##4##(1995-1#1)(2006-12#1)
tertiary structure of protein##2##4##(2005-11#1)(2012-2#1)
tertiary structure of the Ca-ATPase##3##5##(1991-2#3)
tertiary structure of the protein##2##5##(2005-11#1)(2008-9#1)
tertiary structure of the proteins##2##5##(1997-4#1)(2008-10#1)
tertiary structure of the##16##4##(1990-12#1)(1990-5#1)(1991-1#1)(1991-2#3)(1991-5#1)(1994-3#1)(1994-8#1)(1995-1#1)(1996-5#1)(1996-7#1)(1997-4#1)(2005-11#1)(2008-10#1)(2008-9#1)
tertiary structure of##25##3##(1990-12#1)(1990-5#1)(1991-1#1)(1991-2#3)(1991-5#1)(1992-12#1)(1992-6#1)(1994-3#1)(1994-8#2)(1995-1#2)(1996-5#1)(1996-7#1)(1997-4#1)(2005-11#2)(2006-12#2)(2008-10#2)(2008-9#1)(2012-2#1)
tertiary structure prediction##2##3##(2010-7#2)
tertiary structure##83##2##(1990-12#1)(1990-5#3)(1990-7#1)(1991-1#1)(1991-2#3)(1991-4#1)(1991-5#5)(1992-12#2)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#3)(1993-6#1)(1993-8#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-8#3)(1995-1#2)(1995-2#1)(1995-3#4)(1995-4#1)(1995-5#2)(1995-8#1)(1996-5#1)(1996-7#1)(1997-4#5)(1997-6#1)(2005-11#2)(2005-4#1)(2006-10#2)(2006-12#3)(2008-10#2)(2008-11#1)(2008-4#12)(2008-6#1)(2008-7#1)(2008-9#3)(2010-7#3)(2012-2#1)
tertiary structures##7##2##(1990-7#1)(1992-1#1)(1992-9#1)(1995-11#1)(1996-6#1)(2005-11#1)(2007-11#1)
tertiary##370##1##(1990-11#1)(1990-12#1)(1990-5#3)(1990-6#1)(1990-7#4)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#3)(1991-4#2)(1991-5#6)(1991-7#1)(1991-9#2)(1992-1#1)(1992-12#2)(1992-4#1)(1992-6#2)(1992-8#4)(1992-9#4)(1993-1#1)(1993-11#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-2#3)(1994-3#2)(1994-5#2)(1994-8#9)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#5)(1995-4#3)(1995-5#3)(1995-8#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#9)(1997-3#1)(1997-4#6)(1997-6#1)(2004-10#1)(2005-10#1)(2005-11#3)(2005-12#2)(2005-4#1)(2005-8#3)(2006-10#4)(2006-11#1)(2006-12#4)(2006-2#1)(2006-4#2)(2006-7#1)(2007-10#2)(2007-11#5)(2007-12#5)(2007-2#4)(2007-3#4)(2007-6#3)(2007-7#14)(2007-8#4)(2008-1#2)(2008-10#16)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#20)(2008-5#4)(2008-6#3)(2008-7#8)(2008-9#4)(2009-10#1)(2009-4#5)(2009-5#1)(2009-6#1)(2009-7#2)(2010-11#2)(2010-12#1)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#4)(2010-8#3)(2011-1#8)(2011-11#1)(2011-12#6)(2011-2#16)(2012-1#3)(2012-12#4)(2012-2#23)(2012-3#8)(2013-1#16)(2013-7#2)(2013-8#14)
tertiary-care##4##1##(2007-7#1)(2008-3#1)(2009-10#1)(2013-1#1)
tertile##9##1##(1991-5#5)(2008-3#3)(2009-2#1)
tertiles of##4##2##(1991-5#1)(2008-3#2)(2008-7#1)
tertiles##12##1##(1991-5#1)(2008-3#7)(2008-7#1)(2011-1#1)(2011-2#2)
tessellation##3##1##(2008-2#3)
tessulatum##5##1##(1996-12#3)(1996-5#2)
test (BAT)##2##2##(2012-2#1)(2012-3#1)
test (DAT)##5##2##(1993-6#1)(1993-9#1)(1994-12#1)(1996-12#1)(2012-2#1)
test (LNT)##2##2##(2008-9#2)
test (P &lt##2##3##(2009-8#1)(2012-3#1)
test (i##2##2##(1990-7#1)(1996-2#1)
test (p##2##2##(1991-2#1)(2011-1#1)
test (p&lt##3##2##(2008-12#2)(2010-2#1)
test (r = 0##3##4##(2007-2#2)(2012-3#1)
test (r =##4##3##(2005-8#1)(2007-2#2)(2012-3#1)
test (α=0##4##2##(2013-1#3)(2013-8#1)
test -##2##2##(2008-5#2)
test 2##2##2##(1994-3#1)(2005-11#1)
test a hypothesis##3##3##(2008-10#2)(2013-1#1)
test a new##5##3##(1996-6#1)(2006-10#1)(2008-3#1)(2010-2#1)(2010-6#1)
test a##23##2##(1991-12#1)(1993-12#1)(1994-11#1)(1994-7#1)(1996-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
test according to##2##3##(2007-7#1)(2011-2#1)
test accuracy##2##2##(2008-2#1)(2013-8#1)
test after##3##2##(1994-2#2)(2008-10#1)
test against##2##2##(2006-2#1)(2012-2#1)
test agent##3##2##(1993-9#1)(1997-4#1)(2008-10#1)
test agents##4##2##(2006-8#1)(2008-10#1)(2008-5#1)(2010-3#1)
test ages##2##2##(1992-7#1)(2012-2#1)
test allows##2##2##(1994-7#1)(2008-10#1)
test alone##3##2##(1995-8#1)(2007-2#1)(2008-7#1)
test also##6##2##(1995-1#1)(2005-11#1)(2006-3#1)(2008-3#1)(2008-5#1)(2011-2#1)
test among##5##2##(2007-10#1)(2009-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
test an##10##2##(1993-9#1)(1997-2#1)(1997-3#1)(2008-3#1)(2008-6#1)(2009-3#1)(2010-4#1)(2011-2#1)(2013-1#2)
test analyte##4##2##(2008-10#4)
test and 3##2##3##(2005-8#1)(2008-4#1)
test and ANOVA##2##3##(2008-6#1)(2013-8#1)
test and Fisher's exact test##2##5##(2011-1#1)(2013-8#1)
test and Fisher's exact##3##4##(2011-1#1)(2011-2#1)(2013-8#1)
test and Mann-Whitney U test##2##5##(2008-7#1)(2012-2#1)
test and Mann-Whitney##3##3##(2008-7#1)(2012-2#1)(2013-1#1)
test and a##13##3##(1991-1#1)(1996-12#1)(1996-3#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2012-2#1)
test and also##2##3##(2008-10#1)(2012-12#1)
test and antibody##2##3##(1992-6#1)(2009-4#1)
test and compared##2##3##(2006-8#1)(2012-2#1)
test and confirmed##2##3##(2007-7#1)(2010-8#1)
test and control groups##2##4##(2007-7#1)(2008-4#1)
test and control sites##2##4##(2011-2#2)
test and control##5##3##(2007-1#1)(2007-7#1)(2008-4#1)(2011-2#2)
test and could##2##3##(2006-5#1)(2011-2#1)
test and its##4##3##(1993-1#1)(2007-11#1)(2008-5#1)(2013-1#1)
test and no##2##3##(1992-4#1)(1993-5#1)
test and positive##3##3##(2007-3#1)(2008-7#2)
test and serology##2##3##(2006-2#1)(2008-5#1)
test and the##25##3##(1990-11#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-12#1)(1997-2#1)(1997-3#1)(2006-12#3)(2006-2#2)(2008-1#1)(2008-10#1)(2008-3#3)(2008-5#1)(2010-1#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
test and therefore##2##3##(2009-3#1)(2012-1#1)
test and this##2##3##(2007-11#1)(2013-1#1)
test and to##2##3##(2007-7#1)(2012-12#1)
test and two##2##3##(1997-1#1)(2008-5#1)
test and were##3##3##(1993-12#1)(2008-11#1)(2013-1#1)
test and with##2##3##(1996-5#1)(2008-3#1)
test and##209##2##(1990-11#1)(1990-3#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-4#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-4#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-1#1)(1996-1#1)(1996-12#4)(1996-3#1)(1996-5#1)(1996-9#2)(1997-1#3)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-11#2)(2006-12#3)(2006-2#3)(2006-5#2)(2006-6#1)(2006-8#2)(2007-1#3)(2007-11#6)(2007-12#2)(2007-2#2)(2007-3#2)(2007-4#1)(2007-7#9)(2007-8#3)(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#11)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-1#2)(2010-12#1)(2010-2#4)(2010-7#1)(2010-8#4)(2011-1#8)(2011-2#9)(2012-1#4)(2012-12#5)(2012-2#5)(2012-3#1)(2013-1#14)(2013-7#1)(2013-8#5)
test animals and##2##3##(2005-8#1)(2008-9#1)
test animals##10##2##(2005-8#1)(2007-1#2)(2007-8#2)(2008-9#1)(2010-2#2)(2012-3#1)(2013-7#1)
test anxiety may##2##3##(2012-1#2)
test anxiety##3##2##(2012-1#3)
test apparatus##4##2##(1990-10#1)(2007-4#1)(2008-12#1)(2008-4#1)
test applied to##2##3##(1997-8#1)(2012-3#1)
test applied##3##2##(1997-8#1)(2007-7#1)(2012-3#1)
test are not##2##3##(2008-1#1)(2012-3#1)
test are##12##2##(1992-6#1)(1995-11#1)(1995-2#1)(1995-8#1)(2007-12#1)(2007-3#1)(2008-1#2)(2008-2#1)(2008-6#1)(2012-3#1)(2013-1#1)
test as a##6##3##(1992-2#1)(1994-2#1)(2008-7#1)(2008-8#1)(2013-1#1)(2013-7#1)
test as an##3##3##(1990-2#1)(1997-3#1)(2007-7#1)
test as well as the##2##5##(2007-11#1)(2012-2#1)
test as well as##3##4##(2007-11#1)(2008-11#1)(2012-2#1)
test as##21##2##(1990-2#1)(1992-2#1)(1994-2#1)(1994-6#1)(1997-3#1)(1997-4#1)(2005-11#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-6#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
test at 2##2##3##(2006-2#1)(2013-1#1)
test at a##3##3##(2006-10#1)(2008-12#1)(2012-2#1)
test at the##2##3##(2007-4#1)(2007-7#1)
test at##13##2##(1990-6#1)(1993-5#1)(1995-1#1)(2006-10#1)(2006-2#1)(2007-4#1)(2007-7#1)(2008-12#1)(2011-1#2)(2012-2#1)(2013-1#2)
test based on a##2##4##(1996-8#1)(2012-1#1)
test based on the##5##4##(1991-8#1)(2008-2#1)(2008-3#1)(2012-3#1)(2013-1#1)
test based on##15##3##(1990-12#1)(1991-8#1)(1994-7#1)(1996-8#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-3#1)(2012-1#2)(2012-3#1)(2013-1#1)
test based##16##2##(1990-12#1)(1991-8#1)(1993-5#1)(1994-7#1)(1996-8#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-3#1)(2012-1#2)(2012-3#1)(2013-1#1)
test batteries##4##2##(1996-12#1)(2013-7#3)
test battery##6##2##(2008-4#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
test because##3##2##(1996-5#1)(1997-1#1)(2008-9#1)
test bed for##4##3##(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)
test bed##5##2##(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#1)
test being##2##2##(2007-12#1)(2008-10#1)
test between##6##2##(2006-3#1)(2008-11#2)(2011-1#1)(2013-1#1)(2013-8#1)
test box##2##2##(1993-3#1)(1993-6#1)
test but##5##2##(1990-12#1)(1994-9#1)(2007-7#1)(2007-8#1)(2013-1#1)
test by using##5##3##(2008-10#1)(2008-2#1)(2010-2#1)(2013-8#2)
test by##11##2##(1990-5#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-2#1)(2011-1#1)(2013-8#2)
test can be performed##2##4##(1996-11#1)(2012-2#1)
test can be used##2##4##(1995-4#1)(2007-7#1)
test can be##11##3##(1995-4#1)(1996-11#1)(1996-12#2)(2006-5#1)(2007-7#1)(2008-11#1)(2008-7#1)(2012-1#2)(2012-2#1)
test can detect##2##3##(1995-4#1)(2012-3#1)
test can##19##2##(1992-3#1)(1995-4#2)(1996-11#1)(1996-12#2)(2006-5#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#3)
test cannot be##3##3##(1991-12#1)(2008-3#1)(2008-5#1)
test carried out##4##3##(1990-2#1)(1997-1#1)(2008-6#1)(2009-6#1)
test case of a##2##4##(2008-3#2)
test case##13##2##(1991-1#1)(1992-3#1)(1994-9#1)(1996-9#1)(2006-5#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-3#3)(2009-5#1)(2010-2#1)
test cases##8##2##(1990-10#1)(1995-6#1)(2006-10#2)(2008-2#2)(2008-3#1)(2009-10#1)
test changes##2##2##(2008-3#1)(2008-4#1)
test characteristics##3##2##(2012-12#2)(2013-1#1)
test chemical##2##2##(1993-2#1)(1997-2#1)
test circuit##2##2##(2008-2#2)
test compared with##2##3##(1995-12#1)(2007-11#1)
test compound##5##2##(2004-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)
test compounds##8##2##(1995-6#1)(1996-5#1)(2006-12#1)(2008-11#1)(2008-4#2)(2008-5#1)(2011-1#1)
test condition is##2##3##(2006-11#1)(2007-1#1)
test condition##4##2##(2006-11#3)(2007-1#1)
test conditions are recommended##2##4##(2007-1#1)(2008-10#1)
test conditions##22##2##(1993-9#1)(2006-11#3)(2006-12#4)(2007-1#4)(2007-4#4)(2007-7#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-9#1)
test conducted at##2##3##(2006-11#1)(2008-11#1)
test conducted##3##2##(2006-11#1)(2006-8#1)(2008-11#1)
test confirmed##3##2##(2007-8#1)(2008-12#1)(2008-5#1)
test consisted of##2##3##(1992-3#1)(2009-8#1)
test conversion##4##2##(2007-2#4)
test could be##5##3##(1997-4#1)(2006-12#1)(2007-8#1)(2008-10#1)(2012-3#1)
test could##6##2##(1997-4#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2012-3#1)
test data set##4##3##(2008-10#2)(2008-3#1)(2010-7#1)
test data##17##2##(1992-11#1)(2005-11#1)(2006-11#4)(2007-4#1)(2008-10#4)(2008-2#1)(2008-3#2)(2009-10#1)(2010-2#1)(2010-7#1)
test demonstrated##3##2##(2007-11#1)(2007-7#1)(2013-1#1)
test detected##3##2##(2009-2#1)(2011-1#2)
test detection##2##2##(1992-1#1)(2008-10#1)
test detects##2##2##(2008-10#1)(2008-4#1)
test development##2##2##(2008-10#1)(2013-7#1)
test device##4##2##(2006-11#1)(2007-4#2)(2012-2#1)
test devices##6##2##(2006-11#4)(2007-1#1)(2007-4#1)
test did not reveal any##2##5##(2011-1#1)(2013-1#1)
test did not##6##3##(1994-8#1)(2008-5#1)(2009-6#1)(2010-6#1)(2011-1#1)(2013-1#1)
test did##8##2##(1990-6#1)(1994-8#1)(2007-2#1)(2008-5#1)(2009-6#1)(2010-6#1)(2011-1#1)(2013-1#1)
test directly##3##2##(1994-2#1)(2005-7#1)(2006-8#1)
test dose##3##2##(1992-2#1)(2007-9#1)(2008-7#1)
test drug##3##2##(1996-10#1)(1996-5#1)(2008-5#1)
test dummies##3##2##(2006-11#1)(2007-4#2)
test dummy##5##2##(2006-11#2)(2007-4#2)(2012-12#1)
test during##6##2##(2007-2#1)(2008-4#1)(2010-12#1)(2011-1#1)(2013-1#2)
test emulsions##5##2##(2008-5#5)
test established##2##2##(1996-6#1)(2008-5#1)
test evaluation##3##2##(1996-1#1)(1997-8#1)(2012-2#1)
test evaluations##2##2##(1996-8#1)(2008-1#1)
test facility##2##2##(2008-2#1)(2008-5#1)
test field##2##2##(1997-5#1)(2007-5#1)
test following##3##2##(1993-3#1)(1995-12#1)(2013-8#1)
test food##2##2##(2013-8#2)
test for H##2##3##(2006-10#1)(2008-5#1)
test for a##4##3##(1993-1#1)(1995-9#1)(1997-2#1)(2008-4#1)
test for amines##3##3##(2006-10#3)
test for assessing the##2##4##(1990-4#1)(2010-8#1)
test for assessing##3##3##(1990-4#1)(1993-9#1)(2010-8#1)
test for association##2##3##(1996-1#1)(2009-4#1)
test for cervical##2##3##(2006-10#1)(2011-2#1)
test for detection of##3##4##(2007-12#1)(2007-7#1)(2007-8#1)
test for diagnosing##6##3##(1990-11#1)(2006-10#1)(2007-3#1)(2008-10#1)(2009-2#1)(2010-8#1)
test for diagnosis##2##3##(2007-8#1)(2009-5#1)
test for evaluating the##2##4##(1996-5#1)(2010-12#1)
test for evaluating##4##3##(1991-2#1)(1996-5#1)(2008-1#1)(2010-12#1)
test for genetic##2##3##(2008-4#1)(2012-3#1)
test for non-inferiority of the linear##2##6##(2010-2#2)
test for occult##2##3##(1991-6#1)(1995-9#1)
test for paired##2##3##(1990-6#1)(1992-6#1)
test for patients with##2##4##(2007-9#1)(2013-1#1)
test for patients##3##3##(1997-4#1)(2007-9#1)(2013-1#1)
test for rapid##2##3##(1991-12#1)(2012-2#1)
test for significant##2##3##(1994-2#1)(2008-11#1)
test for spatial##4##3##(1994-3#1)(1994-5#1)(1995-6#1)(2012-3#1)
test for the detection of##8##5##(1994-6#1)(1997-6#1)(2005-12#1)(2006-10#1)(2007-7#1)(2008-5#3)
test for the determination of##2##5##(2008-11#1)(2011-1#1)
test for the diagnosis of infectious coryza##2##7##(2008-5#2)
test for the diagnosis of##6##5##(2006-10#2)(2007-11#1)(2008-5#2)(2011-2#1)
test for the evaluation##2##4##(1994-10#1)(2013-1#1)
test for the presence of##3##5##(1993-7#1)(1994-6#1)(2008-4#1)
test for the role of natural selection in the stabilization of transposable element copy number in a population of Drosophila##2##20##(2008-11#2)
test for the role of##3##5##(1995-2#1)(2008-11#2)
test for the##48##3##(1990-11#1)(1991-10#1)(1991-12#1)(1993-7#1)(1994-10#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-2#1)(1996-3#1)(1997-6#1)(2005-10#1)(2005-12#1)(2006-10#4)(2006-5#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#7)(2010-8#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
test for trend##2##3##(1995-2#1)(1997-8#1)
test for##285##2##(1990-11#2)(1990-3#2)(1990-4#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-6#1)(1992-10#1)(1992-11#2)(1992-2#2)(1992-5#1)(1992-6#3)(1992-7#2)(1993-1#2)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#3)(1994-3#1)(1994-5#4)(1994-6#2)(1994-8#1)(1995-1#4)(1995-11#2)(1995-2#3)(1995-3#2)(1995-4#2)(1995-6#1)(1995-7#1)(1995-9#2)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#2)(1997-8#2)(2004-12#1)(2005-1#1)(2005-10#2)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#15)(2006-2#2)(2006-5#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-11#1)(2007-12#3)(2007-2#4)(2007-3#2)(2007-4#1)(2007-7#7)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#13)(2008-11#8)(2008-12#2)(2008-2#7)(2008-3#3)(2008-4#16)(2008-5#14)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#5)(2009-2#1)(2009-4#3)(2009-5#1)(2009-8#1)(2009-9#2)(2010-12#5)(2010-2#3)(2010-8#4)(2011-1#6)(2011-12#1)(2011-2#10)(2012-1#2)(2012-12#1)(2012-2#6)(2012-3#9)(2013-1#7)(2013-8#5)
test from##4##2##(1997-3#1)(2006-8#1)(2008-9#1)(2012-12#1)
test gas##3##2##(2008-10#1)(2008-2#2)
test grating##2##2##(2007-11#1)(2008-3#1)
test group##6##2##(1994-8#1)(2006-2#1)(2007-7#2)(2008-12#2)
test groups##12##2##(1995-8#2)(2008-10#1)(2008-12#1)(2008-4#3)(2009-5#1)(2010-5#1)(2010-7#1)(2012-2#1)(2013-1#1)
test had a sensitivity of##2##5##(1997-8#1)(2006-2#1)
test had a##3##3##(1997-8#1)(2006-2#1)(2013-1#1)
test had##8##2##(1991-3#1)(1991-4#1)(1997-8#1)(2006-2#1)(2011-2#2)(2013-1#1)(2013-7#1)
test has been performed##2##4##(1997-4#1)(2008-2#1)
test has been##4##3##(1997-4#1)(2008-11#1)(2008-2#1)(2012-1#1)
test has proved to be a##2##6##(2008-4#1)(2011-1#1)
test has##15##2##(1997-4#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-8#2)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#2)
test have been used##2##4##(2006-10#1)(2008-10#1)
test have##4##2##(1997-3#1)(2006-10#1)(2007-6#1)(2008-10#1)
test hypotheses about##5##3##(1994-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-3#1)
test hypotheses##8##2##(1993-12#1)(1994-6#1)(2008-10#2)(2008-11#2)(2008-8#1)(2012-3#1)
test if##16##2##(1991-11#1)(1992-5#1)(1993-11#1)(1994-12#1)(1996-10#1)(2004-2#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-1#1)(2012-3#2)
test image##2##2##(2007-12#1)(2008-2#1)
test images##6##2##(2008-2#4)(2009-11#2)
test in a##5##3##(1992-2#1)(1997-2#1)(2007-12#1)(2008-9#1)(2009-5#1)
test in case##2##3##(1996-8#1)(2008-10#1)
test in children with##3##4##(2010-12#1)(2012-12#2)
test in children##4##3##(2008-9#1)(2010-12#1)(2012-12#2)
test in end-stage renal disease patients is##2##7##(2008-7#2)
test in its##2##3##(1991-3#1)(2008-2#1)
test in mice##10##3##(1991-12#1)(1991-2#1)(1991-5#1)(1995-2#1)(1996-12#1)(1997-2#1)(2007-10#1)(2012-12#2)(2013-7#1)
test in patients with##6##4##(1991-3#1)(2007-3#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
test in rats##5##3##(1992-11#1)(1995-12#1)(2009-6#3)
test in the assessment of##2##5##(2008-4#1)(2008-6#1)
test in the diagnosis of##5##5##(1994-3#1)(1996-12#1)(2007-7#2)(2008-4#1)
test in the diagnosis##6##4##(1994-3#1)(1996-12#1)(2007-7#2)(2008-12#1)(2008-4#1)
test in the##25##3##(1990-11#1)(1990-3#1)(1993-8#1)(1994-3#1)(1996-12#1)(1997-2#1)(2006-10#1)(2006-6#1)(2007-2#1)(2007-7#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-2#2)(2012-7#1)(2013-8#1)
test in which##3##3##(1990-7#1)(1996-2#1)(2012-3#1)
test in##121##2##(1990-10#1)(1990-11#1)(1990-3#2)(1990-7#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#5)(1991-5#1)(1992-10#1)(1992-11#2)(1992-2#2)(1992-9#1)(1993-8#1)(1994-11#1)(1994-3#2)(1995-12#1)(1995-2#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#3)(1997-3#1)(1997-5#1)(1997-8#1)(2005-12#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#3)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#4)(2010-1#1)(2010-11#1)(2010-12#2)(2011-1#2)(2011-2#4)(2012-12#4)(2012-2#2)(2012-3#2)(2012-7#1)(2013-1#7)(2013-7#2)(2013-8#1)
test includes##2##2##(2010-12#1)(2011-2#1)
test indicated that##2##3##(2008-10#1)(2010-5#1)
test indicated##4##2##(2008-10#2)(2010-5#1)(2011-2#1)
test interferometer##2##2##(2008-2#1)(2008-3#1)
test is a useful##3##4##(1997-2#1)(2007-7#1)(2009-8#1)
test is a##14##3##(1996-12#1)(1997-2#1)(2005-8#1)(2006-8#1)(2007-12#1)(2007-7#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-8#1)
test is an##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
test is best##2##3##(2006-10#1)(2006-8#1)
test is better than##2##4##(2011-2#1)(2012-3#1)
test is carried out##2##4##(1997-4#1)(2007-1#1)
test is more##2##3##(1995-8#1)(2012-3#1)
test is not suitable for##2##5##(2010-4#1)(2013-1#1)
test is not##8##3##(1990-11#1)(1992-8#1)(1993-8#1)(1997-3#1)(2007-7#1)(2008-7#1)(2010-4#1)(2013-1#1)
test is presented##2##3##(2008-3#1)(2008-4#1)
test is proposed for##2##4##(2008-11#1)(2008-3#1)
test is superior to the##2##5##(2007-8#1)(2013-1#1)
test is the best##2##4##(1994-11#1)(2008-1#1)
test is the##6##3##(1994-11#1)(1996-3#1)(2006-2#1)(2007-7#1)(2008-1#1)(2008-5#1)
test is used to##4##4##(1996-8#1)(2008-10#1)(2008-4#1)(2012-12#1)
test is used##6##3##(1996-8#1)(2008-10#1)(2008-3#1)(2008-4#2)(2012-12#1)
test is useful in##2##4##(1990-3#1)(1991-12#1)
test is widely##2##3##(1997-2#1)(2008-9#1)
test is##102##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1991-12#2)(1992-11#1)(1992-5#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-3#2)(1996-5#1)(1996-8#1)(1997-2#4)(1997-3#2)(1997-4#2)(1997-7#1)(2004-2#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-2#1)(2006-8#2)(2007-1#1)(2007-12#2)(2007-3#1)(2007-7#5)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#6)(2008-5#4)(2008-7#2)(2008-8#3)(2008-9#3)(2009-8#1)(2010-4#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#4)
test it##2##2##(1995-8#1)(2010-8#1)
test items##6##2##(2004-12#1)(2008-11#1)(2009-1#1)(2009-10#1)(2009-12#2)
test its effect on##2##4##(1990-11#1)(2008-12#1)
test its##7##2##(1990-11#1)(1997-1#1)(2006-12#1)(2007-3#1)(2008-12#1)(2008-8#2)
test kit##12##2##(1996-5#4)(2007-12#1)(2008-12#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
test kits for the##2##4##(2005-8#1)(2008-5#1)
test kits for##3##3##(1996-12#1)(2005-8#1)(2008-5#1)
test kits##14##2##(1996-12#1)(1996-5#1)(2005-8#1)(2005-9#1)(2006-4#2)(2007-12#4)(2007-2#1)(2007-7#1)(2008-5#1)(2009-9#1)
test laboratory sediment##2##3##(2008-10#2)
test location##2##2##(2007-12#1)(2009-5#1)
test material for##2##3##(1990-12#1)(2008-9#1)
test material##5##2##(1990-12#1)(2008-11#1)(2008-9#2)(2013-8#1)
test materials##3##2##(2008-10#1)(2013-8#2)
test may be##4##3##(1991-5#1)(1993-7#1)(1994-1#1)(2008-11#1)
test may provide a##2##4##(1996-3#1)(2008-7#1)
test may##9##2##(1991-5#1)(1992-2#1)(1993-7#1)(1994-1#1)(1996-3#1)(2006-8#1)(2008-11#1)(2008-7#1)(2009-4#1)
test meals on##2##3##(2008-3#1)(2008-6#1)
test meals##5##2##(1997-4#1)(2004-11#1)(2008-3#2)(2008-6#1)
test measurements##2##2##(2008-3#2)
test measures##2##2##(2006-10#1)(2008-4#1)
test medium##2##2##(2008-2#1)(2012-2#1)
test method and the##2##4##(1995-4#1)(2008-5#1)
test method and##4##3##(1995-4#1)(2008-10#1)(2008-11#1)(2008-5#1)
test method for##3##3##(1996-12#1)(2004-9#2)
test method to##2##3##(1995-4#1)(2008-5#1)
test method##22##2##(1992-7#1)(1995-4#2)(1996-12#1)(2004-12#1)(2004-9#2)(2005-7#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#4)(2012-3#1)(2013-1#1)
test methodologies##5##2##(1996-12#1)(2008-10#1)(2008-5#2)(2012-2#1)
test methods are##3##3##(1996-12#1)(2008-10#2)
test methods for the##2##4##(1990-11#1)(2011-1#1)
test methods for##6##3##(1990-11#1)(1996-12#1)(2008-10#3)(2011-1#1)
test methods##25##2##(1990-11#1)(1991-6#1)(1992-6#1)(1996-12#3)(2008-10#9)(2008-5#6)(2008-8#1)(2008-9#1)(2011-1#2)
test mixture##5##2##(2008-4#1)(2011-1#2)(2013-1#1)(2013-8#1)
test mixtures##3##2##(2008-10#2)(2013-7#1)
test mode##2##2##(2007-4#1)(2010-5#1)
test must be##3##3##(1990-3#1)(1996-4#1)(2006-6#1)
test nationalities##2##2##(1995-6#2)
test negative##2##2##(1994-9#1)(1996-4#1)
test nerve##3##2##(1997-3#3)
test new drugs##2##3##(1995-9#1)(2009-5#1)
test new##3##2##(1995-9#1)(2008-10#1)(2009-5#1)
test object##8##2##(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#2)(2008-7#1)(2013-8#1)
test objects##4##2##(2007-12#2)(2013-8#2)
test of a##5##3##(2006-8#1)(2007-10#1)(2008-12#1)(2008-2#1)(2008-3#1)
test of charge##2##3##(1994-5#1)(1995-5#1)
test of choice for##3##4##(1990-11#1)(2007-8#1)(2008-10#1)
test of choice##4##3##(1990-11#1)(2006-10#1)(2007-8#1)(2008-10#1)
test of competence##2##3##(2007-12#2)
test of group differences##2##4##(1992-6#1)(1997-3#1)
test of non-verbal##2##3##(2009-4#2)
test of renal##2##3##(1992-7#2)
test of spatial##2##3##(1992-11#1)(1993-5#1)
test of the##28##3##(1992-1#1)(1992-6#1)(1994-3#1)(1995-1#1)(1995-11#1)(1996-2#1)(2006-2#1)(2006-5#1)(2007-12#3)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
test of this hypothesis##2##4##(1994-11#1)(1995-11#1)
test of this##6##3##(1992-7#1)(1994-11#1)(1995-11#1)(2008-9#1)(2012-2#1)(2012-3#1)
test of time##5##3##(2006-9#1)(2007-9#1)(2008-1#1)(2008-2#1)(2013-1#1)
test of working memory##4##4##(1993-3#2)(1993-5#1)(2006-9#1)
test of##150##2##(1990-11#1)(1990-2#1)(1990-3#1)(1991-5#1)(1992-1#1)(1992-11#2)(1992-6#4)(1992-7#3)(1993-2#1)(1993-3#4)(1993-5#3)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-4#1)(1995-5#2)(1996-1#1)(1996-2#1)(1996-3#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-10#5)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#4)(2007-10#4)(2007-11#2)(2007-12#8)(2007-3#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#3)(2008-2#6)(2008-3#2)(2008-4#6)(2008-6#4)(2008-7#1)(2008-8#5)(2008-9#6)(2009-4#2)(2009-5#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#3)
test on the##5##3##(1995-6#1)(1997-2#1)(2008-10#1)(2010-12#1)(2013-8#1)
test on##16##2##(1990-10#1)(1994-6#1)(1995-11#1)(1995-6#1)(1997-2#1)(2006-12#1)(2007-3#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2013-8#1)
test or service##2##3##(2006-8#2)
test or##9##2##(1990-6#1)(1992-9#1)(2006-2#1)(2006-8#2)(2006-9#1)(2008-10#1)(2008-7#1)(2009-7#1)
test organisms##7##2##(2004-4#1)(2005-11#1)(2006-9#1)(2008-11#1)(2008-5#2)(2008-8#1)
test other##2##2##(1996-12#1)(2012-3#1)
test our##5##2##(1997-3#1)(2008-7#1)(2008-8#1)(2012-7#1)(2013-1#1)
test outcomes##2##2##(1997-8#1)(2009-9#1)
test p##2##2##(1990-12#1)(2011-2#1)
test paradigms##2##2##(1994-3#1)(2012-1#1)
test parameters##2##2##(2007-1#1)(2008-4#1)
test patients for##2##3##(1994-4#1)(2006-8#1)
test pattern##9##2##(2004-9#7)(2008-3#2)
test patterns##3##2##(2008-3#2)(2008-6#1)
test peptides to##2##3##(2008-4#2)
test peptides##4##2##(1991-10#1)(2008-4#3)
test performance of##2##3##(1994-10#1)(2008-5#1)
test performance##16##2##(1994-10#1)(1994-12#1)(1996-1#1)(1996-3#2)(1996-7#1)(2006-10#1)(2006-3#1)(2007-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-12#1)(2013-1#1)
test performed on##3##3##(2008-3#1)(2008-5#1)(2009-6#1)
test performed##7##2##(1990-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-3#1)(2009-6#1)
test period##6##2##(1991-5#1)(1996-4#1)(1997-5#1)(2008-10#1)(2009-2#1)(2011-1#1)
test persons##2##2##(2004-9#2)
test piece##2##2##(2008-3#2)
test plant##6##2##(2004-2#1)(2007-6#1)(2008-10#1)(2008-12#1)(2011-12#2)
test plants##7##2##(2004-4#1)(2007-6#1)(2008-10#4)(2008-12#1)
test plasmid##2##2##(1994-3#2)
test population##4##2##(1997-5#1)(2007-1#1)(2008-3#1)(2012-1#1)
test portion into##2##3##(2008-10#2)
test portion##3##2##(2007-8#1)(2008-10#2)
test position##4##2##(2008-12#3)(2008-2#1)
test positive for HIV##2##4##(1996-5#1)(2007-2#1)
test positive##4##2##(1996-4#1)(1996-5#1)(2007-2#1)(2008-10#1)
test potential##2##2##(1992-9#1)(2008-4#1)
test potentials##2##2##(1992-9#1)(1997-2#1)
test predictions of##2##3##(2009-5#1)(2011-1#1)
test probes##3##2##(1996-8#1)(2012-12#2)
test problem##2##2##(2007-12#1)(2008-7#1)
test problems##4##2##(2007-9#2)(2008-10#1)(2008-2#1)
test procedure for the##2##4##(2006-11#1)(2007-8#1)
test procedure for##3##3##(2006-11#1)(2007-8#1)(2008-10#1)
test procedure to##2##3##(2006-11#1)(2008-5#1)
test procedure##19##2##(1993-6#1)(1995-4#1)(1995-9#1)(2006-11#2)(2007-2#1)(2007-4#2)(2007-8#2)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#4)
test procedures and##3##3##(2006-11#1)(2012-2#2)
test procedures for##4##3##(1992-2#2)(2008-10#1)(2008-5#1)
test procedures were##2##3##(2007-8#1)(2008-5#1)
test procedures##15##2##(1992-2#2)(2006-11#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-5#3)(2012-2#2)(2013-1#2)
test produced##2##2##(1996-12#1)(2008-10#1)
test products or placebo for 8 weeks##2##7##(2008-10#2)
test products##5##2##(1995-2#1)(2008-10#2)(2008-5#1)(2009-6#1)
test program##2##2##(2006-11#1)(2007-8#1)
test protein##2##2##(1991-11#1)(2008-2#1)
test proteins were##2##3##(1997-2#2)
test protocol##5##2##(2006-11#1)(2007-7#1)(2008-4#1)(2008-5#2)
test protocols##6##2##(2008-5#2)(2010-12#1)(2012-12#3)
test provided##2##2##(2006-10#1)(2007-2#1)
test provides a##2##3##(2007-7#1)(2013-1#1)
test provides##3##2##(2007-7#1)(2008-10#1)(2013-1#1)
test pulse##2##2##(1992-9#1)(2007-12#1)
test questions##2##2##(2008-12#1)(2010-3#1)
test range##2##2##(2007-7#1)(2008-10#1)
test reactions##3##2##(2005-11#1)(2011-1#1)(2012-2#1)
test refusal##4##2##(2005-10#4)
test remains##2##2##(2006-10#1)(2012-3#1)
test requirements##2##2##(1996-8#1)(2008-3#1)
test respectively##2##2##(2008-10#1)(2008-2#1)
test response##4##2##(1997-5#2)(2007-2#1)(2007-4#1)
test result does not##2##4##(1990-4#1)(1996-5#1)
test result had a##2##4##(1996-6#1)(1996-9#1)
test result is##2##3##(1993-8#1)(1996-9#1)
test result##14##2##(1990-4#1)(1990-5#1)(1990-6#1)(1991-2#1)(1993-8#1)(1996-5#1)(1996-6#1)(1996-9#3)(2005-10#1)(2008-7#1)(2012-2#1)(2013-1#1)
test results and##5##3##(1996-12#1)(2007-5#1)(2008-10#1)(2010-12#1)(2012-3#1)
test results are##3##3##(2008-3#2)(2013-7#1)
test results between##4##3##(2007-10#1)(2008-5#1)(2013-1#2)
test results for all##2##4##(1996-11#2)
test results for the##2##4##(2008-11#1)(2012-2#1)
test results for##5##3##(1996-11#2)(2007-5#1)(2008-11#1)(2012-2#1)
test results from##2##3##(2008-10#2)
test results to##3##3##(1993-12#1)(1996-6#1)(1997-4#1)
test results were##3##3##(1996-6#1)(2008-10#1)(2010-3#1)
test results##89##2##(1991-11#1)(1991-12#1)(1993-12#1)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#1)(1995-12#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-3#2)(1997-4#1)(2005-10#1)(2006-10#4)(2006-11#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#5)(2007-5#2)(2007-7#4)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#2)(2010-12#1)(2010-3#2)(2011-1#4)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#3)
test revealed a##4##3##(1997-1#1)(2009-4#1)(2011-1#1)(2012-3#1)
test revealed that##4##3##(1990-8#1)(2007-10#1)(2007-9#1)(2011-12#1)
test revealed##12##2##(1990-8#1)(1992-8#1)(1997-1#1)(2007-10#1)(2007-7#1)(2007-9#1)(2009-4#1)(2010-6#1)(2011-1#1)(2011-12#1)(2012-2#1)(2012-3#1)
test sample and##2##3##(2006-5#1)(2007-11#1)
test sample of##2##3##(1992-2#1)(2008-3#1)
test sample##27##2##(1992-2#2)(2006-5#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-9#1)(2011-1#6)
test samples and##4##3##(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#1)
test samples are##3##3##(1993-1#1)(1996-8#1)(2008-2#1)
test samples from##2##3##(1991-9#1)(2011-1#1)
test samples of##2##3##(2008-10#2)
test samples were##2##3##(1990-4#1)(2012-12#1)
test samples##28##2##(1990-12#1)(1990-4#1)(1991-9#1)(1993-1#1)(1996-8#1)(2006-5#4)(2007-11#1)(2007-12#2)(2008-10#9)(2008-2#2)(2008-4#2)(2011-1#2)(2012-12#1)
test scores and##2##3##(2009-7#1)(2010-2#1)
test scores were##2##3##(2008-9#2)
test scores##13##2##(1991-12#1)(2004-12#1)(2005-10#1)(2006-10#2)(2007-3#1)(2007-4#1)(2008-12#1)(2008-9#2)(2009-7#2)(2010-2#1)
test screening##2##2##(2013-8#2)
test section##6##2##(2008-2#2)(2008-3#3)(2009-11#1)
test sensitivity##5##2##(1992-11#1)(1997-6#1)(2011-2#3)
test sera##2##2##(1990-12#1)(2010-4#1)
test series were##2##3##(2007-1#1)(2007-4#1)
test series##5##2##(1991-5#1)(2007-1#1)(2007-11#1)(2007-4#1)(2008-10#1)
test session##2##2##(1990-2#1)(1993-6#1)
test sessions##3##2##(1993-6#1)(2009-10#1)(2011-2#1)
test set containing##4##3##(2008-6#1)(2012-3#1)(2013-1#2)
test set of##8##3##(1996-12#1)(1997-2#1)(2008-10#1)(2009-3#1)(2011-1#1)(2012-3#1)(2013-1#2)
test set were##2##3##(2008-10#1)(2008-6#1)
test set##36##2##(1996-12#1)(1997-2#1)(2006-12#1)(2007-11#1)(2007-4#2)(2008-10#8)(2008-2#2)(2008-6#2)(2009-3#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-3#2)(2013-1#10)(2013-8#1)
test sets##8##2##(1996-3#1)(2007-4#3)(2008-10#2)(2009-5#1)(2009-7#1)
test setup##5##2##(2006-6#1)(2007-1#1)(2008-2#2)(2008-3#1)
test should be performed##2##4##(2007-8#1)(2012-12#1)
test should be##4##3##(1991-6#1)(1996-12#1)(2007-8#1)(2012-12#1)
test should##8##2##(1991-6#1)(1994-7#1)(1996-12#1)(1996-3#1)(1996-8#1)(2007-8#1)(2012-12#1)(2013-8#1)
test show that##2##3##(2012-12#1)(2013-8#1)
test showed a##3##3##(2009-8#1)(2012-3#1)(2013-1#1)
test showed that the##2##4##(2008-10#1)(2011-1#1)
test showed that##15##3##(2007-2#1)(2007-7#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#2)(2009-8#1)(2009-9#1)(2010-1#1)(2011-1#2)(2013-8#1)
test showed##28##2##(1992-1#1)(1997-6#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-8#2)(2009-9#1)(2010-1#1)(2011-1#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
test showing##2##2##(1992-9#1)(2010-10#1)
test shows##4##2##(1997-1#1)(1997-2#1)(2008-11#1)(2012-3#1)
test site##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
test sites##9##2##(1992-6#3)(1996-3#1)(2007-1#1)(2007-2#1)(2008-11#1)(2008-3#1)(2012-3#1)
test size##3##2##(1994-9#1)(1997-3#1)(2007-5#1)
test soil##3##2##(2006-3#1)(2009-3#2)
test solutes##2##2##(1994-9#1)(2013-1#1)
test solution##9##2##(2008-10#7)(2008-5#1)(2012-2#1)
test solutions##14##2##(2008-10#12)(2008-4#1)(2010-5#1)
test species##6##2##(2010-11#5)(2012-3#1)
test specific for##2##3##(1991-6#1)(2007-10#1)
test specimen##3##2##(2008-10#2)(2008-3#1)
test specimens were##2##3##(2008-10#1)(2013-1#1)
test specimens##4##2##(2008-10#2)(2013-1#2)
test statistic is##2##3##(1992-9#1)(1995-4#1)
test statistic##10##2##(1992-9#1)(1995-4#1)(1995-9#1)(1997-2#1)(2006-7#1)(2008-10#2)(2009-2#1)(2010-2#1)(2012-1#1)
test statistics and##3##3##(1995-9#1)(2008-10#1)(2010-2#1)
test statistics for##3##3##(2008-5#1)(2008-7#1)(2012-3#1)
test statistics to##3##3##(1997-3#1)(2009-10#1)(2011-2#1)
test statistics##23##2##(1993-4#1)(1995-2#2)(1995-9#1)(1997-3#5)(2006-7#1)(2008-10#4)(2008-5#1)(2008-7#1)(2009-10#2)(2010-2#1)(2011-2#1)(2012-3#3)
test strains##5##2##(1993-11#2)(2005-11#1)(2006-8#1)(2011-2#1)
test strip##7##2##(2008-10#5)(2012-3#2)
test structures##2##2##(2008-2#2)
test subject##3##2##(1992-2#1)(1997-5#2)
test subjects##7##2##(1995-6#2)(1997-5#1)(2007-1#1)(2007-4#1)(2008-5#2)
test substrate##3##2##(2008-11#2)(2010-9#1)
test substrates##2##2##(2006-8#1)(2008-11#1)
test such as##2##3##(2006-10#1)(2007-8#1)
test such##5##2##(1992-9#1)(2006-10#2)(2007-8#1)(2011-2#1)
test suggested that##3##3##(2007-12#1)(2009-7#1)(2013-1#1)
test surface##5##2##(2008-2#2)(2008-3#3)
test system and##2##3##(1995-3#1)(2008-11#1)
test system has been developed##2##5##(1996-2#1)(2013-1#1)
test system has##3##3##(1996-2#1)(2008-11#1)(2013-1#1)
test system is##3##3##(2008-11#2)(2008-5#1)
test system##20##2##(1990-11#1)(1992-9#1)(1995-3#1)(1996-2#1)(1997-2#2)(2008-10#2)(2008-11#4)(2008-5#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
test systems for developmental toxicology##2##5##(1996-5#2)
test systems##16##2##(1990-12#1)(1991-12#1)(1992-6#1)(1994-3#1)(1996-5#2)(1997-8#1)(2006-2#1)(2007-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-9#1)(2012-3#1)
test taken##2##2##(2006-10#1)(2008-2#1)
test target##2##2##(2008-2#1)(2008-3#1)
test technique##2##2##(2008-3#1)(2008-5#1)
test than##3##2##(2008-3#1)(2008-4#1)(2010-2#1)
test that can##2##3##(2005-9#1)(2007-8#1)
test that the##2##3##(2007-12#1)(2010-2#1)
test that was##2##3##(1997-2#1)(2008-10#1)
test that##19##2##(1991-11#1)(1997-2#1)(2005-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-2#1)(2011-2#1)(2012-3#2)(2013-1#1)
test the ability of##3##4##(1993-6#1)(1994-3#1)(2006-8#1)
test the accuracy of##4##4##(1990-12#1)(2007-10#1)(2008-2#2)
test the accuracy##5##3##(1990-12#1)(2007-10#1)(2008-2#2)(2008-3#1)
test the assumption##3##3##(2006-8#1)(2008-3#1)(2010-2#1)
test the capacity of new##2##5##(2008-9#2)
test the effects of##19##4##(1990-10#1)(1992-1#2)(1994-12#1)(1996-1#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-11#1)(2012-12#1)(2012-2#1)(2013-7#1)
test the effects##20##3##(1990-10#1)(1992-1#2)(1994-12#1)(1996-1#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-11#1)(2012-12#1)(2012-2#1)(2013-7#1)
test the efficacy of##3##4##(2008-7#1)(2008-9#1)(2010-8#1)
test the feasibility of this##2##5##(1990-12#1)(2012-11#1)
test the feasibility of##9##4##(1990-12#1)(1996-2#1)(1997-8#1)(2005-11#1)(2008-10#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-11#1)
test the feasibility##10##3##(1990-12#1)(1996-2#1)(1997-8#1)(2005-11#1)(2008-10#1)(2008-11#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-11#1)
test the function of##6##4##(1990-11#1)(1993-2#1)(1995-2#1)(2006-10#1)(2008-1#1)(2008-8#1)
test the hypotheses that##3##4##(1993-9#1)(2011-2#2)
test the hypothesis that the##12##5##(1991-1#1)(1994-6#1)(1995-12#2)(1995-2#1)(1996-5#1)(2007-1#1)(2007-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-7#1)
test the hypothesis that these##2##5##(2008-9#1)(2010-2#1)
test the hypothesis that##70##4##(1990-1#1)(1990-11#1)(1990-8#3)(1991-1#1)(1991-10#1)(1992-9#1)(1993-12#2)(1993-4#1)(1994-10#3)(1994-3#1)(1994-6#2)(1995-12#2)(1995-2#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-7#1)(2004-11#1)(2004-3#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-2#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-5#1)
test the hypothesis##76##3##(1990-1#1)(1990-11#1)(1990-8#3)(1991-1#1)(1991-10#1)(1991-2#1)(1992-9#1)(1993-12#2)(1993-4#1)(1994-10#3)(1994-3#1)(1994-6#2)(1994-8#1)(1995-12#2)(1995-2#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-7#1)(2004-11#1)(2004-3#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#2)(2009-11#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-2#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-5#1)
test the influence of##2##4##(2007-11#1)(2007-8#1)
test the intuition that##3##4##(2009-8#1)(2013-1#2)
test the linearity##2##3##(1992-7#1)(2008-2#1)
test the method##5##3##(1990-11#1)(2008-10#1)(2008-2#2)(2010-12#1)
test the model##4##3##(1995-8#1)(1996-9#1)(2008-3#1)(2008-6#1)
test the null hypothesis that##2##5##(2008-10#1)(2008-5#1)
test the null hypothesis##3##4##(1995-5#1)(2008-10#1)(2008-5#1)
test the performance of the##3##5##(2008-2#1)(2008-3#1)(2010-8#1)
test the performance of##4##4##(2008-2#1)(2008-3#1)(2008-6#1)(2010-8#1)
test the possibility of##3##4##(1997-2#1)(2008-6#1)(2009-2#1)
test the possibility that##4##4##(1991-6#1)(1991-9#1)(2010-12#1)(2013-1#1)
test the possibility##7##3##(1991-6#1)(1991-9#1)(1997-2#1)(2008-6#1)(2009-2#1)(2010-12#1)(2013-1#1)
test the potential##2##3##(1990-2#1)(1991-9#1)
test the relationship between##2##4##(2013-1#1)(2013-8#1)
test the role of the##2##5##(1994-3#1)(1996-8#1)
test the role of##5##4##(1994-3#1)(1995-8#1)(1996-8#1)(2008-5#1)(2008-8#1)
test the safety and efficacy of##2##6##(1997-3#1)(2008-8#1)
test the specificity of the##2##5##(2008-10#1)(2008-5#1)
test the system##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
test the validity of the##5##5##(1997-2#1)(1997-4#1)(2005-11#1)(2007-12#1)(2008-10#1)
test the validity of##11##4##(1990-9#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-5#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)(2010-12#1)
test the##334##2##(1990-1#1)(1990-10#1)(1990-11#4)(1990-12#3)(1990-2#1)(1990-3#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-12#1)(1992-2#2)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-10#4)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#2)(1994-8#1)(1995-12#2)(1995-2#3)(1995-4#1)(1995-5#1)(1995-7#1)(1995-8#3)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#3)(1996-8#1)(1996-9#2)(1997-2#5)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2004-2#1)(2004-3#1)(2004-4#1)(2004-7#1)(2004-9#1)(2005-11#3)(2006-10#2)(2006-11#1)(2006-12#2)(2006-5#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#4)(2007-12#5)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#27)(2008-11#9)(2008-12#1)(2008-2#8)(2008-3#18)(2008-4#3)(2008-5#13)(2008-6#4)(2008-7#9)(2008-8#12)(2008-9#7)(2009-10#1)(2009-11#3)(2009-2#4)(2009-3#4)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#5)(2010-2#3)(2010-3#3)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#6)(2012-1#4)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#1)(2012-5#2)(2013-1#8)(2013-7#2)(2013-8#2)
test their##12##2##(1990-8#1)(1997-1#1)(1997-5#1)(1997-7#1)(2005-10#1)(2006-2#1)(2008-10#2)(2008-5#1)(2009-5#1)(2010-6#1)(2013-8#1)
test theoretical##2##2##(1995-6#1)(2012-3#1)
test these hypotheses##3##3##(2008-8#2)(2009-2#1)
test these predictions##2##3##(2007-9#1)(2009-5#1)
test these results##2##3##(1992-12#1)(2006-10#1)
test these##16##2##(1991-5#1)(1992-12#1)(1994-12#1)(1996-6#1)(2005-10#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#3)(2009-2#1)(2009-5#1)(2012-2#1)
test this assumption##3##3##(1995-5#1)(1996-7#1)(2004-11#1)
test this hypothesis by##3##4##(2008-2#1)(2008-8#1)(2009-7#1)
test this hypothesis using##3##4##(1994-10#1)(2007-11#1)(2011-2#1)
test this hypothesis we##3##4##(1996-7#1)(1997-5#1)(2009-8#1)
test this hypothesis##40##3##(1991-12#1)(1992-8#1)(1993-12#1)(1994-10#1)(1994-6#1)(1995-5#2)(1996-10#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)
test this idea##6##3##(1994-6#1)(2007-10#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-12#1)
test this in##2##3##(1993-11#1)(2008-9#1)
test this model##4##3##(1991-10#1)(1997-1#1)(2008-9#1)(2010-5#1)
test this possibility##3##3##(1991-2#1)(1994-3#1)(2009-4#1)
test this theory##2##3##(2008-11#1)(2008-12#1)
test this##84##2##(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-10#1)(1994-3#1)(1994-6#2)(1995-11#1)(1995-5#3)(1995-8#1)(1996-10#1)(1996-3#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#1)(2006-12#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#2)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-4#4)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#1)
test three##3##2##(1991-12#1)(1997-5#1)(2007-9#1)
test time##2##2##(2008-10#2)
test to assess##2##3##(2008-10#1)(2008-9#1)
test to be##2##3##(1997-2#1)(2004-9#1)
test to compare##3##3##(2006-11#1)(2008-10#1)(2013-8#1)
test to detect##4##3##(1993-9#1)(2007-7#1)(2008-5#1)(2011-12#1)
test to determine the##3##4##(1995-7#1)(2006-8#1)(2011-2#1)
test to determine whether##2##4##(1996-2#1)(2011-2#1)
test to determine##6##3##(1995-7#1)(1996-12#1)(1996-2#1)(2006-8#1)(2011-2#2)
test to discriminate##3##3##(2007-8#2)(2010-2#1)
test to estimate the##2##4##(1990-1#1)(2008-2#1)
test to evaluate##2##3##(2011-12#1)(2012-2#1)
test to identify##3##3##(2006-10#1)(2010-2#1)(2012-3#1)
test to measure##3##3##(2006-10#1)(2008-3#1)(2012-12#1)
test to predict the##2##4##(2008-10#1)(2008-9#1)
test to predict##3##3##(2008-10#1)(2008-9#1)(2011-12#1)
test to the##6##3##(2005-1#1)(2008-10#2)(2011-1#1)(2012-2#1)(2012-3#1)
test to##75##2##(1990-1#2)(1992-9#1)(1993-2#1)(1993-9#1)(1995-11#1)(1995-2#1)(1995-7#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-6#1)(1997-7#1)(2004-3#1)(2004-9#1)(2005-1#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-9#2)(2009-5#1)(2010-2#3)(2010-7#1)(2011-1#1)(2011-12#3)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
test tube##6##2##(1990-12#1)(1992-7#1)(1993-9#1)(2008-4#1)(2010-8#2)
test tubes##5##2##(1991-1#1)(1997-6#1)(2008-4#1)(2009-2#1)(2009-3#1)
test under##5##2##(1996-3#2)(2008-7#1)(2013-1#2)
test use##2##2##(2008-4#1)(2009-5#1)
test used to##2##3##(2008-1#1)(2011-2#1)
test used##5##2##(2005-10#1)(2008-1#1)(2009-4#1)(2011-2#1)(2013-1#1)
test using a##6##3##(2007-12#1)(2007-4#1)(2008-11#1)(2008-5#1)(2008-8#1)(2013-8#1)
test using neural##2##3##(2010-8#2)
test using pollen of##2##4##(2008-11#2)
test using the##4##3##(1990-2#1)(2004-4#1)(2008-12#1)(2009-5#1)
test using##30##2##(1990-2#1)(1991-3#1)(1993-9#1)(1996-12#1)(2004-4#1)(2005-8#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-5#4)(2008-8#3)(2009-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
test value##2##2##(1992-3#1)(2011-2#1)
test values of##2##3##(1995-6#1)(2012-3#1)
test values##4##2##(1995-6#1)(2008-7#1)(2012-12#1)(2012-3#1)
test vessel##2##2##(2008-10#2)
test was also conducted##2##4##(2008-5#1)(2013-1#1)
test was also##3##3##(1991-3#1)(2008-5#1)(2013-1#1)
test was applied to##2##4##(2009-6#1)(2012-12#1)
test was applied##5##3##(2006-7#1)(2008-5#1)(2009-6#1)(2011-1#1)(2012-12#1)
test was calculated##2##3##(2009-8#1)(2012-2#1)
test was carried out for##2##5##(1993-9#1)(2008-4#1)
test was carried out to evaluate statistical significance##2##8##(2007-7#1)(2007-8#1)
test was carried out##8##4##(1993-7#1)(1993-9#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-4#1)(2012-2#1)(2013-1#1)
test was compared##2##3##(2012-2#2)
test was conducted with##2##4##(2008-8#1)(2009-9#1)
test was conducted##4##3##(1996-11#1)(2008-5#1)(2008-8#1)(2009-9#1)
test was developed to##2##4##(2008-10#1)(2008-4#1)
test was developed##6##3##(1991-8#1)(2008-10#2)(2008-4#1)(2011-2#1)(2013-1#1)
test was done##2##3##(2012-12#1)(2013-1#1)
test was evaluated in##2##4##(2007-11#1)(2011-2#1)
test was evaluated##3##3##(2007-11#1)(2010-4#1)(2011-2#1)
test was evident##2##3##(1994-9#1)(2013-7#1)
test was found to be##3##5##(1996-3#1)(2006-2#1)(2010-7#1)
test was found##4##3##(1996-3#1)(2006-10#1)(2006-2#1)(2010-7#1)
test was given##2##3##(1990-7#1)(2008-11#1)
test was negative##5##3##(1994-12#1)(1996-12#1)(2007-7#1)(2011-12#1)(2012-3#1)
test was not##3##3##(1990-6#1)(2011-1#1)(2013-1#1)
test was observed in##2##4##(2011-1#1)(2013-1#1)
test was performed by##4##4##(2004-9#1)(2008-5#1)(2012-3#1)(2013-8#1)
test was performed for##2##4##(2010-10#1)(2013-8#1)
test was performed in the##2##5##(2008-12#1)(2013-8#1)
test was performed in##5##4##(1993-3#1)(2004-9#1)(2008-12#1)(2013-1#1)(2013-8#1)
test was performed to##3##4##(2007-7#1)(2008-10#1)(2013-7#1)
test was performed with##5##4##(1990-3#1)(2008-10#2)(2008-11#1)(2011-2#1)
test was performed##28##3##(1990-3#1)(1992-7#1)(1993-3#1)(1994-6#1)(2004-9#2)(2006-7#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#5)
test was positive in##6##4##(1993-10#1)(2007-7#2)(2008-4#1)(2011-1#1)(2012-3#1)
test was positive##8##3##(1993-10#1)(1997-4#1)(2007-7#2)(2008-4#1)(2010-12#1)(2011-1#1)(2012-3#1)
test was reliable##2##3##(1991-3#1)(2007-7#1)
test was significantly##2##3##(1992-10#1)(2013-7#1)
test was then##2##3##(2008-5#1)(2012-12#1)
test was used and##2##4##(2006-10#1)(2013-8#1)
test was used for##5##4##(1994-9#1)(2007-2#1)(2008-8#1)(2010-4#1)(2013-1#1)
test was used to compare the##2##6##(2008-1#1)(2011-1#1)
test was used to compare##5##5##(2006-8#1)(2008-1#1)(2008-8#1)(2010-6#1)(2011-1#1)
test was used to##16##4##(1992-1#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#2)(2013-1#1)
test was used##25##3##(1992-1#1)(1994-9#1)(2006-10#2)(2006-8#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
test was##171##2##(1990-10#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-3#3)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#2)(1995-11#1)(1996-11#1)(1996-12#2)(1996-3#1)(1997-2#2)(1997-4#1)(2004-4#1)(2004-9#2)(2005-11#1)(2006-10#5)(2006-2#2)(2006-5#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#8)(2007-8#3)(2008-1#1)(2008-10#13)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#7)(2008-8#5)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-6#1)(2010-7#1)(2011-1#5)(2011-12#1)(2011-2#11)(2012-12#6)(2012-2#6)(2012-3#7)(2013-1#12)(2013-7#3)(2013-8#7)
test we##3##2##(1990-2#1)(1991-11#1)(2011-1#1)
test were compared##2##3##(1997-6#1)(2008-5#1)
test were conducted##2##3##(2007-4#1)(2008-10#1)
test were done##2##3##(2007-12#1)(2008-12#1)
test were found##2##3##(1996-3#1)(2008-7#1)
test were performed##5##3##(1994-3#1)(2007-11#1)(2007-8#1)(2008-4#1)(2011-12#1)
test were used to determine##3##5##(2008-10#2)(2008-8#1)
test were used to##5##4##(1990-10#1)(2008-10#2)(2008-8#1)(2013-1#1)
test were used##8##3##(1990-10#1)(2007-10#1)(2008-10#2)(2008-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
test were##40##2##(1990-10#1)(1990-3#1)(1991-12#2)(1992-3#1)(1992-6#1)(1992-9#1)(1994-3#1)(1996-3#1)(1997-6#1)(2005-1#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
test when##2##2##(1995-9#1)(2012-1#1)
test where##2##2##(2008-12#1)(2009-4#1)
test whether a##6##3##(1990-11#1)(2007-3#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-2#1)
test whether the##11##3##(1992-2#1)(1994-3#1)(1995-1#1)(2005-11#1)(2008-2#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-12#1)(2013-1#1)
test whether these##3##3##(2008-10#1)(2009-5#1)(2013-8#1)
test whether##57##2##(1990-11#1)(1992-2#1)(1992-8#2)(1993-2#1)(1994-3#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#2)(2010-11#1)(2010-12#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
test which##4##2##(1991-9#1)(1996-8#1)(2008-8#1)(2009-8#1)
test will be in a##2##5##(2007-12#1)(2007-9#1)
test will be##3##3##(1994-3#1)(2007-12#1)(2007-9#1)
test will##5##2##(1994-3#1)(2007-12#1)(2007-9#1)(2012-12#1)(2012-2#1)
test with a loaded weight of 80 kg##2##7##(2013-1#2)
test with a##12##3##(1991-9#1)(2006-4#1)(2008-2#4)(2008-5#2)(2012-3#1)(2013-1#3)
test with an##2##3##(1991-12#1)(2012-2#1)
test with the##9##3##(1990-3#1)(1993-6#1)(1994-3#1)(1996-3#1)(2005-8#1)(2006-4#1)(2008-11#2)(2009-4#1)
test with##57##2##(1990-3#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-9#1)(1992-6#2)(1992-9#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-6#1)(1996-12#1)(1996-3#2)(1997-4#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-4#2)(2007-10#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-11#2)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-2#2)(2012-3#4)(2013-1#4)
test within the##2##3##(2008-11#1)(2008-12#1)
test within##4##2##(1990-6#1)(2008-11#1)(2008-12#1)(2008-5#1)
test without##3##2##(1996-6#1)(2007-3#1)(2012-1#1)
test word##4##2##(2008-10#4)
test words##3##2##(2008-10#3)
test would##3##2##(1993-8#1)(2008-10#1)(2009-4#1)
test yielded##2##2##(2006-10#1)(2008-9#1)
test##4680##1##(1990-1#3)(1990-10#7)(1990-11#15)(1990-12#15)(1990-2#12)(1990-3#20)(1990-4#6)(1990-5#9)(1990-6#12)(1990-7#4)(1990-8#8)(1990-9#2)(1991-1#11)(1991-10#11)(1991-11#14)(1991-12#25)(1991-2#11)(1991-3#12)(1991-4#9)(1991-5#10)(1991-6#9)(1991-7#1)(1991-8#5)(1991-9#10)(1992-1#8)(1992-10#5)(1992-11#14)(1992-12#6)(1992-2#18)(1992-3#12)(1992-4#7)(1992-5#8)(1992-6#22)(1992-7#19)(1992-8#15)(1992-9#22)(1993-1#6)(1993-10#5)(1993-11#14)(1993-12#12)(1993-2#10)(1993-3#20)(1993-4#7)(1993-5#10)(1993-6#10)(1993-7#5)(1993-8#8)(1993-9#19)(1994-1#4)(1994-10#7)(1994-11#6)(1994-12#9)(1994-2#22)(1994-3#32)(1994-4#2)(1994-5#13)(1994-6#24)(1994-7#7)(1994-8#10)(1994-9#7)(1995-1#12)(1995-10#2)(1995-11#13)(1995-12#11)(1995-2#13)(1995-3#5)(1995-4#20)(1995-5#9)(1995-6#14)(1995-7#5)(1995-8#14)(1995-9#8)(1996-1#12)(1996-10#5)(1996-11#14)(1996-12#52)(1996-2#16)(1996-3#24)(1996-4#10)(1996-5#23)(1996-6#13)(1996-7#8)(1996-8#13)(1996-9#19)(1997-1#12)(1997-2#36)(1997-3#36)(1997-4#18)(1997-5#21)(1997-6#18)(1997-7#12)(1997-8#21)(2004-11#5)(2004-12#5)(2004-2#5)(2004-3#2)(2004-4#6)(2004-7#1)(2004-9#17)(2005-1#3)(2005-10#24)(2005-11#18)(2005-12#3)(2005-7#3)(2005-8#17)(2005-9#7)(2006-1#2)(2006-10#96)(2006-11#43)(2006-12#26)(2006-2#25)(2006-3#6)(2006-4#6)(2006-5#18)(2006-6#11)(2006-7#10)(2006-8#31)(2006-9#13)(2007-1#38)(2007-10#26)(2007-11#43)(2007-12#65)(2007-2#48)(2007-3#20)(2007-4#48)(2007-5#9)(2007-6#12)(2007-7#86)(2007-8#65)(2007-9#20)(2008-1#28)(2008-10#386)(2008-11#95)(2008-12#57)(2008-2#119)(2008-3#144)(2008-4#103)(2008-5#167)(2008-6#29)(2008-7#80)(2008-8#78)(2008-9#68)(2009-1#2)(2009-10#13)(2009-11#10)(2009-12#11)(2009-2#17)(2009-3#15)(2009-4#24)(2009-5#25)(2009-6#18)(2009-7#14)(2009-8#14)(2009-9#17)(2010-1#12)(2010-10#7)(2010-11#10)(2010-12#31)(2010-2#42)(2010-3#18)(2010-4#12)(2010-5#14)(2010-6#12)(2010-7#8)(2010-8#29)(2010-9#5)(2011-1#101)(2011-11#1)(2011-12#18)(2011-2#141)(2011-3#2)(2012-1#41)(2012-11#8)(2012-12#68)(2012-2#84)(2012-3#118)(2012-5#2)(2012-6#1)(2012-7#4)(2013-1#196)(2013-7#29)(2013-8#74)
test&quot##10##1##(1990-4#1)(1990-6#1)(1992-2#2)(1993-3#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-5#1)(2009-3#1)
test' in##2##2##(2007-7#1)(2008-7#1)
test's##6##1##(1990-12#1)(1996-5#1)(1997-3#1)(2004-12#1)(2009-12#1)(2010-2#1)
test) and##8##2##(1991-10#1)(1997-5#1)(2005-8#1)(2006-10#2)(2007-1#1)(2008-1#1)(2008-8#1)
test) is##2##2##(2011-2#1)(2012-3#1)
test) was##3##2##(2010-5#1)(2011-2#1)(2013-1#1)
test) were##4##2##(1994-7#1)(1995-3#1)(2007-10#1)(2008-1#1)
test)##80##1##(1990-4#1)(1990-6#1)(1990-8#2)(1991-10#3)(1991-11#1)(1993-2#1)(1993-7#1)(1994-2#1)(1994-6#1)(1994-7#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-4#1)(1996-6#1)(1996-9#4)(1997-5#2)(1997-6#1)(1997-7#1)(2004-1#1)(2004-11#1)(2005-10#2)(2005-8#1)(2006-10#4)(2007-1#1)(2007-10#1)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-2#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#7)(2013-8#3)
test-bed for##2##2##(2007-12#1)(2007-5#1)
test-bed##4##1##(2007-12#1)(2007-5#2)(2008-2#1)
test-retest reliability##20##2##(1996-3#1)(2006-9#1)(2007-10#1)(2007-12#6)(2007-9#3)(2008-10#2)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
test-retest##29##1##(1995-11#1)(1996-3#1)(2005-12#1)(2006-10#1)(2006-9#1)(2007-10#2)(2007-12#6)(2007-9#3)(2008-10#3)(2008-6#2)(2009-9#1)(2010-12#3)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
test-to-test##2##1##(2006-11#1)(2007-1#1)
test-tube##4##1##(1990-3#1)(1991-5#2)(2008-4#1)
test?##2##1##(2004-12#1)(2007-12#1)
test]##10##1##(1990-11#1)(1990-4#1)(1991-9#1)(1992-3#1)(1993-10#1)(1996-11#1)(1996-9#1)(2008-12#1)(2010-12#1)(2013-1#1)
testa of groundnut shell##3##4##(2007-10#3)
testa##4##1##(2007-10#3)(2009-10#1)
testable hypotheses about##2##3##(1996-11#1)(2008-5#1)
testable hypotheses for##2##3##(2006-3#1)(2008-8#1)
testable hypotheses##9##2##(1996-11#1)(1996-4#1)(2005-10#1)(2006-3#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)
testable hypothesis##2##2##(2008-10#1)(2008-9#1)
testable predictions##5##2##(1997-2#1)(2008-8#1)(2010-10#1)(2010-6#1)(2013-8#1)
testable##25##1##(1996-11#1)(1996-12#1)(1996-4#1)(1997-2#1)(2005-10#1)(2006-2#1)(2006-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-6#1)(2010-1#1)(2010-10#1)(2010-6#1)(2013-8#1)
testaceipes and A##2##3##(2008-6#2)
testaceipes and##3##2##(2008-6#3)
testaceipes##9##1##(2008-6#7)(2013-8#2)
testament to##2##2##(1995-3#1)(2007-12#1)
testbed projector##2##2##(2008-3#2)
testbed##7##1##(2007-5#1)(2008-2#3)(2008-3#3)
tested (0##3##2##(1992-9#1)(1997-2#1)(2013-1#1)
tested (5 to##2##3##(2008-10#2)
tested (5##3##2##(2008-10#2)(2008-5#1)
tested (e##2##2##(1997-6#1)(2008-10#1)
tested 1##2##2##(1997-2#1)(1997-8#1)
tested 14##2##2##(1990-3#1)(1995-12#1)
tested 2##3##2##(1994-3#1)(1994-6#1)(1995-6#1)
tested 24 h after##4##4##(1992-9#1)(1995-5#1)(1996-9#1)(2012-2#1)
tested 24 h##6##3##(1992-9#1)(1994-5#1)(1994-6#1)(1995-5#1)(1996-9#1)(2012-2#1)
tested 24##8##2##(1992-9#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-5#1)(1996-9#1)(2012-2#1)(2013-1#1)
tested HIV positive##4##3##(1993-7#2)(2008-3#1)(2012-3#1)
tested a new##3##3##(1995-12#1)(2008-5#1)(2010-10#1)
tested a series of##2##4##(1995-7#1)(1995-8#1)
tested a variety of##2##4##(1997-1#1)(2008-7#1)
tested a##31##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-3#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-8#2)(1997-1#1)(2006-2#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#2)(2009-7#1)(2010-10#1)(2013-1#1)(2013-8#1)
tested across##2##2##(2008-10#1)(2011-1#1)
tested additional##2##2##(1996-5#1)(2010-12#1)
tested after##4##2##(1993-2#1)(2008-10#1)(2008-12#2)
tested against a panel of##2##5##(2008-10#1)(2008-8#1)
tested against a range of##2##5##(1994-6#1)(2012-12#1)
tested against a##9##3##(1990-10#1)(1992-3#1)(1994-6#1)(1995-11#1)(2008-10#3)(2008-8#1)(2012-12#1)
tested against eight different##2##4##(2007-11#2)
tested against experimental##2##3##(2008-3#1)(2013-1#1)
tested against five##3##3##(2006-8#1)(2007-11#2)
tested against metronidazole##2##3##(2006-8#2)
tested against various##2##3##(2008-5#1)(2012-2#1)
tested against##67##2##(1990-10#1)(1992-3#1)(1992-8#1)(1993-10#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-6#1)(2006-10#1)(2006-4#1)(2006-8#3)(2007-11#6)(2007-6#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
tested also##2##2##(1995-6#1)(2008-10#1)
tested amino acids##2##3##(2006-8#1)(2010-4#1)
tested among##4##2##(2007-8#1)(2008-2#1)(2010-2#1)(2012-2#1)
tested an##7##2##(1990-4#1)(1992-1#1)(1993-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-1#1)
tested and (2)##2##3##(2008-12#1)(2008-3#1)
tested and applied for the##2##5##(2008-10#2)
tested and compared for##2##4##(2008-2#1)(2008-6#1)
tested and compared to a##3##5##(2009-11#1)(2012-11#2)
tested and compared with##2##4##(1996-6#1)(2008-10#1)
tested and compared##8##3##(1996-6#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-11#1)(2010-5#1)(2012-11#2)
tested and confirmed##2##3##(1991-11#1)(1994-9#1)
tested and found to be##3##5##(1991-7#1)(1994-12#1)(2008-10#1)
tested and the##7##3##(1991-3#1)(1991-5#1)(1996-12#1)(2007-12#1)(2007-8#2)(2008-11#1)
tested and##65##2##(1990-5#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-7#1)(1994-12#2)(1994-9#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(2005-11#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-11#2)(2009-12#1)(2009-3#2)(2009-7#1)(2010-1#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-11#3)(2012-2#1)(2012-3#1)(2013-8#1)
tested antibiotics##3##2##(1992-10#1)(2008-10#1)(2012-2#1)
tested are##7##2##(1992-7#1)(1994-3#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2012-12#1)
tested as a potential##3##4##(1993-12#1)(2007-10#1)(2008-7#1)
tested as a##13##3##(1992-3#1)(1993-12#1)(1994-9#1)(1995-5#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2012-1#1)
tested as an alternative##2##4##(2007-8#1)(2008-10#1)
tested as an##4##3##(1994-11#1)(2007-8#1)(2008-10#2)
tested as inhibitors of##4##4##(1990-7#1)(1992-5#1)(1992-8#1)(1995-2#1)
tested as possible inhibitors of##2##5##(1997-8#1)(2004-9#1)
tested as possible##3##3##(1997-8#1)(2004-9#1)(2008-11#1)
tested as potential substrates##2##4##(2007-6#1)(2009-2#1)
tested as potential##3##3##(1995-3#1)(2007-6#1)(2009-2#1)
tested as solid##3##3##(2008-10#2)(2008-5#1)
tested as the##2##3##(2006-12#1)(2008-3#1)
tested as##60##2##(1990-11#3)(1990-7#1)(1990-8#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-8#2)(2004-9#1)(2006-12#1)(2007-10#2)(2007-11#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#14)(2008-11#5)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-2#1)(2010-5#1)(2012-1#1)(2013-1#1)(2013-8#1)
tested at 4##4##3##(1993-9#1)(1995-5#1)(2007-4#2)
tested at 6##3##3##(1992-7#1)(2007-4#2)
tested at a##3##3##(1996-4#1)(1996-9#1)(2007-1#1)
tested at different##3##3##(2006-12#1)(2008-10#1)(2008-5#1)
tested at levels##2##3##(1994-6#1)(2011-2#1)
tested at the##10##3##(1990-9#1)(1992-2#1)(1993-12#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)
tested at various##3##3##(2008-10#3)
tested at##50##2##(1990-9#1)(1992-2#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-5#1)(1996-10#1)(1996-4#1)(1996-6#1)(1996-9#1)(2004-11#1)(2006-12#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-12#1)(2007-4#4)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#3)(2009-5#2)(2010-3#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
tested bacteria##2##2##(2011-2#1)(2012-3#1)
tested both##4##2##(1995-12#1)(2006-8#1)(2008-3#1)(2013-7#1)
tested but was##2##3##(1997-4#1)(2008-10#1)
tested but##5##2##(1997-4#1)(2006-8#1)(2008-10#2)(2011-2#1)
tested by ELISA##6##3##(1991-9#1)(1995-12#2)(1996-11#1)(2006-10#1)(2007-7#1)
tested by a##8##3##(1991-8#1)(1994-3#1)(1995-2#1)(2004-9#1)(2007-12#1)(2008-3#1)(2008-5#1)(2011-2#1)
tested by an##2##3##(2007-12#1)(2012-12#1)
tested by analyzing##5##3##(2007-10#1)(2008-10#3)(2011-2#1)
tested by both##3##3##(2008-8#1)(2013-1#2)
tested by comparing the##3##4##(1990-2#1)(2008-10#1)(2009-8#1)
tested by comparing##5##3##(1990-2#1)(2008-10#1)(2009-8#1)(2011-3#1)(2012-11#1)
tested by comparison with##2##4##(2008-10#1)(2008-2#1)
tested by cross-validation##2##3##(2008-10#1)(2010-4#1)
tested by determining##4##3##(1995-8#1)(2008-10#3)
tested by means of##4##4##(1992-7#1)(1997-2#1)(2008-10#1)(2008-3#1)
tested by measurement of##4##4##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
tested by measuring##8##3##(1991-12#1)(1994-11#1)(1995-1#1)(1997-8#1)(2004-12#1)(2008-11#1)(2008-8#1)(2009-10#1)
tested by the##15##3##(1990-10#1)(1992-6#1)(1994-12#1)(1997-7#1)(2006-10#1)(2008-10#2)(2008-5#3)(2011-1#1)(2012-7#1)(2013-1#1)(2013-7#1)(2013-8#1)
tested by using the##2##4##(1995-8#1)(2008-10#1)
tested by using##7##3##(1995-8#1)(1996-5#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)
tested by##169##2##(1990-10#1)(1990-11#2)(1990-2#1)(1990-3#1)(1991-12#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#1)(1993-2#2)(1993-3#1)(1993-4#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-8#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#3)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#3)(1997-7#2)(1997-8#1)(2004-12#1)(2004-9#1)(2005-1#1)(2005-10#2)(2005-9#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#31)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#4)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-9#1)(2011-1#6)(2011-2#3)(2011-3#1)(2012-11#1)(2012-12#2)(2012-7#1)(2013-1#5)(2013-7#1)(2013-8#2)
tested cells##2##2##(2009-9#1)(2011-2#1)
tested compounds exhibited specific antimicrobial activity##2##6##(2009-6#1)(2011-1#1)
tested compounds were##2##3##(1993-4#1)(2008-8#1)
tested compounds##21##2##(1993-4#1)(1995-12#1)(1997-1#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-5#3)(2008-8#1)(2009-6#2)(2011-1#1)(2011-2#1)(2012-11#2)(2012-3#1)
tested concentrations##5##2##(2008-10#1)(2008-11#2)(2008-7#1)(2013-1#1)
tested could##3##2##(1992-3#1)(1993-6#1)(2007-12#1)
tested criteria##2##2##(2006-10#1)(2006-7#1)
tested decreased in the order of##2##6##(1990-11#1)(2013-1#1)
tested did not##4##3##(1992-11#1)(1997-6#1)(2008-10#1)(2009-8#1)
tested different##3##2##(1996-12#1)(2008-10#1)(2008-11#1)
tested do not##2##3##(1991-9#1)(1992-12#1)
tested dose##2##2##(2005-8#1)(2008-7#1)
tested drugs##2##2##(1991-5#2)
tested during a##2##3##(1991-2#1)(2008-5#1)
tested during the##3##3##(1990-6#1)(2007-6#1)(2010-8#1)
tested during##10##2##(1990-6#1)(1991-2#1)(1992-10#1)(1992-7#1)(1993-5#1)(2007-6#2)(2008-5#1)(2010-8#1)(2012-2#1)
tested empirically##2##2##(2008-8#2)
tested except##5##2##(1996-6#1)(2004-2#1)(2006-8#1)(2007-6#1)(2008-5#1)
tested experimentally##8##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-9#1)
tested first on synthetic##3##4##(2008-10#3)
tested first##5##2##(2008-10#4)(2008-2#1)
tested for 5##2##3##(2008-2#1)(2009-7#1)
tested for HCV RNA##5##4##(1994-8#1)(2007-7#1)(2010-12#1)(2010-4#2)
tested for HIV##16##3##(1993-3#1)(1995-12#1)(1996-11#2)(1996-5#1)(1996-8#1)(2005-10#1)(2007-12#1)(2007-7#2)(2009-5#1)(2010-12#1)(2010-8#1)(2012-3#3)
tested for HIV-1 antibody##2##4##(1991-6#2)
tested for a##8##3##(1990-2#1)(1992-7#1)(1993-2#1)(1995-2#1)(2007-9#1)(2008-10#2)(2008-4#1)
tested for activity against##3##4##(1996-8#1)(1997-2#1)(2006-12#1)
tested for activity##5##3##(1991-4#1)(1996-8#1)(1997-2#1)(2006-12#1)(2008-10#1)
tested for anti##2##3##(1996-5#1)(2007-7#1)
tested for antibodies to##3##4##(1991-6#1)(2007-2#1)(2008-5#1)
tested for binding to##3##4##(1995-1#1)(1996-8#1)(2008-4#1)
tested for binding##4##3##(1992-9#1)(1995-1#1)(1996-8#1)(2008-4#1)
tested for biological activity##2##4##(2004-2#1)(2007-11#1)
tested for cross##2##3##(2010-4#1)(2011-12#1)
tested for cytotoxicity##2##3##(1993-9#1)(2008-5#1)
tested for differences##4##3##(1997-5#1)(2008-10#2)(2008-9#1)
tested for different##2##3##(2008-2#2)
tested for effects on##3##4##(1991-6#1)(1995-12#1)(2008-10#1)
tested for efficacy##2##3##(2007-9#1)(2013-1#1)
tested for inhibition of##5##4##(1992-4#1)(1996-5#1)(1996-8#1)(2010-4#1)(2012-2#1)
tested for initial##2##3##(1991-2#1)(2009-9#1)
tested for its ability to##6##5##(1991-8#1)(1992-2#1)(1992-6#1)(2006-8#1)(2008-10#2)
tested for its##14##3##(1991-8#1)(1992-2#2)(1992-6#1)(1994-6#1)(1996-12#1)(2006-12#1)(2006-8#1)(2008-10#5)(2008-3#1)
tested for pathogenicity on##4##4##(2008-10#4)
tested for potential##4##3##(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)
tested for sensitivity to##2##4##(1993-4#1)(2008-7#1)
tested for specific##4##3##(1992-4#1)(1994-11#1)(2007-2#1)(2008-10#1)
tested for specificity##2##3##(2008-10#2)
tested for the determination of##6##5##(2005-4#1)(2008-10#5)
tested for the presence of##13##5##(1992-7#1)(1992-9#1)(1993-5#1)(2006-10#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2012-3#1)(2013-1#1)
tested for the separation##2##4##(2008-10#1)(2008-7#1)
tested for the three##2##4##(2007-12#1)(2008-10#1)
tested for the##43##3##(1990-12#1)(1991-11#1)(1992-7#1)(1992-9#1)(1993-2#1)(1993-5#1)(1993-7#1)(1994-2#1)(2005-4#1)(2006-10#2)(2007-12#2)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#2)(2010-2#1)(2010-5#1)(2012-11#2)(2012-3#1)(2013-1#1)(2013-8#1)
tested for their ability to bind##2##6##(1991-4#1)(1993-9#1)
tested for their ability to inhibit##7##6##(1991-8#1)(1992-8#1)(1993-11#1)(1994-5#1)(1994-8#1)(1995-11#1)(2008-10#1)
tested for their ability to interact with##2##7##(1992-2#1)(1997-6#1)
tested for their ability to produce##2##6##(2005-11#1)(2007-12#1)
tested for their ability to##28##5##(1990-10#1)(1990-4#1)(1991-4#2)(1991-8#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-7#1)(1997-6#1)(2005-11#1)(2007-12#1)(2007-6#1)(2008-10#6)(2008-4#1)(2008-5#1)
tested for their ability##29##4##(1990-10#1)(1990-4#1)(1991-4#2)(1991-8#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-7#1)(1997-6#1)(2005-11#1)(2007-12#1)(2007-6#1)(2008-10#6)(2008-4#1)(2008-5#2)
tested for their antibacterial activity##2##5##(2006-9#1)(2010-2#1)
tested for their antibacterial##3##4##(2006-9#1)(2010-2#1)(2010-3#1)
tested for their antimicrobial activity##2##5##(2007-11#1)(2012-3#1)
tested for their capacity to##3##5##(1995-3#1)(1996-8#1)(2007-7#1)
tested for their inhibitory##3##4##(1993-4#1)(1994-3#1)(2008-4#1)
tested for their potential##2##4##(1993-9#1)(2005-7#1)
tested for their response to##2##5##(1990-9#1)(2011-2#1)
tested for their##83##3##(1990-10#1)(1990-12#1)(1990-4#1)(1990-9#2)(1991-4#2)(1991-8#1)(1991-9#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-11#2)(2005-7#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-4#3)(2008-5#6)(2008-6#1)(2010-2#1)(2010-3#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
tested for this##2##3##(2006-2#1)(2007-7#1)
tested for toxicity##2##3##(2008-8#1)(2011-1#1)
tested for use##2##3##(2007-9#1)(2008-10#1)
tested for viability##2##3##(1995-3#1)(2008-10#1)
tested for virulence##7##3##(2008-10#5)(2009-2#1)(2009-3#1)
tested for##420##2##(1990-10#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#3)(1991-6#6)(1991-8#3)(1991-9#2)(1992-2#4)(1992-3#1)(1992-4#2)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#2)(1993-4#3)(1993-5#2)(1993-6#2)(1993-7#1)(1993-9#3)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#3)(1994-8#6)(1994-9#2)(1995-1#3)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#2)(1995-8#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#7)(1996-6#1)(1996-7#1)(1996-8#6)(1997-1#1)(1997-2#3)(1997-4#2)(1997-5#2)(1997-6#1)(1997-8#1)(2004-2#1)(2005-10#1)(2005-11#3)(2005-4#2)(2005-7#1)(2006-10#2)(2006-12#4)(2006-2#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#9)(2007-8#3)(2007-9#3)(2008-1#3)(2008-10#95)(2008-11#6)(2008-12#2)(2008-2#7)(2008-3#5)(2008-4#8)(2008-5#18)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#7)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#3)(2009-9#1)(2010-12#2)(2010-2#3)(2010-3#3)(2010-4#4)(2010-5#2)(2010-8#4)(2011-1#1)(2011-12#2)(2011-2#8)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#6)(2012-3#6)(2013-1#9)(2013-7#2)(2013-8#2)
tested four##2##2##(2007-7#2)
tested from##6##2##(1996-12#1)(1997-3#1)(2006-8#2)(2008-10#2)
tested groups##2##2##(1993-7#1)(2007-11#1)
tested had an activity##2##4##(1991-6#2)
tested had the ability to##2##5##(1992-7#1)(2008-10#1)
tested had##10##2##(1991-6#2)(1992-7#1)(1993-7#1)(1994-11#1)(1994-5#1)(2004-9#1)(2007-1#1)(2007-6#1)(2008-10#1)
tested have##2##2##(1993-3#1)(2008-2#1)
tested here in##3##3##(1992-6#1)(1993-12#1)(2008-6#1)
tested here##5##2##(1992-6#1)(1993-12#1)(2008-10#1)(2008-6#1)(2012-5#1)
tested how##2##2##(1997-3#1)(2009-9#1)
tested if##3##2##(1994-10#1)(2008-11#1)(2008-3#1)
tested in 16##2##3##(2005-1#1)(2012-9#1)
tested in 94##2##3##(2008-1#1)(2011-2#1)
tested in a clinical##2##4##(1994-6#1)(2013-1#1)
tested in a field##2##4##(2008-10#1)(2013-8#1)
tested in a randomized##2##4##(1994-4#1)(2008-5#1)
tested in a sample of##3##5##(2009-8#1)(2010-10#1)(2011-1#1)
tested in a series of##4##5##(1995-6#1)(2006-6#1)(2007-12#1)(2008-9#1)
tested in a##57##3##(1990-10#2)(1990-8#1)(1991-3#1)(1991-6#1)(1992-10#1)(1992-9#1)(1993-11#1)(1994-4#1)(1994-6#1)(1995-6#1)(1996-5#1)(1997-7#1)(2004-4#1)(2004-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#3)(2008-10#3)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#2)(2008-9#2)(2009-11#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
tested in an in vivo##2##5##(1990-11#1)(1997-4#1)
tested in an in##3##4##(1990-11#1)(1991-12#1)(1997-4#1)
tested in an##18##3##(1990-11#1)(1990-12#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-3#1)(1993-2#1)(1997-4#2)(2007-11#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-7#1)
tested in animal and##2##4##(2008-7#1)(2010-12#1)
tested in animal models##2##4##(1995-8#1)(2008-5#1)
tested in animal##4##3##(1995-8#1)(2008-5#1)(2008-7#1)(2010-12#1)
tested in clinical trials##11##4##(1991-3#1)(2005-7#1)(2005-8#1)(2008-1#1)(2008-8#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-12#3)
tested in clinical##12##3##(1991-3#1)(2005-7#1)(2005-8#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-12#3)
tested in conjunction with##2##4##(2008-10#1)(2008-3#1)
tested in female##2##3##(2008-10#1)(2008-5#1)
tested in humans##2##3##(2006-12#1)(2008-5#1)
tested in neutral##2##3##(2006-11#2)
tested in order to##6##4##(2005-11#1)(2008-10#3)(2009-3#1)(2011-1#1)
tested in our##2##3##(1997-5#1)(2008-5#1)
tested in several##3##3##(1990-12#1)(2007-11#1)(2008-1#1)
tested in the Morris water##2##5##(1992-11#1)(1994-2#1)
tested in the Morris##3##4##(1992-11#1)(1993-3#1)(1994-2#1)
tested in the analysis of##3##5##(2008-10#3)
tested in the clinic##3##4##(1991-12#1)(2012-12#2)
tested in the clinical setting##2##5##(2006-6#1)(2006-8#1)
tested in the field##3##4##(1996-12#1)(2008-10#2)
tested in the greenhouse##4##4##(2008-10#4)
tested in the in vitro##2##5##(2011-1#2)
tested in the laboratory##6##4##(2004-2#1)(2006-10#1)(2008-10#2)(2008-2#1)(2011-1#1)
tested in the present##2##4##(1994-8#1)(2007-4#1)
tested in the same##2##4##(2005-4#1)(2010-2#1)
tested in the##57##3##(1990-4#1)(1990-5#2)(1990-6#1)(1991-12#1)(1992-11#1)(1993-3#2)(1993-6#1)(1994-2#2)(1994-8#1)(1995-8#1)(1996-10#1)(1996-12#1)(2004-2#1)(2005-4#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#16)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-2#1)(2010-8#1)(2011-1#3)(2012-11#1)(2012-12#2)(2013-1#1)(2013-8#1)
tested in this study was##2##5##(2007-7#1)(2013-1#1)
tested in this study##11##4##(1997-1#1)(2006-12#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-12#2)(2008-5#1)(2013-1#2)
tested in this work##3##4##(1991-2#1)(2008-11#1)(2010-8#1)
tested in this##19##3##(1991-2#1)(1995-3#1)(1997-1#1)(1997-2#1)(2006-12#1)(2006-2#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)(2008-9#1)(2010-10#1)(2010-8#1)(2013-1#2)
tested in three##3##3##(1996-4#1)(2008-5#1)(2013-8#1)
tested in transient##2##3##(1995-3#1)(1996-4#1)
tested in two##6##3##(1997-2#1)(2006-11#1)(2008-10#1)(2008-3#1)(2012-1#1)(2013-8#1)
tested in vitro against##4##4##(2007-11#1)(2008-3#1)(2008-5#1)(2009-3#1)
tested in vitro and in vivo##2##6##(2007-8#1)(2011-2#1)
tested in vitro and in##4##5##(2007-8#1)(2008-10#1)(2008-8#1)(2011-2#1)
tested in vitro on##2##4##(1994-11#1)(2008-3#1)
tested in vitro with##3##4##(1995-2#1)(2007-1#1)(2008-10#1)
tested in vitro##19##3##(1994-11#1)(1995-2#1)(2007-1#2)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#3)(2008-5#2)(2008-8#1)(2009-12#1)(2009-3#1)(2011-12#1)(2011-2#1)(2013-8#1)
tested in vivo for##3##4##(1994-9#1)(1997-3#1)(1997-7#1)
tested in vivo##4##3##(1990-4#1)(1994-9#1)(1997-3#1)(1997-7#1)
tested in##359##2##(1990-10#4)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#2)(1991-12#2)(1991-2#2)(1991-3#3)(1991-6#1)(1992-10#1)(1992-11#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#4)(1993-5#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-6#2)(1994-8#2)(1994-9#3)(1995-1#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-12#3)(1996-4#3)(1996-5#2)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#3)(2004-2#1)(2004-4#3)(2004-8#1)(2004-9#1)(2005-1#1)(2005-11#2)(2005-4#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-11#4)(2006-12#4)(2006-2#1)(2006-5#3)(2006-6#2)(2006-8#2)(2007-1#5)(2007-10#1)(2007-11#10)(2007-12#1)(2007-2#1)(2007-3#3)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#6)(2007-9#2)(2008-1#3)(2008-10#56)(2008-11#8)(2008-12#6)(2008-2#3)(2008-3#12)(2008-4#3)(2008-5#18)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#5)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#4)(2009-7#2)(2009-8#2)(2010-10#2)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#4)(2011-1#7)(2011-12#2)(2011-2#7)(2012-1#3)(2012-11#1)(2012-12#7)(2012-2#2)(2012-3#2)(2012-9#1)(2013-1#5)(2013-7#2)(2013-8#6)
tested include##2##2##(2008-10#1)(2008-3#1)
tested included Bacteroides fragilis##2##4##(2006-5#1)(2006-8#1)
tested included Bacteroides##3##3##(2006-5#1)(2006-8#2)
tested included##4##2##(2005-8#1)(2006-5#1)(2006-8#2)
tested including##3##2##(2008-10#1)(2011-1#1)(2012-3#1)
tested increased##3##2##(1995-11#1)(2009-3#2)
tested individually##2##2##(1996-12#1)(1996-5#1)
tested individuals##2##2##(2006-6#1)(2008-8#1)
tested induced##2##2##(1990-12#1)(2008-5#1)
tested inhibited##3##2##(1995-6#1)(2008-10#1)(2010-3#1)
tested isolates were##3##3##(2006-4#1)(2008-10#1)(2008-12#1)
tested isolates##8##2##(2006-4#1)(2008-10#5)(2008-12#1)(2012-2#1)
tested it in##2##3##(2007-8#1)(2008-9#1)
tested it##5##2##(1992-5#1)(1994-9#1)(2007-8#1)(2008-3#1)(2008-9#1)
tested its##6##2##(1991-11#1)(1991-9#1)(2007-7#1)(2008-11#1)(2008-3#1)(2012-2#1)
tested joints##2##2##(2007-7#1)(2009-7#1)
tested materials##3##2##(2008-10#1)(2008-12#1)(2013-1#1)
tested media##2##2##(2007-11#1)(2008-10#1)
tested members of##2##3##(2008-10#1)(2009-12#1)
tested negative for##6##3##(1993-7#2)(2007-6#1)(2008-10#1)(2008-6#1)(2011-2#1)
tested negative##12##2##(1993-7#2)(1996-5#1)(1996-6#1)(2007-6#1)(2008-10#2)(2008-4#1)(2008-6#1)(2009-4#2)(2011-2#1)
tested on 10##2##3##(1991-3#1)(2013-7#1)
tested on 25##2##3##(2006-8#1)(2008-10#1)
tested on a set of##6##5##(2008-10#1)(2012-1#1)(2013-1#4)
tested on a##26##3##(1993-3#1)(1994-3#2)(1994-6#1)(1995-3#1)(1997-8#2)(2007-8#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-5#1)(2009-10#1)(2009-9#1)(2010-8#1)(2012-1#3)(2012-2#1)(2013-1#4)
tested on an##3##3##(1992-8#1)(2008-3#1)(2008-6#1)
tested on data from##2##4##(2008-10#2)
tested on data##3##3##(2008-10#2)(2008-9#1)
tested on sawbones##2##3##(2007-5#1)(2008-9#1)
tested on seven##3##3##(2008-12#1)(2013-1#2)
tested on several##5##3##(1995-10#1)(2008-10#2)(2008-3#2)
tested on simulated##2##3##(1991-12#1)(2009-8#1)
tested on synthetic##2##3##(2008-10#1)(2008-3#1)
tested on the##18##3##(1991-5#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-2#1)(1994-2#1)(1994-5#1)(1997-5#1)(2004-2#1)(2008-10#4)(2008-2#1)(2008-4#1)(2010-8#1)(2012-2#1)(2012-3#1)
tested on their##2##3##(1992-11#1)(2012-1#1)
tested on three##4##3##(2008-12#1)(2008-3#1)(2010-2#1)(2012-2#1)
tested on two##4##3##(1992-3#1)(1993-7#1)(2006-5#1)(2008-7#1)
tested on##140##2##(1990-2#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-9#1)(1995-10#1)(1995-3#1)(1997-5#1)(1997-6#1)(1997-8#2)(2004-2#1)(2006-5#2)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-5#2)(2007-8#3)(2008-10#30)(2008-11#2)(2008-12#4)(2008-2#7)(2008-3#9)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#2)(2011-1#1)(2012-1#5)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#1)
tested only##3##2##(1991-7#1)(1996-2#1)(2009-3#1)
tested our##6##2##(2012-2#1)(2012-3#1)(2013-1#4)
tested over##5##2##(2007-7#1)(2008-10#3)(2008-2#1)
tested patients##3##2##(2006-6#1)(2007-2#1)(2008-3#1)
tested per##3##2##(2007-11#1)(2010-4#1)(2011-2#1)
tested phenols##2##2##(2008-10#1)(2011-1#1)
tested plants##2##2##(2008-8#1)(2011-1#1)
tested positive by##4##3##(1995-2#1)(2007-2#1)(2008-10#1)(2013-1#1)
tested positive for HIV##2##4##(1991-6#1)(1996-6#1)
tested positive for a##2##4##(2006-8#1)(2007-3#1)
tested positive for circulating AFP mRNA##4##6##(2008-10#4)
tested positive for##24##3##(1991-3#1)(1991-6#1)(1996-6#1)(1996-9#1)(2006-10#1)(2006-8#3)(2007-2#3)(2007-3#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
tested positive to one or##2##5##(2006-10#1)(2008-10#1)
tested positive with##2##3##(2007-8#1)(2008-10#1)
tested positive##41##2##(1991-3#1)(1991-6#2)(1995-2#1)(1996-6#1)(1996-9#1)(2006-10#2)(2006-8#3)(2007-2#6)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-12#1)(2008-3#1)(2008-7#3)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
tested postsurgically for##2##3##(1993-3#2)
tested prior to##2##3##(1994-8#1)(2006-8#1)
tested produced##3##2##(1990-2#1)(1990-7#1)(1994-9#1)
tested prospectively##2##2##(1990-3#1)(2006-7#1)
tested ranged from##2##3##(1995-3#1)(2008-10#1)
tested resulted in##2##3##(2008-10#1)(2011-1#1)
tested sample##3##2##(1993-1#1)(2008-10#2)
tested samples##4##2##(1992-6#1)(1997-4#1)(2008-10#2)
tested separately##4##2##(2008-10#3)(2010-8#1)
tested sera of##2##3##(1994-3#1)(1996-4#1)
tested seropositive##2##2##(2007-2#1)(2013-8#1)
tested several##3##2##(2006-12#1)(2009-10#1)(2012-2#1)
tested showed##5##2##(1990-7#1)(1992-3#1)(2008-10#2)(2008-8#1)
tested significantly##2##2##(2008-10#1)(2008-6#1)
tested since##2##2##(1996-5#1)(2013-1#1)
tested singly##3##2##(1996-4#1)(2004-2#1)(2008-10#1)
tested so far##5##3##(1993-11#1)(1997-4#1)(2006-10#1)(2008-5#1)(2008-7#1)
tested solutions##4##2##(2008-10#1)(2009-6#2)(2011-1#1)
tested species##7##2##(1997-1#3)(2008-10#2)(2008-11#1)(2012-2#1)
tested standard##2##2##(2008-10#1)(2008-3#1)
tested strains##6##2##(2006-8#1)(2008-10#2)(2009-6#1)(2010-4#1)(2011-2#1)
tested substances##4##2##(1992-5#1)(2008-10#1)(2008-5#1)(2009-6#1)
tested substrates##2##2##(2006-10#1)(2010-5#1)
tested successfully##2##2##(1993-6#1)(2008-3#1)
tested such as##2##3##(2008-10#1)(2010-4#1)
tested such##3##2##(2008-10#1)(2008-3#1)(2010-4#1)
tested that##11##2##(1992-11#1)(1993-2#1)(1994-8#1)(1995-10#1)(1997-2#1)(2006-12#1)(2008-10#3)(2008-2#1)(2012-12#1)
tested the ability of##10##4##(1990-5#1)(1993-4#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-5#1)(2008-11#1)(2008-2#1)(2008-5#1)(2012-1#1)
tested the ability##11##3##(1990-5#1)(1993-4#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-5#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-3#1)(2012-1#1)
tested the effect of flupirtine##2##5##(1995-12#2)
tested the effect of##14##4##(1992-3#1)(1993-7#1)(1995-12#3)(1996-9#1)(1997-6#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-8#1)(2012-1#1)(2013-1#1)
tested the effectiveness of##3##4##(1993-3#1)(2008-11#2)
tested the effects of##8##4##(1994-8#1)(1995-2#2)(1997-1#1)(2008-5#1)(2008-9#1)(2009-12#1)(2011-1#1)
tested the effects##9##3##(1994-8#1)(1995-2#2)(1997-1#1)(2008-5#1)(2008-9#1)(2009-12#1)(2011-1#1)(2012-12#1)
tested the efficiency of##2##4##(2009-8#1)(2011-1#1)
tested the feasibility of the##2##5##(2008-5#1)(2008-8#1)
tested the feasibility of##4##4##(2007-9#1)(2008-3#1)(2008-5#1)(2008-8#1)
tested the feasibility##5##3##(2007-9#1)(2008-3#1)(2008-5#1)(2008-8#1)(2013-1#1)
tested the hypothesis that the##14##5##(1992-8#1)(1993-6#1)(1995-11#1)(1995-8#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2012-12#1)(2012-3#1)(2013-1#2)
tested the hypothesis that##51##4##(1990-4#2)(1990-5#1)(1991-5#1)(1992-5#1)(1992-8#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-8#1)(1997-1#1)(1997-5#1)(1997-8#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#4)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-11#2)(2009-5#1)(2009-9#1)(2010-12#2)(2010-2#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
tested the hypothesis##53##3##(1990-4#2)(1990-5#1)(1991-5#1)(1992-5#1)(1992-8#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-8#1)(1997-1#1)(1997-5#1)(1997-8#1)(2004-11#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#4)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-11#2)(2009-5#1)(2009-9#1)(2010-12#2)(2010-2#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
tested the impact of##2##4##(1996-12#1)(1997-3#1)
tested the model##3##3##(2010-2#1)(2013-1#2)
tested the performance of##4##4##(2008-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
tested the possibility that the##2##5##(1992-1#1)(1996-4#1)
tested the possibility that##4##4##(1992-1#1)(1996-4#1)(2009-8#1)(2009-9#1)
tested the possibility##5##3##(1992-1#1)(1996-4#1)(2009-8#1)(2009-9#1)(2010-6#1)
tested the potential##3##3##(1992-12#1)(2009-6#1)(2010-10#1)
tested the prediction##2##3##(2006-3#1)(2012-2#1)
tested the protective##2##3##(2007-9#1)(2009-6#1)
tested the relationship between the##2##5##(2012-11#1)(2012-12#1)
tested the relationship between##3##4##(2011-1#1)(2012-11#1)(2012-12#1)
tested the role of the##2##5##(1991-2#1)(1994-5#1)
tested the role of##3##4##(1991-2#1)(1992-5#1)(1994-5#1)
tested the##180##2##(1990-10#1)(1990-4#2)(1990-5#2)(1991-2#1)(1991-5#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-5#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#5)(1995-2#4)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-3#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-11#1)(2006-11#1)(2006-2#1)(2006-3#1)(2007-10#2)(2007-12#3)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#2)(2008-10#9)(2008-11#4)(2008-2#2)(2008-3#9)(2008-5#7)(2008-7#3)(2008-8#4)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#2)(2010-12#4)(2010-2#5)(2010-6#1)(2010-8#3)(2011-1#3)(2011-2#2)(2012-1#5)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#4)(2013-1#9)(2013-7#1)(2013-8#1)
tested their##5##2##(1996-11#1)(1996-4#1)(1997-3#1)(2011-2#2)
tested them##4##2##(1991-2#1)(1992-3#1)(1993-12#1)(2008-5#1)
tested these predictions in##2##4##(2007-4#1)(2008-8#1)
tested these predictions##3##3##(1995-8#1)(2007-4#1)(2008-8#1)
tested these##5##2##(1995-8#1)(2007-4#1)(2008-2#1)(2008-8#1)(2012-3#1)
tested this hypothesis in##2##4##(1996-3#1)(2009-7#1)
tested this hypothesis##5##3##(1996-3#1)(1996-4#1)(2009-4#1)(2009-7#1)(2009-8#1)
tested this prediction by##3##4##(2008-8#2)(2009-2#1)
tested this prediction##4##3##(2008-1#1)(2008-8#2)(2009-2#1)
tested this##18##2##(1990-6#1)(1991-9#1)(1992-11#1)(1993-6#1)(1996-3#1)(1996-4#2)(1997-3#1)(2006-12#1)(2008-1#1)(2008-8#3)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#2)
tested three##8##2##(1991-3#1)(1992-7#1)(1996-5#1)(2006-3#1)(2008-8#1)(2009-11#1)(2013-1#2)
tested through##8##2##(2008-10#1)(2008-2#1)(2008-5#2)(2010-10#1)(2010-2#1)(2011-2#1)(2013-8#1)
tested thus far##4##3##(1993-11#1)(1997-5#1)(2008-10#1)(2011-1#1)
tested tissues##2##2##(1990-12#1)(1997-4#1)
tested to be##2##3##(2008-10#1)(2008-3#1)
tested to date##2##3##(2008-10#1)(2010-4#1)
tested to determine if the##2##5##(1992-2#1)(2008-5#1)
tested to determine if##3##4##(1992-2#1)(1996-11#1)(2008-5#1)
tested to determine##7##3##(1990-5#1)(1991-5#1)(1991-9#1)(1992-2#1)(1996-11#1)(2008-5#1)(2009-7#1)
tested to establish##2##3##(2008-2#1)(2011-2#1)
tested to failure##4##3##(2006-11#1)(2008-9#2)(2009-3#1)
tested to optimize##3##3##(2008-10#2)(2008-5#1)
tested to reduce##3##3##(1991-4#1)(2006-4#1)(2011-1#1)
tested to##43##2##(1990-5#1)(1991-11#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-2#2)(1995-2#1)(1996-1#1)(1996-11#1)(1997-5#1)(2006-11#2)(2006-4#1)(2008-1#1)(2008-10#12)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#3)(2008-9#2)(2009-3#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
tested two##6##2##(1996-2#1)(2007-2#1)(2007-8#1)(2008-8#1)(2008-9#1)(2009-4#1)
tested under similar conditions##2##4##(2007-11#1)(2009-7#1)
tested under##20##2##(1992-2#1)(1994-2#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2009-3#2)(2009-4#1)(2009-7#1)(2012-2#1)(2012-3#1)
tested using a##13##3##(1993-9#1)(1997-3#1)(2007-1#2)(2008-10#4)(2008-12#1)(2008-3#1)(2010-5#1)(2011-2#1)(2012-1#1)
tested using an##2##3##(2006-8#1)(2007-2#1)
tested using data##3##3##(2008-10#2)(2010-4#1)
tested using the##14##3##(1990-5#1)(1996-2#1)(2007-10#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-3#1)(2009-2#1)(2010-4#1)(2011-2#2)(2013-8#1)
tested using two##4##3##(1995-2#1)(2006-4#1)(2008-10#2)
tested using##69##2##(1990-2#1)(1990-5#2)(1992-6#1)(1992-9#1)(1993-9#1)(1995-2#2)(1996-12#1)(1996-2#1)(1997-3#1)(2006-4#1)(2006-5#2)(2006-8#1)(2007-1#2)(2007-10#1)(2007-12#3)(2007-2#1)(2007-4#1)(2008-10#17)(2008-11#2)(2008-12#2)(2008-3#2)(2008-9#2)(2009-12#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-3#1)(2013-1#2)(2013-8#2)
tested vaccines##2##2##(1995-5#2)
tested versus##2##2##(1994-9#1)(2008-3#1)
tested via##2##2##(2008-10#1)(2012-12#1)
tested was found##2##3##(2008-6#1)(2010-5#1)
tested was observed##3##3##(2008-10#2)(2008-11#1)
tested was##22##2##(1991-5#2)(1992-8#1)(1993-6#1)(1994-12#1)(1995-2#1)(1997-7#1)(2006-8#1)(2007-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-6#1)(2009-7#1)(2010-5#1)(2013-1#1)
tested were highly##2##3##(2008-10#2)
tested were inhibited##2##3##(2008-10#2)
tested were sensitive##2##3##(2008-10#2)
tested were susceptible to##3##4##(2008-10#2)(2012-2#1)
tested were susceptible##4##3##(2008-10#2)(2008-5#1)(2012-2#1)
tested were##43##2##(1991-2#1)(1992-6#1)(1992-9#1)(1993-7#1)(1994-8#1)(1995-3#1)(1995-8#1)(2004-4#1)(2005-9#1)(2006-10#2)(2006-2#1)(2006-8#2)(2008-1#1)(2008-10#15)(2008-5#3)(2008-6#1)(2008-7#1)(2009-5#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-12#3)(2012-2#1)
tested when compared to##2##4##(1990-6#1)(2008-10#1)
tested when##4##2##(1990-6#1)(2007-6#1)(2008-10#2)
tested whether the##7##3##(1991-5#1)(1991-6#1)(1992-12#1)(1994-11#1)(1996-2#1)(2008-9#1)(2012-12#1)
tested whether this##2##3##(2008-4#1)(2013-8#1)
tested whether##38##2##(1991-5#2)(1991-6#1)(1992-10#1)(1992-12#1)(1992-7#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-9#3)(2010-6#2)(2011-12#1)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
tested which##2##2##(1990-12#1)(2005-7#1)
tested while##4##2##(1994-9#1)(2006-11#1)(2007-7#1)(2008-10#1)
tested with a##10##3##(1992-6#1)(1995-2#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-3#2)(2011-2#1)(2012-1#1)
tested with pure##2##3##(1997-6#1)(2013-1#1)
tested with reference##2##3##(2008-2#1)(2011-2#1)
tested with simulated##2##3##(2008-2#2)
tested with the##20##3##(1992-8#2)(1994-2#1)(1994-9#1)(1995-8#1)(1996-10#1)(1997-7#1)(2006-11#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-12#1)(2012-1#2)
tested with their##2##3##(2005-10#1)(2013-1#1)
tested with two##4##3##(1990-6#1)(2007-12#1)(2008-4#1)(2009-4#1)
tested with##119##2##(1990-12#1)(1990-4#1)(1990-6#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-9#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-2#2)(1996-8#1)(1997-1#1)(1997-6#2)(1997-7#2)(1997-8#1)(2005-10#1)(2006-10#1)(2006-11#2)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#4)(2007-8#1)(2007-9#2)(2008-10#27)(2008-11#4)(2008-2#4)(2008-3#7)(2008-4#1)(2008-5#5)(2008-7#2)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-2#3)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#3)(2012-1#4)(2012-12#1)(2013-1#5)
tested within the##4##3##(1995-5#1)(2008-10#1)(2009-4#1)(2010-12#1)
tested within##5##2##(1995-5#1)(2008-10#2)(2009-4#1)(2010-12#1)
tested##3321##1##(1990-1#1)(1990-10#11)(1990-11#16)(1990-12#14)(1990-2#13)(1990-3#8)(1990-4#9)(1990-5#11)(1990-6#7)(1990-7#7)(1990-8#5)(1990-9#6)(1991-1#3)(1991-10#5)(1991-11#6)(1991-12#8)(1991-2#11)(1991-3#17)(1991-4#4)(1991-5#13)(1991-6#17)(1991-7#4)(1991-8#7)(1991-9#14)(1992-1#4)(1992-10#5)(1992-11#7)(1992-12#6)(1992-2#12)(1992-3#15)(1992-4#2)(1992-5#9)(1992-6#14)(1992-7#18)(1992-8#17)(1992-9#12)(1993-1#2)(1993-10#2)(1993-11#10)(1993-12#18)(1993-2#11)(1993-3#18)(1993-4#10)(1993-5#4)(1993-6#16)(1993-7#11)(1993-8#2)(1993-9#15)(1994-1#1)(1994-10#3)(1994-11#10)(1994-12#14)(1994-2#17)(1994-3#21)(1994-4#1)(1994-5#8)(1994-6#14)(1994-8#22)(1994-9#15)(1995-1#11)(1995-10#5)(1995-11#6)(1995-12#20)(1995-2#19)(1995-3#16)(1995-5#13)(1995-6#10)(1995-7#2)(1995-8#13)(1996-1#3)(1996-10#3)(1996-11#9)(1996-12#17)(1996-2#12)(1996-3#4)(1996-4#13)(1996-5#20)(1996-6#13)(1996-7#5)(1996-8#14)(1996-9#6)(1997-1#13)(1997-2#20)(1997-3#14)(1997-4#15)(1997-5#12)(1997-6#17)(1997-7#12)(1997-8#12)(2004-11#4)(2004-12#3)(2004-2#6)(2004-4#7)(2004-8#1)(2004-9#6)(2005-1#3)(2005-10#5)(2005-11#11)(2005-12#2)(2005-4#3)(2005-6#1)(2005-7#6)(2005-8#4)(2005-9#3)(2006-1#1)(2006-10#24)(2006-11#13)(2006-12#19)(2006-2#5)(2006-3#4)(2006-4#5)(2006-5#10)(2006-6#8)(2006-7#4)(2006-8#48)(2006-9#3)(2007-1#16)(2007-10#14)(2007-11#45)(2007-12#36)(2007-2#16)(2007-3#5)(2007-4#17)(2007-5#8)(2007-6#17)(2007-7#36)(2007-8#33)(2007-9#16)(2008-1#21)(2008-10#644)(2008-11#70)(2008-12#36)(2008-2#80)(2008-3#97)(2008-4#22)(2008-5#140)(2008-6#25)(2008-7#49)(2008-8#51)(2008-9#36)(2009-1#2)(2009-10#7)(2009-11#9)(2009-12#9)(2009-2#8)(2009-3#22)(2009-4#10)(2009-5#9)(2009-6#10)(2009-7#18)(2009-8#13)(2009-9#12)(2010-1#3)(2010-10#8)(2010-11#1)(2010-12#20)(2010-2#19)(2010-3#12)(2010-4#25)(2010-5#12)(2010-6#4)(2010-8#22)(2010-9#3)(2011-1#41)(2011-12#6)(2011-2#61)(2011-3#2)(2012-1#28)(2012-11#11)(2012-12#38)(2012-2#40)(2012-3#30)(2012-5#1)(2012-7#1)(2012-9#1)(2013-1#88)(2013-7#15)(2013-8#29)
tested)##4##1##(1992-7#1)(2008-10#3)
tester amplicons##2##2##(2008-2#2)
tester isolate##3##2##(2008-10#3)
tester isolates##6##2##(2008-10#6)
tester strain##2##2##(1992-2#1)(2008-10#1)
tester strains and##2##3##(2008-10#1)(2008-12#1)
tester strains of##3##3##(2008-10#3)
tester strains##10##2##(1991-12#1)(1995-4#1)(2008-10#5)(2008-12#1)(2011-1#1)(2011-12#1)
tester with##2##2##(2007-11#1)(2012-2#1)
tester##53##1##(1991-12#1)(1992-2#1)(1995-4#1)(2004-9#1)(2007-1#1)(2007-11#1)(2008-10#16)(2008-11#1)(2008-12#2)(2008-2#6)(2008-3#9)(2008-5#3)(2009-7#2)(2010-4#1)(2011-1#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
tester's##3##1##(2008-12#2)(2008-3#1)
testers##9##1##(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2010-12#1)
testes and epididymides##3##3##(2005-9#1)(2008-3#1)(2008-5#1)
testes and##16##2##(1990-2#1)(1990-7#1)(2005-9#1)(2006-7#1)(2007-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2010-2#4)
testes are using different regulators to monitor junction turnover##2##9##(2009-10#2)
testes in##4##2##(1990-3#1)(2008-10#1)(2008-12#1)(2008-4#1)
testes of rats##2##3##(1997-1#1)(2013-1#1)
testes of##11##2##(1994-8#2)(1996-8#1)(1997-1#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#1)(2013-1#1)
testes or##4##2##(1990-11#1)(1993-12#1)(1993-7#1)(2006-2#1)
testes was##2##2##(1995-6#1)(2008-3#1)
testes weight and##2##3##(2008-5#2)
testes weight##3##2##(2008-5#2)(2013-7#1)
testes were##7##2##(1992-12#2)(1994-3#1)(2008-5#1)(2008-9#1)(2010-4#1)(2011-1#1)
testes with short spermatic vessels##2##5##(2006-2#1)(2012-2#1)
testes with##3##2##(2006-2#1)(2008-5#1)(2012-2#1)
testes##128##1##(1990-11#2)(1990-2#1)(1990-3#2)(1990-7#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-5#1)(1992-7#1)(1993-12#2)(1993-2#1)(1993-7#1)(1993-9#1)(1994-3#4)(1994-8#3)(1995-10#1)(1995-2#4)(1995-3#1)(1995-6#1)(1996-5#1)(1996-8#3)(1997-1#2)(1997-4#1)(1997-6#1)(2005-9#1)(2006-10#1)(2006-2#4)(2006-5#1)(2006-7#2)(2007-12#1)(2008-1#2)(2008-10#4)(2008-12#5)(2008-3#3)(2008-4#6)(2008-5#12)(2008-6#4)(2008-7#7)(2008-8#1)(2008-9#1)(2009-10#10)(2010-2#5)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-2#8)(2013-1#1)(2013-7#3)
testicle and##2##2##(2006-10#2)
testicle##9##1##(2004-2#1)(2006-10#3)(2006-2#1)(2008-10#3)(2008-5#1)
testicles were##2##2##(2006-10#1)(2012-12#1)
testicles##11##1##(2004-2#1)(2006-10#1)(2008-10#3)(2008-12#1)(2012-12#3)(2013-1#2)
testicular GSH##2##2##(2010-4#2)
testicular and hepatic biotransformation of##2##5##(1995-2#2)
testicular and##6##2##(1995-11#1)(1995-2#2)(2006-10#1)(2010-1#1)(2010-12#1)
testicular autotransplant##2##2##(2006-2#2)
testicular biopsy##3##2##(1990-9#1)(1997-3#1)(2006-2#1)
testicular cancer and##4##3##(1995-5#1)(1996-5#1)(2009-5#1)(2012-2#1)
testicular cancer was##3##3##(1992-5#1)(2006-7#2)
testicular cancer##34##2##(1990-2#1)(1990-9#1)(1992-5#1)(1992-6#1)(1994-7#3)(1995-5#2)(1996-5#1)(2006-7#5)(2007-5#2)(2008-11#1)(2008-7#2)(2009-5#6)(2012-2#8)
testicular cancers##3##2##(1994-7#1)(2007-5#1)(2012-2#1)
testicular cells##3##2##(1991-4#1)(2011-1#1)(2013-7#1)
testicular choriocarcinoma##3##2##(2007-7#3)
testicular descent##6##2##(2006-9#4)(2008-10#2)
testicular dose##4##2##(2008-3#4)
testicular dysfunction##2##2##(2010-4#2)
testicular expression##2##2##(1994-8#1)(2010-5#1)
testicular function##8##2##(1992-12#1)(1997-3#1)(2006-5#2)(2009-10#1)(2011-2#2)(2013-8#1)
testicular germ cell##2##3##(2008-10#1)(2012-2#1)
testicular germ cells##2##3##(1990-8#1)(2012-2#1)
testicular germ##4##2##(1990-8#1)(2008-10#1)(2012-2#2)
testicular histology##2##2##(2008-6#1)(2012-12#1)
testicular hyaluronidase##5##2##(1992-6#1)(1994-5#4)
testicular lipid peroxidation##2##3##(2008-10#1)(2011-2#1)
testicular mass##4##2##(2008-6#1)(2010-7#1)(2011-1#1)(2012-2#1)
testicular neoplasms##5##2##(2006-10#1)(2007-5#3)(2007-6#1)
testicular pain##3##2##(1991-2#1)(1992-4#1)(2007-7#1)
testicular protein band##2##3##(1992-4#2)
testicular protein##4##2##(1992-4#2)(1993-7#1)(1995-6#1)
testicular seminoma##2##2##(2008-6#1)(2011-1#1)
testicular shield##3##2##(2009-11#3)
testicular signaling##2##2##(2012-2#2)
testicular size##2##2##(2006-2#1)(2013-8#1)
testicular sperm morphology##4##3##(2008-5#4)
testicular sperm##12##2##(2008-3#1)(2008-5#8)(2008-6#1)(2012-12#1)(2012-3#1)
testicular spermatogenesis##3##2##(2008-7#2)(2009-10#1)
testicular tissue##7##2##(1995-11#3)(2008-10#1)(2008-4#1)(2013-1#2)
testicular torsion##7##2##(2008-10#7)
testicular tumor##2##2##(1996-5#1)(2008-10#1)
testicular tumors in##2##3##(1992-5#1)(2007-3#1)
testicular tumors##5##2##(1990-9#1)(1992-5#1)(1994-8#1)(2007-3#1)(2008-10#1)
testicular tumours##5##2##(1996-8#1)(2007-7#1)(2011-2#3)
testicular volume##4##2##(2006-10#3)(2012-12#1)
testicular volumes##2##2##(1993-3#2)
testicular##251##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#6)(1991-2#1)(1991-4#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-4#3)(1992-5#2)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-7#1)(1994-11#1)(1994-2#1)(1994-5#5)(1994-7#5)(1994-8#2)(1995-11#7)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#1)(1996-5#3)(1996-8#1)(1996-9#1)(1997-3#2)(2006-10#6)(2006-2#7)(2006-5#2)(2006-7#5)(2006-9#6)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#6)(2007-6#3)(2007-7#5)(2007-8#2)(2008-1#2)(2008-10#23)(2008-11#1)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#8)(2008-6#6)(2008-7#4)(2009-10#6)(2009-11#3)(2009-5#12)(2010-1#2)(2010-12#1)(2010-4#10)(2010-5#2)(2010-7#2)(2011-1#4)(2011-2#8)(2012-1#2)(2012-12#5)(2012-2#22)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
testified by##2##2##(1990-12#1)(2011-3#1)
testified##5##1##(1990-12#1)(2008-10#1)(2008-8#2)(2011-3#1)
testify that##2##2##(2008-11#1)(2013-1#1)
testify the##3##2##(2008-10#2)(2013-1#1)
testify to the##5##3##(2007-12#1)(2008-10#3)(2008-8#1)
testify to##6##2##(2007-12#1)(2008-10#3)(2008-8#1)(2009-2#1)
testify##14##1##(1996-12#1)(2007-12#1)(2007-4#1)(2008-10#5)(2008-11#1)(2008-8#1)(2009-2#1)(2011-12#1)(2013-1#2)
testifying at##2##2##(1991-10#1)(2008-1#1)
testifying##4##1##(1991-10#1)(2008-1#1)(2008-10#1)(2008-7#1)
testimonials##2##1##(2008-7#1)(2008-9#1)
testimonies##2##1##(1994-3#1)(2010-9#1)
testimony are##2##2##(2006-11#1)(2007-4#1)
testimony in the criminal proceedings##2##5##(2011-2#2)
testimony in##5##2##(1992-2#1)(2007-4#1)(2008-10#1)(2011-2#2)
testimony of##3##2##(1994-3#1)(1996-2#1)(2008-10#1)
testimony on##2##2##(1992-3#1)(2011-2#1)
testimony to the##2##3##(2008-9#1)(2009-10#1)
testimony to##3##2##(2008-3#1)(2008-9#1)(2009-10#1)
testimony##33##1##(1992-12#1)(1992-2#1)(1992-3#1)(1994-2#1)(1994-3#1)(1996-2#1)(2005-3#1)(2006-11#1)(2006-8#1)(2007-4#11)(2008-10#2)(2008-12#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-2#1)(2011-2#6)
testing a##11##2##(1993-10#1)(1996-2#1)(1996-7#1)(1997-3#1)(2004-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2012-12#1)(2013-8#1)
testing according to##2##3##(2004-9#1)(2012-11#1)
testing accuracy##2##2##(2008-8#2)
testing against##2##2##(2004-2#1)(2008-5#1)
testing algorithm##3##2##(1997-2#1)(2008-10#1)(2008-2#1)
testing among##6##2##(1996-8#1)(2006-10#2)(2009-5#2)(2010-12#1)
testing and application of##2##4##(2008-10#1)(2008-4#1)
testing and counseling##3##3##(1990-12#2)(1997-5#1)
testing and diagnostic##2##3##(2006-10#1)(2011-2#1)
testing and management##3##3##(1994-9#1)(2012-2#2)
testing and possible##2##3##(2006-8#1)(2007-8#1)
testing and prevention##2##3##(2009-5#1)(2011-2#1)
testing and preventive##2##3##(1990-12#1)(2011-2#1)
testing and situational assessment methods##2##5##(2007-5#2)
testing and the##8##3##(1993-9#1)(2008-3#1)(2008-8#1)(2010-6#1)(2012-12#2)(2012-2#1)(2013-8#1)
testing and treatment##7##3##(1996-1#1)(1997-2#3)(2004-9#1)(2007-10#1)(2011-2#1)
testing and validation##2##3##(2008-10#2)
testing and##108##2##(1990-12#3)(1990-6#1)(1991-2#1)(1993-3#1)(1993-9#1)(1994-9#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-3#2)(1996-4#1)(1996-6#1)(1997-2#3)(1997-5#2)(1997-8#1)(2004-9#2)(2006-10#5)(2006-3#1)(2006-8#2)(2007-10#1)(2007-12#2)(2007-3#1)(2007-5#2)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#6)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#4)(2009-10#2)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#2)(2010-11#1)(2010-5#1)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#1)(2011-2#9)(2011-8#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#2)
testing approaches##3##2##(1994-2#1)(2006-7#1)(2012-3#1)
testing are discussed##2##3##(2006-10#1)(2013-1#1)
testing are important##2##3##(2006-11#1)(2012-12#1)
testing are##12##2##(1992-12#1)(1994-2#1)(1996-12#1)(2006-10#1)(2006-11#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-5#1)(2012-12#1)(2013-1#1)
testing as a##3##3##(1992-1#1)(1996-12#1)(2007-8#1)
testing as an##2##3##(2006-10#1)(2008-10#1)
testing as the##2##3##(2008-12#1)(2008-5#1)
testing as well as##4##4##(2006-10#1)(2008-11#1)(2008-4#1)(2009-5#1)
testing as##17##2##(1990-12#1)(1992-1#1)(1994-12#1)(1996-12#1)(2006-10#3)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-5#1)(2011-1#1)(2012-1#1)
testing assays##2##2##(2007-12#1)(2008-8#1)
testing at five years of age##2##6##(2006-7#2)
testing at the##2##3##(1994-12#1)(1997-4#1)
testing at##13##2##(1991-7#1)(1994-12#1)(1995-12#1)(1997-4#1)(2005-8#1)(2006-7#2)(2006-8#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-4#1)
testing based on##3##3##(1997-7#1)(2008-3#1)(2008-9#1)
testing based##4##2##(1997-7#1)(2008-2#1)(2008-3#1)(2008-9#1)
testing becomes##3##2##(1997-8#1)(2006-10#1)(2008-10#1)
testing before##2##2##(1993-9#1)(2007-2#1)
testing but##5##2##(2005-11#1)(2007-1#1)(2008-12#1)(2010-12#1)(2012-12#1)
testing by the##2##3##(2008-12#1)(2008-5#1)
testing by##17##2##(1994-1#1)(1994-6#1)(2007-9#1)(2008-10#1)(2008-12#4)(2008-5#1)(2008-9#3)(2010-11#1)(2012-3#1)(2013-1#2)(2013-8#1)
testing can be performed##2##4##(1992-6#1)(2007-6#1)
testing can be useful##2##4##(1992-5#1)(2011-1#1)
testing can be##11##3##(1990-3#1)(1992-5#1)(1992-6#1)(2005-10#1)(2006-8#1)(2007-6#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
testing can##16##2##(1990-3#1)(1992-5#1)(1992-6#1)(1994-12#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-6#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#2)
testing capabilities##3##2##(2006-11#1)(2006-6#1)(2010-2#1)
testing conditions##6##2##(1992-11#2)(1993-9#1)(1997-5#1)(2007-6#1)(2012-12#1)
testing confirmed the##2##3##(2005-11#1)(2012-3#1)
testing confirmed##3##2##(2005-11#1)(2009-3#1)(2012-3#1)
testing could##2##2##(1996-5#1)(2006-11#1)
testing cycles##3##2##(2008-6#1)(2013-1#2)
testing data and##2##3##(2008-5#1)(2009-4#1)
testing data##6##2##(2005-10#1)(2008-5#1)(2009-4#1)(2013-1#3)
testing device##3##2##(2007-1#1)(2008-3#1)(2010-4#1)
testing did not##2##3##(2008-9#1)(2011-2#1)
testing different##2##2##(2008-10#1)(2013-1#1)
testing drugs##2##2##(2008-11#1)(2009-3#1)
testing during the##3##3##(1995-11#1)(2011-1#2)
testing during##4##2##(1995-11#1)(2008-5#1)(2011-1#2)
testing for HIV##8##3##(1992-10#4)(1996-5#1)(1996-6#1)(2007-12#1)(2013-1#1)
testing for KRAS##2##3##(2011-2#2)
testing for SIP##2##3##(1993-6#2)
testing for a##5##3##(2007-12#1)(2007-7#1)(2008-3#1)(2008-8#1)(2012-3#1)
testing for both##2##3##(2008-1#1)(2010-5#1)
testing for breast cancer##2##4##(1996-10#1)(2005-7#1)
testing for patients##2##3##(2006-9#1)(2012-3#1)
testing for the##6##3##(2007-11#2)(2008-10#1)(2008-9#1)(2010-3#1)(2012-1#1)
testing for##95##2##(1990-6#1)(1992-1#1)(1992-10#4)(1993-6#2)(1993-7#1)(1994-1#1)(1994-2#1)(1994-8#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#4)(1996-9#1)(1997-2#1)(2004-11#1)(2005-11#1)(2005-5#2)(2005-7#1)(2005-9#1)(2006-10#2)(2006-4#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#3)(2007-12#3)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#6)(2008-5#1)(2008-8#3)(2008-9#1)(2009-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#6)(2013-8#2)
testing from##3##2##(2008-10#1)(2011-1#1)(2012-12#1)
testing ground for##2##3##(2007-12#1)(2008-10#1)
testing has been##3##3##(1996-6#1)(2012-12#1)(2013-1#1)
testing has shown##2##3##(1996-2#1)(2007-8#1)
testing has##15##2##(1994-7#1)(1996-2#1)(1996-6#1)(2007-8#1)(2008-4#1)(2008-6#2)(2009-5#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
testing have##2##2##(2008-10#2)
testing identified##2##2##(2008-8#1)(2011-2#1)
testing in Nigeria##2##3##(2007-12#2)
testing in a##3##3##(1991-12#1)(2006-10#1)(2008-12#1)
testing in an##3##3##(2008-3#2)(2008-4#1)
testing in clinical##3##3##(2006-9#1)(2007-9#1)(2008-10#1)
testing in non-rodent species##2##4##(2008-10#2)
testing in our laboratory##2##4##(1994-9#1)(2007-12#1)
testing in patients with##4##4##(2006-10#1)(2007-5#1)(2008-9#1)(2009-6#1)
testing in patients##6##3##(2006-10#1)(2007-5#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)
testing in primary##2##3##(1996-2#1)(2011-2#1)
testing in the clinical##4##4##(1994-1#2)(2006-10#1)(2009-7#1)
testing in the##17##3##(1991-2#2)(1994-1#2)(1997-3#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-7#1)
testing in this##3##3##(1994-9#1)(2006-8#1)(2010-12#1)
testing in##93##2##(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#2)(1993-10#1)(1994-1#2)(1994-2#1)(1994-9#2)(1995-5#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-8#1)(1997-3#2)(1997-7#1)(2005-11#2)(2006-10#5)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#5)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#2)
testing include##2##2##(1996-4#1)(1996-5#1)
testing includes##2##2##(2010-2#1)(2011-2#1)
testing intervals##2##2##(1992-2#1)(2007-4#1)
testing is a##3##3##(2008-2#1)(2008-3#1)(2010-4#1)
testing is also##2##3##(2011-1#2)
testing is an##2##3##(2005-5#1)(2006-9#1)
testing is not##2##3##(1991-12#1)(2011-2#1)
testing is recommended##2##3##(2010-8#1)(2012-12#1)
testing is##49##2##(1991-12#1)(1993-5#1)(1994-2#1)(1995-9#1)(1996-11#1)(1996-6#1)(1997-3#1)(1997-8#1)(2005-5#1)(2006-10#5)(2006-11#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2009-12#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
testing it##2##2##(2007-12#1)(2013-8#1)
testing its##3##2##(2007-12#1)(2008-5#1)(2008-9#1)
testing machine to##2##3##(2007-1#1)(2008-11#1)
testing machine##16##2##(2004-9#1)(2006-8#1)(2007-1#2)(2007-11#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-12#1)(2013-1#1)(2013-8#1)
testing may be##4##3##(1996-12#1)(2006-10#1)(2007-7#1)(2011-2#1)
testing may##12##2##(1993-9#1)(1994-1#1)(1996-12#1)(2006-10#1)(2007-12#1)(2007-7#2)(2008-10#2)(2009-4#1)(2010-10#1)(2011-2#1)
testing method for##2##3##(2007-7#1)(2011-2#1)
testing method##8##2##(1990-11#1)(2005-11#1)(2007-7#1)(2008-10#2)(2008-2#1)(2011-2#2)
testing methodologies##5##2##(2008-10#1)(2008-5#3)(2012-12#1)
testing methods and##2##3##(2009-5#1)(2010-7#1)
testing methods for##2##3##(2008-3#1)(2012-3#1)
testing methods##10##2##(1995-1#1)(2007-8#2)(2008-3#1)(2009-5#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
testing mice##2##2##(2008-10#1)(2008-4#1)
testing might##2##2##(1996-5#1)(2008-10#1)
testing models##2##2##(2008-10#1)(2008-8#1)
testing negative##2##2##(1991-9#1)(2010-4#1)
testing new##5##2##(1996-6#1)(2008-10#1)(2008-11#1)(2012-12#1)(2013-8#1)
testing of Guthrie cards##2##4##(1991-6#2)
testing of M##2##3##(2007-7#1)(2008-10#1)
testing of a##16##3##(1995-12#1)(1996-2#1)(2006-8#1)(2007-11#1)(2007-5#1)(2008-10#4)(2008-2#1)(2008-3#3)(2010-2#1)(2013-1#2)
testing of an##3##3##(2006-6#1)(2007-8#1)(2008-3#1)
testing of bone##2##3##(2007-8#1)(2009-4#1)
testing of both##2##3##(2008-2#1)(2012-2#1)
testing of children##3##3##(2010-7#1)(2011-2#2)
testing of closed-loop##2##3##(2009-9#2)
testing of health care##2##4##(1991-2#1)(2006-2#1)
testing of healthy##2##3##(2009-4#1)(2012-1#1)
testing of human##2##3##(2009-7#1)(2013-8#1)
testing of multiple##2##3##(2007-8#1)(2010-12#1)
testing of new##2##3##(2008-4#1)(2010-2#1)
testing of novel##2##3##(2006-10#1)(2010-4#1)
testing of rotationally symmetric aspheres##2##5##(2008-3#2)
testing of sunscreens against##2##4##(2008-5#2)
testing of sunscreens##3##3##(2008-5#3)
testing of the donor##2##4##(1994-6#1)(2007-12#1)
testing of the##28##3##(1994-6#1)(1996-3#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-8#1)(2008-9#3)(2009-5#1)(2010-10#3)(2010-12#2)(2010-6#1)(2012-3#1)
testing of this##3##3##(2006-7#1)(2008-2#1)(2009-7#1)
testing of topical##2##3##(2007-8#1)(2008-5#1)
testing of##231##2##(1990-12#2)(1990-3#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-6#4)(1992-10#1)(1992-2#1)(1992-3#2)(1993-3#1)(1993-9#1)(1994-2#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-2#3)(1996-3#2)(1996-5#1)(1996-6#2)(1996-8#3)(1997-5#2)(1997-8#1)(2005-1#1)(2005-10#1)(2006-10#3)(2006-11#2)(2006-12#1)(2006-2#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#5)(2007-3#1)(2007-4#3)(2007-5#2)(2007-7#4)(2007-8#7)(2008-1#1)(2008-10#20)(2008-11#5)(2008-12#2)(2008-2#8)(2008-3#25)(2008-4#8)(2008-5#13)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-3#2)(2009-4#5)(2009-5#2)(2009-7#3)(2009-9#2)(2010-10#4)(2010-12#3)(2010-2#3)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#9)(2012-1#3)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
testing on##12##2##(1993-9#1)(1996-2#1)(1997-8#1)(2006-11#1)(2008-3#1)(2008-6#2)(2009-4#1)(2009-5#1)(2010-7#1)(2012-1#1)(2013-7#1)
testing or##4##2##(1994-6#1)(2008-9#1)(2009-5#1)(2012-2#1)
testing our##3##2##(2007-8#1)(2007-9#1)(2010-9#1)
testing parameters##3##2##(2005-10#1)(2012-2#1)(2013-1#1)
testing performed##3##2##(1994-8#1)(1994-9#1)(1995-1#1)
testing period##3##2##(1994-3#1)(1997-2#1)(2013-8#1)
testing platform##2##2##(2011-1#1)(2013-7#1)
testing possibilities##2##2##(1993-8#1)(2010-2#1)
testing prior to##2##3##(1993-6#1)(2006-2#1)
testing problems##4##2##(1992-2#1)(1993-3#1)(2005-8#1)(2010-11#1)
testing procedure for the##2##4##(1995-9#1)(1996-12#1)
testing procedure##6##2##(1990-11#1)(1994-6#1)(1995-9#1)(1996-12#1)(2008-4#1)(2008-5#1)
testing procedures have##2##3##(2008-12#1)(2011-2#1)
testing procedures##14##2##(1993-3#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-5#2)(2009-9#2)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#1)
testing process##2##2##(2004-12#1)(2006-4#1)
testing program in##2##3##(1997-1#1)(2010-12#1)
testing program##6##2##(1997-1#1)(2009-5#3)(2010-12#2)
testing protocol##4##2##(1994-2#2)(2007-1#1)(2008-8#1)
testing protocols are##2##3##(1994-2#1)(2006-4#1)
testing protocols##3##2##(1994-2#1)(2006-4#1)(2008-5#1)
testing remains##2##2##(2006-10#1)(2010-12#1)
testing requirement##2##2##(1997-5#1)(2012-2#1)
testing requires##2##2##(1997-1#1)(1997-3#1)
testing resistance to##2##3##(1992-1#1)(2008-6#1)
testing resulted in##3##3##(2006-11#2)(2012-1#1)
testing results in##2##3##(1997-8#1)(2012-3#1)
testing results showed that the##2##5##(2007-2#1)(2011-1#1)
testing results##9##2##(1995-9#1)(1997-8#1)(2005-5#1)(2005-8#1)(2007-2#1)(2008-2#1)(2010-5#1)(2011-1#1)(2012-3#1)
testing revealed that##3##3##(2008-10#2)(2008-12#1)
testing revealed##7##2##(1993-4#1)(1997-5#1)(2008-10#2)(2008-12#1)(2008-8#2)
testing samples from##2##3##(2008-10#1)(2013-1#1)
testing services##3##2##(1996-8#1)(2010-12#1)(2013-1#1)
testing sessions##2##2##(2008-5#2)
testing several##3##2##(2008-11#1)(2008-5#1)(2012-12#1)
testing should be considered in patients##2##6##(2006-10#1)(2007-10#1)
testing should be##8##3##(1996-11#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-5#1)(2011-12#1)
testing showed a##3##3##(2004-9#1)(2008-5#1)(2008-6#1)
testing showed##5##2##(2004-9#1)(2008-3#1)(2008-5#1)(2008-6#1)(2012-12#1)
testing shows##3##2##(2009-11#1)(2011-12#1)(2011-2#1)
testing stage##2##2##(1997-6#1)(2008-10#1)
testing strategies##4##2##(2007-1#2)(2008-10#1)(2008-6#1)
testing such##2##2##(1996-11#1)(2007-4#1)
testing system##7##2##(2008-10#2)(2008-3#1)(2011-1#1)(2013-8#3)
testing that##5##2##(2008-3#1)(2008-5#1)(2010-2#1)(2013-1#2)
testing the effectiveness of##2##4##(1990-3#1)(2008-4#1)
testing the efficacy of##4##4##(2007-8#1)(2008-10#1)(2010-4#1)(2012-1#1)
testing the efficacy##5##3##(2007-8#1)(2008-10#1)(2008-11#1)(2010-4#1)(2012-1#1)
testing the hypothesis that the##3##5##(1992-6#1)(1996-3#1)(2007-5#1)
testing the hypothesis that##4##4##(1992-6#1)(1994-12#1)(1996-3#1)(2007-5#1)
testing the proposed##2##3##(2008-9#1)(2010-8#1)
testing the relationship between##2##4##(2008-10#1)(2008-9#1)
testing the role##2##3##(2008-7#1)(2012-3#1)
testing the validity of##2##4##(1997-2#1)(2006-9#1)
testing the##68##2##(1990-11#1)(1990-3#1)(1992-6#1)(1994-12#1)(1994-6#1)(1995-8#2)(1996-3#1)(1996-7#1)(1997-2#1)(2004-9#1)(2005-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#1)(2006-9#1)(2007-5#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-7#1)(2009-9#1)(2010-4#1)(2010-7#1)(2010-8#3)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
testing their##13##2##(1993-9#1)(2005-10#1)(2006-10#8)(2008-10#1)(2008-7#1)(2010-12#1)
testing them##4##2##(1994-11#1)(2004-2#1)(2006-12#1)(2008-11#1)
testing therefore##2##2##(1990-3#1)(2006-11#1)
testing this##4##2##(1991-2#1)(1992-12#1)(1993-9#1)(1997-8#1)
testing time##2##2##(1992-3#1)(1994-3#1)
testing to be##3##3##(1992-9#1)(1997-1#1)(1997-2#1)
testing to exclude##2##3##(2007-12#1)(2012-12#1)
testing to identify##2##3##(2012-2#2)
testing to##26##2##(1992-9#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#2)(2010-11#1)(2010-12#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-7#1)
testing using the##2##3##(2008-6#1)(2009-4#1)
testing using##4##2##(1993-9#1)(1994-1#1)(2008-6#1)(2009-4#1)
testing was also##2##3##(2006-10#1)(2007-7#1)
testing was carried out##2##4##(2007-4#1)(2008-7#1)
testing was conducted##4##3##(2007-4#1)(2008-3#1)(2009-7#1)(2010-10#1)
testing was done##4##3##(1993-11#1)(2006-7#1)(2007-7#2)
testing was not##4##3##(1996-3#1)(2009-2#1)(2010-3#1)(2012-2#1)
testing was performed by##3##4##(2007-12#1)(2010-4#1)(2012-3#1)
testing was performed on##3##4##(2006-8#2)(2007-11#1)
testing was performed using##2##4##(2006-2#1)(2008-7#1)
testing was performed##12##3##(1995-3#1)(2006-2#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-12#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
testing was repeated##2##3##(1994-8#1)(2006-8#1)
testing was##46##2##(1991-2#1)(1993-11#1)(1994-6#2)(1994-8#1)(1995-3#1)(1996-3#1)(2004-1#1)(2006-10#2)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#5)(2007-8#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-2#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-8#1)
testing were##13##2##(1993-6#1)(1995-2#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-4#1)(2011-2#1)(2012-2#1)
testing when##2##2##(1992-4#1)(1997-2#1)
testing where##3##2##(2007-4#1)(2008-1#1)(2008-3#1)
testing whether the##2##3##(1997-6#1)(2008-6#1)
testing whether##4##2##(1997-6#1)(2007-7#1)(2008-6#1)(2013-1#1)
testing which##3##2##(2006-7#1)(2008-12#1)(2008-5#1)
testing will be##2##3##(1991-5#1)(1997-6#1)
testing will##5##2##(1991-5#1)(1997-1#1)(1997-6#1)(2007-11#1)(2008-5#1)
testing with a##2##3##(2008-3#2)
testing with circular gratings##2##4##(2008-3#2)
testing with the##8##3##(2006-8#1)(2007-4#1)(2007-7#1)(2008-5#1)(2008-9#1)(2010-10#1)(2012-2#1)(2013-8#1)
testing with##35##2##(1992-6#1)(1992-7#1)(2006-10#3)(2006-8#1)(2007-4#2)(2007-7#3)(2008-10#1)(2008-3#5)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
testing within##2##2##(2011-1#1)(2012-3#1)
testing would be##2##3##(2008-10#1)(2012-12#1)
testing would##4##2##(1993-9#1)(2006-10#1)(2008-10#1)(2012-12#1)
testing##1951##1##(1990-11#3)(1990-12#9)(1990-2#2)(1990-3#5)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-1#4)(1991-10#2)(1991-11#2)(1991-12#3)(1991-2#6)(1991-3#3)(1991-4#3)(1991-5#1)(1991-6#8)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#3)(1992-10#9)(1992-11#4)(1992-12#3)(1992-2#4)(1992-3#6)(1992-4#1)(1992-5#2)(1992-6#5)(1992-7#5)(1992-9#2)(1993-10#2)(1993-11#5)(1993-12#2)(1993-2#2)(1993-3#9)(1993-4#3)(1993-5#6)(1993-6#7)(1993-7#4)(1993-8#3)(1993-9#16)(1994-1#6)(1994-11#3)(1994-12#7)(1994-2#14)(1994-3#6)(1994-5#1)(1994-6#12)(1994-7#1)(1994-8#3)(1994-9#5)(1995-1#5)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#1)(1995-4#2)(1995-5#4)(1995-6#4)(1995-8#3)(1995-9#7)(1996-1#3)(1996-10#2)(1996-11#6)(1996-12#9)(1996-2#10)(1996-3#11)(1996-4#3)(1996-5#18)(1996-6#16)(1996-7#2)(1996-8#8)(1996-9#1)(1997-1#4)(1997-2#16)(1997-3#8)(1997-4#3)(1997-5#11)(1997-6#3)(1997-7#3)(1997-8#12)(2004-1#1)(2004-11#1)(2004-12#2)(2004-2#2)(2004-9#14)(2005-1#1)(2005-10#10)(2005-11#9)(2005-12#1)(2005-4#2)(2005-5#4)(2005-7#9)(2005-8#8)(2005-9#1)(2006-1#1)(2006-10#72)(2006-11#21)(2006-12#11)(2006-2#10)(2006-3#2)(2006-4#7)(2006-5#8)(2006-6#4)(2006-7#8)(2006-8#27)(2006-9#8)(2007-1#13)(2007-10#11)(2007-11#14)(2007-12#35)(2007-2#11)(2007-3#3)(2007-4#26)(2007-5#8)(2007-6#5)(2007-7#38)(2007-8#31)(2007-9#6)(2008-1#9)(2008-10#136)(2008-11#35)(2008-12#32)(2008-2#34)(2008-3#82)(2008-4#50)(2008-5#72)(2008-6#20)(2008-7#24)(2008-8#25)(2008-9#34)(2009-10#6)(2009-11#8)(2009-12#5)(2009-2#6)(2009-3#10)(2009-4#14)(2009-5#23)(2009-6#1)(2009-7#10)(2009-8#5)(2009-9#8)(2010-1#3)(2010-10#10)(2010-11#7)(2010-12#28)(2010-2#17)(2010-3#5)(2010-4#14)(2010-5#5)(2010-6#5)(2010-7#6)(2010-8#13)(2010-9#4)(2011-1#30)(2011-12#5)(2011-2#69)(2011-8#1)(2012-1#13)(2012-11#3)(2012-12#32)(2012-2#51)(2012-3#30)(2013-1#65)(2013-7#8)(2013-8#29)
testing&quot##4##1##(1995-3#1)(2008-10#1)(2011-2#2)
testing)##2##1##(2007-8#1)(2008-4#1)
testing-induced##3##1##(1993-9#2)(2008-7#1)
testing?##4##1##(1997-3#1)(2006-12#1)(2007-7#1)(2013-1#1)
testings##5##1##(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)
testis 17##2##2##(1992-2#2)
testis and epididymis##2##3##(1996-8#1)(2008-6#1)
testis and in##3##3##(1994-10#1)(1995-10#1)(2012-2#1)
testis and liver##2##3##(1991-6#1)(1996-7#1)
testis and ovary##5##3##(1995-5#1)(2008-7#3)(2009-7#1)
testis and##35##2##(1990-11#1)(1991-1#1)(1991-4#1)(1991-6#1)(1992-12#1)(1992-7#1)(1993-11#1)(1993-4#1)(1994-10#1)(1994-3#1)(1995-10#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-7#2)(1996-8#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-7#1)(2010-12#1)(2011-2#2)(2012-2#3)(2013-8#1)
testis are##4##2##(1990-2#1)(2008-10#1)(2008-4#1)(2012-2#1)
testis as a##2##3##(1992-7#1)(2009-10#1)
testis as well as##2##4##(2008-10#1)(2010-12#1)
testis as##5##2##(1992-7#1)(2008-10#1)(2009-10#1)(2010-12#1)(2012-2#1)
testis at##2##2##(2006-7#1)(2008-5#1)
testis by##3##2##(1994-12#1)(2008-9#1)(2010-5#1)
testis cDNA library##7##3##(1991-1#1)(1991-9#1)(1992-6#1)(1994-11#1)(1994-12#1)(1995-6#1)(2008-9#1)
testis cDNA##8##2##(1991-1#1)(1991-9#1)(1992-6#1)(1994-11#1)(1994-12#1)(1995-6#1)(1997-1#1)(2008-9#1)
testis cancer##4##2##(2006-10#3)(2008-7#1)
testis determination##2##2##(1990-11#1)(2008-4#1)
testis determining gene##3##3##(1994-11#1)(1995-11#2)
testis determining##4##2##(1994-11#1)(1995-11#3)
testis development##3##2##(1990-11#1)(1995-11#2)
testis differentiation##4##2##(1990-11#1)(1994-11#1)(1995-11#2)
testis during##4##2##(2007-9#2)(2008-11#1)(2012-2#1)
testis enzyme##2##2##(1996-7#2)
testis for##2##2##(2009-11#1)(2010-4#1)
testis formation##3##2##(1990-11#1)(1995-11#2)
testis has##2##2##(2008-7#1)(2009-10#1)
testis in##5##2##(2006-9#1)(2008-10#1)(2009-4#1)(2012-2#2)
testis is an immunologically privileged##2##5##(2009-10#1)(2010-4#1)
testis is an##3##3##(2007-6#1)(2009-10#1)(2010-4#1)
testis is##14##2##(1992-12#1)(1996-7#1)(2006-10#1)(2006-2#1)(2007-6#1)(2007-8#1)(2009-10#2)(2010-4#1)(2011-2#1)(2012-2#4)
testis mass##3##2##(2013-1#2)(2013-8#1)
testis of the##3##3##(1995-11#1)(2012-12#2)
testis of##9##2##(1992-12#1)(1994-6#1)(1995-11#1)(1995-6#1)(2008-7#2)(2010-4#1)(2012-12#2)
testis or other##2##3##(1992-2#1)(1995-2#1)
testis or##5##2##(1990-11#1)(1992-2#1)(1993-2#1)(1995-2#1)(2008-7#1)
testis possesses intrinsic mechanisms to modulate and regulate different stages of germ cell development under the intimate and indirect cooperation with Sertoli and Leydig cells##2##25##(2009-10#2)
testis showed##3##2##(1997-3#1)(2006-2#1)(2008-8#1)
testis specific##2##2##(1994-12#2)
testis than##2##2##(1992-4#1)(1996-12#1)
testis that##3##2##(2008-10#1)(2012-2#2)
testis to##5##2##(1996-7#1)(2008-10#1)(2008-5#3)
testis was significantly##2##3##(1995-12#1)(2008-9#1)
testis was##11##2##(1990-5#1)(1992-12#1)(1992-7#1)(1995-12#1)(2006-7#2)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#2)
testis weight##2##2##(2008-6#1)(2012-3#1)
testis weights in##2##3##(2008-9#2)
testis weights##3##2##(2008-9#3)
testis were##6##2##(1992-12#1)(1992-4#1)(1992-7#1)(1995-12#1)(2008-9#1)(2012-2#1)
testis which##2##2##(1995-8#1)(2012-2#1)
testis with seminoma]##2##3##(1997-3#1)(1997-6#1)
testis with##4##2##(1996-7#1)(1997-3#1)(1997-6#1)(2007-6#1)
testis##366##1##(1990-11#7)(1990-2#3)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#3)(1991-2#11)(1991-4#2)(1991-6#2)(1991-7#1)(1991-9#5)(1992-11#1)(1992-12#8)(1992-2#3)(1992-3#2)(1992-4#2)(1992-6#5)(1992-7#7)(1992-8#4)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-7#2)(1994-10#2)(1994-11#5)(1994-12#5)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#1)(1995-10#1)(1995-11#17)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#5)(1995-6#4)(1995-8#6)(1996-10#1)(1996-12#2)(1996-2#1)(1996-7#9)(1996-8#1)(1997-1#1)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-8#1)(2006-10#8)(2006-2#4)(2006-7#5)(2006-9#1)(2007-3#1)(2007-5#2)(2007-6#4)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#22)(2008-11#1)(2008-12#1)(2008-4#6)(2008-5#5)(2008-6#4)(2008-7#9)(2008-8#7)(2008-9#10)(2009-10#11)(2009-11#1)(2009-2#2)(2009-4#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-12#3)(2010-4#7)(2010-5#2)(2011-1#1)(2011-2#9)(2012-12#12)(2012-2#46)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#5)
testis-determining factor##4##2##(1990-11#3)(1991-11#1)
testis-determining gene##4##2##(1990-11#2)(1991-11#1)(1995-11#1)
testis-determining##9##1##(1990-11#5)(1991-11#2)(1995-11#2)
testis-expressed##4##1##(2010-5#1)(2012-2#3)
testis-specific atypical##3##2##(2012-2#3)
testis-specific expression##3##2##(1994-9#1)(1997-4#2)
testis-specific##17##1##(1990-5#1)(1991-9#1)(1992-8#2)(1994-9#1)(1995-5#1)(1997-4#2)(2008-7#1)(2008-9#1)(2009-10#2)(2012-12#2)(2012-2#3)
testosterone (FT)##2##2##(2008-5#1)(2013-1#1)
testosterone (T) and##2##3##(1990-11#1)(1996-2#1)
testosterone (T)##10##2##(1990-11#2)(1991-5#1)(1992-5#1)(1994-11#1)(1996-2#1)(2007-9#1)(2008-1#1)(2008-3#1)(2009-7#1)
testosterone 5 alpha-reductase 2##2##4##(1994-11#2)
testosterone 5 alpha-reductase##3##3##(1990-11#1)(1994-11#2)
testosterone 5α-reductase##5##2##(2012-12#5)
testosterone 6 beta-hydroxylase##2##3##(1991-5#2)
testosterone administration##3##2##(1990-4#1)(1995-12#1)(2008-1#1)
testosterone and progesterone##2##3##(1995-12#1)(2012-2#1)
testosterone and##26##2##(1990-11#1)(1990-12#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-8#2)(1995-12#2)(1995-4#1)(1996-11#1)(2004-1#1)(2006-6#1)(2006-9#2)(2008-1#1)(2008-4#1)(2008-5#1)(2009-4#1)(2011-1#1)(2012-12#2)(2012-2#2)
testosterone but not##2##3##(1990-11#1)(1994-8#1)
testosterone by##2##2##(1990-11#1)(1990-2#1)
testosterone concentrations and##2##3##(2008-9#1)(2012-12#1)
testosterone concentrations in##3##3##(1990-10#1)(2011-1#1)(2013-8#1)
testosterone concentrations with##2##3##(2012-12#2)
testosterone concentrations##8##2##(1990-10#1)(2008-9#1)(2011-1#1)(2012-12#4)(2013-8#1)
testosterone deficiency##2##2##(1996-5#1)(2010-12#1)
testosterone ester##2##2##(1995-2#2)
testosterone esters##4##2##(1995-2#4)
testosterone for##2##2##(2008-5#1)(2008-7#1)
testosterone formation##2##2##(1990-5#1)(1990-6#1)
testosterone glucuronidation##2##2##(1990-12#1)(1992-8#1)
testosterone glucuronide##2##2##(1991-4#1)(2013-8#1)
testosterone hormone##2##2##(2008-10#1)(2008-12#1)
testosterone in the##4##3##(1993-2#1)(1995-2#1)(2008-10#1)(2012-2#1)
testosterone in##12##2##(1993-1#1)(1993-2#1)(1995-2#1)(2006-9#1)(2008-10#4)(2008-5#1)(2012-2#1)(2012-3#2)
testosterone induced##2##2##(1994-11#1)(2008-7#1)
testosterone into##2##2##(1994-2#1)(2008-5#1)
testosterone is##4##2##(1990-6#1)(2008-4#1)(2008-9#1)(2012-3#1)
testosterone level in##2##3##(2007-1#1)(2009-6#1)
testosterone level##4##2##(2007-1#1)(2008-12#1)(2008-5#1)(2009-6#1)
testosterone levels in##3##3##(1990-10#1)(1995-2#1)(2004-1#1)
testosterone levels were##5##3##(1990-10#2)(1992-7#1)(2008-5#2)
testosterone levels##26##2##(1990-10#4)(1990-5#1)(1990-6#2)(1992-7#1)(1993-2#1)(1995-2#1)(1995-3#1)(1996-11#1)(2004-1#1)(2006-6#1)(2008-4#1)(2008-5#4)(2008-6#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-12#2)
testosterone may##2##2##(1995-1#1)(2008-9#1)
testosterone metabolite##2##2##(2010-8#2)
testosterone or##3##2##(2010-8#1)(2012-2#1)(2013-8#1)
testosterone plays##2##2##(1993-4#1)(1995-12#1)
testosterone production##2##2##(1995-11#1)(1996-5#1)
testosterone propionate##6##2##(1990-11#1)(1991-12#1)(1992-4#1)(1992-9#1)(1993-2#1)(2010-8#1)
testosterone r = -0##2##4##(2006-6#2)
testosterone replacement therapy##2##3##(2006-6#1)(2012-12#1)
testosterone replacement##6##2##(1992-4#3)(1994-2#1)(2006-6#1)(2012-12#1)
testosterone secretion##3##2##(1990-5#1)(1994-12#2)
testosterone signals##2##2##(2012-2#2)
testosterone supplementation##2##2##(2008-1#1)(2008-7#1)
testosterone to##5##2##(1993-8#1)(1994-11#1)(1996-9#1)(2008-2#1)(2012-12#1)
testosterone treatment##8##2##(1994-2#1)(1995-5#4)(1996-11#1)(1996-5#1)(1996-8#1)
testosterone was##5##2##(1990-4#2)(1992-12#1)(2008-10#1)(2012-12#1)
testosterone were##3##2##(1992-12#1)(1995-1#1)(2007-7#1)
testosterone with##3##2##(1990-11#1)(2008-10#1)(2012-12#1)
testosterone##308##1##(1990-10#10)(1990-11#15)(1990-12#2)(1990-2#3)(1990-4#4)(1990-5#3)(1990-6#4)(1990-9#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#3)(1992-12#2)(1992-3#1)(1992-4#6)(1992-5#2)(1992-7#2)(1992-8#5)(1992-9#3)(1993-1#4)(1993-2#7)(1993-4#1)(1993-8#3)(1994-11#5)(1994-12#2)(1994-2#8)(1994-3#1)(1994-6#3)(1994-8#5)(1995-1#3)(1995-11#1)(1995-12#9)(1995-2#10)(1995-3#1)(1995-4#1)(1995-5#6)(1996-11#8)(1996-2#2)(1996-5#6)(1996-8#1)(1996-9#2)(2004-1#3)(2006-10#2)(2006-6#5)(2006-9#9)(2007-1#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#5)(2008-10#11)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#21)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#5)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-8#6)(2011-1#5)(2011-2#3)(2012-12#22)(2012-2#9)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#3)
testosterone's##2##1##(2008-8#2)
testosterone-induced##2##1##(2008-5#1)(2012-3#1)
testosterone-treated males##3##2##(1995-5#1)(2008-8#2)
testosterone-treated##5##1##(1993-2#1)(1993-4#1)(1995-5#1)(2008-8#2)
testosteroni JH5##3##2##(2006-3#3)
testosteroni catalyzes the isomerization of a##2##6##(1995-10#1)(1995-11#1)
testosteroni##8##1##(1990-1#2)(1995-10#2)(1995-11#1)(2006-3#3)
tests (3##2##2##(2006-11#1)(2007-4#1)
tests (peak##2##2##(2006-11#1)(2007-4#1)
tests 1 and 2##2##4##(1995-4#2)
tests a##3##2##(1993-1#1)(2007-10#1)(2010-10#1)
tests after##9##2##(1991-8#1)(1993-5#1)(1996-9#1)(2007-11#2)(2007-6#1)(2008-7#2)(2010-5#1)
tests against##4##2##(1992-5#1)(2005-11#1)(2006-10#1)(2013-7#1)
tests allow##2##2##(2008-1#1)(2008-9#1)
tests alone##2##2##(1992-5#1)(2008-11#1)
tests also##4##2##(1991-6#1)(2006-11#1)(2008-10#1)(2008-5#1)
tests and a##8##3##(1994-11#1)(1996-12#1)(1997-3#1)(2006-11#1)(2007-4#2)(2008-12#1)(2010-2#1)
tests and adjusted##2##3##(2011-1#1)(2013-1#1)
tests and also##3##3##(2006-10#1)(2007-2#1)(2012-2#1)
tests and clinical##2##3##(2008-8#1)(2011-2#1)
tests and conventional##2##3##(2008-10#1)(2010-9#1)
tests and enzyme-linked##2##3##(1993-2#1)(1995-11#1)
tests and estimates##3##3##(1994-9#2)(2011-1#1)
tests and examinations##2##3##(2008-12#1)(2009-4#1)
tests and human##2##3##(1996-7#1)(2007-1#1)
tests and in##4##3##(2008-10#3)(2011-1#1)
tests and procedures##3##3##(1996-2#1)(2005-7#1)(2011-12#1)
tests and restriction##2##3##(2008-10#1)(2008-5#1)
tests and the##15##3##(1992-6#1)(1993-1#1)(1996-2#1)(1996-9#1)(2004-1#1)(2006-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-6#1)(2010-8#1)(2013-1#1)
tests and their##5##3##(2008-10#2)(2009-4#1)(2011-3#1)(2013-1#1)
tests and to##5##3##(1990-7#1)(1997-2#1)(2008-10#1)(2008-5#1)(2013-1#1)
tests and treatment##2##3##(2007-11#1)(2007-2#1)
tests and treatments##2##3##(2004-3#1)(2011-2#1)
tests and##186##2##(1990-3#2)(1990-6#1)(1990-7#1)(1990-9#2)(1991-3#1)(1991-4#1)(1991-7#2)(1991-8#2)(1992-1#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-4#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#3)(1996-7#1)(1996-9#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-1#1)(2004-3#1)(2005-10#1)(2005-11#2)(2005-5#1)(2005-7#1)(2006-1#1)(2006-10#4)(2006-11#2)(2006-5#1)(2006-7#1)(2006-9#1)(2007-1#2)(2007-11#3)(2007-12#4)(2007-2#3)(2007-3#1)(2007-4#9)(2007-7#3)(2007-9#1)(2008-1#1)(2008-10#19)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-4#5)(2009-6#1)(2010-12#2)(2010-2#2)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#6)(2011-3#2)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#2)(2012-7#1)(2013-1#7)(2013-8#5)
tests applied##3##2##(1993-5#1)(2008-10#1)(2008-5#1)
tests are available for the##2##5##(1997-2#1)(2010-12#1)
tests are available##4##3##(1990-6#1)(1993-2#1)(1997-2#1)(2010-12#1)
tests are conducted##2##3##(1994-7#1)(2009-7#1)
tests are essential in##2##4##(1997-5#1)(2008-10#1)
tests are essential##3##3##(1997-5#1)(2008-10#1)(2009-5#1)
tests are in##2##3##(2006-6#1)(2010-8#1)
tests are negative##2##3##(1991-12#1)(2012-3#1)
tests are not##5##3##(1993-12#2)(1995-1#1)(2005-10#1)(2010-3#1)
tests are often##4##3##(2006-2#1)(2006-8#1)(2010-12#1)(2010-2#1)
tests are only##2##3##(2007-2#1)(2012-2#1)
tests are performed##2##3##(2007-4#1)(2009-12#1)
tests are presented##2##3##(2007-4#1)(2012-1#1)
tests are the##2##3##(1995-4#1)(2010-6#1)
tests are used to##6##4##(2005-11#1)(2007-12#2)(2008-4#1)(2008-7#1)(2012-2#1)
tests are used##8##3##(2005-11#1)(2007-12#2)(2008-4#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-2#1)
tests are useful##3##3##(1997-1#1)(2008-10#1)(2008-11#1)
tests are##93##2##(1990-2#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-12#1)(1992-6#1)(1993-12#2)(1993-2#1)(1994-7#1)(1995-1#1)(1995-4#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-5#1)(2005-10#2)(2005-11#2)(2006-10#3)(2006-2#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#6)(2007-2#2)(2007-4#4)(2007-7#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#2)
tests as well as##3##4##(1993-12#1)(1995-6#1)(2006-11#1)
tests as##9##2##(1990-2#1)(1993-12#1)(1995-6#1)(1996-2#1)(2006-11#1)(2007-4#1)(2007-7#1)(2008-10#1)(2009-9#1)
tests at 12 months##2##4##(2008-9#1)(2013-1#1)
tests at a##2##3##(1994-3#1)(2010-8#1)
tests at the##3##3##(1991-6#1)(2012-3#1)(2013-1#1)
tests at##13##2##(1991-6#1)(1992-11#1)(1994-3#1)(2007-4#2)(2008-10#3)(2008-9#1)(2010-8#1)(2012-3#1)(2013-1#2)
tests available##2##2##(2008-2#1)(2008-5#1)
tests based on Vibrio fischeri##2##5##(2008-10#2)
tests based on the##8##4##(1996-3#1)(2008-10#5)(2012-12#1)(2012-3#1)
tests based on##19##3##(1996-3#1)(1997-8#1)(2008-10#7)(2008-7#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#4)(2013-1#1)(2013-8#1)
tests before and##2##3##(2007-8#1)(2008-7#1)
tests before##3##2##(2005-11#1)(2007-8#1)(2008-7#1)
tests both##2##2##(2008-12#1)(2011-1#1)
tests but not##2##3##(1992-2#1)(2007-1#1)
tests but##4##2##(1992-2#1)(1996-9#1)(2007-1#1)(2009-3#1)
tests by##3##2##(1992-4#1)(2008-3#1)(2010-1#1)
tests can be considered##2##4##(1994-9#1)(2008-10#1)
tests can be used to##2##5##(2008-10#1)(2008-12#1)
tests can be used##4##4##(2005-11#1)(2008-10#1)(2008-12#1)(2008-4#1)
tests can be##8##3##(1993-11#1)(1993-9#1)(1994-9#1)(2005-11#1)(2008-10#2)(2008-12#1)(2008-4#1)
tests can provide##2##3##(1995-2#1)(2008-10#1)
tests can##20##2##(1993-11#1)(1993-3#1)(1993-9#1)(1994-9#1)(1995-2#1)(1996-3#1)(2005-11#1)(2006-12#1)(2006-9#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2013-1#2)
tests carried out for##2##4##(1993-3#1)(2013-8#1)
tests carried out in##2##4##(1993-3#1)(2008-3#1)
tests carried out##9##3##(1993-3#2)(1994-6#1)(2008-10#4)(2008-3#1)(2013-8#1)
tests combined##2##2##(1997-7#1)(2008-10#1)
tests compared to##3##3##(2007-1#1)(2008-2#1)(2008-9#1)
tests conducted at##3##3##(2007-4#3)
tests conducted in the##2##4##(2008-3#1)(2008-9#1)
tests conducted on a##2##4##(2007-1#1)(2008-2#1)
tests conducted on the##3##4##(2006-11#2)(2008-10#1)
tests conducted on##5##3##(2006-11#2)(2007-1#1)(2008-10#1)(2008-2#1)
tests conducted##12##2##(1996-12#1)(2006-11#2)(2007-1#1)(2007-4#3)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)
tests confirmed that the##4##4##(1991-2#1)(2008-10#1)(2009-3#1)(2010-8#1)
tests confirmed that##6##3##(1991-2#1)(2008-10#2)(2009-3#1)(2010-8#1)(2012-2#1)
tests confirmed the diagnosis of##2##5##(1992-6#1)(2005-12#1)
tests confirmed the##4##3##(1992-6#1)(2005-12#1)(2007-12#1)(2008-10#1)
tests confirmed##13##2##(1991-2#1)(1992-6#1)(2005-12#1)(2007-12#1)(2008-10#5)(2009-3#1)(2010-8#1)(2011-2#1)(2012-2#1)
tests defined##2##2##(1993-7#1)(2006-11#1)
tests demonstrated a##2##3##(1992-1#1)(2008-3#1)
tests demonstrated that the##2##4##(2008-10#1)(2008-9#1)
tests demonstrated that##4##3##(2004-2#1)(2008-10#2)(2008-9#1)
tests demonstrated the##2##3##(2008-5#1)(2008-9#1)
tests demonstrated##13##2##(1992-1#1)(2004-2#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#3)(2009-7#1)(2011-2#1)
tests described##3##2##(2006-8#2)(2007-9#1)
tests did not##7##3##(1992-11#1)(1993-7#1)(1997-8#1)(2007-1#1)(2008-3#1)(2008-7#1)(2009-4#1)
tests disclosed##3##2##(1990-12#1)(1991-10#1)(2012-12#1)
tests do not##3##3##(1994-3#1)(1996-3#1)(2006-10#1)
tests done##5##2##(2006-11#1)(2007-7#1)(2008-10#1)(2012-1#1)(2012-2#1)
tests during##5##2##(1991-3#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-11#1)
tests employed##4##2##(1990-3#1)(2006-8#1)(2008-4#1)(2010-7#1)
tests employing##2##2##(2006-10#1)(2008-10#1)
tests enable##2##2##(2006-2#1)(2007-7#1)
tests for C##3##3##(1991-4#1)(2007-8#1)(2008-5#1)
tests for Chlamydia trachomatis##3##4##(1996-8#1)(1997-6#1)(2006-10#1)
tests for HBV##2##3##(1990-8#1)(2007-12#1)
tests for a correct##2##4##(1991-5#1)(1991-6#1)
tests for a##3##3##(1991-5#1)(1991-6#1)(1993-1#1)
tests for comparing##2##3##(1992-9#1)(1997-4#1)
tests for detecting##2##3##(1997-6#1)(2008-7#1)
tests for malaria diagnosis##2##4##(2007-2#2)
tests for malaria##3##3##(2007-2#3)
tests for such##2##3##(1996-8#1)(2010-2#1)
tests for the detection of##5##5##(1991-3#2)(2008-10#2)(2008-11#1)
tests for the diagnosis of##2##5##(1990-3#1)(1990-9#1)
tests for the##20##3##(1990-3#1)(1990-9#1)(1991-3#2)(1994-9#1)(1995-2#2)(1995-4#1)(1995-5#1)(1996-12#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-9#1)(2012-2#1)(2012-3#1)
tests for viral##2##3##(2006-2#1)(2007-12#1)
tests for##134##2##(1990-2#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#2)(1991-9#2)(1992-1#1)(1992-3#2)(1992-6#1)(1992-9#2)(1993-1#2)(1993-2#2)(1993-3#1)(1993-5#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-2#3)(1995-4#1)(1995-5#2)(1996-12#3)(1996-2#2)(1996-6#1)(1996-8#3)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-11#1)(2005-11#1)(2006-10#3)(2006-2#2)(2006-4#1)(2007-11#2)(2007-12#3)(2007-2#3)(2007-3#1)(2007-7#5)(2007-8#4)(2007-9#1)(2008-10#13)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#4)(2008-9#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#7)(2013-1#2)(2013-8#1)
tests from##2##2##(2006-11#1)(2012-1#1)
tests had##5##2##(1991-5#1)(1995-2#1)(1997-7#1)(2007-1#1)(2011-2#1)
tests has been##2##3##(2008-9#1)(2012-3#1)
tests has##4##2##(1991-11#1)(1992-5#1)(2008-9#1)(2012-3#1)
tests have also##2##3##(2006-11#1)(2008-10#1)
tests have been conducted##2##4##(2006-11#1)(2006-5#1)
tests have been described##2##4##(2005-7#1)(2006-10#1)
tests have been developed##2##4##(2008-10#1)(2010-12#1)
tests have been performed##3##4##(1994-6#1)(2004-1#1)(2012-2#1)
tests have been taken##2##4##(1993-8#1)(2013-1#1)
tests have been##16##3##(1990-8#1)(1993-8#1)(1994-6#1)(1997-1#1)(2004-1#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-2#1)(2008-10#2)(2010-12#2)(2012-2#1)(2013-1#1)
tests have led to##2##4##(2006-4#1)(2007-8#1)
tests have limitations either in detecting pinholes and/or they are difficult to implement for routine testing##2##16##(2012-2#2)
tests have##32##2##(1990-8#1)(1991-9#1)(1993-8#1)(1994-6#1)(1996-11#1)(1997-1#1)(2004-1#1)(2005-7#1)(2006-10#1)(2006-11#2)(2006-4#1)(2006-5#1)(2007-2#2)(2007-3#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-5#1)(2010-12#2)(2012-2#3)(2013-1#2)(2013-8#1)
tests in a##4##3##(1991-4#1)(1996-12#1)(1997-2#1)(2006-11#1)
tests in clinical##4##3##(1996-8#2)(2007-3#1)(2012-12#1)
tests in comparison##2##3##(1993-5#1)(2011-1#1)
tests in order to##3##4##(1997-4#1)(2008-10#1)(2008-5#1)
tests in our##2##3##(1992-4#1)(2008-5#1)
tests in patients with##3##4##(1992-3#1)(2005-1#1)(2011-2#1)
tests in rats##2##3##(2010-2#1)(2013-1#1)
tests in the presence of##2##5##(2008-3#1)(2012-3#1)
tests in the##17##3##(1991-3#1)(1993-3#1)(1995-5#1)(1996-1#1)(1996-9#1)(2006-10#1)(2006-7#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-3#2)(2013-1#1)
tests in which##4##3##(2008-10#2)(2008-11#1)(2008-3#1)
tests in##95##2##(1990-11#1)(1990-12#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-2#1)(1993-3#2)(1993-5#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-8#2)(1996-9#2)(1997-2#1)(1997-4#1)(2005-1#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#1)(2008-9#3)(2009-3#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-8#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#4)
tests include the##3##3##(1992-6#1)(2006-2#1)(2008-1#1)
tests include##7##2##(1992-6#1)(1996-2#1)(2006-2#1)(2006-8#1)(2007-12#1)(2008-1#1)(2010-10#1)
tests included##5##2##(1990-11#1)(1993-7#1)(1996-8#1)(2008-10#1)(2008-9#1)
tests including##4##2##(2006-8#1)(2006-9#1)(2008-12#1)(2011-2#1)
tests indicate that##4##3##(1992-4#1)(2007-9#1)(2008-10#1)(2010-4#1)
tests indicate the##2##3##(1991-12#1)(2008-1#1)
tests indicate##8##2##(1991-12#1)(1992-4#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2009-7#1)(2010-4#1)
tests indicated a##2##3##(1996-12#1)(2008-6#1)
tests indicated that the##3##4##(2008-10#1)(2009-11#1)(2013-1#1)
tests indicated that##6##3##(1991-12#1)(2006-5#1)(2008-10#2)(2009-11#1)(2013-1#1)
tests indicated##10##2##(1991-12#1)(1996-12#1)(2006-5#1)(2008-10#2)(2008-6#1)(2009-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
tests indicates##2##2##(2006-11#1)(2011-2#1)
tests into##2##2##(2007-4#1)(2008-10#1)
tests involving##2##2##(2008-3#1)(2008-7#1)
tests is##18##2##(1991-3#1)(1994-5#1)(1996-7#1)(1997-4#1)(2005-10#1)(2006-11#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#1)(2011-2#1)(2013-1#1)
tests like##2##2##(2005-11#1)(2009-6#1)
tests may be useful##2##4##(2007-9#1)(2012-2#1)
tests may be##5##3##(2007-9#1)(2010-8#1)(2012-2#1)(2013-1#2)
tests may##7##2##(2007-11#1)(2007-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
tests more##2##2##(2007-12#1)(2011-1#1)
tests must be performed##2##4##(1996-6#1)(2007-11#1)
tests of a##6##3##(1995-8#1)(1997-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
tests of an##3##3##(2007-11#1)(2008-2#2)
tests of anxiety##3##3##(2008-4#3)
tests of association##7##3##(1995-12#1)(2012-3#6)
tests of cognitive function##2##4##(1993-5#1)(1995-11#1)
tests of executive function##2##4##(1995-11#2)
tests of executive##3##3##(1995-11#2)(2006-3#1)
tests of general##2##3##(1995-11#1)(2011-1#1)
tests of group##2##3##(1991-10#1)(1992-6#1)
tests of liver function##3##4##(1992-12#2)(1992-5#1)
tests of memory and##2##4##(1991-5#1)(2012-1#1)
tests of reference and working memory##3##6##(1993-11#3)
tests of reference##4##3##(1993-11#4)
tests of spatial memory##3##4##(1993-12#1)(1993-5#2)
tests of the same##3##4##(2007-3#2)(2007-9#1)
tests of the##20##3##(1995-11#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-3#2)(2007-4#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-9#1)(2009-5#1)(2010-2#1)(2011-2#1)
tests of their##2##3##(1993-3#1)(2008-9#1)
tests of this##4##3##(2005-8#1)(2008-2#2)(2011-1#1)
tests of verbal##2##3##(1993-11#1)(2007-8#1)
tests of##159##2##(1990-3#3)(1990-6#1)(1991-10#1)(1991-3#1)(1991-5#2)(1992-1#1)(1992-12#2)(1992-5#1)(1992-6#3)(1992-8#1)(1993-11#6)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#4)(1994-2#1)(1994-5#1)(1995-1#1)(1995-11#6)(1995-12#1)(1995-2#2)(1995-8#1)(1996-7#1)(1996-9#1)(1997-3#3)(1997-5#2)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-3#1)(2006-4#1)(2007-11#1)(2007-12#7)(2007-3#5)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#8)(2008-4#9)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#8)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#3)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#3)(2011-7#1)(2012-1#3)(2012-11#1)(2012-2#1)(2012-3#7)(2013-1#2)(2013-7#1)
tests offer the##2##3##(2006-10#1)(2010-2#1)
tests offer##3##2##(2006-10#1)(2008-10#1)(2010-2#1)
tests on the##6##3##(1992-5#1)(2006-12#1)(2008-3#1)(2008-5#2)(2010-12#1)
tests on two##2##3##(1992-3#1)(2008-12#1)
tests on volunteers##2##3##(2008-2#1)(2008-5#1)
tests on##44##2##(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1996-11#1)(1996-12#3)(2006-11#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-9#1)(2008-10#10)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#9)(2008-9#1)(2009-4#1)(2010-12#1)(2012-12#2)(2012-3#1)
tests only##3##2##(1993-2#1)(2009-10#1)(2013-8#1)
tests or##6##2##(2006-2#1)(2006-6#1)(2007-1#1)(2009-7#1)(2010-11#1)(2012-3#1)
tests over##4##2##(1993-6#1)(1996-9#1)(2009-8#1)(2010-10#1)
tests per##2##2##(1990-9#1)(2008-5#1)
tests performed in##3##3##(2006-11#1)(2007-7#1)(2008-5#1)
tests performed on the##2##4##(2006-11#1)(2008-5#1)
tests performed on##6##3##(2006-11#1)(2007-11#1)(2008-5#3)(2011-2#1)
tests performed were##2##3##(2005-11#1)(2008-6#1)
tests performed##24##2##(1993-4#1)(1994-9#1)(1996-11#1)(2005-11#1)(2006-11#5)(2006-8#1)(2007-11#2)(2007-4#2)(2007-7#1)(2008-2#1)(2008-5#4)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)
tests provide##4##2##(2007-11#1)(2008-2#1)(2013-1#2)
tests provided##3##2##(1997-2#1)(2008-10#2)
tests reported##2##2##(2006-11#1)(2008-2#1)
tests required to##2##3##(1996-1#1)(2008-8#1)
tests requiring##3##2##(1993-11#1)(2008-4#1)(2011-1#1)
tests resulted in##6##3##(2006-11#2)(2007-1#3)(2007-4#1)
tests results##3##2##(2008-2#1)(2008-5#1)(2013-8#1)
tests reveal that##3##3##(1994-1#1)(2008-10#1)(2010-4#1)
tests reveal##4##2##(1994-1#1)(2007-11#1)(2008-10#1)(2010-4#1)
tests revealed a##2##3##(1990-6#1)(2008-10#1)
tests revealed that##4##3##(2008-10#1)(2008-8#1)(2009-2#1)(2012-2#1)
tests revealed##17##2##(1990-6#1)(1991-9#1)(1992-11#1)(2005-9#1)(2006-11#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-8#1)(2009-2#1)(2009-3#1)(2010-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
tests run##3##2##(2007-8#1)(2008-10#1)(2008-3#1)
tests should be performed to##2##5##(2007-8#1)(2009-8#1)
tests should be performed##3##4##(2007-8#1)(2008-7#1)(2009-8#1)
tests should be##5##3##(1993-9#1)(2006-2#1)(2007-8#1)(2008-7#1)(2009-8#1)
tests should##8##2##(1993-9#1)(1997-3#1)(2006-2#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-7#1)(2009-8#1)
tests show that the##3##4##(1992-3#1)(2007-12#1)(2013-1#1)
tests show that##8##3##(1992-3#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-3#2)(2009-12#1)(2013-1#1)
tests show##14##2##(1990-3#1)(1992-3#1)(1995-6#1)(1997-3#1)(2004-9#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-12#1)(2013-1#1)
tests showed a##3##3##(1990-6#1)(1997-3#1)(2013-1#1)
tests showed that the##8##4##(1994-6#1)(2005-11#1)(2007-1#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-8#1)(2012-12#1)
tests showed that##18##3##(1990-10#1)(1994-6#1)(2005-11#1)(2007-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
tests showed the##2##3##(1990-11#1)(2006-11#1)
tests showed##33##2##(1990-10#1)(1990-11#1)(1990-6#1)(1991-3#1)(1992-3#1)(1992-9#1)(1994-6#1)(1995-2#1)(1997-3#1)(2005-11#1)(2006-11#1)(2007-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#1)(2009-10#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
tests such as the##9##4##(1990-11#1)(1994-2#1)(2005-8#1)(2005-9#1)(2007-7#1)(2007-8#1)(2008-11#1)(2011-2#1)(2012-2#1)
tests such as##15##3##(1990-11#1)(1990-8#1)(1994-2#1)(1996-9#1)(2005-8#1)(2005-9#2)(2006-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-8#1)(2011-2#1)(2012-2#1)
tests that are sensitive##2##4##(1993-11#1)(1996-12#1)
tests that are##4##3##(1993-11#1)(1993-3#1)(1996-12#1)(2006-11#1)
tests that can##4##3##(2006-11#1)(2008-12#1)(2008-4#1)(2010-1#1)
tests that compared areas##2##4##(1997-3#2)
tests that require##2##3##(2010-1#1)(2011-2#1)
tests that were##2##3##(2008-12#1)(2008-3#1)
tests that##31##2##(1990-9#1)(1991-2#1)(1993-11#1)(1993-3#1)(1995-12#1)(1996-12#1)(1997-3#2)(2006-10#1)(2006-11#3)(2006-12#1)(2007-2#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-1#2)(2011-2#1)(2012-3#1)(2013-1#3)
tests the hypothesis that the##2##5##(1990-6#1)(2007-3#1)
tests the hypothesis that##6##4##(1990-6#1)(1991-9#1)(2007-3#2)(2008-7#1)(2008-8#1)
tests the##15##2##(1990-3#1)(1990-6#1)(1991-6#1)(1991-9#1)(1995-8#1)(2007-1#2)(2007-3#2)(2007-4#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-2#1)(2013-8#1)
tests they##2##2##(1996-1#1)(2008-7#1)
tests to assess##4##3##(1997-1#1)(2008-10#1)(2008-11#1)(2013-8#1)
tests to be##4##3##(1992-2#1)(2006-6#1)(2007-4#1)(2008-10#1)
tests to characterize##2##3##(1994-12#1)(1996-12#1)
tests to detect##5##3##(1995-4#1)(2004-11#1)(2006-10#1)(2007-7#1)(2007-8#1)
tests to establish##2##3##(2008-4#1)(2011-2#1)
tests to evaluate##2##3##(1996-6#1)(2007-4#1)
tests to measure##2##3##(2005-8#1)(2008-8#1)
tests to predict##2##3##(1995-5#1)(2006-5#1)
tests to the##3##3##(1991-12#1)(2006-10#1)(2006-11#1)
tests to##51##2##(1990-3#1)(1991-12#1)(1992-2#3)(1994-12#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-5#1)(2004-11#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-4#2)(2007-7#2)(2007-8#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
tests under a##2##3##(1992-2#1)(1995-8#1)
tests under##5##2##(1992-2#1)(1995-8#1)(1996-6#1)(1997-3#1)(2006-11#1)
tests used for##6##3##(2008-10#2)(2008-7#1)(2008-9#1)(2010-2#1)(2011-2#1)
tests used in##3##3##(2008-12#1)(2011-2#1)(2012-2#1)
tests used to assess##2##4##(2008-6#1)(2010-7#1)
tests used to##5##3##(1996-11#1)(1997-3#1)(2008-6#1)(2009-3#1)(2010-7#1)
tests used##19##2##(1990-11#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-3#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-2#1)(2010-7#1)(2011-2#2)(2012-2#1)
tests using a##2##3##(2008-10#1)(2008-5#1)
tests using the##2##3##(2007-4#1)(2008-10#1)
tests using three##2##3##(2006-11#1)(2007-4#1)
tests using##20##2##(1992-6#1)(1993-8#1)(2005-8#1)(2006-11#2)(2007-1#1)(2007-4#2)(2007-6#2)(2008-10#5)(2008-11#1)(2008-5#3)(2012-12#1)
tests utilizing##2##2##(1991-1#1)(2006-11#1)
tests was found##2##3##(1992-6#1)(2011-2#1)
tests was varied by##2##4##(2009-11#2)
tests was##22##2##(1991-6#1)(1992-11#1)(1992-6#1)(1994-6#1)(1996-11#1)(1997-3#1)(2006-10#2)(2007-1#2)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-11#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
tests were administered in##2##4##(2005-10#1)(2007-9#1)
tests were administered##5##3##(2005-10#1)(2006-8#1)(2007-9#1)(2008-12#1)(2008-7#1)
tests were also conducted with##2##5##(2004-4#1)(2006-11#1)
tests were also conducted##3##4##(2004-4#1)(2006-11#1)(2007-4#1)
tests were also##8##3##(1993-8#1)(2004-4#1)(2006-11#1)(2007-2#1)(2007-4#1)(2008-10#1)(2013-1#2)
tests were applied to determine##2##5##(2012-12#1)(2013-1#1)
tests were applied##3##3##(2008-10#1)(2012-12#1)(2013-1#1)
tests were carried out in##4##5##(1993-10#1)(2008-3#1)(2009-4#1)(2009-6#1)
tests were carried out to##3##5##(2006-12#1)(2008-5#1)(2013-1#1)
tests were carried out with##2##5##(2008-2#1)(2008-5#1)
tests were carried out##11##4##(1993-10#1)(2006-12#1)(2008-2#1)(2008-3#1)(2008-5#4)(2009-4#1)(2009-6#1)(2013-1#1)
tests were compared##3##3##(1990-11#1)(2007-2#1)(2008-7#1)
tests were conducted at##4##4##(2006-11#1)(2008-10#3)
tests were conducted in##2##4##(2008-10#1)(2009-1#1)
tests were conducted on the##2##5##(2006-11#1)(2008-10#1)
tests were conducted on##7##4##(2004-9#1)(2006-11#3)(2007-1#1)(2008-10#2)
tests were conducted to##4##4##(2006-11#2)(2008-10#1)(2012-11#1)
tests were conducted with##2##4##(2006-11#2)
tests were conducted##23##3##(2004-9#1)(2006-11#9)(2007-1#1)(2007-4#1)(2008-10#7)(2008-6#1)(2008-8#1)(2009-1#1)(2012-11#1)
tests were done##4##3##(1996-3#1)(2007-1#1)(2008-5#1)(2008-6#1)
tests were examined##2##3##(1996-9#1)(2008-12#1)
tests were found##3##3##(1992-9#1)(2007-12#1)(2010-9#1)
tests were negative##3##3##(2006-10#1)(2007-2#1)(2012-3#1)
tests were normal##7##3##(2006-2#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-7#1)(2012-12#2)
tests were not##3##3##(1993-11#1)(2006-10#1)(2011-2#1)
tests were performed at##4##4##(2006-11#2)(2008-12#1)(2013-8#1)
tests were performed for##2##4##(2007-4#1)(2008-8#1)
tests were performed in a##2##5##(2004-11#1)(2007-1#1)
tests were performed in the##2##5##(2007-8#2)
tests were performed in##8##4##(1990-3#1)(1991-4#1)(2004-11#1)(2007-1#1)(2007-8#2)(2008-5#1)(2012-12#1)
tests were performed on##6##4##(1996-9#1)(2008-10#2)(2008-5#1)(2009-4#1)(2012-2#1)
tests were performed to determine##2##5##(2007-10#1)(2007-12#1)
tests were performed to##4##4##(2007-10#1)(2007-12#1)(2007-4#1)(2008-10#1)
tests were performed using##2##4##(2007-1#1)(2011-1#1)
tests were performed with##2##4##(2006-11#1)(2007-4#1)
tests were performed##43##3##(1990-11#1)(1990-3#1)(1991-4#1)(1992-4#1)(1993-5#1)(1996-2#1)(1996-9#1)(2004-11#1)(2006-11#3)(2007-1#2)(2007-10#2)(2007-12#1)(2007-2#1)(2007-4#4)(2007-8#3)(2008-10#3)(2008-12#3)(2008-4#1)(2008-5#2)(2008-8#1)(2009-4#1)(2009-6#1)(2011-1#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-8#1)
tests were repeated##3##3##(1990-10#1)(1997-7#1)(2007-11#1)
tests were significantly lower##2##4##(2009-6#1)(2013-1#1)
tests were significantly##4##3##(1991-6#1)(2008-5#1)(2009-6#1)(2013-1#1)
tests were used for##5##4##(1996-12#1)(2005-9#1)(2006-11#1)(2010-12#1)(2013-1#1)
tests were used to assess the##2##6##(1994-11#1)(2008-5#1)
tests were used to compare##2##5##(2007-9#1)(2011-1#1)
tests were used to determine##3##5##(2006-10#1)(2009-9#1)(2011-12#1)
tests were used to evaluate the##2##6##(2005-11#1)(2007-7#1)
tests were used to##13##4##(1994-11#1)(1994-3#1)(2005-11#1)(2006-10#1)(2007-4#1)(2007-7#1)(2007-9#2)(2008-5#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-12#1)
tests were used##22##3##(1994-11#1)(1994-3#1)(1996-12#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-11#1)(2007-4#1)(2007-7#1)(2007-9#2)(2008-5#1)(2009-9#1)(2010-12#2)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
tests were##195##2##(1990-10#1)(1990-11#3)(1990-3#1)(1991-4#1)(1991-6#2)(1991-7#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-8#2)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#2)(1997-2#1)(1997-6#1)(1997-7#1)(2004-11#1)(2004-4#1)(2004-9#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#5)(2006-11#16)(2006-12#1)(2006-2#1)(2006-8#2)(2007-1#4)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#7)(2007-3#1)(2007-4#9)(2007-7#3)(2007-8#6)(2007-9#5)(2008-10#13)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#10)(2008-6#2)(2008-7#3)(2008-8#2)(2009-1#1)(2009-4#3)(2009-6#3)(2009-9#1)(2010-12#3)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#7)(2012-2#4)(2012-3#2)(2013-1#10)(2013-8#4)
tests when##3##2##(1994-6#1)(2011-2#1)(2012-3#1)
tests whether the##3##3##(1995-2#1)(2010-2#1)(2010-3#1)
tests whether##4##2##(1995-2#1)(1995-5#1)(2010-2#1)(2010-3#1)
tests which were##2##3##(2007-4#1)(2013-8#1)
tests which##7##2##(1992-10#1)(1996-9#1)(2007-4#1)(2011-2#2)(2012-12#1)(2013-8#1)
tests with a##5##3##(1993-9#1)(1997-5#1)(2006-11#1)(2008-10#1)(2009-4#1)
tests with functional endpoints for the##2##6##(2008-11#2)
tests with the##5##3##(1992-4#1)(2006-11#2)(2007-4#1)(2008-10#1)
tests with three##2##3##(2007-4#1)(2008-10#1)
tests with##61##2##(1990-5#1)(1991-6#1)(1992-4#1)(1992-9#1)(1993-2#1)(1993-9#1)(1995-12#1)(1995-5#2)(1996-8#1)(1997-5#1)(2005-11#1)(2006-11#5)(2006-8#1)(2006-9#1)(2007-4#3)(2007-7#1)(2008-10#12)(2008-11#4)(2008-3#3)(2008-5#2)(2009-4#3)(2009-8#1)(2009-9#1)(2010-11#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-7#1)
tests within the##2##3##(2010-12#1)(2010-5#1)
tests within##3##2##(2010-12#1)(2010-2#1)(2010-5#1)
tests would##3##2##(1996-12#1)(2005-9#1)(2006-10#1)
tests##2505##1##(1990-10#3)(1990-11#8)(1990-12#2)(1990-2#7)(1990-3#15)(1990-4#2)(1990-5#1)(1990-6#8)(1990-7#3)(1990-8#7)(1990-9#9)(1991-1#3)(1991-10#7)(1991-11#7)(1991-12#8)(1991-2#4)(1991-3#11)(1991-4#6)(1991-5#4)(1991-6#16)(1991-7#4)(1991-8#3)(1991-9#5)(1992-1#4)(1992-10#3)(1992-11#7)(1992-12#6)(1992-2#11)(1992-3#9)(1992-4#8)(1992-5#7)(1992-6#13)(1992-8#4)(1992-9#7)(1993-1#6)(1993-10#4)(1993-11#10)(1993-12#6)(1993-2#8)(1993-3#17)(1993-4#3)(1993-5#12)(1993-6#5)(1993-7#4)(1993-8#5)(1993-9#6)(1994-1#2)(1994-10#1)(1994-11#4)(1994-12#3)(1994-2#5)(1994-3#11)(1994-5#9)(1994-6#18)(1994-7#2)(1994-8#5)(1994-9#8)(1995-1#4)(1995-10#1)(1995-11#7)(1995-12#5)(1995-2#13)(1995-3#2)(1995-4#13)(1995-5#10)(1995-6#4)(1995-7#2)(1995-8#4)(1995-9#2)(1996-1#7)(1996-11#9)(1996-12#22)(1996-2#14)(1996-3#9)(1996-4#3)(1996-6#7)(1996-7#6)(1996-8#9)(1996-9#19)(1997-1#4)(1997-2#12)(1997-3#21)(1997-4#7)(1997-5#9)(1997-6#6)(1997-7#5)(1997-8#9)(2004-1#2)(2004-11#5)(2004-2#1)(2004-3#1)(2004-4#4)(2004-9#5)(2005-1#1)(2005-10#7)(2005-11#21)(2005-12#3)(2005-5#1)(2005-7#4)(2005-8#7)(2005-9#7)(2006-1#1)(2006-10#55)(2006-11#95)(2006-12#9)(2006-2#13)(2006-3#1)(2006-4#5)(2006-5#6)(2006-6#7)(2006-7#4)(2006-8#18)(2006-9#7)(2007-1#33)(2007-10#7)(2007-11#35)(2007-12#39)(2007-2#29)(2007-3#15)(2007-4#87)(2007-5#3)(2007-6#7)(2007-7#52)(2007-8#32)(2007-9#23)(2008-1#12)(2008-10#280)(2008-11#28)(2008-12#34)(2008-2#32)(2008-3#42)(2008-4#34)(2008-5#87)(2008-6#15)(2008-7#34)(2008-8#20)(2008-9#44)(2009-1#1)(2009-10#4)(2009-11#5)(2009-12#2)(2009-2#5)(2009-3#9)(2009-4#24)(2009-5#5)(2009-6#6)(2009-7#10)(2009-8#10)(2009-9#9)(2010-1#5)(2010-10#5)(2010-11#3)(2010-12#21)(2010-2#21)(2010-3#3)(2010-4#6)(2010-5#8)(2010-6#5)(2010-7#3)(2010-8#15)(2010-9#2)(2011-1#25)(2011-12#10)(2011-2#61)(2011-3#2)(2011-7#2)(2011-8#1)(2012-1#12)(2012-11#4)(2012-12#29)(2012-2#55)(2012-3#56)(2012-4#1)(2012-7#1)(2013-1#80)(2013-7#9)(2013-8#35)
tests&quot##4##1##(2013-1#4)
tests) and##3##2##(2007-4#1)(2008-8#1)(2012-3#1)
tests) in##2##2##(2008-10#1)(2008-11#1)
tests) that##2##2##(2011-1#1)(2011-2#1)
tests)##25##1##(1992-3#1)(1994-8#2)(1997-6#1)(2006-8#1)(2007-4#5)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#2)
tests--are##2##1##(1990-3#1)(1991-3#1)
tests/h)##2##1##(2008-10#2)
tests]##6##1##(1990-10#1)(1992-4#1)(1992-5#1)(1993-7#1)(1996-3#1)(2007-8#1)
testudinum in the##3##3##(2008-5#3)
testudinum were##2##2##(2008-5#2)
testudinum##24##1##(2007-3#5)(2007-5#5)(2008-5#10)(2011-2#4)
tet gene of##2##3##(1990-9#2)
tet gene##7##2##(1990-9#4)(1996-2#3)
tet##11##1##(1990-9#5)(1993-12#1)(1994-12#1)(1994-7#1)(1996-2#3)
tet(B)##2##1##(1995-5#1)(2006-8#1)
tet(K) gene from Staphylococcus aureus##2##5##(1995-5#2)
tet(K)##5##1##(1995-5#2)(1997-7#2)(2006-8#1)
tetanic fade was##4##3##(1997-5#4)
tetanic fade##7##2##(1997-5#7)
tetanic stimulation of##3##3##(1991-6#1)(1994-10#1)(1995-11#1)
tetanic stimulation##10##2##(1991-12#1)(1991-6#1)(1992-3#1)(1993-12#1)(1994-10#1)(1995-11#1)(1997-1#1)(2007-11#1)(2008-7#2)
tetanic tension##2##2##(2008-3#2)
tetanic##23##1##(1991-12#1)(1991-6#1)(1991-7#1)(1992-3#1)(1993-12#1)(1994-10#1)(1995-11#1)(1997-1#1)(1997-5#8)(2007-11#1)(2008-3#2)(2008-7#2)(2012-7#1)(2013-8#1)
tetanization##8##1##(1991-3#4)(1991-8#1)(1995-12#1)(1995-5#2)
tetanomorphum##2##1##(2013-8#2)
tetanus and diphtheria##2##3##(1992-2#1)(1994-8#1)
tetanus and pertussis##2##3##(1992-2#1)(2007-11#1)
tetanus and##6##2##(1992-2#2)(1994-10#1)(1994-8#1)(2007-11#1)(2009-5#1)
tetanus in##3##2##(1992-2#1)(2004-10#1)(2007-2#1)
tetanus toxin##19##2##(1990-3#1)(1990-9#1)(1991-10#3)(1992-7#1)(1994-9#5)(1995-12#1)(1995-2#2)(2008-10#3)(2008-5#2)
tetanus toxoid and##2##3##(1992-2#1)(1994-2#1)
tetanus toxoid in##3##3##(1995-12#1)(1995-2#1)(2009-5#1)
tetanus toxoid##21##2##(1990-4#1)(1992-2#1)(1994-2#1)(1995-12#3)(1995-2#1)(1995-5#2)(2007-8#4)(2008-11#1)(2008-4#3)(2009-5#1)(2011-2#3)
tetanus vaccine##4##2##(1995-5#2)(1996-8#1)(2008-7#1)
tetanus##92##1##(1990-3#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-10#3)(1991-4#1)(1992-2#7)(1992-3#1)(1992-5#3)(1992-7#1)(1993-12#1)(1994-10#1)(1994-2#1)(1994-8#1)(1994-9#5)(1995-12#8)(1995-2#3)(1995-3#1)(1995-5#8)(1995-8#1)(1996-6#1)(1996-8#1)(1996-9#1)(2004-1#1)(2004-10#1)(2006-4#1)(2007-11#2)(2007-2#4)(2007-8#4)(2008-10#3)(2008-11#1)(2008-4#3)(2008-5#2)(2008-7#3)(2009-5#3)(2009-9#2)(2010-12#1)(2010-9#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)
tetanus-based##2##1##(2007-8#2)
tetanus-induced long-term potentiation (LTP) in the##2##6##(1992-12#1)(1992-3#1)
tetanus-induced##3##1##(1992-12#1)(1992-3#1)(2008-7#1)
tetany in patients with##2##4##(2005-1#2)
tetany was##2##2##(2005-1#2)
tetany##9##1##(1991-12#1)(1991-6#1)(2005-1#5)(2012-7#1)(2013-8#1)
tether elasticity##3##2##(2012-1#3)
tether##12##1##(1990-2#1)(1995-1#1)(1996-5#2)(2006-12#1)(2007-10#1)(2008-5#1)(2008-9#1)(2012-1#4)
tethered cord syndrome##5##3##(2006-5#1)(2008-7#3)(2009-3#1)
tethered cord##7##2##(2005-10#1)(2006-5#1)(2007-8#1)(2008-7#3)(2009-3#1)
tethered pelvic assist device (T-PAD)##2##5##(2012-1#2)
tethered to a##2##3##(2008-11#1)(2012-11#1)
tethered to the##2##3##(1996-4#1)(2007-8#1)
tethered to##4##2##(1996-4#1)(2007-8#1)(2008-11#1)(2012-11#1)
tethered vagina syndrome##2##3##(2012-3#2)
tethered##36##1##(1991-5#1)(1991-9#1)(1992-4#1)(1996-1#1)(1996-4#2)(2005-10#1)(2006-12#2)(2006-5#1)(2007-8#2)(2008-11#4)(2008-4#3)(2008-5#1)(2008-7#4)(2009-12#1)(2009-3#1)(2009-5#2)(2010-4#1)(2010-6#1)(2012-1#2)(2012-11#1)(2012-2#1)(2012-3#2)
tetherin##6##1##(2011-2#1)(2013-1#5)
tethering of the##2##3##(1997-4#1)(2007-8#1)
tethering of##5##2##(1997-4#1)(2006-12#1)(2007-8#1)(2012-12#1)(2012-2#1)
tethering the##2##2##(1992-6#1)(1996-5#1)
tethering##17##1##(1992-6#1)(1994-9#1)(1996-5#3)(1997-4#1)(2006-12#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-12#2)(2012-2#2)
tethers the##2##2##(1994-9#1)(1997-7#1)
tethers to##3##2##(2008-3#1)(2008-4#1)(2008-8#1)
tethers##12##1##(1994-9#1)(1997-7#1)(2005-11#1)(2008-3#1)(2008-4#2)(2008-8#2)(2008-9#1)(2010-2#1)(2012-1#2)
tetillapyrone and nortetillapyrone were##3##4##(2008-5#3)
tetillapyrone##5##1##(2008-5#5)
tetra##10##1##(1990-6#1)(1996-9#1)(2008-10#4)(2008-5#1)(2008-8#1)(2009-12#1)(2011-12#1)
tetra-##5##1##(1991-12#1)(1996-5#1)(2007-6#1)(2008-10#1)(2010-5#1)
tetra-3##3##1##(2008-10#3)
tetra-N-hexadecylpyridiniumyl porphyrin##2##2##(2008-10#2)
tetra-coordinate nickel(II) complex##2##3##(2008-10#2)
tetra-n-butyl ammonium##2##2##(1996-6#1)(2009-11#1)
tetra-n-butylammonium fluoride##2##2##(1997-2#1)(2007-12#1)
tetra-n-butylammonium##5##1##(1997-2#1)(2007-12#2)(2008-10#2)
tetra-nucleotides are##2##2##(2012-3#2)
tetra-nucleotides##4##1##(2012-3#4)
tetra-substituted amino aluminum phthalocyanine##2##4##(2008-10#2)
tetra-substituted##4##1##(2008-10#4)
tetraacetal##2##1##(1996-5#2)
tetraacetic acid##9##2##(1992-8#1)(2008-10#4)(2008-3#1)(2009-5#1)(2009-8#1)(2013-1#1)
tetraacetic##12##1##(1991-3#2)(1992-8#1)(2008-10#4)(2008-3#1)(2008-9#1)(2009-5#1)(2009-8#1)(2013-1#1)
tetraalkylammonium salts##3##2##(1990-3#1)(1993-2#1)(2008-10#1)
tetraalkylammonium##6##1##(1990-3#1)(1993-2#1)(2005-11#1)(2008-10#3)
tetraamide##2##1##(2008-10#1)(2008-3#1)
tetraamine##5##1##(1994-9#3)(1996-8#1)(2008-10#1)
tetraamines##2##1##(1994-9#2)
tetraaminophthalocyanine##2##1##(2008-10#2)
tetraantennary complex-type sugar chains##2##4##(1993-11#2)
tetraantennary##3##1##(1991-2#1)(1993-11#2)
tetraazamacrocyclic##2##1##(2008-3#1)(2008-5#1)
tetrabenazine##4##1##(1996-5#2)(2010-6#1)(2011-10#1)
tetrabenzyl##2##1##(2008-10#2)
tetraborate##4##1##(1994-9#1)(1996-5#1)(2008-10#1)(2008-2#1)
tetrabromophenolphthalein##2##1##(2008-10#2)
tetrabutyl ammonium bromide##2##3##(2008-10#2)
tetrabutyl##3##1##(2005-11#1)(2008-10#2)
tetrabutylammonium (TBA)##2##2##(2008-10#2)
tetrabutylammonium bromide (TBABr)##2##3##(2008-10#2)
tetrabutylammonium bromide##9##2##(1990-6#1)(2008-10#8)
tetrabutylammonium fluoride##2##2##(2008-4#1)(2009-5#1)
tetrabutylammonium hydroxide in##3##3##(1990-5#1)(2007-11#2)
tetrabutylammonium hydroxide##6##2##(1990-5#1)(2007-11#2)(2007-8#1)(2008-10#2)
tetrabutylammonium perchlorate##2##2##(2008-10#2)
tetrabutylammonium periodate##3##2##(2008-10#3)
tetrabutylammonium##36##1##(1990-12#1)(1990-5#1)(1990-6#1)(1991-9#1)(1992-2#1)(1992-9#1)(1995-5#2)(1997-3#1)(1997-8#1)(2007-11#2)(2007-8#1)(2008-10#21)(2008-4#1)(2009-5#1)
tetracaine hydrochloride##5##2##(2008-10#5)
tetracaine##22##1##(1990-2#3)(1991-7#1)(1994-3#1)(1995-3#3)(1996-5#1)(1997-5#7)(2008-10#5)(2008-3#1)
tetracarbonyl##2##1##(2007-11#2)
tetracarboxy aluminum phthalocyanine##2##3##(2008-10#2)
tetracene##2##1##(2007-9#2)
tetrachloride##39##1##(1990-11#1)(1990-9#1)(1991-9#1)(1992-3#2)(1992-6#1)(1994-8#1)(1995-3#13)(2004-4#1)(2005-7#1)(2007-11#1)(2007-12#1)(2008-10#7)(2009-3#1)(2009-8#1)(2010-2#1)(2010-5#1)(2011-2#3)(2013-1#1)
tetrachlorinated quinone##2##2##(2008-10#2)
tetrachloro##2##1##(2008-5#2)
tetrachloro-p-benzoquinone##2##1##(2008-10#2)
tetrachlorobenzoquinone reductase##2##2##(2009-3#2)
tetrachlorobenzoquinone##5##1##(2008-10#1)(2009-3#4)
tetrachlorodibenzo-p-dioxin (TCDD)##2##2##(2008-10#2)
tetrachloroethylene##5##1##(1996-11#1)(2008-10#3)(2012-12#1)
tetrachlorohydroquinone and##2##2##(2008-10#1)(2009-3#1)
tetrachlorohydroquinone##10##1##(1990-11#3)(2008-10#1)(2009-3#6)
tetrachloromethane##3##1##(2004-4#1)(2008-10#2)
tetrachloromethane)##2##1##(2008-10#2)
tetrachloroplatinate(ll)##3##1##(2008-5#3)
tetrachlorothallate##4##1##(2008-10#4)
tetracoordinate moncarbene##2##2##(2010-5#2)
tetracoordinate##5##1##(2008-10#1)(2010-5#4)
tetracyanoethylene##2##1##(2008-10#2)
tetracyclic core of##2##3##(2008-10#2)
tetracyclic core##3##2##(2008-10#2)(2013-8#1)
tetracyclic##7##1##(2008-10#3)(2009-10#2)(2013-7#1)(2013-8#1)
tetracyclin and##2##2##(2004-9#1)(2008-12#1)
tetracyclin##5##1##(1997-8#1)(2004-9#1)(2006-10#2)(2008-12#1)
tetracycline (TC)##4##2##(2008-10#3)(2010-5#1)
tetracycline and vancomycin##2##3##(2008-11#1)(2008-12#1)
tetracycline and##14##2##(1995-4#1)(2006-11#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2012-2#2)
tetracycline and/or##2##2##(2006-8#2)
tetracycline antibiotics in##3##3##(2008-10#3)
tetracycline antibiotics##7##2##(1997-8#1)(2008-10#6)
tetracycline hydrochloride##3##2##(2007-7#1)(2011-2#1)(2012-3#1)
tetracycline in the##2##3##(2008-10#2)
tetracycline in##6##2##(1993-2#1)(2008-10#5)
tetracycline resistance gene##2##3##(1993-11#1)(2012-2#1)
tetracycline resistance##5##2##(1993-11#1)(1994-3#1)(1995-5#1)(2008-11#1)(2012-2#1)
tetracycline resistant##3##2##(1994-9#1)(2006-8#2)
tetracycline to##2##2##(1995-8#1)(2008-10#1)
tetracycline transport##2##2##(1995-5#1)(1997-7#1)
tetracycline was##2##2##(1995-5#1)(2005-10#1)
tetracycline##112##1##(1991-6#1)(1991-8#1)(1993-11#1)(1993-2#2)(1993-8#2)(1994-12#1)(1994-3#1)(1994-9#2)(1995-4#1)(1995-5#4)(1995-8#1)(1995-9#1)(1997-7#3)(1997-8#2)(2005-10#7)(2006-11#1)(2006-5#2)(2006-8#9)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#32)(2008-11#6)(2008-12#2)(2008-2#2)(2008-7#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#1)
tetracycline-controlled system##2##2##(2008-1#1)(2008-2#1)
tetracycline-inducible##4##1##(2008-11#1)(2009-10#2)(2012-2#1)
tetracycline-regulated##3##1##(1995-8#1)(2008-11#1)(2008-2#1)
tetracycline-resistance##2##1##(1994-3#1)(2008-11#1)
tetracyclines and##6##2##(1996-3#1)(1997-5#1)(1997-8#1)(2010-4#1)(2012-12#2)
tetracyclines in surface water samples##2##5##(2008-10#2)
tetracyclines in##7##2##(2004-9#1)(2008-10#5)(2010-5#1)
tetracyclines##28##1##(1990-6#1)(1996-3#1)(1997-5#1)(1997-6#4)(1997-8#4)(2004-9#4)(2008-10#9)(2010-4#1)(2010-5#1)(2012-12#2)
tetrad##3##1##(1994-9#1)(1995-6#1)(2008-10#1)
tetradactylum on the##2##3##(2010-8#2)
tetradactylum##5##1##(2010-8#5)
tetradecameric##4##1##(1992-4#1)(1995-3#1)(1995-8#1)(1997-4#1)
tetradecanal##2##1##(2004-2#2)
tetradecapeptide##3##1##(1990-8#2)(1993-12#1)
tetradecyl##3##1##(2005-11#2)(2008-10#1)
tetradecyl-##2##1##(2005-11#2)
tetradecyldimethylbenzylammonium chloride##5##2##(2005-11#2)(2008-10#3)
tetradecylthioacetic##3##1##(1995-3#1)(2009-4#2)
tetradecyltrimethylammonium bromide##2##2##(1994-9#1)(2005-11#1)
tetradentate ligands##2##2##(2008-5#1)(2008-6#1)
tetradentate##11##1##(1997-7#1)(2008-10#2)(2008-3#1)(2008-5#6)(2008-6#1)
tetrads##4##1##(2008-10#2)(2011-12#1)(2012-3#1)
tetraene##4##1##(1991-5#1)(1993-6#1)(2006-9#2)
tetraether lipid##2##2##(1990-2#2)
tetraether##4##1##(1990-2#3)(1991-9#1)
tetraethoxysilane (TEOS)##2##2##(2005-11#1)(2008-5#1)
tetraethoxysilane##6##1##(2005-11#1)(2008-3#1)(2008-5#1)(2010-7#3)
tetraethyl orthosilicate##5##2##(2005-11#2)(2007-8#1)(2008-10#1)(2010-3#1)
tetraethyl##9##1##(2005-11#2)(2006-5#1)(2007-8#1)(2008-10#2)(2010-11#1)(2010-3#1)(2012-11#1)
tetraethylammonium (TEA)##3##2##(1990-7#1)(1996-5#1)(2008-8#1)
tetraethylammonium and##2##2##(1991-1#1)(1994-12#1)
tetraethylammonium chloride##2##2##(1993-9#1)(1994-5#1)
tetraethylammonium##17##1##(1990-5#1)(1990-7#1)(1991-1#1)(1992-11#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1996-5#1)(1997-2#1)(2007-10#1)(2008-10#4)(2008-8#1)
tetraethylene glycol&quot##2##2##(2007-8#2)
tetraethylene##3##1##(2007-10#1)(2007-8#2)
tetraethylenepentamine##3##1##(2008-10#3)
tetraethylorthosilicate (TEOS)##3##2##(2008-10#3)
tetraethylorthosilicate##9##1##(2005-11#2)(2008-10#4)(2008-5#1)(2010-2#1)(2010-4#1)
tetrafluoroborate##4##1##(1994-2#1)(1996-8#1)(2008-10#2)
tetrafluoroethane##2##1##(2013-7#2)
tetrafunctional##3##1##(2008-2#3)
tetragonal space group##2##3##(1996-2#1)(2012-11#1)
tetragonal zirconia##3##2##(2008-10#3)
tetragonal##21##1##(1991-7#1)(1996-2#3)(1996-9#1)(1997-4#2)(1997-7#3)(2006-10#2)(2008-10#4)(2008-2#1)(2008-3#2)(2008-9#1)(2012-11#1)
tetragonus##2##1##(2008-10#2)
tetrahedra##6##1##(1997-7#1)(2005-11#1)(2008-5#1)(2011-2#3)
tetrahedral and octahedral##2##3##(1996-2#1)(2010-12#1)
tetrahedral and##3##2##(1996-2#1)(2008-5#1)(2010-12#1)
tetrahedral complex##2##2##(1992-1#2)
tetrahedral geometry##2##2##(1997-7#1)(2008-5#1)
tetrahedral intermediates##2##2##(1991-2#1)(1991-4#1)
tetrahedral mesh##2##2##(2011-2#2)
tetrahedral##35##1##(1990-2#1)(1991-2#3)(1991-4#2)(1992-1#2)(1992-12#1)(1992-3#2)(1992-5#1)(1993-11#4)(1996-2#2)(1996-8#1)(1997-7#1)(2005-11#4)(2007-10#1)(2007-11#1)(2008-3#1)(2008-5#3)(2008-6#1)(2010-12#1)(2011-2#3)
tetrahedrally coordinated##4##2##(1991-4#1)(1993-3#1)(1996-2#1)(2008-3#1)
tetrahedrally##5##1##(1991-4#1)(1993-3#1)(1995-3#1)(1996-2#1)(2008-3#1)
tetrahelical DNA##2##2##(1994-11#2)
tetrahelical##3##1##(1994-11#3)
tetrahelix##2##1##(1994-11#2)
tetraheme cytochrome subunit##3##3##(1993-8#3)
tetraheme cytochrome##5##2##(1993-8#3)(1994-5#1)(1994-8#1)
tetraheme##7##1##(1993-8#4)(1994-11#1)(1994-5#1)(1994-8#1)
tetrahydro##3##1##(1992-6#1)(1997-1#2)
tetrahydro-beta-carboline##5##1##(2006-12#5)
tetrahydro-beta-carboline-3-carboxylic acids##2##2##(1997-3#2)
tetrahydroaminoacridine##5##1##(1992-8#2)(1993-12#1)(1993-2#1)(1994-10#1)
tetrahydrobiopterin (BH4)##4##2##(1992-12#1)(1993-8#1)(1995-1#1)(1997-5#1)
tetrahydrobiopterin and##2##2##(1992-6#1)(1995-8#1)
tetrahydrobiopterin binding##2##2##(1997-4#2)
tetrahydrobiopterin deficiency##2##2##(1996-9#2)
tetrahydrobiopterin##32##1##(1991-3#5)(1991-8#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-1#2)(1995-5#3)(1995-8#3)(1996-9#3)(1997-4#3)(1997-5#1)(2010-5#1)
tetrahydroborate##13##1##(1992-2#1)(2007-12#1)(2008-10#11)
tetrahydroborate(III)##4##1##(2008-10#4)
tetrahydrocannabinol##4##1##(1996-5#1)(2008-7#1)(2008-9#1)(2010-4#1)
tetrahydrocortisol and tetrahydro##2##3##(1997-1#2)
tetrahydrofolate##9##1##(1990-5#1)(1994-8#1)(1995-7#1)(1997-1#1)(2005-12#5)
tetrahydrofuran (THF)##4##2##(1996-5#1)(2007-12#1)(2008-10#1)(2008-5#1)
tetrahydrofuran and##5##2##(1990-8#1)(1997-8#1)(2007-12#1)(2008-10#2)
tetrahydrofuran##30##1##(1990-8#1)(1992-2#2)(1994-9#1)(1996-5#2)(1996-8#1)(1997-8#1)(2006-3#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2009-5#1)
tetrahydrofurane##3##1##(2008-10#3)
tetrahydrogestrinone##3##1##(2007-8#1)(2010-11#2)
tetrahydroisoquinoline alkaloids##2##2##(2007-11#2)
tetrahydroisoquinoline##5##1##(2007-11#3)(2011-3#2)
tetrahydroisoquinolines and tetrahydro-beta-carbolines##2##3##(1996-8#2)
tetrahydroisoquinolines##3##1##(1993-8#1)(1996-8#2)
tetrahydropentalenolactone##2##1##(1994-5#2)
tetrahydroprotoberberine N-oxide alkaloids##2##3##(2007-1#2)
tetrahydroprotoberberine##3##1##(1997-1#1)(2007-1#2)
tetrahydropterin synthase##8##2##(1992-1#7)(1997-8#1)
tetrahydropterin##13##1##(1991-3#4)(1992-1#7)(1997-8#2)
tetrahydropyridine##4##1##(1992-11#1)(1996-12#2)(2007-11#1)
tetraiodofluorescein##3##1##(2008-10#3)
tetrakis rare-earth compounds of##2##4##(2008-2#2)
tetrakis rare-earth##4##2##(2008-2#4)
tetrakis##11##1##(2008-10#6)(2008-2#4)(2012-11#1)
tetrakis(3##3##1##(2008-5#3)
tetrakis(4-chlorophenyl)borate##6##1##(2008-10#6)
tetrakisphosphate (InsP4)##2##2##(1990-2#1)(1990-5#1)
tetrakisphosphate isomers##2##2##(1990-5#1)(1991-2#1)
tetrakisphosphate##15##1##(1990-2#1)(1990-5#3)(1990-7#2)(1991-2#1)(1992-11#1)(1992-2#1)(1993-6#1)(1996-4#2)(1997-1#2)(2006-10#1)
tetrakisphosphates##4##1##(1992-11#1)(1996-2#2)(1997-1#1)
tetralogy of Fallot (TOF)##2##4##(2007-8#2)
tetralogy of Fallot in##2##4##(2007-8#2)
tetralogy of Fallot##15##3##(1997-1#3)(1997-3#2)(2006-10#1)(2007-8#5)(2009-10#1)(2009-9#3)
tetralogy##18##1##(1993-10#1)(1996-11#1)(1997-1#3)(1997-3#2)(2006-10#1)(2007-8#5)(2008-12#1)(2009-10#1)(2009-9#3)
tetraloop##6##1##(1997-2#6)
tetraloop&quot##3##1##(1997-2#3)
tetraloops##5##1##(1992-3#4)(2006-12#1)
tetramer and##8##2##(1992-6#1)(1993-8#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-11#1)(1997-1#1)(2008-8#1)
tetramer binding##2##2##(2008-8#1)(2008-9#1)
tetramer in##2##2##(1997-4#1)(2007-11#1)
tetramer of##4##2##(1990-12#1)(1995-1#1)(1996-5#1)(2008-9#1)
tetramer##57##1##(1990-10#1)(1990-12#2)(1990-4#1)(1990-8#1)(1991-2#1)(1991-4#1)(1992-6#1)(1992-8#1)(1993-4#4)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-6#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-5#1)(1995-7#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#6)(1997-4#2)(1997-6#1)(1997-7#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-4#2)(2008-8#2)(2008-9#3)
tetramer)##2##1##(1994-9#1)(1995-8#1)
tetrameric arrangement##2##2##(1990-4#1)(1995-10#1)
tetrameric complex##2##2##(1992-2#1)(2008-8#1)
tetrameric enzyme##6##2##(1993-7#1)(1993-9#1)(1994-11#1)(2008-9#1)(2009-2#2)
tetrameric form##4##2##(1995-10#1)(1995-12#2)(1997-4#1)
tetrameric species##2##2##(1990-10#1)(1997-2#1)
tetrameric structure##2##2##(1992-12#1)(2008-9#1)
tetrameric##46##1##(1990-10#1)(1990-2#1)(1990-4#1)(1990-8#4)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-10#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-4#2)(1997-2#1)(1997-4#1)(2006-12#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-8#3)(2008-9#2)(2009-2#2)
tetramerization##10##1##(1991-2#2)(1993-8#7)(1997-2#1)
tetramers and##4##2##(1990-8#1)(1996-6#1)(2008-9#1)(2010-8#1)
tetramers at the##2##3##(1990-8#1)(1995-6#1)
tetramers at##4##2##(1990-8#1)(1995-6#1)(1997-2#1)(2007-11#1)
tetramers can be##2##3##(1997-1#1)(2008-11#1)
tetramers in##2##2##(1990-8#1)(2008-4#1)
tetramers of##3##2##(1994-8#1)(1995-10#1)(2008-11#1)
tetramers to##2##2##(1997-2#1)(2008-4#1)
tetramers with##2##2##(1995-10#1)(2008-8#1)
tetramers##50##1##(1990-10#1)(1990-8#5)(1992-7#1)(1992-9#2)(1994-8#1)(1995-1#1)(1995-10#5)(1995-12#1)(1995-6#1)(1996-4#1)(1996-6#3)(1997-1#2)(1997-2#7)(2006-10#1)(2007-11#2)(2008-11#2)(2008-4#2)(2008-5#1)(2008-8#5)(2008-9#4)(2010-8#1)(2013-7#1)
tetramethyl ammonium chloride##2##3##(1995-11#1)(2008-4#1)
tetramethyl##4##1##(1995-11#1)(2008-4#1)(2008-6#1)(2010-5#1)
tetramethylammonium hydroxide (TMAH)##5##3##(2008-10#3)(2013-1#2)
tetramethylammonium hydroxide (TMAOH)##2##3##(2005-11#1)(2008-10#1)
tetramethylammonium hydroxide##9##2##(2005-11#1)(2008-10#6)(2013-1#2)
tetramethylammonium##14##1##(1992-9#1)(2005-11#1)(2008-10#10)(2013-1#2)
tetramethylarsonium##3##1##(2008-10#3)
tetramethylpyrazine and##2##2##(1991-6#2)
tetramethylpyrazine##8##1##(1991-6#6)(2011-1#1)(2012-12#1)
tetramethylrhodamine##6##1##(1996-9#1)(2006-10#1)(2008-10#2)(2008-9#1)(2009-8#1)
tetrandrine##8##1##(1997-5#8)
tetranectin##8##1##(1992-8#4)(1997-7#4)
tetrangle inequality bound smoothing##2##4##(2007-9#2)
tetrangle inequality##4##2##(2007-9#4)
tetrangle##6##1##(2007-9#6)
tetranitrate (PETN)##4##2##(2008-10#2)(2008-3#1)(2009-5#1)
tetranitrate##7##1##(2008-10#4)(2008-3#1)(2009-5#1)(2010-4#1)
tetranitromethane##2##1##(1990-12#1)(1990-5#1)
tetranorDHLA inhibited##2##2##(1994-2#2)
tetranorDHLA##4##1##(1994-2#4)
tetranuclear##4##1##(1991-2#1)(1996-7#1)(1997-7#1)(2007-11#1)
tetranucleotide repeats##2##2##(1996-6#1)(1997-2#1)
tetranucleotide##9##1##(1990-11#1)(1995-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-5#1)(2008-3#2)
tetraoctylammonium bromide##2##2##(2008-10#2)
tetraoctylammonium##3##1##(2008-10#3)
tetraodon##2##1##(2008-8#2)
tetraparesis##4##1##(2007-10#3)(2011-2#1)
tetrapeptide in##2##2##(2006-12#2)
tetrapeptide motif##2##2##(1991-9#1)(1995-1#1)
tetrapeptide sequence##3##2##(1991-7#1)(1994-3#1)(1997-7#1)
tetrapeptide##48##1##(1990-11#3)(1990-2#1)(1990-6#2)(1990-7#2)(1991-10#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#2)(1992-2#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#3)(1995-1#2)(1997-3#5)(1997-7#1)(2006-12#8)(2008-10#3)(2013-1#1)
tetrapeptides##5##1##(1990-11#2)(1990-12#1)(1991-9#1)(1997-3#1)
tetrapeptidyl##3##1##(1990-7#2)(1994-3#1)
tetrapetalum##2##1##(2008-10#2)
tetraphenyl borate##6##2##(2008-10#6)
tetraphenyl##8##1##(1992-11#1)(2005-11#1)(2008-10#6)
tetraphenylborate as##2##2##(2008-10#2)
tetraphenylborate##19##1##(2008-10#19)
tetraphenylporphine##2##1##(2007-8#1)(2008-10#1)
tetraphenylporphyrin##7##1##(1996-2#1)(2008-10#2)(2010-7#4)
tetraphosphate##4##1##(1992-11#1)(1997-7#1)(2010-4#2)
tetraplegia and##2##2##(2007-11#2)
tetraplegia##14##1##(2006-3#4)(2007-11#6)(2007-7#1)(2012-1#1)(2012-2#2)
tetraplegic patient##2##2##(1990-6#1)(2006-3#1)
tetraplegic patients##3##2##(2007-11#2)(2008-12#1)
tetraplegic##6##1##(1990-6#1)(2006-3#1)(2007-11#2)(2008-12#1)(2012-1#1)
tetraplegics##4##1##(1991-6#2)(1996-9#1)(2007-11#1)
tetraplex structures##2##2##(2007-9#1)(2008-1#1)
tetraplex##3##1##(2007-9#1)(2008-1#2)
tetraploid Elymus species##2##3##(2008-5#2)
tetraploid and##3##2##(2006-12#1)(2008-10#1)(2008-5#1)
tetraploid cell##2##2##(1996-3#1)(2008-11#1)
tetraploid genotypes##2##2##(2006-12#1)(2012-3#1)
tetraploid origin of##2##3##(2008-7#2)
tetraploid wheat##5##2##(2008-10#3)(2012-3#2)
tetraploid##31##1##(1992-8#1)(1995-4#1)(1996-3#1)(2006-12#2)(2008-10#6)(2008-11#2)(2008-5#7)(2008-7#3)(2008-8#1)(2008-9#1)(2009-9#1)(2011-12#1)(2012-3#4)
tetraploids##9##1##(2008-5#7)(2008-9#2)
tetrapod##11##1##(1990-8#1)(1991-5#1)(1994-7#3)(2006-8#1)(2008-8#1)(2012-12#1)(2013-1#3)
tetrapods##13##1##(1990-8#1)(1991-5#4)(1994-7#3)(2007-8#1)(2009-6#2)(2013-1#2)
tetrapus conjoined twins##2##3##(2010-2#2)
tetrapyrrole##13##1##(1991-5#1)(1995-3#6)(1997-7#2)(2006-12#1)(2008-7#1)(2011-1#2)
tetrapyrroles##2##1##(1995-3#1)(2008-9#1)
tetraruthenated porphyrin##2##2##(2008-10#2)
tetrasaccharide##10##1##(1990-9#1)(1991-7#1)(1992-12#2)(1995-1#1)(1995-11#2)(1995-3#1)(1996-4#1)(1996-7#1)
tetrasodium##3##1##(1994-2#1)(2007-11#2)
tetrasomic inheritance##3##2##(2008-5#3)
tetrasomic##4##1##(2008-10#1)(2008-5#3)
tetraspanin molecule##2##2##(2012-12#2)
tetraspanin##5##1##(2009-8#3)(2012-12#2)
tetraspanins##2##1##(2009-8#1)(2012-12#1)
tetrasporic##2##1##(2007-5#1)(2009-12#1)
tetrasubstituted##3##1##(2008-10#1)(2009-3#1)(2010-3#1)
tetrasulfonate##7##1##(1990-11#2)(1992-1#1)(2005-4#3)(2008-10#1)
tetrasulfonated phthalocyanine (CoTSPc)##2##3##(2008-10#2)
tetrasulfonated phthalocyanine##5##2##(1992-1#1)(2005-4#1)(2008-10#3)
tetrasulfonated##9##1##(1992-1#1)(1993-8#1)(2005-4#1)(2008-10#5)(2008-3#1)
tetrasulphonated##3##1##(1996-7#1)(2008-10#2)
tetrathiafulvalene (TTF)##2##2##(1996-5#1)(2007-11#1)
tetrathiafulvalene derivatives##2##2##(2007-12#2)
tetrathiafulvalene##8##1##(1996-5#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-10#1)(2010-12#2)
tetrathiafulvalene-anthracene dyad##2##2##(2007-8#2)
tetrathiafulvalene-anthracene##3##1##(2007-8#3)
tetrathioethers##3##1##(2008-10#3)
tetratricopeptide repeat##3##2##(1995-3#1)(1996-2#2)
tetratricopeptide##4##1##(1995-3#1)(1996-2#2)(1997-7#1)
tetraurelia##8##1##(1990-7#2)(1994-12#2)(1996-1#1)(2008-12#3)
tetravalent##6##1##(1997-4#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2012-2#1)
tetrazole##2##1##(1992-9#1)(2013-1#1)
tetrazole-based##2##1##(2009-5#1)(2013-1#1)
tetrazolium and##3##2##(1991-7#1)(1993-4#1)(2005-8#1)
tetrazolium chloride##2##2##(2007-9#1)(2008-10#1)
tetrazolium dye##2##2##(1995-1#1)(2013-1#1)
tetrazolium salt##6##2##(1992-6#1)(1992-9#1)(1996-12#1)(2008-4#1)(2008-9#1)(2012-2#1)
tetrazolium salts##2##2##(2008-11#1)(2012-2#1)
tetrazolium##44##1##(1991-10#1)(1991-12#1)(1991-7#1)(1992-1#2)(1992-11#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-4#5)(1993-7#1)(1994-12#1)(1995-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-8#1)(2005-8#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#1)(2008-9#1)(2010-2#1)(2012-2#2)(2013-1#2)
tetrodotoxin (10(-6)##2##2##(1993-11#1)(1997-5#1)
tetrodotoxin (10(-7)##2##2##(1992-6#1)(2011-2#1)
tetrodotoxin (TTX)##7##2##(1991-11#1)(1991-9#1)(1992-10#1)(1992-11#1)(1995-5#1)(1996-2#1)(2009-3#1)
tetrodotoxin and##3##2##(1990-7#1)(1993-11#1)(1996-11#1)
tetrodotoxin or in##2##3##(1992-3#2)
tetrodotoxin or##3##2##(1990-7#1)(1992-3#2)
tetrodotoxin##35##1##(1990-5#1)(1990-7#2)(1991-10#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-3#2)(1992-6#1)(1992-7#1)(1993-11#2)(1993-12#1)(1993-3#3)(1995-12#2)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-5#2)(2007-10#1)(2007-9#1)(2009-3#1)(2011-2#1)(2012-12#1)(2013-7#1)
tetrodotoxin-resistant sodium##2##2##(1996-5#1)(2008-8#1)
tetrodotoxin-sensitive##2##1##(1990-5#1)(1996-5#1)
tetrol I-1##9##2##(2008-10#9)
tetrol##10##1##(2008-10#10)
text Thirumandiram##2##2##(2008-1#2)
text a##2##2##(2008-11#1)(2013-1#1)
text alexia##2##2##(2010-7#2)
text analysis##4##2##(1991-8#1)(1994-6#1)(2008-7#1)(2009-7#1)
text and image information##2##4##(2010-8#2)
text and image##4##3##(2009-7#2)(2010-8#2)
text and##18##2##(1994-3#1)(1995-1#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-7#2)(2010-8#3)(2011-2#1)(2013-1#4)
text books##2##2##(2007-5#1)(2010-12#1)
text describing##2##2##(2009-7#2)
text environments##2##2##(1991-8#2)
text field for##2##3##(2010-8#2)
text field##4##2##(2010-8#4)
text files##2##2##(1991-8#1)(1992-8#1)
text for##2##2##(2008-1#1)(2010-12#1)
text from##2##2##(2006-12#1)(2008-10#1)
text in##5##2##(2009-2#1)(2013-1#4)
text is an##2##3##(1992-2#1)(2008-7#1)
text is##4##2##(1992-2#1)(1994-6#1)(2008-7#1)(2013-8#1)
text matching##2##2##(1991-8#2)
text messaging##10##2##(2008-7#1)(2010-12#1)(2012-12#2)(2013-1#6)
text mining##5##2##(2008-7#2)(2010-12#1)(2012-1#2)
text of##9##2##(1991-10#1)(1991-12#1)(2005-7#3)(2007-5#1)(2008-12#1)(2011-1#1)(2011-2#1)
text on##2##2##(2008-1#1)(2009-2#1)
text paging##5##2##(2010-8#5)
text processing##7##2##(2007-12#1)(2008-10#1)(2008-7#4)(2010-12#1)
text reading##8##2##(2007-9#5)(2008-11#1)(2010-7#2)
text to##5##2##(2008-7#1)(2013-1#4)
text##245##1##(1991-10#1)(1991-12#1)(1991-8#10)(1992-2#2)(1992-4#1)(1992-8#2)(1994-3#2)(1994-6#2)(1995-1#2)(1995-11#1)(1996-1#1)(1996-12#1)(1997-8#1)(2005-7#7)(2006-10#2)(2006-11#1)(2006-12#2)(2006-3#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#7)(2007-9#6)(2008-1#11)(2008-10#5)(2008-11#4)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#15)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#2)(2009-4#2)(2009-7#6)(2010-1#2)(2010-12#8)(2010-7#7)(2010-8#18)(2011-1#6)(2011-2#3)(2011-7#1)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#71)(2013-7#2)(2013-8#2)
text)##11##1##(1990-3#1)(1990-7#1)(1991-2#2)(1995-4#1)(2007-9#2)(2009-6#1)(2011-1#1)(2012-3#1)(2013-8#1)
text-based searches##3##2##(2008-4#3)
text-based##8##1##(2008-4#3)(2008-7#1)(2009-7#2)(2013-1#2)
text-messaging##4##1##(2008-7#1)(2012-12#3)
textbook or##2##2##(1995-1#2)
textbook##14##1##(1995-1#2)(2006-5#1)(2007-2#1)(2008-2#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-7#2)(2012-2#2)(2013-7#1)
textbooks and##6##2##(2007-4#1)(2008-5#1)(2009-6#1)(2010-12#1)(2010-9#1)(2013-8#1)
textbooks##31##1##(1995-1#1)(1995-12#1)(1997-3#1)(2005-11#1)(2005-12#3)(2007-4#1)(2007-5#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#2)(2009-6#1)(2010-12#1)(2010-3#2)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#5)
textile industries##2##2##(1990-10#1)(2008-10#1)
textile structure##2##2##(2005-10#1)(2008-11#1)
textile wastewater polluted habitats##4##4##(2008-5#4)
textile workers in##2##3##(2007-4#1)(2009-10#1)
textile workers##3##2##(2007-4#2)(2009-10#1)
textile##28##1##(1990-10#2)(2005-10#1)(2007-4#2)(2008-1#5)(2008-10#4)(2008-11#1)(2008-5#4)(2008-6#1)(2009-10#1)(2010-1#1)(2010-4#1)(2010-8#2)(2012-1#1)(2012-12#1)(2012-2#1)
textiles and##6##2##(2008-10#1)(2010-5#3)(2013-8#2)
textiles##15##1##(1991-6#1)(1995-5#1)(2007-7#1)(2008-10#1)(2008-6#1)(2010-4#1)(2010-5#4)(2011-2#1)(2012-2#1)(2013-8#3)
textilome##3##1##(2012-2#3)
texting behaviors##3##2##(2013-1#3)
texting preferences##2##2##(2013-1#2)
texting##14##1##(2010-12#2)(2013-1#12)
texts and##2##2##(2007-5#2)
texts are##4##2##(2007-5#1)(2012-2#1)(2013-1#2)
texts by##2##2##(2008-5#1)(2009-4#1)
texts from the##2##3##(2007-5#1)(2008-12#1)
texts in##7##2##(1991-8#1)(2008-7#1)(2013-1#5)
texts of##4##2##(2007-10#1)(2009-11#1)(2011-1#2)
texts were##2##2##(2013-1#1)(2013-7#1)
texts which##2##2##(2008-7#1)(2009-4#1)
texts##57##1##(1991-8#1)(1994-6#3)(2005-5#1)(2006-11#1)(2006-12#1)(2006-3#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-5#8)(2008-12#2)(2008-5#1)(2008-6#2)(2008-7#3)(2009-11#1)(2009-4#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2011-7#1)(2012-2#1)(2013-1#16)(2013-7#1)
texts]##3##1##(2007-5#2)(2013-8#1)
textual and graphical##2##3##(2008-10#1)(2008-9#1)
textual and##4##2##(2008-10#1)(2008-9#1)(2013-1#2)
textual##17##1##(2005-12#1)(2008-10#1)(2008-7#2)(2008-9#2)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#7)
textural and##2##2##(2008-6#1)(2010-8#1)
textural class##2##2##(2007-3#2)
textural properties##5##2##(2005-11#1)(2010-2#1)(2010-4#2)(2011-2#1)
textural##17##1##(2005-11#3)(2007-3#2)(2008-10#1)(2008-2#1)(2008-5#2)(2008-6#1)(2010-2#1)(2010-4#4)(2010-8#1)(2011-2#1)
texture analysis##6##2##(2008-2#3)(2008-6#1)(2009-12#1)(2010-8#1)
texture analyzer##2##2##(2008-5#1)(2010-12#1)
texture and the##2##3##(2006-5#1)(2009-6#1)
texture and##18##2##(2004-4#1)(2005-11#1)(2006-3#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-3#1)(2007-7#1)(2008-10#4)(2008-2#2)(2008-5#1)(2009-6#1)(2011-2#1)(2012-1#1)
texture at surface##2##3##(2013-8#2)
texture at##3##2##(2013-8#3)
texture can be##2##3##(2008-2#2)
texture classification##4##2##(2008-2#3)(2011-1#1)
texture discrimination##3##2##(1994-8#1)(2008-2#2)
texture features to##2##3##(2008-2#1)(2010-4#1)
texture features##10##2##(2008-10#1)(2008-2#3)(2008-6#1)(2010-4#2)(2010-8#3)
texture images##2##2##(1995-8#1)(2008-2#1)
texture in a##2##3##(2008-2#1)(2012-2#1)
texture in##7##2##(2008-10#1)(2008-2#2)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#1)
texture information##4##2##(2008-2#1)(2008-6#3)
texture is##6##2##(2005-11#1)(2008-2#3)(2008-6#1)(2012-1#1)
texture measurements##2##2##(2008-2#1)(2010-4#1)
texture of the##3##3##(2010-4#1)(2012-1#1)(2012-11#1)
texture of##13##2##(2005-11#1)(2006-7#1)(2007-7#1)(2008-8#1)(2010-4#2)(2010-8#1)(2012-1#3)(2012-11#1)(2012-2#1)(2013-8#1)
texture pattern##2##2##(2008-6#2)
texture patterns##2##2##(1995-8#1)(2008-6#1)
texture segmentation and##3##3##(1992-7#1)(1995-12#1)(2008-2#1)
texture segmentation##4##2##(1992-7#1)(1995-12#1)(2008-2#2)
texture to##2##2##(2007-12#1)(2008-6#1)
texture type conditions##2##3##(2008-6#2)
texture##194##1##(1992-7#4)(1993-2#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-3#2)(1995-8#2)(1996-11#1)(1996-12#2)(2004-4#1)(2005-11#6)(2006-11#1)(2006-3#1)(2006-4#2)(2006-5#2)(2006-7#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-3#2)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#15)(2008-11#1)(2008-2#45)(2008-4#1)(2008-5#9)(2008-6#28)(2008-8#1)(2009-12#1)(2009-6#1)(2010-12#1)(2010-4#15)(2010-8#7)(2011-1#3)(2011-2#2)(2012-1#7)(2012-11#1)(2012-12#1)(2012-2#3)(2012-6#1)(2013-1#4)(2013-8#5)
texture-based##3##1##(2008-6#3)
textured images##2##2##(2008-2#2)
textured or##2##2##(2008-2#2)
textured##13##1##(2007-12#3)(2008-2#8)(2008-3#1)(2011-12#1)
textures in##2##2##(1996-2#1)(2008-5#1)
textures##33##1##(1992-7#2)(1994-8#2)(1995-7#1)(1995-8#1)(1996-2#1)(2006-4#3)(2007-12#1)(2008-10#2)(2008-2#7)(2008-5#4)(2008-6#7)(2009-2#1)(2011-12#1)
tg##2##1##(2007-2#1)(2008-11#1)
tga1a##3##1##(2008-9#3)
tgr-1##3##1##(2008-10#3)
th centile##2##2##(1996-12#2)
th##16##1##(1990-11#1)(1996-12#2)(2004-9#1)(2005-7#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-2#1)(2011-1#4)(2012-12#1)(2013-8#1)
thai##2##1##(1991-6#1)(2007-8#1)
thalami##6##1##(1993-4#1)(1995-8#1)(2008-6#2)(2012-3#2)
thalamic activity##2##2##(1992-3#1)(1997-2#1)
thalamic afferents##2##2##(1994-3#1)(1997-2#1)
thalamic and##4##2##(1990-5#1)(1996-12#1)(1996-3#1)(2006-10#1)
thalamic complex##2##2##(1995-12#1)(1995-6#1)
thalamic neurons##3##2##(1992-2#1)(1997-7#1)(2012-2#1)
thalamic nuclei and##2##3##(1990-5#1)(1995-11#1)
thalamic nuclei##12##2##(1990-5#1)(1990-7#1)(1991-12#1)(1992-1#1)(1992-8#2)(1993-11#1)(1993-7#1)(1995-11#1)(1996-6#1)(1997-2#1)(1997-3#1)
thalamic nucleus and##2##3##(1997-3#1)(2013-8#1)
thalamic nucleus in the##2##4##(1991-5#1)(1996-1#1)
thalamic nucleus in##3##3##(1991-5#1)(1996-1#2)
thalamic nucleus##15##2##(1991-5#1)(1992-10#1)(1994-10#2)(1994-5#1)(1994-6#1)(1996-1#2)(1996-5#1)(1997-2#2)(1997-3#2)(1997-7#1)(2013-8#1)
thalamic oscillations##3##2##(2008-1#1)(2008-2#2)
thalamic region of##2##3##(1996-1#1)(2010-1#1)
thalamic region##3##2##(1996-1#1)(2010-1#1)(2013-1#1)
thalamic relay##2##2##(1997-7#1)(2008-2#1)
thalamic reticular nucleus##3##3##(1991-5#1)(1995-8#1)(1997-8#1)
thalamic##89##1##(1990-5#2)(1990-7#1)(1991-12#1)(1991-5#2)(1992-1#2)(1992-10#2)(1992-2#1)(1992-3#2)(1992-8#3)(1993-11#1)(1993-12#1)(1993-5#1)(1993-7#1)(1994-10#3)(1994-3#1)(1994-5#2)(1994-6#1)(1995-11#1)(1995-12#2)(1995-4#1)(1995-6#1)(1995-8#2)(1996-1#4)(1996-12#2)(1996-3#1)(1996-5#2)(1996-6#1)(1997-2#7)(1997-3#3)(1997-5#1)(1997-7#4)(1997-8#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-1#2)(2008-2#6)(2008-4#1)(2008-7#6)(2008-8#1)(2008-9#1)(2010-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
thalamically##2##1##(1996-12#1)(1997-2#1)
thalamo-cortical pathway##3##2##(1991-3#3)
thalamo-cortical##5##1##(1991-3#3)(2008-11#2)
thalamocortical (TC)##2##2##(2008-1#1)(2012-2#1)
thalamocortical long-term potentiation##2##3##(2007-8#2)
thalamocortical projection##3##2##(1994-2#2)(1994-5#1)
thalamocortical projections##3##2##(1994-5#3)
thalamocortical##18##1##(1990-5#1)(1991-5#1)(1993-5#1)(1994-2#2)(1994-5#4)(1997-6#1)(2007-8#3)(2008-1#3)(2008-2#1)(2012-2#1)
thalamotomy##2##1##(1990-10#1)(2008-7#1)
thalamus + hypothalamus##2##3##(1992-8#2)
thalamus and basal ganglia##4##4##(1991-12#1)(2008-7#1)(2009-1#1)(2009-6#1)
thalamus and the##4##3##(1992-8#1)(1996-7#1)(1997-3#1)(2008-7#1)
thalamus and##19##2##(1991-12#1)(1992-10#1)(1992-8#1)(1995-11#2)(1995-12#1)(1996-2#1)(1996-7#2)(1997-3#1)(1997-5#2)(2008-1#1)(2008-7#2)(2009-1#1)(2009-6#1)(2012-2#1)(2013-1#1)
thalamus in##7##2##(1992-8#1)(1994-10#1)(1996-12#1)(2006-3#1)(2010-10#1)(2012-12#1)(2012-2#1)
thalamus of##5##2##(1993-2#1)(1993-4#1)(1995-12#1)(1996-1#2)
thalamus to##2##2##(1992-2#1)(2006-4#1)
thalamus was##3##2##(1993-11#1)(1993-2#1)(2007-9#1)
thalamus##102##1##(1990-2#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-10#3)(1992-11#1)(1992-2#2)(1992-3#2)(1992-7#1)(1992-8#4)(1993-11#2)(1993-12#1)(1993-2#2)(1993-4#3)(1993-7#2)(1993-8#1)(1994-10#2)(1994-2#1)(1994-6#2)(1995-1#1)(1995-11#3)(1995-12#3)(1995-5#2)(1996-1#6)(1996-10#1)(1996-12#2)(1996-2#1)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#4)(1997-5#2)(2006-1#1)(2006-3#1)(2006-4#1)(2007-1#2)(2007-10#1)(2007-4#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-7#4)(2009-1#1)(2009-6#1)(2009-9#1)(2010-10#2)(2010-12#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
thalassaemia and sickle cell anaemia patients##2##6##(2013-8#2)
thalassaemia and##3##2##(1995-5#1)(2013-8#2)
thalassaemia major##2##2##(2011-12#1)(2013-8#1)
thalassaemia trait##2##2##(2011-12#2)
thalassaemia##16##1##(1990-8#2)(1995-5#1)(2005-12#2)(2009-4#1)(2011-12#5)(2013-8#5)
thalassaemic patients with chronic hepatitis C##2##6##(2007-11#2)
thalassaemic patients with##3##3##(2007-11#3)
thalassaemic##5##1##(2007-11#3)(2008-8#1)(2011-12#1)
thalassemia by##2##2##(1994-12#1)(2008-10#1)
thalassemia in##3##2##(2007-2#1)(2013-1#2)
thalassemia intermedia##2##2##(2006-10#2)
thalassemia##35##1##(1993-8#1)(1994-12#1)(1995-12#2)(2006-10#4)(2007-10#1)(2007-2#3)(2008-10#7)(2008-3#1)(2008-8#1)(2011-2#3)(2012-11#4)(2012-2#1)(2013-1#6)
thalassemias##2##1##(1993-9#1)(2012-2#1)
thalassemic patients were##2##3##(2012-2#2)
thalassemic patients##12##2##(2008-10#2)(2011-2#6)(2012-2#4)
thalassemic##15##1##(1990-8#1)(2008-10#2)(2011-2#7)(2012-2#5)
thaliana against##2##2##(2008-10#1)(2009-8#1)
thaliana cytidylyltransferase cDNA##2##3##(1997-2#2)
thaliana ecotype##2##2##(2008-10#2)
thaliana ecotypes##3##2##(2008-10#1)(2012-3#2)
thaliana roots##3##2##(2008-10#2)(2012-1#1)
thaliana seedlings##3##2##(2008-9#1)(2009-8#2)
thaliana##154##1##(1991-6#2)(1992-3#1)(1993-2#2)(1994-12#1)(1994-3#1)(1994-8#1)(1995-6#1)(1996-10#4)(1996-4#1)(1996-5#1)(1996-8#1)(1997-2#7)(1997-6#4)(1997-8#3)(2006-12#4)(2007-12#2)(2007-6#2)(2007-9#1)(2008-1#1)(2008-10#35)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#8)(2008-9#11)(2009-10#9)(2009-12#2)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#21)(2010-9#1)(2011-1#4)(2011-10#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-3#6)(2013-8#3)
thalidomide and its##2##3##(2007-11#1)(2011-1#1)
thalidomide and##4##2##(2007-11#1)(2011-1#2)(2011-2#1)
thalidomide can##2##2##(2007-11#1)(2008-5#1)
thalidomide for##2##2##(2005-7#1)(2006-10#1)
thalidomide has##2##2##(2007-11#1)(2008-5#1)
thalidomide in a patient##2##4##(2006-10#2)
thalidomide in a##3##3##(2006-10#3)
thalidomide in the##2##3##(2007-11#1)(2008-5#1)
thalidomide in##15##2##(1991-11#1)(1991-6#1)(2006-10#3)(2006-8#1)(2007-11#3)(2008-3#1)(2008-5#5)
thalidomide is##2##2##(2007-10#1)(2007-11#1)
thalidomide or placebo##3##3##(2008-5#3)
thalidomide##67##1##(1991-11#1)(1991-6#1)(2005-11#1)(2005-7#1)(2006-10#10)(2006-6#2)(2006-8#3)(2006-9#1)(2007-10#7)(2007-11#9)(2007-3#1)(2008-3#1)(2008-5#18)(2008-7#2)(2009-8#1)(2010-2#1)(2010-4#3)(2011-1#2)(2011-2#2)
thaliporphine##3##1##(1993-3#3)
thalli##3##1##(2006-3#1)(2008-10#1)(2010-6#1)
thallium (I)##2##2##(2008-10#2)
thallium (III) and##2##3##(2008-10#2)
thallium (III)##5##2##(2008-10#5)
thallium (Tl)##2##2##(1995-2#1)(2007-8#1)
thallium and lead##3##3##(2008-10#3)
thallium atom##2##2##(1996-2#2)
thallium in the##2##3##(1994-5#2)
thallium in##10##2##(1991-12#1)(1993-9#1)(1994-5#3)(2008-10#5)
thallium is##2##2##(1996-2#2)
thallium scintigraphy after##2##3##(1990-3#1)(1992-5#1)
thallium scintigraphy##5##2##(1990-3#1)(1992-5#2)(1997-1#1)(2007-8#1)
thallium using##2##2##(2008-10#2)
thallium was##2##2##(2008-10#2)
thallium##65##1##(1990-3#1)(1991-12#4)(1992-12#2)(1992-5#3)(1993-7#1)(1993-9#1)(1994-5#5)(1995-2#1)(1996-2#4)(1997-1#2)(2007-11#4)(2007-8#2)(2008-10#32)(2008-2#2)(2013-1#1)
thallium(I)##11##1##(1996-2#1)(2008-10#10)
thallium(III)##3##1##(2007-11#2)(2008-10#1)
thallus##2##1##(2006-3#1)(2008-10#1)
than &quot##7##2##(1991-2#1)(1994-3#1)(1997-5#1)(2007-1#1)(2008-10#1)(2010-7#1)(2012-12#1)
than +/+##2##2##(2008-2#2)
than +/-1##2##2##(2007-8#1)(2008-3#1)
than -20##2##2##(2008-2#1)(2008-3#1)
than -30mV##2##2##(1990-11#1)(1993-3#1)
than 0##620##2##(1990-10#7)(1990-11#16)(1990-12#22)(1990-2#17)(1990-3#9)(1990-4#10)(1990-5#6)(1990-6#10)(1990-7#9)(1990-8#10)(1990-9#9)(1991-1#4)(1991-10#16)(1991-11#6)(1991-12#17)(1991-2#35)(1991-3#9)(1991-4#6)(1991-5#17)(1991-6#12)(1991-7#15)(1991-8#17)(1991-9#23)(1992-1#14)(1992-12#4)(1992-2#11)(1992-3#7)(1992-4#13)(1992-5#13)(1992-6#3)(1992-7#13)(1992-8#11)(1992-9#4)(1993-1#2)(1993-4#1)(1994-1#4)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#3)(1995-2#1)(1995-4#1)(1996-2#1)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#2)(2006-12#2)(2006-4#1)(2006-5#2)(2006-7#1)(2006-9#1)(2007-11#7)(2007-12#7)(2007-5#1)(2007-8#4)(2007-9#1)(2008-1#7)(2008-10#71)(2008-11#1)(2008-12#1)(2008-2#22)(2008-3#25)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-7#2)(2010-12#2)(2010-4#2)(2010-5#1)(2011-1#3)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#7)
than 1 and##3##3##(2008-10#2)(2008-3#1)
than 1 are##2##3##(1992-6#1)(2008-3#1)
than 1 cm in diameter##2##5##(1996-12#1)(2010-7#1)
than 1 cm##5##3##(1996-12#1)(1997-1#1)(1997-4#1)(2008-6#1)(2010-7#1)
than 1 hour##3##3##(1992-4#1)(2006-3#1)(2007-7#1)
than 1 m##3##3##(2008-10#3)
than 1 mJ##2##3##(2007-12#2)
than 1 mM##3##3##(1990-5#1)(1993-6#1)(1995-11#1)
than 1 mM)##2##3##(1990-11#1)(1992-3#1)
than 1 microM##3##3##(1991-4#1)(1994-10#1)(1994-12#1)
than 1 microgram/ml##2##3##(1990-2#1)(1993-5#1)
than 1 micros##2##3##(2006-4#1)(2008-3#1)
than 1 ml##2##3##(2006-2#1)(2011-2#1)
than 1 mm##6##3##(1991-3#1)(2006-6#1)(2008-2#1)(2008-3#2)(2008-9#1)
than 1 month##6##3##(1990-2#1)(2008-10#3)(2008-11#1)(2012-2#1)
than 1 mum##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
than 1 to##2##3##(1990-8#1)(2012-3#1)
than 1 year and##3##4##(1991-2#1)(2009-12#1)(2011-2#1)
than 1 year of age##4##5##(1995-8#1)(2006-7#1)(2013-1#2)
than 1 year of##5##4##(1995-8#1)(2006-7#1)(2008-3#1)(2013-1#2)
than 1 year##19##3##(1991-2#1)(1991-3#1)(1995-8#1)(2004-11#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#4)
than 1##272##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#2)(1990-7#4)(1990-8#1)(1990-9#3)(1991-10#2)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#2)(1991-8#4)(1992-1#2)(1992-2#1)(1992-3#4)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#4)(1993-11#1)(1993-5#2)(1993-6#3)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#3)(2006-1#1)(2006-10#1)(2006-11#1)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#17)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#44)(2008-11#5)(2008-2#12)(2008-3#25)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#3)(2009-3#1)(2009-5#1)(2010-1#1)(2010-11#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#6)(2013-1#6)(2013-8#1)
than 1% and##4##3##(2007-12#1)(2008-10#2)(2009-4#1)
than 1% of infected##2##4##(2007-12#1)(2013-8#1)
than 1% of the##7##4##(1992-3#1)(1993-8#1)(1996-5#1)(2006-3#1)(2008-1#1)(2008-10#1)(2008-3#1)
than 1% of##31##3##(1990-11#1)(1991-12#1)(1992-3#1)(1993-3#1)(1993-6#1)(1993-8#1)(1995-4#1)(1996-11#1)(1996-5#1)(1997-1#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-3#1)(2012-12#1)(2013-1#1)(2013-7#3)(2013-8#1)
than 1% with##2##3##(2008-2#1)(2008-3#1)
than 1%##77##2##(1990-11#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-3#1)(1993-6#1)(1993-8#1)(1995-4#1)(1996-11#1)(1996-5#4)(1997-1#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#17)(2008-2#6)(2008-3#8)(2008-5#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-4#3)(2010-12#1)(2010-2#1)(2010-3#1)(2011-12#1)(2012-12#1)(2013-1#2)(2013-7#3)(2013-8#1)
than 1)##2##2##(1992-5#1)(2006-12#1)
than 10 and##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
than 10 cigarettes/day)##2##3##(1990-10#2)
than 10 cm##3##3##(1990-10#1)(1997-8#1)(2007-8#1)
than 10 days##7##3##(1996-7#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-11#2)
than 10 degrees##2##3##(2006-10#1)(2008-11#1)
than 10 fold##2##3##(1991-5#1)(1994-3#1)
than 10 follicles of 2 to 5 mm in diameter and no follicles &gt##2##14##(2006-5#2)
than 10 h##2##3##(2008-10#2)
than 10 mg##4##3##(2006-2#1)(2007-2#1)(2008-10#1)(2009-8#1)
than 10 min##6##3##(2008-10#4)(2008-3#1)(2008-5#1)
than 10 min)##3##3##(1990-8#1)(1992-8#1)(1996-12#1)
than 10 minutes##3##3##(2007-7#1)(2008-11#1)(2008-8#1)
than 10 mm##8##3##(1993-5#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-12#1)(2013-8#2)
than 10 mm/day)##2##3##(2008-10#2)
than 10 months##2##3##(2008-9#1)(2009-2#1)
than 10 nm##4##3##(2005-11#1)(2007-11#1)(2007-12#1)(2008-2#1)
than 10 times##3##3##(1991-7#1)(1994-11#1)(2008-8#1)
than 10 to 15##2##4##(1991-6#1)(1997-6#1)
than 10 years##9##3##(1990-9#1)(1991-7#1)(2006-6#1)(2007-2#1)(2007-7#1)(2008-11#2)(2008-3#1)(2012-12#1)
than 10##150##2##(1990-10#3)(1990-12#2)(1990-4#1)(1990-5#1)(1990-8#2)(1990-9#3)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#2)(1992-4#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-3#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-8#1)(2004-1#1)(2005-11#3)(2005-4#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2007-10#1)(2007-11#2)(2007-12#10)(2007-2#4)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#18)(2008-11#6)(2008-12#1)(2008-2#4)(2008-3#6)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#2)(2009-11#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#2)
than 10% at##2##3##(1996-6#1)(2008-2#1)
than 10% for##4##3##(1993-2#1)(2007-8#1)(2008-10#2)
than 10% in##2##3##(2004-10#1)(2008-10#1)
than 10% of all##2##4##(2005-12#1)(2007-2#1)
than 10% of the##9##4##(1991-2#1)(1992-3#1)(1992-6#1)(1994-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-8#1)
than 10% of##29##3##(1990-11#1)(1990-5#1)(1991-2#1)(1992-3#1)(1992-6#1)(1994-11#1)(1994-2#1)(1997-6#1)(2005-12#1)(2007-12#1)(2007-2#2)(2007-7#2)(2007-8#1)(2008-10#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-12#1)(2012-2#1)(2013-1#2)
than 10% relative##2##3##(1995-12#1)(2011-1#1)
than 10%##79##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-10#1)(2005-12#1)(2007-12#4)(2007-2#2)(2007-7#3)(2007-8#2)(2008-10#16)(2008-12#1)(2008-2#3)(2008-3#6)(2008-5#1)(2008-7#3)(2008-8#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
than 10%)##6##2##(1990-6#1)(1991-9#1)(2004-9#1)(2008-10#2)(2008-9#1)
than 10(-10)##2##2##(1997-4#1)(2008-2#1)
than 10(-3)##3##2##(1992-9#1)(2008-2#1)(2008-3#1)
than 10(-5) M##2##3##(1990-11#1)(2010-10#1)
than 10(-5) for##2##3##(2006-5#1)(2008-2#1)
than 10(-5)##6##2##(1990-11#1)(1992-5#1)(2006-5#1)(2008-2#2)(2010-10#1)
than 10(-6)##2##2##(1992-7#1)(2008-3#1)
than 10(-7)##2##2##(1991-6#1)(2008-2#1)
than 10(-9) M##2##3##(1997-4#2)
than 10(-9)##5##2##(1997-4#2)(2008-1#1)(2008-3#1)(2010-1#1)
than 10(5)##4##2##(2007-12#1)(2008-7#1)(2009-1#1)(2010-4#1)
than 10(5)-fold##2##2##(1992-5#1)(1995-2#1)
than 10(8)##2##2##(1992-3#1)(2008-2#1)
than 10(9)##2##2##(2008-3#1)(2012-2#1)
than 10-15%##2##2##(2008-2#2)
than 10-fold increase##2##3##(1992-3#1)(1994-9#1)
than 10-fold##12##2##(1990-7#1)(1992-3#1)(1994-9#1)(1995-10#1)(1995-5#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-8#1)(2008-10#2)(2012-2#1)
than 100 amino acids##2##4##(1996-3#1)(1997-3#1)
than 100 amino##3##3##(1995-6#1)(1996-3#1)(1997-3#1)
than 100 kDa##2##3##(1991-9#1)(2008-10#1)
than 100 kHz##2##3##(2008-2#1)(2008-3#1)
than 100 m##3##3##(2007-12#1)(2007-8#1)(2008-10#1)
than 100 mg##2##3##(1997-4#1)(2008-12#1)
than 100 microM##2##3##(1995-5#1)(1996-2#1)
than 100 ml##2##3##(1993-2#1)(2012-12#1)
than 100 mug##2##3##(2008-10#2)
than 100 mum##2##3##(2008-2#2)
than 100 nM##2##3##(1990-12#1)(2008-5#1)
than 100 nm##5##3##(1996-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#1)
than 100 species of##2##4##(2007-5#1)(2010-7#1)
than 100 years##4##3##(1992-3#1)(2008-10#1)(2008-7#1)(2010-5#1)
than 100##120##2##(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-3#2)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-6#1)(1996-7#1)(1997-1#1)(1997-3#2)(1997-4#1)(2005-8#1)(2005-9#1)(2006-7#1)(2007-11#4)(2007-12#5)(2007-2#2)(2007-5#2)(2007-7#2)(2007-8#2)(2008-10#14)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#8)(2008-4#2)(2008-5#4)(2008-7#6)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#2)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-8#1)
than 100%##7##2##(1992-10#1)(1992-4#1)(1994-2#1)(2007-11#1)(2007-12#2)(2008-10#1)
than 100-fold more##2##3##(1990-7#1)(1991-5#1)
than 100-fold##10##2##(1990-2#1)(1990-7#1)(1991-2#1)(1991-5#1)(1992-6#1)(1992-8#1)(1996-5#1)(1996-9#1)(2008-10#1)(2009-9#1)
than 1000##22##2##(1990-9#1)(1991-12#1)(1991-2#1)(1991-9#2)(1992-2#1)(1992-7#1)(1994-12#1)(1995-4#1)(1995-5#1)(1996-12#1)(2005-10#1)(2006-11#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-4#1)(2010-4#1)(2013-1#1)
than 11##10##2##(1993-12#1)(1996-12#1)(1996-8#1)(2006-3#1)(2007-12#1)(2008-10#3)(2012-11#1)(2013-8#1)
than 110##3##2##(1992-8#1)(2008-10#1)(2011-2#1)
than 12 W of##2##4##(2007-11#2)
than 12 hours##3##3##(1990-12#1)(1993-12#1)(2010-7#1)
than 12 months##8##3##(1991-11#1)(1991-2#1)(1996-3#1)(1996-6#1)(2006-10#1)(2006-12#1)(2006-2#1)(2011-2#1)
than 12 years##4##3##(1993-2#1)(2008-7#1)(2008-8#1)(2013-1#1)
than 12##37##2##(1990-12#1)(1990-4#2)(1991-11#1)(1991-2#1)(1992-4#1)(1993-12#1)(1993-2#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-5#1)(2007-11#2)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#2)
than 12% of the##3##4##(1992-6#1)(2008-10#1)(2008-8#1)
than 12% of##4##3##(1992-6#1)(2008-10#1)(2008-8#2)
than 12%##9##2##(1992-6#1)(1996-11#1)(1996-3#1)(1996-8#1)(2008-10#2)(2008-3#1)(2008-8#2)
than 120##5##2##(1991-11#1)(1992-8#1)(1997-7#1)(2007-4#1)(2008-5#1)
than 120%##2##2##(1993-2#1)(2007-8#1)
than 125##3##2##(2007-12#1)(2008-3#1)(2012-1#1)
than 13 days##2##3##(2007-6#1)(2011-12#1)
than 13##10##2##(1992-2#1)(1994-3#1)(1995-2#1)(1997-6#1)(2007-12#2)(2007-6#1)(2008-10#1)(2011-12#1)(2013-7#1)
than 130##5##2##(1991-7#1)(2005-7#1)(2008-1#1)(2008-11#1)(2010-11#1)
than 1300##2##2##(1991-10#1)(1991-11#1)
than 14 days##4##3##(1994-3#1)(1994-6#1)(2005-5#1)(2006-7#1)
than 14 years##2##3##(2007-7#1)(2012-12#1)
than 14##13##2##(1991-12#1)(1991-7#1)(1994-3#1)(1994-6#1)(2005-5#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2012-12#1)(2013-8#1)
than 14%##2##2##(2008-10#1)(2012-3#1)
than 140##2##2##(1997-7#1)(2009-4#1)
than 15 days##2##3##(1992-12#1)(2004-12#1)
than 15 min##3##3##(1994-5#1)(2008-9#1)(2011-2#1)
than 15 min)##2##3##(1990-6#1)(1992-8#1)
than 15 s##2##3##(1991-10#1)(2008-10#1)
than 15 years##10##3##(1994-5#1)(2006-10#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-3#1)(2012-2#1)(2013-1#1)
than 15##44##2##(1990-6#1)(1991-10#1)(1991-11#1)(1991-5#1)(1992-12#1)(1992-7#1)(1992-8#1)(1994-12#1)(1994-3#1)(1994-5#2)(1995-12#2)(1995-9#1)(2004-12#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#3)(2009-7#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
than 15% and the##2##4##(1996-8#1)(2011-3#1)
than 15% and##3##3##(1991-12#1)(1996-8#1)(2011-3#1)
than 15% of the##3##4##(1991-8#1)(2006-8#1)(2013-1#1)
than 15% of##10##3##(1990-5#1)(1990-8#1)(1991-8#1)(1997-6#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#1)
than 15%##25##2##(1990-5#1)(1990-8#1)(1991-12#1)(1991-8#1)(1994-9#1)(1996-3#1)(1996-8#1)(1997-6#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-9#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
than 150##13##2##(1991-11#1)(1996-12#1)(2005-7#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#2)(2011-2#2)(2012-3#1)(2013-1#1)
than 1500 g##5##3##(1992-2#2)(2008-11#2)(2008-12#1)
than 1500##10##2##(1992-2#2)(1992-7#1)(2006-8#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-5#1)(2011-2#1)
than 16 years##5##3##(2013-1#5)
than 16##14##2##(1996-10#1)(2007-3#1)(2008-10#2)(2008-2#2)(2010-4#1)(2012-11#1)(2012-3#1)(2013-1#5)
than 160##3##2##(1990-12#1)(1991-6#1)(2006-10#1)
than 17##5##2##(1992-3#1)(1993-10#1)(1995-11#1)(1997-2#1)(2007-12#1)
than 18 months##3##3##(1993-2#1)(2007-5#1)(2009-10#1)
than 18 years##4##3##(1996-2#1)(2007-1#1)(2010-5#1)(2011-1#1)
than 18##11##2##(1993-2#1)(1996-2#1)(2007-1#1)(2007-11#1)(2007-5#1)(2008-1#1)(2009-10#1)(2009-11#1)(2010-5#1)(2011-1#1)(2013-1#1)
than 180##4##2##(1996-12#1)(2004-1#1)(2007-8#1)(2008-3#1)
than 1800##2##2##(1990-11#1)(2008-2#1)
than 18R##2##2##(1994-9#2)
than 19##4##2##(2007-12#2)(2008-10#1)(2008-7#1)
than 2 and##2##3##(1993-2#1)(2008-10#1)
than 2 billion people##2##4##(2006-12#1)(2013-1#1)
than 2 cm in diameter##3##5##(2011-2#3)
than 2 cm in##5##4##(1991-4#2)(2011-2#3)
than 2 cm##11##3##(1990-9#1)(1991-4#2)(1995-4#2)(1997-4#1)(2008-10#1)(2008-5#1)(2011-2#3)
than 2 decades of##2##4##(2009-4#1)(2012-12#1)
than 2 hours##3##3##(2008-11#1)(2012-2#2)
than 2 million##6##3##(2005-7#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)
than 2 mm##2##3##(2006-12#1)(2008-3#1)
than 2 months##7##3##(1990-10#1)(2006-5#2)(2008-10#2)(2008-11#2)
than 2 weeks##7##3##(1990-7#1)(1991-2#1)(1991-8#1)(1996-11#1)(2005-8#1)(2008-10#1)(2011-2#1)
than 2 x 10(-4)##3##4##(1996-12#1)(2008-1#1)(2008-2#1)
than 2 x##5##3##(1992-9#1)(1996-12#1)(2008-1#1)(2008-2#2)
than 2 years and##3##4##(2007-9#1)(2008-3#1)(2012-2#1)
than 2 years old##2##4##(2005-7#1)(2008-3#1)
than 2 years##12##3##(2005-7#1)(2007-9#2)(2008-3#4)(2008-6#1)(2009-9#1)(2011-2#2)(2012-2#1)
than 2##178##2##(1990-10#3)(1990-12#2)(1990-2#2)(1990-7#3)(1990-8#2)(1990-9#1)(1991-2#1)(1991-3#1)(1991-4#3)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-7#2)(1992-9#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-4#2)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#3)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#2)(1997-7#1)(2004-11#2)(2005-11#1)(2005-7#2)(2005-8#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-5#2)(2007-11#2)(2007-12#6)(2007-2#2)(2007-5#1)(2007-9#2)(2008-1#3)(2008-10#27)(2008-11#5)(2008-2#5)(2008-3#16)(2008-4#1)(2008-5#4)(2008-6#5)(2008-7#1)(2008-8#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-2#9)(2012-11#1)(2012-12#4)(2012-2#4)(2013-1#4)(2013-7#1)
than 2% in##2##3##(2007-6#1)(2008-10#1)
than 2% of the##6##4##(1991-2#1)(1996-2#1)(2007-1#1)(2009-11#1)(2011-2#1)(2012-12#1)
than 2% of##11##3##(1990-11#1)(1991-2#1)(1994-6#1)(1996-2#1)(2007-1#1)(2007-5#1)(2009-11#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
than 2%##37##2##(1990-11#1)(1990-2#1)(1991-2#1)(1992-8#1)(1994-6#1)(1996-2#1)(1996-8#1)(2005-4#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-10#11)(2008-11#1)(2008-3#4)(2009-11#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
than 2-fold##6##2##(1990-5#1)(1990-7#1)(1994-5#1)(1997-2#1)(2007-12#1)(2013-1#1)
than 20 bp##2##3##(1995-8#1)(1997-6#1)
than 20 cm##2##3##(1996-3#1)(2008-3#1)
than 20 days##3##3##(1995-7#1)(2006-2#1)(2013-1#1)
than 20 degrees##2##3##(2007-7#1)(2008-11#1)
than 20 million people##2##4##(2006-8#1)(2012-2#1)
than 20 million##3##3##(2006-10#1)(2006-8#1)(2012-2#1)
than 20 min##5##3##(1994-3#1)(1997-3#1)(2008-10#2)(2008-7#1)
than 20 mm##3##3##(1990-2#1)(1992-9#1)(2008-2#1)
than 20 mmHg##2##3##(2008-7#1)(2010-5#1)
than 20 mum##2##3##(2008-10#1)(2008-3#1)
than 20 percent##4##3##(1994-2#1)(2010-8#2)(2012-2#1)
than 20 s##2##3##(2008-10#2)
than 20 to##2##3##(1992-6#1)(2010-8#1)
than 20 years ago##4##4##(1991-2#1)(1992-2#1)(2004-3#1)(2008-10#1)
than 20 years of##2##4##(1993-10#1)(2010-12#1)
than 20 years##27##3##(1991-2#1)(1992-2#1)(1993-10#1)(1993-3#1)(1995-12#1)(1995-4#1)(2004-3#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-6#2)(2008-7#3)(2008-9#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
than 20##119##2##(1990-12#2)(1990-2#2)(1990-4#1)(1991-2#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-2#2)(1994-3#2)(1994-5#1)(1995-1#1)(1995-12#2)(1995-4#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#1)(2004-1#1)(2004-3#1)(2005-1#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#3)(2007-11#3)(2007-12#4)(2007-5#1)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#6)(2008-5#2)(2008-6#3)(2008-7#7)(2008-8#1)(2008-9#2)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)
than 20% for##2##3##(1996-3#1)(2011-2#1)
than 20% of patients##2##4##(1993-12#1)(2008-8#1)
than 20% of the##7##4##(1992-5#1)(1997-4#1)(2006-2#1)(2006-3#1)(2007-11#1)(2011-1#1)(2013-8#1)
than 20% of##14##3##(1990-8#1)(1992-5#1)(1993-12#1)(1996-5#1)(1997-4#1)(2006-2#1)(2006-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-4#1)(2011-1#1)(2013-8#1)
than 20%##32##2##(1990-8#1)(1992-5#1)(1992-9#1)(1993-12#1)(1996-3#3)(1996-5#1)(1997-4#1)(1997-6#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#2)
than 20%) of##2##3##(1990-5#1)(2007-12#1)
than 20%)##4##2##(1990-5#1)(1991-6#1)(2007-12#1)(2013-1#1)
than 20-fold##5##2##(1990-4#1)(1993-6#1)(1995-3#1)(2008-10#1)(2008-11#1)
than 200 beds##2##3##(1993-2#1)(2007-12#1)
than 200 mW##3##3##(2007-11#1)(2008-1#1)(2008-3#1)
than 200##40##2##(1991-8#1)(1992-5#1)(1993-2#1)(1995-9#1)(1996-3#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-8#2)(2007-11#1)(2007-12#3)(2007-4#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#1)(2012-12#1)
than 2000##9##2##(1995-12#1)(1995-4#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-2#1)(2011-2#1)
than 21##2##2##(1992-5#1)(2005-10#1)
than 22##4##2##(1994-2#1)(2006-4#1)(2008-11#1)(2011-2#1)
than 23##5##2##(2006-4#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-8#1)
than 24 h##4##3##(1995-1#1)(2007-8#1)(2008-10#1)(2008-11#1)
than 24 hours##8##3##(1990-7#1)(1991-1#1)(1994-8#1)(1995-5#1)(1996-2#1)(2007-9#1)(2010-7#1)(2012-12#1)
than 24 months##4##3##(1990-5#1)(1992-10#1)(2008-12#1)(2010-5#1)
than 24##22##2##(1990-5#2)(1990-7#1)(1991-1#1)(1992-10#1)(1993-10#1)(1994-8#1)(1995-1#1)(1995-5#1)(1996-2#1)(2007-12#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-12#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#2)
than 240##2##2##(1996-12#1)(2008-7#1)
than 245##2##2##(2008-10#2)
than 25 dB##2##3##(2007-12#2)
than 25 microM##5##3##(1992-5#1)(2005-8#4)
than 25 ng/ml##3##3##(1991-10#1)(1995-10#2)
than 25 nm##2##3##(2008-2#1)(2013-1#1)
than 25 years##10##3##(2006-10#2)(2006-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)
than 25##43##2##(1990-12#1)(1990-4#1)(1991-10#1)(1992-3#1)(1992-5#1)(1993-2#1)(1995-10#2)(1997-4#1)(2004-5#1)(2005-11#1)(2005-8#4)(2006-10#2)(2006-12#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2010-4#1)(2011-2#4)(2013-1#2)
than 25% of the##2##4##(2006-8#1)(2008-5#1)
than 25% of##5##3##(1991-7#1)(1995-9#1)(2006-8#1)(2007-9#1)(2008-5#1)
than 25%##19##2##(1990-5#1)(1991-7#1)(1993-11#1)(1994-9#1)(1995-9#1)(2006-4#1)(2006-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
than 250##5##2##(1993-9#1)(1996-5#1)(2006-9#1)(2008-10#1)(2008-3#1)
than 2500##2##2##(1991-9#1)(1993-6#1)
than 2700 grams at birth##2##5##(2011-1#2)
than 28##4##2##(1993-2#1)(1993-5#1)(2008-10#1)(2008-11#1)
than 2pi##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
than 3 GPa of Young's##2##5##(2011-1#2)
than 3 GPa of##3##4##(2011-1#3)
than 3 cm##6##3##(1992-3#1)(2005-5#2)(2006-10#1)(2008-5#1)(2008-6#1)
than 3 kDa)##2##3##(1990-5#1)(2008-10#1)
than 3 mm in diameter##3##5##(2007-8#2)(2011-2#1)
than 3 mm##4##3##(2007-8#2)(2011-2#1)(2012-3#1)
than 3 months##10##3##(1991-8#1)(1994-4#1)(2007-11#1)(2008-10#5)(2008-5#1)(2013-1#1)
than 3 positive lymph nodes##2##5##(2008-8#2)
than 3 times##2##3##(1991-7#1)(2010-12#1)
than 3 weeks##2##3##(2008-10#1)(2008-5#1)
than 3 x##2##3##(1991-6#1)(1994-2#1)
than 3 years of age##3##5##(2005-10#1)(2007-8#1)(2008-10#1)
than 3 years##4##3##(1996-5#1)(2005-10#1)(2007-8#1)(2008-10#1)
than 3##120##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1992-11#1)(1992-3#2)(1993-10#1)(1993-4#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-9#3)(1995-7#1)(1995-8#2)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-4#1)(2005-5#2)(2006-10#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-5#1)(2007-8#5)(2008-1#2)(2008-10#24)(2008-11#1)(2008-2#3)(2008-3#6)(2008-5#5)(2008-6#1)(2008-8#2)(2008-9#1)(2009-4#2)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
than 3% for##4##3##(1996-5#1)(2008-10#2)(2008-3#1)
than 3% of the##2##4##(1994-6#1)(2008-2#1)
than 3% of##4##3##(1994-6#1)(2008-2#1)(2010-5#1)(2011-12#1)
than 3%##22##2##(1990-12#1)(1993-1#1)(1994-6#1)(1996-5#1)(2006-11#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-10#7)(2008-2#2)(2008-3#1)(2010-5#1)(2011-12#1)(2013-8#1)
than 3) (n =##2##4##(1992-8#2)
than 3)##3##2##(1990-9#1)(1992-8#2)
than 30 dB##2##3##(2007-11#1)(2007-12#1)
than 30 days##2##3##(2008-10#1)(2009-9#1)
than 30 degrees##2##3##(2005-11#1)(2006-3#1)
than 30 million##2##3##(2006-4#1)(2012-2#1)
than 30 min##10##3##(1990-6#1)(1993-12#1)(1996-5#1)(1997-3#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-8#1)(2013-8#1)
than 30 minutes##6##3##(1993-1#1)(1994-3#1)(1997-2#1)(2007-2#1)(2008-10#1)(2012-3#1)
than 30 years##17##3##(1990-4#1)(1993-8#1)(1994-12#1)(1996-11#1)(2006-10#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-6#1)(2009-8#1)(2010-10#1)(2011-2#2)(2013-1#1)
than 30##95##2##(1990-11#1)(1990-12#2)(1990-4#1)(1990-5#2)(1990-6#1)(1991-2#1)(1992-6#1)(1992-8#3)(1993-1#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-7#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-11#3)(2006-10#3)(2006-3#1)(2006-4#1)(2006-6#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-6#1)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#14)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
than 30% of the##5##4##(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-12#1)
than 30% of##12##3##(1992-12#1)(2005-7#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-12#1)(2011-12#1)(2011-2#2)(2013-1#1)
than 30%##29##2##(1990-12#1)(1992-12#1)(1993-2#1)(1995-6#1)(1996-4#1)(2005-7#1)(2006-10#1)(2006-6#2)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#2)(2009-10#3)(2009-7#1)(2010-12#2)(2011-1#1)(2011-12#1)(2011-2#2)(2013-1#1)
than 30-fold##2##2##(1990-2#1)(2008-6#1)
than 300 bp##2##3##(1995-12#1)(1996-3#1)
than 300 mg##2##3##(1996-11#1)(2008-11#1)
than 300 mutations have been##2##5##(2008-3#2)
than 300##25##2##(1990-1#1)(1990-12#1)(1995-12#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-3#1)(2006-6#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-3#4)(2009-4#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
than 3000##3##2##(1997-6#1)(2008-12#1)(2012-2#1)
than 31##2##2##(2007-12#1)(2008-10#1)
than 32##6##2##(1992-2#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2012-2#1)
than 35 U/ml##2##3##(1991-4#2)
than 35 years##5##3##(1991-4#1)(1992-3#1)(2008-7#2)(2013-1#1)
than 35##11##2##(1991-4#3)(1992-3#1)(1993-6#1)(2007-8#1)(2008-6#1)(2008-7#2)(2011-7#1)(2013-1#1)
than 350##8##2##(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-11#1)(2010-5#1)
than 36 months##2##3##(2009-2#1)(2012-2#1)
than 36##6##2##(1991-8#1)(1997-1#1)(2006-8#1)(2008-5#1)(2009-2#1)(2012-2#1)
than 365 days##2##3##(1990-12#1)(2010-12#1)
than 37 degrees C##3##4##(2004-11#1)(2007-6#1)(2008-9#1)
than 37##6##2##(2004-11#1)(2007-12#1)(2007-6#1)(2008-7#1)(2008-9#1)(2011-2#1)
than 38##2##2##(2005-11#1)(2013-1#1)
than 3min##2##2##(2008-10#2)
than 3 × 10(7)##2##2##(2011-2#2)
than 4 cm##3##3##(2007-8#2)(2008-9#1)
than 4 hours##5##3##(1992-7#1)(2007-1#2)(2007-11#1)(2008-3#1)
than 4 mg/kg##2##3##(2008-1#2)
than 4 months##2##3##(2007-8#1)(2008-10#1)
than 4 weeks##2##3##(2007-7#1)(2008-10#1)
than 4 years##6##3##(1997-4#1)(2007-8#1)(2010-9#1)(2012-1#1)(2012-12#1)(2013-1#1)
than 4##86##2##(1990-12#1)(1990-2#2)(1990-6#3)(1990-9#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-7#2)(1992-9#1)(1994-9#1)(1995-3#1)(1995-7#1)(1997-4#1)(2006-5#1)(2006-8#1)(2007-1#3)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#5)(2008-1#5)(2008-10#20)(2008-2#7)(2008-3#3)(2008-5#2)(2008-8#1)(2008-9#1)(2010-4#2)(2010-9#1)(2011-1#1)(2012-1#2)(2012-12#2)(2013-1#4)(2013-8#2)
than 4%##18##2##(1990-6#1)(1991-11#1)(1996-6#1)(2005-12#1)(2008-1#1)(2008-10#9)(2008-3#3)(2011-1#1)
than 4-fold##2##2##(1990-6#1)(1994-9#1)
than 4-h WD##2##3##(2008-10#2)
than 40 degrees C##2##4##(2007-12#1)(2008-7#1)
than 40 different##3##3##(2008-11#1)(2008-3#1)(2012-12#1)
than 40 mm##2##3##(1992-5#1)(1996-6#1)
than 40 years of age##4##5##(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
than 40 years of##6##4##(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
than 40 years were##2##4##(2010-12#1)(2013-1#1)
than 40 years##16##3##(1996-4#1)(1997-8#1)(2007-9#1)(2008-7#1)(2009-3#1)(2010-12#2)(2010-3#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
than 40##57##2##(1990-2#1)(1990-4#1)(1991-12#2)(1991-2#1)(1991-4#2)(1992-5#1)(1993-2#1)(1993-3#1)(1996-4#1)(1996-6#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-12#4)(2007-2#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#2)(2010-8#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#1)
than 40% in##3##3##(2008-11#1)(2008-7#1)(2008-8#1)
than 40% of##4##3##(2008-3#1)(2008-5#1)(2010-10#1)(2013-1#1)
than 40%##19##2##(1991-12#1)(1997-3#1)(2005-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-10#1)(2012-2#1)(2013-1#1)
than 400 ng/ml)##4##3##(1992-3#4)
than 400##17##2##(1990-12#1)(1992-2#1)(1992-3#5)(1995-4#1)(2006-2#1)(2006-6#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-6#1)
than 400%##2##2##(2008-10#1)(2008-7#1)
than 44##2##2##(2007-12#1)(2008-10#1)
than 45 years##6##3##(1990-12#1)(1990-5#1)(2006-4#1)(2010-3#3)
than 45##11##2##(1990-11#1)(1990-12#1)(1990-5#1)(2006-4#1)(2007-2#1)(2008-7#1)(2010-3#3)(2011-2#1)(2013-1#1)
than 45%##3##2##(2008-2#1)(2011-2#1)(2013-8#1)
than 46%##2##2##(1994-11#1)(2007-11#1)
than 47##2##2##(2011-2#1)(2013-1#1)
than 48 h##4##3##(1992-3#1)(2008-10#1)(2008-6#1)(2012-2#1)
than 48 hours after delivery##2##5##(2005-10#1)(2010-8#1)
than 48 hours##7##3##(1990-12#1)(1993-12#1)(2005-10#1)(2005-2#1)(2006-8#1)(2007-8#1)(2010-8#1)
than 48##11##2##(1990-12#1)(1992-3#1)(1993-12#1)(2005-10#1)(2005-2#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-6#1)(2010-8#1)(2012-2#1)
than 48%##2##2##(1990-5#1)(2006-10#1)
than 5 and##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
than 5 cm in##2##4##(2007-12#1)(2011-2#1)
than 5 cm##6##3##(1996-6#1)(2007-12#1)(2008-8#1)(2011-2#2)(2012-2#1)
than 5 cm)##2##3##(2008-6#1)(2008-7#1)
than 5 mm##12##3##(1991-6#2)(1994-9#1)(1995-10#1)(1997-3#1)(2007-3#1)(2008-10#1)(2008-5#2)(2008-8#1)(2012-12#2)
than 5 ms##2##3##(1995-5#1)(1996-2#1)
than 5 x##4##3##(1995-1#1)(2006-5#1)(2007-12#1)(2008-3#1)
than 5 years##15##3##(1990-6#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1995-2#1)(2004-11#1)(2004-12#1)(2007-11#1)(2008-5#1)(2008-6#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
than 5 years)##2##3##(1990-9#1)(1991-10#1)
than 5##123##2##(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#3)(1991-8#1)(1991-9#1)(1992-3#2)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#2)(2004-11#1)(2004-12#1)(2005-11#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#5)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#5)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-2#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
than 5% and##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
than 5% blasts by the end of the second course of ADE##2##12##(2008-10#2)
than 5% error in the estimate of the 50% control mean##2##11##(2012-2#2)
than 5% error##3##3##(2008-2#1)(2012-2#2)
than 5% in##5##3##(1994-9#1)(2008-10#2)(2008-9#1)(2011-2#1)
than 5% of C##2##4##(2008-5#1)(2011-2#1)
than 5% of its##2##4##(1995-6#1)(2007-12#1)
than 5% of patients##2##4##(2007-10#1)(2008-1#1)
than 5% of the##9##4##(1991-8#1)(1993-12#1)(1995-2#1)(1996-8#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-3#1)
than 5% of##22##3##(1991-12#1)(1991-8#1)(1992-4#1)(1993-12#1)(1995-2#1)(1995-6#1)(1996-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#2)(2009-3#1)(2009-8#1)(2011-2#2)(2012-2#1)
than 5%##75##2##(1990-12#1)(1991-12#1)(1991-8#1)(1992-4#1)(1992-6#1)(1993-12#1)(1994-10#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-8#2)(1997-4#1)(2005-10#1)(2005-4#1)(2005-7#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#22)(2008-2#3)(2008-3#3)(2008-5#4)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-12#1)(2011-2#5)(2012-2#4)(2012-3#1)(2013-1#2)
than 5%) and##2##3##(1990-11#1)(2008-10#1)
than 5%)##4##2##(1990-11#1)(1990-7#1)(2008-10#2)
than 5-fold##2##2##(1993-9#1)(1994-12#1)
than 50 and##4##3##(2004-11#1)(2007-11#1)(2008-10#2)
than 50 cases##2##3##(2006-10#1)(2011-1#1)
than 50 m##2##3##(2008-10#1)(2008-3#1)
than 50 microM##2##3##(1990-2#1)(1990-7#1)
than 50 microm##2##3##(2008-10#2)
than 50 ml##2##3##(1991-2#1)(1993-2#1)
than 50 nm##3##3##(2007-11#1)(2008-3#2)
than 50 percent##3##3##(1993-5#1)(1994-3#1)(1995-2#1)
than 50 years of age##3##5##(1992-8#1)(2004-2#1)(2007-10#1)
than 50 years##14##3##(1990-5#1)(1992-8#1)(1993-8#1)(1995-12#1)(2004-2#1)(2007-10#2)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#1)(2011-3#1)(2012-1#1)
than 50##79##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-6#1)(1992-8#1)(1992-9#1)(1993-2#2)(1993-5#1)(1993-8#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-4#1)(2004-11#2)(2004-2#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#2)(2007-10#2)(2007-11#2)(2007-12#4)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#14)(2008-3#6)(2008-5#3)(2008-6#1)(2008-8#3)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
than 50% (&quot##2##3##(2011-2#2)
than 50% in the##3##4##(1990-5#1)(2008-3#1)(2008-5#1)
than 50% in##5##3##(1990-10#1)(1990-5#1)(1997-3#1)(2008-3#1)(2008-5#1)
than 50% of patients with##3##5##(1990-12#1)(2007-4#1)(2007-8#1)
than 50% of patients##10##4##(1990-12#1)(1990-4#1)(2006-10#1)(2006-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2010-12#1)(2013-1#1)
than 50% of the##20##4##(1994-11#1)(1994-2#1)(1995-11#1)(1995-6#1)(1996-5#1)(1997-6#1)(2004-4#1)(2006-2#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-8#1)
than 50% of these##2##4##(1995-2#1)(2013-1#1)
than 50% of##52##3##(1990-12#2)(1990-2#1)(1990-4#1)(1991-2#1)(1991-5#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-6#1)(2004-4#1)(2006-10#2)(2006-11#1)(2006-2#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-10#2)(2010-12#3)(2011-2#3)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
than 50%##113##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#2)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-7#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#2)(1997-7#1)(2004-4#1)(2005-11#1)(2006-10#4)(2006-11#2)(2006-2#1)(2006-4#1)(2006-8#4)(2007-12#3)(2007-4#1)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-5#1)(2010-12#5)(2010-3#1)(2011-2#7)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
than 50%)##4##2##(1990-2#1)(1992-8#1)(2008-2#1)(2008-3#1)
than 500 years##2##3##(2006-12#1)(2012-3#1)
than 500##20##2##(1991-6#1)(1992-1#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-2#1)(1996-4#1)(2004-4#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-4#2)(2012-2#1)(2012-3#1)(2013-1#1)
than 5000##4##2##(2007-8#1)(2008-11#1)(2012-1#1)(2012-12#1)
than 51##4##2##(2007-2#1)(2008-2#1)(2011-2#2)
than 51%##2##2##(2007-7#1)(2008-10#1)
than 55 microM##2##3##(1991-7#2)
than 55##4##2##(1991-7#2)(2008-5#1)(2012-2#1)
than 57##3##2##(1992-4#1)(2008-10#2)
than 6 cm##3##3##(1992-2#1)(2006-3#1)(2010-6#1)
than 6 days in##2##4##(2004-10#1)(2007-9#1)
than 6 h##4##3##(1993-12#1)(1997-5#1)(2005-11#1)(2008-10#1)
than 6 hours##2##3##(2007-10#1)(2007-9#1)
than 6 months of##5##4##(2005-11#1)(2006-5#3)(2006-8#1)
than 6 months##23##3##(1991-2#1)(1994-4#1)(1996-12#1)(2005-11#1)(2006-5#3)(2006-8#4)(2007-7#2)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-12#1)(2013-1#1)
than 6 years##3##3##(2010-9#1)(2013-1#2)
than 6##73##2##(1990-5#2)(1990-6#1)(1991-2#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-12#1)(1994-11#1)(1994-4#1)(1994-7#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-5#1)(2004-10#1)(2005-11#2)(2006-3#2)(2006-5#3)(2006-8#4)(2007-10#1)(2007-12#3)(2007-7#3)(2007-8#3)(2007-9#2)(2008-10#11)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2010-12#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#5)
than 6% in the##2##4##(1994-9#1)(2008-10#1)
than 6% in##4##3##(1990-12#1)(1994-9#1)(2007-3#1)(2008-10#1)
than 6%##12##2##(1990-12#2)(1992-12#1)(1994-9#1)(1997-8#1)(2005-4#1)(2007-3#1)(2008-10#4)(2010-1#1)
than 6)##2##2##(2007-7#1)(2012-3#1)
than 6/18##3##2##(2010-8#1)(2011-1#2)
than 60 %##3##3##(2005-10#1)(2011-2#1)(2012-12#1)
than 60 days##2##3##(2008-2#1)(2009-4#1)
than 60 mgCl(-1)##2##3##(2008-10#2)
than 60 min##3##3##(1990-12#1)(1995-10#1)(2008-10#1)
than 60 nm##3##3##(2007-12#2)(2008-3#1)
than 60 years##15##3##(1990-12#1)(1990-5#1)(1992-7#1)(1995-9#1)(1996-11#1)(2006-12#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-2#1)(2009-12#1)(2011-2#3)(2012-3#1)
than 60##60##2##(1990-11#1)(1990-12#2)(1990-5#1)(1991-12#1)(1991-6#1)(1992-10#1)(1992-7#1)(1993-10#1)(1993-3#2)(1994-9#1)(1995-10#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#1)(1997-4#1)(2005-10#1)(2006-12#1)(2007-11#1)(2007-12#5)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-8#1)(2011-2#5)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
than 60% for##4##3##(1992-8#1)(1996-12#1)(2008-10#1)(2012-11#1)
than 60% of the##11##4##(1990-12#1)(1994-9#1)(1995-6#1)(1996-10#1)(1997-4#1)(2006-2#1)(2008-3#1)(2008-5#1)(2009-5#1)(2012-12#1)(2013-7#1)
than 60% of##20##3##(1990-12#1)(1994-9#1)(1995-6#1)(1996-10#1)(1997-4#1)(2006-2#1)(2007-7#1)(2008-1#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-5#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-7#1)
than 60%##35##2##(1990-12#1)(1990-4#1)(1991-2#1)(1992-8#1)(1994-6#1)(1994-9#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-4#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#1)(2013-7#2)
than 600##9##2##(1991-3#1)(1991-8#1)(2007-12#2)(2010-7#1)(2010-8#1)(2011-3#1)(2013-8#2)
than 6000 dalton##2##3##(1991-3#2)
than 6000##5##2##(1991-3#2)(1991-5#1)(2008-5#1)(2011-1#1)
than 65 bpm##2##3##(2008-3#2)
than 65 years of age##6##5##(2010-3#1)(2010-9#1)(2011-2#4)
than 65 years##25##3##(1992-10#1)(1992-5#1)(1995-10#1)(2006-8#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-8#4)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#7)(2012-3#1)(2013-1#1)(2013-8#1)
than 65##34##2##(1990-2#1)(1990-3#1)(1992-10#1)(1992-5#1)(1995-10#1)(2006-8#1)(2007-11#2)(2007-8#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-1#1)(2009-8#4)(2010-3#1)(2010-4#2)(2010-9#1)(2011-2#7)(2012-3#1)(2013-1#2)(2013-8#1)
than 65% of##2##3##(2008-10#1)(2008-5#1)
than 65%##5##2##(2005-8#1)(2008-10#1)(2008-5#1)(2009-3#1)(2009-7#1)
than 7 and##2##3##(1990-5#1)(2007-8#1)
than 7 days##3##3##(2004-12#1)(2007-7#1)(2013-8#1)
than 7 in##2##3##(2011-1#2)
than 7 months##3##3##(1992-8#1)(2008-6#1)(2013-1#1)
than 7##36##2##(1990-2#2)(1990-3#2)(1990-5#1)(1990-9#1)(1991-7#1)(1992-4#1)(1992-8#1)(1994-9#1)(1996-11#1)(1996-9#1)(2004-11#1)(2004-12#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-5#1)(2011-1#3)(2011-12#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
than 7% in##2##3##(1997-8#1)(2008-2#1)
than 7% of the##2##4##(1997-6#1)(2008-2#1)
than 7% of##3##3##(1997-6#1)(2006-10#1)(2008-2#1)
than 7%##12##2##(1997-6#1)(1997-8#1)(2006-10#1)(2006-6#1)(2008-10#5)(2008-2#3)
than 70 years##8##3##(1996-2#1)(2007-8#3)(2008-10#1)(2009-9#1)(2010-12#1)(2011-2#1)
than 70##26##2##(1990-10#1)(1991-12#1)(1991-9#1)(1992-2#1)(1993-11#1)(1996-2#1)(1997-3#1)(2005-1#1)(2007-12#1)(2007-8#4)(2008-1#5)(2008-10#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
than 70% of the##12##4##(1991-7#1)(1992-10#1)(1992-2#1)(1995-2#1)(1996-1#1)(2008-10#5)(2008-8#2)
than 70% of##20##3##(1991-7#1)(1992-10#1)(1992-2#1)(1994-4#1)(1995-2#1)(1996-1#1)(2006-5#1)(2006-8#1)(2007-8#1)(2008-10#5)(2008-5#1)(2008-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
than 70%##30##2##(1991-7#1)(1992-10#1)(1992-2#1)(1994-4#1)(1995-2#1)(1996-1#1)(2005-11#1)(2006-11#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-8#1)(2008-10#6)(2008-5#3)(2008-8#2)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)
than 700##7##2##(1992-11#1)(2005-7#1)(2005-8#1)(2006-11#1)(2007-6#1)(2007-7#1)(2008-10#1)
than 72 h##2##3##(2008-9#1)(2009-10#1)
than 73%##2##2##(2008-4#1)(2011-2#1)
than 7300##3##2##(1991-11#1)(2007-7#1)(2008-1#1)
than 75 degrees##2##3##(2008-2#2)
than 75 years of age##4##5##(2005-2#1)(2008-3#1)(2011-2#2)
than 75 years##10##3##(1991-2#1)(1993-9#2)(2005-2#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#2)
than 75##19##2##(1991-2#1)(1992-6#1)(1993-9#2)(1997-4#1)(2005-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#2)(2012-11#1)
than 75% of the##6##4##(1995-10#1)(1995-8#1)(1997-3#1)(2006-2#1)(2007-9#1)(2011-3#1)
than 75% of##9##3##(1995-10#1)(1995-8#1)(1997-3#1)(2006-2#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-6#1)(2011-3#1)
than 75%##19##2##(1991-7#1)(1995-10#1)(1995-8#1)(1997-3#1)(2006-10#3)(2006-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-6#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-3#1)(2012-1#1)
than 750 nests##2##3##(2009-10#2)
than 750##5##2##(2006-10#1)(2008-2#1)(2008-5#1)(2009-10#2)
than 77%##3##2##(1991-2#1)(1991-6#1)(2008-10#1)
than 8 h##2##3##(1993-1#1)(2008-10#1)
than 8 hours##2##3##(2007-7#1)(2008-8#1)
than 8 years of##2##4##(2007-8#1)(2008-5#1)
than 8##34##2##(1990-4#1)(1990-6#1)(1991-12#1)(1991-6#1)(1993-1#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-8#1)(2005-4#2)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-12#1)
than 8% for##4##3##(2007-12#1)(2007-4#1)(2008-10#1)(2008-5#1)
than 8%##12##2##(2007-12#1)(2007-4#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2012-3#1)(2013-7#1)
than 8-human-equivalent years##2##3##(2006-11#2)
than 80##17##2##(1990-12#1)(1990-3#1)(1991-7#1)(1993-5#1)(1994-2#1)(1995-11#1)(1996-3#1)(1996-9#1)(2006-5#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
than 80% of the##10##4##(1993-6#1)(1994-8#1)(1995-2#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-6#1)(2008-8#1)(2010-8#1)
than 80% of##24##3##(1992-3#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-2#1)(1995-6#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#1)(2011-3#1)
than 80%##47##2##(1991-11#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-2#1)(1995-5#2)(1995-6#1)(1997-3#1)(1997-8#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#1)
than 80%)##9##2##(1990-7#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-1#1)(1993-5#2)(2007-11#1)(2007-8#1)
than 800##7##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-5#1)
than 82##2##2##(1992-3#1)(2011-2#1)
than 82%##3##2##(2007-7#1)(2007-8#1)(2013-7#1)
than 84##2##2##(2008-10#1)(2008-3#1)
than 85 years##2##3##(2007-2#1)(2009-8#1)
than 85##4##2##(2006-10#1)(2007-2#1)(2009-8#1)(2011-2#1)
than 85% of##7##3##(1993-12#1)(1995-6#1)(1996-2#1)(2004-12#1)(2008-10#1)(2008-8#1)(2010-4#1)
than 85%##16##2##(1991-8#1)(1993-12#1)(1995-4#1)(1995-6#1)(1996-2#1)(1996-6#1)(2004-12#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-4#1)
than 86%##3##2##(2007-12#1)(2008-10#1)(2008-7#1)
than 87%##2##2##(1993-12#1)(1993-2#1)
than 88##3##2##(1992-8#1)(2012-12#2)
than 88%##6##2##(1990-12#1)(1992-2#1)(2008-10#2)(2008-4#1)(2012-3#1)
than 89%##2##2##(2007-7#1)(2008-10#1)
than 9##14##2##(1990-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1995-3#1)(1996-8#1)(2005-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2011-1#1)(2012-12#1)(2013-1#1)
than 9%##5##2##(1996-11#1)(2007-8#1)(2008-10#2)(2008-3#1)
than 90 degrees##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
than 90 minutes##2##3##(2007-7#1)(2012-2#1)
than 90 ng##2##3##(2008-10#2)
than 90##19##2##(1992-8#1)(1993-12#1)(1993-5#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-7#1)(2009-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
than 90% in##4##3##(1992-12#1)(1992-2#1)(1997-4#1)(2012-12#1)
than 90% of the patients##2##5##(1994-9#1)(2007-7#1)
than 90% of the##21##4##(1991-12#1)(1991-8#1)(1992-6#1)(1993-11#1)(1994-9#2)(1995-3#1)(1997-1#1)(2007-12#3)(2007-7#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-11#1)
than 90% of##42##3##(1991-12#1)(1991-8#1)(1992-6#1)(1993-11#1)(1994-6#1)(1994-9#2)(1995-3#1)(1995-6#1)(1996-1#1)(1997-1#1)(2005-8#1)(2006-8#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#2)(2010-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#2)
than 90% similarity##2##3##(2008-10#1)(2009-5#1)
than 90%##87##2##(1990-10#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-11#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-3#2)(1995-6#1)(1996-1#1)(1996-11#1)(1997-1#1)(1997-4#1)(2005-4#1)(2005-8#1)(2006-8#1)(2007-1#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-12#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#3)(2013-7#1)
than 90%)##5##2##(1990-11#1)(1992-8#1)(1992-9#1)(1993-12#1)(2008-6#1)
than 9000##2##2##(1991-8#1)(2007-12#1)
than 91%##3##2##(2007-1#1)(2008-10#2)
than 92%##2##2##(1992-12#1)(2008-10#1)
than 93%##5##2##(1990-12#1)(1995-5#1)(2008-10#2)(2012-2#1)
than 94%##4##2##(1990-10#1)(2007-11#1)(2008-10#1)(2008-3#1)
than 95 percent of##3##4##(1992-12#1)(1994-3#1)(2010-8#1)
than 95##4##2##(1992-12#1)(1994-3#1)(2005-8#1)(2010-8#1)
than 95% and##4##3##(2008-10#2)(2008-11#1)(2010-7#1)
than 95% of the##8##4##(1990-10#1)(1991-3#1)(1994-2#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-6#1)(2010-9#1)
than 95% of##18##3##(1990-10#1)(1990-12#1)(1990-8#1)(1991-3#1)(1992-3#1)(1992-8#1)(1994-2#1)(1994-8#1)(2006-2#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-6#2)(2010-9#1)(2012-2#1)
than 95% pure##2##3##(1991-5#1)(1997-4#1)
than 95%##49##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-3#1)(1992-8#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-8#1)(1997-4#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#10)(2008-11#2)(2008-2#2)(2008-6#3)(2008-9#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
than 95%)##3##2##(1990-7#1)(1991-1#1)(1991-8#1)
than 96%##3##2##(1994-5#1)(2006-8#1)(2012-3#1)
than 97##2##2##(2005-11#1)(2007-8#1)
than 97% in##2##3##(2008-10#1)(2008-3#1)
than 97%##13##2##(1995-2#1)(1996-10#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#1)(2009-5#1)(2013-8#1)
than 98##3##2##(1990-3#2)(1992-1#1)
than 98% pure##2##3##(1990-12#1)(1992-1#1)
than 98%##16##2##(1990-12#1)(1990-7#1)(1992-1#1)(1993-11#1)(1997-2#1)(2006-6#1)(2008-10#4)(2008-2#1)(2008-8#1)(2008-9#2)(2011-1#1)(2012-12#1)
than 99##10##2##(1990-3#1)(1992-12#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-3#1)
than 99% of the##3##4##(1993-2#1)(1997-1#1)(1997-3#1)
than 99% of##5##3##(1993-2#1)(1997-1#1)(1997-3#1)(2007-3#1)(2008-10#1)
than 99%##23##2##(1990-11#1)(1990-3#1)(1993-2#1)(1994-11#1)(1996-12#1)(1997-1#1)(1997-3#1)(2007-3#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-9#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)
than ?1##2##2##(2008-2#2)
than A3##2##2##(2010-2#2)
than AA##2##2##(1994-11#1)(1996-2#1)
than AAS-found metal##2##3##(2008-10#2)
than AIDS##2##2##(1997-3#1)(2007-7#1)
than ALT activity##2##3##(2006-6#2)
than ALT##3##2##(1996-9#1)(2006-6#2)
than ATP##3##2##(1990-7#1)(1994-9#1)(1996-7#1)
than ATPSm##2##2##(1991-5#2)
than African##2##2##(2009-5#1)(2010-10#1)
than Ag and##2##3##(2007-12#1)(2008-10#1)
than Asians##3##2##(2012-2#3)
than Australian males##2##3##(2007-12#1)(2008-10#1)
than B##4##2##(2008-4#1)(2008-5#2)(2013-8#1)
than B3LYP##3##2##(2008-8#3)
than Br-##2##2##(2008-10#2)
than C mice##2##3##(1995-3#2)
than C##9##2##(1995-3#2)(2007-12#1)(2008-4#1)(2008-5#2)(2012-2#2)(2012-3#1)
than CEA##2##2##(1991-10#1)(1995-10#1)
than CG##2##2##(2013-1#2)
than CON##4##2##(2006-7#1)(2010-4#3)
than CT##2##2##(2004-1#1)(2008-7#1)
than Cantonese##2##2##(2013-8#2)
than Caucasian males##2##3##(2006-7#2)
than Caucasian##5##2##(2006-7#2)(2008-4#1)(2009-5#1)(2012-2#1)
than Caucasians##2##2##(2008-12#1)(2008-4#1)
than Curdlan##2##2##(2011-1#2)
than D2##2##2##(1996-12#1)(2010-6#1)
than DNA##6##2##(1991-4#1)(1992-7#1)(1994-5#1)(2008-11#1)(2008-5#1)(2013-1#1)
than E##2##2##(2008-10#1)(2011-1#1)
than English##4##2##(1996-3#1)(2008-2#1)(2009-8#1)(2011-1#1)
than F##2##2##(2008-10#2)
than FMRFamide##2##2##(1991-2#2)
than Freedom##2##2##(2010-10#2)
than Group B##5##3##(2008-5#3)(2013-7#2)
than Group I##3##3##(2006-8#1)(2008-9#1)(2013-1#1)
than Group##11##2##(2006-8#2)(2008-5#3)(2008-9#2)(2012-12#1)(2013-1#1)(2013-7#2)
than HA##2##2##(2009-7#1)(2013-8#1)
than HF ones##3##3##(2009-1#3)
than HIV-1##2##2##(1997-3#2)
than IGF-I##3##2##(1991-4#2)(1997-4#1)
than IL-1##3##2##(1992-8#2)(2007-12#1)
than IL-6##2##2##(1992-8#2)
than K##2##2##(2008-5#1)(2010-7#1)
than K562##2##2##(1991-7#1)(1992-8#1)
than KS-502##2##2##(1995-6#2)
than L##2##2##(2008-10#1)(2010-8#1)
than LLE##2##2##(2008-10#2)
than LR rats##2##3##(1994-2#2)
than LS174T##2##2##(1994-12#2)
than LUT halftoning##2##3##(2008-2#2)
than M##6##2##(1994-11#1)(2004-2#1)(2008-10#1)(2008-7#1)(2011-12#1)(2012-3#1)
than ME##2##2##(1995-2#2)
than MHC##2##2##(2008-4#1)(2009-2#1)
than MPTP##2##2##(1990-5#2)
than Manzanillo cv##2##3##(2008-12#2)
than Medicare##2##2##(1991-3#2)
than Mg2+##3##2##(1993-8#1)(1995-3#1)(1996-7#1)
than Mn2+##2##2##(1990-11#1)(1996-7#1)
than N##3##2##(1991-7#1)(1997-8#1)(2010-12#1)
than N-acetylneuraminic acid##2##3##(1990-2#1)(1993-11#1)
than NP##4##2##(1997-4#2)(2007-11#2)
than Na##2##2##(2008-10#2)
than OB##5##2##(2008-2#5)
than OO##2##2##(2008-2#2)
than OS##2##2##(2007-6#1)(2008-12#1)
than P##5##2##(2005-8#1)(2008-10#2)(2008-5#2)
than P1##2##2##(1992-9#2)
than PCP##2##2##(1991-2#1)(2007-9#1)
than PCR##3##2##(1997-7#1)(2012-2#1)(2013-8#1)
than PD##2##2##(2008-11#1)(2011-2#1)
than PE##2##2##(1991-7#1)(2008-12#1)
than Q##3##2##(2012-5#1)(2012-9#2)
than R##3##2##(1995-3#1)(2007-3#1)(2008-10#1)
than RGDS##2##2##(1994-12#1)(2008-11#1)
than SA##2##2##(2008-10#1)(2011-1#1)
than SD rats##3##3##(1992-7#1)(1993-3#1)(1996-5#1)
than SD##4##2##(1992-7#1)(1993-3#1)(1996-5#1)(2008-1#1)
than SDR##2##2##(1992-11#2)
than Shanyou63##2##2##(2008-9#2)
than T cell##2##3##(2006-10#1)(2007-11#1)
than T cells##2##3##(1990-12#1)(2008-4#1)
than T##8##2##(1990-12#1)(1991-8#1)(1992-9#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-4#2)
than T(382)##3##2##(2008-10#3)
than US$##2##2##(2008-9#1)(2011-2#1)
than US-1##2##2##(2008-10#2)
than VCG##2##2##(2008-10#2)
than VIP##2##2##(1990-7#1)(1994-12#1)
than WC patients##2##3##(2011-2#2)
than WHO TEQ values)##2##4##(2008-10#2)
than WT##3##2##(2008-9#1)(2013-1#1)(2013-8#1)
than White non-Hispanics##2##3##(2006-12#2)
than White##5##2##(2006-12#2)(2007-12#1)(2008-11#1)(2009-7#1)
than Whites##4##2##(2004-12#3)(2011-2#1)
than X##2##2##(2008-10#2)
than a 3-fold##3##3##(1990-7#1)(2008-10#1)(2008-9#1)
than a century ago##4##4##(1997-3#1)(2007-11#1)(2008-3#1)(2011-2#1)
than a century##20##3##(1992-5#1)(1994-3#2)(1997-3#1)(2006-9#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#2)(2011-2#1)(2012-2#1)(2013-8#2)
than a comparable##2##3##(2008-10#1)(2008-11#1)
than a control##2##3##(2007-12#1)(2008-4#1)
than a conventional##2##3##(2007-12#1)(2008-2#1)
than a daily##2##3##(2007-11#1)(2013-1#1)
than a decade after##2##4##(2007-4#1)(2011-1#1)
than a decade ago##7##4##(1994-4#1)(2005-6#1)(2006-5#1)(2008-1#1)(2009-3#1)(2012-2#2)
than a decade of##6##4##(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
than a decade##23##3##(1993-12#1)(1994-12#1)(1994-4#1)(1996-2#1)(1996-5#1)(1997-4#1)(2005-10#1)(2005-6#1)(2006-5#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-3#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
than a direct##3##3##(1994-8#1)(2006-7#1)(2007-11#1)
than a dozen##2##3##(2006-10#1)(2008-5#1)
than a few##10##3##(1990-3#1)(1991-11#1)(1996-11#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)
than a minimal##2##3##(1990-12#1)(2009-6#1)
than a month##2##3##(2008-11#1)(2010-1#1)
than a normal##2##3##(1991-2#1)(2008-6#1)
than a previously##2##3##(1992-8#1)(1995-8#1)
than a quarter of##3##4##(1990-5#1)(1992-3#1)(1996-9#1)
than a recently##2##3##(2008-2#1)(2008-3#1)
than a similar##3##3##(1995-3#1)(2005-11#1)(2008-7#1)
than a simple##9##3##(1992-8#1)(1996-10#2)(2007-1#1)(2007-8#1)(2008-2#1)(2008-9#1)(2012-1#1)(2012-11#1)
than a single##17##3##(1993-12#1)(1995-11#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#2)(2010-11#1)(2011-1#1)(2012-2#1)(2013-1#2)
than a standard##3##3##(2007-7#1)(2008-11#1)(2010-5#1)
than a traditional##2##3##(2008-10#1)(2008-9#1)
than a wavelength##6##3##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)
than a year##5##3##(2006-10#1)(2007-8#1)(2010-10#1)(2012-3#2)
than a##349##2##(1990-10#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#4)(1990-7#1)(1990-8#3)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#2)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-3#3)(1994-4#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#3)(1995-12#1)(1995-3#2)(1995-4#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#2)(1996-10#2)(1996-11#4)(1996-12#1)(1996-2#2)(1996-4#4)(1996-5#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#3)(1997-7#2)(1997-8#2)(2004-10#1)(2004-12#2)(2004-3#2)(2004-9#1)(2005-10#2)(2005-11#5)(2005-12#1)(2005-6#1)(2005-9#1)(2006-10#12)(2006-11#1)(2006-12#2)(2006-2#2)(2006-5#2)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#15)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#5)(2008-10#18)(2008-11#8)(2008-2#16)(2008-3#15)(2008-4#4)(2008-5#7)(2008-6#2)(2008-7#10)(2008-8#6)(2008-9#8)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#3)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#5)(2011-12#2)(2011-2#6)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#7)(2012-3#4)(2012-9#1)(2013-1#5)(2013-8#7)
than about##11##2##(1990-2#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-2#1)
than above##2##2##(2008-2#1)(2009-4#1)
than absolute values of##2##4##(1990-9#1)(1994-8#1)
than absolute##5##2##(1990-9#1)(1994-8#1)(2005-8#1)(2008-10#1)(2012-2#1)
than acetamide alone##2##3##(2006-5#2)
than acetylsalicylic acid##2##3##(2008-6#2)
than acidic##2##2##(2008-10#1)(2008-11#1)
than acquisition##2##2##(2008-10#2)
than activation of##2##3##(1992-6#1)(2009-10#1)
than activation##4##2##(1991-2#1)(1992-6#1)(1997-6#1)(2009-10#1)
than active##2##2##(2008-7#1)(2012-1#1)
than activity##3##2##(1991-7#1)(1992-5#1)(2010-12#1)
than actual##2##2##(1990-6#1)(1996-9#1)
than acute##2##2##(2005-7#1)(2011-2#1)
than additive effects##3##3##(2008-10#3)
than additive inhibition of##2##4##(1990-2#1)(2008-10#1)
than additive##10##2##(1990-2#1)(1990-5#1)(1996-1#1)(2008-10#7)
than adjacent##3##2##(2010-8#1)(2011-2#1)(2013-7#1)
than adult##5##2##(1991-5#1)(2008-11#1)(2008-5#1)(2010-8#1)(2011-2#1)
than adults and##4##3##(1990-5#1)(1993-12#1)(2006-1#1)(2011-2#1)
than adults##10##2##(1990-5#1)(1993-12#1)(1994-8#1)(1997-7#1)(2006-1#1)(2008-10#1)(2008-11#1)(2008-9#2)(2011-2#1)
than after##18##2##(1991-9#1)(1992-10#1)(1993-2#1)(1993-3#1)(1995-2#1)(1996-2#1)(2006-8#1)(2007-10#2)(2007-11#2)(2008-4#1)(2008-5#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
than against the##2##3##(1996-12#1)(1997-3#1)
than age 65##2##3##(2007-10#1)(2007-12#1)
than age##6##2##(1991-12#1)(1997-3#1)(2006-5#1)(2007-10#1)(2007-12#1)(2008-11#1)
than age-matched controls##2##3##(1991-8#1)(2005-10#1)
than age-matched##4##2##(1991-8#1)(2005-10#1)(2007-5#1)(2012-1#1)
than aged##2##2##(1994-12#1)(1997-2#1)
than air##3##2##(2008-1#1)(2008-6#1)(2011-1#1)
than albumin##3##2##(1990-6#1)(2013-1#2)
than all other groups##2##4##(2007-9#1)(2010-3#1)
than all other##6##3##(1996-9#1)(2007-7#1)(2007-9#1)(2008-10#1)(2010-3#1)(2011-2#1)
than all others##2##3##(2007-11#1)(2007-3#1)
than all the##3##3##(2008-10#1)(2009-5#1)(2013-7#1)
than all##13##2##(1996-9#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-3#1)(2009-5#1)(2010-2#1)(2010-3#1)(2011-2#1)(2013-7#1)
than allowing##2##2##(1994-2#1)(2009-3#1)
than alpha##4##2##(1994-11#1)(1994-12#1)(1995-11#1)(1995-5#1)
than alternative##2##2##(2008-4#1)(2009-4#1)
than among children##4##3##(1993-10#1)(1994-6#1)(1997-2#1)(2011-2#1)
than among men##3##3##(1992-4#1)(1995-5#1)(2009-4#1)
than among other##4##3##(1995-9#1)(1996-3#1)(2007-4#1)(2008-5#1)
than among the general##2##4##(2010-12#1)(2012-1#1)
than among the rest of the sample##2##7##(1991-8#2)
than among the younger##2##4##(2006-10#1)(2008-3#1)
than among the##12##3##(1991-5#1)(1991-8#2)(1995-9#1)(2006-10#1)(2006-12#1)(2006-7#2)(2008-3#1)(2010-12#1)(2010-4#1)(2012-1#1)
than among those with##2##4##(1992-5#1)(2011-2#1)
than among those without##3##4##(1990-6#1)(1991-9#1)(2006-12#1)
than among those##7##3##(1990-6#1)(1991-9#1)(1992-5#1)(2006-12#1)(2007-11#1)(2008-10#1)(2011-2#1)
than among women with##2##4##(1990-6#1)(1997-4#1)
than among##50##2##(1990-10#1)(1990-4#1)(1990-6#2)(1991-5#1)(1991-8#2)(1991-9#1)(1992-4#1)(1992-5#1)(1993-10#2)(1994-3#1)(1994-6#1)(1995-1#2)(1995-5#1)(1995-9#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(2004-12#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-7#2)(2007-11#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)
than an existing##3##3##(2012-2#1)(2012-3#2)
than an increase in##2##4##(1992-1#1)(1997-7#1)
than an order of magnitude##5##5##(1997-4#1)(2007-11#2)(2008-1#1)(2008-10#1)
than an orientation##2##3##(1991-11#1)(2012-2#1)
than an##66##2##(1990-3#1)(1990-7#1)(1991-11#2)(1992-1#1)(1992-2#1)(1992-6#1)(1993-10#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-8#2)(1995-1#1)(1995-12#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#2)(2006-10#2)(2007-11#4)(2007-12#6)(2007-2#2)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2012-1#2)(2012-2#3)(2012-3#2)(2013-8#1)
than and##4##2##(1992-7#1)(2007-11#1)(2008-5#1)(2009-6#1)
than animals##3##2##(1993-5#1)(1993-9#1)(1997-5#1)
than another##3##2##(1992-4#1)(2004-2#1)(2006-2#1)
than antibody##3##2##(1991-8#1)(2008-12#1)(2011-1#1)
than anticipated##7##2##(1990-10#1)(1992-1#1)(1994-2#1)(1996-1#1)(2008-11#1)(2011-2#1)(2012-3#1)
than any known##2##3##(2008-7#1)(2011-2#1)
than any of the other##4##5##(1992-8#1)(2006-12#1)(2008-10#1)(2008-2#1)
than any of the##6##4##(1992-8#1)(2006-12#1)(2008-10#2)(2008-2#1)(2010-5#1)
than any of##8##3##(1992-8#1)(2006-12#1)(2008-10#2)(2008-2#1)(2008-8#1)(2010-5#1)(2012-1#1)
than any other country##2##4##(1991-6#1)(2010-8#1)
than any other disease##2##4##(2008-3#1)(2012-12#1)
than any other group##3##4##(1991-2#2)(1997-2#1)
than any other technique##2##4##(2008-10#2)
than any other##36##3##(1991-2#2)(1991-5#1)(1991-6#1)(1992-8#1)(1994-3#2)(1994-8#1)(1996-5#2)(1997-2#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-1#1)(2010-7#1)(2010-8#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
than any previous##2##3##(2008-2#1)(2008-8#1)
than any previously reported##2##4##(2007-12#1)(2008-2#1)
than any previously##3##3##(1990-11#1)(2007-12#1)(2008-2#1)
than any##63##2##(1990-11#1)(1991-2#2)(1991-5#1)(1991-6#1)(1992-12#1)(1992-8#2)(1992-9#1)(1994-3#2)(1994-8#1)(1995-10#1)(1996-5#2)(1997-2#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-9#1)(2008-10#6)(2008-2#4)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-4#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
than appreciated##2##2##(2006-2#1)(2007-8#1)
than approximately 0##3##3##(2008-3#2)(2010-4#1)
than approximately 10%##2##3##(1990-2#1)(2008-2#1)
than approximately 5 degrees##2##4##(2008-3#2)
than approximately 5##3##3##(2008-3#3)
than approximately 5%##2##3##(2008-3#2)
than approximately##26##2##(1990-2#1)(1997-5#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#13)(2008-5#2)(2010-4#1)
than are available##2##3##(2008-4#1)(2008-9#1)
than are other##3##3##(1993-7#1)(1996-12#1)(2008-4#1)
than are the##4##3##(1991-9#1)(1997-2#1)(2008-10#1)(2008-8#1)
than are their##2##3##(1996-3#1)(2008-3#1)
than are##33##2##(1991-5#2)(1991-9#1)(1992-12#1)(1993-2#1)(1993-6#1)(1993-7#1)(1996-12#2)(1996-3#1)(1996-9#1)(1997-2#1)(1997-7#1)(2004-9#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-3#2)(2008-4#2)(2008-8#1)(2008-9#2)(2009-6#1)(2010-5#1)(2010-8#1)(2013-7#1)(2013-8#1)
than as a##10##3##(1990-5#1)(2006-3#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#2)(2008-7#1)
than as an##5##3##(1996-3#1)(2008-7#1)(2009-12#1)(2013-1#2)
than as the##4##3##(1990-11#1)(1995-8#1)(2008-11#2)
than as##27##2##(1990-11#1)(1990-5#1)(1991-5#1)(1995-8#1)(1996-3#1)(1996-8#1)(2005-10#1)(2006-3#1)(2006-8#2)(2008-10#4)(2008-11#3)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-12#1)(2011-12#1)(2013-1#2)
than aspirin alone##2##3##(2007-10#1)(2010-9#1)
than aspirin in##3##3##(2007-10#2)(2008-8#1)
than aspirin##8##2##(2007-10#3)(2008-5#1)(2008-8#3)(2010-9#1)
than assumed##2##2##(1997-6#1)(2008-1#1)
than asthma##2##2##(2005-8#1)(2010-10#1)
than asymptomatic##2##2##(1990-7#1)(2012-12#1)
than at 20##2##3##(1991-5#1)(2006-2#1)
than at 4##2##3##(1992-7#1)(2008-10#1)
than at ED##2##3##(1993-3#2)
than at a##2##3##(1990-10#1)(2008-10#1)
than at any other time##2##5##(2008-5#1)(2013-1#1)
than at any time##2##4##(1991-12#1)(2007-4#1)
than at any##4##3##(1991-12#1)(2007-4#1)(2008-5#1)(2013-1#1)
than at high##4##3##(1994-12#1)(2004-4#1)(2005-10#1)(2008-10#1)
than at higher##3##3##(1991-2#1)(2008-10#1)(2008-8#1)
than at low##2##3##(1992-8#1)(2008-10#1)
than at pH##4##3##(2008-10#2)(2008-5#1)(2013-1#1)
than at the beginning##2##4##(1993-9#1)(2008-10#1)
than at the nearby non-AP site##2##6##(2008-10#2)
than at the same time before Ramadan##2##7##(2006-2#2)
than at the##21##3##(1993-9#1)(1994-9#1)(1996-6#2)(2006-2#2)(2006-4#1)(2006-7#1)(2007-10#1)(2007-4#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-5#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
than at##97##2##(1990-10#1)(1990-4#1)(1990-7#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-3#4)(1993-9#1)(1994-12#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-6#2)(1996-8#2)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#2)(2004-4#1)(2005-10#1)(2006-10#1)(2006-2#3)(2006-4#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-9#1)(2008-10#18)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#3)(2008-8#2)(2008-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#2)
than at-risk##2##2##(1997-5#1)(2007-12#1)
than athletes with a##2##4##(2012-1#2)
than attempting to##3##3##(2005-7#1)(2008-4#1)(2010-10#1)
than automated##2##2##(2008-10#1)(2011-2#1)
than available##3##2##(1991-1#1)(2013-1#2)
than average##6##2##(1991-5#1)(1994-11#1)(2007-12#2)(2008-9#1)(2010-12#1)
than babies##2##2##(1994-2#1)(2007-2#1)
than bacteria that##2##3##(2006-8#1)(2008-10#1)
than bacterial##2##2##(1993-9#1)(2008-10#1)
than basal##3##2##(2008-10#2)(2011-2#1)
than baseline##2##2##(1990-11#1)(1992-11#1)
than be##2##2##(2004-9#1)(2008-11#1)
than before##15##2##(1991-12#1)(1991-6#1)(1994-1#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-5#1)(2009-6#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#1)
than being a simple##2##4##(2007-7#1)(2008-2#1)
than being a##3##3##(1994-9#1)(2007-7#1)(2008-2#1)
than being##20##2##(1990-5#1)(1991-8#1)(1994-9#1)(1995-3#1)(2006-3#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#2)(2008-4#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
than benefit##2##2##(1994-3#1)(2006-12#1)
than beta##4##2##(1991-5#1)(1991-8#1)(1992-2#1)(2007-8#1)
than between either##2##3##(2008-10#1)(2013-1#1)
than between the##3##3##(1997-6#1)(2008-10#1)(2010-10#1)
than between##14##2##(1992-12#1)(1993-11#1)(1997-4#1)(1997-6#2)(2006-10#1)(2008-10#4)(2008-11#2)(2010-10#1)(2013-1#1)
than biological##2##2##(2008-10#1)(2009-2#1)
than birds##2##2##(2005-9#1)(2008-8#1)
than black##3##2##(2008-10#1)(2012-12#2)
than blood##3##2##(1992-1#1)(1994-11#1)(2007-8#1)
than bone marrow##2##3##(2007-11#1)(2012-12#1)
than bone##4##2##(2006-8#1)(2007-11#1)(2011-2#1)(2012-12#1)
than both the##5##3##(1994-3#1)(2007-6#1)(2008-2#1)(2008-7#1)(2009-4#1)
than both##11##2##(1994-3#1)(1997-2#1)(2005-11#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-4#2)(2010-8#1)(2013-1#1)
than bovine##2##2##(1990-9#1)(2006-11#1)
than boys##12##2##(1990-2#2)(1992-8#1)(1994-12#1)(2007-12#1)(2009-12#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-1#2)(2012-2#1)
than breast cancer##3##3##(1991-10#1)(1991-12#1)(2007-9#1)
than breast##4##2##(1991-10#1)(1991-12#1)(1993-6#1)(2007-9#1)
than bupivacaine alone##2##3##(2007-2#1)(2011-2#1)
than bupivacaine##3##2##(2006-10#1)(2007-2#1)(2011-2#1)
than by a##6##3##(1995-12#2)(1996-12#1)(2007-8#1)(2008-10#1)(2008-3#1)
than by an##2##3##(1996-7#1)(2011-2#1)
than by any##2##3##(1996-7#1)(2008-6#1)
than by the##14##3##(1990-7#1)(1991-6#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-6#1)(2005-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-7#1)(2012-3#1)
than by their##2##3##(2008-3#1)(2008-4#1)
than by using##2##3##(1992-1#1)(2012-3#1)
than by##73##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-7#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-1#1)(1992-6#2)(1993-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-11#1)(1995-12#2)(1996-11#1)(1996-12#1)(1996-5#2)(1996-6#1)(1996-7#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-5#2)(2007-1#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-12#1)(2009-6#1)(2010-1#1)(2010-2#1)(2010-6#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
than cDDP##2##2##(1990-5#2)
than ca##2##2##(2007-8#1)(2008-10#1)
than calculated##2##2##(2008-10#1)(2008-2#1)
than calculating##2##2##(1996-12#1)(2008-2#1)
than can be accounted for by##2##6##(2006-10#1)(2010-5#1)
than can be achieved##3##4##(2008-3#1)(2008-4#1)(2013-1#1)
than can be obtained##4##4##(2008-2#1)(2008-4#2)(2008-5#1)
than can be##16##3##(1996-4#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#1)(2010-5#1)(2010-8#1)(2013-1#1)
than can##18##2##(1996-4#1)(1997-5#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#1)(2010-5#1)(2010-8#1)(2013-1#1)
than carbide##2##2##(2008-4#2)
than caregivers without##2##3##(2010-7#2)
than caregivers##3##2##(2010-7#3)
than cases##2##2##(1991-11#1)(2007-2#1)
than cathepsin##2##2##(1990-6#1)(1991-8#1)
than cell##2##2##(1993-2#1)(2008-10#1)
than cells##9##2##(1991-8#1)(1993-6#1)(1994-3#1)(1994-6#1)(1996-3#1)(2008-11#3)(2012-2#1)
than change##2##2##(1994-5#1)(1996-7#1)
than chicken##2##2##(1990-5#1)(2008-5#1)
than children in the##2##4##(1996-2#1)(2012-2#1)
than children in##3##3##(1995-5#1)(1996-2#1)(2012-2#1)
than children of##2##3##(1994-6#1)(2008-1#1)
than children whose parents##2##4##(1994-6#1)(2005-10#1)
than children with##2##3##(2005-8#1)(2006-10#1)
than children##15##2##(1994-6#2)(1995-1#1)(1995-5#1)(1996-2#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-11#1)(2009-11#1)(2010-3#1)(2012-1#1)(2012-2#1)
than chitosans (CDNP98 &gt##2##4##(2010-12#2)
than chitosans##3##2##(2010-12#3)
than choosing##2##2##(2011-12#1)(2011-2#1)
than chronologic##2##2##(2007-10#1)(2011-1#1)
than cisplatin in##3##3##(2008-3#1)(2012-12#1)(2013-1#1)
than cisplatin##8##2##(1990-5#1)(2008-3#1)(2008-5#3)(2012-12#1)(2012-2#1)(2013-1#1)
than classic##3##2##(1992-8#1)(2008-1#2)
than classical##8##2##(1990-9#1)(1991-10#1)(1996-10#1)(1996-2#1)(2008-7#1)(2010-4#1)(2012-2#1)(2013-1#1)
than clinical##9##2##(1997-3#1)(2005-10#1)(2007-3#1)(2008-10#2)(2008-7#1)(2010-1#1)(2013-1#2)
than clioquinol cream or zinc paste##2##6##(2013-8#2)
than clopidogrel##2##2##(2008-8#1)(2010-9#1)
than cocaine##2##2##(1991-12#1)(1996-6#1)
than combinations##3##2##(1995-9#1)(2007-11#1)(2009-6#1)
than commercial##3##2##(2004-9#1)(2007-8#1)(2008-10#1)
than commercially##2##2##(1994-12#2)
than common##5##2##(1997-3#2)(2008-8#1)(2012-3#1)(2013-1#1)
than commonly used##2##3##(2007-11#1)(2008-3#1)
than commonly##4##2##(2007-11#1)(2008-11#1)(2008-3#1)(2009-11#1)
than community##3##2##(1996-9#1)(1997-1#1)(2006-8#1)
than comparison##3##2##(2004-11#1)(2006-3#1)(2011-2#1)
than competing##2##2##(2012-1#1)(2013-7#1)
than competitive##2##2##(1992-10#1)(2006-10#1)
than complete##2##2##(2005-11#1)(2009-2#1)
than completely##2##2##(2007-11#1)(2008-9#1)
than concentration of##2##3##(2008-10#1)(2011-2#1)
than concentrations##3##2##(2004-4#1)(2008-10#1)(2011-2#1)
than conidia##2##2##(2008-10#2)
than constant##2##2##(2008-10#1)(2012-2#1)
than continuous##3##2##(1991-3#1)(2007-9#2)
than control and##2##3##(2008-10#1)(2008-12#1)
than control cells##6##3##(1994-8#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-12#1)(2012-3#1)
than control group##2##3##(2006-8#1)(2009-6#1)
than control regions##2##3##(2009-8#1)(2009-9#1)
than control samples##3##3##(1994-3#1)(1996-8#1)(2010-4#1)
than control subjects##5##3##(1991-8#1)(2006-3#1)(2007-9#1)(2011-2#1)(2013-1#1)
than control values##3##3##(2008-8#1)(2009-11#1)(2013-1#1)
than control##47##2##(1991-8#2)(1992-9#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-12#2)(2006-3#1)(2006-8#2)(2007-11#1)(2007-9#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-4#2)(2011-2#1)(2012-3#1)(2013-1#3)
than controls and patients with##2##5##(1991-10#1)(2008-7#1)
than controls and patients##3##4##(1991-10#1)(2007-10#1)(2008-7#1)
than controls and##6##3##(1991-10#1)(2006-12#1)(2007-10#1)(2008-7#1)(2012-12#1)(2013-7#1)
than controls in the##2##4##(1993-12#1)(1997-4#1)
than controls in##6##3##(1993-12#1)(1997-4#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
than controls on the##2##4##(2010-8#1)(2012-3#1)
than controls on##6##3##(2008-3#1)(2009-1#2)(2009-4#1)(2010-8#1)(2012-3#1)
than controls##71##2##(1990-5#1)(1991-1#3)(1991-10#1)(1991-12#1)(1991-3#1)(1991-8#1)(1991-9#2)(1992-2#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-3#1)(1994-8#1)(1995-2#1)(1995-7#1)(1996-10#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-5#1)(2006-10#1)(2006-12#1)(2006-6#2)(2006-8#3)(2007-10#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2009-1#2)(2009-4#2)(2009-7#1)(2010-2#1)(2010-8#1)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#1)
than conventional methods##3##3##(2006-8#1)(2008-10#1)(2010-8#1)
than conventional procedures##2##3##(2006-6#1)(2012-3#1)
than conventional##53##2##(1992-3#1)(1992-8#1)(1994-2#1)(1994-4#1)(1995-6#1)(2004-12#1)(2006-12#1)(2006-6#4)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#2)(2011-7#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
than conventionally##3##2##(2008-10#2)(2010-4#1)
than copper##2##2##(2008-10#1)(2012-2#1)
than corresponding values##2##3##(1990-4#1)(2007-2#1)
than corresponding##9##2##(1990-4#1)(1991-12#1)(1991-8#1)(1992-3#1)(1995-7#1)(2007-2#1)(2008-2#1)(2008-5#1)(2008-9#1)
than could be##5##3##(1994-11#1)(1994-12#1)(2009-5#1)(2011-1#1)(2013-1#1)
than could##7##2##(1992-3#1)(1994-11#1)(1994-12#1)(1997-4#1)(2009-5#1)(2011-1#1)(2013-1#1)
than culture##2##2##(2008-2#1)(2008-5#1)
than cultures##2##2##(2006-7#1)(2008-6#1)
than cure##3##2##(2007-11#1)(2008-3#1)(2013-7#1)
than current models of##2##4##(1991-11#1)(2013-8#1)
than current##10##2##(1991-11#1)(1993-6#1)(1994-12#1)(1997-4#1)(2006-10#1)(2006-2#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
than currently##3##2##(1996-11#1)(2006-11#1)(2007-10#1)
than cyclosporin##3##2##(2007-11#3)
than cytology##2##2##(2006-10#1)(2006-9#1)
than cytoplasmic##2##2##(2006-10#1)(2008-8#1)
than data##3##2##(2008-4#1)(2009-4#1)(2012-1#1)
than decrease##2##2##(2008-3#1)(2011-1#1)
than delta##3##2##(1990-2#1)(1991-9#1)(1995-6#1)
than demographic##2##2##(2010-6#1)(2010-8#1)
than desirable##2##2##(1991-6#1)(2011-1#1)
than detection##4##2##(1990-12#1)(2008-10#1)(2009-8#1)(2011-2#1)
than devices##2##2##(2007-12#1)(2008-7#1)
than dialysis##2##2##(2007-8#1)(2008-10#1)
than did D##3##3##(2008-10#3)
than did adult##2##3##(1991-12#1)(1994-3#1)
than did control##2##3##(1993-3#1)(1995-3#1)
than did controls##4##3##(1991-12#1)(1992-2#1)(1994-10#1)(2008-4#1)
than did either##2##3##(1990-10#1)(1995-3#1)
than did males##2##3##(2008-10#1)(2011-12#1)
than did parents of##2##4##(1993-3#1)(2009-7#1)
than did patients##3##3##(1990-6#1)(2007-11#1)(2008-3#1)
than did similar##2##3##(1990-5#1)(1994-9#1)
than did the adherent populations##2##5##(2008-10#2)
than did the untreated controls##2##5##(1997-4#2)
than did the untreated##3##4##(1997-4#2)(2008-11#1)
than did the##39##3##(1991-12#2)(1992-1#1)(1992-5#1)(1992-8#1)(1993-3#1)(1993-5#1)(1994-9#2)(1995-2#1)(1995-5#1)(1997-4#2)(1997-8#1)(2004-11#1)(2006-10#1)(2006-7#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-9#2)(2010-2#2)(2011-2#1)(2012-3#1)(2013-1#1)
than did their##5##3##(1997-3#1)(2006-4#1)(2006-7#1)(2008-10#1)(2008-9#1)
than did those with##2##4##(2004-11#2)
than did those##8##3##(1992-4#1)(1994-10#1)(1996-11#1)(2004-11#3)(2008-11#1)(2013-8#1)
than did women who had##2##5##(1994-2#1)(2007-12#1)
than did##163##2##(1990-10#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-6#2)(1990-9#1)(1991-10#1)(1991-12#4)(1991-2#1)(1991-3#1)(1992-1#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#4)(1993-5#1)(1993-9#1)(1994-1#1)(1994-10#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-8#2)(1996-9#1)(1997-3#1)(1997-4#2)(1997-6#3)(1997-8#2)(2004-11#4)(2006-10#1)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#3)(2008-10#30)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#7)(2009-10#1)(2009-11#2)(2009-4#2)(2009-5#1)(2009-7#1)(2010-2#2)(2010-9#2)(2011-12#2)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
than differences in##4##3##(1993-2#1)(1993-3#1)(2004-4#1)(2007-8#1)
than differences##6##2##(1993-2#1)(1993-3#1)(1997-6#1)(2004-4#1)(2007-8#1)(2008-11#1)
than differentiated##2##2##(1994-3#1)(2011-2#1)
than differentiation##2##2##(1996-11#1)(2008-10#1)
than digital##2##2##(2008-7#1)(2009-5#1)
than diploids##2##2##(2008-11#1)(2008-9#1)
than direct##10##2##(1991-12#1)(1992-3#1)(2006-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2012-1#1)
than directly##4##2##(2007-12#1)(2008-1#1)(2009-5#1)(2012-6#1)
than disease##3##2##(2012-1#2)(2013-8#1)
than diuretics##2##2##(1992-4#1)(1993-2#1)
than do other##3##3##(1990-12#1)(2008-7#1)(2012-1#1)
than do the other##2##4##(1995-1#1)(2008-1#1)
than do the##7##3##(1993-12#2)(1994-2#1)(1995-1#1)(2008-1#1)(2008-3#2)
than do those of any##2##5##(1991-5#2)
than do those of##3##4##(1991-5#2)(1995-8#1)
than do##52##2##(1990-12#3)(1991-1#1)(1991-11#1)(1991-5#2)(1991-7#1)(1993-12#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-3#1)(1997-4#1)(2005-10#2)(2006-7#2)(2007-1#1)(2007-12#4)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#5)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
than does a##2##3##(2008-9#1)(2009-5#1)
than does the wild-type##2##4##(1994-9#1)(2006-12#1)
than does the##12##3##(1994-9#1)(1995-11#1)(1995-3#1)(1996-10#1)(1997-3#1)(2006-12#1)(2008-3#4)(2009-4#1)(2010-9#1)
than does##40##2##(1991-12#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-4#1)(1993-2#2)(1993-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-9#1)(1996-10#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-3#1)(2004-1#1)(2006-12#1)(2006-9#1)(2007-10#1)(2008-1#1)(2008-3#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-8#1)(2010-9#3)(2012-1#1)
than dog##2##2##(2013-1#2)
than dogs##2##2##(2012-2#2)
than dominants##4##2##(1992-1#2)(2008-8#1)(2010-8#1)
than doxorubicin##2##2##(1997-1#1)(2011-2#1)
than dried##2##2##(2008-7#1)(2011-2#1)
than drug##4##2##(1991-2#1)(2010-6#1)(2010-8#1)(2011-2#1)
than during most##2##3##(2006-10#2)
than during the##5##3##(1995-11#1)(1996-3#1)(2004-4#1)(2006-8#1)(2007-9#1)
than during##25##2##(1990-7#1)(1992-1#1)(1992-5#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-11#1)(1996-3#1)(2004-4#1)(2006-10#2)(2006-8#2)(2007-9#3)(2008-11#1)(2009-12#1)(2009-7#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
than each of the##2##4##(2008-10#2)
than each##7##2##(1992-11#1)(1995-3#1)(1996-12#1)(1997-2#1)(2008-10#2)(2008-3#1)
than earlier##7##2##(1992-4#1)(1993-12#1)(1995-6#1)(2006-5#1)(2008-10#2)(2008-3#1)
than early##2##2##(1992-7#1)(2008-2#1)
than eight##7##2##(1990-2#1)(1990-4#2)(1992-5#1)(1995-7#1)(2008-10#1)(2008-9#1)
than either agent alone##2##4##(1994-11#1)(1997-1#1)
than either agent##3##3##(1994-11#1)(1997-1#1)(2007-8#1)
than either of the##4##4##(1990-7#1)(1991-1#1)(2008-5#1)(2008-9#1)
than either of##5##3##(1990-7#1)(1991-1#1)(2006-4#1)(2008-5#1)(2008-9#1)
than either the##4##3##(1995-1#1)(2005-11#1)(2007-11#1)(2012-2#1)
than either treatment alone##4##4##(2008-10#2)(2009-8#1)(2013-1#1)
than either##43##2##(1990-7#2)(1991-1#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-11#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-4#1)(2007-11#2)(2007-8#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-5#3)(2008-9#1)(2009-3#1)(2009-8#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
than elsewhere##2##2##(1992-9#1)(2011-2#1)
than empty##2##2##(2006-12#1)(2012-1#1)
than endogenous##2##2##(1997-4#1)(2008-11#1)
than enhanced##3##2##(1992-8#1)(2008-1#1)(2008-4#1)
than environment##2##2##(1992-1#1)(2008-8#1)
than eperezolid##2##2##(2006-8#2)
than etidronate##2##2##(2008-11#2)
than ever before##11##3##(1991-12#1)(1991-2#1)(1994-3#1)(1995-5#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-4#1)(2012-12#1)
than ever for##2##3##(1992-6#1)(2010-6#1)
than ever in##2##3##(2008-3#1)(2012-3#1)
than ever to##3##3##(2005-3#1)(2008-1#1)(2008-4#1)
than ever##35##2##(1991-12#1)(1991-2#1)(1991-3#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-2#1)(1994-3#1)(1995-5#1)(2005-3#1)(2006-10#2)(2006-3#1)(2006-9#2)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
than every##2##2##(1991-8#1)(2006-5#1)
than exercise##2##2##(2007-6#1)(2009-10#1)
than existing methods##3##3##(1995-8#1)(2007-12#1)(2013-8#1)
than existing##6##2##(1995-8#1)(1997-2#1)(2007-12#2)(2011-9#1)(2013-8#1)
than expected among##2##3##(1997-2#1)(2006-10#1)
than expected based on##2##4##(1995-1#1)(2008-10#1)
than expected because##2##3##(2008-3#1)(2008-7#1)
than expected births are##2##4##(2012-1#2)
than expected by chance##2##4##(2008-10#1)(2012-3#1)
than expected by##4##3##(2007-8#2)(2008-10#1)(2012-3#1)
than expected from the##4##4##(1990-11#1)(1995-10#1)(2005-10#1)(2008-10#1)
than expected from##8##3##(1990-11#1)(1993-2#1)(1995-10#1)(1995-11#1)(2005-10#1)(2005-11#1)(2008-10#1)(2008-8#1)
than expected in the##2##4##(2008-7#1)(2008-8#1)
than expected in##8##3##(1990-12#1)(1992-2#2)(2006-10#1)(2008-7#3)(2008-8#1)
than expected levels##2##3##(1990-5#1)(2009-8#1)
than expected number of##2##4##(2011-2#1)(2013-1#1)
than expected number##3##3##(1996-12#1)(2011-2#1)(2013-1#1)
than expected on the basis of##2##6##(1990-5#1)(2010-4#1)
than expected values##2##3##(2007-7#1)(2008-10#1)
than expected were##2##3##(2006-5#1)(2008-10#1)
than expected##78##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#2)(1992-1#1)(1992-2#2)(1992-3#1)(1993-2#1)(1993-5#1)(1995-1#1)(1995-10#1)(1995-11#2)(1996-12#2)(1996-3#1)(1996-9#1)(1997-2#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-5#1)(2007-1#1)(2007-7#1)(2007-8#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
than experienced##2##2##(1996-6#1)(2013-7#1)
than experiments##2##2##(1995-4#1)(2008-7#1)
than exposure##2##2##(2008-5#1)(2011-1#1)
than external##2##2##(1992-12#1)(1994-4#1)
than extracts from##2##3##(1996-11#1)(1997-1#1)
than family caregivers of##2##4##(2009-7#2)
than fasting##2##2##(2008-3#1)(2011-2#1)
than fat##4##2##(1997-8#1)(2005-8#1)(2007-12#1)(2010-4#1)
than female##6##2##(1991-3#1)(1995-12#1)(1997-5#1)(2007-2#1)(2013-1#1)(2013-8#1)
than females in##2##3##(2008-12#1)(2008-9#1)
than females who##2##3##(1995-2#1)(2012-12#1)
than females##48##2##(1995-2#1)(1995-6#1)(1996-5#1)(2006-10#2)(2006-2#2)(2007-10#1)(2007-12#3)(2007-2#3)(2007-7#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#4)(2013-1#1)(2013-7#1)
than fertile##2##2##(2008-12#1)(2013-7#1)
than first##2##2##(2006-8#1)(2008-12#1)
than five years##3##3##(1991-8#1)(2006-8#1)(2011-11#1)
than five##17##2##(1990-7#1)(1991-2#1)(1991-8#1)(1994-5#1)(1995-8#1)(1996-3#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-2#1)(2008-5#1)(2010-4#1)(2011-11#1)
than food##2##2##(2007-3#1)(2008-8#1)
than for Hispanics##2##3##(2005-10#1)(2012-12#1)
than for P##2##3##(2007-8#1)(2008-10#1)
than for a##5##3##(1994-7#1)(1996-11#1)(1997-1#1)(2008-10#2)
than for any other##3##4##(1994-6#1)(2004-4#1)(2008-4#1)
than for any##7##3##(1994-6#1)(1997-5#1)(2004-4#1)(2005-7#1)(2006-3#1)(2008-4#1)(2008-5#1)
than for males##3##3##(1993-9#1)(1994-3#1)(2006-8#1)
than for men##2##3##(2008-11#1)(2011-2#1)
than for more##2##3##(2008-2#1)(2008-9#1)
than for older##2##3##(1997-3#1)(2011-2#1)
than for other##6##3##(1990-5#1)(1996-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2011-2#1)
than for that of##2##4##(2008-10#2)
than for the case of##2##5##(1995-2#1)(2008-3#1)
than for the other species##2##5##(2008-10#1)(2012-5#1)
than for the other##6##4##(1994-9#1)(2008-10#2)(2011-2#1)(2012-1#1)(2012-5#1)
than for the two##2##4##(1992-1#1)(2005-11#1)
than for the##76##3##(1990-2#2)(1990-8#1)(1991-11#1)(1992-1#1)(1992-2#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-8#1)(1994-3#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-11#2)(1996-12#2)(1996-2#2)(1997-4#1)(1997-7#1)(2004-3#1)(2004-8#2)(2005-10#1)(2005-11#1)(2006-4#1)(2006-5#1)(2007-11#2)(2007-12#3)(2007-5#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#9)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-7#1)
than for those that##2##4##(2008-10#2)
than for those##11##3##(1990-8#1)(1995-11#1)(2004-11#1)(2006-5#1)(2007-11#1)(2008-10#2)(2008-8#1)(2011-2#1)(2013-1#2)
than for urban##2##3##(2011-2#1)(2012-1#1)
than for women##3##3##(1992-5#1)(2012-12#1)(2013-7#1)
than for##286##2##(1990-11#2)(1990-2#2)(1990-3#1)(1990-4#4)(1990-5#1)(1990-6#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#3)(1991-4#3)(1991-8#2)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-5#2)(1992-7#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-2#1)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#3)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#2)(1996-11#7)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#1)(1996-7#2)(1997-1#4)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(2004-11#1)(2004-2#1)(2004-3#1)(2004-4#1)(2004-8#2)(2005-10#2)(2005-11#2)(2005-12#2)(2005-7#2)(2006-10#1)(2006-11#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#5)(2006-8#4)(2007-10#1)(2007-11#3)(2007-12#10)(2007-2#1)(2007-4#2)(2007-5#2)(2007-7#2)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#36)(2008-11#3)(2008-12#2)(2008-2#7)(2008-3#6)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#9)(2009-11#2)(2009-6#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-4#3)(2010-8#1)(2011-2#10)(2012-1#2)(2012-12#2)(2012-2#10)(2012-3#1)(2012-5#1)(2013-1#3)(2013-7#2)(2013-8#2)
than formerly##2##2##(1992-8#1)(1995-5#1)
than found in##4##3##(1991-2#1)(1993-8#1)(2006-8#1)(2008-11#1)
than found##5##2##(1991-2#1)(1991-5#1)(1993-8#1)(2006-8#1)(2008-11#1)
than four months##3##3##(1992-11#1)(2008-10#2)
than four years##3##3##(1992-4#1)(1993-6#1)(1993-7#1)
than four##36##2##(1990-12#2)(1990-4#1)(1992-11#1)(1992-4#1)(1993-6#1)(1993-7#1)(1994-12#1)(1995-4#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-3#1)(2008-10#7)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#4)(2012-3#1)
than free##4##2##(1990-3#1)(1995-12#1)(2008-3#1)(2008-5#1)
than frequency##2##2##(2008-3#1)(2010-8#1)
than fresh TGM##2##3##(1997-2#2)
than fresh##3##2##(1996-3#1)(1997-2#2)
than from a##3##3##(2006-11#1)(2007-11#1)(2007-12#1)
than from an aqueous##2##4##(2008-5#2)
than from an##4##3##(1997-1#1)(2008-5#2)(2011-1#1)
than from single##2##3##(2008-8#1)(2011-1#1)
than from the##4##3##(2007-12#1)(2008-10#1)(2008-7#1)(2009-10#1)
than from##39##2##(1991-9#1)(1992-6#1)(1996-11#2)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-11#1)(2006-3#1)(2006-5#2)(2007-11#1)(2007-12#2)(2008-10#6)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-2#1)(2011-1#3)(2011-12#1)(2011-2#2)(2013-8#1)
than gamma##4##2##(1990-8#1)(1991-1#1)(1991-8#1)(1995-5#1)
than general anesthesia##3##3##(1996-12#1)(2006-10#1)(2013-8#1)
than general##11##2##(1991-2#1)(1993-4#1)(1993-5#1)(1996-12#1)(1996-9#1)(2006-10#2)(2009-4#1)(2013-1#2)(2013-8#1)
than generally appreciated##2##3##(1997-8#1)(2005-8#1)
than generally##8##2##(1994-3#1)(1995-11#1)(1997-8#1)(2004-12#1)(2005-8#1)(2006-10#2)(2012-2#1)
than generating##2##2##(2008-11#1)(2008-2#1)
than genetic##3##2##(2005-12#1)(2008-7#1)(2008-8#1)
than girls on##2##3##(2008-12#1)(2009-7#1)
than girls who experienced less sexism##2##6##(2011-1#2)
than girls##15##2##(2006-2#1)(2006-8#1)(2007-12#2)(2007-7#1)(2008-12#1)(2009-7#1)(2011-1#3)(2011-2#1)(2013-1#2)(2013-7#2)
than giving##2##2##(2009-10#1)(2010-11#1)
than glucagon##2##2##(1991-12#2)
than glucose##4##2##(1994-12#1)(1996-12#1)(1997-7#1)(2006-12#1)
than glutamate##2##2##(1991-5#1)(1997-5#1)
than glycine##2##2##(1991-11#1)(2006-3#1)
than good##3##2##(2006-12#1)(2008-11#1)(2012-2#1)
than gram##2##2##(1997-4#1)(2011-2#1)
than graphite##2##2##(2008-10#1)(2009-2#1)
than group 1##3##3##(2008-7#1)(2009-6#2)
than group 2##2##3##(1990-9#1)(2009-5#1)
than group A##3##3##(2004-11#1)(2008-1#2)
than group B1 RBCs##2##4##(1993-3#2)
than group##17##2##(1990-9#1)(1993-3#4)(1994-11#1)(2004-11#1)(2007-8#1)(2008-1#2)(2008-7#1)(2009-5#1)(2009-6#2)(2011-2#1)(2012-3#1)(2013-8#1)
than growth##2##2##(1994-1#1)(2013-1#1)
than had been##2##3##(1993-7#1)(2008-10#1)
than had previously been##2##4##(2008-11#1)(2008-2#1)
than had##4##2##(1993-7#1)(2008-10#1)(2008-11#1)(2008-2#1)
than half a million##2##4##(2007-9#1)(2008-5#1)
than half a##5##3##(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)
than half are##2##3##(2008-10#1)(2012-2#1)
than half had##2##3##(1991-9#1)(2011-12#1)
than half of all##3##4##(2006-8#1)(2008-1#1)(2012-2#1)
than half of the N-terminal##2##5##(1990-7#1)(2008-7#1)
than half of the patients were##2##6##(1990-4#1)(1990-9#1)
than half of the patients##8##5##(1990-4#1)(1990-9#1)(1992-6#1)(2007-12#1)(2010-12#1)(2012-3#1)(2013-1#2)
than half of the population##2##5##(2008-3#1)(2011-1#1)
than half of the reported##2##5##(2007-7#1)(2008-5#1)
than half of the sample##3##5##(2007-8#1)(2008-1#1)(2011-2#1)
than half of the##49##4##(1990-2#1)(1990-4#1)(1990-7#1)(1990-9#1)(1991-5#1)(1992-6#1)(1995-6#3)(1996-10#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#3)(2011-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
than half of these##3##4##(2007-7#1)(2011-1#1)(2012-2#1)
than half of##72##3##(1990-2#1)(1990-4#1)(1990-7#1)(1990-9#1)(1991-5#1)(1992-6#1)(1993-5#1)(1994-2#1)(1995-6#3)(1996-10#1)(2004-11#1)(2006-2#1)(2006-8#2)(2007-10#2)(2007-12#2)(2007-2#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#5)(2011-2#6)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
than half the##17##3##(1990-11#1)(1990-4#1)(1992-11#1)(1993-2#1)(1993-8#2)(1994-12#1)(1995-5#1)(1997-4#1)(1997-7#1)(2005-7#1)(2006-10#1)(2008-2#1)(2008-3#1)(2010-2#1)(2011-2#1)(2013-1#1)
than half##121##2##(1990-11#1)(1990-2#1)(1990-4#2)(1990-7#1)(1990-9#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-5#1)(1992-6#2)(1993-2#1)(1993-5#1)(1993-8#2)(1994-12#1)(1994-2#1)(1995-5#1)(1995-6#3)(1996-10#1)(1996-3#1)(1996-9#1)(1997-4#1)(1997-7#1)(2004-10#1)(2004-11#1)(2004-12#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-8#2)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#3)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#5)(2008-7#1)(2008-8#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#8)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#6)(2013-8#1)
than haloperidol##3##2##(2005-8#1)(2006-12#2)
than has been previously##2##4##(2007-5#1)(2008-8#1)
than has been reported##3##4##(1992-2#1)(2006-10#1)(2010-2#1)
than has been##11##3##(1991-9#1)(1992-2#1)(1992-9#1)(1993-9#1)(2006-10#1)(2006-4#1)(2007-5#1)(2008-8#3)(2010-2#1)
than has previously been##2##4##(2012-3#1)(2013-8#1)
than has##14##2##(1990-8#1)(1991-9#1)(1992-2#1)(1992-9#1)(1993-9#1)(2006-10#1)(2006-4#1)(2007-5#1)(2008-8#3)(2010-2#1)(2012-3#1)(2013-8#1)
than have been##2##3##(2008-10#1)(2008-3#1)
than have##4##2##(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)
than having a##2##3##(2012-2#1)(2013-1#1)
than having to##2##3##(1991-10#1)(1997-5#1)
than having##7##2##(1991-10#1)(1995-1#1)(1997-5#1)(2006-10#1)(2012-2#2)(2013-1#1)
than healthy controls##2##3##(2006-6#1)(2012-2#1)
than healthy people##2##3##(1990-7#1)(1991-6#1)
than healthy subjects##3##3##(1996-1#1)(2009-9#1)(2010-4#1)
than healthy volunteers##2##3##(1990-7#1)(2007-8#1)
than healthy##15##2##(1990-7#2)(1991-6#2)(1993-2#1)(1995-9#1)(1996-1#1)(2006-6#1)(2007-8#1)(2008-10#1)(2009-5#1)(2009-9#1)(2010-4#1)(2010-9#1)(2012-2#1)
than heart##2##2##(1991-3#1)(2006-10#1)
than heparin##3##2##(2007-11#2)(2011-12#1)
than high school##3##3##(1990-12#2)(2007-11#1)
than high##7##2##(1990-12#2)(1990-5#1)(1992-3#1)(2007-1#1)(2007-11#1)(2008-4#1)
than higher##2##2##(2006-10#1)(2007-11#1)
than highly purified##2##3##(1996-7#1)(2007-11#1)
than hitherto##2##2##(1997-3#1)(2012-7#1)
than homosexual##2##2##(1991-3#1)(1993-6#1)
than hospitals##2##2##(1992-12#1)(1993-3#1)
than host##2##2##(2011-2#2)
than human insulin##2##3##(1997-8#2)
than human##10##2##(1990-11#1)(1992-2#1)(1993-2#1)(1997-8#2)(2006-10#1)(2007-11#1)(2008-6#1)(2008-7#1)(2012-2#1)
than hydrophobic##2##2##(1993-11#1)(1995-8#1)
than hydroxyapatite##2##2##(2011-2#1)(2013-8#1)
than ideal##6##2##(1996-1#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-5#1)(2012-2#1)
than if the##2##3##(2008-10#1)(2008-3#1)
than if they##2##3##(2008-7#1)(2009-12#1)
than if##7##2##(1993-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-12#1)
than immediate##3##2##(1993-10#1)(2007-2#1)(2011-2#1)
than in 1999##2##3##(2011-2#1)(2012-3#1)
than in 2-cell##2##3##(1992-6#1)(1994-3#1)
than in 3-month-old rats##2##4##(1991-12#1)(1991-2#1)
than in 3-month-old##3##3##(1991-12#1)(1991-2#1)(1995-1#1)
than in 87##2##3##(1996-11#2)
than in C##10##3##(2005-1#1)(2010-2#9)
than in CSW2-amended##2##3##(2008-10#2)
than in Caucasian##2##3##(1996-11#1)(2010-3#1)
than in Europe##4##3##(2008-10#2)(2008-8#2)
than in G-1##2##3##(1996-9#2)
than in G-2##2##3##(1996-9#2)
than in Group S##2##4##(2010-7#2)
than in Group##4##3##(2006-5#1)(2007-8#1)(2010-7#2)
than in M##2##3##(1993-4#1)(2009-5#1)
than in MRL(+/+) mice##3##4##(2008-10#3)
than in MSA-P##3##3##(2008-7#3)
than in May##2##3##(2008-10#1)(2008-4#1)
than in NCH##2##3##(2012-3#2)
than in OXP rats##2##4##(2004-11#2)
than in P##2##3##(1995-5#1)(2013-8#1)
than in S##2##3##(2008-10#1)(2012-3#1)
than in WFBR##2##3##(2012-12#2)
than in Wistar rats##6##4##(1993-12#1)(1994-11#1)(2008-4#1)(2010-12#3)
than in Wistar##7##3##(1993-12#1)(1994-11#1)(1995-12#1)(2008-4#1)(2010-12#3)
than in a control group##3##5##(1992-6#1)(1997-7#1)(2006-6#1)
than in a control##5##4##(1992-12#1)(1992-6#1)(1997-7#1)(2006-6#1)(2010-4#1)
than in a conventional##2##4##(2007-12#2)
than in a##21##3##(1992-12#1)(1992-6#1)(1994-5#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-7#1)(2006-6#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-4#1)(2012-12#1)(2013-7#1)
than in adult##2##3##(1993-2#1)(1995-10#1)
than in adults##6##3##(1992-7#1)(1994-3#1)(2004-11#1)(2006-10#1)(2010-12#1)(2013-1#1)
than in age-matched##2##3##(1995-5#1)(2008-10#1)
than in all the other##2##5##(2008-4#1)(2011-2#1)
than in all##4##3##(2004-9#1)(2008-12#1)(2008-4#1)(2011-2#1)
than in an##2##3##(1992-4#1)(1997-6#1)
than in any other##2##4##(1995-12#1)(2008-3#1)
than in any##3##3##(1995-12#1)(2008-3#1)(2010-11#1)
than in apo E3/3##2##4##(1997-2#2)
than in astrocytes##2##3##(1996-12#1)(2008-7#1)
than in autoclaved##2##3##(2008-10#2)
than in birds exposed to S##2##6##(2005-9#2)
than in blood##2##3##(1991-11#1)(2009-11#1)
than in cells##4##3##(1990-4#1)(1992-5#1)(1992-7#1)(2004-11#1)
than in chickens##2##3##(2008-5#1)(2012-1#1)
than in children##4##3##(1994-8#1)(1995-8#1)(2006-4#1)(2012-2#1)
than in comparable##2##3##(1990-5#1)(2008-7#1)
than in control cells##4##4##(1992-3#1)(2008-4#2)(2010-1#1)
than in control group##3##4##(2007-7#1)(2007-9#1)(2013-1#1)
than in control mice##2##4##(1997-2#2)
than in control patients##2##4##(2008-7#2)
than in control rats##6##4##(1990-7#1)(1993-5#1)(1995-12#1)(1995-3#1)(2007-10#1)(2009-5#1)
than in control subjects##3##4##(1991-11#1)(1996-7#1)(2008-6#1)
than in control##36##3##(1990-3#1)(1990-7#1)(1991-11#1)(1991-5#2)(1992-3#1)(1993-12#1)(1993-5#1)(1995-12#1)(1995-3#1)(1996-7#1)(1997-2#2)(2005-8#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-2#1)(2009-5#1)(2010-1#1)(2011-1#1)(2011-12#1)(2013-1#1)(2013-8#1)
than in controls (P &lt##5##5##(1996-9#1)(2007-10#1)(2008-8#1)(2011-1#2)
than in controls (P##7##4##(1996-9#1)(1997-2#1)(2007-10#1)(2008-8#1)(2011-1#2)(2012-3#1)
than in controls (p = 0##2##6##(2008-10#1)(2008-12#1)
than in controls (p##4##4##(1991-5#1)(2008-10#1)(2008-12#1)(2009-2#1)
than in controls and##3##4##(1996-8#1)(1997-8#1)(2011-2#1)
than in controls##49##3##(1991-2#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-4#2)(1994-11#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-5#2)(1996-8#3)(1996-9#2)(1997-2#1)(1997-7#1)(1997-8#1)(2005-1#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-10#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-6#1)(2011-1#2)(2011-11#1)(2011-2#5)(2012-1#1)(2012-3#1)(2012-7#1)(2013-1#1)(2013-8#1)
than in conventional##7##3##(2007-11#1)(2007-12#1)(2008-10#4)(2013-1#1)
than in conventional-till fields##3##4##(2008-10#3)
than in cv##3##3##(2008-10#3)
than in developed countries##5##4##(2007-10#1)(2007-7#1)(2008-8#1)(2012-2#2)
than in developed##6##3##(1991-3#1)(2007-10#1)(2007-7#1)(2008-8#1)(2012-2#2)
than in either of the##2##5##(1990-11#1)(2008-10#1)
than in either##6##3##(1990-11#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-5#1)(2013-1#1)
than in female##4##3##(1994-11#1)(1994-2#1)(1996-6#1)(2008-10#1)
than in females##23##3##(1990-12#3)(1991-5#1)(1991-6#1)(1992-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-6#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-3#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-11#1)(2012-12#1)(2013-1#1)
than in fields with##2##4##(2008-10#2)
than in green##2##3##(1996-10#1)(2004-4#1)
than in group B##4##4##(2007-2#1)(2007-7#1)(2007-8#2)
than in group I##2##4##(2008-8#1)(2010-1#1)
than in group of the patients without##2##7##(2008-7#2)
than in group##15##3##(1992-9#1)(1996-3#1)(2007-2#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-7#2)(2008-8#1)(2010-1#1)(2013-1#1)
than in healthy subjects##4##4##(1995-11#1)(2006-9#1)(2007-11#1)(2008-10#1)
than in healthy##10##3##(1995-11#1)(2006-9#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-4#1)(2012-12#1)
than in individuals with##2##4##(2007-9#1)(2008-2#1)
than in industrialized countries##2##4##(2007-11#1)(2012-1#1)
than in intact##2##3##(1992-6#1)(1995-12#1)
than in its absence##3##4##(1997-7#1)(2006-5#1)(2008-10#1)
than in leaves##3##3##(2008-10#3)
than in liver##2##3##(1994-12#1)(1996-6#1)
than in males##17##3##(1990-11#1)(1991-1#1)(1993-12#1)(1994-7#1)(2006-10#1)(2006-7#2)(2007-12#2)(2008-11#1)(2008-5#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-11#1)
than in mature##2##3##(1995-3#1)(2011-2#1)
than in men##12##3##(1992-3#1)(1997-6#1)(2007-11#1)(2007-8#2)(2008-3#2)(2008-5#1)(2009-11#1)(2011-2#1)(2013-8#2)
than in mice##6##3##(1996-12#1)(1997-2#1)(1997-7#1)(2006-9#1)(2010-11#1)(2013-8#1)
than in mitochondria##5##3##(1990-10#1)(1993-9#2)(2005-8#1)(2008-7#1)
than in most##4##3##(1996-12#1)(2007-7#1)(2008-2#1)(2013-8#1)
than in mouse##2##3##(1994-11#1)(2008-3#1)
than in nondiabetic##2##3##(1990-10#1)(2005-10#1)
than in nontreated##4##3##(2008-10#3)(2008-11#1)
than in normal cells##3##4##(1990-4#1)(1992-12#1)(2007-10#1)
than in normal individuals##2##4##(2006-9#1)(2008-1#1)
than in normal subjects##2##4##(1991-2#1)(2006-10#1)
than in normal volunteers##3##4##(1990-2#1)(1995-11#1)(1996-2#1)
than in normal##22##3##(1990-2#1)(1990-4#1)(1990-5#1)(1991-2#1)(1992-12#1)(1992-4#1)(1994-2#1)(1995-11#1)(1995-12#1)(1996-12#2)(1996-2#1)(1996-5#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-3#1)(2008-1#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#1)
than in normotensive##3##3##(1990-2#1)(1990-7#1)(2008-11#1)
than in old age##2##4##(2005-10#1)(2010-2#1)
than in old##3##3##(1991-12#1)(2005-10#1)(2010-2#1)
than in older##6##3##(1993-12#1)(2005-11#1)(2006-12#1)(2007-1#1)(2011-2#1)(2012-3#1)
than in organic##2##3##(2008-10#2)
than in other groups##2##4##(1994-3#1)(2010-2#1)
than in other##30##3##(1990-11#1)(1990-4#1)(1991-10#1)(1991-2#1)(1993-5#1)(1994-3#1)(1994-9#2)(1995-3#1)(2006-11#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-4#1)(2007-5#1)(2007-9#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2009-10#2)(2010-2#2)(2011-1#1)(2011-2#1)(2012-12#1)
than in our##3##3##(1991-11#1)(1992-9#1)(2008-10#1)
than in past##2##3##(1991-5#1)(2005-10#1)
than in patients not receiving echocardiography##2##6##(2007-10#2)
than in patients who##2##4##(1993-12#1)(1993-7#1)
than in patients with normal##2##5##(2006-6#1)(2012-3#1)
than in patients with##19##4##(1993-11#1)(1993-2#1)(2005-8#1)(2006-11#1)(2006-6#2)(2007-3#1)(2008-1#1)(2008-12#2)(2008-7#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)
than in patients without##5##4##(1991-7#1)(1994-7#1)(2006-2#1)(2007-8#1)(2008-7#1)
than in patients##32##3##(1991-7#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-7#1)(2005-8#1)(2006-11#1)(2006-2#1)(2006-6#2)(2007-10#2)(2007-3#1)(2007-8#1)(2008-1#1)(2008-12#2)(2008-7#2)(2010-10#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-2#1)(2012-3#1)(2013-8#1)
than in permanent##2##3##(2007-10#2)
than in plants##3##3##(2004-2#1)(2008-10#2)
than in postmenopausal##2##3##(1992-3#1)(2007-5#1)
than in previous studies##3##4##(1997-2#1)(2008-8#1)(2011-2#1)
than in previous##6##3##(1990-3#1)(1994-9#1)(1997-2#1)(2008-2#1)(2008-8#1)(2011-2#1)
than in rat colon##2##4##(1997-4#2)
than in rat##3##3##(1997-4#2)(2008-2#1)
than in rats##2##3##(1994-8#1)(2011-2#1)
than in resistant##2##3##(2008-10#2)
than in serum##3##3##(1991-11#1)(2007-2#1)(2009-6#1)
than in similar##2##3##(1990-6#1)(2007-11#1)
than in soil from##2##4##(2008-10#2)
than in soil##4##3##(2008-10#4)
than in soils##2##3##(2008-10#2)
than in solution##2##3##(2008-10#1)(2008-3#1)
than in standard##4##3##(1990-10#1)(2008-10#1)(2008-2#1)(2008-3#1)
than in studies with mean##2##5##(2008-10#2)
than in studies##3##3##(2008-10#3)
than in subjects with normal##2##5##(2006-6#1)(2011-1#1)
than in subjects with##3##4##(2006-6#1)(2011-1#1)(2012-2#1)
than in subjects##4##3##(2005-10#1)(2006-6#1)(2011-1#1)(2012-2#1)
than in summer##4##3##(2008-10#1)(2008-12#1)(2008-3#1)(2011-12#1)
than in susceptible cultivars##2##4##(2008-10#2)
than in susceptible##4##3##(2008-10#4)
than in terra rossa (mean##2##5##(2005-10#2)
than in the HB##2##4##(2011-2#2)
than in the absence of the##2##6##(1991-2#1)(2008-8#1)
than in the absence of##4##5##(1991-2#1)(1993-4#1)(1994-8#1)(2008-8#1)
than in the adult##3##4##(1992-11#1)(1994-9#1)(1996-9#1)
than in the average##2##4##(1992-10#1)(2011-2#1)
than in the case of##8##5##(1990-8#1)(1992-11#1)(2005-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-2#1)
than in the case##9##4##(1990-8#1)(1992-11#1)(2005-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-2#1)
than in the cerebral cortex##2##5##(1990-7#1)(2008-7#1)
than in the control group (p &lt##3##7##(2007-10#1)(2011-1#2)
than in the control group (p##4##6##(2007-10#1)(2011-1#3)
than in the control group##36##5##(1991-12#1)(1991-4#1)(1992-1#3)(1992-4#1)(1993-2#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-5#1)(2006-8#2)(2007-10#3)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#3)(2010-2#1)(2011-1#6)(2011-2#1)
than in the control population##2##5##(1997-4#1)(2009-5#1)
than in the control##45##4##(1991-12#1)(1991-3#1)(1991-4#1)(1992-1#3)(1992-4#1)(1993-2#1)(1995-6#1)(1997-2#1)(1997-4#2)(1997-7#1)(2006-10#1)(2006-5#1)(2006-8#2)(2007-10#3)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#3)(2009-5#1)(2010-2#1)(2011-1#6)(2011-2#1)(2013-8#1)
than in the controls (P&lt##2##5##(2010-12#2)
than in the controls##23##4##(1990-3#3)(1990-5#1)(1991-2#1)(1991-4#1)(1992-2#1)(1994-3#1)(1995-8#1)(2004-11#2)(2006-5#1)(2008-10#1)(2008-6#1)(2008-7#3)(2010-12#2)(2011-1#2)(2011-2#1)(2012-12#1)
than in the corresponding##5##4##(1992-8#1)(1994-11#1)(1996-2#1)(2004-12#1)(2006-6#1)
than in the double-placebo group##2##5##(1995-9#2)
than in the environment##2##4##(1994-3#1)(2008-10#1)
than in the first##2##4##(2004-2#1)(2007-11#1)
than in the free##2##4##(1997-2#1)(2008-10#1)
than in the general population of##3##6##(1990-4#1)(2006-6#1)(2008-1#1)
than in the general population##14##5##(1990-4#1)(1992-9#1)(1993-9#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-1#2)(2008-4#1)(2008-6#1)(2009-6#1)(2012-12#1)(2012-3#1)(2013-1#1)
than in the general##15##4##(1990-4#1)(1992-9#1)(1993-9#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-4#1)(2008-6#1)(2009-6#1)(2012-12#1)(2012-3#1)(2013-1#1)
than in the group of##3##5##(1990-7#1)(1992-3#1)(2013-1#1)
than in the group##6##4##(1990-7#1)(1992-3#1)(1992-5#1)(2007-11#1)(2008-6#1)(2013-1#1)
than in the healthy##3##4##(2006-10#1)(2008-7#1)(2012-3#1)
than in the high##2##4##(1990-10#1)(2008-10#1)
than in the interior##2##4##(2013-7#2)
than in the latter##2##4##(1995-10#1)(2012-2#1)
than in the liver##2##4##(2006-10#1)(2008-7#1)
than in the male rats##2##5##(2013-1#2)
than in the male##5##4##(1994-6#2)(2013-1#3)
than in the native##3##4##(1990-8#1)(1995-5#1)(2006-10#1)
than in the non-MLC601 group##2##5##(2013-1#2)
than in the normal and##2##5##(1994-2#1)(1997-8#1)
than in the normal group##3##5##(1991-12#1)(1996-7#2)
than in the normal population##2##5##(1995-5#1)(1996-6#1)
than in the normal subjects##4##5##(1990-2#1)(1996-1#2)(1996-5#1)
than in the normal##17##4##(1990-10#1)(1990-2#1)(1991-12#1)(1992-9#1)(1994-2#1)(1995-11#1)(1995-5#1)(1996-1#2)(1996-5#1)(1996-6#1)(1996-7#2)(1997-8#1)(2006-12#1)(2008-10#1)(2013-8#1)
than in the other groups##3##5##(1993-12#1)(2008-7#1)(2011-2#1)
than in the other two groups##2##6##(1993-4#1)(2011-2#1)
than in the other two##5##5##(1993-4#1)(2005-11#1)(2007-1#1)(2011-1#1)(2011-2#1)
than in the other##21##4##(1990-2#1)(1992-11#1)(1993-12#1)(1993-4#1)(1996-11#1)(2005-11#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#2)
than in the past##4##4##(1993-12#1)(2007-4#1)(2008-10#1)(2008-11#1)
than in the patients without##2##5##(1994-7#1)(2007-10#1)
than in the patients##4##4##(1994-7#1)(2007-10#1)(2008-7#1)(2009-6#1)
than in the placebo group##4##5##(1992-10#1)(2008-10#1)(2008-5#1)(2012-2#1)
than in the presence of the other compounds##2##8##(1994-2#2)
than in the presence of the##3##6##(1992-3#1)(1994-2#2)
than in the presence of##8##5##(1992-11#1)(1992-3#1)(1994-2#2)(1996-5#1)(1996-9#1)(1997-6#1)(2008-10#1)
than in the previous##3##4##(2006-8#1)(2008-10#1)(2008-11#1)
than in the primary##2##4##(2008-5#1)(2013-8#1)
than in the rat##2##4##(1992-8#1)(2008-8#1)
than in the respective##2##4##(1993-1#1)(1995-11#1)
than in the rest of the country##2##7##(1996-2#1)(2010-9#1)
than in the rest of the##3##6##(1996-2#1)(2006-10#1)(2010-9#1)
than in the second##3##4##(2008-10#1)(2009-8#1)(2011-2#1)
than in the susceptible genotype##2##5##(2008-10#2)
than in the susceptible##3##4##(2008-10#3)
than in the visible##2##4##(2008-3#2)
than in the well-known##2##4##(1996-11#1)(2007-12#1)
than in the wild-type Columbia##2##5##(2009-6#2)
than in the wild-type##5##4##(1991-2#1)(1994-9#1)(2009-2#1)(2009-6#2)
than in the young##3##4##(1990-3#1)(1996-9#1)(2007-9#1)
than in the younger##3##4##(1995-12#1)(2008-6#1)(2008-7#1)
than in the##478##3##(1990-10#4)(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#5)(1990-4#2)(1990-5#3)(1990-7#2)(1990-8#2)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#1)(1991-4#3)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#2)(1992-1#3)(1992-10#3)(1992-11#5)(1992-12#1)(1992-2#3)(1992-3#4)(1992-4#2)(1992-5#5)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-4#4)(1993-5#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#5)(1994-3#3)(1994-6#2)(1994-7#1)(1994-8#3)(1994-9#4)(1995-1#1)(1995-10#2)(1995-11#3)(1995-12#2)(1995-3#1)(1995-5#4)(1995-6#2)(1995-7#2)(1995-8#3)(1995-9#2)(1996-1#3)(1996-10#3)(1996-11#3)(1996-12#2)(1996-2#5)(1996-3#3)(1996-5#2)(1996-6#3)(1996-7#3)(1996-9#5)(1997-2#9)(1997-4#3)(1997-6#2)(1997-7#4)(1997-8#3)(2004-1#2)(2004-11#2)(2004-12#1)(2004-2#1)(2004-4#1)(2005-11#2)(2005-3#1)(2005-4#2)(2006-10#10)(2006-12#1)(2006-3#1)(2006-5#4)(2006-6#3)(2006-8#5)(2006-9#2)(2007-1#3)(2007-10#7)(2007-11#7)(2007-12#6)(2007-2#1)(2007-4#2)(2007-5#4)(2007-6#1)(2007-7#4)(2007-8#10)(2007-9#3)(2008-1#3)(2008-10#41)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#12)(2008-4#6)(2008-5#10)(2008-6#10)(2008-7#20)(2008-8#6)(2009-2#3)(2009-3#1)(2009-5#3)(2009-6#5)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#12)(2011-11#1)(2011-12#2)(2011-2#13)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#12)(2013-7#3)(2013-8#4)
than in their nontransgenic littermates##2##5##(1992-8#2)
than in their##12##3##(1992-8#2)(1993-6#1)(1994-10#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)
than in those fed##3##4##(2004-11#1)(2007-8#1)(2012-2#1)
than in those from##2##4##(1995-12#1)(1996-10#1)
than in those of##5##4##(1991-2#1)(1994-6#1)(1997-4#1)(2008-5#1)(2013-1#1)
than in those receiving formula##2##5##(1991-4#2)
than in those receiving##5##4##(1991-4#2)(2007-11#2)(2011-2#1)
than in those treated##2##4##(2008-1#1)(2012-12#1)
than in those who##3##4##(1990-6#1)(1995-9#1)(2012-3#1)
than in those with no##2##5##(1995-12#1)(2010-7#1)
than in those with normal##2##5##(1990-2#1)(2008-7#1)
than in those with##14##4##(1990-2#1)(1992-1#1)(1992-12#1)(1995-12#1)(2006-10#1)(2006-11#1)(2007-10#2)(2008-5#1)(2008-7#1)(2009-2#1)(2010-7#1)(2011-2#2)
than in those without stroke##2##5##(2007-10#2)
than in those without##11##4##(1990-2#1)(1996-12#1)(1997-1#1)(2006-8#1)(2007-10#3)(2008-5#1)(2010-4#1)(2011-2#1)(2013-1#1)
than in those##59##3##(1990-2#2)(1990-6#1)(1991-2#1)(1991-4#2)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-2#1)(1994-6#1)(1995-12#2)(1995-9#1)(1996-10#1)(1996-12#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-6#1)(2004-10#1)(2004-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-10#6)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#3)(2008-7#1)(2009-2#1)(2010-4#1)(2010-7#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
than in treated##2##3##(2008-10#2)
than in typically##2##3##(2009-4#1)(2011-2#1)
than in uninfected##3##3##(1991-4#1)(2008-10#2)
than in untreated##4##3##(1995-12#1)(2008-10#2)(2008-2#1)
than in urban##2##3##(2008-4#1)(2011-11#1)
than in vitro##5##3##(1996-3#1)(2008-10#2)(2008-11#1)(2008-7#1)
than in vivo##3##3##(1994-2#1)(2008-4#2)
than in water##3##3##(1996-9#1)(2006-10#1)(2008-7#1)
than in wild type##2##4##(2008-3#1)(2008-4#1)
than in wild-type##4##3##(1997-3#1)(2008-10#1)(2008-7#1)(2009-5#1)
than in winter wheat##3##4##(2008-10#3)
than in women with##2##4##(1996-12#1)(2012-12#1)
than in women##13##3##(1990-12#1)(1991-2#1)(1993-11#1)(1994-5#2)(1995-8#1)(1996-12#1)(2006-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
than in young rats##7##4##(1990-7#1)(1995-12#3)(1995-9#1)(2008-7#2)
than in young##10##3##(1990-7#1)(1994-10#1)(1995-12#3)(1995-9#1)(2006-12#1)(2008-7#3)
than in younger patients##3##4##(1990-1#1)(1994-6#1)(2008-7#1)
than in younger##9##3##(1990-1#1)(1991-12#2)(1994-12#1)(1994-6#1)(1996-8#1)(2008-3#1)(2008-7#1)(2012-3#1)
than in##1602##2##(1990-1#1)(1990-10#9)(1990-11#11)(1990-12#7)(1990-2#10)(1990-3#9)(1990-4#7)(1990-5#6)(1990-6#4)(1990-7#7)(1990-8#5)(1991-1#1)(1991-10#2)(1991-11#6)(1991-12#9)(1991-2#10)(1991-3#3)(1991-4#6)(1991-5#12)(1991-6#9)(1991-7#3)(1991-8#3)(1991-9#1)(1992-1#4)(1992-10#4)(1992-11#8)(1992-12#8)(1992-2#5)(1992-3#10)(1992-4#6)(1992-5#7)(1992-6#7)(1992-7#10)(1992-8#7)(1992-9#5)(1993-1#2)(1993-10#1)(1993-11#4)(1993-12#10)(1993-2#6)(1993-3#2)(1993-4#6)(1993-5#3)(1993-6#6)(1993-7#4)(1993-8#6)(1993-9#6)(1994-10#3)(1994-11#6)(1994-12#9)(1994-2#13)(1994-3#8)(1994-5#7)(1994-6#5)(1994-7#3)(1994-8#6)(1994-9#9)(1995-1#5)(1995-10#5)(1995-11#7)(1995-12#19)(1995-2#2)(1995-3#12)(1995-4#1)(1995-5#10)(1995-6#5)(1995-7#5)(1995-8#6)(1995-9#6)(1996-1#4)(1996-10#5)(1996-11#8)(1996-12#12)(1996-2#8)(1996-3#12)(1996-4#3)(1996-5#11)(1996-6#9)(1996-7#10)(1996-8#6)(1996-9#17)(1997-1#5)(1997-2#23)(1997-3#4)(1997-4#8)(1997-6#5)(1997-7#10)(1997-8#10)(2004-1#3)(2004-10#1)(2004-11#7)(2004-12#1)(2004-2#3)(2004-3#1)(2004-4#3)(2004-9#1)(2005-1#2)(2005-10#7)(2005-11#4)(2005-3#2)(2005-4#2)(2005-7#1)(2005-8#7)(2005-9#2)(2006-10#20)(2006-11#3)(2006-12#6)(2006-2#1)(2006-3#3)(2006-4#2)(2006-5#10)(2006-6#9)(2006-7#2)(2006-8#9)(2006-9#6)(2007-1#5)(2007-10#26)(2007-11#20)(2007-12#16)(2007-2#9)(2007-3#2)(2007-4#8)(2007-5#6)(2007-6#7)(2007-7#12)(2007-8#20)(2007-9#9)(2008-1#11)(2008-10#174)(2008-11#29)(2008-12#10)(2008-2#14)(2008-3#27)(2008-4#26)(2008-5#33)(2008-6#15)(2008-7#53)(2008-8#20)(2008-9#15)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#8)(2009-3#3)(2009-4#2)(2009-5#8)(2009-6#6)(2009-8#6)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#12)(2010-2#17)(2010-3#5)(2010-4#9)(2010-5#1)(2010-6#2)(2010-7#5)(2010-8#8)(2010-9#2)(2011-1#25)(2011-11#4)(2011-12#8)(2011-2#51)(2012-1#9)(2012-11#2)(2012-12#14)(2012-2#15)(2012-3#19)(2012-7#2)(2013-1#38)(2013-7#6)(2013-8#16)
than inactive##2##2##(1991-5#1)(2009-12#1)
than increasing the##2##3##(1990-3#1)(2008-10#1)
than increasing##3##2##(1990-3#1)(2008-10#2)
than independent##2##2##(2011-1#2)
than indicated by##3##3##(1990-3#1)(1995-5#1)(2011-2#1)
than indicated##5##2##(1990-3#1)(1992-11#1)(1995-5#1)(2011-2#2)
than individual##6##2##(2005-10#1)(2007-12#1)(2008-10#1)(2010-4#1)(2012-1#1)(2012-2#1)
than individuals with other##2##4##(2008-4#2)
than individuals with##5##3##(2007-12#1)(2007-9#1)(2008-4#2)(2009-4#1)
than individuals##11##2##(1996-8#1)(2007-12#2)(2007-4#1)(2007-9#1)(2008-4#2)(2009-4#1)(2012-12#2)(2013-1#1)
than induced resistance##2##3##(2008-8#2)
than induced##4##2##(1992-6#1)(1992-9#1)(2008-8#2)
than infants##3##2##(2006-8#1)(2007-2#1)(2009-11#1)
than infected##2##2##(2007-6#1)(2012-2#1)
than inhibiting##3##2##(1990-2#1)(1996-5#1)(2012-2#1)
than initially expected##2##3##(1994-2#1)(2010-12#1)
than initially##4##2##(1994-2#1)(2007-8#1)(2008-10#1)(2010-12#1)
than insulin##4##2##(1990-11#1)(1991-12#1)(1993-6#1)(2008-1#1)
than intact##4##2##(1996-12#1)(1997-2#1)(2007-7#1)(2008-10#1)
than intended##2##2##(2009-12#1)(2009-7#1)
than interactions##2##2##(1994-9#1)(2008-8#1)
than intermediate##2##2##(2007-8#1)(2008-8#1)
than internal##2##2##(2010-12#1)(2013-1#1)
than into##2##2##(1990-11#1)(2008-11#1)
than intravenous##3##2##(1990-11#1)(2007-12#1)(2007-4#1)
than invasive carcinomas##2##3##(1997-8#2)
than invasive##3##2##(1994-5#1)(1997-8#2)
than iodine or##2##3##(1990-8#1)(2013-1#1)
than iodine##4##2##(1990-8#1)(1997-8#2)(2013-1#1)
than iron dextran##2##3##(2005-10#1)(2008-1#1)
than iron##5##2##(1991-7#1)(1994-3#1)(2005-10#1)(2008-1#1)(2013-7#1)
than is commonly##2##3##(1995-4#1)(2006-12#1)
than is currently##2##3##(2010-12#1)(2011-2#1)
than is possible with##4##4##(1990-9#1)(2006-6#1)(2007-11#2)
than is possible##6##3##(1990-9#2)(2006-6#1)(2007-11#2)(2008-11#1)
than is seen with##2##4##(2005-8#1)(2008-3#1)
than is the case##3##4##(1997-8#1)(2006-10#1)(2006-8#1)
than is the##14##3##(1990-11#1)(1990-9#1)(1991-9#1)(1992-5#1)(1994-3#1)(1995-1#1)(1997-8#1)(2005-12#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-2#1)(2009-8#1)(2013-8#1)
than is##59##2##(1990-11#1)(1990-8#1)(1990-9#3)(1991-9#1)(1992-5#2)(1993-2#1)(1993-6#1)(1994-1#1)(1994-3#1)(1995-1#2)(1995-11#1)(1995-4#1)(1996-1#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#2)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#3)(2008-8#3)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-2#2)(2011-2#1)(2012-3#1)(2013-8#1)
than isolate##4##2##(2008-10#3)(2008-11#1)
than isolated##2##2##(1992-11#1)(2007-3#1)
than isolates from##2##3##(2008-10#2)
than isolates of the##2##4##(2008-10#2)
than isolates##5##2##(2008-10#5)
than it did in##2##4##(1997-5#1)(2008-8#1)
than it did##4##3##(1997-5#1)(2008-10#1)(2008-8#1)(2010-8#1)
than it does in##3##4##(1991-2#1)(1991-4#1)(2006-10#1)
than it does##6##3##(1991-2#1)(1991-4#1)(1995-11#1)(2006-10#1)(2007-4#1)(2008-8#1)
than it had been##2##4##(2006-10#1)(2010-5#1)
than it is in the##2##5##(1991-4#1)(1996-5#1)
than it is in##3##4##(1991-4#1)(1996-5#1)(2008-3#1)
than it is to##3##4##(1990-12#1)(1990-8#1)(2004-9#1)
than it is##17##3##(1990-12#1)(1990-8#1)(1991-4#1)(1994-1#1)(1995-4#1)(1996-5#1)(1997-6#2)(2004-9#1)(2006-6#1)(2007-6#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2012-3#1)
than it should##2##3##(1990-12#1)(2012-2#1)
than it was for##3##4##(2007-3#1)(2008-10#1)(2012-1#1)
than it was in##2##4##(2007-11#1)(2008-11#1)
than it was##9##3##(1991-5#1)(1996-4#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-11#1)(2012-1#1)(2013-8#1)
than it##45##2##(1990-12#2)(1990-8#1)(1991-2#1)(1991-4#2)(1991-5#1)(1993-10#1)(1994-1#1)(1994-7#1)(1995-11#1)(1995-2#1)(1995-4#1)(1996-4#1)(1996-5#1)(1997-5#1)(1997-6#2)(1997-8#1)(2004-9#1)(2006-10#3)(2006-6#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-6#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-8#2)(2010-5#1)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
than its counterpart##2##3##(1992-8#2)
than its parent compound##2##4##(1997-2#1)(2012-2#1)
than its parent##3##3##(1997-2#1)(2008-9#1)(2012-2#1)
than its##62##2##(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1991-12#1)(1992-12#2)(1992-8#2)(1992-9#1)(1993-3#1)(1994-12#1)(1994-8#3)(1994-9#2)(1995-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-7#1)(2006-12#2)(2006-5#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-10#1)(2010-12#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
than just a##5##3##(1994-2#1)(2006-10#1)(2007-9#1)(2010-10#1)(2013-8#1)
than just the##4##3##(1993-12#1)(2008-11#1)(2009-8#1)(2011-2#1)
than just##23##2##(1990-5#1)(1990-9#1)(1993-12#1)(1994-2#2)(1994-3#1)(1996-4#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-9#1)(2008-11#2)(2008-3#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
than kidney##2##2##(1990-11#1)(1992-11#1)
than known##3##2##(1991-6#1)(1996-12#1)(2008-3#1)
than lack of##3##3##(2005-7#1)(2009-5#1)(2010-5#1)
than laparotomy##2##2##(1996-1#1)(2009-3#1)
than large follicles##2##3##(2011-1#2)
than large##4##2##(1990-9#1)(2009-7#1)(2011-1#2)
than larger##6##2##(1990-2#1)(1995-2#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-2#1)
than late##5##2##(1997-8#1)(2008-10#3)(2008-9#1)
than later##4##2##(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)
than lead##2##2##(1994-6#1)(1996-11#1)
than leaf##2##2##(2008-10#2)
than leaves##3##2##(2008-10#1)(2008-9#1)(2011-12#1)
than lesion##2##2##(2006-7#2)
than less##4##2##(1997-1#1)(2005-10#1)(2008-10#1)(2008-8#1)
than light##3##2##(2008-10#1)(2008-2#1)(2008-9#1)
than linear regression##3##3##(2008-10#1)(2012-3#2)
than linear##7##2##(1990-8#1)(1995-11#1)(2007-11#1)(2008-10#1)(2012-2#1)(2012-3#2)
than liver##3##2##(1990-6#1)(1991-8#1)(2008-8#1)
than losartan##2##2##(2005-7#2)
than lovastatin##3##2##(1992-5#3)
than low##5##2##(1991-3#1)(1994-6#1)(2006-3#1)(2009-4#1)(2011-1#1)
than lower##2##2##(2007-10#1)(2012-12#1)
than magnesium##2##2##(1996-6#1)(1997-7#1)
than male rats##2##3##(1991-10#1)(1994-6#1)
than male subjects##2##3##(2008-5#2)
than male##11##2##(1991-10#1)(1994-6#1)(1995-6#1)(1997-5#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)
than males and##3##3##(1990-12#1)(2008-5#1)(2013-1#1)
than males that##2##3##(1994-6#1)(2009-5#1)
than males##42##2##(1990-12#1)(1991-10#2)(1992-9#1)(1993-2#1)(1994-6#1)(1994-7#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-3#1)(1997-5#1)(2006-7#3)(2007-2#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#4)(2012-12#1)(2013-1#2)(2013-7#1)
than malignant##2##2##(2011-2#1)(2012-2#1)
than maltose##2##2##(1996-2#1)(1997-8#1)
than manual##4##2##(1990-4#1)(2008-10#1)(2008-8#1)(2010-4#1)
than many##3##2##(1991-7#1)(2006-6#1)(2008-9#1)
than married##3##2##(2007-7#1)(2010-2#1)(2013-7#1)
than mastectomy##2##2##(1996-3#1)(2004-1#1)
than maximum likelihood##2##3##(1997-6#1)(2009-12#1)
than may##2##2##(2008-2#1)(2012-12#1)
than mean##3##2##(2008-10#2)(2008-3#1)
than measured##3##2##(2008-11#1)(2008-3#1)(2010-2#1)
than measurement##2##2##(1996-12#1)(2013-7#1)
than meat from##2##3##(2010-4#2)
than medical##4##2##(1996-9#1)(2009-4#2)(2013-1#1)
than members of##2##3##(2008-10#1)(2009-8#1)
than members##3##2##(2008-10#1)(2008-9#1)(2009-8#1)
than membranes##2##2##(1990-4#1)(1994-8#1)
than men and made##2##4##(2007-12#1)(2008-10#1)
than men and##4##3##(2007-12#1)(2008-10#1)(2008-5#1)(2010-5#1)
than men with##3##3##(1996-12#1)(2007-12#1)(2008-7#1)
than men##56##2##(1992-2#1)(1992-5#2)(1995-12#1)(1995-2#1)(1996-12#2)(1996-4#1)(1996-6#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-12#5)(2007-7#2)(2007-9#2)(2008-10#1)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#4)(2009-11#2)(2009-4#1)(2009-5#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#4)
than mere##2##2##(1995-12#1)(1995-8#1)
than merely##5##2##(2006-3#1)(2007-2#1)(2008-10#1)(2008-2#1)(2009-5#1)
than methanol##2##2##(2008-10#1)(2008-7#1)
than methods based on##2##4##(2008-1#1)(2008-10#1)
than methods##3##2##(2008-1#1)(2008-10#1)(2008-6#1)
than methotrexate##2##2##(1997-1#1)(2008-5#1)
than mice##5##2##(1997-2#1)(1997-7#1)(2006-9#1)(2008-10#1)(2009-11#1)
than micelle does##2##3##(2005-4#2)
than might have been expected on the basis of the demographic figures##2##12##(1992-5#2)
than might have been##3##4##(1992-5#2)(2006-7#1)
than might##5##2##(1992-5#2)(2006-7#1)(2006-9#1)(2013-1#1)
than mild##3##2##(2006-11#1)(2007-12#1)(2012-2#1)
than minimal##2##2##(1993-12#1)(1996-1#1)
than mitochondria##2##2##(2009-5#1)(2011-1#1)
than model##2##2##(2007-11#1)(2012-1#1)
than models##4##2##(2008-10#2)(2008-11#1)(2008-12#1)
than moderate##2##2##(2009-12#1)(2010-12#1)
than monotherapy##4##2##(2004-1#1)(2008-8#1)(2009-7#1)(2013-1#1)
than monovalent##2##2##(1990-7#1)(2008-10#1)
than more##8##2##(2008-8#1)(2008-9#1)(2009-10#2)(2009-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
than morphine##5##2##(1990-2#1)(1995-11#1)(1996-7#1)(2007-2#1)(2012-2#1)
than mortality and##2##3##(2005-10#2)
than most of the##2##4##(2007-10#1)(2008-10#1)
than most other##4##3##(2004-11#1)(2007-12#1)(2008-4#1)(2008-9#1)
than most##13##2##(1994-12#1)(1996-8#1)(1997-2#1)(2004-11#1)(2005-11#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2012-2#1)(2013-8#1)
than mothers in the##2##4##(1995-1#1)(2006-9#1)
than mothers##5##2##(1995-1#1)(2006-8#1)(2006-9#1)(2007-2#2)
than motor##2##2##(2011-2#1)(2012-3#1)
than mouse##2##2##(1994-5#1)(1995-5#1)
than mu##2##2##(1990-2#1)(1997-8#1)
than multiple##2##2##(1993-6#1)(2013-8#1)
than murine##2##2##(1995-3#1)(1996-11#1)
than naive##2##2##(1991-2#1)(1993-12#1)
than national##2##2##(2012-12#1)(2012-3#1)
than native##5##2##(1991-9#1)(2008-10#1)(2009-12#1)(2009-2#1)(2012-12#1)
than natural##3##2##(1991-8#1)(2008-10#1)(2012-1#1)
than near##2##2##(1993-11#1)(2009-6#1)
than necessary##4##2##(1991-5#1)(1995-5#1)(2008-5#1)(2011-2#1)
than negative##7##2##(1994-1#1)(1997-1#1)(2005-10#1)(2005-11#1)(2008-11#1)(2008-4#1)(2012-12#1)
than neural##2##2##(1996-8#1)(2008-3#1)
than neuronal##3##2##(1995-12#1)(1996-5#1)(1997-1#1)
than neuropeptide Y##2##3##(1995-12#1)(1996-12#1)
than neutral##2##2##(2005-12#1)(2007-4#1)
than new##2##2##(1992-9#1)(2006-3#1)
than no##4##2##(1992-8#1)(2008-8#1)(2010-2#1)(2012-12#1)
than non##4##2##(2008-11#1)(2008-7#1)(2009-5#1)(2012-2#1)
than non-Hispanic##2##2##(2007-3#1)(2010-10#1)
than non-diabetic##3##2##(1991-10#1)(2006-7#1)(2008-1#1)
than non-oedematous##3##2##(2008-2#3)
than non-participants##2##2##(2006-7#1)(2007-11#1)
than non-smokers##8##2##(1992-9#1)(2008-10#4)(2010-2#1)(2010-3#2)
than non-victims##3##2##(2008-2#3)
than nonresponders##2##2##(2008-6#1)(2010-4#1)
than nontransgender sisters and nontransgender brothers##2##6##(2008-12#2)
than nontransgender sisters##3##3##(2008-12#3)
than nonveterans##2##2##(2013-1#2)
than noradrenaline##2##2##(1993-3#1)(1997-3#1)
than normal children##2##3##(1995-5#1)(2013-1#1)
than normal controls##3##3##(1997-8#1)(2012-2#1)(2013-1#1)
than normal in##4##3##(1992-8#1)(2007-7#3)
than normal subjects##3##3##(1996-5#2)(2005-8#1)
than normal##53##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-3#2)(1993-4#1)(1993-8#1)(1993-9#1)(1995-12#1)(1995-5#2)(1996-4#2)(1996-5#2)(1996-7#1)(1997-3#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-12#1)(2007-12#1)(2007-2#2)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#4)
than normal)##4##2##(1992-9#1)(1996-3#2)(2011-2#1)
than normally##6##2##(1992-11#1)(1993-6#1)(1994-6#1)(2005-10#1)(2005-11#1)(2009-3#1)
than normothermic##2##2##(1994-5#1)(2008-7#1)
than not##5##2##(2008-1#1)(2008-10#1)(2012-12#1)(2012-3#1)(2013-1#1)
than nuclear##3##2##(1995-11#1)(2007-9#1)(2008-8#1)
than nurses##2##2##(1992-3#1)(2013-1#1)
than nursing and##2##3##(1990-12#1)(2008-11#1)
than observed for##3##3##(1995-2#1)(1995-6#1)(1997-8#1)
than observed in##3##3##(1996-10#1)(2007-11#1)(2008-3#1)
than observed previously##2##3##(1993-12#1)(2005-11#1)
than observed with##4##3##(1991-10#1)(1992-6#1)(1994-12#1)(1995-6#1)
than observed##16##2##(1991-10#1)(1992-6#1)(1993-12#1)(1994-12#1)(1995-10#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-10#1)(1997-2#1)(1997-8#1)(2005-11#1)(2007-11#1)(2008-3#1)(2010-8#1)
than occurred##2##2##(2008-10#2)
than odor##2##2##(1992-4#2)
than of the##6##3##(1994-8#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-9#1)
than of##19##2##(1990-8#1)(1991-11#1)(1991-9#1)(1992-12#1)(1994-2#1)(1994-8#1)(1995-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2009-9#1)
than offspring##2##2##(1997-4#1)(2008-9#1)
than older age##2##3##(2006-2#1)(2011-1#1)
than older men##3##3##(2008-10#1)(2008-7#1)(2009-5#1)
than older ones##2##3##(1991-2#1)(1995-5#1)
than older patients##2##3##(2004-2#1)(2011-2#1)
than older##16##2##(1991-2#1)(1995-5#1)(2004-2#1)(2004-3#1)(2006-10#2)(2006-2#1)(2008-10#1)(2008-7#2)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
than omeprazole##2##2##(1997-1#1)(2008-5#1)
than on Camelot##2##3##(2008-10#2)
than on day##3##3##(1995-11#1)(1997-6#1)(2007-10#1)
than on isolines ECW##2##4##(2008-10#2)
than on leaves##2##3##(2008-10#2)
than on the cast##2##4##(2008-11#1)(2008-5#1)
than on the contralateral side##2##5##(1991-6#2)
than on the contralateral##3##4##(1991-6#2)(2008-3#1)
than on the##30##3##(1991-6#2)(1991-7#1)(1993-2#1)(1994-10#1)(1994-8#1)(1994-9#2)(1995-6#1)(1997-8#1)(2006-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#7)(2009-12#1)(2009-6#1)(2010-2#1)(2010-3#1)(2011-2#2)
than on##104##2##(1990-11#1)(1990-3#1)(1991-11#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-2#2)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-6#1)(1997-1#2)(1997-6#2)(1997-8#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#25)(2008-11#1)(2008-3#4)(2008-4#4)(2008-5#10)(2008-6#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-3#1)(2011-12#2)(2011-2#2)(2012-2#2)(2012-3#2)(2012-6#1)(2012-9#1)(2013-7#1)
than once per##2##3##(2008-8#1)(2013-1#1)
than once##14##2##(1991-8#1)(1993-2#1)(1996-12#1)(1997-4#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2012-1#1)(2013-1#1)
than one fifth of##2##4##(2006-10#1)(2012-3#1)
than one genotype##2##3##(2008-10#1)(2013-8#1)
than one in##3##3##(1997-8#1)(2008-8#1)(2013-1#1)
than one month##9##3##(1993-3#1)(1996-9#1)(2006-8#1)(2008-1#2)(2009-5#1)(2010-9#1)(2012-2#1)(2013-1#1)
than one month)##2##3##(2007-12#2)
than one per##2##3##(1996-2#1)(2008-10#1)
than one risk##2##3##(2006-2#1)(2010-12#1)
than one season##2##3##(2008-8#1)(2011-2#1)
than one single##2##3##(1995-6#1)(2011-1#1)
than one third of##4##4##(1997-5#1)(2007-7#1)(2008-1#1)(2013-1#1)
than one third##6##3##(1997-5#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-2#1)(2013-1#1)
than one week##6##3##(1992-1#1)(1994-12#1)(2006-2#1)(2007-10#2)(2007-6#1)
than one year after##3##4##(1993-9#1)(1995-10#1)(1996-8#1)
than one year##15##3##(1992-5#1)(1993-9#1)(1995-10#1)(1996-8#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2009-12#1)(2010-8#1)(2013-1#4)(2013-8#1)
than one##277##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#3)(1990-4#2)(1990-7#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#3)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-4#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#3)(1995-10#3)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#5)(1996-3#2)(1996-6#1)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#2)(2005-11#1)(2005-12#2)(2005-8#1)(2005-9#1)(2006-10#4)(2006-12#2)(2006-2#3)(2006-3#2)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-10#3)(2007-11#1)(2007-12#7)(2007-2#2)(2007-6#3)(2007-7#5)(2007-8#5)(2008-1#8)(2008-10#27)(2008-11#6)(2008-12#1)(2008-2#9)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#8)(2008-9#6)(2009-11#2)(2009-12#3)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#2)(2011-2#6)(2012-12#6)(2012-2#4)(2012-3#4)(2013-1#12)(2013-7#1)(2013-8#5)
than one-fifth##2##2##(1992-1#1)(2011-12#1)
than one-half##3##2##(1994-11#1)(1994-12#1)(2007-7#1)
than one-third of the##4##4##(1992-3#1)(1993-8#1)(1997-2#1)(2007-6#1)
than one-third of##6##3##(1992-3#1)(1993-8#1)(1995-1#1)(1997-2#1)(2007-6#1)(2009-6#1)
than one-third##8##2##(1992-3#1)(1993-8#1)(1995-1#1)(1997-2#1)(2007-2#1)(2007-6#1)(2009-6#1)(2011-2#1)
than only##5##2##(2005-7#1)(2008-4#1)(2009-8#1)(2010-11#1)(2011-1#1)
than open##2##2##(1997-4#1)(2006-10#1)
than operating##2##2##(1993-2#1)(2007-11#1)
than optically##2##2##(2007-12#2)
than optimal##8##2##(1991-2#1)(1996-11#1)(1997-2#1)(2006-8#2)(2008-3#1)(2008-7#1)(2013-1#1)
than optimized##2##2##(2007-12#2)
than or equal to 0##9##5##(1990-12#1)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#2)(1992-5#1)
than or equal to 1##12##5##(1990-11#1)(1990-12#1)(1990-2#4)(1990-5#1)(1991-7#2)(1991-8#1)(1992-2#1)(1992-5#1)
than or equal to 10##3##5##(1991-8#1)(1992-2#1)(1992-4#1)
than or equal to 100##5##5##(1990-2#1)(1990-5#1)(1991-8#1)(1991-9#1)(2011-2#1)
than or equal to 2##3##5##(1991-2#1)(1992-7#1)(1993-2#1)
than or equal to 20##2##5##(1992-3#1)(1992-9#1)
than or equal to 200##2##5##(1990-5#1)(2011-2#1)
than or equal to 3##3##5##(1990-12#1)(1991-10#1)(1992-5#1)
than or equal to 3)##2##5##(1990-12#1)(1992-4#1)
than or equal to 30##3##5##(1990-4#1)(1992-4#1)(2006-6#1)
than or equal to 4##3##5##(1991-7#1)(1992-2#1)(2008-2#1)
than or equal to 40##4##5##(1990-2#1)(1991-11#1)(1992-8#1)(2008-10#1)
than or equal to 5##3##5##(1990-10#1)(1990-4#1)(1992-5#1)
than or equal to 500##3##5##(1990-2#1)(1996-9#1)(2011-2#1)
than or equal to the##3##5##(2008-12#1)(2008-2#1)(2008-9#1)
than or equal to##126##4##(1990-10#3)(1990-11#3)(1990-12#4)(1990-2#11)(1990-3#6)(1990-4#4)(1990-5#4)(1990-6#3)(1991-1#1)(1991-10#2)(1991-11#2)(1991-2#4)(1991-4#3)(1991-5#2)(1991-6#2)(1991-7#8)(1991-8#13)(1991-9#2)(1992-2#4)(1992-3#2)(1992-4#4)(1992-5#4)(1992-6#2)(1992-7#5)(1992-8#2)(1992-9#2)(1993-2#1)(1996-9#1)(2006-2#1)(2006-6#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-2#3)(2008-5#3)(2008-9#1)(2011-2#4)(2012-2#1)(2013-8#1)
than or##131##2##(1990-10#3)(1990-11#3)(1990-12#4)(1990-2#11)(1990-3#6)(1990-4#4)(1990-5#4)(1990-6#3)(1991-1#1)(1991-10#2)(1991-11#2)(1991-2#4)(1991-4#3)(1991-5#2)(1991-6#2)(1991-7#8)(1991-8#13)(1991-9#2)(1992-2#4)(1992-3#2)(1992-4#4)(1992-5#4)(1992-6#2)(1992-7#5)(1992-8#2)(1992-9#2)(1993-2#1)(1995-12#1)(1995-8#1)(1996-9#1)(1997-2#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#3)(2008-9#1)(2011-2#4)(2012-2#1)(2013-8#1)
than oral##4##2##(2006-11#1)(2010-2#2)(2012-12#1)
than original##2##2##(2008-10#1)(2012-2#1)
than originally##6##2##(1991-11#1)(1994-6#1)(1997-2#1)(2007-11#1)(2012-2#2)
than other Medicare##2##3##(1993-12#1)(1995-3#1)
than other PPIs##2##3##(2008-5#2)
than other conventional##2##3##(1993-2#1)(2007-12#1)
than other countries##2##3##(2007-4#1)(2007-7#1)
than other groups##6##3##(1991-10#1)(2008-11#1)(2008-3#1)(2010-2#2)(2013-1#1)
than other hospital##2##3##(1990-2#1)(1990-9#1)
than other methods##3##3##(2006-2#1)(2008-10#1)(2010-3#1)
than other patients##2##3##(2008-7#1)(2013-1#1)
than other people##2##3##(2008-6#1)(2011-2#1)
than other reported##3##3##(2008-10#1)(2009-10#1)(2013-8#1)
than other##133##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#3)(1994-12#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-3#2)(1996-1#2)(1996-3#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#2)(2006-10#2)(2006-12#1)(2006-2#2)(2006-6#2)(2007-10#2)(2007-11#3)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#16)(2008-11#6)(2008-12#2)(2008-2#5)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2009-10#1)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-2#5)(2012-3#2)(2013-1#4)(2013-8#1)
than others and##2##3##(2006-7#1)(2006-8#1)
than others by environmental##2##4##(2008-5#1)(2011-2#1)
than others in##2##3##(2008-1#1)(2012-1#1)
than others to##3##3##(1990-3#1)(2007-4#1)(2010-8#1)
than others##50##2##(1990-3#1)(1992-9#1)(1993-3#1)(1994-2#1)(1995-11#1)(1995-5#1)(1997-7#1)(2004-11#2)(2004-4#1)(2006-10#2)(2006-7#2)(2006-8#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
than our own##2##3##(2008-8#1)(2011-1#1)
than our##6##2##(1995-2#1)(2008-11#1)(2008-2#1)(2008-8#1)(2011-1#2)
than out-of-school adolescents##3##3##(2007-3#3)
than outside##2##2##(2008-10#1)(2012-11#1)
than overt##2##2##(2006-10#1)(2008-10#1)
than oxidized##2##2##(1994-5#1)(2013-1#1)
than pNGT subjects##2##3##(2008-3#2)
than pNGT##3##2##(2008-3#3)
than pain##2##2##(2007-5#1)(2012-2#1)
than parental##6##2##(1993-1#1)(1994-5#1)(2007-12#1)(2008-8#1)(2013-8#2)
than participants without##2##3##(2006-6#1)(2007-12#1)
than participants##5##2##(2006-6#1)(2007-12#1)(2008-11#1)(2012-2#1)(2013-1#1)
than passive##2##2##(1992-1#1)(2005-10#1)
than patients in group L##2##5##(1996-3#2)
than patients in group##3##4##(1996-3#3)
than patients in##7##3##(1991-5#1)(1996-3#3)(2007-10#1)(2008-6#1)(2008-7#1)
than patients on##2##3##(2006-6#1)(2008-5#1)
than patients treated with##2##4##(1996-9#1)(2008-2#1)
than patients who were##2##4##(2007-1#1)(2007-10#1)
than patients who##4##3##(1993-2#1)(2007-1#1)(2007-10#1)(2013-1#1)
than patients whose##2##3##(2007-9#1)(2011-2#1)
than patients with##18##3##(1993-11#1)(1993-2#1)(1995-11#1)(1995-5#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-3#1)(2008-8#1)(2009-10#1)(2011-2#2)(2012-12#1)(2013-1#1)
than patients without##6##3##(1997-8#1)(2004-11#1)(2007-8#1)(2008-4#1)(2011-2#1)(2012-1#1)
than patients##48##2##(1991-5#1)(1993-11#1)(1993-2#2)(1995-11#1)(1995-5#1)(1996-2#1)(1996-3#3)(1996-6#1)(1996-7#1)(1996-9#1)(1997-8#2)(2004-1#1)(2004-11#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-3#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
than people in##3##3##(2008-12#1)(2010-12#1)(2013-1#1)
than people##6##2##(1992-8#1)(1993-7#1)(2008-12#1)(2008-4#1)(2010-12#1)(2013-1#1)
than peridinin##2##2##(2009-9#2)
than peripheral##3##2##(1997-8#1)(2006-10#1)(2008-9#1)
than pharmacologic##3##2##(1995-8#1)(2005-10#1)(2006-10#1)
than phenytoin##2##2##(1990-7#1)(2008-11#1)
than phosphorylation of##2##3##(1995-10#1)(2011-2#1)
than physical##6##2##(1992-3#1)(1995-11#1)(2008-5#1)(2008-8#2)(2011-2#1)
than physician##2##2##(1994-12#1)(2012-1#1)
than physiological##2##2##(2005-12#1)(2013-8#1)
than physostigmine##2##2##(1992-3#1)(1993-11#1)
than placebo in##7##3##(2007-11#2)(2008-3#2)(2008-5#1)(2012-1#1)(2013-1#1)
than placebo##21##2##(1992-4#1)(1993-9#1)(2007-11#5)(2008-3#4)(2008-5#2)(2008-7#1)(2008-9#1)(2009-7#1)(2010-4#1)(2012-1#1)(2013-1#1)(2013-8#2)
than plants##7##2##(2007-6#1)(2008-10#1)(2008-8#1)(2012-3#1)(2012-7#2)(2013-8#1)
than plasma##3##2##(1993-2#1)(1994-11#1)(2006-6#1)
than population##3##2##(1990-3#1)(2008-10#1)(2010-2#1)
than position##2##2##(1990-11#1)(1991-7#1)
than positive##6##2##(1990-2#1)(1993-12#1)(1996-9#1)(1997-3#1)(1997-8#1)(2013-1#1)
than possible##2##2##(2006-7#1)(2008-7#1)
than postmating##2##2##(2008-9#2)
than postoperatively##2##2##(2007-7#1)(2009-6#1)
than potato##2##2##(2008-10#2)
than prairie##2##2##(2008-9#2)
than predicted by classical##2##4##(2007-12#1)(2008-7#1)
than predicted by the##2##4##(2008-7#1)(2008-8#1)
than predicted by##15##3##(1990-5#1)(1992-1#1)(1995-11#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#2)(2013-8#1)
than predicted with##2##3##(2007-11#1)(2008-3#1)
than predicted##27##2##(1990-5#1)(1992-1#2)(1992-4#1)(1992-9#1)(1994-6#1)(1995-11#1)(1996-4#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#3)(2009-5#2)(2010-3#1)(2013-8#1)
than preoperative##2##2##(2008-5#1)(2009-3#1)
than present##2##2##(2010-11#1)(2012-2#1)
than preventive##2##2##(2008-10#1)(2009-9#1)
than previous studies##3##3##(1997-7#1)(2006-10#1)(2008-12#1)
than previous##18##2##(1990-4#1)(1993-3#1)(1997-7#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-2#2)(2008-8#1)(2008-9#1)(2010-2#1)(2010-3#1)(2010-6#1)(2013-1#1)(2013-8#1)
than previously assumed##5##3##(1995-11#1)(2008-10#1)(2008-11#1)(2012-1#1)(2012-2#1)
than previously believed##9##3##(2005-6#1)(2006-2#1)(2007-7#1)(2007-9#2)(2008-10#1)(2012-2#3)
than previously described##3##3##(2008-10#1)(2008-11#1)(2011-12#1)
than previously published##2##3##(2008-10#1)(2008-11#1)
than previously recognized##4##3##(1997-1#1)(2008-10#1)(2008-4#1)(2011-2#1)
than previously reported and##3##4##(1994-11#1)(2004-12#1)(2006-11#1)
than previously reported for##2##4##(1993-11#1)(1994-6#1)
than previously reported in##2##4##(1991-1#1)(2010-7#1)
than previously reported##23##3##(1991-1#1)(1991-2#1)(1992-3#1)(1993-11#1)(1994-11#1)(1994-6#1)(1996-3#2)(1996-5#1)(1997-2#1)(1997-7#1)(2004-12#1)(2006-11#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-7#1)(2010-7#1)(2013-1#1)
than previously shown##2##3##(1991-11#1)(2010-3#1)
than previously suggested##2##3##(1995-1#1)(2008-9#1)
than previously supposed##2##3##(2007-10#1)(2007-8#1)
than previously thought and##6##4##(1993-3#1)(1995-12#1)(2006-10#1)(2008-11#1)(2010-12#1)(2011-2#1)
than previously thought##17##3##(1990-5#1)(1993-3#1)(1993-8#1)(1995-12#1)(2004-9#1)(2005-11#1)(2006-10#2)(2007-9#1)(2008-10#1)(2008-11#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-2#1)
than previously##99##2##(1990-5#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#3)(1996-12#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-7#1)(2004-12#1)(2004-9#1)(2005-11#1)(2005-6#1)(2005-8#1)(2006-10#3)(2006-11#2)(2006-2#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-10#13)(2008-11#4)(2008-12#2)(2008-2#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#2)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#5)(2013-1#2)
than primary##3##2##(1996-5#1)(2008-9#1)(2011-12#1)
than principal##2##2##(2008-10#2)
than prior to##2##3##(2008-10#1)(2008-6#1)
than production of##2##3##(2008-10#1)(2008-4#1)
than protein##4##2##(1993-4#1)(2008-12#1)(2008-5#1)(2011-2#1)
than proximal##2##2##(2008-6#1)(2009-6#1)
than published##5##2##(2006-10#1)(2007-1#1)(2007-8#1)(2008-9#1)(2013-1#1)
than pure##5##2##(1990-8#1)(2008-2#1)(2009-8#1)(2009-9#1)(2010-5#1)
than purely##2##2##(2008-2#1)(2010-11#1)
than purified##2##2##(1992-6#1)(1996-12#1)
than qualitative##3##2##(1995-3#1)(2008-10#1)(2012-2#1)
than quantitative##2##2##(2009-6#1)(2012-2#1)
than r##6##2##(1990-2#4)(1996-11#2)
than race##3##2##(2006-10#1)(2008-10#2)
than rainfall##2##2##(2007-9#1)(2008-10#1)
than random##2##2##(2008-10#1)(2010-10#1)
than rates reported by##2##4##(2013-8#2)
than real##2##2##(1994-1#1)(2012-12#1)
than recently##2##2##(1992-9#1)(2012-3#1)
than recombinant##2##2##(1993-8#1)(2008-11#1)
than recommended##5##2##(1991-6#1)(1997-8#1)(2007-7#1)(2008-5#1)(2008-8#1)
than reduction##2##2##(1992-1#1)(2010-8#1)
than reductive##2##2##(1991-10#1)(2009-10#1)
than regular##6##2##(1995-7#1)(2008-1#1)(2009-2#1)(2012-12#2)(2013-1#1)
than relying##3##2##(2008-10#1)(2008-7#1)(2010-6#1)
than reported in many other##2##5##(1995-7#1)(2006-10#1)
than reported in other##2##4##(1994-7#1)(2006-10#1)
than reported in##6##3##(1994-7#1)(1995-7#1)(2006-10#2)(2008-6#1)(2009-7#1)
than reported##12##2##(1991-11#1)(1993-5#1)(1994-11#1)(1994-7#1)(1995-7#1)(2006-10#2)(2008-10#1)(2008-6#1)(2009-7#1)(2011-1#1)(2013-8#1)
than representing a##2##3##(2008-7#1)(2010-11#1)
than required##5##2##(1996-12#1)(1996-5#1)(1996-8#1)(2007-11#1)(2008-2#1)
than requiring##2##2##(2007-12#1)(2008-10#1)
than rifampin##2##2##(2008-5#2)
than right##3##2##(1993-8#1)(2005-10#1)(2007-10#1)
than roots##2##2##(2008-10#2)
than rough##2##2##(2010-7#1)(2013-1#1)
than rumination##2##2##(2008-8#1)(2009-11#1)
than saline##4##2##(1990-10#1)(2006-9#2)(2013-8#1)
than satisfactory##3##2##(1993-12#1)(1993-8#1)(2008-2#1)
than schizophrenia##3##2##(1997-8#1)(2007-3#1)(2012-2#1)
than schizophyllan and the##2##4##(1991-12#2)
than science##2##2##(2006-10#1)(2007-9#1)
than scu-PA##2##2##(1990-11#2)
than secondary##2##2##(1990-5#1)(2007-12#1)
than sedentary##2##2##(1996-2#1)(2013-8#1)
than seedlings grown##2##3##(2004-4#2)
than seen in##3##3##(2008-11#1)(2010-2#1)(2011-2#1)
than seen with##2##3##(2005-7#1)(2007-11#1)
than seen##5##2##(2005-7#1)(2007-11#1)(2008-11#1)(2010-2#1)(2011-2#1)
than sequences##2##2##(1991-7#1)(2007-9#1)
than sequencing##2##2##(2010-6#1)(2012-3#1)
than seronegative##2##2##(1994-6#1)(2009-5#1)
than serum##3##2##(1990-2#1)(2006-2#1)(2008-2#1)
than seven##7##2##(1990-3#1)(1992-3#1)(1997-2#1)(2008-10#2)(2012-2#1)(2013-8#1)
than several##5##2##(1993-2#1)(1995-6#1)(1997-3#1)(2008-3#1)(2009-8#1)
than sexual##3##2##(1995-2#1)(2008-10#1)(2012-3#1)
than short-term##2##2##(2007-2#1)(2013-8#1)
than similar##2##2##(1991-11#1)(1997-2#1)
than similarly##2##2##(1997-6#1)(2009-7#1)
than simple##5##2##(1993-12#1)(1994-11#1)(1997-3#1)(2008-4#1)(2008-8#1)
than simpler##2##2##(1997-2#1)(2011-12#1)
than simply##11##2##(1990-7#1)(1994-12#1)(2004-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)(2009-3#1)(2012-2#2)(2012-3#1)
than single##14##2##(1990-8#1)(1993-1#1)(1997-3#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-8#1)(2013-1#1)
than six months##3##3##(2008-1#2)(2008-7#1)
than six teeth excluding third molars)##2##6##(2011-1#2)
than six years of##3##4##(1995-2#1)(2009-2#1)(2011-2#1)
than six years##4##3##(1995-2#1)(2009-10#1)(2009-2#1)(2011-2#1)
than six##15##2##(1990-6#1)(1995-2#1)(2007-12#1)(2008-1#2)(2008-7#1)(2009-10#1)(2009-2#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#2)(2013-1#1)
than size##2##2##(1990-12#1)(2008-10#1)
than skin##3##2##(2006-12#1)(2008-5#2)
than slight##2##2##(2007-7#1)(2008-10#1)
than small##4##2##(1991-9#1)(1995-11#1)(1996-12#1)(2013-8#1)
than smaller swarms##2##3##(2013-8#2)
than smaller##3##2##(1996-12#1)(2013-8#2)
than sodium##4##2##(1993-11#1)(1995-12#1)(2008-2#1)(2010-4#1)
than soil##2##2##(2008-5#1)(2010-5#1)
than somatic##2##2##(1990-10#1)(1996-5#1)
than somatostatin##2##2##(1994-11#2)
than some##5##2##(1990-6#1)(1993-3#1)(2008-5#1)(2008-7#1)(2012-3#1)
than sows##2##2##(1992-12#1)(2010-2#1)
than specific##5##2##(1995-2#1)(1995-6#1)(2005-11#1)(2008-11#1)(2010-2#1)
than spermine##3##2##(1990-10#1)(1991-7#1)(2008-8#1)
than spontaneous##3##2##(1997-1#1)(1997-2#1)(2008-5#1)
than sporadic##2##2##(2004-2#1)(2009-8#1)
than spores##2##2##(2008-10#1)(2011-2#1)
than stage##3##2##(2004-1#2)(2008-8#1)
than standard##21##2##(1990-2#1)(1993-10#1)(1995-12#1)(1996-12#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-2#2)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
than static##3##2##(1992-12#1)(1996-12#1)(2012-12#1)
than steady##2##2##(1996-12#1)(2011-2#1)
than stepwise##2##2##(1997-2#1)(2010-4#1)
than students##4##2##(1995-3#2)(1997-2#1)(2012-3#1)
than studies##2##2##(2007-1#1)(2010-8#1)
than subjects in##2##3##(2008-4#1)(2008-5#1)
than subjects with##4##3##(1992-8#1)(1996-9#1)(2008-7#1)(2008-9#1)
than subjects without##3##3##(1997-2#1)(2007-10#1)(2012-3#1)
than subjects##15##2##(1992-8#1)(1994-2#1)(1996-9#1)(1997-2#1)(2007-10#2)(2007-5#1)(2007-6#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-3#1)
than substrate##2##2##(1993-12#1)(1996-2#1)
than substrates##2##2##(1991-4#1)(1991-5#1)
than suggested##2##2##(2006-11#1)(2008-2#1)
than surface##3##2##(2006-12#1)(2007-12#1)(2008-3#1)
than surgery##4##2##(1996-12#1)(2007-8#1)(2010-12#2)
than surveillance figures##2##3##(1992-5#2)
than survivors##3##2##(1993-1#1)(1995-3#1)(2007-8#1)
than susceptible##3##2##(1991-7#1)(2008-10#2)
than tau##3##2##(1992-9#2)(1994-9#1)
than taxol##2##2##(1992-8#2)
than ten cells##2##3##(1993-7#2)
than ten years##5##3##(1994-5#1)(1994-9#1)(2007-2#1)(2007-3#1)(2008-3#1)
than ten years'##2##3##(1990-2#1)(2011-1#1)
than ten##21##2##(1990-2#1)(1990-6#2)(1991-11#1)(1992-1#1)(1993-7#2)(1994-5#1)(1994-9#1)(1995-1#1)(2005-12#1)(2007-2#1)(2007-3#1)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)
than tenfold##2##2##(1991-1#1)(2007-11#1)
than that achieved with##2##4##(2008-10#1)(2008-2#1)
than that achieved##6##3##(2007-12#2)(2008-10#1)(2008-2#2)(2008-5#1)
than that among##2##3##(2008-8#1)(2012-2#1)
than that associated with##2##4##(1991-11#1)(2008-3#1)
than that associated##3##3##(1991-11#1)(2008-10#1)(2008-3#1)
than that at pH 7##2##5##(1995-5#1)(2011-3#1)
than that at the##2##4##(2005-11#1)(2013-8#1)
than that at##8##3##(1990-12#1)(1995-5#1)(2005-11#1)(2008-11#1)(2008-3#1)(2011-3#1)(2012-2#1)(2013-8#1)
than that between the##3##4##(1990-3#1)(2011-1#1)(2012-9#1)
than that between##10##3##(1990-12#2)(1990-3#1)(2005-11#1)(2008-10#1)(2008-5#1)(2008-8#2)(2011-1#1)(2012-9#1)
than that by the##3##4##(1994-9#1)(2008-9#2)
than that by##12##3##(1990-7#1)(1991-12#1)(1994-9#1)(1995-8#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#3)(2010-2#1)(2013-8#1)
than that caused by##6##4##(1990-7#1)(1991-2#1)(1995-5#1)(2008-10#1)(2012-2#1)(2013-8#1)
than that determined##2##3##(2008-11#1)(2008-2#1)
than that during##5##3##(1990-10#1)(1990-11#1)(2004-4#1)(2006-2#1)(2013-8#1)
than that expected from##2##4##(1990-11#1)(2008-10#1)
than that expected##3##3##(1990-11#1)(2007-4#1)(2008-10#1)
than that for a##4##4##(1997-4#1)(2008-2#1)(2008-3#2)
than that for an##2##4##(1991-9#1)(2008-3#1)
than that for the##14##4##(1990-2#1)(1990-8#1)(1990-9#1)(1995-1#1)(1997-4#1)(1997-7#2)(2005-11#2)(2006-7#1)(2006-8#1)(2008-2#2)(2008-8#1)
than that for##60##3##(1990-11#1)(1990-2#1)(1990-8#2)(1990-9#1)(1991-7#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-3#2)(1994-5#1)(1994-7#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#2)(1997-8#1)(2005-11#2)(2006-7#2)(2006-8#1)(2007-10#1)(2007-12#2)(2007-3#1)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#6)(2008-8#1)(2008-9#1)(2009-3#1)(2010-4#1)(2012-2#1)
than that found for##2##4##(1997-7#1)(2008-5#1)
than that found in normal##2##5##(1993-11#1)(1994-11#1)
than that found in the##6##5##(1991-2#1)(1991-9#1)(2004-10#1)(2008-10#1)(2008-11#1)(2011-2#1)
than that found in##12##4##(1990-6#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-8#1)(1991-9#1)(1993-11#1)(1994-11#1)(2004-10#1)(2008-10#1)(2008-11#1)(2011-2#1)
than that found##18##3##(1990-6#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-8#1)(1991-9#1)(1993-11#1)(1994-11#1)(1995-1#1)(1995-11#1)(1997-7#1)(2004-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)
than that from the##2##4##(1991-9#1)(1997-3#1)
than that from##11##3##(1991-9#1)(1992-7#1)(1995-3#1)(1996-1#1)(1996-7#1)(1997-3#1)(1997-6#1)(2005-11#1)(2008-8#1)(2012-12#2)
than that given##2##3##(1991-2#1)(2007-12#1)
than that in control (P &lt##2##6##(2008-10#2)
than that in control##4##4##(2006-4#1)(2008-10#3)
than that in controls##3##4##(1994-2#1)(1996-9#1)(2008-4#1)
than that in group##2##4##(2007-8#2)
than that in hair-healthy men##2##5##(2005-4#2)
than that in other##2##4##(2008-9#1)(2010-5#1)
than that in patients with##2##5##(2007-11#1)(2008-9#1)
than that in sample I -1##2##6##(2005-4#2)
than that in the control group##8##6##(1990-9#1)(1996-12#1)(1997-1#2)(2007-8#1)(2008-9#1)(2012-2#2)
than that in the control##16##5##(1990-9#1)(1994-12#1)(1995-3#1)(1996-10#1)(1996-12#1)(1997-1#2)(2006-4#1)(2007-8#1)(2008-9#1)(2012-2#4)(2013-8#2)
than that in the controls##5##5##(1991-3#1)(2008-10#1)(2010-10#1)(2011-2#1)(2012-2#1)
than that in the general population##3##6##(2007-12#1)(2007-2#1)(2010-8#1)
than that in the high##2##5##(1995-6#1)(2008-3#1)
than that in the##60##4##(1990-10#1)(1990-9#1)(1991-10#1)(1991-3#1)(1994-12#2)(1994-6#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#1)(1997-1#2)(1997-2#1)(1997-3#1)(2004-11#1)(2005-10#1)(2006-10#2)(2006-4#2)(2006-5#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#5)(2009-2#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#5)(2013-8#2)
than that in##137##3##(1990-10#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-3#2)(1992-1#1)(1993-11#1)(1993-7#1)(1993-8#2)(1994-12#2)(1994-2#1)(1994-6#3)(1994-8#2)(1995-10#1)(1995-3#2)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-5#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-7#1)(2004-11#1)(2005-10#1)(2005-11#2)(2005-4#5)(2006-10#2)(2006-4#3)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-8#5)(2008-10#13)(2008-11#6)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#12)(2009-11#1)(2009-2#1)(2010-10#1)(2010-2#1)(2010-5#3)(2010-7#1)(2010-8#2)(2011-1#5)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#3)
than that induced by##3##4##(1990-7#1)(1991-5#1)(1995-8#1)
than that measured for##2##4##(2008-10#2)
than that measured with##2##4##(1991-2#1)(2007-12#1)
than that measured##9##3##(1991-2#1)(1996-12#1)(1996-2#1)(2005-11#1)(2007-12#1)(2008-10#4)
than that needed for##2##4##(1990-11#1)(1997-7#1)
than that observed for##4##4##(1991-4#1)(1993-8#1)(2008-10#1)(2008-11#1)
than that observed in western countries##2##6##(2009-2#2)
than that observed in##11##4##(1993-11#1)(1993-6#1)(1994-2#1)(1995-10#1)(1995-8#1)(1996-2#1)(2008-2#2)(2009-2#2)(2010-4#1)
than that observed with the##2##5##(1990-3#1)(1995-3#1)
than that observed with##5##4##(1990-3#1)(1990-9#1)(1992-12#1)(1994-11#1)(1995-3#1)
than that observed##27##3##(1990-2#1)(1990-3#1)(1990-9#2)(1991-4#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-2#1)(1995-10#1)(1995-3#1)(1995-8#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#1)(2009-2#2)(2010-3#1)(2010-4#1)
than that obtained by##4##4##(1995-12#1)(2007-12#1)(2008-10#1)(2008-2#1)
than that obtained in the##3##5##(2008-10#1)(2008-11#1)(2008-6#1)
than that obtained in##4##4##(1992-1#1)(2008-10#1)(2008-11#1)(2008-6#1)
than that obtained using##3##4##(2008-10#1)(2008-3#1)(2008-4#1)
than that obtained with the##4##5##(1990-12#1)(2008-10#2)(2008-2#1)
than that obtained with##9##4##(1990-12#1)(1996-5#1)(2006-12#1)(2007-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
than that obtained##26##3##(1990-12#1)(1990-3#1)(1991-2#1)(1992-1#1)(1992-9#1)(1995-12#1)(1996-5#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-10#1)
than that of A3##2##4##(2010-2#2)
than that of C##2##4##(2008-10#1)(2012-2#1)
than that of a conventional##2##5##(2008-2#1)(2008-3#1)
than that of a previously##2##5##(1995-11#1)(2010-8#1)
than that of a##18##4##(1991-8#1)(1992-3#1)(1994-6#1)(1995-11#1)(2006-4#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#1)(2008-5#1)(2010-8#1)
than that of acetate ions##2##5##(2008-10#2)
than that of an##4##4##(2007-11#1)(2008-1#1)(2008-2#1)(2008-6#1)
than that of any##2##4##(1991-12#1)(2007-4#1)
than that of both##2##4##(2008-10#2)
than that of cells in##2##5##(2004-11#1)(2008-11#1)
than that of cells##3##4##(2004-11#1)(2008-11#1)(2013-7#1)
than that of control group##2##5##(2011-1#2)
than that of control##7##4##(1990-4#1)(1991-2#1)(2005-10#1)(2008-11#1)(2008-6#1)(2011-1#2)
than that of controls##7##4##(1990-5#1)(1991-9#1)(1997-4#1)(2008-10#1)(2008-8#1)(2011-12#1)(2013-7#1)
than that of conventional##6##4##(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-2#2)
than that of cotyledon##2##4##(2008-9#2)
than that of either##3##4##(1997-4#1)(2008-3#1)(2008-5#1)
than that of exotic##2##4##(2012-11#1)(2012-2#1)
than that of group##3##4##(2008-10#1)(2013-8#2)
than that of indomethacin##2##4##(1996-11#1)(2010-2#1)
than that of isolated##2##4##(1990-12#1)(2009-2#1)
than that of its##8##4##(1990-12#1)(1990-5#1)(2008-10#2)(2008-8#1)(2010-2#2)(2012-2#1)
than that of market capsules##2##5##(2012-3#2)
than that of men##4##4##(2004-11#2)(2006-10#1)(2008-1#1)
than that of more##2##4##(2009-8#1)(2012-1#1)
than that of native##5##4##(1991-7#1)(1992-2#1)(1994-8#2)(1995-5#1)
than that of natural##2##4##(1997-8#1)(2007-12#1)
than that of normal control##3##5##(2011-3#3)
than that of normal##7##4##(2008-5#1)(2008-8#1)(2011-2#2)(2011-3#3)
than that of other##8##4##(1996-7#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-6#1)
than that of patients##4##4##(1992-4#1)(2004-11#1)(2006-6#1)(2007-8#1)
than that of powdered TCP##2##5##(2008-5#2)
than that of silica##4##4##(2007-11#1)(2008-2#3)
than that of streptavidin##2##4##(1990-4#2)
than that of the CML hydrogel##2##6##(2009-7#2)
than that of the control group##5##6##(1997-2#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
than that of the control##11##5##(1993-3#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
than that of the conventional##7##5##(2007-12#2)(2008-10#1)(2008-3#2)(2008-5#1)(2013-8#1)
than that of the gene encoding##2##6##(1990-10#2)
than that of the general population##2##6##(1997-3#1)(2006-10#1)
than that of the integration method##2##6##(2008-3#2)
than that of the native##3##5##(1990-11#1)(2006-10#1)(2008-8#1)
than that of the original strain##2##6##(2008-5#2)
than that of the original system##2##6##(2008-3#2)
than that of the original##5##5##(2008-3#2)(2008-5#2)(2009-7#1)
than that of the other##4##5##(1993-3#1)(1995-3#1)(2008-5#1)(2009-3#1)
than that of the wild type##5##6##(1993-11#1)(1995-7#1)(2008-10#1)(2008-8#1)(2010-10#1)
than that of the wild-type enzyme##2##6##(1990-10#1)(1994-9#1)
than that of the wild-type strain##2##6##(1997-4#1)(2008-6#1)
than that of the wild-type##7##5##(1990-10#1)(1993-3#1)(1994-9#1)(1995-1#1)(1997-4#1)(2006-12#1)(2008-6#1)
than that of the##202##4##(1990-10#4)(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-5#1)(1992-9#2)(1993-11#1)(1993-3#3)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(2005-11#2)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-4#1)(2007-11#1)(2007-12#6)(2007-4#2)(2007-7#1)(2008-1#1)(2008-10#18)(2008-11#6)(2008-2#5)(2008-3#16)(2008-4#2)(2008-5#14)(2008-6#5)(2008-7#2)(2008-8#4)(2008-9#11)(2009-3#1)(2009-5#1)(2009-7#6)(2010-1#1)(2010-10#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#3)(2011-3#1)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#4)
than that of their##2##4##(1995-11#1)(1995-4#1)
than that of treatment##2##4##(1990-3#1)(2013-1#1)
than that of type##2##4##(1991-1#1)(2008-10#1)
than that of wild-type##4##4##(1992-6#1)(1993-12#1)(2006-12#1)(2009-9#1)
than that of women##2##4##(1997-2#1)(2004-11#1)
than that of##619##3##(1990-10#5)(1990-11#2)(1990-12#4)(1990-2#5)(1990-3#1)(1990-4#4)(1990-5#3)(1990-7#4)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#4)(1991-2#3)(1991-3#2)(1991-4#2)(1991-5#4)(1991-7#2)(1991-8#5)(1991-9#3)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#4)(1992-8#2)(1992-9#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#6)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#7)(1994-9#1)(1995-1#2)(1995-11#5)(1995-12#2)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#6)(1995-6#4)(1995-7#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#4)(1996-3#2)(1996-5#4)(1996-6#2)(1996-7#5)(1996-9#3)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#6)(1997-5#3)(1997-6#4)(1997-7#1)(1997-8#4)(2004-11#5)(2004-2#1)(2004-8#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-4#1)(2005-9#1)(2006-1#1)(2006-10#6)(2006-11#2)(2006-12#8)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#3)(2007-11#9)(2007-12#17)(2007-2#1)(2007-3#1)(2007-4#3)(2007-6#1)(2007-7#6)(2007-8#4)(2007-9#1)(2008-1#5)(2008-10#65)(2008-11#14)(2008-12#3)(2008-2#23)(2008-3#23)(2008-4#3)(2008-5#30)(2008-6#8)(2008-7#4)(2008-8#13)(2008-9#18)(2009-10#1)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#8)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#9)(2010-3#2)(2010-4#6)(2010-5#3)(2010-6#2)(2010-8#5)(2010-9#2)(2011-1#7)(2011-12#4)(2011-2#11)(2011-3#5)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#8)(2012-3#2)(2013-1#12)(2013-7#6)(2013-8#11)
than that on the LB##2##5##(2008-11#2)
than that on the##5##4##(2005-11#1)(2008-1#1)(2008-11#3)
than that on##15##3##(1991-2#1)(1992-9#1)(1993-11#1)(1995-11#1)(1996-3#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-5#1)(2008-6#1)(2013-8#1)
than that predicted by##2##4##(2005-11#1)(2009-6#1)
than that predicted##5##3##(1991-2#1)(1993-12#1)(1995-10#1)(2005-11#1)(2009-6#1)
than that previously reported##2##4##(2008-8#1)(2012-12#1)
than that previously##4##3##(1993-11#1)(2008-10#1)(2008-8#1)(2012-12#1)
than that produced by the##2##5##(2006-10#1)(2006-8#1)
than that produced by##8##4##(1990-8#1)(1994-3#1)(1994-6#1)(2006-10#1)(2006-8#1)(2007-10#1)(2008-11#1)(2008-12#1)
than that produced##11##3##(1990-8#1)(1994-3#1)(1994-5#1)(1994-6#1)(1996-7#1)(2004-1#1)(2006-10#1)(2006-8#1)(2007-10#1)(2008-11#1)(2008-12#1)
than that provided by the##2##5##(2008-10#1)(2012-3#1)
than that provided by##3##4##(2008-10#1)(2012-12#1)(2012-3#1)
than that recommended by##2##4##(1995-1#1)(2007-12#1)
than that recorded in##2##4##(1994-8#1)(2008-10#1)
than that reported for##3##4##(1990-9#1)(1996-12#1)(2008-5#1)
than that reported from other##2##5##(2007-7#1)(2008-1#1)
than that reported in##6##4##(1990-12#1)(1994-12#1)(1997-8#1)(2006-10#1)(2008-10#1)(2009-5#1)
than that reported##18##3##(1990-12#1)(1990-9#1)(1994-12#1)(1996-12#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#4)(2009-5#1)(2012-12#1)
than that required for##3##4##(1995-1#1)(2008-10#1)(2008-7#1)
than that required##4##3##(1994-6#1)(1995-1#1)(2008-10#1)(2008-7#1)
than that seen##6##3##(1990-4#1)(1992-2#1)(1996-2#1)(1996-5#1)(1996-6#1)(2008-7#1)
than that to##5##3##(1991-12#1)(1993-8#1)(2008-10#2)(2008-8#1)
than that under##3##3##(2006-8#1)(2008-1#1)(2013-8#1)
than that used in##2##4##(2007-11#1)(2008-2#1)
than that used##6##3##(1990-7#1)(1992-5#2)(2007-11#1)(2008-2#2)
than that using##3##3##(2006-3#1)(2008-11#2)
than that which is##2##4##(2007-12#2)
than that which##4##3##(2007-12#3)(2008-2#1)
than that with symmetrical tetraalkylammonium cations##2##6##(2008-10#2)
than that with the##3##4##(2008-10#3)
than that with##22##3##(1991-2#1)(1993-6#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-2#1)(1996-6#1)(2005-11#1)(2006-5#1)(2008-10#7)(2008-3#1)(2011-1#1)(2013-1#2)(2013-8#1)
than that without##4##3##(2008-3#2)(2008-8#1)(2013-8#1)
than that##1141##2##(1990-10#7)(1990-11#6)(1990-12#9)(1990-2#7)(1990-3#4)(1990-4#5)(1990-5#4)(1990-6#1)(1990-7#9)(1990-8#7)(1990-9#7)(1991-1#1)(1991-10#4)(1991-11#1)(1991-12#7)(1991-2#11)(1991-3#5)(1991-4#3)(1991-5#5)(1991-7#3)(1991-8#6)(1991-9#7)(1992-1#5)(1992-10#1)(1992-11#3)(1992-12#5)(1992-2#2)(1992-3#5)(1992-4#1)(1992-5#3)(1992-6#6)(1992-7#5)(1992-8#2)(1992-9#7)(1993-11#6)(1993-12#4)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#4)(1993-7#2)(1993-8#9)(1993-9#3)(1994-10#1)(1994-11#8)(1994-12#7)(1994-2#4)(1994-3#6)(1994-5#4)(1994-6#7)(1994-7#2)(1994-8#11)(1994-9#5)(1995-1#6)(1995-10#4)(1995-11#7)(1995-12#4)(1995-2#7)(1995-3#7)(1995-4#2)(1995-5#8)(1995-6#7)(1995-7#2)(1995-8#8)(1995-9#2)(1996-1#1)(1996-10#2)(1996-11#3)(1996-12#8)(1996-2#7)(1996-3#3)(1996-5#8)(1996-6#5)(1996-7#7)(1996-9#4)(1997-1#8)(1997-2#4)(1997-3#5)(1997-4#9)(1997-5#3)(1997-6#5)(1997-7#6)(1997-8#6)(2004-1#1)(2004-10#1)(2004-11#6)(2004-2#1)(2004-4#1)(2004-8#1)(2005-10#2)(2005-11#16)(2005-12#1)(2005-4#6)(2005-9#1)(2006-1#1)(2006-10#11)(2006-11#3)(2006-12#10)(2006-2#1)(2006-3#1)(2006-4#5)(2006-5#3)(2006-6#1)(2006-7#2)(2006-8#6)(2007-1#2)(2007-10#3)(2007-11#12)(2007-12#30)(2007-2#3)(2007-3#2)(2007-4#4)(2007-6#1)(2007-7#7)(2007-8#10)(2007-9#1)(2008-1#8)(2008-10#118)(2008-11#36)(2008-12#7)(2008-2#43)(2008-3#39)(2008-4#5)(2008-5#43)(2008-6#13)(2008-7#8)(2008-8#25)(2008-9#37)(2009-10#2)(2009-11#1)(2009-2#6)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#8)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-2#12)(2010-3#3)(2010-4#9)(2010-5#6)(2010-6#2)(2010-7#1)(2010-8#7)(2010-9#2)(2011-1#14)(2011-12#5)(2011-2#17)(2011-3#6)(2012-1#1)(2012-11#1)(2012-12#8)(2012-2#17)(2012-3#5)(2012-9#1)(2013-1#16)(2013-7#6)(2013-8#22)
than the &quot##5##3##(2008-2#1)(2010-11#1)(2010-12#1)(2010-4#1)(2013-1#1)
than the 0##2##3##(2008-2#2)
than the 1##2##3##(1993-11#1)(2012-2#1)
than the 2##2##3##(1994-7#1)(2007-11#1)
than the 20##2##3##(1990-9#1)(2010-8#1)
than the 3##2##3##(1995-3#1)(2008-10#1)
than the 6##3##3##(1991-5#1)(2008-1#1)(2012-2#1)
than the C-terminal##2##3##(1995-10#1)(2006-12#1)
than the CDC##2##3##(2007-2#1)(2008-3#1)
than the DWI volume (mismatch)##2##5##(2007-10#2)
than the GPs##2##3##(1996-12#1)(2006-10#1)
than the Hybrid III##3##4##(2006-11#2)(2007-4#1)
than the L##2##3##(1994-10#1)(1996-9#1)
than the LBD group##2##4##(2010-3#2)
than the MCS+##2##3##(2011-2#2)
than the MPM group##2##4##(1997-4#2)
than the PD##2##3##(2007-8#1)(2012-1#1)
than the SD rats##2##4##(2009-4#2)
than the SD##3##3##(2009-11#1)(2009-4#2)
than the SF group##2##4##(2008-4#2)
than the TD##2##3##(2009-4#2)
than the above##2##3##(1995-1#1)(2008-10#1)
than the activated##2##3##(1990-4#1)(2005-11#1)
than the actual##7##3##(1997-6#1)(2006-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-1#1)(2011-1#1)
than the adjacent##2##3##(2008-8#1)(2013-1#1)
than the affinity of##2##4##(1990-2#1)(1990-4#1)
than the affinity##3##3##(1990-2#1)(1990-4#1)(1995-10#1)
than the age##2##3##(2010-10#1)(2013-8#1)
than the alpha##2##3##(1990-11#1)(1997-8#1)
than the amount of##2##4##(2008-11#1)(2010-5#1)
than the amount##4##3##(2005-3#1)(2008-11#1)(2008-12#1)(2010-5#1)
than the amplitude of##2##4##(1990-7#1)(2012-1#1)
than the amplitude##3##3##(1990-7#1)(1993-1#1)(2012-1#1)
than the analogous##2##3##(1990-5#1)(1997-4#1)
than the angle##2##3##(2008-2#1)(2013-8#1)
than the aperture##2##3##(2008-2#1)(2008-3#1)
than the apparent##4##3##(1992-10#1)(2005-11#1)(2006-10#1)(2007-10#1)
than the approximately##2##3##(1990-4#1)(2008-11#1)
than the average on a##2##5##(2008-10#2)
than the average rate##2##4##(1990-4#1)(1994-12#1)
than the average##17##3##(1990-4#1)(1991-10#1)(1992-3#2)(1992-6#1)(1993-12#1)(1994-12#1)(1995-3#1)(1996-11#2)(1996-7#1)(2006-4#1)(2008-10#3)(2008-2#1)(2011-2#1)
than the bSBP obtained with the##3##6##(2013-8#3)
than the bSBP obtained##4##4##(2013-8#4)
than the background##5##3##(1997-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
than the basal##2##3##(1992-7#1)(2008-8#1)
than the baseline##2##3##(2006-4#1)(2010-3#1)
than the behavioural programme##2##4##(2008-9#2)
than the best##2##3##(1997-8#1)(2008-7#1)
than the binomial##2##3##(2008-10#2)
than the bulk##2##3##(2008-9#1)(2010-9#1)
than the canonical##2##3##(1995-3#1)(2009-8#1)
than the cell##2##3##(2008-5#1)(2008-7#1)
than the cells##2##3##(2008-10#1)(2008-11#1)
than the changes##2##3##(2008-1#1)(2008-5#1)
than the choice of##2##4##(2004-3#1)(2008-3#1)
than the classical##5##3##(1994-3#3)(2007-10#1)(2008-10#1)
than the clinical##2##3##(1993-7#1)(2008-11#1)
than the coherence##2##3##(2007-11#1)(2008-3#1)
than the commercial##4##3##(1990-7#1)(1997-5#1)(2007-2#1)(2013-8#1)
than the common##2##3##(1992-9#1)(1994-3#1)
than the commonly used##4##4##(1992-8#1)(1995-11#1)(1996-1#1)(2008-12#1)
than the commonly##5##3##(1992-8#1)(1995-11#1)(1996-1#1)(2008-10#1)(2008-12#1)
than the comparison group##2##4##(2007-12#2)
than the concentrations##2##3##(2007-3#1)(2008-10#1)
than the contralateral##3##3##(1993-12#2)(2006-3#1)
than the control group in##2##5##(1997-2#1)(2008-8#1)
than the control group##16##4##(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-12#1)(2013-1#4)
than the control mature##2##4##(1990-12#1)(1993-6#1)
than the control subjects##3##4##(1996-9#1)(2009-6#1)(2010-5#1)
than the control values##2##4##(2006-12#1)(2013-1#1)
than the control##51##3##(1990-12#1)(1992-2#1)(1992-4#2)(1992-9#1)(1993-12#1)(1993-6#1)(1994-3#1)(1994-4#1)(1995-12#1)(1995-6#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#1)(2006-12#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2012-1#2)(2012-12#1)(2013-1#6)(2013-8#1)
than the controls and the##2##5##(2013-1#1)(2013-8#1)
than the controls and##4##4##(1991-1#1)(2008-10#1)(2013-1#1)(2013-8#1)
than the controls##20##3##(1991-1#1)(1991-12#1)(1991-5#1)(1995-8#1)(1997-2#2)(1997-8#1)(2006-8#1)(2007-7#1)(2008-10#3)(2008-5#2)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
than the conventional univariate calibration method##2##6##(2008-10#2)
than the conventional##30##3##(2006-2#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#5)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-9#1)(2010-8#1)(2011-2#1)(2012-1#1)
than the corresponding value##2##4##(1990-8#1)(1991-9#1)
than the corresponding values##4##4##(2008-10#2)(2008-2#1)(2009-9#1)
than the corresponding wild-type##2##4##(2008-10#1)(2011-2#1)
than the corresponding##44##3##(1990-4#1)(1990-8#1)(1991-4#1)(1991-7#3)(1991-9#2)(1992-1#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-3#2)(1995-6#1)(1996-6#2)(1996-7#1)(1997-2#2)(1997-4#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-2#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-5#1)(2011-2#1)(2013-1#1)
than the cortex##3##3##(1993-2#1)(1996-3#1)(2008-10#1)
than the cost of providing##2##5##(1993-1#1)(1995-1#1)
than the cost of##5##4##(1993-1#1)(1995-1#1)(2008-5#1)(2008-8#1)(2011-1#1)
than the critical##6##3##(1996-5#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-7#1)
than the crude##2##3##(2007-6#1)(2008-11#1)
than the cumulative##2##3##(2008-7#1)(2012-2#1)
than the current##3##3##(1997-1#1)(2008-10#2)
than the currently used##2##4##(2008-1#1)(2008-2#1)
than the currently##5##3##(1992-4#1)(1995-3#1)(2008-1#1)(2008-10#1)(2008-2#1)
than the data##2##3##(2008-3#1)(2011-1#1)
than the desired##2##3##(1993-3#1)(1994-8#1)
than the detection limit##3##4##(1996-1#1)(2004-4#1)(2008-10#1)
than the determination of##2##4##(2005-7#1)(2008-10#1)
than the development##2##3##(2008-10#1)(2008-4#1)
than the diffraction##2##3##(2007-12#1)(2008-3#1)
than the diffuse##2##3##(2008-2#1)(2008-3#1)
than the diffusion##3##3##(1991-4#1)(2008-10#1)(2008-7#1)
than the direct##8##3##(1992-3#1)(2007-10#1)(2007-12#2)(2007-5#1)(2008-10#1)(2008-11#1)(2009-2#1)
than the dosages required to remove the same percentage of susceptible isolates##2##12##(1993-10#2)
than the dose of 0##2##5##(2011-1#2)
than the drug##2##3##(1996-5#1)(2012-12#1)
than the effect of##3##4##(1994-11#1)(2008-4#1)(2012-2#1)
than the effects of##2##4##(2008-10#1)(2008-11#1)
than the electron##2##3##(2008-10#2)
than the entire##2##3##(2009-6#1)(2013-1#1)
than the enzyme##3##3##(1990-12#1)(1995-2#1)(1995-3#1)
than the equilibration##2##3##(1992-6#1)(1996-5#1)
than the equivalent##4##3##(2008-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
than the ester-type##2##3##(2008-10#2)
than the existing##2##3##(2008-2#1)(2008-5#1)
than the expected##8##3##(1995-10#1)(1996-2#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-7#1)
than the experimental##2##3##(2005-11#1)(2008-2#1)
than the extracellular##2##3##(1995-11#1)(2009-9#1)
than the film##2##3##(2008-3#1)(2013-7#1)
than the first##10##3##(2005-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-3#2)
than the first-order##2##3##(2008-3#2)
than the former##4##3##(1991-4#1)(2007-8#1)(2008-3#1)(2010-8#1)
than the free##2##3##(1997-1#1)(2009-8#1)
than the frequency##3##3##(1995-8#2)(2008-10#1)
than the full##2##3##(2008-3#2)
than the gain##2##3##(2008-3#1)(2008-4#1)
than the gamma##3##3##(1990-12#1)(1996-2#1)(2007-12#1)
than the general population##14##4##(1995-12#1)(1995-4#1)(1996-3#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-8#1)(2009-6#1)(2010-8#1)(2012-12#1)(2013-1#2)
than the general##17##3##(1995-12#1)(1995-4#1)(1996-3#1)(1996-5#1)(2006-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-8#1)(2009-6#1)(2010-8#1)(2012-12#2)(2013-1#2)
than the gross domestic product##2##5##(1993-3#1)(1996-2#1)
than the group##5##3##(1997-8#1)(2006-2#1)(2008-10#1)(2009-5#1)(2012-2#1)
than the healthy##2##3##(1997-6#1)(2007-9#1)
than the high##3##3##(1991-2#1)(2008-3#1)(2013-7#1)
than the highly##2##3##(2010-12#1)(2012-2#1)
than the human##4##3##(1997-4#1)(2007-11#1)(2007-8#1)(2011-1#1)
than the husbands##2##3##(2008-5#1)(2008-9#1)
than the hydrophilic##2##3##(1993-6#1)(2008-5#1)
than the hydrophobic##2##3##(1990-5#1)(2005-11#1)
than the incident##3##3##(2007-12#2)(2008-3#1)
than the increase##2##3##(1992-1#1)(2008-3#1)
than the individual##5##3##(1990-12#1)(2008-8#1)(2009-3#1)(2012-2#1)(2013-8#1)
than the initial##5##3##(1991-5#1)(1995-2#1)(1996-12#1)(2008-8#1)(2012-1#1)
than the intermediate##2##3##(1997-4#1)(2009-3#1)
than the isolated##2##3##(1995-8#1)(2013-8#1)
than the isolates##2##3##(2008-10#1)(2008-5#1)
than the late##3##3##(1995-6#1)(2008-9#1)(2011-2#1)
than the lateral##3##3##(1993-6#1)(2008-3#1)(2009-11#1)
than the latter##6##3##(1993-6#1)(1995-9#1)(1996-5#1)(1996-6#1)(2008-10#1)(2008-8#1)
than the level##3##3##(1995-10#1)(1997-2#1)(2008-10#1)
than the ligand##3##3##(2008-10#2)(2008-5#1)
than the light##2##3##(2005-11#1)(2010-5#1)
than the limit of detection##2##5##(2008-10#2)
than the limit of##4##4##(1997-8#1)(2008-10#2)(2011-2#1)
than the low##5##3##(1994-7#1)(1995-12#1)(2006-7#1)(2007-7#1)(2011-2#1)
than the lower##2##3##(2007-4#1)(2011-12#1)
than the lowest##3##3##(1992-12#1)(2006-4#1)(2009-5#1)
than the maize##2##3##(2009-10#1)(2010-10#1)
than the majority##2##3##(2008-2#1)(2010-5#1)
than the male##4##3##(1996-1#1)(2006-3#1)(2008-5#1)(2011-2#1)
than the males##2##3##(2007-3#1)(2007-7#1)
than the marketed##2##3##(2010-1#1)(2010-12#1)
than the maximal##6##3##(1990-7#1)(1991-2#2)(1991-5#1)(1994-11#1)(1996-5#1)
than the maximum##6##3##(1996-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-8#1)(2011-1#1)
than the mean CBF##2##4##(2008-7#2)
than the mean of the components##4##6##(2008-10#4)
than the mean of##9##4##(2005-11#1)(2008-10#7)(2011-1#1)
than the mean##22##3##(1991-12#1)(2005-11#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-7#2)(2009-11#1)(2011-1#3)(2011-2#1)(2013-7#1)
than the measured##2##3##(1993-2#1)(2008-3#1)
than the mechanical##2##3##(1992-3#1)(2005-8#1)
than the medial##2##3##(2007-2#1)(2013-1#1)
than the membrane##2##3##(1990-5#1)(2005-11#1)
than the men##2##3##(2006-8#1)(2013-8#1)
than the metal##2##3##(1995-11#1)(2008-10#1)
than the middle##3##3##(2006-5#1)(2012-12#2)
than the minimal##2##3##(1993-2#1)(2012-3#1)
than the minimum##2##3##(1997-3#1)(2008-2#1)
than the model group##2##4##(1990-12#2)
than the model##4##3##(1990-12#2)(1996-2#1)(2012-3#1)
than the models##2##3##(2007-12#1)(2013-8#1)
than the molecular##2##3##(1994-10#1)(2008-10#1)
than the more##7##3##(1992-6#1)(1993-2#1)(1994-5#1)(2007-2#1)(2008-10#1)(2008-2#2)
than the most##2##3##(2008-10#1)(2012-2#1)
than the mouse##3##3##(1992-11#2)(1992-5#1)
than the national average##9##4##(2007-2#1)(2008-10#3)(2008-11#1)(2008-6#1)(2010-9#3)
than the national##16##3##(1995-4#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-6#2)(2009-6#1)(2010-5#2)(2010-9#3)(2012-12#1)(2012-3#1)
than the native##6##3##(1992-2#1)(1994-5#1)(1997-2#1)(2009-3#1)(2010-9#1)(2012-2#1)
than the natural##2##3##(1994-11#1)(1997-8#1)
than the nature of the##2##5##(1994-7#1)(2008-10#1)
than the nature##3##3##(1994-7#1)(2006-8#1)(2008-10#1)
than the nominal##2##3##(2008-3#1)(2010-8#1)
than the nonadjuvanted subunit vaccine##2##5##(2007-11#2)
than the nonadjuvanted subunit##3##4##(2007-11#3)
than the nonamended##2##3##(2008-10#2)
than the normal##15##3##(1990-7#1)(1992-7#1)(1993-1#1)(1993-3#1)(1997-2#1)(2004-11#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-1#1)(2008-10#1)(2009-10#1)(2009-8#1)(2012-2#1)(2013-7#1)
than the number of##12##4##(1990-4#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
than the number##13##3##(1990-4#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
than the observed mortality##2##4##(2007-8#1)(2008-8#1)
than the observed##6##3##(1996-2#1)(1996-5#1)(1997-2#1)(2007-8#1)(2008-8#1)(2009-12#1)
than the old##2##3##(1992-2#1)(2005-12#1)
than the older drugs##2##4##(2006-10#1)(2008-11#1)
than the older##4##3##(1996-11#1)(2006-10#1)(2008-11#1)(2008-3#1)
than the one##14##3##(1990-11#1)(1991-9#1)(1994-2#1)(1995-8#1)(1996-4#1)(1996-8#1)(2004-12#1)(2008-10#4)(2008-8#1)(2008-9#1)(2010-9#1)
than the ones##3##3##(2006-11#1)(2008-10#1)(2008-8#1)
than the open##3##3##(2007-7#1)(2009-6#1)(2011-2#1)
than the opening##3##3##(1995-2#1)(2008-8#2)
than the opposite##4##3##(1993-2#1)(2008-10#1)(2008-3#1)(2013-1#1)
than the optimal##2##3##(2008-7#1)(2008-8#1)
than the optimum##2##3##(2009-4#1)(2010-12#1)
than the original##12##3##(2006-12#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-11#1)(2013-1#1)
than the other approaches##2##4##(2007-8#1)(2008-2#1)
than the other components##2##4##(2008-10#1)(2008-4#1)
than the other four##2##4##(2008-10#2)
than the other group##2##4##(1992-8#1)(2008-11#1)
than the other groups##3##4##(1991-2#1)(2007-8#2)
than the other methods##4##4##(1994-12#1)(2008-2#2)(2013-7#1)
than the other species##3##4##(2006-8#1)(2008-10#1)(2011-12#1)
than the other three##7##4##(1992-7#1)(1997-6#1)(2007-8#1)(2009-11#1)(2010-2#1)(2011-1#1)(2013-8#1)
than the other treatments##3##4##(2007-5#1)(2008-10#1)(2011-2#1)
than the other two methods##3##5##(1994-9#1)(1995-2#1)(2008-10#1)
than the other two##14##4##(1994-9#1)(1995-2#1)(2004-11#1)(2006-6#1)(2008-10#4)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#1)(2012-11#1)(2013-8#1)
than the other##96##3##(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-7#1)(1992-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-2#2)(1995-9#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#3)(1997-6#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#4)(2008-10#15)(2008-11#3)(2008-12#3)(2008-2#6)(2008-4#2)(2008-5#3)(2008-7#2)(2008-9#1)(2009-11#1)(2010-2#1)(2010-4#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
than the others##19##3##(1991-11#1)(1993-3#1)(1996-12#1)(1996-9#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-7#1)(2008-10#2)(2008-5#4)(2008-7#1)(2012-3#1)(2013-1#1)(2013-7#1)
than the overall##4##3##(1994-10#1)(1995-3#1)(1997-1#1)(2011-2#1)
than the parent compound##6##4##(1990-12#2)(1993-4#1)(1994-11#1)(1996-7#1)(2008-5#1)
than the parent drug##2##4##(1995-3#1)(2008-8#1)
than the parent strain##2##4##(2013-1#2)
than the parent##21##3##(1990-12#2)(1990-3#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-4#1)(1994-11#1)(1994-8#1)(1995-3#1)(1996-7#1)(1997-6#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-8#1)(2013-1#2)
than the parental cells##2##4##(1993-7#1)(1995-5#1)
than the parental wild-type strain##2##5##(1993-3#1)(2010-12#1)
than the parental##9##3##(1992-4#1)(1993-3#1)(1993-7#1)(1994-12#1)(1995-5#1)(1996-9#1)(2008-10#2)(2010-12#1)
than the patients##3##3##(1992-6#1)(2007-1#1)(2007-8#1)
than the peripheral##2##3##(1990-8#1)(1995-6#1)
than the phase##2##3##(2007-11#1)(2011-2#1)
than the phosphate##2##3##(1991-9#1)(1994-8#1)
than the physical##2##3##(1995-1#1)(2008-3#1)
than the population##2##3##(1991-3#1)(2007-12#1)
than the power##3##3##(2008-1#1)(2008-2#1)(2012-3#1)
than the preferred##2##3##(2011-1#1)(2011-2#1)
than the present##3##3##(1990-5#1)(2008-10#1)(2013-7#1)
than the prevalence##3##3##(2007-2#2)(2010-12#1)
than the previous one##2##4##(2006-12#1)(2008-3#1)
than the previous##10##3##(1992-6#1)(1995-2#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-7#1)(2011-1#1)
than the previously used##2##4##(1993-4#1)(2012-3#1)
than the previously##8##3##(1991-5#1)(1993-4#1)(1996-8#1)(1997-4#1)(2007-11#1)(2008-10#1)(2011-1#1)(2012-3#1)
than the proportion of##2##4##(1990-10#1)(1994-12#1)
than the protein##2##3##(2008-10#1)(2010-10#1)
than the published##2##3##(1992-2#1)(2012-3#1)
than the pulse##2##3##(2007-12#1)(2008-2#1)
than the racemic mixture##2##4##(2006-12#1)(2008-10#1)
than the range##3##3##(2004-11#1)(2008-8#2)
than the rat and##2##4##(1990-3#1)(1995-7#1)
than the rat##3##3##(1990-3#1)(1995-10#1)(1995-7#1)
than the rate for##2##4##(1994-2#1)(2006-9#1)
than the rate of##8##4##(1991-8#1)(1993-11#1)(1995-10#1)(2008-10#2)(2008-7#1)(2010-5#1)(2013-1#1)
than the rate##13##3##(1991-8#1)(1993-11#1)(1993-7#1)(1994-2#1)(1995-10#1)(1997-1#1)(2006-9#1)(2008-10#3)(2008-7#1)(2010-5#1)(2013-1#1)
than the recommended##4##3##(1997-3#1)(2005-3#1)(2011-1#1)(2012-2#1)
than the recovery of activity##2##5##(1992-3#1)(1995-1#1)
than the reference##8##3##(1994-6#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-9#1)(2010-9#1)
than the referred##3##3##(1995-1#1)(2010-8#1)(2010-9#1)
than the related##2##3##(1995-12#1)(1995-3#1)
than the relative##2##3##(2004-4#1)(2008-5#1)
than the relatively##2##3##(2005-10#1)(2008-2#1)
than the release of##2##4##(1995-1#1)(2006-12#1)
than the release##3##3##(1995-1#1)(1995-12#1)(2006-12#1)
than the reported##2##3##(1990-7#1)(2007-9#1)
than the resistant##2##3##(2008-10#2)
than the respective##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
than the response of##2##4##(2008-10#1)(2008-9#1)
than the response##4##3##(1990-4#1)(1996-2#1)(2008-10#1)(2008-9#1)
than the rest of the##3##5##(1997-7#1)(2008-10#1)(2008-2#1)
than the results##4##3##(2005-10#1)(2007-12#1)(2008-10#1)(2008-2#1)
than the right##2##3##(1993-9#1)(2010-2#1)
than the role##2##3##(2006-6#1)(2010-10#1)
than the same##5##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)
than the sample##3##3##(1993-2#1)(2007-12#1)(2010-7#1)
than the second##3##3##(1990-3#1)(1995-12#1)(1995-2#1)
than the sensitive##2##3##(1992-2#1)(1995-1#1)
than the simple##3##3##(2006-4#1)(2008-2#2)
than the single##6##3##(1990-3#1)(1996-4#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-12#1)
than the skin depth##2##4##(2008-2#1)(2008-3#1)
than the skin##5##3##(1997-6#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#1)
than the slope##2##3##(2008-3#1)(2009-8#1)
than the specific##2##3##(2008-10#1)(2008-5#1)
than the spectral##2##3##(2007-11#1)(2008-4#1)
than the standard##14##3##(1993-12#1)(1994-9#1)(1995-7#1)(2007-12#2)(2008-10#1)(2008-2#4)(2008-4#2)(2008-7#1)(2012-12#1)
than the stirred tank bioreactor##2##5##(2008-11#2)
than the stress##2##3##(1995-12#1)(2008-3#1)
than the substrate##3##3##(1992-6#1)(1994-12#1)(2005-11#1)
than the sum of the##4##5##(1990-6#1)(2006-2#1)(2008-4#1)(2009-10#1)
than the sum of##6##4##(1990-6#1)(1996-6#1)(2006-2#1)(2008-11#1)(2008-4#1)(2009-10#1)
than the sunscreen##2##3##(2008-5#1)(2012-12#1)
than the surrounding##7##3##(1996-4#1)(2007-5#1)(2008-2#4)(2008-5#1)
than the synthetic##2##3##(2007-1#1)(2012-12#1)
than the system##2##3##(2008-10#1)(2008-2#1)
than the target##3##3##(1990-12#1)(2007-12#1)(2008-10#1)
than the temperature##2##3##(1990-12#1)(1996-2#1)
than the theoretical##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
than the thickness##2##3##(2007-12#1)(2012-2#1)
than the three##2##3##(1993-3#1)(2008-8#1)
than the threshold for##3##4##(1993-9#1)(2011-2#1)(2012-1#1)
than the threshold##4##3##(1993-9#1)(2008-10#1)(2011-2#1)(2012-1#1)
than the total amount##2##4##(1995-12#1)(2008-1#1)
than the total number of##2##5##(2007-12#1)(2008-4#1)
than the total population of long-term care patients##2##8##(1995-3#2)
than the total##8##3##(1995-12#1)(1995-3#2)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)
than the traditional method##2##4##(2007-12#1)(2010-8#1)
than the traditional methods##2##4##(2005-12#1)(2008-10#1)
than the traditional##19##3##(2005-1#1)(2005-12#1)(2006-5#2)(2007-11#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-11#1)(2010-8#1)(2012-12#1)(2013-1#1)
than the true##2##3##(1991-9#1)(1995-6#1)
than the two other##2##4##(1996-9#1)(2007-6#1)
than the two##6##3##(1994-5#1)(1996-9#1)(2004-11#1)(2006-3#1)(2007-6#1)(2013-1#1)
than the type##2##3##(2009-7#1)(2009-9#1)
than the typical##2##3##(2007-12#1)(2008-2#1)
than the underlying##2##3##(1994-5#1)(2013-1#1)
than the unmodified##2##3##(1997-6#1)(2005-11#1)
than the uptake##2##3##(1994-6#1)(1995-1#1)
than the use of the##2##5##(1997-4#1)(2008-5#1)
than the use of##5##4##(1997-4#1)(2008-3#2)(2008-5#2)
than the user and non-user controls##2##6##(1996-10#1)(1996-7#1)
than the user##4##3##(1996-10#2)(1996-7#2)
than the usual##6##3##(1992-11#1)(1993-12#1)(1993-8#1)(2008-3#1)(2009-12#1)(2012-12#1)
than the vaccine##2##3##(1992-10#1)(1997-6#1)
than the value of##3##4##(1996-11#1)(2008-10#1)(2008-11#1)
than the value##6##3##(1991-1#1)(1996-11#1)(2005-11#1)(2008-10#1)(2008-11#1)(2012-2#1)
than the values for##2##4##(1997-7#1)(2004-4#1)
than the values obtained##2##4##(1992-6#1)(2007-4#1)
than the values##7##3##(1992-6#1)(1997-7#1)(2004-4#1)(2006-12#1)(2007-4#1)(2008-2#1)(2008-7#1)
than the variation##3##3##(2007-3#1)(2008-10#1)(2008-4#1)
than the volume##2##3##(2007-10#1)(2008-7#1)
than the wavelength##6##3##(2007-11#1)(2008-2#2)(2008-3#3)
than the width##2##3##(2008-10#1)(2008-3#1)
than the wild type and##2##5##(1993-3#1)(2008-11#1)
than the wild type##10##4##(1993-3#1)(1994-2#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-4#1)(2008-10#3)(2008-11#1)
than the wild##12##3##(1993-3#1)(1994-2#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#4)(2008-11#1)
than the wild-type enzyme##6##4##(1993-8#1)(1994-9#2)(1995-2#1)(1995-8#1)(1997-6#1)
than the wild-type protein##2##4##(1994-5#1)(2011-1#1)
than the wild-type strain##3##4##(2008-10#3)
than the wild-type##22##3##(1992-7#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-9#2)(1995-2#2)(1995-8#2)(1996-2#1)(1996-7#1)(1997-6#1)(2006-12#1)(2008-10#4)(2008-5#1)(2009-2#1)(2011-1#1)(2012-2#1)
than the young##4##3##(1991-6#1)(1993-4#1)(1994-12#1)(2006-9#1)
than the younger group##2##4##(2006-8#1)(2010-2#1)
than the younger##3##3##(1996-6#1)(2006-8#1)(2010-2#1)
than the##2197##2##(1990-10#3)(1990-11#9)(1990-12#11)(1990-2#7)(1990-3#10)(1990-4#8)(1990-5#8)(1990-6#2)(1990-7#11)(1990-8#5)(1990-9#3)(1991-1#2)(1991-10#4)(1991-11#8)(1991-12#6)(1991-2#10)(1991-3#5)(1991-4#6)(1991-5#12)(1991-6#2)(1991-7#4)(1991-8#4)(1991-9#14)(1992-1#3)(1992-10#2)(1992-11#4)(1992-12#4)(1992-2#7)(1992-3#6)(1992-4#5)(1992-5#6)(1992-6#11)(1992-7#7)(1992-8#6)(1992-9#9)(1993-1#3)(1993-10#2)(1993-11#7)(1993-12#12)(1993-2#12)(1993-3#15)(1993-4#5)(1993-6#7)(1993-7#3)(1993-8#5)(1993-9#7)(1994-1#1)(1994-10#4)(1994-11#10)(1994-12#12)(1994-2#5)(1994-3#10)(1994-4#2)(1994-5#11)(1994-6#7)(1994-7#3)(1994-8#10)(1994-9#8)(1995-1#13)(1995-10#7)(1995-11#9)(1995-12#12)(1995-2#19)(1995-3#21)(1995-4#2)(1995-5#9)(1995-6#7)(1995-7#3)(1995-8#10)(1995-9#4)(1996-1#7)(1996-10#6)(1996-11#8)(1996-12#11)(1996-2#14)(1996-3#7)(1996-4#10)(1996-5#12)(1996-6#11)(1996-7#8)(1996-8#7)(1996-9#10)(1997-1#7)(1997-2#19)(1997-3#7)(1997-4#20)(1997-5#3)(1997-6#12)(1997-7#6)(1997-8#11)(1997-9#1)(2004-1#1)(2004-11#5)(2004-12#1)(2004-2#3)(2004-3#1)(2004-4#5)(2004-9#3)(2005-1#1)(2005-10#2)(2005-11#21)(2005-12#4)(2005-3#2)(2005-4#1)(2005-7#4)(2005-8#7)(2005-9#1)(2006-1#1)(2006-10#16)(2006-11#8)(2006-12#17)(2006-2#8)(2006-3#3)(2006-4#6)(2006-5#10)(2006-6#5)(2006-7#8)(2006-8#18)(2006-9#5)(2007-1#10)(2007-10#14)(2007-11#38)(2007-12#64)(2007-2#12)(2007-3#5)(2007-4#5)(2007-5#4)(2007-6#8)(2007-7#14)(2007-8#28)(2007-9#6)(2008-1#12)(2008-10#242)(2008-11#43)(2008-12#9)(2008-2#88)(2008-3#97)(2008-4#24)(2008-5#79)(2008-6#8)(2008-7#41)(2008-8#35)(2008-9#21)(2009-10#6)(2009-11#4)(2009-12#5)(2009-2#4)(2009-3#6)(2009-4#9)(2009-5#5)(2009-6#11)(2009-7#3)(2009-8#8)(2009-9#8)(2010-1#3)(2010-10#7)(2010-11#4)(2010-12#11)(2010-2#10)(2010-3#5)(2010-4#9)(2010-5#10)(2010-6#1)(2010-7#8)(2010-8#15)(2010-9#11)(2011-1#31)(2011-12#7)(2011-2#40)(2012-1#13)(2012-11#3)(2012-12#26)(2012-2#29)(2012-3#19)(2013-1#48)(2013-7#16)(2013-8#30)
than their Black##2##3##(2009-7#1)(2011-2#1)
than their ability to##2##4##(1991-1#1)(2005-11#1)
than their corresponding##7##3##(1992-7#1)(1997-2#1)(2006-12#2)(2007-4#1)(2008-1#1)(2008-4#1)
than their counterpart in the##2##5##(1994-12#1)(2006-11#1)
than their counterparts##6##3##(1996-3#1)(2006-4#1)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)
than their family##2##3##(1996-3#1)(2011-2#1)
than their female counterparts##4##4##(1996-3#1)(2007-6#1)(2013-1#2)
than their intrinsic features##2##4##(1995-12#2)
than their low##2##3##(2009-4#1)(2009-7#1)
than their male colleagues##3##4##(1991-6#1)(1995-6#1)(1997-6#1)
than their male##4##3##(1991-6#1)(1995-6#1)(1997-6#1)(2009-1#1)
than their normal##3##3##(2005-9#1)(2008-10#1)(2008-6#1)
than their own##2##3##(2008-3#1)(2010-8#1)
than their parental##2##3##(2008-10#2)
than their peers##2##3##(1993-1#1)(2011-1#1)
than their younger##2##3##(2010-9#1)(2013-1#1)
than their##134##2##(1990-12#1)(1991-1#2)(1991-3#1)(1991-6#1)(1991-8#2)(1992-2#2)(1992-7#1)(1992-8#1)(1993-1#1)(1993-2#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-3#3)(1996-5#1)(1996-8#1)(1997-2#1)(1997-6#2)(2004-9#1)(2005-10#2)(2005-11#1)(2005-9#1)(2006-11#2)(2006-12#2)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-12#6)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#3)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#3)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-11#1)(2012-2#3)(2012-3#3)(2013-1#4)
than these##5##2##(1994-9#1)(1996-9#1)(2008-1#1)(2008-7#1)(2009-2#1)
than they are##3##3##(1992-11#1)(1995-2#1)(2006-4#1)
than they did##2##3##(1993-12#1)(2010-2#1)
than they had##2##3##(1997-2#1)(2006-9#1)
than they were in controls##3##5##(1990-5#2)(1995-6#1)
than they were in##7##4##(1990-5#2)(1995-6#1)(2007-3#1)(2008-4#1)(2009-12#1)(2010-3#1)
than they were##9##3##(1990-5#2)(1991-11#1)(1995-6#1)(2007-3#1)(2008-10#1)(2008-4#1)(2009-12#1)(2010-3#1)
than they would##2##3##(1993-12#1)(1997-1#1)
than they##30##2##(1990-5#2)(1991-11#1)(1992-11#1)(1992-4#1)(1992-7#1)(1993-12#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-6#1)(1997-1#1)(1997-2#1)(2005-7#1)(2006-4#1)(2006-9#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-2#2)(2010-3#1)(2013-1#1)
than thioredoxin m##2##3##(1990-12#2)
than thirty##5##2##(1991-5#1)(2007-10#1)(2007-7#1)(2007-8#1)(2013-1#1)
than this##5##2##(1992-9#1)(1997-4#1)(2008-8#1)(2009-10#1)(2012-2#1)
than those achievable with##2##4##(2007-12#1)(2008-10#1)
than those associated##2##3##(1992-9#1)(2012-12#1)
than those at the##2##4##(1993-7#1)(2008-5#1)
than those at##13##3##(1993-7#1)(1994-8#1)(2005-11#1)(2007-6#1)(2007-9#1)(2008-11#1)(2008-5#2)(2009-3#1)(2010-4#1)(2010-8#1)(2012-12#1)(2013-8#1)
than those based on##6##4##(1992-1#1)(2008-2#1)(2008-5#1)(2008-7#1)(2013-1#1)(2013-8#1)
than those before##3##3##(2008-10#1)(2008-8#1)(2009-10#1)
than those by##4##3##(1990-8#1)(1992-4#1)(2008-10#1)(2012-1#1)
than those calculated##2##3##(1990-12#1)(1990-8#1)
than those caused by##3##4##(2008-10#2)(2008-5#1)
than those collected from##2##4##(2008-10#1)(2012-3#1)
than those collected##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
than those containing##3##3##(1994-9#1)(2008-10#1)(2008-5#1)
than those currently##2##3##(2008-11#1)(2008-2#1)
than those derived from##2##4##(1996-8#1)(2006-5#1)
than those derived##3##3##(1996-8#1)(2006-5#1)(2007-10#1)
than those described##2##3##(1990-6#1)(2013-7#1)
than those due to##2##4##(1992-1#1)(2005-11#1)
than those enrolled##2##3##(1991-12#1)(2010-3#1)
than those exposed to##3##4##(1996-10#1)(2008-10#1)(2008-9#1)
than those fed with##2##4##(2008-6#1)(2009-9#1)
than those fed##6##3##(2007-8#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-9#1)
than those for other##2##4##(2007-1#1)(2013-8#1)
than those for the##9##4##(1995-5#1)(2005-11#1)(2007-9#1)(2008-10#3)(2008-11#1)(2010-8#1)(2012-3#1)
than those for##23##3##(1990-10#1)(1992-3#1)(1993-9#1)(1995-3#1)(1995-5#1)(1997-3#1)(2005-10#1)(2005-11#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-8#1)
than those found in##4##4##(1995-3#1)(2007-4#1)(2012-2#1)(2013-1#1)
than those found##5##3##(1995-3#1)(2007-4#1)(2008-10#1)(2012-2#1)(2013-1#1)
than those from BALB/c mice##2##5##(1996-12#2)
than those from HDL##2##4##(1996-4#2)
than those from conventional##2##4##(2007-11#1)(2008-11#1)
than those from the control group##2##6##(2004-11#1)(2008-12#1)
than those from the control##3##5##(2004-11#1)(2008-12#1)(2011-12#1)
than those from the other##2##5##(2008-12#1)(2010-5#1)
than those from the##14##4##(1993-2#1)(2004-11#1)(2006-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2010-11#1)(2010-5#1)(2011-12#1)
than those from##36##3##(1991-12#1)(1991-5#1)(1993-2#1)(1993-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-4#2)(2004-11#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-3#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-5#1)(2011-12#1)(2013-7#1)
than those generated by##2##4##(1995-8#1)(2013-1#1)
than those grown##4##3##(1991-3#1)(1994-12#1)(1996-12#1)(2007-12#1)
than those having##4##3##(1997-4#1)(2008-10#1)(2008-7#1)(2009-2#1)
than those implanted##2##3##(2005-10#1)(2008-9#1)
than those imposed by##2##4##(1994-3#1)(2011-2#1)
than those in Group##3##4##(2007-2#1)(2011-2#1)(2013-1#1)
than those in ambient##2##4##(2008-10#1)(2008-7#1)
than those in cholesterol-normal platelets##2##5##(1990-12#2)
than those in control rats##2##5##(1995-3#1)(2007-10#1)
than those in control##5##4##(1995-3#1)(2007-10#1)(2009-8#1)(2012-12#1)(2013-1#1)
than those in controls##2##4##(1995-6#1)(1997-1#1)
than those in group##2##4##(2007-9#1)(2010-7#1)
than those in normal##3##4##(2005-4#1)(2008-4#1)(2013-8#1)
than those in other##4##4##(1993-3#1)(2008-10#2)(2008-12#1)
than those in the adult##2##5##(1990-5#1)(1996-9#1)
than those in the control and preoperative groups##2##8##(1997-1#2)
than those in the control group##4##6##(2007-8#1)(2008-12#1)(2008-9#1)(2011-2#1)
than those in the control##9##5##(1997-1#2)(2007-8#1)(2008-12#1)(2008-9#2)(2011-2#2)(2013-8#1)
than those in the group##2##5##(1994-12#1)(2013-1#1)
than those in the non-violent group##2##6##(1997-8#2)
than those in the other##2##5##(1991-11#1)(2007-2#1)
than those in the##55##4##(1990-5#1)(1991-11#1)(1991-5#1)(1992-12#1)(1992-5#1)(1993-4#1)(1994-10#1)(1994-12#1)(1994-3#1)(1996-10#1)(1996-7#2)(1996-9#1)(1997-1#2)(1997-8#3)(2004-11#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-10#2)(2007-2#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#6)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
than those in##139##3##(1990-1#1)(1990-12#2)(1990-3#1)(1990-5#1)(1991-11#1)(1991-5#1)(1992-12#1)(1992-5#1)(1992-7#2)(1993-3#1)(1993-4#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#4)(1996-10#1)(1996-3#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#3)(1997-3#1)(1997-5#2)(1997-8#3)(2004-11#1)(2004-4#1)(2005-10#1)(2005-12#1)(2005-3#1)(2005-4#1)(2005-8#2)(2006-1#1)(2006-12#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-10#3)(2007-11#1)(2007-2#4)(2007-3#1)(2007-6#1)(2007-8#3)(2007-9#1)(2008-10#11)(2008-11#4)(2008-12#5)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#6)(2009-11#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#6)
than those incubated at NC##2##5##(2008-5#2)
than those incubated##3##3##(2006-5#1)(2008-5#2)
than those induced by CPT##2##5##(1995-5#2)
than those induced by##8##4##(1991-12#1)(1991-9#1)(1993-3#1)(1995-5#2)(2007-1#1)(2008-8#1)(2011-2#1)
than those living##2##3##(1997-3#1)(2013-1#1)
than those made##2##3##(1996-5#1)(2010-4#1)
than those measured for##3##4##(1990-8#1)(1995-1#1)(2006-8#1)
than those measured in##3##4##(1991-6#1)(2004-4#1)(2006-9#1)
than those measured##7##3##(1990-8#1)(1991-6#1)(1995-1#1)(2004-4#1)(2006-8#1)(2006-9#1)(2008-10#1)
than those not##3##3##(2008-4#1)(2010-8#1)(2011-2#1)
than those observed after##2##4##(1995-5#1)(2008-5#1)
than those observed for##4##4##(1993-9#1)(2006-10#1)(2008-10#2)
than those observed in##6##4##(1997-7#1)(2005-11#1)(2006-10#1)(2010-4#1)(2012-2#1)(2013-1#1)
than those observed##14##3##(1990-2#1)(1993-9#1)(1995-5#1)(1997-7#1)(2005-11#1)(2006-10#2)(2008-10#2)(2008-5#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
than those obtained at##2##4##(2008-10#1)(2008-2#1)
than those obtained by the##6##5##(1990-8#1)(2005-4#1)(2008-10#2)(2008-11#1)(2008-2#1)
than those obtained by##14##4##(1990-10#1)(1990-8#1)(2005-4#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-7#1)(2012-3#1)
than those obtained for##2##4##(2008-10#1)(2009-2#1)
than those obtained from##6##4##(1994-11#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-10#1)
than those obtained in a##2##5##(2008-11#2)
than those obtained in the##3##5##(1995-12#1)(2005-11#1)(2008-10#1)
than those obtained in##7##4##(1992-6#1)(1995-12#1)(2005-11#1)(2006-8#1)(2008-10#1)(2008-11#2)
than those obtained using##2##4##(1995-3#1)(2008-10#1)
than those obtained with the other##2##6##(2008-10#2)
than those obtained with the##5##5##(2004-8#1)(2008-10#3)(2009-3#1)
than those obtained with##10##4##(2004-8#1)(2006-6#1)(2008-10#5)(2008-5#1)(2009-3#1)(2011-2#1)
than those obtained without##2##4##(2008-10#1)(2010-2#1)
than those obtained##49##3##(1990-10#1)(1990-8#1)(1992-6#1)(1994-11#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-6#1)(1997-7#1)(2004-8#1)(2005-11#1)(2005-4#1)(2006-6#1)(2006-8#1)(2007-11#1)(2008-10#19)(2008-11#4)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-3#1)(2010-2#1)(2011-2#1)(2012-3#1)
than those of a##3##4##(1997-3#1)(2008-3#1)(2012-2#1)
than those of control##3##4##(1990-4#1)(1993-12#1)(1994-8#1)
than those of controls##3##4##(1996-1#1)(1996-3#1)(2008-9#1)
than those of conventional##3##4##(2007-12#1)(2008-10#1)(2010-4#1)
than those of females##2##4##(2007-12#1)(2009-8#1)
than those of group II##2##5##(2008-10#2)
than those of healthy##2##4##(2008-10#1)(2011-12#1)
than those of normal##4##4##(1992-3#1)(1993-9#1)(1996-6#1)(2008-5#1)
than those of other##8##4##(1991-4#1)(1992-9#1)(2004-4#1)(2008-10#1)(2008-2#1)(2009-7#1)(2011-1#1)(2012-1#1)
than those of the control group##6##6##(1994-3#1)(2008-10#1)(2008-9#4)
than those of the control##14##5##(1993-9#1)(1994-11#1)(1994-3#1)(2008-1#1)(2008-10#2)(2008-9#8)
than those of the controls after weeks##2##7##(2008-8#1)(2008-9#1)
than those of the controls##9##5##(2008-5#1)(2008-8#2)(2008-9#6)
than those of the corresponding##2##5##(1993-8#1)(1995-11#1)
than those of the latter##2##5##(2008-5#1)(2008-8#1)
than those of the normal controls##2##6##(2008-10#2)
than those of the original##2##5##(1990-5#1)(2008-5#1)
than those of the other##2##5##(2008-3#1)(2010-4#1)
than those of the polymer brushes without charges##2##8##(2005-11#2)
than those of the vehicle controls at##3##7##(2008-9#3)
than those of the vehicle controls##21##6##(2008-9#21)
than those of the vehicle##22##5##(2008-9#22)
than those of the wild-type strain##2##6##(2008-10#2)
than those of the wild-type##3##5##(2006-9#1)(2008-10#2)
than those of the young##2##5##(1995-6#1)(1995-8#1)
than those of the##100##4##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#3)(1991-11#1)(1993-11#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-6#2)(1995-8#1)(1997-2#1)(1997-8#1)(2004-9#1)(2005-11#4)(2006-11#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#36)(2009-5#1)(2010-4#1)(2011-1#2)(2011-2#1)(2011-3#1)(2013-1#1)
than those of their##2##4##(1992-2#1)(2008-12#1)
than those of type##2##4##(2005-10#1)(2008-1#1)
than those of unoriented IPMCs##2##5##(2010-4#2)
than those of untreated##2##4##(2007-12#1)(2008-5#1)
than those of wild-type##2##4##(1995-5#1)(2008-8#1)
than those of younger##2##4##(2006-11#1)(2009-4#1)
than those of##260##3##(1990-11#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#4)(1990-6#2)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-9#2)(1993-11#1)(1993-12#3)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-1#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-3#1)(1996-6#3)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#3)(2004-11#2)(2004-12#1)(2004-4#2)(2004-9#2)(2005-10#1)(2005-11#5)(2006-10#1)(2006-11#3)(2006-12#1)(2006-4#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#6)(2007-2#1)(2007-3#2)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#26)(2008-11#5)(2008-12#3)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#16)(2008-6#2)(2008-7#4)(2008-8#7)(2008-9#37)(2009-10#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#5)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
than those on the##3##4##(2006-4#1)(2008-5#1)(2011-2#1)
than those on##7##3##(1993-3#1)(1996-5#1)(2006-4#1)(2008-10#2)(2008-5#1)(2011-2#1)
than those perceived by their peers##2##6##(2008-10#2)
than those predicted##3##3##(1991-8#1)(1994-8#1)(2006-5#1)
than those prepared from##2##4##(2008-11#1)(2010-4#1)
than those previously reported for##2##5##(1995-5#1)(2012-1#1)
than those previously reported in the literature##2##7##(1994-11#1)(2008-9#1)
than those previously reported##6##4##(1993-2#1)(1994-11#1)(1995-5#1)(2008-10#1)(2008-9#1)(2012-1#1)
than those previously##7##3##(1993-2#1)(1994-11#1)(1995-5#1)(2006-11#1)(2008-10#1)(2008-9#1)(2012-1#1)
than those produced by##5##4##(1996-9#1)(2008-10#2)(2008-2#2)
than those produced##8##3##(1996-8#1)(1996-9#1)(2008-10#4)(2008-2#2)
than those receiving##4##3##(1995-4#1)(2007-12#1)(2007-2#1)(2012-12#1)
than those recorded##2##3##(1990-6#1)(1994-6#1)
than those related to the##2##5##(1992-11#1)(2008-10#1)
than those reported for##2##4##(1995-7#1)(2008-5#1)
than those reported from##3##4##(1991-8#1)(2006-5#1)(2007-7#1)
than those reported in##2##4##(2008-11#1)(2010-9#1)
than those reported previously##2##4##(2007-11#1)(2008-10#1)
than those reported##9##3##(1991-8#1)(1995-7#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-9#1)
than those required by##2##4##(1992-6#1)(2011-2#1)
than those required for##4##4##(1990-7#1)(1994-3#1)(1995-3#1)(2007-11#1)
than those required to##3##4##(1990-7#1)(1992-11#1)(1994-5#1)
than those required##11##3##(1990-7#2)(1991-2#1)(1992-11#1)(1992-6#1)(1994-3#2)(1994-5#1)(1995-3#1)(2007-11#1)(2011-2#1)
than those seen in##4##4##(1991-12#1)(2008-10#1)(2012-12#2)
than those seen##7##3##(1991-12#1)(1992-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#2)
than those shown##2##3##(2007-9#1)(2012-2#1)
than those that are##2##4##(2007-8#1)(2008-2#1)
than those that did not##2##5##(2007-10#1)(2007-12#1)
than those that follow##2##4##(2008-2#2)
than those that##20##3##(1991-5#1)(1993-3#1)(1996-2#1)(1997-6#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-2#6)(2008-3#2)(2008-8#1)(2010-8#1)
than those treated with##2##4##(2008-3#1)(2010-12#1)
than those used in##3##4##(2008-9#2)(2010-3#1)
than those using##3##3##(2005-8#1)(2008-10#1)(2009-7#1)
than those where##2##3##(1994-6#1)(2008-9#1)
than those which##2##3##(1997-2#1)(2010-8#1)
than those who did not become ill abroad##2##8##(2007-2#2)
than those who did not handle##2##6##(2007-12#2)
than those who did not##10##5##(1991-8#1)(1993-3#1)(2004-12#1)(2004-3#1)(2006-9#2)(2007-12#2)(2007-2#2)
than those who had not##2##5##(2007-11#1)(2012-12#1)
than those who had##4##4##(2007-10#1)(2007-11#1)(2011-1#1)(2012-12#1)
than those who have##2##4##(1994-4#1)(2008-1#1)
than those who were##5##4##(1991-7#1)(2007-2#2)(2008-8#1)(2013-8#1)
than those who##32##3##(1991-7#1)(1991-8#1)(1993-1#1)(1993-3#1)(1994-4#1)(1994-8#1)(2004-12#1)(2004-3#1)(2006-9#2)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#4)(2007-9#1)(2008-1#1)(2008-4#1)(2008-8#1)(2009-5#2)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
than those with a##3##4##(1991-12#1)(2007-6#1)(2008-10#1)
than those with less than##2##5##(1993-9#1)(2008-8#1)
than those with lower##2##4##(1994-2#1)(1997-8#1)
than those with mild##2##4##(1995-3#1)(2008-11#1)
than those with no##5##4##(1994-2#1)(1995-4#1)(2006-1#1)(2007-12#1)(2008-9#1)
than those with only##2##4##(1993-2#1)(2008-7#1)
than those with the##5##4##(1992-8#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-2#1)
than those with##45##3##(1990-2#1)(1991-12#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-3#1)(1995-11#1)(1995-3#1)(1995-4#1)(1996-2#1)(1997-8#1)(2006-1#1)(2006-11#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)
than those without DP##2##4##(2013-1#2)
than those without a##3##4##(2007-1#1)(2007-10#1)(2008-9#1)
than those without the##3##4##(1992-11#1)(2007-4#1)(2008-5#1)
than those without##30##3##(1992-1#1)(1992-11#1)(1993-1#1)(1994-12#1)(1996-2#1)(1997-1#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-10#2)(2007-4#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#1)
than those##928##2##(1990-1#1)(1990-10#2)(1990-11#1)(1990-12#4)(1990-2#3)(1990-3#3)(1990-4#1)(1990-5#5)(1990-6#4)(1990-7#2)(1990-8#5)(1991-11#2)(1991-12#7)(1991-2#2)(1991-3#4)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#2)(1991-8#3)(1991-9#1)(1992-1#5)(1992-11#4)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#3)(1992-5#1)(1992-6#6)(1992-7#2)(1992-8#1)(1992-9#5)(1993-1#2)(1993-11#1)(1993-12#4)(1993-2#4)(1993-3#6)(1993-4#2)(1993-7#2)(1993-8#3)(1993-9#8)(1994-1#1)(1994-10#2)(1994-11#5)(1994-12#4)(1994-2#4)(1994-3#7)(1994-4#2)(1994-5#4)(1994-6#3)(1994-7#1)(1994-8#4)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#6)(1995-4#3)(1995-5#8)(1995-6#4)(1995-7#1)(1995-8#6)(1996-1#3)(1996-10#2)(1996-11#4)(1996-12#3)(1996-2#3)(1996-3#2)(1996-4#3)(1996-5#5)(1996-6#5)(1996-7#3)(1996-8#3)(1996-9#2)(1997-1#5)(1997-2#2)(1997-3#6)(1997-4#1)(1997-5#3)(1997-6#4)(1997-7#2)(1997-8#7)(2004-11#4)(2004-12#2)(2004-3#1)(2004-4#5)(2004-8#1)(2004-9#4)(2005-10#4)(2005-11#11)(2005-12#1)(2005-3#1)(2005-4#2)(2005-8#4)(2006-1#2)(2006-10#6)(2006-11#5)(2006-12#5)(2006-2#1)(2006-3#2)(2006-4#2)(2006-5#5)(2006-6#4)(2006-8#5)(2006-9#4)(2007-1#5)(2007-10#11)(2007-11#10)(2007-12#18)(2007-2#10)(2007-3#5)(2007-4#3)(2007-5#2)(2007-6#3)(2007-7#5)(2007-8#8)(2007-9#7)(2008-1#3)(2008-10#109)(2008-11#22)(2008-12#14)(2008-2#20)(2008-3#11)(2008-4#6)(2008-5#38)(2008-6#6)(2008-7#18)(2008-8#20)(2008-9#53)(2009-10#6)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#3)(2009-4#3)(2009-5#3)(2009-6#3)(2009-7#4)(2009-8#2)(2009-9#1)(2010-11#3)(2010-12#4)(2010-2#3)(2010-3#5)(2010-4#9)(2010-5#2)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#8)(2011-12#2)(2011-2#23)(2011-3#1)(2012-1#6)(2012-12#14)(2012-2#13)(2012-3#7)(2013-1#19)(2013-7#4)(2013-8#11)
than three hours##4##3##(1992-8#2)(1996-11#1)(2008-10#1)
than three months of age##3##5##(1992-1#1)(2008-11#1)(2012-2#1)
than three months##13##3##(1990-12#2)(1991-4#1)(1992-1#1)(1996-3#2)(2007-2#2)(2007-6#1)(2008-11#1)(2008-4#1)(2012-2#1)(2012-3#1)
than three years##3##3##(2006-8#1)(2008-11#1)(2010-9#1)
than three##59##2##(1990-12#2)(1991-4#1)(1992-1#1)(1992-8#3)(1992-9#1)(1993-7#2)(1994-12#1)(1995-11#1)(1995-7#1)(1996-11#1)(1996-3#2)(1997-1#1)(1997-2#2)(1997-3#1)(2005-11#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-2#3)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
than three-dimensional##2##2##(1991-5#1)(2009-11#1)
than through##13##2##(1994-1#2)(1994-10#1)(1994-3#1)(1995-6#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)
than time##2##2##(2007-2#1)(2013-1#1)
than tissue PMNs in##2##4##(1995-1#2)
than tissue##4##2##(1995-1#2)(2006-10#1)(2008-7#1)
than to a##5##3##(1991-2#1)(1992-6#1)(1993-8#1)(1994-9#1)(2008-10#1)
than to changes in the##2##5##(2008-10#1)(2008-8#1)
than to changes in##3##4##(2008-10#2)(2008-8#1)
than to differentials with Pc genes from##2##7##(2008-10#2)
than to laminin##2##3##(1991-5#1)(1992-9#1)
than to lose##2##3##(2007-12#1)(2009-4#1)
than to parental cells##2##4##(1996-6#2)
than to the native##2##4##(1991-5#1)(1997-2#1)
than to the same##2##4##(1992-1#1)(2008-2#1)
than to the##25##3##(1990-12#1)(1990-5#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-12#1)(1995-2#2)(1995-5#1)(1996-2#1)(1997-2#1)(2004-12#1)(2005-11#2)(2006-11#1)(2006-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)
than to those##3##3##(1997-3#1)(2007-10#1)(2008-7#1)
than to##136##2##(1990-10#2)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-7#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-8#2)(1994-11#1)(1994-3#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-7#1)(2004-11#1)(2004-12#1)(2004-9#2)(2005-11#3)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#2)(2006-5#1)(2006-6#2)(2006-7#3)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#17)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#4)(2009-2#1)(2009-4#2)(2009-5#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2012-5#1)(2013-8#2)
than today##2##2##(1992-7#1)(2007-7#1)
than total##5##2##(1993-12#2)(2008-12#1)(2008-4#1)(2011-2#1)
than traditional approaches##3##3##(2008-10#1)(2013-1#2)
than traditional techniques##2##3##(2008-10#1)(2008-2#1)
than traditional##22##2##(1993-12#1)(1994-2#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-7#2)(2008-10#3)(2008-2#2)(2008-6#1)(2008-7#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
than transmission##2##2##(2007-12#1)(2011-3#1)
than treating##3##2##(2006-1#1)(2011-1#1)(2011-2#1)
than treatment with##5##3##(1993-8#1)(1995-5#1)(2007-8#1)(2008-5#1)(2008-8#1)
than treatment##6##2##(1993-8#1)(1995-5#1)(2004-9#1)(2007-8#1)(2008-5#1)(2008-8#1)
than true##4##2##(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
than trying to##3##3##(2007-9#1)(2008-1#1)(2010-9#1)
than tubules##2##2##(1997-1#1)(1997-6#1)
than twenty##4##2##(1993-12#1)(2005-11#1)(2010-11#1)(2011-2#1)
than twice the##9##3##(1990-11#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
than twice##24##2##(1990-11#1)(1991-8#2)(1995-5#1)(2005-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-9#2)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
than two days##2##3##(1991-4#1)(2008-10#1)
than two thirds of##3##4##(2004-12#1)(2007-7#1)(2008-2#1)
than two weeks##6##3##(1991-9#1)(1994-6#1)(1995-11#1)(2007-12#1)(2008-5#1)(2009-2#1)
than two years of age##2##5##(2007-7#1)(2010-10#1)
than two years of##3##4##(2007-7#1)(2010-10#1)(2010-11#1)
than two years##13##3##(1990-12#2)(1990-9#1)(1991-4#1)(1996-3#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-7#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-12#1)
than two##72##2##(1990-12#2)(1990-6#1)(1990-9#1)(1991-11#1)(1991-4#2)(1991-9#1)(1992-8#1)(1994-2#2)(1994-6#2)(1995-1#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-3#1)(1997-4#1)(2004-12#1)(2004-4#1)(2005-8#1)(2006-4#1)(2006-5#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#7)(2007-3#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-9#2)(2009-2#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)
than two-thirds of the##2##4##(2006-11#1)(2008-11#1)
than two-thirds of##5##3##(1996-12#1)(2006-11#1)(2007-11#1)(2008-11#1)(2008-4#1)
than twofold##7##2##(1990-11#1)(1996-3#2)(2007-12#1)(2008-10#2)(2009-5#1)
than type 1##2##3##(1991-1#1)(1993-7#1)
than type 2##2##3##(1992-12#1)(1997-1#1)
than type II##3##3##(1990-4#1)(1993-9#1)(2008-2#1)
than type##7##2##(1990-4#1)(1991-1#1)(1992-12#1)(1993-7#1)(1993-9#1)(1997-1#1)(2008-2#1)
than typically##2##2##(2007-7#1)(2008-8#1)
than unaffected##3##2##(1996-5#1)(1997-3#1)(2008-5#1)
than undamaged plants##2##3##(2008-8#2)
than under furrow irrigation##3##4##(2008-10#3)
than under the##2##3##(1993-12#1)(2007-2#1)
than under##16##2##(1993-12#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-1#1)(2006-5#1)(2006-8#2)(2007-2#1)(2008-10#5)(2012-6#1)(2013-8#1)
than unilateral##3##2##(1993-7#1)(1996-1#1)(2009-4#1)
than uninfected females##2##3##(2012-3#2)
than uninfected##7##2##(1992-7#1)(1993-6#1)(1994-11#1)(2008-10#2)(2012-3#2)
than unity##7##2##(1990-8#2)(1993-3#1)(2008-3#4)
than unmodified##3##2##(2006-10#1)(2006-12#1)(2008-4#1)
than untreated##3##2##(2006-7#1)(2007-12#1)(2011-2#1)
than upon##3##2##(1995-5#1)(2006-10#1)(2010-2#1)
than urban##7##2##(1994-2#1)(1996-3#1)(2006-10#1)(2006-4#1)(2007-12#1)(2013-1#2)
than urine##3##2##(1997-3#2)(2010-8#1)
than use of##4##3##(2008-10#1)(2008-12#1)(2008-3#1)(2013-8#1)
than use##5##2##(1991-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2013-8#1)
than used##3##2##(1991-6#1)(1992-11#1)(2007-6#1)
than using a##7##3##(1994-8#1)(1996-4#1)(2006-11#1)(2007-11#1)(2008-10#1)(2008-5#1)(2013-7#1)
than using only the##2##4##(2008-6#1)(2012-1#1)
than using the##3##3##(2008-2#1)(2008-3#1)(2008-6#1)
than using##19##2##(1994-8#1)(1996-4#1)(2006-11#1)(2007-11#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2010-1#2)(2010-2#1)(2011-1#1)(2012-1#1)(2013-7#1)
than usual##6##2##(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-5#1)(2012-2#1)
than usually##5##2##(1990-3#1)(1990-8#1)(1996-3#1)(2008-10#1)(2013-8#1)
than values for##2##3##(1994-8#1)(2009-8#1)
than values##4##2##(1994-8#1)(1997-4#1)(2007-11#1)(2009-8#1)
than verapamil##2##2##(1997-5#2)
than vertical##2##2##(2007-8#1)(2008-3#1)
than via SC##2##3##(2006-10#2)
than via the##2##3##(1992-11#1)(2010-8#1)
than via##5##2##(1992-11#1)(2006-10#2)(2010-8#1)(2012-1#1)
than vice versa##2##3##(2007-1#1)(2009-9#1)
than viewing##3##2##(2007-12#2)(2009-7#1)
than viral##3##2##(1995-2#1)(2009-7#1)(2009-9#1)
than virus##2##2##(2008-10#1)(2008-11#1)
than visible##2##2##(2007-12#1)(2008-10#1)
than visual##3##2##(1992-11#1)(2008-5#1)(2012-11#1)
than vitamin E##2##3##(2008-5#1)(2013-1#1)
than vitamin##3##2##(2008-5#1)(2008-8#1)(2013-1#1)
than was expected##2##3##(1991-7#1)(2006-11#1)
than was observed##2##3##(2008-5#1)(2008-9#1)
than was originally thought##2##4##(2006-10#1)(2010-12#1)
than was possible##2##3##(1990-10#1)(2008-3#1)
than was previously##5##3##(1995-5#1)(1996-4#1)(2006-5#1)(2007-10#1)(2010-8#1)
than was the##5##3##(1995-8#1)(1997-7#1)(2005-11#1)(2008-1#1)(2008-10#1)
than was##35##2##(1990-10#1)(1990-7#1)(1991-7#1)(1993-9#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-4#1)(1997-1#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-3#2)(2008-1#1)(2008-10#4)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-1#1)
than water##5##2##(1994-10#1)(2006-11#1)(2008-10#1)(2008-8#1)(2010-8#1)
than we##4##2##(1996-3#1)(2007-3#1)(2008-11#1)(2010-12#1)
than weight##2##2##(2007-12#1)(2008-3#1)
than well-nourished##2##2##(2008-11#2)
than were girls##2##3##(2006-7#1)(2008-12#1)
than were the##3##3##(1992-2#1)(2008-10#1)(2008-3#1)
than were their##2##3##(2008-10#1)(2008-9#1)
than were those of##2##4##(1994-11#1)(2008-10#1)
than were those##4##3##(1993-3#1)(1994-11#1)(2008-10#1)(2008-12#1)
than were##38##2##(1990-2#1)(1992-2#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-11#1)(1995-5#1)(1996-12#1)(1997-1#1)(2005-12#1)(2006-4#1)(2006-7#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#7)(2008-12#3)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-9#1)(2013-1#1)(2013-8#2)
than what is##7##3##(2006-10#1)(2007-3#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-6#1)
than what would be expected from the##2##7##(2008-6#1)(2008-7#1)
than what would be##3##4##(2008-6#1)(2008-7#1)(2009-7#1)
than what##14##2##(2006-10#1)(2007-2#1)(2007-3#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#1)(2009-6#1)(2009-7#1)
than when a##3##3##(1992-3#1)(2007-11#1)(2008-3#1)
than when it is##4##4##(1991-12#1)(2007-11#1)(2007-12#1)(2009-5#1)
than when it was##4##4##(1993-7#1)(2004-12#1)(2006-9#1)(2012-2#1)
than when it##12##3##(1991-12#1)(1993-12#1)(1993-2#1)(1993-7#1)(2004-12#1)(2006-9#1)(2007-11#1)(2007-12#2)(2008-8#1)(2009-5#1)(2012-2#1)
than when the same##2##4##(1993-12#1)(2007-6#1)
than when the##13##3##(1993-12#1)(1995-12#1)(1995-5#1)(2004-8#1)(2007-6#1)(2008-10#3)(2008-3#3)(2010-5#1)(2012-2#1)
than when they were##3##4##(1993-12#1)(2008-10#1)(2008-6#1)
than when they##6##3##(1992-11#1)(1993-12#1)(2008-10#1)(2008-6#1)(2010-3#1)(2012-1#1)
than when using##2##3##(2009-2#1)(2011-1#1)
than when##67##2##(1990-4#1)(1990-7#1)(1991-12#1)(1991-3#1)(1992-11#1)(1992-3#2)(1992-8#2)(1993-1#2)(1993-12#4)(1993-2#1)(1993-7#1)(1994-5#1)(1995-12#1)(1995-5#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-12#1)(2004-8#1)(2006-9#2)(2007-11#2)(2007-12#2)(2007-6#1)(2008-10#13)(2008-11#1)(2008-3#5)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-5#1)(2010-3#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#1)
than white beneficiaries##2##3##(1995-2#2)
than white patients##2##3##(1995-12#1)(2007-9#1)
than white##9##2##(1995-12#2)(1995-2#3)(1995-8#1)(2007-7#1)(2007-9#1)(2012-3#1)
than whites##8##2##(1995-12#2)(2007-9#1)(2008-1#1)(2010-4#1)(2011-2#3)
than whole##2##2##(1990-12#1)(1990-9#1)
than wild type to##2##4##(1990-2#1)(2006-11#1)
than wild type##6##3##(1990-2#1)(1991-7#1)(1995-2#1)(1995-3#1)(2006-11#1)(2008-10#1)
than wild##7##2##(1990-2#1)(1991-7#1)(1995-2#1)(1995-3#1)(2006-11#1)(2008-10#1)(2012-11#1)
than wild-type AraC##2##3##(1994-9#2)
than wild-type plants##3##3##(2006-12#2)(2009-10#1)
than wild-type##23##2##(1991-2#1)(1991-8#1)(1993-12#1)(1994-11#1)(1994-9#3)(1995-2#1)(1995-8#1)(1995-9#1)(1996-4#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-12#2)(2008-10#4)(2008-5#1)(2009-10#1)(2012-3#1)
than with Group##2##3##(2010-7#2)
than with P##2##3##(2008-10#2)
than with a##13##3##(1993-6#1)(1995-7#1)(2007-11#3)(2007-12#2)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)
than with any other##2##4##(2007-12#1)(2010-12#1)
than with classical##2##3##(2007-12#2)
than with conventional##4##3##(1990-8#1)(1994-9#1)(2008-10#1)(2008-4#1)
than with ethanol##2##3##(1997-8#1)(2008-10#1)
than with other types of##2##5##(2005-10#1)(2009-1#1)
than with other##8##3##(1993-11#1)(1993-6#1)(2005-10#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-1#1)(2010-2#1)
than with patients of##2##4##(2010-2#2)
than with placebo##5##3##(1990-12#2)(1996-9#1)(2007-11#1)(2009-11#1)
than with synthetic##2##3##(1993-4#1)(2008-10#1)
than with the other##3##4##(1990-9#1)(2006-12#1)(2008-10#1)
than with the standard##3##4##(1993-10#1)(2007-12#1)(2009-3#1)
than with the##27##3##(1990-2#1)(1990-9#1)(1992-11#1)(1993-10#1)(1993-11#1)(1993-7#1)(1995-12#1)(1995-8#1)(2004-2#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-4#2)(2007-8#1)(2008-10#3)(2008-3#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-8#1)(2010-9#1)(2012-3#1)
than with those##3##3##(1991-9#1)(2008-10#1)(2012-3#1)
than with traditional##2##3##(2007-9#1)(2008-7#1)
than with unilateral##2##3##(2007-7#1)(2008-8#1)
than with##172##2##(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-5#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-4#2)(1993-6#3)(1993-7#1)(1994-12#3)(1994-5#1)(1994-6#1)(1994-9#2)(1995-10#1)(1995-12#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#3)(1997-4#1)(1997-8#1)(2004-2#1)(2005-10#1)(2005-11#3)(2005-5#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-5#3)(2006-8#2)(2007-11#7)(2007-12#6)(2007-2#3)(2007-4#2)(2007-7#4)(2007-8#2)(2007-9#1)(2008-10#24)(2008-11#1)(2008-2#1)(2008-3#7)(2008-4#5)(2008-5#3)(2008-6#5)(2008-7#4)(2008-8#3)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
than within the##3##3##(1990-6#1)(2008-10#1)(2008-11#1)
than within##7##2##(1990-6#1)(1993-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-2#1)
than without such##2##3##(1990-10#1)(2008-3#1)
than without##14##2##(1990-10#1)(1990-5#1)(1993-5#1)(2006-5#2)(2007-1#1)(2008-10#2)(2008-11#1)(2008-3#4)(2011-2#1)
than women in##3##3##(1995-2#1)(2006-9#1)(2008-12#1)
than women with##5##3##(1996-12#1)(2006-10#1)(2007-2#1)(2008-12#1)(2012-3#1)
than women##34##2##(1991-6#1)(1992-9#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-2#1)(2004-2#1)(2006-10#3)(2006-12#1)(2006-9#2)(2007-12#4)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#2)(2008-12#4)(2008-7#2)(2009-1#1)(2010-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
than words##2##2##(2008-9#1)(2009-8#1)
than would be expected by chance##2##6##(2007-12#1)(2012-2#1)
than would be expected from##2##5##(1993-12#1)(2012-2#1)
than would be expected##5##4##(1993-12#1)(2007-12#1)(2008-10#1)(2012-2#2)
than would be##13##3##(1992-3#1)(1993-12#1)(1994-2#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-2#1)(2012-2#2)
than would##16##2##(1992-3#2)(1993-12#1)(1994-2#1)(2005-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2012-2#2)
than you think##2##3##(1993-5#1)(1996-2#1)
than young adults##4##3##(2008-11#1)(2008-4#1)(2008-7#1)(2013-1#1)
than young##9##2##(1991-1#1)(1994-6#1)(2006-10#1)(2006-7#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2013-1#1)
than younger patients##2##3##(2007-7#1)(2010-2#1)
than younger##8##2##(2004-11#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-6#1)(2010-10#1)(2010-2#1)
than zero##4##2##(1994-2#2)(1996-6#1)(2008-9#1)
than zileuton##2##2##(1993-11#2)
than##19461##1##(1990-1#3)(1990-10#79)(1990-11#117)(1990-12#157)(1990-2#140)(1990-3#74)(1990-4#85)(1990-5#103)(1990-6#64)(1990-7#90)(1990-8#87)(1990-9#68)(1991-1#36)(1991-10#52)(1991-11#71)(1991-12#109)(1991-2#146)(1991-3#60)(1991-4#61)(1991-5#113)(1991-6#72)(1991-7#81)(1991-8#113)(1991-9#97)(1992-1#69)(1992-10#22)(1992-11#46)(1992-12#55)(1992-2#82)(1992-3#103)(1992-4#57)(1992-5#77)(1992-6#72)(1992-7#68)(1992-8#109)(1992-9#97)(1993-1#27)(1993-10#19)(1993-11#49)(1993-12#101)(1993-2#86)(1993-3#85)(1993-4#28)(1993-5#28)(1993-6#53)(1993-7#30)(1993-8#57)(1993-9#57)(1994-1#21)(1994-10#27)(1994-11#66)(1994-12#93)(1994-2#85)(1994-3#91)(1994-4#12)(1994-5#54)(1994-6#61)(1994-7#19)(1994-8#82)(1994-9#95)(1995-1#85)(1995-10#46)(1995-11#70)(1995-12#98)(1995-2#89)(1995-3#97)(1995-4#33)(1995-5#96)(1995-6#68)(1995-7#25)(1995-8#69)(1995-9#33)(1996-1#43)(1996-10#31)(1996-11#67)(1996-12#103)(1996-2#81)(1996-3#90)(1996-4#40)(1996-5#91)(1996-6#64)(1996-7#58)(1996-8#62)(1996-9#71)(1997-1#73)(1997-2#130)(1997-3#83)(1997-4#109)(1997-5#42)(1997-6#79)(1997-7#66)(1997-8#108)(1997-9#2)(2004-1#18)(2004-10#8)(2004-11#53)(2004-12#25)(2004-2#23)(2004-3#8)(2004-4#31)(2004-5#1)(2004-8#5)(2004-9#22)(2005-1#6)(2005-10#66)(2005-11#124)(2005-12#23)(2005-2#2)(2005-3#6)(2005-4#23)(2005-5#4)(2005-6#3)(2005-7#37)(2005-8#59)(2005-9#9)(2006-1#8)(2006-10#239)(2006-11#58)(2006-12#115)(2006-2#67)(2006-3#33)(2006-4#44)(2006-5#94)(2006-6#63)(2006-7#60)(2006-8#134)(2006-9#36)(2007-1#55)(2007-10#112)(2007-11#291)(2007-12#489)(2007-2#111)(2007-3#47)(2007-4#62)(2007-5#36)(2007-6#52)(2007-7#160)(2007-8#248)(2007-9#115)(2008-1#178)(2008-10#2029)(2008-11#369)(2008-12#153)(2008-2#509)(2008-3#629)(2008-4#204)(2008-5#520)(2008-6#146)(2008-7#336)(2008-8#310)(2008-9#299)(2009-1#12)(2009-10#57)(2009-11#37)(2009-12#38)(2009-2#58)(2009-3#41)(2009-4#78)(2009-5#77)(2009-6#57)(2009-7#64)(2009-8#77)(2009-9#49)(2010-1#23)(2010-10#36)(2010-11#40)(2010-12#129)(2010-2#118)(2010-3#55)(2010-4#112)(2010-5#50)(2010-6#32)(2010-7#57)(2010-8#116)(2010-9#44)(2011-1#212)(2011-11#6)(2011-12#68)(2011-2#480)(2011-3#20)(2011-7#2)(2011-9#1)(2012-1#114)(2012-11#39)(2012-12#215)(2012-2#321)(2012-3#197)(2012-4#1)(2012-5#4)(2012-6#3)(2012-7#5)(2012-9#6)(2013-1#436)(2013-4#1)(2013-7#94)(2013-8#249)
thank the##3##2##(2008-4#2)(2011-2#1)
thank to the##3##3##(2006-4#1)(2007-5#1)(2008-10#1)
thank##9##1##(2006-4#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-4#2)(2010-8#1)(2011-2#1)(2013-8#1)
thanked##2##1##(2008-11#1)(2008-5#1)
thanks to an##2##3##(2008-1#1)(2009-12#1)
thanks to its##10##3##(1990-12#1)(1990-5#1)(1990-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2011-2#1)(2012-1#1)(2012-2#2)
thanks to the##20##3##(1990-3#1)(1991-12#1)(1997-6#1)(2005-10#1)(2005-5#1)(2006-1#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#2)(2009-2#1)(2010-10#1)(2010-7#1)(2010-9#1)(2011-2#2)(2013-1#1)
thanks to their##3##3##(2008-5#1)(2009-12#1)(2009-5#1)
thanks to this##2##3##(2006-12#1)(2008-2#1)
thanks to##55##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-6#1)(1994-7#1)(1997-6#1)(2005-10#1)(2005-5#2)(2006-1#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#3)(2008-9#2)(2009-12#2)(2009-2#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-7#1)(2010-9#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
thanks##57##1##(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-6#1)(1994-7#1)(1997-6#1)(2005-10#1)(2005-5#2)(2006-1#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#3)(2008-9#2)(2009-12#2)(2009-2#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-7#1)(2010-9#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
thanthat##2##1##(2008-11#2)
thanthose##2##1##(2008-11#1)(2008-2#1)
thapsigargicin##2##1##(1996-1#1)(2007-1#1)
thapsigargin (TG)##3##2##(1995-3#1)(1997-2#1)(2013-1#1)
thapsigargin (Tg)##2##2##(1991-6#1)(1996-9#1)
thapsigargin and##3##2##(1990-10#1)(1994-3#1)(2006-6#1)
thapsigargin increased##2##2##(1992-5#2)
thapsigargin treatment##2##2##(1996-8#1)(1997-2#1)
thapsigargin##42##1##(1990-10#6)(1991-6#2)(1991-7#1)(1991-8#1)(1992-11#2)(1992-5#4)(1994-11#1)(1994-12#1)(1994-3#2)(1994-6#2)(1995-2#1)(1995-3#1)(1996-5#1)(1996-8#4)(1996-9#1)(1997-2#2)(1997-5#1)(1997-7#2)(2006-6#2)(2007-1#1)(2007-10#1)(2008-11#1)(2008-4#1)(2013-1#1)
thapsigargin-induced##2##1##(1991-8#1)(1992-11#1)
thapsigargin-sensitive Ca2+##2##2##(1991-8#1)(1992-11#1)
thapsigargin-sensitive##5##1##(1991-8#2)(1992-11#1)(2008-4#2)
thapsigargins in##2##2##(2007-1#2)
thapsinum##4##1##(2008-10#3)(2010-10#1)
that &gt##5##2##(1994-12#1)(1994-8#1)(2006-6#1)(2008-10#1)(2008-9#1)
that &lt##2##2##(2008-10#1)(2008-3#1)
that &quot##53##2##(1990-12#1)(1991-2#1)(1991-3#1)(1992-10#1)(1992-6#1)(1993-2#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-9#2)(1996-11#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-10#1)(2006-10#2)(2007-1#1)(2007-10#1)(2007-2#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-3#3)(2013-8#1)
that (1) both##3##3##(1996-10#1)(1996-7#1)(2010-8#1)
that (1) the##18##3##(1993-1#1)(1993-3#1)(1994-8#2)(1995-11#1)(1995-4#1)(1996-12#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#3)(2012-3#1)
that (1)##53##2##(1990-3#1)(1991-3#1)(1991-7#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-5#1)(1994-8#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-4#1)(2004-3#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#5)(2008-8#1)(2009-11#1)(2009-9#1)(2010-8#2)(2011-2#2)(2012-1#2)(2012-3#1)
that (a) the##8##3##(1990-11#1)(1990-3#1)(1994-6#1)(1995-11#1)(2006-7#1)(2007-12#2)(2008-4#1)
that (a)##34##2##(1990-11#1)(1990-3#1)(1990-5#1)(1991-2#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-6#1)(1995-11#1)(1997-6#1)(1997-8#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#3)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-1#1)(2013-7#1)
that (i) a##2##3##(1995-3#1)(2007-11#1)
that (i) if##2##3##(2007-9#1)(2008-10#1)
that (i) in##3##3##(1994-8#1)(1995-2#1)(2006-10#1)
that (i) the##15##3##(1990-11#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-4#1)(2005-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#3)(2012-5#1)
that (i)##48##2##(1990-11#1)(1990-8#1)(1991-10#3)(1991-11#1)(1991-2#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-8#5)(2008-9#3)(2012-1#1)(2012-2#1)(2012-5#1)
that -##2##2##(2007-8#1)(2008-7#1)
that 0##10##2##(1990-3#1)(1991-5#1)(1992-11#1)(1992-7#1)(1993-2#1)(2008-10#4)(2010-12#1)
that 1 and##2##3##(1994-8#1)(2008-11#1)
that 1##24##2##(1990-3#1)(1991-4#2)(1992-12#1)(1992-9#1)(1994-10#1)(1994-11#1)(1994-8#1)(1995-12#2)(1996-12#1)(1997-3#1)(2004-9#1)(2005-4#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-6#1)(2009-7#1)(2010-7#2)(2013-1#1)
that 1) the##5##3##(1994-12#1)(1996-1#1)(2008-2#1)(2013-1#2)
that 1)##13##2##(1992-3#1)(1994-12#1)(1994-2#1)(1994-8#1)(1996-1#1)(1996-5#1)(2006-5#1)(2008-1#1)(2008-2#1)(2010-9#1)(2011-1#1)(2013-1#2)
that 10 microM##2##3##(1997-5#2)
that 10##11##2##(1990-6#1)(1992-7#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-5#2)(2007-7#1)(2008-12#1)(2012-12#1)
that 10-20%##2##2##(1994-6#1)(2005-11#1)
that 100##6##2##(1993-11#1)(1993-7#1)(2006-12#1)(2007-12#1)(2012-12#1)(2012-2#1)
that 100% of##2##3##(1993-2#1)(2011-2#1)
that 100%##3##2##(1993-2#1)(2011-2#1)(2012-2#1)
that 11 of##2##3##(2006-11#1)(2010-8#1)
that 11##5##2##(1992-2#1)(1992-5#1)(2006-11#1)(2010-8#1)(2010-9#1)
that 12##4##2##(1992-11#1)(1992-12#1)(2004-11#1)(2008-10#1)
that 120##2##2##(2007-8#1)(2008-10#1)
that 13##3##2##(1994-6#1)(1995-8#1)(2013-7#1)
that 14##5##2##(1990-2#1)(1990-3#1)(1991-5#1)(2008-1#1)(2008-5#1)
that 14-3-3##2##2##(2008-11#2)
that 14Dea2##2##2##(2008-11#2)
that 15##6##2##(1990-12#1)(1996-2#1)(2009-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
that 16##4##2##(1992-12#1)(1995-10#1)(2007-1#1)(2008-8#1)
that 17 beta-estradiol##3##3##(1990-11#1)(1992-3#1)(1996-10#1)
that 17##4##2##(1990-11#1)(1992-3#1)(1996-10#1)(1996-8#1)
that 18##2##2##(2008-8#1)(2010-4#1)
that 2##12##2##(1995-2#2)(1995-3#1)(2005-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
that 2%##2##2##(1993-1#1)(2009-6#1)
that 2-DG##2##2##(2007-11#1)(2009-6#1)
that 2-azido-[32P]ATP is##2##3##(1995-6#2)
that 2-hydroxyphytanic acid is##2##4##(1994-11#2)
that 20 microM 7 beta-OHC##2##5##(1991-2#2)
that 20%##3##2##(1995-12#1)(2006-3#1)(2007-9#1)
that 200##2##2##(1990-3#1)(2007-12#1)
that 21##4##2##(2007-7#2)(2008-6#1)(2012-2#1)
that 22##2##2##(1993-12#1)(2010-9#1)
that 24##5##2##(1990-11#1)(1990-5#1)(2005-11#1)(2008-7#1)(2009-11#1)
that 24% of##2##3##(1993-5#1)(2008-3#1)
that 24%##3##2##(1990-4#1)(1993-5#1)(2008-3#1)
that 25% of the##2##4##(1990-4#1)(2005-10#1)
that 25%##4##2##(1990-4#1)(2005-10#1)(2008-7#1)(2011-2#1)
that 26##3##2##(1997-7#1)(2006-12#1)(2007-11#1)
that 27##5##2##(1996-12#1)(1997-6#1)(2006-8#1)(2008-7#1)(2012-1#1)
that 28%##2##2##(2006-8#1)(2007-11#1)
that 29##3##2##(1990-12#1)(1997-3#1)(2007-8#1)
that 2f detection##2##3##(2008-3#2)
that 2f##3##2##(2008-3#3)
that 3##6##2##(1991-5#1)(1992-6#2)(1994-3#1)(1996-2#1)(2010-1#1)
that 30% of##3##3##(2006-10#1)(2008-10#1)(2012-12#1)
that 30%##4##2##(1997-8#1)(2006-10#1)(2008-10#1)(2012-12#1)
that 31##2##2##(1996-12#1)(2008-10#1)
that 32##2##2##(2008-10#1)(2013-8#1)
that 33##3##2##(1994-9#1)(1996-12#1)(2011-2#1)
that 37##2##2##(1997-6#1)(2007-12#1)
that 37% of the##2##4##(1993-1#1)(2007-10#1)
that 37% of##5##3##(1993-1#1)(2005-9#1)(2007-10#1)(2010-3#1)(2010-8#1)
that 38% of##2##3##(1997-7#1)(2004-10#1)
that 4##10##2##(1992-5#1)(1993-3#1)(1995-11#1)(1996-5#1)(2007-8#1)(2009-10#1)(2010-5#1)(2012-1#1)(2013-1#1)(2013-8#1)
that 40##5##2##(2009-10#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-12#1)
that 40% of##3##3##(2008-1#1)(2010-12#1)(2011-2#1)
that 40%##4##2##(1990-7#1)(2008-1#1)(2010-12#1)(2011-2#1)
that 41##3##2##(1995-12#1)(2012-12#1)(2012-2#1)
that 42##2##2##(1991-3#1)(2012-12#1)
that 46##2##2##(2006-8#1)(2011-2#1)
that 46% of##3##3##(1995-4#1)(2013-1#2)
that 48##3##2##(1993-9#1)(2010-5#1)(2012-2#1)
that 4f##2##2##(2008-3#2)
that 5##11##2##(1991-11#1)(1992-3#1)(1994-8#1)(1997-7#1)(1997-8#1)(2006-1#1)(2008-10#2)(2009-12#1)(2012-1#1)(2012-2#1)
that 5-HT##9##2##(1990-5#1)(1992-1#1)(1992-8#1)(1993-12#1)(2008-2#1)(2008-4#1)(2008-7#2)(2011-3#1)
that 5-HT3 receptors##2##3##(1990-2#1)(1996-8#1)
that 5-HT3##3##2##(1990-2#1)(1994-2#1)(1996-8#1)
that 5-aza-2'-deoxycytidine-induced##2##2##(1997-4#1)(2006-4#1)
that 5-ethynyl-2(1H)-pyrimidinone##2##2##(1994-3#2)
that 5-lipoxygenase##2##2##(1994-9#1)(1995-3#1)
that 50##3##2##(2007-7#1)(2007-9#1)(2008-10#1)
that 50%##2##2##(1992-5#1)(2007-12#1)
that 52##3##2##(2007-7#1)(2008-5#1)(2010-9#1)
that 53% of##2##3##(1990-6#1)(1994-12#1)
that 59% of##3##3##(2007-7#1)(2013-1#2)
that 59%##4##2##(2007-7#1)(2008-10#1)(2013-1#2)
that 6##6##2##(1994-8#1)(1996-9#1)(2006-1#1)(2008-5#1)(2010-6#1)(2013-7#1)
that 6-year-old children##2##3##(2008-2#2)
that 60##3##2##(1993-12#1)(1995-10#1)(2011-1#1)
that 600##2##2##(2011-1#1)(2013-1#1)
that 63##2##2##(1992-11#1)(1994-8#1)
that 64% of the##2##4##(1992-9#1)(2008-10#1)
that 64% of##3##3##(1992-9#1)(2007-7#1)(2008-10#1)
that 65% of the##2##4##(2006-2#1)(2007-12#1)
that 65% of##3##3##(1992-8#1)(2006-2#1)(2007-12#1)
that 66% of the##2##4##(2008-10#1)(2011-1#1)
that 66% of##3##3##(2008-10#1)(2010-4#1)(2011-1#1)
that 7##5##2##(1991-2#1)(1992-8#1)(1994-5#2)(2008-7#1)
that 70##3##2##(1996-2#1)(2012-12#2)
that 70% of##3##3##(1997-7#1)(2006-6#1)(2010-8#1)
that 75% of##3##3##(2005-10#1)(2008-1#1)(2012-3#1)
that 75%##4##2##(2005-10#2)(2008-1#1)(2012-3#1)
that 8%##2##2##(2004-11#1)(2007-7#1)
that 8-BDB-TA-5'-TP reacts##2##3##(1990-7#2)
that 80% of##2##3##(2009-4#1)(2010-8#1)
that 80%##4##2##(2006-8#1)(2009-4#1)(2010-8#1)(2012-12#1)
that 85##2##2##(2007-10#1)(2007-7#1)
that 85% of the##2##4##(1997-3#1)(2006-8#1)
that 85% of##3##3##(1997-3#1)(2006-8#1)(2008-10#1)
that 89##2##2##(1993-3#1)(2008-12#1)
that 9##6##2##(1992-4#1)(1994-12#1)(1994-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
that 9% of the##2##4##(2006-12#1)(2008-10#1)
that 9-aminoacridine##2##2##(1992-5#2)
that 90% of the##2##4##(1992-12#1)(1995-5#1)
that 90% of##3##3##(1992-12#1)(1995-5#1)(2012-12#1)
that 91% of##2##3##(1993-3#1)(2012-12#1)
that 92% of the##2##4##(1995-3#1)(2008-10#1)
that 92% of##3##3##(1990-12#1)(1995-3#1)(2008-10#1)
that 93% of##2##3##(2010-12#1)(2013-8#1)
that 93%##3##2##(2008-10#1)(2010-12#1)(2013-8#1)
that 95% of the##3##4##(1992-5#1)(2008-10#1)(2008-9#1)
that 95% of##4##3##(1992-5#1)(2006-6#1)(2008-10#1)(2008-9#1)
that 95%##5##2##(1990-12#1)(1992-5#1)(2006-6#1)(2008-10#1)(2008-9#1)
that 99##3##2##(1990-9#1)(1996-6#1)(2008-11#1)
that A beta 1-40##2##4##(1994-11#2)
that A beta##6##3##(1994-10#1)(1994-11#2)(1994-12#1)(1995-3#1)(1996-2#1)
that A##22##2##(1990-12#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-2#1)(2008-10#5)(2008-5#2)(2009-8#1)(2010-12#1)(2011-2#1)(2012-11#1)(2013-1#1)
that A(c)##2##2##(2006-12#2)
that A4H##2##2##(2010-2#2)
that A7##2##2##(1995-11#2)
that AA is##2##3##(1993-7#1)(2008-11#1)
that AA##3##2##(1993-3#1)(1993-7#1)(2008-11#1)
that ABP##2##2##(1992-7#1)(2008-8#1)
that ABP41##2##2##(2009-10#2)
that ACE inhibitors##4##3##(1993-2#4)
that ACE##5##2##(1990-2#1)(1993-2#4)
that ACM##2##2##(1990-3#2)
that ACh at##2##3##(1997-5#1)(2008-8#1)
that ACh##5##2##(1992-7#2)(1995-12#1)(1997-5#1)(2008-8#1)
that AD##3##2##(1992-12#1)(1993-11#1)(2009-11#1)
that ADA##2##2##(1995-8#1)(1996-11#1)
that ADAMTS13 is##2##3##(2009-7#2)
that ADAMTS13##3##2##(2009-7#3)
that ADH-I##2##2##(2008-11#2)
that ADHD is##3##3##(2006-9#3)
that ADHD##4##2##(2006-9#4)
that ADP##2##2##(1992-6#1)(1994-9#1)
that ADT##3##2##(2008-2#2)(2008-7#1)
that AFP##2##2##(1994-6#2)
that AG##4##2##(1995-9#1)(1996-6#1)(1997-6#1)(2007-11#1)
that AGEs##2##2##(1995-8#1)(2011-1#1)
that AGP##2##2##(1991-12#1)(1997-3#1)
that AGR##2##2##(2008-10#2)
that AGTs pose##2##3##(2010-6#2)
that AI##3##2##(2006-5#1)(2007-12#2)
that AIDS is##2##3##(1991-6#1)(1996-9#1)
that AIDS##4##2##(1991-6#1)(1993-1#1)(1996-11#1)(1996-9#1)
that AII##3##2##(1990-10#1)(1997-2#1)(2008-10#1)
that AKR1C3##2##2##(2010-12#2)
that ALR##2##2##(2008-8#2)
that AM##2##2##(1994-11#2)
that AMF##2##2##(2008-8#1)(2011-12#1)
that AMP##2##2##(2008-10#1)(2008-9#1)
that AMPH-induced##2##2##(1991-8#1)(1997-8#1)
that ANN##2##2##(2008-10#1)(2010-8#1)
that ANP##5##2##(1993-11#1)(1993-8#1)(1995-5#1)(2008-5#2)
that AP##3##2##(1991-1#1)(1992-6#1)(1995-1#1)
that AP-1##2##2##(1993-4#1)(2008-11#1)
that APP##10##2##(1991-5#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-9#2)(1995-3#1)(1996-9#1)(2007-11#1)
that AR##4##2##(1991-10#2)(1995-12#1)(2007-7#1)
that ARG1##2##2##(2009-8#2)
that ARNT##3##2##(2008-7#3)
that ASA##2##2##(1994-3#1)(2007-9#1)
that ASY##2##2##(2008-9#2)
that AT##2##2##(1992-2#1)(1993-6#1)
that AT1##3##2##(1995-10#1)(1996-5#1)(1997-8#1)
that ATA is a potent inhibitor of##2##7##(1995-1#2)
that ATP is a##2##4##(2006-12#1)(2008-4#1)
that ATP is##3##3##(2006-12#2)(2008-4#1)
that ATP levels##2##3##(1991-9#1)(1994-8#1)
that ATP##27##2##(1990-10#1)(1990-3#1)(1990-5#2)(1990-7#1)(1991-9#1)(1992-12#1)(1992-8#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-8#1)(1997-7#3)(2005-8#1)(2006-12#3)(2007-10#1)(2008-4#6)(2008-5#1)
that ATRA##2##2##(2008-4#2)
that AV411##2##2##(2008-1#2)
that AZT##3##2##(1990-6#1)(1995-7#1)(1995-9#1)
that Acropyga##2##2##(2007-12#2)
that Address##4##2##(2007-2#4)
that Affect##3##2##(2007-4#1)(2008-10#2)
that Africa##2##2##(2007-6#1)(2008-7#1)
that African American##2##3##(2004-12#1)(2009-5#1)
that African Americans##2##3##(2010-7#1)(2013-1#1)
that African##8##2##(2004-12#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-5#1)(2010-7#1)(2013-1#1)
that Al possesses##2##3##(1996-8#2)
that Al##5##2##(1996-8#4)(2008-10#1)
that Alport syndrome##2##3##(2011-2#2)
that Alzheimer's disease is##3##4##(1995-5#2)(1996-12#1)
that Alzheimer's disease##4##3##(1994-9#1)(1995-5#2)(1996-12#1)
that Amberlite##2##2##(2008-10#2)
that AngCP##3##2##(2008-9#3)
that Ap(n)As##2##2##(1997-7#2)
that Apc##2##2##(2012-2#2)
that Arabidopsis thaliana##3##3##(2009-8#3)
that Argireline##2##2##(2008-5#2)
that Artemia##2##2##(2007-3#1)(2008-7#1)
that As##3##2##(2007-10#1)(2008-10#2)
that As(2)O(3)##3##2##(2008-8#3)
that Asian##4##2##(1996-9#1)(2005-11#1)(2008-3#1)(2008-5#1)
that AtSNX2b is##2##3##(2009-10#2)
that AxRF1##2##2##(2008-9#2)
that B cells##3##3##(2009-8#2)(2012-1#1)
that B lymphocytes##2##3##(2009-8#1)(2011-1#1)
that B##21##2##(1991-12#1)(1994-3#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-6#1)(2009-8#3)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
that B/CYDVs##2##2##(2008-9#2)
that BAL##2##2##(1991-2#2)
that BCC##3##2##(2007-11#2)(2011-12#1)
that BCG revaccination##2##3##(2013-8#2)
that BCMoV##3##2##(2008-10#3)
that BDNF##11##2##(1991-5#1)(1995-5#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-6#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
that BDP##2##2##(2006-2#2)
that BF##3##2##(2005-11#1)(2008-10#1)(2009-3#1)
that BGQ60##2##2##(1995-6#2)
that BK##3##2##(1990-3#1)(1991-3#1)(2007-8#1)
that BMD##2##2##(2005-7#1)(2008-4#1)
that BMI is##2##3##(2007-12#1)(2013-8#1)
that BMI##5##2##(2007-12#2)(2007-8#1)(2008-3#1)(2013-8#1)
that BON cells##2##3##(1994-8#2)
that BP##3##2##(2007-10#1)(2008-5#1)(2010-12#1)
that BPs##2##2##(2008-1#2)
that BR##2##2##(2008-9#2)
that BRAF mutation##2##3##(2008-5#2)
that BS15##3##2##(1996-8#3)
that BSA adsorption##2##3##(2004-9#1)(2013-8#1)
that BSO##2##2##(1997-2#2)
that BTX##2##2##(2008-8#2)
that Baduanjin exercise##2##3##(2013-1#2)
that Bcl-2 may be##2##4##(1995-10#1)(1995-12#1)
that Bcl-2##7##2##(1995-10#2)(1995-12#1)(1996-5#1)(1997-6#1)(2005-8#1)(2007-8#1)
that Bifidobacterium##2##2##(2008-11#1)(2008-5#1)
that Black Deaf##2##3##(2011-2#2)
that Black##5##2##(2009-7#1)(2009-9#1)(2011-2#3)
that Bortezomib##2##2##(2012-12#2)
that Bp-1 protein##2##3##(1992-11#2)
that Bud1 can##2##3##(1997-4#2)
that Bud1##3##2##(1997-4#3)
that Buffon##2##2##(2008-12#2)
that C##32##2##(1991-8#1)(1996-2#1)(2005-12#1)(2006-3#1)(2007-1#1)(2007-12#3)(2007-2#1)(2007-7#2)(2008-10#9)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-1#1)(2011-12#2)(2012-1#2)(2012-11#1)(2012-2#1)(2013-1#1)
that C(-1562)T##2##2##(2006-6#2)
that C(60)##2##2##(2008-5#1)(2010-7#1)
that C-ADR##2##2##(2012-12#2)
that C-peptide##2##2##(2009-8#2)
that C-terminal##2##2##(1992-4#1)(1994-2#1)
that CA 15-3##2##3##(1991-8#1)(1995-10#1)
that CA##5##2##(1991-8#1)(1994-12#1)(1995-10#1)(1995-11#1)(2008-11#1)
that CAT activity##2##3##(1994-3#1)(1997-4#1)
that CB is##2##3##(1997-6#1)(2007-8#1)
that CB##6##2##(1997-6#2)(2007-6#1)(2007-8#2)(2010-6#1)
that CBF is a##2##4##(1995-2#1)(2012-2#1)
that CBF##3##2##(1995-2#1)(2012-2#2)
that CBPs of##2##3##(2006-8#2)
that CC-516##4##2##(2008-5#4)
that CCSV is a##2##4##(2008-10#2)
that CD##3##2##(2008-10#1)(2011-1#2)
that CD39##2##2##(2008-4#2)
that CD4##3##2##(1992-4#2)(1994-6#1)
that CD4(+) T cells were##2##5##(2008-11#2)
that CD4(+) T cells##4##4##(2008-11#3)(2010-5#1)
that CD4(+)##5##2##(2008-11#3)(2010-1#1)(2010-5#1)
that CD44##3##2##(1994-10#1)(2008-4#2)
that CD9##3##2##(1991-8#1)(2009-8#1)(2012-12#1)
that CDS##2##2##(1990-6#1)(2008-3#1)
that CE##2##2##(1994-9#1)(1996-5#1)
that CF##2##2##(2008-5#1)(2012-12#1)
that CFTR##3##2##(1990-8#1)(1994-11#1)(1995-6#1)
that CGRP is##3##3##(1992-6#1)(1992-8#1)(1993-11#1)
that CGRP##8##2##(1990-6#1)(1992-6#4)(1992-8#2)(1993-11#1)
that CH##2##2##(1994-8#1)(2008-6#1)
that CI strains##2##3##(2008-8#2)
that CI##3##2##(2008-8#3)
that CIN##2##2##(2006-11#1)(2010-10#1)
that CL##4##2##(1995-2#2)(2008-8#2)
that CLCrV has a##2##4##(2008-10#2)
that CLIP##2##2##(1995-8#2)
that CMV##5##2##(2007-7#1)(2008-10#4)
that CNP is##3##3##(1990-7#1)(1991-3#1)(1993-11#1)
that CNP##6##2##(1990-7#1)(1991-3#1)(1992-11#1)(1993-11#1)(1994-11#1)(2005-7#1)
that CNTF##2##2##(1996-2#2)
that CNTP##2##2##(2007-8#2)
that CO2##2##2##(1993-6#1)(1997-5#1)
that COS has##2##3##(2006-8#2)
that COS##3##2##(2006-8#3)
that CPAP is##2##3##(2012-12#2)
that CPC##2##2##(2004-9#1)(2008-10#1)
that CPTI##2##2##(1997-4#2)
that CR##5##2##(1995-11#2)(1996-7#1)(2008-10#1)(2009-10#1)
that CRABP II is##2##4##(1992-12#2)
that CRF##5##2##(1994-2#1)(1994-3#1)(1995-12#1)(1997-4#2)
that CRH##3##2##(1994-11#1)(1995-12#1)(1996-12#1)
that CS##3##2##(2013-1#3)
that CSD##2##2##(2008-10#1)(2012-11#1)
that CT##3##2##(2008-1#1)(2008-6#1)(2008-7#1)
that CTAB##3##2##(2005-11#2)(2008-11#1)
that CTC is##2##3##(2008-1#1)(2010-5#1)
that CYP2E1 is##2##3##(1991-8#1)(1994-8#1)
that CYP2E1##3##2##(1991-8#1)(1994-8#1)(2008-8#1)
that Ca and Mg##2##4##(1995-4#1)(2008-10#1)
that Ca(2+)##2##2##(1996-5#1)(2006-10#1)
that Ca2+ binding##3##3##(1990-7#1)(1991-7#1)(1994-5#1)
that Ca2+ inhibits##2##3##(1991-2#1)(1991-9#1)
that Ca2+ ions##3##3##(1992-11#1)(1992-6#2)
that Ca2+ may be##2##4##(1991-2#1)(1993-5#1)
that Ca2+##24##2##(1990-7#3)(1991-1#1)(1991-2#2)(1991-7#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-6#3)(1993-11#1)(1993-5#1)(1993-7#1)(1994-11#1)(1994-5#1)(1995-2#1)(1995-8#1)(1997-6#1)(1997-7#1)(2008-8#1)
that CaM kinase II plays##2##5##(1990-5#1)(1994-2#1)
that CaM kinase II##3##4##(1990-5#2)(1994-2#1)
that CaM kinase##4##3##(1990-5#2)(1994-2#1)(1994-6#1)
that CaM##5##2##(1990-5#2)(1994-2#1)(1994-6#1)(2008-8#1)
that CaS##2##2##(1993-7#2)
that Canada##2##2##(2010-12#2)
that Catalan-Spanish bilingual infants##2##4##(2012-1#2)
that Catalyser-21(TM) has##2##3##(2008-11#2)
that Catalyser-21(TM)##4##2##(2008-11#4)
that Caucasian##3##2##(2008-5#1)(2009-7#1)(2010-8#1)
that Cause##2##2##(2008-10#2)
that Cbfib1##2##2##(1992-5#2)
that Cd##2##2##(1997-2#1)(2008-7#1)
that Cd2+##2##2##(1991-12#2)
that ChMV##2##2##(2008-10#2)
that China##3##2##(1995-9#1)(2007-12#1)(2008-8#1)
that Chlamydia##2##2##(2009-8#1)(2013-8#1)
that Cip1##2##2##(1994-8#2)
that CjDTC protein might be##2##5##(2009-5#2)
that CjDTC##3##2##(2009-5#3)
that Cl-##2##2##(1991-2#1)(1995-1#1)
that Congress##5##2##(1991-1#1)(1995-12#1)(1995-6#1)(2007-9#1)(2010-7#1)
that Crk##2##2##(2012-12#2)
that Cruzan's##2##2##(2008-2#2)
that CsA inhibits##2##3##(1992-7#1)(1994-8#1)
that CsA##7##2##(1990-12#1)(1992-7#1)(1994-3#1)(1994-8#3)(2007-7#1)
that CstF-64##2##2##(1996-11#2)
that CtBP##2##2##(2012-12#2)
that Cu##2##2##(1995-3#1)(2008-10#1)
that Cu(2+) and##2##3##(2008-3#1)(2008-5#1)
that Cu(2+)##3##2##(2005-11#1)(2008-3#1)(2008-5#1)
that Cu(II)##2##2##(1994-12#1)(2005-11#1)
that Cuc E##2##3##(2008-11#2)
that Curdlan derivatives containing sulfopropyl##2##5##(2010-4#2)
that Curdlan##4##2##(2010-4#2)(2011-1#2)
that Cyt1A##2##2##(2004-11#2)
that D##11##2##(1995-2#1)(1995-8#1)(1997-8#1)(2006-8#1)(2007-3#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-5#1)(2009-8#1)
that D1##5##2##(1996-1#1)(1996-10#2)(1996-7#1)(1997-5#1)
that DA##6##2##(1991-12#1)(1993-7#1)(1995-12#1)(1995-3#1)(1997-8#1)(2009-11#1)
that DC##2##2##(1995-1#1)(2008-11#1)
that DC-CASPIC##2##2##(2011-1#2)
that DCs##4##2##(1996-10#2)(2008-11#1)(2009-9#1)
that DHEA##4##2##(1994-6#2)(1995-12#1)(2012-3#1)
that DHO-DH##2##2##(1996-7#2)
that DM##2##2##(2007-7#1)(2008-3#1)
that DMXB##2##2##(1994-2#2)
that DNA damage##3##3##(1990-7#1)(1996-1#1)(2010-5#1)
that DNA fragmentation##2##3##(1992-9#1)(1993-8#1)
that DNA polymerase##2##3##(1990-7#1)(1991-7#1)
that DNA synthesis##3##3##(1990-9#1)(1994-8#1)(1995-11#1)
that DNA##39##2##(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-9#2)(1991-5#1)(1991-7#1)(1992-2#1)(1992-9#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#2)(1995-4#1)(1995-8#1)(1996-1#1)(1996-7#1)(1997-1#1)(1997-6#1)(1997-7#1)(2005-7#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)
that DNA-A##2##2##(2008-10#2)
that DPPC##2##2##(2008-8#2)
that DRG##3##2##(1992-11#2)(1995-11#1)
that DSIP##2##2##(1990-2#1)(1995-12#1)
that DTI##2##2##(2008-11#1)(2011-1#1)
that DTR##2##2##(2007-8#2)
that DYS19##2##2##(2008-12#2)
that Dectin-1##2##2##(2010-4#1)(2011-1#1)
that Delta##2##2##(1997-5#2)
that Democrats##2##2##(2006-7#2)
that DnHP is##2##3##(2005-7#2)
that Dr##4##2##(1993-7#1)(2010-12#1)(2012-2#1)(2012-3#1)
that Drosophila Syncrip##4##3##(2012-12#4)
that Drosophila##6##2##(1990-11#1)(2008-1#1)(2012-12#4)
that DuP##2##2##(1991-5#1)(1991-9#1)
that E##12##2##(1990-4#1)(1995-10#1)(1996-7#1)(2004-4#2)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)
that E-cadherin##2##2##(2012-2#1)(2013-1#1)
that E1##2##2##(1990-11#1)(1992-4#1)
that E2##4##2##(1995-10#1)(1995-9#1)(1996-11#1)(2008-11#1)
that E2F1##2##2##(1996-4#1)(2012-2#1)
that E5050##2##2##(1990-7#2)
that EA##2##2##(2008-10#2)
that EBV##2##2##(1993-8#1)(1994-8#1)
that EC##2##2##(2008-10#1)(2009-6#1)
that ECM##3##2##(2009-10#1)(2009-6#1)(2009-8#1)
that EDIN is a##2##4##(1990-11#1)(1991-1#1)
that EDRF1##3##2##(2008-8#1)(2008-9#2)
that EF-1##2##2##(1991-12#1)(1991-5#1)
that EGF can##2##3##(1993-9#1)(2006-5#1)
that EGF##15##2##(1990-11#1)(1991-1#1)(1991-10#1)(1991-7#1)(1993-12#1)(1993-3#1)(1993-9#2)(1994-6#1)(1995-11#1)(1996-11#1)(1996-8#1)(2006-5#1)(2008-6#1)(2008-8#1)
that EGF-R##3##2##(1994-9#1)(1995-6#1)(2008-1#1)
that EGFP##2##2##(2006-12#1)(2007-8#1)
that EGFR##2##2##(1992-12#1)(2008-1#1)
that ELISA##3##2##(2007-2#1)(2008-10#1)(2011-1#1)
that EMF##2##2##(2008-12#1)(2012-2#1)
that EMG##2##2##(2006-12#2)
that EN##2##2##(1990-2#2)
that EPA##2##2##(1991-2#1)(2006-7#1)
that EPEC##2##2##(2011-2#2)
that ER##4##2##(1992-6#1)(1996-11#2)(2007-12#1)
that ERD2 encodes the##2##4##(1990-6#2)
that ERK1##2##2##(2008-4#2)
that ERW supplemented with##2##4##(2008-11#2)
that ESWL##2##2##(2007-7#1)(2007-9#1)
that ET-1##7##2##(1991-2#1)(1991-5#1)(1993-3#2)(1994-12#1)(1994-5#1)(2006-6#1)
that ET-18-OCH3##2##2##(1993-4#2)
that East Asians##2##3##(2008-5#2)
that Eastern##2##2##(2006-12#1)(2010-4#1)
that Echinacea##2##2##(2007-11#1)(2008-2#1)
that EcoRI##2##2##(1993-11#1)(1994-8#1)
that EcoShield™##2##2##(2013-1#2)
that Ep##2##2##(1990-4#2)
that EtOH intoxication##3##3##(2007-11#1)(2009-6#2)
that EtOH##4##2##(2007-11#1)(2008-8#1)(2009-6#2)
that Evi-1##2##2##(1994-9#2)
that F##10##2##(2008-10#9)(2008-5#1)
that FA##2##2##(2008-8#1)(2012-1#1)
that FALSG93A mice##2##3##(1996-5#2)
that FB##2##2##(2005-11#2)
that FCS##2##2##(2006-5#2)
that FGF##4##2##(1991-12#1)(1995-10#1)(2008-5#1)(2012-12#1)
that FGF-2##2##2##(1997-4#1)(2008-11#1)
that FH-510##2##2##(1993-11#2)
that FHL3##3##2##(2012-3#3)
that FLT1##2##2##(2012-3#2)
that FMRFamide or##2##3##(1991-1#2)
that FSH##2##2##(1993-11#1)(2012-12#1)
that FT##2##2##(1991-8#1)(1994-7#1)
that Fas##4##2##(2007-2#1)(2008-8#1)(2010-3#2)
that Fc##4##2##(1990-7#1)(1991-10#1)(1991-5#1)(2010-12#1)
that Fe##3##2##(1991-10#2)(2008-10#1)
that Fe(II)##2##2##(1996-2#1)(2008-10#1)
that Fluoro-Gold can be transported avidly##2##6##(1990-11#2)
that Fos synthesis##2##3##(1994-10#2)
that Fos##4##2##(1991-3#1)(1994-10#2)(1996-12#1)
that Fusarium##3##2##(2008-12#1)(2008-5#1)(2009-3#1)
that Fyn##2##2##(1997-4#1)(2009-6#1)
that G alpha##2##3##(1991-2#1)(1992-11#1)
that G beta##2##3##(1995-8#2)
that G protein##3##3##(1990-2#1)(2008-4#2)
that G##16##2##(1990-2#1)(1991-2#1)(1992-11#1)(1992-9#1)(1995-8#2)(1996-2#1)(2007-1#1)(2008-3#1)(2008-4#2)(2008-5#1)(2010-3#1)(2010-4#1)(2010-8#2)
that GA##2##2##(2006-12#1)(2007-8#1)
that GABA is##2##3##(1991-5#1)(1997-6#1)
that GABA##9##2##(1990-10#2)(1991-5#1)(1992-3#1)(1994-2#1)(1995-11#1)(1997-6#1)(2008-8#2)
that GABA(C) receptor expression##2##4##(2008-4#2)
that GABA(C)##3##2##(2008-4#2)(2008-9#1)
that GABAA##2##2##(1994-2#1)(1994-5#1)
that GABAB##3##2##(1990-5#1)(1992-3#1)(1993-11#1)
that GAGs##2##2##(1996-8#1)(1997-5#1)
that GAL80##3##2##(1992-5#3)
that GAP-43##3##2##(1994-8#1)(1995-12#1)(2008-9#1)
that GAPDH##2##2##(1994-9#1)(2005-8#1)
that GBP##2##2##(1991-8#1)(1992-6#1)
that GC and##2##3##(1990-5#1)(1992-11#1)
that GC##5##2##(1990-5#1)(1992-11#2)(2006-10#1)(2008-11#1)
that GC7##3##2##(1997-1#3)
that GD12##2##2##(2013-8#2)
that GDNF##4##2##(1995-12#2)(1995-8#2)
that GFP##4##2##(1996-6#1)(1997-5#1)(2008-11#1)(2008-7#1)
that GH replacement##2##3##(1997-8#1)(2006-9#1)
that GH##8##2##(1995-10#1)(1995-3#1)(1997-8#1)(2006-1#1)(2006-9#1)(2010-5#1)(2010-8#1)(2013-7#1)
that GH3##3##2##(2009-6#3)
that GHB is##2##3##(2008-8#2)
that GHB##3##2##(1997-2#1)(2008-8#2)
that GHR##2##2##(2012-1#2)
that GLA is##2##3##(2008-5#1)(2008-7#1)
that GLP-1##3##2##(1996-2#1)(2007-5#1)(2010-11#1)
that GLP-1(7-36)amide##2##2##(1991-8#2)
that GM-CSF##5##2##(1990-11#2)(1991-8#1)(1993-6#1)(2008-7#1)
that GM1##3##2##(1993-3#1)(1995-5#1)(1996-4#1)
that GPR80 is##2##3##(2008-4#2)
that GPR80/99 is an##2##4##(2008-4#2)
that GPR80/99 is##3##3##(2008-4#3)
that GR##3##2##(1994-3#1)(1996-7#1)(2011-2#1)
that GSA aminotransferase##2##3##(1995-3#2)
that GSH##6##2##(1991-8#1)(1992-12#1)(1995-1#2)(2008-10#1)(2013-1#1)
that GTG is the##2##4##(1994-10#1)(2009-5#1)
that GTP##7##2##(1991-10#2)(1994-12#1)(2008-3#2)(2008-4#2)
that GUS##2##2##(2008-9#2)
that Gene##3##2##(1992-3#1)(2013-1#2)
that GhTub1##2##2##(2008-9#2)
that Glu-1##2##2##(2008-10#2)
that God##3##2##(2008-4#1)(2013-1#2)
that Golgi passage is##2##4##(2009-2#2)
that Golgi##3##2##(1995-2#1)(2009-2#2)
that Gram-negative##2##2##(2008-5#1)(2010-12#1)
that H##12##2##(2008-1#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)
that H*(10)##2##2##(2010-9#2)
that H-FABP##2##2##(1994-12#2)
that H2O2##2##2##(1991-10#1)(1997-8#1)
that HA##4##2##(2007-8#1)(2008-10#2)(2013-8#1)
that HAP can##2##3##(2008-5#2)
that HAP##4##2##(2008-5#2)(2008-7#1)(2008-9#1)
that HBV infection##2##3##(2008-10#1)(2012-3#1)
that HBV##4##2##(2008-10#1)(2009-3#1)(2012-12#1)(2012-3#1)
that HCV is##4##3##(1991-9#1)(2006-10#1)(2008-1#1)(2010-12#1)
that HCV##9##2##(1991-9#1)(1995-5#1)(2006-10#1)(2006-2#2)(2008-1#1)(2008-11#1)(2008-8#1)(2010-12#1)
that HCWA may##2##3##(2008-10#2)
that HEX##2##2##(1992-8#2)
that HFBI##2##2##(2010-9#2)
that HG##2##2##(2008-1#1)(2008-7#1)
that HGF##10##2##(1990-12#1)(1991-10#1)(1991-11#1)(1991-4#1)(1991-5#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-3#1)(2006-6#1)
that HIM##2##2##(2007-12#2)
that HIOMT##2##2##(1995-9#2)
that HIV could##2##3##(1994-4#1)(1996-12#1)
that HIV may##2##3##(2010-12#1)(2013-1#1)
that HIV##14##2##(1990-9#1)(1994-4#1)(1996-12#1)(1996-5#2)(1997-5#1)(1997-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2010-12#2)(2011-2#1)(2013-1#1)
that HIV-1##8##2##(1992-4#1)(1992-9#1)(1993-9#2)(1996-4#1)(2006-10#1)(2008-11#1)(2013-1#1)
that HIV-2##2##2##(1996-4#2)
that HIV/AIDS##4##2##(2005-10#1)(2007-2#1)(2007-7#1)(2010-5#1)
that HK##2##2##(1994-12#2)
that HL-60 cells treated with##2##5##(1993-8#1)(1994-3#1)
that HMOs##2##2##(1993-1#1)(1994-3#1)
that HNE##2##2##(1994-3#1)(2010-4#1)
that HPLC##2##2##(1990-8#1)(1991-5#1)
that HPRG##2##2##(1995-2#2)
that HPV 16##2##3##(1992-9#2)
that HPV E7##2##3##(2010-2#2)
that HPV infection in the##2##5##(2013-1#2)
that HPV##10##2##(1991-2#1)(1992-9#2)(2010-2#2)(2010-7#1)(2011-2#2)(2013-1#2)
that HRG##2##2##(1995-3#2)
that HS##2##2##(1995-10#1)(2009-5#1)
that HS-142-1##2##2##(1992-11#2)
that HSA##3##2##(1994-8#1)(1994-9#1)(1997-8#1)
that HSP##3##2##(1994-8#1)(2012-3#2)
that HSPs##2##2##(1996-9#1)(2005-10#1)
that HST-a##3##2##(1991-3#3)
that HTLV-I##3##2##(1991-8#1)(1994-6#1)(2008-8#1)
that HcNPV attachment to Sf21 cells##2##6##(2008-11#2)
that HcNPV##3##2##(2008-11#3)
that HeLa##2##2##(1995-6#1)(2008-11#1)
that Helicobacter pylori may be##2##5##(2006-10#1)(2007-7#1)
that Helicobacter pylori##3##3##(1996-11#1)(2006-10#1)(2007-7#1)
that Hg##4##2##(1995-3#1)(2008-10#2)(2008-3#1)
that Hg(II)##3##2##(1990-2#1)(2008-10#2)
that Hispanic##3##2##(2005-10#1)(2011-2#1)(2012-12#1)
that Hox##2##2##(1995-8#1)(2011-12#1)
that HrHRF##2##2##(2004-12#2)
that Hsp90##2##2##(1997-4#2)
that I reported##2##3##(2007-12#1)(2008-2#1)
that I will discuss##2##4##(2007-5#1)(2010-3#1)
that I##14##2##(1991-12#1)(1991-4#1)(1995-2#1)(2005-9#2)(2006-7#1)(2007-12#1)(2007-5#1)(2007-9#2)(2008-10#2)(2008-2#1)(2010-3#1)
that IBD slopes##2##3##(2008-9#2)
that IBD##5##2##(2006-10#1)(2006-2#1)(2008-9#3)
that ICs##2##2##(1995-8#2)
that IFN alpha##2##3##(1990-7#1)(1994-8#1)
that IFN##5##2##(1990-7#2)(1994-8#2)(1996-5#1)
that IFN-gamma##5##2##(1990-11#1)(1992-12#1)(1996-12#1)(2008-8#1)(2010-12#1)
that IFN-β produced by MSC##2##5##(2011-1#2)
that IFP 53##2##3##(1992-3#2)
that IGF-I##8##2##(1991-1#3)(1991-5#1)(1996-2#1)(1996-8#1)(1997-4#1)(2008-8#1)
that IH##4##2##(1990-7#1)(1997-8#3)
that IK[Ca] channels##2##3##(1994-3#2)
that IL-1 alpha##3##3##(1992-8#1)(1993-8#1)(1994-12#1)
that IL-1 beta##6##3##(1994-10#2)(1994-8#1)(1994-9#1)(1996-3#1)(2007-2#1)
that IL-1 is##3##3##(1990-3#1)(1993-7#1)(2007-12#1)
that IL-1##20##2##(1990-11#1)(1990-12#1)(1990-3#1)(1991-3#1)(1992-4#1)(1992-8#1)(1993-7#1)(1993-8#1)(1994-10#3)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-3#1)(2007-11#1)(2007-12#2)(2007-2#1)
that IL-10 is##2##3##(1993-8#1)(1994-12#1)
that IL-10##6##2##(1993-4#2)(1993-8#1)(1994-12#1)(1996-10#1)(1996-9#1)
that IL-12##7##2##(1996-10#7)
that IL-13##2##2##(2012-2#2)
that IL-17##4##2##(2007-11#4)
that IL-2##3##2##(1994-5#1)(1996-11#1)(1997-4#1)
that IL-4##5##2##(1991-7#1)(1992-12#1)(1994-8#1)(1996-12#1)(2009-12#1)
that IL-6 is involved##2##4##(1990-5#1)(1997-7#1)
that IL-6##6##2##(1990-5#1)(1990-7#1)(1996-2#1)(1996-5#1)(1997-7#1)(2008-9#1)
that IL-8##3##2##(1990-5#1)(1993-6#1)(2008-10#1)
that ILBS is##2##3##(2008-7#2)
that ILBS##3##2##(2008-7#3)
that IP##2##2##(1991-1#1)(2008-7#1)
that IP-10##2##2##(1996-10#2)
that IP3##3##2##(1993-7#1)(1994-3#1)(1994-8#1)
that IQ##2##2##(1997-7#1)(2004-10#1)
that IQGAP1##2##2##(1997-6#2)
that IR##3##2##(2008-10#3)
that IRF-2##2##2##(1995-12#2)
that IS511 is##2##3##(1997-4#2)
that ITD##2##2##(2010-12#2)
that Id##3##2##(1994-3#2)(2011-2#1)
that Id-1##3##2##(2008-8#3)
that IgG##3##2##(1996-12#1)(2007-2#1)(2009-8#1)
that India##2##2##(1994-9#1)(2011-1#1)
that InsP3-R is##2##3##(1993-6#2)
that InsP6 can##2##3##(1997-4#2)
that InsP6##4##2##(1990-7#2)(1997-4#2)
that Islam has##3##3##(2007-10#1)(2007-12#1)(2008-12#1)
that J##2##2##(2008-10#1)(2012-2#1)
that JP-8 exposure is immunosuppressive##2##5##(2008-4#1)(2008-8#1)
that Japanese##2##2##(2005-3#1)(2008-10#1)
that K##4##2##(1990-4#1)(1997-6#1)(2008-4#2)
that K(+)##2##2##(2005-10#1)(2012-2#1)
that K+ channel openers##2##4##(1991-1#1)(1993-11#1)
that K+##3##2##(1991-1#1)(1993-11#1)(1996-6#1)
that K3L##3##2##(1996-5#3)
that KN-93 inhibits##2##3##(1991-12#2)
that KT##2##2##(2013-1#2)
that KW-5092##2##2##(1997-3#2)
that Ki-energy may##2##3##(2008-10#2)
that Kirschner##2##2##(2005-7#1)(2011-2#1)
that Ku##2##2##(1997-4#2)
that Kv11##3##2##(2008-8#3)
that Kv4##2##2##(1997-8#1)(2008-8#1)
that L##7##2##(2004-11#1)(2006-10#1)(2011-1#2)(2012-2#1)(2013-8#2)
that L-PHP##5##2##(2013-7#5)
that L1##3##2##(1995-2#1)(2008-3#1)(2008-7#1)
that LA##2##2##(2007-7#1)(2009-8#1)
that LAIV was more protective##2##5##(2011-2#2)
that LAIV##3##2##(2011-2#3)
that LAVH##2##2##(1995-1#1)(1995-3#1)
that LB1 is##2##3##(2009-11#2)
that LCAT##2##2##(1993-3#1)(1996-5#1)
that LChV-3##2##2##(2008-10#2)
that LD##3##2##(1997-8#2)(2004-10#1)
that LDH##4##2##(1997-4#1)(2008-11#1)(2011-2#2)
that LDL##6##2##(1991-2#1)(1993-4#1)(1995-12#1)(1997-2#2)(2008-1#1)
that LGP85##2##2##(1991-7#2)
that LINC1##2##2##(2009-8#2)
that LIPUS##2##2##(2013-1#2)
that LMWH is##2##3##(2007-7#1)(2008-1#1)
that LNA##2##2##(2009-3#2)
that LP##3##2##(2006-2#1)(2008-10#1)(2008-12#1)
that LPS induced##3##3##(1993-4#1)(2008-10#1)(2010-4#1)
that LPS##9##2##(1990-5#1)(1993-4#1)(1994-8#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-8#2)(2010-4#1)
that LTP##2##2##(1990-4#1)(1996-5#1)
that LXA4##2##2##(1990-3#1)(1991-5#1)
that La##2##2##(1992-11#1)(2008-5#1)
that La(3+)##2##2##(2008-9#2)
that La/B(4)C##2##2##(2007-11#1)(2008-3#1)
that LapSVM##2##2##(2010-7#2)
that Lp(a)##2##2##(2007-7#1)(2008-6#1)
that Lp-PLA2 is a##2##4##(2011-12#2)
that Lp-PLA2##3##2##(2011-12#3)
that Lyn##2##2##(1996-4#1)(1996-5#1)
that M##20##2##(1990-5#1)(2008-10#9)(2008-4#1)(2008-5#3)(2009-8#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-7#1)
that M-CSF##3##2##(1991-5#1)(1993-9#2)
that M79##2##2##(2008-8#2)
that MAAE##2##2##(1996-12#2)
that MAG is##2##3##(1994-6#2)
that MAG##3##2##(1994-6#3)
that MAP kinase is##2##4##(1992-8#1)(1997-7#1)
that MAP##4##2##(1992-8#1)(1996-10#1)(1997-7#1)(2008-4#1)
that MAPKK is##2##3##(1994-12#1)(1995-2#1)
that MAPKK##3##2##(1994-12#2)(1995-2#1)
that MAb##2##2##(1990-10#1)(1995-5#1)
that MB##3##2##(2007-8#1)(2008-10#1)(2012-2#1)
that MBP##2##2##(1992-11#1)(1997-7#1)
that MC1R##3##2##(2008-9#3)
that MDM2##2##2##(1994-3#2)
that MDV##4##2##(2007-6#1)(2013-8#3)
that MG_237##2##2##(2012-2#2)
that MHC class I##3##4##(1993-9#1)(2008-1#2)
that MI is##2##3##(2013-1#1)(2013-8#1)
that MI##3##2##(2013-1#2)(2013-8#1)
that MIF is##2##3##(1994-11#1)(1996-12#1)
that MIF##3##2##(1994-11#1)(1996-12#1)(1997-5#1)
that MJ1 integrase##3##3##(2007-12#3)
that MK-801##3##2##(1991-2#1)(1994-6#1)(1997-5#1)
that MMF is##2##3##(2007-11#1)(2007-8#1)
that MMN##2##2##(2008-8#2)
that MMP2##2##2##(1994-12#2)
that MP##2##2##(2008-9#2)
that MPA##4##2##(1991-10#1)(1992-6#1)(1996-3#1)(2012-12#1)
that MPP+##2##2##(1990-5#2)
that MR##3##2##(1997-8#1)(2007-9#1)(2010-12#1)
that MRI is the##2##4##(1996-9#1)(2010-12#1)
that MRI##3##2##(1996-9#1)(2008-7#1)(2010-12#1)
that MRP##2##2##(1997-7#1)(2005-11#1)
that MS##2##2##(2008-3#2)
that MSBP1##2##2##(2009-10#2)
that MSCs##2##2##(2009-10#1)(2012-12#1)
that MSRs##2##2##(2009-10#2)
that MT##3##2##(1993-12#1)(2006-9#1)(2008-10#1)
that MTHFR##2##2##(2008-1#1)(2009-10#1)
that MTs##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
that MV##2##2##(1997-6#1)(2012-2#1)
that MW##2##2##(2007-8#1)(2008-9#1)
that MZ##2##2##(1997-4#1)(2008-12#1)
that MaMPRV##2##2##(2008-10#2)
that MacMARCKS##3##2##(1996-5#3)
that MafK##2##2##(1995-3#2)
that Malette had##2##3##(1990-3#2)
that Mb##2##2##(2008-10#2)
that Medicaid##3##2##(1995-2#1)(1996-1#1)(1997-1#1)
that Medicare fees are##2##4##(1994-1#1)(2010-2#1)
that Medicare##8##2##(1992-1#1)(1994-1#1)(1995-2#1)(1996-12#1)(1997-3#1)(2007-2#1)(2010-2#2)
that MetS##2##2##(2010-10#1)(2013-1#1)
that MhNPR1##2##2##(2011-10#2)
that Mn##2##2##(2006-6#1)(2008-10#1)
that N##3##2##(1991-3#1)(1991-8#1)(2010-8#1)
that N-terminal##4##2##(1990-12#1)(1997-6#1)(2007-8#1)(2008-7#1)
that NAC##2##2##(1991-9#1)(2011-1#1)
that NAD+##2##2##(2007-11#2)
that NADPH##4##2##(1994-3#1)(1994-9#1)(2008-1#1)(2013-1#1)
that NC##2##2##(2012-12#2)
that NCAM##2##2##(1994-8#2)
that NDP kinase##2##3##(1992-8#2)
that NDP##3##2##(1992-8#2)(2010-1#1)
that NF-kappa B##5##3##(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)
that NF1##3##2##(1991-5#1)(1996-1#1)(2008-7#1)
that NGF and##2##3##(1993-6#1)(1994-3#1)
that NGF can##3##3##(1993-12#2)(2006-10#1)
that NGF may##5##3##(1990-7#1)(1991-7#1)(1992-7#1)(1993-11#1)(1997-5#1)
that NGF##22##2##(1990-7#3)(1991-7#1)(1992-7#1)(1993-11#2)(1993-12#2)(1993-6#1)(1993-7#1)(1994-2#1)(1994-3#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2010-11#1)
that NGFI-B##2##2##(1991-5#1)(1996-11#1)
that NIR##3##2##(2008-10#1)(2010-4#2)
that NIRS##2##2##(2008-10#2)
that NK cells##3##3##(1994-9#1)(2008-4#1)(2009-9#1)
that NK##4##2##(1994-9#1)(2006-10#1)(2008-4#1)(2009-9#1)
that NMDA receptor blockade##2##4##(1992-3#1)(1993-11#1)
that NMDA receptor##4##3##(1992-3#1)(1993-11#1)(1996-12#1)(1997-2#1)
that NMDA receptors are##2##4##(1993-5#1)(1997-7#1)
that NMDA receptors##5##3##(1992-8#1)(1993-5#1)(1994-10#1)(1996-12#1)(1997-7#1)
that NMDA##13##2##(1991-6#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-5#1)(1994-10#1)(1996-12#2)(1996-9#1)(1997-2#1)(1997-5#1)(1997-7#1)
that NMR##2##2##(1996-7#1)(2008-7#1)
that NO does not##2##4##(1996-2#1)(2008-4#1)
that NO is an##2##4##(2008-11#1)(2012-2#1)
that NO is##7##3##(1995-2#1)(1995-5#1)(1997-6#1)(2008-11#1)(2009-8#1)(2011-2#1)(2012-2#1)
that NO may##2##3##(1992-12#1)(1993-4#1)
that NO production was##2##4##(1995-6#1)(2006-8#1)
that NO production##5##3##(1994-5#1)(1994-6#1)(1995-6#1)(2006-8#2)
that NO##33##2##(1992-11#1)(1992-12#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-4#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-6#4)(1997-7#1)(2006-8#2)(2008-11#1)(2008-4#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
that NOD##2##2##(1997-4#1)(2007-5#1)
that NOS##2##2##(1992-3#1)(1997-6#1)
that NPIK##2##2##(1997-8#2)
that NPY##4##2##(1995-12#2)(1996-1#1)(1997-3#1)
that NT##2##2##(1994-10#1)(2008-5#1)
that Na(+)##2##2##(2008-5#1)(2008-8#1)
that Nck is##2##3##(1996-8#1)(1997-4#1)
that Nck##4##2##(1996-8#2)(1997-4#2)
that New##3##2##(1990-2#1)(1995-11#1)(2006-1#1)
that NodB##2##2##(1994-8#2)
that O##4##2##(2008-10#1)(2008-11#1)(2010-8#1)(2013-8#1)
that O/W microemulsion has more##2##5##(2005-4#2)
that O2 is##2##3##(1995-8#1)(2008-10#1)
that O2##3##2##(1995-8#1)(2008-10#1)(2008-3#1)
that OA##2##2##(1992-12#1)(1993-6#1)
that OCD##3##2##(2006-9#1)(2007-6#1)(2009-7#1)
that ODT##2##2##(2007-9#1)(2008-5#1)
that OH-Tam##2##2##(1990-12#2)
that OPC-21268##3##2##(1991-7#3)
that OSF-1##2##2##(1990-11#1)(1992-5#1)
that P is##2##3##(1993-2#1)(2007-12#1)
that P##43##2##(1992-12#1)(1993-11#1)(1993-2#1)(1994-3#1)(2004-2#1)(2006-8#2)(2007-12#1)(2008-10#22)(2008-12#1)(2008-5#2)(2009-5#2)(2009-9#1)(2010-3#3)(2010-8#1)(2011-10#1)(2012-12#1)(2013-7#1)
that P-450aldo##2##2##(1990-11#2)
that P-glycoprotein is a##2##4##(1992-11#1)(2008-11#1)
that P-glycoprotein is##3##3##(1992-11#1)(2008-11#2)
that P-glycoprotein##5##2##(1992-11#1)(2008-11#3)(2008-7#1)
that P1##3##2##(1994-5#1)(1994-6#1)(1996-12#1)
that P2##3##2##(2008-11#2)(2008-4#1)
that P23k bound##2##3##(1992-2#2)
that P23k##3##2##(1992-2#3)
that P2X receptors##3##3##(2008-4#3)
that P50##2##2##(2008-10#2)
that PACAPR-3##3##2##(1994-3#3)
that PAF##8##2##(1991-12#2)(1991-2#1)(1991-4#2)(1993-4#2)(2008-3#1)
that PAI-1##5##2##(1996-2#1)(2007-9#1)(2008-4#1)(2011-2#2)
that PAP##4##2##(1995-8#1)(2008-10#3)
that PC##4##2##(1991-2#1)(1991-5#1)(2008-10#1)(2012-3#1)
that PC12h cells##2##3##(1990-11#1)(1997-8#1)
that PCFV is##2##3##(2008-10#2)
that PCFV##3##2##(2008-10#3)
that PCH will##2##3##(2013-8#2)
that PCNA##2##2##(1994-12#1)(1995-8#1)
that PCOS##2##2##(2008-4#1)(2010-10#1)
that PCP binding##2##3##(1996-12#1)(1997-5#1)
that PCP may##2##3##(1997-5#2)
that PCP##5##2##(1996-12#1)(1997-5#4)
that PCR##2##2##(1993-7#1)(2010-5#1)
that PD patients have##2##4##(2008-7#2)
that PD patients##4##3##(2007-8#1)(2008-7#2)(2009-10#1)
that PD##10##2##(2007-5#1)(2007-8#1)(2008-11#1)(2008-7#3)(2009-10#1)(2012-12#1)(2013-1#2)
that PDE##3##2##(2005-8#1)(2008-3#1)(2013-1#1)
that PDGF##2##2##(1991-3#1)(1997-6#1)
that PDGF-dependent##2##2##(1995-2#1)(2005-8#1)
that PDT##2##2##(1992-8#1)(2008-5#1)
that PE and##2##3##(2004-11#1)(2008-12#1)
that PE##3##2##(1990-5#1)(2004-11#1)(2008-12#1)
that PEMF treatment##2##3##(1997-8#2)
that PEMF##3##2##(1997-8#3)
that PFE##2##2##(2008-9#2)
that PG##2##2##(1997-1#1)(2013-8#1)
that PGD-S is##2##3##(1996-2#2)
that PGE2##2##2##(1990-2#1)(1997-8#1)
that PGIS##3##2##(1993-12#1)(1994-8#2)
that PI 3-kinase##3##3##(1994-3#1)(1995-8#1)(2008-11#1)
that PI##5##2##(1991-7#2)(1994-3#1)(1995-8#1)(2008-11#1)
that PI-3-kinase##2##2##(1997-7#2)
that PIP2-mediated inhibition of##2##4##(1993-6#2)
that PIP3##2##2##(1993-8#2)
that PKA##7##2##(1990-7#1)(1992-6#1)(1993-6#2)(1996-9#1)(2008-8#2)
that PKC activity may be##2##5##(1991-7#1)(1994-2#1)
that PKC activity##4##3##(1990-4#1)(1991-7#1)(1992-6#1)(1994-2#1)
that PKC epsilon##2##3##(1995-2#2)
that PKC##27##2##(1990-12#1)(1990-4#1)(1990-5#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-6#2)(1992-8#1)(1993-12#2)(1993-3#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-7#1)(1996-8#2)(2008-1#1)(2008-11#1)(2008-8#1)
that PL##2##2##(1990-12#1)(2008-7#1)
that PLC-delta 1 gene##2##4##(1992-9#2)
that PM##2##2##(2007-8#1)(2008-10#1)
that PMA##3##2##(1992-6#1)(1994-6#1)(1996-2#1)
that PMM##2##2##(2007-12#2)
that PN-2/APP is##2##3##(1991-2#1)(1992-12#1)
that PN-2/APP##3##2##(1991-2#1)(1992-12#2)
that PNM##2##2##(2013-1#2)
that POMC gene##2##3##(1993-12#1)(1993-5#1)
that POMC##3##2##(1993-12#1)(1993-5#2)
that PP DCs##2##3##(2008-11#2)
that PP##3##2##(2007-4#1)(2008-11#2)
that PPARs##2##2##(1997-4#1)(2008-10#1)
that PPC##2##2##(1992-8#1)(1992-9#1)
that PRL##6##2##(1991-4#1)(1996-8#4)(2008-6#1)
that PRms##2##2##(2008-10#2)
that PSA##2##2##(2008-4#1)(2009-4#1)
that PSD##2##2##(1996-12#1)(2007-10#1)
that PSNL1 mRNA was##2##4##(1996-2#2)
that PSV strain BV-15##2##4##(2008-10#2)
that PSV##5##2##(2007-10#1)(2008-10#3)(2012-11#1)
that PTH and##2##3##(1992-6#1)(1993-6#1)
that PTSD##2##2##(2005-10#1)(2009-8#1)
that PV##2##2##(1993-4#1)(1995-5#1)
that PVN##2##2##(1995-12#1)(1997-8#1)
that Parkinson's disease##3##3##(2008-11#2)(2008-7#1)
that Pb##3##2##(2007-5#1)(2008-7#2)
that Pb2+##2##2##(1995-11#1)(2008-7#1)
that PcpD##2##2##(2009-3#2)
that Platycopia##2##2##(2008-5#2)
that Pleistocene##2##2##(2007-7#1)(2010-8#1)
that PptT is##2##3##(2013-1#2)
that PptT##4##2##(2013-1#4)
that PrP##2##2##(1994-6#1)(1995-11#1)
that Promote##2##2##(2009-11#1)(2011-1#1)
that Pythium##2##2##(2008-10#2)
that QAMP was##2##3##(2013-7#2)
that QKI##2##2##(2006-11#1)(2009-9#1)
that QSYQ##2##2##(2013-1#2)
that QUAD##3##2##(1994-11#3)
that R##10##2##(1991-4#1)(2008-10#6)(2012-2#3)
that RA##8##2##(1990-6#1)(1991-9#1)(1992-11#1)(1993-6#1)(2006-10#1)(2008-11#2)(2013-1#1)
that RA538 could##2##3##(2008-8#2)
that RAM 7s encodes part of a##2##7##(1993-8#2)
that RAM 7s##3##3##(1993-8#3)
that RBC##3##2##(1995-1#1)(2010-9#1)(2011-12#1)
that RBM3##2##2##(1997-7#2)
that RBV##2##2##(2013-1#2)
that RCC##3##2##(1992-12#1)(1997-7#1)(2011-2#1)
that RF##2##2##(2007-11#1)(2008-11#1)
that RFA##3##2##(2006-6#2)(2008-9#1)
that RH##2##2##(1996-1#2)
that RIF##2##2##(2009-10#1)(2010-12#1)
that RNA polymerase II##2##4##(1994-3#1)(2010-11#1)
that RNA polymerase##4##3##(1994-3#1)(1994-8#1)(1994-9#1)(2010-11#1)
that RNA##14##2##(1991-11#1)(1991-9#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-7#1)(2006-10#1)(2006-12#2)(2008-10#1)(2009-3#1)(2010-11#1)(2013-8#1)
that RNAi##2##2##(2008-2#1)(2008-9#1)
that RNase E##2##3##(1996-5#2)
that RNase##5##2##(1990-7#1)(1992-10#1)(1996-5#2)(2007-1#1)
that ROS##8##2##(2009-3#1)(2009-8#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-6#1)
that RR is##2##3##(2013-8#2)
that RS##2##2##(2008-10#1)(2008-8#1)
that RT##2##2##(1996-3#1)(1997-6#1)
that RT-PCR##2##2##(2008-10#1)(2008-5#1)
that RW##2##2##(2008-11#2)
that Rab11 is##2##3##(1997-1#2)
that Rabphilin-3A##2##2##(1994-11#1)(1994-9#1)
that Raintree##2##2##(1996-11#2)
that Raman##2##2##(2007-11#1)(2013-8#1)
that Ras can##4##3##(1994-12#2)(1996-2#1)(1997-6#1)
that Ras##6##2##(1994-12#2)(1994-8#1)(1996-2#1)(1997-6#2)
that Rb##3##2##(1995-2#1)(2003-11#2)
that RepK##2##2##(1997-6#2)
that Rho is##2##3##(2007-8#1)(2009-10#1)
that S##18##2##(1991-6#1)(1992-1#1)(1994-5#1)(1995-12#1)(1997-3#1)(1997-7#1)(2006-4#1)(2006-9#1)(2008-10#4)(2008-3#1)(2008-8#1)(2008-9#1)(2011-12#1)(2012-2#1)(2012-3#1)
that S1 is##2##3##(1997-2#1)(2008-12#1)
that SBI##2##2##(2007-10#2)
that SC##2##2##(2008-5#1)(2011-2#1)
that SCN##2##2##(2009-2#2)
that SCPx##2##2##(1997-7#2)
that SCuPA##2##2##(1990-11#2)
that SERS##2##2##(2009-2#1)(2009-4#1)
that SF-1##2##2##(1995-11#2)
that SFE##2##2##(2008-10#2)
that SH2##2##2##(1993-6#1)(1995-2#1)
that SHPTP2##2##2##(1995-1#2)
that SHR##2##2##(1996-5#1)(2010-12#1)
that SI##5##2##(1991-5#1)(1997-8#1)(2008-7#2)(2011-12#1)
that SIRT1##2##2##(2010-2#1)(2012-2#1)
that SKP2A##2##2##(2009-8#2)
that SLE is more common in##3##6##(2006-10#1)(2007-3#2)
that SLE##4##2##(2006-10#2)(2007-3#2)
that SMRTER##3##2##(2012-12#3)
that SNP##3##2##(1994-2#1)(2008-11#2)
that SO3##2##2##(1994-11#2)
that SP##6##2##(1995-12#1)(1996-3#1)(1997-4#2)(2008-5#1)(2011-1#1)
that SP-B##2##2##(1994-3#1)(2007-11#1)
that SP-containing##2##2##(1992-8#1)(1997-3#1)
that SPG##2##2##(2006-12#2)
that SR##3##2##(1993-11#1)(1995-6#2)
that SRB2##3##2##(1992-5#3)
that SRT1720##2##2##(2012-2#2)
that SS##2##2##(1997-6#1)(2011-2#1)
that SS767##2##2##(2008-10#2)
that STH2##2##2##(2009-8#2)
that STM##4##2##(1990-4#1)(1993-11#1)(2010-9#1)(2013-7#1)
that SV-toxins##2##2##(2008-10#2)
that SVM model##2##3##(2007-8#1)(2013-8#1)
that SVR##2##2##(2011-2#1)(2012-1#1)
that SWEETIE##2##2##(2009-8#2)
that SWNHs##2##2##(2009-2#2)
that SYSV##2##2##(2008-10#2)
that Saccharomyces##2##2##(2011-1#1)(2012-3#1)
that SbPRP##2##2##(2008-8#2)
that Schwann cells##2##3##(1994-3#1)(2009-11#1)
that Sec61##2##2##(1991-2#2)
that Sertoli cells##2##3##(1991-4#1)(2007-9#1)
that Sertoli##3##2##(1991-4#1)(1992-5#1)(2007-9#1)
that Si##3##2##(2008-10#2)(2008-9#1)
that Smad7##4##2##(2012-12#4)
that South##2##2##(2008-3#1)(2011-1#1)
that Sp1##4##2##(1994-8#1)(1996-10#2)(1996-5#1)
that Spata22##2##2##(2013-8#2)
that Sph-1-P##2##2##(1994-2#2)
that SqVYV##2##2##(2008-10#2)
that Src##3##2##(1995-11#1)(1995-6#1)(2011-2#1)
that SspA##2##2##(1994-5#2)
that T cell##2##3##(1997-4#1)(2010-2#1)
that T cells##9##3##(1990-8#1)(1994-3#1)(1995-2#1)(1996-4#1)(2005-10#1)(2008-4#1)(2008-8#1)(2012-12#2)
that T lymphocytes##2##3##(1995-2#1)(2011-2#1)
that T##38##2##(1990-6#1)(1990-8#1)(1994-3#1)(1995-2#2)(1996-2#1)(1996-4#1)(1997-1#1)(1997-4#2)(2005-10#1)(2006-8#1)(2007-3#3)(2008-10#12)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-8#1)
that T-cell##2##2##(1995-12#1)(2013-8#1)
that T-cells are##2##3##(2008-10#2)
that T-cells##3##2##(1997-6#1)(2008-10#2)
that T7 RNA polymerase##2##4##(1996-11#1)(2008-4#1)
that T7##4##2##(1992-2#1)(1996-11#1)(1997-5#1)(2008-4#1)
that TALH-SVE cells##2##3##(1991-1#2)
that TAMs##2##2##(2011-2#1)(2012-1#1)
that TBARS##2##2##(1993-2#1)(2008-10#1)
that TCDD##4##2##(1992-11#1)(1994-8#1)(1995-3#1)(2008-10#1)
that TCDD-induced##2##2##(1992-12#1)(1995-3#1)
that TF##2##2##(1995-8#1)(2010-12#1)
that TFPI-2##2##2##(2013-8#2)
that TGF alpha##2##3##(1992-12#1)(1997-4#1)
that TGF##3##2##(1990-12#1)(1992-12#1)(1997-4#1)
that TGF-beta 1##3##3##(1991-10#1)(1995-3#1)(1995-6#1)
that TGF-beta##11##2##(1990-12#1)(1991-10#1)(1993-12#2)(1993-8#1)(1995-12#1)(1995-3#2)(1995-6#1)(1997-2#1)(2008-11#1)
that TH##2##2##(1996-6#1)(1997-2#1)
that THB##2##2##(1997-1#2)
that TILs##2##2##(1990-10#2)
that TLR##2##2##(2005-10#1)(2009-9#1)
that TLR4##2##2##(2010-8#1)(2011-2#1)
that TLR9##2##2##(2012-12#2)
that TMV-p##2##2##(1997-6#2)
that TNF is an##2##4##(1993-12#1)(1995-3#1)
that TNF is##3##3##(1993-12#1)(1995-3#1)(1996-1#1)
that TNF##14##2##(1990-12#1)(1990-5#2)(1990-7#1)(1992-8#1)(1993-12#2)(1994-9#1)(1995-3#2)(1995-9#1)(1996-1#1)(1997-8#1)(2007-11#1)
that TNF-alpha##7##2##(1996-5#1)(2007-11#2)(2007-8#1)(2008-3#1)(2013-1#2)
that TNT##3##2##(1993-4#1)(1995-6#1)(2008-10#1)
that TOM1L##2##2##(2010-2#2)
that TPA##8##2##(1990-8#1)(1991-6#1)(1991-7#2)(1992-6#1)(1992-8#1)(1992-9#2)
that TPN##2##2##(1994-6#2)
that TR##2##2##(1994-3#1)(1994-9#1)
that TRBP##2##2##(1994-8#2)
that TRH and##2##3##(1991-12#1)(1995-5#1)
that TRH##6##2##(1991-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-5#1)(2013-7#1)
that TS##4##2##(1995-6#1)(1996-5#1)(2008-11#2)
that TSH receptor##2##3##(1991-5#1)(1991-8#1)
that TSH##4##2##(1991-5#1)(1991-8#1)(1993-12#1)(1993-9#1)
that TSP##4##2##(1991-6#1)(1993-8#1)(1993-9#1)(2013-8#1)
that TSPO##3##2##(2012-2#3)
that TSWV##4##2##(2008-10#4)
that TTM##2##2##(2010-12#2)
that TTP##2##2##(1990-9#1)(2009-4#1)
that TTR##2##2##(1993-12#1)(1994-12#1)
that TTX##2##2##(1992-10#1)(1994-10#1)
that TUF is##2##3##(1990-5#1)(2007-4#1)
that TUF##3##2##(1990-5#2)(2007-4#1)
that TWA##2##2##(2006-9#2)
that TYLCV-CHI is##2##3##(2008-8#2)
that TZDs##2##2##(2008-1#1)(2008-3#1)
that Task Orientation##2##3##(1995-1#2)
that Task##4##2##(1995-1#2)(2009-10#1)(2012-3#1)
that Tat##2##2##(1991-3#1)(2009-8#1)
that TdT##2##2##(1997-9#2)
that Tf##3##2##(1994-10#1)(2013-7#2)
that Th2##2##2##(1996-10#1)(2010-12#1)
that Thal##2##2##(2008-3#2)
that Tiam1 is a##2##4##(2012-12#2)
that Tid1##3##2##(2011-2#3)
that Title III##2##3##(1997-5#2)
that ToxR##3##2##(1995-2#3)
that TraG##2##2##(1997-4#2)
that Treg##2##2##(2011-1#1)(2013-8#1)
that Triad1##2##2##(2012-12#2)
that Trichoderma##5##2##(2008-10#4)(2009-8#1)
that Tup1##2##2##(1994-6#2)
that Tween##2##2##(1994-9#1)(2010-5#1)
that Tyr-503 is##2##3##(1990-8#2)
that U##5##2##(1996-2#1)(2007-9#1)(2008-10#2)(2011-2#1)
that UC##2##2##(2007-4#1)(2008-9#1)
that UDCA##2##2##(2008-8#2)
that UFN##2##2##(1993-8#2)
that UR-7280##2##2##(1996-12#2)
that US##3##2##(1996-6#1)(2010-12#1)(2012-12#1)
that UTP##2##2##(1993-8#1)(2008-4#1)
that UV irradiation##2##3##(1995-2#1)(2008-5#1)
that UV##8##2##(1995-2#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)(2012-1#1)
that UVA##2##2##(2008-5#1)(2011-2#1)
that UVB##2##2##(1996-6#1)(2008-5#1)
that UVR##2##2##(2011-2#2)
that UbiG##2##2##(1996-7#2)
that United##2##2##(1996-11#1)(1997-5#1)
that V##8##2##(2004-4#1)(2008-10#3)(2008-9#1)(2009-8#1)(2012-11#2)
that V4 is important for##2##5##(1992-9#1)(1993-2#1)
that V4 is##3##3##(1992-9#1)(1993-2#2)
that V4##5##2##(1992-9#2)(1993-2#2)(2008-5#1)
that VDR##2##2##(1992-12#1)(1995-2#1)
that VEGF##4##2##(1995-1#1)(2008-9#1)(2009-8#2)
that VEGF/VPF##3##2##(1994-3#1)(1995-1#2)
that VIC##2##2##(1990-2#1)(1991-2#1)
that VIP is a##2##4##(1994-9#1)(1997-8#1)
that VIP is##3##3##(1994-9#1)(1997-8#2)
that VIP##7##2##(1994-9#1)(1995-5#2)(1997-8#3)(2008-4#1)
that VPA##4##2##(2007-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
that Vpr##2##2##(1996-10#1)(1997-3#1)
that Vti1p##3##2##(1997-6#3)
that WEP##2##2##(2008-11#2)
that WIPK##2##2##(2009-8#2)
that WM##2##2##(2010-7#1)(2012-2#1)
that WRN##2##2##(2010-2#2)
that WSMV##3##2##(2008-10#3)
that Western##3##2##(1995-7#1)(2006-7#1)(2012-1#1)
that White##2##2##(2005-6#1)(2006-7#1)
that X##9##2##(1997-2#1)(2008-10#7)(2008-9#1)
that Xenopus##2##2##(1992-11#1)(1993-3#1)
that Y##2##2##(2008-8#1)(2013-1#1)
that YY1##4##2##(2008-11#4)
that ZAG##2##2##(1997-4#2)
that ZMA supplementation##2##3##(2008-5#2)
that Zn##6##2##(1993-12#1)(1997-3#1)(2008-10#3)(2008-12#1)
that Zn2+##3##2##(1995-6#2)(1995-7#1)
that [3H]suramin##2##2##(1994-9#2)
that [Ca(2+)](i)##2##2##(2008-9#2)
that a &quot##8##3##(1990-12#1)(1993-1#1)(1994-2#1)(1995-12#1)(1995-7#1)(1996-2#1)(2010-4#1)(2010-7#1)
that a 1##5##3##(1993-12#1)(1996-2#1)(2007-11#1)(2008-7#1)(2013-8#1)
that a 15##2##3##(1997-7#1)(2011-2#1)
that a 2##2##3##(1995-6#1)(2010-9#1)
that a 23##2##3##(1993-8#1)(1997-7#1)
that a 3##2##3##(1994-12#1)(1995-1#1)
that a 6-month##2##3##(2006-10#1)(2007-2#1)
that a Ca2+##2##3##(1994-2#1)(1994-8#1)
that a balance##2##3##(1991-8#1)(1993-4#1)
that a beta##2##3##(1994-9#1)(2010-6#1)
that a better understanding of the##2##6##(2008-1#1)(2011-2#1)
that a better##4##3##(1996-12#1)(2008-1#1)(2008-8#1)(2011-2#1)
that a broad##2##3##(1991-2#1)(1995-2#1)
that a broader spectrum of##2##5##(1992-3#1)(2008-7#1)
that a broader##4##3##(1992-3#1)(1993-3#1)(2008-7#1)(2011-2#1)
that a careful##4##3##(1990-10#1)(2006-10#1)(2009-7#1)(2010-9#1)
that a causal relationship##2##4##(1992-2#1)(1997-4#1)
that a causal##4##3##(1992-2#1)(1997-4#1)(2008-11#1)(2013-7#1)
that a cellular##2##3##(1994-2#1)(1995-6#1)
that a certain##4##3##(1992-11#1)(2007-12#1)(2008-9#1)(2012-2#1)
that a change in the##2##5##(1997-7#1)(2008-9#1)
that a change in##8##4##(1991-2#2)(1997-7#1)(2007-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-7#1)
that a change##9##3##(1991-2#2)(1994-8#1)(1997-7#1)(2007-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-7#1)
that a child##8##3##(1991-10#1)(1993-5#2)(2005-11#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-7#1)
that a clear##2##3##(1992-1#1)(2008-10#1)
that a close##2##3##(1990-2#1)(2009-2#1)
that a coherent##2##3##(2008-10#1)(2008-2#1)
that a combination of##23##4##(1991-11#1)(1991-2#1)(1992-2#1)(1994-8#1)(1996-4#1)(1997-9#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-2#1)(2007-5#1)(2007-6#2)(2007-7#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2010-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
that a combination##25##3##(1991-11#1)(1991-2#1)(1992-2#1)(1994-8#1)(1996-4#1)(1997-9#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-6#2)(2007-7#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
that a combined treatment of##2##5##(1996-2#1)(2011-1#1)
that a combined##4##3##(1996-2#1)(2006-11#1)(2008-10#1)(2011-1#1)
that a common##5##3##(1990-5#1)(1994-12#1)(1997-2#1)(1997-4#1)(2008-5#1)
that a company##2##3##(1991-12#1)(2004-12#1)
that a complete##4##3##(1991-6#1)(2007-8#1)(2010-8#1)(2011-12#1)
that a complex##2##3##(2008-2#1)(2010-4#1)
that a component of##6##4##(1991-9#1)(1997-5#1)(1997-8#1)(2005-10#1)(2008-8#1)(2010-8#1)
that a comprehensive understanding of the##2##6##(2010-7#1)(2012-3#1)
that a conserved##3##3##(1992-8#1)(2008-3#1)(2009-8#1)
that a constant##2##3##(1990-10#1)(2006-5#1)
that a conventional##2##3##(1996-12#1)(2006-9#1)
that a critical##8##3##(1994-2#1)(1995-8#1)(1996-2#1)(2005-11#1)(2008-2#1)(2008-7#1)(2010-2#1)(2010-7#1)
that a crystalline##2##3##(2008-2#1)(2008-5#1)
that a decline##2##3##(2008-7#1)(2009-4#1)
that a decrease in##3##4##(2008-5#1)(2010-3#1)(2012-2#1)
that a decrease of##2##4##(1991-6#1)(1994-5#1)
that a decrease##5##3##(1991-6#1)(1994-5#1)(2008-5#1)(2010-3#1)(2012-2#1)
that a deeper understanding of##2##5##(2008-11#1)(2010-7#1)
that a defect in##2##4##(1995-2#1)(1996-9#1)
that a defined##2##3##(2008-10#1)(2009-5#1)
that a definitive##2##3##(2007-10#1)(2009-2#1)
that a delayed##2##3##(2007-7#1)(2011-1#1)
that a deletion##2##3##(1990-12#1)(2005-8#1)
that a delicate##2##3##(2007-7#1)(2012-2#1)
that a detailed##3##3##(2006-8#1)(2008-4#1)(2012-2#1)
that a diagnostic##2##3##(1991-1#1)(2009-4#1)
that a difference in##4##4##(1990-2#1)(1994-12#1)(1997-1#1)(2013-8#1)
that a different##4##3##(1993-11#1)(1995-2#1)(2008-10#1)(2008-3#1)
that a direct##6##3##(1991-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(2006-12#1)(2007-11#1)
that a disease##2##3##(1992-8#1)(1997-6#1)
that a diverse range of##2##5##(2009-10#1)(2011-2#1)
that a doctor##2##3##(1992-12#1)(1996-11#1)
that a dose of 100##2##5##(2005-7#1)(2008-10#1)
that a dose of##3##4##(2005-7#1)(2007-4#1)(2008-10#1)
that a double##3##3##(2008-10#1)(2008-2#1)(2012-2#1)
that a drug##3##3##(1993-3#1)(1996-12#1)(2010-5#1)
that a factor##3##3##(1991-5#1)(2004-12#1)(2010-11#1)
that a few##6##3##(1990-10#1)(1991-6#1)(2006-10#1)(2007-6#1)(2008-10#1)(2011-2#1)
that a field##3##3##(1996-1#1)(2006-6#1)(2008-5#1)
that a fluorescence##2##3##(1994-8#1)(2008-5#1)
that a focal adhesion-like process##2##5##(2008-7#2)
that a fraction of the##2##5##(1995-6#1)(1996-4#1)
that a fraction of##3##4##(1995-6#1)(1996-4#1)(2007-10#1)
that a fragment from##2##4##(1992-6#1)(1993-3#1)
that a frequency##2##3##(1990-7#1)(2007-12#1)
that a fresh##2##3##(2005-7#1)(2007-8#1)
that a full##2##3##(1993-4#1)(2008-2#1)
that a fully##3##3##(2007-12#1)(2008-3#1)(2008-7#1)
that a functional##7##3##(1992-4#1)(1995-6#1)(1996-5#2)(1997-1#1)(2009-5#1)(2012-2#1)
that a gene##4##3##(1997-3#2)(2006-11#1)(2008-4#1)
that a general and##2##4##(2008-7#1)(2013-7#1)
that a general##6##3##(1990-9#1)(1991-6#1)(1997-3#1)(1997-5#1)(2008-7#1)(2013-7#1)
that a genetic##3##3##(1992-9#1)(2005-11#1)(2007-11#1)
that a given##2##3##(2006-5#1)(2008-11#1)
that a good##6##3##(1993-6#1)(1995-2#1)(2007-11#1)(2007-5#1)(2011-1#1)(2012-12#1)
that a great##2##3##(2007-8#1)(2008-10#1)
that a greater##3##3##(1992-9#1)(2008-5#1)(2009-7#1)
that a group##2##3##(2009-12#1)(2009-2#1)
that a growing##2##3##(2008-7#1)(2009-6#1)
that a high concentration of##3##5##(1994-2#1)(2008-10#1)(2010-4#1)
that a high degree of##4##5##(1992-12#1)(2007-12#1)(2008-10#1)(2008-3#1)
that a high level of##6##5##(1992-9#1)(1997-5#1)(2008-10#1)(2008-11#2)(2008-9#1)
that a high level##7##4##(1992-9#1)(1997-5#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)
that a high percentage of##3##5##(1991-12#1)(2006-10#1)(2008-2#1)
that a high percentage##4##4##(1991-12#1)(2006-10#1)(2008-10#1)(2008-2#1)
that a high rate of##2##5##(1997-7#1)(2006-3#1)
that a high##35##3##(1990-2#1)(1991-11#1)(1991-12#1)(1992-12#1)(1992-9#4)(1993-9#1)(1994-2#1)(1995-8#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-4#2)(2010-6#1)(2011-1#1)(2013-1#1)
that a higher level##2##4##(2009-10#1)(2009-5#1)
that a higher##7##3##(2008-3#1)(2008-8#2)(2009-10#1)(2009-5#1)(2010-4#1)(2012-12#1)
that a highly##7##3##(1990-12#1)(1993-11#1)(1993-4#1)(1994-3#1)(1994-9#1)(2008-1#1)(2008-10#1)
that a history of##2##4##(2007-12#1)(2010-12#1)
that a history##3##3##(2007-10#1)(2007-12#1)(2010-12#1)
that a hospital##3##3##(1991-3#1)(1993-2#1)(1996-2#1)
that a key##6##3##(1994-2#1)(1994-9#1)(2006-10#2)(2010-6#1)(2011-1#1)
that a known##2##3##(2008-2#1)(2008-3#1)
that a lack of##3##4##(1995-11#1)(2008-11#1)(2009-9#1)
that a large number of##13##5##(1994-3#1)(1996-9#1)(1997-4#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-8#1)
that a large proportion of the##2##6##(1992-7#1)(2007-12#1)
that a large proportion of##6##5##(1992-7#1)(2004-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2012-3#1)
that a large prospective##2##4##(2005-10#1)(2010-12#1)
that a large##40##3##(1992-3#1)(1992-7#1)(1994-3#1)(1996-11#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-7#1)(2004-11#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-6#2)(2010-12#2)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-8#1)
that a larger##5##3##(1990-9#1)(1992-9#1)(2008-10#1)(2008-11#1)(2012-12#1)
that a limited##2##3##(2008-10#1)(2008-3#1)
that a linear##4##3##(1995-8#1)(2008-3#3)
that a local##2##3##(2008-2#1)(2008-8#1)
that a long##3##3##(2009-10#1)(2009-5#1)(2012-3#1)
that a longer##2##3##(2007-12#1)(2008-5#1)
that a loss##2##3##(2007-2#1)(2011-12#1)
that a low dose##2##4##(1991-11#1)(2008-3#1)
that a low##12##3##(1991-11#1)(1992-1#1)(1993-8#1)(1994-6#1)(1996-2#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-12#1)(2012-1#1)
that a lower##4##3##(1991-7#1)(2008-3#1)(2011-2#1)(2013-1#1)
that a lumbar support##2##4##(2007-6#2)
that a main##2##3##(1992-6#1)(2011-12#1)
that a major##10##3##(1990-6#1)(1990-8#1)(1993-7#1)(1994-9#1)(1997-2#1)(2005-12#1)(2008-10#2)(2008-8#1)(2009-6#1)
that a majority of patients##2##5##(2006-10#1)(2008-6#1)
that a majority of the people##2##6##(2010-12#2)
that a majority of the##6##5##(1994-2#1)(1996-3#1)(2007-10#1)(2007-2#1)(2010-12#2)
that a majority of##9##4##(1994-2#1)(1996-3#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-6#1)(2010-12#2)
that a majority##10##3##(1994-2#1)(1995-6#1)(1996-3#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-6#1)(2010-12#2)
that a mass transport##2##4##(1997-2#1)(2008-9#1)
that a mass##3##3##(1991-1#1)(1997-2#1)(2008-9#1)
that a maximum##3##3##(2007-12#1)(2008-3#2)
that a mechanism##6##3##(1990-11#1)(1990-4#1)(1995-1#1)(1996-10#1)(2007-9#1)(2008-3#1)
that a member##2##3##(2007-4#1)(2010-12#1)
that a membrane##3##3##(1990-11#1)(1991-9#1)(1992-4#1)
that a methyl-B12 enzyme##2##4##(1992-1#2)
that a minimum of##2##4##(2008-10#1)(2010-4#1)
that a minimum##3##3##(2008-10#1)(2008-2#1)(2010-4#1)
that a minor change in##2##5##(2005-11#1)(2008-10#1)
that a minor##3##3##(1992-2#1)(2005-11#1)(2008-10#1)
that a model##3##3##(1995-11#1)(2008-10#1)(2008-9#1)
that a moderate##2##3##(2008-10#1)(2008-8#1)
that a modified##2##3##(1992-2#1)(1996-7#1)
that a monoclonal##2##3##(1990-9#1)(1994-3#1)
that a more##8##3##(1997-1#1)(2005-11#1)(2006-10#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-9#1)(2011-12#1)
that a multidisciplinary##2##3##(2005-8#1)(2006-10#1)
that a multilayer##3##3##(2007-12#1)(2008-2#1)(2008-5#1)
that a multimodal##2##3##(2008-12#1)(2012-3#1)
that a mutation in the##3##5##(1994-9#1)(1995-1#1)(1996-12#1)
that a mutation in##4##4##(1994-3#1)(1994-9#1)(1995-1#1)(1996-12#1)
that a mutation##7##3##(1994-3#1)(1994-9#1)(1995-1#1)(1996-12#1)(2006-9#1)(2008-10#1)(2011-2#1)
that a nearly##2##3##(2007-12#1)(2008-3#1)
that a negative##6##3##(1996-5#1)(1996-8#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-8#1)
that a network of##2##4##(1990-5#1)(2006-10#1)
that a neural##3##3##(1992-8#1)(1993-6#1)(2008-2#1)
that a new type of##2##5##(2008-10#1)(2012-3#1)
that a new##19##3##(1990-12#1)(1992-1#1)(1992-2#1)(1995-9#1)(1996-1#1)(1996-6#1)(2005-7#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-7#1)
that a nonlinear##2##3##(2007-12#1)(2011-1#1)
that a normal##4##3##(1992-1#1)(2008-4#1)(2009-2#1)(2010-4#1)
that a novel##6##3##(1991-11#1)(1992-12#1)(1994-2#1)(1995-3#1)(1996-12#1)(2012-3#1)
that a nuclear##4##3##(1993-11#1)(1994-11#1)(1995-11#1)(1995-2#1)
that a number of##24##4##(1993-12#2)(1994-3#1)(1995-8#1)(1995-9#1)(1996-9#1)(2004-1#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#2)(2009-2#1)(2009-4#1)(2009-5#1)(2011-1#1)(2012-1#1)(2012-3#2)
that a nurse##2##3##(2007-8#1)(2008-11#1)
that a parent##2##3##(2008-11#1)(2012-3#1)
that a part of the##3##5##(1992-12#1)(1992-9#1)(2006-10#1)
that a part of##5##4##(1992-12#1)(1992-9#1)(2006-10#1)(2006-8#1)(2008-8#1)
that a partially##3##3##(1990-10#1)(1991-3#1)(1992-11#1)
that a particular##5##3##(1994-3#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)
that a particularly##2##3##(1990-12#1)(2008-6#1)
that a pathway##2##3##(1997-6#1)(2010-12#1)
that a patient with##2##4##(1996-11#1)(2004-11#1)
that a patient##7##3##(1993-7#1)(1995-11#1)(1996-11#1)(1996-12#1)(2004-11#1)(2008-7#1)(2010-1#1)
that a peptide##5##3##(1991-12#1)(1991-2#1)(1994-9#1)(1995-6#1)(2013-1#1)
that a percutaneous##2##3##(2004-9#1)(2012-2#1)
that a phase##3##3##(2008-2#2)(2008-5#1)
that a physician##2##3##(1991-3#1)(1997-2#1)
that a policy##2##3##(1991-1#1)(1993-3#1)
that a population##3##3##(1996-9#1)(2007-9#1)(2008-5#1)
that a portion of the##6##5##(1992-10#1)(1992-3#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-8#1)
that a portion##7##3##(1992-10#1)(1992-3#1)(1997-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-8#1)
that a positive test##2##4##(1990-4#1)(1991-12#1)
that a positive##6##3##(1990-4#1)(1991-12#1)(1995-12#1)(1996-9#1)(2007-8#1)(2012-2#1)
that a possible##2##3##(1990-2#1)(2008-10#1)
that a potential##2##3##(1992-5#1)(2013-1#1)
that a practical##2##3##(2008-3#2)
that a previously described##2##4##(1990-6#1)(2008-10#1)
that a previously identified##3##4##(1991-9#2)(1992-9#1)
that a previously##7##3##(1990-6#1)(1991-9#2)(1992-9#1)(1997-3#1)(2008-10#1)(2009-8#1)
that a primary##4##3##(1992-2#1)(1994-11#1)(2008-6#1)(2010-8#1)
that a priori##2##3##(2006-10#1)(2008-2#1)
that a prolonged##4##3##(1995-12#1)(1995-3#1)(2005-10#1)(2008-4#1)
that a pronounced##2##3##(1996-6#1)(1997-2#1)
that a proper##3##3##(1997-2#1)(2008-3#1)(2010-12#1)
that a properly designed##2##4##(2006-4#2)
that a properly##3##3##(2006-4#2)(2008-3#1)
that a protein##4##3##(1992-7#1)(1995-2#1)(1996-5#1)(2008-10#1)
that a proton##2##3##(1990-2#1)(1995-11#1)
that a provider##3##3##(2006-8#3)
that a putative##4##3##(1991-2#1)(1992-1#1)(1993-12#1)(2005-8#1)
that a radial##2##3##(1991-8#1)(2007-8#1)
that a random##2##3##(2008-12#1)(2008-7#1)
that a range of##3##4##(2004-2#1)(2006-11#1)(2008-4#1)
that a rapid##2##3##(1996-8#1)(2007-8#1)
that a recent##2##3##(1995-3#1)(1997-5#1)
that a reduced##2##3##(1994-11#1)(2007-11#1)
that a reduction in the##2##5##(1990-5#1)(1994-5#1)
that a reduction in##7##4##(1990-5#1)(1993-9#1)(1994-5#1)(2008-9#1)(2011-2#1)(2013-1#2)
that a reduction of##2##4##(1997-7#1)(2011-2#1)
that a reduction##9##3##(1990-5#1)(1993-9#1)(1994-5#1)(1997-7#1)(2008-9#1)(2011-2#2)(2013-1#2)
that a reference##3##3##(2008-10#1)(2009-9#1)(2013-7#1)
that a region##6##3##(1992-4#1)(1992-6#1)(1993-6#1)(1995-1#1)(1996-6#1)(1997-3#1)
that a relatively##2##3##(2007-7#1)(2008-5#1)
that a researcher##2##3##(2007-7#1)(2008-7#1)
that a resolution of##2##4##(2007-11#1)(2008-3#1)
that a rise in##2##4##(1994-2#1)(2006-6#1)
that a sample##3##3##(1997-4#1)(2008-10#1)(2011-2#1)
that a search##2##3##(2008-4#1)(2012-2#1)
that a second##4##3##(1991-10#1)(2008-10#1)(2008-7#1)(2008-8#1)
that a selective##3##3##(1990-4#1)(1996-5#1)(2008-8#1)
that a series of##2##4##(1994-3#1)(2012-2#1)
that a serine/threonine##2##3##(1993-6#1)(1995-3#1)
that a set of##4##4##(2008-12#1)(2008-2#2)(2008-3#1)
that a severe##2##3##(2011-12#1)(2013-7#1)
that a shift in##2##4##(2008-5#1)(2008-9#1)
that a shift##3##3##(2008-5#1)(2008-9#1)(2010-2#1)
that a short##4##3##(1990-8#1)(1991-3#1)(2007-11#1)(2013-1#1)
that a significant fraction of the##2##6##(1992-12#1)(1993-9#1)
that a significant improvement##3##4##(1995-4#1)(2007-12#1)(2008-3#1)
that a significant number of##2##5##(1993-12#1)(2007-11#1)
that a significant part of the##2##6##(2005-8#1)(2010-7#1)
that a significant portion of the##2##6##(1990-5#1)(2008-10#1)
that a significant portion of##4##5##(1990-5#1)(2005-12#1)(2008-10#1)(2012-3#1)
that a significant proportion of patients##2##6##(2006-9#1)(2008-1#1)
that a significant proportion of##7##5##(1995-1#1)(1995-7#1)(1996-12#1)(2006-9#1)(2007-3#1)(2008-1#1)(2008-7#1)
that a significant##30##3##(1990-5#1)(1991-6#2)(1992-1#1)(1992-12#1)(1993-12#1)(1993-9#1)(1995-1#1)(1995-4#1)(1995-7#1)(1996-12#1)(1996-4#1)(2005-12#1)(2005-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#2)
that a similar##9##3##(1991-3#1)(1992-7#1)(1993-6#1)(1994-12#1)(1995-8#1)(2006-4#1)(2008-8#1)(2008-9#1)(2009-8#1)
that a simple##15##3##(1992-6#1)(1994-8#1)(2006-12#1)(2006-4#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-2#1)
that a single amino acid##2##5##(1990-11#1)(1997-2#1)
that a single copy of the##2##6##(1992-6#1)(1994-12#1)
that a single copy of##4##5##(1992-6#1)(1993-3#1)(1994-12#1)(1997-2#1)
that a single dominant gene conferred##2##6##(2008-10#2)
that a single dominant gene##3##5##(2008-10#3)
that a single dose of##4##5##(1992-5#1)(1997-5#1)(2005-8#1)(2008-8#1)
that a single major gene##2##5##(2008-10#2)
that a single recessive gene##3##5##(2008-10#3)
that a single##69##3##(1990-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-12#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-2#2)(1997-3#1)(1997-5#2)(2005-8#1)(2006-2#1)(2006-6#1)(2007-12#2)(2007-2#1)(2007-6#1)(2008-10#15)(2008-2#3)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-3#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#1)
that a sizable##3##3##(1990-5#1)(2008-10#1)(2008-2#1)
that a small##10##3##(1992-12#1)(1994-12#1)(1995-11#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-5#1)
that a soluble##2##3##(1994-5#1)(1995-3#1)
that a specific##9##3##(1990-8#1)(1991-3#1)(1994-8#1)(1997-4#1)(2005-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-9#1)
that a spermatozoon contains##2##4##(1990-10#2)
that a stable##3##3##(1995-5#1)(2008-9#1)(2010-12#1)
that a standard##2##3##(2007-11#1)(2008-7#1)
that a strategy##2##3##(1995-7#1)(2008-3#1)
that a strong##4##3##(1992-12#1)(2008-3#1)(2010-8#1)(2012-12#1)
that a subpopulation of##4##4##(1991-8#1)(1992-8#1)(2006-8#1)(2008-11#1)
that a subset of##7##4##(1990-8#1)(1992-7#1)(1994-12#1)(1996-5#1)(2005-6#1)(2006-10#1)(2009-8#1)
that a substantial fraction##2##4##(1993-3#1)(2008-8#1)
that a substantial##5##3##(1992-5#1)(1993-12#1)(1993-3#1)(2008-6#1)(2008-8#1)
that a sufficient##2##3##(2006-4#1)(2007-8#1)
that a supplementation with##2##4##(2008-10#1)(2010-1#1)
that a surgeon##2##3##(1990-8#1)(1993-7#1)
that a surprising number of##2##5##(2008-11#1)(2013-1#1)
that a synthetic peptide##3##4##(1990-11#1)(1990-6#1)(1991-10#1)
that a systematic##2##3##(1996-3#1)(2008-3#1)
that a target##2##3##(1991-9#1)(2007-12#1)
that a third##2##3##(1991-2#1)(2011-2#1)
that a thorough##3##3##(1990-9#1)(2006-5#1)(2008-8#1)
that a threshold##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-8#1)
that a total of##2##4##(2006-8#1)(2008-3#1)
that a total##5##3##(2006-8#1)(2007-12#1)(2008-11#1)(2008-3#1)(2013-1#1)
that a trace##2##3##(2008-3#1)(2008-5#1)
that a transient##2##3##(1994-6#1)(2006-10#1)
that a treatment##2##3##(2007-12#1)(2008-4#1)
that a trial judge##2##4##(1995-12#1)(1997-5#1)
that a truly##2##3##(2008-7#1)(2012-3#1)
that a uniform##2##3##(2007-11#1)(2008-3#1)
that a unique##4##3##(1997-1#1)(2007-8#1)(2008-10#1)(2008-3#1)
that a vaccine##2##3##(2006-10#1)(2007-2#1)
that a variable##2##3##(2008-5#1)(2010-6#1)
that a variant##3##3##(1993-4#1)(1994-3#1)(1997-7#1)
that a variety of##12##4##(1990-11#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-10#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-9#1)(2011-1#1)
that a very##5##3##(1992-6#1)(1994-2#1)(2006-10#1)(2008-3#1)(2011-2#1)
that a weak##2##3##(1990-11#1)(2007-12#1)
that a whole##3##3##(1995-8#1)(2008-11#1)(2008-8#1)
that a wide range of##3##5##(2007-8#1)(2008-10#1)(2008-3#1)
that a wide##6##3##(2007-4#1)(2007-8#3)(2008-10#1)(2008-3#1)
that a wider range of##2##5##(2007-12#1)(2013-1#1)
that a woman's##2##3##(2006-4#1)(2008-4#1)
that a##1754##2##(1990-10#7)(1990-11#11)(1990-12#8)(1990-2#6)(1990-3#5)(1990-4#7)(1990-5#8)(1990-6#5)(1990-7#5)(1990-8#6)(1990-9#7)(1991-1#10)(1991-10#4)(1991-11#8)(1991-12#8)(1991-2#15)(1991-3#8)(1991-4#1)(1991-5#2)(1991-6#9)(1991-7#4)(1991-8#6)(1991-9#9)(1992-1#12)(1992-10#2)(1992-11#9)(1992-12#8)(1992-2#8)(1992-3#6)(1992-4#6)(1992-5#7)(1992-6#10)(1992-7#5)(1992-8#6)(1992-9#11)(1993-1#3)(1993-11#6)(1993-12#10)(1993-2#4)(1993-3#11)(1993-4#6)(1993-5#2)(1993-6#11)(1993-7#5)(1993-8#4)(1993-9#5)(1994-1#1)(1994-11#8)(1994-12#16)(1994-2#16)(1994-3#12)(1994-5#6)(1994-6#7)(1994-8#13)(1994-9#12)(1995-1#10)(1995-11#7)(1995-12#13)(1995-2#14)(1995-3#14)(1995-4#1)(1995-5#7)(1995-6#10)(1995-7#4)(1995-8#10)(1995-9#4)(1996-1#7)(1996-10#2)(1996-11#8)(1996-12#12)(1996-2#11)(1996-3#7)(1996-4#7)(1996-5#12)(1996-6#5)(1996-7#2)(1996-8#5)(1996-9#7)(1997-1#7)(1997-2#14)(1997-3#9)(1997-4#8)(1997-5#12)(1997-6#5)(1997-7#10)(1997-8#3)(1997-9#2)(2004-1#1)(2004-11#3)(2004-12#3)(2004-2#1)(2004-9#3)(2005-1#1)(2005-10#5)(2005-11#12)(2005-12#4)(2005-6#2)(2005-7#4)(2005-8#8)(2005-9#1)(2006-10#32)(2006-11#6)(2006-12#14)(2006-2#2)(2006-3#2)(2006-4#8)(2006-5#8)(2006-6#7)(2006-7#3)(2006-8#11)(2006-9#7)(2007-1#1)(2007-10#6)(2007-11#26)(2007-12#58)(2007-2#9)(2007-3#4)(2007-4#12)(2007-5#4)(2007-6#7)(2007-7#9)(2007-8#25)(2007-9#13)(2008-1#15)(2008-10#106)(2008-11#30)(2008-12#11)(2008-2#53)(2008-3#70)(2008-4#19)(2008-5#42)(2008-6#9)(2008-7#40)(2008-8#41)(2008-9#19)(2009-1#2)(2009-10#10)(2009-11#2)(2009-12#4)(2009-2#7)(2009-3#4)(2009-4#7)(2009-5#8)(2009-6#9)(2009-7#6)(2009-8#12)(2009-9#7)(2010-1#4)(2010-10#2)(2010-11#2)(2010-12#16)(2010-2#8)(2010-3#3)(2010-4#9)(2010-5#4)(2010-6#7)(2010-7#6)(2010-8#7)(2010-9#2)(2011-1#14)(2011-12#6)(2011-2#26)(2011-4#1)(2012-1#5)(2012-11#1)(2012-12#17)(2012-2#25)(2012-3#20)(2013-1#30)(2013-7#11)(2013-8#17)
that a)##3##2##(1990-8#1)(1992-3#1)(1993-11#1)
that aberrant##3##2##(1995-8#1)(2008-11#1)(2008-7#1)
that aberrations##2##2##(2008-3#2)
that ability##2##2##(1997-1#1)(2007-3#1)
that abnormal##13##2##(1996-3#1)(2005-7#1)(2006-10#2)(2006-5#1)(2006-8#1)(2008-11#1)(2009-10#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
that abnormalities of##2##3##(1990-9#1)(1991-12#1)
that abortion##2##2##(1991-10#1)(2013-1#1)
that about 20% of##4##4##(1997-2#1)(2006-11#1)(2006-2#1)(2008-7#1)
that about half of the##3##5##(1990-11#1)(1990-2#1)(1995-9#1)
that about half of##4##4##(1990-11#1)(1990-2#1)(1991-5#1)(1995-9#1)
that about##24##2##(1990-11#1)(1990-2#3)(1991-5#1)(1994-6#1)(1995-4#1)(1995-9#1)(1996-2#1)(1997-2#2)(1997-6#1)(2006-11#1)(2006-2#2)(2007-3#2)(2007-4#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#2)
that above##3##2##(2005-11#1)(2007-11#1)(2008-9#1)
that abrogation of##2##3##(1993-7#1)(2012-2#1)
that absorb##4##2##(1995-11#1)(2007-8#1)(2008-3#2)
that absorbs##3##2##(2008-3#1)(2008-7#1)(2010-5#1)
that absorption##5##2##(2007-12#2)(2008-3#2)(2012-2#1)
that abundant##2##2##(1997-1#1)(2008-5#1)
that academic##4##2##(2007-4#1)(2008-11#1)(2008-12#1)(2010-7#1)
that accelerated##2##2##(2008-10#1)(2008-9#1)
that acceptable##3##2##(1995-7#1)(2007-11#1)(2010-8#1)
that acceptance of##2##3##(2007-12#1)(2008-10#1)
that accepts##4##2##(1995-6#1)(2011-1#1)(2013-1#2)
that access to##2##3##(2006-4#1)(2006-8#1)
that access##6##2##(1993-12#1)(1995-12#1)(1995-2#1)(2006-4#1)(2006-8#1)(2010-7#1)
that accessions##2##2##(2008-10#1)(2008-5#1)
that accidents##2##2##(1990-10#1)(2009-10#1)
that accommodate##6##2##(1996-2#1)(2012-12#1)(2013-1#4)
that accommodates the##4##3##(1991-9#1)(2006-10#1)(2008-3#1)(2013-1#1)
that accommodates##5##2##(1991-9#1)(1995-1#1)(2006-10#1)(2008-3#1)(2013-1#1)
that accommodations##2##2##(2010-2#2)
that accompanied##3##2##(1992-3#1)(2006-4#1)(2007-10#1)
that accompanies the##4##3##(1993-6#1)(1997-2#1)(2007-4#1)(2008-10#1)
that accompanies##17##2##(1990-7#1)(1993-6#1)(1997-2#1)(1997-3#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#2)(2012-12#2)
that accompany cellular##2##3##(2009-4#1)(2012-2#1)
that accompany the##4##3##(1994-12#1)(1995-3#1)(2008-3#1)(2011-1#1)
that accompany##21##2##(1990-3#1)(1991-3#1)(1994-12#1)(1994-8#1)(1995-3#1)(1995-5#1)(1997-4#1)(2006-1#1)(2006-10#2)(2006-7#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-4#1)(2009-5#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-2#1)
that accord##2##2##(1993-3#1)(2006-5#1)
that according to literature would occur in 0##2##8##(2013-1#2)
that according to##4##3##(2006-4#1)(2013-1#3)
that account for a##2##4##(1993-3#1)(2012-3#1)
that account for its##2##4##(1994-12#1)(1997-2#1)
that account for the##3##4##(1993-2#1)(1996-3#1)(2012-3#1)
that account for##16##3##(1993-11#1)(1993-2#1)(1993-3#2)(1994-12#1)(1996-3#1)(1997-2#1)(2008-2#2)(2008-7#1)(2009-5#1)(2011-2#1)(2012-3#3)(2013-7#1)
that accounted for by##3##4##(2005-8#1)(2008-2#1)(2008-9#1)
that accounted for##6##3##(2005-8#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
that accounts for the observed##2##5##(2007-7#1)(2008-3#1)
that accounts for the##12##4##(1991-11#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-2#2)(2008-3#3)(2008-6#1)(2012-3#1)(2013-8#1)
that accounts for##28##3##(1991-11#1)(1991-5#1)(1992-9#1)(1993-9#1)(1995-2#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-2#2)(2008-3#5)(2008-6#1)(2008-8#1)(2009-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
that accumulate in##2##3##(1996-9#1)(2009-12#1)
that accumulate##3##2##(1990-9#1)(1996-9#1)(2009-12#1)
that accumulated##4##2##(1993-12#1)(1995-3#1)(1997-6#1)(2008-10#1)
that accumulates in the brain##2##5##(1992-12#2)
that accumulates in the##3##4##(1992-12#2)(1995-5#1)
that accumulates##4##2##(1992-12#2)(1995-5#1)(2012-3#1)
that accumulation of##4##3##(1996-11#2)(2008-10#1)(2009-10#1)
that accuracy##2##2##(2008-10#1)(2012-1#1)
that accurate##9##2##(1990-9#1)(1996-6#1)(2006-8#1)(2008-2#1)(2008-3#2)(2008-7#1)(2013-1#2)
that accurately##7##2##(2005-4#1)(2008-1#2)(2008-2#1)(2008-3#1)(2008-7#1)(2010-2#1)
that acetyl-L-carnitine##3##2##(1990-7#1)(1992-1#1)(1992-7#1)
that achieve##2##2##(1996-8#1)(2010-12#1)
that achieved a##2##3##(2008-7#1)(2012-1#1)
that achieved by##2##3##(2008-5#1)(2010-12#1)
that achieved during##2##3##(2007-12#1)(2009-8#1)
that achieved in##3##3##(1995-12#1)(2008-10#1)(2008-2#1)
that achieved with##7##3##(1993-2#1)(1996-9#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#1)
that achieved##20##2##(1993-2#1)(1995-12#1)(1996-9#1)(2006-9#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-8#1)(2010-12#1)(2012-1#1)
that achieves##5##2##(1990-9#1)(2007-12#2)(2008-2#1)(2009-12#1)
that achieving##2##2##(1996-1#1)(2007-9#1)
that acid##4##2##(1990-9#1)(1991-9#1)(2008-10#2)
that acidic phospholipids##2##3##(1990-3#1)(1996-7#1)
that acidic##5##2##(1990-3#1)(1992-6#1)(1996-7#1)(1997-8#1)(2008-8#1)
that acknowledge##2##2##(2008-4#1)(2009-6#1)
that acoustic##4##2##(2007-5#1)(2008-3#2)(2013-7#1)
that acquire##2##2##(2008-10#1)(2008-7#1)
that acquired##4##2##(2006-10#1)(2007-4#1)(2008-2#1)(2012-2#1)
that acridones##2##2##(1996-4#2)
that across##2##2##(2007-12#1)(2008-10#1)
that act against##2##3##(1994-4#1)(2008-10#1)
that act as potent##2##4##(2008-10#2)
that act as##14##3##(1992-8#1)(1995-8#2)(1996-11#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2012-12#1)
that act both##2##3##(2008-11#1)(2013-8#1)
that act by increasing##2##4##(1993-11#1)(1995-12#1)
that act by##5##3##(1993-11#1)(1994-6#1)(1995-12#1)(1995-2#1)(2008-8#1)
that act in concert##2##4##(2006-10#1)(2009-10#1)
that act in##5##3##(1996-7#1)(2006-10#1)(2007-8#1)(2008-1#1)(2009-10#1)
that act on##5##3##(1991-5#1)(1993-11#1)(1994-11#1)(2007-11#1)(2008-10#1)
that act via##4##3##(2005-7#4)
that act##51##2##(1991-5#1)(1992-5#1)(1992-8#1)(1993-11#2)(1994-11#1)(1994-4#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-11#1)(1996-7#2)(1997-1#2)(2005-7#4)(2006-10#3)(2007-11#3)(2007-8#1)(2008-1#4)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-10#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
that acted##3##2##(2007-8#1)(2008-10#1)(2009-9#1)
that actin##7##2##(1990-2#2)(1991-2#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)
that action##5##2##(1996-7#1)(2007-12#1)(2008-6#1)(2009-4#1)(2012-1#1)
that actions##2##2##(2008-10#1)(2008-2#1)
that activate protein kinase C##2##5##(1992-4#2)
that activate the##4##3##(1990-6#1)(2008-8#1)(2009-3#1)(2010-10#1)
that activate##24##2##(1990-6#1)(1991-5#1)(1992-4#3)(1994-2#1)(1995-6#1)(2005-10#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-4#3)(2008-7#2)(2008-8#1)(2009-3#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)
that activated T cells##2##4##(1996-10#1)(2006-7#1)
that activated by##2##3##(1991-2#1)(1996-12#1)
that activated##16##2##(1990-7#1)(1991-2#1)(1992-11#1)(1994-12#1)(1995-3#1)(1995-7#1)(1996-10#2)(1996-12#1)(1997-4#1)(2006-7#2)(2007-11#1)(2008-1#2)(2008-7#1)
that activates the##5##3##(1991-3#1)(1991-6#1)(1995-1#1)(1996-8#1)(2007-11#1)
that activates##13##2##(1991-10#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-4#1)(1994-12#1)(1995-1#2)(1995-3#1)(1995-4#1)(1996-8#1)(1997-5#1)(2007-11#1)
that activation of a##3##4##(1993-11#1)(1995-5#1)(2011-2#1)
that activation of the##14##4##(1992-12#1)(1993-11#1)(1993-6#1)(1994-6#1)(1996-5#1)(1997-2#1)(2007-4#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
that activation of these##2##4##(2005-10#1)(2008-4#1)
that activation of##52##3##(1991-10#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-11#2)(1993-12#3)(1993-3#1)(1993-6#1)(1994-2#2)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-7#2)(2005-10#1)(2007-4#1)(2007-7#1)(2008-3#1)(2008-4#4)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-2#2)(2012-1#1)(2013-1#1)
that activation was##2##3##(1994-3#1)(1996-5#1)
that activation##57##2##(1991-10#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-11#2)(1993-12#3)(1993-3#1)(1993-6#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#2)(1996-2#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-7#2)(2005-10#1)(2007-4#1)(2007-7#1)(2008-3#1)(2008-4#4)(2008-7#1)(2008-8#1)(2008-9#2)(2010-11#1)(2010-12#2)(2010-8#1)(2011-2#2)(2012-1#2)(2013-1#1)
that activator##2##2##(1994-6#1)(1996-4#1)
that active##17##2##(1991-12#1)(1991-5#1)(1992-12#1)(1992-4#1)(1996-7#1)(2006-10#1)(2007-11#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-2#1)(2012-3#2)
that activity in##4##3##(1990-7#1)(1995-8#1)(2008-11#1)(2008-6#1)
that activity of the##2##4##(1995-9#1)(2006-6#1)
that activity##14##2##(1990-6#1)(1990-7#1)(1991-2#1)(1994-8#1)(1995-8#1)(1995-9#1)(1996-8#1)(2006-6#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2011-2#1)
that acts as a nucleus##2##5##(1990-5#1)(2008-2#1)
that acts as a##11##4##(1990-5#1)(1991-12#2)(1992-8#1)(1993-5#1)(1995-2#1)(1995-6#1)(1997-4#1)(2007-12#1)(2008-2#1)(2008-7#1)
that acts as an adjunct to##2##6##(1992-1#1)(2006-5#1)
that acts as an enhancer##2##5##(1993-7#1)(1995-1#1)
that acts as an##5##4##(1992-1#1)(1993-7#1)(1995-1#1)(2006-5#1)(2010-2#1)
that acts as##19##3##(1990-5#1)(1991-12#2)(1992-1#1)(1992-8#1)(1993-5#1)(1993-7#1)(1995-1#1)(1995-2#1)(1995-6#1)(1997-4#1)(2006-5#1)(2007-12#1)(2008-2#2)(2008-7#1)(2009-2#1)(2010-2#2)
that acts at the##3##4##(1995-3#1)(1997-6#2)
that acts on##2##3##(1994-12#1)(2007-12#1)
that acts through##2##3##(2007-11#1)(2008-1#1)
that acts to##4##3##(1992-8#1)(2009-11#1)(2009-8#1)(2012-1#1)
that acts##36##2##(1990-5#1)(1991-12#2)(1992-1#1)(1992-8#2)(1993-5#1)(1993-7#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-4#1)(1997-6#2)(2005-7#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-4#1)(2008-1#1)(2008-2#2)(2008-7#1)(2009-11#1)(2009-2#1)(2009-8#2)(2010-2#2)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
that actual##4##2##(1992-3#1)(1996-11#1)(1997-8#1)(2008-5#1)
that actually##4##2##(1996-2#1)(2008-5#1)(2008-6#1)(2011-2#1)
that acupuncture is a##3##4##(2010-5#2)(2010-6#1)
that acupuncture is##5##3##(1997-6#1)(2008-10#1)(2010-5#2)(2010-6#1)
that acupuncture##7##2##(1993-3#1)(1995-9#1)(1997-6#1)(2008-10#1)(2010-5#2)(2010-6#1)
that acute administration of##2##4##(2007-11#1)(2008-10#1)
that acute exposure of rats to##2##6##(1993-12#1)(1995-12#1)
that acute exposure to##2##4##(1992-3#1)(2008-10#1)
that acute exposure##4##3##(1992-3#1)(1993-12#1)(1995-12#1)(2008-10#1)
that acute##29##2##(1990-7#1)(1991-2#1)(1992-3#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#2)(1995-11#1)(1995-12#2)(1996-10#1)(1996-12#2)(1997-3#1)(2007-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-3#3)(2008-5#1)(2008-8#1)
that acutely##2##2##(1995-12#1)(2011-2#1)
that adaptation of##2##3##(1990-2#1)(1997-4#1)
that adaptation to##3##3##(2006-5#1)(2008-9#1)(2011-1#1)
that adaptation##6##2##(1990-2#1)(1997-4#1)(2006-5#1)(2008-9#1)(2011-1#1)(2013-1#1)
that adaptations to##2##3##(1995-8#1)(2008-10#1)
that adaptations##4##2##(1995-8#1)(2008-10#1)(2008-2#1)(2009-8#1)
that adaptive##2##2##(2007-11#2)
that adapts##2##2##(2008-8#1)(2011-2#1)
that add##3##2##(1990-4#1)(2006-10#1)(2012-3#1)
that adding##5##2##(2005-9#1)(2008-6#1)(2008-8#1)(2012-1#1)(2012-12#1)
that addition of the##2##4##(1994-8#1)(1995-8#1)
that addition of##19##3##(1992-10#1)(1993-6#1)(1993-7#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-8#1)(2005-9#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-5#1)(2009-3#1)(2009-4#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)
that additional mechanisms##2##3##(1995-2#1)(2012-2#1)
that additional##40##2##(1990-2#1)(1990-6#1)(1991-12#2)(1991-8#2)(1991-9#2)(1992-12#1)(1993-12#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-7#1)(1996-8#1)(1997-4#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
that additionally##2##2##(2009-7#1)(2012-2#1)
that additive effects##2##3##(2008-10#1)(2009-2#1)
that additive gene action##2##4##(2008-10#2)
that additive##5##2##(2008-10#4)(2009-2#1)
that address the##9##3##(1997-4#1)(2005-11#1)(2007-12#1)(2008-2#1)(2010-11#2)(2010-12#1)(2010-6#1)(2013-1#1)
that address these##4##3##(2005-8#1)(2007-8#1)(2008-10#1)(2010-8#1)
that address this##3##3##(1993-1#1)(2007-6#1)(2012-3#1)
that address##27##2##(1993-1#1)(1993-12#1)(1997-3#1)(1997-4#1)(2005-11#1)(2005-8#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-2#4)(2007-6#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#2)(2009-7#1)(2010-11#2)(2010-12#1)(2010-6#1)(2010-8#1)(2012-3#1)(2013-1#1)
that addressed the##3##3##(2008-6#1)(2009-9#1)(2011-2#1)
that addressed##8##2##(2006-10#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-6#1)(2009-9#1)(2011-2#1)(2013-1#1)
that addresses all##2##3##(2010-6#1)(2013-1#1)
that addresses the##6##3##(2005-10#1)(2008-1#1)(2010-12#1)(2010-6#1)(2011-2#1)(2013-1#1)
that addresses these issues##2##4##(1992-9#1)(2008-2#1)
that addresses these##3##3##(1992-9#1)(2008-2#1)(2012-3#1)
that addresses##24##2##(1991-12#1)(1992-9#1)(1995-12#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#2)(2008-2#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-2#1)(2010-6#2)(2011-12#1)(2011-2#2)(2012-3#1)(2013-1#2)
that adds an##2##3##(2008-4#1)(2013-8#1)
that adds##3##2##(1993-12#1)(2008-4#1)(2013-8#1)
that adenoregulin##2##2##(1993-3#1)(1994-5#1)
that adenosine is##2##3##(2006-1#1)(2009-6#1)
that adenosine might##2##3##(1993-6#1)(2006-1#1)
that adenosine##12##2##(1993-11#1)(1993-6#1)(1994-11#1)(1994-6#2)(1996-11#1)(2006-1#2)(2006-10#1)(2009-6#1)(2010-5#2)
that adenovirus-mediated##2##2##(2007-3#1)(2008-8#1)
that adequate##11##2##(1990-6#1)(1991-4#1)(1992-2#1)(1994-2#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2009-3#1)(2012-12#1)(2012-2#1)
that adequately##2##2##(1995-3#1)(2010-5#1)
that adhered to the leaves##2##5##(2008-10#2)
that adherence to##4##3##(2006-5#1)(2008-10#1)(2008-11#1)(2009-4#1)
that adherence##5##2##(2006-5#2)(2008-10#1)(2008-11#1)(2009-4#1)
that adhesion##2##2##(1990-2#2)
that adhesive AH109A cells##2##4##(2008-11#2)
that adhesive##3##2##(1992-11#1)(2008-11#2)
that adiponectin may##2##3##(2010-10#1)(2013-1#1)
that adiponectin##5##2##(2007-8#1)(2010-10#2)(2011-1#1)(2013-1#1)
that adipose tissue##2##3##(2008-5#1)(2009-2#1)
that adjunctive progestogen##3##3##(1994-9#3)
that adjunctive##7##2##(1994-9#3)(2008-6#4)
that adjusted##2##2##(1995-3#1)(2008-10#1)
that adjustment of##2##3##(1994-11#1)(2008-3#1)
that adjusts##2##2##(2008-10#1)(2008-3#1)
that adjuvant chemotherapy##2##3##(1991-8#1)(2008-5#1)
that adjuvant##4##2##(1991-8#1)(1992-12#1)(2007-5#1)(2008-5#1)
that administration of the##3##4##(1990-5#1)(1991-7#1)(1994-10#1)
that administration of##14##3##(1990-2#1)(1990-5#1)(1991-7#1)(1992-2#1)(1993-7#1)(1994-10#2)(1996-9#2)(2006-10#1)(2006-9#1)(2010-9#1)(2011-2#1)(2013-1#1)
that administrative##2##2##(1993-2#1)(2008-4#1)
that adolescent##5##2##(2006-3#1)(2006-4#1)(2008-9#1)(2010-1#1)(2010-10#1)
that adolescents perceive as being helpful##2##6##(2007-2#2)
that adolescents who##4##3##(1990-5#1)(2008-11#1)(2010-2#1)(2010-7#1)
that adolescents with##3##3##(2005-6#1)(2009-7#1)(2012-2#1)
that adolescents##13##2##(1990-5#1)(2005-6#1)(2007-2#2)(2008-11#2)(2008-2#1)(2009-7#1)(2010-2#2)(2010-7#1)(2012-12#1)(2012-2#1)
that adolescents'##2##2##(2007-2#1)(2009-7#1)
that adopt##3##2##(1997-5#1)(2006-10#1)(2008-7#1)
that adopted a##2##3##(2010-3#1)(2012-2#1)
that adopted##4##2##(1997-7#1)(2009-8#1)(2010-3#1)(2012-2#1)
that adoption##2##2##(2008-9#1)(2009-8#1)
that adrenal##3##2##(1994-11#1)(1995-7#1)(1996-8#1)
that adsorption##4##2##(2005-11#2)(2008-10#1)(2010-5#1)
that adult patients who##2##4##(1991-11#1)(2011-2#1)
that adult##17##2##(1991-11#1)(1992-1#1)(1992-12#1)(1993-11#1)(1994-2#1)(1994-8#1)(1995-5#1)(1996-12#1)(1996-4#1)(1996-9#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
that adults of the##2##4##(2007-12#1)(2011-12#1)
that adults##5##2##(2007-12#1)(2008-4#1)(2008-9#2)(2011-12#1)
that advanced##6##2##(1996-5#1)(1997-7#1)(2006-9#1)(2007-12#1)(2008-1#1)(2010-11#1)
that adverse##3##2##(1997-5#1)(2008-10#1)(2011-1#1)
that adversely##3##2##(2007-8#1)(2008-10#1)(2009-5#1)
that aerobic##2##2##(2013-1#1)(2013-7#1)
that aerosol##3##2##(2008-2#1)(2008-3#1)(2010-3#1)
that affect our##2##3##(2007-11#1)(2008-5#1)
that affect synaptic##2##3##(2009-8#2)
that affect the heterogeneity of##2##5##(2008-11#1)(2008-4#1)
that affect the quality of the##2##6##(2008-2#1)(2008-3#1)
that affect the quality of##3##5##(2008-2#1)(2008-3#1)(2008-5#1)
that affect the world##2##4##(2010-9#1)(2013-1#1)
that affect the##62##3##(1991-4#1)(1991-9#1)(1993-1#1)(1993-12#1)(1994-9#2)(1995-4#1)(1997-3#1)(2006-10#2)(2006-11#1)(2006-9#1)(2007-1#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-12#1)(2009-2#2)(2009-4#1)(2010-9#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)
that affect their ability to##2##5##(1997-1#1)(2004-4#1)
that affect their##5##3##(1990-12#1)(1993-2#1)(1997-1#1)(2004-4#1)(2011-1#1)
that affect this##2##3##(2008-10#1)(2008-8#1)
that affect##135##2##(1990-12#1)(1990-6#1)(1991-4#1)(1991-9#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-9#2)(1995-12#1)(1995-4#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(2004-4#2)(2005-10#2)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-2#2)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-2#6)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#4)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-2#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#3)(2011-2#4)(2012-1#4)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)
that affected both##2##3##(2008-6#1)(2012-12#1)
that affected the##4##3##(1995-3#1)(2005-11#1)(2008-8#1)(2012-12#1)
that affected##13##2##(1990-12#1)(1991-9#1)(1993-7#1)(1995-3#1)(2005-11#1)(2005-8#1)(2007-12#1)(2008-11#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-12#2)
that affects a large##2##4##(2008-5#1)(2009-12#1)
that affects a##3##3##(2006-8#1)(2008-5#1)(2009-12#1)
that affects all##2##3##(2012-12#1)(2012-2#1)
that affects approximately##3##3##(2009-7#1)(2009-9#1)(2012-2#1)
that affects both##4##3##(1991-1#1)(2005-7#1)(2008-2#1)(2011-1#1)
that affects many##3##3##(2008-10#1)(2010-10#1)(2012-11#1)
that affects the##19##3##(1991-6#1)(1992-2#1)(1993-3#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-6#2)(2008-8#1)(2008-9#2)(2009-4#1)(2010-6#1)(2011-1#1)(2012-12#2)(2012-2#1)
that affects##60##2##(1991-1#1)(1991-6#1)(1992-2#2)(1993-3#1)(2005-7#1)(2006-10#3)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#3)(2013-7#1)
that afferent##3##2##(1996-3#1)(2006-7#1)(2013-1#1)
that afflicts##2##2##(2008-7#1)(2013-1#1)
that afford##2##2##(2006-1#1)(2009-5#1)
that afforded##2##2##(1992-9#1)(2008-5#1)
that affords##2##2##(2010-4#1)(2010-5#1)
that aflatoxin##2##2##(1993-7#1)(2008-12#1)
that after July was higher for PRE than for POST##2##10##(2012-2#2)
that after a##6##3##(1993-3#1)(1996-10#1)(2008-11#1)(2008-5#2)(2008-9#1)
that after being##2##3##(1995-5#1)(2008-9#1)
that after controlling for##3##4##(2008-11#1)(2008-3#1)(2012-1#1)
that after the##9##3##(1997-2#1)(2006-2#1)(2009-8#1)(2010-4#1)(2010-8#1)(2012-1#1)(2013-7#1)(2013-8#2)
that after##53##2##(1990-11#1)(1990-3#1)(1992-2#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-2#1)(1997-2#1)(2004-11#1)(2006-2#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-9#2)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#3)
that against##2##2##(2008-11#1)(2008-7#1)
that agarobiose##2##2##(2008-10#2)
that age and##3##3##(2006-6#1)(2008-1#1)(2010-10#1)
that age at first##2##4##(1990-9#1)(2009-5#1)
that age##14##2##(1990-9#2)(1991-6#1)(1992-4#1)(1993-10#1)(1993-9#1)(2005-4#1)(2006-6#1)(2008-1#1)(2008-7#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-12#1)
that age-related changes in##2##4##(2007-8#1)(2008-7#1)
that age-related changes##3##3##(2007-12#1)(2007-8#1)(2008-7#1)
that age-related differences in##2##4##(2008-11#1)(2009-9#1)
that age-related##8##2##(2007-12#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-11#1)(2012-2#1)
that aged##4##2##(1992-12#1)(1993-12#1)(1997-2#2)
that ageing##2##2##(1991-12#1)(1993-12#1)
that agent##2##2##(2012-2#1)(2013-7#1)
that aggregate into##2##3##(2008-3#1)(2009-10#1)
that aggregation##4##2##(1990-4#1)(1992-8#1)(2008-10#2)
that aggressive##10##2##(1991-8#1)(2006-10#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2012-3#1)
that aging is associated with##2##5##(2008-3#1)(2008-7#1)
that aging is##5##3##(1993-11#1)(1994-5#1)(1994-6#1)(2008-3#1)(2008-7#1)
that aging##12##2##(1990-7#1)(1993-11#1)(1994-5#1)(1994-6#1)(2006-6#1)(2008-10#1)(2008-3#2)(2008-7#2)(2010-1#1)(2013-1#1)
that agree with##2##3##(2008-2#1)(2013-8#1)
that agree##4##2##(1991-8#1)(2008-2#2)(2013-8#1)
that agreed well with##2##4##(2008-2#1)(2010-10#1)
that agreed with##2##3##(1994-9#1)(2008-10#1)
that agreed##5##2##(1994-9#1)(2008-10#1)(2008-2#1)(2010-10#1)(2010-7#1)
that agreement between##2##3##(2008-8#1)(2008-9#1)
that aid##2##2##(1994-3#1)(2011-2#1)
that aids in##4##3##(1991-11#1)(1996-5#1)(2006-8#1)(2011-2#1)
that aids##6##2##(1991-11#1)(1996-5#1)(2006-8#1)(2008-2#1)(2011-2#1)(2012-2#1)
that aim at##3##3##(1996-3#1)(2006-6#1)(2008-7#1)
that aim to##8##3##(1996-1#1)(2009-5#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-1#2)
that aim##12##2##(1996-1#1)(1996-3#1)(2006-10#1)(2006-6#1)(2008-7#1)(2009-5#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-1#2)
that aimed to##4##3##(2008-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
that aimed##5##2##(2008-10#1)(2008-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
that aims at##4##3##(2006-10#1)(2006-12#1)(2007-5#1)(2011-1#1)
that aims to##15##3##(1997-4#1)(2006-10#2)(2007-8#2)(2008-10#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-7#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-8#1)
that aims##20##2##(1997-4#1)(2006-10#3)(2006-12#1)(2007-5#1)(2007-8#2)(2008-10#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-8#1)
that air##4##2##(2004-4#1)(2008-10#1)(2008-4#1)(2008-5#1)
that airways##2##2##(1994-5#1)(2011-1#1)
that albumin##3##2##(1995-2#1)(2008-10#1)(2008-11#1)
that alcohol##9##2##(1990-4#1)(1990-8#1)(1994-11#1)(2005-10#1)(2008-1#1)(2009-5#1)(2010-12#1)(2012-12#1)(2012-2#1)
that alcoholism##2##2##(2005-11#1)(2009-10#1)
that aldosterone##3##2##(2005-7#2)(2007-8#1)
that alendronate##6##2##(2005-3#2)(2008-8#2)(2009-3#1)(2010-10#1)
that alerting responses##2##3##(1997-8#2)
that alkaline phosphatase##2##3##(1992-12#1)(1994-8#1)
that alkaline##3##2##(1992-12#1)(1994-8#1)(2008-6#1)
that all 10##2##3##(1993-4#1)(2008-9#1)
that all 11 bR##2##4##(1990-10#2)
that all animals##2##3##(1996-4#1)(1996-5#1)
that all five##3##3##(1991-7#1)(2008-10#1)(2008-7#1)
that all formulations##2##3##(2008-5#1)(2010-12#1)
that all four##4##3##(1991-5#1)(1995-8#1)(1997-4#1)(2008-3#1)
that all individuals##2##3##(2008-11#2)
that all investigated##2##3##(2008-10#1)(2008-7#1)
that all isolates##2##3##(2008-10#2)
that all medical##2##3##(2006-6#1)(2013-1#1)
that all methods##2##3##(1995-6#1)(2012-3#1)
that all models##3##3##(1996-4#1)(2008-12#1)(2012-12#1)
that all monocytes are CD4+##2##5##(1990-12#2)
that all of the##11##4##(1992-12#1)(1995-7#1)(1995-9#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-1#1)(2013-7#1)
that all of these##8##4##(1992-6#1)(1993-12#1)(1994-8#1)(2007-11#2)(2008-10#3)
that all of##21##3##(1992-12#1)(1992-6#1)(1993-12#1)(1994-8#1)(1994-9#1)(1995-7#1)(1995-9#1)(1996-7#1)(2007-11#3)(2008-10#4)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-1#1)(2013-7#1)
that all parties##2##3##(1996-12#1)(2006-7#1)
that all patients##10##3##(1990-3#1)(1993-7#1)(1994-2#1)(1997-8#1)(2007-8#1)(2008-12#1)(2010-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
that all presented##2##3##(2007-10#1)(2010-5#1)
that all seven##2##3##(2008-10#1)(2009-5#1)
that all six##2##3##(1993-9#1)(2009-4#1)
that all strains##2##3##(2006-8#1)(2009-2#1)
that all the compounds##4##4##(1992-11#1)(1996-5#1)(2004-2#1)(2008-5#1)
that all the##42##3##(1990-8#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1995-5#1)(1996-5#2)(1997-1#1)(1997-2#1)(2004-2#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
that all these##4##3##(1993-8#1)(2008-3#1)(2009-4#1)(2010-3#1)
that all three isolates##2##4##(2007-12#1)(2008-10#1)
that all three of these##2##5##(1991-5#1)(2007-12#1)
that all three##27##3##(1990-12#2)(1991-1#1)(1991-10#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-5#1)(1994-3#3)(1996-5#1)(2007-12#3)(2008-10#5)(2008-2#1)(2008-5#1)(2008-8#2)(2008-9#2)(2012-3#1)
that all were##2##3##(1997-2#1)(2008-10#1)
that all##270##2##(1990-10#2)(1990-12#7)(1990-3#3)(1990-8#1)(1991-1#1)(1991-10#2)(1991-5#3)(1991-7#3)(1991-9#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-4#2)(1993-6#1)(1993-7#2)(1993-8#2)(1993-9#2)(1994-2#1)(1994-3#3)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-12#2)(1996-2#1)(1996-4#2)(1996-5#4)(1996-7#1)(1997-1#1)(1997-2#4)(1997-4#1)(1997-6#1)(1997-8#1)(2004-11#2)(2004-2#1)(2005-11#2)(2005-12#2)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#4)(2007-11#9)(2007-12#5)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#32)(2008-11#4)(2008-12#6)(2008-2#7)(2008-3#5)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#5)(2009-10#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#3)(2011-2#2)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#8)(2013-1#11)(2013-7#2)(2013-8#4)
that all-trans retinoic acid##2##4##(1994-8#1)(2012-1#1)
that alleles##3##2##(2008-10#2)(2008-5#1)
that allelic variation##2##3##(1997-4#1)(2012-3#1)
that allergic diseases##2##3##(1994-6#1)(2008-3#1)
that allergic##5##2##(1994-6#1)(2006-10#1)(2008-3#1)(2011-1#1)(2012-3#1)
that allopurinol##2##2##(1995-12#1)(2008-10#1)
that allow a##2##3##(2010-2#1)(2011-1#1)
that allow coexistence##2##3##(2008-8#2)
that allow for the##2##4##(2008-2#1)(2008-9#1)
that allow for##11##3##(1994-9#1)(1997-7#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-12#1)
that allow it to##3##4##(1991-4#1)(2005-10#1)(2008-1#1)
that allow one to predict the##2##6##(1996-4#1)(2008-3#1)
that allow one to##4##4##(1996-4#1)(2008-1#1)(2008-3#2)
that allow quantitative##2##3##(2011-1#1)(2011-2#1)
that allow rapid##3##3##(2008-4#1)(2010-11#1)(2011-2#1)
that allow the simultaneous##2##4##(2007-12#1)(2008-10#1)
that allow the##21##3##(1990-9#1)(1993-12#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-5#1)(2010-6#1)(2011-12#1)(2012-1#1)(2012-3#2)(2013-1#1)
that allow their##3##3##(2006-10#1)(2008-11#1)(2008-5#1)
that allow them to##6##4##(2006-10#2)(2008-10#2)(2009-6#1)(2010-9#1)
that allow to##3##3##(2006-6#1)(2008-10#1)(2008-2#1)
that allow us to##4##4##(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)
that allow users to##2##4##(2008-4#2)
that allow##115##2##(1990-9#1)(1991-4#1)(1991-9#1)(1993-12#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-5#2)(1996-4#1)(1997-7#1)(2005-10#1)(2006-10#4)(2006-6#1)(2007-12#1)(2007-6#1)(2007-9#2)(2008-1#4)(2008-10#8)(2008-11#3)(2008-2#5)(2008-3#6)(2008-4#8)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#8)(2008-9#4)(2009-10#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-11#3)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#3)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)
that allowed for the##2##4##(2008-12#1)(2013-1#1)
that allowed for##4##3##(2008-10#1)(2008-12#1)(2010-7#1)(2013-1#1)
that allowed the##8##3##(1995-8#1)(2008-10#3)(2009-10#1)(2009-8#1)(2011-12#1)(2013-8#1)
that allowed us to##8##4##(1993-8#1)(1995-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-10#1)(2010-2#1)
that allowed us##9##3##(1993-8#1)(1994-3#1)(1995-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-10#1)(2010-2#1)
that allowed##36##2##(1991-3#1)(1993-2#1)(1993-8#1)(1994-3#1)(1995-8#2)(1996-10#1)(1996-7#1)(2004-12#1)(2006-11#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#2)(2009-8#1)(2010-2#1)(2010-7#2)(2011-12#1)(2013-1#1)(2013-8#1)
that allows a##7##3##(1991-4#1)(1997-3#1)(2005-5#1)(2006-2#1)(2009-3#1)(2010-10#1)(2012-2#1)
that allows an##5##3##(2006-3#1)(2008-1#1)(2008-11#1)(2010-6#1)(2010-8#1)
that allows assessment of##2##4##(1995-2#1)(2007-12#1)
that allows construction of##2##4##(2008-2#1)(2008-4#1)
that allows controlled##2##3##(1997-8#1)(2008-11#1)
that allows determination of the##2##5##(1996-4#1)(2005-11#1)
that allows estimation of the##2##5##(1992-12#1)(1993-1#1)
that allows estimation of##3##4##(1992-12#1)(1992-6#1)(1993-1#1)
that allows for a##4##4##(2007-11#1)(2008-4#1)(2008-9#1)(2010-6#1)
that allows for rapid##2##4##(2006-10#1)(2006-9#1)
that allows for the##6##4##(1990-3#1)(2008-3#1)(2008-4#2)(2010-12#1)(2013-8#1)
that allows for##26##3##(1990-3#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#4)(2008-9#1)(2010-12#1)(2010-6#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
that allows improved##2##3##(2007-9#1)(2008-3#1)
that allows integration##2##3##(2007-10#1)(2008-4#1)
that allows joint##2##3##(2008-9#1)(2009-11#1)
that allows one to##6##4##(1997-4#1)(2007-12#2)(2008-3#2)(2011-2#1)
that allows prospective##2##3##(2004-9#1)(2007-2#1)
that allows reconstruction of three-dimensional##2##5##(2007-12#1)(2008-3#1)
that allows simultaneous##7##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#2)(2012-1#1)(2013-8#1)
that allows some##2##3##(2007-6#1)(2008-1#1)
that allows the full##2##4##(2007-12#1)(2008-2#1)
that allows the simultaneous##2##4##(2008-12#1)(2008-3#1)
that allows the use of##2##5##(2008-1#1)(2008-11#1)
that allows the##45##3##(1990-7#1)(1994-9#1)(1995-6#1)(1996-12#1)(1997-3#1)(2006-10#1)(2006-3#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-2#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-6#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
that allows them to##2##4##(2008-2#1)(2012-2#1)
that allows to##6##3##(2006-3#1)(2007-10#1)(2008-10#2)(2011-1#1)(2013-7#1)
that allows us to##10##4##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-8#1)(2010-5#2)(2012-12#1)(2013-1#1)
that allows us##11##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-5#2)(2012-12#1)(2013-1#1)
that allows users to##3##4##(2008-4#1)(2008-9#1)(2012-2#1)
that allows##219##2##(1990-3#1)(1990-7#1)(1991-11#1)(1991-4#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-4#2)(1996-8#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-5#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#4)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#4)(2007-10#3)(2007-11#5)(2007-12#15)(2007-2#2)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#6)(2008-10#5)(2008-11#6)(2008-12#2)(2008-2#17)(2008-3#20)(2008-4#12)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#8)(2009-10#1)(2009-11#2)(2009-3#2)(2009-4#2)(2009-5#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-5#2)(2010-6#3)(2010-8#3)(2010-9#2)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#5)
that almost all of##2##4##(1997-3#1)(2012-2#1)
that almost all the##2##4##(1992-9#1)(1996-4#1)
that almost all##9##3##(1992-7#1)(1992-9#1)(1993-6#1)(1996-4#1)(1997-3#1)(2007-10#1)(2008-7#1)(2012-2#2)
that almost half##4##3##(2007-10#1)(2007-8#1)(2008-1#1)(2008-12#1)
that almost##21##2##(1990-9#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-6#1)(1995-9#1)(1996-4#1)(1997-3#1)(2005-8#1)(2007-10#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-6#1)(2012-2#2)
that along with##3##3##(1995-1#1)(1996-2#1)(2008-10#1)
that alpha and##2##3##(1990-7#1)(1994-12#1)
that alpha##20##2##(1990-12#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#1)(1992-1#1)(1993-2#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1995-10#1)(1995-11#1)(1995-2#1)(1996-12#1)(2008-3#1)(2009-12#1)(2011-2#1)(2012-2#1)
that alpha-CD##2##2##(2008-10#2)
that alpha-MSH##2##2##(1995-2#1)(2008-5#1)
that alpha-amylase##2##2##(2008-10#1)(2008-8#1)
that alpha-helices##2##2##(1995-2#1)(2008-10#1)
that alpha-tocopherol##4##2##(1990-2#1)(1993-2#1)(2008-11#1)(2011-2#1)
that alpha1-AT S##2##3##(1996-5#2)
that already had##2##3##(1992-1#1)(2012-12#1)
that already##6##2##(1992-1#2)(2006-10#1)(2006-4#1)(2012-12#1)(2012-2#1)
that also acts as##2##4##(1990-9#1)(2008-9#1)
that also contained##2##3##(2008-10#1)(2013-1#1)
that also express##2##3##(1990-11#1)(1994-8#1)
that also for##2##3##(1992-11#1)(2008-10#1)
that also has##2##3##(1994-9#1)(2007-11#1)
that also have##2##3##(1994-9#1)(2008-7#1)
that also includes##2##3##(1992-12#1)(2012-12#1)
that also participate in the Caribbean Coastal Marine Productivity##2##9##(2007-5#2)
that also the##2##3##(1992-8#1)(1996-8#1)
that also##67##2##(1990-11#2)(1990-3#1)(1990-9#1)(1991-2#2)(1992-11#1)(1992-12#3)(1992-4#1)(1992-8#1)(1993-2#1)(1994-12#2)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(1996-7#1)(1996-8#2)(2007-11#3)(2007-5#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#4)
that alter the##7##3##(1991-4#1)(1993-6#1)(1997-4#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-3#1)
that alter##19##2##(1990-4#1)(1990-8#1)(1991-4#1)(1991-9#1)(1992-8#1)(1993-6#1)(1994-9#1)(1997-4#1)(2004-11#1)(2006-10#1)(2006-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-3#1)
that alteration of the##2##4##(2008-11#1)(2011-2#1)
that alteration of##4##3##(1996-6#1)(2008-11#1)(2008-8#1)(2011-2#1)
that alteration##5##2##(1996-6#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#1)
that alterations in dNTP##2##4##(1996-10#2)
that alterations in the##5##4##(1991-1#1)(1991-12#1)(2005-10#1)(2006-12#1)(2013-8#1)
that alterations in##13##3##(1991-1#2)(1991-12#1)(1991-6#1)(1995-3#1)(1996-10#2)(1996-5#1)(1997-4#1)(2005-10#1)(2006-12#1)(2011-1#1)(2013-8#1)
that alterations of the##2##4##(2008-8#1)(2008-9#1)
that alterations of##4##3##(1995-10#1)(2008-6#1)(2008-8#1)(2008-9#1)
that alterations##17##2##(1991-1#2)(1991-12#1)(1991-6#1)(1995-10#1)(1995-3#1)(1996-10#2)(1996-5#1)(1997-4#1)(2005-10#1)(2006-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-8#1)
that altered##16##2##(1992-12#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-8#2)(1995-1#1)(1996-3#1)(1997-4#1)(2007-7#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#1)
that alternative approaches##2##3##(2006-10#1)(2010-5#1)
that alternative splicing##2##3##(1990-12#1)(1996-5#1)
that alternative##18##2##(1990-12#1)(1991-1#1)(1991-5#1)(1992-6#1)(1993-12#1)(1995-2#2)(1996-5#1)(1997-2#1)(2006-10#2)(2008-10#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-5#1)(2011-1#1)(2013-1#1)
that alters the expression of##2##5##(1992-2#1)(2008-10#1)
that alters the##4##3##(1992-2#1)(2005-10#1)(2008-10#1)(2013-8#1)
that alters##5##2##(1992-2#1)(1997-3#1)(2005-10#1)(2008-10#1)(2013-8#1)
that although a##3##3##(1990-7#1)(1991-2#1)(1991-6#1)
that although both##3##3##(1991-4#1)(1995-2#1)(2009-12#1)
that although some##3##3##(1992-2#1)(2008-12#1)(2008-2#1)
that although the peak##2##4##(2008-3#1)(2010-3#1)
that although the##19##3##(1990-7#1)(1991-12#1)(1993-12#2)(1993-5#1)(1995-11#1)(1995-3#2)(1997-8#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-7#1)
that although there##2##3##(1996-1#1)(2008-5#1)
that although these##3##3##(1996-8#1)(2006-8#1)(2008-5#1)
that although this##2##3##(2008-8#1)(2013-8#1)
that although##82##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-9#1)(1993-12#2)(1993-5#2)(1994-12#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-9#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#5)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#3)(2013-1#4)(2013-7#1)(2013-8#2)
that altitude##2##2##(2008-3#1)(2008-5#1)
that altruism##2##2##(2008-10#1)(2008-9#1)
that always##3##2##(1997-8#1)(2007-12#1)(2008-10#1)
that amantadine may be##2##4##(1997-2#2)
that amantadine##6##2##(1992-3#1)(1994-10#1)(1997-2#2)(2007-12#1)(2011-2#1)
that ambient##2##2##(2008-10#2)
that amiloride##2##2##(1991-6#1)(2008-4#1)
that amino acid residues##3##4##(1996-5#1)(1997-6#1)(2008-9#1)
that amino acid##6##3##(1996-5#2)(1997-6#1)(2005-11#1)(2008-9#1)(2010-8#1)
that amino acids##3##3##(1991-8#1)(2004-12#1)(2008-10#1)
that amino##10##2##(1991-8#1)(1996-5#2)(1997-6#1)(2004-12#1)(2005-11#1)(2005-3#1)(2008-10#1)(2008-9#1)(2010-8#1)
that aminophylline##2##2##(2007-8#2)
that ammonia##4##2##(1994-5#1)(2006-12#1)(2008-10#1)(2010-5#1)
that amniotic membrane transplantation##2##4##(2011-2#1)(2012-2#1)
that among the##6##3##(1993-9#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-5#2)
that among##19##2##(1990-2#1)(1991-9#1)(1992-5#1)(1993-9#1)(1997-3#1)(2005-10#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#3)(2008-8#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
that amongst the##2##3##(2007-8#1)(2009-4#1)
that amongst##3##2##(1993-2#1)(2007-8#1)(2009-4#1)
that amount##2##2##(1991-1#1)(2007-11#1)
that amphotericin B##2##3##(1992-6#1)(2006-10#1)
that amplification of the##2##4##(1992-11#1)(1994-11#1)
that amplification of##3##3##(1992-11#1)(1994-11#1)(2010-12#1)
that amplified##3##2##(1993-12#1)(2008-10#1)(2008-5#1)
that amplify a##2##3##(2008-10#2)
that amplify##6##2##(2008-10#4)(2010-5#1)(2011-12#1)
that amygdala##3##2##(1994-8#1)(2008-11#1)(2008-4#1)
that amylin##3##2##(1991-12#1)(1991-6#1)(2008-9#1)
that amyloid beta##2##3##(1995-5#1)(1996-6#1)
that amyloid##4##2##(1994-2#1)(1995-5#1)(1996-6#1)(2008-5#1)
that amyloid-like##2##2##(1994-2#1)(1997-7#1)
that an abnormal##3##3##(1992-10#1)(1993-11#1)(1996-5#1)
that an accurate##2##3##(2008-3#1)(2012-2#1)
that an acute##2##3##(2005-8#1)(2011-12#1)
that an additional##5##3##(1991-12#1)(1992-12#1)(1994-9#1)(2008-10#1)(2012-3#1)
that an adequate##3##3##(1991-11#1)(1996-7#1)(2008-10#1)
that an aggressive##2##3##(1990-9#1)(1992-6#1)
that an altered##2##3##(1991-9#1)(1996-5#1)
that an alternative##2##3##(1995-5#1)(2008-7#1)
that an amino acid##3##4##(1991-9#1)(1992-5#1)(2008-10#1)
that an amino group at##2##5##(1996-8#2)
that an amino##5##3##(1991-9#1)(1992-5#1)(1996-8#2)(2008-10#1)
that an antiserum##2##3##(1990-2#1)(2008-10#1)
that an apoptotic process##2##4##(1995-3#1)(2006-11#1)
that an approach##2##3##(2008-1#1)(2013-1#1)
that an appropriate choice of##2##5##(1990-8#1)(2006-10#1)
that an appropriate##7##3##(1990-12#1)(1990-8#1)(1996-9#1)(2006-10#1)(2008-1#1)(2010-4#1)(2011-1#1)
that an area##2##3##(1997-7#1)(2013-1#1)
that an array of##3##4##(2007-11#1)(2008-3#2)
that an attempt##2##3##(2008-10#1)(2010-4#1)
that an autocrine##2##3##(1990-4#1)(1992-8#1)
that an average##2##3##(1996-6#1)(2007-8#1)
that an earlier described nuclear localization sequence (NLS)##2##8##(2012-12#2)
that an earlier##4##3##(1992-9#1)(2006-3#1)(2012-12#2)
that an early##6##3##(1991-12#1)(1992-3#1)(2008-11#1)(2009-6#1)(2009-7#1)(2013-1#1)
that an educational##2##3##(2011-2#1)(2012-2#1)
that an effect of##2##4##(1992-7#1)(2008-11#1)
that an effective##2##3##(1996-9#1)(2008-3#1)
that an electrostatic##2##3##(2008-10#2)
that an elevation in##2##4##(1992-4#1)(1996-10#1)
that an enzyme##2##3##(1990-9#1)(1994-9#1)
that an exclusive##2##3##(1991-11#1)(2011-3#1)
that an experimental##3##3##(1996-12#1)(2008-11#1)(2008-3#1)
that an important factor in##2##5##(2005-11#1)(2007-7#1)
that an important factor##3##4##(2005-11#1)(2007-7#1)(2008-2#1)
that an important##13##3##(1992-2#1)(1992-8#1)(1996-2#1)(1996-5#1)(2005-11#1)(2006-8#1)(2007-7#1)(2008-2#1)(2008-9#1)(2010-12#2)(2011-2#2)
that an improved##2##3##(2006-10#2)
that an inadequate##2##3##(1995-12#1)(2008-4#1)
that an increase in plasma##2##5##(1997-2#1)(2010-8#1)
that an increase in the##3##5##(1996-1#1)(1997-7#1)(2008-10#1)
that an increase in##22##4##(1990-5#1)(1990-9#1)(1991-11#1)(1991-8#1)(1994-12#1)(1994-8#1)(1996-1#1)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-8#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-7#1)(2013-8#1)
that an increase of##7##4##(1990-1#1)(1993-6#1)(1993-9#1)(1994-3#1)(2008-5#2)(2010-10#1)
that an increase##29##3##(1990-1#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-8#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1996-1#1)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-9#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-7#1)(2013-8#1)
that an increased number of##2##5##(2006-1#1)(2008-5#1)
that an increased##6##3##(1994-8#1)(1996-3#1)(2006-1#1)(2006-12#1)(2008-5#1)(2012-12#1)
that an increasing##4##3##(1991-4#1)(2006-6#1)(2008-8#1)(2010-8#1)
that an individual##5##3##(1996-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2010-4#1)
that an individual's##2##3##(2008-5#1)(2012-3#1)
that an individualized##2##3##(2007-7#1)(2009-7#1)
that an inflammatory##2##3##(2008-12#1)(2012-3#1)
that an injury##2##3##(1994-2#1)(2008-7#1)
that an intact##2##3##(1995-12#1)(1995-7#1)
that an intensive##2##3##(2008-7#1)(2012-2#1)
that an interaction between##4##4##(1993-4#1)(1994-2#1)(2007-10#1)(2008-7#1)
that an interaction##5##3##(1993-4#1)(1994-2#1)(2005-11#1)(2007-10#1)(2008-7#1)
that an interplay between##2##4##(1993-9#1)(2008-1#1)
that an intrinsic##2##3##(2008-11#1)(2008-7#1)
that an iron##3##3##(1994-8#1)(1997-6#1)(2010-2#1)
that an optical##4##3##(1994-3#2)(2008-3#2)
that an optimal##3##3##(2008-11#1)(2008-3#2)
that an organism##2##3##(2006-5#1)(2011-2#1)
that an uncharacterized##2##3##(2008-11#1)(2011-1#1)
that an understanding of##2##4##(2006-10#2)
that an unexpected##2##3##(2004-11#1)(2008-5#1)
that an unknown##2##3##(1994-12#1)(1997-3#1)
that an unusual##2##3##(1991-11#1)(2012-12#1)
that an##380##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-4#3)(1990-5#3)(1990-7#1)(1990-8#1)(1990-9#3)(1991-11#4)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#4)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#2)(1993-11#3)(1993-12#3)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#3)(1994-12#4)(1994-2#3)(1994-3#3)(1994-5#2)(1994-8#4)(1994-9#3)(1995-1#1)(1995-10#1)(1995-12#3)(1995-2#5)(1995-3#5)(1995-5#4)(1995-6#2)(1995-7#1)(1995-8#3)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#3)(1996-5#5)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#3)(1997-2#2)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#3)(2004-11#1)(2005-11#3)(2005-3#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#7)(2006-11#1)(2006-12#1)(2006-2#2)(2006-3#3)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#8)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#4)(2007-9#4)(2008-1#4)(2008-10#21)(2008-11#14)(2008-12#3)(2008-2#12)(2008-3#20)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#8)(2009-1#2)(2009-10#1)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#3)(2010-4#3)(2010-6#1)(2010-8#3)(2011-1#3)(2011-12#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#5)(2012-2#5)(2012-3#5)(2013-1#8)(2013-7#1)(2013-8#4)
that analogs##2##2##(1994-8#1)(2008-8#1)
that analyses##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
that analysis of##7##3##(1991-6#1)(1991-9#1)(1995-12#1)(2007-8#1)(2008-11#1)(2008-8#1)(2008-9#1)
that analysis##10##2##(1991-1#1)(1991-6#1)(1991-9#1)(1995-12#1)(2007-8#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-1#1)(2013-8#1)
that anatomically##2##2##(1994-3#1)(2008-9#1)
that androgens##3##2##(1990-11#1)(1991-8#1)(1994-5#1)
that anemia##2##2##(2012-2#2)
that anesthesia##2##2##(2012-12#2)
that anesthetic##2##2##(1994-9#1)(2006-10#1)
that anger##2##2##(2009-8#1)(2011-2#1)
that angiogenic factors##2##3##(2008-1#2)
that angiogenic##3##2##(2008-1#2)(2008-5#1)
that angiotensin II##3##3##(1992-9#1)(1995-6#1)(2005-8#1)
that angle##2##2##(2008-2#1)(2008-3#1)
that animal##6##2##(1994-11#1)(2005-5#1)(2007-8#1)(2008-1#1)(2008-8#1)(2009-8#1)
that animals##8##2##(1993-12#1)(1994-11#1)(1995-12#1)(2006-10#1)(2008-12#1)(2008-8#1)(2012-2#1)(2012-3#1)
that anion##2##2##(1994-8#1)(2008-10#1)
that anisotropic materials##2##3##(2007-9#1)(2008-3#1)
that annexin##3##2##(1996-8#1)(1996-9#1)(2010-12#1)
that another potential##2##3##(1995-5#1)(2006-2#1)
that another##14##2##(1991-9#1)(1992-12#1)(1994-3#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-9#1)(1997-6#1)(2006-2#1)(2007-12#1)(2008-10#3)(2008-2#1)
that answer##2##2##(2005-10#1)(2010-5#1)
that antagonism##3##2##(2008-10#2)(2008-8#1)
that antagonists##2##2##(1995-12#1)(2006-7#1)
that antegrade##2##2##(2007-8#1)(2009-2#1)
that anterior##4##2##(1992-6#1)(2006-8#1)(2008-7#1)(2010-2#1)
that anthocyanins##2##2##(2008-4#1)(2010-12#1)
that anti-metatype antibodies##2##3##(1992-6#2)
that anti-metatype##3##2##(1992-6#3)
that antibacterial lotions##2##3##(2008-5#2)
that antibiosis is##2##3##(2008-10#2)
that antibodies against##3##3##(1991-12#1)(2008-4#1)(2013-8#1)
that antibodies to##2##3##(1994-8#1)(1996-2#1)
that antibodies##8##2##(1991-12#1)(1994-8#1)(1995-7#1)(1996-2#1)(2007-2#1)(2008-4#1)(2009-3#1)(2013-8#1)
that antibody production##2##3##(1990-12#1)(2008-11#1)
that antibody##8##2##(1990-12#1)(1991-12#1)(1994-3#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-11#2)
that anticipation##2##2##(1995-11#1)(2012-1#1)
that antidepressants##3##2##(2005-7#1)(2008-6#1)(2008-9#1)
that antifungal##2##2##(2006-10#1)(2008-10#1)
that antigen##4##2##(1991-12#1)(1993-12#1)(1996-8#1)(2008-11#1)
that antihypertensive therapy with##2##4##(1992-4#1)(1996-9#1)
that antihypertensive therapy##3##3##(1992-12#1)(1992-4#1)(1996-9#1)
that antihypertensive##4##2##(1992-12#1)(1992-4#1)(1996-9#1)(2005-6#1)
that antimicrobial##2##2##(2008-9#1)(2011-2#1)
that antioxidant compounds##2##3##(2010-8#1)(2011-12#1)
that antioxidant##6##2##(1991-9#1)(1995-7#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-12#1)
that antioxidants have##2##3##(1991-7#1)(1993-2#1)
that antioxidants##4##2##(1991-7#1)(1992-12#1)(1993-2#1)(2007-2#1)
that antisense agents can##2##4##(2005-7#2)
that antisense##9##2##(1991-9#1)(1992-8#1)(1994-6#1)(1995-11#1)(2005-7#2)(2005-8#1)(2007-2#1)(2008-8#1)
that antitrypsin Pittsburgh##2##3##(1993-2#2)
that anxiety##3##2##(2008-10#1)(2012-2#1)(2013-8#1)
that any resultant##2##3##(1997-3#1)(2008-3#1)
that any such##2##3##(1995-11#1)(2008-8#1)
that any##49##2##(1990-1#1)(1990-11#1)(1990-6#1)(1991-2#1)(1992-2#1)(1994-11#1)(1994-4#1)(1994-6#1)(1995-11#1)(1995-5#1)(1996-10#1)(1996-12#2)(1996-9#1)(1997-3#1)(1997-5#1)(2004-12#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#3)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#4)(2009-4#1)(2010-6#1)(2012-1#1)(2012-12#2)(2013-8#1)
that apart from the##2##4##(1990-9#1)(2008-10#1)
that apart from##4##3##(1990-9#1)(1994-8#1)(2007-7#1)(2008-10#1)
that aphid transmission##3##3##(2008-10#3)
that apoB##2##2##(1995-3#2)
that apoE is##2##3##(1991-12#1)(1995-1#1)
that apoE##3##2##(1991-12#2)(1995-1#1)
that apolipoprotein##3##2##(1994-9#1)(1995-2#1)(1997-7#1)
that apoptosis is##3##3##(1996-2#1)(1997-3#1)(2012-2#1)
that apoptosis##10##2##(1994-8#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-3#1)(2003-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#1)
that apoptotic cell death##2##4##(1996-12#1)(2012-2#1)
that apparent##2##2##(2006-12#1)(2008-8#1)
that apparently##9##2##(1991-11#1)(1994-2#1)(1994-7#1)(1995-1#1)(1997-3#1)(2007-3#1)(2007-7#1)(2008-10#1)(2013-8#1)
that appeal to##3##3##(2006-10#1)(2010-2#1)(2012-2#1)
that appear in the##2##4##(2007-12#1)(2008-2#1)
that appear in##6##3##(2007-12#4)(2008-2#1)(2008-6#1)
that appear morphologically##2##3##(2011-2#2)
that appear to be##16##4##(1992-8#1)(1993-3#1)(1996-12#1)(1996-3#1)(1997-1#1)(2005-6#1)(2006-11#1)(2008-11#1)(2008-4#2)(2008-5#1)(2009-4#1)(2010-5#1)(2012-12#1)(2013-1#2)
that appear to have##2##4##(2006-12#1)(2007-11#1)
that appear to##30##3##(1991-8#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-7#1)(2005-6#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-5#1)(2010-7#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
that appear##50##2##(1991-8#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-7#1)(2005-6#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
that appeared in##2##3##(2008-10#1)(2012-3#1)
that appeared to be the##2##5##(1994-10#1)(1997-4#1)
that appeared to be##6##4##(1994-10#1)(1997-4#1)(2008-10#1)(2008-4#1)(2009-10#1)(2009-6#1)
that appeared to##10##3##(1992-3#1)(1994-10#1)(1994-5#1)(1997-4#1)(2007-9#1)(2008-10#1)(2008-4#1)(2009-10#1)(2009-12#1)(2009-6#1)
that appeared##18##2##(1992-3#1)(1994-10#1)(1994-2#1)(1994-5#1)(1996-10#1)(1997-4#1)(2006-12#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-4#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2012-3#1)
that appears in this issue##2##5##(2004-2#1)(2008-6#1)
that appears in##8##3##(2004-2#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#1)
that appears to be a##2##5##(1992-2#1)(2008-12#1)
that appears to be##12##4##(1992-2#1)(1992-7#1)(1994-10#1)(2006-10#1)(2006-4#1)(2006-9#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)
that appears to##27##3##(1990-6#1)(1992-2#1)(1992-7#1)(1993-6#1)(1994-10#1)(1994-3#1)(1994-9#1)(1996-8#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-4#1)(2006-7#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)
that appears##41##2##(1990-10#1)(1990-6#1)(1992-2#1)(1992-7#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-9#1)(1996-8#1)(1997-4#1)(1997-7#1)(2004-2#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-7#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-3#1)(2010-12#1)(2011-1#1)(2012-12#1)
that applicant##2##2##(1993-1#2)
that application of this##2##4##(1991-9#1)(1994-12#1)
that application of##14##3##(1991-9#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-7#1)(2011-1#1)(2013-8#2)
that application##15##2##(1991-9#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-7#2)(2011-1#1)(2013-8#2)
that applications##2##2##(1992-5#1)(2008-2#1)
that applied##5##2##(2004-2#1)(2008-10#2)(2011-1#1)(2013-1#1)
that applies the##3##3##(2006-6#2)(2008-3#1)
that applies to##2##3##(2008-6#2)
that applies##9##2##(2006-3#1)(2006-6#2)(2008-3#2)(2008-6#2)(2008-8#1)(2012-1#1)
that apply not only##2##4##(2006-10#1)(2010-4#1)
that apply to##4##3##(1997-1#1)(2005-10#1)(2008-3#1)(2008-5#1)
that apply##9##2##(1997-1#1)(2005-10#1)(2006-10#1)(2008-10#1)(2008-3#2)(2008-5#1)(2010-4#1)(2010-7#1)
that applying##4##2##(1994-3#1)(2008-10#1)(2013-8#2)
that appressoria##2##2##(2008-10#2)
that approach##7##2##(1993-1#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-3#1)(2011-2#1)
that approaches##5##2##(1992-10#1)(1997-1#1)(2007-11#1)(2008-2#1)(2008-7#1)
that appropriate combination of##2##4##(2008-11#1)(2011-1#1)
that appropriate##23##2##(1993-11#1)(1993-6#1)(1994-10#1)(1995-1#1)(1995-8#1)(1996-10#1)(2004-2#1)(2005-9#1)(2006-2#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#3)(2010-12#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-3#1)
that appropriately designed##3##3##(1996-12#1)(2007-12#2)
that appropriately##4##2##(1996-12#1)(2007-12#2)(2008-12#1)
that approved##2##2##(2008-11#1)(2012-2#1)
that approximate##5##2##(2007-8#1)(2008-9#2)(2009-12#1)(2011-2#1)
that approximately 30% of##3##4##(2008-1#1)(2008-10#1)(2013-1#1)
that approximately 40% of the##2##5##(2007-7#1)(2008-3#1)
that approximately 50% of the##2##5##(1997-5#1)(2006-10#1)
that approximately 60% of the##2##5##(1990-10#1)(2012-12#1)
that approximately one third of##2##5##(1996-11#1)(1996-8#1)
that approximately one third##3##4##(1996-11#1)(1996-8#1)(2006-10#1)
that approximately##35##2##(1990-10#1)(1990-11#2)(1990-12#1)(1992-2#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-3#1)(1996-11#2)(1996-8#1)(1997-5#1)(2005-11#1)(2006-10#4)(2007-11#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2012-12#1)(2013-1#2)(2013-8#1)
that aprotinin##3##2##(1990-7#1)(1996-9#1)(2007-8#1)
that aqueous##2##2##(2010-1#1)(2012-2#1)
that are &quot##2##3##(2011-12#1)(2011-2#1)
that are 20 times##2##4##(2007-11#1)(2008-3#1)
that are 20##3##3##(2007-11#1)(2008-1#1)(2008-3#1)
that are a##10##3##(1992-11#1)(1994-8#1)(1997-7#1)(2004-3#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-8#2)
that are able to##21##4##(1990-5#1)(2006-2#1)(2006-7#3)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-3#2)(2013-1#2)
that are absent from the##2##5##(1997-1#1)(2008-9#1)
that are accelerated##2##3##(1994-12#1)(2009-6#1)
that are acceptable to##2##4##(2005-7#1)(2007-5#1)
that are accessible##2##3##(2008-3#1)(2009-10#1)
that are achievable##2##3##(2007-12#1)(2010-6#1)
that are activated by##2##4##(1995-3#1)(1996-2#1)
that are activated upon##2##4##(2008-12#1)(2009-6#1)
that are activated##5##3##(1995-3#1)(1996-2#1)(2008-10#1)(2008-12#1)(2009-6#1)
that are active##3##3##(2006-10#1)(2006-8#1)(2008-11#1)
that are actually##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
that are adjacent to the##2##5##(2007-12#1)(2008-3#1)
that are affected by the##2##5##(1991-8#1)(2008-10#1)
that are affected by##6##4##(1990-5#1)(1991-8#1)(1992-6#1)(1996-7#1)(2008-10#1)(2008-7#1)
that are aimed at##5##4##(1991-4#1)(2008-1#2)(2008-3#1)(2010-12#1)
that are already##8##3##(2005-10#1)(2006-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-3#1)(2012-1#1)(2012-3#1)
that are also##8##3##(1994-11#1)(1995-6#1)(1997-5#1)(2006-11#1)(2008-4#1)(2010-3#1)(2012-2#1)(2013-8#1)
that are altered in##2##4##(1997-5#1)(2008-7#1)
that are altered##3##3##(1997-5#1)(2008-7#1)(2013-1#1)
that are applicable for the##2##5##(2008-3#1)(2008-4#1)
that are applicable to a##2##5##(2006-2#1)(2007-11#1)
that are applicable to the##2##5##(2007-11#1)(2009-12#1)
that are applicable to##7##4##(2006-2#1)(2007-11#2)(2008-3#1)(2009-12#1)(2010-2#1)(2013-1#1)
that are applicable##9##3##(2006-2#1)(2007-11#2)(2008-3#2)(2008-4#1)(2009-12#1)(2010-2#1)(2013-1#1)
that are applied##3##3##(2006-10#1)(2010-11#1)(2013-7#1)
that are appropriate for##3##4##(1991-1#1)(1997-7#1)(2008-2#1)
that are appropriate to##3##4##(1990-5#1)(2005-5#1)(2007-12#1)
that are appropriate##6##3##(1990-5#1)(1991-1#1)(1997-7#1)(2005-5#1)(2007-12#1)(2008-2#1)
that are arranged##2##3##(2008-2#1)(2008-7#1)
that are as much as five##2##6##(2005-11#1)(2005-8#1)
that are as##7##3##(1997-7#1)(1997-8#1)(2005-11#1)(2005-8#1)(2007-12#1)(2008-3#1)(2008-7#1)
that are assigned##2##3##(2007-12#1)(2009-6#1)
that are associated with a##4##5##(1993-11#1)(2007-11#1)(2008-4#1)(2013-1#1)
that are associated with increased##2##5##(2008-10#1)(2008-8#1)
that are associated with the##10##5##(1996-5#1)(1997-4#1)(2006-9#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-7#2)(2010-2#1)(2012-2#1)
that are associated with these##2##5##(2010-9#1)(2011-2#1)
that are associated with##56##4##(1990-12#1)(1991-9#1)(1992-3#1)(1993-11#2)(1994-12#1)(1994-2#1)(1996-5#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-8#1)(2006-9#2)(2007-11#3)(2007-12#2)(2007-8#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-7#6)(2008-8#3)(2009-11#1)(2009-9#1)(2010-2#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
that are at least##4##4##(1993-12#1)(1993-2#1)(1993-3#1)(2006-12#1)
that are at risk of##2##5##(1996-8#1)(1997-7#1)
that are at risk##3##4##(1996-8#1)(1997-7#1)(2007-11#1)
that are at##10##3##(1993-12#1)(1993-2#1)(1993-3#1)(1996-8#1)(1997-7#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-7#1)(2009-4#1)
that are attributable to##2##4##(2008-10#1)(2012-2#1)
that are attributed to##3##4##(1996-7#2)(2007-8#1)
that are automatically##2##3##(2007-12#1)(2007-5#1)
that are available for##4##4##(2005-11#1)(2008-11#1)(2008-3#1)(2010-11#1)
that are available in the##2##5##(2006-6#1)(2010-10#1)
that are available in##3##4##(2005-8#1)(2006-6#1)(2010-10#1)
that are available to the##2##5##(2007-5#1)(2008-5#1)
that are available to##4##4##(2007-5#1)(2008-4#1)(2008-5#1)(2012-12#1)
that are available##22##3##(1992-6#1)(1994-12#1)(1995-10#1)(1995-5#1)(1995-8#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-6#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-10#1)(2010-11#1)(2012-12#1)
that are based on a##3##5##(2006-10#1)(2008-3#1)(2012-2#1)
that are based on the##5##5##(1990-6#1)(2008-2#2)(2008-3#1)(2013-1#1)
that are based on##15##4##(1990-6#1)(1993-2#1)(1996-4#1)(2006-10#1)(2007-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2010-2#1)(2012-2#1)(2013-1#1)
that are basic##2##3##(1995-8#1)(2007-9#1)
that are becoming##3##3##(1995-1#1)(2008-10#2)
that are beginning to##2##4##(2006-10#1)(2006-6#1)
that are being developed##2##4##(2006-11#1)(2008-7#1)
that are being used to##3##5##(1996-7#1)(2010-11#1)(2010-4#1)
that are being used##5##4##(1996-7#1)(2006-6#1)(2010-11#1)(2010-4#1)(2012-2#1)
that are being##16##3##(1996-7#1)(2006-11#1)(2006-6#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-12#1)(2009-3#1)(2010-11#1)(2010-4#1)(2012-2#1)
that are believed to be##4##5##(1992-10#1)(1996-10#1)(2006-12#1)(2008-11#1)
that are believed to##6##4##(1992-10#1)(1996-10#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-4#1)
that are below the##2##4##(2007-12#1)(2008-10#1)
that are below##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
that are beneficial for##2##4##(1997-8#1)(2012-3#1)
that are beneficial##3##3##(1997-8#1)(2008-5#1)(2012-3#1)
that are better suited to##2##5##(1991-12#1)(2010-9#1)
that are better##3##3##(1991-12#1)(2007-11#1)(2010-9#1)
that are biologically##2##3##(2008-11#1)(2008-8#1)
that are both##8##3##(1993-3#1)(1994-11#1)(2007-12#1)(2008-1#1)(2010-11#1)(2011-12#1)(2012-1#1)(2013-1#1)
that are bound to##2##4##(2008-4#2)
that are bound##4##3##(1990-6#1)(1991-5#1)(2008-4#2)
that are bounded##2##3##(2008-2#1)(2008-3#1)
that are brought into##2##4##(1992-9#1)(2009-5#1)
that are brought##4##3##(1992-9#1)(2008-10#1)(2009-5#1)(2012-2#1)
that are calculated##2##3##(1993-1#1)(2009-11#1)
that are capable of transforming##3##5##(1991-9#1)(2007-12#1)(2008-2#1)
that are capable of##19##4##(1990-11#1)(1991-10#1)(1991-12#1)(1991-9#1)(1996-5#1)(2006-10#1)(2006-5#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-11#1)(2012-12#1)
that are capable##20##3##(1990-11#1)(1991-10#1)(1991-12#1)(1991-9#1)(1996-5#1)(2006-10#1)(2006-5#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-11#1)(2011-1#1)(2012-12#1)
that are causally##3##3##(2010-7#1)(2013-1#2)
that are caused by##4##4##(1997-7#1)(2007-11#1)(2008-10#1)(2013-8#1)
that are central to the##2##5##(1997-4#1)(2006-2#1)
that are central to##3##4##(1995-2#1)(1997-4#1)(2006-2#1)
that are characteristic of the##2##5##(1992-9#1)(2007-12#1)
that are characteristic of##12##4##(1990-3#1)(1992-9#1)(1994-8#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-7#1)
that are characteristic##13##3##(1990-3#1)(1992-9#1)(1994-3#1)(1994-8#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-7#1)
that are characterized by##7##4##(1992-3#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-3#1)(2008-7#1)(2009-6#1)
that are closely##5##3##(2005-11#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-5#1)
that are collected##2##3##(1993-12#1)(2008-7#1)
that are commercially available##2##4##(2007-12#1)(2011-12#1)
that are common to both##2##5##(1991-5#1)(2006-12#1)
that are common to##8##4##(1991-5#1)(1994-3#1)(1994-9#1)(1995-3#1)(2006-12#1)(2007-4#1)(2008-4#1)(2008-7#1)
that are common##12##3##(1991-5#1)(1994-3#1)(1994-9#1)(1995-3#1)(2006-12#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-4#2)(2008-7#2)
that are commonly associated with##3##5##(2008-5#1)(2008-9#1)(2012-12#1)
that are commonly present##2##4##(2007-6#1)(2007-8#1)
that are commonly used in##2##5##(2008-4#1)(2009-3#1)
that are commonly used##6##4##(1991-9#1)(2008-4#3)(2009-3#1)(2012-5#1)
that are commonly##21##3##(1991-9#1)(1995-6#1)(1997-2#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-1#1)(2012-12#2)(2012-3#1)(2012-5#1)(2013-3#1)
that are compact##2##3##(1995-1#1)(2006-10#1)
that are comparable to the##2##5##(2006-3#1)(2008-2#1)
that are comparable to those of##2##6##(2007-12#1)(2008-4#1)
that are comparable to those##3##5##(1991-7#1)(2007-12#1)(2008-4#1)
that are comparable to##10##4##(1991-7#1)(2006-3#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)(2010-6#1)(2011-2#1)
that are comparable with##3##4##(1993-4#1)(2007-12#1)(2008-3#1)
that are comparable##13##3##(1991-7#1)(1993-4#1)(2006-3#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-6#1)(2011-2#1)
that are compatible with##3##4##(1994-2#1)(2008-3#1)(2008-7#1)
that are complementary to the##2##5##(2008-10#1)(2008-7#1)
that are complementary to##3##4##(2006-12#1)(2008-10#1)(2008-7#1)
that are completely##2##3##(1994-9#1)(1997-6#1)
that are complex##2##3##(1996-3#1)(2008-8#1)
that are compressed##2##3##(2007-11#1)(2007-12#1)
that are connected##2##3##(2006-6#1)(2007-12#1)
that are conserved among##3##4##(1991-12#1)(1991-2#1)(2008-5#1)
that are conserved in##2##4##(2007-12#1)(2008-5#1)
that are conserved##7##3##(1991-12#1)(1991-2#1)(2007-12#2)(2008-5#2)(2010-2#1)
that are considerably##2##3##(1994-12#2)
that are considered##2##3##(2008-3#1)(2013-1#1)
that are consistent with a##2##5##(2006-10#1)(2008-10#1)
that are consistent with the presence of##2##7##(1994-9#1)(2008-5#1)
that are consistent with the##6##5##(1994-8#1)(1994-9#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-5#1)
that are consistent with##17##4##(1990-3#1)(1991-9#1)(1994-8#1)(1994-9#1)(1996-5#1)(2006-10#3)(2007-12#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2010-2#1)
that are consistently##2##3##(2008-10#1)(2012-12#1)
that are constitutively expressed##2##4##(2008-5#1)(2013-1#1)
that are constitutively##3##3##(2008-5#1)(2012-12#1)(2013-1#1)
that are contained in##2##4##(1991-7#1)(2008-3#1)
that are continuously tunable in##2##5##(2007-11#1)(2007-12#1)
that are contributing to##2##4##(2008-5#1)(2010-12#1)
that are correlated with##5##4##(2007-11#1)(2007-12#1)(2008-4#1)(2008-8#1)(2012-3#1)
that are corrupted with additive##2##5##(2008-2#1)(2008-3#1)
that are coupled to##2##4##(1991-5#1)(1994-3#1)
that are coupled##4##3##(1991-5#1)(1994-3#1)(2006-10#1)(2010-12#1)
that are covered##2##3##(1994-12#1)(2006-10#1)
that are created##2##3##(1996-2#1)(2008-12#1)
that are critical for##8##4##(1994-3#1)(1994-5#1)(2007-12#2)(2008-10#1)(2008-5#1)(2009-10#2)
that are critical to##5##4##(1996-2#1)(2008-2#1)(2008-7#1)(2012-12#1)(2012-2#1)
that are critical##15##3##(1994-3#1)(1994-5#1)(1996-2#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-10#2)(2012-12#1)(2012-2#1)
that are crucial for the##2##5##(1994-2#1)(2007-12#1)
that are crucial for##3##4##(1994-2#1)(2007-12#1)(2010-12#1)
that are crucial to the##3##5##(2008-3#1)(2008-9#2)
that are crucial##7##3##(1994-2#1)(2007-12#1)(2008-3#1)(2008-9#2)(2009-4#1)(2010-12#1)
that are currently available and##2##5##(2008-4#1)(2013-1#1)
that are currently available##3##4##(2007-7#1)(2008-4#1)(2013-1#1)
that are currently being explored##2##5##(2008-1#1)(2008-7#1)
that are currently being used##4##5##(1990-2#1)(2004-9#1)(2007-11#1)(2008-3#1)
that are currently being##10##4##(1990-2#1)(2004-9#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-3#2)(2008-7#1)(2010-5#1)(2012-2#1)
that are currently in##4##4##(2007-6#1)(2008-2#1)(2008-5#1)(2013-1#1)
that are currently under##4##4##(1995-10#1)(2007-12#1)(2008-1#1)(2012-12#1)
that are currently used##2##4##(2008-10#1)(2011-1#1)
that are currently##35##3##(1990-2#1)(1995-10#1)(1996-2#1)(1997-2#1)(2004-2#1)(2004-9#1)(2006-10#2)(2006-4#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
that are deficient in##3##4##(1995-6#1)(1996-8#1)(2008-7#1)
that are defined##2##3##(2005-11#1)(2007-12#1)
that are degraded##2##3##(1995-2#1)(2012-12#1)
that are delivered##2##3##(2009-11#1)(2009-6#1)
that are dependent on the##4##5##(2008-3#1)(2010-10#1)(2013-1#2)
that are dependent on##8##4##(1995-1#1)(1995-3#1)(1997-2#1)(2008-3#1)(2010-10#1)(2010-2#1)(2013-1#2)
that are deposited##2##3##(2007-12#1)(2011-2#1)
that are derived from a##2##5##(1992-4#1)(1997-2#1)
that are derived from##10##4##(1992-4#1)(1997-2#1)(2006-12#1)(2006-6#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-9#1)
that are derived##11##3##(1992-4#1)(1997-2#1)(2006-12#1)(2006-6#1)(2008-11#2)(2008-2#3)(2008-3#1)(2008-9#1)
that are described##5##3##(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#1)
that are designed to##8##4##(2007-11#2)(2007-2#1)(2008-4#1)(2009-7#1)(2010-9#1)(2011-1#1)(2012-2#1)
that are designed##11##3##(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2008-4#1)(2009-7#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
that are detectable with##2##4##(1992-7#1)(2006-11#1)
that are detectable##3##3##(1992-7#1)(2006-11#1)(2012-12#1)
that are detected##2##3##(2007-12#1)(2008-10#1)
that are detrimental to##2##4##(1991-4#1)(2008-8#1)
that are devoid of##3##4##(1992-8#1)(2007-11#1)(2012-12#1)
that are different from the##2##5##(2007-12#1)(2011-2#1)
that are different from##3##4##(2007-12#2)(2011-2#1)
that are different##4##3##(1996-10#1)(2007-12#2)(2011-2#1)
that are differentially##4##3##(1996-5#1)(2008-9#1)(2010-6#1)(2011-2#1)
that are difficult to##8##4##(1994-9#1)(2008-2#1)(2008-4#1)(2008-6#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-8#1)
that are difficult##9##3##(1994-9#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-8#1)
that are directly##2##3##(2005-10#1)(2008-3#1)
that are discussed in the##3##5##(2007-4#1)(2013-1#2)
that are discussed in##5##4##(1997-2#1)(2007-4#1)(2010-7#1)(2013-1#2)
that are discussed##10##3##(1993-8#1)(1997-2#1)(2007-12#3)(2007-4#1)(2008-2#1)(2010-7#1)(2013-1#2)
that are distinct from the##2##5##(1991-5#1)(2008-11#1)
that are distinct in##2##4##(1994-12#1)(2011-2#1)
that are distinct##5##3##(1991-5#1)(1992-6#1)(1994-12#1)(2008-11#1)(2011-2#1)
that are distinguished by a##2##5##(1994-3#1)(1997-4#1)
that are distinguished by##3##4##(1993-9#1)(1994-3#1)(1997-4#1)
that are due to aerosol##2##5##(2008-3#2)
that are due to the##16##5##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#8)
that are due to##50##4##(2007-11#4)(2007-12#12)(2008-10#1)(2008-2#11)(2008-3#22)
that are each##2##3##(1994-12#1)(1995-2#1)
that are easier to##2##4##(2005-10#1)(2012-2#1)
that are easier##3##3##(1990-4#1)(2005-10#1)(2012-2#1)
that are easily##3##3##(1992-11#1)(2008-4#2)
that are effective against##2##4##(1991-11#1)(2008-10#1)
that are effective in inhibiting##2##5##(1994-3#1)(2008-10#1)
that are effective in##8##4##(1994-3#1)(2005-8#1)(2006-6#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-5#1)
that are effective##11##3##(1991-11#1)(1994-3#1)(2005-8#1)(2006-6#1)(2007-6#1)(2008-10#3)(2008-3#1)(2008-5#1)(2012-12#1)
that are either##9##3##(1992-7#1)(1994-9#1)(1996-5#1)(1996-9#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-3#1)
that are embedded in##2##4##(2008-11#1)(2010-5#1)
that are embedded##3##3##(2008-11#1)(2010-5#1)(2010-8#1)
that are emerging##2##3##(2005-8#1)(2008-11#1)
that are encoded by##3##4##(1992-5#1)(1995-1#1)(2008-4#1)
that are encoded in##3##4##(1997-6#1)(2008-4#1)(2008-7#1)
that are encoded##7##3##(1992-5#1)(1994-9#1)(1995-1#1)(1997-6#1)(2008-4#2)(2008-7#1)
that are encountered in##5##4##(1992-8#1)(2007-10#1)(2007-4#1)(2008-3#1)(2008-4#1)
that are encountered##7##3##(1992-8#1)(2005-8#1)(2007-10#1)(2007-4#1)(2008-3#1)(2008-4#1)(2012-2#1)
that are enriched in##2##4##(2006-3#1)(2006-6#1)
that are enriched##3##3##(1994-2#1)(2006-3#1)(2006-6#1)
that are equal##2##3##(2006-11#1)(2008-3#1)
that are especially##3##3##(1992-10#1)(2008-5#1)(2009-9#1)
that are essential for the##3##5##(1994-9#1)(1995-2#1)(1997-4#1)
that are essential for##15##4##(1992-11#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-8#1)(2011-1#2)(2012-12#2)(2012-3#1)
that are essential to##2##4##(1994-5#1)(2008-1#1)
that are essential##18##3##(1992-11#1)(1994-5#2)(1994-9#1)(1995-1#1)(1995-2#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-8#1)(2011-1#2)(2012-12#2)(2012-3#1)
that are evolving##2##3##(1994-2#1)(1996-12#1)
that are exactly##2##3##(1997-2#1)(2006-12#1)
that are exceptionally diverse##2##4##(2008-8#2)
that are expected to be##3##5##(1997-5#1)(2008-3#1)(2008-4#1)
that are expected to##7##4##(1997-5#1)(2008-11#1)(2008-3#2)(2008-4#1)(2012-12#1)(2012-3#1)
that are experienced##2##3##(1993-3#1)(2009-4#1)
that are exposed to##3##4##(1995-11#1)(2008-10#1)(2008-5#1)
that are expressed at##2##4##(1993-6#1)(2010-6#1)
that are expressed in most##2##5##(1991-11#1)(1996-10#1)
that are expressed in##8##4##(1991-11#1)(1992-12#2)(1993-6#2)(1996-10#1)(2011-2#1)(2013-8#1)
that are expressed##17##3##(1991-11#1)(1992-12#2)(1993-6#3)(1993-9#1)(1996-10#1)(2006-12#1)(2007-11#1)(2008-2#1)(2008-4#2)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
that are extremely##2##3##(2007-11#1)(2008-10#1)
that are fabricated##2##3##(2007-9#1)(2008-3#1)
that are familiar to##3##4##(2008-11#1)(2008-9#1)(2013-1#1)
that are favorable for##2##4##(1990-11#1)(2008-3#1)
that are favorable##3##3##(1990-11#1)(2008-3#1)(2008-8#1)
that are formed by##2##4##(1994-9#1)(2007-12#1)
that are formed##4##3##(1994-9#1)(2007-12#2)(2008-10#1)
that are found at##2##4##(1992-12#1)(2008-5#1)
that are found in the##3##5##(1996-11#1)(2009-12#1)(2011-12#1)
that are found in##9##4##(1996-11#1)(2004-4#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-4#1)(2009-12#1)(2011-12#1)(2011-2#1)
that are found##16##3##(1992-12#1)(1995-5#1)(1996-11#1)(1997-6#1)(2004-4#1)(2006-12#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2011-12#1)(2011-2#1)(2013-8#1)
that are free of##4##4##(1993-9#1)(2008-11#1)(2008-2#1)(2010-2#1)
that are freely##2##3##(1996-5#1)(2011-2#1)
that are frequently seen in##2##5##(1993-11#1)(2007-12#1)
that are frequently##7##3##(1993-11#1)(2007-12#2)(2008-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
that are functionally##5##3##(1993-11#1)(1997-2#1)(2010-4#1)(2010-7#1)(2013-1#1)
that are fundamental##2##3##(1990-5#1)(2008-10#1)
that are generally##5##3##(2008-10#1)(2008-2#1)(2010-1#1)(2011-2#1)(2013-8#1)
that are generated by##3##4##(1996-11#1)(2008-4#1)(2010-2#1)
that are generated##7##3##(1991-8#1)(1996-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2010-2#1)
that are genetically identical##2##4##(2008-1#1)(2008-2#1)
that are genetically##5##3##(1997-4#1)(1997-7#1)(2008-1#1)(2008-2#1)(2008-8#1)
that are given##2##3##(1992-9#1)(2007-11#1)
that are going##2##3##(2006-10#1)(2010-4#1)
that are growing##3##3##(1994-3#1)(2008-9#1)(2009-8#1)
that are guaranteed##2##3##(1993-3#1)(2006-10#1)
that are hard to##5##4##(1990-3#1)(1995-12#1)(2006-7#1)(2008-11#1)(2010-7#1)
that are held##2##3##(2006-2#1)(2008-11#1)
that are helping##2##3##(2007-8#1)(2008-7#1)
that are high in##2##4##(1991-11#1)(2007-8#1)
that are higher than##2##4##(2007-11#1)(2011-1#1)
that are highly conserved in the##2##6##(1994-6#1)(2008-7#1)
that are highly conserved in##4##5##(1994-6#1)(1994-8#1)(2006-10#1)(2008-7#1)
that are highly conserved##8##4##(1990-3#1)(1990-8#1)(1994-3#1)(1994-6#1)(1994-8#1)(2006-10#1)(2008-7#1)(2012-2#1)
that are highly expressed in##4##5##(2008-5#1)(2009-10#1)(2009-5#1)(2011-2#1)
that are highly##30##3##(1990-3#1)(1990-5#1)(1990-8#1)(1992-8#1)(1994-3#2)(1994-6#1)(1994-8#1)(1996-4#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-10#2)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
that are homologous to##3##4##(1990-8#1)(2006-12#1)(2007-12#1)
that are homozygous##3##3##(1995-2#1)(2008-9#1)(2010-2#1)
that are ideally##2##3##(2007-12#1)(2012-3#1)
that are identical to those of##2##6##(1995-8#1)(2007-5#1)
that are identical##3##3##(1995-8#1)(2007-5#1)(2008-10#1)
that are identified##3##3##(1996-2#1)(2007-8#1)(2008-7#1)
that are implemented in##2##4##(2007-11#1)(2011-2#1)
that are implemented##3##3##(1994-6#1)(2007-11#1)(2011-2#1)
that are important for its##2##5##(1996-9#1)(2008-8#1)
that are important for the##7##5##(1994-5#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-3#1)(2012-12#1)(2013-1#1)
that are important for##24##4##(1991-6#1)(1994-5#1)(1994-8#1)(1995-3#1)(1996-5#1)(1996-9#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2010-10#2)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#1)
that are important in the##3##5##(1994-8#1)(2008-4#1)(2008-7#1)
that are important in##13##4##(1993-5#1)(1994-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-2#1)(2008-4#4)(2008-7#1)(2008-8#1)(2011-12#1)
that are important to##3##4##(2008-4#1)(2008-7#1)(2010-2#1)
that are important##45##3##(1991-6#1)(1993-5#1)(1994-5#1)(1994-8#2)(1995-3#1)(1996-5#1)(1996-9#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#6)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-3#1)(2010-10#2)(2010-11#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#2)
that are improperly##2##3##(2005-8#1)(2008-11#1)
that are in agreement with##3##5##(2008-10#3)
that are in close proximity##4##5##(1993-3#1)(1994-11#1)(2008-2#2)
that are in close##5##4##(1993-3#1)(1994-11#1)(2005-7#1)(2008-2#2)
that are in contact with##2##5##(2007-12#1)(2008-3#1)
that are in good agreement with the##2##7##(2007-12#1)(2010-7#1)
that are in good agreement with##3##6##(2007-11#1)(2007-12#1)(2010-7#1)
that are in good agreement##4##5##(1994-5#1)(2007-11#1)(2007-12#1)(2010-7#1)
that are in reasonable agreement with##2##6##(1995-4#1)(2007-3#1)
that are in the##4##4##(1992-12#1)(1994-3#2)(2005-11#1)
that are in various stages of##2##6##(1993-11#1)(2008-5#1)
that are in##36##3##(1992-12#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-3#2)(1994-5#1)(1995-4#1)(1996-10#1)(2005-11#1)(2005-7#1)(2006-4#1)(2007-11#2)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#1)
that are incapable of##3##4##(2006-10#1)(2008-10#1)(2008-4#1)
that are included in the##3##5##(2006-10#1)(2008-2#1)(2008-3#1)
that are incompatible with##2##4##(2010-6#1)(2013-8#1)
that are independent of##10##4##(1990-2#1)(1994-3#1)(1997-7#1)(2006-9#1)(2008-4#2)(2008-7#1)(2010-5#1)(2012-12#2)
that are independent##11##3##(1990-2#1)(1994-3#1)(1997-7#1)(2006-9#1)(2008-4#2)(2008-7#1)(2010-5#1)(2011-12#1)(2012-12#2)
that are indicative of##2##4##(2008-11#1)(2008-4#1)
that are indistinguishable from##2##4##(1997-4#1)(2008-10#1)
that are induced by the##2##5##(2008-3#1)(2008-6#1)
that are induced by##5##4##(1997-7#1)(2006-8#1)(2008-2#1)(2008-3#1)(2008-6#1)
that are induced in##3##4##(1995-1#1)(2008-4#1)(2009-8#1)
that are induced##9##3##(1995-1#1)(1997-7#2)(2006-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-8#1)
that are inexpensive##2##3##(2009-10#1)(2011-9#1)
that are influenced by##2##4##(1990-2#1)(2009-3#1)
that are inherent in##4##4##(1993-5#1)(2008-2#1)(2008-3#2)
that are inherent##5##3##(1993-5#1)(2007-12#1)(2008-2#1)(2008-3#2)
that are inspired by##2##4##(2009-9#1)(2012-1#1)
that are intermediate##3##3##(1992-9#1)(2013-8#2)
that are internally##2##3##(1997-8#1)(2005-8#1)
that are introduced##2##3##(2007-12#1)(2009-4#1)
that are invariant with##2##4##(2007-12#1)(2009-10#1)
that are invariant##3##3##(2007-12#1)(2008-2#1)(2009-10#1)
that are involved in the##12##5##(1991-9#1)(1992-11#1)(1993-12#1)(1995-8#1)(1997-6#1)(2008-10#3)(2008-5#1)(2010-2#1)(2010-5#1)(2012-2#1)
that are involved in this process##2##6##(2006-10#1)(2006-12#1)
that are involved in##38##4##(1991-9#1)(1992-11#1)(1993-10#1)(1993-12#1)(1993-6#1)(1994-6#1)(1995-1#1)(1995-8#1)(1996-7#1)(1997-6#1)(1997-7#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-12#4)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-10#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2012-2#1)
that are involved##39##3##(1991-9#1)(1992-11#1)(1993-10#1)(1993-12#1)(1993-6#1)(1994-6#1)(1995-1#1)(1995-8#1)(1996-7#1)(1997-6#1)(1997-7#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-12#4)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-10#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2012-2#1)(2013-8#1)
that are known as##3##4##(2007-7#1)(2012-12#2)
that are known to be##3##5##(1992-3#1)(1993-11#1)(1993-9#1)
that are known to##20##4##(1991-3#1)(1992-3#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-9#1)(2006-12#1)(2006-5#1)(2008-11#2)(2008-3#1)(2008-9#1)(2010-12#2)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
that are known##24##3##(1991-3#1)(1992-3#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-9#1)(2006-12#1)(2006-5#1)(2007-7#1)(2008-11#2)(2008-3#1)(2008-9#1)(2010-12#2)(2011-1#2)(2012-12#3)(2013-1#1)(2013-8#1)
that are large enough to##3##5##(2008-11#1)(2008-4#1)(2011-2#1)
that are large##4##3##(2008-11#1)(2008-4#2)(2011-2#1)
that are largely##5##3##(1992-7#1)(1994-9#1)(2008-9#1)(2009-7#1)(2011-2#1)
that are larger than##2##4##(1994-9#1)(2008-3#1)
that are less##8##3##(2006-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-4#1)
that are likely to be##7##5##(1992-3#1)(1993-12#1)(2005-8#1)(2007-8#1)(2008-4#1)(2011-1#1)(2011-2#1)
that are likely to##19##4##(1990-12#1)(1991-1#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-3#1)(2005-8#2)(2006-5#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)
that are likely##22##3##(1990-12#1)(1991-1#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-3#1)(2005-8#2)(2006-5#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
that are linked to##6##4##(2007-11#1)(2008-10#3)(2008-3#1)(2011-12#1)
that are linked##8##3##(2005-5#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-7#1)(2011-12#1)
that are located at##2##4##(1995-8#1)(1997-6#1)
that are located in##2##4##(1991-6#1)(2008-4#1)
that are located on the##2##5##(2007-12#1)(2008-2#1)
that are located##8##3##(1990-12#1)(1991-6#1)(1993-12#1)(1995-8#1)(1997-6#1)(2007-12#1)(2008-2#1)(2008-4#1)
that are lost##2##3##(2007-8#1)(2008-2#1)
that are low##2##3##(2008-3#1)(2013-1#1)
that are made##7##3##(1990-12#1)(2004-12#1)(2006-3#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-5#1)
that are maintained##2##3##(2007-10#1)(2008-6#1)
that are measured##2##3##(2008-2#2)
that are mediated by##4##4##(1993-3#1)(1996-7#1)(2006-3#1)(2008-10#1)
that are members of##2##4##(1993-4#1)(1994-3#1)
that are more likely to##3##5##(1993-11#1)(2008-10#2)
that are more sensitive##2##4##(2006-10#1)(2008-2#1)
that are more than##3##4##(1993-12#1)(2011-2#1)(2012-2#1)
that are more vulnerable##2##4##(2008-11#1)(2008-4#1)
that are more##26##3##(1993-11#1)(1993-12#1)(1995-6#1)(1997-1#1)(2006-10#2)(2006-11#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#2)(2010-10#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#1)
that are most and least##2##5##(1992-12#1)(2010-2#1)
that are most commonly##2##4##(1993-3#1)(2006-10#1)
that are most frequently##2##4##(1991-12#1)(2008-10#1)
that are most##19##3##(1991-12#1)(1992-12#1)(1993-11#1)(1993-3#1)(2006-10#2)(2006-9#1)(2007-2#1)(2007-4#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#1)(2010-2#1)(2010-3#1)(2012-3#1)
that are much##4##3##(1994-2#1)(2010-4#1)(2012-1#1)(2013-7#1)
that are near##2##3##(1996-7#1)(2008-2#1)
that are necessary for##8##4##(1992-3#1)(1996-3#1)(2006-12#1)(2008-2#1)(2008-3#2)(2009-2#1)(2009-4#1)
that are necessary to##3##4##(2007-11#1)(2008-10#1)(2008-4#1)
that are necessary##12##3##(1992-3#1)(1996-3#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#2)(2009-2#1)(2009-4#1)
that are needed to##2##4##(2008-3#1)(2012-2#1)
that are needed##3##3##(2008-3#1)(2012-12#1)(2012-2#1)
that are neither##2##3##(2008-11#1)(2012-3#1)
that are normally##3##3##(1990-5#1)(1997-5#1)(2008-3#1)
that are not affected by the##2##6##(2008-2#1)(2010-2#1)
that are not affected by##3##5##(1996-4#1)(2008-2#1)(2010-2#1)
that are not based##2##4##(1994-3#1)(2008-8#1)
that are not directly##2##4##(2008-11#1)(2008-7#1)
that are not explained##2##4##(2008-5#1)(2012-1#1)
that are not in##4##4##(2007-3#1)(2008-3#2)(2010-12#1)
that are not included in the##2##6##(1993-3#1)(2008-2#1)
that are not included in##3##5##(1993-3#1)(2008-2#1)(2008-9#1)
that are not limited to##2##5##(2006-10#1)(2008-3#1)
that are not necessarily##4##4##(1995-5#1)(2007-10#1)(2009-9#1)(2013-8#1)
that are not only##2##4##(1995-3#1)(2007-11#1)
that are not possible with##2##5##(1993-3#1)(2008-3#1)
that are not present in the##2##6##(1991-1#1)(1993-6#1)
that are not provided by BLAST##2##6##(2008-4#2)
that are not readily obtained##2##5##(1991-5#1)(2010-6#1)
that are not readily##3##4##(1991-5#1)(2008-10#1)(2010-6#1)
that are not specific to##2##5##(2007-10#1)(2007-9#1)
that are not well##2##4##(1996-5#1)(2008-8#1)
that are not##114##3##(1990-7#1)(1991-1#1)(1991-5#1)(1992-12#1)(1992-6#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-12#2)(1994-3#1)(1995-3#1)(1995-5#1)(1995-8#3)(1996-12#1)(1996-4#1)(1996-5#2)(1997-4#1)(1997-6#1)(2005-7#2)(2006-10#2)(2007-10#4)(2007-11#2)(2007-12#9)(2007-3#1)(2007-4#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-2#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
that are now widely##3##4##(1991-12#1)(1994-11#1)(2006-10#1)
that are now##10##3##(1991-12#1)(1994-11#1)(1997-2#1)(2006-10#2)(2007-4#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-8#1)
that are observed in##4##4##(2006-10#1)(2007-11#1)(2008-11#1)(2008-3#1)
that are observed##12##3##(1993-3#1)(1993-9#1)(1995-12#1)(2004-4#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-4#1)
that are obtained by##2##4##(2007-12#1)(2008-3#1)
that are obtained with##2##4##(2007-8#1)(2008-3#1)
that are obtained##6##3##(2007-12#1)(2007-8#2)(2008-3#2)(2013-1#1)
that are occurring##6##3##(1992-6#1)(1995-1#1)(1996-2#1)(2007-11#1)(2013-1#2)
that are of concern##2##4##(2006-7#1)(2007-11#1)
that are of considerable##2##4##(2006-12#1)(2008-10#1)
that are of importance##2##4##(2008-10#1)(2010-7#1)
that are of relevance to##2##5##(1997-8#1)(2011-1#1)
that are of relevance##3##4##(1997-8#1)(2008-3#1)(2011-1#1)
that are of##16##3##(1997-8#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-6#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-3#1)
that are offered##2##3##(1993-12#1)(2008-11#1)
that are often used##2##4##(2010-6#1)(2011-1#1)
that are often##26##3##(1992-12#1)(2007-4#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-5#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-3#1)(2013-1#2)
that are on##2##3##(1994-3#1)(2012-2#1)
that are only##2##3##(1991-11#1)(2008-2#1)
that are optically##2##3##(2008-2#1)(2012-2#1)
that are or have##2##4##(1990-12#1)(1991-12#1)
that are or##3##3##(1990-12#1)(1991-12#1)(2008-4#1)
that are otherwise##6##3##(2006-5#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#1)(2013-8#1)
that are part of the##3##5##(2008-10#1)(2013-1#1)(2013-7#1)
that are particularly suitable for##2##5##(2008-5#1)(2012-2#1)
that are particularly##6##3##(2006-11#1)(2008-5#1)(2009-10#1)(2009-6#1)(2012-2#1)(2013-1#1)
that are partly##2##3##(2006-1#1)(2010-12#1)
that are pathogenic##2##3##(2008-10#2)
that are perceived##2##3##(1995-1#1)(2008-11#1)
that are performed##4##3##(1997-8#1)(2006-10#1)(2007-5#1)(2007-8#1)
that are phosphorylated##3##3##(1991-3#1)(1994-11#1)(2008-4#1)
that are placed in##3##4##(1990-9#1)(2008-11#1)(2008-2#1)
that are poorly##2##3##(2006-5#1)(2008-5#1)
that are possible##5##3##(1997-8#1)(2004-4#1)(2008-10#1)(2008-3#1)(2008-4#1)
that are possibly##2##3##(2006-10#1)(2008-6#1)
that are potent inhibitors of##2##5##(1996-11#1)(2010-12#1)
that are potent##3##3##(1996-11#1)(2006-9#1)(2010-12#1)
that are potential##5##3##(1995-8#1)(2008-5#1)(2009-8#1)(2010-11#1)(2011-2#1)
that are potentially##6##3##(2005-12#1)(2007-2#1)(2009-4#1)(2011-1#1)(2012-12#2)
that are predicted to have##2##5##(2008-9#1)(2010-3#1)
that are predicted to##4##4##(1997-4#1)(2008-9#1)(2010-3#1)(2011-2#1)
that are preferentially##2##3##(2008-2#1)(2008-3#1)
that are present at the##2##5##(2008-3#1)(2010-12#1)
that are present in the##4##5##(2007-12#1)(2008-10#1)(2008-7#1)(2012-1#1)
that are present in##12##4##(1991-6#1)(1995-1#1)(1995-8#1)(1997-1#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-7#1)(2009-4#1)(2012-1#1)
that are present##17##3##(1991-6#1)(1995-1#1)(1995-8#1)(1997-1#1)(2006-4#1)(2007-12#3)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-12#1)(2012-1#1)
that are presented##2##3##(2009-5#1)(2009-8#1)
that are presently used##2##4##(1994-6#1)(2008-10#1)
that are presently##3##3##(1994-6#1)(2008-10#1)(2010-3#1)
that are presumed to be##2##5##(1994-3#1)(2007-11#1)
that are prevented##2##3##(1994-8#1)(2005-7#1)
that are probably##4##3##(1992-9#1)(1995-11#1)(2006-10#1)(2007-9#1)
that are processed##2##3##(1994-2#1)(2010-7#1)
that are produced##4##3##(1994-11#1)(2007-12#1)(2008-5#1)(2012-2#1)
that are proposed to be involved in##2##7##(1997-7#2)
that are proposed to##3##4##(1997-4#1)(1997-7#2)
that are reactive##2##3##(2008-4#1)(2010-6#1)
that are recognized by##2##4##(1991-2#1)(1993-8#1)
that are recognized##3##3##(1991-2#1)(1992-4#1)(1993-8#1)
that are reconstructed##2##3##(2008-3#2)
that are recovered##2##3##(2008-2#1)(2011-1#1)
that are referred##2##3##(1997-6#1)(2011-2#1)
that are reflected##3##3##(2008-2#1)(2010-10#1)(2011-2#1)
that are refractory to##2##4##(2007-1#1)(2009-8#1)
that are regulated by##4##4##(1990-8#1)(1995-6#1)(1996-10#1)(2008-4#1)
that are regulated##6##3##(1990-8#1)(1995-3#1)(1995-6#1)(1996-10#1)(2008-4#1)(2008-9#1)
that are related to the##8##5##(1991-12#1)(1991-3#1)(1993-6#1)(1997-2#1)(2006-10#1)(2008-3#1)(2008-7#1)(2009-8#1)
that are related to##23##4##(1991-12#1)(1991-3#1)(1993-6#1)(1996-1#1)(1997-2#2)(1997-8#1)(2006-10#2)(2006-4#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-3#1)(2008-7#1)(2009-2#3)(2009-4#2)(2009-8#1)(2010-3#1)(2011-1#1)
that are related##24##3##(1991-12#1)(1991-3#1)(1993-6#1)(1994-8#1)(1996-1#1)(1997-2#2)(1997-8#1)(2006-10#2)(2006-4#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-3#1)(2008-7#1)(2009-2#3)(2009-4#2)(2009-8#1)(2010-3#1)(2011-1#1)
that are relatively##2##3##(1992-9#1)(1996-12#1)
that are released from##5##4##(2006-10#1)(2006-8#1)(2008-4#3)
that are released##7##3##(2006-10#2)(2006-8#1)(2008-4#3)(2010-8#1)
that are relevant for the##2##5##(2008-11#1)(2008-3#1)
that are relevant for##5##4##(2007-11#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-2#1)
that are relevant in##2##4##(2012-1#1)(2012-12#1)
that are relevant to the##4##5##(1995-7#1)(2006-10#1)(2007-8#1)(2008-3#1)
that are relevant to##12##4##(1992-12#1)(1994-2#1)(1995-7#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-3#1)(2013-1#1)
that are relevant##19##3##(1992-12#1)(1994-2#1)(1995-7#1)(2006-10#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2009-2#1)(2009-3#1)(2012-1#1)(2012-12#1)(2013-1#1)
that are reliable and##2##4##(2008-11#1)(2012-12#1)
that are reported to##3##4##(1990-7#1)(1992-9#1)(2013-8#1)
that are reported##4##3##(1990-7#1)(1992-9#1)(2005-7#1)(2013-8#1)
that are representative of##2##4##(2006-11#1)(2008-4#1)
that are repressed##2##3##(1991-10#1)(2012-2#1)
that are required by##2##4##(1990-5#1)(2008-10#1)
that are required for the##4##5##(1994-9#1)(1995-2#1)(1996-8#1)(2012-12#1)
that are required for##18##4##(1991-11#1)(1993-6#1)(1994-11#2)(1994-9#2)(1995-2#1)(1996-5#1)(1996-8#1)(1997-6#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-4#1)(2012-12#3)
that are required to##2##4##(2008-1#1)(2008-11#1)
that are required##26##3##(1990-5#1)(1991-11#1)(1993-6#1)(1994-11#3)(1994-9#2)(1995-2#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-6#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2012-12#3)
that are resistant to other##2##5##(1990-5#1)(2008-3#1)
that are resistant to the##2##5##(2006-9#1)(2009-11#1)
that are resistant to##16##4##(1990-5#1)(1991-8#1)(1995-3#1)(2006-11#2)(2006-9#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-5#2)(2009-11#1)(2011-2#2)(2012-12#1)(2012-3#1)
that are responsible for the observed##2##6##(2008-10#1)(2008-4#1)
that are responsible for the##13##5##(1994-8#1)(1997-2#1)(2005-8#1)(2006-1#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-10#1)(2009-5#1)(2012-12#1)
that are responsible for##22##4##(1991-8#1)(1994-5#1)(1994-8#1)(1996-7#1)(1997-2#1)(2005-8#1)(2006-1#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-10#1)(2012-12#2)(2012-3#2)
that are restricted to##2##4##(2008-10#1)(2008-8#1)
that are rich in##3##4##(1992-7#1)(2007-3#1)(2012-12#1)
that are risk##2##3##(2008-6#1)(2009-6#1)
that are selected##2##3##(2010-2#1)(2012-12#1)
that are selective for##5##4##(1993-11#1)(2005-6#1)(2008-1#1)(2008-11#1)(2008-5#1)
that are selective##6##3##(1993-11#1)(2005-6#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)
that are selectively##3##3##(1994-12#1)(1994-6#1)(1995-3#1)
that are sensitive to the##4##5##(1993-11#1)(1994-11#1)(2007-11#1)(2008-5#1)
that are sensitive to##13##4##(1990-8#1)(1993-11#1)(1994-11#1)(1996-9#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-4#1)
that are sensitive##14##3##(1990-8#1)(1993-11#1)(1994-11#1)(1996-12#1)(1996-9#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-4#1)
that are separated by##3##4##(1996-3#1)(2007-12#1)(2009-8#1)
that are several##2##3##(2008-3#1)(2010-8#1)
that are shared by##3##4##(1993-6#1)(2006-12#1)(2007-12#1)
that are shared##4##3##(1993-6#1)(2006-12#1)(2007-12#1)(2008-9#1)
that are significant##3##3##(2008-2#1)(2013-8#2)
that are significantly##5##3##(1991-8#1)(2007-12#1)(2008-8#1)(2010-4#1)(2012-3#1)
that are similar to a##3##5##(2008-9#2)(2010-12#1)
that are similar to the##3##5##(1993-12#1)(1994-3#1)(1995-2#1)
that are similar to those of##3##6##(1993-3#1)(2006-10#1)(2007-11#1)
that are similar to those##8##5##(1990-8#1)(1991-9#1)(1993-3#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-3#1)(2008-7#1)
that are similar to##21##4##(1990-8#1)(1991-9#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-2#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#2)(2009-10#1)(2010-12#1)
that are similar##23##3##(1990-8#1)(1991-7#1)(1991-9#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-2#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#2)(2009-10#1)(2010-12#1)(2010-2#1)
that are simple##2##3##(1993-9#1)(2005-5#1)
that are sites of##2##4##(1995-8#1)(2005-7#1)
that are slightly##2##3##(1996-8#1)(2006-10#1)
that are small##2##3##(1991-8#1)(2008-7#1)
that are smaller than the##2##5##(2007-12#1)(2008-10#1)
that are smaller##3##3##(2007-12#1)(2008-10#1)(2010-6#1)
that are so##2##3##(2005-5#1)(2008-2#1)
that are sometimes##2##3##(2011-2#1)(2013-1#1)
that are spatially##3##3##(2009-3#1)(2012-1#1)(2013-1#1)
that are specific for either all##2##6##(2013-8#2)
that are specific for##7##4##(1993-11#1)(2008-10#3)(2008-4#1)(2013-8#2)
that are specific to this##2##5##(2007-11#1)(2008-12#1)
that are specific to##7##4##(2006-12#1)(2007-11#1)(2007-4#1)(2008-12#1)(2009-9#1)(2012-1#1)(2012-3#1)
that are specific##15##3##(1993-11#1)(1996-5#1)(2006-12#1)(2007-11#1)(2007-4#1)(2008-10#3)(2008-12#1)(2008-4#1)(2009-9#1)(2012-1#1)(2012-3#1)(2013-8#2)
that are specifically designed##2##4##(2006-9#1)(2008-4#1)
that are specifically expressed in##2##5##(1996-10#1)(2010-7#1)
that are specifically##10##3##(1990-12#1)(1993-3#1)(1995-1#2)(1996-10#1)(1997-3#1)(2006-9#1)(2008-4#1)(2008-7#1)(2010-7#1)
that are spontaneously##2##3##(1996-6#1)(2008-4#1)
that are still in use##2##5##(2009-5#1)(2010-9#1)
that are still##5##3##(1995-12#1)(2007-12#1)(2009-5#1)(2010-9#1)(2013-8#1)
that are strongly##4##3##(1996-4#1)(1997-7#1)(2008-3#1)(2011-1#1)
that are structural##3##3##(1992-12#1)(2008-4#1)(2009-6#1)
that are structurally similar##3##4##(1990-11#1)(1996-7#2)
that are structurally##4##3##(1990-11#2)(1996-7#2)
that are subject to##3##4##(1996-8#1)(2008-8#1)(2010-1#1)
that are subjected to##2##4##(1991-5#1)(2007-9#1)
that are subsequently##2##3##(2006-6#1)(2007-8#1)
that are sufficiently large##2##4##(2007-12#1)(2008-2#1)
that are suitable for##8##4##(2007-11#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-3#2)(2008-6#1)(2011-2#1)
that are superimposed##2##3##(2008-2#1)(2008-3#1)
that are surrounded by##2##4##(1995-2#1)(2011-2#1)
that are susceptible to##2##4##(1991-12#1)(1996-4#1)
that are tailored##2##3##(2008-9#1)(2010-2#1)
that are taken##2##3##(1992-2#1)(1993-11#1)
that are taking place in##2##5##(2006-10#1)(2008-2#1)
that are taking place##3##4##(2006-10#1)(2006-12#1)(2008-2#1)
that are targeted to##3##4##(2005-7#1)(2007-8#1)(2009-7#1)
that are targeted##5##3##(2005-7#1)(2007-8#1)(2007-9#1)(2008-9#1)(2009-7#1)
that are targets##2##3##(2007-12#1)(2008-1#1)
that are the most##6##4##(1993-12#1)(1995-6#1)(2008-1#1)(2008-6#1)(2008-8#1)(2013-8#1)
that are the##18##3##(1990-8#1)(1993-12#1)(1995-6#1)(1997-4#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#1)(2013-8#1)
that are then##3##3##(2007-11#1)(2012-12#2)
that are thought to be involved##2##6##(1996-4#1)(2009-10#1)
that are thought to mediate##2##5##(1993-12#1)(2008-6#1)
that are thought to##6##4##(1993-12#1)(1996-4#1)(2008-6#1)(2009-10#1)(2010-11#1)(2012-12#1)
that are to be##5##4##(1997-4#1)(2004-11#1)(2007-11#1)(2008-4#1)(2011-1#1)
that are too##4##3##(2005-10#1)(2007-12#1)(2008-3#1)(2008-6#1)
that are toxic to##3##4##(1996-3#1)(2008-10#1)(2008-5#1)
that are toxic##4##3##(1996-3#1)(2006-4#1)(2008-10#1)(2008-5#1)
that are traditionally##2##3##(1993-3#1)(2007-6#1)
that are transcribed##2##3##(1990-8#1)(2006-12#1)
that are transparent##2##3##(2007-12#1)(2008-2#1)
that are transported##3##3##(1996-12#1)(1997-6#1)(2008-4#1)
that are treated##2##3##(1995-11#1)(2009-2#1)
that are triggered by##2##4##(2009-8#1)(2012-1#1)
that are tunable in##2##4##(2007-12#1)(2008-3#1)
that are tunable##5##3##(2007-12#3)(2008-1#1)(2008-3#1)
that are typical for##2##4##(2008-10#1)(2008-2#1)
that are typical of##6##4##(1993-2#1)(1995-8#1)(2006-5#1)(2008-12#1)(2008-7#1)(2009-7#1)
that are typical##9##3##(1993-2#1)(1995-8#1)(2006-5#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#1)(2009-7#1)
that are typically used in##3##5##(1997-8#1)(2013-1#2)
that are typically##9##3##(1992-2#1)(1997-8#2)(2008-11#2)(2009-11#1)(2009-8#1)(2013-1#2)
that are unable to##6##4##(1991-11#1)(1993-9#1)(1997-3#1)(2007-7#1)(2008-10#1)(2008-11#1)
that are unattainable##2##3##(1996-5#1)(2009-6#1)
that are unfamiliar##2##3##(2008-2#1)(2008-4#1)
that are unique in##3##4##(2007-11#1)(2007-12#1)(2011-2#1)
that are unique to the##2##5##(2008-3#1)(2008-5#1)
that are unique to##7##4##(2007-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)
that are unique##13##3##(2007-11#2)(2007-12#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-12#1)
that are unlikely to##3##4##(2006-5#1)(2008-8#1)(2009-9#1)
that are unrelated to##2##4##(1992-8#1)(2008-1#1)
that are unresponsive to##2##4##(2006-10#1)(2010-5#1)
that are unusual##9##3##(1995-3#1)(2006-10#8)
that are up to##2##4##(1992-6#1)(2008-11#1)
that are used as the##2##5##(2010-2#1)(2011-1#1)
that are used as##4##4##(1992-9#1)(2004-4#1)(2010-2#1)(2011-1#1)
that are used by##3##4##(1990-12#1)(2008-1#1)(2013-8#1)
that are used for the##3##5##(2008-4#1)(2010-12#1)(2010-5#1)
that are used for##11##4##(2007-6#1)(2007-8#1)(2008-2#1)(2008-4#2)(2008-7#1)(2009-8#2)(2010-12#1)(2010-5#1)(2012-2#1)
that are used in the##3##5##(2008-1#1)(2008-2#1)(2008-4#1)
that are used in##13##4##(1997-2#1)(2005-10#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-4#2)(2009-3#1)(2009-7#1)(2012-12#1)
that are used to characterize the##2##6##(2008-2#2)
that are used to define the##2##6##(2008-3#1)(2008-7#1)
that are used to monitor##2##5##(2008-10#1)(2008-9#1)
that are used to##28##4##(1994-5#1)(1996-2#1)(2006-6#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#3)(2009-5#1)(2010-11#1)(2013-1#1)
that are used widely##2##4##(1996-12#1)(2007-9#1)
that are used##68##3##(1990-12#1)(1992-9#1)(1994-5#1)(1995-2#1)(1996-12#1)(1996-2#2)(1997-2#1)(2004-4#1)(2005-10#2)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-2#5)(2008-3#7)(2008-4#6)(2008-5#1)(2008-7#4)(2008-9#3)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
that are useful for##3##4##(2007-12#1)(2008-3#1)(2008-4#1)
that are useful##7##3##(1994-12#1)(2005-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-12#1)
that are usually##8##3##(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-6#1)(2012-2#1)
that are valid##2##3##(2007-11#1)(2008-11#1)
that are valuable##2##3##(2006-10#1)(2012-2#1)
that are variously##2##3##(1992-3#1)(2013-1#1)
that are very similar to##2##5##(2006-12#1)(2008-1#1)
that are very##9##3##(1995-1#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-11#1)(2010-4#1)
that are virulent##2##3##(2008-10#2)
that are visible on##2##4##(2010-12#1)(2013-1#1)
that are vital for##2##4##(2008-2#1)(2011-1#1)
that are weakly##3##3##(1997-7#1)(2008-2#2)
that are well##4##3##(1991-12#1)(2005-11#1)(2008-3#1)(2010-8#1)
that are widely distributed in##2##5##(2011-12#1)(2012-11#1)
that are widely distributed##3##4##(2009-9#1)(2011-12#1)(2012-11#1)
that are widely used##2##4##(2008-4#1)(2010-11#1)
that are widely##7##3##(1995-12#1)(2008-10#1)(2008-4#1)(2009-9#1)(2010-11#1)(2011-12#1)(2012-11#1)
that are within##3##3##(1995-10#1)(2011-2#1)(2013-1#1)
that are##2701##2##(1990-11#7)(1990-12#9)(1990-2#4)(1990-3#4)(1990-4#2)(1990-5#8)(1990-6#4)(1990-7#4)(1990-8#8)(1990-9#3)(1991-1#3)(1991-10#2)(1991-11#7)(1991-12#9)(1991-2#4)(1991-3#4)(1991-4#2)(1991-5#7)(1991-6#4)(1991-7#4)(1991-8#8)(1991-9#8)(1992-1#4)(1992-10#2)(1992-11#5)(1992-12#11)(1992-2#3)(1992-3#12)(1992-4#2)(1992-5#1)(1992-6#9)(1992-7#4)(1992-8#4)(1992-9#10)(1993-1#1)(1993-10#2)(1993-11#13)(1993-12#15)(1993-2#6)(1993-3#17)(1993-4#2)(1993-5#2)(1993-6#12)(1993-7#2)(1993-8#2)(1993-9#10)(1994-1#4)(1994-11#11)(1994-12#15)(1994-2#10)(1994-3#25)(1994-5#8)(1994-6#6)(1994-8#10)(1994-9#14)(1995-1#17)(1995-10#3)(1995-11#3)(1995-12#8)(1995-2#11)(1995-3#11)(1995-4#1)(1995-5#6)(1995-6#8)(1995-7#2)(1995-8#15)(1995-9#1)(1996-1#4)(1996-10#6)(1996-11#3)(1996-12#6)(1996-2#10)(1996-3#5)(1996-4#8)(1996-5#13)(1996-6#3)(1996-7#11)(1996-8#5)(1996-9#5)(1997-1#5)(1997-2#12)(1997-3#7)(1997-4#13)(1997-5#4)(1997-6#10)(1997-7#18)(1997-8#10)(2004-10#1)(2004-11#1)(2004-12#2)(2004-2#1)(2004-3#1)(2004-4#6)(2004-9#1)(2005-10#10)(2005-11#9)(2005-12#1)(2005-5#6)(2005-6#1)(2005-7#11)(2005-8#12)(2005-9#1)(2006-1#4)(2006-10#64)(2006-11#14)(2006-12#22)(2006-2#6)(2006-3#6)(2006-4#7)(2006-5#7)(2006-6#11)(2006-7#7)(2006-8#7)(2006-9#9)(2007-1#2)(2007-10#9)(2007-11#71)(2007-12#142)(2007-2#8)(2007-3#4)(2007-4#16)(2007-5#8)(2007-6#11)(2007-7#8)(2007-8#27)(2007-9#21)(2008-1#40)(2008-10#145)(2008-11#66)(2008-12#12)(2008-2#117)(2008-3#162)(2008-4#113)(2008-5#49)(2008-6#18)(2008-7#92)(2008-8#44)(2008-9#43)(2009-10#14)(2009-11#7)(2009-12#3)(2009-2#7)(2009-3#12)(2009-4#17)(2009-5#10)(2009-6#11)(2009-7#8)(2009-8#20)(2009-9#15)(2010-1#5)(2010-10#9)(2010-11#16)(2010-12#23)(2010-2#19)(2010-3#9)(2010-4#10)(2010-5#9)(2010-6#15)(2010-7#12)(2010-8#9)(2010-9#6)(2011-1#28)(2011-12#9)(2011-2#61)(2011-3#2)(2011-9#1)(2012-1#18)(2012-11#4)(2012-12#57)(2012-2#42)(2012-3#32)(2012-5#1)(2013-1#71)(2013-3#1)(2013-7#8)(2013-8#31)
that area##9##2##(1994-10#1)(1996-2#1)(1996-4#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#2)
that areas in##2##3##(1993-12#1)(2008-11#1)
that areas of##3##3##(1990-4#1)(1992-1#1)(2007-5#1)
that areas##8##2##(1990-4#1)(1992-1#1)(1993-12#1)(1996-5#1)(1997-8#1)(2007-5#1)(2008-11#1)(2012-1#1)
that arise as a##2##4##(1997-2#1)(2010-12#1)
that arise during##6##3##(1996-4#1)(2006-10#1)(2007-11#1)(2008-10#1)(2009-10#1)(2012-3#1)
that arise from the##3##4##(2007-12#2)(2008-1#1)
that arise from##18##3##(2005-7#1)(2007-12#6)(2007-3#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-3#1)(2009-8#1)(2011-1#1)(2011-2#2)(2013-8#1)
that arise in the##4##4##(1997-6#1)(2007-8#1)(2008-3#1)(2011-2#1)
that arise in##9##3##(1994-2#1)(1995-6#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-3#2)(2008-6#1)(2011-2#1)
that arise when the##2##4##(1992-2#1)(2008-3#1)
that arise when##3##3##(1992-2#1)(2008-3#1)(2012-2#1)
that arise##49##2##(1992-2#1)(1993-1#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-7#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-12#8)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-6#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
that arises from a##2##4##(1992-9#1)(1995-6#1)
that arises from the##3##4##(2007-12#1)(2010-11#1)(2012-2#1)
that arises from##10##3##(1992-9#1)(1995-6#1)(2007-12#3)(2008-2#1)(2008-4#1)(2008-9#1)(2010-11#1)(2012-2#1)
that arises in##4##3##(2007-12#1)(2008-7#1)(2010-4#1)(2011-1#1)
that arises##19##2##(1992-9#1)(1995-6#1)(1996-6#1)(2007-12#4)(2007-5#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#1)
that armodafinil##2##2##(2012-12#2)
that arose from the##2##4##(1995-2#1)(2008-12#1)
that arose in the##2##4##(1997-1#1)(2006-3#1)
that arose in##3##3##(1997-1#1)(2006-11#1)(2006-3#1)
that arose##7##2##(1995-2#1)(1997-1#1)(2006-11#1)(2006-3#1)(2008-12#1)(2009-9#1)(2012-3#1)
that around##4##2##(2007-4#1)(2008-1#1)(2008-11#1)(2013-8#1)
that arrestin##2##2##(1992-5#2)
that arsenate is the main##2##5##(2008-10#2)
that arsenate##3##2##(1995-1#1)(2008-10#2)
that arsenic##3##2##(2008-10#1)(2008-8#1)(2010-2#1)
that arsenite##2##2##(1994-11#1)(2008-10#1)
that arterial##7##2##(1990-5#1)(1995-12#1)(2005-10#1)(2005-12#1)(2006-5#1)(2008-9#1)(2013-7#1)
that article##2##2##(2010-2#1)(2013-1#1)
that articulates##2##2##(2008-11#1)(2011-12#1)
that artificial##4##2##(2008-7#1)(2009-5#1)(2013-1#2)
that as a##5##3##(1993-6#1)(2005-8#1)(2006-12#1)(2007-6#1)(2010-9#1)
that as little as##2##4##(1994-11#1)(1994-2#1)
that as many as##2##4##(2008-1#1)(2008-8#1)
that as much as##4##4##(1993-12#1)(1993-2#1)(1995-2#2)
that as the##7##3##(1992-8#1)(2005-11#1)(2006-8#1)(2009-8#1)(2010-2#1)(2011-2#1)(2013-8#1)
that as##42##2##(1990-11#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-2#2)(1995-4#1)(1995-8#2)(1996-2#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-8#2)
that asbestos##3##2##(1991-12#1)(1995-8#1)(2010-9#1)
that asbestos-induced pleural##2##3##(1991-12#2)
that ascorbic acid##2##3##(1993-12#1)(2008-6#1)
that ascospores##3##2##(2008-10#3)
that asexual##2##2##(2008-5#1)(2013-1#1)
that asparagine##3##2##(1991-4#1)(1994-11#1)(1997-7#1)
that aspartate 63##2##3##(1996-2#2)
that aspartate and##2##3##(1990-2#1)(1995-6#1)
that aspartate##5##2##(1990-2#1)(1995-6#2)(1996-2#2)
that aspect of the##2##4##(1996-3#1)(2010-4#1)
that aspect of##3##3##(1996-3#1)(2007-3#1)(2010-4#1)
that aspects of##2##3##(2007-12#1)(2008-7#1)
that aspirin##3##2##(1991-7#1)(2008-3#1)(2008-8#1)
that assay of##2##3##(1991-3#1)(1993-12#1)
that assay##3##2##(1991-3#1)(1993-12#1)(1995-1#1)
that assays##2##2##(2008-7#1)(2008-9#1)
that assemble##2##2##(1992-1#1)(2009-7#1)
that assembles##4##2##(1995-6#1)(1996-5#1)(2008-4#1)(2010-10#1)
that assess the##2##3##(2006-10#1)(2009-8#1)
that assess##6##2##(1997-2#1)(2006-10#1)(2006-4#1)(2008-10#1)(2009-8#1)(2010-8#1)
that assessed the##4##3##(1994-12#1)(2006-10#1)(2007-9#1)(2012-3#1)
that assessed##11##2##(1994-12#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-10#1)(2009-11#1)(2012-3#2)(2013-1#1)(2013-8#1)
that assesses##4##2##(2008-11#1)(2009-4#1)(2011-2#1)(2013-1#1)
that assessing##2##2##(1997-4#1)(2008-1#1)
that assessment of##4##3##(1992-11#1)(2008-10#1)(2008-12#1)(2011-2#1)
that assessment##6##2##(1992-11#1)(2007-7#1)(2008-10#1)(2008-12#1)(2009-9#1)(2011-2#1)
that assigning##2##2##(2008-7#1)(2008-9#1)
that assist in##2##3##(1994-8#1)(2013-1#1)
that assist##3##2##(1994-2#1)(1994-8#1)(2013-1#1)
that assists##3##2##(2007-2#1)(2008-11#1)(2010-7#1)
that associate##5##2##(1990-6#1)(1996-2#1)(2006-10#1)(2008-1#1)(2010-7#1)
that associated with the##5##4##(1990-7#1)(1993-12#2)(2006-10#1)(2008-2#1)
that associated with##15##3##(1990-7#1)(1991-11#1)(1993-12#3)(1996-3#1)(1997-8#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)
that associated##17##2##(1990-7#1)(1991-11#1)(1993-12#3)(1996-3#1)(1997-8#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)
that associates with the##3##4##(1993-11#1)(1994-12#1)(1995-3#1)
that associates with##6##3##(1993-11#1)(1994-12#1)(1995-3#3)(1996-4#1)
that association of##2##3##(1994-12#1)(2008-10#1)
that association##4##2##(1991-12#1)(1994-12#1)(2008-10#1)(2010-1#1)
that assume##6##2##(2006-10#1)(2007-11#1)(2008-4#2)(2008-8#2)
that assumed##4##2##(1994-11#1)(2008-11#1)(2010-2#2)
that assumes a##3##3##(1992-12#1)(2008-2#1)(2008-3#1)
that assumes##6##2##(1992-12#1)(2007-11#1)(2008-2#1)(2008-3#3)
that astaxanthin production was enhanced by##2##6##(2006-3#2)
that astaxanthin##4##2##(2006-3#2)(2010-10#1)(2013-8#1)
that asthma##3##2##(2005-8#1)(2008-3#1)(2008-7#1)
that astrocytes are##2##3##(1996-12#1)(2007-10#1)
that astrocytes have##2##3##(1993-12#1)(1993-7#1)
that astrocytes##11##2##(1993-12#1)(1993-7#1)(1994-5#1)(1996-11#1)(1996-12#1)(2007-10#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-5#1)(2011-12#1)
that asymmetrical##2##2##(2007-11#1)(2009-2#1)
that asymptomatic HIV##2##3##(1996-11#1)(1996-12#1)
that asymptomatic##6##2##(1996-11#1)(1996-12#1)(2007-10#1)(2007-9#1)(2008-5#2)
that at a concentration of##2##5##(2005-11#1)(2008-5#1)
that at a##8##3##(2005-11#1)(2006-3#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-4#1)
that at age##2##3##(1995-8#1)(2011-1#1)
that at an##4##3##(1994-2#1)(2006-5#1)(2007-12#1)(2009-2#1)
that at any##2##3##(1993-5#1)(2004-9#1)
that at different##2##3##(1994-12#1)(2008-5#1)
that at high##3##3##(2007-12#1)(2008-3#1)(2008-7#1)
that at least 50% of##2##5##(2007-8#1)(2008-9#1)
that at least 7##2##4##(1990-11#1)(1990-9#1)
that at least a part of the##2##7##(1995-10#1)(2007-1#1)
that at least a part of##3##6##(1992-3#1)(1995-10#1)(2007-1#1)
that at least a##6##4##(1991-3#1)(1992-1#1)(1992-3#1)(1995-10#1)(1995-5#1)(2007-1#1)
that at least one of the##2##6##(1991-4#1)(1996-7#1)
that at least one of##3##5##(1991-4#1)(1994-6#1)(1996-7#1)
that at least one##10##4##(1990-9#1)(1991-4#1)(1994-6#1)(1996-7#1)(2004-8#1)(2008-1#1)(2008-6#1)(2008-7#1)(2012-11#1)(2013-1#1)
that at least part of the##3##6##(1990-5#1)(2008-10#2)
that at least part of##4##5##(1990-5#1)(1991-5#1)(2008-10#2)
that at least some of the##7##6##(1990-12#1)(1992-12#1)(1996-7#1)(1997-5#1)(2008-10#1)(2008-2#1)(2008-3#1)
that at least some of##10##5##(1990-12#1)(1992-12#1)(1994-2#1)(1995-4#1)(1996-7#1)(1997-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
that at least some##17##4##(1990-12#1)(1992-12#1)(1994-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-3#1)(1996-7#1)(1997-5#1)(2004-9#1)(2005-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2012-2#1)
that at least the##2##4##(1995-12#1)(1997-7#1)
that at least three of the##2##6##(1991-7#1)(1994-9#1)
that at least three##4##4##(1990-12#1)(1991-7#1)(1994-9#1)(2009-7#1)
that at least two major##2##5##(1991-8#1)(1994-11#1)
that at least two##22##4##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-8#1)(1992-10#2)(1992-11#1)(1992-5#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-4#1)(1996-7#1)(1997-6#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-3#1)
that at least##101##3##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#2)(1990-9#2)(1991-1#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#2)(1995-5#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#3)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-8#1)(2004-9#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-8#3)(2008-1#3)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-8#1)(2012-11#1)(2012-2#1)(2013-1#3)
that at low concentrations##2##4##(1990-11#1)(2006-6#1)
that at low doses##2##4##(2007-3#1)(2010-6#1)
that at low pH##2##4##(1990-8#1)(2008-10#1)
that at low##9##3##(1990-11#1)(1990-2#1)(1990-8#1)(1991-2#1)(2006-6#1)(2007-3#1)(2008-10#1)(2008-7#1)(2010-6#1)
that at pH 6##2##4##(1992-12#1)(1996-7#1)
that at pH##6##3##(1992-12#1)(1995-5#1)(1996-7#1)(2008-10#2)(2011-3#1)
that at physiological##2##3##(1994-5#1)(2013-8#1)
that at present##3##3##(1991-3#1)(1993-9#1)(2011-2#1)
that at the end of##2##5##(2008-7#2)
that at the same time##2##5##(2006-7#1)(2009-5#1)
that at the same##3##4##(2006-7#1)(2008-1#1)(2009-5#1)
that at the##29##3##(1991-5#1)(1993-11#1)(1995-12#1)(1996-9#1)(2005-10#1)(2005-11#3)(2006-7#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-2#1)(2009-5#1)(2010-2#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
that at these##2##3##(1990-6#1)(2011-3#1)
that at this age the##2##5##(1992-10#1)(1992-9#1)
that at this##3##3##(1992-10#1)(1992-9#1)(1994-2#1)
that at##227##2##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#2)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-2#2)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-10#3)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-9#2)(1993-11#1)(1993-3#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-4#2)(1995-5#3)(1995-8#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-6#1)(1996-7#4)(1996-9#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-8#1)(2004-9#2)(2005-10#2)(2005-11#5)(2005-8#1)(2006-10#3)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-5#1)(2007-8#6)(2008-1#4)(2008-10#24)(2008-11#7)(2008-12#1)(2008-2#5)(2008-3#7)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#4)(2009-5#2)(2009-7#1)(2009-8#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#2)(2011-1#1)(2011-2#1)(2011-3#2)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#2)
that atherosclerosis##4##2##(1995-8#1)(1997-8#2)(2008-6#1)
that atmospheric##4##2##(1996-1#1)(2007-11#1)(2007-12#1)(2008-10#1)
that atomic##3##2##(1990-11#1)(2007-12#1)(2008-3#1)
that atrial##4##2##(1993-11#1)(2006-9#1)(2007-8#1)(2008-10#1)
that attachment##2##2##(2008-10#1)(2008-11#1)
that attacks##3##2##(1990-11#1)(2008-10#1)(2013-1#1)
that attempt to##6##3##(1997-1#1)(2005-8#1)(2007-1#1)(2007-6#1)(2008-11#1)(2011-2#1)
that attempts to provide##3##4##(1994-12#1)(1996-8#1)(1997-6#1)
that attempts to##11##3##(1991-1#1)(1994-12#1)(1996-8#1)(1997-6#1)(2006-12#2)(2007-5#1)(2008-3#2)(2008-9#1)(2012-1#1)
that attention is##2##3##(1997-4#1)(2012-12#1)
that attention must##2##3##(2008-1#1)(2008-7#1)
that attention to a stimulus##2##5##(2008-11#1)(2010-5#1)
that attention to##3##3##(2008-11#1)(2008-4#1)(2010-5#1)
that attention##9##2##(1997-4#1)(2008-1#3)(2008-11#1)(2008-4#1)(2008-7#1)(2010-5#1)(2012-12#1)
that attentional##3##2##(1996-2#1)(2006-3#1)(2008-6#1)
that attenuate##2##2##(2008-10#1)(2008-2#1)
that attenuated##3##2##(1990-7#1)(1991-2#1)(1996-8#1)
that attitudes##2##2##(1990-6#1)(2010-10#1)
that attract##3##2##(1993-1#1)(2007-6#1)(2009-3#1)
that atypical##4##2##(1995-4#1)(1996-3#1)(2007-2#1)(2011-2#1)
that auditory##2##2##(1993-9#1)(2006-2#1)
that autism is##2##3##(2009-4#1)(2012-3#1)
that autism##4##2##(2007-8#1)(2009-4#1)(2011-12#1)(2012-3#1)
that autoantibodies directed against##2##4##(1990-5#1)(2007-11#1)
that autoimmunity##2##2##(1997-4#1)(2007-5#1)
that autologous blood donation##2##4##(1996-9#2)
that autologous blood##3##3##(1996-9#3)
that autologous##6##2##(1996-9#4)(2007-9#1)(2012-1#1)
that automatically##7##2##(2008-2#1)(2008-4#1)(2012-3#1)(2013-1#4)
that autophagy is##2##3##(2010-1#1)(2012-3#1)
that autophagy##4##2##(2008-7#1)(2010-1#1)(2012-3#2)
that auxin##3##2##(1993-6#1)(1994-3#1)(2009-8#1)
that available evidence##2##3##(2006-10#1)(2008-8#1)
that available from##2##3##(1992-1#1)(2008-2#1)
that available##7##2##(1992-1#1)(2006-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2012-1#1)(2013-7#1)
that average##9##2##(1993-4#1)(1995-3#1)(2004-4#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-6#1)(2012-12#2)
that averaged##3##2##(1992-2#1)(1993-4#1)(2008-2#1)
that avian##2##2##(2008-9#1)(2013-1#1)
that avoid##4##2##(2006-11#1)(2008-10#1)(2008-4#1)(2012-11#1)
that avoids some of the##2##5##(1997-7#1)(2008-8#1)
that avoids the need for##3##5##(2007-11#1)(2007-7#2)
that avoids the need##4##4##(2007-11#1)(2007-7#2)(2008-4#1)
that avoids the##7##3##(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-4#1)(2008-6#1)
that avoids##16##2##(1996-2#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#2)(2010-7#1)
that await##2##2##(2008-10#1)(2011-2#1)
that awaits##2##2##(2005-9#1)(2010-2#1)
that awareness of##2##3##(2009-8#1)(2012-1#1)
that awareness##4##2##(2005-7#1)(2009-8#1)(2012-1#1)(2013-1#1)
that axial##3##2##(2006-2#1)(2007-1#1)(2008-3#1)
that axillary##3##2##(2004-2#1)(2008-5#2)
that axonal##2##2##(1997-8#1)(2008-7#1)
that axons##3##2##(2008-11#1)(2008-7#1)(2011-2#1)
that axotomy##2##2##(1996-3#1)(2008-4#1)
that bFGF is##3##3##(1991-5#1)(1992-7#1)(1995-10#1)
that bFGF##8##2##(1991-5#1)(1992-3#2)(1992-7#1)(1995-10#1)(1995-12#1)(2007-10#1)(2007-11#1)
that baccalaureate##2##2##(1995-2#1)(2008-11#1)
that back##2##2##(2007-11#1)(2009-8#1)
that bacteria##10##2##(1995-12#1)(2005-12#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-5#3)
that bacterial adherence##2##3##(1990-6#1)(2008-10#1)
that bacterial infection##2##3##(2006-6#1)(2008-7#1)
that bacterial##17##2##(1990-12#1)(1990-6#2)(1991-3#1)(1991-9#1)(1994-8#1)(1997-2#1)(2005-12#1)(2006-10#1)(2006-6#1)(2008-10#2)(2008-5#1)(2008-7#2)(2009-8#1)(2010-5#1)
that baicalein##2##2##(2013-8#2)
that balance the##2##3##(2012-12#1)(2012-3#1)
that balance##4##2##(2005-11#1)(2007-12#1)(2012-12#1)(2012-3#1)
that balances##2##2##(2009-4#1)(2010-11#1)
that balloon##2##2##(1990-8#1)(1996-12#1)
that barrier##2##2##(2008-5#1)(2008-7#1)
that barriers to##2##3##(1991-11#1)(2009-5#1)
that barriers##5##2##(1991-11#1)(2008-1#1)(2009-5#1)(2010-11#1)(2013-1#1)
that basal forebrain##2##3##(1991-1#1)(1996-5#1)
that basal##7##2##(1991-1#1)(1992-5#1)(1995-10#1)(1995-11#1)(1995-12#1)(1996-5#1)(2013-1#1)
that based on##6##3##(1995-9#1)(2007-11#1)(2008-10#1)(2008-9#1)(2012-3#1)(2013-1#1)
that based##7##2##(1995-9#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-9#1)(2012-3#1)(2013-1#1)
that baseline##4##2##(1992-9#1)(1997-8#1)(2008-11#1)(2008-9#1)
that bases##2##2##(1992-7#1)(1997-8#1)
that basic fibroblast growth factor##2##5##(1990-2#1)(1995-12#1)
that basic##6##2##(1990-2#1)(1995-12#1)(2004-9#1)(2007-12#1)(2008-4#1)(2009-1#1)
that bats##2##2##(2007-5#1)(2011-1#1)
that bcl-2##3##2##(1996-10#1)(2008-11#1)(2008-7#1)
that be##3##2##(2006-10#1)(2006-12#1)(2009-9#1)
that bear a##4##3##(1993-8#1)(2007-11#1)(2007-9#1)(2009-12#1)
that bear##9##2##(1993-8#1)(2006-10#1)(2007-11#2)(2007-9#1)(2008-1#1)(2008-9#1)(2009-12#1)(2012-2#1)
that bears##4##2##(1990-11#1)(1997-4#1)(2008-10#1)(2008-9#1)
that became more##2##3##(1990-12#1)(2008-7#1)
that became##16##2##(1990-12#1)(1991-12#1)(1994-2#1)(1994-6#1)(2004-9#1)(2006-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-11#1)
that because of##7##3##(1991-11#1)(1995-6#1)(1996-5#1)(2007-10#1)(2010-1#1)(2010-8#1)(2012-2#1)
that because##13##2##(1991-11#1)(1995-12#1)(1995-6#2)(1996-5#1)(1996-6#1)(1997-5#2)(2007-10#1)(2009-8#1)(2010-1#1)(2010-8#1)(2012-2#1)
that become##9##2##(1992-3#1)(1996-3#1)(2006-10#1)(2007-9#1)(2008-11#1)(2008-3#2)(2008-7#1)(2011-2#1)
that becomes the##2##3##(1993-3#1)(1996-5#1)
that becomes##10##2##(1991-5#1)(1993-3#1)(1994-12#1)(1996-5#1)(1997-8#1)(2008-2#1)(2008-5#1)(2009-4#1)(2011-1#1)(2012-12#1)
that before##8##2##(1995-2#1)(1995-3#1)(1995-5#1)(2008-7#1)(2009-6#1)(2010-3#1)(2013-1#2)
that began in the##3##4##(1995-1#1)(2008-1#1)(2009-4#1)
that began in##4##3##(1995-1#1)(2008-1#1)(2009-4#1)(2011-2#1)
that began with##2##3##(2011-2#1)(2013-1#1)
that began##12##2##(1994-9#1)(1995-1#1)(2008-1#2)(2009-4#1)(2011-1#2)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
that begin to##2##3##(1992-12#1)(1994-2#1)
that begin with##2##3##(1996-8#1)(2010-9#1)
that begin##4##2##(1992-12#1)(1994-2#1)(1996-8#1)(2010-9#1)
that begins at##2##3##(1994-3#1)(2008-6#1)
that begins with##5##3##(2008-11#1)(2010-2#1)(2012-12#3)
that begins##15##2##(1992-9#1)(1994-3#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2010-2#1)(2012-12#5)(2012-2#1)
that behave##2##2##(1994-8#1)(2008-1#1)
that behavior is##2##3##(2006-6#1)(2007-11#1)
that behavior##4##2##(2006-6#1)(2007-11#1)(2007-8#1)(2008-6#1)
that behavioral##7##2##(2007-10#1)(2007-8#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#1)
that behaviors##2##2##(2008-5#1)(2009-7#1)
that behavioural##2##2##(2009-4#1)(2010-8#1)
that being##4##2##(2008-1#2)(2010-7#1)(2013-1#1)
that belief##2##2##(2008-12#1)(2009-4#1)
that belong to the##10##4##(1994-3#1)(1995-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-6#1)(2009-4#1)(2012-12#1)
that belong to##21##3##(1994-3#1)(1995-2#1)(1996-11#1)(1997-7#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#1)(2008-6#1)(2008-9#1)(2009-4#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-3#1)
that belong##22##2##(1994-3#1)(1995-2#1)(1996-11#1)(1997-7#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#1)(2008-6#1)(2008-9#1)(2009-4#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-3#1)
that belonged to##4##3##(2008-10#2)(2008-4#1)(2013-7#1)
that belongs to a##2##4##(1997-4#1)(2011-2#1)
that belongs to the##10##4##(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#2)(1997-2#1)(2008-6#1)(2010-11#1)(2013-8#1)
that belongs to##13##3##(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#2)(1997-2#1)(1997-4#1)(2008-6#1)(2010-10#1)(2010-11#1)(2011-2#1)(2013-8#1)
that below##2##2##(2005-11#1)(2008-7#1)
that benefit both##3##3##(2007-2#1)(2010-10#1)(2010-8#1)
that benefit the##2##3##(2008-11#1)(2011-2#1)
that benefit##8##2##(2007-2#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)
that benefits##3##2##(2006-5#1)(2008-7#1)(2013-8#1)
that besides the##2##3##(2011-2#1)(2012-3#1)
that besides##4##2##(1990-9#1)(2008-9#1)(2011-2#1)(2012-3#1)
that best fits##3##3##(1996-1#2)(2005-4#1)
that best reproduce the##2##4##(1995-6#1)(1997-7#1)
that best##24##2##(1995-6#1)(1996-1#2)(1997-2#1)(1997-3#1)(1997-7#1)(2005-4#1)(2006-11#1)(2007-8#1)(2008-12#3)(2008-2#1)(2008-3#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-6#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
that beta##12##2##(1990-8#1)(1990-9#1)(1991-10#1)(1991-3#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-3#1)(1997-4#1)(1997-6#1)
that beta-CGRP##2##2##(1992-6#2)
that beta-amylase##3##2##(2008-9#3)
that beta-blockers##2##2##(1995-2#1)(1995-6#1)
that beta-carotene##2##2##(1990-5#1)(1993-12#1)
that beta-galactosidase##3##2##(1990-5#2)(2011-2#1)
that betel quid chewing##2##4##(2008-4#2)
that betel##3##2##(2008-1#1)(2008-4#2)
that better##16##2##(2004-11#1)(2006-2#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-9#2)(2008-11#2)(2008-3#1)(2008-9#1)(2010-10#1)(2012-3#1)(2013-8#1)
that between##28##2##(1990-12#2)(1990-3#1)(1990-4#1)(1990-6#1)(1991-2#1)(1992-7#1)(1994-11#1)(1994-2#1)(1996-12#1)(2005-11#1)(2005-12#1)(2007-10#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#3)(2010-1#1)(2010-8#2)(2011-1#1)(2012-12#1)(2012-9#1)(2013-8#1)
that beyond a##2##3##(2007-12#1)(2008-10#1)
that bias##2##2##(2008-8#1)(2009-2#1)
that big##2##2##(2007-4#1)(2007-9#1)
that bilateral##2##2##(1996-1#1)(2007-10#1)
that bilirubin##4##2##(1990-2#2)(1992-3#1)(1992-6#1)
that bimanual##2##2##(1994-3#1)(2007-2#1)
that bind at##2##3##(2010-5#1)(2012-3#1)
that bind specifically to the##3##5##(1994-3#1)(1995-11#1)(1995-6#1)
that bind specifically to##5##4##(1990-8#1)(1994-3#1)(1995-11#1)(1995-6#1)(2008-10#1)
that bind the##5##3##(1990-10#1)(1994-12#1)(1997-4#2)(2008-7#1)
that bind to a##5##4##(1991-10#1)(1992-5#1)(1995-5#1)(2008-1#1)(2008-4#1)
that bind to both##2##4##(2004-2#1)(2008-9#1)
that bind to the same##2##5##(1994-12#1)(1995-5#1)
that bind to the target##2##5##(2007-8#2)
that bind to the##9##4##(1990-12#1)(1992-8#1)(1994-12#1)(1994-3#1)(1995-5#1)(2007-8#2)(2010-1#1)(2013-8#1)
that bind to##35##3##(1990-12#1)(1991-10#1)(1991-3#1)(1992-10#1)(1992-5#2)(1992-8#1)(1993-3#1)(1993-6#2)(1994-12#1)(1994-3#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#1)(1997-7#1)(2004-2#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-4#2)(2008-9#1)(2009-11#1)(2010-1#1)(2013-8#1)
that bind with high affinity to##3##6##(2006-10#1)(2006-12#1)(2008-4#1)
that bind##82##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-8#2)(1991-10#1)(1991-3#1)(1992-10#1)(1992-5#2)(1992-8#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#3)(1994-3#3)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#2)(1996-5#1)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#1)(2004-2#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#4)(2008-4#6)(2008-7#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-5#1)(2012-3#3)(2013-8#2)
that binding of the##5##4##(1993-1#1)(1994-9#1)(1995-8#2)(1997-6#1)
that binding of these##2##4##(1992-12#1)(2007-8#1)
that binding of##23##3##(1990-11#1)(1990-2#1)(1992-10#1)(1992-12#1)(1993-1#1)(1993-11#1)(1994-9#3)(1995-10#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-7#1)(1996-8#1)(1997-6#1)(1997-8#2)(2007-8#1)(2008-3#1)(2010-10#1)
that binding sites for##2##4##(1990-8#1)(1993-3#1)
that binding to##3##3##(1993-6#1)(1994-9#1)(1996-5#1)
that binding##35##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-5#1)(1992-10#1)(1992-12#2)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-9#5)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-6#1)(1997-8#2)(2007-8#1)(2008-3#1)(2008-8#1)(2010-10#1)
that binds ATP##2##3##(1993-8#1)(2008-8#1)
that binds a##2##3##(1991-11#1)(1994-9#1)
that binds both##2##3##(1995-3#1)(2007-12#1)
that binds specifically to the##2##5##(1995-2#1)(2007-11#1)
that binds specifically to##5##4##(1990-11#1)(1990-6#1)(1995-2#1)(2007-11#1)(2008-5#1)
that binds specifically##6##3##(1990-11#1)(1990-6#1)(1995-2#1)(1996-5#1)(2007-11#1)(2008-5#1)
that binds the##2##3##(1996-8#1)(1997-4#1)
that binds to a##3##4##(1991-8#1)(1994-5#1)(2010-3#1)
that binds to the##10##4##(1990-2#1)(1991-10#1)(1992-5#1)(1992-6#1)(1994-12#1)(1994-3#2)(2008-4#1)(2008-5#1)(2009-8#1)
that binds to##29##3##(1990-2#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-8#1)(1992-10#1)(1992-4#2)(1992-5#1)(1992-6#1)(1994-12#1)(1994-3#3)(1994-5#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-7#1)(1996-8#1)(2007-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#1)
that binds##62##2##(1990-11#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#3)(1991-3#1)(1991-4#1)(1991-8#1)(1992-10#1)(1992-4#3)(1992-5#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#4)(1994-5#2)(1994-8#1)(1994-9#1)(1995-2#3)(1995-3#2)(1995-6#2)(1995-8#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#3)(1997-4#1)(1997-5#1)(2005-9#1)(2007-11#2)(2007-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#1)
that biochemical##5##2##(2008-10#1)(2008-11#2)(2008-7#1)(2010-10#1)
that biocompatible##2##2##(2006-10#1)(2009-7#1)
that biocontrol##2##2##(2008-10#2)
that biodegradation##3##2##(2006-10#1)(2008-11#1)(2011-12#1)
that bioelectric or##2##3##(2008-7#2)
that biologic##2##2##(2008-9#1)(2009-6#1)
that biological##3##2##(1994-10#1)(1994-11#1)(1994-6#1)
that biologically##2##2##(1994-8#1)(1996-2#1)
that biology##2##2##(1996-11#1)(2006-7#1)
that biotin efflux##2##3##(2004-11#2)
that biotin##6##2##(1994-3#3)(2004-11#2)(2008-4#1)
that biotinylation by##2##3##(1996-11#2)
that birds##2##2##(2008-5#1)(2008-8#1)
that birth##6##2##(2007-2#4)(2007-6#1)(2012-2#1)
that bisphosphonates##3##2##(2008-6#1)(2008-8#1)(2012-1#1)
that black##5##2##(1995-12#2)(2007-2#1)(2008-10#1)(2013-1#1)
that blastocyst##2##2##(2008-9#2)
that bleaching##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
that block the##7##3##(1995-6#3)(1997-6#1)(2009-8#1)(2012-12#2)
that block##22##2##(1990-4#1)(1991-5#1)(1993-11#1)(1994-9#1)(1995-6#4)(1995-8#1)(1996-10#1)(1996-3#1)(1997-6#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-8#1)(2009-8#1)(2009-9#1)(2012-1#2)(2012-12#2)
that blockade of the##2##4##(1992-5#1)(1996-2#1)
that blockade of##7##3##(1992-5#1)(1994-6#1)(1995-12#1)(1996-2#1)(1997-8#1)(2005-10#1)(2008-2#1)
that blocked##2##2##(1995-12#1)(2007-8#1)
that blocking##6##2##(1994-9#1)(1996-12#1)(2007-7#1)(2009-2#1)(2010-11#1)(2012-12#1)
that blocks the##4##3##(1991-8#1)(1992-9#1)(1993-8#1)(2012-3#1)
that blocks##14##2##(1991-6#1)(1991-8#1)(1992-9#1)(1993-8#1)(1995-1#1)(1997-2#1)(2005-11#1)(2007-3#1)(2008-1#1)(2008-5#1)(2009-8#1)(2010-7#1)(2012-3#2)
that blood banks##2##3##(1995-6#2)
that blood pressure##4##3##(2005-10#1)(2008-1#2)(2013-1#1)
that blood##14##2##(1995-6#2)(1997-3#1)(1997-4#1)(2005-10#1)(2008-1#2)(2008-5#1)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#1)
that boards##3##2##(1991-12#2)(1994-12#1)
that body weight##2##3##(2006-9#1)(2007-12#1)
that body##12##2##(1991-1#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-12#3)(2008-1#1)(2008-5#1)(2008-8#1)(2010-7#1)(2013-7#1)
that bombesin is not the amphibian##2##6##(1991-7#2)
that bombesin##6##2##(1991-5#1)(1991-7#2)(1994-10#1)(1997-7#2)
that bone marrow##3##3##(1991-6#1)(2008-9#1)(2012-12#1)
that bone mineral density##2##4##(2007-11#1)(2010-10#1)
that bone mineral##3##3##(2007-11#1)(2010-10#1)(2011-2#1)
that bone##12##2##(1990-6#1)(1991-6#1)(1993-11#1)(2006-6#1)(2007-11#3)(2008-9#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
that bopindolol##2##2##(1991-9#2)
that border the##2##3##(2008-7#1)(2011-2#1)
that border##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
that borderline##2##2##(2009-10#1)(2010-12#1)
that bore##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
that both CD9 and CD81##2##5##(2012-12#2)
that both a##2##3##(1990-11#1)(1997-6#1)
that both agents##3##3##(1995-10#1)(2009-11#1)(2010-7#1)
that both antibodies##2##3##(1995-6#1)(2008-8#1)
that both are##5##3##(1993-3#1)(1994-12#1)(2006-7#1)(2008-5#1)(2008-7#1)
that both body##2##3##(2008-8#1)(2010-10#1)
that both cases##3##3##(2009-3#1)(2012-2#1)(2013-1#1)
that both converging-diverging and diverging-converging capillaries##2##6##(2005-11#2)
that both drugs##2##3##(2008-5#2)
that both enzymes were##2##4##(2006-8#1)(2008-11#1)
that both enzymes##3##3##(1990-11#1)(2006-8#1)(2008-11#1)
that both females##2##3##(1995-6#1)(2008-8#1)
that both forms of##3##4##(1990-3#1)(1994-11#1)(2011-2#1)
that both forms##5##3##(1990-3#1)(1991-9#1)(1994-11#1)(1995-5#1)(2011-2#1)
that both genes are##3##4##(1990-9#1)(1994-12#1)(2010-3#1)
that both genes were##2##4##(2008-10#2)
that both genes##6##3##(1990-9#1)(1994-12#1)(1997-2#1)(2008-10#2)(2010-3#1)
that both genetic and##2##4##(2008-11#1)(2011-2#1)
that both groups of##4##4##(1997-8#1)(2007-12#1)(2009-11#1)(2009-9#1)
that both groups##5##3##(1997-8#1)(2007-12#1)(2009-11#1)(2009-9#1)(2010-2#1)
that both have##2##3##(2008-11#1)(2008-4#1)
that both human and mouse##2##5##(1995-8#1)(2008-4#1)
that both in##3##3##(1990-11#1)(1991-4#1)(1992-6#1)
that both intermediates##2##3##(1991-7#2)
that both internal##2##3##(1996-2#1)(2008-7#1)
that both ligands##3##3##(1994-5#1)(2007-8#1)(2008-10#1)
that both methods##5##3##(2008-10#3)(2008-2#1)(2008-3#1)
that both molecules##2##3##(1990-2#1)(1993-11#1)
that both mutants##4##3##(1991-4#1)(1992-11#1)(1994-8#1)(1995-8#1)
that both of the##4##4##(1991-8#1)(1993-3#1)(2008-11#1)(2009-8#1)
that both of them##3##4##(1997-4#1)(2008-10#1)(2008-9#1)
that both of these##8##4##(1991-1#1)(1994-9#1)(1995-7#1)(1997-3#1)(2008-10#2)(2008-8#1)(2012-3#1)
that both of##17##3##(1991-1#1)(1991-8#1)(1993-12#1)(1993-3#2)(1994-9#1)(1995-7#1)(1997-3#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-3#1)
that both p53##2##3##(1993-8#1)(1995-6#1)
that both parenting and children's##2##5##(2010-1#2)
that both patients##2##3##(2006-10#1)(2012-3#1)
that both peptides##2##3##(1991-5#1)(2006-12#1)
that both processes##2##3##(1991-4#1)(2007-11#1)
that both proteins##3##3##(1995-6#1)(1996-4#1)(2009-3#1)
that both recombinant##2##3##(1993-8#1)(1994-12#1)
that both sites##2##3##(1992-3#1)(1996-10#1)
that both species are##2##4##(2007-3#1)(2013-7#1)
that both species##3##3##(2007-3#1)(2008-8#1)(2013-7#1)
that both systems are##2##4##(1993-8#1)(2008-11#1)
that both systems##3##3##(1993-8#1)(2007-12#1)(2008-11#1)
that both techniques##2##3##(1991-12#1)(2010-7#1)
that both the number of##2##5##(1990-12#1)(2008-5#1)
that both the##85##3##(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#3)(1991-4#3)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-5#1)(1995-6#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2004-11#1)(2005-11#3)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-10#7)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#2)(2008-9#2)(2009-12#2)(2009-4#1)(2010-11#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-7#1)
that both these##5##3##(1994-10#1)(1996-9#1)(2008-10#1)(2008-5#1)(2010-12#1)
that both treatments##3##3##(1997-5#1)(2008-10#1)(2011-12#1)
that both types of##6##4##(1994-3#1)(1995-8#1)(2007-9#1)(2008-2#1)(2012-1#1)(2012-12#1)
that both were##2##3##(1996-6#1)(2012-3#1)
that both wild-type and##2##4##(1994-11#1)(1994-8#1)
that both##555##2##(1990-10#1)(1990-11#6)(1990-12#3)(1990-2#4)(1990-3#2)(1990-4#3)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#3)(1991-1#6)(1991-10#3)(1991-11#2)(1991-12#9)(1991-2#2)(1991-3#3)(1991-4#7)(1991-5#4)(1991-6#3)(1991-7#4)(1991-8#4)(1991-9#5)(1992-1#4)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#7)(1992-4#3)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#8)(1993-5#1)(1993-6#5)(1993-7#2)(1993-8#4)(1993-9#1)(1994-10#3)(1994-11#4)(1994-12#8)(1994-2#1)(1994-3#3)(1994-5#3)(1994-6#2)(1994-8#6)(1994-9#4)(1995-1#3)(1995-10#5)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#4)(1995-5#7)(1995-6#8)(1995-7#1)(1995-8#6)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#3)(1996-5#3)(1996-6#2)(1996-7#2)(1996-9#3)(1997-1#5)(1997-2#8)(1997-3#3)(1997-4#4)(1997-5#6)(1997-6#5)(1997-7#2)(1997-8#2)(1997-9#1)(2004-11#1)(2004-9#1)(2005-11#8)(2006-10#10)(2006-11#2)(2006-12#6)(2006-3#1)(2006-4#2)(2006-7#1)(2006-8#3)(2007-10#1)(2007-11#5)(2007-12#6)(2007-3#1)(2007-6#1)(2007-8#4)(2007-9#3)(2008-1#1)(2008-10#51)(2008-11#20)(2008-12#1)(2008-2#6)(2008-3#11)(2008-4#7)(2008-5#13)(2008-6#1)(2008-7#8)(2008-8#14)(2008-9#6)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#3)(2009-7#4)(2009-8#5)(2009-9#3)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#3)(2010-7#2)(2010-8#1)(2011-1#2)(2011-10#1)(2011-12#3)(2011-2#3)(2012-1#6)(2012-12#6)(2012-2#7)(2012-3#6)(2013-1#9)(2013-7#4)(2013-8#3)
that bound the##2##3##(1995-9#1)(2008-10#1)
that bound to##2##3##(1996-8#1)(2008-11#1)
that bound##15##2##(1990-11#1)(1992-4#1)(1993-8#1)(1995-2#1)(1995-7#1)(1995-9#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-5#1)(2006-6#1)(2008-10#2)(2008-11#1)(2012-2#1)
that bovine##10##2##(1991-1#1)(1991-6#1)(1992-2#1)(1992-7#1)(1993-12#1)(1994-9#1)(1996-10#1)(1997-2#1)(2006-5#1)(2010-2#1)
that boys##2##2##(1996-6#1)(2013-8#1)
that brain cells##2##3##(1996-9#1)(2007-9#1)
that brain damage##2##3##(1996-5#1)(2010-8#1)
that brain##20##2##(1991-6#1)(1993-4#1)(1995-11#1)(1996-5#1)(1996-9#1)(1997-4#1)(2007-1#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-8#2)
that brain-derived##3##2##(1990-7#1)(1997-2#1)(2008-7#1)
that branch##4##2##(1995-3#1)(2005-11#1)(2007-12#1)(2009-9#1)
that break##2##2##(2008-10#1)(2008-8#1)
that breast cancer is a##2##5##(1990-6#1)(1991-12#1)
that breast cancer is##3##4##(1990-6#1)(1991-12#1)(1995-5#1)
that breast cancer##8##3##(1990-6#1)(1991-12#1)(1992-10#1)(1993-11#1)(1994-12#1)(1995-4#1)(1995-5#1)(2012-12#1)
that breast feeding##3##3##(1994-4#1)(2008-3#2)
that breast##15##2##(1990-10#1)(1990-6#1)(1991-12#1)(1992-10#1)(1992-8#1)(1993-11#1)(1994-12#1)(1994-4#1)(1994-7#1)(1995-4#1)(1995-5#1)(2004-1#1)(2008-3#2)(2012-12#1)
that breastfeeding##3##2##(1991-8#1)(2007-9#1)(2008-10#1)
that breeders##2##2##(2009-2#2)
that breeding##3##2##(2008-10#1)(2008-9#1)(2012-4#1)
that bridge##3##2##(2007-8#1)(2010-5#1)(2013-8#1)
that bridges##2##2##(1997-2#1)(2006-6#1)
that brief##3##2##(1996-9#1)(1997-8#1)(2013-1#1)
that bright##2##2##(1997-6#1)(2008-9#1)
that brings together##2##3##(2008-9#1)(2012-3#1)
that brings##4##2##(1990-5#1)(2008-9#1)(2009-10#1)(2012-3#1)
that broaden##3##2##(1996-6#1)(2008-5#1)(2010-3#1)
that brood amalgamation is##2##4##(2008-9#2)
that brood parasitism##2##3##(2010-8#2)
that brood##4##2##(2008-9#2)(2010-8#2)
that brought together the##2##4##(1997-3#1)(2008-12#1)
that brought##6##2##(1993-7#1)(1997-3#1)(2008-12#1)(2011-12#1)(2011-2#2)
that brown##2##2##(2008-10#2)
that bubbles##2##2##(2008-10#1)(2012-2#1)
that bud##2##2##(1997-3#1)(2009-8#1)
that build##2##2##(1992-9#1)(1994-5#1)
that builds##4##2##(1992-3#1)(2009-4#1)(2009-9#1)(2010-10#1)
that bullying##3##2##(2009-7#3)
that burst##2##2##(1991-5#1)(1996-2#1)
that business##2##2##(1993-3#1)(2007-4#1)
that businesses##2##2##(2006-10#1)(2006-5#1)
that butch women##2##3##(2008-12#2)
that butyrate##2##2##(1991-5#1)(1992-3#1)
that by 2010##2##3##(2010-3#1)(2010-8#1)
that by a##2##3##(1990-3#1)(2008-6#1)
that by applying##2##3##(2008-10#1)(2009-3#1)
that by choosing##2##3##(2008-12#1)(2008-9#1)
that by combining##2##3##(2008-1#1)(2010-4#1)
that by control##3##3##(2008-9#2)(2010-2#1)
that by controls##3##3##(2008-9#3)
that by increasing the##3##4##(1993-11#1)(2005-10#1)(2008-12#1)
that by pursuing##2##3##(2010-2#2)
that by the control groups throughout##5##6##(2008-8#2)(2008-9#3)
that by the##9##3##(1994-9#1)(1997-6#1)(2008-10#1)(2008-8#2)(2008-9#4)
that by use of##2##4##(2008-3#2)
that by using the##4##4##(1995-9#1)(1996-12#1)(2005-11#1)(2007-12#1)
that by using##9##3##(1995-9#1)(1996-12#1)(2005-11#1)(2006-2#1)(2007-10#1)(2007-12#2)(2008-11#1)(2011-1#1)
that by utilizing##2##3##(2007-12#1)(2008-5#1)
that by##102##2##(1990-1#2)(1990-3#1)(1990-4#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1993-11#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-6#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-2#1)(2007-10#2)(2007-11#3)(2007-12#7)(2007-8#3)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#3)(2008-2#4)(2008-3#3)(2008-5#2)(2008-6#1)(2008-8#5)(2008-9#10)(2009-10#1)(2009-12#3)(2009-3#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-2#3)(2010-3#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
that bypass##2##2##(1991-8#1)(1994-12#1)
that bypasses the##2##3##(1994-8#1)(1995-1#1)
that bystander effects##2##3##(2008-7#2)
that bystander##3##2##(2008-7#3)
that c-Abl##2##2##(2012-12#2)
that c-Jun##3##2##(1995-12#1)(1995-2#1)(1996-1#1)
that c-Myc is a##3##4##(2008-11#1)(2008-8#2)
that c-fos##4##2##(1994-8#1)(1995-12#1)(1996-12#1)(1996-9#1)
that c-myc##3##2##(1991-10#1)(1993-11#1)(2008-11#1)
that c-src##2##2##(1994-3#2)
that cAMP may##2##3##(1994-11#1)(1994-6#1)
that cAMP plays a##2##4##(1991-2#1)(1994-11#1)
that cAMP##10##2##(1991-2#2)(1991-3#1)(1994-10#1)(1994-11#2)(1994-6#3)(1996-1#1)
that cDNA##2##2##(1994-6#1)(1997-4#1)
that cN-II##2##2##(2008-4#2)
that cPLA2##2##2##(1992-2#1)(1992-5#1)
that cadmium##3##2##(1991-5#1)(1993-4#1)(1996-7#1)
that caffeine triggers##2##3##(2009-3#2)
that caffeine##6##2##(2008-5#2)(2009-3#2)(2012-12#2)
that calcineurin is##2##3##(1991-9#1)(1992-8#1)
that calcitonin gene-related peptide##2##4##(1992-6#1)(2008-4#1)
that calcitonin##6##2##(1991-9#1)(1992-6#1)(1993-11#1)(2006-12#1)(2008-4#1)(2012-12#1)
that calcium binding##2##3##(1991-7#1)(2013-8#1)
that calcium channel blockers##3##4##(1991-11#1)(1996-9#1)(2010-5#1)
that calcium influx##3##3##(1990-2#1)(1994-11#1)(1994-9#1)
that calcium ions##2##3##(1991-11#1)(2009-12#1)
that calcium is involved in##2##5##(1991-8#1)(1995-7#1)
that calcium##26##2##(1990-10#1)(1990-2#1)(1990-4#1)(1991-11#2)(1991-7#1)(1991-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-7#1)(1996-9#1)(1997-1#1)(2005-3#2)(2007-8#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-5#1)(2013-1#2)(2013-8#1)
that calculated from the##2##4##(1990-8#1)(2008-12#1)
that calculated from##4##3##(1990-8#1)(2008-10#1)(2008-12#1)(2008-3#1)
that calculated##8##2##(1990-8#1)(1995-10#1)(2005-11#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)
that calculates the risk of breast disease based on mammography findings##2##11##(2013-1#2)
that calculates the##4##3##(2007-11#1)(2008-3#1)(2013-1#2)
that calculates##5##2##(1992-7#1)(2007-11#1)(2008-3#1)(2013-1#2)
that calf thymus##2##3##(1990-7#1)(2008-10#1)
that calf##3##2##(1990-7#1)(1997-6#1)(2008-10#1)
that call for##3##3##(1995-9#1)(2008-1#1)(2008-12#1)
that calmodulin proteinase##2##3##(1991-8#2)
that calmodulin##7##2##(1990-3#1)(1990-9#1)(1991-8#2)(1992-12#1)(1992-7#1)(1995-1#1)
that calpain##4##2##(1992-6#1)(1996-3#3)
that calponin##2##2##(1992-5#1)(1995-5#1)
that calsequestrin##2##2##(1994-3#1)(2006-10#1)
that came##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
that can accompany##3##3##(1990-9#1)(2012-2#1)(2013-1#1)
that can accomplish##2##3##(2006-12#1)(2008-7#1)
that can account for the##2##5##(1993-8#1)(2010-4#1)
that can account for##3##4##(1993-8#1)(2005-8#1)(2010-4#1)
that can accurately##2##3##(2007-9#1)(2008-4#1)
that can act as a##2##5##(2008-11#1)(2009-8#1)
that can act as##5##4##(1993-4#1)(2008-11#1)(2008-2#1)(2009-8#1)(2010-7#1)
that can address##3##3##(2010-2#1)(2012-3#2)
that can affect the quality##2##5##(2008-7#1)(2011-2#1)
that can affect the##6##4##(1991-2#1)(1993-11#1)(2008-7#1)(2010-9#1)(2011-2#1)(2013-1#1)
that can affect##14##3##(1990-12#1)(1991-2#1)(1993-11#1)(1997-2#1)(2007-9#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-6#1)(2010-6#1)(2010-9#1)(2011-2#2)(2013-1#1)
that can aid##2##3##(2010-12#1)(2012-2#1)
that can also##4##3##(2007-7#1)(2008-2#1)(2009-10#1)(2012-2#1)
that can alter the##2##4##(2010-7#1)(2011-2#1)
that can always##2##3##(2008-2#1)(2008-7#1)
that can arise in##2##4##(2008-3#1)(2010-12#1)
that can arise with##2##4##(1991-3#1)(2013-1#1)
that can arise##6##3##(1990-8#1)(1991-3#1)(2008-1#1)(2008-3#1)(2010-12#1)(2013-1#1)
that can assist##7##3##(1996-12#1)(1996-2#1)(2006-11#1)(2006-12#1)(2006-3#1)(2008-12#1)(2013-8#1)
that can associate with the##2##5##(1995-6#1)(2012-1#1)
that can associate with##3##4##(1991-5#1)(1995-6#1)(2012-1#1)
that can automatically##2##3##(2006-2#2)
that can be a##3##4##(2008-1#1)(2008-3#1)(2012-12#1)
that can be achieved by##3##5##(2007-4#1)(2008-2#1)(2009-3#1)
that can be achieved using##2##5##(2008-1#1)(2009-8#1)
that can be achieved##9##4##(1992-8#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-2#2)(2009-3#1)(2009-8#1)
that can be acquired##2##4##(2007-3#1)(2008-10#1)
that can be adapted to##3##5##(1996-1#1)(2007-12#1)(2008-11#1)
that can be adapted##4##4##(1996-1#1)(2006-5#1)(2007-12#1)(2008-11#1)
that can be addressed##4##4##(2006-5#1)(2008-10#1)(2010-2#1)(2010-3#1)
that can be administered##2##4##(2007-8#1)(2010-4#1)
that can be adopted##2##4##(2008-10#1)(2008-12#1)
that can be affected##2##4##(1997-4#1)(2008-2#1)
that can be analyzed##4##4##(2007-11#1)(2008-7#1)(2008-9#1)(2010-5#1)
that can be applied for##2##5##(1994-8#1)(2008-2#1)
that can be applied in##2##5##(2008-5#1)(2009-8#1)
that can be applied to a##2##6##(2006-8#1)(2008-7#1)
that can be applied to the##2##6##(2008-12#1)(2008-3#1)
that can be applied to##14##5##(2006-8#1)(2007-1#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-7#3)(2008-9#1)
that can be applied##24##4##(1994-8#1)(2006-8#1)(2007-1#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#4)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#1)
that can be associated with##3##5##(2007-12#1)(2007-2#1)(2010-12#1)
that can be attributed to##2##5##(2008-4#1)(2012-9#1)
that can be carried out##3##5##(2006-12#1)(2008-10#1)(2012-2#1)
that can be carried##4##4##(2006-12#1)(2008-10#1)(2009-12#1)(2012-2#1)
that can be caused by##3##5##(2006-8#1)(2011-2#1)(2012-1#1)
that can be caused##4##4##(1993-2#1)(2006-8#1)(2011-2#1)(2012-1#1)
that can be characterized as a##2##6##(1993-3#1)(2009-10#1)
that can be characterized##3##4##(1993-3#1)(2009-10#1)(2011-12#1)
that can be clearly##2##4##(2008-10#1)(2012-2#1)
that can be combined##2##4##(2008-2#1)(2008-7#1)
that can be compared##2##4##(2012-2#1)(2013-1#1)
that can be considered##2##4##(2008-11#1)(2008-5#1)
that can be controlled##3##4##(1994-2#1)(2008-11#1)(2008-2#1)
that can be converted##2##4##(2006-10#1)(2008-10#1)
that can be coupled with a substance##2##7##(2008-4#1)(2008-9#1)
that can be coupled##5##4##(2008-2#1)(2008-4#3)(2008-9#1)
that can be demonstrated##2##4##(1996-5#1)(2012-2#1)
that can be derived from the##2##6##(2008-2#2)
that can be derived from##4##5##(1992-12#1)(2008-2#2)(2008-4#1)
that can be derived##7##4##(1992-12#1)(2006-11#1)(2008-2#2)(2008-4#1)(2013-1#2)
that can be described by##4##5##(1991-3#1)(2008-10#1)(2008-2#1)(2013-1#1)
that can be described##5##4##(1991-3#1)(2007-10#1)(2008-10#1)(2008-2#1)(2013-1#1)
that can be detected by##2##5##(1993-9#1)(2006-9#1)
that can be detected early##2##5##(2011-12#1)(2011-2#1)
that can be detected##8##4##(1993-9#1)(2006-9#1)(2008-10#2)(2008-4#1)(2008-5#1)(2011-12#1)(2011-2#1)
that can be developed##3##4##(1995-1#1)(2008-10#1)(2011-1#1)
that can be diagnosed##2##4##(2009-1#1)(2011-1#1)
that can be differentially##2##4##(1991-2#1)(1993-3#1)
that can be difficult to##2##5##(2010-12#1)(2010-5#1)
that can be directly##5##4##(1994-4#1)(2006-8#1)(2012-12#1)(2013-1#2)
that can be distinguished by their##2##6##(1991-11#1)(2007-8#1)
that can be done##2##4##(2008-9#1)(2011-1#1)
that can be drawn from##4##5##(1990-7#1)(2008-12#2)(2008-6#1)
that can be drawn##5##4##(1990-7#1)(2008-10#1)(2008-12#2)(2008-6#1)
that can be easily integrated##2##5##(2008-11#1)(2008-2#1)
that can be easily##12##4##(1994-3#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2012-3#1)(2013-1#2)
that can be employed to##2##5##(2007-11#1)(2008-5#1)
that can be employed##4##4##(2007-11#1)(2008-3#1)(2008-4#1)(2008-5#1)
that can be enhanced##2##4##(1995-1#1)(2008-10#1)
that can be established##2##4##(1990-11#1)(2008-2#1)
that can be evaluated##2##4##(2008-3#1)(2012-3#1)
that can be expected##3##4##(2007-12#1)(2007-9#1)(2008-10#1)
that can be explained by##2##5##(2008-10#2)
that can be explained##3##4##(2006-4#1)(2008-10#2)
that can be exploited##2##4##(2008-10#1)(2008-4#1)
that can be extended##3##4##(1994-11#1)(1997-4#1)(2008-3#1)
that can be formed##2##4##(2008-7#2)
that can be found in##6##5##(1995-8#1)(2008-10#3)(2009-5#1)(2011-2#1)
that can be found##7##4##(1995-8#1)(2008-10#3)(2009-5#1)(2011-2#1)(2012-3#1)
that can be further##2##4##(1991-11#1)(2006-10#1)
that can be given##4##4##(1991-8#1)(2006-10#1)(2008-6#1)(2013-8#1)
that can be imaged##2##4##(2008-1#1)(2008-3#1)
that can be implemented by##2##5##(2007-10#1)(2009-3#1)
that can be implemented in##3##5##(2006-7#1)(2007-10#1)(2008-4#1)
that can be implemented##9##4##(1991-12#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-12#1)(2008-4#1)(2009-3#1)(2010-9#1)
that can be important##2##4##(2010-8#1)(2012-2#1)
that can be incorporated into the##2##6##(2009-5#1)(2010-7#1)
that can be incorporated into##4##5##(2004-3#1)(2008-10#1)(2009-5#1)(2010-7#1)
that can be induced##2##4##(1995-12#1)(2008-9#1)
that can be inferred##2##4##(2009-3#1)(2012-2#1)
that can be inserted##2##4##(2006-10#1)(2007-12#1)
that can be integrated##2##4##(2008-3#1)(2008-7#1)
that can be introduced##3##4##(1992-1#1)(1993-3#1)(1993-8#1)
that can be isolated from##4##5##(1997-7#1)(2008-9#2)(2010-6#1)
that can be made##4##4##(1991-1#1)(1997-4#1)(2008-3#1)(2008-4#1)
that can be managed##2##4##(2006-1#1)(2008-10#1)
that can be manipulated##3##4##(2006-12#1)(2006-2#1)(2006-6#1)
that can be measured##5##4##(2008-3#1)(2008-4#1)(2008-9#1)(2010-5#1)(2010-6#1)
that can be modeled##2##4##(2008-3#1)(2009-10#1)
that can be monitored by##3##5##(2008-10#1)(2008-2#1)(2008-4#1)
that can be monitored##4##4##(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)
that can be observed##4##4##(2008-10#1)(2008-2#1)(2008-9#1)(2010-4#1)
that can be obtained from##2##5##(2011-1#1)(2011-2#1)
that can be obtained##9##4##(1995-6#1)(2006-4#1)(2007-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2011-1#1)(2011-2#1)
that can be of##7##4##(1990-8#1)(2007-12#1)(2008-11#1)(2008-4#3)(2008-9#1)
that can be performed to##2##5##(2008-11#1)(2008-4#1)
that can be performed##7##4##(2007-1#1)(2008-1#1)(2008-11#1)(2008-4#3)(2012-2#1)
that can be prepared##2##4##(1991-11#1)(2008-11#1)
that can be processed##2##4##(2005-8#1)(2012-2#1)
that can be quantified##2##4##(2008-10#1)(2012-2#1)
that can be reached by##2##5##(2005-4#1)(2008-3#1)
that can be readily##5##4##(1994-2#1)(2007-12#1)(2008-1#1)(2008-7#1)(2008-8#1)
that can be realized##2##4##(1994-12#1)(2007-12#1)
that can be recognized by##2##5##(1994-11#1)(1996-12#1)
that can be recognized##3##4##(1994-11#1)(1996-12#1)(2006-2#1)
that can be related to##3##5##(2008-10#1)(2013-1#2)
that can be retrieved##3##4##(1991-9#1)(2008-4#2)
that can be safely##4##4##(2006-1#1)(2007-10#1)(2007-8#1)(2008-5#1)
that can be seen##2##4##(1992-12#1)(2008-3#1)
that can be separated by##2##5##(1993-12#1)(2008-10#1)
that can be stored##2##4##(2008-2#2)
that can be successfully##2##4##(1997-8#1)(2008-9#1)
that can be tailored##2##4##(2008-10#1)(2008-7#1)
that can be taken to##2##5##(2008-9#1)(2010-2#1)
that can be taken##3##4##(2008-9#1)(2010-2#1)(2012-2#1)
that can be tested##3##4##(1992-5#1)(2008-10#1)(2008-8#1)
that can be translated##2##4##(1990-8#1)(2008-8#1)
that can be treated effectively##2##5##(2006-2#1)(2013-1#1)
that can be used as a##5##6##(1997-8#1)(2008-10#2)(2008-2#1)(2008-4#1)
that can be used as##12##5##(1991-7#1)(1992-12#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-4#2)(2009-12#1)(2012-2#1)(2013-8#1)
that can be used by##10##5##(1991-1#1)(1992-3#1)(2005-12#1)(2006-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-12#1)
that can be used during##2##5##(2007-8#1)(2008-10#1)
that can be used for both transient and stable transfections##3##10##(2008-1#1)(2008-2#1)(2008-4#1)
that can be used for the##7##6##(1990-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)
that can be used for##42##5##(1990-3#1)(1996-12#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#10)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-11#1)(2013-7#1)
that can be used freely suspended in solution to##2##9##(2008-10#2)
that can be used in a##2##6##(2005-7#1)(2008-4#1)
that can be used in the##5##6##(2008-4#1)(2009-2#1)(2010-10#1)(2012-12#2)
that can be used in##27##5##(1990-3#1)(2005-7#1)(2006-10#2)(2007-8#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-8#1)(2008-9#1)(2009-1#1)(2009-2#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-12#1)(2012-12#3)(2013-1#2)
that can be used on a large##2##7##(1997-3#1)(2008-2#1)
that can be used to analyze##2##6##(1996-2#1)(2008-4#1)
that can be used to characterize the##2##7##(2009-3#1)(2010-5#1)
that can be used to construct##2##6##(2008-2#1)(2012-1#1)
that can be used to derive##2##6##(2008-2#1)(2008-9#1)
that can be used to describe##3##6##(2008-2#1)(2008-7#1)(2010-12#1)
that can be used to determine the##3##7##(2007-8#1)(2008-2#1)(2008-4#1)
that can be used to determine##5##6##(2007-8#2)(2008-2#1)(2008-3#1)(2008-4#1)
that can be used to discriminate##2##6##(2008-7#1)(2012-1#1)
that can be used to distinguish##3##6##(2008-10#1)(2011-1#1)(2013-8#1)
that can be used to estimate the potential risk##2##9##(2008-10#2)
that can be used to evaluate##2##6##(2006-11#1)(2008-4#1)
that can be used to gain##2##6##(1995-11#1)(2008-4#1)
that can be used to generate##2##6##(1990-11#1)(2007-12#1)
that can be used to identify##2##6##(2008-4#1)(2011-2#1)
that can be used to improve the##5##7##(2006-1#1)(2007-12#1)(2008-3#2)(2012-2#1)
that can be used to improve##6##6##(1997-3#1)(2006-1#1)(2007-12#1)(2008-3#2)(2012-2#1)
that can be used to include##2##6##(2012-3#1)(2013-7#1)
that can be used to inform##3##6##(1996-1#1)(2012-12#2)
that can be used to measure the##2##7##(2008-2#1)(2008-4#1)
that can be used to measure##6##6##(2005-11#1)(2008-2#1)(2008-4#4)
that can be used to monitor##2##6##(1994-11#1)(1996-5#1)
that can be used to optimize the##2##7##(2008-2#1)(2008-3#1)
that can be used to study##2##6##(2008-4#1)(2008-9#1)
that can be used to treat##4##6##(2006-7#1)(2007-11#1)(2007-8#1)(2011-2#1)
that can be used to##114##5##(1990-11#1)(1991-2#1)(1994-11#1)(1995-11#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(2005-11#1)(2005-7#1)(2006-1#2)(2006-11#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-11#4)(2007-12#3)(2007-5#1)(2007-8#4)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#9)(2008-3#7)(2008-4#19)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#4)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#3)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
that can be used with##2##5##(2008-3#1)(2013-1#1)
that can be used##228##4##(1990-11#1)(1990-3#2)(1991-1#1)(1991-2#1)(1991-7#1)(1992-12#1)(1992-3#1)(1994-11#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#2)(1997-4#1)(1997-8#2)(2004-10#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#3)(2006-1#2)(2006-10#4)(2006-11#1)(2006-12#2)(2006-6#1)(2006-7#1)(2007-11#6)(2007-12#9)(2007-5#1)(2007-8#7)(2007-9#1)(2008-1#2)(2008-10#12)(2008-11#2)(2008-12#3)(2008-2#16)(2008-3#12)(2008-4#39)(2008-5#1)(2008-7#4)(2008-8#4)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#4)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#5)(2012-1#3)(2012-11#3)(2012-12#7)(2012-2#4)(2012-3#1)(2013-1#9)(2013-7#2)(2013-8#2)
that can be useful in##3##5##(1996-12#1)(2008-10#1)(2009-3#1)
that can be useful##4##4##(1996-12#1)(2008-10#1)(2009-3#1)(2013-8#1)
that can be utilized for##3##5##(1994-11#1)(2008-2#1)(2012-2#1)
that can be utilized to##3##5##(2006-12#1)(2008-9#1)(2012-12#1)
that can be utilized##7##4##(1994-11#1)(2006-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2012-12#1)(2012-2#1)
that can be viewed as a##2##6##(1997-8#1)(2010-12#1)
that can be visualized##2##4##(1993-4#1)(1997-4#1)
that can be written as a sum of##2##8##(2008-2#1)(2013-1#1)
that can be##719##3##(1990-11#2)(1990-12#1)(1990-3#2)(1990-7#1)(1990-8#2)(1991-1#2)(1991-11#3)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#5)(1992-2#1)(1992-3#1)(1992-5#2)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-3#3)(1993-4#2)(1993-8#1)(1993-9#2)(1994-11#4)(1994-12#2)(1994-2#2)(1994-3#2)(1994-4#1)(1994-8#3)(1995-1#3)(1995-11#2)(1995-12#3)(1995-3#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#3)(1996-12#5)(1996-2#2)(1996-5#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#5)(1997-5#1)(1997-7#2)(1997-8#4)(2004-10#1)(2004-11#1)(2004-12#1)(2004-3#1)(2005-10#4)(2005-11#1)(2005-12#1)(2005-4#1)(2005-7#3)(2005-8#1)(2006-1#4)(2006-10#10)(2006-11#3)(2006-12#8)(2006-2#5)(2006-4#3)(2006-5#3)(2006-6#4)(2006-7#2)(2006-8#4)(2006-9#1)(2007-1#4)(2007-10#5)(2007-11#12)(2007-12#31)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#12)(2007-9#3)(2008-1#14)(2008-10#56)(2008-11#12)(2008-12#10)(2008-2#42)(2008-3#34)(2008-4#68)(2008-5#10)(2008-6#2)(2008-7#21)(2008-8#10)(2008-9#23)(2009-1#2)(2009-10#3)(2009-11#3)(2009-12#3)(2009-2#2)(2009-3#7)(2009-4#2)(2009-5#2)(2009-6#3)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#12)(2010-2#3)(2010-3#2)(2010-4#3)(2010-5#5)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#10)(2011-12#5)(2011-2#14)(2012-1#6)(2012-11#3)(2012-12#12)(2012-2#17)(2012-3#6)(2012-9#1)(2013-1#26)(2013-7#2)(2013-8#4)
that can become##2##3##(2008-11#1)(2013-7#1)
that can benefit from such##2##5##(1997-6#1)(2013-8#1)
that can benefit from##3##4##(1994-3#1)(1997-6#1)(2013-8#1)
that can bind to the##2##5##(2008-10#1)(2008-4#1)
that can bind to##3##4##(2008-10#2)(2008-4#1)
that can bind##5##3##(1997-2#1)(2008-10#2)(2008-4#1)(2009-12#1)
that can block the##2##4##(1996-5#1)(2009-8#1)
that can both##2##3##(2006-7#1)(2008-4#1)
that can cause severe##2##4##(1996-11#1)(2007-8#1)
that can cause##17##3##(1996-11#1)(1997-4#1)(2006-2#2)(2007-1#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-2#1)(2011-2#2)(2012-12#2)(2012-2#2)
that can complicate the##2##4##(2007-7#1)(2013-1#1)
that can contribute to the##2##5##(1992-4#1)(1995-1#1)
that can contribute to##4##4##(1992-4#1)(1995-1#1)(2007-6#1)(2012-2#1)
that can contribute##6##3##(1992-4#1)(1995-1#1)(2007-6#1)(2007-8#1)(2012-2#1)(2012-3#1)
that can create an##2##4##(1994-12#1)(2010-8#1)
that can create##3##3##(1994-12#1)(2008-3#1)(2010-8#1)
that can decrease##3##3##(2004-9#1)(2006-10#1)(2009-9#1)
that can degrade##3##3##(2006-10#1)(2008-10#1)(2011-2#1)
that can deliver##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
that can develop##3##3##(2007-11#1)(2011-2#1)(2012-2#1)
that can differentiate##2##3##(2012-12#1)(2013-1#1)
that can discriminate##2##3##(1995-1#1)(2007-12#1)
that can distinguish##4##3##(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)
that can drive##2##3##(1995-1#1)(2013-1#1)
that can dynamically##2##3##(2008-12#1)(2013-7#1)
that can easily be##3##4##(1996-2#1)(2008-5#1)(2010-1#1)
that can easily##5##3##(1996-2#1)(2007-12#1)(2008-5#1)(2010-1#1)(2012-3#1)
that can effectively##2##3##(2007-6#1)(2010-2#1)
that can elicit##2##3##(2011-1#1)(2012-12#1)
that can enhance##2##3##(1996-3#1)(2008-5#1)
that can evolve##2##3##(2008-7#1)(2009-12#1)
that can explain the##2##4##(1991-9#1)(1994-3#1)
that can explain##4##3##(1991-9#1)(1994-3#1)(2007-1#1)(2013-1#1)
that can extract the##2##4##(1996-1#1)(2007-12#1)
that can facilitate the##2##4##(1997-2#1)(2008-12#1)
that can facilitate##3##3##(1997-2#1)(2008-12#1)(2008-4#1)
that can function##3##3##(2008-7#1)(2012-12#2)
that can generate##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)
that can give##2##3##(2004-3#1)(2011-2#1)
that can greatly##3##3##(2006-10#1)(2007-12#1)(2008-10#1)
that can handle##3##3##(2012-2#2)(2012-3#1)
that can have profound effects on the##2##7##(2010-2#1)(2012-1#1)
that can have##6##3##(1990-10#1)(2006-10#1)(2008-3#1)(2010-2#1)(2012-1#1)(2013-1#1)
that can help identify##3##4##(2011-2#1)(2013-1#2)
that can help to##3##4##(2008-12#1)(2008-4#1)(2010-12#1)
that can help##25##3##(1993-2#1)(1994-1#1)(1995-1#1)(1996-12#1)(1997-2#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
that can identify##3##3##(1997-8#1)(2008-10#1)(2011-1#1)
that can impact##3##3##(2010-10#1)(2011-2#1)(2012-12#1)
that can improve the##5##4##(2008-7#1)(2008-9#1)(2009-8#1)(2010-4#2)
that can improve##11##3##(1995-3#1)(2006-8#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-4#2)(2011-12#1)(2012-12#1)(2013-1#2)
that can increase##3##3##(2008-5#1)(2008-7#1)(2009-8#1)
that can induce##5##3##(1996-10#1)(2007-11#1)(2008-10#2)(2010-12#1)
that can influence the##4##4##(1996-3#1)(2008-10#1)(2008-4#1)(2008-9#1)
that can influence##12##3##(1992-7#1)(1993-10#1)(1996-3#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-1#1)(2011-1#1)(2012-2#1)
that can inform##2##3##(2007-12#1)(2011-12#1)
that can inhibit##3##3##(1992-3#1)(2007-6#1)(2010-2#1)
that can interact with##3##4##(1992-12#1)(2008-2#1)(2008-9#1)
that can interfere with##2##4##(1993-3#1)(2010-11#1)
that can interpret##2##3##(2011-1#1)(2012-3#1)
that can involve##4##3##(2006-10#1)(2007-7#1)(2010-7#1)(2013-8#1)
that can lead to increased##2##5##(2008-8#1)(2010-11#1)
that can lead to serious##2##5##(2008-10#1)(2013-1#1)
that can lead to the##4##5##(1996-5#1)(2006-6#1)(2008-5#1)(2012-1#1)
that can lead to##29##4##(1991-6#1)(1992-1#1)(1996-5#1)(1997-4#1)(2006-10#2)(2006-6#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#3)(2008-8#3)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-10#1)(2012-2#2)(2013-1#1)
that can limit##2##3##(2007-11#1)(2009-8#1)
that can maintain##3##3##(2008-5#1)(2008-8#1)(2009-6#1)
that can make##3##3##(2006-6#1)(2012-2#1)(2013-1#1)
that can manifest##2##3##(2008-12#1)(2012-3#1)
that can measure the##3##4##(1991-9#1)(2007-12#1)(2008-2#1)
that can measure##7##3##(1991-9#1)(2007-12#2)(2008-2#1)(2008-6#1)(2012-12#1)(2013-7#1)
that can mediate the##2##4##(1996-11#1)(1996-2#1)
that can mediate##3##3##(1996-11#1)(1996-2#1)(2008-4#1)
that can meet##2##3##(1996-3#1)(2008-10#1)
that can mimic##3##3##(2006-10#1)(2008-10#1)(2012-2#1)
that can minimize##2##3##(2010-12#1)(2010-2#1)
that can modulate##4##3##(1995-3#1)(2005-10#1)(2008-4#1)(2010-2#1)
that can monitor##2##3##(2008-10#1)(2008-2#1)
that can now be##2##4##(2006-10#1)(2007-11#1)
that can now##3##3##(2006-10#1)(2007-11#1)(2010-12#1)
that can obscure the##2##4##(1995-12#1)(2008-2#1)
that can occur and##2##4##(2006-10#1)(2011-2#1)
that can occur during##2##4##(2007-11#1)(2007-12#1)
that can occur in the##3##5##(2006-10#1)(2008-2#1)(2010-9#1)
that can occur in##7##4##(1991-3#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-9#1)
that can occur with##2##4##(2007-10#1)(2009-6#1)
that can occur##18##3##(1991-3#1)(2005-8#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-9#1)(2011-2#1)
that can only be##4##4##(1995-6#1)(2008-11#1)(2009-2#1)(2010-6#1)
that can only partially be##2##5##(2006-7#1)(2009-10#1)
that can only##7##3##(1995-6#1)(2006-7#1)(2008-11#2)(2009-10#1)(2009-2#1)(2010-6#1)
that can operate##2##3##(2007-12#1)(2010-7#1)
that can optimize##2##3##(2007-12#2)
that can overcome##2##3##(1992-1#1)(2011-1#1)
that can perform##4##3##(2006-12#1)(2007-9#1)(2008-10#1)(2008-7#1)
that can potentially##2##3##(2007-3#1)(2008-9#1)
that can predict##5##3##(2008-3#1)(2008-7#1)(2008-8#1)(2013-1#2)
that can present##3##3##(2005-7#1)(2012-11#1)(2012-3#1)
that can prevent##4##3##(2008-11#1)(2010-12#1)(2011-2#1)(2013-8#1)
that can produce a##3##4##(2008-2#1)(2008-3#1)(2012-12#1)
that can produce##8##3##(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
that can protect against##2##4##(2006-10#1)(2008-7#1)
that can protect the##3##4##(1994-2#1)(2008-11#1)(2008-7#1)
that can protect##6##3##(1994-2#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-7#2)
that can provide##14##3##(1990-5#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
that can reach##4##3##(2006-10#1)(2006-12#1)(2006-5#1)(2008-7#1)
that can readily be##2##4##(2008-10#1)(2011-1#1)
that can recognize the##2##4##(2008-2#1)(2012-3#1)
that can recognize##4##3##(1992-4#1)(1992-5#1)(2008-2#1)(2012-3#1)
that can reduce##2##3##(2006-10#1)(2008-5#1)
that can regulate##3##3##(2007-2#1)(2008-12#1)(2010-4#1)
that can reliably##2##3##(2008-2#1)(2008-6#1)
that can replace##2##3##(1994-1#1)(2007-11#1)
that can reproduce##2##3##(2007-4#1)(2008-6#1)
that can resolve##2##3##(2008-12#1)(2008-3#1)
that can result from##3##4##(2006-10#1)(2008-8#1)(2013-8#1)
that can result in##9##4##(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#2)(2010-12#1)(2011-2#2)
that can result##12##3##(2006-10#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#3)(2010-12#1)(2011-2#2)(2013-8#1)
that can reverse##2##3##(2007-9#1)(2008-1#1)
that can safely##2##3##(2006-5#1)(2012-2#1)
that can save##2##3##(2010-9#1)(2013-1#1)
that can serve as##5##4##(1992-3#1)(2008-11#1)(2009-3#1)(2010-9#1)(2012-1#1)
that can serve to##2##4##(1996-12#1)(1997-6#1)
that can serve##7##3##(1992-3#1)(1996-12#1)(1997-6#1)(2008-11#1)(2009-3#1)(2010-9#1)(2012-1#1)
that can significantly##3##3##(2008-3#1)(2012-1#1)(2013-7#1)
that can simulate##2##3##(2006-11#1)(2007-12#1)
that can simultaneously##6##3##(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
that can substantially##2##3##(2007-11#1)(2010-3#1)
that can support##2##3##(1996-6#1)(2008-11#1)
that can suppress##3##3##(2007-8#1)(2008-3#1)(2012-2#1)
that can take##2##3##(2007-11#1)(2007-3#1)
that can then be used for##2##6##(2008-11#1)(2008-9#1)
that can then be used to##2##6##(2008-2#1)(2010-4#1)
that can then be used##4##5##(2008-11#1)(2008-2#1)(2008-9#1)(2010-4#1)
that can then be##7##4##(2006-5#2)(2008-11#1)(2008-2#2)(2008-9#1)(2010-4#1)
that can then##8##3##(2006-5#2)(2008-11#1)(2008-2#2)(2008-9#1)(2010-4#1)(2012-2#1)
that can transport##2##3##(2008-7#1)(2011-2#1)
that can use##4##3##(1992-11#1)(2008-10#1)(2010-2#1)(2012-3#1)
that can vary##4##3##(1992-8#1)(2009-7#1)(2010-11#1)(2013-1#1)
that can yield##2##3##(2012-12#1)(2012-2#1)
that can##1388##2##(1990-10#1)(1990-11#3)(1990-12#2)(1990-3#2)(1990-5#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#2)(1991-11#3)(1991-12#3)(1991-2#3)(1991-3#3)(1991-4#2)(1991-5#4)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#4)(1992-1#3)(1992-11#1)(1992-12#6)(1992-2#1)(1992-3#3)(1992-4#3)(1992-5#3)(1992-7#2)(1992-8#2)(1993-10#2)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#4)(1993-4#3)(1993-8#2)(1993-9#2)(1994-1#2)(1994-11#5)(1994-12#5)(1994-2#3)(1994-3#4)(1994-4#1)(1994-6#1)(1994-8#4)(1995-1#8)(1995-11#2)(1995-12#5)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#4)(1995-8#1)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#2)(1996-12#8)(1996-2#5)(1996-3#3)(1996-5#5)(1996-6#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#6)(1997-3#3)(1997-4#8)(1997-5#2)(1997-6#4)(1997-7#3)(1997-8#5)(2004-10#1)(2004-11#1)(2004-12#1)(2004-3#2)(2004-9#2)(2005-10#6)(2005-11#4)(2005-12#1)(2005-4#1)(2005-7#4)(2005-8#3)(2005-9#3)(2006-1#4)(2006-10#29)(2006-11#5)(2006-12#14)(2006-2#9)(2006-3#1)(2006-4#4)(2006-5#11)(2006-6#6)(2006-7#5)(2006-8#6)(2006-9#2)(2007-1#6)(2007-10#8)(2007-11#28)(2007-12#54)(2007-2#4)(2007-3#4)(2007-4#5)(2007-5#2)(2007-6#6)(2007-7#4)(2007-8#20)(2007-9#10)(2008-1#18)(2008-10#92)(2008-11#28)(2008-12#20)(2008-2#67)(2008-3#57)(2008-4#86)(2008-5#21)(2008-6#7)(2008-7#51)(2008-8#23)(2008-9#34)(2009-1#2)(2009-10#7)(2009-11#3)(2009-12#6)(2009-2#5)(2009-3#9)(2009-4#4)(2009-5#5)(2009-6#6)(2009-7#1)(2009-8#9)(2009-9#3)(2010-1#4)(2010-10#7)(2010-11#5)(2010-12#23)(2010-2#13)(2010-3#3)(2010-4#9)(2010-5#7)(2010-6#5)(2010-7#10)(2010-8#7)(2010-9#7)(2011-1#21)(2011-12#9)(2011-2#34)(2012-1#14)(2012-10#1)(2012-11#5)(2012-12#31)(2012-2#39)(2012-3#20)(2012-9#1)(2013-1#52)(2013-7#6)(2013-8#13)
that cancer cells##2##3##(2008-8#1)(2009-9#1)
that cancer is##2##3##(1990-2#1)(2009-4#1)
that cancer##12##2##(1990-2#1)(1992-4#1)(1992-5#1)(1992-8#1)(1995-2#1)(1997-8#1)(2008-8#1)(2009-4#1)(2009-9#2)(2010-12#1)(2012-2#1)
that cannabinoids##3##2##(2007-11#1)(2009-4#1)(2012-3#1)
that cannabis use##4##3##(2005-10#3)(2007-11#1)
that cannabis##5##2##(2005-10#3)(2007-11#1)(2008-1#1)
that cannot be achieved##3##4##(2008-10#1)(2008-2#1)(2013-1#1)
that cannot be classified##2##4##(2012-12#1)(2013-7#1)
that cannot be completely##2##4##(2008-1#1)(2012-2#1)
that cannot be explained by##4##5##(2005-8#2)(2009-6#1)(2013-1#1)
that cannot be explained##8##4##(1992-2#1)(2005-6#1)(2005-8#2)(2008-8#1)(2009-3#1)(2009-6#1)(2013-1#1)
that cannot be metabolized by##2##5##(2008-6#1)(2009-6#1)
that cannot be obtained by##2##5##(2006-6#1)(2007-12#1)
that cannot be removed##2##4##(1990-1#1)(2008-7#1)
that cannot be##45##3##(1990-1#1)(1992-2#1)(1993-3#1)(1993-8#1)(1995-9#1)(2005-1#1)(2005-6#1)(2005-8#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-6#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#2)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
that cannot easily be##2##4##(1994-8#1)(2008-2#1)
that cannot otherwise be##2##4##(2006-12#1)(2010-12#1)
that cannot produce##2##3##(2008-5#1)(2009-8#1)
that cannot##62##2##(1990-1#1)(1992-11#1)(1992-2#1)(1993-3#1)(1993-8#2)(1994-8#1)(1995-9#1)(1996-3#1)(1997-1#1)(1997-4#1)(2005-1#1)(2005-6#1)(2005-8#2)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-6#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
that capillary##2##2##(1996-5#1)(2008-10#1)
that capitalize on##3##3##(1993-2#1)(2007-2#1)(2009-9#1)
that capitalizes on##4##3##(2008-1#1)(2008-10#1)(2009-10#1)(2012-3#1)
that capsaicin##6##2##(1993-11#1)(1995-11#1)(1997-2#2)(2008-11#1)(2009-9#1)
that captopril##3##2##(1991-5#1)(1992-5#1)(1994-3#1)
that capture the##5##3##(2008-2#1)(2008-4#1)(2009-5#1)(2009-7#1)(2010-11#1)
that capture##9##2##(1997-1#1)(2007-2#1)(2008-2#1)(2008-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-9#1)
that captured##2##2##(2008-7#1)(2012-2#1)
that captures the##6##3##(2007-8#1)(2008-10#1)(2008-2#2)(2009-10#1)(2012-2#1)
that captures##8##2##(2007-8#1)(2008-10#2)(2008-2#2)(2009-10#1)(2010-2#1)(2012-2#1)
that carbachol##3##2##(1992-3#1)(1996-12#2)
that carbohydrate##3##2##(1991-5#1)(1994-10#1)(2007-1#1)
that carbon isotope##2##3##(2012-2#2)
that carbon##8##2##(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-2#2)
that cardenolide##2##2##(2007-1#2)
that cardiac##13##2##(1991-4#1)(1993-4#1)(1993-9#1)(1996-8#1)(1996-9#1)(2007-8#1)(2008-12#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
that cardiopulmonary##3##2##(1991-9#1)(2005-12#1)(2006-10#1)
that cardiovascular diseases##4##3##(1990-6#1)(2009-4#2)(2010-7#1)
that cardiovascular##9##2##(1990-5#1)(1990-6#1)(2007-8#1)(2008-1#1)(2008-7#2)(2009-4#2)(2010-7#1)
that care##12##2##(1991-3#1)(1992-3#1)(1993-3#1)(1994-2#1)(1996-3#1)(1997-2#1)(2005-10#1)(2008-11#1)(2008-9#1)(2010-10#2)(2011-1#1)
that careful##10##2##(1992-3#1)(1995-4#1)(2005-8#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-2#1)(2012-12#1)
that carefully##2##2##(1996-1#1)(2007-12#1)
that caregivers##4##2##(1991-12#2)(1997-8#1)(2008-6#1)
that caregivers'##2##2##(1991-12#1)(2011-2#1)
that caring##2##2##(2006-6#1)(2008-11#1)
that carnosine##2##2##(1994-10#1)(1997-5#1)
that carried a##3##3##(1991-11#1)(1996-6#1)(2008-10#1)
that carried out##2##3##(1992-7#1)(2012-12#1)
that carried the##2##3##(1993-3#1)(2012-3#1)
that carried##11##2##(1990-8#1)(1991-11#1)(1992-7#1)(1993-3#3)(1996-6#1)(2008-10#1)(2010-7#1)(2012-12#1)(2012-3#1)
that carries a##2##3##(2010-7#1)(2012-2#1)
that carries out##2##3##(2008-7#1)(2013-8#1)
that carries the##4##3##(1991-12#1)(1995-2#1)(2006-12#1)(2008-3#1)
that carries##15##2##(1991-12#1)(1993-5#1)(1995-2#1)(1997-1#1)(1997-6#1)(2006-11#1)(2006-12#1)(2008-3#2)(2008-7#1)(2009-9#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
that carry a##4##3##(1990-9#1)(2008-11#1)(2008-4#1)(2012-11#1)
that carry an##2##3##(1995-9#1)(2007-8#1)
that carry out the##2##4##(2004-4#1)(2011-1#1)
that carry out##3##3##(2004-4#1)(2010-12#1)(2011-1#1)
that carry the##5##3##(1991-12#1)(1991-8#1)(2007-12#1)(2008-1#1)(2008-12#1)
that carry##25##2##(1990-5#1)(1990-9#1)(1991-12#1)(1991-8#1)(1993-12#1)(1995-3#1)(1995-9#1)(1997-4#1)(2004-4#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-11#1)
that carry-over effects##2##3##(1995-11#2)
that case managers##2##3##(2006-1#2)
that case##19##2##(1992-9#1)(1994-2#1)(1995-2#1)(1997-4#1)(2005-2#3)(2006-1#2)(2006-8#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-7#1)(2012-12#1)(2013-1#2)
that casein##3##2##(1990-12#1)(1990-7#1)(2005-11#1)
that cases##3##2##(1997-8#1)(2007-11#1)(2011-2#1)
that cast##2##2##(2007-9#1)(2011-1#1)
that catalyses the##2##3##(1993-8#1)(2008-10#1)
that catalyses##3##2##(1990-5#1)(1993-8#1)(2008-10#1)
that catalytic##2##2##(1996-5#1)(2008-10#1)
that catalyze the##3##3##(2007-6#1)(2008-4#1)(2012-2#1)
that catalyze##6##2##(2007-6#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)
that catalyzes the formation of##2##5##(1996-2#1)(2012-12#1)
that catalyzes the hydrolysis of##2##5##(1994-9#1)(1995-3#1)
that catalyzes the##15##3##(1993-5#1)(1994-11#1)(1994-9#3)(1995-2#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-2#2)(2005-11#1)(2006-10#1)(2010-1#1)(2012-12#1)
that catalyzes##24##2##(1991-10#1)(1991-5#1)(1992-7#1)(1992-9#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-9#4)(1995-2#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-6#1)(1997-8#1)(2005-11#1)(2006-10#1)(2008-8#1)(2010-1#1)(2012-12#1)
that cataplexy##2##2##(1991-5#2)
that cathepsin B##2##3##(1991-9#1)(1992-12#1)
that cathepsin D##6##3##(1990-10#1)(1990-12#1)(1990-5#1)(1991-8#2)(1994-5#1)
that cathepsin##9##2##(1990-10#1)(1990-12#1)(1990-5#1)(1991-8#2)(1991-9#1)(1992-12#1)(1994-5#1)(1996-8#1)
that catheter##2##2##(2007-7#1)(2008-8#1)
that cationic##3##2##(1996-12#1)(2005-7#1)(2008-5#1)
that cations##2##2##(2006-5#1)(2007-9#1)
that causal##2##2##(2008-11#1)(2012-3#1)
that cause a variety of##2##5##(2009-5#1)(2012-3#1)
that cause a##6##3##(1997-2#1)(2008-10#2)(2009-5#1)(2009-8#1)(2012-3#1)
that cause an##2##3##(2005-10#1)(2013-8#1)
that cause disease##2##3##(2008-9#1)(2012-2#1)
that cause or##2##3##(2006-10#1)(2009-10#1)
that cause significant morbidity##2##4##(1996-7#1)(2008-7#1)
that cause significant##4##3##(1996-7#1)(2008-10#1)(2008-7#1)(2013-8#1)
that cause the disease##2##4##(2012-2#1)(2013-8#1)
that cause the##7##3##(1993-6#1)(1997-1#1)(2008-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
that cause these##3##3##(1994-12#1)(2008-2#1)(2012-12#1)
that cause this##3##3##(2008-5#1)(2008-8#1)(2012-2#1)
that cause##97##2##(1990-12#1)(1990-7#1)(1991-11#1)(1991-8#1)(1992-12#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-10#1)(2005-11#1)(2005-7#2)(2006-10#4)(2006-3#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#5)(2008-9#3)(2009-10#1)(2009-2#1)(2009-5#2)(2009-8#2)(2010-12#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#4)
that caused a##2##3##(1991-4#1)(2006-10#1)
that caused by the##4##4##(1990-7#1)(1991-10#1)(1993-11#1)(2008-2#1)
that caused by##16##3##(1990-11#1)(1990-3#1)(1990-7#1)(1991-10#2)(1991-2#1)(1992-6#1)(1992-8#1)(1993-11#1)(1995-5#1)(2008-10#1)(2008-2#1)(2009-9#1)(2010-4#1)(2012-2#1)(2013-8#1)
that caused the##5##3##(1994-9#1)(2009-10#1)(2009-8#1)(2013-1#1)(2013-8#1)
that caused##43##2##(1990-11#1)(1990-3#1)(1990-7#1)(1991-10#2)(1991-2#1)(1991-4#1)(1991-8#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
that causes AIDS##2##3##(1996-5#1)(2010-10#1)
that causes a##8##3##(1991-7#1)(1994-3#1)(2006-11#1)(2006-12#1)(2008-10#1)(2008-7#1)(2010-12#1)(2012-2#1)
that causes downy mildew##2##4##(2008-10#2)
that causes rapid##2##3##(2008-10#1)(2013-8#1)
that causes retinal##2##3##(2007-10#1)(2009-4#1)
that causes significant##2##3##(2008-10#2)
that causes the##12##3##(1990-2#1)(1993-2#1)(1994-8#1)(1996-7#1)(2006-12#1)(2006-7#1)(2008-10#2)(2008-3#1)(2009-10#1)(2011-1#1)(2013-7#1)
that causes##95##2##(1990-2#1)(1990-4#1)(1991-7#2)(1992-8#1)(1993-12#1)(1993-2#1)(1994-3#2)(1994-7#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-2#1)(1996-5#2)(1996-7#1)(1997-3#2)(1997-6#1)(2005-10#1)(2005-8#1)(2006-10#5)(2006-11#2)(2006-12#2)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#20)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#1)(2011-1#3)(2011-2#3)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
that causing##2##2##(1994-7#1)(2011-1#1)
that caution is needed##2##4##(1991-12#1)(2008-12#1)
that caution is warranted##2##4##(1997-8#1)(2007-8#1)
that caution is##5##3##(1991-12#1)(1997-8#1)(2007-8#1)(2008-12#1)(2008-5#1)
that caution should be##2##4##(2012-11#1)(2013-8#1)
that caution##8##2##(1991-12#1)(1995-1#1)(1997-8#1)(2007-8#1)(2008-12#1)(2008-5#1)(2012-11#1)(2013-8#1)
that caveolae##2##2##(1995-2#1)(1995-6#1)
that caveolin##2##2##(1995-6#2)
that cavity##2##2##(2008-1#1)(2008-3#1)
that cell cycle##2##3##(1992-8#1)(1996-6#1)
that cell death is##2##4##(1992-9#1)(2011-1#1)
that cell death##7##3##(1992-11#1)(1992-9#1)(1994-5#1)(2007-3#1)(2008-9#1)(2010-11#1)(2011-1#1)
that cell division##2##3##(2008-11#1)(2008-2#1)
that cell surface##4##3##(1992-6#1)(1996-8#1)(1997-9#1)(2012-1#1)
that cell viability##2##3##(2009-3#1)(2011-12#1)
that cell##43##2##(1991-1#1)(1991-8#2)(1992-11#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-7#1)(1994-5#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-9#1)(2005-12#1)(2006-5#1)(2007-3#1)(2008-11#9)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2010-1#1)(2010-11#2)(2010-7#1)(2011-1#1)(2011-12#1)(2012-1#1)
that cells are##2##3##(1995-3#1)(2008-9#1)
that cells can##2##3##(2011-1#1)(2012-12#1)
that cells exposed to##2##4##(2008-11#1)(2008-8#1)
that cells expressing##3##3##(1997-6#1)(2008-11#1)(2008-5#1)
that cells from##4##3##(1992-9#1)(1994-8#1)(1996-7#1)(2011-2#1)
that cells have##2##3##(2010-11#1)(2011-2#1)
that cells in##3##3##(2008-11#1)(2008-5#1)(2008-7#1)
that cells lacking##2##3##(2005-8#1)(2010-2#1)
that cells of##2##3##(1991-6#1)(2003-11#1)
that cells were##3##3##(1995-1#1)(2008-11#2)
that cells##44##2##(1990-11#1)(1991-6#1)(1991-8#2)(1992-8#1)(1992-9#1)(1993-6#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-7#1)(1997-6#1)(2003-11#1)(2005-8#1)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
that cellular##17##2##(1990-12#1)(1990-7#1)(1991-10#1)(1991-8#1)(1994-3#1)(1994-9#1)(1995-2#1)(1997-3#1)(2005-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-5#1)
that centers##2##2##(2008-4#1)(2010-5#1)
that central administration##2##3##(1991-1#1)(1994-2#1)
that central##12##2##(1991-1#1)(1991-11#1)(1993-12#1)(1994-2#1)(1994-6#1)(1995-12#1)(1996-2#1)(1996-7#1)(2005-10#1)(2007-7#1)(2007-8#1)(2008-12#1)
that cephalosporin##2##2##(2008-10#1)(2008-6#1)
that ceramide##4##2##(1996-5#3)(2008-5#1)
that cerebellar##5##2##(1994-3#1)(1995-8#1)(1996-6#1)(2007-10#1)(2008-7#1)
that cerebral##10##2##(1995-3#1)(1995-6#1)(2004-12#1)(2006-7#1)(2007-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-4#1)
that cerebroside##2##2##(2008-10#2)
that certain aspects of##2##4##(1991-4#1)(2012-3#1)
that certain##56##2##(1990-11#1)(1991-4#1)(1991-8#1)(1993-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-4#1)(1996-11#1)(1996-4#1)(1996-8#1)(1997-4#1)(2004-4#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-9#1)(2007-11#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#5)(2008-8#1)(2009-9#1)(2010-1#2)(2010-2#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
that cervical##2##2##(2007-8#1)(2012-12#1)
that challenge##3##2##(2008-11#1)(2008-9#1)(2011-1#1)
that chance##2##2##(1994-3#1)(2008-11#1)
that change in##4##3##(1997-1#1)(2008-10#2)(2010-10#1)
that change is##3##3##(2008-12#1)(2008-2#1)(2012-2#1)
that change##22##2##(1991-3#1)(1995-2#1)(1997-1#1)(2005-8#1)(2006-4#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#1)(2009-10#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-11#1)(2012-2#2)
that changed##11##2##(1992-7#1)(1993-9#1)(1994-2#1)(1996-12#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
that changes in blood##2##4##(1995-12#1)(2004-9#1)
that changes in the##16##4##(1990-4#1)(1991-12#1)(1991-4#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-7#1)(2005-11#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-1#1)
that changes in##59##3##(1990-10#1)(1990-3#1)(1990-4#1)(1990-9#1)(1991-1#2)(1991-12#2)(1991-4#1)(1991-8#1)(1991-9#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-11#2)(1995-12#2)(1995-7#1)(1996-2#1)(1996-7#2)(1997-7#1)(2004-9#1)(2005-10#1)(2005-11#1)(2006-4#1)(2006-8#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2013-1#2)(2013-7#1)
that changes the##2##3##(1994-9#1)(2007-12#1)
that changes to##3##3##(1994-11#1)(2013-1#2)
that changes##76##2##(1990-10#1)(1990-3#1)(1990-4#2)(1990-7#1)(1990-9#1)(1991-1#3)(1991-12#2)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-7#1)(1996-2#1)(1996-7#2)(1997-7#1)(2004-9#1)(2005-10#1)(2005-11#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#4)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#2)(2009-8#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2013-1#4)(2013-7#1)
that changing##3##2##(2008-11#1)(2008-8#1)(2010-12#1)
that channel##3##2##(1993-12#1)(2007-12#1)(2008-6#1)
that chaotic dynamics##2##3##(2008-11#2)
that chaplains##2##2##(1994-12#1)(2010-2#1)
that characterise the##2##3##(1994-12#1)(2009-2#1)
that characterise##3##2##(1994-12#1)(2008-1#1)(2009-2#1)
that characterize individuals##2##3##(2005-6#1)(2010-3#1)
that characterize the##13##3##(2006-2#1)(2007-12#2)(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2009-9#1)(2010-5#1)
that characterize these##2##3##(1993-1#1)(2008-10#1)
that characterize##34##2##(1993-1#1)(1995-5#1)(2005-6#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-12#2)(2007-6#1)(2007-8#1)(2007-9#2)(2008-10#4)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#2)(2009-3#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#2)
that characterized the##2##3##(2004-11#1)(2012-3#1)
that characterizes the##9##3##(2007-12#2)(2007-3#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-5#1)(2012-3#1)
that characterizes##18##2##(1995-3#1)(2006-12#1)(2007-12#3)(2007-3#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2010-5#1)(2010-8#1)(2012-2#1)(2012-3#1)
that characters##2##2##(2008-8#1)(2010-6#1)
that charge##2##2##(1997-1#1)(2008-7#1)
that charges##2##2##(1993-12#1)(2009-6#1)
that chelation##2##2##(2008-10#1)(2010-5#1)
that chemerin regulates β-cell function##2##5##(2012-2#2)
that chemical##10##2##(1996-2#1)(1996-8#1)(1997-5#1)(2004-7#1)(2005-11#1)(2008-10#3)(2011-1#1)(2013-8#1)
that chemically##3##2##(2009-12#1)(2012-12#2)
that chemokines##2##2##(2006-9#1)(2008-1#1)
that chemotherapy##3##2##(2006-8#1)(2010-3#1)(2012-1#1)
that chest pain##2##3##(2006-2#1)(2008-3#1)
that chest##3##2##(2006-2#1)(2008-3#1)(2009-4#1)
that chicken Kit##2##3##(1993-6#2)
that chickens##2##2##(2008-5#2)
that chicks##2##2##(1994-5#1)(2008-9#1)
that child##2##2##(2008-12#1)(2012-12#1)
that childbirth educators##4##3##(2007-2#4)
that childbirth##8##2##(2007-2#4)(2008-9#2)(2010-9#1)(2013-1#1)
that childhood physical and##2##4##(1995-11#1)(2010-2#1)
that childhood##6##2##(1995-11#1)(2009-7#2)(2010-2#1)(2011-2#1)(2012-2#1)
that children are##4##3##(1996-12#1)(2005-7#1)(2006-10#1)(2012-2#1)
that children from##2##3##(2005-9#1)(2013-7#1)
that children in this##2##4##(1995-12#1)(2013-7#1)
that children in##5##3##(1994-6#1)(1995-12#1)(1996-12#1)(2004-10#1)(2013-7#1)
that children should be##2##4##(1990-2#1)(2007-2#1)
that children who##4##3##(1995-1#1)(2006-3#1)(2011-1#1)(2012-12#1)
that children with ADHD##3##4##(1995-1#1)(2005-10#2)
that children with ASD can##2##5##(2010-2#1)(2012-2#1)
that children with ASD##3##4##(2010-2#1)(2012-2#1)(2013-1#1)
that children with autism##2##4##(2006-10#1)(2007-8#1)
that children with##19##3##(1990-12#1)(1995-1#1)(2004-10#1)(2005-10#3)(2006-10#3)(2007-8#1)(2008-6#1)(2008-9#1)(2009-1#2)(2010-2#2)(2012-2#2)(2013-1#1)
that children##53##2##(1990-12#1)(1990-2#1)(1993-12#1)(1994-6#1)(1995-1#2)(1995-12#1)(1996-12#2)(1996-6#1)(2004-10#2)(2005-10#3)(2005-7#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-3#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-2#2)(2008-6#1)(2008-9#1)(2009-1#2)(2009-2#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-2#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#3)(2013-7#2)
that children's##6##2##(1995-3#1)(2007-12#1)(2009-11#1)(2010-11#1)(2010-2#1)(2013-8#1)
that chitinase activity##2##3##(2008-10#1)(2009-3#1)
that chitinase##3##2##(2008-10#2)(2009-3#1)
that chitobiase##2##2##(1992-10#2)
that chlamydiae##4##2##(1991-3#1)(1992-5#1)(2005-12#2)
that chlorambucil##2##2##(2008-11#2)
that choice##4##2##(2008-12#1)(2008-7#1)(2010-4#2)
that cholecystokinin##2##2##(1993-2#1)(2006-10#1)
that cholera toxin##2##3##(1990-3#1)(1996-4#1)
that cholesterol##10##2##(1990-2#2)(1991-9#1)(1993-3#1)(1994-3#1)(1996-7#1)(1997-1#1)(2008-10#1)(2010-4#1)(2011-1#1)
that cholinergic and dopaminergic##2##4##(1990-2#2)
that cholinergic##7##2##(1990-2#2)(1990-7#1)(1991-9#1)(1992-8#1)(1993-11#1)(1996-1#1)
that chondrocytes##3##2##(1993-12#1)(2007-11#1)(2008-11#1)
that choose##2##2##(2005-7#1)(2011-2#1)
that chromatin remodeling##2##3##(2009-6#1)(2009-8#1)
that chromium##2##2##(1996-12#1)(2005-4#1)
that chromosomal##3##2##(2008-5#1)(2008-7#1)(2010-3#1)
that chromosome##7##2##(1996-12#1)(1996-6#1)(1997-4#1)(2008-10#3)(2010-3#1)
that chromosomes##2##2##(1996-6#1)(2008-11#1)
that chronic exposure to##3##4##(1992-5#1)(1994-3#1)(2008-10#1)
that chronic exposure##4##3##(1992-5#1)(1994-3#1)(2008-10#1)(2008-7#1)
that chronic inflammation##2##3##(2008-1#1)(2011-2#1)
that chronic pain##2##3##(2010-7#1)(2011-2#1)
that chronic stress##2##3##(1995-12#1)(2008-11#1)
that chronic treatment##2##3##(1992-3#1)(1996-12#1)
that chronic##44##2##(1990-3#1)(1990-7#1)(1991-2#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#1)(1996-10#1)(1996-12#3)(1997-1#1)(1997-4#1)(2005-10#2)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-7#1)(2011-2#3)(2012-12#1)(2013-1#1)
that chronically##4##2##(1994-12#1)(1995-11#1)(1995-8#1)(2012-3#1)
that chrysotile##2##2##(1991-12#1)(1992-9#1)
that cigarette smoke caused##2##4##(2008-5#2)
that cigarette smoke##7##3##(1991-9#1)(2006-9#2)(2008-5#3)(2008-8#1)
that cigarette smoking##4##3##(2005-8#1)(2006-11#1)(2008-12#2)
that cigarette##12##2##(1991-9#1)(1996-1#1)(2005-8#1)(2006-11#1)(2006-9#2)(2008-12#2)(2008-5#3)(2008-8#1)
that circadian##2##2##(1993-12#1)(2009-8#1)
that circulating EPCs##2##3##(2007-11#1)(2012-2#1)
that circulating##11##2##(1990-3#1)(1993-2#1)(1995-2#1)(1996-8#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-11#1)(2009-11#1)(2012-2#2)
that circumvents##2##2##(2007-12#1)(2010-12#1)
that cis-acting##2##2##(1993-8#1)(2009-3#1)
that cisplatin##2##2##(1991-11#1)(2008-11#1)
that citA##2##2##(1997-4#2)
that claim##2##2##(2008-3#1)(2008-8#1)
that claimed##2##2##(2008-11#1)(2013-8#1)
that claims##2##2##(2006-5#2)
that clarifies##2##2##(2008-12#1)(2008-2#1)
that clarify##2##2##(2006-11#1)(2011-2#1)
that class##3##2##(1992-8#1)(2007-12#1)(2008-10#1)
that classic##2##2##(2006-5#1)(2012-2#1)
that classical##3##2##(2007-6#1)(2008-5#1)(2008-9#1)
that classification##2##2##(1992-12#1)(2005-7#1)
that classify##3##2##(2008-3#1)(2010-2#1)(2012-3#1)
that clear##3##2##(2007-8#1)(2008-4#1)(2012-12#1)
that clearly demonstrate##2##3##(1991-2#1)(2008-2#1)
that clearly distinguished##2##3##(1997-7#1)(2008-5#1)
that clearly show the##2##4##(2007-11#1)(2008-6#1)
that clearly##14##2##(1991-2#1)(1993-2#1)(1994-5#1)(1996-3#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-3#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-1#1)(2013-1#1)
that cleavage occurred at the##2##5##(1991-2#1)(1997-2#1)
that cleavage##6##2##(1991-2#1)(1992-11#1)(1992-4#1)(1995-8#1)(1996-9#1)(1997-2#1)
that cleave##6##2##(1995-10#1)(2008-4#2)(2009-2#1)(2011-2#1)(2012-12#1)
that cleaves the##2##3##(1990-2#1)(2007-12#1)
that cleaves##11##2##(1990-2#1)(1991-4#1)(1993-3#1)(1994-11#2)(1994-9#1)(1996-12#1)(1996-5#1)(2006-12#1)(2007-12#1)(2011-2#1)
that clients##4##2##(1993-12#1)(2008-6#2)(2012-2#1)
that climate##2##2##(1990-8#1)(2012-12#1)
that clinical supervision is##2##4##(1997-7#1)(2009-8#1)
that clinical##25##2##(1995-3#2)(1997-7#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-2#1)(2007-8#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-5#1)(2013-1#1)
that clinically##4##2##(1990-2#1)(2006-10#1)(2012-2#1)(2012-3#1)
that clinicians and##4##3##(1990-4#1)(2010-12#1)(2013-1#2)
that clinicians can use##3##4##(2011-2#1)(2013-1#2)
that clinicians maintain a high##2##5##(2006-10#1)(2010-7#1)
that clinicians##21##2##(1990-4#1)(1992-3#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#6)
that clonal##3##2##(1996-1#1)(2008-10#1)(2008-5#1)
that clones##2##2##(2008-10#1)(2008-6#1)
that close to##2##3##(2006-9#1)(2008-3#1)
that close##3##2##(2006-9#1)(2007-9#1)(2008-3#1)
that closely mimic##2##3##(1991-9#1)(2009-4#1)
that closely resemble##4##3##(1994-3#1)(2008-11#1)(2008-2#2)
that closely resembles##3##3##(1990-8#1)(2008-5#1)(2008-9#1)
that closely##20##2##(1990-8#1)(1991-5#1)(1991-9#1)(1994-3#1)(2005-10#1)(2006-5#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-7#1)(2012-12#1)(2012-3#1)
that closing##2##2##(1995-11#1)(1996-3#1)
that cloud##2##2##(2008-10#2)
that clozapine##2##2##(1996-5#1)(1997-8#1)
that clustered with##2##3##(2008-10#2)
that clustered##3##2##(2008-10#3)
that clustering of##2##3##(1996-8#1)(2008-10#1)
that clustering##3##2##(1996-8#1)(2008-10#1)(2008-2#1)
that clutch##3##2##(2008-9#3)
that co-elute with##2##3##(1990-7#1)(2006-10#1)
that co-express##2##2##(1995-3#1)(2012-2#1)
that co-morbid##2##2##(2005-10#1)(2012-2#1)
that co-occur in##2##3##(2008-10#1)(2010-3#1)
that co-occur##4##2##(2008-10#1)(2008-8#1)(2010-3#2)
that co-segregated with##2##3##(2008-10#2)
that co-suppression occurred##2##3##(2008-9#2)
that coalesce##2##2##(2009-10#1)(2011-2#1)
that coalescence##2##2##(2005-11#2)
that coat##2##2##(2005-7#1)(2008-7#1)
that coating##2##2##(2008-3#1)(2008-7#1)
that cobalt##7##2##(1994-6#4)(2005-11#1)(2009-7#1)(2011-1#1)
that cocaine##4##2##(1990-7#1)(1991-3#1)(1993-12#1)(1996-8#1)
that cochlear implantation is##4##4##(2007-3#1)(2008-9#1)(2012-2#2)
that cochlear##6##2##(2007-3#1)(2008-9#2)(2012-2#3)
that code for##7##3##(1991-3#1)(1992-8#1)(1993-6#3)(2008-10#1)(2010-10#1)
that code##9##2##(1991-3#1)(1992-11#1)(1992-8#1)(1993-6#3)(2006-12#1)(2008-10#1)(2010-10#1)
that codes for a##2##4##(1994-11#1)(1997-7#1)
that codes for##9##3##(1990-10#1)(1990-4#1)(1993-3#1)(1994-11#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-7#1)(2009-3#1)
that coding##5##2##(1993-12#1)(1994-6#1)(2007-12#1)(2012-12#1)(2013-1#1)
that coexistence##3##2##(2008-8#2)(2008-9#1)
that coexpression of##2##3##(1995-3#1)(2009-3#1)
that coexpression##3##2##(1993-6#1)(1995-3#1)(2009-3#1)
that coffee##2##2##(1990-5#1)(1990-7#1)
that cognate##2##2##(1997-8#1)(2008-11#1)
that cognitive##9##2##(1996-3#1)(1997-8#1)(2007-11#1)(2007-2#1)(2008-4#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-1#1)
that coincide with##2##3##(2008-10#1)(2008-3#1)
that coincided with##3##3##(1997-5#2)(2008-10#1)
that coincides with the##2##4##(2006-3#1)(2011-2#1)
that coincides with##5##3##(1993-11#1)(1994-8#1)(1996-5#1)(2006-3#1)(2011-2#1)
that coincides##6##2##(1993-11#1)(1994-8#1)(1996-5#1)(2006-3#1)(2009-5#1)(2011-2#1)
that coinfection##2##2##(2008-10#1)(2008-7#1)
that colchicine##3##2##(1995-5#1)(1997-6#2)
that cold##4##2##(1993-2#1)(2005-11#1)(2012-12#2)
that collaborative##2##2##(1996-11#1)(2010-3#1)
that collagen##2##2##(2008-5#1)(2013-1#1)
that collapsing##3##2##(2012-3#3)
that collect##3##2##(2007-12#1)(2008-12#1)(2010-8#1)
that collecting##2##2##(1996-1#1)(2010-11#1)
that collectively##6##2##(1995-8#1)(2008-10#1)(2009-4#1)(2009-8#1)(2012-2#1)(2012-3#1)
that collects the##2##3##(2007-12#1)(2008-10#1)
that collects##7##2##(1991-3#1)(1994-6#1)(2007-12#1)(2008-10#1)(2008-2#2)(2009-11#1)
that colocalization of##2##3##(1994-2#1)(2008-4#1)
that colonize##4##2##(2005-8#1)(2008-10#2)(2008-9#1)
that colonized##2##2##(2008-10#1)(2010-8#1)
that colonizes##2##2##(2008-10#1)(2013-1#1)
that color##3##2##(1997-1#1)(2008-2#1)(2011-1#1)
that colorectal cancer##3##3##(2009-4#1)(2010-11#1)(2011-2#1)
that colorectal##4##2##(1991-9#1)(2009-4#1)(2010-11#1)(2011-2#1)
that colour##2##2##(2008-4#2)
that combination therapy with##2##4##(2008-5#1)(2011-2#1)
that combination therapy##4##3##(2008-5#1)(2010-10#1)(2011-2#1)(2013-8#1)
that combination treatment##2##3##(2007-8#1)(2012-2#1)
that combination##9##2##(1995-5#1)(2007-8#1)(2008-5#2)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
that combinations of##6##3##(1997-7#1)(2007-1#1)(2007-9#1)(2008-10#1)(2009-8#1)(2012-12#1)
that combinations##7##2##(1997-7#1)(2007-1#1)(2007-9#1)(2008-10#1)(2009-6#1)(2009-8#1)(2012-12#1)
that combine the##5##3##(1994-12#1)(2007-11#1)(2008-3#1)(2008-7#1)(2009-9#1)
that combine##29##2##(1992-2#1)(1993-11#1)(1994-12#1)(1995-1#1)(1995-5#1)(1996-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#3)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-1#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#2)
that combined the##2##3##(2008-10#1)(2013-7#1)
that combined treatment##2##3##(2008-7#1)(2008-8#1)
that combined with##2##3##(1996-12#1)(2008-11#1)
that combined##20##2##(1991-4#1)(1996-12#1)(1997-3#1)(2004-10#1)(2006-6#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-7#1)
that combines a##10##3##(2007-12#3)(2007-8#1)(2008-2#3)(2008-3#1)(2013-1#2)
that combines an##2##3##(1997-2#1)(2008-3#1)
that combines the##26##3##(1993-3#1)(1997-4#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-1#1)(2012-1#1)
that combines##84##2##(1993-3#1)(1994-6#1)(1994-7#1)(1997-2#1)(1997-4#1)(2005-10#1)(2006-1#1)(2006-10#2)(2007-11#2)(2007-12#10)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#9)(2008-3#9)(2008-4#2)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
that combining##6##2##(2006-12#1)(2006-9#1)(2007-6#1)(2008-10#1)(2008-2#1)(2011-2#1)
that come from##2##3##(2007-12#1)(2008-3#1)
that come to##3##3##(2005-10#1)(2007-5#1)(2008-5#1)
that come with the##2##4##(1991-12#1)(2007-9#1)
that come with##4##3##(1991-12#1)(1995-1#1)(2007-9#1)(2008-7#1)
that come##10##2##(1990-6#1)(1991-12#1)(1995-1#1)(2005-10#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-7#1)
that comes from##3##3##(2006-10#1)(2007-12#1)(2008-10#1)
that comes in contact with##2##5##(2006-5#1)(2008-10#1)
that comes##6##2##(1995-6#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-10#2)
that commercial##3##2##(1994-3#1)(2008-10#1)(2008-7#1)
that commercially available##2##3##(2006-5#1)(2007-12#1)
that common genetic##2##3##(2011-2#1)(2012-3#1)
that common spatial origin##2##4##(2009-9#2)
that common variants##2##3##(2012-3#2)
that common##14##2##(1994-9#1)(2005-10#1)(2007-8#1)(2008-3#2)(2009-6#1)(2009-9#2)(2011-2#1)(2012-3#5)
that commonly used##2##3##(2008-8#1)(2011-12#1)
that commonly##14##2##(1991-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#3)(2010-12#1)(2010-2#1)(2011-12#1)(2012-2#1)
that communicate##4##2##(1996-2#1)(2006-5#1)(2008-12#1)(2009-5#1)
that communicating##2##2##(2013-1#1)(2013-8#1)
that communication between the##2##4##(2006-1#1)(2006-10#1)
that communication between##4##3##(1995-8#1)(2006-1#1)(2006-10#1)(2008-12#1)
that communication##8##2##(1995-8#1)(2006-1#1)(2006-10#3)(2008-12#1)(2009-11#1)(2012-3#1)
that community##7##2##(1994-3#1)(1996-2#1)(2007-12#1)(2009-12#1)(2010-9#1)(2011-2#1)(2012-12#1)
that comparative studies##2##3##(1990-8#1)(2008-10#1)
that comparative##5##2##(1990-8#1)(1991-9#1)(2007-12#1)(2008-10#1)(2011-2#1)
that compare favorably with those obtained by the##2##8##(2008-10#2)
that compare favorably with those obtained by##3##7##(2008-10#3)
that compare favorably with##4##4##(2008-10#4)
that compare favorably##5##3##(1992-2#1)(2008-10#4)
that compare the##3##3##(1993-9#1)(2008-10#1)(2012-12#1)
that compare##20##2##(1991-3#1)(1992-2#1)(1993-9#1)(1994-1#1)(1994-6#1)(1996-7#1)(2006-10#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-8#1)(2010-12#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#1)
that compared the##2##3##(1997-5#1)(2007-1#1)
that compared to##6##3##(1992-11#1)(1997-1#1)(2009-7#1)(2011-3#1)(2012-12#1)(2013-8#1)
that compared with the##4##4##(2008-2#1)(2008-5#1)(2009-5#1)(2010-10#1)
that compared with##6##3##(2008-2#1)(2008-5#1)(2009-5#1)(2010-10#1)(2010-7#1)(2011-2#1)
that compared##22##2##(1992-11#1)(1995-8#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-5#1)(2007-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-8#3)
that compares the##4##3##(1995-8#1)(2007-7#1)(2008-2#1)(2010-3#1)
that compares##6##2##(1993-9#1)(1995-8#1)(1997-3#1)(2007-7#1)(2008-2#1)(2010-3#1)
that compensates for the##2##4##(2007-12#1)(2008-2#1)
that compensates for##4##3##(2006-6#1)(2007-12#1)(2008-2#1)(2008-3#1)
that compensates##6##2##(2006-6#1)(2007-12#1)(2008-2#2)(2008-3#2)
that compensatory##2##2##(2006-7#1)(2009-2#1)
that compete for##2##3##(2007-11#1)(2008-8#1)
that compete with##2##3##(2008-4#1)(2009-7#1)
that compete##5##2##(2007-11#1)(2008-4#1)(2008-8#2)(2009-7#1)
that competence##3##2##(2006-10#1)(2007-12#1)(2008-2#1)
that competing##2##2##(1995-1#1)(2008-8#1)
that competition for##3##3##(1996-10#1)(2007-3#1)(2007-9#1)
that competition##6##2##(1996-10#1)(1997-3#1)(2007-3#1)(2007-9#1)(2008-9#2)
that competitive##2##2##(1996-9#2)
that competitors##2##2##(1996-3#1)(2008-8#1)
that complement activation##2##3##(1993-9#1)(2012-12#1)
that complement##9##2##(1991-1#1)(1993-9#1)(1996-5#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-12#1)
that complements the##5##3##(1992-2#1)(1995-4#2)(1997-4#1)(2008-7#1)
that complements##7##2##(1992-2#1)(1995-4#2)(1997-4#2)(2008-7#1)(2008-8#1)
that complete loss of##2##4##(1995-6#1)(2008-10#1)
that complete##13##2##(1990-5#1)(1994-10#1)(1995-5#1)(1995-6#1)(2007-11#1)(2007-8#1)(2008-10#3)(2010-12#1)(2010-2#1)(2013-1#2)
that completely##7##2##(1990-2#1)(2007-7#1)(2008-3#1)(2008-5#1)(2012-2#1)(2013-1#2)
that complex diseases are##2##4##(2008-4#1)(2012-3#1)
that complex formation##2##3##(1991-2#1)(1996-9#1)
that complex##15##2##(1990-4#1)(1991-2#1)(1996-9#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-7#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-8#1)
that complexes##4##2##(1997-7#1)(2008-5#1)(2009-2#1)(2010-7#1)
that complexity##2##2##(2007-11#1)(2012-3#1)
that compliance with the##2##4##(1997-1#1)(2006-8#1)
that compliance##3##2##(1997-1#1)(2006-8#1)(2011-2#1)
that complicate the##3##3##(2007-10#1)(2007-11#1)(2008-8#1)
that complicate##7##2##(1994-10#1)(1996-11#1)(2007-10#1)(2007-11#1)(2008-8#2)(2011-1#1)
that complicates##2##2##(1995-3#1)(2007-2#1)
that complications##3##2##(2006-7#1)(2007-7#1)(2008-6#1)
that components of the##4##4##(1990-6#1)(1994-12#1)(2009-5#1)(2012-12#1)
that components of##6##3##(1990-6#1)(1994-12#1)(1995-12#1)(2009-5#1)(2012-12#1)(2013-1#1)
that components##7##2##(1990-6#1)(1994-12#1)(1994-5#1)(1995-12#1)(2009-5#1)(2012-12#1)(2013-1#1)
that compose the##3##3##(1993-6#1)(2008-10#1)(2008-2#1)
that compose##4##2##(1993-6#1)(2008-10#1)(2008-2#2)
that composites of##2##3##(2009-7#1)(2010-4#1)
that composites##3##2##(2004-9#1)(2009-7#1)(2010-4#1)
that compost-induced##2##2##(2008-10#2)
that compound##5##2##(1991-8#1)(1992-3#1)(2008-10#1)(2011-1#1)(2011-3#1)
that compounds 1 and##2##4##(1994-8#1)(2006-12#1)
that compounds with##2##3##(1994-9#1)(2008-3#1)
that compounds##15##2##(1990-7#1)(1993-4#1)(1993-6#1)(1994-8#1)(1994-9#1)(2006-10#1)(2006-12#3)(2008-11#1)(2008-3#1)(2010-12#1)(2010-5#1)(2012-11#1)(2012-3#1)
that comprise the##10##3##(1995-6#1)(1997-1#1)(1997-8#1)(2007-6#1)(2008-10#1)(2008-4#1)(2009-4#1)(2009-8#1)(2011-2#1)(2013-1#1)
that comprise##17##2##(1995-6#2)(1997-1#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-10#1)(2008-4#2)(2008-5#1)(2009-4#1)(2009-8#1)(2011-2#1)(2013-1#2)
that comprised a##2##3##(2007-11#1)(2008-3#1)
that comprised the##2##3##(2008-6#1)(2010-3#1)
that comprised##7##2##(1997-5#2)(2007-11#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-3#1)
that comprises##8##2##(1993-12#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-3#2)(2009-5#1)(2011-1#1)
that compromise##4##2##(2008-10#1)(2008-4#1)(2008-9#1)(2009-3#1)
that compromises##2##2##(2008-1#1)(2012-2#1)
that computational modelling##2##3##(2006-10#1)(2009-7#1)
that computed tomography##2##3##(2008-3#1)(2010-3#1)
that computed##5##2##(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-3#1)
that computer##3##2##(2007-10#1)(2008-6#1)(2010-8#1)
that computer-based##2##2##(2005-10#1)(2006-10#1)
that computes the##3##3##(2009-2#1)(2013-1#2)
that computes##5##2##(2008-3#1)(2009-2#1)(2010-2#1)(2013-1#2)
that concentrate##2##2##(2008-10#1)(2008-5#1)
that concentrations of##4##3##(1990-7#1)(2008-10#1)(2008-12#1)(2008-7#1)
that concern##6##2##(2006-2#1)(2008-10#2)(2008-2#1)(2008-7#1)(2013-8#1)
that concluded##2##2##(1997-2#1)(2009-8#1)
that conclusions##2##2##(2007-11#1)(2008-2#1)
that concomitant##4##2##(1990-7#1)(2009-4#1)(2011-2#1)(2012-12#1)
that concurrent##3##2##(1993-5#1)(1994-7#1)(2007-11#1)
that condensed##2##2##(1991-3#1)(2010-4#1)
that condition##6##2##(1997-1#1)(2005-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-4#1)
that conditional##2##2##(1995-3#1)(2011-2#1)
that conditioned##4##2##(1990-4#1)(1992-10#1)(2008-10#2)
that conditions##3##2##(1993-1#1)(1995-5#1)(1995-6#1)
that condom breakage##2##3##(2004-10#1)(2012-3#1)
that condom use##2##3##(2012-2#1)(2013-1#1)
that condom##4##2##(2004-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
that condoms##3##2##(1990-6#1)(2007-6#1)(2007-7#1)
that conducts##2##2##(2010-12#1)(2012-12#1)
that confer an##3##3##(1993-11#1)(1996-8#1)(2008-4#1)
that confer resistance to##2##4##(2008-10#1)(2012-12#1)
that confer resistance##3##3##(2008-10#2)(2012-12#1)
that confer##17##2##(1991-5#1)(1992-11#1)(1993-11#1)(1995-1#1)(1995-8#1)(1996-3#1)(1996-8#1)(1997-4#1)(2006-12#1)(2008-10#2)(2008-4#1)(2008-6#1)(2009-11#1)(2011-1#1)(2012-12#1)(2013-1#1)
that conferred by##2##3##(1995-8#1)(2013-8#1)
that conferred##5##2##(1995-8#1)(2011-2#3)(2013-8#1)
that confers a high##2##4##(1991-6#1)(2008-10#1)
that confers a##3##3##(1991-6#1)(2008-10#1)(2008-7#1)
that confers resistance to##2##4##(1995-2#1)(2008-10#1)
that confers resistance##3##3##(1995-2#1)(2008-10#2)
that confers##18##2##(1991-2#1)(1991-6#1)(1991-9#1)(1995-2#1)(1996-3#1)(2006-12#1)(2008-10#6)(2008-4#2)(2008-7#1)(2008-8#1)(2009-2#1)(2011-2#1)
that confirm the##5##3##(2007-11#1)(2007-12#2)(2007-2#1)(2008-2#1)
that confirm##12##2##(2006-3#1)(2007-11#2)(2007-12#3)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-7#1)(2012-12#1)
that confirmed the diagnosis of##2##5##(2006-7#1)(2013-8#1)
that confirmed the##7##3##(2006-2#1)(2006-3#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2013-8#1)
that confirmed##9##2##(2006-2#1)(2006-3#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-2#1)(2012-12#1)(2013-8#1)
that confirms##2##2##(1996-5#1)(2008-3#1)
that conform##2##2##(1995-2#1)(1995-4#1)
that conformational##2##2##(1992-11#1)(2008-4#1)
that conformed to the##2##4##(1997-4#1)(2009-7#1)
that conforms to##2##3##(1995-3#1)(2008-3#1)
that conforms##3##2##(1995-3#1)(2008-3#1)(2011-2#1)
that confront##2##2##(2007-4#1)(2012-11#1)
that confusion##2##2##(2006-10#1)(2011-1#1)
that congenital##2##2##(2007-9#1)(2010-2#1)
that conidia##3##2##(2008-10#3)
that connect the##4##3##(1997-3#1)(1997-5#1)(2007-11#1)(2008-3#1)
that connect##8##2##(1990-8#1)(1991-11#1)(1997-3#1)(1997-5#1)(2007-11#1)(2007-8#1)(2008-3#1)(2010-10#1)
that connects the##5##3##(1992-3#1)(2007-12#1)(2008-3#2)(2011-12#1)
that connects##13##2##(1992-3#1)(1995-6#1)(1997-1#1)(2006-6#1)(2007-12#2)(2008-10#1)(2008-3#4)(2008-6#1)(2011-12#1)
that consider the##3##3##(2005-10#1)(2008-2#1)(2008-7#1)
that consider##7##2##(2005-10#1)(2006-2#1)(2007-12#1)(2008-2#1)(2008-7#1)(2009-5#1)(2009-7#1)
that considerable##4##2##(2008-10#2)(2008-8#2)
that consideration of##5##3##(2006-1#1)(2008-2#1)(2009-12#1)(2012-2#1)(2012-3#1)
that consideration##6##2##(1996-12#1)(2006-1#1)(2008-2#1)(2009-12#1)(2012-2#1)(2012-3#1)
that considered##4##2##(1993-9#1)(2007-1#1)(2008-5#1)(2008-6#1)
that considering the##4##3##(1993-5#1)(1996-5#1)(1997-1#1)(2008-3#1)
that considering##5##2##(1993-5#1)(1996-5#1)(1997-1#1)(2008-3#1)(2012-2#1)
that considers both##3##3##(2007-8#1)(2013-1#2)
that considers the##3##3##(2007-12#1)(2009-4#2)
that considers##9##2##(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2009-4#2)(2011-2#1)(2013-1#2)
that consist of two##2##4##(2007-12#1)(2008-3#1)
that consist of##17##3##(1991-12#1)(1994-9#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#8)(2008-7#1)(2012-2#1)
that consist##18##2##(1991-12#1)(1994-9#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#9)(2008-7#1)(2012-2#1)
that consisted of a##4##4##(1990-4#1)(2008-10#2)(2008-3#1)
that consisted of both##2##4##(1992-1#1)(2007-12#1)
that consisted of polystyrene##2##4##(2007-12#1)(2008-3#1)
that consisted of three##2##4##(1997-6#1)(2011-2#1)
that consisted of##17##3##(1990-4#1)(1992-1#1)(1995-11#1)(1997-6#1)(2005-10#1)(2005-11#1)(2006-8#1)(2007-12#2)(2008-10#4)(2008-3#3)(2011-2#1)
that consisted##18##2##(1990-4#1)(1992-1#1)(1995-11#1)(1997-6#1)(2005-10#1)(2005-11#1)(2006-8#1)(2007-12#3)(2008-10#4)(2008-3#3)(2011-2#1)
that consistent##3##2##(1996-4#1)(2006-12#1)(2008-6#1)
that consistently##7##2##(1992-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-10#2)(2012-2#1)
that consists in##2##3##(2008-3#1)(2011-3#1)
that consists of a##7##4##(1994-9#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
that consists of an##5##4##(2008-10#2)(2008-11#1)(2010-6#1)(2012-12#1)
that consists of two##4##4##(2008-2#3)(2012-12#1)
that consists of##29##3##(1990-11#1)(1994-9#1)(1996-4#1)(2005-11#1)(2007-11#2)(2007-12#4)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#2)(2008-4#2)(2008-8#1)(2009-8#1)(2010-12#1)(2010-6#1)(2012-12#2)
that consists##31##2##(1990-11#1)(1994-9#1)(1996-4#1)(2005-11#1)(2007-11#2)(2007-12#4)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#3)(2008-4#2)(2008-8#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-3#1)(2012-12#2)
that constitute a##4##3##(1991-6#1)(2004-9#1)(2008-2#1)(2010-5#1)
that constitute the##14##3##(1991-6#1)(1993-6#1)(1994-12#1)(1996-10#1)(1996-5#1)(2006-12#1)(2008-1#1)(2008-2#2)(2008-3#1)(2009-6#1)(2012-2#2)(2013-7#1)
that constitute##26##2##(1991-6#3)(1993-3#1)(1993-6#1)(1994-12#1)(1995-8#1)(1996-10#1)(1996-5#1)(2004-9#1)(2006-12#1)(2006-3#1)(2008-1#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-5#1)(2012-2#2)(2013-1#1)(2013-7#1)
that constitutes a##4##3##(2008-10#1)(2008-3#1)(2009-4#1)(2011-2#1)
that constitutes the##2##3##(1995-8#1)(2013-8#1)
that constitutes this##2##3##(1995-2#1)(2008-6#1)
that constitutes##10##2##(1995-2#1)(1995-8#1)(2006-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-4#1)(2010-10#1)(2011-2#1)(2013-8#1)
that constitutive##2##2##(2008-10#1)(2008-3#1)
that constitutively##3##2##(1993-6#1)(2010-11#1)(2012-12#1)
that constrain the##3##3##(2008-2#2)(2008-9#1)
that constrain##5##2##(2008-2#2)(2008-8#1)(2008-9#1)(2012-1#1)
that consumed##4##2##(2008-7#1)(2009-4#1)(2009-5#2)
that consumer satisfaction##2##3##(1993-12#1)(1996-3#1)
that consumer##4##2##(1993-12#1)(1995-1#1)(1996-3#1)(2008-8#1)
that consumers who##2##3##(1993-3#1)(2008-8#1)
that consumers will##2##3##(1997-3#1)(2006-10#1)
that consumers##9##2##(1993-3#1)(1997-3#2)(2006-10#1)(2008-8#2)(2010-1#2)(2010-4#1)
that consumption of##5##3##(2006-10#1)(2007-8#1)(2008-10#2)(2012-12#1)
that consumption##7##2##(2006-10#1)(2007-8#1)(2008-10#2)(2008-4#1)(2012-12#1)(2012-2#1)
that contact with##2##3##(1991-7#1)(2007-2#1)
that contact##6##2##(1991-7#1)(1995-9#1)(1997-1#1)(2006-10#1)(2007-2#1)(2009-1#1)
that contacts##2##2##(1993-6#1)(1994-12#1)
that contain a##13##3##(1994-12#1)(1994-8#1)(1995-1#1)(1995-3#1)(1997-2#1)(1997-4#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-10#1)(2010-2#1)(2012-12#1)(2012-2#1)
that contain an##2##3##(1995-3#1)(2007-11#1)
that contain different##2##3##(2006-12#1)(2008-5#1)
that contain high##2##3##(2008-10#1)(2008-4#1)
that contain multiple##3##3##(1995-2#1)(2008-3#1)(2012-1#1)
that contain only##2##3##(1997-4#1)(2007-12#1)
that contain sequences##2##3##(2006-12#1)(2008-7#1)
that contain the##8##3##(1990-8#1)(1991-2#1)(1991-8#1)(1994-9#1)(2007-10#1)(2008-2#1)(2008-4#2)
that contain##113##2##(1990-8#2)(1991-2#2)(1991-3#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-10#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#2)(1995-12#1)(1995-2#1)(1995-3#3)(1996-12#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(2005-11#1)(2006-12#6)(2006-9#1)(2007-10#2)(2007-11#5)(2007-12#3)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#6)(2008-3#10)(2008-4#9)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-6#1)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#4)
that contained a##10##3##(1992-8#1)(1994-5#1)(2008-10#2)(2008-12#1)(2010-5#1)(2011-12#2)(2012-12#2)
that contained an##3##3##(1991-5#1)(1994-9#1)(2008-10#1)
that contained both the##2##4##(1996-2#1)(2008-7#1)
that contained both##4##3##(1996-2#1)(2005-11#1)(2008-7#2)
that contained either##3##3##(1995-10#1)(1995-8#1)(2011-2#1)
that contained less than##2##4##(2008-10#2)
that contained less##3##3##(2008-10#2)(2008-5#1)
that contained no detectable levels of estrogen receptors##2##8##(2008-11#2)
that contained no##4##3##(1995-10#1)(2008-10#1)(2008-11#2)
that contained one##2##3##(1990-5#1)(2008-10#1)
that contained small##2##3##(1996-4#1)(2008-10#1)
that contained the##10##3##(1990-11#1)(1991-6#1)(1992-8#1)(1994-8#1)(2006-8#1)(2008-10#3)(2008-11#1)(2013-7#1)
that contained##90##2##(1990-11#1)(1990-5#2)(1990-6#5)(1990-7#1)(1991-11#1)(1991-12#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-8#2)(1993-12#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#3)(1995-3#2)(1995-8#1)(1996-2#1)(1996-4#1)(1996-6#2)(1997-3#1)(1997-4#1)(2004-11#1)(2005-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-10#16)(2008-11#7)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#5)(2009-12#1)(2010-5#1)(2010-8#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#4)(2012-3#2)(2013-7#1)
that containing##6##2##(1992-8#1)(1992-9#1)(1993-11#1)(2008-10#2)(2012-12#1)
that contains a##26##3##(1990-3#1)(1991-2#1)(1992-3#1)(1993-6#1)(1994-9#1)(1995-2#1)(1995-8#2)(1996-4#1)(1996-7#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-3#2)(2008-4#5)(2009-2#1)(2009-3#1)
that contains all##2##3##(1995-3#1)(2008-10#1)
that contains an##4##3##(1994-5#1)(1996-5#1)(1997-4#1)(2007-11#1)
that contains information##2##3##(2008-3#1)(2008-4#1)
that contains multiple##2##3##(1997-4#1)(2008-10#1)
that contains only##3##3##(1992-6#1)(2008-3#2)
that contains the##23##3##(1992-12#1)(1992-7#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-2#1)(1995-4#1)(1996-5#1)(1996-8#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2009-9#1)
that contains three##3##3##(1991-7#2)(2008-3#1)
that contains two##5##3##(1995-1#2)(1995-2#1)(1996-7#1)(2008-4#1)
that contains##101##2##(1990-11#1)(1990-3#1)(1991-2#2)(1991-7#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-3#2)(1993-6#2)(1993-9#1)(1994-11#2)(1994-5#2)(1994-9#2)(1995-1#3)(1995-2#3)(1995-3#1)(1995-4#1)(1995-8#2)(1996-4#1)(1996-5#2)(1996-7#2)(1996-8#2)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#2)(2004-8#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#4)(2008-3#13)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#2)(2013-1#1)
that contaminated##2##2##(1995-11#1)(2008-12#1)
that contamination of##3##3##(2007-7#1)(2008-1#1)(2008-10#1)
that contamination##5##2##(1993-9#1)(2007-7#1)(2008-1#1)(2008-10#2)
that context##5##2##(1993-3#1)(2006-4#1)(2009-7#1)(2010-10#1)(2010-2#1)
that contextual##5##2##(2008-4#1)(2009-7#1)(2010-2#1)(2012-2#2)
that continue to##3##3##(1996-10#1)(2008-9#1)(2009-5#1)
that continued##8##2##(1996-4#1)(2008-12#1)(2008-3#1)(2009-8#1)(2011-2#1)(2011-7#1)(2012-2#1)(2012-3#1)
that continues to##3##3##(2006-10#1)(2008-6#1)(2011-12#1)
that continues##6##2##(2006-10#1)(2006-6#1)(2008-3#1)(2008-6#1)(2008-8#1)(2011-12#1)
that continuity##2##2##(1991-7#1)(1996-2#1)
that continuous infusions do better than bolus infusions is still lacking##2##11##(2006-6#2)
that continuous##12##2##(1991-2#1)(1991-3#1)(1995-5#1)(1996-3#1)(2006-6#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-8#1)(2013-8#1)
that continuously##3##2##(2010-7#1)(2012-3#2)
that contraception would##2##3##(2012-12#2)
that contradict##3##2##(1990-9#1)(2006-10#1)(2008-7#1)
that contrary to##5##3##(1993-9#1)(1996-2#1)(2008-11#2)(2011-1#1)
that contrast##3##2##(2006-1#1)(2008-3#1)(2008-7#1)
that contribute most##2##3##(1995-12#1)(2008-4#1)
that contribute to a##6##4##(1991-12#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
that contribute to adaptation##2##4##(2008-8#1)(2011-2#1)
that contribute to an##2##4##(2006-10#1)(2009-9#1)
that contribute to disease##2##4##(2004-1#1)(2010-7#1)
that contribute to multiple##2##4##(2006-10#2)
that contribute to the development of##2##6##(2010-12#1)(2011-2#1)
that contribute to the development##3##5##(2010-12#1)(2011-2#1)(2013-1#1)
that contribute to the##27##4##(1994-6#1)(1994-8#1)(1995-1#1)(1995-5#2)(1996-8#1)(2005-11#1)(2006-10#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-6#1)(2009-12#1)(2009-3#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
that contribute to this##3##4##(2006-11#1)(2008-7#1)(2012-3#1)
that contribute to variation##2##4##(2008-1#1)(2012-3#1)
that contribute to##90##3##(1991-12#1)(1991-6#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-5#2)(1996-2#1)(1996-7#1)(1996-8#1)(2004-1#1)(2005-11#1)(2006-10#4)(2006-11#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#3)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#7)(2013-1#2)(2013-8#1)
that contribute##98##2##(1991-12#1)(1991-6#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-5#2)(1996-2#1)(1996-7#1)(1996-8#1)(2004-1#1)(2005-11#1)(2006-10#4)(2006-11#1)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#4)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#7)(2013-1#2)(2013-8#1)
that contributed to the##8##4##(1994-11#1)(2005-12#1)(2007-8#1)(2008-5#2)(2011-2#1)(2012-12#1)(2012-2#1)
that contributed to##14##3##(1994-11#1)(2005-12#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-5#3)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)
that contributed##15##2##(1994-11#1)(2005-12#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-5#3)(2008-8#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)
that contributes to the##7##4##(1996-5#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-9#1)(2009-8#1)(2011-2#1)
that contributes to##15##3##(1994-9#1)(1996-5#1)(1997-1#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-3#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-6#1)(2011-2#1)(2013-8#1)
that contributes##19##2##(1994-9#1)(1996-5#1)(1997-1#1)(2006-9#1)(2007-11#1)(2007-12#3)(2007-5#1)(2008-1#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-7#2)(2009-8#1)(2010-6#1)(2011-2#1)(2013-8#1)
that control and##2##3##(2009-7#1)(2011-2#1)
that control cell##2##3##(2008-9#1)(2012-12#1)
that control expression of##2##4##(1991-11#1)(2005-7#1)
that control measures##2##3##(1994-6#1)(2007-6#1)
that control of##6##3##(1991-3#1)(2007-12#2)(2008-11#1)(2009-9#1)(2011-2#1)
that control plant##2##3##(2008-7#1)(2009-8#1)
that control the physiological##2##4##(1994-12#1)(2008-11#1)
that control the##25##3##(1990-7#1)(1992-5#1)(1993-3#1)(1994-12#1)(1995-3#2)(1995-6#1)(1995-9#1)(1997-6#1)(2006-12#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)
that control these##2##3##(2007-12#1)(2009-8#1)
that control##89##2##(1990-7#1)(1991-11#1)(1991-3#1)(1992-5#1)(1993-3#1)(1993-6#2)(1994-12#2)(1994-6#1)(1995-12#1)(1995-3#2)(1995-6#1)(1995-9#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-6#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#5)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#4)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#4)(2008-8#5)(2008-9#3)(2009-4#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#2)(2013-7#1)
that controlled##3##2##(1994-6#1)(2008-3#1)(2012-12#1)
that controls both##2##3##(1995-3#1)(2008-5#1)
that controls the synthesis of##2##5##(2005-12#1)(2008-10#1)
that controls the##15##3##(1992-3#1)(1996-4#1)(1996-5#1)(2005-12#1)(2006-7#1)(2007-8#1)(2008-10#4)(2008-2#1)(2009-8#1)(2012-12#1)(2013-7#2)
that controls##31##2##(1992-3#1)(1995-12#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-4#1)(1996-5#1)(1997-1#1)(2005-12#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-5#2)(2008-7#2)(2009-7#1)(2009-8#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-7#2)
that conventional##9##2##(1992-9#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-3#1)(2009-7#1)(2010-10#1)(2010-5#1)
that conventionally##2##2##(1996-5#1)(2010-2#1)
that converge to##2##3##(1997-1#1)(2007-12#1)
that converge##4##2##(1997-1#1)(2007-12#1)(2008-1#1)(2012-2#1)
that conversion of##3##3##(1994-8#1)(1995-1#1)(2008-7#1)
that conversion##5##2##(1992-5#1)(1994-8#1)(1995-1#1)(2007-12#1)(2008-7#1)
that convert##5##2##(1996-8#1)(2007-11#1)(2008-6#1)(2009-12#1)(2012-2#1)
that converted to##2##3##(2008-11#2)
that converted##3##2##(1995-2#1)(2008-11#2)
that converts the##2##3##(1990-8#1)(2008-4#1)
that converts##8##2##(1990-5#1)(1990-8#1)(1994-11#1)(2007-12#1)(2008-3#1)(2008-4#2)(2008-6#1)
that convey##4##2##(1995-11#1)(2006-10#1)(2007-10#1)(2012-2#1)
that cool storage##2##3##(1995-7#2)
that cooperate##2##2##(1991-5#1)(2006-10#1)
that cooperation##5##2##(1990-4#1)(1996-3#1)(2008-8#3)
that cooperative DNA binding is facilitated by##2##7##(1996-8#2)
that cooperative##4##2##(1995-2#1)(1996-8#2)(2008-8#1)
that cooperativity##2##2##(1994-5#1)(1995-8#1)
that coordinates##3##2##(2008-12#1)(2012-2#2)
that copper aspirinate##3##3##(2008-5#3)
that copper is##2##3##(1995-11#1)(2008-5#1)
that copper##13##2##(1995-11#2)(1997-7#1)(2005-11#1)(2008-10#4)(2008-5#4)(2009-2#1)
that copurify with##2##3##(1991-1#1)(1997-3#1)
that cord blood##2##3##(2008-11#2)
that core##3##2##(1996-3#1)(2010-4#1)(2012-1#1)
that corn##2##2##(2008-5#1)(2011-2#1)
that corneal epithelial##2##3##(2005-11#1)(2008-4#1)
that coronary##4##2##(1991-5#1)(2005-1#1)(2007-8#1)(2008-2#1)
that correct##6##2##(1990-5#1)(1992-4#1)(2007-12#1)(2007-6#1)(2008-3#1)(2012-2#1)
that corrected##3##2##(2012-12#1)(2013-1#2)
that corrections##2##2##(1991-10#1)(1992-9#1)
that correctly##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
that correlate with the##2##4##(1994-9#1)(2008-11#1)
that correlate with##5##3##(1993-3#1)(1994-9#1)(2006-10#1)(2008-11#1)(2008-9#1)
that correlate##8##2##(1993-3#1)(1994-9#1)(2006-10#1)(2008-11#1)(2008-9#1)(2009-8#1)(2010-5#1)(2012-2#1)
that correlated with the##7##4##(1994-3#1)(1995-5#1)(1996-1#1)(2008-10#3)(2009-2#1)
that correlated with##15##3##(1992-12#1)(1994-3#1)(1995-5#1)(1996-1#2)(1997-4#1)(2008-10#6)(2009-2#1)(2009-8#1)(2013-1#1)
that correlated##18##2##(1992-12#1)(1994-3#1)(1995-5#1)(1996-1#2)(1997-4#1)(2006-12#1)(2007-4#1)(2008-10#7)(2009-2#1)(2009-8#1)(2013-1#1)
that correlates well with##2##4##(2008-5#2)
that correlates with the##2##4##(1993-11#1)(2008-3#1)
that correlates with##6##3##(1993-11#1)(1995-6#1)(2006-8#2)(2008-11#1)(2008-3#1)
that correlates##10##2##(1993-11#1)(1995-6#1)(2006-8#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2011-12#1)
that correlation##3##2##(1990-1#1)(2007-12#1)(2011-2#1)
that correspond to a##3##4##(2005-11#1)(2008-2#1)(2008-3#1)
that correspond to the##12##4##(1996-5#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2010-2#1)(2013-1#2)
that correspond to two##2##4##(2008-3#2)
that correspond to##29##3##(1992-7#1)(1993-2#1)(1993-5#1)(1996-5#1)(1997-4#1)(2005-11#1)(2007-11#2)(2007-12#3)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#6)(2008-9#1)(2010-2#1)(2013-1#2)
that correspond with the##2##4##(2007-8#1)(2009-10#1)
that correspond##35##2##(1992-11#1)(1992-7#1)(1993-2#1)(1993-5#1)(1994-9#1)(1996-5#1)(1997-4#1)(2005-11#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#6)(2008-9#1)(2009-10#1)(2010-2#1)(2011-12#1)(2013-1#2)
that corresponded to 50%##3##4##(2013-8#3)
that corresponded to the##3##4##(2008-10#1)(2011-2#2)
that corresponded to their##2##4##(2008-10#1)(2008-5#1)
that corresponded to##19##3##(1997-2#1)(2007-12#1)(2008-10#6)(2008-5#2)(2008-6#1)(2009-3#1)(2011-2#2)(2013-8#5)
that corresponded##20##2##(1997-2#1)(2007-12#1)(2008-10#7)(2008-5#2)(2008-6#1)(2009-3#1)(2011-2#2)(2013-8#5)
that corresponding##2##2##(2007-8#1)(2013-1#1)
that corresponds to a##6##4##(1992-12#1)(2007-11#1)(2007-12#3)(2008-3#1)
that corresponds to an##2##4##(2007-4#1)(2008-2#1)
that corresponds to the##11##4##(1996-5#1)(1996-7#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2009-10#1)(2012-12#1)(2013-1#1)
that corresponds to##25##3##(1992-12#1)(1993-6#1)(1994-12#1)(1995-1#1)(1996-5#1)(1996-7#1)(2006-12#1)(2007-11#1)(2007-12#5)(2007-4#1)(2008-10#2)(2008-2#2)(2008-3#3)(2009-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
that corresponds##29##2##(1992-12#1)(1993-6#1)(1994-12#1)(1995-1#1)(1996-5#2)(1996-7#1)(1997-2#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#5)(2007-4#1)(2008-10#2)(2008-2#2)(2008-3#3)(2009-10#1)(2012-12#1)(2012-2#1)(2013-1#2)
that cortical##5##2##(1994-5#1)(1996-9#2)(2007-9#1)(2008-7#1)
that corticosterone##3##2##(1994-5#1)(2007-11#2)
that cosegregates##2##2##(1991-12#1)(2008-8#1)
that cost##9##2##(1990-4#1)(1992-3#1)(1994-1#1)(1994-3#2)(1994-9#1)(2006-10#1)(2009-5#1)(2012-3#1)
that cost-##2##2##(1990-12#1)(2011-1#1)
that costs##3##2##(1996-3#1)(2007-7#1)(2008-8#1)
that could act##3##3##(1994-8#1)(2008-5#2)
that could affect the##5##4##(2006-10#1)(2008-10#2)(2008-2#1)(2013-7#1)
that could affect##8##3##(2006-10#1)(2008-10#2)(2008-2#1)(2011-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
that could aid in##3##4##(2008-10#1)(2008-6#1)(2012-2#1)
that could arise##2##3##(2008-3#1)(2012-2#1)
that could assist##2##3##(2008-11#1)(2012-12#1)
that could be a##4##4##(1990-6#1)(1993-10#1)(2007-10#1)(2008-8#1)
that could be activated##2##4##(1991-4#1)(1993-12#1)
that could be directly##2##4##(1993-12#1)(2006-11#1)
that could be easily##3##4##(2008-10#1)(2011-1#1)(2013-1#1)
that could be explained by##3##5##(2006-10#1)(2008-10#2)
that could be helpful##2##4##(2012-2#2)
that could be implemented to##2##5##(1992-3#1)(2007-8#1)
that could be implemented##4##4##(1992-3#1)(2007-8#1)(2008-1#1)(2008-2#1)
that could be involved in##2##5##(1992-4#1)(2008-1#1)
that could be more##2##4##(2008-10#1)(2008-6#1)
that could be of##2##4##(1991-9#1)(2006-10#1)
that could be related to the##3##6##(1995-1#1)(2006-8#1)(2009-8#1)
that could be related to##4##5##(1995-1#1)(1997-5#1)(2006-8#1)(2009-8#1)
that could be taken##3##4##(2007-4#2)(2011-2#1)
that could be tolerated##2##4##(2006-2#1)(2007-9#1)
that could be used as a##2##6##(1996-3#1)(2012-1#1)
that could be used as##5##5##(1996-3#1)(1997-3#1)(2008-10#2)(2012-1#1)
that could be used for##9##5##(1992-1#1)(1995-2#1)(1997-4#1)(2008-10#2)(2008-6#1)(2009-3#1)(2010-12#1)(2012-2#1)
that could be used in##3##5##(1992-7#1)(2012-3#1)(2013-1#1)
that could be used to detect##2##6##(2006-10#1)(2008-10#1)
that could be used to discriminate between##2##7##(2008-10#1)(2008-7#1)
that could be used to improve##3##6##(2007-10#1)(2009-10#1)(2010-12#1)
that could be used to test##2##6##(2005-10#1)(2010-2#1)
that could be used to##24##5##(1991-9#1)(2005-10#1)(2006-10#2)(2006-4#1)(2007-10#3)(2008-10#7)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-12#1)(2012-1#1)
that could be used##44##4##(1991-9#1)(1992-1#1)(1992-11#1)(1992-7#1)(1995-2#1)(1996-3#1)(1997-3#1)(1997-4#1)(2005-10#1)(2006-10#2)(2006-4#1)(2007-10#3)(2008-10#11)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#2)(2009-3#2)(2009-9#1)(2010-12#2)(2010-2#1)(2011-12#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
that could be useful##2##4##(2008-2#1)(2010-2#1)
that could be##159##3##(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-4#1)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#3)(1992-4#2)(1992-7#2)(1993-1#1)(1993-10#1)(1993-12#2)(1993-8#2)(1994-2#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-8#2)(1996-1#2)(1996-3#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-5#1)(2003-11#1)(2005-10#2)(2005-11#2)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#2)(2007-8#3)(2007-9#3)(2008-1#3)(2008-10#19)(2008-11#2)(2008-2#5)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#2)(2009-2#1)(2009-3#3)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#2)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#3)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)
that could cause##4##3##(1995-2#1)(2008-10#1)(2008-7#1)(2011-2#1)
that could contribute to##6##4##(1997-2#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2011-2#1)
that could distinguish##2##3##(2008-10#1)(2009-4#1)
that could explain the##5##4##(2005-10#1)(2007-12#1)(2007-3#1)(2008-11#1)(2010-12#1)
that could explain##8##3##(1990-12#1)(2005-10#1)(2006-11#1)(2007-12#1)(2007-3#1)(2008-11#1)(2010-12#1)(2012-1#1)
that could facilitate##3##3##(2008-10#1)(2008-12#1)(2008-6#1)
that could form##2##3##(1995-6#1)(2007-11#1)
that could further##2##3##(2005-12#1)(2008-9#1)
that could guide##2##3##(1996-12#1)(2012-2#1)
that could have been##4##4##(1994-7#1)(1996-1#1)(2009-8#1)(2012-3#1)
that could have##11##3##(1990-3#1)(1994-7#1)(1996-1#1)(1997-5#1)(2004-9#1)(2007-9#1)(2008-7#1)(2009-8#1)(2010-12#1)(2012-3#1)(2013-1#1)
that could help to##2##4##(2008-3#1)(2012-12#1)
that could help##7##3##(1994-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-12#1)(2013-8#2)
that could identify patients who##2##5##(2007-8#1)(2009-4#1)
that could improve##3##3##(2005-10#1)(2008-10#1)(2008-9#1)
that could increase the##2##4##(2008-7#1)(2011-2#1)
that could increase##3##3##(2008-7#1)(2011-12#1)(2011-2#1)
that could induce##4##3##(2006-11#1)(2006-9#1)(2007-11#1)(2008-4#1)
that could influence##7##3##(2006-9#1)(2007-4#1)(2008-4#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
that could inhibit##4##3##(1991-12#1)(1996-10#1)(2008-7#1)(2008-8#1)
that could interfere with the##3##5##(2008-2#1)(2012-12#2)
that could interfere with##4##4##(2008-2#1)(2012-1#1)(2012-12#2)
that could lead to the##2##5##(2008-10#1)(2008-7#1)
that could lead to##9##4##(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-10#1)
that could make##2##3##(2007-9#1)(2013-1#1)
that could modify##2##3##(2005-8#1)(2011-2#1)
that could modulate##2##3##(2008-11#1)(2008-5#1)
that could not be##15##4##(1991-4#1)(1992-5#1)(1994-11#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2010-9#1)(2012-2#1)(2012-3#1)
that could not##21##3##(1991-4#1)(1992-5#1)(1992-9#1)(1994-11#1)(1997-2#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-7#2)(2010-9#1)(2011-12#1)(2012-2#1)(2012-3#1)
that could participate in the##2##5##(1991-6#1)(2012-2#1)
that could potentially##4##3##(1997-2#1)(2008-2#1)(2011-2#1)(2012-2#1)
that could present in##2##4##(2006-12#1)(2008-10#1)
that could prevent##3##3##(2008-11#1)(2009-8#1)(2012-12#1)
that could promote##2##3##(2009-3#1)(2012-12#1)
that could prove##2##3##(2008-11#1)(2008-7#1)
that could provide a##2##4##(2009-4#1)(2012-12#1)
that could provide##6##3##(1992-4#1)(2008-10#1)(2009-2#1)(2009-4#1)(2010-12#1)(2012-12#1)
that could reduce##3##3##(2006-10#2)(2008-5#1)
that could reflect##2##3##(1992-2#1)(2007-9#1)
that could replace##3##3##(2004-2#1)(2008-10#1)(2008-5#1)
that could result in##6##4##(1992-1#1)(2006-5#1)(2008-9#1)(2009-9#1)(2011-2#2)
that could serve as##2##4##(1991-9#1)(2008-7#1)
that could support##2##3##(2008-10#1)(2013-1#1)
that could take##2##3##(2004-12#1)(2006-2#1)
that could##413##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-4#2)(1991-6#1)(1991-8#1)(1991-9#3)(1992-1#3)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#3)(1992-5#1)(1992-7#3)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-12#3)(1993-2#1)(1993-8#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#2)(1995-6#1)(1995-8#2)(1996-1#3)(1996-10#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#3)(1997-8#1)(2003-11#1)(2004-12#2)(2004-2#1)(2004-9#1)(2005-10#5)(2005-11#3)(2005-12#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#10)(2006-11#3)(2006-12#4)(2006-2#3)(2006-4#2)(2006-5#1)(2006-7#2)(2006-8#3)(2006-9#3)(2007-1#1)(2007-10#5)(2007-11#7)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#4)(2007-7#1)(2007-8#6)(2007-9#8)(2008-1#5)(2008-10#43)(2008-11#12)(2008-12#4)(2008-2#10)(2008-3#9)(2008-4#4)(2008-5#7)(2008-6#5)(2008-7#14)(2008-8#7)(2008-9#4)(2009-1#1)(2009-10#2)(2009-2#2)(2009-3#5)(2009-4#5)(2009-7#2)(2009-8#4)(2009-9#3)(2010-10#3)(2010-12#7)(2010-2#3)(2010-3#3)(2010-4#1)(2010-5#1)(2010-9#3)(2011-1#5)(2011-12#3)(2011-2#12)(2012-1#5)(2012-12#10)(2012-2#12)(2012-3#5)(2013-1#12)(2013-7#3)(2013-8#5)
that counteract the##4##3##(1995-1#1)(2008-1#1)(2008-6#1)(2010-7#1)
that counteract##5##2##(1995-1#1)(1996-11#1)(2008-1#1)(2008-6#1)(2010-7#1)
that countries##2##2##(2005-5#1)(2008-1#1)
that country##4##2##(1992-3#1)(1997-3#1)(2005-5#1)(2007-9#1)
that couple the##2##3##(1994-8#1)(2013-1#1)
that couple##8##2##(1994-8#1)(1996-11#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-12#1)(2012-2#1)(2013-1#1)
that couples the##2##3##(2008-2#1)(2008-8#1)
that couples##10##2##(1994-12#1)(1996-5#1)(2007-12#1)(2008-2#3)(2008-7#1)(2008-8#1)(2010-2#1)(2013-1#1)
that covalent modification of##2##4##(1992-3#1)(1997-8#1)
that covalent##5##2##(1990-12#1)(1992-3#1)(1993-8#1)(1997-8#2)
that covalently##5##2##(1991-12#1)(1991-2#1)(1993-4#1)(1995-1#1)(1996-8#1)
that cover a##3##3##(2007-11#1)(2008-3#1)(2008-4#1)
that cover the##2##3##(2008-3#1)(2008-5#1)
that cover##6##2##(2007-11#1)(2008-3#3)(2008-4#1)(2008-5#1)
that coverage##3##2##(2005-8#1)(2013-1#2)
that covered##3##2##(2005-9#1)(2006-2#1)(2006-4#1)
that covers a##3##3##(1993-4#1)(2008-10#1)(2008-5#1)
that covers the##4##3##(2008-10#2)(2010-10#1)(2011-12#1)
that covers##12##2##(1993-4#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)(2010-10#1)(2011-12#1)
that create the##2##3##(2008-8#1)(2009-10#1)
that create##10##2##(1992-1#1)(1995-8#1)(1997-3#1)(2006-8#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-8#1)(2011-2#1)
that created a##2##3##(2006-8#1)(2012-3#1)
that created that##2##3##(2007-12#1)(2008-8#1)
that created##5##2##(2006-8#1)(2007-12#1)(2008-1#1)(2008-8#1)(2012-3#1)
that creates the##2##3##(2008-3#1)(2008-9#1)
that creates##12##2##(1991-9#1)(1994-9#1)(1995-8#1)(2006-6#1)(2007-12#1)(2007-3#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-9#1)(2010-2#1)
that creativity##3##2##(1995-1#3)
that critical##8##2##(1995-12#1)(1996-12#1)(2005-10#1)(2005-12#1)(2006-9#1)(2007-6#1)(2010-4#1)(2010-7#1)
that critically##2##2##(2005-10#1)(2008-11#1)
that cross the##2##3##(1992-1#1)(1996-11#1)
that cross##5##2##(1992-1#1)(1996-11#1)(2007-12#1)(2008-8#1)(2013-8#1)
that cross-link##4##2##(2008-1#1)(2008-2#2)(2009-2#1)
that cross-linking of##2##3##(1991-9#1)(1995-1#1)
that cross-linking##5##2##(1991-9#1)(1994-9#1)(1995-1#1)(1996-5#1)(1997-2#1)
that cross-links##2##2##(1994-12#1)(2008-10#1)
that crosstalk##2##2##(2008-11#1)(2008-4#1)
that crowding##2##2##(2008-1#2)
that crude##2##2##(1996-12#1)(2010-9#1)
that crystalline##2##2##(1995-11#1)(2008-3#1)
that culminates##2##2##(1996-5#1)(2007-12#1)
that cultivar##3##2##(2008-10#3)
that cultural##4##2##(2007-12#1)(2007-3#1)(2009-10#2)
that culture##3##2##(1992-6#1)(2008-5#1)(2012-2#1)
that cultured normal##2##3##(2008-4#1)(2008-8#1)
that cultured##7##2##(1990-2#1)(1991-7#1)(1995-3#1)(1997-1#1)(2008-4#1)(2008-8#1)(2012-12#1)
that culturing##2##2##(1994-8#1)(2008-11#1)
that cumulatively##2##2##(2009-8#1)(2012-12#1)
that cupping##2##2##(2013-1#2)
that curcumin##4##2##(2010-12#1)(2011-2#1)(2012-3#2)
that current laws and practices##2##5##(1992-3#1)(1996-2#1)
that current practices##2##3##(1990-11#1)(2005-7#1)
that current##27##2##(1990-11#1)(1990-6#1)(1992-12#1)(1992-3#1)(1992-9#1)(1996-2#1)(2005-7#1)(2006-5#1)(2006-9#2)(2007-12#2)(2007-3#1)(2007-4#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#2)(2009-7#1)(2010-4#1)(2010-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
that currently available##3##3##(1995-2#1)(2009-10#1)(2013-8#1)
that currently exist in##2##4##(2008-1#1)(2012-12#1)
that currently exists##2##3##(1995-12#1)(2007-2#1)
that currently is##2##3##(2008-7#1)(2013-7#1)
that currently##21##2##(1992-6#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-8#1)(1997-3#1)(2007-11#2)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-10#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
that cut##3##2##(2008-7#1)(2008-9#2)
that cutaneous##2##2##(2008-5#1)(2012-3#1)
that cuticle##2##2##(2007-12#1)(2008-10#1)
that cuts across##2##3##(2008-8#1)(2011-12#1)
that cyanide##2##2##(1991-9#1)(1994-9#1)
that cycles of##2##3##(1991-7#1)(2010-8#1)
that cyclic AMP##2##3##(1993-6#1)(1995-1#1)
that cyclic##6##2##(1993-6#1)(1994-11#1)(1995-1#1)(1997-2#1)(2008-10#1)(2012-7#1)
that cycling##2##2##(2008-11#1)(2011-12#1)
that cyclins##2##2##(1997-6#1)(2008-5#1)
that cyclists##3##2##(2011-12#3)
that cyclodextrin##2##2##(1996-8#2)
that cyclosporin A##3##3##(1990-3#1)(1991-10#1)(1992-7#1)
that cyclosporin##7##2##(1990-3#1)(1991-10#1)(1992-7#1)(2007-11#4)
that cysteine##3##2##(1991-9#1)(1996-11#1)(2008-10#1)
that cytochrome##8##2##(1990-5#1)(1990-7#1)(1991-2#1)(1992-12#1)(1992-6#1)(1995-6#1)(1995-8#1)(1996-2#1)
that cytokines##3##2##(1991-10#1)(1992-3#1)(2012-2#1)
that cytoplasmic##3##2##(1993-11#1)(1995-2#1)(2008-8#1)
that cytosolic##3##2##(1997-1#1)(1997-6#1)(1997-7#1)
that cytotoxic##5##2##(1994-8#1)(2007-11#2)(2008-1#1)(2012-12#1)
that daily##7##2##(1990-10#1)(1990-7#1)(1994-2#1)(1995-12#1)(2009-12#1)(2009-7#1)(2010-12#1)
that daintain/AIF-1##3##2##(2008-3#3)
that damage to the##5##4##(1994-10#1)(1994-11#1)(1995-11#1)(2006-4#1)(2008-5#1)
that damage to##6##3##(1994-10#1)(1994-11#1)(1995-11#1)(2006-4#1)(2008-5#1)(2009-1#1)
that damage##12##2##(1994-10#1)(1994-11#1)(1994-5#2)(1995-11#1)(1995-8#1)(2006-4#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-8#1)(2011-2#1)
that damaged##3##2##(1996-1#1)(2008-8#1)(2010-2#1)
that damages##2##2##(2010-12#1)(2011-2#1)
that daptomycin##2##2##(2005-7#2)
that dark##2##2##(2008-3#1)(2013-8#1)
that data are##2##3##(2008-9#1)(2009-12#1)
that data should be##2##4##(2012-3#2)
that data##14##2##(1992-5#1)(1993-10#1)(2005-9#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-12#1)(2011-1#1)(2012-3#3)
that date##2##2##(2008-3#1)(2010-12#1)
that de novo##5##3##(1991-7#1)(1995-8#1)(1997-7#1)(2008-11#1)(2008-5#1)
that deal with##3##3##(1996-2#1)(2007-8#1)(2012-1#1)
that dealt with##4##3##(1992-1#1)(1995-1#1)(2005-7#1)(2007-6#1)
that dealt##5##2##(1992-1#1)(1995-1#1)(2005-7#1)(2007-6#2)
that death##4##2##(1996-11#1)(2006-6#1)(2011-1#1)(2011-2#1)
that deaths##2##2##(1996-11#1)(1996-12#1)
that decision rules##2##3##(2008-10#1)(2008-7#1)
that decision##5##2##(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#1)
that decision-making##2##2##(1995-1#1)(2006-2#1)
that decisions##2##2##(2008-5#1)(2012-11#1)
that declined##2##2##(1990-5#1)(2008-10#1)
that decompose##2##2##(2008-10#1)(2008-7#1)
that decrease in##2##3##(1996-11#1)(2011-12#1)
that decrease the##3##3##(2006-2#1)(2010-11#1)(2010-12#1)
that decrease##8##2##(1993-11#1)(1996-11#1)(2006-10#1)(2006-2#1)(2008-3#1)(2010-11#1)(2010-12#1)(2011-12#1)
that decreased as##2##3##(2008-10#1)(2010-4#1)
that decreased##10##2##(1990-2#1)(1990-5#1)(1995-6#1)(1996-5#1)(2008-1#2)(2008-10#1)(2008-3#1)(2009-7#1)(2010-4#1)
that decreases in##3##3##(1990-6#1)(1997-2#1)(2009-5#1)
that decreases the##3##3##(2007-12#1)(2008-2#1)(2008-5#1)
that decreases to##2##3##(1991-8#2)
that decreases##10##2##(1990-6#1)(1991-8#2)(1997-2#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-5#1)
that deep##6##2##(1992-10#1)(1994-9#1)(1996-2#1)(1997-5#1)(1997-8#1)(2012-2#1)
that defect##2##2##(2007-12#1)(2008-3#1)
that defective##4##2##(1995-8#1)(2006-8#1)(2008-7#1)(2009-10#1)
that defects in##4##3##(1992-12#1)(1994-12#2)(1997-4#1)
that defects##5##2##(1992-12#1)(1994-11#1)(1994-12#2)(1997-4#1)
that defends the##2##3##(2006-7#1)(2011-2#1)
that deficiencies in##2##3##(1991-8#1)(2011-1#1)
that deficiency of##3##3##(1994-11#1)(1994-3#1)(1997-7#1)
that deficits in##2##3##(1991-8#1)(1997-2#1)
that define a##2##3##(1990-8#1)(2012-12#1)
that define and##2##3##(2007-12#1)(2008-10#1)
that define the##6##3##(1991-2#1)(1994-9#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-12#1)
that define##17##2##(1990-8#1)(1991-2#1)(1994-9#1)(1997-4#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#2)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)
that defined##2##2##(2008-11#1)(2013-1#1)
that defines a##2##3##(1995-3#1)(2008-5#1)
that defines the##4##3##(2007-12#1)(2008-2#1)(2009-8#1)(2011-1#1)
that defines##10##2##(1995-3#1)(2006-1#1)(2007-12#1)(2007-6#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-7#1)(2011-1#1)
that definitely##2##2##(2006-10#1)(2006-3#1)
that definitively##2##2##(2005-8#1)(2007-11#1)
that degenerate##2##2##(1994-12#1)(2008-10#1)
that degeneration##3##2##(1997-1#1)(2007-8#1)(2008-9#1)
that degradation of##3##3##(1990-4#1)(2008-3#1)(2008-7#1)
that degrade the##2##3##(2007-10#1)(2009-4#1)
that degrade##5##2##(1991-3#1)(2007-10#1)(2009-4#1)(2012-3#1)(2013-1#1)
that degrades##2##2##(1994-8#1)(2008-5#1)
that degree of##3##3##(1991-12#1)(2008-10#1)(2013-7#1)
that delay malaria diagnosis and treatment##2##6##(2012-12#2)
that delay##4##2##(1990-2#1)(1991-11#1)(2012-12#2)
that delayed##4##2##(1993-4#1)(1995-5#1)(2006-10#1)(2011-2#1)
that delaying##2##2##(2006-10#1)(2010-12#1)
that delays##2##2##(1995-4#1)(2008-4#1)
that deleterious##2##2##(1990-11#1)(2008-5#1)
that deletion of the##2##4##(2012-3#1)(2013-8#1)
that deletion of##5##3##(1993-9#1)(1997-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
that deletion##6##2##(1993-9#1)(1997-3#1)(2012-2#1)(2012-3#1)(2013-8#2)
that deletions##2##2##(2008-11#2)
that deliver##4##2##(2007-11#1)(2007-8#1)(2008-3#1)(2008-6#1)
that delivered##3##2##(1994-3#1)(2004-10#1)(2011-1#1)
that delivers the##2##3##(2008-2#1)(2012-3#1)
that delivers##6##2##(1992-3#1)(1996-11#1)(2007-11#1)(2008-2#1)(2010-6#1)(2012-3#1)
that delivery of a##2##4##(1992-12#1)(2005-6#1)
that delta##4##2##(1991-2#1)(1991-9#1)(1993-3#1)(2008-2#1)
that deltamethrin##2##2##(2008-10#1)(2013-1#1)
that demand##2##2##(2006-10#1)(2008-9#1)
that demand-side##2##2##(2006-4#1)(2010-1#1)
that demands##2##2##(2011-2#1)(2013-1#1)
that demographic variables##2##3##(2007-12#1)(2008-7#1)
that demographic##4##2##(1993-12#1)(1996-3#1)(2007-12#1)(2008-7#1)
that demonstrate a##5##3##(2007-12#1)(2008-2#1)(2008-3#2)(2008-7#1)
that demonstrate that##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
that demonstrate the advantages of the proposed##2##7##(2008-3#1)(2012-12#1)
that demonstrate the proposed##2##4##(2008-3#2)
that demonstrate the##26##3##(1991-1#1)(1992-12#1)(1997-5#1)(2005-11#1)(2007-12#2)(2008-1#1)(2008-2#5)(2008-3#10)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
that demonstrate##56##2##(1991-1#1)(1992-12#1)(1996-6#1)(1997-5#1)(2005-11#1)(2006-10#9)(2007-10#1)(2007-11#1)(2007-12#4)(2007-4#1)(2008-1#1)(2008-11#1)(2008-2#9)(2008-3#14)(2008-6#1)(2008-7#2)(2009-2#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
that demonstrated##6##2##(1990-12#1)(1994-9#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-7#1)
that demonstrates that##3##3##(1996-12#1)(2007-12#1)(2008-5#1)
that demonstrates the##6##3##(1993-1#1)(2007-12#1)(2008-12#1)(2009-8#1)(2011-1#1)(2012-12#1)
that demonstrates##15##2##(1993-1#1)(1996-12#2)(2006-12#2)(2007-12#3)(2008-12#1)(2008-3#2)(2008-5#1)(2009-8#1)(2011-1#1)(2012-12#1)
that dendritic action potentials##2##4##(1997-5#2)
that dendritic cells##3##3##(1996-10#1)(2005-12#1)(2008-10#1)
that dendritic##8##2##(1990-7#1)(1995-6#1)(1996-10#1)(1997-5#3)(2005-12#1)(2008-10#1)
that dense##2##2##(1992-7#1)(2008-10#1)
that dental caries is a##2##5##(1991-6#1)(2010-6#1)
that dental healthcare workers##2##4##(2007-1#2)
that dental hygiene##2##3##(2006-2#1)(2010-5#1)
that dental##13##2##(1991-6#1)(1995-3#1)(2006-2#3)(2007-1#2)(2008-11#1)(2008-9#1)(2010-5#1)(2010-6#1)(2013-1#2)
that dentistry##2##2##(2011-1#2)
that dentists##4##2##(1996-11#1)(2006-2#1)(2008-6#1)(2010-3#1)
that depend on both the##2##5##(1990-7#1)(1992-4#1)
that depend on the##11##4##(1993-2#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-7#1)
that depend on##23##3##(1990-7#1)(1991-2#1)(1992-4#1)(1993-2#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-4#1)(2010-7#1)
that depend##25##2##(1990-7#1)(1991-2#1)(1992-4#1)(1993-2#1)(1995-3#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-2#1)(2010-4#1)(2010-7#1)
that depended##2##2##(1993-6#1)(2005-11#1)
that depends on the degree of##2##6##(1994-5#1)(2007-11#1)
that depends on the##19##4##(1994-5#1)(1994-8#1)(2006-7#1)(2007-11#2)(2007-12#3)(2008-11#1)(2008-2#2)(2008-3#5)(2011-2#1)(2012-12#1)(2013-8#1)
that depends on##28##3##(1990-11#1)(1994-5#1)(1994-8#1)(2006-10#1)(2006-7#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#7)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
that depends##31##2##(1990-11#1)(1993-4#1)(1994-5#1)(1994-8#1)(2006-10#1)(2006-7#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#7)(2008-5#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
that depicts the##2##3##(2008-12#1)(2008-4#1)
that depletes##2##2##(1997-1#1)(2008-12#1)
that depletion of##6##3##(1990-2#1)(1992-8#1)(1994-12#1)(1995-3#1)(2012-12#2)
that depolarization##4##2##(2007-9#1)(2008-10#1)(2008-3#1)(2010-12#1)
that depolarized##2##2##(1996-5#1)(2007-12#1)
that depressed##2##2##(1994-2#1)(2011-2#1)
that depression affects##2##3##(2008-6#1)(2012-2#1)
that depression is associated with increased##2##6##(2008-11#1)(2012-12#1)
that depression is##3##3##(2008-11#1)(2010-12#1)(2012-12#1)
that depression##8##2##(1996-12#1)(2005-6#1)(2008-11#1)(2008-6#1)(2009-10#1)(2010-12#1)(2012-12#1)(2012-2#1)
that depressive##5##2##(2006-4#1)(2008-8#1)(2010-3#1)(2010-4#1)(2013-8#1)
that depth##2##2##(1994-9#1)(2006-5#1)
that deregulated expression of##2##4##(1991-12#1)(2008-1#1)
that deregulation of##2##3##(2008-8#2)
that derive##2##2##(1993-12#1)(2008-3#1)
that derived from the##2##4##(1994-5#1)(2012-12#1)
that derived from##6##3##(1992-12#1)(1992-2#1)(1994-5#1)(2008-3#1)(2008-9#1)(2012-12#1)
that derived##7##2##(1992-12#1)(1992-2#1)(1994-5#1)(1997-5#1)(2008-3#1)(2008-9#1)(2012-12#1)
that derives##2##2##(2008-10#1)(2009-5#1)
that describe a##2##3##(2007-12#1)(2008-3#1)
that describe laser##2##3##(2008-3#2)
that describe the##23##3##(1990-8#1)(1993-12#1)(1993-8#1)(1997-2#1)(1997-7#1)(2007-12#3)(2008-10#2)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
that describe##43##2##(1990-8#1)(1993-12#1)(1993-8#1)(1996-4#1)(1997-2#1)(1997-7#1)(2006-10#1)(2007-12#6)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#2)(2009-6#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#3)(2013-7#1)
that described in##3##3##(1992-10#1)(2006-7#1)(2007-2#1)
that described the##3##3##(2007-2#1)(2008-10#1)(2011-2#1)
that described##21##2##(1990-5#1)(1992-10#1)(1992-9#1)(1997-1#1)(1997-2#1)(2006-7#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-11#2)
that describes a##4##3##(1996-8#1)(2006-10#1)(2008-4#1)(2008-8#1)
that describes the##26##3##(1991-9#1)(1996-11#1)(1997-2#1)(2006-7#1)(2007-11#4)(2007-2#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
that describes##49##2##(1991-9#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-2#1)(2004-12#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-6#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#6)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
that deserve##3##2##(1993-9#1)(2009-10#1)(2012-2#1)
that deserves##2##2##(2007-10#1)(2007-7#1)
that design##2##2##(1990-4#1)(2008-2#1)
that designing##2##2##(2006-6#1)(2009-1#1)
that despite a lack of##2##5##(2010-10#1)(2013-7#1)
that despite a##3##3##(2004-10#1)(2010-10#1)(2013-7#1)
that despite the fact that such##2##6##(2008-7#1)(2012-2#1)
that despite the fact that##3##5##(2007-8#1)(2008-7#1)(2012-2#1)
that despite the##9##3##(1997-5#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#1)
that despite##20##2##(1990-6#1)(1992-2#1)(1997-5#1)(2004-10#1)(2007-8#2)(2008-1#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
that destroy##2##2##(1993-6#1)(2008-1#1)
that destroys the##2##3##(1991-12#1)(2012-3#1)
that destroys##3##2##(1991-12#1)(1996-10#1)(2012-3#1)
that destruction of the##2##4##(1993-2#1)(1994-6#1)
that destruction of##3##3##(1992-9#1)(1993-2#1)(1994-6#1)
that detailed##2##2##(1993-12#1)(2008-9#1)
that detect##5##2##(1990-12#1)(1995-4#1)(2007-12#1)(2008-10#1)(2008-4#1)
that detectable##2##2##(1994-11#1)(2007-12#1)
that detected##7##2##(1990-2#1)(1997-1#1)(2008-10#3)(2008-3#1)(2011-1#1)
that detection and##2##3##(2010-9#1)(2013-8#1)
that detection of##4##3##(2007-8#1)(2008-10#1)(2012-1#1)(2013-8#1)
that detection##10##2##(1997-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-9#1)(2011-1#1)(2012-1#1)(2013-8#2)
that detects the##2##3##(1995-2#1)(2008-4#1)
that detects##8##2##(1994-2#1)(1995-2#1)(2008-2#1)(2008-4#1)(2008-6#1)(2011-1#1)(2013-1#2)
that determination of##4##3##(1991-12#1)(1994-2#1)(2008-10#2)
that determine the##28##3##(1994-5#1)(1997-4#1)(2006-10#3)(2007-11#1)(2007-12#1)(2007-9#1)(2008-2#2)(2008-3#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-4#1)(2009-5#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#2)
that determine whether##2##3##(1993-6#1)(2008-9#1)
that determine##49##2##(1993-1#1)(1993-6#1)(1994-5#1)(1995-3#1)(1997-4#1)(2005-8#1)(2006-10#3)(2006-5#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-11#1)(2009-4#1)(2009-5#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#2)
that determined by the##2##4##(2008-10#1)(2008-2#1)
that determined by##5##3##(1996-7#2)(2008-10#2)(2008-2#1)
that determined for##3##3##(1994-11#1)(1995-8#1)(2008-11#1)
that determined from##3##3##(1990-10#1)(1997-7#1)(2010-4#1)
that determined the##2##3##(1995-8#1)(1997-7#1)
that determined##15##2##(1990-10#1)(1994-11#1)(1995-8#2)(1996-7#2)(1997-7#2)(2008-10#3)(2008-11#1)(2008-2#1)(2010-12#1)(2010-4#1)
that determines its##2##3##(1995-2#1)(2007-9#1)
that determines the##16##3##(1990-6#1)(2005-11#1)(2006-10#1)(2007-9#2)(2008-10#2)(2008-2#3)(2008-3#2)(2008-4#1)(2010-2#1)(2012-2#1)(2013-7#1)
that determines##25##2##(1990-6#1)(1992-12#1)(1994-1#1)(1994-2#1)(1995-2#1)(2005-11#1)(2006-10#1)(2007-9#3)(2008-10#4)(2008-2#3)(2008-3#2)(2008-4#1)(2008-8#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
that develop from##2##3##(1990-12#1)(2008-9#1)
that develop in the##2##4##(2007-11#1)(2009-6#1)
that develop in##4##3##(2007-11#1)(2009-6#1)(2010-12#1)(2010-6#1)
that develop##13##2##(1990-12#1)(1991-11#1)(1993-3#1)(2007-1#1)(2007-11#2)(2008-11#1)(2008-12#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-6#1)(2013-7#1)
that developed from##2##3##(1992-12#1)(2013-8#1)
that developed in a##3##4##(2006-7#1)(2008-3#1)(2012-12#1)
that developed in##4##3##(2006-7#1)(2007-1#1)(2008-3#1)(2012-12#1)
that developed on the##2##4##(2010-6#2)
that developed on##4##3##(2008-10#1)(2010-6#3)
that developed symptoms##2##3##(2008-10#2)
that developed##44##2##(1991-6#1)(1992-12#1)(1992-9#2)(1993-6#1)(1996-12#1)(1996-3#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-5#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-6#3)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
that developing a##2##3##(2006-2#1)(2008-11#1)
that developing##4##2##(2006-2#1)(2007-9#1)(2008-11#1)(2009-4#1)
that development of##4##3##(1991-12#1)(1996-9#1)(1997-6#1)(2008-4#1)
that development##8##2##(1991-12#1)(1992-7#1)(1996-9#1)(1997-6#1)(2008-11#1)(2008-4#1)(2008-9#1)(2012-1#1)
that developmental##5##2##(2006-5#1)(2008-10#2)(2009-2#1)(2011-12#1)
that develops in##3##3##(2008-10#1)(2008-9#1)(2011-1#1)
that develops##11##2##(1996-8#1)(2008-10#3)(2008-5#1)(2008-7#3)(2008-9#1)(2011-1#1)(2012-12#1)
that deviates##2##2##(2006-10#1)(2008-7#1)
that devolution##2##2##(1997-2#2)
that dexamethasone##3##2##(1994-2#1)(1994-5#1)(1995-12#1)
that diabetes##4##2##(2008-1#1)(2008-8#1)(2011-1#1)(2013-8#1)
that diabetic##7##2##(1991-10#1)(1996-11#1)(2007-6#1)(2008-1#2)(2008-3#1)(2008-7#1)
that diagnosed##2##2##(2008-11#1)(2009-10#1)
that diagnosis of##2##3##(2011-2#1)(2012-2#1)
that diagnosis##4##2##(1993-2#1)(2006-8#1)(2011-2#1)(2012-2#1)
that diagnostic##5##2##(1990-12#1)(1993-10#1)(2007-4#1)(2010-5#1)(2012-12#1)
that dictate##5##2##(1993-2#1)(2008-10#1)(2008-4#2)(2012-12#1)
that dictates##2##2##(2010-10#1)(2012-3#1)
that did not affect##2##4##(1995-2#1)(2005-8#1)
that did not alter##2##4##(2008-10#1)(2008-5#1)
that did not exceed the##2##5##(2007-8#1)(2011-1#1)
that did not have a previous##2##6##(2013-1#2)
that did not have##4##4##(1992-6#1)(1997-8#1)(2013-1#2)
that did not increase##2##4##(1994-12#1)(1994-8#1)
that did not produce the##2##5##(2006-8#1)(2008-10#1)
that did not require##6##4##(1990-8#1)(2005-5#1)(2006-8#1)(2007-2#1)(2009-2#1)(2013-1#1)
that did not respond to##5##5##(2006-10#2)(2008-7#1)(2012-12#2)
that did not show##3##4##(2007-3#1)(2008-4#1)(2011-2#1)
that did not##77##3##(1990-3#1)(1990-8#1)(1991-12#1)(1992-12#1)(1992-3#1)(1992-6#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-6#2)(1996-2#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-8#1)(2005-12#1)(2005-5#1)(2005-8#1)(2006-10#2)(2006-8#3)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#3)(2007-9#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-5#5)(2008-7#3)(2008-8#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#4)(2012-3#1)(2013-1#3)
that did or did not##2##5##(1992-12#1)(2008-7#1)
that did##85##2##(1990-3#1)(1990-8#1)(1991-12#1)(1991-3#1)(1992-12#2)(1992-3#1)(1992-6#1)(1994-12#1)(1994-8#2)(1995-2#1)(1995-6#2)(1996-1#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-8#1)(2005-12#1)(2005-5#1)(2005-8#1)(2006-10#2)(2006-8#3)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#3)(2007-9#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-5#7)(2008-7#4)(2008-8#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#4)(2012-3#1)(2013-1#3)
that died during##2##3##(2008-11#1)(2011-1#1)
that died##9##2##(2004-10#1)(2005-7#1)(2008-11#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
that diet##5##2##(1990-8#1)(1994-10#1)(2006-10#1)(2007-3#1)(2008-5#1)
that dietary factors##3##3##(1992-10#1)(2008-7#1)(2011-2#1)
that dietary fat##2##3##(1997-1#1)(2008-4#1)
that dietary fatty##2##3##(1994-2#1)(2004-11#1)
that dietary fish-oil has beneficial effect##2##6##(2006-8#2)
that dietary fish-oil##3##3##(2006-8#3)
that dietary nucleotides##2##3##(2008-11#2)
that dietary restriction##3##3##(1996-7#3)
that dietary supplements##3##3##(1990-5#1)(2006-10#1)(2006-2#1)
that dietary##44##2##(1990-5#1)(1991-2#1)(1992-10#1)(1992-4#1)(1993-9#1)(1994-2#2)(1995-6#1)(1996-7#3)(1997-1#2)(1997-6#1)(2004-11#2)(2006-10#2)(2006-2#1)(2006-8#3)(2006-9#1)(2007-8#4)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#3)(2009-5#1)(2010-1#1)(2010-12#2)(2010-2#1)(2011-2#1)(2012-2#2)(2013-1#1)
that diets##4##2##(2004-11#1)(2008-4#1)(2008-7#1)(2013-1#1)
that differ by one##2##4##(1991-2#1)(1995-3#1)
that differ by##10##3##(1991-2#1)(1994-9#1)(1995-3#1)(1996-5#1)(2004-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-5#1)(2013-8#1)
that differ considerably from##2##4##(2008-10#1)(2010-3#1)
that differ from those of other##2##6##(1991-3#1)(2008-8#1)
that differ from those of##6##5##(1991-3#1)(2006-12#1)(2007-3#1)(2008-4#1)(2008-8#1)(2011-2#1)
that differ from##11##3##(1991-3#1)(2006-11#1)(2006-12#1)(2007-3#1)(2008-4#1)(2008-8#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-3#1)
that differ in levels of##2##5##(1996-12#2)
that differ in quality##2##4##(2007-7#1)(2009-6#1)
that differ in the##4##4##(1991-6#1)(1992-6#1)(2006-12#1)(2008-10#1)
that differ in their##8##4##(1994-2#1)(1994-5#1)(1994-8#1)(1995-3#1)(1997-8#1)(2007-12#1)(2008-10#1)(2013-8#1)
that differ in##25##3##(1991-6#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-3#1)(1996-12#2)(1996-9#1)(1997-8#1)(2006-12#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-10#2)(2009-6#1)(2009-8#1)(2012-1#1)(2013-8#2)
that differ markedly in##2##4##(1994-9#1)(2008-11#1)
that differ only##2##3##(1992-9#1)(2008-3#1)
that differ with respect to virulence and persistence in vivo and in vitro##2##13##(1997-6#2)
that differ with respect to##3##5##(1994-3#1)(1997-6#2)
that differ with##4##3##(1993-5#1)(1994-3#1)(1997-6#2)
that differ##65##2##(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-5#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-3#2)(1995-4#1)(1996-12#2)(1996-5#1)(1996-9#1)(1997-6#2)(1997-8#1)(2004-1#1)(2006-11#1)(2006-12#2)(2006-2#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-3#2)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-8#3)
that differed by##2##3##(1995-2#1)(2008-5#1)
that differed from the##2##4##(2007-10#1)(2008-10#1)
that differed from##5##3##(2007-10#1)(2007-8#1)(2008-10#2)(2008-5#1)
that differed in their##3##4##(2008-11#2)(2009-10#1)
that differed in##10##3##(2008-10#4)(2008-11#2)(2008-8#1)(2008-9#2)(2009-10#1)
that differed##26##2##(1994-1#1)(1995-2#1)(2007-10#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-10#1)(2010-2#2)(2010-5#1)(2010-8#1)
that difference##6##2##(1994-1#1)(1994-6#1)(2008-11#1)(2011-2#3)
that differences between the##2##4##(1997-6#1)(2008-8#1)
that differences between##5##3##(1992-7#1)(1993-1#1)(1997-4#1)(1997-6#1)(2008-8#1)
that differences exist##2##3##(1997-4#1)(2008-11#1)
that differences in the##9##4##(1990-5#1)(1990-7#1)(1995-11#1)(1996-8#1)(1997-3#1)(2008-10#1)(2008-9#2)(2011-12#1)
that differences in##27##3##(1990-5#1)(1990-7#1)(1991-12#1)(1994-2#1)(1995-11#1)(1995-12#1)(1996-8#1)(1997-3#1)(2004-11#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-9#3)(2009-11#1)(2009-4#1)(2009-5#1)(2011-12#1)(2012-12#2)(2013-8#1)
that differences##37##2##(1990-5#1)(1990-7#1)(1991-12#1)(1992-7#1)(1993-1#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-12#1)(1996-8#1)(1997-3#1)(1997-4#2)(1997-6#1)(2004-11#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-4#1)(2009-5#1)(2011-12#1)(2012-12#2)(2013-8#1)
that different analytes##2##3##(2008-10#2)
that different classes of##2##4##(2009-12#1)(2010-9#1)
that different cytochrome##2##3##(1992-1#1)(1992-9#1)
that different diets##2##3##(2005-12#1)(2008-5#1)
that different isoforms of PKC##2##5##(1995-11#2)
that different mechanisms of##2##4##(1990-7#1)(1995-12#1)
that different mechanisms##5##3##(1990-7#1)(1992-1#1)(1995-12#1)(1996-12#1)(2006-8#1)
that different methods##2##3##(1990-7#1)(1992-9#1)
that different signaling cascades##2##4##(2008-11#2)
that different species##2##3##(2007-12#1)(2013-8#1)
that different strains##2##3##(2007-6#1)(2012-3#1)
that different types of##3##4##(2006-12#1)(2006-6#1)(2008-10#1)
that different##106##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-7#2)(1991-12#1)(1991-3#1)(1992-1#3)(1992-12#1)(1992-9#2)(1993-12#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#2)(1995-10#1)(1995-11#2)(1995-12#2)(1995-3#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-7#1)(1997-9#1)(2004-11#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#4)
that differential and##2##3##(1995-12#1)(1995-7#1)
that differential##15##2##(1992-10#1)(1992-7#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-7#1)(1996-11#1)(1997-2#1)(1997-5#1)(2007-9#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)
that differentially expressed##2##3##(2010-10#1)(2010-12#1)
that differentially##4##2##(1993-6#1)(2008-4#1)(2010-10#1)(2010-12#1)
that differentiate the##5##3##(2007-12#1)(2008-10#1)(2011-1#1)(2012-1#2)
that differentiate##13##2##(1995-1#2)(2006-5#1)(2007-12#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-3#1)(2011-1#1)(2012-1#2)(2012-2#1)
that differentiated##6##2##(1994-6#1)(2005-12#1)(2008-10#1)(2009-4#1)(2010-5#1)(2012-2#1)
that differentiates##2##2##(2004-1#1)(2010-10#1)
that differentiating##3##2##(1991-6#1)(2007-9#1)(2008-11#1)
that differentiation of##5##3##(1991-12#1)(1992-9#1)(2008-11#1)(2008-4#1)(2008-6#1)
that differentiation##10##2##(1991-12#1)(1992-8#1)(1992-9#1)(2007-9#2)(2008-11#2)(2008-4#1)(2008-6#1)(2009-8#1)
that differs from the previously##2##5##(2008-10#2)
that differs from the##4##4##(1990-5#1)(1991-12#1)(2008-10#2)
that differs from##6##3##(1990-2#1)(1990-5#1)(1991-12#1)(1991-8#1)(2008-10#2)
that differs in##2##3##(1995-6#1)(2008-10#1)
that differs##12##2##(1990-2#1)(1990-5#1)(1991-12#1)(1991-8#1)(1995-6#1)(2006-5#1)(2008-10#3)(2008-3#1)(2009-7#1)(2012-12#1)
that difficulty##2##2##(1995-1#1)(2009-11#1)
that diffract##2##2##(1991-11#1)(1997-4#1)
that diffuse##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
that diffusing##2##2##(1997-1#1)(2009-6#1)
that diffusion##3##2##(1995-12#1)(1997-5#1)(2012-2#1)
that digital##3##2##(2006-8#1)(2007-11#1)(2008-3#1)
that dimerization of##5##3##(1992-12#1)(1992-3#1)(1994-9#1)(1995-5#1)(1997-4#1)
that dimerization##6##2##(1992-12#1)(1992-3#1)(1994-9#1)(1995-5#1)(1996-5#1)(1997-4#1)
that diminished##4##2##(1995-1#1)(2008-4#1)(2008-7#1)(2008-9#1)
that diphenyleneiodonium##2##2##(1996-10#2)
that direct the##4##3##(2007-11#1)(2008-10#1)(2013-1#2)
that direct##23##2##(1990-4#1)(1991-3#1)(1992-11#1)(1992-9#1)(1993-3#1)(1994-8#1)(1995-2#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
that directed##5##2##(1990-5#1)(1994-11#1)(2006-10#1)(2007-2#1)(2011-1#1)
that directional##2##2##(2009-2#1)(2012-2#1)
that directly address##4##3##(2010-11#1)(2013-1#3)
that directly binds##2##3##(1995-3#1)(2011-2#1)
that directly contribute to##3##4##(2012-12#1)(2012-3#1)(2013-1#1)
that directly##34##2##(1992-6#1)(1995-3#1)(1996-7#1)(1997-2#1)(2006-1#1)(2006-2#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)
that directs the##3##3##(1996-7#1)(2008-2#1)(2008-7#1)
that directs##7##2##(1991-10#1)(1991-6#1)(1994-12#1)(1995-12#1)(1996-7#1)(2008-2#1)(2008-7#1)
that disabled beneficiaries##2##3##(2007-2#2)
that disaster##2##2##(2007-2#1)(2012-1#1)
that disc##2##2##(2006-7#1)(2006-8#1)
that discharge##2##2##(2007-12#1)(2008-11#1)
that disclosed##2##2##(2007-12#1)(2008-9#1)
that discontinuous##2##2##(1991-7#1)(2008-5#1)
that discourage##2##2##(2007-4#1)(2009-7#1)
that discriminate against women##2##4##(1990-2#1)(2007-12#1)
that discriminate##6##2##(1990-2#1)(1994-12#1)(2006-1#1)(2007-12#1)(2009-12#1)(2010-10#1)
that discriminates between##2##3##(2005-9#1)(2010-3#1)
that discriminates##3##2##(2005-9#1)(2009-3#1)(2010-3#1)
that discrimination##4##2##(1990-2#1)(1996-11#1)(2012-1#1)(2012-11#1)
that discusses##2##2##(1993-3#1)(2008-4#1)
that discussion##2##2##(2010-11#1)(2012-3#1)
that disease control##3##3##(2008-10#3)
that disease incidence was##3##4##(2008-10#3)
that disease incidence##6##3##(2008-10#6)
that disease##21##2##(1991-2#1)(1994-7#1)(2006-5#1)(2007-11#1)(2008-10#14)(2008-7#1)(2012-3#2)
that diseases##3##2##(1994-3#1)(1997-3#1)(2010-1#1)
that disinfectants##2##2##(2010-2#2)
that dispersal##3##2##(2008-8#1)(2008-9#2)
that dispersion management##2##3##(2007-12#2)
that dispersion##4##2##(2005-11#1)(2007-12#2)(2008-3#1)
that dispersion-managed solitons##2##3##(2007-11#1)(2007-12#1)
that display similar traits##2##4##(2013-1#2)
that display the##4##3##(2007-11#1)(2008-3#1)(2008-9#1)(2011-2#1)
that display##20##2##(1994-9#1)(1995-3#1)(1996-2#1)(2005-7#1)(2007-11#1)(2007-8#2)(2008-3#2)(2008-4#3)(2008-7#1)(2008-9#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
that displayed both##2##3##(1991-11#1)(2008-7#1)
that displayed##11##2##(1990-4#1)(1991-11#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-4#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)
that displays a##3##3##(1995-12#1)(1996-5#1)(2008-9#1)
that displays many##2##3##(1995-10#1)(2008-8#1)
that displays##14##2##(1992-10#1)(1993-3#1)(1994-5#1)(1995-10#1)(1995-12#1)(1995-8#1)(1996-5#1)(2006-5#1)(2008-3#2)(2008-6#1)(2008-8#1)(2008-9#1)(2012-1#1)
that disproportionately##2##2##(2011-2#1)(2012-11#1)
that disrupt the##2##3##(1997-2#1)(2009-9#1)
that disrupt##8##2##(1993-12#1)(1995-8#1)(1997-2#1)(2008-5#1)(2009-9#1)(2010-10#1)(2011-2#1)(2013-1#1)
that disrupted the##2##3##(2008-2#1)(2011-3#1)
that disruption of##6##3##(1990-8#1)(1993-3#1)(1994-5#1)(1997-3#1)(2007-10#1)(2012-2#1)
that disrupts the##4##3##(1991-7#1)(2006-12#1)(2010-11#1)(2013-1#1)
that disrupts##7##2##(1990-8#1)(1991-7#1)(2006-12#1)(2006-9#1)(2009-10#1)(2010-11#1)(2013-1#1)
that dissociation##2##2##(1995-10#1)(2006-10#1)
that distal##4##2##(1995-6#1)(1997-7#1)(2006-10#1)(2010-11#1)
that distance learning is##2##4##(2008-11#1)(2010-10#1)
that distance learning##3##3##(2008-11#2)(2010-10#1)
that distance##5##2##(2007-12#1)(2008-10#1)(2008-11#2)(2010-10#1)
that distinct##9##2##(1992-3#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-12#1)(1996-9#1)(1997-7#1)(2004-4#1)(2008-5#1)
that distinguish between##2##3##(1990-2#1)(2008-4#1)
that distinguish it from##4##4##(1993-9#1)(1995-10#1)(2007-12#1)(2013-1#1)
that distinguish the##3##3##(1996-6#1)(2008-8#1)(2010-3#1)
that distinguish them##4##3##(1994-8#1)(2006-10#1)(2007-5#1)(2011-2#1)
that distinguish##34##2##(1990-2#1)(1991-12#1)(1991-6#1)(1993-9#1)(1994-8#2)(1995-10#1)(1996-3#1)(1996-6#1)(2006-10#1)(2007-12#2)(2007-3#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-4#4)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
that distinguished##6##2##(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2013-1#1)
that distinguishes the##2##3##(1995-2#1)(2008-10#1)
that distinguishes##9##2##(1993-7#1)(1995-2#1)(2006-6#1)(2007-3#2)(2008-10#2)(2008-12#1)(2008-9#1)
that distortion##2##2##(1991-1#1)(2007-12#1)
that distraction##3##2##(2007-12#1)(2012-12#1)(2012-3#1)
that distribution of##2##3##(1995-12#1)(2007-10#1)
that distribution##3##2##(1995-12#1)(2007-10#1)(2008-8#1)
that disturbance of the##2##4##(2008-1#1)(2011-1#1)
that disturbances in the##2##4##(2007-7#2)
that disturbances of##3##3##(1991-2#1)(1996-1#1)(2007-11#1)
that disturbances##5##2##(1991-2#1)(1996-1#1)(2007-11#1)(2007-7#2)
that disulfide##2##2##(1991-5#1)(1995-5#1)
that disulphide##2##2##(1995-4#1)(1997-8#1)
that diuretics##3##2##(1991-2#1)(1996-9#2)
that divalent cations##2##3##(1990-7#1)(1994-5#1)
that divalent##3##2##(1990-7#1)(1994-5#1)(2006-2#1)
that diverged from the##2##4##(2009-10#1)(2009-8#1)
that diverged from##5##3##(2008-8#1)(2009-10#1)(2009-8#1)(2012-11#1)(2012-2#1)
that diverged##8##2##(1992-6#1)(2008-8#1)(2009-10#1)(2009-8#1)(2012-11#1)(2012-2#2)(2013-1#1)
that diverse##3##2##(2008-8#1)(2010-10#1)(2013-1#1)
that diversity##3##2##(2007-12#1)(2008-8#1)(2011-12#1)
that divided##2##2##(2008-12#1)(2009-12#1)
that divorce##3##2##(2011-2#3)
that do not conform to##2##5##(1990-9#1)(1991-6#1)
that do not conform##3##4##(1990-9#1)(1991-6#1)(1996-3#1)
that do not consider##2##4##(2010-2#1)(2010-6#1)
that do not contain##5##4##(1996-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
that do not contribute to##3##5##(1994-12#1)(2009-8#1)(2011-2#1)
that do not correspond##2##4##(1994-3#1)(1995-1#1)
that do not exhibit##2##4##(1990-8#1)(1991-6#1)
that do not express SM alpha-actin##2##6##(1995-3#2)
that do not express##5##4##(1995-3#3)(1997-1#1)(2008-8#1)
that do not follow##2##4##(1997-4#1)(2009-4#1)
that do not have a##4##5##(1994-3#1)(2011-2#1)(2012-1#1)(2012-12#1)
that do not have the##3##5##(2008-1#1)(2013-1#2)
that do not have##10##4##(1992-4#1)(1994-3#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
that do not include##2##4##(1995-1#1)(2010-7#1)
that do not induce##3##4##(1993-11#1)(1996-11#1)(1997-4#1)
that do not interact##2##4##(1996-2#1)(2010-12#1)
that do not involve##4##4##(2008-11#1)(2008-4#1)(2008-5#1)(2012-12#1)
that do not normally##4##4##(2005-6#1)(2006-10#1)(2008-1#1)(2008-4#1)
that do not produce##3##4##(1993-3#1)(1997-8#1)(2008-5#1)
that do not require##9##4##(1993-12#1)(1995-2#1)(1997-3#1)(2007-7#1)(2008-11#1)(2008-4#2)(2010-5#1)(2011-2#1)
that do not respond to##3##5##(1992-3#1)(2008-7#1)(2010-12#1)
that do not##126##3##(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#2)(1992-3#2)(1992-4#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1995-1#2)(1995-2#3)(1995-3#3)(1995-5#2)(1996-11#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-8#1)(2005-11#1)(2005-5#1)(2005-6#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#3)(2008-4#5)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-12#3)(2010-2#2)(2010-5#1)(2010-6#2)(2010-7#1)(2011-2#4)(2012-1#4)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#6)(2013-7#1)
that do##136##2##(1990-8#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-6#2)(1992-3#2)(1992-4#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-8#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-6#1)(1995-1#2)(1995-2#3)(1995-3#3)(1995-5#2)(1996-11#2)(1996-2#2)(1996-3#3)(1996-4#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-8#1)(2005-11#1)(2005-5#1)(2005-6#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#7)(2008-11#4)(2008-12#2)(2008-2#3)(2008-4#5)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-12#3)(2010-2#2)(2010-5#1)(2010-6#2)(2010-7#1)(2011-2#5)(2012-1#4)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#6)(2013-7#1)
that doctors##7##2##(1992-5#1)(1994-9#1)(1995-2#2)(1995-6#1)(2011-2#2)
that document the##2##3##(2007-4#1)(2010-2#1)
that document##3##2##(2007-4#1)(2010-2#1)(2013-1#1)
that documentation##2##2##(2006-8#1)(2011-2#1)
that documented##5##2##(1996-7#1)(2004-12#1)(2007-7#1)(2008-10#1)(2008-7#1)
that does not appear to##2##5##(1990-10#1)(2008-11#1)
that does not assume a fixed odds ratio produced##2##9##(2012-3#2)
that does not assume##3##4##(1991-2#1)(2012-3#2)
that does not change##2##4##(1996-1#1)(2008-10#1)
that does not depend on the##2##6##(1992-2#1)(2007-12#1)
that does not depend on##5##5##(1992-2#1)(1995-3#1)(2007-12#1)(2008-11#1)(2008-3#1)
that does not have##2##4##(1993-1#1)(2008-10#1)
that does not improve##3##4##(1991-3#1)(1996-12#1)(2010-7#1)
that does not involve##5##4##(1992-6#1)(1994-8#1)(1995-3#1)(1995-8#1)(2008-10#1)
that does not match the##2##5##(1997-7#1)(2012-2#1)
that does not need##3##4##(1996-3#1)(2008-10#1)(2012-3#1)
that does not require a##2##5##(2007-12#1)(2008-10#1)
that does not require any##2##5##(2008-10#1)(2013-8#1)
that does not require##16##4##(1991-7#1)(1995-12#1)(1995-6#1)(1995-8#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#1)(2008-9#1)(2013-8#2)
that does not resemble the##2##5##(1994-12#1)(2011-1#1)
that does not share##2##4##(1991-9#1)(1997-7#1)
that does not use##2##4##(2008-10#1)(2008-2#1)
that does not##94##3##(1990-10#1)(1990-4#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#2)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-3#3)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-9#1)(1997-7#2)(2005-11#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#2)(2008-2#4)(2008-3#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#2)
that domain##3##2##(1990-12#1)(1996-2#1)(2007-12#1)
that domains##2##2##(1995-8#1)(2012-2#1)
that dominance is##2##3##(1994-8#1)(2008-8#1)
that dominant##2##2##(2007-3#1)(2008-8#1)
that dominate current##2##3##(2006-9#1)(2008-10#1)
that dominate##5##2##(2006-9#1)(2007-3#1)(2008-10#1)(2008-2#1)(2009-4#1)
that dominated##3##2##(1995-2#1)(2008-1#1)(2008-10#1)
that dominates##3##2##(1994-12#1)(2008-5#1)(2012-12#1)
that donor##2##2##(1994-3#1)(2007-12#1)
that donors##2##2##(1994-3#1)(2006-7#1)
that dopamine (DA)##2##3##(1993-6#1)(2008-1#1)
that dopamine##8##2##(1992-9#1)(1993-6#1)(1995-2#1)(1996-1#2)(1997-3#1)(2007-2#1)(2008-1#1)
that dopaminergic mechanisms##2##3##(1992-9#1)(1993-6#1)
that dopaminergic##6##2##(1992-9#1)(1993-6#2)(1995-10#2)(2013-1#1)
that dorsal##5##2##(1995-7#1)(2004-2#1)(2006-3#1)(2006-8#1)(2011-2#1)
that dosage##2##2##(1991-5#1)(2005-7#1)
that dose##2##2##(1993-11#1)(2008-2#1)
that doses##3##2##(1995-7#1)(1996-11#1)(2008-7#1)
that dosing##2##2##(2006-10#1)(2008-7#1)
that double##2##2##(2008-9#1)(2011-2#1)
that down-regulation of PKC##2##4##(1991-9#1)(1994-5#1)
that down-regulation of c-myc expression##2##5##(1991-9#1)(1994-8#1)
that down-regulation of c-myc##3##4##(1991-9#1)(1994-8#1)(2008-11#1)
that down-regulation of##8##3##(1991-9#2)(1994-5#1)(1994-8#1)(1996-2#1)(2008-11#1)(2011-2#1)(2013-1#1)
that downregulation of##4##3##(1994-6#1)(2010-11#1)(2010-12#1)(2013-8#1)
that downstream##2##2##(1996-10#1)(2009-6#1)
that dramatically##5##2##(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)
that drastically##3##2##(1993-12#1)(1997-4#1)(2008-2#1)
that draw##2##2##(2006-10#1)(2009-12#1)
that draws on##3##3##(1993-12#1)(2008-8#1)(2012-3#1)
that draws##4##2##(1993-12#1)(1996-12#1)(2008-8#1)(2012-3#1)
that dreaming##2##2##(2013-8#2)
that drinking##2##2##(2008-1#1)(2008-5#1)
that drive it##3##3##(2009-4#1)(2013-1#2)
that drive the##5##3##(2007-12#1)(2008-3#1)(2010-8#1)(2012-3#2)
that drive tumor##2##3##(2007-4#1)(2009-3#1)
that drive##19##2##(1996-5#1)(1996-6#1)(2006-6#1)(2007-12#1)(2007-4#1)(2008-3#2)(2008-9#2)(2009-3#2)(2009-4#1)(2010-8#1)(2012-1#1)(2012-3#3)(2013-1#2)
that drivers##3##2##(1994-6#1)(2012-12#2)
that drives the##8##3##(1996-4#1)(2008-3#2)(2009-3#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#1)
that drives##15##2##(1996-4#1)(2007-12#2)(2008-10#1)(2008-3#2)(2009-3#1)(2010-12#2)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
that driving##3##2##(2007-12#1)(2012-12#1)(2013-8#1)
that drought##2##2##(2009-8#2)
that drug binding##2##3##(1991-4#1)(1994-8#1)
that drug##14##2##(1990-3#1)(1991-12#1)(1991-4#1)(1993-6#1)(1993-7#1)(1994-8#1)(2005-10#1)(2008-11#2)(2008-5#1)(2010-12#1)(2010-5#1)(2012-3#1)(2013-7#1)
that drugs are##2##3##(1990-2#1)(1996-3#1)
that drugs can##2##3##(1990-5#1)(1997-1#1)
that drugs that##2##3##(1996-10#1)(2006-10#1)
that drugs##16##2##(1990-2#1)(1990-5#1)(1993-3#1)(1994-8#1)(1996-10#1)(1996-3#1)(1997-1#1)(2005-10#1)(2005-9#1)(2006-10#1)(2007-11#2)(2008-3#1)(2009-1#1)(2011-1#1)(2012-2#1)
that dsRNA##4##2##(1991-4#1)(2008-10#1)(2008-9#1)(2013-1#1)
that duck##2##2##(2005-9#2)
that due to the##7##4##(1990-6#1)(1991-12#1)(1994-5#1)(2005-7#1)(2007-7#1)(2008-10#1)(2008-5#1)
that due to##13##3##(1990-6#1)(1991-12#1)(1993-4#1)(1994-5#1)(1995-3#1)(1997-5#1)(2005-7#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-5#1)
that due##14##2##(1990-6#1)(1991-12#1)(1993-12#1)(1993-4#1)(1994-5#1)(1995-3#1)(1997-5#1)(2005-7#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-5#1)
that during acute##2##3##(2007-2#1)(2011-2#1)
that during augmented breaths##2##4##(1997-5#2)
that during development##3##3##(1992-5#1)(1996-3#1)(1996-5#1)
that during the course of##3##5##(1995-8#1)(1996-9#1)(2005-12#1)
that during the##15##3##(1990-11#1)(1990-8#1)(1992-1#1)(1992-9#1)(1995-8#1)(1996-9#1)(2005-12#1)(2006-2#2)(2007-10#1)(2007-11#1)(2007-6#1)(2008-2#1)(2008-5#1)(2009-8#1)
that during this##3##3##(2007-12#1)(2008-11#1)(2008-8#1)
that during##65##2##(1990-10#1)(1990-11#2)(1990-3#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-3#1)(1992-5#2)(1992-9#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-5#3)(2004-4#1)(2005-12#1)(2005-8#1)(2006-2#2)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-8#2)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
that dye##4##2##(1992-10#1)(2008-2#1)(2008-4#1)(2011-1#1)
that dynamic##6##2##(1997-6#1)(2008-11#2)(2008-9#1)(2010-8#1)(2012-1#1)
that dynamically##2##2##(1992-5#1)(2012-2#1)
that dynamics##2##2##(2008-10#1)(2008-8#1)
that dysphoric individuals##2##3##(2010-3#2)
that dystrophin##2##2##(1993-4#1)(1997-6#1)
that each cell##4##3##(1990-6#1)(1995-12#1)(2008-6#1)(2012-3#1)
that each gene##2##3##(1993-4#1)(2005-11#1)
that each layer is##3##4##(2008-3#3)
that each layer##4##3##(2008-11#1)(2008-3#3)
that each may##2##3##(1995-8#1)(2009-8#1)
that each of the three##3##5##(1993-11#1)(1994-6#1)(1996-3#1)
that each of the##14##4##(1991-7#1)(1992-7#1)(1993-11#1)(1994-6#1)(1994-8#1)(1996-3#1)(1996-5#1)(2006-9#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2009-2#1)(2013-1#1)
that each of these##5##4##(1991-1#1)(1991-9#1)(2008-11#1)(2008-3#1)(2008-7#1)
that each of##20##3##(1991-1#1)(1991-7#1)(1991-9#1)(1992-7#1)(1993-11#1)(1994-6#1)(1994-8#1)(1996-3#1)(1996-5#1)(2006-9#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-2#1)(2013-1#1)
that each species##2##3##(1991-10#1)(2010-7#1)
that each##115##2##(1990-11#2)(1990-12#2)(1990-6#1)(1991-1#1)(1991-10#2)(1991-12#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-9#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-10#2)(1995-12#2)(1995-3#1)(1995-8#3)(1996-1#1)(1996-3#1)(1996-5#3)(1996-7#1)(1996-9#1)(1997-2#2)(1997-7#2)(1997-8#2)(2005-11#2)(2006-10#1)(2006-12#2)(2006-9#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#2)(2009-10#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-5#1)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
that earlier##2##2##(2006-8#1)(2008-7#1)
that early administration of##2##4##(2013-8#2)
that early and##2##3##(2006-2#1)(2012-1#1)
that early diagnosis and##3##4##(1994-6#1)(2007-11#1)(2009-1#1)
that early intervention##3##3##(1996-7#1)(2007-9#1)(2008-1#1)
that early pharmacological and psychosocial treatment dramatically ameliorates poor prognosis and outcome for individuals with psychotic disorders##2##17##(2009-8#2)
that early recognition##2##3##(2006-10#2)
that early##49##2##(1990-5#1)(1990-9#1)(1991-6#1)(1992-3#1)(1993-12#1)(1993-9#1)(1994-6#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-7#1)(2005-7#1)(2006-10#3)(2006-2#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2009-1#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-10#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#2)
that easily##3##2##(1991-9#1)(2008-5#1)(2013-7#1)
that economic##2##2##(1995-2#1)(2011-1#1)
that ectopic##3##2##(1990-2#1)(2006-12#1)(2008-9#1)
that ectopically expressed##2##3##(2012-12#1)(2012-2#1)
that edelfosine##2##2##(2009-7#2)
that education and##2##3##(1997-8#1)(2008-11#1)
that education##8##2##(1990-12#1)(1994-8#1)(1995-1#1)(1997-8#1)(2006-7#1)(2008-11#1)(2012-2#1)(2012-3#1)
that educational##8##2##(1991-9#1)(1994-6#1)(2006-7#1)(2007-10#1)(2007-2#1)(2008-11#1)(2009-12#1)(2010-7#1)
that educators##2##2##(1995-12#1)(2007-11#1)
that effect##7##2##(1996-4#1)(2006-2#1)(2008-10#2)(2008-11#1)(2013-8#2)
that effective pain control##2##4##(2006-10#1)(2007-2#1)
that effective##21##2##(1992-1#1)(1993-11#1)(1996-2#1)(1996-9#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-11#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-7#1)(2012-10#1)(2012-2#1)
that effectively treat##2##3##(2008-2#1)(2008-6#1)
that effectively##15##2##(1994-7#1)(1995-1#1)(1995-5#1)(2007-3#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-4#1)(2012-12#2)(2013-1#3)
that effectiveness##2##2##(1990-3#1)(2008-10#1)
that effects of##6##3##(1994-9#1)(1995-3#2)(2009-10#1)(2011-2#1)(2013-1#1)
that effects##8##2##(1994-12#1)(1994-9#1)(1995-3#2)(2007-8#1)(2009-10#1)(2011-2#1)(2013-1#1)
that efficacy##3##2##(2007-8#1)(2008-6#1)(2012-12#1)
that efficient##10##2##(1990-5#1)(1995-1#1)(1995-8#1)(1996-3#1)(1997-1#1)(2007-12#2)(2008-2#2)(2008-3#1)
that efficiently##3##2##(1997-4#1)(2008-10#1)(2011-1#1)
that effort##2##2##(1996-12#1)(2008-1#1)
that efforts##4##2##(2006-10#1)(2008-10#1)(2011-2#1)(2012-1#1)
that egg##2##2##(1991-5#1)(2007-3#1)
that eight##5##2##(1997-3#1)(2005-11#1)(2007-11#1)(2007-3#1)(2009-4#1)
that either an##2##3##(1996-4#1)(2010-2#1)
that either are##2##3##(2007-11#1)(2011-12#1)
that either increase or decrease##2##5##(2008-7#1)(2010-12#1)
that either increase##3##3##(2006-10#1)(2008-7#1)(2010-12#1)
that either of##2##3##(1991-7#1)(1994-6#1)
that either or##2##3##(1993-11#1)(1996-3#1)
that either the protein##2##4##(1990-9#1)(1997-4#1)
that either the##8##3##(1990-9#1)(1992-9#1)(1993-5#1)(1997-4#1)(1997-7#1)(2008-10#1)(2009-12#1)(2010-12#1)
that either##55##2##(1990-9#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-11#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-4#1)(1997-7#1)(2004-1#1)(2006-10#3)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-5#2)(2008-7#1)(2008-8#2)(2009-12#1)(2010-12#2)(2010-2#3)(2010-3#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
that elasticity##2##2##(2009-7#1)(2013-8#1)
that elderly patients##2##3##(1993-9#1)(2008-7#1)
that elderly##6##2##(1993-9#1)(1994-6#1)(2006-7#2)(2008-7#2)
that electric##2##2##(1991-6#1)(2009-10#1)
that electrical field stimulation##2##4##(1990-7#1)(1993-11#1)
that electrical stimulation of the##2##5##(1990-5#1)(1994-6#1)
that electrical stimulation##3##3##(1990-5#1)(1994-6#1)(2006-8#1)
that electrical##6##2##(1990-5#1)(1990-7#1)(1993-11#1)(1994-6#1)(2006-1#1)(2006-8#1)
that electron transfer##2##3##(1990-5#1)(1995-6#1)
that electron##6##2##(1990-5#1)(1994-5#1)(1995-6#1)(2007-11#1)(2008-5#1)(2013-1#1)
that electronic nose##2##3##(2008-10#1)(2012-2#1)
that electronic##4##2##(2007-6#1)(2008-10#1)(2008-5#1)(2012-2#1)
that electrostatic interactions##3##3##(1994-5#1)(1995-6#1)(2008-4#1)
that electrostatic##7##2##(1990-8#1)(1992-6#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-8#1)(2008-4#1)
that elements of##2##3##(2008-2#1)(2008-3#1)
that elements##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
that elevate cAMP##2##3##(1996-11#1)(2008-5#1)
that elevate##3##2##(1995-8#1)(1996-11#1)(2008-5#1)
that elevated levels of##2##4##(1991-2#1)(1995-2#1)
that elevated##21##2##(1991-10#1)(1991-12#3)(1991-2#1)(1992-8#1)(1993-12#1)(1994-8#1)(1995-2#1)(1997-5#1)(2005-10#1)(2006-6#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-1#1)(2011-12#1)
that elevates the##2##3##(1991-9#1)(2009-3#1)
that elevates##3##2##(1991-9#1)(2009-3#1)(2010-12#1)
that elevation of##6##3##(1992-7#1)(1996-11#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-5#1)
that elevations in##2##3##(1995-2#1)(2008-7#1)
that elicit disgust##3##3##(2008-11#3)
that elicit##8##2##(1992-5#1)(2005-7#1)(2008-10#1)(2008-11#4)(2012-12#1)
that elicited by##5##3##(1993-3#1)(1996-5#1)(1996-9#1)(1997-3#1)(2008-5#1)
that elicited##7##2##(1993-3#1)(1996-5#1)(1996-9#1)(1997-3#1)(2006-5#1)(2008-10#1)(2008-5#1)
that elicits##2##2##(2008-7#1)(2011-2#1)
that eliminate##6##2##(1992-8#1)(1992-9#2)(1994-9#1)(1997-2#1)(2012-1#1)
that eliminated##3##2##(1994-5#1)(2008-10#2)
that eliminates the##3##3##(2008-3#3)
that eliminates##8##2##(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#4)(2013-1#1)
that elimination of##2##3##(1995-2#1)(2007-12#1)
that ellagic acid##2##3##(1994-6#1)(2011-2#1)
that eluted from##2##3##(1990-12#1)(1991-8#1)
that eluted##4##2##(1990-12#1)(1991-8#1)(1997-2#1)(2008-10#1)
that embed##2##2##(2007-12#1)(2008-3#1)
that embeds##2##2##(2008-2#1)(2008-8#1)
that embodies##2##2##(1997-3#1)(2008-8#1)
that embrace##2##2##(2009-8#2)
that embryonic stem##2##3##(2006-8#1)(2012-11#1)
that embryonic##3##2##(1994-2#1)(2006-8#1)(2012-11#1)
that embryos are##3##3##(2009-5#1)(2012-11#2)
that embryos##8##2##(2008-11#1)(2008-6#1)(2009-5#1)(2012-11#5)
that emerge from the##4##4##(2007-11#1)(2008-11#1)(2008-2#1)(2010-11#1)
that emerge from##6##3##(2007-11#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-11#1)
that emerge##11##2##(1996-2#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-11#1)(2010-12#1)(2012-3#1)
that emerged during##5##3##(1992-8#1)(1994-3#1)(2007-8#1)(2008-11#1)(2009-2#1)
that emerged from the##3##4##(2007-10#1)(2008-11#1)(2008-5#1)
that emerged from##7##3##(1991-12#1)(2007-10#1)(2008-11#2)(2008-5#1)(2013-1#2)
that emerged in the##2##4##(2008-11#1)(2011-2#1)
that emerged in##4##3##(2006-9#1)(2008-11#2)(2011-2#1)
that emerged within##2##3##(2005-10#1)(2007-11#1)
that emerged##21##2##(1991-12#1)(1992-8#1)(1994-3#1)(2005-10#1)(2006-9#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#5)(2008-5#1)(2009-2#1)(2011-2#1)(2013-1#2)(2013-8#1)
that emergency##3##2##(2008-8#1)(2011-2#1)(2012-2#1)
that emerges from##2##3##(2008-3#1)(2012-2#1)
that emerges is##2##3##(2009-6#1)(2009-7#1)
that emerges##4##2##(2008-3#1)(2009-6#1)(2009-7#1)(2012-2#1)
that emit##5##2##(2007-9#3)(2008-2#1)(2009-5#1)
that emits##4##2##(1990-8#1)(2007-11#1)(2007-12#1)(2013-1#1)
that emitted##2##2##(1992-6#1)(2013-1#1)
that emotional##3##2##(2006-8#1)(2008-11#2)
that emphasize a##2##3##(2007-11#1)(2012-2#1)
that emphasize##8##2##(1994-2#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-2#1)
that emphasized##5##2##(1991-3#1)(2008-10#1)(2009-8#3)
that emphasizes the##2##3##(2008-10#1)(2012-3#1)
that emphasizes##9##2##(1995-2#1)(1997-1#1)(2008-10#1)(2009-3#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)
that empirical##3##2##(2008-11#1)(2008-8#1)(2009-4#1)
that employ a##2##3##(2008-8#1)(2010-2#1)
that employ holding beams##2##4##(2007-11#2)
that employ the##3##3##(2007-12#1)(2008-3#1)(2008-4#1)
that employ##21##2##(1993-12#1)(1996-1#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-8#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2013-1#2)
that employed##7##2##(1991-5#1)(2006-12#1)(2007-12#1)(2008-11#1)(2008-2#1)(2010-2#1)(2011-12#1)
that employees##3##2##(1994-3#1)(2008-3#1)(2008-6#1)
that employers and##2##3##(1995-3#1)(2010-3#1)
that employers may##2##3##(1994-3#1)(1995-12#1)
that employers##5##2##(1994-1#1)(1994-3#1)(1995-12#1)(1995-3#1)(2010-3#1)
that employment##3##2##(2008-7#1)(2010-2#1)(2010-6#1)
that employs a##8##3##(1994-5#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#2)
that employs both##2##3##(2008-2#1)(2008-3#1)
that employs the##2##3##(2008-3#2)
that employs this technique##2##4##(2008-2#2)
that employs##38##2##(1994-5#2)(2006-2#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#3)(2008-2#9)(2008-3#10)(2008-4#5)(2011-2#1)(2012-2#1)
that empower##2##2##(1993-1#1)(2008-11#1)
that empty##2##2##(2008-8#2)
that emulate ocean water##2##4##(2008-3#2)
that emulates the##2##3##(2008-2#1)(2008-5#1)
that emulates##3##2##(2007-8#1)(2008-2#1)(2008-5#1)
that enable it to##2##4##(1992-2#1)(1995-1#1)
that enable the##7##3##(2006-10#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-2#1)(2012-2#1)
that enable##32##2##(1992-2#1)(1995-1#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-8#2)
that enabled a##3##3##(1994-2#1)(2007-10#1)(2009-4#1)
that enabled the##3##3##(2008-10#1)(2009-6#1)(2011-1#1)
that enabled##11##2##(1994-2#1)(2004-9#1)(2007-10#1)(2008-10#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2011-1#1)
that enables a##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
that enables control of##2##4##(2011-1#1)(2012-1#1)
that enables it to##2##4##(1997-6#1)(2007-12#1)
that enables one to##3##4##(1996-4#1)(2008-2#1)(2008-6#1)
that enables the determination of##2##5##(2008-10#1)(2010-12#1)
that enables the determination##3##4##(2008-10#2)(2010-12#1)
that enables the##15##3##(1994-9#1)(1995-1#1)(2006-6#1)(2007-11#1)(2007-8#2)(2008-10#3)(2008-3#4)(2008-5#1)(2010-12#1)
that enables us to##9##4##(2006-12#1)(2008-2#1)(2008-3#2)(2010-9#1)(2012-12#2)(2012-2#1)(2012-3#1)
that enables##57##2##(1990-9#1)(1994-9#1)(1995-1#2)(1995-6#1)(1996-11#1)(1996-3#1)(1996-4#1)(1997-6#1)(2006-12#1)(2006-5#1)(2006-6#3)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#5)(2008-11#2)(2008-2#5)(2008-3#8)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)
that encapsulated##2##2##(2007-11#1)(2008-5#1)
that encapsulation##3##2##(2006-12#1)(2008-11#1)(2013-1#1)
that enclose a##2##3##(1991-4#1)(2007-12#1)
that enclose the##2##3##(2008-6#2)
that enclose##4##2##(1991-4#1)(2007-12#1)(2008-6#2)
that encloses a##2##3##(1995-2#1)(2007-12#1)
that encode a##2##3##(1992-12#1)(1993-6#1)
that encode proteins##2##3##(1993-6#1)(1995-8#1)
that encode the##6##3##(1992-8#1)(1994-8#1)(1995-6#1)(1995-8#1)(1997-1#1)(2008-4#1)
that encode##38##2##(1990-12#2)(1991-4#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-8#2)(1993-6#2)(1993-9#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-6#1)(1995-8#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#2)(2011-2#1)(2012-3#1)
that encoded a protein##2##4##(2008-5#1)(2008-9#1)
that encoded a##4##3##(1991-12#1)(1995-1#1)(2008-5#1)(2008-9#1)
that encoded by##3##3##(1995-5#1)(2008-8#2)
that encoded##12##2##(1990-11#1)(1991-12#1)(1995-1#1)(1995-5#1)(1997-6#1)(2005-11#1)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)(2011-2#1)
that encodes a protein##3##4##(1992-1#1)(1997-1#1)(2008-10#1)
that encodes a putative##2##4##(1996-10#1)(2008-10#1)
that encodes a##22##3##(1990-11#1)(1990-12#2)(1991-3#1)(1991-5#1)(1992-1#1)(1993-2#1)(1993-4#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#1)(1996-10#2)(1996-5#1)(1997-1#1)(1997-6#1)(2006-5#1)(2007-12#1)(2008-10#2)
that encodes both##2##3##(1993-5#1)(2007-12#1)
that encodes the major##2##4##(1990-5#1)(1994-12#1)
that encodes the##24##3##(1990-5#1)(1990-7#1)(1991-12#1)(1991-9#1)(1992-1#1)(1993-2#1)(1993-4#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-8#2)(1996-4#2)(1997-4#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-9#2)(2010-12#1)(2011-2#1)(2013-1#2)
that encodes##66##2##(1990-11#1)(1990-12#2)(1990-5#3)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-11#1)(1993-2#2)(1993-4#2)(1993-5#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-8#2)(1996-10#3)(1996-4#2)(1996-5#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2011-2#1)(2013-1#2)
that encompass the##4##3##(2008-12#1)(2008-2#1)(2010-1#1)(2012-3#1)
that encompass##7##2##(2007-12#1)(2008-12#1)(2008-2#1)(2008-4#1)(2010-1#1)(2012-3#1)(2013-1#1)
that encompassed##2##2##(2008-1#1)(2009-4#1)
that encompasses the##2##3##(1991-2#1)(1995-6#1)
that encompasses##11##2##(1991-2#1)(1993-3#1)(1993-6#1)(1995-12#1)(1995-6#1)(2005-6#1)(2006-2#1)(2007-12#1)(2008-8#1)(2010-2#1)(2012-2#1)
that encourage##9##2##(2007-4#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-4#1)(2011-2#2)(2012-2#2)
that encouraged the##2##3##(1993-12#1)(2011-2#1)
that encouraged##3##2##(1993-12#1)(2008-11#1)(2011-2#1)
that encourages##6##2##(1992-12#1)(1994-1#1)(1995-1#1)(2006-2#1)(2008-9#1)(2010-2#1)
that end##15##2##(1992-8#1)(1994-7#1)(1995-1#1)(2005-11#1)(2007-11#1)(2007-4#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-7#1)(2011-2#1)(2013-8#2)
that end-to-end##2##2##(1990-8#1)(2009-6#1)
that endogenous cytokines##2##3##(1993-12#1)(1996-12#1)
that endogenous##34##2##(1990-2#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-7#1)(1992-10#1)(1992-11#2)(1993-11#1)(1993-12#1)(1993-4#1)(1994-10#1)(1994-2#1)(1995-12#4)(1995-3#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-6#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-3#1)(2012-2#1)
that endometriosis##2##2##(1995-12#1)(2007-10#1)
that endos is required##2##4##(2012-3#2)
that endoscopic therapy##2##3##(2005-10#1)(2006-10#1)
that endoscopic##12##2##(1990-6#1)(1992-1#1)(1993-5#1)(2005-10#1)(2006-10#2)(2006-2#1)(2006-5#1)(2008-10#1)(2008-12#1)(2008-5#2)
that endoscopy##3##2##(1997-8#1)(2006-8#1)(2007-3#1)
that endothelial cells are##2##4##(1994-9#1)(2007-9#1)
that endothelial cells##6##3##(1993-3#1)(1994-11#1)(1994-9#1)(1997-7#1)(2007-9#1)(2008-11#1)
that endothelial##10##2##(1993-3#1)(1994-11#1)(1994-9#1)(1997-7#2)(2007-9#1)(2008-11#2)(2011-1#1)(2012-12#1)
that endothelin is##2##3##(1994-11#1)(1995-12#1)
that endothelin##7##2##(1990-10#1)(1990-6#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-11#1)(1995-12#1)
that endovascular##3##2##(1995-11#1)(2007-8#1)(2008-8#1)
that ends with##2##3##(2007-7#1)(2008-5#1)
that ends##4##2##(1990-8#1)(2006-10#1)(2007-7#1)(2008-5#1)
that energetic##2##2##(2005-11#1)(2008-7#1)
that energy transfer##3##3##(2006-12#1)(2007-12#1)(2009-2#1)
that energy##7##2##(2006-12#1)(2006-3#1)(2007-12#1)(2008-12#1)(2009-2#1)(2010-11#1)(2010-8#1)
that engaged##2##2##(2009-4#1)(2010-12#1)
that engineered##2##2##(1995-5#1)(2008-8#1)
that enhance the##5##3##(1993-11#1)(1995-8#1)(2006-3#1)(2007-8#1)(2013-1#1)
that enhance their##2##3##(1995-3#1)(2006-12#1)
that enhance##22##2##(1993-11#1)(1993-9#1)(1994-12#1)(1995-3#1)(1995-8#1)(2005-7#1)(2006-10#2)(2006-12#2)(2006-3#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-1#1)(2013-1#2)
that enhanced expression##3##3##(1991-9#1)(1996-9#1)(2012-2#1)
that enhanced##13##2##(1991-9#2)(1992-7#1)(1996-12#1)(1996-9#1)(2006-12#1)(2008-10#2)(2008-11#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
that enhancement of the##2##4##(1996-10#1)(1997-5#1)
that enhancement of##6##3##(1994-5#2)(1995-6#1)(1996-10#1)(1997-5#1)(2008-5#1)
that enhancement##7##2##(1990-10#1)(1994-5#2)(1995-6#1)(1996-10#1)(1997-5#1)(2008-5#1)
that enhances the##5##3##(1997-3#1)(2007-2#1)(2008-2#1)(2008-9#1)(2012-3#1)
that enhances##18##2##(1991-2#1)(1991-8#1)(1993-6#1)(1994-5#2)(1995-1#1)(1997-3#1)(2006-6#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-9#2)(2012-12#1)(2012-3#1)
that enhancing##3##2##(2009-4#1)(2010-4#1)(2010-7#1)
that ensure that##3##3##(2007-8#1)(2008-11#1)(2008-3#1)
that ensure the##2##3##(2007-8#1)(2009-9#1)
that ensure##14##2##(1995-12#1)(1996-8#1)(2007-2#1)(2007-8#2)(2008-11#2)(2008-12#2)(2008-3#2)(2009-9#1)(2010-11#1)(2010-9#1)
that ensured the##2##3##(2008-10#2)
that ensures a##3##3##(2007-10#1)(2008-5#1)(2012-2#1)
that ensures the##5##3##(1996-11#1)(1996-12#1)(2008-10#1)(2008-8#1)(2013-8#1)
that ensures##13##2##(1995-5#1)(1996-11#1)(1996-12#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-8#1)(2009-5#1)(2012-2#1)(2013-8#1)
that entails##2##2##(1996-3#1)(2009-2#1)
that enter the##3##3##(2006-10#1)(2008-11#1)(2008-7#1)
that enter##6##2##(1991-7#1)(1995-12#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-7#1)
that enters the##3##3##(1994-6#1)(2008-2#1)(2008-3#1)
that enters##4##2##(1994-6#1)(2007-12#1)(2008-2#1)(2008-3#1)
that enveloped##2##2##(1990-2#1)(2005-8#1)
that envelopes##2##2##(2007-11#1)(2007-12#1)
that environment##4##2##(2007-3#2)(2008-10#1)(2013-1#1)
that environmental and##2##3##(2009-8#1)(2013-1#1)
that environmental factors##5##3##(1996-3#1)(2007-11#1)(2008-10#1)(2008-4#1)(2012-2#1)
that environmental##19##2##(1992-4#1)(1993-11#1)(1996-3#1)(1996-6#1)(2006-7#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-2#1)(2011-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
that environmentally##2##2##(2005-12#1)(2008-10#1)
that enzymatic hydrolysis##2##3##(1991-9#1)(1993-9#1)
that enzymatic##3##2##(1991-9#1)(1993-9#1)(2008-12#1)
that enzyme##5##2##(1992-12#1)(1993-3#1)(2006-2#1)(2011-2#1)(2012-2#1)
that enzymes##3##2##(2010-8#1)(2011-1#1)(2013-1#1)
that epidemics of##3##3##(2008-10#2)(2008-8#1)
that epidemics##5##2##(2008-10#4)(2008-8#1)
that epidermal growth factor##2##4##(1991-7#1)(1994-11#1)
that epidermal##4##2##(1991-7#1)(1994-11#1)(2008-10#1)(2010-3#1)
that epidural##6##2##(1993-7#1)(2006-10#1)(2006-8#1)(2008-7#1)(2012-3#2)
that epigenetic mechanisms##2##3##(2009-4#1)(2012-2#1)
that epigenetic##6##2##(2008-1#1)(2008-12#1)(2009-10#1)(2009-4#2)(2012-2#1)
that epilepsy##2##2##(1990-9#1)(2008-8#1)
that epileptic##2##2##(1996-1#1)(2008-7#1)
that epimerization##2##2##(2008-11#1)(2008-5#1)
that epinephrine##2##2##(1992-11#1)(2007-5#1)
that epiphytic##2##2##(2008-10#2)
that epithelial cells##4##3##(1994-2#1)(1994-3#1)(2006-10#2)
that epithelial##5##2##(1994-2#1)(1994-3#1)(1994-5#1)(2006-10#2)
that epitopes##3##2##(1990-7#1)(1996-5#1)(2008-10#1)
that epoetin##2##2##(2008-5#1)(2008-7#1)
that eponemycin##2##2##(1991-12#2)
that epsilon toxin##2##3##(2006-8#2)
that equals##2##2##(2008-10#1)(2013-1#1)
that equilibrium##4##2##(1991-4#1)(1994-9#1)(2008-8#2)
that equivalent##2##2##(2008-2#1)(2009-3#1)
that eradication of##2##3##(1993-12#1)(1997-1#1)
that errors in##2##3##(2007-12#1)(2012-2#1)
that errors##5##2##(1995-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2012-2#1)
that erythrocyte##3##2##(1992-8#1)(1997-7#1)(2005-11#1)
that erythropoietin is##2##3##(1991-6#1)(2006-10#1)
that escapes##2##2##(1994-11#1)(2008-3#1)
that especially##4##2##(1992-1#1)(1997-7#1)(2012-12#2)
that essential##4##2##(2006-6#1)(2008-1#1)(2008-5#2)
that essentially##3##2##(2007-12#1)(2007-9#1)(2011-2#1)
that establish##7##2##(1992-4#1)(1997-4#2)(1997-6#1)(2009-8#1)(2012-1#1)(2012-2#1)
that established the##2##3##(1990-4#1)(2007-4#1)
that establishes the##3##3##(2007-12#1)(2010-12#1)(2012-2#1)
that establishes##8##2##(1991-10#1)(2007-12#2)(2008-11#1)(2008-2#1)(2010-12#1)(2012-2#2)
that establishment of the##2##4##(2007-12#1)(2008-7#1)
that establishment##3##2##(2007-12#1)(2008-10#1)(2008-7#1)
that estimate##2##2##(2008-3#1)(2013-1#1)
that estimated##5##2##(1997-5#1)(2008-12#1)(2008-2#1)(2008-8#1)(2011-2#1)
that estimates of##3##3##(2008-3#1)(2008-8#1)(2008-9#1)
that estimates the##3##3##(2008-2#2)(2008-3#1)
that estimates##8##2##(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
that estimation##2##2##(2008-9#1)(2010-4#1)
that estradiol##5##2##(1990-9#1)(1996-11#1)(2004-11#2)(2009-4#1)
that estrogen##9##2##(1992-3#2)(1994-8#1)(1996-11#1)(1996-2#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-4#1)
that estrogens##4##2##(1996-4#1)(2008-4#1)(2009-7#1)(2013-1#1)
that ethanol exposure##4##3##(1991-8#1)(2009-12#2)(2013-1#1)
that ethanol##16##2##(1990-12#1)(1990-2#1)(1991-8#1)(1992-7#1)(1994-8#2)(1997-8#1)(2006-10#1)(2008-11#1)(2009-12#2)(2009-3#1)(2009-7#1)(2010-2#1)(2012-2#1)(2013-1#1)
that ethanolic extract of##2##4##(2008-12#1)(2011-1#1)
that ethical principles##2##3##(2005-5#1)(2005-7#1)
that ethidium##2##2##(2006-10#1)(2007-11#1)
that ethnic##2##2##(2008-1#1)(2010-1#1)
that ethoxyresorufin##2##2##(1994-8#2)
that ethylene signaling##2##3##(2008-10#1)(2009-8#1)
that eugenol##2##2##(2009-12#2)
that eukaryotic##3##2##(1991-12#1)(2008-7#1)(2009-6#1)
that evaluate the##2##3##(1991-2#1)(2008-7#1)
that evaluate##6##2##(1991-2#1)(2007-4#1)(2008-10#1)(2008-2#2)(2008-7#1)
that evaluated the##5##3##(1990-5#1)(2007-1#1)(2007-10#1)(2007-12#1)(2012-3#1)
that evaluated##12##2##(1990-5#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-2#1)(2008-9#1)(2012-3#1)(2013-1#2)
that evaluates the##3##3##(2006-10#1)(2007-12#1)(2008-11#1)
that evaluates##5##2##(2006-10#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-6#1)
that evaluation of##6##3##(1992-3#1)(1993-2#1)(2007-2#1)(2008-10#1)(2008-7#1)(2009-4#1)
that evaluation##7##2##(1992-3#1)(1993-2#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-7#1)(2009-4#1)
that evanescent##2##2##(2007-12#2)
that even a##3##3##(1997-6#1)(1997-7#1)(2008-3#1)
that even after##5##3##(1994-2#1)(1997-4#1)(2008-7#1)(2009-11#1)(2009-12#1)
that even at##4##3##(1991-5#1)(1992-8#1)(1995-12#1)(2012-2#1)
that even for##4##3##(1994-3#1)(2007-9#3)
that even if the##2##4##(2007-2#1)(2013-8#1)
that even if##6##3##(1990-9#1)(1996-6#1)(2007-2#1)(2008-7#2)(2013-8#1)
that even in##9##3##(1990-2#1)(1992-6#1)(1994-12#1)(1997-1#1)(2005-10#1)(2007-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
that even moderate##3##3##(1993-6#1)(1994-11#1)(1997-4#1)
that even partial##2##3##(2008-8#1)(2011-2#1)
that even short-term##2##3##(1995-4#1)(2013-1#1)
that even small##3##3##(1991-12#1)(1993-2#1)(2010-4#1)
that even the##3##3##(2007-12#1)(2008-1#1)(2013-1#1)
that even though##3##3##(1993-9#1)(2010-2#1)(2011-2#1)
that even when##3##3##(1990-3#1)(2008-10#1)(2012-3#1)
that even with a##2##4##(1997-8#1)(2009-8#1)
that even with##4##3##(1997-8#1)(2009-12#1)(2009-8#1)(2010-12#1)
that even##78##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-12#1)(1991-5#1)(1992-6#2)(1992-8#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-4#1)(1996-6#2)(1997-1#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#2)(2005-10#1)(2005-8#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#3)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#2)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
that evening##2##2##(2004-1#1)(2006-5#1)
that eventually##9##2##(1992-4#1)(1996-3#1)(2006-11#1)(2007-10#1)(2008-1#1)(2008-12#1)(2008-8#1)(2011-2#1)(2012-12#1)
that every##14##2##(1992-3#1)(1995-2#1)(1996-2#1)(1997-4#1)(2006-12#2)(2006-7#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-9#1)(2009-4#1)(2010-4#1)(2012-12#1)
that evidence of##2##3##(1995-6#1)(2010-9#1)
that evidence##5##2##(1992-3#1)(1995-6#1)(2008-9#1)(2010-9#1)(2011-2#1)
that evidenced##2##2##(1993-4#1)(1994-2#1)
that evoke##2##2##(2008-7#1)(2009-8#1)
that evoked by##2##3##(1992-8#1)(1993-4#1)
that evoked##5##2##(1992-8#1)(1993-4#1)(1995-12#2)(2007-8#1)
that evolution of##2##3##(2008-8#2)
that evolution##7##2##(2006-10#1)(2006-2#1)(2007-3#1)(2008-10#1)(2008-7#1)(2008-8#2)
that evolutionary change##2##3##(2006-5#1)(2010-2#1)
that evolutionary theory##2##3##(2006-7#1)(2010-3#1)
that evolutionary##8##2##(1993-9#1)(2006-5#1)(2006-7#1)(2008-10#1)(2010-10#1)(2010-2#1)(2010-3#2)
that evolve in##2##3##(2007-10#1)(2007-12#1)
that evolve##3##2##(1994-1#1)(2007-10#1)(2007-12#1)
that evolved from##2##3##(1994-12#1)(2006-11#1)
that evolved in##2##3##(2007-12#1)(2008-10#1)
that evolved##8##2##(1993-12#1)(1994-12#1)(1995-11#1)(2006-11#1)(2007-12#1)(2008-10#1)(2010-8#1)(2013-1#1)
that evolves##3##2##(2006-10#1)(2008-9#1)(2009-8#1)
that exact##2##2##(1994-9#1)(2012-2#1)
that exactly##2##2##(2006-10#1)(2008-10#1)
that exaggerated##3##2##(1997-1#1)(2007-8#1)(2010-9#1)
that examine##11##2##(2006-10#1)(2007-2#1)(2008-11#1)(2008-7#3)(2009-5#1)(2009-7#1)(2009-9#1)(2011-1#1)(2012-2#1)
that examined the##2##3##(2007-8#2)
that examined##10##2##(1995-1#2)(1996-12#1)(1996-8#1)(2006-7#1)(2007-8#3)(2008-4#1)(2013-1#1)
that examines the##5##3##(2008-12#1)(2008-3#1)(2009-7#1)(2010-11#1)(2011-1#1)
that examines##12##2##(1996-7#1)(2006-4#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-2#1)(2011-1#1)
that exceed##5##2##(1994-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2013-8#1)
that exceeded the##2##3##(1991-8#1)(2009-7#1)
that exceeded##7##2##(1991-11#1)(1991-8#1)(1994-12#1)(1997-4#1)(2008-10#1)(2009-7#1)(2011-2#1)
that exceeds the##4##3##(1995-8#1)(2006-9#1)(2008-2#1)(2008-3#1)
that exceeds##11##2##(1991-6#1)(1995-8#1)(2006-9#1)(2007-12#1)(2008-2#3)(2008-3#1)(2009-5#1)(2013-1#2)
that excellent##3##2##(1994-4#1)(2008-2#1)(2008-5#1)
that excess##6##2##(1995-2#1)(1995-4#1)(1995-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
that excessive##8##2##(1992-3#1)(1994-2#1)(2005-7#1)(2006-8#1)(2008-11#1)(2008-5#1)(2012-2#1)(2012-3#1)
that exchange##2##2##(1997-4#1)(2008-7#1)
that excitation of##2##3##(2007-11#1)(2007-12#1)
that excitatory amino acids##2##4##(1991-3#1)(1992-8#1)
that excitatory amino##3##3##(1991-3#1)(1992-8#2)
that excitatory##5##2##(1991-3#1)(1992-7#1)(1992-8#2)(1993-3#1)
that exclude##3##2##(2007-9#1)(2008-3#1)(2008-4#1)
that excluding##2##2##(2008-12#1)(2012-1#1)
that exclusion of##3##3##(2008-10#3)
that exclusively##2##2##(1995-6#1)(1996-8#1)
that executes##2##2##(2008-3#1)(2009-4#1)
that executive##2##2##(2008-1#1)(2012-1#1)
that exenatide##2##2##(2012-3#2)
that exercise##9##2##(1990-2#1)(1993-11#2)(2006-8#1)(2007-9#2)(2010-3#1)(2012-2#2)
that exert a##2##3##(1991-12#1)(1991-6#1)
that exert##8##2##(1991-12#1)(1991-6#1)(1993-2#1)(2007-12#1)(2008-4#1)(2009-5#1)(2010-2#1)(2012-3#1)
that exerts##2##2##(1993-9#1)(2009-11#1)
that exhibit a wide range of##2##6##(2008-3#1)(2008-7#1)
that exhibit a##7##3##(1991-4#1)(2007-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-11#1)(2012-3#1)
that exhibit both##2##3##(1992-9#1)(2007-11#1)
that exhibit different levels of##3##5##(2008-10#2)(2008-8#1)
that exhibit different##4##3##(1995-6#1)(2008-10#2)(2008-8#1)
that exhibit high##2##3##(2007-12#1)(2008-3#1)
that exhibit the##3##3##(1992-4#1)(2008-3#1)(2010-9#1)
that exhibit##42##2##(1991-4#1)(1991-5#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-2#1)(1995-6#1)(1995-8#1)(2007-11#2)(2007-12#5)(2008-10#5)(2008-2#3)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-5#3)(2009-6#1)(2010-11#1)(2010-9#1)(2012-3#3)
that exhibited by the##2##4##(1990-5#1)(1992-12#1)
that exhibited by##5##3##(1990-5#1)(1992-12#1)(1994-12#1)(2008-10#1)(2008-3#1)
that exhibited extensive##2##3##(1996-10#1)(2008-10#1)
that exhibited the##2##3##(2008-10#1)(2010-2#1)
that exhibited##38##2##(1990-5#1)(1990-7#1)(1992-12#1)(1993-11#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-6#1)(1997-7#1)(2005-7#1)(2008-10#11)(2008-3#1)(2008-6#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
that exhibits a##5##3##(1991-9#1)(1994-11#1)(2007-11#1)(2007-12#1)(2008-3#1)
that exhibits an##2##3##(2007-11#1)(2008-3#1)
that exhibits both##2##3##(2006-11#1)(2012-11#1)
that exhibits comparable##2##3##(1990-11#1)(2008-11#1)
that exhibits similarity to##2##4##(1993-9#1)(1994-6#1)
that exhibits the##2##3##(1992-12#1)(2008-2#1)
that exhibits two##2##3##(2007-12#1)(2009-7#1)
that exhibits##34##2##(1990-11#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-1#1)(1996-12#1)(1996-2#1)(2006-11#1)(2007-11#2)(2007-12#6)(2008-11#1)(2008-2#1)(2008-3#5)(2009-3#1)(2009-7#1)(2010-3#1)(2011-1#1)(2012-11#1)(2012-2#1)
that exist as##2##3##(2007-4#1)(2008-9#1)
that exist between the##3##4##(2008-8#1)(2009-5#1)(2013-7#1)
that exist between them##2##4##(2005-10#1)(2007-11#1)
that exist between##8##3##(2005-10#1)(2007-11#1)(2008-10#1)(2008-8#2)(2009-11#1)(2009-5#1)(2013-7#1)
that exist for##3##3##(2007-10#1)(2007-11#1)(2007-2#1)
that exist in the##8##4##(1991-4#1)(2006-5#1)(2007-5#1)(2008-2#2)(2008-3#2)(2010-4#1)
that exist in##16##3##(1991-4#1)(1993-1#1)(1996-3#1)(2006-5#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-8#1)(2010-4#1)(2012-12#1)
that exist##37##2##(1991-4#1)(1993-1#1)(1996-1#1)(1996-3#1)(2004-12#1)(2005-10#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#5)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-5#1)(2010-4#1)(2012-12#1)(2013-1#1)(2013-7#1)
that existed in##2##3##(1996-4#1)(2008-11#1)
that existed##3##2##(1996-4#1)(1997-4#1)(2008-11#1)
that existence of##2##3##(1996-5#1)(2008-10#1)
that existing##6##2##(2008-3#1)(2009-11#1)(2009-4#1)(2010-10#1)(2013-1#2)
that exists among##2##3##(1997-8#1)(2008-10#1)
that exists as a##3##4##(1992-11#1)(2006-12#1)(2006-9#1)
that exists as##4##3##(1991-11#1)(1992-11#1)(2006-12#1)(2006-9#1)
that exists between##5##3##(1993-12#1)(2006-4#1)(2007-12#1)(2013-1#2)
that exists in the##4##4##(2007-4#1)(2008-1#1)(2008-12#1)(2008-5#1)
that exists in##9##3##(1990-12#1)(1990-5#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2012-3#1)
that exists within##3##3##(2007-5#1)(2008-12#1)(2012-12#1)
that exists##29##2##(1990-12#1)(1990-5#1)(1991-11#1)(1992-11#1)(1993-12#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-8#1)(2006-12#1)(2006-4#1)(2006-9#2)(2007-12#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
that exit from##2##3##(2008-3#1)(2011-2#1)
that exit##3##2##(2008-3#1)(2009-10#1)(2011-2#1)
that exoenzyme S##2##3##(1991-3#2)
that exogenous##19##2##(1990-2#2)(1991-12#1)(1991-3#1)(1992-5#1)(1996-10#1)(1996-2#1)(1997-2#1)(2006-12#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-8#1)(2012-3#1)(2013-8#2)
that exogenously##2##2##(2008-11#1)(2011-10#1)
that exon 2##2##3##(2008-12#1)(2009-4#1)
that exon##4##2##(1997-8#1)(2008-12#2)(2009-4#1)
that expansion of##2##3##(1997-1#1)(2008-9#1)
that expansion##3##2##(1996-12#1)(1997-1#1)(2008-9#1)
that expected for##2##3##(1991-7#1)(1994-9#1)
that expected from the##3##4##(1992-8#1)(2006-10#1)(2008-10#1)
that expected from##8##3##(1990-11#1)(1992-8#1)(1994-12#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-3#1)
that expected##18##2##(1990-11#1)(1991-7#1)(1992-8#1)(1994-12#1)(1994-9#1)(1996-8#2)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-4#1)(2008-10#3)(2008-3#1)(2008-7#1)
that experience##10##2##(2007-11#1)(2008-8#3)(2008-9#3)(2009-8#1)(2012-12#1)(2013-8#1)
that experienced a##2##3##(1995-9#1)(2005-11#1)
that experienced by##3##3##(2007-1#1)(2007-2#1)(2008-7#1)
that experienced##8##2##(1991-5#1)(1992-7#1)(1995-9#1)(2005-11#1)(2007-1#1)(2007-2#1)(2007-3#1)(2008-7#1)
that experiences##3##2##(2006-7#1)(2008-10#1)(2008-8#1)
that experiment##2##2##(2007-12#1)(2008-3#1)
that experimental##11##2##(1993-5#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2009-2#1)(2012-2#1)
that experimentally##2##2##(2007-11#1)(2008-1#1)
that expert##3##2##(2013-1#3)
that explain the##7##3##(1993-3#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-2#1)(2012-12#1)(2013-1#1)
that explain##13##2##(1993-3#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-2#1)(2009-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
that explained##5##2##(2008-10#1)(2008-12#1)(2008-5#1)(2012-12#1)(2013-1#1)
that explains the##3##3##(2006-10#1)(2010-10#1)(2012-12#1)
that explains this##2##3##(2007-12#1)(2012-3#1)
that explains##10##2##(1994-12#1)(2006-10#1)(2007-12#2)(2008-5#1)(2010-10#1)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#1)
that explanations##2##2##(2007-2#1)(2012-12#1)
that explicitly consider the##2##4##(2008-3#1)(2008-8#1)
that explicitly includes##2##3##(1994-2#1)(2008-2#1)
that explicitly##5##2##(1994-2#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-10#1)
that exploit the##6##3##(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)
that exploit##14##2##(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-2#2)(2012-3#1)
that exploits the##5##3##(2008-3#3)(2009-9#1)(2012-2#1)
that exploits##13##2##(1995-6#1)(2007-12#2)(2008-1#1)(2008-3#5)(2008-7#1)(2009-8#1)(2009-9#1)(2012-2#1)
that explore the##4##3##(2008-10#1)(2008-6#1)(2011-2#2)
that explore##5##2##(2008-10#1)(2008-12#1)(2008-6#1)(2011-2#2)
that explored the##7##3##(1996-3#1)(2006-7#1)(2006-9#1)(2007-10#1)(2008-12#1)(2009-12#1)(2011-1#1)
that explored##9##2##(1996-3#1)(2006-7#1)(2006-9#1)(2007-10#1)(2008-12#1)(2009-12#1)(2009-5#1)(2010-4#1)(2011-1#1)
that explores the##2##3##(1992-6#1)(2007-10#1)
that explores##3##2##(1992-6#1)(2007-10#1)(2010-8#1)
that exposed##2##2##(2005-10#1)(2008-2#1)
that exposes##2##2##(2006-2#1)(2007-12#1)
that exposure of human##4##4##(1992-8#1)(1994-11#1)(1994-6#1)(2008-5#1)
that exposure of the##3##4##(1990-3#1)(2005-11#1)(2012-2#1)
that exposure of##13##3##(1990-3#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#2)(1996-6#1)(2005-11#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
that exposure to a##3##4##(1992-1#1)(1992-7#1)(2012-3#1)
that exposure to sublethal##2##4##(1991-12#1)(1994-2#1)
that exposure to the##5##4##(1993-6#1)(2007-12#2)(2008-10#2)
that exposure to these##2##4##(1997-3#1)(2011-1#1)
that exposure to##44##3##(1991-12#1)(1991-4#1)(1992-1#1)(1992-7#2)(1993-6#1)(1993-7#1)(1994-2#1)(1994-6#1)(1995-10#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#3)(2004-4#1)(2005-10#1)(2006-10#1)(2007-12#4)(2007-5#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-5#1)(2011-1#1)(2012-3#2)(2013-1#2)
that exposure was##2##3##(2010-8#1)(2011-2#1)
that exposure##63##2##(1990-3#1)(1991-12#1)(1991-4#1)(1992-1#1)(1992-7#2)(1992-8#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#3)(1995-10#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#3)(2004-11#1)(2004-4#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-12#4)(2007-5#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#2)
that express high levels of##3##5##(1994-9#1)(2008-11#1)(2008-4#1)
that express high##5##3##(1994-9#1)(1995-5#1)(2007-11#1)(2008-11#1)(2008-4#1)
that express low CD4 and/or CCR5##2##6##(2007-11#2)
that express the human##2##4##(1990-11#1)(1997-7#1)
that express the##19##3##(1990-11#1)(1991-5#1)(1991-8#1)(1995-8#1)(1996-4#1)(1997-7#1)(2005-10#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#2)(2009-6#1)(2011-1#1)
that express##59##2##(1990-11#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#2)(2005-10#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#2)(2009-6#1)(2009-8#1)(2010-11#2)(2011-1#1)(2012-3#1)
that expressed the##2##3##(1993-11#1)(2008-10#1)
that expressed##19##2##(1991-5#1)(1993-11#1)(1994-12#1)(1994-5#2)(1994-9#1)(1996-1#1)(1997-4#1)(1997-7#1)(2005-8#1)(2008-10#5)(2008-5#1)(2009-5#1)(2009-6#1)(2010-3#1)
that expresses a##3##3##(1991-10#1)(1991-5#1)(2008-4#1)
that expresses the Bacillus thuringiensis (Bt)##2##6##(2011-2#2)
that expresses the##5##3##(1997-1#1)(2007-8#1)(2008-11#1)(2011-2#2)
that expresses##17##2##(1991-10#1)(1991-5#1)(1992-7#1)(1994-12#1)(1995-2#1)(1997-1#1)(2007-8#1)(2008-11#2)(2008-4#1)(2008-5#1)(2011-2#2)(2012-12#3)(2013-8#1)
that expression levels of##3##4##(2008-11#1)(2008-9#1)(2013-1#1)
that expression of a##2##4##(1991-11#1)(2009-8#1)
that expression of the##13##4##(1990-2#1)(1991-8#1)(1993-7#1)(1994-9#1)(1995-3#2)(1995-8#3)(1996-7#1)(1997-2#1)(1997-4#1)(2008-10#1)
that expression of these##2##4##(1997-8#1)(2009-10#1)
that expression of##42##3##(1990-11#1)(1990-12#1)(1990-2#1)(1991-11#1)(1991-8#1)(1992-9#2)(1993-3#1)(1993-4#1)(1993-7#1)(1994-10#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-7#1)(1995-8#3)(1996-11#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-8#2)(2009-10#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
that expression##50##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-11#1)(1991-8#1)(1992-9#2)(1993-3#1)(1993-4#1)(1993-7#1)(1994-10#1)(1994-3#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-3#2)(1995-7#1)(1995-8#3)(1996-11#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#2)(2008-10#2)(2008-11#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
that extend from the##4##4##(1995-10#1)(1995-11#1)(1997-8#1)(2010-12#1)
that extend the##2##3##(1996-12#1)(2008-8#1)
that extend##15##2##(1995-10#1)(1995-11#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-8#1)(2009-12#1)(2009-2#1)(2010-12#1)
that extended from the##3##4##(2005-7#1)(2011-2#1)(2012-3#1)
that extended from##4##3##(1995-10#1)(2005-7#1)(2011-2#1)(2012-3#1)
that extended into the##2##4##(1990-10#1)(2005-5#1)
that extended throughout the##2##4##(1997-3#1)(2004-2#1)
that extended to##2##3##(2007-8#1)(2008-10#1)
that extended##18##2##(1990-10#1)(1995-10#1)(1997-3#2)(2004-2#1)(2005-5#1)(2005-7#1)(2007-8#2)(2008-10#4)(2008-2#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
that extends from##2##3##(2007-11#1)(2008-2#1)
that extends over##2##3##(2007-12#1)(2008-2#1)
that extends the##5##3##(1996-5#1)(2006-12#1)(2007-11#1)(2008-3#1)(2011-2#1)
that extends##16##2##(1996-5#1)(1997-3#1)(2006-12#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2010-8#1)(2011-2#1)(2012-2#2)
that extension##2##2##(1994-6#1)(2007-1#1)
that extensive##7##2##(1990-12#1)(1992-3#1)(2005-11#1)(2007-8#1)(2008-12#1)(2012-3#1)(2013-1#1)
that external##9##2##(2006-8#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-2#1)(2010-1#1)(2010-10#1)(2011-2#1)
that extinction##2##2##(2008-2#1)(2008-9#1)
that extracellular ATP and other nucleotides##2##6##(2008-4#2)
that extracellular ATP##5##3##(1992-11#1)(1997-1#2)(2008-4#2)
that extracellular Ca2+ is##2##4##(1990-7#1)(1990-8#1)
that extracellular CaM##2##3##(2008-8#2)
that extracellular matrix##2##3##(2009-8#1)(2010-11#1)
that extracellular##27##2##(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#1)(1992-11#1)(1994-11#2)(1995-2#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-6#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-3#1)(2008-4#4)(2008-7#1)(2008-8#2)(2009-6#1)(2009-8#1)(2010-11#1)
that extracts##3##2##(2008-3#1)(2010-2#2)
that extreme##2##2##(1996-6#1)(2012-2#1)
that eye##4##2##(1992-7#1)(2008-11#2)(2011-1#1)
that fabrication##2##2##(2008-10#1)(2008-3#1)
that face##5##2##(2007-4#1)(2008-1#1)(2009-10#1)(2010-3#1)(2012-1#1)
that faces##2##2##(2008-3#1)(2012-1#1)
that facet joint mediated pain is a##2##7##(2006-12#1)(2006-8#1)
that facet joint mediated##3##4##(2006-12#1)(2006-8#2)
that facet##4##2##(2006-12#1)(2006-8#2)(2007-1#1)
that facilitate and hinder##2##4##(1995-3#1)(2006-10#1)
that facilitate the##4##3##(2006-9#1)(2008-11#1)(2008-4#1)(2008-9#1)
that facilitate##23##2##(1993-9#1)(1995-3#1)(2005-8#1)(2006-10#2)(2006-9#1)(2007-8#1)(2008-11#4)(2008-12#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
that facilitated##6##2##(1993-12#1)(1995-1#1)(2007-11#1)(2008-12#1)(2008-6#1)(2013-1#1)
that facilitates##17##2##(1991-2#1)(1994-3#1)(1996-12#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-2#1)(2009-9#1)(2010-6#1)(2010-9#1)(2011-2#1)
that facilitation of##2##3##(1991-5#1)(2012-3#1)
that facilitation##3##2##(1991-5#1)(1993-2#1)(2012-3#1)
that fact##3##2##(2007-11#1)(2008-10#1)(2008-12#1)
that factor##5##2##(1990-2#1)(1992-1#1)(1993-6#1)(1995-2#1)(2009-8#1)
that factors bound to the##2##5##(1992-5#1)(1997-7#1)
that factors in##2##3##(1992-3#1)(2008-7#1)
that factors other than##4##4##(1990-5#1)(1995-2#1)(1997-2#1)(2011-2#1)
that factors such as##4##4##(1991-2#1)(2007-2#1)(2013-1#2)
that factors##22##2##(1990-5#1)(1991-2#1)(1992-3#1)(1992-5#1)(1993-6#1)(1995-2#1)(1997-2#2)(1997-7#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-12#2)(2013-1#2)
that fail to consider##2##4##(2010-12#1)(2012-1#1)
that fail to##15##3##(1990-6#1)(1992-12#2)(1993-3#1)(1994-3#1)(1995-4#1)(1995-8#1)(1997-8#1)(2008-11#1)(2008-9#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-11#1)
that fail##16##2##(1990-6#1)(1992-12#2)(1993-3#1)(1994-3#1)(1995-4#1)(1995-8#1)(1997-8#1)(2008-11#1)(2008-9#2)(2009-10#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-11#1)
that failed to develop##2##4##(2008-10#2)
that failed to heal##2##4##(2008-5#1)(2010-6#1)
that failed to##11##3##(1994-8#1)(1995-3#1)(1996-12#1)(1996-4#1)(2006-10#1)(2008-10#2)(2008-5#1)(2009-6#1)(2010-6#1)(2012-3#1)
that failed##15##2##(1994-8#1)(1995-3#1)(1996-12#1)(1996-4#1)(1997-1#1)(2006-10#1)(2006-2#1)(2008-10#2)(2008-5#1)(2009-3#1)(2009-6#1)(2010-6#1)(2010-7#1)(2012-3#1)
that fails to##3##3##(1995-1#1)(2008-8#1)(2012-12#1)
that fails##4##2##(1995-1#1)(2007-8#1)(2008-8#1)(2012-12#1)
that failure of##2##3##(1994-4#1)(2013-1#1)
that failure to##6##3##(2007-4#1)(2008-10#1)(2008-5#1)(2011-12#1)(2012-1#1)(2012-2#1)
that failure##9##2##(1994-4#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#1)
that faithfully##2##2##(1996-2#1)(2008-11#1)
that fall in##2##3##(2005-7#1)(2008-2#1)
that fall##3##2##(2005-7#1)(2008-2#1)(2008-4#1)
that fallopian tube##2##3##(1996-2#1)(2013-8#1)
that falls##2##2##(2008-2#1)(2009-7#1)
that false recognition##2##3##(2009-1#2)
that false##4##2##(2008-8#1)(2009-1#2)(2012-3#1)
that familial##2##2##(2006-5#1)(2009-10#1)
that familiarity##3##2##(2009-10#2)(2010-2#1)
that families of##2##3##(2008-8#1)(2012-12#1)
that families##4##2##(1991-12#1)(2008-8#1)(2010-9#1)(2012-12#1)
that family members##2##3##(1992-7#1)(2011-2#1)
that family planning and##2##4##(2012-11#2)
that family planning is##2##4##(1990-9#1)(1994-7#1)
that family planning was##2##4##(1992-4#2)
that family planning##8##3##(1990-9#1)(1992-4#3)(1994-7#1)(2006-4#1)(2012-11#2)
that family##23##2##(1990-9#1)(1992-4#3)(1992-7#1)(1994-7#1)(1997-8#1)(2005-10#1)(2006-4#1)(2006-7#1)(2007-4#1)(2007-6#1)(2008-2#1)(2008-5#1)(2009-12#1)(2010-1#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-11#2)(2013-1#1)
that far##3##2##(1992-2#1)(1993-3#1)(2007-8#1)
that farm-related##2##2##(2008-12#2)
that farmers are##2##3##(2007-8#1)(2009-3#1)
that farmers##4##2##(2007-8#1)(2008-12#2)(2009-3#1)
that fast##3##2##(1992-11#1)(1996-7#1)(2008-3#1)
that fast-twitch##2##2##(1991-6#1)(1995-9#1)
that fasting##2##2##(2008-3#1)(2008-4#1)
that fat##4##2##(1994-11#1)(1996-4#1)(2007-11#1)(2008-5#1)
that fatigue is##2##3##(2007-2#2)
that fatigue##3##2##(2007-2#2)(2008-5#1)
that fatty acids are##2##4##(1995-6#1)(2008-8#1)
that fatty acids##3##3##(1995-6#2)(2008-8#1)
that fatty##6##2##(1994-12#1)(1995-6#2)(2006-10#1)(2008-8#1)(2011-1#1)
that favor the##2##3##(2008-9#1)(2011-1#1)
that favor##12##2##(1995-6#2)(1996-3#1)(2006-2#1)(2006-3#2)(2008-2#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#2)
that favored the##2##3##(1994-3#1)(2006-10#1)
that favored##4##2##(1994-3#1)(1994-9#1)(2006-10#1)(2008-1#1)
that favors##6##2##(1990-8#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-6#1)(2013-8#1)
that favour hemi-fusion##2##3##(1991-5#2)
that favour##4##2##(1991-5#2)(1997-4#1)(2008-2#1)
that favours the##2##3##(2007-8#1)(2012-12#1)
that fear##5##2##(1996-11#1)(2008-11#1)(2008-4#1)(2009-8#1)(2012-2#1)
that feature##3##2##(1995-11#1)(2008-1#1)(2009-10#1)
that features##8##2##(1993-3#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#3)
that fecal##2##2##(2006-5#1)(2009-4#1)
that fed##3##2##(2006-10#1)(2009-4#2)
that feed on##4##3##(2004-11#1)(2006-5#1)(2008-10#1)(2012-2#1)
that feed##7##2##(2004-11#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-2#1)
that feedback##2##2##(1995-2#1)(1996-3#1)
that feeding##7##2##(1995-12#1)(1997-4#1)(2008-11#1)(2008-12#1)(2008-8#1)(2012-2#1)(2013-8#1)
that fell##2##2##(1992-3#1)(2010-4#1)
that female##7##2##(1990-12#1)(1993-5#1)(1995-3#1)(2008-12#1)(2008-8#1)(2010-3#1)(2012-3#1)
that females may##2##3##(2008-8#2)
that females were##2##3##(2008-4#1)(2009-9#1)
that females##19##2##(1995-1#1)(2007-7#1)(2007-9#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#6)(2008-9#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-11#1)(2012-12#1)
that fenofibrate##2##2##(2009-11#2)
that ferritin##6##2##(1993-11#1)(1994-5#1)(2008-3#2)(2013-1#1)(2013-8#1)
that fetal cells##2##3##(1996-12#1)(2012-3#1)
that fetal##8##2##(1992-12#1)(1994-2#1)(1995-8#1)(1996-12#1)(2005-11#1)(2007-10#1)(2012-2#1)(2012-3#1)
that fetuin##3##2##(1996-5#3)
that feverfew##2##2##(2008-10#2)
that few patients##2##3##(1997-1#1)(2008-7#1)
that few##7##2##(1991-6#1)(1993-12#1)(1997-1#1)(2006-12#1)(2007-11#1)(2008-7#1)(2012-1#1)
that fibrin##3##2##(1997-2#1)(2005-11#1)(2009-4#1)
that fibroblasts##6##2##(1990-3#1)(1995-1#1)(1995-5#1)(2007-2#1)(2007-3#1)(2008-11#1)
that fibronectin##3##2##(1994-3#1)(2008-11#2)
that fibrous##2##2##(2007-11#1)(2008-5#1)
that field##8##2##(1997-1#1)(2007-10#2)(2008-10#3)(2012-12#1)(2013-8#1)
that fights##2##2##(2008-9#2)
that fill##2##2##(1996-8#1)(2008-10#1)
that fills the##2##3##(1995-11#1)(2007-12#1)
that fills##3##2##(1995-11#1)(2007-12#1)(2009-6#1)
that film##2##2##(2008-3#1)(2010-4#1)
that films##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
that finally leads to##2##4##(1994-3#1)(1995-5#1)
that finally##4##2##(1994-3#1)(1995-5#1)(2008-10#1)(2010-12#1)
that financial##4##2##(1992-1#1)(1994-2#1)(1995-12#1)(2007-9#1)
that find##2##2##(2007-6#1)(2009-10#1)
that finding##3##2##(2008-8#1)(2009-12#1)(2012-11#1)
that finds##2##2##(2008-2#2)
that finite##3##2##(2007-11#1)(2007-12#1)(2008-8#1)
that first##10##2##(1991-3#1)(1995-11#1)(1995-6#1)(1997-1#1)(2004-10#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-9#1)(2011-2#1)
that fish and##2##3##(2008-7#1)(2013-7#1)
that fish##6##2##(2006-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-8#1)(2013-7#1)
that fit the data##2##4##(2008-3#2)
that fit the##7##3##(1990-5#1)(1991-1#1)(1995-10#1)(2008-1#1)(2008-10#1)(2008-3#2)
that fit##10##2##(1990-5#1)(1991-1#1)(1995-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-6#1)
that fitness##2##2##(2008-10#1)(2008-8#1)
that fits with##3##3##(1993-1#1)(1994-3#1)(2010-8#1)
that fits##6##2##(1991-7#1)(1993-1#1)(1994-3#1)(2006-10#1)(2008-4#1)(2010-8#1)
that five had##2##3##(2009-10#1)(2011-2#1)
that five##7##2##(1990-2#1)(1991-9#1)(2008-1#1)(2008-9#1)(2009-10#1)(2009-12#1)(2011-2#1)
that flank the##2##3##(1995-1#1)(2008-7#1)
that flavonoid##2##2##(2008-11#1)(2008-6#1)
that flavonoids are##2##3##(1997-7#1)(2009-10#1)
that flavonoids##6##2##(1997-7#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-10#1)
that flexibility##2##2##(1992-1#1)(1994-11#1)
that flexible##3##2##(2006-1#1)(2008-8#1)(2010-2#1)
that flies##2##2##(2004-11#1)(2011-1#1)
that floral##3##2##(2008-9#1)(2009-6#1)(2013-8#1)
that flow##10##2##(2006-5#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#2)
that flowering##2##2##(2008-9#1)(2009-8#1)
that flowers were##2##3##(2008-10#2)
that flowers##3##2##(2008-10#2)(2013-8#1)
that fluctuating##3##2##(1991-4#1)(1995-2#1)(2008-8#1)
that fluid##4##2##(2007-8#1)(2009-10#1)(2011-2#2)
that flumorph##2##2##(2008-10#2)
that fluorescence intensity##2##3##(1992-8#1)(2010-2#1)
that fluorescence##12##2##(1992-8#1)(1994-11#1)(1996-11#1)(1996-12#1)(2005-4#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-9#1)(2010-2#1)(2011-1#1)
that fluorescent##2##2##(2006-12#1)(2008-10#1)
that focus exclusively on##2##4##(2007-12#1)(2008-11#1)
that focus on the##6##4##(1994-12#1)(1994-3#1)(2007-3#1)(2008-12#1)(2012-3#1)(2013-8#1)
that focus on##17##3##(1992-12#1)(1994-12#1)(1994-3#1)(1997-2#1)(2007-3#1)(2008-12#1)(2008-2#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#2)(2011-2#1)(2012-3#2)(2013-8#1)
that focus##21##2##(1992-12#1)(1994-12#1)(1994-3#1)(1997-2#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#2)(2011-2#1)(2012-3#2)(2013-8#1)
that focused on determining##3##4##(2010-2#1)(2013-1#2)
that focused on the##5##4##(2007-12#1)(2007-2#1)(2007-3#1)(2008-11#1)(2012-1#1)
that focused on##11##3##(1992-9#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-11#1)(2008-7#1)(2010-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
that focuses on the##6##4##(2006-6#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#1)(2012-2#1)
that focuses on##18##3##(1996-12#1)(2006-6#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-10#2)(2010-8#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
that focuses##19##2##(1996-12#1)(2006-6#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-10#2)(2010-8#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
that focusing##2##2##(2008-8#1)(2012-12#1)
that folate##3##2##(1992-3#1)(1992-9#1)(2008-7#1)
that fold into##2##3##(1996-5#1)(2007-9#1)
that foliar##2##2##(2008-10#1)(2008-8#1)
that folic acid##4##3##(2007-11#2)(2008-11#1)(2009-4#1)
that follicular##2##2##(1990-6#1)(1991-9#1)
that follow a##5##3##(1997-2#1)(2008-4#1)(2010-2#1)(2012-2#1)(2012-3#1)
that follow the##3##3##(1994-11#1)(2008-2#1)(2011-2#1)
that follow##20##2##(1992-3#1)(1993-12#1)(1993-6#1)(1994-11#1)(1995-1#1)(1997-2#1)(1997-3#1)(2006-3#1)(2007-9#1)(2008-1#1)(2008-2#2)(2008-4#2)(2009-4#1)(2010-2#1)(2011-2#2)(2012-2#1)(2012-3#1)
that follow-up##3##2##(2006-6#1)(2008-12#1)(2011-2#1)
that followed the##3##3##(1996-12#1)(1996-3#1)(2008-12#1)
that followed##12##2##(1992-11#1)(1993-12#1)(1996-12#1)(1996-3#1)(1997-5#1)(2006-12#1)(2006-5#2)(2008-11#1)(2008-12#2)(2008-6#1)
that following##14##2##(1990-2#1)(1990-4#1)(1991-10#1)(1991-7#1)(1992-8#1)(1992-9#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-5#1)(1996-8#1)(2008-4#1)(2008-6#1)(2008-7#1)
that follows an##2##3##(2012-12#1)(2012-3#1)
that follows the##5##3##(1990-7#1)(1994-12#1)(2008-11#2)(2009-11#1)
that follows##18##2##(1990-4#1)(1990-7#2)(1991-9#1)(1994-12#1)(1995-11#1)(1996-1#1)(1996-7#1)(2007-12#1)(2007-7#1)(2008-11#2)(2008-2#1)(2009-1#1)(2009-11#1)(2010-12#1)(2012-12#1)(2012-3#1)
that food##9##2##(1996-3#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-11#2)(2012-1#1)
that for a given##3##4##(2006-10#1)(2007-6#1)(2013-7#1)
that for a##30##3##(1992-11#1)(1994-6#1)(1997-4#1)(1997-7#1)(2005-11#3)(2006-10#2)(2007-6#1)(2008-1#1)(2008-10#3)(2008-2#6)(2008-3#4)(2010-10#1)(2010-2#1)(2012-2#2)(2013-7#1)(2013-8#1)
that for all##2##3##(1992-8#1)(2006-2#1)
that for an##9##3##(1991-9#1)(1994-2#1)(1995-6#1)(1996-5#1)(2008-3#4)(2012-2#1)
that for both##5##3##(1992-11#1)(2005-11#2)(2007-11#1)(2010-2#1)
that for bovine##2##3##(1990-10#1)(1993-8#1)
that for calcium##2##3##(1997-1#1)(2008-9#1)
that for certain##6##3##(2008-1#1)(2008-11#1)(2008-3#2)(2011-1#1)(2013-8#1)
that for effective##2##3##(2008-11#1)(2012-2#1)
that for many##2##3##(2006-11#1)(2007-5#1)
that for most##5##3##(1991-6#1)(2008-11#1)(2008-8#1)(2011-1#1)(2012-2#1)
that for other##4##3##(1991-7#1)(1994-7#1)(2007-11#1)(2011-2#1)
that for patients##3##3##(2007-7#1)(2007-8#1)(2008-11#1)
that for positive##2##3##(2007-12#1)(2008-2#1)
that for some##5##3##(1994-6#1)(2005-9#1)(2008-3#1)(2008-7#1)(2012-12#1)
that for the##58##3##(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-7#1)(1992-8#1)(1993-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-8#1)(1997-4#2)(1997-7#3)(2005-11#2)(2006-10#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-5#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-12#1)(2010-9#2)(2011-2#1)(2013-8#2)
that for these##3##3##(2006-7#1)(2007-2#1)(2008-9#1)
that for this##3##3##(2007-11#1)(2008-10#1)(2009-12#1)
that for those##4##3##(1995-9#1)(2008-2#2)(2012-12#1)
that for two##2##3##(1995-2#1)(2004-4#1)
that for##314##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#4)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#4)(1991-12#3)(1991-2#3)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#2)(1992-7#4)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#2)(1995-4#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-5#4)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#3)(1997-7#4)(1997-8#1)(2004-4#1)(2004-9#1)(2005-11#11)(2005-4#1)(2005-9#1)(2006-10#3)(2006-11#2)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#1)(2007-10#2)(2007-11#4)(2007-12#13)(2007-2#2)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#21)(2008-11#8)(2008-12#2)(2008-2#21)(2008-3#22)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#2)(2009-7#2)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-9#2)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#7)
that for-profit##2##2##(2008-11#1)(2010-9#1)
that forage with##2##3##(2009-10#2)
that forage##3##2##(2008-8#1)(2009-10#2)
that force##4##2##(1991-5#1)(1995-12#1)(2007-11#1)(2012-11#1)
that foreign##2##2##(2008-7#1)(2012-12#1)
that foreign-born##2##2##(2005-10#1)(2012-12#1)
that form a part of##2##5##(1992-6#1)(2008-1#1)
that form a##8##3##(1991-12#1)(1992-6#1)(1993-11#1)(1995-3#1)(2007-12#2)(2008-1#1)(2008-2#1)
that form during##2##3##(1992-5#1)(2009-2#1)
that form the##13##3##(1991-8#1)(1993-12#1)(1997-6#1)(2005-11#1)(2006-11#1)(2007-12#1)(2007-4#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-8#1)(2010-11#1)(2012-2#1)
that form##44##2##(1990-2#1)(1990-5#1)(1991-12#1)(1991-8#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1995-3#1)(1996-5#1)(1996-9#1)(1997-6#1)(2005-11#2)(2006-11#1)(2007-12#3)(2007-4#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-11#1)(2011-12#1)(2012-12#2)(2012-2#2)(2013-7#1)
that formaldehyde##2##2##(2008-10#1)(2008-8#1)
that formation of##8##3##(1990-2#1)(1993-12#1)(1994-3#1)(1996-2#1)(1997-3#1)(2008-5#1)(2012-11#1)(2013-1#1)
that formation##9##2##(1990-2#1)(1992-11#1)(1993-12#1)(1994-3#1)(1996-2#1)(1997-3#1)(2008-5#1)(2012-11#1)(2013-1#1)
that formed by##2##3##(1992-9#1)(2008-5#1)
that formed##9##2##(1991-3#1)(1992-9#1)(1994-12#1)(1996-5#1)(1997-4#1)(2008-10#1)(2008-5#2)(2013-1#1)
that forms a##8##3##(1991-2#1)(1995-11#1)(2007-11#1)(2007-12#1)(2008-4#1)(2009-8#1)(2010-8#1)(2011-2#1)
that forms the##8##3##(1990-12#1)(1990-3#1)(1995-4#1)(1995-8#1)(2006-5#1)(2008-2#1)(2009-7#1)(2011-1#1)
that forms##26##2##(1990-12#1)(1990-3#1)(1991-2#1)(1991-7#1)(1994-8#1)(1995-11#1)(1995-3#2)(1995-4#1)(1995-8#1)(1996-8#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-1#2)(2011-2#2)
that formulation##4##2##(2006-1#1)(2008-12#1)(2010-12#1)(2012-12#1)
that fornix lesions##2##3##(1994-6#2)
that fornix##3##2##(1993-3#1)(1994-6#2)
that forskolin##2##2##(1994-11#1)(2009-12#1)
that foster##6##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2012-12#1)
that found among##2##3##(2007-8#1)(2008-7#1)
that found at##2##3##(1991-5#1)(1995-1#1)
that found for##8##3##(1990-6#1)(1994-9#1)(1995-8#2)(1997-7#1)(2007-11#1)(2007-12#1)(2008-5#1)
that found in C##2##4##(1991-8#1)(2007-12#1)
that found in either##2##4##(1990-9#1)(1995-12#1)
that found in human##2##4##(1991-8#1)(1993-3#1)
that found in other##5##4##(1990-3#1)(1997-5#1)(2007-2#1)(2007-3#1)(2011-2#1)
that found in the bcl-2##2##5##(1996-5#1)(2008-11#1)
that found in the##15##4##(1990-4#1)(1991-2#1)(1991-9#1)(1994-6#1)(1995-1#1)(1995-6#1)(1996-5#1)(1996-9#1)(2004-10#1)(2006-10#1)(2008-10#1)(2008-11#2)(2011-2#1)(2012-12#1)
that found in##58##3##(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-7#1)(1993-11#1)(1993-3#1)(1994-11#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-5#2)(1996-9#1)(1997-4#1)(1997-5#1)(1997-8#2)(2004-10#1)(2006-10#1)(2006-3#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-6#1)(2008-10#3)(2008-11#3)(2008-5#2)(2008-7#4)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)
that found that##4##3##(1991-7#1)(1997-5#1)(2011-1#1)(2011-2#1)
that found the##2##3##(1996-12#1)(2012-3#1)
that found with the##3##4##(1993-4#1)(1995-11#1)(2007-7#1)
that found with##8##3##(1990-12#1)(1991-3#1)(1992-6#1)(1993-4#1)(1994-5#1)(1995-11#1)(1996-11#1)(2007-7#1)
that found##91##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#2)(1990-9#1)(1991-10#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-5#2)(1996-9#1)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#2)(2004-10#1)(2006-10#1)(2006-3#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-5#3)(2008-7#5)(2008-9#1)(2010-10#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-3#1)
that four##18##2##(1990-7#1)(1991-9#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-7#1)(1996-4#1)(1996-8#1)(1997-3#1)(2005-11#1)(2008-10#2)(2008-3#2)(2008-9#1)(2009-2#1)(2012-12#2)
that fracture##5##2##(2006-11#1)(2006-3#1)(2007-1#1)(2007-11#2)
that fragments of##2##3##(1994-9#1)(2012-2#1)
that fragments##3##2##(1994-9#1)(1995-10#1)(2012-2#1)
that free radicals##5##3##(1993-3#1)(1994-12#1)(1995-8#1)(1996-3#1)(1997-8#1)
that free##16##2##(1990-10#1)(1992-10#1)(1992-12#2)(1993-3#1)(1994-12#1)(1994-2#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-8#1)(2007-9#1)(2008-10#1)(2008-5#2)(2013-1#1)
that frequency of##2##3##(2006-8#1)(2012-1#1)
that frequency##5##2##(1996-11#1)(2006-8#1)(2007-12#1)(2011-2#1)(2012-1#1)
that frequently##10##2##(2005-8#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-7#1)(2012-12#1)(2013-8#1)
that fresh##4##2##(1992-9#1)(2005-11#1)(2007-3#1)(2008-1#1)
that freshly##2##2##(1994-5#1)(2008-3#1)
that from B##2##3##(1996-7#1)(2008-6#1)
that from other##3##3##(1990-6#1)(1995-11#1)(2008-4#1)
that from the##23##3##(1990-5#1)(1991-10#2)(1991-3#1)(1991-9#1)(1992-11#1)(1993-2#1)(1993-3#1)(1995-11#1)(1995-6#1)(1995-7#1)(1995-9#1)(1997-3#1)(2004-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-12#1)
that from##61##2##(1990-2#1)(1990-5#1)(1990-6#1)(1991-10#2)(1991-3#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-7#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#2)(1995-9#1)(1996-1#1)(1996-2#2)(1996-7#1)(1997-3#1)(1997-6#1)(2004-12#1)(2004-4#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#2)(2008-8#2)(2008-9#1)(2009-12#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
that frontal##2##2##(1995-12#1)(2009-3#1)
that frovatriptan##3##2##(2008-3#3)
that frozen sections##2##3##(1995-4#2)
that fructose and glucose##2##4##(2008-9#2)
that fructose##5##2##(1990-3#1)(1990-7#1)(1992-1#1)(2008-9#2)
that fruit##4##2##(1991-5#1)(1994-2#1)(2008-10#2)
that fucoidan extracts##3##3##(2008-11#3)
that fucoidan##4##2##(2005-8#1)(2008-11#3)
that fulfil##2##2##(2008-10#1)(2008-5#1)
that fulfill##5##2##(1997-4#1)(2007-11#2)(2011-2#1)(2012-1#1)
that fulfilled the##2##3##(1992-1#1)(2011-2#1)
that fulfills##2##2##(1994-9#1)(2008-2#1)
that fulfils the##2##3##(2006-2#1)(2008-7#1)
that full##8##2##(1990-6#1)(1990-7#1)(1994-8#1)(1997-3#1)(2006-6#1)(2008-1#1)(2008-7#1)(2012-2#1)
that full-length##2##2##(1993-8#1)(1995-3#1)
that fully##10##2##(1993-11#1)(1994-11#1)(1995-8#1)(1997-5#1)(2006-4#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2012-12#1)
that function as##5##3##(1991-7#1)(2008-1#1)(2009-5#1)(2010-10#1)(2012-2#1)
that function in vesicular trafficking and##2##6##(2009-10#1)(2009-7#1)
that function in##8##3##(2007-12#1)(2007-4#1)(2009-10#3)(2009-7#1)(2012-3#2)
that function of##2##3##(1994-8#1)(2012-12#1)
that function##22##2##(1991-2#1)(1991-7#1)(1994-8#1)(2006-9#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#3)(2009-5#1)(2009-7#1)(2010-10#1)(2012-12#2)(2012-2#2)(2012-3#2)
that functional neuroimaging##2##3##(2007-8#1)(2008-8#1)
that functional##19##2##(1992-8#2)(1993-9#1)(1995-2#1)(1996-10#1)(1996-3#1)(1996-7#1)(2005-7#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2012-1#1)
that functionally different##2##3##(1997-7#1)(2008-8#1)
that functionally##5##2##(1992-12#1)(1994-3#1)(1996-7#1)(1997-7#1)(2008-8#1)
that functions as a##7##4##(1991-10#1)(1994-11#1)(1994-3#1)(1995-6#1)(2008-4#1)(2009-7#1)(2013-1#1)
that functions as##8##3##(1991-10#1)(1994-11#1)(1994-3#1)(1995-6#1)(2008-4#1)(2009-7#1)(2010-8#1)(2013-1#1)
that functions in both##2##4##(1990-8#1)(2008-9#1)
that functions in##6##3##(1990-8#1)(1995-6#1)(1996-2#1)(1996-6#1)(1996-9#1)(2008-9#1)
that functions##16##2##(1990-8#1)(1991-10#1)(1994-11#1)(1994-3#1)(1995-6#3)(1996-2#1)(1996-6#1)(1996-9#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-8#1)(2013-1#1)
that fundamental##3##2##(2008-3#1)(2008-8#1)(2009-8#1)
that funds##2##2##(1996-1#1)(2007-9#1)
that fungal##4##2##(2005-12#1)(2008-10#1)(2009-8#1)(2012-2#1)
that fungicide##2##2##(2008-10#2)
that further clinical trials##2##4##(1993-11#1)(2008-5#1)
that further clinical##3##3##(1993-11#1)(2008-5#1)(2008-8#1)
that further research is needed to##2##6##(2007-4#1)(2009-5#1)
that further research is needed##3##5##(2007-4#1)(2009-5#1)(2010-8#1)
that further research##6##3##(2007-12#1)(2007-4#1)(2009-5#2)(2010-8#1)(2013-1#1)
that further studies will##2##4##(1995-12#1)(2009-8#1)
that further studies##7##3##(1990-12#1)(1994-10#1)(1995-12#1)(2008-9#1)(2009-8#1)(2012-1#1)(2013-8#1)
that further study is##2##4##(2006-9#1)(2008-1#1)
that further study of##2##4##(1996-8#1)(2008-7#1)
that further study##4##3##(1996-8#1)(2006-9#1)(2008-1#1)(2008-7#1)
that further##55##2##(1990-12#1)(1991-2#1)(1993-11#1)(1994-10#1)(1994-11#1)(1994-9#3)(1995-10#1)(1995-12#2)(1996-6#1)(1996-8#1)(1997-2#1)(2006-1#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-2#1)(2009-5#2)(2009-8#1)(2010-8#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
that fuses##2##2##(2006-7#1)(2008-11#1)
that fusicoccin##2##2##(1995-2#2)
that fusion##4##2##(1990-8#1)(2007-12#1)(2008-9#1)(2011-1#1)
that future research##5##3##(1992-8#1)(2006-9#1)(2007-9#1)(2008-5#1)(2008-8#1)
that future studies##2##3##(2008-8#1)(2011-12#1)
that future##26##2##(1992-8#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#1)(2008-8#3)(2010-12#1)(2010-2#1)(2011-12#1)(2012-1#1)(2012-12#1)
that gained##5##2##(1993-10#1)(1997-5#1)(2007-4#1)(2009-4#1)(2012-3#1)
that galanin##4##2##(1993-3#3)(1996-12#1)
that galectin-3##2##2##(1994-11#1)(2009-3#1)
that galectin-9 is##2##3##(1997-2#2)
that gamma##3##2##(1990-2#1)(1994-9#1)(2012-2#1)
that gamma-tubulin is a##2##4##(1990-6#1)(1991-5#1)
that gamma-tubulin is##3##3##(1990-6#2)(1991-5#1)
that gamma-tubulin##6##2##(1990-6#3)(1991-5#3)
that gap##5##2##(1996-1#1)(2008-12#1)(2010-11#1)(2013-1#1)(2013-8#1)
that gastric##3##2##(2006-10#1)(2006-2#1)(2010-8#1)
that gastroenterologists##2##2##(1990-2#1)(2013-1#1)
that gave a##3##3##(1991-2#1)(1995-6#1)(1997-3#1)
that gave rise to##3##4##(2010-7#1)(2010-9#1)(2011-2#1)
that gave##11##2##(1991-2#1)(1991-3#1)(1995-6#1)(1997-3#1)(2007-9#1)(2008-8#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-3#1)
that gay men##2##3##(2007-12#1)(2009-12#1)
that gel##2##2##(2008-10#1)(2008-9#1)
that gender and##2##3##(2007-8#1)(2009-4#1)
that gender##9##2##(1993-8#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-9#1)(2009-4#1)(2012-2#1)(2013-1#1)
that gender-based##2##2##(2007-7#2)
that gene expression analysis##2##4##(2008-10#1)(2009-8#1)
that gene expression and##2##4##(1994-3#1)(2011-2#1)
that gene expression in##2##4##(1995-11#1)(2012-1#1)
that gene expression##8##3##(1994-3#1)(1995-11#1)(1997-1#1)(1997-4#1)(2008-10#1)(2009-8#1)(2011-2#1)(2012-1#1)
that gene flow##6##3##(2008-10#2)(2008-9#1)(2010-8#1)(2012-11#1)(2013-7#1)
that gene therapy##4##3##(1992-8#1)(2007-1#1)(2007-11#1)(2008-8#1)
that gene##31##2##(1991-7#1)(1991-8#1)(1992-8#1)(1993-11#1)(1994-3#1)(1995-11#1)(1996-11#1)(1997-1#1)(1997-4#1)(2005-10#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-3#1)(2008-10#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-11#1)(2013-7#1)
that general anesthesia##2##3##(1993-1#1)(1993-4#1)
that general practitioners##3##3##(1993-1#1)(1993-2#1)(1997-8#1)
that general##8##2##(1992-11#1)(1993-1#2)(1993-2#1)(1993-4#1)(1997-8#1)(2008-7#1)(2009-8#1)
that generalisation##2##2##(2007-4#2)
that generalizes the##3##3##(2007-4#1)(2008-2#1)(2010-6#1)
that generalizes##4##2##(1993-11#1)(2007-4#1)(2008-2#1)(2010-6#1)
that generally occurs##2##3##(2013-8#2)
that generally##17##2##(1990-10#1)(1994-5#1)(1995-12#1)(1996-10#1)(1997-1#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2010-11#1)(2010-2#1)(2011-2#1)(2013-8#2)
that generate a##2##3##(2008-1#1)(2011-1#1)
that generate and##3##3##(1996-2#1)(2007-12#1)(2008-3#1)
that generate the##3##3##(2012-11#1)(2012-12#1)(2013-1#1)
that generate##24##2##(1991-5#1)(1993-6#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-3#1)(2006-10#1)(2006-11#1)(2007-12#1)(2008-1#1)(2008-3#2)(2009-3#1)(2009-4#1)(2011-1#3)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
that generated##6##2##(1992-3#1)(1997-4#1)(2005-10#1)(2008-3#1)(2011-1#1)(2011-2#1)
that generates a##6##3##(1990-5#1)(1994-5#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)
that generates an##2##3##(2007-12#1)(2008-3#1)
that generates the##4##3##(1997-8#1)(2008-2#1)(2008-3#1)(2013-1#1)
that generates##32##2##(1990-5#1)(1994-5#1)(1995-8#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-11#2)(2007-12#6)(2007-4#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2010-1#1)(2010-8#1)(2010-9#1)(2012-1#1)(2013-1#1)
that generic##4##2##(2007-10#1)(2011-1#1)(2013-1#2)
that genes are##2##3##(2008-4#1)(2011-3#1)
that genes for##3##3##(2008-10#3)
that genes##14##2##(1991-5#1)(1995-12#1)(1995-6#1)(1997-6#1)(2008-10#4)(2008-4#1)(2009-8#1)(2010-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
that genetic counseling##2##3##(2006-10#1)(2007-3#1)
that genetic differences##2##3##(2007-3#1)(2008-10#1)
that genetic drift##2##3##(2008-10#2)
that genetic factors are important##3##5##(1991-5#1)(2008-1#1)(2008-7#1)
that genetic factors are##4##4##(1991-5#1)(2008-1#1)(2008-7#1)(2010-12#1)
that genetic factors##7##3##(1991-5#1)(1995-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-7#1)(2010-12#1)
that genetic variability##3##3##(2008-10#2)(2012-12#1)
that genetic variation##2##3##(1997-4#1)(2009-2#1)
that genetic##37##2##(1991-5#1)(1992-8#1)(1995-12#1)(1996-12#1)(1997-4#1)(1997-7#1)(2004-11#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-3#2)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#1)(2008-7#1)(2009-2#2)(2009-4#2)(2009-7#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)
that genetically determined##2##3##(2005-10#1)(2010-8#1)
that genetically##6##2##(2005-10#1)(2008-10#1)(2008-4#1)(2009-4#1)(2009-5#1)(2010-8#1)
that genetics##2##2##(2006-2#1)(2008-1#1)
that genistein##3##2##(1994-9#1)(1997-7#1)(2008-11#1)
that genital##2##2##(1996-12#1)(2010-12#1)
that genome size##2##3##(2008-8#1)(2010-3#1)
that genome##5##2##(1992-3#1)(1992-5#1)(2008-8#1)(2010-3#1)(2011-1#1)
that genomic##5##2##(1994-8#1)(1995-8#1)(1996-3#1)(2009-2#1)(2011-2#1)
that genotoxins##2##2##(1992-6#1)(1996-6#1)
that genotype##3##2##(2007-3#1)(2008-10#2)
that genotypic##2##2##(1993-6#1)(2009-2#1)
that geographic##2##2##(2008-10#2)
that germ##2##2##(2008-10#2)
that germinated##3##2##(2008-10#2)(2008-5#1)
that ghrelin##4##2##(2008-3#1)(2011-1#1)(2011-2#2)
that gicerin expression##2##3##(1997-6#2)
that girls##3##2##(1990-2#1)(2009-12#1)(2012-2#1)
that give rise to the##3##5##(1996-11#1)(2007-11#1)(2010-7#1)
that give rise to##10##4##(1992-4#1)(1995-1#1)(1996-11#1)(1996-4#1)(2007-11#1)(2008-2#1)(2008-3#2)(2010-7#1)(2012-2#1)
that give the##2##3##(1994-11#1)(2006-10#1)
that give##19##2##(1992-4#1)(1994-11#1)(1995-1#1)(1996-11#1)(1996-4#1)(1996-7#1)(1997-8#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)(2008-5#2)(2010-7#1)(2012-2#1)
that given by##2##3##(2007-12#1)(2008-10#1)
that given##5##2##(1991-2#1)(2007-12#1)(2008-10#1)(2008-2#2)
that gives a##5##3##(2006-2#1)(2007-8#1)(2008-11#2)(2013-7#1)
that gives rise to##5##4##(1990-11#1)(1993-2#1)(2007-12#2)(2012-12#1)
that gives the##4##3##(2008-2#2)(2008-3#1)(2010-4#1)
that gives##32##2##(1990-11#1)(1990-3#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-9#1)(2005-7#1)(2006-2#1)(2007-12#3)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2010-4#1)(2012-12#2)(2013-7#1)
that giving##2##2##(1996-5#1)(2010-2#1)
that glial cells##5##3##(1991-11#1)(1997-8#1)(2008-4#1)(2008-5#1)(2008-7#1)
that glial##8##2##(1991-11#1)(1995-5#1)(1997-8#1)(2006-12#1)(2008-4#1)(2008-5#1)(2008-7#2)
that glibenclamide##2##2##(1994-3#1)(1994-8#1)
that global##3##2##(2007-9#1)(2009-7#1)(2009-8#1)
that glove##2##2##(1995-3#2)
that gloves##2##2##(1995-6#1)(2006-8#1)
that glucocorticoid##5##2##(1994-11#2)(1994-9#1)(1995-5#1)(1997-4#1)
that glucocorticoids are##2##3##(1995-12#1)(1996-12#1)
that glucocorticoids##10##2##(1991-6#1)(1994-11#2)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-12#1)(2006-6#1)(2008-7#1)
that glucose and##2##3##(1991-10#1)(1996-1#1)
that glucose##15##2##(1991-10#1)(1992-1#1)(1994-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1997-3#1)(1997-4#1)(2005-10#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-4#1)
that glutamate and##2##3##(1994-10#1)(2008-6#1)
that glutamate is the primary##2##5##(1997-5#2)
that glutamate is the##4##4##(1990-7#1)(1997-5#3)
that glutamate##16##2##(1990-11#1)(1990-7#2)(1992-5#1)(1993-12#1)(1994-10#1)(1996-11#1)(1996-5#1)(1997-5#3)(2007-11#1)(2007-9#1)(2008-6#1)(2009-3#1)(2010-10#1)
that glutamatergic##3##2##(2007-10#1)(2008-7#1)(2012-2#1)
that glutathione##5##2##(1990-12#1)(1994-6#1)(1996-12#1)(2012-2#2)
that glycation of##4##3##(1992-7#1)(1996-5#1)(2012-2#2)
that glycine is##2##3##(1992-1#1)(2008-10#1)
that glycine##4##2##(1990-7#1)(1992-1#1)(1995-7#1)(2008-10#1)
that glycosylation of the##2##4##(1991-8#1)(1994-8#1)
that glycosylation##5##2##(1991-8#1)(1993-8#1)(1994-8#2)(1995-2#1)
that go##4##2##(1991-6#1)(2007-11#1)(2008-1#1)(2012-3#1)
that goal##3##2##(1997-5#1)(2006-10#1)(2008-4#1)
that goes beyond##2##3##(2008-2#1)(2011-1#1)
that goes##4##2##(2007-5#1)(2008-2#1)(2011-1#1)(2012-3#1)
that good##15##2##(1990-12#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#1)(1996-6#1)(2006-11#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2010-12#2)
that govern protein folding##2##4##(1993-6#1)(2010-4#1)
that govern the expression of##2##5##(1994-12#1)(1994-9#1)
that govern the##6##3##(1994-12#1)(1994-9#1)(2004-9#1)(2008-1#1)(2008-7#1)(2012-3#1)
that govern this##2##3##(1991-5#1)(2008-2#1)
that govern##25##2##(1990-9#1)(1991-5#1)(1991-7#1)(1993-1#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-6#1)(2004-9#1)(2006-10#2)(2007-12#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-7#1)(2009-8#1)(2010-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
that governs the##5##3##(1996-5#1)(2007-12#1)(2009-11#1)(2010-8#1)(2011-2#1)
that governs##8##2##(1996-4#1)(1996-5#1)(2007-12#1)(2008-8#1)(2009-10#1)(2009-11#1)(2010-8#1)(2011-2#1)
that gp120##2##2##(1990-2#1)(1996-1#1)
that gp30##2##2##(1990-9#2)
that gp59##3##2##(1994-12#3)
that grade##2##2##(2006-12#1)(2008-12#1)
that gradual##2##2##(2009-6#1)(2010-8#1)
that gradually##2##2##(2009-8#1)(2010-6#1)
that grafting of##2##3##(2006-9#1)(2007-8#1)
that grafts of##3##3##(1993-12#1)(1995-3#1)(2007-11#1)
that granules##2##2##(1997-7#1)(2013-1#1)
that gratings##2##2##(2008-2#1)(2008-3#1)
that gray##2##2##(2007-12#1)(2008-10#1)
that great caution##2##3##(1995-5#1)(2006-3#1)
that great##3##2##(1991-6#1)(1995-5#1)(2006-3#1)
that greater than##5##3##(1990-8#1)(1992-10#1)(1997-1#1)(2007-12#1)(2008-10#1)
that greater##17##2##(1990-8#1)(1992-10#1)(1993-5#1)(1995-3#1)(1997-1#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-2#1)(2012-1#2)(2013-7#1)
that greatly facilitate##2##3##(2007-1#1)(2008-9#1)
that greatly##11##2##(1990-8#1)(1992-11#1)(1997-6#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-1#1)
that green##3##2##(2008-10#2)(2013-8#1)
that grew in##2##3##(1991-5#1)(2008-10#1)
that grew##5##2##(1991-5#1)(2008-10#3)(2012-2#1)
that grey##2##2##(1997-4#1)(2004-4#1)
that grooming asymmetries##2##3##(2007-1#2)
that gross##2##2##(1995-1#1)(2008-3#1)
that group##20##2##(1991-11#1)(1991-2#1)(1991-8#1)(1994-4#1)(1996-3#1)(1997-7#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-4#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-4#1)(2013-8#1)
that grouper##2##2##(2010-5#2)
that grouping##2##2##(2008-9#2)
that groups##4##2##(1995-2#1)(1996-1#1)(2006-3#1)(2008-2#1)
that grow and##2##3##(2007-12#1)(2008-10#1)
that grow as##2##3##(1994-12#1)(2008-4#1)
that grow in##2##3##(2008-1#1)(2012-2#1)
that grow on##2##3##(2009-8#1)(2011-2#1)
that grow##11##2##(1994-12#1)(1996-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)
that grows in##2##3##(1992-2#1)(2008-4#1)
that grows##8##2##(1992-2#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#2)(2012-11#1)(2012-12#1)
that growth factor##2##3##(2007-8#1)(2008-7#1)
that growth factors##5##3##(1994-2#1)(1995-12#1)(2007-8#2)(2012-3#1)
that growth hormone##2##3##(1990-12#1)(1995-10#1)
that growth inhibitory##2##3##(1991-12#1)(2008-4#1)
that growth##21##2##(1990-12#1)(1991-12#1)(1993-9#1)(1994-2#1)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#1)(1996-5#1)(2004-4#1)(2005-9#1)(2007-5#1)(2007-8#3)(2008-4#1)(2008-7#2)(2012-3#1)(2013-7#1)
that guanine##2##2##(1993-6#1)(1997-2#1)
that guarantees##2##2##(2006-3#1)(2007-8#1)
that guide##11##2##(1992-9#1)(1993-12#1)(1997-8#1)(2006-3#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-12#1)(2012-1#1)(2012-12#1)
that guided##4##2##(2008-11#1)(2009-2#1)(2013-1#2)
that guidelines for##2##3##(1996-9#1)(1997-5#1)
that guidelines##3##2##(1996-9#1)(1997-5#1)(2006-8#1)
that guides##2##2##(2012-1#1)(2013-8#1)
that guinea pig##2##3##(1992-7#1)(1994-12#1)
that hCG##2##2##(1992-8#1)(1994-12#1)
that habitat##6##2##(2007-4#1)(2008-10#1)(2008-8#3)(2013-7#1)
that had a detection##2##4##(2008-10#1)(2008-3#1)
that had a higher##2##4##(2010-10#1)(2013-7#1)
that had a##25##3##(1992-9#1)(1996-7#1)(1997-2#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-3#1)(2007-6#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-3#2)(2008-7#1)(2010-10#1)(2011-1#3)(2013-1#2)(2013-7#1)(2013-8#1)
that had already been##4##4##(1991-10#1)(1993-3#1)(1995-8#1)(2008-12#1)
that had an##5##3##(1990-11#1)(1991-1#1)(1994-6#1)(2008-10#2)
that had appeared##2##3##(1992-11#1)(2008-7#1)
that had been coated with##2##5##(1990-12#1)(2008-10#1)
that had been cultured##2##4##(1991-9#1)(2008-11#1)
that had been diagnosed##2##4##(2006-10#1)(2013-8#1)
that had been immersed in##2##5##(2008-5#1)(2008-8#1)
that had been immobilized with##2##5##(2010-4#2)
that had been immunized##2##4##(1996-12#1)(2006-10#1)
that had been implanted##2##4##(2007-12#1)(2008-4#1)
that had been infected with##2##5##(1995-5#1)(1997-4#1)
that had been inoculated with##2##5##(2004-11#1)(2008-10#1)
that had been inoculated##5##4##(2004-11#1)(2008-10#3)(2008-5#1)
that had been intentionally##2##4##(2007-12#1)(2008-10#1)
that had been kept##2##4##(1996-12#1)(2004-11#1)
that had been prepared from##2##5##(1995-2#1)(1997-2#1)
that had been present##3##4##(2005-11#1)(2009-8#1)(2009-9#1)
that had been previously##6##4##(1995-10#1)(2008-10#3)(2013-1#2)
that had been reared##2##4##(2008-8#1)(2009-3#1)
that had been selected for##2##5##(1997-7#1)(2008-8#1)
that had been subjected to##3##5##(1990-2#1)(1994-6#1)(2011-2#1)
that had been treated with##3##5##(2006-5#1)(2006-6#1)(2008-10#1)
that had been treated##5##4##(2006-5#1)(2006-6#1)(2008-10#2)(2008-9#1)
that had been##119##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-3#1)(1993-4#1)(1993-6#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-12#4)(1996-7#3)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(2004-11#3)(2004-4#1)(2005-10#1)(2005-11#3)(2006-10#2)(2006-11#1)(2006-5#3)(2006-6#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#21)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-3#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-4#2)(2011-1#2)(2011-12#1)(2011-2#3)(2012-11#1)(2012-3#1)(2013-1#3)(2013-8#1)
that had developed##2##3##(2006-5#1)(2006-8#1)
that had failed##3##3##(2008-10#2)(2013-7#1)
that had fed on##3##4##(2008-10#3)
that had five##2##3##(2007-11#1)(2008-4#1)
that had good##2##3##(2009-3#1)(2010-10#1)
that had grown##2##3##(1994-12#1)(2010-6#1)
that had lost##2##3##(1992-5#1)(2008-10#1)
that had never been##4##4##(1990-2#1)(1996-11#1)(2008-10#2)
that had never##6##3##(1990-2#1)(1996-11#1)(2007-7#1)(2008-10#2)(2011-2#1)
that had no prior##2##4##(2006-8#1)(2013-1#1)
that had no##5##3##(1992-9#1)(1995-2#1)(2006-6#1)(2006-8#1)(2013-1#1)
that had not been##10##4##(1994-3#1)(1996-7#1)(2004-11#1)(2006-12#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-6#1)(2012-1#1)
that had not yet been##2##5##(2008-10#1)(2011-2#1)
that had not##22##3##(1991-3#1)(1994-2#2)(1994-3#1)(1996-7#1)(2004-11#1)(2006-12#1)(2007-11#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-6#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)
that had occurred##2##3##(1995-8#1)(2007-7#1)
that had previously been##3##4##(2006-11#1)(2008-5#1)(2013-1#1)
that had previously learned the task at##2##7##(1994-8#2)
that had previously##6##3##(1994-8#2)(1995-9#1)(2006-11#1)(2008-5#1)(2013-1#1)
that had received##8##3##(1991-3#1)(1993-6#1)(1996-5#1)(1997-5#1)(1997-6#1)(2006-3#1)(2008-10#1)(2008-5#1)
that had shown##2##3##(1994-2#1)(2013-1#1)
that had significantly##2##3##(2008-10#1)(2008-3#1)
that had taken##3##3##(1993-8#1)(2010-7#1)(2011-1#1)
that had the##3##3##(2008-10#1)(2008-5#1)(2010-4#1)
that had to##2##3##(2008-11#1)(2013-1#1)
that had two##2##3##(2008-2#1)(2008-6#1)
that had undergone##5##3##(1990-10#2)(2005-11#1)(2007-7#1)(2008-4#1)
that had used the##2##4##(2008-10#2)
that had##322##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-9#2)(1991-1#1)(1991-10#3)(1991-3#2)(1991-9#1)(1992-1#1)(1992-11#3)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#3)(1993-11#2)(1993-12#1)(1993-3#2)(1993-4#1)(1993-6#3)(1993-8#3)(1993-9#1)(1994-12#2)(1994-2#4)(1994-3#3)(1994-6#3)(1994-8#4)(1994-9#1)(1995-1#3)(1995-10#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-8#3)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#5)(1996-5#1)(1996-7#5)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(2004-11#4)(2004-2#1)(2004-4#1)(2005-10#1)(2005-11#5)(2006-10#4)(2006-11#2)(2006-12#1)(2006-3#1)(2006-5#4)(2006-6#3)(2006-7#1)(2006-8#4)(2007-10#1)(2007-11#4)(2007-12#3)(2007-3#3)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#3)(2008-1#4)(2008-10#50)(2008-11#8)(2008-12#4)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#9)(2008-6#3)(2008-7#11)(2008-8#7)(2008-9#3)(2009-10#2)(2009-2#2)(2009-3#3)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-3#2)(2010-4#4)(2010-6#1)(2010-7#1)(2011-1#8)(2011-12#2)(2011-2#8)(2012-1#2)(2012-11#1)(2012-2#2)(2012-3#2)(2013-1#9)(2013-7#3)(2013-8#6)
that hair##5##2##(1990-6#1)(2007-7#1)(2008-5#3)
that half of the##4##4##(1992-10#1)(1994-3#1)(1996-9#1)(1997-7#1)
that half##7##2##(1992-10#1)(1993-11#1)(1994-3#1)(1996-2#1)(1996-9#1)(1997-7#1)(2007-3#1)
that halocyanin##2##2##(1993-11#2)
that haloperidol##3##2##(1992-9#1)(1995-12#1)(2007-8#1)
that handles##2##2##(2007-12#1)(2009-12#1)
that haploinsufficiency##2##2##(2009-5#1)(2012-12#1)
that happen##3##2##(2007-7#1)(2008-11#1)(2008-2#1)
that happened##3##2##(2008-1#2)(2012-2#1)
that haptoglobin concentrations##2##3##(2005-7#2)
that harbors##2##2##(1997-7#1)(2007-11#1)
that harbours##3##2##(1995-5#1)(1997-3#1)(2008-1#1)
that has a high degree of##2##6##(1992-12#1)(2007-12#1)
that has a high##3##4##(1992-12#1)(2007-12#2)
that has a pattern##2##4##(2007-11#1)(2008-3#1)
that has a##45##3##(1991-2#1)(1992-11#1)(1992-12#1)(1994-9#1)(1995-8#1)(1996-4#1)(1996-8#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#9)(2008-7#1)(2009-10#1)(2009-12#1)(2009-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-3#2)
that has already been described##2##5##(1994-8#1)(2012-2#1)
that has already been##13##4##(1994-8#1)(2007-12#1)(2008-11#7)(2008-4#1)(2008-7#1)(2012-2#1)(2012-3#1)
that has an IUD##2##4##(2012-2#2)
that has an##10##3##(1992-5#1)(1993-3#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-1#1)(2012-2#2)
that has become increasingly##2##4##(1995-1#1)(2006-10#1)
that has become##5##3##(1995-1#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-8#1)
that has been achieved##2##4##(2008-1#1)(2013-1#1)
that has been applied##2##4##(2007-11#1)(2009-10#1)
that has been approved##2##4##(2007-11#1)(2008-4#1)
that has been associated with##6##5##(1991-8#1)(1997-2#1)(2007-10#2)(2008-10#1)(2010-10#1)
that has been demonstrated to##4##5##(2007-11#1)(2010-2#1)(2013-1#2)
that has been described in##2##5##(2008-1#1)(2008-7#1)
that has been described##4##4##(2008-1#1)(2008-7#2)(2009-7#1)
that has been designed##3##4##(2008-3#2)(2012-1#1)
that has been developed by##2##5##(2008-10#1)(2009-3#1)
that has been developed for the##4##6##(2007-11#1)(2008-10#2)(2008-11#1)
that has been developed for##7##5##(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2010-10#1)
that has been developed##12##4##(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2009-3#1)(2010-10#1)
that has been employed##2##4##(1996-1#1)(2008-12#1)
that has been found##2##4##(1990-7#1)(1996-8#1)
that has been gathered##2##4##(2008-1#1)(2010-12#1)
that has been identified as##2##5##(1992-8#1)(1996-11#1)
that has been identified##5##4##(1991-11#1)(1992-8#1)(1996-11#1)(2007-11#1)(2013-1#1)
that has been implemented in##2##5##(2007-12#1)(2008-2#1)
that has been implemented##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
that has been implicated in the##3##6##(1991-3#1)(1996-12#1)(2012-2#1)
that has been implicated in##6##5##(1991-3#1)(1992-9#1)(1996-12#1)(1997-5#1)(1997-7#1)(2012-2#1)
that has been in##3##4##(2005-10#1)(2007-8#1)(2010-12#1)
that has been made##11##4##(2006-12#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-7#1)(2011-1#1)
that has been observed in##2##5##(1991-2#1)(1996-9#1)
that has been observed##3##4##(1991-2#1)(1996-9#1)(2007-11#1)
that has been previously implicated in##2##6##(1995-8#1)(2009-8#1)
that has been previously##7##4##(1991-9#1)(1995-8#1)(2006-11#1)(2008-10#1)(2009-8#1)(2012-12#1)(2012-3#1)
that has been proposed##3##4##(1995-8#1)(2007-7#1)(2009-8#1)
that has been recently##4##4##(2008-10#1)(2008-5#1)(2013-1#2)
that has been reported in##2##5##(1996-9#1)(2010-7#1)
that has been reported##5##4##(1996-9#1)(2006-11#1)(2006-8#1)(2008-10#1)(2010-7#1)
that has been shown to be effective##2##7##(2006-8#1)(2012-12#1)
that has been shown to be##4##6##(1993-12#1)(2006-8#1)(2012-12#1)(2012-2#1)
that has been shown to##9##5##(1993-12#1)(1996-3#1)(2006-8#1)(2007-11#1)(2008-3#1)(2008-5#1)(2012-12#2)(2012-2#1)
that has been shown##12##4##(1990-12#1)(1992-12#1)(1993-12#1)(1996-3#1)(2006-8#1)(2007-11#1)(2008-3#1)(2008-5#1)(2012-12#2)(2012-2#1)(2013-8#1)
that has been studied##2##4##(2006-2#1)(2007-12#1)
that has been successfully used##2##5##(2004-9#1)(2008-8#1)
that has been successfully##3##4##(1993-3#1)(2004-9#1)(2008-8#1)
that has been suggested as##2##5##(1995-3#1)(2009-8#1)
that has been suggested##3##4##(1994-12#1)(1995-3#1)(2009-8#1)
that has been termed##2##4##(2006-10#1)(2012-12#1)
that has been used for##3##5##(1993-9#1)(2005-8#1)(2006-10#1)
that has been used in the##2##6##(1994-5#1)(2008-9#1)
that has been used in##3##5##(1994-5#1)(2008-11#1)(2008-9#1)
that has been used to##5##5##(1993-9#1)(1996-1#1)(2004-11#1)(2012-2#2)
that has been used##14##4##(1993-9#2)(1994-5#1)(1996-1#1)(2004-11#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#2)
that has been##206##3##(1990-12#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#2)(1993-9#2)(1994-12#3)(1994-5#1)(1994-6#1)(1995-3#1)(1995-8#2)(1996-1#3)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-5#1)(1997-7#2)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#3)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-8#4)(2007-10#2)(2007-11#8)(2007-12#4)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#13)(2008-11#6)(2008-12#1)(2008-2#6)(2008-3#9)(2008-4#10)(2008-5#6)(2008-7#6)(2008-8#6)(2008-9#1)(2009-10#2)(2009-11#2)(2009-3#1)(2009-7#2)(2009-8#4)(2010-10#2)(2010-12#2)(2010-2#1)(2010-7#4)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#6)(2012-2#11)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#1)
that has both##3##3##(1997-7#1)(2006-8#1)(2008-11#1)
that has caused##4##3##(1991-2#1)(1994-3#1)(2008-5#1)(2012-12#1)
that has contributed to##2##4##(2008-1#1)(2013-1#1)
that has demonstrated##2##3##(2008-5#1)(2009-8#1)
that has elapsed since the##3##5##(1993-6#1)(2013-1#2)
that has emerged as a##2##5##(2007-8#1)(2013-8#1)
that has emerged as##3##4##(2007-8#1)(2008-6#1)(2013-8#1)
that has emerged in##2##4##(1994-12#1)(2009-7#1)
that has emerged##6##3##(1994-12#1)(2007-8#1)(2008-6#1)(2009-7#1)(2010-12#1)(2013-8#1)
that has enhanced##2##3##(2008-1#1)(2008-11#1)
that has evolved##5##3##(1996-9#1)(2006-2#1)(2008-1#1)(2008-10#1)(2010-12#1)
that has examined##2##3##(2007-12#2)
that has failed to respond to##2##6##(2007-10#1)(2012-12#1)
that has failed##3##3##(2007-10#1)(2010-8#1)(2012-12#1)
that has generated much##3##4##(1997-2#1)(2007-8#1)(2013-1#1)
that has given rise to##2##5##(2006-4#1)(2008-11#1)
that has helped to##2##4##(1996-12#1)(2011-2#1)
that has its roots##2##4##(2008-9#1)(2013-8#1)
that has its##5##3##(1995-3#1)(2008-1#1)(2008-7#1)(2008-9#1)(2013-8#1)
that has led to the##2##5##(2008-1#1)(2009-8#1)
that has led to##3##4##(2008-1#1)(2008-7#1)(2009-8#1)
that has many##2##3##(1990-8#1)(2009-7#1)
that has no##3##3##(1995-3#1)(2007-12#1)(2008-2#1)
that has not been described##3##5##(1991-9#1)(2008-10#1)(2008-11#1)
that has not been previously##2##5##(2006-8#1)(2008-7#1)
that has not been reported##2##5##(1995-3#1)(1997-3#1)
that has not been##13##4##(1991-2#1)(1991-9#1)(1992-8#1)(1995-3#1)(1997-3#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-1#1)(2013-1#1)
that has not yet been##3##5##(1995-4#1)(2008-10#1)(2008-2#1)
that has not##18##3##(1991-2#1)(1991-9#1)(1992-8#1)(1995-3#1)(1995-4#1)(1997-3#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
that has often##2##3##(2007-4#1)(2008-8#1)
that has only rarely been##2##5##(2006-10#1)(2011-2#1)
that has only##4##3##(1990-11#1)(1996-2#1)(2006-10#1)(2011-2#1)
that has previously been##3##4##(1993-12#1)(2008-7#1)(2012-11#1)
that has produced##2##3##(1996-3#1)(2012-1#1)
that has properties##2##3##(1990-5#1)(2007-11#1)
that has proved##2##3##(2008-6#1)(2013-1#1)
that has proven useful##2##4##(2008-4#1)(2009-10#1)
that has proven##3##3##(2008-4#1)(2008-6#1)(2009-10#1)
that has provided##4##3##(2008-4#1)(2010-4#1)(2013-1#2)
that has quickly##2##3##(2007-11#1)(2008-4#1)
that has received little attention in##2##6##(2006-1#1)(2008-10#1)
that has received little##3##4##(2005-11#1)(2006-1#1)(2008-10#1)
that has received##6##3##(2005-11#1)(2005-7#1)(2006-1#1)(2008-10#1)(2008-2#1)(2008-6#1)
that has recently been##5##4##(1993-1#1)(1994-12#2)(2008-10#1)(2011-1#1)
that has recently##7##3##(1993-1#1)(1994-12#2)(2008-10#1)(2008-11#1)(2008-4#1)(2011-1#1)
that has remained##2##3##(1994-11#1)(2008-10#1)
that has shown##4##3##(2006-10#1)(2008-3#1)(2008-5#2)
that has significant##3##3##(1992-4#1)(1993-9#1)(2012-3#1)
that has the capacity to##2##5##(2010-7#1)(2011-2#1)
that has the potential to##5##5##(2006-9#1)(2008-5#1)(2009-7#1)(2011-7#1)(2013-7#1)
that has the potential##6##4##(2006-9#1)(2008-5#1)(2009-7#1)(2011-7#1)(2013-1#1)(2013-7#1)
that has the##18##3##(1993-12#1)(1997-2#1)(1997-3#1)(2006-9#1)(2007-12#1)(2007-4#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-2#1)(2011-7#1)(2012-12#1)(2013-1#1)(2013-7#1)
that has to be##5##4##(1993-11#1)(1994-3#1)(2008-10#2)(2008-11#1)
that has traditionally been##2##4##(2008-4#1)(2012-2#1)
that has two##2##3##(2007-12#1)(2008-3#1)
that has undergone##2##3##(2008-3#1)(2009-11#1)
that has until now been##2##5##(1992-12#1)(2008-2#1)
that has##556##2##(1990-11#2)(1990-12#2)(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#2)(1991-11#2)(1991-12#2)(1991-2#4)(1991-3#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#4)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#4)(1993-3#4)(1993-6#1)(1993-9#3)(1994-11#1)(1994-12#6)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#4)(1995-4#1)(1995-5#1)(1995-8#3)(1996-1#3)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#3)(1996-6#1)(1996-8#2)(1996-9#3)(1997-2#3)(1997-3#4)(1997-4#3)(1997-5#3)(1997-6#1)(1997-7#3)(1997-8#1)(2004-11#1)(2004-9#2)(2005-10#1)(2005-11#4)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#9)(2006-11#2)(2006-12#3)(2006-2#3)(2006-3#2)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#7)(2006-9#2)(2007-10#3)(2007-11#17)(2007-12#20)(2007-2#3)(2007-3#1)(2007-4#4)(2007-6#2)(2007-7#3)(2007-8#10)(2007-9#2)(2008-1#14)(2008-10#32)(2008-11#23)(2008-12#3)(2008-2#19)(2008-3#29)(2008-4#18)(2008-5#14)(2008-6#4)(2008-7#13)(2008-8#12)(2008-9#3)(2009-1#2)(2009-10#4)(2009-11#3)(2009-12#2)(2009-3#3)(2009-6#1)(2009-7#5)(2009-8#7)(2009-9#2)(2010-10#2)(2010-12#8)(2010-2#3)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#5)(2010-8#1)(2011-1#8)(2011-12#3)(2011-2#11)(2011-7#1)(2012-1#5)(2012-11#2)(2012-12#10)(2012-2#19)(2012-3#8)(2013-1#16)(2013-7#2)(2013-8#5)
that have a common##2##4##(1995-8#1)(2005-7#1)
that have a high##4##4##(1994-9#1)(1996-11#1)(2007-6#1)(2008-11#1)
that have a relatively##2##4##(2008-6#1)(2008-8#1)
that have a role in##2##5##(1991-11#1)(2012-2#1)
that have a##42##3##(1990-12#1)(1991-11#1)(1991-6#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-11#1)(1996-7#1)(1997-2#1)(2005-7#1)(2006-10#2)(2006-12#2)(2006-8#1)(2007-1#1)(2007-11#2)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)
that have access to##2##4##(2006-10#1)(2008-10#1)
that have activity##2##3##(2006-10#1)(2008-7#1)
that have addressed the##2##4##(2008-6#1)(2012-3#1)
that have addressed##3##3##(2008-6#2)(2012-3#1)
that have adopted##2##3##(2006-2#1)(2007-12#1)
that have affected the##2##4##(1994-5#1)(2007-8#1)
that have already been##2##4##(2007-12#1)(2008-4#1)
that have already##4##3##(2007-12#1)(2008-4#1)(2008-5#1)(2008-6#1)
that have an effect on##2##5##(1990-2#1)(1992-3#1)
that have an impact on##2##5##(2006-2#1)(2008-11#1)
that have an##14##3##(1990-2#1)(1992-3#1)(1996-4#1)(1997-2#1)(2006-10#1)(2006-2#1)(2006-5#1)(2008-11#1)(2008-2#1)(2008-4#3)(2009-7#1)(2012-3#1)
that have appeared in the literature##4##6##(1994-9#1)(1996-1#2)(2008-1#1)
that have appeared in##5##4##(1994-9#1)(1996-1#2)(2008-1#1)(2009-10#1)
that have appeared##6##3##(1991-5#1)(1994-9#1)(1996-1#2)(2008-1#1)(2009-10#1)
that have arisen from##2##4##(1995-3#1)(2010-11#1)
that have arisen##3##3##(1995-3#1)(1997-7#1)(2010-11#1)
that have become the##2##4##(2008-10#1)(2012-3#1)
that have become##5##3##(2008-10#1)(2008-2#1)(2008-7#1)(2009-6#1)(2012-3#1)
that have been applied to##2##5##(1992-3#1)(2008-4#1)
that have been applied##5##4##(1992-3#1)(2008-4#2)(2010-7#1)(2012-12#1)
that have been associated with##5##5##(2008-3#1)(2008-7#1)(2009-9#1)(2010-10#1)(2011-2#1)
that have been associated##6##4##(2008-3#1)(2008-7#1)(2009-9#1)(2010-10#1)(2011-2#2)
that have been attributed to##3##5##(1995-3#1)(1996-10#1)(1996-5#1)
that have been characterized##2##4##(1992-3#2)
that have been conducted to date##2##6##(2008-6#1)(2010-9#1)
that have been conducted##5##4##(2008-10#1)(2008-3#1)(2008-6#1)(2010-9#1)(2012-2#1)
that have been confirmed by##2##5##(2004-1#1)(2007-6#1)
that have been critically##2##4##(2007-11#1)(2011-12#1)
that have been described##3##4##(2008-5#1)(2008-7#1)(2009-10#1)
that have been developed for##7##5##(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-12#1)(2010-7#1)(2011-1#1)
that have been developed in##2##5##(2007-1#1)(2008-10#1)
that have been developed to##2##5##(2010-12#1)(2011-12#1)
that have been developed##14##4##(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2009-7#1)(2010-12#2)(2010-7#1)(2011-1#1)(2011-12#1)
that have been encountered##3##4##(2007-11#1)(2008-8#1)(2008-9#1)
that have been exploited##2##4##(1994-3#1)(2005-8#1)
that have been extensively##2##4##(2007-11#1)(2012-12#1)
that have been found to be##2##6##(1993-12#1)(2007-2#1)
that have been found to##3##5##(1993-12#1)(2007-2#1)(2008-4#1)
that have been found##4##4##(1991-7#1)(1993-12#1)(2007-2#1)(2008-4#1)
that have been genetically##3##4##(2008-10#1)(2008-4#1)(2008-5#1)
that have been genotyped in##2##5##(2011-2#2)
that have been hypothesized to##2##5##(1993-12#1)(2011-2#1)
that have been identified in##5##5##(1997-4#1)(2007-1#1)(2009-10#1)(2012-3#1)(2013-1#1)
that have been identified##11##4##(1992-12#1)(1993-10#1)(1994-6#1)(1997-4#1)(2005-11#1)(2007-1#1)(2008-7#1)(2009-10#1)(2012-3#1)(2013-1#2)
that have been implicated as##2##5##(1993-9#1)(2008-4#1)
that have been implicated in the##2##6##(1993-12#1)(2008-1#1)
that have been implicated in##8##5##(1993-12#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-5#1)(1997-4#1)(2007-9#1)(2008-1#1)
that have been implicated##11##4##(1993-12#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-5#1)(1997-4#1)(2007-9#1)(2008-1#1)(2008-4#1)(2013-1#1)
that have been interpreted as##2##5##(1994-5#1)(1995-8#1)
that have been introduced##3##4##(1997-6#1)(2008-10#1)(2009-5#1)
that have been investigated in##2##5##(2008-1#1)(2008-4#1)
that have been investigated##6##4##(1995-11#1)(2005-10#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-6#1)
that have been isolated from##3##5##(1992-4#1)(2011-1#1)(2013-8#1)
that have been isolated##5##4##(1992-4#1)(1996-2#1)(2011-1#1)(2012-12#1)(2013-8#1)
that have been labeled with##2##5##(2008-4#1)(2012-1#1)
that have been learned from##2##5##(2009-6#1)(2010-1#1)
that have been made in three areas##2##7##(1990-12#1)(2006-10#1)
that have been made in##3##5##(1990-12#1)(2006-10#2)
that have been made to##2##5##(1991-1#1)(2008-11#1)
that have been made##13##4##(1990-12#1)(1991-1#1)(2005-7#1)(2006-10#2)(2008-11#1)(2008-2#1)(2008-7#2)(2009-10#1)(2009-12#2)(2009-3#1)
that have been observed in##4##5##(1990-5#1)(2007-12#1)(2008-10#1)(2012-2#1)
that have been observed##8##4##(1990-11#1)(1990-5#2)(1994-6#1)(2007-12#1)(2008-10#1)(2010-2#1)(2012-2#1)
that have been obtained by##2##5##(1990-9#1)(2008-2#1)
that have been occurring##2##4##(1993-6#1)(2008-9#1)
that have been previously##5##4##(1997-8#1)(2007-1#2)(2007-4#1)(2010-12#1)
that have been proposed for##2##5##(2008-10#1)(2008-3#1)
that have been proposed to##4##5##(2007-11#1)(2007-3#1)(2010-12#1)(2012-12#1)
that have been proposed##7##4##(2007-11#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-3#1)(2010-12#1)(2012-12#1)
that have been published##6##4##(2004-11#1)(2006-10#1)(2006-11#1)(2007-3#1)(2008-1#1)(2008-10#1)
that have been recently##6##4##(1991-9#1)(2008-1#1)(2008-2#1)(2008-4#1)(2010-11#1)(2013-8#1)
that have been related to##2##5##(2006-8#1)(2008-10#1)
that have been reported in##3##5##(1997-6#1)(2006-10#2)
that have been reported##10##4##(1991-12#1)(1997-6#1)(2006-10#2)(2008-10#2)(2010-10#1)(2010-2#1)(2011-1#1)(2012-3#1)
that have been shown to be##2##6##(2007-1#1)(2008-7#1)
that have been shown to influence##3##6##(1997-1#1)(2006-10#1)(2008-1#1)
that have been shown to##11##5##(1995-1#1)(1996-4#1)(1996-9#1)(1997-1#1)(2006-10#1)(2007-1#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-8#1)
that have been shown##14##4##(1991-1#1)(1995-1#1)(1996-4#1)(1996-9#1)(1997-1#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-8#1)
that have been specifically##2##4##(1996-1#1)(2008-3#1)
that have been studied##7##4##(2006-10#2)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
that have been subjected to##2##5##(2010-7#1)(2012-12#1)
that have been successful in##3##5##(2008-10#1)(2008-3#1)(2013-8#1)
that have been successfully##3##4##(2006-10#1)(2007-12#1)(2008-9#1)
that have been taken##5##4##(1996-1#1)(2008-11#1)(2009-11#1)(2012-1#1)(2012-3#1)
that have been tested##4##4##(1997-4#1)(2004-4#1)(2005-6#1)(2012-1#1)
that have been the##3##4##(2006-10#1)(2008-7#1)(2010-10#1)
that have been treated with##2##5##(1995-5#1)(1995-8#1)
that have been treated##3##4##(1995-5#1)(1995-8#1)(2007-12#1)
that have been used as##3##5##(1994-3#1)(2008-10#1)(2010-4#1)
that have been used for the##2##6##(2007-11#1)(2009-8#1)
that have been used for##6##5##(2007-11#1)(2008-4#2)(2008-8#1)(2009-8#1)(2012-2#1)
that have been used to study##3##6##(2006-4#1)(2007-11#1)(2008-4#1)
that have been used to treat##2##6##(2008-8#1)(2011-1#1)
that have been used to##11##5##(2006-4#1)(2006-5#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-9#1)(2011-1#1)
that have been used##25##4##(1994-3#1)(1995-3#1)(2006-4#1)(2006-5#1)(2007-1#2)(2007-11#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#4)(2008-5#1)(2008-8#2)(2009-8#1)(2010-4#1)(2010-9#1)(2011-1#3)(2012-2#1)
that have been verified##2##4##(1996-12#1)(2008-4#1)
that have been##343##3##(1990-11#1)(1990-12#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-6#2)(1993-9#1)(1994-3#4)(1994-5#2)(1994-6#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-8#2)(1995-9#1)(1996-1#3)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#2)(1996-5#2)(1996-9#1)(1997-1#2)(1997-4#3)(1997-5#1)(1997-6#2)(1997-8#1)(2004-1#1)(2004-11#1)(2004-4#1)(2004-7#1)(2005-10#1)(2005-11#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#15)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-1#7)(2007-10#2)(2007-11#9)(2007-12#8)(2007-2#2)(2007-3#3)(2007-4#2)(2007-6#3)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#10)(2008-10#22)(2008-11#10)(2008-2#7)(2008-3#7)(2008-4#26)(2008-5#4)(2008-6#1)(2008-7#13)(2008-8#5)(2008-9#7)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#6)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#4)(2010-8#1)(2010-9#2)(2011-1#9)(2011-12#2)(2011-2#6)(2012-1#3)(2012-12#6)(2012-2#5)(2012-3#4)(2013-1#6)(2013-7#2)(2013-8#4)
that have both##5##3##(1997-2#1)(2006-2#1)(2007-11#1)(2008-2#1)(2011-2#1)
that have broad##2##3##(2008-2#1)(2012-3#1)
that have come##2##3##(2008-6#1)(2012-1#1)
that have contributed to the##3##5##(1996-2#1)(2008-6#1)(2010-8#1)
that have contributed to##5##4##(1996-2#1)(2007-12#1)(2008-6#1)(2010-8#1)(2012-2#1)
that have demonstrated##5##3##(1996-12#1)(1996-9#1)(2007-8#1)(2010-5#1)(2012-3#1)
that have developed##2##3##(1993-12#1)(2010-5#1)
that have different##9##3##(1992-9#1)(1995-5#1)(1996-4#1)(2007-12#1)(2008-2#2)(2008-3#3)
that have distinct##2##3##(1995-11#1)(2013-8#1)
that have dominated##2##3##(2008-4#1)(2012-3#1)
that have either a##2##4##(1997-6#1)(2008-3#1)
that have emerged from##2##4##(1996-12#1)(2008-11#1)
that have emerged##4##3##(1996-12#1)(2007-12#1)(2008-11#2)
that have evaluated##3##3##(2008-6#1)(2008-7#1)(2012-2#1)
that have evolved##3##3##(2004-3#1)(2010-5#1)(2013-1#1)
that have examined the##2##4##(2006-10#1)(2008-2#1)
that have examined##3##3##(1992-3#1)(2006-10#1)(2008-2#1)
that have formed the##2##4##(1992-2#1)(1996-8#1)
that have formed##3##3##(1992-2#1)(1994-12#1)(1996-8#1)
that have found##3##3##(1995-1#1)(2008-1#1)(2010-11#1)
that have furthered##2##3##(2006-10#1)(2011-1#1)
that have good##3##3##(1997-1#1)(2008-1#1)(2008-5#1)
that have greatly##2##3##(2007-11#1)(2009-12#1)
that have had##4##3##(2008-10#1)(2011-2#2)(2011-3#1)
that have helped##2##3##(1995-3#1)(2006-10#1)
that have high##7##3##(1996-5#1)(2007-6#1)(2008-3#1)(2009-8#1)(2010-8#1)(2012-11#1)(2012-3#1)
that have implications for##2##4##(1994-1#1)(2007-6#1)
that have implications##3##3##(1994-1#1)(2007-6#1)(2012-12#1)
that have improved##4##3##(2006-10#2)(2010-12#1)(2011-12#1)
that have influenced##3##3##(2007-7#1)(2011-2#1)(2013-1#1)
that have led to a##2##5##(1991-7#1)(2006-10#1)
that have led to the##6##5##(1990-11#1)(1990-12#1)(2008-11#1)(2009-9#1)(2010-10#1)(2010-12#1)
that have led to##13##4##(1990-11#1)(1990-12#1)(1991-7#1)(1997-2#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-8#1)(2013-1#1)
that have led##14##3##(1990-11#1)(1990-12#1)(1991-7#1)(1997-2#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
that have limited##2##3##(1996-2#1)(2007-11#1)
that have long##2##3##(2005-10#1)(2010-10#1)
that have lost##2##3##(2008-11#1)(2010-6#1)
that have low##3##3##(1995-2#1)(2008-3#2)
that have never before been##2##5##(2004-3#1)(2008-7#1)
that have never##3##3##(2004-3#1)(2008-7#1)(2010-12#1)
that have no##6##3##(1990-2#1)(2006-10#1)(2006-11#1)(2007-11#1)(2009-2#1)(2011-2#1)
that have not been previously described##2##6##(1994-2#1)(2010-1#1)
that have not been##8##4##(1994-2#1)(1996-4#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-1#1)(2011-12#1)
that have not previously been##2##5##(1997-7#1)(2008-8#1)
that have not yet been##5##5##(1995-8#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-6#1)
that have not yet##7##4##(1990-12#1)(1995-8#1)(1997-3#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-6#1)
that have not##20##3##(1990-12#1)(1993-12#1)(1994-2#1)(1995-8#1)(1996-4#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-6#3)(2008-7#1)(2008-8#1)(2009-6#1)(2010-1#1)(2011-12#1)
that have occurred during the##2##5##(2008-10#2)
that have occurred in the##4##5##(2006-10#1)(2008-11#1)(2010-12#1)(2011-2#1)
that have occurred in##5##4##(2006-10#1)(2008-11#2)(2010-12#1)(2011-2#1)
that have occurred##11##3##(1991-2#1)(2006-10#1)(2008-10#2)(2008-11#2)(2008-4#1)(2010-12#1)(2010-2#1)(2011-2#2)
that have potential application in##2##5##(1996-3#1)(2008-5#1)
that have potential##4##3##(1996-3#1)(2007-11#1)(2008-4#1)(2008-5#1)
that have previously been##3##4##(1993-12#1)(2007-8#1)(2010-8#1)
that have previously##5##3##(1993-12#1)(2007-12#1)(2007-8#1)(2009-6#1)(2010-8#1)
that have produced##4##3##(1991-12#1)(2008-8#1)(2009-7#1)(2010-5#1)
that have proved to be##2##5##(2007-12#1)(2008-1#1)
that have proved##8##3##(2006-3#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-2#2)(2008-6#1)(2010-12#1)
that have provided##2##3##(2007-8#1)(2011-2#1)
that have received##3##3##(1993-12#1)(2006-12#1)(2011-1#1)
that have recently been##4##4##(2007-11#1)(2009-5#1)(2009-7#1)(2013-8#1)
that have relatively##2##3##(2008-3#1)(2012-11#1)
that have shaped the##2##4##(1994-1#1)(2012-12#1)
that have shaped##3##3##(1994-1#1)(2012-12#1)(2013-1#1)
that have shown a##2##4##(1992-4#1)(2008-12#1)
that have shown promise in##2##5##(2008-8#1)(2010-8#1)
that have shown promise##4##4##(2008-10#1)(2008-8#1)(2010-10#1)(2010-8#1)
that have shown##7##3##(1992-4#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-10#1)(2010-8#1)
that have significant##2##3##(2007-7#1)(2008-11#1)
that have similar##3##3##(1991-12#1)(2008-10#1)(2008-8#1)
that have since been##2##4##(2008-9#1)(2010-12#1)
that have so far been##2##5##(2005-8#1)(2008-11#1)
that have so far##3##4##(1996-5#1)(2005-8#1)(2008-11#1)
that have specific##2##3##(2009-12#1)(2009-6#1)
that have strong##3##3##(1996-10#1)(2007-8#1)(2008-10#1)
that have taken place in##3##5##(1991-3#1)(2008-2#1)(2011-1#1)
that have the capacity to##3##5##(2008-1#1)(2008-10#1)(2008-5#1)
that have the capacity##4##4##(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)
that have the highest##2##4##(1996-2#1)(2008-10#1)
that have the potential to##9##5##(1991-7#1)(2008-12#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#1)
that have the potential##10##4##(1991-7#1)(1995-11#1)(2008-12#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#1)
that have the same##4##4##(2005-10#1)(2007-12#1)(2008-3#2)
that have the##24##3##(1991-7#1)(1995-11#1)(1995-2#1)(1996-2#1)(2005-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-9#1)(2012-1#1)(2012-12#2)(2012-2#2)
that have to be addressed##2##5##(2008-10#1)(2011-1#1)
that have to be considered##2##5##(2008-3#1)(2008-7#1)
that have to be##9##4##(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-1#1)(2012-12#1)
that have undergone##5##3##(1995-6#1)(1996-7#1)(2008-4#1)(2012-11#1)(2013-7#1)
that have used##3##3##(1991-3#1)(2012-2#1)(2012-3#1)
that have##880##2##(1990-11#2)(1990-12#5)(1990-2#3)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#3)(1991-5#1)(1991-6#2)(1991-7#3)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#3)(1992-3#6)(1992-4#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#10)(1993-2#1)(1993-3#2)(1993-6#2)(1993-9#1)(1994-1#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#6)(1994-5#4)(1994-6#4)(1994-8#1)(1994-9#3)(1995-1#4)(1995-10#1)(1995-11#3)(1995-2#6)(1995-3#6)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#4)(1995-9#1)(1996-1#5)(1996-10#2)(1996-11#2)(1996-12#4)(1996-2#7)(1996-3#3)(1996-4#5)(1996-5#4)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#4)(1997-2#5)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#1)(2004-1#1)(2004-10#1)(2004-11#2)(2004-3#2)(2004-4#1)(2004-7#1)(2004-9#1)(2005-10#3)(2005-11#1)(2005-6#2)(2005-7#2)(2005-8#3)(2006-10#30)(2006-11#5)(2006-12#4)(2006-2#6)(2006-3#1)(2006-4#3)(2006-5#4)(2006-6#1)(2006-7#3)(2006-8#5)(2007-1#8)(2007-10#2)(2007-11#22)(2007-12#23)(2007-2#3)(2007-3#3)(2007-4#3)(2007-5#2)(2007-6#6)(2007-7#6)(2007-8#9)(2007-9#2)(2008-1#22)(2008-10#51)(2008-11#22)(2008-12#3)(2008-2#23)(2008-3#33)(2008-4#44)(2008-5#15)(2008-6#12)(2008-7#24)(2008-8#12)(2008-9#17)(2009-1#1)(2009-10#10)(2009-11#2)(2009-12#4)(2009-2#2)(2009-3#5)(2009-4#2)(2009-5#2)(2009-6#7)(2009-7#4)(2009-8#4)(2009-9#2)(2010-1#3)(2010-10#9)(2010-11#4)(2010-12#18)(2010-2#4)(2010-3#1)(2010-4#4)(2010-5#6)(2010-6#4)(2010-7#6)(2010-8#11)(2010-9#4)(2011-1#17)(2011-12#5)(2011-2#24)(2011-3#1)(2012-1#8)(2012-11#5)(2012-12#12)(2012-2#18)(2012-3#13)(2013-1#14)(2013-7#4)(2013-8#9)
that having a##4##3##(2007-12#1)(2008-11#1)(2010-2#1)(2011-2#1)
that having##8##2##(1991-12#1)(2005-10#1)(2007-12#1)(2008-11#1)(2010-2#2)(2011-2#1)(2012-12#1)
that he could not##4##4##(1996-5#1)(2008-9#1)(2013-1#2)
that he did##2##3##(1996-5#1)(1996-6#1)
that he had##10##3##(1990-9#1)(1993-7#1)(1995-6#2)(2007-11#1)(2008-4#1)(2010-11#1)(2012-2#1)(2013-1#2)
that he has##4##3##(2007-9#1)(2008-9#1)(2009-4#1)(2010-8#1)
that he or she##2##4##(2008-4#1)(2013-7#1)
that he was fired##3##4##(1996-11#2)(1996-6#1)
that he was##12##3##(1996-11#6)(1996-6#1)(2006-12#2)(2007-9#1)(2008-1#1)(2011-2#1)
that he would like##2##4##(2008-4#1)(2008-5#1)
that he would##6##3##(1995-12#1)(1995-6#2)(1996-6#1)(2008-4#1)(2008-5#1)
that he##67##2##(1990-11#1)(1990-9#1)(1991-6#1)(1993-5#1)(1993-7#1)(1994-3#3)(1995-12#2)(1995-6#4)(1996-11#9)(1996-12#1)(1996-5#3)(1996-6#3)(2004-3#1)(2005-12#2)(2005-7#1)(2006-1#1)(2006-12#2)(2006-3#1)(2007-1#1)(2007-11#1)(2007-5#1)(2007-9#4)(2008-1#2)(2008-12#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-9#3)(2009-4#1)(2009-7#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-7#1)
that he/she##2##2##(1991-8#1)(2007-6#1)
that headgroup##2##2##(1992-1#1)(1992-6#1)
that health care is##4##4##(1993-3#1)(1996-1#1)(1997-5#1)(2008-7#1)
that health care organizations##3##4##(1994-1#1)(1996-2#1)(2010-7#1)
that health care providers should##2##5##(1994-3#1)(2007-10#1)
that health care providers##4##4##(1994-3#1)(1996-3#1)(2007-10#1)(2007-6#1)
that health care workers##2##4##(1995-9#1)(2008-4#1)
that health care##22##3##(1990-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-5#1)(2007-10#1)(2007-6#1)(2008-4#1)(2008-7#1)(2010-1#1)(2010-7#1)(2010-8#1)
that health is##2##3##(2010-1#1)(2011-1#1)
that health plans##2##3##(1997-1#1)(1997-2#1)
that health professionals##2##3##(2007-2#1)(2011-2#1)
that health services##3##3##(2007-7#1)(2011-2#1)(2012-1#1)
that health workers##3##3##(2007-12#2)(2008-10#1)
that health##51##2##(1990-12#1)(1992-1#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-2#1)(1997-5#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)
that healthcare##7##2##(1994-3#1)(1996-1#1)(2004-10#1)(2008-12#1)(2008-7#1)(2010-11#1)(2011-1#1)
that healthy##2##2##(1991-11#1)(2008-11#1)
that hearing##2##2##(1993-5#1)(2009-9#1)
that heart failure is##2##4##(2005-10#1)(2008-3#1)
that heat shock##2##3##(1994-11#2)
that heat stress##2##3##(2008-12#1)(2012-2#1)
that heat##7##2##(1991-4#1)(1994-11#2)(1994-8#1)(2008-12#1)(2012-2#1)(2013-8#1)
that heavy metals##2##3##(1995-3#1)(2010-11#1)
that heavy##4##2##(1995-3#1)(1995-9#1)(2005-10#1)(2010-11#1)
that helix##4##2##(1990-5#1)(1991-1#1)(1995-4#1)(1995-5#1)
that helodermin##2##2##(1990-7#1)(1994-12#1)
that help to##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
that help##14##2##(1992-2#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)(2009-5#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
that helped##3##2##(1995-1#1)(1997-8#1)(2011-2#1)
that helps the##2##3##(1993-12#1)(2007-7#1)
that helps to##2##3##(2006-6#1)(2007-7#1)
that helps##16##2##(1993-12#1)(1993-3#1)(1997-3#1)(2006-6#1)(2007-2#6)(2007-7#2)(2010-6#1)(2011-2#2)(2012-12#1)
that hematuria was##3##3##(2007-2#3)
that hematuria##4##2##(2007-2#4)
that heme doming##2##3##(1995-1#2)
that heme##4##2##(1995-1#2)(1997-6#1)(2011-2#1)
that hemi-fusion##2##2##(1991-5#2)
that hemin##3##2##(1993-12#1)(2008-10#2)
that hemoglobin##2##2##(2006-8#1)(2012-12#1)
that heparin##6##2##(1990-11#1)(1992-7#1)(1993-8#1)(1994-9#1)(1995-3#1)(1995-5#1)
that hepatic##13##2##(1991-1#2)(1991-2#2)(1991-8#1)(1992-1#1)(1994-10#1)(1995-6#1)(1995-9#1)(1996-7#1)(1997-1#1)(2007-8#1)(2010-8#1)
that hepatitis C virus##2##4##(2006-10#1)(2007-2#1)
that hepatitis C##4##3##(2006-10#3)(2007-2#1)
that hepatitis##7##2##(1995-2#1)(2006-10#3)(2006-2#1)(2007-2#1)(2008-3#1)
that hepatocytes in##2##3##(1991-7#1)(1994-6#1)
that hepatocytes##6##2##(1991-7#1)(1992-12#1)(1993-3#1)(1994-6#1)(1994-8#1)(1995-2#1)
that hepoxilin A3##5##3##(1990-9#3)(1991-8#1)(1994-9#1)
that her##13##2##(1991-12#1)(1994-12#1)(1997-5#1)(1997-8#1)(2007-2#1)(2007-6#1)(2008-4#1)(2008-9#2)(2011-2#1)(2013-1#3)
that herbal##2##2##(2008-10#1)(2008-11#1)
that herbivore##3##2##(2008-9#2)(2012-2#1)
that herbivores##3##2##(2008-8#1)(2008-9#1)(2009-2#1)
that herbivory##2##2##(2007-3#1)(2008-8#1)
that hereditary##2##2##(1996-6#1)(2009-4#1)
that heterogeneity##3##2##(2008-10#1)(2008-9#2)
that heterogeneous##2##2##(2008-2#1)(2012-3#1)
that heterologous##4##2##(1990-10#1)(1994-12#1)(1994-2#1)(2013-1#1)
that heterozygosity for the##2##4##(1997-4#1)(2006-8#1)
that hierarchical##2##2##(1993-4#2)
that high blood pressure##2##4##(1997-5#1)(2010-9#1)
that high concentrations of##4##4##(1994-12#1)(1994-5#1)(1997-6#1)(2010-5#1)
that high doses of##2##4##(2006-10#1)(2007-8#1)
that high expression of##2##4##(1992-11#1)(1995-1#1)
that high glucose##2##3##(1991-4#1)(1992-6#1)
that high level of##2##4##(2007-9#1)(2008-7#1)
that high levels of##16##4##(1990-12#1)(1990-7#1)(1995-12#1)(1995-3#1)(1996-4#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-12#1)(2008-10#3)(2008-8#1)(2009-8#1)(2010-1#1)(2013-8#1)
that high molecular weight##2##4##(1992-7#1)(2004-9#1)
that high quality##2##3##(2006-2#1)(2010-12#1)
that high selective vagotomy##2##4##(1990-6#2)
that high serum cholesterol##2##4##(2007-1#1)(2010-10#1)
that high##82##2##(1990-11#1)(1990-12#2)(1990-6#2)(1990-7#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-11#1)(1992-6#1)(1992-7#1)(1993-5#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-3#2)(1996-4#1)(1997-5#1)(1997-6#1)(2004-9#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-12#4)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#8)(2008-11#2)(2008-2#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-9#2)(2011-2#2)(2013-1#3)(2013-7#1)(2013-8#2)
that high-concentration##2##2##(2006-2#1)(2010-2#1)
that high-dose##2##2##(1991-10#1)(2006-11#1)
that high-intensity##2##2##(2008-3#1)(2013-7#1)
that high-quality##3##2##(2006-5#1)(2008-2#1)(2008-8#1)
that high-resolution##3##2##(2007-5#1)(2008-2#1)(2011-1#1)
that high-risk##2##2##(1997-7#1)(2011-2#1)
that high-sensitivity##2##2##(2008-3#1)(2013-1#1)
that higher doses of##2##4##(2009-7#1)(2012-1#1)
that higher doses##5##3##(1992-5#1)(1993-11#1)(2008-8#1)(2009-7#1)(2012-1#1)
that higher levels of##6##4##(1990-12#1)(1991-12#1)(2007-12#1)(2008-10#1)(2009-5#1)(2012-3#1)
that higher##45##2##(1990-12#1)(1991-12#1)(1992-3#1)(1992-5#1)(1993-11#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-3#1)(2006-12#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#2)(2013-8#1)
that higher-order##3##2##(1995-8#1)(2007-11#1)(2007-12#1)
that highlight the##5##3##(2007-11#1)(2008-11#1)(2010-5#1)(2012-1#1)(2012-12#1)
that highlight##6##2##(2007-11#1)(2008-11#1)(2009-11#1)(2010-5#1)(2012-1#1)(2012-12#1)
that highlights the##3##3##(1991-2#1)(2008-3#1)(2012-2#1)
that highlights##5##2##(1991-2#1)(2008-3#1)(2009-4#1)(2012-2#1)(2013-1#1)
that highly purified##2##3##(1995-10#1)(1995-2#1)
that highly##16##2##(1990-10#1)(1990-9#1)(1995-10#1)(1995-2#1)(2006-7#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-5#1)(2009-11#1)(2009-8#1)(2010-2#2)(2011-2#1)(2013-1#1)
that hinder their##2##3##(2008-7#1)(2010-6#1)
that hinder##4##2##(2006-7#1)(2008-7#1)(2010-6#1)(2011-2#1)
that hinders##2##2##(2006-12#1)(2012-12#1)
that hip##4##2##(2006-11#2)(2007-11#1)(2008-8#1)
that hippocampal##11##2##(1991-5#1)(1992-11#1)(1992-3#1)(1992-9#2)(1993-12#3)(1997-1#1)(2008-11#1)(2008-7#1)
that his employer##2##3##(1991-6#1)(1996-12#1)
that his##16##2##(1991-6#2)(1992-3#1)(1993-7#1)(1994-3#1)(1995-12#2)(1995-6#1)(1996-11#1)(1996-12#1)(2006-6#1)(2008-10#1)(2010-10#1)(2011-2#2)(2013-1#1)
that his/her##2##2##(2009-6#1)(2012-3#1)
that histamine##5##2##(1991-1#1)(1993-3#1)(1995-12#1)(1996-12#1)(2008-12#1)
that histidine##3##2##(1992-4#2)(1993-9#1)
that hold the promise of##2##5##(2008-8#1)(2009-12#1)
that hold##4##2##(2004-12#1)(2008-5#1)(2008-8#1)(2009-12#1)
that holds##4##2##(1997-3#1)(2006-6#1)(2009-3#1)(2009-4#1)
that holistic##2##2##(2009-4#2)
that holoenzyme##2##2##(1994-12#2)
that holographic##2##2##(2008-2#1)(2008-3#1)
that home##3##2##(2008-8#1)(2010-12#1)(2012-12#1)
that homocysteine##3##2##(1992-9#2)(2008-1#1)
that homogeneous##2##2##(2007-12#1)(2008-2#1)
that homologous recombination##2##3##(1995-6#1)(2008-8#1)
that homologous##5##2##(1994-8#1)(1995-6#1)(1997-3#1)(2005-10#1)(2008-8#1)
that homozygous##3##2##(1993-12#1)(1996-9#1)(2008-2#1)
that hope##2##2##(2008-11#1)(2010-10#1)
that horizontal transfer of##2##4##(1996-10#1)(2008-10#1)
that horizontal##6##2##(1996-10#1)(2008-10#3)(2008-5#1)(2009-6#1)
that hormesis##2##2##(2008-7#2)
that hormonal##4##2##(1991-5#1)(1994-2#1)(1995-12#1)(1997-7#1)
that hormone##3##2##(2007-2#1)(2008-11#1)(2010-8#1)
that hormones##6##2##(1993-11#1)(2008-4#1)(2010-2#1)(2010-8#3)
that hospital##8##2##(1992-1#1)(1992-12#1)(1995-3#1)(1997-3#1)(2005-9#1)(2008-11#2)(2008-2#1)
that hospitals can##2##3##(1993-3#1)(1995-2#1)
that hospitals##13##2##(1990-12#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1995-12#1)(1995-2#1)(1997-1#1)(2007-7#1)(2008-11#3)
that host##8##2##(2008-10#7)(2013-7#1)
that households##2##2##(2010-1#1)(2011-2#1)
that how##3##2##(2012-2#1)(2013-1#2)
that hsp-reactive lymphocytes##2##3##(1995-2#2)
that hsp70##2##2##(1994-11#1)(1996-5#1)
that human CGRP##2##3##(1990-6#1)(1997-5#1)
that human brain##2##3##(2005-9#1)(2006-11#1)
that human cells##2##3##(1991-7#1)(2012-2#1)
that human hair##2##3##(2008-5#1)(2012-11#1)
that human immunodeficiency virus##2##4##(1995-1#1)(2008-2#1)
that human lymphocytes##2##3##(1991-9#1)(2007-2#1)
that human neutrophils##2##3##(1994-3#1)(2010-9#1)
that human plasma##2##3##(1995-3#2)
that human salivary alpha-amylase##2##4##(1990-12#2)
that human##91##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#3)(1990-9#3)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-7#2)(1991-8#1)(1991-9#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#1)(1995-1#1)(1995-11#2)(1995-3#2)(1995-5#2)(1995-8#2)(1996-5#1)(1996-7#1)(1997-4#2)(1997-5#1)(1997-6#2)(2004-9#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#5)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#2)(2010-2#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
that humans are##2##3##(2008-10#1)(2012-2#1)
that humans have##4##3##(2006-7#1)(2007-12#1)(2008-5#1)(2009-5#1)
that humans##10##2##(1992-9#1)(1996-3#1)(2006-7#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-5#1)(2011-2#1)(2012-2#1)
that humic##2##2##(2005-11#1)(2008-10#1)
that hundreds of##2##3##(2008-10#1)(2008-7#1)
that hyaluronan##2##2##(1994-2#1)(2010-12#1)
that hybrid##3##2##(1995-5#1)(1995-8#1)(2008-3#1)
that hybridization##3##2##(1990-7#1)(2008-3#1)(2008-8#1)
that hybridized to##2##3##(1990-12#1)(2008-10#1)
that hybridized with##2##3##(1993-11#1)(2008-10#1)
that hybridized##4##2##(1990-12#1)(1993-11#1)(2008-10#2)
that hybridoma cells##2##3##(1994-2#1)(2008-11#1)
that hydration of##2##3##(1991-3#1)(1997-5#1)
that hydraulic and mechanical##2##4##(2009-8#2)
that hydraulic##3##2##(2009-8#2)(2010-6#1)
that hydrogen peroxide (H2O2)##2##4##(1992-3#1)(1993-7#1)
that hydrogen peroxide##3##3##(1990-3#1)(1992-3#1)(1993-7#1)
that hydrogen##7##2##(1990-3#1)(1992-3#1)(1993-7#1)(1995-5#1)(2008-5#1)(2011-2#2)
that hydrolysis of the##2##4##(1992-8#1)(1993-8#1)
that hydrolysis of##3##3##(1990-12#1)(1992-8#1)(1993-8#1)
that hydrolyze##5##2##(1991-3#1)(1992-3#1)(1997-4#1)(2008-4#2)
that hydrolyzes the##2##3##(2010-2#1)(2010-6#1)
that hydrolyzes##5##2##(1995-6#2)(2009-7#1)(2010-2#1)(2010-6#1)
that hydrophilic##3##2##(1995-1#1)(1996-4#1)(1997-6#1)
that hydrophobic amino acids##2##4##(1996-9#1)(2011-2#1)
that hydrophobic##6##2##(1990-2#2)(1995-11#1)(1996-9#1)(2008-10#1)(2011-2#1)
that hyperglycemia increases##2##3##(1995-10#1)(2010-7#1)
that hyperglycemia##5##2##(1994-12#1)(1995-10#1)(2005-10#1)(2007-8#1)(2010-7#1)
that hyperinsulinemia##2##2##(1997-2#1)(2008-3#1)
that hypertension is highly prevalent in the##2##7##(2008-1#2)
that hypertension is##4##3##(1996-9#1)(2008-1#2)(2008-4#1)
that hypertension may##2##3##(1990-2#1)(2012-12#1)
that hypertension##11##2##(1990-2#1)(1992-4#1)(1993-12#1)(1996-9#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-4#1)(2011-1#1)(2012-12#1)
that hyperthermia##3##2##(1995-8#1)(2007-10#1)(2011-2#1)
that hypertrophic##3##2##(2010-11#1)(2012-12#2)
that hypertrophy##2##2##(1990-3#1)(1997-4#1)
that hypothalamic##3##2##(1991-9#1)(2010-12#2)
that hypothermia##4##2##(1991-2#1)(1995-12#1)(2010-1#1)(2012-11#1)
that hypothesis##3##2##(1995-5#1)(2008-10#1)(2008-3#1)
that hypothyroidism##2##2##(1994-6#1)(2008-8#1)
that hypoxia##3##2##(1995-1#1)(1995-5#1)(2010-11#1)
that i##6##2##(1992-3#1)(1993-3#1)(1996-11#1)(1997-5#1)(2008-1#2)
that ibotenic acid lesions of##2##5##(1993-12#1)(1993-6#1)
that ibotenic acid lesions##3##4##(1993-12#2)(1993-6#1)
that ibutilide##2##2##(1993-3#2)
that identical##2##2##(1996-10#2)
that identification of##2##3##(2007-11#1)(2013-1#1)
that identification##3##2##(1991-3#1)(2007-11#1)(2013-1#1)
that identified##7##2##(1992-3#1)(2008-8#1)(2010-12#1)(2011-2#2)(2013-1#2)
that identifies the##5##3##(1996-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2010-2#1)
that identifies##14##2##(1995-12#1)(1996-1#1)(1996-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-2#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2012-2#1)
that identify high-risk##3##3##(2006-10#1)(2013-1#2)
that identify the##4##3##(2006-1#1)(2008-2#1)(2013-1#2)
that identify##18##2##(1994-5#1)(1995-2#1)(1997-1#1)(2006-1#1)(2006-10#2)(2008-10#2)(2008-2#1)(2009-4#1)(2010-11#1)(2011-1#1)(2013-1#6)
that identifying##2##2##(1997-8#1)(2011-1#1)
that if a##5##3##(2008-7#1)(2009-12#1)(2009-6#1)(2013-1#2)
that if an##3##3##(1997-2#1)(2005-7#1)(2013-8#1)
that if one##2##3##(2008-11#1)(2009-9#1)
that if the spatial##2##4##(2008-10#1)(2008-8#1)
that if the##24##3##(1990-9#1)(1992-10#1)(1994-2#1)(1994-9#1)(1995-3#1)(1996-2#1)(2004-1#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-8#2)
that if there are##2##4##(1992-1#1)(2008-4#1)
that if there##3##3##(1992-1#1)(1997-5#1)(2008-4#1)
that if##63##2##(1990-9#1)(1991-4#1)(1992-1#1)(1992-10#1)(1994-2#2)(1994-9#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-5#1)(2004-1#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-12#2)(2007-4#1)(2007-6#3)(2007-7#2)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#3)(2013-1#3)(2013-8#3)
that ignore##3##2##(1994-1#2)(2008-8#1)
that ignores##2##2##(1993-6#1)(2008-9#1)
that illicit##2##2##(2006-1#1)(2006-8#1)
that illness##2##2##(1993-1#1)(2009-11#1)
that illuminates the##3##3##(2007-11#1)(2008-2#1)(2008-7#1)
that illuminates##5##2##(2007-11#1)(2008-2#1)(2008-3#2)(2008-7#1)
that illustrate different##2##3##(1994-2#1)(2008-11#1)
that illustrate the##8##3##(1994-3#1)(1995-8#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-2#1)
that illustrate this##2##3##(2007-12#1)(2008-2#1)
that illustrate##17##2##(1994-2#1)(1994-3#1)(1995-8#1)(2005-7#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-9#1)(2010-11#1)(2012-2#1)
that illustrates how##2##3##(2011-12#1)(2012-2#1)
that illustrates the##5##3##(2007-2#1)(2008-2#1)(2008-7#2)(2012-12#1)
that illustrates##8##2##(2007-2#1)(2007-6#1)(2008-2#1)(2008-7#2)(2011-12#1)(2012-12#1)(2012-2#1)
that image##2##2##(1991-12#1)(2009-5#1)
that images##3##2##(1996-9#1)(2007-12#1)(2008-3#1)
that immature CEs##2##3##(2008-5#2)
that immediate##6##2##(1993-10#1)(1996-2#1)(2007-7#1)(2010-8#1)(2012-1#1)(2013-8#1)
that immediately##2##2##(2005-11#1)(2008-4#1)
that immigrants##2##2##(1991-4#1)(2011-2#1)
that immobilization##2##2##(1994-2#1)(2008-5#1)
that immobilized##4##2##(1996-8#1)(2008-10#1)(2009-2#1)(2011-12#1)
that immune function##2##3##(1995-12#1)(2012-1#1)
that immune response##2##3##(2008-8#1)(2008-9#1)
that immune##12##2##(1995-12#1)(2005-10#2)(2006-10#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#1)(2012-1#1)
that immunity##2##2##(2007-2#1)(2011-2#1)
that immunization with##2##3##(1995-2#1)(2006-10#1)
that immunization##3##2##(1995-2#1)(1996-12#1)(2006-10#1)
that immunologic##2##2##(1991-3#1)(1991-8#1)
that immunological##2##2##(1993-11#1)(2006-8#1)
that immunotherapy##2##2##(2005-10#1)(2010-3#1)
that immunotoxicity testing##2##3##(2008-10#2)
that impact on##5##3##(2007-7#1)(2008-11#1)(2008-3#1)(2009-12#1)(2011-1#1)
that impact the morbidity and mortality of the population##2##9##(2013-8#2)
that impact the##8##3##(2007-2#1)(2008-10#2)(2008-7#1)(2009-3#1)(2011-11#1)(2013-8#2)
that impact upon##2##3##(2008-12#2)
that impact##26##2##(1997-5#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-12#1)(2009-3#1)(2011-1#1)(2011-11#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
that impacted on##3##3##(2007-10#1)(2007-8#1)(2008-4#1)
that impacted##5##2##(2007-10#1)(2007-8#1)(2008-4#1)(2010-12#1)(2011-2#1)
that impacts##4##2##(2007-12#1)(2007-3#1)(2007-7#1)(2008-11#1)
that impair##8##2##(2006-6#2)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2012-1#1)
that impaired##12##2##(1991-1#1)(1995-3#1)(2006-9#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2009-11#1)(2010-10#1)(2010-12#1)(2012-1#1)(2012-12#1)
that impairment of##5##3##(1993-11#1)(1994-10#1)(1994-6#1)(2006-12#1)(2008-10#1)
that impairments##2##2##(1997-8#1)(2006-9#1)
that impairs the##2##3##(2006-11#1)(2008-6#1)
that impairs##4##2##(2006-11#1)(2006-6#1)(2008-11#1)(2008-6#1)
that impede the##2##3##(1996-2#1)(2010-5#1)
that impede##4##2##(1996-2#1)(2006-7#1)(2008-6#1)(2010-5#1)
that impinge on##3##3##(2008-3#1)(2008-9#1)(2013-8#1)
that implants##2##2##(2007-12#1)(2007-2#1)
that implementation is##2##3##(1995-2#1)(1996-1#1)
that implementation of##5##3##(1994-1#1)(1997-1#1)(2004-4#1)(2007-8#1)(2008-3#1)
that implementation##10##2##(1994-1#1)(1995-2#1)(1996-1#1)(1997-1#1)(2004-4#1)(2007-8#1)(2008-3#1)(2008-9#1)(2012-11#2)
that implemented##2##2##(1991-12#1)(2007-4#1)
that implementing a##2##3##(2008-7#1)(2013-1#1)
that implements the##6##3##(1996-2#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-4#1)
that implements##10##2##(1996-2#1)(2007-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2011-2#1)
that implicate##5##2##(1996-6#1)(2007-11#2)(2008-3#1)(2008-9#1)
that implicit##3##2##(2006-10#1)(2009-9#1)(2010-10#1)
that import##2##2##(1994-2#1)(1996-7#1)
that important##5##2##(1992-5#1)(1994-11#1)(2007-4#1)(2008-11#1)(2008-9#1)
that impose##3##2##(1994-12#1)(2008-2#1)(2010-5#1)
that imposes##3##2##(2007-6#1)(2008-2#2)
that improve our understanding of the##3##6##(2006-10#2)(2009-10#1)
that improve the##6##3##(1996-3#1)(2006-10#1)(2007-7#1)(2008-2#1)(2008-7#1)(2012-3#1)
that improve their##2##3##(2008-1#1)(2008-8#1)
that improve##19##2##(1990-9#1)(1994-4#1)(1996-3#1)(2006-10#4)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-1#1)(2012-1#1)(2012-3#1)(2013-1#1)
that improved##17##2##(1994-3#1)(1995-6#2)(1996-12#1)(2005-11#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-9#1)(2009-7#1)(2009-8#1)(2013-1#2)
that improvement##3##2##(1995-1#1)(1995-9#1)(2006-7#1)
that improvements in##3##3##(2006-7#1)(2007-12#1)(2012-2#1)
that improves the##4##3##(1997-2#1)(2008-10#1)(2008-2#1)(2008-8#1)
that improves##9##2##(1997-2#1)(2006-2#1)(2007-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#2)(2013-1#1)
that improving the##2##3##(2010-8#1)(2011-2#1)
that improving##3##2##(2007-2#1)(2010-8#1)(2011-2#1)
that impulse activity##2##3##(2008-5#2)
that impulsivity in##2##3##(2013-1#2)
that impulsivity##3##2##(2006-7#1)(2013-1#2)
that in 150##2##3##(1991-11#1)(1991-5#1)
that in 2005##3##3##(2007-7#2)(2008-10#1)
that in 2009##3##3##(2009-8#1)(2012-3#2)
that in 5##2##3##(1996-9#1)(2008-10#1)
that in C##2##3##(2008-8#2)
that in HCC##2##3##(2008-8#1)(2011-1#1)
that in India##2##3##(1995-10#1)(2012-2#1)
that in P##3##3##(1997-7#1)(2007-1#1)(2008-5#1)
that in Western##2##3##(1995-10#1)(2008-12#1)
that in a##25##3##(1990-11#1)(1993-9#1)(1995-1#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-10#4)(2008-11#3)(2008-2#4)(2008-3#2)
that in addition to its##4##5##(1992-6#1)(2008-11#1)(2008-4#1)(2008-5#1)
that in addition to the##11##5##(1991-3#1)(1992-7#1)(1992-9#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-11#1)(2012-12#2)(2012-3#1)
that in addition to their##3##5##(1992-7#1)(2011-1#1)(2012-12#1)
that in addition to##40##4##(1990-8#1)(1991-3#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-7#1)(1996-10#1)(1997-7#1)(2006-10#1)(2006-2#1)(2007-6#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-11#1)(2011-1#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#2)
that in adult##2##3##(1994-9#1)(1995-9#1)
that in all cases##2##4##(1992-3#1)(1997-6#1)
that in all the##2##4##(2009-2#2)
that in all##11##3##(1990-3#1)(1992-3#1)(1995-1#1)(1996-3#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-2#2)
that in an##7##3##(1995-2#1)(1996-1#1)(1996-3#1)(2008-2#1)(2008-9#1)(2009-11#1)(2012-2#1)
that in animals##3##3##(1992-5#1)(1993-12#1)(2004-11#1)
that in any##2##3##(1993-1#1)(2006-7#1)
that in aqueous##2##3##(2008-10#2)
that in at least##2##4##(1990-5#1)(2010-11#1)
that in both cases##2##4##(2008-7#1)(2009-8#1)
that in both##7##3##(1991-7#1)(1997-2#1)(2007-9#1)(2008-11#1)(2008-7#2)(2009-8#1)
that in brain##2##3##(1993-11#1)(1993-9#1)
that in cases of##2##4##(1992-2#1)(2010-6#1)
that in cases##5##3##(1992-2#1)(2008-10#1)(2010-6#1)(2013-1#2)
that in certain##3##3##(2009-9#1)(2011-2#1)(2012-3#1)
that in comparison to##2##4##(1995-1#1)(2010-1#1)
that in comparison##3##3##(1995-1#1)(2010-1#1)(2013-7#1)
that in contrast to the##2##5##(1994-12#1)(1995-2#1)
that in contrast to##7##4##(1994-12#1)(1994-8#1)(1995-2#1)(1996-5#1)(2008-3#1)(2008-7#1)(2010-2#1)
that in contrast##8##3##(1992-5#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-5#1)(2008-3#1)(2008-7#1)(2010-2#1)
that in control and##2##4##(2008-4#1)(2013-7#1)
that in control subjects##2##4##(1990-4#1)(2011-12#1)
that in control##16##3##(1990-4#1)(1992-4#1)(1993-2#1)(1994-2#1)(1994-3#1)(2006-12#1)(2006-4#1)(2008-10#4)(2008-4#1)(2008-7#1)(2011-12#1)(2013-7#1)(2013-8#1)
that in controls##8##3##(1994-2#2)(1994-7#1)(1996-10#1)(1996-9#1)(2008-4#1)(2009-2#1)(2009-6#1)
that in cultured##2##3##(1990-5#1)(1990-7#1)
that in different##3##3##(1995-5#1)(2008-11#1)(2010-12#1)
that in each##2##3##(1991-10#1)(1995-1#1)
that in either##2##3##(1996-6#1)(2011-2#1)
that in elderly##2##3##(2006-2#1)(2010-10#1)
that in females##3##3##(1993-8#1)(2006-10#1)(2007-12#1)
that in four##2##3##(1996-4#1)(2008-6#1)
that in general the##4##4##(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
that in general##8##3##(1992-4#1)(1994-9#1)(2005-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-12#1)
that in group##4##3##(2007-8#2)(2007-9#1)(2012-2#1)
that in healthy##3##3##(2008-10#1)(2011-1#1)(2012-1#1)
that in hepatocytes##4##3##(1990-12#1)(1990-5#1)(1992-5#1)(1993-8#1)
that in human##7##3##(1990-10#1)(1991-6#1)(1992-8#2)(1993-1#1)(1993-9#1)(1994-3#1)
that in humans the##2##4##(2005-10#1)(2006-1#1)
that in infected##3##3##(2008-10#3)
that in its##2##3##(1990-11#1)(1993-8#1)
that in low##2##3##(1992-12#1)(2008-8#1)
that in many cases##4##4##(2006-10#1)(2008-5#1)(2009-10#1)(2011-2#1)
that in many##7##3##(2006-10#1)(2006-4#1)(2008-5#1)(2008-8#2)(2009-10#1)(2011-2#1)
that in men##3##3##(1997-8#1)(2008-3#2)
that in mixed##2##3##(2005-11#1)(2008-5#1)
that in most cases##2##4##(1992-8#1)(2006-10#1)
that in most of the##2##5##(1990-8#1)(1995-1#1)
that in most of##3##4##(1990-12#1)(1990-8#1)(1995-1#1)
that in most##11##3##(1990-12#1)(1990-8#1)(1991-6#1)(1992-8#1)(1993-2#1)(1994-3#1)(1995-1#1)(2006-10#1)(2008-9#1)(2009-8#1)(2012-3#1)
that in mouse##3##3##(1990-7#1)(1994-6#1)(2008-11#1)
that in non-smokers##2##3##(2008-10#1)(2009-5#1)
that in nontransgenic##2##3##(1994-8#1)(2008-10#1)
that in normal subjects##2##4##(1995-8#1)(1997-2#1)
that in normal##9##3##(1995-8#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#1)(2007-9#1)(2008-7#1)(2012-1#1)
that in normothermic##2##3##(1994-2#1)(1995-12#1)
that in obese##3##3##(1991-1#2)(2008-4#1)
that in one##3##3##(2005-8#1)(2007-9#1)(2008-10#1)
that in only##2##3##(2008-10#1)(2013-1#1)
that in order to achieve##3##5##(2008-10#1)(2009-10#1)(2009-3#1)
that in order to obtain##2##5##(2007-7#1)(2008-5#1)
that in order to##12##4##(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2009-10#1)(2009-3#1)(2010-3#1)(2011-2#2)(2012-3#1)
that in order##13##3##(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2009-10#1)(2009-3#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-3#1)
that in other##10##3##(1991-10#1)(1995-6#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-9#1)(2010-5#1)(2012-2#1)
that in our##5##3##(2004-4#1)(2006-10#1)(2008-11#1)(2010-9#1)(2011-2#1)
that in parental##2##3##(1995-7#1)(2008-9#1)
that in part##2##3##(1997-4#1)(2008-11#1)
that in particular cases##2##4##(2008-10#1)(2008-2#1)
that in patients in##2##4##(2005-10#1)(2013-1#1)
that in patients undergoing##2##4##(2007-10#1)(2012-1#1)
that in patients with chronic##2##5##(1994-12#1)(1997-4#1)
that in patients with##16##4##(1990-8#1)(1991-1#1)(1993-12#1)(1993-2#1)(1994-12#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-4#1)(2008-9#3)(2012-1#1)(2013-8#1)
that in patients##22##3##(1990-8#1)(1991-1#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-12#1)(1997-4#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-8#3)(2008-4#1)(2008-9#3)(2012-1#2)(2013-1#1)(2013-8#1)
that in plants##3##3##(1994-11#1)(2008-12#1)(2009-3#1)
that in practice##3##3##(1991-6#1)(2005-11#1)(2008-2#1)
that in primary##4##3##(1996-2#1)(2008-11#2)(2009-9#1)
that in rat##3##3##(1993-4#1)(1995-5#1)(1995-6#1)
that in rats##2##3##(1992-10#1)(2008-4#1)
that in recent years##3##4##(1991-12#1)(1993-6#1)(2008-5#1)
that in resting##2##3##(1992-6#1)(1997-6#1)
that in rubredoxins##2##3##(1991-11#2)
that in rural##2##3##(1996-3#1)(2008-7#1)
that in selected##4##3##(1995-4#1)(2004-10#1)(2007-8#1)(2008-10#1)
that in serum##3##3##(1990-8#1)(1994-9#1)(2008-11#1)
that in soil##2##3##(2006-3#1)(2008-10#1)
that in solution the##2##4##(2006-4#1)(2008-4#1)
that in solution##3##3##(2006-4#1)(2008-10#1)(2008-4#1)
that in some cases the##2##5##(1992-2#1)(2008-10#1)
that in some cases##4##4##(1992-2#1)(2006-9#1)(2008-10#2)
that in some##14##3##(1992-10#1)(1992-2#1)(1993-6#1)(1995-10#1)(1995-6#1)(1997-2#1)(2005-8#1)(2006-9#1)(2007-10#1)(2008-10#4)(2010-3#1)
that in spite of the##4##5##(1991-4#1)(1992-9#1)(2008-10#1)(2012-12#1)
that in spite of##6##4##(1991-4#1)(1992-9#1)(2005-8#1)(2007-8#1)(2008-10#1)(2012-12#1)
that in subjects with##2##4##(2004-11#1)(2011-2#1)
that in subjects##3##3##(1991-11#1)(2004-11#1)(2011-2#1)
that in such##3##3##(2007-11#1)(2008-12#1)(2008-3#1)
that in susceptible##2##3##(2008-10#2)
that in terms of##2##4##(1992-5#1)(2012-2#1)
that in the LEW/N rat##2##5##(1994-11#2)
that in the Netherlands##2##4##(1991-11#1)(1997-5#1)
that in the PD##2##4##(2007-10#1)(2008-7#1)
that in the absence of the##2##6##(1991-5#1)(2008-11#1)
that in the absence of##17##5##(1990-2#1)(1991-5#2)(1991-7#1)(1992-3#1)(1992-7#1)(1993-3#1)(1994-11#1)(1994-8#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-8#2)(2010-3#1)(2012-12#1)
that in the adult##3##4##(1995-12#1)(2012-12#2)
that in the blood##2##4##(1997-3#1)(2006-5#1)
that in the bulk phase##2##5##(2006-10#1)(2008-6#1)
that in the case of##7##5##(1991-2#1)(1992-12#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)
that in the case##8##4##(1991-2#1)(1992-12#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-4#1)
that in the control cells##2##5##(1990-12#1)(2008-9#1)
that in the control group##13##5##(1990-9#1)(1996-12#1)(1997-1#2)(2006-5#1)(2007-8#3)(2008-10#1)(2008-9#1)(2009-10#1)(2012-2#2)
that in the control group(p&lt##2##5##(1994-12#2)
that in the control##27##4##(1990-12#1)(1990-9#1)(1994-12#2)(1995-3#1)(1996-10#1)(1996-12#1)(1997-1#2)(2006-4#1)(2006-5#1)(2007-8#4)(2008-10#1)(2008-5#1)(2008-9#3)(2009-10#1)(2012-2#4)(2013-8#2)
that in the developing##2##4##(1994-8#1)(2008-9#1)
that in the early##2##4##(2008-10#1)(2011-12#1)
that in the first##4##4##(1990-5#1)(1992-8#1)(2008-1#1)(2013-7#1)
that in the future##5##4##(2007-11#1)(2007-7#1)(2011-2#2)(2013-8#1)
that in the general population##6##5##(2006-2#1)(2007-12#1)(2007-2#1)(2010-2#2)(2010-8#1)
that in the general##7##4##(1996-3#1)(2006-2#1)(2007-12#1)(2007-2#1)(2010-2#2)(2010-8#1)
that in the group##2##4##(2005-1#1)(2006-6#1)
that in the latter##2##4##(2006-10#1)(2008-1#1)
that in the liver##2##4##(1990-11#1)(2008-12#1)
that in the majority of##2##5##(1990-6#1)(2006-10#1)
that in the medium containing##3##5##(1996-11#1)(2008-11#2)
that in the medium##5##4##(1991-3#1)(1996-11#1)(2005-4#1)(2008-11#2)
that in the most##2##4##(1994-9#1)(2008-10#1)
that in the mouse##3##4##(1995-5#1)(1996-10#1)(2013-1#1)
that in the near future##7##5##(1990-12#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-5#1)(2009-8#1)(2011-2#1)
that in the near##8##4##(1990-12#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-5#1)(2009-8#1)(2011-2#1)(2013-1#1)
that in the nucleus##2##4##(1991-7#1)(1994-2#1)
that in the other##2##4##(2008-3#1)(2008-5#1)
that in the peripheral##2##4##(1990-4#1)(1993-3#1)
that in the postoperative state##2##5##(1997-1#2)
that in the presence of both##2##6##(1997-1#1)(2008-11#1)
that in the presence of##14##5##(1991-5#1)(1992-1#1)(1993-8#1)(1995-11#1)(1995-6#1)(1997-1#2)(2008-10#3)(2008-11#1)(2008-6#1)(2009-6#1)(2013-1#1)
that in the present##3##4##(1992-5#1)(2008-10#1)(2011-2#1)
that in the process of##2##5##(1990-5#1)(2013-1#1)
that in the same##2##4##(1994-12#1)(1995-11#1)
that in the three##2##4##(1994-8#1)(2008-10#1)
that in the vehicle controls##2##5##(2008-9#2)
that in the vehicle##5##4##(2008-9#5)
that in the wild-type and the mock-transduced cells##2##8##(2008-8#2)
that in the##321##3##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#4)(1990-3#1)(1990-4#2)(1990-5#3)(1990-6#2)(1990-7#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#5)(1991-7#3)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#2)(1992-7#2)(1992-8#2)(1993-1#1)(1993-11#2)(1993-2#1)(1993-3#3)(1993-4#1)(1993-8#3)(1994-10#1)(1994-11#4)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#2)(1995-7#1)(1995-8#2)(1996-1#1)(1996-10#4)(1996-11#1)(1996-12#1)(1996-3#2)(1996-5#2)(1996-6#1)(1996-7#3)(1997-1#9)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2004-11#1)(2004-4#1)(2005-1#1)(2005-10#1)(2005-12#1)(2005-2#1)(2005-4#1)(2006-10#6)(2006-2#2)(2006-4#2)(2006-5#3)(2006-6#2)(2006-8#1)(2006-9#2)(2007-10#2)(2007-11#6)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#7)(2007-9#2)(2008-1#7)(2008-10#20)(2008-11#11)(2008-12#3)(2008-2#8)(2008-3#3)(2008-4#2)(2008-5#9)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#10)(2009-10#2)(2009-2#2)(2009-4#1)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#1)(2010-10#3)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#2)(2010-8#3)(2011-1#2)(2011-12#2)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#6)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#7)
that in these solvents##2##4##(2008-10#2)
that in these##6##3##(1996-8#1)(2007-2#1)(2008-10#2)(2008-8#1)(2010-2#1)
that in this case##3##4##(2005-1#1)(2008-2#1)(2008-8#1)
that in this##19##3##(1990-12#1)(1990-4#1)(1993-6#1)(1996-12#1)(1996-3#1)(2005-1#1)(2006-6#2)(2007-7#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-8#1)(2009-6#1)(2013-1#2)
that in turn##12##3##(1991-9#1)(1994-11#1)(1994-12#1)(1996-4#1)(1997-4#1)(2006-2#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-2#1)
that in utero##2##3##(1996-4#1)(2011-2#1)
that in vitro synthesized##2##4##(1994-2#1)(1996-9#1)
that in vitro##22##3##(1990-5#1)(1990-7#2)(1992-11#1)(1993-1#1)(1993-12#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-2#1)(1996-9#1)(2005-8#1)(2008-10#2)(2008-11#1)(2008-5#3)(2008-9#1)(2012-12#1)
that in vivo administration of##3##5##(1995-10#2)(2010-12#1)
that in vivo the##2##4##(1990-11#1)(1993-6#1)
that in vivo##16##3##(1990-11#1)(1991-4#1)(1991-7#1)(1993-6#1)(1994-6#2)(1995-1#1)(1995-10#2)(1996-12#1)(1997-2#1)(2004-9#1)(2006-5#1)(2009-3#1)(2010-12#1)(2012-2#1)
that in water##5##3##(2008-10#3)(2008-12#1)(2008-7#1)
that in which##3##3##(1995-11#1)(2006-2#1)(2008-7#1)
that in wild type##2##4##(2008-8#1)(2008-9#1)
that in wild##3##3##(2008-12#1)(2008-8#1)(2008-9#1)
that in women who##2##4##(2011-1#1)(2011-2#1)
that in yeast##2##3##(1993-3#1)(1997-3#1)
that in young animals##2##4##(2008-7#2)
that in young##4##3##(2007-10#1)(2008-7#2)(2013-7#1)
that in##1173##2##(1990-10#3)(1990-11#6)(1990-12#5)(1990-2#6)(1990-3#4)(1990-4#4)(1990-5#10)(1990-6#4)(1990-7#6)(1990-8#7)(1990-9#2)(1991-1#3)(1991-10#3)(1991-11#7)(1991-12#4)(1991-2#3)(1991-3#4)(1991-4#2)(1991-5#8)(1991-6#5)(1991-7#7)(1991-8#3)(1991-9#2)(1992-1#4)(1992-10#3)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#5)(1992-4#2)(1992-5#6)(1992-6#3)(1992-7#4)(1992-8#7)(1992-9#5)(1993-1#4)(1993-11#5)(1993-12#3)(1993-2#6)(1993-3#7)(1993-4#2)(1993-6#4)(1993-7#2)(1993-8#8)(1993-9#5)(1994-10#2)(1994-11#11)(1994-12#10)(1994-2#9)(1994-3#6)(1994-4#1)(1994-5#4)(1994-6#7)(1994-7#1)(1994-8#11)(1994-9#5)(1995-1#6)(1995-10#7)(1995-11#5)(1995-12#11)(1995-2#8)(1995-3#2)(1995-4#2)(1995-5#7)(1995-6#9)(1995-7#4)(1995-8#4)(1995-9#2)(1996-1#2)(1996-10#7)(1996-11#2)(1996-12#8)(1996-2#2)(1996-3#8)(1996-4#5)(1996-5#9)(1996-6#3)(1996-7#7)(1996-8#2)(1996-9#5)(1997-1#13)(1997-2#7)(1997-3#4)(1997-4#8)(1997-5#2)(1997-6#4)(1997-7#10)(1997-8#6)(2004-10#1)(2004-11#3)(2004-4#2)(2004-7#1)(2004-9#1)(2005-1#2)(2005-10#5)(2005-11#7)(2005-12#1)(2005-2#1)(2005-4#8)(2005-8#4)(2006-1#1)(2006-10#18)(2006-12#2)(2006-2#8)(2006-3#1)(2006-4#5)(2006-5#6)(2006-6#8)(2006-7#1)(2006-8#1)(2006-9#5)(2007-1#1)(2007-10#7)(2007-11#12)(2007-12#23)(2007-2#6)(2007-4#3)(2007-5#1)(2007-6#5)(2007-7#9)(2007-8#19)(2007-9#10)(2008-1#10)(2008-10#91)(2008-11#40)(2008-12#9)(2008-2#20)(2008-3#16)(2008-4#13)(2008-5#28)(2008-6#5)(2008-7#22)(2008-8#26)(2008-9#29)(2009-10#6)(2009-11#4)(2009-2#9)(2009-3#4)(2009-4#6)(2009-5#1)(2009-6#5)(2009-7#2)(2009-8#6)(2009-9#3)(2010-1#1)(2010-10#5)(2010-11#2)(2010-12#6)(2010-2#9)(2010-3#6)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#4)(2011-1#15)(2011-12#3)(2011-2#21)(2011-3#1)(2012-1#12)(2012-12#13)(2012-2#18)(2012-3#12)(2013-1#23)(2013-7#6)(2013-8#14)
that in-line##2##2##(2007-12#2)
that inactivate##2##2##(1996-2#1)(1996-5#1)
that inactivated##3##2##(1994-11#1)(2006-10#1)(2008-10#1)
that inactivates the protein##2##4##(1996-4#1)(1997-6#1)
that inactivates the##4##3##(1991-8#1)(1996-4#1)(1997-6#1)(2010-4#1)
that inactivates##6##2##(1990-5#1)(1991-8#2)(1996-4#1)(1997-6#1)(2010-4#1)
that inactivation of the##3##4##(1994-11#1)(1994-8#1)(2010-11#1)
that inactivation of##6##3##(1990-6#1)(1994-11#1)(1994-8#1)(1995-3#1)(2008-4#1)(2010-11#1)
that inactivation##10##2##(1990-6#1)(1992-2#1)(1992-8#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-3#1)(2008-4#1)(2008-8#1)(2010-11#1)
that inadequate##3##2##(2006-10#1)(2008-6#1)(2012-3#1)
that inappropriate##2##2##(2007-1#1)(2007-8#1)
that inbreeding depression##2##3##(2008-8#1)(2008-9#1)
that inbreeding##3##2##(2008-8#1)(2008-9#1)(2012-3#1)
that incidence of##3##3##(1997-7#1)(2008-10#1)(2012-12#1)
that incidence##5##2##(1994-9#1)(1997-7#1)(2008-10#1)(2011-2#1)(2012-12#1)
that include a##2##3##(2008-2#1)(2008-4#1)
that include all##2##3##(2010-3#1)(2011-2#1)
that include information##2##3##(2006-10#1)(2008-3#1)
that include the##8##3##(1995-6#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2011-1#1)
that include those##2##3##(2008-10#1)(2010-6#1)
that include##87##2##(1990-11#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-11#1)(1994-8#1)(1994-9#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1997-5#1)(2006-10#3)(2006-11#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-11#5)(2007-12#3)(2007-3#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#4)(2009-11#1)(2009-12#2)(2009-9#1)(2010-3#2)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)
that included a##9##3##(1992-6#1)(1993-11#1)(1997-1#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-12#1)(2010-3#1)(2012-12#1)
that included all##3##3##(1997-8#1)(2011-2#1)(2012-3#1)
that included an##2##3##(1993-2#1)(2004-10#1)
that included components##2##3##(2008-6#1)(2010-6#1)
that included the##5##3##(1991-2#1)(2008-10#1)(2009-4#2)(2012-3#1)
that included##86##2##(1990-9#1)(1991-2#1)(1991-3#1)(1992-6#1)(1993-11#2)(1993-12#1)(1993-2#1)(1994-3#1)(1995-11#1)(1996-2#1)(1997-1#2)(1997-4#1)(1997-8#1)(2004-10#2)(2004-2#1)(2005-10#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-7#1)(2007-1#1)(2007-10#4)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#2)(2007-7#1)(2007-9#1)(2008-10#9)(2008-11#1)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-4#3)(2010-12#1)(2010-3#2)(2010-4#1)(2010-6#3)(2010-7#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#1)
that includes a##15##3##(1990-8#1)(1991-9#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-2#1)(2008-3#3)(2008-4#1)(2010-2#1)(2011-3#1)
that includes all##2##3##(2010-3#1)(2011-12#1)
that includes an##5##3##(2006-11#1)(2008-1#1)(2008-11#1)(2009-2#1)(2010-12#1)
that includes both##5##3##(1994-12#1)(2006-2#1)(2008-3#1)(2009-7#1)(2009-9#1)
that includes clinical##2##3##(2006-10#1)(2010-7#1)
that includes descriptions of##2##4##(2006-12#1)(2008-9#1)
that includes local##2##3##(2008-11#1)(2008-8#1)
that includes locality##2##3##(2007-5#2)
that includes other##2##3##(2008-1#1)(2008-3#1)
that includes residues##2##3##(1991-2#1)(1996-8#1)
that includes the effects of the##2##6##(2007-12#1)(2010-10#1)
that includes the effects of##3##5##(2007-12#1)(2008-2#1)(2010-10#1)
that includes the##28##3##(1992-9#1)(1995-10#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-12#4)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-3#1)(2009-5#1)(2010-10#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
that includes two##4##3##(2008-3#2)(2008-9#1)(2009-1#1)
that includes##140##2##(1990-4#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-9#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-1#2)(1995-10#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(2005-6#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#8)(2007-2#1)(2007-5#2)(2007-9#2)(2008-1#3)(2008-10#3)(2008-11#4)(2008-2#6)(2008-3#9)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#6)(2009-1#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#2)
that including##5##2##(2006-2#1)(2007-7#1)(2008-2#1)(2010-4#1)(2012-3#1)
that inclusion of##10##3##(1990-11#1)(1992-2#1)(1992-5#1)(1993-3#1)(1995-1#1)(1995-12#1)(2007-10#1)(2008-3#1)(2008-9#1)(2012-2#1)
that income##2##2##(1992-2#1)(2013-1#1)
that incomplete##3##2##(1992-7#1)(2007-12#1)(2008-3#1)
that incorporate a##2##3##(2008-10#1)(2010-3#1)
that incorporate the influence of##2##5##(2009-8#2)
that incorporate the##10##3##(1997-8#1)(2006-5#1)(2008-5#2)(2009-8#2)(2010-6#2)(2011-1#1)(2013-7#1)
that incorporate##39##2##(1995-8#1)(1996-2#1)(1997-8#1)(2006-5#1)(2007-11#1)(2007-7#2)(2008-10#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2009-8#2)(2010-2#1)(2010-3#1)(2010-6#3)(2010-7#1)(2010-9#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#2)
that incorporated##7##2##(2006-12#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-12#1)(2010-4#1)(2010-9#1)
that incorporates a number of##2##5##(1995-2#1)(2009-12#1)
that incorporates a##7##3##(1994-2#1)(1995-2#1)(2007-12#2)(2008-3#2)(2009-12#1)
that incorporates an additional##2##4##(2007-12#1)(2008-2#1)
that incorporates an##5##3##(1992-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-8#1)
that incorporates the##6##3##(2007-12#1)(2008-11#1)(2008-2#2)(2008-7#1)(2008-9#1)
that incorporates##46##2##(1992-2#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-8#1)(2005-7#1)(2006-6#1)(2007-12#7)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
that incorporating##4##2##(2008-10#1)(2009-2#1)(2012-3#2)
that incorporation of##8##3##(1995-3#1)(1996-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-5#1)(2010-1#1)
that increase cAMP in rat platelets##2##6##(1992-9#2)
that increase cAMP##3##3##(1990-7#1)(1992-9#2)
that increase in##3##3##(2007-10#1)(2007-2#1)(2009-7#1)
that increase risk##2##3##(2009-12#2)
that increase the likelihood of##2##5##(2008-8#1)(2012-2#1)
that increase the risk of##4##5##(2007-11#1)(2008-3#1)(2010-6#1)(2011-1#1)
that increase the##16##3##(1993-4#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-7#1)(2008-8#1)(2010-6#1)(2011-1#1)(2012-2#1)
that increase##51##2##(1990-12#2)(1990-5#2)(1990-7#1)(1991-12#1)(1991-7#1)(1992-4#1)(1992-9#2)(1993-11#1)(1993-3#2)(1993-4#1)(1994-3#1)(1995-10#1)(2005-8#2)(2006-10#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#2)(2009-7#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-2#2)(2013-1#2)
that increased expression of##4##4##(1992-3#1)(1994-8#1)(1995-3#1)(2012-1#1)
that increased food intake may##2##5##(2009-12#2)
that increased funding is##2##4##(2008-7#2)
that increased levels of##3##4##(1995-6#1)(2010-4#1)(2013-7#1)
that increased sensitivity of##2##4##(1996-6#1)(2013-1#1)
that increased skin##2##3##(1997-3#1)(2008-5#1)
that increased the##4##3##(1992-12#1)(1993-12#1)(1993-6#1)(2010-4#1)
that increased with increasing##2##4##(1997-1#1)(2008-10#1)
that increased##83##2##(1990-11#1)(1990-4#1)(1991-9#2)(1992-12#2)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-6#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-1#1)(2005-10#1)(2006-1#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#4)(2008-8#2)(2009-12#2)(2009-2#2)(2009-4#1)(2009-5#1)(2009-7#2)(2010-2#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-2#4)(2012-1#3)(2012-6#1)(2013-1#1)(2013-7#1)(2013-8#1)
that increases in##14##3##(1990-5#1)(1993-12#1)(1997-1#1)(1997-6#1)(2006-10#1)(2006-7#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#2)
that increases the##11##3##(1990-9#1)(1992-8#1)(1994-12#1)(1996-5#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)
that increases with##3##3##(1992-4#1)(2008-3#1)(2008-5#1)
that increases##42##2##(1990-5#1)(1990-9#1)(1991-6#1)(1992-4#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-12#2)(1994-5#1)(1995-2#1)(1996-5#1)(1997-1#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2010-12#1)(2010-5#1)(2011-2#2)
that increasing salinity##2##3##(2008-12#1)(2009-8#1)
that increasing the##14##3##(1995-3#1)(1995-6#1)(1997-7#1)(2006-11#1)(2007-9#1)(2008-2#1)(2008-6#1)(2008-8#2)(2008-9#2)(2011-12#1)(2012-12#1)(2012-3#1)
that increasing##39##2##(1993-6#1)(1994-11#1)(1995-3#1)(1995-6#1)(1997-7#2)(2005-10#1)(2005-4#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#2)(2008-8#5)(2008-9#3)(2009-10#1)(2009-5#2)(2009-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
that incubation in Glu or DPDPE##2##6##(1997-8#2)
that incubation of##3##3##(1991-9#1)(1994-12#1)(1995-7#1)
that incubation##7##2##(1991-9#1)(1992-12#1)(1994-12#1)(1995-7#1)(1997-8#2)(2008-8#1)
that indapamide##2##2##(1993-11#1)(2011-2#1)
that indeed##2##2##(2005-11#1)(2008-10#1)
that independent##2##2##(2008-3#1)(2010-10#1)
that independently##2##2##(2007-7#1)(2008-10#1)
that indicate a##2##3##(2009-3#1)(2009-9#1)
that indicate that the##3##4##(1991-12#1)(1995-1#1)(2008-1#1)
that indicate that##9##3##(1991-12#1)(1995-1#1)(1995-5#1)(2005-8#1)(2008-1#1)(2008-7#1)(2008-8#2)(2012-2#1)
that indicate##18##2##(1991-12#1)(1995-1#1)(1995-5#1)(2005-8#1)(2007-1#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-3#1)(2009-8#1)(2009-9#1)(2012-2#1)
that indicated that##3##3##(2007-7#1)(2008-11#1)(2008-7#1)
that indicated the##2##3##(2004-9#1)(2008-10#1)
that indicated##13##2##(1992-4#1)(1994-11#1)(1996-2#1)(2004-9#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#2)
that indicates a##2##3##(1996-5#1)(2010-5#1)
that indicates that the##2##4##(1996-1#1)(2008-8#1)
that indicates that##4##3##(1996-1#1)(1996-11#1)(2008-8#1)(2009-3#1)
that indicates the##2##3##(1993-4#1)(2006-10#1)
that indicates##12##2##(1993-4#1)(1996-1#1)(1996-11#1)(1996-5#1)(2005-11#1)(2006-10#1)(2008-1#1)(2008-2#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-5#1)
that indicators##3##2##(1996-12#1)(2009-4#2)
that indices of##2##3##(2007-9#1)(2008-5#1)
that indirect##3##2##(1990-2#1)(2008-8#1)(2008-9#1)
that individual cells##3##3##(1994-6#1)(1995-11#1)(2008-11#1)
that individual differences in##3##4##(1990-1#1)(2008-11#1)(2009-8#1)
that individual differences##5##3##(1990-1#1)(2008-11#1)(2009-8#1)(2010-2#1)(2013-8#1)
that individual##33##2##(1990-1#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-8#2)(1996-3#1)(1996-8#2)(1997-6#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-3#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-7#1)(2008-8#3)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2012-12#2)(2012-2#1)(2013-8#1)
that individual-level##2##2##(2010-10#1)(2010-4#1)
that individuals and populations##2##4##(2008-8#1)(2012-2#1)
that individuals are##4##3##(1995-2#1)(1996-2#1)(2008-8#1)(2011-2#1)
that individuals have##2##3##(2009-6#1)(2010-2#1)
that individuals who##9##3##(1993-10#1)(2007-12#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-7#1)(2011-2#1)(2012-2#1)
that individuals with##11##3##(1990-4#1)(2005-8#1)(2007-2#1)(2007-8#1)(2007-9#1)(2010-11#1)(2010-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
that individuals##47##2##(1990-4#1)(1991-12#2)(1993-10#1)(1994-2#1)(1995-2#1)(1996-2#1)(2005-8#1)(2005-9#1)(2006-12#1)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#8)(2009-12#1)(2009-6#1)(2009-7#1)(2010-11#2)(2010-2#2)(2011-2#4)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
that indomethacin##2##2##(1991-1#1)(1997-6#1)
that indoor##2##2##(2008-11#1)(2008-5#1)
that induce a##4##3##(1994-9#1)(2008-10#2)(2009-8#1)
that induce apoptosis##2##3##(2003-11#1)(2008-7#1)
that induce the desired##2##4##(1996-10#1)(2010-12#1)
that induce the##8##3##(1990-2#1)(1994-10#1)(1995-5#1)(1996-10#1)(2008-4#2)(2009-7#1)(2010-12#1)
that induce##43##2##(1990-2#1)(1990-8#1)(1991-5#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-5#1)(1996-10#1)(1997-1#1)(2003-11#1)(2006-11#1)(2006-12#2)(2006-9#2)(2007-12#1)(2007-3#1)(2008-10#5)(2008-3#3)(2008-4#4)(2008-7#2)(2008-8#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2012-12#2)
that induced and constitutive##2##4##(2008-8#2)
that induced by irradiation##2##4##(1990-1#1)(1996-5#1)
that induced by the##5##4##(1992-3#1)(1993-3#1)(1996-3#1)(2008-10#1)(2012-1#1)
that induced by##34##3##(1990-1#1)(1990-2#1)(1990-7#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#2)(1993-9#1)(1994-11#2)(1994-2#1)(1995-3#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-4#2)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-10#1)(2012-1#2)
that induced resistance is##3##4##(2008-10#3)
that induced resistance##5##3##(2008-10#5)
that induced the##2##3##(1996-2#1)(2006-12#1)
that induced##54##2##(1990-1#1)(1990-12#1)(1990-2#1)(1990-7#2)(1991-5#2)(1991-6#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#2)(1993-9#2)(1994-11#3)(1994-2#1)(1995-3#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-4#2)(1997-7#1)(2006-10#1)(2006-12#1)(2007-1#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-8#2)(2009-10#1)(2012-1#2)(2012-2#1)
that induces a##4##3##(1994-9#1)(1996-7#1)(2008-10#2)
that induces the##4##3##(1991-11#1)(2010-12#1)(2013-1#2)
that induces##32##2##(1990-11#1)(1991-11#1)(1991-2#1)(1991-7#1)(1993-12#1)(1993-4#1)(1994-11#1)(1994-8#2)(1994-9#2)(1995-8#1)(1996-7#1)(2006-9#1)(2007-1#1)(2007-12#1)(2008-10#5)(2008-4#1)(2009-8#2)(2010-12#1)(2010-3#1)(2012-12#1)(2013-1#3)(2013-8#2)
that inducible##2##2##(1996-2#1)(1997-6#1)
that induction of the##3##4##(1995-6#1)(2008-10#2)
that induction of##17##3##(1990-10#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-8#2)(1995-11#1)(1995-5#1)(1995-6#1)(1996-5#1)(1996-9#1)(2008-10#4)(2008-11#1)(2010-2#1)
that induction##19##2##(1990-10#1)(1991-10#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-8#2)(1995-11#1)(1995-5#1)(1995-6#1)(1996-5#1)(1996-9#1)(2004-1#1)(2008-10#4)(2008-11#1)(2010-2#1)
that industrial##3##2##(2008-3#1)(2008-5#1)(2013-8#1)
that industry##2##2##(2005-7#1)(2009-4#1)
that ineffective##2##2##(1994-1#1)(2008-4#1)
that inefficient##3##2##(1993-11#1)(1994-11#1)(1996-7#1)
that infants##8##2##(1991-6#1)(1992-4#1)(2005-8#1)(2007-2#2)(2008-10#1)(2010-2#1)(2012-1#1)
that infect a##3##3##(2004-11#1)(2007-2#1)(2008-4#1)
that infect the##3##3##(2005-9#1)(2008-5#1)(2013-1#1)
that infect##17##2##(2004-11#1)(2005-9#1)(2007-2#1)(2008-10#8)(2008-4#1)(2008-5#1)(2012-2#1)(2013-1#2)(2013-7#1)
that infected##2##2##(2008-10#1)(2010-10#1)
that infection of tobacco##2##4##(2008-10#1)(2012-2#1)
that infection of##4##3##(2008-10#3)(2012-2#1)
that infection with##5##3##(1996-4#1)(2006-10#1)(2007-11#1)(2008-10#1)(2011-2#1)
that infection##16##2##(1990-3#1)(1993-11#1)(1996-4#1)(2006-10#2)(2006-8#1)(2007-11#1)(2008-10#7)(2011-2#1)(2012-2#1)
that infections##3##2##(2006-8#1)(2008-10#2)
that infects##5##2##(2007-2#1)(2008-10#3)(2010-12#1)
that infer##2##2##(2008-12#1)(2009-4#1)
that infiltrate the##2##3##(1993-5#1)(2008-11#1)
that infiltration of##3##3##(2008-7#1)(2009-3#1)(2011-1#1)
that inflammation and##3##3##(1990-9#1)(1993-11#1)(2012-8#1)
that inflammation is##4##3##(1991-4#1)(2005-10#1)(2006-10#1)(2008-12#1)
that inflammation##9##2##(1990-9#1)(1991-4#1)(1993-11#1)(2005-10#1)(2006-10#1)(2007-1#1)(2008-12#1)(2008-3#1)(2012-8#1)
that inflammatory cytokines##3##3##(1995-12#1)(2006-10#1)(2009-10#1)
that inflammatory##6##2##(1995-12#1)(2006-10#2)(2008-3#1)(2009-10#1)(2010-1#1)
that influence quality of##2##4##(2008-11#1)(2011-2#1)
that influence the quantitative##2##4##(2008-10#1)(2012-3#1)
that influence the##52##3##(1991-11#1)(1991-3#1)(1992-10#1)(1992-2#1)(1993-11#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-5#1)(1997-2#1)(2005-11#1)(2005-4#1)(2006-5#1)(2007-1#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#2)(2009-4#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
that influence their##5##3##(1993-7#1)(2008-11#1)(2008-8#1)(2012-1#2)
that influence them##3##3##(2008-9#1)(2012-1#1)(2012-12#1)
that influence these##3##3##(1992-2#1)(1995-8#1)(2007-12#1)
that influence this##3##3##(2007-3#1)(2008-3#1)(2008-8#1)
that influence whether##2##3##(1992-9#1)(1993-12#1)
that influence##131##2##(1990-12#1)(1991-11#1)(1991-3#1)(1992-10#1)(1992-2#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-7#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#2)(2005-10#1)(2005-11#1)(2005-4#1)(2006-5#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#14)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#6)(2008-9#4)(2009-10#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-10#2)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#4)(2012-11#1)(2012-12#3)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#2)
that influenced the##11##3##(1990-10#2)(1991-2#1)(2005-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
that influenced##21##2##(1990-10#2)(1991-2#1)(1991-6#1)(1996-2#1)(2005-5#1)(2006-9#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-4#1)(2010-11#1)(2010-7#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
that influences##5##2##(1994-12#1)(2007-2#1)(2008-10#1)(2008-5#1)(2009-9#1)
that influenza##5##2##(2004-11#1)(2007-11#2)(2013-1#1)(2013-8#1)
that inform the##2##3##(2008-11#1)(2012-3#1)
that inform##3##2##(2008-11#1)(2009-8#1)(2012-3#1)
that information is##5##3##(1990-12#1)(1992-12#1)(1992-5#1)(1993-2#1)(1996-11#1)
that information on##2##3##(1997-3#1)(2008-10#1)
that information to##2##3##(2008-11#1)(2008-7#1)
that information##22##2##(1990-12#1)(1991-2#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-5#1)(1995-2#1)(1996-11#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-2#1)(2010-6#1)(2012-3#1)
that informed##2##2##(2007-4#1)(2012-12#1)
that informs##2##2##(2012-3#2)
that infrared##2##2##(2008-10#1)(2013-8#1)
that infusion of##2##3##(1993-6#1)(2008-5#1)
that ingested##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
that ingestion of##2##3##(1994-6#1)(2004-11#1)
that inhabit##6##2##(2007-12#1)(2007-3#2)(2008-5#1)(2011-2#1)(2013-1#1)
that inhabits the##2##3##(2007-3#1)(2008-10#1)
that inhalation of##2##3##(2008-10#1)(2008-4#1)
that inhalation##3##2##(2007-1#1)(2008-10#1)(2008-4#1)
that inhaled##6##2##(1990-5#2)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)
that inherited##2##2##(1996-2#1)(2010-12#1)
that inhibit the##16##3##(1990-7#1)(1990-8#1)(1993-6#1)(1993-8#1)(1996-10#1)(2006-9#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-5#1)(2010-12#1)(2012-12#1)(2013-7#1)
that inhibit this##2##3##(1992-2#1)(1995-8#1)
that inhibit##57##2##(1990-11#1)(1990-7#1)(1990-8#1)(1991-10#2)(1992-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-10#1)(1996-2#1)(1996-5#1)(1996-6#2)(1997-5#1)(2006-10#3)(2006-9#2)(2007-10#1)(2007-12#1)(2007-5#1)(2007-6#3)(2007-7#1)(2008-1#2)(2008-10#3)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#1)(2009-10#1)(2009-5#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-7#1)
that inhibited its##2##3##(1992-12#1)(2008-10#1)
that inhibited##10##2##(1990-3#1)(1990-5#1)(1992-12#1)(1992-7#1)(1994-3#1)(1995-8#1)(2007-6#1)(2008-10#1)(2008-9#1)(2011-1#1)
that inhibition by##3##3##(1990-5#1)(1994-12#1)(1994-8#1)
that inhibition of CTGF##2##4##(2012-12#2)
that inhibition of the##7##4##(1990-11#1)(1990-2#1)(1993-11#2)(1997-2#1)(2008-10#1)(2008-4#1)
that inhibition of##32##3##(1990-10#1)(1990-11#1)(1990-2#1)(1991-1#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-7#1)(2005-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-11#1)(2010-2#1)(2011-3#1)(2012-12#2)(2012-2#2)
that inhibition##39##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#1)(1991-1#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-1#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-7#1)(2005-10#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-11#1)(2010-2#1)(2011-3#1)(2012-12#2)(2012-2#2)
that inhibitor##3##2##(1997-4#1)(2007-11#1)(2008-5#1)
that inhibitory##4##2##(1994-2#1)(2006-9#1)(2008-11#1)(2011-2#1)
that inhibits the dissociation of GDP from and the subsequent binding of GTP to##2##14##(1991-1#1)(1991-2#1)
that inhibits the growth of##2##5##(1994-10#1)(2008-10#1)
that inhibits the##11##3##(1991-1#1)(1991-2#1)(1992-9#1)(1994-10#1)(1994-12#1)(1994-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2011-3#1)
that inhibits##31##2##(1990-7#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-8#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-11#4)(2008-10#3)(2008-11#1)(2009-8#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-7#1)
that initial##8##2##(1996-6#1)(2006-10#2)(2008-10#2)(2008-12#1)(2008-3#1)(2012-2#1)
that initially presented with##2##4##(2008-7#1)(2013-7#1)
that initially presented##3##3##(2008-2#1)(2008-7#1)(2013-7#1)
that initially was##2##3##(2007-2#1)(2008-10#1)
that initially##13##2##(1994-12#1)(2005-10#1)(2007-2#1)(2008-10#3)(2008-2#2)(2008-7#1)(2009-10#1)(2012-2#1)(2012-3#1)(2013-7#1)
that initiate and##4##3##(2007-8#1)(2008-4#1)(2008-8#1)(2010-12#1)
that initiate the##2##3##(2008-2#1)(2008-8#1)
that initiate##16##2##(1991-6#1)(1994-11#1)(1994-5#1)(1994-9#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#3)(2010-12#1)(2011-1#1)(2011-2#1)
that initiates the##4##3##(1995-8#1)(2005-12#1)(2006-12#1)(2008-10#1)
that initiates##14##2##(1990-11#1)(1991-9#1)(1993-11#1)(1995-8#1)(1997-4#1)(1997-6#1)(2005-10#1)(2005-12#1)(2006-12#1)(2006-6#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-3#1)
that initiation of##3##3##(1996-11#1)(1996-7#1)(2011-2#1)
that initiation##7##2##(1994-12#1)(1996-11#1)(1996-7#1)(1997-4#1)(2005-10#1)(2011-2#1)(2013-8#1)
that injection of##3##3##(1992-9#1)(1997-4#1)(2008-11#1)
that injection##4##2##(1992-9#1)(1997-4#1)(2007-12#1)(2008-11#1)
that injections##2##2##(1992-10#1)(1996-1#1)
that injured##3##2##(1991-3#1)(2007-11#1)(2008-4#1)
that injuries##3##2##(2006-11#1)(2009-7#1)(2012-1#1)
that injury##2##2##(1996-1#1)(2008-4#1)
that inner##2##2##(2007-10#1)(2007-12#1)
that innervate sublamina##3##3##(1990-12#3)
that innervate the##6##3##(1990-8#1)(1992-8#1)(1993-7#1)(1995-5#1)(2007-1#1)(2010-2#1)
that innervate##12##2##(1990-12#3)(1990-8#1)(1992-8#1)(1993-7#1)(1995-5#1)(1996-3#1)(2007-1#1)(2007-12#1)(2008-2#1)(2010-2#1)
that innervated##2##2##(1995-5#1)(1996-1#1)
that innervates the##2##3##(1995-5#1)(2005-9#1)
that innovation##3##2##(1991-1#1)(2008-7#1)(2013-7#1)
that innovative##2##2##(2008-12#1)(2012-3#1)
that inoculated##3##2##(2008-10#2)(2008-8#1)
that inoculation with##2##3##(2005-9#1)(2009-9#1)
that inoculation##5##2##(2005-9#1)(2006-9#1)(2008-10#1)(2008-5#1)(2009-9#1)
that inoculum##4##2##(2008-10#4)
that inorganic##2##2##(2005-11#1)(2008-10#1)
that inositol##6##2##(1990-11#1)(1990-2#1)(1992-2#1)(1992-8#1)(1993-5#2)
that inpatient##2##2##(1990-12#1)(1991-3#1)
that insect##2##2##(1992-7#1)(2008-9#1)
that insects##3##2##(1994-8#1)(2008-10#1)(2008-9#1)
that insertion of a##2##4##(1997-3#1)(1997-4#1)
that insertion of the##2##4##(1996-9#1)(2013-8#1)
that insertion of##4##3##(1996-9#1)(1997-3#1)(1997-4#1)(2013-8#1)
that insertional editing in Physarum##2##5##(1997-4#2)
that insertional editing##3##3##(1997-4#3)
that inserts##2##2##(1996-4#1)(2007-12#1)
that instability##2##2##(1994-9#1)(2007-12#1)
that institution##2##2##(1991-3#1)(2007-11#1)
that institutional##2##2##(2006-8#1)(2009-4#1)
that instruction##3##2##(2009-11#2)(2013-1#1)
that instructors##2##2##(2005-10#2)
that insulin and##2##3##(1990-8#1)(2008-4#1)
that insulin exerts##2##3##(2008-3#2)
that insulin expression##2##3##(2009-4#1)(2010-11#1)
that insulin is##2##3##(2008-3#2)
that insulin resistance##3##3##(2006-1#1)(2008-1#1)(2008-7#1)
that insulin##33##2##(1990-10#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-5#1)(1992-7#1)(1993-11#1)(1993-6#1)(1994-11#2)(1995-1#1)(1995-3#1)(1997-6#2)(1997-7#1)(2005-10#1)(2006-1#1)(2008-1#1)(2008-10#1)(2008-3#7)(2008-4#1)(2008-7#1)(2009-4#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)
that insulin-like growth##3##3##(1992-12#1)(1994-2#1)(2007-10#1)
that insurers##4##2##(1997-8#2)(2006-8#1)(2008-7#1)
that intact##6##2##(1993-6#1)(1995-5#1)(1996-12#1)(1997-3#1)(2008-12#1)(2009-6#1)
that intake is##2##3##(2008-12#2)
that intake of##3##3##(1994-2#1)(2006-8#1)(2008-7#1)
that intake##6##2##(1994-2#1)(2006-8#1)(2008-12#2)(2008-7#1)(2010-3#1)
that integrate the##2##3##(2009-12#1)(2011-2#1)
that integrate##8##2##(2007-5#1)(2008-12#1)(2008-4#1)(2009-12#1)(2009-8#1)(2011-2#2)(2013-1#1)
that integrated##5##2##(1995-10#1)(2008-10#1)(2008-4#1)(2011-1#1)(2012-2#1)
that integrates a##2##3##(2012-1#1)(2012-12#1)
that integrates complementary##2##3##(2008-3#1)(2011-1#1)
that integrates the##2##3##(2008-2#1)(2009-10#1)
that integrates##22##2##(1993-3#1)(1995-12#1)(1996-11#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#2)(2009-10#2)(2009-12#2)(2009-4#1)(2009-9#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#2)
that integration of HPV-16 DNA##2##5##(1995-2#2)
that integration of##4##3##(1995-2#2)(2008-2#1)(2008-3#1)
that integration##5##2##(1995-2#2)(2008-11#1)(2008-2#1)(2008-3#1)
that integrins and##2##3##(2006-6#1)(2013-1#1)
that integrins##5##2##(1995-2#2)(2006-6#1)(2008-7#1)(2013-1#1)
that intend##2##2##(2012-2#1)(2013-8#1)
that intensities##2##2##(2007-12#1)(2008-4#1)
that intensity##3##2##(2007-12#1)(2008-3#1)(2008-9#1)
that intensive##4##2##(2006-10#1)(2006-6#1)(2008-12#1)(2008-4#1)
that interact directly with##2##4##(1997-4#1)(2008-5#1)
that interact with the##10##4##(1991-7#1)(1992-12#1)(1992-6#1)(1992-7#1)(1994-9#1)(1995-2#1)(1995-3#1)(2009-9#1)(2012-3#1)(2013-1#1)
that interact with##26##3##(1991-12#2)(1991-7#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-4#1)(1996-8#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-9#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
that interact##31##2##(1991-12#2)(1991-7#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-4#1)(1996-8#1)(1997-4#2)(2006-2#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-9#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
that interaction of##7##3##(1990-9#1)(1991-8#1)(1994-12#1)(1995-3#2)(2008-10#1)(2009-8#1)
that interaction with the##3##4##(1995-6#1)(2008-11#1)(2011-2#1)
that interaction with##4##3##(1994-9#1)(1995-6#1)(2008-11#1)(2011-2#1)
that interaction##13##2##(1990-9#1)(1991-8#1)(1992-6#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-6#1)(2008-10#1)(2008-11#1)(2009-8#1)(2011-2#1)
that interactions among##2##3##(1991-10#1)(2008-4#1)
that interactions are##3##3##(1991-8#1)(2007-12#1)(2012-3#1)
that interactions between##6##3##(1991-3#1)(1995-8#1)(1996-1#1)(2008-10#2)(2010-12#1)
that interactions of the##4##4##(1994-8#2)(1995-10#1)(2008-10#1)
that interactions##19##2##(1991-10#1)(1991-3#1)(1991-8#1)(1994-8#2)(1995-10#1)(1995-8#1)(1996-1#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-3#1)
that interacts specifically with##2##4##(1996-8#1)(2008-4#1)
that interacts strongly with the##2##5##(1996-10#1)(2008-10#1)
that interacts with a##2##4##(1995-2#1)(1996-11#1)
that interacts with both##2##4##(1997-6#2)
that interacts with the##9##4##(1990-4#1)(1990-6#1)(1991-6#1)(1994-9#1)(1996-5#1)(1997-1#1)(1997-4#1)(2008-10#1)(2011-1#1)
that interacts with##25##3##(1990-4#1)(1990-6#2)(1991-6#1)(1991-7#2)(1992-8#2)(1994-9#2)(1995-2#1)(1995-3#1)(1995-5#2)(1996-11#1)(1996-5#1)(1997-1#1)(1997-4#2)(1997-6#2)(2008-10#1)(2009-10#1)(2010-2#1)(2011-1#1)
that interacts##31##2##(1990-4#1)(1990-6#2)(1991-6#1)(1991-7#2)(1992-8#2)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-10#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-4#2)(1997-6#2)(2008-10#2)(2008-4#1)(2009-10#1)(2009-8#1)(2010-2#1)(2011-1#1)
that interconnection##2##2##(2008-2#1)(2008-3#1)
that interfacial##4##2##(1991-5#1)(1995-5#1)(2009-11#1)(2009-3#1)
that interfere with the##6##4##(1995-12#1)(2006-10#1)(2007-9#2)(2008-1#1)(2008-9#1)
that interfere with##19##3##(1995-12#1)(1995-3#1)(1996-5#1)(1996-8#1)(2006-10#1)(2006-9#1)(2007-11#2)(2007-9#2)(2008-1#2)(2008-8#1)(2008-9#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
that interfere##21##2##(1995-12#1)(1995-3#1)(1996-5#1)(1996-8#1)(2006-10#1)(2006-9#1)(2007-11#3)(2007-9#2)(2008-1#2)(2008-10#1)(2008-8#1)(2008-9#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
that interfered with##2##3##(1993-6#1)(2008-10#1)
that interference effects##2##3##(2008-2#1)(2010-12#1)
that interference with##2##3##(1993-12#1)(2007-2#1)
that interference##10##2##(1990-5#1)(1993-12#1)(1997-5#1)(2007-2#1)(2008-10#2)(2008-2#2)(2008-5#1)(2010-12#1)
that interferes with##5##3##(1997-6#1)(2006-6#1)(2008-10#1)(2008-7#1)(2010-2#1)
that interferon##2##2##(1992-6#1)(1996-5#1)
that interleukin##2##2##(1991-8#1)(1994-8#1)
that interleukin-1##3##2##(1990-12#1)(1992-1#1)(1992-5#1)
that interleukin-2 (IL-2)##2##3##(1991-10#1)(1996-11#1)
that interleukin-2##3##2##(1991-10#1)(1993-3#1)(1996-11#1)
that intermediate##2##2##(2013-1#1)(2013-8#1)
that intermittent##2##2##(2006-10#1)(2008-8#1)
that intermolecular##2##2##(1997-1#1)(2008-4#1)
that internal##9##2##(1991-10#1)(1991-4#1)(1992-12#1)(1992-6#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-7#1)(2009-4#1)
that international##2##2##(2009-9#1)(2012-3#1)
that interpartner conflict##2##3##(2009-9#2)
that interpersonal##2##2##(2010-12#1)(2012-11#1)
that interphase##2##2##(1997-6#1)(2007-2#1)
that interspecific hybridization##2##3##(1994-3#1)(1996-3#1)
that interspecific##4##2##(1994-3#1)(1996-3#1)(2008-10#1)(2008-9#1)
that intervention##3##2##(1992-12#1)(2010-3#1)(2012-2#1)
that interventions that##2##3##(1996-7#1)(2009-6#1)
that interventions to##2##3##(1996-12#1)(2012-12#1)
that interventions##8##2##(1996-12#1)(1996-7#1)(2008-5#1)(2009-6#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)
that intestinal##4##2##(1994-8#1)(2007-11#1)(2008-8#1)(2010-12#1)
that into##2##2##(1994-7#1)(2008-2#1)
that intraarterial##2##2##(1994-11#1)(1994-3#1)
that intracellular##20##2##(1990-5#1)(1991-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-6#1)(1993-7#1)(1994-6#1)(1995-8#3)(1996-2#1)(1996-9#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-8#2)(2009-7#1)
that intracerebral##2##2##(2007-10#1)(2012-1#1)
that intracerebroventricular injection of##2##4##(1997-8#1)(2013-1#1)
that intracranial##2##2##(2007-10#1)(2008-8#1)
that intragastric##2##2##(2007-11#1)(2008-5#1)
that intramuscular##4##2##(2007-11#1)(2008-7#1)(2010-4#1)(2012-1#1)
that intranasal##2##2##(2007-11#2)
that intraoperative##4##2##(1993-10#1)(2008-7#1)(2010-7#1)(2012-12#1)
that intraperitoneal##3##2##(1992-7#1)(1995-12#1)(2007-2#1)
that intrathecal injection of##2##4##(1991-5#1)(2005-7#1)
that intrathecal##3##2##(1991-5#1)(2005-7#1)(2007-12#1)
that intrauterine##4##2##(1996-12#1)(1996-5#1)(1996-9#1)(2004-10#1)
that intravenous##7##2##(2007-2#1)(2007-7#1)(2008-1#1)(2008-4#1)(2009-6#1)(2011-2#2)
that intrinsic##3##2##(1992-8#1)(1996-11#1)(2008-5#1)
that intrinsically##3##2##(1992-1#1)(2008-11#1)(2009-8#1)
that introduce##4##2##(1993-2#1)(2006-12#1)(2010-12#1)(2010-3#1)
that introduced##3##2##(2008-10#2)(2008-11#1)
that introduces##3##2##(2008-3#1)(2011-2#1)(2012-2#1)
that introduction of##5##3##(2006-5#1)(2008-10#2)(2008-11#1)(2009-8#1)
that intron##2##2##(1995-8#1)(2008-8#1)
that introns are##2##3##(1992-6#1)(2009-5#1)
that invade##2##2##(2006-12#1)(2008-8#1)
that invaded the##2##3##(2006-12#1)(2008-10#1)
that invasive##6##2##(1991-7#1)(1994-5#1)(1996-9#1)(2006-5#1)(2008-6#1)(2008-8#1)
that investigate##3##2##(1997-8#1)(2007-1#1)(2007-10#1)
that investigated the##5##3##(1995-2#1)(2007-10#1)(2008-2#1)(2010-3#1)(2012-11#1)
that investigated##8##2##(1995-2#1)(1996-3#1)(2007-10#1)(2008-10#1)(2008-2#1)(2010-3#1)(2012-11#1)(2013-1#1)
that investigates the##3##3##(2008-2#1)(2008-7#1)(2008-8#1)
that investigates##6##2##(2008-2#2)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)
that investigations##2##2##(2006-10#1)(2013-1#1)
that investigators##5##2##(2008-10#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-8#1)
that involve a##3##3##(2005-9#1)(2008-10#1)(2010-2#1)
that involve both##2##3##(1996-12#1)(2006-6#1)
that involve large##2##3##(1991-8#1)(2007-11#1)
that involve the##16##3##(1991-5#1)(1991-6#1)(1994-11#1)(1997-3#1)(1997-4#1)(2005-11#2)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#2)
that involve##70##2##(1991-5#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-11#2)(2005-9#1)(2006-10#2)(2006-12#2)(2006-6#2)(2007-1#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-7#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#4)(2013-8#1)
that involved in##2##3##(1995-2#1)(2013-1#1)
that involved the##6##3##(2007-1#1)(2008-11#1)(2009-4#1)(2010-12#1)(2011-2#2)
that involved##27##2##(1991-5#1)(1992-7#1)(1994-3#1)(1995-2#1)(2004-3#1)(2007-1#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-4#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
that involvement##2##2##(1990-6#1)(2005-2#1)
that involves a##11##3##(1992-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)
that involves cavernosa urethra##2##4##(2013-1#2)
that involves first##2##3##(2009-2#1)(2011-1#1)
that involves multiple##2##3##(2008-4#1)(2012-3#1)
that involves the##14##3##(1994-3#1)(1994-8#1)(1995-11#1)(1997-2#1)(1997-3#1)(2004-2#1)(2005-8#1)(2007-10#1)(2007-11#1)(2008-2#2)(2010-2#1)(2013-1#2)
that involves two##2##3##(1994-3#1)(2011-2#1)
that involves##71##2##(1992-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-7#1)(1997-2#1)(1997-3#1)(2004-2#1)(2005-10#1)(2005-8#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#4)(2008-4#5)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
that involving##2##2##(2005-7#1)(2008-11#1)
that iodine##2##2##(2005-11#1)(2006-10#1)
that ion##5##2##(1993-12#1)(2005-11#1)(2007-7#1)(2008-10#1)(2013-7#1)
that ionic interactions##2##3##(1993-9#1)(2005-11#1)
that ionic##8##2##(1993-9#1)(1995-3#1)(2005-11#1)(2008-10#3)(2010-6#1)(2012-12#1)
that ionizing radiation##3##3##(1995-8#1)(2008-7#2)
that ionizing##4##2##(1995-12#1)(1995-8#1)(2008-7#2)
that ions##2##2##(2008-10#1)(2009-10#1)
that iron and##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
that iron could##2##3##(1996-2#2)
that iron##12##2##(1992-8#1)(1996-2#2)(1996-5#1)(1996-8#1)(2006-12#1)(2008-1#1)(2008-10#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
that irradiation##5##2##(1995-6#1)(2008-1#1)(2008-10#1)(2010-12#1)(2012-1#1)
that is 15##2##3##(1994-2#1)(2011-2#1)
that is 90%##3##3##(1997-4#1)(2007-11#1)(2010-11#1)
that is a direct##2##4##(2008-2#1)(2013-1#1)
that is a major##2##4##(2008-10#1)(2009-5#1)
that is a member of the##2##6##(1996-12#1)(2009-5#1)
that is a member of##3##5##(1994-3#1)(1996-12#1)(2009-5#1)
that is a much##2##4##(2008-10#1)(2008-3#1)
that is a selective##2##4##(1995-8#1)(2008-5#1)
that is a##36##3##(1990-3#1)(1991-2#1)(1991-3#1)(1993-1#1)(1994-11#1)(1994-3#1)(1995-5#1)(1995-8#2)(1996-11#2)(1996-12#1)(1996-8#1)(1997-4#1)(2005-10#1)(2006-3#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#1)(2009-12#1)(2009-4#1)(2009-5#2)(2010-5#1)(2010-8#2)(2011-2#1)(2012-12#1)(2013-1#1)
that is able to detect##2##5##(2008-3#1)(2010-11#1)
that is able to##19##4##(1995-11#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-8#3)
that is about##2##3##(1990-6#1)(1995-11#1)
that is absent from##2##4##(1995-1#1)(2008-10#1)
that is absent in##3##4##(1993-2#1)(2008-3#1)(2012-2#1)
that is absent##5##3##(1993-2#1)(1995-1#1)(2008-10#1)(2008-3#1)(2012-2#1)
that is absorbed##2##3##(2008-3#1)(2012-2#1)
that is acceptable##2##3##(1997-3#1)(2008-2#1)
that is accessible to##3##4##(2008-12#1)(2008-9#1)(2010-12#1)
that is accessible##5##3##(2008-12#1)(2008-3#1)(2008-9#1)(2010-12#1)(2010-8#1)
that is accompanied by##2##4##(1993-8#1)(2006-10#1)
that is accompanied##3##3##(1993-8#1)(2006-10#1)(2008-3#1)
that is accumulated##2##3##(1994-12#1)(2007-12#1)
that is achieved##2##3##(2008-10#1)(2011-1#1)
that is activated by##7##4##(1990-5#1)(1991-3#1)(1992-8#1)(1993-2#1)(1994-9#1)(1997-6#1)(2006-12#1)
that is activated for##2##4##(1990-5#1)(2008-6#1)
that is activated##10##3##(1990-5#2)(1991-3#1)(1992-8#1)(1993-2#1)(1994-9#1)(1997-6#1)(2006-12#1)(2008-4#1)(2008-6#1)
that is active in##2##4##(1991-10#1)(1994-2#1)
that is active##4##3##(1991-10#1)(1991-8#1)(1993-5#1)(1994-2#1)
that is added to##2##4##(2009-9#1)(2013-7#1)
that is adequate##2##3##(2008-10#1)(2010-2#1)
that is affected##3##3##(1997-6#1)(2006-2#1)(2007-12#1)
that is aimed at##2##4##(2007-9#1)(2008-7#1)
that is almost##3##3##(2008-10#1)(2008-3#1)(2010-2#1)
that is already##3##3##(1991-4#1)(2006-10#1)(2006-8#1)
that is also##13##3##(1991-3#1)(1992-5#1)(1994-6#1)(1994-8#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-3#1)(2010-2#1)(2012-2#1)
that is amenable to##3##4##(2007-4#1)(2008-10#1)(2012-2#1)
that is an##8##3##(1991-7#1)(1994-9#1)(1995-6#1)(2007-2#2)(2008-3#1)(2012-12#2)
that is analogous to the##2##5##(1994-11#1)(2010-7#1)
that is applicable to the##2##5##(2008-2#1)(2008-4#1)
that is applicable to##8##4##(2007-8#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-5#1)(2010-2#1)(2010-4#1)
that is applicable##10##3##(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#1)(2009-5#1)(2010-2#1)(2010-4#1)
that is applied to##3##4##(2007-12#1)(2008-3#1)(2009-6#1)
that is applied##4##3##(2007-12#1)(2007-8#1)(2008-3#1)(2009-6#1)
that is appropriate for##2##4##(2008-2#1)(2008-6#1)
that is appropriate##3##3##(2007-6#1)(2008-2#1)(2008-6#1)
that is approximately##4##3##(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#1)
that is as##4##3##(1994-8#1)(2008-10#1)(2008-9#2)
that is associated with significant morbidity##2##6##(2008-1#1)(2008-7#1)
that is associated with significant##3##5##(2008-1#1)(2008-7#1)(2012-11#1)
that is associated with the##4##5##(1992-11#1)(2006-10#1)(2008-2#1)(2008-3#1)
that is associated with##32##4##(1991-12#1)(1992-11#1)(1993-12#1)(1993-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-7#1)
that is associated##33##3##(1991-12#1)(1992-11#1)(1993-12#1)(1993-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-7#1)
that is at##6##3##(1997-6#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
that is attracting##2##3##(2005-7#1)(2006-5#1)
that is attributed to the##2##5##(1995-6#1)(2007-12#1)
that is attributed to##3##4##(1990-3#1)(1995-6#1)(2007-12#1)
that is available##9##3##(1992-9#1)(2007-12#1)(2008-2#2)(2008-7#2)(2008-9#1)(2010-8#1)(2013-8#1)
that is backscattered##2##3##(2008-3#2)
that is based on a##7##5##(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#2)
that is based on the use of##3##7##(2008-2#1)(2008-3#2)
that is based on the##15##5##(1992-2#1)(1992-8#1)(1993-1#1)(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#6)
that is based on##46##4##(1992-2#1)(1992-8#1)(1993-1#1)(2006-4#1)(2007-11#4)(2007-12#9)(2008-1#3)(2008-10#2)(2008-2#8)(2008-3#14)(2008-7#1)(2009-2#1)
that is based only on##2##5##(2007-8#1)(2010-5#1)
that is based##51##3##(1992-2#1)(1992-8#1)(1993-1#1)(1997-1#1)(2006-4#1)(2007-11#5)(2007-12#9)(2007-8#1)(2008-1#3)(2008-10#2)(2008-2#8)(2008-3#14)(2008-7#1)(2009-2#1)(2010-5#1)(2013-7#1)
that is becoming##3##3##(2006-1#1)(2008-1#1)(2013-8#1)
that is being developed##2##4##(2005-8#1)(2008-3#1)
that is being increasingly used##2##5##(2008-3#1)(2012-11#1)
that is being increasingly##3##4##(2006-10#1)(2008-3#1)(2012-11#1)
that is being measured##2##4##(2007-12#1)(2008-3#1)
that is being##14##3##(1996-2#1)(2005-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2012-11#1)(2013-1#1)
that is believed to be##2##5##(2005-7#1)(2008-2#1)
that is believed to##4##4##(2005-7#1)(2008-10#1)(2008-2#1)(2008-7#1)
that is best suited for##2##5##(1996-11#1)(2011-2#1)
that is best##6##3##(1996-11#1)(1997-6#2)(2010-7#1)(2011-2#2)
that is better##2##3##(1991-7#1)(2008-2#1)
that is biased##2##3##(2007-12#1)(2010-7#1)
that is both safe and##2##5##(1992-2#1)(2012-3#1)
that is both##10##3##(1992-1#1)(1992-2#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
that is broadly tunable in the##2##6##(2007-12#2)
that is built around##2##4##(1997-3#1)(2010-12#1)
that is capable of efficiently##2##5##(2008-1#1)(2012-2#1)
that is capable of making##2##5##(2007-11#1)(2007-12#1)
that is capable of measuring##2##5##(2008-2#1)(2008-3#1)
that is capable of producing##3##5##(2005-8#1)(2007-12#1)(2008-3#1)
that is capable of##40##4##(1991-9#1)(1992-3#1)(1993-12#1)(2004-11#1)(2005-8#1)(2006-10#2)(2007-11#1)(2007-12#9)(2008-1#2)(2008-11#1)(2008-2#4)(2008-3#10)(2010-1#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-7#1)
that is carried out##2##4##(2008-4#1)(2009-12#1)
that is catalytically##2##3##(2008-11#1)(2012-2#1)
that is caused by a##2##5##(1991-12#1)(1995-3#1)
that is caused by##6##4##(1991-12#1)(1995-3#1)(2008-10#1)(2008-2#2)(2008-3#1)
that is central to the##3##5##(2006-8#1)(2008-12#1)(2012-12#1)
that is central to##4##4##(2006-8#1)(2008-11#1)(2008-12#1)(2012-12#1)
that is challenging to##4##4##(2006-12#2)(2009-12#1)(2010-6#1)
that is characteristic of##9##4##(1995-3#1)(1996-10#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2009-8#1)
that is characterized as##2##4##(2008-10#1)(2011-12#1)
that is characterized by a##2##5##(2008-1#1)(2010-6#1)
that is characterized by an##2##5##(1995-12#1)(2009-7#1)
that is characterized by excessive##2##5##(2008-4#1)(2012-12#1)
that is characterized by the##2##5##(2010-6#1)(2012-12#1)
that is characterized by##18##4##(1994-5#1)(1995-12#1)(2005-10#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-6#2)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
that is characterized##22##3##(1994-5#1)(1995-12#1)(2005-10#1)(2006-10#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-6#2)(2011-1#1)(2011-12#1)(2012-12#2)(2012-2#1)(2013-1#1)
that is clearly##3##3##(1992-11#1)(2005-7#1)(2008-3#1)
that is clinically##2##3##(2008-7#1)(2008-9#1)
that is close to##3##4##(1990-12#1)(1995-1#1)(2007-12#1)
that is closely related to##2##5##(1990-11#1)(1991-9#1)
that is closely##5##3##(1990-11#1)(1991-9#1)(1997-7#1)(2008-10#1)(2009-5#1)
that is closer to the##2##5##(1990-2#2)
that is common in##3##4##(1991-11#1)(2007-11#1)(2008-5#1)
that is common to both##2##5##(2007-12#1)(2008-4#1)
that is common to##4##4##(1992-2#1)(1995-6#1)(2007-12#1)(2008-4#1)
that is common##8##3##(1991-11#1)(1992-2#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-5#1)
that is commonly used for##2##5##(2011-1#1)(2012-12#1)
that is commonly used in##2##5##(2007-12#1)(2011-2#1)
that is commonly used##5##4##(2007-12#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
that is commonly##10##3##(1991-11#1)(1993-9#1)(1996-2#1)(2007-12#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#2)(2012-12#1)
that is comparable to that##2##5##(2007-12#2)
that is comparable to##3##4##(2007-12#3)
that is comparable with that##2##5##(2008-10#2)
that is comparable with the##2##5##(2007-12#2)
that is comparable with##5##4##(2007-11#1)(2007-12#2)(2008-10#2)
that is comparable##9##3##(2007-11#1)(2007-12#5)(2008-10#2)(2008-3#1)
that is compatible with##4##4##(1993-5#1)(1997-1#1)(2007-10#1)(2010-8#1)
that is competitive with the##2##5##(2008-3#1)(2008-5#1)
that is competitive with##3##4##(1994-5#1)(2008-3#1)(2008-5#1)
that is completely##2##3##(2010-12#1)(2010-8#1)
that is composed of##5##4##(1992-2#1)(2008-5#1)(2008-6#1)(2011-1#1)(2013-7#1)
that is composed##6##3##(1992-2#1)(2008-5#1)(2008-6#1)(2010-2#1)(2011-1#1)(2013-7#1)
that is connected##2##3##(1996-4#1)(2007-9#1)
that is conserved in##5##4##(1993-11#1)(1993-9#1)(1995-6#1)(2008-8#1)(2010-10#1)
that is conserved##8##3##(1992-11#1)(1993-11#1)(1993-12#1)(1993-9#1)(1995-2#1)(1995-6#1)(2008-8#1)(2010-10#1)
that is considerably##2##3##(1997-3#1)(2012-3#1)
that is considered to be a##2##6##(1990-12#1)(2006-10#1)
that is considered to be##3##5##(1990-12#1)(2006-10#1)(2011-2#1)
that is considered to##4##4##(1990-12#1)(2006-10#1)(2007-11#1)(2011-2#1)
that is consistent with the##4##5##(1997-4#1)(2007-8#1)(2008-10#1)(2008-5#1)
that is consistent with##14##4##(1991-3#1)(1995-12#1)(1997-4#1)(2005-11#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#2)(2010-3#1)(2011-12#1)
that is consistently##2##3##(1990-5#1)(2008-11#1)
that is constructed##2##3##(2008-10#1)(2012-12#1)
that is continuously##2##3##(2008-10#1)(2009-4#1)
that is controlled by##2##4##(1990-11#1)(2012-12#1)
that is converted##3##3##(2008-3#1)(2008-8#1)(2011-2#1)
that is correlated with##2##4##(2006-7#1)(2008-10#1)
that is coupled to the##3##5##(1994-9#1)(2007-12#1)(2008-7#1)
that is coupled to##5##4##(1994-5#1)(1994-9#1)(1996-8#1)(2007-12#1)(2008-7#1)
that is coupled##6##3##(1994-5#1)(1994-9#1)(1996-8#1)(2007-12#1)(2008-2#1)(2008-7#1)
that is created##2##3##(2007-12#1)(2008-3#1)
that is critical for##5##4##(1995-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)
that is cross polarized to the##2##6##(2007-11#2)
that is crucial##2##3##(1995-8#1)(2010-12#1)
that is currently being##4##4##(2004-4#1)(2006-5#1)(2008-10#1)(2008-11#1)
that is currently in##2##4##(2008-3#1)(2012-12#1)
that is currently used##2##4##(2008-10#1)(2008-7#1)
that is currently##13##3##(1993-12#1)(1994-5#1)(2004-4#1)(2006-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-12#1)(2013-1#1)
that is delivered##3##3##(1997-2#1)(2007-8#1)(2009-8#1)
that is dependent on the##5##5##(1992-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2013-1#1)
that is dependent upon##2##4##(2008-2#1)(2010-2#1)
that is dependent##7##3##(1992-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-2#1)(2013-1#1)
that is derived from the##2##5##(1991-6#1)(2008-2#1)
that is derived from##5##4##(1991-6#1)(1996-7#1)(2006-7#1)(2008-2#1)(2013-1#1)
that is derived##7##3##(1991-6#1)(1996-7#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-2#1)(2013-1#1)
that is designed to##7##4##(1996-2#1)(2008-2#2)(2008-3#3)(2008-7#1)
that is determined##2##3##(2008-10#1)(2008-3#1)
that is different from all##2##5##(1993-12#1)(2008-10#1)
that is different from##4##4##(1993-12#1)(2008-10#2)(2008-2#1)
that is different##5##3##(1993-12#1)(2008-10#2)(2008-2#1)(2010-11#1)
that is difficult to define##2##5##(2005-8#1)(2008-9#1)
that is difficult to##7##4##(2005-8#1)(2008-9#3)(2009-4#1)(2013-1#1)(2013-8#1)
that is directed##3##3##(2008-2#1)(2010-9#1)(2013-1#1)
that is directly related to##2##5##(2007-12#1)(2007-2#1)
that is directly##11##3##(2007-12#4)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)
that is distinct from the##2##5##(1995-11#1)(2007-12#1)
that is distinct from##6##4##(1991-8#1)(1993-7#1)(1995-11#1)(2007-12#1)(2008-10#1)(2010-12#1)
that is due to a##2##5##(2007-11#1)(2008-2#1)
that is due to both##2##5##(2007-12#1)(2008-3#1)
that is due to depolarization##2##5##(2007-12#1)(2008-2#1)
that is due to the difference in##2##7##(2007-11#1)(2008-3#1)
that is due to the##31##5##(1996-5#1)(2005-10#1)(2007-11#5)(2007-12#6)(2008-2#7)(2008-3#11)
that is due to##87##4##(1993-3#1)(1996-5#1)(2005-10#1)(2007-11#11)(2007-12#16)(2008-1#2)(2008-2#26)(2008-3#29)
that is due##88##3##(1993-3#1)(1996-5#1)(2005-10#1)(2007-11#11)(2007-12#17)(2008-1#2)(2008-2#26)(2008-3#29)
that is dynamic##2##3##(2006-2#2)
that is easily##4##3##(2007-11#1)(2007-8#1)(2008-10#2)
that is easy to##3##4##(2008-2#1)(2012-1#1)(2012-2#1)
that is effective in##2##4##(1993-12#1)(2009-11#1)
that is effective##5##3##(1993-12#1)(1996-7#1)(2006-10#1)(2008-10#1)(2009-11#1)
that is efficacious##2##3##(2008-7#1)(2012-2#1)
that is either##4##3##(2005-3#1)(2007-11#1)(2008-7#1)(2011-12#1)
that is encoded by the##2##5##(1992-5#1)(1993-2#1)
that is encoded by##4##4##(1992-5#3)(1993-2#1)
that is encoded##5##3##(1992-5#3)(1993-2#1)(2008-3#1)
that is endowed with the##2##5##(2008-4#1)(2008-8#1)
that is endowed with##3##4##(1997-2#1)(2008-4#1)(2008-8#1)
that is equivalent to the##2##5##(2007-11#1)(2007-12#1)
that is especially suitable for##2##5##(2008-3#2)
that is especially##4##3##(2008-2#1)(2008-3#2)(2009-6#1)
that is essential for signaling##2##5##(1994-3#1)(1997-6#1)
that is essential for the##3##5##(1996-8#1)(1997-4#1)(2010-7#1)
that is essential for##16##4##(1990-6#1)(1992-1#1)(1994-11#2)(1994-3#1)(1994-5#1)(1995-2#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-6#1)(2007-10#1)(2008-10#1)(2010-10#1)(2010-7#1)(2011-1#1)
that is essential to##2##4##(2008-5#1)(2012-3#1)
that is essential##19##3##(1990-6#1)(1992-1#1)(1994-11#2)(1994-3#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-6#1)(2007-10#1)(2008-10#1)(2008-5#1)(2010-10#1)(2010-7#1)(2011-1#1)(2012-3#1)
that is evolutionarily##2##3##(1994-3#1)(2008-8#1)
that is excited##2##3##(2008-2#1)(2008-3#1)
that is exclusively##2##3##(1996-5#1)(2012-2#1)
that is exhibited##2##3##(1995-11#1)(2008-4#1)
that is expected to##2##4##(2007-7#1)(2007-8#1)
that is expected##4##3##(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#1)
that is expressed at##2##4##(1990-10#1)(1991-9#1)
that is expressed by##2##4##(2008-1#1)(2012-12#1)
that is expressed in both##2##5##(1995-11#1)(1997-2#1)
that is expressed in the##2##5##(1993-3#1)(1997-7#1)
that is expressed in##9##4##(1991-6#1)(1993-3#1)(1994-9#1)(1995-11#1)(1997-2#1)(1997-7#2)(2008-4#1)(2011-12#1)
that is expressed on the##2##5##(1994-8#1)(2008-5#1)
that is expressed on##3##4##(1992-7#1)(1994-8#1)(2008-5#1)
that is expressed##22##3##(1990-10#1)(1990-11#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-7#1)(1993-12#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1996-4#1)(1997-2#1)(1997-7#2)(2007-5#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-12#1)(2012-12#1)
that is extremely sensitive to##2##5##(1990-3#1)(2009-5#1)
that is extremely##3##3##(1990-3#1)(2008-10#1)(2009-5#1)
that is far##3##3##(1991-3#1)(1995-5#1)(2006-7#1)
that is fed##2##3##(2007-12#1)(2009-4#1)
that is followed by##2##4##(1996-4#1)(2006-2#1)
that is formed in the##2##5##(1992-6#1)(1994-5#1)
that is formed##6##3##(1992-6#1)(1994-5#1)(2008-10#2)(2008-2#2)
that is found in##6##4##(1994-12#1)(1995-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-12#1)
that is found##8##3##(1990-8#1)(1994-12#1)(1995-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-12#1)
that is free from##2##4##(1991-12#1)(2007-12#1)
that is free##3##3##(1991-12#1)(2007-12#1)(2008-3#1)
that is frequently used##2##4##(2008-3#1)(2008-4#1)
that is frequently##7##3##(2005-12#1)(2007-3#1)(2008-3#2)(2008-4#1)(2008-5#1)(2013-1#1)
that is fully##2##3##(2006-6#1)(2007-11#1)
that is functionally##3##3##(1995-5#1)(2008-11#1)(2009-8#1)
that is further##2##3##(2008-10#1)(2008-4#1)
that is furthermore marked by H3K9me2##2##6##(2012-12#2)
that is generally##7##3##(1991-3#1)(2007-11#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
that is given by the##2##5##(2008-3#1)(2010-10#1)
that is given##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2010-10#1)
that is going to##2##4##(2008-7#1)(2011-2#1)
that is greater than##4##4##(1991-5#1)(1993-11#1)(2006-2#1)(2007-12#1)
that is greater##5##3##(1991-5#1)(1993-11#1)(2006-2#1)(2007-12#1)(2008-2#1)
that is highly conserved##4##4##(1995-3#1)(1997-1#1)(2008-4#1)(2012-2#1)
that is highly enriched in##2##5##(2008-4#1)(2008-7#1)
that is highly expressed in##4##5##(1994-12#1)(1994-6#1)(1996-8#1)(2011-2#1)
that is highly homologous to##2##5##(1991-7#1)(1994-2#1)
that is highly selective to##2##5##(2008-10#2)
that is highly selective##3##4##(2008-10#3)
that is highly##29##3##(1991-7#1)(1992-11#1)(1992-12#1)(1992-9#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-3#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-4#1)(2004-3#1)(2006-11#1)(2007-12#2)(2008-10#3)(2008-4#3)(2008-5#1)(2008-7#1)(2009-7#1)(2011-12#1)(2011-2#1)(2012-2#1)
that is homologous to##6##4##(1990-11#1)(1993-3#1)(1995-1#1)(1995-3#1)(1995-6#1)(1997-7#1)
that is identical to##3##4##(1996-4#1)(2008-10#1)(2008-4#1)
that is imaged onto##2##4##(2007-12#1)(2008-2#1)
that is immediately##2##3##(1994-12#1)(1997-4#1)
that is immunoreactive##2##3##(1990-7#1)(1992-4#1)
that is implemented##4##3##(1993-2#1)(2008-2#1)(2008-3#2)
that is important for the##2##5##(2010-2#1)(2013-1#1)
that is important for##4##4##(1995-6#1)(1996-5#1)(2010-2#1)(2013-1#1)
that is important in the##3##5##(1994-2#1)(1995-2#1)(2007-2#1)
that is important in##5##4##(1991-11#1)(1994-2#1)(1995-2#1)(2007-2#1)(2013-1#1)
that is important to##3##4##(1992-7#1)(1994-2#1)(2009-11#1)
that is important##12##3##(1991-11#1)(1992-7#1)(1994-2#2)(1995-2#1)(1995-6#1)(1996-5#1)(2007-2#1)(2009-11#1)(2010-2#1)(2013-1#2)
that is in accordance with##2##5##(1997-7#1)(2008-2#1)
that is in agreement with the##2##6##(1990-3#1)(2006-10#1)
that is in agreement with##4##5##(1990-3#1)(1993-3#1)(2006-10#1)(2007-12#1)
that is in contact with##2##5##(1994-5#1)(2005-11#1)
that is in the##3##4##(1995-8#1)(2008-2#2)
that is in##17##3##(1990-3#1)(1993-3#1)(1994-5#1)(1995-8#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-2#4)(2008-5#1)(2012-12#1)(2012-2#1)
that is incident upon a##3##5##(2007-11#1)(2007-12#2)
that is incident upon##5##4##(2007-11#1)(2007-12#4)
that is incident##6##3##(2007-11#1)(2007-12#4)(2008-3#1)
that is increased in##2##4##(1990-11#1)(1995-12#1)
that is increased##3##3##(1990-11#1)(1995-12#1)(2008-12#1)
that is increasingly##8##3##(1996-2#1)(1997-1#1)(2004-11#1)(2006-10#1)(2006-2#1)(2007-2#1)(2008-2#1)(2013-1#1)
that is independent of the input##2##6##(2007-12#2)
that is independent of the##11##5##(1991-2#1)(1994-12#1)(1997-4#1)(2005-8#1)(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)(2008-8#1)
that is independent of##16##4##(1991-2#1)(1994-12#1)(1995-2#1)(1996-5#1)(1997-4#1)(2005-10#1)(2005-8#1)(2007-11#1)(2007-12#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-1#1)
that is independent##17##3##(1990-7#1)(1991-2#1)(1994-12#1)(1995-2#1)(1996-5#1)(1997-4#1)(2005-10#1)(2005-8#1)(2007-11#1)(2007-12#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-1#1)
that is indistinguishable from##4##4##(1993-12#1)(2008-7#1)(2012-12#2)
that is induced by##6##4##(1990-11#2)(2007-12#1)(2008-11#1)(2008-2#1)(2010-3#1)
that is induced in##2##4##(1995-5#1)(1996-5#1)
that is induced##9##3##(1990-11#2)(1993-4#1)(1995-5#1)(1996-5#1)(2007-12#1)(2008-11#1)(2008-2#1)(2010-3#1)
that is inducible##2##3##(1991-5#1)(1995-2#1)
that is influenced##2##3##(2008-10#1)(2008-5#1)
that is inherent in the##3##5##(2007-12#1)(2008-3#2)
that is inherent in##6##4##(2007-11#1)(2007-12#1)(2008-3#2)(2011-2#1)(2012-3#1)
that is initiated by##2##4##(1994-5#1)(1996-9#1)
that is initiated##6##3##(1990-5#2)(1994-5#1)(1996-9#1)(2006-10#1)(2006-3#1)
that is insensitive to the##2##5##(2008-2#1)(2008-8#1)
that is insensitive to##5##4##(2008-2#3)(2008-8#2)
that is integrated##2##3##(2007-12#1)(2008-2#1)
that is intended to##5##4##(2008-3#1)(2008-7#1)(2012-1#1)(2013-1#2)
that is invariant##3##3##(2007-12#1)(2008-3#2)
that is involved in the correct##2##6##(2007-4#1)(2009-10#1)
that is involved in the##11##5##(1990-6#1)(1991-11#1)(1992-6#1)(1994-9#1)(1995-8#1)(2007-11#1)(2007-4#1)(2007-9#1)(2009-10#2)(2013-8#1)
that is involved in##24##4##(1990-6#1)(1991-11#1)(1992-6#1)(1994-9#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-8#1)(1997-1#2)(1997-6#1)(1997-8#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-5#1)(2008-7#1)(2009-10#2)(2009-8#1)(2010-11#1)(2013-8#1)
that is involved##26##3##(1990-6#1)(1991-11#1)(1992-6#1)(1994-9#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-8#1)(1997-1#2)(1997-6#1)(1997-8#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-10#2)(2009-8#1)(2010-11#1)(2012-3#1)(2013-8#1)
that is known to be##4##5##(1990-8#1)(1996-2#1)(1997-8#1)(2008-4#1)
that is known to##8##4##(1990-8#1)(1996-2#2)(1997-7#1)(1997-8#1)(2008-3#1)(2008-4#1)(2008-5#1)
that is known##9##3##(1990-8#1)(1996-2#2)(1997-7#1)(1997-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)
that is largely##3##3##(1994-5#1)(1997-3#1)(2011-1#1)
that is less harmful##2##4##(2008-4#1)(2013-8#1)
that is less than the##3##5##(2007-11#1)(2007-12#2)
that is less##8##3##(1995-1#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-4#1)(2013-8#1)
that is likely to be a##2##6##(1993-2#1)(1997-2#1)
that is likely to be involved in##4##7##(1991-7#1)(1996-5#1)(2008-7#1)(2010-10#1)
that is likely to be##11##5##(1991-7#1)(1993-2#1)(1994-8#1)(1995-5#1)(1996-5#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-7#1)(2010-10#1)(2012-1#1)
that is likely to##17##4##(1990-11#1)(1991-7#1)(1993-2#1)(1994-8#1)(1995-5#1)(1996-5#1)(1997-2#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-7#2)(2009-5#1)(2010-10#1)(2012-1#1)(2012-3#1)
that is likely##18##3##(1990-11#1)(1991-7#1)(1993-2#1)(1994-8#1)(1995-5#1)(1996-5#1)(1997-2#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-12#1)(2008-7#2)(2009-5#1)(2010-10#1)(2012-1#1)(2012-3#1)
that is limited##2##3##(1994-11#1)(2008-5#1)
that is linear##2##3##(2005-10#1)(2008-3#1)
that is linearly proportional to##3##5##(2007-11#1)(2008-2#1)(2011-2#1)
that is linked to##3##4##(1994-12#1)(2008-5#1)(2010-10#1)
that is linked##4##3##(1994-12#1)(1997-7#1)(2008-5#1)(2010-10#1)
that is localized##2##3##(1995-8#1)(2012-2#1)
that is located in the##2##5##(1995-11#1)(2008-5#1)
that is located##7##3##(1995-11#1)(1997-2#2)(2007-11#1)(2008-5#1)(2009-8#1)(2011-2#1)
that is made##3##3##(2006-2#1)(2008-3#2)
that is maintained##4##3##(1990-7#1)(1995-2#1)(2007-12#1)(2008-1#1)
that is measured at##2##4##(2008-10#1)(2008-3#1)
that is measured in##2##4##(2008-9#1)(2013-1#1)
that is measured##6##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2013-1#1)
that is mediated by##6##4##(1990-5#1)(1992-3#1)(1995-1#1)(1996-10#1)(2007-5#1)(2012-2#1)
that is modulated##3##3##(1995-12#1)(2007-12#2)
that is more consistent with##2##5##(2004-12#1)(2009-12#1)
that is more than##3##4##(1996-9#1)(2007-8#1)(2008-2#1)
that is more##19##3##(1991-7#1)(1996-9#1)(1997-2#1)(2004-12#1)(2007-8#2)(2008-10#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-9#2)(2009-12#1)(2010-5#1)(2013-1#2)
that is most important for##2##5##(1996-11#1)(2008-10#1)
that is most important##3##4##(1994-3#1)(1996-11#1)(2008-10#1)
that is most##10##3##(1994-3#1)(1996-11#2)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2013-8#1)
that is much##6##3##(1991-5#1)(1993-11#1)(2005-9#1)(2008-3#1)(2011-2#1)(2012-12#1)
that is naturally##2##3##(2007-12#1)(2008-5#1)
that is nearly##2##3##(2008-10#1)(2008-3#1)
that is necessary for##7##4##(1997-2#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-3#1)(2012-12#1)(2012-3#1)
that is necessary to##4##4##(1997-2#1)(2008-2#1)(2011-2#1)(2012-2#1)
that is necessary##12##3##(1997-2#2)(2006-12#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
that is needed for##2##4##(1995-6#1)(1997-6#1)
that is needed to##2##4##(2008-10#1)(2008-3#1)
that is needed##6##3##(1993-6#1)(1994-1#1)(1995-6#1)(1997-6#1)(2008-10#1)(2008-3#1)
that is no##2##3##(1991-2#1)(1992-12#1)
that is non-invasive##2##3##(1997-6#1)(2013-8#1)
that is normally induced##2##4##(1997-4#1)(2012-12#1)
that is normally##7##3##(1991-12#1)(1993-1#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-3#1)(2012-12#1)
that is not absorbed##2##4##(2008-3#2)
that is not associated with##3##5##(1992-6#1)(2006-10#1)(2008-4#1)
that is not dependent##2##4##(1993-7#1)(2008-7#1)
that is not observed in##2##5##(1996-2#1)(2007-11#1)
that is not predicted by##2##5##(1996-12#1)(2012-2#1)
that is not present in the##2##6##(1992-2#1)(2008-7#1)
that is not recognized##2##4##(2006-9#1)(2011-2#1)
that is not restricted to##2##5##(1990-6#1)(1991-1#1)
that is not yet##2##4##(1997-6#1)(2006-10#1)
that is not##77##3##(1990-5#1)(1990-6#1)(1991-1#2)(1991-7#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-3#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-5#1)(1995-1#1)(1995-5#1)(1996-10#1)(1996-12#2)(1996-2#1)(1997-6#1)(2005-8#1)(2006-10#6)(2006-12#1)(2006-5#2)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-2#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
that is now available##2##4##(1992-12#1)(2008-2#1)
that is now##4##3##(1992-12#1)(2006-4#1)(2006-5#1)(2008-2#1)
that is observed##5##3##(1990-4#1)(1991-2#1)(1993-8#1)(1996-5#1)(2010-5#1)
that is obtained with##2##4##(2008-2#1)(2008-4#1)
that is obtained##6##3##(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#2)(2008-4#1)
that is of##2##3##(2005-7#1)(2008-2#1)
that is offered##2##3##(2007-11#1)(2010-1#1)
that is often a##2##4##(2007-2#1)(2007-9#1)
that is often associated with##4##5##(2006-9#1)(2007-12#1)(2008-4#1)(2009-9#1)
that is often encountered in##2##5##(2009-5#1)(2010-12#1)
that is often seen in##2##5##(2007-12#1)(2010-7#1)
that is often used##2##4##(2007-12#1)(2012-3#1)
that is often##33##3##(1994-3#1)(1996-2#1)(1996-7#1)(2006-8#1)(2006-9#1)(2007-12#3)(2007-2#2)(2007-9#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
that is one##4##3##(1997-4#1)(2006-2#1)(2007-12#1)(2008-2#1)
that is only expressed in##2##5##(1992-12#1)(2012-12#1)
that is only##12##3##(1990-8#1)(1992-12#1)(1995-3#1)(1996-5#1)(1997-4#1)(1997-8#1)(1997-9#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-4#1)(2012-12#1)
that is open to the##2##5##(2007-10#1)(2008-3#1)
that is open to##3##4##(1995-5#1)(2007-10#1)(2008-3#1)
that is open##5##3##(1992-5#1)(1995-5#1)(2007-10#1)(2008-3#1)(2008-7#1)
that is optically##2##3##(2007-12#1)(2008-3#1)
that is optimal for the##2##5##(2008-6#1)(2008-8#1)
that is optimal for##3##4##(2008-4#1)(2008-6#1)(2008-8#1)
that is part of the##3##5##(1996-11#1)(2009-11#1)(2012-2#1)
that is part of##4##4##(1990-4#1)(1996-11#1)(2009-11#1)(2012-2#1)
that is passed##2##3##(2006-5#1)(2008-2#1)
that is passively mode locked by##2##6##(2007-12#2)
that is passively##3##3##(2007-12#3)
that is performed##4##3##(2007-12#1)(2007-7#1)(2008-4#1)(2010-2#1)
that is phase##3##3##(2007-12#3)
that is poised##2##3##(2008-4#1)(2013-8#1)
that is poorly##2##3##(2005-7#1)(2008-10#1)
that is positive##2##3##(2008-10#1)(2009-6#1)
that is possible in##2##4##(2004-1#1)(2007-12#1)
that is possible with##2##4##(2008-2#1)(2008-3#1)
that is possible##5##3##(1995-5#1)(2004-1#1)(2007-12#1)(2008-2#1)(2008-3#1)
that is potentially##3##3##(2007-12#1)(2008-4#1)(2012-2#1)
that is predicted##3##3##(1993-12#1)(2008-2#1)(2008-3#1)
that is predictive##2##3##(2012-3#1)(2013-8#1)
that is present both##2##4##(1994-12#1)(1995-6#1)
that is present in the##3##5##(1994-5#1)(2006-1#1)(2008-3#1)
that is present in##9##4##(1991-11#1)(1991-9#1)(1992-4#1)(1994-5#1)(1997-3#1)(1997-4#1)(2006-1#1)(2008-3#1)(2011-2#1)
that is present##13##3##(1991-11#1)(1991-9#1)(1992-4#1)(1994-12#1)(1994-5#1)(1995-6#1)(1997-3#1)(1997-4#1)(2006-1#1)(2008-10#1)(2008-3#1)(2009-4#1)(2011-2#1)
that is presented##2##3##(2005-10#1)(2007-10#1)
that is presumably##3##3##(1993-6#1)(1997-7#1)(2009-11#1)
that is primarily##2##3##(1990-12#1)(2009-10#1)
that is produced by a##2##5##(1992-12#1)(2008-3#1)
that is produced by##5##4##(1992-12#1)(2007-11#1)(2008-2#1)(2008-3#2)
that is produced##9##3##(1990-8#1)(1992-12#1)(2007-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)
that is proportional to the##2##5##(2008-3#2)
that is proportional to##3##4##(2007-12#1)(2008-3#2)
that is pumped by a##2##5##(2007-11#1)(2008-1#1)
that is pumped by##3##4##(2007-11#1)(2008-1#2)
that is quite common in##2##5##(1995-3#1)(2008-3#1)
that is quite##4##3##(1995-3#1)(2007-11#1)(2007-12#1)(2008-3#1)
that is rapidly converted##2##4##(1996-8#1)(2008-5#1)
that is rapidly##4##3##(1994-12#1)(1996-8#1)(2008-5#1)(2013-1#1)
that is rarely found in##2##5##(2008-5#2)
that is rarely##3##3##(2008-5#2)(2011-2#1)
that is readily##3##3##(2007-11#1)(2007-12#1)(2007-4#1)
that is recognized by##5##4##(1992-11#1)(1992-12#1)(1993-11#1)(2006-10#1)(2008-11#1)
that is recognized##6##3##(1992-11#1)(1992-12#1)(1993-11#1)(1994-8#1)(2006-10#1)(2008-11#1)
that is recommended##2##3##(2008-3#1)(2008-4#1)
that is recorded##3##3##(2008-2#2)(2008-3#1)
that is reduced##2##3##(2008-1#1)(2008-10#1)
that is reflected in##2##4##(2006-7#1)(2007-11#1)
that is reflected##5##3##(2006-7#1)(2007-11#1)(2008-3#1)(2009-5#1)(2010-8#1)
that is regulated by##3##4##(2006-10#1)(2007-12#1)(2008-2#1)
that is regulated##5##3##(2006-10#1)(2007-12#1)(2008-1#2)(2008-2#1)
that is related to the##4##5##(2007-12#1)(2008-3#1)(2008-4#1)(2012-12#1)
that is related to##9##4##(1990-8#1)(2006-5#1)(2007-12#1)(2008-12#1)(2008-3#2)(2008-4#2)(2012-12#1)
that is relatively##5##3##(1994-9#1)(2008-10#1)(2008-3#1)(2010-12#1)(2010-3#1)
that is released##4##3##(1990-12#1)(1997-2#1)(2009-10#1)(2010-4#1)
that is relevant to##2##4##(2008-3#1)(2009-10#1)
that is relevant##3##3##(2008-3#2)(2009-10#1)
that is removed##4##3##(1992-2#1)(1994-12#1)(1997-6#1)(1997-7#1)
that is repeatedly##2##3##(2007-12#1)(2010-8#1)
that is required for T-cell##2##5##(1994-3#1)(2013-7#1)
that is required for the##7##5##(1990-2#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-9#1)(2008-9#1)
that is required for##30##4##(1990-10#1)(1990-2#1)(1991-12#1)(1991-7#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-3#2)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-11#1)(1996-9#1)(1997-5#1)(2005-10#1)(2008-3#2)(2008-9#2)(2009-10#2)(2009-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#1)
that is required in##3##4##(1993-11#1)(2007-12#1)(2011-2#1)
that is required is##2##4##(2007-8#1)(2008-3#1)
that is required to##4##4##(1995-11#1)(1997-4#1)(2008-5#1)(2009-3#1)
that is required##43##3##(1990-10#1)(1990-2#1)(1991-12#1)(1991-7#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-3#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-11#1)(1996-9#1)(1997-4#1)(1997-5#1)(2005-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-3#4)(2008-5#1)(2008-9#2)(2009-10#2)(2009-3#1)(2009-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
that is resistant to##2##4##(1993-8#1)(2005-8#1)
that is responsible for a##2##5##(2005-7#1)(2008-1#1)
that is responsible for information##2##5##(2008-3#1)(2011-1#1)
that is responsible for the##4##5##(1992-12#1)(1997-8#1)(2008-3#1)(2008-5#1)
that is responsible for##14##4##(1991-12#1)(1991-5#1)(1992-12#1)(1997-1#1)(1997-8#1)(2004-11#1)(2005-7#1)(2007-12#1)(2008-1#1)(2008-3#3)(2008-5#1)(2011-1#1)
that is responsive to##2##4##(1997-2#1)(2008-9#1)
that is responsive##3##3##(1997-2#1)(2006-2#1)(2008-9#1)
that is roughly##2##3##(1996-4#1)(1997-7#1)
that is secreted##2##3##(2007-11#1)(2010-10#1)
that is seen in the##2##5##(1995-9#1)(2012-3#1)
that is seen in##3##4##(1995-9#1)(2006-10#1)(2012-3#1)
that is seen with##2##4##(1992-4#1)(2007-12#1)
that is seen##9##3##(1992-4#1)(1995-9#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-8#1)(2012-3#1)(2013-1#2)
that is selectively##3##3##(1994-3#1)(1997-7#1)(2008-2#1)
that is sensitive to##3##4##(1992-2#1)(1995-10#1)(1995-11#1)
that is separated from##2##4##(2006-8#1)(2011-2#1)
that is shared by all##3##5##(1991-1#1)(1997-3#1)(2008-10#1)
that is shared by##4##4##(1991-1#1)(1996-5#1)(1997-3#1)(2008-10#1)
that is similar in##3##4##(1990-5#1)(2008-11#1)(2008-7#1)
that is similar to that##4##5##(1994-9#1)(1995-2#1)(1997-2#1)(2012-3#1)
that is similar to the##5##5##(1997-4#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-6#1)
that is similar to##15##4##(1991-7#1)(1994-9#1)(1995-2#1)(1995-8#1)(1997-2#1)(1997-4#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2012-3#1)
that is similar##19##3##(1990-5#1)(1991-7#1)(1994-9#1)(1995-2#1)(1995-8#1)(1997-2#1)(1997-4#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-3#1)
that is simultaneously##2##3##(2007-12#1)(2007-9#1)
that is slightly##2##3##(2008-3#1)(2012-3#1)
that is smaller than##3##4##(1995-10#1)(1996-6#1)(2013-1#1)
that is sometimes##2##3##(1997-4#1)(2008-10#1)
that is spatially##2##3##(2007-12#1)(2009-5#1)
that is specific for the##3##5##(1996-1#1)(2008-10#1)(2011-1#1)
that is specific for##4##4##(1996-1#1)(2008-10#1)(2008-4#1)(2011-1#1)
that is specific to the##2##5##(1997-8#1)(2007-11#1)
that is specific to##3##4##(1997-8#1)(2007-11#1)(2008-10#1)
that is specific##7##3##(1996-1#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-4#1)(2011-1#1)
that is specifically##5##3##(1992-5#1)(1993-3#1)(1994-3#1)(2005-11#1)(2012-3#1)
that is stabilized by##2##4##(2007-12#2)
that is stable##3##3##(2008-2#1)(2011-2#1)(2013-8#1)
that is still##7##3##(1991-5#1)(1994-1#1)(1995-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2012-3#1)
that is stimulated by##2##4##(1990-11#1)(2008-10#1)
that is strongly##5##3##(1993-2#1)(1994-12#1)(2007-11#1)(2009-5#1)(2012-2#1)
that is structurally related to##2##5##(2005-8#1)(2007-8#1)
that is structurally##4##3##(1990-11#1)(1994-8#1)(2005-8#1)(2007-8#1)
that is subject to##3##4##(2006-11#1)(2007-2#1)(2008-3#1)
that is subsequently##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-1#1)
that is sufficient##2##3##(1991-5#1)(2006-9#1)
that is suggestive of##3##4##(2008-4#1)(2008-7#1)(2011-2#1)
that is suitable for##14##4##(2006-12#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#4)(2010-8#1)(2011-1#1)(2012-12#1)
that is superior##2##3##(1995-3#1)(2008-3#1)
that is supported by##3##4##(2013-1#2)(2013-7#1)
that is supported##4##3##(2008-10#1)(2013-1#2)(2013-7#1)
that is surrounded by##2##4##(1994-12#1)(2007-12#1)
that is surrounded##3##3##(1994-12#1)(2007-12#2)
that is synthesized by##2##4##(2008-4#1)(2008-9#1)
that is synthesized##3##3##(1996-3#1)(2008-4#1)(2008-9#1)
that is taken##2##3##(2011-2#1)(2012-2#1)
that is taking##2##3##(1997-3#1)(2008-6#1)
that is the most##2##4##(1991-6#1)(2012-2#1)
that is the question##4##4##(1994-3#1)(1996-1#1)(2006-8#1)(2008-10#1)
that is the reverse##2##4##(2007-11#1)(2008-9#1)
that is the##37##3##(1990-3#1)(1991-12#2)(1991-6#2)(1994-3#2)(1995-10#1)(1995-3#1)(1996-1#1)(1997-2#1)(1997-7#1)(2005-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-9#1)(2009-10#1)(2009-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
that is then##5##3##(2007-11#2)(2008-10#1)(2008-2#1)(2008-8#1)
that is thought to be##4##5##(1991-2#1)(2008-11#1)(2008-4#1)(2012-2#1)
that is thought to##7##4##(1991-2#1)(1992-8#1)(1994-12#1)(2008-11#1)(2008-4#1)(2008-9#1)(2012-2#1)
that is to##3##3##(1993-5#1)(2008-7#1)(2010-8#1)
that is too##2##3##(1991-7#1)(1996-5#1)
that is transferred##2##3##(2007-12#1)(2008-9#1)
that is transmitted##3##3##(2008-10#1)(2008-8#1)(2009-8#1)
that is treated##4##3##(2005-11#1)(2006-10#2)(2011-1#1)
that is tunable##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
that is typical for##2##4##(2006-4#1)(2008-2#1)
that is typical of##3##4##(2007-11#1)(2008-2#1)(2010-9#1)
that is typical##5##3##(2006-4#1)(2007-11#1)(2008-2#2)(2010-9#1)
that is ubiquitously##2##3##(2009-10#1)(2011-2#1)
that is unable to##2##4##(1994-9#1)(2008-5#1)
that is uncommon##2##3##(1994-11#1)(2010-10#1)
that is uniformly##2##3##(2008-3#1)(2010-6#1)
that is unique to the##2##5##(2008-1#1)(2008-7#1)
that is unique to##3##4##(1996-7#1)(2008-1#1)(2008-7#1)
that is unique##6##3##(1996-7#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-7#1)(2012-1#1)
that is unresponsive to##5##4##(1995-4#1)(2006-10#2)(2012-12#2)
that is used as a##3##5##(2007-1#1)(2007-12#1)(2008-1#1)
that is used as##4##4##(2007-1#1)(2007-12#2)(2008-1#1)
that is used by##3##4##(1990-12#1)(2007-12#1)(2012-3#1)
that is used for##3##4##(2008-2#1)(2008-4#1)(2012-3#1)
that is used in##2##4##(2008-1#1)(2011-1#1)
that is used to treat##2##5##(2008-10#1)(2008-8#1)
that is used to##10##4##(2006-12#1)(2007-11#1)(2008-10#2)(2008-3#3)(2008-4#1)(2008-8#1)(2010-7#1)
that is used widely##2##4##(1994-11#1)(2008-10#1)
that is used with##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
that is used##29##3##(1990-12#1)(1994-11#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#4)(2008-1#2)(2008-10#3)(2008-2#3)(2008-3#5)(2008-4#2)(2008-8#1)(2010-7#1)(2011-1#1)(2012-3#2)
that is useful for##2##4##(2008-2#1)(2011-1#1)
that is useful##5##3##(2008-2#2)(2010-11#1)(2011-1#1)(2011-2#1)
that is usually##13##3##(1991-6#1)(1996-3#1)(1997-7#1)(2006-6#1)(2008-2#1)(2008-3#3)(2010-2#1)(2011-2#2)(2012-2#1)(2013-1#1)
that is valid for##2##4##(2008-2#1)(2013-8#1)
that is valid##3##3##(2006-8#1)(2008-2#1)(2013-8#1)
that is varied##2##3##(2007-12#1)(2008-2#1)
that is verified##2##3##(2008-1#1)(2008-3#1)
that is very##4##3##(1994-8#1)(2006-12#1)(2007-8#1)(2008-2#1)
that is well recognized##2##4##(1993-12#1)(2011-2#1)
that is well suited for##2##5##(2007-12#1)(2011-1#1)
that is well suited to##2##5##(2010-2#1)(2012-1#1)
that is well suited##4##4##(2007-12#1)(2010-2#1)(2011-1#1)(2012-1#1)
that is well##9##3##(1993-12#1)(2007-12#1)(2010-2#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
that is widely used in##2##5##(2007-12#1)(2008-10#1)
that is widely used##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
that is widely##8##3##(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-8#1)(2009-3#1)
that is##2450##2##(1990-10#4)(1990-11#10)(1990-12#9)(1990-2#4)(1990-3#6)(1990-4#3)(1990-5#12)(1990-6#4)(1990-7#4)(1990-8#7)(1991-1#5)(1991-10#1)(1991-11#7)(1991-12#13)(1991-2#9)(1991-3#7)(1991-4#1)(1991-5#8)(1991-6#8)(1991-7#10)(1991-8#4)(1991-9#6)(1992-1#3)(1992-10#2)(1992-11#7)(1992-12#10)(1992-2#8)(1992-3#4)(1992-4#3)(1992-5#7)(1992-6#6)(1992-7#2)(1992-8#5)(1992-9#2)(1993-1#5)(1993-11#7)(1993-12#12)(1993-2#10)(1993-3#9)(1993-4#1)(1993-5#4)(1993-6#3)(1993-7#3)(1993-8#4)(1993-9#5)(1994-1#3)(1994-10#1)(1994-11#10)(1994-12#18)(1994-2#8)(1994-3#14)(1994-5#11)(1994-6#5)(1994-7#1)(1994-8#9)(1994-9#12)(1995-1#10)(1995-10#4)(1995-11#12)(1995-12#9)(1995-2#11)(1995-3#13)(1995-4#5)(1995-5#11)(1995-6#14)(1995-7#1)(1995-8#8)(1995-9#2)(1996-1#2)(1996-10#5)(1996-11#7)(1996-12#7)(1996-2#11)(1996-3#3)(1996-4#9)(1996-5#12)(1996-6#3)(1996-7#5)(1996-8#9)(1996-9#4)(1997-1#11)(1997-2#18)(1997-3#8)(1997-4#16)(1997-5#1)(1997-6#13)(1997-7#15)(1997-8#8)(1997-9#1)(2004-1#1)(2004-11#3)(2004-12#1)(2004-3#1)(2004-4#1)(2004-9#2)(2005-10#11)(2005-11#7)(2005-12#1)(2005-3#1)(2005-5#1)(2005-7#7)(2005-8#8)(2005-9#1)(2006-1#3)(2006-10#41)(2006-11#2)(2006-12#16)(2006-2#14)(2006-3#4)(2006-4#3)(2006-5#11)(2006-6#4)(2006-7#5)(2006-8#7)(2006-9#5)(2007-1#6)(2007-10#9)(2007-11#98)(2007-12#179)(2007-2#11)(2007-3#2)(2007-4#9)(2007-5#4)(2007-6#3)(2007-7#7)(2007-8#24)(2007-9#17)(2008-1#35)(2008-10#122)(2008-11#30)(2008-12#13)(2008-2#167)(2008-3#231)(2008-4#53)(2008-5#43)(2008-6#13)(2008-7#52)(2008-8#26)(2008-9#37)(2009-1#1)(2009-10#14)(2009-11#6)(2009-12#7)(2009-2#5)(2009-3#8)(2009-4#9)(2009-5#13)(2009-6#9)(2009-7#8)(2009-8#13)(2009-9#7)(2010-1#2)(2010-10#9)(2010-11#11)(2010-12#15)(2010-2#17)(2010-3#4)(2010-4#7)(2010-5#9)(2010-6#9)(2010-7#9)(2010-8#14)(2010-9#6)(2011-1#27)(2011-12#6)(2011-2#40)(2012-1#11)(2012-11#4)(2012-12#37)(2012-2#36)(2012-3#24)(2013-1#45)(2013-7#9)(2013-8#23)
that isatin is present in human##2##6##(1997-3#2)
that ischemia##6##2##(1991-9#2)(1993-6#2)(2006-8#1)(2007-9#1)
that ischemic##4##2##(1995-2#2)(1996-9#1)(2007-7#1)
that isocratic##2##2##(2008-10#2)
that isolated##4##2##(1992-4#1)(2007-2#1)(2008-10#1)(2012-2#1)
that isolates from##3##3##(2008-10#2)(2010-10#1)
that isolates of##6##3##(2008-10#5)(2008-6#1)
that isolates##14##2##(2008-10#10)(2008-6#1)(2010-10#1)(2011-2#1)(2012-2#1)
that issues##2##2##(2005-10#1)(2008-9#1)
that it activates##2##3##(1994-12#1)(2006-12#1)
that it acts as a##2##5##(1995-8#1)(2010-3#1)
that it acts##3##3##(1995-8#1)(2008-4#1)(2010-3#1)
that it affects the##2##4##(1991-10#1)(2007-11#1)
that it affects##4##3##(1991-10#1)(1991-8#1)(2007-11#1)(2008-11#1)
that it allows##4##3##(2006-10#1)(2006-3#1)(2007-12#1)(2008-9#1)
that it also##9##3##(1990-7#1)(1992-7#1)(1994-11#1)(1995-11#1)(1997-5#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#1)
that it be##5##3##(1991-8#1)(2005-8#1)(2008-10#1)(2008-2#1)(2008-7#1)
that it becomes a##2##4##(2008-11#1)(2008-8#1)
that it becomes more##2##4##(2007-3#1)(2011-2#1)
that it becomes##6##3##(2007-10#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
that it behaves##2##3##(2007-11#1)(2012-1#1)
that it belongs to the##2##5##(1990-10#1)(2007-12#1)
that it belongs to##3##4##(1990-10#1)(2007-12#1)(2013-8#1)
that it binds to##3##4##(1994-11#1)(1994-3#1)(1994-9#1)
that it binds##7##3##(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-9#1)
that it can also be a##2##6##(1995-1#1)(2012-11#1)
that it can also be##6##5##(1995-1#1)(1996-12#2)(2008-2#2)(2012-11#1)
that it can also##8##4##(1995-1#1)(1996-12#2)(2007-11#1)(2008-2#2)(2008-4#1)(2012-11#1)
that it can be used as##3##6##(2008-11#1)(2008-3#1)(2013-1#1)
that it can be used in##2##6##(2008-10#1)(2010-5#1)
that it can be used to measure the##2##8##(2008-3#2)
that it can be used to##3##6##(1994-5#1)(2008-3#2)
that it can be used##11##5##(1994-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2009-5#1)(2010-5#1)(2013-1#1)
that it can be##39##4##(1990-12#1)(1990-9#1)(1991-9#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-8#1)(1995-9#1)(1996-7#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-5#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
that it can only be##2##5##(2008-4#1)(2008-8#1)
that it can promote##2##4##(2010-6#1)(2013-8#1)
that it can##69##3##(1990-12#2)(1990-9#1)(1991-9#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-5#1)(1995-1#2)(1995-11#1)(1995-8#2)(1995-9#1)(1996-12#2)(1996-2#1)(1996-7#2)(2007-11#3)(2007-12#3)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#9)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#2)(2009-5#1)(2010-5#1)(2010-6#2)(2012-1#2)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
that it causes##2##3##(2006-2#1)(2008-10#1)
that it codes for##2##4##(1990-10#1)(1997-2#1)
that it consists of##2##4##(1991-7#1)(1991-9#1)
that it contained##6##3##(1990-3#1)(1991-9#1)(1994-5#1)(1995-12#1)(1997-2#1)(2008-10#1)
that it contains a##2##4##(1994-8#1)(1997-3#1)
that it contains##8##3##(1990-1#1)(1990-3#1)(1993-6#1)(1994-8#1)(1994-9#1)(1997-3#1)(1997-8#1)(2008-3#1)
that it could be##8##4##(1992-12#1)(1997-2#1)(2006-12#1)(2008-10#1)(2008-3#1)(2011-1#1)(2012-2#1)(2013-8#1)
that it could produce##2##4##(2005-11#1)(2008-10#1)
that it could##23##3##(1990-5#1)(1990-6#1)(1992-12#1)(1992-3#1)(1997-2#1)(2005-11#1)(2005-8#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2010-12#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#3)
that it delivers##2##3##(2008-6#1)(2011-2#1)
that it did not##4##4##(1990-5#2)(1997-4#1)(2007-12#1)
that it did##5##3##(1990-5#2)(1997-4#1)(2007-10#1)(2007-12#1)
that it does not have##2##5##(1996-11#1)(2007-2#1)
that it does not inhibit##2##5##(1990-9#1)(2008-3#1)
that it does not need##2##5##(1992-4#1)(2008-5#1)
that it does not##17##4##(1990-9#1)(1992-4#2)(1993-11#1)(1994-11#1)(1995-1#1)(1995-8#1)(1996-11#1)(2005-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-5#1)(2009-3#1)(2009-4#1)
that it does##19##3##(1990-9#1)(1992-4#2)(1993-11#1)(1994-11#1)(1995-1#1)(1995-8#1)(1996-11#1)(1997-8#1)(2005-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-3#1)(2009-4#1)
that it encodes a mature LIP protein##2##7##(1990-12#1)(1991-8#1)
that it encodes a##6##4##(1990-11#1)(1990-12#1)(1991-8#1)(1993-11#1)(1995-8#1)(2008-9#1)
that it encodes##7##3##(1990-11#1)(1990-12#1)(1991-8#1)(1993-11#1)(1994-8#1)(1995-8#1)(2008-9#1)
that it exists##2##3##(1991-12#1)(1993-3#1)
that it extends##2##3##(1993-6#1)(1997-4#1)
that it forms a##3##4##(1992-3#1)(1997-2#1)(2006-8#1)
that it forms##6##3##(1992-3#1)(1997-2#1)(2006-8#1)(2007-12#1)(2008-1#1)(2011-1#1)
that it generates##4##3##(1994-8#1)(2006-7#1)(2008-10#2)
that it had a##4##4##(1994-9#1)(1995-3#1)(2008-5#1)(2008-7#1)
that it had been##2##4##(2006-8#1)(2011-2#1)
that it had##14##3##(1990-2#1)(1993-11#1)(1993-3#1)(1994-9#1)(1995-3#1)(2005-8#1)(2006-8#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-7#1)(2010-12#1)(2011-2#1)
that it has a high##3##5##(1992-8#1)(2007-3#2)
that it has a##15##4##(1992-8#1)(1993-4#1)(1995-4#1)(1995-8#1)(2007-3#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-2#2)(2009-5#1)(2010-4#1)(2013-8#1)
that it has an important##2##5##(1990-12#1)(1993-12#1)
that it has been##2##4##(1993-11#1)(2008-8#1)
that it has better##2##4##(2005-4#1)(2011-2#1)
that it has no##3##4##(1992-12#1)(2008-7#1)(2010-6#1)
that it has potential##2##4##(1996-10#1)(2008-10#1)
that it has taken##2##4##(1990-8#1)(2008-10#1)
that it has the potential to##2##6##(2008-10#1)(2008-11#1)
that it has##46##3##(1990-12#1)(1990-8#1)(1991-2#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-4#1)(1995-4#1)(1995-8#1)(1996-10#1)(1996-8#1)(1997-4#1)(2005-10#1)(2005-4#1)(2006-10#1)(2007-10#1)(2007-3#2)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#1)(2013-8#1)
that it improves##2##3##(2006-8#1)(2010-7#1)
that it increases##3##3##(1997-4#1)(2008-10#1)(2008-3#1)
that it induces##2##3##(2008-2#1)(2009-6#1)
that it is a major##2##5##(1992-4#1)(2013-1#1)
that it is a novel##2##5##(2006-8#1)(2008-10#1)
that it is a##39##4##(1990-11#1)(1991-11#1)(1992-12#1)(1992-4#2)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#2)(1994-12#1)(1994-6#2)(1994-9#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-4#1)(1997-4#2)(2005-11#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-9#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-11#1)(2013-1#1)
that it is able to##2##5##(1990-2#1)(2008-11#1)
that it is active##2##4##(1992-12#1)(2008-8#1)
that it is almost##2##4##(1995-3#1)(2010-11#1)
that it is also##4##4##(1990-12#2)(1990-3#1)(2010-5#1)
that it is an integral##3##5##(1991-2#1)(1991-5#1)(2008-7#1)
that it is an##8##4##(1991-2#1)(1991-5#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-7#1)(2011-2#1)
that it is associated with##2##5##(1993-6#1)(1994-2#1)
that it is beneficial to##2##5##(2008-3#1)(2008-8#1)
that it is better to##2##5##(1990-9#1)(2006-2#1)
that it is closely related to##2##6##(1996-12#1)(2008-10#1)
that it is closely related##3##5##(1996-12#1)(2008-10#2)
that it is composed of##4##5##(1994-12#1)(1995-2#1)(1996-6#1)(2009-10#1)
that it is crucial to##2##5##(1991-12#1)(1996-11#1)
that it is difficult to##6##5##(1994-2#1)(1995-12#1)(1997-2#1)(2006-3#1)(2010-10#1)(2012-1#1)
that it is difficult##8##4##(1991-3#1)(1994-2#1)(1995-12#1)(1997-2#1)(2006-3#1)(2008-8#1)(2010-10#1)(2012-1#1)
that it is due to##3##5##(2008-5#2)(2011-2#1)
that it is essential that##2##5##(2006-10#1)(2013-8#1)
that it is essential to##2##5##(2008-8#1)(2008-9#1)
that it is essential##5##4##(2006-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-8#1)
that it is expressed##3##4##(1992-11#1)(1994-8#1)(1995-11#1)
that it is feasible to use##2##6##(2008-10#1)(2013-1#1)
that it is feasible to##7##5##(1992-8#1)(2006-8#1)(2008-10#1)(2008-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
that it is generally##4##4##(2007-12#1)(2008-3#1)(2008-8#1)(2009-3#1)
that it is highly##3##4##(1993-6#1)(1996-2#1)(2009-7#1)
that it is identical to the##2##6##(1995-1#1)(1997-6#1)
that it is important for##2##5##(1994-3#1)(1995-3#1)
that it is important to##6##5##(1995-1#1)(2006-4#1)(2008-10#1)(2008-7#1)(2009-4#1)(2013-1#1)
that it is important##8##4##(1994-3#1)(1995-1#1)(1995-3#1)(2006-4#1)(2008-10#1)(2008-7#1)(2009-4#1)(2013-1#1)
that it is impossible to##2##5##(1992-12#1)(2007-9#1)
that it is impossible##3##4##(1992-12#1)(2007-7#1)(2007-9#1)
that it is less##2##4##(2010-4#1)(2010-6#1)
that it is likely that##2##5##(1993-9#1)(2008-5#1)
that it is likely##3##4##(1993-9#1)(2008-10#1)(2008-5#1)
that it is more appropriate to##2##6##(1996-3#1)(2008-8#1)
that it is more##5##4##(1996-3#1)(2006-12#1)(2008-5#1)(2008-7#1)(2008-8#1)
that it is most##2##4##(1994-9#1)(1996-3#1)
that it is necessary to##7##5##(1991-9#1)(1996-12#1)(2008-11#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)
that it is necessary##9##4##(1991-9#1)(1996-12#1)(2008-11#2)(2011-2#2)(2012-11#1)(2012-12#1)(2012-3#1)
that it is not a##2##5##(1995-6#1)(2008-3#1)
that it is not necessary to##2##6##(1997-6#1)(2008-11#1)
that it is not the##2##5##(1991-2#1)(2008-11#1)
that it is not##25##4##(1991-2#1)(1991-9#1)(1992-2#1)(1992-3#1)(1995-2#1)(1995-6#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-11#2)(2008-3#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-8#1)(2012-2#1)(2013-1#2)
that it is now##3##4##(1992-3#1)(2006-5#1)(2008-12#1)
that it is of##4##4##(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)
that it is only##2##4##(1994-12#1)(2008-10#1)
that it is possible for##2##5##(2007-12#2)
that it is possible to avoid##2##6##(2007-11#1)(2008-2#1)
that it is possible to construct##2##6##(2008-2#1)(2008-3#1)
that it is possible to design##2##6##(1992-8#1)(2008-2#1)
that it is possible to detect##2##6##(2008-10#1)(2008-3#1)
that it is possible to differentiate##2##6##(1994-9#1)(2013-8#1)
that it is possible to estimate##2##6##(2008-10#1)(2008-3#1)
that it is possible to identify##2##6##(2006-12#1)(2012-3#1)
that it is possible to increase the##3##7##(2006-10#1)(2007-12#1)(2008-4#1)
that it is possible to measure##2##6##(2004-9#1)(2008-3#1)
that it is possible to obtain##4##6##(2007-12#1)(2008-10#2)(2010-4#1)
that it is possible to produce##2##6##(2007-1#1)(2008-5#1)
that it is possible to take##2##6##(1996-1#1)(2008-10#1)
that it is possible to transfer##3##6##(1993-9#1)(1996-5#1)(2007-12#1)
that it is possible to##71##5##(1990-12#1)(1990-5#1)(1990-8#1)(1992-8#1)(1993-9#1)(1994-9#1)(1995-5#1)(1996-1#1)(1996-5#1)(2004-9#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#5)(2007-7#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#9)(2008-3#9)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
that it is possible##78##4##(1990-12#1)(1990-5#1)(1990-8#1)(1992-8#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-5#1)(1996-1#1)(1996-5#1)(2004-9#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#8)(2007-7#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#10)(2008-3#9)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
that it is potentially##2##4##(1990-11#1)(1997-5#1)
that it is predominantly##2##4##(1990-12#1)(1994-12#1)
that it is primarily##2##4##(1992-12#1)(2009-9#1)
that it is produced##2##4##(2008-11#1)(2009-3#1)
that it is quite##2##4##(1994-3#1)(2008-8#1)
that it is reasonable to##4##5##(2008-5#1)(2011-2#2)(2012-3#1)
that it is relatively##2##4##(2007-11#1)(2009-6#1)
that it is required for##2##5##(1997-1#1)(2013-1#1)
that it is simple##2##4##(2009-10#1)(2012-2#1)
that it is sufficient to##2##5##(2008-2#1)(2008-3#1)
that it is the most##3##5##(2007-9#1)(2008-1#1)(2008-7#1)
that it is the##21##4##(1990-2#1)(1991-10#2)(1993-9#1)(1994-8#1)(1995-1#1)(1997-2#1)(2006-10#1)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-7#1)(2013-8#1)
that it is unlikely that##2##5##(1997-6#1)(2010-9#1)
that it is useful##2##4##(1991-1#1)(2008-10#1)
that it is very##3##4##(1993-2#1)(2008-11#1)(2008-3#1)
that it is written##2##4##(2005-7#1)(2008-6#1)
that it is##429##3##(1990-10#1)(1990-11#3)(1990-12#7)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#2)(1991-8#1)(1991-9#3)(1992-11#2)(1992-12#5)(1992-2#1)(1992-3#4)(1992-4#3)(1992-6#4)(1992-7#1)(1992-8#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-9#4)(1994-11#1)(1994-12#8)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#5)(1994-8#3)(1994-9#5)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#5)(1995-5#1)(1995-6#4)(1995-8#2)(1996-1#2)(1996-11#2)(1996-12#5)(1996-2#2)(1996-3#3)(1996-4#3)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#3)(2004-9#1)(2005-11#3)(2005-7#1)(2005-9#2)(2006-10#7)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#2)(2007-1#2)(2007-11#9)(2007-12#13)(2007-5#2)(2007-7#2)(2007-8#2)(2007-9#4)(2008-1#5)(2008-10#36)(2008-11#14)(2008-12#6)(2008-2#17)(2008-3#16)(2008-4#6)(2008-5#13)(2008-6#2)(2008-7#10)(2008-8#9)(2008-9#3)(2009-1#1)(2009-10#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#2)(2011-2#12)(2012-1#3)(2012-11#2)(2012-12#7)(2012-2#4)(2012-3#5)(2013-1#9)(2013-7#1)(2013-8#5)
that it lacked##2##3##(1992-3#1)(2008-10#1)
that it makes##5##3##(1995-12#1)(1997-8#1)(2007-2#1)(2008-3#1)(2008-5#1)
that it may act as a##3##6##(1994-10#1)(2008-7#1)(2008-8#1)
that it may act##4##4##(1991-11#1)(1994-10#1)(2008-7#1)(2008-8#1)
that it may also##2##4##(2008-3#1)(2012-11#1)
that it may be a##8##5##(1990-2#1)(1991-5#1)(1993-2#1)(1993-6#1)(2007-11#1)(2008-10#3)
that it may be an effective##3##6##(1997-5#1)(2008-11#1)(2008-9#1)
that it may be an##4##5##(1997-5#1)(2008-11#1)(2008-9#1)(2012-2#1)
that it may be associated##2##5##(2009-10#1)(2009-9#1)
that it may be involved in the##3##7##(1991-5#1)(1997-2#2)
that it may be involved in##4##6##(1991-5#1)(1993-12#1)(1997-2#2)
that it may be of##2##5##(2006-8#2)
that it may be possible to##10##6##(1993-7#1)(1997-4#1)(1997-8#1)(2006-10#2)(2008-11#1)(2008-3#2)(2009-4#1)(2012-12#1)
that it may be useful##3##5##(1995-5#1)(2012-2#1)(2013-8#1)
that it may be##50##4##(1990-2#1)(1991-1#1)(1991-5#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-7#1)(1995-5#1)(1996-11#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-8#1)(2004-1#1)(2006-10#3)(2006-8#3)(2007-11#4)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-10#2)(2009-4#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-12#1)(2012-12#1)(2012-2#2)(2013-8#1)
that it may have a##2##5##(2007-8#1)(2008-4#1)
that it may have##3##4##(2005-8#1)(2007-8#1)(2008-4#1)
that it may not be##2##5##(1990-11#1)(1992-10#1)
that it may not##4##4##(1990-11#1)(1992-10#1)(1997-3#1)(2010-8#1)
that it may play a##4##5##(1991-5#1)(1992-12#1)(1993-3#1)(2008-10#1)
that it may play##6##4##(1991-11#1)(1991-5#1)(1992-12#1)(1993-3#1)(2008-10#2)
that it may represent a##2##5##(1997-2#1)(2011-2#1)
that it may serve as##2##5##(1992-12#1)(2008-10#1)
that it may##89##3##(1990-11#1)(1990-2#1)(1991-1#1)(1991-11#2)(1991-5#3)(1991-8#1)(1992-10#2)(1992-12#3)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-4#1)(1995-5#1)(1996-11#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-1#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-8#3)(2007-11#4)(2007-8#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-8#1)
that it mediates##2##3##(1993-12#1)(2008-5#1)
that it might also##2##4##(2007-11#1)(2008-7#1)
that it might be possible to##2##6##(2004-4#1)(2008-2#1)
that it might be##5##4##(2004-4#1)(2005-11#1)(2008-2#1)(2009-8#1)(2013-8#1)
that it might##16##3##(1990-3#1)(1991-8#1)(1996-12#1)(2004-1#1)(2004-4#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-7#1)(2009-8#1)(2011-1#1)(2012-2#2)(2013-8#1)
that it must##4##3##(1994-3#1)(1997-4#1)(2007-10#1)(2008-2#1)
that it occurred through##2##4##(2006-7#2)
that it occurs##2##3##(1997-6#1)(2008-4#1)
that it offers##2##3##(2008-5#1)(2009-9#1)
that it played##2##3##(2008-10#1)(2008-3#1)
that it plays a##5##4##(1990-10#1)(1991-7#1)(1993-8#1)(1997-1#1)(1997-6#1)
that it possesses##2##3##(1992-9#1)(2008-4#1)
that it provides a##3##4##(2009-8#1)(2010-12#1)(2010-6#1)
that it provides##7##3##(2008-1#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-12#1)(2010-6#1)(2013-8#1)
that it raises##2##3##(1995-2#1)(2012-1#1)
that it reduced##2##3##(2007-8#1)(2010-7#1)
that it reduces##2##3##(2008-6#1)(2012-12#1)
that it remains##3##3##(1991-12#1)(2007-8#1)(2008-6#1)
that it represents##2##3##(2008-10#1)(2011-12#1)
that it requires##3##3##(1991-3#1)(2008-10#1)(2008-4#1)
that it serves##2##3##(1996-7#1)(2008-10#1)
that it should be possible to develop##2##7##(1997-4#1)(2008-9#1)
that it should be possible to##5##6##(1997-4#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-12#1)
that it should be##14##4##(1992-6#1)(1994-4#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-3#1)
that it should##17##3##(1992-6#1)(1994-4#1)(1997-4#1)(2006-4#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-9#1)(2012-12#1)(2012-3#1)
that it takes##2##3##(2008-7#1)(2012-3#1)
that it undergoes##2##3##(1995-1#1)(1997-7#1)
that it values##2##3##(2007-4#1)(2010-3#1)
that it was a##7##4##(1990-5#1)(1995-12#1)(1996-11#1)(2005-11#1)(2008-10#1)(2013-7#1)(2013-8#1)
that it was caused by##2##5##(1997-7#1)(2010-1#1)
that it was localized##2##4##(1990-12#1)(1997-1#1)
that it was more##2##4##(2006-2#1)(2008-8#1)
that it was not##6##4##(1994-8#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
that it was part of##2##5##(2007-9#1)(2009-7#1)
that it was possible to##2##5##(2008-10#1)(2012-11#1)
that it was present##2##4##(2008-10#1)(2012-12#1)
that it was the##3##4##(1990-6#1)(1991-8#1)(1994-11#1)
that it was too##3##4##(1992-6#1)(1992-8#1)(1995-12#1)
that it was##77##3##(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#1)(1991-3#1)(1991-8#2)(1992-5#1)(1992-6#1)(1992-8#3)(1993-3#2)(1993-6#2)(1994-11#1)(1994-8#1)(1995-1#1)(1995-12#3)(1995-6#1)(1995-8#1)(1996-11#2)(1996-12#2)(1997-1#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2013-1#5)(2013-7#1)(2013-8#2)
that it will be a##2##5##(2008-5#1)(2009-5#1)
that it will be##12##4##(1996-8#1)(1997-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-5#1)(2011-2#1)
that it will become##3##4##(1990-2#1)(2007-3#1)(2007-4#1)
that it will enable##2##4##(2008-11#1)(2012-2#1)
that it will not##2##4##(1993-3#1)(2012-12#1)
that it will##26##3##(1990-2#1)(1993-3#1)(1995-8#1)(1996-8#1)(1997-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-3#2)(2007-4#1)(2007-9#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#1)
that it would be more##4##5##(1993-2#1)(1994-1#2)(2009-5#1)
that it would be##11##4##(1992-12#1)(1993-2#1)(1994-1#2)(1996-3#1)(1996-6#1)(1997-8#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-7#1)
that it would##18##3##(1992-12#1)(1993-2#1)(1994-1#2)(1996-3#1)(1996-6#1)(1997-8#1)(2006-8#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2010-4#1)(2011-2#1)(2013-7#1)
that it##1112##2##(1990-1#1)(1990-10#5)(1990-11#6)(1990-12#13)(1990-2#9)(1990-3#7)(1990-4#2)(1990-5#5)(1990-6#2)(1990-7#2)(1990-8#3)(1990-9#3)(1991-1#3)(1991-10#3)(1991-11#5)(1991-12#3)(1991-2#4)(1991-3#4)(1991-4#1)(1991-5#5)(1991-7#2)(1991-8#8)(1991-9#6)(1992-10#2)(1992-11#2)(1992-12#11)(1992-2#1)(1992-3#7)(1992-4#5)(1992-5#1)(1992-6#6)(1992-7#3)(1992-8#8)(1992-9#1)(1993-11#5)(1993-12#4)(1993-2#4)(1993-3#10)(1993-4#1)(1993-6#9)(1993-7#3)(1993-8#1)(1993-9#7)(1994-1#2)(1994-10#1)(1994-11#5)(1994-12#12)(1994-2#3)(1994-3#5)(1994-4#3)(1994-5#3)(1994-6#5)(1994-8#9)(1994-9#8)(1995-1#8)(1995-10#2)(1995-11#3)(1995-12#6)(1995-2#8)(1995-3#7)(1995-4#1)(1995-5#2)(1995-6#6)(1995-8#10)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#7)(1996-12#11)(1996-2#4)(1996-3#6)(1996-4#3)(1996-5#2)(1996-6#4)(1996-7#3)(1996-8#2)(1996-9#1)(1997-1#6)(1997-2#9)(1997-3#4)(1997-4#13)(1997-5#5)(1997-6#6)(1997-7#5)(1997-8#5)(2004-1#2)(2004-3#1)(2004-4#1)(2004-9#1)(2005-10#3)(2005-11#7)(2005-12#1)(2005-4#1)(2005-5#1)(2005-7#1)(2005-8#5)(2005-9#3)(2006-10#16)(2006-12#4)(2006-2#6)(2006-3#2)(2006-4#3)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#10)(2006-9#1)(2007-1#2)(2007-10#4)(2007-11#22)(2007-12#22)(2007-2#4)(2007-3#6)(2007-4#5)(2007-5#3)(2007-7#5)(2007-8#14)(2007-9#11)(2008-1#15)(2008-10#85)(2008-11#31)(2008-12#11)(2008-2#37)(2008-3#41)(2008-4#17)(2008-5#25)(2008-6#6)(2008-7#22)(2008-8#20)(2008-9#10)(2009-1#1)(2009-10#5)(2009-2#1)(2009-3#4)(2009-4#4)(2009-5#5)(2009-6#6)(2009-7#6)(2009-8#6)(2009-9#4)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#8)(2010-3#5)(2010-4#6)(2010-5#6)(2010-6#7)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#9)(2011-12#5)(2011-2#22)(2012-1#8)(2012-11#8)(2012-12#18)(2012-2#11)(2012-3#10)(2013-1#18)(2013-7#3)(2013-8#19)
that it's##5##2##(1995-3#1)(2007-9#1)(2009-8#1)(2010-4#1)(2012-12#1)
that its DNA-binding##2##3##(1994-9#1)(1996-2#1)
that its amino##2##3##(1991-8#1)(2008-10#1)
that its association with##3##4##(1992-10#1)(1992-3#1)(1994-8#1)
that its effect##2##3##(1995-11#1)(2007-8#1)
that its effects were##2##4##(1992-4#1)(2010-4#1)
that its effects##3##3##(1992-4#1)(1992-8#1)(2010-4#1)
that its expression##3##3##(1991-9#1)(1996-10#1)(2013-8#1)
that its gene##2##3##(1995-8#1)(2008-5#1)
that its mRNA##3##3##(1992-11#1)(1994-11#1)(2005-8#1)
that its potential##2##3##(2007-9#1)(2012-3#1)
that its resistance may##2##4##(2008-10#1)(2008-12#1)
that its use will##2##4##(2010-12#1)(2011-7#1)
that its use##6##3##(2007-8#2)(2010-12#1)(2010-5#1)(2011-7#1)(2013-8#1)
that its##115##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#4)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-9#1)(1994-11#2)(1994-6#2)(1994-8#2)(1994-9#2)(1995-11#1)(1995-2#2)(1995-6#1)(1995-8#3)(1995-9#1)(1996-10#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(2005-8#2)(2006-3#1)(2006-7#1)(2007-11#3)(2007-12#1)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#5)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#2)
that job##2##2##(1994-3#1)(2007-4#1)
that joint##5##2##(1996-9#1)(2006-10#1)(2008-11#1)(2008-12#1)(2013-1#1)
that judges##3##2##(1991-3#1)(2006-4#1)(2013-1#1)
that just##3##2##(1996-7#1)(2006-12#1)(2010-9#1)
that juvenile##5##2##(2008-10#1)(2008-9#1)(2010-8#2)(2013-8#1)
that juveniles##3##2##(2007-5#1)(2008-8#1)(2012-2#1)
that kainate##3##2##(1990-2#1)(1995-11#1)(2012-2#1)
that keeps##5##2##(2007-4#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-8#1)
that keratinocytes##2##2##(1997-5#1)(2008-5#1)
that keratoconus##2##2##(2005-11#2)
that ketamine##2##2##(1996-8#1)(2007-4#1)
that key##4##2##(1992-9#1)(2008-7#1)(2009-12#1)(2011-1#1)
that kidded in the##2##4##(2008-3#2)
that kidney##3##2##(1996-6#1)(2006-10#1)(2007-2#1)
that kill##3##2##(1992-6#1)(2007-12#1)(2009-8#1)
that kills the##2##3##(1994-11#1)(2008-9#1)
that kills##4##2##(1994-11#1)(1996-9#1)(1997-2#1)(2008-9#1)
that kind of##2##3##(1995-11#1)(2011-2#1)
that kinesin##3##2##(1990-8#3)
that knee##3##2##(2006-11#2)(2008-12#1)
that know##2##2##(2006-10#1)(2008-10#1)
that knowledge of stroke is##2##5##(2007-10#1)(2007-9#1)
that knowledge of stroke##4##4##(2007-10#1)(2007-9#3)
that knowledge of the##3##4##(2007-12#1)(2008-3#2)
that knowledge of##9##3##(1995-8#1)(2007-10#1)(2007-12#1)(2007-9#4)(2008-3#2)
that knowledge##18##2##(1995-11#1)(1995-8#1)(1997-8#3)(2007-10#1)(2007-12#1)(2007-9#4)(2008-11#1)(2008-3#2)(2012-12#1)(2013-7#2)(2013-8#1)
that known as##3##3##(1991-2#1)(1996-2#1)(2006-10#1)
that known##7##2##(1990-6#1)(1991-2#1)(1996-2#1)(1997-4#2)(1997-8#1)(2006-10#1)
that kringle 1##2##3##(1990-5#1)(2008-8#1)
that kuz##2##2##(1996-8#2)
that labeled with##2##3##(1994-11#1)(2008-10#1)
that labeled##4##2##(1994-11#1)(1996-5#1)(2008-10#2)
that labeling##3##2##(1994-9#1)(1995-1#1)(2007-7#1)
that laccase##2##2##(1993-4#1)(2011-1#1)
that lack a##5##3##(1997-7#1)(2006-12#1)(2008-8#1)(2012-1#1)(2012-2#1)
that lack mitochondrial##2##3##(1997-6#2)
that lack of##9##3##(1995-2#1)(1995-5#1)(2007-4#1)(2008-10#1)(2008-5#1)(2010-5#1)(2010-7#1)(2012-11#1)(2013-7#1)
that lack one or##2##4##(1992-3#1)(1995-5#1)
that lack the##8##3##(1990-3#1)(1991-8#1)(1993-12#1)(1994-3#1)(1994-9#1)(2006-12#2)(2012-3#1)
that lack these##2##3##(1993-9#1)(2008-8#1)
that lack##52##2##(1990-3#1)(1990-8#1)(1991-8#1)(1992-3#1)(1992-8#1)(1993-12#2)(1993-9#1)(1994-12#2)(1994-3#2)(1994-8#1)(1994-9#1)(1995-2#2)(1995-5#2)(1995-8#2)(1997-6#2)(1997-7#2)(2006-10#1)(2006-12#4)(2007-10#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-8#1)(2010-5#1)(2010-7#1)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
that lacked the##3##3##(1991-8#1)(1994-9#1)(2008-10#1)
that lacked##11##2##(1991-8#1)(1991-9#1)(1992-3#1)(1993-9#1)(1994-6#1)(1994-9#2)(2008-10#2)(2010-3#1)(2013-1#1)
that lacks the C-terminal##2##4##(1995-6#1)(2008-8#1)
that lacks the##9##3##(1991-2#1)(1993-12#1)(1994-8#1)(1995-6#1)(1997-3#1)(1997-6#1)(2008-8#2)(2009-9#1)
that lacks##16##2##(1991-2#1)(1993-12#1)(1993-3#1)(1994-8#1)(1995-10#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-3#1)(1997-6#1)(2008-4#1)(2008-8#2)(2009-9#1)(2012-12#2)
that lactate and##2##3##(1995-8#1)(2008-7#1)
that lactate##5##2##(1990-4#1)(1995-7#1)(1995-8#1)(1996-2#1)(2008-7#1)
that lactation increased the##2##4##(1994-3#2)
that lambda##3##2##(1992-6#2)(1995-2#1)
that land##2##2##(2008-5#1)(2013-8#1)
that language##8##2##(2006-3#1)(2007-8#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-3#1)(2013-8#2)
that languages##2##2##(2012-3#1)(2013-8#1)
that laparoscopic##9##2##(1993-3#3)(1995-9#1)(2006-10#1)(2006-6#1)(2010-11#1)(2011-1#1)(2012-11#1)
that large amounts of##3##4##(1993-12#1)(2008-11#2)
that large swarms##2##3##(2013-8#2)
that large##26##2##(1990-7#1)(1991-11#2)(1991-4#1)(1993-12#1)(1994-5#1)(1995-12#1)(1996-3#2)(1996-4#1)(1997-4#1)(2004-4#1)(2006-4#1)(2007-12#1)(2007-2#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-3#1)(2013-1#2)(2013-8#2)
that large-scale##2##2##(2006-10#1)(2008-9#1)
that largely##2##2##(2010-9#1)(2013-8#1)
that larger##8##2##(1997-1#1)(1997-2#1)(2007-5#1)(2008-9#1)(2010-8#1)(2011-2#2)(2013-8#1)
that larval##2##2##(2008-11#1)(2011-12#1)
that laser##6##2##(1991-1#1)(1992-3#1)(2007-12#1)(2008-2#2)(2008-3#1)
that last##3##2##(2006-12#1)(2007-3#1)(2013-1#1)
that lasted for more than##2##5##(2006-8#1)(2013-1#1)
that lasted for##5##3##(2006-8#1)(2007-2#1)(2007-9#1)(2008-3#1)(2013-1#1)
that lasted##9##2##(1995-9#1)(2004-12#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-2#1)(2008-3#1)(2013-1#1)
that lasts##3##2##(2007-7#1)(2008-7#2)
that late##2##2##(2008-7#1)(2008-8#1)
that latent##4##2##(2008-10#2)(2009-12#1)(2013-8#1)
that later##4##2##(1995-8#1)(2006-10#1)(2007-12#1)(2008-5#1)
that lateral##4##2##(1990-2#1)(1994-5#1)(2008-3#2)
that law##2##2##(1991-3#1)(2008-8#1)
that lay##2##2##(2011-2#1)(2012-2#1)
that lead latent infection to fruit rot##2##7##(2008-10#2)
that lead to death##2##4##(2006-1#1)(2011-2#1)
that lead to decreased##2##4##(2013-7#1)(2013-8#1)
that lead to optimal##2##4##(2008-1#1)(2013-8#1)
that lead to the##18##4##(1995-8#1)(1996-4#1)(1996-5#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2010-10#1)(2010-11#1)(2012-2#2)(2012-3#2)(2013-1#1)
that lead to##79##3##(1991-6#1)(1991-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1995-8#1)(1996-10#2)(1996-4#1)(1996-5#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-4#3)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#5)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#3)
that lead##96##2##(1991-6#1)(1991-8#1)(1991-9#1)(1994-11#2)(1994-12#1)(1994-2#2)(1995-4#1)(1995-8#1)(1996-10#2)(1996-4#1)(1996-5#1)(1997-2#3)(1997-4#2)(2005-8#1)(2006-1#1)(2006-10#4)(2006-4#3)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#5)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#4)
that leadership##3##2##(1996-1#1)(2009-10#1)(2009-5#1)
that leads to a##2##4##(2008-2#1)(2009-4#1)
that leads to generation of a##2##6##(1997-8#1)(2007-11#1)
that leads to increased##2##4##(2008-8#1)(2008-9#1)
that leads to the development of##3##6##(1993-2#1)(2007-4#1)(2012-2#1)
that leads to the##12##4##(1990-5#1)(1993-2#1)(1993-9#1)(1994-9#1)(2006-7#1)(2007-4#1)(2008-2#1)(2008-3#3)(2009-6#1)(2012-2#1)
that leads to##63##3##(1990-5#1)(1991-7#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-10#1)(1994-9#1)(1995-2#2)(1995-7#1)(1996-5#1)(1997-8#1)(2004-11#1)(2005-11#1)(2006-10#3)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#5)(2011-9#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
that leads##68##2##(1990-5#1)(1991-7#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-10#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-7#1)(1996-5#1)(1997-8#1)(2004-11#1)(2005-11#1)(2006-10#3)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#5)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#6)(2011-9#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
that leaf##6##2##(2007-6#1)(2008-10#4)(2012-5#1)
that learned##3##2##(1994-8#1)(2013-1#2)
that learning##4##2##(2008-11#1)(2008-12#1)(2011-2#1)(2012-1#1)
that leaves##5##2##(1991-7#1)(1994-2#1)(1994-8#1)(2007-1#1)(2008-7#1)
that lecturers##2##2##(2008-11#2)
that led the##2##3##(2008-5#1)(2008-8#1)
that led them to##2##4##(2012-1#2)
that led to a##4##4##(2008-8#2)(2009-3#1)(2011-2#1)
that led to an##2##4##(2007-12#1)(2012-12#1)
that led to its##2##4##(2007-12#1)(2010-12#1)
that led to the development of##3##6##(1995-12#1)(2007-11#1)(2008-3#1)
that led to the##30##4##(1990-2#1)(1993-9#1)(1994-8#1)(1995-12#1)(1996-2#1)(2007-11#1)(2007-4#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#2)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#5)
that led to##47##3##(1990-2#1)(1993-9#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-2#1)(1997-4#1)(1997-6#1)(2006-12#1)(2007-11#2)(2007-12#2)(2007-4#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-3#2)(2009-4#2)(2009-8#1)(2010-12#3)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#5)
that led##55##2##(1990-2#1)(1993-9#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-2#1)(1997-4#1)(1997-6#1)(2006-11#1)(2006-12#1)(2007-11#2)(2007-12#2)(2007-4#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2009-3#2)(2009-4#2)(2009-8#1)(2010-12#3)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2013-1#1)(2013-8#5)
that left ventricular##4##3##(1995-6#1)(1997-1#1)(1997-8#1)(2006-2#1)
that left##11##2##(1995-6#1)(1997-1#1)(1997-8#1)(2006-2#1)(2006-9#1)(2007-10#1)(2008-1#1)(2008-5#1)(2009-6#1)(2010-7#1)(2012-2#1)
that left-handers##2##2##(2012-2#2)
that lemon##2##2##(2008-10#1)(2011-2#1)
that leptin may##3##3##(2006-10#2)(2013-8#1)
that leptin##6##2##(1997-4#1)(2006-10#3)(2008-4#1)(2013-8#1)
that lesions of the##2##4##(1993-12#1)(1994-2#1)
that lesions##4##2##(1990-5#1)(1991-1#1)(1993-12#1)(1994-2#1)
that less than##7##3##(1990-12#1)(1992-12#1)(1993-12#1)(1996-9#1)(1997-6#1)(2006-8#1)(2013-1#1)
that less##14##2##(1990-12#1)(1992-12#1)(1993-12#1)(1996-12#1)(1996-9#1)(1997-3#1)(1997-6#2)(2006-8#1)(2007-11#1)(2008-2#1)(2009-11#1)(2012-12#1)(2013-1#1)
that lethal##2##2##(1994-2#1)(2008-5#1)
that lettuce##3##2##(2008-10#1)(2008-11#2)
that leukocyte##2##2##(1991-9#1)(2007-10#1)
that leukocytes##2##2##(1994-2#1)(1996-1#1)
that leukotrienes##2##2##(1994-8#1)(2010-1#1)
that level##5##2##(1995-12#2)(1996-5#1)(2008-10#1)(2009-8#1)
that levels of##9##3##(1991-12#1)(1992-8#1)(1995-12#1)(2007-11#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-2#1)(2013-1#1)
that levels##10##2##(1991-12#1)(1992-8#1)(1995-12#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-2#1)(2013-1#1)
that levofloxacin##3##2##(2006-12#1)(2010-11#2)
that lexical##2##2##(2008-2#1)(2009-2#1)
that lie at the##2##4##(2008-2#1)(2011-1#1)
that lie beyond the##2##4##(1993-6#1)(2008-8#1)
that lie in the##2##4##(1993-7#1)(2008-2#1)
that lie in##4##3##(1993-12#1)(1993-7#1)(1994-3#1)(2008-2#1)
that lie##14##2##(1990-12#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-3#1)(1994-8#2)(2008-2#3)(2008-3#1)(2008-8#1)(2010-8#1)(2011-1#1)
that lies in##2##3##(1997-4#1)(2013-8#1)
that lies##4##2##(1991-9#1)(1993-3#1)(1997-4#1)(2013-8#1)
that life##6##2##(1990-11#1)(1997-6#1)(2008-4#1)(2008-8#1)(2009-9#1)(2011-2#1)
that lifestyle##3##2##(2008-3#1)(2008-7#1)(2009-8#1)
that ligand binding##2##3##(2003-11#1)(2008-4#1)
that ligand##8##2##(1990-2#1)(1993-8#1)(1997-5#1)(2003-11#1)(2008-10#2)(2008-4#1)(2010-4#1)
that light##9##2##(1993-3#1)(2004-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)
that light-induced##2##2##(1994-2#1)(1995-8#1)
that lignoceroyl-CoA ligase activity##2##4##(1993-9#2)
that like##5##2##(1992-6#1)(1993-8#1)(1996-5#1)(2007-7#1)(2009-10#1)
that likely contribute to##2##4##(2008-10#1)(2008-8#1)
that likely##16##2##(1993-11#1)(1994-2#1)(1994-3#1)(1996-7#1)(2008-1#2)(2008-10#1)(2008-8#2)(2009-6#1)(2009-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
that limb##2##2##(1994-11#1)(2010-9#1)
that limbic##2##2##(1992-9#1)(1994-8#1)
that limit its##2##3##(2008-10#1)(2010-8#1)
that limit the##13##3##(1992-10#1)(1997-2#1)(2007-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-2#1)(2012-2#1)
that limit their##2##3##(2007-11#1)(2011-1#1)
that limit##24##2##(1992-10#1)(1992-3#1)(1996-8#1)(1997-2#1)(2007-11#3)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
that limitations in##2##3##(2008-7#1)(2012-3#1)
that limitations##3##2##(2007-12#1)(2008-7#1)(2012-3#1)
that limited data sets##2##4##(2008-3#2)
that limited##14##2##(1991-7#1)(1993-9#1)(1994-7#1)(1994-8#1)(2006-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-10#1)(2010-3#2)(2012-1#1)
that limits the##3##3##(2007-11#1)(2008-3#1)(2013-7#1)
that limits##8##2##(1994-1#1)(1996-7#1)(2006-3#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#1)(2013-7#1)
that line##6##2##(1991-9#1)(1995-11#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-4#1)
that linear##5##2##(1990-5#1)(1993-6#1)(1993-9#1)(1994-8#1)(1995-6#1)
that linger##2##2##(1995-1#1)(2012-1#1)
that link the##2##3##(2008-1#1)(2008-3#1)
that link##12##2##(1991-2#1)(1993-3#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2012-3#1)(2013-1#5)
that linkage##3##2##(1993-11#1)(2008-8#1)(2012-3#1)
that linked##3##2##(2008-10#1)(2008-11#1)(2009-7#1)
that links##14##2##(1994-8#1)(1996-2#1)(2006-2#1)(2007-8#2)(2008-3#3)(2008-4#1)(2008-8#2)(2009-7#1)(2011-2#1)(2013-1#1)
that lip##2##2##(2005-11#1)(2008-6#1)
that lipid peroxidation##2##3##(1995-3#1)(2008-8#1)
that lipid##14##2##(1991-4#1)(1991-7#1)(1993-11#1)(1995-3#1)(1995-8#1)(1997-6#1)(1997-8#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-1#2)
that lipoprotein##3##2##(1990-12#1)(1995-4#1)(1995-5#1)
that liposomal##3##2##(1994-12#1)(1995-2#1)(1995-5#1)
that liposomes##2##2##(1990-12#1)(1995-5#1)
that lipoxygenase##2##2##(1995-5#1)(2006-1#1)
that liquid membrane##2##3##(2005-11#1)(2011-1#1)
that liquid##7##2##(1995-11#1)(2005-11#1)(2007-6#1)(2008-11#1)(2008-7#1)(2010-4#1)(2011-1#1)
that lists##2##2##(2008-4#1)(2012-2#1)
that lithium is##2##3##(1992-2#1)(2012-12#1)
that lithium stimulated##2##3##(1997-4#1)(2012-12#1)
that lithium##5##2##(1990-7#1)(1992-2#1)(1997-4#1)(2012-12#2)
that little attention##2##3##(1990-4#1)(2009-8#1)
that little or no##3##4##(1992-3#1)(1992-8#1)(1994-2#1)
that little##14##2##(1990-10#1)(1990-4#1)(1991-3#1)(1992-3#1)(1992-8#1)(1993-3#1)(1994-2#1)(1994-5#1)(2006-12#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-8#1)(2011-1#1)
that live in##4##3##(2008-8#1)(2009-4#1)(2009-8#1)(2011-2#1)
that live##9##2##(2007-3#1)(2007-5#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-8#1)(2011-12#1)(2011-2#1)
that lived##4##2##(2008-1#1)(2008-10#1)(2011-2#1)(2012-12#1)
that liver function##2##3##(2010-5#1)(2013-8#1)
that liver injury##2##3##(2006-10#1)(2008-4#1)
that liver##13##2##(1990-2#1)(1991-2#1)(1991-3#1)(1992-6#1)(1992-9#1)(1993-7#1)(2006-10#1)(2008-4#1)(2008-8#1)(2010-5#1)(2010-8#1)(2011-12#1)(2013-8#1)
that lives in the##2##4##(1996-12#1)(2007-9#1)
that lives in##3##3##(1996-12#1)(2007-9#1)(2008-10#1)
that lives##5##2##(1996-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-7#1)
that livestock##2##2##(2011-1#1)(2011-2#1)
that living##4##2##(1995-11#1)(2007-7#1)(2008-9#1)(2012-3#1)
that lizard##2##2##(2010-3#1)(2013-8#1)
that load##2##2##(1994-6#1)(2013-8#1)
that local administration of##4##4##(1996-10#1)(2008-12#1)(2009-10#1)(2011-2#1)
that local application of##2##4##(1990-5#1)(1997-2#1)
that local processes##2##3##(2008-9#2)
that local##38##2##(1990-5#1)(1992-9#1)(1993-2#1)(1994-3#1)(1994-5#2)(1995-12#1)(1996-10#2)(1996-12#2)(1997-2#1)(2004-10#1)(2005-11#1)(2005-5#1)(2006-10#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#3)(2009-3#1)(2009-4#1)(2011-12#1)(2011-2#3)
that localization##2##2##(2008-1#1)(2008-8#1)
that locally##2##2##(2008-5#1)(2010-12#1)
that location##3##2##(1994-3#1)(2008-10#1)(2008-11#1)
that log##2##2##(1995-4#1)(2008-8#1)
that long term##3##3##(2011-2#2)(2013-8#1)
that long##13##2##(1991-2#1)(1991-3#1)(2006-6#1)(2008-12#1)(2008-3#1)(2010-12#2)(2011-2#5)(2013-8#1)
that long-lasting##2##2##(1991-8#1)(2009-12#1)
that long-range##3##2##(1990-8#1)(2007-12#1)(2011-2#1)
that long-term administration of##3##4##(1995-12#1)(2007-2#1)(2007-5#1)
that long-term exposure to##2##4##(1994-5#1)(2006-10#1)
that long-term exposure##3##3##(1993-7#1)(1994-5#1)(2006-10#1)
that long-term treatment with##3##4##(1992-11#1)(1994-6#1)(1996-3#1)
that long-term treatment##4##3##(1990-6#1)(1992-11#1)(1994-6#1)(1996-3#1)
that long-term use of##3##4##(2008-6#1)(2012-11#2)
that long-term##29##2##(1990-6#1)(1991-2#1)(1991-3#1)(1992-11#1)(1993-11#1)(1993-7#1)(1994-5#1)(1994-6#1)(1995-12#2)(1996-2#1)(1996-3#1)(1997-2#1)(2006-10#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-2#1)(2010-1#1)(2012-11#2)(2013-1#1)(2013-8#1)
that longer##5##2##(1991-6#1)(1992-2#1)(1992-9#2)(2011-2#1)
that looked at the##2##4##(2007-3#1)(2007-6#1)
that loop##2##2##(1996-8#1)(2008-11#1)
that loperamide##2##2##(2012-1#2)
that losing##2##2##(2012-2#2)
that loss of the##2##4##(1993-11#1)(2011-1#1)
that loss of##21##3##(1990-11#2)(1992-11#1)(1993-11#1)(1994-3#1)(1995-2#1)(1996-3#1)(2007-12#1)(2008-10#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#2)(2013-7#1)
that lost##3##2##(1993-10#1)(2013-1#2)
that loteprednol etabonate 0##2##4##(2007-11#2)
that lovastatin##2##2##(2005-8#1)(2006-12#1)
that low concentrations of##2##4##(1994-2#1)(1996-8#1)
that low dose radiation##2##4##(2007-10#1)(2008-7#1)
that low dose##7##3##(1991-12#1)(1992-4#1)(1994-5#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-7#1)
that low doses of##4##4##(1990-10#1)(2008-7#3)
that low doses##8##3##(1990-10#1)(2005-8#1)(2008-7#6)
that low intensity##2##3##(2006-1#1)(2011-2#1)
that low levels of##4##4##(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
that low molecular##2##3##(1997-7#1)(2012-2#1)
that low##59##2##(1990-10#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-4#1)(1994-2#2)(1994-5#1)(1994-6#1)(1995-12#2)(1995-7#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-6#1)(1997-7#2)(2005-3#1)(2005-8#1)(2006-1#1)(2006-12#3)(2007-10#2)(2007-8#2)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#8)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-12#1)(2011-2#4)(2012-12#1)(2012-2#3)(2013-1#2)
that low- and##2##3##(2007-10#1)(2013-8#1)
that low-dose##4##2##(2006-7#1)(2006-8#1)(2008-7#1)(2010-4#1)
that low-frequency##2##2##(2007-12#2)
that low-grade##2##2##(2008-6#1)(2009-10#1)
that lower doses of##2##4##(2006-12#1)(2007-9#1)
that lower the##2##3##(1992-9#1)(1997-4#1)
that lower##17##2##(1992-9#1)(1993-6#1)(1994-5#1)(1996-3#1)(1997-2#1)(1997-4#1)(2004-11#1)(2006-12#1)(2007-10#1)(2007-9#1)(2008-10#2)(2009-12#1)(2010-6#1)(2011-1#1)(2012-1#1)(2013-1#1)
that lowered##2##2##(1996-9#1)(2008-7#1)
that lumbar##2##2##(2006-8#1)(2007-8#1)
that lung cancer##3##3##(1990-10#2)(2008-7#1)
that lung##10##2##(1990-10#2)(1994-12#1)(1994-3#1)(1997-1#1)(2005-8#1)(2008-6#2)(2008-7#1)(2012-12#1)
that luteal##2##2##(1992-9#1)(2008-9#1)
that lymphocyte##2##2##(1991-5#1)(2004-12#1)
that lymphocytes from##2##3##(1990-8#1)(1992-2#1)
that lymphocytes##6##2##(1990-8#1)(1991-8#1)(1992-2#1)(1996-12#2)(2011-2#1)
that lysine##5##2##(1994-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(2010-4#1)
that lysoPI##2##2##(1991-7#2)
that lysosomal hydrolases##4##3##(2012-12#4)
that lysosomal##5##2##(1990-4#1)(2012-12#4)
that lysosomes##2##2##(1992-8#1)(2008-4#1)
that lysozyme does not##2##4##(1997-5#1)(1997-7#1)
that lysozyme##5##2##(1997-5#3)(1997-7#1)(2005-4#1)
that mAbs##2##2##(1991-8#1)(1996-12#1)
that mGlu##2##2##(1995-12#1)(1997-5#1)
that mGluR1 alpha##2##3##(1995-12#2)
that mGluR5##2##2##(1997-5#2)
that mRNA encoding##2##3##(1994-8#1)(2008-6#1)
that mRNA levels##3##3##(1993-5#1)(1993-8#1)(1994-5#1)
that mRNA of##2##3##(1993-3#1)(2008-6#1)
that mRNA##8##2##(1993-3#1)(1993-5#1)(1993-8#1)(1994-5#1)(1994-8#2)(2008-6#2)
that mRNAs##3##2##(1991-4#1)(1992-3#1)(1995-10#1)
that macrophage##2##2##(1995-8#1)(1996-12#1)
that macrophages are##2##3##(2007-10#1)(2008-10#1)
that macrophages from##2##3##(1995-12#1)(1996-12#1)
that macrophages##6##2##(1991-5#1)(1995-12#1)(1996-12#1)(2007-10#1)(2008-10#1)(2008-9#1)
that made##9##2##(1994-12#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-4#1)(2008-8#1)(2010-4#1)(2010-7#1)
that magnesium may##2##3##(1991-3#1)(2007-8#1)
that magnesium##5##2##(1991-3#2)(2007-8#1)(2010-1#2)
that magnetic field##2##3##(2008-9#2)
that magnetic resonance imaging##2##4##(1990-12#1)(2008-7#1)
that magnetic resonance##3##3##(1990-12#1)(2006-10#1)(2008-7#1)
that magnetic##6##2##(1990-12#1)(1992-1#1)(2006-10#1)(2008-7#1)(2008-9#2)
that magnolol##3##2##(2011-2#3)
that main##2##2##(2011-2#1)(2012-3#1)
that mainly##5##2##(2007-12#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
that maintain homeostasis##2##3##(2009-12#1)(2013-1#1)
that maintain the##2##3##(1995-2#1)(2007-11#1)
that maintain##18##2##(1992-8#1)(1995-2#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-4#2)(2008-8#2)(2009-12#2)(2010-10#1)(2011-1#1)(2013-1#3)(2013-7#1)
that maintained##3##2##(1995-12#1)(2005-11#1)(2012-1#1)
that maintaining##2##2##(2009-8#1)(2010-9#1)
that maintains##9##2##(1990-11#1)(1994-8#1)(1996-8#1)(2006-10#1)(2006-9#1)(2007-3#1)(2008-6#1)(2008-7#1)(2012-1#1)
that maintenance of##2##3##(1992-1#1)(2013-1#1)
that maize##2##2##(2008-10#1)(2008-7#1)
that major##12##2##(1991-10#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-5#2)(1996-6#1)(1997-5#1)(2007-9#1)(2008-10#2)(2009-5#1)
that majority of the##2##4##(2010-3#1)(2012-2#1)
that majority of##4##3##(2010-3#1)(2010-8#1)(2012-2#2)
that majority##5##2##(2007-3#1)(2010-3#1)(2010-8#1)(2012-2#2)
that make it a##3##4##(2008-4#1)(2013-1#2)
that make it difficult to##2##5##(2008-2#1)(2008-7#1)
that make it difficult##3##4##(1990-12#1)(2008-2#1)(2008-7#1)
that make it more##2##4##(1996-8#1)(2008-8#1)
that make it particularly##2##4##(1993-12#1)(2011-12#1)
that make it possible to##3##5##(1992-5#1)(2008-3#1)(2010-3#1)
that make it##21##3##(1990-12#1)(1992-5#1)(1993-12#1)(1996-8#1)(1997-2#1)(2006-10#1)(2006-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#1)(2010-3#1)(2011-12#1)(2011-2#1)(2013-1#2)
that make possible##2##3##(1994-3#1)(2011-2#1)
that make the##2##3##(1996-12#1)(2008-11#1)
that make them suitable##2##4##(2008-4#1)(2008-9#1)
that make them##10##3##(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)
that make up the##12##4##(1992-6#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#2)
that make up##14##3##(1992-6#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#2)
that make use of the##2##5##(2012-1#1)(2012-3#1)
that make use of these##2##5##(2008-2#2)
that make use of##7##4##(1992-9#1)(1995-8#1)(2008-2#3)(2012-1#1)(2012-3#1)
that make##80##2##(1990-12#1)(1991-6#1)(1992-2#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-3#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-2#2)(1997-8#1)(2005-5#1)(2006-10#2)(2006-11#1)(2006-7#1)(2007-12#3)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#5)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-7#2)(2010-12#1)(2010-3#1)(2010-7#1)(2011-12#2)(2011-2#6)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
that makes it possible to compute the##2##7##(2008-3#2)
that makes it possible to##4##5##(2006-5#1)(2007-8#1)(2008-3#2)
that makes it##6##3##(2006-5#1)(2007-8#1)(2008-3#3)(2010-5#1)
that makes them##2##3##(2007-3#1)(2008-11#1)
that makes up the##2##4##(2007-12#1)(2010-8#1)
that makes up##3##3##(1994-9#1)(2007-12#1)(2010-8#1)
that makes use of a##3##5##(2008-2#2)(2009-4#1)
that makes use of the##3##5##(2008-2#1)(2008-3#2)
that makes use of##14##4##(1992-6#1)(2007-12#3)(2008-2#6)(2008-3#3)(2009-4#1)
that makes##44##2##(1990-3#1)(1992-6#1)(1994-9#1)(1996-8#1)(1997-3#1)(2006-5#1)(2006-8#1)(2007-12#6)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#8)(2008-3#9)(2008-8#3)(2009-3#1)(2009-4#1)(2009-6#1)(2010-5#1)(2010-8#1)(2013-8#1)
that malaria##3##2##(2005-8#1)(2008-4#2)
that male and##2##3##(2006-5#1)(2008-10#1)
that male physicians##2##3##(2008-8#1)(2011-2#1)
that male voles##2##3##(2009-6#2)
that male##22##2##(1990-12#1)(1993-8#1)(1995-8#1)(2005-7#1)(2006-5#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-6#3)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
that males are##3##3##(1991-1#1)(2010-2#1)(2012-11#1)
that males with##2##3##(2008-12#1)(2009-10#1)
that males##18##2##(1991-1#1)(2006-6#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-8#3)(2009-10#1)(2009-6#2)(2010-2#1)(2012-11#1)(2012-12#2)(2013-8#1)
that malignant##2##2##(2008-11#1)(2010-9#1)
that malnutrition is a##2##4##(2008-4#2)
that malnutrition##3##2##(2008-4#2)(2012-2#1)
that malondialdehyde##2##2##(1990-4#1)(2008-8#1)
that mammalian sperm##2##3##(1990-11#2)
that mammalian##8##2##(1990-11#2)(1990-12#1)(1990-7#1)(1991-1#1)(1991-6#1)(1996-11#1)(1996-4#1)
that mammals express##2##3##(1990-2#2)
that mammary cells##2##3##(1996-4#1)(2012-12#1)
that mammary##6##2##(1990-5#2)(1995-5#1)(1996-4#1)(2007-8#1)(2012-12#1)
that mammography##2##2##(1995-2#1)(2006-10#1)
that manage##3##2##(1995-12#1)(1997-3#1)(2008-10#1)
that managed care##3##3##(1993-12#1)(1994-3#1)(2008-7#1)
that managed##6##2##(1993-12#1)(1994-3#1)(1995-1#1)(2008-10#1)(2008-3#1)(2008-7#1)
that management of##3##3##(2007-12#1)(2008-10#2)
that management##7##2##(1993-12#1)(1994-12#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#1)
that managers##8##2##(1992-1#1)(1993-2#1)(1994-2#2)(1995-12#1)(2006-5#1)(2010-5#1)(2013-8#1)
that managing##2##2##(1997-2#1)(2008-1#1)
that manifest in##2##3##(2011-2#1)(2013-7#1)
that manifest##8##2##(2007-12#1)(2008-2#1)(2008-3#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
that manifests as##2##3##(2009-12#1)(2011-1#1)
that manifests##6##2##(2008-2#1)(2009-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
that manipulating the##4##3##(2008-10#1)(2008-3#1)(2010-7#1)(2012-12#1)
that manipulating##7##2##(2006-12#1)(2008-10#1)(2008-3#1)(2010-7#1)(2012-12#1)(2013-1#2)
that manipulation of##3##3##(1995-12#1)(2007-2#1)(2010-11#1)
that manual##4##2##(2008-10#2)(2011-1#1)(2012-2#1)
that manufacturers##3##2##(2008-10#2)(2008-11#1)
that many PD patients##2##4##(2008-7#1)(2009-10#1)
that many aspects of##2##4##(2008-3#1)(2009-10#1)
that many cases of##2##4##(2007-12#1)(2007-7#1)
that many cases##3##3##(2007-12#2)(2007-7#1)
that many children##3##3##(1995-12#1)(1997-1#1)(1997-4#1)
that many clinical##2##3##(2006-10#1)(2007-8#1)
that many drugs##2##3##(2007-11#1)(2007-6#1)
that many genes##2##3##(1995-6#1)(2013-8#1)
that many more##3##3##(1990-2#1)(1992-3#1)(2008-10#1)
that many new##2##3##(1994-3#1)(2008-10#1)
that many of the same##3##5##(1992-10#1)(1997-6#1)(2008-3#1)
that many of the##28##4##(1990-12#1)(1991-2#1)(1991-5#1)(1992-10#1)(1992-4#1)(1993-12#1)(1993-3#1)(1995-11#1)(1996-10#1)(1996-3#1)(1997-6#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#1)(2010-1#1)(2012-3#1)
that many of these##13##4##(1994-6#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-7#1)(2009-3#2)(2009-4#1)(2010-3#2)(2011-2#1)(2012-2#1)
that many of##45##3##(1990-12#1)(1990-6#1)(1991-2#1)(1991-5#1)(1992-10#1)(1992-4#1)(1993-12#1)(1993-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1996-10#1)(1996-3#1)(1997-6#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-10#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-3#2)(2009-4#1)(2009-8#1)(2010-1#1)(2010-3#2)(2011-2#1)(2012-2#1)(2012-3#1)
that many participants##2##3##(2007-7#1)(2013-8#1)
that many patients##3##3##(2010-12#1)(2011-1#1)(2012-2#1)
that many people do not##3##5##(2008-5#1)(2013-1#2)
that many people##5##3##(2008-5#1)(2009-10#1)(2011-2#1)(2013-1#2)
that many researchers##2##3##(2007-8#2)
that many women##2##3##(2004-1#1)(2011-1#1)
that many##170##2##(1990-1#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-10#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-1#1)(2004-10#1)(2005-10#1)(2005-11#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#8)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#4)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#4)(2009-10#4)(2009-12#1)(2009-3#3)(2009-4#5)(2009-5#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-7#2)(2011-1#5)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#2)(2013-8#2)
that map##4##2##(1991-12#1)(2007-6#1)(2013-1#2)
that mapped on chromosome##2##4##(1996-10#1)(2008-10#1)
that mapped##4##2##(1996-10#1)(2008-10#2)(2008-5#1)
that mapping in##2##3##(2008-3#1)(2008-8#1)
that mapping##4##2##(2008-3#1)(2008-8#1)(2013-1#2)
that maps a##2##3##(2007-12#1)(2010-5#1)
that maps to##2##3##(1993-5#1)(2008-10#1)
that maps##4##2##(1993-5#1)(2007-12#1)(2008-10#1)(2010-5#1)
that marginal##2##2##(2008-10#1)(2011-2#1)
that marine##3##2##(2008-11#1)(2011-1#1)(2012-2#1)
that marked##2##2##(1997-6#1)(2008-2#1)
that markedly##2##2##(1996-10#1)(2011-12#1)
that marriage##2##2##(2009-11#1)(2011-2#1)
that maspin is##2##3##(1995-6#2)
that maspin##3##2##(1995-6#3)
that mass##4##2##(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)
that mast cells are##2##4##(1995-12#1)(2008-7#1)
that mast cells##4##3##(1995-12#1)(2008-7#2)(2011-2#1)
that match the##4##3##(2006-11#1)(2007-11#1)(2007-12#1)(2010-2#1)
that matched##4##2##(1996-10#1)(2008-10#1)(2010-5#1)(2012-12#1)
that matches the##4##3##(1994-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
that matches##6##2##(1994-12#1)(1997-4#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)
that mate##2##2##(2008-8#2)
that material##3##2##(1990-8#1)(1995-12#1)(1996-12#1)
that maternal hyperglycemia##2##3##(2008-1#1)(2008-3#1)
that maternal##15##2##(1990-5#1)(1996-11#1)(1996-3#1)(1996-4#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-8#2)(2010-7#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
that matrix effects were##2##4##(1997-2#1)(2008-10#1)
that matrix##4##2##(1997-2#1)(2008-10#2)(2008-8#1)
that matters##2##2##(1997-2#1)(2012-12#1)
that maturation of CEs was##2##5##(2008-5#2)
that maturation of##4##3##(1992-2#1)(1995-8#1)(2008-5#2)
that maximal expression##2##3##(1995-8#1)(1997-4#1)
that maximal##7##2##(1990-2#1)(1994-11#1)(1995-2#1)(1995-8#1)(1996-5#1)(1997-4#1)(2008-10#1)
that maximize the##7##3##(1990-2#1)(1996-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-1#1)
that maximize##12##2##(1990-2#1)(1996-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-4#1)(2012-2#1)(2013-1#1)
that maximizes the##8##3##(2008-11#1)(2008-2#3)(2008-3#2)(2008-8#1)(2013-8#1)
that maximizes##15##2##(1997-1#1)(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-8#3)(2008-9#2)(2013-8#1)
that maximum##9##2##(1990-3#1)(1995-6#2)(2006-11#1)(2007-10#1)(2007-6#1)(2008-10#2)(2008-8#1)
that may account for the##3##5##(2008-10#1)(2010-1#1)(2012-3#1)
that may account for##4##4##(2008-10#1)(2008-6#1)(2010-1#1)(2012-3#1)
that may act as a##3##5##(1990-5#1)(1991-5#1)(2008-10#1)
that may act as##4##4##(1990-5#1)(1991-5#1)(2008-10#1)(2009-2#1)
that may activate##2##3##(1991-4#1)(2011-1#1)
that may affect the##8##4##(1992-3#1)(1993-10#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-2#1)
that may affect their##2##4##(1992-3#1)(2012-3#1)
that may affect##20##3##(1992-3#2)(1993-10#1)(1997-2#1)(1997-5#1)(2005-10#1)(2005-6#1)(2005-7#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#2)(2010-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
that may aid##2##3##(2007-5#1)(2011-7#1)
that may also##4##3##(1996-5#1)(1997-3#1)(2008-7#1)(2011-1#1)
that may alter the##2##4##(2009-9#1)(2011-1#1)
that may alter##4##3##(2006-5#1)(2008-8#1)(2009-9#1)(2011-1#1)
that may arise in##7##4##(2007-10#1)(2007-11#1)(2007-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-6#1)
that may arise##15##3##(1992-10#1)(1994-4#1)(1997-3#1)(2005-5#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-9#1)(2012-2#1)
that may be a##3##4##(1991-12#1)(1995-12#1)(2008-11#1)
that may be affected by##2##5##(2010-2#1)(2013-1#1)
that may be amenable to##2##5##(2006-10#1)(2008-6#1)
that may be answered##2##4##(1994-3#1)(2012-12#1)
that may be associated with##11##5##(1990-7#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-7#1)
that may be associated##13##4##(1990-7#1)(2005-8#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-10#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-7#1)
that may be considered##2##4##(2007-2#1)(2011-2#1)
that may be difficult to##3##5##(2006-10#1)(2007-8#1)(2009-10#1)
that may be due to##4##5##(1990-11#1)(1991-12#1)(1997-7#1)(2011-2#1)
that may be employed to##2##5##(2008-2#1)(2008-4#1)
that may be employed##3##4##(2008-2#1)(2008-4#1)(2008-6#1)
that may be encountered in##2##5##(1995-8#1)(2010-12#1)
that may be encountered when##2##5##(1993-2#1)(1996-9#1)
that may be encountered##7##4##(1993-2#1)(1995-8#1)(1996-9#1)(2008-2#1)(2010-12#1)(2011-1#1)(2012-2#1)
that may be helpful##2##4##(2006-10#1)(2008-1#1)
that may be important for##4##5##(1996-12#1)(1997-4#1)(2008-2#1)(2012-2#1)
that may be important in##2##5##(2008-10#1)(2010-10#1)
that may be important##6##4##(1996-12#1)(1997-4#1)(2008-10#1)(2008-2#1)(2010-10#1)(2012-2#1)
that may be imposed##2##4##(1991-2#1)(2012-11#1)
that may be involved in the##5##6##(1991-1#1)(2006-10#1)(2008-1#1)(2008-5#1)(2010-2#1)
that may be involved in##11##5##(1991-1#1)(1992-3#1)(1995-7#1)(2006-10#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-10#1)(2010-2#1)
that may be mediated by##2##5##(2008-1#1)(2008-9#1)
that may be more##2##4##(2008-7#1)(2010-6#1)
that may be necessary##2##4##(2009-11#1)(2009-5#1)
that may be of interest to##2##6##(2006-10#1)(2011-1#1)
that may be of##9##4##(1997-6#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-2#1)(2007-6#1)(2008-2#1)(2010-11#1)(2011-1#1)
that may be potentially useful##2##5##(1992-6#1)(2013-7#1)
that may be present in the##2##6##(1996-5#1)(2007-10#1)
that may be present in##4##5##(1991-9#1)(1996-5#1)(2007-10#1)(2010-4#1)
that may be present##5##4##(1991-9#1)(1996-5#1)(2007-10#1)(2007-12#1)(2010-4#1)
that may be related to##5##5##(1992-5#1)(2007-12#1)(2008-5#1)(2010-1#1)(2010-2#1)
that may be relevant to the##2##6##(1994-2#1)(1994-8#1)
that may be responsible for its##2##6##(2011-2#1)(2012-2#1)
that may be responsible for the##3##6##(1993-9#1)(2007-12#1)(2008-7#1)
that may be responsible for##6##5##(1993-9#1)(2007-11#1)(2007-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
that may be the##2##4##(2007-7#1)(2011-1#1)
that may be used as##2##5##(2008-1#1)(2009-11#1)
that may be used for##3##5##(2008-1#1)(2008-4#1)(2008-7#1)
that may be used in##2##5##(1992-8#1)(2013-8#1)
that may be used to##6##5##(2006-10#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#1)
that may be used##15##4##(1992-8#1)(2006-10#1)(2007-3#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-11#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-8#1)
that may be useful for##5##5##(1996-9#1)(1997-5#1)(2005-7#1)(2008-7#1)(2013-8#1)
that may be useful in##7##5##(1994-8#1)(1994-9#1)(2005-9#1)(2008-4#2)(2008-7#1)(2013-8#1)
that may be useful to##3##5##(1993-12#1)(2007-2#2)
that may be useful##17##4##(1993-12#1)(1994-8#1)(1994-9#1)(1996-9#1)(1997-5#1)(2005-7#1)(2005-9#1)(2006-12#1)(2007-2#2)(2008-4#3)(2008-7#2)(2013-8#2)
that may be##230##3##(1990-11#1)(1990-7#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-6#2)(1994-8#2)(1994-9#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-8#1)(1996-9#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-11#2)(2005-7#3)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#10)(2006-11#1)(2006-12#2)(2006-2#2)(2006-3#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#5)(2007-2#3)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#8)(2008-10#11)(2008-11#5)(2008-12#5)(2008-2#5)(2008-3#4)(2008-4#9)(2008-5#3)(2008-6#4)(2008-7#6)(2008-9#3)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#4)(2010-10#3)(2010-11#1)(2010-12#3)(2010-2#3)(2010-4#3)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#8)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#8)
that may become##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
that may bind##2##3##(1994-5#1)(2010-10#1)
that may cause mutations##2##4##(1993-8#1)(1994-5#1)
that may cause##8##3##(1992-2#1)(1993-8#1)(1994-5#1)(2006-10#1)(2006-2#1)(2008-11#1)(2012-2#1)(2013-7#1)
that may come##3##3##(2008-8#1)(2009-3#1)(2009-6#1)
that may compromise##2##3##(1996-2#1)(2006-10#1)
that may contain##3##3##(2008-1#1)(2008-7#1)(2009-4#1)
that may contribute to disease##2##5##(2005-8#1)(2008-10#1)
that may contribute to suicidal behaviors##2##6##(2012-12#2)
that may contribute to the##3##5##(2006-3#1)(2009-9#1)(2013-7#1)
that may contribute to##19##4##(1992-2#1)(1992-9#1)(1996-12#1)(2005-8#1)(2006-3#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2009-9#1)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
that may control the##2##4##(1994-3#1)(2008-1#1)
that may control##7##3##(1992-7#1)(1994-3#1)(1994-8#1)(1996-11#1)(2008-1#1)(2009-11#1)(2013-8#1)
that may decrease##2##3##(2008-6#1)(2010-8#1)
that may differ##2##3##(1993-9#1)(2008-7#1)
that may either##2##3##(2007-11#1)(2008-10#1)
that may enable them to##2##5##(2007-2#1)(2012-3#1)
that may enable##3##3##(2007-2#1)(2012-3#1)(2013-8#1)
that may enhance##4##3##(1992-12#1)(1994-2#1)(2005-7#1)(2013-1#1)
that may exceed##2##3##(2009-3#1)(2009-9#1)
that may exert##3##3##(2007-11#1)(2008-11#1)(2012-2#1)
that may exist##3##3##(2007-4#1)(2008-2#1)(2008-9#1)
that may explain##5##3##(1994-9#1)(1995-2#1)(2006-9#1)(2009-8#1)(2012-2#1)
that may facilitate the##2##4##(2008-8#1)(2009-3#1)
that may facilitate##5##3##(2006-6#1)(2008-8#1)(2009-3#1)(2010-12#2)
that may follow##3##3##(2006-10#1)(2007-11#2)
that may form##2##3##(2008-1#1)(2008-10#1)
that may further##3##3##(2008-1#1)(2009-5#1)(2012-2#1)
that may generate##2##3##(2007-7#1)(2008-8#1)
that may guide##3##3##(2006-7#1)(2010-8#1)(2012-1#1)
that may have a##4##4##(1996-7#1)(2007-12#1)(2010-8#1)(2012-3#1)
that may have an##2##4##(2006-10#1)(2006-6#1)
that may have been##5##4##(1990-9#1)(1994-3#1)(2008-10#1)(2008-9#1)(2010-8#1)
that may have##31##3##(1990-9#1)(1992-2#1)(1992-9#1)(1993-6#1)(1994-3#1)(1996-7#1)(2005-7#1)(2006-10#4)(2006-6#1)(2007-12#1)(2007-6#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-3#2)
that may help clinicians##2##4##(2005-7#1)(2012-1#1)
that may help increase##2##4##(2006-5#1)(2008-11#1)
that may help the##2##4##(2007-11#1)(2010-12#1)
that may help##15##3##(2005-7#1)(2006-2#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-5#1)(2010-12#1)(2010-3#1)(2012-1#2)(2012-12#1)(2013-1#1)
that may impact on##3##4##(2006-10#1)(2007-11#1)(2010-11#1)
that may impact the##2##4##(2007-7#1)(2008-10#1)
that may impact##6##3##(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2010-11#1)(2012-2#1)
that may impair##2##3##(2007-11#1)(2007-2#1)
that may improve the##3##4##(2005-10#1)(2006-10#1)(2012-1#1)
that may improve##5##3##(1993-12#1)(2005-10#1)(2006-10#1)(2010-4#1)(2012-1#1)
that may in turn##2##4##(2006-10#1)(2006-5#1)
that may in##3##3##(2006-10#1)(2006-5#1)(2011-2#1)
that may include##3##3##(2007-8#1)(2011-3#1)(2012-2#1)
that may increase the##2##4##(2006-10#1)(2011-2#1)
that may increase##5##3##(2006-10#1)(2007-12#1)(2008-5#1)(2009-9#1)(2011-2#1)
that may indicate##5##3##(1993-1#1)(1995-1#1)(2008-4#2)(2008-5#1)
that may influence the##5##4##(2008-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)
that may influence##19##3##(1995-6#1)(2006-10#2)(2006-5#2)(2007-10#1)(2007-12#1)(2008-12#1)(2008-4#1)(2008-6#1)(2010-12#1)(2010-2#3)(2010-7#1)(2010-8#1)(2011-1#3)
that may interact with##2##4##(2008-8#1)(2012-12#1)
that may interfere with##2##4##(2013-1#1)(2013-8#1)
that may involve the##2##4##(2007-6#1)(2012-2#1)
that may involve##8##3##(1993-9#1)(1994-2#1)(1996-8#1)(2005-10#1)(2006-12#1)(2007-12#1)(2007-6#1)(2012-2#1)
that may lead to a##2##5##(2006-10#1)(2010-7#1)
that may lead to an##2##5##(2010-12#1)(2013-1#1)
that may lead to the##2##5##(1997-2#1)(2011-2#1)
that may lead to##18##4##(1994-7#1)(1995-9#1)(1997-2#1)(2006-10#3)(2007-12#1)(2008-11#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#2)
that may link##2##3##(2009-5#1)(2012-12#1)
that may make##5##3##(2006-10#2)(2006-9#1)(2008-12#1)(2010-2#1)
that may mediate the##2##4##(1997-4#1)(2010-2#1)
that may mediate##5##3##(1991-5#1)(1995-6#1)(1997-4#1)(2010-2#1)(2012-12#1)
that may mimic a##2##4##(1991-6#1)(2011-2#1)
that may mimic##7##3##(1991-6#1)(2005-8#1)(2006-10#1)(2008-3#1)(2009-3#1)(2010-8#1)(2011-2#1)
that may not be directly##2##5##(1991-7#1)(1995-3#1)
that may not be##11##4##(1991-7#1)(1995-3#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2011-2#1)(2013-1#3)
that may not##15##3##(1991-7#1)(1995-3#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-1#5)
that may occur at the##2##5##(2007-1#1)(2008-2#1)
that may occur during##6##4##(1996-8#1)(2006-12#1)(2007-11#1)(2010-8#1)(2011-2#1)(2013-1#1)
that may occur in##5##4##(2005-8#2)(2007-10#1)(2007-11#1)(2011-1#1)
that may occur##22##3##(1994-3#1)(1996-8#1)(2005-8#2)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-9#1)(2008-2#1)(2008-4#1)(2008-5#2)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
that may offer##2##3##(2010-7#1)(2011-2#1)
that may often##2##3##(1992-3#1)(2013-8#1)
that may or may not be associated with##2##8##(2006-10#1)(2013-1#1)
that may or may not be##4##6##(2006-10#1)(2010-1#1)(2012-11#1)(2013-1#1)
that may overcome##3##3##(2006-12#1)(2009-11#1)(2010-6#1)
that may participate in the##3##5##(1991-5#1)(1994-6#1)(2013-1#1)
that may persist##2##3##(2011-2#1)(2013-1#1)
that may play a role in the##4##7##(2006-8#1)(2011-12#1)(2012-2#2)
that may play a role in##7##6##(1994-12#1)(1995-8#1)(2006-8#1)(2009-4#1)(2011-12#1)(2012-2#2)
that may play a##12##4##(1994-12#2)(1995-3#1)(1995-8#1)(2006-8#2)(2007-11#1)(2009-4#1)(2010-12#1)(2011-12#1)(2012-2#2)
that may play important roles in##2##6##(1995-11#1)(2012-2#1)
that may play##15##3##(1994-12#2)(1995-11#1)(1995-3#1)(1995-8#1)(1997-1#1)(2006-8#2)(2007-11#1)(2009-4#1)(2010-12#1)(2011-12#1)(2012-2#3)
that may pose a##2##4##(2007-1#1)(2007-2#1)
that may pose##3##3##(2007-1#1)(2007-2#1)(2013-7#1)
that may possibly##3##3##(1990-12#1)(2008-6#1)(2013-1#1)
that may potentially##3##3##(1996-12#1)(2007-4#1)(2009-9#1)
that may precede##2##3##(2006-5#1)(2008-10#1)
that may predict##2##3##(2009-10#1)(2009-6#1)
that may predispose the##2##4##(2005-8#1)(2008-12#1)
that may predispose##6##3##(1990-9#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-12#1)
that may present in##2##4##(2007-12#1)(2012-11#1)
that may present##5##3##(2006-10#1)(2007-12#1)(2007-2#1)(2008-7#1)(2012-11#1)
that may prevent##5##3##(2006-12#1)(2008-5#1)(2009-4#1)(2010-1#1)(2010-2#1)
that may promote##4##3##(2008-1#1)(2008-9#1)(2009-11#1)(2011-2#1)
that may prove useful##2##4##(2008-11#1)(2008-4#1)
that may prove##6##3##(1994-11#1)(1996-10#1)(2008-11#1)(2008-4#1)(2010-12#1)(2010-8#1)
that may provide##6##3##(1993-3#1)(1996-6#1)(2005-8#1)(2006-12#1)(2008-1#1)(2010-8#1)
that may reduce the##2##4##(2007-12#1)(2009-5#1)
that may reduce##4##3##(2007-12#1)(2008-10#1)(2009-5#1)(2011-2#1)
that may reflect the##3##4##(1993-2#1)(1995-12#1)(2009-3#1)
that may reflect##4##3##(1993-2#1)(1995-12#1)(2009-3#1)(2012-3#1)
that may regulate##3##3##(1993-3#1)(2009-8#1)(2012-2#1)
that may replace##2##3##(1994-9#1)(2012-3#1)
that may represent a##2##4##(2006-7#1)(2012-2#1)
that may represent##6##3##(1991-2#1)(1993-11#1)(1993-7#1)(1995-11#1)(2006-7#1)(2012-2#1)
that may require##5##3##(1995-11#1)(2006-10#1)(2007-12#1)(2012-1#1)(2012-2#1)
that may respond to##2##4##(2006-2#1)(2008-2#1)
that may result from##8##4##(1992-2#1)(1995-9#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-5#1)(2012-2#1)
that may result in##10##4##(1993-3#1)(1995-10#1)(2006-8#1)(2008-3#1)(2008-4#1)(2009-2#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
that may result##18##3##(1992-2#1)(1993-3#1)(1995-10#1)(1995-9#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-2#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
that may serve as an##2##5##(2007-2#1)(2010-11#1)
that may serve as##7##4##(1990-5#1)(1990-9#1)(2006-10#1)(2007-2#1)(2007-9#1)(2010-11#1)(2013-1#1)
that may serve##8##3##(1990-5#1)(1990-9#1)(1996-1#1)(2006-10#1)(2007-2#1)(2007-9#1)(2010-11#1)(2013-1#1)
that may shape##2##3##(2011-2#1)(2012-3#1)
that may significantly##2##3##(2008-2#1)(2008-9#1)
that may ultimately##3##3##(2006-8#1)(2013-1#2)
that may underlie the##4##4##(1994-8#1)(1996-2#2)(2012-12#1)
that may underlie these##3##4##(1990-8#1)(2006-10#1)(2008-9#1)
that may underlie##11##3##(1990-8#1)(1994-8#1)(1996-2#2)(2006-10#1)(2006-12#1)(2008-9#1)(2010-10#1)(2012-12#1)(2013-1#2)
that may##799##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#4)(1991-1#3)(1991-11#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#5)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-10#2)(1993-11#1)(1993-12#3)(1993-2#4)(1993-3#4)(1993-4#1)(1993-6#3)(1993-7#2)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#6)(1994-4#1)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#4)(1994-9#3)(1995-1#1)(1995-10#2)(1995-11#4)(1995-12#2)(1995-2#2)(1995-3#3)(1995-6#2)(1995-7#1)(1995-8#3)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#4)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#4)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#2)(2005-10#4)(2005-11#2)(2005-5#1)(2005-6#1)(2005-7#7)(2005-8#9)(2005-9#1)(2006-1#1)(2006-10#41)(2006-11#1)(2006-12#9)(2006-2#5)(2006-3#2)(2006-4#1)(2006-5#9)(2006-6#2)(2006-7#4)(2006-8#5)(2006-9#4)(2007-1#3)(2007-10#7)(2007-11#16)(2007-12#17)(2007-2#9)(2007-3#1)(2007-4#4)(2007-5#1)(2007-6#3)(2007-7#6)(2007-8#6)(2007-9#7)(2008-1#17)(2008-10#34)(2008-11#17)(2008-12#9)(2008-2#12)(2008-3#10)(2008-4#23)(2008-5#12)(2008-6#13)(2008-7#13)(2008-8#8)(2008-9#13)(2009-10#2)(2009-11#6)(2009-12#1)(2009-2#2)(2009-3#8)(2009-4#5)(2009-5#7)(2009-6#4)(2009-7#2)(2009-8#2)(2009-9#7)(2010-1#7)(2010-10#5)(2010-11#6)(2010-12#12)(2010-2#10)(2010-3#1)(2010-4#5)(2010-5#1)(2010-6#3)(2010-7#4)(2010-8#13)(2010-9#2)(2011-1#12)(2011-12#3)(2011-2#27)(2011-3#1)(2011-7#1)(2012-1#11)(2012-11#4)(2012-12#13)(2012-2#26)(2012-3#11)(2013-1#26)(2013-7#6)(2013-8#15)
that maybe##3##2##(2006-8#1)(2008-10#1)(2011-2#1)
that mean antibody values##2##4##(2011-2#2)
that mean##14##2##(1990-11#1)(1991-6#1)(1992-7#2)(2008-8#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2013-1#1)
that meaningful##2##2##(1994-2#1)(2010-12#1)
that means##6##2##(1993-5#1)(1995-1#1)(2005-10#1)(2008-10#1)(2008-12#1)(2010-1#1)
that measurable##2##2##(1996-4#1)(2010-8#1)
that measure the##5##3##(2008-1#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-12#1)
that measure##12##2##(1992-10#1)(1994-3#1)(1997-6#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-12#2)
that measured by a##2##4##(1996-12#1)(2008-10#1)
that measured by##5##3##(1995-7#1)(1996-12#1)(2008-10#1)(2012-11#1)(2013-1#1)
that measured for##5##3##(1992-9#1)(1997-8#1)(2008-10#2)(2008-3#1)
that measured in the##3##4##(1990-2#1)(1990-5#1)(1996-2#1)
that measured in##6##3##(1990-2#1)(1990-5#1)(1996-2#1)(2008-2#1)(2012-3#1)(2013-1#1)
that measured the##4##3##(2007-11#1)(2008-10#1)(2008-5#1)(2010-8#1)
that measured with##3##3##(1991-2#1)(1992-9#1)(2007-12#1)
that measured##33##2##(1990-2#1)(1990-5#1)(1991-2#1)(1992-9#2)(1993-12#1)(1994-3#1)(1995-7#1)(1996-12#1)(1996-2#1)(1997-8#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-5#2)(2009-11#1)(2010-8#1)(2012-11#1)(2012-3#1)(2013-1#2)(2013-8#1)
that measurement of the##3##4##(1990-2#1)(2007-12#1)(2013-8#1)
that measurement of##14##3##(1990-2#1)(1990-8#1)(1991-11#1)(1992-7#1)(1993-11#1)(1993-12#1)(1994-12#1)(1995-7#1)(1996-6#1)(2005-8#1)(2007-12#1)(2008-12#1)(2013-1#1)(2013-8#1)
that measurement##16##2##(1990-2#1)(1990-8#1)(1991-11#1)(1992-7#1)(1993-11#1)(1993-12#1)(1994-12#1)(1995-7#1)(1996-12#1)(1996-6#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2013-1#1)(2013-8#1)
that measurements made##2##3##(1992-12#1)(1996-5#1)
that measurements of##3##3##(1992-4#1)(1994-7#1)(2013-1#1)
that measurements##7##2##(1992-12#1)(1992-4#1)(1994-7#1)(1996-5#1)(2008-2#1)(2008-3#1)(2013-1#1)
that measures the##14##3##(1991-11#1)(1995-1#1)(1995-3#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#2)(2010-4#1)(2011-1#1)(2013-1#1)
that measures##29##2##(1991-11#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-12#2)(2008-2#2)(2008-3#5)(2008-7#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-1#1)(2013-1#3)(2013-8#1)
that measuring##2##2##(2008-11#1)(2010-12#1)
that meat##2##2##(2008-4#1)(2010-4#1)
that mechanical properties of the##2##5##(2007-8#1)(2010-4#1)
that mechanical##9##2##(1990-11#1)(1990-12#1)(1992-7#1)(2006-11#1)(2007-8#1)(2007-9#1)(2008-4#1)(2010-4#1)(2012-2#1)
that mechanism##4##2##(1991-5#1)(2008-10#1)(2008-11#1)(2008-5#1)
that mechanisms of##5##3##(1993-9#1)(1997-8#1)(2006-10#1)(2006-2#1)(2009-2#1)
that mechanisms other than##5##4##(1994-3#1)(1995-9#1)(1996-10#1)(2008-10#1)(2008-8#1)
that mechanisms##12##2##(1992-9#1)(1993-9#1)(1994-3#1)(1995-9#1)(1996-10#1)(1997-8#1)(2006-10#1)(2006-2#1)(2008-10#2)(2008-8#1)(2009-2#1)
that media##2##2##(2007-12#2)
that medial##3##2##(1992-11#1)(1992-8#1)(2008-6#1)
that median##3##2##(1990-9#1)(2004-2#1)(2010-10#1)
that mediate myocardial##2##3##(2010-8#1)(2012-12#1)
that mediate the interaction##2##4##(1990-4#1)(2012-3#1)
that mediate the##10##3##(1990-4#1)(1991-11#1)(1994-4#1)(1995-2#1)(1996-2#1)(1996-5#1)(2008-1#1)(2009-8#1)(2011-2#1)(2012-3#1)
that mediate this##2##3##(1997-1#1)(2012-2#1)
that mediate##42##2##(1990-4#1)(1991-11#1)(1991-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-8#1)(1995-2#1)(1995-3#2)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(2006-10#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
that mediated by##2##3##(1990-7#1)(2009-8#1)
that mediates a##2##3##(1995-2#1)(2013-1#1)
that mediates the##8##3##(1990-11#1)(1991-2#1)(1992-1#1)(1994-12#1)(1995-8#1)(2007-11#1)(2009-8#1)(2012-2#1)
that mediates##27##2##(1990-11#1)(1991-2#1)(1992-1#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1997-7#1)(2004-11#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-4#1)(2009-8#2)(2010-9#1)(2012-2#1)(2013-1#3)(2013-7#1)
that medical device##2##3##(2005-10#1)(2007-11#1)
that medical personnel##2##3##(1997-5#1)(2006-7#1)
that medical therapy##2##3##(1990-11#1)(2007-11#1)
that medical##22##2##(1990-11#1)(1992-3#1)(1993-3#1)(1993-5#1)(1996-2#1)(1996-6#1)(1997-5#1)(2005-10#1)(2006-10#1)(2006-7#2)(2007-11#2)(2007-4#1)(2007-7#1)(2008-12#2)(2008-7#1)(2010-1#1)(2010-12#1)(2011-2#1)(2011-7#1)
that medicated##2##2##(2008-7#1)(2013-7#1)
that meditation##2##2##(2008-11#1)(2010-2#1)
that medium##2##2##(1991-3#1)(2008-2#1)
that meet the criteria##2##4##(1997-2#1)(2012-1#1)
that meet the needs of##2##5##(1996-3#1)(1997-2#1)
that meet the##6##3##(1996-3#1)(1997-2#3)(2008-9#1)(2012-1#1)
that meet##15##2##(1991-1#1)(1993-12#1)(1996-3#1)(1997-2#3)(2006-5#1)(2007-1#1)(2007-2#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-1#1)(2013-1#1)
that meeting##3##2##(1996-12#1)(2006-10#1)(2008-11#1)
that meets all##2##3##(2008-3#1)(2008-4#1)
that meets the information needs of##2##6##(1997-3#1)(2007-7#1)
that meets the##6##3##(1994-2#2)(1997-3#1)(2007-7#1)(2008-1#1)(2008-10#1)
that meets##11##2##(1993-2#1)(1994-2#2)(1996-3#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#1)
that melanoma##3##2##(1994-5#1)(1995-4#1)(2007-11#1)
that melatonin may##2##3##(1994-5#1)(1995-7#1)
that melatonin##9##2##(1990-2#1)(1991-7#1)(1994-5#2)(1994-8#2)(1995-7#1)(1997-8#1)(2008-8#1)
that melittin##2##2##(1991-7#1)(2008-10#1)
that members of the##6##4##(1994-10#1)(1994-11#1)(1995-3#2)(1996-3#1)(1996-8#1)
that members of##8##3##(1994-10#1)(1994-11#1)(1995-1#1)(1995-3#2)(1996-3#1)(1996-8#1)(2012-12#1)
that membrane asymmetry##2##3##(2005-11#1)(2010-4#1)
that membrane##13##2##(1990-3#1)(1991-4#1)(1993-9#1)(1994-8#1)(1997-1#1)(1997-6#1)(2005-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-4#1)
that membranes##3##2##(1992-7#1)(1994-8#1)(2009-7#1)
that memory T cells##2##4##(2007-8#1)(2008-8#1)
that memory for##2##3##(1990-10#1)(2010-2#1)
that memory##11##2##(1990-10#1)(1994-8#1)(1995-11#1)(2007-8#1)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-2#1)
that men and women##2##4##(2008-1#1)(2010-5#1)
that men were##2##3##(2007-7#1)(2008-1#1)
that men with##3##3##(2006-10#1)(2006-7#1)(2009-5#1)
that men##16##2##(2006-10#2)(2006-7#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-11#1)(2009-5#4)(2010-10#1)(2010-5#1)(2011-2#1)(2012-12#1)
that men's##4##2##(2007-12#1)(2009-5#1)(2010-12#2)
that menopause##2##2##(2007-1#1)(2007-9#1)
that mental health nurses##2##4##(2007-3#1)(2008-12#1)
that mental health##4##3##(2007-3#1)(2008-12#1)(2013-1#2)
that mental##7##2##(1997-8#1)(2007-3#1)(2008-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
that menthol##2##2##(1994-6#1)(2011-1#1)
that mentoring is##2##3##(2008-12#1)(2009-4#1)
that mercury in##2##3##(2004-9#1)(2007-5#1)
that mercury##6##2##(2004-9#1)(2005-11#2)(2007-5#1)(2008-10#1)(2008-3#1)
that mere##2##2##(2008-11#1)(2009-10#1)
that merges the##2##3##(1993-2#1)(2008-5#1)
that merit##3##2##(1991-1#1)(2008-8#1)(2012-2#1)
that mesenchymal##2##2##(2008-9#1)(2011-1#1)
that mesothelial cells##2##3##(2010-12#1)(2012-2#1)
that met the##5##3##(1997-5#1)(2005-8#1)(2007-10#1)(2007-4#1)(2011-2#1)
that met##14##2##(1997-5#1)(2005-8#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-4#1)(2008-1#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#4)
that meta I##2##3##(1994-11#2)
that metabolic##6##2##(1992-7#1)(2008-3#1)(2008-8#1)(2009-5#1)(2010-2#1)(2011-2#1)
that metabolism of##4##3##(1991-12#1)(1992-3#1)(1992-6#1)(1994-5#1)
that metabolism##5##2##(1991-12#1)(1992-3#1)(1992-6#1)(1994-5#1)(2008-8#1)
that metabolizes##4##2##(1992-4#1)(2008-10#1)(2010-2#1)(2013-1#1)
that metal ions##2##3##(1994-9#1)(2008-5#1)
that metal##6##2##(1994-9#1)(2006-12#1)(2008-5#1)(2010-11#1)(2012-11#2)
that metallic##2##2##(2007-8#1)(2009-6#1)
that metallothionein##2##2##(2007-12#1)(2008-10#1)
that metastases##2##2##(2007-12#1)(2008-1#1)
that metastasis##4##2##(2009-3#1)(2009-8#1)(2010-8#1)(2011-2#1)
that metastasized to the##2##4##(2006-8#1)(2008-3#1)
that metastasized to##3##3##(2006-8#1)(2008-3#1)(2009-5#1)
that metastatic##5##2##(1990-2#1)(2007-7#1)(2008-4#1)(2008-6#1)(2009-3#1)
that metformin##3##2##(2008-1#1)(2011-2#1)(2013-1#1)
that methamphetamine##2##2##(1995-3#1)(2007-11#1)
that methanol##2##2##(2007-11#1)(2012-2#1)
that method##2##2##(2008-3#1)(2008-6#1)
that methods of##2##3##(1995-3#1)(2008-7#1)
that methods##6##2##(1993-2#1)(1995-3#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-2#1)
that methyl##3##2##(1996-5#1)(1997-2#1)(2008-5#1)
that methylation of##3##3##(1990-11#1)(1994-5#1)(2008-1#1)
that methylation##6##2##(1990-11#1)(1992-5#1)(1994-5#1)(2006-12#1)(2007-11#1)(2008-1#1)
that methylphenidate##2##2##(1997-8#1)(2008-9#1)
that miR-143##2##2##(2013-8#2)
that miR399s##2##2##(2009-8#2)
that miRNA##2##2##(2009-5#1)(2013-8#1)
that miRNAs are##2##3##(2009-12#1)(2009-5#1)
that miRNAs may##2##3##(2011-2#2)
that miRNAs##6##2##(2009-12#1)(2009-5#1)(2010-11#1)(2010-7#1)(2011-2#2)
that mice homozygous for this##2##5##(1991-6#1)(1996-2#1)
that mice with a##2##4##(2006-7#1)(2012-2#1)
that mice with##4##3##(2006-7#1)(2012-12#2)(2012-2#1)
that mice##12##2##(1991-6#1)(1993-11#1)(1996-2#1)(2005-11#1)(2006-7#1)(2008-5#1)(2010-11#1)(2012-12#2)(2012-2#3)
that microbial##2##2##(1992-11#1)(1994-11#1)
that microglia##3##2##(1995-3#1)(2007-11#1)(2008-7#1)
that microglial activation##2##3##(2008-7#1)(2012-2#1)
that microglial##4##2##(1993-11#1)(2008-4#1)(2008-7#1)(2012-2#1)
that microinjection of##2##3##(1996-5#1)(1997-4#1)
that micromolar concentrations of##2##4##(1994-8#1)(2012-12#1)
that microsatellite##2##2##(1996-11#1)(2008-9#1)
that microsurgical##2##2##(1995-7#1)(2010-12#1)
that microtubule##2##2##(1997-6#1)(2006-10#1)
that microtubules##3##2##(1994-8#1)(2008-4#1)(2010-7#1)
that might affect##3##3##(1993-12#1)(2006-10#1)(2010-12#1)
that might allow##3##3##(2006-10#1)(2007-2#1)(2013-7#1)
that might also##2##3##(2006-10#1)(2009-3#1)
that might arise in##2##4##(2012-2#1)(2013-8#1)
that might arise##4##3##(2008-11#1)(2008-2#1)(2012-2#1)(2013-8#1)
that might be either a##3##5##(2008-2#3)
that might be employed##3##4##(1992-12#1)(2008-10#1)(2008-11#1)
that might be in##2##4##(1994-2#1)(2007-8#1)
that might be involved in##2##5##(2006-7#1)(2008-10#1)
that might be relevant to##2##5##(2007-12#1)(2008-6#1)
that might be responsible for##3##5##(1995-1#1)(2008-10#1)(2010-12#1)
that might be used to##2##5##(2007-9#1)(2009-6#1)
that might be used##3##4##(2007-9#1)(2009-6#1)(2011-2#1)
that might be useful in##2##5##(2008-3#1)(2011-1#1)
that might be useful##3##4##(2007-10#1)(2008-3#1)(2011-1#1)
that might be##54##3##(1990-12#1)(1991-1#1)(1992-12#2)(1993-12#1)(1994-2#1)(1995-1#1)(1996-5#1)(1997-4#1)(2006-11#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-2#6)(2008-3#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-12#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
that might benefit from##2##4##(2008-10#1)(2012-7#1)
that might explain this##2##4##(1995-2#1)(2007-7#1)
that might explain##7##3##(1995-2#1)(1996-5#1)(1996-8#1)(2005-10#1)(2006-10#1)(2007-7#1)(2010-4#1)
that might have been##6##4##(1991-4#1)(1993-10#1)(2006-10#1)(2006-12#1)(2008-3#1)(2013-1#1)
that might have##11##3##(1991-4#1)(1993-10#1)(2005-9#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2012-12#1)(2013-1#1)
that might help to##2##4##(2008-1#1)(2009-12#1)
that might help##6##3##(2006-10#1)(2006-6#1)(2007-7#1)(2008-1#1)(2009-1#1)(2009-12#1)
that might improve##2##3##(2005-8#1)(2007-4#1)
that might induce##3##3##(2009-9#1)(2012-12#2)
that might influence##4##3##(1993-1#1)(2010-2#1)(2011-1#1)(2012-3#1)
that might interact with##2##4##(1995-2#1)(1995-3#1)
that might lead to##3##4##(1992-9#1)(2007-10#1)(2008-4#1)
that might not##2##3##(1997-1#1)(2008-4#1)
that might otherwise##2##3##(2008-10#1)(2008-2#1)
that might play a role in##2##6##(1991-5#1)(1993-8#1)
that might result in##2##4##(2005-8#1)(2010-12#1)
that might result##3##3##(2005-8#1)(2010-12#1)(2010-2#1)
that might##175##2##(1990-11#1)(1990-12#2)(1991-1#2)(1991-4#1)(1991-5#1)(1992-11#1)(1992-12#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-6#1)(1993-8#2)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-4#2)(2005-10#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#7)(2006-11#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-2#3)(2007-4#3)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#7)(2008-11#5)(2008-12#2)(2008-2#9)(2008-3#2)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#1)(2009-3#3)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-4#1)(2010-9#1)(2011-1#5)(2011-2#2)(2012-1#3)(2012-12#5)(2012-2#3)(2012-3#2)(2012-7#1)(2013-1#10)(2013-7#1)(2013-8#2)
that migraine##3##2##(2008-9#2)(2012-2#1)
that migrate from##2##3##(1995-2#1)(1995-8#1)
that migrate##5##2##(1995-2#1)(1995-5#1)(1995-8#1)(2007-9#1)(2012-12#1)
that migrated into the##2##4##(2007-8#1)(2008-5#1)
that migrated into##3##3##(1994-3#1)(2007-8#1)(2008-5#1)
that migrated##6##2##(1990-2#1)(1994-3#1)(1994-8#1)(2007-8#1)(2008-5#1)(2010-8#1)
that migrates##2##2##(1991-7#1)(2008-4#1)
that migration can##2##3##(2008-8#1)(2013-1#1)
that migration##8##2##(1993-9#1)(2008-10#2)(2008-8#2)(2013-1#2)(2013-8#1)
that mild##5##2##(1992-11#1)(1993-12#1)(2006-10#1)(2008-5#1)(2008-7#1)
that mimic acute##2##3##(2005-8#1)(2008-3#1)
that mimic the##10##3##(1994-2#1)(1996-4#1)(1997-4#1)(1997-6#1)(2005-11#1)(2008-11#1)(2008-5#1)(2009-7#1)(2010-2#1)(2011-1#1)
that mimic those##2##3##(2008-4#1)(2010-9#1)
that mimic##27##2##(1994-2#1)(1996-4#1)(1997-4#1)(1997-6#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-11#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#1)(2013-8#1)
that mimicked the##2##3##(2008-2#1)(2008-5#1)
that mimicked##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
that mimics##7##2##(1994-5#1)(2004-11#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-9#1)
that minimal##2##2##(1991-4#1)(2013-1#1)
that minimize the##5##3##(1996-8#1)(2008-10#1)(2008-3#2)(2008-6#1)
that minimize##10##2##(1996-8#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#2)(2011-2#1)(2013-1#1)
that minimizes the##7##3##(1990-8#1)(2006-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-6#1)
that minimizes##15##2##(1990-8#1)(2006-10#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#2)(2008-8#2)(2010-6#1)(2011-2#1)(2012-1#1)
that minimizing##2##2##(1996-7#1)(2008-9#1)
that minor##4##2##(2008-10#2)(2008-12#1)(2013-8#1)
that mirror##4##2##(2006-6#2)(2009-4#2)
that mirrors##2##2##(2008-1#1)(2012-3#1)
that mismatch##2##2##(1997-1#1)(2008-8#1)
that missing##2##2##(1997-8#1)(2012-12#1)
that mithramycin##3##2##(1991-4#3)
that mitocans##2##2##(2008-1#2)
that mitochondria##7##2##(1990-8#1)(2007-10#1)(2008-2#1)(2008-7#1)(2009-5#1)(2010-11#1)(2012-2#1)
that mitochondrial##8##2##(1991-2#1)(1994-12#1)(1994-3#1)(2005-8#1)(2009-5#1)(2009-8#1)(2012-11#1)(2012-2#1)
that mitotic##2##2##(1994-8#1)(2012-12#1)
that mitral##2##2##(2012-2#1)(2013-1#1)
that mixed##3##2##(1992-12#1)(2008-2#1)(2008-5#1)
that mixing##2##2##(2006-10#1)(2008-5#1)
that mode##2##2##(2008-1#1)(2011-1#1)
that model the##3##3##(2008-2#1)(2012-2#1)(2012-3#1)
that model##9##2##(1995-4#1)(1997-7#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-2#1)(2012-3#1)
that modeling##4##2##(1990-2#1)(2008-7#1)(2013-1#2)
that models of##3##3##(1996-4#1)(2009-12#1)(2011-12#1)
that models such as##2##4##(2008-12#1)(2008-5#1)
that models the##4##3##(1990-9#1)(2008-3#1)(2008-9#1)(2010-4#1)
that models##15##2##(1990-9#1)(1995-4#1)(1996-4#1)(2007-6#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-4#1)(2010-8#1)(2011-12#1)(2012-2#1)
that moderate amounts##2##3##(2005-10#1)(2008-3#1)
that moderate##13##2##(1990-3#1)(1990-4#1)(1991-7#1)(1994-2#1)(1994-9#1)(2005-10#1)(2005-11#1)(2007-8#1)(2008-3#1)(2008-8#1)(2010-12#1)(2011-1#1)(2013-1#1)
that modern medicine##2##3##(2007-6#1)(2013-8#1)
that modern##7##2##(1991-11#1)(2006-11#1)(2006-4#1)(2007-11#1)(2007-6#1)(2008-11#1)(2013-8#1)
that modest##5##2##(1994-2#1)(2009-10#1)(2010-9#1)(2013-1#2)
that modification of##8##3##(1991-8#1)(1993-11#1)(1994-11#2)(1997-1#1)(1997-8#1)(2008-1#1)(2010-3#1)
that modification##12##2##(1991-2#1)(1991-8#1)(1992-12#1)(1993-11#1)(1994-11#2)(1997-1#1)(1997-8#1)(2005-11#1)(2007-2#1)(2008-1#1)(2010-3#1)
that modified##2##2##(2006-12#1)(2008-5#1)
that modifies the##3##3##(2008-2#2)(2012-2#1)
that modify the##6##3##(1991-8#1)(2005-8#1)(2006-6#1)(2007-11#1)(2008-3#1)(2010-7#1)
that modify##11##2##(1991-8#1)(1993-4#1)(1994-5#1)(2005-8#1)(2006-6#1)(2007-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-7#1)
that modulate cellular##3##3##(2008-7#1)(2009-8#1)(2011-2#1)
that modulate the activity of##3##5##(1993-12#1)(2008-1#1)(2009-5#1)
that modulate the##7##3##(1993-12#1)(1993-7#1)(1994-5#1)(2008-1#1)(2008-9#1)(2009-5#1)(2012-1#1)
that modulate##23##2##(1991-3#1)(1993-12#1)(1993-7#1)(1994-5#1)(1995-8#1)(1996-7#1)(2005-7#1)(2008-1#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-5#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
that modulated##2##2##(1991-11#1)(2008-3#1)
that modulates the##5##3##(1995-8#1)(1996-1#1)(2007-11#1)(2008-11#1)(2011-1#1)
that modulates##14##2##(1990-5#1)(1991-10#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-8#1)(1996-1#1)(1996-5#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-1#1)
that modulation of the##3##4##(1995-10#1)(1995-3#2)
that modulation of##9##3##(1990-12#1)(1991-7#1)(1995-10#1)(1995-3#2)(1996-1#1)(1996-2#1)(2007-11#1)(2010-12#1)
that modulation##10##2##(1990-12#1)(1991-7#1)(1995-10#1)(1995-3#2)(1996-1#1)(1996-2#1)(2007-11#1)(2008-10#1)(2010-12#1)
that molar##3##2##(1990-5#1)(1993-9#1)(2008-10#1)
that molecular##16##2##(1990-11#1)(1992-11#1)(1994-6#1)(1995-3#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#1)
that molecules##3##2##(1994-5#1)(1994-9#1)(2005-11#1)
that monetary gains and losses##2##5##(2009-2#2)
that monitor the##2##3##(2007-7#1)(2008-12#1)
that monitor##3##2##(2007-7#1)(2008-12#1)(2008-9#1)
that monitoring##4##2##(2006-8#1)(2008-10#1)(2011-2#1)(2013-7#1)
that monitors##5##2##(1993-12#1)(1995-8#1)(2010-12#1)(2013-1#2)
that monkey##2##2##(1992-12#1)(1993-2#1)
that monkeys with V4 lesions##3##5##(1992-11#1)(1993-2#2)
that monkeys with##4##3##(1992-11#1)(1993-11#1)(1993-2#2)
that monkeys##8##2##(1992-11#2)(1993-11#1)(1993-2#2)(1993-9#1)(1994-2#1)(2010-2#1)
that monoclonal antibodies (mAbs)##2##4##(1994-2#1)(2010-1#1)
that monoclonal antibodies against##3##4##(1990-5#1)(1994-6#1)(2012-2#1)
that monoclonal antibodies##6##3##(1990-5#1)(1994-2#1)(1994-6#1)(1995-12#1)(2010-1#1)(2012-2#1)
that monoclonal##8##2##(1990-5#1)(1994-2#1)(1994-6#1)(1995-12#1)(2008-5#1)(2008-8#1)(2010-1#1)(2012-2#1)
that monocytes##2##2##(1993-6#1)(2007-8#1)
that monotherapy##3##2##(2011-1#1)(2012-12#1)(2013-8#1)
that mood stabilizers##2##3##(2006-9#1)(2008-7#1)
that mood##3##2##(1996-3#1)(2006-9#1)(2008-7#1)
that moral##3##2##(2008-11#1)(2009-6#1)(2013-8#1)
that more accurately##3##3##(1991-12#1)(2006-10#1)(2013-1#1)
that more attention##2##3##(2006-10#1)(2011-2#1)
that more closely resemble##2##4##(2006-11#1)(2008-11#1)
that more closely##4##3##(2006-10#1)(2006-11#1)(2006-12#1)(2008-11#1)
that more effective##2##3##(1990-12#1)(2012-2#1)
that more efficiently##2##3##(2009-3#1)(2011-1#1)
that more frequent##3##3##(2004-9#1)(2008-5#1)(2009-11#1)
that more intensive##2##3##(2007-3#1)(2008-4#1)
that more patients are##2##4##(2007-9#1)(2013-8#1)
that more patients##3##3##(2007-9#1)(2008-7#1)(2013-8#1)
that more research is##2##4##(2006-8#1)(2008-11#1)
that more research##4##3##(2006-8#1)(2007-2#1)(2008-11#1)(2010-11#1)
that more than 1##2##4##(1997-7#1)(2006-2#1)
that more than 20 percent of##2##6##(2010-8#2)
that more than 20##3##4##(2006-10#1)(2010-8#2)
that more than 99% of the##2##6##(1997-1#1)(1997-3#1)
that more than half of the##3##6##(2007-10#1)(2011-2#1)(2012-3#1)
that more than half of##4##5##(2007-10#1)(2008-5#1)(2011-2#1)(2012-3#1)
that more than half##5##4##(1993-8#1)(2007-10#1)(2008-5#1)(2011-2#1)(2012-3#1)
that more than one##5##4##(1990-2#1)(1991-2#1)(1995-10#1)(1997-2#1)(2008-5#1)
that more than two thirds of##2##6##(2007-7#1)(2008-2#1)
that more than##37##3##(1990-2#1)(1991-2#1)(1991-5#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-10#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#3)(2010-8#4)(2011-2#1)(2012-11#2)(2012-12#1)(2012-3#2)
that more##118##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-9#2)(1993-1#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#2)(2004-4#1)(2004-9#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#4)(2007-9#2)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#3)(2008-8#1)(2009-11#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#5)(2011-1#2)(2011-2#4)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
that morphine##5##2##(1991-3#1)(1991-8#1)(1992-3#1)(1995-12#1)(2007-11#1)
that morphological##3##2##(1992-12#1)(1997-2#1)(2008-8#1)
that mortality is##2##3##(2007-8#1)(2008-8#1)
that mortality##9##2##(1991-6#1)(2005-10#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-8#1)
that mosquitoes##2##2##(2004-11#1)(2008-12#1)
that most affect##3##3##(1994-2#1)(2006-10#1)(2008-9#1)
that most cases of##3##4##(2006-9#1)(2012-2#1)(2013-8#1)
that most cases##4##3##(2006-9#1)(2008-11#1)(2012-2#1)(2013-8#1)
that most closely##3##3##(1994-5#1)(1994-9#1)(2008-10#1)
that most commonly##4##3##(2008-12#1)(2008-7#1)(2012-3#1)(2013-1#1)
that most frequently affect the##2##5##(2009-2#1)(2012-2#1)
that most frequently##3##3##(2008-10#1)(2009-2#1)(2012-2#1)
that most likely##2##3##(1990-3#1)(2012-1#1)
that most of the compounds##2##5##(2010-12#2)
that most of the##46##4##(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#1)(1992-6#1)(1993-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-2#1)(1997-1#1)(1997-6#2)(2006-10#1)(2006-12#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-2#2)(2013-1#1)(2013-8#1)
that most of them are##2##5##(1995-7#1)(2007-7#1)
that most of them##5##4##(1995-7#1)(2007-7#2)(2010-12#1)(2013-1#1)
that most of these##7##4##(1994-3#1)(1997-2#1)(1997-3#1)(2008-5#1)(2011-3#1)(2012-2#1)(2012-3#1)
that most of##64##3##(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#1)(1992-6#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-7#1)(1996-2#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-6#2)(2006-10#1)(2006-12#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
that most often##3##3##(2005-7#1)(2007-11#1)(2012-3#1)
that most patients with##2##4##(1993-9#1)(2008-8#1)
that most patients##11##3##(1990-11#1)(1990-2#1)(1990-3#1)(1993-9#1)(1997-4#1)(2005-8#1)(2006-12#1)(2008-8#1)(2010-12#1)(2010-8#1)(2013-1#1)
that most people##2##3##(2007-12#1)(2008-1#1)
that most##190##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-8#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-12#4)(1995-2#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-2#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#2)(1997-4#1)(1997-6#3)(2005-7#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#3)(2006-2#2)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#3)(2007-11#5)(2007-12#6)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#4)(2008-10#17)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#5)(2010-2#3)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#6)(2011-3#1)(2012-1#2)(2012-2#7)(2012-3#5)(2013-1#6)(2013-8#3)
that mostly##2##2##(2007-12#1)(2007-3#1)
that mothers##11##2##(1991-8#1)(1994-9#1)(2008-10#1)(2008-2#1)(2009-2#1)(2009-9#1)(2011-1#2)(2012-11#1)(2012-3#1)(2013-1#1)
that motivate##2##2##(1994-2#1)(2013-8#1)
that motivation##2##2##(2009-6#1)(2012-2#1)
that motivational##3##2##(1994-3#1)(2008-6#1)(2009-3#1)
that motor##6##2##(1995-12#2)(2008-7#1)(2010-7#1)(2011-12#1)(2013-8#1)
that mouse##8##2##(1990-11#1)(1991-11#1)(1991-6#1)(1994-9#1)(1996-4#1)(1997-4#1)(2006-1#1)(2010-6#1)
that move##7##2##(1990-7#1)(1993-12#1)(1994-12#1)(2007-11#1)(2008-7#1)(2008-8#1)(2010-12#1)
that moved##2##2##(1996-12#1)(2012-1#1)
that movement##4##2##(1990-11#1)(1993-5#1)(2007-12#1)(2008-7#1)
that moves the##2##3##(1992-9#1)(1994-12#1)
that moves##4##2##(1992-9#1)(1994-12#1)(2007-1#1)(2008-3#1)
that mu- and##2##3##(1991-9#1)(1997-1#1)
that mu-opioid##2##2##(1997-5#2)
that much of the##8##4##(1991-12#1)(1993-11#1)(2005-10#1)(2007-11#1)(2007-5#1)(2008-8#1)(2012-12#1)(2013-1#1)
that much of##12##3##(1991-12#1)(1993-11#1)(1995-12#1)(1996-3#1)(2005-10#1)(2006-8#1)(2007-11#1)(2007-5#1)(2008-8#2)(2012-12#1)(2013-1#1)
that much##24##2##(1990-12#1)(1990-2#1)(1991-12#1)(1993-11#1)(1993-12#1)(1995-12#1)(1996-3#1)(1996-9#1)(2005-10#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-8#3)(2010-2#1)(2012-12#1)(2013-1#1)
that mucosal##2##2##(2007-5#1)(2007-7#1)
that multicomponent##4##2##(1995-11#3)(2007-11#1)
that multimodal##2##2##(2012-2#2)
that multimode##2##2##(2007-12#1)(2008-3#1)
that multiple genetic##2##3##(1993-11#1)(2008-10#1)
that multiple infections##3##3##(2008-10#2)(2008-9#1)
that multiple mechanisms##3##3##(1991-7#1)(1994-9#1)(2008-7#1)
that multiple rare variants##2##4##(2012-3#2)
that multiple sclerosis##2##3##(1995-12#1)(2006-8#1)
that multiple##61##2##(1990-3#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-7#2)(1992-11#1)(1992-5#1)(1992-6#1)(1993-11#1)(1994-12#1)(1994-2#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-3#1)(2008-10#7)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-12#1)(2012-3#3)
that murine##8##2##(1993-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1997-4#1)(1997-8#1)(2010-4#1)
that muscarinic receptors##2##3##(1990-7#1)(1991-6#1)
that muscarinic##6##2##(1990-7#1)(1991-6#1)(1995-7#1)(1996-5#1)(1997-5#2)
that muscle##3##2##(1991-11#1)(1996-2#1)(2007-2#1)
that muscles##3##2##(2008-6#1)(2012-1#1)(2012-2#1)
that music##8##2##(1993-2#1)(2007-6#3)(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#1)
that must be addressed##4##4##(1995-2#1)(2007-12#1)(2009-12#1)(2011-2#1)
that must be considered in the design##2##7##(2006-5#1)(2008-4#1)
that must be considered in##3##5##(1997-2#1)(2006-5#1)(2008-4#1)
that must be considered when##4##5##(2005-7#1)(2008-4#2)(2013-1#1)
that must be considered##12##4##(1991-4#1)(1992-2#1)(1997-2#1)(2005-7#1)(2006-5#1)(2006-9#1)(2007-12#1)(2008-4#3)(2008-7#1)(2013-1#1)
that must be known##2##4##(2007-5#1)(2008-9#1)
that must be met##3##4##(1995-2#1)(2008-7#2)
that must be removed##2##4##(1996-2#1)(2008-5#1)
that must be taken##2##4##(1995-2#1)(2008-4#1)
that must be##61##3##(1991-4#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-10#1)(1995-2#3)(1996-2#1)(1996-8#2)(1997-2#1)(2005-11#1)(2005-7#2)(2006-5#2)(2006-9#1)(2007-11#1)(2007-12#3)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#6)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2010-11#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-3#2)(2013-1#2)
that must have##2##3##(1994-6#1)(2006-5#1)
that must occur##2##3##(1995-2#1)(2008-7#1)
that must##73##2##(1991-4#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-10#1)(1994-6#1)(1995-2#4)(1996-2#1)(1996-5#1)(1996-8#2)(1997-2#1)(2005-11#1)(2005-12#1)(2005-7#2)(2006-10#1)(2006-5#3)(2006-9#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#6)(2008-5#4)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#2)(2010-11#2)(2010-7#1)(2010-8#2)(2010-9#2)(2011-12#1)(2011-2#1)(2012-11#1)(2012-3#2)(2013-1#2)(2013-8#1)
that mutant forms of##2##4##(2006-12#1)(2011-2#1)
that mutant##7##2##(1991-5#1)(1997-5#1)(2006-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)
that mutants that##2##3##(1995-8#1)(2008-10#1)
that mutants##4##2##(1995-8#1)(2008-10#2)(2008-5#1)
that mutation of the##2##4##(1995-10#1)(2008-11#1)
that mutation of##7##3##(1994-11#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-8#1)(1996-5#1)(2008-11#1)
that mutation##11##2##(1992-2#1)(1994-11#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-8#2)(1996-5#1)(1997-7#1)(2008-11#1)(2008-8#1)
that mutational##3##2##(1995-4#1)(1995-6#1)(2010-6#1)
that mutations in the##5##4##(1992-8#1)(1993-12#1)(1995-1#1)(1996-12#1)(2008-4#1)
that mutations in##12##3##(1992-11#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-3#1)(1995-1#1)(1995-8#1)(1996-12#1)(1997-6#1)(2008-10#1)(2008-4#1)(2010-8#1)
that mutations of##3##3##(1991-12#1)(2006-9#1)(2008-4#1)
that mutations##18##2##(1991-12#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-3#1)(1995-1#2)(1995-3#1)(1995-8#1)(1996-12#1)(1997-6#1)(2006-9#1)(2008-10#1)(2008-4#2)(2010-8#1)
that mutual growth##2##3##(1991-5#2)
that my##4##2##(1997-3#1)(2007-2#1)(2010-5#1)(2011-1#1)
that mycoparasitism##2##2##(2008-10#2)
that myelin##4##2##(1992-1#1)(1992-7#1)(2008-7#2)
that myocardial##2##2##(1991-10#1)(2005-10#1)
that myosin light chain kinase##2##5##(1991-2#1)(1997-7#1)
that myristoylation##2##2##(1990-12#1)(1994-3#1)
that n##3##2##(1994-8#1)(2008-2#1)(2009-5#1)
that name##2##2##(2013-7#2)
that nanoparticle##3##2##(2008-3#1)(2008-7#1)(2010-9#1)
that nanoparticles can##2##3##(2007-8#1)(2008-7#1)
that nanoparticles##3##2##(2007-8#1)(2008-10#1)(2008-7#1)
that narrow##2##2##(2007-7#1)(2008-10#1)
that national##5##2##(1992-9#1)(1994-2#1)(1996-9#1)(2009-4#1)(2011-1#1)
that native##6##2##(1990-12#1)(1993-4#1)(1994-8#1)(1995-10#1)(1995-8#1)(2008-4#1)
that natural disasters##2##3##(2013-1#2)
that natural killer##3##3##(1993-6#1)(1997-7#1)(2011-1#1)
that natural selection in##2##4##(2008-9#2)
that natural selection##5##3##(2006-7#1)(2008-9#2)(2009-8#1)(2013-1#1)
that natural##23##2##(1993-6#1)(1997-7#1)(2006-7#1)(2007-11#1)(2008-11#1)(2008-8#4)(2008-9#2)(2009-3#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#4)
that naturally occurring##3##3##(1995-2#1)(2005-11#1)(2008-11#1)
that naturally##8##2##(1995-2#1)(1996-7#1)(2005-11#1)(2006-12#1)(2008-10#2)(2008-11#1)(2012-1#1)
that near-field##2##2##(2007-12#2)
that near-infrared spectroscopy##4##3##(1997-6#4)
that near-infrared##5##2##(1997-6#4)(2008-3#1)
that nearly all##3##3##(1993-9#1)(2008-5#1)(2010-10#1)
that nearly##9##2##(1990-2#1)(1993-9#1)(2005-11#1)(2007-9#1)(2008-11#2)(2008-5#1)(2009-7#1)(2010-10#1)
that necrosis was##2##3##(2008-10#2)
that nectar production##2##3##(2013-8#2)
that nectar##3##2##(2009-8#1)(2013-8#2)
that need further investigation##3##4##(1997-7#1)(2013-1#2)
that need is##2##3##(2005-7#1)(2007-4#1)
that need to be addressed are##2##6##(2008-11#1)(2009-3#1)
that need to be addressed in##3##6##(1990-12#1)(2006-5#1)(2008-4#1)
that need to be addressed to##3##6##(2008-7#1)(2011-2#1)(2013-8#1)
that need to be addressed##26##5##(1990-12#1)(1993-11#1)(1994-2#1)(2006-10#1)(2006-5#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-2#2)(2012-2#1)(2013-8#11)
that need to be considered in##2##6##(2007-8#1)(2011-2#1)
that need to be considered##5##5##(2007-8#1)(2008-3#1)(2008-4#1)(2009-1#1)(2011-2#1)
that need to be overcome for##2##6##(2010-6#1)(2010-9#1)
that need to be resolved##2##5##(1995-11#1)(2008-11#1)
that need to be##52##4##(1990-12#1)(1993-11#1)(1993-12#1)(1994-2#1)(1995-11#1)(1995-12#1)(1997-8#1)(2004-12#1)(2006-10#2)(2006-5#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-3#1)(2010-6#1)(2010-9#2)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#11)
that need to##55##3##(1990-12#1)(1993-11#1)(1993-12#1)(1994-2#1)(1995-11#1)(1995-12#1)(1997-8#1)(2004-12#1)(2006-10#2)(2006-5#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-3#1)(2010-6#1)(2010-9#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#11)
that need##67##2##(1990-12#1)(1993-11#1)(1993-12#1)(1994-2#1)(1995-11#1)(1995-12#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-7#1)(2006-10#2)(2006-5#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-3#1)(2009-6#1)(2010-6#1)(2010-9#2)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#11)
that needed to be##2##4##(2010-3#1)(2011-1#1)
that needed to##3##3##(1993-6#1)(2010-3#1)(2011-1#1)
that needed##10##2##(1990-11#1)(1990-9#1)(1993-10#1)(1993-6#1)(1997-7#1)(2006-10#1)(2007-7#1)(2010-3#2)(2011-1#1)
that needle##2##2##(2007-7#1)(2008-11#1)
that needs to be##5##4##(1992-9#1)(1993-5#1)(1997-2#1)(2007-3#1)(2009-10#1)
that needs##14##2##(1992-9#1)(1993-5#1)(1996-4#1)(1997-2#1)(2007-3#2)(2007-9#1)(2008-10#1)(2008-7#2)(2009-10#1)(2010-9#1)(2011-1#1)(2012-12#1)
that negative##5##2##(1990-8#1)(1997-3#1)(2008-11#1)(2008-6#1)(2010-10#1)
that negatively impacts##2##3##(2007-11#1)(2012-1#1)
that negatively regulate gene expression post-transcriptionally##2##6##(2010-7#1)(2011-2#1)
that negatively regulate gene expression##3##5##(2008-7#1)(2010-7#1)(2011-2#1)
that negatively##11##2##(2006-1#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#2)(2010-7#2)(2011-2#1)(2012-1#1)
that neglects##2##2##(2007-12#1)(2008-2#1)
that neighborhood characteristics##2##3##(2010-7#2)
that neighborhood##4##2##(2008-5#1)(2009-7#1)(2010-7#2)
that neither of##2##3##(1992-6#1)(2009-3#1)
that neither the presence of##2##5##(1991-3#1)(1996-6#1)
that neither the##11##3##(1991-3#1)(1992-11#1)(1992-4#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-6#1)(2008-6#1)(2008-7#1)(2010-6#1)
that neither##51##2##(1990-11#2)(1990-7#1)(1991-3#2)(1991-5#2)(1991-9#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-5#1)(1994-8#2)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-5#1)(1996-6#2)(1997-1#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-3#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-8#3)
that nelarabine##2##2##(2008-5#2)
that nematode##2##2##(2008-10#1)(2009-3#1)
that nematodes##4##2##(2008-10#2)(2010-12#2)
that neonatal##7##2##(1993-5#1)(1994-8#1)(1995-4#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-10#1)
that neoplastic MC##2##3##(2011-2#2)
that nerve growth factor##3##4##(1993-11#1)(1994-8#1)(2008-10#1)
that nerve##5##2##(1992-6#1)(1993-11#1)(1994-8#1)(2007-11#1)(2008-10#1)
that nest in##2##3##(2008-6#2)
that net##2##2##(1995-11#1)(2013-1#1)
that neural activity##2##3##(1996-5#1)(2010-12#1)
that neural##7##2##(1996-5#1)(2009-8#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-1#2)
that neurasthenia##2##2##(2008-7#2)
that neuroblastoma##2##2##(1990-4#1)(2012-12#1)
that neurocalcin##2##2##(1992-5#2)
that neurodegenerative diseases##2##3##(1991-12#1)(2007-11#1)
that neurofibromin##3##2##(1994-12#2)(1995-7#1)
that neurogenesis##2##2##(1996-5#1)(2008-1#1)
that neurological##2##2##(1991-6#1)(2008-4#1)
that neuronal##11##2##(1992-7#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-5#1)(2007-10#2)(2008-11#1)(2009-6#1)(2010-4#1)(2012-12#1)
that neurons are##3##3##(1993-11#1)(1995-12#1)(2006-3#1)
that neurons in the##3##4##(1996-6#1)(1997-1#1)(1997-8#1)
that neurons in##4##3##(1996-6#1)(1997-1#1)(1997-8#1)(2008-4#1)
that neurons near PWCs##2##4##(2012-2#2)
that neurons##16##2##(1990-4#1)(1991-3#1)(1991-5#1)(1993-11#1)(1995-12#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-6#1)(1997-8#2)(2006-3#1)(2008-4#1)(2009-8#1)(2012-2#2)
that neuropeptide Y##2##3##(1991-8#1)(1997-3#1)
that neuroscience##3##2##(2013-7#3)
that neuroticism##4##2##(2008-5#1)(2009-4#2)(2012-1#1)
that neurotoxic effects of##2##4##(1993-12#1)(2008-7#1)
that neurotrophin-3##2##2##(1996-3#2)
that neutrophils##2##2##(1994-3#1)(2007-9#1)
that never##9##2##(2006-2#1)(2006-7#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)
that new##29##2##(1991-10#1)(1991-5#1)(1993-10#1)(1994-3#1)(1995-2#1)(1996-1#1)(1997-1#1)(1997-4#1)(2006-10#1)(2007-10#2)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2009-12#1)(2009-7#1)(2010-4#1)(2011-12#1)(2012-1#1)(2012-11#1)(2012-2#1)
that new-onset##2##2##(2004-12#1)(2008-1#1)
that newly synthesized##4##3##(1991-2#1)(1994-3#1)(1996-8#1)(2013-1#1)
that newly##6##2##(1991-2#1)(1992-8#1)(1994-3#1)(1996-8#1)(2008-10#1)(2013-1#1)
that nickel##2##2##(1995-3#1)(2008-3#1)
that nicotinic acetylcholine receptor##2##4##(2008-8#2)
that nicotinic##4##2##(1992-3#1)(1994-2#1)(2008-8#2)
that nine##4##2##(1996-8#1)(1997-2#1)(2008-11#1)(2013-8#1)
that nitrate##3##2##(2004-12#1)(2008-10#2)
that nitric oxide (NO)##6##4##(1991-10#1)(1992-8#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-5#1)
that nitric oxide may##2##4##(1991-3#1)(2004-12#1)
that nitric oxide plays a##2##5##(1992-8#1)(2004-12#1)
that nitric oxide synthase##2##4##(1991-10#1)(1995-12#1)
that nitric oxide##19##3##(1991-10#2)(1991-3#1)(1992-8#2)(1993-3#1)(1993-6#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-5#1)(2004-12#2)(2007-1#1)(2008-11#1)(2009-8#1)(2010-12#1)(2013-7#1)
that nitric##20##2##(1990-8#1)(1991-10#2)(1991-3#1)(1992-8#2)(1993-3#1)(1993-6#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-5#1)(2004-12#2)(2007-1#1)(2008-11#1)(2009-8#1)(2010-12#1)(2013-7#1)
that nitrite production##2##3##(1993-11#2)
that nitrite##3##2##(1990-5#1)(1993-11#2)
that nitrogen##3##2##(1990-5#1)(1996-2#1)(2011-12#1)
that no blood##2##3##(1990-3#1)(2008-11#1)
that no longer##3##3##(1994-3#1)(2008-2#1)(2013-7#1)
that no matter how##2##4##(2008-10#1)(2008-7#1)
that no matter##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
that no one##3##3##(2006-4#1)(2008-11#1)(2010-3#1)
that no significant changes##2##4##(2008-11#1)(2011-1#1)
that no significant difference##4##4##(2006-1#1)(2007-1#1)(2009-9#1)(2011-2#1)
that no significant##14##3##(1991-4#2)(1991-8#1)(1992-3#1)(1995-5#1)(1997-3#1)(2006-1#1)(2007-1#1)(2008-10#1)(2008-11#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#1)
that no single##7##3##(1997-7#1)(2007-11#1)(2008-11#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)
that no specific##2##3##(1993-8#1)(1994-11#1)
that no##94##2##(1990-3#1)(1990-7#1)(1991-12#1)(1991-4#2)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-7#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#3)(1994-6#1)(1994-8#2)(1995-12#1)(1995-5#1)(1995-8#2)(1996-12#1)(1996-3#1)(1997-3#1)(1997-5#1)(1997-7#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#8)(2008-2#5)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#4)(2009-8#2)(2009-9#1)(2010-12#2)(2010-2#2)(2010-3#2)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#1)
that noble metal##2##3##(2007-8#1)(2010-4#1)
that noise sensitivity##2##3##(2005-11#2)
that noise##4##2##(2005-11#2)(2006-10#1)(2007-10#1)
that non-NMDA##2##2##(1992-3#1)(1994-2#1)
that non-communicable##2##2##(2012-1#1)(2012-12#1)
that non-proven therapies##2##3##(1997-6#2)
that none of the individual##2##5##(1994-2#1)(2008-3#1)
that none of the##13##4##(1990-12#1)(1994-2#1)(1995-7#1)(1996-6#1)(2005-11#1)(2006-12#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-1#1)
that none of these##4##4##(1995-8#1)(2007-9#1)(2008-5#1)(2012-2#1)
that none of##18##3##(1990-12#1)(1994-2#1)(1995-7#1)(1995-8#1)(1996-6#1)(2005-11#1)(2006-12#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2010-12#1)(2011-1#1)(2012-2#1)
that noninvasive positive pressure ventilation may##2##6##(1997-4#2)
that nonlinear##8##2##(2007-11#1)(2007-12#2)(2008-3#2)(2008-8#1)(2009-8#2)
that nonprofit decisionmakers##2##3##(1992-12#2)
that nonprofit##5##2##(1992-12#2)(1992-3#1)(1995-2#2)
that nonuniform##2##2##(1996-4#1)(2007-6#1)
that noradrenaline##6##2##(1990-7#1)(1990-8#1)(1991-6#1)(1995-9#1)(1996-10#1)(1996-2#1)
that normal##25##2##(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-2#1)(1995-1#1)(1995-10#1)(1995-8#1)(1997-4#1)(2005-10#1)(2006-10#2)(2006-6#1)(2006-9#1)(2008-6#1)(2010-3#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
that normalization of##3##3##(2008-2#1)(2008-3#1)(2012-1#1)
that normally follows##2##3##(1994-10#1)(2008-11#1)
that normally occurs in##2##4##(1995-6#1)(2012-2#1)
that normally occurs##5##3##(1994-11#1)(1995-6#1)(1995-8#1)(2009-10#1)(2012-2#1)
that normally##28##2##(1990-8#1)(1991-2#1)(1991-9#2)(1993-2#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-8#1)(1997-3#1)(2006-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-8#1)(2009-10#1)(2011-1#1)(2012-2#1)
that normative##3##2##(2006-7#2)(2010-2#1)
that nosocomial##3##2##(2006-10#1)(2007-7#1)(2010-4#1)
that not a##2##3##(1994-11#1)(2009-2#1)
that not all of the##2##5##(1994-5#1)(2010-3#1)
that not all patients with##2##5##(2006-2#1)(2009-6#1)
that not all##17##3##(1992-1#1)(1992-12#1)(1994-2#1)(1994-5#1)(1995-4#1)(2006-2#2)(2007-11#1)(2007-2#1)(2008-10#3)(2008-11#1)(2009-3#1)(2009-6#1)(2010-3#1)(2012-2#1)
that not only is the##2##5##(2008-11#1)(2013-1#1)
that not only is##3##4##(1991-12#1)(2008-11#1)(2013-1#1)
that not only the##8##4##(1992-2#1)(1994-8#1)(1994-9#1)(2008-10#2)(2008-11#2)(2008-3#1)
that not only##34##3##(1991-12#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-2#1)(1994-8#1)(1994-9#2)(1995-5#1)(1996-2#1)(1997-1#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-12#3)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#3)(2009-4#1)(2010-6#1)(2011-12#1)(2011-2#1)(2013-1#1)
that not##62##2##(1991-12#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-4#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-6#1)(1997-7#1)(2004-12#1)(2006-10#1)(2006-2#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-8#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-3#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-3#1)(2010-6#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
that novel##10##2##(1990-4#1)(1991-8#1)(1996-6#1)(1997-4#1)(1997-7#1)(2005-8#1)(2006-10#1)(2008-8#1)(2011-2#1)(2012-2#1)
that now##9##2##(1991-3#1)(1993-4#1)(1996-12#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-4#1)(2009-9#1)(2012-2#1)
that nsL-TP##3##2##(1991-11#1)(1994-12#2)
that nuclear cdk2 complexes##2##4##(1994-9#2)
that nuclear medicine##2##3##(2010-9#1)(2012-2#1)
that nuclear##19##2##(1993-8#1)(1994-8#1)(1994-9#3)(1995-1#1)(1996-1#1)(1996-7#1)(1996-9#1)(2006-12#1)(2008-7#1)(2008-8#3)(2010-9#1)(2012-12#2)(2012-2#2)
that nuclei##2##2##(1991-3#1)(2008-10#1)
that nucleolar##2##2##(2008-8#1)(2011-12#1)
that nucleoside##2##2##(1990-11#1)(2007-12#1)
that nucleotide##4##2##(2009-5#1)(2009-8#1)(2010-3#1)(2013-8#1)
that nucleotides and##2##3##(1991-3#1)(2008-4#1)
that nucleotides##8##2##(1991-3#1)(1993-4#1)(1996-7#1)(2008-11#1)(2008-4#4)
that number##3##2##(1993-10#1)(2005-10#1)(2008-8#1)
that numerous##6##2##(1991-7#1)(1993-6#1)(1995-6#2)(2006-10#1)(2011-2#1)
that nurse##3##2##(2008-1#1)(2008-11#1)(2008-12#1)
that nurses and##3##3##(2007-10#1)(2011-2#1)(2012-3#1)
that nurses are drawing##2##4##(2010-8#2)
that nurses are##5##3##(2008-11#1)(2010-8#2)(2013-1#2)
that nurses have##3##3##(2011-2#2)(2013-1#1)
that nurses must##2##3##(2008-12#1)(2013-8#1)
that nurses should##2##3##(2005-7#1)(2008-4#1)
that nurses##31##2##(1992-3#1)(1996-2#1)(2004-10#1)(2005-11#1)(2005-7#1)(2007-10#3)(2008-11#5)(2008-12#1)(2008-4#2)(2010-7#1)(2010-8#2)(2011-2#3)(2012-3#3)(2013-1#4)(2013-8#2)
that nursing##12##2##(1990-12#1)(2006-5#1)(2007-3#1)(2007-8#1)(2008-11#2)(2008-12#1)(2010-10#1)(2010-11#1)(2012-3#1)(2013-1#2)
that nutrient enrichment##2##3##(2011-1#2)
that nutrient##5##2##(2008-10#1)(2008-11#1)(2008-12#1)(2011-1#2)
that nutrition##4##2##(1994-3#1)(1995-2#1)(2008-9#1)(2009-3#1)
that nutritional factors##2##3##(2006-10#1)(2008-2#1)
that nutritional##5##2##(2005-1#1)(2006-10#1)(2006-2#1)(2008-2#1)(2009-3#1)
that obese young##2##3##(2008-4#1)(2013-1#1)
that obese##4##2##(1996-12#1)(2008-4#1)(2011-2#1)(2013-1#1)
that obesity in##2##3##(2006-1#1)(2011-2#1)
that obesity is a##3##4##(2006-9#1)(2007-11#1)(2008-10#1)
that obesity is##5##3##(2006-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2011-2#1)
that obesity##13##2##(1991-7#1)(2006-1#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2011-1#2)(2011-2#2)(2012-1#1)
that obey a##2##3##(2007-11#1)(2007-12#1)
that obey##4##2##(1990-8#1)(2007-11#2)(2007-12#1)
that object identification##2##3##(1993-12#1)(1997-8#1)
that object##6##2##(1993-12#1)(1994-6#1)(1996-2#1)(1997-8#1)(2008-11#1)(2011-1#1)
that objective##2##2##(2005-10#1)(2008-5#1)
that obligatory##3##2##(1990-9#1)(2006-7#1)(2013-8#1)
that observed after##4##3##(1992-10#1)(1994-5#1)(1997-7#1)(2008-6#1)
that observed at the##3##4##(1990-9#1)(1991-9#1)(2008-8#1)
that observed at##6##3##(1990-9#1)(1991-9#1)(1992-1#1)(2008-10#2)(2008-8#1)
that observed by##4##3##(1991-2#1)(1992-6#1)(1993-8#1)(2010-5#1)
that observed differences##3##3##(1992-2#1)(2009-11#1)(2012-2#1)
that observed during##6##3##(1990-11#1)(1990-8#1)(1990-9#1)(1993-11#1)(1996-8#1)(2009-5#1)
that observed following##3##3##(1994-3#1)(2006-10#1)(2007-12#1)
that observed for the##7##4##(1990-3#1)(1991-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1995-3#1)(1996-7#1)
that observed for##32##3##(1990-2#1)(1990-3#1)(1991-10#1)(1991-3#1)(1991-4#2)(1992-3#1)(1992-7#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-5#2)(1996-7#1)(1997-9#1)(2007-3#1)(2008-10#6)(2008-11#2)(2008-7#1)(2009-2#1)(2009-3#1)(2011-2#1)
that observed in human##2##4##(1991-3#1)(1993-6#1)
that observed in the control##2##5##(1991-8#1)(2008-5#1)
that observed in the##12##4##(1991-2#1)(1991-6#1)(1991-8#1)(1994-9#1)(1995-12#1)(1996-6#1)(2005-7#1)(2008-10#3)(2008-5#1)(2009-12#1)
that observed in##70##3##(1990-3#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#3)(1996-12#3)(1996-2#1)(1996-5#2)(1996-6#2)(1997-2#1)(1997-3#1)(1997-4#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-9#3)(2008-10#7)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-12#2)(2009-2#2)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
that observed on the##2##4##(2010-3#1)(2012-2#1)
that observed on##4##3##(1994-10#1)(2007-12#1)(2010-3#1)(2012-2#1)
that observed under##2##3##(1994-11#1)(2007-11#1)
that observed when##2##3##(1996-5#1)(2008-10#1)
that observed with a##2##4##(1993-12#1)(2008-10#1)
that observed with##23##3##(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-11#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-3#1)(1996-5#1)(1996-6#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-7#1)
that observed##167##2##(1990-11#1)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#3)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-4#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-11#3)(1993-12#1)(1993-5#1)(1993-6#3)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-8#4)(1996-12#3)(1996-2#1)(1996-5#6)(1996-6#3)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-9#1)(2005-11#1)(2005-7#1)(2006-10#2)(2007-11#2)(2007-12#2)(2007-3#1)(2007-9#4)(2008-1#1)(2008-10#20)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#2)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#2)
that observers##2##2##(2008-11#2)
that obtain##3##2##(2008-11#1)(2008-5#1)(2008-8#1)
that obtained at##4##3##(1994-9#1)(2008-10#2)(2008-11#1)
that obtained by the##3##4##(2008-10#3)
that obtained by##11##3##(1993-5#1)(1993-6#1)(1995-12#1)(2007-12#2)(2008-10#4)(2008-2#1)(2012-2#1)
that obtained for the enzyme##2##5##(1992-12#1)(1993-8#1)
that obtained for the##3##4##(1990-7#1)(1992-12#1)(1993-8#1)
that obtained for##8##3##(1990-7#1)(1992-12#1)(1993-8#1)(1995-8#1)(2007-12#1)(2008-10#2)(2008-5#1)
that obtained from the##7##4##(1990-3#2)(1991-2#1)(2005-11#1)(2007-1#1)(2007-12#1)(2008-11#1)
that obtained from##15##3##(1990-3#2)(1991-2#1)(1992-6#1)(1993-12#1)(1994-9#1)(2005-11#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#1)(2008-11#1)(2010-4#1)
that obtained in the absence of##2##6##(1993-6#1)(2008-10#1)
that obtained in the##4##4##(1993-6#1)(2008-10#1)(2008-11#1)(2008-6#1)
that obtained in##14##3##(1990-12#1)(1992-1#1)(1992-12#1)(1993-6#1)(1995-5#1)(1996-12#1)(1997-7#1)(2008-10#2)(2008-11#4)(2008-6#1)
that obtained using##6##3##(2005-11#2)(2008-10#2)(2008-3#1)(2008-4#1)
that obtained when##3##3##(2007-11#1)(2008-10#1)(2008-5#1)
that obtained with the red light##2##6##(2008-2#2)
that obtained with the##10##4##(1990-12#3)(2004-8#1)(2008-10#2)(2008-2#3)(2010-2#1)
that obtained with##29##3##(1990-12#3)(1990-8#1)(1991-2#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-5#1)(2004-8#1)(2006-12#1)(2007-1#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#2)(2010-2#1)(2013-7#1)
that obtained##97##2##(1990-12#4)(1990-3#2)(1990-7#1)(1990-8#1)(1991-2#3)(1992-1#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-5#1)(1993-6#2)(1993-8#1)(1994-2#1)(1994-9#2)(1995-1#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-7#1)(2004-8#1)(2005-11#3)(2006-12#1)(2007-1#2)(2007-11#2)(2007-12#6)(2007-5#1)(2007-8#1)(2008-10#21)(2008-11#7)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2009-10#1)(2010-2#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-7#1)
that occupational exposure to##2##4##(2006-5#1)(2009-5#1)
that occupational exposure##3##3##(2006-5#2)(2009-5#1)
that occupational##9##2##(1991-12#1)(2006-5#2)(2008-10#1)(2008-12#1)(2009-5#1)(2010-5#1)(2011-2#1)(2013-7#1)
that occupied the##3##3##(2006-11#1)(2008-10#1)(2009-3#1)
that occupied##4##2##(2006-11#1)(2008-10#1)(2009-3#1)(2010-9#1)
that occupy##3##2##(2006-12#1)(2008-2#1)(2008-7#1)
that occur after##5##3##(1991-3#2)(1996-3#1)(2007-12#1)(2008-4#1)
that occur as a##2##4##(2008-3#1)(2012-1#1)
that occur as##6##3##(2007-8#1)(2008-3#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-1#1)
that occur at the##3##4##(1994-11#1)(1996-3#1)(2008-3#1)
that occur at##9##3##(1994-11#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-3#1)(2008-11#1)(2008-3#1)(2009-7#1)(2012-12#1)
that occur between##4##3##(1997-4#1)(2007-11#1)(2007-12#2)
that occur during the##6##4##(2008-10#1)(2008-8#1)(2008-9#1)(2010-11#1)(2012-2#1)(2013-1#1)
that occur during##27##3##(1991-1#1)(1991-3#1)(1993-9#1)(1994-11#1)(1995-1#1)(1996-4#1)(1997-5#2)(2006-10#1)(2006-11#1)(2008-10#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-4#1)(2009-8#1)(2010-11#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
that occur in affected##2##4##(1990-12#1)(2012-12#1)
that occur in dry skin##2##5##(2008-5#2)
that occur in humans##2##4##(2008-4#1)(2009-4#1)
that occur in response to##3##5##(1994-6#1)(2006-10#1)(2008-4#1)
that occur in striatal##2##4##(2008-11#2)
that occur in the muscles##2##5##(2008-10#1)(2008-5#1)
that occur in the##15##4##(1996-7#2)(2006-1#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2011-2#1)
that occur in##56##3##(1990-12#1)(1991-12#1)(1994-6#1)(1995-12#1)(1996-7#2)(1997-7#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-5#1)(2007-11#1)(2007-12#4)(2007-4#1)(2008-10#4)(2008-11#3)(2008-2#4)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-7#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
that occur on##3##3##(1997-5#1)(2005-11#1)(2008-10#1)
that occur secondary to##2##4##(2007-11#1)(2008-1#1)
that occur when##5##3##(1996-11#1)(2006-5#1)(2007-11#1)(2008-3#1)(2012-12#1)
that occur with##9##3##(1991-11#1)(1991-5#1)(2007-12#1)(2007-9#1)(2008-2#1)(2010-4#2)(2010-7#1)(2012-3#1)
that occur within the##2##4##(1993-12#1)(2007-9#1)
that occur within##8##3##(1993-12#1)(1997-7#1)(2005-7#1)(2007-10#1)(2007-5#1)(2007-9#1)(2008-7#1)(2009-7#1)
that occur##157##2##(1990-12#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#3)(1991-5#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-11#2)(1994-6#2)(1995-1#1)(1995-12#2)(1995-8#1)(1996-11#1)(1996-3#2)(1996-4#1)(1996-7#2)(1997-4#1)(1997-5#3)(1997-7#2)(2004-3#1)(2005-10#1)(2005-11#3)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-11#2)(2006-5#2)(2007-10#1)(2007-11#5)(2007-12#9)(2007-4#1)(2007-5#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#6)(2008-2#6)(2008-3#8)(2008-4#7)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#4)(2009-12#1)(2009-3#1)(2009-4#2)(2009-7#3)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#5)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
that occurred after the##2##4##(2007-8#1)(2011-2#1)
that occurred after##6##3##(2007-6#1)(2007-7#1)(2007-8#1)(2009-3#1)(2011-12#1)(2011-2#1)
that occurred as a##2##4##(2007-4#1)(2012-3#1)
that occurred as##3##3##(2007-4#1)(2008-10#1)(2012-3#1)
that occurred at the##3##4##(1996-5#1)(2007-5#1)(2007-9#1)
that occurred at##4##3##(1996-5#1)(2007-10#1)(2007-5#1)(2007-9#1)
that occurred during the##2##4##(2011-1#1)(2011-2#1)
that occurred during##4##3##(2007-7#1)(2008-2#1)(2011-1#1)(2011-2#1)
that occurred in a patient##2##5##(2008-1#1)(2012-3#1)
that occurred in the United States##2##6##(1995-6#1)(2012-12#1)
that occurred in the##17##4##(1993-12#1)(1993-3#1)(1994-3#1)(1995-6#1)(1997-4#1)(2004-4#1)(2006-7#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-12#1)
that occurred in their##2##4##(2006-11#1)(2007-12#1)
that occurred in##34##3##(1990-11#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-6#1)(1996-11#1)(1996-6#1)(1997-4#1)(2004-4#1)(2006-11#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#1)
that occurred on the##3##4##(1995-11#1)(2008-10#1)(2010-5#1)
that occurred on##4##3##(1995-11#1)(2008-10#1)(2009-3#1)(2010-5#1)
that occurred prior to##2##4##(1996-4#1)(2009-2#1)
that occurred when##2##3##(1991-12#1)(1996-10#1)
that occurred with##2##3##(1994-12#1)(2007-12#1)
that occurred##73##2##(1990-11#1)(1990-12#1)(1991-12#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-6#1)(1996-10#1)(1996-11#2)(1996-4#1)(1996-5#2)(1996-6#1)(1997-4#1)(1997-6#1)(2004-4#1)(2005-8#1)(2006-11#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#3)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#2)(2010-10#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#2)
that occurring in##2##3##(2008-10#1)(2008-3#1)
that occurring##3##2##(1997-2#1)(2008-10#1)(2008-3#1)
that occurs after##6##3##(2006-3#1)(2007-12#1)(2008-11#1)(2008-8#1)(2010-2#1)(2010-6#1)
that occurs at the##2##4##(1990-10#1)(2008-11#1)
that occurs at##7##3##(1990-10#1)(1991-9#1)(2008-11#1)(2008-4#1)(2009-10#1)(2009-5#1)(2012-1#1)
that occurs between##3##3##(1997-4#1)(2008-10#1)(2011-1#1)
that occurs during##10##3##(1992-2#1)(1994-9#1)(1995-12#1)(1996-11#1)(1997-6#1)(1997-7#1)(2004-3#1)(2007-11#1)(2008-10#1)(2012-2#1)
that occurs for##2##3##(2007-12#1)(2008-3#1)
that occurs in a##2##4##(2009-11#1)(2010-12#1)
that occurs in patients with##2##5##(1997-7#1)(2008-6#1)
that occurs in the same##2##5##(1995-6#1)(2007-11#1)
that occurs in the##10##4##(1992-7#1)(1993-12#1)(1995-3#1)(1995-6#1)(1997-2#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-5#1)
that occurs in this##2##4##(2006-10#1)(2008-5#1)
that occurs in##36##3##(1992-7#1)(1993-12#1)(1995-3#1)(1995-6#1)(1996-10#1)(1997-2#1)(1997-7#1)(2006-10#3)(2006-2#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-12#2)(2010-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
that occurs when##6##3##(1992-6#1)(2004-12#1)(2006-10#1)(2008-3#1)(2008-4#1)(2012-1#1)
that occurs with##8##3##(1990-8#1)(1994-12#1)(1994-6#1)(2006-9#1)(2007-11#1)(2008-10#1)(2009-5#1)(2010-8#1)
that occurs within##3##3##(1992-6#1)(1993-7#1)(2004-3#1)
that occurs##110##2##(1990-10#1)(1990-2#1)(1990-8#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-6#2)(1992-7#1)(1993-12#1)(1993-7#1)(1994-12#1)(1994-6#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-11#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(2004-12#1)(2004-3#2)(2006-10#6)(2006-2#1)(2006-3#1)(2006-4#1)(2006-9#1)(2007-11#3)(2007-12#3)(2007-9#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-3#3)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#3)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)
that octreotide##2##2##(1991-7#1)(1995-5#1)
that odor##2##2##(2007-5#1)(2008-4#1)
that oestrogen receptor##2##3##(1992-1#1)(2007-10#1)
that oestrogen##4##2##(1992-1#1)(1992-8#2)(2007-10#1)
that of &quot##3##3##(1997-3#1)(2007-10#1)(2008-8#1)
that of 1 alpha##2##4##(1991-1#1)(1992-12#1)
that of 1##9##3##(1990-2#1)(1991-1#2)(1992-12#1)(2006-12#1)(2008-5#1)(2010-12#1)(2010-8#1)(2012-3#1)
that of 17E8##2##3##(1995-2#2)
that of 18C6##2##3##(2008-10#2)
that of 2##3##3##(2008-10#3)
that of 4##4##3##(1992-3#1)(1994-6#1)(1997-2#1)(2007-7#1)
that of 59##2##3##(2013-1#1)(2013-8#1)
that of A##3##3##(1997-6#1)(2007-1#1)(2008-10#1)
that of ASG-Tn with##2##4##(1995-2#2)
that of ATP##2##3##(1991-9#1)(2008-4#1)
that of C##3##3##(2008-10#2)(2012-2#1)
that of CA 19-9##2##4##(1991-2#2)
that of Ca2+ release##2##4##(1995-6#2)
that of CaMV 35S promoter##2##5##(2008-9#2)
that of CaMV 35S##3##4##(2008-9#3)
that of Cu(II)##2##3##(2008-10#2)
that of D##5##3##(1993-12#1)(2006-8#2)(2012-2#2)
that of DH5alpha##2##3##(2005-11#2)
that of DNA##3##3##(1991-8#1)(1993-6#1)(2012-2#1)
that of EF-Tu H84A##2##4##(1995-5#2)
that of Group##2##3##(2010-4#1)(2013-8#1)
that of HMG##2##3##(1990-3#2)
that of HMW##2##3##(1990-12#1)(1992-7#1)
that of HRP##2##3##(2008-10#2)
that of Hb##2##3##(1990-8#1)(1994-9#1)
that of IL-1β##2##3##(2011-2#2)
that of L##2##3##(1990-7#1)(2013-1#1)
that of Lowry##2##3##(2008-10#2)
that of P##4##3##(2006-8#1)(2007-1#1)(2008-10#1)(2013-8#1)
that of PKC##2##3##(1991-10#1)(1995-10#1)
that of PKC-zeta##2##3##(1994-2#2)
that of PS-1 protein##2##4##(1997-5#2)
that of S##5##3##(1990-5#1)(1994-9#1)(1995-3#1)(2008-8#1)(2012-3#1)
that of T##3##3##(2008-5#1)(2011-12#1)(2012-1#1)
that of Xmsx-1##2##3##(2008-6#2)
that of a classic##2##4##(2007-12#1)(2008-3#1)
that of a commercial##2##4##(1991-8#1)(1995-8#1)
that of a control group##2##5##(1991-3#1)(2007-9#1)
that of a control sample##2##5##(2008-4#2)
that of a control##4##4##(1991-3#1)(2007-9#1)(2008-4#2)
that of a conventional##8##4##(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)
that of a null##2##4##(1996-4#1)(1997-6#1)
that of a population##2##4##(2008-10#1)(2011-2#1)
that of a previous##3##4##(2008-3#1)(2011-1#1)(2011-2#1)
that of a random##2##4##(1994-9#1)(2008-11#1)
that of a reference##3##4##(2008-2#1)(2008-3#1)(2008-4#1)
that of a similar##3##4##(1990-6#1)(2008-5#2)
that of a single##4##4##(2006-5#1)(2008-3#2)(2013-1#1)
that of a standard##4##4##(2007-11#1)(2007-3#1)(2008-10#1)(2011-1#1)
that of a typical##3##4##(2007-12#1)(2007-3#1)(2008-5#1)
that of a##154##3##(1990-2#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-3#2)(1991-7#1)(1991-8#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#1)(1994-10#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#3)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-9#1)(2005-9#1)(2006-10#4)(2006-4#1)(2006-5#2)(2006-8#2)(2007-11#8)(2007-12#11)(2007-3#3)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#14)(2008-3#15)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-5#1)(2010-8#2)(2011-1#3)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
that of activated carbon##2##4##(1992-6#1)(2005-11#1)
that of adults##2##3##(1992-4#1)(2008-9#1)
that of age##2##3##(1996-5#1)(2008-10#1)
that of all##8##3##(2006-2#1)(2006-8#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-5#1)(2011-3#1)
that of alpha-tocopherol##2##3##(1996-2#1)(1997-8#1)
that of ampicillin##2##3##(2006-5#1)(2007-11#1)
that of an##21##3##(1991-12#1)(1991-7#1)(1991-9#1)(1994-2#1)(1997-4#1)(1997-6#1)(2006-8#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-6#1)(2010-12#2)(2010-5#1)
that of another##3##3##(1993-11#1)(1997-1#1)(2008-11#1)
that of any other##4##4##(1992-7#1)(1997-4#1)(2007-4#1)(2009-5#1)
that of any##6##3##(1991-11#1)(1991-12#1)(1992-7#1)(1997-4#1)(2007-4#1)(2009-5#1)
that of ara-C##3##3##(1992-5#3)
that of arterial blood##2##4##(1996-3#1)(1996-4#1)
that of aspirin##2##3##(2013-8#2)
that of asymptomatic##2##3##(2008-10#1)(2013-8#1)
that of authentic##3##3##(1990-12#1)(1990-8#1)(1994-9#1)
that of bare##2##3##(2008-10#1)(2008-3#1)
that of being##3##3##(1994-3#1)(2010-10#1)(2012-1#1)
that of beta##2##3##(1990-1#1)(1996-9#1)
that of big ET-1##2##4##(1990-9#1)(1991-1#1)
that of binding##2##3##(1991-8#1)(1994-8#1)
that of both##4##3##(1995-12#1)(2008-10#2)(2008-8#1)
that of bovine##2##3##(1995-2#1)(1997-7#1)
that of bulk##2##3##(2005-11#1)(2007-11#1)
that of bupivacaine##2##3##(1993-7#2)
that of calmodulin##2##3##(1990-5#1)(1994-8#1)
that of catalytic sites for ATP##3##6##(1990-7#3)
that of cathepsin##2##3##(1990-6#1)(1992-4#1)
that of cell##2##3##(1997-3#1)(2007-12#1)
that of cells##7##3##(1991-1#1)(1992-6#1)(2004-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-7#1)
that of chicken##3##3##(1991-3#1)(1993-2#1)(2008-5#1)
that of children##2##3##(1997-4#1)(2009-10#1)
that of classical##2##3##(2008-5#1)(2008-7#1)
that of clinical##2##3##(1991-4#1)(1997-3#1)
that of commercially##2##3##(2007-11#1)(2008-10#1)
that of compound##3##3##(1990-10#1)(1994-6#1)(1995-3#1)
that of control CF(1)##2##4##(2005-10#2)
that of control cells##3##4##(1990-4#1)(2008-11#2)
that of control##28##3##(1990-1#1)(1990-4#2)(1991-2#1)(1991-9#1)(1992-10#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-6#1)(2005-10#2)(2008-10#2)(2008-11#7)(2008-6#1)(2008-7#1)(2008-9#2)(2010-4#1)(2011-1#2)
that of controls##16##3##(1990-11#1)(1990-5#1)(1991-9#1)(1992-2#1)(1992-9#1)(1997-4#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-4#1)(2011-12#2)(2013-1#1)(2013-7#1)
that of conventional##23##3##(1994-5#1)(1997-1#1)(1997-6#1)(1997-7#1)(2007-11#3)(2007-12#5)(2008-10#1)(2008-2#3)(2008-3#3)(2009-7#1)(2010-12#1)(2012-12#1)(2012-2#1)
that of cotyledon##3##3##(2008-9#3)
that of diagnostic##3##3##(2007-2#2)(2010-8#1)
that of doxorubicin##2##3##(1997-1#1)(2008-5#1)
that of each##2##3##(2008-2#1)(2008-3#1)
that of either##4##3##(1994-11#1)(1997-4#1)(2008-3#1)(2008-5#1)
that of female##3##3##(1990-8#1)(2008-2#1)(2012-12#1)
that of free##5##3##(1993-6#1)(1995-2#2)(1997-7#1)(2010-2#1)
that of gamma##2##3##(1995-5#1)(2008-8#1)
that of general##2##3##(2006-10#1)(2013-1#1)
that of glass##2##3##(2006-10#1)(2007-11#1)
that of glucose##4##3##(2008-1#1)(2008-11#1)(2010-11#1)(2011-2#1)
that of group I##2##4##(1992-2#1)(2008-10#1)
that of group##5##3##(1992-2#1)(1997-2#1)(2008-10#1)(2013-8#2)
that of healthy subjects##2##4##(1993-11#1)(2009-9#1)
that of healthy##4##3##(1993-11#1)(2006-6#1)(2008-10#1)(2009-9#1)
that of heat##2##3##(1992-9#1)(2005-12#1)
that of heme##3##3##(1996-2#1)(1997-2#1)(1997-3#1)
that of heterotrophic##2##3##(2009-10#1)(2013-7#1)
that of holo##2##3##(1994-2#1)(2008-11#1)
that of how##2##3##(2007-1#1)(2008-3#1)
that of human##20##3##(1990-7#1)(1990-9#1)(1991-7#1)(1993-11#1)(1993-12#1)(1993-6#2)(1994-8#3)(1995-12#1)(1995-2#1)(1996-4#1)(1996-7#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-4#1)(2008-6#1)(2012-2#1)
that of humans##3##3##(2007-8#1)(2012-2#1)(2013-7#1)
that of individuals##2##3##(1997-1#1)(2008-12#1)
that of indomethacin##5##3##(1996-11#1)(2010-2#3)(2011-1#1)
that of infectious##2##3##(1997-3#1)(2007-7#1)
that of insulin##5##3##(1992-10#1)(1994-3#1)(2008-8#1)(2008-9#2)
that of intact##4##3##(1992-11#1)(1994-9#1)(1996-1#1)(1996-8#1)
that of iron##2##3##(1990-7#1)(2008-5#1)
that of its human counterpart##2##5##(1996-10#1)(1997-7#1)
that of its##24##3##(1990-12#1)(1990-5#2)(1990-7#1)(1991-10#1)(1991-7#1)(1993-1#1)(1996-10#1)(1996-7#1)(1997-2#1)(1997-7#2)(2003-11#1)(2007-12#2)(2008-10#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-2#2)(2012-2#1)(2012-3#1)
that of ketoconazole##2##3##(2008-11#2)
that of known##2##3##(1990-11#1)(1993-6#1)
that of late##2##3##(2007-11#1)(2009-2#1)
that of low##3##3##(1993-8#1)(2007-7#1)(2008-8#1)
that of lung##2##3##(1992-3#1)(2007-11#1)
that of males##3##3##(1995-6#1)(2010-8#1)(2011-1#1)
that of mammalian##5##3##(1991-1#1)(1992-11#1)(1994-9#1)(1997-8#1)(2009-5#1)
that of many other##2##4##(1990-4#1)(2008-10#1)
that of mature##4##3##(1990-12#1)(1992-12#1)(1994-12#1)(2008-5#1)
that of medical##2##3##(1996-9#1)(2008-3#1)
that of men##5##3##(1997-5#1)(2004-11#2)(2006-10#1)(2008-1#1)
that of milk xanthine oxidase##2##5##(1992-12#1)(1992-3#1)
that of monoclonal##2##3##(1990-12#1)(2008-9#1)
that of monomeric##2##3##(1997-2#1)(2008-10#1)
that of morphine##2##3##(2007-2#1)(2008-3#1)
that of mouse##2##3##(1993-6#2)
that of mtRNA(Leu(UUR))##2##3##(2008-8#2)
that of multiple##2##3##(1993-6#1)(2008-10#1)
that of murine##2##3##(1992-9#1)(1994-6#1)
that of native protein##2##4##(1992-8#1)(1993-11#1)
that of native##17##3##(1991-4#1)(1991-7#1)(1992-2#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-6#1)(1994-8#3)(1995-2#1)(1995-5#1)(2008-8#1)
that of natural##7##3##(1990-5#1)(1994-12#1)(1996-9#1)(1997-8#1)(2007-12#1)(2008-10#1)(2013-8#1)
that of naturally##2##3##(1994-8#1)(2009-10#1)
that of neuronal##2##3##(1994-6#1)(1996-5#1)
that of nicotinic##2##3##(1990-6#1)(1997-5#1)
that of normal human##2##4##(1990-10#1)(2008-5#1)
that of normal##22##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-8#1)(1992-6#1)(1992-9#1)(1993-2#1)(1994-11#2)(1996-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#3)(2011-3#3)
that of normoxic##2##3##(1992-1#1)(2009-9#1)
that of older##2##3##(1996-2#1)(2009-6#1)
that of ordinary##2##3##(2007-12#1)(2007-4#1)
that of other centres##3##4##(1991-4#1)(2006-8#2)
that of other known##3##4##(1990-9#1)(2008-5#1)(2010-6#1)
that of other##62##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-4#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-5#1)(1995-1#1)(1996-7#1)(1997-3#2)(1997-6#1)(2005-11#1)(2005-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-8#1)(2010-6#2)(2010-8#1)(2011-2#2)(2012-2#1)
that of others##3##3##(1990-11#1)(2006-2#1)(2013-8#1)
that of parental##2##3##(1996-6#1)(2007-12#1)
that of patients in##2##4##(1992-4#1)(2011-2#1)
that of patients with##3##4##(1991-8#1)(2007-8#1)(2010-3#1)
that of patients##8##3##(1991-8#1)(1992-4#1)(2004-11#1)(2006-6#1)(2007-8#1)(2008-7#1)(2010-3#1)(2011-2#1)
that of peripheral##2##3##(1996-3#1)(1997-7#1)
that of plasma##2##3##(1993-4#1)(1994-11#1)
that of plasminogen##2##3##(1991-6#1)(2010-3#1)
that of previous##2##3##(2008-10#1)(2013-7#1)
that of previously reported##2##4##(1996-3#1)(2010-12#1)
that of previously##8##3##(1990-11#1)(1996-10#1)(1996-3#1)(2007-11#1)(2008-2#1)(2008-7#1)(2009-10#1)(2010-12#1)
that of primary##3##3##(1996-2#2)(2011-1#1)
that of promoting##2##3##(1996-3#1)(2007-11#1)
that of protein kinase##2##4##(1990-4#1)(2008-10#1)
that of pure##7##3##(1990-3#1)(1990-5#1)(2005-11#2)(2008-2#1)(2008-3#2)
that of rabbit##2##3##(1990-7#1)(1992-12#1)
that of ranitidine##3##3##(1991-5#1)(2013-8#2)
that of rat##7##3##(1990-5#1)(1992-6#1)(1993-12#1)(1994-8#1)(1996-12#1)(2008-11#2)
that of rats##2##3##(2007-10#1)(2011-3#1)
that of reference##2##3##(1993-3#1)(2008-5#1)
that of same age##2##4##(2006-7#1)(2008-10#1)
that of standard##3##3##(1995-2#1)(2007-12#1)(2010-5#1)
that of strain##2##3##(2008-10#2)
that of substrate/product##2##3##(1995-5#2)
that of synthetic grafts##2##4##(2007-7#2)
that of synthetic##5##3##(1990-12#1)(1994-6#1)(1994-8#1)(2007-7#2)
that of the Antarctic##2##4##(1991-5#1)(2013-8#1)
that of the E##2##4##(1991-8#1)(1996-7#1)
that of the EB-PVD##2##4##(2009-7#2)
that of the NC##2##4##(1996-7#2)
that of the POF##2##4##(2008-3#2)
that of the activated carbon##2##5##(2005-11#2)
that of the activated##3##4##(1994-5#1)(2005-11#2)
that of the adult##2##4##(2008-11#1)(2012-12#1)
that of the adults##4##4##(1993-2#1)(2011-1#1)(2012-12#1)(2013-8#1)
that of the amyloid##2##4##(1992-3#1)(1996-2#1)
that of the background##2##4##(2008-10#1)(2008-2#1)
that of the batch##2##4##(2008-6#1)(2008-7#1)
that of the bottom##2##4##(2008-10#1)(2008-2#1)
that of the bovine##2##4##(1996-9#1)(1997-7#1)
that of the bulk##2##4##(2007-12#2)
that of the cell##3##4##(2007-2#1)(2008-11#1)(2008-8#1)
that of the cells in##2##5##(2008-11#1)(2012-12#1)
that of the cells##4##4##(2008-11#2)(2009-7#1)(2012-12#1)
that of the common##2##4##(1994-3#1)(2008-7#1)
that of the comparison##2##4##(2006-3#1)(2010-2#1)
that of the complex##2##4##(1993-3#1)(1995-4#1)
that of the control group was##2##6##(2007-10#1)(2008-8#1)
that of the control group##9##5##(1994-5#1)(1997-2#1)(2007-10#1)(2008-10#1)(2008-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
that of the control groups##7##5##(2008-5#1)(2008-8#1)(2008-9#5)
that of the control level##2##5##(1992-1#1)(2013-8#1)
that of the control rats##3##5##(1993-11#1)(1995-12#1)(1997-2#1)
that of the control##33##4##(1990-12#1)(1992-1#1)(1993-11#2)(1993-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1997-2#4)(2007-10#1)(2008-10#2)(2008-5#1)(2008-8#2)(2008-9#7)(2010-3#1)(2011-12#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
that of the controls##4##4##(1990-5#1)(1994-2#2)(2011-2#1)
that of the conventional##14##4##(1995-1#1)(2007-12#4)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2012-12#1)(2013-8#1)
that of the core##2##4##(2007-12#1)(2008-3#1)
that of the corresponding##6##4##(1990-4#1)(1992-6#1)(1995-3#1)(1995-8#1)(2008-3#1)(2008-4#1)
that of the culture##3##4##(2008-11#3)
that of the entire##2##4##(1991-11#1)(2008-5#1)
that of the enzyme##3##4##(1991-2#1)(1996-7#1)(1997-4#1)
that of the first##3##4##(2008-2#1)(2008-3#1)(2013-1#1)
that of the free##2##4##(1994-3#1)(2010-2#1)
that of the fundamental##2##4##(2007-11#1)(2008-2#1)
that of the gene##3##4##(1990-10#2)(1992-11#1)
that of the general population##7##5##(1991-2#1)(1993-1#1)(1997-3#1)(2006-10#2)(2008-12#1)(2010-12#1)
that of the general##8##4##(1991-2#1)(1993-1#1)(1997-3#1)(2006-10#2)(2007-7#1)(2008-12#1)(2010-12#1)
that of the healthy##2##4##(1996-7#1)(2008-5#1)
that of the holoenzyme##2##4##(1991-2#1)(1992-11#1)
that of the human##12##4##(1990-12#1)(1990-4#1)(1991-12#1)(1993-11#1)(1993-5#1)(1994-12#1)(1996-5#1)(2007-7#1)(2008-4#1)(2008-8#1)(2010-12#1)(2011-1#1)
that of the increase in##2##5##(1990-7#1)(1993-8#1)
that of the initial##3##4##(1990-5#1)(1991-8#1)(2005-11#1)
that of the input##4##4##(1992-6#1)(2008-1#1)(2008-2#1)(2008-3#1)
that of the intact##5##4##(1990-2#1)(1991-8#1)(1992-3#1)(1993-6#1)(1995-5#1)
that of the internal##3##4##(1990-4#1)(1993-2#1)(2008-7#1)
that of the known##2##4##(1990-6#1)(1993-6#1)
that of the linear##4##4##(1996-8#2)(2008-3#2)
that of the local##4##4##(2004-11#1)(2008-2#2)(2008-3#1)
that of the major##3##4##(1991-7#1)(1992-8#1)(1997-5#1)
that of the male##2##4##(2007-12#2)
that of the most##4##4##(1991-3#1)(1994-11#1)(1996-4#1)(2008-10#1)
that of the native enzyme##3##5##(1990-11#2)(1995-3#1)
that of the native state##2##5##(2006-10#2)
that of the native##12##4##(1990-11#4)(1995-11#1)(1995-3#1)(2006-10#2)(2007-11#1)(2008-11#1)(2008-8#2)
that of the natural##3##4##(1990-8#1)(1995-1#1)(1995-10#1)
that of the non##2##4##(2006-9#1)(2008-10#1)
that of the normal subjects##2##5##(1994-12#1)(2009-8#1)
that of the normal##4##4##(1990-4#1)(1994-12#1)(2008-9#1)(2009-8#1)
that of the object##2##4##(2007-12#1)(2008-3#1)
that of the original strain##3##5##(2008-10#1)(2008-5#2)
that of the original##13##4##(1990-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2009-7#1)(2010-2#1)(2010-7#1)(2012-11#1)
that of the other##10##4##(1991-2#1)(1993-11#1)(1993-3#1)(1994-6#1)(1995-3#1)(1996-4#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-3#1)
that of the parent strain##2##5##(1997-7#1)(2008-10#1)
that of the parent##5##4##(1996-7#1)(1997-5#1)(1997-7#1)(2007-1#1)(2008-10#1)
that of the parental##6##4##(1990-8#1)(1994-2#1)(1996-11#1)(2005-11#1)(2008-10#1)(2013-8#1)
that of the peptide##2##4##(1992-11#1)(1993-3#1)
that of the precursor##2##4##(1990-8#1)(2008-6#1)
that of the present-day##2##4##(2008-3#2)
that of the previously reported##2##5##(2007-11#1)(2011-1#1)
that of the previously sequenced##2##5##(1991-2#1)(1993-12#1)
that of the previously studied##2##5##(1993-4#1)(2010-4#1)
that of the previously##7##4##(1991-2#1)(1993-12#1)(1993-4#1)(1994-9#1)(2007-11#1)(2010-4#1)(2011-1#1)
that of the primary##2##4##(1992-8#1)(2008-5#1)
that of the product##2##4##(1997-2#1)(2008-5#1)
that of the pump##3##4##(2007-12#3)
that of the pure##3##4##(1990-4#1)(2005-11#1)(2010-4#1)
that of the purified##2##4##(1992-11#1)(1996-7#1)
that of the rat##7##4##(1991-7#1)(1993-4#1)(1994-11#1)(1994-8#1)(1996-5#1)(2008-8#1)(2011-2#1)
that of the reference##4##4##(1995-3#1)(2008-3#2)(2008-5#1)
that of the resting form##2##5##(1990-10#2)
that of the resting##3##4##(1990-10#2)(1992-6#1)
that of the standard##5##4##(1997-3#1)(2007-12#1)(2008-2#1)(2008-8#1)(2012-1#1)
that of the traditional##5##4##(1991-12#1)(1994-2#1)(1996-5#1)(2008-2#1)(2012-3#1)
that of the untreated##3##4##(2008-10#1)(2008-4#1)(2012-2#1)
that of the vehicle control groups##5##6##(2008-9#5)
that of the vehicle controls##2##5##(2008-9#2)
that of the vehicle##7##4##(2008-9#7)
that of the well-known##2##4##(1997-7#1)(2008-6#1)
that of the whole##2##4##(1992-5#1)(2006-12#1)
that of the wild type##18##5##(1990-5#2)(1991-8#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#3)(1995-1#1)(1995-7#1)(1995-8#1)(1996-5#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-10#1)
that of the wild-type GLUT1##2##5##(1992-4#2)
that of the wild-type enzyme##9##5##(1990-10#1)(1992-3#1)(1992-6#2)(1994-11#1)(1994-5#1)(1994-9#1)(1995-1#1)(1996-11#1)
that of the wild-type enzyme)##4##5##(1994-5#3)(1995-1#1)
that of the wild-type protein##2##5##(1994-6#1)(1997-5#1)
that of the wild-type##29##4##(1990-10#1)(1992-3#1)(1992-4#2)(1992-6#2)(1993-3#2)(1994-11#1)(1994-5#4)(1994-6#1)(1994-9#1)(1995-1#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-7#1)(1997-2#2)(1997-4#1)(1997-5#1)(2006-12#1)(2008-10#1)(2008-6#1)
that of the young##2##4##(1992-3#1)(2010-7#1)
that of the##913##3##(1990-10#8)(1990-11#7)(1990-12#9)(1990-2#7)(1990-3#1)(1990-4#6)(1990-5#13)(1990-6#2)(1990-7#5)(1990-8#7)(1990-9#1)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#4)(1991-2#7)(1991-3#2)(1991-4#1)(1991-5#4)(1991-6#3)(1991-7#9)(1991-8#7)(1991-9#6)(1992-1#3)(1992-10#1)(1992-11#4)(1992-12#2)(1992-2#1)(1992-3#6)(1992-4#4)(1992-5#2)(1992-6#10)(1992-7#1)(1992-8#4)(1992-9#5)(1993-1#1)(1993-11#7)(1993-12#2)(1993-2#2)(1993-3#12)(1993-4#4)(1993-5#2)(1993-6#7)(1993-7#2)(1993-8#2)(1993-9#5)(1994-11#6)(1994-12#5)(1994-2#8)(1994-3#4)(1994-5#7)(1994-6#3)(1994-8#6)(1994-9#5)(1995-1#10)(1995-10#1)(1995-11#5)(1995-12#4)(1995-2#5)(1995-3#7)(1995-4#1)(1995-5#6)(1995-6#7)(1995-7#2)(1995-8#5)(1995-9#1)(1996-10#1)(1996-11#5)(1996-12#3)(1996-2#5)(1996-4#2)(1996-5#8)(1996-6#3)(1996-7#11)(1996-8#4)(1996-9#3)(1997-1#5)(1997-2#15)(1997-3#4)(1997-4#8)(1997-5#7)(1997-6#7)(1997-7#4)(1997-8#2)(2004-11#1)(2004-12#1)(2005-11#9)(2005-9#2)(2006-10#8)(2006-11#3)(2006-12#8)(2006-3#1)(2006-4#4)(2006-5#3)(2006-8#5)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#10)(2007-12#31)(2007-2#2)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#4)(2008-10#64)(2008-11#15)(2008-12#3)(2008-2#35)(2008-3#42)(2008-4#5)(2008-5#32)(2008-6#9)(2008-7#14)(2008-8#23)(2008-9#27)(2009-10#2)(2009-12#3)(2009-3#4)(2009-4#3)(2009-5#1)(2009-7#8)(2009-8#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#7)(2010-3#1)(2010-4#6)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#3)(2011-1#10)(2011-12#2)(2011-2#17)(2011-3#1)(2012-1#3)(2012-11#2)(2012-12#7)(2012-2#10)(2012-3#4)(2013-1#8)(2013-7#3)(2013-8#11)
that of their##10##3##(1995-11#1)(1995-4#1)(1997-1#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
that of those##3##3##(2006-6#1)(2010-11#1)(2012-2#1)
that of thymidine##2##3##(1997-8#2)
that of tissue from##2##4##(2008-10#2)
that of total##3##3##(1990-3#1)(1990-4#1)(1995-3#1)
that of two##5##3##(1991-8#1)(1993-1#1)(1994-12#1)(2008-10#1)(2008-2#1)
that of type STMV##3##4##(2008-10#3)
that of type##5##3##(1991-1#1)(2008-1#1)(2008-10#3)
that of typical##2##3##(1992-6#1)(1995-12#1)
that of untreated##3##3##(1991-1#1)(1996-11#1)(1997-4#1)
that of water##2##3##(2008-10#1)(2008-2#1)
that of well-established##2##3##(2007-2#1)(2008-7#1)
that of wild type##2##4##(1993-11#1)(2009-8#1)
that of wild##3##3##(1993-11#1)(2008-11#1)(2009-8#1)
that of wild-type##15##3##(1990-2#1)(1991-2#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-11#1)(1996-11#1)(1997-6#1)(2006-12#1)(2008-10#1)(2009-9#1)(2010-10#1)
that of women##3##3##(1991-9#1)(1997-2#1)(2004-11#1)
that of yeast##2##3##(1990-11#1)(1994-6#1)
that of young subjects##3##4##(1992-12#1)(1993-1#1)(1996-11#1)
that of young##9##3##(1990-5#1)(1992-1#1)(1992-12#1)(1993-1#1)(1996-11#1)(1996-3#2)(2008-5#1)(2009-12#1)
that of younger patients##2##4##(2007-7#2)
that of younger##4##3##(2005-10#1)(2006-11#1)(2007-7#2)
that of##2931##2##(1990-1#5)(1990-10#16)(1990-11#19)(1990-12#21)(1990-2#20)(1990-3#13)(1990-4#17)(1990-5#28)(1990-6#9)(1990-7#23)(1990-8#21)(1990-9#10)(1991-1#11)(1991-10#10)(1991-11#5)(1991-12#11)(1991-2#16)(1991-3#11)(1991-4#6)(1991-5#17)(1991-6#4)(1991-7#21)(1991-8#18)(1991-9#16)(1992-1#9)(1992-10#5)(1992-11#9)(1992-12#11)(1992-2#11)(1992-3#22)(1992-4#9)(1992-5#9)(1992-6#22)(1992-7#13)(1992-8#13)(1992-9#14)(1993-1#7)(1993-11#23)(1993-12#11)(1993-2#10)(1993-3#20)(1993-4#7)(1993-5#2)(1993-6#18)(1993-7#7)(1993-8#13)(1993-9#13)(1994-10#2)(1994-11#21)(1994-12#24)(1994-2#22)(1994-3#12)(1994-5#12)(1994-6#18)(1994-7#2)(1994-8#28)(1994-9#23)(1995-1#23)(1995-10#7)(1995-11#17)(1995-12#14)(1995-2#24)(1995-3#22)(1995-4#4)(1995-5#19)(1995-6#19)(1995-7#4)(1995-8#17)(1995-9#5)(1996-1#5)(1996-10#8)(1996-11#13)(1996-12#15)(1996-2#16)(1996-3#11)(1996-4#9)(1996-5#21)(1996-6#6)(1996-7#20)(1996-8#9)(1996-9#10)(1997-1#14)(1997-2#34)(1997-3#18)(1997-4#30)(1997-5#17)(1997-6#19)(1997-7#22)(1997-8#17)(2003-11#1)(2004-10#1)(2004-11#6)(2004-12#4)(2004-2#2)(2004-4#1)(2004-8#1)(2004-9#1)(2005-10#5)(2005-11#30)(2005-12#1)(2005-4#3)(2005-7#2)(2005-9#3)(2006-1#2)(2006-10#34)(2006-11#5)(2006-12#21)(2006-2#6)(2006-3#2)(2006-4#7)(2006-5#11)(2006-6#3)(2006-7#1)(2006-8#21)(2006-9#2)(2007-1#7)(2007-10#12)(2007-11#50)(2007-12#85)(2007-2#15)(2007-3#6)(2007-4#6)(2007-5#2)(2007-6#5)(2007-7#20)(2007-8#16)(2007-9#7)(2008-1#19)(2008-10#248)(2008-11#60)(2008-12#21)(2008-2#85)(2008-3#92)(2008-4#18)(2008-5#95)(2008-6#20)(2008-7#38)(2008-8#63)(2008-9#54)(2009-10#11)(2009-12#4)(2009-2#4)(2009-3#6)(2009-4#8)(2009-5#7)(2009-6#6)(2009-7#13)(2009-8#8)(2009-9#8)(2010-1#3)(2010-10#3)(2010-11#8)(2010-12#18)(2010-2#18)(2010-3#5)(2010-4#15)(2010-5#7)(2010-6#5)(2010-7#6)(2010-8#12)(2010-9#2)(2011-1#29)(2011-10#2)(2011-12#9)(2011-2#49)(2011-3#7)(2012-1#7)(2012-11#7)(2012-12#20)(2012-2#32)(2012-3#15)(2013-1#29)(2013-7#14)(2013-8#35)
that offer many##2##3##(1994-2#1)(2008-1#1)
that offer the##2##3##(2007-10#1)(2008-10#1)
that offer##15##2##(1991-1#1)(1994-2#1)(1994-3#1)(1996-1#1)(2004-11#1)(2004-12#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-3#1)
that offered##4##2##(1991-2#1)(1995-11#1)(2006-5#1)(2008-12#1)
that offers a##4##3##(2006-9#1)(2008-10#1)(2008-11#1)(2010-2#1)
that offers an##2##3##(2006-1#1)(2008-11#1)
that offers the##3##3##(1996-12#1)(2010-2#1)(2011-7#1)
that offers##16##2##(1996-12#1)(2006-1#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-2#1)(2010-2#2)(2011-7#1)(2013-1#2)
that often accompany##2##3##(1991-8#1)(2013-1#1)
that often have##3##3##(2008-4#2)(2010-8#1)
that often include##2##3##(2006-10#1)(2008-10#1)
that often is##3##3##(2004-4#1)(2006-6#1)(2008-9#1)
that often presents##3##3##(1992-6#1)(2007-7#1)(2008-1#1)
that often results##5##3##(1996-7#1)(2007-9#1)(2008-8#1)(2013-1#2)
that often the##2##3##(1990-12#1)(2008-8#1)
that often were##2##3##(2008-10#1)(2012-11#1)
that often##48##2##(1990-10#1)(1990-12#1)(1991-8#1)(1991-9#1)(1992-6#1)(1994-12#1)(1995-11#1)(1996-7#1)(1997-3#1)(2004-4#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-9#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#5)
that old##3##2##(1993-4#1)(2006-10#1)(2008-10#1)
that older adults##4##3##(2007-1#1)(2007-12#1)(2011-2#1)(2012-11#1)
that older people##4##3##(1991-1#1)(2008-3#1)(2008-7#2)
that older##19##2##(1991-1#1)(1992-6#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-7#2)(2009-11#1)(2009-7#1)(2011-2#3)(2012-11#2)(2012-12#1)
that olfactory##6##2##(1992-8#1)(1994-8#1)(1995-5#1)(1997-7#1)(2008-11#1)(2012-2#1)
that oligomerization##2##2##(1994-8#1)(2011-1#1)
that oligosaccharides##2##2##(1990-2#1)(2008-11#1)
that omeprazole##2##2##(1993-11#1)(2012-2#1)
that on a##3##3##(2006-5#1)(2008-10#2)
that on the basis of##2##5##(2006-6#1)(2009-7#1)
that on the cast##2##4##(2008-11#2)
that on the##15##3##(1990-5#1)(1994-9#1)(1996-2#1)(2005-11#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#4)(2008-5#1)(2009-7#1)
that on##51##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1994-9#1)(1995-11#1)(1996-2#1)(1996-3#1)(2005-11#2)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#5)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2009-7#1)(2012-3#1)(2013-8#1)
that once daily subcutaneous sermorelin 30 microg/kg bodyweight##2##8##(2007-11#2)
that once##12##2##(1991-10#1)(1994-1#1)(1995-2#1)(1996-1#1)(1996-3#1)(1997-5#1)(2007-11#2)(2008-10#1)(2008-8#1)(2012-2#1)(2013-8#1)
that oncogenes##3##2##(1995-2#1)(1997-7#1)(2008-11#1)
that one can control##2##4##(2007-11#1)(2008-3#1)
that one can easily##2##4##(2007-12#1)(2008-3#1)
that one can tune the##2##5##(2007-12#1)(2008-1#1)
that one can use##3##4##(1994-11#1)(2008-2#1)(2008-3#1)
that one can##24##3##(1993-1#1)(1994-11#1)(2007-11#3)(2007-12#7)(2008-1#3)(2008-2#4)(2008-3#4)(2008-5#1)
that one function of the##2##5##(1994-3#1)(2008-9#1)
that one function of##5##4##(1990-8#1)(1994-3#1)(1995-10#1)(2005-11#1)(2008-9#1)
that one function##6##3##(1990-8#1)(1993-4#1)(1994-3#1)(1995-10#1)(2005-11#1)(2008-9#1)
that one gene##2##3##(1990-8#1)(2009-3#1)
that one has to##2##4##(2005-11#1)(2007-12#1)
that one has##3##3##(2005-11#1)(2007-12#1)(2008-2#1)
that one is##2##3##(2008-4#1)(2010-12#1)
that one major##2##3##(2006-7#1)(2008-10#1)
that one mechanism##3##3##(1992-3#1)(2005-10#1)(2010-1#1)
that one must##4##3##(1994-11#1)(1994-9#1)(2008-2#1)(2009-5#1)
that one of the main##2##5##(2008-4#1)(2009-8#1)
that one of the major##2##5##(2004-10#1)(2010-11#1)
that one of the most##3##5##(2006-7#1)(2009-9#1)(2013-1#1)
that one of the two##3##5##(1997-4#1)(2008-11#1)(2008-5#1)
that one of the##43##4##(1990-11#1)(1990-5#2)(1991-10#1)(1991-12#1)(1993-12#1)(1993-8#2)(1994-2#2)(1994-8#1)(1995-4#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-10#1)(2005-11#1)(2005-4#1)(2005-9#1)(2006-6#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#2)(2009-9#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#2)
that one of them##3##4##(1992-4#1)(1997-5#1)(2007-12#1)
that one of these##7##4##(1991-2#1)(1992-11#1)(2006-7#1)(2008-10#1)(2008-2#2)(2009-8#1)
that one of##55##3##(1990-11#1)(1990-5#2)(1991-10#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-4#1)(1993-12#1)(1993-8#2)(1994-2#2)(1994-8#1)(1995-4#1)(1996-11#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-10#1)(2005-11#1)(2005-4#1)(2005-9#1)(2006-6#1)(2006-7#3)(2007-12#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#3)(2009-9#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#2)
that one or more of these##2##6##(1994-6#2)
that one or more tyrosine##2##5##(1995-1#1)(1995-8#1)
that one or more##11##4##(1990-7#1)(1990-8#1)(1991-7#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#2)
that one or##15##3##(1990-7#1)(1990-8#1)(1991-12#1)(1991-7#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#2)(2006-11#1)(2007-11#1)(2008-9#1)
that one reason##2##3##(1991-11#1)(2008-10#1)
that one should be##2##4##(2008-5#1)(2012-2#1)
that one specific##2##3##(2008-10#1)(2008-5#1)
that one such##3##3##(1992-10#1)(1995-5#1)(1996-12#1)
that one way to##2##4##(1994-12#1)(2006-4#1)
that one way##3##3##(1994-12#1)(2006-10#1)(2006-4#1)
that one##201##2##(1990-11#2)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-8#2)(1994-11#2)(1994-12#3)(1994-2#3)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#2)(1995-10#2)(1995-2#1)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-10#1)(2005-10#2)(2005-11#3)(2005-12#1)(2005-4#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-4#1)(2006-6#1)(2006-7#4)(2007-11#4)(2007-12#11)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#13)(2008-11#3)(2008-2#11)(2008-3#8)(2008-4#3)(2008-5#10)(2008-7#1)(2008-8#3)(2008-9#5)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#3)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#3)
that one-dimensional##2##2##(2007-12#1)(2010-4#1)
that one-third of the##2##4##(1995-6#1)(2008-11#1)
that ongoing##2##2##(2010-2#1)(2012-3#1)
that online##2##2##(2008-4#1)(2008-9#1)
that only 4##2##3##(1992-6#1)(2008-10#1)
that only 5% of##2##4##(1996-8#1)(2008-10#1)
that only a fraction of the##2##6##(1997-2#1)(2005-11#1)
that only a fraction of##3##5##(1997-2#1)(2005-11#1)(2007-4#1)
that only a single##2##4##(2008-2#1)(2009-12#1)
that only a small##6##4##(1991-9#1)(1996-1#1)(2008-3#1)(2008-6#1)(2008-7#1)(2013-1#1)
that only a##20##3##(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1993-6#1)(1996-1#1)(1997-2#1)(2004-11#1)(2005-11#1)(2007-4#1)(2008-2#2)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2013-1#1)
that only certain##2##3##(1993-6#1)(2008-8#1)
that only five##2##3##(2008-6#1)(2012-12#1)
that only in##4##3##(1996-11#1)(2007-2#1)(2007-7#1)(2008-5#1)
that only one of##2##4##(2007-12#1)(2008-10#1)
that only one##8##3##(1993-6#1)(1995-9#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)
that only produces##2##3##(1991-5#1)(2004-11#1)
that only the first##2##4##(1994-8#1)(2008-10#1)
that only the##37##3##(1990-12#1)(1990-9#1)(1992-3#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-3#1)(1996-2#1)(1996-8#1)(1997-4#1)(2003-11#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-2#1)
that only two##5##3##(1990-4#1)(1992-6#1)(2006-12#1)(2008-2#2)
that only##194##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-4#1)(1992-6#2)(1992-7#1)(1993-11#1)(1993-4#1)(1993-6#6)(1993-8#1)(1993-9#2)(1994-10#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#3)(1994-9#2)(1995-11#2)(1995-3#3)(1995-4#1)(1995-5#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-8#3)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-8#2)(2003-11#1)(2004-11#2)(2005-11#1)(2005-5#1)(2005-9#1)(2006-10#1)(2006-12#2)(2006-5#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-12#6)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#5)(2008-4#2)(2008-5#4)(2008-6#5)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#3)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#2)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#4)(2013-7#1)
that onset of##2##3##(2005-11#1)(2008-7#1)
that onset##3##2##(2005-11#1)(2006-2#1)(2008-7#1)
that oogenesis##3##2##(2007-12#1)(2008-12#1)(2008-5#1)
that oospores##3##2##(2008-10#3)
that open access##2##3##(1996-6#1)(2010-5#1)
that open##5##2##(1996-6#1)(2008-6#1)(2009-10#1)(2009-3#1)(2010-5#1)
that opens the##2##3##(1991-3#1)(2011-2#1)
that opens##5##2##(1991-3#1)(2007-12#1)(2008-3#1)(2010-7#1)(2011-2#1)
that operate at##2##3##(2007-12#1)(2008-7#1)
that operate in a##2##4##(1990-10#1)(2012-2#1)
that operate in the##2##4##(2007-12#1)(2008-2#1)
that operate in##6##3##(1990-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-2#1)
that operate##18##2##(1990-10#1)(1990-9#1)(2007-12#2)(2008-10#1)(2008-11#5)(2008-2#3)(2008-4#1)(2008-5#1)(2008-7#1)(2011-12#1)(2012-2#1)
that operates at a##2##4##(2007-11#1)(2008-2#1)
that operates at the##2##4##(2006-11#1)(2008-2#1)
that operates at##6##3##(1997-2#1)(2006-11#1)(2007-11#1)(2008-2#2)(2008-3#1)
that operates in a##3##4##(1995-6#2)(2008-2#1)
that operates in the##2##4##(1993-12#1)(2008-3#1)
that operates in##7##3##(1993-12#1)(1995-6#2)(2008-10#1)(2008-2#1)(2008-3#2)
that operates##22##2##(1993-12#1)(1995-6#2)(1996-6#1)(1997-2#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#1)
that operating##3##2##(1996-5#1)(2007-9#1)(2008-10#1)
that operation##2##2##(2007-11#1)(2007-8#1)
that opiate##2##2##(1996-1#1)(1996-10#1)
that opiates##2##2##(1990-7#1)(1995-7#1)
that opioid receptors##2##3##(1990-3#1)(1993-12#1)
that opioid release##2##3##(1992-12#1)(1995-7#1)
that opioid##7##2##(1990-3#1)(1992-12#1)(1993-12#1)(1993-4#1)(1995-7#1)(2007-2#1)(2008-2#1)
that opioids may have##2##4##(1995-6#1)(2007-9#1)
that opportunities##2##2##(1993-2#1)(2007-9#1)
that optical##7##2##(1992-4#1)(1997-6#1)(2007-12#2)(2008-11#1)(2008-3#2)
that optimal##10##2##(1996-8#1)(1996-9#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-4#1)(2012-12#1)
that optimally##6##2##(1994-2#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-2#1)
that optimization##2##2##(2008-2#1)(2008-3#1)
that optimize the##5##3##(1994-8#1)(2007-12#1)(2008-3#2)(2012-12#1)
that optimize##10##2##(1994-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2012-12#1)(2013-1#1)
that optimized##4##2##(2008-3#1)(2010-10#1)(2011-1#1)(2013-1#1)
that optimizes the##3##3##(1995-8#1)(1996-8#1)(2007-11#1)
that optimizes##8##2##(1991-4#1)(1995-8#1)(1996-8#1)(2007-11#1)(2008-10#2)(2008-3#1)(2011-2#1)
that optimum##4##2##(1996-6#1)(2007-7#1)(2008-2#1)(2010-5#1)
that oral administration of##8##4##(1997-4#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2009-8#1)(2013-8#1)
that oral##24##2##(1991-3#1)(1997-4#1)(2005-11#1)(2007-8#2)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
that orally administered##3##3##(1990-2#1)(2004-11#1)(2008-11#1)
that orally fed##2##3##(2008-11#2)
that orally##6##2##(1990-2#1)(2004-11#1)(2008-11#3)(2012-12#1)
that orange juice##2##3##(2007-8#2)
that orchestrate##2##2##(2009-5#1)(2012-3#1)
that orchid##2##2##(2008-5#2)
that order##9##2##(1990-10#1)(1992-1#1)(1996-6#1)(1997-6#1)(2007-1#2)(2008-6#1)(2011-1#1)(2012-1#1)
that organic matter##2##3##(2008-10#1)(2008-11#1)
that organic##7##2##(1992-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2010-4#1)
that organisms##5##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-5#1)
that organizational##2##2##(1992-1#1)(2010-2#1)
that organize##2##2##(2008-4#1)(2009-3#1)
that orient##2##2##(2008-10#1)(2008-3#1)
that originate from the##2##4##(2007-11#1)(2008-2#1)
that originate from##6##3##(2006-10#1)(2007-11#1)(2007-12#3)(2008-2#1)
that originate in the##2##4##(1993-12#1)(2007-12#1)
that originate in##3##3##(1993-12#1)(1997-3#1)(2007-12#1)
that originate##10##2##(1993-12#1)(1996-9#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#4)(2008-2#1)
that originated from the##2##4##(2008-2#1)(2008-5#1)
that originated from##8##3##(1993-12#1)(1993-3#1)(2008-10#3)(2008-2#1)(2008-5#1)(2010-6#1)
that originated in the##3##4##(2008-1#1)(2009-4#1)(2011-2#1)
that originated in##4##3##(2008-1#1)(2008-10#1)(2009-4#1)(2011-2#1)
that originated##16##2##(1993-12#1)(1993-3#1)(2007-4#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-5#1)(2009-12#1)(2009-4#1)(2010-6#1)(2011-2#1)
that originates from##4##3##(2008-7#1)(2010-12#1)(2010-2#1)(2012-12#1)
that originates##5##2##(2008-3#1)(2008-7#1)(2010-12#1)(2010-2#1)(2012-12#1)
that oscillates##2##2##(2007-12#1)(2008-2#1)
that oscillations##4##2##(1995-11#1)(1997-1#1)(1997-7#1)(2010-10#1)
that osteoarthritis##2##2##(1991-10#1)(2007-8#1)
that osteoporosis is##2##3##(2008-6#1)(2010-3#1)
that osteoporosis##3##2##(1996-6#1)(2008-6#1)(2010-3#1)
that other factors are involved##2##5##(2006-8#1)(2008-1#1)
that other factors are##3##4##(2006-8#1)(2008-1#1)(2013-1#1)
that other factors in the##2##5##(2004-11#1)(2010-8#1)
that other factors may be##2##5##(1990-6#1)(2013-1#1)
that other factors may##3##4##(1990-6#1)(2006-12#1)(2013-1#1)
that other factors##13##3##(1990-6#1)(1994-8#1)(1997-4#1)(1997-7#1)(2004-11#1)(2006-12#1)(2006-8#1)(2008-1#1)(2008-10#2)(2010-8#1)(2013-1#2)
that other genes##2##3##(1992-7#1)(1993-11#1)
that other host##2##3##(2006-10#1)(2008-10#1)
that other mechanisms##4##3##(2008-10#2)(2008-4#1)(2010-12#1)
that other than##2##3##(1991-7#1)(2013-1#1)
that other##79##2##(1990-2#2)(1990-3#1)(1990-6#1)(1990-9#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-11#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-8#2)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
that others can##2##3##(1990-12#1)(2012-1#1)
that others have##2##3##(2012-1#1)(2013-1#1)
that others##6##2##(1990-12#1)(2007-11#1)(2009-1#1)(2012-1#2)(2013-1#1)
that otherwise##11##2##(1992-5#1)(1997-2#1)(2005-12#1)(2005-6#1)(2006-10#1)(2007-11#1)(2008-10#2)(2009-3#1)(2010-3#1)(2013-8#1)
that our algorithm##5##3##(2008-2#2)(2009-12#1)(2013-1#2)
that our approach is##2##4##(2007-11#1)(2008-10#1)
that our approach##8##3##(2007-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2012-3#2)(2013-1#2)
that our data##2##3##(2007-12#1)(2008-7#1)
that our findings##4##3##(1992-1#1)(2007-7#1)(2008-8#1)(2012-2#1)
that our framework##2##3##(2008-2#1)(2012-3#1)
that our method has##2##4##(2009-3#1)(2012-3#1)
that our method##8##3##(2007-7#1)(2007-8#1)(2008-3#2)(2009-3#1)(2010-5#1)(2012-3#2)
that our model##3##3##(2007-12#1)(2008-10#2)
that our optical ring##4##4##(2008-3#4)
that our proposed##4##3##(1994-5#1)(2008-2#1)(2013-1#2)
that our results are##3##4##(1993-7#1)(1995-6#1)(2008-8#1)
that our system is##2##4##(2008-10#1)(2008-11#1)
that our system##4##3##(2008-10#1)(2008-11#1)(2013-1#2)
that our##116##2##(1990-2#2)(1991-12#1)(1991-5#1)(1992-1#1)(1992-8#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-4#1)(1996-6#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#1)(2006-10#2)(2007-11#2)(2007-12#3)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-2#5)(2008-3#9)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#5)(2012-3#10)(2013-1#11)(2013-8#1)
that out of the##4##4##(1997-7#1)(2005-10#1)(2006-11#1)(2010-5#1)
that out of##13##3##(1997-7#2)(2005-10#1)(2006-10#1)(2006-11#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-8#1)(2009-7#1)(2010-5#1)(2012-2#1)
that outbreaks of##2##3##(1996-8#1)(1997-6#1)
that outcomes##3##2##(2008-3#1)(2009-5#1)(2012-12#1)
that outlined##2##2##(1996-5#1)(2006-8#1)
that outpatient##3##2##(1990-8#1)(1992-12#1)(2007-3#1)
that outperforms##2##2##(2011-1#1)(2012-2#1)
that outward##3##2##(2005-10#1)(2008-10#1)(2008-8#1)
that ovarian cancer##2##3##(1993-9#1)(2012-2#1)
that ovarian##6##2##(1993-6#1)(1993-9#1)(2004-2#1)(2006-5#1)(2012-2#2)
that over 50% of the##2##5##(2009-4#1)(2011-1#1)
that over 50% of##3##4##(2006-8#1)(2009-4#1)(2011-1#1)
that over 90% of##2##4##(2006-2#1)(2008-10#1)
that over the##4##3##(1997-8#1)(2007-12#1)(2008-10#1)(2008-3#1)
that over##18##2##(1990-12#1)(1994-12#1)(1994-2#1)(1996-1#1)(1996-2#1)(1997-8#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-3#1)(2009-4#1)(2011-1#1)
that over-expresses##2##2##(1993-2#1)(1995-3#1)
that over-expression of##4##3##(1990-3#1)(1996-12#1)(2008-11#2)
that overall##10##2##(1994-3#1)(1997-1#1)(2006-4#1)(2006-8#1)(2007-4#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-3#1)(2011-2#1)
that overcomes the##3##3##(1996-5#1)(2007-7#1)(2008-3#1)
that overcomes these##2##3##(2007-11#1)(2007-12#1)
that overcomes this##2##3##(2007-12#1)(2008-2#1)
that overcomes##8##2##(1996-5#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-2#1)(2008-3#1)
that overexpress the##3##3##(1992-7#1)(2008-11#1)(2008-6#1)
that overexpress##9##2##(1990-9#1)(1992-7#1)(1994-3#2)(1994-5#1)(1995-8#1)(1996-6#1)(2008-11#1)(2008-6#1)
that overexpressed##5##2##(1990-9#1)(1992-7#1)(1994-3#1)(2008-10#2)
that overexpression of the##2##4##(1995-3#1)(2008-10#1)
that overexpression of##15##3##(1992-12#1)(1994-11#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-5#1)(2003-11#1)(2007-1#1)(2008-10#2)(2008-11#1)(2009-5#1)(2009-8#1)(2010-7#1)(2012-2#1)
that overheating##2##2##(1992-4#2)
that overlap with##2##3##(2007-11#1)(2009-11#1)
that overlap##4##2##(1997-3#1)(2007-11#1)(2008-4#1)(2009-11#1)
that overlaps the##3##3##(1994-8#2)(2008-10#1)
that overlaps with##2##3##(2008-10#1)(2011-1#1)
that overlaps##7##2##(1994-8#2)(1996-10#1)(2008-10#2)(2008-7#1)(2011-1#1)
that overturned##2##2##(1996-11#1)(2006-10#1)
that overwintered in##2##3##(2008-10#2)
that ovulation##3##2##(1990-4#1)(2009-4#2)
that oxalic acid##2##3##(2009-8#2)
that oxidation##3##2##(2005-11#1)(2008-5#1)(2013-7#1)
that oxidative damage is##2##4##(2008-3#1)(2010-12#1)
that oxidative metabolism##2##3##(1994-2#2)
that oxidative stress is an##2##5##(1992-9#1)(2013-8#1)
that oxidative stress is##4##4##(1992-9#1)(1995-6#1)(2009-6#1)(2013-8#1)
that oxidative stress may##2##4##(1992-12#1)(1994-10#1)
that oxidative stress##10##3##(1992-11#1)(1992-12#1)(1992-9#1)(1994-10#1)(1995-6#1)(1996-3#1)(2009-6#2)(2010-8#1)(2013-8#1)
that oxidative##18##2##(1992-11#1)(1992-12#1)(1992-2#1)(1992-9#1)(1994-10#1)(1994-2#2)(1994-6#1)(1995-6#1)(1996-3#1)(2008-3#1)(2008-6#1)(2009-6#2)(2009-8#1)(2010-12#1)(2010-8#1)(2013-8#1)
that oxidised LDL is##2##4##(2005-7#2)
that oxygen free radicals##3##4##(1991-9#1)(1995-12#1)(1996-2#1)
that oxygen radicals##2##3##(1994-10#1)(1996-9#1)
that oxygen##16##2##(1990-7#1)(1991-5#1)(1991-9#1)(1992-6#1)(1994-10#1)(1994-2#1)(1995-12#1)(1996-2#1)(1996-9#2)(2005-11#1)(2008-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2013-8#1)
that oxytocin##2##2##(1994-10#1)(1995-5#1)
that ozone##5##2##(2005-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-3#1)
that p16(INK4A)##3##2##(2013-1#3)
that p16INK4a##2##2##(1996-4#2)
that p21##4##2##(1995-6#3)(1996-6#1)
that p21ras##2##2##(1992-12#1)(1995-3#1)
that p300/CBP##2##2##(1996-11#2)
that p33##2##2##(1996-5#2)
that p38##4##2##(1995-3#3)(2008-11#1)
that p45##2##2##(1996-2#1)(1996-4#1)
that p53 and##2##3##(1991-8#1)(2012-2#1)
that p53 is##2##3##(1996-1#1)(2008-9#1)
that p53##11##2##(1991-8#1)(1992-3#1)(1993-9#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-1#1)(2008-9#2)(2011-2#1)(2012-2#1)
that p56##2##2##(1990-5#2)
that p56lck is##2##3##(1994-12#2)
that p59##2##2##(1993-8#2)
that p72syk is##4##3##(1992-6#2)(1993-11#2)
that p72syk##5##2##(1992-6#2)(1993-11#3)
that p73##2##2##(2010-3#2)
that p75##2##2##(1997-5#2)
that p85alpha##2##2##(1996-8#2)
that pH of##2##3##(2007-2#1)(2008-10#1)
that pH##6##2##(1997-4#1)(2005-11#1)(2007-2#1)(2008-10#2)(2008-11#1)
that pS2##2##2##(1990-2#2)
that pacifier use##2##3##(2007-10#2)
that pain affects##2##3##(2006-11#2)
that pain management##2##3##(1997-5#1)(2007-11#1)
that pain##14##2##(1992-5#1)(1997-5#1)(2005-9#1)(2006-10#1)(2006-11#2)(2006-8#1)(2007-11#2)(2009-12#1)(2010-4#1)(2012-2#1)(2013-1#2)
that pairing##2##2##(2008-10#1)(2009-11#1)
that palmitoylation##2##2##(1996-8#2)
that paracrine##2##2##(2011-1#1)(2013-1#1)
that parallel##5##2##(1992-3#1)(1996-5#2)(2008-3#1)(2010-2#1)
that parallels the##2##3##(1994-8#1)(2011-12#1)
that parameters of##2##3##(2007-9#1)(2011-1#1)
that parameters##3##2##(2006-6#1)(2007-9#1)(2011-1#1)
that parasites##7##2##(2007-3#1)(2008-8#2)(2008-9#1)(2009-2#1)(2010-2#1)(2010-3#1)
that parasitism##2##2##(2008-8#1)(2011-12#1)
that parasitize##2##2##(2007-3#1)(2013-8#1)
that parasitizes Pseudaletia separata##2##4##(2007-12#2)
that parasitizes##3##2##(2007-12#3)
that parental##8##2##(1990-10#1)(1990-5#1)(1994-9#1)(1996-2#1)(2007-12#1)(2008-11#1)(2009-10#1)(2010-1#1)
that parenteral##3##2##(1992-1#1)(2006-10#1)(2012-12#1)
that parents##13##2##(1992-2#1)(1992-4#1)(1995-12#1)(1995-5#1)(1996-12#1)(2007-12#1)(2010-10#1)(2010-2#2)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)
that parents'##2##2##(2009-7#2)
that part of the##18##4##(1990-11#1)(1991-9#1)(1992-11#1)(1992-9#1)(1993-9#1)(1995-11#1)(1995-2#1)(2006-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-5#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#1)
that part of##21##3##(1990-11#1)(1990-12#1)(1991-9#1)(1992-11#1)(1992-9#1)(1993-9#2)(1995-11#1)(1995-2#1)(2006-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-5#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#1)
that part##22##2##(1990-11#1)(1990-12#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-9#2)(1995-11#1)(1995-2#1)(2006-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-5#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#1)
that partial##9##2##(1991-12#1)(1993-4#1)(1994-11#1)(1996-1#1)(2006-10#1)(2008-10#3)(2011-2#1)
that partially##9##2##(1990-6#1)(1992-2#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#1)(2008-1#1)(2010-12#1)
that participants had##2##3##(2009-10#1)(2010-9#1)
that participants who##3##3##(2009-9#1)(2010-12#1)(2013-8#1)
that participants##17##2##(1995-1#1)(2006-9#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
that participants'##3##2##(2007-10#1)(2007-12#1)(2013-7#1)
that participate in the##9##4##(1993-12#1)(2008-1#2)(2008-2#1)(2008-5#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
that participate in##17##3##(1990-7#1)(1993-12#1)(1994-8#1)(1996-8#1)(1997-2#1)(1997-4#2)(2008-1#2)(2008-2#1)(2008-5#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
that participate##18##2##(1990-7#2)(1993-12#1)(1994-8#1)(1996-8#1)(1997-2#1)(1997-4#2)(2008-1#2)(2008-2#1)(2008-5#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
that participated in##4##3##(1994-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
that participated##6##2##(1994-12#1)(2007-12#1)(2008-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
that participates in the##2##4##(1991-2#1)(2012-12#1)
that participates in##5##3##(1991-2#1)(1995-1#1)(1996-7#1)(2012-12#1)(2013-8#1)
that participation in the##2##4##(2006-4#1)(2006-6#1)
that participation in##5##3##(2006-4#1)(2006-6#1)(2007-12#1)(2007-8#1)(2010-11#1)
that particle##2##2##(1990-12#1)(1993-6#1)
that particles of##2##3##(2008-10#1)(2008-5#1)
that particles##8##2##(1997-2#1)(2005-11#2)(2005-4#1)(2008-10#2)(2008-2#1)(2008-5#1)
that particular##14##2##(1994-7#1)(1996-2#1)(1997-4#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
that partitioning##2##2##(2006-10#1)(2008-10#1)
that partly##5##2##(1991-4#1)(1994-12#1)(2009-4#1)(2012-2#1)(2012-3#1)
that parts of the##2##4##(2007-12#1)(2011-2#1)
that parvalbumin##3##2##(1991-3#1)(1994-2#2)
that pass##3##2##(1995-3#1)(2008-2#1)(2013-1#1)
that passed through the##4##4##(2008-2#1)(2008-3#1)(2010-2#1)(2013-8#1)
that passed through##5##3##(2008-2#1)(2008-3#1)(2010-2#2)(2013-8#1)
that passed##8##2##(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-2#2)(2013-8#1)
that passes through the##5##4##(2007-11#1)(2007-12#1)(2008-3#2)(2010-8#1)
that passes##7##2##(2007-11#1)(2007-12#1)(2008-3#2)(2009-9#1)(2010-8#2)
that passive##4##2##(1996-3#1)(2007-12#1)(2008-3#1)(2009-7#1)
that past##6##2##(1995-3#1)(2006-5#1)(2007-4#1)(2008-10#1)(2010-8#1)(2012-2#1)
that pathogen##3##2##(2008-10#3)
that pathogenic##3##2##(1995-1#1)(2008-10#1)(2008-7#1)
that pathogens##2##2##(2008-10#2)
that pathological##3##2##(1995-12#1)(1997-4#1)(2013-1#1)
that pathway##2##2##(2008-10#1)(2012-3#1)
that patient was##2##3##(1995-9#1)(2012-2#1)
that patient##13##2##(1995-9#1)(2006-10#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-10#1)(2011-2#1)(2012-2#1)(2013-1#3)
that patients are##5##3##(1994-12#1)(1996-2#1)(1996-7#1)(2008-4#1)(2008-7#1)
that patients can##4##3##(1996-12#1)(2004-1#1)(2008-11#1)(2008-7#1)
that patients in##4##3##(1990-4#1)(2008-7#1)(2008-8#1)(2010-12#1)
that patients need##2##3##(2006-1#1)(2013-8#1)
that patients presenting with##2##4##(1990-7#1)(2006-8#1)
that patients receiving##6##3##(1990-12#1)(1997-1#1)(2008-11#1)(2008-5#1)(2013-1#2)
that patients seek##2##3##(2007-9#1)(2008-3#1)
that patients should##3##3##(1996-3#1)(2008-8#1)(2013-1#1)
that patients treated with##3##4##(1997-8#1)(2008-5#1)(2008-7#1)
that patients who have##3##4##(2007-10#1)(2007-9#1)(2012-2#1)
that patients who present##2##4##(2007-10#1)(2008-6#1)
that patients who were##2##4##(2006-3#1)(2008-10#1)
that patients who##14##3##(1993-2#1)(2006-3#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-6#1)(2010-4#1)(2012-1#1)(2012-2#1)
that patients with a family history of atherosclerosis had a##2##10##(1997-8#2)
that patients with a##4##4##(1997-8#2)(2005-7#1)(2008-7#1)
that patients with chronic##2##4##(1991-3#1)(2010-12#1)
that patients with schizophrenia##4##4##(1996-7#2)(1996-8#1)(1997-8#1)
that patients with severe##2##4##(2006-10#1)(2007-9#1)
that patients with soft tissue sarcomas##2##6##(2008-6#2)
that patients with suspected##2##4##(2007-7#1)(2008-3#1)
that patients with##67##3##(1990-7#1)(1991-3#1)(1991-5#2)(1992-8#1)(1993-10#1)(1993-11#2)(1993-9#1)(1995-10#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-11#1)(1996-7#3)(1996-8#1)(1997-8#3)(2005-7#1)(2006-10#4)(2006-11#1)(2006-2#1)(2007-10#3)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#3)(2008-1#2)(2008-3#1)(2008-6#5)(2008-7#2)(2009-10#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-2#5)(2012-3#2)(2013-1#1)
that patients##148##2##(1990-12#1)(1990-4#1)(1990-7#3)(1991-3#2)(1991-5#2)(1992-8#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-5#1)(1993-9#1)(1994-12#1)(1995-10#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-7#4)(1996-8#1)(1997-1#1)(1997-3#1)(1997-8#4)(2004-1#1)(2004-10#1)(2005-7#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-8#3)(2006-9#1)(2007-10#7)(2007-11#3)(2007-2#1)(2007-6#2)(2007-7#3)(2007-8#3)(2007-9#5)(2008-1#2)(2008-10#1)(2008-11#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#7)(2008-7#6)(2008-8#2)(2009-10#2)(2009-4#1)(2009-8#2)(2010-11#1)(2010-12#3)(2010-4#3)(2010-5#1)(2010-8#2)(2011-2#6)(2012-1#1)(2012-11#1)(2012-2#6)(2012-3#3)(2013-1#5)(2013-8#3)
that patients'##2##2##(2012-2#1)(2013-7#1)
that patterning##2##2##(1991-5#1)(1997-3#1)
that patterns of##7##3##(1994-3#1)(1996-1#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#1)
that patterns##9##2##(1994-3#1)(1996-1#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-8#2)(2009-9#1)(2013-1#1)
that payers##2##2##(1997-3#1)(2007-10#1)
that payment##4##2##(1993-12#1)(1994-12#1)(2007-12#1)(2007-2#1)
that peak##5##2##(1997-3#1)(2007-7#1)(2010-3#1)(2013-1#2)
that peaked##4##2##(1994-5#1)(1995-2#1)(1997-7#2)
that pediatric##4##2##(2006-9#1)(2007-1#1)(2008-8#1)(2010-3#1)
that peer##2##2##(1991-4#1)(2007-12#1)
that pegaptanib sodium##3##3##(2009-8#3)
that penetrate##2##2##(1992-9#1)(2008-7#1)
that penetrated the##2##3##(2008-10#2)
that penetrated##4##2##(2008-10#3)(2013-1#1)
that penetrates##2##2##(1992-12#1)(2007-12#1)
that penetration##3##2##(2008-10#2)(2012-2#1)
that people can##2##3##(1997-8#1)(2012-11#1)
that people in##2##3##(2008-8#1)(2011-2#1)
that people living with##2##4##(2007-7#1)(2010-12#1)
that people who##5##3##(1993-12#1)(2008-2#1)(2010-3#1)(2011-1#1)(2011-2#1)
that people with dementia##2##4##(2013-8#2)
that people with disabilities##2##4##(1995-6#1)(1996-1#1)
that people with##11##3##(1995-6#1)(1996-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2010-4#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#2)
that people##42##2##(1993-12#1)(1995-6#1)(1996-1#3)(1996-3#1)(1997-8#1)(2006-9#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#2)
that people's##3##2##(2008-5#1)(2008-8#1)(2013-7#1)
that peptide IR(TM)-GP##2##3##(1994-11#2)
that peptide##5##2##(1991-2#1)(1991-5#1)(1994-11#2)(2009-9#1)
that peptides containing##2##3##(1991-2#1)(1994-5#1)
that peptides which##2##3##(1991-10#1)(1995-1#1)
that peptides##10##2##(1991-10#1)(1991-2#1)(1991-5#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-3#1)(2008-1#1)
that perceived##6##2##(1994-3#1)(2006-7#1)(2008-4#1)(2009-7#2)(2010-1#1)
that perceivers##3##2##(2008-11#2)(2013-8#1)
that percentage##2##2##(1991-2#1)(1995-1#1)
that perception of##2##3##(2005-7#1)(2012-2#1)
that perception##3##2##(2005-7#1)(2012-12#1)(2012-2#1)
that perceptions of##2##3##(2007-9#1)(2009-10#1)
that perceptual##3##2##(2007-12#2)(2012-2#1)
that perfectly matches##2##3##(1993-11#1)(2011-1#1)
that perform##6##2##(2006-6#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-12#1)(2013-8#1)
that performance in the##3##4##(1992-11#1)(1992-12#1)(1996-7#1)
that performance of##3##3##(1992-8#1)(1993-12#1)(2013-7#1)
that performance##14##2##(1992-11#1)(1992-12#1)(1992-8#1)(1993-12#1)(1996-7#1)(2007-2#1)(2007-5#1)(2008-7#1)(2009-11#1)(2009-4#2)(2010-12#1)(2012-2#1)(2013-7#1)
that performed##6##2##(1994-3#1)(1995-12#1)(2006-7#1)(2009-4#1)(2011-2#1)(2012-1#1)
that performs a##2##3##(2008-3#1)(2008-9#1)
that performs an##2##3##(2008-2#1)(2008-8#1)
that performs the##2##3##(2008-10#1)(2008-3#1)
that performs##13##2##(1994-5#1)(2008-10#1)(2008-2#3)(2008-3#5)(2008-8#1)(2008-9#1)(2011-1#1)
that perhaps the##4##3##(1991-7#1)(2005-12#1)(2008-3#1)(2010-3#1)
that perhaps##6##2##(1990-8#1)(1991-7#1)(1994-11#1)(2005-12#1)(2008-3#1)(2010-3#1)
that period of time##2##4##(1991-6#1)(2004-10#1)
that period##19##2##(1991-6#1)(1994-6#1)(1996-3#1)(2004-10#1)(2006-10#1)(2006-5#1)(2007-7#1)(2008-12#2)(2008-5#1)(2009-2#1)(2009-4#1)(2010-1#1)(2010-4#1)(2010-7#1)(2010-9#2)(2011-2#1)(2012-12#1)
that periodic##2##2##(2008-1#1)(2009-11#1)
that perioperative##3##2##(1997-6#1)(2006-10#1)(2007-4#1)
that peripheral##17##2##(1990-4#1)(1990-7#1)(1990-8#1)(1991-2#1)(1992-9#1)(1993-9#1)(1994-10#1)(1997-2#1)(2004-3#1)(2007-8#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#2)
that permeates##2##2##(1991-4#1)(2012-3#1)
that permit a##2##3##(1994-9#1)(2008-7#1)
that permit the##8##3##(2005-10#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2013-1#1)
that permit##29##2##(1991-5#1)(1994-5#1)(1994-9#1)(1996-11#1)(2005-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-8#1)(2013-1#2)
that permits a##3##3##(2007-11#1)(2008-1#1)(2008-4#1)
that permits analysis of##2##4##(1992-8#1)(2008-4#1)
that permits one to retrieve physical parameters of tropospheric particle size distributions##2##12##(2008-3#2)
that permits one to##3##4##(2008-2#1)(2008-3#2)
that permits rapid##2##3##(2008-1#1)(2008-11#1)
that permits reliable##2##3##(2008-3#1)(2012-2#1)
that permits the generation of##2##5##(1994-3#1)(2008-2#1)
that permits the measurement##2##4##(2007-11#1)(2008-3#1)
that permits the##16##3##(1994-3#1)(2006-3#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#4)(2009-4#1)
that permits to##2##3##(2008-2#1)(2012-2#1)
that permits us to##2##4##(2008-2#1)(2012-2#1)
that permits##56##2##(1992-3#1)(1992-8#1)(1993-3#1)(1994-3#1)(2005-10#1)(2006-12#1)(2006-3#1)(2007-11#6)(2007-12#10)(2007-8#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-2#9)(2008-3#9)(2008-4#2)(2008-6#1)(2009-4#1)(2010-10#1)(2012-2#3)
that permitted##7##2##(2006-6#1)(2007-11#2)(2007-9#1)(2008-2#2)(2008-3#1)
that peroxisomes are##2##3##(1994-12#1)(1995-6#1)
that peroxisomes##4##2##(1994-12#1)(1994-6#2)(1995-6#1)
that persist despite##2##3##(2011-1#1)(2012-2#1)
that persist##8##2##(1991-1#1)(2006-4#1)(2007-11#1)(2007-7#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-2#1)
that persisted for##4##3##(1991-12#1)(2007-2#1)(2011-12#1)(2013-8#1)
that persisted until the##2##4##(1992-9#1)(1993-10#1)
that persisted##12##2##(1990-5#1)(1991-12#1)(1992-9#1)(1993-10#1)(1996-5#1)(1997-3#1)(2006-11#1)(2007-2#1)(2008-10#1)(2011-12#1)(2011-2#1)(2013-8#1)
that persistent infection##2##3##(1994-10#1)(2012-12#1)
that persistent##6##2##(1994-10#1)(2007-10#1)(2008-8#2)(2009-8#1)(2012-12#1)
that persists in##3##3##(2008-4#2)(2009-8#1)
that persists##7##2##(2006-12#1)(2006-8#1)(2008-4#2)(2008-5#2)(2009-8#1)
that personal##7##2##(1990-12#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-12#1)(2012-2#1)
that personality##6##2##(2006-9#1)(2008-11#2)(2009-12#1)(2010-12#1)(2012-12#1)
that persons with##5##3##(1990-4#1)(1997-2#1)(2008-1#1)(2008-7#2)
that persons##8##2##(1990-12#1)(1990-4#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-7#2)(2013-1#1)
that pertain to the##2##4##(1997-3#1)(2006-10#1)
that pertain to##6##3##(1991-3#1)(1996-6#1)(1997-3#1)(2006-10#1)(2007-11#1)(2010-9#1)
that perturbation of##2##3##(1996-1#1)(2008-6#1)
that perturbation##3##2##(1994-8#1)(1996-1#1)(2008-6#1)
that pertussis toxin##2##3##(1991-12#2)
that pertussis##4##2##(1990-9#1)(1991-12#2)(1994-9#1)
that phage##4##2##(1997-1#1)(2007-7#1)(2008-8#1)(2013-1#1)
that phagocytosis of##2##3##(1991-6#1)(1994-3#1)
that pharmaceutical##2##2##(2008-5#1)(2012-1#1)
that pharmacists##2##2##(2011-1#1)(2013-8#1)
that pharmacological activation of##2##4##(1993-12#1)(1997-5#1)
that pharmacological##5##2##(1993-12#1)(1994-8#1)(1997-5#1)(2008-4#1)(2008-8#1)
that pharmacologically##3##2##(1990-5#1)(2008-10#1)(2012-12#1)
that phase##8##2##(1992-9#1)(2007-12#3)(2008-2#1)(2008-3#2)(2008-5#1)
that phenanthrene##2##2##(1994-5#1)(2008-10#1)
that phenolic##2##2##(2008-10#1)(2013-1#1)
that phenolics##3##2##(2008-10#2)(2012-11#1)
that phenotypes##2##2##(2006-5#1)(2008-10#1)
that phenotypic##2##2##(2008-8#1)(2012-2#1)
that phenylalanine##2##2##(1994-12#1)(1995-1#1)
that phenytoin##5##2##(1991-3#1)(1995-7#1)(2007-11#1)(2008-11#2)
that philosophy##2##2##(2006-3#1)(2008-2#1)
that phonological awareness##2##3##(2007-9#1)(2011-1#1)
that phonological##3##2##(2007-9#1)(2011-1#1)(2013-8#1)
that phorbol ester##2##3##(1992-8#1)(1992-9#1)
that phorbol esters##2##3##(1992-4#1)(1995-5#1)
that phorbol##6##2##(1991-3#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-4#1)(1995-5#1)
that phosphatase##2##2##(1995-3#1)(1997-2#1)
that phosphate##5##2##(1992-3#2)(1992-6#2)(1996-8#1)
that phospho-Spo0A##2##2##(1995-6#2)
that phospholipase C##3##3##(1990-10#1)(1994-12#2)
that phospholipase##5##2##(1990-10#1)(1991-9#1)(1994-12#2)(1997-8#1)
that phospholipid##2##2##(1990-2#1)(1993-6#1)
that phosphoramidon-sensitive##2##2##(1991-10#1)(1991-6#1)
that phosphorylate##4##2##(1993-2#1)(1995-3#1)(2008-9#1)(2010-9#1)
that phosphorylates##6##2##(1991-2#1)(1993-6#2)(1995-3#2)(1997-1#1)
that phosphorylation at##4##3##(1994-11#2)(1996-5#1)(2010-11#1)
that phosphorylation is##2##3##(1991-1#1)(1993-8#1)
that phosphorylation of the##2##4##(1990-11#1)(2005-8#1)
that phosphorylation of##13##3##(1990-11#1)(1990-3#1)(1992-9#1)(1994-12#2)(1994-9#2)(1996-5#1)(1997-4#1)(2005-8#1)(2008-5#1)(2010-12#1)(2011-2#1)
that phosphorylation##22##2##(1990-11#1)(1990-3#1)(1991-1#1)(1991-10#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-9#3)(1996-5#2)(1997-4#1)(2005-8#1)(2008-5#1)(2010-11#1)(2010-12#1)(2011-2#1)
that photoactivated##2##2##(1993-8#1)(2009-6#1)
that photographs can##2##3##(2008-2#1)(2012-12#1)
that photographs##3##2##(2008-2#2)(2012-12#1)
that photoirradiation of anhydroretinol##2##4##(2008-8#2)
that physical activity is##2##4##(2005-10#1)(2009-12#1)
that physical activity##8##3##(2005-10#1)(2006-2#1)(2009-12#2)(2013-1#4)
that physical therapy##2##3##(1994-3#1)(1995-3#1)
that physical##15##2##(1992-6#1)(1994-3#1)(1995-3#1)(2005-10#1)(2006-2#1)(2009-12#2)(2009-2#1)(2010-2#1)(2011-1#1)(2013-1#4)(2013-7#1)
that physically##2##2##(2008-5#1)(2013-1#1)
that physician##3##2##(1995-12#1)(2007-4#1)(2008-12#1)
that physicians and##3##3##(1991-2#1)(1997-6#1)(2008-4#1)
that physicians are##3##3##(1994-4#1)(2006-8#1)(2007-4#1)
that physicians can##2##3##(1993-10#1)(1997-1#1)
that physicians have##2##3##(1991-12#1)(2008-8#1)
that physicians must##3##3##(2007-2#1)(2008-8#2)
that physicians should##4##3##(1991-1#1)(2006-10#1)(2009-6#1)(2010-1#1)
that physicians##32##2##(1990-2#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1993-1#1)(1993-10#1)(1994-1#2)(1994-4#1)(1995-6#1)(1996-6#1)(1997-1#1)(1997-6#1)(2006-10#3)(2006-8#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-8#4)(2009-6#1)(2010-1#1)
that physicians' perceptions of##3##4##(1993-12#1)(2013-1#2)
that physiological responses##3##3##(1994-11#1)(2004-4#1)(2009-8#1)
that physiological##7##2##(1990-11#1)(1994-11#1)(1997-6#1)(2004-4#1)(2008-10#1)(2009-8#1)(2011-2#1)
that physiologically##5##2##(1992-5#1)(1994-5#1)(1995-12#1)(1995-3#1)(1997-8#1)
that physiotherapists##2##2##(1992-12#1)(2008-3#1)
that phytopathogenic##2##2##(2006-10#1)(2008-10#1)
that phytoplasma##2##2##(2008-10#2)
that pig##2##2##(2006-6#1)(2013-8#1)
that pigs##4##2##(1995-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
that pilocarpine##2##2##(1990-11#1)(2010-7#1)
that pituitary##3##2##(1991-1#1)(2008-5#1)(2011-2#1)
that place##6##2##(1993-3#1)(1997-3#1)(2006-2#1)(2008-7#1)(2012-12#1)(2012-2#1)
that placebo##2##2##(1993-3#1)(2012-2#1)
that placed##2##2##(1992-1#1)(2007-4#1)
that placental##3##2##(1995-11#1)(2007-7#1)(2013-1#1)
that places##6##2##(1992-4#1)(1992-8#1)(1993-1#1)(2007-4#1)(2008-11#1)(2008-3#1)
that plakoglobin##2##2##(1994-8#2)
that planning and##2##3##(2008-2#1)(2010-11#1)
that planning##3##2##(1994-2#1)(2008-2#1)(2010-11#1)
that plans##2##2##(1991-2#1)(1991-3#1)
that plant and##2##3##(2008-10#2)
that plant resistance##2##3##(2008-8#1)(2008-9#1)
that plant##12##2##(2004-11#1)(2006-4#1)(2008-10#3)(2008-8#3)(2008-9#2)(2009-8#2)
that plants and##2##3##(1994-12#1)(2006-5#1)
that plants##15##2##(1990-9#1)(1994-12#1)(2006-11#1)(2006-5#1)(2008-10#3)(2008-11#1)(2009-6#1)(2009-8#4)(2012-7#1)(2013-8#1)
that plasma and##4##3##(1991-9#1)(1994-11#1)(1995-7#1)(2011-12#1)
that plasma concentrations##2##3##(2007-11#1)(2007-9#1)
that plasma##22##2##(1991-9#1)(1992-12#1)(1992-9#1)(1994-11#1)(1994-6#1)(1995-7#1)(1996-5#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-8#1)(2007-9#2)(2008-12#1)(2008-4#1)(2008-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
that plasmapheresis##2##2##(1997-7#1)(2012-12#1)
that plasmid##3##2##(1990-9#1)(1995-8#1)(1996-2#1)
that plasmids##4##2##(1994-12#1)(1996-7#1)(1997-7#1)(2007-7#1)
that plasminogen##2##2##(1991-1#1)(1997-2#1)
that platelet activation##2##3##(1990-7#1)(1997-7#1)
that platelet aggregation is##2##4##(1992-8#1)(1994-12#1)
that platelet factor##2##3##(1992-8#1)(2007-12#1)
that platelet##9##2##(1990-6#1)(1990-7#1)(1992-8#2)(1993-8#1)(1994-12#1)(1997-7#1)(2007-11#1)(2007-12#1)
that platelets##6##2##(1990-12#1)(2006-6#4)(2008-10#1)
that play a central role in the##2##7##(2006-7#1)(2008-10#1)
that play a key role in the##2##7##(2008-4#1)(2009-4#1)
that play a key role in##4##6##(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)
that play a role in the##3##6##(2005-11#1)(2008-2#1)(2012-12#1)
that play a role in##11##5##(2005-11#1)(2007-11#1)(2008-10#2)(2008-2#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-12#3)
that play a##22##3##(2005-11#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-12#3)(2013-8#1)
that play an important role in the##2##7##(2008-1#1)(2013-7#1)
that play an important role in##3##6##(2005-10#1)(2008-1#1)(2013-7#1)
that play critical roles in##2##5##(2009-9#2)
that play important roles in the regulation of##2##8##(2008-1#1)(2013-1#1)
that play important roles in##6##5##(2008-1#1)(2008-10#1)(2008-9#1)(2009-8#1)(2011-1#1)(2013-1#1)
that play important##7##3##(1995-8#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-8#1)(2011-1#1)(2013-1#1)
that play key roles in##3##5##(1996-10#1)(2007-12#1)(2013-1#1)
that play##46##2##(1992-10#1)(1995-8#1)(1996-10#1)(2005-10#1)(2005-11#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-7#1)(2011-1#3)(2011-2#2)(2012-11#1)(2012-12#3)(2013-1#2)(2013-7#1)(2013-8#1)
that played##2##2##(2008-1#1)(2012-1#1)
that playing##2##2##(1996-6#1)(2011-1#1)
that plays a critical role in##4##6##(2008-10#1)(2012-12#1)(2012-2#2)
that plays a crucial##2##4##(2008-10#1)(2008-3#1)
that plays a key##2##4##(1995-1#1)(2006-11#1)
that plays a major role in the##2##7##(1995-6#1)(2006-10#1)
that plays a major role in##3##6##(1995-6#1)(2006-10#2)
that plays a pivotal role in##2##6##(1995-6#1)(2008-10#1)
that plays a vital role in##2##6##(2011-2#1)(2013-1#1)
that plays a##19##3##(1991-5#1)(1995-1#1)(1995-6#2)(2006-10#2)(2006-11#1)(2007-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
that plays an important role in##4##6##(1993-11#1)(1995-1#1)(2008-4#1)(2008-7#1)
that plays an##5##3##(1993-11#1)(1995-1#1)(2008-4#1)(2008-6#1)(2008-7#1)
that plays##29##2##(1991-5#1)(1993-11#1)(1995-1#2)(1995-6#2)(2006-10#2)(2006-11#1)(2007-1#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
that plots##2##2##(1995-3#1)(2008-10#1)
that podoplanin##2##2##(2013-1#2)
that point mutations##2##3##(1995-11#1)(1996-6#1)
that point##10##2##(1995-11#1)(1996-6#2)(2007-12#1)(2007-4#1)(2007-6#1)(2012-12#2)(2012-2#2)
that points##4##2##(2006-6#1)(2007-12#1)(2008-2#1)(2008-7#1)
that pol alpha##2##3##(1993-3#2)
that pol##5##2##(1993-3#2)(1994-9#2)(2006-12#1)
that polar auxin transport is##2##5##(2009-6#1)(2009-8#1)
that polar##4##2##(1994-3#1)(2008-10#1)(2009-6#1)(2009-8#1)
that polarization##4##2##(2006-12#1)(2007-11#1)(2008-3#2)
that polarized light##2##3##(2007-12#1)(2008-3#1)
that policy##3##2##(1993-3#1)(2010-8#1)(2012-1#1)
that polio##3##2##(1994-9#1)(2008-8#1)(2012-12#1)
that polyamine depletion##2##3##(1992-8#1)(1994-5#1)
that polyamine##3##2##(1991-7#1)(1992-8#1)(1994-5#1)
that polymer##2##2##(2005-11#2)
that polymerase##3##2##(1990-9#1)(1994-9#1)(1996-8#1)
that polymerization##2##2##(1991-8#1)(1993-8#1)
that polymorphic##5##2##(1994-3#1)(1996-5#1)(2006-12#1)(2008-10#1)(2010-2#1)
that polymorphisms in##2##3##(2008-7#1)(2012-12#1)
that polyphenols##3##2##(2009-3#1)(2009-8#1)(2012-12#1)
that poor nutrition##2##3##(1994-6#1)(2010-6#1)
that poor##17##2##(1992-10#1)(1994-6#1)(1995-7#1)(1996-12#1)(1996-3#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-5#1)(2010-6#1)(2012-1#1)(2013-1#1)
that poorly##3##2##(1996-2#1)(2007-12#1)(2008-10#1)
that population structure##2##3##(2008-8#1)(2012-3#1)
that population##12##2##(1993-1#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-7#1)(2008-8#3)(2010-5#1)(2010-8#2)(2012-3#1)
that populations of##5##3##(2007-5#1)(2008-10#4)
that populations##11##2##(2007-5#1)(2008-10#6)(2008-8#1)(2009-6#1)(2010-8#1)(2013-1#1)
that porcine##3##2##(1990-10#1)(1991-12#1)(1994-11#1)
that portion of the##4##4##(1990-5#1)(1991-6#1)(1993-12#1)(2007-12#1)
that portion of##5##3##(1990-5#1)(1991-6#1)(1993-12#1)(2007-12#1)(2012-2#1)
that portion##6##2##(1990-5#1)(1991-6#1)(1993-12#1)(1995-8#1)(2007-12#1)(2012-2#1)
that pose##4##2##(1993-1#1)(1993-3#1)(1994-3#1)(2007-1#1)
that position##11##2##(1991-7#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1996-3#1)(2006-2#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-6#1)
that positions##4##2##(1993-8#1)(2006-6#1)(2008-3#1)(2012-1#1)
that positive feedback##2##3##(1990-8#1)(1991-9#1)
that positive selection##2##3##(1994-8#1)(2012-3#1)
that positive##15##2##(1990-8#2)(1991-12#1)(1991-9#1)(1994-12#1)(1994-8#1)(1996-12#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-12#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
that positively charged##2##3##(1994-12#1)(1994-9#1)
that positively##6##2##(1992-5#1)(1994-12#1)(1994-9#1)(2007-12#1)(2008-11#1)(2008-9#1)
that possess a##2##3##(2008-1#1)(2009-6#1)
that possess an##2##3##(2008-7#1)(2012-1#1)
that possess the ability to##2##5##(2007-12#1)(2008-9#1)
that possess the##3##3##(2007-11#1)(2007-12#1)(2008-9#1)
that possess##18##2##(1992-3#1)(1993-6#1)(1996-4#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-1#1)(2013-1#1)
that possesses a##3##3##(2007-11#1)(2007-8#1)(2009-5#1)
that possesses the##3##3##(2008-2#1)(2008-8#1)(2012-1#1)
that possesses##11##2##(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#1)(2012-1#1)
that possible##6##2##(1990-9#1)(1992-11#1)(2008-10#1)(2008-11#1)(2009-4#1)(2011-2#1)
that possibly##4##2##(1997-4#1)(2008-10#1)(2011-2#2)
that post-training##2##2##(1990-7#1)(1993-12#1)
that post-transcriptional##3##2##(1993-6#1)(1994-9#1)(1996-12#1)
that post-translational modifications##2##3##(1990-9#1)(2011-2#1)
that post-translational##4##2##(1990-9#1)(1991-7#1)(1995-8#1)(2011-2#1)
that posterior##2##2##(1997-3#1)(2008-9#1)
that postmenopausal##2##2##(1993-12#1)(2008-3#1)
that postnatal##3##2##(1992-3#1)(1996-4#1)(1997-6#1)
that postoperative##5##2##(1993-7#1)(2008-9#1)(2009-3#1)(2012-2#1)(2013-8#1)
that postpartum##2##2##(2004-3#1)(2007-10#1)
that posttranslational##3##2##(1992-11#1)(1994-11#1)(1995-2#1)
that postulates##2##2##(2007-6#1)(2010-2#1)
that potassium channels are##2##4##(2007-12#1)(2008-8#1)
that potential patients##2##3##(1996-2#1)(2010-8#1)
that potential##10##2##(1991-12#1)(1996-2#1)(2007-3#1)(2007-8#1)(2008-1#1)(2010-4#1)(2010-8#1)(2012-12#2)(2013-8#1)
that potentially can be##2##4##(2007-11#1)(2012-12#1)
that potentially##16##2##(1991-9#1)(1994-3#1)(1994-9#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2009-3#1)(2012-12#2)(2013-1#2)
that potentiation##3##2##(1991-6#1)(1995-3#1)(1996-10#1)
that potently##3##2##(1991-12#1)(1992-7#1)(2010-7#1)
that poverty##2##2##(1994-6#1)(2008-11#1)
that power is##2##3##(1997-3#1)(2012-3#1)
that power##4##2##(1997-3#1)(2012-3#2)(2013-1#1)
that pp60c-src##2##2##(1991-7#1)(1994-6#1)
that practical##4##2##(2008-10#1)(2008-3#1)(2010-11#1)(2011-2#1)
that practice##4##2##(1994-3#1)(2008-11#2)(2010-9#1)
that practices that##2##3##(2008-10#1)(2008-9#1)
that practices##3##2##(2008-10#1)(2008-9#1)(2013-7#1)
that practicing##2##2##(1996-2#1)(2008-3#1)
that practitioners##7##2##(1991-12#1)(2005-6#1)(2008-11#1)(2010-8#1)(2012-12#2)(2012-3#1)
that prayer##2##2##(2008-1#1)(2008-12#1)
that pre-existing##3##2##(1991-3#1)(1995-11#1)(2013-1#1)
that pre-registration##2##2##(2008-11#2)
that prebiotics##3##2##(2009-3#1)(2011-2#1)(2012-12#1)
that precede##7##2##(1990-4#1)(2008-12#1)(2008-2#2)(2008-8#1)(2012-12#1)(2012-3#1)
that preceded the##7##3##(1991-2#1)(1995-1#1)(1997-4#1)(2006-12#1)(2006-4#1)(2008-1#1)(2012-12#1)
that preceded##9##2##(1991-2#1)(1991-6#1)(1995-1#1)(1997-4#1)(2006-12#1)(2006-4#1)(2006-5#1)(2008-1#1)(2012-12#1)
that precedes the##4##3##(1992-11#1)(2008-2#1)(2009-8#1)(2011-2#1)
that precedes##8##2##(1991-2#1)(1992-11#1)(1993-12#1)(1995-11#1)(1996-10#1)(2008-2#1)(2009-8#1)(2011-2#1)
that precipitated##2##2##(1996-8#1)(2006-6#1)
that precipitates##2##2##(2008-10#1)(2010-12#1)
that precise##3##2##(1992-12#1)(2007-8#1)(2008-5#1)
that precisely##4##2##(2008-10#2)(2008-3#1)(2008-7#1)
that precision##2##2##(2005-10#1)(2008-10#1)
that preclude##2##2##(2008-4#1)(2008-5#1)
that predators##2##2##(2008-8#2)
that predict for in vitro##2##5##(2010-5#2)
that predict the##5##3##(2008-1#1)(2008-2#1)(2008-3#1)(2009-5#1)(2012-12#1)
that predict##21##2##(1992-9#2)(1995-3#1)(1995-9#1)(2004-12#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#1)(2009-5#1)(2010-5#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
that predicted by the##5##4##(2008-3#3)(2008-8#1)(2009-6#1)
that predicted by##10##3##(2005-11#2)(2008-2#1)(2008-3#4)(2008-8#2)(2009-6#1)
that predicted for##3##3##(1991-2#1)(2007-12#2)
that predicted from the##2##4##(1991-2#1)(1993-12#1)
that predicted from##5##3##(1990-4#1)(1991-2#1)(1993-12#1)(1995-10#1)(1996-2#1)
that predicted##21##2##(1990-4#1)(1991-2#2)(1993-12#1)(1993-6#1)(1995-10#1)(1996-2#1)(1997-2#1)(2005-11#2)(2007-12#3)(2008-2#1)(2008-3#4)(2008-8#2)(2009-6#1)
that prediction##2##2##(2004-4#1)(2008-5#1)
that predictions##2##2##(2008-3#1)(2008-9#1)
that predicts a##3##3##(1995-8#1)(2006-11#1)(2008-11#1)
that predicts that##2##3##(1992-6#1)(2008-8#1)
that predicts the probability##2##4##(1993-9#1)(2008-2#1)
that predicts the##13##3##(1993-9#1)(2005-11#1)(2007-10#1)(2007-12#1)(2008-2#2)(2008-3#5)(2008-7#1)(2009-8#1)
that predicts##30##2##(1990-5#1)(1992-6#1)(1993-11#1)(1993-9#1)(1995-8#2)(2005-11#1)(2006-11#1)(2006-7#1)(2007-10#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#6)(2008-7#1)(2008-8#3)(2009-8#1)
that predispose individuals to##2##4##(2007-6#1)(2012-3#1)
that predispose to##10##3##(1991-12#1)(1993-10#2)(2008-10#1)(2008-4#2)(2008-8#1)(2009-10#1)(2011-2#1)(2012-2#1)
that predispose##19##2##(1991-12#1)(1993-10#2)(2006-1#1)(2006-5#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-10#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
that predisposes##5##2##(1993-10#1)(2009-10#1)(2009-12#1)(2012-1#1)(2012-12#1)
that predominantly##5##2##(1993-11#1)(2007-11#1)(2008-10#1)(2008-9#1)(2011-1#1)
that preferences##2##2##(2011-1#1)(2012-12#1)
that preferential##4##2##(1990-12#1)(1991-5#1)(1997-7#1)(2010-2#1)
that preferentially##10##2##(1991-11#1)(1992-8#1)(1993-8#1)(1994-9#1)(1996-7#1)(2009-12#1)(2010-1#1)(2012-1#1)(2012-12#1)(2013-8#1)
that preferred by##2##3##(1996-8#1)(1997-7#1)
that preformed##2##2##(2005-11#1)(2010-5#1)
that pregnancy##4##2##(2004-10#1)(2009-1#1)(2010-12#1)(2013-1#1)
that pregnant women##4##3##(1991-11#1)(1995-6#1)(2009-4#1)(2011-12#1)
that pregnenolone sulfate##3##3##(1996-2#1)(1997-1#2)
that premating barriers##2##3##(2008-8#1)(2012-3#1)
that premating##4##2##(2008-8#1)(2008-9#2)(2012-3#1)
that premature##3##2##(1990-11#1)(1997-1#1)(2012-12#1)
that prenatal exposure to##4##4##(1991-1#1)(1995-12#1)(2004-11#1)(2011-2#1)
that prenatal##10##2##(1991-1#1)(1994-10#2)(1995-12#1)(2004-11#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-7#1)
that preoperative##2##2##(2006-10#1)(2007-9#1)
that prepare##2##2##(2008-11#1)(2010-6#1)
that prepared##2##2##(2008-11#1)(2010-1#1)
that prescribe##2##2##(2013-8#2)
that prescribing##2##2##(1995-6#1)(2006-10#1)
that presence of##4##3##(2008-1#1)(2008-10#2)(2012-2#1)
that present a##3##3##(2007-12#1)(2007-5#1)(2008-1#1)
that present in the##2##4##(1996-12#1)(1997-4#1)
that present in##5##3##(1996-12#2)(1997-4#1)(2008-10#1)(2013-8#1)
that present##19##2##(1994-11#1)(1996-12#2)(1997-4#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-4#1)(2010-5#1)(2011-2#1)(2012-9#1)(2013-8#1)
that presented as##4##3##(2008-10#1)(2009-9#1)(2010-6#1)(2013-1#1)
that presented in##2##3##(2009-2#1)(2012-12#1)
that presented to##4##3##(2007-2#1)(2007-8#1)(2008-8#1)(2013-1#1)
that presented with##11##3##(2007-2#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#2)(2010-12#2)(2010-3#1)(2013-1#2)
that presented##30##2##(2004-11#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-2#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-2#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#4)
that presently##2##2##(1992-1#1)(2007-8#1)
that presents a##2##3##(1991-3#1)(2007-12#1)
that presents as##2##3##(2009-9#1)(2012-12#1)
that presents with##6##3##(1997-1#1)(2006-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-2#1)
that presents##20##2##(1991-3#1)(1992-5#1)(1997-1#1)(2005-6#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-9#1)(2012-12#1)(2012-2#1)
that preservation of the##2##4##(1990-6#1)(1993-4#1)
that preservation of##3##3##(1990-6#1)(1993-4#1)(2012-2#1)
that preservation##6##2##(1990-6#1)(1993-4#1)(1996-12#1)(2008-1#1)(2008-10#1)(2012-2#1)
that preserve##2##2##(2008-9#1)(2009-4#1)
that preserves##9##2##(1994-5#1)(1997-8#1)(2007-12#1)(2008-10#2)(2009-8#1)(2009-9#1)(2010-5#1)(2012-3#1)
that pressure##2##2##(2006-10#1)(2010-4#1)
that presumably##3##2##(1993-12#1)(1996-3#1)(2007-11#1)
that pretreatment of animals with##2##5##(1994-11#1)(2005-11#1)
that pretreatment of cells with##3##5##(2007-10#1)(2008-4#1)(2011-2#1)
that pretreatment of##6##3##(1994-11#1)(1997-4#1)(2005-11#1)(2007-10#1)(2008-4#1)(2011-2#1)
that pretreatment##9##2##(1991-6#1)(1994-11#1)(1997-4#1)(2005-11#1)(2007-10#1)(2008-4#1)(2011-12#1)(2011-2#2)
that prevalence of##4##3##(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)
that prevalence##6##2##(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-11#1)(2009-4#1)
that prevent##18##2##(1993-12#1)(1996-8#1)(2005-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-3#1)(2009-7#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-7#1)(2013-8#1)
that prevented##6##2##(1996-9#1)(1997-1#1)(2008-10#1)(2008-7#1)(2012-12#2)
that prevention##2##2##(2006-10#1)(2010-4#1)
that preventive outpatient commitment##2##4##(2006-5#2)
that preventive##8##2##(1991-8#1)(1996-4#1)(2006-10#1)(2006-5#3)(2009-5#1)(2010-8#1)
that prevents the##3##3##(1993-6#1)(1995-2#1)(2007-11#1)
that prevents their secretion##2##4##(1990-6#2)
that prevents##21##2##(1990-6#2)(1992-3#1)(1993-6#1)(1994-8#2)(1995-10#1)(1995-2#1)(1995-8#1)(1996-6#1)(2005-9#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#2)(2013-7#1)
that previous exposure##2##3##(1996-12#1)(1997-3#1)
that previous studies have##2##4##(1992-9#1)(2010-5#1)
that previous studies##3##3##(1992-9#1)(2008-10#1)(2010-5#1)
that previous##16##2##(1990-12#1)(1991-2#1)(1992-9#1)(1993-5#1)(1994-2#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-3#1)(2008-10#1)(2008-7#1)(2008-8#3)(2010-5#1)(2013-8#1)
that previously described for##4##4##(1991-9#1)(1995-3#1)(1996-5#1)(2005-9#1)
that previously described##5##3##(1990-4#1)(1991-9#1)(1995-3#1)(1996-5#1)(2005-9#1)
that previously observed##3##3##(1996-5#1)(1997-7#1)(2010-8#1)
that previously obtained##2##3##(1990-2#1)(2007-12#1)
that previously published##2##3##(1990-4#1)(2008-10#1)
that previously reported for##4##4##(1990-1#1)(1991-2#1)(2006-5#1)(2008-8#1)
that previously reported##10##3##(1990-1#1)(1991-2#1)(1991-8#1)(1993-1#1)(1993-12#1)(1995-12#1)(2006-5#1)(2008-8#1)(2012-12#2)
that previously were not##2##4##(2006-11#1)(2008-3#1)
that previously##40##2##(1990-1#1)(1990-2#1)(1990-4#2)(1990-8#1)(1991-2#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-5#2)(1997-7#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-8#1)(2010-8#1)(2011-1#2)(2012-12#2)(2012-2#1)
that primarily affects the##3##4##(1993-7#1)(2007-7#1)(2008-1#1)
that primarily affects##4##3##(1993-7#1)(2006-10#1)(2007-7#1)(2008-1#1)
that primarily##9##2##(1993-7#1)(1996-10#2)(2006-10#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-7#1)(2011-1#1)
that primary afferent inputs##2##4##(2010-12#2)
that primary care practitioners##2##4##(2011-1#2)
that primary care##3##3##(2006-9#1)(2011-1#2)
that primary##21##2##(1991-5#1)(1993-12#1)(1994-2#1)(1995-11#1)(1996-11#1)(1997-8#1)(2005-9#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-3#2)(2008-10#1)(2008-8#1)(2010-12#2)(2011-1#2)(2011-2#1)(2013-7#1)(2013-8#1)
that primates##2##2##(1991-11#2)
that prior exposure to##2##4##(1993-12#1)(2010-8#1)
that prior##4##2##(1993-12#1)(2010-10#1)(2010-8#1)(2012-2#1)
that private##2##2##(1997-5#1)(2006-7#1)
that proMMP-7##2##2##(1996-1#2)
that probably acts##2##3##(1997-3#1)(2013-8#1)
that probably##16##2##(1990-8#1)(1992-5#1)(1993-3#1)(1997-3#1)(2006-10#2)(2007-11#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-12#1)(2011-2#1)(2013-8#1)
that probe##2##2##(2008-10#1)(2008-4#1)
that probiotic##4##2##(2008-4#1)(2010-10#1)(2010-9#1)(2012-2#1)
that probiotics##6##2##(2006-10#1)(2008-10#1)(2011-2#1)(2012-1#2)(2013-7#1)
that problem##3##2##(2005-8#1)(2007-11#1)(2010-11#1)
that problems##3##2##(1992-1#1)(2008-3#1)(2008-7#1)
that procedures are##2##3##(2006-9#1)(2011-2#1)
that procedures##4##2##(2006-9#1)(2007-8#1)(2008-2#1)(2011-2#1)
that proceeds##2##2##(1990-6#1)(2012-1#1)
that process##15##2##(1994-12#1)(1994-2#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#1)(2010-4#1)(2013-1#2)
that processed##3##2##(1993-2#1)(2005-12#1)(2008-5#1)
that processes the##2##3##(2008-2#2)
that processes##6##2##(1993-12#1)(2008-2#2)(2008-3#1)(2008-9#1)(2010-9#1)
that processing of##6##3##(1992-2#1)(1993-6#1)(1994-9#1)(2008-11#1)(2010-7#1)(2011-1#1)
that processing##10##2##(1992-2#1)(1993-6#1)(1994-9#1)(1996-7#1)(1997-1#1)(2008-11#1)(2008-5#1)(2010-10#1)(2010-7#1)(2011-1#1)
that produce 2##2##3##(2008-10#2)
that produce a##2##3##(2008-2#2)
that produce higher##2##3##(1992-12#1)(1993-2#1)
that produce phase##2##3##(1992-3#1)(1994-2#1)
that produce significant##2##3##(1993-11#1)(2008-5#1)
that produce the antibiotic 2##2##5##(2008-10#2)
that produce the##5##3##(2006-12#1)(2007-11#1)(2008-10#2)(2011-1#1)
that produce these##2##3##(2006-1#1)(2011-1#1)
that produce##57##2##(1990-11#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-11#2)(1993-2#1)(1993-3#2)(1994-2#1)(1994-4#1)(1995-1#1)(1996-4#1)(1996-5#1)(1997-4#1)(1997-5#2)(2006-1#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-6#1)(2008-10#9)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-9#2)(2010-12#1)(2011-1#2)(2011-2#1)
that produced SLS##2##3##(2008-10#2)
that produced a##3##3##(2008-12#1)(2008-5#2)
that produced by the##5##4##(1994-3#1)(1996-5#1)(1997-2#1)(2006-10#1)(2006-8#1)
that produced by##23##3##(1990-8#1)(1990-9#1)(1991-8#1)(1992-10#1)(1992-8#1)(1993-3#2)(1994-3#2)(1994-6#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-5#2)(2006-10#2)(2006-8#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-5#1)
that produced high amounts of IAA##2##6##(2008-10#2)
that produced high##3##3##(2007-8#1)(2008-10#2)
that produced the most##2##4##(1991-9#1)(2009-2#1)
that produced the##7##3##(1991-9#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-8#1)(2013-1#1)
that produced##65##2##(1990-8#1)(1990-9#1)(1991-12#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-8#1)(1993-12#2)(1993-3#2)(1993-6#1)(1994-10#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-2#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-5#3)(2004-1#1)(2006-10#2)(2006-11#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#11)(2008-11#2)(2008-12#3)(2008-3#3)(2008-5#3)(2008-7#2)(2009-2#1)(2009-5#1)(2009-8#1)(2013-1#1)
that produces a##3##3##(2008-10#2)(2008-4#1)
that produces an##6##3##(1996-5#1)(2004-8#1)(2008-3#2)(2012-3#1)(2013-1#1)
that produces the##9##3##(1995-4#1)(2007-12#2)(2007-7#1)(2008-3#1)(2008-4#3)(2009-8#1)
that produces##62##2##(1993-11#1)(1993-12#1)(1995-1#1)(1995-4#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-4#1)(2004-3#1)(2004-8#1)(2007-10#1)(2007-11#6)(2007-12#19)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#4)(2008-4#4)(2008-6#1)(2008-8#1)(2009-10#2)(2009-4#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
that producing##2##2##(1991-8#1)(2010-12#1)
that product##2##2##(2008-5#1)(2011-1#1)
that production of##4##3##(1992-10#1)(1992-5#1)(1993-8#1)(2003-11#1)
that production##5##2##(1992-10#1)(1992-5#1)(1993-8#1)(2003-11#1)(2013-8#1)
that productive binding##2##3##(1990-7#1)(1993-8#1)
that productive##3##2##(1990-7#1)(1993-8#1)(2007-5#1)
that products of##2##3##(1996-5#1)(2009-9#1)
that products##5##2##(1990-11#1)(1991-9#1)(1996-5#1)(2005-11#1)(2009-9#1)
that professional##3##2##(1994-12#1)(2004-10#1)(2013-8#1)
that professionals##3##2##(1991-12#1)(2011-2#1)(2013-1#1)
that profilin##2##2##(1990-3#1)(1994-2#1)
that profoundly##4##2##(1990-12#1)(1994-12#1)(1995-2#1)(2008-11#1)
that progesterone##5##2##(1993-2#1)(2007-10#1)(2007-12#2)(2008-4#1)
that programs##3##2##(2007-7#1)(2008-6#1)(2013-8#1)
that progress##6##2##(1997-3#1)(2006-10#1)(2008-8#1)(2008-9#2)(2010-9#1)
that progressed to##3##3##(2007-2#1)(2009-3#1)(2011-1#1)
that progressed##5##2##(1992-5#1)(2007-2#1)(2009-3#1)(2011-1#1)(2012-1#1)
that progresses##3##2##(2006-10#1)(2006-12#1)(2007-6#1)
that progression of##2##3##(1992-6#1)(1996-5#1)
that progression##3##2##(1992-6#1)(1993-12#1)(1996-5#1)
that progressive##6##2##(1991-10#1)(2006-2#1)(2006-8#1)(2008-11#1)(2008-4#1)(2012-1#1)
that progressively##2##2##(1992-9#1)(1996-10#1)
that prohibit##2##2##(1996-11#1)(2013-8#1)
that proinflammatory cytokines##3##3##(2007-8#1)(2009-9#1)(2010-4#1)
that project to the##4##4##(1995-11#1)(1995-8#1)(2008-11#1)(2013-8#1)
that project to##5##3##(1995-11#1)(1995-2#1)(1995-8#1)(2008-11#1)(2013-8#1)
that project##8##2##(1995-11#1)(1995-2#1)(1995-8#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-4#1)(2013-8#1)
that projects to the##2##4##(1991-6#1)(2010-10#1)
that projects##3##2##(1991-6#1)(1993-3#1)(2010-10#1)
that prolactin##4##2##(1990-4#1)(1991-11#1)(1996-8#1)(2008-12#1)
that proliferation of##3##3##(1991-9#1)(2008-10#1)(2010-11#1)
that proline##2##2##(1991-12#2)
that prolong the##2##3##(2007-7#1)(2008-10#1)
that prolong##5##2##(2006-10#1)(2007-7#1)(2008-10#1)(2008-8#1)(2010-7#1)
that prolonged##14##2##(1991-9#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-12#1)(1996-3#1)(1996-6#1)(2006-10#2)(2007-11#1)(2008-8#1)(2012-12#1)(2013-1#1)
that prolongs the##3##3##(1992-6#1)(2008-8#1)(2010-5#1)
that prolyl##2##2##(1990-5#1)(1991-2#1)
that promote a##4##3##(1992-12#1)(2007-12#1)(2008-7#1)(2013-1#1)
that promote health##2##3##(2008-3#1)(2009-6#1)
that promote the development of##2##5##(1992-9#1)(2008-11#1)
that promote the##8##3##(1992-9#1)(1996-6#1)(2007-7#1)(2008-11#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-8#1)
that promote their##2##3##(2009-3#1)(2012-1#1)
that promote tumor##3##3##(2009-3#2)(2011-2#1)
that promote##56##2##(1992-12#1)(1992-5#1)(1992-9#1)(1993-1#1)(1994-1#1)(1994-8#1)(1995-2#1)(1996-2#1)(1996-6#1)(2005-12#1)(2006-10#2)(2007-12#2)(2007-2#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#5)(2008-7#2)(2009-12#2)(2009-3#4)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
that promoted##5##2##(1990-2#1)(2004-8#1)(2009-12#1)(2013-1#2)
that promotes cell##2##3##(2007-2#1)(2010-12#1)
that promotes the##4##3##(1991-3#1)(1994-12#1)(2006-2#1)(2007-8#1)
that promotes##22##2##(1991-3#1)(1992-11#1)(1992-3#1)(1992-8#1)(1994-12#1)(1995-8#1)(1997-2#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-12#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-6#1)(2012-3#1)(2013-7#1)
that prompt##3##2##(1993-8#1)(2007-8#1)(2013-1#1)
that prompted the##2##3##(2008-3#1)(2009-10#1)
that prompted##4##2##(2006-10#1)(2008-3#1)(2009-10#1)(2010-2#1)
that propagate along##2##3##(2007-12#1)(2008-3#1)
that propagate at##2##3##(2007-12#1)(2008-3#1)
that propagate in##3##3##(2007-11#2)(2007-12#1)
that propagate##11##2##(2006-10#1)(2007-11#2)(2007-12#4)(2008-2#1)(2008-3#3)
that propagates##6##2##(1995-8#1)(2007-11#1)(2007-12#1)(2008-3#3)
that propagules##2##2##(2008-10#1)(2008-8#1)
that proper selection##2##3##(2006-1#1)(2007-7#1)
that proper##8##2##(2006-1#1)(2007-6#1)(2007-7#1)(2008-2#1)(2008-8#1)(2012-12#2)(2013-1#1)
that properly##7##2##(1991-12#1)(1996-1#1)(2007-4#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-2#1)
that prophylactic##9##2##(2006-10#1)(2007-11#1)(2007-8#3)(2008-7#1)(2010-7#1)(2011-12#1)(2013-1#1)
that proportionally##2##2##(2006-7#1)(2009-4#1)
that proposed##5##2##(1995-10#1)(2007-2#1)(2008-8#1)(2008-9#1)(2012-3#1)
that proposes that##2##3##(2009-9#1)(2012-3#1)
that prosaposin##2##2##(1991-4#1)(1997-4#1)
that prosopagnosia##2##2##(1991-11#1)(2009-4#1)
that prospective##3##2##(1990-12#1)(1991-5#1)(1994-2#1)
that prostaglandin##4##2##(1991-3#1)(1994-5#1)(1996-12#1)(2008-7#1)
that prostate cancer is##2##4##(2010-10#1)(2011-2#1)
that protect against##6##3##(1992-2#1)(2005-9#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)
that protect cells##2##3##(1996-10#1)(2005-7#1)
that protect the##7##3##(1994-11#1)(2006-10#2)(2008-7#2)(2009-6#1)(2011-2#1)
that protect##19##2##(1991-9#1)(1992-2#1)(1994-11#1)(1996-10#1)(2005-7#1)(2005-9#1)(2006-10#2)(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#3)(2009-6#1)(2009-7#1)(2010-11#1)(2011-2#1)
that protected##2##2##(2004-11#1)(2008-1#1)
that protection against##3##3##(1991-5#1)(1995-12#1)(1997-4#1)
that protection##8##2##(1991-5#1)(1995-12#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2010-4#1)(2012-7#1)
that protective##3##2##(2007-11#1)(2008-3#1)(2008-4#1)
that protects cells##2##3##(1994-11#1)(1995-8#1)
that protects the##2##3##(1995-2#1)(2008-4#1)
that protects##9##2##(1994-11#1)(1995-2#1)(1995-8#1)(2006-7#1)(2007-12#1)(2008-4#2)(2008-6#1)(2009-12#1)
that protein E1##2##3##(1992-7#2)
that protein G-liposomal nanovesicles##2##4##(2008-10#2)
that protein O-GlcNAcylation##2##3##(2012-3#2)
that protein binding##4##3##(1991-6#2)(1992-12#1)(2008-5#1)
that protein deficiency##3##3##(1991-11#1)(2008-12#2)
that protein disulfide isomerase##2##4##(1990-7#1)(1996-7#1)
that protein folding##3##3##(1992-1#1)(1997-1#1)(1997-4#1)
that protein kinase A##4##4##(1992-12#1)(1993-8#1)(2008-1#1)(2008-11#1)
that protein kinase C has a##2##6##(1990-9#1)(1995-6#1)
that protein kinase C is##2##5##(1990-8#1)(1991-7#1)
that protein kinase C##6##4##(1990-5#1)(1990-8#1)(1990-9#1)(1991-7#1)(1995-6#1)(2008-11#1)
that protein kinase##10##3##(1990-5#1)(1990-8#1)(1990-9#1)(1991-7#1)(1992-12#1)(1993-8#1)(1995-6#1)(2008-1#1)(2008-11#2)
that protein phosphorylation##2##3##(1992-9#1)(1995-12#1)
that protein splicing##3##3##(1995-8#2)(2011-3#1)
that protein synthesis may be##2##5##(1994-2#1)(1997-1#1)
that protein synthesis##3##3##(1991-6#1)(1994-2#1)(1997-1#1)
that protein tyrosine##2##3##(1997-6#1)(2009-6#1)
that protein##71##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-5#2)(1991-6#3)(1991-7#2)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-7#2)(1992-9#1)(1993-11#1)(1993-8#2)(1994-2#2)(1994-9#2)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-4#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-11#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#4)(2008-8#1)(2008-9#2)(2009-6#1)(2009-8#2)(2011-3#1)(2012-11#1)(2012-3#2)(2013-1#1)
that protein(s) that bind the##2##5##(1997-4#2)
that proteinases##2##2##(1990-5#1)(2012-12#1)
that proteins can##2##3##(2008-1#1)(2010-4#1)
that proteins from##3##3##(1996-5#1)(2008-10#1)(2010-4#1)
that proteins##11##2##(1991-5#1)(1992-5#1)(1995-2#1)(1996-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2010-4#2)(2012-2#1)
that proteinuria##2##2##(1996-12#1)(2008-1#1)
that proteolysis##2##2##(1991-8#1)(2008-9#1)
that proteolytic##2##2##(1991-4#1)(1996-11#1)
that proteomic##2##2##(2008-7#1)(2013-1#1)
that proton##3##2##(1994-12#1)(1996-5#1)(2008-10#1)
that protonation##3##2##(1995-3#1)(1996-2#1)(1997-1#1)
that protrude from##2##3##(1994-8#1)(2009-8#1)
that proved to be##3##4##(2008-10#1)(2011-2#1)(2012-3#1)
that proved to##4##3##(2008-10#2)(2011-2#1)(2012-3#1)
that proved##7##2##(1994-2#1)(2005-11#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-3#1)
that provide a##16##3##(1993-12#1)(2006-10#2)(2006-5#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-3#2)(2009-3#1)(2011-1#2)(2012-12#2)(2012-2#1)(2013-8#1)
that provide an##6##3##(1997-4#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-6#1)(2012-2#1)
that provide complete##2##3##(1992-8#1)(2008-2#1)
that provide evidence##2##3##(2011-2#1)(2012-2#1)
that provide information about##3##4##(1991-7#1)(1992-12#1)(1996-4#1)
that provide information##7##3##(1991-7#1)(1992-12#1)(1996-4#1)(2006-12#1)(2007-2#1)(2008-2#1)(2009-9#1)
that provide more##3##3##(1996-4#1)(2007-2#1)(2008-3#1)
that provide new##2##3##(2007-7#1)(2013-8#1)
that provide stability##2##3##(2008-9#1)(2012-1#1)
that provide the basis for##2##5##(2008-5#2)
that provide the##11##3##(1994-12#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2011-1#1)
that provide##108##2##(1991-1#1)(1991-3#1)(1991-7#1)(1992-12#2)(1992-2#1)(1992-8#1)(1993-12#2)(1994-1#2)(1994-12#1)(1995-1#2)(1996-3#1)(1996-4#2)(1997-4#1)(1997-8#1)(2004-10#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-5#1)(2006-8#1)(2007-1#1)(2007-12#4)(2007-2#5)(2007-7#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#6)(2008-3#5)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#4)(2012-1#5)(2012-11#1)(2012-12#3)(2012-2#4)(2013-1#2)(2013-8#2)
that provided by the##7##4##(1990-5#1)(2008-10#4)(2011-1#1)(2012-3#1)
that provided by##14##3##(1990-5#1)(1992-5#1)(2005-7#1)(2007-10#1)(2008-10#5)(2008-9#1)(2011-1#1)(2012-12#1)(2012-3#2)
that provided relief##2##3##(2006-5#1)(2011-2#1)
that provided the##4##3##(1995-8#1)(2006-2#1)(2008-10#1)(2008-5#1)
that provided##30##2##(1990-5#1)(1992-5#1)(1993-2#1)(1995-8#1)(1996-3#1)(2004-11#1)(2005-7#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-12#2)(2008-10#6)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)
that provider##3##2##(1994-1#2)(2009-3#1)
that providers##3##2##(1992-3#1)(1997-1#1)(2006-8#1)
that provides a##20##3##(1996-3#1)(2007-12#3)(2007-8#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-9#1)(2012-12#2)(2013-1#4)
that provides an##5##3##(1996-2#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)
that provides evidence##2##3##(1995-8#1)(1996-11#1)
that provides for##2##3##(2008-9#1)(2009-7#1)
that provides free##2##3##(2007-2#1)(2007-4#1)
that provides functional information##2##4##(2010-9#1)(2011-1#1)
that provides high##2##3##(2008-2#1)(2008-3#1)
that provides simultaneous##2##3##(2007-11#1)(2008-3#1)
that provides structural##2##3##(2009-8#1)(2012-2#1)
that provides the most accurate##2##5##(2008-2#1)(2008-5#1)
that provides the##15##3##(1994-3#1)(1997-7#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2011-1#1)
that provides##108##2##(1991-12#1)(1991-4#1)(1992-1#1)(1992-8#1)(1994-3#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-2#2)(2006-5#1)(2007-11#5)(2007-12#9)(2007-2#2)(2007-3#1)(2007-4#2)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#9)(2008-3#10)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#6)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#6)(2013-8#2)
that providing##2##2##(1995-1#1)(2007-11#1)
that provocative discography##2##3##(2006-8#2)
that provokes##2##2##(1994-2#1)(2009-8#1)
that proximal and distal##2##4##(1993-9#1)(2009-11#1)
that proximal hypospadias##2##3##(2009-10#2)
that proximal##6##2##(1993-9#1)(2009-10#2)(2009-11#1)(2012-3#1)(2013-1#1)
that pruritus##2##2##(2008-1#2)
that pseudomonic acid##2##3##(1994-9#2)
that psilocybin##2##2##(2013-8#2)
that psychiatric##4##2##(1996-5#1)(2006-8#1)(2008-1#1)(2013-1#1)
that psychiatry##2##2##(2008-2#1)(2008-4#1)
that psychological stress##3##3##(2007-11#2)(2008-6#1)
that psychological##7##2##(1993-8#1)(2006-10#1)(2006-3#1)(2007-11#2)(2008-12#1)(2008-6#1)
that psychopaths##2##2##(2010-12#2)
that psychosocial factors##3##3##(1996-12#1)(2008-2#1)(2008-9#1)
that psychosocial##4##2##(1996-12#1)(2008-2#1)(2008-9#2)
that public health and medical##2##5##(2012-1#2)
that public health##8##3##(1995-12#1)(1996-2#1)(2008-1#1)(2008-10#1)(2010-9#2)(2012-1#2)
that public relations activities##2##4##(2008-12#2)
that public relations##3##3##(2008-12#3)
that public##15##2##(1991-3#1)(1995-12#1)(1996-2#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-12#3)(2008-7#1)(2010-9#2)(2011-1#1)(2012-1#2)
that publish##2##2##(1996-12#1)(2011-2#1)
that published##3##2##(2008-1#1)(2008-7#1)(2012-3#1)
that pulmonary##3##2##(1997-1#1)(2008-1#2)
that pump##2##2##(2007-11#1)(2008-3#1)
that purified##11##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-7#1)(1991-8#1)(1995-2#1)(2011-1#1)(2012-2#1)
that purport to##2##3##(2009-5#1)(2010-12#1)
that purpose##16##2##(1993-1#1)(1994-2#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-7#1)(2004-11#1)(2005-11#1)(2006-5#1)(2006-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)
that put##7##2##(1990-12#1)(2008-2#1)(2008-9#2)(2012-1#1)(2013-1#2)
that putative##3##2##(1995-5#1)(1996-9#1)(2009-10#1)
that putrescine##2##2##(1991-2#1)(1994-8#1)
that pycnogenol##2##2##(2004-12#2)
that pyridine##2##2##(1992-7#1)(1994-3#1)
that pyrimidine##2##2##(1990-2#2)
that pyriproxyfen##2##2##(2007-12#1)(2012-12#1)
that pyruvate##3##2##(1991-8#1)(1992-5#1)(1993-8#1)
that quail##2##2##(2008-5#1)(2009-7#1)
that qualitative##2##2##(2008-5#1)(2013-1#1)
that qualitatively##6##2##(2007-11#1)(2008-11#1)(2008-2#1)(2008-8#1)(2013-1#2)
that quality of##3##3##(1996-3#1)(2007-11#1)(2013-8#1)
that quality##8##2##(1996-3#2)(2006-5#1)(2007-11#1)(2007-5#1)(2008-3#1)(2012-3#1)(2013-8#1)
that quantifies the##3##3##(2007-11#1)(2008-10#1)(2011-12#1)
that quantifies##5##2##(2006-10#1)(2007-11#1)(2008-10#1)(2010-8#1)(2011-12#1)
that quantify the##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
that quantify##4##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)
that quantitative##9##2##(1993-12#1)(1995-3#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-9#1)
that quantitatively##2##2##(2007-12#1)(2008-8#1)
that quantity of##3##3##(1992-3#1)(1993-12#1)(2005-11#1)
that quantum##2##2##(2007-9#1)(2012-2#1)
that quercetin##3##2##(1997-8#1)(2008-10#1)(2008-4#1)
that question##2##2##(2010-10#1)(2011-2#1)
that quick##2##2##(2008-5#2)
that quickly##3##2##(1991-12#1)(1996-12#1)(2008-10#1)
that quite##2##2##(2008-2#1)(2008-7#1)
that rabbit##7##2##(1990-8#1)(1991-2#1)(1992-6#1)(1992-7#1)(1993-8#1)(1994-3#1)(2008-4#1)
that race is##3##3##(1996-9#1)(2007-3#2)
that race##7##2##(1996-9#1)(2007-3#2)(2008-10#3)(2012-11#1)
that radial##2##2##(2007-8#1)(2008-10#1)
that radiation##5##2##(1990-12#1)(2006-8#1)(2007-12#1)(2008-3#1)(2008-7#1)
that radiation-induced##3##2##(2008-2#1)(2008-7#2)
that radiative##2##2##(2007-11#1)(2008-2#1)
that radical surgery##2##3##(1990-9#1)(2009-4#1)
that radical##5##2##(1990-9#2)(2005-12#1)(2009-2#1)(2009-4#1)
that radiofrequency##2##2##(1991-6#1)(2006-8#1)
that radiolabeled##3##2##(1992-2#1)(1994-12#1)(1995-8#1)
that radiologists are##2##3##(2007-4#1)(2012-2#1)
that radiologists##8##2##(2004-9#1)(2007-4#4)(2012-2#1)(2013-1#2)
that radiology##3##2##(2007-4#3)
that radiotherapy is##2##3##(1990-12#1)(2007-11#1)
that radiotherapy##4##2##(1990-12#1)(2007-11#2)(2007-8#1)
that raf##2##2##(1991-1#1)(1993-6#1)
that raise##3##2##(2006-5#1)(2007-10#1)(2008-3#1)
that raised##5##2##(1990-5#1)(1997-1#1)(2006-8#1)(2010-5#1)(2011-2#1)
that raises##2##2##(2008-4#1)(2010-8#1)
that raising the##2##3##(1990-11#1)(2008-7#1)
that ran##2##2##(1995-12#1)(2005-7#1)
that random##4##2##(2007-12#1)(2008-10#1)(2008-7#1)(2013-7#1)
that range from##9##3##(1993-8#1)(1996-2#1)(1996-9#1)(2008-2#3)(2010-4#1)(2011-2#2)
that range##17##2##(1991-10#1)(1993-8#1)(1996-2#1)(1996-9#1)(2007-12#1)(2008-2#3)(2008-3#3)(2008-5#1)(2010-4#1)(2011-2#2)(2012-12#2)
that ranged from 0##2##4##(2008-10#1)(2010-5#1)
that ranged from mild##2##4##(1995-8#1)(2008-10#1)
that ranged from##10##3##(1995-8#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-5#1)(2010-5#1)
that ranolazine##2##2##(2005-8#2)
that rapamycin##2##2##(1993-11#2)
that rapid##14##2##(1990-8#1)(1991-6#1)(1992-6#1)(1993-8#1)(1993-9#1)(1995-2#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-1#1)(2013-8#1)
that rapidly##10##2##(1990-11#1)(1990-2#1)(1991-12#1)(1991-4#1)(1994-9#1)(1995-1#1)(2008-10#2)(2010-12#1)(2013-1#1)
that rare functional variants are##2##5##(2012-3#2)
that rare variants##3##3##(2012-3#3)
that rare##12##2##(1990-7#1)(2008-6#2)(2008-9#1)(2012-3#8)
that rarely##6##2##(1991-9#1)(1993-5#1)(2010-2#1)(2010-6#1)(2012-11#1)(2012-12#1)
that rat##20##2##(1990-2#2)(1990-4#1)(1990-6#1)(1990-7#1)(1992-8#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-12#2)(1994-6#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-5#1)(2008-10#1)(2013-1#1)
that rate of aging##2##4##(2008-9#2)
that rate of##4##3##(2007-4#1)(2008-9#3)
that rate##6##2##(2007-4#1)(2008-3#1)(2008-9#3)(2009-3#1)
that rates of##7##3##(1990-12#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-7#1)
that rates##8##2##(1990-12#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-7#1)(2011-2#1)
that rather than##4##3##(2008-10#2)(2009-9#1)(2012-2#1)
that rather##5##2##(1990-4#1)(2008-10#2)(2009-9#1)(2012-2#1)
that rats are##2##3##(1992-5#1)(1996-12#1)
that rats with##2##3##(1995-3#1)(2011-1#1)
that rats##11##2##(1990-12#1)(1992-5#1)(1995-3#1)(1995-9#1)(1996-12#1)(1997-8#2)(2009-11#1)(2010-3#1)(2011-1#1)(2013-1#1)
that rbFGF##3##2##(1994-12#3)
that reach the##2##3##(1996-9#1)(2008-2#1)
that reach##3##2##(1992-3#1)(1996-9#1)(2008-2#1)
that reached##3##2##(1994-11#1)(2011-2#1)(2012-2#1)
that reaches the##5##3##(2005-11#1)(2008-1#1)(2008-2#1)(2008-5#2)
that reaches##10##2##(1994-5#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-5#3)(2012-1#1)
that react with the##2##4##(1995-2#1)(2006-6#1)
that react with##8##3##(1991-11#1)(1995-2#1)(2006-6#1)(2008-4#1)(2008-7#1)(2011-12#1)(2012-12#2)
that react##9##2##(1991-11#1)(1995-2#1)(2006-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-12#1)(2012-12#2)
that reacted with##4##3##(1993-6#1)(1994-6#1)(2008-10#2)
that reacted##7##2##(1992-11#1)(1992-12#1)(1993-6#2)(1994-6#1)(2008-10#2)
that reaction##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
that reactivate##2##2##(2009-4#1)(2009-9#1)
that reactivation##2##2##(2006-10#1)(2013-1#1)
that reactive oxygen species (ROS)##3##5##(1994-6#1)(2008-1#1)(2008-6#1)
that reactive oxygen species##5##4##(1994-6#1)(1997-3#1)(2005-10#1)(2008-1#1)(2008-6#1)
that reactive##9##2##(1990-2#1)(1994-6#1)(1997-3#1)(2005-10#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2013-7#1)
that reacts with##5##3##(1992-7#1)(1994-8#1)(1996-2#1)(2007-9#1)(2008-10#1)
that reacts##9##2##(1990-5#1)(1992-7#1)(1994-8#1)(1995-12#1)(1996-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2010-5#1)
that readers##2##2##(2007-8#1)(2007-9#1)
that readily available##2##3##(2004-11#1)(2008-7#1)
that real##6##2##(1990-12#1)(1994-1#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-2#1)
that real-time##5##2##(2007-7#1)(2008-1#1)(2008-2#1)(2008-7#1)(2010-6#1)
that realize the half-order differentiation##2##5##(2008-2#2)
that realize##3##2##(2007-8#1)(2008-2#2)
that realized##2##2##(2008-3#1)(2009-12#1)
that rearrangement of##2##3##(1995-6#1)(1996-6#1)
that rearrangement##3##2##(1993-11#1)(1995-6#1)(1996-6#1)
that reasonable##4##2##(2005-4#1)(2007-11#1)(2007-4#1)(2008-2#1)
that recapitulate##3##2##(2007-11#1)(2012-2#1)(2013-1#1)
that recapitulates##2##2##(1992-2#1)(2008-4#1)
that receive input from the##2##5##(1991-5#1)(1995-11#1)
that receive##7##2##(1991-5#1)(1995-11#1)(1997-2#1)(2007-12#1)(2008-3#1)(2008-8#1)(2012-2#1)
that received a##5##3##(1993-12#1)(2004-4#1)(2007-2#1)(2009-10#1)(2012-3#1)
that received cytochrome c##2##4##(1995-5#2)
that received more than##2##4##(2008-10#1)(2011-2#1)
that received no##2##3##(2008-5#2)
that received one##3##3##(2007-2#1)(2008-10#1)(2011-2#1)
that received the##3##3##(2005-12#1)(2006-10#1)(2008-3#1)
that received##56##2##(1990-12#1)(1990-4#1)(1990-5#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#1)(1995-12#1)(1995-2#1)(1995-5#4)(1995-8#1)(1996-12#1)(1997-2#1)(1997-6#1)(2004-4#1)(2005-12#1)(2006-10#3)(2007-10#1)(2007-2#2)(2007-8#2)(2007-9#1)(2008-10#6)(2008-12#2)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
that receivers##2##2##(1995-5#2)
that receives##3##2##(1996-3#1)(2007-8#1)(2013-1#1)
that recent##8##2##(1994-2#1)(1995-3#1)(2007-11#1)(2007-5#1)(2007-6#1)(2010-2#1)(2011-2#2)
that recently##6##2##(1993-3#1)(1994-3#2)(2006-10#1)(2008-8#1)(2013-8#1)
that receptor##3##2##(1994-9#1)(1997-7#1)(2009-9#1)
that receptors##3##2##(1992-12#1)(1995-3#1)(2011-1#1)
that recognition of the##4##4##(2007-11#1)(2007-7#1)(2008-10#2)
that recognition of##7##3##(1991-5#1)(1993-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)
that recognition##10##2##(1991-5#1)(1993-3#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#2)(2009-10#1)
that recognize intact proteins##6##4##(2008-2#2)(2008-4#4)
that recognize specific##3##3##(2008-1#2)(2008-4#1)
that recognize the##8##3##(1992-4#1)(1994-6#1)(1995-6#1)(1996-2#1)(2008-4#1)(2008-9#1)(2009-3#1)(2012-1#1)
that recognize##41##2##(1990-11#1)(1991-11#2)(1991-12#2)(1991-9#1)(1992-4#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-6#1)(1996-12#3)(1996-2#1)(1997-4#1)(2008-1#2)(2008-2#2)(2008-4#10)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-1#1)
that recognized the##2##3##(2008-7#1)(2012-3#1)
that recognized##7##2##(1991-9#1)(1993-9#1)(1995-1#2)(2008-10#1)(2008-7#1)(2012-3#1)
that recognizes a##3##3##(1991-9#1)(1995-8#1)(1997-7#1)
that recognizes human##2##3##(1992-6#1)(1994-12#1)
that recognizes the##4##3##(1992-10#1)(1992-9#1)(2008-4#1)(2011-1#1)
that recognizes##16##2##(1991-9#1)(1992-10#1)(1992-6#2)(1992-9#1)(1994-12#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-8#1)(1997-7#1)(2004-10#1)(2007-8#1)(2008-4#1)(2011-1#1)
that recombinant human##3##3##(1995-3#1)(2006-9#1)(2008-11#1)
that recombinant##14##2##(1991-3#1)(1991-7#1)(1992-11#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-4#1)(2006-9#1)(2008-11#3)(2009-2#1)
that recombination##8##2##(1990-5#1)(1996-10#1)(2008-10#5)(2013-8#1)
that recommendations##2##2##(2007-11#1)(2011-1#1)
that recommended by##3##3##(1995-1#1)(2007-12#1)(2010-11#1)
that recommended##6##2##(1991-12#1)(1991-8#1)(1995-1#1)(2007-12#1)(2010-11#2)
that reconstruction##3##2##(1991-4#1)(2008-2#1)(2012-2#1)
that reconstructs the##3##3##(1993-3#1)(2007-12#1)(2008-3#1)
that record##2##2##(2006-10#1)(2008-10#1)
that recorded in the##2##4##(1994-8#1)(2008-3#1)
that recorded in##5##3##(1994-8#1)(2008-10#1)(2008-3#1)(2010-10#1)(2012-3#1)
that recorded##7##2##(1994-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2010-10#1)(2012-3#1)
that recovered##3##2##(1991-2#1)(2008-10#2)
that recovery##4##2##(1995-8#1)(2008-2#1)(2012-11#1)(2013-1#1)
that recruit##6##2##(2006-10#1)(2007-8#1)(2009-10#1)(2011-1#1)(2012-1#1)(2013-8#1)
that recycles##2##2##(2006-11#1)(2012-1#1)
that red##6##2##(1990-12#1)(1990-5#1)(1992-12#1)(1995-3#1)(2009-3#1)(2012-2#1)
that redesigning##2##2##(1993-2#1)(2009-4#1)
that redox##2##2##(1995-6#1)(1997-8#1)
that reduce the risk of##2##5##(2007-8#1)(2009-11#1)
that reduce the##10##3##(1997-4#1)(2006-5#1)(2006-6#1)(2007-8#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-6#1)(2012-3#1)
that reduce##28##2##(1991-11#1)(1995-8#1)(1996-8#1)(1997-4#2)(2005-10#1)(2005-8#1)(2006-5#1)(2006-6#1)(2007-8#1)(2008-10#4)(2008-12#2)(2008-2#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#1)(2012-3#1)
that reduced##21##2##(1990-2#1)(1991-2#1)(1992-12#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-6#1)(1996-9#1)(1997-2#1)(1997-4#1)(2007-8#1)(2008-10#2)(2008-6#2)(2010-10#1)(2011-2#1)(2012-2#1)
that reduces cannibalism and##2##4##(2011-12#2)
that reduces the##13##3##(2005-7#1)(2007-12#3)(2008-10#1)(2008-3#4)(2008-6#1)(2008-7#2)(2008-8#1)
that reduces##35##2##(1995-2#1)(1996-11#1)(1996-2#1)(2005-7#1)(2006-2#1)(2007-10#1)(2007-12#4)(2007-7#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2011-1#1)(2011-12#2)(2011-2#2)(2013-8#1)
that reducing the##5##3##(1992-4#1)(2007-8#1)(2008-2#1)(2008-9#1)(2010-11#1)
that reducing##12##2##(1992-4#1)(1992-6#1)(2005-11#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-11#1)(2010-8#1)
that reduction##4##2##(1992-1#1)(1996-9#1)(2006-8#1)(2013-8#1)
that reductive##2##2##(2004-4#1)(2008-10#1)
that redundant##2##2##(2007-5#1)(2008-10#1)
that reelin##2##2##(2009-8#1)(2011-2#1)
that refer to##2##3##(1992-5#1)(2009-3#1)
that refer##3##2##(1991-1#1)(1992-5#1)(2009-3#1)
that referent##2##2##(1995-2#1)(2007-12#1)
that refers to##2##3##(2007-2#1)(2008-1#1)
that reflect a##2##3##(2008-10#2)
that reflect an##2##3##(2007-12#1)(2011-2#1)
that reflect the##13##3##(1991-3#1)(1993-3#1)(1995-12#1)(1997-8#1)(2007-11#1)(2007-2#1)(2008-12#1)(2008-9#3)(2009-12#1)(2012-12#1)(2013-7#1)
that reflect their##2##3##(1994-3#1)(2011-1#1)
that reflect this##2##3##(2006-6#1)(2010-9#1)
that reflect##34##2##(1991-3#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-8#2)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#2)(2008-8#1)(2008-9#3)(2009-12#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-7#1)
that reflected the##2##3##(2008-2#1)(2009-5#1)
that reflection##5##2##(2007-11#1)(2007-12#1)(2008-11#3)
that reflects only##2##3##(2007-11#1)(2008-3#1)
that reflects the##8##3##(1996-4#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)
that reflects##16##2##(1994-5#1)(1996-4#1)(1997-2#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-11#1)(2008-3#3)(2008-6#1)(2008-8#1)
that regarding##2##2##(1992-12#1)(2008-11#1)
that regardless of##4##3##(2006-11#1)(2007-8#1)(2011-12#1)(2011-2#1)
that regenerated host axons##2##4##(2011-2#2)
that regenerated##3##2##(2011-2#3)
that regeneration##2##2##(1994-2#1)(2008-12#1)
that region was##2##3##(2008-5#1)(2008-7#1)
that region##13##2##(1990-3#1)(1990-5#1)(1994-8#1)(1994-9#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-5#1)
that regional##7##2##(1991-6#1)(1996-12#1)(1997-7#1)(2007-10#1)(2007-9#1)(2008-7#1)(2013-7#1)
that regions##6##2##(1990-5#1)(1993-3#1)(2008-12#2)(2008-2#1)(2013-8#1)
that registered##2##2##(2006-1#1)(2008-10#1)
that regular##5##2##(1991-8#1)(1996-12#1)(2006-10#1)(2009-5#1)(2012-3#1)
that regulate a variety of##2##5##(2008-1#1)(2009-11#1)
that regulate a##3##3##(2008-1#1)(2009-10#1)(2009-11#1)
that regulate cell##3##3##(1995-8#1)(2007-4#1)(2012-3#1)
that regulate cellular##3##3##(1997-4#1)(2011-12#1)(2012-12#1)
that regulate gene expression##7##4##(1995-6#1)(2008-1#1)(2008-11#2)(2008-3#1)(2009-8#1)(2012-12#1)
that regulate inflammation##3##3##(2011-2#1)(2012-1#2)
that regulate innate##2##3##(2007-11#1)(2012-1#1)
that regulate neuronal differentiation##2##4##(2008-11#1)(2008-4#1)
that regulate neurotransmitter##2##3##(1995-12#1)(1996-12#1)
that regulate the activity of##2##5##(1996-5#1)(2008-1#1)
that regulate the expression of##2##5##(2008-1#1)(2009-12#1)
that regulate the growth of##2##5##(1993-5#1)(1995-8#1)
that regulate the##21##3##(1991-3#1)(1992-2#1)(1992-5#1)(1993-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-6#1)(2006-10#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2012-2#1)
that regulate transcription##3##3##(1994-6#1)(1995-1#1)(1997-2#1)
that regulate##110##2##(1990-2#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-5#1)(1994-6#1)(1995-1#1)(1995-12#2)(1995-6#2)(1995-8#3)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-4#2)(1997-6#1)(2003-11#1)(2005-11#1)(2006-10#3)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-1#7)(2008-10#3)(2008-11#5)(2008-12#1)(2008-3#3)(2008-4#6)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#3)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-12#1)(2011-2#2)(2012-1#3)(2012-12#9)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#1)
that regulated##2##2##(1993-3#1)(2006-10#1)
that regulates biofilm decay in P##2##6##(2009-6#2)
that regulates cell##3##3##(2008-1#1)(2008-11#1)(2009-8#1)
that regulates insulin##2##3##(1990-8#1)(1997-4#1)
that regulates the expression of##4##5##(1991-9#1)(1992-3#1)(2009-4#1)(2010-7#1)
that regulates the##12##3##(1991-9#1)(1992-3#1)(1997-6#1)(2005-7#1)(2006-10#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-2#1)
that regulates this##2##3##(2008-8#1)(2012-2#1)
that regulates##47##2##(1990-8#2)(1990-9#1)(1991-9#1)(1992-3#1)(1993-8#1)(1995-12#3)(1995-3#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-4#1)(1997-6#1)(2005-7#1)(2006-10#2)(2006-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#1)(2009-6#2)(2009-8#2)(2010-11#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-2#4)
that regulation of the##6##4##(1991-9#1)(1994-6#1)(1996-3#1)(1997-2#1)(1997-3#1)(2012-1#1)
that regulation of##16##3##(1991-9#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(2008-7#2)(2008-8#3)(2012-1#1)
that regulation##17##2##(1991-9#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(2008-7#2)(2008-8#3)(2009-10#1)(2012-1#1)
that regulatory mechanisms##2##3##(1992-7#1)(2007-12#1)
that regulatory##8##2##(1992-7#1)(1995-8#1)(1996-2#1)(1997-4#1)(2006-11#1)(2006-7#1)(2007-12#1)(2008-7#1)
that rehabilitation##2##2##(2009-8#1)(2013-1#1)
that reinforce##3##2##(2006-10#1)(2013-1#1)(2013-7#1)
that reinforces the##2##3##(2008-12#1)(2013-8#1)
that reinforces##3##2##(2008-12#1)(2009-10#1)(2013-8#1)
that relapsed##2##2##(2007-5#1)(2008-1#1)
that relate directly to##2##4##(1993-1#1)(1995-12#1)
that relate the##3##3##(2008-3#2)(2012-12#1)
that relate to##11##3##(1995-3#1)(1996-2#1)(1997-8#1)(2005-7#2)(2005-8#1)(2007-9#2)(2008-3#1)(2009-9#1)(2012-11#1)
that relate##21##2##(1993-1#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-8#1)(2005-7#2)(2005-8#1)(2006-1#1)(2007-9#2)(2008-10#1)(2008-3#5)(2009-9#1)(2012-11#1)(2012-12#1)(2012-2#1)
that related to##2##3##(1993-3#1)(2010-1#1)
that related##4##2##(1992-4#1)(1993-3#1)(1996-11#1)(2010-1#1)
that relates the##5##3##(1994-9#1)(2007-11#1)(2008-3#3)
that relates to##4##3##(2008-3#1)(2008-7#1)(2013-1#2)
that relates##15##2##(1990-10#1)(1990-8#1)(1994-9#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-3#5)(2008-7#1)(2013-1#2)
that relationship##6##2##(1992-3#1)(1994-6#1)(2006-8#1)(2008-10#1)(2009-9#1)(2010-2#1)
that relationships##2##2##(1996-9#1)(2012-1#1)
that relative to##3##3##(2006-10#1)(2007-12#1)(2009-4#1)
that relative##9##2##(2006-10#1)(2007-12#1)(2008-10#1)(2008-3#2)(2009-4#1)(2010-2#1)(2011-1#1)(2013-8#1)
that relatively few##3##3##(2006-2#1)(2007-11#1)(2008-10#1)
that relatively large##2##3##(2008-3#2)
that relatively little##2##3##(2006-8#1)(2008-11#1)
that relatively simple##2##3##(1995-2#1)(2007-12#1)
that relatively##16##2##(1991-4#1)(1995-2#1)(1995-5#1)(1997-1#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2013-1#2)
that relaxin##3##2##(2005-7#3)
that release of##8##3##(1991-5#1)(1991-8#1)(1992-3#1)(1992-5#1)(1994-11#2)(1994-12#1)(2008-4#1)
that release##17##2##(1990-2#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-5#1)(1994-11#2)(1994-12#1)(1996-8#1)(1997-1#3)(2008-4#2)(2008-7#1)(2008-8#1)(2013-7#1)
that released##5##2##(1993-6#1)(1995-5#1)(2009-12#1)(2009-4#1)(2013-7#1)
that releases##4##2##(1993-6#1)(1996-4#1)(2009-3#1)(2009-8#1)
that relevant##2##2##(1997-1#1)(2010-12#1)
that reliable results can be obtained##2##6##(2008-10#2)
that reliable##6##2##(1995-6#1)(2007-11#1)(2008-10#3)(2008-4#1)
that relies on##9##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-5#1)(2009-7#1)(2010-1#1)
that relies##11##2##(1996-1#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-5#1)(2009-7#1)(2010-1#1)
that religious##5##2##(1993-12#1)(2008-12#1)(2009-11#1)(2009-8#1)(2013-8#1)
that rely on the##5##4##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)
that rely on##22##3##(1993-4#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-1#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2009-2#1)(2009-8#1)(2009-9#1)(2011-1#1)(2013-1#2)
that rely##26##2##(1993-4#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-1#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2009-2#1)(2009-8#1)(2009-9#1)(2011-1#2)(2012-12#1)(2013-1#2)
that remain in##2##3##(1997-1#1)(2012-2#1)
that remain to be##6##4##(1994-5#1)(1995-4#1)(2008-8#1)(2009-6#1)(2010-7#1)(2012-12#1)
that remain unanswered##2##3##(2012-1#1)(2013-8#1)
that remain##21##2##(1990-8#1)(1991-11#1)(1994-5#1)(1995-4#1)(1997-1#1)(2006-2#1)(2006-5#1)(2007-12#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
that remained##11##2##(1991-2#1)(1995-2#1)(2006-12#1)(2006-8#1)(2007-3#1)(2008-10#2)(2009-5#1)(2010-8#1)(2013-1#1)(2013-8#1)
that remains in##2##3##(2007-12#1)(2008-5#1)
that remains to be elucidated##2##5##(1996-4#1)(2006-11#1)
that remains to be##5##4##(1996-4#1)(2006-11#1)(2008-10#2)(2008-11#1)
that remains##13##2##(1994-6#1)(1996-4#1)(2006-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
that remote##2##2##(2008-10#1)(2008-11#1)
that removal of the##9##4##(1991-1#1)(1991-3#1)(1992-2#1)(1992-3#1)(2006-12#1)(2008-11#1)(2008-12#1)(2008-4#1)(2012-12#1)
that removal of##17##3##(1991-1#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-9#1)(1994-2#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-12#1)
that removal##18##2##(1991-1#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-9#1)(1994-2#1)(1997-6#1)(1997-7#1)(2006-12#2)(2007-5#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-12#1)
that remove##3##2##(2007-12#1)(2008-10#1)(2011-1#1)
that removed the##2##3##(1993-5#1)(1994-8#1)
that removed##4##2##(1991-1#1)(1993-5#1)(1994-8#1)(2005-5#1)
that removes palmitate from##2##4##(1995-3#1)(1996-4#1)
that removes the COOH-terminal tripeptide from##2##6##(1990-2#2)
that removes the##6##3##(1990-2#2)(1995-5#1)(1996-4#1)(1996-8#1)(2008-3#1)
that removes##12##2##(1990-2#2)(1991-9#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-4#2)(1996-8#1)(2006-2#1)(2008-3#1)(2010-2#1)
that renal function##2##3##(1992-8#1)(2012-1#1)
that renal transplantation##2##3##(2008-1#1)(2011-2#1)
that renal##11##2##(1992-7#1)(1992-8#1)(1993-4#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-4#1)(2008-7#1)(2011-2#1)(2012-1#1)
that render them##2##3##(2008-9#1)(2010-7#1)
that render##5##2##(1990-8#1)(1997-3#1)(2008-4#1)(2008-9#1)(2010-7#1)
that rendered##2##2##(1994-3#1)(1996-11#1)
that renders the##3##3##(1997-1#1)(2008-1#1)(2009-7#1)
that renders##5##2##(1994-5#1)(1997-1#1)(2006-3#1)(2008-1#1)(2009-7#1)
that reorientations##2##2##(1994-11#2)
that repair##4##2##(1994-5#2)(2006-3#1)(2008-7#1)
that repeated doses of##2##4##(2004-12#2)
that repeated doses##3##3##(2004-12#3)
that repeated##18##2##(1991-5#1)(1993-12#2)(1993-2#1)(1995-2#1)(1996-10#1)(1996-12#1)(2004-12#3)(2007-11#1)(2007-2#1)(2008-10#2)(2008-7#1)(2010-12#2)(2012-2#1)
that repeatedly##3##2##(2008-10#2)(2008-8#1)
that repetitive##3##2##(1996-1#1)(1997-4#1)(2008-7#1)
that replace the##2##3##(2008-2#1)(2008-3#1)
that replacement of Ser142##2##4##(1995-3#2)
that replacement of the##4##4##(1994-12#1)(1994-9#1)(2007-8#1)(2008-4#1)
that replacement of##9##3##(1994-12#1)(1994-9#3)(1995-11#1)(1995-3#2)(2007-8#1)(2008-4#1)
that replaces the##2##3##(1994-11#1)(2012-2#1)
that replaces##4##2##(1993-12#1)(1994-11#1)(1997-7#1)(2012-2#1)
that replicate the##2##3##(1995-1#1)(2008-3#1)
that replicate##6##2##(1990-5#1)(1994-8#2)(1995-1#1)(1997-2#1)(2008-3#1)
that replicates##2##2##(2008-3#1)(2008-9#1)
that replication of##2##3##(1991-10#1)(2008-10#1)
that replication##3##2##(1991-10#1)(1993-9#1)(2008-10#1)
that replicative##2##2##(1997-3#1)(2007-11#1)
that report##4##2##(1997-8#1)(2008-12#1)(2009-1#1)(2013-8#1)
that reported by##3##3##(1990-7#1)(2008-6#1)(2012-12#1)
that reported for other##5##4##(1990-9#1)(1993-6#1)(2004-11#1)(2007-12#1)(2007-3#1)
that reported for the##6##4##(1991-6#1)(1992-5#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-1#1)
that reported for##22##3##(1990-9#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#3)(1994-3#1)(1995-1#1)(1995-12#1)(1996-12#1)(2004-11#1)(2007-12#1)(2007-3#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-11#1)
that reported from other##3##4##(2007-2#1)(2007-7#1)(2008-1#1)
that reported from##4##3##(1990-12#1)(2007-2#1)(2007-7#1)(2008-1#1)
that reported in other##2##4##(2008-10#1)(2008-6#1)
that reported in the literature##4##5##(1991-2#1)(1991-3#1)(1996-9#1)(2008-1#1)
that reported in the##5##4##(1991-2#1)(1991-3#1)(1996-9#1)(2006-10#1)(2008-1#1)
that reported in##15##3##(1990-12#1)(1991-2#1)(1991-3#1)(1993-5#1)(1994-12#1)(1994-6#1)(1996-9#1)(1997-8#1)(2004-3#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-5#1)(2012-12#1)
that reported previously for##2##4##(2008-10#1)(2008-2#1)
that reported previously##5##3##(1990-2#1)(1991-2#1)(1997-8#1)(2008-10#1)(2008-2#1)
that reported##76##2##(1990-12#2)(1990-2#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-8#2)(2004-11#1)(2004-3#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#1)(2009-2#3)(2009-5#1)(2010-3#1)(2010-8#1)(2011-11#1)(2011-2#1)(2012-12#5)
that represent a##3##3##(2006-11#1)(2008-11#1)(2008-3#1)
that represent an##2##3##(2008-7#1)(2012-2#1)
that represent different##2##3##(2008-9#1)(2009-10#1)
that represent the most##2##4##(1996-2#1)(1997-6#1)
that represent the##13##3##(1995-9#2)(1996-2#1)(1997-6#1)(2006-3#1)(2008-10#2)(2008-2#1)(2008-8#2)(2008-9#1)(2010-10#1)(2010-8#1)
that represent##37##2##(1995-12#1)(1995-3#1)(1995-9#2)(1996-2#1)(1997-6#1)(2006-11#2)(2006-12#1)(2006-3#1)(2007-2#1)(2007-3#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
that representations##2##2##(1992-5#1)(1997-8#1)
that represented the##2##3##(1996-9#1)(2012-1#1)
that represented##6##2##(1996-9#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2012-1#1)
that represents a##2##3##(1995-2#1)(2006-2#1)
that represents an##2##3##(2009-1#1)(2009-3#1)
that represents the probability that the##2##6##(2006-10#2)
that represents the##15##3##(1996-7#1)(2005-11#2)(2006-10#2)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-6#1)(2009-6#1)(2010-5#1)(2013-8#1)
that represents##21##2##(1994-3#1)(1995-2#1)(1996-7#1)(2005-11#2)(2006-10#2)(2006-2#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-2#1)(2008-6#1)(2009-1#1)(2009-3#1)(2009-6#1)(2010-5#1)(2013-8#1)
that represses##4##2##(2008-11#1)(2009-8#3)
that repression of##2##3##(1992-8#1)(2009-8#1)
that reproduce sexually##2##3##(2008-8#2)
that reproduce##5##2##(2007-8#1)(2008-3#1)(2008-8#3)
that reproduces the##2##3##(1995-3#1)(1997-7#1)
that reproduces##4##2##(1995-3#1)(1997-7#1)(2008-10#1)(2008-2#1)
that reproduction occurs##2##3##(2008-9#1)(2011-2#1)
that reproduction##3##2##(2007-6#1)(2008-9#1)(2011-2#1)
that reproductive success##2##3##(2008-8#1)(2008-9#1)
that reproductive##5##2##(1994-3#1)(1996-3#1)(2008-8#2)(2008-9#1)
that require a high##2##4##(2006-10#1)(2011-2#1)
that require a##6##3##(1991-6#1)(2006-10#1)(2007-7#1)(2008-2#1)(2008-4#1)(2011-2#1)
that require an##3##3##(2006-3#1)(2008-2#1)(2010-10#1)
that require immediate##4##3##(1991-5#1)(2008-3#1)(2009-4#1)(2010-2#1)
that require more##4##3##(2006-7#1)(2009-5#1)(2011-1#2)
that require new##2##3##(1996-3#1)(2005-7#1)
that require surgery##2##3##(2008-3#1)(2008-5#1)
that require the##5##3##(1997-4#1)(2006-6#1)(2007-11#1)(2008-12#1)(2008-9#1)
that require##93##2##(1990-2#1)(1990-6#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-6#1)(1994-3#1)(1994-9#1)(1996-3#1)(1997-4#1)(1997-6#1)(2005-7#1)(2006-10#3)(2006-3#2)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#2)(2007-12#3)(2007-5#2)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#5)(2009-12#1)(2009-3#2)(2009-4#3)(2009-5#1)(2010-1#2)(2010-10#1)(2010-2#2)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#6)(2013-8#1)
that required a second##2##4##(1994-9#1)(2007-2#1)
that required a##3##3##(1994-3#1)(1994-9#1)(2007-2#1)
that required for##10##3##(1995-1#1)(1995-3#1)(1996-7#1)(2006-9#1)(2007-12#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
that required the##4##3##(1997-6#1)(2008-6#1)(2011-1#1)(2013-8#1)
that required to##3##3##(1994-6#1)(2008-5#1)(2008-7#1)
that required##55##2##(1990-8#1)(1991-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-9#2)(1996-12#1)(1996-3#1)(1996-7#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-12#1)(2009-2#1)(2009-4#1)(2010-4#1)(2011-1#1)(2012-12#2)(2013-1#4)(2013-8#2)
that requirements for##2##3##(1992-9#1)(2007-8#1)
that requires a##6##3##(1996-4#1)(2005-7#1)(2008-1#1)(2008-10#1)(2011-2#2)
that requires immediate##2##3##(2007-3#1)(2008-9#1)
that requires little##2##3##(1990-5#1)(2005-7#1)
that requires multiple##2##3##(2008-1#1)(2008-3#1)
that requires no##6##3##(1994-3#1)(2007-12#2)(2008-11#1)(2008-2#2)
that requires only##3##3##(1997-6#1)(2005-9#1)(2012-2#1)
that requires the presence of##2##5##(1996-5#1)(2008-4#1)
that requires the##5##3##(1996-10#1)(1996-5#2)(2008-4#1)(2008-7#1)
that requires##64##2##(1990-2#1)(1990-4#1)(1990-5#1)(1991-11#1)(1993-2#2)(1994-12#2)(1994-2#1)(1994-3#1)(1996-10#1)(1996-4#1)(1996-5#2)(1997-6#1)(2004-3#1)(2005-7#2)(2005-9#1)(2006-10#3)(2006-3#1)(2006-8#1)(2007-11#3)(2007-12#3)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-2#4)(2008-3#3)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2011-2#5)(2012-2#2)
that research should be##2##4##(1996-12#1)(2007-2#1)
that research##14##2##(1993-2#1)(1996-11#1)(1996-12#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-2#1)(2008-11#1)(2009-6#1)(2009-8#1)(2011-1#2)(2012-12#1)
that researchers should##2##3##(1997-5#1)(2010-6#1)
that researchers##13##2##(1992-3#1)(1997-5#1)(2004-10#1)(2007-2#1)(2008-3#1)(2008-4#3)(2008-7#1)(2010-6#1)(2012-12#1)(2013-1#2)
that resection##2##2##(1991-4#1)(2007-11#1)
that resemble the##3##3##(1991-5#1)(1992-7#1)(1994-8#1)
that resemble those##3##3##(1991-3#1)(2008-10#1)(2008-4#1)
that resemble##14##2##(1991-3#1)(1991-5#1)(1991-9#1)(1992-7#1)(1994-8#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#3)(2008-8#1)(2012-3#1)
that resembled##6##2##(1990-11#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-5#1)(2011-2#1)
that resembles that##2##3##(1992-3#1)(2007-7#1)
that resembles the##5##3##(1991-4#1)(1995-10#1)(1997-6#1)(2007-12#1)(2008-4#1)
that resembles##13##2##(1991-4#1)(1991-5#1)(1992-3#1)(1992-5#1)(1994-12#1)(1994-3#1)(1995-10#1)(1997-6#1)(2006-6#1)(2007-12#2)(2007-7#1)(2008-4#1)
that reside in the##2##4##(1992-12#1)(1997-4#1)
that reside##6##2##(1992-12#1)(1994-9#1)(1997-4#1)(2011-12#1)(2011-2#1)(2013-1#1)
that residents##3##2##(1995-3#2)(2007-4#1)
that residual##5##2##(2006-12#1)(2008-10#2)(2008-9#1)(2009-9#1)
that residue##3##2##(1993-6#1)(1995-11#1)(1995-5#1)
that residues in##2##3##(1996-5#1)(2008-9#1)
that residues##8##2##(1991-8#1)(1994-8#1)(1994-9#2)(1995-6#1)(1996-5#1)(2008-8#1)(2008-9#1)
that resistance in##4##3##(2008-10#4)
that resistance to these##2##4##(2008-10#2)
that resistance to##14##3##(1991-2#1)(1994-6#1)(1994-8#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-10#7)(2008-11#1)
that resistance##26##2##(1991-2#1)(1994-6#1)(1994-8#1)(2006-10#2)(2007-7#1)(2007-9#1)(2008-10#18)(2008-11#1)
that resistant##2##2##(2006-10#2)
that resisted##3##2##(1995-1#1)(2008-10#1)(2010-7#1)
that resolution##2##2##(2008-10#1)(2008-3#1)
that resolved with##2##3##(1996-9#1)(2008-6#1)
that resolved##8##2##(1996-9#1)(2006-10#1)(2006-8#1)(2007-10#1)(2008-6#1)(2008-9#1)(2012-12#1)(2012-2#1)
that resolves##2##2##(2007-11#1)(2008-2#1)
that resonates##2##2##(2008-2#1)(2012-12#1)
that respect##2##2##(1996-12#1)(2012-12#1)
that respects the##2##3##(1997-5#1)(2007-2#1)
that respects##3##2##(1997-5#1)(2007-2#1)(2008-12#1)
that respiratory##5##2##(1996-12#1)(1996-5#1)(1997-4#1)(2008-7#1)(2013-1#1)
that respond to##13##3##(1990-9#1)(1992-8#1)(1994-12#1)(1997-6#1)(2004-3#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#2)(2011-1#1)(2011-2#1)(2013-8#1)
that respond with##2##3##(1995-12#1)(2012-2#1)
that respond##20##2##(1990-9#1)(1991-6#1)(1992-2#1)(1992-8#1)(1994-12#1)(1995-12#1)(1996-2#1)(1997-6#1)(2004-3#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
that responded specifically to##2##4##(1990-9#1)(2007-12#1)
that responded to the##2##4##(1995-1#1)(1997-8#1)
that responded to##12##3##(1990-7#1)(1992-6#2)(1992-9#1)(1995-1#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-10#1)(2010-6#1)
that responded##16##2##(1990-7#1)(1990-9#1)(1992-6#2)(1992-9#1)(1995-1#1)(1997-8#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-10#1)(2010-6#1)
that respondents##2##2##(2007-12#1)(2009-7#1)
that responds to the##4##4##(1994-9#1)(2008-11#1)(2008-12#1)(2008-9#1)
that responds to##11##3##(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(2007-12#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)
that responds##15##2##(1990-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-9#1)
that response##6##2##(1995-8#1)(1996-12#1)(1997-1#1)(2008-4#1)(2012-1#1)(2013-8#1)
that responses to##3##3##(2004-4#1)(2008-8#1)(2011-2#1)
that responses##5##2##(2004-4#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#1)
that rest##2##2##(2006-7#1)(2013-8#1)
that resting##2##2##(2008-7#1)(2012-2#1)
that restoration of##2##3##(1993-12#1)(1995-8#1)
that restore##4##2##(2006-6#1)(2007-11#1)(2007-12#1)(2008-9#1)
that restored##4##2##(2008-6#1)(2010-7#1)(2011-1#1)(2011-2#1)
that restores##7##2##(1991-3#1)(1995-6#1)(2006-3#1)(2007-9#1)(2008-3#1)(2008-6#1)(2012-12#1)
that restrict the##2##3##(2006-5#1)(2008-5#1)
that restrict##6##2##(1991-5#1)(1992-5#1)(2006-5#1)(2008-5#2)(2008-7#1)
that restricted##2##2##(2007-2#1)(2013-1#1)
that restriction of##4##3##(2005-11#1)(2007-11#1)(2008-10#2)
that restriction##5##2##(2005-11#1)(2007-11#1)(2008-10#2)(2010-12#1)
that result from the##7##4##(1995-11#1)(2007-11#1)(2008-3#2)(2009-8#1)(2012-12#1)(2012-2#1)
that result from these##2##4##(1996-4#1)(2007-12#1)
that result from##30##3##(1990-8#1)(1994-3#1)(1995-11#1)(1995-5#1)(1996-4#1)(2005-11#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#7)(2008-8#3)(2008-9#1)(2009-8#1)(2010-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
that result in a high##2##5##(1991-12#1)(2008-11#1)
that result in a##7##4##(1991-12#1)(1994-12#2)(2006-10#1)(2008-11#1)(2008-8#1)(2009-2#1)
that result in improved##2##4##(1992-3#1)(2008-3#1)
that result in increased##2##4##(1995-2#1)(2008-1#1)
that result in more##2##4##(1994-3#1)(2012-12#1)
that result in the production of##2##6##(2007-8#1)(2008-4#1)
that result in the##7##4##(1990-4#1)(1997-5#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-4#1)
that result in##47##3##(1990-4#1)(1991-12#1)(1992-3#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-2#1)(1997-4#1)(1997-5#1)(2004-11#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-2#2)(2006-9#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#3)(2009-2#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
that result##83##2##(1990-4#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-3#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-3#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-4#1)(1997-4#1)(1997-5#1)(2004-11#1)(2005-10#1)(2005-11#2)(2006-10#2)(2006-2#2)(2006-9#1)(2007-11#1)(2007-12#5)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#9)(2008-4#1)(2008-5#2)(2008-8#6)(2008-9#4)(2009-2#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
that resulted from the##5##4##(1992-2#1)(2006-8#1)(2008-2#2)(2008-3#1)
that resulted from##8##3##(1992-2#1)(2006-8#1)(2008-10#3)(2008-2#2)(2008-3#1)
that resulted in a##7##4##(1991-9#1)(1994-2#1)(2006-10#1)(2007-2#1)(2008-2#1)(2008-3#1)(2008-8#1)
that resulted in an##4##4##(1996-12#1)(2006-12#1)(2008-10#1)(2012-2#1)
that resulted in the##5##4##(1992-2#1)(1995-6#1)(2006-12#1)(2007-4#1)(2013-1#1)
that resulted in##39##3##(1991-9#1)(1992-2#1)(1992-3#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-6#1)(1996-12#1)(1996-7#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-11#1)(2006-12#2)(2007-2#1)(2007-4#2)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#1)
that resulted##50##2##(1991-9#1)(1992-2#3)(1992-3#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-6#1)(1996-12#1)(1996-7#1)(1997-6#1)(1997-7#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-5#1)(2006-8#1)(2007-2#1)(2007-4#2)(2007-7#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#2)(2008-7#1)(2008-8#1)(2009-12#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#1)
that resulting from##3##3##(1990-4#1)(1991-3#1)(1995-12#1)
that results from a##4##4##(2007-1#1)(2007-12#1)(2008-3#2)
that results from the interaction between##2##6##(2006-10#1)(2006-12#1)
that results from the use of a##2##7##(2008-10#2)
that results from the##18##4##(1991-9#1)(1996-12#1)(2006-10#1)(2006-12#1)(2007-11#4)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#3)(2010-9#1)
that results from##39##3##(1990-5#1)(1990-9#1)(1991-9#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-5#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#5)(2007-12#2)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#7)(2008-8#2)(2009-10#1)(2009-11#1)(2010-2#1)(2010-9#2)(2013-1#1)
that results in a##12##4##(1991-5#1)(1992-4#1)(1992-8#1)(1994-5#1)(1995-3#1)(1996-5#1)(2007-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-7#1)
that results in an amino acid##2##6##(1996-6#1)(1997-7#1)
that results in an##4##4##(1991-7#1)(1996-6#1)(1997-7#1)(2008-2#1)
that results in optimal##2##4##(1997-1#1)(2007-4#1)
that results in reduced##2##4##(2007-8#1)(2008-1#1)
that results in the delivery of a drug injection##2##9##(2008-4#1)(2012-3#1)
that results in the##10##4##(1994-12#1)(1996-5#1)(2005-9#1)(2006-12#1)(2007-8#1)(2008-4#1)(2009-12#1)(2012-3#1)(2013-1#2)
that results in##64##3##(1991-5#1)(1991-7#1)(1991-8#1)(1992-4#1)(1992-8#1)(1994-12#2)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-12#3)(2007-4#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
that results of##3##3##(1997-8#1)(2006-2#1)(2012-2#1)
that results##115##2##(1990-5#1)(1990-9#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-4#1)(1992-8#1)(1994-12#2)(1994-5#1)(1995-12#2)(1995-2#2)(1995-3#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#3)(1996-6#1)(1997-1#1)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-12#2)(2006-2#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#5)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#4)(2008-12#1)(2008-2#4)(2008-3#12)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-9#2)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
that resveratrol is##2##3##(2008-5#1)(2009-12#1)
that resveratrol##3##2##(2008-5#2)(2009-12#1)
that retain their##2##3##(1995-8#1)(2008-1#1)
that retain##13##2##(1991-11#1)(1995-8#1)(1996-11#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-1#1)(2012-11#1)
that retained the##3##3##(1990-9#1)(1995-3#1)(2007-11#1)
that retained##7##2##(1990-9#1)(1994-11#1)(1995-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2012-2#1)
that retains the##4##3##(1992-11#1)(2007-12#1)(2008-2#1)(2008-5#1)
that retains##5##2##(1992-11#1)(2006-11#1)(2007-12#1)(2008-2#1)(2008-5#1)
that retention##2##2##(2008-11#1)(2008-5#1)
that retinal##2##2##(1995-1#1)(1997-3#1)
that retinoic acid##4##3##(1991-1#1)(1992-8#1)(1993-3#1)(2006-10#1)
that retinoic##5##2##(1991-1#1)(1992-8#1)(1993-3#1)(1996-5#1)(2006-10#1)
that retinoids may play##2##4##(1993-12#1)(2006-10#1)
that retinoids##5##2##(1991-9#1)(1993-12#1)(1995-9#1)(2006-10#1)(2008-4#1)
that retinol##2##2##(2008-5#2)
that retinol-binding protein##2##3##(1995-6#2)
that retrieved##2##2##(2008-2#1)(2008-3#1)
that retrieves##2##2##(1990-6#1)(2008-3#1)
that retroviral##3##2##(1990-11#1)(1994-12#1)(2012-12#1)
that reveal the##2##3##(2008-3#1)(2011-1#1)
that reveal##8##2##(2007-12#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#2)(2012-3#1)
that revealed a##2##3##(2010-12#1)(2013-8#1)
that revealed the##5##3##(1996-9#1)(2007-12#1)(2008-6#1)(2009-4#1)(2012-2#1)
that revealed##13##2##(1990-5#1)(1996-12#1)(1996-9#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-6#1)(2009-4#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
that reveals the##2##3##(1995-10#1)(2008-9#1)
that reveals##4##2##(1995-10#1)(2008-11#1)(2008-4#1)(2008-9#1)
that reverse##3##2##(1996-11#1)(2007-11#1)(2007-8#1)
that reversible##3##2##(1990-2#1)(1992-12#1)(2008-3#1)
that reward##2##2##(2008-4#1)(2009-2#1)
that rhabdomyolysis##2##2##(2011-2#1)(2013-8#1)
that rhizosphere priming may##2##4##(2013-8#2)
that rho##3##2##(1992-12#1)(1992-5#1)(1994-11#1)
that rib fractures in##2##4##(2006-11#2)
that ribosome##2##2##(1995-3#1)(2013-1#1)
that rice##5##2##(2008-10#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-2#1)
that right##3##2##(1997-1#1)(2006-12#1)(2007-10#1)
that rigidity##2##2##(2008-12#1)(2009-7#1)
that riluzole##2##2##(2008-7#1)(2011-12#1)
that ring##2##2##(1995-10#1)(2008-10#1)
that rising##4##2##(1991-3#1)(1995-8#1)(1996-9#1)(2009-10#1)
that risk factors##3##3##(2007-8#1)(2009-4#1)(2013-1#1)
that risk##15##2##(1993-1#1)(1994-6#1)(1997-1#1)(2006-10#1)(2007-8#2)(2008-3#1)(2008-7#2)(2009-10#1)(2009-12#1)(2009-4#1)(2011-2#1)(2012-11#1)(2013-1#1)
that rituximab##2##2##(2008-3#1)(2010-12#1)
that rivals##2##2##(2006-10#1)(2012-2#1)
that robotic##4##2##(2007-5#1)(2012-1#2)(2013-1#1)
that robotics##2##2##(2007-8#1)(2013-1#1)
that robust##2##2##(2007-12#2)
that rodent##2##2##(1991-2#1)(2010-6#1)
that role models##2##3##(2009-7#2)
that role##10##2##(1991-1#1)(1993-2#1)(1994-1#1)(1994-3#1)(1997-1#1)(1997-3#1)(2009-4#1)(2009-7#2)(2012-1#1)
that root colonization##2##3##(2008-10#2)
that root##6##2##(2008-10#5)(2009-10#1)
that roots##2##2##(2009-8#2)
that rotates##2##2##(2008-2#1)(2008-3#1)
that rotation##2##2##(2007-11#1)(2007-8#1)
that round and##3##3##(1997-4#2)(2011-2#1)
that routine##11##2##(1990-2#1)(1990-8#1)(1992-8#1)(1993-1#1)(1997-8#1)(2006-10#1)(2007-1#1)(2007-3#1)(2007-7#1)(2008-10#1)(2013-8#1)
that routinely##4##2##(2007-8#1)(2008-9#1)(2013-1#2)
that rpGH##2##2##(2008-9#2)
that rps14 is##2##3##(1996-6#2)
that rumination is##2##3##(2008-8#1)(2009-11#1)
that run on##2##3##(2007-9#1)(2008-3#1)
that run##6##2##(2007-12#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-2#1)
that runs##6##2##(1994-11#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-6#1)(2012-2#1)
that rupintrivir##2##2##(2008-10#2)
that rupture##2##2##(1990-4#1)(1996-4#1)
that rural##2##2##(1996-3#1)(2007-7#1)
that s##2##2##(1991-9#1)(2007-11#1)
that safer##2##2##(2007-3#1)(2008-11#1)
that saline##2##2##(2012-11#2)
that salivary glands##2##3##(1994-7#1)(2008-4#1)
that salivary##6##2##(1991-1#1)(1994-7#1)(2008-4#2)(2013-1#2)
that salt##6##2##(1996-8#1)(2007-7#1)(2008-9#1)(2009-6#2)(2013-1#1)
that same##3##2##(2005-10#1)(2008-5#1)(2008-9#1)
that sample##10##2##(1993-9#1)(2005-11#1)(2008-10#4)(2010-2#1)(2010-4#1)(2013-1#1)(2013-8#1)
that samples##3##2##(1991-3#1)(2008-10#1)(2008-6#1)
that sampling##6##2##(1994-12#1)(2005-11#1)(2008-10#1)(2010-6#1)(2012-2#1)(2013-1#1)
that sanguinarine##3##2##(2006-10#1)(2011-2#2)
that satisfaction with##2##3##(2007-6#1)(2008-9#1)
that satisfaction##4##2##(1994-2#1)(1995-1#1)(2007-6#1)(2008-9#1)
that satisfactory##3##2##(1996-12#1)(2006-9#1)(2008-10#1)
that satisfies the##4##3##(2008-2#2)(2008-3#2)
that satisfies##8##2##(2008-2#2)(2008-3#3)(2008-7#2)(2009-12#1)
that satisfy the##5##3##(1994-12#1)(1996-4#1)(2005-9#1)(2008-2#1)(2008-3#1)
that satisfy##8##2##(1994-12#1)(1995-10#1)(1996-4#1)(2005-9#1)(2008-2#1)(2008-3#2)(2008-6#1)
that saturation##2##2##(2008-1#1)(2008-3#1)
that scale##2##2##(2008-10#1)(2009-2#1)
that scaling relations##2##3##(2008-8#2)
that scaling##3##2##(2008-1#1)(2008-8#2)
that scatter light##2##3##(2008-2#1)(2008-3#1)
that scattered##2##2##(2008-10#1)(2008-3#1)
that scattering##4##2##(2008-2#2)(2008-3#2)
that scatters##2##2##(2008-2#1)(2008-3#1)
that schizoaffective##2##2##(1997-8#2)
that schizophrenia is characterised by an executive dysfunction##2##8##(2006-3#2)
that schizophrenia is##4##3##(1997-8#2)(2006-3#2)
that schizophrenia##5##2##(1997-8#2)(2006-3#2)(2006-4#1)
that schizophrenic patients##4##3##(1996-1#1)(1997-8#2)(2013-1#1)
that schizophrenic##6##2##(1996-1#1)(1997-8#4)(2013-1#1)
that schizophrenics##2##2##(1997-8#1)(2006-3#1)
that schizophyllan##2##2##(2006-12#2)
that school##5##2##(1992-2#1)(2008-12#1)(2009-9#1)(2012-2#2)
that schools of##3##3##(1996-1#1)(2008-11#1)(2010-8#1)
that science##2##2##(2008-5#1)(2009-4#1)
that scientific advisers##2##3##(2008-5#2)
that scientific##9##2##(2007-9#2)(2008-5#2)(2009-3#1)(2009-4#2)(2012-2#2)
that scientists##2##2##(2007-9#1)(2010-12#1)
that scores##2##2##(1990-9#1)(2008-11#1)
that screening for##2##3##(1991-10#1)(1992-5#1)
that screening is##4##3##(1991-6#1)(1992-2#1)(2012-12#2)
that screening##10##2##(1991-10#1)(1991-6#1)(1992-2#1)(1992-5#1)(1993-3#1)(1993-9#1)(1994-6#1)(2011-1#1)(2012-12#2)
that seafarers##2##2##(2011-2#2)
that searches##2##2##(2008-3#1)(2008-8#1)
that season##3##2##(2007-4#1)(2008-5#1)(2012-2#1)
that seasonal variations##2##3##(1992-7#1)(2009-4#1)
that seasonal##5##2##(1992-7#1)(1993-6#1)(2009-4#1)(2013-1#1)(2013-7#1)
that seasonality##2##2##(1995-1#1)(1996-3#1)
that second##3##2##(1991-4#1)(1996-5#1)(2007-12#1)
that secondary spread##2##3##(2008-10#2)
that secondary##7##2##(1991-9#1)(1994-9#1)(1995-8#1)(2006-10#1)(2008-10#2)(2008-3#1)
that secrete##4##2##(1995-10#1)(2007-12#1)(2008-10#1)(2011-2#1)
that secreted##2##2##(1990-12#1)(2012-3#1)
that secretion of##3##3##(1992-6#1)(1996-6#1)(2008-10#1)
that secretion##5##2##(1992-6#1)(1996-6#1)(1997-3#1)(2008-10#1)(2009-8#1)
that secretory##3##2##(1990-12#1)(1990-3#1)(2009-8#1)
that section##2##2##(1993-9#1)(1995-2#1)
that secure##2##2##(2009-8#1)(2012-1#1)
that sedentary##3##2##(1993-11#1)(2008-3#2)
that seeds##2##2##(2008-10#1)(2012-9#1)
that seek to improve##2##4##(2008-3#1)(2010-11#1)
that seek to##5##3##(1996-12#1)(2008-3#1)(2008-7#2)(2010-11#1)
that seek##6##2##(1996-12#1)(2008-3#1)(2008-7#2)(2010-11#1)(2011-2#1)
that seeks to##3##3##(1996-7#1)(2008-11#1)(2008-2#1)
that seem to be##5##4##(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-6#1)
that seem to##8##3##(1996-3#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-12#1)
that seem##10##2##(1993-11#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-12#1)
that seemed to##3##3##(2008-1#1)(2008-9#1)(2010-8#1)
that seemed##4##2##(2008-1#1)(2008-9#1)(2009-7#1)(2010-8#1)
that seems to be##2##4##(1992-3#1)(2008-11#1)
that seems to##6##3##(1992-12#1)(1992-3#1)(1996-6#1)(2007-3#1)(2008-11#1)(2013-1#1)
that seems##9##2##(1992-12#1)(1992-3#1)(1994-8#1)(1996-6#1)(2006-7#1)(2007-3#1)(2007-8#1)(2008-11#1)(2013-1#1)
that seen after##3##3##(1994-3#1)(1995-12#2)
that seen for##4##3##(1990-4#1)(1991-10#1)(1994-12#1)(2013-1#1)
that seen in control##2##4##(1993-11#1)(1995-5#1)
that seen in other##3##4##(1996-4#1)(2006-10#1)(2008-10#1)
that seen in the##8##4##(1992-8#1)(1994-8#1)(1995-1#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-11#1)(2012-2#1)
that seen in##26##3##(1992-10#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-11#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-5#2)(1996-4#1)(1996-5#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
that seen with the##3##4##(1995-10#1)(1996-11#1)(2007-11#1)
that seen with##12##3##(1990-5#1)(1992-2#1)(1992-4#1)(1993-8#2)(1995-1#1)(1995-10#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-3#1)(2007-11#1)
that seen##50##2##(1990-4#1)(1990-5#2)(1991-10#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-8#2)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#2)(1995-10#1)(1995-12#2)(1995-5#3)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#2)(1996-6#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
that segregated for##3##3##(2008-10#2)(2012-3#1)
that segregated##5##2##(2008-10#4)(2012-3#1)
that segregates the##2##3##(2009-10#1)(2012-2#1)
that segregates##4##2##(1997-1#1)(2008-2#1)(2009-10#1)(2012-2#1)
that segregation of##2##3##(2006-2#1)(2008-10#1)
that segregation##3##2##(1996-6#1)(2006-2#1)(2008-10#1)
that seismic##2##2##(2008-2#1)(2009-6#1)
that select##4##2##(2009-3#1)(2012-12#2)(2012-2#1)
that selected##4##2##(1991-12#1)(1992-2#1)(1992-4#1)(2007-8#1)
that selecting an##2##3##(2008-10#1)(2008-9#1)
that selecting##6##2##(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-2#1)
that selection at##2##3##(2012-3#1)(2013-1#1)
that selection for##5##3##(1996-1#1)(2008-10#3)(2008-9#1)
that selection of##3##3##(1995-8#1)(2006-3#1)(2008-10#1)
that selection##23##2##(1995-8#2)(1996-1#1)(1997-1#1)(1997-7#1)(2004-1#1)(2006-3#1)(2007-9#1)(2008-10#6)(2008-8#3)(2008-9#2)(2010-8#1)(2012-3#1)(2013-1#2)
that selective##16##2##(1991-5#1)(1992-1#1)(1993-12#1)(1996-1#1)(1996-10#1)(1997-1#1)(1997-7#1)(1997-8#1)(2008-1#2)(2008-10#2)(2008-9#1)(2010-1#1)(2010-12#1)(2012-1#1)
that selectively modulate##2##3##(2006-11#1)(2007-11#1)
that selectively##27##2##(1993-7#1)(1994-3#1)(1994-9#1)(1995-11#1)(1996-3#1)(1996-5#2)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-11#1)(2007-11#2)(2008-2#1)(2008-4#1)(2009-11#1)(2009-12#1)(2009-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#1)
that selects the##2##3##(2008-1#1)(2008-3#1)
that selects##4##2##(1996-4#1)(2008-1#1)(2008-3#1)(2009-8#1)
that selenium##4##2##(1992-11#1)(2008-6#3)
that self monitoring##2##3##(1997-3#2)
that self-assemble to form##2##4##(1991-11#1)(2007-8#1)
that self-regulation##2##2##(2007-4#1)(2012-3#1)
that self-replication is##2##3##(1993-2#2)
that sense##5##2##(1995-8#1)(2009-8#1)(2012-1#2)(2012-2#1)
that senses##3##2##(1995-8#1)(2007-11#1)(2010-10#1)
that sensitive##2##2##(1994-6#1)(2008-10#1)
that sensitively##3##2##(2008-2#1)(2008-3#1)(2009-7#1)
that sensitivity to Ptr##2##4##(2008-10#2)
that sensitivity to##4##3##(1990-12#1)(2008-10#2)(2008-11#1)
that sensitivity##5##2##(1990-12#1)(2008-10#2)(2008-11#1)(2012-1#1)
that sensory neurons##3##3##(2007-12#2)(2008-4#1)
that sensory##11##2##(1992-6#1)(1995-11#1)(1996-3#1)(2007-12#2)(2008-11#1)(2008-4#1)(2012-12#1)(2012-2#1)(2013-8#2)
that separate the##2##3##(2008-3#1)(2008-4#1)
that separate##8##2##(1993-12#1)(1995-1#1)(2007-11#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-8#1)
that separated the##2##3##(2008-9#1)(2011-2#1)
that separated##6##2##(2006-3#1)(2008-10#1)(2008-9#2)(2011-2#1)(2012-1#1)
that separates the##2##3##(2005-11#1)(2008-3#1)
that separates##4##2##(2005-11#1)(2007-7#1)(2008-3#1)(2011-2#1)
that separation##4##2##(1991-4#1)(2005-11#1)(2008-10#2)
that sequence##5##2##(1990-10#1)(1991-10#1)(1995-2#1)(1996-6#1)(2008-5#1)
that sequences flanking##2##3##(1995-2#1)(1996-4#1)
that sequences in the##2##4##(1992-12#1)(1993-5#1)
that sequences##13##2##(1990-6#1)(1992-12#2)(1993-5#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-2#1)(2008-10#1)
that sequential##3##2##(1996-2#1)(2007-5#1)(2008-7#1)
that sequesters##2##2##(1991-9#1)(2008-11#1)
that sequestration of##3##3##(1992-2#1)(1994-8#1)(1996-3#1)
that serial##3##2##(1990-1#1)(2008-2#1)(2011-2#1)
that serine##2##2##(1994-11#1)(1995-1#1)
that serious##3##2##(2007-1#1)(2008-10#1)(2013-8#1)
that serotonin plays##2##3##(1993-3#1)(2008-5#1)
that serotonin##7##2##(1990-12#1)(1992-8#1)(1993-3#1)(1995-12#1)(2007-8#1)(2008-5#1)(2010-12#1)
that serotonin3##2##2##(1996-2#1)(1996-8#1)
that serum laminin P1##2##4##(1996-8#2)
that serum levels##2##3##(1997-5#1)(2006-2#1)
that serum starvation of##2##4##(2008-9#2)
that serum##28##2##(1990-10#1)(1990-11#1)(1990-3#1)(1995-10#1)(1995-2#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-5#1)(2005-12#1)(2006-2#2)(2006-6#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#3)(2011-12#1)(2011-2#1)(2012-5#1)(2013-1#1)(2013-8#1)
that serve as##8##3##(1992-6#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-2#1)(2010-10#1)(2012-12#1)(2012-2#1)
that serve both##2##3##(2007-11#1)(2009-10#1)
that serve to##5##3##(1995-12#1)(1996-7#1)(1997-3#1)(2007-12#1)(2008-7#1)
that serve##16##2##(1992-6#1)(1995-12#1)(1996-7#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-7#2)(2009-10#1)(2010-10#1)(2012-12#1)(2012-2#1)
that served as a##5##4##(2008-1#1)(2013-1#4)
that served as##9##3##(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2013-1#4)
that serves as a##7##4##(1993-12#1)(1994-9#1)(2008-1#1)(2008-7#1)(2009-10#1)(2012-2#2)
that serves as an##3##4##(1991-5#1)(2008-4#1)(2009-9#1)
that serves as the##2##4##(2008-3#2)
that serves as##13##3##(1991-5#1)(1993-12#1)(1994-9#1)(2008-1#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-2#1)(2012-2#2)
that serves the##2##3##(1991-3#1)(2010-5#1)
that serves##17##2##(1991-3#1)(1991-5#1)(1993-12#1)(1994-9#1)(2008-1#2)(2008-3#2)(2008-4#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-2#1)(2010-5#1)(2012-2#2)(2012-3#1)
that service industries are##2##4##(1995-1#1)(2009-8#1)
that service##6##2##(1994-2#1)(1995-1#1)(2005-5#1)(2008-11#1)(2008-8#1)(2009-8#1)
that services##2##2##(1991-12#1)(1996-3#1)
that sesamin##2##2##(2009-10#2)
that set the##2##3##(2010-1#1)(2010-2#1)
that sets##3##2##(1991-10#1)(2010-4#1)(2010-7#1)
that setting##2##2##(1992-11#1)(1993-12#1)
that settlers win space by winning fights##2##7##(2008-9#2)
that seven of##2##3##(1993-5#1)(2008-3#1)
that seven##5##2##(1993-5#1)(1995-5#1)(2008-3#1)(2010-12#1)(2010-7#1)
that several aspects##2##3##(1994-5#1)(2008-1#1)
that several different##3##3##(1997-7#1)(2008-10#1)(2012-12#1)
that several of##3##3##(1991-9#1)(2008-10#1)(2010-12#1)
that several##82##2##(1990-4#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-5#1)(1993-8#1)(1994-10#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-7#3)(2006-12#1)(2007-2#3)(2008-1#2)(2008-10#5)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-8#4)(2009-9#1)(2010-12#2)(2010-2#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
that severe##7##2##(1992-10#1)(1996-12#1)(2006-5#1)(2007-2#1)(2008-10#1)(2008-7#1)(2012-1#1)
that severely##2##2##(1996-2#1)(2007-11#1)
that severity of##2##3##(1993-3#1)(2011-2#1)
that severity##3##2##(1993-3#1)(2008-10#1)(2011-2#1)
that sex ratio##2##3##(2008-8#2)
that sex##12##2##(1991-12#1)(1995-11#1)(1997-7#1)(2007-1#1)(2008-11#1)(2008-5#2)(2008-8#2)(2008-9#1)(2012-3#2)
that sexual and##2##3##(2009-4#1)(2012-3#1)
that sexual recombination is##2##4##(2008-10#2)
that sexual recombination may##2##4##(2008-10#2)
that sexual recombination##7##3##(2008-10#7)
that sexual reproduction##3##3##(2008-10#3)
that sexual selection is##2##4##(1995-2#1)(2006-5#1)
that sexual selection##3##3##(1995-2#1)(2006-5#1)(2008-8#1)
that sexual##21##2##(1991-3#1)(1991-8#1)(1993-9#1)(1994-6#1)(1995-2#1)(2006-5#1)(2008-10#10)(2008-8#2)(2009-4#1)(2012-3#1)(2013-1#1)
that sexually active##2##3##(2009-7#1)(2012-2#1)
that sexually##4##2##(1990-3#1)(2006-10#1)(2009-7#1)(2012-2#1)
that sgcD##2##2##(2008-9#2)
that shape the##9##3##(2007-12#1)(2007-2#1)(2008-1#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-8#1)
that shape##22##2##(1993-4#1)(2004-9#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
that shaped##3##2##(2006-5#1)(2008-12#1)(2009-10#1)
that share a##5##3##(1991-7#1)(2006-12#1)(2007-12#1)(2008-8#1)(2009-10#1)
that share common##3##3##(2011-2#1)(2012-3#1)(2013-8#1)
that share similar##2##3##(1992-11#1)(2007-4#1)
that share the same##2##4##(2008-2#1)(2012-3#1)
that share the##4##3##(1993-9#1)(2008-1#1)(2008-2#1)(2012-3#1)
that share##27##2##(1991-12#2)(1991-7#1)(1992-11#1)(1993-9#1)(1995-11#1)(2006-12#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-8#1)
that shared##5##2##(1990-7#1)(1992-3#1)(1994-9#1)(2008-5#1)(2012-1#1)
that shares sequence similarity##2##4##(1995-3#1)(1996-9#1)
that shares sequence##4##3##(1993-9#1)(1995-3#1)(1996-9#1)(1997-4#1)
that shares##14##2##(1992-7#1)(1993-12#1)(1993-9#2)(1994-3#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-9#1)(1997-4#1)(1997-7#1)(2008-10#2)(2010-3#1)
that shaving##2##2##(2008-5#2)
that she did not##3##4##(1996-11#1)(1996-6#1)(2008-1#1)
that she had##9##3##(1992-6#1)(1993-7#2)(2005-11#1)(2006-10#1)(2011-12#1)(2011-2#2)(2012-2#1)
that she has##3##3##(2004-1#1)(2013-1#2)
that she is##2##3##(2007-7#1)(2012-11#1)
that she was##3##3##(1995-12#1)(1996-5#1)(2007-12#1)
that she##31##2##(1992-6#1)(1992-9#1)(1993-7#2)(1994-11#1)(1994-4#1)(1995-12#2)(1995-6#1)(1996-11#2)(1996-12#1)(1996-5#1)(1996-6#2)(2004-1#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-7#1)(2008-1#1)(2011-12#2)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#3)
that shed light on the##3##5##(2008-4#1)(2010-12#1)(2010-7#1)
that shed##5##2##(2006-12#1)(2007-8#1)(2008-4#1)(2010-12#1)(2010-7#1)
that sheds light on##2##4##(2006-10#1)(2008-4#1)
that sheds##3##2##(2006-10#1)(2008-4#1)(2008-8#1)
that shields##2##2##(2006-7#1)(2007-11#1)
that shifting the##3##3##(1991-9#1)(2007-12#1)(2008-8#1)
that shifting##4##2##(1991-9#1)(2007-12#1)(2008-2#1)(2008-8#1)
that shifts in##2##3##(2009-10#1)(2012-2#1)
that shifts##5##2##(2006-4#1)(2009-10#1)(2012-2#1)(2013-1#2)
that short DNA##3##3##(2008-11#2)(2009-6#1)
that short##11##2##(1994-9#1)(1995-6#1)(2007-9#1)(2008-11#2)(2009-6#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#2)
that short-chain##2##2##(1992-6#1)(2008-5#1)
that short-term##11##2##(1990-6#1)(1995-11#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-8#1)(2012-3#1)
that shortening fractions in the##2##5##(1997-1#2)
that shorter##3##2##(1993-4#1)(2008-11#1)(2008-8#1)
that should be addressed in##2##5##(2010-2#1)(2013-1#1)
that should be addressed##8##4##(2007-12#2)(2007-4#1)(2010-2#1)(2012-2#2)(2013-1#2)
that should be considered by##2##5##(1994-1#1)(2007-12#1)
that should be considered for##2##5##(1992-5#1)(2008-10#1)
that should be considered in the differential diagnosis of##2##9##(2008-7#1)(2011-2#1)
that should be considered in the##5##6##(2007-10#1)(2008-7#1)(2010-9#1)(2011-2#1)(2013-1#1)
that should be considered in##8##5##(1991-8#1)(1992-12#1)(2007-10#1)(2008-7#1)(2008-8#1)(2010-9#1)(2011-2#1)(2013-1#1)
that should be considered when##4##5##(1995-1#1)(2007-6#1)(2008-10#1)(2012-12#1)
that should be considered##22##4##(1991-8#1)(1992-12#1)(1992-5#1)(1994-1#1)(1995-1#1)(1997-4#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-9#1)(2011-2#2)(2012-12#3)(2013-1#1)
that should be differentiated from##2##5##(2006-3#1)(2011-2#1)
that should be followed##2##4##(1997-6#1)(2008-9#1)
that should be handled in##2##5##(1991-4#2)
that should be performed##4##4##(2008-4#2)(2010-9#2)
that should be readily##2##4##(2008-3#1)(2010-11#1)
that should be taken into account##3##6##(1992-3#1)(2009-8#1)(2012-11#1)
that should be taken into consideration when##2##7##(1994-4#1)(2010-8#1)
that should be taken into consideration##3##6##(1994-4#1)(2008-7#1)(2010-8#1)
that should be taken into##6##5##(1992-3#1)(1994-4#1)(2008-7#1)(2009-8#1)(2010-8#1)(2012-11#1)
that should be used##2##4##(2008-4#2)
that should be useful##2##4##(2008-10#1)(2008-8#1)
that should be##80##3##(1991-4#2)(1991-8#1)(1992-12#2)(1992-3#1)(1992-5#1)(1994-1#1)(1994-4#1)(1995-1#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#2)(2006-3#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-12#4)(2007-2#1)(2007-4#1)(2007-6#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#4)(2008-7#4)(2008-8#2)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-8#1)(2010-9#5)(2011-1#1)(2011-2#5)(2012-11#1)(2012-12#3)(2012-2#4)(2013-1#3)
that should enhance##2##3##(1991-9#1)(2008-8#1)
that should not be##4##4##(2006-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
that should not##5##3##(2006-10#1)(2008-8#1)(2009-10#1)(2011-2#1)(2013-1#1)
that should prove##2##3##(1995-1#1)(2007-12#1)
that should##107##2##(1991-4#2)(1991-8#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-5#1)(1994-1#1)(1994-4#1)(1995-1#2)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#2)(2006-10#1)(2006-3#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-4#1)(2007-6#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-8#1)(2010-9#5)(2011-1#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#4)(2013-1#7)
that show a##11##3##(1994-12#1)(1996-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-3#1)(2013-1#1)
that show different##2##3##(2008-12#1)(2008-9#1)
that show high##2##3##(1991-6#1)(2008-1#1)
that show how##5##3##(2006-4#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-8#1)
that show no##2##3##(1993-11#1)(2013-1#1)
that show promise##2##3##(2008-2#1)(2010-10#1)
that show significant differences##3##4##(2006-11#1)(2013-1#2)
that show that the##3##4##(1994-5#1)(2007-12#2)
that show that##10##3##(1994-5#1)(2007-12#3)(2008-2#2)(2008-3#2)(2008-4#1)(2012-1#1)
that show the##11##3##(1990-8#1)(1993-11#1)(1994-9#1)(1995-6#1)(2008-10#1)(2008-2#3)(2008-3#1)(2009-12#1)(2009-4#1)
that show##78##2##(1990-8#1)(1991-10#1)(1991-6#1)(1991-9#1)(1993-11#2)(1994-12#1)(1994-5#1)(1994-9#1)(1995-6#1)(1996-8#1)(1997-1#1)(1997-5#1)(2006-11#2)(2006-4#1)(2006-9#1)(2007-11#3)(2007-12#6)(2007-2#1)(2008-1#2)(2008-10#5)(2008-12#1)(2008-2#10)(2008-3#7)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-12#2)(2009-4#1)(2010-10#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#4)
that showed a significant##2##4##(2006-8#1)(2013-8#1)
that showed a##11##3##(1994-11#1)(1994-8#1)(1995-2#1)(2006-8#1)(2006-9#1)(2007-12#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-8#1)
that showed high##2##3##(2008-10#1)(2013-8#1)
that showed no##2##3##(2008-10#1)(2008-3#1)
that showed significant##2##3##(1995-8#1)(2008-10#1)
that showed that##5##3##(1993-3#1)(1994-11#1)(2008-10#1)(2008-3#1)(2011-2#1)
that showed the##6##3##(2007-12#1)(2008-10#2)(2008-5#1)(2012-12#1)(2012-2#1)
that showed##63##2##(1990-8#1)(1990-9#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-3#1)(1994-11#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-7#1)(1997-4#1)(2005-11#1)(2006-10#4)(2006-8#1)(2006-9#1)(2007-12#3)(2007-2#1)(2007-8#1)(2008-10#8)(2008-3#2)(2008-5#4)(2008-7#3)(2008-8#2)(2009-5#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
that shown by##4##3##(1991-6#1)(1993-2#1)(1995-5#1)(2006-11#1)
that shown##5##2##(1991-6#1)(1993-2#1)(1995-5#1)(2006-11#1)(2008-10#1)
that shows a##8##3##(1992-2#1)(1992-6#1)(1994-5#1)(1994-9#1)(1995-8#1)(1997-3#1)(2005-7#1)(2010-6#1)
that shows good##2##3##(2008-2#1)(2008-3#1)
that shows high##2##3##(2008-2#1)(2008-3#1)
that shows how##2##3##(2008-2#1)(2008-7#1)
that shows increased##2##3##(1994-3#1)(2007-12#1)
that shows that##6##3##(1994-3#1)(1994-5#1)(2005-11#1)(2007-11#1)(2008-3#1)(2008-5#1)
that shows the##4##3##(1997-1#1)(2007-12#1)(2008-2#1)(2008-3#1)
that shows##43##2##(1992-2#1)(1992-6#1)(1994-3#2)(1994-5#2)(1994-9#1)(1995-6#2)(1995-8#2)(1997-1#2)(1997-3#1)(2005-11#2)(2005-7#2)(2005-8#1)(2006-12#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-6#1)(2012-12#1)
that side##4##2##(2008-10#1)(2008-2#1)(2009-6#1)(2012-12#1)
that sigma##4##2##(1991-7#1)(1993-12#1)(1994-3#1)(1996-3#1)
that sigma-1 receptors##2##3##(2008-3#2)
that sigma-1##3##2##(2008-3#3)
that sigma1 receptors##3##3##(1995-12#2)(1996-12#1)
that signal peptide##2##3##(1991-9#1)(1997-8#1)
that signal the##2##3##(2008-10#1)(2010-12#1)
that signal transduction##2##3##(1995-8#1)(2010-5#1)
that signal##13##2##(1991-9#1)(1995-8#1)(1997-8#1)(2008-10#2)(2008-3#3)(2008-8#1)(2010-12#1)(2010-5#1)(2012-12#1)(2013-8#1)
that signaling by##2##3##(1992-2#1)(2008-4#1)
that signaling##7##2##(1992-2#1)(1994-3#1)(1996-5#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#1)
that signals from##2##3##(2008-12#1)(2012-12#1)
that signals##5##2##(2007-8#1)(2008-10#1)(2008-12#1)(2008-9#1)(2012-12#1)
that significant improvements in##2##4##(1996-2#1)(2007-11#1)
that significant##26##2##(1990-3#1)(1990-6#1)(1993-3#1)(1994-2#1)(1995-12#1)(1996-2#1)(1997-2#2)(1997-4#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#2)(2010-5#1)(2011-2#1)(2013-8#1)
that significantly affect the##2##4##(1995-5#1)(2009-8#1)
that significantly higher##2##3##(2007-12#1)(2013-8#1)
that significantly increase##2##3##(2006-12#1)(2007-11#1)
that significantly increases the##2##4##(2007-11#1)(2008-2#1)
that significantly more##3##3##(2006-8#1)(2008-10#1)(2011-12#1)
that significantly##28##2##(1990-7#1)(1992-2#1)(1995-5#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-8#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#1)
that signs of##3##3##(1997-7#1)(2008-5#1)(2012-1#1)
that silicon##2##2##(2008-10#1)(2012-2#1)
that silver##2##2##(1997-8#1)(2013-7#1)
that sim is##2##3##(1991-12#2)
that sim##4##2##(1991-12#4)
that similar to##2##3##(1996-9#1)(2009-4#1)
that similar##15##2##(1991-8#1)(1994-12#1)(1994-2#1)(1995-10#1)(1995-11#1)(1995-8#2)(1996-9#1)(1997-7#1)(2006-6#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-4#1)(2012-2#1)
that simple##14##2##(1991-4#1)(1993-9#1)(1994-3#1)(1995-5#1)(1996-6#1)(1997-6#1)(2006-12#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2012-2#1)
that simply##2##2##(2008-8#1)(2011-1#1)
that simulate##6##2##(1991-11#1)(1991-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-1#1)
that simulated##3##2##(2008-2#1)(2008-3#1)(2012-1#1)
that simulates a##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
that simulates the##9##3##(1994-6#1)(2007-3#1)(2007-4#1)(2008-10#4)(2008-2#1)(2009-10#1)
that simulates##14##2##(1994-6#1)(2007-3#1)(2007-4#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-8#1)(2009-10#1)(2011-2#1)
that simulation##2##2##(2006-10#1)(2008-11#1)
that simultaneous determination##2##3##(2008-10#2)
that simultaneous second-harmonic generation##2##4##(2007-12#2)
that simultaneous##12##2##(1994-11#1)(2007-12#3)(2007-2#1)(2008-10#3)(2008-2#1)(2008-3#3)
that simultaneously detects##2##3##(2008-2#1)(2012-3#1)
that simultaneously##16##2##(1990-11#1)(1991-7#1)(1994-2#1)(2007-10#1)(2007-12#1)(2008-2#2)(2008-3#2)(2008-7#1)(2010-8#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
that since the##2##3##(1996-11#1)(2008-10#1)
that since##6##2##(1990-12#1)(1993-7#1)(1996-11#1)(2008-10#2)(2009-12#1)
that single##21##2##(1990-9#1)(1992-12#1)(1992-7#1)(1993-1#1)(1994-8#1)(1996-12#1)(1996-4#1)(1997-2#1)(2006-12#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-7#1)(2012-1#2)
that single-stranded##2##2##(1995-6#1)(2008-10#1)
that site##7##2##(1995-2#1)(1995-5#1)(1996-5#1)(2007-5#1)(2008-3#1)(2008-5#1)(2008-8#1)
that sites##2##2##(2008-10#1)(2012-3#1)
that six of##4##3##(1991-8#1)(1997-4#1)(2006-9#1)(2008-11#1)
that six##10##2##(1991-8#1)(1993-12#1)(1994-10#1)(1994-9#1)(1997-4#1)(2006-9#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-7#1)
that size##4##2##(1997-5#1)(2007-11#1)(2008-10#1)(2008-11#1)
that skin##11##2##(1992-7#1)(1994-9#1)(2007-7#1)(2008-5#8)
that sleep##9##2##(1991-1#1)(1996-1#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-1#2)(2008-12#1)(2013-1#1)
that slightly##3##2##(1991-7#1)(2007-4#1)(2013-1#1)
that slime##2##2##(1991-3#1)(2006-10#1)
that slow the progression of##2##5##(2009-11#1)(2011-2#1)
that slow the##3##3##(2009-11#1)(2009-5#1)(2011-2#1)
that slow##6##2##(1996-3#1)(2008-1#1)(2008-10#1)(2009-11#1)(2009-5#1)(2011-2#1)
that slowly##2##2##(2005-11#1)(2008-10#1)
that small RNAs##2##3##(2008-1#1)(2009-3#1)
that small amounts##2##3##(1996-5#1)(2005-10#1)
that small and##2##3##(2008-4#1)(2008-9#1)
that small changes in##2##4##(2005-11#1)(2006-12#1)
that small molecules##2##3##(1993-3#1)(2008-9#1)
that small peptides##2##3##(2007-1#1)(2008-10#1)
that small##31##2##(1990-7#1)(1990-8#1)(1991-1#1)(1991-7#1)(1993-3#1)(1993-7#1)(1994-11#1)(1995-11#2)(1996-5#1)(1996-9#1)(2005-10#1)(2005-11#1)(2006-12#1)(2007-1#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#3)(2009-3#1)(2009-7#1)(2011-1#2)(2013-1#1)
that smokers##3##2##(2010-2#1)(2010-3#1)(2011-2#1)
that smoking cessation##4##3##(2010-2#1)(2010-4#2)(2012-3#1)
that smoking is##3##3##(2010-9#1)(2011-2#1)(2013-1#1)
that smoking related##2##3##(1997-7#1)(2006-8#1)
that smoking##15##2##(1997-7#1)(2004-10#1)(2005-10#1)(2006-10#1)(2006-7#1)(2006-8#1)(2008-8#1)(2010-2#1)(2010-4#2)(2010-9#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
that smooth muscle##2##3##(1995-2#1)(1997-7#1)
that snail##2##2##(2011-1#1)(2012-3#1)
that snow##2##2##(2008-10#2)
that so far##2##3##(2007-12#1)(2011-2#1)
that so##3##2##(1996-12#1)(2007-12#1)(2011-2#1)
that so-called##2##2##(1994-5#1)(2010-12#1)
that social and##2##3##(2006-2#1)(2011-2#1)
that social factors##2##3##(2008-11#1)(2011-2#1)
that social##23##2##(1994-12#1)(2006-2#1)(2006-4#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)
that society##4##2##(1992-8#1)(1996-1#1)(2004-12#1)(2009-2#1)
that sodium fluoride##2##3##(1993-11#1)(1995-12#1)
that sodium##12##2##(1990-2#1)(1992-3#1)(1992-9#1)(1993-11#1)(1995-12#1)(1996-12#1)(2005-4#1)(2006-10#1)(2008-10#2)(2008-11#1)(2011-1#1)
that soft##3##2##(2004-9#1)(2010-8#1)(2013-1#1)
that soil##7##2##(2006-3#1)(2008-10#3)(2008-5#1)(2012-2#1)(2013-8#1)
that soils are a substantial source of##2##7##(2008-11#2)
that soils##4##2##(2004-2#1)(2008-11#3)
that solar##2##2##(2007-9#1)(2008-3#1)
that solid##5##2##(1995-4#1)(1996-1#1)(2008-10#1)(2008-7#1)(2013-1#1)
that soliton##2##2##(2007-12#2)
that soluble##8##2##(1990-2#1)(1992-4#1)(1994-8#2)(2004-4#1)(2008-1#1)(2008-10#2)
that solution##3##2##(2006-10#1)(2008-10#1)(2008-3#1)
that solutions##3##2##(1994-6#1)(2008-2#1)(2008-6#1)
that solvent##3##2##(1990-8#1)(1996-2#1)(2008-4#1)
that somatic##2##2##(1990-11#1)(2007-12#1)
that somatostatin##2##2##(1997-4#2)
that somatropin##2##2##(2007-11#2)
that some bacterial##2##3##(2008-12#1)(2009-5#1)
that some cases##4##3##(1996-9#1)(2006-12#1)(2008-4#1)(2008-8#1)
that some components of##3##4##(1995-1#1)(2006-12#1)(2008-10#1)
that some components##4##3##(1995-1#1)(2006-12#1)(2008-10#2)
that some important##2##3##(2005-11#1)(2008-8#1)
that some individuals##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
that some kind of##2##4##(1997-3#1)(2008-12#1)
that some neurons in the##2##5##(1990-7#1)(2009-10#1)
that some neurons in##3##4##(1990-7#1)(1996-9#1)(2009-10#1)
that some of the##28##4##(1991-9#1)(1992-9#1)(1993-7#2)(1994-10#1)(1995-1#1)(1995-8#1)(1996-5#1)(1996-6#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-6#1)(2008-10#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-6#1)(2012-1#1)(2013-1#1)
that some of them##2##4##(1996-4#1)(2007-11#1)
that some of these##10##4##(1996-3#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-8#1)(2010-4#1)(2012-2#1)
that some of##41##3##(1990-2#1)(1991-9#1)(1992-9#1)(1993-7#2)(1994-10#1)(1995-1#1)(1995-8#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-11#3)(2007-6#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-6#1)(2009-8#1)(2010-4#1)(2012-1#1)(2012-2#1)(2013-1#1)
that some other##2##3##(1992-2#1)(2008-11#1)
that some patients##2##3##(2008-7#2)
that some species of##2##4##(2008-11#1)(2008-8#1)
that some species##3##3##(1990-7#1)(2008-11#1)(2008-8#1)
that some##245##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-7#3)(1990-8#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#2)(1992-10#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-6#2)(1993-7#2)(1994-10#1)(1994-2#4)(1995-1#4)(1995-11#2)(1995-12#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-4#5)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#3)(1997-2#1)(1997-3#3)(1997-4#1)(1997-8#1)(1997-9#1)(2005-10#1)(2005-11#5)(2005-7#1)(2006-10#4)(2006-12#5)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-6#1)(2007-8#1)(2007-9#6)(2008-1#1)(2008-10#22)(2008-11#4)(2008-12#5)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#10)(2008-8#7)(2008-9#8)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#2)(2009-9#2)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-1#4)(2012-11#2)(2012-12#4)(2012-2#7)(2012-3#3)(2013-1#4)(2013-8#4)
that someone##2##2##(1996-3#1)(2005-9#1)
that something had to be done##2##6##(1991-1#1)(2007-2#1)
that something##4##2##(1991-1#1)(2007-2#1)(2007-9#1)(2011-2#1)
that sometimes##4##2##(1991-6#1)(2006-12#1)(2006-2#1)(2007-8#1)
that sorting##2##2##(1997-6#1)(2008-8#1)
that sorts##2##2##(1990-6#1)(2007-12#1)
that sought to##6##3##(2005-12#1)(2007-8#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#1)
that sought##7##2##(2005-12#1)(2006-10#1)(2007-8#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#1)
that soybean##2##2##(2012-11#1)(2012-2#1)
that span the##5##3##(2007-9#1)(2008-10#1)(2008-4#1)(2008-8#1)(2012-3#1)
that span##20##2##(1991-2#1)(1991-5#1)(1992-11#1)(1992-5#1)(1993-6#1)(1994-11#1)(1996-10#1)(1997-4#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
that spans the##3##3##(1991-5#1)(2008-12#1)(2008-5#1)
that spans##5##2##(1991-2#1)(1991-5#1)(2007-12#1)(2008-12#1)(2008-5#1)
that spared##2##2##(2008-4#1)(2009-8#1)
that spatial memory##2##3##(1995-11#1)(2008-7#1)
that spatial redistribution##2##3##(2008-8#2)
that spatial resolution##2##3##(2008-2#1)(2008-8#1)
that spatial variation in##2##4##(2008-8#2)
that spatial##23##2##(1995-11#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-7#1)(2008-8#9)(2009-12#1)(2009-5#1)(2009-8#2)(2009-9#1)
that spatiotemporal##2##2##(2007-11#1)(2008-8#1)
that special##4##2##(1995-2#1)(2007-11#1)(2012-1#1)(2012-2#1)
that specialized##3##2##(1990-6#1)(2008-9#1)(2011-2#1)
that specially##2##2##(1993-2#1)(1995-3#1)
that speciation##3##2##(2006-5#1)(2013-1#2)
that species richness##4##3##(2007-5#1)(2008-8#3)
that species were##2##3##(2008-12#2)
that species##22##2##(1990-6#1)(1994-12#1)(2006-12#1)(2007-5#1)(2008-10#2)(2008-12#3)(2008-8#6)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2012-3#2)(2012-6#1)
that species-specific##2##2##(2008-9#1)(2011-12#1)
that specific and##3##3##(1994-6#1)(1995-12#1)(2008-8#1)
that specific binding of##2##4##(1990-3#1)(2008-9#1)
that specific binding##4##3##(1990-2#1)(1990-3#1)(1992-8#1)(2008-9#1)
that specific patterns of##2##4##(1997-8#1)(2009-4#1)
that specific therapy##2##3##(2006-7#1)(2011-12#1)
that specific##63##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#2)(1991-10#1)(1991-12#1)(1992-12#1)(1992-3#2)(1992-8#2)(1993-9#3)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#1)(1996-11#1)(1996-5#1)(1997-1#1)(1997-4#2)(1997-6#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#2)(2009-4#2)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
that specifically affect##3##3##(1996-5#1)(2006-12#1)(2008-7#1)
that specifically and##2##3##(1996-11#1)(2007-1#1)
that specifically bind to the##3##5##(1994-9#1)(2008-7#1)(2012-12#1)
that specifically bind to##4##4##(1992-8#1)(1994-9#1)(2008-7#1)(2012-12#1)
that specifically bind##7##3##(1992-8#1)(1994-9#1)(1996-8#1)(1997-1#1)(2008-1#1)(2008-7#1)(2012-12#1)
that specifically binds to##4##4##(1990-2#2)(1995-1#1)(2008-11#1)
that specifically binds##10##3##(1990-2#2)(1991-3#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-1#1)(2008-11#1)
that specifically cleaves the##2##4##(1992-3#1)(1997-1#1)
that specifically inhibit##2##3##(2008-8#1)(2009-12#1)
that specifically recognize##3##3##(1992-8#1)(1995-2#1)(1996-5#1)
that specifically recognized##3##3##(1990-5#1)(1995-6#1)(2005-12#1)
that specifically recognizes##2##3##(1994-8#1)(1995-5#1)
that specifically target the##3##4##(2008-4#1)(2010-2#1)(2010-4#1)
that specifically target##5##3##(2008-1#1)(2008-4#1)(2010-2#1)(2010-4#1)(2010-6#1)
that specifically##65##2##(1990-11#1)(1990-2#2)(1990-5#1)(1991-2#1)(1991-3#1)(1992-3#1)(1992-8#3)(1993-12#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-11#1)(1996-5#2)(1996-8#1)(1997-1#3)(1997-2#1)(2004-11#1)(2005-12#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#2)(2008-7#3)(2008-8#2)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2012-12#1)(2012-2#2)
that specificity##2##2##(1994-2#1)(2012-2#1)
that specifies##9##2##(1990-11#1)(1997-7#1)(2005-8#1)(2007-3#1)(2008-10#1)(2009-12#1)(2009-9#1)(2012-12#2)
that specify the##2##3##(1997-1#1)(2007-12#1)
that specify##8##2##(1995-1#1)(1997-1#1)(2006-5#1)(2007-12#2)(2008-2#1)(2009-3#1)(2012-12#1)
that specimens##3##2##(2008-10#2)(2008-5#1)
that spectral##8##2##(2007-12#2)(2008-10#2)(2008-2#2)(2009-4#1)(2009-9#1)
that speech##2##2##(2008-9#1)(2013-8#1)
that sperm are##2##3##(2007-12#1)(2008-8#1)
that sperm##13##2##(1990-10#1)(1990-11#1)(1990-2#1)(1992-5#1)(2006-5#1)(2007-12#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
that spermine##2##2##(1994-11#1)(2008-8#1)
that spherical aberration##2##3##(2008-2#1)(2009-4#1)
that spheroids##2##2##(2012-12#2)
that sphingosine is##2##3##(1992-11#1)(1992-6#1)
that sphingosine##3##2##(1990-10#1)(1992-11#1)(1992-6#1)
that spin##2##2##(2010-7#1)(2012-2#1)
that spinal##6##2##(1991-2#1)(1997-8#1)(2006-11#1)(2008-4#2)(2013-1#1)
that spirituality is##3##3##(2008-12#1)(2013-1#2)
that spirituality##7##2##(2008-12#1)(2008-4#4)(2013-1#2)
that spirometry is##2##3##(2006-5#2)
that spirometry##3##2##(2006-5#3)
that splenectomized patients run increased risk of##2##7##(1990-9#1)(1994-9#1)
that splenic##3##2##(2006-8#1)(2008-11#2)
that splicing of##2##3##(1993-5#1)(1996-4#1)
that splicing##3##2##(1993-5#1)(1996-4#1)(1996-7#1)
that splits##2##2##(2007-5#1)(2008-3#1)
that spontaneous recovery##2##3##(1997-2#1)(2006-2#1)
that spontaneous##11##2##(1990-5#1)(1991-7#1)(1996-11#1)(1997-2#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-4#1)(2009-3#1)
that spontaneously##2##2##(2008-4#1)(2009-7#1)
that sporadic##3##2##(1991-10#1)(2007-8#1)(2010-12#1)
that spore##2##2##(2008-10#2)
that spores of##3##3##(2008-10#2)(2008-8#1)
that spores##4##2##(2008-10#3)(2008-8#1)
that spreading##2##2##(1991-8#1)(2005-11#1)
that spreads##2##2##(2008-11#1)(2009-8#1)
that spurious##2##2##(1996-11#1)(2008-3#1)
that stabilization of the##2##4##(1990-8#1)(2006-8#1)
that stabilization of##4##3##(1990-8#1)(1991-5#1)(2006-8#1)(2008-8#1)
that stabilization##6##2##(1990-8#1)(1991-5#1)(2006-12#1)(2006-8#1)(2008-3#1)(2008-8#1)
that stabilize the##3##3##(1990-9#1)(2006-12#1)(2007-8#1)
that stabilize##7##2##(1990-9#1)(1991-6#1)(1991-8#1)(1995-8#1)(2005-8#1)(2006-12#1)(2007-8#1)
that stabilized##2##2##(1995-1#1)(2005-11#1)
that stabilizes##3##2##(2005-11#1)(2008-4#1)(2010-11#1)
that stable##7##2##(1992-2#1)(2007-12#1)(2008-10#2)(2011-2#1)(2012-1#1)(2013-8#1)
that stably##2##2##(1991-7#1)(1994-8#1)
that staff##7##2##(2004-8#1)(2005-5#1)(2007-11#1)(2007-3#1)(2010-10#1)(2011-2#1)(2012-12#1)
that stage##3##2##(1996-11#1)(2007-12#1)(2010-2#1)
that stained positive for##2##4##(2008-4#2)
that stained##7##2##(1993-4#1)(1996-10#1)(2005-11#1)(2008-10#2)(2008-4#2)
that staining##2##2##(1995-8#1)(1996-12#1)
that standard##14##2##(1995-3#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)
that standards##3##2##(1992-3#1)(2008-12#1)(2008-5#1)
that standing##2##2##(2004-2#1)(2008-6#1)
that starch##3##2##(2005-11#1)(2008-6#1)(2009-8#1)
that started in##2##3##(2011-2#1)(2013-7#1)
that started##5##2##(2007-9#1)(2008-2#1)(2011-1#1)(2011-2#1)(2013-7#1)
that starts with##2##3##(2007-11#1)(2010-10#1)
that state##7##2##(1992-2#1)(1995-3#1)(1995-6#1)(2008-11#2)(2008-3#1)(2010-2#1)
that states##2##2##(1994-2#1)(2011-2#1)
that static##3##2##(2007-12#1)(2008-10#1)(2008-9#1)
that statins##2##2##(2008-1#1)(2010-10#1)
that statistical##4##2##(1992-4#1)(1996-4#1)(1997-7#1)(2008-9#1)
that staurosporine##3##2##(1990-12#1)(1993-6#1)(1995-12#1)
that steady-state levels of##2##4##(1995-12#1)(2006-9#1)
that steady-state##3##2##(1994-9#1)(1995-12#1)(2006-9#1)
that stem cells##3##3##(2007-8#1)(2008-10#1)(2011-2#1)
that stem from##2##3##(2008-3#1)(2010-2#1)
that stem##6##2##(2007-8#1)(2008-10#1)(2008-3#1)(2010-2#1)(2011-2#1)(2012-12#1)
that step##2##2##(1992-2#1)(1997-5#1)
that steps##2##2##(1995-1#1)(1996-1#1)
that stereotactic##3##2##(2006-7#1)(2007-12#1)(2008-7#1)
that stereotypies##2##2##(2008-11#2)
that steroid hormones##2##3##(1995-2#1)(2005-8#1)
that steroid##5##2##(1994-6#1)(1995-2#1)(2005-8#1)(2008-1#1)(2012-12#1)
that steroids##3##2##(2006-10#1)(2007-8#1)(2011-2#1)
that sterol##2##2##(1991-10#1)(1993-3#1)
that still need to be addressed##2##6##(1993-3#1)(2007-12#1)
that still need to be##4##5##(1993-3#1)(2007-12#1)(2008-7#1)(2009-12#1)
that still##11##2##(1993-3#1)(1995-8#1)(1997-1#1)(2007-12#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-12#1)(2013-8#1)
that stimulate the##4##3##(2007-8#1)(2008-5#1)(2008-7#1)(2011-2#1)
that stimulate##23##2##(1990-11#1)(1992-2#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-6#1)(1996-7#1)(1997-2#1)(1997-7#1)(2004-12#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-7#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
that stimulated by##2##3##(1991-3#1)(1991-7#1)
that stimulated##7##2##(1991-3#1)(1991-7#1)(2007-11#2)(2008-11#1)(2008-2#1)(2009-10#1)
that stimulates expression##2##3##(1994-9#1)(2011-2#1)
that stimulates the##4##3##(1991-12#1)(1992-11#1)(1992-6#1)(1994-8#1)
that stimulates##14##2##(1990-7#1)(1991-12#1)(1992-11#2)(1992-3#1)(1992-6#1)(1994-8#1)(1994-9#1)(1996-10#1)(1997-4#1)(1997-7#1)(2009-8#1)(2010-10#1)(2011-2#1)
that stimulation of DNA synthesis##2##5##(1990-8#1)(1997-7#1)
that stimulation of the##4##4##(1994-9#1)(1996-2#1)(1997-6#1)(1997-7#1)
that stimulation of##22##3##(1990-11#1)(1990-8#1)(1990-9#1)(1991-5#1)(1991-6#1)(1994-2#1)(1994-9#2)(1995-11#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-5#3)(1997-2#1)(1997-6#1)(1997-7#2)(2010-12#1)(2012-1#1)(2013-1#1)
that stimulation##24##2##(1990-11#1)(1990-8#1)(1990-9#1)(1991-5#1)(1991-6#1)(1994-11#1)(1994-2#1)(1994-9#2)(1995-11#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-5#3)(1997-2#1)(1997-6#1)(1997-7#2)(2006-3#1)(2010-12#1)(2012-1#1)(2013-1#1)
that stimulus##2##2##(1996-7#1)(2007-9#1)
that stochastic##3##2##(2007-12#1)(2008-2#1)(2011-1#1)
that stoichiometric##2##2##(1991-5#1)(2008-10#1)
that stopped##2##2##(1997-2#1)(2012-12#1)
that storage##2##2##(1995-11#1)(2008-10#1)
that store##2##2##(1990-11#1)(2013-7#1)
that stored##3##2##(1995-11#1)(1996-8#1)(2008-9#1)
that stores##2##2##(2008-2#1)(2008-3#1)
that storytelling##2##2##(2008-11#1)(2008-12#1)
that strain DCY55(T)##4##3##(2012-2#4)
that strain##10##2##(2006-8#2)(2008-10#3)(2008-7#1)(2012-2#4)
that strains of X##2##4##(2008-10#2)
that strategies##5##2##(2008-11#1)(2009-7#1)(2010-4#1)(2012-2#1)(2012-3#1)
that streptokinase##2##2##(1995-6#1)(2008-8#1)
that stress can##3##3##(1993-11#1)(1996-10#1)(2008-11#1)
that stress the##2##3##(1994-2#1)(2007-7#1)
that stress##18##2##(1993-11#1)(1994-11#2)(1994-2#1)(1995-12#1)(1996-10#1)(1996-6#1)(2004-12#1)(2004-9#1)(2007-7#1)(2008-11#2)(2008-7#2)(2009-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
that stress-induced VEGF##2##3##(1995-1#2)
that stress-induced##3##2##(1990-11#1)(1995-1#2)
that stressful##2##2##(2008-2#1)(2011-2#1)
that stretch##2##2##(2008-1#1)(2012-1#1)
that striatal##4##2##(1995-5#1)(1997-1#1)(2007-11#1)(2008-11#1)
that strict##2##2##(2009-9#1)(2010-9#1)
that strictly##2##2##(2008-10#1)(2012-12#1)
that strike##2##2##(2006-2#1)(2012-3#1)
that stroke could be##2##4##(2007-9#2)
that stroke##5##2##(2007-10#1)(2007-9#4)
that stromal cells##2##3##(1993-9#1)(2009-4#1)
that stromal##3##2##(1993-9#1)(2009-4#1)(2013-1#1)
that strong##13##2##(1996-12#1)(1996-4#1)(1997-4#1)(2006-10#1)(2007-12#2)(2008-10#2)(2008-3#2)(2008-8#1)(2009-8#1)(2012-2#1)
that strongly##9##2##(1994-6#1)(1995-11#1)(1995-3#1)(2005-11#1)(2006-12#1)(2008-10#2)(2008-9#1)(2012-12#1)
that strontium ranelate##2##3##(2013-1#2)
that strontium##3##2##(2004-9#1)(2013-1#2)
that structural changes##3##3##(1992-7#1)(1996-8#1)(2009-8#1)
that structural differences##3##3##(1993-12#1)(2008-5#1)(2008-7#1)
that structural##14##2##(1992-7#1)(1993-12#1)(1994-9#1)(1995-8#1)(1996-8#1)(2005-11#2)(2006-12#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-8#1)
that structurally different##2##3##(2009-12#2)
that structurally##3##2##(2009-12#3)
that structure##3##2##(2007-12#2)(2008-4#1)
that structured##3##2##(2008-11#1)(2012-2#1)(2013-8#1)
that structures##2##2##(2006-4#1)(2008-11#1)
that student nurses##2##3##(2008-11#2)
that students are##4##3##(2007-8#1)(2008-11#2)(2008-12#1)
that students can##2##3##(1996-12#1)(2012-1#1)
that students have##3##3##(2008-11#1)(2010-3#1)(2012-12#1)
that students##23##2##(1993-3#1)(1996-1#1)(1996-12#1)(2005-10#1)(2007-8#1)(2008-11#6)(2008-12#4)(2009-7#1)(2010-3#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#2)
that students' attitudes##2##3##(2007-3#1)(2008-4#1)
that students'##8##2##(2007-3#1)(2008-11#1)(2008-12#2)(2008-4#1)(2010-3#2)(2013-1#1)
that studied##2##2##(2008-10#1)(2012-2#1)
that studies of##2##3##(2008-11#2)
that studies##9##2##(2007-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)
that study##12##2##(1991-7#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-8#1)(2008-11#1)(2008-2#1)(2010-12#1)(2010-4#1)(2013-1#2)
that studying##2##2##(2008-1#1)(2010-12#1)
that subacute PCP may produce##2##5##(1996-10#2)
that subacute##4##2##(1995-12#1)(1996-10#2)(2007-11#1)
that subchronic##3##2##(1995-3#1)(1996-10#2)
that subcultured isolates##2##3##(2008-10#2)
that subcutaneous##2##2##(1990-11#1)(2008-11#1)
that subjective##3##2##(1995-11#1)(2007-12#1)(2009-7#1)
that subjects with##5##3##(1992-8#1)(2008-10#1)(2010-5#1)(2011-1#1)(2012-2#1)
that subjects##13##2##(1991-2#1)(1992-8#1)(1994-2#1)(1995-5#1)(1995-6#1)(2008-10#2)(2010-5#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-2#1)
that subpopulations of##3##3##(1996-3#1)(1997-3#1)(1997-4#1)
that subpopulations##5##2##(1996-3#1)(1997-3#1)(1997-4#1)(2008-10#2)
that subsequent to the##2##4##(1990-5#1)(1994-8#1)
that subsequent##6##2##(1990-5#1)(1994-8#1)(2008-11#1)(2008-4#1)(2009-10#1)(2010-2#1)
that subsequently##10##2##(1990-11#1)(1990-9#1)(1995-1#1)(2005-9#1)(2007-6#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-8#1)(2012-1#1)
that substance P##3##3##(1990-2#1)(1992-3#1)(1993-11#1)
that substantial##8##2##(1993-3#1)(1994-12#1)(1996-3#1)(1996-9#1)(2007-12#1)(2008-1#1)(2008-2#1)(2010-12#1)
that substantially##5##2##(2007-11#1)(2007-12#1)(2007-9#1)(2008-2#2)
that substituent##2##2##(1991-4#1)(2010-11#1)
that substitute##2##2##(1997-2#1)(2010-10#1)
that substituted##3##2##(1991-5#1)(1996-2#1)(1997-6#1)
that substitutes##2##2##(1994-12#1)(2012-2#1)
that substitution of##5##3##(1990-2#1)(1994-2#1)(1994-9#1)(1996-8#1)(2006-12#1)
that substitution##6##2##(1990-2#1)(1990-7#1)(1994-2#1)(1994-9#1)(1996-8#1)(2006-12#1)
that substitutions of##2##3##(1993-3#1)(1996-7#1)
that substitutions##3##2##(1992-6#1)(1993-3#1)(1996-7#1)
that substrate##4##2##(1991-9#1)(1992-5#1)(1995-10#1)(1997-2#1)
that subtelomeres##2##2##(2009-10#2)
that subtle changes##2##3##(1995-6#1)(2012-1#1)
that subtle differences##2##3##(2008-10#1)(2012-2#1)
that subtle##9##2##(1991-11#1)(1993-3#1)(1994-2#1)(1995-6#1)(1996-7#1)(2006-9#1)(2008-10#1)(2012-1#1)(2012-2#1)
that subtotal hysterectomy##2##3##(2004-10#2)
that subunit##3##2##(1991-3#1)(1994-9#1)(1995-11#1)
that success in##2##3##(1993-3#1)(2007-2#1)
that successful##13##2##(1993-1#1)(1995-12#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2010-6#1)(2012-1#1)
that successfully##3##2##(2008-11#1)(2008-2#2)
that such a correlation##2##4##(2008-12#1)(2012-2#1)
that such a method##2##4##(1997-6#1)(2007-9#1)
that such a##32##3##(1992-12#1)(1992-3#1)(1993-3#1)(1994-8#1)(1995-12#2)(1997-6#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-5#1)(2012-12#1)(2012-2#1)
that such activities##2##3##(1996-11#1)(2011-1#1)
that such an approach has##2##5##(2010-12#1)(2012-2#1)
that such an approach##5##4##(1995-2#1)(2010-12#1)(2012-2#1)(2013-1#2)
that such an##11##3##(1991-5#1)(1995-2#1)(1997-5#1)(2006-8#1)(2007-9#1)(2008-3#1)(2009-10#1)(2010-12#1)(2012-2#1)(2013-1#2)
that such approaches##2##3##(2006-5#1)(2008-7#1)
that such cells are##2##4##(1995-1#1)(1995-2#1)
that such differences##2##3##(1995-12#1)(1997-2#1)
that such effects##3##3##(1991-8#1)(2006-12#1)(2012-2#1)
that such estimates##2##3##(1992-3#1)(1994-5#1)
that such experience##2##3##(1992-12#1)(2008-11#1)
that such interactions##3##3##(1995-6#1)(2007-12#1)(2008-1#1)
that such interventions##2##3##(2006-4#1)(2010-5#1)
that such patients##5##3##(2007-10#1)(2007-12#1)(2009-7#1)(2009-9#1)(2010-12#1)
that such therapy##3##3##(2005-10#1)(2005-8#1)(2011-12#1)
that such##174##2##(1990-11#1)(1990-3#1)(1990-7#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#3)(1991-8#1)(1992-12#2)(1992-3#2)(1993-12#1)(1993-3#3)(1994-10#1)(1994-3#2)(1994-5#2)(1994-8#1)(1995-1#2)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(2005-10#2)(2005-11#2)(2005-7#1)(2005-8#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-4#2)(2006-5#1)(2006-7#3)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#12)(2007-4#2)(2007-8#1)(2007-9#4)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#2)(2008-2#5)(2008-3#10)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#3)(2009-10#3)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-9#2)(2010-12#3)(2010-2#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#5)(2013-1#8)(2013-8#1)
that suddenly##2##2##(1996-1#1)(2008-2#1)
that suffer from##2##3##(2007-4#1)(2009-8#1)
that suffered##2##2##(2007-8#1)(2008-5#1)
that suffering##3##2##(2007-8#1)(2008-5#1)(2011-2#1)
that sufficient##11##2##(1993-5#1)(1993-6#1)(1994-2#1)(1994-9#1)(1996-2#1)(2006-9#2)(2008-10#1)(2008-9#1)(2009-5#1)(2012-1#1)
that suggest a##2##3##(2008-11#1)(2009-10#1)
that suggest an##2##3##(2010-11#1)(2013-1#1)
that suggest that##10##3##(1992-1#1)(1996-7#1)(2006-7#1)(2007-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-11#1)
that suggest the##5##3##(1993-7#1)(1995-12#1)(2008-11#1)(2008-3#1)(2008-7#1)
that suggest##28##2##(1992-1#1)(1993-7#1)(1995-12#1)(1995-4#1)(1995-8#1)(1996-7#1)(2006-10#1)(2006-7#2)(2007-11#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#3)(2009-10#1)(2009-8#1)(2010-11#1)(2010-2#2)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
that suggested by the##2##4##(1997-3#1)(2004-12#1)
that suggested by##4##3##(1992-6#1)(1997-3#1)(2004-12#1)(2005-11#1)
that suggested the##2##3##(2006-6#1)(2010-2#1)
that suggested##11##2##(1990-4#1)(1992-6#1)(1997-1#1)(1997-3#1)(2004-12#1)(2005-11#1)(2006-6#1)(2008-10#1)(2009-9#1)(2010-2#1)(2013-1#1)
that suggests a##3##3##(1993-12#1)(2006-12#1)(2007-9#1)
that suggests that##5##3##(1995-4#1)(1995-6#1)(2008-4#1)(2008-5#1)(2013-1#1)
that suggests##14##2##(1993-12#1)(1994-11#1)(1995-11#1)(1995-4#1)(1995-6#1)(2005-8#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-4#1)(2008-5#1)(2009-4#1)(2012-12#1)(2013-1#1)
that suits##2##2##(2008-2#1)(2011-2#1)
that summarize##3##2##(2007-12#1)(2013-1#2)
that summarizes##4##2##(1996-3#1)(2008-10#1)(2008-2#1)(2010-9#1)
that summer##2##2##(2007-1#1)(2008-10#1)
that superior##2##2##(2008-2#1)(2009-5#1)
that superoxide anion##2##3##(1994-2#1)(1995-8#1)
that superoxide##4##2##(1994-2#1)(1995-8#1)(2005-8#1)(2008-5#1)
that supervised##2##2##(1995-3#1)(2009-7#1)
that suplatast##2##2##(1996-12#1)(2008-1#1)
that supplemental##2##2##(2006-5#1)(2012-2#1)
that supplementary##2##2##(2007-11#1)(2010-2#1)
that supplementation of##2##3##(1995-6#1)(2013-7#1)
that supplementation##3##2##(1995-6#1)(2008-12#1)(2013-7#1)
that supplies##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
that supply the##2##3##(2007-12#1)(2008-7#1)
that supply##10##2##(1995-3#1)(2007-12#3)(2007-8#1)(2008-7#1)(2008-9#1)(2010-2#1)(2012-12#2)
that support a##4##3##(2007-11#1)(2010-11#1)(2011-12#1)(2013-1#1)
that support and organise cells into coherent tissues##2##8##(2012-11#2)
that support and##4##3##(1996-2#1)(2008-6#1)(2012-11#2)
that support for##2##3##(2007-4#1)(2008-10#1)
that support the##9##3##(1991-6#1)(1992-1#1)(1996-2#1)(2006-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2011-12#1)(2013-7#1)
that support this##2##3##(2006-12#1)(2008-1#1)
that support##53##2##(1991-6#1)(1992-1#1)(1992-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1996-2#2)(1996-3#1)(2004-10#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-6#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-12#2)(2012-1#1)(2012-11#3)(2012-12#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
that supported a##2##3##(2007-8#1)(2010-12#1)
that supported##5##2##(1993-6#1)(1996-3#1)(2007-11#1)(2007-8#1)(2010-12#1)
that supportive##2##2##(2010-1#1)(2013-8#1)
that supports the use of##3##5##(2008-10#1)(2008-3#1)(2009-10#1)
that supports the##9##3##(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#1)(2012-12#1)
that supports their##2##3##(2006-2#1)(2009-3#1)
that supports##26##2##(1992-12#1)(1994-3#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-3#2)(2012-1#1)(2012-12#1)(2013-1#1)
that suppress fire blight##2##4##(2008-10#2)
that suppress the##4##3##(1994-12#1)(2006-7#1)(2008-10#1)(2008-12#1)
that suppress##13##2##(1990-8#1)(1992-12#1)(1994-12#1)(2006-7#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
that suppresses the##3##3##(1995-12#1)(2008-10#1)(2008-3#1)
that suppresses##6##2##(1995-12#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-3#1)
that suppression of##8##3##(1991-4#1)(1992-4#1)(2008-10#3)(2008-11#2)(2010-4#1)
that suppression##11##2##(1991-4#1)(1992-4#1)(1995-8#1)(2008-10#5)(2008-11#2)(2010-4#1)
that suprathreshold##2##2##(2008-9#1)(2011-2#1)
that suramin inhibits##3##3##(1990-5#1)(1994-9#1)(1995-12#1)
that suramin##7##2##(1990-5#1)(1993-11#1)(1994-9#4)(1995-12#1)
that surface plasmons can##2##4##(2007-12#1)(2008-2#1)
that surface##15##2##(1994-8#1)(1996-1#1)(1996-5#1)(1996-9#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2010-2#1)(2010-4#1)(2010-5#1)(2013-8#1)
that surfaces##2##2##(2008-10#1)(2008-3#1)
that surfactant##5##2##(1994-5#1)(1997-2#1)(2008-10#2)(2008-6#1)
that surgeons##3##2##(2008-4#1)(2009-1#1)(2012-2#1)
that surgery can##2##3##(1992-5#1)(2011-2#1)
that surgery##11##2##(1991-9#1)(1992-5#1)(1993-10#1)(1996-9#1)(2007-11#1)(2007-7#2)(2008-5#1)(2008-8#1)(2009-10#1)(2011-2#1)
that surgical intervention##2##3##(2009-8#1)(2013-1#1)
that surgical treatment##2##3##(1992-9#1)(2010-12#1)
that surgical##12##2##(1992-9#1)(1993-9#1)(2006-10#1)(2006-12#1)(2007-8#2)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-12#1)(2013-1#1)
that surround the##3##3##(1990-6#1)(1991-5#1)(2008-2#1)
that surround##5##2##(1990-6#1)(1991-5#1)(1994-9#1)(2008-12#1)(2008-2#1)
that surrounded##2##2##(2007-10#1)(2012-2#1)
that surrounds the##5##3##(1990-6#1)(2007-12#3)(2008-7#1)
that surrounds##7##2##(1990-6#1)(2007-12#4)(2008-2#1)(2008-7#1)
that surveillance##2##2##(1991-10#1)(2007-8#1)
that survey##2##2##(1994-1#1)(1997-1#1)
that surveys##2##2##(1993-9#1)(1996-3#1)
that survival##7##2##(1990-9#1)(1992-6#1)(1995-9#1)(1996-12#1)(2004-11#1)(2008-7#1)(2009-4#1)
that survive##7##2##(1991-11#1)(1992-9#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2013-7#1)
that survived##6##2##(1995-1#1)(1995-12#1)(1995-2#1)(2006-7#1)(2008-10#1)(2012-2#1)
that survivin##2##2##(2008-4#1)(2009-3#1)
that susceptibility of##3##3##(2007-6#1)(2008-10#1)(2011-12#1)
that susceptibility to##3##3##(2004-12#1)(2006-12#1)(2011-2#1)
that susceptibility##7##2##(1996-5#1)(2004-12#1)(2006-12#1)(2007-6#1)(2008-10#1)(2011-12#1)(2011-2#1)
that sustain##3##2##(2007-1#1)(2008-4#1)(2010-5#1)
that sustained##7##2##(1995-11#1)(1995-3#1)(1996-5#2)(2006-3#1)(2008-11#1)(2009-8#1)
that sustains##3##2##(2007-4#1)(2008-11#1)(2008-12#1)
that sw is##2##3##(1991-11#2)
that swelling##2##2##(1993-12#1)(2008-10#1)
that switching##3##2##(2007-12#1)(2008-7#1)(2009-6#1)
that sympathetic##3##2##(2005-10#1)(2008-10#1)(2008-7#1)
that symptom##4##2##(1996-5#1)(2007-2#1)(2008-10#1)(2009-9#1)
that symptomless##2##2##(2008-10#2)
that symptoms of##2##3##(2008-10#1)(2008-2#1)
that symptoms##6##2##(2006-3#1)(2008-10#3)(2008-2#1)(2010-11#1)
that synapsin##2##2##(1994-8#1)(2007-10#1)
that synaptic##4##2##(1992-3#1)(1992-7#1)(1993-12#1)(2008-11#1)
that synchronization##2##2##(2007-9#1)(2009-8#1)
that synchrotron##2##2##(2006-5#1)(2008-5#1)
that synergistic interactions##2##3##(1995-5#1)(2008-9#1)
that synthesis of##5##3##(1990-2#1)(1991-2#1)(1992-4#1)(1992-5#1)(1993-12#1)
that synthesize##5##2##(1995-6#1)(2007-12#1)(2008-4#1)(2008-6#1)(2010-12#1)
that synthesized##2##2##(2008-10#1)(2008-6#1)
that synthesizes a##2##3##(1997-4#1)(2007-12#1)
that synthesizes##6##2##(1995-8#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#1)(2010-12#1)
that synthetic##2##2##(1993-8#1)(2012-2#1)
that system##9##2##(1991-12#1)(1992-3#1)(1995-2#1)(1997-3#1)(2007-4#1)(2008-10#1)(2009-3#1)(2013-1#2)
that systematic##7##2##(1996-4#1)(2004-10#1)(2008-2#1)(2008-5#1)(2010-1#2)(2011-1#1)
that systematically##3##2##(1996-3#1)(2008-10#1)(2008-2#1)
that systemic absorption of##2##4##(2005-8#1)(2007-11#1)
that systemic administration of##2##4##(1996-10#1)(2013-1#1)
that systemic infection##2##3##(2008-10#2)
that systemic##16##2##(1991-1#1)(1992-3#1)(1995-2#1)(1995-9#1)(1996-10#1)(1997-2#1)(2005-8#1)(2007-11#1)(2008-10#4)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
that systemically administered##3##3##(1993-12#3)
that systems##5##2##(1990-5#1)(1995-2#1)(2008-11#1)(2008-3#1)(2012-2#1)
that systolic blood pressure##2##4##(2008-7#1)(2013-1#1)
that systolic##3##2##(2008-7#1)(2010-7#1)(2013-1#1)
that tPA##3##2##(1990-11#1)(1990-9#1)(2008-8#1)
that tacrine##2##2##(1996-9#2)
that tail##2##2##(1994-4#1)(2008-9#1)
that take into account the##3##5##(1992-2#1)(2005-5#1)(2008-3#1)
that take into account##6##4##(1992-2#1)(2005-5#1)(2008-3#1)(2008-8#1)(2010-6#1)(2011-2#1)
that take into consideration##2##4##(2008-1#1)(2008-9#1)
that take into##8##3##(1992-2#1)(2005-5#1)(2008-1#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#1)
that take place during##3##4##(2008-10#1)(2012-12#2)
that take place in the##6##5##(1994-10#1)(2005-11#1)(2008-3#1)(2009-12#1)(2009-3#1)(2012-1#1)
that take place in##9##4##(1994-10#1)(2005-11#1)(2007-5#1)(2008-3#1)(2009-12#1)(2009-3#1)(2010-2#1)(2011-12#1)(2012-1#1)
that take place##14##3##(1994-10#1)(2005-11#1)(2005-8#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-12#1)(2009-3#1)(2010-2#1)(2011-12#1)(2012-1#1)(2012-12#2)
that take##25##2##(1992-2#1)(1994-10#1)(1996-1#1)(2005-11#1)(2005-5#1)(2005-8#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2010-2#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-7#1)
that takes advantage of the##4##5##(1991-9#1)(2007-12#1)(2008-3#1)(2008-4#1)
that takes into account the##7##5##(1995-4#1)(2006-10#1)(2007-9#2)(2008-3#2)(2009-2#1)
that takes into account##16##4##(1995-4#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-9#2)(2008-2#2)(2008-3#3)(2008-8#2)(2009-2#1)(2010-3#1)(2012-3#1)
that takes into##17##3##(1995-4#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-9#2)(2008-2#2)(2008-3#3)(2008-8#2)(2009-2#1)(2009-5#1)(2010-3#1)(2012-3#1)
that takes##28##2##(1991-9#1)(1995-4#1)(1995-6#1)(1997-8#1)(2006-10#1)(2007-12#3)(2007-9#2)(2008-10#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-8#2)(2009-2#1)(2009-5#1)(2010-3#1)(2012-3#2)(2013-8#1)
that talin##2##2##(1990-9#2)
that taltirelin##3##2##(2005-8#3)
that tamoxifen##3##2##(1994-8#1)(1996-9#1)(2008-7#1)
that taps into##2##3##(1997-8#1)(2010-6#1)
that taps##3##2##(1997-1#1)(1997-8#1)(2010-6#1)
that target both##2##3##(2007-8#1)(2008-1#1)
that target multiple##2##3##(1996-9#1)(2009-12#1)
that target specific##3##3##(2006-10#1)(2010-12#1)(2012-2#1)
that target the##8##3##(1994-12#1)(2005-11#1)(2008-1#1)(2008-11#1)(2008-5#1)(2013-1#2)(2013-8#1)
that target these##2##3##(2011-2#1)(2012-2#1)
that target this##2##3##(1997-6#1)(2009-7#1)
that target##53##2##(1993-7#1)(1994-12#2)(1996-4#1)(1996-9#1)(1997-6#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-11#3)(2007-8#1)(2008-1#4)(2008-10#1)(2008-11#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-4#2)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#1)
that targeted a##2##3##(2008-9#1)(2010-2#1)
that targeted the##2##3##(2008-10#1)(2012-3#1)
that targeted therapy##2##3##(2006-10#1)(2013-1#1)
that targeted##18##2##(2006-10#2)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-7#1)(2010-10#1)(2010-2#1)(2012-3#2)(2013-1#4)
that targeting##5##2##(2008-1#1)(2008-4#1)(2008-7#1)(2012-2#1)(2013-1#1)
that targets all##2##3##(2007-10#1)(2011-1#1)
that targets of##2##3##(2008-11#2)
that targets the##5##3##(1993-11#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)
that targets these##2##3##(1993-1#1)(2011-1#1)
that targets##20##2##(1991-12#1)(1993-1#1)(1993-11#1)(1995-1#1)(2007-10#2)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)
that task##4##2##(1991-2#1)(2008-4#1)(2011-12#1)(2012-1#1)
that taste##3##2##(1993-9#1)(2008-7#1)(2013-1#1)
that tat##2##2##(1994-11#2)
that taurine##3##2##(1994-2#1)(1995-1#1)(2008-5#1)
that teachers##4##2##(2005-12#1)(2006-7#1)(2008-12#1)(2013-1#1)
that teachers'##2##2##(2007-9#1)(2008-12#1)
that technical##2##2##(2008-12#1)(2008-7#1)
that technique##4##2##(2007-7#1)(2008-10#1)(2008-4#1)(2011-2#1)
that technology##3##2##(1997-1#1)(2005-9#1)(2008-7#1)
that tegaserod is##2##3##(2008-3#2)
that telephone##2##2##(2004-7#1)(2012-1#1)
that teliospores##2##2##(2008-10#2)
that telomerase activity##2##3##(2004-1#1)(2009-5#1)
that telomerase##4##2##(2004-1#1)(2007-11#1)(2008-5#1)(2009-5#1)
that telomere##2##2##(1990-8#1)(2011-2#1)
that telomeres##2##2##(2008-11#1)(2011-2#1)
that temperature##9##2##(2005-11#1)(2006-10#1)(2008-10#4)(2008-2#1)(2008-3#1)(2013-7#1)
that temporal##5##2##(1997-7#1)(2007-3#1)(2008-8#1)(2011-2#1)(2012-1#1)
that temporally##2##2##(1995-2#1)(2008-3#1)
that tend to be##2##4##(1996-7#1)(2007-12#1)
that tend##3##2##(1996-7#1)(2007-12#1)(2008-11#1)
that tends to##2##3##(1994-6#1)(2011-2#1)
that terminate in##2##3##(1996-7#1)(2007-12#1)
that terminated##2##2##(1994-7#1)(2008-3#1)
that terminates the##2##3##(1997-4#1)(2012-3#1)
that terrestrial##2##2##(1995-8#1)(2004-11#1)
that territorial##2##2##(2008-8#2)
that test##7##2##(2005-10#1)(2006-10#1)(2006-12#1)(2008-4#1)(2008-7#1)(2012-1#1)(2012-3#1)
that tested a##2##3##(2008-7#1)(2013-8#1)
that tested##8##2##(1993-11#1)(1994-1#1)(1997-3#1)(2007-3#1)(2008-10#1)(2008-7#1)(2008-9#1)(2013-8#1)
that testing##3##2##(1991-2#1)(1993-6#1)(2009-2#1)
that testosterone##7##2##(1995-12#1)(1996-11#1)(1996-5#1)(2006-9#1)(2008-7#1)(2008-9#1)(2012-3#1)
that tetanus toxin##2##3##(1994-9#2)
that tethers##2##2##(1994-9#1)(2008-9#1)
that thalidomide##3##2##(2006-10#2)(2008-5#1)
that that the##5##3##(2007-11#1)(2008-1#1)(2008-8#1)(2010-10#1)(2013-8#1)
that that##10##2##(1995-8#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)(2010-10#1)(2013-8#1)
that the &quot##21##3##(1990-12#1)(1991-1#1)(1992-11#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-8#1)(1997-5#1)(2004-11#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-11#1)(2008-8#1)(2009-3#1)(2012-12#1)(2013-7#1)(2013-8#1)
that the (alpha##2##3##(1990-7#2)
that the 1##8##3##(1990-12#1)(1990-2#1)(1991-10#1)(1991-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-2#1)
that the 12##2##3##(2008-10#1)(2013-8#1)
that the 14-kDa##2##3##(1991-12#1)(1995-6#1)
that the 175R##2##3##(1993-2#2)
that the 2##6##3##(1990-8#1)(1991-10#1)(2008-10#2)(2008-3#1)(2008-8#1)
that the 22##2##3##(1994-12#1)(2011-2#1)
that the 25##2##3##(1990-8#1)(2012-12#1)
that the 3'-untranslated##2##3##(1994-9#1)(1995-8#1)
that the 40-kDa##2##3##(1990-3#1)(1997-1#1)
that the 42##2##3##(1992-9#1)(1996-9#1)
that the 5##4##3##(1994-8#1)(2008-10#1)(2008-8#1)(2009-5#1)
that the 5-HT##3##3##(1993-7#1)(1994-2#1)(1996-5#1)
that the 5-HT1A##2##3##(1993-3#1)(1994-6#1)
that the 5-year##2##3##(1993-4#1)(1997-7#1)
that the 55##2##3##(1993-6#1)(1994-12#1)
that the 5th##2##3##(1997-1#1)(2008-7#1)
that the 67##3##3##(1991-5#1)(1994-5#1)(1995-12#1)
that the 75 kDa protein is##2##6##(1990-8#1)(2008-7#1)
that the A##3##3##(1990-2#1)(1991-4#1)(1992-9#1)
that the A1##2##3##(1990-5#1)(1992-9#1)
that the A33 antigen is##2##5##(1997-7#2)
that the AAT-1##2##3##(2008-5#2)
that the AC##2##3##(1990-5#1)(2005-11#1)
that the AM##2##3##(1994-8#1)(1995-12#1)
that the ASC-DHA pair##2##4##(2008-11#2)
that the AT2 receptor##3##4##(1994-9#1)(1996-8#2)
that the ATP##2##3##(1990-5#1)(1994-6#1)
that the ATPase and histone kinase##2##6##(1992-6#2)
that the ATPase##4##3##(1991-2#1)(1992-6#3)
that the American##4##3##(1990-12#1)(1995-6#1)(2008-3#1)(2011-1#1)
that the Arabidopsis##3##3##(2006-12#1)(2009-6#1)(2009-8#1)
that the B##7##3##(1992-12#1)(1995-6#1)(1996-5#1)(1997-2#2)(2007-12#1)(2008-10#1)
that the BBB##3##3##(1993-12#1)(2008-7#1)(2008-8#1)
that the BHA##2##3##(1992-9#1)(2008-10#1)
that the Black Death##2##4##(1990-6#2)
that the C##6##3##(1997-6#1)(2008-10#2)(2008-11#1)(2010-11#1)(2011-2#1)
that the C-domain##2##3##(1997-7#1)(2008-9#1)
that the C-terminal amino acids##2##5##(1991-7#1)(1996-12#1)
that the C-terminal hydrophobic region##2##5##(1991-8#1)(2008-8#1)
that the C-terminal portion of the##2##6##(1994-8#1)(1996-5#1)
that the C-terminal portion of##3##5##(1990-12#1)(1994-8#1)(1996-5#1)
that the C-terminal region##2##4##(1990-4#1)(1990-7#1)
that the C-terminal##17##3##(1990-12#1)(1990-4#1)(1990-7#1)(1991-5#1)(1991-7#2)(1991-8#1)(1993-11#1)(1994-8#1)(1996-12#1)(1996-5#1)(1997-2#2)(1997-6#1)(2008-8#1)(2008-9#2)
that the C-terminus##2##3##(1994-5#1)(1997-3#1)
that the CCOT was##2##4##(2007-9#2)
that the CNS##2##3##(1995-3#1)(2007-11#1)
that the CO2##2##3##(1992-6#1)(1993-6#1)
that the COOH-terminal##2##3##(1991-12#1)(1992-8#1)
that the CPT##2##3##(1996-3#1)(1997-2#1)
that the CUL3-KLHL18 ligase##2##4##(2012-12#2)
that the Ca2+##2##3##(1995-11#1)(1997-2#1)
that the Chief Medical Officer##2##5##(1993-3#2)
that the Chinese##3##3##(2007-12#1)(2011-1#1)(2011-3#1)
that the Cl-##2##3##(1990-2#1)(1994-9#1)
that the Colombian X##2##4##(2006-3#1)(2008-10#1)
that the Court's##2##3##(2005-11#2)
that the Cuban-produced vaccine##2##4##(1992-10#2)
that the D1##2##3##(1995-11#1)(1996-10#1)
that the DA##2##3##(1990-2#1)(1996-1#1)
that the DNA binding##3##4##(1992-7#1)(1995-5#1)(1997-7#1)
that the DNA##12##3##(1992-7#1)(1993-3#2)(1993-8#1)(1995-2#1)(1995-5#1)(1996-8#1)(1997-7#1)(2007-11#1)(2008-10#2)(2009-5#1)
that the DNA-binding##3##3##(1991-12#1)(1992-4#1)(2008-9#1)
that the DPH2 gene##2##4##(1993-9#2)
that the Drosophila##3##3##(1992-4#1)(1993-6#1)(2011-1#1)
that the E##9##3##(1990-2#1)(1995-10#1)(1995-11#1)(1995-2#1)(1996-7#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-8#1)
that the EAP##2##3##(1992-10#1)(1995-6#1)
that the ELISA##6##3##(1994-3#1)(1994-9#1)(2008-10#2)(2008-5#1)(2011-1#1)
that the Escherichia coli##2##4##(1990-5#1)(1991-7#1)
that the European##2##3##(2008-10#1)(2009-2#1)
that the FLO1 gene is##2##5##(1995-4#1)(1997-6#1)
that the G##2##3##(1993-9#1)(2008-10#1)
that the GLUT3##2##3##(1992-7#2)
that the GTP##2##3##(1990-7#1)(1993-12#1)
that the Glu##2##3##(1990-8#1)(1992-11#1)
that the Glu-50--&gt##2##3##(1995-6#2)
that the H##2##3##(1994-10#1)(1996-11#1)
that the H(2)O(2) system containing Cu(2+)##2##6##(2008-10#2)
that the H-Wave(R) device##3##4##(2010-1#3)
that the HC-Pro##2##3##(2008-10#2)
that the HIV##3##3##(1996-5#1)(2005-6#1)(2009-4#1)
that the HMG##2##3##(1993-2#1)(2008-8#1)
that the HR##2##3##(2008-10#1)(2013-8#1)
that the HepG2 cell##2##4##(1992-3#1)(1996-5#1)
that the Ht1 gene##2##4##(2008-10#2)
that the I##2##3##(1991-4#1)(2011-1#1)
that the IACh##2##3##(1991-8#1)(1997-1#1)
that the ILS##2##3##(2008-10#2)
that the IQ-achievement discrepancy##2##4##(2004-10#2)
that the IR##2##3##(2007-12#1)(2013-8#1)
that the Internet##5##3##(1996-5#1)(2007-12#1)(2007-4#1)(2008-12#1)(2009-5#1)
that the Kd values##2##4##(1994-8#1)(2008-8#1)
that the Kd##3##3##(1991-4#1)(1994-8#1)(2008-8#1)
that the Kobs##2##3##(1995-2#2)
that the L1##2##3##(1994-12#1)(1997-7#1)
that the LDH##2##3##(2008-11#1)(2010-4#1)
that the LRNB##2##3##(2008-3#2)
that the M-D approach##2##4##(2008-2#2)
that the MAF##3##3##(2010-11#1)(2011-1#2)
that the MFT##2##3##(2007-10#2)
that the MIC##2##3##(2005-7#1)(2008-5#1)
that the MNS is##3##4##(2008-11#2)(2012-1#1)
that the Mn##2##3##(1994-12#1)(2007-8#1)
that the N terminus##3##4##(1990-11#1)(1993-2#1)(1994-12#1)
that the N##8##3##(1990-11#1)(1993-2#1)(1994-12#1)(1995-5#1)(1995-8#1)(1997-7#1)(2008-10#1)(2013-8#1)
that the N-terminal domain of##3##5##(1992-3#1)(1997-6#1)(2008-9#1)
that the N-terminal half##2##4##(2006-12#1)(2008-10#1)
that the N-terminal region of the##2##6##(1990-2#1)(1991-7#1)
that the N-terminal region of##3##5##(1990-2#1)(1991-5#1)(1991-7#1)
that the N-terminal region##4##4##(1990-11#1)(1990-2#1)(1991-5#1)(1991-7#1)
that the N-terminal##23##3##(1990-11#1)(1990-2#1)(1991-10#1)(1991-5#1)(1991-7#1)(1992-3#2)(1992-4#1)(1992-6#1)(1993-3#1)(1994-12#2)(1994-3#1)(1994-5#1)(1997-1#1)(1997-6#3)(2006-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-10#1)
that the NADH##2##3##(2008-10#1)(2008-11#1)
that the NFL theorems##3##4##(2010-3#3)
that the NH2-terminal region##2##4##(1992-11#1)(1994-8#1)
that the NH2-terminal##6##3##(1991-2#1)(1992-11#1)(1994-8#1)(1995-3#1)(1996-8#1)(1997-1#1)
that the NMDA receptor##3##4##(1992-6#1)(1994-8#1)(1996-12#1)
that the NMDA##4##3##(1991-9#1)(1992-6#1)(1994-8#1)(1996-12#1)
that the NO##2##3##(1993-3#1)(2007-10#1)
that the NO-nps##2##3##(2010-12#2)
that the NR##2##3##(1993-6#1)(2010-9#1)
that the NSE##3##3##(1992-5#2)(2011-2#1)
that the Na##3##3##(1991-9#1)(1994-8#2)
that the P##7##3##(1993-11#1)(1994-9#1)(1995-6#1)(2008-10#2)(2008-5#1)(2013-8#1)
that the PAG##2##3##(1994-6#2)
that the PANI##2##3##(2008-10#2)
that the PCR##2##3##(2008-5#1)(2010-10#1)
that the PDE##2##3##(1990-2#1)(1993-7#1)
that the PEP##2##3##(1994-11#1)(2009-12#1)
that the PI##2##3##(1990-11#1)(2008-8#1)
that the PKC##4##3##(1992-6#1)(1994-2#2)(1994-9#1)
that the PMD##2##3##(2007-11#2)
that the PPTg##2##3##(1994-10#1)(1994-2#1)
that the PRS3##2##3##(1992-1#2)
that the PSTs##2##3##(2009-4#2)
that the PTS1-binding##2##3##(1995-3#2)
that the PVP##2##3##(2006-2#1)(2010-4#1)
that the P[1##2##3##(1991-3#2)
that the Pdx-1##2##3##(2010-11#2)
that the Q##3##3##(1991-8#2)(2007-12#1)
that the QTL##2##3##(2008-10#2)
that the Qo site##2##4##(1992-3#1)(1997-3#1)
that the R##5##3##(1991-12#1)(1993-6#1)(2008-10#3)
that the RGD##3##3##(1995-2#1)(1995-6#1)(2008-7#1)
that the RGDS##2##3##(1990-12#1)(1992-1#1)
that the RNA integrity##2##4##(2008-7#1)(2009-12#1)
that the RNA##5##3##(1997-7#2)(2008-7#1)(2009-12#1)(2011-1#1)
that the RR##2##3##(2008-10#2)
that the RT-PCR##2##3##(2008-10#1)(2008-5#1)
that the Raman##2##3##(2008-1#1)(2013-8#1)
that the RpoN sigma factor##2##5##(1993-12#2)
that the S##6##3##(1991-7#1)(2004-7#1)(2007-12#1)(2007-6#1)(2008-10#2)
that the S-dsRNA was##2##4##(2008-10#2)
that the SERS##2##3##(2013-1#1)(2013-8#1)
that the SH2 domain##3##4##(1995-2#2)(1996-5#1)
that the SLN##2##3##(2008-10#1)(2008-5#1)
that the SP##2##3##(1993-3#1)(1997-4#1)
that the Ser##2##3##(1992-3#2)
that the Span80-CPL##2##3##(2008-11#2)
that the T##8##3##(1990-11#1)(1991-5#2)(1997-8#2)(2005-10#1)(2007-10#1)(2008-10#1)
that the TF##2##3##(1995-8#1)(2010-12#1)
that the THz##2##3##(2007-12#1)(2012-2#1)
that the TPA-induced##2##3##(1990-2#1)(2012-3#1)
that the TdT promoter##2##4##(1996-4#2)
that the Tyr hydroxyl##2##4##(1990-9#2)
that the U##2##3##(2008-10#2)
that the US##4##3##(1996-11#1)(1996-6#1)(2005-7#1)(2011-12#1)
that the United States##3##4##(1990-12#1)(2007-8#1)(2008-12#1)
that the V-ATPase##2##3##(1995-6#1)(1996-5#1)
that the VLDL receptor##2##4##(1995-6#1)(1995-8#1)
that the VLO is##2##4##(1994-3#2)
that the VLO##3##3##(1994-3#3)
that the X##2##3##(1990-4#2)
that the Y##2##3##(1995-11#2)
that the ZFPOU1 transcripts##2##4##(1992-9#2)
that the ability of a##2##5##(2008-4#1)(2013-8#1)
that the ability of the##4##5##(2006-7#1)(2008-10#1)(2008-9#1)(2009-12#1)
that the ability of##19##4##(1991-2#1)(1992-12#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-10#1)(1997-2#1)(2006-7#1)(2008-10#5)(2008-4#1)(2008-9#1)(2009-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
that the ability to produce##2##5##(2008-10#1)(2008-4#1)
that the ability to##17##4##(1990-11#1)(1990-12#1)(1991-2#1)(1992-10#1)(1993-7#1)(1994-2#1)(1995-8#1)(2006-9#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#1)
that the ability##37##3##(1990-11#1)(1990-12#1)(1991-2#2)(1992-10#1)(1992-12#1)(1993-7#1)(1994-2#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-10#1)(1997-2#1)(2006-7#1)(2006-9#1)(2007-5#1)(2008-10#6)(2008-3#1)(2008-4#2)(2008-9#1)(2009-12#1)(2009-7#1)(2010-12#2)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
that the ablation##2##3##(1993-5#1)(2011-1#1)
that the abnormal##3##3##(1991-12#1)(2008-11#1)(2008-8#1)
that the abomasum##2##3##(2011-2#2)
that the above##12##3##(1990-9#1)(1991-1#1)(1991-6#1)(1992-6#1)(1994-9#1)(1996-11#1)(2004-9#1)(2006-10#1)(2006-6#1)(2008-10#1)(2009-11#1)(2012-2#1)
that the absence of a##3##5##(1992-5#1)(2013-1#2)
that the absence of##13##4##(1992-5#1)(1994-12#1)(1995-12#1)(2006-9#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-6#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
that the absolute##2##3##(1995-3#1)(2008-3#1)
that the absorbance##4##3##(2005-11#1)(2005-4#1)(2008-10#1)(2011-1#1)
that the absorption and scattering##3##5##(2008-3#2)(2009-12#1)
that the absorption coefficient##2##4##(2008-2#1)(2008-3#1)
that the absorption of##2##4##(2007-8#1)(2011-3#1)
that the absorption##15##3##(2007-8#1)(2008-1#1)(2008-2#4)(2008-3#4)(2008-8#1)(2009-12#1)(2010-2#2)(2011-3#1)
that the abundance of##4##4##(1991-4#1)(1994-11#1)(2009-4#1)(2010-8#1)
that the accessibility of##2##4##(1996-8#1)(2009-12#1)
that the accumulation of##7##4##(1995-1#2)(1996-4#1)(2006-12#1)(2008-10#1)(2008-7#2)
that the accumulation##8##3##(1995-1#2)(1996-4#1)(2006-12#1)(2008-10#2)(2008-7#2)
that the accuracy of the##4##5##(2008-3#3)(2010-5#1)
that the accuracy of##9##4##(2008-10#1)(2008-2#1)(2008-3#4)(2010-5#1)(2012-1#1)(2013-8#1)
that the accuracy##10##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#4)(2010-5#1)(2012-1#1)(2013-8#1)
that the acetylation of tyrosine 252##2##6##(2008-4#2)
that the acquired##2##3##(2006-10#1)(2010-2#1)
that the acquisition of##4##4##(2006-2#2)(2010-10#1)(2013-1#1)
that the actin cytoskeleton##2##4##(2008-11#1)(2008-9#1)
that the actin##5##3##(1990-12#1)(1990-6#1)(1992-3#1)(2008-11#1)(2008-9#1)
that the actin-based##2##3##(2008-10#2)
that the actin-binding domain##2##4##(1990-5#1)(1997-6#1)
that the actin-binding##4##3##(1990-5#1)(1993-8#1)(1997-6#2)
that the action of##10##4##(1991-5#1)(1991-9#1)(1992-3#1)(1994-6#1)(1996-1#1)(2006-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-5#1)
that the actions of##2##4##(1991-12#1)(1996-5#1)
that the activated##3##3##(1992-11#1)(1994-2#1)(1996-1#1)
that the activation barrier for hydrogen desorption##2##7##(2008-10#2)
that the activation barrier for##3##5##(1997-7#1)(2008-10#2)
that the activation energy##3##4##(1997-1#1)(2005-11#1)(2008-10#1)
that the activation of PKA is directly linked to the change of osteoblast proliferation by##2##15##(1991-5#1)(1991-8#1)
that the activation of PKA##3##5##(1991-5#1)(1991-8#1)(1994-2#1)
that the activation of PKC##2##5##(1992-6#1)(1997-2#1)
that the activation of the##5##5##(1993-11#1)(1995-2#1)(1995-8#1)(1997-2#2)
that the activation of##24##4##(1990-8#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-6#1)(1993-11#1)(1993-6#1)(1994-2#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-5#2)(1997-2#3)(1997-4#1)(1997-6#1)(2006-6#1)(2008-8#2)(2012-2#1)(2013-1#1)
that the activation##32##3##(1990-8#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-5#2)(1997-1#1)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-6#1)(2008-10#3)(2008-8#2)(2012-2#1)(2013-1#1)
that the active form of##2##5##(2010-12#1)(2012-2#1)
that the active site is in the##2##7##(1992-5#2)
that the active site##3##4##(1992-5#2)(2008-4#1)
that the active##19##3##(1990-5#1)(1991-11#1)(1992-5#3)(1994-3#3)(1995-3#1)(1995-6#1)(1996-11#1)(1996-2#1)(1997-2#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-12#1)(2012-2#1)
that the activities of##3##4##(1995-11#1)(1996-9#1)(2008-7#1)
that the activity is a##2##5##(1990-8#1)(2009-2#1)
that the activity is##4##4##(1990-8#1)(1991-8#1)(1994-2#1)(2009-2#1)
that the activity of the##9##5##(1991-1#1)(1992-1#1)(1993-12#1)(1995-3#1)(1997-2#1)(1997-6#1)(2007-7#1)(2008-4#1)(2008-9#1)
that the activity of##21##4##(1991-1#2)(1992-1#1)(1992-2#1)(1992-8#1)(1993-12#1)(1994-12#1)(1995-3#1)(1996-8#1)(1997-2#3)(1997-6#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-9#2)(2012-2#1)(2012-3#1)
that the activity##33##3##(1990-8#1)(1991-1#2)(1991-8#1)(1992-1#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-3#2)(1996-8#1)(1997-2#3)(1997-6#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-9#2)(2009-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
that the actual##8##3##(1993-2#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-6#1)(2012-1#1)
that the acute##4##3##(1990-5#1)(1994-8#1)(1996-5#1)(2008-10#1)
that the added##3##3##(1994-11#1)(1997-6#1)(2013-1#1)
that the addition of a##4##5##(1996-7#1)(2006-10#1)(2007-11#1)(2008-5#1)
that the addition of##34##4##(1990-3#2)(1992-3#1)(1993-6#1)(1993-9#1)(1994-3#1)(1996-1#1)(1996-11#1)(1996-7#1)(2005-11#2)(2005-7#1)(2006-10#1)(2007-11#3)(2007-7#1)(2008-10#4)(2008-11#2)(2008-5#5)(2008-8#1)(2008-9#1)(2010-2#1)(2010-4#1)(2013-1#2)
that the addition##35##3##(1990-3#2)(1992-3#1)(1993-6#1)(1993-9#1)(1994-3#1)(1996-1#1)(1996-11#1)(1996-7#1)(2005-11#2)(2005-7#1)(2006-10#1)(2007-11#3)(2007-7#1)(2008-10#5)(2008-11#2)(2008-5#5)(2008-8#1)(2008-9#1)(2010-2#1)(2010-4#1)(2013-1#2)
that the additional##5##3##(1994-5#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-1#1)
that the adduct##2##3##(1992-3#1)(1993-12#1)
that the adipose eyelid##2##4##(2010-8#2)
that the adipose##3##3##(2010-8#3)
that the administration of a##2##5##(2008-1#1)(2012-2#1)
that the administration of##12##4##(1991-9#1)(1992-6#1)(1994-8#1)(1996-3#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-2#1)
that the administration##14##3##(1991-9#1)(1992-6#1)(1994-8#1)(1996-3#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)
that the adolescents##2##3##(1993-5#1)(2008-9#1)
that the adrenal##3##3##(1990-2#1)(1992-8#1)(1995-12#1)
that the adsorbed##4##3##(2005-11#3)(2008-7#1)
that the adsorption of##7##4##(2005-11#4)(2005-4#1)(2008-10#2)
that the adsorption process is exothermic##2##6##(2005-11#2)
that the adsorption##13##3##(2005-11#7)(2005-4#1)(2008-10#5)
that the adult##2##3##(1993-12#1)(2007-12#1)
that the adults##2##3##(1996-1#1)(2007-12#1)
that the advantages of##2##4##(1997-6#1)(2007-7#1)
that the advantages##4##3##(1997-6#1)(2006-10#1)(2007-7#1)(2008-1#1)
that the advent of##2##4##(2008-10#1)(2009-5#1)
that the adverse##2##3##(2007-8#1)(2008-7#1)
that the aerobic##2##3##(2008-5#1)(2010-12#1)
that the affinity of the##3##5##(1990-7#1)(1991-2#1)(2006-12#1)
that the affinity of##8##4##(1990-7#1)(1990-8#1)(1991-2#1)(1992-4#1)(1993-6#1)(1996-12#1)(1997-2#1)(2006-12#1)
that the affinity##14##3##(1990-7#1)(1990-8#3)(1991-2#1)(1992-4#1)(1993-6#1)(1994-6#1)(1994-9#1)(1996-12#1)(1997-2#1)(2005-11#1)(2005-12#1)(2006-12#1)
that the age##3##3##(1996-3#1)(2005-8#1)(2008-10#1)
that the age-dependent##4##3##(1990-3#1)(1991-4#1)(1992-12#1)(2008-7#1)
that the age-related decline in##2##5##(1992-12#1)(1995-12#1)
that the age-related##5##3##(1992-12#1)(1995-12#1)(1995-9#1)(2008-7#1)(2011-2#1)
that the agent has##2##4##(2007-11#1)(2009-8#1)
that the agent##3##3##(1996-5#1)(2007-11#1)(2009-8#1)
that the agents##2##3##(1992-8#1)(2008-10#1)
that the aggregates##3##3##(1991-2#1)(1997-6#1)(2011-2#1)
that the aggregation of##2##4##(1994-9#1)(2008-10#1)
that the algorithm is##2##4##(2008-10#1)(2008-2#1)
that the algorithm##8##3##(2006-10#1)(2008-10#2)(2008-2#5)
that the algorithms##2##3##(2008-3#1)(2008-9#1)
that the alkyl##3##3##(2005-11#1)(2008-11#1)(2008-5#1)
that the allosteric mechanism##2##4##(1995-11#2)
that the allosteric##3##3##(1990-8#1)(1995-11#2)
that the alpha 2 beta 2##2##6##(1995-10#1)(1995-3#1)
that the alpha subunit of##2##5##(1996-5#1)(1997-4#1)
that the alpha##14##3##(1990-12#1)(1990-8#1)(1991-5#1)(1992-2#1)(1994-12#1)(1994-3#1)(1995-10#1)(1995-11#1)(1995-3#2)(1996-12#1)(1996-5#1)(1997-4#1)(1997-7#1)
that the alpha-2##2##3##(1993-12#1)(1997-5#1)
that the alteration in##2##4##(1993-3#1)(2008-8#1)
that the alteration of##3##4##(1991-12#1)(2008-8#1)(2008-9#1)
that the alteration##5##3##(1991-12#1)(1993-3#1)(2008-8#2)(2008-9#1)
that the altered##8##3##(1990-10#1)(1990-12#2)(1992-10#1)(1992-3#1)(1997-1#1)(2007-11#1)(2008-10#1)
that the alternative##5##3##(1996-5#2)(2008-8#1)(2009-8#1)(2013-1#1)
that the amide group##2##4##(1997-1#1)(2011-2#1)
that the amide-(15)N CSA tensor##3##5##(2008-5#3)
that the amino acid residues##2##5##(1990-12#1)(1997-2#1)
that the amino acid sequence##3##5##(1991-10#1)(1994-2#1)(1995-3#1)
that the amino acid##8##4##(1990-12#1)(1991-10#1)(1994-2#1)(1995-3#1)(1995-7#1)(1997-2#1)(1997-8#1)(2008-10#1)
that the amino##12##3##(1990-12#1)(1991-10#1)(1991-2#1)(1991-8#2)(1994-2#1)(1995-3#1)(1995-7#1)(1997-2#1)(1997-8#1)(2005-11#1)(2008-10#1)
that the amino-terminal##6##3##(1991-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1997-2#1)
that the amount of the specific##2##6##(1991-9#1)(1994-12#1)
that the amount of the##3##5##(1991-9#1)(1994-12#1)(2008-10#1)
that the amount of##30##4##(1990-1#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-5#1)(1991-9#1)(1993-9#1)(1994-12#1)(1996-5#1)(1996-6#1)(2005-11#1)(2007-10#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-6#3)(2008-8#1)(2009-7#1)(2011-1#2)(2012-12#1)(2012-2#2)(2013-8#1)
that the amount##32##3##(1990-1#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-5#1)(1991-9#1)(1993-9#1)(1994-12#1)(1996-5#1)(1996-6#1)(2005-11#1)(2007-10#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-6#3)(2008-8#2)(2009-7#1)(2011-1#2)(2012-12#1)(2012-2#2)(2013-8#1)
that the amounts of##7##4##(1994-11#1)(1994-3#2)(1997-3#1)(2008-10#1)(2008-12#2)
that the amphiphilic##2##3##(2005-4#1)(2008-10#1)
that the amplified##3##3##(1992-7#1)(1997-6#1)(2007-12#1)
that the amplifier##2##3##(2008-1#1)(2008-2#1)
that the amplitude of the##3##5##(1993-1#1)(2007-1#1)(2008-3#1)
that the amplitude of##5##4##(1993-1#1)(2007-1#1)(2007-12#1)(2008-3#1)(2010-6#1)
that the amygdala contributes to##2##5##(1993-6#1)(2008-4#1)
that the amygdala##6##3##(1991-5#1)(1993-12#1)(1993-6#2)(2008-4#1)(2013-8#1)
that the anaerobic##2##3##(2009-6#1)(2013-1#1)
that the analysed##2##3##(2007-1#1)(2008-10#1)
that the analysis of##7##4##(1993-7#1)(1996-6#1)(2007-7#1)(2008-10#3)(2012-3#1)
that the analysis##11##3##(1990-7#1)(1993-7#1)(1996-6#1)(2007-7#1)(2008-10#5)(2008-3#1)(2012-3#1)
that the analyzed##2##3##(2006-10#1)(2008-3#1)
that the anatomical##3##3##(1994-3#1)(2007-3#1)(2009-1#1)
that the angiogenic##2##3##(1990-4#1)(1992-3#1)
that the angle##2##3##(2006-4#1)(2012-2#1)
that the anhydrides##2##3##(1993-11#2)
that the animal##4##3##(2007-2#1)(2008-11#1)(2008-4#1)(2008-5#1)
that the animals##3##3##(1993-2#1)(1995-5#1)(2008-4#1)
that the anionic##2##3##(1997-1#1)(2010-5#1)
that the anisotropic##2##3##(2008-3#2)
that the annual##3##3##(1995-3#1)(1996-11#1)(2009-9#1)
that the antagonist##2##3##(2008-10#2)
that the antagonistic##4##3##(1994-2#1)(2008-10#2)(2008-4#1)
that the antenatal classes had prepared them##2##7##(2007-2#2)
that the antenatal##3##3##(2007-2#2)(2008-1#1)
that the anterior##3##3##(1990-10#1)(1991-8#1)(2007-12#1)
that the anti-inflammatory effect of##2##5##(1995-7#1)(2006-12#1)
that the anti-inflammatory properties of##2##5##(2008-5#1)(2012-2#1)
that the anti-inflammatory##5##3##(1990-3#1)(1995-7#1)(2006-12#1)(2008-5#1)(2012-2#1)
that the antibodies##4##3##(1993-2#1)(1994-5#1)(1997-2#1)(2006-8#1)
that the antibody is##3##4##(1992-11#1)(2008-10#1)(2011-1#1)
that the antibody##10##3##(1992-11#1)(1994-6#1)(1995-10#1)(1995-2#1)(2008-10#1)(2008-8#1)(2011-1#1)(2013-1#3)
that the anticipated##2##3##(1992-3#1)(2007-2#1)
that the antifungal##4##3##(1992-11#1)(2008-10#2)(2009-2#1)
that the antigen##2##3##(1994-6#2)
that the antigenic##2##3##(1990-8#1)(2011-1#1)
that the antinociceptive##2##3##(1996-2#1)(2008-11#1)
that the antioxidant##8##3##(1992-9#1)(1993-4#1)(2005-12#1)(2008-10#1)(2008-11#1)(2009-8#1)(2011-1#1)(2012-2#1)
that the antioxidative property of##2##5##(2008-11#2)
that the antioxidative##3##3##(1996-11#1)(2008-11#2)
that the antitumor activity of##2##5##(1992-7#1)(2008-5#1)
that the antitumor##3##3##(1991-6#1)(1992-7#1)(2008-5#1)
that the apparent##10##3##(1991-9#1)(1994-8#1)(1995-6#1)(1996-11#1)(1997-8#1)(2004-12#1)(2006-10#1)(2007-8#1)(2008-10#1)(2009-8#1)
that the appearance of##5##4##(1992-3#1)(1997-8#1)(2008-6#1)(2009-2#1)(2009-3#1)
that the appearance##6##3##(1992-3#1)(1997-8#1)(2007-12#1)(2008-6#1)(2009-2#1)(2009-3#1)
that the applicability of##2##4##(2008-10#2)
that the application of polarized##2##5##(1997-4#1)(2008-3#1)
that the application of the##2##5##(2008-10#1)(2008-3#1)
that the application of##15##4##(1991-5#1)(1991-7#1)(1992-2#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#2)(2011-12#1)
that the applied##3##3##(2008-10#2)(2008-5#1)
that the approach to##3##4##(2008-7#1)(2008-8#1)(2009-2#1)
that the approach##9##3##(1992-2#1)(1997-2#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2012-2#2)
that the appropriate##7##3##(1990-11#1)(1992-10#1)(1993-11#1)(1994-12#1)(1995-11#1)(2007-12#1)(2008-2#1)
that the approximation##3##3##(1997-4#1)(2007-12#1)(2008-3#1)
that the aqueous and methanol extracts##2##6##(2011-2#2)
that the aqueous extract of##3##5##(2007-1#1)(2010-2#2)
that the aqueous extract##4##4##(2007-1#1)(2010-2#2)(2010-4#1)
that the aqueous##9##3##(1992-11#1)(2006-12#1)(2007-1#1)(2009-12#1)(2010-2#2)(2010-4#1)(2011-2#2)
that the area##5##3##(1992-11#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-5#1)
that the areas##2##3##(1995-1#1)(2007-7#1)
that the arterial##3##3##(1997-5#1)(1997-7#1)(2007-12#1)
that the artificial##4##3##(1991-7#1)(1995-12#1)(2005-4#1)(2008-3#1)
that the aspect ratio##2##4##(2005-11#2)
that the assay is##3##4##(1990-1#1)(2010-2#1)(2011-3#1)
that the assay##6##3##(1990-1#1)(1990-12#1)(1992-9#1)(2008-10#1)(2010-2#1)(2011-3#1)
that the assessment of##4##4##(1990-8#1)(1994-6#1)(1997-3#1)(2006-11#1)
that the associated##2##3##(1990-11#1)(2008-10#1)
that the association between##8##4##(2005-10#1)(2006-11#1)(2007-1#1)(2007-12#1)(2008-3#1)(2009-7#1)(2009-8#1)(2013-1#1)
that the association of##10##4##(1992-12#1)(1995-2#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-12#1)
that the association process##2##4##(1996-1#1)(2008-10#1)
that the association##25##3##(1992-12#1)(1994-11#1)(1995-2#1)(1995-8#1)(1996-1#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
that the assumption of a linear increase in risk with increasing dose in##2##13##(2008-7#2)
that the assumption of##4##4##(2008-2#1)(2008-6#1)(2008-7#2)
that the asymmetric##2##3##(1994-9#1)(2006-10#1)
that the asymmetry##2##3##(1992-2#1)(2008-5#1)
that the asymptotic##3##3##(1994-2#1)(2008-3#1)(2010-1#1)
that the atherosclerotic process##2##4##(2008-6#1)(2013-8#1)
that the atomic##2##3##(2007-12#1)(2008-7#1)
that the atrial##2##3##(1991-8#1)(2008-11#1)
that the attachment##2##3##(2005-10#1)(2008-5#1)
that the attenuated##2##3##(2008-5#1)(2013-8#1)
that the attenuation##3##3##(1997-8#1)(2008-3#2)
that the atypical isoforms aPKCι and ζ underly different mechanisms regarding their regulation of subcellular localization and translocation into the nucleus in MDCK cells##2##24##(2012-12#2)
that the auditory system##2##4##(2006-2#1)(2008-9#1)
that the auditory##3##3##(1991-6#1)(2006-2#1)(2008-9#1)
that the augmentation of##2##4##(1992-8#1)(1995-12#1)
that the authors##5##3##(1996-12#1)(2006-7#1)(2008-2#1)(2008-4#1)(2008-7#1)
that the availability of##7##4##(1996-3#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-7#1)
that the available##3##3##(2008-5#1)(2010-12#1)(2013-7#1)
that the average age of##2##5##(1992-2#2)
that the average size of the##2##6##(2005-11#1)(2008-2#1)
that the average##33##3##(1990-4#1)(1990-9#1)(1991-4#1)(1992-2#2)(1994-11#1)(1994-6#1)(1995-1#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-4#1)(1997-6#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#2)
that the avian##4##3##(1993-6#1)(1995-11#1)(1995-12#1)(2008-4#1)
that the axial##2##3##(2007-4#1)(2013-8#1)
that the axillary##3##3##(2004-2#1)(2008-5#2)
that the aziridine##2##3##(1991-5#2)
that the background##6##3##(1991-12#1)(2005-4#1)(2008-3#2)(2008-5#1)(2012-12#1)
that the backscattering##2##3##(2008-3#2)
that the bacteria##2##3##(1995-9#1)(2008-8#1)
that the bacterial##5##3##(1994-6#1)(1995-2#1)(1997-1#1)(2008-10#1)(2008-12#1)
that the bacterium##3##3##(1990-11#1)(1991-11#1)(1996-11#1)
that the balance of##3##4##(1992-3#1)(2006-10#1)(2008-8#1)
that the balance##5##3##(1992-3#1)(2006-10#1)(2008-4#1)(2008-8#1)(2008-9#1)
that the ban##2##3##(1995-6#1)(1996-6#1)
that the band##2##3##(2008-4#1)(2013-8#1)
that the bandwidth of##2##4##(2007-5#1)(2008-3#1)
that the barrier function##2##4##(2008-5#1)(2008-7#1)
that the barrier##8##3##(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)
that the basal ganglia##3##4##(1994-3#1)(1997-3#1)(2009-10#1)
that the basal##7##3##(1994-3#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-10#1)
that the basic##12##3##(1990-2#1)(1992-2#1)(1995-3#1)(1995-6#1)(1996-8#2)(2006-5#1)(2007-4#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-12#1)
that the basin##2##3##(1992-1#1)(2008-11#1)
that the basis for##2##4##(2007-8#1)(2012-2#1)
that the basis##3##3##(1993-11#1)(2007-8#1)(2012-2#1)
that the bcl-2##2##3##(1993-3#1)(1994-10#1)
that the behavior of the##2##5##(2008-10#1)(2008-2#1)
that the behavior of##5##4##(1992-4#1)(2008-10#2)(2008-2#1)(2008-3#1)
that the behavior##9##3##(1992-4#1)(2007-2#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2009-11#1)
that the behavioral##3##3##(1997-2#1)(2006-7#1)(2008-10#1)
that the behaviour of##2##4##(2008-10#1)(2011-2#1)
that the beneficial effect of##2##5##(2006-8#1)(2008-10#1)
that the beneficial effects of##2##5##(1992-7#1)(1994-6#1)
that the beneficial##5##3##(1992-7#1)(1994-6#1)(2006-8#1)(2008-10#1)(2013-1#1)
that the benefit##3##3##(1994-7#1)(1995-12#1)(2011-2#1)
that the benefits clearly##2##4##(2012-2#1)(2013-1#1)
that the benefits of the##2##5##(1992-12#1)(1996-8#1)
that the benefits of##6##4##(1992-12#1)(1996-8#1)(2005-10#1)(2005-7#1)(2006-4#1)(2012-12#1)
that the benefits##9##3##(1992-12#1)(1996-8#1)(2005-10#1)(2005-7#1)(2006-4#1)(2007-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
that the best approach##2##4##(1992-2#1)(2013-7#1)
that the best outcomes##2##4##(2007-11#1)(2007-7#1)
that the best results are obtained with##3##7##(1992-12#1)(2008-2#1)(2008-3#1)
that the best results are obtained##4##6##(1992-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
that the best results##5##4##(1992-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-3#1)
that the best way to##2##5##(2007-12#1)(2007-9#1)
that the best##36##3##(1991-3#1)(1992-12#1)(1992-2#2)(1995-12#1)(1995-5#1)(1996-3#2)(1996-5#1)(2006-10#1)(2006-3#1)(2007-11#4)(2007-12#1)(2007-7#2)(2007-9#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-5#2)(2009-11#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)
that the beta##3##3##(1991-5#1)(1995-3#1)(2006-5#1)
that the beta-sheet##3##3##(1995-1#1)(1995-5#1)(2005-11#1)
that the better##2##3##(2008-3#1)(2010-4#1)
that the bilaterally##2##3##(2007-12#1)(2008-5#1)
that the binding affinity##2##4##(1994-11#1)(1995-2#1)
that the binding of ATP##2##5##(1995-2#1)(1995-3#1)
that the binding of the##3##5##(1994-12#1)(1994-9#1)(2008-7#1)
that the binding of##28##4##(1990-12#1)(1990-3#1)(1990-8#1)(1991-6#1)(1991-9#1)(1992-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-9#4)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
that the binding site##4##4##(1994-11#1)(2005-7#1)(2008-11#1)(2008-8#1)
that the binding##51##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-8#2)(1991-4#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#2)(1994-9#4)(1995-1#1)(1995-10#2)(1995-2#3)(1995-3#1)(1995-5#1)(1996-10#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-7#1)(2005-7#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#4)(2011-1#1)
that the biobead##2##3##(2007-12#2)
that the biochemical##3##3##(1995-1#1)(2006-8#1)(2011-2#1)
that the biocontrol##2##3##(2008-10#2)
that the biological activity of##2##5##(1990-5#1)(1994-3#1)
that the biological activity##3##4##(1990-5#1)(1994-3#1)(1997-4#1)
that the biological##10##3##(1990-5#1)(1994-3#1)(1997-4#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-4#1)(2011-2#1)
that the biomass##2##3##(1991-11#1)(2008-3#1)
that the biosynthesis of##2##4##(1996-2#1)(2006-12#1)
that the birth##2##3##(1997-2#1)(2007-6#1)
that the blockade of##5##4##(1990-5#1)(1992-12#1)(1995-1#1)(2005-7#1)(2013-1#1)
that the blood##9##3##(1990-3#1)(1991-7#1)(1992-4#2)(1993-9#1)(1997-3#1)(2008-8#1)(2011-1#1)(2012-1#1)
that the body##5##3##(2007-12#1)(2011-1#3)(2013-7#1)
that the bonding##2##3##(2007-12#1)(2008-11#1)
that the bone marrow##2##4##(2009-3#1)(2009-4#1)
that the bone##3##3##(1993-11#1)(2009-3#1)(2009-4#1)
that the boron atom is##2##5##(1993-11#2)
that the botanical##2##3##(2008-10#2)
that the bound protein##2##4##(1995-1#1)(2006-10#1)
that the bound##4##3##(1990-2#1)(1993-11#1)(1995-1#1)(2006-10#1)
that the brain is##2##4##(1994-5#1)(2008-11#1)
that the brain##9##3##(1991-2#1)(1992-1#1)(1992-9#1)(1994-5#1)(1995-12#1)(1997-8#1)(2008-11#2)(2009-2#1)
that the brains##2##3##(1992-12#1)(2007-12#1)
that the brown##2##3##(1991-7#1)(1995-8#1)
that the bulk of##4##4##(1990-12#1)(1993-3#1)(2008-12#1)(2011-1#1)
that the bulk##5##3##(1990-12#1)(1991-10#1)(1993-3#1)(2008-12#1)(2011-1#1)
that the burden of##2##4##(1996-11#1)(2012-3#1)
that the burden##3##3##(1993-3#1)(1996-11#1)(2012-3#1)
that the cAMP##3##3##(1993-3#1)(1994-12#1)(2008-11#1)
that the cDNA obtained##2##4##(1997-2#1)(1997-7#1)
that the cDNA##10##3##(1990-12#1)(1992-5#1)(1993-6#1)(1994-8#1)(1995-8#1)(1996-5#1)(1997-2#2)(1997-7#1)(2008-8#1)
that the calcium##2##3##(1993-7#1)(2010-8#1)
that the calculated##3##3##(1991-3#1)(2008-10#2)
that the campaign##2##3##(1995-1#2)
that the capacity for##2##4##(1995-1#1)(2012-11#1)
that the capacity of the##4##5##(1995-11#1)(1995-2#1)(2008-3#1)(2012-1#1)
that the capacity of##6##4##(1995-11#1)(1995-2#1)(1997-5#1)(2008-3#1)(2012-1#1)(2012-2#1)
that the capacity to##2##4##(1991-5#1)(2008-1#1)
that the capacity##10##3##(1991-5#1)(1995-1#1)(1995-11#1)(1995-2#1)(1997-5#1)(2008-1#1)(2008-3#1)(2012-1#1)(2012-11#1)(2012-2#1)
that the carbohydrate##3##3##(1991-7#1)(1992-4#1)(1994-8#1)
that the carbon##3##3##(1993-10#1)(2011-2#1)(2013-1#1)
that the carbonyl##2##3##(1992-6#1)(2008-10#1)
that the carboxy##2##3##(1993-8#1)(2006-12#1)
that the carboxy-terminal##2##3##(1991-5#1)(1993-3#1)
that the carboxyl groups##2##4##(2008-10#2)
that the carboxyl##3##3##(1992-7#1)(2008-10#2)
that the carboxyl-terminal##4##3##(1991-10#1)(1992-6#1)(1994-9#1)(1995-2#1)
that the cardiac##8##3##(1993-3#1)(1994-12#1)(1995-12#1)(1995-2#1)(2005-10#1)(2008-10#1)(2011-12#1)(2012-3#1)
that the cardiovascular##3##3##(1993-12#1)(2007-12#1)(2012-2#1)
that the case##2##3##(2007-9#1)(2012-11#1)
that the cases##2##3##(1992-2#1)(1992-5#1)
that the catalytic domain##2##4##(1994-10#1)(1997-3#1)
that the catalytic##7##3##(1992-12#1)(1994-10#1)(1994-9#1)(1997-3#1)(2008-10#1)(2009-12#1)(2009-9#1)
that the cationic##3##3##(1994-12#1)(2007-8#1)(2008-5#1)
that the causative agent##2##4##(2006-8#1)(2007-6#1)
that the cause of the##3##5##(2008-10#1)(2008-2#1)(2011-2#1)
that the cause of##13##4##(1990-12#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2011-2#3)(2013-1#3)
that the cause##14##3##(1990-12#1)(2006-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2011-2#3)(2013-1#3)
that the cavity##3##3##(1996-2#1)(2007-12#2)
that the cell cycle##2##4##(1991-1#1)(1997-3#1)
that the cell density##2##4##(2008-11#1)(2012-1#1)
that the cell growth##2##4##(1992-9#1)(2005-11#1)
that the cell membrane##2##4##(1990-2#1)(2008-4#1)
that the cell##17##3##(1990-2#1)(1990-4#1)(1991-1#1)(1992-9#1)(1997-1#1)(1997-3#1)(2005-11#1)(2008-11#4)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-1#1)(2012-1#1)
that the cells are##3##4##(1992-6#1)(1995-7#1)(2008-11#1)
that the cells in the##2##5##(2006-8#1)(2007-11#1)
that the cells were##2##4##(2008-11#1)(2008-5#1)
that the cells##12##3##(1990-7#1)(1992-6#1)(1995-7#1)(1996-2#1)(2006-5#1)(2006-8#1)(2007-11#1)(2008-11#2)(2008-5#2)(2008-9#1)
that the cellular and##2##4##(2013-1#2)
that the cellular##7##3##(1991-9#1)(1994-6#1)(2004-9#1)(2008-5#1)(2009-3#1)(2013-1#2)
that the central##12##3##(1990-4#1)(1991-7#1)(1993-12#1)(1993-3#1)(1994-11#1)(1997-5#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2013-8#1)
that the centrifugal##2##3##(1994-2#1)(1995-11#1)
that the cerebellar##3##3##(1990-7#1)(1992-3#1)(1996-9#1)
that the cerebellum participates in##2##5##(2007-8#2)
that the cerebellum##7##3##(1991-1#1)(1991-8#1)(1993-7#1)(2007-8#4)
that the chain##2##3##(1997-8#1)(2013-1#1)
that the change from##2##4##(1990-8#1)(2008-6#1)
that the change in##4##4##(1990-8#1)(1991-5#1)(2006-10#1)(2009-5#1)
that the change of##2##4##(1995-1#1)(2005-4#1)
that the change##10##3##(1990-8#2)(1991-5#1)(1993-3#1)(1995-1#1)(2005-4#1)(2006-10#1)(2008-6#1)(2009-5#1)(2012-12#1)
that the changes in the##2##5##(1996-10#1)(2008-7#1)
that the changes in##8##4##(1992-1#1)(1993-3#1)(1996-10#1)(1997-8#1)(2005-11#1)(2008-7#1)(2008-9#1)(2012-2#1)
that the changes##12##3##(1990-9#1)(1992-1#1)(1993-3#1)(1996-10#1)(1997-8#1)(2005-11#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-3#1)(2012-2#1)(2013-8#1)
that the channel is##2##4##(1990-11#1)(2006-10#1)
that the channel##3##3##(1990-11#1)(1995-5#1)(2006-10#1)
that the channels##2##3##(1991-12#1)(1995-6#1)
that the chaperone system evolved##2##5##(2008-11#2)
that the characteristic##4##3##(1993-2#1)(1996-1#1)(2008-10#2)
that the charge transfer##2##4##(1993-6#1)(2008-10#1)
that the charge##6##3##(1993-6#1)(1996-11#1)(2005-11#1)(2008-10#2)(2008-8#1)
that the chemical step is rate-limiting##2##6##(1991-7#1)(1995-10#1)
that the chemical step##3##4##(1991-7#2)(1995-10#1)
that the chemical##6##3##(1991-7#2)(1995-10#1)(1996-2#1)(2009-3#2)
that the chemokine##2##3##(2008-1#1)(2010-11#1)
that the child##5##3##(1990-12#1)(1991-7#1)(2006-10#1)(2010-8#1)(2013-1#1)
that the children with##2##4##(2006-3#1)(2007-8#1)
that the children##5##3##(2006-3#1)(2007-8#1)(2008-4#1)(2008-9#1)(2011-1#1)
that the choice of##7##4##(1994-6#1)(1996-10#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-2#1)(2011-1#1)
that the choice##9##3##(1994-6#1)(1996-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-4#1)(2010-2#1)(2011-1#1)
that the chromophore##3##3##(1990-12#1)(1993-3#1)(2006-6#1)
that the chromosomal##3##3##(1991-5#1)(2009-6#1)(2010-12#1)
that the chromosome##4##3##(1997-4#1)(2008-8#1)(2012-3#1)(2013-7#1)
that the circadian##4##3##(1991-2#1)(1995-2#1)(2006-1#2)
that the class##4##3##(1995-5#1)(1995-8#1)(2007-8#1)(2008-10#1)
that the classic##5##3##(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-5#1)
that the classical##4##3##(2006-9#1)(2008-4#1)(2008-6#1)(2008-7#1)
that the classification##2##3##(2010-2#1)(2012-1#1)
that the cleavage##3##3##(1991-3#1)(1995-3#1)(2011-1#1)
that the clinical and##4##4##(1991-12#1)(2005-8#1)(2008-10#1)(2008-11#1)
that the clinical data##3##4##(1993-12#1)(2013-1#2)
that the clinical outcome of##2##5##(1996-11#1)(2013-1#1)
that the clinical##21##3##(1991-12#1)(1992-3#1)(1993-12#2)(1996-11#1)(1996-6#1)(1997-8#1)(2005-8#1)(2006-12#1)(2006-5#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-12#1)(2012-1#1)(2012-12#1)(2013-1#4)
that the clonal##2##3##(1996-10#1)(2008-10#1)
that the clone##3##3##(1994-8#1)(2008-8#2)
that the cloned##8##3##(1990-10#1)(1990-4#1)(1992-3#1)(1993-12#1)(1993-8#1)(1997-1#2)(1997-5#1)
that the close##2##3##(2008-10#2)
that the closest##2##3##(2008-10#1)(2010-11#1)
that the clusters##2##3##(1990-12#1)(1994-2#1)
that the coating##2##3##(2004-9#1)(2008-5#1)
that the coding##2##3##(1993-2#1)(2008-12#1)
that the cofactor##3##3##(1992-12#1)(1994-11#1)(1997-7#1)
that the coherence##2##3##(2007-11#1)(2007-12#1)
that the cold##2##3##(1994-12#1)(2009-8#1)
that the collagen sheets are##2##5##(2010-8#2)
that the collagen##4##3##(1991-9#1)(2008-10#1)(2010-8#2)
that the collapse##2##3##(1993-4#1)(2007-12#1)
that the collection##2##3##(1996-10#1)(2008-10#1)
that the collicular##2##3##(1991-5#1)(1994-2#1)
that the colonization##4##3##(1993-9#1)(2008-10#1)(2008-8#1)(2013-8#1)
that the color##2##3##(2008-3#2)
that the combination of a##3##5##(1997-1#1)(2007-11#1)(2008-5#1)
that the combination of##35##4##(1990-8#1)(1995-6#1)(1997-1#2)(1997-7#1)(1997-8#1)(2005-12#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-3#1)(2012-12#2)(2013-1#3)(2013-8#2)
that the combination##40##3##(1990-8#1)(1993-7#1)(1995-5#1)(1995-6#1)(1997-1#2)(1997-7#1)(1997-8#1)(2005-12#1)(2006-12#1)(2006-2#2)(2006-4#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-10#1)(2010-3#1)(2012-12#2)(2013-1#3)(2013-8#2)
that the combined##10##3##(1991-7#1)(1993-9#1)(2007-12#2)(2008-3#1)(2008-4#1)(2009-12#1)(2010-2#1)(2013-1#2)
that the common##13##3##(1990-11#1)(1991-8#1)(1992-5#1)(1995-5#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-2#1)(2010-8#1)
that the commonly used##4##4##(1992-6#1)(2006-10#1)(2008-3#1)(2013-1#1)
that the communication##2##3##(2008-12#1)(2008-2#1)
that the community can##2##4##(2008-11#1)(2011-2#1)
that the community##3##3##(1997-8#1)(2008-11#1)(2011-2#1)
that the competitive##2##3##(2007-4#1)(2012-2#1)
that the complete resistance to subgroup##2##6##(2008-10#2)
that the complete##10##3##(1990-5#1)(1992-12#1)(1993-3#1)(1995-3#1)(1995-5#1)(1996-4#1)(2008-10#3)(2008-3#1)
that the complex is##2##4##(2008-5#1)(2010-12#1)
that the complex##16##3##(1991-4#1)(1992-11#2)(1993-8#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-3#1)(1996-12#1)(1996-2#2)(2008-10#3)(2008-5#1)(2010-12#1)
that the complexation##4##3##(2006-12#1)(2008-10#3)
that the complexes are##4##4##(1995-5#1)(2008-5#1)(2008-6#1)(2009-8#1)
that the complexes##9##3##(1990-12#1)(1991-9#1)(1995-1#1)(1995-5#1)(1995-8#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-8#1)
that the complexity##2##3##(1991-7#1)(2006-7#1)
that the complicated##2##3##(2008-11#1)(2012-1#1)
that the complication##2##3##(2010-8#1)(2011-2#1)
that the component##3##3##(1995-2#2)(2012-1#1)
that the components of the##3##5##(2007-12#2)(2008-3#1)
that the components of##4##4##(2007-12#2)(2008-12#1)(2008-3#1)
that the components##5##3##(1992-12#1)(2007-12#2)(2008-12#1)(2008-3#1)
that the composite nanofiber mat##2##5##(2009-11#2)
that the composite##5##3##(2007-12#2)(2008-7#1)(2009-11#2)
that the composition of the##2##5##(2008-10#1)(2008-8#1)
that the composition of##5##4##(1994-11#1)(2007-1#1)(2008-10#1)(2008-8#1)(2008-9#1)
that the composition##6##3##(1994-11#1)(2004-9#1)(2007-1#1)(2008-10#1)(2008-8#1)(2008-9#1)
that the compound has##3##4##(1993-11#1)(1993-9#1)(2005-8#1)
that the compound was##2##4##(2005-7#1)(2008-10#1)
that the compound would##2##4##(2005-6#1)(2005-8#1)
that the compound##10##3##(1993-11#2)(1993-9#1)(2004-12#1)(2005-6#1)(2005-7#1)(2005-8#2)(2007-12#1)(2008-10#1)
that the compounds##7##3##(1991-12#1)(1992-12#1)(1994-9#1)(2006-8#1)(2007-11#1)(2008-10#1)(2012-3#1)
that the computed##2##3##(2008-2#1)(2010-2#1)
that the concentration of##10##4##(1997-6#1)(2005-6#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
that the concentration##13##3##(1997-2#1)(1997-6#1)(2005-11#1)(2005-6#1)(2007-12#1)(2008-10#2)(2008-5#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
that the concentrations of the##2##5##(1991-10#1)(2008-10#1)
that the concentrations of##9##4##(1991-10#1)(1992-6#1)(1996-4#1)(1996-8#1)(2008-10#2)(2010-5#1)(2011-2#1)(2012-1#1)
that the concentrations##10##3##(1991-10#1)(1992-6#1)(1995-3#1)(1996-4#1)(1996-8#1)(2008-10#2)(2010-5#1)(2011-2#1)(2012-1#1)
that the concept of a##2##5##(2006-10#1)(2006-6#1)
that the concept of##8##4##(1992-12#1)(2006-10#1)(2006-6#1)(2007-7#1)(2007-8#1)(2011-2#2)(2012-2#1)
that the concept##13##3##(1992-12#1)(2006-10#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-9#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
that the concerns##2##3##(2010-11#1)(2012-11#1)
that the condition##4##3##(2007-11#1)(2008-1#1)(2008-8#1)(2012-2#1)
that the conditions for##2##4##(2008-11#1)(2008-8#1)
that the conditions##5##3##(1995-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
that the conducting##3##3##(1991-6#1)(2006-7#1)(2008-11#1)
that the conformation of the##6##5##(1990-4#1)(1990-5#1)(1991-4#2)(1997-4#1)(2008-8#1)
that the conformation of##12##4##(1990-4#1)(1990-5#1)(1991-4#2)(1994-3#1)(1994-6#1)(1997-4#1)(2005-4#1)(2008-10#3)(2008-8#1)
that the conformation##14##3##(1990-4#1)(1990-5#1)(1991-4#2)(1992-6#1)(1994-3#1)(1994-6#1)(1997-4#1)(2005-4#1)(2006-10#1)(2008-10#3)(2008-8#1)
that the conformational##5##3##(1990-7#1)(1991-4#1)(1992-8#1)(1995-11#1)(2008-5#1)
that the conformations##2##3##(1996-2#1)(1996-8#1)
that the conserved##2##3##(1995-6#1)(1996-5#1)
that the considered##2##3##(2008-2#1)(2008-3#1)
that the constituent##2##3##(1991-11#1)(2007-1#1)
that the constitutive##2##3##(2012-12#1)(2013-1#1)
that the constructed##3##3##(2008-3#1)(2008-7#1)(2012-1#1)
that the construction of##3##4##(1990-11#1)(2008-8#1)(2012-2#1)
that the consumption of##2##4##(2004-11#1)(2008-1#1)
that the consumption##3##3##(2004-11#1)(2008-1#1)(2008-10#1)
that the contact##4##3##(1991-5#1)(1996-8#1)(2005-11#1)(2007-7#1)
that the content of##4##4##(1990-5#1)(2008-10#2)(2012-1#1)
that the content##5##3##(1990-5#1)(2008-1#1)(2008-10#2)(2012-1#1)
that the continued##3##3##(2007-11#1)(2008-3#1)(2012-2#1)
that the continuous##6##3##(1996-2#1)(2005-12#1)(2006-12#1)(2007-6#1)(2008-10#1)(2009-8#1)
that the contractile##4##3##(1991-6#2)(1996-12#1)(2008-4#1)
that the contribution of the##2##5##(1990-8#1)(1991-5#1)
that the contribution of##8##4##(1990-8#1)(1991-5#1)(1994-10#1)(1997-8#1)(2008-10#1)(2008-3#2)(2008-6#1)
that the contribution##10##3##(1990-8#1)(1991-5#1)(1994-10#1)(1997-8#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-6#1)
that the control group##2##4##(2007-10#1)(2010-6#1)
that the control of the##2##5##(1997-3#1)(2009-8#1)
that the control of##5##4##(1997-3#1)(2005-7#1)(2008-8#1)(2009-8#1)(2012-2#1)
that the control##10##3##(1997-3#1)(1997-8#1)(2005-7#1)(2007-10#1)(2008-8#2)(2009-8#1)(2010-4#1)(2010-6#1)(2012-2#1)
that the conventional##4##3##(1995-9#1)(1997-7#1)(2006-10#1)(2008-8#1)
that the conversion of##2##4##(2006-10#1)(2009-12#1)
that the conversion##5##3##(2006-10#1)(2007-12#2)(2008-2#1)(2009-12#1)
that the cooperative##3##3##(1994-8#1)(2006-10#1)(2008-8#1)
that the coordinate regulation of##2##5##(1991-5#1)(1996-7#1)
that the coordination##4##3##(1994-11#1)(1994-9#1)(1997-4#1)(2010-5#1)
that the copper##3##3##(1992-12#1)(1994-9#1)(1995-3#1)
that the core of the##2##5##(1992-8#1)(1995-1#1)
that the core of##3##4##(1992-8#1)(1995-1#1)(2006-10#1)
that the core protein##2##4##(1990-12#1)(2008-8#1)
that the core region##2##4##(1990-4#1)(2009-8#1)
that the core##14##3##(1990-10#1)(1990-12#1)(1990-4#1)(1992-8#1)(1994-5#1)(1995-1#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-10#1)(2008-5#1)(2008-8#1)(2009-8#1)(2012-3#1)
that the cornea##2##3##(2008-2#1)(2011-3#1)
that the correct diagnosis was##2##5##(1990-12#1)(1997-5#1)
that the correct##5##3##(1990-1#1)(1990-12#1)(1997-5#1)(2005-11#1)(2010-8#1)
that the correction##2##3##(2008-2#1)(2008-3#1)
that the correlation between##3##4##(1996-5#1)(2008-5#1)(2012-2#1)
that the correlation##8##3##(1991-2#1)(1996-5#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-11#1)(2012-2#1)
that the corresponding##7##3##(1991-2#1)(1997-1#1)(1997-7#1)(2006-12#1)(2007-11#1)(2008-3#2)
that the cost of##4##4##(2007-1#1)(2008-8#1)(2010-1#1)(2010-8#1)
that the cost##7##3##(1995-10#1)(1996-12#1)(2007-1#1)(2007-4#1)(2008-8#1)(2010-1#1)(2010-8#1)
that the costs##2##3##(2010-5#1)(2012-11#1)
that the cotransporter##2##3##(1991-4#1)(2008-8#1)
that the coupler has##2##4##(2008-2#2)
that the coupler##3##3##(2007-11#1)(2008-2#2)
that the coupling of##2##4##(2008-3#1)(2010-2#1)
that the coupling##5##3##(1994-8#1)(2008-3#2)(2010-2#1)(2010-5#1)
that the course##3##3##(1990-11#1)(2010-7#1)(2012-12#1)
that the court##2##3##(1990-11#2)
that the covalent##2##3##(1991-2#1)(2008-11#1)
that the coverage##2##3##(1990-12#1)(2008-10#1)
that the criteria of##2##4##(2008-4#1)(2010-2#1)
that the criteria##3##3##(2008-4#1)(2010-2#2)
that the critical##4##3##(1993-11#1)(1996-5#1)(2011-1#1)(2012-3#1)
that the cross talk##2##4##(1996-4#1)(2008-2#1)
that the crude extract##2##4##(1996-4#1)(2011-2#1)
that the crude##3##3##(1996-4#1)(2008-12#1)(2011-2#1)
that the crystal structure##3##4##(1997-5#1)(1997-7#1)(2008-10#1)
that the crystal##8##3##(1996-5#1)(1997-5#1)(1997-7#1)(2005-4#1)(2007-5#1)(2008-10#1)(2013-1#1)(2013-8#1)
that the cumulative##2##3##(2005-7#1)(2011-2#1)
that the current system##2##4##(1997-2#1)(2008-7#1)
that the current was##2##4##(1991-2#1)(1993-3#1)
that the current##30##3##(1991-2#1)(1993-2#1)(1993-3#2)(1994-12#1)(1995-12#1)(1995-9#1)(1996-2#1)(1996-5#1)(1997-2#1)(2005-11#1)(2007-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-11#1)(2013-1#1)
that the cw##2##3##(2007-12#1)(2008-2#1)
that the cyclic##3##3##(1995-1#1)(1995-9#1)(2009-8#1)
that the cyst##2##3##(2007-8#1)(2008-5#1)
that the cysteines##2##3##(1991-2#1)(1994-11#1)
that the cytokine##4##3##(1996-4#1)(2007-11#2)(2013-8#1)
that the cytoplasm of teosinte##3##5##(2008-5#3)
that the cytoplasm##5##3##(1991-11#1)(1995-1#1)(2008-5#3)
that the cytoplasmic domain of##3##5##(1991-1#1)(1994-9#1)(1995-8#1)
that the cytoplasmic domains of the##2##6##(1996-5#1)(2011-1#1)
that the cytoplasmic##12##3##(1990-10#1)(1991-1#1)(1992-5#1)(1994-9#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-9#1)(2009-2#1)(2011-1#1)
that the cytotoxic##2##3##(2008-10#1)(2012-12#1)
that the damage##4##3##(1990-5#1)(1996-7#1)(2008-10#1)(2013-8#1)
that the data are##5##4##(1990-8#1)(1992-2#1)(1993-5#1)(1994-2#1)(2010-2#1)
that the data from##4##4##(1992-11#1)(2008-10#1)(2008-6#1)(2010-6#1)
that the data##21##3##(1990-8#1)(1992-11#2)(1992-2#1)(1993-5#1)(1994-12#1)(1994-2#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-7#1)(2010-2#2)(2010-6#1)(2012-1#1)(2012-2#1)(2013-1#1)
that the death##2##3##(2005-8#1)(2013-8#1)
that the decision##5##3##(1991-7#1)(2004-10#1)(2006-10#1)(2010-2#1)(2010-8#1)
that the decline##2##3##(1991-2#1)(2006-12#1)
that the decrease in the##2##5##(1993-12#1)(1994-6#1)
that the decrease in##10##4##(1991-10#1)(1993-12#2)(1993-9#1)(1994-6#1)(1997-2#1)(2006-10#1)(2007-10#1)(2008-1#1)(2013-1#1)
that the decrease of##2##4##(1993-3#1)(2008-8#1)
that the decrease##15##3##(1991-10#1)(1991-8#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-6#1)(1997-2#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-8#1)(2012-12#1)(2013-1#1)
that the decreased##8##3##(1990-7#1)(1991-5#1)(1992-6#1)(1994-6#1)(1995-2#1)(1996-12#1)(1997-3#1)(2008-3#1)
that the deduced amino acid##2##5##(1996-10#1)(2008-9#1)
that the deduced##5##3##(1994-12#1)(1996-10#1)(1997-1#1)(2008-2#1)(2008-9#1)
that the deer##2##3##(2013-7#2)
that the defect in##2##4##(1994-8#1)(2008-11#1)
that the defects##2##3##(2008-10#1)(2008-4#1)
that the defendant##2##3##(1991-6#1)(1995-12#1)
that the deficiency##2##3##(2010-11#1)(2013-8#1)
that the deformation##3##3##(2005-11#1)(2011-1#1)(2013-1#1)
that the degeneracy##3##3##(1995-5#1)(2008-8#1)(2010-7#1)
that the degradation of##3##4##(1991-5#1)(2006-8#1)(2011-12#1)
that the degradation##5##3##(1991-5#1)(2006-8#1)(2008-3#1)(2009-11#1)(2011-12#1)
that the degree and##2##4##(2008-11#1)(2008-9#1)
that the degree of saturation##2##5##(2006-3#1)(2013-1#1)
that the degree of##12##4##(1990-11#1)(1990-12#1)(1992-9#1)(1993-3#1)(1994-8#1)(1996-9#1)(2006-3#1)(2007-8#1)(2008-2#2)(2011-1#1)(2013-1#1)
that the degree##14##3##(1990-11#1)(1990-12#1)(1992-9#1)(1993-3#1)(1994-8#1)(1996-9#1)(2006-3#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-9#1)(2011-1#1)(2013-1#1)
that the delay##3##3##(1996-2#1)(1997-2#2)
that the delayed##3##3##(1994-3#1)(2008-4#1)(2010-10#1)
that the deleted##2##3##(1993-6#1)(2013-8#1)
that the deletion of##2##4##(1991-10#1)(1997-3#1)
that the deletion##5##3##(1990-11#1)(1991-10#1)(1993-6#1)(1997-3#1)(2007-11#1)
that the delivered dose##2##4##(1996-2#2)
that the delivered##4##3##(1996-2#2)(2008-11#1)(2010-12#1)
that the demographic##3##3##(1995-2#1)(2007-7#1)(2008-7#1)
that the denaturation##2##3##(1991-2#1)(2006-10#1)
that the denatured##2##3##(1997-2#1)(2006-10#1)
that the dense##2##3##(2005-11#1)(2008-10#1)
that the density effect on spore production##2##7##(2008-10#2)
that the density of##2##4##(1994-5#1)(1996-5#1)
that the density##5##3##(1994-5#1)(1996-5#1)(2008-10#2)(2008-6#1)
that the dentate##2##3##(1994-11#1)(1994-8#1)
that the dependence of the##4##5##(2007-9#1)(2008-2#2)(2012-2#1)
that the dependence of##6##4##(2007-11#1)(2007-9#1)(2008-1#1)(2008-2#2)(2012-2#1)
that the depletion of##2##4##(1990-4#1)(1996-5#1)
that the depolarization##2##3##(1992-5#1)(2007-11#1)
that the deposit##3##3##(1995-12#1)(2008-10#1)(2010-4#1)
that the deposition of##3##4##(1991-1#1)(1995-6#1)(2006-4#1)
that the deposition##5##3##(1991-1#1)(1994-2#1)(1995-6#1)(2005-11#1)(2006-4#1)
that the depression##2##3##(1992-8#1)(1995-12#1)
that the derivative##3##3##(2005-11#1)(2008-10#2)
that the derived##2##3##(1997-2#1)(2012-1#1)
that the described##3##3##(1997-2#1)(2004-9#1)(2008-11#1)
that the desensitization##2##3##(1994-8#1)(2008-4#1)
that the design##4##3##(2006-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
that the designed##5##3##(1991-9#1)(1995-1#1)(1997-8#1)(2008-3#1)(2013-1#1)
that the desired##4##3##(1997-2#1)(2007-12#1)(2008-3#1)(2008-8#1)
that the destruction of##3##4##(1993-11#1)(2007-3#1)(2011-2#1)
that the detailed##2##3##(1990-11#1)(2008-2#1)
that the details of the##2##5##(2008-7#1)(2008-8#1)
that the detected##3##3##(2008-2#3)
that the detection limit of the##2##6##(1992-2#1)(2005-4#1)
that the detection limit of##3##5##(1992-2#1)(2005-4#1)(2008-11#1)
that the detection limit##5##4##(1992-2#1)(2005-4#2)(2008-10#1)(2008-11#1)
that the detection of##3##4##(1994-9#1)(2008-10#1)(2008-7#1)
that the detection##9##3##(1992-2#1)(1994-9#1)(2005-4#2)(2008-10#3)(2008-11#1)(2008-7#1)
that the detector is##2##4##(2007-12#1)(2008-3#1)
that the detector##4##3##(2007-12#2)(2008-10#1)(2008-3#1)
that the determination of##3##4##(1992-2#1)(2005-4#1)(2008-10#1)
that the developed biosensor is##2##5##(2007-8#1)(2008-10#1)
that the developed method##4##4##(2007-8#1)(2008-10#1)(2011-1#1)(2012-12#1)
that the developed models##2##4##(2007-8#1)(2008-8#1)
that the developed##11##3##(2005-11#1)(2007-8#3)(2008-10#3)(2008-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
that the development of a##3##5##(1996-8#1)(2006-11#1)(2012-1#1)
that the development of##16##4##(1990-8#1)(1994-9#1)(1995-1#1)(1996-8#1)(2005-7#1)(2006-11#1)(2006-12#1)(2007-11#2)(2007-8#1)(2008-1#1)(2009-3#1)(2010-7#1)(2012-1#1)(2012-12#1)(2013-7#1)
that the development##17##3##(1990-8#1)(1994-9#1)(1995-1#1)(1996-8#1)(2005-7#1)(2006-11#1)(2006-12#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-5#1)(2009-3#1)(2010-7#1)(2012-1#1)(2012-12#1)(2013-7#1)
that the developmental##4##3##(1996-5#1)(2006-11#1)(2007-1#1)(2007-12#1)
that the deviations from##2##4##(2007-11#1)(2008-7#1)
that the deviations##3##3##(1995-7#1)(2007-11#1)(2008-7#1)
that the device was##2##4##(2008-11#1)(2012-3#1)
that the device##6##3##(2008-11#3)(2008-2#1)(2009-5#1)(2012-3#1)
that the devices##2##3##(1996-2#1)(2008-11#1)
that the diagnosis of##5##4##(1996-12#1)(2006-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
that the diagnosis##8##3##(1996-12#2)(1997-8#1)(2006-10#1)(2007-4#1)(2008-3#1)(2008-7#1)(2011-2#1)
that the diagnostic##4##3##(1991-4#1)(1996-12#1)(2007-6#1)(2013-1#1)
that the dielectric##2##3##(1995-1#2)
that the difference between the##2##5##(2008-2#1)(2012-1#1)
that the difference between##3##4##(1992-2#1)(2008-2#1)(2012-1#1)
that the difference in the##6##5##(1994-12#1)(1996-7#1)(1997-2#1)(2008-2#2)(2012-2#1)
that the difference in##13##4##(1993-12#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-7#1)(1997-2#1)(2006-5#1)(2007-9#2)(2008-2#2)(2008-5#1)(2012-2#1)
that the difference of##4##4##(1990-4#1)(1996-4#1)(2008-11#1)(2010-7#1)
that the difference##22##3##(1990-4#1)(1991-4#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-4#1)(1996-7#1)(1997-2#1)(2006-5#1)(2007-9#2)(2008-11#2)(2008-2#3)(2008-5#1)(2010-7#1)(2012-1#1)(2012-2#1)
that the differences between the##3##5##(2008-1#1)(2008-10#1)(2013-8#1)
that the differences between##4##4##(1996-12#1)(2008-1#1)(2008-10#1)(2013-8#1)
that the differences in##8##4##(1992-11#1)(1995-8#1)(2008-11#1)(2008-2#1)(2009-2#1)(2009-8#1)(2012-2#1)(2012-3#1)
that the differences##15##3##(1990-1#1)(1992-11#1)(1995-8#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-1#1)(2009-11#1)(2009-2#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
that the different types of##2##5##(1992-2#1)(1993-8#1)
that the different##28##3##(1990-8#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-2#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2010-2#2)(2010-4#1)(2012-1#1)
that the differential expression of##2##5##(1993-12#1)(1997-8#1)
that the differential##14##3##(1991-2#1)(1991-5#2)(1993-12#1)(1995-12#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-8#1)(2011-12#1)(2011-2#1)(2013-8#1)
that the differentiation##4##3##(1993-6#1)(2008-9#1)(2012-1#1)(2013-7#1)
that the difficulties##2##3##(2007-8#1)(2008-4#1)
that the diffraction efficiency of a##2##6##(2008-2#1)(2008-3#1)
that the diffraction efficiency##3##4##(2008-2#1)(2008-3#2)
that the diffraction##5##3##(2008-1#1)(2008-2#2)(2008-3#2)
that the diffusion##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
that the digestion##3##3##(2008-10#3)
that the digestive##2##3##(2006-2#1)(2010-12#1)
that the dimer##2##3##(1992-12#1)(2010-5#1)
that the diminished##2##3##(1990-10#1)(1993-8#1)
that the direct##7##3##(1991-6#1)(1992-9#1)(1994-5#1)(2008-10#2)(2008-5#1)(2009-11#1)
that the direction of the##3##5##(2007-11#1)(2008-3#1)(2009-2#1)
that the direction of##4##4##(1997-6#1)(2007-11#1)(2008-3#1)(2009-2#1)
that the direction##6##3##(1997-6#1)(2007-11#1)(2008-3#1)(2008-8#1)(2009-2#1)(2010-7#1)
that the disease is##4##4##(2007-5#1)(2008-10#1)(2008-4#1)(2008-5#1)
that the disease may##2##4##(2006-10#1)(2012-12#1)
that the disease was##4##4##(1996-3#1)(2008-10#1)(2012-3#1)(2013-1#1)
that the disease##15##3##(1990-8#1)(1996-3#1)(2006-10#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-4#1)(2008-5#1)(2009-10#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
that the disorder##3##3##(2007-12#1)(2008-12#1)(2008-7#1)
that the displacement##2##3##(2008-3#2)
that the disruption of##3##4##(1997-1#1)(2007-11#1)(2008-12#1)
that the dissection##2##3##(2006-10#1)(2006-4#1)
that the dissociation##2##3##(1993-9#1)(1994-9#1)
that the dissolution of##2##4##(1991-8#1)(2005-11#1)
that the distal##4##3##(1991-6#1)(1996-11#1)(1996-5#1)(2007-12#1)
that the distance between##2##4##(1994-8#1)(1995-8#1)
that the distance##5##3##(1991-5#1)(1994-8#1)(1995-8#1)(1997-3#1)(2012-3#1)
that the distinction between##2##4##(2006-3#1)(2008-10#1)
that the distribution of the##7##5##(1990-12#1)(2005-11#1)(2006-6#1)(2008-11#1)(2008-5#1)(2011-1#1)(2013-1#1)
that the distribution of##20##4##(1990-12#1)(1996-4#1)(1997-1#1)(2005-11#1)(2006-10#1)(2006-6#1)(2006-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#4)(2008-9#1)(2010-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
that the distribution##22##3##(1990-12#1)(1996-4#1)(1997-1#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-6#1)(2006-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2010-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
that the distributions##2##3##(1997-8#1)(2010-11#1)
that the district##2##3##(1997-6#1)(2010-8#1)
that the disulfide##3##3##(1993-11#1)(1994-9#1)(2006-12#1)
that the doctor##3##3##(1992-12#1)(2007-2#1)(2008-4#1)
that the domain##2##3##(1994-12#1)(2008-10#1)
that the dominant contribution to##2##5##(2007-12#1)(2008-3#1)
that the dominant##16##3##(1994-6#1)(1996-12#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-8#1)(2011-1#1)(2012-12#2)
that the donor##2##3##(1991-7#1)(1994-3#1)
that the dopamine##3##3##(1995-11#1)(1996-10#1)(1996-5#1)
that the dopaminergic system is##2##5##(2006-9#1)(2009-6#1)
that the dopaminergic##3##3##(2006-9#1)(2007-10#1)(2009-6#1)
that the dorsal##2##3##(1993-9#1)(1995-12#1)
that the dose of##2##4##(1996-7#1)(2008-7#1)
that the dose##5##3##(1996-7#1)(2005-8#1)(2007-5#1)(2008-10#1)(2008-7#1)
that the doses##2##3##(1994-9#1)(2010-12#1)
that the dosing time##2##4##(2008-8#2)
that the double##3##3##(1992-8#1)(1996-5#1)(2008-5#1)
that the downstream region##2##4##(1992-4#2)
that the downstream##4##3##(1992-4#2)(1994-11#1)(2008-9#1)
that the drinking##2##3##(2007-3#1)(2008-11#1)
that the droplets##2##3##(2005-11#1)(2013-8#1)
that the drug has##2##4##(1994-2#1)(1995-4#1)
that the drug is##4##4##(1991-5#1)(2005-8#1)(2006-4#1)(2008-10#1)
that the drug was##3##4##(2008-5#2)(2010-5#1)
that the drug##23##3##(1990-10#1)(1990-4#1)(1991-5#1)(1992-9#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-4#1)(2005-8#1)(2006-4#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#4)(2010-4#1)(2010-5#1)(2011-2#1)(2012-3#1)
that the drugs##3##3##(1990-5#1)(1996-5#1)(2005-4#1)
that the dsRNA##2##3##(2008-10#2)
that the dual##2##3##(2012-12#1)(2013-8#1)
that the duplication##2##3##(1992-7#1)(2012-3#1)
that the duration of the##5##5##(1991-11#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)
that the duration of##8##4##(1991-11#1)(1993-2#1)(1997-5#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)
that the duty ratio##2##4##(2006-10#1)(2008-3#1)
that the dynamic##6##3##(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#1)(2012-2#1)
that the dynamics of the##2##5##(2007-12#1)(2008-8#1)
that the dynamics of##6##4##(1997-1#1)(2007-12#2)(2008-8#2)(2008-9#1)
that the dynamics##8##3##(1997-1#1)(2007-12#2)(2008-8#4)(2008-9#1)
that the earlier##4##3##(1992-8#1)(1993-7#1)(2008-11#1)(2013-8#1)
that the early##14##3##(1990-11#1)(1990-8#1)(1992-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-4#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-9#1)(2013-1#1)(2013-8#1)
that the education##2##3##(1997-1#1)(2006-2#1)
that the eel##3##3##(2005-8#1)(2008-5#2)
that the efe gene##4##4##(2008-10#4)
that the effect is##3##4##(1990-2#1)(1991-5#1)(2008-5#1)
that the effect of aging on the##2##7##(2008-7#2)
that the effect of melatonin##2##5##(2008-4#1)(2009-12#1)
that the effect of the##7##5##(1991-12#1)(1991-2#1)(1992-6#1)(1995-12#1)(2008-10#2)(2008-2#1)
that the effect of##54##4##(1990-10#1)(1990-11#1)(1991-1#1)(1991-12#1)(1991-2#2)(1992-6#2)(1993-3#2)(1994-11#1)(1994-3#3)(1994-8#2)(1995-10#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-2#2)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#5)(2009-12#1)(2009-3#1)(2009-6#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-7#1)
that the effect was##3##4##(1992-8#1)(2007-9#1)(2008-11#1)
that the effect##66##3##(1990-10#1)(1990-11#1)(1990-2#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-5#1)(1992-6#2)(1992-8#1)(1993-12#1)(1993-3#2)(1994-11#1)(1994-2#1)(1994-3#3)(1994-8#2)(1995-10#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#5)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#5)(2009-12#1)(2009-3#1)(2009-6#1)(2010-2#1)(2010-8#1)(2012-2#1)(2012-3#2)(2013-7#1)
that the effective##13##3##(1993-4#1)(1996-8#1)(1997-4#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-2#1)(2013-8#1)
that the effectiveness of##3##4##(1992-5#1)(1992-9#1)(2013-8#1)
that the effects observed##3##4##(1991-3#1)(1991-5#1)(2011-1#1)
that the effects of OP-1##2##5##(1994-6#2)
that the effects of the visceral stimuli were##2##8##(1991-8#2)
that the effects of the##5##5##(1991-8#2)(1992-2#1)(1996-11#1)(2008-11#1)
that the effects of these two##2##6##(1990-7#1)(1996-1#1)
that the effects of these##4##5##(1990-7#1)(1996-1#1)(2007-7#1)(2008-4#1)
that the effects of##52##4##(1990-10#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-8#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-3#1)(1994-6#2)(1994-9#2)(1996-1#1)(1996-11#1)(1996-3#1)(1997-7#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#4)(2008-9#1)(2009-11#1)(2010-12#1)(2010-8#2)(2011-2#4)(2012-3#1)(2013-1#1)
that the effects were not##2##5##(1991-1#1)(1994-2#1)
that the effects were##3##4##(1991-1#1)(1991-6#1)(1994-2#1)
that the effects##61##3##(1990-10#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-9#2)(1996-1#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-7#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#4)(2008-9#1)(2009-11#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#1)
that the efficacy of the##2##5##(2008-1#1)(2008-6#1)
that the efficacy of##8##4##(2007-11#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-6#1)(2009-9#1)(2010-5#1)
that the efficiency of the##3##5##(2007-11#1)(2008-3#1)(2009-10#1)
that the efficiency of##8##4##(1993-3#1)(1996-4#1)(1996-8#1)(2006-12#1)(2007-11#1)(2008-3#1)(2008-7#1)(2009-10#1)
that the efficiency##10##3##(1993-3#1)(1996-4#1)(1996-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)
that the egg##3##3##(2007-12#1)(2008-5#1)(2008-9#1)
that the eggs of##2##4##(2011-12#2)
that the eggs##3##3##(1997-6#1)(2011-12#2)
that the eigenmodes##2##3##(2007-11#1)(2007-12#1)
that the eight##2##3##(2008-7#1)(2010-7#1)
that the elderly##5##3##(1993-12#1)(2006-7#1)(2007-7#1)(2009-10#1)(2012-12#1)
that the electric##2##3##(2009-12#1)(2013-8#1)
that the electrical##2##3##(1990-5#1)(2009-8#1)
that the electrode potential##2##4##(2008-10#2)
that the electrode##9##3##(2007-8#1)(2008-10#8)
that the electrodes##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
that the electron transfer##5##4##(1991-8#1)(1994-12#1)(1997-7#1)(2005-11#1)(2008-10#1)
that the electronic##4##3##(1991-7#1)(2008-7#1)(2010-2#2)
that the electrostatic interactions##2##4##(1991-5#1)(2005-11#1)
that the electrostatic restoring##2##4##(2013-8#2)
that the electrostatic##7##3##(1991-5#1)(1994-5#1)(1995-10#1)(2005-11#2)(2013-8#2)
that the element##2##3##(1995-2#1)(2008-2#1)
that the elevated##4##3##(1990-8#1)(1992-10#1)(1995-12#1)(2008-5#1)
that the elevation of##2##4##(1991-2#1)(1995-7#1)
that the elimination of##2##4##(1992-8#1)(2010-7#1)
that the embryo##3##3##(1994-9#1)(2008-10#1)(2012-11#1)
that the embryonic##2##3##(2008-8#2)
that the emergence of##3##4##(2008-6#1)(2009-2#1)(2010-3#1)
that the emission##3##3##(2005-4#1)(2006-5#1)(2008-2#1)
that the emotional##2##3##(2006-3#1)(2007-7#1)
that the emphasis##3##3##(2010-9#1)(2012-2#1)(2013-7#1)
that the employed##2##3##(2006-10#1)(2009-11#1)
that the employee##2##3##(1995-6#1)(1996-12#1)
that the employer had##2##4##(1995-6#1)(1996-11#1)
that the end##3##3##(1994-12#1)(2006-1#1)(2008-3#1)
that the endogenous##7##3##(1990-11#1)(1990-5#1)(1991-11#1)(1995-6#1)(2008-5#1)(2008-7#1)(2009-10#1)
that the endometrium##2##3##(1991-3#1)(2012-3#1)
that the endonuclease##2##3##(1995-8#1)(2008-8#1)
that the endoscopic##2##3##(2006-6#1)(2009-2#1)
that the energy transfer##2##4##(1993-9#1)(2008-8#1)
that the energy##8##3##(1993-9#1)(1994-9#1)(2006-10#1)(2006-5#1)(2007-8#1)(2008-2#1)(2008-8#1)(2009-5#1)
that the enhanced##12##3##(1990-5#1)(1991-6#1)(1993-11#1)(1994-2#1)(1995-1#1)(1995-8#1)(1997-6#1)(2008-10#4)(2008-5#1)
that the enhancement in##2##4##(2008-3#1)(2008-7#1)
that the enhancement of the##2##5##(2007-12#1)(2008-10#1)
that the enhancement of##8##4##(1990-2#1)(1992-8#1)(1996-11#1)(1997-2#1)(2005-11#1)(2007-12#1)(2008-10#2)
that the enhancement##11##3##(1990-2#1)(1992-8#1)(1996-11#1)(1997-2#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)
that the enthalpy##2##3##(1997-2#1)(2006-10#1)
that the entire##9##3##(1994-12#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-9#1)(2010-3#1)
that the entrapped##2##3##(2008-11#1)(2011-2#1)
that the environment of##2##4##(1990-2#1)(1991-7#1)
that the environment##4##3##(1990-2#1)(1991-7#1)(2007-3#1)(2008-5#1)
that the environmental##9##3##(1991-6#1)(1992-3#1)(1992-6#1)(1996-9#1)(2008-10#1)(2008-3#1)(2011-3#1)(2012-2#1)(2013-1#1)
that the enzymatic##4##3##(1990-7#1)(1996-2#1)(1997-7#1)(2008-10#1)
that the enzyme exists##2##4##(1990-9#1)(1994-8#1)
that the enzyme is##8##4##(1990-2#1)(1991-3#1)(1991-7#1)(1992-3#1)(1992-4#1)(1992-9#1)(1994-11#1)(2008-9#1)
that the enzyme preferentially##2##4##(1990-10#1)(1994-5#1)
that the enzyme preparation is##2##5##(1991-3#1)(1995-5#1)
that the enzyme was##6##4##(1990-7#1)(1990-8#1)(1991-5#1)(1991-8#1)(1991-9#1)(1995-3#1)
that the enzyme which##2##4##(1995-1#1)(1996-6#1)
that the enzyme##43##3##(1990-10#1)(1990-2#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#2)(1992-9#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-6#2)(1997-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#2)(2011-1#1)
that the enzymes are##3##4##(1990-5#1)(1991-3#1)(1996-7#1)
that the enzymes##4##3##(1990-5#1)(1991-3#1)(1991-4#1)(1996-7#1)
that the epithelial##2##3##(1992-1#1)(2008-5#1)
that the epitopes##2##3##(1990-12#1)(2008-10#1)
that the equation##2##3##(1995-2#1)(2008-3#1)
that the equilibrium##3##3##(1993-6#1)(2008-10#1)(2008-8#1)
that the equivalent##3##3##(2008-3#2)(2009-8#1)
that the error in##2##4##(2008-2#2)
that the error##11##3##(1997-2#2)(2008-2#5)(2008-3#2)(2009-4#1)(2012-3#1)
that the errors in the##2##5##(2007-12#1)(2008-2#1)
that the errors in##3##4##(2007-12#1)(2008-2#2)
that the erythrocyte##2##3##(1991-2#1)(1995-6#1)
that the essential##6##3##(1994-2#1)(1996-7#1)(2005-11#1)(2008-10#1)(2008-4#1)(2010-12#1)
that the establishment of an##2##5##(1997-7#1)(2007-9#1)
that the establishment of##5##4##(1997-7#1)(2006-10#1)(2007-9#1)(2012-12#2)
that the esterase##2##3##(1991-5#1)(2012-2#1)
that the estimated##2##3##(1994-8#1)(2007-12#1)
that the estimation##3##3##(1990-5#1)(2008-2#2)
that the estrogen receptor##2##4##(1990-7#1)(1996-2#1)
that the estrogen##3##3##(1990-7#1)(1996-2#1)(2013-1#1)
that the ethanol##2##3##(2005-10#1)(2008-10#1)
that the etiology of##3##4##(1996-3#1)(1996-9#1)(2011-3#1)
that the etiology##4##3##(1993-8#1)(1996-3#1)(1996-9#1)(2011-3#1)
that the event will##2##4##(2008-10#2)
that the evidence##6##3##(2006-9#1)(2007-6#1)(2010-7#1)(2011-2#2)(2012-1#1)
that the evolution of##3##4##(2008-8#2)(2012-3#1)
that the evolution##5##3##(2007-12#1)(2008-8#2)(2008-9#1)(2012-3#1)
that the evolutionarily stable##2##4##(2008-8#1)(2008-9#1)
that the evolutionarily##3##3##(1994-8#1)(2008-8#1)(2008-9#1)
that the evolutionary##3##3##(2008-10#2)(2010-4#1)
that the exact##3##3##(1995-11#1)(2008-10#1)(2008-3#1)
that the excellent##2##3##(2008-10#2)
that the excess##3##3##(1995-6#1)(2005-10#1)(2008-2#1)
that the exchange##2##3##(1995-2#1)(2008-10#1)
that the existence of an##2##5##(2008-7#1)(2013-7#1)
that the existence of the##3##5##(1990-12#1)(2007-1#1)(2008-1#1)
that the existence of##12##4##(1990-12#1)(1994-9#1)(1997-2#1)(2006-7#1)(2007-1#1)(2007-6#1)(2008-1#1)(2008-7#2)(2008-8#1)(2010-3#1)(2013-7#1)
that the existence##13##3##(1990-12#1)(1994-9#1)(1997-2#1)(2006-7#1)(2007-1#1)(2007-6#1)(2008-1#1)(2008-7#2)(2008-8#1)(2010-3#1)(2013-7#1)(2013-8#1)
that the existing##6##3##(1995-1#1)(2007-7#1)(2008-11#1)(2010-12#1)(2011-2#1)(2012-2#1)
that the expected runtime##2##4##(2010-2#2)
that the expected##4##3##(2007-12#1)(2008-9#1)(2010-2#2)
that the experience##2##3##(1996-3#1)(2010-3#1)
that the experimental##17##3##(1990-11#1)(1990-8#1)(1991-4#1)(1996-2#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-12#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2012-12#1)
that the experimentally##3##3##(1992-5#1)(2005-11#1)(2009-5#1)
that the exposure of##5##4##(2008-1#1)(2008-11#1)(2009-7#1)(2010-12#1)(2012-2#1)
that the exposure##6##3##(2008-1#1)(2008-11#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-2#1)
that the expressed##5##3##(1992-5#1)(1994-5#1)(1994-8#1)(2008-8#1)(2010-6#1)
that the expression and##3##4##(1993-6#1)(1994-12#1)(1995-2#1)
that the expression level##3##4##(2008-10#1)(2008-8#1)(2009-8#1)
that the expression levels of##2##5##(1994-11#1)(2008-10#1)
that the expression levels##3##4##(1994-11#1)(2008-10#1)(2008-9#1)
that the expression of a##2##5##(1993-6#1)(1994-2#1)
that the expression of the##13##5##(1990-5#1)(1991-5#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-7#1)(1996-4#2)(1997-2#1)(1997-7#1)(2007-11#1)(2008-9#1)(2013-1#1)
that the expression of these two##2##6##(1991-9#1)(1992-1#1)
that the expression of these##4##5##(1991-9#1)(1992-1#2)(1997-3#1)
that the expression of##62##4##(1990-11#1)(1990-5#2)(1991-10#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-3#2)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#3)(1995-7#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-7#3)(2005-8#1)(2007-11#1)(2008-10#1)(2008-8#3)(2008-9#4)(2009-10#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-1#3)(2013-8#1)
that the expression pattern of##2##5##(1993-6#1)(2008-6#1)
that the expression product##2##4##(2008-8#1)(2008-9#1)
that the expression##78##3##(1990-11#1)(1990-5#2)(1991-10#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-3#2)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#3)(1993-8#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-2#2)(1995-3#3)(1995-7#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-7#3)(2005-8#1)(2007-11#2)(2008-10#3)(2008-6#1)(2008-8#5)(2008-9#6)(2009-10#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-1#3)(2013-8#1)
that the extensive##2##3##(2007-12#1)(2009-6#1)
that the extent of a##2##5##(1994-10#1)(2006-8#1)
that the extent of adsorption##2##5##(2005-11#1)(2008-6#1)
that the extent of##15##4##(1990-5#1)(1994-10#1)(1994-8#1)(2005-11#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-5#4)(2008-6#1)(2010-12#1)
that the extent##16##3##(1990-5#1)(1994-10#1)(1994-8#1)(2005-11#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-5#4)(2008-6#1)(2010-12#1)
that the extinction##2##3##(2007-12#1)(2008-2#1)
that the extra allele is##2##5##(2008-12#2)
that the extracellular##4##3##(1991-10#1)(1991-9#2)(1993-3#1)
that the extract of A##2##5##(2013-7#2)
that the extract##6##3##(2008-10#1)(2009-5#1)(2009-6#1)(2013-7#3)
that the extractability##2##3##(1994-8#1)(2008-10#1)
that the extracted##2##3##(1997-3#1)(2012-1#1)
that the extraction of##2##4##(2008-10#2)
that the extraction##5##3##(2007-8#1)(2008-10#3)(2012-1#1)
that the extreme##2##3##(1996-2#1)(2006-12#1)
that the facilitatory effect##2##4##(1991-2#1)(1995-11#1)
that the facility##2##3##(1991-12#1)(2012-2#1)
that the fact##2##3##(2008-2#2)
that the factor may act##2##5##(1992-11#1)(1996-11#1)
that the factor##7##3##(1990-2#2)(1992-11#1)(1992-3#1)(1996-11#1)(1996-2#1)(2007-8#1)
that the factors and##2##4##(2007-12#1)(2008-10#1)
that the factors##6##3##(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#3)
that the failure to##4##4##(1991-12#1)(2009-2#1)(2013-1#2)
that the failure##6##3##(1991-12#1)(1995-1#1)(1995-10#1)(2009-2#1)(2013-1#2)
that the fall##3##3##(2007-8#1)(2013-1#2)
that the familiar##2##3##(1994-1#1)(2008-2#1)
that the family of##2##4##(1994-9#1)(2008-1#1)
that the family should##2##4##(2006-12#1)(2008-5#1)
that the family##6##3##(1994-9#1)(2006-12#1)(2008-1#1)(2008-5#1)(2009-8#1)(2011-2#1)
that the fat##5##3##(1991-11#1)(1995-7#1)(2007-10#1)(2007-12#1)(2011-2#1)
that the fatty acid##2##4##(1990-2#1)(2013-1#1)
that the fear of##2##4##(2007-8#1)(2013-8#1)
that the features of##2##4##(1992-4#1)(2007-12#1)
that the features##4##3##(1992-4#1)(2007-12#1)(2008-3#1)(2013-8#1)
that the federal government##3##4##(1997-2#1)(1997-3#1)(2008-2#1)
that the federal##5##3##(1995-2#1)(1997-2#1)(1997-3#1)(2008-2#1)(2009-10#1)
that the feedback##2##3##(2008-8#1)(2009-8#1)
that the fiber##2##3##(2007-12#2)
that the fiber-optic##2##3##(2008-2#1)(2011-1#1)
that the fibrin##2##3##(2011-2#1)(2012-12#1)
that the fibrinogen##2##3##(1995-2#1)(2011-1#1)
that the field of##3##4##(1994-1#1)(1997-6#1)(2008-3#1)
that the field##4##3##(1994-1#1)(1997-6#1)(2008-12#1)(2008-3#1)
that the filamentous##3##3##(2008-10#1)(2012-11#2)
that the film surface##2##4##(2005-11#1)(2013-1#1)
that the film##4##3##(2005-11#1)(2008-10#2)(2013-1#1)
that the films##3##3##(1991-3#1)(2008-2#2)
that the filter##2##3##(2008-2#1)(2008-3#1)
that the final##8##3##(1992-12#1)(2007-12#1)(2008-3#2)(2008-5#2)(2010-3#1)(2013-8#1)
that the finding of##2##4##(1991-12#1)(2008-7#1)
that the findings##5##3##(1993-12#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-12#1)
that the fine##3##3##(2006-11#1)(2007-11#2)
that the finite##2##3##(1990-5#1)(2008-2#1)
that the first and##2##4##(1994-12#1)(1997-4#1)
that the first intron##2##4##(2008-9#2)
that the first peak##2##4##(1992-9#1)(2008-3#1)
that the first type##2##4##(2008-2#1)(2008-3#1)
that the first##40##3##(1990-12#1)(1990-8#1)(1991-1#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-1#1)(1996-5#1)(1996-7#1)(1997-4#1)(1997-6#2)(2004-1#1)(2005-5#1)(2006-10#1)(2006-2#1)(2006-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
that the fish should##2##4##(2008-7#1)(2010-8#1)
that the fish##3##3##(2008-7#1)(2010-8#1)(2012-1#1)
that the five##4##3##(1993-11#1)(1996-8#1)(2008-10#1)(2008-5#1)
that the flanking##2##3##(1992-5#1)(1997-2#1)
that the flexibility of the##2##5##(1990-12#1)(1994-9#1)
that the flexibility of##3##4##(1990-12#1)(1994-9#1)(1997-1#1)
that the flexible##5##3##(1992-11#1)(1994-2#1)(1994-8#1)(1997-6#1)(2007-10#1)
that the flexural##2##3##(2009-5#1)(2009-7#1)
that the flow rate##2##4##(1996-6#1)(2007-8#1)
that the flow##6##3##(1996-12#1)(1996-6#1)(2005-10#1)(2007-10#1)(2007-8#1)(2008-2#1)
that the fluctuations are##2##4##(1996-4#1)(2007-12#1)
that the fluctuations##4##3##(1995-6#1)(1996-4#1)(2007-12#1)(2008-5#1)
that the fluid##2##3##(2005-11#1)(2008-6#1)
that the fluorescence intensity of##3##5##(2008-10#2)(2008-5#1)
that the fluorescence intensity##4##4##(2008-10#2)(2008-5#1)(2008-7#1)
that the fluorescence##14##3##(1993-9#1)(1994-11#1)(1995-5#1)(2005-11#1)(2008-10#5)(2008-3#2)(2008-5#1)(2008-7#1)(2010-12#1)
that the fluorescent##2##3##(2005-4#1)(2008-2#1)
that the fluorosilicone copolymers##2##4##(2005-11#2)
that the fly##3##3##(2008-10#3)
that the focal##2##3##(2007-12#2)
that the focus##2##3##(1993-12#1)(2008-2#1)
that the folding of##2##4##(1996-5#1)(1997-1#1)
that the folding##5##3##(1995-6#1)(1996-5#1)(1997-1#1)(1997-2#2)
that the following##3##3##(1991-4#1)(1994-5#1)(2008-11#1)
that the food##2##3##(2008-1#1)(2009-8#1)
that the forced##2##3##(2009-12#1)(2011-2#1)
that the form of the##3##5##(2008-10#1)(2008-2#1)(2008-8#1)
that the form of##5##4##(2008-10#2)(2008-2#1)(2008-8#2)
that the form##7##3##(1990-2#1)(1991-11#1)(2008-10#2)(2008-2#1)(2008-8#2)
that the formation of the##5##5##(1990-2#1)(1991-3#1)(1993-11#1)(1995-10#1)(2008-5#1)
that the formation of this##2##5##(1992-9#1)(2007-12#1)
that the formation of##19##4##(1990-2#1)(1991-3#1)(1991-7#1)(1992-9#1)(1993-11#1)(1994-2#1)(1994-8#2)(1995-10#2)(1997-2#1)(1997-7#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-5#1)(2009-7#1)(2012-11#1)(2013-1#1)
that the formation##21##3##(1990-2#1)(1991-3#1)(1991-7#1)(1992-9#1)(1993-11#1)(1994-2#1)(1994-8#2)(1995-10#2)(1997-2#1)(1997-7#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-11#1)(2008-5#1)(2009-7#1)(2010-4#1)(2012-11#1)(2013-1#1)
that the former is##2##4##(1990-12#1)(2008-3#1)
that the former##12##3##(1990-12#1)(1993-6#1)(1996-5#1)(1997-7#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-8#1)(2012-12#1)
that the formulations##2##3##(2008-5#2)
that the four##7##3##(1990-11#1)(1997-4#1)(2008-10#2)(2008-12#1)(2008-5#1)(2013-8#1)
that the fractal dimension##2##4##(2005-11#2)
that the fraction of##9##4##(1991-7#1)(1997-7#1)(2005-11#2)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#2)
that the fractions##2##3##(2008-10#2)
that the fracture is##2##4##(2006-3#1)(2007-11#1)
that the fracture##3##3##(2006-11#1)(2006-3#1)(2007-11#1)
that the fragment contains one complete open reading##2##8##(2005-11#1)(2008-8#1)
that the fragment is##2##4##(1992-6#2)
that the fragment##6##3##(1991-4#1)(1992-6#2)(1995-3#1)(2005-11#1)(2008-8#1)
that the fragmentation of Cu##2##5##(1997-8#2)
that the framework##2##3##(1996-2#1)(2006-12#1)
that the free##3##3##(1991-2#1)(2006-10#1)(2006-11#1)
that the frequency of the##3##5##(2008-3#1)(2012-1#1)(2013-1#1)
that the frequency of##15##4##(1993-5#1)(1994-11#1)(1997-4#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-10#1)(2008-11#2)(2008-3#1)(2009-5#1)(2011-12#1)(2012-1#1)(2013-1#1)
that the frequency##18##3##(1993-5#1)(1994-11#1)(1997-4#1)(2007-11#2)(2007-2#1)(2007-7#2)(2008-10#2)(2008-11#2)(2008-3#1)(2009-5#1)(2011-12#1)(2012-1#1)(2012-12#1)(2013-1#1)
that the frequent##2##3##(1992-5#1)(2008-2#1)
that the full length of##2##5##(2005-11#1)(2008-8#1)
that the full##4##3##(2005-11#1)(2007-12#1)(2008-1#1)(2008-8#1)
that the full-length##2##3##(1992-11#1)(1997-4#1)
that the fully##3##3##(1990-8#1)(2008-3#2)
that the function of the##3##5##(1995-5#1)(1995-7#1)(2008-6#1)
that the function of##7##4##(1995-5#1)(1995-7#1)(1997-4#1)(1997-7#1)(2008-11#1)(2008-6#1)(2008-9#1)
that the function##8##3##(1995-5#1)(1995-7#1)(1997-4#1)(1997-7#1)(2007-4#1)(2008-11#1)(2008-6#1)(2008-9#1)
that the functional##20##3##(1990-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1995-1#1)(1995-3#1)(1995-9#2)(1997-7#3)(2007-1#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-4#1)(2012-2#1)
that the functionality##2##3##(1995-12#1)(2009-3#1)
that the functions of##2##4##(1990-3#1)(2007-10#1)
that the functions##4##3##(1990-3#1)(1995-2#1)(2007-10#1)(2012-3#1)
that the fundamental##7##3##(1992-2#1)(1993-6#1)(2005-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-8#1)
that the fungal##4##3##(1990-12#1)(2008-10#1)(2008-12#1)(2008-9#1)
that the fungus produced##2##4##(2008-10#2)
that the fungus##9##3##(2008-10#8)(2012-11#1)
that the fusion of##2##4##(1991-5#1)(2008-8#1)
that the fusion protein##2##4##(2005-11#1)(2008-8#1)
that the fusion##7##3##(1991-5#1)(1994-11#1)(1994-12#1)(1997-3#1)(2005-11#1)(2008-8#2)
that the future of##2##4##(1996-2#1)(2009-5#1)
that the future##6##3##(1990-2#1)(1996-2#2)(2006-10#1)(2008-1#1)(2009-5#1)
that the gain##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
that the gamma subunit is##2##5##(1990-12#1)(2008-8#1)
that the gamma subunit##3##4##(1990-12#1)(1992-11#1)(2008-8#1)
that the gamma##7##3##(1990-10#1)(1990-12#1)(1992-11#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-8#1)
that the gas##2##3##(2008-11#1)(2011-12#1)
that the gastric##2##3##(1997-4#1)(2008-5#1)
that the gating##3##3##(1990-11#1)(2006-2#1)(2008-8#1)
that the gel##2##3##(2005-11#1)(2008-4#1)
that the gender##2##3##(2006-2#1)(2011-2#1)
that the gene encoding the##2##5##(2008-10#1)(2008-9#1)
that the gene encoding this##2##5##(1994-10#1)(1995-6#1)
that the gene encoding##4##4##(1994-10#1)(1995-6#1)(2008-10#1)(2008-9#1)
that the gene is##4##4##(1990-5#1)(1992-7#1)(1993-2#1)(1995-8#1)
that the gene product##2##4##(1991-10#1)(1997-4#1)
that the gene was##4##4##(1995-5#1)(1995-8#1)(1997-2#1)(2008-10#1)
that the gene##32##3##(1990-11#1)(1990-5#2)(1990-7#1)(1991-10#1)(1991-4#1)(1992-3#1)(1992-7#1)(1993-2#1)(1994-10#1)(1994-12#1)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#2)(1996-10#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
that the general public##2##4##(2007-11#1)(2007-12#1)
that the general##9##3##(2005-12#1)(2005-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-12#1)(2011-2#1)(2013-1#1)
that the generation of##5##4##(1990-8#1)(1994-5#1)(1997-4#1)(2010-2#1)(2010-7#1)
that the genes##10##3##(1991-9#1)(1993-3#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-7#1)(2006-8#1)(2007-11#1)(2012-3#2)
that the genetic##17##3##(1991-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-3#1)(1996-4#1)(1997-5#1)(2008-10#3)(2008-8#1)(2008-9#2)(2009-8#1)(2012-12#1)
that the genetics of##2##4##(1996-5#1)(2008-10#1)
that the genome##3##3##(2009-5#1)(2011-2#2)
that the genomic##4##3##(1993-6#1)(1997-6#1)(2010-3#1)(2013-8#1)
that the genus##5##3##(1996-3#1)(2008-6#1)(2009-5#1)(2010-3#2)
that the geographical##2##3##(2008-8#2)
that the geometry of##2##4##(1997-3#1)(1997-4#1)
that the glass##2##3##(2007-12#1)(2009-3#1)
that the global conformation of##2##5##(1990-4#1)(2008-8#1)
that the global##6##3##(1990-4#1)(1991-4#1)(1996-5#1)(2007-9#1)(2008-2#1)(2008-8#1)
that the glucose##4##3##(1994-2#1)(2007-8#1)(2008-10#2)
that the glutamatergic system##2##4##(2008-7#2)
that the glutamatergic##3##3##(2008-3#1)(2008-7#2)
that the glycine residue##2##4##(1991-2#1)(1996-5#1)
that the gold##4##3##(2007-12#1)(2008-10#2)(2009-2#1)
that the government##2##3##(2008-11#1)(2010-1#1)
that the granule##2##3##(1994-8#1)(1995-8#1)
that the grating##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
that the greater##4##3##(1997-1#1)(2005-11#1)(2007-6#1)(2009-8#1)
that the greatest##7##3##(1993-11#1)(1994-8#1)(2006-10#1)(2007-6#1)(2008-6#1)(2008-7#1)(2008-8#1)
that the ground##2##3##(2007-1#1)(2008-3#1)
that the group##7##3##(1993-3#2)(2006-2#1)(2007-10#1)(2008-10#1)(2009-2#1)(2012-3#1)
that the groups##2##3##(2007-11#1)(2008-11#1)
that the growth of##5##4##(1994-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
that the growth rate##2##4##(2008-7#1)(2009-9#1)
that the growth##13##3##(1990-3#2)(1991-3#1)(1993-7#1)(1994-10#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-4#1)
that the growth-phase-dependent##2##3##(1991-12#1)(2009-6#1)
that the guards were concerned about##2##6##(1995-6#2)
that the guiding##2##3##(2007-12#2)
that the gut##3##3##(1995-6#1)(2008-5#1)(2012-1#1)
that the hKLK2##2##3##(1993-6#2)
that the half-life of##2##4##(1992-4#1)(1993-12#1)
that the half-life##3##3##(1992-4#1)(1993-12#1)(1995-6#1)
that the health##5##3##(1995-6#1)(2006-5#1)(2007-3#1)(2008-6#1)(2008-7#1)
that the heart##3##3##(1991-4#1)(1993-12#1)(1994-7#1)
that the heat capacity of##2##5##(1997-2#1)(2006-10#1)
that the heat capacity##4##4##(1997-2#1)(2006-10#3)
that the heat##9##3##(1991-2#1)(1992-6#1)(1994-8#1)(1997-2#1)(2006-10#4)(2008-5#1)
that the heavy##2##3##(1997-9#1)(2008-10#1)
that the helix##3##3##(1991-4#1)(1992-1#1)(1995-1#1)
that the heme iron of the##2##6##(1997-4#2)
that the heme##8##3##(1990-7#1)(1993-6#1)(1995-11#1)(1997-4#2)(1997-6#1)(2009-3#2)
that the heparan##2##3##(1990-10#1)(1997-3#1)
that the hepatic##4##3##(1992-3#1)(1993-9#1)(1994-3#1)(1995-6#1)
that the heterodimer##2##3##(2008-9#1)(2011-1#1)
that the heterogeneity of##2##4##(2008-1#1)(2009-4#1)
that the heterogeneity##3##3##(2008-1#1)(2008-8#1)(2009-4#1)
that the hexamer##3##3##(1994-6#1)(1995-3#1)(1997-2#1)
that the high affinity##6##4##(1990-4#1)(1990-5#1)(1991-1#1)(1992-4#1)(1996-8#1)(1996-9#1)
that the high level of##2##5##(2007-7#1)(2008-10#1)
that the high prevalence of##3##5##(2006-8#1)(2011-1#1)(2011-2#1)
that the high rate of##2##5##(1991-12#1)(2008-9#1)
that the high##30##3##(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1992-4#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-7#1)(1996-8#1)(1996-9#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)
that the high-affinity##2##3##(1994-3#1)(1995-12#1)
that the high-risk##2##3##(1991-6#1)(2010-2#1)
that the high-temperature##2##3##(2008-10#2)
that the higher the##5##4##(1994-2#1)(2006-12#1)(2007-10#1)(2008-11#1)(2008-5#1)
that the higher##22##3##(1990-12#1)(1990-9#1)(1993-2#1)(1994-2#1)(1996-12#1)(1996-7#1)(2004-9#1)(2005-12#1)(2006-12#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#2)(2012-11#1)(2013-1#1)(2013-8#1)
that the highest rates of##2##5##(2006-3#1)(2008-7#1)
that the highest##14##3##(1990-11#1)(2006-3#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#2)(2008-7#1)(2008-8#1)(2012-12#1)
that the highly##4##3##(1991-2#1)(1995-11#1)(1996-2#1)(2012-2#1)
that the hinge##3##3##(1994-2#1)(2012-12#2)
that the hippocampal##2##3##(1990-10#1)(1992-8#1)
that the hippocampus##4##3##(1993-5#1)(1993-6#1)(1994-11#1)(2013-8#1)
that the historic##2##3##(2007-5#1)(2009-4#1)
that the historical##2##3##(2008-10#1)(2013-1#1)
that the history of##2##4##(2006-5#1)(2010-1#1)
that the homeodomain of Bcd alone##2##6##(1996-8#2)
that the homogeneity##2##3##(1996-9#1)(2008-10#1)
that the homology##2##3##(2008-9#1)(2012-2#1)
that the horizontal##3##3##(1991-1#1)(1991-3#1)(2008-2#1)
that the hormonal##2##3##(1992-9#1)(2008-3#1)
that the hormone##3##3##(1994-3#1)(1995-12#1)(2008-10#1)
that the hospital##2##3##(1996-2#1)(2011-2#1)
that the hospital's##2##3##(1991-7#1)(1994-1#1)
that the host##10##3##(1990-12#1)(1992-10#1)(2007-12#1)(2008-10#4)(2008-8#2)(2008-9#1)
that the human ancestral lineage##2##5##(1997-4#2)
that the human##41##3##(1990-7#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-11#3)(1992-5#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-4#3)(1997-7#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-6#1)(2008-9#1)(2009-2#1)(2011-1#1)
that the hybrid model##2##4##(1995-8#1)(2008-3#1)
that the hybrid##6##3##(1995-8#1)(2008-10#1)(2008-3#2)(2008-8#1)(2013-7#1)
that the hydrated##2##3##(1991-2#1)(2008-10#1)
that the hydrocarbon production from##2##5##(2008-6#2)
that the hydrogel##2##3##(2008-5#2)
that the hydrolase##2##3##(1991-7#1)(1992-8#1)
that the hydrophobic and##2##4##(2008-10#2)
that the hydrophobic effect##2##4##(1993-6#1)(1996-7#1)
that the hydrophobic##10##3##(1990-11#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-5#1)(1996-7#2)(2006-10#1)(2008-10#2)
that the hydrophobicity of the##2##5##(1993-11#1)(2008-10#1)
that the hydrophobicity##3##3##(1993-11#1)(2008-10#2)
that the hydroxyl group of##2##5##(1990-2#1)(1994-9#1)
that the hydroxyl##5##3##(1990-2#1)(1992-3#1)(1992-6#1)(1994-9#1)(1995-6#1)
that the hypertension##2##3##(1997-6#1)(2008-4#1)
that the idea of##3##4##(2010-10#1)(2010-11#1)(2011-2#1)
that the idea##4##3##(2005-10#1)(2010-10#1)(2010-11#1)(2011-2#1)
that the ideal##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
that the identification of##5##4##(1991-2#1)(1997-7#1)(2007-3#1)(2008-10#1)(2012-12#1)
that the identity##2##3##(1991-2#1)(2010-3#1)
that the illness##3##3##(1997-6#1)(2006-10#1)(2009-9#1)
that the illumination##2##3##(2008-2#1)(2008-3#1)
that the image of##2##4##(2007-12#1)(2008-2#1)
that the image quality##3##4##(1997-8#1)(2008-2#1)(2008-3#1)
that the image##9##3##(1997-8#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#2)
that the immobilization##3##3##(1995-3#1)(2008-10#2)
that the immobilized##4##3##(2008-10#2)(2008-5#1)(2008-7#1)
that the immune response##2##4##(2006-10#2)
that the immune system is##3##5##(2012-1#1)(2013-1#2)
that the immune system##6##4##(2006-10#2)(2012-1#1)(2013-1#2)(2013-7#1)
that the immune##9##3##(2006-10#4)(2008-11#1)(2012-1#1)(2013-1#2)(2013-7#1)
that the immunosuppressive##3##3##(1990-5#2)(1993-11#1)
that the impact of##8##4##(1992-8#1)(1992-9#1)(2008-10#2)(2008-2#1)(2008-8#1)(2010-2#1)(2012-12#1)
that the impact##9##3##(1992-1#1)(1992-8#1)(1992-9#1)(2008-10#2)(2008-2#1)(2008-8#1)(2010-2#1)(2012-12#1)
that the impacts##2##3##(2008-1#1)(2008-5#1)
that the impairment of##3##4##(1996-7#1)(1997-2#1)(2008-5#1)
that the implant##4##3##(2008-7#1)(2008-9#1)(2010-8#1)(2012-11#1)
that the implanted##3##3##(1997-4#1)(2008-9#1)(2012-12#1)
that the implementation of##2##4##(1997-2#1)(2011-1#1)
that the implementation##3##3##(1997-2#1)(2008-2#1)(2011-1#1)
that the importance of the##2##5##(2006-10#1)(2008-1#1)
that the importance of##5##4##(2006-10#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-2#1)
that the improved##7##3##(1996-11#1)(2006-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2013-1#1)(2013-8#1)
that the improvement of##3##4##(1993-3#1)(1994-2#1)(2008-10#1)
that the improvement##6##3##(1993-3#1)(1994-2#1)(2008-10#2)(2008-5#1)(2012-1#1)
that the improvements##2##3##(2010-7#1)(2013-8#1)
that the in vitro##8##4##(1990-1#2)(1990-11#1)(1996-5#1)(1996-9#1)(1997-4#1)(2005-10#1)(2008-5#1)
that the in vivo##3##4##(1991-3#1)(1992-4#1)(2005-8#1)
that the in##12##3##(1990-1#2)(1990-11#1)(1991-3#1)(1992-4#1)(1996-5#1)(1996-9#1)(1997-4#1)(2005-10#1)(2005-8#1)(2008-5#1)(2009-3#1)
that the in-flight##2##3##(1990-11#1)(2008-3#1)
that the inactive##2##3##(1994-2#1)(1995-6#1)
that the incidence and##2##4##(2008-10#1)(2010-5#1)
that the incidence of##26##4##(1991-11#1)(1991-7#1)(1994-3#1)(1994-6#1)(1997-3#1)(2006-10#4)(2006-11#1)(2006-9#1)(2007-11#2)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)
that the incidence##32##3##(1991-11#1)(1991-7#1)(1994-3#1)(1994-6#1)(1997-3#1)(2005-11#1)(2006-10#4)(2006-11#1)(2006-9#1)(2007-11#2)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)
that the incidences of##2##4##(2006-10#1)(2011-1#1)
that the incident light##2##4##(2007-11#1)(2008-10#1)
that the incident##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
that the inclusion of##3##4##(1995-1#1)(2007-12#1)(2008-3#1)
that the inclusion##6##3##(1995-1#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
that the incorporation of##6##4##(1990-2#1)(1990-9#1)(1994-6#1)(2011-2#2)(2012-2#1)
that the increase in the##6##5##(1992-12#1)(1996-11#2)(2005-11#1)(2008-11#1)(2008-3#1)
that the increase in##38##4##(1990-10#1)(1990-11#1)(1990-2#1)(1990-8#1)(1991-11#1)(1991-9#2)(1992-12#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-6#2)(1996-11#2)(1997-1#1)(1997-2#1)(2004-9#1)(2005-11#3)(2006-1#1)(2006-2#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2012-2#1)(2013-8#1)
that the increase of##7##4##(1990-2#1)(1990-4#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)
that the increase##46##3##(1990-10#1)(1990-11#1)(1990-2#2)(1990-4#1)(1990-8#1)(1991-11#1)(1991-9#2)(1992-12#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-6#2)(1996-11#2)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#3)(2006-1#1)(2006-2#1)(2006-8#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-8#1)(2012-2#1)(2013-8#1)
that the increased expression of##4##5##(1991-9#1)(1992-8#1)(1995-2#1)(1996-7#1)
that the increased risk of##2##5##(1991-5#1)(2008-11#1)
that the increased risk##4##4##(1991-5#1)(2008-11#1)(2008-7#1)(2010-9#1)
that the increased susceptibility##2##4##(2008-10#2)
that the increased##32##3##(1990-11#1)(1990-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-5#1)(1995-10#1)(1995-2#1)(1995-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-10#1)(2010-9#1)(2011-1#2)(2013-1#1)
that the incubation##4##3##(1993-4#1)(2006-10#1)(2008-3#1)(2008-8#1)
that the independent variables##2##4##(1992-1#1)(2008-5#1)
that the independent##3##3##(1992-1#1)(2008-3#1)(2008-5#1)
that the index##3##3##(1993-6#1)(2007-12#1)(2007-6#1)
that the individual##9##3##(1990-12#1)(1995-9#1)(1996-12#1)(1996-4#1)(2006-12#1)(2008-10#1)(2008-3#1)(2010-2#1)(2011-1#1)
that the individuals##5##3##(1990-7#1)(1997-8#1)(2007-2#1)(2009-5#1)(2009-6#1)
that the indole##3##3##(1992-12#3)
that the induced##4##3##(1990-12#1)(2007-11#1)(2008-11#1)(2008-2#1)
that the inducible##2##3##(1992-4#1)(1992-9#1)
that the induction of metallothionein by##2##6##(1991-5#2)
that the induction of the##2##5##(1991-12#1)(2008-5#1)
that the induction of##12##4##(1991-12#1)(1991-5#2)(1994-11#2)(1996-7#1)(1996-8#1)(1997-2#1)(2006-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
that the induction##15##3##(1991-12#1)(1991-5#2)(1991-6#1)(1994-11#2)(1994-12#1)(1996-10#1)(1996-7#1)(1996-8#1)(1997-2#1)(2006-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
that the infant##2##3##(1990-8#1)(1994-12#1)
that the infection##5##3##(1991-3#1)(1997-1#1)(2011-2#1)(2012-3#2)
that the inferior##2##3##(1992-11#1)(2008-2#1)
that the influence of the##2##5##(2007-12#1)(2007-9#1)
that the influence of##10##4##(1992-3#1)(1996-12#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-9#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-2#1)
that the influence##12##3##(1992-3#1)(1996-12#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-9#1)(2008-10#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-2#1)
that the information##12##3##(1992-8#1)(1993-2#1)(1997-8#2)(2007-12#1)(2008-3#1)(2008-4#1)(2008-9#2)(2013-1#2)(2013-7#1)
that the ingestion of##2##4##(1993-9#1)(2006-4#1)
that the inherent##2##3##(2007-11#1)(2010-8#1)
that the inheritance of##2##4##(2008-10#1)(2008-4#1)
that the inhibition by##2##4##(1990-2#1)(1994-5#1)
that the inhibition of##16##4##(1991-4#1)(1993-12#1)(1993-4#1)(1994-11#1)(1994-9#1)(1995-3#1)(1996-4#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-5#1)(2009-9#1)
that the inhibition##24##3##(1990-2#1)(1991-4#2)(1993-12#1)(1993-4#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-4#3)(1996-6#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-5#1)(2009-9#1)
that the inhibitor was##3##4##(1990-5#1)(1991-3#1)(1993-3#1)
that the inhibitor##7##3##(1990-5#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-9#1)
that the inhibitory activity##2##4##(1990-5#1)(1996-11#1)
that the inhibitory effect is##2##5##(1991-9#2)
that the inhibitory effect of##9##5##(1991-12#1)(1991-6#1)(1994-12#1)(1994-8#1)(1995-6#1)(1996-12#1)(1997-7#1)(2006-4#1)(2008-6#1)
that the inhibitory effect was##2##5##(1990-7#1)(1991-9#1)
that the inhibitory effect##13##4##(1990-7#1)(1991-12#1)(1991-6#1)(1991-9#3)(1994-12#1)(1994-8#1)(1995-6#1)(1996-12#1)(1997-7#1)(2006-4#1)(2008-6#1)
that the inhibitory effects of##4##5##(1991-12#1)(1995-11#1)(2008-10#1)(2008-11#1)
that the inhibitory effects##5##4##(1991-12#1)(1995-11#1)(2008-10#2)(2008-11#1)
that the inhibitory region of##2##5##(1990-4#1)(1995-8#1)
that the inhibitory##25##3##(1990-4#1)(1990-5#1)(1990-7#1)(1991-12#2)(1991-6#1)(1991-9#3)(1992-7#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1997-7#2)(2006-4#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)
that the initial rate of##2##5##(1990-11#1)(1994-5#1)
that the initial##30##3##(1990-10#1)(1990-11#1)(1991-9#1)(1992-6#1)(1993-3#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-6#2)(2004-9#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2009-11#1)(2010-2#1)(2010-5#1)(2010-7#1)(2013-1#1)
that the initiation of##2##4##(2008-10#1)(2008-6#1)
that the initiation##4##3##(2007-7#1)(2008-10#1)(2008-6#2)
that the injection of##4##4##(1991-9#1)(2007-11#1)(2008-8#1)(2012-3#1)
that the injection##5##3##(1991-9#1)(2007-11#1)(2007-4#1)(2008-8#1)(2012-3#1)
that the injury##3##3##(2004-1#1)(2006-11#1)(2008-9#1)
that the inmate##2##3##(1990-2#1)(1990-5#1)
that the inner##4##3##(1991-4#1)(1995-3#1)(2008-8#1)(2009-12#1)
that the insertion##3##3##(1991-10#1)(2008-8#1)(2009-7#1)
that the instrument##5##3##(2008-10#1)(2008-2#1)(2008-3#2)(2010-12#1)
that the insulin##2##3##(1996-7#1)(2008-4#1)
that the intact##3##3##(1996-2#1)(2007-1#1)(2008-8#1)
that the intake##2##3##(1992-8#1)(2011-2#1)
that the integrated##2##3##(1997-8#1)(2008-10#1)
that the integration of##3##4##(2006-2#2)(2006-9#1)
that the integrity of the##5##5##(1991-1#1)(1993-12#1)(1995-5#1)(2008-10#1)(2008-7#1)
that the integrity of##6##4##(1991-1#1)(1993-12#1)(1995-5#2)(2008-10#1)(2008-7#1)
that the intensity of the##3##5##(2007-12#1)(2008-10#1)(2008-3#1)
that the intensity of##6##4##(1997-2#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-3#2)
that the intensity##9##3##(1997-2#1)(2006-12#1)(2007-12#2)(2008-10#1)(2008-3#4)
that the interaction between##8##4##(1990-2#1)(1991-7#2)(1996-9#1)(2006-10#1)(2008-8#2)(2012-12#1)
that the interaction is##4##4##(1995-3#1)(1997-7#1)(1997-8#1)(2008-10#1)
that the interaction of##11##4##(1991-5#1)(1994-5#1)(1994-6#2)(1995-5#1)(1997-6#1)(2005-11#1)(2008-10#3)(2008-9#1)
that the interaction was##2##4##(1996-5#2)
that the interaction##32##3##(1990-2#1)(1991-2#1)(1991-5#1)(1991-7#2)(1994-5#2)(1994-6#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-5#2)(1996-9#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-11#1)(2006-10#2)(2008-1#1)(2008-10#5)(2008-8#2)(2008-9#1)(2012-12#1)
that the interactions between##3##4##(1994-9#1)(2008-10#1)(2009-8#1)
that the interactions of##4##4##(1995-6#1)(1996-12#1)(1996-4#1)(2013-1#1)
that the interactions##10##3##(1994-9#1)(1995-6#1)(1996-12#1)(1996-4#1)(1997-1#1)(2005-11#1)(2008-10#1)(2008-3#1)(2009-8#1)(2013-1#1)
that the intercalated##2##3##(1997-7#1)(2008-10#1)
that the intercalation##2##3##(2008-10#1)(2008-5#1)
that the interfacial tension##2##4##(2005-11#2)
that the interference fringes##2##4##(2006-4#1)(2013-8#1)
that the interference from##2##4##(2008-10#1)(2008-3#1)
that the interference##9##3##(2005-4#1)(2006-4#1)(2007-12#3)(2008-10#1)(2008-3#2)(2013-8#1)
that the interferences##2##3##(2008-10#2)
that the interferogram##2##3##(2007-11#1)(2008-3#1)
that the intermediary##2##3##(2008-10#2)
that the intermediate##4##3##(1991-7#1)(1994-6#1)(1995-5#1)(1996-8#1)
that the intermolecular##2##3##(1991-2#1)(2006-12#1)
that the internal##4##3##(1990-3#1)(1995-8#1)(1996-5#1)(2007-4#1)
that the interplay between the##2##5##(1997-6#1)(2006-4#1)
that the interplay between##3##4##(1997-6#1)(2006-4#1)(2008-11#1)
that the interpretation of##2##4##(2008-9#1)(2010-9#1)
that the intervention##3##3##(2006-12#1)(2008-12#1)(2008-9#1)
that the intestinal##4##3##(1994-9#1)(1995-3#1)(2007-11#1)(2010-12#1)
that the intracavity dispersion of##2##5##(2007-12#2)
that the intracellular##9##3##(1990-5#1)(1991-10#1)(1992-11#1)(1992-9#1)(1994-3#1)(1994-6#1)(1995-3#1)(1996-1#1)(1996-7#1)
that the intranuclear##2##3##(1994-11#1)(1994-2#1)
that the intrinsic##6##3##(1992-6#2)(1994-2#1)(1994-9#1)(2007-8#1)(2008-8#1)
that the introduction and##2##4##(1991-4#1)(2008-10#1)
that the introduction of the##2##5##(2006-10#1)(2013-1#1)
that the introduction of##12##4##(1990-5#1)(1992-6#1)(1993-4#1)(1996-2#1)(2005-10#1)(2006-10#1)(2006-2#1)(2008-11#2)(2008-3#2)(2013-1#1)
that the introduction##14##3##(1990-5#1)(1991-4#1)(1992-6#1)(1993-4#1)(1996-2#1)(2005-10#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-11#2)(2008-3#2)(2013-1#1)
that the inverse##2##3##(2008-2#1)(2008-5#1)
that the ion##2##3##(1996-1#1)(2008-10#1)
that the ions##3##3##(2005-4#1)(2008-10#1)(2008-9#1)
that the ipsilateral##2##3##(1992-10#1)(1997-8#1)
that the iron chalcogenide membrane comprises##2##6##(2008-10#2)
that the iron##9##3##(1994-5#1)(1996-9#1)(2006-10#1)(2006-9#1)(2008-10#3)(2010-2#1)(2012-12#1)
that the irreversible##2##3##(1991-9#1)(2011-2#1)
that the isoforms##2##3##(1991-1#1)(1994-8#1)
that the isolate##3##3##(2005-11#1)(2007-12#1)(2012-12#1)
that the isolated alpha subunit##2##5##(1994-3#2)
that the isolated##4##3##(1994-3#2)(2008-10#1)(2008-8#1)
that the isolates were##2##4##(1996-12#1)(2008-10#1)
that the isolates##5##3##(1996-12#1)(2008-10#3)(2012-2#1)
that the isolation of##2##4##(1992-9#1)(2008-5#1)
that the issue##2##3##(1997-8#1)(2007-10#1)
that the jitter##2##3##(2008-3#2)
that the judicial bypass##2##4##(1997-1#1)(1997-6#1)
that the jump##2##3##(2007-12#1)(2008-9#1)
that the keto##2##3##(1993-11#1)(2008-11#1)
that the key step##2##4##(1992-1#1)(1992-8#1)
that the key to##3##4##(2008-7#1)(2011-2#2)
that the key##7##3##(1992-1#1)(1992-8#1)(1996-4#1)(2006-6#1)(2008-7#1)(2011-2#2)
that the kidney is##2##4##(1994-5#1)(1994-6#1)
that the kinetics of##5##4##(1992-11#1)(1992-12#1)(2006-10#1)(2007-3#1)(2012-2#1)
that the known##2##3##(1992-12#1)(2010-4#1)
that the laboratory##2##3##(2008-10#1)(2012-3#1)
that the lack of##14##4##(1991-2#1)(1993-7#1)(1994-3#1)(1994-7#1)(1994-8#1)(2005-11#1)(2006-6#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-10#1)(2009-12#1)(2013-8#1)
that the lamellar##2##3##(2006-10#1)(2012-2#1)
that the land##2##3##(2007-9#1)(2013-8#1)
that the large majority of##2##5##(2008-10#1)(2008-3#1)
that the large##14##3##(1991-12#1)(1991-4#1)(1992-4#1)(1995-5#1)(1995-8#1)(1997-1#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-3#1)(2010-6#1)
that the larger the##2##4##(1995-11#1)(2008-3#1)
that the larger##6##3##(1991-3#1)(1995-11#1)(1995-5#1)(1996-8#1)(2008-3#2)
that the largest##6##3##(1991-2#1)(2008-10#1)(2008-6#1)(2009-8#1)(2013-8#2)
that the laser##3##3##(1992-10#1)(2008-3#1)(2013-8#1)
that the last##3##3##(1991-2#1)(2007-12#2)
that the lateral nucleus##2##4##(1996-6#2)
that the lateral tegmental field plays an important role in the##2##11##(1992-7#2)
that the lateral##8##3##(1992-7#2)(1993-6#1)(1996-6#2)(2008-3#2)(2009-10#1)
that the latter is not##3##5##(1990-5#1)(1994-3#1)(1995-8#1)
that the latter is##6##4##(1990-5#1)(1991-4#1)(1994-3#1)(1995-8#1)(2008-10#1)(2008-3#1)
that the latter method##2##4##(2008-10#1)(2011-2#1)
that the latter##22##3##(1990-5#1)(1991-12#1)(1991-4#2)(1992-3#1)(1993-11#1)(1994-3#1)(1995-1#1)(1995-6#1)(1995-8#1)(1997-5#1)(2008-10#2)(2008-3#3)(2008-5#1)(2009-8#1)(2011-2#3)(2013-1#1)
that the law##7##3##(1991-9#1)(1995-9#1)(1997-1#1)(1997-8#1)(2006-10#1)(2007-4#1)(2008-8#1)
that the leader##2##3##(1992-8#1)(2008-1#1)
that the leading##2##3##(2005-10#1)(2012-2#1)
that the leaf##2##3##(2008-10#1)(2009-5#1)
that the learning##2##3##(1995-2#1)(2006-6#1)
that the lectin##2##3##(1991-12#1)(1992-6#1)
that the left hemisphere##2##4##(1993-9#1)(2008-11#1)
that the left##4##3##(1993-9#2)(2006-9#1)(2008-11#1)
that the legal##2##3##(2008-11#1)(2008-8#1)
that the length of##3##4##(2011-12#1)(2011-2#1)(2012-12#1)
that the length##5##3##(2008-10#1)(2008-3#1)(2011-12#1)(2011-2#1)(2012-12#1)
that the lesion was a##2##5##(2005-10#1)(2013-8#1)
that the lesion was##6##4##(2005-10#1)(2008-5#1)(2010-5#1)(2013-1#2)(2013-8#1)
that the lesion##9##3##(1990-4#1)(1992-2#1)(2005-10#1)(2008-5#1)(2010-5#1)(2010-6#1)(2013-1#2)(2013-8#1)
that the lesions##5##3##(1990-5#1)(1993-11#1)(2006-7#1)(2008-11#1)(2011-2#1)
that the less##2##3##(2007-4#1)(2013-8#1)
that the let-60##2##3##(1990-11#2)
that the level of ubiquinol-10 in human plasma##2##8##(1997-2#2)
that the level of##40##4##(1991-5#1)(1991-7#1)(1991-9#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-2#2)(2004-11#1)(2005-10#1)(2006-1#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-7#2)(2008-8#3)(2009-6#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#3)
that the level##41##3##(1991-5#1)(1991-7#1)(1991-9#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-2#2)(2004-11#1)(2005-10#1)(2006-1#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-7#2)(2008-8#3)(2009-6#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#3)
that the levels of the##3##5##(1991-2#1)(1992-8#1)(2011-12#1)
that the levels of##20##4##(1990-3#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-8#1)(1994-12#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#1)(1997-2#1)(2007-10#1)(2007-12#1)(2008-7#1)(2009-10#1)(2009-12#1)(2011-12#1)(2013-8#1)
that the levels##21##3##(1990-3#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-8#1)(1994-12#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#1)(1997-2#1)(2007-10#1)(2007-12#1)(2008-7#2)(2009-10#1)(2009-12#1)(2011-12#1)(2013-8#1)
that the library##2##3##(1995-3#1)(1997-4#1)
that the lidar##4##3##(2008-2#1)(2008-3#3)
that the lifetime of the##3##5##(2010-2#2)(2013-8#1)
that the lifetime##4##3##(1995-11#1)(2010-2#2)(2013-8#1)
that the ligand##3##3##(1991-12#1)(1993-2#1)(1994-12#1)
that the light##8##3##(1991-7#1)(1994-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2013-8#1)
that the likelihood of##4##4##(2006-10#1)(2006-6#1)(2010-3#1)(2010-4#1)
that the likelihood##5##3##(2006-10#1)(2006-6#1)(2008-12#1)(2010-3#1)(2010-4#1)
that the limited##5##3##(1991-6#1)(2008-10#1)(2008-5#1)(2009-10#1)(2012-1#1)
that the line##2##3##(2008-2#1)(2008-3#1)
that the linear##6##3##(1997-6#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-2#1)(2010-1#1)
that the link##2##3##(1997-2#1)(2013-8#1)
that the linkage##2##3##(1993-3#1)(1995-1#1)
that the lipid##3##3##(1991-9#1)(2008-8#1)(2009-2#1)
that the liver##6##3##(1990-1#1)(1990-8#1)(2007-5#1)(2008-12#1)(2008-8#1)(2013-7#1)
that the local##16##3##(1990-12#1)(1990-2#1)(1992-1#1)(1992-6#1)(1993-7#1)(1995-2#1)(1995-4#1)(1996-1#1)(1996-9#3)(2006-10#1)(2008-7#2)(2012-2#1)(2013-1#1)
that the local-field##2##3##(2007-11#1)(2008-3#1)
that the localization of##3##4##(1993-12#1)(1994-9#1)(1997-2#1)
that the localization##4##3##(1993-12#1)(1994-9#2)(1997-2#1)
that the location of##4##4##(1995-12#1)(2008-5#1)(2009-5#1)(2011-1#1)
that the location##5##3##(1995-12#1)(2008-10#1)(2008-5#1)(2009-5#1)(2011-1#1)
that the locations of##2##4##(1995-8#1)(2008-2#1)
that the locomotor##2##3##(1993-3#1)(2013-1#1)
that the locus##4##3##(1991-12#1)(1995-12#1)(1995-5#1)(2008-10#1)
that the log##2##3##(1995-4#1)(2008-7#1)
that the logistic##2##3##(2007-8#1)(2008-10#1)
that the long axes of the##3##6##(1995-8#2)(1996-7#1)
that the long##8##3##(1991-6#1)(1993-8#1)(1994-8#1)(1995-8#2)(1996-11#1)(1996-7#1)(2008-5#1)
that the long-term##7##3##(1992-10#1)(1995-12#1)(2006-10#1)(2007-10#1)(2008-9#1)(2012-12#1)(2013-7#1)
that the longer##6##3##(1990-2#1)(1995-8#2)(1996-2#1)(2005-11#1)(2008-5#1)
that the loop##3##3##(1995-2#2)(1997-2#1)
that the loss of##14##4##(1992-7#1)(1993-2#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-5#1)(1997-7#1)(2008-7#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
that the loss##15##3##(1992-7#1)(1993-2#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-5#1)(1997-7#1)(2008-3#1)(2008-7#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
that the low abundance##2##4##(1990-3#1)(2013-8#1)
that the low##17##3##(1990-3#1)(1991-2#1)(1991-4#1)(1991-9#1)(1993-11#1)(1994-4#1)(1995-11#1)(1996-8#1)(2007-12#2)(2008-10#1)(2008-11#1)(2010-2#1)(2010-5#1)(2011-2#1)(2013-7#1)(2013-8#1)
that the lower the##4##4##(2007-4#1)(2008-2#1)(2010-8#1)(2013-8#1)
that the lower##13##3##(1991-12#1)(1993-11#1)(1994-9#1)(1996-4#1)(2007-11#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-4#1)(2010-8#1)(2013-1#1)(2013-8#1)
that the lung##3##3##(2005-10#1)(2010-5#1)(2011-3#1)
that the lysine##3##3##(1995-5#1)(1997-6#1)(2008-4#1)
that the mAb##2##3##(1997-7#2)
that the mRNA for##2##4##(1990-11#1)(1994-5#1)
that the mRNA##8##3##(1990-11#1)(1994-10#2)(1994-5#1)(1994-9#1)(1995-8#1)(1996-12#1)(2013-8#1)
that the macroscopic##2##3##(2008-3#1)(2012-12#1)
that the magnetic field increased##2##5##(2008-8#2)
that the magnetic field##4##4##(2008-8#4)
that the magnetic##6##3##(2007-12#1)(2008-12#1)(2008-8#4)
that the magnitude of the##8##5##(1991-8#1)(1994-8#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-9#2)
that the magnitude of##12##4##(1991-8#1)(1994-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-6#1)(2008-8#1)(2008-9#2)(2011-2#1)
that the magnitude##13##3##(1991-8#1)(1994-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#2)(2011-2#1)
that the main cause of##2##5##(2004-9#1)(2006-10#1)
that the main portion##2##4##(1991-2#1)(1992-12#1)
that the main reason for the##2##6##(1992-2#1)(2007-9#1)
that the main reason##3##4##(1990-6#1)(1992-2#1)(2007-9#1)
that the main target##2##4##(2008-11#1)(2013-7#1)
that the main##36##3##(1990-6#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1995-12#1)(1995-5#1)(1996-6#1)(1997-8#1)(2004-9#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#1)(2010-9#1)(2011-12#1)(2012-12#2)(2012-3#1)(2013-7#2)
that the maintenance of the##2##5##(1991-2#1)(2007-1#1)
that the maintenance of##5##4##(1991-2#1)(1997-6#1)(2007-1#1)(2008-10#1)(2013-1#1)
that the major cell##2##4##(1990-7#1)(1994-3#1)
that the major part of the##2##6##(1993-5#1)(2008-5#1)
that the major part of##3##5##(1991-2#1)(1993-5#1)(2008-5#1)
that the major reasons##2##4##(2008-1#1)(2009-2#1)
that the major site of##2##5##(1992-7#1)(1997-8#1)
that the major##54##3##(1990-10#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-5#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-5#2)(1996-7#1)(1996-8#1)(1997-8#1)(1997-9#1)(2004-3#1)(2005-7#1)(2005-8#1)(2007-10#1)(2007-3#1)(2007-6#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-8#1)(2011-12#1)(2011-3#1)(2012-1#1)
that the majority of cases##2##5##(1990-8#1)(2007-7#1)
that the majority of patients##3##5##(2006-12#1)(2006-2#1)(2007-2#1)
that the majority of the##13##5##(1990-11#1)(1991-11#1)(1994-11#1)(1995-10#1)(1996-12#1)(1996-6#1)(1997-3#2)(2007-3#1)(2007-6#1)(2008-6#1)(2008-7#1)(2011-2#1)
that the majority of these##2##5##(2005-8#1)(2013-1#1)
that the majority of##52##4##(1990-11#1)(1990-7#1)(1990-8#1)(1991-11#1)(1992-8#1)(1993-2#1)(1994-11#1)(1995-10#1)(1995-3#2)(1996-11#1)(1996-12#1)(1996-6#1)(1997-3#2)(1997-8#2)(2004-3#1)(2005-8#3)(2006-10#1)(2006-12#1)(2006-2#2)(2006-5#1)(2007-12#1)(2007-2#1)(2007-3#4)(2007-6#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-9#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
that the majority were##2##4##(2008-12#1)(2011-2#1)
that the majority##59##3##(1990-11#1)(1990-7#1)(1990-8#1)(1991-11#1)(1992-8#1)(1993-2#1)(1994-11#1)(1995-10#1)(1995-2#1)(1995-3#2)(1996-11#1)(1996-12#1)(1996-6#1)(1997-3#2)(1997-8#2)(2004-3#1)(2005-8#3)(2006-10#1)(2006-12#1)(2006-2#2)(2006-5#1)(2007-12#1)(2007-2#1)(2007-3#4)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
that the male##4##3##(2008-8#2)(2010-5#1)(2011-1#1)
that the males##2##3##(1991-2#1)(1996-12#1)
that the mammalian##3##3##(1993-12#1)(1997-1#1)(1997-6#1)
that the management of##3##4##(1991-3#1)(2006-2#1)(2010-3#1)
that the management##8##3##(1991-3#1)(1994-3#1)(1996-3#1)(2006-2#1)(2007-5#1)(2008-5#1)(2010-3#1)(2012-3#1)
that the manifestation of##4##4##(1995-12#1)(1995-2#1)(1996-12#1)(2008-5#1)
that the mannosidase##2##3##(1990-2#1)(1995-2#1)
that the markers are##2##4##(1994-8#1)(2008-4#1)
that the mass was a##2##5##(2008-7#1)(2013-8#1)
that the mass##7##3##(2005-11#1)(2006-10#1)(2007-8#1)(2008-7#1)(2008-9#1)(2012-1#1)(2013-8#1)
that the material##3##3##(2007-8#1)(2008-3#1)(2008-7#1)
that the materials##3##3##(1992-6#1)(2007-5#1)(2012-3#1)
that the mating##3##3##(1992-9#1)(2006-10#1)(2008-9#1)
that the matrix##3##3##(1992-12#1)(2006-9#1)(2008-2#1)
that the mature protein##3##4##(1991-11#1)(1991-3#1)(1994-9#1)
that the mature##5##3##(1990-7#1)(1991-11#1)(1991-3#1)(1994-9#1)(1997-2#1)
that the maximal##4##3##(1995-12#1)(2007-9#1)(2008-10#1)(2008-7#1)
that the maximum a posteriori (MAP)##2##6##(2008-2#2)
that the maximum statistics method##2##5##(2012-3#2)
that the maximum##30##3##(1990-11#1)(1996-9#1)(2005-11#3)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-2#6)(2008-3#1)(2008-4#1)(2008-5#2)(2009-3#1)(2009-4#1)(2010-5#1)(2010-6#1)(2011-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
that the mean relative##2##4##(2008-3#1)(2012-3#1)
that the mean value##2##4##(2008-10#1)(2008-2#1)
that the mean##25##3##(1990-2#1)(1991-9#1)(1992-11#1)(1994-1#1)(1997-8#1)(2006-10#1)(2006-3#1)(2006-9#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2009-11#1)(2009-2#1)(2010-7#2)(2011-2#1)(2012-3#3)
that the meaning of##2##4##(1990-12#1)(2013-8#1)
that the measure##3##3##(1995-6#2)(2008-10#1)
that the measured##11##3##(1995-1#1)(2005-11#1)(2007-12#1)(2008-2#3)(2008-3#3)(2009-4#1)(2012-2#1)
that the measurement of##4##4##(2006-4#1)(2006-6#1)(2008-10#1)(2011-1#1)
that the measurement##8##3##(2006-4#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2011-1#1)
that the measurements##3##3##(2008-2#1)(2008-3#1)(2011-2#1)
that the mechanical##6##3##(1995-2#1)(2004-9#1)(2007-12#1)(2008-7#1)(2009-7#2)
that the mechanism by which##4##5##(1993-3#1)(1994-3#1)(1994-5#1)(2008-8#1)
that the mechanism for##3##4##(2005-12#1)(2006-5#1)(2007-12#1)
that the mechanism of action of##4##6##(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#1)
that the mechanism of action##5##5##(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#1)(2012-1#1)
that the mechanism of##31##4##(1990-2#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-7#1)(1992-10#1)(1993-11#1)(1994-3#1)(1995-5#1)(1995-8#2)(1996-8#1)(1997-2#1)(1997-8#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-11#1)(2012-1#1)(2012-3#1)(2013-8#2)
that the mechanism##42##3##(1990-2#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-7#1)(1992-10#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-3#2)(1994-5#1)(1995-5#1)(1995-8#2)(1996-8#1)(1997-2#1)(1997-8#1)(2005-11#1)(2005-12#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-11#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
that the mechanisms by which##2##5##(1993-9#1)(2006-2#1)
that the mechanisms by##3##4##(1993-9#1)(1995-3#1)(2006-2#1)
that the mechanisms causing##2##4##(2006-10#1)(2008-7#1)
that the mechanisms of##5##4##(2008-5#1)(2008-8#2)(2010-3#1)(2011-2#1)
that the mechanisms##16##3##(1991-11#1)(1991-3#1)(1993-9#1)(1995-3#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#2)(2010-3#1)(2011-2#1)
that the mechanistic##2##3##(1995-10#1)(2008-8#1)
that the medial##4##3##(1992-12#1)(1993-12#1)(2008-11#1)(2008-7#1)
that the medical##7##3##(1992-3#1)(1996-11#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-4#1)(2010-8#1)
that the medium##2##3##(2008-11#1)(2008-7#1)
that the members of a##2##5##(2008-9#1)(2011-2#1)
that the membrane##8##3##(1991-9#2)(1992-12#1)(1992-9#1)(1993-9#1)(1997-7#1)(2010-3#1)(2011-1#1)
that the memory##4##3##(2008-1#1)(2008-12#1)(2008-2#1)(2013-7#1)
that the mentor##2##3##(2008-12#1)(2008-7#1)
that the mercury##3##3##(2005-11#1)(2008-10#1)(2010-5#1)
that the message##2##3##(1994-11#1)(1995-12#1)
that the metabolic syndrome##2##4##(2008-3#1)(2009-10#1)
that the metabolic##3##3##(2008-3#1)(2009-10#1)(2011-1#1)
that the metabolism of##3##4##(1990-5#1)(1992-1#1)(2006-10#1)
that the metal##6##3##(1992-11#1)(1994-12#1)(2004-4#1)(2005-11#1)(2006-12#1)(2008-3#1)
that the metallic##2##3##(1990-7#1)(2005-11#1)
that the metapopulation##2##3##(2008-10#1)(2008-8#1)
that the method can be applied to##2##7##(2005-12#1)(2008-10#1)
that the method can be used to##2##7##(1996-5#1)(2008-2#1)
that the method can be used##3##6##(1996-5#1)(1997-8#1)(2008-2#1)
that the method can be##5##5##(1996-5#1)(1997-8#1)(2005-12#1)(2008-10#1)(2008-2#1)
that the method can##6##4##(1996-5#1)(1997-8#1)(2005-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
that the method could##2##4##(2008-10#1)(2013-8#1)
that the method had##2##4##(1997-8#1)(2012-3#1)
that the method has a##2##5##(1991-2#1)(2008-2#1)
that the method has##4##4##(1991-2#1)(1991-8#1)(2005-4#1)(2008-2#1)
that the method is able to##2##6##(2008-3#1)(2012-1#1)
that the method is suitable for the##3##7##(1991-5#1)(2008-10#2)
that the method is suitable for##5##6##(1991-5#1)(1996-12#1)(2008-10#3)
that the method is##19##4##(1991-5#1)(1996-12#1)(2005-12#2)(2007-11#1)(2007-12#1)(2008-10#8)(2008-3#2)(2008-9#1)(2009-5#1)(2012-1#1)
that the method of##4##4##(1992-12#1)(2005-4#1)(2007-8#1)(2013-8#1)
that the method presented##2##4##(2008-10#1)(2013-8#1)
that the method provides##3##4##(1996-1#1)(2007-11#1)(2008-3#1)
that the method was##7##4##(2007-8#1)(2008-10#3)(2008-8#1)(2010-2#1)(2013-8#1)
that the method##61##3##(1990-4#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-12#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-8#2)(2005-12#3)(2005-4#2)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#19)(2008-2#3)(2008-3#5)(2008-8#1)(2008-9#1)(2009-5#1)(2010-2#1)(2010-6#2)(2012-1#1)(2012-3#1)(2013-8#4)
that the methodology##4##3##(2007-11#1)(2008-10#2)(2008-8#1)
that the methods are##3##4##(1993-12#1)(1996-12#1)(2011-1#1)
that the methods##9##3##(1993-1#1)(1993-12#1)(1995-9#1)(1996-12#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)
that the methylation of##2##4##(2007-11#1)(2010-11#1)
that the methylation##3##3##(1994-9#1)(2007-11#1)(2010-11#1)
that the microcrystalline cellulose##2##4##(2010-12#2)
that the microenvironment of##2##4##(2008-10#2)
that the microenvironment##3##3##(1992-8#1)(2008-10#2)
that the microorganism##2##3##(2006-10#1)(2011-1#1)
that the microscopic##2##3##(2008-10#1)(2008-5#1)
that the microsomal##3##3##(1990-11#1)(1990-2#1)(1991-3#1)
that the minimal##5##3##(1993-12#1)(1995-3#1)(1997-6#1)(2012-2#2)
that the minimum##6##3##(1996-5#1)(2004-12#1)(2007-2#1)(2008-2#1)(2008-5#1)(2009-9#1)
that the mitochondrial##3##3##(1991-4#1)(1994-8#1)(2008-2#1)
that the mitogenic##3##3##(1991-8#1)(1994-2#1)(1996-2#1)
that the mixed##4##3##(1990-2#1)(2005-11#1)(2008-10#1)(2009-5#1)
that the mixture of##2##4##(2007-1#1)(2011-12#1)
that the mixture##5##3##(1990-12#1)(2004-9#1)(2007-1#1)(2011-12#1)(2012-3#1)
that the mobile##2##3##(1996-6#1)(2006-10#1)
that the mobility##3##3##(1994-3#1)(1997-8#1)(2005-11#1)
that the mode field##2##4##(2007-11#1)(2008-2#1)
that the mode of##4##4##(1996-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
that the mode##7##3##(1996-7#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-9#1)(2011-2#1)(2013-1#1)
that the model can##4##4##(2006-10#1)(2008-3#1)(2008-7#1)(2009-9#1)
that the model has##2##4##(2008-10#1)(2013-8#1)
that the model is##4##4##(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#1)
that the model##26##3##(1991-12#1)(1993-8#1)(1996-4#1)(2005-11#1)(2006-10#1)(2006-11#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#4)(2008-7#2)(2009-9#1)(2011-2#1)(2013-1#3)(2013-8#1)
that the model's##2##3##(2006-10#1)(2007-1#1)
that the models##3##3##(2007-11#1)(2010-12#1)(2010-2#1)
that the modes are##2##4##(2007-12#2)
that the modes##3##3##(2007-12#2)(2008-2#1)
that the modification of the##2##5##(1993-9#1)(2008-7#1)
that the modification of##4##4##(1993-9#1)(2008-10#1)(2008-7#1)(2012-11#1)
that the modification##7##3##(1993-9#1)(1995-5#1)(1995-6#1)(2008-10#1)(2008-7#1)(2009-3#1)(2012-11#1)
that the modified electrode##2##4##(2008-10#2)
that the modified nucleotides##2##4##(2008-8#2)
that the modified##11##3##(1991-1#1)(1991-10#1)(1992-5#1)(1995-2#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-8#2)
that the modulation of an##2##5##(2008-3#1)(2013-1#1)
that the modulation of##4##4##(1993-9#1)(2008-3#1)(2012-2#1)(2013-1#1)
that the modulation##9##3##(1993-9#1)(1994-6#1)(2007-11#1)(2008-3#2)(2010-12#1)(2012-2#2)(2013-1#1)
that the modulatory##2##3##(1994-8#1)(2011-2#1)
that the molecular mass##2##4##(1995-3#1)(1996-5#1)
that the molecular structure of##2##5##(2008-7#1)(2012-2#1)
that the molecular##15##3##(1990-6#1)(1991-2#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-5#1)(2005-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-6#1)(2010-12#1)(2012-2#1)
that the molecule##6##3##(1990-11#1)(1990-7#1)(1993-11#2)(1993-3#1)(2008-6#1)
that the molecules##2##3##(2008-1#1)(2008-10#1)
that the monoclonal antibody##2##4##(1990-5#2)
that the monoclonal##3##3##(1990-5#2)(1994-3#1)
that the monolayer##2##3##(1996-8#1)(2008-10#1)
that the more##11##3##(1994-12#1)(1995-11#1)(1997-3#1)(2005-11#1)(2008-10#1)(2008-3#1)(2008-5#2)(2009-3#1)(2009-7#1)(2013-8#1)
that the morphological##3##3##(1997-8#1)(2007-12#1)(2008-8#1)
that the morphology of the##2##5##(2008-7#1)(2008-8#1)
that the morphology of##5##4##(1991-12#1)(2008-7#2)(2008-8#1)(2011-2#1)
that the most common##6##4##(2007-10#1)(2007-2#1)(2007-9#1)(2008-8#1)(2008-9#1)(2011-2#1)
that the most cost-effective##2##4##(1994-3#1)(2008-11#1)
that the most frequent##3##4##(1993-9#1)(2011-2#1)(2012-2#1)
that the most important##7##4##(1994-3#1)(1995-12#1)(2008-10#2)(2008-4#1)(2008-9#1)(2010-8#1)
that the most likely##5##4##(1993-8#1)(1996-4#1)(2006-10#1)(2008-10#1)(2012-3#1)
that the most probable##2##4##(1996-7#1)(2008-3#1)
that the most significant##2##4##(1990-4#1)(1994-3#1)
that the most stable##2##4##(1996-7#1)(2012-3#1)
that the most##50##3##(1990-4#1)(1993-8#1)(1993-9#1)(1994-3#4)(1994-8#1)(1994-9#1)(1995-12#1)(1996-4#1)(1996-7#2)(2004-12#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#4)(2009-8#1)(2010-8#3)(2011-2#2)(2012-2#1)(2012-3#2)
that the mouse##6##3##(1992-11#1)(1992-7#1)(1994-8#1)(1996-11#1)(2008-8#1)(2008-9#1)
that the mtDNA##3##3##(1995-1#2)(1996-2#1)
that the multidisciplinary team##2##4##(2012-2#1)(2013-1#1)
that the multidisciplinary##3##3##(2007-1#1)(2012-2#1)(2013-1#1)
that the multiple##2##3##(1990-5#1)(2008-11#1)
that the murine##3##3##(1990-11#1)(1993-9#1)(1996-10#1)
that the muscle##2##3##(1992-3#1)(1995-2#1)
that the mutant##7##3##(1991-2#1)(1994-6#1)(1995-2#1)(1995-3#1)(2008-10#2)(2008-8#1)
that the mutants##3##3##(1992-7#1)(1997-3#1)(2008-10#1)
that the mutation in##2##4##(1990-12#1)(2013-8#1)
that the mutation is##2##4##(1997-4#1)(2008-12#1)
that the mutation##11##3##(1990-12#1)(1990-8#1)(1991-4#1)(1994-3#1)(1995-1#1)(1997-4#1)(2007-6#1)(2008-12#1)(2008-9#1)(2011-2#1)(2013-8#1)
that the mutations specifically##2##4##(1992-12#1)(1995-6#1)
that the mutations##12##3##(1992-1#1)(1992-12#1)(1993-11#1)(1994-9#1)(1995-1#1)(1995-6#1)(1997-2#1)(1997-5#1)(2008-10#2)(2008-8#1)(2009-3#1)
that the mutual interactions##2##4##(1990-11#1)(2006-10#1)
that the mutual##4##3##(1990-11#1)(2006-10#1)(2007-12#1)(2013-7#1)
that the myosin##2##3##(1993-6#1)(1994-11#1)
that the nanoparticles##2##3##(2008-10#1)(2008-7#1)
that the native enzyme##3##4##(1990-2#1)(1990-5#1)(1994-9#1)
that the native##12##3##(1990-2#2)(1990-5#1)(1990-7#1)(1993-8#2)(1993-9#1)(1994-8#1)(1994-9#1)(1996-11#1)(2008-10#1)(2008-3#1)
that the natural history of##3##5##(1991-9#1)(2008-6#1)(2010-10#1)
that the natural resistance of##2##5##(1990-5#1)(1997-2#1)
that the natural##12##3##(1990-5#1)(1990-8#1)(1991-9#1)(1994-12#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-6#1)(2010-1#1)(2010-10#1)(2010-2#1)(2011-1#1)
that the naturally occurring##2##4##(1994-9#2)
that the nature of the##9##5##(1992-8#1)(1995-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(2006-9#1)(2008-11#1)(2008-3#1)(2010-8#1)
that the nature of##13##4##(1992-8#1)(1994-5#1)(1995-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(2006-10#1)(2006-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-8#1)
that the nature##14##3##(1992-7#1)(1992-8#1)(1994-5#1)(1995-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(2006-10#1)(2006-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-8#1)
that the nearest##2##3##(1996-1#1)(2008-10#1)
that the necessary##4##3##(1997-6#1)(2008-2#1)(2008-3#1)(2010-2#1)
that the neck##4##3##(1994-4#1)(1995-8#1)(2007-1#2)
that the need##2##3##(2009-12#1)(2012-3#1)
that the needle##2##3##(1996-12#1)(2008-10#1)
that the needs of##5##4##(1996-2#1)(2008-1#1)(2008-10#1)(2008-8#1)(2013-1#1)
that the needs##6##3##(1996-2#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-8#1)(2013-1#1)
that the negative##11##3##(1990-12#1)(1995-9#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)
that the negatively charged##2##4##(1995-10#1)(1996-8#1)
that the neonatal##2##3##(1992-7#1)(1993-5#1)
that the nerve##2##3##(1997-2#1)(2006-12#1)
that the net##5##3##(1996-2#1)(1996-6#1)(2005-10#1)(2007-12#1)(2008-10#1)
that the network##5##3##(1994-3#1)(1997-8#1)(2008-10#1)(2009-10#1)(2012-2#1)
that the neural mechanisms##2##4##(2012-2#1)(2013-8#1)
that the neural network##2##4##(2008-10#1)(2010-8#1)
that the neural##11##3##(1991-2#1)(1996-2#1)(1996-5#1)(2008-10#1)(2008-11#3)(2010-8#1)(2012-1#1)(2012-2#1)(2013-8#1)
that the neurological##2##3##(2008-7#1)(2010-12#1)
that the neurons##4##3##(1992-3#1)(1996-5#1)(2007-9#1)(2009-2#1)
that the neutral##2##3##(1991-2#1)(2013-8#1)
that the new design##2##4##(2009-6#1)(2012-2#1)
that the new method##5##4##(2007-8#1)(2008-2#2)(2008-3#1)(2013-1#1)
that the new test##2##4##(2007-7#1)(2012-1#1)
that the new##42##3##(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1994-9#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-5#1)(2006-7#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#3)(2008-4#2)(2008-7#1)(2009-2#1)(2009-5#1)(2009-6#2)(2010-10#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
that the newly##2##3##(1992-4#1)(1997-3#1)
that the next generation of##2##5##(2008-11#1)(2008-7#1)
that the nitric oxide##4##4##(1994-2#1)(1995-5#1)(1996-11#1)(1997-4#1)
that the noise##3##3##(2008-2#1)(2008-3#1)(2009-5#1)
that the non-functional##2##3##(1992-8#1)(1995-5#1)
that the nonlinear##6##3##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)
that the nonlinearity##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
that the noradrenergic##2##3##(1995-5#1)(1996-5#1)
that the normal##10##3##(1990-3#1)(1990-8#1)(1991-5#1)(1992-9#1)(1994-7#1)(1994-8#1)(1995-12#1)(2008-12#1)(2008-5#1)(2008-9#1)
that the notion of##2##4##(2008-7#1)(2012-2#1)
that the novel porous beta-TCP scaffolds##2##6##(2008-5#2)
that the novel##7##3##(1992-8#1)(1996-10#1)(2005-11#1)(2008-10#1)(2008-5#2)(2010-10#1)
that the nuclear##3##3##(1996-4#1)(1997-2#1)(2008-8#1)
that the nucleotide##6##3##(1990-2#1)(1990-5#1)(1991-4#1)(1993-12#1)(1995-2#1)(2011-1#1)
that the nucleus accumbens##2##4##(1994-2#1)(2008-7#1)
that the nucleus##3##3##(1994-2#1)(2008-7#1)(2009-8#1)
that the null##2##3##(2008-10#1)(2008-12#1)
that the number of binding##2##5##(1995-8#1)(2010-4#1)
that the number of##59##4##(1990-6#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-8#1)(1993-12#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-8#2)(1995-9#1)(1996-5#1)(1997-2#1)(1997-8#1)(2004-2#1)(2006-10#2)(2006-5#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#3)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#2)
that the number##63##3##(1990-6#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-8#1)(1993-12#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1995-10#1)(1995-12#1)(1995-8#2)(1995-9#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-8#1)(2004-2#1)(2006-10#2)(2006-5#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#2)
that the numerical##2##3##(2008-3#1)(2012-1#1)
that the nurse##2##3##(2007-12#1)(2012-12#1)
that the nurses##3##3##(1994-4#1)(2008-1#1)(2009-4#1)
that the nursing##4##3##(1990-12#1)(1994-3#1)(2007-10#1)(2011-1#1)
that the object##6##3##(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#2)(2012-1#1)
that the objective of##2##4##(2007-11#1)(2009-6#1)
that the objective##3##3##(2007-11#1)(2009-6#1)(2013-1#1)
that the observation of##3##4##(1997-7#1)(2007-11#1)(2008-2#1)
that the observed effects##2##4##(1990-6#1)(1995-1#1)
that the observed##37##3##(1990-11#1)(1990-6#1)(1991-9#1)(1992-12#1)(1992-7#1)(1992-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1997-6#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-10#4)(2008-3#3)(2008-7#2)(2008-9#1)(2010-2#1)(2013-7#1)
that the obtained##4##3##(2008-10#1)(2010-12#1)(2012-12#1)(2013-8#1)
that the occupation of##2##4##(1996-5#1)(2011-2#1)
that the occurrence and##3##4##(1990-11#1)(2007-9#1)(2008-7#1)
that the occurrence of##10##4##(2006-10#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-8#2)(2010-5#1)(2011-1#1)(2013-8#1)
that the occurrence##13##3##(1990-11#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-5#1)(2011-1#1)(2013-8#1)
that the oculomotor system##2##4##(1996-1#1)(1997-8#1)
that the odds for##2##4##(2010-7#1)(2011-2#1)
that the off-axis##2##3##(2008-3#2)
that the oil##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
that the olfactory##3##3##(2008-11#1)(2008-5#1)(2011-2#1)
that the oligosaccharide##2##3##(1991-9#1)(1996-10#1)
that the oligosaccharides##2##3##(1993-11#2)
that the only##10##3##(1990-10#1)(1990-4#1)(1991-7#1)(1994-8#1)(1996-6#1)(2006-2#1)(2007-11#1)(2008-5#1)(2010-12#1)(2012-2#1)
that the onset of##4##4##(1992-7#1)(1994-8#1)(2007-7#1)(2010-8#1)
that the open##5##3##(1994-2#1)(1996-11#1)(1997-8#1)(2008-10#2)
that the opening##2##3##(2008-9#2)
that the operation##4##3##(2006-2#1)(2006-6#1)(2007-8#1)(2008-2#1)
that the opportunity cost##2##4##(2011-2#1)(2013-8#1)
that the opportunity##3##3##(2008-1#1)(2011-2#1)(2013-8#1)
that the opposing##2##3##(2009-4#1)(2013-1#1)
that the optical nonlinearity##2##4##(2006-12#1)(2007-12#1)
that the optical properties##2##4##(2008-2#1)(2008-3#1)
that the optical response##2##4##(1990-8#1)(2008-2#1)
that the optical##18##3##(1990-8#1)(2006-12#1)(2007-12#3)(2008-2#7)(2008-3#4)(2013-8#2)
that the optimal##19##3##(1990-12#1)(1994-11#1)(1995-8#1)(1996-8#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#4)(2013-1#1)
that the optimization##2##3##(1997-2#1)(2006-5#1)
that the optimum##6##3##(2008-10#3)(2008-3#2)(2012-12#1)
that the oral##3##3##(1992-9#1)(2005-11#1)(2006-9#1)
that the order of magnitude of the##2##7##(2007-12#1)(2008-3#1)
that the order of reactivity##2##5##(1995-11#1)(1997-7#1)
that the order of##11##4##(1991-7#1)(1994-3#1)(1995-11#1)(1996-10#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-3#1)(2012-2#2)(2013-8#1)
that the order##13##3##(1991-7#1)(1994-3#1)(1995-11#1)(1995-8#1)(1996-10#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-3#2)(2012-2#2)(2013-8#1)
that the organisation of the##2##5##(1990-11#1)(1995-6#1)
that the organism##3##3##(1995-9#1)(2005-7#1)(2007-7#1)
that the organization of##3##4##(2007-12#1)(2013-1#2)
that the orientation of##2##4##(1991-2#1)(2008-6#1)
that the orientation##3##3##(1991-2#1)(1991-6#1)(2008-6#1)
that the origin of the##2##5##(1991-3#1)(2007-12#1)
that the origin of##6##4##(1991-2#1)(1991-3#1)(1991-6#1)(2007-12#1)(2008-10#1)(2013-8#1)
that the original##6##3##(1995-9#1)(1997-7#1)(2008-11#1)(2008-2#1)(2009-4#1)(2010-5#1)
that the oscillation##2##3##(2008-10#1)(2010-10#1)
that the oscillatory##2##3##(1991-7#1)(2009-6#1)
that the other two##2##4##(2008-3#1)(2008-7#1)
that the other##9##3##(1991-1#1)(1992-6#1)(1993-5#1)(1997-3#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-2#1)
that the outbreak##2##3##(2008-5#1)(2013-8#1)
that the outcome of##5##4##(2006-10#1)(2007-1#1)(2007-9#1)(2009-5#1)(2012-3#1)
that the outcome##6##3##(2006-10#1)(2007-1#1)(2007-9#1)(2008-10#1)(2009-5#1)(2012-3#1)
that the outer##4##3##(1997-8#1)(2008-11#1)(2008-2#1)(2008-7#1)
that the outpatient##2##3##(1994-2#1)(2008-11#1)
that the output##8##3##(2006-9#1)(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#1)
that the overall structure of##2##5##(1994-8#1)(2011-12#1)
that the overall##32##3##(1991-10#1)(1991-6#1)(1992-6#1)(1993-2#1)(1994-8#1)(1995-11#1)(1995-4#1)(1995-5#1)(1996-11#1)(1997-1#1)(1997-2#1)(2005-5#1)(2007-10#1)(2007-12#1)(2007-8#3)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-12#1)(2012-2#2)(2013-8#1)
that the overexpression of##4##4##(1992-12#1)(1995-6#2)(2008-10#1)
that the overlap between##2##4##(2008-11#1)(2009-2#1)
that the overproduction of##2##4##(1995-8#1)(2009-8#1)
that the oxidation of##3##4##(1993-3#1)(1996-3#1)(1997-8#1)
that the oxidative burst##2##4##(1995-6#1)(2008-10#1)
that the oxidative##6##3##(1991-5#1)(1995-6#1)(2006-8#1)(2008-10#1)(2009-8#1)(2010-4#1)
that the oxygen##4##3##(1996-7#1)(2008-7#1)(2012-2#2)
that the p53 mutations##2##4##(1991-10#1)(1992-3#1)
that the p53##3##3##(1990-8#1)(1991-10#1)(1992-3#1)
that the pH##2##3##(2008-5#1)(2009-11#1)
that the pancreatic##3##3##(1990-8#1)(2008-7#1)(2010-12#1)
that the panel##2##3##(2008-2#1)(2010-12#1)
that the paradigm##3##3##(1991-1#1)(1994-12#1)(2013-8#1)
that the parallel##2##3##(1991-5#1)(1997-7#1)
that the parameter##2##3##(2008-10#1)(2008-8#1)
that the parameters##2##3##(1990-12#1)(1991-2#1)
that the parasite is able to##2##6##(1990-2#1)(2007-6#1)
that the parasite is##3##4##(1990-2#1)(2007-2#1)(2007-6#1)
that the parasite##6##3##(1990-2#1)(1996-6#1)(2007-2#1)(2007-3#1)(2007-6#1)(2008-8#1)
that the parent##4##3##(1990-2#1)(1992-2#1)(1992-9#1)(1995-10#1)
that the parents##2##3##(1995-12#1)(2008-10#1)
that the partial##4##3##(1991-9#1)(1997-2#1)(2008-11#2)
that the participants##2##3##(2010-1#1)(2011-2#1)
that the particles were##2##4##(1997-1#1)(2010-4#1)
that the particles##6##3##(1996-12#1)(1997-1#1)(2009-3#1)(2010-4#1)(2012-11#2)
that the partitioning##2##3##(1990-4#1)(2006-10#1)
that the pathogen##7##3##(2008-10#6)(2008-8#1)
that the pathogenesis of##2##4##(2008-10#1)(2009-4#1)
that the pathogens##2##3##(2006-8#1)(2008-12#1)
that the pathological changes in##2##5##(1990-5#1)(2008-7#1)
that the pathological##3##3##(1990-5#1)(2008-7#2)
that the pathway##2##3##(2008-10#1)(2011-3#1)
that the patient and##2##4##(1991-7#1)(2006-2#1)
that the patient had a##3##5##(1994-12#1)(1996-6#1)(2006-9#1)
that the patient had##9##4##(1991-3#1)(1994-12#1)(1996-6#2)(2006-9#1)(2011-2#1)(2012-2#1)(2013-8#2)
that the patient has##3##4##(1996-5#1)(2007-5#1)(2008-11#1)
that the patient is##7##4##(1990-11#1)(1992-1#1)(1992-8#1)(2007-2#1)(2007-5#1)(2011-2#1)(2013-1#1)
that the patient was##3##4##(1990-3#1)(1996-5#1)(2006-7#1)
that the patient##38##3##(1990-11#1)(1990-3#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-11#1)(1994-12#1)(1995-4#1)(1996-5#2)(1996-6#3)(1997-1#1)(2005-12#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-7#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-5#2)(2007-7#1)(2008-11#1)(2009-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
that the patient's##2##3##(1994-6#1)(2008-4#1)
that the patients with##3##4##(1994-12#1)(1995-10#1)(2011-2#1)
that the patients##16##3##(1990-8#1)(1994-12#1)(1995-10#1)(1995-4#2)(1996-2#1)(1997-2#1)(2005-7#1)(2007-5#2)(2007-7#1)(2008-4#1)(2008-7#1)(2011-2#2)(2012-2#1)
that the patients'##2##3##(1994-2#1)(2010-12#1)
that the pattern of distribution##3##5##(2008-10#1)(2013-1#2)
that the pattern of##10##4##(1991-6#1)(1993-9#1)(1994-5#1)(1995-2#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2013-1#2)
that the pattern##13##3##(1991-6#1)(1993-9#1)(1994-5#1)(1995-2#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-2#1)(2013-1#2)
that the patterns of##3##4##(2007-7#1)(2008-1#1)(2008-8#1)
that the peak current##2##4##(2008-10#2)
that the peak##10##3##(1996-5#1)(1997-3#1)(2005-4#1)(2007-1#1)(2008-10#6)
that the peptide was##2##4##(1995-5#1)(2008-10#1)
that the peptide##19##3##(1991-1#1)(1991-2#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#2)(1997-4#2)(2006-12#1)(2008-10#1)
that the peptides are##2##4##(1993-9#1)(1994-9#1)
that the peptides##8##3##(1990-4#1)(1990-7#1)(1993-9#2)(1994-9#1)(1997-2#1)(2006-10#1)(2008-9#1)
that the percentage of the##2##5##(2007-2#1)(2008-8#1)
that the percentage of##7##4##(1991-8#1)(2005-11#1)(2007-2#1)(2008-10#1)(2008-8#1)(2009-4#1)(2011-12#1)
that the percentage##8##3##(1991-8#1)(1996-9#1)(2005-11#1)(2007-2#1)(2008-10#1)(2008-8#1)(2009-4#1)(2011-12#1)
that the percentages of##3##4##(1996-7#1)(2005-10#1)(2008-10#1)
that the perception of##4##4##(2007-10#1)(2008-5#1)(2009-3#1)(2013-1#1)
that the perceptual##2##3##(1997-8#1)(2007-10#1)
that the performance of the##8##5##(1992-2#1)(2007-11#1)(2008-12#1)(2008-2#4)(2008-3#1)
that the performance of this##2##5##(2007-12#1)(2008-2#1)
that the performance of##18##4##(1992-2#1)(1992-9#1)(1993-6#1)(2006-7#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#1)
that the performance##21##3##(1992-2#2)(1992-9#1)(1993-6#1)(2006-7#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#2)
that the performances of##2##4##(2005-11#1)(2008-6#1)
that the perinatal mortality rate##2##5##(1990-3#1)(1995-6#1)
that the period of##4##4##(1996-6#1)(1996-9#1)(2008-10#2)
that the period##5##3##(1996-6#1)(1996-9#1)(2008-10#2)(2008-5#1)
that the periodic##2##3##(2007-11#1)(2008-7#1)
that the permeability##2##3##(2008-11#1)(2008-7#1)
that the persistent##2##3##(1991-10#1)(1997-6#1)
that the perturbation of##2##4##(1994-12#1)(2008-7#1)
that the pharmaceutical industry##2##4##(2005-9#1)(2006-10#1)
that the pharmaceutical##3##3##(2005-9#1)(2006-10#1)(2008-10#1)
that the pharmacological##2##3##(2007-11#1)(2013-8#1)
that the phase##9##3##(2005-11#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#3)
that the phase-shifting##2##3##(1994-2#1)(1996-6#1)
that the phenomena##2##3##(2007-8#1)(2009-12#1)
that the phenomenon of##7##4##(1991-8#1)(1992-3#1)(2004-11#1)(2007-11#1)(2008-10#1)(2008-9#1)(2011-2#1)
that the phenomenon##8##3##(1991-8#1)(1992-3#1)(2004-11#1)(2007-11#1)(2008-10#2)(2008-9#1)(2011-2#1)
that the phenotype##4##3##(2006-8#1)(2008-8#1)(2012-12#1)(2012-3#1)
that the phosphate##2##3##(1990-11#1)(2009-10#1)
that the phosphorylated##2##3##(1994-5#1)(1994-9#1)
that the phosphorylation of the##3##5##(1991-11#1)(1996-2#1)(1997-2#1)
that the phosphorylation of##5##4##(1991-11#1)(1994-11#1)(1995-6#1)(1996-2#1)(1997-2#1)
that the phosphorylation##8##3##(1991-10#1)(1991-11#1)(1993-8#1)(1994-11#1)(1995-6#2)(1996-2#1)(1997-2#1)
that the photodynamic action##2##4##(1992-2#1)(1997-1#1)
that the photoinduced##3##3##(2007-12#1)(2008-1#1)(2008-2#1)
that the photostability of##2##4##(2008-10#1)(2008-5#1)
that the physical##5##3##(1996-12#1)(2008-2#1)(2009-3#1)(2011-1#1)(2011-2#1)
that the physician##4##3##(1990-6#1)(1991-10#1)(2008-7#1)(2012-2#1)
that the physiological processes##2##4##(2005-9#1)(2008-8#1)
that the physiological##7##3##(1990-12#1)(1990-2#1)(1993-7#1)(2005-9#1)(2008-4#1)(2008-8#1)(2013-1#1)
that the phytoplasma##2##3##(2005-11#1)(2008-10#1)
that the phytoplasmas##2##3##(2008-10#2)
that the pigeons##2##3##(1990-10#1)(1994-2#1)
that the pineal gland##2##4##(1995-3#1)(2010-4#1)
that the pineal hormone melatonin##2##5##(1992-12#1)(1994-8#1)
that the pineal##5##3##(1992-12#1)(1994-8#1)(1994-9#1)(1995-3#1)(2010-4#1)
that the plant##6##3##(1992-3#1)(1994-11#1)(1994-6#1)(2008-5#1)(2008-6#1)(2013-1#1)
that the plasma membrane##4##4##(1990-11#1)(1991-2#1)(1992-8#1)(2007-8#1)
that the plasma##10##3##(1990-11#1)(1991-2#2)(1992-8#2)(2007-8#1)(2009-8#1)(2011-12#1)(2011-2#1)(2013-8#1)
that the plasmids##2##3##(1994-3#1)(1997-3#1)
that the platelet##2##3##(1990-12#1)(1994-12#1)
that the point##3##3##(1997-8#1)(2008-11#1)(2008-3#1)
that the polar##2##3##(1992-9#1)(1994-10#1)
that the polarization##5##3##(1990-9#1)(2007-12#2)(2008-2#1)(2008-3#1)
that the polarizing##2##3##(1991-5#1)(2007-11#1)
that the policy##3##3##(1992-12#1)(1996-5#1)(2010-12#1)
that the polyclonal##2##3##(1990-5#1)(2008-4#1)
that the polymer brushes##2##4##(2005-11#2)
that the polymer##11##3##(1991-8#1)(2005-11#2)(2006-9#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-12#1)(2011-3#1)(2012-12#1)
that the polymerase##2##3##(1990-9#1)(1996-2#1)
that the polymerization##2##3##(2007-11#1)(2008-3#1)
that the polymorphism##3##3##(1995-11#1)(2008-2#1)(2010-12#1)
that the polysaccharide is##2##4##(1991-7#1)(1995-11#1)
that the poor##3##3##(1991-2#1)(1992-2#1)(2011-3#1)
that the population is##2##4##(2008-10#1)(2008-12#1)
that the population of##6##4##(1993-5#1)(1996-11#1)(2007-12#1)(2008-10#2)(2011-2#1)
that the population##15##3##(1992-9#1)(1993-5#1)(1996-11#1)(2007-10#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)
that the population-based##3##3##(2009-8#1)(2013-1#2)
that the populations are##2##4##(2008-10#1)(2008-6#1)
that the populations##3##3##(2005-11#1)(2008-10#1)(2008-6#1)
that the porcine##3##3##(1997-5#1)(2008-11#1)(2012-2#1)
that the pore size##2##4##(1994-8#1)(2009-7#1)
that the position of the##2##5##(1996-7#1)(2007-12#1)
that the position of##6##4##(1996-7#1)(2005-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-3#1)
that the position##7##3##(1990-4#1)(1996-7#1)(2005-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-3#1)
that the positive##6##3##(1990-1#1)(1994-2#1)(1997-7#1)(2008-6#1)(2008-8#1)(2010-4#1)
that the possibility of##2##4##(1992-12#1)(2006-10#1)
that the possibility##3##3##(1992-12#1)(1995-6#1)(2006-10#1)
that the possible##2##3##(2007-6#1)(2013-8#1)
that the post-translational##2##3##(1997-2#1)(1997-6#1)
that the posterior##5##3##(1997-7#1)(2008-11#1)(2009-3#1)(2010-12#1)(2011-1#1)
that the potency##2##3##(1992-3#1)(1994-8#1)
that the potent##2##3##(1995-3#1)(2008-10#1)
that the potential for##5##4##(1993-8#1)(1996-2#1)(2007-1#1)(2007-11#1)(2012-3#1)
that the potential of##3##4##(1991-8#1)(1997-6#1)(2005-10#1)
that the potential to##2##4##(1991-3#1)(2004-1#1)
that the potential##17##3##(1991-3#1)(1991-8#1)(1993-8#1)(1996-2#1)(1997-6#1)(2004-1#1)(2005-10#1)(2007-1#1)(2007-11#1)(2007-4#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-2#1)(2012-12#2)(2012-3#1)
that the potentiating effect of##3##5##(1994-5#1)(1996-12#1)(2008-4#1)
that the power of the##2##5##(2008-2#2)
that the power of##3##4##(2008-2#2)(2008-5#1)
that the practice##4##3##(1993-6#1)(2006-7#1)(2008-11#1)(2012-2#1)
that the precise##3##3##(1991-8#1)(2013-1#2)
that the precision can be##2##5##(2008-2#1)(2008-3#1)
that the precision##3##3##(2008-2#2)(2008-3#1)
that the precursor##4##3##(1990-12#1)(1993-3#1)(1997-2#1)(2008-3#1)
that the predicted##7##3##(1993-12#1)(1994-8#1)(1996-8#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-9#1)
that the predictions##3##3##(1995-8#1)(2007-11#1)(2008-10#1)
that the predictive ability##2##4##(1996-8#1)(2008-10#1)
that the predictive##3##3##(1996-8#1)(2007-3#1)(2008-10#1)
that the predominant##8##3##(1990-7#1)(1992-12#1)(1993-6#1)(1995-4#1)(2007-4#1)(2007-5#1)(2008-12#1)(2010-9#1)
that the preference##2##3##(2008-5#1)(2008-9#1)
that the preferential##3##3##(1991-8#1)(1992-3#1)(1993-12#1)
that the preferred##2##3##(2008-11#1)(2010-6#1)
that the preparation##3##3##(1990-2#1)(1991-8#1)(1995-7#1)
that the preparatory##2##3##(2012-3#1)(2013-8#1)
that the prepared##5##3##(2008-10#2)(2008-5#1)(2010-5#1)(2012-12#1)
that the presence of a second##2##6##(1996-7#1)(2007-6#1)
that the presence of a##14##5##(1992-3#1)(1992-6#1)(1996-4#1)(1996-7#1)(1997-2#1)(2004-9#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-4#1)(2008-7#1)(2011-1#1)(2012-12#1)
that the presence of an##6##5##(1995-2#1)(1995-8#1)(1996-6#1)(2006-10#1)(2007-12#1)(2011-2#1)
that the presence of as##2##5##(1996-1#1)(2008-8#1)
that the presence of such##2##5##(2007-6#1)(2008-3#1)
that the presence of the Y122 residue##2##7##(1995-10#2)
that the presence of the##10##5##(1994-11#1)(1994-6#1)(1995-10#2)(1997-7#1)(2007-11#1)(2008-10#2)(2008-5#1)(2011-2#1)
that the presence of##115##4##(1990-5#3)(1990-7#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-3#2)(1993-5#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-10#2)(1995-11#1)(1995-2#1)(1995-6#2)(1995-8#2)(1996-1#2)(1996-4#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#2)(1997-7#2)(2004-11#1)(2004-9#2)(2005-11#3)(2006-10#2)(2006-11#1)(2006-9#1)(2007-11#4)(2007-12#3)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#2)(2009-1#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#3)
that the presence##116##3##(1990-5#3)(1990-7#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-3#2)(1993-5#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-10#2)(1995-11#1)(1995-2#1)(1995-6#2)(1995-8#2)(1996-1#2)(1996-4#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#2)(1997-7#2)(2004-11#1)(2004-9#2)(2005-11#3)(2006-10#3)(2006-11#1)(2006-9#1)(2007-11#4)(2007-12#3)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#2)(2009-1#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#3)
that the present##16##3##(1990-4#1)(1991-6#1)(1992-9#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-12#1)(1996-8#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2010-6#1)(2012-1#1)
that the presented##2##3##(2008-10#1)(2008-11#1)
that the presently##2##3##(1991-2#1)(1995-12#1)
that the presequence##2##3##(1991-12#1)(1994-11#1)
that the pressor effect of##2##5##(1993-4#1)(1995-1#1)
that the pressor##4##3##(1993-11#1)(1993-4#1)(1995-1#1)(1997-2#1)
that the pressure on##2##4##(2008-2#1)(2010-4#1)
that the pressure##3##3##(2006-5#1)(2008-2#1)(2010-4#1)
that the presynaptic NMDA receptor##2##5##(1994-8#1)(1996-1#1)
that the presynaptic##4##3##(1992-8#1)(1994-8#1)(1996-1#1)(1997-8#1)
that the prevalence of body dissatisfaction##2##6##(2007-12#2)
that the prevalence of##33##4##(1990-11#1)(1990-6#1)(1993-12#1)(1994-6#1)(1997-3#1)(2006-10#1)(2006-4#1)(2006-8#3)(2006-9#2)(2007-10#1)(2007-12#3)(2007-3#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-3#1)(2010-12#3)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
that the prevalence rate##2##4##(2006-8#1)(2013-8#1)
that the prevalence##36##3##(1990-11#1)(1990-6#1)(1993-12#1)(1994-6#1)(1997-3#1)(2006-10#1)(2006-4#1)(2006-8#4)(2006-9#2)(2007-10#1)(2007-12#3)(2007-3#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-3#1)(2010-12#4)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
that the prevention of##2##4##(1993-11#1)(1996-10#1)
that the prevention##3##3##(1993-11#1)(1996-10#1)(2011-12#1)
that the previous##4##3##(1990-7#1)(1991-9#1)(2007-8#1)(2013-8#1)
that the previously reported##2##4##(1990-5#1)(1995-12#1)
that the previously##8##3##(1990-5#1)(1992-4#1)(1993-12#1)(1994-3#1)(1995-12#1)(1995-9#1)(1996-8#1)(2005-11#1)
that the prg##2##3##(2008-10#2)
that the primary effect of##2##5##(1994-2#1)(1994-8#1)
that the primary##28##3##(1990-11#1)(1990-5#1)(1991-5#1)(1992-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-12#1)(1997-7#1)(2005-8#1)(2006-5#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-5#1)(2012-2#1)
that the principal##6##3##(1991-8#1)(1992-4#1)(1993-2#1)(2008-10#1)(2008-11#1)(2009-4#1)
that the principles##2##3##(2008-5#1)(2008-9#1)
that the prior##2##3##(2008-10#1)(2008-11#1)
that the pro-peptide of##2##4##(1990-5#1)(1993-3#1)
that the probability of a##2##5##(2007-9#1)(2008-10#1)
that the probability of##9##4##(1990-8#1)(1991-9#1)(2007-10#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-2#1)
that the probability##13##3##(1990-8#1)(1991-9#1)(1996-4#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#1)
that the probe##2##3##(1995-5#1)(2007-5#1)
that the problem of##5##4##(1993-6#1)(1997-4#1)(2007-12#2)(2008-2#1)
that the problem##9##3##(1993-6#1)(1997-4#1)(2007-10#1)(2007-12#2)(2008-2#2)(2009-6#1)(2009-9#1)
that the procedure could be##2##5##(1996-9#1)(2009-8#1)
that the procedure is##5##4##(2006-6#1)(2008-10#2)(2008-7#1)(2011-2#1)
that the procedure will##2##4##(2007-12#1)(2008-4#1)
that the procedure##16##3##(1995-12#1)(1996-9#1)(2006-6#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-2#1)
that the process can##2##4##(2007-8#1)(2008-7#1)
that the process of##4##4##(2008-11#1)(2008-3#1)(2008-9#1)(2012-3#1)
that the process##16##3##(1990-11#1)(1992-2#1)(1994-11#1)(1994-3#1)(1994-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
that the processes of##2##4##(1992-5#1)(2008-3#1)
that the processes##5##3##(1992-5#1)(1994-10#1)(2008-3#1)(2008-7#1)(2008-8#1)
that the processing##3##3##(1991-6#1)(1991-9#1)(1992-12#1)
that the product of the##4##5##(1991-5#1)(1993-12#1)(1997-1#1)(2008-3#1)
that the product of##6##4##(1990-2#1)(1991-5#1)(1993-12#1)(1997-1#1)(2008-10#1)(2008-3#1)
that the product##15##3##(1990-2#1)(1991-5#1)(1993-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2011-2#1)(2012-2#1)
that the production of##17##4##(1990-12#1)(1990-3#1)(1993-11#1)(1994-3#2)(1994-8#1)(1997-2#1)(1997-7#2)(1997-8#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-7#1)(2013-8#2)
that the products of these##2##5##(1990-9#1)(1994-8#1)
that the products of##4##4##(1990-9#1)(1994-8#1)(1995-6#1)(2011-1#1)
that the products##6##3##(1990-9#1)(1994-8#1)(1995-6#1)(2008-5#1)(2011-1#1)(2011-2#1)
that the profession##3##3##(2006-2#1)(2007-4#1)(2011-1#1)
that the prognosis of##3##4##(1996-12#1)(2008-4#1)(2008-6#1)
that the prognosis##4##3##(1992-6#1)(1996-12#1)(2008-4#1)(2008-6#1)
that the prognostic##3##3##(1993-9#1)(2009-4#1)(2012-3#1)
that the program has##3##4##(1991-1#1)(1992-2#1)(1995-12#1)
that the program##6##3##(1991-1#1)(1992-12#1)(1992-2#1)(1995-12#1)(2006-3#1)(2007-1#1)
that the programme is##3##4##(1991-11#1)(1992-3#1)(2010-9#1)
that the programme##5##3##(1991-11#1)(1992-3#1)(2007-7#1)(2008-1#1)(2010-9#1)
that the programs##3##3##(1990-12#1)(1996-6#1)(2009-4#1)
that the projection##2##3##(1991-8#1)(1991-9#1)
that the prokaryotic##2##3##(2005-11#1)(2011-2#1)
that the proliferative##2##3##(2007-12#1)(2008-10#1)
that the promoter is##3##4##(1997-4#1)(1997-7#1)(2008-2#1)
that the promoter region##2##4##(1993-3#1)(2007-10#1)
that the promoter##7##3##(1993-3#1)(1996-12#1)(1997-4#1)(1997-7#1)(2007-10#1)(2008-2#1)(2011-1#1)
that the prone position##2##4##(1992-11#1)(1992-4#1)
that the propagation speed of##2##5##(2008-2#1)(2008-5#1)
that the propagation##3##3##(1991-3#1)(2008-2#1)(2008-5#1)
that the proper##2##3##(2007-12#1)(2011-12#1)
that the properties of the##4##5##(1991-4#1)(1993-8#1)(1995-1#1)(2007-1#1)
that the properties of##6##4##(1991-4#1)(1993-8#1)(1994-9#1)(1995-1#1)(2007-1#1)(2007-12#1)
that the proportion of##11##4##(1991-3#1)(1992-12#1)(1992-2#1)(1992-9#1)(1996-1#1)(2005-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-1#1)(2013-8#1)
that the proportion##12##3##(1991-3#1)(1992-12#1)(1992-2#1)(1992-9#1)(1996-1#1)(2005-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-1#1)(2012-3#1)(2013-8#1)
that the proportions of##3##4##(2006-2#1)(2007-2#1)(2008-7#1)
that the proposed algorithm##5##4##(2008-2#4)(2008-3#1)
that the proposed algorithms##2##4##(2008-2#2)
that the proposed approach is able to##2##7##(2012-2#1)(2013-7#1)
that the proposed approach##3##4##(2012-2#1)(2013-7#1)(2013-8#1)
that the proposed framework##2##4##(2008-2#2)
that the proposed method can##2##5##(2013-1#1)(2013-8#1)
that the proposed method is robust##3##6##(2012-3#1)(2013-1#2)
that the proposed method is##8##5##(2008-10#3)(2008-2#1)(2008-3#1)(2012-3#1)(2013-1#2)
that the proposed method provides##2##5##(2007-8#1)(2012-12#1)
that the proposed method##17##4##(2007-12#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
that the proposed model is##2##5##(2008-7#1)(2012-1#1)
that the proposed model##5##4##(2008-11#1)(2008-3#1)(2008-7#1)(2012-1#1)(2013-1#1)
that the proposed optical##2##4##(2008-2#1)(2008-3#1)
that the proposed procedure##6##4##(2008-10#5)(2012-1#1)
that the proposed scheme##2##4##(2007-12#1)(2008-2#1)
that the proposed technique##2##4##(2006-8#1)(2008-10#1)
that the proposed##92##3##(1993-12#1)(1993-6#1)(1994-5#1)(1995-9#1)(1996-10#1)(2006-8#1)(2007-11#2)(2007-12#4)(2007-8#2)(2008-10#17)(2008-11#1)(2008-2#20)(2008-3#6)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-8#4)(2010-9#1)(2011-2#1)(2012-1#5)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#2)
that the prosthesis was##2##4##(1990-2#1)(2009-3#1)
that the prosthesis##3##3##(1990-2#2)(2009-3#1)
that the protease##5##3##(1991-1#1)(1992-3#2)(1995-3#1)(2008-10#1)
that the protection##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
that the protective effect##3##4##(1993-11#1)(1993-6#1)(1995-12#1)
that the protective effects of##3##5##(1995-1#1)(1996-10#1)(2010-7#1)
that the protective effects##4##4##(1995-1#1)(1996-10#1)(2008-11#1)(2010-7#1)
that the protective##8##3##(1993-11#1)(1993-6#1)(1995-1#1)(1995-12#1)(1996-10#1)(2008-11#1)(2008-8#1)(2010-7#1)
that the protein encoded by##2##5##(1990-9#1)(1993-12#1)
that the protein encoded##3##4##(1990-9#1)(1993-11#1)(1993-12#1)
that the protein has##2##4##(1991-7#1)(1994-9#1)
that the protein is a##3##5##(1991-2#1)(1994-2#1)(1994-9#1)
that the protein is##14##4##(1990-4#1)(1991-2#2)(1992-11#1)(1993-7#1)(1994-2#1)(1994-9#2)(1996-12#1)(1996-3#1)(2008-5#1)(2012-12#3)
that the protein kinase domain##2##5##(1990-7#1)(1997-6#1)
that the protein kinase##3##4##(1990-7#1)(1994-3#1)(1997-6#1)
that the protein may be##2##5##(1991-2#1)(1993-6#1)
that the protein may##3##4##(1991-2#1)(1993-6#1)(2008-9#1)
that the protein was##6##4##(1990-5#1)(1990-6#1)(1991-9#2)(1992-11#1)(2006-12#1)
that the protein##63##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-2#4)(1991-5#1)(1991-7#1)(1991-9#3)(1992-11#2)(1992-12#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#4)(1995-10#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-12#1)(2008-11#2)(2008-5#1)(2008-9#2)(2009-7#1)(2010-1#1)(2010-5#1)(2012-11#1)(2012-12#4)
that the protein-bound##2##3##(1994-11#1)(2010-6#1)
that the proteins are##3##4##(1990-7#1)(1991-1#2)
that the proteins were##2##4##(1995-8#1)(1996-2#1)
that the proteins##11##3##(1990-1#1)(1990-5#1)(1990-7#1)(1991-1#2)(1994-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-7#1)(2008-4#1)
that the proteolysis##2##3##(1997-4#1)(2011-1#1)
that the protocol##2##3##(1997-1#1)(2008-9#1)
that the proton##2##3##(2008-5#1)(2008-8#1)
that the proximal##3##3##(1993-12#1)(1995-10#1)(1997-7#1)
that the public##6##3##(1996-11#1)(1996-3#1)(1997-8#1)(2007-1#1)(2007-9#1)(2010-5#1)
that the purified material##2##4##(1990-12#1)(1996-9#1)
that the purified##14##3##(1990-10#1)(1990-12#1)(1993-5#1)(1993-7#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-4#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-9#1)(2012-2#1)
that the purity of##2##4##(2008-11#1)(2008-8#1)
that the purity##3##3##(1994-12#1)(2008-11#1)(2008-8#1)
that the purpose of##2##4##(2008-11#1)(2012-2#1)
that the purpose##3##3##(2008-11#1)(2012-2#2)
that the putative##12##3##(1991-9#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-6#1)(1995-5#1)(1997-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-3#1)
that the quality of the##7##5##(1991-6#1)(1995-8#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
that the quality of##14##4##(1991-6#1)(1992-2#1)(1994-5#1)(1995-8#1)(1997-1#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
that the quality##17##3##(1991-6#1)(1992-2#1)(1994-5#1)(1995-8#1)(1997-1#1)(2006-2#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)
that the quantitative##9##3##(1991-9#1)(1994-8#1)(1996-12#1)(2008-10#3)(2008-5#1)(2010-10#1)(2011-1#1)
that the quaternary##2##3##(1990-4#1)(1994-9#1)
that the questionnaire##3##3##(2004-10#2)(2012-12#1)
that the radar##2##3##(2008-3#2)
that the radiation##2##3##(2007-12#1)(2008-2#1)
that the radiative transfer from a heated metal to a lossless dielectric##2##12##(2007-12#2)
that the radiative transfer##3##4##(2007-12#2)(2008-3#1)
that the radical##2##3##(1995-10#1)(1996-2#1)
that the radius##2##3##(2006-11#1)(2008-2#1)
that the range of validity of##2##6##(2008-2#2)
that the range of##5##4##(1990-3#1)(2008-2#2)(2008-3#2)
that the rapid and##2##4##(1993-4#1)(1995-6#1)
that the rapid##10##3##(1991-7#1)(1992-2#1)(1993-11#1)(1993-3#1)(1993-4#1)(1995-6#1)(2011-1#1)(2011-12#1)(2012-12#1)(2013-8#1)
that the rat##12##3##(1990-11#1)(1990-12#1)(1991-6#1)(1992-3#1)(1992-7#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-6#1)(1996-5#1)(1997-6#1)(1997-8#1)
that the rate and extent of##2##6##(1997-3#1)(2007-11#1)
that the rate of increase in##2##6##(1990-7#1)(2007-8#1)
that the rate of increase##3##5##(1990-7#1)(1993-3#1)(2007-8#1)
that the rate of transcription of the##2##7##(1991-7#1)(1992-1#1)
that the rate of##33##4##(1990-12#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-7#1)(1992-1#2)(1992-11#1)(1992-6#1)(1993-3#2)(1994-11#2)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(2005-11#1)(2005-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-8#1)(2011-1#1)(2012-2#1)
that the rate##40##3##(1990-12#1)(1990-5#1)(1990-7#1)(1991-2#2)(1991-7#1)(1992-1#2)(1992-11#1)(1992-6#1)(1993-3#2)(1994-11#2)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
that the rate-limiting step in##2##5##(1991-5#1)(1995-10#1)
that the rate-limiting step of##2##5##(1992-12#1)(1997-4#1)
that the rate-limiting step##4##4##(1991-5#1)(1992-12#1)(1995-10#1)(1997-4#1)
that the rate-limiting##5##3##(1990-2#1)(1991-5#1)(1992-12#1)(1995-10#1)(1997-4#1)
that the rates of##2##4##(1996-7#1)(2009-4#1)
that the ratio of the##3##5##(1994-12#1)(2004-12#1)(2008-10#1)
that the ratio of##10##4##(1991-12#1)(1994-12#1)(1994-2#1)(1996-8#1)(2004-12#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-4#1)
that the ratio##11##3##(1991-12#1)(1994-12#1)(1994-2#1)(1996-8#1)(2004-12#1)(2006-8#1)(2008-10#2)(2008-11#2)(2008-4#1)
that the rats treated with##2##5##(2011-2#1)(2013-1#1)
that the reaction follows##2##4##(1991-12#1)(1995-1#1)
that the reaction of##3##4##(1996-5#1)(2008-10#2)
that the reaction rate##3##4##(2008-10#2)(2011-2#1)
that the reaction##16##3##(1990-10#1)(1990-2#1)(1990-5#1)(1991-12#1)(1995-1#2)(1995-8#1)(1996-5#1)(2008-10#6)(2008-7#1)(2011-2#1)
that the reactions##3##3##(2008-10#2)(2008-3#1)
that the reactive intermediate##2##4##(1995-6#2)
that the reactive##3##3##(1995-6#3)
that the reader will##2##4##(2008-4#1)(2012-3#1)
that the real problem is##2##5##(1994-1#1)(2007-4#1)
that the real##3##3##(1994-1#1)(2007-4#1)(2010-12#1)
that the recall##2##3##(2008-2#1)(2010-11#1)
that the recent##2##3##(2008-2#1)(2012-3#1)
that the recently introduced##2##4##(1992-4#1)(2008-10#1)
that the recently reported##2##4##(1996-2#1)(1997-6#1)
that the recently##7##3##(1992-4#1)(1993-6#1)(1996-2#1)(1997-6#1)(2008-10#1)(2008-3#1)(2011-2#1)
that the receptor is##4##4##(1990-11#1)(1993-3#1)(1994-8#1)(1995-1#1)
that the receptor##11##3##(1990-11#1)(1991-5#1)(1991-9#1)(1993-3#1)(1993-9#1)(1994-8#1)(1995-1#1)(1996-4#1)(1997-6#1)(2008-4#1)(2008-7#1)
that the reciprocal##2##3##(1991-10#1)(2008-3#1)
that the recognition##2##3##(1990-12#1)(2008-2#1)
that the recombinant protein##2##4##(1990-11#1)(1994-12#1)
that the recombinant##13##3##(1990-11#1)(1991-7#2)(1993-11#1)(1994-12#1)(1994-5#1)(1995-10#1)(2007-11#1)(2008-11#1)(2008-8#2)(2009-3#1)(2011-2#1)
that the recombination##5##3##(1990-4#1)(1995-8#1)(2006-5#1)(2008-10#1)(2013-8#1)
that the reconstituted##2##3##(1993-8#1)(2008-11#1)
that the reconstructed##2##3##(1993-5#1)(2008-3#1)
that the reconstruction accuracy of the##2##6##(2007-11#1)(2007-12#1)
that the reconstruction##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2012-1#1)
that the recovery of##4##4##(2008-10#2)(2008-3#1)(2008-5#1)
that the recovery rate was##2##5##(2008-10#1)(2013-8#1)
that the recovery##8##3##(1995-11#1)(2008-10#3)(2008-3#1)(2008-5#1)(2013-8#2)
that the red##2##3##(1993-3#1)(2008-8#1)
that the redox##3##3##(1995-8#2)(2008-8#1)
that the reduced##14##3##(1991-8#1)(1995-12#1)(1996-7#1)(1997-3#1)(1997-5#1)(2006-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#1)(2011-12#1)(2012-2#1)
that the reduction in the##3##5##(1991-1#1)(1995-3#1)(2008-10#1)
that the reduction in##10##4##(1991-1#1)(1991-6#1)(1995-3#1)(1996-9#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-8#1)(2010-12#1)(2010-7#1)
that the reduction of##8##4##(1992-4#1)(1992-8#1)(1992-9#1)(2006-6#1)(2007-11#1)(2007-6#1)(2009-4#1)(2011-2#1)
that the reduction##19##3##(1990-8#1)(1991-1#1)(1991-6#1)(1992-4#1)(1992-8#1)(1992-9#1)(1995-3#1)(1996-9#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-7#1)(2011-2#1)
that the reductions in##2##4##(1996-1#1)(2008-10#1)
that the reference##2##3##(2010-3#1)(2011-2#1)
that the reflectance##2##3##(2006-12#1)(2008-2#1)
that the reflection##2##3##(2007-12#1)(2008-2#1)
that the reflex##2##3##(1996-6#1)(2012-1#1)
that the refractive index of##2##5##(2008-2#1)(2008-3#1)
that the refractive index##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
that the regenerated A##2##4##(2008-5#2)
that the region of##4##4##(1990-10#1)(1994-12#1)(1994-9#1)(1996-1#1)
that the region spanning##2##4##(1992-12#1)(1995-3#1)
that the region##12##3##(1990-10#1)(1992-12#1)(1992-9#1)(1994-12#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-1#1)(1997-7#1)(1997-8#1)(2008-8#2)
that the regions##3##3##(1995-8#1)(1997-7#1)(2013-8#1)
that the regular##4##3##(1996-4#1)(2008-5#2)(2008-7#1)
that the regulation of##13##4##(1990-11#1)(1991-2#1)(1992-8#1)(1993-11#1)(1994-2#2)(1994-9#2)(1995-10#1)(1996-2#1)(2006-10#1)(2006-5#1)(2008-11#1)
that the regulator##2##3##(1990-7#2)
that the regulatory mechanism##2##4##(1992-11#1)(2011-10#1)
that the regulatory##9##3##(1990-5#1)(1990-7#1)(1992-11#1)(1992-6#1)(1995-12#1)(1996-1#1)(1996-11#1)(1997-1#1)(2011-10#1)
that the related##3##3##(1993-8#1)(2009-8#1)(2012-12#1)
that the relation##2##3##(2008-2#1)(2010-7#1)
that the relationship between##15##4##(1994-2#2)(1994-5#1)(2005-4#1)(2006-7#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-8#2)(2012-12#1)(2013-8#1)
that the relationship##19##3##(1992-8#1)(1994-2#2)(1994-5#1)(2005-10#1)(2005-4#1)(2006-7#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-8#2)(2011-2#1)(2012-12#1)(2013-8#1)
that the relationships between##2##4##(2009-7#2)
that the relative standard deviation##2##5##(2008-10#1)(2013-8#1)
that the relative standard##3##4##(2008-10#2)(2013-8#1)
that the relative##27##3##(1991-7#1)(1994-10#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-2#1)(2005-10#1)(2006-10#2)(2007-11#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#2)
that the relatively##2##3##(1993-2#1)(1996-8#1)
that the relaxation##2##3##(2008-12#1)(2008-3#1)
that the release mechanism##2##4##(1995-3#1)(2010-1#1)
that the release of ligands##2##5##(1997-6#2)
that the release of##11##4##(1990-11#1)(1992-6#1)(1994-2#1)(1996-5#1)(1997-6#2)(2008-10#3)(2008-11#1)(2008-4#1)
that the release##14##3##(1990-11#1)(1990-2#1)(1992-6#1)(1994-2#1)(1995-3#1)(1996-5#1)(1997-6#2)(2008-10#3)(2008-11#1)(2008-4#1)(2010-1#1)
that the relevant##3##3##(1991-5#1)(2006-6#1)(2008-10#1)
that the remaining##6##3##(1997-1#1)(2007-12#2)(2008-2#1)(2009-3#1)(2009-4#1)
that the removal of##5##4##(1992-12#1)(1997-4#1)(2006-10#1)(2008-10#1)(2009-9#1)
that the renal##5##3##(1990-11#1)(1996-7#1)(2007-8#1)(2008-10#1)(2009-2#1)
that the renin-angiotensin system (RAS)##2##5##(1993-12#1)(2005-7#1)
that the repair##2##3##(1992-6#1)(2012-12#1)
that the replacement of two##2##5##(2006-12#1)(2012-12#1)
that the replacement of##5##4##(1991-2#1)(1992-8#1)(1994-5#1)(2006-12#1)(2012-12#1)
that the replacement##6##3##(1991-2#1)(1992-8#1)(1994-5#1)(1997-5#1)(2006-12#1)(2012-12#1)
that the reported##9##3##(1990-11#1)(1991-2#1)(1991-7#1)(1996-12#1)(1997-5#1)(2005-10#1)(2006-12#1)(2007-3#2)
that the reporter gene##2##4##(2006-12#1)(2008-9#1)
that the reproductive success##2##4##(2008-9#1)(2009-12#1)
that the reproductive##4##3##(1991-12#1)(2006-10#1)(2008-9#1)(2009-12#1)
that the required##2##3##(2008-3#2)
that the requirements##2##3##(1992-11#1)(2008-11#1)
that the research subjects##2##4##(1996-3#2)
that the research##6##3##(1995-1#1)(1996-3#3)(2008-11#1)(2008-2#1)
that the reserve##2##3##(2007-10#1)(2008-5#1)
that the residual##6##3##(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2012-2#1)
that the residues##4##3##(1991-4#1)(1995-5#1)(1997-5#1)(1997-6#1)
that the resistance is##4##4##(2008-10#3)(2013-1#1)
that the resistance of the##2##5##(1991-5#1)(2008-10#1)
that the resistance of##5##4##(1991-5#1)(2008-10#4)
that the resistance was##2##4##(2008-10#2)
that the resistance##17##3##(1991-5#1)(2008-10#14)(2011-2#1)(2013-1#1)
that the resistant##2##3##(1995-6#1)(2008-10#1)
that the resolution of##3##4##(2005-8#1)(2008-1#1)(2010-3#1)
that the resonant##3##3##(2007-12#1)(2008-3#2)
that the respective##3##3##(1995-11#1)(2008-1#1)(2008-3#1)
that the respondents##2##3##(1991-6#1)(2010-8#1)
that the response is##3##4##(2008-10#1)(2008-3#1)(2008-6#1)
that the response of##8##4##(1990-7#1)(1997-3#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-7#1)
that the response to##2##4##(2006-10#1)(2008-11#1)
that the response##23##3##(1990-7#2)(1993-9#1)(1994-10#1)(1996-9#1)(1997-3#1)(1997-4#1)(2006-10#2)(2008-10#6)(2008-11#4)(2008-3#1)(2008-6#1)(2008-7#1)(2009-8#1)
that the responses to##3##4##(1991-5#1)(1995-12#1)(2009-8#1)
that the responses##4##3##(1991-5#1)(1995-12#1)(2008-9#1)(2009-8#1)
that the restoration##2##3##(1994-10#1)(2011-2#1)
that the resultant##2##3##(2007-12#1)(2009-6#1)
that the resulting##17##3##(1991-6#1)(1993-2#1)(1995-11#1)(2005-11#2)(2007-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-3#1)(2010-4#2)(2010-8#1)(2012-1#1)(2012-12#1)(2013-1#1)
that the results and##2##4##(1993-8#1)(1995-3#1)
that the results are##7##4##(2005-5#1)(2008-2#3)(2009-8#1)(2010-8#1)(2012-2#1)
that the results obtained by##2##5##(2008-10#2)
that the results obtained##6##4##(1996-9#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#2)
that the results of the##2##5##(2006-10#1)(2011-2#1)
that the results of##12##4##(1993-9#1)(1996-11#1)(1997-6#1)(2006-10#3)(2007-7#1)(2008-8#2)(2011-2#1)(2012-2#1)(2012-3#1)
that the results##33##3##(1991-6#1)(1993-8#1)(1993-9#1)(1995-3#1)(1996-11#1)(1996-9#1)(1997-1#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-5#1)(2006-10#3)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-2#3)(2008-8#2)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-8#2)
that the retention mechanism##2##4##(2005-12#1)(2008-10#1)
that the retention##7##3##(1992-6#1)(1996-5#1)(2005-12#2)(2008-10#3)
that the retrieved##3##3##(2008-2#1)(2008-3#2)
that the reverse##2##3##(2006-4#1)(2008-10#1)
that the reversible##2##3##(1992-12#1)(1995-6#1)
that the rice##3##3##(1997-2#1)(2006-12#1)(2012-1#1)
that the right##5##3##(1991-6#1)(1997-1#1)(1997-2#1)(2006-4#1)(2008-11#1)
that the rise in##2##4##(1995-10#1)(2008-3#1)
that the risk is##3##4##(2008-9#1)(2013-1#2)
that the risk of falls##2##5##(2013-8#2)
that the risk of##20##4##(1990-12#1)(1991-12#1)(1992-9#1)(1993-12#1)(2006-10#1)(2006-11#2)(2007-8#1)(2008-11#1)(2008-3#2)(2008-4#1)(2009-11#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#2)
that the risk##35##3##(1990-12#1)(1991-12#1)(1992-2#1)(1992-9#1)(1993-12#2)(1994-3#1)(2006-10#1)(2006-11#2)(2007-8#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-11#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#10)
that the rms##2##3##(2008-3#2)
that the robot##2##3##(2012-1#2)
that the rod's##2##3##(2008-2#2)
that the rodent##2##3##(1997-6#1)(2010-2#1)
that the role of the##3##5##(1990-8#1)(1992-1#1)(2007-10#1)
that the role of##21##4##(1990-3#1)(1990-4#1)(1990-8#1)(1991-5#1)(1992-1#1)(1993-11#1)(1994-4#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-12#1)(2005-7#1)(2007-1#1)(2007-10#2)(2008-2#1)(2010-1#1)(2011-1#1)(2011-2#1)(2013-1#1)
that the role##24##3##(1990-3#1)(1990-4#1)(1990-8#1)(1991-5#1)(1992-1#1)(1993-11#1)(1994-4#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-12#1)(2005-7#1)(2007-1#1)(2007-10#2)(2008-11#1)(2008-2#1)(2010-1#1)(2011-1#1)(2011-2#2)(2013-1#2)
that the roles of##2##4##(1996-4#1)(2011-1#1)
that the roles##3##3##(1994-1#1)(1996-4#1)(2011-1#1)
that the roughness##2##3##(2008-2#1)(2008-3#1)
that the rules##2##3##(2007-11#1)(2009-9#1)
that the rust##2##3##(2008-10#2)
that the safety of the##4##5##(2006-10#1)(2007-1#1)(2013-1#2)
that the safety##7##3##(2006-10#1)(2007-1#1)(2008-6#1)(2012-12#1)(2013-1#2)(2013-8#1)
that the salivary gland##2##4##(1994-7#1)(2007-12#1)
that the salivary##3##3##(1994-7#1)(2007-12#1)(2008-4#1)
that the same gene##2##4##(2008-10#2)
that the same mechanism is involved in##2##7##(1990-8#1)(2008-7#1)
that the same molecular##2##4##(1990-8#1)(2009-8#1)
that the same##45##3##(1990-11#1)(1990-2#1)(1990-8#2)(1994-12#2)(1994-3#1)(1994-8#2)(1995-2#1)(1995-3#1)(1996-1#2)(1996-10#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-3#1)(2006-10#1)(2006-3#1)(2006-9#1)(2007-5#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-4#1)(2009-8#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)
that the sample size##2##4##(1995-9#1)(2009-11#1)
that the sample##8##3##(1995-9#1)(1996-4#1)(2008-10#2)(2009-11#1)(2010-3#1)(2011-12#1)(2012-12#1)
that the samples##4##3##(2008-10#2)(2008-3#1)(2012-2#1)
that the sampling##2##3##(2008-10#2)
that the scaffold##3##3##(2008-5#2)(2010-4#1)
that the scale##2##3##(2008-5#1)(2008-9#1)
that the scanner##2##3##(2008-3#1)(2011-1#1)
that the scattering##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
that the schistosomiasis##2##3##(2012-3#2)
that the scientific community##2##4##(2007-9#1)(2011-1#1)
that the scientific##7##3##(2007-8#1)(2007-9#1)(2010-12#1)(2011-1#2)(2012-3#1)(2013-1#1)
that the scope##2##3##(1993-1#1)(1997-8#1)
that the sea##2##3##(1992-5#1)(2007-5#1)
that the search for##2##4##(1994-2#1)(2013-7#1)
that the search##3##3##(1994-2#1)(2008-2#1)(2013-7#1)
that the second zinc finger##2##5##(1994-9#2)
that the second##16##3##(1992-9#1)(1994-9#2)(1995-6#1)(1997-2#1)(1997-5#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)
that the second-order##2##3##(1991-4#1)(2008-3#1)
that the secondary structure of##5##5##(1992-8#1)(1993-8#1)(2008-10#2)(2012-2#1)
that the secondary structure##7##4##(1990-10#1)(1991-5#1)(1992-8#1)(1993-8#1)(2008-10#2)(2012-2#1)
that the secondary##10##3##(1990-10#1)(1991-5#1)(1992-8#1)(1993-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2012-2#1)
that the selected##4##3##(1993-9#1)(2006-12#1)(2008-10#1)(2010-3#1)
that the selection of##3##4##(1993-12#1)(2008-8#1)(2011-2#1)
that the selection##4##3##(1993-12#1)(2008-10#1)(2008-8#1)(2011-2#1)
that the selectivity of the##3##5##(1996-5#1)(2008-10#2)
that the selectivity of##4##4##(1993-4#1)(1996-5#1)(2008-10#2)
that the selectivity##6##3##(1993-4#1)(1996-5#1)(2008-10#4)
that the sensitivity of the##10##5##(1995-7#1)(1997-2#1)(2005-9#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-8#1)(2013-8#1)
that the sensitivity of##23##4##(1995-2#1)(1995-7#1)(1997-2#1)(1997-4#1)(1997-5#1)(2005-4#1)(2005-9#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2012-2#1)(2013-8#1)
that the sensitivity##30##3##(1995-2#1)(1995-7#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-4#1)(2005-9#1)(2006-8#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#4)(2008-7#1)(2008-8#2)(2011-1#1)(2012-2#1)(2013-8#1)
that the sensitizer##2##3##(1992-2#2)
that the sensor can be used##2##6##(2008-10#1)(2008-3#1)
that the sensor can be##3##5##(2007-8#1)(2008-10#1)(2008-3#1)
that the sensor can detect##2##5##(2007-11#1)(2008-10#1)
that the sensor can##6##4##(2007-11#1)(2007-8#2)(2008-10#2)(2008-3#1)
that the sensor##11##3##(2007-11#3)(2007-8#2)(2008-10#4)(2008-2#1)(2008-3#1)
that the sensory##5##3##(1990-7#1)(1996-1#1)(2007-12#2)(2008-8#1)
that the separate##2##3##(1994-9#1)(1995-5#1)
that the separation##2##3##(1996-5#1)(2011-1#1)
that the sequence of the##3##5##(1996-2#1)(1997-2#1)(2008-10#1)
that the sequence of##5##4##(1996-2#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-4#1)
that the sequence##12##3##(1991-3#1)(1991-7#1)(1993-4#1)(1993-8#1)(1996-11#1)(1996-2#1)(1997-2#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)
that the sequences of##4##4##(1992-2#1)(1995-8#1)(1996-10#1)(1996-2#1)
that the sequences##9##3##(1992-2#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-7#2)(2008-8#1)(2011-2#1)(2011-3#1)
that the sequential##2##3##(1996-4#1)(2008-10#1)
that the serine##3##3##(1992-12#1)(1993-3#1)(2006-10#1)
that the serotonin##2##3##(2008-5#2)
that the serotype##2##3##(1991-3#1)(2008-5#1)
that the serum##3##3##(1994-12#1)(2007-2#1)(2011-1#1)
that the set##3##3##(1992-4#1)(2008-11#1)(2013-1#1)
that the setting##3##3##(1991-6#1)(1996-11#1)(2004-9#1)
that the seven##2##3##(1994-11#1)(2012-3#1)
that the severity of the effects##2##6##(1991-12#1)(2009-7#1)
that the severity of the##3##5##(1991-12#1)(2008-5#1)(2009-7#1)
that the severity of##6##4##(1991-12#1)(1991-9#1)(2004-11#1)(2008-5#1)(2009-7#1)(2012-2#1)
that the severity##7##3##(1991-12#1)(1991-9#1)(2004-11#1)(2008-5#1)(2009-7#1)(2010-3#1)(2012-2#1)
that the sex difference in##3##5##(1993-4#1)(1994-2#1)(2008-4#1)
that the sex##7##3##(1993-4#1)(1994-2#1)(2008-4#1)(2008-5#1)(2010-3#1)(2012-3#1)(2013-8#1)
that the shape of the##5##5##(1994-8#1)(1996-5#1)(2006-11#1)(2007-12#1)(2010-6#1)
that the shape of##6##4##(1994-8#1)(1996-5#1)(2006-11#1)(2007-12#1)(2008-7#1)(2010-6#1)
that the shape##8##3##(1990-3#1)(1994-8#1)(1996-5#1)(2006-11#1)(2007-12#1)(2008-2#1)(2008-7#1)(2010-6#1)
that the shift in##3##4##(1992-9#1)(2008-10#1)(2008-6#1)
that the shift##4##3##(1990-7#1)(1992-9#1)(2008-10#1)(2008-6#1)
that the shifting##2##3##(2008-3#2)
that the short##2##3##(2008-1#1)(2010-3#1)
that the shortest##2##3##(1990-12#1)(2007-12#1)
that the side chain of Thr-23 is##2##7##(1993-6#2)
that the side chain of Thr-23##3##6##(1993-6#3)
that the side chain of##6##5##(1993-6#4)(1994-10#1)(2013-8#1)
that the side##7##3##(1993-6#4)(1994-10#1)(1995-8#1)(2013-8#1)
that the signal and##2##4##(2007-11#1)(2008-2#1)
that the signal for##2##4##(1996-3#1)(2006-10#1)
that the signal peptide##2##4##(1992-7#1)(1997-7#1)
that the signal transduction pathway##2##5##(1991-5#1)(1997-4#1)
that the signal##16##3##(1991-12#1)(1991-5#1)(1992-7#1)(1993-8#1)(1996-3#1)(1996-7#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-8#1)
that the signal-to-noise ratio##2##4##(2007-12#1)(2008-10#1)
that the signaling##4##3##(1992-12#1)(1995-8#1)(2008-8#1)(2010-4#1)
that the signals are##2##4##(1990-11#1)(2009-6#1)
that the signals of##2##4##(1996-10#1)(2013-8#1)
that the signals##7##3##(1990-11#1)(1996-10#1)(1996-12#1)(1997-6#1)(2008-1#1)(2009-6#1)(2013-8#1)
that the significance of##2##4##(2008-11#1)(2008-5#1)
that the similar##3##3##(1993-8#1)(2007-2#1)(2010-4#1)
that the similarity##2##3##(1991-7#1)(1992-8#1)
that the simple##7##3##(1993-12#1)(2005-11#1)(2006-4#1)(2007-11#1)(2008-3#1)(2009-4#1)(2013-1#1)
that the simplified##2##3##(1994-2#1)(2007-8#1)
that the simultaneous##3##3##(1995-12#1)(1996-12#1)(2008-10#1)
that the single tryptophan residue##2##5##(1991-2#1)(2005-11#1)
that the single##9##3##(1991-2#1)(1992-12#2)(1993-12#1)(2005-11#1)(2007-7#2)(2008-10#1)(2012-2#1)
that the site of##4##4##(1990-10#1)(1990-5#1)(1992-11#1)(1994-5#1)
that the site##7##3##(1990-10#1)(1990-5#1)(1992-11#1)(1994-5#1)(1994-6#1)(2008-10#1)(2008-5#1)
that the sites are##3##4##(1991-3#1)(1994-5#2)
that the sites##6##3##(1991-3#1)(1993-8#1)(1994-5#2)(1996-10#1)(1997-5#1)
that the situation##2##3##(2005-4#1)(2008-10#1)
that the six##4##3##(1994-3#1)(1994-6#1)(2008-8#1)(2013-1#1)
that the size and##2##4##(1992-8#1)(1995-3#1)
that the size of a##2##5##(2006-10#1)(2009-9#1)
that the size of the visual span##2##7##(2008-1#2)
that the size of the##8##5##(1991-9#1)(1993-11#1)(1995-2#1)(1997-2#1)(2008-1#2)(2008-8#2)
that the size of##13##4##(1991-9#1)(1993-11#1)(1995-2#1)(1997-2#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-7#1)(2008-8#2)(2009-9#1)(2011-2#1)
that the size##19##3##(1991-10#1)(1991-9#1)(1992-8#1)(1993-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-2#1)(2005-11#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-7#1)(2008-8#3)(2009-9#1)(2011-2#1)
that the skeletal##2##3##(1991-11#1)(1991-9#1)
that the skill set##2##4##(2007-12#2)
that the skills##2##3##(2008-11#1)(2012-2#1)
that the skin would cover the exposed##2##7##(2009-3#2)
that the skin##9##3##(1995-11#1)(2008-10#1)(2008-5#3)(2009-3#2)(2010-9#2)
that the slope of##2##4##(2008-2#2)
that the slope##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
that the slow##2##3##(1994-11#1)(1997-4#1)
that the small inclination##2##4##(2008-3#2)
that the small##6##3##(1991-5#1)(2008-10#1)(2008-3#3)(2012-3#1)
that the smaller##2##3##(1990-8#1)(1996-3#1)
that the smallest##3##3##(1992-3#1)(1995-8#1)(2008-2#1)
that the social##4##3##(1996-12#1)(2006-7#1)(2006-8#1)(2010-1#1)
that the soil##6##3##(2008-10#2)(2008-5#1)(2011-12#1)(2012-2#1)(2013-8#1)
that the solid##2##3##(2008-1#1)(2008-10#1)
that the solubility of##4##4##(2007-8#1)(2008-10#2)(2008-5#1)
that the solubility##5##3##(2007-8#1)(2008-10#2)(2008-5#2)
that the soluble##6##3##(1992-12#1)(1992-6#2)(1993-2#1)(1997-6#2)
that the solution##4##3##(1996-11#1)(2007-8#1)(2008-12#1)(2008-2#1)
that the somatic##2##3##(2007-4#1)(2008-9#1)
that the source##3##3##(2007-11#1)(2007-12#1)(2007-7#1)
that the spacing between the##2##5##(2007-12#1)(2008-3#1)
that the spacing##4##3##(2006-10#2)(2007-12#1)(2008-3#1)
that the spatial and##2##4##(2007-5#1)(2008-4#1)
that the spatial coherence of a##2##6##(2007-12#1)(2008-2#1)
that the spatial coherence of##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
that the spatial distribution of##2##5##(2008-10#1)(2009-4#1)
that the spatial distribution##4##4##(2007-12#1)(2008-10#1)(2008-2#1)(2009-4#1)
that the spatial##18##3##(1990-3#1)(1993-12#1)(2007-12#2)(2007-5#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2009-4#1)(2010-11#1)(2011-12#1)(2012-2#1)
that the species##16##3##(1991-7#1)(2007-3#2)(2008-10#3)(2008-5#1)(2008-8#3)(2008-9#1)(2009-2#1)(2010-8#1)(2011-12#1)(2012-2#1)(2012-3#1)
that the specific##23##3##(1990-9#1)(1992-2#1)(1992-5#2)(1993-11#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-3#1)(1996-2#1)(1996-5#1)(1996-8#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-8#1)(2009-3#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
that the specificity of the##2##5##(1991-12#1)(1994-3#1)
that the specificity of##5##4##(1991-12#1)(1992-8#1)(1994-3#1)(1996-5#1)(2008-3#1)
that the specificity##9##3##(1991-12#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-3#1)(1996-5#1)(2008-3#1)
that the spectra##2##3##(2008-3#2)
that the spectral features##2##4##(1991-4#1)(2007-12#1)
that the spectral properties of##2##5##(1994-11#1)(2013-1#1)
that the spectral properties##3##4##(1992-1#1)(1994-11#1)(2013-1#1)
that the spectral##17##3##(1991-4#1)(1992-1#1)(1994-11#1)(1997-7#1)(2007-12#5)(2008-2#2)(2008-3#1)(2010-5#1)(2013-1#2)(2013-8#2)
that the speech##2##3##(2008-2#1)(2008-9#1)
that the speed of##2##4##(2008-10#1)(2008-6#1)
that the speed##3##3##(1991-10#1)(2008-10#1)(2008-6#1)
that the spinach curtovirus##2##4##(2008-10#2)
that the spinal cord##2##4##(2011-1#1)(2012-1#1)
that the spinal##3##3##(2007-12#1)(2011-1#1)(2012-1#1)
that the spiral##2##3##(2005-10#1)(2008-10#1)
that the split##2##3##(1993-6#1)(2008-11#1)
that the spontaneous##2##3##(1993-9#1)(1994-3#1)
that the spots##2##3##(2007-12#1)(2008-3#1)
that the spread##2##3##(1997-6#1)(2008-1#1)
that the stability of the##7##5##(1991-9#1)(1993-11#1)(1993-3#1)(1995-3#1)(1996-4#1)(2005-11#1)(2007-12#1)
that the stability of##12##4##(1990-2#1)(1991-9#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-8#1)(1995-10#1)(1995-3#1)(1996-4#1)(2005-11#1)(2007-12#1)(2008-10#1)
that the stability##14##3##(1990-2#1)(1991-9#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-8#1)(1995-10#1)(1995-3#1)(1996-4#1)(2005-11#1)(2007-12#1)(2008-10#3)
that the staining was##2##4##(1991-10#1)(1992-11#1)
that the standard##10##3##(1990-6#1)(1995-9#1)(1996-11#2)(2006-7#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-9#1)(2012-12#1)
that the start##2##3##(1991-7#1)(1996-10#1)
that the startle correlated potential##2##5##(1991-11#2)
that the state##4##3##(1995-2#2)(2008-11#1)(2008-2#1)
that the static##2##3##(1995-12#1)(2005-11#1)
that the statistical##3##3##(2008-10#1)(2012-2#1)(2012-3#1)
that the status of##2##4##(1995-3#1)(2008-10#1)
that the statute##2##3##(1997-1#1)(2006-8#1)
that the steady-state levels of##2##5##(1994-5#1)(2008-8#1)
that the steady-state##4##3##(1990-8#1)(1994-12#1)(1994-5#1)(2008-8#1)
that the step##2##3##(1990-11#1)(1996-4#1)
that the stereochemistry of##3##4##(1990-10#1)(1996-5#1)(2011-2#1)
that the steric##3##3##(1996-2#1)(2008-8#1)(2012-2#1)
that the stimulation of##9##4##(1990-12#1)(1992-6#1)(1994-8#1)(1995-12#2)(2006-3#1)(2008-11#2)(2013-1#1)
that the stimulatory effect of the##2##6##(1993-3#1)(1997-8#1)
that the stimulatory##3##3##(1993-3#1)(1997-8#1)(2013-1#1)
that the stochastic##2##3##(2008-2#2)
that the stoichiometry of the##2##5##(1990-2#1)(2008-10#1)
that the stoichiometry of##3##4##(1990-2#1)(1991-5#1)(2008-10#1)
that the stoichiometry##5##3##(1990-2#1)(1991-5#1)(1996-2#1)(1997-7#1)(2008-10#1)
that the stomach##3##3##(1990-11#1)(1992-2#1)(2010-8#1)
that the stop##2##3##(1996-7#1)(2008-9#1)
that the strain##5##3##(1990-7#1)(1993-3#2)(2008-10#1)(2008-2#1)
that the strains##6##3##(1992-2#1)(1996-12#1)(2008-10#3)(2013-8#1)
that the strategy##3##3##(2006-10#1)(2007-9#1)(2011-2#1)
that the stratum corneum##3##4##(2008-5#2)(2012-2#1)
that the strength of selection##2##5##(2008-8#1)(2013-1#1)
that the strength of the##3##5##(2007-12#1)(2008-11#1)(2008-2#1)
that the strength of##9##4##(2007-12#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-8#1)(2012-2#2)(2013-1#1)
that the strength##11##3##(1991-8#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-8#1)(2009-9#1)(2012-2#2)(2013-1#1)
that the stress##3##3##(1996-1#1)(2006-7#1)(2009-4#1)
that the stress-induced##3##3##(1995-12#1)(1996-11#1)(2007-11#1)
that the striatal##5##3##(1995-9#1)(1996-2#1)(1997-6#1)(1997-8#2)
that the striking##2##3##(1995-1#1)(2008-8#1)
that the strong association##2##4##(1994-3#1)(2008-3#1)
that the strong##5##3##(1994-3#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)
that the strongly##2##3##(2008-6#1)(2012-12#1)
that the structural changes##2##4##(1991-3#1)(1991-4#1)
that the structural##16##3##(1990-3#1)(1991-3#1)(1991-4#1)(1992-12#1)(1993-6#1)(1993-9#1)(1994-8#1)(1995-5#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-8#2)
that the structure and##4##4##(1991-8#1)(1994-3#1)(2008-4#1)(2012-1#1)
that the structure of the##5##5##(1990-7#1)(1992-6#1)(1994-11#1)(1995-3#1)(1996-7#1)
that the structure of##13##4##(1990-7#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-3#1)(1996-7#1)(1997-1#1)(1997-4#1)(2006-2#1)(2012-11#1)
that the structure##20##3##(1990-7#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-3#2)(1995-3#2)(1996-7#1)(1997-1#1)(1997-4#1)(2006-2#1)(2008-3#1)(2008-4#1)(2012-1#1)(2012-11#1)
that the structures of the##2##5##(1992-6#1)(2006-3#1)
that the structures of##4##4##(1990-12#1)(1992-6#1)(2006-3#1)(2008-8#1)
that the structures##8##3##(1990-12#1)(1991-2#1)(1992-4#1)(1992-6#1)(1996-2#1)(2006-3#1)(2008-7#1)(2008-8#1)
that the student##2##3##(2008-11#2)
that the students##5##3##(2005-10#1)(2008-11#1)(2008-12#1)(2009-4#1)(2013-1#1)
that the studies##3##3##(1996-9#1)(2007-11#1)(2011-1#1)
that the study of ethics offers no right or wrong responses##2##11##(1994-1#2)
that the study of##3##4##(1994-1#2)(2011-2#1)
that the study was##4##4##(1993-3#1)(2008-11#1)(2008-3#1)(2011-2#1)
that the study##11##3##(1993-3#1)(1994-1#2)(2007-7#2)(2008-11#1)(2008-3#1)(2011-1#1)(2011-2#3)
that the subject##7##3##(1990-2#1)(1996-1#1)(2008-11#1)(2008-12#1)(2012-1#2)(2013-1#1)
that the subjects##2##3##(1990-10#1)(2012-1#1)
that the substitution of##3##4##(1990-7#1)(1991-9#1)(2008-10#1)
that the substitution##5##3##(1990-7#1)(1991-9#1)(1997-5#1)(2007-1#1)(2008-10#1)
that the substrate##5##3##(1993-2#1)(2008-3#1)(2008-5#1)(2008-7#2)
that the subunits##2##3##(2005-11#1)(2009-9#1)
that the success rate##3##4##(1995-7#1)(2008-11#1)(2012-2#1)
that the success##4##3##(1995-7#1)(2008-11#1)(2008-7#1)(2012-2#1)
that the successful##2##3##(2008-12#1)(2010-6#1)
that the sudden##3##3##(1991-9#1)(2006-7#1)(2010-5#1)
that the sum of the##3##5##(2007-12#1)(2008-10#1)(2008-2#1)
that the sum of##5##4##(1995-11#1)(1996-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
that the superior##3##3##(2007-12#1)(2008-7#1)(2008-8#1)
that the supply of##3##4##(1993-2#1)(1996-3#1)(2008-10#1)
that the suppression of the##2##5##(1993-12#1)(2008-5#1)
that the suppression of##7##4##(1992-4#1)(1993-12#1)(1994-3#1)(1997-1#1)(2007-11#1)(2008-11#1)(2008-5#1)
that the suppression##8##3##(1991-12#1)(1992-4#1)(1993-12#1)(1994-3#1)(1997-1#1)(2007-11#1)(2008-11#1)(2008-5#1)
that the suppressive effect of##2##5##(1991-3#1)(1994-3#1)
that the suppressive effect##3##4##(1991-3#1)(1994-3#1)(2009-8#1)
that the suppressive##5##3##(1991-3#1)(1994-3#1)(1997-6#1)(2008-10#1)(2009-8#1)
that the surface of the##2##5##(2009-2#1)(2013-1#1)
that the surface of##4##4##(1992-12#1)(2005-11#1)(2009-2#1)(2013-1#1)
that the surface tension##2##4##(2005-11#1)(2013-8#1)
that the surface##22##3##(1992-12#1)(2005-11#4)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-8#1)(2009-2#1)(2009-7#1)(2010-9#1)(2013-1#1)(2013-8#2)
that the surfaces##3##3##(1994-5#1)(1996-8#1)(2010-4#1)
that the surfactant##2##3##(2005-11#1)(2008-10#1)
that the surgeon##3##3##(2006-9#1)(2007-5#1)(2011-2#1)
that the surgeons##2##3##(1993-9#1)(2006-8#1)
that the surveillance##2##3##(1994-2#1)(2011-12#1)
that the survival of##3##4##(1991-3#1)(1993-8#1)(1996-3#1)
that the susceptibility of##2##4##(1991-12#1)(1997-2#1)
that the susceptibility##3##3##(1991-12#1)(1993-3#1)(1997-2#1)
that the swarming##2##3##(2009-6#2)
that the switching##2##3##(1997-3#1)(2008-7#1)
that the synthesis of the##2##5##(1990-11#1)(1997-6#1)
that the synthesis of##6##4##(1990-11#1)(1991-8#1)(1993-2#1)(1996-11#1)(1997-1#1)(1997-6#1)
that the synthesis##7##3##(1990-11#1)(1991-8#1)(1993-2#1)(1995-11#1)(1996-11#1)(1997-1#1)(1997-6#1)
that the synthetic##7##3##(1990-8#1)(1992-9#1)(1993-2#1)(1995-8#1)(2008-2#1)(2008-5#2)
that the system can recognize##2##5##(2008-2#1)(2008-3#1)
that the system can##8##4##(2006-5#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2013-1#1)
that the system is##6##4##(1994-1#1)(2005-5#1)(2007-12#1)(2009-12#1)(2011-2#1)(2012-1#1)
that the system##26##3##(1991-2#1)(1992-8#1)(1994-1#1)(2005-5#1)(2006-5#1)(2007-12#4)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#3)(2009-12#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#3)
that the tRNA##2##3##(1991-11#1)(1992-11#1)
that the tablets remained##2##4##(2012-2#2)
that the tablets##3##3##(2010-12#1)(2012-2#2)
that the tail domain of##2##5##(1990-11#1)(1997-6#1)
that the talpid3 mutation does not affect##2##7##(2003-11#2)
that the tandemly##2##3##(1993-12#1)(1995-8#1)
that the target##3##3##(1991-6#1)(2007-11#1)(2007-7#1)
that the task##2##3##(1997-8#1)(2008-6#1)
that the team##2##3##(2006-8#1)(2008-11#1)
that the technique can be##2##5##(2007-1#1)(2010-8#1)
that the technique can##4##4##(1992-10#1)(2007-1#1)(2008-2#1)(2010-8#1)
that the technique could##2##4##(2008-10#1)(2008-7#1)
that the technique is##4##4##(2007-11#1)(2008-2#1)(2008-7#1)(2011-1#1)
that the technique may be##2##5##(1992-2#1)(2006-6#1)
that the technique of##2##4##(1996-3#1)(2008-1#1)
that the technique proposed##2##4##(2008-2#1)(2008-3#1)
that the technique##25##3##(1992-10#1)(1992-2#1)(1996-3#1)(2005-12#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#5)(2008-3#3)(2008-7#2)(2010-8#1)(2011-1#1)(2012-12#1)
that the technology##2##3##(2007-9#1)(2011-2#1)
that the temperature and the##2##5##(2007-3#1)(2008-10#1)
that the temperature and##3##4##(2007-3#1)(2008-10#1)(2008-3#1)
that the temperature dependence of the##2##6##(1994-12#1)(2008-5#1)
that the temperature dependence of##3##5##(1994-12#1)(2008-3#1)(2008-5#1)
that the temperature##9##3##(1991-1#1)(1994-12#1)(1994-3#1)(2007-3#1)(2008-10#2)(2008-3#2)(2008-5#1)
that the temporal##9##3##(1993-3#1)(1996-2#1)(1997-8#1)(2006-7#1)(2007-1#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-11#1)
that the tensile strength of##2##5##(2008-5#1)(2008-7#1)
that the tensile##3##3##(2008-5#1)(2008-7#1)(2009-7#1)
that the term &quot##4##4##(1991-12#1)(1997-2#1)(2008-8#1)(2009-11#1)
that the term##7##3##(1991-12#1)(1997-2#1)(2005-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-11#1)
that the terminal##4##3##(2008-12#1)(2008-5#1)(2008-8#1)(2011-12#1)
that the tertiary structure of the##3##6##(1990-12#1)(1990-5#1)(2005-11#1)
that the tertiary structure of##5##5##(1990-12#1)(1990-5#1)(1992-12#1)(2005-11#2)
that the test##5##3##(1995-6#1)(2005-10#1)(2008-10#1)(2008-3#1)(2010-2#1)
that the tested##3##3##(2008-12#1)(2009-6#1)(2012-11#1)
that the testing of##2##4##(1993-3#1)(2012-2#1)
that the testing##3##3##(1990-12#1)(1993-3#1)(2012-2#1)
that the theoretical##6##3##(2007-12#1)(2008-11#1)(2008-2#1)(2010-2#1)(2012-3#1)(2013-8#1)
that the theory##3##3##(2005-11#1)(2008-11#1)(2008-3#1)
that the therapeutic use of##2##5##(1994-5#1)(2007-11#1)
that the therapeutic##4##3##(1993-2#1)(1994-5#1)(2006-4#1)(2007-11#1)
that the therapy has##2##4##(1996-8#1)(2006-10#1)
that the thermal##6##3##(1990-2#1)(1992-5#1)(2005-11#1)(2007-12#1)(2008-10#2)
that the thermodynamic##3##3##(1990-7#1)(1991-11#1)(1992-4#1)
that the thickness of the##2##5##(2007-4#1)(2010-2#1)
that the thickness of##3##4##(2007-4#1)(2009-3#1)(2010-2#1)
that the thickness##5##3##(2007-4#1)(2008-3#1)(2008-5#1)(2009-3#1)(2010-2#1)
that the thin##2##3##(2007-12#1)(2008-3#1)
that the third##3##3##(1990-8#1)(1991-2#1)(1992-8#1)
that the threat of##2##4##(1994-2#1)(2011-2#1)
that the three groups##2##4##(2008-10#1)(2009-9#1)
that the three strains##2##4##(2008-10#1)(2008-7#1)
that the three##34##3##(1991-10#1)(1991-9#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-7#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
that the three-dimensional##3##3##(1993-6#1)(1995-2#1)(2008-3#1)
that the threshold for##2##4##(1994-6#1)(2007-4#1)
that the threshold##7##3##(1993-12#1)(1994-6#1)(2007-12#1)(2007-4#1)(2008-10#1)(2009-9#1)(2010-4#1)
that the thymic##2##3##(1993-12#1)(2013-7#1)
that the thyroid gland##2##4##(1996-3#1)(2010-11#1)
that the thyroid hormone##2##4##(1990-8#1)(1997-7#1)
that the thyroid##6##3##(1990-8#1)(1991-5#1)(1992-2#1)(1996-3#1)(1997-7#1)(2010-11#1)
that the time course of##2##5##(1992-8#1)(2011-2#1)
that the time course##4##4##(1992-8#1)(1994-9#1)(2007-10#1)(2011-2#1)
that the time##18##3##(1992-8#1)(1994-9#1)(2005-11#2)(2005-4#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
that the timing and##2##4##(2006-10#1)(2010-8#1)
that the timing jitter##2##4##(2007-12#1)(2008-1#1)
that the timing##5##3##(1995-11#1)(2006-10#1)(2007-12#1)(2008-1#1)(2010-8#1)
that the tissue##4##3##(1992-9#2)(2008-2#1)(2008-6#1)
that the tissue-specific##2##3##(1994-9#1)(2008-10#1)
that the tolerance##2##3##(2006-11#1)(2008-10#1)
that the torque##2##3##(2008-3#1)(2012-1#1)
that the total amount of##3##5##(1991-6#1)(2004-11#1)(2008-10#1)
that the total number of##3##5##(1995-12#1)(2008-4#1)(2012-2#1)
that the total##30##3##(1991-6#1)(1991-7#1)(1991-8#1)(1993-2#1)(1994-12#1)(1994-5#1)(1995-12#1)(1997-7#1)(2004-11#1)(2006-12#1)(2006-4#2)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-8#1)(2012-11#1)(2012-2#1)(2013-7#1)(2013-8#2)
that the toxicity of the##2##5##(2007-2#1)(2008-12#1)
that the toxicity of##4##4##(1995-8#1)(2007-2#1)(2008-12#1)(2013-8#1)
that the toxicity##5##3##(1995-8#1)(2007-2#1)(2008-12#1)(2012-3#1)(2013-8#1)
that the toxin##3##3##(2008-10#3)
that the toxins##2##3##(1992-8#1)(1994-3#1)
that the traditional##7##3##(1996-1#1)(2006-5#2)(2008-1#1)(2008-10#1)(2012-3#2)
that the training##2##3##(1990-4#1)(2008-4#1)
that the trait##2##3##(1997-7#1)(2008-8#1)
that the transactivating##2##3##(1993-12#1)(1995-3#1)
that the transcription factor##2##4##(2008-5#1)(2010-11#1)
that the transcription of the##2##5##(1995-6#1)(1996-4#1)
that the transcription of##4##4##(1990-5#1)(1994-12#1)(1995-6#1)(1996-4#1)
that the transcription rate of##2##5##(1994-12#2)
that the transcription start##2##4##(1993-12#1)(2008-9#1)
that the transcription##12##3##(1990-5#1)(1991-7#1)(1992-4#1)(1993-12#1)(1994-12#3)(1995-6#1)(1996-4#1)(2008-5#1)(2008-9#1)(2010-11#1)
that the transcriptional##7##3##(1991-1#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-9#1)(1997-4#1)(2011-2#1)
that the transfected##3##3##(1992-6#1)(1994-8#1)(2005-10#1)
that the transfer of##4##4##(1992-3#1)(2008-11#1)(2008-3#1)(2009-2#1)
that the transfer##7##3##(1992-3#1)(2007-12#2)(2008-11#1)(2008-3#1)(2009-11#1)(2009-2#1)
that the transfersomal gel##2##4##(2012-12#2)
that the transformation##2##3##(2008-6#1)(2013-1#1)
that the transgene##3##3##(1996-3#1)(2008-10#1)(2008-12#1)
that the transgenic##3##3##(2008-9#2)(2009-8#1)
that the transit##2##3##(1997-7#1)(2007-11#1)
that the transition state##2##4##(1991-7#1)(1996-11#1)
that the transition##6##3##(1991-12#1)(1991-7#1)(1992-6#1)(1995-1#1)(1995-2#1)(1996-11#1)
that the translation of##2##4##(1990-4#1)(2010-6#1)
that the translation##4##3##(1990-4#1)(1997-2#1)(2008-9#1)(2010-6#1)
that the translocation##4##3##(1993-9#2)(1996-6#1)(2008-8#1)
that the transmission##8##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2013-8#1)
that the transmittance of##2##4##(2008-3#2)
that the transplantation of##2##4##(1995-7#1)(2012-2#1)
that the transport of##4##4##(1991-4#1)(1991-6#2)(1994-6#1)
that the transport##5##3##(1991-4#1)(1991-6#2)(1994-6#1)(2008-10#1)
that the transverse##3##3##(2007-12#2)(2008-3#1)
that the treating##2##3##(2005-12#1)(2007-12#1)
that the treatment of##9##4##(1990-5#1)(1991-8#1)(1994-2#1)(1996-10#1)(2007-11#1)(2008-2#1)(2010-12#1)(2012-2#2)
that the treatment with furosemide impairs##2##6##(1992-8#2)
that the treatment with##3##4##(1992-8#2)(2013-8#1)
that the treatment##21##3##(1990-5#1)(1991-8#1)(1992-8#2)(1993-9#1)(1994-11#1)(1994-2#1)(1996-10#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-2#1)(2009-4#1)(2010-12#1)(2010-2#1)(2012-2#3)(2013-8#2)
that the trend of##3##4##(2005-11#1)(2006-10#1)(2007-6#1)
that the trial##4##3##(1996-5#1)(1997-5#1)(2005-8#1)(2009-6#1)
that the trimeric##2##3##(1996-7#1)(2008-8#1)
that the tropical##2##3##(1996-2#1)(2007-9#1)
that the true##3##3##(1995-4#1)(2008-7#1)(2008-8#1)
that the truncated##3##3##(1991-11#1)(1992-2#1)(2011-2#1)
that the tryptophans##2##3##(1994-11#2)
that the tumor cells##5##4##(1997-1#2)(2007-12#1)(2008-6#1)(2009-8#1)
that the tumor is##2##4##(2008-2#1)(2012-2#1)
that the tumor was composed##2##5##(2008-12#1)(2013-8#1)
that the tumor was##9##4##(1994-7#2)(2006-12#1)(2007-12#3)(2008-12#1)(2013-1#1)(2013-8#1)
that the tumor##25##3##(1991-5#1)(1991-8#1)(1994-7#2)(1997-1#2)(2006-12#1)(2007-12#4)(2007-3#1)(2008-12#1)(2008-2#2)(2008-6#1)(2009-8#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
that the tumour was##3##4##(2008-7#1)(2012-2#1)(2013-8#1)
that the tumour##5##3##(2006-6#1)(2007-8#1)(2008-7#1)(2012-2#1)(2013-8#1)
that the turn conformation##2##4##(1993-6#2)
that the turn##3##3##(1993-6#2)(1994-9#1)
that the turnover of##2##4##(1997-2#1)(2008-10#1)
that the turnover##3##3##(1995-12#1)(1997-2#1)(2008-10#1)
that the two cloned##2##4##(1995-8#1)(2008-9#1)
that the two enzymes have##2##5##(1990-9#1)(2009-8#1)
that the two enzymes##5##4##(1990-9#1)(1991-5#1)(1993-12#1)(2008-11#1)(2009-8#1)
that the two events##2##4##(1995-12#1)(1995-6#1)
that the two families##2##4##(1994-2#1)(2008-7#1)
that the two genes##3##4##(1990-11#1)(1990-4#1)(2008-10#1)
that the two maize progenitors diverged##2##6##(2008-7#2)
that the two major##2##4##(1994-3#1)(1995-3#1)
that the two methods are##2##5##(2008-2#1)(2008-3#1)
that the two methods##6##4##(1993-12#1)(2005-4#1)(2008-2#1)(2008-3#1)(2009-10#1)(2013-7#1)
that the two species##3##4##(2008-10#2)(2008-9#1)
that the two types of##2##5##(2006-10#1)(2013-7#1)
that the two##135##3##(1990-11#2)(1990-2#4)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-8#3)(1992-11#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#2)(1995-6#3)(1995-8#1)(1996-11#1)(1996-2#3)(1996-4#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-12#1)(2005-4#3)(2005-8#1)(2006-10#1)(2006-12#2)(2006-3#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-2#7)(2008-3#5)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#2)(2009-3#1)(2009-8#4)(2010-2#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#2)
that the type I error##2##5##(2012-3#1)(2013-1#1)
that the type I##3##4##(1995-3#1)(2012-3#1)(2013-1#1)
that the type and##2##4##(1995-12#1)(2008-11#1)
that the type of oligosaccharide##2##5##(1997-4#2)
that the type of##7##4##(1995-11#1)(1997-2#1)(1997-4#2)(1997-6#1)(2008-10#1)(2011-2#1)
that the type##17##3##(1990-6#1)(1992-5#1)(1992-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-2#1)(1997-4#2)(1997-6#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
that the tyrosine kinase inhibitor##2##5##(1991-8#1)(1993-8#1)
that the tyrosine##3##3##(1991-8#1)(1993-8#1)(1994-9#1)
that the underlying##4##3##(1992-9#1)(1994-8#1)(2008-10#1)(2013-1#1)
that the understanding of##2##4##(2007-12#1)(2008-9#1)
that the unique##7##3##(1993-12#1)(1995-12#1)(1996-4#1)(1996-5#1)(2006-8#1)(2007-11#1)(2008-6#1)
that the university##4##3##(2008-10#3)(2008-12#1)
that the unusual##4##3##(1993-3#1)(1995-12#1)(2006-10#1)(2008-10#1)
that the unusually##3##3##(2006-10#1)(2008-5#1)(2008-8#1)
that the upper##2##3##(2008-2#1)(2008-3#1)
that the upstream##2##3##(1995-8#1)(1997-7#1)
that the uptake of the##2##5##(2013-7#2)
that the uptake of##6##4##(1990-5#1)(1992-5#1)(2008-10#1)(2011-2#1)(2013-7#2)
that the uptake##10##3##(1990-5#1)(1992-5#1)(1992-8#1)(1993-4#1)(1997-8#1)(2006-10#1)(2008-10#1)(2011-2#1)(2013-7#2)
that the use of G-CSF##2##5##(1994-3#1)(2010-12#1)
that the use of a##5##5##(1992-2#1)(2006-12#1)(2007-9#1)(2008-10#1)(2008-6#1)
that the use of an##2##5##(2008-3#1)(2008-5#1)
that the use of calcium-based phosphate binders##2##7##(2007-8#1)(2012-12#1)
that the use of prophylactic##2##5##(2008-3#1)(2008-7#1)
that the use of the##14##5##(1991-9#1)(1995-3#1)(2006-11#1)(2006-6#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
that the use of this##6##5##(1992-1#1)(2008-11#1)(2008-3#1)(2012-3#1)(2013-1#2)
that the use of##114##4##(1990-11#2)(1990-12#2)(1990-2#1)(1990-7#2)(1990-8#1)(1991-9#1)(1992-1#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-3#2)(1994-9#1)(1995-10#1)(1995-3#1)(1996-2#1)(1997-2#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-7#4)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#2)(2011-2#7)(2011-3#1)(2012-12#2)(2012-3#4)(2013-1#9)(2013-8#2)
that the users##2##3##(1996-4#1)(2008-11#1)
that the utilization of##4##4##(2007-4#1)(2008-1#1)(2008-5#1)(2010-4#1)
that the vaccine##4##3##(1995-9#1)(2005-7#2)(2012-3#1)
that the validity of##3##4##(2008-3#1)(2008-4#1)(2008-9#1)
that the validity##4##3##(2006-8#1)(2008-3#1)(2008-4#1)(2008-9#1)
that the value of##5##4##(1990-7#1)(1991-11#1)(1995-12#1)(2008-3#1)(2008-8#1)
that the values of##3##4##(2007-11#1)(2008-10#1)(2010-6#1)
that the values##5##3##(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-6#1)
that the variability in the##2##5##(1991-12#1)(2008-10#1)
that the variable##3##3##(1992-4#1)(1997-1#1)(2010-2#1)
that the variables used##2##4##(1994-2#1)(2010-5#1)
that the variables##3##3##(1994-2#1)(2009-4#1)(2010-5#1)
that the variance in the##2##5##(1991-12#1)(2007-11#1)
that the variance##3##3##(1991-12#1)(2007-11#1)(2008-7#1)
that the variant##5##3##(1992-12#2)(1993-6#1)(1995-8#1)(2008-12#1)
that the variants##2##3##(2006-9#1)(2013-7#1)
that the variation of##3##4##(1991-7#1)(1996-5#1)(2009-5#1)
that the variation##4##3##(1991-7#1)(1996-5#1)(2009-5#1)(2010-10#1)
that the various##13##3##(1991-2#1)(1992-12#1)(1993-8#1)(1994-8#1)(1995-5#1)(1995-6#1)(2006-4#1)(2007-5#1)(2008-12#2)(2011-2#1)(2012-1#1)(2012-2#1)
that the vascular##7##3##(1990-10#1)(1990-5#1)(1991-9#1)(1994-12#1)(1997-6#1)(2008-10#1)(2008-5#1)
that the vasculature##3##3##(2007-1#1)(2009-4#2)
that the vasorelaxant##2##3##(1990-11#1)(2009-5#1)
that the vast majority of##5##5##(2007-11#1)(2008-11#2)(2008-9#1)(2009-3#1)
that the vast##7##3##(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-3#1)
that the vehicle in which a chemical is##2##8##(2008-5#2)
that the vehicle##4##3##(2008-5#4)
that the ventral##3##3##(1993-6#1)(1997-8#1)(2007-1#1)
that the very##2##3##(1990-9#1)(1991-7#1)
that the vesicular ER##2##4##(2009-8#2)
that the vessel density is##2##5##(1993-9#2)
that the vessel density##3##4##(1993-9#3)
that the vessel##4##3##(1993-9#3)(2006-6#1)
that the viral load##2##4##(2008-5#1)(2012-3#1)
that the viral##4##3##(1997-2#1)(2008-5#1)(2008-8#1)(2012-3#1)
that the virulence##2##3##(2008-10#2)
that the virus capsid##2##4##(2008-10#1)(2008-7#1)
that the virus is##2##4##(2008-10#1)(2013-1#1)
that the virus was##2##4##(1997-6#1)(2008-10#1)
that the virus##12##3##(1997-6#1)(2007-6#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2013-1#1)
that the viscosity and##2##4##(2008-10#1)(2008-5#1)
that the viscosity of the##2##5##(2008-10#2)
that the viscosity##4##3##(2008-10#3)(2008-5#1)
that the visual input is both necessary and sufficient for the##2##11##(1991-2#2)
that the visual system is##2##5##(1996-10#2)
that the visual system##5##4##(1995-5#1)(1996-1#1)(1996-10#2)(1997-3#1)
that the visual##9##3##(1991-2#2)(1995-12#1)(1995-5#1)(1996-1#1)(1996-10#2)(1997-3#1)(2008-8#1)
that the vitamin##2##3##(1992-1#1)(1996-6#1)
that the volume of##3##4##(1990-5#1)(1992-8#1)(2012-2#1)
that the volume##6##3##(1990-5#1)(1992-8#1)(1997-5#1)(2008-3#2)(2012-2#1)
that the vulnerability of##3##4##(1996-9#1)(2012-2#1)(2013-1#1)
that the waiver program is##2##5##(1991-1#1)(1993-1#1)
that the waiver##3##3##(1991-1#1)(1992-2#1)(1993-1#1)
that the water molecules##3##4##(1992-9#1)(1995-5#1)(2006-10#1)
that the water##5##3##(1991-2#1)(1992-9#1)(1995-5#1)(2006-10#1)(2008-1#1)
that the water-soluble fraction of Kefram-Kefir##2##6##(2008-11#2)
that the water-soluble fraction of##3##5##(2008-11#3)
that the wavelength##3##3##(2007-12#1)(2008-10#2)
that the wavelengths##2##3##(2006-3#1)(2007-12#1)
that the weak CL of##2##5##(2008-10#2)
that the weak##4##3##(2008-10#3)(2011-1#1)
that the weight##2##3##(1993-2#1)(2008-10#1)
that the whole##5##3##(1993-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
that the widely##2##3##(1992-5#1)(1997-6#1)
that the width of the##2##5##(1994-8#1)(2008-3#1)
that the width##3##3##(1994-8#1)(2008-3#2)
that the wild-type##6##3##(1990-5#1)(1994-9#1)(1995-1#1)(2006-12#1)(2008-10#1)(2013-8#1)
that the wireless ECG##2##4##(2010-8#2)
that the women##2##3##(1990-8#1)(2012-12#1)
that the work##4##3##(2005-7#1)(2006-10#1)(2006-7#1)(2007-8#1)
that the working##2##3##(1995-8#1)(2010-9#1)
that the workshops##2##3##(2008-12#1)(2008-2#1)
that the year##2##3##(1994-3#1)(2011-2#1)
that the yeast##7##3##(1994-10#1)(1995-8#1)(1996-7#1)(1996-9#1)(2008-2#1)(2008-7#1)(2008-8#1)
that the yield of##3##4##(1991-9#1)(1992-8#1)(2008-6#1)
that the yield##4##3##(1991-9#1)(1992-8#1)(2008-6#1)(2012-2#1)
that the zinc##2##3##(1994-3#1)(2008-11#1)
that the##14516##2##(1990-1#11)(1990-10#40)(1990-11#98)(1990-12#76)(1990-2#89)(1990-3#31)(1990-4#44)(1990-5#90)(1990-6#20)(1990-7#74)(1990-8#77)(1990-9#25)(1991-1#44)(1991-10#37)(1991-11#39)(1991-12#72)(1991-2#107)(1991-3#44)(1991-4#50)(1991-5#79)(1991-6#51)(1991-7#71)(1991-8#66)(1991-9#83)(1992-1#41)(1992-10#22)(1992-11#46)(1992-12#90)(1992-2#58)(1992-3#72)(1992-4#39)(1992-5#35)(1992-6#79)(1992-7#38)(1992-8#72)(1992-9#84)(1993-1#13)(1993-10#4)(1993-11#72)(1993-12#90)(1993-2#50)(1993-3#89)(1993-4#26)(1993-5#18)(1993-6#83)(1993-7#22)(1993-8#52)(1993-9#64)(1994-1#11)(1994-10#28)(1994-11#86)(1994-12#105)(1994-2#81)(1994-3#119)(1994-4#7)(1994-5#63)(1994-6#64)(1994-7#10)(1994-8#133)(1994-9#107)(1995-1#69)(1995-10#48)(1995-11#63)(1995-12#90)(1995-2#98)(1995-3#98)(1995-4#13)(1995-5#70)(1995-6#119)(1995-7#14)(1995-8#103)(1995-9#28)(1996-1#40)(1996-10#49)(1996-11#66)(1996-12#78)(1996-2#88)(1996-3#41)(1996-4#54)(1996-5#115)(1996-6#49)(1996-7#59)(1996-8#55)(1996-9#47)(1997-1#81)(1997-2#132)(1997-3#53)(1997-4#98)(1997-5#38)(1997-6#87)(1997-7#118)(1997-8#84)(1997-9#3)(2003-11#2)(2004-1#4)(2004-10#5)(2004-11#10)(2004-12#7)(2004-2#4)(2004-3#2)(2004-4#3)(2004-7#1)(2004-8#2)(2004-9#18)(2005-10#37)(2005-11#184)(2005-12#23)(2005-3#2)(2005-4#36)(2005-5#5)(2005-6#3)(2005-7#25)(2005-8#29)(2005-9#5)(2006-1#8)(2006-10#168)(2006-11#28)(2006-12#86)(2006-2#37)(2006-3#29)(2006-4#28)(2006-5#38)(2006-6#31)(2006-7#37)(2006-8#44)(2006-9#29)(2007-1#41)(2007-10#64)(2007-11#212)(2007-12#364)(2007-2#37)(2007-3#28)(2007-4#44)(2007-5#34)(2007-6#36)(2007-7#67)(2007-8#124)(2007-9#65)(2008-1#111)(2008-10#1179)(2008-11#356)(2008-12#105)(2008-2#454)(2008-3#518)(2008-4#130)(2008-5#380)(2008-6#106)(2008-7#247)(2008-8#337)(2008-9#185)(2009-1#6)(2009-10#40)(2009-11#29)(2009-12#26)(2009-2#41)(2009-3#51)(2009-4#44)(2009-5#38)(2009-6#46)(2009-7#35)(2009-8#78)(2009-9#27)(2010-1#20)(2010-10#23)(2010-11#31)(2010-12#79)(2010-2#80)(2010-3#43)(2010-4#61)(2010-5#55)(2010-6#31)(2010-7#38)(2010-8#64)(2010-9#22)(2011-1#133)(2011-10#2)(2011-12#49)(2011-2#226)(2011-3#20)(2012-1#102)(2012-11#33)(2012-12#155)(2012-2#185)(2012-3#131)(2012-5#1)(2012-7#1)(2012-8#1)(2013-1#258)(2013-7#52)(2013-8#226)
that their 5'##2##3##(1997-6#1)(2008-8#1)
that their activation##2##3##(1992-5#1)(1995-12#1)
that their development##2##3##(1994-3#1)(2010-3#1)
that their efforts##2##3##(2009-8#1)(2012-3#1)
that their epitopes##2##3##(2008-8#2)
that their experiences##2##3##(2006-3#1)(2008-11#1)
that their expression##3##3##(2008-12#1)(2008-6#1)(2010-4#1)
that their health##2##3##(2008-2#1)(2008-5#1)
that their levels##2##3##(1995-10#1)(2008-10#1)
that their mechanisms##2##3##(2008-10#1)(2008-4#1)
that their needs are##2##4##(2005-7#1)(2010-2#1)
that their needs##4##3##(1991-8#1)(2005-7#1)(2008-11#1)(2010-2#1)
that their overall##2##3##(2009-7#1)(2012-1#1)
that their parents##3##3##(1991-8#1)(2010-10#1)(2013-7#1)
that their treatment##2##3##(2007-8#1)(2009-7#1)
that their work##2##3##(2007-4#1)(2013-1#1)
that their##178##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-7#1)(1992-8#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#2)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-10#3)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-10#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#3)(2006-3#2)(2006-5#2)(2006-7#1)(2006-8#2)(2007-11#2)(2007-12#7)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#8)(2008-11#5)(2008-12#2)(2008-2#5)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#2)(2009-2#1)(2009-6#2)(2009-7#3)(2009-8#2)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#3)
that then##7##2##(1995-10#1)(2006-10#1)(2008-3#1)(2008-5#1)(2009-9#1)(2010-7#1)(2013-1#1)
that theory##2##2##(2008-8#1)(2013-8#1)
that therapeutic##10##2##(1996-2#1)(2005-8#1)(2006-2#1)(2007-11#2)(2008-11#1)(2008-6#1)(2009-6#1)(2010-12#1)(2011-1#1)
that therapy with##3##3##(1990-11#1)(2007-10#1)(2010-12#1)
that therapy##7##2##(1990-11#1)(1995-3#1)(2006-10#1)(2007-10#1)(2008-7#1)(2010-12#1)(2010-9#1)
that there are a##4##4##(2008-4#1)(2008-5#1)(2008-8#1)(2010-2#1)
that there are alternative##2##4##(2005-8#1)(2010-11#1)
that there are approximately##2##4##(1996-11#1)(2012-11#1)
that there are at least three##3##6##(1992-8#1)(1992-9#1)(1993-2#1)
that there are at least two##6##6##(1990-8#1)(1992-5#1)(1994-3#1)(1997-2#1)(1997-6#1)(2007-6#1)
that there are at least##14##5##(1990-8#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-2#1)(1993-7#1)(1994-3#1)(1996-4#1)(1997-2#1)(1997-6#1)(2007-6#1)(2008-10#1)(2008-11#1)
that there are barriers##2##4##(1995-2#1)(1996-2#1)
that there are both##2##4##(1991-1#1)(1993-9#1)
that there are differences in the##3##6##(1991-7#1)(1996-10#1)(1997-2#1)
that there are differences in##4##5##(1991-7#1)(1993-2#1)(1996-10#1)(1997-2#1)
that there are different##3##4##(1995-10#1)(1995-12#1)(1997-7#1)
that there are distinct##2##4##(1994-9#1)(1995-3#1)
that there are fewer##2##4##(2007-7#1)(2007-9#1)
that there are five##2##4##(2006-9#1)(2008-10#1)
that there are functional differences between##2##6##(1994-2#1)(1994-3#1)
that there are important##2##4##(1995-3#1)(2011-10#1)
that there are insufficient##2##4##(2008-11#1)(2012-3#1)
that there are many##5##4##(1994-2#1)(2007-12#1)(2007-2#1)(2008-11#1)(2009-1#1)
that there are more##4##4##(1990-3#1)(2008-4#1)(2008-9#1)(2011-1#1)
that there are multiple##4##4##(1991-2#1)(2005-8#1)(2007-12#1)(2008-5#1)
that there are no significant differences between##2##7##(2008-10#2)
that there are no significant##5##5##(2008-10#2)(2008-11#1)(2010-2#1)(2010-3#1)
that there are no##18##4##(1990-3#1)(1994-9#1)(1995-6#1)(1996-2#1)(1996-6#1)(1997-6#1)(2005-7#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-9#1)(2009-4#1)(2010-2#1)(2010-3#1)(2012-2#1)
that there are not adequate##2##5##(1990-6#2)
that there are not##4##4##(1990-6#2)(2007-4#1)(2008-4#1)
that there are only##3##4##(2008-10#1)(2008-3#2)
that there are patients##2##4##(1990-12#1)(2007-2#1)
that there are regional differences##2##5##(1992-8#1)(2013-8#1)
that there are several##4##4##(2004-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
that there are significant##7##4##(1995-9#1)(1996-5#1)(2007-3#1)(2008-1#1)(2008-12#1)(2010-12#1)(2011-2#1)
that there are six##2##4##(1994-2#1)(2010-1#1)
that there are some##5##4##(1992-3#1)(2006-11#1)(2008-11#1)(2008-3#1)(2012-3#1)
that there are three##3##4##(1995-3#1)(1995-6#1)(2010-5#1)
that there are two separate##2##5##(2006-12#1)(2008-4#1)
that there are two types of##3##6##(1996-12#1)(2008-3#1)(2008-5#1)
that there are two##31##4##(1991-3#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-3#2)(1993-6#1)(1994-5#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-7#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#2)(2010-4#1)(2011-3#1)
that there are various##2##4##(2007-7#1)(2008-2#1)
that there are##219##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#2)(1990-8#2)(1991-1#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-7#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-8#4)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-4#4)(1993-6#1)(1993-7#1)(1993-9#1)(1994-2#4)(1994-3#2)(1994-5#3)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#4)(1995-6#2)(1995-7#2)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#2)(1997-2#2)(1997-4#1)(1997-6#2)(1997-7#3)(1997-8#1)(2004-10#1)(2004-12#1)(2004-4#1)(2005-11#2)(2005-4#1)(2005-7#2)(2005-8#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#3)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#12)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#8)(2008-4#6)(2008-5#8)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#4)(2009-1#1)(2009-10#1)(2009-4#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-10#1)(2011-2#2)(2011-3#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#2)
that there be##2##3##(1992-11#1)(2011-1#1)
that there can be##3##4##(2008-12#1)(2008-8#2)
that there could be a##2##5##(1993-7#1)(2009-3#1)
that there could be##3##4##(1993-7#1)(1997-6#1)(2009-3#1)
that there exist##4##3##(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)
that there exists a##6##4##(1990-12#1)(1993-3#1)(2006-4#1)(2007-5#1)(2008-3#1)(2008-5#1)
that there exists an optimal##2##5##(1990-12#1)(2008-2#1)
that there exists an##4##4##(1990-12#1)(2008-1#1)(2008-2#1)(2011-2#1)
that there exists##13##3##(1990-12#2)(1992-2#1)(1993-3#1)(1997-2#1)(2006-4#1)(2007-5#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)
that there had been no##2##5##(1991-5#1)(1996-1#1)
that there has been a##2##5##(1995-2#1)(2008-10#1)
that there has been##5##4##(1995-2#1)(1996-6#1)(2007-2#1)(2008-10#1)(2012-2#1)
that there has##6##3##(1995-2#1)(1996-6#1)(2007-2#2)(2008-10#1)(2012-2#1)
that there have been##3##4##(2008-11#1)(2008-9#1)(2010-3#1)
that there is a complex##2##5##(2010-8#1)(2011-2#1)
that there is a connection between##2##6##(2007-10#1)(2008-8#1)
that there is a conserved##2##5##(1994-11#1)(1994-12#1)
that there is a correlation##2##5##(2006-10#1)(2008-10#1)
that there is a critical##2##5##(2005-11#1)(2011-2#1)
that there is a decrease in##2##6##(2008-5#1)(2011-2#1)
that there is a family of##2##6##(1994-3#1)(1997-4#1)
that there is a finite##2##5##(1990-8#1)(2008-9#1)
that there is a general##2##5##(1992-12#1)(1992-6#1)
that there is a good##4##5##(1993-1#1)(1994-3#1)(2008-10#1)(2008-6#1)
that there is a high##4##5##(2008-10#1)(2008-9#1)(2010-8#1)(2011-2#1)
that there is a higher prevalence##2##6##(2006-11#1)(2011-2#1)
that there is a huge##2##5##(1995-12#1)(2005-7#1)
that there is a large##3##5##(1993-9#1)(1995-8#1)(2008-9#1)
that there is a low##2##5##(1992-6#1)(2007-2#1)
that there is a moral##2##5##(2008-5#1)(2012-2#1)
that there is a need for##8##6##(2007-2#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-12#1)(2013-1#3)
that there is a need to improve the##2##8##(2010-4#1)(2010-5#1)
that there is a need##10##5##(2007-2#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-4#1)(2010-5#1)(2013-1#3)
that there is a possibility of##3##6##(2007-6#1)(2007-8#1)(2012-12#1)
that there is a significant##7##5##(1992-1#1)(1995-11#1)(2006-7#1)(2007-9#1)(2008-10#1)(2008-9#1)(2009-8#1)
that there is a simple##2##5##(2007-12#1)(2009-11#1)
that there is a single##2##5##(2006-9#1)(2008-5#1)
that there is a strong##6##5##(1991-2#1)(1997-1#1)(2006-7#1)(2007-10#1)(2009-4#1)(2011-2#1)
that there is a trade-off between##2##6##(2008-2#1)(2013-1#1)
that there is a very##2##5##(2008-10#1)(2008-5#1)
that there is a##138##4##(1990-2#1)(1990-5#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-6#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-4#2)(1997-5#1)(2005-11#2)(2005-7#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-12#2)(2007-2#2)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#6)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#9)(2013-7#1)
that there is also a##2##5##(1992-5#1)(2007-7#1)
that there is an association##2##5##(2004-12#1)(2011-2#1)
that there is an increased##3##5##(1994-5#1)(2007-2#1)(2008-1#1)
that there is an intrinsic##2##5##(1993-2#1)(2008-10#1)
that there is an inverse relationship between##2##7##(2008-10#1)(2008-12#1)
that there is an optimum##2##5##(2008-2#2)
that there is an##33##4##(1990-7#1)(1991-1#1)(1993-2#1)(1994-5#1)(1994-6#1)(1996-3#1)(1997-7#1)(2004-12#1)(2006-1#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-2#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#3)(2012-2#1)
that there is considerable##3##4##(1991-11#1)(1992-6#1)(2008-10#1)
that there is direct##2##4##(2008-7#1)(2011-2#1)
that there is enough##2##4##(2008-5#1)(2009-8#1)
that there is evidence that##2##5##(2007-8#1)(2012-12#1)
that there is evidence##6##4##(2007-6#1)(2007-8#3)(2009-10#1)(2012-12#1)
that there is insufficient##2##4##(2005-7#1)(2013-7#1)
that there is less##2##4##(2005-8#1)(2008-10#1)
that there is little##8##4##(1996-3#1)(2004-7#1)(2007-8#1)(2008-11#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
that there is more##2##4##(1996-3#1)(2005-11#1)
that there is need##2##4##(2007-7#1)(2012-2#1)
that there is no association between##2##6##(2009-6#1)(2010-8#1)
that there is no detectable##2##5##(1990-8#1)(1995-1#1)
that there is no direct relationship between##2##7##(1996-2#1)(2008-5#1)
that there is no direct##3##5##(1996-2#1)(2008-5#1)(2009-2#1)
that there is no evidence for##2##6##(2007-6#1)(2012-3#1)
that there is no evidence##5##5##(2007-6#2)(2007-8#1)(2008-6#1)(2012-3#1)
that there is no relationship between the##2##7##(2008-12#1)(2008-8#1)
that there is no relationship between##3##6##(2008-11#1)(2008-12#1)(2008-8#1)
that there is no significant##5##5##(1990-6#1)(1996-7#1)(2005-11#1)(2008-10#1)(2008-6#1)
that there is no such##2##5##(1992-2#1)(2008-3#1)
that there is no##61##4##(1990-2#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#1)(1994-5#1)(1995-1#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-8#2)(2004-12#1)(2004-9#1)(2005-11#2)(2005-12#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#2)(2007-8#3)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-8#3)(2009-2#1)(2009-3#1)(2009-6#2)(2009-7#1)(2010-8#1)(2011-2#2)(2012-3#2)(2013-1#2)
that there is not##4##4##(2006-5#1)(2008-3#1)(2008-5#1)(2010-8#1)
that there is room for improvement in the##2##8##(1996-2#1)(2008-3#1)
that there is room for improvement in##3##7##(1996-2#1)(2008-3#1)(2012-3#1)
that there is significant##3##4##(1993-7#1)(2008-10#1)(2011-2#1)
that there is some##3##4##(1990-7#1)(1992-5#1)(2008-9#1)
that there is still a##4##5##(2008-4#2)(2009-5#1)(2011-2#1)
that there is still##6##4##(1994-9#1)(2007-2#1)(2008-4#2)(2009-5#1)(2011-2#1)
that there is strong evidence##2##5##(2007-8#1)(2010-12#1)
that there is strong##3##4##(2007-8#1)(2010-12#1)(2010-8#1)
that there is substantial##5##4##(1994-3#2)(2008-3#1)(2010-11#1)(2010-9#1)
that there is widespread##2##4##(1992-3#1)(2008-7#1)
that there is##340##3##(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-7#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#4)(1994-5#3)(1994-6#1)(1994-9#3)(1995-1#2)(1995-11#2)(1995-12#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#6)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#3)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#3)(1997-9#1)(2004-12#2)(2004-7#1)(2004-9#1)(2005-11#5)(2005-12#1)(2005-5#1)(2005-7#3)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#4)(2007-2#6)(2007-6#5)(2007-7#4)(2007-8#14)(2007-9#1)(2008-1#5)(2008-10#17)(2008-11#7)(2008-12#4)(2008-2#6)(2008-3#12)(2008-4#8)(2008-5#12)(2008-6#3)(2008-7#4)(2008-8#11)(2008-9#8)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#2)(2011-12#2)(2011-2#17)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#5)(2013-1#11)(2013-7#2)(2013-8#2)
that there may be a##10##5##(1991-10#1)(1991-2#1)(1992-2#1)(1996-12#1)(1996-5#1)(2004-3#1)(2006-5#1)(2008-9#1)(2013-7#1)(2013-8#1)
that there may be no##2##5##(2005-8#1)(2011-2#1)
that there may be##29##4##(1991-10#1)(1991-2#1)(1992-2#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-3#1)(2004-3#1)(2005-8#1)(2006-3#1)(2006-5#1)(2007-12#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2011-2#2)(2013-7#1)(2013-8#1)
that there may exist##2##4##(1995-5#1)(2008-8#1)
that there may have been##2##5##(1996-12#1)(2008-10#1)
that there may not be a##2##6##(2007-9#1)(2008-8#1)
that there may##35##3##(1991-10#1)(1991-2#1)(1992-2#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-7#1)(1997-3#1)(2004-3#1)(2005-8#1)(2006-3#1)(2006-5#1)(2007-12#1)(2007-9#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-3#1)(2011-2#2)(2013-7#1)(2013-8#1)
that there might be a##3##5##(1993-4#1)(1994-12#1)(2010-10#1)
that there might be##7##4##(1992-4#1)(1993-4#1)(1994-11#1)(1994-12#1)(2009-10#1)(2010-10#1)(2012-2#1)
that there must be##2##4##(2008-11#1)(2009-9#1)
that there should be##2##4##(1991-9#1)(2006-10#1)
that there was a good##2##5##(2008-10#1)(2008-5#1)
that there was a lack of##2##6##(2008-10#1)(2012-2#1)
that there was a significant decrease in the##2##8##(1990-8#1)(2008-10#1)
that there was a significant decrease in##3##7##(1990-8#1)(2008-10#1)(2013-8#1)
that there was a significant increase##2##6##(2009-5#1)(2013-1#1)
that there was a significant##10##5##(1990-8#1)(1995-12#1)(2008-1#1)(2008-10#3)(2008-12#1)(2009-5#1)(2013-1#1)(2013-8#1)
that there was a strong##2##5##(1994-8#1)(2008-10#1)
that there was a wide variation in##2##7##(1997-3#1)(2012-3#1)
that there was a##42##4##(1990-8#1)(1991-12#1)(1991-3#1)(1991-7#1)(1994-8#1)(1995-12#1)(1996-12#1)(1997-3#1)(1997-4#1)(2005-11#1)(2005-4#1)(2006-11#1)(2007-10#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
that there was an improvement##3##5##(2008-5#3)
that there was an inadequate##2##5##(2006-8#1)(2008-9#1)
that there was an##12##4##(1997-8#1)(2006-8#1)(2007-5#1)(2008-10#1)(2008-5#4)(2008-9#1)(2009-3#1)(2012-2#1)(2013-8#1)
that there was insufficient evidence to##2##6##(2006-12#1)(2006-2#1)
that there was less##4##4##(2007-8#2)(2008-11#1)(2013-8#1)
that there was little##2##4##(2006-7#1)(2010-8#1)
that there was no evidence of##2##6##(2008-10#1)(2013-1#1)
that there was no evidence##4##5##(2007-6#1)(2008-10#1)(2009-5#1)(2013-1#1)
that there was no significant difference between##2##7##(1997-8#1)(2008-10#1)
that there was no significant difference in the##2##8##(2009-5#1)(2011-1#1)
that there was no significant difference in##3##7##(2007-7#1)(2009-5#1)(2011-1#1)
that there was no significant difference##7##6##(1997-8#1)(2007-2#1)(2007-7#1)(2008-10#1)(2009-5#1)(2011-1#2)
that there was no significant##8##5##(1995-12#1)(1997-8#1)(2007-2#1)(2007-7#1)(2008-10#1)(2009-5#1)(2011-1#2)
that there was no statistically significant difference##2##7##(2006-9#1)(2008-12#1)
that there was no##34##4##(1990-5#1)(1991-2#1)(1992-12#2)(1992-7#1)(1995-12#1)(1996-5#1)(1997-8#1)(2006-8#1)(2006-9#1)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#2)(2009-7#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#2)
that there was not##2##4##(2007-6#1)(2008-7#1)
that there was##127##3##(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-7#3)(1992-12#2)(1992-7#1)(1994-3#2)(1994-8#1)(1995-12#2)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-8#2)(2005-11#1)(2005-4#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#2)(2007-2#3)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#16)(2008-11#6)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#8)(2008-7#2)(2008-8#2)(2008-9#4)(2009-2#1)(2009-3#2)(2009-5#3)(2009-7#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#4)(2013-8#3)
that there were 4##2##4##(2008-9#1)(2010-12#1)
that there were four##2##4##(2006-7#1)(2007-11#1)
that there were many##3##4##(2008-10#2)(2008-8#1)
that there were no significant##4##5##(1996-11#1)(1996-2#1)(2006-8#1)(2011-1#1)
that there were no##17##4##(1992-10#1)(1995-10#1)(1995-3#1)(1996-11#1)(1996-2#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#2)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-3#1)
that there were significant differences among##3##6##(1993-2#1)(2007-3#1)(2012-3#1)
that there were significant differences in##4##6##(1994-2#1)(2007-12#1)(2007-7#1)(2008-10#1)
that there were significant differences##9##5##(1993-2#1)(1994-2#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-12#1)(2012-3#1)
that there were some##3##4##(2012-1#1)(2012-12#1)(2012-2#1)
that there were three##2##4##(2008-9#1)(2010-8#1)
that there were two##3##4##(1992-8#1)(1993-9#1)(2010-2#1)
that there were##66##3##(1990-4#1)(1990-5#2)(1991-8#1)(1992-10#1)(1992-11#1)(1992-8#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-10#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(2005-11#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-2#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
that there will be##4##4##(1991-6#1)(2008-5#1)(2010-12#1)(2011-2#1)
that there would be a difference in##2##7##(1990-8#1)(1995-2#1)
that there would be a difference##3##6##(1990-8#2)(1995-2#1)
that there would be a##4##5##(1990-8#2)(1995-2#1)(2011-2#1)
that there would be##6##4##(1990-8#2)(1995-2#1)(2006-4#1)(2007-12#1)(2011-2#1)
that there##853##2##(1990-11#1)(1990-12#3)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#4)(1990-6#3)(1990-7#2)(1990-8#8)(1991-1#3)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#6)(1991-3#4)(1991-5#2)(1991-6#4)(1991-7#5)(1991-8#1)(1991-9#2)(1992-1#3)(1992-10#1)(1992-11#3)(1992-12#5)(1992-2#3)(1992-3#3)(1992-4#2)(1992-5#4)(1992-6#3)(1992-7#1)(1992-8#6)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#5)(1993-3#3)(1993-4#5)(1993-6#2)(1993-7#4)(1993-9#3)(1994-11#2)(1994-12#4)(1994-2#6)(1994-3#8)(1994-5#6)(1994-6#2)(1994-8#1)(1994-9#7)(1995-1#4)(1995-10#2)(1995-11#3)(1995-12#5)(1995-2#5)(1995-3#5)(1995-5#1)(1995-6#2)(1995-7#2)(1995-8#3)(1995-9#1)(1996-1#5)(1996-10#1)(1996-11#2)(1996-12#8)(1996-2#7)(1996-3#8)(1996-4#1)(1996-5#4)(1996-6#5)(1996-7#2)(1996-8#1)(1997-1#3)(1997-2#3)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#4)(1997-8#6)(1997-9#1)(2004-10#1)(2004-12#3)(2004-3#1)(2004-4#1)(2004-7#1)(2004-9#1)(2005-11#9)(2005-12#1)(2005-4#2)(2005-5#1)(2005-7#5)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#7)(2006-11#4)(2006-12#2)(2006-2#3)(2006-3#2)(2006-4#3)(2006-5#2)(2006-6#2)(2006-7#5)(2006-8#7)(2006-9#3)(2007-1#1)(2007-10#6)(2007-11#5)(2007-12#10)(2007-2#15)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#8)(2007-7#8)(2007-8#18)(2007-9#4)(2008-1#12)(2008-10#54)(2008-11#22)(2008-12#13)(2008-2#12)(2008-3#22)(2008-4#17)(2008-5#32)(2008-6#5)(2008-7#10)(2008-8#29)(2008-9#25)(2009-1#2)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#4)(2009-3#6)(2009-4#3)(2009-5#4)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#4)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#5)(2010-2#4)(2010-3#2)(2010-4#4)(2010-5#4)(2010-7#2)(2010-8#8)(2010-9#2)(2011-1#9)(2011-10#1)(2011-12#3)(2011-2#26)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#11)(2012-2#14)(2012-3#13)(2013-1#19)(2013-7#3)(2013-8#9)
that therefore##4##2##(1991-12#1)(2006-10#1)(2008-4#1)(2011-2#1)
that thermal lens spectrometry##2##4##(2008-10#2)
that thermal##7##2##(1993-4#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-9#1)
that thermally induced##2##3##(2008-3#2)
that thermally##3##2##(2008-2#1)(2008-3#2)
that these DNA##2##3##(1997-1#1)(2011-12#1)
that these TH-only-ir neurons##2##4##(1997-5#2)
that these X##2##3##(1993-6#1)(2008-10#1)
that these actions##5##3##(1997-2#1)(2008-11#1)(2012-12#1)(2012-2#1)(2013-7#1)
that these agents can##3##4##(1991-12#1)(2006-10#1)(2008-8#1)
that these agents##13##3##(1991-12#1)(1993-12#1)(1995-6#1)(2005-7#2)(2006-10#2)(2007-11#2)(2008-7#1)(2008-8#1)(2010-11#1)(2010-5#1)
that these alterations##3##3##(1990-2#1)(1994-5#1)(1995-12#1)
that these amino##2##3##(1997-4#1)(2006-8#1)
that these and other##3##4##(2006-12#1)(2007-3#1)(2008-1#1)
that these and##5##3##(1995-4#1)(2006-12#1)(2007-3#1)(2008-1#1)(2010-9#1)
that these animals are##2##4##(2006-1#1)(2008-5#1)
that these antibodies are##2##4##(1991-2#1)(1995-12#1)
that these antibodies##7##3##(1991-2#1)(1991-9#1)(1992-8#1)(1993-2#1)(1994-9#1)(1995-12#1)(2008-11#1)
that these are##13##3##(1995-10#1)(1996-1#1)(1996-11#1)(2005-7#1)(2006-1#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#2)(2010-8#1)(2011-12#1)(2012-3#1)
that these aspects of##2##4##(2007-12#1)(2008-11#1)
that these associations##2##3##(2007-5#1)(2013-1#1)
that these benefits##2##3##(2006-9#1)(2007-11#1)
that these can be used##2##5##(1995-3#1)(2008-3#1)
that these can be##4##4##(1995-3#1)(2008-3#1)(2008-5#1)(2012-3#1)
that these can##5##3##(1995-3#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-3#1)
that these cases##3##3##(2008-10#1)(2009-4#1)(2010-4#1)
that these cells have a##2##5##(1994-12#1)(1995-8#1)
that these cells may be##2##5##(1990-8#1)(2005-12#1)
that these cells may##4##4##(1990-8#1)(1997-6#1)(2005-12#1)(2010-12#1)
that these cells were##2##4##(1996-11#1)(1996-12#1)
that these cells##15##3##(1990-8#2)(1991-1#1)(1991-3#1)(1993-12#1)(1994-12#1)(1995-8#1)(1996-11#1)(1996-12#1)(1997-6#2)(2005-12#1)(2006-10#1)(2008-11#1)(2010-12#1)
that these changes are##3##4##(1992-6#1)(1993-4#1)(2006-9#1)
that these changes may##2##4##(1990-9#1)(1992-9#1)
that these changes##8##3##(1990-9#1)(1992-6#1)(1992-9#1)(1993-4#1)(1995-8#1)(2006-9#1)(2008-1#1)(2011-2#1)
that these channels##2##3##(2006-10#1)(2008-5#1)
that these characteristics##2##3##(1991-3#1)(2008-5#1)
that these children##2##3##(1993-1#1)(2005-9#1)
that these clusters are##2##4##(1993-11#1)(1997-8#1)
that these complexes##2##3##(1996-8#1)(2008-5#1)
that these components##2##3##(2008-11#1)(2013-1#1)
that these compounds are##6##4##(1991-9#1)(2006-6#1)(2008-10#2)(2008-8#1)(2013-1#1)
that these compounds had##2##4##(2012-11#2)
that these compounds possess##2##4##(2008-10#1)(2008-5#1)
that these compounds##20##3##(1991-5#1)(1991-9#1)(1992-1#1)(1996-8#1)(1997-2#1)(1997-5#1)(2004-2#1)(2006-10#1)(2006-6#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2012-11#2)(2012-2#1)(2013-1#1)
that these concerns are##2##4##(2008-12#1)(2008-3#1)
that these concerns##3##3##(2008-12#1)(2008-3#1)(2009-4#1)
that these conditions##2##3##(2008-10#1)(2008-3#1)
that these conserved##2##3##(2012-2#1)(2012-3#1)
that these cytokines are##2##4##(1992-8#1)(2008-3#1)
that these cytokines##3##3##(1992-8#1)(2007-12#1)(2008-3#1)
that these data##4##3##(1990-2#1)(2006-11#1)(2008-3#1)(2008-7#1)
that these differences are##6##4##(1993-3#1)(1994-1#1)(1997-7#1)(2006-5#1)(2008-3#1)(2011-12#1)
that these differences may have##2##5##(1991-8#1)(1997-3#1)
that these differences may##3##4##(1991-8#1)(1997-3#1)(1997-7#1)
that these differences##12##3##(1991-8#1)(1992-3#1)(1993-3#2)(1994-1#1)(1994-8#1)(1997-3#1)(1997-7#2)(2006-5#1)(2008-3#1)(2011-12#1)
that these diseases##3##3##(2005-10#1)(2006-10#1)(2008-10#1)
that these disorders are##2##4##(1995-11#1)(2012-3#1)
that these disorders##4##3##(1995-11#1)(2007-6#1)(2011-2#1)(2012-3#1)
that these domains##2##3##(1990-7#1)(1996-5#1)
that these drugs are##2##4##(2007-5#1)(2012-1#1)
that these drugs may##4##4##(1993-2#1)(1993-8#1)(1995-2#1)(2007-11#1)
that these drugs##10##3##(1991-10#1)(1993-12#1)(1993-2#1)(1993-8#1)(1995-2#1)(2005-8#2)(2007-11#1)(2007-5#1)(2012-1#1)
that these dynamic##3##3##(1995-2#1)(2006-12#1)(2008-1#1)
that these effects are##5##4##(1991-7#1)(1991-8#1)(1992-11#1)(1997-4#1)(2009-6#1)
that these effects might##2##4##(1991-10#1)(2008-3#1)
that these effects were##3##4##(1993-12#1)(1993-9#1)(1994-12#1)
that these effects##16##3##(1991-10#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-6#1)(2012-3#1)
that these elements are##3##4##(1994-8#1)(1995-8#1)(2008-10#1)
that these enzymes are##3##4##(2006-8#1)(2008-4#1)(2009-8#1)
that these enzymes##4##3##(1993-2#1)(2006-8#1)(2008-4#1)(2009-8#1)
that these evaluations should##2##4##(2006-5#2)
that these events##2##3##(1991-1#1)(1991-8#1)
that these exposures##2##3##(2009-6#1)(2011-2#1)
that these factors##10##3##(1993-12#1)(1993-2#1)(1994-12#1)(1995-1#1)(1996-6#1)(1997-5#1)(2008-10#1)(2008-11#2)(2012-3#1)
that these features##3##3##(2006-10#1)(2006-6#1)(2008-3#1)
that these findings were##2##4##(2007-12#1)(2008-11#1)
that these findings##5##3##(2007-12#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-3#1)
that these forms##2##3##(1997-1#1)(2009-2#1)
that these four##3##3##(1990-7#1)(2007-10#1)(2008-10#1)
that these fragments##2##3##(1992-9#1)(2008-8#1)
that these genes are##3##4##(1990-8#1)(2008-7#1)(2009-8#1)
that these genes encode##2##4##(1995-6#1)(1995-8#1)
that these genes may play##3##5##(1992-6#1)(2008-7#2)
that these genes may##5##4##(1992-6#1)(2008-10#2)(2008-7#2)
that these genes were##2##4##(1996-8#1)(2010-4#1)
that these genes##16##3##(1990-8#1)(1991-9#1)(1992-3#1)(1992-6#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-8#1)(1997-8#1)(2008-10#2)(2008-7#3)(2009-8#1)(2010-4#1)
that these glycosylated##2##3##(1992-11#1)(2005-12#1)
that these groups##2##3##(1992-2#1)(2007-3#1)
that these guidelines##2##3##(2006-5#1)(2008-11#1)
that these had##2##3##(1990-6#1)(1996-12#1)
that these hydrogels##2##3##(2013-7#2)
that these individuals##3##3##(1991-12#2)(2008-10#1)
that these induced##2##3##(2008-7#1)(2009-10#1)
that these inflammatory##2##3##(1991-7#1)(2009-10#1)
that these isoforms##2##3##(1990-12#1)(1992-5#1)
that these issues##3##3##(1993-7#1)(2008-10#1)(2012-2#1)
that these lesions##3##3##(1990-5#1)(1997-8#1)(2006-12#1)
that these materials##3##3##(2005-11#1)(2008-2#1)(2009-2#1)
that these may##2##3##(1990-8#1)(1991-7#1)
that these membrane##2##3##(2005-8#1)(2008-11#1)
that these metal ions##3##4##(2008-10#3)
that these methods are##2##4##(2008-1#1)(2008-5#1)
that these methods##8##3##(1993-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-12#1)(2011-2#1)(2013-1#2)
that these molecules##3##3##(1995-2#1)(2008-4#1)(2008-5#1)
that these mutations##5##3##(1990-1#1)(1993-11#1)(1994-9#1)(1995-2#1)(1997-4#1)
that these neurons are##4##4##(1990-2#1)(1990-8#1)(2010-10#1)(2013-8#1)
that these neurons##6##3##(1990-2#1)(1990-8#1)(1991-11#1)(2009-10#1)(2010-10#1)(2013-8#1)
that these new##3##3##(2006-10#1)(2008-2#1)(2011-1#1)
that these novel##5##3##(1995-6#1)(2008-2#1)(2008-9#1)(2012-2#1)(2012-3#1)
that these nuclear##2##3##(1992-12#1)(2007-12#1)
that these nurses##3##3##(2008-1#1)(2008-7#1)(2010-8#1)
that these parameters##3##3##(1992-3#1)(1996-5#1)(2008-7#1)
that these pathways##2##3##(1996-10#1)(2008-5#1)
that these patients are##2##4##(1991-4#1)(2009-5#1)
that these patients##13##3##(1991-4#1)(1995-3#1)(1996-3#1)(1996-6#1)(2006-12#1)(2007-7#1)(2009-5#1)(2010-12#1)(2012-3#1)(2013-8#4)
that these patterns##3##3##(2008-11#1)(2008-8#2)
that these peptides may##2##4##(1994-6#1)(2008-1#1)
that these peptides##4##3##(1994-6#1)(1996-12#1)(2007-11#1)(2008-1#1)
that these phenomena##4##3##(1996-8#1)(2008-7#1)(2009-5#1)(2010-3#1)
that these populations are##2##4##(2008-10#2)
that these populations##4##3##(2008-10#3)(2011-2#1)
that these preliminary##2##3##(2011-1#1)(2012-12#1)
that these processes##3##3##(2008-10#1)(2008-7#1)(2011-1#1)
that these products are##2##4##(1994-8#1)(2012-2#1)
that these proteins are##7##4##(1990-4#1)(1994-11#1)(1997-5#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-3#1)
that these proteins may##4##4##(1995-5#1)(1996-5#1)(2008-7#1)(2011-1#1)
that these proteins##17##3##(1990-4#1)(1992-5#1)(1993-5#1)(1993-8#1)(1994-11#2)(1995-5#1)(1996-5#1)(1997-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
that these receptors are##2##4##(1995-7#1)(1996-10#1)
that these receptors may##2##4##(1995-12#1)(2008-4#1)
that these receptors##5##3##(1995-12#1)(1995-7#1)(1996-10#1)(2008-4#1)(2008-5#1)
that these regions are##3##4##(1995-6#1)(2007-12#1)(2010-2#1)
that these regions##5##3##(1991-12#1)(1995-6#1)(2007-12#1)(2008-10#1)(2010-2#1)
that these relationships##3##3##(1990-11#1)(2009-4#1)(2009-5#1)
that these residues are##3##4##(1990-7#1)(1995-5#1)(1996-9#1)
that these responses##2##3##(1990-9#1)(1995-12#1)
that these results are##2##4##(2007-12#1)(2008-9#1)
that these results were##2##4##(1992-3#1)(2008-8#1)
that these results##10##3##(1992-3#1)(1997-2#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2013-8#1)
that these same##2##3##(1993-11#1)(2008-3#1)
that these sequences can##2##4##(1990-5#1)(1997-4#1)
that these sites##3##3##(1994-8#1)(1997-5#1)(1997-7#1)
that these species are##4##4##(2004-4#1)(2008-10#1)(2008-11#1)(2008-7#1)
that these species##7##3##(1997-7#1)(2004-4#1)(2008-10#2)(2008-11#1)(2008-7#1)(2013-1#1)
that these states##2##3##(2007-11#1)(2007-9#1)
that these steroids##3##3##(1990-2#1)(1991-6#1)(1995-12#1)
that these strains##3##3##(2008-10#1)(2013-8#2)
that these structures##4##3##(1991-1#1)(1993-5#1)(2007-12#1)(2008-7#1)
that these students had##2##4##(2008-11#2)
that these students##3##3##(2008-11#3)
that these studies##5##3##(2006-10#1)(2007-8#1)(2008-7#1)(2009-2#1)(2009-3#1)
that these symptoms##2##3##(2008-11#1)(2008-3#1)
that these synthetic##2##3##(1994-9#1)(1997-3#1)
that these systematic##2##3##(2006-10#1)(2011-2#1)
that these techniques are##2##4##(2008-10#1)(2008-5#1)
that these techniques##3##3##(1996-12#1)(2008-10#1)(2008-5#1)
that these three##6##3##(1991-4#1)(1993-11#1)(1993-6#1)(1995-12#1)(1995-3#1)(1997-1#1)
that these tissues##3##3##(1992-9#1)(2008-1#1)(2012-2#1)
that these tools##3##3##(2006-5#1)(2013-1#2)
that these treatments##2##3##(2008-10#1)(2009-7#1)
that these tumors##2##3##(2008-6#1)(2010-11#1)
that these two forms##2##4##(1992-12#1)(1997-7#1)
that these two proteins are##3##5##(1990-8#1)(1993-11#1)(1997-4#1)
that these two proteins##4##4##(1990-8#1)(1993-11#1)(1997-4#1)(1997-7#1)
that these two##57##3##(1990-12#2)(1990-5#1)(1990-8#1)(1991-8#1)(1992-12#2)(1992-2#2)(1992-5#1)(1993-11#1)(1993-12#3)(1993-4#1)(1994-11#1)(1994-3#1)(1994-6#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#2)(1996-12#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-7#2)(1997-8#1)(2007-12#2)(2007-3#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
that these types of##2##4##(2007-12#1)(2010-4#1)
that these tyrosine residues may be##2##6##(1992-9#2)
that these vectors##2##3##(1997-4#2)
that these were##2##3##(2004-4#1)(2012-2#1)
that these will##2##3##(2008-11#1)(2009-5#1)
that these##878##2##(1990-1#1)(1990-10#3)(1990-11#1)(1990-12#6)(1990-2#7)(1990-3#1)(1990-4#2)(1990-5#5)(1990-6#3)(1990-7#10)(1990-8#8)(1990-9#2)(1991-1#6)(1991-10#2)(1991-11#1)(1991-12#6)(1991-2#3)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#3)(1991-7#4)(1991-8#4)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#4)(1992-12#8)(1992-2#3)(1992-3#6)(1992-4#1)(1992-5#3)(1992-6#4)(1992-7#2)(1992-8#5)(1992-9#5)(1993-1#1)(1993-11#7)(1993-12#8)(1993-2#5)(1993-3#2)(1993-4#2)(1993-5#4)(1993-6#4)(1993-7#2)(1993-8#3)(1993-9#3)(1994-1#1)(1994-11#4)(1994-12#7)(1994-2#2)(1994-3#4)(1994-5#2)(1994-6#6)(1994-8#7)(1994-9#3)(1995-1#3)(1995-10#2)(1995-11#5)(1995-12#8)(1995-2#12)(1995-3#7)(1995-4#1)(1995-5#7)(1995-6#4)(1995-7#1)(1995-8#6)(1996-1#3)(1996-10#2)(1996-11#3)(1996-12#5)(1996-2#3)(1996-3#1)(1996-5#10)(1996-6#2)(1996-7#3)(1996-8#5)(1996-9#5)(1997-1#3)(1997-2#7)(1997-3#3)(1997-4#12)(1997-5#6)(1997-6#3)(1997-7#8)(1997-8#4)(2004-12#1)(2004-2#2)(2004-4#2)(2005-10#3)(2005-11#4)(2005-12#2)(2005-5#1)(2005-7#5)(2005-8#3)(2005-9#1)(2006-1#3)(2006-10#18)(2006-11#2)(2006-12#6)(2006-3#2)(2006-4#2)(2006-5#5)(2006-6#3)(2006-7#2)(2006-8#5)(2006-9#3)(2007-10#3)(2007-11#10)(2007-12#22)(2007-2#2)(2007-3#6)(2007-4#2)(2007-5#5)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#13)(2008-10#57)(2008-11#27)(2008-12#3)(2008-2#8)(2008-3#17)(2008-4#8)(2008-5#23)(2008-6#4)(2008-7#23)(2008-8#11)(2008-9#9)(2009-1#2)(2009-10#6)(2009-11#1)(2009-12#2)(2009-2#5)(2009-3#4)(2009-4#5)(2009-5#6)(2009-6#3)(2009-7#4)(2009-8#6)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#7)(2010-3#4)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#5)(2010-9#1)(2011-1#10)(2011-12#4)(2011-2#15)(2011-9#1)(2012-1#4)(2012-11#2)(2012-12#7)(2012-2#19)(2012-3#13)(2012-6#1)(2013-1#13)(2013-7#4)(2013-8#14)
that theta##2##2##(1995-5#1)(2010-9#1)
that they &quot##2##3##(1990-6#1)(1993-3#1)
that they act as##2##4##(1992-2#1)(1992-9#1)
that they act##3##3##(1992-2#1)(1992-9#1)(2009-8#1)
that they all##6##3##(1991-2#1)(1992-11#1)(1994-3#1)(2006-8#1)(2008-12#1)(2011-2#1)
that they allow##3##3##(1992-3#1)(2006-6#1)(2008-10#1)
that they also##2##3##(1991-10#1)(2013-1#1)
that they appear to##2##4##(1990-7#1)(1991-7#1)
that they are able to##2##5##(1993-3#1)(2006-10#1)
that they are all##2##4##(1994-6#1)(1996-10#1)
that they are both##2##4##(1994-12#1)(2008-6#1)
that they are effective##3##4##(2008-10#1)(2008-6#1)(2008-9#1)
that they are good estimates of the true unknown class membership probabilities##2##12##(2013-1#2)
that they are highly##2##4##(1993-3#1)(2007-3#1)
that they are homologous##2##4##(1996-2#1)(2008-10#1)
that they are in##5##4##(2008-10#1)(2008-12#1)(2008-7#1)(2009-6#1)(2011-2#1)
that they are indeed##2##4##(1991-10#1)(2008-10#1)
that they are less##3##4##(1994-5#1)(1997-8#1)(2004-2#1)
that they are members of the##2##6##(1991-5#1)(1996-10#1)
that they are not##11##4##(1991-12#1)(1997-6#1)(2004-11#1)(2005-4#1)(2006-3#1)(2006-9#1)(2007-12#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-8#1)
that they are probably##3##4##(1994-11#1)(2008-5#2)
that they are separated by##2##5##(2008-10#1)(2008-8#1)
that they are similar##2##4##(1994-6#1)(1995-8#1)
that they are simply##2##4##(1995-1#1)(2009-12#1)
that they are the##2##4##(1991-2#1)(2008-11#1)
that they are transcribed##2##4##(1996-6#1)(2012-3#1)
that they are two##2##4##(1990-12#1)(2008-10#1)
that they are unable to##2##5##(2008-11#1)(2008-4#1)
that they are##160##3##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-1#2)(1991-10#2)(1991-12#1)(1991-2#1)(1991-5#2)(1991-7#2)(1992-11#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#2)(1993-3#3)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-6#3)(1994-9#1)(1995-1#3)(1995-12#1)(1995-2#1)(1995-3#3)(1995-7#1)(1995-8#1)(1996-10#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#1)(2004-2#1)(2005-11#2)(2005-4#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-3#2)(2006-7#1)(2006-8#1)(2006-9#2)(2007-11#2)(2007-12#8)(2007-2#1)(2007-3#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#2)(2011-1#3)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
that they be##2##3##(2010-5#1)(2012-12#1)
that they believe##2##3##(1990-2#1)(2008-2#1)
that they belong to##2##4##(2008-11#1)(2008-8#1)
that they bind##2##3##(1991-9#1)(2007-12#1)
that they can be used##2##5##(2006-10#1)(2008-9#1)
that they can be##19##4##(1994-3#1)(1997-3#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#3)(2009-9#1)(2010-8#1)(2011-2#1)(2013-8#1)
that they can##42##3##(1991-3#1)(1991-7#1)(1994-3#1)(1995-4#1)(1995-5#1)(1997-3#1)(1997-4#1)(1997-5#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-1#2)(2007-11#1)(2007-12#4)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-9#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
that they cause##4##3##(2006-3#1)(2008-10#1)(2008-5#1)(2011-2#1)
that they chose##2##3##(2006-7#1)(2009-6#1)
that they considered##2##3##(2007-7#1)(2013-1#1)
that they contain##4##3##(1991-5#1)(1992-7#1)(2009-3#1)(2010-8#1)
that they could be##3##4##(1995-2#1)(1996-9#1)(2008-10#1)
that they could##10##3##(1994-3#1)(1995-2#1)(1996-2#1)(1996-9#1)(2008-10#1)(2008-12#1)(2008-9#1)(2012-12#2)(2013-8#1)
that they did not know##2##5##(1996-2#1)(2012-12#1)
that they did not##8##4##(1991-6#1)(1996-2#1)(2006-7#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-12#1)
that they differ from##2##4##(1990-10#1)(2008-4#1)
that they differ in##2##4##(1991-5#1)(1997-4#1)
that they differ##7##3##(1990-10#1)(1991-5#1)(1993-5#1)(1996-5#1)(1997-4#1)(2008-4#1)(2008-7#1)
that they do not have an##3##6##(2006-10#1)(2012-12#2)
that they do not wish to##3##6##(1993-6#1)(2013-1#2)
that they do not wish##5##5##(1993-6#1)(2013-1#4)
that they do not##23##4##(1992-12#1)(1992-2#1)(1992-8#1)(1993-2#1)(1993-6#1)(1993-8#1)(1995-5#1)(1997-1#1)(2005-8#1)(2006-10#2)(2006-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-12#1)(2012-12#2)(2013-1#4)
that they do##26##3##(1991-2#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-2#1)(1993-6#1)(1993-8#1)(1995-5#1)(1997-1#1)(2005-8#1)(2006-10#2)(2006-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-12#1)(2012-12#2)(2013-1#4)
that they either##2##3##(1995-5#1)(2007-12#1)
that they exert##2##3##(2010-10#1)(2013-1#1)
that they experience##2##3##(2008-5#1)(2008-6#1)
that they experienced##3##3##(2010-3#1)(2011-12#1)(2012-2#1)
that they felt##3##3##(1991-3#1)(1994-3#1)(2008-11#1)
that they found##2##3##(1996-4#1)(2008-12#1)
that they function in##2##4##(2007-1#1)(2008-6#1)
that they function##3##3##(1993-12#1)(2007-1#1)(2008-6#1)
that they gained##2##3##(2011-1#1)(2012-12#1)
that they had a##2##4##(2009-3#1)(2011-2#1)
that they had been##2##4##(1992-2#1)(2007-2#1)
that they had experienced##2##4##(2007-8#1)(2010-2#1)
that they had learned##2##4##(1992-6#1)(2008-1#1)
that they had not##2##4##(2008-8#1)(2011-2#1)
that they had received##3##4##(1994-2#1)(1995-6#1)(2007-7#1)
that they had##32##3##(1991-3#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-6#2)(1996-2#1)(1996-3#1)(1997-3#1)(2006-7#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-11#1)(2008-4#1)(2008-8#1)(2009-3#1)(2010-2#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)
that they have a##4##4##(1991-12#1)(2008-1#1)(2008-5#2)
that they have already been##2##5##(2009-11#1)(2012-2#1)
that they have an##2##4##(1994-12#1)(2009-4#1)
that they have been##3##4##(1994-6#1)(2008-1#1)(2008-10#1)
that they have different##3##4##(1990-11#1)(1991-1#1)(2008-7#1)
that they have the##3##4##(1992-1#1)(2007-8#1)(2008-5#1)
that they have to##2##4##(1993-9#1)(2012-2#1)
that they have##52##3##(1990-11#2)(1990-7#1)(1991-1#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-11#1)(1996-1#1)(1997-8#2)(2005-7#1)(2006-10#1)(2006-7#2)(2006-8#1)(2007-6#1)(2007-8#2)(2008-1#5)(2008-10#3)(2008-11#1)(2008-5#3)(2008-7#1)(2008-9#2)(2009-11#1)(2009-4#1)(2009-8#1)(2010-12#3)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
that they include##2##3##(1997-3#1)(2008-11#1)
that they inhibit##2##3##(1997-1#1)(2006-10#1)
that they interact##2##3##(1994-2#1)(2008-4#1)
that they interfere with the##2##5##(2006-12#1)(2008-5#1)
that they interfere##3##3##(2006-12#1)(2007-12#1)(2008-5#1)
that they lacked##2##3##(2008-10#1)(2011-1#1)
that they may be involved in##2##6##(1994-5#1)(2010-4#1)
that they may be##10##4##(1990-7#1)(1993-8#1)(1994-5#1)(2005-11#1)(2005-7#1)(2008-11#1)(2008-8#1)(2009-3#1)(2010-4#1)(2012-12#1)
that they may have##4##4##(1991-2#1)(1992-2#1)(2007-12#1)(2008-5#1)
that they may represent a##2##5##(1996-3#1)(2008-7#1)
that they may##36##3##(1990-7#1)(1991-2#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-5#1)(1996-12#1)(1996-3#2)(2005-11#1)(2005-7#1)(2005-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#3)(2008-8#2)(2009-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#1)
that they might be##3##4##(1996-2#1)(2007-12#1)(2011-12#1)
that they might have##2##4##(1993-4#1)(2007-4#1)
that they might##8##3##(1993-4#1)(1996-2#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-3#1)(2009-8#1)(2011-12#1)
that they must##2##3##(1996-2#1)(2008-12#1)
that they need##2##3##(2007-2#1)(2007-4#1)
that they needed##4##3##(1997-6#1)(2007-10#1)(2009-9#1)(2012-2#1)
that they never##2##3##(1993-1#1)(2008-8#1)
that they offer a##2##4##(2008-10#1)(2008-7#1)
that they offer##4##3##(2007-3#1)(2008-10#1)(2008-7#1)(2008-8#1)
that they often have##2##4##(2008-10#1)(2013-1#1)
that they often##4##3##(2006-10#1)(2008-10#1)(2011-2#1)(2013-1#1)
that they originate from##2##4##(1992-3#1)(1997-1#1)
that they originate##3##3##(1992-3#1)(1996-7#1)(1997-1#1)
that they perceive##3##3##(2005-7#2)(2010-11#1)
that they perceived##2##3##(2008-11#1)(2012-3#1)
that they persist##2##3##(2006-8#1)(2012-2#1)
that they play a##3##4##(2008-10#2)(2008-7#1)
that they play an important role in the##3##8##(1994-12#1)(2007-9#1)(2008-1#1)
that they play an important role in##4##7##(1991-3#1)(1994-12#1)(2007-9#1)(2008-1#1)
that they play##7##3##(1991-3#1)(1994-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-7#1)
that they possess##4##3##(1990-2#1)(1996-2#1)(1996-8#1)(2007-12#1)
that they produce##3##3##(1996-4#1)(2012-1#1)(2012-3#1)
that they provide##3##3##(2007-7#1)(2008-3#1)(2008-9#1)
that they reduce the##2##4##(1996-6#1)(2008-9#1)
that they remain##2##3##(1997-4#1)(2008-1#1)
that they represent##6##3##(1993-12#1)(1995-1#1)(2004-4#1)(2008-10#2)(2011-2#1)
that they select##2##3##(2007-10#1)(2011-2#1)
that they share##6##3##(1995-2#1)(1997-4#1)(2007-12#1)(2008-10#2)(2011-2#1)
that they should##2##3##(2008-4#1)(2008-8#1)
that they support the##2##4##(2010-5#1)(2012-2#1)
that they take##2##3##(1995-9#1)(2008-1#1)
that they too##2##3##(1991-7#1)(2008-3#1)
that they took##3##3##(2006-4#1)(2009-5#1)(2013-1#1)
that they use##3##3##(1993-12#1)(2008-11#1)(2012-12#1)
that they used##5##3##(2007-11#1)(2007-3#1)(2008-10#1)(2008-3#1)(2010-3#1)
that they were derived from a single##2##7##(1997-1#1)(2008-10#1)
that they were derived from##4##5##(1997-1#1)(2008-10#3)
that they were either##2##4##(2007-12#1)(2013-8#1)
that they were not##8##4##(1991-2#1)(1991-9#1)(1993-10#1)(1995-1#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-7#1)
that they were only##2##4##(2006-2#1)(2008-12#1)
that they were too##2##4##(2007-12#1)(2013-8#1)
that they were##77##3##(1990-10#1)(1990-2#1)(1990-4#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-9#1)(1993-10#1)(1993-12#1)(1993-8#1)(1993-9#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#11)(2008-11#6)(2008-12#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2010-12#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#2)
that they will be##7##4##(1992-2#1)(1996-8#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-3#1)(2007-3#1)
that they will become##2##4##(2008-12#1)(2010-3#1)
that they will not##2##4##(1996-12#2)
that they will##19##3##(1992-12#1)(1992-2#1)(1996-12#2)(1996-8#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-3#1)(2006-10#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#1)
that they wish##2##3##(2006-12#1)(2008-12#1)
that they would have##2##4##(1995-12#1)(2007-9#1)
that they would prescribe##2##4##(1993-2#1)(2007-2#1)
that they would use##2##4##(2007-7#1)(2007-9#1)
that they would##25##3##(1990-6#2)(1991-2#1)(1991-8#1)(1993-2#1)(1995-12#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-9#2)(2008-12#1)(2010-4#4)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#1)
that they##813##2##(1990-1#1)(1990-10#2)(1990-11#3)(1990-12#1)(1990-2#4)(1990-4#1)(1990-5#1)(1990-6#4)(1990-7#4)(1990-8#2)(1991-1#3)(1991-10#4)(1991-11#1)(1991-12#5)(1991-2#8)(1991-3#5)(1991-5#5)(1991-6#2)(1991-7#5)(1991-8#2)(1991-9#3)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#8)(1992-3#6)(1992-4#3)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#4)(1992-9#3)(1993-1#4)(1993-10#1)(1993-11#3)(1993-12#7)(1993-2#4)(1993-3#5)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#4)(1993-9#4)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#4)(1994-5#5)(1994-6#5)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#6)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#3)(1995-4#2)(1995-5#5)(1995-6#5)(1995-7#1)(1995-8#2)(1995-9#2)(1996-1#4)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#8)(1996-3#4)(1996-4#3)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#4)(1997-2#4)(1997-3#6)(1997-4#6)(1997-5#3)(1997-6#4)(1997-7#2)(1997-8#5)(2004-11#1)(2004-2#1)(2004-3#1)(2004-4#1)(2005-10#2)(2005-11#6)(2005-4#1)(2005-7#4)(2005-8#2)(2005-9#4)(2006-10#14)(2006-11#4)(2006-12#5)(2006-2#2)(2006-3#3)(2006-4#2)(2006-5#1)(2006-6#2)(2006-7#6)(2006-8#6)(2006-9#2)(2007-1#3)(2007-10#4)(2007-11#10)(2007-12#29)(2007-2#11)(2007-3#6)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#7)(2007-8#6)(2007-9#7)(2008-1#19)(2008-10#50)(2008-11#23)(2008-12#13)(2008-2#10)(2008-3#9)(2008-4#9)(2008-5#20)(2008-6#5)(2008-7#21)(2008-8#17)(2008-9#14)(2009-11#2)(2009-12#2)(2009-3#3)(2009-4#3)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#5)(2010-2#2)(2010-3#5)(2010-4#7)(2010-5#4)(2010-7#1)(2010-8#9)(2010-9#3)(2011-1#8)(2011-12#5)(2011-2#26)(2012-1#8)(2012-11#2)(2012-12#23)(2012-2#12)(2012-3#6)(2013-1#14)(2013-7#3)(2013-8#8)
that they'll##2##2##(1992-2#1)(2013-8#1)
that thiamine##2##2##(1994-11#1)(2008-1#1)
that thin##4##2##(2008-2#2)(2008-3#1)(2009-4#1)
that thinking##2##2##(2008-12#1)(2010-8#1)
that thioredoxin##3##2##(1992-2#1)(1994-9#2)
that third variables##3##3##(1997-4#3)
that this &quot##5##3##(1992-7#1)(1993-1#1)(1995-5#1)(1996-9#1)(2009-3#1)
that this DNA fragment##2##4##(2008-8#2)
that this ability##2##3##(2006-6#1)(2012-1#1)
that this action##4##3##(1990-5#1)(1994-10#1)(1995-11#1)(1995-7#1)
that this activation##5##3##(1991-12#1)(1993-12#1)(1994-2#1)(2012-12#1)(2012-2#1)
that this activity is##4##4##(1992-10#1)(1994-9#1)(1996-5#1)(2008-4#1)
that this activity may##2##4##(1992-12#1)(1992-3#1)
that this activity##7##3##(1992-10#1)(1992-12#1)(1992-3#1)(1994-9#1)(1996-5#1)(1997-1#1)(2008-4#1)
that this agent can##3##4##(1995-2#1)(2005-8#1)(2008-1#1)
that this agent is##3##4##(1995-8#1)(2007-11#1)(2008-7#1)
that this agent##8##3##(1995-2#1)(1995-8#1)(2005-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)
that this algorithm can##2##4##(2008-2#1)(2011-1#1)
that this algorithm##3##3##(2006-10#1)(2008-2#1)(2011-1#1)
that this alternative##2##3##(1993-8#1)(2012-1#1)
that this amino acid##3##4##(1992-8#1)(1995-3#1)(2010-8#1)
that this analogue##2##3##(1990-6#1)(1991-7#1)
that this antibody recognized##2##4##(1991-3#1)(2008-6#1)
that this antibody##7##3##(1991-3#1)(1991-4#1)(1995-8#1)(1997-3#1)(2008-6#1)(2013-1#2)
that this apparent##2##3##(2006-9#1)(2007-12#1)
that this approach can be used for##2##7##(1993-7#1)(2008-11#1)
that this approach can be##3##5##(1993-7#1)(1996-4#1)(2008-11#1)
that this approach can##7##4##(1993-7#1)(1995-6#1)(1996-4#1)(2008-11#1)(2008-2#1)(2008-6#1)(2010-2#1)
that this approach is##6##4##(1992-9#1)(1996-6#1)(2007-12#1)(2008-2#1)(2008-5#1)(2009-5#1)
that this approach may be##2##5##(2011-1#1)(2012-3#1)
that this approach may##3##4##(1997-3#1)(2011-1#1)(2012-3#1)
that this approach will##2##4##(2007-10#1)(2007-11#1)
that this approach yields##2##4##(2005-8#1)(2007-12#1)
that this approach##27##3##(1992-9#1)(1993-7#1)(1995-6#1)(1996-4#1)(1996-6#1)(1997-3#1)(2005-8#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-3#1)
that this approximation##3##3##(2007-12#1)(2008-3#1)(2013-1#1)
that this area may##2##4##(2007-12#1)(2008-10#1)
that this area##6##3##(1993-8#1)(2007-12#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-12#1)
that this arrangement is##2##4##(1990-4#2)
that this arrangement##3##3##(1990-4#3)
that this aspect##2##3##(1995-5#1)(2006-3#1)
that this assay##2##3##(1996-12#1)(2008-5#1)
that this bacterium##2##3##(2006-8#1)(2010-3#1)
that this balance##2##3##(2006-10#1)(2008-10#1)
that this binding##4##3##(1990-12#1)(1994-8#1)(1994-9#1)(1995-11#1)
that this cDNA##3##3##(1990-12#1)(1993-11#1)(2008-8#1)
that this can be##4##4##(2006-6#1)(2007-12#1)(2008-3#1)(2008-7#1)
that this can##5##3##(1990-11#1)(2006-6#1)(2007-12#1)(2008-3#1)(2008-7#1)
that this case##3##3##(1997-6#1)(2007-9#1)(2009-5#1)
that this cell line##2##4##(1990-5#1)(1994-12#1)
that this cell##3##3##(1990-5#1)(1994-12#1)(2008-3#1)
that this change in##2##4##(2006-10#1)(2008-7#1)
that this change##4##3##(2006-10#1)(2008-10#1)(2008-7#1)(2008-8#1)
that this channel is##2##4##(1994-2#1)(2009-8#1)
that this channel##4##3##(1990-10#1)(1994-2#1)(1997-5#1)(2009-8#1)
that this character##2##3##(2008-11#1)(2008-8#1)
that this class of##2##4##(1993-4#1)(2008-5#1)
that this class##3##3##(1991-11#1)(1993-4#1)(2008-5#1)
that this clone##3##3##(1991-9#1)(1993-6#1)(2008-8#1)
that this combination##5##3##(1997-7#1)(2013-1#3)(2013-7#1)
that this complex is##2##4##(1994-8#1)(1995-11#1)
that this component##4##3##(1994-12#1)(2008-10#1)(2008-5#1)(2008-7#1)
that this compound could##2##4##(1991-5#1)(2008-5#1)
that this compound##10##3##(1990-7#1)(1991-5#1)(1991-8#1)(1993-9#1)(1994-12#1)(1995-2#1)(1996-6#1)(1997-1#1)(2008-10#1)(2008-5#1)
that this condition is##2##4##(2008-3#1)(2009-4#1)
that this condition##4##3##(2008-10#2)(2008-3#1)(2009-4#1)
that this current##2##3##(1996-7#1)(1997-8#1)
that this cycle##2##3##(2008-9#2)
that this cysteine is##2##4##(1992-3#1)(1992-8#1)
that this decrease is##2##4##(1995-3#1)(2007-9#1)
that this decrease##3##3##(1993-3#1)(1995-3#1)(2007-9#1)
that this device##5##3##(2008-1#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-11#1)
that this did not##2##4##(1996-12#1)(2012-12#1)
that this difference is##3##4##(1991-7#1)(1996-7#1)(2008-2#1)
that this difference##5##3##(1991-7#1)(1994-3#1)(1996-7#1)(2008-2#1)(2012-3#1)
that this discussion will##2##4##(1992-2#1)(2008-11#1)
that this disease##4##3##(1991-9#1)(1994-8#1)(1994-9#1)(1997-8#1)
that this disorder##2##3##(2006-10#1)(2008-10#1)
that this distinction##3##3##(2008-1#1)(2008-11#1)(2008-3#1)
that this drug has##2##4##(1990-10#1)(1997-5#1)
that this drug##7##3##(1990-10#1)(1994-5#1)(1997-5#1)(2007-11#1)(2011-2#1)(2012-1#1)(2012-12#1)
that this effect can be##4##5##(1994-9#1)(2008-2#1)(2008-3#2)
that this effect is due to##2##6##(2005-11#1)(2009-10#1)
that this effect is mediated by##3##6##(1993-3#1)(1993-4#1)(1993-9#1)
that this effect is mediated##4##5##(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)
that this effect is##11##4##(1992-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1997-8#1)(2005-11#1)(2007-10#1)(2008-11#1)(2009-10#1)(2009-4#1)
that this effect may be##5##5##(1991-9#1)(1994-8#1)(2008-3#1)(2008-4#1)(2013-1#1)
that this effect was due to##2##6##(1993-11#1)(2011-2#1)
that this effect was##5##4##(1990-8#1)(1993-11#1)(1995-5#1)(2011-2#2)
that this effect##34##3##(1990-10#1)(1990-8#1)(1991-9#1)(1992-11#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-5#1)(1995-6#1)(1996-1#1)(1997-8#1)(2005-11#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-7#1)(2009-10#1)(2009-4#1)(2010-4#1)(2011-2#2)(2013-1#1)
that this enzyme does not##2##5##(1990-9#1)(1996-6#1)
that this enzyme is##2##4##(1991-9#1)(2008-7#1)
that this enzyme was##3##4##(1991-5#1)(2005-11#1)(2008-6#1)
that this enzyme##13##3##(1990-3#1)(1990-9#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-4#1)(1994-9#1)(1995-1#1)(1996-6#1)(2005-11#1)(2008-3#1)(2008-6#1)(2008-7#1)
that this event was##2##4##(1994-8#1)(2007-7#1)
that this event##5##3##(1994-10#1)(1994-8#1)(2007-7#1)(2008-10#1)(2009-10#1)
that this experience##2##3##(1993-3#1)(2008-9#1)
that this factor##4##3##(1992-3#1)(1992-6#1)(1994-12#1)(2006-10#1)
that this family of##3##4##(1996-9#1)(2008-6#1)(2010-3#1)
that this family##4##3##(1996-9#1)(2008-6#1)(2010-12#1)(2010-3#1)
that this finding##2##3##(1993-4#1)(2011-1#1)
that this form is##2##4##(1990-5#1)(1995-8#1)
that this form of##3##4##(1993-6#1)(2006-11#1)(2011-2#1)
that this form##6##3##(1990-5#1)(1993-6#1)(1994-11#1)(1995-8#1)(2006-11#1)(2011-2#1)
that this fragment##3##3##(1990-5#1)(1991-9#1)(1996-8#1)
that this function##2##3##(1995-3#1)(2008-8#1)
that this functional##2##3##(1996-9#1)(2008-11#1)
that this fungus##2##3##(2007-2#1)(2009-9#1)
that this gene and##2##4##(1992-3#1)(1994-12#1)
that this gene is not##2##5##(1994-12#1)(1996-7#1)
that this gene is##9##4##(1990-12#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1993-9#1)(1994-12#1)(1996-7#1)
that this gene##18##3##(1990-12#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-3#1)(1993-9#1)(1994-12#2)(1995-3#1)(1995-8#1)(1996-7#1)(2008-2#1)(2008-8#2)(2008-9#1)
that this group of##3##4##(2008-11#1)(2009-10#1)(2012-2#1)
that this group##6##3##(1994-9#1)(2004-12#1)(2008-11#1)(2008-2#1)(2009-10#1)(2012-2#1)
that this growth##2##3##(2008-10#1)(2008-11#1)
that this has##4##3##(1990-4#1)(2008-10#1)(2008-11#1)(2008-3#1)
that this hypothesis##2##3##(2010-5#1)(2013-7#1)
that this impairment##2##3##(2006-8#1)(2009-2#1)
that this improvement is##2##4##(2006-10#1)(2008-3#1)
that this in vitro##4##4##(2008-11#2)(2008-5#2)
that this in##6##3##(1990-12#1)(2008-11#2)(2008-5#2)(2010-4#1)
that this increase in##3##4##(1994-5#1)(1994-9#1)(2008-11#1)
that this increase is##4##4##(1993-8#1)(2005-11#1)(2007-11#1)(2011-1#1)
that this increase was##2##4##(1995-5#1)(2010-8#1)
that this increase##12##3##(1992-2#1)(1993-8#1)(1994-5#1)(1994-9#2)(1995-5#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-11#1)(2010-8#1)(2011-1#1)
that this increased##5##3##(1994-5#1)(1995-3#1)(2008-10#1)(2008-7#2)
that this information will be useful##2##6##(2008-12#1)(2012-2#1)
that this information##3##3##(1992-5#1)(2008-12#1)(2012-2#1)
that this inhibition is##4##4##(1993-8#1)(1994-11#1)(1997-3#1)(2011-1#1)
that this inhibition##5##3##(1993-8#1)(1994-11#1)(1997-3#1)(1997-6#1)(2011-1#1)
that this inhibitor##2##3##(1992-8#1)(1994-2#1)
that this inhibitory action##2##4##(1990-3#1)(2008-10#1)
that this inhibitory effect##2##4##(1996-2#1)(1997-1#1)
that this inhibitory##5##3##(1990-3#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-7#1)
that this interaction is not##2##5##(1997-4#1)(1997-6#1)
that this interaction is##5##4##(1994-9#2)(1997-4#1)(1997-6#1)(2008-10#1)
that this interaction##10##3##(1990-8#2)(1994-9#2)(1997-4#1)(1997-6#2)(2008-10#1)(2012-12#1)(2013-8#1)
that this is a consequence of##2##6##(1991-3#1)(1995-6#1)
that this is a##20##4##(1990-8#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-2#1)(1995-4#1)(1995-6#1)(2006-10#2)(2006-8#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-8#1)(2009-1#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-7#1)
that this is also##3##4##(1995-6#1)(1997-5#1)(2008-11#1)
that this is an important##2##5##(1993-1#1)(2008-10#1)
that this is an##5##4##(1993-1#1)(2007-6#1)(2008-1#1)(2008-10#1)(2009-2#1)
that this is associated with##2##5##(1990-12#1)(1994-8#1)
that this is due to the##4##6##(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)
that this is due to##5##5##(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-3#1)
that this is due##6##4##(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-3#2)
that this is indeed the case##2##6##(1990-11#1)(1994-2#1)
that this is indeed##3##4##(1990-11#1)(1993-11#1)(1994-2#1)
that this is not a##2##5##(1994-2#1)(2008-3#1)
that this is not##8##4##(1993-7#1)(1994-2#1)(2007-12#1)(2008-3#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-12#1)
that this is the first##6##5##(1994-9#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-9#1)(2010-3#1)
that this is the only##2##5##(2007-8#1)(2008-4#1)
that this is the##10##4##(1994-9#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-3#1)
that this is##71##3##(1990-11#1)(1990-12#1)(1990-8#1)(1991-3#1)(1992-1#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-7#2)(1994-2#2)(1994-8#1)(1994-9#1)(1995-4#1)(1995-6#2)(1996-2#1)(1997-5#1)(1997-8#1)(2006-10#4)(2006-11#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-1#2)(2009-2#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
that this isolate##2##3##(2007-2#1)(2012-2#1)
that this kind of##7##4##(1990-10#1)(1991-2#1)(1995-4#1)(1996-5#1)(1997-5#1)(2007-8#1)(2008-3#1)
that this laser##5##3##(2007-12#2)(2008-2#1)(2008-3#1)(2009-5#1)
that this ligand has a higher##2##6##(2010-5#2)
that this ligand##4##3##(1994-2#1)(1994-9#1)(2010-5#2)
that this locus is##2##4##(1994-8#1)(2010-12#1)
that this locus##3##3##(1994-8#1)(2008-10#1)(2010-12#1)
that this makes##2##3##(2008-4#1)(2011-1#1)
that this may be a##3##5##(1994-11#1)(1995-6#1)(2008-8#1)
that this may be explained##2##5##(2005-11#1)(2007-2#1)
that this may be the##2##5##(1991-12#1)(1995-6#1)
that this may be##15##4##(1990-5#1)(1991-12#1)(1991-2#1)(1992-3#1)(1994-11#1)(1994-8#1)(1995-6#2)(2005-11#1)(2007-2#1)(2008-4#1)(2008-8#1)(2009-4#2)(2010-2#1)
that this may not##2##4##(2006-11#1)(2008-7#1)
that this may##24##3##(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-6#2)(2005-11#1)(2005-12#1)(2006-11#1)(2007-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-4#2)(2010-12#1)(2010-2#1)(2012-11#1)
that this mechanism may##2##4##(1991-12#1)(1994-8#1)
that this mechanism##3##3##(1991-12#1)(1994-8#1)(2008-11#1)
that this membrane##2##3##(1993-3#1)(1997-1#1)
that this metabolic##2##3##(1995-9#1)(2012-2#1)
that this method can be applied to##2##7##(1994-9#1)(2008-3#1)
that this method can be##7##5##(1992-5#1)(1994-9#1)(1996-12#1)(2007-8#1)(2008-11#1)(2008-3#2)
that this method can##11##4##(1992-5#1)(1994-9#1)(1996-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-3#2)(2012-12#1)
that this method could##2##4##(1997-4#1)(2007-8#1)
that this method has a##2##5##(2008-10#1)(2013-8#1)
that this method has##3##4##(2008-10#1)(2008-2#1)(2013-8#1)
that this method is useful for##2##6##(2007-11#1)(2008-2#1)
that this method is##5##4##(2007-11#1)(2007-12#1)(2007-7#1)(2008-2#1)(2013-8#1)
that this method might##3##4##(2007-10#1)(2008-10#2)
that this method of##3##4##(1992-4#1)(2008-11#1)(2010-8#1)
that this method will##3##4##(2007-11#1)(2008-4#1)(2011-2#1)
that this method##40##3##(1991-12#1)(1992-4#1)(1992-5#1)(1994-9#1)(1996-12#2)(1997-4#1)(2005-4#2)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#2)
that this methodology is##3##4##(1992-11#1)(2012-12#2)
that this methodology##6##3##(1992-11#1)(1993-3#1)(1993-9#1)(2011-2#1)(2012-12#2)
that this might##2##3##(1997-2#1)(2008-12#1)
that this missense mutation##2##4##(1993-6#1)(1994-12#1)
that this mode of##3##4##(1996-7#1)(2007-8#1)(2012-11#1)
that this model is##2##4##(2007-12#1)(2008-10#1)
that this model##11##3##(1995-4#1)(1996-8#1)(2005-11#1)(2007-12#1)(2007-4#2)(2008-10#2)(2008-2#1)(2012-2#1)(2013-8#1)
that this molecule could##2##4##(1992-3#1)(2005-7#1)
that this molecule may be##2##5##(2008-10#1)(2012-12#1)
that this molecule may##3##4##(1993-12#1)(2008-10#1)(2012-12#1)
that this molecule##8##3##(1991-8#1)(1992-3#1)(1993-12#1)(1993-6#1)(2005-7#1)(2008-10#2)(2012-12#1)
that this motif##2##3##(1996-5#1)(2009-7#1)
that this mouse model##2##4##(2008-10#1)(2012-3#1)
that this mutant##2##3##(1991-4#1)(2009-10#1)
that this mutation is##2##4##(1991-9#1)(1995-12#1)
that this mutation##5##3##(1991-9#1)(1993-4#1)(1994-9#1)(1995-12#1)(2008-12#1)
that this new approach##2##4##(2007-12#1)(2012-3#1)
that this new method##2##4##(1991-8#1)(2008-3#1)
that this new##27##3##(1991-2#1)(1991-8#1)(1992-8#1)(1996-10#1)(1996-8#1)(1996-9#1)(1997-3#1)(2007-12#2)(2007-7#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#3)(2008-8#1)(2009-7#1)(2011-2#1)(2011-7#1)(2012-2#2)(2012-3#1)
that this newly developed##2##4##(2007-12#1)(2008-3#1)
that this novel##5##3##(1991-5#1)(1995-3#1)(1997-4#1)(2008-3#1)(2011-1#1)
that this number##2##3##(1994-6#1)(2011-2#1)
that this oblique##2##3##(1990-11#1)(1991-3#1)
that this operation##4##3##(2008-2#1)(2008-3#2)(2009-2#1)
that this organism##2##3##(1997-1#1)(1997-7#1)
that this paper##2##3##(2008-12#1)(2008-6#1)
that this parameter##2##3##(2009-2#1)(2010-2#1)
that this part##2##3##(1990-11#1)(2007-12#1)
that this particular##5##3##(1992-3#1)(1995-5#1)(2008-10#1)(2009-1#1)(2011-1#1)
that this pathogen##3##3##(2008-10#2)(2012-3#1)
that this pathway may##2##4##(1995-12#1)(1995-2#1)
that this patient's##2##3##(2010-2#1)(2010-3#1)
that this pattern is##2##4##(1990-3#1)(1994-3#1)
that this pattern##3##3##(1990-3#1)(1994-3#1)(1997-7#1)
that this peptide##4##3##(1991-2#1)(1992-7#1)(2008-10#1)(2008-3#1)
that this pest##2##3##(2011-2#1)(2013-8#1)
that this phenomenon is##3##4##(1990-2#1)(1992-8#1)(1997-7#1)
that this phenomenon occurs##2##4##(2006-10#1)(2007-11#1)
that this phenomenon was##2##4##(1990-5#1)(2008-9#1)
that this phenomenon##8##3##(1990-2#1)(1990-5#1)(1992-8#1)(1997-5#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-9#1)
that this phenotype is##2##4##(1995-8#1)(2012-3#1)
that this phosphorylation##2##3##(1994-9#1)(2005-8#1)
that this plant##2##3##(2008-2#1)(2012-12#1)
that this policy##2##3##(2009-2#2)
that this population##3##3##(2008-10#2)(2013-1#1)
that this problem##3##3##(1997-8#1)(2007-11#1)(2008-1#1)
that this procedure is##3##4##(2008-1#1)(2008-10#1)(2008-3#1)
that this procedure##8##3##(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2009-8#1)(2012-2#1)
that this process can be##2##5##(1994-8#1)(2010-4#1)
that this process is##6##4##(1990-6#1)(1997-7#1)(2007-11#1)(2008-3#1)(2008-6#1)(2008-8#1)
that this process##17##3##(1990-12#1)(1990-6#1)(1991-11#1)(1994-8#1)(1997-7#1)(2005-7#1)(2005-9#1)(2006-4#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-8#1)(2009-3#1)(2010-12#1)(2010-4#1)
that this progress##2##3##(2007-8#1)(2008-11#1)
that this property can be##2##5##(2008-2#1)(2011-2#1)
that this property##4##3##(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#1)
that this protection is##2##4##(1994-10#1)(2008-5#1)
that this protection##3##3##(1994-10#1)(1996-9#1)(2008-5#1)
that this protein could##3##4##(1994-5#1)(2010-2#1)(2012-12#1)
that this protein has a##2##5##(1991-5#1)(1994-3#1)
that this protein is a##2##5##(1994-11#1)(1994-9#1)
that this protein is##10##4##(1990-5#1)(1990-7#1)(1991-11#1)(1992-4#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-9#1)(2008-4#1)
that this protein may play a##2##6##(1996-5#1)(2009-4#1)
that this protein##28##3##(1990-4#1)(1990-5#2)(1990-7#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-4#2)(1993-6#1)(1993-8#2)(1994-11#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-5#1)(2007-10#1)(2008-10#1)(2008-4#1)(2009-4#1)(2010-2#2)(2012-12#1)
that this rare##3##3##(1991-4#1)(1996-3#1)(2006-1#1)
that this reaction##3##3##(1991-6#1)(1992-8#1)(2008-7#1)
that this receptor is##4##4##(1995-11#1)(1996-5#1)(1997-6#1)(2008-5#1)
that this receptor##8##3##(1993-3#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-5#1)(1997-6#1)(2008-5#1)
that this regimen##2##3##(1991-12#1)(2007-12#1)
that this region contained at least##2##6##(1996-12#1)(1997-4#1)
that this region could##2##4##(1991-7#1)(1994-12#1)
that this region is##10##4##(1990-12#1)(1990-6#1)(1990-8#1)(1991-8#1)(1993-11#1)(1994-9#1)(1995-11#1)(1996-7#1)(2008-5#1)(2012-12#1)
that this region of##3##4##(1994-9#1)(1997-3#1)(2008-5#1)
that this region##22##3##(1990-12#1)(1990-6#1)(1990-8#1)(1991-7#1)(1991-8#2)(1993-11#1)(1994-12#1)(1994-9#2)(1995-11#1)(1995-8#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-4#1)(2007-9#1)(2008-11#1)(2008-5#2)(2012-12#1)
that this regulation is##2##4##(1993-5#1)(2008-8#1)
that this relationship can##2##4##(2008-10#1)(2013-1#1)
that this relationship is##2##4##(2006-10#1)(2008-4#1)
that this relationship##5##3##(2006-10#1)(2008-10#1)(2008-4#1)(2013-1#2)
that this residue is##2##4##(1992-8#1)(1993-8#1)
that this residue##4##3##(1990-8#2)(1992-8#1)(1993-8#1)
that this resistance##4##3##(2008-10#2)(2009-9#1)(2012-12#1)
that this response is##2##4##(1991-5#1)(2006-4#1)
that this response##4##3##(1991-5#1)(1992-3#1)(1997-2#1)(2006-4#1)
that this result##4##3##(2007-12#1)(2010-7#1)(2011-2#1)(2012-2#1)
that this results in a##2##5##(1992-3#1)(2008-10#1)
that this results in##5##4##(1992-3#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-6#1)
that this results##6##3##(1992-3#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-6#1)(2010-4#1)
that this review##2##3##(2008-5#1)(2009-9#1)
that this role is##3##4##(1992-9#1)(1997-7#1)(2012-2#1)
that this role##4##3##(1992-9#1)(1997-7#1)(2008-10#1)(2012-2#1)
that this sector##2##3##(2008-2#1)(2008-5#1)
that this segment##2##3##(1996-11#1)(2009-10#1)
that this sensor can##2##4##(2008-10#1)(2008-2#1)
that this sequence is##4##4##(1991-11#1)(1991-12#1)(1994-3#1)(1995-6#1)
that this sequence##5##3##(1991-11#1)(1991-12#1)(1994-3#1)(1995-6#1)(1997-4#1)
that this should be##2##4##(2005-9#1)(2006-6#1)
that this simple##2##3##(2008-3#1)(2010-3#1)
that this site may be##2##5##(1991-1#1)(1997-3#1)
that this site may##3##4##(1991-1#1)(1991-12#1)(1997-3#1)
that this site##5##3##(1991-1#1)(1991-12#1)(1992-5#1)(1997-3#1)(2008-9#1)
that this species has a##2##5##(2007-5#1)(2010-8#1)
that this species has##3##4##(2007-5#1)(2008-5#1)(2010-8#1)
that this species is##4##4##(2004-11#1)(2008-10#1)(2010-6#1)(2012-6#1)
that this species may##2##4##(1992-8#1)(2008-6#1)
that this species##10##3##(1992-8#1)(2004-11#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-6#1)(2010-8#1)(2012-6#1)
that this specific##2##3##(1996-5#1)(2011-2#1)
that this steroid##2##3##(1990-10#1)(2008-4#1)
that this strain##2##3##(2008-10#1)(2012-2#1)
that this strategy##3##3##(1997-2#1)(2008-3#1)(2010-11#1)
that this structure is##2##4##(1994-9#1)(2012-1#1)
that this structure##5##3##(1994-11#1)(1994-9#1)(2007-11#1)(2008-10#1)(2012-1#1)
that this study will##2##4##(2007-1#1)(2007-8#1)
that this study##7##3##(1991-6#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-6#1)(2010-8#1)(2013-8#1)
that this syndrome##3##3##(1995-12#1)(2006-10#1)(2007-11#1)
that this system is##4##4##(1996-4#1)(2004-2#1)(2006-8#1)(2008-3#1)
that this system##9##3##(1996-4#1)(1997-8#1)(2004-2#1)(2006-2#1)(2006-8#1)(2008-11#1)(2008-3#1)(2009-11#1)(2010-2#1)
that this technique can also be used to##2##8##(2008-3#1)(2013-8#1)
that this technique can also##3##5##(2008-3#1)(2009-2#1)(2013-8#1)
that this technique can be##2##5##(1996-8#1)(2008-3#1)
that this technique can##8##4##(1996-8#1)(2007-11#1)(2008-10#2)(2008-3#2)(2009-2#1)(2013-8#1)
that this technique has##2##4##(1994-11#1)(2008-1#1)
that this technique is still##2##5##(1997-7#1)(2009-6#1)
that this technique is##7##4##(1997-7#1)(2007-11#1)(2008-3#1)(2009-6#1)(2009-7#1)(2011-1#1)(2012-2#1)
that this technique will be useful for##2##7##(1992-3#1)(2007-12#1)
that this technique will##4##4##(1992-3#1)(2007-12#1)(2008-2#1)(2012-2#1)
that this technique##29##3##(1990-10#1)(1992-3#1)(1993-12#1)(1994-11#1)(1996-8#1)(1997-7#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#4)(2009-2#1)(2009-6#1)(2009-7#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
that this technology may##2##4##(2006-6#1)(2013-1#1)
that this technology##5##3##(2006-6#1)(2006-7#1)(2008-10#1)(2011-2#1)(2013-1#1)
that this therapy may##2##4##(2006-8#1)(2012-2#1)
that this therapy##3##3##(1990-9#1)(2006-8#1)(2012-2#1)
that this tool##2##3##(1993-12#1)(1993-5#1)
that this treatment is##2##4##(1991-9#1)(1993-5#1)
that this treatment##7##3##(1990-2#1)(1991-9#1)(1993-5#1)(2006-2#1)(2006-7#1)(2008-8#1)(2010-5#1)
that this tumor##2##3##(1993-7#1)(2010-11#1)
that this type of##8##4##(1991-11#1)(1994-11#1)(1995-9#1)(1997-5#1)(1997-7#1)(2007-6#1)(2008-5#1)(2013-1#1)
that this unusual##2##3##(1995-8#1)(1996-2#1)
that this variation##2##3##(1992-5#1)(2008-8#1)
that this virus##5##3##(2008-10#4)(2008-12#1)
that this was a primary##2##5##(2006-9#1)(2007-2#1)
that this was a##4##4##(1993-5#1)(2006-9#1)(2007-2#1)(2011-2#1)
that this was an##3##4##(1993-12#1)(2007-12#1)(2010-8#1)
that this was due to##3##5##(2007-3#1)(2008-10#1)(2012-2#1)
that this was##14##3##(1993-12#1)(1993-5#1)(1995-5#1)(2006-4#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
that this will be##3##4##(2005-11#1)(2008-11#1)(2008-5#1)
that this will increase##2##4##(2007-11#1)(2008-3#1)
that this will##11##3##(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-8#1)
that this would be##2##4##(1994-5#1)(2008-10#1)
that this would lead##2##4##(2007-12#1)(2008-10#1)
that this would##6##3##(1994-5#1)(1997-1#1)(2007-12#1)(2008-10#2)(2013-1#1)
that this yeast##2##3##(2008-7#1)(2009-12#1)
that this##1451##2##(1990-10#8)(1990-11#9)(1990-12#8)(1990-2#5)(1990-3#5)(1990-4#7)(1990-5#11)(1990-6#5)(1990-7#7)(1990-8#11)(1990-9#5)(1991-1#4)(1991-10#3)(1991-11#5)(1991-12#12)(1991-2#6)(1991-3#6)(1991-4#4)(1991-5#9)(1991-6#3)(1991-7#5)(1991-8#5)(1991-9#11)(1992-1#3)(1992-10#1)(1992-11#3)(1992-12#5)(1992-2#4)(1992-3#12)(1992-4#7)(1992-5#6)(1992-6#5)(1992-7#2)(1992-8#11)(1992-9#4)(1993-1#3)(1993-11#6)(1993-12#8)(1993-2#3)(1993-3#8)(1993-4#4)(1993-5#5)(1993-6#10)(1993-7#6)(1993-8#9)(1993-9#7)(1994-1#1)(1994-10#4)(1994-11#10)(1994-12#14)(1994-2#8)(1994-3#11)(1994-5#6)(1994-6#1)(1994-7#1)(1994-8#14)(1994-9#20)(1995-1#5)(1995-11#10)(1995-12#8)(1995-2#7)(1995-3#15)(1995-4#4)(1995-5#11)(1995-6#8)(1995-7#1)(1995-8#14)(1995-9#3)(1996-1#6)(1996-10#1)(1996-11#3)(1996-12#11)(1996-2#6)(1996-3#4)(1996-4#5)(1996-5#11)(1996-6#6)(1996-7#8)(1996-8#5)(1996-9#6)(1997-1#8)(1997-2#9)(1997-3#8)(1997-4#7)(1997-5#8)(1997-6#6)(1997-7#10)(1997-8#6)(2004-11#2)(2004-12#1)(2004-2#2)(2005-10#2)(2005-11#10)(2005-12#2)(2005-4#2)(2005-7#6)(2005-8#3)(2005-9#2)(2006-1#2)(2006-10#18)(2006-11#4)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#4)(2006-5#1)(2006-6#7)(2006-7#4)(2006-8#5)(2006-9#5)(2007-1#2)(2007-10#7)(2007-11#22)(2007-12#36)(2007-2#8)(2007-3#2)(2007-4#2)(2007-5#3)(2007-6#2)(2007-7#8)(2007-8#13)(2007-9#6)(2008-1#10)(2008-10#95)(2008-11#44)(2008-12#9)(2008-2#39)(2008-3#50)(2008-4#17)(2008-5#44)(2008-6#13)(2008-7#24)(2008-8#28)(2008-9#13)(2009-1#4)(2009-10#7)(2009-11#1)(2009-12#1)(2009-2#12)(2009-3#3)(2009-4#6)(2009-5#5)(2009-6#5)(2009-7#5)(2009-8#7)(2009-9#3)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#6)(2010-2#8)(2010-3#7)(2010-4#7)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#8)(2010-9#2)(2011-1#17)(2011-12#1)(2011-2#22)(2011-7#1)(2012-1#5)(2012-11#4)(2012-12#19)(2012-2#28)(2012-3#13)(2012-6#1)(2013-1#27)(2013-7#8)(2013-8#15)
that thoracic##3##2##(2006-7#2)(2008-12#1)
that thoracoscopic##2##2##(2006-7#1)(2006-8#1)
that those involved in the##2##5##(2005-5#1)(2008-11#1)
that those involved in##3##4##(2005-5#1)(2008-11#1)(2008-8#1)
that those of##3##3##(2006-7#1)(2007-10#1)(2008-10#1)
that those participants##2##3##(2007-12#1)(2010-2#1)
that those subjects with##2##4##(1991-5#1)(1996-8#1)
that those who##5##3##(1995-6#1)(2006-12#1)(2009-7#1)(2010-2#1)(2012-3#1)
that those with##4##3##(2008-7#1)(2009-12#1)(2009-7#1)(2011-1#1)
that those##41##2##(1991-10#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-7#1)(1994-6#1)(1995-6#1)(1996-11#1)(1996-5#1)(1996-8#1)(2005-5#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-2#2)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
that though##4##2##(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
that threaten##4##2##(1994-12#1)(2007-4#1)(2008-12#1)(2012-12#1)
that threatens the##3##3##(2007-5#1)(2007-7#1)(2008-11#1)
that three different##4##3##(2005-11#1)(2008-10#1)(2008-12#1)(2011-1#1)
that three factors##2##3##(1997-8#1)(2009-7#1)
that three independent##2##3##(2007-12#1)(2008-3#1)
that three of the##3##4##(1992-9#1)(1994-9#1)(1997-1#1)
that three of them##2##4##(2007-3#1)(2008-3#1)
that three of these##3##4##(1996-7#1)(1997-7#1)(2008-10#1)
that three of##9##3##(1991-10#1)(1992-9#1)(1994-9#1)(1996-7#1)(1997-1#1)(1997-7#1)(2007-3#1)(2008-10#1)(2008-3#1)
that three##45##2##(1990-3#1)(1990-8#1)(1991-10#1)(1992-12#1)(1992-8#1)(1992-9#1)(1994-12#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-5#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-7#1)(1997-8#2)(2005-11#1)(2006-10#1)(2006-5#1)(2007-12#2)(2007-3#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#4)(2008-5#1)(2008-9#1)(2009-7#1)(2011-1#1)(2012-3#1)
that three-dimensional##4##2##(2007-12#1)(2008-2#2)(2012-2#1)
that threonine##2##2##(1990-8#1)(2008-11#1)
that thrips##2##2##(2008-10#2)
that thrombin receptor##2##3##(1995-3#1)(1997-5#1)
that thrombin##6##2##(1994-12#1)(1995-3#1)(1997-5#1)(1997-7#2)(2007-10#1)
that through the##2##3##(2008-12#1)(2013-8#1)
that through##9##2##(2007-12#1)(2007-6#1)(2008-12#1)(2008-2#1)(2008-5#1)(2010-2#1)(2013-1#2)(2013-8#1)
that thymocyte##2##2##(2007-3#1)(2010-2#1)
that thymocytes##6##2##(1994-6#2)(1995-8#1)(2008-10#1)(2008-5#1)(2008-8#1)
that thyroid hormones affect##2##4##(2006-11#1)(2013-8#1)
that thyroid hormones##4##3##(1990-8#1)(1995-7#1)(2006-11#1)(2013-8#1)
that thyroid##8##2##(1990-8#1)(1992-10#1)(1993-3#1)(1995-7#1)(2006-11#1)(2009-5#1)(2011-1#1)(2013-8#1)
that thyroxine##2##2##(1993-12#1)(2007-1#1)
that tight##2##2##(1996-5#1)(2012-2#1)
that tightly##2##2##(1992-7#1)(2013-1#1)
that tilmicosin##2##2##(2008-5#2)
that tilting##2##2##(2007-11#1)(2008-2#1)
that time it##2##3##(1994-3#1)(2008-9#1)
that time of##3##3##(2005-7#1)(2005-8#1)(2008-1#1)
that time period##2##3##(1993-11#1)(1996-12#1)
that time the##3##3##(2007-11#1)(2007-7#1)(2011-1#1)
that time##75##2##(1990-10#1)(1990-5#1)(1990-8#1)(1991-4#1)(1992-1#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-3#3)(1995-12#1)(1996-12#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-5#1)(2004-3#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#2)(2009-3#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
that time-gating##2##2##(2008-2#2)
that timing jitter##2##3##(2007-12#2)
that timing##5##2##(2007-12#2)(2008-1#1)(2008-10#1)(2010-7#1)
that tissue##11##2##(1992-2#1)(1993-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-2#1)(2007-11#1)(2008-10#1)(2009-9#1)(2011-1#2)
that tissues##2##2##(2005-12#1)(2007-8#1)
that to achieve##3##3##(1995-1#1)(2008-2#1)(2008-7#1)
that to obtain a##2##4##(2009-7#1)(2010-5#1)
that to the##7##3##(1991-1#1)(1995-1#1)(1996-5#1)(2007-8#1)(2008-10#3)
that to##42##2##(1991-1#1)(1991-12#2)(1991-8#1)(1992-1#1)(1992-6#1)(1993-8#2)(1994-2#1)(1994-3#2)(1995-1#2)(1995-2#1)(1995-5#1)(1996-5#1)(1997-2#1)(2005-7#1)(2006-12#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-12#1)(2010-5#1)(2011-3#1)(2012-12#1)(2013-1#5)
that tobacco##10##2##(1996-1#1)(1996-11#2)(2006-2#2)(2007-12#1)(2008-12#1)(2008-4#1)(2009-11#1)(2010-9#1)
that tocilizumab##2##2##(2008-5#2)
that today##5##2##(2006-6#1)(2007-11#1)(2007-7#1)(2013-1#2)
that together##8##2##(1995-3#2)(2007-8#1)(2008-10#3)(2008-11#1)(2011-2#1)
that tolerance of deviance##2##4##(2011-12#2)
that tolerance of##3##3##(2011-12#2)(2011-2#1)
that tolerance##9##2##(1992-3#1)(2006-11#1)(2007-4#1)(2008-10#1)(2008-3#1)(2011-12#2)(2011-2#1)(2012-12#1)
that tonic##2##2##(2008-11#1)(2008-4#1)
that too many##3##3##(2005-10#1)(2007-11#1)(2010-12#1)
that too##6##2##(2005-10#1)(2007-11#1)(2008-11#1)(2009-6#1)(2010-12#1)(2012-12#1)
that took into account##3##4##(1992-9#1)(1997-5#1)(2008-10#1)
that took place during the##2##5##(1994-3#1)(2006-10#1)
that took place in##4##4##(1997-5#1)(2007-2#1)(2012-2#1)(2013-1#1)
that took place##11##3##(1994-3#1)(1997-5#1)(2006-10#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
that took##17##2##(1991-4#1)(1992-9#1)(1994-3#1)(1997-5#2)(2006-10#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
that topical application of##3##4##(1990-11#1)(1990-2#1)(2013-1#1)
that topical application##4##3##(1990-11#1)(1990-2#1)(2011-2#1)(2013-1#1)
that topical ketanserin##2##3##(2013-8#2)
that topical##10##2##(1990-11#1)(1990-2#1)(1994-5#1)(2006-12#1)(2008-8#1)(2011-2#1)(2013-1#2)(2013-8#2)
that topically##2##2##(2008-5#1)(2008-8#1)
that topoisomerase##2##2##(1996-7#1)(1997-4#1)
that topological distance indices##2##4##(2007-11#2)
that total##13##2##(1993-3#1)(1994-3#1)(1995-1#2)(1997-7#1)(2005-12#1)(2007-12#1)(2008-12#2)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#1)
that totally##2##2##(2007-7#1)(2008-2#1)
that touch##2##2##(2008-2#1)(2011-2#1)
that toxic##2##2##(1990-4#1)(2008-11#1)
that toxicity##2##2##(2008-10#1)(2008-9#1)
that trace##6##2##(2008-1#1)(2008-10#4)(2013-1#1)
that tracheae##2##2##(2007-12#2)
that traditional##15##2##(1995-3#1)(1996-1#1)(1996-3#1)(2006-2#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-7#2)(2010-12#1)(2012-2#2)
that traditionally have##2##3##(1993-12#1)(2008-3#1)
that traditionally##4##2##(1993-12#1)(2007-8#1)(2008-3#1)(2012-2#1)
that trafficking##2##2##(2009-2#1)(2012-2#1)
that training based on##3##4##(2007-11#1)(2013-1#2)
that training##11##2##(1992-1#1)(1995-12#1)(2007-11#2)(2007-4#2)(2008-12#1)(2010-3#1)(2011-2#1)(2013-1#2)
that trait##5##2##(2008-11#2)(2008-8#1)(2009-12#1)(2012-3#1)
that traits that##2##3##(2008-8#1)(2012-3#1)
that tramadol##4##2##(1996-7#3)(2008-5#1)
that tranexamic acid##2##3##(1993-9#1)(2007-8#1)
that tranilast##2##2##(1995-11#1)(1996-12#1)
that trans fatty acids##2##4##(2006-7#2)
that trans-resveratrol##2##2##(1995-3#1)(2008-10#1)
that transcervical##2##2##(2007-8#1)(2012-2#1)
that transcription factors other than##2##5##(1997-2#2)
that transcription of the##4##4##(1990-11#1)(1994-8#1)(1995-10#1)(1995-8#1)
that transcription of##5##3##(1990-11#1)(1994-8#1)(1995-10#1)(1995-6#1)(1995-8#1)
that transcription was initiated##2##4##(1990-9#1)(2008-5#1)
that transcription##13##2##(1990-11#1)(1990-9#1)(1991-12#1)(1992-3#1)(1993-2#1)(1994-8#1)(1995-10#1)(1995-6#1)(1995-8#1)(1997-2#2)(2008-2#1)(2008-5#1)
that transcriptional control##2##3##(1993-8#1)(1994-12#1)
that transcriptional##13##2##(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-3#1)(1996-11#1)(1997-6#1)(2006-11#1)(2008-8#1)(2012-12#1)(2012-3#2)(2013-8#1)
that transcripts of##2##3##(1990-11#1)(2011-1#1)
that transcripts##4##2##(1990-11#1)(1991-9#1)(1994-11#1)(2011-1#1)
that transduce mechanical##2##3##(2008-9#1)(2009-8#1)
that transducin##3##2##(1990-2#1)(1992-6#1)(1995-1#1)
that transfer of##3##3##(1991-11#1)(1992-12#1)(2008-2#1)
that transfer##8##2##(1991-11#1)(1992-12#1)(1997-5#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-2#1)(2013-1#1)
that transfers##4##2##(1995-3#1)(2004-9#1)(2008-1#1)(2013-1#1)
that transform##2##2##(2007-9#1)(2010-11#1)
that transformation of##3##3##(1991-9#1)(1996-5#1)(2011-2#1)
that transformation##7##2##(1991-10#1)(1991-8#1)(1991-9#1)(1995-1#1)(1996-5#1)(2004-4#1)(2011-2#1)
that transforming growth factor-beta##2##4##(1993-12#2)
that transforming##4##2##(1993-12#2)(1997-2#1)(2008-6#1)
that transforms the##2##3##(2006-10#1)(2008-3#1)
that transforms##6##2##(1991-7#1)(2004-4#1)(2006-10#1)(2008-2#1)(2008-3#2)
that transgenic##7##2##(1996-6#1)(2006-12#1)(2008-10#3)(2008-11#1)(2008-8#1)
that transient expression##2##3##(1997-7#1)(2008-9#1)
that transient transfection##2##3##(1991-5#1)(2008-11#1)
that transient##10##2##(1991-3#1)(1991-5#1)(1997-7#1)(2006-10#2)(2007-12#1)(2007-8#2)(2008-11#1)(2008-9#1)
that transiently##2##2##(2006-12#1)(2008-11#1)
that translates##2##2##(2008-10#1)(2008-8#1)
that translation of##2##3##(1991-1#1)(2008-10#1)
that translation##3##2##(1990-7#1)(1991-1#1)(2008-10#1)
that translocation of##4##3##(1991-12#1)(1994-12#1)(1994-8#1)(2008-9#1)
that translocation##6##2##(1991-12#1)(1994-12#2)(1994-8#1)(2008-9#1)(2009-2#1)
that transmission of##3##3##(2007-11#1)(2008-10#2)
that transmission##9##2##(1990-6#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#1)
that transmit##5##2##(2006-7#1)(2007-12#1)(2008-10#2)(2012-2#1)
that transmits##6##2##(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2012-12#1)
that transmitted##2##2##(1990-8#1)(2010-1#1)
that transmitter##2##2##(1992-8#1)(1995-12#1)
that transoral laser surgery##2##4##(1991-4#1)(2011-1#1)
that transplantation of##5##3##(1991-5#1)(1994-3#1)(2010-12#1)(2011-2#1)(2012-2#1)
that transplantation##6##2##(1991-5#1)(1994-3#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)
that transplanted##2##2##(2012-12#1)(2012-7#1)
that transport of##4##3##(1990-3#1)(1991-2#1)(1991-4#1)(1993-2#1)
that transport##9##2##(1990-3#1)(1991-2#1)(1991-4#1)(1993-2#1)(1995-1#1)(2007-11#1)(2007-4#1)(2010-12#1)(2011-2#1)
that transposase##2##2##(1994-9#1)(1995-8#1)
that transposition##2##2##(1995-1#1)(1997-2#1)
that traumatic##3##2##(1991-9#1)(1997-5#1)(2007-7#1)
that travel##6##2##(2006-12#1)(2007-2#2)(2008-1#1)(2008-3#1)(2012-1#1)
that travellers##2##2##(2007-2#2)
that treat##7##2##(2006-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-8#1)(2011-12#1)
that treated##6##2##(1994-5#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)
that treating##4##2##(1996-2#1)(2008-8#1)(2012-12#1)(2013-8#1)
that treatment aimed at the##2##5##(2010-1#1)(2010-9#1)
that treatment of the##2##4##(1997-1#1)(2008-4#1)
that treatment of##19##3##(1990-5#1)(1992-1#1)(1992-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(1997-1#1)(1997-5#1)(2006-11#1)(2006-5#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-4#2)(2011-2#1)(2012-2#1)
that treatment was##2##3##(1992-9#1)(2008-10#1)
that treatment with VPA##2##4##(2011-2#2)
that treatment with mud compresses##2##5##(2006-10#2)
that treatment with this##2##4##(1991-11#1)(1991-7#1)
that treatment with##39##3##(1990-12#1)(1990-6#1)(1991-11#1)(1991-7#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-3#1)(1995-1#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-3#1)(2006-10#2)(2007-11#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#2)(2009-10#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#2)
that treatment##84##2##(1990-12#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-4#2)(1991-7#1)(1992-1#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#3)(1994-3#2)(1994-8#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-1#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-7#1)(2007-11#4)(2007-12#1)(2007-4#5)(2007-8#3)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#3)(2009-10#1)(2009-11#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)
that treatments for##2##3##(2012-12#1)(2012-2#1)
that treatments##7##2##(1997-5#1)(2004-10#2)(2008-3#1)(2011-10#1)(2012-12#1)(2012-2#1)
that treats##5##2##(1995-8#1)(2007-12#1)(2008-1#1)(2008-2#1)(2012-3#1)
that trehalose##3##2##(1990-10#1)(2011-1#1)(2013-1#1)
that tretinoin-loaded lipid-core nanocapsules##2##4##(2010-12#2)
that trigger##6##2##(1994-3#1)(1994-9#1)(1995-3#1)(1996-4#1)(2011-2#1)(2012-3#1)
that triggered##5##2##(1996-10#2)(2008-5#1)(2008-9#1)(2012-2#1)
that triggers##8##2##(1991-5#1)(1992-3#1)(1994-8#1)(1996-5#1)(2007-11#1)(2009-5#1)(2010-3#1)(2013-8#1)
that trophic##3##2##(1993-4#1)(2008-8#1)(2010-8#1)
that tropical##2##2##(1992-7#1)(2010-2#1)
that true##8##2##(1992-6#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)
that truly##4##2##(2006-10#1)(2006-12#2)(2008-10#1)
that truncated##2##2##(1995-8#1)(2009-12#1)
that try to##2##3##(2009-8#1)(2011-2#1)
that try##4##2##(1995-1#1)(2008-9#1)(2009-8#1)(2011-2#1)
that trypsin cleaved the##2##4##(1993-11#2)
that trypsin##4##2##(1992-3#1)(1993-11#2)(2013-8#1)
that trypsin-like protease(s)##2##3##(1994-3#2)
that tuberculosis##2##2##(2006-2#1)(2007-8#1)
that tumor##21##2##(1990-9#1)(1991-8#1)(1994-11#1)(1994-12#1)(1996-11#2)(2005-8#1)(2006-10#2)(2006-12#1)(2007-3#1)(2007-8#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
that tumors with##2##3##(2008-12#1)(2008-5#1)
that tumors##4##2##(1996-11#1)(1997-4#1)(2008-12#1)(2008-5#1)
that tumour cells##2##3##(1994-6#1)(2011-2#1)
that tumour necrosis##2##3##(1992-8#1)(2007-6#1)
that tumour##10##2##(1992-8#1)(1992-9#1)(1993-4#1)(1994-6#1)(2007-5#1)(2007-6#1)(2008-1#2)(2009-3#1)(2011-2#1)
that tumours##2##2##(1990-5#1)(2008-6#1)
that turns##2##2##(1995-12#1)(2008-2#1)
that twin##2##2##(1993-1#1)(2007-11#1)
that two classes of##2##4##(1990-5#1)(1996-10#1)
that two different##6##3##(1990-4#1)(1994-5#1)(1995-5#1)(2008-7#1)(2008-8#1)(2009-2#1)
that two distinct##3##3##(1993-6#1)(2006-8#1)(2008-7#1)
that two factors##2##3##(2005-10#1)(2011-1#1)
that two highly##2##3##(1990-11#1)(1992-4#1)
that two independent##3##3##(1994-8#1)(2006-12#1)(2010-5#1)
that two main##2##3##(1993-11#1)(1993-3#1)
that two major##2##3##(1996-7#1)(1997-2#1)
that two of the four##3##5##(1992-11#1)(1992-3#1)(1996-5#1)
that two of the##9##4##(1992-11#1)(1992-3#2)(1992-6#1)(1994-11#2)(1996-12#1)(1996-5#1)(2008-10#1)
that two of them##2##4##(2008-9#1)(2012-3#1)
that two of these##2##4##(1992-11#1)(1995-12#1)
that two of##15##3##(1990-2#1)(1992-11#2)(1992-3#2)(1992-6#1)(1994-11#2)(1995-12#1)(1995-8#1)(1996-12#1)(1996-5#1)(2008-10#1)(2008-9#1)(2012-3#1)
that two regions##2##3##(1991-2#1)(1992-9#1)
that two separate##2##3##(1994-5#1)(1996-9#1)
that two sets of##3##4##(1992-2#1)(2007-8#1)(2008-6#1)
that two types of##3##4##(1997-6#1)(2008-2#1)(2008-6#1)
that two tyrosine##2##3##(1994-6#1)(1996-5#1)
that two##127##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-7#1)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#3)(1996-10#1)(1996-12#2)(1996-5#2)(1996-7#1)(1996-9#1)(1997-2#2)(1997-5#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-8#2)(2007-12#1)(2007-8#4)(2008-10#12)(2008-2#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#5)(2009-10#2)(2009-2#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-8#1)
that two-photon##3##2##(2008-3#3)
that type 2 immunity##2##4##(2008-2#2)
that type 2##3##3##(2006-2#1)(2008-2#2)
that type I##3##3##(1990-12#1)(1995-7#1)(1996-5#1)
that type II##4##3##(1991-7#1)(1991-8#1)(1994-11#1)(1994-2#1)
that type IV##2##3##(2008-8#2)
that type##19##2##(1990-12#1)(1991-4#2)(1991-7#1)(1991-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-7#1)(1996-4#1)(1996-5#1)(2006-2#1)(2006-5#1)(2007-12#1)(2008-2#2)(2008-8#2)(2012-12#1)
that typical##2##2##(1995-12#1)(2007-2#1)
that typically develops##2##3##(1991-12#1)(2008-4#1)
that typically##14##2##(1991-12#1)(2004-3#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-12#1)
that typify##2##2##(1992-3#1)(2008-6#1)
that tyrosine phosphorylation is##2##4##(1990-3#1)(1994-2#1)
that tyrosine phosphorylation of##5##4##(1993-8#1)(1994-3#1)(1996-2#1)(1996-5#1)(1997-7#1)
that tyrosine phosphorylation##9##3##(1990-3#1)(1993-8#1)(1994-2#1)(1994-3#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-7#2)
that tyrosine sulfation##2##3##(1990-3#2)
that tyrosine##17##2##(1990-3#3)(1991-4#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-7#2)
that u-PA##2##2##(1990-11#1)(1991-1#1)
that ultimately lead to##3##4##(2007-9#1)(2008-11#1)(2011-2#1)
that ultimately leads to##4##4##(1995-3#1)(2008-10#1)(2008-11#1)(2012-12#1)
that ultimately##21##2##(1991-6#1)(1993-12#1)(1995-3#1)(1996-5#1)(1997-6#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
that ultra-fine##2##2##(2008-10#2)
that ultrasound##8##2##(1990-3#1)(1991-6#1)(1992-12#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2011-2#1)
that under certain circumstances##2##4##(1995-8#1)(2007-8#1)
that under certain conditions##4##4##(1992-3#1)(1994-2#1)(1997-7#1)(2007-11#1)
that under certain##6##3##(1992-3#1)(1994-2#1)(1995-8#1)(1997-7#1)(2007-11#1)(2007-8#1)
that under conditions of##5##4##(1995-12#1)(2006-6#1)(2011-2#1)(2012-1#1)(2013-1#1)
that under some conditions##2##4##(1992-3#1)(1996-10#1)
that under some##3##3##(1992-3#1)(1996-10#1)(2012-1#1)
that under the conditions of##2##5##(1990-6#1)(1990-7#1)
that under the same##2##4##(2010-12#1)(2013-8#1)
that under the##9##3##(1990-6#1)(1990-7#1)(1995-6#1)(2008-1#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-8#2)
that under this condition##2##4##(1996-9#1)(1997-4#1)
that under##55##2##(1990-12#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-12#2)(1992-3#2)(1992-9#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-5#1)(1996-9#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-1#3)(2013-1#1)(2013-8#3)
that undergirds##2##2##(1997-2#1)(2008-12#1)
that undergo##8##2##(1990-7#1)(1994-8#1)(1997-2#1)(2006-10#1)(2008-8#1)(2009-5#1)(2010-4#2)
that undergoes##13##2##(1991-9#1)(1994-3#1)(1995-10#1)(1996-2#1)(1996-4#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-7#2)(2010-5#1)(2013-8#1)
that undergoing##2##2##(2007-12#1)(2008-11#1)
that underlie the##11##3##(1997-3#1)(2005-11#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-11#1)
that underlie these##2##3##(2008-11#1)(2009-3#1)
that underlie this##4##3##(1994-3#1)(2008-11#1)(2012-12#2)
that underlie##37##2##(1994-3#1)(1995-11#1)(1997-3#1)(2005-10#1)(2005-11#1)(2006-10#2)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-8#1)(2010-2#1)(2010-4#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#4)(2013-1#1)
that underlies the##3##3##(1996-5#1)(2008-10#1)(2010-6#1)
that underlies##11##2##(1992-11#1)(1996-5#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-11#1)(2010-6#1)(2010-8#1)(2010-9#1)(2012-3#2)
that underlying##2##2##(2009-8#1)(2010-7#1)
that underpin##3##2##(2008-11#1)(2008-9#2)
that understanding##4##2##(1994-11#1)(2006-7#1)(2008-11#1)(2011-1#1)
that underwent##18##2##(1990-6#1)(1996-5#1)(1996-7#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-11#1)(2008-5#2)(2008-9#1)(2009-2#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
that undifferentiated##2##2##(1992-12#1)(1992-3#1)
that unemployment##2##2##(1991-11#1)(2007-12#1)
that unfolding##2##2##(1990-7#1)(1997-6#1)
that uniform##3##2##(2008-1#1)(2008-9#1)(2010-2#1)
that unilateral##4##2##(1993-12#1)(2012-1#1)(2012-2#1)(2013-8#1)
that unique##3##2##(2007-12#1)(2008-10#1)(2008-4#1)
that uniquely##3##2##(1997-4#1)(2007-12#1)(2008-7#1)
that universal##2##2##(1995-2#1)(2010-4#1)
that unknown##2##2##(1995-2#1)(2012-1#1)
that unless##2##2##(2007-7#1)(2011-1#1)
that unlike other##2##3##(1992-10#1)(1997-2#1)
that unlike##5##2##(1990-5#1)(1991-1#1)(1992-10#1)(1995-11#1)(1997-2#1)
that unrelated##2##2##(2007-8#1)(2008-7#1)
that until##4##2##(1992-11#1)(1995-5#1)(2007-11#1)(2008-8#1)
that untreated##2##2##(2006-9#1)(2010-5#1)
that up to 20% of##2##5##(2007-11#1)(2008-6#1)
that up to##10##3##(1997-1#1)(2007-11#2)(2007-7#1)(2008-11#1)(2008-6#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
that up##12##2##(1997-1#1)(2007-11#3)(2007-7#2)(2008-11#1)(2008-6#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
that up-regulation and##2##3##(2008-3#1)(2008-4#1)
that up-regulation of##2##3##(1996-12#1)(2008-4#1)
that up-regulation##4##2##(1996-12#1)(2008-3#1)(2008-4#2)
that upon##9##2##(1993-3#2)(1993-4#1)(1995-3#1)(1995-6#1)(1997-2#1)(2005-7#1)(2009-4#1)(2010-4#1)
that upregulation of##2##3##(1995-12#1)(2008-4#1)
that upregulation##3##2##(1995-12#1)(2008-4#2)
that urgent##3##2##(1994-10#1)(2008-3#1)(2008-8#1)
that urinary##7##2##(1991-12#1)(1992-3#1)(1993-9#1)(2008-10#2)(2008-7#1)(2013-1#1)
that urine##5##2##(1990-12#1)(1990-2#1)(1995-3#1)(2006-7#1)(2011-2#1)
that use a single##2##4##(2008-3#2)
that use a##10##3##(2007-8#1)(2008-1#1)(2008-2#2)(2008-3#4)(2010-1#1)(2011-12#1)
that use an##2##3##(1992-6#1)(2007-11#1)
that use of a##4##4##(2008-10#2)(2008-5#1)(2012-2#1)
that use of this##4##4##(1994-2#1)(2006-3#1)(2008-10#1)(2010-7#1)
that use of##20##3##(1993-12#1)(1994-2#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-3#1)(2007-6#1)(2008-10#6)(2008-12#1)(2008-5#1)(2010-10#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)
that use optical##2##3##(2007-12#1)(2008-3#1)
that use the##13##3##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-8#1)(2009-12#1)(2010-12#1)(2012-3#1)
that use various##2##3##(2008-3#1)(2008-7#1)
that use##115##2##(1990-7#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-5#1)(1995-2#2)(1996-11#1)(1996-4#1)(2005-6#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-4#1)(2007-10#1)(2007-11#4)(2007-12#7)(2007-3#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#15)(2008-3#23)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-7#1)(2010-9#2)(2011-12#1)(2011-2#1)(2012-2#5)(2012-3#1)(2013-1#5)
that used a##6##3##(2008-2#1)(2008-3#2)(2013-1#3)
that used an##2##3##(2007-10#1)(2009-9#1)
that used by the##2##4##(2008-10#1)(2008-2#1)
that used by##3##3##(1993-6#1)(2008-10#1)(2008-2#1)
that used in the##2##4##(2008-2#1)(2008-3#1)
that used in##7##3##(1990-9#1)(1994-6#1)(2005-8#1)(2007-11#1)(2008-2#1)(2008-3#1)(2010-10#1)
that used only##4##3##(2006-8#1)(2008-10#1)(2008-4#1)(2009-10#1)
that used the##3##3##(2005-10#1)(2009-2#1)(2012-2#1)
that used##59##2##(1990-7#1)(1990-9#1)(1992-5#2)(1993-6#1)(1994-6#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-5#1)(2004-10#1)(2004-9#1)(2005-10#1)(2005-8#1)(2006-8#2)(2007-10#2)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-10#7)(2008-2#3)(2008-3#5)(2008-4#2)(2009-10#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#10)
that useful##3##2##(1990-12#1)(2013-1#2)
that users of##2##3##(2007-12#1)(2011-2#1)
that users##3##2##(2007-12#1)(2008-9#1)(2011-2#1)
that uses a novel##2##4##(2007-11#1)(2007-12#1)
that uses a simple##3##4##(2006-12#1)(2007-12#2)
that uses a single##6##4##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)
that uses a strong##2##4##(2008-2#1)(2008-3#1)
that uses a##81##3##(1993-1#1)(1993-11#1)(2006-12#1)(2007-11#8)(2007-12#14)(2007-4#1)(2008-1#1)(2008-2#11)(2008-3#30)(2008-4#1)(2008-6#2)(2008-7#3)(2009-12#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
that uses an inclined##2##4##(2008-3#2)
that uses an##15##3##(1995-1#1)(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#6)(2012-3#1)(2013-1#1)
that uses fully phase encryption##2##5##(2008-3#2)
that uses human##2##3##(1994-12#1)(2013-1#1)
that uses local##2##3##(2007-12#1)(2012-3#1)
that uses only##3##3##(2007-11#1)(2008-3#1)(2008-8#1)
that uses phase##2##3##(2007-11#1)(2008-2#1)
that uses pulsed##2##3##(1997-7#1)(2007-11#1)
that uses second-harmonic generation##2##4##(2007-12#2)
that uses the##30##3##(2007-12#4)(2008-1#3)(2008-10#1)(2008-2#9)(2008-3#8)(2008-4#1)(2008-6#1)(2009-5#1)(2011-12#1)(2012-1#1)
that uses two##7##3##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#2)
that uses##281##2##(1991-5#1)(1992-6#1)(1993-1#1)(1993-11#1)(1994-12#1)(1995-1#1)(1995-12#1)(1997-2#1)(1997-7#1)(2006-12#1)(2007-11#22)(2007-12#37)(2007-3#1)(2007-4#1)(2007-5#1)(2008-1#10)(2008-10#6)(2008-12#1)(2008-2#49)(2008-3#87)(2008-4#7)(2008-5#3)(2008-6#3)(2008-7#7)(2008-8#2)(2008-9#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-5#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#5)(2013-1#6)(2013-7#1)
that using a##5##3##(1995-1#1)(2008-10#1)(2008-11#2)(2013-1#1)
that using an##2##3##(2005-7#1)(2008-10#1)
that using the##6##3##(2006-3#1)(2008-3#1)(2008-8#1)(2010-5#1)(2012-1#1)(2012-3#1)
that using##44##2##(1990-10#1)(1991-5#1)(1993-2#1)(1994-10#1)(1994-2#1)(1994-6#1)(1995-1#1)(1996-6#1)(1996-8#1)(1997-1#1)(2005-7#1)(2006-3#1)(2006-8#1)(2007-4#2)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#4)(2008-7#2)(2008-8#1)(2009-11#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
that usually appears##2##3##(2008-3#1)(2013-1#1)
that usually occurs in##4##4##(2008-11#1)(2013-1#3)
that usually##25##2##(1995-3#1)(1997-3#1)(2005-10#1)(2006-10#1)(2007-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#4)
that utilitarian##2##2##(2006-4#1)(2008-11#1)
that utilization##2##2##(1993-3#1)(1996-3#1)
that utilize both##2##3##(2008-4#1)(2008-9#1)
that utilize the##5##3##(1997-4#1)(2007-12#1)(2008-2#1)(2009-12#1)(2010-5#1)
that utilize##25##2##(1990-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(2004-9#1)(2006-7#1)(2006-9#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-5#1)(2012-12#1)(2013-1#2)
that utilized##4##2##(1996-7#1)(2008-10#2)(2012-2#1)
that utilizes a##4##3##(2004-1#1)(2008-1#1)(2008-2#2)
that utilizes an##2##3##(1992-1#1)(2008-3#1)
that utilizes the##9##3##(1994-5#1)(2007-1#1)(2007-11#2)(2007-12#1)(2008-3#2)(2011-1#1)(2012-2#1)
that utilizes##33##2##(1992-1#1)(1994-5#1)(1995-10#1)(1996-3#1)(1997-2#1)(2004-1#1)(2005-12#1)(2006-10#2)(2007-1#1)(2007-11#2)(2007-12#2)(2008-1#3)(2008-2#5)(2008-3#4)(2008-4#1)(2008-9#1)(2009-2#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-2#1)
that vaccination of##3##3##(1992-8#1)(2007-2#1)(2008-5#1)
that vaccination with##4##3##(1991-5#1)(2006-7#1)(2007-11#1)(2013-1#1)
that vaccination##12##2##(1991-5#1)(1992-8#1)(1996-3#1)(2005-7#1)(2006-7#1)(2007-11#1)(2007-2#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
that vaccine-induced##2##2##(1995-9#1)(2013-1#1)
that vaccines##2##2##(2008-5#1)(2011-2#1)
that vagus nerve stimulation##2##4##(1996-1#1)(2008-1#1)
that value##6##2##(1995-5#1)(1997-2#1)(2008-10#3)(2008-12#1)
that values of##3##3##(1990-10#1)(2006-6#1)(2008-3#1)
that values##7##2##(1990-10#1)(1991-8#1)(2006-6#1)(2007-4#1)(2007-7#1)(2008-3#1)(2012-2#1)
that van##2##2##(2006-7#1)(2008-10#1)
that variability in the##2##4##(2006-10#1)(2008-10#1)
that variability in##4##3##(1995-11#1)(2006-10#1)(2008-10#1)(2008-7#1)
that variability##5##2##(1995-11#1)(2006-10#1)(2008-10#1)(2008-6#1)(2008-7#1)
that variable##2##2##(1990-11#1)(2008-8#1)
that variation in the##2##4##(2010-11#1)(2010-8#1)
that variation in##9##3##(2007-5#1)(2008-1#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)
that variation##11##2##(1990-7#1)(2007-5#1)(2008-1#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)
that variations in the##3##4##(1997-1#1)(2006-10#1)(2008-10#1)
that variations in##10##3##(1991-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1997-1#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-5#1)
that variations##13##2##(1991-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1997-1#1)(2005-10#1)(2006-10#2)(2007-12#1)(2008-10#1)(2008-3#1)(2009-5#1)(2010-12#1)
that varied between##2##3##(1997-2#1)(2008-2#1)
that varied considerably in##2##4##(1994-2#1)(2007-10#1)
that varied from##5##3##(1994-11#2)(1995-3#1)(1995-8#1)(2008-11#1)
that varied in##6##3##(1997-1#1)(2007-12#1)(2007-6#1)(2008-10#1)(2009-5#1)(2012-12#1)
that varied with##2##3##(2013-1#2)
that varied##22##2##(1994-11#2)(1994-2#1)(1995-1#1)(1995-3#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-5#1)(2012-12#1)(2013-1#4)
that varies from##2##3##(2007-12#1)(2012-12#1)
that varies with##3##3##(2007-2#1)(2010-2#1)(2011-2#1)
that varies##12##2##(1997-2#1)(2007-12#2)(2007-2#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-2#1)(2011-2#1)(2012-12#1)
that various##24##2##(1991-2#2)(1994-11#1)(1994-3#1)(1994-6#1)(1996-12#1)(1997-2#1)(1997-3#1)(2005-12#1)(2006-12#1)(2006-8#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
that vary according to##2##4##(1995-1#1)(2010-6#1)
that vary by##3##3##(1996-1#1)(2007-11#1)(2011-2#1)
that vary in their##2##4##(1993-9#1)(2008-8#1)
that vary in##7##3##(1991-8#1)(1992-7#1)(1993-9#1)(2008-12#1)(2008-5#1)(2008-8#1)(2013-1#1)
that vary over##2##3##(1993-5#1)(2007-12#1)
that vary with respect to##2##5##(1994-12#1)(2007-9#1)
that vary with the##2##4##(2008-11#1)(2008-2#1)
that vary with##4##3##(1994-12#1)(2007-9#1)(2008-11#1)(2008-2#1)
that vary##28##2##(1991-8#1)(1992-7#1)(1993-5#1)(1993-9#1)(1994-12#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
that varying the##4##3##(2008-10#1)(2008-3#1)(2010-1#1)(2012-1#1)
that varying##5##2##(2008-10#2)(2008-3#1)(2010-1#1)(2012-1#1)
that vascular##7##2##(1990-12#1)(1991-2#1)(1993-10#1)(1994-12#1)(1994-9#2)(2009-1#1)
that vasectomy##2##2##(1990-9#2)
that vasoactive intestinal polypeptide##2##4##(1990-4#1)(1997-8#1)
that vasoactive##3##2##(1990-4#1)(1994-9#1)(1997-8#1)
that vasopressin##2##2##(1993-11#1)(1996-2#1)
that vehicle##2##2##(2012-12#1)(2012-2#1)
that venous##2##2##(2010-6#1)(2012-3#1)
that ventral striatal##2##3##(2011-1#2)
that ventral##3##2##(2006-8#1)(2011-1#2)
that venular resistance##2##3##(2008-3#2)
that verbal##4##2##(1995-12#1)(2008-2#1)(2008-9#1)(2012-2#1)
that vertebral##3##2##(2007-8#1)(2011-2#2)
that vertebrate##2##2##(2011-2#1)(2012-3#1)
that vertical transmission##3##3##(2008-8#1)(2008-9#1)(2011-3#1)
that vertical##5##2##(1991-1#1)(2008-8#1)(2008-9#1)(2011-3#2)
that very few##2##3##(1996-11#1)(2010-12#1)
that very little##3##3##(1992-12#1)(2008-7#1)(2010-8#1)
that very low##2##3##(1991-12#1)(2008-10#1)
that very##16##2##(1990-9#1)(1991-12#1)(1992-12#1)(1994-12#1)(1996-11#1)(1997-8#1)(2007-11#2)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-11#1)
that vestibulo-ocular reflex##2##3##(2008-4#2)
that viability##2##2##(2008-11#1)(2009-7#1)
that victims##3##2##(2008-2#1)(2009-7#1)(2012-12#1)
that victims' reciprocal##2##3##(2009-7#2)
that vinyl carbamate##2##3##(1994-2#2)
that vinyl##3##2##(1993-9#1)(1994-2#2)
that viral infections##2##3##(1992-11#1)(2011-1#1)
that viral##4##2##(1992-11#1)(2008-10#1)(2011-1#1)(2013-8#1)
that virions##2##2##(2008-10#2)
that virtually all##4##3##(1991-12#1)(1994-2#1)(1997-2#1)(2008-10#1)
that virulence##3##2##(2008-10#3)
that virus replication##3##3##(1997-3#1)(2008-10#2)
that virus##11##2##(1997-3#2)(2007-8#1)(2008-10#5)(2008-8#1)(2008-9#1)(2011-2#1)
that visceral##3##2##(1992-2#1)(2008-4#1)(2013-8#1)
that visual information##2##3##(2008-1#1)(2011-1#1)
that visual##11##2##(1990-10#2)(1993-2#1)(1994-8#1)(1995-11#2)(1996-2#1)(2008-1#1)(2008-4#1)(2011-1#1)(2011-12#1)
that vitamin A##3##3##(1994-12#1)(1995-9#1)(2012-1#1)
that vitamin B(6)##2##3##(2004-11#1)(2008-8#1)
that vitamin B12 deficiency##3##4##(1991-2#1)(1993-12#1)(1995-11#1)
that vitamin B12##5##3##(1991-2#1)(1993-12#1)(1995-11#2)(2008-8#1)
that vitamin C##3##3##(1994-2#1)(2008-5#1)(2010-12#1)
that vitamin D##4##3##(2005-1#1)(2010-6#1)(2012-3#1)(2013-7#1)
that vitamin E##3##3##(1993-6#1)(1996-3#1)(2013-1#1)
that vitamin K##2##3##(1990-6#1)(1992-12#1)
that vitamin##27##2##(1990-6#1)(1991-2#1)(1992-12#2)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#2)(1995-9#1)(1996-3#1)(2004-11#1)(2005-1#1)(2008-11#2)(2008-5#1)(2008-8#3)(2010-12#1)(2010-6#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
that volatile##3##2##(1994-2#1)(2008-11#2)
that volume##3##2##(1992-1#1)(1996-9#1)(2007-12#1)
that volunteers##2##2##(1994-3#2)
that wall##2##2##(2006-10#1)(2006-7#1)
that warfarin and##2##3##(1994-5#1)(2007-10#1)
that warfarin##4##2##(1994-5#2)(2006-8#1)(2007-10#1)
that warming##2##2##(2013-8#2)
that warrant##4##2##(1996-2#1)(2006-11#1)(2008-11#1)(2011-2#1)
that warrants##4##2##(2006-10#1)(2008-5#1)(2011-2#1)(2012-3#1)
that was accompanied by a##3##5##(1991-2#1)(1991-7#1)(2006-11#1)
that was accompanied by##4##4##(1991-2#1)(1991-7#1)(2006-11#1)(2011-2#1)
that was accompanied##5##3##(1991-2#1)(1991-7#1)(2006-11#1)(2011-2#1)(2012-1#1)
that was achieved by##2##4##(1990-12#1)(2008-3#1)
that was also##4##3##(1995-12#1)(1995-2#1)(2008-5#1)(2009-2#1)
that was amplified by##2##4##(2007-12#1)(2008-10#1)
that was associated with##3##4##(1994-3#1)(2007-8#1)(2008-8#1)
that was attributed to##2##4##(1990-5#1)(2008-3#1)
that was better than that##2##5##(2008-10#1)(2008-3#1)
that was blocked by##2##4##(1995-12#1)(2010-4#1)
that was caused by##2##4##(2008-5#1)(2008-9#1)
that was clearly different from##2##5##(1992-2#1)(2008-10#1)
that was cloned##2##3##(1993-12#1)(2008-5#1)
that was comparable##2##3##(1993-7#1)(2008-10#1)
that was complicated##2##3##(2012-12#1)(2013-1#1)
that was conducted##4##3##(1996-2#1)(2005-10#1)(2008-2#1)(2010-3#1)
that was confirmed by##5##4##(1995-8#1)(2005-11#1)(2007-3#1)(2007-8#1)(2011-1#1)
that was confirmed##7##3##(1990-11#1)(1995-8#1)(2005-11#1)(2007-3#1)(2007-8#1)(2011-1#1)(2012-2#1)
that was consistent with##2##4##(2006-10#1)(2008-10#1)
that was consistently##2##3##(2008-10#1)(2008-9#1)
that was continuously##2##3##(2007-12#1)(2008-10#1)
that was created in##2##4##(1996-1#1)(2007-11#1)
that was decreased##2##3##(1997-7#1)(2013-1#1)
that was dependent on the presence of##2##7##(2008-4#1)(2012-12#1)
that was dependent on##3##4##(2008-4#1)(2008-5#1)(2012-12#1)
that was derived##2##3##(2006-10#1)(2008-10#1)
that was designed and##2##4##(2008-2#1)(2009-12#1)
that was designed to##4##4##(2008-1#1)(2008-2#1)(2008-3#1)(2012-1#1)
that was designed##8##3##(2007-2#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-12#1)(2012-1#1)
that was detectable##2##3##(1994-3#1)(2006-8#1)
that was detected##3##3##(1995-1#1)(2008-10#1)(2010-12#1)
that was determined##2##3##(2007-2#1)(2008-2#1)
that was developed and##2##4##(2008-10#2)
that was developed at##2##4##(2007-5#1)(2008-1#1)
that was developed by##2##4##(1995-2#1)(2008-10#1)
that was developed for##6##4##(2008-10#1)(2008-2#2)(2008-3#2)(2009-3#1)
that was developed to##3##4##(1994-3#1)(2007-4#1)(2012-11#1)
that was developed##18##3##(1992-2#1)(1994-3#1)(1995-2#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#3)(2009-3#1)(2011-2#1)(2012-11#1)
that was diagnosed##6##3##(2005-9#1)(2006-8#1)(2007-7#1)(2007-8#1)(2011-3#1)(2012-3#1)
that was directly##2##3##(1996-3#1)(2008-10#1)
that was distinct from##2##4##(2007-12#1)(2008-10#1)
that was due to the##2##5##(2007-12#2)
that was due to##7##4##(1995-5#1)(2007-12#3)(2008-3#3)
that was either##4##3##(1993-12#1)(1997-1#1)(2008-10#1)(2008-11#1)
that was enhanced##3##3##(1992-8#1)(1995-3#1)(2008-4#1)
that was enriched##2##3##(1993-6#1)(2007-8#1)
that was established##2##3##(2008-10#1)(2008-5#1)
that was eventually##2##3##(2008-10#1)(2013-8#1)
that was excited by##2##4##(2008-3#2)
that was first##5##3##(1995-6#1)(2006-8#1)(2008-10#1)(2008-4#1)(2011-2#1)
that was followed by##5##4##(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-8#1)
that was found in##3##4##(2008-5#1)(2013-1#2)
that was found to be##2##5##(2005-5#1)(2007-12#1)
that was found to##3##4##(2005-5#1)(2007-12#1)(2008-3#1)
that was found##8##3##(2005-5#2)(2007-1#1)(2007-12#1)(2008-3#1)(2008-5#1)(2013-1#2)
that was greater##2##3##(1996-10#1)(2008-2#1)
that was heated##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
that was held##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
that was highly homologous to##2##5##(1990-4#1)(1991-5#1)
that was highly##4##3##(1990-4#1)(1991-5#1)(1994-6#1)(1996-9#1)
that was identified##4##3##(1991-11#1)(2007-7#1)(2012-2#2)
that was implemented##2##3##(1992-3#1)(2011-2#1)
that was in##3##3##(2008-10#2)(2011-1#1)
that was increased##4##3##(1993-6#1)(2008-10#1)(2008-5#1)(2009-3#1)
that was independent of the##2##5##(1992-2#1)(1995-6#1)
that was independent of##4##4##(1992-2#1)(1992-6#1)(1993-3#1)(1995-6#1)
that was induced by##3##4##(2007-11#1)(2008-10#2)
that was inhibited by##4##4##(1995-2#1)(1996-6#2)(1996-9#1)
that was introduced##2##3##(2006-12#1)(2011-1#1)
that was isolated from##2##4##(2011-2#2)
that was isolated##3##3##(1996-7#1)(2011-2#2)
that was largely##2##3##(1991-12#1)(1997-3#1)
that was located near##2##4##(2012-3#2)
that was made##2##3##(1990-10#1)(2008-4#1)
that was maintained for##2##4##(2004-11#1)(2009-12#1)
that was maintained##7##3##(2004-11#1)(2006-7#1)(2008-1#1)(2008-3#1)(2009-12#1)(2010-2#1)(2011-2#1)
that was managed##2##3##(2010-11#1)(2012-12#1)
that was markedly##2##3##(1992-4#1)(1994-12#1)
that was measured##2##3##(2007-11#1)(2008-7#1)
that was missed##2##3##(1991-11#1)(2012-12#1)
that was more##3##3##(1990-5#1)(2008-11#1)(2008-12#1)
that was no longer##2##4##(1995-2#1)(2008-11#1)
that was not associated with##2##5##(2007-10#1)(2008-7#1)
that was not observed in##3##5##(1991-12#1)(2008-10#1)(2008-11#1)
that was not the##2##4##(1993-6#1)(2008-5#1)
that was not used##2##4##(1992-11#1)(1996-12#1)
that was not##36##3##(1990-12#1)(1991-12#1)(1992-11#1)(1993-6#1)(1995-10#1)(1995-7#1)(1996-12#1)(1996-8#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-3#1)(2009-6#2)(2010-11#1)(2010-12#1)(2011-1#1)(2011-12#1)(2013-1#3)
that was observed in##2##4##(2008-10#1)(2008-2#1)
that was observed##8##3##(1990-9#1)(1992-1#1)(1993-8#1)(1995-1#1)(2004-4#1)(2008-10#1)(2008-2#1)(2012-2#1)
that was obtained##4##3##(1992-2#1)(2007-12#1)(2008-1#1)(2008-3#1)
that was only##2##3##(1994-3#1)(2008-2#1)
that was originally##5##3##(1992-9#1)(2006-10#1)(2008-10#1)(2008-4#1)(2009-3#1)
that was part of##3##4##(2008-7#1)(2010-10#1)(2010-8#1)
that was perpendicular to##2##4##(2007-11#1)(2008-3#1)
that was predicted##3##3##(1990-12#1)(1992-2#1)(2008-2#1)
that was prepared##2##3##(1994-3#1)(2008-10#1)
that was present in##4##4##(1994-2#1)(1996-8#1)(1997-4#1)(2008-10#1)
that was present##5##3##(1994-2#1)(1996-8#1)(1997-4#1)(2008-10#1)(2010-6#1)
that was presented##2##3##(2007-9#1)(2012-3#1)
that was prevented by##4##4##(1993-5#1)(1994-3#1)(2005-8#1)(2008-11#1)
that was previously shown to##3##5##(1991-4#1)(1993-9#1)(1997-4#1)
that was previously##10##3##(1991-4#1)(1993-9#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)
that was published##2##3##(2005-10#1)(2006-12#1)
that was recently##4##3##(2006-10#1)(2007-11#1)(2012-12#1)(2013-1#1)
that was recognized by##2##4##(1994-12#1)(1994-8#1)
that was reduced in the##2##5##(2010-5#2)
that was reduced in##4##4##(1990-5#1)(2010-5#2)(2012-2#1)
that was refractory to##4##4##(2006-10#2)(2012-12#1)(2012-3#1)
that was related to##3##4##(2006-10#1)(2007-12#1)(2008-10#1)
that was reported##3##3##(2007-10#1)(2008-10#1)(2008-11#1)
that was required##2##3##(1997-8#1)(2008-10#1)
that was resistant to##2##4##(1993-12#1)(1996-7#1)
that was seen##2##3##(1996-2#1)(1997-2#1)
that was segregating##2##3##(2008-10#2)
that was shown to be##2##5##(1994-9#1)(2007-11#1)
that was shown to##3##4##(1994-9#1)(2007-11#1)(2011-1#1)
that was significantly##6##3##(1990-7#1)(1992-3#1)(2006-9#1)(2008-4#1)(2009-11#1)(2012-12#1)
that was similar to##3##4##(1990-11#1)(1991-9#1)(2008-7#1)
that was similar##5##3##(1990-11#1)(1991-9#1)(1996-3#1)(2008-1#1)(2008-7#1)
that was spreading##2##3##(2009-10#1)(2009-6#1)
that was statistically##2##3##(2008-10#1)(2010-3#1)
that was stimulated##2##3##(1995-6#1)(1997-3#1)
that was strongly##2##3##(2008-10#1)(2009-2#1)
that was subsequently##3##3##(2007-12#1)(2009-8#1)(2010-6#1)
that was successfully treated with##2##5##(2012-1#1)(2012-12#1)
that was successfully treated##4##4##(2007-11#1)(2010-12#1)(2012-1#1)(2012-12#1)
that was successfully##7##3##(2006-12#1)(2007-11#1)(2008-11#1)(2010-12#2)(2012-1#1)(2012-12#1)
that was suggested##2##3##(2007-9#1)(2008-2#1)
that was supported by##2##4##(2008-3#1)(2009-4#1)
that was supported##3##3##(2008-1#1)(2008-3#1)(2009-4#1)
that was sustained##2##3##(1992-8#1)(2009-9#1)
that was the##4##3##(2008-10#1)(2008-8#1)(2013-1#2)
that was then##2##3##(2008-10#1)(2008-2#1)
that was thought to be##2##5##(2007-8#1)(2013-1#1)
that was treated with##5##4##(2007-8#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-2#1)
that was treated##6##3##(2007-8#1)(2008-5#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-2#1)
that was used as##2##4##(2007-8#1)(2008-5#1)
that was used for##3##4##(2007-12#2)(2011-2#1)
that was used to##5##4##(1997-2#1)(2007-7#1)(2008-10#1)(2008-2#1)(2009-12#1)
that was used##17##3##(1990-5#1)(1997-2#1)(2005-8#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#2)(2009-12#2)(2011-2#1)
that was within##2##3##(1996-5#1)(2008-3#1)
that was##650##2##(1990-10#1)(1990-11#3)(1990-12#3)(1990-3#1)(1990-4#1)(1990-5#5)(1990-6#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#3)(1991-4#1)(1991-5#3)(1991-7#1)(1991-9#1)(1992-1#2)(1992-10#3)(1992-11#1)(1992-2#5)(1992-3#3)(1992-4#1)(1992-6#5)(1992-8#4)(1992-9#1)(1993-12#5)(1993-3#2)(1993-5#2)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#13)(1994-5#2)(1994-6#3)(1994-8#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#4)(1995-2#5)(1995-3#3)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#2)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-5#4)(1996-6#2)(1996-7#3)(1996-8#4)(1996-9#3)(1997-1#1)(1997-2#6)(1997-3#6)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#4)(1997-8#3)(2004-11#1)(2004-4#1)(2005-10#3)(2005-11#2)(2005-12#1)(2005-5#2)(2005-6#1)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#10)(2006-11#3)(2006-12#4)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#5)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#12)(2007-12#28)(2007-2#6)(2007-3#1)(2007-4#3)(2007-5#3)(2007-6#1)(2007-7#5)(2007-8#13)(2007-9#4)(2008-1#8)(2008-10#68)(2008-11#16)(2008-12#6)(2008-2#24)(2008-3#34)(2008-4#7)(2008-5#18)(2008-6#3)(2008-7#8)(2008-8#6)(2008-9#4)(2009-10#2)(2009-11#4)(2009-12#4)(2009-2#2)(2009-3#7)(2009-4#2)(2009-5#1)(2009-6#3)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#4)(2010-2#5)(2010-3#4)(2010-4#4)(2010-5#5)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#6)(2011-12#1)(2011-2#21)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#14)(2012-2#10)(2012-3#8)(2012-7#1)(2013-1#18)(2013-8#3)
that wasn't##2##2##(1993-12#1)(1996-2#1)
that wastewater##2##2##(2010-5#2)
that water immersion##3##3##(2008-3#1)(2008-5#2)
that water##15##2##(1994-8#1)(1996-4#1)(2005-11#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#3)(2009-2#1)(2010-9#1)(2011-2#1)(2013-7#1)
that wave##2##2##(2008-3#1)(2009-8#1)
that way##6##2##(2008-1#1)(2008-10#1)(2008-11#1)(2010-4#1)(2010-8#1)(2012-2#1)
that we and##2##3##(2008-1#1)(2009-3#1)
that we are able to##2##5##(2010-12#1)(2010-2#1)
that we are only##2##4##(2007-8#1)(2013-8#1)
that we are##19##3##(1994-12#1)(1996-2#1)(1997-6#1)(2005-11#1)(2005-7#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-12#1)(2012-3#1)(2013-8#1)
that we begin to##2##4##(2008-11#1)(2010-11#1)
that we believe are##2##4##(2007-4#1)(2012-2#1)
that we believe##6##3##(2006-7#1)(2007-4#1)(2008-10#1)(2008-7#2)(2012-2#1)
that we call the##2##4##(2008-3#1)(2013-7#1)
that we call##7##3##(1990-3#1)(1990-5#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2013-7#1)
that we called##3##3##(1992-3#1)(2010-8#1)(2012-2#1)
that we can transfer##2##4##(2008-11#1)(2008-3#1)
that we can##26##3##(1992-5#1)(1993-1#1)(1995-1#1)(1996-7#1)(2006-3#1)(2006-6#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#4)(2008-3#1)(2008-8#1)(2010-11#2)(2011-2#2)(2012-12#1)(2013-7#2)(2013-8#1)
that we could##5##3##(1995-8#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)
that we currently##3##3##(2008-9#1)(2010-1#1)(2010-7#1)
that we developed to##2##4##(2007-12#1)(2008-2#1)
that we developed##6##3##(1992-8#1)(1995-5#1)(2007-12#1)(2008-2#1)(2012-1#1)(2012-12#1)
that we do not##4##4##(1997-8#1)(2005-10#1)(2007-8#1)(2008-5#1)
that we found##2##3##(1994-8#1)(2007-7#1)
that we have actually##2##4##(2006-2#1)(2008-9#1)
that we have designed##2##4##(2007-12#1)(2008-2#1)
that we have developed for##2##5##(2008-2#1)(2008-7#1)
that we have developed##4##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)
that we have identified a##2##5##(1994-12#1)(1996-5#1)
that we have identified##3##4##(1994-12#1)(1996-5#1)(2013-8#1)
that we have previously##5##4##(1995-11#1)(1995-2#1)(1997-1#1)(2008-10#1)(2012-2#1)
that we have produced##3##4##(1994-12#1)(1995-12#1)(2010-11#1)
that we have studied##2##4##(1995-9#1)(2008-7#1)
that we have##35##3##(1991-5#1)(1992-11#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-5#1)(1997-1#1)(1997-8#1)(2004-12#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-12#2)(2008-10#2)(2008-2#3)(2008-5#1)(2008-7#2)(2008-9#1)(2010-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
that we hypothesize##2##3##(2008-10#1)(2010-1#1)
that we identified##3##3##(2007-8#2)(2008-10#1)
that we introduce##2##3##(2008-2#1)(2009-12#1)
that we know##2##3##(1994-3#1)(2008-10#1)
that we may##2##3##(1994-1#1)(2013-1#1)
that we might##2##3##(1997-2#1)(2006-6#1)
that we must##3##3##(1992-5#1)(2008-2#1)(2011-2#1)
that we named##5##3##(2005-10#2)(2008-11#1)(2008-5#1)(2010-10#1)
that we need##2##3##(1997-3#1)(2013-1#1)
that we observed##3##3##(2008-3#2)(2012-2#1)
that we obtained##3##3##(2008-1#1)(2008-3#1)(2008-8#1)
that we present##2##3##(2007-12#1)(2008-2#1)
that we previously reported##2##4##(1997-1#1)(2008-11#1)
that we previously##5##3##(1995-5#1)(1997-1#1)(2008-11#1)(2008-2#1)(2008-9#1)
that we propose##4##3##(1996-3#1)(2006-5#1)(2008-3#2)
that we recently##3##3##(1994-9#1)(2008-5#1)(2011-2#1)
that we reported##2##3##(2007-11#1)(2010-7#1)
that we screened##2##3##(2008-10#1)(2009-8#1)
that we see##3##3##(1991-6#1)(2008-11#1)(2008-12#1)
that we should##3##3##(2008-8#1)(2010-2#1)(2013-1#1)
that we use to##2##4##(2007-12#1)(2009-4#1)
that we use##5##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-9#1)(2009-4#1)
that we used##3##3##(2008-3#1)(2008-8#1)(2009-11#1)
that we will##4##3##(2008-2#1)(2008-9#1)(2009-11#1)(2009-3#1)
that we would##3##3##(1991-9#1)(2007-11#1)(2008-8#1)
that we##254##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-3#2)(1992-5#2)(1992-8#2)(1993-1#2)(1993-12#2)(1993-2#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#2)(2004-12#1)(2005-10#3)(2005-11#2)(2005-7#1)(2006-10#2)(2006-2#1)(2006-3#2)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-11#5)(2007-12#12)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#4)(2008-10#9)(2008-11#7)(2008-12#7)(2008-2#15)(2008-3#14)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#9)(2008-8#9)(2008-9#7)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#2)(2010-2#2)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#5)(2013-7#3)(2013-8#4)
that weak##2##2##(1991-4#1)(2007-12#1)
that wear##2##2##(2008-8#2)
that weighs##2##2##(2008-3#1)(2013-1#1)
that weight loss##2##3##(2008-3#1)(2009-10#1)
that weight##5##2##(2008-12#1)(2008-3#1)(2009-10#1)(2010-12#1)(2010-8#1)
that well##2##2##(2008-4#1)(2009-6#1)
that went##4##2##(1992-12#1)(1997-5#1)(2007-7#1)(2009-2#1)
that were 2##2##3##(1996-11#1)(1997-7#1)
that were able to amplify##2##5##(2006-8#1)(2008-10#1)
that were able to##7##4##(1993-2#1)(1996-9#1)(2006-5#2)(2006-8#1)(2008-10#1)(2008-5#1)
that were active in##2##4##(2009-10#1)(2010-3#1)
that were also present in##2##5##(2006-12#1)(2008-10#1)
that were also##6##3##(1992-10#1)(1995-11#1)(2006-12#1)(2008-10#2)(2009-4#1)
that were an order of magnitude##2##6##(2010-8#1)(2011-2#1)
that were analyzed##4##3##(1996-8#1)(2008-9#1)(2009-11#1)(2010-8#1)
that were approximately##2##3##(1993-5#1)(2008-5#1)
that were assigned to##2##4##(2005-11#1)(2008-5#1)
that were associated with the##4##5##(1994-7#1)(1997-4#2)(2009-12#1)
that were associated with##11##4##(1994-7#1)(1997-4#2)(2006-11#1)(2008-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2012-2#2)(2013-1#1)
that were associated##13##3##(1994-7#1)(1997-4#2)(2006-11#1)(2008-10#2)(2009-12#1)(2009-2#1)(2009-5#1)(2012-2#3)(2013-1#1)
that were audio-taped##2##3##(2011-1#2)
that were based on##2##4##(2006-2#1)(2008-11#1)
that were being##2##3##(2008-12#1)(2009-6#1)
that were blocked by##2##4##(1996-5#1)(2010-4#1)
that were both##2##3##(1995-8#1)(2011-2#1)
that were characteristic of##2##4##(1992-8#1)(2008-10#1)
that were characterized by##4##4##(1993-12#1)(2006-12#1)(2011-12#1)(2011-3#1)
that were clinically##2##3##(1990-10#1)(2006-10#1)
that were collected and##2##4##(1992-1#1)(2008-5#1)
that were collected in the##4##5##(2007-8#1)(2008-10#3)
that were collected in##6##4##(2007-10#1)(2007-8#1)(2008-10#4)
that were collected##14##3##(1992-1#1)(2007-10#1)(2007-8#3)(2008-10#5)(2008-5#1)(2010-8#1)(2012-3#1)(2013-7#1)
that were common##2##3##(2008-2#1)(2008-5#1)
that were comparable to##3##4##(1990-5#1)(1993-12#1)(2013-1#1)
that were comparable##4##3##(1990-5#1)(1993-12#1)(1995-6#1)(2013-1#1)
that were compared with##2##4##(2008-10#2)
that were compared##3##3##(2008-10#2)(2010-9#1)
that were compatible##2##3##(2006-4#1)(2008-10#1)
that were composed of##4##4##(2008-10#1)(2009-4#1)(2013-1#1)(2013-8#1)
that were confirmed by##3##4##(1997-6#1)(2006-12#1)(2007-6#1)
that were connected##2##3##(2006-10#1)(2011-2#1)
that were considered##4##3##(1992-7#1)(2007-7#1)(2008-5#1)(2010-7#1)
that were consistent with the##2##5##(2008-11#2)
that were consistent with##4##4##(2007-9#1)(2008-10#1)(2008-11#2)
that were consistent##6##3##(2007-9#1)(2008-10#2)(2008-11#2)(2008-8#1)
that were consistently##2##3##(2010-8#1)(2011-12#1)
that were converted to##2##4##(2008-2#1)(2012-12#1)
that were correlated with##2##4##(2013-7#2)
that were cultured in##2##4##(2006-5#1)(2011-2#1)
that were delivered##3##3##(2006-6#1)(2008-7#2)
that were depleted of##2##4##(1996-8#1)(1996-9#1)
that were described##2##3##(2008-5#1)(2013-1#1)
that were designed to##6##4##(1994-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2012-12#1)
that were designed##8##3##(1991-9#1)(1994-1#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2012-12#1)
that were detected##5##3##(2008-10#4)(2013-1#1)
that were determined##3##3##(2007-2#1)(2010-4#1)(2011-1#1)
that were developed by##3##4##(2006-8#1)(2007-12#2)
that were developed for##3##4##(1990-8#1)(2008-3#1)(2012-3#1)
that were developed##11##3##(1990-8#1)(2006-10#1)(2006-8#1)(2007-12#2)(2008-10#2)(2008-3#1)(2009-3#1)(2010-1#1)(2012-3#1)
that were directed at the##2##5##(1994-2#1)(2008-10#1)
that were distributed##3##3##(1993-2#1)(1995-11#1)(2012-3#1)
that were drawn from##2##4##(1993-2#1)(2007-11#1)
that were due to##5##4##(2006-10#1)(2008-2#3)(2008-3#1)
that were effective##2##3##(1992-4#1)(2008-10#1)
that were either##8##3##(1991-11#1)(1994-2#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-2#1)(2009-8#1)
that were evaluated##4##3##(2006-4#1)(2007-2#1)(2008-10#2)
that were examined##5##3##(1993-3#1)(2007-2#1)(2008-10#1)(2008-3#1)(2011-1#1)
that were experimentally##2##3##(2007-11#1)(2008-4#1)
that were exposed to##6##4##(2008-10#1)(2008-7#1)(2010-11#1)(2010-4#1)(2011-12#1)(2013-1#1)
that were exposed##7##3##(2005-10#1)(2008-10#1)(2008-7#1)(2010-11#1)(2010-4#1)(2011-12#1)(2013-1#1)
that were expressed##2##3##(2008-9#1)(2012-2#1)
that were extracted##3##3##(2008-5#1)(2013-1#2)
that were fabricated##2##3##(2007-12#1)(2008-2#1)
that were fed##4##3##(2008-4#1)(2008-8#1)(2009-3#1)(2009-9#1)
that were found in##3##4##(2006-6#1)(2008-10#1)(2008-5#1)
that were found to be significantly##2##6##(2007-12#1)(2008-12#1)
that were found to be##5##5##(1993-1#1)(2004-2#1)(2007-12#1)(2008-11#1)(2008-12#1)
that were found to##6##4##(1992-3#1)(1993-1#1)(2004-2#1)(2007-12#1)(2008-11#1)(2008-12#1)
that were found##14##3##(1992-3#1)(1993-1#1)(1994-3#1)(2004-2#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)
that were free##2##3##(2008-10#1)(2008-5#1)
that were further##2##3##(2007-10#1)(2011-2#1)
that were generated by##3##4##(1990-10#1)(1994-3#1)(2007-12#1)
that were generated##4##3##(1990-10#1)(1994-3#1)(2007-12#1)(2008-2#1)
that were genetically##2##3##(1991-12#1)(1995-3#1)
that were greater than##2##4##(2008-10#2)
that were grouped##2##3##(2008-10#1)(2008-11#1)
that were higher than the##2##5##(1996-4#1)(2010-9#1)
that were higher than##3##4##(1996-4#1)(2009-3#1)(2010-9#1)
that were highly##3##3##(1993-12#1)(2008-10#2)
that were hospitalized##2##3##(2011-2#1)(2013-1#1)
that were identical##2##3##(1996-8#1)(2007-12#1)
that were identified as##5##4##(1996-12#1)(2008-10#2)(2012-3#1)(2013-8#1)
that were identified by##3##4##(1990-10#1)(1995-6#1)(1997-6#1)
that were identified##11##3##(1990-10#1)(1995-6#1)(1996-12#1)(1997-6#1)(2008-10#3)(2010-2#1)(2011-2#1)(2012-3#1)(2013-8#1)
that were immunoreactive for##2##4##(1997-2#1)(1997-8#1)
that were in good agreement with##2##6##(1991-7#1)(2007-2#1)
that were in good agreement##3##5##(1991-7#1)(2007-2#1)(2008-10#1)
that were in the##3##4##(2008-10#3)
that were in##11##3##(1991-7#1)(1996-5#1)(2007-2#1)(2008-10#4)(2008-5#1)(2009-4#1)(2012-12#1)(2013-1#1)
that were incubated##3##3##(1992-12#2)(2006-8#1)
that were independently##2##3##(2007-12#1)(2008-10#1)
that were indistinguishable from##2##4##(1992-8#1)(1994-8#1)
that were indistinguishable##5##3##(1991-6#1)(1992-8#1)(1994-8#1)(2008-11#1)(2008-5#1)
that were infected with R##2##5##(2008-10#2)
that were infected with##3##4##(2008-10#3)
that were initially##4##3##(1994-3#1)(2006-2#1)(2009-12#1)(2012-2#1)
that were inoculated with##3##4##(2007-12#1)(2008-10#2)
that were inoculated##6##3##(2007-12#1)(2008-10#5)
that were intermediate##3##3##(1992-7#1)(2008-12#1)(2008-5#1)
that were introduced##4##3##(1993-11#1)(2006-10#1)(2007-8#1)(2011-2#1)
that were isolated from##2##4##(1990-12#1)(2008-6#1)
that were isolated##6##3##(1990-12#1)(2008-10#1)(2008-12#1)(2008-6#1)(2012-12#2)
that were labeled by the##2##5##(1993-12#2)
that were labeled by##3##4##(1993-12#2)(2008-10#1)
that were labeled##4##3##(1992-12#1)(1993-12#2)(2008-10#1)
that were larger##2##3##(2011-12#1)(2012-1#1)
that were later##3##3##(1992-1#1)(2009-8#1)(2010-12#1)
that were less##2##3##(2008-10#1)(2008-5#1)
that were made##4##3##(1990-11#1)(2006-2#1)(2008-3#1)(2008-5#1)
that were maintained for##2##4##(2007-2#1)(2012-12#1)
that were maintained##4##3##(1992-11#1)(2007-2#1)(2008-10#1)(2012-12#1)
that were measured##6##3##(1990-4#1)(1997-2#1)(2007-2#1)(2007-8#1)(2008-3#1)(2012-3#1)
that were mediated by##2##4##(2007-10#1)(2008-4#1)
that were modified##2##3##(1990-9#1)(2007-12#1)
that were more##11##3##(1995-1#1)(2005-11#1)(2006-4#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-8#1)(2009-4#1)(2010-7#1)(2012-2#1)
that were most##4##3##(2007-7#1)(2010-11#1)(2012-12#1)(2013-1#1)
that were much##2##3##(1993-3#1)(2009-10#1)
that were not apparent##2##4##(2007-12#1)(2013-1#1)
that were not detected##2##4##(1994-9#1)(2009-6#1)
that were not exposed to the##2##6##(2008-12#1)(2008-7#1)
that were not in##2##4##(2005-10#1)(2008-7#1)
that were not previously##4##4##(2010-4#1)(2012-12#1)(2013-1#2)
that were not subjected to##2##5##(1993-6#1)(2004-4#1)
that were not##57##3##(1991-4#1)(1992-12#1)(1993-6#1)(1994-9#1)(1996-10#1)(1997-2#1)(1997-3#1)(1997-4#1)(2004-4#1)(2005-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-2#2)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#4)
that were observed in##3##4##(1996-4#1)(2007-12#1)(2011-1#1)
that were observed##7##3##(1996-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#1)
that were obtained from a##2##5##(2008-1#1)(2009-3#1)
that were obtained from##3##4##(2008-1#1)(2008-2#1)(2009-3#1)
that were obtained in the##2##5##(2007-8#1)(2008-2#1)
that were obtained##10##3##(1995-8#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-2#2)(2008-3#2)(2009-3#1)
that were open##2##3##(1992-9#1)(2008-10#1)
that were originally##5##3##(2008-10#2)(2008-11#1)(2011-1#1)(2012-3#1)
that were over##2##3##(1991-10#1)(1995-12#1)
that were partially##2##3##(1994-8#1)(2008-10#1)
that were performed to##2##4##(2008-10#1)(2008-2#1)
that were performed##6##3##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-4#1)
that were polymorphic##2##3##(2008-10#1)(2008-4#1)
that were positive##2##3##(1992-6#1)(1993-1#1)
that were potentially##3##3##(2012-3#1)(2013-1#2)
that were predicted##2##3##(1997-5#1)(2007-12#1)
that were prepared##2##3##(2008-10#1)(2008-5#1)
that were present in##4##4##(2008-3#2)(2008-4#1)(2010-4#1)
that were present##5##3##(2008-10#1)(2008-3#2)(2008-4#1)(2010-4#1)
that were presented##3##3##(1993-12#1)(2007-3#1)(2013-8#1)
that were previously##10##3##(1991-4#1)(1996-2#1)(1997-5#1)(2005-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-10#1)(2010-6#1)(2013-8#1)
that were published in the##2##5##(2007-3#1)(2008-5#1)
that were published##3##3##(2007-3#1)(2008-5#1)(2010-2#1)
that were raised on##2##4##(2008-5#2)
that were raised##3##3##(2008-5#3)
that were randomly allocated into one of three groups completed the study##2##12##(2008-10#2)
that were recently##4##3##(2007-11#1)(2008-2#1)(2008-4#1)(2008-7#1)
that were recorded##2##3##(2008-3#2)
that were recovered from##3##4##(2008-10#3)
that were related##2##3##(2007-2#1)(2008-10#1)
that were relatively##2##3##(1995-12#1)(2004-9#1)
that were reported to##2##4##(1994-9#1)(2009-8#1)
that were reported##4##3##(1994-9#1)(2008-2#1)(2009-8#1)(2012-2#1)
that were required##3##3##(2006-8#1)(2013-1#2)
that were resistant to all three##2##6##(2008-10#1)(2008-5#1)
that were resistant to##4##4##(2007-7#1)(2008-10#2)(2008-5#1)
that were resistant##5##3##(2007-7#1)(2008-10#3)(2008-5#1)
that were seen##4##3##(1991-10#1)(1997-3#1)(2008-4#1)(2013-8#1)
that were sensitive to##2##4##(2007-7#1)(2008-10#1)
that were sensitive##4##3##(2007-7#1)(2008-10#3)
that were sent##2##3##(2006-10#1)(2012-12#1)
that were separated##2##3##(2008-10#1)(2013-1#1)
that were significantly associated with##2##5##(1997-4#1)(2012-3#1)
that were significantly longer##2##4##(2006-4#1)(2009-10#1)
that were significantly lower##2##4##(2008-10#1)(2013-8#1)
that were significantly more##2##4##(2007-9#1)(2013-1#1)
that were significantly##12##3##(1991-12#1)(1997-4#1)(2006-12#1)(2006-4#1)(2007-6#1)(2007-9#1)(2008-10#1)(2009-10#1)(2009-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
that were similar to those##2##5##(1994-3#1)(2012-3#1)
that were similar to##4##4##(1994-3#1)(1994-8#1)(2006-7#1)(2012-3#1)
that were similar##5##3##(1992-3#1)(1994-3#1)(1994-8#1)(2006-7#1)(2012-3#1)
that were slaughtered##2##3##(1994-7#1)(2011-1#1)
that were slightly higher##2##4##(1992-1#1)(2012-1#1)
that were slightly##3##3##(1992-1#1)(1993-12#1)(2012-1#1)
that were spatially##3##3##(2009-5#1)(2013-1#2)
that were specific for each##2##5##(2008-10#2)
that were specific for##3##4##(2008-10#3)
that were specific##4##3##(2008-10#4)
that were stimulated##2##3##(1996-8#1)(2008-11#1)
that were stored in##2##4##(1994-3#1)(2008-3#1)
that were strongly##2##3##(2008-7#1)(2010-5#1)
that were studied##4##3##(2006-5#1)(2007-7#1)(2008-10#1)(2012-2#1)
that were subjected to##2##4##(2007-4#1)(2011-1#1)
that were subsequently##3##3##(1991-12#1)(1995-1#1)(2013-1#1)
that were successfully enriched##2##4##(2008-10#2)
that were successfully##4##3##(2006-10#1)(2008-10#2)(2012-12#1)
that were susceptible##2##3##(1991-8#1)(2011-2#1)
that were synthesized##2##3##(2008-10#2)
that were taken##3##3##(1990-11#1)(2007-12#1)(2007-8#1)
that were tested for##2##4##(1993-2#1)(2008-10#1)
that were tested##7##3##(1993-2#1)(2008-10#4)(2008-7#1)(2012-12#1)
that were the##3##3##(2004-3#1)(2007-1#1)(2008-7#1)
that were too low to##2##5##(1994-9#1)(2011-1#1)
that were treated with np-BNR##2##5##(2008-10#2)
that were treated with##7##4##(2008-10#4)(2009-3#1)(2011-2#1)(2012-12#1)
that were treated##11##3##(2007-8#2)(2008-10#4)(2009-1#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-12#1)
that were typical of##2##4##(1991-7#1)(2012-1#1)
that were unable to##2##4##(1996-7#1)(2008-9#1)
that were unaffected by##2##4##(1994-8#1)(1996-12#1)
that were unique to##2##4##(1991-12#1)(1997-4#1)
that were used for the##2##5##(1990-2#1)(2009-4#1)
that were used for##3##4##(1990-2#1)(2008-6#1)(2009-4#1)
that were used to##2##4##(2009-8#1)(2012-2#1)
that were used##8##3##(1990-2#1)(2007-12#1)(2008-6#1)(2009-4#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
that were utilized##2##3##(1995-3#1)(2008-10#1)
that were virulent on##2##4##(2008-10#2)
that were well##3##3##(2008-5#1)(2008-8#2)
that were within##2##3##(1997-3#1)(2008-3#1)
that were##955##2##(1990-10#3)(1990-11#5)(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#5)(1991-3#2)(1991-4#2)(1991-6#1)(1991-7#4)(1991-8#1)(1991-9#3)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#4)(1992-4#1)(1992-6#3)(1992-7#3)(1992-8#5)(1992-9#1)(1993-1#2)(1993-11#3)(1993-12#9)(1993-2#6)(1993-3#3)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-1#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#8)(1994-7#2)(1994-8#5)(1994-9#6)(1995-1#4)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#3)(1995-5#1)(1995-6#5)(1995-8#7)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#3)(1996-4#3)(1996-5#6)(1996-7#1)(1996-8#5)(1996-9#3)(1997-1#1)(1997-2#6)(1997-3#6)(1997-4#10)(1997-5#2)(1997-6#7)(1997-7#2)(1997-8#2)(2004-10#1)(2004-2#1)(2004-3#1)(2004-4#2)(2004-9#2)(2005-10#3)(2005-11#4)(2005-12#1)(2005-7#1)(2006-1#1)(2006-10#9)(2006-11#6)(2006-12#10)(2006-2#5)(2006-3#1)(2006-4#6)(2006-5#7)(2006-6#3)(2006-7#1)(2006-8#7)(2006-9#1)(2007-1#4)(2007-10#5)(2007-11#7)(2007-12#22)(2007-2#10)(2007-3#3)(2007-4#3)(2007-5#1)(2007-6#3)(2007-7#8)(2007-8#14)(2007-9#4)(2008-1#3)(2008-10#176)(2008-11#22)(2008-12#12)(2008-2#19)(2008-3#24)(2008-4#14)(2008-5#31)(2008-6#5)(2008-7#12)(2008-8#15)(2008-9#10)(2009-1#3)(2009-10#8)(2009-11#1)(2009-12#3)(2009-2#3)(2009-3#5)(2009-4#9)(2009-5#4)(2009-6#2)(2009-7#3)(2009-8#9)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#8)(2010-3#2)(2010-4#8)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#7)(2010-9#2)(2011-1#16)(2011-12#5)(2011-2#24)(2011-3#2)(2011-9#1)(2012-1#6)(2012-11#1)(2012-12#16)(2012-2#11)(2012-3#14)(2012-7#1)(2013-1#33)(2013-7#4)(2013-8#8)
that what##6##2##(1993-7#1)(1994-1#1)(1996-2#1)(2006-10#1)(2006-12#1)(2008-4#1)
that whatever##2##2##(2007-2#1)(2013-8#1)
that wheat##3##2##(1990-4#1)(1992-9#1)(2010-1#1)
that when a##10##3##(1992-9#1)(1993-12#1)(1996-3#1)(2006-7#1)(2007-8#1)(2008-3#2)(2008-5#1)(2009-10#1)(2013-8#1)
that when compared##2##3##(2011-12#1)(2012-2#1)
that when comparing##2##3##(1994-6#1)(2009-4#1)
that when it is##3##4##(1994-6#1)(2006-11#1)(2010-1#1)
that when the##21##3##(1992-3#1)(1993-12#1)(1993-9#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-4#1)(1997-2#1)(2005-4#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-2#1)(2013-1#1)(2013-8#2)
that when there is##2##4##(2007-12#1)(2010-12#1)
that when used##2##3##(1992-2#1)(1996-9#1)
that when##120##2##(1990-6#1)(1991-3#2)(1991-5#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-12#3)(1993-3#1)(1993-9#1)(1994-2#2)(1994-6#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#3)(1996-10#1)(1996-3#1)(1996-4#1)(1996-9#3)(1997-2#1)(1997-4#1)(2005-10#2)(2005-4#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-1#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-6#2)(2009-9#2)(2010-1#1)(2010-12#1)(2010-2#3)(2010-3#1)(2011-12#1)(2011-2#2)(2012-2#6)(2012-3#2)(2013-1#2)(2013-8#4)
that whenever the##2##3##(2007-12#1)(2008-7#1)
that whenever##3##2##(1996-9#1)(2007-12#1)(2008-7#1)
that where##2##2##(2008-3#1)(2011-2#1)
that whereas the##3##3##(1991-10#1)(1996-5#1)(2009-11#1)
that whereas##8##2##(1991-10#1)(1996-5#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-4#1)(2009-11#1)
that which arises from##2##4##(2007-12#1)(2008-2#1)
that which can##2##3##(1994-5#1)(2013-7#1)
that which is##5##3##(1993-8#1)(2007-12#2)(2007-7#1)(2008-11#1)
that which occurs##2##3##(2007-11#1)(2008-10#1)
that which was##2##3##(1997-4#1)(2008-3#1)
that which would##2##3##(2007-1#1)(2012-12#1)
that which##28##2##(1990-4#1)(1993-8#1)(1993-9#1)(1994-5#1)(1997-4#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#4)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-8#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)
that while a##3##3##(2006-2#1)(2009-6#1)(2009-9#1)
that while activation of##2##4##(1992-8#1)(2013-1#1)
that while both##3##3##(1994-3#1)(1994-8#1)(2009-7#1)
that while the##14##3##(1990-5#1)(1995-1#1)(1996-10#1)(1996-3#1)(1996-8#1)(1996-9#1)(2006-8#1)(2007-8#2)(2008-11#1)(2009-8#1)(2010-2#1)(2013-1#2)
that while##79##2##(1990-5#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-8#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#1)(1996-10#1)(1996-3#3)(1996-5#2)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-6#2)(2006-2#1)(2006-8#2)(2007-5#1)(2007-8#3)(2008-10#2)(2008-11#4)(2008-4#2)(2008-5#1)(2008-8#2)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-2#2)(2010-4#2)(2010-9#2)(2011-2#1)(2012-11#2)(2012-2#2)(2012-3#1)(2013-1#9)(2013-8#1)
that whilst the##2##3##(2004-10#1)(2008-7#1)
that whilst##6##2##(2004-10#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-7#1)(2010-11#1)
that white##2##2##(1991-3#1)(2013-7#1)
that whole##2##2##(1997-4#1)(2007-11#1)
that wide##3##2##(1993-7#1)(2007-8#1)(2008-6#1)
that widespread##4##2##(1995-1#1)(2006-2#1)(2008-4#1)(2008-5#1)
that wild type##2##3##(1991-8#1)(2008-8#1)
that wild##6##2##(1991-8#1)(2008-10#1)(2008-5#2)(2008-8#1)(2010-8#1)
that will achieve##2##3##(2008-3#1)(2008-4#1)
that will activate##2##3##(2006-10#1)(2007-8#1)
that will affect##5##3##(1993-1#1)(1993-2#2)(2009-5#1)(2010-2#1)
that will allow##6##3##(1991-12#1)(1991-2#1)(1997-3#1)(2008-10#1)(2008-4#1)(2012-1#1)
that will be discussed in this##2##6##(2004-11#1)(2012-2#1)
that will be discussed##3##4##(2004-11#1)(2008-10#1)(2012-2#1)
that will be needed by##2##5##(1990-12#1)(2008-1#1)
that will be needed in##2##5##(2006-4#1)(2008-10#1)
that will be needed##4##4##(1990-12#1)(2006-4#1)(2008-1#1)(2008-10#1)
that will be of##2##4##(2006-11#1)(2009-2#1)
that will be required to##2##5##(2008-10#1)(2008-11#1)
that will be required##4##4##(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#1)
that will be reviewed##2##4##(2007-5#1)(2008-10#1)
that will be used as##2##5##(2008-10#1)(2008-7#1)
that will be used to##3##5##(1992-2#1)(1995-2#1)(2008-3#1)
that will be used##7##4##(1992-2#1)(1995-2#1)(2008-10#1)(2008-3#2)(2008-7#1)(2012-2#1)
that will be useful for##3##5##(2008-7#1)(2010-10#1)(2012-11#1)
that will be useful##4##4##(2006-11#1)(2008-7#1)(2010-10#1)(2012-11#1)
that will be##53##3##(1990-12#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1995-1#1)(1995-2#2)(1995-4#1)(1996-2#1)(1996-3#1)(2004-11#1)(2006-11#2)(2006-4#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-2#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#1)
that will become available in the##2##6##(2006-10#1)(2013-1#1)
that will become##4##3##(2006-10#1)(2008-1#1)(2008-10#1)(2013-1#1)
that will continue to##2##4##(1990-11#1)(1997-2#1)
that will enable physicians##2##4##(1996-2#1)(2006-6#1)
that will enable researchers##3##4##(2008-11#1)(2012-12#2)
that will enable the##3##4##(2007-8#1)(2008-7#1)(2010-9#1)
that will enable them to##3##5##(2007-10#1)(2007-4#1)(2010-3#1)
that will enable##17##3##(1996-2#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-3#2)(2010-9#1)(2012-12#2)(2013-1#1)
that will enhance##2##3##(1995-12#1)(2011-2#1)
that will ensure##3##3##(2006-10#1)(2011-1#1)(2011-2#1)
that will eventually##2##3##(1992-2#1)(2011-2#1)
that will facilitate##4##3##(2006-5#1)(2008-1#1)(2008-2#1)(2008-7#1)
that will foster##2##3##(2008-10#1)(2012-3#1)
that will give##3##3##(1996-12#1)(2008-11#1)(2008-2#1)
that will guide##3##3##(2008-3#1)(2008-4#1)(2011-2#1)
that will help##9##3##(1996-2#1)(1996-3#1)(2006-1#1)(2007-4#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-8#1)(2011-2#1)
that will hopefully##2##3##(2007-7#1)(2008-11#1)
that will improve the##3##4##(2006-5#1)(2007-2#1)(2010-3#1)
that will improve##5##3##(1996-2#1)(2006-5#1)(2007-2#2)(2010-3#1)
that will influence##3##3##(2006-12#1)(2009-3#1)(2011-3#1)
that will lead to the##2##5##(2007-8#1)(2009-11#1)
that will lead to##5##4##(2007-12#1)(2007-8#1)(2008-11#1)(2009-11#1)(2012-3#1)
that will likely##2##3##(2009-11#1)(2012-12#1)
that will make##2##3##(1997-1#1)(2011-2#1)
that will measure the##2##4##(1995-2#1)(2008-3#1)
that will measure##3##3##(1995-2#1)(2007-4#1)(2008-3#1)
that will meet the##3##4##(1993-2#1)(1994-12#1)(2008-3#1)
that will meet##4##3##(1993-2#2)(1994-12#1)(2008-3#1)
that will need to be##2##5##(1992-9#1)(2008-11#1)
that will optimize##3##3##(2005-8#1)(2005-9#1)(2008-2#1)
that will predict##2##3##(2007-3#1)(2008-3#1)
that will produce##2##3##(2008-11#1)(2008-4#1)
that will provide the##3##4##(2005-5#1)(2006-10#1)(2012-11#1)
that will provide##7##3##(2005-10#1)(2005-5#1)(2006-10#1)(2006-8#1)(2011-2#2)(2012-11#1)
that will recognize##2##3##(1994-6#1)(1997-4#1)
that will reduce the##2##4##(2007-7#1)(2012-12#1)
that will reduce##5##3##(2007-7#1)(2008-3#1)(2010-8#1)(2011-2#1)(2012-12#1)
that will require##4##3##(1994-12#1)(2006-10#1)(2007-7#1)(2012-12#1)
that will result in a##3##5##(1991-2#1)(1994-12#1)(2008-10#1)
that will result in##5##4##(1991-2#1)(1994-12#1)(2005-7#1)(2008-10#1)(2008-6#1)
that will result##6##3##(1991-2#1)(1994-12#1)(2005-10#1)(2005-7#1)(2008-10#1)(2008-6#1)
that will support##2##3##(2006-2#1)(2007-12#1)
that will ultimately##2##3##(2010-2#1)(2011-1#1)
that will##275##2##(1990-11#2)(1990-12#4)(1991-10#1)(1991-12#1)(1991-2#2)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-2#5)(1993-5#2)(1994-1#1)(1994-12#3)(1994-3#2)(1994-6#1)(1995-1#2)(1995-10#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#4)(1996-3#4)(1996-6#1)(1997-1#4)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(2004-11#1)(2005-10#2)(2005-11#1)(2005-2#1)(2005-5#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#9)(2006-11#2)(2006-12#1)(2006-2#1)(2006-4#2)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#2)(2007-10#2)(2007-11#4)(2007-12#3)(2007-2#4)(2007-3#1)(2007-4#6)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#4)(2008-1#4)(2008-10#16)(2008-11#12)(2008-12#1)(2008-2#9)(2008-3#15)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-2#3)(2010-3#3)(2010-8#2)(2010-9#2)(2011-1#4)(2011-2#13)(2011-3#1)(2012-1#5)(2012-11#2)(2012-12#6)(2012-2#4)(2012-3#5)(2013-1#5)(2013-8#2)
that wing##2##2##(2007-12#1)(2008-3#1)
that winter##2##2##(2010-8#2)
that with a grating structure##2##5##(2007-12#2)
that with a limited##2##4##(1990-12#1)(2008-5#1)
that with a##8##3##(1990-12#1)(1990-2#1)(2007-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2012-1#1)
that with advances in##2##4##(2005-9#1)(2008-3#1)
that with an##4##3##(1992-2#1)(2005-10#1)(2008-2#1)(2008-5#1)
that with conventional##3##3##(1996-6#1)(2008-1#1)(2013-8#1)
that with normal##2##3##(1994-8#1)(2013-8#1)
that with the right##2##4##(2005-10#1)(2008-11#1)
that with the use of##2##5##(2008-10#1)(2008-11#1)
that with the##24##3##(1990-9#1)(1992-3#1)(1992-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-7#1)(2005-10#1)(2007-11#1)(2007-2#1)(2008-10#7)(2008-11#2)(2008-7#1)(2010-12#1)(2013-1#2)
that with this method##2##4##(1991-5#1)(2008-2#1)
that with this technique##2##4##(2007-12#1)(2008-1#1)
that with this##8##3##(1991-5#1)(1994-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#1)
that with##114##2##(1990-12#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-6#2)(1994-10#2)(1994-5#1)(1994-8#3)(1994-9#3)(1995-1#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-5#1)(1996-6#1)(1996-7#1)(2005-10#2)(2005-11#1)(2005-7#1)(2005-9#1)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#5)(2007-12#5)(2007-2#1)(2007-5#1)(2008-1#2)(2008-10#17)(2008-11#2)(2008-2#4)(2008-3#5)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-2#1)(2010-12#3)(2010-4#1)(2011-1#1)(2011-2#4)(2012-1#1)(2013-1#5)(2013-8#2)
that withdrawal effects##2##3##(1995-12#1)(2013-8#1)
that withdrawal of##2##3##(2010-5#1)(2012-2#1)
that withdrawal##5##2##(1995-12#1)(2007-11#1)(2010-5#1)(2012-2#1)(2013-8#1)
that within a relatively##2##4##(2006-2#1)(2009-7#1)
that within a##4##3##(2005-1#1)(2006-2#1)(2008-5#1)(2009-7#1)
that within the next##2##4##(2004-12#1)(2008-12#1)
that within the##7##3##(1993-3#1)(1994-3#1)(2004-12#1)(2005-11#1)(2008-10#1)(2008-12#1)(2012-3#1)
that within##17##2##(1991-1#1)(1992-4#1)(1993-3#1)(1994-3#1)(2004-12#1)(2005-1#1)(2005-11#1)(2006-2#1)(2007-12#1)(2008-10#2)(2008-12#2)(2008-5#1)(2009-7#1)(2012-1#1)(2012-3#1)
that without##14##2##(1991-10#1)(1994-5#1)(1995-4#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-8#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-8#1)
that wives##2##2##(2008-9#2)
that women are##5##3##(1994-7#1)(1995-12#1)(2007-4#1)(2008-1#1)(2012-12#1)
that women had##3##3##(2006-10#1)(2006-12#1)(2006-8#1)
that women should##2##3##(2007-2#1)(2013-1#1)
that women who##2##3##(2006-5#1)(2007-12#1)
that women with##4##3##(2007-7#1)(2008-12#1)(2008-4#1)(2011-1#1)
that women##44##2##(1990-12#1)(1990-2#2)(1991-10#1)(1994-7#1)(1995-12#1)(1996-12#1)(1996-4#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#2)(2007-12#4)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#3)(2007-9#1)(2008-1#1)(2008-12#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#2)(2009-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
that work by##2##3##(1991-12#1)(2007-11#1)
that work in##5##3##(2008-1#1)(2008-2#1)(2010-2#1)(2012-12#1)(2013-1#1)
that work with##3##3##(2007-12#1)(2008-3#1)(2011-2#1)
that work##25##2##(1990-12#1)(1991-12#1)(1991-2#1)(1996-2#1)(1997-1#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-7#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
that worked in##3##3##(1996-3#1)(1997-1#1)(2011-1#1)
that works on##3##3##(2008-10#1)(2008-4#1)(2010-4#1)
that works with##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
that works##12##2##(1992-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#1)(2010-4#1)(2013-1#1)
that worst-case##2##2##(2008-3#2)
that wortmannin##3##2##(1995-6#2)(1997-3#1)
that would allow##8##3##(2004-3#1)(2005-9#1)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-8#1)
that would also##2##3##(1992-12#1)(2008-10#1)
that would appeal##2##3##(1991-1#1)(2010-9#1)
that would assist##2##3##(2007-4#1)(2011-12#1)
that would be beneficial##2##4##(2010-9#1)(2012-1#1)
that would be considered##2##4##(2007-2#1)(2009-9#1)
that would be consistent with an inflammatory response related to the dermatitis observed histopathologically##3##14##(2008-9#3)
that would be consistent with##5##5##(2008-9#5)
that would be difficult##2##4##(2007-12#1)(2008-7#1)
that would be expected##8##4##(1994-3#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2013-1#1)
that would be important##2##4##(2007-10#1)(2008-12#1)
that would be required##2##4##(1996-1#1)(2008-3#1)
that would be##48##3##(1990-11#1)(1990-8#1)(1991-12#1)(1992-3#1)(1993-9#1)(1994-3#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-9#1)(1997-1#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#5)(2009-9#3)(2010-11#1)(2010-9#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
that would benefit from this##2##5##(2008-3#1)(2010-12#1)
that would benefit from##3##4##(2007-12#1)(2008-3#1)(2010-12#1)
that would cater##2##3##(2006-2#1)(2012-2#1)
that would contribute to##2##4##(2006-10#1)(2011-2#1)
that would eliminate##2##3##(1991-4#1)(2013-1#1)
that would enable##4##3##(1992-11#1)(2008-10#1)(2012-1#1)(2012-2#1)
that would eventually##3##3##(2010-9#1)(2013-1#2)
that would explain##2##3##(1996-5#1)(2008-9#1)
that would facilitate##2##3##(2008-6#1)(2012-3#1)
that would favor##2##3##(2008-9#1)(2009-10#1)
that would have been##5##4##(1995-12#1)(2008-10#1)(2008-7#2)(2012-3#1)
that would have##17##3##(1992-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-2#1)(2006-7#2)(2007-9#1)(2008-10#2)(2008-7#2)(2008-9#1)(2011-1#1)(2012-1#1)(2012-3#1)
that would increase##2##3##(2008-11#1)(2013-1#1)
that would indicate##2##3##(2007-11#1)(2007-7#1)
that would inform##2##3##(2007-3#1)(2009-5#1)
that would make the##2##4##(1995-11#1)(2008-12#1)
that would make##4##3##(1990-2#1)(1995-11#1)(2007-10#1)(2008-12#1)
that would minimize##3##3##(2004-3#1)(2013-1#2)
that would not##3##3##(2005-10#1)(2007-1#1)(2007-12#1)
that would otherwise be##2##4##(2007-4#1)(2011-1#1)
that would otherwise have##2##4##(1992-7#1)(2006-10#1)
that would otherwise interfere with##2##5##(1990-11#1)(2008-10#1)
that would otherwise lead to##2##5##(1993-2#1)(2009-2#1)
that would otherwise##17##3##(1990-11#1)(1992-7#1)(1993-2#1)(1994-12#1)(1996-3#1)(2006-10#1)(2007-4#1)(2007-9#1)(2008-10#3)(2008-2#2)(2009-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
that would provide better##2##4##(1997-3#1)(2005-11#1)
that would provide##7##3##(1997-3#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-4#1)(2009-7#1)
that would remain##2##3##(1996-12#1)(2013-1#1)
that would render##2##3##(1991-12#1)(2010-7#1)
that would represent##2##3##(2008-11#1)(2011-2#1)
that would require##2##3##(1993-3#1)(2009-7#1)
that would result##2##3##(1997-7#1)(2006-4#1)
that would support##2##3##(1991-4#1)(2007-12#1)
that would##231##2##(1990-10#1)(1990-11#2)(1990-2#1)(1990-4#1)(1990-8#2)(1991-1#2)(1991-12#3)(1991-4#2)(1992-11#1)(1992-12#2)(1992-3#2)(1992-7#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-12#2)(1994-3#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2004-3#2)(2005-10#1)(2005-11#1)(2005-5#1)(2005-7#2)(2005-9#1)(2006-10#5)(2006-2#2)(2006-3#1)(2006-4#1)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#5)(2007-2#2)(2007-3#1)(2007-4#3)(2007-5#2)(2007-7#5)(2007-8#1)(2007-9#5)(2008-1#4)(2008-10#13)(2008-11#5)(2008-12#3)(2008-2#6)(2008-3#5)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#7)(2008-9#10)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#2)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#4)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#10)(2013-7#1)
that wound##2##2##(2012-10#2)
that wrap around##2##3##(1994-5#1)(2008-9#1)
that wtip##2##2##(2012-12#2)
that x-ray##2##2##(2008-2#1)(2008-3#1)
that xylanase##2##2##(2008-5#1)(2011-2#1)
that year##9##2##(1990-2#1)(1991-1#1)(1991-2#1)(1993-12#1)(1993-6#1)(1997-3#2)(2005-7#1)(2008-10#1)
that years##2##2##(1995-1#1)(2009-7#1)
that yeast cells##2##3##(1997-3#1)(2007-12#1)
that yeast##12##2##(1990-2#1)(1993-6#1)(1996-3#1)(1996-9#3)(1997-3#2)(2007-12#1)(2008-10#2)(2011-2#1)
that yield a##2##3##(2008-2#1)(2008-3#1)
that yield##18##2##(1993-9#1)(1996-12#2)(1996-3#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#3)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
that yielded by##2##3##(1995-10#1)(2008-3#1)
that yielded##11##2##(1991-2#1)(1995-10#1)(2006-12#1)(2007-11#1)(2008-10#4)(2008-3#2)(2012-2#1)
that yields a##3##3##(1990-8#1)(2008-2#1)(2008-3#1)
that yields the maximum##3##4##(2007-12#1)(2008-3#2)
that yields the##8##3##(2006-10#1)(2007-12#1)(2008-10#1)(2008-3#4)(2009-10#1)
that yields##25##2##(1990-8#1)(1995-10#1)(1996-12#1)(2006-10#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#6)(2008-3#7)(2008-5#1)(2009-10#1)
that you will##2##3##(2007-8#1)(2011-12#1)
that you##10##2##(1991-3#2)(1994-2#1)(1995-3#1)(1996-3#1)(2006-4#1)(2007-4#1)(2007-8#1)(2011-12#1)(2012-2#1)
that young and##2##3##(1996-9#1)(2008-4#1)
that young children##3##3##(2007-4#1)(2008-2#1)(2009-2#1)
that young people##4##3##(2012-12#2)(2012-3#2)
that young persons##2##3##(1996-1#1)(2007-3#1)
that young##25##2##(1993-5#1)(1994-12#1)(1995-5#1)(1996-1#1)(1996-9#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-2#1)(2008-4#1)(2009-12#2)(2009-2#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-8#1)(2012-12#3)(2012-3#2)(2013-1#1)
that younger##4##2##(1994-4#1)(2008-10#1)(2009-12#1)(2011-2#1)
that your organization##2##3##(1992-12#1)(1994-1#1)
that your##3##2##(1992-12#1)(1994-1#1)(1996-3#1)
that youth and##2##3##(2006-12#1)(2008-3#1)
that youth who##3##3##(2008-7#1)(2009-7#1)(2010-4#1)
that youth##7##2##(2006-12#1)(2008-3#1)(2008-7#2)(2009-7#1)(2009-9#1)(2010-4#1)
that zeta##2##2##(1995-6#1)(2005-11#1)
that zinc and##2##3##(1991-12#1)(1995-8#1)
that zinc##20##2##(1991-12#1)(1991-2#1)(1991-4#1)(1992-6#1)(1992-9#1)(1993-2#1)(1994-11#1)(1994-6#2)(1995-8#2)(2004-11#1)(2007-10#1)(2008-10#2)(2008-4#1)(2008-5#2)(2013-1#1)(2013-7#1)
that α7 nAChRs##2##3##(2011-1#2)
that α7##4##2##(2011-1#4)
that!##2##1##(2006-4#1)(2007-10#1)
that##88650##1##(1990-1#34)(1990-10#187)(1990-11#397)(1990-12#414)(1990-2#379)(1990-3#208)(1990-4#205)(1990-5#395)(1990-6#179)(1990-7#326)(1990-8#319)(1990-9#204)(1991-1#220)(1991-10#196)(1991-11#210)(1991-12#431)(1991-2#412)(1991-3#284)(1991-4#213)(1991-5#371)(1991-6#230)(1991-7#307)(1991-8#295)(1991-9#371)(1992-1#200)(1992-10#111)(1992-11#244)(1992-12#407)(1992-2#266)(1992-3#417)(1992-4#195)(1992-5#216)(1992-6#348)(1992-7#216)(1992-8#382)(1992-9#355)(1993-1#124)(1993-10#36)(1993-11#392)(1993-12#523)(1993-2#278)(1993-3#438)(1993-4#155)(1993-5#109)(1993-6#379)(1993-7#142)(1993-8#257)(1993-9#336)(1994-1#70)(1994-10#124)(1994-11#451)(1994-12#601)(1994-2#466)(1994-3#616)(1994-4#34)(1994-5#340)(1994-6#365)(1994-7#47)(1994-8#607)(1994-9#567)(1995-1#468)(1995-10#193)(1995-11#340)(1995-12#569)(1995-2#576)(1995-3#570)(1995-4#96)(1995-5#372)(1995-6#510)(1995-7#107)(1995-8#553)(1995-9#129)(1996-1#244)(1996-10#234)(1996-11#309)(1996-12#480)(1996-2#435)(1996-3#337)(1996-4#260)(1996-5#568)(1996-6#228)(1996-7#283)(1996-8#320)(1996-9#279)(1997-1#431)(1997-2#562)(1997-3#371)(1997-4#600)(1997-5#310)(1997-6#445)(1997-7#507)(1997-8#416)(1997-9#16)(2003-11#17)(2004-1#28)(2004-10#51)(2004-11#108)(2004-12#73)(2004-2#41)(2004-3#31)(2004-4#60)(2004-7#6)(2004-8#10)(2004-9#80)(2005-1#8)(2005-10#288)(2005-11#629)(2005-12#92)(2005-2#7)(2005-3#15)(2005-4#78)(2005-5#41)(2005-6#29)(2005-7#222)(2005-8#239)(2005-9#79)(2006-1#88)(2006-10#1330)(2006-11#221)(2006-12#546)(2006-2#271)(2006-3#156)(2006-4#179)(2006-5#308)(2006-6#265)(2006-7#267)(2006-8#409)(2006-9#212)(2007-1#227)(2007-10#429)(2007-11#1488)(2007-12#2473)(2007-2#446)(2007-3#250)(2007-4#323)(2007-5#197)(2007-6#223)(2007-7#477)(2007-8#918)(2007-9#542)(2008-1#1026)(2008-10#6295)(2008-11#2163)(2008-12#742)(2008-2#2421)(2008-3#3107)(2008-4#1467)(2008-5#1959)(2008-6#621)(2008-7#1805)(2008-8#1945)(2008-9#1399)(2009-1#58)(2009-10#430)(2009-11#192)(2009-12#276)(2009-2#285)(2009-3#345)(2009-4#428)(2009-5#327)(2009-6#289)(2009-7#298)(2009-8#647)(2009-9#266)(2010-1#158)(2010-10#262)(2010-11#263)(2010-12#691)(2010-2#571)(2010-3#281)(2010-4#402)(2010-5#320)(2010-6#215)(2010-7#285)(2010-8#448)(2010-9#209)(2011-1#981)(2011-10#14)(2011-11#2)(2011-12#315)(2011-2#1857)(2011-3#66)(2011-4#1)(2011-7#9)(2011-9#4)(2012-1#661)(2012-10#6)(2012-11#216)(2012-12#1341)(2012-2#1496)(2012-3#1014)(2012-4#2)(2012-5#8)(2012-6#5)(2012-7#9)(2012-8#3)(2012-9#4)(2013-1#2054)(2013-3#1)(2013-7#363)(2013-8#1126)
that's##6##1##(1990-8#1)(1991-7#1)(1992-3#1)(2007-9#1)(2008-11#1)(2010-6#1)
that?##2##1##(2008-1#1)(2008-9#1)
thatthe##7##1##(2008-11#6)(2008-2#1)
thaumatin##3##1##(1997-4#1)(2007-5#1)(2008-10#1)
thaumatin-like protein##4##2##(2008-10#4)
thaw##7##1##(1992-8#1)(1996-8#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#2)
thawed DS##3##2##(2011-2#3)
thawed at##3##2##(2006-5#3)
thawed##14##1##(2006-5#3)(2007-8#2)(2008-11#1)(2008-4#1)(2008-9#2)(2010-4#1)(2011-2#4)
thawing procedures##2##2##(2006-5#2)
thawing temperature##2##2##(2006-5#1)(2006-8#1)
thawing##42##1##(1990-10#1)(1990-2#1)(1992-8#1)(1994-11#1)(1994-8#1)(1995-3#1)(1996-3#1)(2006-2#2)(2006-5#5)(2006-8#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-4#4)(2008-5#1)(2008-8#1)(2008-9#3)(2009-5#1)(2010-3#1)(2010-4#5)(2013-7#2)
thaxtomin A in##2##3##(2008-10#2)
thaxtomin A##5##2##(2008-10#5)
thaxtomin##8##1##(2008-10#8)
thdF##2##1##(1996-12#2)
the % mol##2##3##(1994-3#2)
the %##6##2##(1991-5#1)(1992-11#1)(1994-3#2)(1997-4#1)(2004-9#1)
the &amp##3##2##(1996-2#2)(2011-2#1)
the &gt##12##2##(1992-10#1)(1995-6#1)(1996-2#1)(2006-5#3)(2007-1#1)(2007-8#1)(2008-10#1)(2012-12#1)(2012-2#1)(2013-8#1)
the &lt##12##2##(1994-12#1)(1995-6#1)(2006-5#1)(2006-6#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-4#1)(2009-7#1)(2012-12#1)
the &quot##762##2##(1990-10#5)(1990-11#1)(1990-12#6)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#6)(1990-9#2)(1991-1#2)(1991-10#2)(1991-11#4)(1991-12#3)(1991-2#1)(1991-3#3)(1991-4#8)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#2)(1992-6#2)(1992-7#1)(1992-8#1)(1993-10#4)(1993-11#3)(1993-12#2)(1993-2#4)(1993-3#8)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-11#3)(1994-12#2)(1994-2#7)(1994-3#7)(1994-4#1)(1994-5#2)(1994-6#2)(1994-8#4)(1994-9#6)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#7)(1995-3#4)(1995-5#4)(1995-6#5)(1995-8#2)(1995-9#1)(1996-1#7)(1996-10#1)(1996-11#3)(1996-12#4)(1996-2#2)(1996-3#2)(1996-4#8)(1996-5#2)(1996-6#2)(1996-7#4)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#8)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#1)(2004-10#2)(2004-11#1)(2004-3#4)(2004-4#1)(2004-7#1)(2005-10#3)(2005-11#12)(2005-12#1)(2005-3#1)(2005-4#1)(2005-6#1)(2005-9#1)(2006-10#11)(2006-11#2)(2006-12#1)(2006-2#2)(2006-4#2)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#11)(2006-9#3)(2007-1#6)(2007-10#3)(2007-11#10)(2007-12#12)(2007-2#4)(2007-3#13)(2007-4#12)(2007-5#6)(2007-6#1)(2007-7#6)(2007-8#15)(2007-9#9)(2008-1#9)(2008-10#30)(2008-11#13)(2008-12#7)(2008-2#7)(2008-3#10)(2008-4#16)(2008-5#24)(2008-6#10)(2008-7#5)(2008-8#19)(2008-9#13)(2009-1#1)(2009-10#6)(2009-11#1)(2009-12#5)(2009-2#2)(2009-3#6)(2009-4#9)(2009-5#5)(2009-6#3)(2009-7#3)(2009-8#3)(2009-9#1)(2010-11#6)(2010-12#10)(2010-2#7)(2010-3#3)(2010-4#5)(2010-6#1)(2010-7#4)(2010-8#7)(2010-9#2)(2011-1#7)(2011-12#4)(2011-2#25)(2011-3#1)(2012-1#6)(2012-11#1)(2012-12#8)(2012-2#16)(2012-3#6)(2013-1#33)(2013-7#5)(2013-8#12)
the '90s##6##2##(1990-4#1)(1991-3#1)(1992-1#1)(1992-3#1)(1994-3#2)
the 'B'##2##2##(1997-6#2)
the 'König' reaction and##2##4##(1993-8#2)
the 'König' reaction##9##3##(1993-8#9)
the 'Oketsu'##3##2##(2008-10#3)
the 'a'##3##2##(1995-4#2)(2006-12#1)
the 'all on##2##3##(2010-5#2)
the 'da Vinci'##2##3##(2007-8#2)
the 'epidemic##2##2##(2008-10#2)
the 'era of##2##3##(2006-10#2)
the 'excess##2##2##(1996-7#1)(2011-10#1)
the 'fusion peptide'##2##3##(1991-5#2)
the 'gold standard'##2##3##(2007-7#1)(2008-7#1)
the 'hand extension'##3##3##(1997-8#3)
the 'in step'##2##3##(1996-10#2)
the 'in##3##2##(1996-10#2)(2008-10#1)
the 'in-step'##2##2##(1996-10#2)
the 'long' (145 m) ID19##2##5##(2006-4#1)(2006-5#1)
the 'low lateral' approach to the internal jugular vein##2##9##(2007-7#2)
the 'no##2##2##(1993-9#1)(2004-10#1)
the 'on'##2##2##(1993-3#1)(2008-7#1)
the 'parent'##2##2##(1997-1#2)
the 'position stop'##2##3##(2007-8#2)
the 'protein##2##2##(1997-7#1)(2006-10#1)
the 'resistant##2##2##(2008-10#1)(2008-4#1)
the 'rullepølse'##2##2##(2010-4#2)
the 'shrinking building illusion'##2##4##(2012-2#2)
the 'source'##2##2##(1994-3#1)(1997-8#1)
the 'state of##2##3##(2005-9#1)(2011-2#1)
the 'stop' cue##3##3##(2008-11#3)
the 'theory of mind'##2##4##(2006-2#1)(2008-11#1)
the 'urgent' cases##2##3##(1994-3#2)
the (+)- and##2##3##(1996-7#1)(1996-9#1)
the (-)-trans-anti-[BPh]dA##3##2##(1995-1#3)
the (0##2##2##(2008-3#2)
the (001)##3##2##(2005-11#2)(2007-12#1)
the (1##5##2##(1991-8#3)(2008-3#2)
the (1)H NMR spectrum##6##4##(2008-10#1)(2008-3#4)(2008-4#1)
the (1)H NMR##11##3##(2006-10#1)(2008-10#1)(2008-3#4)(2008-4#1)(2010-5#1)(2010-6#1)(2012-12#2)
the (1)H##16##2##(1997-7#1)(2006-10#1)(2008-10#2)(2008-3#4)(2008-4#1)(2008-5#1)(2009-7#2)(2010-5#1)(2010-6#1)(2012-12#2)
the (1)H-NMR##2##2##(2007-10#1)(2008-10#1)
the (1--&gt##6##2##(1994-3#2)(1995-11#4)
the (129)Xe##2##2##(2006-1#2)
the (13)C NMR##2##3##(1996-5#1)(2008-10#1)
the (13)C##3##2##(1996-5#1)(2008-10#1)(2009-7#1)
the (131)I##2##2##(2006-11#2)
the (14S)-epimer##2##2##(2006-12#2)
the (2##3##2##(1991-9#1)(2007-12#1)(2008-2#1)
the (2----6) sialosides##2##3##(1991-9#2)
the (23)Na##3##2##(1997-7#3)
the (27)Al NMR##2##3##(2008-10#2)
the (2S##2##2##(1995-3#1)(2009-12#1)
the (3)A(2g) --&gt##2##3##(1997-7#2)
the (44)Ca/(42)Ca isotope##2##3##(2008-10#2)
the (45)Ca(2+) uptake##2##3##(2008-11#2)
the (4p)(2) (5s)(1) (4)P(1/2)##2##4##(2008-2#2)
the (N/T)KXD##2##2##(1994-9#2)
the (Na##3##2##(1990-11#2)(1997-8#1)
the (R)##2##2##(1990-7#1)(2009-12#1)
the (S)##2##2##(1990-7#2)
the (SSB)35 mode in##2##4##(1997-2#2)
the (SSB)35 mode##4##3##(1997-2#4)
the (a+l)TGF-beta##3##2##(1995-2#3)
the (alpha beta)2##2##3##(1990-7#2)
the (alpha##3##2##(1990-7#3)
the (dA)n##2##2##(1995-5#2)
the (n##2##2##(2008-10#1)(2008-3#1)
the (negative)##2##2##(2005-11#1)(2008-10#1)
the +/-1##2##2##(2008-3#2)
the +1##9##2##(1990-5#1)(2007-12#1)(2008-2#2)(2008-3#5)
the +2##2##2##(1997-4#1)(2008-2#1)
the +3 oxidation state##2##4##(1996-2#1)(2008-5#1)
the +4 oxidation state##3##4##(2008-5#3)
the +49(∗)G allele##2##3##(2010-12#2)
the +5##3##2##(2008-5#3)
the -1 order##7##3##(2008-2#4)(2008-3#3)
the -1##12##2##(2008-2#5)(2008-3#5)(2008-8#1)(2013-1#1)
the -13915(*)G##2##2##(2012-12#2)
the -2##2##2##(1995-1#1)(1997-7#1)
the -2548G/A polymorphism and##2##4##(2006-9#2)
the -2548G/A polymorphism##4##3##(2006-9#4)
the -2548G/A##5##2##(2006-9#5)
the -30 region##4##3##(1995-2#1)(1996-4#3)
the -CH(2)-O-CH(2)-PO(3)##2##2##(2008-5#2)
the -ESHH-##2##2##(2008-3#2)
the -SH##2##2##(1995-3#1)(1996-12#1)
the -c face of##2##4##(2008-2#2)
the 0##106##2##(1990-4#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-3#1)(1992-2#1)(1994-11#1)(1994-12#2)(1994-5#3)(1994-9#1)(1995-12#1)(1996-6#1)(1996-8#1)(1997-1#1)(2005-4#2)(2006-4#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-8#11)(2007-9#1)(2008-10#35)(2008-11#2)(2008-2#10)(2008-3#6)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2012-1#2)(2012-2#2)(2013-1#1)
the 0%##4##2##(2009-3#1)(2010-2#1)(2012-2#2)
the 0's##2##2##(2007-12#2)
the 0-50##2##2##(2008-10#2)
the 1 kb##2##3##(1995-8#1)(2006-12#1)
the 1 to##2##3##(2007-12#1)(2008-10#1)
the 1##236##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#6)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#5)(1991-11#1)(1991-4#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#6)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#4)(1992-9#1)(1993-1#1)(1993-11#8)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-5#1)(1994-7#2)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-2#6)(1996-3#1)(1996-5#6)(1996-7#1)(1997-1#4)(1997-2#4)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#2)(2004-9#1)(2005-11#2)(2005-3#1)(2005-4#1)(2006-10#1)(2006-12#3)(2006-5#1)(2007-1#2)(2007-10#2)(2007-11#1)(2007-12#17)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#40)(2008-11#2)(2008-2#12)(2008-3#11)(2008-4#3)(2008-5#9)(2008-8#3)(2008-9#2)(2009-3#1)(2010-11#2)(2010-4#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-2#4)(2013-1#1)(2013-8#2)
the 1%##3##2##(2008-10#1)(2008-2#1)(2008-7#1)
the 1'##4##2##(1991-4#1)(1993-11#2)(1994-9#1)
the 1- to##2##3##(2008-10#1)(2012-12#1)
the 1-##4##2##(1995-3#1)(2008-10#1)(2009-5#1)(2012-12#1)
the 1-3-1 model##2##3##(2006-8#2)
the 1-4 year old population of##2##6##(2008-4#2)
the 1-Mb##2##2##(1996-8#2)
the 1-[4-(benzoylamino)benzoyl]-2##2##2##(1996-8#2)
the 1-m##2##2##(2008-3#1)(2008-6#1)
the 1-month##5##2##(2006-12#1)(2008-10#2)(2008-5#2)
the 1-ms component##2##3##(1992-11#2)
the 1-position of PI##2##4##(1991-7#2)
the 1-position of##4##3##(1991-7#3)(2008-10#1)
the 1-position##7##2##(1991-7#5)(2008-10#1)(2010-6#1)
the 1-week##3##2##(1995-9#1)(2012-12#2)
the 1-year PRWE score##2##4##(2008-9#2)
the 1-year follow up##2##4##(2010-12#2)
the 1-year follow-up##4##3##(2008-10#1)(2012-2#2)(2012-3#1)
the 1-year survival rate was##3##5##(1990-12#1)(1991-2#2)
the 1-year survival rate##4##4##(1990-12#2)(1991-2#2)
the 1-year##19##2##(1990-12#2)(1991-2#2)(1991-8#1)(1996-1#1)(2008-10#1)(2008-4#1)(2008-9#3)(2010-12#2)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)
the 1-year-survival rate decreased by 15%##2##6##(2013-1#2)
the 1/e##2##2##(2008-2#1)(2011-1#1)
the 1/e(2)##2##2##(2008-3#2)
the 10 Commandments##2##3##(2008-12#2)
the 10 day##2##3##(1990-8#1)(2010-8#1)
the 10 different##2##3##(1996-9#1)(1997-2#1)
the 10 inoculated isolates##2##4##(2008-10#2)
the 10 mg##3##3##(2005-9#1)(2008-10#2)
the 10 months##2##3##(1996-2#2)
the 10 nm##2##3##(2008-8#1)(2009-5#1)
the 10 patients with##3##4##(2004-11#1)(2006-9#1)(2007-12#1)
the 10 patients##7##3##(1997-3#1)(2004-11#1)(2004-12#1)(2006-5#1)(2006-9#1)(2007-12#1)(2007-7#1)
the 10 years##4##3##(1991-7#1)(2008-12#1)(2008-3#1)(2010-11#1)
the 10##98##2##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-7#1)(1992-1#1)(1992-11#2)(1993-12#1)(1993-7#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-6#1)(1996-12#2)(1996-2#2)(1996-5#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-7#2)(1997-8#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-9#2)(2006-12#1)(2006-5#3)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#14)(2008-11#1)(2008-12#5)(2008-2#2)(2008-3#3)(2008-5#5)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#2)(2013-1#1)(2013-8#2)
the 10%##5##2##(2004-12#1)(2004-4#1)(2005-11#1)(2008-10#1)(2008-9#1)
the 10(-4)##2##2##(1994-9#1)(2008-10#1)
the 10(-5)##2##2##(1993-3#1)(2012-2#1)
the 10-16-nm-wavelength##2##2##(2007-12#2)
the 10-day##3##2##(1995-2#1)(2008-10#2)
the 10-fold##2##2##(1992-12#1)(1992-6#1)
the 10-kDa##2##2##(1991-7#1)(1995-8#1)
the 10-mg dose##3##3##(1996-2#3)
the 10-week##4##2##(1996-1#1)(1996-11#1)(2010-2#1)(2012-12#1)
the 10-year follow-up##2##3##(2012-12#1)(2013-1#1)
the 10-year interval##2##3##(2007-12#1)(2009-10#1)
the 10-year period##3##3##(1990-3#1)(1993-2#1)(1997-2#1)
the 10-year probability of##2##4##(2013-1#2)
the 10-year##13##2##(1990-3#1)(1993-2#1)(1997-2#1)(2007-12#1)(2008-3#1)(2009-10#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)
the 100 cases##4##3##(1996-11#1)(2007-1#1)(2007-7#1)(2007-9#1)
the 100 keV##2##3##(2006-4#2)
the 100##31##2##(1993-6#1)(1994-11#1)(1994-12#1)(1995-4#1)(1996-1#1)(1996-11#1)(2006-12#1)(2006-4#2)(2006-8#1)(2007-1#1)(2007-2#3)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-5#1)(2008-9#5)(2009-5#1)(2010-2#1)(2013-1#2)(2013-8#2)
the 100%##4##2##(1995-1#1)(2007-11#1)(2008-10#1)(2009-11#1)
the 1000 Genomes Project and simulated phenotypes##2##7##(2012-3#2)
the 1000 Genomes Project##8##4##(2012-3#8)
the 1000 Genomes##9##3##(2012-3#9)
the 1000##12##2##(1990-3#1)(2007-3#1)(2009-11#1)(2012-3#9)
the 1000-W##2##2##(2008-3#2)
the 100th anniversary of##4##4##(1996-12#1)(2007-9#1)(2008-1#1)(2008-8#1)
the 100th##5##2##(1994-3#1)(1996-12#1)(2007-9#1)(2008-1#1)(2008-8#1)
the 101-point scale##2##3##(2012-2#2)
the 103##5##2##(1992-4#1)(1997-4#1)(2007-7#1)(2007-9#1)(2009-3#1)
the 1047-nm##2##2##(2008-3#2)
the 105##4##2##(2008-10#1)(2010-12#1)(2011-2#1)(2013-8#1)
the 106##2##2##(2008-10#1)(2011-2#1)
the 1064-nm##5##2##(2007-12#3)(2008-2#1)(2008-3#1)
the 109 individuals##2##3##(2006-8#2)
the 109##4##2##(2006-2#1)(2006-8#2)(2010-8#1)
the 10K##2##2##(2008-5#2)
the 10th day##4##3##(1993-7#1)(1995-2#1)(2008-5#1)(2013-8#1)
the 10th grade##2##3##(2006-8#1)(2007-9#1)
the 10th percentile of OPs was 13##2##7##(2013-8#2)
the 10th##25##2##(1990-12#2)(1992-1#1)(1992-12#1)(1993-7#1)(1995-2#1)(1996-6#1)(2005-8#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#3)
the 11 kDa delta-zein##6##4##(2006-12#6)
the 11 patients##6##3##(1990-2#1)(1990-9#1)(1995-9#1)(1996-9#1)(1997-7#1)(2008-10#1)
the 11##51##2##(1990-2#1)(1990-9#1)(1992-1#1)(1992-11#1)(1993-11#1)(1993-2#2)(1993-9#1)(1995-3#1)(1995-8#1)(1995-9#2)(1996-12#1)(1996-8#1)(1996-9#1)(1997-7#1)(2006-12#6)(2007-11#1)(2007-8#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#2)(2008-8#1)(2008-9#3)(2010-4#1)(2011-2#1)(2012-12#1)(2013-8#2)
the 110 kDa protein##2##4##(1991-9#1)(1994-11#1)
the 110 kDa##3##3##(1990-11#1)(1991-9#1)(1994-11#1)
the 110##6##2##(1990-11#1)(1991-9#1)(1994-11#1)(1994-9#1)(2003-11#1)(2009-7#1)
the 111##2##2##(2004-10#2)
the 112##2##2##(1994-11#1)(1996-3#1)
the 113##2##2##(1992-8#1)(2006-11#1)
the 114##2##2##(2008-10#1)(2008-4#1)
the 115##2##2##(1992-5#1)(2007-3#1)
the 116##3##2##(2006-8#1)(2007-8#1)(2008-10#1)
the 117##3##2##(1996-9#1)(2007-3#1)(2008-10#1)
the 11th##7##2##(1991-6#1)(2007-12#1)(2008-11#2)(2010-12#1)(2012-2#1)(2013-1#1)
the 12 amino##2##3##(1991-9#1)(2013-1#1)
the 12 and##2##3##(1990-2#1)(2012-12#1)
the 12 genes##2##3##(2009-10#2)
the 12 lead##2##3##(1995-6#1)(2006-9#1)
the 12 lesions##2##3##(2008-5#1)(2012-3#1)
the 12 mg/kg group##3##4##(2008-9#3)
the 12 months##3##3##(1991-6#1)(2006-10#1)(2011-2#1)
the 12 patients##3##3##(1991-11#1)(1997-7#1)(1997-8#1)
the 12##71##2##(1990-2#1)(1990-3#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-9#2)(1995-6#1)(1996-11#1)(1996-12#2)(1996-6#2)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2004-11#1)(2005-10#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-2#2)(2007-3#2)(2007-7#2)(2007-8#1)(2008-10#7)(2008-2#1)(2008-5#4)(2008-7#1)(2008-9#4)(2009-10#3)(2009-8#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
the 12-##2##2##(2008-4#1)(2009-7#1)
the 12-h##3##2##(1992-2#1)(2007-8#1)(2008-3#1)
the 12-kDa##3##2##(1993-6#2)(1995-6#1)
the 12-month##3##2##(2008-3#1)(2008-5#1)(2011-2#1)
the 12-week##5##2##(2008-10#1)(2008-2#1)(2008-7#1)(2010-9#1)(2012-2#1)
the 120##3##2##(1994-2#1)(2008-10#2)
the 120-kDa protein##2##3##(1993-5#1)(2004-11#1)
the 121##2##2##(2008-10#1)(2008-3#1)
the 122##2##2##(1996-3#1)(2006-5#1)
the 125 and##2##3##(1991-1#1)(2008-9#1)
the 125 kDa polypeptide##2##4##(1991-1#2)
the 125 kDa##3##3##(1991-1#3)
the 125##7##2##(1991-1#4)(2008-1#1)(2008-2#1)(2008-9#1)
the 126##4##2##(1990-12#1)(1991-8#1)(2006-12#1)(2008-10#1)
the 127 kDa##2##3##(1990-11#2)
the 128##2##2##(2008-5#1)(2008-9#1)
the 129##4##2##(1993-11#1)(1993-8#1)(2013-1#2)
the 12S ATPase##2##3##(1991-2#2)
the 12S rRNA gene##2##4##(1996-3#1)(2009-5#1)
the 12S##4##2##(1991-2#2)(1996-3#1)(2009-5#1)
the 12h immersion##2##3##(2013-7#2)
the 12th Annual##2##3##(2007-11#1)(2008-7#1)
the 12th World Congress of Psychiatry##2##6##(2006-9#2)
the 12th World##3##3##(2006-9#2)(2008-5#1)
the 12th day##2##3##(1990-5#1)(2012-2#1)
the 12th##14##2##(1990-5#1)(1992-8#2)(1993-9#1)(1994-6#1)(1996-6#1)(2006-9#2)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-5#1)(2012-2#1)
the 13 patients with##2##4##(2007-8#1)(2008-3#1)
the 13 patients##9##3##(1992-5#1)(2004-11#1)(2007-2#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)
the 13##44##2##(1991-12#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-10#1)(1994-2#1)(1994-5#1)(1994-7#1)(1995-2#1)(1996-12#2)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(2004-10#1)(2004-11#1)(2006-12#1)(2007-2#2)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#2)(2010-8#3)(2012-5#1)(2013-8#1)
the 13-nm wavelength##2##3##(2007-12#1)(2008-3#1)
the 13-valent##2##2##(2012-12#2)
the 130##4##2##(1993-2#1)(2007-7#1)(2012-2#2)
the 130K replication protein##2##4##(2008-10#2)
the 131##2##2##(2008-10#1)(2008-4#1)
the 132 patients##2##3##(1990-12#1)(2007-3#1)
the 133 RILs##2##3##(2008-10#2)
the 133 bp##3##3##(1993-9#3)
the 133##7##2##(1993-5#1)(1993-9#3)(2008-1#1)(2008-10#2)
the 135 patients##2##3##(2012-12#2)
the 135##3##2##(2008-10#1)(2012-12#2)
the 139##2##2##(1990-4#1)(1991-9#1)
the 13C NMR chemical##2##4##(1993-11#1)(2005-8#1)
the 13C NMR##3##3##(1992-12#1)(1993-11#1)(2005-8#1)
the 13C##7##2##(1991-7#1)(1992-12#1)(1993-11#1)(1995-10#2)(2005-8#1)(2006-10#1)
the 13C-NMR##3##2##(1990-3#2)(1992-8#1)
the 13S##2##2##(1990-7#1)(1993-2#1)
the 13th##12##2##(1992-4#1)(1993-3#1)(1993-7#1)(1995-10#1)(1996-5#1)(2006-1#1)(2007-12#1)(2008-11#1)(2008-8#1)(2010-12#1)(2011-2#1)(2011-7#1)
the 14 analytes##2##3##(2012-12#2)
the 14 and##2##3##(1996-12#1)(2010-2#1)
the 14 cases##4##3##(1990-11#1)(2007-12#2)(2009-8#1)
the 14 counties##2##3##(1991-6#1)(1992-3#1)
the 14 patients who had##2##5##(1995-6#1)(2008-4#1)
the 14 patients with##5##4##(1990-5#2)(1990-8#1)(1991-4#1)(1996-4#1)
the 14 patients##11##3##(1990-5#2)(1990-8#1)(1991-4#1)(1995-6#1)(1996-11#1)(1996-4#1)(2006-7#1)(2007-2#1)(2007-3#1)(2008-4#1)
the 14##56##2##(1990-11#1)(1990-5#2)(1990-8#1)(1991-2#1)(1991-4#1)(1991-6#2)(1991-8#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-7#2)(1996-11#1)(1996-12#1)(1996-4#1)(1996-6#1)(2006-11#1)(2006-4#2)(2006-7#1)(2006-9#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-2#1)(2012-12#3)(2013-1#2)(2013-7#1)(2013-8#1)
the 14-3-3##4##2##(1993-4#1)(1995-6#1)(1997-3#1)(2009-10#1)
the 14-38 disulfide##3##3##(1992-6#2)(1997-2#1)
the 14-kDa##5##2##(1991-12#1)(1995-6#2)(2007-8#1)(2008-10#1)
the 14-membered ring##2##3##(2006-11#2)
the 140 pS channel##2##4##(1991-2#2)
the 140##6##2##(1991-2#2)(1992-2#1)(1994-8#1)(2006-10#2)
the 140-kDa##2##2##(1990-12#1)(1994-12#1)
the 140th##2##2##(2007-8#1)(2013-8#1)
the 143##2##2##(1996-4#1)(2013-1#1)
the 144##5##2##(2007-7#2)(2008-10#2)(2008-12#1)
the 145##2##2##(1992-3#1)(1995-6#1)
the 145Met variant##2##3##(2004-10#2)
the 147##3##2##(1994-8#1)(2007-10#1)(2007-7#1)
the 1492 or 1493 position##2##5##(2008-4#2)
the 14C##2##2##(1991-3#2)
the 14C-labeled D-galactose analog##2##4##(1990-5#2)
the 14th day##5##3##(1990-12#1)(1991-4#2)(2008-5#1)(2008-7#1)
the 14th to##2##3##(1991-4#1)(2011-2#1)
the 14th##22##2##(1990-12#1)(1991-4#5)(1994-4#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-4#8)(2008-5#1)(2008-7#1)(2011-2#2)
the 15 days##2##3##(1992-8#1)(1994-10#1)
the 15 min##2##3##(1994-6#1)(2008-5#1)
the 15 patients##2##3##(2006-2#1)(2008-9#1)
the 15##44##2##(1990-2#1)(1991-10#1)(1991-11#1)(1991-3#1)(1992-1#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-9#2)(1997-2#1)(1997-5#1)(1997-8#1)(2004-10#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-9#2)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-5#2)(2008-7#1)(2008-9#3)(2009-5#1)(2010-12#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-3#1)
the 15%##2##2##(2007-9#1)(2008-10#1)
the 15- and##4##3##(1990-12#1)(1994-3#2)(2005-7#1)
the 15-##6##2##(1990-12#1)(1992-5#1)(1994-3#3)(2005-7#1)
the 15-day##3##2##(1997-1#1)(2008-3#1)(2009-4#1)
the 15-ketosterol##3##2##(1993-6#3)
the 15-month##3##2##(1994-3#1)(2008-3#2)
the 150 kDa##3##3##(1990-5#1)(1992-11#1)(1997-2#1)
the 150##9##2##(1990-5#1)(1992-11#1)(1992-8#1)(1994-8#1)(1997-2#1)(2006-2#1)(2008-10#1)(2008-5#2)
the 1550-nm##4##2##(2007-11#2)(2007-12#1)(2008-2#1)
the 15C##2##2##(2004-11#2)
the 15N##4##2##(1994-11#1)(1996-4#1)(1997-7#1)(2009-7#1)
the 15RKR17/AAA mutation##3##3##(2008-8#3)
the 15th century##2##3##(1990-4#1)(2008-10#1)
the 15th day##3##3##(1990-11#1)(2007-9#1)(2008-7#1)
the 15th##13##2##(1990-11#1)(1990-2#1)(1990-4#1)(1995-8#1)(1996-4#1)(2004-7#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-10#1)(2012-2#1)
the 16 K##2##3##(1990-3#2)
the 16 S and 23 S genes##2##7##(1997-1#2)
the 16 S rRNA##2##4##(1994-12#1)(1996-8#1)
the 16 S##4##3##(1994-12#1)(1996-8#1)(1997-1#2)
the 16 days##2##3##(1996-3#1)(2012-2#1)
the 16 patients##5##3##(1995-2#1)(1996-8#1)(2006-8#1)(2008-10#1)(2008-6#1)
the 16 studies##2##3##(2007-6#1)(2009-6#1)
the 16##60##2##(1990-3#2)(1991-10#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-2#1)(1992-7#1)(1992-9#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-10#1)(1995-2#1)(1996-10#1)(1996-3#2)(1996-8#2)(1997-1#2)(1997-3#1)(1997-6#1)(2006-12#1)(2006-8#1)(2007-2#2)(2007-6#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#4)(2009-3#1)(2009-6#2)(2009-9#1)(2010-2#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
the 16-item##2##2##(2007-12#1)(2008-12#1)
the 160##5##2##(1996-7#1)(2008-10#2)(2008-7#1)(2013-8#1)
the 1629-bp##2##2##(1993-12#2)
the 165##4##2##(1991-10#1)(1993-12#2)(2008-10#1)
the 167##2##2##(1993-6#1)(2006-11#1)
the 16S and 23S##2##4##(1992-4#1)(1993-9#1)
the 16S rDNA and##2##4##(2005-11#1)(2008-10#1)
the 16S rDNA##9##3##(1997-3#1)(2005-11#2)(2006-8#3)(2008-10#1)(2008-12#2)
the 16S rRNA gene##9##4##(2006-8#3)(2008-10#3)(2009-6#1)(2012-2#1)(2013-8#1)
the 16S rRNA##18##3##(1995-8#1)(2005-7#1)(2006-8#6)(2008-10#6)(2009-6#1)(2012-2#2)(2013-8#1)
the 16S ribosomal RNA gene##3##5##(1993-4#1)(2011-2#1)(2013-1#1)
the 16S##36##2##(1992-4#1)(1993-4#1)(1993-9#1)(1995-8#1)(1997-3#1)(2005-11#2)(2005-7#1)(2006-8#9)(2007-12#1)(2008-10#8)(2008-12#2)(2009-6#1)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
the 16S-23S rDNA spacer region##2##5##(2008-10#2)
the 16S-23S rDNA##3##3##(2008-10#3)
the 16S-23S##7##2##(1997-1#1)(2006-3#1)(2008-10#5)
the 16SrI-B subgroup##2##3##(2008-10#2)
the 16s rRNA gene##2##4##(2008-10#1)(2008-12#1)
the 16th and##2##3##(2008-10#1)(2008-8#1)
the 16th century##2##3##(2007-12#1)(2011-2#1)
the 16th century]##3##3##(2007-10#1)(2008-11#2)
the 16th##11##2##(1990-2#1)(1997-4#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
the 17 lesions 5 mm or larger##2##7##(2008-5#2)
the 17 patients with##2##4##(1991-4#1)(1994-5#1)
the 17 patients##5##3##(1991-11#1)(1991-3#1)(1991-4#1)(1994-5#1)(2008-1#1)
the 17##35##2##(1990-2#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-4#2)(1991-7#1)(1992-11#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-10#1)(1996-5#1)(2004-2#1)(2007-4#1)(2008-1#3)(2008-10#7)(2008-11#3)(2008-12#1)(2008-5#2)(2010-7#1)(2010-9#1)(2011-2#1)
the 17-kDa protein were##2##4##(2008-10#2)
the 17-kDa protein##4##3##(2008-10#4)
the 1700s##2##2##(2005-8#1)(2009-2#1)
the 171##4##2##(1993-2#3)(2008-10#1)
the 175-kDa protein##2##3##(1992-3#2)
the 175R protein##3##3##(1993-2#3)
the 175R##4##2##(1993-2#4)
the 178##3##2##(1995-8#1)(2007-2#1)(2008-12#1)
the 17th century##3##3##(1990-12#1)(2008-10#2)
the 17th century]##5##3##(2008-10#3)(2008-9#2)
the 17th##21##2##(1990-12#1)(1997-8#1)(2006-11#1)(2006-9#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#1)(2012-2#2)(2013-1#1)
the 18 cases##2##3##(1992-3#1)(2007-6#1)
the 18 patients##3##3##(1996-11#1)(2008-1#1)(2013-1#1)
the 18##35##2##(1990-3#1)(1991-2#1)(1991-7#1)(1992-10#1)(1992-12#1)(1992-3#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-3#1)(2007-3#1)(2007-6#1)(2008-1#2)(2008-10#5)(2008-5#2)(2009-8#1)(2010-12#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
the 18%##2##2##(2010-2#1)(2012-3#1)
the 18(V/KPEP)##2##2##(1995-2#2)
the 18-kDa protein##4##3##(1992-3#2)(1995-3#2)
the 18-kDa##7##2##(1992-3#2)(1995-12#1)(1995-3#3)(1997-7#1)
the 18-mer##2##2##(1992-9#2)
the 18-month follow-up##2##3##(2006-12#1)(2008-5#1)
the 18-month##4##2##(1996-8#1)(2006-12#1)(2008-4#1)(2008-5#1)
the 180##4##2##(2006-5#1)(2007-10#1)(2009-9#1)(2010-2#1)
the 1800s##4##2##(2008-8#1)(2010-3#1)(2010-8#1)(2011-7#1)
the 181-bp PRE##2##3##(2012-3#2)
the 184##2##2##(2007-2#1)(2008-5#1)
the 1850s##2##2##(2008-12#1)(2013-1#1)
the 187 patients##2##3##(2004-3#1)(2012-5#1)
the 1870s##6##2##(1996-3#1)(2008-7#2)(2010-3#1)(2013-1#2)
the 1880s##3##2##(2008-12#1)(2010-3#1)(2013-1#1)
the 18F-labeled compound##2##3##(1990-5#2)
the 18F-labeled##4##2##(1990-5#4)
the 18S rDNA and##2##4##(2007-3#1)(2013-1#1)
the 18S rDNA##3##3##(2007-3#1)(2008-10#1)(2013-1#1)
the 18S rRNA and##2##4##(2006-11#2)
the 18S rRNA sequences 987-1001 and##2##6##(1997-2#2)
the 18S rRNA##9##3##(1997-2#3)(1997-6#1)(2006-11#5)
the 18S region##2##3##(2008-5#1)(2008-9#1)
the 18S##18##2##(1997-2#3)(1997-6#1)(2006-11#5)(2007-3#1)(2008-10#5)(2008-5#1)(2008-9#1)(2013-1#1)
the 18q- syndrome##3##3##(1997-3#3)
the 18th and##4##3##(1993-11#1)(2008-6#1)(2011-1#2)
the 18th century##8##3##(1993-11#2)(1994-3#1)(2008-12#1)(2010-1#1)(2010-8#1)(2012-2#1)(2013-1#1)
the 18th century]##11##3##(2008-8#10)(2008-9#1)
the 18th##32##2##(1993-11#3)(1994-3#1)(1996-4#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-6#2)(2008-7#1)(2008-8#11)(2008-9#1)(2010-1#1)(2010-11#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#1)
the 19##30##2##(1990-2#1)(1990-7#1)(1991-1#2)(1991-2#2)(1992-10#1)(1992-2#1)(1992-6#1)(1994-9#1)(1995-6#1)(1997-7#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-2#1)(2010-11#1)(2010-2#1)(2011-2#1)(2013-8#1)
the 19(th) century##5##3##(2008-12#2)(2009-8#1)(2010-12#1)(2012-12#1)
the 190/170-kDa PFn fragment##2##4##(1991-4#2)
the 1906##2##2##(1990-11#2)
the 1918 influenza pandemic##2##4##(2009-4#2)
the 1918 pandemic virus##2##4##(2011-1#2)
the 1918 pandemic##4##3##(2011-1#4)
the 1918##8##2##(2009-4#2)(2011-1#6)
the 1918-1919 influenza pandemic in##4##5##(2009-7#1)(2010-7#1)(2011-2#2)
the 1918-1919 influenza pandemic##6##4##(2009-7#1)(2010-7#2)(2011-2#3)
the 1918-1919##7##2##(2009-7#1)(2010-7#3)(2011-2#3)
the 1920s##9##2##(1997-3#1)(2008-1#1)(2008-10#1)(2009-10#1)(2009-4#2)(2010-1#1)(2011-7#1)(2012-11#1)
the 1930's##3##2##(1993-3#1)(1994-12#1)(2007-5#1)
the 1930s to##2##3##(2007-12#1)(2013-8#1)
the 1930s##13##2##(1991-12#1)(1993-12#1)(1995-5#1)(2007-12#1)(2007-5#2)(2008-8#1)(2009-4#1)(2010-1#1)(2010-11#1)(2010-8#1)(2012-2#1)(2013-8#1)
the 1940s and##4##3##(1992-12#1)(2006-9#1)(2009-2#1)(2012-2#1)
the 1940s##13##2##(1992-12#1)(1993-6#1)(1994-5#1)(2006-9#1)(2009-2#2)(2009-7#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
the 1950's##3##2##(1992-8#1)(2006-8#1)(2007-3#1)
the 1950s##30##2##(1991-4#1)(1991-6#1)(1992-5#1)(1993-11#1)(1993-6#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-4#1)(1996-2#1)(1996-9#1)(1997-3#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-10#1)(2011-7#1)(2012-1#1)(2012-2#1)
the 1960's##2##2##(1990-2#1)(1993-2#1)
the 1960s and 1970s##4##4##(1992-3#1)(2006-2#1)(2010-2#1)(2012-2#1)
the 1960s and##7##3##(1992-3#1)(2006-2#1)(2008-10#2)(2010-2#1)(2012-2#1)(2013-1#1)
the 1960s to the##3##4##(2007-12#1)(2008-3#1)(2013-8#1)
the 1960s##34##2##(1990-12#1)(1992-1#1)(1992-3#1)(1992-4#1)(1996-3#2)(1997-2#2)(1997-3#1)(2006-12#1)(2006-2#1)(2006-3#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#2)(2008-6#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
the 1970##2##2##(1990-2#1)(2007-11#1)
the 1970s and 1980s and##2##5##(2005-11#1)(2008-10#1)
the 1970s and 1980s##8##4##(1990-12#1)(1992-2#1)(1996-9#1)(2005-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2009-12#1)
the 1970s and##10##3##(1990-12#2)(1992-2#1)(1996-9#1)(2005-11#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2009-12#1)
the 1970s the##2##3##(1991-3#1)(1992-2#1)
the 1970s to##3##3##(1997-4#1)(2008-9#1)(2011-2#1)
the 1970s##61##2##(1990-12#2)(1990-3#1)(1991-2#2)(1991-3#3)(1992-2#2)(1992-5#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-3#1)(1997-4#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-2#2)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
the 1978##2##2##(1996-4#1)(2011-2#1)
the 1980's and early 1990's##2##5##(2008-10#1)(2008-11#1)
the 1980's##9##2##(1993-3#2)(2008-10#2)(2008-11#2)(2008-8#1)(2010-2#1)(2011-2#1)
the 1980s and 1990s##3##4##(2006-4#1)(2008-10#1)(2011-1#1)
the 1980s and the 1990s##2##5##(2004-9#1)(2007-11#1)
the 1980s and##9##3##(1991-3#1)(1997-1#1)(2004-9#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-4#1)(2008-10#1)(2011-1#1)
the 1980s by the##2##4##(1994-9#1)(2008-7#1)
the 1980s by##3##3##(1994-9#1)(2008-4#1)(2008-7#1)
the 1980s that##2##3##(1990-12#1)(2011-2#1)
the 1980s the##3##3##(1997-4#1)(2006-2#1)(2006-7#1)
the 1980s there was##2##4##(1992-2#2)
the 1980s to##3##3##(1990-4#1)(1997-3#1)(2006-4#1)
the 1980s##70##2##(1990-12#1)(1990-4#1)(1990-5#1)(1991-11#1)(1991-3#2)(1992-2#4)(1993-12#1)(1993-2#1)(1993-3#2)(1994-11#1)(1994-2#1)(1994-9#1)(1996-1#2)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#1)(2004-3#1)(2004-4#1)(2004-9#1)(2006-10#2)(2006-2#1)(2006-4#2)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-4#1)(2010-12#2)(2010-3#1)(2011-1#2)(2011-2#5)(2012-3#1)(2013-1#1)
the 1982 American College of##3##5##(2006-10#1)(2007-3#2)
the 1982##5##2##(1991-1#1)(1995-2#1)(2006-10#1)(2007-3#2)
the 1983##2##2##(1991-2#1)(2008-7#1)
the 1984##3##2##(1991-8#1)(1993-3#1)(2008-5#1)
the 1985##7##2##(1991-1#1)(1991-12#1)(1992-12#1)(1992-3#2)(1996-2#1)(2011-2#1)
the 1986##3##2##(1991-1#1)(1993-3#1)(2012-2#1)
the 1987##6##2##(1991-1#1)(1991-12#2)(1997-3#1)(1997-6#1)(2008-6#1)
the 1988 1990 data##2##4##(1995-9#2)
the 1988 guidelines##2##3##(1995-6#2)
the 1988##9##2##(1990-12#1)(1992-1#1)(1992-2#1)(1994-3#1)(1995-6#2)(1995-9#2)(2006-9#1)
the 1988/89##3##2##(1996-6#1)(2007-6#1)(2012-12#1)
the 1989 Loma Prieta earthquake##2##5##(1990-11#2)
the 1989##10##2##(1990-11#2)(1990-12#1)(1991-1#1)(1992-1#1)(1992-2#1)(1993-3#1)(1993-5#1)(1995-12#1)(1995-2#1)
the 1989-90 influenza##2##3##(1992-6#2)
the 1989-90##3##2##(1992-6#2)(1994-3#1)
the 1989/90 season##2##3##(1996-6#2)
the 1990 census##2##3##(1991-5#1)(2008-8#1)
the 1990 samples##2##3##(1997-4#2)
the 1990##20##2##(1990-3#1)(1991-5#1)(1992-12#1)(1992-3#2)(1993-1#1)(1995-2#1)(1997-4#2)(2005-10#1)(2005-8#1)(2006-10#1)(2006-7#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#1)(2010-7#1)(2011-1#1)
the 1990's##3##2##(1991-3#1)(2008-10#1)(2008-8#1)
the 1990-1991##2##2##(1994-6#1)(2007-10#1)
the 1990-91 influenza##2##3##(1992-6#2)
the 1990s has##2##3##(2006-10#1)(2013-8#1)
the 1990s##93##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-1#3)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#5)(1991-8#1)(1992-1#2)(1992-12#3)(1992-2#1)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-12#3)(1994-2#1)(1995-1#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#3)(1997-6#2)(2004-1#1)(2004-9#1)(2005-11#2)(2005-5#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-7#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#4)(2008-8#1)(2009-2#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
the 1991 Gulf War##3##4##(1997-4#1)(2011-2#2)
the 1991##11##2##(1994-7#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-4#2)(2005-10#1)(2006-10#1)(2009-3#1)(2011-2#2)
the 1992 Medicare Current Beneficiary Survey (MCBS)##2##7##(1995-3#1)(1996-3#1)
the 1992##14##2##(1993-12#1)(1993-3#1)(1994-3#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-4#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-6#1)
the 1992-1993##2##2##(1992-2#1)(1993-9#1)
the 1993##7##2##(1994-1#1)(1994-12#1)(1994-3#1)(1994-6#1)(1996-3#1)(2007-7#1)(2008-10#1)
the 1994 meeting in##2##4##(2008-5#2)
the 1994 samples##2##3##(1997-4#2)
the 1994##9##2##(1995-12#1)(1996-12#1)(1996-2#1)(1997-4#3)(2007-6#1)(2008-5#2)
the 1994/95 season##2##3##(1996-6#2)
the 1995##9##2##(1996-4#1)(1996-6#2)(1997-2#1)(1997-3#1)(2008-10#3)(2012-3#1)
the 1996 to 1997##2##4##(2008-10#2)
the 1996 to##3##3##(2008-10#2)(2008-9#1)
the 1996##10##2##(1997-6#1)(2006-4#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-9#1)
the 1997 and 1999##2##4##(2008-10#1)(2013-8#1)
the 1997 and##3##3##(2008-10#2)(2013-8#1)
the 1997##11##2##(1993-10#1)(1997-4#1)(2006-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-8#1)(2012-3#1)(2013-8#1)
the 1997-1998##2##2##(1997-2#1)(2007-5#1)
the 1997-98 El##2##3##(2007-8#2)
the 1997-98##5##2##(2006-7#2)(2007-8#2)(2008-3#1)
the 1998 and 1999##2##4##(2007-4#1)(2008-10#1)
the 1998 and 2005 bleaching events##2##6##(2011-2#2)
the 1998 and##4##3##(2007-4#1)(2008-10#1)(2011-2#2)
the 1998##15##2##(2004-4#2)(2007-4#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2011-2#2)(2012-12#1)
the 1999##17##2##(2006-9#2)(2007-12#1)(2008-10#7)(2008-11#7)
the 19th Annual##2##3##(2006-9#1)(2008-8#1)
the 19th Century##4##3##(2009-10#1)(2010-9#1)(2012-2#1)(2013-1#1)
the 19th and 20th centuries##3##5##(2008-1#1)(2008-3#1)(2010-9#1)
the 19th and 20th##4##4##(2007-8#1)(2008-1#1)(2008-3#1)(2010-9#1)
the 19th century and##4##4##(2005-11#1)(2008-10#1)(2009-7#1)(2011-2#1)
the 19th century##23##3##(1990-12#1)(1991-6#1)(1994-5#1)(1996-1#1)(2004-3#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#3)(2009-2#1)(2009-4#1)(2009-7#2)(2011-2#2)(2012-2#1)
the 19th century]##3##3##(1993-11#1)(2009-10#1)(2009-4#1)
the 19th##40##2##(1990-12#1)(1991-6#1)(1993-11#1)(1994-5#1)(1995-11#1)(1996-1#1)(2004-3#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-9#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-8#4)(2009-10#2)(2009-2#1)(2009-4#2)(2009-7#2)(2010-9#2)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#1)
the 1B chromosome of##2##4##(2008-10#2)
the 1BL##2##2##(2008-10#2)
the 1D x-ray transform##2##4##(2012-1#2)
the 1D##4##2##(1995-7#1)(2009-11#1)(2012-1#2)
the 1H NMR##5##3##(1991-4#1)(1992-9#1)(1994-10#1)(1994-5#1)(1995-8#1)
the 1H##13##2##(1991-4#1)(1991-7#1)(1992-9#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-10#2)(1995-8#1)(2009-7#2)
the 1H-NMR spectra##3##3##(1992-1#1)(1994-3#1)(2006-12#1)
the 1H-NMR##5##2##(1990-5#1)(1991-12#1)(1992-1#1)(1994-3#1)(2006-12#1)
the 1PS paper##3##3##(2008-10#3)
the 1s##2##2##(1995-10#1)(2008-2#1)
the 1st European##2##3##(2008-4#1)(2008-7#1)
the 1st U##2##3##(1996-11#2)
the 1st and 2nd##3##4##(1990-10#1)(1992-12#1)(2011-1#1)
the 1st and##5##3##(1990-10#2)(1992-12#1)(2008-7#1)(2011-1#1)
the 1st antibody##3##3##(2008-10#3)
the 1st day of life##2##5##(1993-12#1)(2008-10#1)
the 1st of##7##3##(2006-8#2)(2007-7#1)(2007-8#1)(2012-2#3)
the 1st to the 14th##2##5##(1991-4#2)
the 1st trimester##2##3##(1990-3#1)(2010-12#1)
the 1st week of##2##4##(1997-5#1)(2008-12#1)
the 1st week##3##3##(1992-8#1)(1997-5#1)(2008-12#1)
the 1st year of life##2##5##(2008-7#1)(2011-12#1)
the 1st year of##4##4##(1993-11#1)(1993-4#1)(2008-7#1)(2011-12#1)
the 1st##57##2##(1990-10#3)(1990-12#2)(1990-3#1)(1990-8#1)(1991-4#3)(1992-10#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-8#2)(1996-11#2)(1997-5#1)(2006-8#2)(2007-7#2)(2007-8#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-12#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#4)
the 2 and##5##3##(1994-12#1)(1994-9#1)(1996-3#1)(2008-4#2)
the 2 cell lines##2##4##(1993-9#1)(1995-5#1)
the 2 drugs##2##3##(1992-4#1)(2006-12#1)
the 2 groups##27##3##(1990-7#1)(1991-11#4)(1993-4#1)(1997-3#1)(2006-12#1)(2006-2#1)(2007-10#2)(2007-11#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-4#2)(2008-6#1)(2009-10#1)(2009-3#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
the 2 h##3##3##(1996-2#1)(1997-2#1)(2005-7#1)
the 2 major##2##3##(1993-9#1)(2009-8#1)
the 2 methods##3##3##(2004-9#3)
the 2 microns plasmid##3##4##(1990-4#1)(1993-9#2)
the 2 microns##5##3##(1990-4#3)(1993-9#2)
the 2 most##3##3##(1995-5#1)(2008-7#1)(2012-2#1)
the 2 week##2##3##(1995-12#1)(2007-10#1)
the 2 weeks##2##3##(1997-3#1)(2009-3#1)
the 2 x 2##2##4##(2008-2#1)(2008-3#1)
the 2 years##7##3##(1993-10#1)(2004-12#1)(2006-3#1)(2008-10#4)
the 2##224##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-4#3)(1990-6#1)(1990-7#4)(1990-8#1)(1990-9#2)(1991-10#3)(1991-11#4)(1991-12#3)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-9#3)(1993-10#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-9#7)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-9#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#1)(1997-6#1)(2004-11#1)(2004-12#1)(2004-4#1)(2004-9#3)(2005-7#3)(2005-8#3)(2006-10#1)(2006-12#2)(2006-2#1)(2006-3#2)(2006-5#1)(2006-9#1)(2007-10#7)(2007-11#9)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#3)(2008-10#33)(2008-11#2)(2008-2#4)(2008-3#7)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#6)(2009-7#1)(2009-8#2)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
the 2%##2##2##(2008-10#1)(2010-8#1)
the 2'##8##2##(1991-4#3)(1993-11#1)(1994-8#2)(1995-11#1)(1995-8#1)
the 2'-hydroxyl group##2##3##(1990-4#1)(2008-4#1)
the 2'-hydroxyl##3##2##(1990-4#1)(2008-4#2)
the 2'-position of##2##3##(2008-4#1)(2009-3#1)
the 2'-position##3##2##(2006-12#1)(2008-4#1)(2009-3#1)
the 2(n(n-1))##2##2##(2007-9#2)
the 2(n)##2##2##(2008-2#1)(2008-7#1)
the 2(nd)##4##2##(2010-4#1)(2011-1#1)(2012-12#2)
the 2- and##6##3##(1995-3#2)(1997-4#3)(2008-4#1)
the 2-##8##2##(1995-3#3)(1997-4#4)(2008-4#1)
the 2-D##12##2##(1997-7#1)(2008-2#3)(2008-3#4)(2008-4#1)(2010-12#1)(2010-8#1)(2012-1#1)
the 2-DE maps##2##3##(2011-3#2)
the 2-DE##3##2##(2008-12#1)(2011-3#2)
the 2-amino group##2##3##(1995-2#2)
the 2-amino##4##2##(1995-2#2)(1997-2#2)
the 2-chloro##2##2##(1997-2#2)
the 2-day##4##2##(2005-1#2)(2009-10#1)(2010-1#1)
the 2-deoxyglucose##2##2##(1992-3#1)(1996-9#1)
the 2-dimensional##2##2##(2007-12#1)(2010-8#1)
the 2-methyl-2-phenylpropyl radical##2##3##(1996-5#2)
the 2-mum##2##2##(2007-12#1)(2008-3#1)
the 2-position of the##2##4##(1997-2#1)(2008-12#1)
the 2-position##10##2##(1991-5#1)(1993-4#2)(1994-5#1)(1995-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(2008-12#1)(2009-9#1)
the 2-pyrrolidone compound##3##3##(1990-5#3)
the 2-week##5##2##(1993-5#1)(1996-11#1)(2007-12#1)(2008-10#1)(2012-1#1)
the 2-year follow-up##3##3##(1995-1#1)(2006-7#1)(2007-8#1)
the 2-year survival rate was##2##5##(1993-2#1)(2007-12#1)
the 2-year##14##2##(1993-2#1)(1995-1#1)(1996-11#1)(1996-5#1)(2006-7#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-8#1)(2009-10#1)(2009-3#1)(2011-2#1)(2013-1#2)
the 2-yr##3##2##(2007-8#3)
the 20 amino acids##2##4##(1994-3#1)(1995-12#1)
the 20 and##3##3##(2008-10#2)(2009-7#1)
the 20 degrees##2##3##(1993-1#1)(1997-7#1)
the 20 patients were##2##4##(1992-5#1)(2008-6#1)
the 20 patients##7##3##(1990-7#1)(1992-5#1)(1997-5#1)(2008-6#3)(2013-1#1)
the 20 reported##2##3##(2008-10#2)
the 20 virulent strains##2##4##(2008-10#2)
the 20##74##2##(1990-11#1)(1990-2#1)(1990-7#1)(1990-9#2)(1991-3#1)(1991-7#1)(1991-8#1)(1992-5#1)(1993-1#1)(1993-11#1)(1994-10#3)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-10#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-5#1)(1997-7#1)(2006-10#3)(2006-8#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#15)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#3)(2008-8#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-11#1)(2013-1#1)(2013-8#2)
the 20% of the subjects with the##2##7##(2007-4#2)
the 20% of the##3##4##(1993-5#1)(2007-4#2)
the 20% of##4##3##(1993-5#1)(2007-4#2)(2012-2#1)
the 20%##10##2##(1992-9#1)(1993-5#1)(1997-3#1)(2004-11#1)(2007-4#2)(2008-8#1)(2009-6#1)(2012-2#1)(2013-8#1)
the 20-29##2##2##(1993-11#1)(2007-2#1)
the 20-carbon##4##2##(1990-3#1)(1994-11#1)(1995-1#1)(1995-11#1)
the 20-dB##2##2##(2007-12#2)
the 20-kDa##6##2##(1990-2#1)(1993-11#1)(1993-12#2)(1994-11#1)(1995-8#1)
the 20-mg dose##3##3##(1996-2#3)
the 200##5##2##(1990-3#1)(1991-5#1)(2006-10#1)(2008-1#1)(2012-3#1)
the 2000 census##3##3##(2010-11#1)(2011-1#1)(2011-2#1)
the 2000##24##2##(2006-11#1)(2007-2#1)(2007-9#1)(2008-10#4)(2008-11#8)(2008-8#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-3#1)
the 2000s##4##2##(2007-12#1)(2008-10#1)(2010-12#1)(2012-3#1)
the 2001 National##2##3##(2007-8#1)(2013-1#1)
the 2001##26##2##(2007-1#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#10)(2008-5#2)(2009-5#1)(2010-5#1)(2012-12#1)(2013-1#1)
the 2002 National##2##3##(2008-10#1)(2010-2#1)
the 2002##21##2##(2006-2#3)(2007-2#1)(2008-10#5)(2008-11#6)(2008-3#1)(2008-7#2)(2010-11#1)(2010-2#1)(2011-2#1)
the 2003##28##2##(2006-10#1)(2006-9#2)(2007-12#1)(2007-4#2)(2008-10#2)(2008-11#8)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#2)(2009-7#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-1#1)
the 2003-2009##2##2##(2011-2#2)
the 2004##21##2##(2007-12#1)(2007-4#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#8)(2008-12#1)(2008-4#1)(2009-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
the 2005 National##2##3##(2007-8#1)(2009-7#1)
the 2005 southern##2##3##(2008-11#1)(2009-5#1)
the 2005##22##2##(2007-8#1)(2008-10#1)(2008-11#8)(2008-12#1)(2008-4#2)(2008-8#1)(2009-5#2)(2009-7#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
the 2005-06##2##2##(2012-12#2)
the 2006 to##2##3##(2011-2#2)
the 2006##22##2##(2007-10#1)(2008-10#1)(2008-11#9)(2008-12#1)(2008-6#2)(2008-8#1)(2009-11#1)(2011-2#3)(2012-3#1)(2013-1#2)
the 2006-2007##2##2##(2008-12#1)(2008-7#1)
the 2007 Australian Children's Survey##4##5##(2012-1#4)
the 2007 National##2##3##(2012-12#1)(2013-1#1)
the 2007##21##2##(2008-11#4)(2008-12#1)(2009-11#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#4)(2012-12#1)(2012-5#1)(2013-1#3)
the 2008##9##2##(2009-10#1)(2010-8#3)(2011-2#1)(2012-1#2)(2012-2#1)(2013-7#1)
the 2009 H1N1 pandemic##3##4##(2011-2#3)
the 2009 S-OIV##2##3##(2011-1#2)
the 2009 influenza##3##3##(2011-2#1)(2012-12#1)(2013-1#1)
the 2009 pandemic##2##3##(2011-1#1)(2013-1#1)
the 2009##15##2##(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-12#1)(2013-1#2)(2013-8#1)
the 2010##18##2##(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#7)(2013-7#1)
the 2011##4##2##(2011-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
the 2042##2##2##(2012-12#2)
the 209##3##2##(2008-11#2)(2008-6#1)
the 20S RNA replicon##2##4##(1996-9#2)
the 20S##9##2##(1990-5#1)(1995-12#1)(1996-9#2)(1997-7#1)(2008-4#2)(2008-5#2)
the 20s##3##2##(2006-5#3)
the 20th century but##2##4##(2004-3#1)(2008-9#1)
the 20th century##45##3##(1994-12#1)(2004-3#2)(2006-10#7)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-5#1)(2007-8#4)(2008-1#3)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#4)(2010-1#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-7#1)(2013-8#1)
the 20th postnatal##2##3##(1993-12#2)
the 20th week##3##3##(1990-9#1)(1993-7#1)(2009-6#1)
the 20th##62##2##(1990-9#1)(1992-6#1)(1993-12#2)(1993-7#1)(1994-12#1)(1994-3#1)(1997-2#1)(2004-3#2)(2006-10#7)(2006-7#1)(2006-8#1)(2006-9#3)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#4)(2008-1#3)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2009-7#4)(2010-1#1)(2010-10#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#2)(2011-7#1)(2013-8#1)
the 21 day##2##3##(1996-12#1)(2012-2#1)
the 21 kDa pea protein##2##5##(1993-6#2)
the 21 sites##2##3##(1997-5#2)
the 21 survivors##2##3##(2006-11#1)(2008-7#1)
the 21##30##2##(1991-12#1)(1991-2#1)(1993-3#1)(1993-6#2)(1993-9#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-5#2)(2006-11#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)
the 21(st) century##4##3##(2007-9#1)(2008-11#1)(2008-7#1)(2012-12#1)
the 21(st)##5##2##(2006-12#1)(2007-9#1)(2008-11#1)(2008-7#1)(2012-12#1)
the 21-##2##2##(1995-5#1)(2008-10#1)
the 210##2##2##(1993-2#1)(1994-9#1)
the 212-kDa##3##2##(1993-3#3)
the 21q22##3##2##(1996-6#1)(1997-2#1)(1997-8#1)
the 21st Annual##2##3##(2009-5#1)(2011-1#1)
the 21st Century##6##3##(1995-12#1)(2007-10#1)(2007-2#1)(2009-4#1)(2011-1#1)(2011-2#1)
the 21st amino##2##3##(2012-2#2)
the 21st century and##3##4##(2007-7#1)(2008-11#1)(2012-12#1)
the 21st century are##2##4##(1991-12#1)(2006-10#1)
the 21st century##75##3##(1990-12#1)(1991-1#1)(1991-12#1)(1992-12#1)(1994-1#1)(1994-12#1)(1994-2#5)(1994-3#1)(1995-1#1)(1995-12#1)(1995-9#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#3)(2005-1#1)(2005-10#1)(2005-12#1)(2006-10#3)(2006-6#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#3)(2007-7#1)(2008-1#5)(2008-10#2)(2008-11#4)(2008-12#3)(2008-3#1)(2008-4#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#2)(2009-3#1)(2010-12#1)(2010-5#2)(2011-1#2)(2012-12#2)(2013-1#3)
the 21st century?##4##3##(1994-3#1)(2007-4#2)(2012-3#1)
the 21st##100##2##(1990-12#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-12#1)(1992-12#1)(1994-1#1)(1994-12#1)(1994-2#5)(1994-3#2)(1995-1#2)(1995-12#2)(1995-2#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#3)(2005-1#1)(2005-10#1)(2005-12#1)(2005-8#2)(2006-10#3)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#5)(2007-7#1)(2008-1#6)(2008-10#2)(2008-11#4)(2008-12#3)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#2)(2010-5#2)(2011-1#4)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)
the 22 kDa##5##3##(1994-11#1)(1994-12#4)
the 22 patients who##2##4##(2006-6#1)(2010-12#1)
the 22 patients##8##3##(1997-8#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-7#1)(2010-12#1)
the 22##33##2##(1991-1#1)(1991-2#2)(1992-2#1)(1993-8#1)(1994-11#1)(1994-12#5)(1994-8#1)(1994-9#2)(1997-8#2)(2004-2#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-7#3)(2007-8#1)(2008-10#2)(2008-3#2)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#1)
the 22-kDa##3##2##(1993-3#1)(1995-8#1)(2008-10#1)
the 22-month-old##2##2##(1994-3#2)
the 224##2##2##(1997-3#1)(2009-12#1)
the 224-nm##3##2##(2008-2#3)
the 225##3##2##(1992-8#1)(2005-8#1)(2006-6#1)
the 22nd##2##2##(1990-12#1)(2011-2#1)
the 22q11##5##2##(1996-3#1)(1997-3#3)(2012-12#1)
the 23 kDa##2##3##(1993-6#1)(1996-7#1)
the 23 mothers prepared##2##4##(1991-9#2)
the 23 patients with##2##4##(1992-8#1)(1993-10#1)
the 23 patients##5##3##(1991-2#1)(1992-6#1)(1992-8#1)(1993-10#1)(2008-6#1)
the 23##30##2##(1991-10#1)(1991-2#1)(1991-7#1)(1991-9#2)(1992-10#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-6#1)(1994-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-6#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-2#2)(2007-3#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-12#1)(2013-8#1)
the 23-kDa protein##3##3##(1993-6#1)(1994-12#1)(2009-11#1)
the 23-kDa##6##2##(1990-12#1)(1990-5#1)(1993-6#1)(1994-12#1)(1996-4#1)(2009-11#1)
the 23-valent pneumococcal##2##3##(1994-9#1)(2012-12#1)
the 23S rRNA##2##3##(2005-7#2)
the 23S##7##2##(1992-3#1)(1993-12#1)(1995-8#3)(2005-7#2)
the 23rd##7##2##(2006-3#1)(2006-9#1)(2007-6#1)(2007-8#1)(2009-5#1)(2010-7#1)(2012-2#1)
the 24 h period##2##4##(1995-12#1)(1996-12#1)
the 24 h preceding the##2##5##(1995-6#1)(1996-5#1)
the 24 h##16##3##(1990-12#1)(1990-2#1)(1995-12#1)(1995-6#1)(1996-12#3)(1996-2#1)(1996-5#1)(2004-4#1)(2004-9#1)(2008-10#2)(2008-11#2)(2008-3#1)
the 24 hours after##2##4##(1993-2#1)(2012-12#1)
the 24 patients with##3##4##(2007-10#1)(2008-1#1)(2008-6#1)
the 24 patients##5##3##(1993-4#1)(1993-8#1)(2007-10#1)(2008-1#1)(2008-6#1)
the 24##58##2##(1990-12#1)(1990-2#2)(1991-10#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-2#2)(1993-4#1)(1993-8#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-6#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-5#1)(1996-9#1)(1997-6#1)(2004-4#1)(2004-9#1)(2005-8#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-4#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-3#1)(2008-6#2)(2008-8#1)(2010-1#1)(2011-1#1)(2012-12#3)(2012-3#2)(2013-1#2)(2013-8#1)
the 24- and 51-kDa subunits##2##5##(1991-2#2)
the 24- and##3##3##(1991-2#3)
the 24-##4##2##(1991-2#4)
the 24-h mean##2##3##(1990-3#2)
the 24-h##7##2##(1990-3#2)(1994-8#1)(1995-11#1)(2005-8#1)(2008-10#1)(2008-9#1)
the 24-hour period##2##3##(2008-3#1)(2013-1#1)
the 24-hour urinary total protein##2##5##(2008-5#2)
the 24-hour##9##2##(1992-8#2)(2007-11#1)(2008-1#1)(2008-3#1)(2008-5#2)(2011-1#1)(2013-1#1)
the 24-item##2##2##(1993-2#1)(2010-8#1)
the 24-kDa##3##2##(1992-12#1)(2009-10#2)
the 240##4##2##(1990-5#1)(2008-1#1)(2008-3#1)(2011-2#1)
the 24h##2##2##(2007-8#1)(2009-4#1)
the 24th hour##2##3##(2008-4#1)(2010-12#1)
the 24th##9##2##(1994-3#1)(1995-8#2)(1996-11#1)(2008-4#2)(2010-12#2)(2011-1#1)
the 25 and##2##3##(1990-8#1)(2008-10#1)
the 25 cases##2##3##(2008-6#1)(2011-12#1)
the 25 degrees##4##3##(2008-5#4)
the 25 years##3##3##(1996-4#1)(1997-8#1)(2007-11#1)
the 25##31##2##(1990-8#2)(1991-2#1)(1992-12#2)(1994-4#1)(1996-4#1)(1997-8#1)(2004-11#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-1#1)(2011-1#1)(2011-12#1)(2012-12#1)
the 25%##2##2##(2007-1#1)(2013-1#1)
the 25-hydroxysterol and the 15-ketosterol##2##5##(1993-6#2)
the 25-item##2##2##(2011-1#2)
the 25-kDa##3##2##(1990-12#1)(1993-11#1)(2008-10#1)
the 257 patients##2##3##(1996-11#1)(2011-2#1)
the 257##4##2##(1996-11#1)(2005-7#1)(2011-2#1)(2012-2#1)
the 25S rDNA##4##3##(1996-9#4)
the 25th##3##2##(2007-8#1)(2008-9#1)(2011-2#1)
the 26 cases##2##3##(1996-11#1)(2012-3#1)
the 26 kDa##2##3##(1996-11#1)(2006-12#1)
the 26##16##2##(1991-6#1)(1993-12#1)(1995-11#1)(1995-2#1)(1996-11#3)(2006-12#1)(2006-8#1)(2009-4#1)(2009-9#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
the 260##3##2##(1994-9#1)(2010-8#1)(2011-1#1)
the 262##2##2##(2013-1#1)(2013-8#1)
the 265##2##2##(2008-10#1)(2013-1#1)
the 26S protease##2##3##(1997-7#2)
the 26S proteasome and ribosome##3##5##(2009-8#3)
the 26S proteasome##10##3##(1996-11#3)(2007-12#1)(2008-4#2)(2009-8#4)
the 26S##12##2##(1996-11#3)(1997-7#2)(2007-12#1)(2008-4#2)(2009-8#4)
the 27 kD##2##3##(1990-7#1)(2008-5#1)
the 27 kDa##4##3##(1990-12#1)(1990-8#3)
the 27 patients##2##3##(2006-8#1)(2012-1#1)
the 27##14##2##(1990-12#1)(1990-7#1)(1990-8#3)(1991-1#1)(1997-2#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-5#2)(2010-11#1)(2012-1#1)
the 275##2##2##(1995-11#1)(2005-10#1)
the 27th International##2##3##(2008-7#1)(2010-3#1)
the 27th##7##2##(1995-1#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-3#1)(2012-12#1)
the 28 patients##2##3##(2008-7#1)(2013-1#1)
the 28##19##2##(1990-11#1)(1991-3#1)(1992-6#1)(1993-8#1)(1996-10#1)(1996-12#3)(1996-7#1)(1997-2#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-11#1)(2013-1#1)
the 28-day##2##2##(2010-6#1)(2010-8#1)
the 286##2##2##(2007-12#1)(2007-7#1)
the 28S rRNA##6##3##(1991-5#1)(1992-12#1)(1994-12#1)(1995-8#1)(2008-5#1)(2010-4#1)
the 28S##9##2##(1991-5#1)(1992-12#1)(1994-12#1)(1995-8#1)(2007-12#1)(2008-10#2)(2008-5#1)(2010-4#1)
the 28th day##4##3##(1991-4#1)(1992-10#1)(1996-12#1)(2012-2#1)
the 28th week##2##3##(1993-5#1)(1995-6#1)
the 28th##9##2##(1991-4#2)(1992-10#1)(1993-5#1)(1995-6#1)(1996-12#1)(2008-10#1)(2010-12#1)(2012-2#1)
the 29 kDa amino terminal fragment of fibronectin##2##8##(1994-3#2)
the 29 kDa##4##3##(1994-3#3)(2009-7#1)
the 29 patients##2##3##(1991-12#1)(1991-4#1)
the 29##24##2##(1991-10#1)(1991-11#1)(1991-12#2)(1991-4#1)(1993-5#1)(1993-9#1)(1994-3#3)(1995-11#1)(1995-6#1)(1996-8#1)(1997-7#1)(2005-11#1)(2008-10#3)(2008-4#1)(2009-2#1)(2009-7#2)(2010-5#1)(2011-1#1)
the 29-base region##4##3##(1994-9#4)
the 29-kDa protein##2##3##(1992-12#2)
the 29-kb plasmid##2##3##(2008-10#2)
the 29th##3##2##(1992-10#1)(2008-4#1)(2013-8#1)
the 2D and 3D##3##4##(2010-8#1)(2012-1#1)(2013-1#1)
the 2D separation##2##3##(2008-10#2)
the 2D##18##2##(1992-3#1)(1996-2#1)(2005-8#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-5#1)(2010-8#1)(2011-1#3)(2012-1#4)(2013-1#1)
the 2Fe-2S* cluster##2##3##(1991-7#2)
the 2Fe-2S*##4##2##(1991-7#4)
the 2H NMR##2##3##(1991-4#1)(1994-5#1)
the 2H##3##2##(1991-4#1)(1994-5#1)(2008-10#1)
the 2R4F##4##2##(2007-8#4)
the 2a##2##2##(2008-10#2)
the 2b protein##2##3##(2012-2#2)
the 2d##2##2##(1990-12#1)(1990-3#1)
the 2f##2##2##(2008-3#2)
the 2nd Helsingborg Declaration##3##4##(2008-8#3)
the 2nd and 3rd trimesters##3##5##(2010-12#2)(2011-1#1)
the 2nd and 3rd##10##4##(1994-12#1)(2006-6#1)(2008-7#1)(2010-12#2)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#1)
the 2nd and##14##3##(1994-12#1)(1995-2#1)(1996-11#1)(1997-3#1)(2006-6#1)(2007-1#1)(2008-7#1)(2010-12#2)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#1)
the 2nd antibody##3##3##(2008-10#3)
the 2nd case##3##3##(2007-7#1)(2010-9#2)
the 2nd day after##2##4##(1995-2#1)(2008-5#1)
the 2nd week##3##3##(1990-11#1)(1993-8#1)(2005-11#1)
the 2nd year##2##3##(2006-7#1)(2008-7#1)
the 2nd##47##2##(1990-10#1)(1990-11#1)(1990-8#1)(1991-3#1)(1992-1#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-2#2)(1996-11#1)(1997-3#1)(2004-1#1)(2005-11#1)(2006-12#1)(2006-3#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-2#1)(2007-7#4)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#3)(2010-12#2)(2010-3#2)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#1)
the 2p##2##2##(1993-8#1)(2008-2#1)
the 2x2 method##3##3##(1992-10#3)
the 3 Pharmacopoeias##2##3##(2007-8#2)
the 3 days##2##3##(2008-3#1)(2013-1#1)
the 3 groups##3##3##(1997-4#1)(2007-10#1)(2013-7#1)
the 3 h##4##3##(1992-5#1)(1992-7#1)(1994-11#1)(2008-10#1)
the 3 main##2##3##(2008-3#1)(2011-1#1)
the 3 major##2##3##(1996-5#1)(2005-7#1)
the 3 mg/kg group##3##4##(2008-9#3)
the 3 months##5##3##(1990-3#1)(1994-2#1)(2007-7#2)(2007-9#1)
the 3 patients##5##3##(1997-6#1)(1997-7#3)(2011-2#1)
the 3 strains##3##3##(1992-7#1)(2007-11#2)
the 3 types of##2##4##(1997-4#1)(2012-2#1)
the 3 x 1 S##2##5##(1997-8#2)
the 3 x##3##3##(1997-8#2)(2008-2#1)
the 3 year period##2##4##(2008-7#2)
the 3 years of##2##4##(2008-10#1)(2009-2#1)
the 3 years##8##3##(1995-12#1)(2008-10#6)(2009-2#1)
the 3##150##2##(1990-11#2)(1990-3#1)(1990-4#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-9#1)(1992-1#1)(1992-3#2)(1992-5#2)(1992-7#2)(1993-5#1)(1993-7#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#5)(1995-4#1)(1995-9#1)(1996-2#2)(1996-5#2)(1997-1#1)(1997-2#2)(1997-4#3)(1997-6#2)(1997-7#3)(1997-8#2)(2004-3#2)(2004-9#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#5)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#16)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-2#2)(2009-4#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)
the 3%##3##2##(2008-10#1)(2008-3#2)
the 3' UTR of the##2##5##(1996-12#1)(2011-2#1)
the 3' UTR of##5##4##(1996-12#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-3#1)
the 3' UTR##7##3##(1996-12#2)(1997-2#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-3#1)
the 3' coding##2##3##(1991-2#1)(1992-5#1)
the 3' direction##2##3##(1990-7#1)(2012-1#1)
the 3' end of a##5##5##(1991-7#1)(1993-11#1)(1994-9#1)(2006-11#1)(2008-10#1)
the 3' end of the gene##2##6##(1990-8#1)(1993-11#1)
the 3' end of the genome##2##6##(2008-10#1)(2008-11#1)
the 3' end of the human apolipoprotein B gene##2##9##(1990-8#2)
the 3' end of the lacZ gene##2##7##(1991-7#2)
the 3' end of the open reading frame##2##8##(1992-6#1)(1992-8#1)
the 3' end of the##30##5##(1990-3#1)(1990-4#1)(1990-8#3)(1991-7#2)(1992-3#3)(1992-6#1)(1992-8#1)(1993-11#1)(1993-5#1)(1993-9#1)(1994-12#2)(1994-3#1)(1995-8#1)(1996-8#1)(1997-2#1)(1997-4#2)(2008-10#3)(2008-11#1)(2008-4#1)(2010-2#1)(2013-1#1)
the 3' end of viral genomic##2##6##(2008-10#2)
the 3' end of##48##4##(1990-3#1)(1990-4#2)(1990-8#3)(1991-7#3)(1992-12#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-11#2)(1993-5#1)(1993-9#1)(1994-12#4)(1994-3#1)(1994-9#2)(1995-8#1)(1996-8#1)(1997-2#2)(1997-4#2)(1997-7#1)(2006-11#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-2#1)(2013-1#1)
the 3' end##65##3##(1990-2#1)(1990-3#1)(1990-4#2)(1990-8#3)(1991-5#1)(1991-7#3)(1992-12#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-5#1)(1993-9#1)(1994-12#4)(1994-3#3)(1994-9#2)(1995-8#1)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-4#3)(1997-7#1)(2005-11#2)(2006-11#1)(2007-12#2)(2008-10#9)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-2#1)(2013-1#1)(2013-8#1)
the 3' ends of the##3##5##(1994-12#1)(1995-2#1)(1996-7#1)
the 3' ends of##6##4##(1992-2#1)(1994-12#1)(1995-2#1)(1995-8#1)(1996-7#1)(2008-9#1)
the 3' flanking##2##3##(1990-9#1)(1996-6#1)
the 3' half##3##3##(1991-5#1)(1993-5#1)(2008-8#1)
the 3' non-coding##4##3##(1990-4#1)(1990-7#1)(1993-12#1)(1997-7#1)
the 3' noncoding##4##3##(1990-12#1)(1992-11#1)(1992-5#1)(2008-10#1)
the 3' nontranslated##3##3##(1993-3#1)(1995-11#1)(2008-10#1)
the 3' part of the##2##5##(1997-3#1)(2008-10#1)
the 3' part##3##3##(1997-3#1)(2008-10#2)
the 3' region of the##2##5##(1991-6#1)(1997-3#1)
the 3' region of##3##4##(1991-6#1)(1997-3#2)
the 3' region##5##3##(1991-6#1)(1995-8#1)(1997-3#2)(2008-10#1)
the 3' regions of##2##4##(1996-7#1)(1997-6#1)
the 3' side##3##3##(1993-12#1)(1993-6#1)(2008-8#1)
the 3' terminal##6##3##(1991-7#1)(1991-9#1)(1997-3#2)(2008-10#2)
the 3' termini of##2##4##(2008-10#1)(2008-8#1)
the 3' termini##3##3##(2008-10#2)(2008-8#1)
the 3' terminus of the##2##5##(1994-8#1)(1996-5#1)
the 3' terminus of##3##4##(1994-8#1)(1996-5#1)(1996-8#1)
the 3' terminus##4##3##(1994-8#1)(1996-5#1)(1996-8#1)(2008-10#1)
the 3' untranslated region (3'UTR) of##2##6##(2008-10#1)(2009-5#1)
the 3' untranslated region (3'UTR)##4##5##(1994-3#1)(2008-10#2)(2009-5#1)
the 3' untranslated region of the##3##6##(1991-10#1)(1995-2#1)(1997-6#1)
the 3' untranslated region of##7##5##(1991-10#1)(1991-11#1)(1995-2#1)(1997-6#2)(2007-2#1)(2008-7#1)
the 3' untranslated region##16##4##(1990-2#1)(1991-10#1)(1991-11#1)(1991-9#1)(1994-11#1)(1994-3#1)(1995-2#1)(1997-4#1)(1997-6#3)(2007-2#1)(2008-10#2)(2008-7#1)(2009-5#1)
the 3' untranslated##21##3##(1990-2#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-9#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-4#1)(1997-4#1)(1997-6#3)(1997-8#1)(2007-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-5#1)
the 3'##185##2##(1990-11#1)(1990-12#1)(1990-2#4)(1990-3#1)(1990-4#5)(1990-5#1)(1990-7#3)(1990-8#4)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#2)(1991-5#2)(1991-6#1)(1991-7#5)(1991-9#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#4)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#3)(1993-11#2)(1993-12#5)(1993-2#1)(1993-3#2)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#5)(1994-3#4)(1994-8#3)(1994-9#3)(1995-11#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-8#4)(1996-12#2)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#4)(1996-9#1)(1997-2#4)(1997-3#5)(1997-4#4)(1997-6#4)(1997-7#2)(1997-8#1)(2005-11#2)(2006-11#1)(2007-1#1)(2007-12#2)(2007-2#2)(2008-10#24)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#4)(2008-8#5)(2008-9#3)(2009-5#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-3#4)(2013-1#1)(2013-8#1)
the 3'- and##3##3##(1997-1#1)(2008-4#2)
the 3'- or##2##3##(1990-5#1)(2006-12#1)
the 3'-##6##2##(1990-5#1)(1997-1#1)(1997-6#1)(2006-12#1)(2008-4#2)
the 3'-5' exonuclease activity of##2##5##(1990-2#1)(1997-6#1)
the 3'-5' exonuclease activity##4##4##(1990-2#1)(1997-6#3)
the 3'-5' exonuclease##7##3##(1990-2#2)(1997-6#5)
the 3'-UTR of##3##3##(1996-7#1)(2008-1#1)(2013-1#1)
the 3'-UTR##5##2##(1995-12#1)(1996-7#1)(2008-1#2)(2013-1#1)
the 3'-end of the##4##4##(1990-3#1)(1991-8#1)(1993-4#1)(1993-8#1)
the 3'-end of##10##3##(1990-3#1)(1991-6#1)(1991-8#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-8#1)(2013-1#2)
the 3'-end##13##2##(1990-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-8#1)(1996-4#1)(2006-12#1)(2013-1#2)
the 3'-hydroxyl group##2##3##(1995-8#1)(1996-6#1)
the 3'-hydroxyl##4##2##(1995-8#1)(1996-6#1)(1996-7#1)(1997-2#1)
the 3'-noncoding region of the##2##5##(1991-12#1)(1993-7#1)
the 3'-noncoding region of##3##4##(1991-12#1)(1993-7#1)(1997-2#1)
the 3'-phenyl ring##2##3##(1994-9#1)(1997-4#1)
the 3'-phosphodiesterase##2##2##(1995-1#2)
the 3'-tRNA-like structure of##2##4##(1997-3#2)
the 3'-terminal exon##3##3##(1995-8#3)
the 3'-terminal region of insA##2##5##(1990-3#2)
the 3'-terminal region of##4##4##(1990-3#2)(1997-2#1)(2008-10#1)
the 3'-terminal##12##2##(1990-3#2)(1992-6#1)(1993-8#1)(1994-9#1)(1995-1#1)(1995-8#3)(1997-2#1)(2008-10#2)
the 3'-untranslated region of##6##4##(1990-5#1)(1994-12#1)(1994-9#3)(2011-2#1)
the 3'-untranslated region##20##3##(1990-5#2)(1993-2#1)(1994-12#2)(1994-9#7)(1995-12#1)(1995-3#1)(1996-4#2)(1996-5#1)(2006-12#1)(2008-10#1)(2011-2#1)
the 3'-untranslated regions##3##3##(1990-5#2)(1995-8#1)
the 3'-untranslated##24##2##(1990-5#4)(1993-2#2)(1994-12#2)(1994-9#7)(1995-12#1)(1995-3#1)(1995-8#1)(1996-4#2)(1996-5#1)(2006-12#1)(2008-10#1)(2011-2#1)
the 3'UTR of##6##3##(1993-11#1)(1994-12#1)(1997-5#1)(2008-10#1)(2008-9#1)(2011-2#1)
the 3'UTR##7##2##(1993-11#1)(1994-12#2)(1997-5#1)(2008-10#1)(2008-9#1)(2011-2#1)
the 3'alpha-##2##2##(1993-4#2)
the 3'untranslated##2##2##(2007-12#1)(2008-11#1)
the 3(rd)##3##2##(2008-5#1)(2012-12#2)
the 3- and##2##3##(1995-8#1)(2007-11#1)
the 3-##3##2##(1995-8#1)(2007-11#1)(2013-8#1)
the 3-(4##3##2##(2007-11#1)(2008-4#1)(2010-8#1)
the 3-(N-tert-butylcarboxamido)-1-propyl##2##2##(2008-4#2)
the 3-21G*##2##2##(1992-9#1)(2008-11#1)
the 3-4##4##2##(1992-6#2)(2007-7#1)(2010-6#1)
the 3-5##3##2##(2009-5#1)(2011-1#1)(2013-8#1)
the 3-5-microm##2##2##(2007-11#1)(2008-3#1)
the 3-D culture##2##3##(2008-11#1)(2009-3#1)
the 3-D images##2##3##(2007-11#1)(2008-5#1)
the 3-D model of hIL-6R##2##5##(2008-8#2)
the 3-D model##4##3##(2008-3#1)(2008-5#1)(2008-8#2)
the 3-D structure of##4##4##(1992-12#2)(2008-4#1)(2011-1#1)
the 3-D structure##5##3##(1992-12#2)(2008-4#1)(2011-1#2)
the 3-D wavelet##2##3##(2008-2#2)
the 3-D##36##2##(1992-12#2)(2007-11#1)(2008-11#2)(2008-2#9)(2008-3#9)(2008-4#2)(2008-5#2)(2008-8#2)(2009-3#1)(2011-1#3)(2011-2#2)(2012-2#1)
the 3-amidoethane side chain##2##4##(1995-3#2)
the 3-dimensional##3##2##(1997-7#1)(2006-12#1)(2008-11#1)
the 3-h##3##2##(2006-5#1)(2008-10#2)
the 3-hour##3##2##(2006-6#1)(2007-10#1)(2007-9#1)
the 3-microm##2##2##(2007-12#1)(2008-3#1)
the 3-month follow-up##4##3##(1997-2#1)(2008-6#1)(2011-2#1)(2012-2#1)
the 3-month mark##2##3##(2008-8#1)(2011-2#1)
the 3-month##11##2##(1994-3#2)(1997-2#1)(2006-12#1)(2008-6#1)(2008-8#1)(2011-2#3)(2012-2#1)(2012-3#1)
the 3-oxoacyl-CoA esters of##2##4##(1997-7#2)
the 3-position of##3##3##(1993-4#1)(1996-8#1)(1997-3#1)
the 3-position##4##2##(1993-4#1)(1994-11#1)(1996-8#1)(1997-3#1)
the 3-thia fatty acids##2##4##(1995-3#2)
the 3-thia fatty##3##3##(1995-3#3)
the 3-thia##4##2##(1995-3#3)(2007-8#1)
the 3-week##5##2##(1996-1#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-12#1)
the 3-year follow-up##2##3##(2006-12#1)(2006-7#1)
the 3-year period##3##3##(1995-1#1)(2005-12#1)(2008-6#1)
the 3-year##7##2##(1995-1#1)(2005-12#1)(2006-12#1)(2006-7#1)(2008-6#1)(2011-2#2)
the 3-year-old##2##2##(2007-4#1)(2008-10#1)
the 30 degrees C-acclimated carp contained##2##6##(1997-7#2)
the 30 patients##5##3##(1991-2#1)(1993-2#1)(1997-6#1)(2004-1#1)(2009-8#1)
the 30##39##2##(1990-7#1)(1990-8#1)(1991-2#2)(1992-12#1)(1993-2#1)(1994-7#1)(1995-1#1)(1995-4#1)(1995-6#1)(1996-11#1)(1997-6#1)(1997-7#2)(2004-1#1)(2006-10#1)(2007-11#1)(2007-3#1)(2007-6#1)(2007-7#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-2#4)(2012-3#1)
the 30%##3##2##(2006-12#1)(2008-10#1)(2010-12#1)
the 30-day##7##2##(2007-10#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#2)(2010-6#1)
the 30-kDa enzyme##2##3##(1994-11#2)
the 30-kDa##6##2##(1992-9#1)(1993-3#2)(1994-11#2)(1995-2#1)
the 30-m##2##2##(2008-10#1)(2012-12#1)
the 30-minute##2##2##(2008-6#1)(2011-2#1)
the 300 MHz FID signal##2##5##(2007-3#2)
the 305/311##2##2##(2008-3#2)
the 309##2##2##(1990-5#1)(1993-2#1)
the 30S ribosomal subunit##2##4##(1992-2#1)(1992-6#1)
the 30S ribosomal##3##3##(1992-2#1)(1992-6#1)(2009-9#1)
the 30S small ribosomal subunit##2##5##(2009-9#2)
the 30S subunit##2##3##(1993-11#1)(2005-7#1)
the 30S##7##2##(1992-2#1)(1992-6#1)(1993-11#1)(2005-7#1)(2009-9#3)
the 30th day##4##3##(1993-7#1)(2007-12#1)(2008-7#1)(2012-3#1)
the 30th##11##2##(1993-7#1)(1994-2#1)(1995-8#1)(2006-2#1)(2007-12#1)(2007-4#1)(2008-12#1)(2008-5#2)(2008-7#1)(2012-3#1)
the 31##14##2##(1990-2#3)(1990-9#1)(1991-6#1)(1997-8#1)(2006-8#1)(2007-5#2)(2007-8#1)(2008-10#3)(2008-9#1)
the 31P##4##2##(1992-2#1)(1993-6#1)(1995-10#1)(1995-7#1)
the 31P-NMR spectrum##2##3##(1991-1#2)
the 31P-NMR##3##2##(1991-1#2)(1991-9#1)
the 32 kDa##2##3##(1993-12#1)(2012-2#1)
the 32 patients##6##3##(1993-9#1)(1994-3#1)(1996-2#1)(2006-12#1)(2008-4#1)(2011-2#1)
the 32##22##2##(1993-12#1)(1993-9#2)(1994-12#1)(1994-3#1)(1994-9#1)(1995-10#1)(1996-2#1)(2006-12#1)(2006-8#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
the 32- and##2##3##(1994-12#1)(1995-6#1)
the 32-##3##2##(1994-12#1)(1995-6#1)(2008-10#1)
the 32-kDa##3##2##(1994-11#1)(1994-9#1)(2008-10#1)
the 323##2##2##(1996-11#1)(2008-7#1)
the 32P-postlabeling assay##4##3##(1992-7#3)(1993-2#1)
the 32P-postlabeling##5##2##(1992-1#1)(1992-7#3)(1993-2#1)
the 32nd week of gestation##2##5##(1994-6#2)
the 32nd week##3##3##(1994-6#2)(1996-11#1)
the 32nd##8##2##(1992-10#1)(1993-5#1)(1994-6#2)(1996-11#1)(2006-2#1)(2007-7#1)(2008-8#1)
the 33 kDa protein##2##4##(1994-12#2)
the 33 kDa##5##3##(1993-6#1)(1994-12#4)
the 33##19##2##(1990-3#1)(1990-8#1)(1991-12#1)(1991-2#1)(1993-6#1)(1994-12#4)(1994-2#1)(1995-11#2)(1996-12#1)(1997-5#1)(2008-10#2)(2008-9#1)(2011-2#2)
the 33-kD AX3##2##3##(1992-12#2)
the 33-kDa protein##2##3##(1994-12#1)(1996-5#1)
the 33-kDa##4##2##(1994-12#2)(1995-8#1)(1996-5#1)
the 33rd##5##2##(1991-11#1)(2011-1#3)(2011-2#1)
the 34 kDa band but not p31##2##7##(1997-6#2)
the 34 kDa##8##3##(1991-12#1)(1995-5#1)(1997-6#2)(2009-7#4)
the 34##18##2##(1990-9#1)(1991-12#1)(1993-3#1)(1994-12#1)(1995-5#2)(1996-3#2)(1997-6#2)(2008-3#1)(2008-7#1)(2009-7#4)(2010-5#1)(2012-11#1)
the 34-kDa##2##2##(1990-5#1)(1993-6#1)
the 347##3##2##(1993-6#1)(1996-6#1)(2006-5#1)
the 34th##2##2##(1997-8#1)(2007-8#1)
the 35 patients##3##3##(1993-2#1)(1995-4#1)(2007-11#1)
the 35 years##2##3##(1991-3#1)(2013-8#1)
the 35##23##2##(1990-12#1)(1991-3#1)(1992-12#1)(1993-1#1)(1993-2#1)(1994-3#1)(1995-4#1)(1996-3#1)(1996-8#1)(2006-12#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#2)(2008-8#1)(2008-9#2)(2013-1#2)(2013-8#1)
the 35S-proteoglycans##2##2##(1994-12#2)
the 35th Annual Meeting##2##4##(2009-9#1)(2010-3#1)
the 35th Annual##3##3##(2008-7#1)(2009-9#1)(2010-3#1)
the 36 patients##5##3##(1990-11#1)(1991-3#1)(1991-8#1)(1997-5#1)(2007-8#1)
the 36##18##2##(1990-11#1)(1990-2#1)(1991-2#1)(1991-3#1)(1991-8#1)(1993-1#1)(1994-7#1)(1997-5#1)(2006-5#1)(2007-3#1)(2007-8#3)(2008-10#2)(2008-2#1)(2008-5#2)
the 36-kDa protein##2##3##(1994-9#2)
the 36-kDa##3##2##(1992-11#1)(1994-9#2)
the 36th Annual##2##3##(2007-7#1)(2010-9#1)
the 36th##3##2##(1996-12#1)(2007-7#1)(2010-9#1)
the 37 LRP and##2##4##(1991-5#2)
the 37 LRP##3##3##(1991-5#3)
the 37 degrees##3##3##(1995-11#1)(2008-5#2)
the 37 kDa protein##3##4##(1990-3#1)(1990-8#1)(1991-10#1)
the 37##17##2##(1990-3#1)(1990-8#1)(1991-10#1)(1991-5#3)(1993-3#1)(1995-11#2)(1997-7#1)(2008-10#1)(2008-5#2)(2008-6#1)(2009-5#1)(2009-7#1)(2010-8#1)
the 370-bp##3##2##(1992-4#2)(1993-11#1)
the 37th Annual##2##3##(2007-7#1)(2008-5#1)
the 37th##5##2##(1992-4#1)(2007-2#2)(2007-7#1)(2008-5#1)
the 38 kDa##2##3##(1993-12#1)(1995-9#1)
the 38 patients##2##3##(1992-11#1)(2008-12#1)
the 38##13##2##(1990-4#1)(1990-9#1)(1992-11#2)(1993-12#1)(1995-9#1)(1996-3#1)(2006-2#1)(2007-8#1)(2008-12#1)(2010-8#1)(2011-2#2)
the 381##3##2##(1993-2#1)(2006-8#2)
the 38th##4##2##(2007-2#1)(2009-6#1)(2011-1#1)(2012-12#1)
the 39 cases##2##3##(1995-10#1)(2006-4#1)
the 39 patients##3##3##(1990-6#1)(2007-8#1)(2008-5#1)
the 39##11##2##(1990-6#1)(1991-9#1)(1995-10#1)(1996-11#1)(1997-7#1)(2006-4#2)(2007-8#2)(2008-10#1)(2008-5#1)
the 397##2##2##(1996-11#1)(2004-1#1)
the 39K##4##2##(1993-4#1)(1995-1#2)(1997-3#1)
the 3Bs rule (biocompatibility##2##4##(2008-11#2)
the 3Bs rule##3##3##(2008-11#3)
the 3C##2##2##(1993-11#1)(1995-8#1)
the 3CaO##2##2##(2008-10#2)
the 3D CT##2##3##(2008-11#2)
the 3D model##2##3##(1997-1#1)(2008-9#1)
the 3D reconstruction of the sellar region##2##7##(2012-3#2)
the 3D reconstruction of##3##4##(2012-3#3)
the 3D reference##3##3##(2008-3#3)
the 3D scene##2##3##(2008-3#2)
the 3D structure of##2##4##(1996-7#1)(2010-5#1)
the 3D structure##3##3##(1996-7#2)(2010-5#1)
the 3D##50##2##(1995-11#1)(1996-2#1)(1996-7#3)(1997-1#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#3)(2008-6#1)(2008-9#1)(2009-4#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-1#3)(2012-2#2)(2012-3#4)(2013-1#3)
the 3T3##2##2##(1993-9#1)(1994-3#1)
the 3d##4##2##(1990-9#1)(2007-12#1)(2008-5#2)
the 3p##2##2##(1990-5#1)(2007-12#1)
the 3rd International##3##3##(2007-5#1)(2011-1#1)(2012-11#1)
the 3rd National##2##3##(2008-12#2)
the 3rd and 4th##2##4##(1991-9#1)(2008-5#1)
the 3rd and 6th##4##4##(1997-3#1)(2007-11#1)(2012-2#2)
the 3rd and##8##3##(1991-9#1)(1995-8#1)(1996-2#1)(1997-3#1)(2007-11#1)(2008-5#1)(2012-2#2)
the 3rd day of starvation##2##5##(2013-1#2)
the 3rd day of##3##4##(2011-2#1)(2013-1#2)
the 3rd day##4##3##(2007-11#1)(2011-2#1)(2013-1#2)
the 3rd month and##2##4##(1990-8#1)(2007-7#1)
the 3rd month##4##3##(1990-8#1)(1994-6#1)(2007-11#1)(2007-7#1)
the 3rd peak##2##3##(1992-7#2)
the 3rd week##2##3##(1992-2#1)(1992-8#1)
the 3rd year of life##2##5##(1991-8#2)
the 3rd year of##3##4##(1991-8#2)(2011-1#1)
the 3rd##54##2##(1990-8#1)(1991-5#2)(1991-8#2)(1991-9#1)(1992-10#1)(1992-2#1)(1992-7#3)(1992-8#1)(1992-9#1)(1993-12#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-3#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-9#2)(2007-11#3)(2007-12#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-12#3)(2008-5#1)(2008-7#4)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#3)
the 3sigma##3##2##(2008-10#3)
the 4 beta-methyl group of##2##5##(1992-3#2)
the 4 degrees C##3##4##(2005-10#1)(2008-10#1)(2012-2#1)
the 4 groups##3##3##(1990-7#1)(2008-3#1)(2013-8#1)
the 4 kN load limiter##2##5##(2006-11#1)(2007-4#1)
the 4 kN##3##3##(2006-11#2)(2007-4#1)
the 4 localities##3##3##(2011-1#3)
the 4 months of##2##4##(2010-10#1)(2011-1#1)
the 4 patients in##2##4##(1996-6#1)(2008-7#1)
the 4 patients##5##3##(1991-2#1)(1996-6#1)(2007-8#1)(2008-7#1)(2011-1#1)
the 4 study years##2##4##(1993-3#2)
the 4 weeks##2##3##(2008-10#1)(2009-10#1)
the 4 years##3##3##(2008-10#2)(2010-4#1)
the 4##102##2##(1990-12#1)(1990-7#2)(1990-8#1)(1991-10#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-3#2)(1992-9#3)(1993-2#2)(1993-3#2)(1994-10#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-2#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#3)(2005-10#1)(2005-11#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
the 4'-position of##2##3##(1994-9#1)(1996-1#1)
the 4(th)##2##2##(2012-2#1)(2013-8#1)
the 4- and##2##3##(1991-5#1)(2008-2#1)
the 4-##5##2##(1991-5#1)(1994-9#1)(2007-11#1)(2008-2#1)(2008-3#1)
the 4-amine##2##2##(1995-3#2)
the 4-carbonyl##3##2##(1993-3#3)
the 4-cell stage##4##3##(1993-3#2)(1995-8#1)(1996-8#1)
the 4-fold##2##2##(1997-7#1)(2013-1#1)
the 4-hydroxyaniline##2##2##(1990-12#2)
the 4-nitro group##2##3##(1995-3#2)
the 4-position of the##3##4##(1991-3#1)(1997-2#1)(1997-8#1)
the 4-position of##6##3##(1991-3#1)(1993-4#1)(1997-2#3)(1997-8#1)
the 4-position##10##2##(1991-3#1)(1993-4#1)(1995-5#1)(1996-8#1)(1997-2#3)(1997-8#2)(2008-10#1)
the 4-substituted##2##2##(1995-11#1)(1996-8#1)
the 4-thia##2##2##(1995-3#1)(2007-8#1)
the 4-week##8##2##(1990-5#1)(1994-8#1)(1996-1#1)(1996-12#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-10#1)
the 4-year period##3##3##(2008-10#3)
the 4-year##7##2##(2008-10#6)(2013-1#1)
the 40 kDa##3##3##(1994-2#2)(2006-10#1)
the 40##28##2##(1990-5#1)(1994-2#3)(1995-2#1)(1995-8#1)(1996-12#3)(1996-5#2)(1997-3#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-2#1)(2007-8#5)(2008-4#1)(2008-5#3)(2008-9#1)(2011-1#1)
the 40-kDa complex##3##3##(1997-1#3)
the 40-kDa kinase##2##3##(1990-3#2)
the 40-kDa outer membrane protein##2##5##(1993-9#2)
the 40-kDa##11##2##(1990-3#2)(1992-9#1)(1993-9#3)(1995-5#1)(1997-1#3)(2006-8#1)
the 400 bp##2##3##(2008-5#2)
the 400##9##2##(1990-3#1)(1993-2#1)(1996-2#1)(1997-3#1)(2008-2#1)(2008-5#2)(2011-2#1)(2012-12#1)
the 407##2##2##(1993-10#1)(1993-4#1)
the 40th##3##2##(2007-9#2)(2013-8#1)
the 41 protein##3##3##(1994-12#3)
the 41##8##2##(1994-12#3)(1995-5#1)(1996-10#1)(1996-6#1)(2007-10#1)(2007-8#1)
the 41-week study##3##3##(2008-9#3)
the 42 patients with##2##4##(1990-3#1)(1994-7#1)
the 42##13##2##(1990-2#1)(1990-3#1)(1990-6#2)(1992-5#1)(1992-9#1)(1994-7#1)(1996-9#1)(2007-10#1)(2007-6#2)(2013-1#1)(2013-8#1)
the 422 patients##2##3##(1993-2#1)(2007-9#1)
the 42nd##2##2##(2007-8#1)(2008-11#1)
the 43 kDa protein##2##4##(1991-1#2)
the 43 kDa##5##3##(1991-1#2)(1991-12#1)(1991-8#1)(2009-7#1)
the 43 patients##2##3##(1991-4#1)(2007-9#1)
the 43##18##2##(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-9#1)(1995-5#1)(1996-3#1)(2006-4#1)(2007-11#1)(2007-7#1)(2007-9#2)(2008-11#1)(2009-7#1)(2011-2#1)
the 434##2##2##(1995-4#1)(1995-9#1)
the 435##2##2##(2006-10#1)(2007-12#1)
the 438##2##2##(1994-12#1)(2007-12#1)
the 44##5##2##(1997-1#1)(2007-7#1)(2007-9#1)(2008-11#1)(2013-1#1)
the 44/62##2##2##(1994-9#2)
the 442-nm##2##2##(2008-2#2)
the 45 degrees##2##3##(2008-11#1)(2008-5#1)
the 45 patients with##2##4##(2007-7#1)(2008-1#1)
the 45 patients##4##3##(1996-11#1)(1996-2#1)(2007-7#1)(2008-1#1)
the 45##25##2##(1993-11#1)(1994-12#1)(1994-9#2)(1995-11#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-4#1)(2011-1#1)
the 45-kDa##6##2##(1991-8#1)(1993-1#1)(1994-11#1)(1995-11#1)(1996-4#1)(1996-8#1)
the 45Ca##2##2##(1991-1#1)(1997-5#1)
the 45Ca2+##2##2##(1993-11#1)(1995-5#1)
the 45th day##2##3##(2008-7#1)(2012-1#1)
the 45th##3##2##(2008-10#1)(2008-7#1)(2012-1#1)
the 46##9##2##(1990-11#1)(1991-3#1)(1991-6#1)(1992-3#2)(1997-2#1)(1997-3#1)(2012-11#1)(2013-1#1)
the 47th##2##2##(1990-2#2)
the 48 hours##2##3##(2007-2#1)(2013-1#1)
the 48 hr##2##3##(1992-1#1)(1995-1#1)
the 48 min##2##3##(2005-8#2)
the 48##12##2##(1992-1#1)(1995-1#1)(2004-12#1)(2005-8#2)(2007-2#1)(2007-9#1)(2008-2#1)(2008-5#1)(2008-9#1)(2013-1#1)(2013-8#1)
the 48-hour##2##2##(2007-1#1)(2007-10#1)
the 49##5##2##(1994-3#1)(1997-1#1)(2008-1#1)(2008-6#1)(2012-1#1)
the 49-mer by##2##3##(1995-1#2)
the 49K protein##2##3##(1991-1#2)
the 49th##2##2##(2007-7#1)(2010-1#1)
the 4CMenB##2##2##(2012-12#2)
the 4Pi confocal##2##3##(2007-12#1)(2008-2#1)
the 4f##3##2##(2008-3#3)
the 4th International##11##3##(2007-1#10)(2011-12#1)
the 4th and##5##3##(2006-2#1)(2006-3#1)(2007-7#1)(2008-5#1)(2013-1#1)
the 4th hour##2##3##(2007-7#1)(2008-4#1)
the 4th larval instar##2##4##(2008-12#1)(2008-5#1)
the 4th larval##3##3##(2008-12#1)(2008-5#1)(2011-1#1)
the 4th week of##2##4##(1992-7#1)(2008-10#1)
the 4th week##4##3##(1990-12#1)(1992-7#1)(2008-10#1)(2008-5#1)
the 4th##49##2##(1990-12#1)(1991-11#1)(1991-5#2)(1992-10#1)(1992-7#1)(1992-9#1)(1993-11#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-2#1)(2006-2#1)(2006-3#1)(2006-8#2)(2007-1#10)(2007-7#2)(2007-9#1)(2008-10#3)(2008-12#2)(2008-4#1)(2008-5#4)(2008-7#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#1)(2013-1#2)
the 5 A Day##2##4##(1997-1#1)(2012-2#1)
the 5 and 10##2##4##(2008-10#1)(2008-5#1)
the 5 days preceding##2##4##(1996-5#1)(2010-8#1)
the 5 days##4##3##(1993-6#1)(1996-5#1)(2010-2#1)(2010-8#1)
the 5 patients who##2##4##(1991-5#1)(2013-1#1)
the 5 patients##7##3##(1990-10#1)(1991-5#1)(2007-10#1)(2007-11#1)(2008-1#1)(2011-2#1)(2013-1#1)
the 5 position##4##3##(1995-11#1)(2007-11#1)(2008-4#2)
the 5 years##4##3##(1992-8#1)(2008-10#1)(2011-2#2)
the 5##108##2##(1990-10#1)(1990-5#2)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#3)(1995-11#3)(1995-12#2)(1995-2#1)(1995-9#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#3)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#2)(2005-1#1)(2007-10#2)(2007-11#3)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#17)(2008-11#1)(2008-12#2)(2008-4#4)(2008-5#4)(2008-6#1)(2008-8#4)(2009-5#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#2)
the 5%##3##2##(1992-9#1)(2008-10#1)(2008-6#1)
the 5' UTR##3##3##(2008-10#2)(2012-3#1)
the 5' and 3' ends of##2##6##(1991-12#1)(1995-3#1)
the 5' and 3' ends##4##5##(1991-12#1)(1995-3#1)(2008-10#2)
the 5' and 3' regions of##2##6##(1992-8#1)(2008-10#1)
the 5' and 3' untranslated regions of the##2##8##(1993-2#1)(1997-4#1)
the 5' and 3'##16##4##(1991-12#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-12#1)(1995-3#1)(1997-1#1)(1997-4#1)(1997-8#1)(2006-12#1)(2008-10#4)(2008-8#1)
the 5' and the##2##4##(2008-10#2)
the 5' and##19##3##(1991-12#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-3#1)(1997-1#1)(1997-4#1)(1997-8#1)(2006-12#1)(2008-10#6)(2008-8#1)
the 5' end and##2##4##(1990-4#1)(2013-8#1)
the 5' end of a##2##5##(1994-9#1)(1997-7#1)
the 5' end of the coding region of##2##8##(1996-1#1)(2008-8#1)
the 5' end of the coding##3##6##(1991-5#1)(1996-1#1)(2008-8#1)
the 5' end of the gene##5##6##(1991-10#1)(1991-11#1)(1993-9#1)(1996-2#1)(2008-7#1)
the 5' end of the viral##2##6##(1992-12#2)
the 5' end of the##35##5##(1990-11#1)(1990-12#2)(1990-5#1)(1991-10#1)(1991-11#1)(1991-5#2)(1992-12#3)(1992-9#1)(1993-6#1)(1993-9#2)(1994-10#1)(1994-12#2)(1994-8#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-4#2)(1997-7#1)(2006-12#1)(2007-12#1)(2008-10#4)(2008-7#1)(2008-8#1)(2008-9#1)
the 5' end of##44##4##(1990-11#1)(1990-12#2)(1990-5#1)(1991-10#1)(1991-11#1)(1991-5#2)(1992-12#3)(1992-9#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-10#1)(1994-12#3)(1994-5#1)(1994-8#1)(1994-9#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-4#2)(1997-7#2)(2006-12#1)(2006-8#1)(2007-12#1)(2008-10#4)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)
the 5' end##50##3##(1990-11#1)(1990-12#2)(1990-4#2)(1990-5#2)(1991-10#1)(1991-11#1)(1991-5#2)(1992-12#3)(1992-6#1)(1992-9#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-10#1)(1994-12#3)(1994-5#1)(1994-8#1)(1994-9#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-4#2)(1997-7#2)(2006-12#1)(2006-8#1)(2007-12#1)(2008-10#5)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2013-8#1)
the 5' ends of##3##4##(1991-7#1)(1994-12#1)(2007-12#1)
the 5' ends##4##3##(1991-7#1)(1994-12#1)(2007-12#1)(2008-11#1)
the 5' exon and##2##4##(1991-2#1)(1991-5#1)
the 5' exon##7##3##(1991-2#5)(1991-5#1)(1991-9#1)
the 5' exonuclease##3##3##(1997-8#3)
the 5' flanking region and##3##5##(1991-1#1)(1996-10#1)(1997-2#1)
the 5' flanking region of Ha-ras in##2##7##(1997-7#2)
the 5' flanking region of Ha-ras##4##6##(1997-7#4)
the 5' flanking region of the gene##3##7##(1991-5#1)(1993-3#1)(1997-4#1)
the 5' flanking region of the##6##6##(1991-5#2)(1992-11#1)(1993-12#1)(1993-3#1)(1997-4#1)
the 5' flanking region of##12##5##(1991-5#2)(1992-11#1)(1993-12#1)(1993-3#1)(1997-4#2)(1997-7#5)
the 5' flanking region##22##4##(1990-9#1)(1991-1#1)(1991-12#1)(1991-5#2)(1992-11#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-8#1)(1996-10#1)(1997-2#1)(1997-4#2)(1997-7#5)(2008-7#1)
the 5' flanking sequences##2##4##(1994-12#2)
the 5' flanking##28##3##(1990-9#1)(1991-1#1)(1991-12#1)(1991-5#2)(1991-6#1)(1992-11#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1994-12#2)(1994-8#1)(1996-10#1)(1997-2#1)(1997-4#2)(1997-7#5)(2008-7#1)
the 5' half of the##2##5##(1995-8#1)(2008-10#1)
the 5' half##3##3##(1995-8#1)(2008-10#1)(2008-8#1)
the 5' non-coding region##4##4##(1991-9#1)(1994-2#1)(1995-6#1)(2012-12#1)
the 5' non-coding##5##3##(1991-9#1)(1994-2#1)(1995-6#1)(1996-2#1)(2012-12#1)
the 5' noncoding##4##3##(1994-3#1)(1995-5#1)(2008-10#1)(2008-8#1)
the 5' portion of the##3##5##(1990-11#1)(1994-12#1)(1997-3#1)
the 5' position##2##3##(2008-4#1)(2008-8#1)
the 5' promoter region of the##2##6##(1991-6#1)(1993-6#1)
the 5' promoter region of##3##5##(1991-6#1)(1992-7#1)(1993-6#1)
the 5' promoter region##4##4##(1991-6#1)(1992-7#1)(1993-6#1)(1996-8#1)
the 5' promoter##5##3##(1991-6#1)(1992-6#1)(1992-7#1)(1993-6#1)(1996-8#1)
the 5' region of the gene##2##6##(1994-9#1)(2008-8#1)
the 5' region of the human##2##6##(1991-6#1)(1991-7#1)
the 5' region of the##11##5##(1990-1#1)(1990-3#1)(1990-9#1)(1991-6#3)(1991-7#1)(1994-9#1)(1995-2#1)(1995-8#1)(2008-8#1)
the 5' region of##13##4##(1990-1#1)(1990-3#1)(1990-9#1)(1991-6#3)(1991-7#1)(1992-3#1)(1993-5#1)(1994-9#1)(1995-2#1)(1995-8#1)(2008-8#1)
the 5' region##17##3##(1990-1#1)(1990-3#1)(1990-9#2)(1991-6#4)(1991-7#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-5#1)(1994-9#1)(1995-2#1)(1995-8#1)(2008-8#1)
the 5' regions##2##3##(1994-12#1)(1995-8#1)
the 5' side##5##3##(1993-12#1)(1993-6#1)(1994-6#1)(1995-6#2)
the 5' splice site##3##4##(1991-11#1)(1991-5#2)
the 5' terminal##2##3##(2005-11#1)(2008-10#1)
the 5' terminus of an oligonucleotide##3##6##(2008-4#3)
the 5' terminus of the oligonucleotide##3##6##(2008-4#3)
the 5' terminus of the##5##5##(1996-5#1)(2005-11#1)(2008-4#3)
the 5' terminus of##9##4##(1996-5#1)(2005-11#1)(2008-4#7)
the 5' terminus##11##3##(1991-2#1)(1996-5#1)(2005-11#1)(2008-4#8)
the 5' to 3'##2##4##(1990-12#1)(2008-10#1)
the 5' untranslated region of##7##5##(1991-9#1)(1992-3#1)(1994-5#1)(1995-5#1)(1997-8#1)(2008-11#1)(2012-2#1)
the 5' untranslated region##13##4##(1991-9#1)(1992-11#1)(1992-3#2)(1994-5#1)(1995-10#1)(1995-5#1)(1996-11#1)(1997-8#1)(2008-10#1)(2008-11#1)(2009-5#1)(2012-2#1)
the 5' untranslated sequences##2##4##(1992-9#1)(1994-12#1)
the 5' untranslated##18##3##(1990-12#1)(1991-9#1)(1992-11#2)(1992-3#2)(1992-9#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-5#1)(1996-11#1)(1997-8#1)(2008-10#1)(2008-11#1)(2009-5#1)(2012-2#1)
the 5' upstream region of the##3##6##(1990-9#1)(1991-3#1)(1992-12#1)
the 5' upstream region##4##4##(1990-9#1)(1991-3#1)(1992-12#1)(1997-2#1)
the 5' upstream##5##3##(1990-9#1)(1991-3#1)(1992-12#1)(1997-2#2)
the 5'##225##2##(1990-1#1)(1990-11#2)(1990-12#4)(1990-3#1)(1990-4#4)(1990-5#2)(1990-7#1)(1990-9#4)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#6)(1991-3#1)(1991-5#8)(1991-6#6)(1991-7#2)(1991-9#4)(1992-11#4)(1992-12#5)(1992-3#5)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#2)(1993-12#3)(1993-2#2)(1993-3#4)(1993-4#1)(1993-5#3)(1993-6#6)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#11)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#3)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#3)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#2)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#5)(1997-7#7)(1997-8#5)(2005-11#2)(2006-12#3)(2006-8#1)(2007-12#2)(2008-10#22)(2008-11#2)(2008-4#11)(2008-7#3)(2008-8#7)(2008-9#1)(2009-5#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
the 5'- and 3'-sides##3##4##(1990-5#1)(1990-9#1)(1991-7#1)
the 5'- and 3'-untranslated regions of##2##6##(1990-11#1)(2008-9#1)
the 5'- and 3'-untranslated regions##3##5##(1990-11#1)(1993-12#1)(2008-9#1)
the 5'- and##8##3##(1990-11#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-7#1)(1993-12#1)(2008-10#1)(2008-9#1)
the 5'-AMP-activated protein kinase##2##4##(1991-12#2)
the 5'-CG-3'##2##2##(1995-2#2)
the 5'-UTR##7##2##(1996-5#5)(1996-7#1)(2012-3#1)
the 5'-donor splice##2##3##(1990-11#2)
the 5'-end of the##6##4##(1991-8#1)(1993-8#1)(1995-1#1)(1995-2#1)(1996-7#1)(2008-10#1)
the 5'-end of##8##3##(1991-8#1)(1993-4#1)(1993-8#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-7#1)(2008-10#1)
the 5'-end##17##2##(1991-7#1)(1991-8#1)(1993-4#2)(1993-8#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-7#1)(2005-11#1)(2006-10#1)(2006-12#3)(2008-10#2)
the 5'-flanking DNA of##2##4##(1990-10#1)(1991-11#1)
the 5'-flanking DNA##3##3##(1990-10#1)(1991-11#1)(1994-2#1)
the 5'-flanking region and the first##2##6##(1992-4#1)(2010-5#1)
the 5'-flanking region and##3##4##(1991-7#1)(1992-4#1)(2010-5#1)
the 5'-flanking region of the bovine pancreatic ribonuclease gene##2##9##(1992-12#2)
the 5'-flanking region of the gene##3##6##(1993-8#1)(1997-2#1)(1997-6#1)
the 5'-flanking region of the human##2##6##(1995-2#1)(1997-7#1)
the 5'-flanking region of the##15##5##(1991-2#1)(1991-5#1)(1992-12#2)(1993-8#3)(1994-11#1)(1994-9#1)(1995-2#1)(1995-3#1)(1997-2#1)(1997-6#1)(1997-7#1)(2008-9#1)
the 5'-flanking region of##21##4##(1991-2#2)(1991-5#1)(1992-12#2)(1993-8#3)(1994-11#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-8#1)(1997-2#2)(1997-6#1)(1997-7#1)(1997-8#1)(2008-9#1)
the 5'-flanking region##34##3##(1990-12#1)(1991-11#2)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-12#2)(1992-4#1)(1993-11#1)(1993-2#1)(1993-8#3)(1994-11#2)(1994-12#1)(1994-9#2)(1995-2#1)(1995-3#1)(1996-2#1)(1996-8#1)(1997-2#2)(1997-6#1)(1997-7#2)(1997-8#1)(2008-9#1)(2010-5#2)
the 5'-flanking sequence of##3##4##(1990-8#1)(1997-7#1)(2008-8#1)
the 5'-flanking sequence##6##3##(1990-8#1)(1992-5#1)(1995-6#1)(1997-7#2)(2008-8#1)
the 5'-flanking##50##2##(1990-10#1)(1990-12#1)(1990-8#1)(1991-11#3)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-12#2)(1992-4#1)(1992-5#3)(1993-11#1)(1993-2#1)(1993-7#1)(1993-8#3)(1994-11#2)(1994-12#4)(1994-2#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-6#2)(1996-2#1)(1996-8#1)(1997-2#2)(1997-6#1)(1997-7#4)(1997-8#1)(2008-8#1)(2008-9#1)(2010-5#2)
the 5'-hydroxyl##3##2##(1997-2#1)(2008-4#2)
the 5'-noncoding region##2##3##(1990-9#1)(2008-9#1)
the 5'-noncoding##4##2##(1990-9#1)(1993-3#1)(2006-10#1)(2008-9#1)
the 5'-nucleotidase##4##2##(1994-2#2)(1995-1#1)(2008-4#1)
the 5'-phosphate##3##2##(1995-8#2)(2008-10#1)
the 5'-region of##2##3##(1997-4#1)(2008-11#1)
the 5'-side of the##2##4##(1991-8#1)(1995-1#1)
the 5'-terminal sequence##2##3##(1993-11#2)
the 5'-terminal##6##2##(1993-11#2)(1993-3#1)(1994-8#1)(2006-12#1)(2008-10#1)
the 5'-terminus of##4##3##(1991-1#1)(2008-4#3)
the 5'-terminus##6##2##(1991-1#2)(2008-4#4)
the 5'-triphosphate##2##2##(1991-2#1)(2011-1#1)
the 5'-triphosphates of##2##3##(1991-2#1)(1993-3#1)
the 5'-untranslated and##2##3##(1992-2#1)(1995-3#1)
the 5'-untranslated region (5'-UTR) of##2##5##(1993-4#1)(1996-7#1)
the 5'-untranslated region (UTR) of the##2##6##(1996-5#1)(2008-10#1)
the 5'-untranslated region (UTR)##3##4##(1990-12#1)(1996-5#1)(2008-10#1)
the 5'-untranslated region of##4##4##(1990-2#2)(1993-4#1)(1997-2#1)
the 5'-untranslated region##13##3##(1990-12#1)(1990-2#2)(1991-4#1)(1991-6#1)(1991-7#1)(1993-4#2)(1994-12#1)(1996-5#1)(1996-7#1)(1997-2#1)(2008-10#1)
the 5'-untranslated##16##2##(1990-12#1)(1990-2#2)(1991-4#1)(1991-6#1)(1991-7#1)(1992-2#1)(1993-2#1)(1993-4#2)(1994-12#1)(1995-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(2008-10#1)
the 5'-upstream region of##7##4##(1992-11#2)(1992-5#1)(1993-12#1)(1996-3#2)(1997-7#1)
the 5'-upstream region##9##3##(1992-11#2)(1992-5#1)(1993-12#1)(1995-3#1)(1996-3#2)(1997-7#2)
the 5'-upstream##10##2##(1992-11#2)(1992-5#1)(1993-12#1)(1995-3#1)(1996-3#2)(1997-7#2)(2008-11#1)
the 5'UTRs of##3##3##(2008-5#3)
the 5(th) percentile female##3##4##(2006-11#2)(2007-1#1)
the 5- and##2##3##(1990-3#1)(2010-3#1)
the 5-##4##2##(1990-3#1)(1997-3#1)(2010-3#1)(2012-12#1)
the 5-2-1-AN message##2##3##(2010-8#2)
the 5-55 disulfide##3##3##(1992-6#3)
the 5-55##4##2##(1992-6#4)
the 5-HT receptor##2##3##(1991-5#1)(1996-12#1)
the 5-HT transporter##2##3##(1996-10#1)(2005-9#1)
the 5-HT uptake##2##3##(1991-5#1)(1993-7#1)
the 5-HT##13##2##(1991-5#2)(1993-7#2)(1994-2#2)(1995-12#1)(1996-10#1)(1996-12#2)(1996-5#1)(2005-9#1)(2008-8#1)
the 5-HT-induced inhibition of the TF reflex##2##7##(1990-7#2)
the 5-HT-induced##3##2##(1990-7#2)(1992-8#1)
the 5-HT1A agonist 8-OH-DPAT##3##4##(1994-11#1)(1994-6#1)(1995-12#1)
the 5-HT1A agonist##4##3##(1994-11#1)(1994-12#1)(1994-6#1)(1995-12#1)
the 5-HT1A antagonist##2##3##(1995-12#1)(1996-12#1)
the 5-HT1A receptor agonist##2##4##(1993-3#1)(1996-10#1)
the 5-HT1A receptor and##3##4##(1991-2#1)(1994-2#1)(2008-1#1)
the 5-HT1A receptor antagonist##3##4##(1993-3#1)(1994-2#1)(1996-12#1)
the 5-HT1A receptor binding##3##4##(1991-2#1)(1996-8#1)(1997-5#1)
the 5-HT1A receptor that##2##4##(1996-8#1)(1997-1#1)
the 5-HT1A receptor##22##3##(1991-2#4)(1993-3#4)(1994-2#3)(1995-12#2)(1996-10#1)(1996-12#1)(1996-8#2)(1997-1#2)(1997-5#2)(2008-1#1)
the 5-HT1A##32##2##(1991-2#5)(1993-3#4)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-6#1)(1994-9#1)(1995-12#4)(1996-10#1)(1996-12#2)(1996-8#2)(1997-1#3)(1997-5#2)(2008-1#1)
the 5-HT1B##2##2##(1994-2#1)(1995-12#1)
the 5-HT1B/1D agonist##2##3##(1995-12#1)(1997-3#1)
the 5-HT1B/1D##3##2##(1995-12#1)(1997-3#2)
the 5-HT1D alpha##3##3##(1996-10#3)
the 5-HT1D receptor##3##3##(1991-2#2)(1995-12#1)
the 5-HT1D##9##2##(1991-2#2)(1995-12#2)(1996-10#4)(1997-5#1)
the 5-HT2 receptor##5##3##(1990-7#1)(1991-12#1)(1993-9#1)(1995-3#1)(2005-8#1)
the 5-HT2##6##2##(1990-7#1)(1991-12#1)(1993-9#1)(1994-12#1)(1995-3#1)(2005-8#1)
the 5-HT2A receptor##4##3##(1995-9#2)(1997-5#1)(2008-1#1)
the 5-HT2A##5##2##(1995-9#2)(1997-5#2)(2008-1#1)
the 5-HT2C receptor gene##3##4##(1995-12#2)(1996-12#1)
the 5-HT2C receptor mRNA##2##4##(1996-12#2)
the 5-HT2C receptor##8##3##(1995-12#3)(1996-12#5)
the 5-HT3 antagonist##3##3##(1991-11#1)(1994-2#1)(1996-8#1)
the 5-HT3 receptor-gated ion##2##4##(1994-2#2)
the 5-HT3##8##2##(1991-11#1)(1992-3#1)(1993-3#1)(1994-2#3)(1996-8#1)(2008-7#1)
the 5-HT7 receptor##2##3##(2008-5#2)
the 5-LO##4##2##(1991-8#1)(1993-7#1)(1994-12#2)
the 5-choice serial reaction time task##3##6##(1992-11#1)(2008-4#2)
the 5-day##5##2##(1990-3#1)(1991-8#1)(1992-12#1)(2008-10#2)
the 5-hydroxytryptamine##3##2##(1993-12#1)(1996-6#1)(2012-12#1)
the 5-methoxyl group##3##3##(1995-3#3)
the 5-month-old##2##2##(1995-8#1)(1996-1#1)
the 5-position of##3##3##(1992-2#1)(1996-6#2)
the 5-position##5##2##(1992-2#1)(1996-6#2)(1996-8#1)(1997-1#1)
the 5-year EFS of##2##4##(2010-3#1)(2011-2#1)
the 5-year EFS##3##3##(2010-3#2)(2011-2#1)
the 5-year actuarial##2##3##(2008-6#1)(2012-2#1)
the 5-year and 10-year##2##4##(2011-2#2)
the 5-year disease-free survival rate##3##5##(1994-7#1)(1997-7#2)
the 5-year disease-free##4##3##(1994-7#1)(1997-7#3)
the 5-year follow-up##3##3##(1995-11#1)(2007-12#1)(2008-7#1)
the 5-year non-recurrence rate##3##4##(1997-7#3)
the 5-year period##4##3##(1990-2#1)(1995-9#1)(2007-8#2)
the 5-year survival rate was##3##5##(1990-9#1)(2007-1#1)(2007-8#1)
the 5-year survival rate##6##4##(1990-9#1)(1997-7#1)(2007-1#1)(2007-8#1)(2007-9#1)(2008-5#1)
the 5-year survival##7##3##(1990-9#1)(1997-7#1)(2007-1#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-5#1)
the 5-year##35##2##(1990-2#1)(1990-9#1)(1992-8#1)(1993-4#2)(1994-7#2)(1995-11#1)(1995-9#1)(1997-7#7)(2007-1#1)(2007-12#1)(2007-8#3)(2007-9#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2010-3#2)(2011-1#1)(2011-2#4)(2012-2#1)
the 50 kDa##3##3##(1991-10#1)(1994-5#2)
the 50 mg/kg/dose regimen##2##4##(2008-10#2)
the 50 patients##8##3##(1992-2#2)(1993-2#2)(1996-8#1)(2006-7#1)(2007-7#1)(2008-4#1)
the 50 states and##2##4##(1997-2#1)(2010-5#1)
the 50 states##3##3##(1991-11#1)(1997-2#1)(2010-5#1)
the 50##37##2##(1991-10#1)(1991-11#1)(1992-2#2)(1993-11#2)(1993-2#2)(1994-5#2)(1996-8#1)(1997-2#1)(1997-4#4)(2006-10#1)(2006-7#1)(2007-2#2)(2007-7#2)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)(2010-5#1)(2012-2#1)(2013-1#1)
the 50% control##3##3##(2012-2#3)
the 50% inhibitory concentration##2##4##(1993-7#1)(2008-4#1)
the 50% inhibitory##3##3##(1993-7#1)(1996-1#1)(2008-4#1)
the 50% of##3##3##(1997-8#1)(2013-1#2)
the 50% survival age##2##4##(1996-2#2)
the 50%##20##2##(1993-7#1)(1996-1#1)(1996-2#2)(1997-8#2)(2007-4#1)(2007-8#1)(2008-10#1)(2008-4#3)(2009-5#1)(2009-8#1)(2012-2#3)(2013-1#3)
the 50-kDa##4##2##(1995-6#1)(2005-11#1)(2008-10#2)
the 500 mg/kg##3##3##(2008-9#3)
the 500 ppm##2##3##(1990-5#1)(1996-12#1)
the 500##11##2##(1990-5#1)(1995-1#1)(1996-12#1)(1997-5#1)(2006-12#1)(2008-9#3)(2010-5#2)(2011-2#1)
the 50K SNPs##3##3##(2012-1#3)
the 50K##5##2##(1990-7#1)(2012-1#4)
the 50S##3##2##(1993-11#2)(2005-7#1)
the 50th percentile##4##3##(1993-9#1)(2006-10#1)(2006-11#1)(2013-1#1)
the 50th##5##2##(1993-9#1)(2006-10#1)(2006-11#1)(2013-1#1)(2013-8#1)
the 51##6##2##(1996-12#1)(2006-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2012-11#1)
the 514##2##2##(1997-7#1)(2008-2#1)
the 51Cr##3##2##(1990-12#1)(1995-6#2)
the 52##6##2##(1995-2#1)(2008-10#2)(2008-3#1)(2012-12#2)
the 52-kDa protein##2##3##(1993-12#1)(1994-8#1)
the 53##5##2##(1992-8#1)(1994-1#1)(1997-6#2)(2011-2#1)
the 53-day##2##2##(2008-7#2)
the 54 patients##3##3##(1991-2#1)(2007-9#1)(2008-1#1)
the 54##13##2##(1990-2#1)(1991-2#1)(1995-5#1)(2006-8#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#4)(2011-2#1)
the 54-kDa##2##2##(1994-11#1)(1995-8#1)
the 543##2##2##(1995-1#1)(2007-8#1)
the 55 kDa##5##3##(1992-8#1)(1994-12#1)(1994-2#2)(2013-8#1)
the 55##16##2##(1992-4#1)(1992-8#1)(1993-6#1)(1994-12#1)(1994-2#2)(1996-12#1)(2006-10#1)(2006-8#2)(2007-6#2)(2007-8#1)(2008-2#1)(2008-8#1)(2013-8#1)
the 552##2##2##(2007-12#1)(2011-1#1)
the 56 kDa protein##3##4##(1991-3#3)
the 56 kDa##5##3##(1991-3#4)(1995-5#1)
the 56##8##2##(1990-3#1)(1991-3#4)(1995-5#1)(2010-9#1)(2013-8#1)
the 57 amino acids##2##4##(1995-12#2)
the 57 amino##3##3##(1992-7#1)(1995-12#2)
the 57##9##2##(1990-8#1)(1992-7#1)(1994-10#1)(1995-12#2)(1997-4#1)(2008-10#1)(2009-10#1)(2012-12#1)
the 57-kDa form was##2##4##(1995-8#2)
the 57-kDa##3##2##(1992-6#1)(1995-8#2)
the 58##5##2##(1996-3#1)(2004-4#1)(2007-9#1)(2008-10#1)(2008-5#1)
the 58-kDa B subunit##2##4##(1995-6#1)(1996-5#1)
the 58K-like protein##2##3##(2008-8#2)
the 59 protein##4##3##(1994-12#4)
the 59##5##2##(1994-12#4)(2013-1#1)
the 59-kDa protein##3##3##(1990-5#3)
the 5A/6A##2##2##(1996-5#2)
the 5B11 clone##2##3##(1991-9#2)
the 5F-Trp127 and -133##2##4##(1991-4#2)
the 5FU##2##2##(1995-5#2)
the 5HT1A receptor##2##3##(1996-2#2)
the 5HT1D pseudogene##2##3##(1993-12#2)
the 5HT1D##4##2##(1993-12#3)(2008-6#1)
the 5HT2A receptor##3##3##(1996-7#3)
the 5P(3/2)##2##2##(2008-3#2)
the 5S##6##2##(1993-9#1)(1995-11#2)(2008-10#3)
the 5S(1/2) ?##3##3##(2007-12#2)(2008-3#1)
the 5Z-syn##2##2##(1990-8#1)(1992-3#1)
the 5th International##4##3##(2007-1#1)(2007-12#1)(2008-5#1)(2009-6#1)
the 5th day after##2##4##(1997-2#1)(2008-11#1)
the 5th day##3##3##(1997-2#1)(2007-10#1)(2008-11#1)
the 5th exposure to stress##2##5##(1995-12#2)
the 5th intron of##2##4##(1997-1#2)
the 5th percentile female##3##4##(2006-11#3)
the 5th year##3##3##(2008-8#2)(2011-2#1)
the 5th##38##2##(1991-2#1)(1991-7#1)(1991-9#2)(1992-2#1)(1993-4#1)(1995-12#2)(1995-2#1)(1995-8#1)(1997-1#2)(1997-2#1)(2004-10#1)(2006-11#4)(2006-2#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-6#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#2)(2013-7#1)
the 5x5 method##2##3##(1992-10#2)
the 6 and 12 mg/kg##2##5##(2008-9#2)
the 6 kN##2##3##(2006-11#1)(2007-4#1)
the 6 months before##2##4##(2008-1#1)(2013-1#1)
the 6 months##5##3##(1995-1#1)(2008-1#2)(2008-3#1)(2013-1#1)
the 6 patients who were##2##5##(2006-10#1)(2008-1#1)
the 6 patients with##5##4##(1994-7#1)(1995-12#1)(1997-4#1)(2006-9#1)(2010-8#1)
the 6 patients##9##3##(1994-7#1)(1995-12#1)(1997-4#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-1#1)(2010-8#1)
the 6 years##2##3##(2008-10#1)(2009-4#1)
the 6##68##2##(1990-5#1)(1990-9#1)(1991-10#2)(1991-5#1)(1991-9#1)(1992-2#1)(1992-7#1)(1994-7#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-5#1)(1996-6#2)(1997-2#1)(1997-4#1)(2004-10#1)(2005-11#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-8#3)(2008-1#3)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#4)(2009-3#1)(2009-4#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#3)
the 6% w/w##2##3##(2004-1#2)
the 6%##3##2##(2004-1#2)(2010-8#1)
the 6(2)P(3/2)( degrees )##2##4##(2007-12#2)
the 6- and 12-month post-implementation##2##5##(2008-5#2)
the 6-##3##2##(1995-11#1)(2008-5#2)
the 6-7 year olds##3##4##(2007-2#3)
the 6-OHDA lesioned SN##2##4##(1996-9#2)
the 6-OHDA##3##2##(1996-9#3)
the 6-day##2##2##(1995-8#1)(2009-10#1)
the 6-kDa##2##2##(1992-6#2)
the 6-kb##2##2##(1996-5#1)(1997-7#1)
the 6-methylquinolinium##2##2##(2008-10#2)
the 6-min##2##2##(1994-8#1)(2006-10#1)
the 6-minute walk test##5##4##(2007-7#2)(2011-2#1)(2012-12#2)
the 6-minute walk##7##3##(2007-7#4)(2011-2#1)(2012-12#2)
the 6-month follow-up period##2##4##(1997-2#1)(2007-11#1)
the 6-month follow-up##4##3##(1997-2#1)(2007-11#1)(2007-8#2)
the 6-month intervention period##4##4##(2008-6#4)
the 6-month period##2##3##(1991-1#1)(2008-6#1)
the 6-month##14##2##(1991-1#1)(1997-2#1)(2007-11#1)(2007-8#2)(2008-5#2)(2008-6#5)(2008-8#1)(2013-1#1)
the 6-phosphogluconate dehydrogenase##2##3##(1997-3#1)(2008-5#1)
the 6-position of the##2##4##(1994-9#1)(2008-10#1)
the 6-position of##3##3##(1994-9#1)(1997-2#1)(2008-10#1)
the 6-position##5##2##(1994-9#2)(1997-2#2)(2008-10#1)
the 6-week NCEP Step 1 diet##2##6##(2008-3#2)
the 6-week##7##2##(1997-6#1)(2008-3#2)(2008-4#1)(2010-2#1)(2013-1#2)
the 6-year##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
the 60 kDa IGBP##2##4##(1996-12#2)
the 60 kDa protein##2##4##(1990-11#2)
the 60 kDa##5##3##(1990-11#3)(1996-12#2)
the 60 patients##2##3##(1990-12#1)(2006-8#1)
the 60##18##2##(1990-11#3)(1990-12#2)(1993-12#1)(1996-12#2)(1996-5#1)(1996-9#1)(2004-12#1)(2005-1#1)(2006-8#1)(2007-7#1)(2009-10#1)(2010-8#1)(2011-1#1)(2013-8#1)
the 60-kDa##3##2##(1990-3#1)(1990-5#1)(1994-9#1)
the 60-month##2##2##(2007-7#1)(2013-1#1)
the 600##3##2##(1990-8#1)(1992-11#1)(2013-1#1)
the 600-nm##2##2##(1994-5#1)(1994-8#1)
the 60s##2##2##(2009-4#1)(2011-2#1)
the 61 patients##4##3##(2008-8#1)(2011-2#3)
the 61##10##2##(1990-11#1)(1992-6#1)(1993-9#1)(2008-10#1)(2008-8#1)(2009-10#1)(2011-2#3)(2012-1#1)
the 62 bp##2##3##(1994-12#2)
the 62 patients##2##3##(1991-11#1)(1995-9#1)
the 62##9##2##(1991-11#1)(1991-4#1)(1992-9#1)(1994-12#2)(1995-9#1)(1996-12#1)(2006-8#1)(2012-2#1)
the 63##6##2##(1991-12#2)(1992-11#1)(2005-10#1)(2007-1#1)(2008-1#1)
the 633-nm##2##2##(2008-2#1)(2008-3#1)
the 64##12##2##(1992-11#1)(1996-12#1)(1996-9#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-9#1)(2011-2#1)(2013-1#1)
the 64-kDa##3##2##(1992-6#1)(1995-6#1)(1996-5#1)
the 64th##2##2##(2007-5#1)(2007-6#1)
the 65 kDa##3##3##(1992-12#1)(1994-2#1)(1996-12#1)
the 65##10##2##(1992-12#1)(1994-2#1)(1996-12#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-10#1)(2011-2#1)
the 650-bp##2##2##(2008-10#2)
the 657##2##2##(1992-4#1)(2007-7#1)
the 66 and##2##3##(1990-12#1)(2008-8#1)
the 66 kDa EGF prohormone##2##5##(1993-12#2)
the 66 kDa##3##3##(1991-8#1)(1993-12#2)
the 66##10##2##(1990-12#1)(1991-8#1)(1993-12#2)(1994-12#1)(1994-9#1)(2007-2#1)(2008-4#1)(2008-8#1)(2013-1#1)
the 67 K protein##6##4##(1995-12#6)
the 67 K##7##3##(1995-12#7)
the 67 LR##3##3##(1991-5#3)
the 67 kDa##4##3##(1991-5#2)(1993-12#1)(1996-12#1)
the 67##20##2##(1990-7#1)(1991-5#5)(1993-12#1)(1994-5#1)(1995-12#7)(1996-12#1)(2009-12#1)(2009-2#1)(2012-2#1)(2013-8#1)
the 68 isolates##2##3##(2008-10#1)(2013-8#1)
the 68 kDa##2##3##(1991-5#1)(1997-2#1)
the 68##10##2##(1991-11#1)(1991-4#1)(1991-5#1)(1997-2#1)(2006-8#1)(2007-12#1)(2007-5#1)(2008-10#2)(2013-8#1)
the 68-72 kDa gelatinase/type IV collagenase##2##6##(1991-12#2)
the 69##7##2##(1990-11#1)(1990-8#1)(1991-12#1)(1994-12#1)(2008-10#1)(2013-1#2)
the 695##4##2##(1991-9#1)(1992-12#1)(1992-9#1)(1995-10#1)
the 697##3##2##(2012-3#3)
the 6A allele##2##3##(1996-5#2)
the 6MWD##2##2##(2012-12#2)
the 6MWT##3##2##(2012-12#3)
the 6th International Conference on##2##5##(2009-10#2)
the 6th International Conference##3##4##(1990-10#1)(2009-10#2)
the 6th International##7##3##(1990-10#1)(2007-10#1)(2007-2#1)(2009-10#2)(2011-2#2)
the 6th and 7th##3##4##(1993-2#1)(2009-7#1)(2010-2#1)
the 6th and##4##3##(1993-2#1)(2008-5#1)(2009-7#1)(2010-2#1)
the 6th day of##2##4##(2004-9#1)(2008-10#1)
the 6th day##3##3##(2004-9#1)(2008-10#1)(2012-2#1)
the 6th to##3##3##(1993-10#1)(1997-6#1)(2007-5#1)
the 6th##32##2##(1990-10#1)(1990-12#1)(1993-10#2)(1993-12#1)(1993-2#1)(1993-6#1)(1996-4#1)(1997-2#2)(1997-6#1)(2004-9#1)(2007-10#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-7#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2011-4#1)(2012-2#1)
the 7 and##2##3##(1996-12#1)(2012-12#1)
the 7 cases##2##3##(1995-4#1)(2011-2#1)
the 7 days of treatment##2##5##(1992-10#1)(2008-8#1)
the 7 days##3##3##(1992-10#1)(1993-2#1)(2008-8#1)
the 7 patients with##2##4##(1991-5#1)(1995-12#1)
the 7 patients##9##3##(1990-3#1)(1991-5#1)(1995-12#1)(2007-8#2)(2010-2#2)(2013-1#2)
the 7 position##2##3##(1991-10#1)(2008-4#1)
the 7 samples##2##3##(2007-2#1)(2008-10#1)
the 7##62##2##(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-3#3)(1991-5#1)(1992-10#1)(1993-2#1)(1993-6#1)(1993-7#1)(1995-12#1)(1995-4#1)(1996-12#1)(1996-2#1)(2004-3#1)(2005-11#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-5#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#2)(2010-8#2)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#3)(2013-7#2)
the 7- and 10-positions##2##4##(1997-4#2)
the 7- and 10-substituted analogues##2##5##(1997-4#2)
the 7- and 10-substituted##3##4##(1997-4#3)
the 7- and##7##3##(1997-4#7)
the 7-##8##2##(1997-4#7)(2007-11#1)
the 7-amino##3##2##(1992-3#2)(1994-9#1)
the 7-day##3##2##(1997-5#1)(2008-2#2)
the 7-ku##3##2##(2008-9#3)
the 7-valent##2##2##(2012-12#2)
the 7-year##3##2##(2007-8#1)(2008-10#1)(2013-8#1)
the 70 kDa##3##3##(1992-12#1)(1994-9#1)(1997-4#1)
the 70 patients##2##3##(1992-1#1)(2007-8#1)
the 70##16##2##(1990-6#1)(1992-1#1)(1992-12#2)(1993-8#1)(1994-3#2)(1994-9#1)(1997-4#1)(1997-7#1)(2004-1#1)(2006-9#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-5#1)
the 70's##2##2##(1990-6#1)(2007-4#1)
the 70th##2##2##(2006-10#1)(2008-7#1)
the 71%##2##2##(2007-3#1)(2008-5#1)
the 72 kDa##2##3##(1994-11#1)(1994-12#1)
the 72##5##2##(1991-10#1)(1994-11#1)(1994-12#1)(1996-7#1)(1997-2#1)
the 72bp##2##2##(1994-8#2)
the 7436 bp deletion##2##4##(1995-12#2)
the 75 kDa protein##3##4##(1990-8#1)(2008-7#2)
the 75 kDa##5##3##(1990-3#1)(1990-8#1)(2008-7#3)
the 75 years##2##3##(2007-8#1)(2011-2#1)
the 75##11##2##(1990-3#1)(1990-8#1)(1992-12#1)(2007-8#1)(2008-2#1)(2008-7#4)(2011-2#1)(2012-12#1)
the 75-kDa##6##2##(1990-12#2)(1991-2#3)(1993-3#1)
the 75th##7##2##(1996-9#1)(1997-3#1)(2007-11#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-1#1)
the 76##4##2##(1993-1#1)(1994-11#1)(2007-3#1)(2011-2#1)
the 78##2##2##(1995-11#1)(2011-2#1)
the 79 degrees-81 degrees region of the Bacillus subtilis genome##2##10##(1996-8#2)
the 79##5##2##(1994-9#1)(1996-8#2)(1997-2#1)(2007-12#1)
the 793/B##5##2##(2008-5#5)
the 7DL suppressor##4##3##(2008-10#4)
the 7Li##2##2##(1990-4#2)
the 7S##2##2##(1990-5#1)(1991-12#1)
the 7q31-q32 region##2##3##(1996-6#2)
the 7th International##3##3##(2008-6#1)(2011-2#1)(2013-8#1)
the 7th and##4##3##(2006-8#1)(2007-1#1)(2007-2#1)(2013-8#1)
the 7th day after##2##4##(1993-4#1)(1996-1#1)
the 7th day##5##3##(1993-4#1)(1996-1#1)(1997-7#1)(2008-10#1)(2013-8#1)
the 7th month##2##3##(1992-12#1)(2007-11#1)
the 7th##25##2##(1992-12#1)(1992-5#1)(1993-4#1)(1996-1#1)(1997-5#1)(1997-7#1)(2005-7#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-6#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#3)
the 8##32##2##(1990-2#2)(1990-3#1)(1991-3#1)(1992-10#1)(1992-3#1)(1993-7#1)(1994-12#1)(1995-10#1)(1996-3#1)(1996-5#1)(1997-7#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#1)(2009-10#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)
the 8%##4##2##(1991-4#1)(2004-11#1)(2008-7#2)
the 8(th)##5##2##(2009-3#3)(2012-12#2)
the 8-alkynyl derivatives##2##3##(2008-4#2)
the 8-aza##2##2##(1994-9#1)(2008-3#1)
the 8-bp sequence##4##3##(1995-6#4)
the 8-cell stage##2##3##(2006-5#1)(2008-5#1)
the 8-kDa##2##2##(1992-6#2)
the 8-position##3##2##(1993-1#1)(1994-11#1)(1994-9#1)
the 8-week##3##2##(1994-12#1)(2007-12#1)(2012-2#1)
the 8-yr##2##2##(2004-11#2)
the 80 kDa##5##3##(1991-5#1)(1991-8#1)(1992-6#1)(1993-9#1)(1996-2#1)
the 80##12##2##(1991-5#2)(1991-7#1)(1991-8#1)(1992-6#1)(1993-9#1)(1996-2#1)(1996-4#1)(2007-10#1)(2008-5#1)(2008-7#1)(2012-2#1)
the 80% of##2##3##(2004-9#1)(2013-8#1)
the 80%##3##2##(2004-9#1)(2008-10#1)(2013-8#1)
the 800##2##2##(1994-5#1)(2011-2#1)
the 800-nm##2##2##(2007-12#1)(2008-3#1)
the 802##3##2##(2008-10#1)(2008-7#2)
the 803##2##2##(2011-2#1)(2013-8#1)
the 809 cm(-1)##2##3##(2007-11#2)
the 82##4##2##(2008-10#1)(2009-12#1)(2011-1#1)(2013-1#1)
the 83 kDa peptide is##2##5##(1990-11#2)
the 83 kDa peptide##3##4##(1990-11#3)
the 84 non-flashbackers##2##3##(1996-10#2)
the 84##6##2##(1993-2#1)(1996-10#2)(2006-10#1)(2007-8#1)(2012-3#1)
the 85##4##2##(2007-7#1)(2008-2#1)(2008-6#1)(2011-2#1)
the 86 patients##2##3##(1993-11#1)(2007-11#1)
the 86##3##2##(1993-11#1)(2007-11#1)(2009-3#1)
the 86Rb+##2##2##(1990-4#1)(1991-1#1)
the 87##6##2##(1990-6#1)(1991-12#1)(2008-10#1)(2008-7#1)(2010-2#1)(2012-2#1)
the 88 patients##2##3##(2007-8#1)(2012-2#1)
the 88##3##2##(1990-3#1)(2007-8#1)(2012-2#1)
the 88-kDa##2##2##(1990-7#1)(1997-4#1)
the 8th day##3##3##(1991-10#1)(2006-8#1)(2008-7#1)
the 8th grade##2##3##(1993-10#1)(2013-7#1)
the 8th week##3##3##(2005-11#1)(2008-5#1)(2013-1#1)
the 8th##20##2##(1991-10#1)(1992-3#1)(1993-10#1)(1994-8#1)(2005-11#1)(2006-8#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-7#1)(2009-12#1)(2010-12#1)(2010-5#1)(2011-2#1)(2011-4#1)(2012-2#1)(2013-1#1)(2013-7#1)
the 9 cases##2##3##(1993-9#1)(1994-7#1)
the 9 patients with##2##4##(1991-5#1)(1992-8#1)
the 9 patients##3##3##(1991-5#1)(1992-4#1)(1992-8#1)
the 9##26##2##(1990-7#1)(1991-5#2)(1992-4#1)(1992-8#1)(1993-11#1)(1993-9#2)(1994-7#1)(2005-12#1)(2007-1#1)(2008-10#1)(2008-12#5)(2008-2#1)(2008-3#2)(2008-7#2)(2010-5#1)(2011-2#3)
the 9-##2##2##(1996-5#1)(2010-2#1)
the 9-cis retinoic acid receptor (RXR)##2##6##(1992-12#1)(1995-2#1)
the 9-cis##3##2##(1992-12#1)(1995-10#1)(1995-2#1)
the 9-month##2##2##(2008-10#1)(2008-6#1)
the 90 degrees geometry##4##4##(2007-11#1)(2007-12#2)(2008-2#1)
the 90 degrees##8##3##(1993-8#1)(2007-1#2)(2007-11#1)(2007-12#2)(2008-2#1)(2009-5#1)
the 90 kDa protein##2##4##(2008-7#2)
the 90##20##2##(1990-12#1)(1990-6#1)(1993-8#1)(1995-5#1)(1996-11#1)(2007-1#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-7#2)(2009-5#1)(2010-10#1)(2011-2#1)(2012-11#1)
the 90% confidence interval##3##4##(1990-11#1)(2004-12#1)(2008-7#1)
the 90% of##2##3##(1993-9#1)(2013-7#1)
the 90%##6##2##(1990-11#1)(1991-12#1)(1993-9#1)(2004-12#1)(2008-7#1)(2013-7#1)
the 90's##4##2##(1993-3#1)(1993-4#1)(1993-9#1)(2008-1#1)
the 90-day##2##2##(2004-10#1)(2008-11#1)
the 90-kDa##2##2##(1993-3#1)(1996-12#1)
the 900 MHz mobile phone-induced endometrial##2##6##(2008-6#2)
the 900##3##2##(2008-6#2)(2013-1#1)
the 900-bp intron##2##3##(2008-10#2)
the 90s##5##2##(1991-12#1)(1991-3#1)(1994-1#1)(1994-2#1)(1995-12#1)
the 90th percentile##2##3##(1993-9#1)(2006-10#1)
the 90th##3##2##(1993-9#2)(2006-10#1)
the 91##2##2##(1993-6#1)(2008-6#1)
the 92 kDa gelatinase/type IV collagenase##4##6##(1991-12#4)
the 92 kDa##5##3##(1991-12#4)(1994-11#1)
the 92 patients##2##3##(1996-3#1)(1997-3#1)
the 92##9##2##(1991-12#4)(1994-11#1)(1996-3#1)(1997-3#1)(2008-7#1)(2011-1#1)
the 93##3##2##(1992-9#1)(1996-9#1)(1997-8#1)
the 94##6##2##(1991-9#2)(1994-3#1)(2007-7#1)(2010-3#1)(2013-7#1)
the 95##2##2##(1990-3#1)(1997-2#1)
the 95% confidence interval for the##2##6##(1991-5#1)(2007-1#1)
the 95% confidence interval for##3##5##(1991-5#1)(1994-2#1)(2007-1#1)
the 95% confidence interval of##3##5##(1997-1#1)(2008-10#1)(2010-3#1)
the 95% confidence interval##8##4##(1991-5#1)(1994-2#1)(1997-1#2)(2007-1#1)(2008-10#2)(2010-3#1)
the 95% confidence intervals##2##4##(2008-10#1)(2008-9#1)
the 95% confidence limit##2##4##(1992-5#1)(1996-9#1)
the 95% confidence##37##3##(1991-5#1)(1992-5#1)(1994-2#1)(1995-5#1)(1996-9#1)(1997-1#2)(2007-1#1)(2007-8#1)(2008-10#26)(2008-9#1)(2010-3#1)
the 95%##44##2##(1991-5#1)(1992-5#1)(1994-2#1)(1995-5#1)(1996-9#1)(1997-1#2)(2006-10#1)(2007-1#1)(2007-8#1)(2008-10#30)(2008-12#1)(2008-9#1)(2010-3#1)(2012-2#1)
the 95-kDa protein##5##3##(1991-7#5)
the 95-kDa receptor and##2##4##(1994-9#2)
the 95-kDa receptor##4##3##(1994-9#4)
the 95-kDa##10##2##(1991-7#5)(1994-9#4)(1996-12#1)
the 95th percentile##2##3##(2008-7#1)(2010-8#1)
the 95th##3##2##(1996-12#1)(2008-7#1)(2010-8#1)
the 96##5##2##(1990-2#1)(1994-9#1)(1997-4#1)(2006-4#1)(2007-7#1)
the 97 kDa polypeptide##2##4##(1991-1#2)
the 97##4##2##(1991-1#2)(1993-11#1)(1997-6#1)
the 98 kDa##2##3##(1994-6#2)
the 98##6##2##(1994-6#2)(2007-3#1)(2007-8#1)(2008-10#1)(2012-2#1)
the 98- to 120-aa##2##4##(2008-10#2)
the 980-nm##2##2##(2007-12#1)(2008-2#1)
the 99##5##2##(1991-9#1)(1996-5#1)(1997-2#1)(2007-8#1)(2008-10#1)
the 9alpha-hydroxylase system##2##3##(2008-11#2)
the 9th International##2##3##(2008-12#1)(2008-8#1)
the 9th and 10th##4##4##(1992-3#1)(2007-12#1)(2010-4#1)(2013-1#1)
the 9th day of##2##4##(1994-7#1)(2013-8#1)
the 9th day##7##3##(1992-10#1)(1994-7#1)(2008-10#1)(2008-11#1)(2009-8#1)(2013-8#2)
the 9th grade##3##3##(1991-9#3)
the 9th##28##2##(1991-9#3)(1992-10#1)(1992-3#1)(1993-3#1)(1994-3#1)(1994-4#1)(1994-7#1)(1995-10#1)(1996-4#1)(1996-8#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#1)(2010-4#1)(2013-1#2)(2013-8#3)
the ?(3/2) (v?##2##3##(2008-3#2)
the A allele##2##3##(1995-9#1)(2010-6#1)
the A alpha fibrinogen gene##3##5##(1995-3#3)
the A alpha-chain##3##3##(1992-5#1)(1994-12#2)
the A and B chains##2##5##(1996-11#1)(1996-2#1)
the A and B##10##4##(1990-11#1)(1990-3#1)(1993-6#1)(1995-2#1)(1996-11#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-12#1)(2009-3#1)
the A and C rings##2##5##(1993-6#1)(2008-3#1)
the A and##15##3##(1990-11#1)(1990-2#1)(1990-3#1)(1993-6#2)(1995-11#1)(1995-2#1)(1996-11#1)(1996-2#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-3#1)
the A beta P##2##4##(1995-5#2)
the A beta##10##3##(1994-11#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#2)(1996-6#3)(1996-8#1)
the A chain##4##3##(1991-10#1)(1993-11#2)(1997-4#1)
the A genotype##4##3##(2008-10#4)
the A or B##2##4##(2007-11#1)(2008-10#1)
the A or##4##3##(1994-5#1)(2007-11#1)(2008-10#2)
the A site##5##3##(1990-5#1)(1994-5#1)(2006-11#3)
the A subunit with respect to the B pentamer##2##9##(1992-6#2)
the A subunit##6##3##(1992-6#2)(1995-2#1)(1995-6#2)(1996-5#1)
the A transferase##2##3##(1992-8#1)(2005-7#1)
the A##113##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-4#2)(1991-7#1)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#1)(1993-3#3)(1993-6#3)(1994-11#1)(1994-12#2)(1994-5#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#3)(1996-7#3)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2005-7#1)(2006-11#3)(2007-10#1)(2007-11#1)(2008-10#16)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#2)(2008-9#1)(2009-3#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
the A(2A)R##2##2##(2008-4#2)
the A(section)E((R)) discrimination test##2##4##(2008-9#2)
the A(section)E((R))##3##2##(2008-9#3)
the A*##3##2##(2009-6#3)
the A-B-C##2##2##(2006-10#1)(2009-9#1)
the A-T phenotype##2##3##(1997-4#2)
the A-X##2##2##(2008-2#1)(2008-3#1)
the A-chain##4##2##(1990-11#1)(1992-3#1)(1996-11#1)(1996-7#1)
the A-complex##2##2##(1995-6#2)
the A-form##3##2##(1991-4#1)(1992-8#1)(1994-6#1)
the A-ring##6##2##(1991-10#1)(1996-9#4)(2008-10#1)
the A-site of the ribosome##3##5##(1997-2#1)(2006-12#2)
the A-site##7##2##(1990-2#2)(1992-8#1)(1997-2#1)(2006-12#3)
the A-type##2##2##(1991-9#1)(2008-10#1)
the A/B region of##2##4##(1994-12#2)
the A/B##4##2##(1991-4#1)(1994-12#2)(2007-11#1)
the A/J##2##2##(2011-2#1)(2013-1#1)
the A/V effect##2##3##(2005-11#2)
the A/V ratio##2##3##(2005-11#2)
the A/V##4##2##(2005-11#4)
the A1 adenosine receptor##3##4##(1993-3#1)(1993-6#1)(1994-5#1)
the A1 and A2##2##4##(2008-10#1)(2008-9#1)
the A1 cell group##2##4##(1990-5#2)
the A1 pulley in##2##4##(2008-9#2)
the A1 pulley##4##3##(2008-9#3)(2009-5#1)
the A1##26##2##(1990-12#1)(1990-5#3)(1991-2#1)(1991-9#2)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-5#1)(1994-6#1)(1995-7#1)(2008-10#3)(2008-9#4)(2009-5#1)(2011-2#2)
the A1- and the A2-sequences##2##5##(2008-2#2)
the A1- and##3##3##(1994-6#1)(2008-2#2)
the A10##2##2##(1991-1#1)(1995-3#1)
the A2 allele##2##3##(2008-12#1)(2011-2#1)
the A2 fragment##3##3##(1991-5#1)(2011-2#2)
the A2 genotype frequency##2##4##(2011-2#2)
the A2 mating type##4##4##(2008-10#4)
the A2##21##2##(1991-5#1)(1991-6#1)(1993-6#1)(1996-3#3)(2004-11#1)(2008-10#5)(2008-12#1)(2008-9#3)(2011-2#5)
the A2-receptor-induced##2##2##(1994-6#2)
the A3 promoter##3##3##(1990-11#3)
the A33 antigen##3##3##(1997-7#3)
the A3V##3##2##(1997-8#3)
the A4##5##2##(1990-7#1)(1991-1#1)(1994-5#1)(1996-2#1)(1996-7#1)
the A6##4##2##(1993-2#1)(1994-5#2)(2012-2#1)
the A6-cut and##2##3##(2008-6#2)
the A6-cut##4##2##(2008-6#4)
the A7 monoclonal antibody##2##4##(2008-11#2)
the A7##3##2##(1991-8#1)(2008-11#2)
the AA##13##2##(1990-12#1)(1990-5#2)(1996-2#1)(2005-11#2)(2008-3#2)(2008-8#1)(2009-4#1)(2011-2#3)
the AAA aortic stent graft##2##5##(2006-1#2)
the AAA##6##2##(2006-1#2)(2008-7#1)(2012-12#3)
the AABB##6##2##(1995-6#5)(1996-6#1)
the AAC##3##2##(2008-10#3)
the AACT##2##2##(1996-1#2)
the AADI##2##2##(2006-7#2)
the AAPCC##6##2##(1993-3#5)(1997-1#1)
the AAS##5##2##(2008-10#5)
the AAT##2##2##(2008-5#1)(2009-1#1)
the AB##5##2##(1990-2#1)(2009-4#2)(2012-1#1)(2012-2#1)
the ABA contents of cotton roots and leaves##2##8##(2013-8#2)
the ABA##5##2##(1994-11#1)(2007-9#1)(2008-8#1)(2013-8#2)
the ABBP##3##2##(2008-8#3)
the ABC ring##2##3##(2008-7#1)(2009-10#1)
the ABC transporter superfamily##2##4##(1997-1#1)(2008-11#1)
the ABC transporter##4##3##(1994-12#1)(1997-1#1)(2008-11#1)(2011-2#1)
the ABC transporters##2##3##(1997-4#1)(2010-12#1)
the ABC##16##2##(1993-12#1)(1994-12#1)(1994-3#2)(1997-1#1)(1997-4#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-12#1)(2011-2#3)(2013-1#2)
the ABCD matrix##2##3##(2008-2#1)(2008-3#1)
the ABCD##7##2##(2007-1#1)(2007-12#1)(2008-2#3)(2008-3#1)(2009-10#1)
the ABI##3##2##(2007-7#1)(2008-9#1)(2013-1#1)
the ABL##7##2##(1997-6#3)(2008-2#4)
the ABM approach##2##3##(2008-5#2)
the ABO and##2##3##(1993-3#1)(1994-6#1)
the ABO##4##2##(1992-9#1)(1993-3#1)(1994-6#1)(2009-5#1)
the ABQ##2##2##(2010-11#2)
the ABRZ##3##2##(2013-7#2)(2013-8#1)
the AC activity##3##3##(1993-7#3)
the AC oxygen content##3##4##(2005-11#3)
the AC##20##2##(1990-5#2)(1991-1#1)(1991-11#1)(1993-7#5)(1994-12#1)(2005-11#4)(2006-10#1)(2008-10#1)(2008-7#1)(2009-11#1)(2009-5#1)(2013-1#1)
the ACA##2##2##(2006-11#1)(2013-7#1)
the ACC##8##2##(2005-11#2)(2008-10#1)(2008-3#1)(2009-1#2)(2009-5#1)(2009-6#1)
the ACC/AHA Guidelines##3##3##(2008-3#3)
the ACCx##4##2##(1996-9#4)
the ACDF group##2##3##(2012-12#2)
the ACE D/I##3##3##(2010-6#3)
the ACE gene##7##3##(1991-12#3)(2007-11#1)(2008-6#1)(2010-6#2)
the ACE inhibitor##4##3##(1992-4#1)(1993-9#1)(2007-11#1)(2008-7#1)
the ACE##24##2##(1990-2#1)(1991-12#4)(1992-4#1)(1993-9#1)(1995-9#1)(2005-10#1)(2007-11#2)(2008-1#1)(2008-6#1)(2008-7#2)(2008-9#4)(2010-6#5)
the ACEHSA##2##2##(1996-12#2)
the ACF##3##2##(2007-12#1)(2007-8#2)
the ACI patients##3##3##(2007-11#3)
the ACI##6##2##(2007-11#6)
the ACIS##2##2##(2008-10#2)
the ACL tear##2##3##(2009-9#2)
the ACL##15##2##(1996-11#3)(1997-8#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-4#1)(2009-9#2)(2013-1#3)
the ACP and##2##3##(2005-9#2)
the ACP##6##2##(1995-6#1)(2005-9#4)(2013-1#1)
the ACP1 gene product##3##4##(1992-12#3)
the ACPM and BCPM##2##4##(1995-11#2)
the ACR Committee on Ethics##2##5##(2007-4#2)
the ACR and other##2##4##(2007-4#2)
the ACR and the##2##4##(2007-4#2)
the ACR and##5##3##(2007-4#4)(2012-12#1)
the ACR##23##2##(2007-4#21)(2007-6#1)(2012-12#1)
the ACR's##2##2##(2007-4#2)
the ACS##8##2##(2005-8#2)(2008-4#2)(2008-5#3)(2008-6#1)
the ACT-4D##4##2##(2012-1#4)
the ACTH receptor##2##3##(1995-12#1)(2011-1#1)
the ACTH##6##2##(1992-8#1)(1994-2#1)(1995-12#1)(1996-3#2)(2011-1#1)
the ACh content of##2##4##(1992-8#1)(1997-3#1)
the ACh##7##2##(1990-2#1)(1992-8#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-5#1)(2009-12#1)
the ACh-induced##2##2##(1997-1#2)
the AChE layer##2##3##(2008-10#2)
the AChE##5##2##(1992-9#1)(1995-12#1)(1995-3#1)(2008-10#2)
the AChE-positive##2##2##(1992-8#1)(1997-8#1)
the AChR##3##2##(1997-5#1)(2008-4#1)(2012-2#1)
the AD cases##5##3##(1991-1#4)(1997-7#1)
the AD duration##3##3##(1992-12#1)(1994-2#2)
the AD group##6##3##(1994-11#1)(1995-11#1)(2008-7#2)(2011-2#2)
the AD patients##2##3##(2007-8#1)(2012-1#1)
the AD##23##2##(1991-1#4)(1992-12#1)(1993-2#1)(1994-11#1)(1994-2#2)(1995-11#1)(1996-1#1)(1997-7#1)(2007-8#1)(2007-9#1)(2008-7#3)(2011-2#4)(2012-1#1)(2012-2#1)
the AD3 subtype##2##3##(1995-8#2)
the ADA##18##2##(1994-1#2)(1995-12#3)(1995-6#2)(1996-1#2)(1996-11#1)(1996-5#2)(1997-5#2)(2004-9#2)(2007-5#1)(2008-3#1)
the ADH promoter##2##3##(1993-3#2)
the ADH##3##2##(1993-3#2)(1997-8#1)
the ADH1 gene##2##3##(1990-5#2)
the ADH1 promoter##3##3##(1990-5#2)(1997-3#1)
the ADH1##5##2##(1990-5#4)(1997-3#1)
the ADHD##3##2##(2006-10#2)(2012-1#1)
the ADI method##4##3##(2008-2#4)
the ADI##6##2##(2008-2#6)
the ADL##3##2##(2008-7#1)(2012-1#2)
the ADM##2##2##(2006-3#2)
the ADP##5##2##(1990-11#1)(1990-5#1)(1990-7#1)(1996-7#1)(2006-6#1)
the ADP- and##2##3##(1992-12#1)(1997-7#1)
the ADP-ribosylation of HMG##2##4##(1990-3#2)
the ADP-ribosylation of the##2##4##(1992-12#1)(1993-3#1)
the ADP-ribosylation of two##2##4##(1991-10#1)(1993-3#1)
the ADP-ribosylation of##14##3##(1990-3#4)(1991-10#1)(1992-11#1)(1992-12#1)(1993-3#5)(1993-6#1)(1995-6#1)
the ADP-ribosylation##17##2##(1990-3#4)(1991-10#1)(1992-11#1)(1992-12#2)(1993-3#5)(1993-6#1)(1994-3#1)(1995-6#1)(1997-4#1)
the ADP-ribosyltransferase##2##2##(1990-2#1)(1991-1#1)
the ADR of##2##3##(2008-10#2)
the ADR##4##2##(2008-10#2)(2011-2#1)(2013-8#1)
the ADR/AE##3##2##(2011-2#3)
the ADS##2##2##(2008-10#1)(2009-10#1)
the ADT##2##2##(2008-2#2)
the ADV##2##2##(2006-10#1)(2011-2#1)
the AF group##2##3##(2008-5#2)
the AF plus PVPP group##3##5##(2008-5#3)
the AF plus PVPP##5##4##(2008-5#5)
the AF##11##2##(2008-10#1)(2008-5#9)(2012-2#1)
the AF4Q initiative has##3##4##(2013-1#3)
the AF4Q initiative##8##3##(2013-1#8)
the AF4Q##11##2##(2013-1#11)
the AFC assay##5##3##(2008-10#5)
the AFC##11##2##(2008-10#5)(2011-2#6)
the AFIP##2##2##(2010-7#2)
the AFLP data##2##3##(2008-10#2)
the AFLP groups##2##3##(2008-10#2)
the AFLP##12##2##(2008-10#12)
the AFM tip is##2##4##(2007-12#1)(2008-7#1)
the AFM tip##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
the AFM##11##2##(2005-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#1)(2009-10#2)
the AFP##5##2##(1992-11#3)(1997-6#1)(2008-8#1)
the AG##4##2##(2006-9#1)(2007-8#1)(2008-10#2)
the AGL2 gene family from##2##5##(1997-2#2)
the AGL2 gene family##4##4##(1997-2#3)(1997-8#1)
the AGL2##6##2##(1997-2#4)(1997-8#2)
the AGT activity##3##3##(1993-11#1)(1995-12#1)(1995-5#1)
the AGT##6##2##(1993-11#1)(1995-12#1)(1995-5#3)(2008-5#1)
the AGabaA##3##2##(2012-12#3)
the AH receptor##3##3##(1997-2#3)
the AH##7##2##(1991-8#1)(1993-8#1)(1994-10#2)(1997-2#3)
the AH109A invasion##2##3##(2008-11#2)
the AH109A##3##2##(2008-11#3)
the AHA##4##2##(1991-12#2)(1997-3#1)(2006-10#1)
the AHA's##3##2##(1991-1#1)(1991-3#1)(1992-12#1)
the AHI##3##2##(2007-7#2)(2011-1#1)
the AHP##5##2##(1993-2#1)(1994-1#1)(1995-1#1)(1995-3#1)(2008-10#1)
the AHRA Statistical Resource Committee##3##5##(1991-12#1)(1991-3#1)(1993-1#1)
the AHRA surveyed its##2##4##(1995-3#1)(1996-1#1)
the AHRA##9##2##(1991-12#3)(1991-3#1)(1993-1#1)(1994-1#1)(1995-12#1)(1995-3#1)(1996-1#1)
the AHRA's &quot##3##3##(1990-12#1)(1992-12#1)(1993-2#1)
the AHRA's##6##2##(1990-12#1)(1992-12#1)(1993-2#4)
the AI##3##2##(2007-12#1)(2008-10#1)(2013-1#1)
the AIDS crisis##3##3##(1992-12#2)(1993-1#1)
the AIDS epidemic in##3##4##(1990-3#1)(1993-3#1)(2008-4#1)
the AIDS epidemic##18##3##(1990-12#2)(1990-3#3)(1993-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1996-1#1)(1996-5#1)(1996-6#1)(2004-9#1)(2007-6#1)(2007-7#1)(2008-4#1)(2008-5#1)(2010-5#1)
the AIDS patients##2##3##(2007-12#1)(2008-5#1)
the AIDS virus##7##3##(1990-5#2)(1990-6#1)(1991-5#1)(1992-12#1)(1992-9#1)(1993-1#1)
the AIDS##52##2##(1990-11#1)(1990-12#2)(1990-3#4)(1990-5#2)(1990-6#1)(1991-2#1)(1991-5#2)(1992-12#3)(1992-9#3)(1993-1#2)(1993-3#2)(1994-1#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-3#2)(1997-5#1)(2004-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#3)(2008-4#1)(2008-5#3)(2010-10#1)(2010-3#1)(2010-5#1)(2012-2#1)
the AIDS-associated##3##2##(1994-7#1)(2009-8#2)
the AIDS-related##2##2##(1994-10#1)(2009-8#1)
the AIF-PI method##2##3##(2009-9#2)
the AII receptor antagonists##2##4##(2005-7#2)
the AII##5##2##(1990-6#1)(1993-4#1)(1994-12#1)(2005-7#2)
the AII-induced##3##2##(1991-5#2)(1993-4#1)
the AIS##3##2##(2008-10#2)(2010-7#1)
the AK##2##2##(1994-12#1)(1996-5#1)
the ALD gene##2##3##(1993-3#1)(1994-12#1)
the ALD##5##2##(1993-12#1)(1993-3#1)(1994-12#1)(1995-2#1)(2010-12#1)
the ALIF group##2##3##(2007-8#2)
the ALP activity and##2##4##(2008-5#1)(2010-10#1)
the ALP activity at##2##4##(2008-1#1)(2010-10#1)
the ALP activity##5##3##(2008-1#1)(2008-5#2)(2010-10#2)
the ALP##10##2##(1990-12#1)(1991-5#3)(1992-1#1)(2008-1#1)(2008-5#2)(2010-10#2)
the ALS##3##2##(1992-9#1)(2008-3#1)(2009-9#1)
the ALT##3##2##(2005-11#1)(2008-1#2)
the AM bundle##2##3##(2009-9#2)
the AM##16##2##(1992-2#1)(1992-6#1)(1993-2#1)(1994-2#2)(1994-8#1)(1995-12#3)(2006-3#1)(2008-11#1)(2008-7#1)(2009-8#1)(2009-9#2)(2012-2#1)
the AMA##2##2##(2008-6#1)(2011-12#1)
the AMARTIS model##2##3##(2008-3#2)
the AMARTIS##3##2##(2008-3#3)
the AMBER##2##2##(1991-7#1)(2008-10#1)
the AML##6##2##(2008-10#3)(2008-6#3)
the AMP##4##2##(1990-11#1)(1993-3#1)(1993-6#1)(2008-10#1)
the AMPA receptor##3##3##(1993-12#1)(1994-2#1)(1995-7#1)
the AMPA##8##2##(1993-12#1)(1994-2#1)(1995-11#1)(1995-5#1)(1995-7#1)(1997-7#1)(2008-1#1)(2010-3#1)
the AMPA/kainate##3##2##(1994-10#1)(1995-11#1)(1995-5#1)
the AMPK##2##2##(2009-12#1)(2010-12#1)
the AMPs##3##2##(1996-10#3)
the AN##2##2##(1991-11#2)
the AN-13 enzyme##2##3##(1997-1#2)
the ANCOVA with equal slopes and##2##6##(2012-1#2)
the ANCOVA with equal slopes##4##5##(2012-1#4)
the ANCOVA with equal##5##4##(2012-1#5)
the ANCOVA with##6##3##(2012-1#6)
the ANCOVA##8##2##(1993-1#1)(2012-1#7)
the ANF##2##2##(1990-12#1)(2008-6#1)
the ANF-C receptor##2##3##(1991-9#2)
the ANN method proved to be##2##6##(2008-10#2)
the ANN model##2##3##(2006-12#1)(2008-10#1)
the ANN##12##2##(2006-12#1)(2008-10#7)(2008-2#1)(2009-3#1)(2010-4#1)(2010-8#1)
the ANN/FTNIR##2##2##(2008-10#2)
the ANP##3##2##(1990-11#2)(2006-11#1)
the ANS##2##2##(2011-1#1)(2013-8#1)
the AO##6##2##(1995-3#1)(2007-11#1)(2008-2#2)(2008-3#1)(2010-5#1)
the AOA##3##2##(2009-10#2)(2012-12#1)
the AOAC##6##2##(2008-10#6)
the AOS##3##2##(1995-11#1)(2006-6#1)(2008-2#1)
the AOSD##2##2##(2006-10#2)
the AOT##3##2##(1995-2#1)(2005-11#2)
the AP site##6##3##(1995-2#1)(2007-8#3)(2008-10#2)
the AP##20##2##(1991-1#2)(1992-7#1)(1994-5#1)(1994-8#1)(1995-2#1)(1997-8#1)(2007-12#1)(2007-4#1)(2007-8#3)(2008-10#2)(2009-11#1)(2010-2#2)(2010-4#1)(2012-1#1)(2013-8#1)
the AP-1 binding site##2##4##(1990-5#1)(1994-11#1)
the AP-1 binding##4##3##(1990-5#1)(1994-11#1)(1996-10#1)(1997-6#1)
the AP-1##8##2##(1990-5#1)(1994-11#2)(1995-12#1)(1996-10#1)(1996-5#1)(1997-6#2)
the APC gene##4##3##(2006-2#1)(2008-4#2)(2008-8#1)
the APC##9##2##(1994-11#1)(1995-1#1)(2006-2#1)(2007-3#1)(2007-9#1)(2008-4#2)(2008-8#2)
the APCs##4##2##(2007-9#2)(2008-4#1)(2012-3#1)
the API##6##2##(2007-8#2)(2008-5#1)(2008-7#1)(2009-6#1)(2011-2#1)
the APO-induced##3##2##(1996-1#3)
the APOE gene##3##3##(2012-12#3)
the APOE##9##2##(1996-5#2)(1996-6#1)(2012-12#6)
the APOE4 allele##2##3##(1995-1#1)(1996-6#1)
the APP gene##5##3##(1991-9#1)(1992-1#1)(1995-6#1)(1996-12#1)(1996-6#1)
the APP molecule##2##3##(1992-12#2)
the APP##16##2##(1990-9#1)(1991-9#1)(1992-1#1)(1992-12#3)(1992-9#1)(1993-11#1)(1993-3#1)(1995-6#1)(1996-12#1)(1996-6#3)(2012-12#2)
the APP717##3##2##(1994-12#3)
the APR indicators##2##3##(2007-9#2)
the APRT gene##3##3##(1990-12#1)(1995-1#1)(1995-5#1)
the APS##8##2##(2005-9#1)(2006-10#2)(2006-5#1)(2008-10#1)(2008-11#1)(2008-6#2)
the APT##2##2##(2012-12#2)
the APTT##2##2##(1990-12#1)(1994-9#1)
the AR and##2##3##(1996-5#1)(2006-12#1)
the AR cDNA##2##3##(1995-12#2)
the AR in##3##3##(1990-11#1)(1992-8#1)(2010-1#1)
the AR of##2##3##(1990-11#1)(2008-8#1)
the AR##26##2##(1990-11#2)(1990-8#1)(1992-8#1)(1993-4#1)(1994-11#2)(1994-2#1)(1995-12#2)(1995-3#2)(1996-5#4)(1997-1#1)(2006-12#1)(2007-2#1)(2008-2#1)(2008-8#3)(2010-1#1)(2010-8#1)(2011-2#1)
the AR2##2##2##(2006-6#2)
the ARC##3##2##(1994-8#2)(2008-10#1)
the ARE##4##2##(1995-6#2)(2008-9#1)(2009-8#1)
the ARF##2##2##(1993-6#1)(1997-4#1)
the ARF-family##2##2##(1996-7#2)
the ARF18-C##2##2##(2008-10#2)
the ARIA##3##2##(2012-12#3)
the ARIC study##2##3##(1990-12#1)(2007-6#1)
the ARIC##4##2##(1990-12#3)(2007-6#1)
the ARNT##2##2##(2008-7#1)(2010-7#1)
the ARS##4##2##(2008-10#1)(2008-3#1)(2008-6#2)
the ARS1 region##2##3##(1990-10#2)
the ARS1##3##2##(1990-10#2)(1997-8#1)
the ART##3##2##(2008-4#1)(2009-4#1)(2012-12#1)
the AS##14##2##(1993-5#1)(2008-5#1)(2009-4#1)(2012-12#11)
the AS-like##2##2##(1992-11#2)
the ASA##7##2##(1997-6#5)(2009-5#1)(2011-11#1)
the ASAD##2##2##(2012-2#2)
the ASC mice##2##3##(2013-1#2)
the ASC##4##2##(2012-4#1)(2013-1#3)
the ASCCP##2##2##(2006-10#2)
the ASD##6##2##(2007-8#1)(2008-2#2)(2008-3#1)(2009-4#1)(2013-1#1)
the ASE cartridge##2##3##(2008-10#2)
the ASE##5##2##(2007-11#1)(2008-10#3)(2008-2#1)
the ASI##4##2##(1991-1#1)(2011-1#3)
the ASIA scale##2##3##(2007-11#2)
the ASIA##3##2##(2007-11#2)(2012-1#1)
the ASM##2##2##(2005-8#1)(2012-1#1)
the ASMF##3##2##(2008-3#3)
the ASR was##2##3##(1996-5#1)(2011-2#1)
the ASR##3##2##(1992-2#1)(1996-5#1)(2011-2#1)
the ASRC given##2##3##(1996-12#2)
the ASRC##4##2##(1996-12#4)
the ASRT to##2##3##(1996-3#1)(2007-4#1)
the ASTM##2##2##(2008-10#2)
the ASV peaks##2##3##(2008-10#2)
the ASV##4##2##(2008-10#4)
the AT region##3##3##(1995-6#3)
the AT##8##2##(1990-5#1)(1992-3#1)(1993-3#1)(1995-10#1)(1995-6#3)(2008-5#1)
the AT1 receptor subtype##4##4##(1992-3#1)(1993-3#1)(1994-8#1)(1994-9#1)
the AT1 receptor##12##3##(1992-3#1)(1992-7#1)(1993-3#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-6#1)(1996-8#1)(1997-8#2)(2005-7#1)
the AT1##14##2##(1992-3#1)(1992-7#1)(1993-3#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-6#1)(1996-8#1)(1997-8#2)(2005-7#1)(2006-6#1)(2008-8#1)
the AT1- and AT2-receptors##2##4##(2007-1#2)
the AT1-receptor##5##2##(2007-1#5)
the AT1A-R##3##2##(1996-5#3)
the AT2 receptor##10##3##(1994-8#2)(1994-9#1)(1995-10#1)(1996-5#1)(1996-8#5)
the AT2##12##2##(1991-9#1)(1994-8#2)(1994-9#2)(1995-10#1)(1996-5#1)(1996-8#5)
the AT2-receptor##2##2##(2007-1#2)
the AT2R1 A1166 --&gt##2##4##(2010-6#2)
the AT2R1##3##2##(2010-6#3)
the ATA##4##2##(1992-5#3)(1994-8#1)
the ATD tests##2##3##(2007-1#2)
the ATD##4##2##(2006-11#1)(2007-1#3)
the ATG and##2##3##(1991-7#1)(2007-5#1)
the ATG codon##4##3##(1990-3#2)(1991-5#1)(1992-12#1)
the ATG##16##2##(1990-3#2)(1990-9#1)(1991-5#1)(1991-7#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-12#1)(1994-8#1)(2007-5#4)(2007-9#1)
the ATG12##2##2##(2013-1#2)
the ATL was increased##3##4##(2007-1#3)
the ATL##4##2##(2007-1#3)(2008-5#1)
the ATM gene##3##3##(2007-2#3)
the ATM##5##2##(2007-2#3)(2008-8#1)(2012-2#1)
the ATOM##2##2##(2009-1#2)
the ATP binding site of##2##5##(1991-6#1)(2011-2#1)
the ATP binding site##5##4##(1991-6#1)(1994-11#1)(1995-3#1)(1995-6#1)(2011-2#1)
the ATP binding##9##3##(1990-3#1)(1991-6#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-6#1)(2011-2#1)
the ATP content of##2##4##(1994-6#1)(1997-6#1)
the ATP content##3##3##(1990-6#1)(1994-6#1)(1997-6#1)
the ATP hydrolysis and the proton-pumping activities##2##7##(2006-8#2)
the ATP hydrolysis cycle##2##4##(1992-11#1)(1997-4#1)
the ATP hydrolysis##8##3##(1991-10#1)(1992-11#1)(1993-9#1)(1997-4#3)(2006-8#2)
the ATP level of##2##4##(1991-9#1)(1992-3#1)
the ATP site##2##3##(1991-4#1)(2008-5#1)
the ATP transient is##2##4##(1992-1#2)
the ATP##57##2##(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-2#1)(1992-3#1)(1993-3#1)(1993-4#1)(1993-6#4)(1993-8#4)(1993-9#1)(1994-11#2)(1994-6#2)(1994-9#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-7#1)(1997-4#4)(1997-6#1)(1997-7#1)(2005-12#1)(2005-8#2)(2006-8#2)(2007-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#2)(2013-1#1)
the ATP- and##2##3##(1991-9#1)(1995-12#1)
the ATP-binding site of##3##4##(1990-12#2)(2006-6#1)
the ATP-binding site##4##3##(1990-12#3)(2006-6#1)
the ATP-binding##12##2##(1990-12#3)(1991-2#1)(1991-6#1)(1995-4#1)(1996-7#1)(1997-4#2)(2006-10#1)(2006-6#1)(2008-11#1)
the ATP-citrate lyase mRNA##3##4##(1992-11#3)
the ATP-cytochrome c adducts##2##4##(1995-2#2)
the ATP-dependent##13##2##(1990-11#1)(1991-5#1)(1991-9#1)(1992-11#1)(1994-12#1)(1995-6#1)(1995-8#2)(1996-7#1)(1997-4#1)(1997-7#1)(2005-11#1)(2008-8#1)
the ATP-evoked##2##2##(1990-5#1)(2008-4#1)
the ATP-induced dissociation of##2##4##(1995-2#1)(1995-3#1)
the ATP-induced##7##2##(1990-5#2)(1992-11#1)(1995-2#1)(1995-3#1)(1997-4#1)(2008-4#1)
the ATP-sensitive##4##2##(1990-10#1)(1994-11#1)(1994-3#1)(1996-2#1)
the ATP/2e- ratio##2##3##(1997-7#2)
the ATP7B gene##4##3##(2007-12#1)(2008-3#2)(2008-9#1)
the ATPase activity of BiP##2##5##(1997-6#2)
the ATPase activity of the##2##5##(1990-2#1)(1994-12#1)
the ATPase activity of##7##4##(1990-2#1)(1992-6#1)(1994-12#1)(1997-2#1)(1997-6#2)(2008-8#1)
the ATPase activity##14##3##(1990-2#1)(1992-6#1)(1993-3#1)(1993-9#1)(1994-12#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#2)(2008-8#1)
the ATPase and##5##3##(1992-6#2)(1993-3#1)(1995-3#1)(2010-7#1)
the ATPase complex##3##3##(1995-3#2)(1995-6#1)
the ATPase reaction##3##3##(1992-6#2)(1997-6#1)
the ATPase##41##2##(1990-2#2)(1991-10#1)(1991-2#1)(1992-11#1)(1992-6#6)(1993-3#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-3#5)(1995-6#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#3)(1997-6#3)(1997-7#3)(2006-6#1)(2008-8#1)(2010-7#1)(2012-3#1)
the ATPase's##2##2##(1991-2#1)(2010-7#1)
the ATR spectra##2##3##(2006-12#1)(2007-8#1)
the ATR##8##2##(2006-12#1)(2007-8#3)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)
the ATR1##3##2##(2013-1#3)
the AUC of##2##3##(2008-11#1)(2011-1#1)
the AUC##7##2##(1996-6#1)(2008-11#3)(2008-5#1)(2010-2#1)(2011-1#1)
the AUD severity factor##2##4##(2013-8#2)
the AUDPC##3##2##(2008-10#3)
the AUG##2##2##(1991-12#1)(1993-11#1)
the AUS/FLUS category##3##3##(2013-8#3)
the AUUUA##2##2##(1994-9#1)(1996-7#1)
the AV##5##2##(1992-2#1)(1992-5#1)(2008-5#1)(2011-3#2)
the AVF##7##2##(1996-9#1)(2006-6#1)(2007-7#3)(2007-8#2)
the AVM without##2##3##(2008-7#2)
the AVM##13##2##(1997-6#1)(2006-2#1)(2007-10#1)(2008-7#10)
the AVP##3##2##(1991-7#1)(1992-9#2)
the AZA##2##2##(1992-8#1)(2009-4#1)
the Ab production efficiency##3##4##(2008-11#3)
the Ab##4##2##(1996-8#1)(2008-11#3)
the Abbe##2##2##(2008-3#1)(2012-1#1)
the Abbott##2##2##(1996-4#1)(2008-10#1)
the Abbreviated Injury Scale##2##4##(1992-2#1)(2005-9#1)
the Abbreviated##3##2##(1992-2#1)(2005-9#1)(2010-12#1)
the Abitibi region##2##3##(2008-2#2)
the Abl kinase##3##3##(2008-1#1)(2009-3#1)(2012-12#1)
the Abl tyrosine kinase##2##4##(1995-2#1)(2009-3#1)
the Abl##8##2##(1994-10#1)(1995-2#3)(2008-1#1)(2009-3#2)(2012-12#1)
the Aboriginals##3##2##(2008-2#3)
the Abu##2##2##(2007-2#1)(2011-1#1)
the Ac elements are##2##4##(2012-3#2)
the Ac elements##3##3##(2012-3#3)
the Ac##5##2##(2012-3#5)
the Ac-LDL##2##2##(1991-8#2)
the AcChT##3##2##(1992-6#3)
the AcChT-VR##2##2##(1992-6#2)
the AcNPV##2##2##(1997-4#2)
the Academic##2##2##(1993-7#1)(2008-3#1)
the Academy of Medicine##2##4##(2007-7#1)(2012-2#1)
the Academy of##6##3##(2007-7#1)(2008-8#1)(2009-7#1)(2010-1#1)(2012-2#1)(2012-3#1)
the Acb##3##2##(2007-8#3)
the Accreditation Council for Continuing Medical Education##9##7##(2006-10#8)(2007-4#1)
the Accreditation Council for##10##4##(2006-10#9)(2007-4#1)
the Accreditation Council##11##3##(2006-10#9)(2007-4#2)
the Accreditation##14##2##(1995-2#2)(2006-10#9)(2007-4#2)(2010-8#1)
the Accuracy of##2##3##(2009-9#1)(2013-1#1)
the Achatina##3##2##(1991-2#1)(1991-5#2)
the Achilles tendon##7##3##(1995-8#1)(2006-11#1)(2007-12#1)(2008-4#1)(2009-10#2)(2012-1#1)
the Achilles##10##2##(1995-8#1)(1997-8#1)(2006-11#1)(2007-12#1)(2008-4#1)(2008-5#1)(2009-10#2)(2011-2#1)(2012-1#1)
the Achilles' heel of##2##4##(2007-7#1)(2008-8#1)
the Acholeplasma##2##2##(1993-12#1)(1993-3#1)
the Acomys##2##2##(2010-11#2)
the Acrobot##2##2##(2007-5#2)
the Act and##3##3##(1991-1#1)(2006-8#1)(2012-3#1)
the Act##13##2##(1991-1#1)(1991-10#1)(1993-3#2)(1993-4#1)(1997-8#1)(2006-11#1)(2006-8#3)(2012-3#3)
the Activator##5##2##(2007-6#5)
the Active##4##2##(1991-6#1)(1996-2#1)(2008-12#1)(2013-8#1)
the Activity of##2##3##(2008-10#2)
the Acute Care##2##3##(1993-3#1)(2010-9#1)
the Acute Stroke Unit##2##4##(2007-9#2)
the Acute##9##2##(1993-3#1)(1997-1#1)(2007-9#2)(2008-10#1)(2008-7#1)(2010-7#1)(2010-9#1)(2013-1#1)
the Ad-2 MLP##3##3##(1990-4#3)
the Ad9 E4 region##3##4##(1992-9#3)
the Adair##4##2##(1990-8#4)
the Addiction Severity Index (ASI)##2##5##(2011-1#2)
the Addiction Severity Index##3##4##(2011-1#3)
the Addiction##4##2##(1992-12#1)(2011-1#3)
the Adjusted##2##2##(1997-1#1)(2008-7#1)
the Adult##2##2##(2008-3#1)(2008-4#1)
the Advanced Earth Observing Satellite II##2##6##(2008-2#2)
the Advanced Photon Source at Argonne National Laboratory##2##8##(2008-11#1)(2008-3#1)
the Advanced Photon Source##6##4##(2006-4#3)(2006-5#1)(2008-11#1)(2008-3#1)
the Advanced##16##2##(2006-4#3)(2006-5#1)(2006-6#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2010-8#1)
the Advancement of##3##3##(1996-6#1)(2007-9#1)(2008-8#1)
the Adventist##2##2##(1996-1#1)(2011-2#1)
the Advisory Committee on##4##4##(1994-11#1)(1996-3#1)(2004-12#2)
the Advisory Committee##5##3##(1990-12#1)(1994-11#1)(1996-3#1)(2004-12#2)
the Aedes##2##2##(2008-1#1)(2008-11#1)
the Aerobics Center Longitudinal Study (ACLS)##2##6##(2009-3#2)
the Affymetrix GeneChip Wheat Genome Array##2##6##(2010-2#2)
the Affymetrix GeneChip##3##3##(2008-4#1)(2010-2#2)
the Affymetrix##10##2##(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#2)(2010-11#1)(2010-2#3)
the Afmadow to Garissa routes##2##5##(2011-2#2)
the African American sample##2##4##(2007-7#2)
the African American##6##3##(2007-7#2)(2010-8#3)(2012-12#1)
the African continent##3##3##(2006-8#1)(2007-12#1)(2010-5#1)
the African nationalist movement##2##4##(2006-7#2)
the African##35##2##(1991-7#1)(1992-8#1)(1994-2#1)(1996-11#1)(2005-9#1)(2006-4#2)(2006-7#2)(2006-8#1)(2007-12#2)(2007-4#1)(2007-7#3)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-2#1)(2010-12#1)(2010-5#1)(2010-8#5)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
the Afro-Andean##3##2##(2008-10#3)
the AfsR##3##2##(1990-10#3)
the Ag electrode##3##3##(2008-10#1)(2013-1#2)
the Ag nanoparticles##2##3##(2005-11#1)(2010-7#1)
the Ag##12##2##(1990-5#1)(1995-2#1)(1996-2#1)(2005-11#1)(2007-12#1)(2008-10#2)(2010-7#1)(2013-1#4)
the Ag(+)##3##2##(2008-3#1)(2010-5#2)
the Ag(2)S##3##2##(2008-10#1)(2008-3#2)
the Aga Khan University Hospital##3##5##(2007-7#1)(2012-2#1)(2013-8#1)
the Age of Enlightenment##4##4##(2008-12#3)(2012-2#1)
the Age of##6##3##(1996-5#1)(2008-12#3)(2012-1#1)(2012-2#1)
the Age##8##2##(1996-5#1)(2008-12#3)(2009-12#1)(2009-7#1)(2012-1#1)(2012-2#1)
the Agency for Health Care Policy and Research##3##8##(1992-8#1)(1993-12#1)(1993-7#1)
the Agency for Healthcare Research and Quality (AHRQ)##3##8##(2006-8#3)
the Agency for Healthcare Research and Quality##4##7##(2006-8#3)(2011-2#1)
the Agency for Toxic Substances and Disease Registry##4##8##(2006-12#1)(2007-12#3)
the Agency for##11##3##(1992-8#1)(1993-12#1)(1993-7#1)(2006-12#1)(2006-8#3)(2007-12#3)(2011-2#1)
the Agency##12##2##(1992-8#1)(1993-12#1)(1993-7#1)(1997-3#1)(2006-12#1)(2006-8#3)(2007-12#3)(2011-2#1)
the Agp2 genes are##2##4##(2006-12#2)
the Agreement##2##2##(1991-10#2)
the Agricultural Health Study##2##4##(2008-6#2)
the Agricultural Production-Crops industry##2##4##(2008-12#2)
the Agricultural Production-Crops##4##3##(2008-12#4)
the Agricultural##9##2##(2008-12#6)(2008-6#2)(2009-7#1)
the Agrobacterium##6##2##(1990-3#1)(1991-7#1)(2006-12#2)(2006-3#1)(2008-9#1)
the Ah receptor in##2##4##(1993-12#1)(1993-3#1)
the Ah receptor##11##3##(1992-11#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-8#3)(1995-11#1)(1997-3#2)(1997-4#1)
the Ah##17##2##(1992-11#1)(1992-12#1)(1993-12#2)(1993-3#1)(1994-8#3)(1995-11#1)(1995-2#2)(1997-3#2)(1997-4#1)(2004-4#2)(2005-11#1)
the AhR complex##2##3##(1993-11#2)
the AhR##9##2##(1993-11#3)(2008-10#4)(2009-3#2)
the Aid##2##2##(1992-2#1)(2008-1#1)
the Air Force##2##3##(2006-10#1)(2008-3#1)
the Air##4##2##(2006-10#1)(2008-3#1)(2011-2#1)(2013-1#1)
the Airy caustics##3##3##(2008-2#3)
the Airy rings##2##3##(2007-11#1)(2008-1#1)
the Airy##9##2##(2007-11#4)(2008-1#1)(2008-2#4)
the Akaike information criterion##2##4##(2006-10#1)(2011-1#1)
the Akaike##3##2##(2006-10#1)(2008-6#1)(2011-1#1)
the Akt##2##2##(2010-4#1)(2012-12#1)
the Al adsorbent was##3##4##(2005-11#3)
the Al adsorbent##4##3##(2005-11#4)
the Al concentration##2##3##(2008-10#2)
the Al electrode##2##3##(2008-10#1)(2009-11#1)
the Al powder industry##2##4##(2013-8#2)
the Al##23##2##(1996-8#4)(2005-11#4)(2007-2#1)(2007-8#1)(2008-10#7)(2008-3#1)(2009-11#1)(2010-4#2)(2013-8#2)
the Al13##2##2##(2005-11#2)
the Ala minihelix##2##3##(1995-2#2)
the Ala##4##2##(1992-6#1)(1995-2#3)
the Ala-Pro##2##2##(1992-6#1)(1993-2#1)
the Alabama##3##2##(1993-6#1)(2010-8#1)(2011-1#1)
the Albanian##2##2##(2008-10#1)(2011-2#1)
the Alberta Catholic Hospitals Foundation##2##5##(1993-12#1)(1994-1#1)
the Alberta##7##2##(1993-12#3)(1994-1#1)(1996-1#1)(2006-10#1)(2012-12#1)
the Alcian blue##2##3##(1991-1#1)(1994-9#1)
the Alcohol and Drug##2##4##(2007-10#1)(2010-8#1)
the Alcohol##6##2##(1991-2#1)(2007-10#1)(2008-8#1)(2010-7#1)(2010-8#1)(2013-8#1)
the Algerian##2##2##(2010-1#1)(2013-7#1)
the Aligning Forces for Quality (AF4Q)##2##6##(2013-1#2)
the Aligning Forces for Quality##4##5##(2013-1#4)
the All India Institute of Medical Sciences##2##7##(1991-6#1)(1995-5#1)
the All##4##2##(1991-6#1)(1995-5#1)(1996-12#1)(2011-2#1)
the Allan##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
the Allee effect##6##3##(2008-10#1)(2008-8#5)
the Allen's test##3##3##(2007-8#3)
the Allied##2##2##(2006-2#1)(2007-2#1)
the AlloMap test##2##3##(2008-10#2)
the AlloMap##3##2##(2008-10#3)
the Alpha and##2##3##(1995-3#1)(1997-1#1)
the Alps##3##2##(2008-11#3)
the Alternate##2##2##(2008-10#1)(2008-4#1)
the Alu consensus sequence##2##4##(1991-5#1)(1993-12#1)
the Alu##7##2##(1990-11#2)(1991-5#2)(1993-12#1)(1995-2#1)(1997-2#1)
the Alu-binding protein##2##3##(1991-7#2)
the Alvarado Lagoon##2##3##(2007-3#1)(2008-5#1)
the Alzheimer amyloid precursor protein gene##2##6##(1993-8#1)(1994-8#1)
the Alzheimer amyloid##5##3##(1992-8#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-8#1)
the Alzheimer##22##2##(1990-3#3)(1992-12#1)(1992-8#2)(1992-9#1)(1993-11#3)(1993-8#1)(1994-11#2)(1994-5#3)(1994-8#1)(1995-11#1)(1996-11#1)(2006-6#1)(2008-7#1)(2008-8#1)
the Alzheimer's Disease Cooperative Study##2##5##(2008-5#1)(2011-2#1)
the Alzheimer's Disease##5##3##(1995-11#1)(2004-3#1)(2007-5#1)(2008-5#1)(2011-2#1)
the Alzheimer's disease##7##3##(1990-5#1)(1992-12#1)(1995-10#2)(1995-8#1)(2004-11#1)(2008-7#1)
the Alzheimer's##18##2##(1990-5#2)(1991-10#1)(1991-11#1)(1992-12#1)(1992-7#1)(1995-10#2)(1995-11#1)(1995-8#1)(2004-11#1)(2004-3#1)(2007-5#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-4#1)(2011-2#1)
the Amazon molly##3##3##(2009-2#1)(2013-1#2)
the Amazon rainforest##2##3##(2010-7#2)
the Amazon##20##2##(1991-11#1)(1994-7#1)(2006-12#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-2#1)(2010-7#3)(2011-2#3)(2012-2#1)(2013-1#2)(2013-7#1)
the Amberlite##2##2##(2008-10#2)
the Amendment's##2##2##(1993-12#2)
the American Academy of Pediatrics Section on Urology##3##8##(2006-9#3)
the American Academy of Pediatrics##7##5##(1996-6#1)(2006-9#3)(2008-11#1)(2010-8#1)(2013-1#1)
the American Academy of##13##4##(1995-2#1)(1996-6#1)(2006-12#1)(2006-9#3)(2007-11#1)(2007-7#1)(2008-11#1)(2008-8#1)(2010-8#1)(2011-1#1)(2013-1#1)
the American Association for Partial Hospitalization##2##6##(1991-1#2)
the American Association for the Study of Liver Diseases##2##9##(2005-6#1)(2006-10#1)
the American Association for##5##4##(1991-1#2)(2005-6#1)(2006-10#1)(2008-9#1)
the American Association of Blood Banks (AABB)##2##7##(1995-6#1)(1996-6#1)
the American Association of Neurological Surgeons##2##6##(2006-12#1)(2012-3#1)
the American Association of##9##4##(1995-6#1)(1996-4#1)(1996-6#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-5#1)(2012-2#1)(2012-3#1)
the American Association##14##3##(1991-1#2)(1995-6#1)(1996-4#1)(1996-6#1)(2005-6#1)(2006-10#2)(2006-12#1)(2008-1#1)(2008-5#1)(2008-9#1)(2012-2#1)(2012-3#1)
the American Astronomical Society's##3##4##(2007-8#2)(2007-9#1)
the American Astronomical##4##3##(1995-6#1)(2007-8#2)(2007-9#1)
the American Board of Radiology##2##5##(2007-4#2)
the American Board of##4##4##(1991-2#1)(2007-4#2)(2011-2#1)
the American Cancer Society##3##4##(1995-9#1)(2006-10#1)(2010-9#1)
the American Chemical Society##4##4##(2005-8#1)(2008-5#2)(2009-10#1)
the American Civil War##3##4##(2009-7#2)(2013-1#1)
the American Civil##4##3##(2009-4#1)(2009-7#2)(2013-1#1)
the American College of Cardiology##3##5##(2008-3#2)(2009-6#1)
the American College of Cardiology/American Heart Association guidelines##2##8##(2008-3#2)
the American College of Cardiology/American Heart Association##3##7##(2008-3#3)
the American College of Chest Physicians##2##6##(2005-8#1)(2011-2#1)
the American College of Physicians##4##5##(1993-12#2)(1993-7#1)(2010-8#1)
the American College of Radiology##3##5##(1990-12#1)(1993-3#1)(2007-4#1)
the American College of Rheumatology##3##5##(2005-8#1)(2006-10#1)(2007-8#1)
the American College of Surgeons##4##5##(2008-4#1)(2008-6#3)
the American College of##30##4##(1990-12#1)(1993-12#2)(1993-3#1)(1993-7#1)(1994-12#1)(1996-2#1)(2005-8#3)(2006-10#1)(2007-10#1)(2007-4#1)(2007-8#1)(2008-3#5)(2008-4#1)(2008-6#3)(2009-6#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#3)
the American Dental Association##3##4##(1995-6#1)(2011-12#1)(2012-3#1)
the American Diabetes Association##3##4##(2008-3#1)(2008-5#1)(2011-1#1)
the American Dietetic Association##2##4##(1994-2#1)(1995-2#1)
the American Heart Association (AHA)##3##5##(2006-10#1)(2008-3#1)(2012-3#1)
the American Heart Association and the##2##6##(1996-6#1)(2008-3#1)
the American Heart Association and##4##5##(1996-6#2)(2008-3#1)(2010-9#1)
the American Heart Association##18##4##(1991-7#1)(1996-6#2)(2005-8#1)(2006-10#1)(2007-8#1)(2008-3#5)(2008-4#1)(2009-5#1)(2010-1#1)(2010-9#1)(2012-12#2)(2012-3#1)
the American Heart##19##3##(1991-7#1)(1996-6#2)(2005-8#1)(2006-10#1)(2007-8#1)(2008-3#5)(2008-4#1)(2009-5#1)(2010-1#1)(2010-8#1)(2010-9#1)(2012-12#2)(2012-3#1)
the American Holistic##2##3##(2010-7#2)
the American Hospital Association Annual Survey##2##6##(1992-2#1)(2008-11#1)
the American Hospital Association##4##4##(1992-2#2)(1992-3#1)(2008-11#1)
the American Hospital##5##3##(1992-2#2)(1992-3#1)(2005-11#1)(2008-11#1)
the American Indian community##2##4##(1996-2#1)(2007-2#1)
the American Indian##3##3##(1996-2#1)(2007-2#1)(2010-2#1)
the American Medical Association and##3##5##(1993-3#1)(1993-7#1)(2007-12#1)
the American Medical Association##14##4##(1991-8#2)(1993-3#1)(1993-7#1)(1996-12#1)(2006-10#8)(2007-12#1)
the American National Standards Institute (ANSI)##2##6##(2006-8#1)(2011-1#1)
the American National##5##3##(1997-5#1)(1997-8#1)(2006-8#1)(2008-3#1)(2011-1#1)
the American Osteopathic##2##3##(1991-12#1)(2007-12#1)
the American Pain Society##2##4##(2006-12#1)(2007-12#1)
the American Psychiatric##2##3##(2009-6#1)(2013-8#1)
the American Psychological Association##5##4##(1994-12#3)(2004-12#1)(2006-2#1)
the American Psychological##6##3##(1994-12#3)(2004-12#1)(2006-11#1)(2006-2#1)
the American Public Health##2##4##(1992-7#1)(1997-8#1)
the American Red Cross##2##4##(1995-6#1)(1996-11#1)
the American Society for##5##4##(1996-4#1)(1997-7#1)(2005-7#1)(2011-1#1)(2011-2#1)
the American Society of Clinical Oncology and##2##7##(2009-8#1)(2010-11#1)
the American Society of Clinical Oncology##6##6##(2007-11#1)(2008-7#3)(2009-8#1)(2010-11#1)
the American Society of Clinical##7##5##(2007-1#1)(2007-11#1)(2008-7#3)(2009-8#1)(2010-11#1)
the American Society of Gene Therapy##2##6##(2008-5#2)
the American Society of Naturalists##2##5##(2008-8#1)(2013-1#1)
the American Society of##22##4##(2005-9#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#3)(2007-8#1)(2008-5#2)(2008-7#5)(2008-8#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
the American Society##27##3##(1996-4#1)(1997-7#1)(2005-7#1)(2005-9#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#3)(2007-8#1)(2008-5#2)(2008-7#5)(2008-8#1)(2009-8#1)(2010-11#1)(2011-1#2)(2011-2#2)(2013-1#1)
the American Thoracic Society##2##4##(2008-7#1)(2013-1#1)
the American Urological Association##5##4##(2006-10#1)(2006-9#4)
the American cockroach##4##3##(1997-8#4)
the American health care system##4##5##(1992-3#1)(1993-12#1)(1995-3#1)(2007-4#1)
the American lobster Homarus americanus##2##5##(2009-12#2)
the American population##4##3##(1993-12#1)(1996-2#1)(2008-10#1)(2012-3#1)
the American##250##2##(1990-12#3)(1990-6#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-7#1)(1991-8#2)(1992-2#2)(1992-3#2)(1992-7#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-7#2)(1994-12#4)(1994-2#2)(1995-1#1)(1995-2#2)(1995-3#1)(1995-6#4)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#4)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#6)(2004-12#1)(2005-11#1)(2005-6#1)(2005-7#1)(2005-8#6)(2005-9#1)(2006-10#16)(2006-11#1)(2006-12#3)(2006-2#1)(2006-7#1)(2006-8#2)(2006-9#8)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#7)(2007-7#1)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#13)(2008-4#3)(2008-5#8)(2008-6#7)(2008-7#7)(2008-8#4)(2008-9#3)(2009-10#1)(2009-12#2)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#1)(2010-1#3)(2010-11#2)(2010-12#2)(2010-2#1)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#5)(2011-12#1)(2011-2#10)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#5)(2013-1#4)(2013-8#1)
the Americans With Disabilities Act (ADA)##4##6##(1994-1#2)(2004-9#2)
the Americans With Disabilities Act##6##5##(1991-12#1)(1994-1#2)(1995-1#1)(2004-9#2)
the Americans in##2##3##(1993-7#1)(1994-9#1)
the Americans with Disabilities Act (ADA) and the##3##8##(1995-12#1)(1996-6#1)(1997-5#1)
the Americans with Disabilities Act (ADA) by##2##7##(1995-6#1)(1996-5#1)
the Americans with Disabilities Act (ADA)##15##6##(1995-12#4)(1995-6#2)(1996-1#1)(1996-11#2)(1996-12#1)(1996-5#1)(1996-6#1)(1997-5#3)
the Americans with Disabilities Act##21##5##(1992-12#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-12#5)(1995-6#2)(1996-1#2)(1996-11#2)(1996-12#1)(1996-5#1)(1996-6#1)(1997-5#3)
the Americans with Disabilities##23##4##(1992-12#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-12#5)(1995-6#2)(1996-1#2)(1996-11#2)(1996-12#1)(1996-5#1)(1996-6#1)(1997-5#3)(2005-10#1)
the Americans##31##2##(1991-12#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-1#3)(1994-2#1)(1994-9#1)(1995-1#1)(1995-12#5)(1995-6#2)(1996-1#2)(1996-11#2)(1996-12#1)(1996-5#1)(1996-6#1)(1997-5#3)(2004-9#2)(2005-10#1)
the Americas and was##2##4##(1994-9#1)(2008-10#1)
the Americas and##3##3##(1993-8#1)(1994-9#1)(2008-10#1)
the Americas##24##2##(1993-3#1)(1993-8#1)(1994-9#2)(2006-10#2)(2006-7#1)(2007-2#1)(2008-10#5)(2008-5#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#5)
the Amerlite MAB free T3##2##5##(1996-12#2)
the Ames test##5##3##(1993-9#1)(1997-3#1)(2008-4#1)(2011-1#1)(2011-2#1)
the Ames##7##2##(1993-9#1)(1996-12#1)(1997-3#1)(2008-2#1)(2008-4#1)(2011-1#1)(2011-2#1)
the Amide I##4##3##(1990-3#4)
the Amide##5##2##(1990-3#5)
the Amoy##2##2##(2007-5#1)(2008-5#1)
the AmpFISTR Identifiler kit##2##4##(2008-12#1)(2010-9#1)
the AmpFISTR Identifiler##4##3##(2008-12#2)(2010-9#2)
the Amplatzer##2##2##(1997-8#1)(2013-1#1)
the Amplitype##4##2##(1996-7#4)
the An aphA##2##3##(1995-8#2)
the An##6##2##(1995-3#1)(1995-8#3)(2004-11#1)(2007-12#1)
the An1##2##2##(1993-6#2)
the Anabaena##4##2##(1991-8#1)(1994-9#2)(1995-1#1)
the Anabaptist##3##2##(2008-12#3)
the Analysis of##3##3##(2008-2#1)(2008-3#1)(2009-8#1)
the Anarrhichomenum complex##6##3##(2008-10#6)
the Anatomical Society of Great Britain and##12##7##(2006-11#12)
the Anatomical Society of##14##4##(2006-11#14)
the Ancestral Recombination Graph##2##4##(2006-10#2)
the Andalusian##2##2##(2008-11#1)(2009-10#1)
the Andean highlands##2##3##(2008-10#2)
the Andean region##2##3##(2006-4#1)(2012-12#1)
the Andean##14##2##(1997-6#1)(2006-4#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-12#1)(2013-7#1)
the Anderson##3##2##(1993-3#1)(2008-10#1)(2010-5#1)
the Andes of##2##3##(2008-10#1)(2008-5#1)
the Andes##14##2##(2008-10#6)(2008-3#1)(2008-5#3)(2008-8#3)(2013-1#1)
the Ang##3##2##(1996-4#1)(2005-6#1)(2009-4#1)
the AngIV sites##2##3##(1995-5#2)
the Angiogenesis##2##2##(1996-6#1)(2013-8#1)
the Angle##2##2##(2008-2#1)(2010-2#1)
the Anglo-American##3##2##(1993-3#1)(1997-5#1)(2012-2#1)
the Anglo-Saxon literature##2##3##(2006-12#2)
the Annual Meeting of the##3##5##(2006-9#1)(2011-2#1)(2012-1#1)
the Annual Review of Physical Chemistry##29##6##(2010-12#2)(2011-1#16)(2012-1#11)
the Annual Review of##149##4##(2010-12#8)(2011-1#53)(2011-12#4)(2011-2#11)(2012-1#73)
the Annual##155##2##(2006-11#2)(2006-9#1)(2008-11#1)(2010-12#8)(2011-1#53)(2011-12#4)(2011-2#12)(2012-1#74)
the Anopheles##2##2##(2007-2#1)(2010-1#1)
the Anoxomat##6##2##(2006-8#6)
the Antagonist##2##2##(2008-10#2)
the Antagonistic##2##2##(2008-10#2)
the Antarctic teleost Trematomus##2##4##(2012-12#2)
the Antarctic##12##2##(1991-5#1)(1992-3#1)(1995-3#1)(1996-1#1)(2007-10#1)(2012-12#5)(2013-8#2)
the Anterior##4##2##(1997-6#1)(2008-12#1)(2013-1#2)
the Anticancer##2##2##(2007-5#1)(2011-12#1)
the Antiviral##3##2##(2008-10#1)(2008-5#2)
the Ap4A phosphorylase##2##3##(1990-10#2)
the Ap4A##3##2##(1990-10#2)(1993-3#1)
the Apc gene in##2##4##(1995-1#1)(1997-5#1)
the Apc gene##4##3##(1995-1#2)(1997-5#1)(2012-2#1)
the Apennine side##2##3##(2008-8#2)
the Apennine##3##2##(2008-8#3)
the Apgar score##5##3##(1994-6#1)(1995-6#1)(2007-2#2)(2008-4#1)
the Aphid Schizaphis graminum##2##4##(2008-10#2)
the Aplysia##5##2##(1990-7#1)(1994-2#1)(1997-2#1)(2008-6#2)
the ApoE E4 allele frequency was##2##6##(1995-3#2)
the ApoE##3##2##(1995-3#2)(1997-7#1)
the Apple##4##2##(1991-12#1)(2008-10#3)
the Application of##3##3##(2005-5#2)(2012-1#1)
the Appropriateness##3##2##(1997-6#1)(2010-12#2)
the Approved Lists of Bacterial Names##2##6##(2008-10#2)
the Aqueous##3##2##(2006-2#1)(2008-8#1)(2012-11#1)
the Arab World##2##3##(2007-7#1)(2008-10#1)
the Arab dominated groups##2##4##(2008-1#2)
the Arab##14##2##(2007-5#1)(2007-7#1)(2008-1#4)(2008-10#1)(2008-4#5)(2012-2#1)(2013-1#1)
the Arabian Peninsula##6##3##(2006-12#1)(2007-3#1)(2008-1#1)(2011-2#1)(2012-12#2)
the Arabian peninsula##2##3##(2007-2#1)(2007-3#1)
the Arabian##9##2##(2006-12#1)(2007-2#1)(2007-3#2)(2008-1#1)(2008-3#1)(2011-2#1)(2012-12#2)
the Arabidopsis ADS1 gene##2##4##(2006-12#2)
the Arabidopsis ADS1##3##3##(2006-12#3)
the Arabidopsis CAB2##2##3##(1995-2#2)
the Arabidopsis Information Resource (TAIR)##2##5##(2008-4#2)
the Arabidopsis genome and##2##4##(2008-7#2)
the Arabidopsis genome##11##3##(2006-12#1)(2007-12#1)(2008-7#6)(2009-10#3)
the Arabidopsis thaliana genome##2##4##(1997-6#1)(2007-6#1)
the Arabidopsis thaliana##6##3##(1994-12#1)(1997-6#1)(1997-8#1)(2007-6#1)(2008-10#1)(2009-8#1)
the Arabidopsis##43##2##(1994-12#2)(1994-3#1)(1995-2#3)(1995-8#1)(1996-5#1)(1997-6#1)(1997-8#1)(2006-12#6)(2007-12#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-4#2)(2008-7#8)(2008-9#1)(2009-10#3)(2009-6#1)(2009-8#6)(2012-3#1)
the Arc##2##2##(2007-11#2)
the Arctic Sun##2##3##(2007-10#2)
the Arctic polar##2##3##(1991-5#2)
the Arctic##12##2##(1991-11#2)(1991-5#2)(1994-7#3)(2007-10#2)(2008-11#1)(2010-1#1)(2010-8#1)
the Area Resource File##2##4##(2008-11#2)
the Area Under##2##3##(2006-9#1)(2010-2#1)
the Area de Conservación##2##4##(2007-3#1)(2008-5#1)
the Area de##3##3##(2007-3#2)(2008-5#1)
the Area##7##2##(2006-9#1)(2007-3#2)(2008-11#2)(2008-5#1)(2010-2#1)
the Arg and##2##3##(1992-4#1)(1995-6#1)
the Arg residue##2##3##(1991-10#1)(1994-12#1)
the Arg##5##2##(1991-10#1)(1992-4#1)(1994-12#1)(1995-4#1)(1995-6#1)
the Arg38 side-chain##2##3##(1996-6#2)
the Argentine##2##2##(2008-5#1)(2009-10#1)
the Argentinian##3##2##(2009-7#1)(2010-10#2)
the Arina##3##2##(2008-10#3)
the Arizona Cognitive Test Battery##2##5##(2011-1#2)
the Arizona##5##2##(1995-12#1)(1997-8#1)(2008-5#1)(2011-1#2)
the Army##3##2##(1992-12#1)(2009-4#1)(2009-7#1)
the Arp2/3 complex##4##3##(2008-1#1)(2009-8#1)(2012-2#2)
the Arrhenius equation##4##3##(2005-12#1)(2006-10#1)(2008-5#1)(2009-8#1)
the Arrhenius##11##2##(1990-3#1)(1993-12#2)(1993-4#1)(1994-8#1)(2005-12#1)(2005-4#1)(2006-10#1)(2008-5#2)(2009-8#1)
the ArsA protein##3##3##(1994-5#3)
the Arsenazo##2##2##(1991-1#1)(2008-10#1)
the Arthropoda##2##2##(2007-12#2)
the As matrix##2##3##(2008-10#2)
the As##3##2##(2008-10#3)
the As(3+)-DDTP##2##2##(2008-10#2)
the As(III)##2##2##(2008-10#2)
the AsA##3##2##(2008-10#1)(2013-8#2)
the Ascidian Halocynthia roretzi##2##4##(2008-5#1)(2008-6#1)
the Ascidian##3##2##(1996-2#1)(2008-5#1)(2008-6#1)
the Ash Split Cath##2##4##(2007-7#2)
the Asia-Pacific region##5##3##(2005-8#1)(2008-10#2)(2009-8#2)
the Asia-Pacific##7##2##(2005-8#1)(2008-10#4)(2009-8#2)
the Asian Pacific##2##3##(2005-8#1)(2009-8#1)
the Asian patient##3##3##(2010-8#3)
the Asian##23##2##(2005-8#2)(2006-12#1)(2006-4#3)(2006-9#1)(2008-10#1)(2009-11#1)(2009-8#1)(2010-6#1)(2010-8#7)(2011-2#2)(2013-1#1)(2013-8#2)
the Asian-African##3##2##(2013-1#3)
the Asians##2##2##(1991-9#1)(2007-7#1)
the Asir##13##2##(2007-2#5)(2007-3#8)
the Asp 26##2##3##(1991-7#2)
the Asp residue##2##3##(1990-10#1)(1996-5#1)
the Asp##5##2##(1990-10#2)(1991-7#2)(1996-5#1)
the Aspergillus nidulans trpC##2##4##(2008-10#1)(2011-1#1)
the Aspergillus nidulans##4##3##(1991-7#1)(1994-9#1)(2008-10#1)(2011-1#1)
the Aspergillus niger##2##3##(1995-8#1)(1997-4#1)
the Aspergillus##10##2##(1991-7#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-8#1)(1997-4#1)(2007-12#1)(2008-10#2)(2011-1#1)
the Assessment of##6##3##(1996-7#2)(2007-12#1)(2007-7#2)(2012-12#1)
the Assessment##7##2##(1996-7#2)(1997-2#1)(2007-12#1)(2007-7#2)(2012-12#1)
the Association for Volunteer Administration##2##5##(1994-3#1)(1995-12#1)
the Association for##6##3##(1992-3#1)(1994-3#2)(1995-12#1)(2008-7#1)(2008-8#1)
the Association of Medical Microbiology and Infectious Disease Canada##2##9##(2007-12#1)(2008-4#1)
the Association of Medical##3##4##(2007-12#1)(2008-12#1)(2008-4#1)
the Association of Official Analytical Chemists##2##6##(2006-10#1)(2008-10#1)
the Association of Official##3##4##(2006-10#1)(2008-10#2)
the Association of Psychologists in Academic Health Centers (APAHC)##2##9##(2008-12#2)
the Association of Psychologists in Academic Health Centers##4##8##(2008-12#4)
the Association of##22##3##(1991-3#1)(1994-3#1)(1995-12#1)(2005-5#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-12#5)(2008-4#1)(2009-11#1)(2009-2#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
the Association##39##2##(1990-6#1)(1991-3#1)(1992-3#1)(1994-3#3)(1995-12#3)(1995-4#1)(2004-3#1)(2005-5#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-12#5)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#1)(2010-3#1)(2010-9#1)(2011-2#1)(2011-4#1)(2012-12#2)(2012-3#2)
the Astro-E##2##2##(2008-3#2)
the Asymptomatic Carotid Atherosclerosis Study##2##5##(2006-11#2)
the Asymptomatic##3##2##(1994-4#1)(2006-11#2)
the Ataxia Telangiectasia##2##3##(2008-7#1)(2009-5#1)
the Ataxia##3##2##(1995-6#1)(2008-7#1)(2009-5#1)
the Atherosclerosis Risk in Communities##2##5##(2006-12#1)(2009-12#1)
the Atkins diet##2##3##(2008-3#2)
the Atkins##4##2##(2008-3#4)
the Atlantic Ocean##3##3##(1996-4#1)(2010-6#1)(2012-3#1)
the Atlantic and##2##3##(2007-3#1)(2013-1#1)
the Atlantic coast##2##3##(2004-4#1)(2008-10#1)
the Atlantic salmon##3##3##(1991-7#1)(1994-2#1)(1995-11#1)
the Atlantic##23##2##(1991-7#1)(1991-8#1)(1994-2#1)(1995-11#1)(1996-4#2)(2004-4#1)(2007-3#2)(2007-9#2)(2008-10#1)(2008-7#3)(2009-4#1)(2010-12#1)(2010-6#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#2)
the Atmospheric##2##2##(2008-3#2)
the Atp7a gene##4##3##(2008-12#4)
the Attachment Q-Set##2##3##(2006-3#2)
the Au surface##5##3##(1996-11#3)(2008-10#2)
the Au##13##2##(1996-11#3)(2007-8#2)(2008-10#4)(2008-2#2)(2009-11#1)(2011-1#1)
the AuAE##2##2##(2008-10#2)
the Auger process##2##3##(2007-5#2)
the Auger##3##2##(2007-5#3)
the August##3##2##(1996-12#1)(1996-5#1)(2007-7#1)
the Aurora##3##2##(2013-1#3)
the Australasian##4##2##(2007-2#2)(2008-4#1)(2008-7#1)
the Australian 'fire-beetle' Merimna atrata##2##5##(2007-12#2)
the Australian NH&amp##2##3##(1994-2#2)
the Australian Quality Awards##2##4##(1995-3#2)
the Australian and##3##3##(2009-4#1)(2011-2#1)(2013-1#1)
the Australian experience##2##3##(2007-8#2)
the Australian health##2##3##(1995-3#1)(2006-4#1)
the Australian population##3##3##(2007-11#1)(2007-12#1)(2011-2#1)
the Australian##47##2##(1990-2#3)(1991-2#1)(1994-12#1)(1994-2#2)(1995-3#3)(2005-7#1)(2006-4#1)(2006-5#1)(2007-11#3)(2007-12#5)(2007-2#3)(2007-4#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#3)(2009-2#1)(2009-4#1)(2010-4#1)(2011-2#4)(2012-12#1)(2013-1#3)(2013-8#1)
the Austrian##5##2##(1990-7#1)(2012-12#4)
the Author##4##2##(1990-1#1)(1990-5#1)(1991-9#1)(2011-2#1)
the Author's##2##2##(1991-10#1)(1991-5#1)
the Authors conclude##2##3##(1990-9#1)(2007-7#1)
the Authors describe a##2##4##(1990-3#1)(1992-9#1)
the Authors describe the##2##4##(1990-9#1)(1991-1#1)
the Authors describe##5##3##(1990-1#1)(1990-3#1)(1990-9#1)(1991-1#1)(1992-9#1)
the Authors discuss the##2##4##(1990-2#1)(1991-10#1)
the Authors discuss##3##3##(1990-10#1)(1990-2#1)(1991-10#1)
the Authors emphasize the##2##4##(1991-1#1)(1992-10#1)
the Authors emphasize##3##3##(1990-5#1)(1991-1#1)(1992-10#1)
the Authors report a##2##4##(1990-10#1)(1992-9#1)
the Authors report##3##3##(1990-10#1)(1991-9#1)(1992-9#1)
the Authors to##2##3##(1990-10#1)(1991-5#1)
the Authors underline the##2##4##(1991-1#1)(1991-9#1)
the Authors underline##3##3##(1991-1#1)(1991-5#1)(1991-9#1)
the Authors##42##2##(1990-1#1)(1990-10#5)(1990-2#1)(1990-3#4)(1990-5#1)(1990-6#1)(1990-9#3)(1991-1#3)(1991-10#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-9#5)(1992-10#5)(1992-6#1)(1992-9#4)(2007-7#1)(2011-2#1)
the Authors'##4##2##(1991-4#1)(1991-5#1)(1992-10#1)(1992-6#1)
the Autism Spectrum##2##3##(2012-11#2)
the Autism##3##2##(2012-11#2)(2012-12#1)
the Autographa californica nuclear polyhedrosis virus (AcNPV)##2##7##(1997-4#1)(2008-7#1)
the Autographa californica nuclear polyhedrosis virus##3##6##(1997-4#2)(2008-7#1)
the Autographa californica##5##3##(1993-12#1)(1997-3#1)(1997-4#2)(2008-7#1)
the Automated##4##2##(1995-3#1)(2011-2#1)(2013-1#2)
the Autonomous Community of##2##4##(1996-9#1)(2012-11#1)
the Autonomous##6##2##(1995-9#1)(1996-9#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)
the Avahan program##5##3##(2012-3#5)
the Avahan##11##2##(2012-3#11)
the Award##2##2##(1996-2#2)
the Axl##3##2##(2012-12#2)(2013-1#1)
the Azores##4##2##(1997-5#3)(2013-7#1)
the Azotobacter vinelandii##3##3##(1995-8#2)(2009-7#1)
the B allele##4##3##(1995-9#3)(2008-12#1)
the B and##4##3##(1990-7#1)(1990-9#1)(2008-4#2)
the B antigen##3##3##(1992-12#1)(1996-3#2)
the B biotype of##2##4##(2008-10#1)(2011-2#1)
the B biotype##3##3##(2008-10#2)(2011-2#1)
the B cell antigen receptor##3##5##(1994-9#1)(2008-4#1)(2008-5#1)
the B cell antigen##4##4##(1994-9#1)(2006-10#1)(2008-4#1)(2008-5#1)
the B cell##13##3##(1991-12#1)(1991-3#1)(1992-7#1)(1992-9#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-3#1)(1997-6#1)(2006-10#1)(2008-4#1)(2008-5#1)(2012-1#1)
the B cells##2##3##(1995-3#1)(2008-4#1)
the B chains##2##3##(1995-11#1)(1997-4#1)
the B conformation##2##3##(1995-11#1)(2006-10#1)
the B control region##2##4##(1995-2#2)
the B detector##3##3##(2008-3#3)
the B domain##2##3##(1994-12#1)(1997-8#1)
the B fragment##4##3##(1990-3#3)(1997-3#1)
the B ring##3##3##(1993-6#1)(2007-11#1)(2008-11#1)
the B site##3##3##(1994-5#2)(1996-2#1)
the B subunit of##3##4##(1995-3#2)(1996-5#1)
the B subunit##8##3##(1995-3#2)(1995-6#1)(1996-5#5)
the B subunit-binding domain##3##4##(1995-6#3)
the B##148##2##(1990-11#3)(1990-2#2)(1990-3#3)(1990-5#1)(1990-6#1)(1990-7#2)(1990-9#3)(1991-12#2)(1991-3#1)(1991-5#1)(1992-12#2)(1992-6#2)(1992-7#1)(1992-9#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#4)(1994-9#1)(1995-11#3)(1995-2#3)(1995-3#5)(1995-6#4)(1995-9#3)(1996-2#1)(1996-3#3)(1996-5#5)(1997-2#5)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#1)(2005-7#1)(2006-10#3)(2006-5#3)(2006-8#11)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#26)(2008-11#1)(2008-12#4)(2008-3#3)(2008-4#5)(2008-5#4)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-5#1)(2011-2#4)(2012-1#1)(2012-3#1)
the B(rd)##2##2##(2008-12#2)
the B- and##2##3##(1995-2#2)
the B-Twin system##2##3##(2008-11#2)
the B-Twin##4##2##(2008-11#4)
the B-Z##2##2##(1992-5#1)(2007-8#1)
the B-cell##3##2##(1992-6#1)(1994-9#2)
the B-chain##3##2##(1991-10#1)(1992-3#1)(1993-7#1)
the B-domain##2##2##(1994-8#1)(1997-1#1)
the B-form of##2##3##(1991-5#1)(1992-5#1)
the B-form##4##2##(1991-5#1)(1992-5#1)(1994-6#1)(2006-10#1)
the B-lymphocytes##2##2##(2008-10#2)
the B1##8##2##(1993-3#1)(1994-11#2)(1994-5#1)(1994-9#3)(2008-10#1)
the B2##8##2##(1991-12#1)(1991-5#2)(1993-3#1)(1995-3#2)(2008-8#1)(2008-9#1)
the B37##3##2##(1997-5#3)
the B3LYP##3##2##(2008-8#1)(2009-2#1)(2010-7#1)
the B7##2##2##(1997-9#1)(2011-1#1)
the B73 genome##3##3##(2012-3#3)
the B73 x Tex6 cross##2##5##(2008-10#2)
the B73##5##2##(2008-10#2)(2012-3#3)
the B800-850 complex##3##3##(1993-3#1)(2007-12#2)
the BA steels##2##3##(2009-5#2)
the BA##8##2##(2007-9#4)(2009-5#2)(2013-1#2)
the BAA showed##2##3##(2011-2#2)
the BAC##5##2##(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#1)
the BAC-by-BAC##2##2##(2008-7#2)
the BAC2##2##2##(2008-8#2)
the BACs##2##2##(2008-7#1)(2008-8#1)
the BAK##2##2##(1992-11#1)(2006-8#1)
the BAL##9##2##(1994-6#4)(2007-8#1)(2009-4#2)(2010-12#2)
the BAL-induced activation##3##3##(1991-2#3)
the BALB/c##4##2##(1991-1#1)(1992-9#1)(1996-10#2)
the BAR##2##2##(1992-12#1)(2009-6#1)
the BAS##2##2##(2007-12#2)
the BB##4##2##(1992-5#1)(2006-11#1)(2008-2#1)(2008-4#1)
the BB84##2##2##(2007-12#1)(2008-2#1)
the BBA##6##2##(2008-11#6)
the BBB and##2##3##(1995-3#1)(2008-7#1)
the BBB is##3##3##(2007-11#2)(2008-7#1)
the BBB##30##2##(1993-12#2)(1995-12#2)(1995-3#4)(1996-4#1)(1996-5#2)(2005-8#1)(2006-7#1)(2007-10#1)(2007-11#7)(2008-1#3)(2008-7#4)(2008-8#2)
the BBO crystal##2##3##(2007-12#1)(2008-3#1)
the BBO##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
the BBS##2##2##(2010-3#2)
the BC muscle##2##3##(1992-7#1)(1994-5#1)
the BC##7##2##(1992-7#1)(1993-3#1)(1994-5#1)(2008-9#1)(2009-4#2)(2009-9#1)
the BCA##3##2##(1992-12#1)(2008-10#2)
the BCC##2##2##(2011-12#1)(2012-3#1)
the BCL2 gene##2##3##(1996-4#2)
the BCL2##3##2##(1996-4#3)
the BCMA##4##2##(2013-1#4)
the BCR##4##2##(2008-10#4)
the BCR-ABL##5##2##(2006-6#1)(2007-12#2)(2011-1#1)(2012-12#1)
the BD##2##2##(2009-6#1)(2013-8#1)
the BDD##3##2##(2007-12#1)(2008-10#2)
the BDI##3##2##(1996-2#1)(2008-6#1)(2012-2#1)
the BEF-1##2##2##(1994-9#2)
the BET surface area##2##4##(2005-11#1)(2009-11#1)
the BET##4##2##(2005-11#1)(2007-8#1)(2009-11#1)(2012-12#1)
the BF##2##2##(2005-11#1)(2009-5#1)
the BG rate of change##4##5##(2009-9#4)
the BG##6##2##(2007-5#1)(2008-11#1)(2009-9#4)
the BGE##4##2##(1996-5#2)(2008-10#2)
the BH4##2##2##(1995-1#1)(1997-5#1)
the BHA##5##2##(1992-9#4)(2008-10#1)
the BHLF1 promoter##2##3##(1997-3#2)
the BHLF1##3##2##(1997-3#3)
the BHS##3##2##(2009-7#1)(2010-7#2)
the BHT-task##2##2##(2013-8#2)
the BHU##3##2##(2011-2#3)
the BI and FIM subset##2##5##(2007-10#2)
the BI and##3##3##(2007-10#3)
the BI channel##2##3##(1994-9#2)
the BI##9##2##(1993-7#1)(1994-9#3)(2006-10#1)(2007-10#4)
the BIACORE##2##2##(2008-4#2)
the BIC##3##2##(1996-1#1)(2006-9#1)(2011-2#1)
the BIP Index##3##3##(2012-3#3)
the BIS scale##2##3##(2009-9#2)
the BIS##4##2##(2009-4#1)(2009-9#3)
the BIS/BAS scales##2##3##(2009-12#2)
the BJR##5##2##(2010-11#5)
the BK##6##2##(1990-12#2)(2007-8#1)(2008-8#1)(2009-2#2)
the BK(Ca) channel##2##3##(1996-12#2)
the BLA##3##2##(1991-6#1)(1995-11#2)
the BLAST package##3##3##(2008-4#3)
the BLAST##7##2##(2008-4#5)(2008-9#1)(2009-5#1)
the BLCG group##2##3##(1993-11#2)
the BLCG##3##2##(1993-11#3)
the BLS##4##2##(2008-10#1)(2008-2#3)
the BM##3##2##(1991-8#1)(2009-5#1)(2012-12#1)
the BMD and##3##3##(2009-3#3)
the BMD of##2##3##(2005-7#1)(2007-7#1)
the BMD##5##2##(2005-7#1)(2007-7#1)(2009-3#3)
the BMES##3##2##(2006-10#3)
the BMI and the##2##4##(2007-8#1)(2008-1#1)
the BMI and##3##3##(2007-8#1)(2008-1#1)(2010-10#1)
the BMI##14##2##(2007-8#4)(2008-1#2)(2008-12#1)(2008-3#1)(2009-2#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-8#1)
the BMP-2##2##2##(2007-1#2)
the BN whiskers##2##3##(2008-10#2)
the BN##6##2##(2008-10#2)(2009-5#1)(2010-10#3)
the BNR##2##2##(2008-10#2)
the BNST##2##2##(1995-6#1)(1997-8#1)
the BOD##5##2##(2008-10#4)(2009-6#1)
the BOLD##3##2##(2008-11#1)(2010-12#2)
the BP neural network##2##4##(2008-2#1)(2013-1#1)
the BP titer##3##3##(2008-11#3)
the BP##15##2##(1996-5#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#2)(2008-7#1)(2009-1#1)(2010-12#1)(2013-1#1)
the BPD patients with##2##4##(2010-12#2)
the BPD patients##3##3##(2010-12#3)
the BPE##2##2##(2013-7#2)
the BPI##3##2##(2008-7#3)
the BPMV-pCP##2##2##(2008-10#2)
the BPP calibration set##3##4##(2007-12#3)
the BPP spectra set##2##4##(2007-12#2)
the BPP spectra##3##3##(2007-12#3)
the BPP##7##2##(2007-12#7)
the BPs##5##2##(2008-7#5)
the BR display##3##3##(2007-12#3)
the BR muscle##2##3##(2006-3#2)
the BR##12##2##(1991-10#1)(1991-12#1)(2006-3#3)(2007-11#1)(2007-12#4)(2009-4#1)(2009-8#1)
the BRA-3 mRNA##2##3##(1993-6#2)
the BRDF##4##2##(2008-3#4)
the BRP##3##2##(2007-12#1)(2013-1#2)
the BS15-rRNA interaction##2##3##(1996-8#2)
the BSA##6##2##(1993-2#1)(1997-2#1)(2007-2#2)(2008-10#1)(2013-8#1)
the BSC##2##2##(2009-4#2)
the BSE##5##2##(1997-7#1)(2005-8#1)(2011-2#3)
the BTB integrity##3##3##(2009-10#1)(2012-2#2)
the BTB is##2##3##(2012-2#2)
the BTB must##2##3##(2009-10#2)
the BTB to##2##3##(2009-10#1)(2012-2#1)
the BTB##33##2##(2009-10#10)(2012-12#1)(2012-2#22)
the BTB/POZ domain##2##3##(2008-11#2)
the BVS##2##2##(1997-7#2)
the BX-C##2##2##(1995-8#2)
the BYDV##2##2##(2008-10#1)(2008-8#1)
the BYSV CP##3##3##(2008-10#3)
the BZ oscillating chemical system##3##5##(2008-10#3)
the BZD##3##2##(1991-12#3)
the BaP-BeP (1##2##3##(1992-4#2)
the BaP-BeP##3##2##(1992-4#3)
the Babyhaler##4##2##(2004-12#4)
the Bacillus cereus group collected in##2##6##(2011-2#2)
the Bacillus cereus group##3##4##(2011-2#3)
the Bacillus stearothermophilus##4##3##(1996-8#3)(1997-5#1)
the Bacillus subtilis##10##3##(1990-11#1)(1991-9#1)(1993-12#1)(1993-6#1)(1995-12#1)(1996-8#2)(1997-7#2)(2012-2#1)
the Bacillus thuringiensis##4##3##(1990-7#1)(2008-10#1)(2011-2#2)
the Bacillus##27##2##(1990-11#1)(1990-7#1)(1991-9#1)(1993-12#1)(1993-6#1)(1995-12#1)(1996-7#1)(1996-8#5)(1997-5#1)(1997-7#2)(2008-10#3)(2008-3#1)(2010-10#1)(2011-2#6)(2012-2#1)
the Bacterial##2##2##(2008-10#1)(2008-7#1)
the Bacteroides fragilis recA gene##2##5##(1990-9#2)
the Bacteroides fragilis##5##3##(1990-9#2)(2006-8#3)
the Bacteroides##6##2##(1990-9#2)(1997-2#1)(2006-8#3)
the Bactiguard coating##3##3##(2010-4#3)
the Bahamas##5##2##(2007-5#1)(2008-12#1)(2008-5#2)(2009-7#1)
the Bahia Magdalena##2##3##(2008-5#1)(2012-2#1)
the Bahia##5##2##(2008-5#2)(2008-8#1)(2009-10#1)(2012-2#1)
the Bahian##5##2##(2009-10#5)
the Baja California peninsula##3##4##(2007-3#1)(2008-5#1)(2010-8#1)
the Baja California##4##3##(2007-3#1)(2008-5#1)(2010-8#2)
the Balance##3##2##(2008-11#1)(2009-3#1)(2010-12#1)
the Balanced Budget Act (BBA)##2##5##(2007-2#1)(2008-11#1)
the Balanced Budget Act of 1997##3##6##(2008-1#1)(2008-7#2)
the Balanced Budget Act##6##4##(2007-2#1)(2008-1#1)(2008-11#2)(2008-7#2)
the Balanced Budget##7##3##(2007-2#1)(2008-1#1)(2008-11#3)(2008-7#2)
the Balanced##8##2##(2007-2#1)(2008-1#1)(2008-11#3)(2008-7#2)(2009-4#1)
the Balbiani body##2##3##(2007-12#2)
the Baldrige criteria##2##3##(1995-12#1)(1995-3#1)
the Baldrige##3##2##(1995-12#1)(1995-2#1)(1995-3#1)
the Bali bombing##5##3##(2007-2#5)
the Balint group##2##3##(1990-10#2)
the Balkan countries##3##3##(2007-3#1)(2011-1#2)
the Balkan##4##2##(2007-3#1)(2011-1#3)
the Baltic Sea and##3##4##(2007-12#2)(2008-5#1)
the Baltic Sea##9##3##(2006-3#1)(2007-12#2)(2008-11#2)(2008-5#2)(2010-8#2)
the Baltic##11##2##(1995-2#1)(2006-3#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-5#2)(2010-8#2)
the Baltimore VA Medical Center##2##5##(2004-9#1)(2007-4#1)
the Baltimore##5##2##(2004-9#1)(2007-4#1)(2009-4#1)(2010-2#1)(2011-2#1)
the BamHI##3##2##(1990-7#1)(1997-6#1)(2008-5#1)
the Banff schema##2##3##(1995-2#2)
the Banff##3##2##(1995-2#3)
the Bangladesh##3##2##(2008-10#1)(2010-1#1)(2012-3#1)
the Bantu##3##2##(1991-11#1)(2008-12#1)(2012-12#1)
the Bar##2##2##(2008-2#1)(2012-3#1)
the Barbary##2##2##(2008-10#1)(2008-8#1)
the Barcelona Clinic Liver Cancer (BCLC) system has emerged as the predominant system##4##13##(2013-8#4)
the Barker hypothesis##2##3##(2011-1#2)
the Barley Scald##2##3##(2008-10#2)
the Barley##4##2##(2008-10#4)
the Baroque and Rococo lacquer films##2##6##(2008-10#2)
the Barthel Index and##2##4##(2007-9#1)(2012-2#1)
the Barthel Index##8##3##(2007-10#1)(2007-9#6)(2012-2#1)
the Barthel##9##2##(2007-10#2)(2007-9#6)(2012-2#1)
the Basel##2##2##(1996-8#1)(2008-5#1)
the Basic Protocol##9##3##(2008-4#9)
the Basic##16##2##(1993-6#1)(2008-11#1)(2008-4#10)(2008-9#1)(2011-2#2)(2012-1#1)
the Basque Country##3##3##(2008-10#1)(2008-4#1)(2012-11#1)
the Basque##5##2##(2008-10#2)(2008-4#1)(2012-11#2)
the Bavarian##2##2##(2008-4#1)(2012-6#1)
the Bay##3##2##(2007-5#1)(2009-2#1)(2012-3#1)
the Bayer DCA 2000 in##2##5##(2008-6#2)
the Bayer##3##2##(2006-10#1)(2008-6#2)
the Bayesian Network##2##3##(2013-1#2)
the Bayesian approach##3##3##(1995-6#1)(1997-2#1)(2008-2#1)
the Bayesian##20##2##(1994-9#3)(1995-6#1)(1997-2#1)(1997-8#1)(2008-2#4)(2008-4#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#5)
the Bayley##5##2##(1991-2#1)(2006-10#1)(2006-12#3)
the Baylor College of Medicine##3##5##(1996-12#1)(2006-11#1)(2008-5#1)
the BazookaSPECT detector##2##3##(2009-6#2)
the Bb 23S##2##3##(1995-8#2)
the Bcl-2 expression was##2##4##(2008-9#2)
the Bcl-2 family##8##3##(1996-10#1)(2008-11#2)(2009-12#2)(2011-2#3)
the Bcl-2##15##2##(1995-12#2)(1996-10#1)(2007-6#1)(2008-11#3)(2008-9#2)(2009-12#2)(2010-9#1)(2011-2#3)
the Bcl-2/Bax ratio##2##3##(2013-1#1)(2013-8#1)
the Bcl-2/Bax##3##2##(2013-1#2)(2013-8#1)
the Bean##3##2##(2008-10#3)
the Beck Depression Inventory (BDI)##2##5##(1991-2#1)(1996-2#1)
the Beck Depression Inventory##9##4##(1991-2#1)(1996-2#1)(2008-6#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
the Beck##10##2##(1991-2#1)(1996-2#1)(2008-6#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
the Becton Dickinson FACS Calibur##2##5##(2008-4#2)
the Beer-Lambert law##4##3##(2008-10#1)(2008-3#1)(2008-4#2)
the Beer-Lambert##5##2##(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#2)
the Beet##2##2##(2008-10#2)
the Behavioral##7##2##(1993-2#1)(2008-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
the Behring Nephelometer##2##3##(2008-10#2)
the Belgian##6##2##(2006-6#1)(2008-10#3)(2010-4#1)(2011-2#1)
the Bell##2##2##(2012-2#1)(2013-7#1)
the Belmont Report##2##3##(2006-11#1)(2012-2#1)
the Belmont##3##2##(2006-11#1)(2007-11#1)(2012-2#1)
the Belousov-Zhabotinsky##2##2##(2008-10#2)
the Benes##3##2##(2008-2#3)
the Benesi-Hildebrand##2##2##(2008-10#1)(2010-2#1)
the Berg Balance Scale##2##4##(2010-9#1)(2012-2#1)
the Berg Balance##3##3##(2007-7#1)(2010-9#1)(2012-2#1)
the Berg##4##2##(2007-7#1)(2010-3#1)(2010-9#1)(2012-2#1)
the Berlin Aging Study (BASE)##2##5##(1994-6#2)
the Berlin Heart##2##3##(2011-2#2)
the Berlin##7##2##(1994-6#2)(1995-1#1)(2007-1#2)(2011-2#2)
the Bernese##3##2##(1990-5#1)(1995-2#1)(2008-6#1)
the Bessel beam##2##3##(2007-12#1)(2008-2#1)
the Bessel function##4##3##(2008-2#1)(2008-3#3)
the Bessel##6##2##(2007-12#1)(2008-2#2)(2008-3#3)
the Better Beginnings##5##3##(1995-3#5)
the Bezold-Jarisch reflex##3##3##(2006-10#1)(2010-11#1)(2011-2#1)
the Bezold-Jarisch##4##2##(1990-7#1)(2006-10#1)(2010-11#1)(2011-2#1)
the Bhutanese##2##2##(2008-7#1)(2010-5#1)
the Bi films##2##3##(2007-11#2)
the Bi2WO6##2##2##(2013-8#2)
the BiP##2##2##(2008-11#1)(2008-7#1)
the Biblioteca##2##2##(2007-5#2)
the Bic-D protein##2##3##(1991-11#2)
the Biceps femoris##4##3##(2010-4#4)
the Bielschowsky##2##2##(1991-1#1)(2013-1#1)
the Big Bend##2##3##(1996-4#1)(2008-10#1)
the Big##4##2##(1996-4#1)(2008-10#2)(2010-12#1)
the Bill &amp##3##3##(2007-9#1)(2010-12#1)(2012-3#1)
the Bill and Melinda Gates Foundation##2##6##(2007-9#1)(2008-5#1)
the Bill and##3##3##(2006-10#1)(2007-9#1)(2008-5#1)
the Bill##6##2##(2006-10#1)(2007-9#2)(2008-5#1)(2010-12#1)(2012-3#1)
the Binding##2##2##(2008-10#1)(2009-2#1)
the BioBreeding (BB) rat##2##4##(1992-5#1)(2008-4#1)
the BioRID II data##2##4##(2007-4#2)
the BioRID II##8##3##(2006-11#4)(2007-4#4)
the BioRID##9##2##(2006-11#4)(2007-4#4)(2013-8#1)
the Biocontrol Agent##5##3##(2008-10#5)
the Biocontrol Fungus##2##3##(2008-10#2)
the Biocontrol##10##2##(2008-10#10)
the Bioinformatics##2##2##(2008-7#2)
the Biological Control of##2##4##(2008-10#2)
the Biological Control##3##3##(2008-10#3)
the Biological Weapons Convention##2##4##(1992-12#1)(2006-7#1)
the Biological##10##2##(1992-12#1)(2006-7#1)(2007-3#1)(2008-10#3)(2008-6#1)(2010-4#1)(2012-12#2)
the Biology of##2##3##(2007-6#1)(2008-10#1)
the Biomedical##2##2##(2010-5#1)(2012-12#1)
the Biomolecular Screening##2##3##(2008-10#2)
the Bipolar##2##2##(2013-8#2)
the Birmingham##5##2##(1991-2#1)(2004-10#4)
the Birth##2##2##(1992-11#1)(2006-6#1)
the Bischof-Köhler hypothesis##4##3##(2010-2#4)
the Black Sea##4##3##(2007-9#3)(2010-8#1)
the Black##7##2##(1990-6#2)(2007-9#3)(2009-9#1)(2010-8#1)
the Bland-Altman##2##2##(2011-1#1)(2012-7#1)
the Bligh-Dyer##2##2##(2008-10#1)(2008-11#1)
the Bloch##2##2##(2008-3#2)
the Blood##2##2##(2007-12#1)(2011-2#1)
the Blue Cross and Blue Shield Association##2##7##(1994-12#1)(2007-4#1)
the Blue Cross and Blue Shield##3##6##(1994-12#1)(2007-4#1)(2008-4#1)
the Blue##5##2##(1990-12#1)(1994-12#1)(1997-6#1)(2007-4#1)(2008-4#1)
the Bm86##2##2##(1994-3#2)
the BmNPV##5##2##(1997-1#1)(1997-3#3)(1997-4#1)
the Bmax of##2##3##(1992-3#1)(1997-2#1)
the Bmax values for##2##4##(1994-3#1)(1994-8#1)
the Bmax values##3##3##(1994-3#1)(1994-8#1)(1997-2#1)
the Bmax##10##2##(1990-10#1)(1990-7#1)(1992-3#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-2#2)(1997-5#1)
the Board of Health##3##4##(1993-1#1)(1993-3#1)(1993-8#1)
the Board of##7##3##(1991-12#1)(1993-1#1)(1993-3#1)(1993-8#1)(1994-12#1)(2008-10#1)(2008-8#1)
the Board##11##2##(1991-12#1)(1993-1#1)(1993-3#4)(1993-8#1)(1994-12#1)(2007-12#1)(2008-10#1)(2008-8#1)
the Body Image States Scale##2##5##(2007-12#2)
the Body Mass Index (BMI)##3##5##(2007-8#1)(2008-3#1)(2013-8#1)
the Body##12##2##(2007-1#1)(2007-12#4)(2007-8#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2013-8#1)
the Boehringer##2##2##(2005-12#1)(2008-10#1)
the Bohr effect in##3##4##(1990-8#1)(1994-8#1)(1994-9#1)
the Bohr effect of##4##4##(1990-8#2)(1994-8#2)
the Bohr effect##10##3##(1990-8#5)(1994-8#3)(1994-9#2)
the Bohr##13##2##(1990-8#5)(1994-8#6)(1994-9#2)
the Bolton overall ratio##4##4##(2010-2#4)
the Bolton overall##5##3##(2010-2#5)
the Bolton##8##2##(2010-2#8)
the Boltzmann##6##2##(1992-12#1)(2007-12#3)(2008-2#1)(2010-5#1)
the Bombyx mori##3##3##(1995-6#1)(1997-4#1)(2008-11#1)
the Bon Accord Lagoon##2##4##(2007-5#2)
the Bon##3##2##(2007-5#2)(2012-3#1)
the Bonferroni##2##2##(2012-2#1)(2013-1#1)
the Boolean##2##2##(1995-12#1)(2008-9#1)
the Boomers##2##2##(1997-3#1)(2011-1#1)
the Bordetella pertussis##2##3##(1992-3#1)(1995-8#1)
the Bordetella##3##2##(1992-3#1)(1995-8#2)
the Born approximation##2##3##(2008-2#2)
the Born##4##2##(1997-2#1)(2007-12#1)(2008-2#2)
the Bosnian crisis##2##3##(2012-3#2)
the Bosnian##3##2##(2012-3#3)
the Boston EMS##3##3##(2008-3#3)
the Boston##8##2##(2007-12#1)(2008-3#4)(2008-9#1)(2012-11#2)
the Boswellia serrata at##2##4##(2013-1#2)
the Boswellia serrata##3##3##(2013-1#3)
the Bournemouth Collaborative Model##2##4##(2008-11#2)
the Bowman##2##2##(1992-1#1)(2008-10#1)
the Box##2##2##(1996-6#1)(2007-10#1)
the Boyacá##2##2##(2013-1#2)
the BqsS-BqsR two-component system##2##4##(2009-6#2)
the BrAAP component##2##3##(1994-5#2)
the Bradford Hill criteria##3##4##(2013-8#3)
the Bradford##5##2##(2008-1#1)(2008-10#1)(2013-8#3)
the Bragg angle##6##3##(2007-11#1)(2008-2#4)(2008-3#1)
the Bragg condition##3##3##(2008-1#1)(2008-2#2)
the Bragg grating##6##3##(2007-11#3)(2007-12#1)(2008-2#2)
the Bragg reflection##5##3##(2006-5#2)(2007-11#1)(2007-12#1)(2008-2#1)
the Bragg scattering##2##3##(2007-12#1)(2008-3#1)
the Bragg wavelength was##2##4##(2007-11#2)
the Bragg wavelength##11##3##(2007-11#4)(2007-12#6)(2008-1#1)
the Bragg##40##2##(2006-5#2)(2007-11#9)(2007-12#10)(2008-1#2)(2008-2#12)(2008-3#4)(2008-7#1)
the Brain##4##2##(2007-9#2)(2008-2#1)(2008-6#1)
the Branch &amp##2##3##(2008-6#2)
the Branchiopoda##4##2##(2007-12#4)
the Brassica genome##2##3##(2008-7#2)
the Brassica##6##2##(2008-10#1)(2008-7#3)(2011-10#1)(2012-3#1)
the Bratton-Marshall##3##2##(2008-10#3)
the Brazilian Health System##2##4##(1991-9#1)(1993-3#1)
the Brazilian Medical Association for the##2##6##(2011-2#2)
the Brazilian Medical Association##3##4##(2011-2#3)
the Brazilian Ministry of Health##2##5##(1993-3#1)(2011-2#1)
the Brazilian Research Network in Bipolar Disorder##2##7##(2013-8#2)
the Brazilian continental slope between 11 degrees and 23 degrees S##2##11##(2010-8#2)
the Brazilian experience##2##3##(2009-3#1)(2013-1#1)
the Brazilian population##3##3##(1991-9#1)(1993-6#1)(2013-8#1)
the Brazilian##58##2##(1991-12#2)(1991-9#2)(1993-3#2)(1993-6#2)(2006-5#3)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#4)(2009-10#2)(2009-3#1)(2009-4#1)(2009-7#1)(2010-3#1)(2010-8#2)(2011-1#2)(2011-2#13)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#6)
the BrdU-labelled##2##2##(1995-11#1)(1996-5#1)
the Breast Cancer##2##3##(1995-9#1)(2013-1#1)
the Breast##16##2##(1994-12#1)(1994-7#2)(1995-4#2)(1995-9#1)(1996-3#1)(1996-6#5)(1997-1#1)(1997-7#1)(2013-1#1)(2013-8#1)
the Brewer##2##2##(2008-2#2)
the Brewster angle##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
the Brewster dip on reflection from##2##6##(2007-11#2)
the Brewster##11##2##(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#5)
the Brief COPE Scale##2##4##(2011-1#2)
the Brief Psychiatric Rating Scale (BPRS)##2##6##(1997-2#1)(1997-8#1)
the Brief Psychiatric Rating Scale##4##5##(1996-3#1)(1997-2#1)(1997-8#1)(2007-7#1)
the Brief##10##2##(1996-3#1)(1997-2#1)(1997-8#1)(2007-7#1)(2008-7#2)(2010-2#1)(2010-3#1)(2011-1#2)
the Brillouin backscattered##3##3##(2007-12#1)(2008-3#2)
the Brillouin backscattered-light power spectrum##2##5##(2008-3#2)
the Brillouin gain##2##3##(2007-11#2)
the Brillouin signal is##2##4##(2007-11#1)(2007-12#1)
the Brillouin##12##2##(2007-11#3)(2007-12#4)(2008-2#1)(2008-3#4)
the Brillouin-loss##4##2##(2007-12#3)(2008-3#1)
the Bristol##2##2##(2005-7#2)
the British Columbia##2##3##(2007-12#1)(2010-12#1)
the British Pharmacological Society##2##4##(2005-8#2)
the British Pharmacopoeia##4##3##(2008-10#3)(2010-12#1)
the British Society for##2##4##(2005-7#1)(2005-8#1)
the British##52##2##(1990-9#1)(1991-1#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-3#1)(1995-8#1)(1996-8#1)(1997-8#1)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-9#2)(2008-10#7)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#2)(2010-12#3)(2010-2#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)
the Brn-3##3##2##(1996-12#3)
the Brookhaven##3##2##(1990-12#1)(1991-10#1)(1995-7#1)
the Brown Norway rat##4##4##(1993-4#1)(2008-10#3)
the Brown##5##2##(1993-4#1)(2008-10#4)
the Brownian motion of##2##4##(2007-12#1)(2008-3#1)
the Brownian motion##3##3##(2007-12#1)(2008-3#1)(2008-8#1)
the Brownian##6##2##(2005-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-8#1)
the Brugada syndrome##5##3##(2008-12#3)(2011-2#1)(2013-1#1)
the Bruggeman effective medium##2##4##(2008-2#1)(2008-3#1)
the Bruggeman##3##2##(2008-2#2)(2008-3#1)
the Bruhat##2##2##(1991-12#2)
the Bruton##2##2##(2007-2#2)
the Brønsted##2##2##(1991-7#1)(2009-7#1)
the Bs##6##2##(1995-2#1)(1996-10#2)(2008-12#1)(2008-5#1)(2010-3#1)
the Bt-10##2##2##(2008-10#2)
the Buccoo Reef##2##3##(2007-5#2)
the Buccoo##3##2##(2007-5#3)
the Bufo alpha-subunit was phosphorylated##2##5##(1994-9#2)
the Bufo##3##2##(1992-11#1)(1994-9#2)
the Bulimic##2##2##(1996-2#1)(2013-8#1)
the Bulletin##3##2##(2005-7#1)(2007-8#1)(2013-1#1)
the Bureau of##5##3##(1993-1#1)(2008-1#2)(2008-10#1)(2011-1#1)
the Bureau##7##2##(1993-1#1)(1993-8#1)(2008-1#2)(2008-10#2)(2011-1#1)
the Burmese python##2##3##(1997-8#2)
the Buscopan group##2##3##(1990-8#2)
the Buscopan plus group##4##4##(1990-8#4)
the Buscopan##6##2##(1990-8#6)
the Bush##2##2##(2006-8#1)(2007-9#1)
the Bussgang algorithm##2##3##(2008-2#2)
the Bussgang##3##2##(2008-2#3)
the Button Sampler##5##3##(2008-5#5)
the Button##6##2##(2008-5#6)
the Byk##2##2##(1992-12#2)
the C = O and CH2 stretching frequencies##2##8##(1994-3#2)
the C = O and##3##5##(1992-6#1)(1994-3#2)
the C = O##5##4##(1990-2#1)(1992-6#1)(1994-3#3)
the C allele##3##3##(2009-4#1)(2010-6#1)(2011-1#1)
the C alpha##2##3##(1991-4#1)(1994-3#1)
the C and N##3##4##(2005-12#1)(2008-11#1)(2013-8#1)
the C and##4##3##(1993-6#1)(2005-12#1)(2008-11#1)(2013-8#1)
the C balance##2##3##(2008-11#2)
the C derived from##2##4##(2010-3#2)
the C method##2##3##(2008-2#2)
the C protein##2##3##(1997-4#2)
the C residue##4##3##(1992-9#4)
the C ring##3##3##(2004-2#1)(2008-11#1)(2009-9#1)
the C terminal##3##3##(2008-8#1)(2008-9#2)
the C terminus of the protein##3##6##(1990-4#1)(1994-12#1)(1994-9#1)
the C terminus of the##13##5##(1990-4#1)(1991-6#1)(1994-12#3)(1994-8#1)(1994-9#2)(1995-2#1)(1995-3#2)(1995-6#1)(2012-3#1)
the C terminus of##20##4##(1990-4#1)(1991-6#1)(1992-8#1)(1994-12#3)(1994-8#2)(1994-9#3)(1995-2#2)(1995-3#3)(1995-6#1)(1997-2#1)(1997-4#1)(2012-3#1)
the C terminus##35##3##(1990-10#1)(1990-4#1)(1990-5#1)(1991-6#1)(1992-8#1)(1993-6#1)(1994-12#5)(1994-8#2)(1994-9#7)(1995-1#1)(1995-2#3)(1995-3#3)(1995-6#3)(1996-5#2)(1997-2#1)(1997-4#1)(2012-3#1)
the C##166##2##(1990-10#1)(1990-2#1)(1990-4#1)(1990-5#3)(1990-6#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-6#2)(1992-8#1)(1992-9#6)(1993-12#2)(1993-6#2)(1993-8#1)(1993-9#2)(1994-12#7)(1994-3#6)(1994-6#1)(1994-8#2)(1994-9#7)(1995-1#1)(1995-11#1)(1995-2#3)(1995-3#3)(1995-5#2)(1995-6#3)(1995-8#3)(1996-3#1)(1996-5#3)(1996-6#2)(1996-7#2)(1997-2#1)(1997-4#3)(1997-6#1)(2004-2#1)(2005-11#1)(2005-12#1)(2006-4#1)(2007-11#2)(2007-12#16)(2007-7#1)(2008-10#19)(2008-11#4)(2008-2#2)(2008-5#2)(2008-6#4)(2008-8#2)(2008-9#3)(2009-4#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-6#3)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-11#2)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#3)
the C(14)-center##2##2##(2006-12#2)
the C(18) phase##2##3##(2008-10#2)
the C(18)##6##2##(2008-10#6)
the C(2)##2##2##(1995-10#1)(2008-8#1)
the C(30)##2##2##(2006-12#2)
the C(4)##3##2##(1992-11#2)(2008-9#1)
the C(60)##2##2##(1994-7#1)(2008-3#1)
the C(8)##2##2##(1990-7#1)(2011-1#1)
the C(alpha) position of##2##4##(1995-10#2)
the C- and##2##3##(1997-4#1)(2006-12#1)
the C- or##2##3##(1992-2#1)(2008-7#1)
the C-##5##2##(1991-5#1)(1992-2#1)(1997-4#1)(2006-12#1)(2008-7#1)
the C-1 ring spread##2##4##(2006-9#2)
the C-1##5##2##(1995-3#1)(1997-7#1)(2006-9#3)
the C-2 position##3##3##(1992-9#1)(1997-1#1)(2007-11#1)
the C-2##8##2##(1992-9#1)(1994-8#3)(1995-3#1)(1996-7#1)(1997-1#1)(2007-11#1)
the C-3 and##2##3##(1994-8#1)(2012-11#1)
the C-3 position of##2##4##(1995-2#1)(2012-11#1)
the C-3##7##2##(1992-5#1)(1994-8#1)(1995-2#1)(2007-1#1)(2012-11#3)
the C-4##3##2##(1994-11#1)(1996-5#1)(2007-12#1)
the C-C mode##2##3##(2007-1#2)
the C-C##6##2##(1991-9#1)(1996-5#1)(2005-9#1)(2007-1#2)(2009-3#1)
the C-D method##5##3##(2007-11#1)(2007-7#4)
the C-D##7##2##(1995-10#1)(2007-11#1)(2007-7#5)
the C-H activated##2##3##(2010-5#2)
the C-H##5##2##(1992-6#1)(1993-3#1)(2010-4#1)(2010-5#2)
the C-Leg##3##2##(2013-1#3)
the C-NC##2##2##(2006-12#2)
the C-PR##6##2##(1991-6#6)
the C-Value##4##2##(2013-1#4)
the C-arm##3##2##(2006-6#1)(2007-5#1)(2011-1#1)
the C-domain of IGF-1##2##4##(2008-9#2)
the C-domain of##4##3##(1991-4#1)(2008-9#3)
the C-domain##8##2##(1990-11#1)(1991-4#1)(1997-7#3)(2008-9#3)
the C-fiber##3##2##(1991-9#1)(1996-12#1)(1997-3#1)
the C-fibre##2##2##(1995-12#1)(1995-7#1)
the C-peptide##4##2##(1990-2#1)(1990-8#1)(2006-6#1)(2012-12#1)
the C-propeptide##4##2##(1994-9#3)(1997-7#1)
the C-system in##3##3##(1996-6#3)
the C-terminal 18##2##3##(1991-6#1)(1995-2#1)
the C-terminal 35-kDa##2##3##(1990-3#2)
the C-terminal 4 amino acids##2##5##(1992-8#2)
the C-terminal DNA-binding domain##3##4##(1996-7#1)(2007-3#1)(2008-9#1)
the C-terminal SH2 domain of##2##5##(1994-5#1)(1994-6#1)
the C-terminal actin-binding domain##2##4##(2009-7#2)
the C-terminal amino acids##3##4##(1991-7#1)(1994-2#1)(1996-12#1)
the C-terminal amino##4##3##(1991-7#2)(1994-2#1)(1996-12#1)
the C-terminal cytoplasmic domain of##2##5##(1996-8#2)
the C-terminal cytoplasmic##4##3##(1995-10#1)(1996-2#1)(1996-8#2)
the C-terminal dodecapeptide of##2##4##(1991-6#1)(1996-9#1)
the C-terminal domain of human##2##5##(1996-1#1)(2011-1#1)
the C-terminal domain of the##5##5##(1996-10#1)(1996-8#1)(2005-6#1)(2009-7#1)(2011-1#1)
the C-terminal domain of##14##4##(1990-1#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-10#1)(1996-7#1)(1996-8#1)(1997-4#2)(2005-6#1)(2008-9#1)(2009-7#1)(2011-1#2)
the C-terminal domain##32##3##(1990-1#1)(1991-4#1)(1992-7#3)(1992-9#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-2#2)(1995-6#1)(1996-1#1)(1996-10#1)(1996-7#2)(1996-8#1)(1997-4#2)(1997-5#2)(1997-6#1)(2005-6#1)(2006-5#1)(2008-4#1)(2008-9#1)(2009-7#1)(2011-1#2)(2012-2#1)
the C-terminal domains of##3##4##(1990-1#1)(2006-5#1)(2008-10#1)
the C-terminal domains##5##3##(1990-1#1)(1993-8#1)(2006-5#1)(2008-10#2)
the C-terminal end of the##4##5##(1994-11#1)(1995-5#1)(1997-4#1)(2010-6#1)
the C-terminal end of##6##4##(1994-11#1)(1994-9#1)(1995-5#1)(1997-4#1)(1997-6#1)(2010-6#1)
the C-terminal end##11##3##(1991-7#1)(1992-3#1)(1994-11#2)(1994-9#1)(1995-5#1)(1996-12#1)(1997-4#2)(1997-6#1)(2010-6#1)
the C-terminal extension##2##3##(1992-9#1)(1993-12#1)
the C-terminal fragment##5##3##(1994-2#1)(1995-1#1)(1996-8#1)(1997-4#1)(2008-11#1)
the C-terminal half of the##6##5##(1990-11#1)(1991-7#1)(1993-11#1)(1994-5#1)(1995-1#1)(2008-10#1)
the C-terminal half of##9##4##(1990-11#1)(1991-7#1)(1992-3#1)(1993-11#1)(1994-5#1)(1995-1#1)(1995-8#1)(2008-10#1)(2010-5#1)
the C-terminal half##13##3##(1990-11#1)(1991-7#1)(1992-3#1)(1993-11#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-8#1)(2006-12#3)(2008-10#1)(2010-5#1)
the C-terminal hexapeptide##2##3##(1991-8#1)(1994-3#1)
the C-terminal hydrophobic region of##2##5##(1991-8#1)(2008-8#1)
the C-terminal hydrophobic region##3##4##(1991-8#2)(2008-8#1)
the C-terminal hydrophobic##5##3##(1991-8#2)(1994-8#1)(1995-5#1)(2008-8#1)
the C-terminal i3 loop junction##2##5##(1995-3#2)
the C-terminal of the##2##4##(1992-9#1)(1997-6#1)
the C-terminal of##6##3##(1992-9#1)(1995-10#1)(1997-6#1)(2008-3#1)(2008-6#1)(2008-9#1)
the C-terminal part of a##2##5##(1991-3#1)(1992-7#1)
the C-terminal part of the##2##5##(1997-7#1)(2008-10#1)
the C-terminal part of##7##4##(1990-5#1)(1990-9#1)(1991-3#1)(1992-7#1)(1997-4#1)(1997-7#1)(2008-10#1)
the C-terminal part##8##3##(1990-5#1)(1990-9#1)(1991-3#1)(1992-7#1)(1996-12#1)(1997-4#1)(1997-7#1)(2008-10#1)
the C-terminal pentapeptide##2##3##(1992-1#1)(1992-11#1)
the C-terminal peptide##2##3##(1995-2#2)
the C-terminal portion of the##3##5##(1994-8#1)(1995-1#1)(1996-5#1)
the C-terminal portion of##4##4##(1990-12#1)(1994-8#1)(1995-1#1)(1996-5#1)
the C-terminal region and##2##4##(1990-3#1)(1990-9#1)
the C-terminal region of the insulin##3##6##(1992-6#1)(1992-8#2)
the C-terminal region of the##14##5##(1990-2#1)(1990-4#1)(1991-7#1)(1992-6#1)(1992-8#2)(1993-7#1)(1994-9#1)(1995-11#1)(1995-6#2)(1997-4#1)(2006-10#1)(2008-4#1)
the C-terminal region of##25##4##(1990-2#1)(1990-4#1)(1990-7#1)(1991-10#2)(1991-3#1)(1991-4#1)(1991-7#1)(1992-6#1)(1992-8#2)(1993-7#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-6#2)(1996-5#1)(1997-4#1)(1997-7#1)(2006-10#1)(2008-4#1)(2012-2#1)
the C-terminal region##40##3##(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#2)(1990-9#1)(1991-10#2)(1991-11#1)(1991-3#1)(1991-4#2)(1991-7#2)(1992-6#1)(1992-8#2)(1993-7#1)(1993-8#1)(1994-12#2)(1994-5#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-10#1)(1996-5#1)(1997-2#3)(1997-4#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-4#1)(2012-2#1)
the C-terminal regions of##2##4##(1993-8#1)(2011-12#1)
the C-terminal repeat domain##2##4##(1990-11#1)(1993-12#1)
the C-terminal repeat##4##3##(1990-11#2)(1993-12#1)(1995-8#1)
the C-terminal residue##2##3##(1991-7#1)(1993-3#1)
the C-terminal residues##2##3##(1990-12#1)(1992-9#1)
the C-terminal sequence of the##2##5##(1992-8#1)(1994-11#1)
the C-terminal sequence of##6##4##(1991-2#1)(1992-1#1)(1992-8#1)(1994-11#1)(1997-6#1)(2008-4#1)
the C-terminal sequence##12##3##(1990-7#1)(1991-2#1)(1992-1#1)(1992-8#1)(1993-11#1)(1994-11#1)(1995-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(2008-4#1)
the C-terminal side of the##3##5##(1991-2#1)(1996-5#1)(2012-12#1)
the C-terminal side of##6##4##(1991-2#1)(1991-4#1)(1992-2#1)(1995-6#1)(1996-5#1)(2012-12#1)
the C-terminal side##7##3##(1991-2#1)(1991-4#1)(1992-2#1)(1995-2#1)(1995-6#1)(1996-5#1)(2012-12#1)
the C-terminal tail##2##3##(1991-4#1)(1992-7#1)
the C-terminal tetrapeptide##2##3##(1990-2#1)(1991-9#1)
the C-terminal third of##2##4##(1991-2#1)(1995-3#1)
the C-terminal tryptic##2##3##(1993-6#1)(1994-8#1)
the C-terminal##265##2##(1990-1#2)(1990-11#3)(1990-12#3)(1990-2#3)(1990-3#3)(1990-4#1)(1990-5#4)(1990-7#5)(1990-9#2)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#2)(1991-4#5)(1991-5#1)(1991-6#2)(1991-7#7)(1991-8#3)(1991-9#1)(1992-1#2)(1992-11#1)(1992-2#1)(1992-3#2)(1992-6#3)(1992-7#7)(1992-8#6)(1992-9#6)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#3)(1993-7#1)(1993-8#4)(1994-11#4)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#5)(1994-6#1)(1994-8#5)(1994-9#5)(1995-1#4)(1995-10#3)(1995-11#1)(1995-12#1)(1995-2#8)(1995-3#5)(1995-5#2)(1995-6#7)(1995-8#4)(1996-1#1)(1996-10#3)(1996-12#3)(1996-2#1)(1996-4#2)(1996-5#5)(1996-7#5)(1996-8#4)(1996-9#2)(1997-2#5)(1997-4#11)(1997-5#3)(1997-6#4)(1997-7#4)(1997-8#1)(2005-6#1)(2006-10#1)(2006-12#3)(2006-5#2)(2007-3#1)(2008-10#7)(2008-11#4)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-7#3)(2010-5#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#1)
the C-termini##2##2##(1995-1#1)(2013-8#1)
the C-terminus and##2##3##(1996-6#1)(2008-8#1)
the C-terminus had##2##3##(1994-3#1)(2008-8#1)
the C-terminus is##3##3##(1994-2#1)(1997-3#1)(2009-10#1)
the C-terminus of IFN gamma##2##5##(1994-5#1)(1994-9#1)
the C-terminus of the protein##2##5##(1997-2#1)(2011-1#1)
the C-terminus of the##14##4##(1990-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-12#1)(1995-5#1)(1995-8#1)(1997-2#1)(2006-12#1)(2007-6#2)(2008-10#1)(2011-1#1)(2012-2#1)
the C-terminus of##39##3##(1990-12#1)(1990-7#1)(1991-4#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-9#2)(1993-11#2)(1993-12#1)(1993-3#1)(1994-12#2)(1994-5#1)(1994-9#1)(1995-5#1)(1995-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-6#2)(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2011-1#1)(2012-2#1)(2012-3#1)
the C-terminus##76##2##(1990-12#2)(1990-7#3)(1991-10#1)(1991-4#1)(1991-7#3)(1991-8#2)(1991-9#3)(1992-11#1)(1992-2#2)(1992-3#2)(1992-4#2)(1992-6#2)(1992-9#2)(1993-11#3)(1993-12#1)(1993-3#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-11#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#1)(2006-12#2)(2007-6#2)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#3)(2009-10#2)(2009-12#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
the C-truncated variant##2##3##(1994-12#2)
the C-type lectin superfamily##2##4##(1997-7#2)
the C-type lectin##4##3##(1997-7#2)(2012-1#1)(2012-3#1)
the C-type##7##2##(1997-7#2)(2012-1#1)(2012-3#3)(2013-7#1)
the C/EBP##6##2##(1993-3#2)(1995-3#2)(1996-10#1)(1996-5#1)
the C/N##2##2##(2008-10#1)(2008-12#1)
the C1 and C2##2##4##(2006-8#1)(2013-1#1)
the C1 and##3##3##(1994-5#1)(2006-8#1)(2013-1#1)
the C1 side chain were##2##5##(1994-9#2)
the C1 side chain##3##4##(1994-9#3)
the C1##15##2##(1990-12#1)(1990-8#2)(1990-9#1)(1994-5#1)(1994-9#3)(2006-8#1)(2007-1#1)(2008-10#1)(2012-12#3)(2013-1#1)
the C1-2 joints##2##3##(2006-9#1)(2012-3#1)
the C1-2##4##2##(2006-7#1)(2006-9#2)(2012-3#1)
the C1-C2##3##2##(1993-8#1)(2007-11#1)(2011-2#1)
the C10##3##2##(1990-8#1)(1993-11#2)
the C102T variant of##2##4##(1990-7#2)
the C102T variant##3##3##(1990-7#3)
the C11-C12##2##2##(1994-3#1)(2009-8#1)
the C13+ cells##2##3##(1995-5#2)
the C16##2##2##(2008-8#1)(2013-1#1)
the C16TAB##5##2##(2005-11#5)
the C18##5##2##(1993-2#1)(1997-3#1)(2007-8#2)(2013-1#1)
the C19-GAs##2##2##(1994-8#2)
the C1q-deficient SLE patient group##2##5##(2011-2#2)
the C1q-deficient SLE##4##3##(2011-2#4)
the C2 content##3##3##(2007-12#3)
the C2##13##2##(1992-4#1)(1993-11#1)(1994-12#1)(1995-5#1)(1997-6#1)(2007-11#1)(2007-12#4)(2008-6#1)(2009-10#1)(2012-3#1)
the C2/C3##4##2##(2007-4#2)(2012-12#2)
the C26-CBS/diC14-PC mixture##2##3##(1993-8#2)
the C272S mutant##3##3##(1993-6#3)
the C3 exoenzyme from##2##4##(1992-12#1)(1996-5#1)
the C3 exoenzyme##3##3##(1992-12#2)(1996-5#1)
the C3##8##2##(1990-8#1)(1992-12#5)(1996-5#1)(2008-10#1)
the C3/C4##3##2##(1994-3#1)(2007-4#2)
the C4##4##2##(1992-12#1)(1992-3#1)(1994-8#1)(1995-2#1)
the C40/C40+##2##2##(2008-9#2)
the C5##10##2##(1990-4#1)(1992-5#1)(1996-6#2)(1997-4#1)(2005-11#1)(2005-5#2)(2006-11#1)(2008-9#1)
the C5-deficient##2##2##(1996-6#2)
the C57BL/6 strain##2##3##(1995-2#1)(1997-3#1)
the C57BL/6##3##2##(1995-2#1)(1997-3#1)(2008-4#1)
the C57BL/6J and##2##3##(1990-7#1)(1996-10#1)
the C57BL/6J mouse##2##3##(1990-7#1)(1996-10#1)
the C57BL/6J##6##2##(1990-7#2)(1995-11#1)(1996-10#2)(1996-11#1)
the C6##8##2##(1990-2#1)(1994-9#1)(2005-11#1)(2005-5#2)(2007-1#1)(2007-11#1)(2012-3#1)
the C60 derivative##2##3##(2007-8#2)
the C60##3##2##(2007-11#1)(2007-8#2)
the C7##5##2##(1993-6#1)(1994-5#1)(1996-7#1)(2007-7#1)(2009-3#1)
the C8##2##2##(2008-4#2)
the C=C##3##2##(2005-4#1)(2007-1#2)
the C?N stretching##3##3##(2008-2#3)
the CA and OR##2##4##(2008-10#2)
the CA and##3##3##(1995-11#1)(2008-10#2)
the CA method were##2##4##(2008-5#2)
the CA method##3##3##(2008-5#3)
the CA##16##2##(1991-4#1)(1992-7#1)(1994-2#1)(1995-11#2)(1995-3#1)(2006-10#1)(2008-10#2)(2008-5#3)(2011-1#4)
the CA-MRSA isolates##2##3##(2012-12#2)
the CA-MRSA##3##2##(2012-12#3)
the CA-PVD##2##2##(2009-7#2)
the CA-clonal##3##2##(2008-10#3)
the CA1 and CA2##3##4##(1994-5#1)(1996-12#1)(2008-4#1)
the CA1 area of the hippocampus##3##6##(1994-5#2)(1995-8#1)
the CA1 area of the##5##5##(1994-2#1)(1994-5#2)(1995-5#1)(1995-8#1)
the CA1 pyramidal cells##3##4##(1990-5#1)(1994-5#1)(1997-8#1)
the CA1 pyramidal neurons##2##4##(1993-2#1)(1994-10#1)
the CA1 pyramidal##5##3##(1990-5#1)(1993-2#1)(1994-10#1)(1994-5#1)(1997-8#1)
the CA1 region of rat hippocampal slices##3##7##(1992-3#1)(1996-8#2)
the CA1 region of rat hippocampus##2##6##(1991-3#1)(1997-5#1)
the CA1 region of rat##5##5##(1991-3#1)(1992-3#1)(1996-8#2)(1997-5#1)
the CA1 region of the##4##5##(1995-12#1)(1996-1#1)(1996-12#1)(2009-5#1)
the CA1 region of##10##4##(1991-3#1)(1992-3#1)(1995-12#2)(1996-1#1)(1996-12#1)(1996-8#2)(1997-5#1)(2009-5#1)
the CA1 region##20##3##(1990-7#1)(1991-3#1)(1991-8#1)(1992-3#2)(1995-12#5)(1995-3#1)(1996-1#1)(1996-12#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-5#1)(1997-7#1)(2009-5#1)
the CA1 sector##3##3##(1990-2#3)
the CA1 subfield of the reeler mouse##2##7##(1994-10#2)
the CA1 subfield of the reeler##3##6##(1994-10#3)
the CA1 subfield of the##7##5##(1990-4#2)(1990-7#1)(1994-10#4)
the CA1 subfield of##9##4##(1990-4#2)(1990-7#2)(1994-10#5)
the CA1 subfield##12##3##(1990-2#1)(1990-4#2)(1990-5#2)(1990-7#2)(1994-10#5)
the CA1##58##2##(1990-2#4)(1990-4#2)(1990-5#3)(1990-7#3)(1991-11#1)(1991-3#2)(1991-8#1)(1992-3#2)(1993-12#1)(1993-2#1)(1994-10#6)(1994-2#1)(1994-5#4)(1994-6#1)(1995-12#5)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-8#2)(1996-9#1)(1997-2#1)(1997-5#3)(1997-7#1)(1997-8#2)(2008-4#2)(2009-5#1)(2011-2#2)
the CA2##2##2##(1990-2#1)(1995-5#1)
the CA3 and CA1##2##4##(1995-12#1)(1996-12#1)
the CA3 and dentate##2##4##(1992-8#1)(1997-8#1)
the CA3 and##6##3##(1992-8#2)(1995-12#1)(1996-12#1)(1997-8#2)
the CA3 region##6##3##(1992-3#2)(1994-11#1)(1997-5#2)(2010-12#1)
the CA3##20##2##(1990-2#1)(1990-5#1)(1992-3#2)(1992-7#1)(1992-8#2)(1994-11#1)(1995-12#1)(1996-12#1)(1996-7#1)(1997-5#2)(1997-8#2)(2008-11#2)(2009-8#1)(2010-12#1)(2011-2#1)
the CAA##2##2##(2008-10#2)
the CAAT/enhancer binding protein##2##4##(1991-1#2)
the CABG##2##2##(2007-8#2)
the CAC##4##2##(2006-6#3)(2009-9#1)
the CAD and##2##3##(1993-12#1)(1997-2#1)
the CAD##5##2##(1993-12#1)(1997-2#2)(2006-12#1)(2012-2#1)
the CAF##2##2##(1994-7#2)
the CAF+FT group##5##3##(1997-7#5)
the CAF+FT##6##2##(1997-7#6)
the CAF+FT+ADR group##2##3##(1997-7#2)
the CAF+FT+TAM group##4##3##(1997-7#4)
the CAG repeats##3##3##(1992-1#2)(1997-5#1)
the CAG##5##2##(1992-1#2)(1996-5#2)(1997-5#1)
the CAGE##2##2##(2008-11#1)(2008-7#1)
the CAK activity##2##3##(1997-1#2)
the CALUX bioassay for##3##4##(2008-10#3)
the CALUX bioassay##8##3##(2008-10#8)
the CALUX response##3##3##(2008-10#3)
the CALUX technique##2##3##(2008-10#2)
the CALUX##17##2##(2008-10#17)
the CAM##13##2##(2008-1#1)(2008-10#1)(2008-5#3)(2009-5#1)(2013-1#7)
the CAP##3##2##(1990-10#1)(1990-2#1)(1994-11#1)
the CAPD##2##2##(2007-12#2)
the CARICOMP protocol##3##3##(2008-5#2)(2011-2#1)
the CARICOMP site##3##3##(2008-5#1)(2011-2#2)
the CARICOMP##8##2##(2008-5#3)(2011-2#5)
the CARS signal##2##3##(2007-11#1)(2008-2#1)
the CARS##3##2##(2007-11#1)(2008-2#2)
the CART models##2##3##(2008-10#2)
the CART##3##2##(2008-10#3)
the CAS established a committee in 2001 to review the literature on MADs##2##13##(2007-6#2)
the CAS##4##2##(2006-12#1)(2007-6#2)(2011-2#1)
the CASA assay##2##3##(1993-2#2)
the CAT activity##2##3##(1990-12#1)(1993-8#1)
the CAT reporter##2##3##(1992-12#1)(2008-4#1)
the CAT##9##2##(1990-12#1)(1990-3#1)(1990-9#1)(1992-12#1)(1993-8#1)(1993-9#1)(1997-8#1)(2008-4#1)(2009-5#1)
the CATT/T##2##2##(2011-2#2)
the CAdSV##4##2##(2008-10#4)
the CArG box##3##3##(1993-8#2)(1995-3#1)
the CArG boxes##2##3##(1993-8#1)(1995-3#1)
the CArG##6##2##(1993-8#3)(1995-3#2)(2009-8#1)
the CB CO##2##3##(1993-12#2)
the CB and##2##3##(1993-2#1)(2008-11#1)
the CB receptors##2##3##(2005-8#1)(2009-12#1)
the CB subtype##2##3##(2008-2#2)
the CB##13##2##(1993-12#2)(1993-2#1)(2005-8#2)(2007-1#1)(2008-11#3)(2008-2#2)(2009-12#1)(2010-6#1)
the CB(1)##2##2##(2007-11#1)(2009-8#1)
the CB(2)##2##2##(2009-8#2)
the CB1 receptor##2##3##(1996-1#1)(1997-8#1)
the CB1##5##2##(1996-1#2)(1997-8#1)(2007-11#1)(2009-12#1)
the CB3##2##2##(1994-5#2)
the CBA strain##2##3##(2008-12#1)(2013-1#1)
the CBA##3##2##(1995-12#1)(2008-12#1)(2013-1#1)
the CBF##2##2##(1997-5#1)(2008-7#1)
the CBO changes##2##3##(2007-9#2)
the CBP##2##2##(1994-11#1)(1995-7#1)
the CBS##5##2##(1993-8#4)(2008-10#1)
the CBT##4##2##(2008-12#1)(2008-6#1)(2011-1#2)
the CC and##2##3##(1991-4#1)(1995-2#1)
the CC genotype##2##3##(2011-1#1)(2013-1#1)
the CC group##2##3##(2008-10#2)
the CC##17##2##(1991-4#4)(1995-2#1)(2007-5#1)(2008-10#3)(2008-7#1)(2010-12#4)(2011-1#1)(2012-2#1)(2013-1#1)
the CC-1065 analogue U-73975##2##4##(1991-7#2)
the CCA##7##2##(1992-2#1)(2007-12#1)(2008-4#2)(2009-12#1)(2011-2#2)
the CCAAT##5##2##(1992-11#1)(1993-2#2)(1994-9#2)
the CCAAT/enhancer binding protein (C/EBP)##2##5##(1990-5#1)(1993-3#1)
the CCABG group##3##3##(2007-8#3)
the CCAM##4##2##(2013-1#4)
the CCCP induced current##2##4##(1994-3#2)
the CCD and##2##3##(2007-12#1)(2012-12#1)
the CCD array##3##3##(2008-2#1)(2008-3#2)
the CCD camera##6##3##(2006-4#1)(2008-2#3)(2008-3#2)
the CCD chip##2##3##(2007-12#1)(2008-2#1)
the CCD is##2##3##(2008-1#1)(2008-3#1)
the CCD sensor##4##3##(2006-6#2)(2008-3#2)
the CCD##40##2##(2006-4#1)(2006-6#2)(2007-11#1)(2007-12#4)(2008-1#2)(2008-2#15)(2008-3#10)(2008-5#2)(2011-1#1)(2011-2#1)(2012-12#1)
the CCK##3##2##(1992-8#1)(1996-4#1)(2010-12#1)
the CCK(B) receptor##2##3##(1996-12#2)
the CCK-B##4##2##(1992-2#1)(1992-3#1)(1996-2#1)(2005-8#1)
the CCKA receptor antagonist devazepide##2##5##(1993-6#1)(1995-12#1)
the CCKA receptor antagonist##3##4##(1993-11#1)(1993-6#1)(1995-12#1)
the CCKA receptor##4##3##(1993-11#1)(1993-6#1)(1995-12#1)(1996-2#1)
the CCKA##5##2##(1993-11#1)(1993-6#1)(1995-12#2)(1996-2#1)
the CCL##2##2##(2005-7#2)
the CCOP and its##2##4##(1992-12#2)
the CCOP and##3##3##(1992-12#3)
the CCOP##5##2##(1992-12#5)
the CCP##7##2##(2005-9#2)(2006-5#5)
the CCR4-NOT complex##3##3##(2011-1#3)
the CCR4-NOT##4##2##(2011-1#4)
the CCS##3##2##(1992-4#3)
the CCT##2##2##(2010-1#2)
the CCl4##2##2##(1990-9#1)(1994-5#1)
the CD Hopf method##2##4##(2007-7#2)
the CD Hopf##3##3##(2007-7#3)
the CD Plus##3##3##(1991-12#2)(1992-2#1)
the CD _ 2 bending and CH _ 2 rocking modes##2##11##(2008-5#2)
the CD _ 2##3##4##(2008-5#3)
the CD and##2##3##(1995-5#1)(2008-10#1)
the CD changes##2##3##(1990-2#1)(1990-8#1)
the CD of##2##3##(1995-4#1)(2012-1#1)
the CD results##2##3##(1990-10#2)
the CD spectra of##3##4##(1992-8#1)(1995-10#1)(1995-4#1)
the CD spectra##6##3##(1990-5#1)(1992-8#1)(1995-10#1)(1995-4#1)(1996-1#1)(1997-4#1)
the CD spectrum of##4##4##(1994-11#1)(1994-5#1)(1997-4#1)(1997-7#1)
the CD spectrum##10##3##(1993-6#2)(1994-11#4)(1994-5#1)(1997-4#1)(1997-7#2)
the CD##54##2##(1990-10#2)(1990-2#2)(1990-5#1)(1990-8#1)(1991-12#2)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-6#2)(1994-11#5)(1994-5#2)(1994-8#1)(1995-10#1)(1995-4#4)(1995-5#3)(1996-1#1)(1996-5#1)(1996-6#1)(1997-4#2)(1997-7#3)(2004-7#1)(2006-10#1)(2007-12#1)(2007-7#4)(2008-10#3)(2008-12#1)(2008-5#3)(2010-4#1)(2012-1#1)
the CD-ROM##2##2##(1991-3#1)(2008-11#1)
the CD2##2##2##(1995-3#2)
the CD20 antigen##2##3##(2007-11#1)(2010-12#1)
the CD28##2##2##(1994-3#2)
the CD3##3##2##(1993-9#1)(1994-3#1)(2007-11#1)
the CD34+##3##2##(2008-1#1)(2008-4#1)(2012-12#1)
the CD4 cell count##3##4##(2007-7#1)(2009-8#1)(2012-2#1)
the CD4 positive##2##3##(1993-12#1)(1997-4#1)
the CD4 receptor##5##3##(1992-3#1)(1992-5#1)(1993-9#2)(2005-7#1)
the CD4##25##2##(1990-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-9#2)(1994-8#2)(1997-4#1)(1997-7#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-7#1)(2009-8#1)(2010-12#1)(2012-2#2)(2013-8#1)
the CD4(+)##2##2##(2008-11#1)(2008-9#1)
the CD4+##4##2##(1990-12#1)(1990-2#1)(1995-2#1)(1996-3#1)
the CD4+/CD8+##4##2##(1995-7#1)(2010-8#2)(2013-8#1)
the CD4/CD8 ratio##2##3##(1991-6#2)
the CD40##3##2##(1992-7#1)(2008-1#1)(2008-11#1)
the CD4000##5##2##(2008-10#5)
the CD45##2##2##(2008-4#2)
the CD46##2##2##(1991-10#1)(1997-4#1)
the CD8##2##2##(1991-12#1)(2008-4#1)
the CD8+ T cell##2##4##(1992-7#1)(1996-3#1)
the CD8+##4##2##(1991-12#1)(1992-7#1)(1996-3#1)(1997-6#1)
the CD95##3##2##(1997-7#2)(2006-5#1)
the CDC##16##2##(1992-6#1)(1995-2#1)(1996-1#1)(1996-5#2)(2006-7#1)(2007-2#2)(2008-2#1)(2008-3#1)(2008-8#1)(2010-12#2)(2011-2#2)(2012-12#1)
the CDDP sensitivity##2##3##(1993-9#2)
the CDDP/DOX##2##2##(2010-3#2)
the CDEI##2##2##(1992-12#2)
the CDER##2##2##(2010-11#2)
the CDI process##2##3##(2010-8#2)
the CDOM##2##2##(2008-2#2)
the CDP-choline pathway of phosphatidylcholine synthesis at the CTP##2##9##(1995-3#2)
the CDP-treated##2##2##(1994-3#2)
the CDR-based peptides##2##3##(1997-4#2)
the CDR3##2##2##(1997-7#1)(1997-9#1)
the CDS##8##2##(2007-8#1)(2008-3#6)(2008-5#1)
the CE and##2##3##(2007-3#1)(2008-10#1)
the CE method##3##3##(1997-2#1)(2008-10#2)
the CE procedure developed##2##4##(2008-10#2)
the CE separation of##2##4##(1996-5#2)
the CE##22##2##(1996-5#3)(1997-2#1)(2006-10#1)(2006-6#1)(2007-3#2)(2007-8#2)(2008-1#2)(2008-10#7)(2008-5#3)
the CEA##11##2##(1990-10#1)(1990-5#2)(1991-4#2)(1992-11#1)(1993-4#1)(1994-2#1)(1994-5#1)(2007-10#1)(2009-11#1)
the CEDO 1##2##3##(1993-9#2)
the CEDO##4##2##(1993-9#4)
the CEF##3##2##(2007-12#1)(2008-10#2)
the CEO##2##2##(1996-3#1)(2013-8#1)
the CEPM##2##2##(2007-8#2)
the CEPS##2##2##(2007-8#2)
the CER##2##2##(2007-6#1)(2012-12#1)
the CER3 and##4##3##(2008-10#4)
the CER3##6##2##(2008-10#6)
the CER3/PA-d(31) dispersion at pH 5##2##6##(2008-10#2)
the CERHR##6##2##(2005-7#4)(2006-12#2)
the CEs##2##2##(2008-10#1)(2008-5#1)
the CF##4##2##(1990-3#1)(1990-8#1)(2008-5#2)
the CFC##2##2##(1991-12#1)(2010-3#1)
the CFH and Worland##3##4##(2008-10#3)
the CFH##6##2##(2008-10#6)
the CFI##2##2##(1997-5#1)(2007-1#1)
the CFTR gene##4##3##(1994-11#1)(1997-1#2)(1997-3#1)
the CFTR protein##3##3##(1990-8#3)
the CFTR##7##2##(1990-8#3)(1994-11#1)(1997-1#2)(1997-3#1)
the CFU##2##2##(1997-2#1)(2008-5#1)
the CG and##3##3##(1991-5#1)(2013-1#2)
the CG##6##2##(1991-5#3)(1991-8#1)(2013-1#2)
the CGA##3##2##(1992-9#2)(2005-11#1)
the CGG##2##2##(1991-12#1)(1993-9#1)
the CGH##2##2##(2008-3#2)
the CGRP receptor##3##3##(1992-6#1)(1995-8#1)(1997-5#1)
the CGRP##6##2##(1990-10#1)(1992-6#2)(1995-8#1)(1997-3#1)(1997-5#1)
the CH _ 2##2##4##(2008-5#2)
the CH cartridge##2##3##(2008-10#2)
the CH##10##2##(2008-10#6)(2008-2#1)(2008-5#2)(2008-6#1)
the CH(2) antisymmetric##2##3##(2008-10#2)
the CH(2)##9##2##(1997-2#1)(2008-10#6)(2008-5#1)(2011-1#1)
the CH(2)Cl(2) extract##2##3##(2007-1#2)
the CH(3) scissoring##2##3##(2008-10#2)
the CH(3) symmetric and asymmetric stretching##2##6##(2008-10#2)
the CH(3)##5##2##(2008-10#5)
the CH1 domain##2##3##(1992-7#1)(1993-6#1)
the CH1##4##2##(1992-7#1)(1993-6#1)(1997-2#1)(2008-5#1)
the CH2##3##2##(1991-9#1)(1994-3#1)(2012-12#1)
the CH2Cl2##2##2##(2006-12#2)
the CHAC##2##2##(1991-3#2)
the CHAP domain##2##3##(2009-6#2)
the CHAP-SH3b fusion##2##3##(2009-6#2)
the CHC taxonomy##2##3##(2013-7#2)
the CHF patients##2##3##(2010-10#2)
the CHIN (community health information network)##3##6##(1996-1#3)
the CHIN##4##2##(1996-1#4)
the CHO cells##4##3##(1992-7#1)(1995-3#1)(2008-11#2)
the CHO##10##2##(1992-7#1)(1993-8#1)(1994-1#1)(1994-7#1)(1995-3#1)(2008-11#5)
the CHO-K1 cell##2##3##(1997-1#1)(2008-11#1)
the CHOP regimen##3##3##(2009-8#3)
the CHR##2##2##(2007-2#2)
the CHUM##2##2##(2012-12#2)
the CI##3##2##(1993-10#1)(2007-10#1)(2008-10#1)
the CI-1 proteins##2##3##(1994-6#2)
the CIC##3##2##(1995-12#1)(2007-11#1)(2008-10#1)
the CIE##3##2##(2008-2#2)(2008-3#1)
the CIP##3##2##(2008-10#3)
the CIPIC-conjugated CCL##2##3##(2008-10#2)
the CIS strategy##2##3##(2008-9#2)
the CIS##3##2##(1994-9#1)(2008-9#2)
the CK-MB##2##2##(1992-3#1)(2007-8#1)
the CKD##2##2##(2012-2#1)(2013-1#1)
the CL detection##5##3##(2008-10#5)
the CL emission##3##3##(2008-10#3)
the CL intensity of##3##4##(2008-10#2)(2010-4#1)
the CL intensity was linear to the##2##7##(2008-10#2)
the CL intensity was linear##3##5##(2008-10#3)
the CL intensity##12##3##(2008-10#11)(2010-4#1)
the CL reaction between##3##4##(2008-10#3)
the CL reaction of##8##4##(2008-10#8)
the CL reaction was##2##4##(2008-10#2)
the CL reaction##15##3##(2007-8#1)(2008-10#14)
the CL response##2##3##(1991-9#1)(2008-10#1)
the CL striatum##2##3##(2008-11#2)
the CL##57##2##(1991-9#2)(1993-12#1)(1996-6#1)(2007-8#1)(2008-10#43)(2008-11#2)(2008-8#2)(2008-9#3)(2010-4#2)
the CL-1000##5##2##(2008-11#5)
the CL-emission generated##2##3##(2007-8#1)(2008-10#1)
the CLA group##2##3##(2008-5#2)
the CLA##3##2##(2007-8#1)(2008-5#2)
the CLB dose was##2##4##(2007-10#2)
the CLB dose##3##3##(2007-10#3)
the CLB skin received##2##4##(2007-10#2)
the CLB skin##3##3##(2007-10#3)
the CLB##6##2##(2007-10#6)
the CLCrV DNA-A##2##3##(2008-10#2)
the CLM LCAL##2##3##(2008-2#2)
the CLMMG mucosa##2##3##(2009-3#2)
the CLMMG##3##2##(2009-3#3)
the CLN-proteins into##2##3##(2009-5#2)
the CLN-proteins##3##2##(2009-5#3)
the CLP##4##2##(2012-3#4)
the CLPT##3##2##(2012-3#3)
the CLS##2##2##(2008-10#1)(2010-4#1)
the CM group##3##3##(2007-8#1)(2012-3#2)
the CM##12##2##(1993-6#1)(1993-9#1)(1994-5#1)(2007-8#2)(2008-10#3)(2011-2#2)(2012-3#2)
the CM8##2##2##(1996-7#2)
the CMC##8##2##(2007-8#1)(2008-10#3)(2008-5#1)(2011-1#1)(2012-3#2)
the CMCC##2##2##(2007-6#1)(2010-7#1)
the CME##3##2##(2008-10#3)
the CMF##3##2##(1992-12#1)(2012-12#2)
the CMI##2##2##(2006-10#1)(2008-3#1)
the CML stem cell##2##4##(2010-4#2)
the CML##4##2##(2009-7#2)(2010-4#2)
the CMM group##3##3##(2008-7#3)
the CMRD##3##2##(2008-2#3)
the CMS##6##2##(1996-7#3)(2008-9#1)(2010-6#1)(2013-7#1)
the CMT##2##2##(2005-11#2)
the CMV promoter##3##3##(1995-12#1)(2008-11#1)(2008-8#1)
the CMV vector but##2##4##(2009-10#2)
the CMV vector##4##3##(2008-8#1)(2009-10#3)
the CMV##11##2##(1992-6#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-8#2)(2009-10#4)
the CMV-based##2##2##(2008-8#2)
the CN films##3##3##(2005-4#3)
the CN##7##2##(1993-12#1)(2005-4#4)(2008-10#1)(2012-2#1)
the CN-##2##2##(1992-9#2)
the CNA##2##2##(1995-2#1)(2008-6#1)
the CNC##5##2##(2013-8#5)
the CNPHI has##2##3##(2008-11#2)
the CNR##2##2##(2008-2#1)(2008-3#1)
the CNS and##22##3##(1990-11#1)(1992-3#1)(1993-5#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-12#1)(2006-1#1)(2007-11#4)(2007-2#1)(2007-9#1)(2008-11#1)(2008-2#2)(2008-7#2)(2010-11#1)(2011-2#1)(2012-2#1)
the CNS disease##2##3##(2008-11#1)(2013-1#1)
the CNS for##2##3##(1990-3#1)(1996-5#1)
the CNS from the##2##4##(2008-5#1)(2008-8#1)
the CNS in##2##3##(1990-4#1)(1992-10#1)
the CNS is##5##3##(1990-4#1)(2007-11#3)(2008-8#1)
the CNS occurs##2##3##(1995-12#1)(2007-11#1)
the CNS of##8##3##(1990-5#1)(1991-10#1)(1991-9#1)(1992-3#1)(1994-2#2)(2008-11#1)(2008-7#1)
the CNS to##3##3##(1995-5#1)(2007-12#1)(2008-5#1)
the CNS were##3##3##(1996-12#1)(2008-5#1)(2010-12#1)
the CNS with the most##2##5##(1991-2#1)(1993-7#1)
the CNS##179##2##(1990-1#1)(1990-11#3)(1990-3#2)(1990-4#3)(1990-5#1)(1991-10#1)(1991-12#4)(1991-2#1)(1991-3#3)(1991-9#1)(1992-10#3)(1992-3#2)(1992-8#1)(1993-2#1)(1993-5#2)(1993-7#2)(1993-9#1)(1994-10#2)(1994-11#2)(1994-12#2)(1994-2#2)(1994-5#1)(1994-9#1)(1995-12#6)(1995-2#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-12#4)(1996-4#1)(1996-5#2)(1997-3#1)(1997-5#1)(2005-7#1)(2005-9#1)(2006-1#3)(2006-10#1)(2006-3#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-11#21)(2007-12#5)(2007-2#1)(2007-3#2)(2007-8#1)(2007-9#1)(2008-1#5)(2008-11#8)(2008-12#2)(2008-2#6)(2008-4#4)(2008-5#7)(2008-7#17)(2008-8#7)(2009-10#1)(2009-9#1)(2010-11#2)(2010-12#3)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#1)
the CNSS##2##2##(2008-7#2)
the CNT and CCD##4##4##(2012-12#4)
the CNT##9##2##(2008-10#1)(2008-7#1)(2010-7#1)(2012-12#4)(2013-8#2)
the CNTF gene##3##3##(1996-5#3)
the CNTF##5##2##(1995-12#1)(1996-5#4)
the CNTO 328/dex##2##3##(2009-4#2)
the CNVM##2##2##(2010-10#2)
the CO 2 laser via laparoscopy##2##6##(1991-3#2)
the CO 2 laser##8##4##(1991-3#2)(1992-1#3)(1992-3#3)
the CO 2##9##3##(1991-3#2)(1992-1#3)(1992-3#4)
the CO isolate##2##3##(2008-10#2)
the CO oxidation##3##3##(1992-12#3)
the CO stretching##2##3##(2008-10#1)(2008-8#1)
the CO##33##2##(1991-3#2)(1991-7#1)(1992-1#3)(1992-12#3)(1992-3#4)(1992-6#1)(1994-11#1)(1995-5#2)(1996-2#1)(1997-4#1)(2006-12#1)(2007-11#1)(2008-10#4)(2008-2#2)(2008-3#4)(2008-8#2)
the CO(2) and##2##3##(2008-10#1)(2008-2#1)
the CO(2) band##2##3##(2008-2#2)
the CO(2) concentration##2##3##(2008-10#1)(2008-11#1)
the CO(2)##16##2##(2008-10#7)(2008-11#1)(2008-2#6)(2009-6#1)(2012-3#1)
the CO-bound NiFe complex is##2##5##(1992-12#2)
the CO-bound##5##2##(1992-12#3)(1993-6#1)(1995-5#1)
the CO-sensing##2##2##(2008-10#2)
the CO-stretching##4##2##(1992-12#4)
the CO2 activation##2##3##(1993-6#2)
the CO2 laser##4##3##(1992-10#1)(1994-12#2)(2013-8#1)
the CO2 molecule##2##3##(1990-8#2)
the CO2##12##2##(1990-8#4)(1992-10#1)(1992-6#1)(1993-6#2)(1994-12#2)(2013-8#2)
the CO3 PDF##2##3##(2008-6#2)
the CO3##3##2##(1997-4#1)(2008-6#2)
the COD##2##2##(2008-1#1)(2008-10#1)
the COLIPA##3##2##(2008-5#3)
the COMFORT Behavior##2##3##(2012-2#2)
the COMFORT-B##2##2##(2012-2#2)
the CONNJUR application##3##3##(2012-1#3)
the CONNJUR##4##2##(2012-1#4)
the CONTINUUM project##2##3##(1995-3#2)
the COOH terminus of##4##4##(1994-9#2)(1995-3#1)(1996-5#1)
the COOH terminus##8##3##(1991-7#1)(1993-3#1)(1994-3#1)(1994-9#3)(1995-3#1)(1996-5#1)
the COOH##9##2##(1991-7#1)(1993-3#1)(1994-3#1)(1994-9#3)(1995-3#1)(1995-8#1)(1996-5#1)
the COOH-terminal domain of the##3##5##(1992-3#1)(1995-6#2)
the COOH-terminal domain of##5##4##(1992-3#1)(1995-3#1)(1995-6#3)
the COOH-terminal domain##7##3##(1991-12#2)(1992-3#1)(1995-3#1)(1995-6#3)
the COOH-terminal fragment##2##3##(1992-8#1)(1996-5#1)
the COOH-terminal part##2##3##(1990-11#1)(1994-12#1)
the COOH-terminal region of##3##4##(1990-2#1)(1995-6#2)
the COOH-terminal tripeptide from 125I-hANF##2##5##(1990-2#2)
the COOH-terminal tripeptide from##3##4##(1990-2#3)
the COOH-terminal tripeptide##4##3##(1990-2#4)
the COOH-terminal##33##2##(1990-11#1)(1990-2#5)(1990-8#1)(1991-12#2)(1992-11#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#2)(1994-12#4)(1994-9#1)(1995-3#3)(1995-6#5)(1996-5#4)(1997-4#1)
the COOH-terminus of the##2##4##(1991-12#1)(1992-9#1)
the COOH-terminus of##5##3##(1991-12#1)(1992-11#1)(1992-2#1)(1992-9#1)(1995-6#1)
the COOH-terminus##8##2##(1990-11#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-9#1)(1995-6#1)
the COP layer##2##3##(2008-2#2)
the COP##9##2##(1994-1#2)(2007-4#2)(2008-2#2)(2009-7#1)(2012-12#2)
the COPII##4##2##(1997-6#1)(2011-2#1)(2012-2#2)
the COS cell##2##3##(1991-9#2)
the COS##3##2##(1991-9#2)(2006-8#1)
the COVER survey##2##3##(2012-2#2)
the COX-2 inhibitors##4##3##(2008-3#1)(2008-8#1)(2009-1#2)
the COX-2##8##2##(2006-10#2)(2006-12#1)(2008-3#1)(2008-8#1)(2009-1#3)
the CP and the##3##4##(2007-12#1)(2008-10#2)
the CP and##6##3##(1995-6#1)(1997-8#1)(2007-12#1)(2008-10#2)(2013-8#1)
the CP gene of##2##4##(2008-10#2)
the CP gene##11##3##(1997-6#1)(2008-10#10)
the CP individuals were##2##4##(2009-4#2)
the CP of##2##3##(2008-10#2)
the CP sequences of##2##4##(2008-10#2)
the CP transgene##2##3##(2008-8#2)
the CP was##2##3##(1997-8#1)(2008-10#1)
the CP##48##2##(1992-6#1)(1995-6#1)(1997-6#3)(1997-8#4)(2005-11#1)(2007-12#1)(2007-7#1)(2008-10#28)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#2)(2010-2#1)(2013-8#1)
the CP7 mutant##2##3##(2008-10#2)
the CPA##4##2##(2006-11#3)(2012-3#1)
the CPAx score##2##3##(2012-12#2)
the CPAx##4##2##(2012-12#4)
the CPC##4##2##(2004-9#1)(2008-10#1)(2008-2#1)(2008-3#1)
the CPE##2##2##(2008-10#1)(2008-4#1)
the CPM splint##2##3##(2007-11#2)
the CPM##7##2##(2007-11#2)(2007-2#1)(2008-11#2)(2008-2#1)(2012-1#1)
the CPMG sequence##2##3##(2011-2#2)
the CPMG##3##2##(2011-1#1)(2011-2#2)
the CPOE##2##2##(2010-8#2)
the CPP##4##2##(1993-6#3)(2009-8#1)
the CPPSU##2##2##(2008-11#2)
the CPR##3##2##(1993-12#1)(1993-7#1)(2013-1#1)
the CPT and the SPAN##3##5##(1997-2#3)
the CPT and##6##3##(1996-3#1)(1997-2#5)
the CPT##9##2##(1996-3#2)(1997-2#5)(2007-11#1)(2008-3#1)
the CPTQ##4##2##(2008-12#4)
the CPU is##2##3##(2008-3#2)
the CPU##5##2##(2008-3#3)(2009-6#1)(2012-12#1)
the CPu##2##2##(1991-8#1)(1994-2#1)
the CPy(+) cation##2##3##(2008-10#2)
the CQ##4##2##(2005-8#4)
the CQI##2##2##(1993-2#1)(1994-3#1)
the CR lever##3##3##(1993-6#3)
the CR##12##2##(1993-6#4)(2008-10#1)(2008-7#1)(2009-5#3)(2009-8#1)(2010-8#1)(2012-12#1)
the CR011-vcMMAE antibody-drug conjugate##2##4##(2009-4#2)
the CR3 complement receptor##2##4##(1995-6#1)(1997-3#1)
the CR3##4##2##(1992-8#2)(1995-6#1)(1997-3#1)
the CRABI ATD##3##3##(2006-11#3)
the CRB##2##2##(2008-10#2)
the CRC##2##2##(2008-7#1)(2012-2#1)
the CRD##2##2##(1997-7#1)(2012-3#1)
the CRE##4##2##(1994-11#1)(1997-2#1)(2013-1#2)
the CREB binding protein##2##4##(1995-3#1)(2010-12#1)
the CREB##4##2##(1995-3#1)(1995-5#1)(1996-10#1)(2010-12#1)
the CRF receptor##2##3##(1997-4#1)(2008-4#1)
the CRF test##3##3##(1990-3#3)
the CRF##8##2##(1990-3#3)(1997-4#1)(2008-1#2)(2008-4#2)
the CRF1 receptor##2##3##(1995-1#2)
the CRF2 receptor##2##3##(1995-1#2)
the CRH##2##2##(1995-5#1)(2010-3#1)
the CRL##2##2##(2008-3#2)
the CRM##3##2##(2008-10#1)(2012-3#1)(2013-8#1)
the CRMs##2##2##(2008-10#2)
the CROC##2##2##(2012-3#2)
the CRP binding##3##3##(1994-9#3)
the CRP##9##2##(1990-12#1)(1992-12#1)(1994-9#3)(1995-8#1)(1997-6#1)(2006-7#1)(2010-12#1)
the CRQ##2##2##(2009-7#2)
the CRS##3##2##(1994-6#1)(2007-11#1)(2008-3#1)
the CRSM##3##2##(2010-1#3)
the CRT##2##2##(2008-2#1)(2008-3#1)
the CS and##4##3##(1995-11#1)(1996-7#1)(2012-2#1)(2012-3#1)
the CS##14##2##(1995-11#2)(1995-12#2)(1996-7#1)(2008-10#1)(2008-5#3)(2008-7#1)(2012-2#2)(2012-3#2)
the CSE effect on##2##4##(2006-9#2)
the CSF of##3##3##(1995-12#1)(2007-10#1)(2007-9#1)
the CSF##19##2##(1993-12#1)(1995-12#2)(1996-12#1)(1996-2#1)(1997-7#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-12#1)(2008-3#4)(2011-2#1)(2012-3#2)
the CSF-1 receptor##2##3##(1993-4#1)(1997-7#1)
the CSF-1##6##2##(1991-6#2)(1993-4#1)(1997-7#3)
the CSLH##3##2##(2006-4#3)
the CT activity of##2##4##(2008-7#2)
the CT and##3##3##(2007-11#2)(2007-9#1)
the CT depth##2##3##(2013-8#2)
the CT findings##2##3##(2005-8#1)(2012-12#1)
the CT scan##6##3##(1991-1#1)(1991-9#1)(1992-5#1)(2007-7#1)(2013-1#2)
the CT scans##2##3##(2008-7#2)
the CT##39##2##(1990-6#1)(1991-1#1)(1991-12#1)(1991-9#1)(1992-5#1)(1995-3#1)(1996-3#1)(1997-7#1)(2005-8#2)(2006-4#1)(2006-9#1)(2007-11#3)(2007-5#1)(2007-7#1)(2007-9#2)(2008-2#1)(2008-4#1)(2008-7#4)(2009-5#2)(2010-12#1)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#2)(2013-8#3)
the CT60(∗)G allele##2##3##(2010-12#2)
the CTA##2##2##(1992-11#1)(2008-9#1)
the CTD##7##2##(1992-5#5)(1995-2#2)
the CTGGGA##3##2##(1995-3#3)
the CTN##2##2##(1997-2#2)
the CTP##3##2##(1995-3#3)
the CTR##4##2##(2011-1#4)
the CTV status of##2##4##(2008-10#2)
the CTV##9##2##(2008-10#7)(2008-2#2)
the CTV-PTV safety zone##2##4##(2012-12#2)
the CU##3##2##(1990-6#2)(1993-11#1)
the CUDS##2##2##(2008-10#2)
the CUG##2##2##(1990-9#1)(2006-11#1)
the CV and FOL##2##4##(1993-12#2)
the CV and##4##3##(1993-12#2)(2007-12#1)(2008-10#1)
the CV##10##2##(1993-12#2)(2005-7#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-8#1)(2010-9#1)
the CVB1##3##2##(2013-8#3)
the CVC as##2##3##(2007-7#2)
the CVC##7##2##(2007-7#6)(2007-9#1)
the CVMA##2##2##(2007-4#2)
the CXC##2##2##(1995-2#1)(1995-3#1)
the CXR##2##2##(2007-7#1)(2008-9#1)
the CYBA gene##4##3##(2013-8#4)
the CYBB##2##2##(2007-2#2)
the CYP##2##2##(2007-11#2)
the CYP11B1 and##3##3##(1994-2#2)(1995-10#1)
the CYP11B1##4##2##(1994-2#3)(1995-10#1)
the CYP11B2 enzyme##2##3##(1994-2#2)
the CYP11B2##3##2##(1994-2#2)(1994-9#1)
the CYP11B3##3##2##(1995-10#3)
the CYP19a gene##3##3##(2009-7#3)
the CYP1A subfamily##2##3##(1994-6#1)(1994-8#1)
the CYP1A##5##2##(1992-12#2)(1994-6#1)(1994-8#2)
the CYP1A1 enhancer##2##3##(2006-12#2)
the CYP1A1##8##2##(1992-12#1)(1994-6#2)(1994-8#1)(1997-2#1)(2006-12#2)(2011-1#1)
the CYP21 gene##2##3##(2008-1#2)
the CYP21##3##2##(2008-1#3)
the CYP2A6 gene##2##3##(2007-8#1)(2008-8#1)
the CYP2A6##5##2##(2007-8#1)(2008-8#4)
the CYP2D6##3##2##(1996-1#1)(1996-3#1)(2008-4#1)
the CYP2E1 gene is##2##4##(1990-11#2)
the CYP2E1##4##2##(1990-11#2)(1995-3#1)(2008-8#1)
the CYP3A metabolic ratio##2##4##(1996-3#2)
the CYP3A subfamily##2##3##(1994-5#1)(1994-8#1)
the CYP3A##7##2##(1994-5#2)(1994-8#1)(1996-3#2)(2011-2#2)
the CYT-18 protein##5##3##(1995-1#5)
the CYVD strains##2##3##(2008-10#2)
the CZ##4##2##(1994-6#4)
the Ca##9##2##(1991-9#1)(1992-11#1)(1997-7#1)(2005-4#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-1#1)
the Ca( 2+##2##3##(2007-10#2)
the Ca(2##2##2##(2008-10#1)(2009-8#1)
the Ca(2+) messenger##2##3##(2008-4#2)
the Ca(2+)##10##2##(2006-10#1)(2008-11#1)(2008-4#4)(2008-8#1)(2009-6#1)(2010-2#1)(2012-2#1)
the Ca(2+)- and##2##3##(1991-9#1)(1994-12#1)
the Ca(2+)-##3##2##(1991-9#1)(1994-12#1)(1994-3#1)
the Ca(2+)-ATPase of sarcoplasmic reticulum##3##5##(1991-9#1)(1992-11#1)(1994-10#1)
the Ca(2+)-ATPase of##5##3##(1991-9#1)(1992-11#1)(1993-8#1)(1994-10#2)
the Ca(2+)-ATPase##12##2##(1991-9#3)(1992-11#1)(1992-5#1)(1992-6#3)(1993-8#1)(1994-10#2)(1997-1#1)
the Ca(2+)-activated K+##2##3##(1992-6#1)(1996-5#1)
the Ca(2+)-activated##4##2##(1992-6#2)(1996-5#1)(1997-2#1)
the Ca(2+)-binding##7##2##(1991-12#1)(1992-12#2)(1992-6#1)(1992-8#1)(1994-12#1)(1996-7#1)
the Ca(2+)-dependent inhibition##2##3##(1994-8#1)(2008-8#1)
the Ca(2+)-dependent##8##2##(1992-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-1#1)(2008-8#1)
the Ca(2+)-independent PLA2 in##2##4##(1995-8#2)
the Ca(2+)-independent PLA2##3##3##(1995-8#3)
the Ca(2+)-independent##5##2##(1991-8#1)(1995-8#4)
the Ca(2+)-induced##3##2##(1992-6#1)(1993-2#1)(1993-3#1)
the Ca(2+)-mediated##2##2##(1991-12#1)(1992-1#1)
the Ca(2+)-triggered##2##2##(1992-6#1)(2012-2#1)
the Ca(II) site##4##3##(1991-4#4)
the Ca-ATPase##7##2##(1991-2#5)(1991-7#2)
the Ca/P ratio up to 1##3##6##(2006-7#3)
the Ca2(+)-ATPase##4##2##(1990-3#4)
the Ca2(+)-calmodulin##2##2##(1990-10#1)(1991-2#1)
the Ca2(+)-dependent##2##2##(1990-11#1)(1990-7#1)
the Ca2+ affinity of##2##4##(1992-3#1)(1997-2#1)
the Ca2+ binding site##2##4##(1990-7#2)
the Ca2+ binding##4##3##(1990-7#2)(1992-12#1)(1994-11#1)
the Ca2+ channel##9##3##(1990-10#1)(1991-10#1)(1993-3#2)(1994-3#2)(1994-9#1)(1995-12#1)(1995-6#1)
the Ca2+ concentration##2##3##(1997-1#1)(2009-3#1)
the Ca2+ form##2##3##(1994-12#2)
the Ca2+ influx##2##3##(1993-11#1)(1996-2#1)
the Ca2+ ionophore A23187##4##4##(1991-5#1)(1992-1#1)(1994-12#1)(1994-6#1)
the Ca2+ ionophore ionomycin##3##4##(1990-3#1)(1992-12#1)(2008-8#1)
the Ca2+ ionophore##9##3##(1990-3#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#1)(1994-12#1)(1994-3#1)(1994-6#1)(2008-8#1)
the Ca2+ mobilizing##2##3##(1992-1#1)(1995-2#1)
the Ca2+ pump of##2##4##(1994-11#1)(1995-11#1)
the Ca2+ pump##7##3##(1991-8#2)(1994-11#1)(1994-5#1)(1994-9#2)(1995-11#1)
the Ca2+ release from the##2##5##(1995-12#1)(1997-1#1)
the Ca2+ release##3##3##(1995-12#1)(1995-3#1)(1997-1#1)
the Ca2+ response##4##3##(1991-12#1)(1993-8#1)(1994-12#1)(1994-3#1)
the Ca2+ signal##2##3##(1990-11#1)(1994-12#1)
the Ca2+##69##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#4)(1992-1#4)(1992-12#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#2)(1994-11#2)(1994-12#5)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#1)(1994-9#4)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-2#1)(1997-1#3)(1997-2#1)(2008-8#1)(2009-3#1)
the Ca2+-dependent##2##2##(2012-2#1)(2013-1#1)
the Ca2+-sensitive##2##2##(1997-4#1)(2008-9#1)
the Ca2+/CaM/CaN signal pathway in 5-HT-induced proliferation of rat##2##9##(2011-3#2)
the Ca2+/calmodulin-bound##2##2##(1996-8#2)
the CaF2 hollow microspheres##2##4##(2010-4#2)
the CaF2##3##2##(2010-4#3)
the CaG-channel remained##2##3##(1990-2#2)
the CaG-channel##4##2##(1990-2#4)
the CaM-BP68##3##2##(1994-5#3)
the CaMV 35S promoter##5##4##(1993-5#1)(1997-2#1)(1997-6#1)(1997-8#1)(2011-10#1)
the CaSR mRNA##2##3##(2008-11#2)
the Caco-2 cell monolayers##3##4##(1992-6#1)(2008-11#2)
the Caco-2 cell##4##3##(1992-6#1)(2008-11#3)
the Caco-2##6##2##(1992-6#1)(2007-11#1)(2008-11#4)
the Caenorhabditis elegans homologue##2##4##(1995-6#2)
the Caenorhabditis elegans##7##3##(1993-12#1)(1995-6#2)(1996-5#1)(2007-8#1)(2012-3#2)
the California Critical Thinking##2##4##(2008-11#2)
the California isolates##2##3##(2008-10#2)
the California##24##2##(1990-12#1)(1995-12#3)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#1)(2004-2#1)(2007-9#1)(2008-10#8)(2008-11#2)(2010-8#2)(2011-2#1)(2012-2#1)
the Calu-6##2##2##(1992-9#2)
the Camberwell Family Interview (CFI)##2##5##(1997-5#1)(2007-1#1)
the Camberwell##3##2##(1990-11#1)(1997-5#1)(2007-1#1)
the Cambridge Study in Delinquent Development##2##6##(2009-7#2)
the Cambridge classification##2##3##(2006-6#2)
the Cambridge##10##2##(2005-8#1)(2006-6#2)(2007-10#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-7#2)(2011-1#1)
the Canada Basin##4##3##(1991-11#2)(1994-7#2)
the Canada##8##2##(1991-11#2)(1994-7#2)(2007-9#1)(2008-12#1)(2010-11#1)(2010-9#1)
the Canadian Academy of Child and Adolescent Psychiatry##2##8##(2008-4#1)(2010-11#1)
the Canadian C-Spine Rule study##2##5##(2007-7#2)
the Canadian C-Spine Rule##4##4##(2007-7#4)
the Canadian C-Spine##5##3##(2007-4#1)(2007-7#4)
the Canadian College of##3##4##(1996-2#1)(1997-2#1)(2009-4#1)
the Canadian Committee on Antibiotic Resistance##3##6##(2007-12#3)
the Canadian Coordinating Office for Health Technology Assessment##2##8##(2006-5#2)
the Canadian Criminal Code##2##4##(1993-9#1)(1996-1#1)
the Canadian Dietetic Association##2##4##(1994-2#2)
the Canadian Emergency Department Triage and Acuity Scale##2##8##(2007-3#1)(2007-5#1)
the Canadian Health Services Research Foundation (CHSRF)##3##7##(2009-4#3)
the Canadian Health Services Research Foundation##8##6##(2009-3#1)(2009-4#5)(2010-5#1)(2010-8#1)
the Canadian Health##9##3##(2008-12#1)(2009-3#1)(2009-4#5)(2010-5#1)(2010-8#1)
the Canadian Institute for Health Information##2##6##(2008-6#1)(2012-12#1)
the Canadian Institute for Health##3##5##(2007-7#1)(2008-6#1)(2012-12#1)
the Canadian Institute##4##3##(1991-3#1)(2007-7#1)(2008-6#1)(2012-12#1)
the Canadian Institutes of Health Research and the##2##8##(2007-12#1)(2007-6#1)
the Canadian Institutes of Health Research##5##6##(2007-12#2)(2007-6#1)(2009-4#2)
the Canadian Memorial Chiropractic College (CMCC)##2##6##(2007-6#1)(2008-5#1)
the Canadian Nosocomial Infection Surveillance Program##2##6##(2007-12#2)
the Canadian Paediatric Society##4##4##(1994-11#1)(2008-4#1)(2010-11#1)(2010-4#1)
the Canadian and##2##3##(2007-6#1)(2008-10#1)
the Canadian guideline values for##2##5##(2008-10#2)
the Canadian health care system##5##5##(1993-3#1)(1994-1#1)(1996-12#1)(2007-7#1)(2008-6#1)
the Canadian health system##2##4##(1994-2#1)(1995-1#1)
the Canadian health##8##3##(1993-3#1)(1994-1#1)(1994-2#1)(1995-1#1)(1996-12#1)(2007-7#1)(2008-6#1)(2011-2#1)
the Canadian healthcare system##2##4##(1997-3#2)
the Canadian public##3##3##(2007-5#1)(2007-7#1)(2009-4#1)
the Canadian##118##2##(1990-10#1)(1991-11#1)(1991-3#1)(1993-3#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#3)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-2#1)(1997-3#2)(2004-3#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-4#3)(2006-5#2)(2007-12#13)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#5)(2007-7#7)(2007-9#1)(2008-10#8)(2008-11#5)(2008-12#5)(2008-4#2)(2008-5#1)(2008-6#3)(2009-3#1)(2009-4#9)(2009-5#1)(2010-11#3)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-2#2)(2012-12#2)(2013-1#3)
the Canary Island##2##3##(2008-10#2)
the Canary Islands##3##3##(1996-4#1)(2008-10#2)
the Canary##5##2##(1996-4#1)(2008-10#4)
the Cancer Atlas Viewer##2##4##(2008-5#2)
the Cancer Care Monitor##2##4##(2008-7#2)
the Cancer Registry##3##3##(1991-5#1)(1995-2#1)(1996-7#1)
the Cancer##13##2##(1991-3#1)(1991-5#2)(1995-2#1)(1996-7#1)(2008-5#2)(2008-6#1)(2008-7#3)(2011-1#1)(2012-2#1)
the Candida albicans##4##3##(1990-5#1)(1997-6#1)(2008-7#1)(2012-12#1)
the Candida##12##2##(1990-5#1)(1991-9#1)(1996-11#1)(1996-7#1)(1997-6#1)(2005-8#1)(2008-7#1)(2010-5#2)(2011-2#1)(2012-12#1)(2013-1#1)
the Canton of##4##3##(1990-6#1)(1996-11#3)
the Canton##5##2##(1990-6#1)(1993-5#1)(1996-11#3)
the Cantonal Hospital##2##3##(1992-10#1)(1996-11#1)
the Capacity##2##2##(1997-1#1)(2011-2#1)
the Cape##4##2##(1992-8#1)(2007-7#1)(2007-9#1)(2011-2#1)
the Capital Health##2##3##(1992-1#1)(2007-5#1)
the Capital##4##2##(1992-1#1)(2007-2#2)(2007-5#1)
the Captopril-Test##2##2##(1990-2#2)
the Carboseal composite valve graft##2##5##(2007-8#2)
the Carboseal##3##2##(2007-8#3)
the Cardiac##3##2##(2005-12#1)(2008-5#1)(2010-8#1)
the Cardinal##2##2##(2013-1#2)
the Cardiology Department##2##3##(2005-10#1)(2006-6#1)
the Cardiology##4##2##(2005-10#1)(2006-6#1)(2008-10#1)(2009-3#1)
the Cardiothoracic##3##2##(2007-8#1)(2008-1#1)(2011-2#1)
the Cardiovascular Hospitalization Atherosclerosis Management Program##2##6##(2008-3#2)
the Cardiovascular##5##2##(2007-12#1)(2008-3#2)(2009-12#1)(2013-7#1)
the Care of##4##3##(1992-3#1)(1994-3#1)(2010-7#1)(2012-12#1)
the Care##5##2##(1992-3#1)(1994-3#1)(1995-3#1)(2010-7#1)(2012-12#1)
the Caregiver##2##2##(2006-10#1)(2008-6#1)
the Caribbean Basin##6##3##(2008-10#6)
the Caribbean and in##2##4##(1991-11#1)(2007-5#1)
the Caribbean and##11##3##(1991-11#1)(2007-5#2)(2008-10#2)(2008-5#2)(2009-7#1)(2010-7#1)(2011-2#2)
the Caribbean are##2##3##(1996-6#1)(2007-5#1)
the Caribbean coast##5##3##(2007-5#3)(2008-5#2)
the Caribbean islands##2##3##(1996-6#1)(2007-10#1)
the Caribbean region and##2##4##(2008-10#2)
the Caribbean region##7##3##(2007-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2012-12#1)
the Caribbean##84##2##(1991-11#1)(1991-3#1)(1996-6#2)(2005-10#1)(2006-4#1)(2007-10#1)(2007-12#3)(2007-2#2)(2007-3#2)(2007-5#18)(2007-8#1)(2008-10#15)(2008-11#1)(2008-12#2)(2008-4#2)(2008-5#6)(2009-7#4)(2010-4#1)(2010-7#1)(2011-2#14)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)
the Caring Institute##3##3##(2009-5#3)
the Caring##5##2##(2009-5#5)
the Cariotester##2##2##(2013-8#2)
the Carolinas##5##2##(2008-8#5)
the Carotid##2##2##(2006-11#1)(2013-8#1)
the Carr-Purcell-Meiboom-Gill (CPMG)##2##3##(2011-1#1)(2011-2#1)
the Cartesian coordinate system##2##4##(2008-3#2)
the Cartesian##4##2##(2007-9#2)(2008-3#2)
the Casa do Indio##2##4##(1991-12#2)
the Casa##3##2##(1991-12#2)(2013-8#1)
the Caspian##3##2##(2008-12#1)(2008-7#1)(2010-8#1)
the Catania brachydactylous type of##2##5##(1996-6#2)
the Catania##3##2##(1996-6#2)(2007-1#1)
the Catholic University of##3##4##(1990-8#1)(2013-1#2)
the Catholic##11##2##(1990-6#1)(1990-8#1)(1991-3#1)(1994-1#1)(1994-4#1)(1995-2#1)(1996-12#1)(2006-2#1)(2011-2#1)(2013-1#2)
the Catterall##3##2##(2007-7#3)
the Caucasian population##3##3##(1990-12#1)(2008-7#1)(2010-8#1)
the Caucasian##7##2##(1990-12#1)(2008-1#1)(2008-7#1)(2010-2#1)(2010-5#1)(2010-8#2)
the Caucasus##9##2##(2008-10#7)(2008-11#1)(2012-1#1)
the Causal Agent of Bacterial##2##5##(2008-10#2)
the Causal Agent of Green Mold##2##6##(2008-10#2)
the Causal Agent of##13##4##(2008-10#13)
the Cause of Citrus Greasy Spot##2##6##(2008-10#2)
the Cause of##5##3##(2008-10#5)
the Cbl##2##2##(1991-12#1)(1991-8#1)
the Cd##8##2##(1995-3#1)(2004-4#1)(2008-10#4)(2008-9#1)(2011-12#1)
the Cd-protein##2##2##(1996-2#2)
the Ce##3##2##(1995-11#1)(2007-12#1)(2013-8#1)
the Ce-PbO(2) modified electrode was##2##5##(2008-10#2)
the CeAX rat##2##3##(1993-12#2)
the Cell SELEX##2##3##(2010-5#2)
the Cell##5##2##(2006-10#1)(2009-7#1)(2010-5#2)(2013-8#1)
the Cellscreen system##2##3##(2008-11#2)
the Celltac F hematology analyzer##2##5##(2008-10#2)
the Celltac F##3##3##(2008-10#3)
the Cellular##2##2##(2008-10#1)(2008-11#1)
the Cellulomonas fimi##2##3##(1994-11#1)(2008-7#1)
the Census##3##2##(1990-12#1)(1992-3#1)(1997-2#1)
the Centenary##2##2##(2009-7#1)(2012-2#1)
the Center for Devices and Radiological Health##2##7##(1993-3#1)(2010-6#1)
the Center for##20##3##(1990-11#2)(1993-3#1)(1997-2#1)(1997-5#1)(2007-11#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2010-5#1)(2010-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
the Center of Origin##2##4##(2008-10#2)
the Center of##8##3##(1994-1#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-12#1)(2011-2#1)
the Center##34##2##(1990-11#2)(1992-2#3)(1993-3#1)(1994-1#1)(1994-3#1)(1997-2#1)(1997-5#1)(2007-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
the Centers for Disease Control and Prevention (CDC)##11##8##(1995-12#2)(1995-6#3)(1996-12#1)(1996-5#1)(1997-1#1)(2008-8#1)(2009-11#1)(2010-12#1)
the Centers for Disease Control and Prevention and##4##8##(1997-2#1)(2007-12#3)
the Centers for Disease Control and Prevention##27##7##(1995-12#2)(1995-6#3)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(2004-9#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-12#5)(2007-2#1)(2008-10#1)(2008-8#2)(2009-11#1)(2010-12#1)(2012-3#1)
the Centers for Disease Control and##31##6##(1995-12#2)(1995-6#3)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#2)(2004-9#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-12#5)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-12#1)(2012-3#1)
the Centers for Disease Control##40##5##(1990-12#2)(1991-2#2)(1992-2#1)(1995-12#2)(1995-6#3)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#2)(2004-9#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-12#5)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-12#1)(2011-2#1)(2012-3#2)
the Centers for Medicare &amp##4##5##(2007-4#1)(2007-5#1)(2013-1#2)
the Centers for Medicare##5##4##(2007-12#1)(2007-4#1)(2007-5#1)(2013-1#2)
the Centers for##46##3##(1990-12#2)(1991-2#2)(1992-2#1)(1995-12#2)(1995-6#3)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#2)(2004-9#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-12#6)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
the Centocor RIA##2##3##(1992-12#2)
the Central American Gap##2##4##(2013-7#2)
the Central American##3##3##(2008-5#1)(2013-7#2)
the Central Hospital of Akershus##2##5##(1990-3#1)(1991-9#1)
the Central Hospital##3##3##(1990-3#1)(1990-4#1)(1991-9#1)
the Central Nervous System##2##4##(2006-10#1)(2008-2#1)
the Central and##2##3##(2007-5#1)(2008-10#1)
the Central##34##2##(1990-10#1)(1990-3#1)(1990-4#1)(1991-9#1)(1996-5#2)(2005-5#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-3#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#4)(2013-7#2)(2013-8#1)
the Centre for##6##3##(1990-3#1)(2005-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)
the Centre hospitalier Robert-Giffard##4##4##(1993-12#1)(2008-2#3)
the Centre hospitalier##5##3##(1993-12#1)(2008-2#4)
the Centre##16##2##(1990-3#1)(1992-5#1)(1993-12#1)(2005-10#1)(2007-12#1)(2008-11#1)(2008-2#7)(2008-6#1)(2008-7#1)(2011-2#1)
the Centre's##2##2##(1995-12#2)
the Centro de##2##3##(1993-3#1)(2012-12#1)
the Centro##4##2##(1993-3#1)(2008-10#1)(2011-2#1)(2012-12#1)
the Cercospora##2##2##(2008-10#2)
the Cerebral##2##2##(1992-10#1)(2007-9#1)
the Cerrado##3##2##(2008-6#1)(2008-8#1)(2010-3#1)
the Cerro##4##2##(2008-10#2)(2012-12#2)
the Cg1/Cg2 area##4##3##(1991-11#4)
the Cg3 area##2##3##(1991-11#2)
the ChL##3##2##(2008-10#3)
the Chair and Department of Forensic Medicine##2##7##(2009-4#2)
the Chair and Department of##3##5##(2007-11#1)(2009-4#2)
the Chair of##3##3##(2007-11#1)(2008-5#1)(2012-2#1)
the Chair##6##2##(2007-11#2)(2008-5#1)(2009-4#2)(2012-2#1)
the Chairman##2##2##(1993-2#1)(2008-5#1)
the Chamber of##2##3##(1991-4#1)(1994-6#1)
the Changbai Mountain##2##3##(2008-9#2)
the Channel##3##2##(2007-5#2)(2010-1#1)
the Chantuto-Panzacola##2##2##(2007-3#2)
the Characterization of##2##3##(1997-7#1)(2008-10#1)
the Charlson Comorbidity Index)##2##4##(2013-1#2)
the Chaudière-Appalaches region##2##3##(2008-2#2)
the Chemical##2##2##(2008-5#1)(2012-12#1)
the Chernobyl accident##5##3##(1992-4#3)(2008-10#1)(2009-12#1)
the Chernobyl nuclear##4##3##(2006-10#1)(2008-10#1)(2008-4#1)(2010-4#1)
the Chernobyl##13##2##(1992-4#3)(2006-10#1)(2008-10#2)(2008-4#2)(2008-7#1)(2009-12#1)(2010-4#2)(2011-1#1)
the Chernoff criterion##2##3##(2008-6#2)
the Chernoff##3##2##(2008-6#3)
the Chetumal Bay##2##3##(2008-5#2)
the Chi square test##3##4##(2011-2#1)(2013-8#2)
the Chiari osteotomy##4##3##(2007-7#4)
the Chicago##4##2##(1996-3#2)(2007-10#1)(2008-2#1)
the Chicxulub##2##2##(1997-5#2)
the Chief##6##2##(1993-1#1)(1993-3#2)(2005-5#1)(2007-8#1)(2008-12#1)
the Chikungunya IgM antibody##2##4##(2013-8#2)
the Chikungunya##6##2##(2013-8#6)
the Child Behavior Checklist (CBCL)##2##5##(1993-1#1)(2006-7#1)
the Child Behavior Checklist##3##4##(1993-1#1)(2006-10#1)(2006-7#1)
the Child and Adolescent Social Support Scale##2##7##(2010-1#2)
the Child and Adolescent##3##4##(2008-11#1)(2010-1#2)
the Child and##4##3##(2008-11#1)(2010-1#2)(2011-1#1)
the Child##19##2##(1992-12#1)(1992-7#1)(1993-1#1)(1996-12#1)(1996-9#1)(2004-11#1)(2006-10#1)(2006-7#1)(2008-11#1)(2008-9#3)(2009-11#1)(2010-1#2)(2011-1#4)
the Child--Pugh##2##2##(1995-4#2)
the Child-Pugh classification##3##3##(2006-10#1)(2007-8#1)(2013-1#1)
the Child-Pugh##5##2##(2006-10#1)(2007-8#1)(2009-3#1)(2009-9#1)(2013-1#1)
the Childbearing##2##2##(2008-9#1)(2009-4#1)
the Children##5##2##(1993-5#1)(2008-9#3)(2010-7#1)
the Children's Hospital Association and the University of Utah##2##9##(2013-1#2)
the Children's Hospital of##2##4##(2007-12#1)(2008-11#1)
the Children's Hospital##7##3##(2005-12#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-11#1)(2013-1#2)
the Children's Oncology Group##2##4##(2008-6#1)(2010-5#1)
the Children's##16##2##(1994-3#1)(1996-7#1)(2005-10#1)(2005-12#1)(2006-8#1)(2007-12#2)(2007-9#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#1)(2010-5#1)(2012-12#1)(2013-1#2)
the Chilean##4##2##(2007-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
the China##3##2##(2008-7#1)(2011-2#2)
the Chinese Han population##5##4##(2010-12#1)(2011-1#1)(2012-2#1)(2013-7#2)
the Chinese National##2##3##(2011-2#1)(2012-11#1)
the Chinese University##2##3##(2008-5#1)(2009-3#1)
the Chinese femur##2##3##(1995-6#2)
the Chinese hamster ovary##2##4##(1995-11#1)(2008-11#1)
the Chinese hamster##4##3##(1994-12#1)(1995-11#1)(1997-7#1)(2008-11#1)
the Chinese herbal##7##3##(2006-4#1)(2007-1#1)(2007-6#1)(2008-10#3)(2013-1#1)
the Chinese isolate##3##3##(2008-10#3)
the Chinese mainland##2##3##(2008-7#1)(2009-6#1)
the Chinese onion cultivars with##2##5##(2013-8#2)
the Chinese onion cultivars##5##4##(2013-8#5)
the Chinese onion##6##3##(2013-8#6)
the Chinese population##4##3##(2008-7#1)(2010-2#1)(2011-1#2)
the Chinese traditional medicine##3##4##(1990-8#2)(2011-1#1)
the Chinese traditional##4##3##(1990-8#2)(2008-8#1)(2011-1#1)
the Chinese##78##2##(1990-12#1)(1990-8#3)(1994-12#1)(1995-11#1)(1995-6#2)(1997-5#1)(1997-7#2)(2005-11#2)(2006-4#1)(2006-7#1)(2007-1#5)(2007-12#2)(2007-6#1)(2007-7#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#6)(2008-8#3)(2009-3#1)(2009-6#1)(2010-12#1)(2010-2#1)(2011-1#7)(2011-2#3)(2011-3#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#7)
the Chlamydia trachomatis##2##3##(1991-9#1)(1993-9#1)
the Chlamydia##6##2##(1991-4#1)(1991-9#1)(1993-9#1)(2008-5#1)(2008-9#1)(2013-8#1)
the Cholesterol-Lowering Atherosclerosis Study (CLAS)##2##5##(1991-7#1)(1991-8#1)
the Choquet integral##2##3##(2008-2#1)(2008-6#1)
the Christian##3##2##(2007-10#1)(2008-12#1)(2008-7#1)
the Chronic##2##2##(2004-4#1)(2007-2#1)
the Cibacron Blue##2##3##(1990-12#1)(1997-2#1)
the Cincinnati##5##2##(1994-12#2)(1995-3#1)(2008-5#1)(2011-2#1)
the Cis##2##2##(1992-12#2)
the City of##4##3##(1991-12#1)(2007-5#1)(2011-2#2)
the City##5##2##(1991-12#2)(2007-5#1)(2011-2#2)
the Civil War##3##3##(2008-8#1)(2010-12#1)(2013-1#1)
the Civil##5##2##(1994-1#1)(2007-2#1)(2008-8#1)(2010-12#1)(2013-1#1)
the Civilian Health and Medical Program of the Uniformed Services (CHAMPUS)##2##11##(1994-12#1)(1996-12#1)
the Cl##3##2##(1991-5#1)(2006-4#1)(2010-5#1)
the Cl- channel##2##3##(1994-9#1)(1995-12#1)
the Cl- channels##2##3##(1990-2#2)
the Cl- current##2##3##(1994-5#2)
the Cl-##7##2##(1990-2#3)(1994-5#2)(1994-9#1)(1995-12#1)
the Clarion##5##2##(2008-9#5)
the Classification##3##2##(1991-12#2)(2009-11#1)
the Classroom##3##2##(2008-2#2)(2011-1#1)
the Clauss##2##2##(2008-10#2)
the Cleveland Clinic Foundation##3##4##(1995-12#1)(2006-12#1)(2008-7#1)
the Cleveland Clinic##4##3##(1995-12#1)(2006-12#1)(2008-7#1)(2011-2#1)
the Cleveland##5##2##(1995-12#1)(1996-1#1)(2006-12#1)(2008-7#1)(2011-2#1)
the Clinic for##2##3##(2010-9#1)(2011-2#1)
the Clinic of Orthopedics##3##4##(2007-7#1)(2007-8#1)(2012-3#1)
the Clinic of##13##3##(1996-11#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-8#1)(2008-9#4)(2010-12#1)(2012-3#1)(2013-8#1)
the Clinic##22##2##(1993-12#1)(1994-12#1)(1995-9#1)(1996-11#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-8#1)(2008-9#4)(2010-12#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-8#3)
the Clinic's##2##2##(2007-7#2)
the Clinical Efficacy##2##3##(1993-12#1)(2010-8#1)
the Clinical Hospital##4##3##(2010-9#2)(2011-2#1)(2013-1#1)
the Clinical Laboratory##4##3##(1992-4#1)(1994-2#1)(2008-10#1)(2009-8#1)
the Clinical Test of Executive Functions##2##6##(2007-11#2)
the Clinical and Translational Science##2##5##(2012-12#2)
the Clinical##28##2##(1992-12#1)(1992-2#1)(1992-4#1)(1993-12#1)(1994-2#1)(2007-11#2)(2007-6#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-8#1)(2010-12#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#1)(2012-12#3)(2013-1#3)
the Clinton Administration##2##3##(1994-12#1)(1996-11#1)
the Clinton##9##2##(1994-12#1)(1995-1#2)(1995-2#2)(1995-6#1)(1996-11#1)(1996-2#1)(2006-8#1)
the Clostridium##6##2##(1991-7#1)(1995-2#1)(1997-4#1)(2006-5#1)(2007-12#1)(2008-5#1)
the Cluster##3##2##(1996-2#1)(1997-5#1)(2008-10#1)
the Co##6##2##(1992-2#1)(1997-7#1)(2006-12#1)(2008-10#1)(2012-11#2)
the Co(2+)##5##2##(2007-11#1)(2008-3#3)(2008-5#1)
the Co(II)##3##2##(1992-9#1)(2008-10#1)(2010-5#1)
the Co-4##3##2##(2008-10#3)
the Co-TDM##2##2##(2012-11#2)
the CoHCF##2##2##(2008-10#2)
the Coalition for Improving Maternity Services##3##6##(2007-2#2)(2008-9#1)
the Coalition##4##2##(2007-2#2)(2008-9#1)(2010-12#1)
the Coastal##2##2##(2008-2#1)(2008-3#1)
the Coat Protein Gene##2##4##(2008-10#2)
the Coat Protein##3##3##(2008-10#3)
the Cobb angle and rotation##2##5##(2007-8#2)
the Cobb angle##5##3##(2007-7#1)(2007-8#4)
the Cobb##6##2##(2007-7#1)(2007-8#5)
the Cochrane Central Register of Controlled Trials##4##7##(2007-8#2)(2013-8#2)
the Cochrane Central Register of Controlled##5##6##(2007-8#2)(2012-12#1)(2013-8#2)
the Cochrane Collaboration##2##3##(2008-9#1)(2010-9#1)
the Cochrane Database of Systematic Reviews##4##6##(1993-12#1)(2007-2#1)(2010-4#1)(2011-2#1)
the Cochrane Library##4##3##(2007-10#1)(2013-1#2)(2013-8#1)
the Cochrane##25##2##(1993-12#1)(1995-4#1)(2006-2#1)(2007-10#1)(2007-2#1)(2007-8#2)(2008-6#1)(2008-9#1)(2009-9#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#5)
the Code##2##2##(2004-3#1)(2005-5#1)
the Codex Alimentarius Austriacus##2##4##(2012-12#2)
the Codex Alimentarius Commission##4##4##(2005-11#1)(2011-2#1)(2012-12#2)
the Codex Alimentarius##9##3##(2005-11#1)(2008-7#1)(2011-2#1)(2012-12#5)(2013-8#1)
the Codman Hakim programmable valve##3##5##(2006-8#3)
the Codman##4##2##(2006-8#3)(2007-11#1)
the Cognitive##4##2##(1991-1#1)(2005-10#2)(2008-12#1)
the Cohesion to Therapist Scale##2##5##(2013-1#2)
the Colección Nacional de##3##4##(2007-3#1)(2007-5#2)
the Colección##4##2##(2007-3#2)(2007-5#2)
the Collaborative##3##2##(1990-11#1)(2004-10#1)(2006-5#1)
the College and##2##3##(2007-11#1)(2007-6#1)
the College of Education##3##4##(2007-1#1)(2007-3#1)(2009-4#1)
the College of##13##3##(1990-12#2)(1993-12#1)(1993-9#1)(1996-2#1)(2007-1#1)(2007-3#1)(2007-4#1)(2008-12#1)(2009-4#1)(2010-9#1)(2011-2#2)
the College##21##2##(1990-12#2)(1993-12#1)(1993-9#1)(1996-2#1)(2007-1#1)(2007-11#2)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#2)(2008-12#1)(2008-6#1)(2009-4#1)(2010-9#2)(2011-2#2)
the Collins##4##2##(1994-8#4)
the Colombian Caribbean##6##3##(2007-3#1)(2007-5#4)(2008-5#1)
the Colombian##22##2##(2006-3#2)(2007-3#1)(2007-5#7)(2008-10#1)(2008-12#1)(2008-5#3)(2012-12#4)(2013-1#1)(2013-7#2)
the Colorado potato beetle##3##4##(2008-10#3)
the Colorado##6##2##(1992-1#1)(2007-8#1)(2008-10#4)
the Columbia Basin of Washington and Oregon##2##7##(2008-10#2)
the Columbia Basin of Washington##3##5##(2008-10#3)
the Columbia Basin##7##3##(2008-10#7)
the Columbia##10##2##(2008-10#7)(2008-7#1)(2010-8#1)(2013-7#1)
the Combined##2##2##(2008-3#1)(2010-1#1)
the Comment##2##2##(2007-12#2)
the Commentary##4##2##(2007-4#1)(2008-4#3)
the Commission for Health##2##4##(2008-7#2)
the Commission on##3##3##(1990-12#1)(2012-12#1)(2012-2#1)
the Commission##13##2##(1990-12#1)(1996-12#1)(2008-10#2)(2008-2#2)(2008-7#2)(2010-5#1)(2010-9#1)(2012-12#2)(2012-2#1)
the Committee for##3##3##(2008-11#1)(2008-7#1)(2012-12#1)
the Committee on##8##3##(1991-1#1)(1996-2#1)(2007-11#1)(2007-4#1)(2008-4#2)(2008-7#1)(2013-1#1)
the Committee##15##2##(1991-1#1)(1993-1#2)(1993-5#1)(1996-2#2)(2007-11#1)(2007-4#1)(2008-11#1)(2008-4#2)(2008-7#2)(2012-12#1)(2013-1#1)
the Common Bean##2##3##(2008-10#2)
the Common##11##2##(1996-5#1)(2006-8#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#1)(2009-11#1)(2013-1#1)(2013-8#1)
the Commonwealth of##5##3##(2006-6#1)(2008-1#3)(2013-8#1)
the Communications Decency Act##3##4##(1996-12#1)(1996-5#1)(1996-6#1)
the Community##10##2##(1991-5#1)(1992-12#1)(1992-5#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2012-2#1)
the Complaints score##2##3##(1991-6#2)
the Complex##4##2##(1994-11#1)(1997-7#1)(2008-11#1)(2008-12#1)
the Comprehensive##4##2##(1996-12#1)(2011-2#2)(2012-3#1)
the Concentric##2##2##(1994-3#1)(2012-1#1)
the Conference on##2##3##(2007-6#1)(2008-10#1)
the Conference##4##2##(2007-6#1)(2008-1#1)(2008-10#1)(2013-7#1)
the Confusion Assessment Method (CAM)##3##5##(2008-7#1)(2013-1#2)
the Congo##2##2##(2007-7#1)(2008-10#1)
the Congress##4##2##(1994-3#1)(1995-3#1)(2008-1#1)(2010-11#1)
the Connecticut##3##2##(1995-5#1)(1997-3#1)(2012-2#1)
the Consejo Superior de Investigaciones##2##5##(2008-10#2)
the Consortium for##2##3##(2007-8#1)(2012-2#1)
the Consortium##3##2##(2007-8#1)(2012-12#1)(2012-2#1)
the Constant##2##2##(2007-8#1)(2011-2#1)
the Constitution of##2##3##(2005-5#1)(2011-2#1)
the Constitution##4##2##(2005-5#1)(2011-2#2)(2012-12#1)
the Consumer Price Index for prescription drugs##2##7##(1993-1#2)
the Consumer Price Index##3##4##(1993-1#2)(1993-3#1)
the Consumer##4##2##(1993-1#2)(1993-3#1)(2008-7#1)
the Consumption##2##2##(2008-4#1)(2010-11#1)
the Content##2##2##(2008-12#1)(2011-2#1)
the Continental##2##2##(2008-10#1)(2012-3#1)
the Continuous Performance Test (CPT)##2##5##(1996-3#1)(1997-2#1)
the Continuous Performance Test##4##4##(1995-1#1)(1996-3#2)(1997-2#1)
the Continuous Performance##5##3##(1995-1#1)(1996-3#2)(1997-2#2)
the Contour##2##2##(2007-12#1)(2012-2#1)
the Contrast##2##2##(2008-2#2)
the Control condition##2##3##(2008-4#2)
the Control##9##2##(1990-8#1)(2008-4#3)(2011-1#3)(2011-2#2)
the Controlled##2##2##(2008-5#1)(2010-12#1)
the Convention##5##2##(1990-2#1)(1992-12#3)(2005-11#1)
the Conventional##2##2##(2007-12#1)(2012-1#1)
the Converge system##2##3##(2007-8#2)
the Converge##4##2##(2007-8#4)
the Cookie Theft##2##3##(2013-1#2)
the Coomassie brilliant blue##2##4##(2008-10#2)
the Cooperative##2##2##(2010-3#1)(2011-1#1)
the Copenhagen Male Study##3##4##(1994-2#1)(2008-3#2)
the Copenhagen Psychosocial Questionnaire##7##4##(2011-1#7)
the Copenhagen Psychosocial##8##3##(2011-1#8)
the Copenhagen Stroke Study##2##4##(2007-10#1)(2007-9#1)
the Copenhagen stroke study##2##4##(2007-10#2)
the Copenhagen##20##2##(1990-4#1)(1992-10#1)(1994-2#1)(1996-9#1)(2007-10#3)(2007-8#1)(2007-9#1)(2008-3#2)(2011-1#8)(2012-2#1)
the Coping##2##2##(2008-11#1)(2008-12#1)
the Core##4##2##(1995-12#1)(1996-6#1)(2006-9#1)(2008-10#1)
the Cornell##2##2##(2007-3#1)(2008-3#1)
the Corneometer##2##2##(2008-5#2)
the Corolla and##2##3##(2012-1#2)
the Corolla##3##2##(2012-1#3)
the Coronary##4##2##(1991-8#2)(2006-1#1)(2011-2#1)
the Coroner's##3##2##(1996-1#2)(2011-2#1)
the Correlation of##2##3##(2008-10#1)(2011-1#1)
the Cortés##2##2##(2008-5#2)
the Corynebacterium##3##2##(1990-11#1)(1991-8#1)(2008-5#1)
the Costa Rica intertidal zones##2##5##(2007-5#2)
the Costa Rican##6##3##(1996-5#1)(2007-3#2)(2007-5#2)(2011-2#1)
the Costa##8##2##(1996-5#1)(2007-3#2)(2007-5#4)(2011-2#1)
the Costs of##2##3##(1994-2#1)(1996-2#1)
the Coulomb##4##2##(1992-9#1)(1996-2#1)(1996-7#1)(2012-2#1)
the Council of##4##3##(1995-6#1)(2005-11#1)(2006-10#1)(2007-4#1)
the Council on##2##3##(1991-8#1)(1997-3#1)
the Council##11##2##(1991-8#1)(1995-6#5)(1997-3#1)(2005-11#1)(2006-10#2)(2007-4#1)
the County of##3##3##(1991-9#1)(1992-3#1)(1997-3#1)
the County##5##2##(1991-9#1)(1992-3#2)(1997-3#1)(2013-8#1)
the Course of##4##3##(2009-12#1)(2010-1#1)(2010-2#1)(2012-3#1)
the Court of Appeal on a##2##6##(1993-5#1)(1997-5#1)
the Court of Appeal##5##4##(1993-5#1)(1997-5#3)(2006-4#1)
the Court of Appeals##2##4##(1991-10#1)(1995-12#1)
the Court of##8##3##(1991-10#1)(1993-5#1)(1995-12#1)(1997-5#3)(2006-4#1)(2011-12#1)
the Court##10##2##(1991-10#1)(1992-6#1)(1993-5#1)(1995-12#1)(1997-5#3)(2006-4#1)(2010-12#1)(2011-12#1)
the Court's##4##2##(1991-12#1)(2005-11#3)
the Cox maze##2##3##(2007-8#2)
the Cox model##2##3##(1994-7#1)(1997-2#1)
the Cox proportional hazards model##3##5##(1995-4#2)(2007-10#1)
the Cox proportional##4##3##(1995-4#2)(1997-3#1)(2007-10#1)
the Cox##13##2##(1994-7#1)(1995-4#2)(1997-2#1)(1997-3#1)(2006-7#1)(2007-10#1)(2007-8#2)(2008-3#1)(2008-6#1)(2009-10#1)(2010-7#1)
the Coxiella burnetii##2##3##(1995-4#1)(1995-8#1)
the Cp##4##2##(1991-7#1)(1996-2#1)(1997-8#1)(2008-5#1)
the CpG islands##2##3##(1996-6#1)(2012-2#1)
the CpG site##2##3##(1990-4#1)(1995-2#1)
the CpG##9##2##(1990-4#1)(1990-5#1)(1991-5#1)(1994-5#1)(1995-2#1)(1996-6#1)(1997-4#2)(2012-2#1)
the Cr##14##2##(2007-11#3)(2007-12#2)(2008-10#2)(2008-2#6)(2008-3#1)
the Cr(3+)##2##2##(2008-10#1)(2008-2#1)
the Cr(4+)##4##2##(2007-12#2)(2008-3#2)
the Cr(III)##2##2##(2008-10#1)(2011-2#1)
the Cr(VI) concentrations##2##3##(2008-10#2)
the Cr(VI)##8##2##(2008-10#8)
the Cr2 gene##3##3##(2008-10#3)
the Cr2 phenotype##2##3##(2008-10#2)
the Cr2##6##2##(2008-10#6)
the CrCL##2##2##(2012-3#2)
the Crack##2##2##(2008-10#2)
the Cracow##4##2##(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)
the Cre recombinase##2##3##(2008-9#1)(2012-12#1)
the Cre##3##2##(1996-4#1)(2008-9#1)(2012-12#1)
the Cre-LoxP system##2##3##(2005-6#1)(2008-9#1)
the Cre-loxP##3##2##(1995-2#1)(2008-2#1)(2008-4#1)
the Cricket##4##2##(2005-12#1)(2008-5#2)(2008-6#1)
the Crimea##2##2##(2008-8#1)(2009-7#1)
the Criminal Law (Rape)##2##4##(1990-12#2)
the Criminal##3##2##(1990-12#2)(2007-4#1)
the Crisis Center for##2##4##(1995-5#2)
the Critical Indicator Project in##2##5##(1992-2#2)
the Critical Path##2##3##(1995-12#1)(1996-6#1)
the Critical##7##2##(1992-2#2)(1995-12#1)(1996-6#1)(2010-2#1)(2013-1#2)
the Critically##2##2##(2007-5#1)(2012-12#1)
the Croatian Ministry of Health##2##5##(2010-9#2)
the Croatian##11##2##(2008-10#2)(2010-9#4)(2011-2#3)(2013-1#2)
the Cross##3##2##(2008-10#1)(2009-11#1)(2013-1#1)
the Crotalidae##2##2##(1992-8#1)(1994-12#1)
the Cryptosporidium DNA##2##3##(2008-10#2)
the Cs##2##2##(1996-8#1)(1997-7#1)
the CsA##4##2##(1992-12#1)(1992-7#1)(1997-2#2)
the Csfm gene##2##3##(1990-5#2)
the Csfm##4##2##(1990-5#4)
the Cu coating##2##3##(2012-1#2)
the Cu##11##2##(1993-11#1)(1995-3#1)(1997-4#1)(1997-8#1)(2007-11#1)(2008-10#3)(2008-12#1)(2012-1#2)
the Cu(2+)##2##2##(1997-7#1)(2008-10#1)
the Cu(Arm)(PA) complexes##2##3##(2008-5#2)
the Cu(II) complex##4##3##(2005-11#1)(2008-10#1)(2008-3#2)
the Cu(II) concentration##2##3##(2005-11#1)(2008-10#1)
the Cu(II)##15##2##(1992-8#1)(1996-2#1)(1996-8#1)(2005-11#2)(2007-8#1)(2008-10#3)(2008-3#3)(2008-5#3)
the Cu(II)-DDTC complex##3##3##(2008-10#3)
the Cu/Zn##3##2##(1996-10#2)(2013-8#1)
the CuA redox state##2##4##(1997-6#2)
the CuA##6##2##(1994-8#4)(1997-6#2)
the CuN(6) units on site##2##5##(1996-2#2)
the CuN(6)##3##2##(1996-2#3)
the CuO2##2##2##(1992-8#1)(1996-9#1)
the Cuban##6##2##(1996-11#1)(2005-9#1)(2007-5#2)(2008-5#1)(2009-4#1)
the Cupin superfamily##2##3##(2009-8#2)
the Curie##2##2##(2008-3#2)
the Curriculum##2##2##(2006-12#1)(2008-11#1)
the Cushing##2##2##(1991-11#1)(2009-3#1)
the Cx26##2##2##(2006-10#2)
the CyA##2##2##(2008-10#2)
the Cys##6##2##(1990-12#1)(1991-11#1)(1991-2#1)(1993-3#1)(1994-12#1)(2008-10#1)
the Cyt1A##2##2##(2004-11#2)
the Cytochrome c##2##3##(2007-1#1)(2013-1#1)
the Czech Republic and##4##4##(1990-6#1)(2005-1#1)(2005-8#1)(2010-4#1)
the Czech Republic##28##3##(1990-11#1)(1990-6#1)(1990-9#1)(1996-7#2)(2004-4#1)(2005-1#2)(2005-8#1)(2006-12#1)(2006-2#1)(2006-6#2)(2006-8#3)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#3)
the Czech resistance during World War II##2##7##(1990-11#1)(1990-9#1)
the Czech##43##2##(1990-11#3)(1990-6#1)(1990-9#4)(1996-7#3)(2004-4#1)(2005-1#4)(2005-8#1)(2006-12#1)(2006-2#1)(2006-6#2)(2006-8#3)(2007-10#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#3)(2013-1#3)
the D and##4##3##(1992-12#1)(1995-3#1)(2008-10#2)
the D genotype##2##3##(2008-10#2)
the D loop of##2##4##(1993-11#2)
the D##51##2##(1990-4#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-1#2)(1992-12#1)(1992-7#2)(1993-11#2)(1993-2#3)(1993-4#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-2#2)(1995-3#1)(1995-8#6)(1996-2#1)(2004-4#1)(2006-8#2)(2007-12#2)(2008-10#12)(2008-11#1)(2008-2#1)(2008-9#1)(2013-1#1)
the D(1) line##4##3##(2007-11#2)(2007-12#2)
the D(1)##5##2##(2007-11#3)(2007-12#2)
the D(2) line##2##3##(2007-11#2)
the D(2)##5##2##(2007-11#2)(2007-12#1)(2008-2#2)
the D-1##2##2##(1993-9#2)
the D-2##3##2##(1990-2#1)(1993-9#2)
the D-E region##3##3##(1994-8#3)
the D-alanyl##2##2##(1995-6#2)
the D-dimer##2##2##(1992-2#1)(2011-2#1)
the D-enantiomer##3##2##(1992-12#1)(1994-2#1)(1996-7#1)
the D-galactose##5##2##(1990-5#1)(1991-12#1)(1991-4#3)
the D-glucose##3##2##(1991-5#1)(1991-9#1)(2007-11#1)
the D-helix and##2##3##(1997-2#1)(1997-4#1)
the D-helix sequence##3##3##(1997-4#3)
the D-helix##9##2##(1991-7#1)(1997-2#1)(1997-4#7)
the D-lactate##3##2##(1991-12#1)(1995-9#1)(2008-7#1)
the D-loop and##2##3##(1993-4#1)(1996-9#1)
the D-loop region##4##3##(1990-7#1)(2009-5#2)(2011-2#1)
the D-loop##10##2##(1990-7#1)(1993-4#1)(1994-10#1)(1996-9#1)(2008-5#1)(2008-8#1)(2009-5#3)(2011-2#1)
the D-wave##2##2##(2008-7#2)
the D1 agonist SKF 38393##2##5##(1993-12#1)(1993-6#1)
the D1 antagonist SCH 23390##3##5##(1993-12#1)(1993-2#1)(1996-1#1)
the D1 dopamine receptor##3##4##(1995-11#2)(1996-10#1)
the D1 dopamine##4##3##(1994-8#1)(1995-11#2)(1996-10#1)
the D1 protein##5##3##(1994-8#3)(1994-9#2)
the D1 receptor##6##3##(1991-5#1)(1995-11#2)(1996-10#1)(2006-9#1)(2007-11#1)
the D1##23##2##(1990-10#1)(1991-5#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-8#4)(1994-9#3)(1995-11#4)(1996-1#1)(1996-10#2)(2006-10#1)(2006-9#1)(2007-11#1)
the D12 subunit##2##3##(1994-9#2)
the D12##3##2##(1994-9#3)
the D1A-deficient mouse##2##3##(1997-7#2)
the D2 agonist quinpirole##2##4##(1993-12#1)(1993-6#1)
the D2 agonist##3##3##(1991-8#1)(1993-12#1)(1993-6#1)
the D2 antagonist##4##3##(1991-8#1)(1993-12#1)(1993-3#1)(1997-6#1)
the D2 dopamine##2##3##(1991-6#1)(1993-3#1)
the D2 receptor gene##2##4##(1990-12#2)
the D2 receptor##10##3##(1990-12#3)(1990-5#1)(1991-5#1)(1993-2#1)(1995-2#1)(1995-3#1)(2005-8#1)(2008-1#1)
the D2##26##2##(1990-12#3)(1990-5#2)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-9#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-6#1)(2005-8#2)(2008-1#1)(2008-7#1)
the D2-specific##2##2##(1996-1#1)(1997-6#1)
the D2/Taq I##3##3##(1990-12#3)
the D214N mutant##2##3##(1996-11#2)
the D222A or D222N enzyme##2##5##(1992-6#2)
the D222A##3##2##(1992-6#3)
the D3 receptor##5##3##(1995-2#4)(2012-1#1)
the D3##7##2##(1993-2#1)(1995-12#1)(1995-2#4)(2012-1#1)
the D333N mutant##2##3##(1994-9#2)
the D6-2 transgenic##2##3##(2008-4#2)
the D63N mutant##2##3##(1996-2#2)
the D96N mutant of bR##2##5##(1992-11#2)
the D96N mutant##3##3##(1992-11#3)
the DA D-1##2##3##(1990-2#2)
the DA D-2 receptor##3##4##(1990-2#3)
the DA hypothesis##2##3##(2005-8#2)
the DA level in rat adrenal glands##2##7##(1990-2#2)
the DA level##3##3##(1990-2#3)
the DA neuron##3##3##(1990-7#3)
the DA transporter##4##3##(1996-1#3)(1996-6#1)
the DA##32##2##(1990-2#8)(1990-7#3)(1993-2#2)(1993-6#1)(1994-12#1)(1994-5#2)(1996-1#3)(1996-10#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-5#1)(2005-8#3)(2008-1#1)(2008-10#1)(2009-1#2)
the DAD1##2##2##(1997-9#1)(2009-8#1)
the DAFS##2##2##(2006-5#2)
the DAG##4##2##(1991-12#3)(2010-6#1)
the DAM##2##2##(1995-11#2)
the DAMGO-induced##2##2##(1995-12#1)(1997-5#1)
the DAPI complex##2##3##(1993-3#2)
the DAPI##4##2##(1992-3#1)(1993-3#3)
the DAS pump##2##3##(2006-7#2)
the DAS##5##2##(2004-8#2)(2006-7#2)(2007-10#1)
the DASH##2##2##(2008-9#1)(2010-2#1)
the DAT gene##2##3##(1995-11#2)
the DAT was##2##3##(1992-6#1)(1996-12#1)
the DAT##15##2##(1992-3#1)(1992-6#2)(1993-9#2)(1994-12#1)(1995-11#4)(1996-12#1)(1996-8#1)(1997-2#2)(2005-8#1)
the DAV##2##2##(2008-8#2)
the DAX-8 and XAD-8 resins##2##5##(2008-10#2)
the DAX-8##3##2##(2008-10#3)
the DBS##3##2##(2005-10#1)(2008-2#1)(2009-8#1)
the DBSQ ligand##2##3##(1996-2#2)
the DC##2##2##(2008-10#1)(2013-8#1)
the DCA##2##2##(1996-11#1)(2008-6#1)
the DCC##3##2##(1992-10#2)(2007-12#1)
the DCH and the phase of##2##6##(2008-2#2)
the DCT domain##3##3##(2008-2#3)
the DCT##7##2##(2008-2#7)
the DD##5##2##(2008-10#3)(2013-1#2)
the DD-FD-OCT##2##2##(2011-1#2)
the DDR##5##2##(2011-2#3)(2013-1#2)
the DDX13 gene##2##3##(1997-6#2)
the DE##3##2##(2008-6#1)(2009-12#1)(2010-12#1)
the DEA##3##2##(1996-12#2)(2007-7#1)
the DEB test to##2##4##(2008-4#2)
the DEB test##3##3##(2008-4#3)
the DEB##4##2##(2008-4#3)(2010-4#1)
the DEC model##2##3##(2010-6#2)
the DEF##2##2##(2007-10#1)(2008-11#1)
the DEHP##2##2##(2007-4#1)(2011-2#1)
the DEHPA##2##2##(1997-5#1)(2008-10#1)
the DEJ##3##2##(2008-5#1)(2010-10#2)
the DERO##2##2##(2007-11#2)
the DFB##3##2##(2004-2#1)(2008-3#2)
the DFG##2##2##(2012-12#1)(2012-2#1)
the DFHT##2##2##(2008-3#2)
the DFM##5##2##(2007-12#2)(2012-11#3)
the DFT##8##2##(2007-11#1)(2007-9#3)(2008-2#1)(2010-5#1)(2012-12#2)
the DFWM##2##2##(2007-12#2)
the DG##8##2##(1991-12#1)(1996-12#2)(2007-7#2)(2009-8#1)(2012-12#2)
the DGC##2##2##(2012-2#2)
the DGD##3##2##(2007-12#3)
the DGGE profiles##2##3##(2005-11#1)(2006-8#1)
the DGGE##3##2##(2005-11#1)(2006-8#1)(2011-12#1)
the DGN##6##2##(2012-2#6)
the DH gene##2##3##(2008-8#2)
the DH##4##2##(2008-10#2)(2008-8#2)
the DHA##5##2##(1991-9#1)(2008-5#1)(2013-8#3)
the DHFR##6##2##(1994-12#1)(1994-2#2)(1995-2#1)(1996-5#1)(2008-2#1)
the DHI##2##2##(2011-1#2)
the DHI-I##2##2##(2011-1#2)
the DHP##3##2##(1991-2#1)(1995-3#1)(2008-2#1)
the DI##3##2##(1995-11#1)(2008-10#1)(2008-3#1)
the DIAL system##2##3##(2008-2#1)(2008-3#1)
the DIAL##7##2##(2008-2#5)(2008-3#2)
the DIDS-binding 30-kDa protein##3##4##(2006-10#3)
the DII progress##2##3##(2008-10#2)
the DII##3##2##(2008-10#3)
the DIN 6800-2 protocol and##2##5##(2012-1#2)
the DIPD##2##2##(2008-10#2)
the DL##3##2##(2008-10#1)(2008-3#2)
the DLCA case##3##3##(2005-11#3)
the DLCA##4##2##(2005-11#4)
the DLPFC##3##2##(2006-9#1)(2008-10#2)
the DLQI##2##2##(2012-1#2)
the DLVO theory##3##3##(2005-11#2)(2013-1#1)
the DLVO##4##2##(2005-11#3)(2013-1#1)
the DM group##2##3##(2011-2#2)
the DM soliton##3##3##(2007-12#3)
the DM##6##2##(2004-9#1)(2007-12#3)(2011-2#2)
the DM-Allo group##2##3##(2011-2#2)
the DME##3##2##(2008-10#1)(2012-12#2)
the DMFT##2##2##(2008-9#2)
the DMI##2##2##(2008-10#2)
the DMN in##2##3##(2012-1#2)
the DMN is##2##3##(2012-1#2)
the DMN##7##2##(2012-1#5)(2013-8#2)
the DMP##4##2##(1997-6#4)
the DMP+##2##2##(1996-1#2)
the DMS task##9##3##(1991-3#5)(1993-2#4)
the DMSO##2##2##(2006-10#1)(2008-10#1)
the DNA IQ System##2##4##(2008-12#2)
the DNA and protein##2##4##(1994-2#1)(1995-4#1)
the DNA and##10##3##(1991-2#1)(1994-2#1)(1994-8#1)(1995-4#1)(1995-8#1)(1996-10#1)(1996-4#1)(1997-4#1)(2006-6#1)(2008-4#1)
the DNA at the##2##4##(1992-6#1)(1995-1#1)
the DNA at##4##3##(1992-6#1)(1992-9#1)(1993-3#1)(1995-1#1)
the DNA backbone##4##3##(1994-5#1)(1996-11#1)(2008-10#2)
the DNA binding activity of a##2##6##(1994-9#2)
the DNA binding activity of##3##5##(1994-9#2)(1997-7#1)
the DNA binding activity##4##4##(1994-9#2)(1997-7#1)(2008-7#1)
the DNA binding and##2##4##(1995-8#1)(1997-1#1)
the DNA binding domain of c-Myb##2##6##(1992-7#2)
the DNA binding domain of the##2##6##(1996-8#1)(1997-4#1)
the DNA binding domain of##8##5##(1990-11#1)(1990-8#1)(1992-7#2)(1995-2#1)(1995-6#1)(1996-8#1)(1997-4#1)
the DNA binding domain##10##4##(1990-11#1)(1990-8#1)(1992-7#3)(1994-11#1)(1995-2#1)(1995-6#1)(1996-8#1)(1997-4#1)
the DNA binding of##3##4##(1990-2#3)
the DNA binding properties of the##2##6##(1991-3#1)(1995-5#1)
the DNA binding properties of##5##5##(1991-3#1)(1993-6#1)(1994-9#1)(1995-5#1)(1996-3#1)
the DNA binding site for the##2##6##(1991-5#1)(1992-8#1)
the DNA binding site for##3##5##(1991-5#2)(1992-8#1)
the DNA binding site##5##4##(1990-11#1)(1991-5#2)(1992-8#1)(1995-10#1)
the DNA binding specificity of##2##5##(1995-5#2)
the DNA binding wing##2##4##(1997-7#2)
the DNA binding##41##3##(1990-11#2)(1990-2#3)(1990-8#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1992-7#3)(1992-8#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-9#3)(1995-10#1)(1995-2#1)(1995-5#3)(1995-6#1)(1995-8#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-4#2)(1997-7#3)(2008-2#2)(2008-7#1)(2012-12#1)(2012-2#1)
the DNA by##3##3##(1991-4#1)(1992-9#1)(2009-5#1)
the DNA chip##2##3##(2006-5#1)(2008-12#1)
the DNA cleavage##5##3##(1993-3#1)(1995-8#1)(1997-8#2)(2008-10#1)
the DNA concentration##4##3##(1991-5#1)(1997-8#1)(2008-10#1)(2008-11#1)
the DNA content##3##3##(1991-6#1)(1991-7#1)(2008-11#1)
the DNA damage checkpoint##3##4##(2007-9#1)(2008-11#1)(2013-1#1)
the DNA damage response (DDR)##2##5##(2011-2#1)(2013-1#1)
the DNA damage response##4##4##(2011-2#1)(2012-12#1)(2013-1#2)
the DNA damage##14##3##(1995-6#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-12#2)(2013-1#4)
the DNA damaging##2##3##(2008-7#1)(2010-2#1)
the DNA data##2##3##(1997-6#2)
the DNA double helix##5##4##(1990-2#1)(1992-6#1)(1995-1#1)(2008-10#1)(2008-11#1)
the DNA double##6##3##(1990-2#1)(1992-6#1)(1995-1#1)(1996-2#1)(2008-10#1)(2008-11#1)
the DNA elements and##2##4##(1995-1#1)(2008-11#1)
the DNA elements##3##3##(1990-9#1)(1995-1#1)(2008-11#1)
the DNA enzyme##2##3##(1997-4#2)
the DNA extraction##3##3##(2008-12#1)(2012-3#2)
the DNA fingerprint probe pSTL70##2##5##(2008-10#2)
the DNA fragment##9##3##(1990-1#1)(1990-3#1)(1992-1#1)(1993-5#1)(1995-2#1)(1996-11#1)(1997-6#1)(2008-4#2)
the DNA fragmentation##3##3##(1991-12#1)(1993-8#1)(2003-11#1)
the DNA fragments##7##3##(1995-3#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)
the DNA helix##3##3##(1994-5#1)(1995-1#1)(1996-2#1)
the DNA hybridization##3##3##(2008-10#3)
the DNA in a##2##4##(1995-3#1)(2007-10#1)
the DNA in##7##3##(1993-3#1)(1993-8#1)(1995-3#1)(1995-8#1)(1997-4#1)(2007-10#1)(2009-5#1)
the DNA insert##2##3##(1991-7#1)(1997-6#1)
the DNA is##7##3##(1990-9#1)(1992-2#1)(1993-11#1)(1994-6#1)(2006-8#1)(2008-2#1)(2008-4#1)
the DNA methylation##3##3##(1990-5#1)(2007-11#1)(2010-12#1)
the DNA microarray##6##3##(2006-5#1)(2008-10#1)(2008-7#1)(2012-3#3)
the DNA minor groove##3##4##(1995-10#1)(1997-1#1)(2008-7#1)
the DNA molecule##9##3##(1990-5#2)(2008-11#2)(2008-5#1)(2009-8#2)(2010-12#2)
the DNA molecules##3##3##(1995-8#1)(2008-2#1)(2008-7#1)
the DNA of interest##2##4##(2008-4#2)
the DNA of the##4##4##(1990-12#1)(1993-8#1)(2005-11#1)(2008-5#1)
the DNA of##17##3##(1990-12#1)(1991-5#1)(1991-7#1)(1993-11#1)(1993-8#1)(1994-7#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-7#1)(2005-11#1)(2008-10#1)(2008-4#2)(2008-5#1)(2013-1#2)
the DNA persistence length##2##4##(2006-10#2)
the DNA polymerase alpha##4##4##(1991-7#1)(1993-3#1)(1995-4#1)(1995-6#1)
the DNA polymerase delta##2##4##(1990-12#1)(1994-8#1)
the DNA polymerase##13##3##(1990-12#1)(1991-1#1)(1991-7#1)(1992-3#1)(1993-3#1)(1994-8#1)(1994-9#2)(1995-4#1)(1995-6#1)(1996-10#1)(1997-6#1)(2009-8#1)
the DNA polymerases##2##3##(1990-12#1)(2007-8#1)
the DNA primer site##2##4##(1991-10#2)
the DNA repair system##3##4##(2005-11#1)(2009-5#2)
the DNA repair##7##3##(1990-7#1)(1995-1#1)(1995-2#1)(2005-11#1)(2007-10#1)(2009-5#2)
the DNA replication##2##3##(1993-3#1)(1994-9#1)
the DNA samples##2##3##(1990-5#1)(2008-4#1)
the DNA sequence are##2##4##(1992-3#1)(2009-3#1)
the DNA sequence at the##2##5##(1993-3#1)(1996-5#1)
the DNA sequence of the##8##5##(1990-11#1)(1992-7#1)(1993-12#1)(1993-8#1)(1995-3#1)(1997-8#1)(2008-10#1)(2008-4#1)
the DNA sequence of##11##4##(1990-11#1)(1992-7#1)(1993-12#1)(1993-8#1)(1995-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-4#1)
the DNA sequence##26##3##(1990-11#1)(1991-1#1)(1991-4#1)(1992-3#1)(1992-7#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-8#2)(1995-3#1)(1996-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)
the DNA sequences of the##3##5##(2007-12#1)(2008-10#1)(2008-8#1)
the DNA sequences of##5##4##(1997-7#2)(2007-12#1)(2008-10#1)(2008-8#1)
the DNA sequences##10##3##(1993-6#1)(1994-3#1)(1997-7#2)(2007-12#1)(2008-10#3)(2008-8#1)(2008-9#1)
the DNA sequencing##2##3##(1994-12#1)(2012-2#1)
the DNA strand##2##3##(1993-11#1)(1995-8#1)
the DNA strands##4##3##(1993-3#1)(1995-8#1)(2008-5#1)(2009-5#1)
the DNA substrate##3##3##(1991-9#1)(1994-11#1)(1997-3#1)
the DNA surface##3##3##(1994-6#1)(1997-2#1)(1997-5#1)
the DNA synthesis##7##3##(1991-3#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#1)(1993-8#1)
the DNA target##2##3##(1994-3#1)(2008-10#1)
the DNA template##9##3##(1994-8#2)(1995-1#1)(1995-2#1)(1995-5#1)(1996-11#1)(2008-4#1)(2008-5#1)(2008-7#1)
the DNA to be##2##4##(1994-9#1)(2008-11#1)
the DNA to##3##3##(1993-3#1)(1994-9#1)(2008-11#1)
the DNA unwinding##2##3##(1993-3#1)(1995-3#1)
the DNA was##7##3##(1993-8#2)(1994-6#1)(1997-6#1)(2006-8#1)(2008-10#1)(2012-12#1)
the DNA which##2##3##(1994-8#1)(2008-10#1)
the DNA##441##2##(1990-1#1)(1990-11#4)(1990-12#4)(1990-2#5)(1990-3#2)(1990-5#5)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#3)(1991-10#2)(1991-12#1)(1991-2#5)(1991-3#2)(1991-4#3)(1991-5#5)(1991-6#2)(1991-7#4)(1991-9#2)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#4)(1992-4#1)(1992-6#6)(1992-7#5)(1992-8#1)(1992-9#2)(1993-11#6)(1993-12#1)(1993-2#1)(1993-3#13)(1993-5#1)(1993-6#3)(1993-8#8)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#5)(1994-5#2)(1994-6#4)(1994-7#1)(1994-8#9)(1994-9#10)(1995-1#9)(1995-10#2)(1995-11#1)(1995-2#8)(1995-3#6)(1995-4#2)(1995-5#6)(1995-6#7)(1995-8#10)(1996-10#5)(1996-11#3)(1996-2#3)(1996-3#1)(1996-4#3)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#3)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#8)(1997-5#2)(1997-6#7)(1997-7#7)(1997-8#8)(2003-11#1)(2005-11#5)(2005-8#1)(2006-10#9)(2006-12#1)(2006-2#1)(2006-5#3)(2006-6#1)(2006-8#3)(2007-10#3)(2007-11#4)(2007-12#1)(2007-3#1)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#30)(2008-11#12)(2008-12#6)(2008-2#7)(2008-3#1)(2008-4#17)(2008-5#6)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#3)(2009-10#1)(2009-3#1)(2009-5#5)(2009-8#3)(2010-12#5)(2010-2#1)(2010-4#2)(2010-5#2)(2011-2#2)(2012-12#4)(2012-2#7)(2012-3#5)(2013-1#6)
the DNA-A and DNA-B##2##4##(2008-10#2)
the DNA-A##3##2##(2008-10#3)
the DNA-B##2##2##(2008-10#2)
the DNA-DNA##2##2##(1995-11#1)(2005-11#1)
the DNA-binding activity of the##2##5##(1991-7#1)(1994-12#1)
the DNA-binding activity of##3##4##(1991-7#1)(1994-12#1)(2008-9#1)
the DNA-binding activity##4##3##(1991-7#1)(1994-12#1)(1994-9#1)(2008-9#1)
the DNA-binding domain of the##4##5##(1990-11#1)(1991-4#1)(1995-2#1)(1995-4#1)
the DNA-binding domain of##11##4##(1990-11#2)(1991-12#1)(1991-4#1)(1991-6#1)(1994-9#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-4#1)(1997-1#1)
the DNA-binding domain##19##3##(1990-11#3)(1991-12#1)(1991-4#1)(1991-6#2)(1993-11#1)(1993-12#1)(1993-3#1)(1994-9#1)(1995-2#1)(1995-4#1)(1995-8#2)(1996-4#3)(1997-1#1)
the DNA-binding domains##2##3##(1994-12#1)(2005-6#1)
the DNA-binding protein##2##3##(2008-2#2)
the DNA-binding specificity##2##3##(1992-4#2)
the DNA-binding##37##2##(1990-11#4)(1991-11#1)(1991-12#1)(1991-4#2)(1991-6#2)(1991-7#1)(1992-4#2)(1992-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#2)(1994-8#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-8#3)(1996-4#3)(1997-1#1)(2005-6#1)(2008-2#2)(2008-9#1)(2009-3#1)
the DNA-bound##2##2##(1995-1#1)(1997-6#1)
the DNA-dependent ATPase and##2##4##(1993-3#1)(1996-8#1)
the DNA-dependent protein kinase##2##4##(1997-4#2)
the DNA-dependent##4##2##(1993-3#1)(1996-8#1)(1997-4#2)
the DNA-directed##2##2##(1990-7#1)(2008-4#1)
the DNA-protein complex##2##3##(1992-11#1)(2008-4#1)
the DNA-protein##6##2##(1992-11#1)(1995-3#2)(1996-7#1)(2008-10#1)(2008-4#1)
the DNA/protein complex containing##2##4##(1994-9#2)
the DNA/protein##5##2##(1994-9#2)(1995-3#1)(1997-4#2)
the DNASER##2##2##(2006-5#2)
the DNAbeta molecules##2##3##(2008-10#2)
the DNAbeta##3##2##(2008-10#3)
the DNAzyme##2##2##(2008-10#2)
the DNB and NBM##2##4##(1993-3#2)
the DNB and##3##3##(1993-3#3)
the DNB##4##2##(1993-3#4)
the DNC diet##3##3##(2010-2#3)
the DNC##5##2##(2010-2#5)
the DNMTP-task##2##2##(1993-9#2)
the DNP initiative##2##3##(2012-2#2)
the DNP probe##2##3##(2007-9#2)
the DNP##7##2##(2007-9#2)(2012-11#1)(2012-2#4)
the DNPH-method and##2##3##(2010-4#2)
the DNPH-method##3##2##(2010-4#3)
the DNR##6##2##(1992-12#2)(1996-1#4)
the DNS##5##2##(2008-6#2)(2013-8#3)
the DNase I##3##3##(1990-5#2)(1994-12#1)
the DNase##6##2##(1990-5#2)(1990-7#1)(1991-8#1)(1991-9#1)(1994-12#1)
the DO##2##2##(1994-3#1)(2008-11#1)
the DOE##3##2##(2007-12#1)(2007-8#1)(2008-3#1)
the DOF##5##2##(2008-3#1)(2010-8#4)
the DOTS program##3##3##(1995-9#3)
the DOTS##4##2##(1995-9#3)(2013-7#1)
the DP method##2##3##(2008-2#2)
the DP##3##2##(2008-2#2)(2010-1#1)
the DPD signal##5##3##(2008-2#5)
the DPD##6##2##(2008-10#1)(2008-2#5)
the DPE's we designed##2##4##(2008-3#2)
the DPE's##3##2##(2007-12#1)(2008-3#2)
the DPH##3##2##(1990-2#1)(2006-10#1)(2008-9#1)
the DPH2 gene##3##3##(1993-9#3)
the DPH2##6##2##(1993-9#6)
the DPM##3##2##(2008-5#3)
the DPP##2##2##(2008-10#2)
the DPPC##4##2##(1993-3#1)(1995-10#1)(2005-11#1)(2006-10#1)
the DPPH assay##4##3##(2008-10#1)(2008-5#1)(2010-4#1)(2012-1#1)
the DPPH radical##2##3##(2007-1#1)(2010-2#1)
the DPPH##13##2##(2006-12#1)(2007-1#1)(2008-10#2)(2008-11#2)(2008-5#3)(2010-2#1)(2010-4#1)(2011-2#1)(2012-1#1)
the DQB1(*)0602##2##2##(1997-9#2)
the DR locus##3##3##(2008-7#3)
the DR##8##2##(1996-12#1)(2008-7#5)(2010-8#1)(2011-1#1)
the DR-CALUX((R)) measured##2##3##(2008-10#2)
the DR-CALUX((R))##3##2##(2008-10#3)
the DR1 site and##2##4##(2013-8#2)
the DR1 site##3##3##(2013-8#3)
the DR1##4##2##(1995-2#1)(2013-8#3)
the DRA##2##2##(2007-12#2)
the DRC of##2##3##(2008-11#2)
the DRC##6##2##(2007-8#2)(2008-11#4)
the DRD5##2##2##(1991-12#2)
the DRE was##2##3##(1996-11#2)
the DRE##7##2##(1993-11#2)(1996-11#5)
the DRE-AP-1##2##2##(1996-11#2)
the DRG##11##2##(1991-12#1)(1991-2#1)(1992-11#1)(1992-2#1)(1993-1#1)(1994-12#2)(1997-2#2)(2008-9#2)
the DRN##3##2##(1995-5#3)
the DRPLA gene##2##3##(1997-3#2)
the DRR206 promoter##3##3##(2008-10#3)
the DRUJ##6##2##(2006-3#2)(2008-9#3)(2012-2#1)
the DS##8##2##(1996-2#3)(1996-6#1)(2008-10#1)(2008-3#1)(2010-12#1)(2011-2#1)
the DSC##3##2##(1996-1#1)(2006-10#1)(2007-11#1)
the DSES##3##2##(2009-11#3)
the DSF##3##2##(2012-11#2)(2013-1#1)
the DSM##7##2##(1992-5#1)(1996-9#1)(2006-4#2)(2009-10#2)(2010-12#1)
the DSM-III-R##2##2##(1993-6#1)(1994-11#1)
the DSM-IV and##2##3##(2006-8#1)(2008-11#1)
the DSM-IV criteria for##2##4##(2007-7#1)(2010-2#1)
the DSM-IV criteria##5##3##(2007-10#1)(2007-7#1)(2010-2#1)(2011-2#2)
the DSM-IV##12##2##(2004-3#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2010-2#1)(2011-2#3)(2013-1#1)
the DSM-IV-TR##2##2##(2010-4#1)(2012-2#1)
the DSP##2##2##(2008-2#1)(2008-3#1)
the DSRU##2##2##(2008-11#2)
the DSS##3##2##(1995-11#3)
the DSTD##3##2##(2008-10#3)
the DT method##2##3##(2007-11#2)
the DT##4##2##(2007-11#2)(2011-1#2)
the DTD##2##2##(1995-1#2)
the DTH response##4##3##(1991-12#2)(2008-10#1)(2008-4#1)
the DTP##2##2##(1994-11#1)(2005-11#1)
the DU-PAN-2 antigen##2##3##(1997-7#2)
the DUF683 family##2##3##(2009-7#2)
the DVS##3##2##(2005-5#3)
the DWI abnormalities##2##3##(2007-10#2)
the DWI##4##2##(2007-10#4)
the DXR PKS##2##3##(1994-12#2)
the Dacron sheet##2##3##(2007-8#2)
the Dagua river estuary##2##4##(2008-5#2)
the Dagua##3##2##(2008-5#3)
the Dahihandi festival##2##3##(2013-1#2)
the Dahihandi##4##2##(2013-1#4)
the Daily Telegraph##2##3##(2007-9#2)
the Daily##4##2##(1996-2#1)(2007-9#2)(2009-11#1)
the Dana-Farber Cancer Institute##2##4##(2008-5#1)(2013-1#1)
the Dane County Drug Treatment Court##2##6##(2010-6#2)
the Danish Cancer Registry##3##4##(1990-12#1)(1993-8#1)(1997-7#1)
the Danish National##2##3##(1990-12#1)(1992-3#1)
the Danish Psychiatric Society##2##4##(1993-8#2)
the Danish SPF##2##3##(1992-5#2)
the Danish health care system##2##5##(1993-3#1)(1995-5#1)
the Danish population##2##3##(1990-4#1)(2013-7#1)
the Danish##27##2##(1990-12#3)(1990-4#2)(1991-9#1)(1992-3#2)(1992-5#2)(1992-8#1)(1993-3#3)(1993-8#3)(1994-6#1)(1995-5#2)(1995-7#1)(1997-3#1)(1997-7#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-7#1)
the Danube and##2##3##(2008-8#1)(2010-8#1)
the Danube##3##2##(2008-10#1)(2008-8#1)(2010-8#1)
the Darcy number##4##3##(2005-11#4)
the Darwinian concept##2##3##(1995-2#1)(2006-7#1)
the Darwinian##3##2##(1995-2#1)(2006-7#2)
the Data Protection##2##3##(1997-5#1)(2006-10#1)
the Data Usage Index (DUI)##2##5##(2012-3#2)
the Data##9##2##(1990-12#1)(1995-3#1)(1996-6#1)(1997-5#1)(2006-10#1)(2011-2#1)(2012-3#2)(2013-8#1)
the DeBakey##2##2##(2007-8#1)(2011-2#1)
the DeFord and Hume formalism##2##5##(2008-10#2)
the Deaf##3##2##(2011-2#3)
the Debye approximation##3##3##(2007-12#3)
the Debye length##3##3##(1997-6#2)(2005-11#1)
the Debye##6##2##(1997-6#2)(2005-11#1)(2007-12#3)
the Debye-Hückel equation##2##3##(2008-10#2)
the Debye-Hückel##3##2##(1994-11#1)(2008-10#2)
the December##5##2##(1995-12#1)(2005-7#2)(2009-8#1)(2011-2#1)
the Deficit##2##2##(1997-2#1)(2008-10#1)
the Deinobacter grandis##3##3##(2005-11#3)
the Delft University of Technology##2##5##(2006-6#1)(2008-2#1)
the Delirium##2##2##(2008-7#1)(2011-2#1)
the Delta##3##2##(1993-1#1)(1997-1#1)(2008-10#1)
the DeltassrA##3##2##(2006-11#3)
the Democratic##4##2##(2006-7#1)(2007-7#1)(2007-8#1)(2012-2#1)
the Demographic and Health Survey##3##5##(2006-4#2)(2012-12#1)
the Demographic##5##2##(2006-4#2)(2007-10#1)(2010-5#1)(2012-12#1)
the Dental School in##2##4##(2006-8#2)
the Dental##5##2##(1996-11#1)(2006-8#2)(2011-1#1)(2013-7#1)
the Department and Clinic of##2##5##(2007-11#1)(2008-9#1)
the Department and##3##3##(2007-11#1)(2008-9#2)
the Department for##4##3##(1991-12#1)(2007-2#1)(2008-10#1)(2010-9#1)
the Department of Agriculture##2##4##(2006-9#1)(2007-11#1)
the Department of Biochemistry##2##4##(2008-10#1)(2008-8#1)
the Department of Cardiovascular Surgery##2##5##(2007-8#1)(2012-2#1)
the Department of Child##2##4##(1997-8#1)(2006-10#1)
the Department of Clinical##2##4##(1991-5#1)(2005-10#1)
the Department of Correction's##2##4##(1997-5#2)
the Department of Defense (DOD)##2##5##(1995-6#1)(1996-5#1)
the Department of Defense##3##4##(1995-6#1)(1996-12#1)(1996-5#1)
the Department of Energy (DOE)##3##5##(2008-10#1)(2008-5#1)(2011-2#1)
the Department of Energy##6##4##(2007-9#2)(2008-10#1)(2008-5#1)(2011-2#2)
the Department of Family##2##4##(1994-7#1)(2010-11#1)
the Department of Forensic##3##4##(2009-4#2)(2011-2#1)
the Department of General##3##4##(2010-2#1)(2011-12#1)(2011-2#1)
the Department of Gynaecology##2##4##(1991-4#1)(1991-9#1)
the Department of Health and Human Services (DHHS)##2##8##(1996-5#1)(2006-8#1)
the Department of Health and Human Services##9##7##(1990-12#2)(1994-2#1)(1996-5#1)(2006-8#4)(2007-9#1)
the Department of Health and Human##10##6##(1990-12#2)(1994-2#1)(1996-5#1)(1997-3#1)(2006-8#4)(2007-9#1)
the Department of Health##19##4##(1990-12#2)(1991-2#1)(1992-1#1)(1994-2#1)(1996-5#1)(1997-3#1)(2005-9#1)(2006-8#4)(2007-2#1)(2007-9#1)(2008-2#1)(2008-9#1)(2011-2#2)(2013-8#1)
the Department of Infection Control and Prevention##2##7##(2010-6#2)
the Department of Internal Medicine##3##5##(1995-11#1)(2007-12#1)(2013-8#1)
the Department of Medical Microbiology##2##5##(2007-12#1)(2007-7#1)
the Department of Microbiology##3##4##(2011-1#1)(2013-1#1)(2013-8#1)
the Department of Nursing##2##4##(1992-2#1)(2008-11#1)
the Department of Obstetrics and Gynaecology##5##6##(1994-2#1)(1996-1#1)(2006-6#1)(2007-7#1)(2008-3#1)
the Department of Obstetrics and Gynecology##3##6##(1996-9#1)(2006-7#1)(2013-8#1)
the Department of Obstetrics and##8##5##(1994-2#1)(1996-1#1)(1996-9#1)(2006-6#1)(2006-7#1)(2007-7#1)(2008-3#1)(2013-8#1)
the Department of Oncology##3##4##(1993-3#2)(1995-5#1)
the Department of Oral and##2##5##(2008-9#1)(2013-1#1)
the Department of Orthopaedics and Traumatology##2##6##(2013-1#2)
the Department of Orthopedics##3##4##(2007-11#3)
the Department of Paediatric##3##4##(1993-1#1)(2012-12#2)
the Department of Paediatrics##3##4##(2005-12#1)(2008-11#1)(2009-5#1)
the Department of Pathology of the##2##6##(1990-4#1)(1993-1#1)
the Department of Pathology##12##4##(1990-4#1)(1991-9#1)(1993-1#1)(2006-10#1)(2006-7#1)(2008-4#1)(2008-5#1)(2009-5#1)(2012-2#1)(2013-7#1)(2013-8#2)
the Department of Pediatrics##3##4##(1991-6#1)(2009-5#1)(2012-2#1)
the Department of Radiation Oncology##2##5##(2008-10#1)(2008-6#1)
the Department of Surgery##7##4##(1991-9#1)(1992-3#2)(1992-8#1)(2006-6#1)(2007-7#1)(2011-1#1)
the Department of Veterans Affairs health care system##2##8##(1992-12#1)(2008-12#1)
the Department of Veterans Affairs##5##5##(1992-12#1)(1992-2#1)(1996-3#1)(2006-10#1)(2008-12#1)
the Department of the##3##4##(1992-12#1)(2007-8#1)(2008-9#1)
the Department of##192##3##(1990-10#2)(1990-12#2)(1990-2#1)(1990-4#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-1#3)(1992-12#2)(1992-2#2)(1992-3#2)(1992-8#1)(1993-1#2)(1993-3#3)(1993-5#1)(1994-1#1)(1994-2#2)(1994-6#1)(1994-7#1)(1995-1#1)(1995-11#2)(1995-5#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#1)(2005-1#1)(2005-10#2)(2005-12#1)(2005-5#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-4#1)(2006-6#2)(2006-7#2)(2006-8#6)(2006-9#1)(2007-11#6)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#3)(2007-7#5)(2007-8#5)(2007-9#5)(2008-10#9)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#3)(2009-4#2)(2009-5#3)(2010-11#1)(2010-2#3)(2010-6#2)(2011-1#3)(2011-12#1)(2011-2#10)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#10)(2013-7#2)(2013-8#9)
the Department##206##2##(1990-10#2)(1990-12#2)(1990-2#1)(1990-4#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-1#3)(1992-12#2)(1992-2#2)(1992-3#2)(1992-8#1)(1993-1#2)(1993-3#3)(1993-5#1)(1994-1#1)(1994-2#2)(1994-6#1)(1994-7#1)(1995-1#1)(1995-11#2)(1995-5#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#2)(2005-1#1)(2005-10#2)(2005-12#1)(2005-5#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-4#1)(2006-6#2)(2006-7#2)(2006-8#6)(2006-9#1)(2007-11#8)(2007-12#2)(2007-2#2)(2007-4#1)(2007-5#3)(2007-7#6)(2007-8#5)(2007-9#5)(2008-10#11)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#5)(2009-4#2)(2009-5#3)(2010-11#1)(2010-2#3)(2010-6#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#12)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#10)(2013-7#2)(2013-8#9)
the Department's##2##2##(1990-10#1)(1995-1#1)
the Departments of##3##3##(1991-9#1)(1996-12#1)(2007-7#1)
the Depression##3##2##(1991-2#1)(2007-12#1)(2007-7#1)
the Dermatology Life Quality Index (DLQI)##3##6##(2007-7#1)(2012-1#1)(2013-1#1)
the Dermatology Life Quality Index##4##5##(2007-7#1)(2012-1#1)(2012-12#1)(2013-1#1)
the Descartes##2##2##(2008-2#1)(2008-3#1)
the Design of##3##3##(2010-2#1)(2013-1#2)
the Desulfovibrio vulgaris##2##3##(1990-4#1)(1994-5#1)
the Detection##7##2##(1996-9#1)(2007-12#2)(2008-10#2)(2008-3#1)(2009-3#1)
the Development of the##2##4##(1997-6#1)(2006-11#1)
the Development of##12##3##(1994-7#1)(1997-6#1)(2006-11#1)(2007-3#1)(2008-10#3)(2009-12#1)(2010-11#1)(2010-7#1)(2011-1#1)(2012-2#1)
the Development##14##2##(1994-7#1)(1997-6#1)(2006-11#1)(2007-12#1)(2007-3#1)(2008-10#4)(2009-12#1)(2010-11#1)(2010-7#1)(2011-1#1)(2012-2#1)
the Developmental##2##2##(2008-4#1)(2012-12#1)
the Dfd##2##2##(1990-11#2)
the Diabetes##3##2##(2007-11#1)(2009-11#2)
the Diagnosis of##6##3##(2006-10#1)(2007-12#1)(2008-10#1)(2011-2#2)(2013-1#1)
the Diagnosis##11##2##(1992-10#1)(2004-3#1)(2006-10#2)(2006-9#1)(2007-12#1)(2008-10#1)(2010-8#1)(2011-2#2)(2013-1#1)
the Diagnostic Interview Schedule##2##4##(1990-12#1)(2010-4#1)
the Diagnostic Interview##3##3##(1990-12#1)(2008-11#1)(2010-4#1)
the Diagnostic and Statistical Manual of Mental Disorders##13##8##(1990-12#1)(2007-6#1)(2007-7#2)(2008-1#2)(2009-7#1)(2010-11#1)(2011-1#2)(2011-2#3)
the Diagnostic and Statistical Manual##14##5##(1990-12#1)(2007-6#1)(2007-7#2)(2008-1#2)(2009-7#1)(2010-11#1)(2011-1#2)(2011-2#4)
the Diagnostic##17##2##(1990-12#2)(2007-6#1)(2007-7#2)(2008-1#2)(2008-11#1)(2009-7#1)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#4)
the Dialock##2##2##(2007-7#2)
the Dialysis##3##2##(2007-12#2)(2007-7#1)
the Dictyostelium discoideum##2##3##(1995-8#2)
the Dictyostelium##4##2##(1993-6#1)(1994-12#1)(1995-8#2)
the Diels-Alder reaction of##3##4##(1996-5#2)(2007-11#1)
the Diels-Alder##6##2##(1996-5#5)(2007-11#1)
the Diet##2##2##(2005-5#1)(2010-4#1)
the Dietary Guidelines##2##3##(2009-7#1)(2012-2#1)
the Dif phenotype##2##3##(1995-2#2)
the Dimension##5##2##(2008-10#5)
the Directorate of Health in##2##5##(1993-5#1)(2006-8#1)
the Directorate of Health##5##4##(1990-10#1)(1990-5#1)(1993-5#1)(2006-10#1)(2006-8#1)
the Disc Unloader brace on##5##5##(2006-7#5)
the Disc Unloader brace##8##4##(2006-7#8)
the Disease##11##2##(2008-1#1)(2009-4#10)
the Diskus##5##2##(1996-2#5)
the District Court##2##3##(1991-10#1)(1996-12#1)
the District of Columbia##13##4##(1991-11#1)(1991-5#1)(1992-3#1)(1992-5#1)(1996-12#4)(1997-1#1)(1997-2#1)(1997-5#1)(2010-5#1)(2010-9#1)
the District of##15##3##(1991-11#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-5#1)(1995-9#1)(1996-12#4)(1997-1#1)(1997-2#1)(1997-5#1)(2010-5#1)(2010-9#1)
the District##20##2##(1991-10#1)(1991-11#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-10#1)(1995-9#1)(1996-12#5)(1997-1#1)(1997-2#1)(1997-5#1)(2007-7#1)(2008-7#1)(2010-5#1)(2010-9#1)
the Division of##9##3##(1991-12#2)(1991-6#1)(1995-6#1)(1996-3#2)(2005-11#1)(2008-8#2)
the Diyala River##2##3##(2013-1#2)
the Dizziness Handicap Inventory (DHI)##2##5##(2011-1#2)
the DnaA protein##2##3##(1995-1#2)
the DnaB helicase##2##3##(1991-12#2)
the DnaK##2##2##(1995-6#2)
the Do Not Resuscitate-Comfort Care##2##5##(2005-2#2)
the Dobson##2##2##(2008-3#2)
the Dominican Republic and##3##4##(2007-8#1)(2008-10#1)(2008-5#1)
the Dominican Republic in the##2##5##(2008-10#2)
the Dominican Republic##17##3##(2007-2#1)(2007-8#1)(2008-10#10)(2008-11#2)(2008-5#2)(2011-2#1)
the Donnan effect##5##3##(2011-2#4)(2013-8#1)
the Donnan membrane technique##2##4##(2007-8#2)
the Donnan##8##2##(2005-11#1)(2007-8#2)(2011-2#4)(2013-8#1)
the Dopamine##2##2##(2008-5#1)(2012-1#1)
the Doppler bandwidth in##2##4##(2007-11#1)(2008-3#1)
the Doppler bandwidth##3##3##(2007-11#2)(2008-3#1)
the Doppler effect##3##3##(2007-12#2)(2008-2#1)
the Doppler frequency##2##3##(2008-3#2)
the Doppler shift in the frequency##2##6##(2008-3#2)
the Doppler shift in the##3##5##(2008-2#1)(2008-3#2)
the Doppler shift##10##3##(2007-12#2)(2008-1#1)(2008-2#4)(2008-3#3)
the Doppler##30##2##(2006-10#1)(2007-11#4)(2007-12#6)(2008-1#2)(2008-2#5)(2008-3#11)(2011-1#1)
the Doppler-shifted##2##2##(2008-2#2)
the Dothideomycetes##2##2##(2010-3#1)(2011-1#1)
the Doto area##2##3##(2010-8#2)
the Doto##3##2##(2010-8#3)
the Down syndrome##4##3##(1996-2#2)(1997-2#1)(2008-11#1)
the Down's syndrome##2##3##(1996-5#1)(2008-7#1)
the Dr##2##2##(1996-7#1)(2008-10#1)
the Drosophila CNS##2##3##(1991-12#1)(2008-7#1)
the Drosophila Gld##2##3##(1994-3#2)
the Drosophila blastoderm embryo##2##4##(1991-11#2)
the Drosophila blastoderm##3##3##(1991-11#2)(1995-8#1)
the Drosophila eye##2##3##(2008-9#2)
the Drosophila gene encoding the TATA##2##6##(1990-6#2)
the Drosophila genome##3##3##(1990-11#1)(1993-6#1)(2008-10#1)
the Drosophila head##2##3##(1994-8#2)
the Drosophila homologue##2##3##(2007-12#1)(2012-12#1)
the Drosophila male germ line##2##5##(2009-3#2)
the Drosophila melanogaster gene##3##4##(1991-12#2)(1993-11#1)
the Drosophila melanogaster##14##3##(1991-12#2)(1993-11#1)(1993-2#2)(1993-4#2)(1993-6#2)(1994-12#1)(1994-8#1)(1995-2#1)(1997-6#1)(2012-12#1)
the Drosophila segment polarity gene hedgehog##2##6##(1993-12#1)(1994-12#1)
the Drosophila segment polarity gene##5##5##(1990-8#1)(1993-12#3)(1994-12#1)
the Drosophila segmentation gene##2##4##(1992-4#1)(1997-1#1)
the Drosophila system##2##3##(1994-8#1)(2008-10#1)
the Drosophila visual system##3##4##(2007-12#1)(2008-3#1)(2008-9#1)
the Drosophila##108##2##(1990-11#4)(1990-6#3)(1990-7#1)(1990-8#1)(1991-11#4)(1991-12#4)(1991-5#1)(1992-3#1)(1992-4#2)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-4#2)(1993-5#1)(1993-6#4)(1994-12#3)(1994-2#1)(1994-3#2)(1994-8#6)(1995-1#1)(1995-2#2)(1995-6#4)(1995-8#2)(1996-10#1)(1996-5#1)(1997-1#5)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#5)(1997-8#1)(2007-12#3)(2007-3#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#11)(2009-10#1)(2009-3#4)(2011-1#1)(2012-12#8)(2012-3#1)
the Drude model##3##3##(2008-2#1)(2008-3#2)
the Drug Enforcement Administration##2##4##(1996-11#1)(2006-8#1)
the Drug##6##2##(1991-3#1)(1996-11#1)(2006-8#1)(2008-11#1)(2013-1#1)(2013-7#1)
the DrugBank##2##2##(2008-4#2)
the Ds##2##2##(2008-10#1)(2012-3#1)
the Dubinin-Astakhov equation##2##3##(2005-11#2)
the Duffy blood group##2##4##(1993-4#1)(1996-6#1)
the Duffy##7##2##(1993-4#3)(1996-6#4)
the Dutch Society of Family##3##5##(1996-8#1)(1996-9#2)
the Dutch Society of##4##4##(1996-8#1)(1996-9#2)(2006-12#1)
the Dutch Society##5##3##(1996-8#1)(1996-9#3)(2006-12#1)
the Dutch TAD soils##2##4##(2008-10#2)
the Dutch variant##2##3##(1991-9#2)
the Dutch##30##2##(1991-5#1)(1991-9#2)(1992-10#1)(1992-6#1)(1994-12#1)(1994-5#1)(1996-8#1)(1996-9#3)(1997-8#1)(2004-2#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-2#2)(2009-8#1)(2013-8#1)
the Dynabeads##2##2##(1990-12#2)
the E and##2##3##(1990-5#1)(1995-10#1)
the E degrees' values##2##4##(1995-5#2)
the E receptor##2##3##(1995-10#1)(1995-11#1)
the E##104##2##(1990-10#1)(1990-11#6)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#3)(1991-10#1)(1991-2#1)(1991-3#1)(1991-4#7)(1991-5#1)(1991-8#1)(1991-9#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#3)(1994-2#2)(1994-7#1)(1994-9#2)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#2)(1995-8#2)(1996-1#1)(1996-12#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#4)(1997-8#1)(2005-11#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-9#3)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#2)
the E(2)##2##2##(1996-5#1)(2006-5#1)
the E(pa)##2##2##(2008-10#2)
the E-box##4##2##(1997-7#2)(2012-12#2)
the E-cadherin##3##2##(1995-1#1)(2008-7#1)(2009-3#1)
the E-cadherin-catenin##2##2##(1991-11#1)(1994-11#1)
the E-test##3##2##(2007-7#3)
the E1 alpha and E1 beta subunits of##2##8##(1990-10#1)(1990-7#1)
the E1 alpha subunit##3##4##(1990-10#2)(1990-7#1)
the E1 alpha##7##3##(1990-10#3)(1990-7#4)
the E1 beta subunit##3##4##(1990-10#1)(1991-2#1)(1994-8#1)
the E1 beta##4##3##(1990-10#1)(1991-2#1)(1994-8#1)(1995-1#1)
the E1 enzyme##2##3##(2008-5#1)(2008-9#1)
the E1 isozyme##3##3##(1991-8#3)
the E1 region##2##3##(1994-5#1)(1997-4#1)
the E1##21##2##(1990-10#4)(1990-3#1)(1990-7#5)(1991-2#1)(1991-8#3)(1994-5#1)(1994-8#1)(1995-1#1)(1997-4#1)(2008-5#1)(2008-9#2)
the E1A activation domain##3##4##(1994-3#3)
the E1A and E1B##2##4##(1993-2#1)(1994-2#1)
the E1A##9##2##(1991-12#1)(1993-2#1)(1994-2#1)(1994-3#4)(1997-4#1)(2008-11#1)
the E1A/E1B sequence##2##3##(2008-11#2)
the E1P##2##2##(1990-11#1)(1990-3#1)
the E2 conformation of##2##4##(1990-5#1)(1997-1#1)
the E2 conformation##3##3##(1990-5#1)(1997-1#2)
the E2 protein##2##3##(1990-5#1)(2008-10#1)
the E2 subunit##2##3##(1991-1#1)(1995-3#1)
the E2##21##2##(1990-3#1)(1990-5#2)(1991-1#4)(1991-2#1)(1991-8#1)(1992-6#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-1#2)(1997-2#1)(2008-10#4)(2010-12#1)
the E2F transcription factor##2##4##(1993-6#1)(1995-2#1)
the E2F##8##2##(1993-6#1)(1994-12#1)(1995-2#2)(2012-12#2)(2012-2#2)
the E4 isoform##2##3##(1996-2#1)(2012-12#1)
the E4##3##2##(1991-5#1)(1996-2#1)(2012-12#1)
the E5-1 gene##2##3##(1995-8#2)
the E5-1##3##2##(1995-8#3)
the E6 and E7##3##4##(1993-12#1)(1993-9#1)(2007-11#1)
the E6##5##2##(1993-12#2)(1993-9#1)(1997-4#1)(2007-11#1)
the E6-E7##3##2##(1992-9#1)(1993-9#2)
the E7##3##2##(1993-12#1)(1996-7#1)(2009-3#1)
the EA##2##2##(1995-2#1)(2008-10#1)
the EAA##2##2##(1991-6#2)
the EAAT4##3##2##(1997-7#3)
the EAE##2##2##(1991-12#1)(2010-12#1)
the EAP##5##2##(1992-10#2)(1995-6#2)(2012-12#1)
the EASE##4##2##(2008-11#4)
the EAT##2##2##(2007-7#1)(2013-8#1)
the EB##3##2##(2005-8#1)(2008-10#1)(2008-3#1)
the EB-PVD##3##2##(2009-7#3)
the EBCM##2##2##(2008-2#1)(2008-3#1)
the EBF2 expression levels##2##4##(2009-8#2)
the EBF2##4##2##(2009-8#4)
the EBID##2##2##(2009-11#2)
the EBL##5##2##(2008-11#1)(2008-12#1)(2008-3#2)(2009-2#1)
the EBV##10##2##(1990-5#1)(1994-8#1)(1995-2#2)(1997-3#1)(2008-5#3)(2008-8#1)(2011-2#1)
the EBs##2##2##(2008-11#2)
the EC Standards##2##3##(2008-10#2)
the EC and##2##3##(2009-10#1)(2012-2#1)
the EC##9##2##(1994-2#1)(2007-8#1)(2008-10#2)(2008-7#1)(2009-10#1)(2011-2#2)(2012-2#1)
the EC(50) values##2##3##(2008-10#1)(2008-11#1)
the EC(50)##3##2##(1996-2#1)(2008-10#1)(2008-11#1)
the EC1 antibody##2##3##(1990-5#2)
the EC3##3##2##(2008-10#3)
the EC50 for##3##3##(1991-1#1)(1994-3#1)(1996-12#1)
the EC50##8##2##(1990-5#1)(1991-1#1)(1993-11#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-12#1)
the ECA to##2##3##(2008-7#2)
the ECA##3##2##(1995-7#1)(2008-7#2)
the ECD##4##2##(1995-12#1)(1997-8#1)(2008-10#1)(2009-12#1)
the ECDs##2##2##(1997-8#2)
the ECG and##3##3##(2008-10#1)(2011-2#2)
the ECG exercise##2##3##(1992-3#1)(1996-3#1)
the ECG signal##2##3##(2011-1#1)(2013-1#1)
the ECG##24##2##(1990-3#2)(1991-3#1)(1991-5#1)(1992-1#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-8#1)(1994-6#1)(1995-8#2)(1996-3#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)
the ECHC##2##2##(1991-10#2)
the ECL intensity of##2##4##(2008-10#2)
the ECL intensity##3##3##(2008-10#3)
the ECL of##5##3##(2008-10#5)
the ECL##12##2##(2007-8#2)(2008-10#10)
the ECM##12##2##(1993-3#1)(1995-4#1)(2007-8#2)(2008-11#4)(2008-3#1)(2009-12#1)(2009-8#2)
the ECR##5##2##(1995-11#3)(2008-10#2)
the ECT##3##2##(1996-1#1)(2008-12#1)(2012-12#1)
the ED and##3##3##(2007-7#1)(2009-6#1)(2010-8#1)
the ED for##2##3##(2008-11#1)(2009-8#1)
the ED or##2##3##(1997-2#1)(2008-11#1)
the ED to##2##3##(2008-3#1)(2013-1#1)
the ED with##3##3##(2007-5#1)(2008-11#1)(2008-3#1)
the ED##59##2##(1997-2#3)(1997-8#1)(2004-12#1)(2004-5#1)(2007-11#1)(2007-3#2)(2007-4#1)(2007-5#3)(2007-7#7)(2008-11#5)(2008-3#7)(2009-6#3)(2009-8#4)(2009-9#1)(2010-8#2)(2011-12#1)(2012-2#2)(2013-1#14)
the ED(50)##4##2##(2008-10#2)(2008-11#2)
the ED50 for##2##3##(1992-3#1)(1994-12#1)
the ED50 values for##2##4##(1990-11#1)(1995-12#1)
the ED50 values##3##3##(1990-11#1)(1993-11#1)(1995-12#1)
the ED50##8##2##(1990-11#1)(1990-12#1)(1992-3#1)(1993-11#1)(1994-12#1)(1995-10#1)(1995-12#1)(1996-12#1)
the EDFA##4##2##(2008-2#4)
the EDI-2##2##2##(2006-7#2)
the EDL and##2##3##(1991-6#1)(2011-2#1)
the EDL##5##2##(1991-6#3)(1995-9#1)(2011-2#1)
the EDNRB##3##2##(1994-12#1)(1996-4#2)
the EDP was##2##3##(2008-7#2)
the EDP##9##2##(1994-6#2)(2008-7#7)
the EDTA##8##2##(1993-3#1)(2006-10#1)(2008-10#4)(2008-11#1)(2010-5#1)
the EDXRF##3##2##(2005-4#1)(2008-10#2)
the EEC MRL and##2##4##(2007-7#2)
the EEC##14##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(1992-9#1)(2006-10#2)(2007-7#2)
the EEG power##2##3##(2013-7#2)
the EEG spectrum##2##3##(1995-12#2)
the EEG##20##2##(1990-9#1)(1991-5#1)(1991-9#1)(1992-8#2)(1992-9#1)(1993-9#1)(1995-12#2)(1995-3#2)(1996-3#1)(2009-8#2)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-7#2)
the EEVC##2##2##(2006-11#2)
the EEZ##2##2##(2007-3#2)
the EF##5##2##(1993-9#1)(1994-3#1)(1994-8#1)(2008-10#2)
the EF-hand##6##2##(1991-12#2)(1992-11#1)(1995-6#1)(1997-7#1)(2011-1#1)
the EFG##2##2##(2007-12#2)
the EFS##2##2##(2008-10#1)(2008-5#1)
the EFS-evoked##5##2##(1997-4#2)(2008-2#3)
the EGF +61##2##3##(2011-2#2)
the EGF receptor with##2##4##(1996-11#1)(1997-6#1)
the EGF receptor##11##3##(1990-9#1)(1993-8#3)(1993-9#1)(1994-11#1)(1995-2#1)(1996-11#1)(1997-6#2)(2006-10#1)
the EGF signaling##2##3##(1996-8#1)(2007-12#1)
the EGF##19##2##(1990-4#1)(1990-9#1)(1993-8#3)(1993-9#1)(1994-11#1)(1995-2#1)(1995-3#2)(1996-11#1)(1996-8#1)(1997-6#2)(2006-10#1)(2007-12#1)(2008-4#1)(2011-2#2)
the EGF-R##8##2##(1992-9#1)(1994-8#1)(1995-1#2)(1995-6#1)(1996-8#2)(2008-1#1)
the EGFP expression##2##3##(2008-11#2)
the EGFP##6##2##(2006-12#1)(2008-11#5)
the EGFR gene##5##3##(1993-3#1)(2008-4#1)(2008-5#1)(2012-1#2)
the EGFR kinase domain##3##4##(2008-4#3)
the EGFR kinase##4##3##(1997-6#1)(2008-4#3)
the EGFR##21##2##(1990-9#1)(1993-3#1)(1993-8#1)(1996-5#4)(1997-6#1)(2008-4#4)(2008-5#2)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#2)(2013-7#1)(2013-8#1)
the EGL##4##2##(2010-12#4)
the EGL-30##2##2##(2007-12#2)
the EGTA##2##2##(1990-8#1)(1991-9#1)
the EH2##2##2##(1990-12#1)(1992-1#1)
the EHR value##2##3##(2010-8#2)
the EHR##8##2##(2010-8#2)(2013-1#6)
the EHV and##2##3##(2008-7#2)
the EI mass##2##3##(2013-7#2)
the EI##4##2##(2011-1#1)(2013-1#1)(2013-7#2)
the EIA##5##2##(1990-4#1)(1995-2#1)(1996-1#1)(2008-10#1)(2008-5#1)
the EIAs##2##2##(1992-12#1)(1993-2#1)
the EIIScr##2##2##(1990-10#2)
the EKF approach##2##3##(2008-2#1)(2008-3#1)
the ELBW children##3##3##(2006-7#3)
the ELBW group##3##3##(2006-7#3)
the ELBW##6##2##(2006-7#6)
the ELISA and GC/MS##3##4##(2008-10#1)(2011-1#2)
the ELISA and a commercial##2##5##(1992-4#1)(1995-4#1)
the ELISA and##10##3##(1992-4#1)(1992-5#3)(1992-7#1)(1995-4#1)(1997-3#1)(2008-10#1)(2011-1#2)
the ELISA method##6##3##(2007-8#1)(2008-10#4)(2008-7#1)
the ELISA technique##3##3##(2006-10#1)(2008-6#1)(2013-1#1)
the ELISA test##2##3##(1995-6#1)(1996-6#1)
the ELISA to detect##2##4##(2005-10#1)(2005-11#1)
the ELISA was##3##3##(1990-2#1)(1994-9#1)(2011-2#1)
the ELISA were##2##3##(1997-3#1)(2008-10#1)
the ELISA##61##2##(1990-12#1)(1990-2#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-5#5)(1992-7#1)(1994-3#1)(1994-9#1)(1995-2#2)(1995-4#1)(1995-6#1)(1996-6#1)(1997-3#4)(1997-4#1)(1997-7#4)(2005-10#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#1)(2007-8#2)(2008-10#10)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
the ELISA-based LDA##2##3##(1996-11#2)
the ELISA-based assays are##2##4##(2008-10#2)
the ELISA-based##4##2##(1996-11#2)(2008-10#2)
the ELISE##3##2##(2008-3#3)
the ELISPOT assay##4##3##(2008-4#4)
the ELISPOT##5##2##(2008-4#5)
the ELISPOT-based LDA##4##3##(1996-11#4)
the EM algorithm##3##3##(1995-4#1)(2008-2#1)(2008-8#1)
the EM sputum##2##3##(2013-1#2)
the EM##7##2##(1995-4#1)(2008-2#3)(2008-8#1)(2013-1#2)
the EMAS II##3##3##(2012-1#3)
the EMBL Outstation##2##3##(2006-5#2)
the EMBL##5##2##(1991-9#1)(1996-8#1)(1997-4#1)(2006-5#2)
the EMC test system of##2##5##(2012-3#2)
the EMC##3##2##(2012-3#3)
the EMEP##2##2##(2008-10#2)
the EMG pattern##2##3##(1993-12#2)
the EMG##6##2##(1993-12#2)(2005-1#1)(2008-9#1)(2010-2#1)(2013-1#1)
the EMR##5##2##(2008-4#1)(2008-6#1)(2011-2#1)(2013-1#2)
the EMS method##2##3##(1996-1#2)
the EMS-induced##2##2##(2008-4#2)
the EN 12341 standard##3##4##(2008-10#3)
the EN##7##2##(1990-2#1)(2007-8#1)(2008-10#3)(2008-11#2)
the ENDOSAFE-IPT kit##2##3##(2007-8#2)
the ENT##5##2##(1990-8#1)(1991-6#1)(1993-5#1)(2009-9#1)(2011-1#1)
the ENTO##3##2##(1994-3#3)
the ENase##2##2##(1990-4#1)(1990-9#1)
the ENs in this study determined their own scope of practice##2##11##(2007-10#2)
the ENs##3##2##(2007-10#3)
the EO##6##2##(2007-11#1)(2008-2#2)(2013-1#3)
the EOF modifier##2##3##(1996-5#2)
the EOF##6##2##(1996-5#2)(2005-12#1)(2007-8#2)(2008-10#1)
the EOPO##2##2##(2007-12#2)
the EORTC Data Center##2##4##(1991-7#1)(1994-3#1)
the EORTC##5##2##(1991-7#1)(1992-10#1)(1994-3#1)(2008-6#2)
the EP##4##2##(1992-5#1)(1994-12#1)(2008-10#1)(2013-8#1)
the EPA##4##2##(2007-8#1)(2008-10#1)(2008-2#1)(2010-8#1)
the EPCS substrate##2##3##(2011-2#2)
the EPD##2##2##(1997-4#1)(2009-10#1)
the EPIC##2##2##(1991-12#1)(2007-11#1)
the EPO##6##2##(2007-7#1)(2007-8#1)(2008-11#2)(2008-5#2)
the EPR signal##3##3##(1992-9#1)(1996-7#1)(1997-7#1)
the EPR spectra##4##3##(1992-9#1)(1993-11#1)(1994-11#1)(1996-7#1)
the EPR spectrum##6##3##(1990-3#2)(1992-3#1)(1993-11#1)(1997-4#2)
the EPR##17##2##(1990-3#2)(1992-3#1)(1992-9#2)(1993-11#2)(1994-11#1)(1994-12#1)(1996-7#2)(1997-4#2)(1997-7#1)(2007-3#1)(2008-10#1)(2010-4#1)
the EPS##3##2##(1994-7#2)(1997-8#1)
the EPSP##14##2##(1991-8#1)(1992-7#1)(1992-8#4)(1993-12#1)(1993-2#5)(1996-6#1)(2008-9#1)
the EPSPs##2##2##(1992-8#1)(2007-10#1)
the EPSR##2##2##(2008-2#2)
the EQ-5D and##3##3##(2008-6#2)(2009-11#1)
the EQ-5D health##2##3##(2009-11#1)(2011-2#1)
the EQ-5D in##2##3##(2008-6#1)(2008-7#1)
the EQ-5D##9##2##(2008-6#4)(2008-7#1)(2009-11#2)(2011-2#1)(2012-12#1)
the EQ-SD##2##2##(2007-6#2)
the EQCM##2##2##(2005-11#1)(2008-10#1)
the ER and the##2##4##(1996-2#1)(2008-2#1)
the ER and##8##3##(1990-12#1)(1991-6#1)(1996-11#1)(1996-2#1)(1997-6#1)(2008-2#1)(2009-2#1)(2011-2#1)
the ER form##2##3##(1993-6#1)(1997-6#1)
the ER gene##5##3##(1996-11#2)(1997-4#1)(1997-7#2)
the ER in##4##3##(1994-12#1)(1995-3#1)(1997-2#1)(2008-11#1)
the ER is##2##3##(1997-6#1)(2012-2#1)
the ER lumen##2##3##(1990-6#1)(1991-2#1)
the ER of##6##3##(1995-3#1)(1996-5#1)(1996-9#2)(1997-6#1)(2009-8#1)
the ER to##3##3##(2008-4#1)(2009-10#1)(2009-8#1)
the ER##85##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#2)(1990-7#1)(1991-2#2)(1991-6#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#3)(1993-8#1)(1994-11#1)(1994-12#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#2)(1996-11#3)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#2)(1996-9#3)(1997-1#3)(1997-2#1)(1997-4#1)(1997-6#5)(1997-7#2)(2008-11#7)(2008-2#1)(2008-4#2)(2008-8#4)(2009-10#1)(2009-2#3)(2009-8#3)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#3)(2013-1#1)
the ER-##2##2##(1992-4#1)(2009-10#1)
the ER-negative##2##2##(1993-9#1)(1996-8#1)
the ER-positive breast cancer##2##4##(1990-5#1)(1996-8#1)
the ER-positive breast##3##3##(1990-5#1)(1996-8#1)(1997-4#1)
the ER-positive##5##2##(1990-5#1)(1993-9#1)(1996-3#1)(1996-8#1)(1997-4#1)
the ERBB2##3##2##(1994-6#1)(1995-8#1)(2012-12#1)
the ERD2 gene##3##3##(1990-6#2)(1992-1#1)
the ERE##2##2##(1994-8#1)(1995-2#1)
the ERGO study (Erasmus Rotterdam Health and the Elderly)]##3##9##(1995-9#3)
the ERK##8##2##(1995-6#1)(1996-5#1)(2007-11#1)(2008-3#1)(2008-4#2)(2009-8#1)(2010-10#1)
the ERP##5##2##(2004-11#1)(2006-5#2)(2013-8#2)
the ERPs to targets presented at##2##6##(1996-6#2)
the ERPs to##4##3##(1996-1#1)(1996-6#3)
the ERPs##5##2##(1996-1#1)(1996-6#3)(2008-8#1)
the ES##5##2##(1995-2#1)(2008-8#2)(2012-2#2)
the ES-2 dummy##4##3##(2006-11#4)
the ES-2##6##2##(2006-11#6)
the ES-2re dummy##2##3##(2006-11#2)
the ES-2re##3##2##(2006-11#3)
the ESA##3##2##(2007-5#1)(2008-3#1)(2010-11#1)
the ESAS##4##2##(1994-2#2)(2008-7#2)
the ESB##2##2##(1992-4#2)
the ESC##3##2##(2010-10#1)(2010-2#1)(2013-1#1)
the ESCRT complex is also##2##5##(2013-1#2)
the ESCRT complex##3##3##(2013-1#3)
the ESEEM##3##2##(1996-7#3)
the ESI##2##2##(1997-8#1)(2011-2#1)
the ESLI appliqué##2##3##(2008-3#2)
the ESLI##4##2##(2008-3#3)(2008-8#1)
the ESR spectra of the##2##5##(1990-5#1)(2005-11#1)
the ESR spectra##3##3##(1990-5#1)(2005-11#1)(2008-10#1)
the ESR##10##2##(1990-12#1)(1990-5#3)(1997-6#1)(2005-11#1)(2008-10#3)(2012-2#1)
the ESRD patients##3##3##(2007-7#2)(2013-8#1)
the ESRD population is##2##4##(1991-3#2)
the ESRD##8##2##(1991-3#2)(1996-2#2)(2007-7#2)(2012-12#1)(2013-8#1)
the ESRF##14##2##(2006-4#4)(2006-5#10)
the ESS level of selfishness is##2##6##(2008-9#2)
the ESS##7##2##(2008-8#3)(2008-9#3)(2012-3#1)
the EST##4##2##(2006-12#1)(2008-7#1)(2008-9#1)(2010-4#1)
the ET##9##2##(1990-12#1)(1995-10#1)(1996-2#1)(2008-1#1)(2008-10#1)(2009-3#1)(2013-1#1)(2013-8#2)
the ET(A) and ET(B) receptors##2##5##(2008-1#2)
the ET-1##5##2##(1991-6#1)(1992-3#1)(1992-9#1)(1994-3#1)(1995-11#1)
the ET-3##2##2##(1990-10#1)(1990-2#1)
the ETA and ETB receptor subtypes##3##6##(1993-3#1)(1997-1#1)(1997-3#1)
the ETA and ETB receptors##2##5##(1994-5#1)(1995-10#1)
the ETA and ETB##5##4##(1993-3#1)(1994-5#1)(1995-10#1)(1997-1#1)(1997-3#1)
the ETA receptor##5##3##(1992-9#3)(1994-8#1)(1997-1#1)
the ETA##13##2##(1991-11#1)(1992-9#3)(1993-3#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-10#1)(1997-1#2)(1997-3#1)(2012-2#1)
the ETAAS##6##2##(2008-10#6)
the ETB receptor##5##3##(1992-6#1)(1994-12#1)(1994-5#1)(1995-10#1)(1997-1#1)
the ETB##8##2##(1991-7#1)(1992-6#2)(1994-12#1)(1994-3#1)(1994-5#1)(1995-10#1)(1997-1#1)
the ETI##3##2##(1995-11#1)(2008-5#2)
the ETS##4##2##(1994-10#2)(2008-6#2)
the ETV##2##2##(2008-10#2)
the EU race##2##3##(2008-10#2)
the EU##27##2##(2005-5#1)(2006-1#1)(2006-2#2)(2006-9#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-8#1)(2009-8#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
the EURACHEM Guide##2##3##(2008-10#2)
the EURACHEM##3##2##(2008-10#3)
the EURAMOS##2##2##(2010-3#2)
the EUS##3##2##(2005-1#1)(2006-10#1)(2013-1#1)
the EUV reflectance##2##3##(2008-3#2)
the EUV spectral region##2##4##(2008-3#2)
the EUV##12##2##(2007-11#1)(2008-3#11)
the EV71 strains##2##3##(2008-12#2)
the EV71##4##2##(2008-12#2)(2008-8#1)(2011-1#1)
the EVAR-1 trial criteria##2##4##(2012-2#2)
the EWS##2##2##(2008-6#2)
the EXAFS data##2##3##(1995-8#1)(2012-12#1)
the EXAFS spectra##2##3##(2005-4#1)(2006-5#1)
the EXAFS##7##2##(1994-8#1)(1995-8#1)(2005-4#2)(2006-5#2)(2012-12#1)
the Earl##2##2##(1996-6#1)(2008-10#1)
the Early Bird##2##3##(2007-2#2)
the Early Cretaceous##4##3##(2006-7#3)(2009-2#1)
the Early Detection##3##3##(2006-10#1)(2006-9#1)(2010-1#1)
the Early##23##2##(1993-12#1)(1993-4#2)(1995-11#1)(2006-10#1)(2006-7#3)(2006-9#1)(2007-2#2)(2008-10#3)(2008-5#2)(2009-2#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#2)
the Earth Observing System##2##4##(2008-3#2)
the Earth Summit##3##3##(2006-7#3)
the Earth and##2##3##(1997-5#1)(2008-10#1)
the Earth##27##2##(1993-7#1)(1994-6#1)(1996-4#1)(1997-5#4)(2006-10#1)(2006-7#4)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#10)(2011-2#1)
the Earth's atmosphere##6##3##(2008-11#1)(2008-2#1)(2008-3#4)
the Earth's surface##7##3##(2006-12#1)(2008-2#4)(2008-3#1)(2009-7#1)
the Earth's##25##2##(1992-1#3)(1995-8#1)(2006-12#2)(2006-7#1)(2008-11#1)(2008-2#7)(2008-3#9)(2009-7#1)
the Earth-atmosphere system##2##3##(2008-3#2)
the East African##3##3##(2007-6#1)(2007-7#1)(2008-10#1)
the East Asian region##3##4##(2008-8#3)
the East Asian##6##3##(2008-8#3)(2010-3#2)(2011-2#1)
the East China Sea##3##4##(2008-10#1)(2010-8#2)
the East and##2##3##(2005-11#1)(2011-2#1)
the East##27##2##(1993-4#1)(1993-5#1)(2005-11#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-3#2)(2010-8#3)(2011-2#4)
the Eastern Cooperative Oncology Group##2##5##(2008-6#2)
the Eastern Mediterranean##5##3##(2008-9#1)(2012-1#2)(2013-7#2)
the Eastern Province of Saudi Arabia##2##6##(2007-2#2)
the Eastern Province##3##3##(2006-12#1)(2007-2#2)
the Eastern Region of the##2##5##(2005-8#1)(2007-2#1)
the Eastern##26##2##(1995-4#1)(1996-9#1)(1997-5#2)(2005-8#1)(2006-12#1)(2007-2#3)(2007-5#1)(2007-7#2)(2008-10#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-1#3)(2013-7#4)
the Eating Attitudes Test##3##4##(2006-7#2)(2009-2#1)
the Eating Disorder##3##3##(2006-7#2)(2012-5#1)
the Eating##8##2##(2006-7#4)(2009-2#1)(2012-5#2)(2013-8#1)
the Ebro river basin##3##4##(2008-10#3)
the Ec##3##2##(1995-8#3)
the Echis time##2##3##(1990-11#2)
the Eckhaus and##2##3##(1995-2#1)(2007-11#1)
the EcoRV modification methyltransferase##2##4##(1995-8#2)
the EcoRV recognition site##2##4##(1995-1#2)
the EcoRV restriction endonuclease##2##4##(1995-1#1)(1995-8#1)
the EcoRV restriction##3##3##(1995-1#1)(1995-8#2)
the EcoRV##8##2##(1995-1#4)(1995-8#4)
the Economic Stabilization Program##2##4##(1994-12#2)
the Ecuadorian##5##2##(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)
the Edinburgh##6##2##(1995-11#1)(1995-6#1)(2008-7#2)(2013-1#1)(2013-8#1)
the Edinger-Westphal nucleus and##2##4##(1993-12#2)
the Edinger-Westphal nucleus##10##3##(1992-8#1)(1993-12#9)
the Editor and##2##3##(2005-7#2)
the Editor of##2##3##(2005-7#1)(2008-10#1)
the Editor##15##2##(2005-7#3)(2005-9#1)(2007-11#1)(2008-10#2)(2008-4#1)(2009-10#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
the Editor-in-Chief##2##2##(2008-5#1)(2013-1#1)
the Editorial Board##4##3##(2005-7#4)
the Editorial##5##2##(2005-7#4)(2010-7#1)
the Editors##2##2##(2008-8#1)(2010-5#1)
the Editors-in-Chief are retracting this article##2##6##(2008-10#2)
the Editors-in-Chief##5##2##(2008-10#5)
the Edmonton Symptom Assessment##2##4##(2008-7#2)
the Edmonton##4##2##(1995-4#1)(2008-7#2)(2010-11#1)
the EfPKS1##3##2##(2010-10#3)
the EfSTE12##3##2##(2010-10#3)
the Effect of##4##3##(2008-10#3)(2008-4#1)
the Effect##5##2##(2008-10#3)(2008-4#1)(2008-6#1)
the Effects of##6##3##(2008-10#4)(2008-11#1)(2010-7#1)
the Egyptian population##4##3##(2011-2#1)(2012-12#1)(2013-7#2)
the Egyptian##15##2##(2007-1#1)(2008-1#1)(2008-10#2)(2009-5#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-7#2)(2013-8#1)
the Ehrlich ascites tumour##2##4##(1990-5#2)
the Ehrlich##3##2##(1990-5#2)(2012-3#1)
the Eighth##6##2##(1991-1#1)(1996-11#1)(2005-5#1)(2008-9#1)(2010-3#1)(2010-6#1)
the Eimeria##2##2##(1997-6#1)(2008-5#1)
the El Niño##3##3##(2008-5#1)(2008-9#1)(2010-8#1)
the El Niño/Southern Oscillation##2##4##(2006-7#2)
the El##9##2##(1992-5#1)(1994-2#1)(2006-7#2)(2008-12#1)(2008-5#1)(2008-9#1)(2010-8#1)(2012-12#1)
the Elderly (PACE)##4##3##(1992-1#1)(1994-2#1)(1995-1#1)(2008-7#1)
the Elderly##15##2##(1990-10#1)(1992-1#1)(1992-4#1)(1994-2#1)(1995-1#1)(1996-9#1)(1997-3#2)(2008-4#1)(2008-7#1)(2009-7#1)(2012-12#1)(2012-3#2)(2013-1#1)
the Electronic Health Record (EHR)##4##5##(2013-1#4)
the Electronic Health Record##7##4##(2008-11#1)(2013-1#6)
the Electronic##8##2##(1997-7#1)(2008-11#1)(2013-1#6)
the Eleventh##2##2##(1994-1#1)(1995-6#1)
the Emergency Department (ED)##5##4##(2007-9#1)(2008-11#1)(2008-3#2)(2012-2#1)
the Emergency Department##20##3##(1991-12#1)(1997-2#1)(2006-8#1)(2007-9#1)(2008-11#1)(2008-3#4)(2009-10#1)(2009-6#2)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#1)
the Emergency Room##3##3##(2007-11#2)(2007-2#1)
the Emergency##29##2##(1991-12#1)(1992-6#1)(1994-6#1)(1997-2#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-9#2)(2008-11#1)(2008-3#4)(2009-10#1)(2009-6#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#1)
the Emory##2##2##(1995-3#1)(2007-4#1)
the Employee##2##2##(1991-6#1)(2012-3#1)
the Employers##2##2##(1994-12#1)(2007-8#1)
the End of Life##2##4##(1993-3#1)(2010-6#1)
the Endangered Species Act##2##4##(2006-7#2)
the Endocrinology##2##2##(1996-8#1)(2007-7#1)
the Endophytic##2##2##(2008-10#2)
the Endoscopy##2##2##(1993-6#1)(2007-3#1)
the Endotoxin Standard##3##3##(2007-8#3)
the English National Board##2##4##(2008-11#2)
the English language literature##2##4##(2006-10#1)(2009-5#1)
the English language##4##3##(2006-10#2)(2009-5#1)(2012-3#1)
the English literature##25##3##(2005-1#1)(2005-11#1)(2006-10#1)(2006-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-3#3)(2009-7#1)(2009-8#1)(2010-6#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
the English medical literature##3##4##(1996-6#1)(2010-6#2)
the English version of the##2##5##(2009-11#1)(2012-1#1)
the English##50##2##(1993-9#1)(1995-2#1)(1995-3#1)(1996-6#1)(2005-1#1)(2005-11#1)(2006-10#3)(2006-12#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#3)(2009-5#1)(2009-7#1)(2009-8#1)(2010-6#5)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
the English-language literature##5##3##(1992-2#1)(2006-10#1)(2007-10#1)(2012-12#2)
the Enneking##4##2##(2007-11#1)(2007-7#1)(2008-6#2)
the Enterobacteriaceae##5##2##(1997-2#1)(2006-10#1)(2008-4#1)(2011-1#2)
the Enterococcus genus##2##3##(1996-10#2)
the Enterococcus##3##2##(1996-10#2)(2010-8#1)
the Entity hierarchy is audited##2##5##(2013-1#2)
the Entity hierarchy##4##3##(2013-1#4)
the Entrez system##4##3##(2008-4#4)
the Environment##9##2##(1995-6#1)(2006-4#1)(2008-10#1)(2008-11#2)(2009-2#1)(2010-4#1)(2013-1#2)
the Environmental Protection Agency (EPA)##2##5##(1992-1#1)(2006-7#1)
the Environmental Protection Agency##3##4##(1992-1#1)(2006-7#1)(2008-2#1)
the Environmental Protection##4##3##(1992-1#1)(2006-7#1)(2008-2#1)(2010-9#1)
the Environmental Satellite##2##3##(2008-3#2)
the Environmental##10##2##(1992-1#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2010-8#1)(2010-9#1)(2011-1#1)
the Ephemeroptera##3##2##(2007-12#3)
the EpiAir Project]##4##3##(2010-9#4)
the EpiAir##6##2##(2010-9#6)
the Epidemic of##2##3##(2011-2#1)(2012-1#1)
the Epstein-Barr virus (EBV)##3##4##(1991-9#1)(1993-8#1)(1994-2#1)
the Epstein-Barr virus##10##3##(1991-7#1)(1991-9#1)(1993-4#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-2#1)(2006-12#1)(2007-12#1)(2011-2#1)
the Epstein-Barr-virus (EBV)##2##3##(1991-7#1)(1997-7#1)
the Epworth Sleepiness Scale (ESS)##2##5##(2007-2#1)(2012-3#1)
the Epworth Sleepiness Scale##3##4##(2007-2#1)(2008-8#1)(2012-3#1)
the Equal##2##2##(1990-5#1)(1995-9#1)
the Er##8##2##(1991-9#2)(2006-12#1)(2008-2#2)(2008-7#2)(2013-1#1)
the Er(3+)##2##2##(2007-12#1)(2008-3#1)
the Er-doped##2##2##(2007-12#2)
the ErbB-2##2##2##(1994-9#1)(1996-6#1)
the ErbB3 protein##2##3##(1995-3#2)
the Eremothecium##2##2##(2012-3#2)
the Erie County##2##3##(1991-10#1)(2007-11#1)
the Erwinia##3##2##(1992-5#1)(2008-10#1)(2010-11#1)
the EryA strains##2##3##(1990-5#2)
the Escherichia coli DNA##2##4##(1992-3#2)
the Escherichia coli F1-ATPase##2##4##(1994-10#2)
the Escherichia coli GroEL##2##4##(1990-1#1)(2006-8#1)
the Escherichia coli K-12##14##4##(1990-3#2)(1990-5#1)(1990-7#1)(1994-9#1)(1996-12#4)(1996-6#3)(1997-4#2)
the Escherichia coli and##3##4##(1991-5#1)(1997-1#1)(1997-2#1)
the Escherichia coli cell##2##4##(1996-10#1)(1997-1#1)
the Escherichia coli chaperonin GroEL##2##5##(1991-7#1)(1994-9#1)
the Escherichia coli chromosome##6##4##(1990-7#2)(1991-5#1)(1994-12#1)(1995-2#1)(1997-7#1)
the Escherichia coli lacZ beta-galactosidase##2##5##(1994-6#1)(1997-4#1)
the Escherichia coli lacZ gene##2##5##(1990-5#1)(1991-12#1)
the Escherichia coli lacZ##6##4##(1990-5#1)(1990-9#1)(1991-12#1)(1994-6#1)(1996-3#1)(1997-4#1)
the Escherichia coli metH gene##2##5##(1991-3#2)
the Escherichia coli protein##2##4##(1997-6#1)(1997-7#1)
the Escherichia coli ribosome##2##4##(1992-6#1)(1993-11#1)
the Escherichia coli##101##3##(1990-1#1)(1990-10#1)(1990-11#1)(1990-3#2)(1990-4#1)(1990-5#5)(1990-7#4)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#2)(1991-7#3)(1992-3#2)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-5#1)(1994-10#2)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#4)(1995-1#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#3)(1996-10#1)(1996-12#4)(1996-3#2)(1996-4#3)(1996-6#3)(1996-7#1)(1996-8#1)(1997-1#4)(1997-2#3)(1997-4#5)(1997-6#1)(1997-7#2)(1997-8#1)(2006-12#2)(2006-8#1)(2008-4#1)(2013-1#1)
the Estonian##3##2##(2006-8#2)(2012-12#1)
the Estrogen Receptor##2##3##(1997-7#1)(2013-1#1)
the Ethical##2##2##(1991-3#2)
the Ethics in Patient Referrals Act##2##6##(1991-1#1)(1996-3#1)
the Ethics##6##2##(1991-1#1)(1996-3#1)(2006-2#2)(2008-1#1)(2012-2#1)
the Etiology of##2##3##(2008-10#1)(2010-2#1)
the Etude##3##2##(2008-2#3)
the Eu##3##2##(2006-5#1)(2006-9#1)(2008-11#1)
the Eu(3+)##4##2##(2007-12#1)(2008-10#1)(2008-3#2)
the Eu(III)##7##2##(2008-10#7)
the Eu3+##2##2##(1995-2#1)(2008-3#1)
the Euclidean distance##2##3##(2008-3#1)(2010-7#1)
the Euclidean perimeter of the##2##5##(2008-6#2)
the Euclidean##6##2##(2007-12#1)(2008-3#1)(2008-6#2)(2010-7#1)(2011-2#1)
the Euglena##2##2##(1993-9#1)(2007-3#1)
the Euler formula##2##3##(2011-1#2)
the Euler##4##2##(2008-6#1)(2011-1#3)
the Eurasian badger##2##3##(2008-12#2)
the Eurasian group and##2##4##(2010-8#2)
the Eurasian##7##2##(2008-12#2)(2008-9#1)(2010-3#1)(2010-8#3)
the EuroQol##2##2##(2008-10#1)(2008-3#1)
the EuroSCORE##2##2##(2007-8#2)
the EuroSID-1 dummy##2##3##(2006-11#2)
the EuroSID-1##3##2##(2006-11#3)
the European (EU) race of Gremmeniella abietina##2##7##(2008-10#2)
the European Agency for the Evaluation of Medicinal Products##2##9##(2008-5#1)(2009-3#1)
the European Agency##3##3##(2008-5#1)(2008-8#1)(2009-3#1)
the European Association of##4##4##(2006-9#2)(2009-4#2)
the European Association##5##3##(1996-3#1)(2006-9#2)(2009-4#2)
the European Bioinformatics##2##3##(2008-4#1)(2008-7#1)
the European Brain Injury##2##4##(2007-10#1)(2008-9#1)
the European Carotid Surgery Trial##2##5##(2006-11#1)(2008-7#1)
the European Commission##7##3##(1996-1#1)(2008-10#6)
the European Community Respiratory Health Survey##3##6##(2006-10#2)(2006-8#1)
the European Community##11##3##(1990-9#1)(1993-2#1)(1994-5#1)(1994-6#1)(1995-7#1)(2006-10#2)(2006-8#1)(2007-1#1)(2008-10#2)
the European Economic##2##3##(1990-2#1)(2008-3#1)
the European Heart##2##3##(2005-8#1)(2013-1#1)
the European Institute of Oncology##2##5##(2007-7#1)(2011-1#1)
the European Medicines Agency (EMA)##2##5##(2012-12#1)(2012-3#1)
the European Medicines Agency for the##2##6##(2008-3#1)(2008-7#1)
the European Medicines Agency##6##4##(2008-3#1)(2008-7#1)(2012-12#2)(2012-3#1)(2013-1#1)
the European Medicines##7##3##(2008-3#1)(2008-7#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)
the European Organization for Research and Treatment of Cancer (EORTC)##2##10##(1994-3#1)(1997-6#1)
the European Organization for Research and Treatment of Cancer##3##9##(1994-3#1)(1997-6#1)(2005-4#1)
the European Pharmacopoeia (Ph##2##4##(2007-8#1)(2008-10#1)
the European Pharmacopoeia for##2##4##(2007-8#1)(2012-12#1)
the European Pharmacopoeia##11##3##(2007-8#7)(2008-10#2)(2008-5#1)(2012-12#1)
the European Race of Gremmeniella abietina##2##6##(2008-10#2)
the European Respiratory Society (ERS)##2##5##(2010-10#1)(2012-11#1)
the European Science Foundation##3##4##(2008-7#2)(2010-3#1)
the European Society for##2##4##(2008-10#1)(2013-1#1)
the European Society of Cardiology (ESC)##2##6##(2010-10#1)(2012-3#1)
the European Society of Cardiology##6##5##(2008-3#1)(2010-10#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
the European Society of Hypertension##2##5##(2011-2#2)
the European Society of Radiology (ESR)##3##6##(2012-2#3)
the European Society of Radiology##7##5##(2012-2#7)
the European Society of##21##4##(1992-10#1)(1993-12#1)(2008-3#1)(2008-6#1)(2008-7#3)(2010-10#1)(2010-12#1)(2011-2#2)(2012-2#7)(2012-3#1)(2013-1#1)(2013-8#1)
the European Society##23##3##(1992-10#1)(1993-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#3)(2010-10#1)(2010-12#1)(2011-2#2)(2012-2#7)(2012-3#1)(2013-1#2)(2013-8#1)
the European Space Agency (ESA)##3##5##(2007-9#2)(2008-3#1)
the European Space Agency project##2##5##(2008-2#1)(2008-3#1)
the European Space Agency##6##4##(2007-9#2)(2008-2#1)(2008-3#3)
the European Space##7##3##(2007-9#3)(2008-2#1)(2008-3#3)
the European Standard##2##3##(2007-7#1)(2008-10#1)
the European Synchrotron Radiation Facility##5##5##(2006-4#1)(2006-5#4)
the European Union (EU) and##3##5##(2006-2#1)(2007-8#1)(2010-9#1)
the European Union (EU)##5##4##(2006-2#1)(2007-8#1)(2010-10#1)(2010-9#1)(2013-8#1)
the European Union and##5##4##(2007-11#1)(2007-5#1)(2008-10#3)
the European Union##31##3##(1996-11#1)(1996-3#1)(1997-6#1)(1997-8#1)(2005-11#2)(2006-2#1)(2006-8#1)(2007-11#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-10#9)(2008-5#2)(2009-4#1)(2009-6#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-8#1)
the European Union's##2##3##(2007-9#1)(2008-10#1)
the European and American##2##4##(2006-10#1)(2012-3#1)
the European and##3##3##(2006-10#1)(2007-1#1)(2012-3#1)
the European classification criteria##2##4##(2006-10#2)
the European countries##2##3##(2006-10#1)(2010-4#1)
the European market##4##3##(2007-1#1)(2007-8#1)(2008-11#1)(2008-5#1)
the European particle physics laboratory##2##5##(2007-8#1)(2007-9#1)
the European particle physics##3##4##(2007-8#2)(2007-9#1)
the European population##2##3##(1993-1#1)(1997-6#1)
the European response##2##3##(2007-2#2)
the European##260##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-3#1)(1991-7#2)(1992-10#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-9#1)(1995-4#1)(1995-6#2)(1995-7#2)(1996-1#2)(1996-11#1)(1996-12#1)(1996-3#2)(1997-6#3)(1997-8#1)(2005-1#1)(2005-11#3)(2005-12#1)(2005-4#1)(2005-7#2)(2005-8#4)(2006-10#8)(2006-11#2)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#4)(2006-6#2)(2006-8#3)(2006-9#2)(2007-1#4)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#16)(2007-9#6)(2008-1#1)(2008-10#38)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#10)(2008-6#3)(2008-7#10)(2008-8#5)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#5)(2009-6#1)(2009-8#1)(2010-10#4)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#4)(2010-6#1)(2010-8#5)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#8)(2012-3#4)(2013-1#7)(2013-7#2)(2013-8#5)
the Euroscore##4##2##(2007-8#4)
the Eustachian tube##4##3##(1995-4#3)(1996-12#1)
the Eustachian##5##2##(1995-4#3)(1996-12#1)(2013-1#1)
the Evaluation and Management of##2##5##(2008-4#1)(2010-9#1)
the Evaluation and##4##3##(2008-4#1)(2010-9#1)(2011-12#1)(2011-2#1)
the Evaluation of##9##3##(2005-7#2)(2006-12#1)(2008-11#1)(2008-5#1)(2009-3#1)(2010-3#1)(2012-3#1)(2013-8#1)
the Evaluation##13##2##(2005-7#2)(2006-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-3#1)(2010-3#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
the Evidence##3##2##(2006-10#1)(2010-1#1)(2010-12#1)
the Evolutionary##2##2##(2009-8#1)(2011-2#1)
the Ewald summation##2##3##(1992-6#1)(2006-10#1)
the Ewald##4##2##(1992-6#2)(2006-10#1)(2012-2#1)
the Excimer-laser##2##2##(1991-9#2)
the Executive Branch##2##3##(2008-6#1)(2008-9#1)
the Executive Office Building##2##4##(1995-6#2)
the Executive##6##2##(1992-2#1)(1995-6#2)(1996-9#1)(2008-6#1)(2008-9#1)
the Exercise Dependence##2##3##(2006-7#1)(2008-12#1)
the Expanded Disability##2##3##(2006-12#1)(2008-11#1)
the Expectation Maximization algorithm##2##4##(1991-12#2)
the Experimental Lidar##2##3##(2008-3#2)
the Experimental##3##2##(2008-12#1)(2008-3#2)
the Expert Panel Report##6##4##(2005-7#4)(2006-12#2)
the Expert##8##2##(1994-3#1)(2005-7#4)(2006-12#2)(2008-10#1)
the Expression of##4##3##(2010-8#3)(2013-1#1)
the F protein cleavage site##2##5##(2007-6#1)(2008-5#1)
the F protein##4##3##(2007-6#1)(2008-5#3)
the F sex factor TraD protein##2##6##(1992-7#2)
the F##33##2##(1990-11#2)(1991-7#1)(1992-7#2)(1992-9#1)(2007-12#1)(2007-6#1)(2008-10#15)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-8#1)(2011-2#1)(2013-1#1)
the F(0)F(1) ATPase activity##2##4##(2005-12#2)
the F(1) generation##4##3##(2008-10#4)
the F(1) hybrid of##2##4##(2008-10#2)
the F(1) hybrid##3##3##(2008-10#2)(2008-9#1)
the F(1) hybrids##2##3##(2008-10#2)
the F(1)##18##2##(2008-10#15)(2008-9#1)(2009-9#1)(2012-11#1)
the F(2) and##3##3##(2008-10#3)
the F(2) generation and##2##4##(2008-10#2)
the F(2) generation##3##3##(2008-10#3)
the F(2) population##6##3##(2008-10#4)(2008-8#1)(2012-11#1)
the F(2)##14##2##(2008-10#12)(2008-8#1)(2012-11#1)
the F(3) and##3##3##(2008-10#3)
the F(3)##7##2##(2008-10#7)
the F(c)##2##2##(2005-11#1)(2008-1#1)
the F-actin content##3##3##(1994-6#2)(1997-1#1)
the F-actin##9##2##(1993-8#1)(1993-9#1)(1994-6#2)(1997-1#1)(2007-12#2)(2008-10#1)(2010-7#1)
the F-test##2##2##(2008-10#2)
the F0 sector##2##3##(1992-11#2)
the F0##6##2##(1992-11#3)(1995-3#1)(2013-8#2)
the F0F1##3##2##(1991-9#1)(1992-11#1)(1994-8#1)
the F1 and F2 populations##2##5##(2008-10#2)
the F1 and##3##3##(1996-3#1)(2008-10#2)
the F1 progeny##2##3##(1990-7#1)(2008-5#1)
the F1##15##2##(1990-7#1)(1991-10#1)(1991-5#1)(1995-3#1)(1996-3#1)(2005-8#1)(2008-10#3)(2008-12#1)(2008-5#3)(2011-2#1)(2013-8#1)
the F1021##2##2##(1997-7#2)
the F1Fo-ATPsynthase in##2##3##(2012-2#2)
the F2##5##2##(1991-12#1)(1992-4#1)(1994-8#1)(1996-12#1)(2007-6#1)
the F3 generation##2##3##(2008-12#2)
the F3##3##2##(2008-12#3)
the F3W##2##2##(2012-2#2)
the F9##3##2##(1993-8#3)
the FA##18##2##(1994-9#1)(1995-1#2)(2007-3#2)(2007-8#2)(2008-10#6)(2008-8#1)(2009-1#2)(2010-4#2)
the FAAS##2##2##(2008-10#2)
the FAB##6##2##(1991-2#1)(1992-10#1)(1992-6#1)(2007-12#1)(2008-2#1)(2013-8#1)
the FAD cofactor##2##3##(1990-12#1)(1992-1#1)
the FAD##4##2##(1990-12#1)(1990-7#1)(1992-1#1)(1997-5#1)
the FAM##2##2##(1990-2#1)(2008-10#1)
the FAME##2##2##(2008-10#1)(2009-8#1)
the FAO/WHO Codex##2##3##(2012-12#2)
the FAO/WHO##3##2##(2007-7#1)(2012-12#2)
the FAS and CTLA-4 genes##2##5##(2009-8#2)
the FAS promoter##2##3##(1992-1#2)
the FAS##6##2##(1992-1#2)(1997-5#1)(2009-8#2)(2009-9#1)
the FASTA##3##2##(1994-9#1)(2008-4#2)
the FB##4##2##(2007-8#1)(2012-12#1)(2012-2#2)
the FBI##5##2##(1992-12#4)(1993-2#1)
the FBN1 gene##8##3##(1996-3#4)(2008-4#1)(2012-2#3)
the FBR##3##2##(2008-6#1)(2009-11#2)
the FC bacteria##2##3##(2005-11#2)
the FC##7##2##(1994-10#2)(2005-11#2)(2008-3#1)(2009-4#1)(2013-1#1)
the FCO##3##2##(2008-7#3)
the FCR##2##2##(2007-3#1)(2010-12#1)
the FCTC##3##2##(2009-12#3)
the FCU##3##2##(2013-7#3)
the FD data are##2##4##(2008-3#2)
the FD##4##2##(2008-10#1)(2008-3#2)(2008-7#1)
the FDA and##2##3##(2008-1#1)(2013-8#1)
the FDA as##3##3##(2005-7#1)(2007-5#1)(2008-5#1)
the FDA for the treatment of##2##6##(2008-1#1)(2008-5#1)
the FDA for##8##3##(2005-7#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-3#1)(2012-12#1)
the FDA in##3##3##(2005-7#1)(2005-9#1)(2008-1#1)
the FDA issued##2##3##(2008-9#1)(2013-8#1)
the FDA##52##2##(1991-1#1)(1994-12#1)(1994-2#1)(1997-4#1)(2005-6#3)(2005-7#5)(2005-8#6)(2005-9#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#1)(2008-1#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-6#1)(2010-12#1)(2010-9#1)(2012-12#5)(2012-3#1)(2013-1#4)(2013-8#2)
the FDA's warning##2##3##(2013-8#2)
the FDA's##5##2##(1997-5#1)(2008-5#1)(2012-12#1)(2013-8#2)
the FDC##2##2##(2004-4#1)(2009-9#1)
the FDC-P2##2##2##(1991-12#1)(1997-7#1)
the FDPM##3##2##(2008-3#3)
the FDTD method is##2##4##(2008-3#2)
the FDTD method##3##3##(2008-3#3)
the FDTD##8##2##(2007-11#1)(2008-3#7)
the FE##2##2##(2007-4#2)
the FEAT protein##2##3##(2012-2#2)
the FED##2##2##(1996-12#2)
the FEF##2##2##(1993-2#1)(2010-5#1)
the FEFs##2##2##(1995-1#2)
the FES##5##2##(2008-2#3)(2012-1#2)
the FEV1##2##2##(2008-7#1)(2009-6#1)
the FFA##5##2##(2007-8#1)(2008-1#1)(2008-12#1)(2008-5#1)(2013-8#1)
the FFF##2##2##(1991-8#1)(2008-10#1)
the FFT##4##2##(1996-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
the FG##4##2##(1993-12#1)(2008-9#2)(2012-2#1)
the FGF family##4##3##(1993-6#1)(1994-11#1)(1997-7#1)(2008-1#1)
the FGF receptor##3##3##(1993-6#1)(2012-3#2)
the FGF##13##2##(1993-6#3)(1994-11#1)(1995-1#1)(1997-7#1)(2008-1#1)(2012-12#1)(2012-3#5)
the FGF-2##2##2##(1996-12#1)(1997-4#1)
the FGF1 mRNA 1##2##4##(1996-2#2)
the FGF1 mRNA##3##3##(1996-2#3)
the FH##2##2##(1992-12#1)(2007-10#1)
the FHB##2##2##(2008-10#2)
the FHG22 mRNA levels##3##4##(1996-11#3)
the FHG22 mRNA##5##3##(1996-11#5)
the FHG22##6##2##(1996-11#6)
the FHIT gene##2##3##(2009-5#1)(2011-2#1)
the FHL protein family##2##4##(2008-5#1)(2012-3#1)
the FHL##6##2##(2008-5#3)(2009-10#2)(2012-3#1)
the FHR##3##2##(2011-1#3)
the FI system##5##3##(2008-10#5)
the FI##10##2##(2008-10#10)
the FIA method##2##3##(2008-10#2)
the FIA system and##3##4##(2008-10#3)
the FIA system##8##3##(2008-10#8)
the FIA##18##2##(1995-3#1)(2008-10#17)
the FIE##2##2##(2007-8#2)
the FIELD study##2##3##(2009-11#2)
the FIELD##3##2##(2009-11#3)
the FIM##2##2##(2007-10#1)(2007-9#1)
the FISH technique##2##3##(2008-11#1)(2010-12#1)
the FISH##5##2##(1996-3#1)(1996-8#1)(2008-11#1)(2008-9#1)(2010-12#1)
the FITC-ConA##2##2##(2006-5#2)
the FKBPs##2##2##(2008-7#2)
the FKNMS by##2##3##(2007-5#2)
the FKNMS##4##2##(2007-5#4)
the FKRP gene##2##3##(2008-7#2)
the FLACC##3##2##(2012-2#3)
the FLAIR model##2##3##(2008-10#2)
the FLC##5##2##(2008-2#5)
the FLI1 antibody##2##3##(2008-6#2)
the FLIPR##4##2##(2005-8#1)(2008-10#3)
the FLO1 gene##6##3##(1995-4#4)(1995-6#1)(1997-6#1)
the FLO5 gene##2##3##(1995-6#2)
the FLT3##2##2##(2008-5#1)(2012-12#1)
the FM##2##2##(2007-12#1)(2008-3#1)
the FMD##2##2##(2005-5#1)(2009-2#1)
the FMLP receptor##4##3##(1994-3#4)
the FMN##2##2##(1992-12#1)(1994-8#1)
the FMO##2##2##(2006-10#1)(2010-2#1)
the FMR1##3##2##(2006-12#1)(2009-5#2)
the FMS##2##2##(2011-2#2)
the FMSS##2##2##(1996-3#1)(1997-8#1)
the FN##2##2##(1991-6#1)(2010-4#1)
the FNAC showed benign pathology##2##5##(2012-12#2)
the FNN controller##3##3##(2008-2#3)
the FNR protein##3##3##(1992-3#2)(1994-2#1)
the FNR##5##2##(1992-3#3)(1994-2#1)(1995-2#1)
the FOAD-hypothesis##3##2##(2013-1#3)
the FOB##4##2##(2008-9#4)
the FOCS##2##2##(2008-3#2)
the FOITS##3##2##(2008-5#3)
the FOV##2##2##(2008-3#2)
the FP##2##2##(2008-3#1)(2009-2#1)
the FPGA##3##2##(2008-2#1)(2009-6#1)(2013-7#1)
the FPI transmission comb##2##4##(2008-3#2)
the FPI##4##2##(2008-2#1)(2008-3#3)
the FPI's free spectral range##2##5##(2008-3#2)
the FPP##2##2##(1990-2#1)(1993-3#1)
the FRET efficiency##2##3##(2009-8#2)
the FRET##7##2##(2007-9#1)(2008-4#1)(2008-9#2)(2009-8#2)(2009-9#1)
the FRFT##2##2##(2008-1#2)
the FROC##2##2##(2012-3#2)
the FROG##2##2##(2008-3#2)
the FRS##3##2##(2011-1#3)
the FRT##5##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
the FRVPNs##2##2##(2009-3#2)
the FS##10##2##(1990-11#1)(1991-12#2)(2005-11#1)(2011-2#3)(2012-12#2)(2013-8#1)
the FSH receptor##2##3##(1995-11#1)(2010-8#1)
the FSH##4##2##(1992-4#1)(1993-12#1)(1995-11#1)(2010-8#1)
the FSMD##3##2##(2008-10#3)
the FSW##2##2##(2012-3#2)
the FSWs##4##2##(2010-8#1)(2011-12#2)(2012-3#1)
the FT##4##2##(1991-11#2)(2008-7#1)(2012-2#1)
the FT-IR method##2##3##(2006-12#1)(2008-10#1)
the FT-IR spectra of##2##4##(2007-12#1)(2008-10#1)
the FT-IR spectra##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
the FT-IR##10##2##(2006-12#2)(2007-12#1)(2008-10#4)(2008-2#2)(2008-5#1)
the FT-Raman##3##2##(1996-2#1)(2007-11#1)(2008-10#1)
the FTIR spectra##4##3##(2008-10#3)(2013-8#1)
the FTIR##13##2##(1991-10#1)(1991-2#1)(2005-4#1)(2007-8#1)(2008-10#7)(2008-3#1)(2013-8#1)
the FVIII gene##3##3##(2012-12#1)(2012-2#2)
the FWER##2##2##(2009-9#1)(2012-3#1)
the FWHM of the##3##4##(2008-1#2)(2008-3#1)
the FWHM##6##2##(2007-11#1)(2007-12#1)(2008-1#2)(2008-3#1)(2010-2#1)
the FY##2##2##(1992-12#1)(1994-1#1)
the Fab and exhibited a rotational correlation time (theta##2##9##(1995-5#2)
the Fab and##3##3##(1990-6#1)(1995-5#2)
the Fab with##2##3##(1995-5#2)
the Fab##8##2##(1990-6#1)(1993-6#1)(1995-5#6)
the Fab'-LDM inhibited the##2##4##(2012-3#2)
the Fabry-Perot interferometer##3##3##(2008-2#1)(2008-3#2)
the Fabry-Perot##16##2##(2007-11#2)(2007-12#3)(2008-1#1)(2008-2#3)(2008-3#5)(2013-8#2)
the Face##5##2##(2007-12#1)(2009-4#2)(2010-1#2)
the Factor##2##2##(2008-5#1)(2012-12#1)
the Facts##2##2##(2007-2#1)(2010-10#1)
the Facultad de##2##3##(2007-3#1)(2008-5#1)
the Faculty of Dentistry at##3##5##(2011-2#2)(2012-2#1)
the Faculty of Medicine in##2##5##(2010-1#1)(2010-12#1)
the Faculty of Medicine of the##3##6##(1994-2#1)(2009-7#1)(2011-2#1)
the Faculty of Medicine of##4##5##(1994-2#1)(2007-5#1)(2009-7#1)(2011-2#1)
the Faculty of Medicine##9##4##(1994-2#1)(2007-11#1)(2007-5#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-2#2)
the Faculty of##17##3##(1994-2#1)(1996-12#1)(2006-10#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-12#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#1)
the Faculty##18##2##(1994-2#1)(1996-12#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-12#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#1)
the Fagerström Test for Nicotine Dependence (FTND)##2##7##(2008-8#1)(2013-1#1)
the Fair##3##2##(1995-12#1)(1996-6#1)(1997-5#1)
the False##3##2##(2007-7#1)(2008-11#1)(2012-2#1)
the Family Court##2##3##(2006-10#1)(2006-4#1)
the Family Health Program##6##4##(2008-9#6)
the Family Health Strategy##6##4##(2011-2#2)(2012-12#4)
the Family Health##14##3##(2008-9#7)(2011-1#1)(2011-2#2)(2012-12#4)
the Family Life and HIV Education Curriculum##2##7##(2010-8#2)
the Family Life##3##3##(2009-12#1)(2010-8#2)
the Family and##2##3##(1994-3#1)(2006-4#1)
the Family##37##2##(1994-3#1)(1997-1#1)(1997-5#1)(1997-6#1)(2004-3#1)(2006-10#1)(2006-4#2)(2006-8#1)(2008-10#4)(2008-2#2)(2008-6#1)(2008-9#9)(2009-12#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#4)(2013-8#1)
the Fanconi Syndrome##2##3##(2008-1#2)
the Fano factor can##2##4##(2010-10#2)
the Fano factor##3##3##(2010-10#3)
the Far East##5##3##(2007-11#1)(2007-9#1)(2008-5#1)(2010-8#1)(2013-1#1)
the Far##7##2##(2007-11#1)(2007-9#1)(2008-3#1)(2008-5#1)(2010-8#1)(2013-1#2)
the Faraday effect##4##3##(2008-1#1)(2008-2#1)(2008-3#2)
the Faraday##7##2##(1993-5#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#2)
the Faroe Islands##2##3##(1996-12#1)(2011-4#1)
the Faroe##3##2##(1996-12#1)(1996-6#1)(2011-4#1)
the Faroes and Denmark##2##4##(1994-2#2)
the Farr assay##2##3##(1994-3#2)
the Fas##3##2##(1995-8#1)(2003-11#1)(2010-3#1)
the Fas/Fas ligand system##2##4##(2006-11#1)(2008-8#1)
the Fas/Fas ligand##3##3##(2006-11#1)(2008-8#1)(2009-9#1)
the Fas/FasL interaction##2##3##(2009-9#2)
the Fas/FasL system in##2##4##(2009-9#1)(2012-2#1)
the Fas/FasL##5##2##(2009-9#3)(2010-3#1)(2012-2#1)
the Fast##3##2##(2007-9#2)(2009-12#1)
the Fc portion of##5##4##(1990-12#1)(1990-6#1)(2008-4#2)(2012-2#1)
the Fc##18##2##(1990-12#4)(1990-6#1)(1990-7#1)(1991-8#3)(1996-11#2)(2007-11#1)(2008-11#2)(2008-4#2)(2009-2#1)(2012-2#1)
the Fc-binding##2##2##(1997-4#1)(2008-10#1)
the FcepsilonRI##4##2##(1996-5#1)(2004-12#1)(2008-11#2)
the Fd##3##2##(1992-12#1)(1993-6#2)
the Fe##12##2##(1991-10#1)(1995-8#2)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-11#1)(2010-5#1)
the Fe(II)##6##2##(1991-8#1)(2007-12#1)(2008-10#3)(2008-5#1)
the Fe(III)##4##2##(1993-3#1)(1997-7#1)(2008-10#2)
the Fe3+##2##2##(1991-5#1)(1997-7#1)
the Fear of##2##3##(2012-1#1)(2012-2#1)
the Feature##2##2##(2008-2#1)(2010-8#1)
the Federal Court##2##3##(2010-12#2)
the Federal Government through##2##4##(1995-3#1)(1996-1#1)
the Federal Government##7##3##(1995-3#1)(1996-1#2)(1997-2#1)(2008-11#1)(2008-6#2)
the Federal Republic of Germany##7##5##(1990-12#1)(1991-10#1)(1991-12#1)(1991-2#1)(1992-1#2)(1995-1#1)
the Federal Republic of##9##4##(1990-12#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#2)(1993-10#1)(1995-1#1)
the Federal Republic##10##3##(1990-12#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#3)(1993-10#1)(1995-1#1)
the Federal Trade Commission##2##4##(1993-1#2)
the Federal University of##3##4##(1993-6#1)(2011-2#1)(2013-8#1)
the Federal government##4##3##(1995-12#1)(1996-12#1)(1996-6#1)(1997-5#1)
the Federal##50##2##(1990-12#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#5)(1992-12#1)(1993-1#2)(1993-10#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-1#2)(1996-12#2)(1996-6#1)(1997-2#2)(1997-5#2)(2005-9#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#3)(2010-12#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
the Federation of##2##3##(1994-7#1)(2013-7#1)
the Federation##3##2##(1994-7#1)(2013-7#2)
the Feiring##2##2##(1994-11#2)
the Feldenkrais method##2##3##(2010-6#2)
the Fellowship##2##2##(1996-1#1)(1996-12#1)
the Female##2##2##(2008-10#1)(2008-7#1)
the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study##2##10##(2009-11#2)
the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD)##4##9##(2009-11#4)
the Fenton reaction##3##3##(1997-8#1)(2008-10#1)(2008-5#1)
the Fermi level##7##3##(1991-6#2)(2008-10#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-7#1)
the Fermi##11##2##(1991-6#2)(2008-10#3)(2008-3#1)(2008-7#2)(2009-2#1)(2010-7#1)(2011-1#1)
the Ferric Reducing Antioxidant Power (FRAP)##2##6##(2013-8#2)
the Ferrier rearrangement##3##3##(2007-11#3)
the Fertile Crescent##3##3##(2008-10#3)
the Fertility Registry##2##3##(1996-7#1)(1997-7#1)
the Fib75##2##2##(1990-12#1)(1991-2#1)
the Field##7##2##(2007-8#1)(2008-10#3)(2008-2#1)(2009-11#1)(2011-2#1)
the Fifth##6##2##(1996-9#1)(2005-8#1)(2008-2#1)(2010-12#1)(2012-12#2)
the Fight Against##2##3##(2007-7#1)(2011-2#1)
the Fiji Islands##2##3##(2008-1#2)
the Fiji School of Medicine##3##5##(2008-1#3)
the Fiji School of##4##4##(2008-1#4)
the Fiji##11##2##(2008-1#10)(2012-12#1)
the Final Rule##2##3##(2009-4#2)
the Final##4##2##(1992-12#1)(2006-8#1)(2009-4#2)
the Finnish##8##2##(1991-8#1)(1996-3#1)(2005-10#1)(2005-11#1)(2007-7#1)(2009-4#1)(2011-1#1)(2013-7#1)
the Fire##2##2##(1993-12#1)(2008-10#1)
the First Congress of Serbian Physicians and Scientists##2##8##(2008-1#2)
the First Dental Home##2##4##(2011-2#2)
the First Department of##2##4##(2007-8#1)(2008-7#1)
the First International##3##3##(2005-9#1)(2008-12#1)(2010-6#1)
the First Republic##2##3##(2007-5#2)
the First Surgical Clinic##2##4##(2006-6#1)(2009-2#1)
the First World War##7##4##(2008-1#1)(2008-10#2)(2009-7#1)(2011-4#1)(2013-8#2)
the First##40##2##(1993-10#1)(1994-11#1)(1994-2#1)(1994-7#1)(1995-1#1)(1995-9#1)(1996-2#3)(2005-9#1)(2006-6#1)(2007-12#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-7#1)(2010-6#1)(2011-2#2)(2011-4#1)(2013-1#1)(2013-8#2)
the Firth of Forth##5##4##(2004-4#5)
the Firth of Vistula##2##4##(2008-11#2)
the Firth of##7##3##(2004-4#5)(2008-11#2)
the Fisher##6##2##(2008-2#1)(2008-3#1)(2008-6#1)(2009-8#1)(2013-1#1)(2013-7#1)
the Five##4##2##(2008-10#1)(2011-1#2)(2012-12#1)
the Flexitouch system##2##3##(2010-2#2)
the Flint River##3##3##(2012-3#3)
the Flo##2##2##(2011-2#2)
the Florence District##2##3##(1992-10#1)(1992-2#1)
the Florence##3##2##(1992-10#2)(1992-2#1)
the Florida Cracker##2##3##(2012-1#2)
the Florida Keys National Marine Sanctuary##3##6##(2007-5#2)(2011-2#1)
the Florida Keys##8##3##(2007-5#6)(2011-2#2)
the Florida##20##2##(1991-8#1)(1992-5#1)(1996-11#1)(1996-2#1)(2007-5#6)(2007-9#1)(2008-10#3)(2008-12#1)(2008-2#1)(2011-2#2)(2012-1#2)
the Flory-Rehner model##2##3##(2007-10#2)
the Flu-6plx PCR##2##3##(2011-2#2)
the Flu-6plx##3##2##(2011-2#3)
the Fluorescence##2##2##(2008-11#1)(2008-5#1)
the Fn-calcium phosphate composite layer##2##5##(2008-5#2)
the Fny-CMV##2##2##(2008-10#2)
the Fokker-Planck equation##2##3##(2007-11#1)(2007-12#1)
the Folin-Ciocalteu##2##2##(2008-10#1)(2012-12#1)
the Fontan operation##3##3##(2007-8#2)(2007-9#1)
the Food Frequency Questionnaire##2##4##(2010-9#1)(2012-2#1)
the Food Intake##2##3##(2008-1#1)(2009-2#1)
the Food and Agriculture Organization##2##5##(2012-1#1)(2012-12#1)
the Food and Drug Administration (FDA)##10##6##(1995-9#1)(1996-5#2)(1997-5#1)(2005-7#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-4#1)
the Food and Drug Administration and the##2##7##(2008-7#1)(2010-6#1)
the Food and Drug Administration and##4##6##(1990-5#1)(1994-1#1)(2008-7#1)(2010-6#1)
the Food and Drug Administration to##3##6##(2008-1#1)(2008-7#1)(2008-8#1)
the Food and Drug Administration##30##5##(1990-5#1)(1994-1#1)(1995-9#1)(1996-2#1)(1996-5#2)(1997-5#1)(2005-7#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-4#1)(2009-9#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
the Food and Drug##31##4##(1990-5#1)(1994-1#1)(1995-9#1)(1996-2#1)(1996-5#2)(1997-5#1)(2005-7#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-4#1)(2009-9#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
the Food and##34##3##(1990-5#1)(1994-1#1)(1995-9#1)(1996-2#1)(1996-5#2)(1997-5#1)(2005-7#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-4#1)(2009-9#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
the Food##47##2##(1990-5#1)(1991-2#1)(1994-1#1)(1995-9#1)(1996-2#1)(1996-5#2)(1997-5#1)(2005-7#1)(2006-10#2)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#3)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-4#2)(2010-6#1)(2010-9#1)(2011-1#1)(2012-1#3)(2012-12#1)(2012-2#3)(2013-1#1)
the Forensic##2##2##(2005-8#1)(2009-4#1)
the Formation of##2##3##(2008-10#2)
the Formosan subterranean termite##2##4##(2009-5#1)(2011-2#1)
the Forum##2##2##(2010-11#2)
the Fos##2##2##(1994-10#1)(1997-2#1)
the Fos-related##2##2##(1994-3#1)(1996-10#1)
the Foster/CIho 4780##3##3##(2008-10#3)
the Foster/CIho##4##2##(2008-10#4)
the Foundation for##4##3##(1994-3#1)(2006-5#1)(2007-8#1)(2008-10#1)
the Foundation##5##2##(1994-3#1)(2006-5#1)(2007-8#1)(2008-10#1)(2009-3#1)
the Fourier plane is##2##4##(2008-2#1)(2008-3#1)
the Fourier plane##13##3##(2007-11#1)(2007-12#1)(2008-2#7)(2008-3#4)
the Fourier spectrum of##2##4##(2007-12#1)(2008-3#1)
the Fourier spectrum##6##3##(2007-12#1)(2008-2#3)(2008-3#2)
the Fourier transform method##2##4##(2008-2#1)(2008-3#1)
the Fourier transform of the##4##5##(1992-9#1)(2007-12#2)(2008-3#1)
the Fourier transform of##6##4##(1992-9#1)(2007-12#3)(2008-3#2)
the Fourier transform##15##3##(1991-5#1)(1992-9#1)(2007-12#3)(2008-1#1)(2008-2#3)(2008-3#5)(2009-10#1)
the Fourier transform-infrared spectrum of##2##5##(2008-5#2)
the Fourier##72##2##(1991-5#1)(1992-9#1)(1995-8#3)(1997-8#1)(2007-11#7)(2007-12#7)(2008-1#2)(2008-2#20)(2008-3#25)(2008-4#1)(2008-5#2)(2009-10#1)(2012-1#1)
the Fourier-transform infrared##2##3##(1993-6#1)(2007-12#1)
the Fourier-transform method##2##3##(2008-3#2)
the Fourier-transform##9##2##(1993-6#1)(2006-5#1)(2007-12#4)(2008-2#1)(2008-3#2)
the Fourier-transformed##2##2##(2008-1#1)(2008-3#1)
the Fourteenth##2##2##(1990-12#1)(2013-8#1)
the Fourth Paradigm##2##3##(1994-11#2)
the Fourth Scope of Work##2##5##(1993-2#2)
the Fourth##13##2##(1990-12#2)(1993-2#2)(1994-11#2)(1995-6#2)(1997-6#1)(2005-8#1)(2008-11#1)(2008-4#1)(2008-5#1)
the Fp promoter##2##3##(1995-8#2)
the Fp##3##2##(1995-8#3)
the Fragile X##3##3##(1992-2#1)(2009-5#2)
the Framingham Heart Study##6##4##(1990-5#2)(1995-6#1)(1995-8#1)(2009-12#2)
the Framingham Heart##7##3##(1990-5#2)(1995-6#2)(1995-8#1)(2009-12#2)
the Framingham Offspring Study##4##4##(1996-9#3)(2008-1#1)
the Framingham Study##3##3##(1993-3#1)(1995-8#2)
the Framingham risk score##2##4##(2010-5#1)(2011-1#1)
the Framingham##21##2##(1990-5#2)(1993-3#1)(1995-6#2)(1995-8#3)(1996-9#3)(2007-10#1)(2008-1#2)(2008-3#3)(2009-12#2)(2010-5#1)(2011-1#1)
the Frankfurt##4##2##(2007-7#1)(2013-8#3)
the Franz-Keldysh effect##2##3##(2008-2#2)
the Franz-Keldysh##3##2##(2007-12#1)(2008-2#2)
the Fraunhofer##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
the Free State province##2##4##(2012-12#2)
the Free State##3##3##(2012-12#3)
the Free University##2##3##(1993-7#1)(2005-8#1)
the Free##6##2##(1993-7#1)(2005-8#1)(2008-3#1)(2012-12#3)
the FreeStyle Navigator##2##3##(2009-9#2)
the Freedom of Access to Clinic Entrances Act (FACE)##2##9##(1995-6#1)(1997-1#1)
the Freedom of##3##3##(1995-6#1)(1997-1#1)(2009-6#1)
the Freedom##4##2##(1995-6#1)(1997-1#1)(2009-11#1)(2009-6#1)
the Frejka pillow is##2##4##(2007-8#2)
the Frejka pillow##4##3##(2007-8#4)
the French National##2##3##(2009-6#1)(2013-1#1)
the French health care system##2##5##(2012-3#2)
the French public health##2##4##(2008-4#1)(2012-12#1)
the French##49##2##(1990-8#3)(1991-9#1)(1992-11#1)(1994-12#1)(1995-5#1)(2005-5#1)(2007-2#1)(2007-3#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-2#1)(2009-5#1)(2009-6#2)(2010-12#2)(2010-9#2)(2011-12#1)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#4)
the Frequency of##2##3##(2011-2#1)(2012-12#1)
the Fresnel approximation is no longer valid##2##7##(2008-2#1)(2008-3#1)
the Fresnel approximation##5##3##(2008-2#1)(2008-3#4)
the Fresnel diffraction pattern of a##2##6##(2008-2#1)(2008-3#1)
the Fresnel diffraction region##4##4##(2007-11#1)(2007-12#2)(2008-3#1)
the Fresnel diffraction##9##3##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#3)
the Fresnel number is##2##4##(2008-3#2)
the Fresnel number of the##2##5##(2007-12#1)(2008-2#1)
the Fresnel number##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
the Fresnel reflection##2##3##(2008-2#1)(2008-3#1)
the Fresnel##32##2##(2007-11#2)(2007-12#7)(2008-2#9)(2008-3#14)
the Fresnel-Kirchhoff diffraction theory##2##4##(2008-3#2)
the Fresnel-Kirchhoff integral##3##3##(2008-2#2)(2008-3#1)
the Fresnel-Kirchhoff##6##2##(2008-2#3)(2008-3#3)
the Freundlich##4##2##(2008-10#2)(2008-5#1)(2013-1#1)
the Friend##2##2##(1993-5#1)(1995-7#1)
the Front##2##2##(2008-7#1)(2009-12#1)
the Frumkin##2##2##(2005-11#2)
the Fs##2##2##(2013-8#2)
the FsphDNase##2##2##(2008-10#2)
the Fugl-Meyer##2##2##(2012-1#1)(2012-2#1)
the Fukushima Daiichi Nuclear Power Plant##2##6##(2012-2#2)
the Fukushima Daiichi##4##3##(2012-2#3)(2013-1#1)
the Fukushima nuclear crisis##2##4##(2012-2#2)
the Fukushima##8##2##(2012-2#7)(2013-1#1)
the Fukuyutaka##2##2##(2012-11#2)
the Function##2##2##(1992-9#1)(2009-5#1)
the Functional Assessment of Cancer##4##5##(2008-7#2)(2009-11#1)(2011-2#1)
the Functional Independence Measure (FIM)##2##5##(2007-10#1)(2007-7#1)
the Functional Independence Measure##4##4##(2007-10#1)(2007-7#1)(2007-9#1)(2012-1#1)
the Functional##12##2##(1993-1#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-7#3)(2009-11#1)(2011-2#3)(2012-1#1)
the Fund for##2##3##(1997-3#1)(2008-11#1)
the Fund has##2##3##(2010-9#2)
the Fund##4##2##(1997-3#1)(2008-11#1)(2010-9#2)
the Fungus##5##2##(2008-10#5)
the Fur protein##3##3##(1990-1#1)(1996-4#2)
the Fur##4##2##(1990-1#1)(1994-5#1)(1996-4#2)
the Fusarium oxysporum##3##3##(2008-10#3)
the Fusarium redolens-F##2##3##(2008-10#2)
the Fusarium##12##2##(1995-2#1)(2008-10#9)(2009-3#1)(2010-10#1)
the Future Search##3##3##(1996-3#3)
the Future of##2##3##(1996-2#1)(2008-10#1)
the Future##12##2##(1994-12#2)(1996-2#1)(1996-3#3)(2008-10#2)(2008-4#2)(2010-7#1)(2013-1#1)
the Fv##3##2##(1990-10#2)(1993-8#1)
the Fyn##2##2##(1994-9#1)(1997-4#1)
the G alpha s##2##4##(1993-7#1)(1996-4#1)
the G alpha subunit##2##4##(1993-9#1)(2007-12#1)
the G alpha##7##3##(1993-7#1)(1993-9#1)(1996-4#1)(1997-2#1)(2007-12#2)(2013-1#1)
the G bead##2##3##(2008-6#2)
the G beta gamma dimer##2##5##(1993-9#2)
the G beta gamma##3##4##(1993-9#2)(1994-8#1)
the G beta##5##3##(1993-9#2)(1994-8#2)(1995-8#1)
the G domain##3##3##(1990-12#2)(1997-4#1)
the G gamma subunit##2##4##(1994-8#1)(2007-12#1)
the G line of the HiPco composite (1% mass fraction)##2##10##(2008-10#2)
the G protein##9##3##(1992-2#1)(1993-8#1)(1995-7#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-4#1)(2013-1#1)
the G protein-coupled receptor family##2##5##(1992-5#1)(1993-8#1)
the G protein-coupled receptor##6##4##(1991-5#1)(1992-5#1)(1993-8#1)(1994-12#2)(1996-2#1)
the G protein-coupled##7##3##(1991-5#1)(1992-5#1)(1993-8#1)(1994-12#2)(1996-2#1)(2009-7#1)
the G proteins##2##3##(1991-2#1)(1993-9#1)
the G##64##2##(1990-11#1)(1990-12#2)(1990-6#1)(1991-11#3)(1991-2#1)(1991-4#1)(1991-5#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-7#1)(1993-8#2)(1993-9#4)(1994-12#2)(1994-8#3)(1995-7#1)(1995-8#1)(1996-2#2)(1996-4#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-7#1)(2007-12#3)(2008-10#8)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#2)(2009-12#1)(2009-4#1)(2009-7#1)(2011-12#1)(2012-11#1)(2013-1#2)
the G(1)##2##2##(2008-11#2)
the G+C content##2##3##(1993-11#1)(1997-4#1)
the G+C##3##2##(1993-11#1)(1997-4#1)(2008-8#1)
the G- and H-helices of myoglobin##3##6##(1993-6#3)
the G- and H-helices of##4##5##(1993-6#4)
the G- and H-helix##4##4##(1993-6#4)
the G- and##8##3##(1993-6#8)
the G-R##2##2##(1996-4#2)
the G-TsF/TGF-beta 2 gene##2##4##(1990-9#2)
the G-box##2##2##(1994-3#2)
the G-protein coupled##4##3##(1991-9#1)(1993-6#1)(1994-5#1)(2013-8#1)
the G-protein##12##2##(1990-7#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-6#1)(1994-5#2)(1996-2#1)(2008-1#1)(2008-4#1)(2008-7#1)(2013-8#1)
the G-protein-coupled receptor##2##3##(1995-11#1)(1995-8#1)
the G-protein-coupled##4##2##(1995-11#1)(1995-8#1)(1996-10#1)(2008-4#1)
the G0##3##2##(1990-7#1)(1992-8#1)(1994-12#1)
the G0/G1##9##2##(1991-5#1)(1992-12#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1996-5#1)(1996-7#1)(2008-11#1)
the G1 cell cycle##3##4##(1995-8#1)(2008-11#2)
the G1 phase of cell cycle##2##6##(1993-3#1)(1996-7#1)
the G1 phase of the cell cycle##8##7##(1994-3#2)(1994-5#1)(1994-6#1)(1995-8#1)(1996-10#1)(1996-5#1)(2007-9#1)
the G1 phase of##10##4##(1993-3#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-8#1)(1996-10#1)(1996-5#1)(1996-7#1)(2007-9#1)
the G1 phase##19##3##(1991-7#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-8#1)(1996-10#1)(1996-5#1)(1996-7#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-5#1)(2009-8#1)
the G1 to S transition##2##5##(1995-3#1)(2008-11#1)
the G1 to S##3##4##(1994-2#1)(1995-3#1)(2008-11#1)
the G1##33##2##(1990-7#1)(1991-7#1)(1992-10#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-8#3)(1996-10#2)(1996-4#1)(1996-5#1)(1996-7#1)(1997-7#1)(2007-8#1)(2007-9#1)(2008-11#5)(2008-5#1)(2009-8#1)(2012-3#1)
the G1-S transition##2##3##(1994-3#1)(2012-12#1)
the G1-phase of the cell cycle##2##6##(1997-1#1)(2007-9#1)
the G1-phase##7##2##(1997-1#1)(2007-9#3)(2008-11#1)(2008-7#1)(2012-3#1)
the G1-to-S transition##2##3##(1994-3#2)
the G1-to-S##3##2##(1991-5#1)(1994-3#2)
the G1/S boundary##5##3##(1992-4#1)(1995-2#2)(1997-1#2)
the G1/S phase##2##3##(1990-10#1)(1994-5#1)
the G1/S transition##3##3##(1992-6#1)(1993-11#1)(1995-2#1)
the G1/S##14##2##(1990-10#2)(1992-4#1)(1992-6#1)(1993-11#1)(1994-5#1)(1994-9#3)(1995-2#3)(1997-1#2)
the G190E RT##2##3##(1996-7#2)
the G190E##5##2##(1996-7#5)
the G2 phase##2##3##(1991-9#1)(1997-6#1)
the G2##5##2##(1991-9#1)(1994-3#1)(1997-6#1)(2008-10#1)(2013-1#1)
the G2/M##8##2##(1990-10#2)(1993-11#1)(1993-6#1)(1994-12#1)(1995-8#1)(2008-4#1)(2012-3#1)
the G212V##2##2##(1995-2#2)
the G870A polymorphism##2##3##(2007-11#2)
the GA and##2##3##(1993-4#1)(2008-2#1)
the GA##15##2##(1993-12#4)(1993-4#1)(1995-1#1)(2005-11#1)(2008-10#2)(2008-2#4)(2009-8#2)
the GA/AGS mixture##2##3##(2005-11#2)
the GAB mutant##2##3##(2008-10#2)
the GAB##5##2##(2008-10#3)(2010-4#2)
the GABA current##3##3##(1997-5#3)
the GABA response##6##3##(1994-2#1)(1995-6#4)(1996-1#1)
the GABA##24##2##(1991-2#2)(1992-3#1)(1992-6#2)(1994-2#1)(1995-11#1)(1995-5#1)(1995-6#5)(1995-7#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-5#3)(2007-12#1)(2010-8#1)(2013-1#1)
the GABA(A) receptor complex##2##4##(1997-5#2)
the GABA(A) receptor##4##3##(1990-7#1)(1997-5#3)
the GABA(A)##5##2##(1990-7#1)(1997-5#3)(2007-9#1)
the GABAA receptor complex##3##4##(1990-10#1)(1995-11#1)(1997-3#1)
the GABAA receptor##15##3##(1990-10#3)(1991-9#1)(1992-8#2)(1994-2#1)(1995-11#1)(1995-12#1)(1995-7#1)(1996-10#2)(1997-3#1)(1997-7#1)(2008-1#1)
the GABAA receptors##2##3##(1992-3#1)(1994-2#1)
the GABAA##23##2##(1990-10#3)(1990-5#1)(1991-9#1)(1992-3#1)(1992-8#2)(1994-2#4)(1995-11#2)(1995-12#2)(1995-7#2)(1996-10#2)(1997-3#1)(1997-7#1)(2008-1#1)
the GABAA-receptor##2##2##(1994-2#2)
the GABAA/benzodiazepine##2##2##(1990-7#2)
the GABAB antagonist##2##3##(1992-3#1)(1993-12#1)
the GABAB##5##2##(1992-3#1)(1993-12#2)(1994-2#2)
the GABAergic##4##2##(1990-10#1)(1991-1#1)(1992-11#1)(1993-12#1)
the GAC mutant##2##3##(2008-10#2)
the GAC##3##2##(1996-11#1)(2008-10#2)
the GAL##3##2##(1990-5#1)(1995-2#1)(1997-3#1)
the GAL1 promoter##2##3##(1991-7#1)(1995-6#1)
the GAL1##3##2##(1991-7#1)(1995-6#1)(1997-1#1)
the GAL4 DNA binding domain##2##5##(1990-8#1)(1995-3#1)
the GAL4##7##2##(1990-8#1)(1991-4#2)(1993-11#1)(1995-3#1)(1995-4#1)(1997-4#1)
the GAME(Wheels) system##3##3##(2007-10#3)
the GAP##2##2##(1995-11#1)(2013-1#1)
the GAP1 gene##2##3##(1990-5#2)
the GAP1##4##2##(1990-5#4)
the GAPDH##4##2##(1990-4#1)(1991-9#1)(1995-6#1)(2008-4#1)
the GARP model##2##3##(2008-8#2)
the GARP##3##2##(2008-8#3)
the GATA##2##2##(1991-8#1)(2011-2#1)
the GATA-1 first intron##2##4##(1997-4#2)
the GATA-1 gene##2##3##(1997-4#2)
the GATA-1##4##2##(1997-4#4)
the GATA-a motif##2##3##(2012-2#2)
the GATATC##3##2##(1995-8#2)(1997-5#1)
the GAW17 data sets##2##4##(2012-3#2)
the GAW17 data##7##3##(2012-3#7)
the GAW17 simulation model##2##4##(2012-3#2)
the GAW17##10##2##(2012-3#10)
the GB of the##2##4##(2006-3#2)
the GB##7##2##(1997-7#1)(2006-3#2)(2008-10#3)(2009-12#1)
the GBIF##3##2##(2012-3#3)
the GBS##5##2##(1994-11#1)(2008-7#1)(2010-4#1)(2011-2#2)
the GC box##2##3##(1993-5#2)
the GC electrode##2##3##(2008-10#2)
the GC rich region##2##4##(1993-3#2)
the GC sensitivity of the immune system##2##7##(2006-10#2)
the GC##23##2##(1993-11#1)(1993-3#2)(1993-5#2)(1997-2#1)(2005-8#1)(2006-10#2)(2007-1#1)(2008-10#9)(2008-7#1)(2012-1#2)(2013-1#1)
the GC-HM condition##2##3##(2012-1#2)
the GC-HRMS##6##2##(2008-10#6)
the GC-MS##4##2##(1996-8#1)(1997-8#1)(2008-10#2)
the GC-box##2##2##(1994-12#2)
the GC-rich##2##2##(1996-7#1)(2012-3#1)
the GC/MS##3##2##(2008-10#3)
the GCAP##6##2##(1992-3#2)(1996-7#4)
the GCG##2##2##(1992-6#1)(2008-4#1)
the GCN4##3##2##(1993-3#1)(2008-9#2)
the GCP fraction##2##3##(1991-7#2)
the GCS##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
the GD##2##2##(2008-10#1)(2013-1#1)
the GDB##2##2##(2004-2#1)(2008-12#1)
the GDC##3##2##(1997-6#2)(2006-8#1)
the GDH##2##2##(2008-8#1)(2009-8#1)
the GDI##3##2##(1997-4#1)(2013-1#2)
the GDP##3##2##(1992-12#1)(1993-3#1)(1996-2#1)
the GDP-bound form of##2##4##(1992-5#1)(1997-4#1)
the GDP-bound##3##2##(1992-5#1)(1997-4#1)(1997-7#1)
the GDS##3##2##(2006-10#2)(2007-9#1)
the GEE##3##2##(1993-9#3)
the GEPR##2##2##(1996-12#2)
the GEPR-3##2##2##(1996-12#2)
the GFAP gene and##2##4##(2011-2#2)
the GFAP##5##2##(1990-7#1)(1997-2#1)(2007-10#1)(2011-2#2)
the GFD##2##2##(2011-2#2)
the GFP##6##2##(1997-6#2)(2004-4#1)(2008-10#1)(2008-4#1)(2008-9#1)
the GFR##2##2##(2007-8#1)(2011-1#1)
the GG genotype##2##3##(2007-11#1)(2011-1#1)
the GG##4##2##(1995-3#1)(2007-11#1)(2008-10#1)(2011-1#1)
the GGP1##2##2##(1996-3#2)
the GGT gene##3##3##(1992-9#3)
the GGT##5##2##(1992-9#5)
the GH receptor gene##2##4##(2006-9#1)(2008-1#1)
the GH receptor##9##3##(1995-3#3)(1995-8#1)(1996-2#1)(2006-9#1)(2008-1#2)(2008-4#1)
the GH secretagogue##2##3##(2007-7#1)(2010-5#1)
the GH##18##2##(1995-11#1)(1995-3#3)(1995-8#1)(1996-11#1)(1996-2#1)(2006-1#1)(2006-9#1)(2007-7#1)(2008-1#2)(2008-4#1)(2008-7#2)(2010-5#1)(2010-8#1)(2011-1#1)
the GH3##3##2##(2007-12#1)(2009-6#2)
the GHF3##2##2##(1996-8#2)
the GHQ-12##3##2##(2012-1#3)
the GHR1##4##2##(1995-8#4)
the GHRH-responding cells##2##3##(1994-3#2)
the GI frequency##2##3##(1992-6#2)
the GI tract is##2##4##(2008-12#1)(2009-8#1)
the GI tract##9##3##(2007-5#1)(2008-12#3)(2009-8#1)(2010-2#1)(2012-1#3)
the GI##26##2##(1992-6#4)(1996-9#2)(2005-10#1)(2007-12#1)(2007-5#2)(2008-1#2)(2008-10#1)(2008-12#3)(2008-4#1)(2009-8#1)(2010-2#1)(2012-1#5)(2013-8#2)
the GI-tract##2##2##(2006-10#1)(2006-8#1)
the GINA##2##2##(2010-5#2)
the GIT is##2##3##(2012-2#1)(2013-1#1)
the GJIC##2##2##(1993-7#1)(2008-8#1)
the GK##5##2##(2006-12#1)(2008-1#1)(2008-4#2)(2008-8#1)
the GLF##2##2##(1996-7#2)
the GLM##2##2##(2008-10#2)
the GLO##2##2##(2012-2#2)
the GLS##5##2##(2008-10#1)(2008-5#4)
the GLU and PWB##2##4##(2010-8#2)
the GLUT1 isoform##2##3##(1993-6#2)
the GLUT1 transporter##3##3##(1996-12#3)
the GLUT1##8##2##(1992-4#1)(1993-6#3)(1996-12#4)
the GLUT3##3##2##(1992-7#3)
the GLUT4##4##2##(1994-11#1)(1995-1#3)
the GM varieties##2##3##(2011-2#2)
the GM variety in##2##4##(2011-2#2)
the GM##9##2##(2008-8#1)(2009-7#2)(2011-2#6)
the GM-CSF##3##2##(2008-7#3)
the GM-kappa##2##2##(1994-12#2)
the GM1 treatment##2##3##(1993-5#1)(1995-5#1)
the GM1##6##2##(1993-5#1)(1994-8#2)(1995-5#1)(1997-7#1)(2011-1#1)
the GMC##13##2##(1992-10#2)(1993-1#10)(1993-2#1)
the GMM##3##2##(2012-3#3)
the GMS##2##2##(2006-4#1)(2008-8#1)
the GN innervating skin##2##4##(1991-10#2)
the GN innervating##3##3##(1991-10#3)
the GN##5##2##(1991-10#4)(2007-7#1)
the GNRA tetraloop-receptor interaction##2##4##(1997-2#2)
the GNRA##3##2##(1997-2#3)
the GNRs##2##2##(2012-12#2)
the GO##9##2##(2008-4#1)(2008-7#4)(2008-9#2)(2010-1#1)(2012-2#1)
the GP is##2##3##(2008-7#1)(2013-1#1)
the GP sensilla##3##3##(2007-12#3)
the GP##13##2##(1990-6#1)(1990-7#1)(1990-9#1)(1991-9#1)(1993-12#1)(1997-4#1)(2007-12#3)(2008-11#1)(2008-7#1)(2008-8#1)(2013-1#1)
the GP's##3##2##(1997-4#2)(2011-1#1)
the GPC##2##2##(2007-11#1)(2007-8#1)
the GPDCM##2##2##(2008-2#2)
the GPIIIa##4##2##(2006-6#4)
the GPO##2##2##(2007-9#1)(2008-10#1)
the GPRD##2##2##(2008-11#2)
the GPU##7##2##(2010-2#1)(2011-1#2)(2012-12#3)(2013-8#1)
the GPi##5##2##(1996-8#3)(2012-1#1)(2012-2#1)
the GPs##8##2##(1994-4#1)(1996-12#2)(2006-10#1)(2006-2#1)(2007-2#2)(2013-8#1)
the GPx4 T/C 718 SNP##2##5##(2008-10#2)
the GPx4##3##2##(2008-10#3)
the GR and##4##3##(1994-11#1)(1996-7#2)(2012-3#1)
the GR##15##2##(1994-11#5)(1995-7#1)(1996-5#2)(1996-7#2)(2008-4#1)(2010-10#1)(2012-3#3)
the GRACE##2##2##(2013-8#2)
the GRAV CP sequence##2##4##(2008-10#2)
the GRAV CP##3##3##(2008-10#3)
the GRAV##4##2##(2008-10#4)
the GRIN material##2##3##(2010-4#2)
the GRIN##7##2##(2007-12#1)(2010-4#6)
the GRNN##2##2##(2008-10#2)
the GROC and had a##2##5##(2008-12#2)
the GROC and##3##3##(2008-12#3)
the GRP##8##2##(1990-5#1)(1995-8#2)(1997-7#1)(2012-12#4)
the GS gene amplification system##2##5##(2008-11#2)
the GS##5##2##(1992-11#1)(1993-12#1)(2008-11#2)(2008-2#1)
the GS-FLX##2##2##(2011-2#2)
the GSA##2##2##(2008-11#1)(2012-3#1)
the GSC and its##2##4##(2011-2#2)
the GSC##3##2##(2011-2#3)
the GSEM##2##2##(2008-10#2)
the GSH levels##2##3##(1990-2#1)(2013-1#1)
the GSH##8##2##(1990-2#2)(1990-3#1)(1992-9#1)(1995-9#1)(1997-5#1)(2011-1#1)(2013-1#1)
the GSH-MFO system##2##3##(1997-8#2)
the GSH-MFO##3##2##(1997-8#3)
the GSR##3##2##(2013-7#3)
the GST pi##2##3##(1993-11#1)(1997-7#1)
the GST##10##2##(1990-2#1)(1993-11#1)(1994-2#1)(1995-6#1)(1997-7#2)(2005-11#1)(2007-10#1)(2009-11#2)
the GTA##2##2##(1994-8#1)(2010-9#1)
the GTFICAT transformants##2##3##(2006-11#2)
the GTFICAT##3##2##(2006-11#3)
the GTH-II##3##2##(2008-5#3)
the GTP binding site of##2##5##(1996-5#2)
the GTP gamma S-induced##2##4##(1990-7#2)
the GTP gamma##4##3##(1990-7#3)(1995-8#1)
the GTP##10##2##(1990-2#1)(1990-7#4)(1993-12#1)(1995-8#1)(1996-5#2)(2013-1#1)
the GTP-binding protein##3##3##(1990-3#1)(1991-11#2)
the GTP-binding proteins##5##3##(1991-1#2)(1991-12#1)(1992-11#1)(1993-9#1)
the GTP-binding site##2##3##(2008-4#2)
the GTP-binding##14##2##(1990-3#1)(1990-7#1)(1991-1#2)(1991-11#3)(1991-12#1)(1992-11#1)(1993-9#2)(1994-2#1)(2008-4#2)
the GTP-bound form of##2##4##(1997-7#2)
the GTP-bound form##4##3##(1992-7#1)(1994-12#1)(1997-7#2)
the GTP-bound##5##2##(1992-7#1)(1993-8#1)(1994-12#1)(1997-7#2)
the GTP-dependent##2##2##(1990-7#1)(1997-7#1)
the GTP-induced enhancement##2##3##(1990-7#2)
the GTP-induced##5##2##(1990-7#4)(2008-4#1)
the GTPase activating protein##3##4##(1992-8#2)(1997-7#1)
the GTPase activity of EF-Tu##2##5##(1995-5#2)
the GTPase activity of the##6##5##(1990-12#1)(1992-11#5)
the GTPase activity of##9##4##(1990-12#1)(1992-11#6)(1995-5#2)
the GTPase activity##10##3##(1990-12#2)(1992-11#6)(1995-5#2)
the GTPase##17##2##(1990-12#2)(1992-11#6)(1992-8#2)(1995-2#1)(1995-5#3)(1996-7#1)(1997-7#2)
the GTPase-activating activity##2##3##(1997-6#2)
the GTPase-activating##4##2##(1993-12#1)(1995-11#1)(1997-6#2)
the GTS1 gene in a##2##5##(1997-6#2)
the GTS1 gene##4##3##(1997-6#4)
the GTV##4##2##(2008-2#3)(2010-9#1)
the GTV-4DCT bolus##2##3##(2010-9#2)
the GUM##2##2##(2008-10#2)
the GUS (beta-glucuronidase) reporter##2##4##(2006-12#1)(2008-10#1)
the GUS gene##4##3##(1997-2#3)(2006-12#1)
the GUS##7##2##(1997-2#3)(2006-12#2)(2008-10#1)(2012-2#1)
the GV##2##2##(1995-3#1)(2013-1#1)
the GVD of##2##3##(2008-3#2)
the GaAs surface##2##3##(2009-11#1)(2009-6#1)
the GaAs##10##2##(2007-12#2)(2008-2#3)(2008-3#1)(2009-11#2)(2009-6#2)
the Gait Deviation Index##2##4##(2013-1#2)
the Gait##3##2##(2013-1#2)(2013-7#1)
the Gal##2##2##(1990-5#1)(1995-3#1)
the GalNAc##4##2##(1995-3#3)(1996-5#1)
the Galician##2##2##(2008-10#2)
the Galápagos Islands##2##3##(2013-8#2)
the Galápagos##3##2##(2008-8#1)(2013-8#2)
the Gamma Knife##3##3##(1997-4#2)(2009-5#1)
the Gamma nail##2##3##(2007-8#2)
the Gamma##6##2##(1996-3#1)(1997-4#2)(2007-8#2)(2009-5#1)
the Garden##2##2##(2007-11#1)(2008-1#1)
the GasPak##5##2##(2006-8#5)
the Gaussian beam TL##2##4##(2008-3#2)
the Gaussian beam##6##3##(2008-2#2)(2008-3#4)
the Gaussian distribution##2##3##(1994-6#1)(2008-2#1)
the Gaussian##25##2##(1994-6#1)(2008-10#1)(2008-11#1)(2008-2#11)(2008-3#11)
the Gazeta Medica da##2##4##(2009-10#2)
the Gazeta##4##2##(2009-10#4)
the Gb mRNAs##2##3##(1991-5#2)
the Gcm pathway##2##3##(2008-7#2)
the Gd-BOPTA##2##2##(2008-7#2)
the Gel'fand-Graev##2##2##(2012-1#2)
the Gemini##2##2##(2008-2#1)(2008-3#1)
the GenBank and##2##3##(1991-8#1)(2008-7#1)
the GenBank database##2##3##(1994-12#1)(1995-2#1)
the GenBank##8##2##(1991-8#1)(1994-12#1)(1994-8#1)(1995-2#1)(1997-4#1)(2008-7#1)(2009-2#1)(2011-1#1)
the GenMark##2##2##(1995-12#2)
the Gene Ontologies##2##3##(2008-4#1)(2008-9#1)
the Gene Ontology (GO)##4##4##(2008-4#1)(2008-7#3)
the Gene Ontology Consortium##3##4##(2008-7#3)
the Gene Ontology##17##3##(2008-4#1)(2008-7#11)(2008-9#2)(2010-4#1)(2011-2#1)(2013-1#1)
the Gene##21##2##(2008-4#3)(2008-7#11)(2008-9#4)(2010-4#1)(2011-2#1)(2013-1#1)
the GeneMark##2##2##(1996-6#1)(2008-4#1)
the General Health Questionnaire##4##4##(2008-1#2)(2008-11#1)(2008-3#1)
the General Health##6##3##(1994-3#1)(2008-1#2)(2008-11#1)(2008-3#1)(2012-12#1)
the General Life Functioning##2##4##(1996-7#2)
the General Practice##2##3##(2008-11#1)(2008-3#1)
the General##22##2##(1991-1#1)(1992-10#1)(1992-5#1)(1994-3#1)(1995-9#1)(1996-6#1)(1996-7#2)(2006-8#1)(2007-10#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-3#2)(2010-12#1)(2012-12#1)(2012-2#2)
the Generalized##3##2##(2006-10#1)(2011-1#1)(2012-2#1)
the Generation##3##2##(2008-10#2)(2010-10#1)
the Generic##2##2##(2008-4#2)
the Genetic Analysis Workshop 17 (GAW17) data set##3##8##(2012-3#3)
the Genetic Analysis Workshop 17 (GAW17) data##5##7##(2012-3#5)
the Genetic Analysis Workshop 17 (GAW17)##6##6##(2012-3#6)
the Genetic Analysis Workshop 17 data to##3##7##(2012-3#3)
the Genetic Analysis Workshop 17 data##15##6##(2012-3#15)
the Genetic Analysis Workshop 17 exome##2##6##(2012-3#2)
the Genetic Analysis Workshop 17 mini-exome data##5##7##(2012-3#5)
the Genetic Analysis Workshop 17 mini-exome sequence data##3##8##(2012-3#3)
the Genetic Analysis Workshop 17 mini-exome sequence##4##7##(2012-3#4)
the Genetic Analysis Workshop 17 mini-exome##10##6##(2012-3#10)
the Genetic Analysis Workshop 17 simulated data##2##7##(2012-3#2)
the Genetic Analysis Workshop 17 unrelated individuals data set##2##9##(2012-3#2)
the Genetic Analysis Workshop 17 unrelated individuals data##3##8##(2012-3#3)
the Genetic Analysis Workshop 17##45##5##(2012-3#45)
the Genetic Diversity of##2##4##(2008-10#2)
the Genetic##50##2##(2008-10#4)(2009-5#1)(2012-3#45)
the Genome Browser##2##3##(2008-4#2)
the Genome##6##2##(2008-10#1)(2008-12#1)(2008-4#3)(2008-7#1)
the Genomic Standards Consortium##2##4##(2011-2#2)
the Genomic##43##2##(2008-10#1)(2011-2#42)
the Genus##5##2##(2008-10#4)(2010-2#1)
the Georgia system##3##3##(1996-12#3)
the Georgia##4##2##(1996-12#3)(2010-12#1)
the Gerbich##2##2##(1992-6#2)
the Geriatric Depression Scale (GDS)##4##5##(2006-10#3)(2007-9#1)
the Geriatric Depression Scale##8##4##(2006-10#3)(2007-10#2)(2007-9#1)(2008-7#1)(2010-9#1)
the Geriatric##10##2##(2006-10#3)(2006-4#1)(2007-10#2)(2007-9#1)(2008-7#2)(2010-9#1)
the German Health##3##3##(1994-6#1)(2009-7#1)(2012-2#1)
the German Institute##2##3##(2011-2#1)(2012-2#1)
the German Red Cross Blood Donor Service##3##7##(2012-12#3)
the German Society of##6##4##(1993-4#1)(1997-4#1)(2005-11#1)(2005-8#1)(2007-9#1)(2012-2#1)
the German cockroach##3##3##(2007-11#1)(2011-2#2)
the German##51##2##(1990-11#1)(1990-6#1)(1993-4#1)(1994-3#1)(1994-6#1)(1997-4#1)(1997-8#1)(2005-11#7)(2005-12#1)(2005-7#1)(2005-8#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-7#4)(2011-1#1)(2011-2#5)(2012-12#3)(2012-2#5)(2013-1#2)(2013-8#2)
the Germans##3##2##(1992-11#1)(1995-4#2)
the Ghanaian sample##2##3##(2007-7#2)
the Ghent##2##2##(2008-4#1)(2011-2#1)
the Gi##3##2##(1990-3#1)(2008-4#2)
the Gi/G(o) protein##2##3##(1996-1#2)
the Gi2 alpha##2##3##(1994-9#1)(1996-10#1)
the Gi2##3##2##(1994-9#1)(1996-10#2)
the Gibberella##2##2##(1995-2#1)(2008-10#1)
the Gibbs free energy##4##4##(1995-6#1)(2006-10#1)(2008-10#1)(2010-5#1)
the Gibbs free##5##3##(1991-4#1)(1995-6#1)(2006-10#1)(2008-10#1)(2010-5#1)
the Gibbs sampler to estimate##2##5##(1993-6#1)(1994-9#1)
the Gibbs sampler##3##3##(1993-6#1)(1994-9#1)(1997-7#1)
the Gibbs##14##2##(1990-11#1)(1991-4#1)(1993-6#1)(1994-9#1)(1995-6#1)(1997-2#2)(1997-7#1)(2006-10#1)(2008-10#2)(2008-4#1)(2010-5#1)(2011-2#1)
the Gibbs-Donnan model##2##3##(2008-10#2)
the Gillespie algorithm##3##3##(2006-10#3)
the Gla domain##2##3##(1991-7#1)(1995-6#1)
the Gla##3##2##(1991-7#1)(1995-2#1)(1995-6#1)
the Glasgow Coma Scale##2##4##(2007-10#1)(2011-2#1)
the Glasgow##3##2##(2007-10#1)(2011-2#1)(2012-3#1)
the Gleason##2##2##(2008-10#1)(2011-1#1)
the Glioma##2##2##(2006-12#1)(2008-2#1)
the Global Biodiversity Information Facility##3##5##(2012-3#3)
the Global Biodiversity##4##3##(2007-9#1)(2012-3#3)
the Global Deterioration Scale (GDS)##2##5##(1994-6#1)(2007-2#1)
the Global Oscillation Network Group (GONG)##3##6##(1996-5#3)
the Global Ozone Monitoring by Occultation of Stars (GOMOS)##2##9##(2008-3#2)
the Global Ozone Monitoring##3##4##(2008-3#3)
the Global##34##2##(1991-2#1)(1994-6#1)(1995-10#1)(1996-5#3)(1996-8#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-3#3)(2013-7#1)
the Glu and##2##3##(1991-5#1)(1992-3#1)
the Glu##7##2##(1990-8#1)(1991-5#1)(1992-11#1)(1992-3#2)(1993-12#1)(1994-9#1)
the Glu-204 mutants##2##3##(1997-4#2)
the Glu-50--&gt##7##2##(1995-6#7)
the Glu-98--&gt##2##2##(1996-2#2)
the GluR delta 2##4##4##(1996-4#4)
the GluR1##2##2##(1997-7#2)
the Gluma##2##2##(1991-4#1)(1991-5#1)
the Gly variant##2##3##(1992-9#2)
the Gly##5##2##(1992-6#1)(1992-9#2)(1994-9#1)(2008-5#1)
the GnRH##9##2##(1994-6#2)(1995-11#1)(1995-8#1)(1996-2#1)(1996-8#2)(2006-5#1)(2008-5#1)
the GnRH-associated##2##2##(1995-11#1)(1995-8#1)
the Go phase##2##3##(1991-7#2)
the Go##3##2##(1991-7#2)(1995-2#1)
the Golden##4##2##(1991-6#1)(1992-10#1)(2009-6#1)(2012-2#1)
the Goldmann##2##2##(2008-7#1)(2010-8#1)
the Golgi apparatus and##2##4##(1991-1#1)(1992-12#1)
the Golgi apparatus is##2##4##(2009-2#1)(2012-2#1)
the Golgi apparatus to the##2##5##(2007-9#1)(2011-1#1)
the Golgi apparatus were##2##4##(1997-7#1)(2007-9#1)
the Golgi apparatus##29##3##(1990-4#1)(1990-5#1)(1990-7#4)(1991-1#1)(1992-12#2)(1992-7#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-5#1)(1997-7#2)(2007-9#4)(2008-11#3)(2009-2#1)(2009-8#2)(2011-1#1)(2012-2#2)
the Golgi complex and in the##2##6##(1997-6#1)(2008-7#1)
the Golgi complex##14##3##(1990-10#1)(1990-12#3)(1992-11#1)(1994-9#1)(1995-1#1)(1997-5#1)(1997-6#3)(2008-7#3)
the Golgi is##5##3##(1997-6#1)(2006-10#1)(2009-2#3)
the Golgi##89##2##(1990-10#1)(1990-12#3)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#4)(1991-1#1)(1992-11#1)(1992-12#5)(1992-2#1)(1992-7#1)(1993-12#3)(1993-3#1)(1993-6#1)(1994-12#2)(1994-3#2)(1994-9#2)(1995-1#1)(1995-2#3)(1995-5#1)(1995-8#2)(1997-5#1)(1997-6#11)(1997-7#2)(1997-8#1)(2006-10#2)(2007-9#4)(2008-11#6)(2008-4#2)(2008-7#4)(2008-8#1)(2009-2#6)(2009-8#4)(2010-12#1)(2011-1#1)(2012-2#4)
the Gompertz model##6##3##(2008-10#5)(2008-9#1)
the Gompertz##10##2##(1993-12#1)(2008-1#2)(2008-10#6)(2008-9#1)
the Goos-Hänchen##3##2##(2007-11#3)
the Gordon-Haus##4##2##(2007-12#4)
the Gouy phase shift##2##4##(2007-11#2)
the Gouy##3##2##(2007-11#2)(2007-12#1)
the Gouy-Chapman theory##4##3##(1990-11#1)(1991-9#1)(1992-6#1)(2008-10#1)
the Gouy-Chapman##5##2##(1990-11#1)(1991-9#2)(1992-6#1)(2008-10#1)
the Gouy-Chapman-Stern-Grahame##2##2##(2005-11#2)
the Government of##4##3##(1995-3#2)(2004-3#1)(2010-12#1)
the Government##12##2##(1992-9#1)(1995-3#2)(1996-4#1)(2004-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-12#1)(2012-3#1)
the Gpal##2##2##(1994-3#2)
the Graham##2##2##(1997-3#1)(2008-9#1)
the Grain##2##2##(2008-12#2)
the Gram positive bacteria Streptococcus pneumoniae##2##6##(2006-8#2)
the Gram positive bacteria##3##4##(2006-8#2)(2012-2#1)
the Gram stain allows one to distinguish between Gram-positive and Gram-negative bacteria on the basis of differential staining with a crystal violet-iodine complex and a safranin counterstain##2##27##(2008-4#1)(2008-9#1)
the Gram stain##6##3##(2004-4#1)(2008-4#2)(2008-9#2)(2012-2#1)
the Gram staining##2##3##(2010-12#1)(2012-2#1)
the Gram##12##2##(2004-4#1)(2006-8#3)(2008-4#2)(2008-9#2)(2010-12#1)(2012-2#3)
the Gram-negative##4##2##(1997-8#1)(2006-5#1)(2007-7#1)(2010-1#1)
the Gram-positive##3##2##(1996-7#1)(2006-5#1)(2007-8#1)
the Gray##2##2##(2008-10#1)(2008-7#1)
the Grb2##3##2##(1996-5#2)(2006-12#1)
the Great East Japan Earthquake##2##5##(2012-2#1)(2013-8#1)
the Great Lakes##3##3##(1994-6#1)(2008-10#1)(2010-5#1)
the Great Plains##6##3##(2008-10#6)
the Great##24##2##(1994-6#1)(2006-8#1)(2008-10#7)(2008-5#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#2)(2013-1#3)(2013-8#2)
the Greater##16##2##(1993-9#1)(1995-2#2)(2006-12#2)(2007-1#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-3#2)(2008-8#1)(2010-5#1)(2010-9#2)(2011-2#1)
the Greek##8##2##(1995-12#1)(2007-3#1)(2008-11#1)(2008-5#1)(2009-1#1)(2010-2#1)(2011-2#1)(2012-2#1)
the Green##4##2##(2008-10#1)(2009-6#1)(2009-8#1)(2011-2#1)
the Green's function##5##3##(2008-3#4)(2011-1#1)
the Green's##6##2##(2008-10#1)(2008-3#4)(2011-1#1)
the Greenhouse##2##2##(1992-3#1)(2008-10#1)
the Greenwood frequency##2##3##(2008-2#2)
the Griess reaction##2##3##(2007-8#1)(2008-5#1)
the Griess##3##2##(2007-8#1)(2008-5#1)(2013-8#1)
the Grignard##2##2##(1996-5#1)(2008-5#1)
the Gross Motor##2##3##(2011-2#1)(2013-7#1)
the Gross##3##2##(2010-6#1)(2011-2#1)(2013-7#1)
the Group A##2##3##(2008-10#1)(2013-7#1)
the Group##14##2##(1996-8#1)(1997-7#1)(2006-5#1)(2008-10#1)(2008-11#2)(2008-5#1)(2013-1#2)(2013-7#3)(2013-8#2)
the Groups##3##2##(1993-6#3)
the Grubbs reagent##2##3##(2007-11#2)
the Grubbs##3##2##(2006-12#1)(2007-11#2)
the Gs alpha gene among 24##2##6##(1992-11#2)
the Gs alpha gene##4##4##(1992-11#4)
the Gs alpha##5##3##(1992-11#4)(1992-3#1)
the Guglielmi##2##2##(1996-9#1)(2008-7#1)
the Guiana Shield##2##3##(2007-3#2)
the Guidelines##5##2##(2006-12#1)(2008-7#1)(2008-9#1)(2011-2#2)
the Gulf States##2##3##(2009-4#1)(2012-2#1)
the Gulf War##3##3##(1997-4#1)(2004-7#1)(2006-10#1)
the Gulf of California is##2##5##(2007-5#2)
the Gulf of California##17##4##(2007-5#10)(2008-5#2)(2009-2#1)(2010-8#1)(2012-2#3)
the Gulf of Gdańsk##2##4##(2008-11#2)
the Gulf of Mexico##7##4##(2006-8#1)(2007-5#4)(2012-2#1)(2013-7#1)
the Gulf of Mexico]##3##4##(2007-5#2)(2008-5#1)
the Gulf of Nicoya estuary##3##5##(2007-5#3)
the Gulf of Nicoya##15##4##(2007-5#7)(2008-5#6)(2013-7#2)
the Gulf of Paria##11##4##(2007-5#11)
the Gulf of Tehuantepec##4##4##(2008-5#3)(2013-7#1)
the Gulf of##69##3##(2006-8#1)(2007-3#1)(2007-5#37)(2008-11#2)(2008-5#16)(2009-2#1)(2010-8#1)(2011-2#2)(2012-2#4)(2013-7#4)
the Gulf##84##2##(1997-4#2)(2004-7#4)(2006-10#1)(2006-8#1)(2007-3#1)(2007-5#41)(2008-11#2)(2008-5#16)(2009-2#1)(2009-4#1)(2010-11#1)(2010-8#1)(2011-2#3)(2012-2#5)(2013-7#4)
the Gus##3##2##(1993-8#3)
the Gushov-Solodkin algorithm##2##3##(2008-3#2)
the Gutenberg-Richter##2##2##(1996-4#2)
the Guttmacher Institute##2##3##(2013-1#2)
the Guyon's canal and##2##4##(1992-6#1)(2008-9#1)
the Guyon's canal##4##3##(1992-6#1)(2008-9#3)
the H and##2##3##(2008-11#1)(2011-2#1)
the H group##5##3##(1997-2#1)(2011-2#4)
the H type##3##3##(1996-11#3)
the H##42##2##(1990-9#1)(1991-3#1)(1992-11#5)(1993-2#1)(1994-10#1)(1994-11#1)(1994-8#2)(1996-10#1)(1996-11#3)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#1)(2008-5#2)(2011-2#7)(2012-2#1)
the H(+)##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
the H(+)-ATPase from##4##3##(1990-12#1)(1994-9#1)(1995-2#2)
the H(+)-ATPase##9##2##(1990-12#1)(1990-3#2)(1992-11#1)(1992-6#1)(1994-9#1)(1995-2#2)(2006-8#1)
the H(+)-extrusion rate is reduced##2##5##(2006-8#2)
the H(2)##4##2##(1996-2#1)(2006-4#1)(2010-5#1)(2011-2#1)
the H(2)O##3##2##(2008-2#1)(2008-3#2)
the H(2)O(2) generated##2##3##(2008-10#2)
the H(2)O(2)##9##2##(2008-10#9)
the H+ gradient##2##3##(1990-11#1)(1994-6#1)
the H+##7##2##(1990-11#1)(1994-11#1)(1994-6#2)(1997-1#1)(1997-8#1)(2006-2#1)
the H+L*##2##2##(2013-8#2)
the H-2##2##2##(1992-8#1)(2008-5#1)
the H-Wave(R) device is##2##4##(2010-1#2)
the H-Wave(R) device##7##3##(2010-1#7)
the H-bond##4##2##(1992-10#1)(2006-10#1)(2008-10#1)(2009-2#1)
the H-bonding##3##2##(1993-11#2)(2006-12#1)
the H-bonds are##2##3##(2006-12#2)
the H-phosphonate##2##2##(2008-4#2)
the H-point and generalised H-point standard##2##6##(2008-10#2)
the H-point standard addition method##6##5##(2008-10#6)
the H-point standard##7##3##(2008-10#7)
the H-point##9##2##(2008-10#9)
the H-ras##2##2##(1990-7#1)(1992-7#1)
the H-reflex##5##2##(1993-12#3)(2013-1#2)
the H-type##2##2##(2008-10#2)
the H1 and H2##2##4##(1995-1#1)(1996-6#1)
the H1 and##4##3##(1992-9#2)(1995-1#1)(1996-6#1)
the H1 receptor and##2##4##(1992-11#2)
the H1 receptor##5##3##(1991-6#1)(1992-11#3)(1996-12#1)
the H1##14##2##(1991-6#1)(1992-11#3)(1992-9#2)(1993-6#2)(1994-2#1)(1995-1#1)(1996-12#1)(1996-6#1)(2008-11#1)(2008-2#1)
the H1-H2 domain##2##3##(2013-1#2)
the H120##2##2##(1992-10#1)(2010-4#1)
the H1N1##3##2##(2010-12#1)(2010-4#1)(2011-1#1)
the H1a subtype##3##3##(1992-7#3)
the H1b and H1d subtypes##2##5##(1992-7#2)
the H2 receptor##3##3##(1991-8#1)(1991-9#1)(1994-2#1)
the H2##8##2##(1990-12#1)(1991-8#1)(1991-9#1)(1992-9#1)(1994-2#2)(1995-3#1)(2008-11#1)
the H2A##4##2##(1994-9#3)(2009-5#1)
the H2O2 formed during the irradiation of##2##7##(1990-1#2)
the H2O2##8##2##(1990-1#2)(1997-1#3)(1997-7#2)(1997-8#1)
the H3 loop##2##3##(1996-6#2)
the H3##5##2##(1992-3#1)(1995-1#1)(1996-4#1)(1996-6#2)
the H5##2##2##(1992-9#1)(2008-5#1)
the HA and##3##3##(1993-12#1)(2007-8#1)(2008-5#1)
the HA group##4##3##(2004-9#1)(2011-2#3)
the HA molecular weights##2##4##(2008-5#2)
the HA samples##2##3##(2008-10#1)(2013-8#1)
the HA was##2##3##(1992-9#1)(2008-5#1)
the HA##39##2##(1992-12#1)(1992-9#3)(1993-12#2)(1996-12#1)(1996-7#1)(2004-9#4)(2006-12#1)(2006-7#7)(2007-7#2)(2007-8#1)(2008-10#3)(2008-5#6)(2010-8#1)(2011-2#4)(2013-7#1)(2013-8#1)
the HA1##5##2##(1994-8#3)(1997-6#2)
the HAART era##2##3##(2007-12#1)(2008-3#1)
the HAART##4##2##(2007-12#1)(2008-3#2)(2012-2#1)
the HAD##2##2##(2009-10#1)(2011-1#1)
the HAL##2##2##(2006-12#2)
the HAP nanoparticles##3##3##(2008-5#3)
the HAP##7##2##(2006-6#1)(2008-5#4)(2008-7#2)
the HASYLAB##3##2##(2006-5#1)(2008-2#2)
the HAV##2##2##(1996-4#2)
the HB group##2##3##(2011-2#2)
the HB##3##2##(2011-2#3)
the HB-EGF##2##2##(2013-8#2)
the HBV core##2##3##(1997-4#1)(2008-8#1)
the HBV vaccine##2##3##(2007-12#1)(2008-9#1)
the HBV##14##2##(1993-12#1)(1997-4#3)(2005-10#1)(2007-12#1)(2008-10#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#1)(2013-1#2)
the HBX protein##4##3##(2008-8#4)
the HBsAg##3##2##(2006-12#2)(2008-7#1)
the HC##6##2##(1991-12#1)(2008-10#4)(2012-3#1)
the HC-Pro##4##2##(2008-10#3)(2008-9#1)
the HCA##2##2##(1997-7#1)(2009-8#1)
the HCC##6##2##(1993-2#1)(2006-6#1)(2008-8#2)(2009-8#1)(2011-1#1)
the HCMV##2##2##(1997-3#1)(2013-1#1)
the HCP##3##2##(2008-10#3)
the HCT-8##3##2##(1994-8#1)(1995-7#2)
the HCV core##2##3##(1994-8#2)
the HCV##13##2##(1994-8#2)(1996-2#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-8#3)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
the HCl##3##2##(2008-10#3)
the HD group##2##3##(2010-8#2)
the HD population##2##3##(2007-8#1)(2010-4#1)
the HD region##2##3##(1996-8#2)
the HD sessions##4##3##(2008-1#4)
the HD treatment##2##3##(2010-8#2)
the HD##22##2##(1995-5#1)(1996-6#1)(1996-8#2)(2007-7#3)(2007-8#3)(2008-1#5)(2008-3#2)(2010-4#1)(2010-8#4)
the HDC activity##3##3##(1992-5#3)
the HDC##5##2##(1992-5#3)(1997-1#2)
the HDEL##3##2##(1990-6#2)(1992-2#1)
the HDI of the##2##4##(2010-5#2)
the HDI##3##2##(2010-5#3)
the HDL cholesterol##2##3##(2007-8#1)(2008-4#1)
the HDL##5##2##(1995-3#2)(2007-8#1)(2008-3#1)(2008-4#1)
the HDL-Atherosclerosis Treatment Study (HATS)##2##5##(2008-7#2)
the HDL-C##3##2##(2007-10#1)(2013-1#2)
the HDT##2##2##(2008-5#2)
the HE(11) mode##2##3##(2012-11#2)
the HEC##2##2##(1994-2#1)(2004-9#1)
the HELEX device##2##3##(2008-4#2)
the HELEX##3##2##(2008-4#3)
the HERA##2##2##(2008-2#1)(2008-9#1)
the HERG gene##2##3##(1996-2#1)(2010-8#1)
the HERG##4##2##(1996-2#2)(2008-8#1)(2010-8#1)
the HEV71 strains##3##3##(2013-8#3)
the HEXACO model##3##3##(2008-5#3)
the HF + HClO(4) digestion##2##5##(2008-10#2)
the HF##8##2##(1994-12#2)(2007-11#1)(2008-10#2)(2008-9#2)(2009-3#1)
the HFA group##2##3##(2009-4#2)
the HFA##3##2##(1996-1#1)(2009-4#2)
the HFD test##3##3##(2008-7#3)
the HFED##3##2##(2006-10#3)
the HG##3##2##(2008-10#2)(2009-5#1)
the HGDP-CEPH##2##2##(2012-3#2)
the HGF gene##4##3##(1990-11#3)(1991-6#1)
the HGF receptor##2##3##(1991-11#1)(1991-4#1)
the HGF##8##2##(1990-11#3)(1991-10#1)(1991-11#1)(1991-4#1)(1991-5#1)(1991-6#1)
the HGF/SF##2##2##(1996-5#2)
the HI group##5##3##(1996-5#5)
the HI##12##2##(1992-9#1)(1996-12#1)(1996-5#5)(2008-5#5)
the HIC1##2##2##(2009-8#2)
the HIGH##2##2##(1991-4#1)(1994-9#1)
the HII phase of##2##4##(1996-1#2)
the HII phase##5##3##(1990-12#3)(1996-1#2)
the HII##7##2##(1990-12#4)(1996-1#2)(2012-3#1)
the HIM##3##2##(2007-12#3)
the HIP##2##2##(1995-12#1)(1997-3#1)
the HIPAA privacy regulations##2##4##(2006-8#2)
the HIPAA privacy##5##3##(2005-8#2)(2006-8#2)(2007-12#1)
the HIPAA transactions and code sets rule##3##7##(2006-7#2)(2006-8#1)
the HIPAA##8##2##(2005-8#2)(2006-7#2)(2006-8#3)(2007-12#1)
the HIS Knowledge Hub##2##4##(2012-12#2)
the HIS or RIS##3##4##(2004-9#3)
the HIS##8##2##(1993-12#1)(2004-9#3)(2007-10#1)(2012-12#3)
the HITRAN database##2##3##(2008-2#1)(2008-3#1)
the HITRAN##4##2##(2008-2#3)(2008-3#1)
the HIV epidemic in the##3##5##(1995-1#1)(2007-12#1)(2012-3#1)
the HIV epidemic in##6##4##(1990-12#1)(1991-2#1)(1995-1#1)(2007-12#1)(2012-12#1)(2012-3#1)
the HIV epidemic##26##3##(1990-12#1)(1990-6#1)(1991-2#1)(1992-9#1)(1993-12#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-11#1)(1997-3#1)(2004-9#1)(2006-10#2)(2006-9#1)(2007-12#1)(2007-7#1)(2009-7#1)(2010-5#4)(2011-2#1)(2012-12#1)(2012-3#3)
the HIV infected##4##3##(1993-12#1)(1993-8#1)(1997-3#1)(2013-7#1)
the HIV infection##4##3##(1993-5#1)(1997-5#1)(2006-4#1)(2008-11#1)
the HIV replication cycle##2##4##(2008-4#1)(2011-1#1)
the HIV risk##2##3##(1990-12#1)(2007-7#1)
the HIV transmission##3##3##(1991-1#1)(1996-1#1)(2012-1#1)
the HIV virus##4##3##(1996-11#1)(2007-2#1)(2012-2#2)
the HIV##90##2##(1990-12#2)(1990-6#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-5#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#2)(1996-1#3)(1996-11#2)(1996-5#2)(1996-8#1)(1997-3#3)(1997-5#2)(1997-6#1)(2004-9#1)(2005-6#2)(2005-7#1)(2006-10#2)(2006-4#2)(2006-9#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-7#4)(2008-1#1)(2008-11#1)(2008-4#4)(2008-7#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#2)(2010-5#4)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#3)(2013-7#1)
the HIV-1 LTR##5##3##(1991-3#2)(1993-12#1)(1997-6#1)(2008-4#1)
the HIV-1 antigen test##2##4##(1994-2#2)
the HIV-1 envelope glycoprotein##3##4##(1994-9#1)(1997-4#2)
the HIV-1 envelope##4##3##(1994-8#1)(1994-9#1)(1997-4#2)
the HIV-1 enzyme##2##3##(1990-8#1)(1995-8#1)
the HIV-1 long terminal repeat##6##5##(1990-6#1)(1991-5#2)(1992-12#1)(1994-8#1)(1997-4#1)
the HIV-1 protease##3##3##(1990-8#1)(1991-3#1)(2005-9#1)
the HIV-1##50##2##(1990-6#2)(1990-8#2)(1991-3#3)(1991-5#2)(1992-12#1)(1993-12#1)(1993-9#1)(1994-2#3)(1994-8#4)(1994-9#2)(1995-8#2)(1996-1#1)(1996-10#1)(1997-1#1)(1997-3#1)(1997-4#4)(1997-6#2)(2005-9#1)(2007-11#1)(2008-11#3)(2008-2#1)(2008-4#2)(2011-2#1)(2011-3#3)(2012-1#1)(2013-1#4)
the HIV-2##5##2##(1996-4#3)(1997-5#1)(2012-11#1)
the HIV-infected##3##2##(2006-10#1)(2007-7#1)(2008-11#1)
the HIV-infection##2##2##(1993-1#2)
the HIV-positive##7##2##(1992-12#1)(1993-8#1)(1996-12#1)(1996-5#1)(2007-7#1)(2010-5#1)(2010-8#1)
the HIV/AIDS epidemic##4##3##(2005-7#1)(2007-7#2)(2010-12#1)
the HIV/AIDS patient##2##3##(1996-2#1)(2013-7#1)
the HIV/AIDS##11##2##(1994-2#1)(1996-11#1)(1996-2#1)(2005-7#1)(2006-8#1)(2007-7#2)(2010-12#1)(2011-2#1)(2013-7#2)
the HL##4##2##(1992-12#1)(2007-8#2)(2012-2#1)
the HL-60 cells##2##3##(1994-5#1)(1995-3#1)
the HL-60##6##2##(1993-8#1)(1994-5#2)(1994-8#1)(1995-3#1)(2008-5#1)
the HL-test##2##2##(2006-10#2)
the HL7##3##2##(2010-8#1)(2013-1#2)
the HLA class I##2##4##(2008-4#1)(2011-1#1)
the HLA system##2##3##(1991-11#1)(1997-5#1)
the HLA##17##2##(1991-11#3)(1994-8#1)(1997-5#1)(2006-10#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#3)(2011-1#3)(2011-2#1)
the HLA-A##3##2##(1991-2#1)(1995-8#2)
the HLA-B##2##2##(1997-8#1)(2013-8#1)
the HLA-B27 antigen##2##3##(1990-11#1)(2008-9#1)
the HLA-B27##4##2##(1990-11#2)(1995-1#1)(2008-9#1)
the HLA-DQ##3##2##(1991-2#2)(1997-9#1)
the HLA-DR##2##2##(1991-2#1)(1997-9#1)
the HLH##3##2##(1994-3#1)(2008-8#1)(2011-2#1)
the HM contents in the plant shoots##2##7##(2008-2#2)
the HM##4##2##(2008-10#1)(2008-2#3)
the HMG box##6##3##(1991-11#1)(1993-2#2)(1996-7#2)(2008-8#1)
the HMG##9##2##(1991-11#1)(1993-2#3)(1995-8#1)(1996-7#2)(2008-8#2)
the HMG-CoA reductase inhibitor Pravastatin##2##5##(1991-12#2)
the HMG-CoA reductase inhibitors##2##4##(1994-11#1)(2008-5#1)
the HMG-CoA reductase##5##3##(1991-12#2)(1994-11#1)(1994-9#1)(2008-5#1)
the HMG2 gene##4##3##(1995-2#4)
the HMGCoA reductase##2##3##(1991-6#2)
the HMM##2##2##(1996-12#1)(2008-2#1)
the HMO industry##2##3##(1991-3#2)
the HMO##14##2##(1991-1#2)(1991-3#3)(1993-3#2)(1994-12#1)(1996-2#3)(1997-1#1)(1997-3#1)(2007-2#1)
the HMOs##2##2##(1991-3#1)(1993-12#1)
the HMPS pathway##2##3##(1993-3#2)
the HN##3##2##(2007-6#1)(2008-11#1)(2008-9#1)
the HNDB and##2##3##(1994-3#2)
the HNDB##3##2##(1994-3#3)
the HNE-modified proteins##2##3##(1994-3#2)
the HNF-1 alpha promoter##2##4##(1992-2#2)
the HOE's##3##2##(2008-2#3)
the HOMO##3##2##(1996-5#1)(2007-11#1)(2010-5#1)
the HOOK domain##2##3##(2008-8#2)
the HOOK##3##2##(2008-8#3)
the HOOK-domain##4##2##(2008-8#4)
the HOS##2##2##(2008-3#2)
the HOX##2##2##(1993-9#1)(2007-12#1)
the HP##6##2##(1990-5#1)(1993-8#1)(1996-5#1)(2008-10#1)(2010-5#1)(2013-8#1)
the HPA axis and##2##4##(1990-3#1)(2008-4#1)
the HPA axis is##2##4##(1993-3#1)(2013-1#1)
the HPA axis##27##3##(1990-3#1)(1993-3#1)(1994-2#2)(1995-12#13)(2006-10#1)(2007-11#3)(2007-12#2)(2008-4#2)(2011-2#1)(2013-1#1)
the HPA##31##2##(1990-3#1)(1993-3#1)(1994-11#1)(1994-2#2)(1995-12#14)(1995-5#1)(2006-10#1)(2007-11#3)(2007-12#3)(2008-4#2)(2011-2#1)(2013-1#1)
the HPAA##4##2##(1994-11#3)(1995-12#1)
the HPAEC-PAD##2##2##(1995-2#2)
the HPE spectrum##2##3##(1996-12#2)
the HPE##3##2##(1996-12#3)
the HPLC analysis##3##3##(1995-8#1)(2008-5#1)(2010-12#1)
the HPLC and##3##3##(1993-1#1)(1997-4#1)(2008-8#1)
the HPLC column##4##3##(1993-2#1)(1995-3#1)(1997-3#1)(2008-10#1)
the HPLC determination of##3##4##(2008-10#3)
the HPLC method can##2##4##(2008-10#1)(2012-12#1)
the HPLC method was##3##4##(1990-8#1)(1996-6#1)(2008-10#1)
the HPLC method with##2##4##(2008-10#2)
the HPLC method##17##3##(1990-8#2)(1996-6#1)(1997-3#1)(2008-10#8)(2008-5#1)(2008-6#1)(2009-8#2)(2012-12#1)
the HPLC procedure##2##3##(1995-2#1)(2008-10#1)
the HPLC profiles of##2##4##(1990-8#1)(1992-3#1)
the HPLC separation##2##3##(2008-10#1)(2011-1#1)
the HPLC system and##2##4##(1996-8#1)(1997-3#1)
the HPLC system##9##3##(1990-8#1)(1992-1#1)(1996-6#1)(1996-8#1)(1997-3#2)(1997-8#1)(2008-10#2)
the HPLC##58##2##(1990-6#1)(1990-8#7)(1992-1#1)(1992-3#1)(1993-1#1)(1993-2#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-6#2)(1996-8#2)(1997-3#6)(1997-4#1)(1997-8#1)(2008-10#21)(2008-5#2)(2008-6#2)(2008-8#1)(2009-8#2)(2010-12#1)(2011-1#1)(2012-12#1)
the HPLC-UV##2##2##(2008-10#2)
the HPQ##3##2##(1995-11#2)(2008-6#1)
the HPQ-PS##2##2##(2008-6#2)
the HPSAM and GHPSAM##2##4##(2008-10#2)
the HPSAM##3##2##(2008-10#3)
the HPSP##3##2##(2012-3#3)
the HPTLC##2##2##(2008-10#1)(2010-5#1)
the HPV vaccine##6##3##(2008-11#1)(2011-2#1)(2013-1#4)
the HPV##14##2##(1991-2#2)(1996-7#1)(2008-11#1)(2011-1#2)(2011-2#4)(2013-1#4)
the HPV-11##2##2##(1996-7#2)
the HR deceleration##2##3##(2013-8#2)
the HR in##2##3##(2008-10#2)
the HR##15##2##(1996-3#1)(2008-10#5)(2008-11#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#5)
the HRCT##3##2##(2005-8#1)(2011-2#1)(2012-2#1)
the HRE##2##2##(1997-4#2)
the HRG ligand##2##3##(1995-3#2)
the HRQL##2##2##(2006-10#2)
the HRQoL##2##2##(2006-2#1)(2012-2#1)
the HRS##3##2##(1995-5#2)(1997-7#1)
the HRT##2##2##(2008-3#1)(2008-5#1)
the HS concentration##2##3##(2008-10#2)
the HS##6##2##(2008-10#5)(2013-8#1)
the HS-SPME##2##2##(2007-8#1)(2008-10#1)
the HS2core DNA sequence which##2##5##(2008-8#2)
the HS2core DNA sequence##3##4##(2008-8#3)
the HSA##8##2##(1994-8#1)(1996-1#2)(2005-11#2)(2008-10#1)(2008-3#1)(2008-4#1)
the HSA-hormone binding and##2##4##(2008-10#2)
the HSAD system is##2##4##(2008-6#2)
the HSAD system##4##3##(2008-6#4)
the HSC niche##3##3##(2008-9#3)
the HSC##4##2##(2008-9#3)(2012-12#1)
the HSCCC##2##2##(2008-10#1)(2011-1#1)
the HSD##3##2##(2006-10#3)
the HSE hypothesis##2##3##(2013-1#2)
the HSE##6##2##(1991-9#1)(1994-8#1)(1995-5#1)(2013-1#2)(2013-7#1)
the HSGC##2##2##(2008-10#2)
the HSI##2##2##(2008-5#1)(2012-2#1)
the HSP##7##2##(1993-4#1)(1994-11#3)(2008-10#1)(2012-3#2)
the HSP60##2##2##(2006-8#2)
the HSP70 gene##4##3##(1994-8#2)(1996-2#1)(2010-2#1)
the HSP70##9##2##(1994-6#1)(1994-8#2)(1996-2#1)(2006-8#1)(2008-10#2)(2010-2#1)(2012-3#1)
the HSS##4##2##(2007-11#1)(2008-8#3)
the HSV-2##2##2##(2011-1#2)
the HSs function independently##2##4##(1997-4#2)
the HT plan##2##3##(2008-11#2)
the HT-29##2##2##(1991-9#1)(1995-3#1)
the HTH##2##2##(1992-4#1)(2008-7#1)
the HTLV-1##2##2##(2012-12#2)
the HTLV-I protein p27rex##2##4##(1991-2#2)
the HTLV-I##4##2##(1991-12#1)(1991-2#2)(1991-8#1)
the HTS group##2##3##(2008-10#2)
the HUT11##2##2##(1995-6#2)
the HV pulse##2##3##(2009-10#2)
the HV##4##2##(2009-10#4)
the HVLV##2##2##(2009-10#2)
the HVTN##2##2##(2012-12#2)
the HWST##2##2##(2010-4#2)
the HY##2##2##(1990-10#2)
the HYP and AMB##2##4##(1993-12#2)
the HZA indices##2##3##(2006-5#2)
the HZA##4##2##(2006-5#4)
the HaCaT##2##2##(1997-1#1)(2008-11#1)
the HaRGC1 cluster##3##3##(2006-12#3)
the Hach##2##2##(2008-10#2)
the Hacinas monster##2##3##(2009-10#2)
the Hacinas##4##2##(2009-10#4)
the Hadamard matrix##2##3##(2007-8#1)(2008-3#1)
the Hadamard##5##2##(2007-8#3)(2008-10#1)(2008-3#1)
the Haddon Matrix##3##3##(2008-2#3)
the Haemophilus influenzae type b##2##5##(1995-5#1)(2007-2#1)
the Haemophilus influenzae##5##3##(1995-5#1)(1996-10#1)(2007-2#1)(2008-11#1)(2008-7#1)
the Hagen's glands##2##3##(2007-12#2)
the Hagen's##3##2##(2007-12#3)
the Hajj##4##2##(2007-2#1)(2009-9#3)
the Hall coefficient##2##3##(1992-3#1)(1993-3#1)
the Hall##9##2##(1992-3#1)(1993-3#2)(2008-10#2)(2009-5#1)(2013-1#3)
the Hamilton Depression Rating Scale##2##5##(1997-3#1)(2011-2#1)
the Hamilton Depression Rating##3##4##(1996-2#1)(1997-3#1)(2011-2#1)
the Hamilton Rating Scale for##2##5##(1996-2#1)(1996-3#1)
the Hamilton##6##2##(1995-12#1)(1996-2#2)(1996-3#1)(1997-3#1)(2011-2#1)
the Hamilton-Zuk hypothesis or the immunocompetence##2##6##(2008-8#2)
the Hamiltonian parameters##2##3##(2007-12#1)(2009-5#1)
the Hammett##2##2##(2008-10#1)(2008-8#1)
the Han##2##2##(2008-8#1)(2011-1#1)
the Hap particles##2##3##(2005-11#2)
the Hardy-Weinberg expectation##2##3##(2008-10#1)(2008-5#1)
the Hardy-Weinberg##4##2##(2008-10#1)(2008-5#2)(2013-8#1)
the Harran##5##2##(2008-12#5)
the Harrington method##2##3##(2007-7#2)
the Harrington##3##2##(2007-7#3)
the Harris##3##2##(2007-7#2)(2008-3#1)
the Hartmann test##3##3##(2008-3#3)
the Hartmann##5##2##(2008-10#1)(2008-2#1)(2008-3#3)
the Harvard Medical##3##3##(1992-1#1)(1993-3#1)(2013-1#1)
the Harvard##8##2##(1990-11#1)(1992-1#1)(1993-3#1)(1997-2#1)(2008-1#1)(2010-5#1)(2011-2#1)(2013-1#1)
the Harvey##2##2##(1992-12#1)(1992-7#1)
the Haversian canals##3##3##(1995-6#2)(2013-1#1)
the Haversian##5##2##(1995-6#2)(2013-1#3)
the Hawaii##3##2##(1991-7#1)(1995-1#1)(2007-10#1)
the Hawaiian##4##2##(1996-6#1)(2008-3#1)(2008-4#1)(2008-8#1)
the Hayward##2##2##(2007-9#2)
the Hazard##3##2##(1993-3#1)(1996-12#1)(2009-6#1)
the Hazardous##2##2##(1996-12#1)(2007-10#1)
the Hb##4##2##(1991-2#1)(1992-9#1)(1995-8#1)(2011-2#1)
the HbA1c##2##2##(2007-10#1)(2011-1#1)
the HbO-HA ELISA##2##3##(1990-12#2)
the Hct was##2##3##(1994-12#1)(1997-6#1)
the He##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
the HeLa cell##2##3##(1991-3#1)(2008-11#1)
the HeLa##6##2##(1990-4#1)(1991-3#1)(1992-3#1)(1997-4#1)(2008-11#2)
the Head##2##2##(2008-6#1)(2009-4#1)
the Health Belief Model (HBM)##2##5##(2008-4#1)(2011-1#1)
the Health Belief Model##3##4##(1990-8#1)(2008-4#1)(2011-1#1)
the Health Care Financing Administration (HCFA) to##3##7##(1994-1#1)(1995-12#1)(1997-3#1)
the Health Care Financing Administration (HCFA)##12##6##(1994-1#2)(1994-12#1)(1994-3#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-2#3)(1997-3#1)(2006-8#1)
the Health Care Financing Administration is##2##6##(1994-2#1)(1997-3#1)
the Health Care Financing Administration##21##5##(1991-1#1)(1991-2#2)(1991-3#1)(1992-1#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-12#1)(1996-2#2)(1996-3#1)(1997-2#3)(1997-3#2)(2006-8#1)
the Health Care Financing Administration's##3##5##(1993-2#1)(1996-2#1)(2005-9#1)
the Health Care Financing##30##4##(1991-1#1)(1991-2#2)(1991-3#1)(1992-1#1)(1992-2#1)(1993-2#1)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-12#1)(1996-1#1)(1996-2#4)(1996-3#2)(1997-2#3)(1997-3#3)(2005-9#1)(2006-8#1)
the Health Care Quality Improvement Act of 1986##2##8##(1990-12#1)(1991-1#1)
the Health Care Quality Improvement Act##6##6##(1990-12#1)(1991-1#2)(1991-3#1)(1992-2#1)(1994-1#1)
the Health Care Quality Improvement##8##5##(1990-12#1)(1991-1#2)(1991-3#1)(1992-2#1)(1993-2#1)(1994-1#1)(1996-2#1)
the Health Care Quality##9##4##(1990-12#1)(1991-1#2)(1991-3#1)(1992-2#1)(1993-2#1)(1994-1#1)(1996-2#2)
the Health Care##45##3##(1990-12#1)(1991-1#3)(1991-2#2)(1991-3#2)(1992-1#1)(1992-2#2)(1993-2#2)(1993-5#1)(1994-1#4)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1995-12#1)(1996-1#1)(1996-2#6)(1996-3#3)(1997-2#3)(1997-3#3)(2005-9#1)(2006-8#1)(2008-11#1)(2013-8#1)
the Health Council##2##3##(1996-8#2)
the Health Education##2##3##(2004-10#1)(2012-3#1)
the Health Information##2##3##(2009-6#1)(2010-2#1)
the Health Insurance Portability and Accountability Act (HIPAA)##2##8##(2006-8#1)(2007-12#1)
the Health Insurance Portability and Accountability Act of 1996 (HIPAA)##3##10##(2006-8#2)(2007-4#1)
the Health Insurance Portability and Accountability Act##5##7##(2006-8#3)(2007-12#1)(2007-4#1)
the Health Insurance##6##3##(1994-2#1)(2006-8#3)(2007-12#1)(2007-4#1)
the Health Level 7 CDS Work Group reviewed the literature##2##10##(2013-1#2)
the Health Level 7##4##4##(2013-1#4)
the Health Level##5##3##(2013-1#5)
the Health Sector Database##3##4##(2006-10#3)
the Health Services##3##3##(1996-1#1)(1997-2#1)(2010-3#1)
the Health Utilities Index##2##4##(2007-10#1)(2007-9#1)
the Health Utilities##3##3##(2007-10#2)(2007-9#1)
the Health and Retirement Study##3##5##(2009-12#1)(2010-11#1)(2010-2#1)
the Health and Safety##2##4##(2004-12#1)(2011-2#1)
the Health and Social##2##4##(1994-1#1)(2011-2#1)
the Health and##13##3##(1993-11#1)(1994-1#1)(1995-6#2)(2004-12#1)(2007-2#1)(2008-10#1)(2009-12#1)(2010-11#1)(2010-2#1)(2011-2#2)(2012-3#1)
the Health e-Technologies Initiative##2##4##(2007-10#2)
the Health##112##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-1#3)(1991-12#1)(1991-2#3)(1991-3#2)(1992-1#1)(1992-2#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-5#1)(1994-1#5)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#1)(1994-7#1)(1995-1#1)(1995-12#1)(1995-6#2)(1996-1#2)(1996-2#7)(1996-3#4)(1996-8#2)(1997-2#6)(1997-3#3)(2004-10#1)(2004-12#1)(2005-9#1)(2006-10#3)(2006-2#1)(2006-8#4)(2007-10#4)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-2#2)(2010-3#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
the Healthcare##5##2##(2007-12#2)(2008-11#1)(2008-12#1)(2008-9#1)
the Healthy Moves##2##3##(2010-2#2)
the Healthy##4##2##(1994-3#1)(1995-1#1)(2010-2#2)
the Heaney method##2##3##(1995-12#2)
the Heaney##3##2##(1995-12#3)
the Heart of##2##3##(2007-2#1)(2007-9#1)
the Heart##4##2##(2007-2#1)(2007-9#1)(2008-4#1)(2010-6#1)
the Hebrew##4##2##(2008-4#1)(2009-11#1)(2011-2#2)
the Hebrides##2##2##(1996-6#2)
the Hedgehog pathway##2##3##(2013-7#2)
the Hedgehog##4##2##(2008-9#2)(2013-7#2)
the Heisenberg##2##2##(1993-8#1)(2012-2#1)
the Helicobacter pylori##4##3##(1996-11#2)(2006-2#1)(2008-5#1)
the Helicobacter##5##2##(1996-11#2)(2006-2#1)(2007-5#1)(2008-5#1)
the Hellenic##2##2##(2006-10#1)(2008-5#1)
the Helmholtz-Kirchhoff##2##2##(2007-12#1)(2008-2#1)
the Helsinki area##3##3##(1992-3#3)
the Helsinki##7##2##(1992-3#3)(1992-8#1)(2008-2#1)(2008-7#1)(2010-9#1)
the Hematology##5##2##(2008-9#3)(2012-2#1)(2013-8#1)
the Henderson##2##2##(1994-3#1)(2008-10#1)
the Hep G2##2##3##(1991-4#1)(1992-11#1)
the HepG2 cell line##5##4##(1992-3#3)(1993-12#1)(2007-10#1)
the HepG2 cell##6##3##(1992-3#3)(1993-12#1)(1996-5#1)(2007-10#1)
the HepG2##8##2##(1992-3#3)(1993-12#1)(1996-5#1)(2007-10#3)
the Hepatic##2##2##(2008-4#1)(2008-6#1)
the Hepatitis B##2##3##(2008-10#1)(2008-11#1)
the Hermite##2##2##(2009-12#2)
the Hermite-Gaussian modes##2##3##(2007-12#2)
the Herpes##2##2##(1996-5#1)(2009-4#1)
the Herpesviridae##2##2##(2006-10#1)(2008-9#1)
the Herring classification##2##3##(2007-7#2)
the Herring system##2##3##(2007-7#2)
the Herring##5##2##(2007-7#5)
the Hertfordshire##3##2##(2008-11#1)(2012-12#2)
the Hes-1##2##2##(1994-8#2)
the Hessian##6##2##(2006-4#4)(2008-3#2)
the Hg electrode##4##3##(2008-10#4)
the Hg##8##2##(2007-11#1)(2008-10#7)
the Hg(2+)##2##2##(2008-10#2)
the Hg(II)##4##2##(2008-10#4)
the Hg(II)/HS ratio##2##3##(2008-10#2)
the Hg-agarose column##3##3##(1990-12#3)
the Hg-agarose##4##2##(1990-12#4)
the Hg-agarose-bound nucleosomes##3##3##(1990-12#3)
the HgCdTe detector##2##3##(2008-2#2)
the HgI(2)##2##2##(2008-3#2)
the HiPco composite##3##3##(2008-10#3)
the HiPco##5##2##(2008-10#5)
the HiRIS##4##2##(2008-10#4)
the High Court##2##3##(1995-6#2)
the High Energy##2##3##(2006-5#1)(2007-8#1)
the High Resolution##4##3##(2007-8#1)(2008-2#1)(2008-3#1)(2011-1#1)
the High Throughput Screening##2##4##(2009-6#2)
the High##20##2##(1992-12#1)(1993-4#1)(1995-6#2)(2006-5#1)(2007-8#2)(2008-11#1)(2008-2#1)(2008-3#2)(2009-6#2)(2009-8#1)(2011-1#1)(2012-12#2)(2012-7#1)(2013-1#2)
the High-##2##2##(2008-10#1)(2008-3#1)
the High-Resolution##2##2##(2008-3#1)(2013-8#1)
the Higher##3##2##(1995-3#1)(2008-11#1)(2012-3#1)
the Hilbert transform##3##3##(2008-11#1)(2008-2#1)(2012-1#1)
the Hilbert transformation##2##3##(1996-6#1)(2007-11#1)
the Hilbert##5##2##(1996-6#1)(2007-11#1)(2008-11#1)(2008-2#1)(2012-1#1)
the Hill coefficient was##3##4##(1991-1#1)(1993-8#1)(1995-11#1)
the Hill coefficient##12##3##(1990-11#1)(1991-1#2)(1991-5#1)(1993-3#1)(1993-8#1)(1994-6#1)(1995-11#2)(1997-1#1)(1997-6#1)(2008-8#1)
the Hill##15##2##(1990-11#1)(1990-8#1)(1991-1#2)(1991-5#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-6#1)(1995-11#2)(1997-1#1)(1997-6#1)(2007-10#1)(2008-8#1)
the Hill-Robertson effect##2##3##(1995-11#2)
the Himalayan##4##2##(2008-7#1)(2008-8#1)(2011-2#2)
the Hira##2##2##(2008-7#2)
the His residue##2##3##(1991-4#2)
the His##5##2##(1991-4#2)(1994-8#1)(1995-11#1)(1996-7#1)
the Hispanic population##2##3##(2005-10#1)(2010-8#1)
the Hispanic##5##2##(2005-10#2)(2010-8#2)(2012-2#1)
the History of##4##3##(1994-2#1)(1995-12#1)(2010-6#1)(2013-1#1)
the Hitachi##2##2##(1990-8#1)(2008-10#1)
the Ho##3##2##(2007-12#2)(2008-3#1)
the Hodgkin##2##2##(1997-6#1)(1997-7#1)
the Hoehn##2##2##(2008-7#1)(2013-8#1)
the Hofmeister##4##2##(2009-10#2)(2009-2#1)(2012-2#1)
the Holliday##2##2##(2006-10#1)(2012-3#1)
the Holy##5##2##(1993-12#1)(2006-11#1)(2013-8#3)
the Home Health##2##3##(1994-2#1)(1995-3#1)
the Home##5##2##(1991-2#1)(1994-2#1)(1995-3#1)(2006-10#1)(2006-12#1)
the Homemakers' Clubs of Saskatchewan##2##5##(2009-7#2)
the Hong Kong##6##3##(2005-8#2)(2008-8#1)(2010-2#1)(2011-1#1)(2012-6#1)
the Honiara##2##2##(2012-12#2)
the Hopfield##2##2##(2008-2#1)(2008-3#1)
the Hopkins##2##2##(2006-4#1)(2012-1#1)
the Hosmer-Lemeshow goodness-of-fit test##2##4##(2013-1#2)
the Hosmer-Lemeshow statistic##2##3##(2006-6#2)
the Hosmer-Lemeshow##5##2##(2006-6#2)(2007-8#1)(2013-1#2)
the Hospice##2##2##(1993-12#1)(2005-4#1)
the Hospital Anxiety and Depression Scale (HADS)##2##7##(2007-11#1)(2008-10#1)
the Hospital Medical Records Institute (HMRI)##2##6##(1993-12#1)(1994-3#1)
the Hospital for Special Surgery##3##5##(2008-8#2)(2009-3#1)
the Hospital for the Ruptured and Crippled##4##7##(2008-8#4)
the Hospital for##8##3##(2008-8#6)(2009-3#1)(2013-8#1)
the Hospital of##3##3##(1993-5#1)(2007-9#1)(2013-8#1)
the Hospital##32##2##(1990-9#1)(1993-12#1)(1993-5#1)(1994-3#1)(1995-2#1)(1996-2#1)(2006-2#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#7)(2009-3#1)(2009-7#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-1#2)(2013-8#4)
the Hospital's##2##2##(2008-11#1)(2008-12#1)
the Host##3##2##(2008-10#3)
the House of Delegates of the International Federation of Dental##2##10##(2006-2#2)
the House of##5##3##(1991-10#1)(2006-2#2)(2008-11#1)(2011-1#1)
the House version##3##3##(1995-6#3)
the House##15##2##(1991-10#2)(1995-12#1)(1995-6#5)(1996-5#1)(1996-6#1)(1997-2#1)(2006-2#2)(2008-11#1)(2011-1#1)
the Howard##2##2##(2008-9#1)(2013-1#1)
the Hox clusters##2##3##(2008-1#1)(2011-12#1)
the Hox gene##3##3##(2007-12#1)(2008-1#2)
the Hox##8##2##(1990-11#1)(2007-12#2)(2008-1#3)(2010-12#1)(2011-12#1)
the Hox-2##2##2##(1990-11#2)
the Hoxa-2##2##2##(1993-12#2)
the Hpa II##2##3##(1990-12#1)(1995-10#1)
the HrcC protein##2##3##(2008-10#2)
the Hsp70##4##2##(1991-9#2)(1995-4#1)(2009-5#1)
the Hsp90##5##2##(1995-3#3)(2008-4#1)(2010-4#1)
the Ht1 gene##7##3##(2008-10#7)
the Ht1##8##2##(2008-10#8)
the HtrA stress-response##2##3##(1996-10#2)
the HtrA##3##2##(1996-10#3)
the Hubbard##2##2##(1993-3#1)(1997-4#1)
the Hubble Space Telescope##7##4##(1990-11#1)(1997-5#1)(2008-2#4)(2008-3#1)
the Hubble constant##3##3##(1997-5#1)(2006-7#2)
the Hubble##11##2##(1990-11#1)(1997-5#3)(2006-7#2)(2008-2#4)(2008-3#1)
the Human Fertilisation and Embryology##2##5##(2006-11#2)
the Human Genome Project##7##4##(1990-6#1)(1994-9#1)(2007-3#2)(2008-4#1)(2008-7#1)(2009-5#1)
the Human Genome##12##3##(1990-6#1)(1994-9#2)(2007-3#2)(2008-4#4)(2008-5#1)(2008-7#1)(2009-5#1)
the Human Rights##2##3##(1996-5#1)(1997-5#1)
the Human##34##2##(1990-6#1)(1994-9#2)(1996-5#1)(1997-5#1)(2005-8#1)(2006-11#4)(2007-3#2)(2007-4#2)(2008-10#1)(2008-11#1)(2008-4#5)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#2)
the Hungarian##9##2##(1993-1#1)(1993-5#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-6#1)(2005-7#1)(2005-8#1)(2012-2#1)
the Hunger##2##2##(2012-12#2)
the Hunter Region##4##3##(2007-10#4)
the Huntington disease##2##3##(1995-5#1)(2007-11#1)
the Huntington's disease##4##3##(1996-8#2)(2011-2#1)(2012-2#1)
the Huntington's##5##2##(1995-9#1)(1996-8#2)(2011-2#1)(2012-2#1)
the HupBF3##2##2##(1990-11#2)
the Huygens-Fresnel principle##3##3##(2008-2#1)(2008-3#2)
the Hv-p68 gene##2##3##(2008-10#2)
the Hv-p68##3##2##(2008-10#3)
the HvirGABAB-R1##2##2##(2013-8#2)
the Hybrid III 3-year-old##4##4##(2007-4#4)
the Hybrid III 3-yearold##2##4##(2007-4#2)
the Hybrid III and CRABI families of frontal impact dummies##2##10##(2006-11#2)
the Hybrid III and##8##4##(2006-11#7)(2007-4#1)
the Hybrid III are##2##4##(2006-11#2)
the Hybrid III dummy##2##4##(2007-4#2)
the Hybrid III##40##3##(2006-11#19)(2007-4#21)
the Hybrid##41##2##(2006-11#19)(2007-4#21)(2011-2#1)
the Hydrogen Bond##2##3##(2008-10#1)(2009-10#1)
the Hydrogen##3##2##(1991-8#1)(2008-10#1)(2009-10#1)
the Hydrolight radiative transfer model##2##5##(2008-3#2)
the Hydrolight radiative transfer##3##4##(2008-3#3)
the Hydrolight##6##2##(2008-2#1)(2008-3#5)
the Hypersensitive Response##2##3##(2008-10#2)
the Hückel##2##2##(2008-10#2)
the I (ATP)##4##3##(2008-4#4)
the I allele##3##3##(2008-10#2)(2012-11#1)
the I and##3##3##(1996-8#1)(2008-10#2)
the I form##3##3##(1991-4#3)
the I locus##2##3##(2012-11#2)
the I phase of starvation##2##5##(2013-1#2)
the I##33##2##(1991-4#3)(1992-2#1)(1995-8#1)(1996-8#2)(2006-5#1)(2007-5#1)(2008-10#5)(2008-4#7)(2010-4#1)(2011-1#1)(2011-2#3)(2012-11#4)(2013-1#2)(2013-8#1)
the I'-form##6##2##(1994-11#6)
the I-V##2##2##(1993-12#1)(1996-10#1)
the I-numbers##2##2##(2007-8#2)
the I1/I3 ratio##2##3##(2005-11#2)
the I2##3##2##(2008-12#3)
the IA##3##2##(1992-8#1)(2010-3#1)(2012-2#1)
the IABP##3##2##(2007-8#1)(2010-8#2)
the IAC##5##2##(2006-5#2)(2008-10#3)
the IACh##5##2##(1991-8#2)(1997-1#3)
the IAEA##2##2##(1993-11#1)(2008-10#1)
the IAHSS##4##2##(1992-12#2)(1993-2#1)(1997-2#1)
the IAI##3##2##(2008-12#3)
the IAM##5##2##(1996-6#5)
the IAPP##3##2##(1992-1#2)(1992-12#1)
the IAR translates in the##2##5##(2012-2#2)
the IAR##4##2##(2012-2#4)
the IAT##7##2##(1993-9#1)(1994-9#4)(2008-4#2)
the IAsys##3##2##(2008-4#3)
the IBD##2##2##(2009-9#1)(2011-2#1)
the IBG System##2##3##(1994-6#2)
the IBGE##2##2##(1991-9#2)
the IBM##4##2##(1996-12#1)(2008-8#1)(2012-3#2)
the IBV##5##2##(1997-6#4)(2008-5#1)
the IBZM##2##2##(1996-12#2)
the IC columns##2##3##(2008-10#2)
the IC##13##2##(1990-7#1)(1991-3#1)(1996-4#1)(2007-1#1)(2008-10#7)(2008-5#1)(2013-7#1)
the IC(50) value##2##3##(2008-7#1)(2011-2#1)
the IC(50) values##3##3##(2008-11#1)(2008-7#1)(2013-1#1)
the IC(50)##5##2##(2008-11#1)(2008-7#2)(2011-2#1)(2013-1#1)
the IC50 for##3##3##(1994-3#1)(1996-3#1)(1997-2#1)
the IC50 of##2##3##(1995-12#1)(1995-7#1)
the IC50 value for##3##4##(1992-6#1)(1996-2#1)(1997-7#1)
the IC50 values were##2##4##(1995-8#1)(2012-2#1)
the IC50 values##4##3##(1993-11#1)(1995-8#1)(1997-1#1)(2012-2#1)
the IC50##16##2##(1992-6#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-7#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-7#1)(2012-12#2)(2012-2#1)
the ICA##11##2##(1997-3#2)(2005-5#1)(2005-9#1)(2006-12#1)(2007-8#1)(2007-9#1)(2012-12#1)(2012-3#1)(2013-1#2)
the ICBI##2##2##(2007-11#2)
the ICCs##2##2##(1997-6#2)
the ICD##4##2##(1994-3#1)(2006-12#1)(2008-10#1)(2012-2#1)
the ICD-10 map##6##3##(2013-1#6)
the ICD-10##9##2##(1995-4#1)(2006-8#1)(2012-2#1)(2013-1#6)
the ICDSC##2##2##(2007-11#2)
the ICEUs##3##2##(2008-7#3)
the ICF##5##2##(2011-2#4)(2012-12#1)
the ICG##3##2##(1995-11#3)
the ICH##4##2##(2008-10#3)(2010-11#1)
the ICM##3##2##(2006-5#1)(2007-12#1)(2008-5#1)
the ICP level##2##3##(2008-7#2)
the ICP##5##2##(1996-9#1)(2008-10#2)(2008-7#2)
the ICP-AES method##3##3##(2008-10#3)
the ICP-AES##4##2##(2008-10#4)
the ICP-MS determination##2##3##(2008-10#2)
the ICP-MS##9##2##(2008-10#9)
the ICPD##5##2##(1994-9#5)
the ICR##3##2##(1990-3#1)(2008-10#1)(2011-2#1)
the ICRP##3##2##(1996-6#1)(1997-8#1)(2013-1#1)
the ICSH/ISLH reference method##2##4##(2008-10#2)
the ICU and##4##3##(1996-9#1)(2007-12#1)(2008-5#1)(2009-6#1)
the ICU as##2##3##(2006-4#1)(2008-3#1)
the ICU experience##2##3##(1992-2#1)(1995-12#1)
the ICU is##2##3##(1991-2#1)(2011-12#1)
the ICU with##2##3##(2009-6#1)(2013-1#1)
the ICU##50##2##(1991-2#3)(1992-2#5)(1995-12#1)(1996-9#3)(2004-1#2)(2005-10#2)(2005-8#4)(2006-10#5)(2006-4#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#2)(2010-11#3)(2010-12#1)(2010-5#1)(2010-7#1)(2011-12#1)(2012-3#1)(2013-1#3)(2013-8#3)
the ICs##4##2##(2008-8#4)
the ID50##3##2##(1991-12#1)(1992-2#1)(1995-3#1)
the IDA##2##2##(2008-10#1)(2008-2#1)
the IDH##4##2##(2008-9#4)
the IDO##2##2##(1992-11#2)
the IDP##5##2##(2008-7#5)
the IDPN-treated rats##4##3##(1993-2#4)
the IDS-C(30) and IDS-SR(30)##2##4##(2007-12#2)
the IE1##2##2##(1993-8#2)
the IEC##2##2##(2006-10#2)
the IF##2##2##(2007-3#2)
the IF2##2##2##(1990-3#2)
the IFAT##3##2##(1997-3#2)(2008-5#1)
the IFCC##2##2##(1994-12#1)(2008-10#1)
the IFM##2##2##(2008-9#1)(2009-9#1)
the IFN-gamma inducible IDO##2##4##(2008-11#2)
the IFN-gamma secretion##2##3##(2008-10#1)(2008-11#1)
the IFN-gamma##8##2##(1996-12#1)(1996-2#1)(2006-10#1)(2008-10#1)(2008-11#4)
the IFN-inducible RNase L##2##4##(2007-1#2)
the IFN-inducible##3##2##(2007-1#3)
the IFNbeta-1a preparations##2##3##(2007-11#2)
the IFSP process##2##3##(1991-12#2)
the IGF##2##2##(2008-5#1)(2010-3#1)
the IGF-1 receptor##3##3##(1990-11#1)(1994-11#1)(2010-11#1)
the IGF-1##5##2##(1990-11#1)(1994-11#2)(2008-4#1)(2010-11#1)
the IGF-1R##2##2##(1996-11#2)
the IGF-I gene##3##3##(1992-9#1)(1995-10#1)(2008-11#1)
the IGF-I receptor and##2##4##(1993-9#1)(1996-2#1)
the IGF-I receptor in##2##4##(1990-9#2)
the IGF-I receptor##9##3##(1990-9#3)(1991-5#1)(1993-9#2)(1994-12#1)(1996-2#1)(2008-5#1)
the IGF-I##15##2##(1990-9#3)(1991-5#1)(1992-9#2)(1993-9#2)(1994-12#1)(1995-10#1)(1996-2#2)(1997-5#1)(2008-11#1)(2008-5#1)
the IGF-II##5##2##(1992-9#3)(1994-9#1)(2008-6#1)
the IGF-II/Man6P receptor##3##3##(1990-5#3)
the IGFIR##5##2##(1995-6#5)
the IGKC##2##2##(1997-8#2)
the IGS##2##2##(2008-10#2)
the IHA##6##2##(1992-5#6)
the IHR##3##2##(2008-1#2)(2010-5#1)
the II phase##2##3##(2013-1#2)
the II##3##2##(1993-8#1)(2013-1#2)
the IIA##5##2##(1992-2#3)(1995-1#2)
the IIB promoter##2##3##(1995-6#2)
the III##2##2##(2008-4#1)(2012-3#1)
the IIP##2##2##(2007-8#1)(2009-7#1)
the IKDC##3##2##(2007-7#1)(2009-9#1)(2013-1#1)
the IL and##2##3##(2010-4#2)
the IL##7##2##(1997-2#1)(2008-11#1)(2010-4#5)
the IL-1 beta precursor##2##4##(1992-4#1)(1995-2#1)
the IL-1 beta##6##3##(1992-4#1)(1995-2#2)(1996-12#2)(2008-4#1)
the IL-1 receptor antagonist##3##4##(1993-11#1)(1994-10#1)(1995-2#1)
the IL-1##13##2##(1990-9#1)(1992-4#1)(1992-5#2)(1993-11#1)(1994-10#1)(1995-2#3)(1996-12#2)(2007-11#1)(2008-4#1)
the IL-10##2##2##(1994-8#1)(2008-11#1)
the IL-12##2##2##(2008-8#2)
the IL-13##3##2##(2007-2#2)(2012-2#1)
the IL-13R alpha 2##2##4##(2008-8#2)
the IL-2 NF-AT##2##3##(1995-3#2)
the IL-2 promoter##2##3##(1994-11#1)(1996-5#1)
the IL-2 receptor##5##3##(1991-9#1)(1995-3#1)(1995-8#1)(2004-12#1)(2007-11#1)
the IL-2##15##2##(1991-9#1)(1992-5#1)(1994-11#2)(1994-5#1)(1995-3#3)(1995-8#1)(1996-5#1)(2004-12#1)(2007-11#1)(2008-8#1)(2010-2#2)
the IL-22 gene##2##3##(2012-2#2)
the IL-2R alpha##2##3##(1994-9#1)(1995-8#1)
the IL-3 receptor##2##3##(1990-12#1)(1993-12#1)
the IL-4##3##2##(1995-5#1)(2008-1#1)(2009-5#1)
the IL-6##13##2##(1990-5#2)(1992-6#2)(1994-2#1)(1995-2#1)(1996-2#2)(1996-5#1)(2007-8#1)(2009-6#2)(2012-3#1)
the IL2##4##2##(1991-10#1)(1996-2#1)(2010-12#2)
the ILBD cases##2##3##(2012-1#2)
the ILL algorithm##2##3##(2008-3#2)
the ILS in##3##3##(2008-10#2)(2008-3#1)
the ILS##6##2##(2008-10#4)(2008-3#2)
the ILTV##3##2##(1993-12#1)(2013-8#2)
the IMA graft##2##3##(2007-8#2)
the IMA##3##2##(2007-8#2)(2009-10#1)
the IMAC and##2##3##(2005-8#2)
the IMAC##4##2##(2005-8#2)(2007-8#1)(2012-3#1)
the IMC technique##2##3##(2008-3#2)
the IMC##3##2##(2008-3#3)
the IMG##3##2##(2008-2#2)(2008-3#1)
the IMI##2##2##(2013-1#2)
the IML##7##2##(1991-3#5)(1993-12#1)(1995-12#1)
the IMMP##4##2##(2008-11#1)(2008-8#3)
the IMR##2##2##(1994-5#1)(2013-1#1)
the IMRT treatment##2##3##(2009-10#2)
the IMS##6##2##(2008-10#6)
the IMx##3##2##(1992-6#2)(1996-4#1)
the IN isolate##2##3##(2008-10#2)
the IN subtype##5##3##(2008-2#5)
the IN##9##2##(1995-12#1)(2008-10#3)(2008-2#5)
the INM##3##2##(2009-9#1)(2011-2#2)
the IOF##2##2##(2009-9#2)
the IOM report##3##3##(2007-3#1)(2013-1#2)
the IOM##5##2##(2007-12#1)(2007-3#1)(2010-3#1)(2013-1#2)
the ION##3##2##(1995-11#2)(2010-12#1)
the IOP##8##2##(2008-3#1)(2008-4#1)(2011-2#2)(2013-7#1)(2013-8#3)
the IOR effect##2##3##(2008-2#2)
the IOR##3##2##(1997-4#1)(2008-2#2)
the IP##5##2##(2006-12#3)(2006-5#1)(2008-5#1)
the IP(L) condition##2##3##(2008-10#2)
the IP3 receptor##4##3##(1995-3#3)(1997-4#1)
the IP3##6##2##(1991-2#1)(1994-8#1)(1995-3#3)(1997-4#1)
the IP3-sensitive Ca2+ pool is##2##5##(1990-10#1)(1991-10#1)
the IP3-sensitive Ca2+##4##3##(1990-10#1)(1991-10#1)(1993-8#2)
the IPA##2##2##(1997-3#2)
the IPC##2##2##(2007-8#1)(2013-1#1)
the IPD##2##2##(2008-10#1)(2008-7#1)
the IPM##2##2##(1990-6#1)(2007-12#1)
the IPS##2##2##(1996-9#1)(2008-10#1)
the IPSF##2##2##(2008-11#2)
the IPT##3##2##(2007-8#3)
the IPTpd research##2##3##(2009-6#2)
the IQ-achievement discrepancy definition of##2##5##(2004-10#2)
the IQ-achievement discrepancy##4##3##(2004-10#4)
the IR absorption##3##3##(2005-4#1)(2007-11#1)(2008-3#1)
the IR region##2##3##(2008-2#2)
the IR spectra##3##3##(2007-11#2)(2013-8#1)
the IR spectral##2##3##(2007-11#1)(2008-3#1)
the IR##39##2##(1990-3#2)(1990-8#1)(1992-6#1)(1993-3#1)(1993-5#1)(1994-11#1)(1996-2#1)(2005-11#1)(2005-4#1)(2007-11#4)(2007-12#6)(2008-1#1)(2008-10#4)(2008-2#4)(2008-3#4)(2008-7#3)(2010-12#1)(2010-5#1)(2013-8#1)
the IRB-RAT##3##2##(2009-4#3)
the IRFC##3##2##(2008-9#3)
the IRMA code##2##3##(2009-11#2)
the IRMA##7##2##(1993-2#4)(2009-11#3)
the IRS##6##2##(1991-2#1)(1991-4#1)(1995-2#1)(1996-10#1)(2006-8#1)(2008-12#1)
the IS##4##2##(1990-7#1)(1993-3#1)(2008-10#2)
the IS1112 probe##2##3##(2008-10#2)
the ISE##3##2##(2008-10#3)
the ISO gene##3##3##(1990-11#3)
the ISO##11##2##(1990-11#3)(2007-1#1)(2007-4#2)(2008-10#2)(2008-12#1)(2008-2#1)(2011-1#1)
the ISR assessment##2##3##(2010-11#2)
the ISSN##2##2##(2008-5#2)
the IT15##2##2##(1995-5#1)(1996-8#1)
the ITA##5##2##(2007-8#5)
the ITF##4##2##(2005-9#4)
the ITFDE##3##2##(1993-12#3)
the ITM##2##2##(1993-11#1)(2008-10#1)
the ITN LC grating##3##4##(2008-2#3)
the ITO##5##2##(2005-4#2)(2009-11#1)(2010-6#1)(2010-7#1)
the ITS 1##2##3##(2008-10#2)
the ITS region##10##3##(2008-10#8)(2009-2#1)(2010-3#1)
the ITS##22##2##(1997-5#1)(2008-10#18)(2009-2#1)(2010-3#2)
the ITS-1##2##2##(2008-10#1)(2008-9#1)
the ITS1 region of##3##4##(2008-10#2)(2008-5#1)
the ITS1 region##4##3##(2008-10#2)(2008-5#2)
the ITS1##6##2##(2008-10#2)(2008-5#3)(2010-3#1)
the ITU##2##2##(2012-2#2)
the IUCN##4##2##(2008-5#1)(2012-2#1)(2013-1#1)(2013-7#1)
the IUD##3##2##(1992-7#1)(1993-12#1)(2012-2#1)
the IV##4##2##(1994-11#1)(1994-4#1)(1995-5#1)(2006-10#1)
the IVB and IVB/IVT groups##2##5##(2011-2#2)
the IVB and##4##3##(2011-2#4)
the IVB##5##2##(2011-2#5)
the IVB/IVT##4##2##(2011-2#4)
the IVC is##2##3##(2007-8#1)(2013-1#1)
the IVC##14##2##(2007-8#4)(2008-7#1)(2011-2#7)(2013-1#2)
the IVD##3##2##(2005-8#1)(2012-2#2)
the IVF##4##2##(1990-2#3)(1995-7#1)
the IVF-ET##2##2##(2012-3#1)(2013-1#1)
the IVIG solution##2##3##(1996-3#2)
the IX##3##2##(1991-9#2)(1992-3#1)
the Ia##2##2##(2008-10#2)
the Iberian Peninsula##4##3##(2008-10#2)(2013-1#1)(2013-8#1)
the Iberian##7##2##(2006-5#1)(2007-5#1)(2008-10#3)(2013-1#1)(2013-8#1)
the Icelandic Cancer Registry##4##4##(2006-10#1)(2006-7#1)(2006-8#2)
the Icelandic Cancer##5##3##(2006-10#2)(2006-7#1)(2006-8#2)
the Icelandic part of the European Community Respiratory Health Survey##2##10##(2006-10#2)
the Icelandic part of##3##4##(2006-10#3)
the Icelandic population##10##3##(2006-10#5)(2006-8#5)
the Icelandic##36##2##(1993-3#1)(2006-10#14)(2006-7#3)(2006-8#16)(2012-1#2)
the If##2##2##(2008-1#2)
the Ig##2##2##(2008-1#1)(2012-12#1)
the Ig-fold##2##2##(2011-2#2)
the IgA##8##2##(1991-12#1)(1994-2#2)(1994-8#2)(1996-2#1)(2007-11#1)(2008-10#1)
the IgE molecule##2##3##(2004-12#2)
the IgE test##2##3##(1997-2#2)
the IgE##8##2##(1995-2#1)(1997-2#2)(2004-12#3)(2009-2#1)(2010-5#1)
the IgE-binding##2##2##(1994-2#1)(2006-12#1)
the IgE-sensitized##2##2##(1991-5#1)(2013-1#1)
the IgG anti-Toxoplasma##2##3##(2007-10#2)
the IgG response##2##3##(1992-7#1)(2008-10#1)
the IgG##28##2##(1990-11#1)(1990-12#2)(1991-11#1)(1991-12#1)(1992-7#2)(1992-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#2)(1996-12#1)(1996-3#1)(1997-3#1)(2007-10#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2013-8#1)
the IgG-binding proteins##2##3##(1996-12#1)(2008-4#1)
the IgG-binding##6##2##(1990-8#1)(1994-11#2)(1995-5#1)(1996-12#1)(2008-4#1)
the IgM##5##2##(1990-12#1)(1996-4#1)(1996-8#1)(2007-10#1)(2008-10#1)
the Iga##2##2##(1996-10#2)
the Ih##4##2##(1995-7#3)(1997-4#1)
the Ilizarov apparatus##5##3##(2006-4#1)(2007-11#2)(2007-8#1)(2009-4#1)
the Ilizarov method is##2##4##(2007-8#1)(2013-1#1)
the Ilizarov method##8##3##(2007-11#1)(2007-8#4)(2008-8#2)(2013-1#1)
the Ilizarov technique##6##3##(2007-8#1)(2008-4#3)(2009-3#2)
the Ilizarov##20##2##(2006-4#1)(2007-11#3)(2007-8#6)(2008-4#3)(2008-8#2)(2009-3#2)(2009-4#1)(2013-1#2)
the Ilizarow method##2##3##(2007-11#1)(2007-8#1)
the Ilizarow##3##2##(2007-11#1)(2007-8#2)
the Illinois##4##2##(1992-9#1)(1996-12#1)(1996-6#1)(2008-9#1)
the Immigration and##2##3##(1996-6#1)(2010-12#1)
the Immunization Programme##4##3##(2009-5#4)
the Impact of Events##2##4##(2008-1#1)(2010-2#1)
the Impact of##7##3##(2008-1#2)(2008-10#1)(2009-4#1)(2010-2#1)(2010-8#1)(2012-2#1)
the Imperial##2##2##(2008-10#1)(2008-5#1)
the Implementation Teams##2##3##(1996-1#2)
the Implementation of##4##3##(2008-10#1)(2008-12#1)(2008-9#1)(2012-12#1)
the Implementation##6##2##(1996-1#2)(2008-10#1)(2008-12#1)(2008-9#1)(2012-12#1)
the Importance of##3##3##(2007-2#1)(2009-4#1)(2010-2#1)
the Incidence of##4##3##(1996-3#1)(2007-1#1)(2008-10#1)(2009-3#1)
the IndOEt##4##2##(2010-1#4)
the Independence##2##2##(2011-1#2)
the Index of Well-being##2##4##(1991-6#2)
the Index of##3##3##(1991-6#2)(2008-2#1)
the Index##4##2##(1991-6#2)(2007-6#1)(2008-2#1)
the India AIDS Initiative##4##4##(2012-3#4)
the India AIDS##5##3##(2012-3#5)
the India##6##2##(2011-2#1)(2012-3#5)
the Indian Academy of##2##4##(2009-11#1)(2011-1#1)
the Indian Ocean##12##3##(2006-7#9)(2008-11#2)(2010-6#1)
the Indian Subcontinent##3##3##(2004-4#1)(2007-2#2)
the Indian community##3##3##(2008-5#2)(2012-2#1)
the Indian population##5##3##(1997-8#1)(2008-8#1)(2010-12#1)(2010-5#1)(2012-2#1)
the Indian subcontinent##8##3##(2006-2#1)(2007-12#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
the Indian##74##2##(1991-3#1)(1992-12#1)(1992-6#1)(1993-9#2)(1994-8#1)(1997-8#2)(2004-4#1)(2006-12#1)(2006-2#1)(2006-7#11)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-5#1)(2007-7#5)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#3)(2008-5#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2010-12#3)(2010-2#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#6)(2013-1#1)(2013-8#2)
the Indiana and##2##3##(2008-10#2)
the Indiana##9##2##(2004-11#1)(2008-10#4)(2008-6#1)(2008-7#1)(2013-1#2)
the Indians##3##2##(1991-12#2)(1997-8#1)
the Indigenous##2##2##(2008-1#1)(2008-10#1)
the Indo-Pacific##3##2##(2008-5#3)
the Infant##3##2##(2008-6#1)(2010-2#1)(2010-5#1)
the Infection of##2##3##(2008-10#2)
the Influence##2##2##(2008-10#1)(2009-3#1)
the Information##14##2##(1991-3#1)(1991-9#2)(1995-12#1)(1996-3#1)(2007-12#1)(2007-4#1)(2008-1#2)(2009-8#1)(2011-1#2)(2011-2#1)(2012-2#1)
the Infrared Atmospheric Sounding Interferometer##3##5##(2008-2#2)(2008-3#1)
the Infrared##4##2##(1996-2#1)(2008-2#2)(2008-3#1)
the Inhibition of##2##3##(2010-8#1)(2012-3#1)
the Initial##2##2##(2006-8#1)(2007-12#1)
the Initiative##4##2##(1995-3#1)(1996-12#1)(2009-7#1)(2010-5#1)
the Injury Severity Score##2##4##(1992-3#1)(2006-2#1)
the Injury##3##2##(1992-3#1)(2006-2#1)(2007-1#1)
the Innovative##2##2##(2008-2#1)(2013-7#1)
the Ins(1##7##2##(1990-11#1)(1990-7#2)(1991-2#1)(1991-3#1)(1994-12#1)(1994-5#1)
the InsP(3) binding activity##2##4##(2008-8#2)
the InsP3##3##2##(1990-10#1)(1993-12#1)(2007-9#1)
the InsP3-R##2##2##(1993-6#2)
the Inslow group##4##3##(2008-4#4)
the Institut Pasteur##3##3##(2010-1#3)
the Institut für##3##3##(2008-10#2)(2008-11#1)
the Institut##9##2##(1990-10#1)(1992-9#1)(2008-10#3)(2008-11#1)(2010-1#3)
the Institute for##10##3##(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-7#1)
the Institute of Forensic Medicine##4##5##(1990-4#1)(1995-3#1)(1997-8#2)
the Institute of Mathematics and Physics##3##6##(2006-5#3)
the Institute of Medicine (IOM)##2##5##(2007-12#1)(2010-3#1)
the Institute of Medicine report##2##5##(1997-2#1)(2011-2#1)
the Institute of Medicine##11##4##(1996-1#1)(1996-5#1)(1997-2#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-9#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)
the Institute of Rheumatology##3##4##(2007-11#3)
the Institute of Social Sciences##2##5##(2006-10#1)(2009-4#1)
the Institute of##48##3##(1990-2#1)(1990-4#1)(1991-10#1)(1991-11#1)(1991-6#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-8#2)(2006-10#2)(2006-2#1)(2006-5#3)(2007-11#3)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-3#2)(2008-4#1)(2008-8#2)(2009-4#2)(2009-5#1)(2010-10#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#1)
the Institute##65##2##(1990-2#1)(1990-4#1)(1991-10#1)(1991-11#2)(1991-6#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-8#2)(2006-10#2)(2006-2#1)(2006-5#5)(2007-11#3)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2009-4#2)(2009-5#1)(2010-1#2)(2010-10#1)(2010-3#1)(2010-4#2)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#1)(2013-7#1)
the Institutes for##2##3##(1994-12#1)(2012-2#1)
the Institution##3##2##(2008-11#2)(2012-2#1)
the Institutional##2##2##(2009-4#1)(2013-8#1)
the Instituto Nacional de##3##4##(1997-2#1)(2008-10#1)(2011-2#1)
the Instituto Oswaldo Cruz##2##4##(1993-6#1)(2006-5#1)
the Instituto Oswaldo##3##3##(1993-6#1)(2006-5#2)
the Instituto##10##2##(1993-6#1)(1997-2#1)(2006-5#3)(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-7#1)
the Insulin##3##2##(2008-6#1)(2008-9#1)(2010-4#1)
the Integrated##2##2##(2008-4#1)(2008-8#1)
the Intensive Care Unit##6##4##(2006-4#2)(2008-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
the Intensive Care##7##3##(2006-4#2)(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the Intensive##8##2##(1990-9#1)(2006-4#2)(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the Interaction Between##4##3##(2008-10#3)(2008-5#1)
the Interaction of##2##3##(2008-10#1)(2008-5#1)
the Interaction##6##2##(2008-10#4)(2008-5#2)
the Interdisciplinary Home Care Program##2##5##(2008-9#2)
the Intergroup##2##2##(2006-10#1)(2008-6#1)
the Internal Medicine Department##2##4##(1996-11#1)(2009-8#1)
the Internal Medicine##4##3##(1992-5#1)(1996-11#1)(2008-11#1)(2009-8#1)
the Internal Revenue Code##3##4##(1991-2#1)(1996-3#1)(2007-4#1)
the Internal Revenue##4##3##(1991-2#1)(1992-12#1)(1996-3#1)(2007-4#1)
the Internal##13##2##(1991-2#1)(1992-12#1)(1992-5#1)(1995-6#1)(1996-11#1)(1996-3#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-8#1)(2013-8#1)
the International AIDS##3##3##(1990-11#2)(2013-1#1)
the International Agency for Research on Cancer##2##7##(2009-4#1)(2013-1#1)
the International Association for the Study of Pain##6##8##(2006-10#2)(2006-12#1)(2006-7#1)(2006-8#2)
the International Association for##7##4##(2006-10#2)(2006-12#1)(2006-7#1)(2006-8#3)
the International Blackleg of Crucifers Network##2##6##(2008-10#2)
the International Breast Cancer##2##4##(1993-5#1)(2008-6#1)
the International Classification of Diseases##4##5##(1991-9#1)(1997-8#1)(2007-7#1)(2007-8#1)
the International Classification of Sleep Disorders##2##6##(2008-8#1)(2012-12#1)
the International Classification of##10##4##(1990-12#1)(1991-9#1)(1994-3#1)(1994-6#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-8#1)(2012-12#1)
the International Code of##3##4##(2008-10#2)(2010-5#1)
the International Committee##2##3##(2012-2#1)(2012-3#1)
the International Conference on Harmonisation of Technical Requirements for Registration of##2##11##(2006-3#1)(2008-10#1)
the International Conference on Harmonization##2##5##(2008-10#1)(2013-7#1)
the International Conference on Population and Development##2##7##(2007-4#1)(2008-11#1)
the International Conference on##9##4##(1990-5#1)(2006-3#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)(2013-7#1)
the International Congress of Chemotherapy##2##5##(2005-8#2)
the International Congress##3##3##(2005-8#2)(2011-2#1)
the International Federation of##3##4##(2006-2#2)(2008-10#1)
the International Federation##4##3##(1994-3#1)(2006-2#2)(2008-10#1)
the International Headache Society##3##4##(2008-4#1)(2012-2#1)(2012-3#1)
the International Knee Documentation Committee (IKDC)##2##6##(2007-7#1)(2012-2#1)
the International Labour Office (ILO)##2##5##(1991-12#2)
the International League Against Epilepsy (ILAE) classification##4##7##(2013-1#4)
the International Liaison Committee on Resuscitation##2##6##(2008-11#2)
the International Maritime Organization##2##4##(2008-11#2)
the International Obesity Task Force##2##5##(2008-3#1)(2011-2#1)
the International Organization for Standardization##5##5##(2005-5#1)(2008-10#1)(2008-3#2)(2011-2#1)
the International Organization##7##3##(2005-5#1)(2006-11#1)(2007-4#1)(2008-10#1)(2008-3#2)(2011-2#1)
the International Prognostic Scoring System##2##5##(2009-2#1)(2010-11#1)
the International Prognostic##3##3##(2007-5#1)(2009-2#1)(2010-11#1)
the International Registry of##4##4##(2007-8#1)(2009-5#2)(2011-3#1)
the International Rice Research Institute##2##5##(2006-4#1)(2008-7#1)
the International Society for##12##4##(2005-8#2)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-5#2)(2009-11#1)(2010-12#1)(2011-2#1)(2011-9#1)
the International Society of##11##4##(1994-9#1)(1996-6#1)(2005-8#3)(2008-5#2)(2008-8#1)(2010-11#1)(2011-2#1)(2012-2#1)
the International Society##25##3##(1993-6#1)(1994-9#1)(1996-2#1)(1996-6#1)(2005-8#5)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-5#4)(2008-8#1)(2009-11#1)(2010-11#1)(2010-12#1)(2011-2#2)(2011-9#1)(2012-2#1)
the International Standards##3##3##(2006-11#1)(2007-11#2)
the International Subarachnoid Aneurysm Trial##2##5##(2005-11#2)
the International Symposium on##2##4##(2007-8#1)(2008-6#1)
the International Triticeae Mapping Initiative##3##5##(2008-10#3)
the International Workshop on##2##4##(2008-4#1)(2009-4#1)
the International##170##2##(1990-11#2)(1990-12#1)(1990-5#1)(1991-12#2)(1991-5#1)(1991-9#1)(1993-12#2)(1993-5#1)(1993-6#1)(1994-11#1)(1994-3#3)(1994-6#1)(1994-9#2)(1995-12#2)(1996-1#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-3#1)(2005-11#2)(2005-5#2)(2005-8#8)(2006-10#3)(2006-11#2)(2006-12#1)(2006-2#3)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#3)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-10#16)(2008-11#7)(2008-12#2)(2008-3#3)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#3)(2009-5#3)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#4)(2011-12#1)(2011-2#8)(2011-3#1)(2011-9#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#8)(2013-7#2)(2013-8#3)
the Internet and information technology to##2##6##(2008-11#2)
the Internet and other##3##4##(2006-5#1)(2007-4#1)(2011-1#1)
the Internet and##12##3##(1994-3#1)(2005-10#1)(2006-5#1)(2007-4#1)(2008-11#2)(2008-4#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2013-7#1)
the Internet are##3##3##(1994-12#1)(2006-6#1)(2008-11#1)
the Internet as##2##3##(2009-5#1)(2010-12#1)
the Internet at##2##3##(2005-9#1)(2008-2#1)
the Internet can##3##3##(2006-6#1)(2007-8#1)(2009-5#1)
the Internet for information##2##4##(2008-4#1)(2008-9#1)
the Internet for##8##3##(1994-12#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-4#1)(2008-9#1)(2011-1#1)(2012-3#1)
the Internet has##4##3##(2007-2#1)(2008-12#1)(2009-5#1)(2011-1#1)
the Internet have##2##3##(2006-10#1)(2006-6#1)
the Internet in##4##3##(2007-12#1)(2008-1#1)(2008-9#1)(2010-8#1)
the Internet is##4##3##(1996-5#1)(2004-10#1)(2006-6#1)(2007-2#1)
the Internet to##9##3##(1997-1#1)(2005-12#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)
the Internet using a##2##4##(2008-10#1)(2008-7#1)
the Internet will##3##3##(1996-2#1)(2006-6#2)
the Internet##127##2##(1994-12#2)(1994-3#2)(1995-1#1)(1995-12#1)(1996-12#4)(1996-2#5)(1996-5#1)(1996-8#1)(1997-1#2)(2004-10#1)(2004-12#1)(2005-10#2)(2005-12#2)(2005-9#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#13)(2006-7#1)(2007-10#1)(2007-11#5)(2007-12#5)(2007-2#6)(2007-4#5)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#9)(2008-12#1)(2008-2#3)(2008-4#6)(2008-6#1)(2008-7#8)(2008-9#4)(2009-5#6)(2009-9#1)(2010-12#3)(2010-8#2)(2011-1#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)
the Interpersonal##2##2##(2007-10#1)(2009-9#1)
the Intervention condition##2##3##(2008-4#2)
the Intervention##4##2##(2008-4#4)
the Intrinsic##2##2##(2011-2#1)(2012-1#1)
the Invasive##2##2##(2008-10#1)(2012-12#1)
the Inventory of##5##3##(1995-11#1)(2007-12#1)(2009-12#1)(2009-7#1)(2012-2#1)
the Iowa##9##2##(1994-2#1)(1996-12#1)(1997-1#2)(2008-10#2)(2009-2#1)(2012-2#1)(2013-1#1)
the Ip amplitude and##2##4##(1996-1#2)
the Ip-V relationship##2##3##(1996-1#2)
the Iranian oil industry##4##4##(2006-2#4)
the Iranian##15##2##(2006-2#5)(2007-2#1)(2008-12#4)(2008-7#2)(2012-11#2)(2012-2#1)
the Iraqi MDVs##2##3##(2013-8#2)
the Iraqi##4##2##(2006-4#1)(2007-12#1)(2013-8#2)
the Irish##2##2##(2008-11#1)(2013-8#1)
the Iron##2##2##(2013-8#2)
the Isc##3##2##(2008-1#1)(2008-5#2)
the Islamic Republic of Iran##6##5##(2006-2#4)(2012-1#1)(2013-1#1)
the Islamic##7##2##(2006-2#4)(2009-9#1)(2012-1#1)(2013-1#1)
the Island of Rab##2##4##(2011-2#2)
the Island of##5##3##(1995-11#1)(2008-1#1)(2008-5#1)(2011-2#2)
the Island##8##2##(1995-11#1)(2008-1#2)(2008-5#1)(2010-9#2)(2011-2#2)
the Israel##2##2##(1993-12#1)(2011-12#1)
the Israeli Medical Association##3##4##(1997-8#3)
the Israeli##20##2##(1991-6#1)(1997-8#3)(2007-10#1)(2008-1#3)(2008-10#6)(2008-7#2)(2011-12#2)(2013-1#1)(2013-7#1)
the Istituto Nazionale Tumori of Milan##2##6##(1991-12#1)(2011-2#1)
the Istituto Nazionale Tumori of##3##5##(1990-12#1)(1991-12#1)(2011-2#1)
the Istituto Nazionale Tumori##5##4##(1990-12#1)(1991-12#1)(1991-4#1)(1991-6#1)(2011-2#1)
the Istituto##7##2##(1990-12#1)(1991-12#1)(1991-4#1)(1991-6#1)(2008-10#1)(2010-4#1)(2011-2#1)
the Italian Group on Rare Tumors##2##6##(2008-6#2)
the Italian Health##2##3##(1994-6#1)(2008-6#1)
the Italian National##2##3##(1990-6#1)(2010-11#1)
the Italian Society for##2##4##(2011-2#2)
the Italian Society##6##3##(1990-8#1)(1991-6#1)(2007-1#1)(2011-2#3)
the Italian population##6##3##(2008-6#1)(2008-7#1)(2010-11#1)(2011-1#3)
the Italian version of the##4##5##(2008-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
the Italian##67##2##(1990-3#1)(1990-6#1)(1990-8#4)(1991-10#1)(1991-12#1)(1991-6#2)(1991-8#1)(1992-10#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-1#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-6#6)(2008-7#4)(2008-8#2)(2009-5#1)(2010-1#1)(2010-11#2)(2010-3#1)(2010-9#3)(2011-1#7)(2011-2#6)(2011-3#1)(2012-2#2)(2013-8#2)
the Itata river##2##3##(2007-3#2)
the Iturbide reservoir##2##3##(2012-2#2)
the Iturbide##3##2##(2012-2#3)
the Ivory##4##2##(1996-7#1)(2006-2#1)(2008-10#2)
the Ixodes##2##2##(2004-11#1)(2011-2#1)
the IxxLxQ motif##2##3##(1997-8#2)
the J##4##2##(1992-10#1)(2008-10#2)(2008-7#1)
the JA##4##2##(2009-6#2)(2009-8#2)
the JAK##2##2##(1996-2#1)(2008-1#1)
the JAM test##2##3##(2008-4#2)
the JAS##2##2##(2013-8#2)
the JCAHO will##2##3##(1992-6#1)(1993-2#1)
the JCAHO##9##2##(1990-12#1)(1992-6#1)(1993-2#4)(1995-1#3)
the JCAHO's##4##2##(1992-6#1)(1993-2#1)(1995-1#1)(1996-2#1)
the JDBM##2##2##(2012-2#2)
the JE/MCP-1 gene expression##2##4##(1994-8#2)
the JFP##2##2##(1995-6#2)
the JNDs measured##2##3##(1990-11#2)
the JNK pathway in##2##4##(2008-1#2)
the JNK pathway##7##3##(2008-1#7)
the JNK signaling pathway##2##4##(1995-6#1)(2011-2#1)
the JNK signaling##3##3##(1995-6#2)(2011-2#1)
the JNK##11##2##(1995-6#2)(1996-5#1)(2008-1#7)(2011-2#1)
the JPR##3##2##(2007-12#3)
the JSTP##2##2##(2012-1#2)
the JTC##4##2##(2008-2#1)(2008-3#2)(2012-1#1)
the JTPS##2##2##(2008-3#2)
the JUPITER trial##4##3##(2010-12#1)(2010-4#3)
the JUPITER##6##2##(2010-12#2)(2010-4#4)
the Jaccard index##2##3##(2008-10#2)
the Jackson Heart Study##3##4##(2011-2#2)(2013-8#1)
the Jackson##7##2##(1991-1#1)(1993-12#1)(1994-1#2)(2011-2#2)(2013-8#1)
the Jacky dragon##2##3##(2008-10#1)(2008-11#1)
the Jagiellonian University##4##3##(2007-11#2)(2007-8#1)(2012-1#1)
the Jagiellonian##5##2##(2007-11#3)(2007-8#1)(2012-1#1)
the Jak/STAT pathway##2##3##(1996-5#2)
the Jalowiec Coping Scale##2##4##(2010-10#1)(2010-5#1)
the Jamaican##3##2##(1992-1#1)(2010-1#1)(2011-2#1)
the January##3##2##(2008-2#1)(2009-8#1)(2011-2#1)
the Janus##2##2##(1996-2#1)(2008-4#1)
the Japan##7##2##(2006-6#1)(2007-10#1)(2008-11#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-8#1)
the Japanese Erwinia##2##3##(2008-10#2)
the Japanese Society of Clinical Chemistry##2##6##(1994-12#2)
the Japanese Society of Clinical##3##5##(1994-12#3)
the Japanese Society of##9##4##(1994-12#3)(2009-12#2)(2010-1#1)(2012-1#1)(2012-11#2)
the Japanese diet##2##3##(2005-3#1)(2012-1#1)
the Japanese market##2##3##(2005-8#1)(2010-8#1)
the Japanese patients##3##3##(1993-4#1)(1995-4#1)(1997-2#1)
the Japanese pear##2##3##(2008-10#2)
the Japanese puffer fish##2##4##(1995-2#1)(2008-7#1)
the Japanese##81##2##(1990-4#1)(1991-5#1)(1991-9#1)(1993-3#2)(1993-4#1)(1994-12#3)(1995-1#1)(1995-2#1)(1995-4#1)(1997-2#1)(1997-8#3)(2005-11#1)(2005-3#2)(2005-8#1)(2006-11#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#8)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#4)(2009-12#3)(2010-1#3)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-3#1)(2012-1#4)(2012-11#4)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
the Jebsen-Taylor##3##2##(2007-10#1)(2011-1#1)(2012-1#1)
the Jeddah Kidney Center##4##4##(2007-7#1)(2008-1#3)
the Jeddah##6##2##(2007-1#1)(2007-7#2)(2008-1#3)
the Jehovah's Witness##3##3##(1990-3#1)(2009-4#2)
the Jennings Disaster Nursing Management Model##2##6##(2008-11#2)
the Jet Propulsion Laboratory##2##4##(2007-9#1)(2008-2#1)
the Jet Propulsion##3##3##(2007-9#1)(2008-2#1)(2008-3#1)
the Jichi cohort##2##3##(2012-7#2)
the Jichi##3##2##(1992-4#1)(2012-7#2)
the Job##3##2##(2008-10#2)(2012-1#1)
the Johannesburg##3##2##(1994-6#1)(2008-12#1)(2010-12#1)
the Johns Hopkins Ambulatory Care Group##2##6##(1995-2#2)
the Johns Hopkins##6##3##(1992-3#1)(1993-1#1)(1995-2#2)(1996-9#1)(2011-2#1)
the Johnson##2##2##(2011-1#2)
the Joint Commission on Accreditation of Healthcare Organizations##2##8##(1993-2#1)(1995-3#1)
the Joint Commission on Accreditation of##3##6##(1990-12#1)(1993-2#1)(1995-3#1)
the Joint Commission on##4##4##(1990-12#1)(1993-2#1)(1995-3#1)(2010-8#1)
the Joint Commission##6##3##(1990-12#1)(1993-2#2)(1995-3#1)(1996-2#1)(2010-8#1)
the Joint Commission's##4##3##(1993-2#1)(1995-2#1)(2004-5#1)(2009-9#1)
the Joint Council of Governmental Public Health Agencies##3##8##(1996-3#3)
the Joint National Committee on Detection##2##6##(1993-12#1)(1996-9#1)
the Joint National##3##3##(1993-12#1)(1996-9#2)
the Joint##21##2##(1990-12#1)(1993-12#1)(1993-2#3)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#3)(1996-9#2)(2004-5#1)(2006-11#1)(2008-8#1)(2009-9#2)(2010-8#1)(2010-9#1)(2011-2#1)
the Jones matrix##6##3##(2007-12#2)(2008-2#3)(2008-3#1)
the Jones##9##2##(2007-12#2)(2007-8#1)(2008-2#4)(2008-3#2)
the Jones-matrix formalism##2##3##(2008-2#1)(2008-3#1)
the Jordan University Hospital##2##4##(2004-10#1)(2008-1#1)
the Jordan##5##2##(2004-10#1)(2004-11#1)(2008-1#2)(2009-2#1)
the Journal of the Optical Society of America A##2##9##(2008-3#2)
the Journal of the##4##4##(1990-6#1)(2007-11#1)(2008-3#2)
the Journal of##23##3##(1990-6#1)(2006-9#1)(2007-11#2)(2007-2#1)(2007-6#1)(2008-10#3)(2008-3#2)(2008-4#2)(2008-5#2)(2009-10#1)(2009-4#1)(2009-8#2)(2010-7#1)(2010-8#1)(2011-2#2)
the Journal##34##2##(1990-6#1)(1993-9#1)(1994-3#1)(1997-1#1)(2005-7#1)(2005-8#2)(2006-11#1)(2006-9#1)(2007-11#2)(2007-2#1)(2007-6#1)(2008-10#5)(2008-3#2)(2008-4#2)(2008-5#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#2)(2010-7#1)(2010-8#1)(2011-2#2)(2011-4#1)
the Juan de Fuca Ridge##2##5##(1995-3#1)(2007-7#1)
the July 1996##2##3##(2008-2#2)
the July##3##2##(2005-8#1)(2008-2#2)
the Jun##2##2##(1996-10#1)(1996-11#1)
the June##2##2##(1995-6#1)(1997-6#1)
the Jurkat T-cell line##2##4##(1992-8#1)(1994-11#1)
the Jurkat leukemic cell line##2##5##(1994-3#2)
the Jurkat##6##2##(1992-8#1)(1994-11#1)(1994-3#2)(1997-6#1)(2008-5#1)
the Justice Department##2##3##(1995-12#1)(1995-6#1)
the K group##2##3##(1992-5#2)
the K##18##2##(1990-2#1)(1990-6#1)(1992-5#2)(1992-6#2)(1994-11#3)(1994-9#1)(1995-6#1)(1997-1#1)(1997-2#1)(1997-7#4)(2006-5#1)
the K&amp##2##2##(2008-10#2)
the K(+)##3##2##(2006-10#1)(2008-4#1)(2008-8#1)
the K(+)-evoked release of##3##4##(1990-2#1)(1992-3#1)(1993-4#1)
the K(+)-evoked##6##2##(1990-2#1)(1992-3#1)(1993-3#1)(1993-4#1)(1997-2#2)
the K(ex##3##2##(2008-10#3)
the K(m) for the##3##4##(2008-7#3)
the K(m) for##5##3##(1996-7#1)(2008-7#3)(2009-2#1)
the K(m)##8##2##(1996-7#3)(2008-5#1)(2008-7#3)(2009-2#1)
the K(m)(app) values##2##3##(1996-7#1)(2008-10#1)
the K+ channel blocker##2##4##(1995-7#1)(1997-1#1)
the K+ channel##6##3##(1991-1#1)(1993-11#1)(1995-7#1)(1996-2#1)(1997-1#1)(1997-7#1)
the K+ channels##2##3##(1990-7#2)
the K+ entry##2##3##(1990-12#1)(1997-1#1)
the K+##21##2##(1990-12#1)(1990-7#3)(1991-1#1)(1991-11#1)(1991-9#1)(1992-6#1)(1993-11#2)(1994-2#2)(1994-9#2)(1995-7#1)(1996-2#1)(1997-1#3)(1997-4#1)(1997-7#1)
the K+-evoked release of##2##4##(1995-12#2)
the K+-evoked##3##2##(1995-12#3)
the K+/H+##2##2##(1991-1#1)(1993-11#1)
the K-ras oncogene##2##3##(2006-10#1)(2010-12#1)
the K-ras##5##2##(1995-2#1)(2004-1#2)(2006-10#1)(2010-12#1)
the K/T boundary##2##3##(1997-5#2)
the K/T##4##2##(1997-5#4)
the K0##2##2##(1994-6#1)(1997-1#1)
the K1 antigen and##2##4##(1991-8#2)
the K1 capsular antigen##2##4##(1991-8#2)
the K1##5##2##(1991-8#4)(2006-12#1)
the K22DAP complexes of##2##4##(2008-10#2)
the K497A##2##2##(1996-8#2)
the K497D##2##2##(1996-8#2)
the K562##3##2##(1991-9#1)(1995-3#1)(2008-11#1)
the KAIT##3##2##(2004-12#3)
the KB##3##2##(2006-12#3)
the KBD of##2##3##(2012-3#2)
the KBD##4##2##(2012-3#4)
the KBr##2##2##(2008-2#2)
the KCl concentration##2##3##(1990-5#1)(1992-7#1)
the KCl##4##2##(1990-5#1)(1992-7#1)(1993-7#1)(1995-12#1)
the KCl-induced##2##2##(1995-12#1)(1996-5#1)
the KD for##2##3##(1993-9#1)(1994-9#1)
the KD of##2##3##(1991-8#1)(1994-11#1)
the KD##8##2##(1990-11#1)(1991-8#1)(1993-9#1)(1994-11#1)(1994-9#1)(2011-2#2)(2013-1#1)
the KDN-containing##2##2##(1994-5#2)
the KEGG database##2##3##(2008-4#1)(2010-4#1)
the KEGG##4##2##(2008-4#1)(2008-7#1)(2010-12#1)(2010-4#1)
the KF##3##2##(1993-9#1)(1996-5#1)(2008-10#1)
the KHN##3##2##(2013-8#3)
the KI##3##2##(2007-7#2)(2008-10#1)
the KIII##2##2##(2008-2#2)
the KIT##2##2##(2010-4#1)(2010-5#1)
the KM for##2##3##(1995-1#1)(1995-8#1)
the KM value for##3##4##(1993-6#1)(1994-5#1)(1995-8#1)
the KM##8##2##(1993-6#1)(1994-5#1)(1995-1#1)(1995-8#2)(1996-11#1)(2007-8#2)
the KMSKS sequence##2##3##(1994-9#2)
the KMSKS##4##2##(1994-9#4)
the KOH-to-PSI ratio##3##3##(2005-11#3)
the KP theory is##2##4##(2009-9#2)
the KP theory##5##3##(2009-9#5)
the KP##7##2##(2009-6#1)(2009-9#5)(2010-8#1)
the KPI domain##4##3##(1990-9#2)(1992-12#1)(1992-7#1)
the KPI##6##2##(1990-9#2)(1992-12#1)(1992-7#1)(1996-12#1)(1996-3#1)
the KPS was##4##3##(2008-5#4)
the KPSC##2##2##(2010-8#2)
the KR##3##2##(2008-10#3)
the KRAS mutation##3##3##(2011-2#2)(2012-12#1)
the KRAS##4##2##(2011-2#2)(2012-12#2)
the KSA##3##2##(2007-7#2)(2008-4#1)
the KTH complex##4##3##(2006-11#4)
the KTH##5##2##(2006-11#5)
the KTP##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
the Ka##2##2##(1991-12#1)(1995-2#1)
the Kaiwá##2##2##(1991-12#2)
the Kallmann##2##2##(1993-6#2)
the Kalman filter##4##3##(2005-4#1)(2008-10#1)(2008-2#1)(2008-3#1)
the Kaneda device##2##3##(2006-8#2)
the Kano##2##2##(1994-12#1)(2008-8#1)
the Kaplan--Meier##2##2##(1996-1#2)
the Kaplan-Meier estimator##2##3##(1993-4#1)(2008-7#1)
the Kaplan-Meier method and##2##4##(2008-6#1)(2012-1#1)
the Kaplan-Meier method##5##3##(2005-5#1)(2007-8#1)(2008-6#1)(2012-1#1)(2013-8#1)
the Kaplan-Meier##9##2##(1991-8#1)(1993-4#1)(2005-5#1)(2007-6#1)(2007-8#1)(2008-6#1)(2008-7#1)(2012-1#1)(2013-8#1)
the Kappa statistics##2##3##(1991-9#1)(2009-8#1)
the Kappa value##2##3##(2008-5#2)
the Kappa##5##2##(1991-9#1)(2008-5#2)(2008-9#1)(2009-8#1)
the Kardar-Parisi-Zhang##2##2##(1992-9#1)(2012-2#1)
the Karnofski scale##3##3##(2008-1#3)
the Karnofsky##2##2##(1991-6#1)(2007-7#1)
the Kassena-Nankana District##5##3##(2006-4#5)
the Kassena-Nankana##6##2##(2006-4#6)
the Kathmandu##3##2##(2008-7#1)(2011-1#1)(2012-3#1)
the KcsA##2##2##(2007-3#1)(2008-8#1)
the Kd for##4##3##(1995-3#1)(1995-6#2)(1997-1#1)
the Kd of##2##3##(1991-4#1)(1993-12#1)
the Kd value of##3##4##(1992-12#1)(1993-7#1)(1994-8#1)
the Kd value##4##3##(1992-12#1)(1993-7#1)(1994-8#1)(1996-2#1)
the Kd values##4##3##(1990-7#1)(1992-6#1)(1994-8#1)(2008-8#1)
the Kd##17##2##(1990-7#1)(1991-4#1)(1992-12#1)(1992-6#1)(1993-12#2)(1993-7#1)(1994-11#1)(1994-8#2)(1995-3#1)(1995-6#2)(1996-2#1)(1997-1#1)(1997-2#1)(2008-8#1)
the Kebele##2##2##(2010-8#2)
the Keck##4##2##(2008-2#1)(2008-3#3)
the Kefir extract##5##3##(2008-11#5)
the Keggin complexes##2##3##(2005-11#2)
the Keggin##8##2##(2005-11#5)(2010-5#2)(2010-6#1)
the Kell blood group##2##4##(1993-3#1)(2012-2#1)
the Kentucky##2##2##(1994-3#1)(2008-10#1)
the Kenya Association of Professional Counsellors (KAPC)##2##7##(2007-7#2)
the Kenya##4##2##(2007-2#1)(2007-7#3)
the Kenyan##5##2##(1997-4#1)(2006-4#2)(2009-3#1)(2012-12#1)
the Kerr nonlinearity##3##3##(2007-12#2)(2008-1#1)
the Kerr##6##2##(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#1)
the Keystone action plan criteria##3##5##(2011-1#3)
the Ki for##3##3##(1991-4#1)(1995-1#1)(1995-2#1)
the Ki value##2##3##(1991-2#1)(1992-8#1)
the Ki values for##2##4##(1995-7#1)(1997-1#1)
the Ki values##4##3##(1992-1#1)(1993-4#1)(1995-7#1)(1997-1#1)
the Ki##12##2##(1991-2#1)(1991-4#1)(1992-1#1)(1992-8#1)(1993-4#1)(1993-8#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-7#1)(1997-1#1)
the Ki-67##4##2##(2004-9#3)(2013-8#1)
the Kidd##3##2##(1995-6#2)(2013-1#1)
the Kidney##6##2##(2006-9#1)(2007-12#1)(2007-2#1)(2008-4#1)(2008-7#1)(2012-12#1)
the Kii Channel##2##3##(2010-8#2)
the King Faisal Specialist Hospital and Research Centre##2##8##(2007-2#2)
the King Faisal Specialist Hospital and Research##4##7##(2007-2#2)(2008-1#1)(2008-4#1)
the King Khalid University Hospital##3##5##(2008-1#2)(2008-4#1)
the King##15##2##(2004-10#1)(2007-2#2)(2007-3#2)(2007-7#4)(2008-1#3)(2008-4#2)(2009-4#1)
the Kingdom of Saudi Arabia (KSA)##3##6##(2008-1#1)(2008-4#1)(2013-1#1)
the Kingdom of Saudi Arabia##10##5##(2007-2#2)(2007-3#3)(2008-1#2)(2008-4#2)(2013-1#1)
the Kingdom of##12##3##(2007-2#2)(2007-3#3)(2007-7#1)(2008-1#2)(2008-10#1)(2008-4#2)(2013-1#1)
the Kingdom##24##2##(2007-2#5)(2007-3#6)(2007-7#1)(2008-1#6)(2008-10#1)(2008-4#3)(2009-6#1)(2013-1#1)
the Kinkazan deer##3##3##(2008-5#3)
the Kinkazan population##2##3##(2008-5#2)
the Kinkazan##5##2##(2008-5#5)
the Kirby##2##2##(2009-4#1)(2011-2#1)
the Kirby-Bauer disc diffusion##2##4##(2008-7#1)(2012-2#1)
the Kirby-Bauer##4##2##(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
the Kirby-style program would##2##4##(2009-4#2)
the Kirby-style program##3##3##(2009-4#3)
the Kirchhoff approximation##5##3##(2007-11#1)(2008-2#3)(2008-3#1)
the Kirchhoff##9##2##(2007-11#2)(2008-2#3)(2008-3#4)
the Kit/Kitl pathway##2##3##(2012-2#2)
the Kit/Kitl##3##2##(2012-2#3)
the Kitchener-Waterloo Hospital was##2##4##(1993-1#2)
the Kiyosawa and Shiyomi model##3##5##(2008-10#3)
the Kjeldahl method##4##3##(2008-10#3)(2008-5#1)
the Kjeldahl##6##2##(2008-10#5)(2008-5#1)
the Klenow##3##2##(1991-7#1)(1992-9#2)
the Km and##4##3##(1990-11#1)(1990-3#1)(1991-12#1)(1994-5#1)
the Km for NADH##2##4##(1994-12#2)
the Km for the##4##4##(1990-11#2)(1992-2#1)(1996-5#1)
the Km for##15##3##(1990-11#2)(1990-3#1)(1990-5#1)(1991-1#1)(1992-2#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-2#1)(1996-5#1)(1997-7#1)
the Km of##6##3##(1990-5#1)(1990-8#1)(1991-5#1)(1993-12#1)(1995-3#1)(1995-8#1)
the Km value for##2##4##(1990-12#1)(1992-2#1)
the Km value##3##3##(1990-12#1)(1992-2#1)(1992-6#1)
the Km values for##3##4##(1995-6#3)
the Km values##6##3##(1990-5#1)(1990-8#1)(1995-6#3)(1997-2#1)
the Km was##2##3##(1990-8#1)(2005-11#1)
the Km##41##2##(1990-11#3)(1990-12#1)(1990-3#4)(1990-5#3)(1990-8#3)(1991-1#1)(1991-12#1)(1991-5#1)(1992-2#2)(1992-6#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-5#2)(1994-8#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-6#3)(1995-8#1)(1996-5#1)(1997-2#1)(1997-7#1)(2005-11#1)(2008-5#1)
the Km's for the primer and##2##6##(1990-5#2)
the Km's##3##2##(1990-5#2)(1994-8#1)
the Knoevenagel condensation##2##3##(2007-11#2)
the Knoevenagel##3##2##(2007-11#2)(2010-5#1)
the Knoop hardness##2##3##(2013-8#2)
the Knowledge##2##2##(1990-12#1)(2010-7#1)
the Kobs for##2##3##(1995-2#2)
the Kobs##3##2##(1995-2#3)
the Kondo effect##2##3##(1992-12#1)(2007-9#1)
the Kondo##3##2##(1992-12#1)(1993-8#1)(2007-9#1)
the Korea##5##2##(1991-9#1)(2008-7#1)(2010-12#1)(2011-2#2)
the Korean##14##2##(1992-12#1)(1997-6#2)(2006-12#1)(2008-10#2)(2009-3#1)(2010-12#2)(2010-6#3)(2011-2#1)(2012-12#1)
the Korle Bu Teaching Hospital##2##5##(2007-2#2)
the KpnI##2##2##(1993-3#1)(2008-10#1)
the Kramers-Kronig##2##2##(2008-3#2)
the Krawtchouk moments##2##3##(2008-2#2)
the Krebs TCA cycle##2##4##(1993-11#2)
the Krebs cycle##2##3##(1991-1#2)
the Krebs##5##2##(1991-1#2)(1993-11#2)(2009-11#1)
the Kretschmann configuration##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
the Kruskal-Wallis test##3##3##(2010-3#1)(2013-1#2)
the Kubelka-Munk##4##2##(2008-10#3)(2008-3#1)
the Kumba Health District##5##4##(2007-2#1)(2007-7#4)
the Kuna##2##2##(2010-4#2)
the Kunitz protease inhibitor domain##2##5##(1990-9#1)(1991-2#1)
the Kunitz protease inhibitor##4##4##(1990-3#1)(1990-9#1)(1991-2#1)(1992-12#1)
the Kunitz##6##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-2#1)(1992-12#1)(1992-8#1)
the Kunitz-type protease inhibitor (KPI)##3##5##(1992-7#1)(1996-12#2)
the Kunitz-type protease inhibitor##4##4##(1992-7#2)(1996-12#2)
the Kunitz-type##6##2##(1991-11#1)(1992-7#2)(1994-11#1)(1996-12#2)
the Kupffer cell##2##3##(1992-11#1)(1995-3#1)
the Kupffer cells##3##3##(1990-11#1)(2007-3#1)(2008-4#1)
the Kupffer##7##2##(1990-11#3)(1992-11#1)(1995-3#1)(2007-3#1)(2008-4#1)
the Kuruma Prawn##2##3##(2008-5#1)(2008-6#1)
the Kuwait##3##2##(1996-3#1)(1997-4#1)(2007-2#1)
the Kv1##4##2##(1994-2#1)(1996-2#1)(1996-5#1)(1997-2#1)
the Kv4##2##2##(1997-8#2)
the Kyiv##2##2##(2008-8#1)(2010-4#1)
the Kyoto Encyclopedia of Genes and Genomes (KEGG)##3##8##(2008-4#2)(2009-11#1)
the Kyoto Encyclopedia of Genes and Genomes##5##7##(2008-4#2)(2009-11#1)(2013-1#2)
the Kyoto##6##2##(2007-8#1)(2008-4#2)(2009-11#1)(2013-1#2)
the Kölliker-Fuse nucleus##2##3##(1993-9#1)(1996-5#1)
the Kölliker-Fuse##3##2##(1993-7#1)(1993-9#1)(1996-5#1)
the L alpha -I##3##4##(1994-3#3)
the L alpha##4##3##(1993-11#1)(1994-3#3)
the L axon##2##3##(1996-9#2)
the L intermediate of##2##4##(1995-5#2)
the L intermediate##4##3##(1995-5#4)
the L isomer##3##3##(1992-1#1)(1994-5#1)(2006-10#1)
the L##33##2##(1992-1#1)(1992-8#2)(1993-11#1)(1993-2#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-3#3)(1994-5#1)(1995-5#4)(1996-11#1)(1996-9#2)(1997-4#1)(2006-10#2)(2008-10#4)(2008-7#1)(2010-4#1)(2011-2#3)(2013-8#1)
the L(4) resistance gene##2##4##(2008-10#2)
the L(4)##4##2##(2008-10#4)
the L- and##4##3##(1996-6#1)(1996-7#1)(1997-5#2)
the L-3-phenyllactyl residue##2##3##(1991-9#2)
the L-5 vertebral body##3##4##(2006-8#3)
the L-5##4##2##(2006-8#4)
the L-A##5##2##(1996-9#1)(1997-3#4)
the L-L diastereomer##2##3##(1993-8#2)
the L-L##5##2##(1993-8#3)(1994-3#1)(2007-8#1)
the L-NAME##2##2##(1992-3#1)(2008-4#1)
the L-arginine##3##2##(1994-9#1)(1997-7#1)(2005-1#1)
the L-arginine-nitric oxide pathway##3##4##(1993-3#1)(1995-12#1)(2005-7#1)
the L-dopa##2##2##(2013-8#2)
the L-dsRNA##3##2##(2008-10#3)
the L-lactate##2##2##(1991-5#1)(1993-11#1)
the L-malate##2##2##(1990-3#2)
the L-myc##2##2##(1993-7#2)
the L-type Ca2+ channel##2##4##(1996-9#1)(1997-5#1)
the L-type Ca2+##3##3##(1996-9#1)(1997-5#2)
the L-type calcium channel##4##4##(1993-7#1)(1994-11#1)(1995-3#2)
the L-type calcium##7##3##(1993-7#1)(1994-11#1)(1995-3#4)(2004-11#1)
the L-type pyruvate kinase##3##4##(1990-8#1)(1995-5#1)(1997-4#1)
the L-type voltage sensitive##2##4##(1995-3#1)(1997-2#1)
the L-type##21##2##(1990-7#1)(1990-8#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-3#5)(1995-5#1)(1996-3#2)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#2)(2004-11#1)(2008-5#1)
the L/K/B alkaline phosphatase##2##4##(1993-6#2)
the L1 and##3##3##(2007-11#1)(2008-5#1)(2011-2#1)
the L1##14##2##(1991-11#1)(1992-9#1)(1993-11#1)(1994-12#1)(1995-3#1)(1996-11#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-5#1)(2011-1#1)(2011-2#2)(2013-8#1)
the L2##4##2##(1990-2#1)(2008-3#1)(2009-3#1)(2011-2#1)
the L3##5##2##(1991-11#1)(1992-8#1)(1993-12#1)(2006-7#1)(2008-8#1)
the L4##7##2##(1995-9#1)(2006-8#1)(2007-12#1)(2008-7#1)(2011-2#2)(2013-8#1)
the L4-5##3##2##(2008-3#1)(2012-3#2)
the L4/5##4##2##(2006-8#1)(2007-11#3)
the L5 and##2##3##(1993-12#1)(1993-4#1)
the L5 dorsal root ganglion (DRG)##2##6##(1991-6#1)(1997-5#1)
the L5 spinal cord##2##4##(1991-6#2)
the L5 ventral root##2##4##(1991-6#2)
the L5 vertebra##2##3##(2007-11#2)
the L5##18##2##(1991-6#5)(1992-5#1)(1993-12#1)(1993-4#2)(1997-5#1)(2006-7#4)(2007-11#3)(2012-2#1)
the L5-L6##2##2##(1995-11#2)
the L929##2##2##(2008-5#2)
the LA and##5##3##(2005-8#1)(2008-2#1)(2011-2#3)
the LA##10##2##(2005-8#3)(2007-8#1)(2008-10#1)(2008-2#1)(2011-2#4)
the LAB diet##3##3##(2011-1#3)
the LAB##4##2##(2006-11#1)(2011-1#3)
the LACC##2##2##(2007-6#2)
the LAD and##2##3##(1990-4#1)(2007-8#1)
the LAD group and##2##4##(2013-1#2)
the LAD group##4##3##(2013-1#4)
the LAD was##2##3##(2006-6#1)(2007-8#1)
the LAD##17##2##(1990-4#1)(2005-12#2)(2006-12#2)(2006-6#1)(2007-8#4)(2013-1#4)(2013-7#3)
the LAF assay##3##3##(1991-1#3)
the LAF##4##2##(1991-1#4)
the LAL- and##2##3##(2007-9#2)
the LAMP##2##2##(2009-6#2)
the LAN##2##2##(2007-12#2)
the LANL2DZ##2##2##(2009-2#1)(2013-8#1)
the LAP score##2##3##(1991-4#2)
the LAS##2##2##(2008-10#2)
the LASSO method##2##3##(2012-3#2)
the LASSO##5##2##(2012-3#5)
the LAVH group##3##3##(1994-2#1)(2010-3#2)
the LAVH##5##2##(1994-2#1)(1996-2#1)(2010-3#3)
the LB films##5##3##(2007-12#1)(2007-9#1)(2008-11#3)
the LB##11##2##(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#7)(2013-1#1)
the LBD group##3##3##(2010-3#3)
the LBL##2##2##(2008-10#2)
the LBO crystal##2##3##(2007-12#1)(2008-3#1)
the LBS activity##2##3##(1996-5#2)
the LBS##3##2##(1996-5#3)
the LBW##2##2##(2007-3#1)(2008-7#1)
the LC group##2##3##(2008-4#2)
the LC##12##2##(1993-2#2)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-4#2)(2011-2#1)
the LC(50)##2##2##(2008-10#1)(2011-12#1)
the LC(DeltaPSPG-I) strain##2##3##(2009-9#2)
the LC-NE system is##2##4##(2011-1#2)
the LC-NE system##4##3##(2011-1#4)
the LC-UV##2##2##(2013-7#2)
the LC/MS##4##2##(2007-8#2)(2008-10#1)(2009-8#1)
the LC/SC##2##2##(1992-1#2)
the LC50##4##2##(2005-11#1)(2008-12#1)(2008-8#2)
the LCAT gene##3##3##(1991-12#1)(1991-7#2)
the LCD##7##2##(2007-7#1)(2008-2#3)(2008-3#2)(2010-9#1)
the LCPM as##2##3##(2008-2#2)
the LCR##4##2##(1993-2#2)(1996-7#1)(1997-4#1)
the LCT diet##3##3##(2007-8#3)
the LCT##4##2##(2007-8#3)(2012-12#1)
the LCV##2##2##(1995-11#1)(1997-2#1)
the LCWS##2##2##(2008-3#2)
the LD and##2##3##(2007-10#1)(2007-11#1)
the LD##13##2##(1992-3#1)(2007-10#1)(2007-11#1)(2008-3#2)(2010-4#4)(2010-8#3)(2011-2#1)
the LD50##2##2##(1995-4#1)(2008-4#1)
the LDH activity##2##3##(1993-12#1)(2008-11#1)
the LDH##5##2##(1993-12#1)(1997-2#1)(2008-11#1)(2010-4#2)
the LDL particle##2##3##(1996-6#1)(2011-1#1)
the LDL receptor##12##3##(1990-7#4)(1992-5#1)(1993-10#1)(1993-9#3)(1995-6#1)(2008-6#2)
the LDL##41##2##(1990-7#4)(1991-1#1)(1991-12#2)(1991-6#2)(1991-8#3)(1992-5#2)(1993-10#1)(1993-11#3)(1993-12#1)(1993-6#1)(1993-9#4)(1994-3#4)(1995-5#1)(1995-6#3)(1996-5#1)(1996-6#1)(1997-7#1)(2005-7#1)(2006-12#2)(2008-6#2)(2011-1#1)
the LDL-C##2##2##(2011-2#1)(2013-8#1)
the LDL-cholesterol goal of##2##4##(1991-7#2)
the LDLR##2##2##(1995-2#2)
the LDM fraction##2##3##(1990-2#2)
the LDSV fraction##2##3##(1990-2#2)
the LE model##5##3##(2008-10#5)
the LEAP##4##2##(1996-3#3)(2007-10#1)
the LEC##4##2##(1990-11#1)(1993-12#1)(1995-3#2)
the LED##5##2##(2008-12#1)(2008-3#2)(2011-2#1)(2012-12#1)
the LEF-1##2##2##(1995-8#2)
the LEH##2##2##(1994-12#2)
the LEOPARD syndrome##3##3##(2013-8#3)
the LES##4##2##(2011-2#1)(2013-8#3)
the LEU2##2##2##(1991-7#1)(1995-4#1)
the LEW/N rat##3##3##(1994-11#2)(1994-2#1)
the LFD##3##2##(2008-10#2)(2012-2#1)
the LFF##2##2##(2007-12#2)
the LG##6##2##(2008-10#3)(2008-7#2)(2012-2#1)
the LGB##3##2##(2010-8#3)
the LGC/VAM protocol##2##3##(2008-10#2)
the LGN##5##2##(1995-5#3)(2008-1#2)
the LGS##3##2##(2007-12#2)(2008-3#1)
the LH beta##2##3##(1995-2#1)(1997-2#1)
the LH receptor in functionally active gonadal cells##2##8##(1995-10#2)
the LH receptor##4##3##(1995-10#3)(1996-5#1)
the LH##17##2##(1990-2#2)(1994-6#1)(1994-9#1)(1995-10#4)(1995-2#1)(1996-11#1)(1996-5#1)(1997-2#1)(2006-5#1)(2009-10#4)
the LH/hCG receptor##3##3##(1990-10#1)(1995-8#2)
the LH1##2##2##(1995-6#1)(2010-2#1)
the LHA of##2##3##(1995-5#1)(1996-1#1)
the LHA##4##2##(1995-5#1)(1996-1#3)
the LHC##2##2##(2007-8#1)(2007-9#1)
the LHR promoter##3##3##(1996-5#3)
the LHR##5##2##(1996-5#4)(2008-8#1)
the LHRH system##2##3##(1996-4#1)(2008-4#1)
the LHRH##6##2##(1991-4#1)(1992-12#2)(1993-2#1)(1996-4#1)(2008-4#1)
the LIBS##4##2##(2006-12#1)(2008-10#1)(2008-2#1)(2013-8#1)
the LIDT of##3##3##(2007-11#1)(2008-3#2)
the LIDT##7##2##(2007-11#1)(2007-12#1)(2008-3#5)
the LIF##4##2##(2008-2#3)(2008-3#1)
the LILACS##2##2##(2012-3#2)
the LIM protein##2##3##(1994-8#1)(2008-9#1)
the LIM##4##2##(1994-8#2)(2007-12#1)(2008-9#1)
the LIMA##3##2##(2006-12#1)(2007-8#2)
the LIP proteins##3##3##(1990-12#1)(1991-8#2)
the LIP##4##2##(1990-12#2)(1991-8#2)
the LIPWP##5##2##(2006-4#5)
the LITA##5##2##(2007-8#4)(2008-3#1)
the LLNA##5##2##(1997-2#1)(2008-10#2)(2008-5#2)
the LLPS##2##2##(2008-10#2)
the LMA##4##2##(1992-10#2)(1992-6#1)(2010-2#1)
the LMM##2##2##(2007-5#2)
the LMP gene##2##3##(1990-5#2)
the LMP##3##2##(1990-5#2)(2010-4#1)
the LMP2##2##2##(1997-9#1)(2012-2#1)
the LMWH##2##2##(2007-7#1)(2008-10#1)
the LNAA##2##2##(1995-3#2)
the LNN##3##2##(2008-2#2)(2008-3#1)
the LNR##3##2##(2010-12#3)
the LNT model##2##3##(2008-7#1)(2013-1#1)
the LNT theory##2##3##(2008-7#2)
the LNT##6##2##(2008-7#5)(2013-1#1)
the LOD was##2##3##(2008-10#2)
the LOD##7##2##(2008-10#6)(2012-1#1)
the LODs were##2##3##(2008-10#1)(2013-8#1)
the LODs##4##2##(2008-10#3)(2013-8#1)
the LOPES gait##3##3##(2012-1#3)
the LOQ##3##2##(1992-8#1)(1997-3#1)(2011-3#1)
the LOS##6##2##(1992-12#1)(2004-11#1)(2007-12#1)(2009-10#1)(2011-2#2)
the LOV##3##2##(2008-10#2)(2011-12#1)
the LP hens##3##3##(2007-8#3)
the LP##8##2##(2006-10#1)(2006-8#1)(2007-8#3)(2008-4#1)(2008-6#1)(2010-2#1)
the LP(01) mode of##2##4##(2007-11#1)(2008-3#1)
the LP(01) mode##3##3##(2007-11#2)(2008-3#1)
the LP(01)##5##2##(2007-11#2)(2007-12#1)(2008-3#2)
the LP-P##2##2##(1995-11#2)
the LPIA##5##2##(2008-3#5)
the LPL##5##2##(1993-3#3)(1994-11#2)
the LPO##5##2##(1997-6#3)(2005-8#1)(2013-1#1)
the LPP##6##2##(1992-1#2)(1994-8#2)(2008-1#1)(2008-5#1)
the LPS##4##2##(1990-2#1)(1996-10#2)(2008-11#1)
the LPS-induced IL-12##2##3##(2008-8#2)
the LPS-induced secretion##2##3##(2008-11#1)(2008-8#1)
the LPS-induced##11##2##(1993-4#2)(1995-12#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-8#4)(2011-2#1)
the LPT group and##4##4##(2007-7#4)
the LPT group##6##3##(2007-7#6)
the LR parsing##3##3##(2011-3#3)
the LR##6##2##(1996-10#1)(2008-10#1)(2009-7#1)(2011-3#3)
the LRTI group##2##3##(2009-3#2)
the LS method##2##3##(2008-10#2)
the LS##3##2##(1997-3#1)(2008-10#2)
the LS174T##2##2##(1991-7#2)
the LSC##2##2##(2008-5#1)(2013-1#1)
the LSPR sensing##2##3##(2007-8#2)
the LSPR##5##2##(2007-8#4)(2008-10#1)
the LSPV##2##2##(2011-2#2)
the LSU##2##2##(1993-11#1)(1995-8#1)
the LSW theory##4##3##(2005-11#4)
the LSW##5##2##(2005-11#5)
the LTB4-induced##2##2##(1994-9#2)
the LTR##7##2##(1991-2#1)(1991-5#2)(1994-12#1)(1994-8#1)(2005-10#1)(2009-10#1)
the LV##9##2##(1991-3#2)(1997-4#1)(2007-8#1)(2008-10#2)(2009-10#1)(2009-4#1)(2012-2#1)
the La##6##2##(1995-1#3)(1995-3#1)(2008-5#2)
the Lab##2##2##(2008-2#1)(2009-12#1)
the Labor##2##2##(1996-11#1)(2007-2#1)
the Laboratory for##2##3##(2008-3#1)(2010-5#1)
the Laboratory of##5##3##(2008-10#1)(2008-5#1)(2010-12#1)(2011-2#2)
the Laboratory##14##2##(1990-11#1)(1995-9#1)(2005-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
the Labour Inspection##2##3##(1992-5#1)(1995-2#1)
the LacI family of repressors##2##5##(1994-9#1)(1996-8#1)
the LacZ##2##2##(2007-6#1)(2008-11#1)
the Lachman test was##2##4##(2009-9#2)
the Lachman##3##2##(2009-9#3)
the Lactobacillus##5##2##(1991-7#1)(1995-6#1)(1997-1#2)(1997-2#1)
the Lactococcus lactis##2##3##(1997-6#1)(2013-1#1)
the Lagoa do Peixe##2##4##(2013-7#2)
the Lagoa do##3##3##(2013-7#3)
the Lagos University Teaching Hospital##3##5##(2010-9#2)(2011-11#1)
the Lagos##4##2##(2010-8#1)(2010-9#2)(2011-11#1)
the Lagrangian approach##3##3##(2008-7#3)
the Laguerre-Gauss##2##2##(2007-11#1)(2007-12#1)
the Laitinen questionnaire##3##3##(2007-8#3)
the Lake Maggiore##2##3##(2008-10#2)
the Lake##6##2##(2008-10#3)(2010-8#1)(2013-8#2)
the Lamaze##3##2##(2007-2#2)(2008-6#1)
the Lambert##2##2##(2008-10#2)
the Lambertian##3##2##(2008-2#2)(2008-3#1)
the Lamellar Gel##3##3##(2008-5#3)
the Lamm equation##2##3##(2006-10#2)
the Landers earthquake##2##3##(1996-4#1)(2008-3#1)
the LandmarXtrade mark##2##3##(2006-12#2)
the Landolt paradigm##3##3##(2013-8#3)
the Landolt##4##2##(2013-8#4)
the Langerhans##2##2##(1990-3#1)(2008-5#1)
the Langmuir adsorption##2##3##(2005-11#1)(2008-10#1)
the Langmuir isotherm approach##2##4##(2008-10#2)
the Langmuir isotherm model##2##4##(2007-8#1)(2008-10#1)
the Langmuir isotherm##5##3##(1991-7#1)(2007-8#1)(2008-10#3)
the Langmuir model##3##3##(2005-11#1)(2008-5#1)(2008-6#1)
the Langmuir##14##2##(1991-7#1)(1994-5#1)(2005-11#2)(2007-8#1)(2008-10#7)(2008-5#1)(2008-6#1)
the Langmuir-Blodgett technique##3##3##(2007-11#1)(2007-12#1)(2008-7#1)
the Langmuir-Blodgett##6##2##(2005-11#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-7#1)
the Laplace transform##2##3##(2008-2#2)
the Laplace##5##2##(2005-11#1)(2008-2#2)(2008-7#1)(2012-1#1)
the Laplacian##4##2##(2006-4#2)(2008-10#1)(2008-2#1)
the Large Hadron Collider (LHC)##2##5##(2007-8#1)(2007-9#1)
the Large Hadron Collider##3##4##(2007-8#1)(2007-9#2)
the Large##7##2##(2007-11#1)(2007-8#1)(2007-9#4)(2008-3#1)
the Laser Interferometer Gravitational Wave Observatory##4##6##(2007-11#1)(2008-2#1)(2008-3#2)
the Laser Interferometer Gravitational-Wave Observatory (LIGO)##3##6##(2008-3#3)
the Laser Interferometer##7##3##(2007-11#1)(2008-2#1)(2008-3#5)
the Laser##9##2##(2007-11#1)(2008-2#1)(2008-3#7)
the Late##4##2##(1992-5#1)(2006-7#1)(2010-5#1)(2010-6#1)
the Lateral and##2##3##(2005-5#1)(2008-3#1)
the Lateral##5##2##(1994-8#1)(2005-5#1)(2007-7#1)(2008-3#1)(2013-1#1)
the Latin American clade##2##4##(2008-10#2)
the Latin American##7##3##(1992-5#1)(2007-3#1)(2008-10#3)(2010-10#1)(2011-2#1)
the Latin##10##2##(1992-5#1)(2007-10#1)(2007-3#1)(2008-10#3)(2010-10#1)(2011-2#1)(2012-2#2)
the Latium##2##2##(1992-9#2)
the Laue##3##2##(2006-4#1)(2006-5#2)
the Laurentian Great Lakes##3##4##(2012-3#3)
the Laurentian##4##2##(2007-12#1)(2012-3#3)
the Law##3##2##(1993-5#1)(2007-9#1)(2011-2#1)
the Lawrence##3##2##(2006-4#1)(2008-3#1)(2009-4#1)
the Le##3##2##(1993-3#1)(1995-4#1)(2007-12#1)
the Le(a+b+)##2##2##(1996-2#2)
the Least##2##2##(2007-5#1)(2013-1#1)
the Leaves##5##2##(2008-8#1)(2011-2#1)(2013-1#3)
the Lebanese Osteoporosis Guidelines##2##4##(2008-9#2)
the Lebanese##6##2##(2008-9#6)
the Lebanon##2##2##(2009-2#1)(2010-4#1)
the Lee and Frost filters##2##5##(2008-2#2)
the Lee filter##2##3##(2008-2#2)
the Lee##7##2##(2008-2#6)(2008-9#1)
the Leeward Islands of the Netherlands Antilles##2##7##(1992-2#2)
the Lehigh Valley##2##3##(2007-10#1)(2007-9#1)
the Lehigh##3##2##(2007-10#1)(2007-9#1)(2010-2#1)
the Leishmania##10##2##(1993-11#1)(1994-9#1)(2005-8#1)(2006-10#1)(2008-4#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#2)
the Lena##2##2##(2010-8#2)
the Leptosphaeria##3##2##(2008-10#3)
the Lequesne Index##3##3##(2006-10#3)
the Let-7##2##2##(2010-7#2)
the Leu##2##2##(1992-6#1)(1992-9#1)
the Leu15-Tyr16##2##2##(1991-4#2)
the Leuven Intensive Insulin Therapy Trial##2##6##(2010-12#2)
the Levenberg-Marquardt algorithm##3##3##(2008-10#1)(2008-2#1)(2010-8#1)
the Levenberg-Marquardt##4##2##(2008-10#1)(2008-2#2)(2010-8#1)
the Lewis acid##2##3##(2005-11#1)(2009-2#1)
the Lewis lung##2##3##(1990-6#1)(2006-11#1)
the Lewis##8##2##(1990-6#1)(1991-3#1)(1994-2#1)(1996-5#1)(2005-11#1)(2006-11#1)(2009-2#1)(2013-8#1)
the LexA repressor of Ec##2##5##(1995-2#2)
the LexA##3##2##(1994-6#1)(1995-2#2)
the Leydig cell##2##3##(2009-10#1)(2010-1#1)
the Leydig##3##2##(1990-6#1)(2009-10#1)(2010-1#1)
the Li##3##2##(2005-11#1)(2008-10#1)(2010-5#1)
the LiF##3##2##(2008-2#1)(2008-3#2)
the Library##3##2##(1995-3#1)(2013-1#2)
the Lidar In-Space Technology Experiment##2##5##(2008-3#2)
the Life Course##3##3##(2008-5#1)(2009-10#1)(2012-12#1)
the LifeSite Hemodialysis Access System##2##5##(2007-7#2)
the LifeSite System##4##3##(2007-7#4)
the LifeSite##6##2##(2007-7#6)
the LifeSite(R) Hemodialysis Access System##2##5##(2007-7#2)
the LifeSite(R)##3##2##(2007-7#3)
the Ligasure##4##2##(2009-2#2)(2011-2#2)
the Lindenberg Aerosol Characterization Experiment##2##5##(2008-3#2)
the Linear##3##2##(1996-9#1)(2006-9#1)(2008-7#1)
the Lineweaver-Burk##2##2##(1991-8#1)(2008-5#1)
the Link module##2##3##(1997-6#2)
the Lipid Study Leipzig (LSL)##2##5##(2008-7#2)
the Lipid##6##2##(1993-9#1)(2006-5#1)(2008-3#1)(2008-7#2)(2011-12#1)
the Lisbon-Setúbal axis##2##3##(2004-4#2)
the Listening to Mothers II##3##5##(2008-9#3)
the Listening to Mothers##4##4##(2007-2#1)(2008-9#3)
the Literature##20##2##(1997-3#1)(2005-5#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
the Lithuanian health system##2##4##(2013-8#2)
the Lithuanian##3##2##(2007-10#1)(2013-8#2)
the LittlEARS(®)##2##2##(2011-12#2)
the Liver##4##2##(2006-6#1)(2009-3#1)(2009-8#2)
the Living Sky Health District##2##5##(1996-1#2)
the Living##3##2##(1996-1#2)(2013-7#1)
the Lixiscope##2##2##(1997-3#2)
the Ln##2##2##(1997-7#2)
the Local Health##3##3##(2007-1#1)(2011-2#1)(2012-12#1)
the Local Lymph Node Assay##2##5##(2008-10#2)
the Local##10##2##(1994-6#2)(2007-1#1)(2008-10#2)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
the Loewe additivity model##3##4##(2009-12#3)
the Log TG/HDL-C ratio##3##4##(2008-3#3)
the Logan Rep protein##2##4##(2008-10#2)
the Lokomat##2##2##(2012-1#2)
the Loma##2##2##(1992-12#1)(1993-2#1)
the Lombardia##2##2##(1994-6#1)(2007-1#1)
the Lombardy##2##2##(1992-10#1)(2007-7#1)
the Lomonosov##2##2##(1991-11#1)(1994-7#1)
the London Health Sciences Centre##2##5##(2008-11#2)
the London##8##2##(1993-9#2)(1997-1#1)(2006-12#1)(2008-1#1)(2008-11#2)(2012-2#1)
the Long Ashton splashmeter##2##4##(2008-10#2)
the Long##3##2##(2008-10#2)(2011-2#1)
the Lorentz##2##2##(1995-5#1)(2008-2#1)
the Lorentz-Lorenz formula##2##3##(2008-2#2)
the Lorentzian##2##2##(2008-10#1)(2008-3#1)
the Los Alamos National Laboratory##2##5##(2007-8#2)
the Los Alamos##3##3##(2007-8#2)(2013-1#1)
the Los Angeles##6##3##(2004-12#1)(2006-12#1)(2007-2#1)(2007-6#1)(2008-5#1)(2011-2#1)
the Los##11##2##(2004-12#1)(2006-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#2)(2008-5#2)(2011-2#1)(2013-1#1)
the Lotka-Volterra##2##2##(2008-8#2)
the Louisiana State University Medical Center##2##6##(1996-1#2)
the Louisiana##8##2##(1996-1#2)(1996-6#1)(2008-10#1)(2011-2#3)(2012-2#1)
the Lovelace##2##2##(1996-1#1)(1996-12#1)
the Low##4##2##(1992-12#1)(1997-3#1)(2008-3#1)(2012-7#1)
the Lowenstein-Jensen##2##2##(2013-1#1)(2013-8#1)
the Lower Jimi Valley##5##4##(2008-4#5)
the Lower##8##2##(2006-10#1)(2008-10#1)(2008-4#5)(2013-8#1)
the Lowry method##3##3##(2008-1#1)(2008-2#1)(2008-9#1)
the Lp(a)##5##2##(1991-12#1)(1993-2#3)(1995-2#1)
the Lr26##2##2##(2008-10#2)
the Lu##2##2##(2005-8#1)(2008-8#1)
the Lublin Orthopedic Clinic##2##4##(2007-7#2)
the Lublin##4##2##(2007-11#2)(2007-7#2)
the Lung##6##2##(1995-3#1)(2007-10#1)(2008-5#1)(2010-8#2)(2013-1#1)
the Lutheran##2##2##(1992-3#2)
the Luttinger##2##2##(1991-12#1)(1992-8#1)
the Lutzomyia##2##2##(2008-8#1)(2012-12#1)
the Ly-49+##2##2##(1995-2#2)
the Lyapunov##2##2##(1992-3#1)(2007-12#1)
the Lycopersicon genus##2##3##(2005-10#2)
the Lycopersicon##3##2##(2005-10#3)
the Lyme disease spirochete##2##4##(1995-5#1)(2010-6#1)
the Lyme disease spirochetes in Japan##2##6##(1997-4#2)
the Lyme disease spirochetes##3##4##(1997-4#3)
the Lyme disease##5##3##(1995-5#1)(1997-4#3)(2010-6#1)
the Lyme##6##2##(1995-5#1)(1997-4#3)(2004-11#1)(2010-6#1)
the Lys residues##4##3##(1991-8#2)(1995-6#2)
the Lys##7##2##(1990-8#1)(1991-7#1)(1991-8#2)(1994-12#1)(1995-6#2)
the Lysholm and##2##3##(2007-8#1)(2008-5#1)
the Lysholm##5##2##(2007-8#1)(2008-5#2)(2011-2#1)(2013-1#1)
the M =##2##3##(1996-2#1)(2008-3#1)
the M genotypes##2##3##(2008-10#2)
the M group##3##3##(1992-5#3)
the M intermediate in##2##4##(1994-11#2)
the M intermediate##5##3##(1994-11#3)(1995-5#1)(1997-4#1)
the M protein##2##3##(1994-2#1)(1997-4#1)
the M side of the membrane##2##6##(1993-3#1)(2011-2#1)
the M side of##3##4##(1993-3#1)(2011-2#2)
the M spike##2##3##(2006-10#2)
the M##68##2##(1990-5#1)(1992-3#2)(1992-5#3)(1993-12#1)(1993-3#1)(1994-11#6)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#4)(1995-5#1)(1996-2#1)(1996-9#1)(1997-3#5)(1997-4#2)(1997-5#1)(1997-6#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-2#1)(2008-10#6)(2008-3#4)(2008-5#7)(2008-7#5)(2008-9#1)(2009-3#1)(2009-6#1)(2010-4#1)(2010-8#1)(2011-10#1)(2011-2#2)
the M(2) factor and##3##4##(2007-12#1)(2008-3#2)
the M(2) factor##4##3##(2007-12#2)(2008-3#2)
the M(2)##7##2##(2007-12#3)(2008-2#2)(2008-3#2)
the M(Mepp)(-) complexes##2##3##(2008-5#2)
the M(r)##4##2##(1992-8#1)(1993-12#1)(1994-5#2)
the M* x##2##3##(1997-4#2)
the M-CSF##2##2##(1990-11#1)(1991-5#1)
the M-D##4##2##(2008-2#4)
the M-cell monolayer##2##3##(2008-11#2)
the M/# is##3##3##(2007-12#1)(2008-3#2)
the M/###5##2##(2007-12#2)(2008-2#1)(2008-3#2)
the M1 and M2##2##4##(1990-2#1)(1992-10#1)
the M1##6##2##(1990-2#2)(1992-10#1)(1993-9#1)(1996-7#1)(2013-8#1)
the M1-selective agonist##2##3##(1994-8#2)
the M13##4##2##(1991-7#1)(1994-12#1)(2006-8#1)(2008-4#1)
the M2##8##2##(1990-2#1)(1992-8#1)(1995-1#2)(2007-12#1)(2008-2#1)(2011-1#2)
the M2(D)##3##2##(2008-8#3)
the M3##5##2##(1994-3#1)(1997-7#1)(2007-10#1)(2011-2#1)(2013-1#1)
the M4 segment of the##2##5##(2008-12#2)
the M4##3##2##(1991-2#1)(2008-12#2)
the M412##2##2##(1990-2#2)
the MA Advanced##2##3##(2008-11#2)
the MA values##2##3##(1990-8#2)
the MA##7##2##(1990-8#2)(2008-10#2)(2008-11#2)(2008-3#1)
the MA-induced##2##2##(1997-8#2)
the MABC-2##2##2##(2013-7#2)
the MAC genome##2##3##(2012-3#2)
the MAC##4##2##(2008-4#2)(2012-3#2)
the MAD##3##2##(2006-4#1)(2007-6#2)
the MADS##3##2##(1997-2#1)(1997-8#2)
the MADS-box genes in orchids##2##5##(2012-2#2)
the MADS-box genes##3##3##(2012-2#3)
the MADS-box##4##2##(2012-2#4)
the MAF or##2##3##(2011-1#2)
the MAF##6##2##(2005-5#1)(2010-11#1)(2011-1#4)
the MAFF##3##2##(2005-5#3)
the MAGE index##2##3##(2009-11#2)
the MAGIC##3##2##(2007-4#1)(2007-8#1)(2008-7#1)
the MAI##2##2##(2012-12#2)
the MALDI##3##2##(2007-8#2)(2008-10#1)
the MAN##2##2##(1991-6#1)(2009-5#1)
the MAO-B##2##2##(1994-6#1)(1994-8#1)
the MAP kinase pathway##2##4##(1996-2#1)(1996-3#1)
the MAP kinase##10##3##(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-3#2)(1996-4#1)(1997-6#1)(2008-4#1)(2012-12#1)
the MAP kinase/ERK##2##3##(1996-5#2)
the MAP kinases##3##3##(1993-6#1)(1995-6#1)(1997-7#1)
the MAP##24##2##(1992-7#2)(1993-6#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-7#1)(1997-4#1)(1997-6#1)(1997-7#2)(2006-7#1)(2007-12#2)(2008-4#2)(2012-12#1)
the MAP-sensitized##2##2##(1996-10#2)
the MAPK cascade in##2##4##(1995-1#1)(1995-2#1)
the MAPK cascade##4##3##(1995-1#2)(1995-2#1)(2009-8#1)
the MAPK module is localized to##2##6##(2009-8#2)
the MAPK module is##3##4##(2009-8#3)
the MAPK module##4##3##(2009-8#4)
the MAPK signal##2##3##(2008-11#2)
the MAPK##22##2##(1995-1#2)(1995-2#1)(2008-1#2)(2008-11#2)(2008-2#2)(2009-8#7)(2012-3#4)(2013-8#2)
the MAPKK##2##2##(1994-12#2)
the MARCKS##4##2##(1991-7#1)(1993-11#1)(1996-5#2)
the MAS##5##2##(2008-1#1)(2008-3#3)(2012-1#1)
the MAT-1 pheromone##2##3##(2008-10#2)
the MAT-1##3##2##(2008-10#3)
the MAX##3##2##(1990-3#1)(1995-6#2)
the MAb##6##2##(1992-12#1)(1997-2#2)(2008-10#1)(2008-11#1)(2008-4#1)
the MAbs##4##2##(1993-9#1)(1994-3#1)(2008-10#2)
the MB signal##2##3##(2008-10#2)
the MB##6##2##(1992-10#1)(1993-8#1)(2008-10#4)
the MBAS total##2##3##(2007-12#2)
the MBC##2##2##(2006-8#1)(2012-11#1)
the MBCp frequency##2##3##(1996-11#2)
the MBDCG plate##2##3##(2008-2#2)
the MBDCG##3##2##(2008-2#3)
the MBI##2##2##(2008-10#1)(2008-9#1)
the MBP gene##2##3##(1991-6#1)(1993-3#1)
the MBP##3##2##(1991-6#1)(1993-3#1)(2013-8#1)
the MC##15##2##(1992-12#1)(1996-5#1)(1997-7#1)(1997-8#1)(2007-11#4)(2007-3#1)(2008-10#2)(2008-11#1)(2011-1#1)(2012-2#2)
the MC1R##2##2##(2006-12#1)(2008-9#1)
the MCA##17##2##(1996-5#1)(2006-11#5)(2007-10#6)(2007-9#1)(2008-12#4)
the MCBS##3##2##(1995-2#1)(1996-2#1)(1997-1#1)
the MCCB##3##2##(2012-12#3)
the MCF-7 human breast cancer cell line##2##7##(2008-11#1)(2012-3#1)
the MCF-7##6##2##(1992-9#1)(1994-12#1)(2008-11#1)(2008-5#1)(2012-3#2)
the MCI procedure##3##3##(2006-11#3)
the MCI##5##2##(2006-11#4)(2013-8#1)
the MCMC##3##2##(2009-12#1)(2009-4#1)(2012-7#1)
the MCO##2##2##(2007-1#1)(2012-2#1)
the MCP##3##2##(1990-2#2)(2012-1#1)
the MCS##7##2##(1991-7#3)(1994-12#1)(1997-2#1)(2007-8#1)(2011-2#1)
the MCS+##4##2##(2011-2#4)
the MCT diet##5##3##(2007-8#5)
the MD##5##2##(1991-4#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
the MDA levels##2##3##(2013-8#2)
the MDA##5##2##(2008-3#1)(2009-4#1)(2011-1#1)(2013-8#2)
the MDA-MB-134##2##2##(1990-5#2)
the MDB##5##2##(2010-8#5)
the MDCK##4##2##(1995-11#3)(2008-11#1)
the MDG##2##2##(2011-1#2)
the MDI##11##2##(1992-3#5)(1996-1#3)(1996-2#2)(1997-2#1)
the MDM##3##2##(2008-3#2)(2008-9#1)
the MDR phenotype##2##3##(2008-11#2)
the MDR##4##2##(1993-3#1)(1996-5#1)(2008-11#2)
the MDR1 gene##5##3##(1992-11#1)(1994-3#1)(2008-11#2)(2011-2#1)
the MDR1##11##2##(1992-11#1)(1994-3#1)(1994-5#1)(2007-10#3)(2008-11#3)(2011-2#2)
the MDS##2##2##(2008-1#1)(2008-4#1)
the MDV genome##3##3##(2007-6#1)(2013-8#2)
the ME##5##2##(1991-4#1)(2011-2#2)(2013-1#1)(2013-8#1)
the MECC##2##2##(1994-9#2)
the MED##4##2##(1992-2#2)(2006-8#1)(2007-7#1)
the MED-EL COMBI 40+##2##4##(2008-9#2)
the MED-EL##4##2##(2008-9#4)
the MEDLINE##3##2##(2004-3#1)(2013-1#1)(2013-8#1)
the MEF##3##2##(1996-8#1)(2008-8#2)
the MEK-8118 haematology analyser##2##4##(2008-10#2)
the MEK-ERK pathway##2##3##(2011-2#2)
the MEKC##3##2##(1996-5#2)(1997-8#1)
the MELAS and FICM patients##2##5##(1991-4#2)
the MELAS and##3##3##(1991-4#2)(2006-11#1)
the MELAS##4##2##(1991-4#2)(2006-11#2)
the MEN1##2##2##(2010-2#2)
the MEP##3##2##(2008-11#2)(2008-7#1)
the MERRF##2##2##(1991-4#1)(2006-11#1)
the MET receptor tyrosine kinase##2##5##(2009-4#2)
the MET signaling pathway##3##4##(2009-4#3)
the MET##8##2##(2009-4#6)(2012-1#1)(2012-12#1)
the MF alpha 1##3##4##(1993-3#1)(1993-9#1)(1994-2#1)
the MF##4##2##(1993-3#1)(1993-9#1)(1994-2#1)(2008-10#1)
the MF-exposed rats##2##3##(1993-7#2)
the MF-exposed##3##2##(1993-7#3)
the MF1-ATPase##2##2##(1992-12#2)
the MFN was##2##3##(2008-11#2)
the MFN##3##2##(2008-11#3)
the MFS##8##2##(1994-1#6)(1996-1#1)(2011-1#1)
the MG content##2##3##(2008-6#2)
the MG##6##2##(1996-2#1)(2006-12#1)(2007-8#1)(2008-5#1)(2008-6#2)
the MGED ontology##2##3##(2008-7#2)
the MGMT gene##2##3##(1992-3#2)
the MGMT##4##2##(1992-3#3)(2006-12#1)
the MH##2##2##(1996-12#1)(2007-7#1)
the MHC class I gene##2##5##(1996-2#1)(2007-5#1)
the MHC class I##6##4##(1992-4#2)(1996-2#1)(2007-5#1)(2008-4#2)
the MHC class II##4##4##(1992-4#1)(1993-6#1)(1995-8#1)(2008-4#1)
the MHC class##10##3##(1992-4#3)(1993-6#1)(1995-8#1)(1996-2#1)(2007-5#1)(2008-4#3)
the MHC molecule##2##3##(2007-11#1)(2008-4#1)
the MHC molecules##2##3##(1995-5#2)
the MHC region##3##3##(1997-9#1)(2008-4#2)
the MHC##29##2##(1990-5#1)(1992-4#3)(1993-6#1)(1995-5#2)(1995-8#3)(1996-2#1)(1997-6#1)(1997-9#1)(2007-11#1)(2007-5#1)(2008-4#11)(2008-5#1)(2008-9#1)(2010-5#1)
the MHLW##2##2##(2005-5#1)(2010-8#1)
the MHO phenotype##3##3##(2013-1#3)
the MHSIP##2##2##(1992-12#2)
the MI in##2##3##(1990-6#1)(2008-11#1)
the MI##7##2##(1990-6#1)(1991-4#1)(1993-7#1)(1993-8#1)(1996-3#1)(2008-11#1)(2008-5#1)
the MI-MII equilibrium of rhodopsin##2##5##(1990-6#1)(1991-4#1)
the MIB-1##3##2##(2007-12#2)(2008-6#1)
the MIC and##3##3##(2005-7#2)(2007-7#1)
the MIC values of##3##4##(2008-5#2)(2011-12#1)
the MIC values##4##3##(2006-8#1)(2008-5#2)(2011-12#1)
the MIC##15##2##(1990-9#1)(2005-7#2)(2006-8#2)(2007-1#1)(2007-7#1)(2008-5#4)(2011-12#1)(2012-2#3)
the MICs of##4##3##(2007-7#1)(2008-12#1)(2008-5#1)(2010-6#1)
the MICs##7##2##(2007-12#1)(2007-7#2)(2008-11#1)(2008-12#1)(2008-5#1)(2010-6#1)
the MIH##4##2##(2008-6#1)(2013-1#3)
the MIM complex##3##3##(1995-6#3)
the MIMIC II##4##3##(2013-1#4)
the MIMS response of##3##4##(2008-10#3)
the MIMS response##4##3##(2008-10#4)
the MINT##2##2##(2008-4#2)
the MIP##4##2##(2005-11#1)(2008-10#2)(2010-5#1)
the MIQ-RS##3##2##(2008-10#3)
the MIS##5##2##(1993-12#1)(1995-11#2)(2008-4#1)(2008-8#1)
the MIT-Skywalker##2##2##(2012-1#2)
the MITF gene##2##3##(1996-2#2)
the MITS##3##2##(2004-1#3)
the ML##7##2##(1993-9#1)(2007-11#1)(2007-12#2)(2008-10#1)(2010-8#1)(2012-2#1)
the MLC##2##2##(2009-8#2)
the MLEs##2##2##(1993-9#2)
the MLL gene##2##3##(1996-10#1)(2012-12#1)
the MLL##4##2##(1996-10#1)(2011-3#2)(2012-12#1)
the MLPNN##2##2##(2010-8#2)
the MLR##6##2##(1991-11#3)(1991-3#1)(1995-2#1)(2008-10#1)
the MLS##3##2##(2008-5#2)(2012-2#1)
the MM group and 31##2##5##(1991-8#1)(2011-2#1)
the MM##6##2##(1991-8#1)(1997-7#1)(2007-10#1)(2007-8#1)(2009-8#1)(2011-2#1)
the MM3##4##2##(1991-2#1)(1995-11#1)(1996-5#2)
the MMA##4##2##(2005-9#1)(2007-9#1)(2008-12#2)
the MMBI##2##2##(2008-3#2)
the MMDM##3##2##(2008-2#1)(2008-3#2)
the MME##2##2##(2008-3#1)(2009-3#1)
the MMP-1 and MMP-9 expressions##2##5##(2012-3#2)
the MMP-1 and MMP-9 mRNA##2##5##(2012-3#2)
the MMP-1 and MMP-9##4##4##(2012-3#4)
the MMP-1##5##2##(2008-5#1)(2012-3#4)
the MMP-9##2##2##(2007-10#1)(2007-11#1)
the MMR##3##2##(2006-8#1)(2008-6#1)(2013-1#1)
the MMSE##5##2##(2007-10#1)(2007-11#2)(2008-7#1)(2013-1#1)
the MMV##2##2##(2007-2#2)
the MMVP system##2##3##(2010-9#2)
the MNS##9##2##(1991-6#1)(2008-11#6)(2012-1#2)
the MO##2##2##(1990-9#1)(2008-3#1)
the MOF is##2##3##(2008-10#2)
the MOL##4##2##(1997-4#4)
the MONICA##3##2##(2006-10#2)(2006-8#1)
the MOPITT##2##2##(2008-3#2)
the MOSFET##3##2##(2009-5#3)
the MP##13##2##(1991-9#1)(1997-3#1)(1997-6#2)(2008-10#1)(2008-6#5)(2008-9#3)
the MPA##6##2##(1996-1#2)(1996-3#3)(2005-4#1)
the MPC##4##2##(1994-5#1)(1996-2#1)(2007-12#1)(2008-11#1)
the MPG##3##2##(1992-8#2)(2008-2#1)
the MPI##3##2##(1995-6#2)(2008-2#1)
the MPM##4##2##(1997-4#2)(2010-9#1)(2013-1#1)
the MPN test##2##3##(2007-12#2)
the MPOA##3##2##(1992-5#1)(1994-2#2)
the MPQ as##2##3##(2012-2#2)
the MPQ in##2##3##(2012-2#2)
the MPQ##7##2##(2012-2#7)
the MPTP-treated##2##2##(1995-12#1)(1996-8#1)
the MPV##2##2##(2013-8#2)
the MPs of##2##3##(2007-11#1)(2008-10#1)
the MR and##3##3##(2007-9#1)(2008-7#1)(2011-2#1)
the MR aortography##5##3##(2007-9#5)
the MR appearance##2##3##(1996-6#1)(2007-11#1)
the MR findings##2##3##(1995-4#1)(2011-2#1)
the MR images##2##3##(2006-5#1)(2008-2#1)
the MR##27##2##(1991-6#1)(1993-12#2)(1995-4#2)(1996-6#1)(1997-8#1)(2006-5#1)(2007-11#4)(2007-9#6)(2008-10#1)(2008-2#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-2#1)
the MRC##4##2##(2006-5#1)(2006-7#1)(2007-12#1)(2012-3#1)
the MRI contrast##2##3##(2012-11#1)(2012-12#1)
the MRI##22##2##(1992-3#1)(1995-6#1)(2006-1#1)(2007-11#2)(2007-4#2)(2008-1#2)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#2)(2010-2#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)
the MRIs##2##2##(1996-3#1)(2007-11#1)
the MRKH syndrome##2##3##(2007-7#2)
the MRKH##3##2##(2007-7#3)
the MRL regulated by##3##4##(2013-8#3)
the MRM group##2##3##(1995-10#1)(1995-4#1)
the MRM##3##2##(1995-10#1)(1995-4#1)(2008-2#1)
the MRS##3##2##(2004-7#1)(2007-9#1)(2008-6#1)
the MRSA##5##2##(1994-7#1)(2007-8#2)(2009-3#1)(2011-2#1)
the MS is##4##3##(2008-3#4)
the MS model##2##3##(2008-7#1)(2013-1#1)
the MS was##3##3##(2007-8#1)(2008-3#2)
the MS##39##2##(1994-3#1)(1995-12#1)(1996-12#2)(2005-12#1)(2005-6#1)(2007-1#1)(2007-8#2)(2008-10#5)(2008-3#17)(2008-7#2)(2009-12#1)(2009-3#1)(2010-4#1)(2012-3#2)(2013-1#1)
the MS-ATP##2##2##(2008-3#2)
the MS-WHO##2##2##(2008-3#2)
the MS/MS##3##2##(2007-8#1)(2008-4#1)(2008-8#1)
the MSA##2##2##(1993-12#1)(1995-2#1)
the MSDchem##2##2##(2008-4#2)
the MSE##2##2##(2008-3#2)
the MSFS##2##2##(2006-12#2)
the MSH 'core'##2##3##(1995-12#2)
the MSH##3##2##(1993-5#1)(1995-12#2)
the MSH27Ep##2##2##(2008-8#2)
the MSKCC grading##2##3##(2011-2#2)
the MSKCC##3##2##(2009-11#1)(2011-2#2)
the MSMA##2##2##(2007-10#2)
the MSN##2##2##(2008-11#1)(2008-7#1)
the MSP procedure##2##3##(2008-10#2)
the MSP##3##2##(2007-11#1)(2008-10#2)
the MSR group##2##3##(2008-5#2)
the MSR##4##2##(1995-12#1)(2008-5#2)(2009-10#1)
the MSSA and##2##3##(2009-3#2)
the MST patients##2##3##(2004-1#2)
the MST##5##2##(2004-1#4)(2008-6#1)
the MSV resistance of##2##4##(2008-10#2)
the MT##14##2##(1996-4#1)(1997-2#2)(2008-10#9)(2009-8#1)(2013-1#1)
the MT-1 peak##2##3##(2008-10#2)
the MT-1##3##2##(2008-10#3)
the MT-2 isoform was##2##4##(2008-10#2)
the MT-like##2##2##(1990-5#2)
the MT1 receptor##3##3##(2013-7#3)
the MT1##4##2##(2013-7#4)
the MTA##4##2##(2010-8#3)(2013-1#1)
the MTAS-treated microsomes##3##3##(1991-9#3)
the MTC test##4##3##(2008-7#4)
the MTD of##2##3##(2006-6#1)(2008-6#1)
the MTD##8##2##(1990-9#1)(2006-6#2)(2007-11#1)(2008-6#3)(2012-3#1)
the MTF of##2##3##(2008-2#1)(2008-3#1)
the MTF##7##2##(2006-5#1)(2008-2#4)(2008-3#1)(2013-8#1)
the MTHFR gene##4##3##(1996-6#2)(2007-10#1)(2008-1#1)
the MTHFR##5##2##(1996-6#2)(2007-10#1)(2008-1#1)(2010-3#1)
the MTP##2##2##(2008-7#2)
the MTR##3##2##(2006-9#3)
the MTT assay##8##3##(1992-2#1)(1992-7#1)(1996-12#1)(2008-5#1)(2011-2#1)(2012-3#2)(2013-1#1)
the MTT##13##2##(1992-2#1)(1992-7#1)(1996-12#1)(2007-10#2)(2008-11#1)(2008-5#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#1)
the MTX concentration##2##3##(2008-11#2)
the MTX##8##2##(1991-2#1)(1992-8#1)(1994-2#1)(1996-11#3)(2008-11#2)
the MTX2##2##2##(1995-1#2)
the MTs##2##2##(2008-10#1)(2009-10#1)
the MUC1##4##2##(1991-7#3)(1992-5#1)
the MV receptor##2##3##(1997-4#2)
the MVB group were##2##4##(2007-7#2)
the MVB group##7##3##(2007-7#7)
the MVB##8##2##(2007-7#8)
the MVM P4 promoter##2##4##(1993-5#2)
the MW##3##2##(2006-8#1)(2007-8#1)(2008-10#1)
the MWC model##2##3##(1990-8#1)(2012-1#1)
the MWM##2##2##(1993-2#1)(2008-2#1)
the MWNT-film##2##2##(2008-10#2)
the MWNTs##2##2##(2008-10#2)
the MX line##7##3##(2008-10#7)
the MYC gene##2##3##(2009-2#1)(2011-1#1)
the MYC##3##2##(2009-2#1)(2011-1#1)(2011-2#1)
the MZI##2##2##(1994-2#1)(2007-8#1)
the Mabs##2##2##(2008-5#2)
the Mach-Zehnder configuration##2##3##(2008-3#2)
the Mach-Zehnder interferometer##2##3##(2007-8#1)(2008-3#1)
the Mach-Zehnder##7##2##(2007-12#1)(2007-8#1)(2008-2#2)(2008-3#3)
the Macintosh computer##3##3##(1996-12#3)
the Macintosh##5##2##(1992-10#1)(1996-12#3)(2008-9#1)
the Madin-Darby canine kidney##2##4##(1991-11#1)(2008-8#1)
the Madison##2##2##(1994-12#1)(2010-11#1)
the Madrid##2##2##(1997-2#1)(2008-11#1)
the Magellan Region##2##3##(2007-5#2)
the Magic 1##2##3##(1997-3#2)
the Magna prosthesis##2##3##(2007-8#2)
the Magnetic##2##2##(1995-1#1)(2011-2#1)
the Maillard reaction in##3##4##(1993-5#1)(1995-1#1)(1996-5#1)
the Maillard reaction##8##3##(1991-5#1)(1993-5#2)(1994-6#1)(1995-1#2)(1996-5#1)(2006-12#1)
the Maine##3##2##(1991-1#1)(1996-11#1)(2007-5#1)
the Maintenance of##2##3##(2007-4#1)(2008-8#1)
the Major##2##2##(2008-10#1)(2008-11#1)
the Majority##2##2##(2010-9#2)
the Malaria##2##2##(2006-4#1)(2012-3#1)
the Malassezia spp##3##3##(2008-5#2)(2011-2#1)
the Malayan##3##2##(1994-6#1)(2006-12#1)(2007-2#1)
the Malaysian##3##2##(2005-12#1)(2012-2#2)
the Maldives##2##2##(2012-3#2)
the Male##3##2##(1996-3#1)(2007-12#1)(2013-8#1)
the Malignant##2##2##(1991-7#1)(1994-12#1)
the Malwa region of Punjab##4##5##(2013-8#4)
the Mamdani##2##2##(2009-3#2)
the Man##5##2##(1990-1#1)(1990-2#2)(2009-10#2)
the Management and##2##3##(2008-12#1)(2011-2#1)
the Management of Aggression in People with Dementia Attitude Questionnaire was##2##11##(2011-2#2)
the Management of##14##3##(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-3#2)(2008-6#1)(2010-6#1)(2011-1#1)(2011-2#4)
the Management##17##2##(1993-12#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-3#2)(2008-6#1)(2010-6#1)(2011-1#1)(2011-2#5)
the Mancozeb##2##2##(2008-10#2)
the Mann-Whitney test##3##3##(2009-3#1)(2010-5#1)(2013-1#1)
the Mann-Whitney##8##2##(1992-6#1)(1997-3#1)(2007-8#1)(2008-9#1)(2009-3#1)(2010-5#1)(2013-1#1)(2013-8#1)
the Mantel test##2##3##(2010-6#1)(2012-3#1)
the Mantel##3##2##(2010-6#1)(2012-3#2)
the Manus Basin##4##3##(2008-6#4)
the Manyatta regimen##2##3##(2005-9#2)
the Mapping##3##2##(2008-2#1)(2013-1#2)
the March##4##2##(2009-3#1)(2009-8#2)(2012-12#1)
the Marek's disease virus (MDV)##3##5##(2007-6#1)(2013-8#2)
the Marek's disease##4##3##(2007-6#1)(2013-8#3)
the Marfan syndrome##3##3##(2013-1#3)
the Marfan##5##2##(1996-3#1)(2008-8#1)(2013-1#3)
the Marian Weiss Rehabilitation Center in Konstancin##3##7##(2007-11#3)
the Marine##4##2##(2007-5#1)(2008-3#2)(2009-9#1)
the Markov chain Monte Carlo##2##5##(2010-2#1)(2012-7#1)
the Markov chain##4##3##(1997-4#1)(2008-7#1)(2010-2#1)(2012-7#1)
the Markov model##3##3##(1990-9#1)(2008-6#1)(2008-8#1)
the Markov property##2##3##(2007-12#2)
the Markov##10##2##(1990-9#1)(1991-12#1)(1997-4#1)(2007-12#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-7#1)
the Mars##3##2##(1992-2#1)(2006-4#2)
the Marshall Islands##15##3##(1994-9#3)(2005-11#3)(2008-1#5)(2008-10#1)(2013-8#3)
the Marshall##17##2##(1994-9#3)(2005-11#3)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#1)(2013-8#3)
the Martian surface##2##3##(1990-8#1)(2010-5#1)
the Martian##3##2##(1990-8#1)(2010-5#2)
the Masaoka##2##2##(2007-8#2)
the Mashona heifers##2##3##(1996-12#2)
the Mashona##3##2##(1996-12#3)
the Maslach Burnout Inventory (MBI)##2##5##(2008-11#1)(2011-2#1)
the Maslach Burnout Inventory##7##4##(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#1)(2009-7#1)(2010-7#1)(2011-2#1)
the Massachusetts Behavioral Risk Factor Surveillance System##2##7##(2008-12#2)
the Massachusetts General Hospital##21##4##(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-12#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-7#1)(2007-10#1)
the Massachusetts strain##2##3##(1997-6#1)(2008-5#1)
the Massachusetts##33##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-12#2)(1993-9#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-12#2)(2008-5#3)
the Maternal and##2##3##(2005-11#1)(2011-2#1)
the Maternal##5##2##(1995-3#1)(2005-11#1)(2007-10#1)(2010-5#1)(2011-2#1)
the Maturation##2##2##(2008-10#1)(2009-9#1)
the Maudsley##3##2##(1996-2#1)(1997-8#1)(2005-6#1)
the Maximizer##4##2##(2008-11#4)
the Maximum##3##2##(1993-3#1)(1996-3#1)(2008-5#1)
the Maxwell-Garnett##2##2##(2008-2#1)(2008-3#1)
the May##3##2##(1991-2#1)(2009-8#1)(2010-9#1)
the Mayer-Salovey-Caruso Emotional Intelligence Test##2##5##(2013-1#1)(2013-7#1)
the Mayo Clinic##11##3##(1991-10#1)(1996-6#1)(2004-11#1)(2008-5#1)(2009-11#2)(2009-5#1)(2013-1#4)
the Mayo##16##2##(1991-10#1)(1996-6#1)(2004-11#2)(2006-11#1)(2008-1#1)(2008-5#1)(2009-11#2)(2009-2#1)(2009-5#1)(2009-7#1)(2013-1#4)
the McGill Journal of Medicine##2##5##(2008-6#2)
the McGill Pain Questionnaire##3##4##(2009-12#1)(2010-6#1)(2012-2#1)
the McGill Quality of Life Questionnaire##2##6##(2005-4#1)(2011-2#1)
the McGill##8##2##(1996-2#1)(2005-4#1)(2008-6#2)(2009-12#1)(2010-6#1)(2011-2#1)(2012-2#1)
the Mch-1##2##2##(2008-5#2)
the Me##2##2##(2006-12#2)
the MeHV-1 genome##2##3##(2013-8#2)
the MeOH extract of##4##4##(2006-12#2)(2008-5#1)(2010-7#1)
the MeOH extract##6##3##(2006-12#3)(2008-11#1)(2008-5#1)(2010-7#1)
the MeOH##7##2##(2006-12#3)(2008-11#2)(2008-5#1)(2010-7#1)
the MeSH##3##2##(1995-1#1)(2008-1#1)(2013-1#1)
the Mean##3##2##(2008-10#1)(2008-12#1)(2013-8#1)
the Meaningful##2##2##(2011-1#2)
the Measure of##2##3##(2007-12#1)(2007-8#1)
the Mechanism##3##2##(1994-11#1)(2008-4#1)(2008-6#1)
the Mechanisms##2##2##(2008-10#2)
the Meckel's diverticulum##4##3##(2012-2#4)
the Mecklenburg Medical Group##2##4##(1991-1#2)
the Mecklenburg Medical##3##3##(1991-1#3)
the Medaka##4##2##(2008-4#1)(2008-5#2)(2008-6#1)
the Medicaid and Medicare##2##4##(1995-12#1)(1995-3#1)
the Medicaid program##9##3##(1996-1#4)(1996-11#1)(1997-2#1)(2005-10#1)(2007-10#1)(2012-12#1)
the Medicaid##19##2##(1991-2#1)(1991-3#1)(1993-1#1)(1994-2#2)(1995-12#1)(1995-3#1)(1996-1#4)(1996-11#1)(1997-2#3)(2005-10#1)(2007-10#1)(2008-11#1)(2012-12#1)
the Medicaid-eligible elderly##2##3##(1993-3#1)(1997-2#1)
the Medical Birth Registry of Norway##2##6##(1995-6#1)(1996-11#1)
the Medical Department##4##3##(1990-10#1)(1992-9#1)(1996-3#2)
the Medical Education##2##3##(1991-8#1)(2013-8#1)
the Medical Faculty##2##3##(1993-6#1)(2007-8#1)
the Medical Outcomes Study##3##4##(2006-10#1)(2007-9#1)(2012-12#1)
the Medical Outcomes##4##3##(2006-10#1)(2007-9#1)(2010-2#1)(2012-12#1)
the Medical Research Council##2##4##(1990-10#1)(2012-12#1)
the Medical Research##4##3##(1990-10#1)(1996-3#1)(2008-7#1)(2012-12#1)
the Medical School##4##3##(2005-8#1)(2007-12#1)(2008-1#2)
the Medical University in Warsaw##2##5##(2007-11#2)
the Medical University in##3##4##(2007-11#2)(2007-8#1)
the Medical University of Warsaw##2##5##(2007-8#1)(2009-4#1)
the Medical University of##6##4##(2006-11#1)(2007-8#1)(2008-10#2)(2008-7#1)(2009-4#1)
the Medical University##11##3##(2006-11#1)(2007-11#2)(2007-8#2)(2008-10#2)(2008-7#1)(2008-9#2)(2009-4#1)
the Medical##62##2##(1990-10#2)(1991-8#2)(1992-12#2)(1992-9#1)(1993-2#1)(1993-6#2)(1995-11#2)(1995-6#1)(1996-1#1)(1996-11#1)(1996-3#3)(1997-2#1)(1997-5#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-9#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#2)(2008-4#1)(2008-7#2)(2008-9#3)(2009-10#1)(2009-4#1)(2010-2#1)(2012-11#1)(2012-12#2)(2013-1#5)(2013-8#3)
the Medicare Current Beneficiary Survey (MCBS)##6##6##(1994-1#1)(1995-12#3)(1995-2#1)(1997-2#1)
the Medicare Current Beneficiary Survey##7##5##(1994-1#1)(1995-12#3)(1995-2#2)(1997-2#1)
the Medicare Part A##2##4##(1991-1#1)(1993-3#1)
the Medicare Part##3##3##(1991-1#1)(1993-3#1)(2010-2#1)
the Medicare and Medicaid programs##2##5##(1991-2#1)(1996-3#1)
the Medicare and Medicaid##5##4##(1991-12#2)(1991-2#1)(1992-12#1)(1996-3#1)
the Medicare and##6##3##(1991-12#3)(1991-2#1)(1992-12#1)(1996-3#1)
the Medicare diagnosis-related groups##2##4##(1994-12#2)
the Medicare fee schedule (MFS)##4##5##(1994-1#2)(1994-12#1)(1996-1#1)
the Medicare fee schedule##10##4##(1991-12#1)(1993-3#1)(1994-1#4)(1994-12#1)(1996-1#1)(1996-3#1)(2007-3#1)
the Medicare home health##2##4##(1992-3#1)(1995-3#1)
the Medicare hospice benefit##3##4##(1991-3#1)(1994-12#1)(1995-2#1)
the Medicare inpatient##2##3##(1993-3#1)(2007-12#1)
the Medicare managed care##2##4##(1997-2#1)(2007-2#1)
the Medicare population##7##3##(1993-12#2)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(2005-9#1)
the Medicare program##13##3##(1991-1#2)(1991-3#2)(1992-12#1)(1994-3#1)(1995-1#1)(1995-2#2)(1997-3#2)(2007-4#1)(2008-10#1)
the Medicare prospective payment system (PPS)##3##6##(1992-12#1)(1993-12#1)(1993-3#1)
the Medicare prospective payment system##6##5##(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-3#1)
the Medicare prospective payment##7##4##(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#2)(1993-12#1)(1993-3#1)
the Medicare##96##2##(1990-12#2)(1991-1#3)(1991-12#4)(1991-2#3)(1991-3#4)(1992-1#2)(1992-12#5)(1992-2#4)(1992-3#1)(1993-1#1)(1993-12#4)(1993-3#5)(1994-1#6)(1994-12#6)(1994-3#2)(1995-1#1)(1995-12#7)(1995-2#6)(1995-3#2)(1996-1#1)(1996-12#2)(1996-3#3)(1997-1#2)(1997-2#2)(1997-3#3)(2005-9#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#5)(2008-10#1)(2008-11#1)(2008-6#1)(2010-2#1)
the Medication##2##2##(2007-9#1)(2012-3#1)
the Medici##2##2##(2009-2#2)
the Medicinal##2##2##(2008-10#1)(2008-5#1)
the Mediterranean Basin##5##3##(2008-10#3)(2011-2#2)
the Mediterranean Region##2##3##(2008-10#1)(2008-4#1)
the Mediterranean Sea##2##3##(2007-9#1)(2008-10#1)
the Mediterranean countries##2##3##(1995-5#1)(2012-2#1)
the Mediterranean diet as##2##4##(2012-12#2)
the Mediterranean diet##4##3##(2010-12#1)(2010-4#1)(2012-12#2)
the Mediterranean region##3##3##(2008-8#1)(2010-12#1)(2013-1#1)
the Mediterranean##37##2##(1990-8#2)(1995-5#1)(1996-11#1)(1996-4#1)(1996-7#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-4#1)(2008-8#2)(2010-1#1)(2010-12#2)(2010-4#1)(2011-2#5)(2012-12#4)(2012-2#1)(2013-1#3)
the Medline##4##2##(2006-7#1)(2007-11#1)(2008-10#1)(2011-1#1)
the Medtronic##3##2##(2006-7#1)(2006-8#1)(2011-2#1)
the Meig1 gene##2##3##(2012-12#2)
the Melbourne perspective##2##3##(2008-10#2)
the Melbourne##4##2##(2008-10#2)(2008-9#1)(2012-2#1)
the Member States##2##3##(2008-10#1)(2012-2#1)
the Member##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
the Men1##2##2##(2010-2#2)
the Menkes##2##2##(1993-11#2)
the Mental Health Act##5##4##(1991-6#1)(1994-11#1)(2008-7#1)(2010-1#1)(2013-1#1)
the Mental Health##7##3##(1991-6#1)(1992-12#1)(1994-11#1)(1997-8#1)(2008-7#1)(2010-1#1)(2013-1#1)
the Mental##10##2##(1991-6#1)(1992-12#1)(1994-11#1)(1997-8#1)(2008-7#2)(2009-7#1)(2010-1#1)(2010-12#1)(2013-1#1)
the Mersey##2##2##(2008-6#2)
the Mesay##2##2##(2008-5#2)
the Mesozoic##3##2##(1991-6#1)(1994-7#1)(1996-3#1)
the Met##2##2##(1991-9#1)(1993-11#1)
the MetF##2##2##(1992-1#2)
the MetH holoenzyme##2##3##(1992-1#2)
the MetS and non-MetS subgroups##2##5##(2008-3#2)
the Metrohm##2##2##(2008-10#2)
the Metropolitan Area of Costa##2##5##(2008-5#2)
the Metropolitan Region of Santiago##2##5##(2012-2#1)(2013-1#1)
the Metropolitan Region##4##3##(2012-2#2)(2013-1#2)
the Metropolitan##10##2##(1994-1#1)(1997-6#1)(2007-8#1)(2008-5#3)(2012-2#2)(2013-1#2)
the Mexican Caribbean##4##3##(2007-5#3)(2008-5#1)
the Mexican National##2##3##(2005-11#1)(2008-10#1)
the Mexican Social Security Institute (IMSS##2##6##(2011-2#2)
the Mexican state##2##3##(2009-7#1)(2012-3#1)
the Mexican##39##2##(1990-5#1)(1991-9#1)(1993-6#1)(1994-8#1)(2005-11#1)(2006-10#1)(2007-3#1)(2007-5#6)(2008-10#5)(2008-12#1)(2008-5#6)(2009-7#1)(2011-1#3)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
the Mg##2##2##(1990-11#1)(2008-10#1)
the Mg(2+)##3##2##(2008-10#2)(2008-5#1)
the Mg(2+)-ATPase##3##2##(2004-4#2)(2005-10#1)
the Mg(2+)-free##2##2##(1995-1#1)(2008-8#1)
the Mg(2+)-sensitive probe##2##3##(2008-5#2)
the Mg2+ form##2##3##(1994-12#2)
the Mg2+##9##2##(1990-5#2)(1990-7#1)(1991-2#1)(1992-3#2)(1994-12#2)(1997-1#1)
the MgATP##2##2##(1992-12#1)(1997-4#1)
the MgO##2##2##(2006-12#1)(2008-3#1)
the Mi##3##2##(1995-11#2)(2008-10#1)
the Michaelis complex##2##3##(1994-8#1)(1995-2#1)
the Michaelis constant for##3##4##(1991-5#1)(1991-9#1)(1992-6#1)
the Michaelis constant##6##3##(1990-5#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-3#1)(2007-6#1)
the Michaelis##9##2##(1990-5#1)(1991-5#2)(1991-9#1)(1992-6#1)(1993-3#1)(1994-8#1)(1995-2#1)(2007-6#1)
the Michaelis-Menten kinetics##2##3##(1996-9#1)(2006-12#1)
the Michaelis-Menten##3##2##(1996-3#1)(1996-9#1)(2006-12#1)
the Michelson Interferometer for Passive Atmospheric Sounding (MIPAS)##2##8##(2008-3#2)
the Michelson Interferometer for Passive Atmospheric Sounding##4##7##(2008-3#4)
the Michelson##8##2##(2008-2#4)(2008-3#4)
the Michigan##5##2##(1994-9#1)(1995-12#1)(1996-2#1)(2005-12#1)(2012-2#1)
the Microbial##4##2##(2007-3#1)(2008-10#3)
the Microbiology##3##2##(2007-10#1)(2009-5#1)(2010-8#1)
the Micronesia##2##2##(2005-11#2)
the Mid##3##2##(2008-10#1)(2013-8#2)
the Middle Ages##7##3##(2006-12#1)(2007-10#1)(2008-10#1)(2008-8#1)(2009-10#1)(2013-8#2)
the Middle Atlantic Bight##4##4##(2008-2#1)(2008-3#3)
the Middle East and##7##4##(1997-8#1)(2007-3#2)(2008-10#1)(2009-2#1)(2011-2#1)(2012-2#1)
the Middle East##28##3##(1995-3#1)(1995-5#1)(1997-8#1)(2005-10#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#3)(2011-2#4)(2012-2#1)
the Middle Eastern and##2##4##(2008-10#1)(2012-2#1)
the Middle Eastern##5##3##(2008-10#2)(2009-4#1)(2012-1#1)(2012-2#1)
the Middle Volga region##3##4##(2013-1#3)
the Middle##54##2##(1992-5#1)(1995-3#1)(1995-5#1)(1997-8#1)(2005-10#1)(2006-12#2)(2006-2#3)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#3)(2009-4#1)(2009-7#1)(2011-2#4)(2012-1#1)(2012-2#2)(2013-1#3)(2013-8#2)
the Midwestern##2##2##(2008-10#1)(2009-7#1)
the Mie theory##7##3##(2008-2#3)(2008-3#3)(2009-6#1)
the Mie##10##2##(2008-2#3)(2008-3#6)(2009-6#1)
the Milan##3##2##(1991-6#1)(1992-2#1)(2010-12#1)
the Milky Way##3##3##(1992-4#1)(1997-5#1)(2007-9#1)
the Millennium Development Goals##4##4##(2008-11#1)(2008-8#1)(2010-12#1)(2010-5#1)
the Mini Mental State Examination##3##5##(2008-7#2)(2013-1#1)
the Mini Mental State##5##4##(1994-6#1)(2008-7#2)(2011-2#1)(2013-1#1)
the Mini##6##2##(1994-6#1)(2008-7#2)(2011-1#1)(2011-2#1)(2013-1#1)
the Mini-Mental State Examination (MMSE)##2##5##(2008-6#1)(2008-7#1)
the Mini-Mental State Examination##5##4##(1996-2#1)(2008-6#2)(2008-7#2)
the Mini-Mental##7##2##(1996-2#1)(2006-12#1)(2007-3#1)(2008-6#2)(2008-7#2)
the Minimum Data##2##3##(2006-7#1)(2008-11#1)
the Minimum##3##2##(2006-7#1)(2008-11#1)(2008-2#1)
the Ministry of Agriculture##5##4##(1993-8#1)(2005-5#2)(2008-8#1)(2010-4#1)
the Ministry of Health (MOH)##3##5##(1991-6#1)(2007-7#1)(2011-2#1)
the Ministry of Health and Social Affairs has##2##8##(1993-6#1)(1994-2#1)
the Ministry of Health and Social Affairs##4##7##(1990-10#1)(1993-6#2)(1994-2#1)
the Ministry of Health and Social##5##6##(1990-10#1)(1993-6#2)(1994-2#1)(2013-1#1)
the Ministry of Health and Welfare##3##6##(2005-3#1)(2008-5#1)(2012-2#1)
the Ministry of Health and the##3##6##(1993-1#1)(2007-5#1)(2013-1#1)
the Ministry of Health and##11##5##(1990-10#1)(1993-1#1)(1993-6#2)(1994-2#1)(2005-3#1)(2007-5#1)(2008-5#1)(2012-2#1)(2013-1#2)
the Ministry of Health of##2##5##(2008-1#1)(2008-8#1)
the Ministry of Health##38##4##(1990-10#1)(1991-2#1)(1991-6#1)(1993-1#1)(1993-6#2)(1994-12#1)(1994-2#1)(2005-11#1)(2005-3#1)(2005-5#1)(2006-4#1)(2007-1#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#4)(2008-10#2)(2008-5#1)(2008-8#1)(2009-5#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)
the Ministry of Health's##2##4##(2010-10#1)(2012-12#1)
the Ministry of Interior##2##4##(2008-10#1)(2012-12#1)
the Ministry of Science and Technology##2##6##(2005-12#1)(2008-7#1)
the Ministry of Science##3##4##(2005-12#1)(2006-4#1)(2008-7#1)
the Ministry of the##3##4##(2009-12#1)(2010-4#1)(2012-12#1)
the Ministry of##62##3##(1990-10#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1993-1#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-2#1)(1996-8#1)(2004-7#1)(2005-11#1)(2005-12#1)(2005-3#1)(2005-5#3)(2006-4#2)(2007-1#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#4)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-4#2)(2011-1#3)(2011-2#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
the Ministry##64##2##(1990-10#1)(1990-9#1)(1991-2#2)(1991-3#1)(1991-6#1)(1993-1#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-2#1)(1995-4#1)(1996-8#1)(2004-7#1)(2005-11#1)(2005-12#1)(2005-3#1)(2005-5#3)(2006-4#2)(2007-1#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#4)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-4#2)(2011-1#3)(2011-2#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
the Minnesota Department of Health's##2##5##(2012-12#2)
the Minnesota Multiphasic Personality##2##4##(2008-9#1)(2011-1#1)
the Minnesota##11##2##(1990-2#2)(1990-5#1)(1991-2#1)(2008-10#1)(2008-9#1)(2010-1#1)(2011-1#1)(2012-12#2)(2012-2#1)
the Miocene##3##2##(2007-5#1)(2008-10#1)(2008-6#1)
the Mississippi##6##2##(2007-10#2)(2008-10#2)(2008-8#1)(2010-9#1)
the Missouri##3##2##(1995-12#1)(1996-2#1)(1996-6#1)
the Mitsunobu reaction##6##3##(2007-11#2)(2008-4#2)(2008-6#2)
the Mitsunobu##8##2##(2007-11#4)(2008-4#2)(2008-6#2)
the Mixed##2##2##(2008-10#1)(2009-10#1)
the Mmd1 gene##2##3##(2008-10#2)
the Mmd1##3##2##(2008-10#3)
the Mn cluster##4##3##(1995-8#2)(1997-7#2)
the Mn##10##2##(1994-12#2)(1995-8#2)(1996-7#1)(1997-7#2)(2007-8#2)(2008-10#1)
the Mn(II)##4##2##(1996-7#4)
the Mn-Mn ferromagnetic##2##3##(2010-5#2)
the Mo##3##2##(2008-10#1)(2009-11#2)
the MoAb##2##2##(1992-10#1)(2008-7#1)
the Mode of##2##3##(1997-7#1)(2008-10#1)
the Mode##3##2##(1997-7#1)(2008-10#1)(2010-11#1)
the Modern##2##2##(2008-8#1)(2012-1#1)
the Modified Bromley's Methodology (MBM)##2##5##(2008-10#2)
the Modified##7##2##(2006-11#1)(2007-10#1)(2007-7#1)(2008-10#2)(2011-2#1)(2012-2#1)
the Modulation##2##2##(2008-2#1)(2012-12#1)
the Molecular##6##2##(1996-8#1)(2006-3#1)(2008-10#1)(2010-5#1)(2010-7#1)(2013-1#1)
the Moloney murine sarcoma virus enhancer-promoter element##2##7##(1992-11#2)
the Moloney##3##2##(1992-11#2)(2008-11#1)
the Molt-4 T-lymphoblastic leukemia cell line##2##6##(1993-9#2)
the Mono Q column##2##4##(1993-12#1)(2008-10#1)
the Mono Q##3##3##(1991-12#1)(1993-12#1)(2008-10#1)
the Monte Carlo method##9##4##(1992-6#1)(1994-3#1)(2008-10#2)(2008-2#3)(2008-3#2)
the Monte Carlo simulation##3##4##(2008-2#2)(2012-2#1)
the Monte Carlo simulations##2##4##(2008-2#1)(2010-2#1)
the Monte Carlo technique##4##4##(2008-2#1)(2008-3#3)
the Monte Carlo##25##3##(1992-6#1)(1994-3#2)(2008-10#2)(2008-2#10)(2008-3#8)(2010-2#1)(2012-2#1)
the Monte##26##2##(1992-6#1)(1994-3#2)(2008-10#2)(2008-2#10)(2008-3#9)(2010-2#1)(2012-2#1)
the Montreal Biodome##3##3##(2009-4#3)
the Montreal Protocol##5##3##(1992-3#2)(1992-4#1)(1996-1#1)(1996-2#1)
the Montreal##11##2##(1992-3#3)(1992-4#1)(1996-1#1)(1996-2#1)(2007-8#1)(2009-4#3)(2009-7#1)
the Mood Disorder Questionnaire##4##4##(2011-1#2)(2011-2#2)
the Mood##5##2##(2010-12#1)(2011-1#2)(2011-2#2)
the Moon##5##2##(1997-5#1)(2008-2#2)(2008-3#1)(2012-3#1)
the Moose of Kadiogo##2##4##(2008-2#2)
the Moose of##3##3##(2008-2#3)
the More Individuals Hypothesis##3##4##(2008-9#3)
the Morphology and##2##3##(2008-2#1)(2010-6#1)
the Morris water maze task and##2##6##(2005-8#1)(2008-10#1)
the Morris water maze test##2##5##(2011-2#1)(2012-3#1)
the Morris water maze##28##4##(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#10)(1993-2#1)(1993-3#1)(1994-2#1)(1994-6#2)(1995-12#1)(1996-6#1)(1997-2#1)(2005-8#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-3#1)
the Morris water task and##2##5##(1992-11#2)
the Morris water task##3##4##(1992-11#3)
the Morris water##32##3##(1992-11#3)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#11)(1993-2#1)(1993-3#1)(1994-2#1)(1994-6#2)(1995-12#1)(1996-6#1)(1997-2#1)(2005-8#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-3#1)
the Morris water-maze##2##3##(1993-3#1)(1994-8#1)
the Morris##36##2##(1992-11#3)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#11)(1993-2#1)(1993-3#2)(1994-2#2)(1994-6#2)(1994-8#1)(1995-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(2005-8#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-3#1)
the Morse potential##2##3##(2009-8#1)(2009-9#1)
the Morse##3##2##(2009-8#1)(2009-9#1)(2010-7#1)
the Mos##3##2##(1994-8#3)
the Moscow##2##2##(1992-12#1)(2011-2#1)
the Motor##3##2##(1995-9#1)(2012-1#2)
the Mount Sinai##3##3##(1991-12#1)(1995-8#1)(1996-3#1)
the Mount##7##2##(1991-12#1)(1992-1#1)(1995-8#1)(1996-3#1)(2005-10#1)(2008-8#1)(2010-6#1)
the Mouse##4##2##(2008-4#1)(2008-5#2)(2009-12#1)
the Movement##3##2##(1996-12#1)(2008-10#1)(2013-7#1)
the Mr 47##2##3##(1991-1#2)
the Mr##7##2##(1990-2#1)(1990-9#1)(1991-1#2)(1991-3#1)(1991-7#1)(1992-1#1)
the Mrh protein##3##3##(1990-3#3)
the Mt##5##2##(2008-2#3)(2008-3#1)(2008-8#1)
the Mueller matrix elements##2##4##(2008-2#1)(2008-3#1)
the Mueller matrix##17##3##(2007-11#3)(2008-2#5)(2008-3#7)(2009-5#2)
the Mueller scattering##2##3##(2008-2#1)(2008-3#1)
the Mueller##20##2##(2007-11#3)(2008-2#6)(2008-3#9)(2009-5#2)
the Multicenter AIDS Cohort Study (MACS)##2##6##(1993-1#2)
the Multicenter AIDS Cohort Study##3##5##(1993-1#2)(1993-11#1)
the Multicenter##4##2##(1993-1#2)(1993-11#1)(2008-5#1)
the Multidimensional##6##2##(2006-1#1)(2007-12#1)(2008-12#2)(2008-6#1)(2012-2#1)
the Multinational Brassica Genome Project##2##5##(2008-7#2)
the Multinational##4##2##(2008-7#3)(2011-2#1)
the Multiple Risk Factor Intervention Trial##2##6##(1991-8#1)(1992-9#1)
the Municipal Forest##4##3##(2008-5#4)
the Municipal##12##2##(1993-1#1)(1997-5#1)(2007-11#1)(2007-8#1)(2008-5#5)(2008-9#3)
the Murchison meteorite##3##3##(1995-11#2)(1996-5#1)
the Murchison##4##2##(1995-11#2)(1996-5#2)
the Museu Nacional##2##3##(2009-4#1)(2013-8#1)
the Museu##3##2##(2009-4#1)(2013-8#2)
the Museum of##2##3##(2007-11#1)(2011-2#1)
the Museum##4##2##(2007-11#1)(2010-1#2)(2011-2#1)
the MycER##2##2##(2008-11#2)
the Mycobacterium tuberculosis complex##2##4##(2007-9#1)(2008-7#1)
the Mycobacterium##6##2##(1992-12#1)(2007-8#1)(2007-9#1)(2008-7#1)(2008-8#1)(2011-1#1)
the Mycoparasite Pythium oligandrum##2##4##(2008-10#2)
the Mycoparasite##3##2##(2008-10#3)
the Myoviridae##2##2##(2011-12#1)(2013-1#1)
the Müller-Lyer##2##2##(1997-1#2)
the N and C domains##2##5##(1995-5#2)
the N and C termini##2##5##(1997-4#1)(1997-8#1)
the N and C##5##4##(1995-5#2)(1997-4#1)(1997-8#1)(2009-9#1)
the N and C-terminal##2##4##(1994-9#2)
the N and##9##3##(1994-9#2)(1995-5#2)(1997-4#1)(1997-8#1)(2008-5#1)(2009-9#1)(2012-5#1)
the N application rate in last season##2##7##(2013-8#2)
the N application rate##3##4##(2013-8#3)
the N atoms##2##3##(1996-2#1)(2008-5#1)
the N epsilon##2##3##(1991-3#1)(1994-5#1)
the N gene of##2##4##(2008-10#2)
the N gene##4##3##(2008-10#4)
the N intermediate of the wild type##2##7##(1997-4#2)
the N intermediate##3##3##(1997-4#3)
the N protein of##2##4##(2008-10#2)
the N protein##4##3##(2008-10#4)
the N status##2##3##(2008-8#2)
the N terminus and the##2##5##(1993-2#1)(1994-9#1)
the N terminus and two##2##5##(1994-8#1)(1996-6#1)
the N terminus and##5##4##(1993-2#1)(1994-8#1)(1994-9#1)(1996-6#1)(2008-10#1)
the N terminus in##2##4##(1994-12#1)(1995-6#1)
the N terminus of protein p4##2##6##(1990-11#2)
the N terminus of the##6##5##(1990-3#1)(1990-5#1)(1991-4#1)(1995-3#1)(1997-2#1)(1997-6#1)
the N terminus of##14##4##(1990-10#1)(1990-11#3)(1990-3#1)(1990-5#1)(1991-4#1)(1994-3#1)(1995-3#1)(1996-5#1)(1997-2#1)(1997-6#1)(2008-10#1)(2012-3#1)
the N terminus##32##3##(1990-10#1)(1990-11#3)(1990-3#2)(1990-4#1)(1990-5#1)(1991-4#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-3#1)(1995-6#4)(1995-8#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#2)(2008-10#2)(2008-6#1)(2012-3#1)
the N##101##2##(1990-10#1)(1990-11#3)(1990-3#2)(1990-4#1)(1990-5#1)(1991-1#1)(1991-3#2)(1991-4#1)(1992-11#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-8#1)(1994-9#4)(1995-3#2)(1995-5#5)(1995-6#4)(1995-8#3)(1996-10#3)(1996-2#3)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#5)(1997-6#2)(1997-7#3)(1997-8#1)(2006-4#1)(2008-10#16)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-8#2)(2009-9#1)(2010-5#2)(2011-2#1)(2012-3#2)(2012-5#1)(2013-8#6)
the N(2)##4##2##(2005-11#1)(2008-3#3)
the N(6)- and 4'-position##2##4##(2008-4#2)
the N- and C-terminal halves##2##5##(1990-10#1)(1992-3#1)
the N- and C-terminal regions of the##3##7##(1990-2#1)(1996-7#1)(2013-1#1)
the N- and C-terminal##10##4##(1990-10#1)(1990-2#1)(1990-7#1)(1991-5#1)(1992-3#1)(1992-6#1)(1994-9#1)(1995-2#1)(1996-7#1)(2013-1#1)
the N- and C-termini##3##4##(1992-4#1)(1997-4#1)(1997-6#1)
the N- and##16##3##(1990-10#1)(1990-2#1)(1990-7#1)(1991-5#1)(1992-3#1)(1992-4#1)(1992-6#2)(1994-11#1)(1994-9#1)(1995-2#1)(1995-4#1)(1996-7#1)(1997-4#1)(1997-6#1)(2013-1#1)
the N- or##3##3##(1990-10#1)(1995-8#1)(1996-12#1)
the N-##20##2##(1990-10#2)(1990-2#1)(1990-7#1)(1991-5#1)(1992-3#1)(1992-4#1)(1992-6#2)(1994-11#1)(1994-9#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-12#1)(1996-7#1)(1997-4#1)(1997-6#1)(2010-6#1)(2013-1#1)
the N-1 and N-2##2##4##(2007-11#2)
the N-1 and##3##3##(1994-9#1)(2007-11#2)
the N-1##4##2##(1994-9#1)(2007-11#3)
the N-3 substituent##2##3##(1994-9#2)
the N-CAM gene##3##3##(1994-3#3)
the N-H and##2##3##(1994-9#1)(1995-10#1)
the N-H bond##2##3##(1995-11#1)(2008-5#1)
the N-H##5##2##(1993-4#1)(1994-9#1)(1995-10#1)(1995-11#1)(2008-5#1)
the N-N##2##2##(1996-5#1)(2008-10#1)
the N-O##2##2##(1992-10#1)(2008-5#1)
the N-S##2##2##(1992-10#1)(2008-10#1)
the N-acetyl##5##2##(1991-5#1)(1994-3#1)(1994-9#1)(2007-9#1)(2010-2#1)
the N-acetyl-beta-D-hexosaminidase##3##2##(1990-5#2)(1997-6#1)
the N-acetylation of##2##3##(1992-6#1)(1993-5#1)
the N-acetylglucosamine##2##2##(1994-8#1)(2011-2#1)
the N-alkyl substituent##2##3##(1997-2#1)(2008-2#1)
the N-alkyl##4##2##(1997-2#1)(2008-2#1)(2008-6#2)
the N-domain##2##2##(1997-7#2)
the N-end rule pathway##2##4##(1991-11#1)(2013-8#1)
the N-end rule##4##3##(1991-11#2)(1992-11#1)(2013-8#1)
the N-fatty##2##2##(1995-6#2)
the N-formyl##3##2##(1991-8#1)(2007-11#1)(2008-5#1)
the N-glucuronide of 4-aminobiphenyl##3##4##(1996-6#3)
the N-glycosylation sites##2##3##(1993-8#1)(1993-9#1)
the N-glycosylation##3##2##(1993-8#1)(1993-9#1)(2006-12#1)
the N-heterocyclic##2##2##(2010-5#1)(2012-12#1)
the N-linked oligosaccharide##2##3##(1992-12#1)(2008-7#1)
the N-linked oligosaccharides##3##3##(1993-11#1)(1997-4#1)(2008-4#1)
the N-linked##13##2##(1990-2#1)(1990-5#1)(1992-12#1)(1992-7#1)(1993-11#1)(1993-8#1)(1996-7#1)(1997-4#1)(2008-11#1)(2008-4#1)(2008-7#3)
the N-methyl##3##2##(1995-11#1)(1996-8#2)
the N-methyl-D-aspartate (NMDA) glutamate receptor##2##5##(1994-8#1)(1997-6#1)
the N-methyl-D-aspartate (NMDA) receptor antagonist##3##5##(1990-4#1)(1992-8#1)(1995-12#1)
the N-methyl-D-aspartate (NMDA) receptor##10##4##(1990-4#1)(1992-1#1)(1992-8#2)(1993-2#1)(1994-10#1)(1995-12#1)(1997-2#2)(2010-4#1)
the N-methyl-D-aspartate (NMDA) type of glutamate receptors is a particularly important site of ethanol's action##2##15##(2008-3#1)(2009-3#1)
the N-methyl-D-aspartate (NMDA) type of##3##5##(1991-3#1)(2008-3#1)(2009-3#1)
the N-methyl-D-aspartate (NMDA) type##4##4##(1991-3#2)(2008-3#1)(2009-3#1)
the N-methyl-D-aspartate (NMDA)##23##3##(1990-4#1)(1991-3#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-8#3)(1993-2#1)(1994-10#1)(1994-8#2)(1995-12#1)(1995-7#1)(1997-2#3)(1997-6#1)(1997-8#1)(2008-3#1)(2009-3#1)(2010-4#1)
the N-methyl-D-aspartate receptor complex##3##4##(1990-7#2)(1996-8#1)
the N-methyl-D-aspartate receptor##13##3##(1990-7#4)(1991-4#1)(1992-3#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-8#1)(1997-2#1)(1997-4#1)(2010-2#1)
the N-methyl-D-aspartate##42##2##(1990-4#1)(1990-7#5)(1991-11#1)(1991-3#2)(1991-4#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-3#1)(1992-8#3)(1993-2#1)(1994-10#1)(1994-2#1)(1994-5#1)(1994-8#3)(1995-12#2)(1995-3#1)(1995-7#1)(1996-8#1)(1997-2#4)(1997-4#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-3#1)(2009-3#1)(2010-2#1)(2010-4#1)
the N-methyl-D-aspartic acid##2##3##(1991-8#1)(1995-6#1)
the N-methyl-D-aspartic##3##2##(1991-8#1)(1992-3#1)(1995-6#1)
the N-methylation of##2##3##(1990-1#2)
the N-myc oncogene##3##3##(1996-12#3)
the N-myc##7##2##(1996-12#3)(1996-2#3)(1997-7#1)
the N-myristoyl and##2##3##(1990-7#2)
the N-oxide##2##2##(1996-9#1)(2007-11#1)
the N-propyl##2##2##(1996-8#2)
the N-ras##3##2##(1994-8#1)(1995-2#2)
the N-substituted##2##2##(1992-11#1)(1997-4#1)
the N-terminal 41% of human apolipoprotein B##2##7##(1995-1#2)
the N-terminal Met##2##3##(1994-12#1)(1994-3#1)
the N-terminal SH3 domain of Grb2##2##6##(2006-12#2)
the N-terminal SH3 domain of##3##5##(2006-12#3)
the N-terminal alpha-helix of##2##4##(1994-3#1)(1996-11#1)
the N-terminal alpha-helix##3##3##(1991-7#1)(1994-3#1)(1996-11#1)
the N-terminal amino acid (aa)##2##5##(1990-4#1)(1995-2#1)
the N-terminal amino acid sequence of##3##6##(1995-3#1)(2008-6#1)(2009-2#1)
the N-terminal amino acid sequence##6##5##(1990-4#1)(1991-8#1)(1995-3#1)(2007-12#1)(2008-6#1)(2009-2#1)
the N-terminal amino acid##11##4##(1990-4#3)(1991-8#1)(1993-9#1)(1994-8#1)(1995-2#1)(1995-3#1)(2007-12#1)(2008-6#1)(2009-2#1)
the N-terminal amino group##3##4##(1990-7#1)(1994-11#1)(2012-3#1)
the N-terminal amino##15##3##(1990-4#3)(1990-7#1)(1991-8#1)(1993-9#1)(1994-11#2)(1994-8#1)(1995-2#1)(1995-3#1)(2007-12#1)(2008-6#1)(2009-2#1)(2012-3#1)
the N-terminal amphiphilic leader##2##4##(1991-10#2)
the N-terminal and C-terminal domains of##2##6##(1995-2#1)(1995-8#1)
the N-terminal and C-terminal##3##4##(1994-12#1)(1995-2#1)(1995-8#1)
the N-terminal and##6##3##(1991-2#1)(1991-7#1)(1992-11#1)(1994-12#1)(1995-2#1)(1995-8#1)
the N-terminal arm##7##3##(1994-8#3)(1995-5#2)(2008-9#2)
the N-terminal domain I of##2##5##(1992-9#2)
the N-terminal domain of GPIIIa##2##5##(1997-7#1)(2006-6#1)
the N-terminal domain of the GPIIIa subunit##2##7##(2006-6#2)
the N-terminal domain of the##9##5##(1991-7#1)(1992-8#1)(1995-3#1)(1997-5#1)(1997-6#1)(2006-6#2)(2006-8#1)(2012-2#1)
the N-terminal domain of##23##4##(1990-2#1)(1991-7#1)(1992-3#1)(1992-8#1)(1993-11#1)(1994-12#1)(1995-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-5#1)(2006-6#3)(2006-8#1)(2008-9#2)(2009-7#3)(2009-8#1)(2011-1#1)(2012-2#1)
the N-terminal domain##38##3##(1990-11#1)(1990-2#1)(1991-7#1)(1992-3#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-3#3)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2006-5#1)(2006-6#3)(2006-8#1)(2008-4#1)(2008-9#2)(2009-7#3)(2009-8#1)(2010-10#1)(2011-1#1)(2012-2#1)
the N-terminal domains##2##3##(1996-10#1)(2008-10#1)
the N-terminal end of the##6##5##(1993-8#1)(1994-12#2)(1995-1#1)(1996-10#1)(1996-8#1)
the N-terminal end of##7##4##(1993-8#1)(1994-12#2)(1995-1#1)(1996-10#1)(1996-8#1)(1997-2#1)
the N-terminal end##13##3##(1990-10#1)(1993-8#1)(1994-12#2)(1995-1#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-8#1)(1997-2#1)(1997-6#1)(2006-12#1)
the N-terminal extension##2##3##(1992-3#1)(1994-12#1)
the N-terminal extracellular domain##6##4##(1991-12#2)(1992-9#1)(1995-12#3)
the N-terminal extracellular##8##3##(1991-12#2)(1991-8#1)(1992-9#2)(1995-12#3)
the N-terminal glycine of##2##4##(1995-8#2)
the N-terminal half of the RTD##2##6##(2008-10#2)
the N-terminal half of the protein##2##6##(2009-10#1)(2011-1#1)
the N-terminal half of the##8##5##(1992-11#1)(1992-7#1)(1994-2#1)(2008-10#3)(2009-10#1)(2011-1#1)
the N-terminal half##12##3##(1992-11#2)(1992-7#1)(1994-2#1)(1997-2#1)(2006-12#2)(2008-10#3)(2009-10#1)(2011-1#1)
the N-terminal helix##2##3##(1990-8#1)(1991-5#1)
the N-terminal methionine##4##3##(1993-3#1)(1994-11#2)(1995-8#1)
the N-terminal of the##3##4##(1990-2#1)(2006-6#1)(2008-11#1)
the N-terminal of##4##3##(1990-2#1)(2006-6#1)(2006-8#1)(2008-11#1)
the N-terminal part of the##6##5##(1992-6#1)(1994-11#1)(1996-9#1)(1997-4#1)(2007-10#1)(2011-1#1)
the N-terminal part of##9##4##(1991-5#1)(1992-6#1)(1992-9#1)(1994-11#1)(1996-11#1)(1996-9#1)(1997-4#1)(2007-10#1)(2011-1#1)
the N-terminal part##10##3##(1990-4#1)(1991-5#1)(1992-6#1)(1992-9#1)(1994-11#1)(1996-11#1)(1996-9#1)(1997-4#1)(2007-10#1)(2011-1#1)
the N-terminal peptide##2##3##(1991-2#1)(1994-3#1)
the N-terminal portion of the##8##5##(1990-5#1)(1990-9#1)(1991-7#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-6#1)
the N-terminal portion of##10##4##(1990-5#2)(1990-9#1)(1991-7#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-6#1)(1997-1#1)
the N-terminal portion##12##3##(1990-5#2)(1990-7#1)(1990-9#1)(1991-7#1)(1993-6#2)(1994-11#1)(1994-12#2)(1994-6#1)(1997-1#1)
the N-terminal portions of##2##4##(1990-3#1)(1993-2#1)
the N-terminal region of human La##2##6##(2009-7#2)
the N-terminal region of the peptide##2##6##(1990-2#1)(1991-7#1)
the N-terminal region of the protein##2##6##(1992-12#1)(1996-3#1)
the N-terminal region of the##8##5##(1990-2#1)(1991-7#2)(1992-12#1)(1992-9#1)(1996-10#1)(1996-3#1)(2008-10#1)
the N-terminal region of##15##4##(1990-2#1)(1991-5#1)(1991-7#2)(1992-12#1)(1992-9#1)(1994-11#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-3#1)(2008-10#1)(2009-7#2)(2010-4#1)
the N-terminal region##22##3##(1990-11#1)(1990-2#1)(1991-5#1)(1991-7#3)(1992-1#1)(1992-12#1)(1992-9#2)(1994-11#1)(1994-12#1)(1994-5#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-3#2)(2008-10#1)(2009-7#2)(2010-4#1)
the N-terminal regions of the human##2##6##(1997-6#2)
the N-terminal regions of the##3##5##(1997-6#2)(2008-10#1)
the N-terminal regions##4##3##(1997-6#2)(2006-5#1)(2008-10#1)
the N-terminal segment##2##3##(1995-8#2)
the N-terminal sequence of the##9##5##(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-11#1)(1993-3#1)(1994-11#1)(1994-12#1)(1996-7#1)
the N-terminal sequence of##14##4##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-11#1)(1992-7#1)(1993-3#1)(1994-11#1)(1994-12#2)(1995-3#1)(1996-7#1)(1997-8#1)
the N-terminal sequence##21##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-7#1)(1992-7#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-5#1)(1995-3#1)(1996-12#1)(1996-7#1)(1997-6#2)(1997-8#2)
the N-terminal side of##2##4##(1995-12#1)(1996-5#1)
the N-terminal side##3##3##(1995-12#1)(1996-12#1)(1996-5#1)
the N-terminal signal peptide##2##4##(1993-11#1)(2008-12#1)
the N-terminal tail of##2##4##(1992-8#1)(2008-7#1)
the N-terminal tail##3##3##(1992-8#1)(1997-2#1)(2008-7#1)
the N-terminal tripeptide of##2##4##(1991-1#1)(1992-8#1)
the N-terminal truncated enzyme##2##4##(1995-2#2)
the N-terminal##314##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#5)(1990-3#2)(1990-4#5)(1990-5#3)(1990-6#1)(1990-7#11)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#5)(1991-11#2)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#4)(1991-7#8)(1991-8#3)(1992-1#1)(1992-11#4)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#6)(1992-9#9)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#5)(1993-6#3)(1993-8#2)(1993-9#1)(1994-11#11)(1994-12#15)(1994-2#4)(1994-3#3)(1994-5#5)(1994-6#1)(1994-8#5)(1994-9#4)(1995-1#7)(1995-11#1)(1995-12#5)(1995-2#6)(1995-3#8)(1995-5#5)(1995-6#1)(1995-8#11)(1996-10#3)(1996-11#3)(1996-12#2)(1996-3#2)(1996-4#2)(1996-5#1)(1996-7#3)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#7)(1997-4#3)(1997-5#2)(1997-6#7)(1997-7#3)(1997-8#5)(2005-7#1)(2006-10#1)(2006-12#7)(2006-5#2)(2006-6#4)(2006-8#2)(2007-10#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#5)(2009-10#1)(2009-12#2)(2009-2#1)(2009-7#7)(2009-8#1)(2010-10#2)(2010-4#1)(2011-1#3)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
the N-terminally##2##2##(2008-8#1)(2012-3#1)
the N-termini of##4##3##(1990-2#1)(1991-6#1)(1991-8#1)(1995-11#1)
the N-terminus and##4##3##(1991-2#1)(1991-8#1)(1994-5#1)(1997-7#1)
the N-terminus of MCF##2##4##(1994-2#2)
the N-terminus of human##3##4##(1991-9#1)(1993-9#1)(1994-2#1)
the N-terminus of the protein##3##5##(1992-12#1)(1992-6#1)(1996-11#1)
the N-terminus of the##12##4##(1990-2#2)(1991-1#2)(1992-12#1)(1992-6#1)(1993-12#1)(1995-1#1)(1996-11#1)(1996-7#1)(1997-3#1)(2008-10#1)
the N-terminus of##31##3##(1990-2#3)(1990-7#1)(1991-1#2)(1991-7#2)(1991-9#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-2#3)(1994-5#3)(1995-1#1)(1995-11#1)(1995-12#1)(1996-11#1)(1996-7#2)(1996-9#1)(1997-3#1)(1997-9#1)(2008-10#1)(2008-8#1)(2013-8#1)
the N-terminus##63##2##(1990-2#3)(1990-4#1)(1990-5#2)(1990-7#3)(1990-8#1)(1991-1#2)(1991-2#1)(1991-7#3)(1991-8#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-2#3)(1994-5#4)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-7#3)(1996-9#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-9#1)(2005-12#1)(2006-12#2)(2008-10#1)(2008-8#1)(2008-9#3)(2009-9#1)(2010-11#1)(2013-8#1)
the N-type voltage-sensitive##2##3##(1993-2#1)(1994-3#1)
the N-type##5##2##(1993-11#1)(1993-2#1)(1994-3#1)(1994-9#1)(2008-8#1)
the N1##5##2##(1992-5#1)(1994-9#1)(2008-4#1)(2008-8#2)
the N2##9##2##(1990-5#1)(1991-7#1)(1992-7#1)(1996-7#1)(2005-11#2)(2008-11#2)(2009-10#1)
the N2-guanine adduct##2##3##(1990-2#2)
the N250##2##2##(2009-9#2)
the N4-[(p-fluorobenzoyl)amino]ethyl substituent##2##3##(1997-1#2)
the N6##3##2##(1990-10#1)(1990-5#1)(1992-3#1)
the N7##3##2##(1992-6#1)(2006-11#1)(2008-4#1)
the NA and##4##3##(1994-10#2)(1994-3#2)
the NA is##2##3##(2007-11#1)(2008-3#1)
the NA##14##2##(1990-5#2)(1992-7#1)(1993-12#2)(1993-7#1)(1994-10#2)(1994-3#2)(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#1)
the NAC##7##2##(1996-5#2)(2008-6#2)(2011-1#3)
the NAD(+)##3##2##(2008-10#3)
the NAD(P)H##2##2##(1996-2#1)(2008-10#1)
the NAD+ binding site##2##4##(1990-10#1)(1997-8#1)
the NAD+##3##2##(1990-10#1)(1990-11#1)(1997-8#1)
the NAD+/NADH ratio##3##3##(1990-11#2)(1993-4#1)
the NADH concentration##2##3##(2008-10#2)
the NADH dehydrogenase##2##3##(1994-11#1)(1996-2#1)
the NADH oxidase activity##3##4##(1994-12#3)
the NADH oxidase of##2##4##(1992-7#1)(1994-12#1)
the NADH oxidase##6##3##(1992-7#1)(1994-12#4)(1995-4#1)
the NADH oxidation##2##3##(1990-3#1)(1992-7#1)
the NADH reductase component of the steroid 9alpha-hydroxylase##2##8##(2008-11#2)
the NADH##25##2##(1990-11#1)(1990-3#1)(1992-2#1)(1992-7#2)(1993-11#1)(1993-6#1)(1994-11#1)(1994-12#4)(1995-3#3)(1995-4#1)(1996-2#1)(1997-8#2)(2008-10#3)(2008-11#2)(2010-5#1)
the NADH-alcohol dehydrogenase complex##2##4##(1992-2#2)
the NADH-binding##2##2##(1991-1#1)(1991-8#1)
the NADH-dependent##2##2##(1990-7#1)(1996-9#1)
the NADP+##3##2##(1991-2#2)(1992-1#1)
the NADPH oxidase##8##3##(1990-2#1)(1990-5#1)(1992-7#1)(1994-6#1)(1995-4#1)(1996-2#2)(2012-12#1)
the NADPH##12##2##(1990-2#1)(1990-5#1)(1991-2#1)(1992-3#2)(1992-7#1)(1994-6#1)(1994-9#1)(1995-4#1)(1996-2#2)(2012-12#1)
the NADPH-binding##2##2##(1994-8#2)
the NADPH-dependent oxidase##2##3##(1990-11#1)(1992-9#1)
the NADPH-dependent##6##2##(1990-11#1)(1991-7#1)(1992-9#1)(1993-5#1)(1994-8#1)(1997-2#1)
the NADPH-diaphorase##2##2##(1994-5#1)(1997-6#1)
the NADase activity##4##3##(1996-5#4)
the NADase##5##2##(1996-5#5)
the NANA residue##2##3##(1990-4#2)
the NAND gate##2##3##(2009-3#2)
the NARP##2##2##(1997-7#2)
the NART and the##2##4##(2006-3#2)
the NAS##5##2##(1992-10#1)(1993-12#2)(1993-6#1)(1994-11#1)
the NASA##6##2##(1996-5#1)(2008-2#3)(2008-3#2)
the NAT##2##2##(1995-11#1)(2011-1#1)
the NAc##7##2##(2008-7#7)
the NB##3##2##(1991-9#1)(2008-10#1)(2008-3#1)
the NB1-RGB cells##2##3##(2008-11#2)
the NB4##2##2##(1994-5#1)(2013-1#1)
the NBD##2##2##(1994-5#1)(2011-12#1)
the NBDL##3##2##(2007-1#3)
the NBICU##2##2##(1991-12#2)
the NBM and COMB groups##2##5##(1993-3#2)
the NBM##5##2##(1992-8#2)(1993-3#3)
the NBME USMLE steps 1 and 2 examinations##2##8##(2012-3#2)
the NBMPR-sensitive transporter##2##3##(1995-8#2)
the NBPs##2##2##(1995-1#2)
the NBRP##2##2##(2012-11#2)
the NBS domain were##2##4##(2008-10#2)
the NBS##3##2##(2008-10#3)
the NBS1 gene##3##3##(2009-5#3)
the NBS1##5##2##(2009-5#4)(2011-1#1)
the NC and##2##3##(2010-2#2)
the NC diet##2##3##(2010-2#2)
the NC subjects##2##3##(1996-7#2)
the NC##16##2##(1990-9#1)(1996-7#3)(2006-12#1)(2007-10#1)(2008-10#4)(2010-2#5)(2012-12#1)
the NC-ras2##2##2##(1997-4#2)
the NCBI Entrez##3##3##(1993-12#1)(2008-4#2)
the NCBI##8##2##(1993-12#1)(2008-4#5)(2012-3#1)(2013-1#1)
the NCCLS reference##2##3##(2007-7#2)
the NCCLS##4##2##(1992-5#1)(2007-7#2)(2008-1#1)
the NCCLS-approved##2##2##(2006-5#1)(2006-8#1)
the NCI##9##2##(1992-1#1)(2005-10#1)(2005-6#1)(2008-5#1)(2008-7#3)(2009-4#1)(2012-3#1)
the NCLEX##2##2##(2010-3#2)
the NCLEX-RN##5##2##(2006-12#4)(2006-5#1)
the ND and##2##3##(2013-1#1)(2013-8#1)
the ND##6##2##(1995-2#3)(2011-2#1)(2013-1#1)(2013-8#1)
the ND4##2##2##(2008-2#1)(2008-5#1)
the NDA##2##2##(2005-6#1)(2005-8#1)
the NDELA content of##2##4##(2008-5#2)
the NDFWM signal##2##3##(2007-12#2)
the NDH-1##2##2##(1991-1#2)
the NDNAD##2##2##(2008-12#2)
the NE levels in the##2##5##(1996-10#1)(1996-7#1)
the NE##5##2##(1995-7#1)(1996-10#1)(1996-7#1)(2004-4#1)(2011-2#1)
the NETT##2##2##(2005-11#2)
the NF-AT##2##2##(1994-11#1)(1994-3#1)
the NF-kappa B binding##2##4##(1995-1#2)
the NF-kappa B##13##3##(1995-1#6)(1995-12#1)(1995-3#3)(1995-8#1)(1996-9#1)(1997-3#1)
the NF-kappa##16##2##(1993-6#1)(1995-1#6)(1995-12#1)(1995-2#1)(1995-3#4)(1995-8#1)(1996-9#1)(1997-3#1)
the NF-kappaB pathway##2##3##(2006-10#1)(2008-1#1)
the NF-kappaB##7##2##(2006-10#2)(2007-5#1)(2008-1#1)(2008-8#1)(2008-9#1)(2012-12#1)
the NF-κB##2##2##(2011-2#2)
the NF1 gene##6##3##(1992-8#1)(1994-2#2)(1996-12#1)(2013-1#2)
the NF1##7##2##(1992-8#1)(1994-2#2)(1996-12#1)(1997-3#1)(2013-1#2)
the NFL theorems are not##2##5##(2010-3#2)
the NFL theorems##5##3##(2010-3#5)
the NFL##7##2##(1991-10#1)(1991-5#1)(2010-3#5)
the NFP hospital tax exemption##2##5##(2008-11#2)
the NFT200##2##2##(1991-8#2)
the NG corn fed group##2##5##(2009-4#2)
the NG##3##2##(2009-4#2)(2013-8#1)
the NGC/NGC alpha produced##2##4##(1991-5#2)
the NGC/NGC alpha##6##3##(1991-5#6)
the NGF##3##2##(1991-2#1)(1992-8#1)(1993-11#1)
the NGF-activated##2##2##(1994-3#1)(1995-2#1)
the NH##5##2##(1991-2#1)(1991-5#1)(2008-10#2)(2008-2#1)
the NH(2)##3##2##(2005-11#2)(2008-5#1)
the NH2 terminal sequence##3##4##(1991-3#1)(1991-7#2)
the NH2 terminus of##4##4##(1992-12#1)(1995-3#1)(1995-6#1)(1996-5#1)
the NH2 terminus##13##3##(1991-7#2)(1992-12#1)(1992-4#1)(1992-9#1)(1993-3#1)(1994-9#3)(1995-3#1)(1995-6#2)(1996-5#1)
the NH2##19##2##(1991-3#1)(1991-7#4)(1992-12#1)(1992-4#1)(1992-9#2)(1993-3#1)(1994-9#4)(1995-3#1)(1995-6#2)(1996-5#2)
the NH2-terminal domain##2##3##(1990-11#1)(1991-12#1)
the NH2-terminal methionine is removed after translation of the mRNA and has a molecular weight of##2##16##(1993-4#1)(1994-5#1)
the NH2-terminal methionine is removed after translation of the mRNA##5##10##(1993-4#3)(1994-5#2)
the NH2-terminal region and##2##4##(1990-4#1)(1994-12#1)
the NH2-terminal region of the##2##5##(1994-11#1)(1994-9#1)
the NH2-terminal region of##3##4##(1992-11#1)(1994-11#1)(1994-9#1)
the NH2-terminal region##9##3##(1990-4#1)(1990-6#2)(1992-11#1)(1994-11#1)(1994-12#2)(1994-8#1)(1994-9#1)
the NH2-terminal sequence##3##3##(1991-8#1)(1995-6#1)(1997-6#1)
the NH2-terminal##42##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-4#1)(1990-6#3)(1990-7#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-8#1)(1992-11#1)(1992-9#2)(1993-4#3)(1994-11#1)(1994-12#3)(1994-5#2)(1994-8#2)(1994-9#3)(1995-12#1)(1995-3#1)(1995-6#2)(1996-5#2)(1996-8#2)(1997-1#2)(1997-6#1)
the NH2-terminus of the##4##4##(1991-10#1)(1992-11#1)(1997-1#1)(1997-7#1)
the NH2-terminus of thyroglobulin##2##4##(1992-12#2)
the NH2-terminus of##7##3##(1991-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1997-1#1)(1997-7#1)
the NH2-terminus##11##2##(1991-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-8#2)(1997-1#1)(1997-7#1)(2008-8#1)
the NH4+##2##2##(2005-11#1)(2008-8#1)
the NHANES##2##2##(2010-8#1)(2011-1#1)
the NHC samples##2##3##(2013-8#2)
the NHC##5##2##(2010-5#2)(2013-8#3)
the NHS was##2##3##(2008-7#1)(2013-8#1)
the NHS##42##2##(1991-3#1)(1991-6#2)(1991-8#1)(1992-10#1)(1993-10#1)(1993-5#1)(1994-7#1)(1995-9#1)(1996-1#1)(1996-11#1)(1997-5#5)(2005-8#1)(2005-9#1)(2008-11#5)(2008-12#1)(2008-4#1)(2008-7#4)(2009-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#8)
the NHS?##2##2##(1991-3#1)(1993-5#1)
the NHTSA##2##2##(2006-11#2)
the NIA##2##2##(1992-12#1)(2009-5#1)
the NIC calculation##2##3##(2007-4#2)
the NIC##3##2##(2007-4#2)(2008-3#1)
the NICE guidance##2##3##(2010-2#2)
the NICE guidelines##2##3##(2008-7#1)(2013-8#1)
the NICE##6##2##(2008-7#1)(2010-2#3)(2013-1#1)(2013-8#1)
the NICHD##2##2##(2008-12#1)(2010-7#1)
the NICU##15##2##(1991-1#2)(1991-12#3)(1993-5#1)(1994-2#3)(1995-1#2)(2007-12#1)(2009-6#1)(2010-10#1)(2013-1#1)
the NIDDM##2##2##(1996-9#1)(2008-5#1)
the NIH Stroke Scale##2##4##(2007-9#1)(2008-6#1)
the NIH##14##2##(1997-3#1)(2005-9#1)(2007-10#1)(2007-4#1)(2007-9#1)(2008-11#2)(2008-12#2)(2008-5#1)(2008-6#1)(2011-1#1)(2012-2#1)(2012-3#1)
the NIHSS score##2##3##(2007-9#1)(2010-12#1)
the NIHSS##3##2##(2007-10#1)(2007-9#1)(2010-12#1)
the NIL sets##2##3##(2008-10#2)
the NIL##5##2##(1992-12#1)(2008-10#3)(2012-11#1)
the NILs##11##2##(2008-10#11)
the NIMH Genetics Initiative##3##4##(1997-5#3)
the NIMH genetics initiative##5##4##(1997-5#5)
the NIMH##9##2##(1997-5#9)
the NIOSH##2##2##(2008-10#1)(2008-8#1)
the NIR spectra of##2##4##(2008-10#2)
the NIR spectra##4##3##(2008-10#3)(2011-1#1)
the NIR spectral##2##3##(2008-10#1)(2012-12#1)
the NIR##10##2##(2008-10#6)(2008-3#2)(2011-1#1)(2012-12#1)
the NIRS technique##3##3##(2008-10#3)
the NIRS##5##2##(2007-9#1)(2008-10#3)(2008-3#1)
the NIS##2##2##(1995-3#1)(1997-1#1)
the NIST##8##2##(2008-1#1)(2008-10#4)(2008-3#3)
the NJ##2##2##(2008-9#1)(2010-7#1)
the NK##6##2##(1990-10#1)(1996-9#1)(2008-11#1)(2008-4#2)(2008-8#1)
the NK-1 receptor antagonists##5##4##(2008-7#5)
the NK-1 receptor##6##3##(1991-4#1)(2008-7#5)
the NK-1##9##2##(1991-11#1)(1991-4#1)(1995-5#2)(2008-7#5)
the NK-2 agonist##2##3##(1991-11#1)(1995-5#1)
the NK-2##5##2##(1991-11#1)(1994-9#2)(1995-5#2)
the NK-3##3##2##(1993-12#1)(1994-9#2)
the NK1 antagonist##2##3##(1992-10#1)(2008-5#1)
the NK1 receptor antagonist##2##4##(1996-3#1)(1997-4#1)
the NK1 receptor##8##3##(1992-10#1)(1993-11#1)(1993-12#1)(1993-3#1)(1996-3#2)(1997-4#1)(2008-5#1)
the NK1##12##2##(1992-10#4)(1993-11#1)(1993-12#1)(1993-3#1)(1996-3#2)(1997-4#1)(2008-5#2)
the NK1R agonist##2##3##(1997-8#2)
the NK2 receptor##3##3##(1993-3#3)
the NK2##4##2##(1992-10#1)(1993-3#3)
the NL-3 K strain##2##4##(2008-10#2)
the NL-3 K##3##3##(2008-10#3)
the NL-3##4##2##(2008-10#4)
the NLM##2##2##(1996-3#1)(2010-5#1)
the NMDA antagonist##3##3##(1994-10#2)(1996-2#1)
the NMDA induced STP##2##4##(1991-9#2)
the NMDA receptor and##2##4##(1996-1#1)(2013-8#1)
the NMDA receptor antagonist##5##4##(1990-7#1)(1991-9#1)(1992-3#1)(1993-3#1)(1996-12#1)
the NMDA receptor blocker##2##4##(1992-8#1)(1996-2#1)
the NMDA receptor by##2##4##(1993-12#1)(1994-2#1)
the NMDA receptor channels##2##4##(1995-3#1)(2008-8#1)
the NMDA receptor complex##8##4##(1991-9#2)(1996-1#1)(1996-12#3)(1996-2#1)(1996-8#1)
the NMDA receptor in the##3##5##(1992-6#1)(1994-8#1)(2010-12#1)
the NMDA receptor in##4##4##(1992-6#1)(1994-8#1)(1996-10#1)(2010-12#1)
the NMDA receptor##61##3##(1990-2#3)(1990-7#1)(1991-6#2)(1991-8#1)(1991-9#4)(1992-3#2)(1992-6#5)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-2#1)(1994-6#2)(1994-8#5)(1995-12#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-1#4)(1996-10#1)(1996-12#6)(1996-2#4)(1996-5#1)(1996-8#3)(1997-2#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2013-8#1)
the NMDA receptor-mediated##2##3##(1992-3#1)(1995-11#1)
the NMDA receptor/channel##2##3##(1996-12#2)
the NMDA receptors##6##3##(1992-8#1)(1993-11#1)(1997-2#1)(2008-3#1)(2011-1#1)(2012-12#1)
the NMDA##91##2##(1990-2#3)(1990-7#1)(1991-11#1)(1991-6#2)(1991-8#1)(1991-9#6)(1992-1#1)(1992-3#3)(1992-6#5)(1992-8#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1994-10#3)(1994-2#1)(1994-6#2)(1994-8#5)(1994-9#5)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-1#4)(1996-10#2)(1996-12#8)(1996-2#5)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#3)(1997-2#3)(1997-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-8#1)
the NMDA-evoked release##3##3##(1990-7#2)(1995-12#1)
the NMDA-evoked##4##2##(1990-7#2)(1995-12#1)(2008-8#1)
the NMDA-receptor##2##2##(1995-12#1)(1997-7#1)
the NMDAR1 current##2##3##(1996-1#2)
the NMDAR1##5##2##(1995-3#2)(1995-5#1)(1996-1#2)
the NMJ has##2##3##(2009-11#2)
the NMJ##4##2##(1990-5#1)(2009-11#2)(2009-8#1)
the NMN adenylyltransferase##2##3##(1992-12#2)
the NMN##3##2##(1991-8#1)(1992-12#2)
the NMP##3##2##(1992-1#2)(2005-11#1)
the NMR and##3##3##(1995-3#1)(1997-4#1)(2012-11#1)
the NMR assignment of the##2##5##(2009-7#2)
the NMR data##7##3##(1990-5#1)(1992-11#1)(1994-9#1)(1995-1#2)(1995-3#1)(2008-7#1)
the NMR results##3##3##(1991-8#1)(1995-10#1)(2006-11#1)
the NMR signals of##2##4##(1994-5#1)(1997-5#1)
the NMR spectra##3##3##(1991-11#1)(1994-8#1)(1997-4#1)
the NMR spectrum##3##3##(1991-2#1)(1995-3#1)(1997-4#1)
the NMR timescale##2##3##(2009-3#1)(2010-7#1)
the NMR##51##2##(1990-4#1)(1990-5#3)(1991-11#3)(1991-2#2)(1991-8#2)(1992-11#1)(1993-4#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#3)(1995-10#2)(1995-3#3)(1996-7#1)(1997-4#3)(1997-5#1)(1997-7#1)(2006-11#1)(2007-11#2)(2007-9#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-3#1)(2009-7#5)(2009-9#2)(2010-4#1)(2010-6#1)(2010-7#1)(2012-11#1)
the NNB##4##2##(2012-11#4)
the NNRTI##2##2##(1993-9#1)(2009-11#1)
the NNS##2##2##(2009-12#1)(2009-9#1)
the NO acceptor##2##3##(1995-5#2)
the NO donor##3##3##(1995-5#1)(2007-10#2)
the NO donors##2##3##(1995-5#1)(1997-6#1)
the NO message##2##3##(2011-2#2)
the NO production##2##3##(2006-8#2)
the NO synthase inhibitor##3##4##(1993-12#1)(1993-3#1)(1995-5#1)
the NO synthase##6##3##(1992-11#1)(1992-6#1)(1993-12#1)(1993-3#1)(1995-5#1)(1996-2#1)
the NO##28##2##(1990-10#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-5#5)(1996-2#1)(1996-6#1)(1997-6#2)(2006-8#2)(2007-10#2)(2008-2#1)(2009-2#1)(2011-2#2)(2013-1#1)
the NO(2)(-)##2##2##(2008-10#2)
the NO-synthase##4##2##(1992-8#1)(1997-5#1)(2008-8#2)
the NOD mouse##4##3##(1993-11#1)(2006-1#1)(2007-5#1)(2010-11#1)
the NOD##7##2##(1993-11#1)(1995-12#1)(1997-4#1)(2006-1#1)(2007-5#2)(2010-11#1)
the NOE##5##2##(1993-11#1)(1994-11#2)(1995-10#1)(1995-3#1)
the NOE's##3##2##(1990-10#2)(1993-11#1)
the NOESY spectra##3##3##(1991-11#1)(1996-7#1)(2008-5#1)
the NOESY spectrum of##2##4##(1990-4#1)(1991-7#1)
the NOESY spectrum##3##3##(1990-4#1)(1991-7#1)(1996-7#1)
the NOESY##7##2##(1990-4#1)(1991-11#1)(1991-7#1)(1996-7#2)(2008-5#2)
the NOLM##2##2##(2007-12#2)
the NOM##3##2##(1992-5#2)(2008-3#1)
the NOS reaction##4##3##(1993-6#1)(2008-5#2)(2009-9#1)
the NOS##11##2##(1993-6#1)(1994-2#1)(1995-6#1)(1997-6#1)(2008-10#4)(2008-5#2)(2009-9#1)
the NOS-positive nerve fibres##2##4##(1992-8#2)
the NOS-positive##3##2##(1992-8#2)(1997-6#1)
the NOS2##3##2##(1996-2#3)
the NOTCH##2##2##(2007-8#1)(2010-3#1)
the NOTES##2##2##(2009-2#1)(2010-12#1)
the NP##5##2##(2008-10#1)(2009-12#1)(2009-9#1)(2012-12#2)
the NPC##13##2##(1993-6#3)(2011-2#10)
the NPD##2##2##(2008-9#2)
the NPEY motif of the##2##5##(1995-6#2)
the NPPV group##2##3##(2008-1#2)
the NPPV##3##2##(2008-1#3)
the NPRO##2##2##(1991-7#1)(2007-12#1)
the NPS##4##2##(2007-12#2)(2008-9#2)
the NPSH content##2##3##(1994-3#2)
the NPSH##3##2##(1994-3#3)
the NPY-induced##2##2##(1991-6#1)(1992-9#1)
the NQF Quality Data Model##4##5##(2013-1#4)
the NR##3##2##(1993-6#1)(2008-10#1)(2010-9#1)
the NR1##4##2##(1993-9#1)(1996-3#1)(2008-3#1)(2010-12#1)
the NR1a##2##2##(1996-8#2)
the NR2B subunit##2##3##(1997-3#1)(2009-5#1)
the NR2B##4##2##(1995-12#1)(1997-3#1)(2008-3#1)(2009-5#1)
the NRC vision##2##3##(2011-1#2)
the NRC##3##2##(2011-1#3)
the NRE##2##2##(1991-5#1)(1994-8#1)
the NRM##3##2##(1991-3#2)(1993-7#1)
the NRS-11##2##2##(2006-12#2)
the NS##5##2##(1995-4#2)(2007-7#1)(2010-7#1)(2012-1#1)
the NS3 protease##2##3##(2012-2#2)
the NS3##3##2##(2008-10#1)(2012-2#2)
the NSAID##2##2##(1997-2#1)(2007-12#1)
the NSAIDs and##2##3##(2008-3#1)(2010-12#1)
the NSAIDs##9##2##(1990-11#1)(1993-2#1)(2005-8#1)(2007-12#3)(2008-3#2)(2010-12#1)
the NSCs cultured in##2##4##(2008-11#2)
the NSE concentrations##2##3##(1992-11#2)
the NSE##7##2##(1990-11#1)(1992-11#2)(1992-5#3)(2011-2#1)
the NSF##3##2##(1997-6#1)(2008-7#1)(2010-12#1)
the NSI##4##2##(2011-1#2)(2013-1#2)
the NSLS##3##2##(2006-4#3)
the NSP##3##2##(2012-12#3)
the NSSF##3##2##(2008-6#3)
the NSW##2##2##(1990-2#1)(2007-11#1)
the NSm##3##2##(2008-10#3)
the NSs##3##2##(2008-10#3)
the NT##4##2##(2006-10#2)(2012-3#2)
the NT(+)##2##2##(2008-11#2)
the NTG##2##2##(2013-8#2)
the NTP Brief##6##3##(2005-7#4)(2006-12#2)
the NTP reached the following conclusions regarding the possible effects of exposure to##3##13##(2005-7#2)(2006-12#1)
the NTP##15##2##(1993-3#1)(2005-7#8)(2006-12#3)(2007-2#1)(2008-9#1)(2009-3#1)
the NTP-binding##2##2##(2008-10#2)
the NTPDase isoforms##2##3##(2008-4#2)
the NTPDase##3##2##(2008-4#3)
the NTRC##4##2##(1995-1#3)(2009-10#1)
the NTS##16##2##(1991-8#2)(1992-3#2)(1992-9#3)(1995-12#1)(1997-2#3)(1997-5#4)(2013-1#1)
the NUE##3##2##(2012-1#1)(2013-8#2)
the NUM 114 strain##2##4##(2006-8#2)
the NW##10##2##(2004-4#1)(2007-10#2)(2008-11#1)(2008-7#3)(2009-2#3)
the NXSM##2##2##(1994-8#2)
the NYAPs##3##2##(2008-10#3)
the NYC##2##2##(1991-2#1)(1996-3#1)
the NZ##4##2##(2008-11#2)(2008-8#1)(2011-2#1)
the NZVJ##5##2##(2005-7#5)
the Na channel##4##3##(1991-9#2)(1994-8#2)
the Na##28##2##(1990-3#6)(1991-9#2)(1992-11#5)(1992-9#1)(1994-8#8)(1994-9#4)(1997-7#1)(2006-5#1)
the Na(+)-K(+)-ATPase##2##2##(1996-7#1)(2008-8#1)
the Na(+)-dependent##3##2##(1990-12#1)(1991-12#1)(1994-9#1)
the Na(2)CO(3) fusion##2##3##(2008-10#2)
the Na(V)1##2##2##(2008-8#2)
the Na+ binding site##3##4##(1997-1#1)(1997-2#1)(1997-7#1)
the Na+ binding##5##3##(1997-1#2)(1997-2#2)(1997-7#1)
the Na+ channel##3##3##(1995-11#1)(1996-11#1)(2006-9#1)
the Na+ current##3##3##(1992-3#1)(1995-12#1)(1996-10#1)
the Na+ gradient##2##3##(1994-12#1)(1995-11#1)
the Na+ pump##2##3##(1996-1#1)(1997-6#1)
the Na+##37##2##(1990-2#4)(1990-8#2)(1991-8#5)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#2)(1995-12#2)(1996-1#1)(1996-10#1)(1996-11#1)(1997-1#2)(1997-2#2)(1997-6#2)(1997-7#1)(1997-8#1)(2006-9#1)(2008-8#1)
the Na+-ATPase##2##2##(2008-11#2)
the Na+/H+ antiport##2##3##(1990-2#1)(1991-3#1)
the Na+/H+ antiporter##5##3##(1990-2#2)(1990-7#2)(1995-6#1)
the Na+/H+ exchange##2##3##(1992-4#1)(1994-3#1)
the Na+/H+ exchanger and##2##4##(1993-3#2)
the Na+/H+ exchanger in##3##4##(1991-2#1)(1991-4#1)(1991-9#1)
the Na+/H+ exchanger is##2##4##(1990-2#1)(1991-9#1)
the Na+/H+ exchanger##13##3##(1990-2#1)(1991-2#2)(1991-4#1)(1991-9#2)(1992-4#1)(1993-3#2)(1997-7#3)(2005-8#1)
the Na+/H+##22##2##(1990-2#4)(1990-7#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-9#2)(1992-4#2)(1993-3#2)(1994-3#1)(1995-6#1)(1997-7#3)(2005-8#1)
the Na+/K(+)-ATPase activity##2##3##(1990-12#2)
the Na+/K(+)-ATPase##8##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#2)(1991-2#1)(1994-12#1)
the Na+/K+ ATPase##2##3##(1990-12#1)(2007-10#1)
the Na+/K+ pump in the##2##5##(1994-8#2)
the Na+/K+ pump##4##3##(1994-8#3)(1996-1#1)
the Na+/K+##7##2##(1990-12#1)(1994-8#3)(1996-1#2)(2007-10#1)
the Na-ASP-2##3##2##(2006-10#3)
the Na-K-2Cl cotransporter##2##3##(2007-7#1)(2008-8#1)
the Na-only mode##6##3##(1990-3#6)
the NaCl concentration##9##3##(1992-3#1)(1992-9#3)(1996-7#1)(1996-8#1)(1997-2#1)(2006-10#1)(2008-5#1)
the NaCl##13##2##(1992-3#1)(1992-9#3)(1996-7#1)(1996-8#1)(1997-2#1)(2006-10#1)(2008-10#2)(2008-5#1)(2010-4#1)(2013-1#1)
the Nafion##2##2##(2008-10#2)
the Nafion/MV modified GDME##2##4##(2008-10#2)
the Nafion/MV modified##4##3##(2008-10#4)
the Nafion/MV##5##2##(2008-10#5)
the Nagle algorithm##3##3##(2004-9#3)
the Naples High-##2##3##(1993-5#2)
the Naples##4##2##(1993-5#3)(2008-2#1)
the Nation##10##2##(1990-12#1)(1992-3#2)(1993-3#1)(1996-1#1)(1996-2#1)(2007-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
the Nation's first##2##3##(1996-1#1)(2008-6#1)
the Nation's##9##2##(1990-12#1)(1992-12#1)(1992-3#1)(1993-3#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(2008-6#1)
the National AIDS Coordination Program##2##5##(1997-7#2)
the National AIDS##3##3##(1996-4#1)(1997-7#2)
the National Academy of##2##4##(2007-6#1)(2008-1#1)
the National Accident Sampling System (NASS)##2##6##(2006-11#1)(2007-4#1)
the National Association of##5##4##(1992-3#1)(1994-12#1)(1996-5#1)(2005-8#1)(2006-4#1)
the National Association##6##3##(1992-3#1)(1994-12#1)(1996-5#1)(2005-8#1)(2006-4#1)(2009-4#1)
the National Asthma##3##3##(2005-8#1)(2008-6#1)(2009-6#1)
the National Board of Health##2##5##(1991-2#1)(1996-9#1)
the National Board of##3##4##(1991-2#1)(1996-9#1)(2012-3#1)
the National Cancer Center##3##4##(2005-10#1)(2007-8#1)(2008-7#1)
the National Cancer Institute (NCI)##6##5##(1997-1#1)(1997-3#1)(2006-12#1)(2008-5#1)(2010-12#1)(2013-8#1)
the National Cancer Institute of Milan##2##6##(1992-4#1)(1993-6#1)
the National Cancer Institute##23##4##(1991-3#1)(1991-5#1)(1992-4#1)(1993-6#1)(1997-1#2)(1997-3#1)(2006-12#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-8#1)
the National Cancer Institute's##3##4##(1994-9#1)(2007-4#1)(2008-7#1)
the National Cancer##34##3##(1991-3#1)(1991-5#1)(1992-4#1)(1993-6#1)(1994-9#1)(1997-1#2)(1997-3#1)(2005-10#1)(2006-12#1)(2007-1#1)(2007-4#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-4#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-3#1)(2013-8#2)
the National Capital District##3##4##(2006-2#2)(2008-4#1)
the National Center for Health Statistics##2##6##(1990-12#1)(1997-8#1)
the National Center for Prevention Services##2##6##(1997-3#2)
the National Center for##7##4##(1990-12#1)(1997-3#2)(1997-8#1)(2007-1#1)(2007-7#1)(2008-4#1)
the National Center##8##3##(1990-12#1)(1997-3#2)(1997-8#1)(2007-1#1)(2007-10#1)(2007-7#1)(2008-4#1)
the National Cholesterol Education Program (NCEP)##4##6##(1991-8#1)(1993-9#1)(2008-3#2)
the National Cholesterol Education Program Expert Panel##2##7##(2008-1#1)(2008-3#1)
the National Cholesterol Education Program##9##5##(1991-2#1)(1991-8#1)(1993-9#1)(2008-1#1)(2008-3#4)(2010-9#1)
the National Cholesterol Education##10##4##(1991-2#1)(1991-8#1)(1993-9#1)(2008-1#1)(2008-3#5)(2010-9#1)
the National Committee for Clinical Laboratory Standards##2##7##(2008-5#1)(2010-8#1)
the National Committee for##3##4##(1996-3#1)(2008-5#1)(2010-8#1)
the National Committee##4##3##(1996-3#1)(2006-5#1)(2008-5#1)(2010-8#1)
the National Coordinator for##5##4##(2013-1#5)
the National Correct Coding##2##4##(2006-8#2)
the National Council Licensure Examination for Registered Nurses##2##8##(2006-12#1)(2006-5#1)
the National Council##6##3##(1990-6#1)(1995-2#1)(2006-12#1)(2006-5#3)
the National Drug Codes##2##4##(2006-8#2)
the National Emphysema Treatment Trial##2##5##(2005-11#2)
the National Health Accounts##3##4##(1991-2#1)(1997-1#1)(2005-9#1)
the National Health Fund##2##4##(2007-7#2)
the National Health Insurance Fund##2##5##(2007-5#1)(2013-8#1)
the National Health Insurance##3##4##(1992-9#1)(2007-5#1)(2013-8#1)
the National Health Interview Survey##4##5##(1995-12#1)(1996-5#1)(1996-8#1)(1997-3#1)
the National Health Screening Service conducted cardiovascular risk factor screening of##2##11##(1991-6#1)(1994-11#1)
the National Health Screening Service##4##5##(1991-6#1)(1994-11#3)
the National Health Service (NHS)##6##5##(2008-11#1)(2008-7#1)(2011-2#1)(2012-1#1)(2013-1#2)
the National Health Service##13##4##(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#2)(2008-7#1)(2011-2#1)(2012-1#1)(2013-1#2)
the National Health and Nutrition Examination Survey##3##7##(2008-1#1)(2010-12#1)(2011-2#1)
the National Health and Nutrition Examination##6##6##(2008-1#1)(2009-4#3)(2010-12#1)(2011-2#1)
the National Health##43##3##(1991-2#1)(1991-6#1)(1992-9#1)(1994-11#3)(1994-3#1)(1995-11#1)(1995-12#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#1)(2005-7#1)(2005-8#1)(2005-9#1)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#2)(2008-7#1)(2009-4#3)(2010-12#1)(2011-1#2)(2011-2#4)(2012-1#1)(2013-1#2)(2013-8#1)
the National Heart Attack Alert##2##5##(2008-3#2)
the National Heart##16##3##(1991-10#1)(1993-9#1)(1996-12#1)(1996-6#1)(2005-11#1)(2007-10#1)(2008-3#5)(2009-12#2)(2009-4#2)(2011-2#1)
the National Highway Traffic Safety Administration##2##6##(2006-11#1)(2007-1#1)
the National Highway Traffic Safety##3##5##(1991-8#1)(2006-11#1)(2007-1#1)
the National Hospital Discharge##2##4##(1993-8#1)(2007-1#1)
the National Hospital##6##3##(1993-8#1)(1996-4#1)(1997-2#2)(2007-1#1)(2011-2#1)
the National Human##2##3##(2008-11#1)(2008-4#1)
the National Ignition Facility (NIF)##2##5##(2008-2#1)(2008-3#1)
the National Ignition Facility##7##4##(2008-2#2)(2008-3#5)
the National Institute for Health and Clinical Excellence##2##8##(2008-7#1)(2011-1#1)
the National Institute for Health and##3##6##(2008-7#1)(2011-1#2)
the National Institute for Occupational Safety and Health##2##8##(2008-10#1)(2012-12#1)
the National Institute for##8##4##(1993-7#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-1#2)(2012-12#1)(2013-1#1)
the National Institute of Allergy and Infectious Diseases##3##8##(2007-4#1)(2008-5#1)(2011-2#1)
the National Institute of Allergy and Infectious##4##7##(2005-8#1)(2007-4#1)(2008-5#1)(2011-2#1)
the National Institute of Cardiology##6##5##(2008-10#6)
the National Institute of Environmental Health Sciences##2##7##(2008-9#2)
the National Institute of Health Stroke Scale##2##7##(2007-9#1)(2012-2#1)
the National Institute of Health Stroke##3##6##(2007-9#1)(2008-5#1)(2012-2#1)
the National Institute of Health##4##5##(1996-4#1)(2007-9#1)(2008-5#1)(2012-2#1)
the National Institute of Neurological Disorders and Stroke (NINDS)##5##9##(2007-10#1)(2007-9#3)(2008-7#1)
the National Institute of Neurological Disorders and Stroke##8##8##(2007-10#3)(2007-9#3)(2008-7#1)(2011-2#1)
the National Institute of Neurological##9##5##(2005-8#1)(2007-10#3)(2007-9#3)(2008-7#1)(2011-2#1)
the National Institute of Public Health##2##6##(1996-1#1)(2013-1#1)
the National Institute of Standards and Technology (NIST)##2##8##(2008-10#1)(2008-3#1)
the National Institute of Standards and Technology##8##7##(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#4)
the National Institute of Standards##9##5##(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#4)(2013-8#1)
the National Institute of##47##4##(1991-3#3)(1992-12#1)(1994-7#1)(1996-1#1)(1996-4#1)(2005-8#2)(2006-2#1)(2006-9#1)(2007-10#3)(2007-4#1)(2007-8#1)(2007-9#5)(2008-10#7)(2008-2#2)(2008-3#4)(2008-5#3)(2008-7#2)(2008-9#2)(2009-9#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
the National Institute on Aging (NIA)##2##6##(2008-7#1)(2009-5#1)
the National Institute on Aging##3##5##(2008-7#1)(2009-5#1)(2010-5#1)
the National Institute on Drug Abuse##2##6##(1996-4#1)(2007-11#1)
the National Institute on##6##4##(1992-3#1)(1996-4#1)(2007-11#1)(2008-7#1)(2009-5#1)(2010-5#1)
the National Institute##61##3##(1991-3#3)(1992-12#1)(1992-3#1)(1993-7#1)(1994-7#1)(1996-1#1)(1996-4#2)(2005-8#2)(2006-2#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-4#1)(2007-8#1)(2007-9#5)(2008-10#8)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#3)(2008-7#4)(2008-9#2)(2009-5#1)(2009-9#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
the National Institutes of Health (NIH)##8##6##(1996-6#1)(1997-8#1)(2007-4#1)(2008-12#2)(2008-5#1)(2008-7#1)(2011-2#1)
the National Institutes of Health Stroke Scale##2##7##(2007-10#2)
the National Institutes of Health##33##5##(1996-5#1)(1996-6#1)(1996-9#1)(1997-8#1)(2005-8#2)(2006-10#1)(2006-9#1)(2007-10#2)(2007-4#2)(2008-1#1)(2008-12#2)(2008-5#2)(2008-7#2)(2011-2#3)(2012-3#1)(2013-8#10)
the National Institutes of Health's##2##5##(2007-9#1)(2012-12#1)
the National Institutes of##38##4##(1992-5#1)(1994-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-5#1)(1997-8#1)(2005-8#2)(2006-10#1)(2006-9#1)(2007-10#2)(2007-4#2)(2007-9#1)(2008-1#1)(2008-12#2)(2008-5#2)(2008-7#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#10)
the National Insurance Administration and##2##5##(1990-4#1)(1995-2#1)
the National Insurance Administration##5##4##(1990-4#3)(1995-2#1)(1996-2#1)
the National Insurance##9##3##(1990-4#4)(1991-8#2)(1995-2#1)(1996-2#1)(1997-6#1)
the National Library of Medicine (NLM)##4##6##(1991-2#1)(1992-1#1)(1992-2#1)(1994-12#1)
the National Library of Medicine##12##5##(1991-2#2)(1992-1#2)(1992-2#1)(1994-12#1)(1995-1#1)(1996-3#1)(2010-4#1)(2010-5#1)(2012-2#1)(2012-3#1)
the National Library of Medicine's Unified Medical Language System (UMLS)##2##10##(2008-7#2)
the National Library of Medicine's##5##5##(1993-3#1)(1995-11#1)(2008-7#2)(2012-2#1)
the National Library of##17##4##(1991-2#2)(1992-1#2)(1992-2#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-11#1)(1996-3#1)(2008-7#2)(2010-4#1)(2010-5#1)(2012-2#2)(2012-3#1)
the National Lipid Association##2##4##(2013-7#2)
the National Longitudinal Study of Adolescent Health##11##7##(2008-2#1)(2008-5#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-4#1)(2010-7#2)(2012-12#1)(2013-8#1)
the National Longitudinal##14##3##(2008-2#1)(2008-5#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-7#2)(2012-1#1)(2012-12#1)(2013-8#1)
the National Museum of Natural History##5##6##(2007-5#4)(2009-2#1)
the National Notification System for##2##5##(1995-4#1)(1996-11#1)
the National Nutrition##3##3##(1995-1#1)(2006-4#1)(2008-4#1)
the National Oceanic and Atmospheric Administration##2##6##(2008-2#1)(2008-3#1)
the National Park##2##3##(2012-2#1)(2013-7#1)
the National Practitioner Data Bank##8##5##(1990-12#3)(1992-1#1)(1992-3#2)(1994-2#1)(2007-3#1)
the National Public Health Laboratory##2##5##(2007-2#1)(2011-2#1)
the National Public Health##3##4##(2007-2#1)(2010-9#1)(2011-2#1)
the National Reference Laboratory##3##4##(2005-9#1)(2007-11#1)(2013-1#1)
the National Reference##6##3##(2005-9#1)(2007-11#1)(2008-10#1)(2008-4#1)(2010-4#1)(2013-1#1)
the National Registry of Acute Coronary##2##6##(2008-10#1)(2011-1#1)
the National Registry of##3##4##(2008-10#1)(2008-3#1)(2011-1#1)
the National Research Council of Canada##2##6##(2008-10#1)(2008-2#1)
the National Research##5##3##(1996-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-8#1)
the National Science Foundation (NSF)##3##5##(2007-8#1)(2007-9#1)(2008-10#1)
the National Science Foundation##7##4##(2007-8#1)(2007-9#4)(2008-10#1)(2013-8#1)
the National Science Foundation's##2##4##(1997-6#1)(2010-12#1)
the National Science##9##3##(1997-6#1)(2007-8#1)(2007-9#4)(2008-10#1)(2010-12#1)(2013-8#1)
the National Service Framework##2##4##(2008-11#1)(2008-3#1)
the National Statistics##2##3##(2012-12#1)(2013-1#1)
the National Survey of Families and Households##2##7##(2008-2#1)(2011-12#1)
the National Survey of##5##4##(2008-2#1)(2009-5#2)(2010-10#1)(2011-12#1)
the National University Hospital##2##4##(2006-10#1)(2012-12#1)
the National University of##2##4##(2011-2#1)(2013-7#1)
the National University##4##3##(2006-10#1)(2011-2#1)(2012-12#1)(2013-7#1)
the National##485##2##(1990-12#5)(1990-4#4)(1990-6#1)(1991-10#1)(1991-12#1)(1991-2#6)(1991-3#4)(1991-5#1)(1991-6#1)(1991-8#4)(1992-1#3)(1992-12#1)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#2)(1994-7#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#4)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#5)(1996-5#4)(1996-6#3)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#2)(1997-3#5)(1997-5#1)(1997-6#5)(1997-7#2)(1997-8#2)(2005-10#1)(2005-11#3)(2005-5#2)(2005-7#1)(2005-8#8)(2005-9#2)(2006-10#3)(2006-11#3)(2006-12#3)(2006-2#4)(2006-4#3)(2006-5#7)(2006-7#1)(2006-8#6)(2006-9#2)(2007-1#6)(2007-10#9)(2007-11#4)(2007-2#2)(2007-3#3)(2007-4#7)(2007-5#5)(2007-6#2)(2007-7#6)(2007-8#5)(2007-9#12)(2008-1#7)(2008-10#21)(2008-11#9)(2008-12#4)(2008-2#11)(2008-3#27)(2008-4#5)(2008-5#10)(2008-6#1)(2008-7#15)(2008-8#1)(2008-9#6)(2009-10#1)(2009-12#2)(2009-2#1)(2009-4#9)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#4)(2010-2#3)(2010-4#4)(2010-5#3)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#8)(2011-12#3)(2011-2#20)(2012-1#3)(2012-11#1)(2012-12#9)(2012-2#6)(2012-3#5)(2013-1#17)(2013-7#4)(2013-8#20)
the Nationwide##5##2##(2012-3#1)(2013-1#4)
the Natural##4##2##(1990-3#1)(2008-10#2)(2010-2#1)
the Nature##2##2##(2008-10#1)(2008-7#1)
the Nautilus##2##2##(1997-4#2)
the Navajo##2##2##(1996-2#1)(2004-12#1)
the Naval Medical##2##3##(1996-12#1)(2013-1#1)
the Navarre##3##2##(2011-2#1)(2013-1#2)
the Navon task##3##3##(2008-11#2)(2008-9#1)
the Navrongo##2##2##(2006-4#2)
the Nazi##2##2##(2005-11#2)
the Naïve Bayes (NB) algorithm achieved an area under the curve value of 81%##2##14##(2013-1#2)
the Nd##22##2##(1991-3#2)(1994-10#1)(1994-2#1)(1996-6#1)(2004-2#2)(2007-11#1)(2007-12#4)(2008-10#3)(2008-2#3)(2008-3#4)
the Nd(3+)##4##2##(2007-11#3)(2008-3#1)
the Nd-YAG laser##3##3##(2008-5#2)(2010-8#1)
the Near East##3##3##(1991-11#1)(2012-2#1)(2012-9#1)
the Neck Disability Index##2##4##(2008-12#2)
the Neck##3##2##(2006-8#1)(2008-12#2)
the Nederlands Tijdschrift voor Geneeskunde##4##5##(1991-6#1)(1995-12#1)(1995-9#1)(1996-11#1)
the Nederlands Tijdschrift voor##5##4##(1991-6#1)(1995-12#2)(1995-9#1)(1996-11#1)
the Nederlandse Anatomen Vereniging##3##4##(2006-11#3)
the Need for##2##3##(2007-12#1)(2011-2#1)
the Nef##2##2##(1997-3#1)(2005-7#1)
the Neonatal Intensive Care Unit##2##5##(1991-6#1)(2007-2#1)
the Neonatal##5##2##(1991-6#1)(2007-10#1)(2007-2#1)(2009-9#1)(2012-2#1)
the Neotropical##5##2##(2007-12#1)(2007-3#2)(2008-5#2)
the Neotropics and##2##3##(2012-2#1)(2013-7#1)
the Neotropics##5##2##(2007-3#1)(2008-5#1)(2012-2#1)(2013-7#2)
the Nepalese##4##2##(2008-7#1)(2008-8#2)(2012-3#1)
the Nephrology##2##2##(2007-5#1)(2007-7#1)
the Nera River##2##3##(2008-4#2)
the Nernstian response##2##3##(2005-11#1)(2008-10#1)
the Nervous##3##2##(2008-2#1)(2009-5#1)(2010-11#1)
the Nestin gene##2##3##(2011-2#2)
the Net##4##2##(1996-2#1)(2004-10#2)(2006-10#1)
the Netherlands Antilles##4##3##(1992-2#2)(1994-12#1)(1997-8#1)
the Netherlands Centre for Monitoring of Adverse Reactions to Drugs##2##10##(1992-2#1)(1993-8#1)
the Netherlands and the##2##4##(2008-10#1)(2012-12#1)
the Netherlands and##5##3##(1996-1#1)(2006-2#1)(2008-10#2)(2012-12#1)
the Netherlands centre##2##3##(1993-8#2)
the Netherlands has##2##3##(2007-9#1)(2008-2#1)
the Netherlands were##4##3##(1992-12#2)(2008-10#2)
the Netherlands##99##2##(1990-12#1)(1990-3#2)(1991-11#2)(1991-4#1)(1991-5#1)(1991-8#2)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#5)(1992-5#1)(1993-4#1)(1993-5#1)(1993-8#5)(1994-12#3)(1995-12#2)(1995-3#1)(1995-4#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-8#2)(1997-3#1)(1997-5#2)(1997-8#2)(2004-2#2)(2006-2#4)(2006-7#1)(2006-9#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#20)(2008-11#1)(2008-12#5)(2008-2#1)(2008-5#1)(2008-7#3)(2009-12#1)(2009-2#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-8#1)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
the Network of Pediatric Audiologists of Canada##3##7##(2011-12#3)
the Network of##4##3##(1991-3#1)(2011-12#3)
the Network##6##2##(1991-3#2)(2008-3#1)(2011-12#3)
the Neumann##2##2##(2008-3#2)
the Neuro Emotional Technique##2##4##(2008-7#1)(2009-8#1)
the Neurobehavioral Symptom Inventory##2##4##(2013-1#2)
the Neurological and Functional Classification of Spinal##2##7##(2007-11#2)
the Neurosciences##2##2##(1997-5#1)(2010-6#1)
the Neurospora circadian##3##3##(2011-1#3)
the Neurospora crassa plasma membrane H(+)-ATPase##2##6##(1990-11#2)
the Neurospora crassa##3##3##(1990-11#2)(1995-8#1)
the Neurospora##6##2##(1990-11#2)(1995-8#1)(2011-1#3)
the New Brunswick##2##3##(1994-1#1)(1996-1#1)
the New England Medical Center Stroke Registry##2##7##(2007-9#2)
the New Jersey##2##3##(1991-11#1)(1997-3#1)
the New Mexico##2##3##(1997-3#2)
the New World Sciurus and the##2##6##(2008-5#2)
the New World Sciurus##4##4##(2008-5#4)
the New World##10##3##(2008-10#2)(2008-5#4)(2011-2#3)(2012-12#1)
the New York Academy of Sciences##2##6##(1990-3#1)(1994-12#1)
the New York City Board of Education##2##7##(1991-12#2)
the New York City##4##4##(1991-12#2)(1996-11#1)(1996-3#1)
the New York State Department of Health##3##7##(1994-12#1)(1996-3#1)(1997-1#1)
the New York State##7##4##(1992-3#1)(1992-8#1)(1994-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)
the New York experience##2##4##(1996-1#1)(1997-1#1)
the New York statutory model--Part##2##5##(1992-12#1)(1992-3#1)
the New York##27##3##(1990-3#1)(1991-10#1)(1991-12#2)(1992-12#2)(1992-3#2)(1992-8#1)(1994-12#3)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-1#2)(2006-2#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-8#1)(2011-2#1)
the New Zealand Society of Animal Production##2##7##(2005-7#2)
the New Zealand Society of##3##5##(2005-7#2)(2007-2#1)
the New Zealand Veterinary Association##2##5##(2005-7#2)
the New Zealand Veterinary Journal##5##5##(2005-7#5)
the New Zealand Veterinary##7##4##(2005-7#7)
the New Zealand##25##3##(1991-2#2)(1996-6#1)(1997-4#1)(1997-6#1)(2005-7#10)(2007-1#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-8#2)(2011-1#1)
the New##84##2##(1990-2#1)(1990-3#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#2)(1992-12#2)(1992-3#2)(1992-8#1)(1994-1#1)(1994-12#3)(1996-1#2)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#2)(1997-3#3)(1997-4#1)(1997-6#1)(2005-7#10)(2006-10#1)(2006-12#2)(2006-2#1)(2007-1#1)(2007-12#2)(2007-2#2)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#3)(2008-3#3)(2008-4#1)(2008-5#4)(2008-8#3)(2010-12#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)
the Newcastle##2##2##(2007-8#1)(2008-5#1)
the News##3##2##(1992-7#1)(2007-4#2)
the Newt Micronucleus Test##2##4##(1993-9#2)
the Newtonian##3##2##(2009-6#1)(2013-8#2)
the Next Generation##2##3##(1991-3#1)(2007-9#1)
the Next##4##2##(1991-3#1)(2005-8#1)(2007-9#2)
the NgoII##2##2##(1993-9#2)
the Ni##4##2##(1994-11#1)(2007-8#1)(2008-10#2)
the Ni-Ti alloy electrode##2##4##(2008-10#2)
the Ni-Ti##3##2##(2008-10#3)
the NiFe complex##3##3##(1992-12#3)
the NiFe##4##2##(1992-12#4)
the NiFeC EPR signal##2##4##(1992-12#2)
the NiFeC##3##2##(1992-12#3)
the Nicotiana##2##2##(2005-10#1)(2008-7#1)
the NifA##2##2##(1993-12#1)(2008-9#1)
the Niger Delta##4##3##(1996-8#1)(2006-12#2)(2013-7#1)
the Nigerian##5##2##(1990-3#1)(2007-12#2)(2011-1#1)(2013-1#1)
the Night##2##2##(2010-8#1)(2012-11#1)
the Nijmegen##2##2##(2009-5#1)(2013-1#1)
the Nike##3##2##(2008-2#3)
the Nikolskii-Eisenman equation##2##3##(2008-10#2)
the Nikolskii-Eisenman##3##2##(2008-10#3)
the Nile River Delta and##2##5##(2008-10#2)
the Nile River Delta##3##4##(2008-10#3)
the Nile##5##2##(1993-4#1)(2008-10#4)
the Ninth##3##2##(1990-2#1)(1997-8#1)(2005-8#1)
the Nipah virus##3##3##(2005-12#1)(2008-12#2)
the No##2##2##(2008-8#1)(2013-1#1)
the Nobel Prize of Medicine##2##5##(2007-4#1)(2013-1#1)
the Nobel Prize##4##3##(2007-4#1)(2007-8#1)(2010-7#1)(2013-1#1)
the Nobel##7##2##(2007-4#1)(2007-8#1)(2007-9#1)(2009-4#1)(2010-1#1)(2010-7#1)(2013-1#1)
the NodZ protein##2##3##(1997-4#2)
the NodZ##3##2##(1997-4#3)
the Nordic Psychiatric##2##3##(2011-4#2)
the Nordic countries##11##3##(1990-11#2)(1990-6#1)(1992-11#1)(1992-2#1)(1997-6#1)(2008-10#3)(2011-4#1)(2013-1#1)
the Nordic##22##2##(1990-11#2)(1990-6#1)(1991-2#2)(1992-11#1)(1992-2#1)(1997-6#1)(2006-10#1)(2007-3#1)(2008-10#3)(2008-2#1)(2009-12#1)(2011-4#5)(2013-1#2)
the Normalized##2##2##(2008-8#1)(2009-2#1)
the Norse##2##2##(2008-3#2)
the North Adriatic Sea##2##4##(2008-4#2)
the North American Great Lakes##4##5##(2008-11#4)
the North American IgA Nephropathy Study##2##6##(2007-8#2)
the North American Symptomatic Carotid Endarterectomy Trial##3##7##(2006-11#2)(2008-7#1)
the North American opossum##2##4##(1996-5#2)
the North American##27##3##(1994-3#1)(1995-2#1)(1996-5#2)(2006-10#1)(2006-11#2)(2006-12#1)(2006-7#1)(2007-10#1)(2007-8#2)(2008-10#4)(2008-11#4)(2008-7#1)(2009-2#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-7#1)
the North Atlantic##3##3##(1992-5#1)(2007-8#1)(2010-8#1)
the North Carolina sample##3##4##(2008-10#3)
the North Central Cancer##2##4##(1992-8#1)(2008-7#1)
the North Central##3##3##(1991-1#1)(1992-8#1)(2008-7#1)
the North Fiji Basin##5##4##(2008-6#5)
the North Island of New Zealand##2##6##(2005-7#1)(2011-1#1)
the North London##2##3##(1991-3#1)(1994-12#1)
the North Pacific Ocean##2##4##(1995-8#2)
the North Pacific##6##3##(1995-8#4)(2008-5#2)
the North Sea##7##3##(1994-6#1)(2004-4#1)(2006-6#1)(2008-10#1)(2009-10#3)
the North West##3##3##(2007-11#1)(2012-11#1)(2012-12#1)
the North and Nicaraguan dialect##2##5##(2009-9#2)
the North and South##3##4##(1992-2#1)(1994-7#1)(2009-9#1)
the North and West##2##4##(2011-2#2)
the North and##9##3##(1992-2#1)(1994-7#1)(2009-9#3)(2011-1#1)(2011-2#2)(2013-7#1)
the North coast##2##3##(2011-2#2)
the North of##4##3##(1990-8#1)(2007-8#1)(2008-12#1)(2008-3#1)
the North to##2##3##(2010-12#1)(2011-2#1)
the North##95##2##(1990-12#1)(1990-8#1)(1991-1#1)(1991-3#1)(1992-2#4)(1992-5#3)(1992-8#1)(1993-1#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-7#2)(1995-2#1)(1995-8#4)(1996-5#2)(2004-4#1)(2005-7#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-8#5)(2008-10#9)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#5)(2008-7#2)(2008-9#1)(2009-10#3)(2009-2#1)(2009-9#3)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-11#1)(2012-12#1)(2012-2#1)(2013-7#3)
the North-East##5##2##(1991-4#1)(2007-2#3)(2007-7#1)
the North-West##2##2##(1995-5#1)(2011-2#1)
the Northeast##8##2##(1995-6#2)(2007-10#3)(2008-4#1)(2008-6#1)(2012-3#1)
the Northern Cape Province of South Africa and in Namibia##2##10##(2011-1#2)
the Northern Cape Province##4##4##(2011-1#4)
the Northern Chinese Han population##2##5##(2013-1#2)
the Northern Ireland##3##3##(1996-3#1)(2012-2#2)
the Northern Manhattan Stroke Study##2##5##(2006-2#1)(2007-10#1)
the Northern blot data##2##4##(2008-7#2)
the Northern blot##3##3##(2008-7#2)(2008-8#1)
the Northern parts of China##3##5##(2011-1#3)
the Northern parts of##4##4##(2011-1#4)
the Northern##54##2##(1992-2#1)(1993-10#1)(1993-6#1)(1994-9#1)(1995-1#1)(1996-12#1)(1996-3#2)(1996-9#1)(2006-2#1)(2007-1#1)(2007-10#2)(2007-5#1)(2007-8#2)(2008-1#5)(2008-10#4)(2008-12#2)(2008-5#2)(2008-7#3)(2008-8#3)(2010-6#1)(2011-1#8)(2011-2#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#4)
the Northwest##8##2##(1993-10#1)(2007-12#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-8#1)(2012-12#1)
the Northwestern##6##2##(1996-12#1)(2006-10#1)(2007-12#1)(2007-8#1)(2011-2#1)(2012-11#1)
the Norwegian Board of Health##2##5##(1996-6#1)(1997-8#1)
the Norwegian Gastrointestinal Cancer Group]##2##5##(1996-1#1)(1997-8#1)
the Norwegian Institute of Public Health##2##6##(2008-10#1)(2010-6#1)
the Norwegian Institute of##3##4##(1996-6#1)(2008-10#1)(2010-6#1)
the Norwegian Medical Association##5##4##(1990-6#2)(1994-2#1)(1995-4#1)(1997-6#1)
the Norwegian Medical##6##3##(1990-6#2)(1991-11#1)(1994-2#1)(1995-4#1)(1997-6#1)
the Norwegian Medicines Control Authority##2##5##(1990-4#1)(1997-5#1)
the Norwegian Mother and Child Cohort Study##2##7##(2010-6#2)
the Norwegian National Insurance##2##4##(1991-8#1)(1993-9#1)
the Norwegian Radium Hospital##7##4##(1991-2#1)(1993-10#1)(1993-9#2)(1995-4#1)(1996-4#2)
the Norwegian Society of##2##4##(1994-6#1)(1996-2#1)
the Norwegian population##4##3##(1990-6#2)(1992-11#1)(1996-3#1)
the Norwegian public##2##3##(1990-6#1)(1993-8#1)
the Norwegian##69##2##(1990-4#2)(1990-5#2)(1990-6#6)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-10#2)(1993-6#1)(1993-8#2)(1993-9#4)(1994-2#2)(1994-6#1)(1994-9#2)(1995-11#1)(1995-4#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#2)(1996-3#1)(1996-4#3)(1996-6#3)(1996-8#2)(1996-9#2)(1997-5#1)(1997-6#4)(1997-8#2)(2008-10#1)(2010-6#3)(2011-2#2)(2012-3#1)
the Notch pathway##7##3##(2010-3#1)(2012-12#6)
the Notch signaling pathway##2##4##(2007-12#2)
the Notch##12##2##(2007-12#2)(2008-1#1)(2010-3#2)(2012-12#7)
the Nototheniidae##2##2##(2012-12#2)
the Nottingham##7##2##(1991-3#1)(1993-7#1)(1994-5#1)(2004-10#2)(2007-9#1)(2008-9#1)
the Nova##3##2##(1996-1#1)(2008-1#1)(2008-5#1)
the NtrC protein##2##3##(1994-10#2)
the Nuclear##4##2##(2007-11#1)(2008-11#1)(2009-10#1)(2011-2#1)
the Nucleus 24 cochlear implant system##4##6##(2008-9#4)
the Nucleus 24 cochlear implant##5##5##(2008-9#5)
the Nucleus##13##2##(2008-9#9)(2012-2#4)
the Nuffield##2##2##(1996-11#1)(2008-2#1)
the Nugent test##2##3##(2013-1#2)
the Number of##4##3##(2008-10#1)(2010-3#1)(2012-12#2)
the Number##6##2##(1996-9#1)(2008-10#1)(2009-5#1)(2010-3#1)(2012-12#2)
the Nur77 family##3##3##(1994-12#3)
the Nuremberg##2##2##(2005-11#1)(2006-8#1)
the Nurse##3##2##(2008-6#1)(2009-8#2)
the Nurses'##2##2##(2007-10#1)(2009-7#1)
the Nursing Care Comfort Scale##2##5##(2008-11#2)
the Nursing Curriculum##2##3##(2008-11#1)(2012-2#1)
the Nursing Outcomes Classification##2##4##(2013-1#2)
the Nursing##17##2##(2008-11#6)(2008-12#1)(2009-4#2)(2010-10#2)(2011-2#1)(2012-2#1)(2013-1#4)
the Nutrition##2##2##(1995-1#1)(2011-1#1)
the Nyquist plot##2##3##(2008-10#2)
the Nyquist sampling##3##3##(2007-11#1)(2008-3#2)
the Nyquist##10##2##(2007-11#2)(2008-10#2)(2008-2#1)(2008-3#5)
the O RF mice##2##4##(1996-7#2)
the O antigen of##2##4##(1996-12#2)
the O atoms##2##3##(2006-5#1)(2008-10#1)
the O intermediate##5##3##(1994-11#1)(1997-4#4)
the O state##2##3##(1994-11#2)
the O##25##2##(1994-11#3)(1996-12#2)(1996-7#3)(1997-2#1)(1997-4#5)(2006-5#1)(2007-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2010-7#1)(2013-1#1)
the O'Brien##2##2##(1996-3#1)(1997-3#1)
the O(2) A-band absorption##2##4##(2008-2#2)
the O(2)##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
the O(2)-evolving##2##2##(2009-2#2)
the O(3)##4##2##(2008-3#4)
the O-H##3##2##(1995-10#1)(2008-3#1)(2009-10#1)
the O-SP##2##2##(1995-4#2)
the O-antigen##3##2##(1991-7#2)(1992-12#1)
the O-atom energy##2##3##(2010-4#2)
the O-buffer##2##2##(2008-6#2)
the O-linked glycans##2##3##(1994-9#2)
the O-linked##4##2##(1994-9#2)(1995-3#1)(2009-12#1)
the O-specific polysaccharide##3##3##(1990-3#1)(1995-4#1)(1996-10#1)
the O-specific##4##2##(1990-3#1)(1995-4#1)(1996-10#1)(1996-2#1)
the O-sulfo derivative of MK-447##2##5##(1991-8#2)
the O111 and O145##2##4##(2012-2#2)
the O2##6##2##(1997-4#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2013-8#1)
the O3##2##2##(1990-8#1)(1996-2#1)
the O3FA group##2##3##(2007-8#2)
the O45 antigen##2##3##(1995-11#2)
the O66##2##2##(1995-11#2)
the OAP system##3##3##(2008-11#3)
the OB gene##2##3##(2006-10#2)
the OB##6##2##(1991-9#1)(1992-8#1)(1996-5#1)(2006-10#2)(2012-2#1)
the OBCS Surveillance and Body Shame Scales were related to desired##2##11##(2007-12#2)
the OBCS##3##2##(2007-12#3)
the OC spectrum##2##3##(2008-1#2)
the OC##4##2##(1990-11#1)(2008-1#2)(2009-7#1)
the OCI##2##2##(2008-2#2)
the OCLC Online Union Catalog##2##5##(1991-12#2)
the OCN##3##2##(2010-2#3)
the OCS##2##2##(2008-5#2)
the OCT imaging depth at##3##5##(2011-1#3)
the OCT##14##2##(2007-12#3)(2008-3#3)(2009-4#1)(2011-1#4)(2011-7#2)(2013-1#1)
the OD##3##2##(2008-3#2)(2012-2#1)
the ODA molecules##2##3##(2005-11#2)
the ODA##4##2##(1995-12#1)(2005-11#3)
the ODC##3##2##(1991-12#2)(1993-8#1)
the ODNs##2##2##(1994-12#2)
the ODT##4##2##(2007-9#1)(2008-5#2)(2009-6#1)
the OEC##2##2##(2008-7#1)(2012-2#1)
the OECD##5##2##(1994-1#1)(2008-5#1)(2010-8#1)(2011-1#2)
the OEIS complex##2##3##(2008-10#2)
the OGTT##5##2##(2007-8#1)(2008-3#1)(2011-1#3)
the OH function##2##3##(2006-12#2)
the OH group of##3##4##(1991-6#1)(1993-11#1)(2008-8#1)
the OH group##5##3##(1991-6#1)(1993-11#1)(2006-12#1)(2008-10#1)(2008-8#1)
the OH stretching##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
the OH tag##2##3##(2008-3#2)
the OH##19##2##(1991-10#1)(1991-6#1)(1993-11#1)(2006-12#3)(2007-11#1)(2007-12#5)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)
the OH(-) group in##2##4##(2008-10#2)
the OH-group##2##2##(1990-4#1)(2005-11#1)
the OHP##3##2##(2010-6#3)
the OHS##2##2##(2012-12#2)
the OIE (World Organisation for Animal Health)##2##7##(2005-5#2)
the OIE (World##4##3##(2005-5#4)
the OIE and##2##3##(2005-5#1)(2011-2#1)
the OIE##17##2##(2005-5#8)(2011-2#9)
the OIG's##2##2##(2006-8#1)(2007-1#1)
the OIM##3##2##(2005-10#3)
the OLP##2##2##(1997-4#1)(2006-2#1)
the OLUC##2##2##(1991-12#2)
the OMIM database##3##3##(2008-4#2)(2008-9#1)
the ON##2##2##(1993-2#1)(2008-9#1)
the ONC SHARP Harvard project developing the SMArt platform (smartplaforms##2##10##(2013-1#2)
the ONL##2##2##(2010-1#2)
the OPA##4##2##(2007-12#1)(2008-2#3)
the OPC instrument##3##3##(2010-10#3)
the OPD##5##2##(2007-7#1)(2008-2#1)(2008-3#2)(2011-2#1)
the OPG##3##2##(2007-12#1)(2013-8#2)
the OPO cavity mirrors##2##4##(2008-2#1)(2008-3#1)
the OPO cavity##5##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)
the OPO generates##2##3##(2008-1#1)(2008-3#1)
the OPO has a##2##4##(2008-1#1)(2008-2#1)
the OPO##25##2##(2007-11#1)(2007-12#12)(2008-1#4)(2008-2#4)(2008-3#4)
the OPRM1##2##2##(2012-12#2)
the OR for##2##3##(1991-9#1)(2011-1#1)
the OR staff##2##3##(1994-3#1)(2007-5#1)
the OR was##2##3##(1991-4#1)(2011-2#1)
the OR##19##2##(1991-4#2)(1991-9#1)(1994-3#1)(1997-1#1)(2006-6#7)(2007-5#1)(2008-4#1)(2008-6#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
the ORA##5##2##(2008-2#3)(2008-3#2)
the ORC##2##2##(2007-12#1)(2007-8#1)
the ORF I##2##3##(2008-10#2)
the ORF was##2##3##(1997-4#1)(2008-8#1)
the ORF##10##2##(1990-11#1)(1990-4#1)(1994-12#1)(1995-2#1)(1997-4#1)(2008-10#2)(2008-7#1)(2008-8#2)
the ORF-36##2##2##(1990-11#2)
the ORF3 protein##2##3##(1997-4#2)
the ORFs##11##2##(1991-7#1)(1993-12#1)(1994-12#2)(1996-3#1)(1997-3#2)(1997-4#2)(2008-5#1)(2008-7#1)
the ORL-1 receptor##4##3##(2008-11#4)
the OS##4##2##(1991-8#1)(2006-1#1)(2008-10#1)(2008-6#1)
the OSC amplitude in##3##4##(2008-6#3)
the OSC amplitude##7##3##(2008-6#7)
the OSC##9##2##(2008-5#1)(2008-6#8)
the OSCE is##2##3##(2008-11#1)(2012-1#1)
the OSCE##6##2##(1994-2#1)(2006-10#1)(2008-11#3)(2012-1#1)
the OSCP##2##2##(1994-9#2)
the OSS##3##2##(2013-8#3)
the OTDR##2##2##(2007-12#1)(2008-3#1)
the OTF##2##2##(2007-12#1)(2008-3#1)
the OUR##2##2##(2008-11#2)
the OVA##3##2##(1991-2#1)(2005-10#1)(2008-11#1)
the OVA/IL12##3##2##(2008-11#3)
the OWM##2##2##(1997-4#1)(2013-1#1)
the OY phytoplasmas##2##3##(2008-10#2)
the Obligate Biotroph##2##3##(2008-10#2)
the Obligate##3##2##(2008-10#3)
the Occupational Safety and Health Administration (OSHA)##2##7##(1993-3#1)(2004-9#1)
the Occupational Safety and Health Administration##3##6##(1993-3#1)(1994-3#1)(2004-9#1)
the Occupational Safety and Health Administration's (OSHA)##2##7##(1991-11#1)(2006-8#1)
the Occupational Safety and Health##6##5##(1991-11#1)(1993-12#1)(1993-3#1)(1994-3#1)(2004-9#1)(2006-8#1)
the Occupational##8##2##(1991-11#1)(1993-12#1)(1993-3#2)(1994-3#1)(2004-9#1)(2006-8#1)(2013-7#1)
the Oct and##2##3##(1991-12#2)
the October##2##2##(2005-7#1)(2008-8#1)
the Odin##2##2##(2008-3#2)
the Odontella gamma subunit##2##4##(1993-3#2)
the Office of Inspector General##2##5##(1991-12#1)(1993-12#1)
the Office of the National Coordinator for Health Information Technology sponsored a project to address safety concerns in electronic health record-enabled (EHR) healthcare systems##2##24##(2013-1#2)
the Office of the National Coordinator for Health Information Technology##4##10##(2013-1#4)
the Office of the##6##4##(2006-8#1)(2008-1#1)(2013-1#4)
the Office of##10##3##(1991-1#1)(1991-12#1)(1993-12#1)(2006-8#1)(2008-1#1)(2008-2#1)(2013-1#4)
the Office##12##2##(1991-1#1)(1991-12#1)(1993-12#1)(2006-8#1)(2007-6#1)(2008-1#1)(2008-2#1)(2008-7#1)(2013-1#4)
the Offord##2##2##(1996-5#2)
the Ohio##2##2##(1997-5#1)(2008-10#1)
the Oka strain##2##3##(2007-11#1)(2008-4#1)
the Oka##3##2##(2007-11#2)(2008-4#1)
the Okavango Delta##3##3##(2008-10#3)
the Oklahoma##4##2##(1994-3#1)(1995-12#1)(2008-10#1)(2011-1#1)
the Old Bad Pfäfers##2##4##(1994-3#2)
the Old World Sciurus##3##4##(2008-5#3)
the Old World monkey and great ape lineages##2##8##(1990-11#2)
the Old World monkeys##2##4##(1995-11#1)(2008-8#1)
the Old World##8##3##(1990-11#2)(1995-11#1)(2008-5#4)(2008-8#1)
the Old##17##2##(1990-11#2)(1994-3#2)(1995-11#1)(1995-4#1)(2008-10#2)(2008-12#1)(2008-5#4)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
the Olympus##4##2##(1992-6#4)
the OmniLog(TM) system##3##3##(2013-1#3)
the Omnibus Budget Reconciliation Act (OBRA) of 1990##2##8##(1991-12#1)(1997-3#1)
the Omnibus Budget Reconciliation Act (OBRA) of##3##7##(1991-12#1)(1994-3#1)(1997-3#1)
the Omnibus Budget Reconciliation Act of##2##6##(1994-1#1)(1996-3#1)
the Omnibus Budget Reconciliation Act##5##5##(1991-12#1)(1994-1#1)(1994-3#1)(1996-3#1)(1997-3#1)
the Omnibus Budget Reconciliation##6##4##(1991-12#1)(1994-1#1)(1994-12#1)(1994-3#1)(1996-3#1)(1997-3#1)
the Omnibus##7##2##(1991-1#1)(1991-12#1)(1994-1#1)(1994-12#1)(1994-3#1)(1996-3#1)(1997-3#1)
the On-X##2##2##(2007-8#2)
the Oncomelania##2##2##(2012-3#1)(2013-7#1)
the Oncoshare##4##2##(2013-1#4)
the Ontario Hospital Association##2##4##(1991-2#1)(1994-3#1)
the Ontario Hospital##3##3##(1991-2#1)(1994-3#1)(2007-7#1)
the Ontario Ministry of Health and##2##6##(1991-2#1)(2011-2#1)
the Ontario Ministry of Health##4##5##(1991-2#2)(1994-1#1)(2011-2#1)
the Ontario Ministry of##5##4##(1991-2#2)(1994-1#1)(1995-3#1)(2011-2#1)
the Ontario Superior Court of Justice##2##6##(2010-12#2)
the Ontario##20##2##(1991-2#6)(1993-3#1)(1994-1#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-1#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-6#1)(2010-12#2)(2011-2#1)
the Ontology of Clinical Research (OCRe) provides the reference semantics##2##10##(2013-1#2)
the Ontology of Clinical Research (OCRe)##4##6##(2013-1#4)
the Open##3##2##(2007-4#1)(2008-7#1)(2013-8#1)
the Operating Room##2##3##(2012-3#1)(2013-1#1)
the Opposite Sex##2##3##(2007-12#1)(2010-2#1)
the Optical Properties of##2##4##(2008-2#1)(2008-3#1)
the Optical Properties##3##3##(2008-2#1)(2008-3#2)
the Optical Society of America##5##5##(2008-2#2)(2008-3#3)
the Optical##14##2##(2008-2#8)(2008-3#6)
the Optimal##5##2##(2007-2#1)(2008-4#1)(2008-6#1)(2012-2#1)(2013-7#1)
the Oral##4##2##(2006-8#1)(2007-8#1)(2011-2#1)(2013-1#1)
the Orchidaceae##2##2##(1997-4#1)(2012-2#1)
the Order of##2##3##(2008-3#1)(2012-12#1)
the Order##3##2##(2008-3#1)(2010-1#1)(2012-12#1)
the Orders##2##2##(2010-8#1)(2011-2#1)
the Oregon Coast Range##3##4##(2008-10#3)
the Oregon coast##2##3##(2008-10#2)
the Oregon experience##2##3##(2005-10#1)(2007-9#1)
the Oregon##13##2##(1992-2#1)(1993-1#1)(1995-1#1)(1996-1#1)(2005-10#1)(2007-9#1)(2008-10#5)(2008-12#2)
the Organization for Economic Cooperation and Development (OECD)##2##8##(1993-2#1)(1993-3#1)
the Organization for Economic Cooperation and Development countries##2##8##(1993-3#1)(1994-1#1)
the Organization for Economic Cooperation and Development##4##7##(1993-2#1)(1993-3#2)(1994-1#1)
the Organization##5##2##(1993-2#1)(1993-3#2)(1994-1#1)(1996-11#1)
the Origin of##5##3##(1996-11#2)(1996-5#1)(2008-10#1)(2010-5#1)
the Oromia##2##2##(2008-8#1)(2011-2#1)
the Orsay Museum##2##3##(2006-10#2)
the OrthoPilot##2##2##(2007-8#2)
the Orthopedic Clinic##4##3##(2007-11#1)(2007-7#1)(2007-8#2)
the Orthopedic Department of the##2##5##(1993-8#1)(1997-6#1)
the Orthopedic and Traumatology Department##2##5##(2007-11#1)(2007-7#1)
the Orthopedic and Traumatology##3##4##(2007-11#2)(2007-7#1)
the Orthopedic##11##2##(1993-8#1)(1997-6#1)(2007-11#3)(2007-7#4)(2007-8#2)
the Orthopedics and Traumatology Clinic in##2##6##(2007-7#2)
the Orthopedics and Traumatology##5##4##(2007-7#3)(2007-8#2)
the Orthopedics and##7##3##(2007-7#3)(2007-8#3)(2013-1#1)
the Orthopedics##10##2##(2007-11#1)(2007-7#4)(2007-8#4)(2013-1#1)
the Ortigas river##2##3##(2008-10#2)
the Oryza##3##2##(2007-3#1)(2008-10#2)
the OsMADS genes##2##3##(1997-8#2)
the Oslo area##3##3##(1990-2#1)(1990-5#1)(1992-6#1)
the Oslo##4##2##(1990-2#1)(1990-5#2)(1992-6#1)
the Ostwald ripening mechanism##2##4##(2010-4#2)
the Oswestry Disability##2##3##(2007-8#1)(2012-12#1)
the Oswestry Low Back Pain Disability Questionnaire##2##7##(2006-8#2)
the Oswestry Low Back Pain Disability##3##6##(2006-8#2)(2007-8#1)
the Oswestry scale##2##3##(2007-11#2)
the Oswestry##8##2##(2006-8#2)(2007-11#2)(2007-8#3)(2012-12#1)
the Ottoman##2##2##(2008-11#1)(2011-2#1)
the Outcome of##2##3##(2008-11#1)(2011-2#1)
the Overton Prize winner##2##4##(2008-7#2)
the Ox-LDL##2##2##(1991-8#2)
the Oxford Colposcopy Clinic##2##4##(1994-2#2)
the Oxford Colposcopy##3##3##(1994-2#2)(2004-10#1)
the Oxford##6##2##(1993-7#1)(1994-2#2)(2004-10#1)(2007-10#1)(2008-2#1)
the Oxfordshire Community Stroke Project##2##5##(2007-9#2)
the Oxfordshire Community Stroke##3##4##(2007-10#1)(2007-9#2)
the P = O##2##4##(1990-2#2)
the P absorption band##2##4##(1993-11#2)
the P and L types##2##5##(1996-11#2)
the P and##3##3##(1996-11#2)(2008-12#1)
the P site of##2##4##(1993-11#2)
the P site##5##3##(1990-5#1)(1993-11#2)(2006-11#2)
the P##91##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-9#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-7#1)(1993-11#5)(1993-9#2)(1994-8#1)(1994-9#2)(1995-2#1)(1995-6#1)(1995-7#1)(1996-10#2)(1996-11#2)(1996-4#1)(1996-7#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#1)(2006-11#2)(2006-3#1)(2006-8#1)(2007-3#1)(2007-6#1)(2008-10#27)(2008-12#1)(2008-3#1)(2008-5#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#6)(2012-1#4)(2013-1#2)(2013-8#2)
the P(1)(2)##2##2##(2008-3#2)
the P(33) 6-3 transition##2##4##(2008-3#2)
the P(33) 6-3##3##3##(2008-3#3)
the P-R interval##4##3##(1994-5#2)(1994-6#2)
the P-SOM##2##2##(2008-2#2)
the P-T-Q index##2##3##(1994-6#2)
the P-glycoprotein efflux transporter##2##4##(1996-8#1)(2012-12#1)
the P-glycoprotein of A2-1 cells##2##5##(1995-11#2)
the P-glycoprotein##11##2##(1992-12#1)(1994-11#1)(1995-11#2)(1995-6#1)(1996-8#1)(2008-11#4)(2012-12#1)
the P-gp##2##2##(1995-10#1)(1996-1#1)
the P-laminae##2##2##(1995-11#2)
the P-region##5##2##(1994-8#4)(2006-10#1)
the P-selectin##2##2##(1993-3#2)
the P-site##3##2##(1990-2#1)(1992-8#1)(2006-12#1)
the P1 and P2##2##4##(1991-4#2)
the P1 and##3##3##(1991-4#2)(2008-10#1)
the P1 helix##2##3##(1995-6#2)
the P1 position##6##3##(1990-7#2)(1991-1#1)(1994-5#2)(1995-1#1)
the P1 residue##2##3##(1994-6#1)(1995-5#1)
the P1##29##2##(1990-10#1)(1990-7#2)(1991-1#1)(1991-4#3)(1993-11#1)(1993-12#2)(1994-3#1)(1994-5#2)(1994-6#1)(1995-1#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-2#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-8#1)(2008-9#1)(2011-1#1)
the P1' side chain##2##4##(1992-8#1)(1997-4#1)
the P1' site##2##3##(1990-10#2)
the P1'##6##2##(1990-10#2)(1991-6#1)(1992-8#1)(1997-4#2)
the P11##3##2##(2008-2#2)(2008-3#1)
the P2 Tin protein##2##4##(1997-3#2)
the P2 and##2##3##(1990-11#1)(1997-4#1)
the P2 promoter##2##3##(1993-12#1)(1995-6#1)
the P2 protein##2##3##(1995-12#1)(1995-2#1)
the P2##14##2##(1990-11#1)(1990-8#1)(1993-12#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#3)(1997-3#2)(1997-4#1)(2008-2#1)(2008-4#1)
the P2'##4##2##(1990-10#1)(1992-11#2)(1995-1#1)
the P2000##2##2##(2008-3#2)
the P2X(7)R##3##2##(2008-4#3)
the P2Y##3##2##(1995-11#1)(2008-4#2)
the P2Y(1) receptor##8##3##(2008-4#7)(2008-7#1)
the P2Y(12)##3##2##(2008-4#3)
the P2Y(2) receptor##2##3##(2008-4#2)
the P2Y(4) receptor##2##3##(2008-4#2)
the P2Y(4)##3##2##(2008-4#3)
the P3##6##2##(1994-5#2)(1997-1#1)(2004-11#1)(2008-10#2)
the P300##3##2##(1997-8#2)(2008-11#1)
the P3HT/PCBM##5##2##(2010-4#5)
the P4 and WOMAC##2##4##(2010-9#2)
the P4 and##3##3##(2010-9#3)
the P4##9##2##(1990-11#1)(1993-5#1)(1993-6#1)(2010-9#6)
the P450##8##2##(1990-12#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(2009-9#2)
the P815##2##2##(2008-4#2)
the PA method##3##3##(2012-2#3)
the PA##9##2##(1990-11#1)(2007-11#1)(2008-5#1)(2009-11#1)(2009-6#1)(2012-2#4)
the PAA##4##2##(2005-10#2)(2008-10#2)
the PAAFS##3##2##(2007-12#3)
the PAC to##2##3##(1996-6#1)(2008-10#1)
the PAC##5##2##(1995-5#1)(1996-6#3)(2008-10#1)
the PACE##4##2##(1992-1#1)(2008-7#3)
the PACS##4##2##(2004-9#4)
the PACU and##2##3##(2006-8#1)(2012-2#1)
the PACU##6##2##(1994-2#1)(2006-8#4)(2012-2#1)
the PAD and##2##3##(2008-10#2)
the PAD##4##2##(1990-5#1)(2008-10#3)
the PADT##3##2##(2007-2#3)
the PAF receptor##3##3##(1996-2#3)
the PAF##4##2##(1991-8#1)(1996-2#3)
the PAG##6##2##(1991-3#1)(1994-6#4)(1997-5#1)
the PAH##5##2##(1996-3#1)(2008-10#2)(2010-10#1)(2010-5#1)
the PAHs##4##2##(1997-5#1)(2008-10#3)
the PAI##3##2##(1995-2#1)(2008-10#2)
the PAI-1 binding##3##3##(1996-5#3)
the PAI-1##4##2##(1996-5#3)(2007-9#1)
the PAL##3##2##(2006-12#2)(2010-4#1)
the PAM process##4##3##(2008-7#4)
the PAM##5##2##(2008-7#4)(2008-9#1)
the PANAS##4##2##(2013-8#4)
the PANI film##3##3##(2008-10#3)
the PANI##5##2##(2005-11#1)(2008-10#4)
the PANSS##2##2##(2008-12#1)(2008-6#1)
the PAP system##3##3##(2008-11#3)
the PAP##8##2##(1992-8#1)(2008-11#6)(2008-2#1)
the PAR##3##2##(2007-12#1)(2008-10#1)(2012-12#1)
the PAR1 region##2##3##(2008-7#2)
the PARI IS-2##2##3##(1995-3#2)
the PARP##2##2##(1993-12#1)(2010-6#1)
the PART and##2##3##(1996-3#2)
the PAS##4##2##(1995-11#1)(2007-12#3)
the PAT##2##2##(1996-3#2)
the PAV##2##2##(2008-10#2)
the PAX8 gene##2##3##(2010-11#2)
the PB film##2##3##(2008-10#2)
the PB layer##4##3##(2008-10#4)
the PB modified##2##3##(2008-10#2)
the PB##13##2##(1997-2#1)(2005-11#2)(2008-10#10)
the PB/HC-OES method and##2##4##(2010-11#2)
the PBAN gene##3##3##(1992-11#3)
the PBC and##2##3##(1992-6#1)(1992-8#1)
the PBC##5##2##(1992-6#4)(1992-8#1)
the PBL##6##2##(2008-10#1)(2008-12#1)(2008-5#1)(2013-8#3)
the PBMC of##2##3##(1991-10#1)(2009-9#1)
the PBMC##4##2##(1991-10#1)(2008-7#1)(2009-9#1)(2010-12#1)
the PBN##3##2##(1992-10#1)(2009-10#2)
the PBS##3##2##(2008-11#1)(2008-2#1)(2010-1#1)
the PC diet compared with##2##5##(2010-2#2)
the PC diet##4##3##(2010-2#4)
the PC##17##2##(1993-8#2)(1996-12#1)(1997-1#1)(2006-10#2)(2007-12#3)(2007-2#1)(2008-10#1)(2010-2#5)(2012-2#1)
the PC/TD system##3##3##(2008-10#3)
the PC12 cells##3##3##(1992-12#2)(2008-11#1)
the PC12##8##2##(1992-12#2)(1994-10#1)(1995-12#1)(1997-6#3)(2008-11#1)
the PCA##5##2##(2007-9#2)(2008-10#1)(2011-1#1)(2013-8#1)
the PCA-BP neural network##2##4##(2013-8#2)
the PCB##4##2##(2007-5#1)(2008-10#2)(2011-12#1)
the PCBI##2##2##(2011-2#2)
the PCD##4##2##(2009-8#4)
the PCDD/Fs##2##2##(2008-10#2)
the PCEA group##2##3##(1993-4#2)
the PCF##2##2##(2007-11#2)
the PCI##3##2##(1991-4#1)(2008-3#2)
the PCL##4##2##(2007-1#4)
the PCNA gene##2##3##(1995-6#2)
the PCNA promoter##6##3##(1994-8#4)(1997-4#2)
the PCNA##9##2##(1994-7#1)(1994-8#4)(1995-6#2)(1997-4#2)
the PCOS##8##2##(2010-10#1)(2010-4#1)(2011-1#4)(2011-2#1)(2013-1#1)
the PCR amplification##2##3##(2005-11#1)(2012-12#1)
the PCR and##3##3##(2008-10#1)(2008-4#2)
the PCR assay##4##3##(2005-9#1)(2008-10#2)(2008-5#1)
the PCR assays##2##3##(2008-10#1)(2010-10#1)
the PCR product was##3##4##(1994-2#1)(2005-11#1)(2006-5#1)
the PCR product##6##3##(1994-12#1)(1994-2#1)(2005-11#1)(2006-5#1)(2008-10#1)(2008-9#1)
the PCR products were##2##4##(2006-8#1)(2008-10#1)
the PCR products##10##3##(1990-11#1)(1992-8#1)(1992-9#1)(1995-2#1)(1996-6#1)(2004-11#1)(2006-8#1)(2008-10#3)
the PCR protocol##2##3##(1997-6#1)(2013-1#1)
the PCR reaction##2##3##(1994-11#1)(2008-8#1)
the PCR technique##5##3##(1992-11#1)(1992-9#1)(2006-10#1)(2008-5#1)(2012-12#1)
the PCR test##3##3##(2008-5#3)
the PCR##72##2##(1990-11#1)(1990-2#1)(1991-5#1)(1992-11#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-8#1)(1995-2#2)(1995-6#1)(1996-4#1)(1996-6#1)(1997-6#2)(2004-11#2)(2005-11#3)(2005-9#1)(2006-10#1)(2006-5#1)(2006-8#2)(2007-8#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#9)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#2)(2012-12#4)(2012-3#1)(2013-1#2)
the PCR-S##2##2##(1997-7#2)
the PCR-amplified##4##2##(1993-11#1)(1994-11#1)(2008-10#2)
the PCR-based##5##2##(1993-3#1)(1996-7#1)(2008-10#2)(2008-5#1)
the PCS and SCS##5##4##(2008-7#5)
the PCS and##6##3##(2008-7#6)
the PCS##7##2##(1995-5#1)(2008-7#6)
the PCT group##10##3##(2007-7#10)
the PCT##12##2##(2007-11#1)(2007-7#10)(2010-12#1)
the PCV7##2##2##(2012-12#2)
the PD and##2##3##(2012-3#1)(2013-1#1)
the PD patients##5##3##(2007-8#1)(2008-7#4)
the PD##22##2##(2004-9#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#6)(2011-2#4)(2012-1#1)(2012-3#1)(2013-1#3)
the PD-score##2##2##(2010-8#2)
the PDA##10##2##(2006-1#1)(2007-12#1)(2008-10#3)(2008-12#2)(2012-12#2)(2012-2#1)
the PDB##7##2##(2008-4#2)(2008-7#3)(2011-3#2)
the PDC test##2##3##(2007-8#2)
the PDC##4##2##(2007-7#2)(2007-8#2)
the PDC1##2##2##(1990-3#1)(2008-6#1)
the PDE IV##2##3##(1993-7#1)(2008-3#1)
the PDE gamma##2##3##(1991-12#1)(1992-6#1)
the PDE##6##2##(1990-2#2)(1991-12#1)(1992-6#1)(1993-7#1)(2008-3#1)
the PDF1##3##2##(2009-6#2)(2009-8#1)
the PDFE##3##2##(2008-2#3)
the PDGF alpha-receptor##2##3##(1995-3#2)
the PDGF beta-receptor##2##3##(1990-3#1)(1995-3#1)
the PDGF receptor##5##3##(1996-6#1)(1996-8#4)
the PDGF##14##2##(1990-3#1)(1991-10#1)(1992-9#1)(1994-6#2)(1995-2#1)(1995-3#3)(1996-6#1)(1996-8#4)
the PDGF-B##2##2##(1996-10#2)
the PDH complex##2##3##(2010-2#2)
the PDH##3##2##(1994-11#1)(2010-2#2)
the PDI##3##2##(2012-12#2)(2013-1#1)
the PDL##5##2##(2004-3#1)(2008-11#3)(2008-3#1)
the PDLC##3##2##(2008-2#1)(2008-3#2)
the PDLLA##2##2##(2008-5#2)
the PDMS##7##2##(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-2#1)(2010-4#1)(2010-8#1)
the PDR##2##2##(2004-12#1)(2008-11#1)
the PDS##4##2##(2008-2#1)(2011-1#2)(2012-12#1)
the PDSI##2##2##(2008-7#2)
the PDT group##4##3##(2008-5#4)
the PDT##8##2##(1994-1#1)(2008-3#1)(2008-5#6)
the PDTS##3##2##(2005-11#3)
the PDZ##2##2##(2008-7#1)(2008-8#1)
the PDZ-binding domain##2##3##(2011-2#2)
the PE##5##2##(1991-1#1)(1994-3#1)(2006-5#1)(2008-3#2)
the PE50 tubing##4##3##(2008-11#4)
the PE50##5##2##(2008-11#5)
the PECs##2##2##(1996-11#2)
the PEEK component in##2##4##(2004-9#2)
the PEEK##5##2##(2004-9#3)(2008-10#1)(2010-4#1)
the PEG hydrogel group##3##4##(2012-3#3)
the PEG hydrogel##4##3##(2012-3#4)
the PEG##13##2##(1994-9#3)(2005-11#1)(2008-11#1)(2008-3#1)(2008-4#1)(2012-1#2)(2012-3#4)
the PEI##3##2##(1992-11#1)(1996-11#1)(2008-11#1)
the PEMA cement reinforced with silanated HA##2##7##(2004-9#2)
the PEMA cements##2##3##(2004-9#2)
the PEMA##4##2##(2004-9#4)
the PEMS##2##2##(2009-5#2)
the PENTAX##2##2##(2008-5#2)
the PEO##2##2##(1997-1#1)(2008-5#1)
the PEP##5##2##(1994-11#1)(1997-3#1)(2009-12#3)
the PEPCK gene##4##3##(1993-3#1)(1994-8#1)(1995-6#1)(1996-2#1)
the PEPCK promoter##2##3##(1995-6#2)
the PEPCK##6##2##(1993-3#1)(1994-8#1)(1995-6#3)(1996-2#1)
the PET and CT##2##4##(2012-12#1)(2012-2#1)
the PET##9##2##(1992-10#1)(2010-3#1)(2011-2#2)(2012-12#3)(2012-2#2)
the PF contact##2##3##(2007-1#1)(2011-2#1)
the PF-LIF signal##2##3##(2008-2#2)
the PFA##4##2##(2010-7#1)(2011-2#3)
the PFC of##3##3##(1997-2#3)
the PFC##16##2##(1996-5#2)(1997-2#7)(2008-4#1)(2008-7#1)(2013-8#5)
the PFGE##2##2##(1992-6#1)(2006-10#1)
the PFH model##2##3##(1992-12#2)
the PFH##5##2##(1992-12#3)(1993-2#2)
the PFK##2##2##(1995-5#1)(1996-3#1)
the PFO##2##2##(1996-6#1)(2011-2#1)
the PG##13##2##(1990-2#3)(2004-1#2)(2007-12#1)(2007-8#4)(2008-10#1)(2008-8#1)(2011-2#1)
the PGC column##2##3##(1996-5#1)(2008-10#1)
the PGE(2)##2##2##(2010-9#2)
the PGE2 release##2##3##(1996-8#2)
the PGE2##5##2##(1992-1#2)(1996-8#3)
the PGF2alpha##3##2##(1997-7#3)
the PGHS##3##2##(1997-1#3)
the PGIS##2##2##(1994-8#2)
the PGs##4##2##(1990-2#2)(2012-2#2)
the PH##9##2##(1993-2#3)(1994-8#1)(1995-1#1)(1996-3#2)(2008-3#1)(2013-8#1)
the PHC##5##2##(2008-1#1)(2010-11#2)(2011-2#1)(2013-1#1)
the PHCs##2##2##(1994-3#2)
the PHRAP##2##2##(2008-4#2)
the PHTS has##2##3##(2008-4#2)
the PHTS##4##2##(2008-4#4)
the PI pathway##2##3##(2008-8#2)
the PI##16##2##(1990-10#1)(1990-11#1)(1992-1#1)(1992-6#1)(1994-11#1)(1994-4#1)(1994-9#2)(1996-2#1)(2008-8#2)(2009-3#3)(2011-2#1)(2012-2#1)
the PI3-K-PKB-mTOR signalling pathway##2##4##(2009-7#2)
the PI3K pathway##3##3##(2010-9#2)(2012-1#1)
the PI3K##6##2##(2009-4#1)(2010-9#2)(2012-1#1)(2012-3#1)(2013-7#1)
the PI3K/Akt pathway##3##3##(2009-9#1)(2010-11#1)(2013-7#1)
the PI3K/Akt signaling pathway##2##4##(2013-7#1)(2013-8#1)
the PI3K/Akt##6##2##(2009-9#1)(2010-11#1)(2013-7#2)(2013-8#2)
the PICA##2##2##(2007-9#1)(2008-7#1)
the PICC##2##2##(2009-4#2)
the PIG1 locus##2##3##(2008-10#2)
the PIHCP##3##2##(2008-1#3)
the PILP approach##2##3##(2009-11#2)
the PILP models learned from##2##5##(2009-11#2)
the PILP##4##2##(2009-11#4)
the PINPPO1##2##2##(2006-12#2)
the PIP2##2##2##(1990-3#1)(1991-3#1)
the PIR##4##2##(1997-2#1)(2008-3#2)(2008-5#1)
the PISHG##3##2##(2008-3#3)
the PK##5##2##(2010-11#1)(2011-2#1)(2013-1#3)
the PKA inhibitor Rp-8-Cl-cAMPS##2##4##(1996-9#2)
the PKA inhibitor##5##3##(1993-3#1)(1993-6#1)(1996-9#2)(2011-12#1)
the PKA##8##2##(1993-3#1)(1993-6#1)(1993-7#1)(1996-8#1)(1996-9#3)(2011-12#1)
the PKC activator##4##3##(1994-12#1)(1994-2#1)(1996-11#2)
the PKC epsilon##2##3##(1994-9#1)(1995-2#1)
the PKC inhibitor staurosporine##2##4##(1993-3#1)(1994-12#1)
the PKC inhibitor##7##3##(1992-6#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-3#1)(2008-4#1)(2011-12#1)
the PKC inhibitors##3##3##(1993-6#1)(1995-5#1)(1996-8#1)
the PKC isoforms in##2##4##(1995-5#1)(1996-5#1)
the PKC isozymes##2##3##(1995-2#1)(1996-8#1)
the PKC stimulation##2##3##(1994-2#2)
the PKC##36##2##(1990-12#1)(1990-6#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-2#4)(1994-8#1)(1994-9#3)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-11#2)(1996-5#2)(1996-8#2)(1997-6#1)(2008-4#1)(2011-12#1)(2012-2#2)
the PKC- and/or cAMP-dependent##2##4##(1997-2#2)
the PKC-mediated##2##2##(1990-11#1)(1995-5#1)
the PKD1 domain##3##3##(2013-8#3)
the PKI##2##2##(1995-2#1)(1996-3#1)
the PL##8##2##(1993-8#1)(1994-3#3)(2004-11#1)(2007-8#1)(2007-9#1)(2008-7#1)
the PL-free diet group##3##4##(2008-7#3)
the PLA2##4##2##(1992-2#1)(1993-12#1)(1996-8#1)(1996-9#1)
the PLC##4##2##(1992-12#1)(2008-4#1)(2009-3#2)
the PLGA##2##2##(2010-1#1)(2012-2#1)
the PLH##2##2##(1994-12#1)(2008-10#1)
the PLL is##2##3##(2008-10#2)
the PLLA##3##2##(2008-6#1)(2009-7#2)
the PLNA##3##2##(2008-10#3)
the PLP##2##2##(1992-6#2)
the PLS and##2##3##(2007-8#1)(2008-10#1)
the PLS method##2##3##(2008-10#1)(2013-8#1)
the PLS model##2##3##(2008-10#2)
the PLS models##3##3##(2008-10#2)(2011-1#1)
the PLS##14##2##(2007-11#1)(2007-8#2)(2008-10#7)(2008-5#1)(2011-1#2)(2013-8#1)
the PLTP##2##2##(1997-4#2)
the PLWHA##4##2##(2007-12#1)(2012-12#3)
the PM and##2##3##(2008-10#1)(2008-7#1)
the PM##15##2##(1995-12#1)(2008-10#3)(2008-7#7)(2009-10#1)(2010-2#2)(2012-2#1)
the PM(2##3##2##(2008-5#3)
the PM3##2##2##(1996-7#1)(2007-11#1)
the PMA##3##2##(1993-6#1)(1995-8#1)(2005-11#1)
the PMC##4##2##(1995-10#3)(2008-5#1)
the PMD parameter##2##3##(2007-11#2)
the PMD##7##2##(2007-11#5)(2007-12#1)(2008-3#1)
the PMDF##2##2##(2008-3#2)
the PMG##4##2##(2008-1#4)
the PMI##3##2##(2006-1#1)(2011-1#2)
the PML gene##2##3##(1991-11#1)(2012-2#1)
the PML##4##2##(1991-11#1)(2008-3#2)(2012-2#1)
the PMMA##4##2##(2004-9#1)(2007-11#1)(2008-2#1)(2009-11#1)
the PMMV-k##2##2##(1997-6#2)
the PMP22##2##2##(1997-3#2)
the PMT model##2##3##(2010-3#2)
the PMT##9##2##(2008-10#3)(2008-3#2)(2008-5#1)(2010-3#3)
the PNDC##3##2##(2008-11#3)
the PNN##3##2##(2010-8#3)
the PNS##5##2##(1990-7#2)(2006-1#1)(2008-7#2)
the PNW were##2##3##(2008-10#2)
the PNW##3##2##(2008-10#3)
the PO2##5##2##(1996-9#1)(2007-8#1)(2013-8#3)
the POA neurons in##2##4##(2008-8#2)
the POA neurons##3##3##(2008-8#3)
the POA##5##2##(1995-10#1)(1997-3#1)(2008-8#3)
the POAG##4##2##(2012-2#2)(2013-8#2)
the POF##3##2##(2008-3#3)
the POM complex##2##3##(2010-5#2)
the POM##8##2##(1990-5#3)(1995-2#1)(2010-5#2)(2010-6#2)
the POMC##2##2##(1993-12#1)(1993-5#1)
the POR##2##2##(1993-1#1)(1995-5#1)
the POU domain##3##3##(1992-6#2)(1996-5#1)
the POU##6##2##(1992-6#2)(1996-5#1)(1997-1#1)(1997-7#2)
the POUSE method##2##3##(2011-12#2)
the POUSE##3##2##(2011-12#3)
the POX##2##2##(1997-4#2)
the PP RTA##2##3##(2007-12#2)
the PP##6##2##(1990-8#1)(1993-7#1)(1995-2#1)(2007-12#2)(2008-10#1)
the PP-fold family of##3##4##(1993-3#3)
the PP-fold##4##2##(1993-3#4)
the PP1 activity##3##3##(1996-2#1)(1997-6#2)
the PP1##5##2##(1993-7#1)(1996-2#1)(1997-6#2)(2012-12#1)
the PPA/HP-beta-CD##2##2##(2008-10#2)
the PPCC##2##2##(2011-1#2)
the PPD##2##2##(1992-10#1)(2008-5#1)
the PPED##2##2##(2008-2#2)
the PPG##2##2##(1996-8#2)
the PPI mRNA level and##2##5##(1994-2#2)
the PPI paradigm##2##3##(2008-4#2)
the PPI##6##2##(1994-2#2)(1996-5#1)(2008-4#2)(2012-2#1)
the PPLN crystal##3##3##(2007-12#3)
the PPLN##5##2##(2007-12#5)
the PPN##3##2##(2008-11#2)(2008-7#1)
the PPO##2##2##(1996-12#1)(2005-11#1)
the PPP##2##2##(2008-7#2)
the PPS##4##2##(1992-12#1)(2008-2#3)
the PPSDHM##2##2##(2011-1#2)
the PPT##4##2##(1992-1#2)(2009-5#2)
the PPTg is##2##3##(1994-10#2)
the PPTg##7##2##(1994-10#3)(1994-2#3)(1995-12#1)
the PPy##2##2##(2008-10#2)
the PR##9##2##(1991-2#2)(1993-11#2)(1994-9#1)(1996-5#1)(2008-10#2)(2010-1#1)
the PRBS##2##2##(1996-4#1)(2008-2#1)
the PRDII domain##4##3##(1990-3#4)
the PRL profile##2##3##(2008-7#2)
the PRL##6##2##(1990-11#1)(2008-10#1)(2008-7#4)
the PRN##3##2##(1997-6#1)(2006-4#1)(2007-3#1)
the PROM TEST##2##3##(1996-9#2)
the PROT protein##2##3##(1995-6#2)
the PRP##2##2##(1991-2#1)(2007-9#1)
the PRRS##2##2##(2008-3#2)
the PRS3 gene##2##3##(1992-1#2)
the PRS3##3##2##(1992-1#3)
the PS II reaction center##2##5##(1994-8#1)(1997-6#1)
the PS II##3##3##(1994-8#2)(1997-6#1)
the PS and##2##3##(2007-9#1)(2008-1#1)
the PS sphere##4##3##(2010-4#4)
the PS##21##2##(1993-2#3)(1994-8#2)(1997-5#2)(1997-6#1)(2006-10#1)(2007-1#1)(2007-9#1)(2008-1#2)(2008-10#3)(2009-2#1)(2010-4#4)
the PS-1 gene##4##3##(1995-12#1)(1997-1#1)(1997-5#2)
the PS-1##6##2##(1995-12#1)(1997-1#2)(1997-5#3)
the PS-binding site##2##3##(1991-12#2)
the PSA density##2##3##(2009-2#2)
the PSA##8##2##(2006-9#1)(2008-3#1)(2008-4#1)(2009-2#2)(2009-5#1)(2009-6#1)(2011-1#1)
the PSC##8##2##(1997-2#4)(2010-10#4)
the PSC(R)A##2##2##(2008-2#2)
the PSD in##2##3##(1996-12#1)(2008-2#1)
the PSD is consistent with##2##5##(1996-12#1)(2008-4#1)
the PSD##16##2##(1996-12#4)(1997-2#1)(2005-11#1)(2008-2#2)(2008-3#3)(2008-4#5)
the PSG##2##2##(1990-5#1)(2008-3#1)
the PSI##3##2##(2008-5#1)(2008-7#1)(2008-8#1)
the PSID##4##2##(2010-2#4)
the PSII extrinsic polypeptides##2##4##(2008-4#2)
the PSII##5##2##(2008-4#3)(2008-8#1)(2009-2#1)
the PSP temperatures##2##3##(2008-3#2)
the PSP##6##2##(2008-3#6)
the PSP-I/PSP-II##2##2##(1995-5#2)
the PSS##2##2##(2007-9#1)(2008-3#1)
the PSV resistance##2##3##(2012-11#2)
the PT##6##2##(2004-12#1)(2006-10#1)(2006-3#2)(2012-12#1)(2013-1#1)
the PTB##2##2##(1996-4#2)
the PTB-metabolizing enzyme(s)##2##3##(1996-4#2)
the PTBR##2##2##(1997-5#2)
the PTFE##8##2##(2005-11#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-3#1)
the PTGBD pathway##2##3##(2013-1#2)
the PTGBD##5##2##(2013-1#5)
the PTH##12##2##(1990-9#1)(1991-4#1)(1994-12#1)(1996-11#1)(1997-5#1)(1997-7#2)(2006-7#1)(2007-8#2)(2008-10#1)(2008-8#1)
the PTH(1-34) effect##3##3##(2011-12#3)
the PTH2 receptor##2##3##(1995-6#2)
the PTK pathway##2##3##(1994-9#2)
the PTK##3##2##(1994-8#1)(1994-9#2)
the PTSD patients##2##3##(1996-7#1)(2005-10#1)
the PTSD##3##2##(1996-7#1)(2005-10#1)(2012-1#1)
the PTT##3##2##(1994-4#3)
the PTV##7##2##(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#2)(2009-5#2)
the PU##7##2##(1995-1#1)(2007-7#4)(2007-8#1)(2008-10#1)
the PUFA/SFA##2##2##(2010-4#2)
the PV arm##2##3##(2004-1#2)
the PV##4##2##(2004-1#3)(2008-11#1)
the PVA##7##2##(2008-10#2)(2008-12#1)(2008-5#2)(2009-10#1)(2009-12#1)
the PVDF##2##2##(2007-8#2)
the PVN may##3##3##(1993-7#1)(1994-2#1)(2005-10#1)
the PVN##17##2##(1993-7#3)(1994-10#1)(1994-12#1)(1994-2#2)(1994-8#2)(1995-12#3)(1997-8#2)(2005-10#3)
the PVP layer##2##3##(2010-4#2)
the PVP motif##3##3##(2006-2#3)
the PVP##12##2##(2005-11#1)(2006-2#3)(2008-10#2)(2008-5#1)(2010-4#5)
the PVV isolates##2##3##(2008-10#2)
the PVX##2##2##(1995-2#1)(2008-10#1)
the Pacific Island Countries##2##4##(2008-1#2)
the Pacific Island Health Care Project (PIHCP)##2##7##(2008-1#2)
the Pacific Island##5##3##(2008-1#5)
the Pacific Islands##2##3##(2008-1#1)(2010-8#1)
the Pacific Northwest##11##3##(2008-10#10)(2008-5#1)
the Pacific Ocean##8##3##(1990-4#1)(1996-4#1)(2006-7#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-5#1)(2012-2#1)
the Pacific Public Health Surveillance Network (PPHSN)##2##7##(2008-1#2)
the Pacific Public Health Surveillance Network##3##6##(2008-1#3)
the Pacific Region##2##3##(2008-1#1)(2012-12#1)
the Pacific and##5##3##(2007-3#1)(2007-5#1)(2008-1#3)
the Pacific coast of Mexico##2##5##(2007-3#1)(2008-10#1)
the Pacific coast of the##2##5##(2010-8#2)
the Pacific coast of##8##4##(2007-3#1)(2007-5#2)(2008-10#1)(2009-2#1)(2010-8#2)(2012-12#1)
the Pacific coast##12##3##(2007-3#1)(2007-5#4)(2008-10#1)(2008-5#1)(2009-2#1)(2010-8#2)(2012-12#2)
the Pacific region##4##3##(2008-1#4)
the Pacific waters of Panama##2##5##(2007-5#2)
the Pacific##115##2##(1990-12#1)(1990-4#1)(1994-9#1)(1995-11#2)(1995-8#1)(1996-4#1)(2006-7#1)(2007-3#4)(2007-5#10)(2008-1#45)(2008-10#11)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#7)(2008-9#1)(2009-2#1)(2009-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-2#1)(2012-12#11)(2012-2#1)(2013-7#4)(2013-8#1)
the Pacificans'##2##2##(2008-1#2)
the Paediatric##8##2##(1993-5#1)(2006-2#2)(2008-4#2)(2009-5#1)(2011-11#1)(2013-1#1)
the Page serovar C##2##4##(2008-5#2)
the Pain Assessment and Documentation Tool##2##6##(2007-2#2)
the Pain##3##2##(2006-12#1)(2007-2#2)
the Painlevé##2##2##(1991-9#2)
the Pakistan##2##2##(1990-9#1)(2007-5#1)
the Pakistani##3##2##(1993-1#2)(1997-6#1)
the Palau AHEC##3##3##(2008-1#3)
the Palau Ministry of Health##2##5##(2008-1#2)
the Palau##10##2##(2005-11#1)(2008-1#9)
the Palm##2##2##(2008-10#1)(2009-11#1)
the Pan American Health Organization##3##5##(1992-5#1)(1994-9#1)(2013-1#1)
the Pan American Health##4##4##(1992-5#1)(1994-9#1)(2011-2#1)(2013-1#1)
the Pan American##5##3##(1992-5#1)(1994-9#1)(2007-4#1)(2011-2#1)(2013-1#1)
the Pan##6##2##(1992-5#1)(1994-9#1)(2007-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
the Panama##2##2##(2007-5#1)(2007-9#1)
the Pancharatnam##2##2##(2007-11#1)(2008-2#1)
the Panel Study of Income Dynamics (PSID)##5##7##(2009-12#1)(2010-2#4)
the Panel Study of Income Dynamics##10##6##(2009-10#1)(2009-12#1)(2010-2#8)
the Panhandle##2##2##(2008-10#2)
the Pantanal##4##2##(2013-7#4)
the Pap smear##7##3##(1991-6#2)(1992-3#3)(2006-10#1)(2011-2#1)
the Pap test##2##3##(1991-6#1)(2008-11#1)
the Pap##10##2##(1991-6#3)(1992-3#3)(2006-10#1)(2008-11#1)(2011-2#2)
the Papua New Guinea##5##4##(2006-2#2)(2008-4#3)
the Parallel##2##2##(2008-10#1)(2008-4#1)
the Parametric Go/No-Go##2##3##(2007-9#1)(2013-8#1)
the Paramyxoviridae family##2##3##(2008-12#1)(2010-12#1)
the Parasitic##2##2##(2008-10#2)
the Parent##3##2##(1992-2#1)(1994-3#1)(2011-2#1)
the Parental##3##2##(1990-12#1)(1992-2#1)(2009-11#1)
the Paridae##2##2##(2008-9#2)
the Paris##3##2##(2008-2#1)(2010-1#1)(2012-3#1)
the Parkinson's##4##2##(2008-7#3)(2013-1#1)
the Parliament##2##2##(2007-5#1)(2009-7#1)
the Parque Nacional Cahuita##3##4##(2011-2#3)
the Parque Nacional##6##3##(2007-3#1)(2008-5#2)(2011-2#3)
the Parry##2##2##(2008-3#2)
the Parsonnet##2##2##(1992-10#1)(2007-8#1)
the Part##2##2##(1993-12#1)(1995-12#1)
the Parties##2##2##(1996-1#2)
the Partnered Research Center for Quality Care##2##7##(2012-2#2)
the Pastorate of the Child##3##5##(2011-1#3)
the Pastorate of the##4##4##(2011-1#4)
the Patent Act##2##3##(2010-7#2)
the Pathogen##3##2##(2008-10#3)
the Pathogenesis of##3##3##(2006-10#1)(2007-12#1)(2011-2#1)
the Pathology Department##2##3##(2007-2#1)(2011-2#1)
the Pathology##4##2##(1992-8#1)(2005-12#1)(2007-2#1)(2011-2#1)
the Patient Safety Authority##4##4##(2007-4#4)
the Patient Self-Determination Act##3##4##(1992-12#1)(1992-4#1)(1993-3#1)
the Patient##19##2##(1992-12#1)(1992-4#1)(1993-3#2)(1994-1#1)(1994-3#1)(1996-1#1)(2004-11#1)(2005-11#1)(2007-4#4)(2008-7#1)(2009-8#1)(2010-2#1)(2011-1#1)(2012-1#2)
the Patient's##2##2##(2007-2#1)(2009-9#1)
the Patrick and Chou##2##4##(2007-1#2)
the Paul##2##2##(1992-10#1)(2010-5#1)
the Pavlik harness in##2##4##(2007-8#2)
the Pavlik harness##5##3##(2007-8#5)
the Pavlik##6##2##(2007-8#6)
the Pb concentration in##2##4##(1992-3#2)
the Pb isotopic##4##3##(2013-8#4)
the Pb##6##2##(1992-3#2)(2013-8#4)
the Pb2+ concentration##2##3##(2013-8#2)
the Pb2+##4##2##(2013-8#4)
the PbS##3##2##(1990-9#2)(2009-2#1)
the PbTiO(3)##2##2##(2008-2#2)
the Pd(II)##3##2##(2007-8#2)(2010-5#1)
the Peabody Developmental Motor Scales##3##5##(2006-10#3)
the Peabody Developmental Motor##4##4##(2006-10#4)
the Peabody##5##2##(2006-10#5)
the Pearl##2##2##(1992-7#1)(2010-12#1)
the Pearson correlation##3##3##(2008-1#1)(2011-1#2)
the Pearson##5##2##(1996-12#1)(1997-8#1)(2008-1#1)(2011-1#2)
the Ped gene (Qa-2(a))##2##4##(2008-5#2)
the Ped gene##3##3##(2008-5#3)
the Pediatric Clinic##2##3##(2008-9#1)(2011-1#1)
the Pediatric Emergency##3##3##(2009-6#1)(2011-2#1)(2013-8#1)
the Pediatric##23##2##(1990-2#1)(2006-10#2)(2007-7#1)(2008-1#1)(2008-3#1)(2008-9#1)(2009-4#2)(2009-6#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#6)(2013-8#1)
the Peltier##2##2##(2008-10#1)(2008-9#1)
the Pelvic##2##2##(2006-7#1)(2011-2#1)
the Penal Code##2##3##(2009-4#1)(2010-9#1)
the Penaz method##2##3##(1991-4#2)
the Penaz##3##2##(1991-4#3)
the Penicillium##3##2##(1996-9#1)(2007-3#1)(2008-4#1)
the Peninsula Maternal and Neonatal##2##5##(2010-3#2)
the Peninsula##3##2##(2010-3#2)(2012-12#1)
the Penn##2##2##(2010-2#1)(2012-2#1)
the Pennsylvania Patient Safety Authority##2##5##(2007-4#2)
the Pennsylvania##5##2##(1995-1#1)(2007-4#2)(2008-1#1)(2010-1#1)
the Pentagon##4##2##(1996-5#2)(2006-7#1)(2007-9#1)
the People's Republic of China##5##5##(1997-3#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-7#1)
the Perception of##3##3##(1995-10#1)(2009-12#1)(2011-2#1)
the Perceptual##2##2##(2007-10#1)(2007-12#1)
the Performance of##4##3##(2006-11#1)(2007-12#1)(2008-11#1)(2010-8#1)
the Performance##5##2##(2006-11#1)(2007-12#2)(2008-11#1)(2010-8#1)
the Perl's Prussian blue reaction##2##5##(2013-8#2)
the Persian Gulf##3##3##(2008-12#3)
the Persian##4##2##(2008-12#3)(2012-1#1)
the Personal##3##2##(2007-12#1)(2007-8#1)(2010-9#1)
the Peruvian Amazon##6##3##(2007-3#1)(2011-2#5)
the Peruvian coast##2##3##(2009-2#1)(2013-8#1)
the Peruvian##20##2##(2007-3#1)(2008-10#3)(2008-8#1)(2009-2#3)(2011-2#8)(2013-8#4)
the Petri plates##2##3##(1992-5#1)(2006-10#1)
the Petén region of Guatemala##2##5##(2007-2#2)
the Petén region##3##3##(2007-2#3)
the Pfam database##2##3##(2008-4#2)
the Pfam##3##2##(2008-4#2)(2010-10#1)
the Pgp##3##2##(1996-5#1)(1996-7#2)
the Ph##2##2##(2006-12#1)(2007-8#1)
the Pharmaceutical Research and Manufacturers##2##5##(2006-10#1)(2008-11#1)
the Pharmaceutical##6##2##(2005-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-4#1)
the Pharmacy##3##2##(2011-1#1)(2012-3#2)
the Phase II##2##3##(1996-9#1)(2006-10#1)
the Phase##7##2##(1996-7#1)(1996-9#1)(2006-10#1)(2008-2#1)(2008-3#2)(2009-4#1)
the Phe M197--&gt##2##3##(1993-11#2)
the Phe and Arg residues are##2##6##(1992-4#1)(1996-8#1)
the Phe and Arg side chains##2##6##(1996-8#2)
the Phe and Arg##4##4##(1992-4#1)(1996-8#3)
the Phe##9##2##(1990-9#1)(1992-4#1)(1992-8#1)(1993-11#2)(1995-11#1)(1996-8#3)
the Philadelphia chromosome##5##3##(2007-12#1)(2008-6#1)(2009-3#1)(2011-2#1)(2012-12#1)
the Philadelphia##7##2##(1996-11#1)(2007-12#1)(2008-6#1)(2009-3#1)(2010-1#1)(2011-2#1)(2012-12#1)
the Philippine##4##2##(2008-10#3)(2010-6#1)
the Philippines##15##2##(1992-2#1)(1995-5#1)(2006-10#1)(2006-2#1)(2007-5#2)(2008-10#1)(2008-5#1)(2008-8#2)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)
the Phoenix##2##2##(2008-4#2)
the Phoma##2##2##(2010-3#2)
the Photosystem II reaction center##2##5##(1994-12#2)
the Phr3-encoding cDNA##2##3##(1991-12#2)
the Phreatoicidea##2##2##(2007-12#2)
the Physarum plasmodium##2##3##(2006-10#2)
the Physical Appearance##2##3##(2007-12#2)
the Physical##7##2##(1994-3#1)(1997-3#1)(2007-12#3)(2008-4#1)(2011-1#1)
the Physician##2##2##(1994-1#1)(2012-1#1)
the Physikalisch-Meteorologisches Observatorium##2##3##(2008-2#1)(2008-3#1)
the Physiological##2##2##(2005-12#1)(2008-7#1)
the Physiotherapy##3##2##(1992-3#2)(2008-9#1)
the Phytophthora alpha1 mating hormone##2##5##(2008-11#2)
the Phytophthora genus-specific amplicon##2##4##(2008-10#2)
the Phytophthora genus-specific primer pair##2##5##(2008-10#2)
the Phytophthora genus-specific##5##3##(2008-10#5)
the Phytophthora sp-h isolates##4##4##(2008-10#4)
the Phytophthora##14##2##(2008-10#12)(2008-11#2)
the Pi##5##2##(1994-11#1)(1994-9#1)(1997-1#1)(2009-8#1)(2010-8#1)
the Pi-ta##4##2##(2008-10#4)
the Picture Description Task##2##4##(2008-7#2)
the Piepkorn type of lethal##2##5##(1997-1#2)
the Pierre##4##2##(1990-5#1)(2008-2#1)(2008-3#2)
the Pigache Attention Task##2##4##(1996-3#2)
the Pik##3##2##(2008-10#3)
the PipMaker##2##2##(2008-4#2)
the Pista River##2##3##(2013-1#2)
the Pittsburgh##4##2##(2006-10#1)(2008-10#1)(2011-2#1)(2012-12#1)
the Pituitary##2##2##(1996-3#1)(2008-4#1)
the Plan##3##2##(2008-7#1)(2012-3#1)(2013-1#1)
the Planck function##2##3##(2008-2#1)(2008-3#1)
the Planetary##2##2##(2008-2#2)
the Plant Ontology##5##3##(2008-7#5)
the Plant##12##2##(2008-10#3)(2008-7#8)(2009-8#1)
the Plant-Parasitic##3##2##(2008-10#3)
the Plaque Assay and##2##4##(2008-10#2)
the Plaque Assay##5##3##(2008-10#5)
the Plasmodium falciparum##3##3##(2007-1#1)(2008-8#1)(2012-12#1)
the Plasmodium yoelii yoelii##2##4##(1994-12#2)
the Plasmodium yoelii##3##3##(1994-12#2)(2008-3#1)
the Plasmodium##10##2##(1990-9#1)(1994-12#2)(2006-4#1)(2007-1#1)(2008-3#1)(2008-8#1)(2012-12#3)
the Plastic##2##2##(2008-7#1)(2012-12#1)
the Platform##2##2##(1995-9#2)
the Playmates##2##2##(2007-12#2)
the Pleistocene##8##2##(1995-11#1)(1996-6#1)(2006-7#1)(2008-8#1)(2008-9#2)(2010-8#2)
the Pliocene##2##2##(1993-4#1)(2010-8#1)
the Plum pox virus##2##4##(2008-10#2)
the Plum##4##2##(2007-9#1)(2008-10#2)(2011-2#1)
the Pluronic##4##2##(2005-11#3)(2013-1#1)
the Pm-AMP1##4##2##(2008-10#4)
the Pm3##2##2##(2008-10#2)
the Pockels readout optical modulator##2##5##(2008-2#2)
the Podoviridae##2##2##(2011-12#1)(2013-1#1)
the Poisson distribution##2##3##(1995-6#1)(2008-10#1)
the Poisson##6##2##(1990-7#1)(1995-6#1)(2008-10#3)(2008-3#1)
the Poisson-Boltzmann##2##2##(2006-10#1)(2008-4#1)
the Pol##3##2##(1992-3#1)(1996-5#2)
the Polar environments##2##3##(2012-12#2)
the Polar##4##2##(2008-3#1)(2012-12#3)
the Polish Armed Forces##2##4##(2012-2#2)
the Polish Pediatric Leukemia/Lymphoma Study Group##2##6##(2011-2#2)
the Polish intelligentsia##2##3##(2008-12#2)
the Polish version of the##2##5##(2007-7#1)(2012-12#1)
the Polish version of##3##4##(2007-7#1)(2012-12#1)(2012-2#1)
the Polish##34##2##(2007-7#1)(2007-8#3)(2008-11#2)(2008-12#2)(2008-7#4)(2008-9#3)(2009-2#1)(2009-5#1)(2010-9#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#2)
the Polymerase Chain Reaction##3##4##(2008-10#2)(2013-8#1)
the Population##9##2##(1995-5#1)(1996-3#1)(1996-8#1)(2006-3#1)(2008-10#3)(2008-3#1)(2010-12#1)
the Port Moresby General Hospital##3##5##(2006-2#3)
the Portuguese##7##2##(2009-10#2)(2009-7#2)(2012-12#2)(2013-8#1)
the Positive and Negative Syndrome Scale##3##6##(1996-5#1)(2008-6#1)(2011-1#1)
the Positive and Negative##4##4##(1996-5#1)(2008-6#1)(2011-1#1)(2013-8#1)
the Postgraduate##2##2##(1990-12#1)(2012-3#1)
the Postharvest##3##2##(2008-10#3)
the Potato##2##2##(2008-10#2)
the Potential Benefits of##2##4##(2006-10#1)(2013-8#1)
the Potential##9##2##(2005-7#2)(2006-10#1)(2006-12#1)(2008-10#2)(2010-5#1)(2011-12#1)(2013-8#1)
the Pourbaix##2##2##(2008-10#2)
the Power##3##2##(2007-9#1)(2009-11#1)(2013-1#1)
the PowerPlex##2##2##(2008-12#1)(2010-9#1)
the Poznań##3##2##(2007-11#2)(2008-7#1)
the PrP gene##4##3##(1993-2#4)
the PrP##5##2##(1993-2#4)(2008-11#1)
the Practice##2##2##(2007-4#1)(2013-1#1)
the Pregnancy##2##2##(2006-1#1)(2013-1#1)
the Presence of##9##3##(1994-7#1)(1996-2#1)(1996-5#1)(2008-10#4)(2008-6#1)(2011-1#1)
the President of##4##3##(1992-3#1)(2008-1#1)(2008-7#2)
the President signed into law House Resolution##3##7##(1991-12#1)(1991-3#1)(1993-1#1)
the President signed into law##4##5##(1991-12#1)(1991-3#1)(1993-1#1)(1994-3#1)
the President##12##2##(1991-10#1)(1991-12#1)(1991-3#1)(1992-3#1)(1993-1#1)(1994-1#1)(1994-3#1)(1995-12#1)(1996-11#1)(2008-1#1)(2008-7#2)
the President's##3##2##(1993-5#1)(2009-12#1)(2010-1#1)
the Presidential##2##2##(1995-6#1)(2007-3#1)
the Press Ganey##3##3##(2008-8#2)(2010-8#1)
the Prestige's##2##2##(2008-10#2)
the Prevention of##6##3##(2007-10#1)(2008-11#1)(2010-12#1)(2011-1#2)(2013-8#1)
the Prevotella-Bacteroides group##2##3##(2006-8#2)
the Primary Care##2##3##(1996-1#1)(1996-2#1)
the Primary Health Care##3##4##(1990-6#1)(2009-10#1)(2011-2#1)
the Primary Health##4##3##(1990-6#1)(2009-10#1)(2011-2#1)(2013-8#1)
the Primary##11##2##(1990-6#1)(1996-1#1)(1996-2#1)(2007-12#1)(2008-10#3)(2008-5#1)(2009-10#1)(2011-2#1)(2013-8#1)
the Prime##2##2##(2005-5#1)(2013-1#1)
the Prince of##2##3##(2008-1#1)(2012-6#1)
the Principles##2##2##(2008-8#2)
the Pro##5##2##(1990-5#1)(1992-9#1)(1995-5#1)(2008-12#1)(2011-2#1)
the ProDisc-L device##2##3##(2008-8#2)
the ProFLOK-ELISA##3##2##(2005-9#3)
the Problem##2##2##(2004-3#1)(2012-2#1)
the Proceedings of the##2##4##(2007-9#1)(2008-6#1)
the Process##2##2##(1997-7#1)(2008-11#1)
the Production of##4##3##(2008-10#1)(2008-11#2)(2013-1#1)
the Production##5##2##(2008-10#2)(2008-11#2)(2013-1#1)
the Professional College of##2##4##(1991-3#1)(1992-8#1)
the Professional##4##2##(1991-3#1)(1992-8#1)(1996-2#1)(2008-5#1)
the Profile of Mood States##3##5##(1996-2#1)(1996-3#1)(2006-10#1)
the Profile of##5##3##(1996-2#1)(1996-3#1)(2006-10#1)(2009-10#1)(2013-8#1)
the Profile##6##2##(1996-2#1)(1996-3#1)(2006-10#1)(2008-4#1)(2009-10#1)(2013-8#1)
the Program for##2##3##(1993-6#1)(2007-3#1)
the Program of##3##3##(1991-2#1)(1994-2#1)(2008-2#1)
the Program##9##2##(1991-2#1)(1991-8#1)(1993-6#1)(1994-2#1)(1995-12#1)(2007-3#1)(2008-2#1)(2008-7#1)(2013-1#1)
the Programme of Action##3##4##(2008-11#3)
the Programme##4##2##(1990-6#1)(2008-11#3)
the Programmed Restraint System##2##4##(2007-4#2)
the Progressive##2##2##(2004-3#1)(2013-8#1)
the Project 2000 curriculum##2##4##(2008-11#2)
the Project 2000##3##3##(2008-11#3)
the Protection##2##2##(2007-11#1)(2008-10#1)
the Protein Data Bank (PDB)##2##5##(2008-4#2)
the Protein Data Bank##7##4##(2008-4#4)(2011-2#2)(2011-3#1)
the Protein##10##2##(1990-9#1)(2008-4#4)(2010-7#1)(2011-1#1)(2011-2#2)(2011-3#1)
the Proton##2##2##(2006-3#1)(2009-6#1)
the Province of##7##3##(1991-2#1)(1991-6#1)(1992-12#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-12#1)
the Prunus##2##2##(2011-2#2)
the Prussian blue##2##3##(2008-10#2)
the Prussian##5##2##(2008-10#5)
the Pseudomonas aeruginosa##3##3##(1992-3#1)(1995-2#1)(1996-9#1)
the Pseudomonas##9##2##(1992-3#1)(1995-2#1)(1996-4#1)(1996-9#1)(2008-10#3)(2009-6#1)(2013-7#1)
the Psoriasis Study Group##2##4##(2005-11#2)
the Pt##7##2##(2007-8#1)(2008-10#2)(2008-11#1)(2010-5#3)
the PtPP2C##2##2##(1994-12#2)
the PubMed##8##2##(2007-12#1)(2008-11#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#3)
the Public Health Service Act##2##5##(1991-1#1)(1991-10#1)
the Public Health Service##3##4##(1991-1#1)(1991-10#1)(2012-2#1)
the Public Health##12##3##(1991-1#1)(1991-10#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-11#1)(2009-2#1)(2011-2#2)(2012-12#2)(2012-2#1)
the Public##16##2##(1991-1#1)(1991-10#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-2#1)(2011-2#2)(2012-12#2)(2012-2#1)
the Puerto##2##2##(2007-5#1)(2011-2#1)
the Puglia region##3##3##(2007-1#3)
the Pulse##2##2##(2013-7#2)
the Punta Morales##3##3##(2007-3#2)(2007-5#1)
the Punta##4##2##(2007-3#2)(2007-5#2)
the Puntarenas estuary##2##3##(2007-5#2)
the Puntarenas##3##2##(2007-5#2)(2013-7#1)
the PurR function##2##3##(2008-8#2)
the PurR##3##2##(2008-8#3)
the Purkinje cell layer##4##4##(1994-10#1)(1996-4#1)(2012-3#1)(2013-8#1)
the Purkinje cell##8##3##(1992-12#2)(1992-9#1)(1994-10#1)(1996-4#2)(2012-3#1)(2013-8#1)
the Purkinje cells of##2##4##(1993-4#1)(1997-8#1)
the Purkinje cells##4##3##(1993-4#1)(1994-2#1)(1996-4#1)(1997-8#1)
the Purkinje##13##2##(1992-12#2)(1992-9#1)(1993-4#1)(1994-10#1)(1994-2#1)(1996-4#3)(1997-8#1)(2008-10#1)(2012-3#1)(2013-8#1)
the Pygmy##2##2##(1993-6#1)(2011-2#1)
the Pyr &lt##2##3##(1995-6#2)
the Pyramidal##2##2##(2007-5#1)(2012-2#1)
the Pythium##3##2##(2008-10#3)
the Q factor of the##2##5##(2007-12#1)(2008-3#1)
the Q factor of##5##4##(2007-11#1)(2007-12#1)(2008-3#3)
the Q factor##6##3##(2007-11#2)(2007-12#1)(2008-3#3)
the Q##20##2##(1991-8#2)(1992-3#1)(1994-8#2)(1995-12#2)(1995-6#1)(2007-11#2)(2007-12#2)(2008-3#4)(2010-5#1)(2011-2#2)(2012-12#1)
the Q-switched mode##4##3##(2008-3#4)
the Q-switched pulse##3##3##(2008-3#3)
the Q-switched##8##2##(2007-12#1)(2008-3#7)
the Q-switching##2##2##(2008-3#2)
the Q/R site##3##3##(1993-12#1)(1995-5#2)
the Q/R##4##2##(1993-12#1)(1995-5#2)(1997-4#1)
the Q151A mutant##2##3##(1995-5#2)
the Q3 and Hybrid III 3-year-old dummies were##2##8##(2007-4#2)
the Q3 and Hybrid III 3-year-old##3##6##(2007-4#3)
the Q3 and Hybrid III##4##5##(2007-4#4)
the Q3 dummy##3##3##(2007-4#3)
the Q3##10##2##(2007-4#10)
the QA##2##2##(1992-3#1)(1994-10#1)
the QA-810 V##4##3##(2008-10#4)
the QB##3##2##(1992-3#1)(1994-8#2)
the QBC technique##2##3##(2007-8#2)
the QBC##4##2##(2007-8#4)
the QC##2##2##(2007-12#1)(2010-10#1)
the QCM##8##2##(2005-11#1)(2008-10#5)(2009-6#2)
the QDA##2##2##(2008-10#2)
the QDM##4##2##(2013-1#4)
the QDs##2##2##(2013-8#2)
the QERN phenotype##2##3##(1996-4#2)
the QI process was modified to include real-time feedback##2##9##(2007-5#2)
the QI##4##2##(1993-2#1)(1994-12#1)(2007-5#2)
the QIAamp DNA Investigator Kit and PrepFiler Forensic DNA Extraction Kit##2##11##(2010-9#2)
the QIAamp DNA Investigator Kit and##3##6##(2010-9#3)
the QIAamp DNA Investigator Kit##4##5##(2010-9#4)
the QIs##3##2##(1996-2#2)(2013-1#1)
the QKI##2##2##(2006-11#1)(2009-9#1)
the QOL score##2##3##(1994-12#2)
the QOL##6##2##(1994-12#3)(1995-4#1)(2008-4#1)(2012-2#1)
the QR##2##2##(2010-2#2)
the QRS complex##3##3##(1995-6#1)(2010-8#2)
the QRS##7##2##(1995-6#1)(1995-9#1)(2008-10#1)(2010-1#1)(2010-8#2)(2013-8#1)
the QS##2##2##(2010-10#1)(2012-12#1)
the QS-L1##2##2##(1997-4#2)
the QSAR##3##2##(1996-8#2)(2005-10#1)
the QT interval on##4##4##(2011-2#4)
the QT interval##10##3##(2007-2#2)(2008-8#4)(2011-2#4)
the QT##12##2##(2005-7#1)(2007-2#2)(2008-12#1)(2008-8#4)(2011-2#4)
the QTL and##2##3##(2008-10#1)(2012-11#1)
the QTL for##4##3##(2008-10#3)(2012-1#1)
the QTL on##3##3##(2008-10#3)
the QTL##19##2##(2006-12#1)(2008-10#12)(2009-10#1)(2009-5#2)(2012-1#1)(2012-11#1)(2012-3#1)
the QTLs##3##2##(2008-10#1)(2008-4#1)(2008-8#1)
the QTc##2##2##(2005-6#1)(2008-8#1)
the QUART group##2##3##(1995-10#2)
the QWB##2##2##(1996-7#2)
the Qinghai-Tibet Plateau##3##3##(2008-9#2)(2009-5#1)
the Qinghai-Tibetan Plateau##3##3##(2012-3#1)(2013-7#2)
the Qo site of##2##4##(1997-3#2)
the Qo site##7##3##(1992-3#4)(1997-3#3)
the QoL##5##2##(2004-1#1)(2008-10#1)(2010-8#1)(2011-1#1)(2013-8#1)
the Qpool##2##2##(1992-3#2)
the Quality Assurance##3##3##(1997-2#1)(2008-10#1)(2008-11#1)
the Quality Data Model (QDM)##2##5##(2013-1#2)
the Quality of Life in##2##5##(1995-4#1)(2004-3#1)
the Quality of Life##8##4##(1994-3#2)(1995-4#1)(2004-3#1)(2005-4#1)(2007-7#1)(2010-3#1)(2011-2#1)
the Quality of##12##3##(1994-3#2)(1995-4#1)(1996-7#1)(2004-3#1)(2005-4#1)(2006-10#1)(2007-7#1)(2008-10#1)(2010-3#1)(2011-2#1)(2013-1#1)
the Quality##18##2##(1993-12#1)(1994-3#2)(1995-4#1)(1996-7#1)(1997-2#1)(2004-3#1)(2005-4#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-11#1)(2010-3#1)(2011-2#1)(2013-1#3)
the Quebec experience##2##3##(2012-2#2)
the Quebec##10##2##(1991-12#1)(1993-12#1)(1997-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-5#2)(2012-2#2)
the Queensland##2##2##(2006-8#1)(2010-8#1)
the Quercus species##2##3##(2012-6#1)(2012-9#1)
the Query Integrator issues queries distributed over the data##2##9##(2013-1#2)
the Quick Test##6##3##(2006-3#6)
the Quick Vue test and##2##5##(2007-1#2)
the Quick Vue test##5##4##(2007-1#5)
the Quick Vue##7##3##(2007-1#7)
the Quick##13##2##(2006-3#6)(2007-1#7)
the QuickVue##3##2##(2011-2#3)
the Québec##3##2##(2008-2#3)
the R and##3##3##(2005-7#1)(2008-5#1)(2013-7#1)
the R effect##2##3##(1991-8#2)
the R package##2##3##(2008-5#1)(2009-7#1)
the R region##2##3##(1991-3#1)(1992-1#1)
the R state##4##3##(1990-8#2)(1993-9#1)(2008-11#1)
the R##72##2##(1990-8#5)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#2)(1992-1#1)(1992-3#1)(1992-7#1)(1993-6#6)(1993-9#1)(1995-3#3)(1995-8#1)(1996-2#1)(1996-8#1)(2005-7#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#29)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-7#1)(2010-10#1)(2013-7#1)
the R&amp##5##2##(2008-5#3)(2008-8#2)
the R(50) transition##2##3##(2008-3#2)
the R(61##11##2##(1995-10#11)
the R-D-LSI##3##2##(2012-2#3)
the R-isomer##3##2##(1992-3#1)(1993-3#1)(2006-10#1)
the R-state is##2##3##(1990-9#1)(1992-7#1)
the R-state##5##2##(1990-9#2)(1992-7#1)(1995-2#1)(1995-6#1)
the R1 protein##3##3##(1993-11#1)(1995-10#2)
the R1##6##2##(1993-11#1)(1994-11#1)(1995-10#2)(1997-7#1)(2008-10#1)
the R2 protein##5##3##(1993-11#2)(1995-10#3)
the R2##7##2##(1993-11#2)(1994-8#1)(1995-10#3)(1997-7#1)
the R3##3##2##(1991-7#1)(2008-3#1)(2011-1#1)
the R304K mutant##2##3##(1995-2#2)
the R3f trimer##2##3##(1995-11#2)
the R3f##3##2##(1995-11#3)
the R8##2##2##(1991-12#2)
the RA receptor##2##3##(1995-10#2)
the RA##14##2##(1993-4#1)(1994-11#2)(1994-8#1)(1995-10#2)(2006-10#1)(2007-4#2)(2007-8#1)(2008-11#2)(2008-3#1)(2008-5#1)
the RA5 antibody##2##3##(2008-6#2)
the RAAS##6##2##(2005-7#1)(2007-1#1)(2008-1#3)(2012-12#1)
the RACE##3##2##(1994-6#1)(2008-3#1)(2009-7#1)
the RAD3##2##2##(1993-12#1)(1995-9#1)
the RAD57##3##2##(1991-8#2)(1996-6#1)
the RAM##3##2##(1993-2#1)(2008-10#1)(2012-2#1)
the RAND Appropriateness Method##2##4##(2007-10#1)(2010-12#1)
the RAND##4##2##(2007-10#1)(2008-10#2)(2010-12#1)
the RAP1##4##2##(1996-7#4)
the RAPD analysis##2##3##(2007-1#1)(2008-5#1)
the RAPD##8##2##(2005-10#1)(2007-1#1)(2008-10#3)(2008-5#3)
the RAR##2##2##(1991-2#1)(1997-2#1)
the RAS is##2##3##(2008-4#1)(2012-3#1)
the RAS##12##2##(1993-12#2)(2005-7#2)(2005-8#1)(2008-4#1)(2008-6#1)(2009-10#2)(2011-3#1)(2012-3#1)(2013-1#1)
the RB##7##2##(1992-8#1)(1993-8#1)(1996-12#1)(1996-2#1)(1996-4#1)(2008-10#1)(2013-1#1)
the RBC membrane phospholipid##2##4##(1995-2#1)(2008-8#1)
the RBC##11##2##(1992-11#1)(1994-2#1)(1995-1#2)(1995-2#1)(2004-4#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#2)
the RBCM##3##2##(1994-12#3)
the RBCs##3##2##(1993-9#1)(1994-12#2)
the RBD##2##2##(1996-5#2)
the RBF network##2##3##(2008-10#1)(2008-2#1)
the RBP##3##2##(1991-2#1)(1991-9#1)(2007-12#1)
the RBRVS##4##2##(1994-12#1)(2006-10#2)(2007-4#1)
the RC##2##2##(2008-11#1)(2012-11#1)
the RCA cells##2##3##(1992-3#2)
the RCA##7##2##(1992-3#3)(2007-8#3)(2008-10#1)
the RCCS bioreactor##2##3##(2009-7#2)
the RCH##4##2##(2006-8#4)
the RCT##2##2##(2010-11#1)(2011-2#1)
the RE and##2##3##(2007-8#1)(2008-10#1)
the RE##8##2##(1993-3#3)(1993-4#1)(2007-8#1)(2008-10#2)(2010-2#1)
the REE concentrations##2##3##(2008-10#2)
the REE##5##2##(2008-10#5)
the REP1##2##2##(1990-4#2)
the RESEARCH and T-SEARCH##2##4##(2008-11#2)
the RET##3##2##(1996-6#1)(2012-2#2)
the REV##3##2##(2008-5#2)(2013-8#1)
the REX limit##3##3##(2006-4#3)
the RF##10##2##(1990-10#1)(1990-4#1)(1994-12#1)(2005-10#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-12#1)
the RFC##3##2##(2008-9#3)
the RFLP and RAPD##2##4##(2008-5#2)
the RFLP markers##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
the RFLP##8##2##(2008-10#2)(2008-4#2)(2008-5#3)(2008-9#1)
the RFN##2##2##(1993-12#2)
the RGC##2##2##(2009-12#1)(2012-12#1)
the RGD motif##3##3##(1994-12#1)(1995-2#2)
the RGD sequence is##2##4##(1994-12#1)(1995-6#1)
the RGD sequence##7##3##(1994-11#2)(1994-12#1)(1995-6#4)
the RGD##14##2##(1994-11#2)(1994-12#2)(1995-2#2)(1995-6#4)(1996-5#1)(1997-2#1)(2008-7#2)
the RGDS##5##2##(1990-12#1)(1990-5#2)(1991-6#1)(1992-1#1)
the RGR Trainer##3##3##(2012-1#3)
the RGS##5##2##(2008-4#1)(2013-1#4)
the RH##4##2##(1994-12#1)(1996-1#1)(2008-10#1)(2013-1#1)
the RHAE##2##2##(1993-3#2)
the RHD##2##2##(2012-2#1)(2012-3#1)
the RHIA##2##2##(2007-12#2)
the RI and##2##3##(1994-5#1)(2013-1#1)
the RI of##2##3##(2007-11#2)
the RI##7##2##(1990-10#1)(1994-5#1)(2007-11#2)(2008-10#2)(2013-1#1)
the RIA is##2##3##(1992-7#2)
the RIA##12##2##(1990-11#1)(1991-8#1)(1992-7#5)(1993-9#1)(1994-10#3)(2008-7#1)
the RICH test##2##3##(2005-8#2)
the RID2##8##2##(2006-11#3)(2007-4#5)
the RID2a##5##2##(2007-4#5)
the RIG##2##2##(2008-10#2)
the RII##2##2##(1991-6#1)(1994-8#1)
the RIL population##5##3##(2008-10#4)(2012-11#1)
the RILs##2##2##(2008-10#2)
the RIP##2##2##(2008-10#1)(2008-2#1)
the RIPs##2##2##(1990-12#2)
the RIS##3##2##(1994-2#1)(1996-3#2)
the RITA##2##2##(2007-8#2)
the RK motif##3##3##(1995-6#3)
the RK##6##2##(1995-6#5)(2009-8#1)
the RLS of##2##3##(2008-10#2)
the RLS signals of##2##4##(2008-10#2)
the RLS signals##4##3##(2008-10#4)
the RLS##8##2##(2008-10#8)
the RLV-2100 &quot##2##3##(1991-3#2)
the RM##5##2##(1991-4#1)(1996-2#1)(2007-8#1)(2008-10#2)
the RMI show that 62##2##5##(2013-8#2)
the RMI##3##2##(2008-1#1)(2013-8#2)
the RMS##2##2##(2008-2#1)(2013-8#1)
the RMSE##2##2##(2008-2#1)(2013-8#1)
the RN buddy role##2##4##(2008-12#2)
the RN##9##2##(1992-12#1)(2008-1#1)(2008-12#4)(2009-7#1)(2010-2#1)(2010-4#1)
the RN's##2##2##(2010-11#2)
the RNA binding##4##3##(1996-4#1)(1996-5#1)(1997-5#1)(2009-7#1)
the RNA component of##3##4##(1994-3#1)(2008-11#1)(2008-9#1)
the RNA from##2##3##(1993-8#1)(2008-10#1)
the RNA is##6##3##(1990-4#2)(1997-1#1)(1997-7#2)(2008-2#1)
the RNA of##3##3##(1992-11#1)(1996-4#1)(2009-2#1)
the RNA polymerase II CTD##3##5##(1992-5#2)(2010-11#1)
the RNA polymerase II##7##4##(1990-6#1)(1992-5#2)(1995-2#1)(1997-7#1)(2008-10#1)(2010-11#1)
the RNA polymerase III##3##4##(1993-9#1)(1995-1#1)(1995-2#1)
the RNA polymerase##18##3##(1990-4#1)(1990-6#1)(1991-8#1)(1992-5#2)(1993-9#1)(1995-1#1)(1995-2#2)(1995-6#2)(1996-11#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#1)(2010-11#1)
the RNA product##3##3##(1994-8#1)(2008-4#2)
the RNA secondary structure##3##4##(1991-9#2)(2011-3#1)
the RNA secondary##4##3##(1991-9#2)(2008-4#1)(2011-3#1)
the RNA sequence##2##3##(2005-11#1)(2011-1#1)
the RNA structure##2##3##(1994-11#1)(2008-10#1)
the RNA substrate##2##3##(1991-11#1)(2004-1#1)
the RNA world##2##3##(1995-8#1)(2008-11#1)
the RNA##105##2##(1990-11#1)(1990-12#1)(1990-4#4)(1990-5#1)(1990-6#1)(1991-11#1)(1991-8#1)(1991-9#2)(1992-11#2)(1992-5#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#4)(1995-8#1)(1996-11#1)(1996-4#2)(1996-5#2)(1996-7#3)(1996-8#3)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#3)(2004-1#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-2#3)(2008-4#7)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-7#1)(2010-11#1)(2010-6#1)(2011-1#3)(2011-3#1)(2012-3#1)
the RNA-binding##3##2##(1992-9#2)(1993-11#1)
the RNA-dependent RNA polymerase gene##2##5##(2008-10#2)
the RNA-dependent RNA polymerase##4##4##(2008-10#4)
the RNAP##3##2##(1995-2#1)(1997-5#2)
the RNAi##3##2##(2008-1#1)(2009-8#1)(2012-3#1)
the RNAs##6##2##(1990-2#1)(1990-8#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-9#1)
the RNAse##2##2##(1991-6#1)(1995-10#1)
the RNFL##5##2##(2007-11#1)(2009-4#4)
the RNN based##2##3##(2008-2#2)
the RNN##4##2##(2008-2#3)(2010-8#1)
the RNase H domain##3##4##(1992-9#1)(1995-3#2)
the RNase H##4##3##(1992-9#1)(1995-3#2)(1997-1#1)
the RNase##10##2##(1990-11#1)(1992-11#3)(1992-9#1)(1995-3#2)(1997-1#1)(2007-1#1)(2008-4#1)
the RO children at##2##4##(2008-11#2)
the RO children were##2##4##(2008-11#2)
the RO children##5##3##(2008-11#5)
the RO##6##2##(2008-11#6)
the ROBIN##2##2##(2012-1#2)
the ROC curve##13##3##(2007-8#1)(2008-10#1)(2008-2#1)(2010-2#2)(2010-8#1)(2010-9#1)(2012-1#2)(2013-1#4)
the ROC##16##2##(1992-2#1)(2007-8#2)(2008-10#1)(2008-2#1)(2010-2#2)(2010-8#1)(2010-9#1)(2012-1#2)(2012-12#1)(2013-1#4)
the ROI##2##2##(2010-2#1)(2010-8#1)
the ROM-check Immunoassay##2##3##(1992-2#2)
the ROM-check Membrane Immunoassay##3##4##(1993-1#3)
the ROM-check##7##2##(1992-2#3)(1993-1#4)
the ROS production##2##3##(2010-12#1)(2010-4#1)
the ROS##4##2##(1995-5#1)(2009-10#1)(2010-12#1)(2010-4#1)
the RP extract##3##3##(1996-4#3)
the RP##8##2##(1996-4#3)(2010-1#1)(2010-10#1)(2010-12#1)(2012-2#2)
the RP-HPLC official method##2##4##(2008-10#2)
the RP-HPLC##3##2##(1990-2#1)(2008-10#2)
the RP25 interval##2##3##(2008-5#2)
the RP25##4##2##(2008-5#4)
the RPA##3##2##(2007-8#2)(2008-10#1)
the RPE melanin is##2##4##(1992-2#2)
the RPE melanin##3##3##(1992-2#3)
the RPE##14##2##(1990-6#2)(1992-11#1)(1992-2#3)(1995-9#3)(2008-3#4)(2008-4#1)
the RPLPPLP motif##2##3##(1994-9#2)
the RPP and##2##3##(2007-12#2)
the RPP calibration set##3##4##(2007-12#3)
the RPP sample set##2##4##(2007-12#2)
the RPP##9##2##(2007-12#9)
the RPT technique##4##3##(2008-3#4)
the RPT##6##2##(2008-2#1)(2008-3#5)
the RPn##2##2##(1991-3#2)
the RR for##2##3##(1991-9#1)(2008-10#1)
the RR values##2##3##(2008-10#2)
the RR was##2##3##(1992-9#1)(2013-8#1)
the RR##10##2##(1991-9#1)(1992-9#1)(1994-11#2)(1994-12#1)(2008-10#3)(2013-8#2)
the RRE and##2##3##(1994-8#2)
the RRE with##3##3##(1993-8#3)
the RRE##10##2##(1993-8#8)(1994-8#2)
the RRS intensity##2##3##(2008-10#2)
the RRS technology##2##3##(2008-10#2)
the RRS##8##2##(2007-8#2)(2008-10#6)
the RRs##2##2##(1993-9#1)(2013-1#1)
the RS and IRS##2##4##(2008-12#2)
the RS##8##2##(1991-9#2)(1993-11#1)(1995-3#1)(2008-10#1)(2008-12#2)(2009-2#1)
the RS+##3##2##(1997-8#3)
the RSC##3##2##(2008-10#1)(2012-12#2)
the RSD of the##4##4##(2008-10#4)
the RSD was##3##3##(2008-10#3)
the RSD##11##2##(2005-4#1)(2008-10#10)
the RT and##3##3##(1995-5#1)(1996-3#1)(2007-2#1)
the RT of##2##3##(1995-8#2)
the RT##10##2##(1993-2#1)(1995-5#1)(1995-8#2)(1996-3#1)(1997-3#3)(2007-2#1)(2011-2#1)
the RT-PCR##11##2##(2007-1#1)(2008-10#3)(2008-5#3)(2008-8#1)(2009-12#1)(2010-5#1)(2012-2#1)
the RT1##2##2##(1995-2#1)(2009-9#1)
the RTCs##11##2##(2009-4#11)
the RTD##4##2##(2008-10#4)
the RTP quenching##2##3##(2008-10#2)
the RTP##11##2##(2008-10#11)
the RTS endpoints##2##3##(2008-10#2)
the RTS##3##2##(2008-10#3)
the RUC##2##2##(2009-7#2)
the RV##3##2##(2007-8#1)(2008-10#2)
the RVC##4##2##(2008-10#4)
the RVLM##8##2##(1991-5#2)(1995-3#3)(1997-2#1)(1997-8#2)
the RWJF##2##2##(2013-1#2)
the RXR##2##2##(1993-3#1)(1995-8#1)
the RXRs##2##2##(1996-8#2)
the RYSV##2##2##(2008-8#2)
the Rab##2##2##(1994-9#1)(1995-6#1)
the Rad21 protein##3##3##(1995-3#3)
the Radiation Therapy##2##3##(1994-10#1)(1996-1#1)
the Radiation##4##2##(1994-10#1)(1996-1#1)(2008-10#2)
the Radiology##5##2##(1990-10#1)(1992-1#1)(2005-10#1)(2007-4#1)(2008-6#1)
the Radionics##2##2##(2008-7#2)
the Radon transform##3##3##(2008-2#3)
the Radon##4##2##(2008-2#4)
the Rainbow Trout##2##3##(2008-5#1)(2008-6#1)
the Raji cells##2##3##(2008-5#2)
the Raji##3##2##(1993-9#1)(2008-5#2)
the Ram1##2##2##(1993-9#2)
the Raman contribution##2##3##(2008-3#2)
the Raman cross section of O(2)(a(1)D(g))##2##6##(2008-1#2)
the Raman cross section of##4##5##(2008-1#3)(2009-5#1)
the Raman cross##5##3##(2008-1#3)(2008-3#1)(2009-5#1)
the Raman differential absorption lidar##2##5##(2008-3#2)
the Raman effect##4##3##(2007-12#3)(2008-10#1)
the Raman gain coefficient was##2##5##(2007-11#1)(2008-3#1)
the Raman gain coefficients##2##4##(2007-12#1)(2008-3#1)
the Raman gain##8##3##(2007-11#3)(2007-12#2)(2008-1#1)(2008-3#2)
the Raman peaks##2##3##(1996-2#1)(2007-11#1)
the Raman scattering coefficient##3##4##(2008-2#2)(2008-3#1)
the Raman scattering cross section of##2##6##(2008-3#2)
the Raman scattering cross section##3##5##(2007-12#1)(2008-3#2)
the Raman scattering##9##3##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#3)(2011-1#1)
the Raman signal##2##3##(2008-10#1)(2009-4#1)
the Raman source function##2##4##(2008-3#2)
the Raman spectra of the cells##2##6##(2006-7#2)
the Raman spectra of the##3##5##(2006-7#2)(2010-8#1)
the Raman spectra of##5##4##(2006-7#2)(2008-2#1)(2010-8#1)(2013-8#1)
the Raman spectra##12##3##(2005-4#3)(2006-3#1)(2006-7#2)(2008-1#1)(2008-10#1)(2008-2#1)(2010-8#1)(2013-8#2)
the Raman spectroscopy##2##3##(2013-8#2)
the Raman spectrum of##2##4##(2008-2#1)(2008-3#1)
the Raman spectrum##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-4#1)
the Raman##93##2##(1991-5#1)(1996-2#2)(2005-4#4)(2006-12#1)(2006-3#1)(2006-7#2)(2007-11#13)(2007-12#9)(2008-1#5)(2008-10#8)(2008-2#8)(2008-3#18)(2008-4#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#1)(2013-7#1)(2013-8#8)
the Raman-Nath##3##2##(2007-12#1)(2008-2#2)
the Raman-scattered##2##2##(2008-2#2)
the Rankin Scale##2##3##(2007-9#2)
the Rankin##3##2##(2007-9#3)
the RapID ANA II##2##4##(2006-8#2)
the Rapid##4##2##(1997-6#1)(2006-8#1)(2007-6#1)(2008-3#1)
the Ras signaling pathway##2##4##(1994-8#2)
the Ras##13##2##(1990-3#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-8#3)(1995-2#2)(1995-8#1)(1996-5#1)(2006-10#1)(2008-5#1)
the Ras-binding domain##3##3##(1995-5#2)(1997-7#1)
the Ras-binding##4##2##(1995-5#2)(1997-7#1)(2013-8#1)
the Ras-guanine nucleotide exchange factor##2##5##(1993-4#2)
the Ras-induced##3##2##(1994-12#3)
the Ras-related GTP-binding protein##2##4##(1991-11#1)(1991-5#1)
the Ras-related##3##2##(1991-11#1)(1991-5#1)(1997-4#1)
the Rasch model##4##3##(2008-11#1)(2009-11#1)(2012-2#2)
the Rasch##6##2##(2008-11#1)(2009-11#1)(2011-2#1)(2012-2#3)
the Rat##2##2##(2008-12#1)(2009-10#1)
the Rayleigh limit of resolution##2##5##(2008-3#2)
the Rayleigh limit##4##3##(2008-2#1)(2008-3#3)
the Rayleigh range divided##2##4##(2008-2#2)
the Rayleigh range##3##3##(2008-2#3)
the Rayleigh scattering##3##3##(2008-2#1)(2008-3#2)
the Rayleigh##20##2##(2007-11#1)(2008-10#1)(2008-2#11)(2008-3#7)
the Rayleigh-Gans approximation##2##3##(2008-2#2)
the Rayleigh-Sommerfeld##3##2##(2008-2#1)(2008-3#2)
the Rb##3##2##(1992-6#1)(1996-4#1)(1997-7#1)
the ReView##2##2##(2008-11#2)
the Reactome database##3##3##(2008-4#3)
the Reagan administration##5##3##(1991-1#5)
the Reagan##7##2##(1991-1#5)(1993-2#2)
the Real Economic Stabilization##2##4##(2008-9#2)
the Real##3##2##(2008-5#1)(2008-9#2)
the Rear##2##2##(2006-11#1)(2013-8#1)
the RecA##3##2##(1990-9#1)(1995-8#2)
the RecQ-Ct domain##2##3##(2012-2#2)
the Recognition of##2##3##(2008-10#1)(2011-2#1)
the Recognition##3##2##(2008-10#1)(2009-4#1)(2011-2#1)
the Red Cross##5##3##(1990-12#1)(1991-11#1)(1992-11#1)(2006-8#1)(2008-10#1)
the Red Queen hypothesis##3##4##(2009-2#3)
the Red##9##2##(1990-12#1)(1991-11#1)(1992-11#1)(2006-8#1)(2008-10#1)(2009-2#3)(2010-8#1)
the Reduced##2##2##(1990-11#1)(2008-10#1)
the Reference##3##2##(1995-1#1)(2010-9#1)(2013-1#1)
the Reformation##3##2##(2008-11#1)(2008-8#1)(2011-7#1)
the Region##3##2##(2005-11#2)(2011-2#1)
the Regional Office##2##3##(1991-12#1)(2012-1#1)
the Regional Training Centres (RTCs)##4##5##(2009-4#4)
the Regional Training Centres##6##4##(2009-4#6)
the Regional##21##2##(1990-2#2)(1990-8#1)(1991-12#1)(1997-8#1)(2007-4#1)(2008-10#3)(2009-4#6)(2011-2#1)(2012-1#1)(2012-12#2)(2013-8#2)
the Register of##2##3##(1994-12#1)(2010-9#1)
the Registered Health Information Administrator##2##5##(2007-12#2)
the Registered##5##2##(2007-10#2)(2007-12#2)(2012-1#1)
the Registrar General of##2##4##(2008-10#1)(2009-4#1)
the Regulation##3##2##(2011-2#2)(2012-1#1)
the Rehabilitation Act##3##3##(1992-12#1)(1995-12#2)
the Rehabilitation Clinic##3##3##(2007-11#2)(2007-8#1)
the Rehabilitation##9##2##(1992-12#1)(1995-12#2)(2007-11#3)(2007-7#1)(2007-8#1)(2008-10#1)
the Relational Completion Procedure##4##4##(2011-2#4)
the Relations##2##2##(2008-5#1)(2010-8#1)
the Relationship Between##4##3##(2006-7#3)(2008-10#1)
the Relationship between##4##3##(1996-9#1)(2008-3#1)(2010-3#1)(2013-1#1)
the Relationship##9##2##(1996-9#1)(2006-7#3)(2008-10#1)(2008-3#1)(2010-3#1)(2010-8#1)(2013-1#1)
the Release of##3##3##(2008-10#2)(2009-11#1)
the Release##4##2##(2008-10#3)(2009-11#1)
the Religious Society of Friends##2##5##(2012-2#2)
the Renaissance##7##2##(2005-12#1)(2006-12#1)(2008-11#1)(2008-8#1)(2009-2#1)(2011-2#1)(2013-1#1)
the Renal##2##2##(2008-1#1)(2008-6#1)
the Rep gene##3##3##(2008-10#3)
the Rep##7##2##(2008-10#7)
the RepA##2##2##(2008-5#2)
the Repetitive##2##2##(2012-2#1)(2013-8#1)
the Reproductive##6##2##(2004-3#1)(2005-7#2)(2006-12#1)(2008-5#1)(2013-8#1)
the Republic of Belarus##2##4##(2008-10#1)(2011-2#1)
the Republic of Croatia##4##4##(2011-2#2)(2013-1#2)
the Republic of Ireland##2##4##(1997-8#1)(2008-10#1)
the Republic of Korea and Japan##3##6##(2005-5#3)
the Republic of Korea##7##4##(2005-5#5)(2012-2#2)
the Republic of Palau and##3##5##(2008-1#2)(2013-8#1)
the Republic of Palau##11##4##(2008-1#9)(2013-8#2)
the Republic of the Marshall Islands##4##6##(2008-1#2)(2013-8#2)
the Republic of the##5##4##(2008-1#3)(2013-8#2)
the Republic of##40##3##(1995-3#1)(1997-8#1)(2005-5#5)(2005-9#1)(2008-1#13)(2008-10#2)(2008-4#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#5)(2012-2#2)(2013-1#2)(2013-8#4)
the Republic##44##2##(1995-3#1)(1997-8#1)(2005-5#5)(2005-9#1)(2008-1#14)(2008-10#2)(2008-4#1)(2009-4#2)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#4)
the Republicans##2##2##(1995-6#1)(1997-2#1)
the Research Ethics##2##3##(2011-2#1)(2012-3#1)
the Research##12##2##(1992-2#1)(1997-8#1)(2006-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-4#1)(2011-2#2)(2012-12#1)(2012-3#1)
the Resection##4##2##(2008-4#3)(2012-3#1)
the Residency##2##2##(2004-3#1)(2007-12#1)
the Resident##2##2##(2008-6#1)(2010-11#1)
the Resource Utilization Groups##2##4##(1993-2#1)(1997-1#1)
the Resource##3##2##(1993-2#1)(1994-3#1)(1997-1#1)
the Response of##2##3##(2007-1#1)(2008-10#1)
the Response##4##2##(2007-1#1)(2008-10#2)(2009-4#1)
the Restin##2##2##(2008-9#2)
the Results##2##2##(2009-4#1)(2013-8#1)
the Retreat##2##2##(2008-7#2)
the Rev virus##2##3##(2007-6#2)
the Rev##4##2##(1993-8#1)(1996-4#1)(2007-6#2)
the Rev-mediated RNA nuclear export##2##5##(2011-3#2)
the Rev-responsive element##3##3##(1991-7#1)(1994-8#2)
the Rev-responsive##4##2##(1991-7#2)(1994-8#2)
the Reveal equipment##2##3##(2006-10#2)
the Reveal test##3##3##(2006-10#3)
the Reveal##6##2##(2006-10#6)
the Revised##4##2##(2008-11#1)(2008-6#1)(2009-7#1)(2013-1#1)
the Revolution##4##2##(1990-12#1)(2011-1#3)
the Rex-1 promoter##2##3##(1994-9#2)
the Rex-1##6##2##(1994-9#6)
the Reykjavik Health##2##3##(2006-10#1)(2006-7#1)
the Reykjavik Study##2##3##(2006-8#2)
the Reykjavik##10##2##(2006-10#6)(2006-7#2)(2006-8#2)
the Reykjavík##4##2##(2006-10#2)(2006-7#2)
the Reynolds number##2##3##(2006-12#1)(2008-7#1)
the Rh##5##2##(1992-12#1)(1992-9#1)(1994-12#2)(2008-2#1)
the RhB##2##2##(2008-10#2)
the Rheumatoorthopedics Department##2##3##(2007-11#2)
the Rhizobium##2##2##(1994-8#1)(1996-7#1)
the Rhizobium-legume symbiosis##2##3##(2008-11#2)
the Rhodamine##3##2##(2008-10#1)(2008-2#1)(2009-11#1)
the Rhodophyta##3##2##(1997-4#2)(2008-5#1)
the Rhône##2##2##(2008-10#1)(2010-8#1)
the Ri##3##2##(2007-8#3)
the Rice##5##2##(1997-4#1)(2008-10#2)(2009-10#1)(2013-8#1)
the Richards function##2##3##(2008-10#2)
the Richards model##2##3##(2008-10#2)
the Richards##5##2##(2008-10#5)
the Richmond##3##2##(1990-8#1)(1993-9#1)(2010-6#1)
the Rieske##2##2##(1995-11#1)(1996-9#1)
the Right##8##2##(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#4)
the Rio Coto Colorado##2##4##(2007-5#2)
the Rio Grande Valley##2##4##(2008-10#2)
the Rio de la Plata##2##5##(2007-5#1)(2008-8#1)
the Rio##9##2##(2006-7#1)(2007-5#3)(2008-10#3)(2008-5#1)(2008-8#1)
the Rippey and the Rodel appliqués##2##6##(2008-3#2)
the Rippey and##3##3##(2008-3#3)
the Rippey##4##2##(2008-3#4)
the Risk of##4##3##(1996-3#1)(2008-10#2)(2009-6#1)
the Risk##7##2##(1996-3#1)(1997-3#1)(2008-10#2)(2009-6#1)(2010-7#1)(2013-8#1)
the Ritz-Carlton's approach to strategic planning##2##6##(1994-2#1)(1994-3#1)
the River Wye##2##3##(1992-6#2)
the River##6##2##(1992-6#2)(2004-4#1)(2008-10#1)(2010-8#1)(2011-1#1)
the Riyadh##3##2##(2008-1#2)(2013-1#1)
the Road Map##3##3##(2011-1#3)
the Road##4##2##(2005-9#1)(2011-1#3)
the Robert Wood Johnson Foundation's##2##5##(1996-12#1)(2013-1#1)
the Robert Wood Johnson##4##4##(1993-2#1)(1996-12#1)(2007-10#1)(2013-1#1)
the Robert##6##2##(1993-2#1)(1996-1#1)(1996-12#1)(2007-10#1)(2011-2#1)(2013-1#1)
the Roberts wavelet filter##2##4##(2008-2#2)
the Roberts##3##2##(2008-2#3)
the Robo1##2##2##(2011-2#2)
the Robotic Sensory Trainer##2##4##(2012-1#2)
the Roche##3##2##(1990-8#1)(2008-10#1)(2011-2#1)
the Rochester##3##2##(1992-12#1)(1996-2#1)(2009-7#1)
the Rockefeller Foundation##3##3##(1995-5#1)(1997-3#1)(2008-5#1)
the Rocky Mountains##2##3##(1991-2#1)(2008-10#1)
the Rocky##4##2##(1991-2#1)(2007-2#1)(2008-10#1)(2008-9#1)
the Rodel##3##2##(2008-3#3)
the Role of##19##3##(2006-10#1)(2008-10#3)(2008-5#1)(2008-6#1)(2009-10#2)(2010-12#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)
the Role##20##2##(2006-10#1)(2008-10#3)(2008-5#1)(2008-6#1)(2009-10#2)(2009-11#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)
the Roles##3##2##(1997-2#1)(2013-1#2)
the Roman##7##2##(1990-12#1)(1997-2#1)(2008-10#2)(2008-3#1)(2010-1#2)
the Romanian##3##2##(1990-5#1)(2008-1#1)(2010-4#1)
the Romanow Commission##3##3##(2007-7#2)(2009-4#1)
the Romanowsky stains##2##3##(2008-4#1)(2008-9#1)
the Ronchi test##4##3##(2008-2#1)(2008-3#3)
the Ronchi##6##2##(2008-2#1)(2008-3#5)
the Root##3##2##(2008-10#2)(2009-4#1)
the Root-Knot Nematode##2##3##(2008-10#2)
the Rosascos##3##2##(1996-5#3)
the RosetteSep kit from StemCell technologies##2##6##(2008-11#2)
the Ross River##2##3##(2007-11#1)(2008-1#1)
the Ross##3##2##(2007-11#1)(2008-1#1)(2012-2#1)
the Rotterdam Study##2##3##(1995-9#1)(2009-12#1)
the Rotterdam##3##2##(1992-7#1)(1995-9#1)(2009-12#1)
the Royal College of Obstetricians and##2##6##(2004-10#1)(2005-8#1)
the Royal College of Physicians##5##5##(1990-9#1)(1994-12#1)(1996-8#2)(2008-2#1)
the Royal College of##12##4##(1990-3#1)(1990-9#1)(1994-12#2)(1996-8#2)(2004-10#1)(2005-8#1)(2008-2#1)(2012-11#1)(2012-12#1)(2012-3#1)
the Royal College##13##3##(1990-3#1)(1990-9#1)(1994-12#2)(1996-8#2)(2004-10#1)(2005-8#1)(2008-11#1)(2008-2#1)(2012-11#1)(2012-12#1)(2012-3#1)
the Royal Free Hospital##2##4##(2006-11#1)(2011-1#1)
the Royal Free##3##3##(2006-11#2)(2011-1#1)
the Royal Infirmary of Edinburgh##2##5##(2010-12#1)(2011-2#1)
the Royal Marsden Hospital##2##4##(2008-6#2)
the Royal New Zealand##2##4##(1990-2#1)(1997-3#1)
the Royal Orthopaedic Hospital##2##4##(2008-6#2)
the Royal Society of##3##4##(2006-10#1)(2007-9#1)(2008-5#1)
the Royal Society##4##3##(2006-10#1)(2006-7#1)(2007-9#1)(2008-5#1)
the Royal##41##2##(1990-2#1)(1990-3#1)(1990-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-12#2)(1996-11#1)(1996-8#2)(1997-3#1)(2004-10#1)(2005-8#2)(2006-10#1)(2006-11#3)(2006-7#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#4)(2008-8#2)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-3#1)
the Rp isomer of##2##4##(1990-12#1)(2009-2#1)
the Rp##4##2##(1990-12#1)(1994-12#2)(2009-2#1)
the RpII LS##3##3##(1997-7#3)
the Rpc1 locus##2##3##(2008-10#2)
the Rph3##2##2##(2008-10#2)
the Ru(II)##2##2##(2008-10#1)(2010-5#1)
the Rubini strain##2##3##(1997-6#2)
the Rubini##4##2##(1997-6#4)
the Runt domain##3##3##(1997-1#3)
the Rural Health##3##3##(1996-2#1)(1996-3#1)(2008-12#1)
the Rural##4##2##(1996-2#1)(1996-3#1)(2008-12#1)(2008-7#1)
the Russian Federation##7##3##(1994-4#1)(1995-3#1)(1997-1#1)(2008-11#2)(2008-8#1)(2012-12#1)
the Russian population##2##3##(2008-7#1)(2009-8#1)
the Russian##20##2##(1994-4#1)(1995-3#1)(1997-1#1)(2004-3#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#2)(2011-2#1)(2012-12#1)(2013-1#2)
the Rust Fungus##2##3##(2008-10#2)
the Rust##3##2##(2008-10#3)
the Rutgers Ankle CP##2##4##(2012-1#2)
the Rx1##2##2##(2008-10#2)
the RyR Ca(2+) release channel##2##5##(2006-10#2)
the RyR##5##2##(1995-3#2)(2006-10#3)
the RyR1s##5##2##(2008-9#5)
the Ryan White CARE Act and##2##6##(1995-12#1)(1996-5#1)
the Ryan White CARE Act##6##5##(1995-12#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#2)
the Ryan White##7##3##(1995-12#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#2)
the Ría##2##2##(2010-5#2)
the S RNA##3##3##(2008-10#3)
the S and##6##3##(1994-3#1)(2004-7#1)(2008-10#2)(2008-11#1)(2008-5#1)
the S column##3##3##(1995-3#3)
the S function##2##3##(2008-3#2)
the S phase of the cell cycle##6##7##(1992-6#1)(1994-12#1)(1994-8#1)(2008-4#1)(2008-9#1)(2009-9#1)
the S phase##20##3##(1991-9#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#2)(1994-8#1)(1994-9#1)(1997-6#1)(2004-11#1)(2008-11#2)(2008-4#1)(2008-9#2)(2009-9#1)
the S strain##4##3##(2008-10#3)(2008-5#1)
the S##94##2##(1990-10#1)(1990-2#1)(1990-3#3)(1990-5#1)(1990-8#1)(1990-9#3)(1991-5#2)(1991-7#1)(1991-9#2)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-2#3)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#3)(1994-3#3)(1994-8#1)(1994-9#2)(1995-1#2)(1995-3#4)(1995-5#1)(1995-6#1)(1996-6#3)(1997-5#1)(1997-6#1)(1997-7#1)(2004-11#2)(2004-7#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#16)(2008-11#6)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#2)(2009-9#1)(2010-10#1)(2010-3#1)(2010-8#2)
the S(1)##3##2##(2006-5#1)(2007-1#1)(2009-9#1)
the S(2)##4##2##(2006-4#4)
the S- and R-isomers of 17##2##6##(1992-3#2)
the S- and##3##3##(1992-3#2)(2009-10#1)
the S-(-)##2##2##(1990-12#2)
the S-100 family##2##3##(1991-6#2)
the S-100##3##2##(1991-6#2)(1994-6#1)
the S-N bond##3##3##(2008-6#3)
the S-ROM prosthesis##2##3##(2009-3#2)
the S-dsRNA##5##2##(2008-10#5)
the S-enantiomer##2##2##(1996-3#1)(2008-10#1)
the S-isomer of omeprazole##2##4##(2006-10#1)(2008-5#1)
the S-isomer of##3##3##(1993-3#1)(2006-10#1)(2008-5#1)
the S-isomer##4##2##(1992-3#1)(1993-3#1)(2006-10#1)(2008-5#1)
the S-nitroso adduct of##3##4##(1995-5#3)
the S-phase fraction##3##3##(1993-1#1)(1993-11#1)(1994-12#1)
the S-phase of the cell cycle##2##6##(1994-12#1)(2009-5#1)
the S-phase of##3##3##(1994-12#1)(2008-4#1)(2009-5#1)
the S-phase##9##2##(1991-10#1)(1993-1#1)(1993-11#1)(1994-12#2)(1997-1#2)(2008-4#1)(2009-5#1)
the S-shaped##2##2##(2008-10#1)(2010-2#1)
the S-strain##2##2##(2008-10#1)(2008-5#1)
the S/B##2##2##(1994-12#2)
the S/G2##3##2##(1997-6#3)
the S/N ratio##2##3##(2007-8#2)
the S/N##4##2##(1996-4#1)(2007-8#2)(2008-10#1)
the S1 and S2 states of the##2##7##(1997-7#2)
the S1 and S2##3##4##(1994-9#1)(1997-7#2)
the S1 and##4##3##(1994-9#1)(1997-7#2)(2008-10#1)
the S1 gene##2##3##(1994-9#1)(2008-5#1)
the S1 protein##2##3##(1997-3#1)(2008-5#1)
the S1 state##2##3##(1997-7#2)
the S1##24##2##(1994-12#1)(1994-9#2)(1997-1#1)(1997-3#4)(1997-4#3)(1997-7#5)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#4)
the S1' and##2##3##(1991-2#1)(1995-3#1)
the S100 family##2##3##(1992-6#2)
the S14##2##2##(1991-8#1)(1992-1#1)
the S182 gene on chromosome 14q24##2##6##(1995-8#2)
the S182 gene##3##3##(1995-8#3)
the S182##4##2##(1995-8#4)
the S1NPV polh promoter##2##4##(1997-4#2)
the S2 and S3##2##4##(1992-9#1)(1996-4#1)
the S2 and##3##3##(1992-9#1)(1996-4#1)(1996-8#1)
the S2 state##4##3##(1997-7#4)
the S2##10##2##(1992-9#1)(1994-12#1)(1996-4#1)(1996-8#1)(1997-7#5)(2011-12#1)
the S20##2##2##(1994-9#1)(2008-6#1)
the S3##4##2##(1993-2#2)(1994-12#1)(1996-7#1)
the S4##3##2##(1995-8#1)(2008-5#1)(2008-8#1)
the S4-S5 loop##2##3##(1994-9#2)
the S6 helix##5##3##(2006-2#4)(2008-8#1)
the S6 strain of##2##4##(1997-6#1)(2008-5#1)
the S6##7##2##(1997-6#1)(2006-2#4)(2008-5#1)(2008-8#1)
the SA concentration range##2##4##(2008-10#2)
the SA pathway##3##3##(1997-5#1)(2009-6#1)(2009-8#1)
the SA receptor##2##3##(2009-8#2)
the SA##13##2##(1995-11#1)(1997-5#1)(2008-10#3)(2008-2#1)(2009-6#2)(2009-8#3)(2011-10#1)(2012-12#1)
the SA-dependent##2##2##(2009-6#2)
the SAA##7##2##(1993-6#2)(1995-3#4)(2008-10#1)
the SAB1##2##2##(1997-8#2)
the SAD group##4##3##(1996-1#4)
the SAE##2##2##(2007-4#2)
the SAFER##3##2##(2008-3#1)(2013-1#2)
the SAGE II##2##3##(2008-2#2)
the SAGE##4##2##(2008-2#3)(2008-4#1)
the SAM##21##2##(2005-11#1)(2006-12#1)(2008-10#11)(2008-2#1)(2008-4#2)(2009-3#3)(2010-4#1)(2012-2#1)
the SAM/SAH##2##2##(1994-12#2)
the SAMDC mRNA##2##3##(1996-7#2)
the SAMs##5##2##(2005-11#1)(2007-9#1)(2008-10#3)
the SAPHO syndrome##3##3##(1996-12#2)(2006-10#1)
the SAPS-I algorithm##6##3##(2013-1#6)
the SAR signal##2##3##(2009-8#2)
the SAR##6##2##(1992-3#1)(2008-3#1)(2008-8#2)(2009-8#2)
the SAR-inducing##3##2##(2008-10#3)
the SARS epidemic##2##3##(2008-7#2)
the SARS##4##2##(2007-5#1)(2008-7#2)(2009-7#1)
the SARS-CoV##2##2##(2005-10#1)(2008-5#1)
the SARS-associated coronavirus##2##3##(2005-10#1)(2007-7#1)
the SAS##2##2##(2008-7#1)(2009-8#1)
the SATAQ-3##3##2##(2007-12#3)
the SAVE trial##2##3##(1993-2#2)
the SAW##2##2##(2007-8#1)(2008-3#1)
the SB-1##2##2##(2013-8#2)
the SBCH##3##2##(2008-2#3)
the SBD##4##2##(1993-5#1)(1996-6#2)(2006-12#1)
the SBS##3##2##(2006-8#1)(2007-11#1)(2007-12#1)
the SC and HDC##2##4##(2008-10#2)
the SC and##3##3##(2008-10#2)(2008-5#1)
the SC barrier function##2##4##(2008-5#2)
the SC on##2##3##(2008-5#2)
the SC##39##2##(1993-9#1)(2008-10#4)(2008-2#2)(2008-4#2)(2008-5#29)(2009-11#1)
the SCA 4 l/min group##2##5##(2011-2#2)
the SCA1##3##2##(1997-5#2)(2011-2#1)
the SCAR locus##2##3##(2008-10#2)
the SCAR##7##2##(2008-10#4)(2009-10#2)(2012-12#1)
the SCAVM##2##2##(1995-11#1)(1997-6#1)
the SCC-DFTB##3##2##(2008-10#1)(2012-12#2)
the SCEKAN cassette can be##2##5##(1996-10#2)
the SCG##2##2##(1991-12#1)(1994-8#1)
the SCGE assay##2##3##(1997-4#2)
the SCI##2##2##(2009-12#1)(2012-1#1)
the SCID mouse##5##3##(1994-2#1)(1995-8#3)(2008-11#1)
the SCID##8##2##(1994-2#2)(1995-5#1)(1995-8#3)(1996-1#1)(2008-11#1)
the SCM##2##2##(2007-1#1)(2011-2#1)
the SCMV##3##2##(2008-10#3)
the SCN were##2##3##(1996-1#2)
the SCN##27##2##(1992-8#1)(1993-12#5)(1993-9#2)(1994-10#2)(1994-2#4)(1994-5#1)(1995-11#4)(1996-1#2)(1996-6#1)(1996-9#1)(1997-5#3)(2009-2#1)
the SCR##2##2##(2008-10#1)(2011-2#1)
the SD of HbA1c levels (r = 0##2##6##(2012-5#2)
the SD of HbA1c levels##3##5##(2012-5#3)
the SD rats##3##3##(1992-7#1)(2009-4#2)
the SD##12##2##(1990-7#3)(1992-7#1)(2008-6#1)(2009-11#1)(2009-4#2)(2012-5#3)(2013-1#1)
the SDC##2##2##(1991-9#2)
the SDLA##2##2##(2008-3#2)
the SDQ##2##2##(2008-10#1)(2012-2#1)
the SDR##2##2##(1993-1#2)
the SDS gel##2##3##(2008-10#2)
the SDS##11##2##(1992-11#1)(1994-9#1)(2005-11#3)(2007-1#1)(2008-10#4)(2008-5#1)
the SDS-PAGE##3##2##(1990-8#1)(1992-12#1)(2012-3#1)
the SE United States##2##4##(2008-10#2)
the SE##8##2##(2008-10#5)(2008-11#1)(2008-3#1)(2011-12#1)
the SEA##4##2##(1993-6#4)
the SEC##3##2##(1991-2#1)(1997-2#1)(2004-4#1)
the SEM and##3##3##(1991-6#1)(1995-4#1)(2008-5#1)
the SEM##5##2##(1991-6#1)(1995-4#1)(2008-5#2)(2013-1#1)
the SEPS technique##2##3##(2006-6#2)
the SERCA##2##2##(1992-11#1)(2007-10#1)
the SERS measurement##2##3##(2007-12#1)(2008-2#1)
the SERS spectra of HA##2##5##(2013-8#2)
the SERS spectra of##3##4##(2009-8#1)(2013-8#2)
the SERS spectra##4##3##(2006-12#1)(2009-8#1)(2013-8#2)
the SERS spectrum##2##3##(2008-10#2)
the SERS##11##2##(2006-12#1)(2007-12#1)(2008-10#2)(2008-2#1)(2009-8#1)(2010-4#1)(2013-1#2)(2013-8#2)
the SERS-active##2##2##(2008-10#2)
the SERT##2##2##(1997-2#1)(2005-9#1)
the SERVQUAL scale##2##3##(1993-12#2)
the SF and##2##3##(1994-7#1)(2008-10#1)
the SF##7##2##(1994-7#2)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#1)
the SF-36 questionnaire##3##3##(2011-2#1)(2013-8#2)
the SF-36##14##2##(1994-3#2)(1996-3#1)(2006-8#2)(2007-10#2)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#2)
the SF-CO(2) extraction##2##3##(2008-10#2)
the SF-CO(2)##3##2##(2008-10#3)
the SFC##3##2##(2008-10#1)(2008-2#1)(2008-6#1)
the SFE and##2##3##(2008-10#2)
the SFE##5##2##(2008-10#5)
the SFG nonresonant signal##2##4##(2008-10#2)
the SFG##4##2##(2008-10#4)
the SFJ##2##2##(1991-10#2)
the SFLLR##2##2##(1992-4#2)
the SFO##3##2##(1992-5#1)(1994-2#2)
the SFS##2##2##(2008-10#1)(2008-2#1)
the SFV expression##2##3##(2008-11#2)
the SFV##3##2##(2008-1#1)(2008-11#2)
the SG##5##2##(1993-12#2)(2012-2#2)(2013-1#1)
the SGA##2##2##(2008-4#1)(2013-1#1)
the SGC##4##2##(1995-2#1)(2008-3#3)
the SGD##3##2##(2013-8#3)
the SGP##2##2##(1994-11#2)
the SGR##3##2##(2007-3#2)(2008-4#1)
the SGV-H2##2##2##(2008-4#2)
the SH group##11##3##(1990-12#4)(1991-1#1)(1991-5#2)(1995-8#1)(1996-5#2)(2006-6#1)
the SH##19##2##(1990-12#4)(1991-1#1)(1991-5#2)(1994-11#1)(1995-8#1)(1996-5#4)(2006-6#1)(2007-12#4)(2008-5#1)
the SH2 and SH3##2##4##(1991-12#1)(1993-6#1)
the SH2 domain of##5##4##(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-7#1)
the SH2 domain##10##3##(1995-2#4)(1995-3#1)(1995-6#2)(1996-5#2)(1997-7#1)
the SH2 domains of Src##2##5##(1995-6#2)
the SH2 domains of##3##4##(1995-6#3)
the SH2##16##2##(1991-12#1)(1993-6#1)(1995-2#4)(1995-3#1)(1995-6#5)(1996-5#3)(1997-7#1)
the SH3 domain of##2##4##(1994-9#1)(1997-4#1)
the SH3 domain##3##3##(1993-6#1)(1994-9#1)(1997-4#1)
the SH3##5##2##(1993-6#1)(1994-9#2)(1997-4#1)(2008-8#1)
the SH3-domain##2##2##(2008-8#2)
the SHAPE##2##2##(2008-3#2)
the SHC##2##2##(1995-3#1)(1996-5#1)
the SHG##4##2##(2007-11#1)(2007-12#3)
the SHHS##2##2##(2010-3#2)
the SHIP2-SH2 domain##2##3##(2012-2#2)
the SHIP2-SH2##3##2##(2012-2#3)
the SHM##3##2##(2008-8#2)(2011-2#1)
the SHR##8##2##(1990-7#1)(1993-2#3)(1994-2#1)(1994-8#1)(2009-4#2)
the SI system##2##3##(2008-10#2)
the SI##11##2##(1991-5#1)(1994-10#1)(1996-2#1)(2006-10#1)(2007-12#1)(2008-10#3)(2012-2#3)
the SIA system##5##3##(2008-10#5)
the SIA##6##2##(2008-10#6)
the SIBID-S##2##2##(2007-12#2)
the SIDS population##2##3##(1994-4#2)
the SIDS##3##2##(1992-4#1)(1994-4#2)
the SIJ is related to##2##5##(2006-12#2)
the SIJ is##3##3##(2006-12#3)
the SIJ##8##2##(2006-12#5)(2006-8#2)(2010-1#1)
the SIL##6##2##(2007-12#2)(2008-3#4)
the SIMD array of neurons##2##5##(2008-2#2)
the SIMD array##3##3##(2008-2#3)
the SIMon FEHM##2##3##(2006-11#2)
the SIMon##4##2##(2006-11#4)
the SIP##5##2##(2008-3#5)
the SIP68##2##2##(2007-10#2)
the SIR##3##2##(1993-9#1)(1996-7#1)(2012-2#1)
the SIV##3##2##(1992-6#1)(1994-12#1)(2007-3#1)
the SJL##3##2##(1992-8#1)(2008-4#2)
the SK-N-MC cells##2##3##(2008-7#2)
the SL##5##2##(1991-4#1)(1992-12#2)(2007-9#2)
the SLE patients##5##3##(1990-6#1)(1994-3#1)(2006-10#2)(2008-8#1)
the SLE##10##2##(1990-6#1)(1994-3#1)(2006-10#3)(2008-8#1)(2010-5#1)(2012-12#3)
the SLIV##2##2##(2012-2#2)
the SLM##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2012-1#1)
the SLN and##3##3##(1993-12#2)(2013-1#1)
the SLN##7##2##(1993-12#3)(2008-10#1)(2008-5#1)(2013-1#2)
the SLO##2##2##(1997-1#1)(2008-2#1)
the SLOS##2##2##(1997-1#2)
the SLP-14##3##2##(1993-2#3)
the SM and##2##3##(2012-3#2)
the SM concentration##2##3##(2010-1#2)
the SM group were significantly lower than##2##7##(2012-3#2)
the SM group were significantly##3##5##(2012-3#3)
the SM group were##4##4##(2010-12#1)(2012-3#3)
the SM group##5##3##(2010-12#2)(2012-3#3)
the SM results to the measured##2##6##(2007-12#2)
the SM results##3##3##(2007-12#3)
the SM##20##2##(1996-2#1)(2005-11#1)(2007-12#4)(2008-5#2)(2010-1#2)(2010-12#2)(2012-3#8)
the SMA##4##2##(1993-9#2)(1994-8#1)(2005-10#1)
the SMAQ##2##2##(2007-12#2)
the SMART##3##2##(2011-2#2)(2012-1#1)
the SMArt##4##2##(2013-1#4)
the SMBG##2##2##(2009-11#2)
the SMD was -0##2##4##(2013-8#2)
the SMD was -1##2##4##(2013-8#2)
the SMD was 0##2##4##(2013-8#2)
the SMD was##6##3##(2013-8#6)
the SMI##3##2##(2009-6#2)(2010-8#1)
the SMR##4##2##(1993-7#1)(2008-10#1)(2008-8#1)(2009-7#1)
the SN and##2##3##(1991-10#1)(1994-2#1)
the SN of##2##3##(1992-11#1)(1996-9#1)
the SN##13##2##(1991-10#3)(1992-11#1)(1994-12#1)(1994-2#5)(1996-9#2)(2010-8#1)
the SNAP-25 gene##2##3##(1996-12#1)(1997-7#1)
the SNAP-25 promoter##3##3##(1996-12#3)
the SNAP-25##5##2##(1996-12#4)(1997-7#1)
the SNB motoneurons##2##3##(1995-5#2)
the SNB of##2##3##(1994-5#1)(1995-5#1)
the SNB##9##2##(1994-5#2)(1995-5#3)(2007-8#1)(2011-2#3)
the SNF benefit##2##3##(1990-12#1)(1994-2#1)
the SNF##3##2##(1990-12#1)(1994-12#1)(1994-2#1)
the SNF1##3##2##(1992-7#2)(1994-3#1)
the SNOM##4##2##(2008-3#4)
the SNOMED CT##8##3##(2013-1#8)
the SNP##8##2##(2008-10#2)(2008-4#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2012-5#1)
the SNP-PCR##2##2##(2011-2#2)
the SNP-based##3##2##(2012-3#3)
the SNPs##5##2##(2011-1#1)(2012-1#2)(2012-2#1)(2012-3#1)
the SNR##8##2##(2004-10#2)(2007-12#1)(2008-3#5)
the SNS##7##2##(1994-9#1)(2011-1#6)
the SNT##4##2##(2005-9#4)
the SNpc##3##2##(1994-12#2)(1995-3#1)
the SO##4##2##(1990-8#1)(1997-8#2)(2010-12#1)
the SO(2)##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
the SOA##5##2##(2007-12#2)(2008-3#1)(2008-4#1)(2010-8#1)
the SOC(4) -conjugates##2##3##(2011-2#2)
the SOD activity##2##3##(1996-3#1)(2008-7#1)
the SOD##6##2##(1990-11#1)(1995-2#2)(1996-3#1)(1997-8#1)(2008-7#1)
the SOD1 activity##2##3##(2006-8#2)
the SOD1##3##2##(1996-10#1)(2006-8#2)
the SOEE##4##2##(2007-10#4)
the SOHO spacecraft##3##3##(2008-3#3)
the SOHO##6##2##(2008-2#2)(2008-3#4)
the SOI##3##2##(2007-12#3)
the SOL##3##2##(2008-7#3)
the SOLVD##3##2##(1990-1#1)(1993-2#2)
the SOM (or MENK)##3##4##(1995-2#3)
the SOM and##2##3##(1992-1#1)(2008-2#1)
the SOM##12##2##(1992-1#2)(1995-2#3)(2008-2#4)(2011-12#1)(2012-3#2)
the SON and PVN##2##4##(1993-12#1)(1995-5#1)
the SON##6##2##(1993-12#1)(1995-5#1)(1996-8#4)
the SOOF was##2##3##(2010-12#2)
the SOP cell##3##3##(2009-5#3)
the SOP##4##2##(2007-12#1)(2009-5#3)
the SOS response##4##3##(1990-11#1)(1994-9#3)
the SOS##6##2##(1990-11#1)(1994-9#3)(1995-2#1)(2006-10#1)
the SOWG##4##2##(2008-10#4)
the SOX3-positive primordial germ cells develop toward##2##7##(2010-5#2)
the SP and the##2##4##(1995-2#1)(1995-5#1)
the SP and##3##3##(1995-2#1)(1995-5#1)(2008-10#1)
the SP antagonist##3##3##(1995-12#1)(1997-4#2)
the SP of##2##3##(1993-3#2)
the SP##20##2##(1990-11#1)(1993-11#1)(1993-12#2)(1993-3#2)(1995-12#1)(1995-2#1)(1995-5#1)(1997-4#3)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-12#1)
the SP-induced##2##2##(1993-12#1)(1996-3#1)
the SP1##2##2##(1991-2#2)
the SPA-intermediate group##3##3##(1990-5#3)
the SPA-negative group##3##3##(1990-5#3)
the SPA-positive group##3##3##(1990-5#3)
the SPD##2##2##(2008-5#2)
the SPE cartridge##3##3##(1997-2#2)(2008-10#1)
the SPE column##5##3##(2007-8#2)(2008-10#3)
the SPE module##2##3##(2007-8#2)
the SPE procedure##3##3##(2007-8#2)(2012-12#1)
the SPE step##2##3##(2008-10#2)
the SPE##27##2##(1996-8#1)(1997-2#3)(2007-11#1)(2007-8#6)(2008-10#13)(2011-2#1)(2012-12#1)(2013-1#1)
the SPECT##3##2##(1992-10#2)(2005-1#1)
the SPF##7##2##(1993-1#1)(2008-5#5)(2012-12#1)
the SPH&amp##2##2##(2008-1#2)
the SPIO##2##2##(2012-2#2)
the SPM##4##2##(2008-2#2)(2012-2#2)
the SPME fiber##3##3##(2008-10#3)
the SPME fibre##3##3##(2008-10#3)
the SPME##10##2##(2007-8#1)(2008-10#8)(2011-12#1)
the SPOTscan##3##2##(1996-11#3)
the SPR angle and##2##4##(2008-3#2)
the SPR biosensor##2##3##(2008-10#2)
the SPR intensity##3##3##(2008-10#3)
the SPR sensor system##2##4##(2008-10#2)
the SPR sensor##6##3##(2008-10#5)(2008-4#1)
the SPR##24##2##(2005-11#1)(2008-10#16)(2008-2#2)(2008-3#4)(2008-4#1)
the SPSS##6##2##(2008-11#1)(2010-6#1)(2011-1#1)(2012-3#1)(2013-8#2)
the SPY system##3##3##(2007-8#3)
the SQUID##2##2##(2008-7#2)
the SR membrane##2##3##(1994-12#1)(1994-8#1)
the SR##11##2##(1990-11#1)(1991-5#1)(1992-4#2)(1994-12#1)(1994-8#1)(1995-6#1)(2006-10#2)(2008-10#2)
the SRA##2##2##(2012-2#2)
the SRBC##2##2##(2008-10#1)(2008-4#1)
the SRE and##2##3##(1994-11#1)(1996-5#1)
the SRE##4##2##(1993-6#1)(1994-11#1)(1995-6#1)(1996-5#1)
the SRMs were compared##2##4##(2007-8#1)(2008-10#1)
the SRO##4##2##(2007-12#3)(2008-1#1)
the SRS protocol##2##3##(2007-7#2)
the SRS##6##2##(2006-5#2)(2007-7#3)(2008-2#1)
the SRY gene##3##3##(1990-11#2)(2008-12#1)
the SS genotype##2##3##(1993-7#2)
the SS inlet##2##3##(2008-10#2)
the SS##15##2##(1993-7#2)(1993-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-6#2)(2009-11#1)(2010-4#2)(2011-2#1)(2012-12#1)
the SS1##2##2##(2006-10#1)(2011-2#1)
the SSA can be##2##4##(2010-8#2)
the SSA can##3##3##(2010-8#3)
the SSB##2##2##(1995-8#1)(2008-10#1)
the SSC##3##2##(1990-12#1)(1991-3#1)(1993-2#1)
the SSCF##2##2##(2008-5#1)(2008-6#1)
the SSCP analysis##2##3##(2008-10#2)
the SSCT##5##2##(2008-9#5)
the SSE##2##2##(2013-1#1)(2013-8#1)
the SSEE and##3##3##(2007-10#3)
the SSEE##4##2##(2007-10#4)
the SSF##4##2##(2008-6#4)
the SSG##4##2##(1995-11#4)
the SSLB resistance##2##3##(2008-10#2)
the SSO genes##2##3##(1997-3#2)
the SSP protein##2##3##(1994-12#2)
the SSP##4##2##(1994-12#2)(2008-1#1)(2013-7#1)
the SSRs##2##2##(2007-6#2)
the SSSI##3##2##(2006-8#3)
the SSTR2##2##2##(1993-3#2)
the ST segment##5##3##(1990-3#2)(1993-11#1)(1996-4#1)(2008-7#1)
the ST##11##2##(1990-3#2)(1993-11#1)(1996-4#1)(1996-6#1)(2007-8#1)(2008-10#4)(2008-7#1)
the STA##2##2##(1995-6#1)(2008-10#1)
the STAR##2##2##(2008-10#2)
the STARD and QUADAS##2##4##(2008-12#2)
the STARD##3##2##(2008-12#3)
the STAT##2##2##(1995-3#1)(2011-12#1)
the STD clinic##4##3##(2007-7#4)
the STIKO##2##2##(2008-4#2)
the STM##3##2##(1992-2#1)(1993-3#1)(2010-7#1)
the STN##5##2##(1997-7#2)(2008-11#2)(2012-2#1)
the STR##8##2##(1991-9#1)(1994-12#1)(1996-7#1)(2008-12#3)(2008-7#1)(2009-4#1)
the STRokE DOC system##2##4##(2008-8#2)
the STS##2##2##(2007-12#1)(2008-1#1)
the SU +##2##3##(2008-3#2)
the SUMER##2##2##(2008-3#2)
the SUMO-1##2##2##(2011-2#2)
the SV1 epitope##4##3##(1992-6#4)
the SV1##5##2##(1992-6#5)
the SV40 early promoter##3##4##(1992-8#1)(1995-6#1)(2008-11#1)
the SV40 early##5##3##(1990-11#1)(1992-8#1)(1993-12#1)(1995-6#1)(2008-11#1)
the SV40 promoter##9##3##(1991-1#1)(1992-5#1)(1992-8#2)(1993-12#4)(1996-10#1)
the SV40##24##2##(1990-11#4)(1990-8#1)(1991-1#1)(1992-5#1)(1992-8#3)(1993-12#5)(1994-12#1)(1995-6#1)(1996-10#2)(1997-2#1)(2008-11#2)(2008-2#2)
the SVC and##2##3##(2007-7#1)(2008-1#1)
the SVC##5##2##(2007-7#1)(2007-8#3)(2008-1#1)
the SVM##6##2##(2007-8#1)(2008-2#3)(2011-1#2)
the SVO nanowires##3##3##(2009-2#3)
the SVP##2##2##(1993-6#2)
the SVZ##5##2##(2008-7#4)(2012-2#1)
the SW and##2##3##(1991-8#1)(2008-10#1)
the SW##3##2##(1991-8#1)(2008-10#1)(2008-5#1)
the SW-Trypsin##2##2##(2013-8#2)
the SW613-S human colon carcinoma cell line##2##7##(1992-9#2)
the SW613-S##3##2##(1992-9#3)
the SWI/SNF complex##2##3##(1996-2#2)
the SWNTs##4##2##(2008-10#1)(2008-7#2)(2010-8#1)
the SYBR Green real-time PCR##2##5##(2012-3#2)
the SZ##4##2##(2009-7#4)
the SZBA##3##2##(2006-5#3)
the Sac locus##2##3##(2008-2#2)
the Sac##3##2##(1990-5#1)(2008-2#2)
the Saccharomyces cerevisiae genome##2##4##(1991-8#1)(2008-7#1)
the Saccharomyces cerevisiae mitochondrial##2##4##(2005-8#1)(2008-7#1)
the Saccharomyces cerevisiae##34##3##(1990-5#2)(1990-7#1)(1991-11#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-4#2)(1995-8#2)(1995-9#1)(1996-6#1)(1996-7#2)(1997-1#1)(1997-3#1)(1997-6#2)(1997-8#1)(2005-8#1)(2007-2#1)(2008-10#1)(2008-7#2)(2010-4#1)(2012-3#1)
the Saccharomyces complex##2##3##(2012-3#2)
the Saccharomyces##36##2##(1990-5#2)(1990-7#1)(1991-11#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-4#2)(1995-8#2)(1995-9#1)(1996-6#1)(1996-7#2)(1997-1#1)(1997-3#1)(1997-6#2)(1997-8#1)(2005-8#1)(2007-2#1)(2008-10#1)(2008-7#2)(2010-4#1)(2012-3#3)
the Safe Motherhood##2##3##(1994-3#1)(2010-12#1)
the Safe##3##2##(1993-12#1)(1994-3#1)(2010-12#1)
the Safety of##3##3##(2008-10#2)(2012-3#1)
the Safety##5##2##(2008-10#2)(2008-11#1)(2012-2#1)(2012-3#1)
the Sagnac frequency##2##3##(2008-2#2)
the Sagnac interferometer##4##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)
the Sagnac##10##2##(2007-11#3)(2007-12#2)(2008-1#1)(2008-2#4)
the Saguenay##2##2##(2008-2#2)
the Saint Gaudens specimen##2##4##(2011-2#2)
the Saint##5##2##(2008-10#1)(2008-12#1)(2011-1#1)(2011-2#2)
the SalI##4##2##(1991-9#1)(1994-12#3)
the Salinas valley##2##3##(2008-10#2)
the Salinas##6##2##(2008-10#6)
the Salivary##2##2##(2010-7#1)(2013-8#1)
the Salmonella assay##2##3##(1995-11#1)(1996-2#1)
the Salmonella##12##2##(1990-3#1)(1991-1#1)(1991-12#1)(1995-11#1)(1996-2#1)(1996-6#1)(1997-4#1)(2008-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
the Same##4##2##(2008-10#1)(2008-12#1)(2012-1#1)(2012-12#1)
the San Andreas fault near Parkfield##2##6##(1991-3#2)
the San Andreas fault##5##4##(1990-11#1)(1991-3#3)(1996-4#1)
the San Andreas##6##3##(1990-11#1)(1991-3#3)(1996-4#2)
the San Antonio##2##3##(2008-1#1)(2009-8#1)
the San Francisco Bay##2##4##(2007-8#1)(2007-9#1)
the San Francisco##5##3##(1991-2#1)(1996-12#1)(2007-8#1)(2007-9#1)(2008-11#1)
the San Joaquin Valley##3##4##(2008-10#3)
the San##19##2##(1990-11#1)(1991-2#1)(1991-3#3)(1996-12#1)(1996-4#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-8#1)(2010-8#1)(2012-12#1)
the Sanjabi##2##2##(2008-12#2)
the Santa##5##2##(2007-5#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-10#1)
the Santiago de Cuba Techo strain##2##6##(2007-10#2)
the Santiago de Cuba##3##4##(2007-10#3)
the Santiago##4##2##(2007-10#3)(2012-2#1)
the Sarason##2##2##(1992-1#2)
the Sarcoma 180##2##3##(1992-3#2)
the Sargasso Sea##2##3##(2008-2#1)(2008-3#1)
the Sargassum##2##2##(2008-5#1)(2011-2#1)
the Sasakawa Peace Foundation##2##4##(2010-8#2)
the Saskatchewan##5##2##(1995-12#1)(2007-12#1)(2008-7#2)(2008-8#1)
the Satterthwaite##4##2##(1994-8#4)
the Sau3AI##2##2##(1990-9#1)(1997-1#1)
the Saudi diabetic population##2##4##(2007-3#2)
the Saudi population##2##3##(2007-2#2)
the Saudi##6##2##(2007-2#2)(2007-3#4)
the Sauerbrey shift##2##3##(2009-5#2)
the Sc##2##2##(1995-8#2)
the Scale for the Assessment of Negative Symptoms##3##8##(1996-7#2)(2007-7#1)
the Scale for the Assessment of##4##6##(1996-7#2)(2007-7#2)
the Scandinavian Simvastatin Survival##2##4##(1997-6#1)(2006-5#1)
the Scandinavian##9##2##(1991-4#1)(1996-12#1)(1997-6#1)(2006-5#1)(2008-3#1)(2010-3#1)(2011-4#3)
the Scatchard plot##2##3##(2008-10#1)(2008-4#1)
the Scatchard plots##2##3##(1995-11#1)(2006-10#1)
the Scatchard##5##2##(1995-11#1)(2006-10#1)(2008-10#2)(2008-4#1)
the Scattering##2##2##(1995-1#1)(1996-9#1)
the Schaffer collateral##2##3##(1991-3#1)(1991-6#1)
the Schaffer collateral-CA1 region##2##4##(2008-7#2)
the Schaffer collateral/commissural##2##3##(1990-4#1)(1991-6#1)
the Schaffer epsp##2##3##(1991-6#2)
the Schaffer##12##2##(1990-4#1)(1991-3#1)(1991-6#4)(1995-12#1)(1997-1#2)(2008-7#3)
the Scheimpflug PIV##2##3##(2008-2#2)
the Scheimpflug##4##2##(2008-2#4)
the Schiff base of##3##4##(1995-10#1)(2006-12#1)(2008-10#1)
the Schiff base##19##3##(1992-11#1)(1994-5#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-5#3)(2006-12#2)(2007-8#1)(2008-10#4)(2008-5#2)
the Schiff bases##2##3##(2007-10#1)(2008-5#1)
the Schiff##22##2##(1992-11#1)(1994-5#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-5#3)(2006-12#2)(2007-10#1)(2007-8#1)(2008-10#5)(2008-5#3)
the Schiff-base and its##2##4##(2008-5#2)
the Schizosaccharomyces pombe##7##3##(1991-8#1)(1993-11#1)(1993-3#1)(1993-5#1)(1994-12#1)(1995-3#1)(1997-6#1)
the Schlieren effect##3##3##(2008-10#3)
the Schlieren##4##2##(2008-10#4)
the School of Medical Sciences##3##5##(2008-10#2)(2013-8#1)
the School of Medicine in Pelotas##2##6##(1994-6#2)
the School of Medicine in##4##5##(1994-6#2)(2008-1#2)
the School of Medicine of the##2##6##(2008-10#1)(2010-12#1)
the School of Medicine of##4##5##(2008-10#1)(2010-12#1)(2012-3#2)
the School of Medicine##11##4##(1992-1#1)(1994-6#2)(2008-1#3)(2008-10#1)(2008-4#1)(2010-12#1)(2012-3#2)
the School of Nursing and Midwifery##2##6##(2008-11#2)
the School of Nursing##4##4##(2008-11#2)(2008-12#1)(2010-3#1)
the School of##26##3##(1992-1#1)(1994-6#2)(1996-1#1)(2006-11#1)(2006-8#1)(2007-7#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#2)(2008-4#1)(2010-12#1)(2010-3#2)(2012-12#1)(2012-3#2)(2013-8#1)
the School##31##2##(1992-1#1)(1994-6#2)(1996-1#1)(2006-11#1)(2006-8#1)(2007-7#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-12#3)(2008-4#1)(2009-9#1)(2010-12#1)(2010-3#2)(2010-9#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-8#1)
the Schwann##3##2##(1990-7#1)(2007-10#1)(2012-12#1)
the Science##5##2##(2005-10#1)(2010-8#1)(2012-11#1)(2013-7#1)(2013-8#1)
the Scientific##7##2##(1991-3#1)(1993-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-7#1)(2012-1#1)
the Scope##2##2##(2012-12#1)(2012-2#1)
the Scottish Health##2##3##(1996-12#1)(2012-3#1)
the Scottish##9##2##(1996-12#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-9#1)(2012-3#1)
the Scp1##2##2##(1990-4#2)
the Scripps##2##2##(2005-6#1)(2008-3#1)
the Sda##2##2##(1991-10#2)
the Se-induced rise in plasma glucose##3##6##(1993-3#3)
the Sea of Galilee##2##4##(2005-10#2)
the Sea##8##2##(2005-10#2)(2007-9#2)(2008-2#1)(2008-5#2)(2009-2#1)
the Sea-Viewing Wide##2##3##(2008-3#2)
the SeaWiFS 765-nm band##2##4##(2008-2#2)
the SeaWiFS 765-nm##3##3##(2008-2#3)
the SeaWiFS##16##2##(2008-2#6)(2008-3#10)
the Seattle Social Development Project##2##5##(2007-9#1)(2010-4#1)
the Seattle##3##2##(2007-9#1)(2008-5#1)(2010-4#1)
the Seattle-King County Department of##2##5##(1992-5#1)(1996-2#1)
the SecA membrane##2##3##(1997-7#1)(2008-10#1)
the SecA##7##2##(1993-9#1)(1994-8#1)(1997-7#2)(2008-10#2)(2012-1#1)
the Second World War##7##4##(1990-9#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-7#2)(2011-4#1)
the Second##23##2##(1990-4#1)(1990-9#1)(1995-4#1)(1996-5#1)(1997-7#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-7#1)(2011-1#1)(2011-2#2)(2011-4#1)
the Secret##2##2##(1995-6#2)
the Secretary of##3##3##(1991-12#1)(1996-5#1)(2006-8#1)
the Sedillot triangle##2##3##(2007-7#2)
the Seidel##2##2##(2008-2#2)
the Self##4##2##(2006-4#1)(2008-11#2)(2012-2#1)
the Self-Help Clearinghouse of Metropolitan Toronto##2##6##(1994-1#1)(1996-3#1)
the Self-Help Clearinghouse##3##3##(1994-1#2)(1996-3#1)
the SemRep database##4##3##(2013-1#4)
the Semliki Forest Virus##3##4##(1997-5#1)(2008-11#2)
the Semliki Forest##6##3##(1997-5#1)(2008-11#3)(2008-7#2)
the Semliki##7##2##(1997-5#1)(2008-11#3)(2008-7#2)(2012-12#1)
the Senate##10##2##(1991-10#1)(1995-6#6)(1997-2#1)(2007-9#1)(2008-8#1)
the Sendai##2##2##(2012-12#2)
the September##6##2##(2007-8#2)(2007-9#1)(2008-10#1)(2008-9#1)(2012-2#1)
the Septoria tritici##2##3##(2008-10#2)
the Septoria##3##2##(2008-10#3)
the Sequoia District##2##3##(1996-3#2)
the Ser mutant##2##3##(1992-9#1)(1994-9#1)
the Ser residue##3##3##(1992-3#2)(1992-4#1)
the Ser##7##2##(1992-3#3)(1992-4#1)(1992-9#2)(1994-9#1)
the Serb##2##2##(1993-10#1)(2007-9#1)
the Serbian Archives##2##3##(2008-1#2)
the Serbian Medical Society##2##4##(2008-1#2)
the Serbian##6##2##(2008-1#6)
the Serbian-Bulgarian##2##2##(2010-12#2)
the Serbians##2##2##(2010-4#2)
the Serengeti##2##2##(2012-2#2)
the Serpyllum##2##2##(2007-1#2)
the Serra de Baturité##2##4##(2007-3#2)
the Sertoli cell##4##3##(1992-5#1)(2012-2#3)
the Sertoli cells##3##3##(2009-10#1)(2012-12#1)(2013-1#1)
the Sertoli##12##2##(1992-5#1)(1994-3#1)(2009-10#1)(2012-12#1)(2012-2#7)(2013-1#1)
the Serum Response##2##3##(1994-6#2)
the Serum##5##2##(1992-6#1)(1994-6#2)(2012-3#1)(2013-8#1)
the Service##6##2##(2005-5#1)(2008-2#2)(2008-3#1)(2010-9#1)(2013-1#1)
the Seventh##3##2##(2011-2#1)(2013-7#1)(2013-8#1)
the Severin##2##2##(2007-7#1)(2007-8#1)
the Severity##2##2##(2008-7#1)(2010-1#1)
the Sexual Stage of##2##4##(2008-10#2)
the Sexual##6##2##(1994-4#1)(2008-10#2)(2012-3#3)
the Shack-Hartmann sensor##2##3##(2008-3#2)
the Shack-Hartmann wave-front sensor##2##4##(2008-3#2)
the Shack-Hartmann##4##2##(2008-3#4)
the Shackleford Banks##2##3##(2012-1#2)
the Shaker##2##2##(1994-8#1)(2010-12#1)
the Shanghai##2##2##(2009-9#1)(2013-8#1)
the Shannon index##2##3##(2008-10#2)
the Shannon##3##2##(2008-10#2)(2008-8#1)
the Shapiro-Francia##2##2##(1993-1#2)
the Sharp##2##2##(1997-3#1)(2007-7#1)
the Shc##4##2##(1994-12#1)(1997-7#3)
the Sherman paradox##2##3##(1991-12#2)
the Sherman##3##2##(1991-12#2)(1995-3#1)
the Shewanella##2##2##(2006-8#1)(2012-2#1)
the Shiga-like##2##2##(1992-3#1)(2011-1#1)
the Shigella##2##2##(1993-12#1)(2008-4#1)
the Shine-Dalgarno sequence were##2##4##(1992-6#1)(1996-8#1)
the Shine-Dalgarno sequence##4##3##(1992-6#2)(1996-8#1)(1997-2#1)
the Short Form 36##2##4##(1996-3#1)(2008-10#1)
the Short Form##5##3##(1996-3#1)(2006-8#1)(2008-10#2)(2011-1#1)
the Short Form-36 (SF-36)##2##4##(2008-10#1)(2013-8#1)
the Short Form-36##3##3##(2008-10#1)(2011-1#1)(2013-8#1)
the Short##12##2##(1996-3#1)(2006-8#1)(2007-10#1)(2008-10#3)(2009-10#1)(2010-8#1)(2011-1#2)(2013-7#1)(2013-8#1)
the Shroud##3##2##(2008-2#3)
the Si##8##2##(2005-11#1)(2006-12#1)(2007-11#4)(2007-12#1)(2008-10#1)
the SiC##2##2##(1996-5#1)(2008-3#1)
the SiO(2)##2##2##(2007-11#1)(2008-2#1)
the SiO2##3##2##(2006-6#1)(2007-8#1)(2008-7#1)
the Siberian##3##2##(1994-2#1)(2008-6#1)(2010-8#1)
the Sickness Impact Profile##3##4##(2006-10#1)(2007-10#1)(2007-9#1)
the Siemens##3##2##(2008-3#1)(2009-8#2)
the Sierra##4##2##(2006-7#1)(2008-10#2)(2011-2#1)
the Sigma##2##2##(1993-12#1)(2008-10#1)
the Significant##3##2##(2012-2#2)(2013-1#1)
the Silesian##3##2##(2007-11#1)(2007-7#1)(2008-9#1)
the Simon effect and the##2##5##(2008-4#2)
the Simon effect and##3##4##(2008-4#3)
the Simon##4##2##(2008-4#4)
the Simple##2##2##(2011-1#2)
the Simulium##2##2##(1990-6#2)
the Simultaneous##9##2##(2008-10#1)(2010-2#2)(2010-5#1)(2011-1#2)(2012-2#1)(2013-7#2)
the Singapore Chinese Health Study##3##5##(2010-6#3)
the Singapore##4##2##(2009-10#1)(2010-6#3)
the Single##3##2##(2007-2#1)(2012-12#1)(2012-2#1)
the Singular Spectrum Analysis (SSA)##2##5##(2010-8#1)(2012-2#1)
the Sistani##2##2##(2008-12#1)(2013-8#1)
the Sisters of the Holy Child Mary##2##7##(2013-8#2)
the Sisters of the Holy Child##3##6##(2013-8#3)
the Sisters of##5##3##(1991-2#1)(2013-8#4)
the Sixth International##2##3##(2008-5#1)(2012-3#1)
the Sixth##5##2##(1996-1#1)(2008-5#2)(2009-2#1)(2012-3#1)
the Slave River##5##3##(1997-4#5)
the Slump Test in##2##4##(2008-12#2)
the Slump Test##5##3##(2008-12#5)
the Sm##4##2##(1993-2#1)(1994-8#1)(1997-9#1)(2008-10#1)
the Smad2 conditional##2##3##(2008-9#2)
the Smads##2##2##(2006-10#2)
the Smith-Lemli-Opitz syndrome (SLOS)##2##4##(1997-1#2)
the Smith-Lemli-Opitz syndrome##3##3##(1997-1#3)
the Smoking##2##2##(2006-7#1)(2008-7#1)
the Smoluchowski equation##2##3##(2005-11#2)
the Smoluchowski##3##2##(2005-11#3)
the Sn oxide##2##3##(2008-2#2)
the Sn##3##2##(2004-9#1)(2008-2#2)
the Snail density##3##3##(2011-1#3)
the Sobel wavelet filter##2##4##(2008-2#2)
the Sobel wavelet##3##3##(2008-2#3)
the Social Action##2##3##(2008-11#2)
the Social Science Citation Index##2##5##(2013-7#2)
the Social Science##3##3##(2006-8#1)(2013-7#2)
the Social Security Administration##3##4##(1996-12#1)(2013-1#2)
the Social Security number##3##4##(1993-9#3)
the Social Security##9##3##(1992-2#1)(1993-1#1)(1993-9#3)(1996-12#1)(2012-12#1)(2013-1#2)
the Social##27##2##(1992-2#1)(1993-1#1)(1993-3#1)(1993-9#3)(1995-5#1)(1996-12#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-11#2)(2009-4#1)(2009-7#1)(2010-12#2)(2011-1#2)(2012-12#3)(2013-1#2)(2013-7#2)(2013-8#1)
the Society for Neuroscience##3##4##(2005-7#1)(2007-9#1)(2012-1#1)
the Society for the##3##4##(2011-1#2)(2013-1#1)
the Society for##11##3##(1996-8#1)(2005-7#1)(2007-9#1)(2008-7#1)(2011-1#3)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
the Society of General##2##4##(1994-6#1)(2007-9#1)
the Society of Thoracic Surgeons##2##5##(2005-12#2)
the Society of##16##3##(1994-6#1)(2005-12#2)(2006-11#1)(2006-9#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-4#2)(2010-3#1)(2010-4#1)(2012-2#1)(2013-1#1)
the Society##33##2##(1994-12#1)(1994-6#1)(1996-8#1)(2005-12#2)(2005-7#1)(2006-11#2)(2006-9#1)(2007-11#1)(2007-2#1)(2007-9#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#3)(2009-4#2)(2010-3#1)(2010-4#1)(2011-1#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
the Sociocultural Attitudes Toward Appearance##2##5##(2007-12#2)
the Sociocultural Attitudes Towards Appearance Questionnaire-3##3##6##(2007-12#3)
the Sociocultural Attitudes Towards Appearance##4##5##(2007-12#3)(2010-9#1)
the Sociocultural Attitudes##6##3##(2007-12#5)(2010-9#1)
the Sokoto##2##2##(2010-4#2)
the Solanaceae family##2##3##(2005-10#2)
the Solanaceae##8##2##(1993-12#1)(1996-8#1)(2005-10#2)(2008-7#4)
the Solar and Heliospheric Observatory (SOHO) are##2##7##(2008-3#2)
the Solar and Heliospheric Observatory (SOHO)##3##6##(2008-3#3)
the Solar##6##2##(1996-5#1)(2008-2#1)(2008-3#4)
the Solidarity Community##5##3##(2008-9#5)
the SoloSTAR and FlexPen##2##4##(2009-11#2)
the Solomon Islands##2##3##(2012-12#2)
the Somogyi-Nelson batch procedure##2##4##(2008-10#2)
the Songhua River##2##3##(2007-12#1)(2008-9#1)
the Sonoran Desert##5##3##(2008-10#4)(2009-8#1)
the Sorensen model##2##3##(2010-2#2)
the Soret band and band III##2##6##(1991-7#2)
the Soret band and##3##4##(1991-7#3)
the Soret band##9##3##(1990-8#3)(1991-7#4)(1992-12#1)(1995-2#1)
the Soret peak##2##3##(2008-6#1)(2009-2#1)
the Soret##14##2##(1990-8#3)(1991-7#5)(1992-12#1)(1995-2#1)(1997-4#1)(2008-10#1)(2008-6#1)(2009-2#1)
the South African National##3##4##(2007-6#1)(2010-12#1)(2010-7#1)
the South African government##2##4##(2010-12#1)(2012-3#1)
the South African##12##3##(2005-8#1)(2007-12#1)(2007-6#1)(2008-8#1)(2009-10#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-7#1)(2011-2#1)(2012-3#1)
the South American##5##3##(1997-4#1)(2008-10#2)(2010-3#1)(2011-2#1)
the South Asia region##2##4##(2011-2#1)(2012-3#1)
the South Asian##2##3##(2011-2#1)(2012-2#1)
the South Carolina##3##3##(1996-6#1)(2008-10#1)(2011-2#1)
the South Central##2##3##(1992-3#1)(2006-9#1)
the South China Sea##3##4##(2010-8#2)(2013-8#1)
the South East Asian region##2##5##(2007-6#1)(2009-6#1)
the South East Asian##3##4##(2007-6#2)(2009-6#1)
the South East##5##3##(2007-6#2)(2009-4#2)(2009-6#1)
the South Island##2##3##(1995-8#1)(2008-12#1)
the South Pacific##11##3##(2005-11#1)(2008-1#8)(2008-5#2)
the South West##4##3##(1993-10#1)(2008-11#2)(2008-5#1)
the South of Brazil##2##4##(2011-1#1)(2011-2#1)
the South of##4##3##(2008-4#1)(2011-1#2)(2011-2#1)
the South to##2##3##(1992-5#1)(2008-10#1)
the South##83##2##(1990-11#1)(1992-1#1)(1992-2#3)(1992-3#1)(1992-5#1)(1993-10#2)(1995-8#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-4#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#4)(2008-1#8)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#3)(2008-8#2)(2009-10#1)(2009-4#2)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#1)
the South-East##2##2##(2007-2#1)(2013-1#1)
the Southeast Asian##2##3##(1990-7#1)(2008-10#1)
the Southeast and##2##3##(2008-5#1)(2008-9#1)
the Southeast##12##2##(1990-7#1)(1993-6#1)(2007-2#2)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-1#1)
the Southern California##3##3##(2008-2#2)(2010-8#1)
the Southern Hemisphere##5##3##(1995-1#1)(1996-3#2)(2007-8#1)(2008-10#1)
the Southern region##2##3##(2011-2#1)(2013-7#1)
the Southern##32##2##(1990-8#1)(1993-12#1)(1995-1#1)(1995-12#1)(1996-3#2)(1997-1#1)(2006-1#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-7#4)
the Southwest##6##2##(1995-6#1)(2007-3#1)(2007-8#1)(2008-3#1)(2008-8#2)
the Southwestern##2##2##(2008-12#1)(2013-1#1)
the Soviet Union and##3##4##(1992-5#1)(2008-12#1)(2011-2#1)
the Soviet Union##8##3##(1990-3#3)(1992-5#1)(2008-12#2)(2011-2#1)(2012-2#1)
the Soviet##10##2##(1990-12#1)(1990-3#4)(1992-5#1)(2008-12#2)(2011-2#1)(2012-2#1)
the Soybean##4##2##(2008-10#4)
the Sp1##3##2##(1995-3#1)(1996-10#1)(1996-5#1)
the SpA##2##2##(1994-6#2)
the Span of Apprehension##2##4##(1997-2#2)
the Span80-CPL##3##2##(2008-11#3)
the Spanish isolates##2##3##(2008-10#2)
the Spanish population##4##3##(1990-9#2)(2008-10#1)(2008-5#1)
the Spanish##33##2##(1990-8#1)(1990-9#2)(1993-5#2)(1995-2#1)(1996-5#1)(1997-6#1)(2007-12#1)(2008-10#11)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#3)(2009-5#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#2)(2012-2#1)
the Spatial##6##2##(2008-10#2)(2009-12#1)(2010-11#1)(2010-9#1)(2011-2#1)
the Spatiotemporal##2##2##(2008-10#1)(2008-11#1)
the Spearman correlation##2##3##(2011-1#1)(2013-7#1)
the Spearman##4##2##(2008-10#1)(2008-4#1)(2011-1#1)(2013-7#1)
the Special Supplemental Nutrition Program for Women##3##7##(1996-12#1)(2007-2#2)
the Special Supplemental##4##3##(1996-12#2)(2007-2#2)
the Special##7##2##(1996-12#2)(1996-8#1)(2006-2#1)(2007-2#2)(2009-4#1)
the Spectra Optia##5##3##(2011-2#5)
the Spectral##2##2##(2008-3#1)(2012-12#1)
the Spectromètre à Diodes Laser Accordables##2##6##(2008-3#2)
the Spg##2##2##(2012-2#2)
the Spinal##2##2##(2008-5#1)(2008-7#1)
the Spiritual Pathway Project##2##4##(2010-2#2)
the Spiritual##4##2##(2010-2#2)(2013-1#2)
the Split-Dalmatia County##3##3##(2010-9#3)
the Spo0A##2##2##(1995-6#1)(2011-2#1)
the Spodoptera frugiperda##4##3##(1991-7#1)(2008-11#2)(2008-7#1)
the Spontaneous##2##2##(1996-7#1)(2008-10#1)
the Sports##2##2##(2009-9#1)(2012-3#1)
the Spr3 locus##3##3##(2009-10#3)
the Spread of##2##3##(2008-10#2)
the Spread##3##2##(2008-10#3)
the Spring##2##2##(1994-3#1)(2007-10#1)
the Squash leaf curl virus##2##5##(2008-10#2)
the SrTiO(3)##3##2##(2008-3#2)(2012-2#1)
the Src and##2##3##(1994-9#1)(2011-2#1)
the Src family##2##3##(1994-3#1)(1996-5#1)
the Src homology 3 (SH3) domain##2##6##(1994-9#2)
the Src homology 3##4##4##(1994-9#4)
the Src homology##6##3##(1994-9#4)(1995-3#2)
the Src##13##2##(1994-3#1)(1994-9#6)(1995-2#1)(1995-3#2)(1995-6#1)(1996-5#1)(2011-2#1)
the Src-related kinase Lyn##2##4##(1996-5#2)
the Sri Lankan strains##3##4##(2008-10#3)
the Sry##2##2##(1995-11#2)
the Sso##2##2##(1997-3#2)
the St Giles##2##3##(2008-1#2)
the St##8##2##(1993-12#1)(1993-2#1)(1996-3#1)(2006-6#1)(2007-8#1)(2007-9#1)(2008-1#2)
the Stability of##4##3##(1996-9#1)(2008-10#1)(2008-5#1)(2009-12#1)
the Standard##5##2##(2008-10#1)(2008-9#1)(2010-12#1)(2013-1#2)
the Standardized##2##2##(1995-8#1)(2011-1#1)
the Standing##2##2##(1991-3#1)(2008-12#1)
the Stanford Synchrotron Radiation##2##4##(2006-5#1)(2009-12#1)
the Stanford##9##2##(1992-5#1)(1995-9#2)(2006-5#1)(2007-8#2)(2008-11#1)(2009-12#1)(2013-1#1)
the Staphylococcus aureus##6##3##(1993-11#1)(1995-8#1)(1996-12#1)(1996-6#1)(2007-7#1)(2007-8#1)
the Staphylococcus##9##2##(1991-7#1)(1993-11#1)(1995-8#1)(1996-12#1)(1996-6#1)(1997-1#1)(2007-7#1)(2007-8#1)(2008-2#1)
the Star##2##2##(1996-5#1)(2009-10#1)
the Star-PAP##2##2##(2013-1#2)
the Stark tuning rate##3##4##(2008-10#3)
the Stark##5##2##(1996-3#1)(2007-12#1)(2008-10#3)
the State Food and Drug Administration##2##6##(2011-2#1)(2012-3#1)
the State Food and Veterinary Service of Lithuania##2##8##(2005-5#2)
the State Food and Veterinary Service##3##6##(2005-5#3)
the State Food and##5##4##(2005-5#3)(2011-2#1)(2012-3#1)
the State Social Security Institute of Iceland##6##7##(2006-10#2)(2006-8#4)
the State Social Security Institute##8##5##(2006-10#2)(2006-7#1)(2006-8#5)
the State and##2##3##(1993-3#1)(2009-10#1)
the State of Maranhão##2##4##(2011-2#2)
the State of Minas Gerais##2##5##(2008-6#1)(2010-10#1)
the State of##31##3##(1990-11#1)(1991-1#1)(1991-8#2)(1993-3#2)(1993-6#1)(1994-3#1)(1994-6#1)(1994-9#1)(1997-3#1)(2008-10#2)(2008-6#3)(2008-8#2)(2009-11#1)(2010-10#2)(2011-1#1)(2011-2#5)(2012-2#1)(2013-1#1)(2013-7#2)
the State should##2##3##(2007-7#1)(2008-1#1)
the State##74##2##(1990-11#1)(1990-12#1)(1991-1#1)(1991-8#2)(1992-1#1)(1993-3#5)(1993-6#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-11#2)(1996-6#1)(1997-3#1)(2005-5#3)(2005-7#1)(2006-10#2)(2006-7#1)(2006-8#5)(2007-11#1)(2007-5#2)(2007-7#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-6#3)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#1)(2010-10#2)(2011-1#1)(2011-2#6)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#2)
the State's##6##2##(1996-12#2)(2007-10#1)(2007-7#1)(2011-1#1)(2013-8#1)
the State-Trait Anxiety Inventory##5##4##(1995-12#2)(2007-7#1)(2010-6#1)(2013-8#1)
the Statement##2##2##(1993-11#2)
the States##8##2##(1992-3#1)(1994-1#1)(1994-3#2)(1995-1#1)(1997-2#1)(2008-7#1)(2009-5#1)
the Statistical Package for the Social Sciences##4##7##(2009-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
the Statistical Package for##5##4##(2009-7#1)(2011-1#2)(2012-12#1)(2013-8#1)
the Statistical##7##2##(2006-10#1)(2009-7#1)(2010-6#1)(2011-1#2)(2012-12#1)(2013-8#1)
the Stauffer and Coventry classification##2##5##(1993-11#2)
the Stb4 locus in##2##4##(2008-10#2)
the Stb4 locus##3##3##(2008-10#3)
the Stb4##4##2##(2008-10#4)
the Stem##2##2##(2008-10#2)
the Steris System##2##3##(2011-2#2)
the Stern layer conductance##2##4##(2005-11#2)
the Stern layer##3##3##(2005-11#3)
the Stern-Volmer constant for##2##4##(1991-2#1)(1992-6#1)
the Stern-Volmer plot##2##3##(2008-10#2)
the Stern-Volmer##6##2##(1991-2#1)(1992-6#1)(2008-10#4)
the Stiles-Crawford##2##2##(2010-9#2)
the Stockholm area##2##3##(1993-1#1)(1993-9#1)
the Stockholm workshop scale##3##4##(2008-9#3)
the Stockholm##5##2##(1993-1#1)(1993-9#1)(2008-9#3)
the Stoffel fragment##2##3##(2008-5#2)
the Stokes and anti-Stokes##2##4##(2007-11#2)
the Stokes parameters of##2##4##(2007-12#2)
the Stokes parameters##6##3##(2007-12#6)
the Stokes radius and##2##4##(1993-8#1)(1995-8#1)
the Stokes radius##3##3##(1993-8#1)(1995-8#1)(1996-5#1)
the Stokes shift##2##3##(2008-10#1)(2008-2#1)
the Stokes vector##3##3##(2008-2#2)(2008-3#1)
the Stokes vectors##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
the Stokes##33##2##(1990-5#1)(1993-8#1)(1995-8#1)(1996-5#1)(2005-11#1)(2007-11#4)(2007-12#9)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#9)(2008-3#2)
the Stone maze##3##3##(1994-6#3)
the Stone##4##2##(1994-6#3)(2008-1#1)
the StrAn##2##2##(2012-11#2)
the Strait of Georgia##2##4##(1990-11#1)(2010-8#1)
the Strategic##2##2##(1995-2#1)(2008-4#1)
the Stratospheric Aerosol and Gas Experiment II##2##7##(2008-2#1)(2008-3#1)
the Stratospheric Aerosol and Gas Experiment##4##6##(2008-2#3)(2008-3#1)
the Strehl intensity ratio##2##4##(2008-3#2)
the Strehl ratio and the##2##5##(2008-2#1)(2008-3#1)
the Strehl ratio##12##3##(2008-2#9)(2008-3#3)
the Strehl##15##2##(2008-2#9)(2008-3#6)
the Strep##2##2##(1994-12#1)(2008-4#1)
the Streptococcus pneumoniae bacteriophages##2##4##(1990-1#1)(1991-7#1)
the Streptococcus pneumoniae##6##3##(1990-1#1)(1990-9#1)(1991-7#1)(1991-9#1)(1992-5#1)(2011-2#1)
the Streptococcus##12##2##(1990-1#1)(1990-9#1)(1991-7#1)(1991-9#1)(1992-5#1)(1994-8#1)(1996-10#1)(2009-6#2)(2011-1#1)(2011-2#2)
the Streptomyces cattleya phage##2##4##(1990-9#2)
the Streptomyces##8##2##(1990-1#1)(1990-9#3)(1994-12#3)(1995-8#1)
the Stress##3##2##(2007-2#1)(2008-6#1)(2009-7#1)
the Stroke##6##2##(2007-10#1)(2007-9#3)(2012-12#1)(2012-2#1)
the Stroke-Adapted Sickness Impact Profile##2##5##(2007-10#1)(2010-9#1)
the Strong##3##2##(1996-9#1)(2012-3#1)(2013-1#1)
the Stroop task##4##3##(2007-1#2)(2008-9#1)(2013-1#1)
the Stroop##10##2##(1995-1#1)(1997-2#1)(2006-4#3)(2007-1#2)(2007-8#1)(2008-9#1)(2013-1#1)
the Structure and##3##3##(1996-2#1)(2008-5#1)(2010-2#1)
the Structure of##2##3##(1996-2#1)(2008-10#1)
the Structure##5##2##(1996-2#2)(2008-10#1)(2008-5#1)(2010-2#1)
the Structured Clinical Interview for DSM-III-R##2##6##(1996-1#1)(1996-8#1)
the Structured Clinical Interview for DSM-IV##3##6##(2004-3#1)(2007-7#1)(2012-12#1)
the Structured Clinical Interview for##7##5##(1996-1#1)(1996-8#1)(2004-3#1)(2007-7#2)(2012-12#2)
the Student t-test##3##3##(2011-2#1)(2013-1#2)
the Student##8##2##(2008-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#1)
the Student's t test##3##4##(2007-8#1)(2011-1#1)(2013-8#1)
the Student's t-test##5##3##(2004-1#1)(2008-10#1)(2011-12#1)(2012-12#1)(2013-8#1)
the Student's##9##2##(2004-1#1)(2007-8#1)(2008-10#2)(2011-1#1)(2011-12#1)(2012-12#1)(2013-8#2)
the Students##2##2##(2007-2#1)(2011-2#1)
the Study Group##2##3##(1997-7#1)(2009-9#1)
the Study of##28##3##(1992-2#1)(1995-11#2)(2005-6#1)(2005-8#4)(2006-10#3)(2006-12#1)(2006-7#1)(2006-8#2)(2008-10#2)(2008-4#1)(2008-5#1)(2009-8#2)(2009-9#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
the Study##32##2##(1992-2#1)(1995-11#2)(1997-7#1)(2005-6#1)(2005-8#4)(2006-10#3)(2006-12#1)(2006-7#1)(2006-8#2)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#2)(2009-9#2)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#1)
the Stulberg##3##2##(2007-7#3)
the Stöber##3##2##(2005-11#1)(2008-10#1)(2009-2#1)
the Subjective##2##2##(2004-12#1)(2006-2#1)
the Sudan##4##2##(2005-9#1)(2008-10#2)(2013-1#1)
the Suffern##2##2##(2008-10#2)
the Sugarcane Leaf Scald Pathogen##2##5##(2008-10#2)
the Sultanate of Oman##2##4##(2007-8#1)(2008-10#1)
the Summer##3##2##(1994-1#1)(2006-11#1)(2010-12#1)
the Sun in the##2##4##(2008-2#2)
the Sun is##2##3##(2008-3#2)
the Sun##15##2##(1991-9#1)(1996-5#1)(2007-12#1)(2008-2#8)(2008-3#4)
the Sunnybrook Health Science Centre##3##5##(1995-12#1)(1995-2#1)(1997-3#1)
the Sunnybrook##5##2##(1995-12#1)(1995-2#1)(1997-3#1)(2007-9#1)(2008-7#1)
the Superior##2##2##(2008-9#1)(2013-1#1)
the Superior-Inferior##2##2##(2008-5#2)
the Supplemental Security Income Program##2##5##(1995-12#2)
the Supplemental Security Income##3##4##(1992-1#1)(1995-12#2)
the Support##2##2##(2008-4#1)(2010-8#1)
the Suppression of##3##3##(2008-10#3)
the Suppression##4##2##(2008-10#3)(2008-5#1)
the Supreme Court##4##3##(1992-6#1)(2005-11#2)(2013-8#1)
the Supreme Court's##2##3##(1991-12#1)(1992-2#1)
the Supreme##7##2##(1991-12#1)(1992-2#1)(1992-6#1)(2005-11#2)(2010-12#1)(2013-8#1)
the Surgical Department of##3##4##(1990-9#1)(1993-3#1)(2008-10#1)
the Surgical Department##5##3##(1990-9#1)(1992-4#1)(1993-3#1)(1993-5#1)(2008-10#1)
the Surgical Division of##2##4##(1991-4#1)(1991-5#1)
the Surgical##14##2##(1990-9#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-4#1)(1993-3#1)(1993-5#1)(1994-12#1)(1997-8#1)(2007-7#1)(2008-10#2)(2008-9#1)(2011-2#1)
the Suruí##3##2##(1991-12#3)
the Surveillance##3##2##(2008-1#1)(2010-2#1)(2012-3#1)
the Survey of Respirator Use and Practices##2##7##(2008-12#2)
the Survey of##5##3##(1992-2#1)(2008-12#2)(2013-1#1)(2013-8#1)
the Survey##6##2##(1992-2#1)(2008-12#2)(2008-4#1)(2013-1#1)(2013-8#1)
the Survival of##4##3##(2008-10#2)(2010-12#1)(2010-7#1)
the Surviving##2##2##(2008-12#1)(2008-6#1)
the Suzuki-BJP##2##2##(1997-8#2)
the Swedish Environmental Specimen Bank##2##5##(1992-4#2)
the Swedish Medical Journal##2##4##(2011-1#2)
the Swedish##23##2##(1990-5#1)(1991-11#1)(1992-4#2)(1996-12#1)(1996-5#1)(1997-7#2)(2006-10#1)(2007-4#1)(2007-8#1)(2008-2#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-3#2)(2011-1#4)(2012-12#1)(2013-1#1)
the Swiss Canton of Vaud##5##5##(1990-4#2)(1991-5#1)(1993-9#2)
the Swiss Federal##3##3##(1991-11#2)(2008-3#1)
the Swiss population##2##3##(1991-11#1)(2013-7#1)
the Swiss##22##2##(1990-12#1)(1990-4#2)(1991-11#4)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1993-9#2)(1996-12#1)(1996-8#1)(2007-8#1)(2008-10#1)(2008-3#2)(2011-2#1)(2012-2#1)(2013-7#1)
the SyF##2##2##(2008-10#2)
the SyFS##3##2##(2008-10#3)
the Sydney##3##2##(2008-3#1)(2008-9#1)(2010-8#1)
the Symposium##4##2##(2006-11#1)(2009-3#2)(2010-5#1)
the Symptom##3##2##(2008-10#1)(2011-2#1)(2012-5#1)
the Symptoms##3##2##(2008-1#1)(2013-1#2)
the Syndrome##2##2##(2008-10#1)(2013-1#1)
the Synechocystis##2##2##(1995-12#1)(1996-6#1)
the Synthes##2##2##(2006-8#2)
the Synthesis of##7##3##(1996-2#1)(1996-5#1)(2008-5#2)(2009-11#1)(2009-3#1)(2009-5#1)
the Synthesis##8##2##(1996-2#1)(1996-5#1)(2006-3#1)(2008-5#2)(2009-11#1)(2009-3#1)(2009-5#1)
the Syrian hamster##6##3##(1990-7#4)(1992-2#1)(1996-8#1)
the Syrian##8##2##(1990-6#1)(1990-7#4)(1992-2#1)(1996-8#1)(2012-12#1)
the System of##3##3##(2008-2#1)(2008-5#1)(2013-8#1)
the Systems Biology Markup Language (SBML)##2##6##(2006-10#2)
the Systems##3##2##(1997-3#1)(2006-10#2)
the Systolic Hypertension in the Elderly Program (SHEP)##2##8##(1997-3#2)
the Szeged and PI indices of##2##6##(2009-3#2)
the Szeged and##3##3##(2009-3#3)
the São Paulo##4##3##(1990-12#1)(2011-2#1)(2012-3#1)(2013-7#1)
the São##8##2##(1990-12#1)(2009-10#2)(2009-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-7#1)
the T allele##3##3##(2007-10#3)
the T alpha acyl chain##3##5##(1994-11#3)
the T and R##2##4##(1990-8#2)
the T and##3##3##(1990-8#2)(1995-6#1)
the T beta gamma farnesyl chain##3##6##(1994-11#3)
the T cell antigen receptor (TCR)##2##6##(1994-9#1)(1997-6#1)
the T cell antigen receptor##3##5##(1993-11#1)(1994-9#1)(1997-6#1)
the T cell clones##4##4##(1990-6#1)(1994-2#2)(2008-11#1)
the T cell receptor (TCR)##3##5##(1997-2#1)(2008-4#1)(2011-1#1)
the T cell receptor##10##4##(1991-12#1)(1991-5#1)(1994-12#1)(1995-8#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-4#1)(2011-1#1)
the T cell##32##3##(1990-11#1)(1990-6#1)(1991-12#3)(1991-5#1)(1992-12#2)(1993-11#1)(1994-12#1)(1994-2#2)(1994-9#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#2)(2007-11#1)(2007-12#1)(2008-11#3)(2008-4#2)(2010-12#1)(2011-1#2)
the T cells##5##3##(1991-12#2)(2005-10#2)(2009-9#1)
the T current##2##3##(1992-8#2)
the T growth##2##3##(2013-8#2)
the T helper 1##2##4##(2007-11#1)(2011-2#1)
the T helper##3##3##(2007-11#1)(2009-9#1)(2011-2#1)
the T loop##2##3##(1995-2#2)
the T lymphocyte##3##3##(1992-12#1)(2008-4#1)(2013-1#1)
the T matrix##5##3##(2008-2#3)(2008-3#2)
the T or##2##3##(1990-8#1)(1993-3#1)
the T quaternary structure##3##4##(1991-5#1)(1993-6#2)
the T quaternary##4##3##(1990-8#1)(1991-5#1)(1993-6#2)
the T residue##3##3##(1991-3#1)(1992-9#2)
the T state##10##3##(1990-8#3)(1991-5#1)(1993-9#3)(1995-1#2)(2008-11#1)
the T wave##2##3##(1991-5#1)(1993-1#1)
the T##132##2##(1990-11#2)(1990-6#2)(1990-7#3)(1990-8#8)(1991-1#1)(1991-11#1)(1991-12#6)(1991-3#1)(1991-5#5)(1992-11#1)(1992-12#3)(1992-8#3)(1992-9#3)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#3)(1994-11#6)(1994-12#1)(1994-2#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#4)(1995-3#1)(1995-6#2)(1995-8#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-8#3)(2005-10#2)(2006-10#3)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#2)(2008-10#11)(2008-11#6)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#1)(2008-8#1)(2009-9#2)(2010-12#1)(2011-1#2)(2011-2#3)(2012-12#2)(2013-1#2)(2013-8#2)
the T(1)##2##2##(2008-10#1)(2010-8#1)
the T(2) progeny of line##2##5##(2008-10#2)
the T(2) progeny of##3##4##(2008-10#3)
the T(2)##4##2##(2008-10#3)(2012-11#1)
the T(in)##7##2##(1995-2#1)(2008-4#6)
the T- and##2##3##(1992-7#1)(2008-10#1)
the T--&gt##2##2##(1994-8#1)(1995-6#1)
the T-DNA in a##2##4##(2008-10#2)
the T-DNA insertion##2##3##(2006-12#1)(2008-10#1)
the T-DNA transfer##2##3##(1990-11#1)(1992-5#1)
the T-DNA##10##2##(1990-11#2)(1992-5#1)(2006-12#1)(2008-10#6)
the T-cell antigen receptor##2##4##(1991-10#1)(2006-10#1)
the T-cell receptor##5##3##(1990-5#1)(1992-2#1)(1992-4#1)(1994-3#1)(1995-8#1)
the T-cell repertoire##2##3##(1995-2#1)(2010-7#1)
the T-cell response##2##3##(1996-10#1)(2006-8#1)
the T-cell##27##2##(1990-5#2)(1991-10#1)(1992-2#2)(1992-4#2)(1994-12#3)(1994-3#1)(1995-1#1)(1995-2#2)(1995-7#1)(1995-8#1)(1996-10#1)(1997-6#1)(2006-10#2)(2006-8#1)(2007-9#1)(2008-10#2)(2010-7#1)(2012-2#1)(2013-8#1)
the T-cell-dependent antigen##3##3##(1993-12#1)(1994-3#1)(2008-10#1)
the T-cell-dependent##4##2##(1993-12#1)(1994-3#1)(2008-10#2)
the T-helper##2##2##(1996-10#1)(2009-9#1)
the T-lymphocyte##3##2##(1993-6#1)(2008-10#1)(2010-12#1)
the T-matrix and the finite-difference time-domain methods##2##7##(2008-3#2)
the T-matrix method to##2##4##(2008-3#2)
the T-matrix##5##2##(2008-3#5)
the T-state##10##2##(1990-9#2)(1991-1#2)(1992-7#4)(1994-8#1)(1994-9#1)
the T-tubule##2##2##(1991-2#2)
the T-tubules##4##2##(2007-9#2)(2013-8#2)
the T/B##2##2##(2007-10#1)(2013-7#1)
the T/C##2##2##(2008-9#1)(2009-4#1)
the T1 acceleration##2##3##(2007-4#2)
the T1 and T2##3##4##(1992-12#1)(2006-12#1)(2009-7#1)
the T1 and##4##3##(1992-12#1)(2006-12#1)(2009-7#1)(2012-12#1)
the T1##10##2##(1990-2#1)(1990-3#1)(1992-12#1)(1995-11#1)(2006-12#2)(2007-4#2)(2009-7#1)(2012-12#1)
the T2##5##2##(1990-3#2)(1994-11#1)(2006-12#1)(2008-1#1)
the T2DM group##2##3##(2011-1#2)
the T2DM##4##2##(2011-1#2)(2012-2#2)
the T3 generation##2##3##(2006-12#2)
the T3 isolate##2##3##(2008-10#2)
the T3 receptor (TR) beta gene##2##6##(1995-10#1)(1995-8#1)
the T3 receptor##3##3##(1995-10#2)(1995-8#1)
the T3##12##2##(1995-10#2)(1995-8#1)(2006-12#3)(2008-10#5)(2012-12#1)
the T3-resistant##2##2##(2008-10#2)
the T36##3##2##(2008-10#3)
the T4 DNA##7##3##(1990-4#1)(1990-5#1)(1994-12#2)(1994-9#3)
the T4 gene##2##3##(1994-12#1)(1995-6#1)
the T4 primosome##2##3##(1994-12#2)
the T4##25##2##(1990-3#1)(1990-4#1)(1990-5#2)(1991-3#1)(1994-12#8)(1994-9#4)(1995-6#1)(1995-8#2)(1997-3#2)(2006-12#1)(2008-10#1)(2008-6#1)
the T4-encoded##2##2##(1990-3#1)(1994-12#1)
the T7 RNA polymerase gene##2##5##(1990-4#1)(1991-9#1)
the T7 RNA polymerase##7##4##(1990-11#1)(1990-4#1)(1991-9#1)(1993-11#1)(1993-3#1)(1996-11#1)(2008-8#1)
the T7 RNA##9##3##(1990-11#1)(1990-4#1)(1991-1#1)(1991-12#1)(1991-9#1)(1993-11#1)(1993-3#1)(1996-11#1)(2008-8#1)
the T7 promoter##3##3##(1990-4#1)(1997-1#1)(2008-11#1)
the T7##23##2##(1990-11#1)(1990-3#1)(1990-4#2)(1991-1#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-2#4)(1993-11#1)(1993-3#1)(1996-11#1)(1997-1#1)(1997-5#1)(2006-12#1)(2007-6#2)(2008-11#1)(2008-8#1)(2009-3#1)
the TA* photoproduct##3##3##(1995-1#3)
the TA*##4##2##(1995-1#4)
the TA2 domain was##2##4##(1995-6#2)
the TAC##3##2##(2007-3#1)(2013-8#2)
the TACCs##2##2##(2008-5#2)
the TAD soils##2##3##(2008-10#2)
the TAD##3##2##(2008-10#3)
the TAG72##2##2##(1993-2#1)(1997-2#1)
the TAL1##2##2##(1990-3#1)(1994-8#1)
the TAOS from##2##3##(2007-12#2)
the TAOS##4##2##(2007-12#4)
the TAP##2##2##(2007-8#1)(2008-7#1)
the TAR loop##3##3##(1994-8#3)
the TAR##5##2##(1992-12#1)(1994-12#1)(1994-8#3)
the TAT gene##2##3##(1991-11#1)(1994-12#1)
the TAT peptide##2##3##(2009-6#2)
the TAT##7##2##(1991-11#1)(1994-12#1)(1997-4#1)(2008-1#1)(2008-2#1)(2009-6#2)
the TATA binding protein##2##4##(1990-6#2)
the TATA box binding protein##4##5##(1990-6#1)(1994-3#2)(1996-4#1)
the TATA box##18##3##(1990-6#2)(1993-12#1)(1993-5#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-8#4)(1996-4#2)(1997-2#1)
the TATA element##5##3##(1992-2#1)(1994-9#1)(1995-2#1)(1995-8#2)
the TATA##27##2##(1990-6#5)(1992-2#1)(1993-12#1)(1993-5#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-2#1)(1995-8#6)(1996-4#2)(1997-2#2)
the TATA-binding protein (TBP)##2##4##(1993-9#1)(1997-2#1)
the TATA-binding protein##6##3##(1992-5#1)(1993-8#1)(1993-9#1)(1995-8#2)(1997-2#1)
the TATA-binding##9##2##(1992-5#2)(1993-8#1)(1993-9#1)(1995-8#3)(1996-5#1)(1997-2#1)
the TATA-box##2##2##(1994-12#2)
the TB##5##2##(1994-4#1)(1995-9#1)(2007-8#1)(2008-10#1)(2013-8#1)
the TB/C3-bcl2##2##2##(2008-11#2)
the TB/C3-pEF##2##2##(2008-11#2)
the TBI patients##2##3##(2007-11#1)(2008-8#1)
the TBI##3##2##(2007-11#1)(2008-8#1)(2008-9#1)
the TBP extraction method##2##4##(2008-10#2)
the TC##3##2##(2007-3#1)(2008-7#1)(2012-2#1)
the TCA cycle and##3##4##(2008-10#1)(2009-10#1)(2012-1#1)
the TCA cycle##14##3##(1993-11#1)(1993-6#1)(1994-11#1)(1995-11#1)(1996-2#1)(2005-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
the TCA##15##2##(1993-11#1)(1993-6#1)(1994-11#1)(1995-11#1)(1996-2#1)(2005-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
the TCD##2##2##(2008-7#1)(2012-1#1)
the TCDD##2##2##(1992-8#1)(2008-11#1)
the TCDD-liganded AhR/ARNT##2##3##(2006-12#2)
the TCI##2##2##(2006-7#1)(2009-9#1)
the TCNQ##2##2##(2007-11#1)(2008-10#1)
the TCR approach##2##3##(2006-6#2)
the TCR repertoire##3##3##(1997-7#1)(2008-4#1)(2012-3#1)
the TCR##25##2##(1990-3#1)(1990-9#1)(1991-12#3)(1992-5#1)(1994-3#1)(1995-3#1)(1997-6#2)(1997-7#3)(2006-6#2)(2008-11#3)(2008-4#2)(2011-1#2)(2012-1#2)(2012-3#1)
the TCR-associated CD3 zeta polypeptides##2##5##(1994-9#2)
the TCRAC gene##3##3##(1997-9#3)
the TCRAC##4##2##(1997-9#4)
the TD controls##3##3##(2009-4#3)
the TD x##2##3##(1996-8#1)(2008-10#1)
the TD##10##2##(1996-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2009-4#4)(2009-8#1)(2010-12#1)
the TDAR to##2##3##(2008-10#2)
the TDH##2##2##(2007-1#2)
the TDT##3##2##(2008-4#1)(2008-9#2)
the TDX system##4##3##(1993-8#4)
the TE and TM##2##4##(2008-2#2)
the TE##9##2##(2006-5#1)(2007-11#1)(2008-10#1)(2008-2#4)(2008-3#1)(2008-5#1)
the TE-polarized image##2##3##(2007-12#1)(2008-3#1)
the TEA-Ch##2##2##(2005-10#2)
the TED15 antigen is##2##4##(1992-2#2)
the TEFRA##2##2##(1990-12#1)(1994-3#1)
the TEM##4##2##(2005-11#1)(2006-12#1)(2006-6#1)(2008-10#1)
the TEM(00)##2##2##(2007-12#1)(2008-3#1)
the TEM00##2##2##(2008-3#2)
the TEMPO+##8##2##(2008-9#8)
the TES##3##2##(2008-2#3)
the TEWL##4##2##(2008-5#4)
the TF reflex##10##3##(1990-7#7)(1991-5#3)
the TF##16##2##(1990-7#7)(1991-5#3)(1993-11#1)(1993-3#1)(1995-8#3)(2010-12#1)
the TFIIB gene##2##3##(1997-6#2)
the TFIID complex##2##3##(1993-9#1)(1995-6#1)
the TFIID##4##2##(1990-6#1)(1993-9#1)(1995-6#1)(1997-6#1)
the TFIIIA gene##3##3##(1991-3#2)(1992-11#1)
the TFIIIA##4##2##(1991-12#1)(1991-3#2)(1992-11#1)
the TFO##3##2##(1995-5#3)
the TGF beta superfamily##2##4##(1992-4#2)
the TGF beta##6##3##(1992-4#2)(1992-8#3)(2013-8#1)
the TGF##9##2##(1991-1#1)(1992-4#2)(1992-8#3)(1996-4#1)(1997-1#1)(2013-8#1)
the TGF-beta 1##3##3##(1990-9#3)
the TGF-beta element##2##3##(2008-9#2)
the TGF-beta receptor##2##3##(1991-4#1)(1992-9#1)
the TGF-beta superfamily of##2##4##(1994-12#1)(2013-1#1)
the TGF-beta type I##3##4##(2009-4#2)(2011-2#1)
the TGF-beta type##4##3##(1995-2#1)(2009-4#2)(2011-2#1)
the TGF-beta##23##2##(1990-9#4)(1991-4#1)(1992-9#1)(1994-12#1)(1995-2#5)(1995-3#1)(2005-8#1)(2008-6#1)(2008-9#3)(2009-4#3)(2011-2#1)(2013-1#1)
the TGF-beta-related##2##2##(1996-5#1)(2007-12#1)
the TGF-beta1/SMAD signaling pathway##5##4##(2011-2#5)
the TGF-beta1/SMAD##6##2##(2011-2#6)
the TH CRE##2##3##(1997-2#2)
the TH gene##6##3##(1997-2#4)(1997-5#2)
the TH promoter and##2##4##(1995-12#1)(2010-12#1)
the TH##18##2##(1990-12#1)(1991-12#1)(1993-8#1)(1995-12#2)(1997-2#7)(1997-5#3)(2007-12#1)(2010-12#1)(2011-2#1)
the THA##2##2##(2009-3#1)(2012-2#1)
the THF##2##2##(1992-10#1)(2007-1#1)
the THG##3##2##(2008-3#2)(2013-1#1)
the THO complex##2##3##(2006-11#2)
the THOR and Hybrid III##2##5##(2006-11#2)
the THOR dummy##2##3##(2006-11#2)
the THOR##4##2##(2006-11#4)
the THOR-alpha is##2##3##(2006-11#2)
the THOR-alpha##6##2##(2006-11#6)
the THz wave##3##3##(2008-3#3)
the THz##14##2##(2007-12#9)(2008-3#3)(2011-1#1)(2012-2#1)
the TI##3##2##(2009-12#2)(2011-2#1)
the TIGR##2##2##(2008-4#2)
the TIIS##2##2##(2008-2#2)
the TIM barrel structure##2##4##(1994-10#2)
the TIMI##3##2##(2008-3#2)(2013-8#1)
the TIR##4##2##(2006-12#1)(2008-3#1)(2008-8#2)
the TIR-60 UP leads##2##4##(2008-3#2)
the TIRF-based biosensor##2##3##(2008-10#2)
the TIS11 family of immediate early genes##2##7##(1994-12#2)
the TJ permeability##2##3##(1997-1#1)(2008-11#1)
the TJ##4##2##(1997-1#2)(2006-5#1)(2008-11#1)
the TK##4##2##(1990-11#2)(1992-11#1)(1992-12#1)
the TL##3##2##(2008-10#1)(2008-3#2)
the TLC assay##2##3##(1997-3#2)
the TLC method##2##3##(1997-3#1)(2005-11#1)
the TLC##10##2##(1996-5#1)(1997-3#3)(2005-11#4)(2007-1#1)(2008-10#1)
the TLC-LSD method##2##3##(2008-10#2)
the TLR##2##2##(2008-10#1)(2009-9#1)
the TLR4##5##2##(2008-10#1)(2008-2#1)(2010-2#1)(2013-8#2)
the TLV##6##2##(1994-6#6)
the TM polarization##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
the TM##25##2##(1991-10#1)(1991-8#1)(1994-3#2)(1996-5#3)(2007-11#2)(2008-2#3)(2008-3#2)(2009-7#6)(2011-2#4)(2013-8#1)
the TMG##2##2##(2008-10#2)
the TMIA group##2##3##(2009-3#2)
the TMJ was##2##3##(2010-2#1)(2011-2#1)
the TMJ##8##2##(2007-12#3)(2010-2#2)(2011-2#1)(2012-11#1)(2012-3#1)
the TMP##2##2##(1990-3#2)
the TMS coil##2##3##(2010-7#2)
the TMS##3##2##(2008-10#1)(2010-7#2)
the TMS320C6701##2##2##(2008-2#2)
the TNBS assay##2##3##(1995-1#1)(2011-2#1)
the TNF alpha-308 polymorphism##2##4##(1995-12#2)
the TNF receptor##5##3##(1996-5#1)(1997-6#2)(2007-11#1)(2007-8#1)
the TNF##17##2##(1992-8#1)(1994-2#1)(1994-9#1)(1995-12#2)(1995-3#2)(1996-5#1)(1997-2#1)(1997-6#2)(2006-10#2)(2007-11#1)(2007-8#1)(2008-8#1)(2009-3#1)
the TNF-alpha and##2##3##(1991-6#1)(1995-1#1)
the TNF-alpha##11##2##(1991-6#1)(1992-12#1)(1995-1#2)(1995-12#2)(2007-12#1)(2008-10#1)(2011-1#2)(2013-1#1)
the TNF-beta gene##3##3##(1991-6#1)(1997-7#2)
the TNF-beta locus##2##3##(1997-7#2)
the TNF-beta##5##2##(1991-6#1)(1997-7#4)
the TNM classification##4##3##(1993-11#1)(2007-8#1)(2012-1#1)(2013-7#1)
the TNM##5##2##(1993-11#1)(2007-8#1)(2012-1#1)(2012-3#1)(2013-7#1)
the TNT##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
the TOA##2##2##(2008-2#1)(2008-3#1)
the TOAST##2##2##(2007-10#1)(2007-9#1)
the TP##3##2##(1993-9#1)(2008-10#1)(2008-3#1)
the TP53 gene##2##3##(2008-7#1)(2009-8#1)
the TP53 locus##2##3##(2009-8#2)
the TP53##5##2##(2007-6#1)(2008-7#1)(2009-8#3)
the TP82-induced intracellular Ca2+##2##4##(1990-8#2)
the TPA effect##2##3##(1990-4#1)(1991-7#1)
the TPA##7##2##(1990-4#1)(1991-2#1)(1991-7#5)
the TPA-induced MMP-1 and MMP-9##2##5##(2012-3#2)
the TPA-induced##7##2##(1990-2#1)(1991-7#2)(1992-9#1)(1993-12#1)(2012-3#2)
the TPDE##2##2##(2008-10#2)
the TPE##2##2##(1990-9#1)(2011-1#1)
the TPF##6##2##(2008-10#2)(2008-3#4)
the TPMT##4##2##(1996-3#2)(2008-8#1)(2013-1#1)
the TPO##2##2##(1995-12#1)(2010-10#1)
the TPS##2##2##(1991-12#1)(2009-5#1)
the TQM##3##2##(1993-3#1)(1994-1#1)(1994-12#1)
the TR##4##2##(1990-11#1)(1996-2#1)(2008-3#1)(2010-12#1)
the TRA##4##2##(2011-2#4)
the TRA-1-60 antigen##2##3##(1991-9#2)
the TRAMP##2##2##(2008-4#1)(2013-1#1)
the TRF spectra##2##3##(2008-10#2)
the TRH##2##2##(1992-2#1)(1996-9#1)
the TRH-induced transient increase in [Ca2+]i##2##6##(1991-10#2)
the TRH1##2##2##(1996-5#2)
the TRIPS agreement##3##3##(2008-6#3)
the TRK##2##2##(1991-5#2)
the TRL legform impactor##4##4##(2007-4#4)
the TRL##5##2##(2006-11#1)(2007-4#4)
the TRL-PLI##2##2##(2006-11#2)
the TRLFS##2##2##(2008-10#2)
the TRP1##4##2##(1991-8#1)(1997-3#2)(1997-8#1)
the TS##7##2##(1992-12#1)(1994-5#1)(2006-12#1)(2008-11#3)(2008-2#1)
the TSA##2##2##(1990-6#1)(2008-9#1)
the TSC##2##2##(1992-1#2)
the TSD##3##2##(2008-2#3)
the TSH receptor##12##3##(1990-12#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#2)(1993-3#1)(1996-5#4)
the TSH##21##2##(1990-12#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-7#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-11#2)(1995-5#2)(1996-5#4)(2006-10#1)
the TSH-R##2##2##(1991-12#1)(1991-9#1)
the TSHR##4##2##(1991-8#2)(1994-3#1)(1995-12#1)
the TSHr##3##2##(1994-11#1)(2008-4#2)
the TSI##5##2##(2012-3#5)
the TSK##5##2##(1990-11#2)(1997-8#2)(2008-10#1)
the TSP##2##2##(1995-3#1)(2013-8#1)
the TSPO##9##2##(2012-2#9)
the TSPO-labeled##2##2##(2012-2#2)
the TSS concentration##4##3##(2013-8#4)
the TSS##6##2##(2009-4#1)(2011-1#1)(2013-8#4)
the TSST-1##3##2##(1993-3#2)(1997-2#1)
the TST##3##2##(2010-5#3)
the TSWV N##2##3##(2008-10#2)
the TSWV##5##2##(2008-10#5)
the TT##2##2##(1993-3#1)(2011-2#1)
the TTF-1 binding sites##2##4##(1997-2#2)
the TTF-1 binding##3##3##(1997-2#3)
the TTFM##2##2##(2013-1#2)
the TTM scheme##2##3##(2012-2#2)
the TTM##5##2##(2010-12#1)(2010-2#2)(2012-2#2)
the TTRF compared to the##2##5##(2005-12#2)
the TTRF##5##2##(2005-12#5)
the TUG##3##2##(2010-3#3)
the TUNEL assay##2##3##(2007-8#1)(2008-11#1)
the TUNEL##6##2##(1995-12#1)(2003-11#1)(2007-8#1)(2008-11#1)(2008-7#1)(2010-1#1)
the TXA2 receptor antagonist##2##4##(1995-3#2)
the TXA2 receptor##4##3##(1995-3#4)
the TXA2##5##2##(1995-3#5)
the TYS1 gene##2##3##(1995-6#1)(1997-3#1)
the Taiwan habu##2##3##(1994-12#2)
the Taiwan##5##2##(1994-12#2)(2008-8#1)(2010-8#1)(2013-1#1)
the Talbot effect##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
the Talbot interferometry##2##3##(2008-3#2)
the Talbot##8##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)(2012-12#2)
the Talipexole##2##2##(2007-10#2)
the Tanba##3##2##(2012-11#3)
the Tanzania##2##2##(2008-2#1)(2010-8#1)
the Tapajós National Forest##2##4##(2013-7#2)
the Tapajós##3##2##(2013-7#3)
the Taq DNA polymerase##2##4##(1990-3#1)(2007-8#1)
the Taq##4##2##(1990-3#2)(1991-6#1)(2007-8#1)
the TaqMan probes##2##3##(2008-10#1)(2012-2#1)
the TaqMan##4##2##(2008-10#2)(2010-4#1)(2012-2#1)
the Tar-16##2##2##(1994-8#2)
the Tarasca is##2##3##(2009-10#2)
the Tarasca##8##2##(2009-10#8)
the Tarasca's##2##2##(2009-10#2)
the Target Tendon Harvester##2##4##(2008-4#2)
the Target##3##2##(2008-4#2)(2008-8#1)
the Task Force on##2##4##(1995-12#1)(2007-6#1)
the Task##3##2##(1995-12#1)(2007-6#1)(2009-4#1)
the Tasmanian##3##2##(2008-9#2)(2009-12#1)
the Tawanchai Cleft##2##3##(2011-2#2)
the Tawanchai##3##2##(2011-2#3)
the Taxus##2##2##(2009-5#1)(2012-7#1)
the Taylor's##2##2##(2008-10#1)(2008-2#1)
the Tayrona##2##2##(2007-3#1)(2011-2#1)
the Tb-Gd-Trp-SDBS system##2##3##(2008-10#2)
the Tb3+##3##2##(1990-7#1)(1995-5#2)
the Tc##2##2##(1991-5#1)(1994-9#1)
the Tca DNA polymerase##2##4##(1997-4#2)
the Tco##3##2##(1997-8#3)
the TdT promoter##3##3##(1996-4#3)
the Teacher##2##2##(2006-10#1)(2011-2#1)
the Teaching##2##2##(1996-2#1)(2009-10#1)
the Teakettle##2##2##(2008-10#2)
the Teflon AF##2##3##(2010-8#2)
the Teflon##6##2##(2008-10#3)(2008-2#1)(2010-8#2)
the Tegner##2##2##(2009-6#1)(2011-2#1)
the Telephone##2##2##(2008-8#2)
the Temperament##2##2##(2011-1#1)(2013-8#1)
the Temporal##3##2##(1997-1#1)(2008-10#1)(2009-6#1)
the Tennessee##2##2##(1996-3#2)
the Tenth##3##2##(1996-6#1)(2010-11#1)(2013-8#1)
the Terrestrial##2##2##(2005-5#1)(2008-6#1)
the Tesio##2##2##(2007-7#2)
the Test of##3##3##(2005-10#1)(2010-3#1)(2013-7#1)
the Test##5##2##(2005-10#1)(2006-11#1)(2007-8#1)(2010-3#1)(2013-7#1)
the TetON vector##3##3##(2009-10#3)
the Tetraconata##2##2##(2007-12#2)
the Texas Department of Health##2##5##(1996-2#1)(2007-1#1)
the Texas Medical Association##2##4##(2007-1#1)(2010-8#1)
the Texas##12##2##(1996-2#1)(2006-12#1)(2007-1#2)(2008-10#5)(2010-8#1)(2011-2#1)(2012-3#1)
the Tg##5##2##(2005-11#1)(2007-11#1)(2008-8#1)(2008-9#2)
the Th1-derived cytokines##2##3##(1996-9#2)
the Th1-derived##3##2##(1996-9#3)
the Th2 immune##2##3##(2009-5#1)(2012-12#1)
the Th2##4##2##(2005-10#1)(2006-10#1)(2009-5#1)(2012-12#1)
the Thai PWI and##2##4##(2010-9#2)
the Thai##3##2##(2008-8#1)(2010-9#2)
the Theory of Reasoned Action (TRA)##2##6##(2008-9#1)(2011-1#1)
the Theory of Reasoned Action##3##5##(2008-4#1)(2008-9#1)(2011-1#1)
the TheraDrive##2##2##(2012-1#2)
the Therapeutic##2##2##(2005-7#1)(2006-10#1)
the Thermal##2##2##(2008-3#1)(2012-1#1)
the Thermoanaerobacter tengcongensis##2##3##(2012-12#2)
the Thessaloniki##2##2##(2006-1#1)(2008-3#1)
the Third International##4##3##(2007-8#1)(2008-11#1)(2008-7#1)(2011-2#1)
the Third National##2##3##(2005-5#1)(2011-2#1)
the Third##19##2##(1991-4#1)(1991-5#3)(1993-6#1)(2005-5#1)(2006-9#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#3)(2011-2#5)(2013-1#1)
the Thirteenth Amendment##5##3##(2011-2#5)
the Thor-alpha##2##2##(2006-11#2)
the Thr147##2##2##(2012-2#2)
the Three Gorge Reservoir areas##3##5##(2011-12#3)
the Thyroid Gland##2##3##(1993-4#1)(2013-1#1)
the Ti film##2##3##(2009-7#2)
the Ti##20##2##(1990-11#1)(1992-5#1)(1997-7#1)(2004-9#2)(2007-11#3)(2007-12#3)(2008-10#2)(2008-3#2)(2008-5#1)(2008-8#1)(2009-7#3)
the Ti-H##2##2##(2006-4#2)
the TiNi foam samples##2##4##(2009-7#2)
the TiNi##3##2##(2009-7#3)
the TiO(2) film##3##3##(2007-12#2)(2008-10#1)
the TiO(2)##8##2##(2005-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2009-11#1)(2012-2#1)
the TiO2 surface##2##3##(2005-11#1)(2010-4#1)
the TiO2##8##2##(2005-11#1)(2007-12#4)(2010-4#3)
the Tibia##2##2##(2007-1#1)(2007-4#1)
the Tigris River##4##3##(2013-1#4)
the Time##4##2##(1991-8#1)(2008-3#1)(2009-12#1)(2010-11#1)
the Title##2##2##(1991-1#1)(1991-10#1)
the Tm by 2##2##4##(1997-7#2)
the Tm of##3##3##(1990-4#1)(1990-8#1)(1997-6#1)
the Tm value##2##3##(1991-2#1)(1995-6#1)
the Tm##15##2##(1990-4#1)(1990-7#1)(1990-8#1)(1991-2#1)(1995-5#1)(1995-6#2)(1997-6#2)(1997-7#2)(2007-12#3)(2008-3#1)
the Tn antigen##4##3##(1992-8#4)
the Tn3##2##2##(1996-12#2)
the Tn5 insertion##2##3##(1993-9#1)(2008-10#1)
the Tn5##4##2##(1993-9#1)(2008-10#1)(2013-8#2)
the Tn903##2##2##(1995-2#1)(1997-2#1)
the Tobacco Etiology Research Network##2##5##(2008-8#2)
the Tobacco##3##2##(2008-10#1)(2008-8#2)
the Tokyo Institute of Technology##2##5##(2006-6#1)(2007-9#1)
the Tokyo##7##2##(2006-6#1)(2007-9#1)(2012-11#1)(2013-8#4)
the Toll gene##2##3##(1994-2#2)
the Toll##5##2##(1991-5#2)(1994-2#2)(2010-11#1)
the Toll-like receptor##2##3##(2005-10#1)(2011-1#1)
the Toluca Valley of##2##4##(2008-10#2)
the Toluca Valley##5##3##(2008-10#5)
the Toluca valley##2##3##(2008-10#2)
the Toluca##7##2##(2008-10#7)
the Tomlinson report##2##3##(1993-1#1)(1996-8#1)
the Tongan##3##2##(2008-1#3)
the Toronto Clearinghouse##3##3##(1996-3#3)
the Toronto##10##2##(1991-11#1)(1992-3#1)(1996-3#4)(2006-10#1)(2007-12#1)(2008-6#1)(2008-7#1)
the Torpedo electric organ##3##4##(1990-11#1)(1992-6#1)(1993-3#1)
the Torpedo nicotinic acetylcholine receptor##3##5##(1994-5#2)(1995-1#1)
the Torpedo##7##2##(1990-11#1)(1991-7#1)(1992-6#1)(1993-3#1)(1994-5#2)(1995-1#1)
the Total Synthesis of##2##4##(2008-3#1)(2010-8#1)
the Total##4##2##(1995-3#1)(2004-4#1)(2008-3#1)(2010-8#1)
the Tower of Hanoi##2##4##(2012-1#1)(2012-2#1)
the ToxA##2##2##(1990-11#1)(2008-10#1)
the Toxoplasma gondii##2##3##(1993-9#1)(2007-9#1)
the Toyota Production System##4##4##(2012-2#4)
the Toyota##5##2##(2012-2#4)(2013-8#1)
the TrA##2##2##(2010-12#2)
the TraG##2##2##(1997-4#2)
the Traditional##2##2##(1995-12#1)(2009-5#1)
the Trail Making Test##2##4##(2007-9#1)(2012-12#1)
the Trail##3##2##(2007-9#1)(2012-12#1)(2013-8#1)
the Training##3##2##(1996-6#1)(2012-12#1)(2013-7#1)
the Transcultural##2##2##(2008-11#1)(2008-2#1)
the Transdisciplinary Tobacco Use Research Centers##2##6##(2008-8#2)
the Transdisciplinary Tobacco Use Research##3##5##(2008-8#3)
the Translocator Protein (TSPO)##3##4##(2012-2#3)
the Translocator Protein##4##3##(2012-2#4)
the Transtheoretical Model##2##3##(2008-4#1)(2013-1#1)
the Transverse Ranges##2##3##(1995-6#2)
the Transverse##3##2##(1995-6#2)(2011-2#1)
the Traumatic##2##2##(2006-4#1)(2012-1#1)
the Traumatology Clinic##2##3##(2007-11#2)
the Traumatology##3##2##(1991-11#1)(2007-11#2)
the Treatment of##33##3##(1994-7#1)(1996-9#1)(1997-3#1)(2006-10#1)(2006-9#2)(2007-10#2)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-6#3)(2008-7#2)(2009-6#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#4)(2013-7#1)
the Treatment##34##2##(1994-7#1)(1996-9#1)(1997-3#1)(2006-10#1)(2006-9#2)(2007-10#2)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-6#3)(2008-7#2)(2009-6#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#5)(2013-7#1)
the Trendelenburg##2##2##(2007-7#1)(2007-8#1)
the Tri-Service##2##2##(1996-12#1)(2006-5#1)
the Tri5 gene##2##3##(2008-10#1)(2010-10#1)
the Trichoderma##5##2##(2008-10#4)(2009-8#1)
the Trieste##2##2##(2008-2#2)
the Tris-induced##2##2##(1990-3#2)
the Triton X-100-insoluble##2##3##(1994-12#1)(1995-11#1)
the Triton##6##2##(1990-11#1)(1993-6#1)(1994-12#3)(1995-11#1)
the Trk##2##2##(1995-3#1)(1996-3#1)
the Trop-ELISA##4##2##(2005-9#4)
the Tropospheric##2##2##(1996-5#1)(2008-3#1)
the Trp residue##2##3##(1992-12#1)(1997-8#1)
the Trp residues##3##3##(1993-3#1)(1997-8#2)
the Trp##9##2##(1991-12#1)(1991-7#1)(1992-12#1)(1993-3#1)(1997-8#3)(2008-4#1)(2008-5#1)
the Ts65Dn mouse model of##2##5##(2012-2#2)
the Tsukuba and Chiba populations##2##5##(2008-10#2)
the Tumor##2##2##(2010-8#1)(2013-1#1)
the Tunisian##3##2##(2007-8#1)(2008-10#1)(2009-10#1)
the Turkana of Lodwar township##2##5##(2009-4#2)
the Turkana##4##2##(2007-6#1)(2009-4#3)
the Turkish##9##2##(1997-5#1)(2008-12#1)(2008-2#3)(2008-9#1)(2010-11#1)(2011-1#1)(2013-7#1)
the Turo group##3##3##(2008-10#3)
the Turo##5##2##(2008-10#5)
the Tutotest in a hybrid##2##5##(2008-10#2)
the Tutotest##4##2##(2008-10#4)
the Twyman-Green interferometer##2##3##(2008-3#2)
the Twyman-Green##3##2##(2008-3#3)
the Type 2 Cu##2##4##(1992-9#2)
the Type 2##4##3##(1990-8#1)(1992-9#3)
the Type I error rate##3##5##(2012-2#3)
the Type I error##4##4##(2006-7#1)(2012-2#3)
the Type I##7##3##(1990-8#1)(1994-12#1)(1994-5#1)(2006-7#1)(2012-2#3)
the Type II##3##3##(1990-4#1)(1997-5#1)(2006-8#1)
the Type##18##2##(1990-4#1)(1990-8#2)(1992-9#4)(1994-12#1)(1994-5#1)(1996-10#1)(1997-5#1)(2006-7#1)(2006-8#1)(2012-12#1)(2012-2#3)(2013-1#1)
the Tyr hydroxyl##3##3##(1990-9#3)
the Tyr##9##2##(1990-9#6)(1994-12#1)(1994-5#1)(1994-9#1)
the Tłįchǫ##4##2##(2012-3#4)
the U##233##2##(1990-11#2)(1990-2#1)(1990-4#2)(1990-6#1)(1991-10#4)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#3)(1992-3#3)(1993-1#1)(1993-12#1)(1993-2#3)(1993-3#2)(1993-9#1)(1994-1#4)(1994-12#3)(1994-2#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#4)(1996-3#2)(1996-5#1)(1996-6#3)(1997-1#5)(1997-6#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-7#3)(2007-10#2)(2007-12#3)(2007-4#3)(2007-5#3)(2007-7#4)(2007-8#7)(2007-9#10)(2008-1#7)(2008-10#26)(2008-12#3)(2008-2#3)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#5)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#5)(2009-5#3)(2009-7#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#5)(2010-9#3)(2011-1#5)(2011-12#1)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#7)(2012-2#4)(2012-3#4)(2013-1#9)(2013-8#5)
the U-G units##3##3##(1997-3#3)
the U1 snRNP-C autoantigen##2##4##(1996-11#2)
the U1##5##2##(1991-6#1)(1995-6#1)(1996-11#2)(1997-7#1)
the U2 snRNP##2##3##(1993-6#1)(1995-6#1)
the U2##4##2##(1991-6#1)(1993-6#1)(1993-8#1)(1995-6#1)
the U32##2##2##(2005-11#2)
the U5 repressive element##2##4##(1996-5#2)
the U5##4##2##(1994-8#1)(1996-5#3)
the U5RE##2##2##(1996-5#2)
the U6 chimeric ribozyme##2##4##(2008-9#2)
the U6##3##2##(1993-9#1)(2008-9#2)
the UC##2##2##(2007-4#1)(2011-1#1)
the UCLA Natural History Interview##2##5##(2011-1#2)
the UCLA##4##2##(1997-2#1)(2010-7#1)(2011-1#2)
the UCS inflation procedure##2##4##(1996-6#2)
the UCS##5##2##(1995-12#1)(1996-4#1)(1996-6#2)(2007-5#1)
the UCSC Genome##2##3##(2008-4#2)
the UCSC##4##2##(2008-4#4)
the UDP##3##2##(1991-1#1)(1992-8#2)
the UDP-GlcNAc##2##2##(1991-1#1)(1996-5#1)
the UFuRT##4##2##(2013-1#4)
the UG reflex##4##3##(1994-2#4)
the UGA stop codon##2##4##(1992-3#1)(1993-11#1)
the UGA##3##2##(1992-3#1)(1993-11#1)(2012-2#1)
the UGT2B17 deletion##2##3##(2013-8#2)
the UGT2B17 genotype##3##3##(2013-8#3)
the UGT2B17##6##2##(2013-8#6)
the UICC##2##2##(1991-8#1)(1994-12#1)
the UK National##4##3##(2008-2#1)(2009-2#2)(2009-4#1)
the UK and Ireland##3##4##(2008-10#2)(2008-12#1)
the UK and USA##3##4##(2012-1#3)
the UK and##22##3##(1991-4#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#4)(2009-4#1)(2012-1#3)(2013-8#1)
the UK is##4##3##(2009-4#1)(2009-9#1)(2012-12#1)(2013-8#1)
the UK to##2##3##(2006-10#1)(2009-1#1)
the UK was##3##3##(2006-12#1)(2007-2#1)(2008-11#1)
the UK##165##2##(1991-3#2)(1991-4#2)(1992-10#1)(1992-12#3)(1992-2#1)(1992-5#2)(1992-6#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#2)(1997-4#3)(1997-8#3)(2004-1#2)(2004-2#2)(2004-7#1)(2005-7#4)(2005-8#4)(2006-10#2)(2006-12#11)(2006-5#3)(2007-11#1)(2007-2#4)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#8)(2008-11#21)(2008-12#8)(2008-2#3)(2008-5#8)(2008-6#1)(2008-7#3)(2008-9#2)(2009-1#2)(2009-2#3)(2009-4#7)(2009-9#1)(2010-11#1)(2010-2#1)(2010-4#3)(2010-5#1)(2011-1#2)(2011-2#5)(2012-1#4)(2012-12#6)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#7)
the UK's##2##2##(2006-6#1)(2009-4#1)
the UKCC##2##2##(1996-2#1)(2008-11#1)
the UL5/52 core enzyme##2##4##(1996-8#2)
the UL5/52##4##2##(1996-8#4)
the UL9 gene of##2##4##(1994-11#2)
the UL9 promoter##3##3##(1994-11#3)
the UL9 protein##2##3##(1994-3#2)
the UL9##7##2##(1994-11#5)(1994-3#2)
the UMLS is##3##3##(2008-7#1)(2013-1#2)
the UMLS##22##2##(2008-7#12)(2013-1#10)
the UMP##2##2##(1993-2#1)(1993-5#1)
the UN##5##2##(1990-2#1)(1994-10#2)(1995-5#2)
the UNICEF##4##2##(2008-11#2)(2010-3#1)(2010-5#1)
the UNRES##2##2##(2010-2#2)
the UP layers##3##3##(1997-7#3)
the UP##4##2##(1997-7#4)
the UPD##2##2##(2009-4#2)
the UPDRS##4##2##(2008-7#4)
the UR cell line##2##4##(2008-11#2)
the UR##3##2##(2008-11#2)(2008-2#1)
the URA3 gene##3##3##(1991-7#2)(2008-10#1)
the URA3 promoter##3##3##(1991-7#3)
the URA3##10##2##(1991-7#7)(1995-4#1)(2008-10#2)
the URA5##3##2##(1995-4#3)
the URS##3##2##(2011-2#3)
the US Congress passed##2##4##(1994-8#1)(2008-8#1)
the US Congress##4##3##(1994-8#1)(2008-1#1)(2008-5#1)(2008-8#1)
the US Constitution##2##3##(1995-6#1)(2008-2#1)
the US Court of Appeals for the##3##7##(1995-6#2)(1996-6#1)
the US Department of Health##2##5##(1991-10#1)(2008-6#1)
the US Department of##4##4##(1991-10#1)(2008-6#1)(2009-2#1)(2011-1#1)
the US Environmental Protection##3##4##(2006-12#1)(2008-10#2)
the US FDA for the##2##5##(2008-5#2)
the US FDA for##4##4##(2008-5#2)(2010-12#1)(2011-2#1)
the US FDA##9##3##(2005-9#1)(2008-5#5)(2010-12#1)(2010-5#1)(2011-2#1)
the US Food and Drug Administration (FDA)##8##7##(1997-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2011-1#1)(2012-12#1)(2013-1#1)
the US Food and Drug Administration and the##2##8##(2008-5#1)(2012-12#1)
the US Food and Drug Administration and##4##7##(2006-10#1)(2008-3#1)(2008-5#1)(2012-12#1)
the US Food and Drug Administration##28##6##(1995-8#1)(1997-4#1)(2005-9#1)(2006-10#3)(2006-9#1)(2007-11#2)(2007-4#2)(2007-7#1)(2008-3#3)(2008-5#3)(2008-7#1)(2008-9#2)(2009-9#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-12#2)(2013-1#1)
the US Food and Drug Administration's##2##6##(2006-10#1)(2008-11#1)
the US Food and Drug##30##5##(1995-8#1)(1997-4#1)(2005-9#1)(2006-10#4)(2006-9#1)(2007-11#2)(2007-4#2)(2007-7#1)(2008-11#1)(2008-3#3)(2008-5#3)(2008-7#1)(2008-9#2)(2009-9#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-12#2)(2013-1#1)
the US National Institute of##2##5##(1995-5#1)(1996-12#1)
the US National Institute##3##4##(1995-5#1)(1996-12#1)(2008-5#1)
the US National Library of Medicine##2##6##(2008-7#1)(2013-1#1)
the US National##9##3##(1995-5#1)(1996-12#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-12#1)(2013-1#1)
the US ONCHIT##2##3##(2010-8#2)
the US Pharmacopoeia##2##3##(2008-10#2)
the US Supreme Court##2##4##(1995-6#1)(1996-6#1)
the US adult dose)##2##4##(2013-1#2)
the US adult##3##3##(2006-12#1)(2013-1#2)
the US and Europe##6##4##(2005-7#1)(2005-8#1)(2005-9#1)(2008-5#1)(2010-12#1)(2012-12#1)
the US and Japan##3##4##(2008-5#2)(2010-12#1)
the US and##24##3##(2005-7#2)(2005-8#3)(2005-9#2)(2006-5#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#5)(2009-8#1)(2010-12#3)(2011-2#1)(2012-12#2)
the US for the treatment of##5##6##(2005-6#1)(2005-9#1)(2008-3#1)(2008-5#2)
the US for##9##3##(2005-6#1)(2005-9#1)(2008-3#1)(2008-5#5)(2010-12#1)
the US from##3##3##(1993-12#1)(1996-6#1)(2010-7#1)
the US government##3##3##(2008-11#1)(2008-8#1)(2009-3#1)
the US health care system##4##5##(2008-11#3)(2008-7#1)
the US image##2##3##(1990-9#2)
the US in##5##3##(1994-6#1)(1996-6#1)(2007-11#2)(2008-5#1)
the US is##4##3##(2007-11#1)(2008-5#1)(2011-2#2)
the US population##6##3##(2008-9#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)
the US##265##2##(1990-2#1)(1990-7#1)(1990-9#2)(1991-10#1)(1992-5#1)(1993-12#1)(1993-6#2)(1993-7#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-4#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-5#1)(1995-6#5)(1995-8#1)(1996-11#2)(1996-12#1)(1996-6#5)(1996-8#1)(1996-9#4)(1997-2#4)(1997-4#2)(1997-7#1)(2004-2#1)(2005-6#1)(2005-7#7)(2005-8#9)(2005-9#7)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#6)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#16)(2007-2#2)(2007-4#4)(2007-5#1)(2007-7#4)(2008-1#3)(2008-10#9)(2008-11#8)(2008-2#1)(2008-3#5)(2008-5#32)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#3)(2009-2#1)(2009-3#3)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#12)(2010-2#1)(2010-4#2)(2010-5#4)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#6)(2012-12#6)(2012-2#3)(2013-1#9)(2013-7#1)(2013-8#4)
the US)##2##2##(1996-11#1)(2005-8#1)
the US-1 genotype##3##3##(2008-10#3)
the US-1##9##2##(2008-10#9)
the US-7##4##2##(2008-10#4)
the US-8 genotype##4##3##(2008-10#4)
the US-8##10##2##(2008-10#10)
the USA and Canada##3##4##(1992-2#1)(2008-2#1)(2008-9#1)
the USA and Europe##2##4##(2006-2#1)(2009-4#1)
the USA and one##2##4##(2008-1#1)(2010-11#1)
the USA and##22##3##(1990-9#1)(1992-2#1)(1992-6#1)(1993-5#1)(1995-3#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-2#1)(2008-1#2)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-12#3)(2012-11#2)
the USA for##2##3##(2008-4#1)(2010-11#1)
the USA has##4##3##(1996-11#1)(2006-10#1)(2007-7#1)(2012-1#1)
the USA in##5##3##(1996-11#1)(2008-3#1)(2008-4#1)(2009-11#1)(2009-4#1)
the USA is##2##3##(2007-3#1)(2010-12#1)
the USA than##2##3##(2006-2#1)(2011-2#1)
the USA with##2##3##(2005-9#1)(2009-4#1)
the USA##95##2##(1990-9#1)(1992-2#2)(1992-6#1)(1993-3#1)(1993-5#1)(1994-3#1)(1995-3#2)(1996-11#3)(1996-2#1)(1996-6#1)(1997-8#1)(2004-7#1)(2005-11#1)(2005-12#1)(2005-7#6)(2005-8#1)(2005-9#2)(2006-10#6)(2006-12#1)(2006-2#4)(2006-6#1)(2006-9#2)(2007-2#2)(2007-3#2)(2007-7#1)(2008-1#4)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#6)(2010-10#1)(2010-11#4)(2010-12#5)(2010-4#1)(2011-2#4)(2012-1#2)(2012-11#2)(2013-8#1)
the USAPIs##2##2##(2008-1#2)
the USA]##4##2##(1991-8#1)(1992-3#1)(1993-3#1)(1993-5#1)
the USDA##4##2##(2008-7#4)
the USDA's Food Guide Pyramid diet##2##6##(2008-3#2)
the USDA-ARS##2##2##(2008-10#2)
the USEPA##2##2##(2008-10#2)
the USGS##2##2##(1995-6#1)(2007-8#1)
the USP and##2##3##(2008-5#1)(2012-2#1)
the USP##6##2##(2008-10#3)(2008-5#1)(2012-2#2)
the USPTO issued US-05792783 to SUGEN##2##6##(2005-6#2)
the USSR##3##2##(1990-2#1)(1990-3#2)
the UTP##4##2##(1990-5#1)(1993-8#1)(1994-8#1)(1995-3#1)
the UV absorption spectra##2##4##(2008-5#1)(2011-2#1)
the UV absorption##4##3##(2007-12#1)(2008-10#1)(2008-5#1)(2011-2#1)
the UV and##2##3##(2008-10#1)(2009-12#1)
the UV detection##2##3##(2008-10#2)
the UV detector##2##3##(1997-3#1)(2008-3#1)
the UV irradiation##2##3##(1990-8#1)(2007-8#1)
the UV light in##2##4##(2006-10#2)
the UV light##9##3##(2006-10#2)(2007-12#1)(2008-10#1)(2008-3#4)(2009-12#1)
the UV protection##2##3##(2008-5#2)
the UV radiation##2##3##(2011-2#2)
the UV range##2##3##(2008-10#1)(2009-11#1)
the UV spectra##5##3##(1992-2#1)(1996-5#1)(2005-11#2)(2008-10#1)
the UV to##2##3##(1994-11#1)(2007-12#1)
the UV##78##2##(1990-8#1)(1991-12#1)(1992-2#1)(1993-8#1)(1994-11#1)(1996-5#1)(1997-3#3)(2005-11#2)(2006-10#2)(2007-12#12)(2007-8#2)(2008-10#16)(2008-2#8)(2008-3#11)(2008-5#7)(2009-11#1)(2009-12#2)(2010-5#1)(2011-2#3)(2013-7#2)
the UV-A##3##2##(2006-3#1)(2008-11#1)(2008-2#1)
the UV-B##3##2##(2004-4#1)(2008-2#2)
the UV-MFRSR divided by##2##4##(2008-2#2)
the UV-MFRSR##3##2##(2008-2#3)
the UV-VIS##3##2##(2008-10#1)(2010-11#1)(2010-5#1)
the UV-Vis##2##2##(2005-11#1)(2008-10#1)
the UV-blocking capacity##2##3##(2008-5#2)
the UV-spectrophotometric##2##2##(2008-10#2)
the UV-vis spectra of##2##4##(2008-10#2)
the UV-vis spectra##3##3##(2005-11#1)(2008-10#2)
the UV-vis##6##2##(1995-2#1)(2005-11#1)(2008-10#3)(2008-3#1)
the UV-visible spectra##2##3##(1996-5#1)(2010-4#1)
the UV-visible spectrum##2##3##(1997-4#1)(1997-7#1)
the UV-visible##6##2##(1996-5#1)(1997-4#1)(1997-7#1)(2005-11#1)(2008-3#1)(2010-4#1)
the UVA protection##2##3##(2008-5#2)
the UVA##8##2##(1994-3#1)(2008-5#7)
the UVA-induced sebum##2##3##(2008-5#2)
the UVA-induced##3##2##(1992-6#1)(2008-5#2)
the UVA/UVB ratio##3##3##(2008-5#3)
the UVA/UVB##4##2##(2008-5#4)
the UVS112 gene##2##3##(1995-9#2)
the Ubang and##2##3##(2012-3#2)
the Ubx-HD##2##2##(1996-7#2)
the Ugandan success story##2##4##(2009-4#2)
the Ugandan##3##2##(2009-4#2)(2012-2#1)
the Ukrainian##2##2##(2008-7#1)(2008-8#1)
the Ultrafast##2##2##(2006-5#1)(2008-3#1)
the Understanding##2##2##(2008-4#1)(2013-1#1)
the Unified Health System (SUS) in##2##6##(2011-2#1)(2012-3#1)
the Unified Medical Language##3##4##(2008-7#1)(2013-1#2)
the Unified Medical##4##3##(1996-2#1)(2008-7#1)(2013-1#2)
the Unified National Health System##2##5##(2011-1#2)
the Unified Parkinson's Disease Rating Scale (UPDRS)##2##7##(2008-7#2)
the Unified Parkinson's##3##3##(2008-7#3)
the Unified##13##2##(1996-2#1)(2008-7#5)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
the Uniform Clinical Data Set##3##5##(1993-2#3)
the Uniform##5##2##(1991-3#1)(1993-2#3)(1996-12#1)
the UniformMu##3##2##(2012-3#3)
the Unit of##2##3##(2007-8#1)(2012-3#1)
the Unit##4##2##(2007-11#1)(2007-8#1)(2008-9#1)(2012-3#1)
the United Arab Emirates##14##4##(2005-9#2)(2007-2#2)(2007-3#3)(2008-1#1)(2008-5#1)(2012-1#1)(2013-1#3)(2013-8#1)
the United Kingdom (UK)##2##4##(2008-11#1)(2013-1#1)
the United Kingdom Prospective Diabetes Study (UKPDS)##2##7##(2007-5#1)(2008-3#1)
the United Kingdom and the United States##2##7##(2007-12#1)(2008-12#1)
the United Kingdom and##6##4##(1991-10#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-4#1)
the United Kingdom have##2##4##(1991-3#1)(2006-10#1)
the United Kingdom since##3##4##(2008-10#1)(2009-4#1)(2011-1#1)
the United Kingdom##99##3##(1990-12#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-3#2)(1991-8#2)(1992-1#1)(1992-10#1)(1993-2#1)(1994-12#2)(1994-6#1)(1994-7#2)(1995-1#2)(1995-2#1)(1995-4#1)(1996-11#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-8#1)(2004-1#1)(2004-10#2)(2006-10#2)(2006-5#2)(2006-8#1)(2007-12#2)(2007-2#3)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#11)(2008-11#7)(2008-12#4)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#3)(2011-1#3)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#1)
the United Kingdom's National Health Service##2##6##(1995-3#1)(1996-2#1)
the United Kingdom's National##3##4##(1995-3#1)(1996-2#1)(2012-3#1)
the United Kingdom's##6##3##(1995-3#1)(1996-2#1)(2008-11#1)(2008-5#1)(2010-2#1)(2012-3#1)
the United Nations (UN)##2##4##(1996-1#1)(2006-4#1)
the United Nations Children's Fund##4##5##(1996-3#1)(2010-12#3)
the United Nations in##2##4##(2008-9#1)(2012-2#1)
the United Nations##18##3##(1992-10#1)(1992-4#1)(1992-6#1)(1995-9#1)(1996-1#1)(1996-3#1)(2006-4#1)(2007-4#1)(2008-11#1)(2008-5#1)(2008-9#2)(2010-12#3)(2012-12#2)(2012-2#1)
the United Network##2##3##(2006-10#1)(2007-11#1)
the United States (U##4##4##(2008-10#1)(2008-12#1)(2009-12#1)(2012-12#1)
the United States (US)##3##4##(2006-5#1)(2010-12#1)(2013-1#1)
the United States Army##2##4##(2006-4#1)(2012-3#1)
the United States Court of Appeals for the District of Columbia Circuit##3##12##(1996-12#3)
the United States Department of Agriculture##2##6##(2008-10#1)(2009-2#1)
the United States Department of Health and Human Services##2##9##(1994-3#1)(2008-7#1)
the United States Department of##7##5##(1994-3#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-11#1)(2009-2#1)
the United States Food and Drug Administration##3##7##(2006-5#1)(2008-7#1)(2010-11#1)
the United States Pharmacopeia##4##4##(2008-10#4)
the United States Pharmacopoeia##2##4##(2008-10#1)(2008-5#1)
the United States Supreme Court##2##5##(1991-12#1)(1992-6#1)
the United States and Brazil##2##5##(2008-10#2)
the United States and Canada##16##5##(1991-12#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-8#1)(2012-2#2)
the United States and Canadian##3##5##(1996-3#1)(2007-12#1)(2008-1#1)
the United States and Europe##7##5##(2005-3#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-8#1)(2013-1#1)
the United States and European##2##5##(2011-2#1)(2012-12#1)
the United States and elsewhere##3##5##(1992-2#1)(2006-7#1)(2012-1#1)
the United States and the Soviet Union##2##7##(1990-3#2)
the United States and the##7##5##(1990-3#2)(1991-12#1)(2006-8#1)(2008-10#1)(2009-4#1)(2012-11#1)
the United States and##98##4##(1990-10#1)(1990-3#2)(1991-12#2)(1991-6#1)(1992-1#1)(1992-2#1)(1992-6#1)(1993-1#1)(1995-1#1)(1996-3#1)(2005-11#1)(2005-3#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-12#4)(2007-2#3)(2007-4#1)(2008-1#3)(2008-10#26)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2009-11#4)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-12#2)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
the United States are##12##4##(1991-2#1)(1993-1#1)(2005-8#1)(2006-8#1)(2006-9#1)(2007-4#1)(2007-8#1)(2008-5#1)(2009-6#1)(2010-6#1)(2010-8#1)(2011-2#1)
the United States as##6##4##(1996-7#1)(2007-7#1)(2008-10#1)(2009-4#1)(2009-5#1)(2011-1#1)
the United States between##3##4##(2008-11#1)(2012-12#2)
the United States by##6##4##(1990-12#2)(1995-3#1)(2008-2#1)(2008-9#1)(2012-12#1)
the United States during the##4##5##(1992-5#1)(2007-2#1)(2008-5#1)(2013-1#1)
the United States during##5##4##(1992-5#1)(1995-6#1)(2007-2#1)(2008-5#1)(2013-1#1)
the United States faces##2##4##(1996-12#1)(2008-12#1)
the United States has not##2##5##(1990-12#1)(2012-1#1)
the United States has##12##4##(1990-12#1)(1991-8#1)(1994-3#1)(1994-6#1)(1997-2#2)(2004-12#1)(2006-10#1)(2008-10#1)(2008-12#1)(2010-3#1)(2012-1#1)
the United States have##13##4##(1990-12#1)(1993-3#2)(2004-12#1)(2005-10#2)(2006-5#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-5#1)(2011-1#1)(2013-1#1)
the United States in the##2##5##(1995-8#1)(2007-4#1)
the United States in##16##4##(1993-2#1)(1994-1#1)(1994-2#2)(1995-8#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-4#1)(2008-10#5)(2008-8#1)(2011-2#1)
the United States increased##3##4##(1996-11#1)(1997-1#1)(2010-5#1)
the United States is estimated to##2##6##(2009-4#1)(2013-1#1)
the United States is##12##4##(1990-12#1)(1991-5#1)(1992-3#1)(2007-4#1)(2008-1#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-9#1)(2011-2#1)(2013-1#1)
the United States may not be##2##6##(2005-10#1)(2008-10#1)
the United States may##5##4##(1990-11#1)(1990-2#1)(2005-10#1)(2007-2#1)(2008-10#1)
the United States of America##8##5##(2007-12#1)(2008-1#1)(2009-3#1)(2010-12#1)(2010-3#1)(2012-12#1)(2013-1#2)
the United States on##4##4##(2006-2#1)(2006-8#1)(2007-12#1)(2008-10#1)
the United States since##7##4##(1992-8#1)(1995-3#1)(1997-1#1)(2006-6#1)(2008-1#1)(2008-10#1)(2012-3#1)
the United States than##7##4##(2006-10#1)(2006-11#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-3#1)(2010-12#1)
the United States that##2##4##(1997-1#1)(2011-2#1)
the United States to##9##4##(1992-5#1)(1993-7#1)(2004-12#1)(2006-10#1)(2008-10#1)(2010-11#1)(2011-1#1)(2012-3#1)(2013-1#1)
the United States was##4##4##(2007-1#1)(2008-10#2)(2011-2#1)
the United States were characterized##2##5##(2008-10#2)
the United States were tested##2##5##(2008-10#1)(2008-5#1)
the United States were##16##4##(1990-11#1)(2007-12#1)(2007-7#1)(2008-10#11)(2008-5#1)(2013-1#1)
the United States who##3##4##(1992-2#1)(2007-2#1)(2008-10#1)
the United States will##5##4##(1993-3#1)(1995-12#1)(1995-2#1)(2007-8#1)(2012-12#1)
the United States with##5##4##(1991-12#1)(1993-2#1)(2008-3#1)(2008-8#1)(2010-10#1)
the United States##898##3##(1990-10#1)(1990-11#3)(1990-12#18)(1990-2#1)(1990-3#3)(1991-1#1)(1991-11#1)(1991-12#8)(1991-2#2)(1991-3#5)(1991-5#1)(1991-6#3)(1991-8#4)(1992-1#3)(1992-12#5)(1992-2#3)(1992-3#2)(1992-5#8)(1992-6#2)(1992-7#3)(1992-8#2)(1992-9#1)(1993-1#4)(1993-12#4)(1993-2#6)(1993-3#7)(1993-6#1)(1993-7#2)(1993-9#3)(1994-1#1)(1994-12#8)(1994-2#4)(1994-3#6)(1994-6#1)(1995-1#7)(1995-12#3)(1995-2#1)(1995-3#5)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#2)(1996-11#2)(1996-12#6)(1996-2#2)(1996-3#3)(1996-4#1)(1996-6#3)(1996-7#4)(1996-8#2)(1996-9#2)(1997-1#12)(1997-2#7)(1997-3#9)(1997-5#1)(1997-8#2)(2004-11#2)(2004-12#6)(2004-3#1)(2005-10#12)(2005-11#3)(2005-3#1)(2005-6#1)(2005-7#4)(2005-8#6)(2006-1#1)(2006-10#17)(2006-11#6)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#7)(2006-6#2)(2006-7#4)(2006-8#7)(2006-9#4)(2007-1#5)(2007-10#3)(2007-11#3)(2007-12#17)(2007-2#14)(2007-4#12)(2007-6#2)(2007-7#4)(2007-8#13)(2007-9#10)(2008-1#11)(2008-10#156)(2008-11#14)(2008-12#12)(2008-2#6)(2008-3#16)(2008-4#4)(2008-5#15)(2008-6#4)(2008-7#7)(2008-8#10)(2008-9#8)(2009-1#1)(2009-11#13)(2009-12#6)(2009-2#2)(2009-3#4)(2009-4#6)(2009-5#9)(2009-6#4)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#4)(2010-11#8)(2010-12#6)(2010-2#4)(2010-3#4)(2010-4#3)(2010-5#4)(2010-6#3)(2010-7#5)(2010-8#9)(2010-9#8)(2011-1#13)(2011-12#2)(2011-2#32)(2012-1#8)(2012-11#3)(2012-12#20)(2012-2#13)(2012-3#13)(2013-1#25)(2013-7#2)(2013-8#16)
the United States'##2##3##(1996-12#1)(2007-8#1)
the United States)##5##3##(2005-10#1)(2007-2#1)(2008-10#1)(2008-7#1)(2011-2#1)
the United States-Mexico border##2##4##(2006-10#2)
the United##1064##2##(1990-10#1)(1990-11#3)(1990-12#19)(1990-2#1)(1990-3#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#8)(1991-2#3)(1991-3#7)(1991-5#1)(1991-6#3)(1991-8#6)(1992-1#4)(1992-10#2)(1992-12#5)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#8)(1992-6#4)(1992-7#3)(1992-8#2)(1992-9#1)(1993-1#4)(1993-12#4)(1993-2#8)(1993-3#7)(1993-6#1)(1993-7#2)(1993-9#3)(1994-1#1)(1994-12#10)(1994-2#4)(1994-3#7)(1994-6#2)(1994-7#2)(1995-1#9)(1995-12#3)(1995-2#2)(1995-3#6)(1995-4#2)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#3)(1996-1#3)(1996-11#4)(1996-12#7)(1996-2#3)(1996-3#4)(1996-4#1)(1996-6#3)(1996-7#4)(1996-8#2)(1996-9#2)(1997-1#12)(1997-2#8)(1997-3#11)(1997-5#2)(1997-8#3)(2004-1#1)(2004-10#2)(2004-11#2)(2004-12#6)(2004-3#1)(2005-10#13)(2005-11#3)(2005-3#1)(2005-6#1)(2005-7#4)(2005-8#6)(2005-9#2)(2006-1#1)(2006-10#22)(2006-11#6)(2006-12#1)(2006-2#1)(2006-4#3)(2006-5#9)(2006-6#2)(2006-7#4)(2006-8#8)(2006-9#4)(2007-1#5)(2007-10#4)(2007-11#4)(2007-12#19)(2007-2#21)(2007-3#4)(2007-4#13)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#15)(2007-9#12)(2008-1#14)(2008-10#170)(2008-11#23)(2008-12#17)(2008-2#7)(2008-3#19)(2008-4#4)(2008-5#19)(2008-6#4)(2008-7#12)(2008-8#12)(2008-9#12)(2009-1#1)(2009-10#1)(2009-11#13)(2009-12#6)(2009-2#2)(2009-3#5)(2009-4#10)(2009-5#9)(2009-6#4)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#4)(2010-11#9)(2010-12#9)(2010-2#5)(2010-3#4)(2010-4#3)(2010-5#4)(2010-6#3)(2010-7#5)(2010-8#9)(2010-9#8)(2011-1#16)(2011-12#3)(2011-2#36)(2012-1#11)(2012-11#4)(2012-12#24)(2012-2#17)(2012-3#14)(2013-1#30)(2013-7#2)(2013-8#19)
the Units##2##2##(2008-9#1)(2012-3#1)
the Universal##3##2##(2008-6#1)(2008-9#1)(2013-1#1)
the Universe##2##2##(1991-12#1)(2006-7#1)
the Universidad##5##2##(2007-3#1)(2007-5#1)(2010-12#1)(2011-2#2)
the Universidade##3##2##(2008-6#1)(2013-8#2)
the Universitary##3##2##(2006-10#1)(2008-5#1)(2012-3#1)
the University Clinic##5##3##(1991-11#1)(1993-1#1)(1995-5#1)(2013-1#2)
the University Hospital in##7##4##(1990-8#1)(1991-5#1)(1992-12#1)(1993-1#1)(1994-3#1)(2006-8#1)(2006-9#1)
the University Hospital of the West Indies##5##7##(2011-2#5)
the University Hospital of the##6##5##(2011-2#6)
the University Hospital of##14##4##(1991-3#1)(1993-3#1)(1996-11#1)(1996-6#1)(2008-10#1)(2009-5#1)(2011-2#6)(2012-11#2)
the University Hospital##31##3##(1990-8#1)(1991-3#1)(1991-5#1)(1992-12#1)(1993-1#1)(1993-3#1)(1993-8#1)(1994-3#1)(1996-11#1)(1996-6#1)(2005-12#1)(2006-10#1)(2006-8#4)(2006-9#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-5#1)(2011-2#8)(2012-11#2)
the University Hospitals Case Medical Center##4##6##(2013-1#4)
the University Hospitals##5##3##(2006-8#1)(2013-1#4)
the University Medical##3##3##(1996-12#1)(1996-5#1)(2005-8#1)
the University of Alabama##3##4##(2007-9#1)(2008-12#1)(2009-8#1)
the University of Alberta Hospitals##3##5##(1992-12#1)(1995-3#1)(1996-3#1)
the University of Alberta##6##4##(1992-12#1)(1995-12#1)(1995-3#2)(1996-3#1)(2005-7#1)
the University of Arizona##3##4##(1997-5#1)(2007-8#1)(2010-7#1)
the University of Auckland##2##4##(2008-1#1)(2008-12#1)
the University of Belgrade##2##4##(2007-9#1)(2008-1#1)
the University of Benin Teaching Hospital##2##6##(2007-7#1)(2013-8#1)
the University of Benin##3##4##(2007-1#1)(2007-7#1)(2013-8#1)
the University of Bologna##2##4##(2007-8#1)(2008-7#1)
the University of Buenos Aires##2##5##(2006-10#1)(2009-7#1)
the University of Calabar Teaching Hospital##2##6##(2007-1#1)(2008-4#1)
the University of California##12##4##(1997-5#1)(2006-6#1)(2006-8#1)(2007-8#1)(2007-9#3)(2008-10#2)(2008-3#1)(2009-8#1)(2010-10#1)
the University of Chicago##5##4##(2006-10#1)(2007-9#3)(2008-5#1)
the University of Dundee##4##4##(2006-11#1)(2008-11#2)(2008-12#1)
the University of Edinburgh##2##4##(2008-10#1)(2012-2#1)
the University of Florida experience##2##5##(1992-1#1)(1995-4#1)
the University of Illinois##2##4##(2009-7#1)(2010-5#1)
the University of Ilorin Teaching Hospital##2##6##(2012-12#2)
the University of KwaZulu-Natal##2##4##(2010-3#1)(2013-8#1)
the University of Massachusetts Medical Center##2##6##(1995-1#1)(2007-2#1)
the University of Massachusetts##5##4##(1995-1#1)(1997-2#1)(2007-12#1)(2007-2#1)(2008-11#1)
the University of Michigan##6##4##(1991-3#1)(1994-1#1)(1995-1#1)(1995-3#1)(1996-1#1)(2008-11#1)
the University of Pennsylvania in##2##5##(2007-9#1)(2012-12#1)
the University of Pennsylvania##9##4##(1991-3#1)(1993-2#1)(1996-12#1)(2005-6#1)(2007-9#2)(2008-2#1)(2008-8#1)(2012-12#1)
the University of Pittsburgh##4##4##(1991-3#1)(1997-1#1)(2009-10#1)(2009-5#1)
the University of Queensland##2##4##(2006-8#1)(2012-12#1)
the University of Sheffield##2##4##(2006-11#1)(2008-12#1)
the University of Southern California (USC)##2##6##(1992-12#1)(2005-8#1)
the University of Surrey##2##4##(2010-11#2)
the University of Tennessee##2##4##(2004-3#1)(2010-5#1)
the University of Texas Dental Branch##2##6##(2012-3#2)
the University of Texas##6##4##(2007-12#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-3#2)
the University of Toronto##6##4##(1991-1#1)(1991-2#1)(1996-12#1)(2007-3#1)(2007-5#1)(2008-11#1)
the University of Tromsø##3##4##(1993-6#2)(1996-9#1)
the University of Utah##3##4##(2008-3#1)(2013-1#2)
the University of Uyo##2##4##(2007-1#1)(2012-12#1)
the University of Vienna##2##4##(1990-10#1)(1996-3#1)
the University of Wales##2##4##(1996-7#1)(2005-12#1)
the University of Washington##4##4##(1995-2#1)(1996-1#1)(2008-5#1)(2012-12#1)
the University of Western Ontario##3##5##(2010-11#1)(2011-12#2)
the University of the West Indies##2##6##(2011-2#2)
the University of the##4##4##(2008-1#1)(2011-2#3)
the University of##230##3##(1990-10#1)(1990-11#1)(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-5#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-6#4)(1993-1#2)(1993-2#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-11#2)(1994-2#2)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#3)(1995-3#4)(1995-4#1)(1996-1#3)(1996-12#2)(1996-2#1)(1996-3#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#2)(1997-6#1)(2004-3#2)(2005-12#1)(2005-6#1)(2005-7#1)(2005-8#2)(2006-10#4)(2006-11#5)(2006-5#3)(2006-6#2)(2006-8#2)(2007-1#3)(2007-12#3)(2007-2#1)(2007-3#3)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#14)(2008-1#4)(2008-10#7)(2008-11#8)(2008-12#9)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#3)(2008-7#6)(2008-8#1)(2009-10#2)(2009-12#1)(2009-3#2)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#4)(2010-3#1)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#8)(2012-1#4)(2012-12#9)(2012-2#5)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#7)
the University##295##2##(1990-10#1)(1990-11#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#4)(1991-5#2)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-6#4)(1993-1#4)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#2)(1994-1#1)(1994-11#2)(1994-2#2)(1994-3#2)(1994-6#1)(1995-1#2)(1995-12#1)(1995-2#3)(1995-3#4)(1995-4#1)(1995-5#1)(1996-1#3)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#2)(1997-6#2)(2004-2#1)(2004-3#2)(2005-12#3)(2005-6#1)(2005-7#2)(2005-8#3)(2006-10#5)(2006-11#5)(2006-5#3)(2006-6#2)(2006-8#7)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#4)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#3)(2007-9#15)(2008-1#4)(2008-10#11)(2008-11#11)(2008-12#9)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#3)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-3#2)(2009-5#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#4)(2010-3#1)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#16)(2012-1#4)(2012-11#2)(2012-12#9)(2012-2#5)(2012-3#4)(2013-1#12)(2013-7#1)(2013-8#8)
the Upper Atmosphere Research Satellite##2##5##(2008-2#2)
the Upper Galilee##4##3##(2011-2#4)
the Upper Madeira##2##3##(1993-6#2)
the Upper Silesia##2##3##(2010-9#2)
the Upper##22##2##(1991-12#1)(1993-6#2)(1994-7#1)(2006-4#2)(2007-12#1)(2007-7#1)(2008-10#4)(2008-2#2)(2010-9#2)(2011-2#5)(2012-1#1)
the Use of##11##3##(2007-7#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-3#1)(2009-4#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
the Use##12##2##(2007-7#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
the Ushuaia##2##2##(2008-3#2)
the Ussing chamber##2##3##(2008-3#1)(2008-4#1)
the Utah##2##2##(2008-4#1)(2008-6#1)
the Utstein protocol##3##3##(2006-10#3)
the Utstein##4##2##(2006-10#4)
the V##22##2##(1990-10#2)(1991-12#1)(1993-7#1)(1993-9#1)(1996-10#1)(1996-11#1)(1996-7#1)(1997-1#1)(2004-4#1)(2007-3#1)(2008-10#3)(2008-2#1)(2008-5#1)(2009-8#1)(2010-5#1)(2011-2#2)(2012-10#1)(2012-11#1)
the V(D)J recombination reaction##2##4##(1997-7#1)(2012-1#1)
the V(D)J##5##2##(1995-1#1)(1997-7#1)(2008-7#2)(2012-1#1)
the V-ATPase##14##2##(1993-11#2)(1994-9#1)(1995-6#5)(1996-5#5)(2008-9#1)
the V-PPase##2##2##(2008-11#2)
the V-osteotomy##3##2##(2008-4#3)
the V0##2##2##(1994-12#1)(2007-8#1)
the V1##6##2##(1990-11#1)(1991-7#1)(1993-4#1)(1995-10#1)(2007-8#1)(2008-5#1)
the V281L mutation##3##3##(2008-1#3)
the V2O5 nanowires##2##3##(2009-2#2)
the V2R##2##2##(1994-8#2)
the V3 domain of gp120##2##5##(1994-9#2)
the V3 domain of##3##4##(1994-6#1)(1994-9#2)
the V3 domain##4##3##(1994-6#1)(1994-9#3)
the V3 region##3##3##(1990-12#1)(1992-2#1)(1994-9#1)
the V3##10##2##(1990-12#2)(1992-2#2)(1994-6#1)(1994-9#4)(2008-10#1)
the V4 region##2##3##(2008-5#1)(2011-2#1)
the V4##3##2##(2008-5#2)(2011-2#1)
the VA##5##2##(2006-10#1)(2006-11#1)(2007-5#1)(2012-1#1)(2012-3#1)
the VAS##11##2##(2006-12#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-6#1)(2012-2#1)
the VAT##2##2##(2008-12#1)(2008-5#1)
the VATS##3##2##(2012-12#2)(2012-2#1)
the VB##3##2##(2005-11#3)
the VCSEL wavelength##2##3##(2008-3#2)
the VCSEL's##2##2##(2008-2#1)(2008-3#1)
the VDCC##3##2##(1997-4#3)
the VDJ##2##2##(1990-5#1)(1997-9#1)
the VDR gene##6##3##(1992-6#2)(1994-11#1)(1997-7#1)(2008-4#1)(2013-1#1)
the VDR mRNA level##2##4##(1992-6#1)(1993-6#1)
the VDR mRNA##3##3##(1992-6#2)(1993-6#1)
the VDR##12##2##(1992-12#2)(1992-6#4)(1993-6#1)(1994-11#2)(1997-7#1)(2008-4#1)(2013-1#1)
the VDRE##2##2##(1994-11#2)
the VDT##2##2##(2007-4#2)
the VEGF##8##2##(1992-3#1)(1997-4#1)(2006-9#1)(2008-3#1)(2009-8#1)(2010-12#2)(2013-8#1)
the VEP latency##2##3##(1995-12#2)
the VEP##3##2##(1991-4#1)(1995-12#2)
the VFA##3##2##(2008-10#1)(2008-3#2)
the VG##5##2##(1997-7#3)(2008-10#1)(2010-11#1)
the VH##3##2##(1996-6#1)(1997-2#1)(1997-9#1)
the VHA has been##2##4##(2008-7#2)
the VHA##4##2##(2008-7#2)(2013-1#2)
the VI##5##2##(2006-8#1)(2008-10#1)(2012-12#2)(2012-3#1)
the VII South Pacific Mini Games##2##6##(2008-1#2)
the VII##3##2##(1991-6#1)(2008-1#2)
the VIP##4##2##(1990-5#1)(1990-7#1)(1993-9#1)(1997-8#1)
the VIP-receptor##2##2##(1994-3#1)(1995-11#1)
the VL##3##2##(1994-12#1)(1996-6#1)(2008-3#1)
the VLDL receptor is##2##4##(1995-6#1)(1995-8#1)
the VLDL receptor##5##3##(1995-6#4)(1995-8#1)
the VLDL##7##2##(1995-3#1)(1995-6#4)(1995-8#1)(2004-11#1)
the VLH in##2##3##(1995-5#2)
the VLH##4##2##(1995-5#4)
the VLO##7##2##(1994-3#7)
the VM##4##2##(1997-7#1)(2012-3#3)
the VMH and##2##3##(1993-2#1)(1993-9#1)
the VMH##6##2##(1993-2#3)(1993-9#1)(1995-10#2)
the VNO##4##2##(1993-2#4)
the VNTR##2##2##(1992-3#1)(2008-10#1)
the VO(2)##3##2##(2007-11#3)
the VOC levels##2##3##(1992-4#1)(2008-11#1)
the VP group##2##3##(2007-10#2)
the VP##3##2##(1996-5#1)(2007-10#2)
the VP1 coding regions of##2##5##(2013-8#2)
the VP1##5##2##(2005-11#1)(2008-12#1)(2008-7#1)(2013-8#2)
the VP6 cDNA##5##3##(2006-12#4)(2008-5#1)
the VP6##6##2##(2006-12#4)(2008-5#2)
the VPFC and amygdala##2##4##(2010-8#2)
the VQTAM##2##2##(2008-2#2)
the VR##7##2##(1992-6#7)
the VR1##2##2##(1995-5#2)
the VSCC##7##2##(1996-8#1)(2007-9#6)
the VSF##3##2##(2008-3#3)
the VSV##2##2##(1995-8#2)
the VT group##2##3##(2008-10#2)
the VT##3##2##(2008-10#3)
the VTA and##2##3##(1993-2#1)(1994-12#1)
the VTA##19##2##(1992-10#1)(1993-12#5)(1993-2#4)(1993-6#2)(1994-12#3)(1996-12#1)(1997-5#3)
the VTG gene##2##3##(1995-10#2)
the VUV##2##2##(2007-12#1)(2008-2#1)
the VWA STR##2##3##(2008-12#2)
the VWA##3##2##(2008-12#3)
the VZ##3##2##(1996-5#3)
the Validation of##2##3##(1997-8#1)(2008-10#1)
the Valley##4##2##(2007-3#3)(2008-10#1)
the Valsalva maneuver and adenosine##3##5##(2006-4#3)
the Valsalva maneuver##6##3##(2006-4#3)(2008-7#1)(2012-3#2)
the Valsalva##9##2##(1994-3#1)(2006-4#3)(2007-8#2)(2008-7#1)(2012-3#2)
the Vancouver##2##2##(2008-8#2)
the VanderLugt##2##2##(2007-12#1)(2008-3#1)
the Vanderbilt##4##2##(2013-1#4)
the Vatican##3##2##(1990-6#1)(1992-5#1)(1994-9#1)
the Vector##3##2##(2008-10#3)
the Vectra Graft##2##3##(2007-7#2)
the Veillonella species##3##3##(2006-8#3)
the Veillonella##4##2##(2006-8#4)
the Venetian##3##2##(2007-9#1)(2008-10#1)(2013-8#1)
the Venezuelan Andes##2##3##(2008-5#2)
the Venezuelan##8##2##(2008-10#1)(2008-5#6)(2008-9#1)
the Venus flytrap##2##3##(2009-8#2)
the Venus##4##2##(1991-5#1)(1992-7#1)(2009-8#2)
the Verbal##3##2##(1995-11#1)(2007-12#1)(2013-8#1)
the Vermont Academic Medical Center##2##5##(1994-2#2)
the Very##3##2##(1990-9#1)(2008-3#1)(2009-12#1)
the Veterans Administration##4##3##(2006-11#1)(2008-3#1)(2009-11#1)(2012-12#1)
the Veterans Affairs Medical Center##2##5##(1990-11#1)(2007-7#1)
the Veterans Health Administration##2##4##(2008-7#2)
the Veterans##9##2##(1990-11#1)(2006-11#1)(2007-7#1)(2008-3#1)(2008-7#2)(2009-11#1)(2012-12#1)(2013-1#1)
the Veterinary Service##3##3##(2005-5#3)
the Veterinary Services of##3##4##(2005-5#3)
the Veterinary Services##7##3##(2005-5#7)
the Veterinary##14##2##(1992-2#1)(1996-12#1)(2005-5#11)(2007-2#1)
the Vf gene##5##3##(2008-10#5)
the Vf##8##2##(2008-10#8)
the Vg##3##2##(1996-11#1)(2008-10#2)
the Vibrio##3##2##(1990-10#2)(1996-10#1)
the Victorian##10##2##(1995-6#1)(2005-8#1)(2005-9#1)(2008-1#1)(2009-2#1)(2009-4#1)(2011-2#3)(2012-12#1)
the Vienna RNA package##2##4##(2008-4#2)
the Vienna##3##2##(1990-10#1)(2008-4#2)
the Vietnam Era Twin##2##4##(1993-9#2)
the Vietnam##4##2##(1993-9#2)(2006-4#1)(2011-2#1)
the Viking##2##2##(1995-10#1)(1995-3#1)
the Virginia##2##2##(1992-3#1)(1997-1#1)
the Virtual##3##2##(2005-10#1)(2008-10#1)(2012-12#1)
the Virulence##2##2##(1992-5#1)(2008-10#1)
the Visible##2##2##(2006-11#1)(2008-3#1)
the Vistula River##2##3##(2008-11#2)
the Visual Analogue Scale (VAS)##3##5##(1996-1#1)(2007-7#1)(2007-8#1)
the Visual##4##2##(1996-1#1)(2007-7#1)(2007-8#1)(2008-12#1)
the Vitamin D receptor##2##4##(2008-1#1)(2012-3#1)
the Vitamin D##3##3##(2008-1#1)(2012-12#1)(2012-3#1)
the Vitamin##6##2##(2005-7#1)(2008-1#1)(2008-10#2)(2012-12#1)(2012-3#1)
the Viterbi algorithm##2##3##(2008-3#2)
the Vm of the##2##4##(1992-6#2)
the Vm##8##2##(1992-6#3)(1996-9#5)
the Vmax of the reaction##3##5##(1992-6#1)(1993-6#1)(1994-6#1)
the Vmax of the##5##4##(1990-3#1)(1990-5#1)(1992-6#1)(1993-6#1)(1994-6#1)
the Vmax of##13##3##(1990-3#1)(1990-5#1)(1990-8#1)(1991-5#1)(1992-6#1)(1993-6#1)(1993-9#1)(1994-5#2)(1994-6#1)(1995-3#2)(1996-6#1)
the Vmax values##2##3##(1990-1#1)(1997-2#1)
the Vmax was##2##3##(1991-8#1)(1993-6#1)
the Vmax##32##2##(1990-1#1)(1990-11#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#2)(1991-8#1)(1992-1#2)(1992-6#3)(1993-6#2)(1993-9#1)(1994-5#2)(1994-6#2)(1994-8#2)(1995-2#1)(1995-3#2)(1996-5#1)(1996-6#1)(1997-2#1)(2011-2#1)
the Vmax/Km##2##2##(1994-12#1)(1995-1#1)
the Vmes##3##2##(1990-4#3)
the Vmo##2##2##(1990-4#2)
the Volterra system##2##3##(2008-2#2)
the Volume##3##2##(1993-12#1)(2008-10#1)(2012-2#1)
the Voluntary##2##2##(1994-2#1)(1995-2#1)
the W (VI)##2##3##(2008-10#2)
the W chromosome##2##3##(2008-5#1)(2010-3#1)
the W##7##2##(2008-10#4)(2008-3#1)(2008-5#1)(2010-3#1)
the W/O/W multiple emulsion##2##4##(2008-5#2)
the W/O/W multiple##4##3##(2005-11#1)(2008-5#3)
the W54S##3##2##(1997-2#3)
the W60dS mutant##2##3##(1997-2#2)
the WAIS-R##3##2##(1995-11#1)(2006-3#2)
the WAN##4##2##(2010-3#4)
the WB##6##2##(1993-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2012-2#1)
the WCST and##2##3##(1995-1#1)(1995-11#1)
the WCST##8##2##(1995-1#2)(1995-11#2)(1996-3#2)(1996-8#1)(2006-3#1)
the WD-40 family##2##3##(1994-12#2)
the WDF##3##2##(2008-2#3)
the WDM##2##2##(2008-2#1)(2008-3#1)
the WFCE##2##2##(2008-2#2)
the WFPs##2##2##(2011-2#2)
the WFTS##2##2##(2012-1#2)
the WGA diet##2##3##(2008-7#2)
the WGA-fed larvae##2##3##(2008-7#2)
the WGM##2##2##(2007-11#1)(2007-12#1)
the WHO World Mental Health (WMH)##2##6##(2013-8#2)
the WHO classification##2##3##(2006-6#1)(2008-7#1)
the WHO criteria##3##3##(2008-3#1)(2008-9#1)(2011-1#1)
the WHO guidelines##4##3##(2006-12#1)(2007-10#1)(2008-8#1)(2011-2#1)
the WHO in##4##3##(2008-1#1)(2008-9#1)(2009-6#1)(2011-1#1)
the WHO##77##2##(1990-10#2)(1990-11#1)(1990-12#3)(1990-6#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-4#1)(1994-9#1)(1995-9#1)(1996-3#1)(1996-6#1)(1997-5#1)(2004-4#2)(2005-12#1)(2006-12#2)(2006-6#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-2#7)(2007-7#2)(2008-1#6)(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#1)(2009-12#1)(2009-6#1)(2010-6#1)(2011-1#5)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
the WHOQOL-OLD##3##2##(2011-1#1)(2011-2#2)
the WKY homozygotes##2##3##(1991-12#2)
the WKY##4##2##(1991-12#2)(1997-5#2)
the WLC##4##2##(2007-11#1)(2008-7#2)(2010-9#1)
the WMS##3##2##(1995-11#3)
the WOE##2##2##(1994-8#2)
the WOMAC pain and physical function##2##6##(2010-9#2)
the WOMAC pain and##3##4##(2006-10#1)(2010-9#2)
the WOMAC pain##4##3##(2006-10#1)(2010-9#3)
the WOMAC##8##2##(2006-10#1)(2008-3#1)(2010-9#5)(2013-1#1)
the WPA##9##2##(2006-4#1)(2006-9#6)(2011-1#2)
the WR##2##2##(1995-11#1)(2008-7#1)
the WRAP##3##2##(2008-11#3)
the WRN##2##2##(2008-8#1)(2009-12#1)
the WS method##2##3##(2012-3#2)
the WS##3##2##(2010-2#1)(2012-3#2)
the WT mice##2##3##(2007-10#1)(2012-12#1)
the WT strain##4##3##(2008-4#4)
the WT##16##2##(1993-6#1)(1995-11#2)(1995-5#1)(1995-6#1)(2007-10#1)(2008-10#2)(2008-4#4)(2008-8#1)(2012-12#2)(2013-8#1)
the WT-voltammetric analyzer##2##3##(2008-10#2)
the WT1##2##2##(1991-10#2)
the WTL strategy##2##3##(2006-12#2)
the WTL##4##2##(1990-11#1)(2006-12#3)
the WTLAS##2##2##(2006-12#2)
the WTP##2##2##(2013-8#2)
the WWTP##6##2##(2007-8#2)(2008-10#3)(2013-1#1)
the Wada##3##2##(2009-9#1)(2010-2#2)
the Walter Reed##2##3##(1990-2#1)(2006-4#1)
the Walter##3##2##(1990-2#1)(2006-4#1)(2013-8#1)
the Warburg effect##4##3##(2010-12#4)
the Warsaw##3##2##(2007-11#1)(2007-7#1)(2007-9#1)
the Washington State##2##3##(1996-1#1)(1997-2#1)
the Washington##7##2##(1996-1#1)(1997-2#1)(1997-8#1)(2005-10#1)(2007-2#1)(2008-5#1)(2013-1#1)
the Water##6##2##(2007-9#1)(2008-10#3)(2011-2#1)(2012-12#1)
the Wave Bioreactor##3##3##(2008-11#3)
the Wave##5##2##(1996-7#1)(2008-11#4)
the Ways##2##2##(1994-12#1)(2010-8#1)
the Web and##3##3##(2008-4#1)(2013-1#2)
the Web interface##2##3##(2007-7#1)(2008-4#1)
the Web or##3##3##(2008-4#2)(2008-9#1)
the Web##31##2##(2006-10#1)(2006-12#5)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#9)(2008-6#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#6)
the Wechsler Adult Intelligence Scale-Revised##2##5##(1995-11#1)(1997-8#1)
the Wechsler##6##2##(1995-11#3)(1997-8#1)(2008-7#1)(2010-2#1)
the Wei-Lachin##2##2##(1992-6#1)(1997-3#1)
the Weibull function##3##3##(2004-2#1)(2008-10#2)
the Weibull model##4##3##(2008-9#1)(2010-4#2)(2011-2#1)
the Weibull##12##2##(2004-2#1)(2005-11#1)(2008-10#4)(2008-9#2)(2010-4#2)(2011-2#1)(2012-2#1)
the Wellcome Trust##5##3##(2008-2#1)(2008-7#3)(2008-8#1)
the Wellcome##6##2##(2008-2#1)(2008-7#4)(2008-8#1)
the Wells criteria##2##3##(2010-8#2)
the Welsh##3##2##(1996-7#1)(2008-10#1)(2008-7#1)
the Wen Ho Lee case##2##5##(2007-8#2)
the Werner syndrome protein##2##4##(2010-2#2)
the West African##9##3##(1990-6#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#1)(2012-12#1)(2012-2#3)
the West Indies##10##3##(1991-12#1)(2008-8#1)(2011-2#8)
the West Midlands##3##3##(1991-12#1)(2004-10#1)(2004-2#1)
the West coast##3##3##(2011-2#3)
the West in##2##3##(2008-10#1)(2009-4#1)
the West of Scotland##2##4##(2004-2#1)(2006-5#1)
the West##62##2##(1990-6#1)(1991-12#2)(1993-9#1)(1994-4#2)(1995-1#3)(1995-2#1)(1996-8#1)(2004-10#1)(2004-2#2)(2005-10#1)(2005-11#2)(2005-8#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-5#3)(2007-7#1)(2007-9#1)(2008-10#5)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-4#3)(2009-7#2)(2010-8#1)(2011-2#12)(2012-12#1)(2012-2#4)(2013-1#1)
the Western Atlantic##2##3##(2008-5#1)(2013-7#1)
the Western Cape##5##3##(2010-3#2)(2011-2#1)(2012-11#2)
the Western Hemisphere##7##3##(2007-8#1)(2008-10#4)(2008-4#1)(2013-7#1)
the Western United States##2##4##(2008-10#2)
the Western blot assay##2##4##(1992-3#1)(1995-1#1)
the Western blot##6##3##(1990-7#1)(1992-3#1)(1995-1#2)(2007-3#1)(2008-11#1)
the Western countries##4##3##(1993-11#1)(2009-4#1)(2010-2#2)
the Western hemisphere##2##3##(2007-2#2)
the Western region##3##3##(2007-3#1)(2009-5#1)(2010-12#1)
the Western world##13##3##(1991-5#1)(1997-8#1)(2006-12#1)(2008-1#3)(2008-7#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#1)
the Western##74##2##(1990-7#1)(1991-5#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-11#1)(1994-6#1)(1995-1#2)(1995-6#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-12#1)(2007-2#3)(2007-3#2)(2007-5#1)(2007-8#2)(2008-1#3)(2008-10#10)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#1)(2010-9#1)(2011-2#4)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#4)(2013-8#1)
the Wheat##3##2##(1997-8#1)(2008-10#2)
the WhiA##2##2##(2012-2#2)
the White House##7##3##(1991-10#1)(1992-9#1)(1994-12#1)(1995-6#1)(1996-11#2)(2007-4#1)
the White##9##2##(1991-10#1)(1992-9#1)(1994-12#1)(1995-6#1)(1996-11#2)(2007-4#1)(2007-9#1)(2008-3#1)
the Widal test##2##3##(2007-2#2)
the Widal##3##2##(2007-2#3)
the Wider Caribbean##2##3##(2011-2#2)
the Wigner distribution function of##2##5##(2007-12#1)(2008-3#1)
the Wigner distribution function##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
the Wigner distribution##5##3##(2007-12#1)(2008-2#3)(2008-3#1)
the Wigner function##2##3##(2007-12#2)
the Wigner transform of a##2##5##(2007-12#2)
the Wigner transform of##5##4##(2007-12#5)
the Wigner##15##2##(1995-1#1)(2007-11#1)(2007-12#9)(2008-2#3)(2008-3#1)
the Wilcoxon rank-sum##2##3##(1996-3#1)(2012-1#1)
the Wilcoxon signed rank test##3##5##(1997-8#1)(2006-10#1)(2010-6#1)
the Wilcoxon signed-rank test##2##4##(2008-7#2)
the Wilcoxon test##3##3##(1992-8#1)(1996-3#1)(2013-1#1)
the Wilcoxon##12##2##(1992-8#1)(1996-3#3)(1997-8#1)(2006-10#1)(2006-11#1)(2008-7#2)(2010-6#1)(2012-1#1)(2013-1#1)
the Wild Coast region##2##4##(2012-3#2)
the Wild Coast##4##3##(2012-3#4)
the Williams 82##2##3##(2012-11#2)
the Williams##4##2##(1993-12#1)(2007-2#1)(2012-11#2)
the Wilms' tumor##2##3##(1990-11#1)(1990-6#1)
the Wilson disease##2##3##(1993-11#1)(1995-3#1)
the Wilson##4##2##(1993-11#1)(1995-3#1)(2008-10#1)(2008-5#1)
the Windows##2##2##(2008-10#1)(2008-4#1)
the Winkler##2##2##(2007-3#1)(2008-10#1)
the Winter##4##2##(2006-11#1)(2008-10#1)(2008-7#1)(2010-12#1)
the Wisconsin Card Sorting Test (WCST)##3##6##(1995-1#1)(1995-11#1)(1996-8#1)
the Wisconsin Card Sorting Test##9##5##(1995-1#2)(1995-11#1)(1996-3#1)(1996-8#2)(2006-4#2)(2008-7#1)
the Wisconsin Card Sorting##11##4##(1995-1#2)(1995-11#1)(1995-5#1)(1996-3#1)(1996-8#2)(2006-4#2)(2007-8#1)(2008-7#1)
the Wisconsin Card##12##3##(1995-1#2)(1995-11#1)(1995-5#1)(1996-3#1)(1996-8#2)(2006-3#1)(2006-4#2)(2007-8#1)(2008-7#1)
the Wisconsin Longitudinal Study##2##4##(2010-11#1)(2010-8#1)
the Wisconsin biotype##3##3##(2008-10#3)
the Wisconsin##25##2##(1992-5#1)(1995-1#2)(1995-11#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-3#1)(1996-7#1)(1996-8#2)(1997-6#1)(2006-3#1)(2006-4#2)(2007-11#1)(2007-8#1)(2008-10#3)(2008-7#1)(2008-8#1)(2010-11#1)(2010-2#1)(2010-8#1)
the Wistar##3##2##(1990-7#1)(2008-1#1)(2008-3#1)
the Wld(S) mutation##4##3##(1997-3#4)
the Wld(S)##5##2##(1997-3#5)
the Wnt signaling pathway in##2##5##(1995-8#1)(2012-2#1)
the Wnt##9##2##(1994-9#2)(1995-8#1)(2007-12#1)(2008-10#1)(2010-12#1)(2012-2#1)(2013-1#2)
the Wobbler##3##2##(1992-7#3)
the Wolff-Parkinson-White pattern##2##3##(1995-6#2)
the Wolff-Parkinson-White##3##2##(1995-6#2)(2006-9#1)
the Women's##5##2##(1991-10#1)(2004-10#1)(2006-10#1)(2009-12#1)(2013-8#1)
the Woodlands No##2##3##(2008-5#2)
the Workers'##2##2##(1993-6#1)(2009-4#1)
the Workforce##2##2##(2004-8#1)(2006-8#1)
the Working Group on##3##4##(2005-11#1)(2007-9#1)(2010-12#1)
the Working Group##4##3##(1996-6#1)(2005-11#1)(2007-9#1)(2010-12#1)
the Working##5##2##(1996-6#1)(2005-11#1)(2007-9#1)(2008-4#1)(2010-12#1)
the Worland##2##2##(2008-10#2)
the World AIDS Day##2##4##(1990-11#2)
the World Anti-Doping Agency##2##4##(2010-4#1)(2013-7#1)
the World Bank and##2##4##(1990-3#1)(1997-8#1)
the World Bank##6##3##(1990-3#1)(1994-10#1)(1995-5#1)(1997-8#2)(2007-2#1)
the World Federation of##4##4##(2005-8#1)(2008-2#1)(2010-6#1)(2011-2#1)
the World Health Assembly##4##4##(2007-4#1)(2008-1#1)(2008-8#2)
the World Health Organisation##7##4##(2008-1#1)(2008-10#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
the World Health Organization (WHO)##28##5##(1994-3#1)(1994-9#1)(1995-5#1)(1996-2#1)(1997-6#1)(2006-4#1)(2008-1#2)(2008-12#1)(2008-3#4)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#3)(2013-8#1)
the World Health Organization and##5##5##(1997-8#1)(2006-2#1)(2007-12#1)(2007-2#1)(2011-2#1)
the World Health Organization are##2##5##(1990-3#1)(2007-8#1)
the World Health Organization criteria##2##5##(1993-9#1)(2010-3#1)
the World Health Organization##86##4##(1990-11#1)(1990-3#1)(1991-12#1)(1991-9#2)(1992-1#1)(1993-11#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-3#2)(1994-9#3)(1995-5#1)(1995-9#1)(1996-2#1)(1996-9#1)(1997-6#2)(1997-8#1)(2005-11#1)(2005-12#1)(2006-10#4)(2006-2#1)(2006-4#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2011-7#1)(2012-1#2)(2012-12#5)(2012-2#2)(2013-1#7)(2013-8#1)
the World Health Organization's (WHO)##2##5##(2006-10#1)(2007-4#1)
the World Health Organization's##3##4##(2006-10#1)(2007-4#1)(2012-2#1)
the World Health##102##3##(1990-11#1)(1990-3#1)(1991-12#1)(1991-9#2)(1992-1#1)(1993-11#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-3#2)(1994-9#3)(1995-5#1)(1995-9#1)(1996-2#1)(1996-9#1)(1997-6#2)(1997-8#1)(2005-11#1)(2005-12#1)(2006-10#5)(2006-11#1)(2006-2#1)(2006-4#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-8#1)(2008-1#5)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-8#4)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#4)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2011-7#1)(2012-1#2)(2012-12#6)(2012-2#4)(2013-1#8)(2013-8#1)
the World Organisation for Animal Health (OIE)##2##7##(2011-2#2)
the World Organisation for Animal Health##5##6##(2011-2#5)
the World Summit for Children##2##5##(2006-10#2)
the World Summit##3##3##(2006-10#2)(2007-4#1)
the World Trade Center##6##4##(2006-7#1)(2007-2#1)(2007-3#1)(2008-8#3)
the World Trade Organization (WTO) Agreement on the Application of Sanitary and Phytosanitary Measures##2##14##(2005-5#2)
the World Trade Organization (WTO)##3##5##(2005-5#3)
the World Trade Organization##4##4##(2005-5#4)
the World Trade##10##3##(2005-5#4)(2006-7#1)(2007-2#1)(2007-3#1)(2008-8#3)
the World War##2##3##(2007-2#1)(2011-1#1)
the World Wide Web to##2##5##(1997-5#2)
the World Wide Web##22##4##(1996-11#1)(1996-2#1)(1996-9#2)(1997-5#2)(1997-6#1)(1997-8#1)(2005-10#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-4#1)(2008-10#3)(2008-2#3)(2008-4#2)(2009-4#1)
the World-Wide Web##4##3##(1996-12#2)(2007-11#1)(2008-3#1)
the WorldSID prototype dummy##2##4##(2007-4#2)
the WorldSID prototype##3##3##(2007-4#3)
the WorldSID##7##2##(2007-1#1)(2007-4#6)
the WorldSID-alpha##2##2##(2006-11#2)
the Wright##3##2##(2008-4#1)(2008-9#1)(2012-2#1)
the X and Y chromosomes##2##5##(1991-5#1)(2010-5#1)
the X and Y coordinates##2##5##(1994-1#2)
the X and Y##7##4##(1991-5#1)(1994-1#2)(1995-11#1)(2008-7#1)(2008-8#1)(2010-5#1)
the X and##9##3##(1991-5#1)(1994-1#2)(1995-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-5#2)
the X axis##2##3##(2008-10#1)(2008-3#1)
the X chromosome at##2##4##(1993-10#1)(2008-12#1)
the X chromosome##20##3##(1990-12#1)(1991-12#1)(1993-10#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-5#1)(1996-12#2)(1996-6#1)(1997-5#1)(2006-10#1)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2010-4#1)(2012-1#1)
the X-Club##2##2##(2009-2#2)
the X-POL potential##3##3##(2008-11#3)
the X-Ray##2##2##(2006-8#1)(2013-8#1)
the X-chromosome##9##2##(1990-8#1)(1994-11#1)(1997-2#1)(1997-4#1)(1997-5#3)(2008-12#2)
the X-linked PGK-1##2##3##(1992-8#2)
the X-linked##7##2##(1992-8#2)(1995-11#1)(1996-12#1)(2006-8#1)(2008-4#1)(2008-9#1)
the X-ray beam from##2##4##(2006-5#2)
the X-ray beam##8##3##(1995-2#1)(2006-4#2)(2006-5#3)(2008-10#1)(2008-3#1)
the X-ray crystal structure of the##2##6##(1990-4#1)(1992-6#1)
the X-ray crystal structure of##4##5##(1990-4#1)(1992-6#1)(1996-6#1)(2013-7#1)
the X-ray crystal structure##5##4##(1990-4#1)(1991-2#1)(1992-6#1)(1996-6#1)(2013-7#1)
the X-ray crystal structures of two##2##6##(1996-5#1)(2008-10#1)
the X-ray crystal structures of##3##5##(1996-5#1)(2008-10#1)(2010-5#1)
the X-ray crystal##8##3##(1990-4#1)(1991-2#1)(1992-6#1)(1996-5#1)(1996-6#1)(2008-10#1)(2010-5#1)(2013-7#1)
the X-ray film##2##3##(2006-5#2)
the X-ray structure of the##5##5##(1991-4#1)(1994-8#2)(1996-8#1)(2007-11#1)
the X-ray structure of##6##4##(1991-4#1)(1993-3#1)(1994-8#2)(1996-8#1)(2007-11#1)
the X-ray structure##11##3##(1991-4#3)(1993-3#1)(1993-8#2)(1994-8#2)(1995-8#1)(1996-8#1)(2007-11#1)
the X-ray##64##2##(1990-4#1)(1991-2#1)(1991-4#4)(1991-5#2)(1991-7#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-8#2)(1994-8#3)(1995-2#1)(1995-8#2)(1996-5#1)(1996-6#2)(1996-8#1)(1997-8#1)(2006-4#5)(2006-5#7)(2006-6#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2010-12#1)(2010-5#1)(2011-1#1)(2012-12#3)(2013-7#1)(2013-8#3)
the X-rays##3##2##(2006-4#1)(2008-6#1)(2011-12#1)
the X2##2##2##(1995-2#1)(2012-2#1)
the XAD-8 resin##2##3##(2008-10#2)
the XE-2100##6##2##(2008-10#6)
the XIII##3##2##(1994-2#1)(1994-9#1)(2007-8#1)
the XLD spectrum##2##3##(2006-4#2)
the XLD##3##2##(2006-4#3)
the XR data##3##3##(2006-5#3)
the XR##5##2##(1995-8#1)(2006-5#4)
the XRD##3##2##(2005-11#1)(2010-2#2)
the XRT group##2##3##(1991-4#2)
the XVII##3##2##(1991-6#1)(1996-3#1)(2008-11#1)
the XVIIIth century##2##3##(2008-8#1)(2011-2#1)
the XVIIIth##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
the XX##7##2##(2007-12#1)(2008-2#4)(2008-9#1)(2011-1#1)
the Xa22(t) locus##2##3##(2008-10#2)
the Xenopus laevis##8##3##(1993-12#1)(1993-6#2)(1994-12#2)(1995-2#1)(1995-8#1)(1997-6#1)
the Xenopus melanophore assay##2##4##(1995-3#2)
the Xenopus oocyte expression system##3##5##(1992-6#1)(1995-2#1)(1997-2#1)
the Xenopus oocyte##5##3##(1990-2#1)(1992-6#1)(1995-2#1)(1995-8#1)(1997-2#1)
the Xenopus##26##2##(1990-2#1)(1992-6#3)(1993-12#1)(1993-6#4)(1994-12#2)(1995-2#2)(1995-3#2)(1995-8#2)(1996-5#1)(1996-7#2)(1997-2#1)(1997-6#1)(1997-7#2)(2008-5#1)(2012-3#1)
the XerC and XerD binding sites##2##6##(1997-2#2)
the Xist gene##2##3##(1994-11#2)
the Xoo##2##2##(1993-9#2)
the XylS##2##2##(1993-11#2)
the Y chromosome and##3##4##(1990-11#1)(1996-12#1)(2008-8#1)
the Y chromosome is##2##4##(1995-11#2)
the Y chromosome of##2##4##(1992-5#1)(1995-11#1)
the Y chromosome##27##3##(1990-11#8)(1992-5#2)(1993-9#2)(1995-11#6)(1996-12#2)(1996-5#2)(2005-10#1)(2008-4#1)(2008-8#2)(2012-3#1)
the Y transfer set##2##4##(2007-12#2)
the Y##46##2##(1990-11#10)(1992-5#2)(1993-8#1)(1993-9#4)(1995-11#9)(1996-12#2)(1996-5#2)(1996-7#1)(2005-10#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#3)(2012-3#1)(2013-8#1)
the Y(1) receptor##2##3##(2005-6#2)
the Y(1)##4##2##(2005-6#4)
the Y(5)##2##2##(2005-6#2)
the Y-branch DWG##3##3##(2007-11#3)
the Y-chromosome gene SRY##2##4##(1995-11#2)
the Y-linked##3##2##(1995-11#2)(2008-4#1)
the Y-shaped##2##2##(2008-10#1)(2009-5#1)
the Y12##2##2##(1993-2#2)
the Y139C SNP##2##3##(2012-12#2)
the Y139C##5##2##(2012-12#5)
the Y2 receptor##2##3##(1996-9#1)(1997-5#1)
the Y70F##3##2##(1991-7#3)
the YAC contigs##2##3##(1995-6#1)(1996-10#1)
the YAC##5##2##(1991-9#1)(1995-6#1)(1996-10#2)(1996-12#1)
the YAG##2##2##(2008-2#1)(2013-8#1)
the YC group##2##3##(1995-11#1)(2008-7#1)
the YCDTDS##3##2##(1990-9#3)
the YG bead caused##2##4##(2008-6#2)
the Yale##2##2##(2007-10#1)(2007-9#1)
the Yale-Brown Obsessive Compulsive Scale##3##5##(2004-3#2)(2008-3#1)
the Yanomámi territory##2##3##(1991-12#2)
the Yanomámi##4##2##(1991-12#4)
the Year##9##2##(1992-1#1)(2009-4#8)
the Yeast##3##2##(1997-3#1)(2008-10#1)(2011-2#1)
the Yellow##3##2##(2008-2#1)(2012-12#1)(2013-8#1)
the Yerkes##2##2##(2007-12#2)
the Yersinia##4##2##(1992-1#1)(1995-10#1)(2013-8#2)
the York Retreat##2##3##(2008-7#2)
the Yorkshire Cochlear Implant##2##4##(2008-9#1)(2012-2#1)
the Yorkshire##3##2##(2007-8#1)(2008-9#1)(2012-2#1)
the Yoshida##2##2##(1991-9#1)(1993-8#1)
the Young's modulus of##3##4##(2007-12#1)(2009-7#1)(2009-9#1)
the Young's modulus##6##3##(2007-11#1)(2007-12#1)(2009-7#1)(2009-9#2)(2010-8#1)
the Young's##7##2##(2007-11#1)(2007-12#1)(2009-7#2)(2009-9#2)(2010-8#1)
the Youth##2##2##(1990-12#1)(2012-1#1)
the Yucatan##3##2##(2008-10#1)(2008-5#2)
the Z axis##2##3##(2007-12#1)(2008-3#1)
the Z##13##2##(1992-3#1)(1994-11#2)(2007-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#3)(2010-5#1)
the Z- and C-forms##2##4##(2009-9#2)
the Z-DNA conformation##2##3##(1995-11#1)(1997-5#1)
the Z-form and the H(L)-form##2##5##(2006-10#2)
the Z-form##4##2##(1992-5#2)(2006-10#2)
the Z-scan technique##5##3##(2007-11#2)(2007-12#2)(2010-5#1)
the ZEB proteins##2##3##(2012-12#2)
the ZESPOL##2##2##(2007-11#2)
the ZFPOU1 transcripts were##2##4##(1992-9#2)
the ZFPOU1 transcripts##3##3##(1992-9#3)
the ZFS tensor##2##3##(2007-12#2)
the ZFS##3##2##(2007-12#3)
the ZIP code##4##3##(2013-1#4)
the ZIP##5##2##(2013-1#4)(2013-8#1)
the ZP3##2##2##(2008-4#2)
the ZPA##3##2##(1993-12#3)
the ZRs contents of cotton roots and##2##7##(2013-8#2)
the ZRs contents of cotton roots##3##6##(2013-8#3)
the ZRs contents##4##3##(2013-8#4)
the Zaboli ethnic group##2##4##(2007-2#2)
the Zea genus##2##3##(1995-12#2)
the Zea mays L##2##4##(2009-8#1)(2011-2#1)
the Zea##4##2##(1995-12#2)(2009-8#1)(2011-2#1)
the Zeeman laser##3##3##(2008-2#3)
the Zeeman modulation##3##3##(2008-2#1)(2008-3#2)
the Zeeman shift##2##3##(2008-2#2)
the Zeeman##10##2##(2008-2#6)(2008-3#4)
the Zernike##7##2##(2007-12#1)(2008-1#1)(2008-3#5)
the Zeus##4##2##(2007-8#3)(2011-2#1)
the Zimbabwe 1994 demographic health survey data to determine##2##9##(2007-6#1)(2007-7#1)
the Zimbabwe##4##2##(1997-7#1)(2007-6#1)(2007-7#1)(2012-12#1)
the Zmspds2##2##2##(2009-8#2)
the Zn (-) treatment##2##4##(2013-8#2)
the Zn##9##2##(1993-12#1)(2008-10#4)(2010-11#1)(2012-12#1)(2013-8#2)
the Zn(2+)##2##2##(2008-10#2)
the Zn(2+)-binding##2##2##(1995-8#1)(2009-9#1)
the Zn2+ concentration##2##3##(1991-2#2)
the Zn2+ concentration-inhibition curve##2##4##(1996-8#2)
the Zn2+##5##2##(1991-2#2)(1996-8#2)(1997-4#1)
the ZnO##5##2##(2006-12#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-4#1)
the ZnS##2##2##(2005-11#1)(2008-11#1)
the Zone Diet##2##3##(2008-3#2)
the Zone of Maximal Protection##2##5##(2008-7#2)
the Zone##4##2##(2008-3#2)(2008-7#2)
the Zulu##2##2##(1996-5#1)(2006-8#1)
the Zurich##3##2##(1993-8#1)(1996-11#2)
the [(MGD)2-Fe2+] complex##2##3##(1993-9#1)(1994-5#1)
the [1-L]acetaldehyde product##2##3##(1995-10#2)
the [14C]Nbf-O-derivative of tyrosine-beta 311##2##5##(1991-3#2)
the [14C]Nbf-O-derivative##3##2##(1991-3#3)
the [2Fe-2S] cluster##3##3##(1992-3#2)(1997-3#1)
the [2Fe-2S]##5##2##(1991-4#1)(1992-3#3)(1997-3#1)
the [4Fe-4S] cluster##5##3##(1995-6#2)(1995-8#2)(1996-7#1)
the [BPh]dA6##3##2##(1995-1#3)
the [Ca2+]##2##2##(1994-12#1)(1995-11#1)
the [Ca2+]IC##2##2##(1992-4#2)
the [Ca2+]i response##3##3##(1991-5#2)(1994-10#1)
the [Ca2+]i##10##2##(1990-7#2)(1991-5#2)(1993-3#2)(1994-10#2)(1994-3#1)(1996-2#1)
the [Cl-/HCO3-] exchanger##2##3##(1991-8#2)
the [Fe(4)S(4)]##2##2##(1996-2#2)
the [K+##2##2##(1991-8#2)
the [K5HPg]##2##2##(1993-8#2)
the [Lys]10kDa-SP-B##2##2##(1994-3#2)
the [Na+##2##2##(1991-8#2)
the [Na+]i##2##2##(1992-7#2)
the [formula##2##2##(1991-11#2)
the a and##2##3##(1996-8#1)(2008-4#1)
the a priori##7##3##(2008-11#1)(2008-2#1)(2008-3#4)(2008-9#1)
the a##19##2##(1996-12#1)(1996-2#1)(1996-4#1)(1996-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-9#2)(2009-4#1)
the a-factor##2##2##(1991-12#1)(1993-12#1)
the a-wave##2##2##(2006-8#2)
the a3##2##2##(2008-10#1)(2008-8#1)
the aa sequence deduced from the##2##6##(1993-5#1)(1997-2#1)
the aa sequence of##3##4##(1990-11#1)(1990-5#1)(1993-5#1)
the aa sequence##9##3##(1990-11#1)(1990-5#1)(1991-6#1)(1993-2#1)(1993-5#2)(1993-6#1)(1997-1#1)(1997-2#1)
the aa sequences of##5##4##(1990-11#1)(1990-3#1)(1991-9#1)(1993-12#1)(1995-8#1)
the aa sequences##6##3##(1990-11#1)(1990-3#1)(1991-9#1)(1993-12#2)(1995-8#1)
the aa##22##2##(1990-11#2)(1990-3#2)(1990-5#1)(1991-12#1)(1991-6#2)(1991-9#1)(1993-12#3)(1993-2#1)(1993-5#2)(1993-6#1)(1993-7#1)(1995-8#1)(1997-1#1)(1997-2#1)(2005-8#1)(2011-1#1)
the ab initio calculations##2##4##(1996-5#1)(2006-4#1)
the ab initio##5##3##(1996-5#2)(1997-7#1)(2006-4#1)(2007-11#1)
the ab##6##2##(1994-10#1)(1996-5#2)(1997-7#1)(2006-4#1)(2007-11#1)
the abandonment of the##2##4##(2006-12#1)(2009-2#1)
the abandonment of##3##3##(2006-12#1)(2007-3#1)(2009-2#1)
the abatement of##2##3##(2011-2#1)(2013-1#1)
the abattoir##5##2##(2010-4#4)(2011-1#1)
the abattoirs##3##2##(2011-1#2)(2011-2#1)
the abaxial##3##2##(2008-10#1)(2008-5#1)(2013-7#1)
the abbreviated##2##2##(2008-10#1)(2012-2#1)
the abdomen and pelvis and##2##5##(2012-2#2)
the abdomen and pelvis##4##4##(2007-4#1)(2009-8#1)(2012-2#2)
the abdomen and##14##3##(1993-10#1)(1997-5#1)(2006-10#1)(2006-8#1)(2007-4#1)(2008-4#1)(2009-10#1)(2009-2#2)(2009-8#1)(2009-9#1)(2012-2#2)(2013-8#1)
the abdomen by##2##3##(1992-10#1)(2006-11#1)
the abdomen can cause##2##4##(1992-4#1)(2008-6#1)
the abdomen developed##2##3##(2007-4#2)
the abdomen in##2##3##(1991-5#1)(2008-11#1)
the abdomen was##2##3##(1993-6#1)(2011-2#1)
the abdomen with##2##3##(1995-11#1)(2012-3#1)
the abdomen##78##2##(1990-10#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-4#1)(1992-5#1)(1993-10#1)(1993-6#1)(1993-8#1)(1995-11#1)(1995-3#2)(1996-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(2006-1#1)(2006-10#2)(2006-11#4)(2006-2#1)(2006-4#2)(2006-6#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-4#6)(2007-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#3)(2009-10#1)(2009-2#2)(2009-8#1)(2009-9#1)(2010-6#1)(2010-9#2)(2011-2#4)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#4)
the abdominal and##3##3##(2008-4#1)(2012-1#1)(2012-3#1)
the abdominal aorta and##2##4##(2006-10#2)
the abdominal aorta##12##3##(1991-9#3)(1992-4#1)(1993-11#1)(1997-8#3)(2006-10#2)(2008-5#1)(2010-11#1)
the abdominal approach##2##3##(1990-4#1)(2013-1#1)
the abdominal cavity and##4##4##(2009-2#1)(2011-1#1)(2012-1#1)(2013-1#1)
the abdominal cavity was##2##4##(2007-8#1)(2012-12#1)
the abdominal cavity##17##3##(1991-2#1)(1993-6#1)(1993-9#1)(2006-2#1)(2006-6#2)(2007-8#1)(2008-1#1)(2008-4#1)(2009-2#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
the abdominal gland##2##3##(2008-6#2)
the abdominal muscles##3##3##(1993-10#1)(2007-3#1)(2008-10#1)
the abdominal organs##2##3##(1992-8#1)(2012-1#1)
the abdominal pain##3##3##(1992-3#1)(2013-1#2)
the abdominal region##4##3##(2007-4#1)(2009-6#1)(2011-2#1)(2012-2#1)
the abdominal wall and##3##4##(1990-10#1)(2008-9#2)
the abdominal wall##26##3##(1990-10#2)(1990-5#1)(1991-12#1)(1991-9#1)(1995-3#2)(1995-9#1)(1996-3#1)(1996-8#1)(1996-9#1)(2007-7#1)(2008-10#2)(2008-9#2)(2011-2#8)(2012-12#1)(2012-2#1)
the abdominal wall]##2##3##(1990-5#1)(1992-4#1)
the abdominal##109##2##(1990-10#2)(1990-4#1)(1990-5#2)(1990-6#1)(1991-12#1)(1991-2#1)(1991-9#4)(1992-3#1)(1992-4#2)(1992-8#1)(1993-10#2)(1993-11#1)(1993-12#1)(1993-6#2)(1993-9#1)(1995-3#2)(1995-9#1)(1996-1#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-8#3)(2006-10#2)(2006-2#1)(2006-4#1)(2006-6#2)(2007-11#1)(2007-12#4)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#4)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#4)(2009-2#4)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#11)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
the abducens nerve was##2##4##(2006-12#2)
the abducens nerve##9##3##(2006-12#7)(2012-3#2)
the abducens##10##2##(1991-3#1)(2006-12#7)(2012-3#2)
the abduction and adduction##2##4##(2012-2#2)
the abduction and##3##3##(1990-2#1)(2012-2#2)
the abduction angle##2##3##(2007-7#2)
the abduction##5##2##(1990-2#1)(2007-7#2)(2012-2#2)
the abductor##4##2##(2006-3#1)(2008-12#2)(2013-7#1)
the aberrant activation##2##3##(2009-12#1)(2012-12#1)
the aberrant##15##2##(1991-12#1)(1993-9#2)(2007-10#1)(2007-12#2)(2007-8#2)(2008-7#1)(2008-8#1)(2009-12#1)(2012-12#1)(2012-2#2)(2012-3#1)
the aberration of##2##3##(2008-3#2)
the aberration##7##2##(2008-2#2)(2008-3#5)
the aberrations of an##2##4##(2007-12#1)(2008-3#1)
the aberrations of the cornea##2##5##(2007-12#2)
the aberrations of the##3##4##(2007-12#3)
the aberrations of##5##3##(2007-12#4)(2008-3#1)
the aberrations that are##2##4##(2008-3#2)
the aberrations up to##2##4##(2008-3#2)
the aberrations##16##2##(2007-12#4)(2008-2#2)(2008-3#10)
the abilities of the selective##2##5##(1994-6#2)
the abilities of the##4##4##(1992-8#1)(1994-6#2)(1995-5#1)
the abilities of##8##3##(1992-8#1)(1994-6#2)(1995-10#1)(1995-5#1)(1995-8#1)(2007-7#1)(2008-3#1)
the abilities to##3##3##(1991-7#1)(1995-1#1)(2008-9#1)
the abilities##15##2##(1991-7#1)(1992-8#1)(1994-6#2)(1995-1#1)(1995-10#1)(1995-5#1)(1995-8#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-2#2)(2011-1#1)
the ability and willingness of the##2##6##(2008-5#1)(2010-12#1)
the ability and##5##3##(1994-9#1)(1995-12#1)(2008-11#1)(2008-5#1)(2010-12#1)
the ability for##3##3##(1996-3#1)(2005-11#1)(2008-10#1)
the ability of 1##2##4##(1992-10#1)(1992-12#1)
the ability of C##4##4##(2008-10#3)(2011-1#1)
the ability of EGF to induce##2##6##(1996-8#2)
the ability of FGF2 to stimulate##2##6##(2008-4#2)
the ability of NGF to##2##5##(1995-3#1)(1997-2#1)
the ability of Pab1p to##2##5##(1997-5#2)
the ability of Trichoderma spp##2##5##(2008-10#2)
the ability of a dummy to##2##6##(2006-11#2)
the ability of a newly developed##2##6##(2007-7#1)(2013-8#1)
the ability of a species to##2##6##(2008-8#2)
the ability of a##35##4##(1990-4#2)(1991-12#1)(1992-7#1)(1992-8#1)(1993-7#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-3#1)(1996-5#1)(1997-1#1)(2006-11#3)(2006-5#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-7#1)(2010-5#1)(2013-8#3)
the ability of an##5##4##(1997-3#1)(1997-5#1)(2009-1#1)(2012-12#2)
the ability of bacteria to##2##5##(2008-10#1)(2008-11#1)
the ability of both##4##4##(1990-9#2)(1994-11#1)(2008-5#1)
the ability of cells to##7##5##(1994-11#1)(1994-3#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-4#1)
the ability of cells##9##4##(1992-12#1)(1994-11#1)(1994-3#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
the ability of countries to##2##5##(2008-5#1)(2009-7#1)
the ability of dietary##2##4##(1992-8#1)(1993-12#1)
the ability of different##3##4##(1990-2#1)(1994-9#1)(2010-2#1)
the ability of each type##2##5##(1993-2#1)(2008-5#1)
the ability of endogenous##2##4##(1994-12#1)(2008-12#1)
the ability of free##2##4##(1992-3#1)(2010-1#1)
the ability of health##2##4##(1994-3#1)(2008-11#1)
the ability of human##6##4##(1994-3#1)(1995-5#1)(1995-6#1)(2008-5#2)(2010-2#1)
the ability of in vitro##2##5##(2008-8#1)(2008-9#1)
the ability of neutrophils to##3##5##(1990-11#1)(1991-9#1)(2010-9#1)
the ability of osteosarcoma##2##4##(1997-7#1)(2010-3#1)
the ability of p53 to##4##5##(1993-12#1)(1994-8#2)(1996-10#1)
the ability of patients to##2##5##(2008-7#1)(2010-9#1)
the ability of physicians##2##4##(2007-9#1)(2008-11#1)
the ability of rats to##2##5##(2007-10#1)(2012-2#1)
the ability of rats##3##4##(2007-10#1)(2008-7#1)(2012-2#1)
the ability of recombinant##2##4##(1994-9#1)(2010-12#1)
the ability of some##4##4##(2007-9#2)(2008-10#2)
the ability of specific##3##4##(1996-3#1)(2008-11#1)(2008-7#1)
the ability of such##2##4##(1995-2#1)(2010-7#1)
the ability of the bacteria to##2##6##(1995-2#1)(2011-2#1)
the ability of the bird to##2##6##(2005-9#2)
the ability of the drug to##2##6##(2008-11#1)(2008-3#1)
the ability of the enzyme##2##5##(1990-2#1)(1992-3#1)
the ability of the human##2##5##(1993-9#1)(2006-10#1)
the ability of the intestine to adapt to an altered nutrient##2##11##(1993-9#2)
the ability of the kidney to##2##6##(1995-9#1)(2010-1#1)
the ability of the receptor to bind##2##7##(1995-3#1)(1996-11#1)
the ability of the receptor to##3##6##(1995-3#1)(1996-11#1)(1996-8#1)
the ability of the subunit##2##5##(1992-11#1)(1995-8#1)
the ability of the##113##4##(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-2#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#2)(1993-11#1)(1993-6#1)(1993-9#3)(1994-2#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-5#1)(1997-7#2)(1997-8#2)(2004-9#1)(2005-11#1)(2005-9#2)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#1)(2006-7#1)(2006-8#2)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#2)(2008-10#11)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#5)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#5)(2012-2#1)
the ability of their##2##4##(1993-7#1)(2009-2#1)
the ability of these cells to##3##6##(1996-2#1)(2007-11#1)(2012-3#1)
the ability of these species to##2##6##(2006-5#1)(2009-2#1)
the ability of these##25##4##(1990-5#1)(1991-1#1)(1991-2#1)(1992-11#1)(1992-12#2)(1992-6#1)(1993-9#1)(1994-6#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-5#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2009-2#1)(2010-11#1)(2012-3#1)(2013-1#1)
the ability of this enzyme to##2##6##(1993-5#1)(1994-8#1)
the ability of this##10##4##(1990-2#1)(1993-5#1)(1994-8#1)(1995-10#1)(1995-3#1)(1995-5#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-5#1)
the ability of three##2##4##(1990-7#1)(2007-6#1)
the ability of tumour cells to##2##6##(1992-9#2)
the ability of##580##3##(1990-10#1)(1990-11#3)(1990-12#5)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#3)(1990-7#1)(1990-8#1)(1990-9#6)(1991-1#2)(1991-12#3)(1991-2#6)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#3)(1992-12#5)(1992-2#2)(1992-3#2)(1992-4#3)(1992-6#2)(1992-7#3)(1992-8#4)(1992-9#2)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#3)(1993-5#1)(1993-6#2)(1993-7#2)(1993-9#6)(1994-10#1)(1994-11#6)(1994-12#6)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#6)(1994-8#5)(1994-9#5)(1995-1#5)(1995-10#4)(1995-11#6)(1995-12#2)(1995-2#5)(1995-3#8)(1995-5#5)(1995-6#5)(1995-8#9)(1995-9#1)(1996-1#1)(1996-10#3)(1996-11#2)(1996-12#5)(1996-2#2)(1996-3#5)(1996-4#2)(1996-5#3)(1996-7#2)(1996-8#5)(1996-9#1)(1997-1#3)(1997-2#6)(1997-3#1)(1997-5#7)(1997-6#3)(1997-7#6)(1997-8#4)(2004-11#1)(2004-9#1)(2005-11#2)(2005-7#3)(2005-9#2)(2006-10#8)(2006-11#4)(2006-12#4)(2006-2#2)(2006-4#1)(2006-5#3)(2006-7#4)(2006-8#4)(2007-10#2)(2007-11#5)(2007-12#7)(2007-6#3)(2007-7#1)(2007-8#2)(2007-9#6)(2008-1#2)(2008-10#52)(2008-11#19)(2008-12#3)(2008-2#6)(2008-3#7)(2008-4#23)(2008-5#26)(2008-6#1)(2008-7#12)(2008-8#11)(2008-9#10)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#4)(2009-5#4)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#5)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#3)(2010-8#3)(2010-9#3)(2011-1#6)(2011-12#1)(2011-2#9)(2012-1#2)(2012-11#1)(2012-12#9)(2012-2#6)(2012-3#6)(2013-1#3)(2013-8#11)
the ability to access and##2##5##(2008-11#1)(2008-7#1)
the ability to acclimate to##2##5##(2009-8#1)(2012-5#1)
the ability to achieve##2##4##(2007-12#1)(2011-1#1)
the ability to activate##8##4##(1990-6#1)(1991-11#1)(1993-8#1)(1996-9#1)(1997-2#1)(2008-3#1)(2009-8#1)(2010-2#1)
the ability to adhere##2##4##(1992-11#1)(2008-9#1)
the ability to analyze##4##4##(1992-11#1)(1996-12#1)(2008-9#1)(2009-2#1)
the ability to assess##2##4##(1994-3#1)(2009-9#1)
the ability to be##11##4##(2006-9#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)
the ability to bind to##4##5##(1990-4#1)(1993-9#1)(1994-12#1)(1996-2#1)
the ability to bind##12##4##(1990-4#1)(1990-5#1)(1993-12#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#1)(1995-3#1)(1996-2#1)(2008-4#1)(2010-10#1)
the ability to capture##2##4##(2006-7#1)(2008-9#1)
the ability to cause##3##4##(1997-6#1)(2008-10#2)
the ability to change##2##4##(2008-11#1)(2011-2#1)
the ability to colonize##2##4##(2008-10#1)(2008-8#1)
the ability to combine##2##4##(2008-2#1)(2009-5#1)
the ability to communicate##3##4##(2008-11#1)(2013-1#2)
the ability to compete with the##2##6##(1994-5#1)(2013-8#1)
the ability to compete with##3##5##(1994-12#1)(1994-5#1)(2013-8#1)
the ability to compete##4##4##(1994-12#1)(1994-5#1)(2005-11#1)(2013-8#1)
the ability to conduct##2##4##(2008-11#1)(2009-6#1)
the ability to contract##2##4##(2005-7#2)
the ability to control the##4##5##(2007-11#1)(2007-12#1)(2008-11#1)(2008-7#1)
the ability to control##6##4##(2007-11#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-7#2)
the ability to convert##3##4##(1995-5#1)(1996-2#1)(2007-12#1)
the ability to create##4##4##(1996-12#1)(2012-12#1)(2013-1#2)
the ability to decrease##4##4##(1997-1#1)(2007-7#1)(2008-1#1)(2008-7#1)
the ability to degrade##2##4##(2008-10#1)(2008-4#1)
the ability to deliver##3##4##(1996-12#1)(2008-10#1)(2008-3#1)
the ability to detect##11##4##(1992-2#1)(1994-12#1)(1997-5#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-11#1)(2009-10#1)(2010-4#1)
the ability to determine##3##4##(2011-1#1)(2013-1#2)
the ability to diagnose it during life##2##7##(2008-7#2)
the ability to diagnose##4##4##(1995-3#1)(2007-12#1)(2008-7#2)
the ability to differentiate into##4##5##(2006-6#1)(2008-1#1)(2008-9#2)
the ability to differentiate##9##4##(1990-5#1)(1991-12#1)(2006-12#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#2)
the ability to discriminate between##2##5##(2008-7#1)(2010-2#1)
the ability to discriminate##6##4##(1993-8#1)(2008-10#1)(2008-7#1)(2010-2#1)(2013-1#2)
the ability to distinguish between##2##5##(1994-9#1)(2006-12#1)
the ability to distinguish##6##4##(1990-12#1)(1994-9#1)(2006-12#1)(2007-7#1)(2008-9#1)(2009-4#1)
the ability to do##2##4##(2009-4#1)(2010-12#1)
the ability to elevate##2##4##(1992-8#1)(2007-11#1)
the ability to elicit##2##4##(2008-10#1)(2008-4#1)
the ability to enforce##2##4##(2008-10#1)(2013-1#1)
the ability to examine##2##4##(2007-12#1)(2008-12#1)
the ability to express##3##4##(1995-11#1)(2010-2#1)(2012-2#1)
the ability to follow##2##4##(2006-2#1)(2007-7#1)
the ability to form H-bonds##2##5##(1992-10#2)
the ability to form a##2##5##(1990-11#1)(2008-7#1)
the ability to form complexes with##2##6##(1995-5#1)(1995-8#1)
the ability to form##9##4##(1990-11#1)(1992-10#2)(1994-12#1)(1994-6#1)(1995-5#1)(1995-8#1)(2008-10#1)(2008-7#1)
the ability to generate##7##4##(1990-2#1)(1993-2#1)(1994-11#1)(2007-11#1)(2008-4#1)(2008-7#1)(2008-9#1)
the ability to give rise to##2##6##(2008-1#1)(2008-8#1)
the ability to give##3##4##(1995-9#1)(2008-1#1)(2008-8#1)
the ability to grow on##4##5##(1990-5#1)(1997-2#1)(2008-10#1)(2008-8#1)
the ability to grow##7##4##(1990-5#1)(1995-11#1)(1997-2#1)(2008-10#1)(2008-8#1)(2009-10#1)(2009-11#1)
the ability to handle##7##4##(2007-11#1)(2008-10#1)(2008-4#2)(2009-12#1)(2013-1#2)
the ability to hydrolyze##2##4##(1994-12#1)(2008-10#1)
the ability to identify anomalous utilization cases where the patients incurred levels of utilization that are unexpected given their clinical characteristics which may require corrective actions##2##26##(2013-1#2)
the ability to identify in a timely manner heavy users of the systems and their patterns of utilization so that targeted intervention programs can be instituted##2##26##(2013-1#2)
the ability to identify##10##4##(2007-8#1)(2008-11#1)(2009-6#1)(2012-3#1)(2013-1#5)(2013-7#1)
the ability to implement##2##4##(1994-3#1)(2008-2#1)
the ability to improve##3##4##(2006-3#1)(2008-7#1)(2010-12#1)
the ability to induce the##2##5##(2008-10#2)
the ability to induce##11##4##(1992-6#1)(2006-6#1)(2008-1#1)(2008-10#6)(2008-8#1)(2011-2#1)
the ability to infect##2##4##(2008-10#2)
the ability to inhibit##3##4##(1994-9#1)(2006-4#1)(2009-10#1)
the ability to interact with##3##5##(1991-8#1)(1996-5#1)(2008-9#1)
the ability to interact##4##4##(1991-8#1)(1996-5#1)(2008-9#1)(2011-1#1)
the ability to kill##2##4##(1995-2#1)(2008-4#1)
the ability to learn##2##4##(2009-3#1)(2010-6#1)
the ability to maintain a##2##5##(2005-12#1)(2008-8#1)
the ability to maintain normal blood glucose homeostasis##2##8##(2008-3#2)
the ability to maintain##6##4##(2005-12#1)(2008-3#2)(2008-8#1)(2012-2#1)(2012-3#1)
the ability to make##8##4##(1992-12#1)(2006-10#1)(2007-12#1)(2011-2#3)(2012-2#2)
the ability to measure##7##4##(2006-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2011-1#1)(2012-2#1)(2013-8#1)
the ability to mobilize##2##4##(1992-8#1)(2008-3#1)
the ability to modify##3##4##(1997-8#1)(2006-5#1)(2006-8#1)
the ability to modulate##2##4##(2008-4#1)(2010-1#1)
the ability to multiply##2##4##(1995-2#1)(2008-10#1)
the ability to obtain##4##4##(2006-10#1)(2008-2#1)(2010-12#1)(2010-8#1)
the ability to organize##3##4##(1994-3#1)(1997-6#1)(2008-7#1)
the ability to penetrate the##2##5##(1993-11#1)(2008-8#1)
the ability to penetrate##3##4##(1993-11#1)(2008-10#1)(2008-8#1)
the ability to perform##8##4##(1996-12#1)(2007-11#1)(2007-7#1)(2008-12#1)(2010-2#2)(2012-12#1)(2013-1#1)
the ability to potentiate##2##4##(2006-10#1)(2008-1#1)
the ability to predict##5##4##(1995-12#1)(2008-3#2)(2009-6#1)(2012-12#1)
the ability to prevent##3##4##(1997-8#1)(2006-10#1)(2008-5#1)
the ability to produce##13##4##(1992-3#1)(2005-12#1)(2006-12#1)(2007-11#1)(2008-10#7)(2008-4#1)(2012-2#1)
the ability to proliferate##3##4##(2008-11#2)(2012-12#1)
the ability to protect cells and##2##6##(1991-10#1)(1994-11#1)
the ability to provide##2##4##(2007-4#1)(2008-11#1)
the ability to reach##2##4##(1996-8#1)(2008-2#1)
the ability to recognize and##2##5##(2004-3#1)(2006-10#1)
the ability to recognize##5##4##(1991-2#1)(1994-3#1)(2004-3#1)(2006-10#1)(2008-5#1)
the ability to reduce##4##4##(1991-10#1)(2005-9#1)(2008-10#2)
the ability to regulate##2##4##(1995-8#1)(2011-2#1)
the ability to release##3##4##(2008-5#1)(2012-12#2)
the ability to reliably##2##4##(2009-3#1)(2012-3#1)
the ability to replicate##2##4##(1995-8#1)(1997-3#1)
the ability to resolve##3##4##(2008-3#1)(2008-7#1)(2008-9#1)
the ability to respond to##5##5##(1991-10#1)(1991-9#1)(1992-7#1)(2008-1#1)(2008-8#1)
the ability to reverse##3##4##(2008-1#1)(2012-1#1)(2012-12#1)
the ability to segment language##3##5##(2012-3#3)
the ability to segment##5##4##(1992-7#1)(2012-3#4)
the ability to select##3##4##(1994-5#1)(2008-2#1)(2009-10#1)
the ability to stimulate##3##4##(1996-11#1)(1996-12#1)(2012-11#1)
the ability to suppress the##2##5##(1996-12#1)(2011-2#1)
the ability to suppress##3##4##(1996-12#1)(2008-10#1)(2011-2#1)
the ability to survive##3##4##(2008-7#1)(2013-8#2)
the ability to synthesize##4##4##(1994-12#1)(2007-11#1)(2008-9#1)(2012-2#1)
the ability to tune##3##4##(2007-11#1)(2008-10#1)(2012-12#1)
the ability to understand and##2##5##(2010-11#1)(2013-1#1)
the ability to understand##3##4##(1993-1#1)(2010-11#1)(2013-1#1)
the ability to use##7##4##(2008-10#1)(2008-5#1)(2008-7#1)(2009-4#1)(2012-2#2)(2013-7#1)
the ability to visualize and##2##5##(2006-9#1)(2008-11#1)
the ability to visualize##4##4##(1997-6#1)(2006-9#2)(2008-11#1)
the ability to walk##5##4##(1996-9#2)(2007-10#1)(2007-11#1)(2012-2#1)
the ability to##548##3##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#1)(1990-8#1)(1991-10#3)(1991-11#2)(1991-12#2)(1991-2#1)(1991-8#2)(1991-9#2)(1992-10#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#3)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#7)(1994-2#1)(1994-3#4)(1994-5#5)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#2)(1995-5#4)(1995-6#1)(1995-7#1)(1995-8#6)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#6)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#3)(1997-1#2)(1997-2#2)(1997-3#2)(1997-5#2)(1997-6#4)(1997-7#2)(1997-8#2)(2004-3#1)(2005-11#1)(2005-12#2)(2005-7#4)(2005-9#1)(2006-1#1)(2006-10#10)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#4)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#5)(2007-1#1)(2007-10#2)(2007-11#14)(2007-12#12)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#4)(2008-1#14)(2008-10#50)(2008-11#16)(2008-12#5)(2008-2#10)(2008-3#12)(2008-4#12)(2008-5#8)(2008-6#1)(2008-7#18)(2008-8#8)(2008-9#14)(2009-10#4)(2009-11#2)(2009-12#2)(2009-2#3)(2009-3#3)(2009-4#9)(2009-5#1)(2009-6#5)(2009-7#2)(2009-8#6)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#7)(2010-2#5)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#12)(2012-1#8)(2012-11#1)(2012-12#14)(2012-2#14)(2012-3#11)(2012-5#1)(2013-1#20)(2013-7#3)(2013-8#4)
the ability##1140##2##(1990-10#1)(1990-11#5)(1990-12#7)(1990-2#4)(1990-3#2)(1990-4#3)(1990-5#7)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#6)(1991-1#2)(1991-10#3)(1991-11#2)(1991-12#5)(1991-2#7)(1991-3#1)(1991-5#2)(1991-8#3)(1991-9#4)(1992-10#3)(1992-11#5)(1992-12#6)(1992-2#3)(1992-3#3)(1992-4#3)(1992-6#3)(1992-7#5)(1992-8#6)(1992-9#4)(1993-1#1)(1993-11#5)(1993-12#4)(1993-2#2)(1993-3#3)(1993-4#4)(1993-5#4)(1993-6#3)(1993-7#3)(1993-8#2)(1993-9#7)(1994-10#2)(1994-11#8)(1994-12#14)(1994-2#4)(1994-3#7)(1994-5#6)(1994-6#7)(1994-8#6)(1994-9#9)(1995-1#6)(1995-10#4)(1995-11#8)(1995-12#4)(1995-2#9)(1995-3#10)(1995-5#9)(1995-6#7)(1995-7#1)(1995-8#15)(1995-9#2)(1996-1#2)(1996-10#3)(1996-11#4)(1996-12#11)(1996-2#4)(1996-3#7)(1996-4#2)(1996-5#4)(1996-7#3)(1996-8#7)(1996-9#4)(1997-1#5)(1997-2#8)(1997-3#3)(1997-5#9)(1997-6#7)(1997-7#8)(1997-8#6)(2004-11#1)(2004-3#1)(2004-9#1)(2005-11#4)(2005-12#2)(2005-7#7)(2005-9#3)(2006-1#1)(2006-10#18)(2006-11#4)(2006-12#9)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#7)(2006-6#2)(2006-7#5)(2006-8#7)(2006-9#5)(2007-1#1)(2007-10#4)(2007-11#19)(2007-12#19)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#4)(2007-7#8)(2007-8#6)(2007-9#6)(2008-1#16)(2008-10#103)(2008-11#36)(2008-12#8)(2008-2#16)(2008-3#19)(2008-4#35)(2008-5#35)(2008-6#2)(2008-7#30)(2008-8#19)(2008-9#24)(2009-1#1)(2009-10#5)(2009-11#3)(2009-12#3)(2009-2#5)(2009-3#4)(2009-4#13)(2009-5#5)(2009-6#6)(2009-7#5)(2009-8#7)(2009-9#7)(2010-1#3)(2010-10#4)(2010-11#3)(2010-12#11)(2010-2#9)(2010-3#2)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#6)(2010-9#3)(2011-1#10)(2011-12#1)(2011-2#21)(2012-1#10)(2012-11#2)(2012-12#23)(2012-2#20)(2012-3#17)(2012-5#1)(2013-1#23)(2013-7#3)(2013-8#15)
the abiotic environment##3##3##(2007-4#1)(2010-2#1)(2013-8#1)
the abiotic##8##2##(2007-4#1)(2008-10#2)(2008-8#1)(2009-6#1)(2010-2#1)(2013-7#1)(2013-8#1)
the ablated material##2##3##(2008-1#1)(2008-3#1)
the ablated##5##2##(1995-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)
the ablation and##2##3##(2006-8#1)(2011-2#1)
the ablation of##9##3##(1993-5#1)(1995-2#1)(1995-8#1)(1996-5#1)(2006-12#2)(2007-12#1)(2007-8#1)(2009-10#1)
the ablation##27##2##(1992-2#1)(1993-2#1)(1993-5#1)(1995-2#1)(1995-8#1)(1996-5#1)(2006-12#2)(2006-8#2)(2007-12#3)(2007-8#2)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#3)(2009-10#1)(2011-1#3)(2011-2#1)
the abnormal EF group##2##4##(2011-2#2)
the abnormal development of##2##4##(2008-4#1)(2012-2#1)
the abnormal endophenotype##2##3##(2010-2#2)
the abnormal or##2##3##(2007-7#1)(2008-8#1)
the abnormal##38##2##(1990-11#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-9#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-11#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-2#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-8#1)
the abnormalities in##4##3##(1990-6#1)(2006-4#2)(2013-1#1)
the abnormalities of##5##3##(1992-5#1)(2005-1#1)(2006-4#1)(2006-9#1)(2012-2#1)
the abnormalities##18##2##(1990-6#1)(1991-6#1)(1992-5#1)(1997-8#1)(2005-1#1)(2006-4#3)(2006-5#1)(2006-9#1)(2007-8#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#3)
the abnormality of the difference between##2##6##(2008-4#2)
the abnormality##6##2##(1996-1#1)(2008-4#2)(2011-2#3)
the abnormally##5##2##(1991-1#1)(1992-3#1)(1994-8#1)(1995-3#1)(2009-4#1)
the abolishment of a##2##4##(1992-1#1)(1997-1#1)
the abolishment of##3##3##(1992-1#1)(1993-3#1)(1997-1#1)
the abolition of##6##3##(1993-9#2)(1994-11#1)(1995-12#1)(1997-2#1)(2008-8#1)
the abolition##7##2##(1993-9#2)(1994-11#1)(1995-12#1)(1997-2#1)(2008-10#1)(2008-8#1)
the abomasum##6##2##(1991-8#1)(2010-2#1)(2011-2#4)
the abortion care seekers##2##4##(2007-3#2)
the abortion of##3##3##(2004-12#1)(2008-7#1)(2008-8#1)
the abortion##12##2##(1991-8#2)(1996-12#1)(1996-5#1)(2004-12#1)(2005-11#1)(2006-7#1)(2007-3#2)(2008-7#1)(2008-8#1)(2011-1#1)
the above compounds##3##3##(1991-6#1)(1994-3#1)(2004-2#1)
the above conditions##3##3##(2007-12#1)(2008-10#1)(2011-3#1)
the above effects##3##3##(1994-1#1)(2011-1#1)(2013-7#1)
the above factors##2##3##(1996-3#1)(2008-2#1)
the above findings##7##3##(1990-8#1)(1992-10#1)(1992-7#1)(1997-8#1)(2008-10#3)
the above five##2##3##(1995-1#1)(2009-7#1)
the above group##2##3##(1996-11#1)(2006-6#1)
the above information##2##3##(1993-5#1)(2009-11#1)
the above loci are##2##4##(1994-9#1)(2008-4#1)
the above mentioned chemical##2##4##(2008-10#1)(2010-2#1)
the above mentioned parameters##3##4##(1990-9#1)(2008-10#1)(2010-12#1)
the above mentioned##38##3##(1990-9#1)(1991-1#1)(1991-10#1)(1993-5#1)(1993-9#1)(1994-4#1)(1994-6#1)(1994-9#1)(1996-2#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-8#1)
the above method##2##3##(1991-6#1)(1997-2#1)
the above parameters and##2##4##(1996-1#1)(2008-8#1)
the above parameters in##2##4##(1995-9#1)(1996-5#1)
the above parameters##16##3##(1994-4#1)(1994-5#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-5#1)(2006-6#1)(2006-9#2)(2007-11#1)(2008-8#1)(2009-6#1)(2011-12#1)(2013-1#3)
the above procedure has been successfully employed for the analysis of##2##11##(2008-10#2)
the above procedure has been successfully employed for##3##8##(2008-10#3)
the above procedure##5##3##(1996-1#1)(2008-10#4)
the above questions##2##3##(1991-1#1)(1992-2#1)
the above reactions##2##3##(1994-9#1)(2008-11#1)
the above requirements##3##3##(2004-11#1)(2008-1#1)(2008-3#1)
the above results##7##3##(1991-12#1)(1993-12#1)(1994-3#1)(1994-8#1)(2008-10#2)(2012-2#1)
the above said##5##3##(1992-6#1)(2008-1#1)(2008-12#1)(2012-2#2)
the above samples##2##3##(1992-2#1)(1997-5#1)
the above sectors##2##3##(2007-10#2)
the above species##5##3##(2008-10#2)(2008-4#2)(2009-12#1)
the above substrates##2##3##(1990-7#1)(2005-11#1)
the above system##3##3##(1991-2#1)(2008-10#2)
the above techniques##2##3##(2008-2#1)(2010-3#1)
the above theory##2##3##(2008-1#1)(2008-2#1)
the above three##5##3##(1995-1#1)(2007-11#1)(2008-10#1)(2008-5#1)(2011-1#1)
the above two##9##3##(1991-5#1)(1992-4#1)(1995-11#1)(1995-4#1)(2005-8#1)(2008-4#1)(2009-11#1)(2010-5#1)(2012-2#1)
the above##297##2##(1990-11#3)(1990-12#2)(1990-4#4)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#5)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-3#1)(1993-5#3)(1993-6#1)(1993-9#1)(1994-1#1)(1994-3#4)(1994-4#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#5)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#2)(1995-5#2)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-11#1)(2004-2#1)(2004-4#1)(2004-9#3)(2005-1#2)(2005-11#2)(2005-7#1)(2005-8#2)(2006-10#2)(2006-12#2)(2006-5#2)(2006-6#9)(2006-9#2)(2007-1#2)(2007-10#3)(2007-11#3)(2007-12#3)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#5)(2008-10#45)(2008-11#6)(2008-12#4)(2008-2#12)(2008-3#3)(2008-4#5)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#2)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#7)
the above-ground##3##2##(2004-4#1)(2007-1#1)(2011-2#1)
the above-mentioned result##2##3##(2007-12#1)(2008-1#1)
the above-mentioned##41##2##(1991-10#1)(1992-4#1)(1992-9#1)(1993-3#1)(1993-7#1)(1995-1#1)(1995-6#1)(1997-5#1)(1997-7#2)(1997-8#2)(2004-10#1)(2005-11#1)(2006-11#1)(2006-12#3)(2006-6#2)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#2)(2009-2#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)
the abovementioned##4##2##(2008-10#2)(2008-3#1)(2011-2#1)
the abrasion##2##2##(2007-3#1)(2008-10#1)
the abrasives##2##2##(2008-5#2)
the abrupt occurrence of##2##4##(1990-11#1)(1992-1#1)
the abrupt##5##2##(1990-11#1)(1992-1#1)(1995-6#1)(2008-11#1)(2010-10#1)
the abscess and##4##3##(1993-1#1)(1993-9#1)(2013-8#2)
the abscess##13##2##(1992-12#1)(1993-1#1)(1993-9#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-9#1)(2010-12#2)(2013-8#4)
the abscesses##2##2##(1994-7#1)(2010-4#1)
the abscissa##3##2##(2008-10#3)
the absence and presence of##34##5##(1990-11#1)(1990-3#1)(1990-8#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-6#1)(1993-3#2)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-6#1)(1996-7#3)(1997-1#1)(1997-6#1)(2005-11#2)(2008-10#3)(2008-11#1)(2008-4#2)(2008-7#2)(2011-2#2)(2012-5#1)
the absence and presence##35##4##(1990-11#1)(1990-3#1)(1990-8#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-6#1)(1993-3#2)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#3)(1997-1#1)(1997-6#1)(2005-11#2)(2008-10#3)(2008-11#1)(2008-4#2)(2008-7#2)(2011-2#2)(2012-5#1)
the absence and the presence of##7##6##(1990-2#1)(1991-12#1)(1993-9#1)(1995-5#1)(1996-5#1)(1997-4#1)(2010-5#1)
the absence and##51##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-6#1)(1991-8#1)(1992-6#1)(1993-3#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-5#2)(1996-6#1)(1996-7#3)(1997-1#1)(1997-4#1)(1997-6#1)(2005-11#3)(2006-10#1)(2008-10#4)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2010-5#1)(2011-2#2)(2012-5#1)
the absence of &quot##2##4##(1995-5#1)(2007-3#1)
the absence of 1##2##4##(1990-9#1)(2006-12#1)
the absence of ATP##9##4##(1990-5#1)(1990-8#1)(1993-6#1)(1993-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-4#1)
the absence of CYP1A induction##3##5##(2008-10#3)
the absence of Ca2+##18##4##(1990-11#1)(1990-7#2)(1991-1#1)(1991-12#1)(1991-4#1)(1991-9#2)(1992-1#1)(1992-2#1)(1992-6#1)(1992-8#1)(1994-12#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-1#1)
the absence of Dgp71WD leads to defects in the assembly of the acentrosomal female Meiosis I spindle that are more severe than those seen in Augmin or γ-TuRC mutants##2##29##(2012-12#2)
the absence of Lyn##2##4##(1996-5#2)
the absence of Mg2+##5##4##(1991-2#1)(1993-6#1)(1994-12#1)(1995-3#1)(1997-6#1)
the absence of O2##2##4##(1992-12#1)(1995-6#1)
the absence of TTR##2##4##(1994-12#2)
the absence of a clear##3##5##(1991-5#1)(2005-8#1)(2010-1#1)
the absence of a history of insecticide##2##7##(2006-4#1)(2011-2#1)
the absence of a male##2##5##(2009-4#2)
the absence of a significant##2##5##(1996-1#1)(1997-4#1)
the absence of a##83##4##(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-2#1)(1992-3#1)(1992-5#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-2#2)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-5#2)(1997-4#2)(1997-5#1)(1997-7#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-10#1)(2007-12#3)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#4)(2008-3#1)(2008-6#3)(2008-8#3)(2008-9#3)(2009-4#3)(2009-5#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#2)
the absence of abdominal##2##4##(2005-10#1)(2008-8#1)
the absence of added##10##4##(1990-11#1)(1992-5#1)(1993-12#1)(1994-12#1)(1994-8#1)(1996-2#1)(1996-3#1)(1997-8#1)(2005-11#1)(2008-10#1)
the absence of additional##3##4##(1990-12#1)(1991-7#1)(2007-12#1)
the absence of adequate##3##4##(2004-11#1)(2006-12#1)(2006-3#1)
the absence of aminoacylation##3##4##(1997-3#3)
the absence of an##20##4##(1990-3#1)(1991-2#2)(1991-6#1)(1993-2#1)(1994-9#1)(1996-12#1)(1997-6#1)(2007-1#1)(2007-11#3)(2008-2#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)
the absence of any other##4##5##(1990-2#1)(1992-9#1)(2007-12#1)(2008-8#1)
the absence of any##48##4##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-8#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-8#1)(2006-10#1)(2006-8#2)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-7#1)(2010-10#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#3)
the absence of apoptosis##2##4##(2008-11#1)(2012-1#1)
the absence of appropriate##2##4##(1990-5#1)(1993-11#1)
the absence of calcification##3##4##(1993-4#3)
the absence of calmodulin##2##4##(1994-9#1)(1997-1#1)
the absence of clinical##4##4##(2006-10#1)(2008-6#1)(2008-7#1)(2013-8#1)
the absence of competitive##2##4##(1992-2#1)(2008-8#1)
the absence of controlled##2##4##(2006-10#1)(2012-1#1)
the absence of coronary artery disease##2##6##(1991-7#1)(2011-2#1)
the absence of data from##2##5##(2008-10#1)(2008-4#1)
the absence of data##4##4##(2008-10#1)(2008-4#1)(2008-9#2)
the absence of detectable##7##4##(1990-12#1)(1992-6#1)(1995-6#1)(1996-1#1)(2008-10#1)(2012-3#1)(2013-8#1)
the absence of direct##5##4##(1992-6#1)(2008-7#1)(2010-12#1)(2012-11#2)
the absence of divalent##8##4##(1990-2#1)(1991-2#2)(1995-1#2)(1995-2#1)(1995-5#1)(1997-5#1)
the absence of either##3##4##(1994-5#1)(1996-5#1)(2006-10#1)
the absence of estrogen##2##4##(1997-7#1)(2008-6#1)
the absence of evidence##3##4##(1997-1#1)(2006-9#1)(2008-7#1)
the absence of exogenous##6##4##(1990-2#1)(1991-12#1)(1994-8#1)(2006-10#1)(2008-11#1)(2012-3#1)
the absence of external Ca2+##4##5##(1990-7#1)(1993-12#2)(1997-5#1)
the absence of external##11##4##(1990-5#1)(1990-7#1)(1993-12#2)(1993-3#1)(1996-9#1)(1997-5#1)(2008-10#1)(2008-4#2)(2012-2#1)
the absence of extracellular calcium##3##5##(1990-5#1)(1990-7#1)(1995-11#1)
the absence of extracellular##8##4##(1990-5#1)(1990-6#1)(1990-7#1)(1992-3#1)(1992-4#1)(1995-11#1)(1997-4#1)(1997-6#1)
the absence of functional##4##4##(1993-10#1)(1993-7#1)(1995-12#1)(2009-8#1)
the absence of glucose in##3##5##(1991-5#1)(1995-8#1)(2009-10#1)
the absence of glucose##4##4##(1991-5#1)(1995-8#2)(2009-10#1)
the absence of glutamine##2##4##(2008-11#2)
the absence of gross##4##4##(1991-12#1)(1994-2#1)(2008-10#1)(2013-8#1)
the absence of hemin##2##4##(1994-5#2)
the absence of hormone##3##4##(1994-11#1)(1996-12#1)(2007-6#1)
the absence of insulin receptors##2##5##(1993-7#1)(2008-1#1)
the absence of iron##2##4##(1995-6#1)(2008-8#1)
the absence of large##2##4##(1992-3#1)(1994-6#1)
the absence of ligand##6##4##(1990-8#1)(1993-8#1)(1994-12#2)(1995-10#1)(1996-11#1)
the absence of light##5##4##(1991-10#1)(1993-8#1)(1994-5#1)(1994-8#1)(2009-8#1)
the absence of local##2##4##(2005-12#1)(2007-8#1)
the absence of long-term##2##4##(1997-4#1)(2009-8#1)
the absence of nerve growth factor##2##6##(1993-5#1)(2008-11#1)
the absence of neurological##2##4##(1992-7#1)(2007-8#1)
the absence of nuclear##2##4##(2005-8#1)(2008-9#1)
the absence of other##13##4##(1991-12#1)(1991-3#1)(2007-12#1)(2007-8#1)(2008-4#4)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#2)
the absence of salt##3##4##(1990-2#1)(1990-5#1)(1994-8#1)
the absence of scattering##2##4##(2008-3#1)(2008-7#1)
the absence of scientific##2##4##(2006-4#1)(2008-9#1)
the absence of selection##3##4##(1990-3#1)(1997-5#2)
the absence of selenium##2##4##(2008-10#1)(2008-7#1)
the absence of serum##9##4##(1990-11#1)(1991-10#1)(1991-5#1)(1993-9#1)(1996-2#1)(2008-11#4)
the absence of sex##2##4##(1996-5#1)(2010-3#1)
the absence of significant##5##4##(1997-4#1)(2007-11#1)(2008-10#2)(2009-10#1)
the absence of specific##5##4##(1992-9#1)(2006-4#1)(2007-1#1)(2007-8#1)(2008-9#1)
the absence of stimuli##2##4##(2008-2#1)(2013-8#1)
the absence of stress##2##4##(2007-11#1)(2010-4#1)
the absence of substrate##2##4##(1996-7#1)(2011-1#1)
the absence of such##7##4##(1991-12#1)(1991-2#1)(1994-8#1)(2004-4#1)(2008-10#1)(2008-11#1)(2013-8#1)
the absence of systemic##3##4##(2006-2#1)(2007-12#1)(2007-8#1)
the absence of the first##2##5##(1990-10#1)(1996-5#1)
the absence of the##88##4##(1990-10#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-7#1)(1990-8#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-3#2)(1992-9#1)(1993-12#1)(1993-2#3)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#3)(1996-10#1)(1996-5#3)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-1#1)(2007-11#1)(2007-12#2)(2007-7#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#2)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
the absence of these##6##4##(1993-8#1)(1994-8#1)(1995-2#1)(2008-11#1)(2009-10#1)(2011-1#1)
the absence of this##5##4##(1990-11#1)(1991-3#1)(1993-5#1)(1994-8#1)(1995-12#1)
the absence of traditional##2##4##(2007-10#1)(2007-3#1)
the absence of tumor##2##4##(1991-10#1)(1994-3#1)
the absence of visible##2##4##(2008-10#1)(2013-1#1)
the absence of##1179##3##(1990-10#5)(1990-11#14)(1990-12#9)(1990-2#9)(1990-3#7)(1990-4#4)(1990-5#10)(1990-6#6)(1990-7#10)(1990-8#11)(1990-9#2)(1991-1#4)(1991-10#6)(1991-11#2)(1991-12#10)(1991-2#15)(1991-3#4)(1991-4#4)(1991-5#9)(1991-6#6)(1991-7#5)(1991-8#5)(1991-9#9)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#5)(1992-2#5)(1992-3#8)(1992-4#4)(1992-5#2)(1992-6#5)(1992-7#4)(1992-8#5)(1992-9#9)(1993-1#1)(1993-10#1)(1993-11#4)(1993-12#8)(1993-2#5)(1993-3#4)(1993-4#3)(1993-5#3)(1993-6#13)(1993-7#3)(1993-8#10)(1993-9#7)(1994-11#7)(1994-12#16)(1994-2#4)(1994-3#7)(1994-5#9)(1994-6#9)(1994-8#12)(1994-9#12)(1995-1#6)(1995-10#6)(1995-11#6)(1995-12#7)(1995-2#12)(1995-3#17)(1995-4#2)(1995-5#8)(1995-6#11)(1995-7#1)(1995-8#13)(1995-9#1)(1996-1#8)(1996-10#3)(1996-11#3)(1996-12#3)(1996-2#6)(1996-3#3)(1996-4#1)(1996-5#19)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#12)(1997-2#3)(1997-3#6)(1997-4#16)(1997-5#12)(1997-6#7)(1997-7#8)(1997-8#7)(2004-11#2)(2004-2#1)(2004-4#1)(2005-10#4)(2005-11#13)(2005-12#2)(2005-5#1)(2005-7#3)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#20)(2006-11#2)(2006-12#5)(2006-2#3)(2006-3#2)(2006-4#4)(2006-5#2)(2006-6#3)(2006-8#4)(2006-9#2)(2007-1#4)(2007-10#6)(2007-11#9)(2007-12#16)(2007-3#6)(2007-4#1)(2007-5#3)(2007-6#4)(2007-7#7)(2007-8#14)(2007-9#4)(2008-1#9)(2008-10#79)(2008-11#37)(2008-12#3)(2008-2#9)(2008-3#17)(2008-4#17)(2008-5#16)(2008-6#9)(2008-7#15)(2008-8#28)(2008-9#22)(2009-1#1)(2009-10#7)(2009-11#4)(2009-2#4)(2009-3#1)(2009-4#4)(2009-5#4)(2009-6#5)(2009-7#2)(2009-8#8)(2009-9#4)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#8)(2010-2#3)(2010-3#3)(2010-4#5)(2010-5#8)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#9)(2011-12#1)(2011-2#22)(2012-1#4)(2012-11#2)(2012-12#11)(2012-2#17)(2012-3#9)(2012-7#1)(2013-1#18)(2013-7#5)(2013-8#12)
the absence or presence of##22##5##(1990-7#1)(1990-9#1)(1991-3#1)(1992-12#1)(1992-9#1)(1993-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-11#1)(2008-9#1)(2011-2#3)(2013-7#1)
the absence or the presence of##2##6##(1994-8#1)(1995-8#1)
the absence or the##3##4##(1994-8#1)(1995-8#1)(2005-5#1)
the absence or##31##3##(1990-2#1)(1990-7#1)(1990-9#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#1)(1997-4#1)(1997-6#1)(2005-5#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-6#1)(2011-2#3)(2013-7#1)
the absence##1280##2##(1990-10#5)(1990-11#15)(1990-12#9)(1990-2#11)(1990-3#9)(1990-4#4)(1990-5#11)(1990-6#6)(1990-7#11)(1990-8#12)(1990-9#3)(1991-1#4)(1991-10#6)(1991-11#2)(1991-12#12)(1991-2#18)(1991-3#5)(1991-4#5)(1991-5#9)(1991-6#7)(1991-7#5)(1991-8#6)(1991-9#10)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#6)(1992-2#6)(1992-3#9)(1992-4#4)(1992-5#2)(1992-6#6)(1992-7#4)(1992-8#5)(1992-9#10)(1993-1#1)(1993-10#1)(1993-11#4)(1993-12#8)(1993-2#5)(1993-3#7)(1993-4#3)(1993-5#3)(1993-6#13)(1993-7#3)(1993-8#10)(1993-9#10)(1994-11#9)(1994-12#17)(1994-2#4)(1994-3#7)(1994-5#9)(1994-6#11)(1994-8#13)(1994-9#13)(1995-1#7)(1995-10#6)(1995-11#6)(1995-12#8)(1995-2#13)(1995-3#17)(1995-4#2)(1995-5#10)(1995-6#13)(1995-7#2)(1995-8#16)(1995-9#1)(1996-1#9)(1996-10#3)(1996-11#3)(1996-12#4)(1996-2#6)(1996-3#3)(1996-4#1)(1996-5#22)(1996-6#3)(1996-7#4)(1996-8#3)(1996-9#2)(1997-1#13)(1997-2#3)(1997-3#6)(1997-4#18)(1997-5#12)(1997-6#10)(1997-7#10)(1997-8#7)(2004-11#2)(2004-2#1)(2004-4#1)(2005-10#4)(2005-11#16)(2005-12#2)(2005-5#2)(2005-7#3)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#21)(2006-11#2)(2006-12#5)(2006-2#3)(2006-3#2)(2006-4#4)(2006-5#3)(2006-6#3)(2006-8#4)(2006-9#2)(2007-1#4)(2007-10#6)(2007-11#10)(2007-12#16)(2007-3#6)(2007-4#1)(2007-5#3)(2007-6#4)(2007-7#7)(2007-8#14)(2007-9#4)(2008-1#9)(2008-10#84)(2008-11#40)(2008-12#4)(2008-2#9)(2008-3#17)(2008-4#20)(2008-5#18)(2008-6#9)(2008-7#17)(2008-8#29)(2008-9#23)(2009-1#1)(2009-10#7)(2009-11#4)(2009-2#4)(2009-3#1)(2009-4#4)(2009-5#4)(2009-6#6)(2009-7#2)(2009-8#8)(2009-9#4)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#8)(2010-2#3)(2010-3#3)(2010-4#5)(2010-5#9)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#9)(2011-12#1)(2011-2#28)(2012-1#4)(2012-11#2)(2012-12#11)(2012-2#17)(2012-3#9)(2012-5#1)(2012-7#1)(2013-1#18)(2013-7#6)(2013-8#12)
the absolute EC50/IC50##2##3##(2012-2#2)
the absolute absorptance of##2##4##(2008-2#2)
the absolute amount of##4##4##(1990-12#1)(1990-8#1)(1991-2#1)(1997-2#1)
the absolute amounts of##3##4##(1996-3#1)(2005-11#1)(2008-8#1)
the absolute amounts##4##3##(1996-12#1)(1996-3#1)(2005-11#1)(2008-8#1)
the absolute and relative##7##4##(1992-4#1)(1997-4#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-6#1)
the absolute and##9##3##(1992-4#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-6#1)(2012-3#1)
the absolute calibration##2##3##(2008-2#1)(2008-3#1)
the absolute cardiovascular risk##2##4##(2008-3#2)
the absolute concentration of##4##4##(2005-11#1)(2008-10#2)(2008-5#1)
the absolute configuration of the##2##5##(1992-12#1)(2008-10#1)
the absolute configuration of##6##4##(1992-12#1)(2006-12#3)(2008-10#1)(2009-10#1)
the absolute configuration##7##3##(1992-12#1)(2006-12#4)(2008-10#1)(2009-10#1)
the absolute levels of##3##4##(1992-4#1)(1994-3#1)(1995-12#1)
the absolute number of##8##4##(1991-3#1)(1993-1#1)(2007-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-7#1)
the absolute number##10##3##(1991-3#1)(1993-1#1)(2007-11#1)(2007-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-1#1)(2013-7#1)
the absolute numbers##2##3##(1991-10#1)(1996-3#1)
the absolute phase shift##2##4##(2008-2#1)(2008-8#1)
the absolute phase##5##3##(2007-12#1)(2008-2#1)(2008-3#2)(2008-8#1)
the absolute requirement##2##3##(1991-9#1)(1995-8#1)
the absolute risk reductions were##3##5##(2011-11#3)
the absolute risk reductions##4##4##(2011-11#4)
the absolute risk##6##3##(2008-9#1)(2010-12#1)(2011-11#4)
the absolute stereochemistry of##2##4##(1997-2#1)(2010-12#1)
the absolute stereochemistry##3##3##(1995-3#1)(1997-2#1)(2010-12#1)
the absolute value of the##5##5##(2007-1#1)(2007-12#1)(2008-3#3)
the absolute values of the##3##5##(1997-2#1)(2008-3#1)(2008-6#1)
the absolute values of##5##4##(1993-12#2)(1997-2#1)(2008-3#1)(2008-6#1)
the absolute wavelength##2##3##(2008-3#2)
the absolute##149##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-10#3)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-4#2)(1992-6#2)(1993-1#1)(1993-10#1)(1993-12#2)(1993-5#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-3#2)(1996-4#1)(1996-9#1)(1997-2#3)(1997-4#2)(1997-5#1)(2004-11#1)(2004-4#1)(2005-10#1)(2005-11#2)(2006-10#3)(2006-12#4)(2007-1#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#14)(2008-3#25)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-6#1)(2011-11#4)(2011-3#2)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
the absolutely conserved##2##3##(1994-8#1)(1995-6#1)
the absorbance and fluorescence spectra were##2##6##(2008-10#2)
the absorbance and fluorescence##3##4##(2008-10#3)
the absorbance and the fluorescence##2##5##(1992-8#1)(2006-10#1)
the absorbance and##6##3##(1992-8#1)(2006-10#1)(2008-10#4)
the absorbance as##2##3##(2007-12#1)(2008-10#1)
the absorbance at##9##3##(1990-9#1)(1995-3#1)(2006-10#1)(2008-10#6)
the absorbance change##2##3##(1990-12#1)(2008-10#1)
the absorbance data##2##3##(2008-10#2)
the absorbance increased##2##3##(2007-8#1)(2008-10#1)
the absorbance of MB##2##4##(2008-10#2)
the absorbance of the dye##2##5##(2008-10#2)
the absorbance of the formed##2##5##(2008-10#2)
the absorbance of the##21##4##(2005-4#1)(2007-8#1)(2008-10#19)
the absorbance of##33##3##(2005-4#1)(2007-8#1)(2008-10#30)(2011-1#1)
the absorbance spectra##4##3##(2008-6#4)
the absorbance values and##2##4##(2008-10#2)
the absorbance values##4##3##(2005-11#1)(2008-10#3)
the absorbance versus the##2##4##(2008-10#2)
the absorbance versus##4##3##(2008-10#4)
the absorbance##93##2##(1990-12#1)(1990-9#1)(1991-12#1)(1992-8#1)(1995-3#1)(1997-1#1)(2005-11#1)(2005-4#2)(2006-10#2)(2007-12#1)(2007-8#2)(2008-10#68)(2008-2#2)(2008-3#1)(2008-6#4)(2008-8#1)(2011-1#2)(2013-1#1)
the absorbances##2##2##(2008-10#2)
the absorbed dose##3##3##(2008-10#1)(2008-2#1)(2013-7#1)
the absorbed pump power##8##4##(2007-11#2)(2007-12#5)(2008-3#1)
the absorbed pump##9##3##(2007-11#2)(2007-12#5)(2008-3#2)
the absorbed##19##2##(1996-8#1)(2007-11#3)(2007-12#6)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2011-1#1)(2013-7#1)
the absorbent##4##2##(2008-10#3)(2008-5#1)
the absorber and##3##3##(2007-12#1)(2008-2#2)
the absorber##8##2##(2007-12#2)(2008-2#3)(2008-3#2)(2012-2#1)
the absorbing medium is##2##4##(2008-3#2)
the absorbing medium##5##3##(2007-12#1)(2008-3#4)
the absorbing solution##3##3##(2008-10#3)
the absorbing structures in the##2##5##(2007-12#1)(2008-3#1)
the absorbing##14##2##(2007-11#1)(2007-12#3)(2008-10#4)(2008-2#1)(2008-3#5)
the absorption and backscattering coefficients##4##5##(2008-2#2)(2008-3#2)
the absorption and emission##3##4##(1996-8#1)(2008-7#1)(2010-5#1)
the absorption and reduced scattering coefficients of##2##7##(2008-3#2)
the absorption and reduced scattering coefficients##4##6##(2007-11#1)(2008-3#3)
the absorption and scattering coefficients of##3##6##(2007-11#1)(2008-2#1)(2008-3#1)
the absorption and scattering coefficients##7##5##(2007-11#1)(2008-2#2)(2008-3#4)
the absorption and scattering properties of##2##6##(2008-3#1)(2013-1#1)
the absorption and scattering##11##4##(2007-11#1)(2008-2#3)(2008-3#5)(2009-12#1)(2013-1#1)
the absorption and the reduced scattering coefficients##4##7##(2007-12#1)(2008-2#1)(2008-3#2)
the absorption and the reduced-scattering coefficients of##2##7##(2008-2#2)
the absorption and the transport scattering##2##6##(2008-2#1)(2008-3#1)
the absorption and the##10##4##(1997-6#1)(2007-12#1)(2008-2#4)(2008-3#3)(2013-8#1)
the absorption and##42##3##(1992-8#1)(1994-11#1)(1996-8#1)(1997-6#1)(2006-10#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#10)(2008-3#15)(2008-5#1)(2008-7#2)(2009-12#1)(2010-5#1)(2013-1#1)(2013-8#1)
the absorption at##3##3##(2005-4#1)(2007-12#1)(2008-10#1)
the absorption band of##2##4##(2008-10#1)(2010-4#1)
the absorption band##8##3##(1994-11#1)(2007-11#1)(2008-10#2)(2008-2#2)(2010-4#1)(2010-7#1)
the absorption bands at##2##4##(2008-10#1)(2008-3#1)
the absorption bands##8##3##(1991-7#1)(2005-4#1)(2006-12#1)(2008-10#1)(2008-3#2)(2010-2#1)(2010-4#1)
the absorption changes##2##3##(1997-3#1)(2008-10#1)
the absorption coefficient a##2##4##(2008-2#1)(2008-3#1)
the absorption coefficient and##5##4##(2008-2#3)(2008-3#2)
the absorption coefficient has##2##4##(2008-3#2)
the absorption coefficient is##4##4##(2008-2#1)(2008-3#3)
the absorption coefficient of pulsed##3##5##(2008-2#3)
the absorption coefficient of the##4##5##(2007-12#1)(2008-2#1)(2008-3#2)
the absorption coefficient of##13##4##(2007-12#1)(2008-2#7)(2008-3#5)
the absorption coefficient##48##3##(2007-11#2)(2007-12#7)(2008-2#16)(2008-3#23)
the absorption coefficients of##4##4##(2007-12#1)(2008-3#3)
the absorption coefficients##7##3##(2007-12#1)(2008-2#2)(2008-3#4)
the absorption cross section of##2##5##(2008-2#2)
the absorption cross section##7##4##(2007-11#1)(2008-2#3)(2008-3#3)
the absorption cross##8##3##(2007-11#1)(2008-2#4)(2008-3#3)
the absorption distribution##3##3##(2008-3#3)
the absorption edge##3##3##(2008-2#3)
the absorption edges of##2##4##(2005-11#1)(2006-4#1)
the absorption effect##2##3##(2008-2#2)
the absorption efficiency and single-scattering albedo of##3##7##(2008-3#3)
the absorption efficiency##4##3##(2008-3#3)(2013-1#1)
the absorption field##2##3##(2008-3#2)
the absorption grating##2##3##(2007-12#1)(2008-3#1)
the absorption in the##2##4##(2008-2#1)(2009-11#1)
the absorption in##3##3##(2008-2#1)(2008-3#1)(2009-11#1)
the absorption index##2##3##(2008-10#1)(2008-3#1)
the absorption is##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
the absorption line shape##2##4##(2007-12#1)(2008-2#1)
the absorption line##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
the absorption lines##2##3##(2008-2#1)(2008-3#1)
the absorption loss of##2##4##(2008-3#2)
the absorption maximum of##3##4##(2008-10#1)(2008-8#2)
the absorption maximum##7##3##(1990-3#1)(1994-5#2)(2008-10#2)(2008-8#2)
the absorption minimum is##2##4##(2008-2#2)
the absorption of Hct##2##4##(2011-3#2)
the absorption of a##2##4##(2007-12#1)(2008-10#1)
the absorption of the defect##2##5##(2007-11#2)
the absorption of the##11##4##(1993-11#1)(2006-10#2)(2007-11#3)(2007-8#1)(2008-2#2)(2008-3#2)
the absorption of##42##3##(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-4#1)(1993-11#1)(1994-9#1)(1997-1#1)(2005-10#1)(2005-4#1)(2006-10#2)(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#3)(2008-3#6)(2008-5#2)(2008-8#2)(2010-12#1)(2011-3#5)
the absorption optical depth##2##4##(2008-2#2)
the absorption peak of which was##3##6##(2007-8#3)
the absorption peak of##4##4##(2007-8#3)(2008-8#1)
the absorption peak##7##3##(2005-11#1)(2007-11#1)(2007-8#3)(2008-8#1)(2013-8#1)
the absorption peaks of##2##4##(2008-10#1)(2008-8#1)
the absorption properties of##2##4##(2007-12#1)(2008-2#1)
the absorption properties##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
the absorption rate##2##3##(2004-12#1)(2007-12#1)
the absorption signal##3##3##(2008-10#2)(2008-3#1)
the absorption spectra by##3##4##(2005-11#1)(2008-3#2)
the absorption spectra of the##6##5##(2007-12#2)(2008-10#4)
the absorption spectra of##13##4##(2007-12#2)(2008-1#1)(2008-10#8)(2008-9#1)(2011-1#1)
the absorption spectra##22##3##(2005-11#2)(2007-12#2)(2008-1#1)(2008-10#9)(2008-2#2)(2008-3#3)(2008-8#1)(2008-9#1)(2011-1#1)
the absorption spectrum and##2##4##(2005-4#1)(2008-5#1)
the absorption spectrum of a##3##5##(1992-3#1)(2007-12#2)
the absorption spectrum of pure water##3##6##(2008-2#2)(2008-3#1)
the absorption spectrum of the##3##5##(1994-2#1)(1994-9#1)(2008-10#1)
the absorption spectrum of##15##4##(1991-7#1)(1992-3#1)(1994-2#1)(1994-9#1)(2006-10#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#1)
the absorption spectrum##24##3##(1991-7#1)(1991-9#1)(1992-3#1)(1994-2#1)(1994-9#1)(2005-4#1)(2006-10#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#2)(2008-5#2)(2008-8#1)
the absorption that is due to##2##6##(2008-2#1)(2008-3#1)
the absorption wavelengths in the ultraviolet##2##6##(2008-2#1)(2008-3#1)
the absorption##329##2##(1990-12#1)(1990-3#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-7#2)(1991-9#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-11#1)(1994-11#2)(1994-2#1)(1994-5#2)(1994-9#2)(1996-8#2)(1997-1#1)(1997-3#2)(1997-4#1)(1997-6#2)(2004-12#1)(2005-10#1)(2005-11#4)(2005-4#5)(2006-10#4)(2006-12#1)(2006-4#1)(2007-11#17)(2007-12#24)(2007-8#4)(2008-1#5)(2008-10#32)(2008-11#4)(2008-2#69)(2008-3#86)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#8)(2008-9#1)(2009-11#1)(2009-12#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-3#6)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
the absorptive##4##2##(2007-11#2)(2007-12#1)(2008-10#1)
the abstract##5##2##(1992-2#1)(2008-11#1)(2009-4#3)
the abstracted C(2)-hydron##2##3##(1995-10#2)
the abstractness of children's##2##4##(2008-2#2)
the abstracts of##2##3##(2013-1#1)(2013-8#1)
the abstracts##4##2##(2008-5#1)(2010-12#1)(2013-1#1)(2013-8#1)
the abundance and diversity##2##4##(2008-10#1)(2013-7#1)
the abundance and##7##3##(1996-7#1)(2006-5#1)(2008-10#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-7#1)
the abundance of glutamate receptors (GluRs)##2##6##(2012-12#2)
the abundance of mRNA encoding##2##5##(1990-8#2)
the abundance of the##6##4##(1994-6#1)(2007-3#1)(2008-9#1)(2010-10#1)(2013-1#1)(2013-7#1)
the abundance of##60##3##(1990-11#1)(1990-3#1)(1990-8#2)(1991-4#1)(1991-7#1)(1994-11#2)(1994-2#3)(1994-5#1)(1994-6#1)(1995-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-12#2)(2007-3#2)(2007-6#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#5)(2009-4#1)(2009-6#1)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#2)
the abundance of C##2##3##(2012-3#2)
the abundance##76##2##(1990-11#1)(1990-3#1)(1990-8#2)(1991-4#1)(1991-7#1)(1994-11#2)(1994-2#3)(1994-5#2)(1994-6#1)(1995-3#1)(1996-7#1)(1997-4#1)(1997-6#2)(1997-8#1)(2006-12#1)(2006-5#1)(2007-12#2)(2007-3#2)(2007-6#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#5)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#4)(2013-8#2)
the abundances of##5##3##(1990-8#1)(1994-2#1)(2007-5#1)(2008-9#1)(2011-2#1)
the abundances##6##2##(1990-8#1)(1994-2#1)(2007-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
the abundant presence##2##3##(2007-12#1)(2008-5#1)
the abundant##20##2##(1990-5#1)(1990-9#1)(1991-1#1)(1991-11#1)(1992-12#1)(1994-9#1)(1997-2#1)(2006-12#3)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2009-8#1)(2010-4#1)(2012-2#1)
the abuse of prescription##2##4##(2008-3#1)(2012-1#1)
the abuse of##7##3##(1993-12#1)(2008-3#2)(2010-11#1)(2010-4#1)(2010-7#1)(2012-1#1)
the abuse##15##2##(1993-12#1)(1993-5#1)(2006-4#1)(2008-3#3)(2008-4#2)(2010-11#1)(2010-4#1)(2010-7#1)(2010-9#1)(2012-1#1)(2012-3#2)
the abused##2##2##(1995-5#1)(2006-7#1)
the abuser##2##2##(2006-7#1)(2010-3#1)
the abusers##6##2##(1990-2#1)(1993-12#1)(1993-5#2)(1996-5#1)(2010-3#1)
the abyss##3##2##(1992-1#1)(1993-2#1)(1995-1#1)
the ac##6##2##(2006-12#2)(2007-12#2)(2008-3#1)(2008-5#1)
the academic and research##2##4##(1996-12#1)(2013-1#1)
the academic and##4##3##(1996-12#1)(2006-12#1)(2009-4#1)(2013-1#1)
the academic cancer##2##3##(2009-4#2)
the academic community##3##3##(1990-2#1)(1996-1#1)(2008-10#1)
the academic engagement##2##3##(2008-12#2)
the academic performance and##2##4##(2013-8#2)
the academic performance##8##3##(2013-8#8)
the academic world##2##3##(2009-10#1)(2009-11#1)
the academic##43##2##(1990-2#2)(1991-8#1)(1993-6#1)(1994-12#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-2#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-12#4)(2008-4#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#4)(2010-1#1)(2011-1#1)(2012-1#2)(2012-3#2)(2013-1#1)(2013-8#8)
the academy##3##2##(1991-1#1)(2004-3#1)(2011-2#1)
the accelerated atherosclerosis##2##3##(1997-7#1)(2008-1#1)
the accelerated decline in lung function##2##6##(1991-10#1)(2010-5#1)
the accelerated failure time model##2##5##(2008-10#2)
the accelerated##15##2##(1991-10#1)(1995-8#1)(1997-7#1)(2005-7#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-5#2)(2010-5#1)(2011-1#1)(2012-2#1)(2013-7#1)
the accelerating effect of##4##4##(1996-10#1)(2008-10#2)(2008-11#1)
the accelerating##7##2##(1996-10#1)(1996-4#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-3#1)
the acceleration of##8##3##(1996-2#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-12#1)
the acceleration##17##2##(1994-12#1)(1994-9#1)(1996-2#1)(1996-5#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2012-12#3)(2013-8#1)
the accelerator head##2##3##(2008-3#1)(2009-10#1)
the accelerator##4##2##(2008-3#2)(2009-10#1)(2009-11#1)
the accelerometer##4##2##(2007-4#1)(2008-2#2)(2013-1#1)
the accentuation principle##2##3##(2012-2#2)
the accentuation##4##2##(1997-2#1)(2012-2#3)
the acceptability and##4##3##(2009-11#1)(2010-10#1)(2013-1#2)
the acceptability of the##4##4##(2007-9#1)(2010-4#1)(2013-1#2)
the acceptability of##11##3##(2006-3#1)(2006-5#1)(2007-9#1)(2009-11#1)(2010-4#1)(2011-2#3)(2013-1#3)
the acceptability##16##2##(2006-3#1)(2006-5#1)(2007-9#1)(2008-7#1)(2009-11#2)(2010-10#1)(2010-4#1)(2011-2#3)(2013-1#5)
the acceptable quality of##2##4##(2007-10#2)
the acceptable range##4##3##(1991-4#1)(2008-10#1)(2008-11#1)(2011-12#1)
the acceptable##17##2##(1991-4#1)(1996-12#1)(1996-8#1)(2006-4#2)(2007-10#2)(2007-6#2)(2008-10#3)(2008-11#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-8#1)
the acceptance and##3##3##(2004-4#1)(2006-10#1)(2011-2#1)
the acceptance of a##2##4##(1994-7#1)(1995-2#1)
the acceptance of advanced rider assistance systems##3##7##(2012-12#3)
the acceptance of the##3##4##(2008-1#1)(2008-4#1)(2011-1#1)
the acceptance of##22##3##(1994-7#1)(1995-2#2)(2007-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-6#1)(2010-11#1)(2011-1#1)(2012-1#1)(2012-12#6)(2012-2#1)
the acceptance or rejection of##2##5##(2007-10#1)(2013-7#1)
the acceptance or##4##3##(2007-10#1)(2008-10#1)(2013-7#2)
the acceptance##37##2##(1994-7#1)(1995-2#2)(2004-4#1)(2006-10#1)(2007-10#2)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-6#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#7)(2012-2#1)(2013-1#1)(2013-7#2)
the accepted rate##2##3##(1991-8#1)(1991-9#1)
the accepted##14##2##(1991-11#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1993-3#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)
the acceptor liquid##2##3##(2007-8#2)
the acceptor sites##3##3##(1994-9#2)(1996-11#1)
the acceptor solution##2##3##(2008-10#1)(2012-1#1)
the acceptor stream##4##3##(2008-10#4)
the acceptor##34##2##(1990-12#1)(1991-10#1)(1991-2#1)(1991-7#1)(1992-11#1)(1993-4#2)(1994-9#2)(1995-6#1)(1996-11#1)(1996-4#1)(1996-5#1)(2007-11#1)(2007-8#3)(2008-1#1)(2008-10#13)(2009-2#1)(2012-1#1)(2013-8#1)
the access and##3##3##(1994-12#1)(1994-2#1)(2010-5#1)
the access of choice##2##4##(2007-7#2)
the access of the##4##4##(2008-10#1)(2009-8#1)(2011-2#1)(2012-2#1)
the access of##14##3##(1990-11#1)(1993-8#1)(1995-1#1)(1996-6#1)(2007-7#2)(2008-10#2)(2008-8#1)(2009-8#1)(2011-2#3)(2012-2#1)
the access to##6##3##(1991-9#1)(1994-2#1)(1995-11#1)(2005-7#1)(2008-7#1)(2012-2#1)
the access##28##2##(1990-11#1)(1991-9#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-8#1)(1995-1#1)(1995-11#1)(1996-3#1)(1996-6#1)(2005-7#1)(2007-7#3)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-5#1)(2011-2#4)(2012-2#2)
the accessibility of the##4##4##(1990-3#1)(2008-1#1)(2009-12#1)(2011-1#1)
the accessibility of this##2##4##(1996-8#1)(2008-8#1)
the accessibility of##16##3##(1990-3#1)(1990-8#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-9#1)(1993-12#1)(1995-2#1)(1996-8#1)(1996-9#1)(2008-1#1)(2008-4#1)(2008-8#1)(2009-12#1)(2011-1#1)(2012-11#1)
the accessibility##17##2##(1990-3#1)(1990-8#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-9#1)(1993-12#1)(1995-2#1)(1996-8#1)(1996-9#1)(2008-1#1)(2008-4#1)(2008-8#1)(2009-12#1)(2011-1#1)(2012-11#1)(2013-7#1)
the accessible surface area##2##4##(2006-12#1)(2013-1#1)
the accessible surface##3##3##(2006-12#1)(2008-11#1)(2013-1#1)
the accessible##10##2##(1992-6#1)(1993-11#1)(1995-2#1)(1997-6#1)(2006-12#1)(2008-11#2)(2008-3#1)(2010-5#1)(2013-1#1)
the accessions##5##2##(2008-10#3)(2011-12#2)
the accessory duct##3##3##(1990-3#3)
the accessory nerve##2##3##(2008-7#2)
the accessory nuclei##2##3##(2007-12#1)(2008-7#1)
the accessory olfactory bulb (AOB)##2##5##(1992-8#1)(1997-7#1)
the accessory olfactory bulb##6##4##(1990-11#1)(1992-8#2)(1997-7#3)
the accessory olfactory##7##3##(1990-11#1)(1992-8#2)(1994-10#1)(1997-7#3)
the accessory pathway##3##3##(2006-9#3)
the accessory##36##2##(1990-11#1)(1990-3#3)(1992-8#2)(1993-3#1)(1994-10#1)(1994-8#1)(1995-11#1)(1995-5#1)(1997-2#1)(1997-4#1)(1997-7#3)(2006-9#3)(2007-12#4)(2008-10#1)(2008-4#1)(2008-7#5)(2009-5#2)(2010-11#1)(2011-1#1)(2012-2#1)(2013-1#1)
the accident and emergency department##3##5##(2006-12#1)(2007-3#1)(2013-1#1)
the accident and##4##3##(2006-12#1)(2007-3#1)(2007-7#1)(2013-1#1)
the accident at##2##3##(2008-4#1)(2012-2#1)
the accident study##2##3##(2006-11#2)
the accident##34##2##(1990-12#2)(1990-9#2)(1991-11#1)(1992-4#1)(1995-11#1)(1995-3#1)(2006-11#2)(2006-12#1)(2006-4#4)(2007-11#2)(2007-3#1)(2007-7#2)(2008-4#2)(2009-10#2)(2012-12#2)(2012-2#5)(2013-1#2)(2013-7#1)
the accidental##4##2##(1993-5#1)(1997-8#1)(2006-4#1)(2009-10#1)
the accidents##5##2##(2005-12#3)(2008-11#1)(2013-8#1)
the acclimation phase##2##3##(2008-7#2)
the acclimation##4##2##(2008-7#3)(2010-8#1)
the accommodation##4##2##(1991-10#1)(1992-7#1)(2010-8#1)(2012-1#1)
the accompanying paper##8##3##(1990-11#1)(1991-3#1)(1993-9#1)(1994-12#1)(1994-9#3)(1996-8#1)
the accompanying##36##2##(1990-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-10#1)(1992-5#1)(1993-2#2)(1993-9#1)(1994-12#1)(1994-9#3)(1995-12#1)(1995-3#1)(1996-8#1)(1997-8#1)(2006-10#2)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-8#1)(2011-2#2)(2012-2#2)(2013-7#2)
the accomplishment of##3##3##(2008-9#1)(2009-5#1)(2013-1#1)
the accomplishments##2##2##(2007-11#1)(2009-10#1)
the account##3##2##(2011-2#2)(2012-2#1)
the accountability##2##2##(2010-11#1)(2012-3#1)
the accreditation##6##2##(1996-12#2)(2005-5#1)(2007-4#1)(2007-9#1)(2009-4#1)
the accumbens##3##2##(1991-5#1)(1993-6#1)(1997-8#1)
the accumulated evidence##3##3##(1994-6#1)(2010-12#1)(2013-8#1)
the accumulated##22##2##(1990-8#1)(1992-3#1)(1992-7#1)(1994-6#1)(1996-9#1)(1997-1#1)(2005-11#2)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)(2013-8#1)
the accumulating##7##2##(1993-4#1)(1993-5#1)(1994-5#1)(2007-11#1)(2008-7#1)(2012-3#2)
the accumulation and##4##3##(1991-7#1)(1996-9#1)(2008-10#2)
the accumulation in##2##3##(1990-4#1)(2008-10#1)
the accumulation of G1##2##4##(1996-4#1)(1997-7#1)
the accumulation of a##7##4##(1990-10#1)(1994-11#1)(1995-12#1)(1996-11#1)(2007-8#1)(2010-2#1)(2011-2#1)
the accumulation of cells##2##4##(1993-11#1)(1995-2#1)
the accumulation of cisplatin in human ovarian cancer cells##2##9##(1995-5#2)
the accumulation of cisplatin in##4##5##(1995-5#4)
the accumulation of deleterious mutations##2##5##(2008-8#1)(2010-3#1)
the accumulation of fat in the##2##6##(2008-1#1)(2008-6#1)
the accumulation of fat##3##4##(2008-1#2)(2008-6#1)
the accumulation of intracellular##2##4##(1993-12#1)(2008-7#1)
the accumulation of malonyl-CoA##2##4##(1995-6#2)
the accumulation of mutations##3##4##(1995-8#1)(2008-5#1)(2008-7#1)
the accumulation of point mutations##3##5##(1995-8#3)
the accumulation of sequence data##2##5##(1995-7#1)(1997-2#1)
the accumulation of sequence##3##4##(1995-7#1)(1995-8#1)(1997-2#1)
the accumulation of soil##2##4##(2013-8#2)
the accumulation of superoxide##2##4##(1994-11#1)(2008-10#1)
the accumulation of the##16##4##(1990-2#1)(1991-6#1)(1992-11#1)(1992-7#1)(1994-9#1)(1996-10#1)(1997-6#1)(2006-12#1)(2008-10#5)(2008-3#1)(2008-7#1)(2012-12#1)
the accumulation of these##4##4##(1994-3#1)(2008-10#1)(2008-5#1)(2011-1#1)
the accumulation of toxic##2##4##(2007-5#1)(2008-10#1)
the accumulation of two##2##4##(1996-7#1)(2008-10#1)
the accumulation of viral##2##4##(1992-11#1)(2008-9#1)
the accumulation of##203##3##(1990-10#3)(1990-11#1)(1990-2#2)(1990-4#2)(1990-5#3)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#3)(1991-7#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-4#2)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#4)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#5)(1995-6#5)(1995-7#2)(1995-8#5)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-12#5)(2006-3#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#33)(2008-11#2)(2008-3#2)(2008-5#3)(2008-6#3)(2008-7#10)(2008-8#5)(2008-9#3)(2009-10#2)(2009-12#1)(2009-7#1)(2009-8#3)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#4)(2011-2#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#5)(2013-8#2)
the accumulation time##6##3##(1992-3#1)(2008-10#5)
the accumulation##227##2##(1990-10#3)(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#3)(1990-5#3)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#3)(1991-7#2)(1992-11#2)(1992-12#1)(1992-3#2)(1992-4#2)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#4)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#3)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#5)(1995-6#5)(1995-7#2)(1995-8#5)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-4#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-12#6)(2006-3#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#44)(2008-11#4)(2008-3#2)(2008-5#3)(2008-6#3)(2008-7#10)(2008-8#5)(2008-9#3)(2009-10#2)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#4)(2011-2#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#6)(2013-8#2)
the accumulations of##2##3##(1990-10#1)(1997-1#1)
the accumulative##2##2##(2008-3#1)(2008-4#1)
the accuracy and precision of the##4##6##(1992-1#1)(2008-10#2)(2008-3#1)
the accuracy and precision of##11##5##(1991-3#1)(1992-1#1)(1995-1#1)(2007-12#1)(2008-10#5)(2008-3#1)(2012-3#1)
the accuracy and precision##13##4##(1991-3#1)(1992-1#1)(1995-1#1)(2007-12#1)(2008-10#7)(2008-3#1)(2012-3#1)
the accuracy and reliability of##3##5##(2005-8#1)(2008-3#1)(2012-3#1)
the accuracy and reproducibility of##3##5##(2008-10#2)(2008-9#1)
the accuracy and sensitivity of the##2##6##(2004-10#1)(2007-12#1)
the accuracy and sensitivity of##3##5##(2004-10#1)(2007-12#1)(2013-8#1)
the accuracy and the sensitivity##2##5##(2008-1#1)(2008-10#1)
the accuracy and the##12##4##(1991-11#1)(1993-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#4)(2010-8#1)
the accuracy and##53##3##(1991-11#1)(1991-3#1)(1992-1#1)(1993-12#3)(1995-1#1)(2004-10#1)(2005-8#1)(2006-2#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#15)(2008-11#1)(2008-2#2)(2008-3#7)(2008-6#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-3#2)(2013-8#2)
the accuracy for the##2##4##(2008-10#2)
the accuracy for##3##3##(1994-12#1)(2008-10#2)
the accuracy in the determination of the##2##7##(2008-2#1)(2008-3#1)
the accuracy in the determination of##3##6##(2008-10#1)(2008-2#1)(2008-3#1)
the accuracy in##7##3##(2006-6#1)(2007-10#1)(2008-10#3)(2008-2#1)(2008-3#1)
the accuracy is##2##3##(2008-10#1)(2008-3#1)
the accuracy levels##2##3##(2008-2#2)
the accuracy of DNA##2##4##(2008-3#1)(2008-9#1)
the accuracy of a##2##4##(1992-3#1)(2007-10#1)
the accuracy of an##3##4##(2007-12#1)(2008-2#1)(2012-1#1)
the accuracy of both##3##4##(2005-11#1)(2007-12#1)(2008-3#1)
the accuracy of children's dietary recalls##2##6##(2006-5#2)
the accuracy of clinical##3##4##(2006-12#1)(2006-6#1)(2008-6#1)
the accuracy of diagnosis##2##4##(2007-10#1)(2008-6#1)
the accuracy of evaluations of##2##5##(2008-4#2)
the accuracy of evaluations##3##4##(2008-4#3)
the accuracy of imputation##2##4##(2012-1#2)
the accuracy of imputing##2##4##(2012-1#2)
the accuracy of its##2##4##(2006-3#1)(2012-3#1)
the accuracy of patient setup##2##5##(2012-12#2)
the accuracy of predictions##2##4##(1994-3#1)(2008-10#1)
the accuracy of the analysis##3##5##(2008-10#1)(2012-2#1)(2013-7#1)
the accuracy of the derived##2##5##(2008-3#1)(2008-7#1)
the accuracy of the determined##2##5##(2008-3#2)
the accuracy of the developed method##4##6##(2008-10#4)
the accuracy of the interferometer##2##5##(2008-3#2)
the accuracy of the measurement##2##5##(2008-10#1)(2008-2#1)
the accuracy of the method##4##5##(2007-8#1)(2008-10#3)
the accuracy of the procedure##3##5##(2008-10#1)(2008-3#1)(2010-5#1)
the accuracy of the proposed method##4##6##(2008-10#3)(2008-2#1)
the accuracy of the proposed procedure##2##6##(2007-10#1)(2008-10#1)
the accuracy of the proposed##8##5##(2007-10#1)(2008-10#6)(2008-2#1)
the accuracy of the reference##2##5##(2007-12#1)(2008-3#1)
the accuracy of the results##2##5##(2008-10#1)(2008-3#1)
the accuracy of the retrieved##2##5##(2008-2#1)(2008-3#1)
the accuracy of the technique##6##5##(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)
the accuracy of the##115##4##(1991-12#1)(1991-4#1)(1992-2#2)(1992-6#1)(1993-1#2)(1993-9#1)(1996-11#1)(1997-2#1)(2004-12#1)(2006-3#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-12#4)(2007-5#2)(2007-8#2)(2008-1#1)(2008-10#26)(2008-2#17)(2008-3#26)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#5)(2013-1#2)(2013-7#1)
the accuracy of this approach we##2##6##(2007-12#1)(2008-3#1)
the accuracy of this##10##4##(1990-12#1)(1991-11#1)(2007-12#1)(2008-2#1)(2008-3#3)(2010-4#1)(2010-7#1)(2013-8#1)
the accuracy of##263##3##(1990-12#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-4#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-1#2)(1993-9#2)(1994-2#1)(1994-3#3)(1995-1#1)(1995-2#1)(1995-7#1)(1996-11#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(2004-12#1)(2005-10#1)(2005-11#2)(2005-4#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#3)(2006-6#1)(2006-8#1)(2007-1#2)(2007-10#4)(2007-11#1)(2007-12#8)(2007-2#1)(2007-5#3)(2007-8#3)(2008-1#1)(2008-10#32)(2008-11#2)(2008-2#35)(2008-3#43)(2008-4#4)(2008-5#1)(2008-6#5)(2008-7#2)(2008-8#2)(2008-9#2)(2009-12#2)(2009-5#2)(2009-7#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#3)(2011-1#1)(2011-2#2)(2011-3#2)(2012-1#5)(2012-12#5)(2012-2#8)(2012-3#2)(2012-7#1)(2013-1#15)(2013-7#1)(2013-8#5)
the accuracy or##2##3##(2007-5#1)(2008-3#1)
the accuracy was##5##3##(1993-1#1)(1996-6#1)(1996-8#1)(2008-10#2)
the accuracy with which the##2##5##(2008-2#1)(2009-11#1)
the accuracy with which##6##4##(2005-8#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-11#1)
the accuracy##371##2##(1990-12#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#2)(1992-6#1)(1993-1#3)(1993-10#1)(1993-12#3)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#3)(1995-1#2)(1995-2#1)(1995-7#1)(1996-11#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-2#1)(1997-3#2)(2004-10#1)(2004-12#1)(2005-10#1)(2005-11#2)(2005-4#1)(2005-8#3)(2006-10#2)(2006-12#2)(2006-2#3)(2006-3#2)(2006-4#1)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#5)(2007-11#3)(2007-12#11)(2007-2#1)(2007-5#5)(2007-8#3)(2008-1#2)(2008-10#62)(2008-11#3)(2008-12#1)(2008-2#43)(2008-3#60)(2008-4#5)(2008-5#1)(2008-6#6)(2008-7#2)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#3)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#3)(2011-1#3)(2011-2#3)(2011-3#2)(2012-1#5)(2012-11#1)(2012-12#5)(2012-2#8)(2012-3#4)(2012-7#1)(2013-1#16)(2013-7#1)(2013-8#7)
the accurate analysis of##2##4##(2008-10#1)(2008-2#1)
the accurate analysis##3##3##(2008-10#1)(2008-2#1)(2010-8#1)
the accurate assessment of##2##4##(2008-10#1)(2009-10#1)
the accurate determination of##7##4##(1996-6#1)(1997-4#1)(2007-8#1)(2008-10#3)(2009-7#1)
the accurate diagnosis and##2##4##(2008-1#1)(2008-5#1)
the accurate diagnosis of this##2##5##(2008-1#1)(2012-2#1)
the accurate diagnosis of##3##4##(2008-1#1)(2011-2#1)(2012-2#1)
the accurate diagnosis##5##3##(2008-1#2)(2008-5#1)(2011-2#1)(2012-2#1)
the accurate identification of##2##4##(1992-11#1)(2012-2#1)
the accurate identification##3##3##(1992-11#1)(2009-2#1)(2012-2#1)
the accurate mass##2##3##(2008-10#1)(2008-11#1)
the accurate measurement of##3##4##(1991-11#1)(2008-3#2)
the accurate molecular##2##3##(1997-2#1)(2008-4#1)
the accurate recovery of##2##4##(2008-3#2)
the accurate##54##2##(1990-11#1)(1991-11#1)(1992-11#1)(1993-5#1)(1994-3#1)(1996-6#1)(1997-2#1)(1997-4#1)(2006-12#1)(2007-11#2)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#10)(2008-11#2)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-7#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)
the accused##3##2##(1990-12#1)(1996-3#1)(2011-1#1)
the accuser##2##2##(1990-12#2)
the acellular##4##2##(1992-12#1)(2007-11#1)(2007-12#1)(2009-10#1)
the acentrosomal Meiosis I spindle##4##5##(2012-12#4)
the acentrosomal##6##2##(2012-12#6)
the acetabular component in##2##4##(2008-8#1)(2009-3#1)
the acetabular component##9##3##(1993-8#1)(2007-7#1)(2008-11#1)(2008-3#2)(2008-8#2)(2009-3#2)
the acetabular fragment##2##3##(2007-7#1)(2007-8#1)
the acetabular rim##5##3##(2007-7#1)(2008-5#1)(2011-12#1)(2013-7#2)
the acetabular roof in##2##4##(2007-8#2)
the acetabular roof##4##3##(2007-8#4)
the acetabular shell##2##3##(2008-11#1)(2009-3#1)
the acetabular##29##2##(1993-8#1)(2004-9#1)(2007-7#3)(2007-8#5)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-8#3)(2009-3#4)(2011-12#1)(2013-7#2)
the acetabulum and##2##3##(2007-4#1)(2008-8#1)
the acetabulum##32##2##(1995-9#2)(2006-11#1)(2007-4#1)(2007-7#12)(2007-8#1)(2008-5#2)(2008-6#1)(2008-8#2)(2009-3#3)(2009-4#2)(2011-12#1)(2013-1#2)(2013-8#2)
the acetamido group##3##3##(1990-5#1)(1993-6#2)
the acetate salt of##2##4##(1997-2#1)(1997-8#1)
the acetate##11##2##(1995-7#1)(1996-4#1)(1997-2#2)(1997-8#1)(2008-10#2)(2008-6#1)(2008-7#2)(2011-1#1)
the acetic acid##3##3##(1992-7#1)(2012-12#1)(2013-7#1)
the acetic acid-induced writhing model##3##5##(2013-7#3)
the acetic acid-induced writhing##4##4##(2011-1#1)(2013-7#3)
the acetic##7##2##(1992-7#1)(2011-1#1)(2012-12#1)(2013-7#4)
the acetone and##2##3##(2006-12#1)(2007-8#1)
the acetone extract of the##2##5##(2007-1#1)(2008-11#1)
the acetone extract of##3##4##(2007-1#1)(2007-10#1)(2008-11#1)
the acetone extract##4##3##(2007-1#1)(2007-10#1)(2008-11#2)
the acetone powder from##2##4##(2008-5#2)
the acetone powder##3##3##(2008-5#3)
the acetone##11##2##(2006-12#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-5#3)
the acetoxy##2##2##(1996-5#2)
the acetoxymethyl ester##3##3##(1992-5#2)(2010-11#1)
the acetyl##7##2##(1991-10#1)(1991-9#1)(1995-2#1)(1997-2#1)(2005-12#1)(2005-7#1)(2011-1#1)
the acetylated##3##2##(1990-3#1)(1995-8#1)(2008-6#1)
the acetylation and##3##3##(1991-2#1)(2007-10#1)(2011-1#1)
the acetylation##8##2##(1991-2#1)(2007-10#1)(2008-10#1)(2008-4#2)(2011-1#2)(2012-12#1)
the acetylcholine receptor##4##3##(1991-3#1)(1993-3#1)(1994-11#1)(1994-5#1)
the acetylcholine transporter##2##3##(1992-6#2)
the acetylcholine transporter-vesamicol receptor##3##4##(1992-6#3)
the acetylcholine##17##2##(1990-7#2)(1990-9#1)(1991-3#1)(1992-3#1)(1992-6#5)(1992-9#1)(1993-3#1)(1994-11#1)(1994-5#1)(1995-11#1)(1997-2#1)(2008-10#1)
the acetylcholine-##2##2##(1997-5#2)
the acetylcholine-induced relaxation##2##3##(1997-5#2)
the acetylcholine-induced##4##2##(1997-5#3)(2013-7#1)
the acetylcholinesterase (AChE)##3##3##(2008-11#2)(2010-11#1)
the acetylcholinesterase inhibitor##3##3##(1995-1#1)(1996-9#1)(2012-2#1)
the acetylcholinesterase##8##2##(1995-1#1)(1996-9#1)(2008-10#1)(2008-11#3)(2010-11#1)(2012-2#1)
the achievable##6##2##(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#3)
the achieved##8##2##(1995-5#1)(2005-11#1)(2006-7#1)(2007-1#1)(2008-10#1)(2008-3#1)(2013-1#2)
the achievement of a##5##4##(1994-3#1)(1996-2#1)(1996-4#1)(2007-5#1)(2009-12#1)
the achievement of##29##3##(1994-2#1)(1994-3#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-3#2)(2011-2#1)(2012-2#2)(2012-3#1)
the achievement probability##3##3##(2012-2#3)
the achievement##34##2##(1994-2#1)(1994-3#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-3#2)(2011-2#1)(2012-2#5)(2012-3#1)
the achievements and##2##3##(2008-5#1)(2010-8#1)
the achievements of schistosomiasis control##2##5##(2011-12#1)(2012-3#1)
the achievements of the##2##4##(2008-12#2)
the achievements of##6##3##(1995-1#1)(2007-8#1)(2008-12#2)(2011-12#1)(2012-3#1)
the achievements##11##2##(1995-1#1)(2007-8#1)(2008-12#2)(2008-5#1)(2009-5#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-7#1)
the achromatic device AD-1##2##4##(2008-2#2)
the achromatic##6##2##(2008-2#4)(2008-3#2)
the acid and the##3##4##(2008-10#1)(2008-5#1)(2008-9#1)
the acid and##10##3##(1990-7#1)(1996-9#1)(1997-7#1)(2005-4#1)(2008-10#2)(2008-5#3)(2008-9#1)
the acid chloride##2##3##(2007-11#1)(2008-10#1)
the acid form of superoxide anion radical##2##7##(1991-4#2)
the acid form##3##3##(1991-4#2)(2008-10#1)
the acid hydrazide 2##2##4##(2007-11#2)
the acid phosphatase activity##2##4##(2007-3#1)(2008-7#1)
the acid phosphatase##5##3##(1992-12#2)(1992-7#1)(2007-3#1)(2008-7#1)
the acid secretion##2##3##(2007-1#1)(2008-12#1)
the acid secretory##2##3##(1991-2#1)(1995-12#1)
the acid##71##2##(1990-5#1)(1990-7#1)(1991-2#2)(1991-4#2)(1992-12#2)(1992-7#1)(1992-9#1)(1994-11#1)(1994-8#1)(1995-12#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-7#1)(2004-9#1)(2005-11#1)(2005-12#1)(2005-4#1)(2006-12#1)(2007-1#1)(2007-11#4)(2007-3#1)(2007-6#1)(2008-10#23)(2008-12#1)(2008-2#1)(2008-5#10)(2008-7#2)(2008-9#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-1#1)
the acid-base balance##2##3##(2006-6#2)
the acid-base behaviour of##2##4##(2008-10#2)
the acid-base properties of the##2##5##(1995-6#1)(2008-10#1)
the acid-base properties of##3##4##(1995-6#1)(2008-10#2)
the acid-base properties##4##3##(1995-6#1)(2008-10#3)
the acid-base reaction##2##3##(2004-9#1)(2008-10#1)
the acid-base##17##2##(1991-2#1)(1994-5#1)(1995-6#1)(2004-9#1)(2005-11#1)(2005-12#1)(2006-6#2)(2008-10#9)
the acid-extractable##2##2##(2008-10#2)
the acid-soluble##3##2##(1990-5#1)(1992-4#2)
the acid-washed PM 1648 instilled##2##5##(2008-10#2)
the acid-washed PM 1648##3##4##(2008-10#3)
the acidic agent##2##3##(2005-11#1)(2008-5#1)
the acidic and##4##3##(1993-11#1)(2008-10#3)
the acidic environment of the##2##5##(1990-6#1)(1997-1#1)
the acidic groups##2##3##(1991-5#1)(2008-10#1)
the acidic hydrolysis of lorazepam##2##5##(2008-10#2)
the acidic hydrolysis of##3##4##(2007-8#1)(2008-10#2)
the acidic pH##2##3##(1993-12#1)(2008-10#1)
the acidic phospholipid##3##3##(1991-9#1)(1995-8#1)(2008-7#1)
the acidic solution##3##3##(2004-12#2)(2008-10#1)
the acidic##52##2##(1990-6#1)(1990-7#1)(1991-2#2)(1991-5#1)(1991-9#1)(1993-11#2)(1993-12#1)(1994-3#1)(1994-5#2)(1995-1#1)(1995-4#1)(1995-8#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#1)(2004-12#2)(2005-11#5)(2006-6#1)(2006-8#1)(2007-8#1)(2008-10#16)(2008-5#4)(2008-7#1)(2009-10#1)(2010-12#1)
the acidification of the##2##4##(1990-11#1)(2009-8#1)
the acidification of##3##3##(1990-11#1)(1994-8#1)(2009-8#1)
the acidification##6##2##(1990-11#1)(1990-7#1)(1994-8#1)(2008-10#1)(2009-8#1)(2012-3#1)
the acidity and##2##3##(2008-10#2)
the acidity of the##5##4##(2005-11#1)(2008-10#4)
the acidity of##9##3##(2005-11#1)(2006-4#1)(2008-10#6)(2008-9#1)
the acidity##17##2##(2005-11#2)(2006-4#1)(2008-10#13)(2008-9#1)
the acidotic preparations and##2##4##(1994-2#2)
the acidotic preparations##3##3##(1994-2#3)
the acidotic##4##2##(1994-2#3)(1994-3#1)
the acids##5##2##(2008-10#3)(2008-5#1)(2012-1#1)
the acinar cells##3##3##(1990-5#1)(1992-8#1)(1995-11#1)
the acinar##5##2##(1990-5#2)(1992-8#1)(1995-11#1)(2008-7#1)
the acinary regions##2##3##(2007-9#2)
the acinus##5##2##(1995-11#1)(2007-12#4)
the acitric allele##2##3##(2008-5#2)
the acknowledged##2##2##(2006-10#1)(2008-5#1)
the acknowledgment of##2##3##(2006-7#1)(2008-9#1)
the acknowledgment that##2##3##(2008-5#1)(2013-1#1)
the acknowledgment##4##2##(2006-7#1)(2008-5#1)(2008-9#1)(2013-1#1)
the acm gene##2##3##(1990-3#2)
the acne##3##2##(2010-5#2)(2012-12#1)
the acorn barnacle##5##3##(1990-5#4)(1993-6#1)
the acoustic and##2##3##(2006-12#1)(2009-9#1)
the acoustic field##4##3##(2008-2#3)(2008-3#1)
the acoustic frequency##2##3##(2007-12#1)(2008-3#1)
the acoustic measures##2##3##(2011-1#2)
the acoustic startle response##3##4##(1991-1#2)(1996-2#1)
the acoustic velocity##2##3##(2008-3#2)
the acoustic##36##2##(1991-1#2)(1996-2#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-12#6)(2007-5#1)(2008-2#5)(2008-3#8)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-9#3)(2010-12#1)(2011-1#2)
the acousto-optic modulator##2##3##(2007-12#1)(2008-2#1)
the acousto-optic##3##2##(2007-12#2)(2008-2#1)
the acquired data##4##3##(1993-5#1)(1997-6#1)(2008-2#1)(2011-1#1)
the acquired images##3##3##(1992-10#1)(2008-10#1)(2012-1#1)
the acquired immune deficiency syndrome (AIDS)##3##6##(1991-9#1)(1994-10#1)(2008-3#1)
the acquired immune response##5##4##(2006-10#2)(2006-5#2)(2010-9#1)
the acquired immune##8##3##(1991-9#1)(1994-10#1)(2006-10#2)(2006-5#2)(2008-3#1)(2010-9#1)
the acquired immunodeficiency syndrome (AIDS)##7##5##(1990-6#1)(1990-9#1)(1991-2#1)(1992-8#1)(1993-12#1)(1995-8#1)(1996-12#1)
the acquired immunodeficiency syndrome##16##4##(1990-6#1)(1990-9#2)(1991-12#1)(1991-2#2)(1991-5#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-9#1)(1995-8#1)(1996-12#1)(2005-10#1)(2008-1#2)
the acquired immunodeficiency##17##3##(1990-6#1)(1990-9#2)(1991-12#1)(1991-2#2)(1991-5#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-9#1)(1995-8#1)(1996-12#1)(2005-10#1)(2007-8#1)(2008-1#2)
the acquired information##2##3##(2008-3#1)(2013-1#1)
the acquired resistance to uranyl##2##5##(1997-2#2)
the acquired resistance to##3##4##(1997-2#3)
the acquired resistance##4##3##(1997-2#4)
the acquired##56##2##(1990-6#1)(1990-9#2)(1991-12#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-10#1)(1994-8#1)(1995-8#1)(1996-12#1)(1997-2#4)(1997-6#1)(2005-10#1)(2006-10#2)(2006-5#2)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-3#3)(2009-8#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#1)(2012-1#2)(2012-3#1)(2013-1#3)
the acquisition and##8##3##(1992-1#1)(1992-11#1)(2006-11#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
the acquisition of a##10##4##(1991-1#1)(1992-10#2)(1993-6#2)(1993-7#1)(1993-9#1)(1997-7#1)(2008-10#1)(2008-2#1)
the acquisition of data##2##4##(2008-10#1)(2008-7#1)
the acquisition of drug##3##4##(1992-10#1)(1994-12#1)(2010-11#1)
the acquisition of specific##2##4##(1996-10#1)(2007-8#1)
the acquisition of spectra##2##4##(1997-2#1)(2006-5#1)
the acquisition of the##8##4##(1991-1#2)(1991-2#1)(2006-2#1)(2008-5#1)(2009-3#2)(2012-12#1)
the acquisition of this##2##4##(1993-3#1)(2010-10#1)
the acquisition of visual##2##4##(1993-7#1)(2010-6#1)
the acquisition of##80##3##(1990-7#2)(1991-1#6)(1991-10#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-10#4)(1992-2#1)(1992-6#1)(1993-3#1)(1993-6#2)(1993-7#2)(1993-9#1)(1994-12#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-3#1)(1996-10#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-2#2)(2006-5#2)(2006-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
the acquisition##103##2##(1990-7#2)(1991-1#6)(1991-10#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-1#2)(1992-10#5)(1992-11#1)(1992-2#1)(1992-6#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-7#2)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(2004-9#2)(2006-10#1)(2006-11#1)(2006-2#2)(2006-5#2)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#3)(2009-3#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
the acridine##4##2##(1997-4#1)(2008-3#3)
the acro-renal-ocular syndrome##2##3##(1996-3#2)
the acromegalic patients##2##3##(1997-2#1)(2013-1#1)
the acromioclavicular joint##3##3##(1995-8#1)(2007-1#2)
the acromioclavicular##4##2##(1995-8#1)(2007-1#2)(2009-5#1)
the acronym of##3##3##(2008-3#2)(2011-2#1)
the acronym##6##2##(1996-12#1)(2008-3#4)(2011-2#1)
the acrophase##3##2##(1992-3#1)(2010-8#2)
the acroplaxome##3##2##(2012-2#3)
the acrosomal complex##2##3##(2007-12#2)
the acrosomal membrane##2##3##(1994-8#2)
the acrosomal region of acrosome-reacted##2##5##(1995-10#1)(2006-5#1)
the acrosomal region##6##3##(1995-10#1)(2006-5#3)(2008-7#2)
the acrosomal##16##2##(1994-8#3)(1995-10#3)(2006-5#3)(2007-12#2)(2008-7#3)(2012-12#2)
the acrosome and##6##3##(2008-7#3)(2012-12#2)(2012-2#1)
the acrosome reaction##12##3##(1990-10#2)(1992-8#2)(1995-10#1)(2008-8#7)
the acrosome status##2##3##(2006-5#1)(2009-6#1)
the acrosome##34##2##(1990-10#2)(1990-5#1)(1992-7#4)(1992-8#2)(1994-2#1)(1995-10#1)(2006-5#1)(2008-4#1)(2008-7#6)(2008-8#7)(2009-6#1)(2012-12#6)(2012-2#1)
the acrylamide##2##2##(1994-9#1)(2007-8#1)
the acrylic acid##2##3##(2005-11#1)(2008-5#1)
the acrylic liver phantom##2##4##(2008-2#2)
the acrylic##7##2##(2004-9#1)(2005-11#2)(2008-2#2)(2008-5#1)(2013-8#1)
the act of##6##3##(2007-6#1)(2009-10#1)(2009-4#1)(2011-2#1)(2012-11#1)(2013-1#1)
the act##9##2##(1990-12#2)(1994-1#1)(2007-6#1)(2009-10#1)(2009-4#1)(2011-2#1)(2012-11#1)(2013-1#1)
the actin and##2##3##(1990-12#1)(2009-10#1)
the actin binding##3##3##(1994-8#1)(1996-5#1)(2009-7#1)
the actin cytoskeleton and##5##4##(1996-2#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-5#1)
the actin cytoskeleton in##5##4##(2008-10#1)(2008-11#2)(2009-10#1)(2009-12#1)
the actin cytoskeleton is##3##4##(1997-4#1)(2011-2#1)(2012-12#1)
the actin cytoskeleton which##2##4##(2011-12#2)
the actin cytoskeleton##40##3##(1991-5#1)(1993-9#1)(1995-3#1)(1996-12#2)(1996-2#1)(1997-4#3)(1997-6#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#7)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#3)(2009-7#2)(2009-8#1)(2011-1#2)(2011-12#3)(2011-2#1)(2012-12#2)
the actin filament##4##3##(1993-12#2)(1996-5#1)(2009-3#1)
the actin filaments##3##3##(1991-2#1)(1997-6#1)(2008-9#1)
the actin gene##4##3##(1991-8#1)(1994-8#1)(2008-10#2)
the actin was##2##3##(1990-6#1)(1992-3#1)
the actin##73##2##(1990-12#2)(1990-6#2)(1990-7#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#2)(1992-3#3)(1993-12#2)(1993-9#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-3#2)(1996-12#2)(1996-2#1)(1996-5#2)(1997-4#4)(1997-6#3)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#10)(2008-5#1)(2008-7#1)(2008-9#3)(2009-10#2)(2009-12#3)(2009-3#1)(2009-7#3)(2009-8#1)(2011-1#2)(2011-12#3)(2011-2#1)(2012-12#2)
the actin-activated ATPase activity of##2##5##(1990-3#1)(1990-7#1)
the actin-activated ATPase activity##4##4##(1990-3#1)(1990-7#2)(1995-1#1)
the actin-activated ATPase##5##3##(1990-3#1)(1990-7#3)(1995-1#1)
the actin-activated##7##2##(1990-3#1)(1990-7#4)(1993-6#1)(1995-1#1)
the actin-binding site##3##3##(1993-8#2)(1997-6#1)
the actin-binding##10##2##(1990-5#1)(1993-8#3)(1994-8#2)(1997-6#3)(2011-1#1)
the actin-myosin##2##2##(1995-5#1)(2010-12#1)
the actin-related protein centractin (Arp-1)##2##5##(1995-2#2)
the acting##2##2##(1997-8#1)(2005-10#1)
the actinobacterial family Cellulomonadaceae##2##4##(2011-2#2)
the actinobacterial family##4##3##(2011-2#4)
the actinobacterial##6##2##(2008-7#1)(2011-2#5)
the action and##2##3##(1996-2#1)(2008-7#1)
the action line##3##3##(1992-5#3)
the action of PAF on [Ca2+]i##2##6##(1991-2#2)
the action of TSH##2##4##(1991-5#1)(1996-5#1)
the action of a beta##2##5##(1995-5#2)
the action of a##17##4##(1991-10#1)(1991-11#1)(1992-5#1)(1993-3#1)(1994-11#1)(1995-1#1)(1995-5#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#1)(2010-3#1)
the action of an##3##4##(1990-11#1)(1990-2#1)(1995-7#1)
the action of both##3##4##(1990-2#1)(1994-6#1)(2006-10#1)
the action of glutamate##2##4##(1995-12#1)(2008-7#1)
the action of histamine##3##4##(1994-5#1)(2007-1#1)(2007-7#1)
the action of insulin on##3##5##(1994-9#1)(1995-6#1)(1996-2#1)
the action of insulin##7##4##(1991-5#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-2#1)(2008-11#1)(2011-2#1)
the action of many##2##4##(1992-12#1)(2008-4#1)
the action of other##3##4##(1990-4#1)(1991-4#1)(2008-5#1)
the action of the##25##4##(1990-11#1)(1990-4#1)(1990-5#2)(1991-12#1)(1992-3#2)(1995-1#1)(1995-11#1)(1995-4#1)(1996-3#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
the action of these##5##4##(1990-2#1)(1991-9#1)(2008-10#1)(2008-11#1)(2008-4#1)
the action of this cytokine##2##5##(1992-11#1)(2006-3#1)
the action of this##7##4##(1990-11#1)(1992-11#1)(1992-3#1)(1994-3#1)(1997-2#1)(2006-3#1)(2006-8#1)
the action of two##3##4##(1993-3#1)(1995-1#1)(1995-10#1)
the action of various##2##4##(2008-4#1)(2011-1#1)
the action of##238##3##(1990-10#2)(1990-11#4)(1990-2#5)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#2)(1991-10#3)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#2)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#5)(1992-4#2)(1992-5#1)(1992-6#3)(1993-11#1)(1993-12#4)(1993-2#2)(1993-3#3)(1993-6#8)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#3)(1994-6#4)(1994-8#2)(1994-9#1)(1995-1#3)(1995-10#2)(1995-11#2)(1995-12#6)(1995-2#2)(1995-4#1)(1995-5#4)(1995-6#2)(1995-7#2)(1995-8#1)(1996-1#1)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#2)(1997-2#4)(1997-5#1)(1997-6#3)(1997-7#2)(2005-8#1)(2006-10#3)(2006-12#2)(2006-3#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#2)(2007-11#4)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#7)(2008-2#3)(2008-3#4)(2008-4#6)(2008-5#9)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#1)(2009-11#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#2)
the action plan##2##3##(1991-3#1)(1995-3#1)
the action potential duration##2##4##(1993-3#1)(1994-3#1)
the action potential##13##3##(1990-7#3)(1991-5#2)(1992-8#1)(1993-3#1)(1994-3#2)(1996-2#2)(2008-11#1)(2009-5#1)
the action potentials##2##3##(1991-11#1)(1995-8#1)
the action taken##2##3##(2004-9#2)
the action##285##2##(1990-10#2)(1990-11#4)(1990-2#5)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#5)(1990-9#2)(1991-10#3)(1991-11#2)(1991-12#4)(1991-2#3)(1991-3#2)(1991-4#2)(1991-5#4)(1991-9#3)(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#5)(1992-4#2)(1992-5#4)(1992-6#3)(1992-8#1)(1993-11#1)(1993-12#4)(1993-2#2)(1993-3#4)(1993-6#8)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#3)(1994-6#5)(1994-8#2)(1994-9#1)(1995-1#3)(1995-10#2)(1995-11#2)(1995-12#7)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#4)(1995-6#2)(1995-7#2)(1995-8#2)(1996-1#1)(1996-2#5)(1996-3#1)(1996-4#2)(1996-5#3)(1997-2#4)(1997-5#1)(1997-6#3)(1997-7#2)(2004-9#2)(2005-4#1)(2005-8#1)(2006-10#5)(2006-12#3)(2006-3#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#2)(2007-11#4)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#8)(2008-11#10)(2008-2#3)(2008-3#4)(2008-4#9)(2008-5#10)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#3)
the action-perception cycle and##2##4##(2008-11#2)
the action-perception cycle##4##3##(2008-11#4)
the actions and##2##3##(2004-12#1)(2007-1#1)
the actions of adenosine##2##4##(1993-11#1)(2008-4#1)
the actions of ethanol##2##4##(1994-10#1)(2008-1#1)
the actions of other##3##4##(1995-3#1)(2005-7#1)(2008-1#1)
the actions of others##2##4##(2007-12#1)(2008-9#1)
the actions of the##6##4##(1990-5#1)(1990-8#1)(1994-10#1)(1996-10#1)(2006-6#1)(2012-11#1)
the actions of these##2##4##(1990-10#1)(1996-5#1)
the actions of##64##3##(1990-10#1)(1990-4#2)(1990-5#4)(1990-8#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-9#2)(1992-10#1)(1992-2#1)(1992-4#1)(1992-9#2)(1993-11#2)(1993-2#1)(1994-10#2)(1994-11#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-10#2)(1996-3#1)(1996-5#1)(1997-1#1)(2005-7#1)(2006-6#1)(2007-1#1)(2007-12#2)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-10#1)(2012-11#1)(2012-2#1)
the actions taken##2##3##(1992-1#1)(1994-7#1)
the actions##77##2##(1990-10#1)(1990-4#2)(1990-5#4)(1990-8#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-2#1)(1992-4#1)(1992-9#2)(1993-11#2)(1993-2#1)(1994-10#2)(1994-11#1)(1994-2#1)(1994-7#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-10#2)(1996-3#1)(1996-5#1)(1997-1#1)(1997-6#1)(2004-12#1)(2005-7#1)(2006-6#1)(2007-1#2)(2007-12#2)(2007-6#3)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-11#1)(2012-2#1)
the activated carbon##12##3##(2005-11#6)(2008-10#5)(2010-5#1)
the activated enzyme##2##3##(1995-2#1)(1996-5#1)
the activated macrophages##3##3##(2008-11#2)(2009-12#1)
the activated membranes##2##3##(1994-8#2)
the activated partial thromboplastin time##4##5##(1991-2#1)(1994-4#1)(1994-9#1)(2004-11#1)
the activated partial thromboplastin##5##4##(1991-2#1)(1994-4#1)(1994-9#1)(2004-11#1)(2008-9#1)
the activated partial##8##3##(1991-2#1)(1994-4#1)(1994-9#1)(1996-6#1)(2004-11#1)(2007-11#1)(2008-1#1)(2008-9#1)
the activated polycarbonate##3##3##(2008-10#3)
the activated receptor##6##3##(1991-11#1)(1991-4#1)(1994-9#1)(1996-2#1)(1997-7#1)(2012-3#1)
the activated sludge samples##3##4##(2005-11#3)
the activated sludge##4##3##(2005-11#4)
the activated state of##3##4##(1991-11#1)(1994-3#2)
the activated##91##2##(1990-2#2)(1990-4#1)(1990-7#3)(1991-11#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-9#3)(1992-11#1)(1992-12#1)(1992-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-4#1)(1994-5#2)(1994-8#2)(1994-9#3)(1995-11#2)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#2)(1997-6#1)(1997-7#3)(2004-11#1)(2004-9#1)(2005-11#11)(2005-7#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-4#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-11#1)(2010-2#1)(2010-5#1)(2012-3#1)
the activating agent##2##3##(2005-11#1)(2008-4#1)
the activating capacity##2##3##(1991-8#2)
the activating effect of ET-1##2##5##(1994-8#2)
the activating effect of##4##4##(1990-7#1)(1994-8#2)(2008-4#1)
the activating enzyme##2##3##(1997-4#1)(2005-8#1)
the activating sequence##3##3##(1992-5#3)
the activating##21##2##(1990-7#1)(1990-9#1)(1991-8#2)(1992-5#3)(1992-7#1)(1993-12#1)(1994-11#1)(1994-8#2)(1995-2#1)(1997-4#1)(2005-11#1)(2005-7#2)(2005-8#1)(2008-3#1)(2008-4#2)
the activation and##8##3##(1992-12#1)(1993-8#1)(2005-10#1)(2005-8#1)(2007-11#1)(2008-4#1)(2008-5#1)(2008-8#1)
the activation and/or##2##3##(1992-11#1)(1992-12#1)
the activation barrier for##4##4##(1996-11#1)(1997-7#1)(2008-10#2)
the activation barrier##5##3##(1996-11#1)(1997-7#1)(2006-3#1)(2008-10#2)
the activation by##3##3##(1992-6#1)(1996-7#1)(1997-1#1)
the activation curve##3##3##(1995-12#2)(1996-10#1)
the activation energy for the##3##5##(2008-10#3)
the activation energy for##6##4##(2008-10#5)(2012-2#1)
the activation energy of the##2##5##(2006-3#1)(2007-12#1)
the activation energy of##6##4##(1990-2#1)(1996-7#1)(1997-1#1)(1997-7#1)(2006-3#1)(2007-12#1)
the activation energy##19##3##(1990-2#1)(1993-12#1)(1996-7#2)(1997-1#1)(1997-7#1)(2005-11#2)(2006-10#1)(2006-3#1)(2007-12#1)(2008-10#7)(2012-2#1)
the activation in the##2##4##(1997-7#1)(2008-1#1)
the activation in##3##3##(1997-7#1)(2008-1#1)(2008-5#1)
the activation is##2##3##(1995-3#1)(2008-4#1)
the activation loop##3##3##(1995-2#1)(2012-12#2)
the activation of 2'##2##4##(1990-6#2)
the activation of ATP-sensitive K+ channels##2##6##(1997-5#1)(1997-7#1)
the activation of CRP##2##4##(1995-8#2)
the activation of Fc gamma Rs##2##6##(1994-6#2)
the activation of N-methyl-D-aspartate (NMDA) receptors##3##6##(1996-8#1)(2009-8#1)(2012-2#1)
the activation of NADPH oxidase##2##5##(1993-6#1)(1994-6#1)
the activation of NF-kappaB##2##4##(1996-5#1)(2007-11#1)
the activation of NMDA receptors##2##5##(1990-7#1)(2009-8#1)
the activation of PKA##4##4##(1991-5#1)(1991-8#1)(1994-2#1)(2012-2#1)
the activation of PKC##3##4##(1992-6#1)(1997-2#1)(2008-8#1)
the activation of SMP-II##2##4##(1991-2#2)
the activation of STAT5##3##4##(1996-9#1)(2008-8#1)(2012-12#1)
the activation of Stat3 and Stat1##2##6##(1995-3#1)(1996-5#1)
the activation of T##2##4##(1994-3#1)(2008-4#1)
the activation of a common##2##5##(1991-6#1)(1994-2#1)
the activation of a specific##2##5##(1996-5#1)(2011-2#1)
the activation of a##20##4##(1990-4#1)(1991-1#1)(1991-6#1)(1992-8#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-5#2)(2008-1#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#1)
the activation of adenosine##2##4##(1997-5#1)(2008-7#1)
the activation of alpha##2##4##(1994-10#1)(1995-5#1)
the activation of an##3##4##(1991-12#1)(1994-8#1)(2008-5#1)
the activation of caspase-3##2##4##(2009-4#1)(2010-6#1)
the activation of cell##2##4##(1993-3#1)(2012-12#1)
the activation of complement##2##4##(1993-3#2)
the activation of cytotoxic##2##4##(1991-9#1)(1996-10#1)
the activation of either##2##4##(1996-2#2)
the activation of heat shock factor##3##6##(1994-8#2)(2010-2#1)
the activation of latent##2##4##(1995-3#1)(1995-5#1)
the activation of nuclear factor##2##5##(2006-10#1)(2012-3#1)
the activation of nuclear##3##4##(1992-9#1)(2006-10#1)(2012-3#1)
the activation of osteoclasts##2##4##(2008-7#1)(2012-3#1)
the activation of other##3##4##(1996-2#1)(2006-2#1)(2012-1#1)
the activation of p72syk##4##4##(1992-6#1)(1993-11#2)(1994-5#1)
the activation of phosphoinositide hydrolysis##2##5##(1994-6#2)
the activation of phospholipase A2##2##5##(1996-2#1)(1997-6#1)
the activation of phospholipase C##2##5##(1991-8#1)(1995-5#1)
the activation of phospholipase##6##4##(1990-9#1)(1991-8#1)(1992-9#1)(1995-5#1)(1996-2#1)(1997-6#1)
the activation of plasminogen by##2##5##(1990-11#1)(1997-2#1)
the activation of presynaptic##2##4##(1996-1#1)(2008-7#1)
the activation of protein kinase C##5##6##(1990-12#1)(1990-8#1)(1992-6#1)(1993-6#1)(1996-5#1)
the activation of protein##9##4##(1990-12#1)(1990-8#1)(1992-6#1)(1993-6#1)(1994-3#1)(1995-11#1)(1995-5#1)(1996-5#1)(2008-7#1)
the activation of proto-oncogenes##2##4##(2008-7#1)(2011-2#1)
the activation of quiescent##2##4##(2008-10#2)
the activation of respiration##2##4##(1995-6#1)(2008-7#1)
the activation of specific##4##4##(1993-3#1)(2007-11#1)(2008-1#1)(2012-2#1)
the activation of the cell##2##5##(1991-5#1)(2008-5#1)
the activation of the complement##2##5##(2007-11#1)(2008-1#1)
the activation of the protease##2##5##(1990-10#1)(1992-1#1)
the activation of the respiratory burst##2##6##(1993-6#1)(1994-3#1)
the activation of the##52##4##(1990-10#1)(1990-2#2)(1990-7#1)(1991-11#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-3#2)(1993-6#2)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#2)(1995-8#1)(1996-2#1)(1996-5#1)(1997-2#2)(2006-10#3)(2006-12#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-1#1)(2009-2#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#2)
the activation of these##4##4##(1992-9#1)(1993-11#1)(2008-6#1)(2008-8#1)
the activation of this##3##4##(1991-3#1)(1991-5#1)(2011-2#1)
the activation of transcription factors##4##5##(1994-2#1)(1995-3#2)(2013-1#1)
the activation of various##4##4##(2005-11#1)(2008-11#1)(2010-7#1)(2013-1#1)
the activation of which##2##4##(1990-2#1)(1993-7#1)
the activation of##355##3##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#2)(1991-5#4)(1991-6#3)(1991-8#6)(1991-9#1)(1992-1#2)(1992-11#3)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#4)(1992-8#2)(1992-9#5)(1993-11#5)(1993-12#2)(1993-3#8)(1993-4#1)(1993-6#5)(1993-7#1)(1993-8#2)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#8)(1994-3#4)(1994-5#3)(1994-6#6)(1994-8#5)(1994-9#2)(1995-10#1)(1995-11#4)(1995-12#4)(1995-2#4)(1995-3#6)(1995-5#6)(1995-6#6)(1995-8#6)(1996-1#1)(1996-10#2)(1996-12#1)(1996-2#7)(1996-3#1)(1996-5#9)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#2)(1997-7#1)(2003-11#1)(2005-10#2)(2005-11#2)(2005-7#1)(2006-10#7)(2006-12#3)(2006-2#1)(2006-6#2)(2007-11#6)(2007-12#3)(2007-5#1)(2007-7#1)(2008-1#7)(2008-10#7)(2008-11#2)(2008-3#2)(2008-4#16)(2008-5#6)(2008-6#4)(2008-7#10)(2008-8#8)(2009-1#1)(2009-10#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#6)(2010-10#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#5)(2011-3#2)(2012-1#4)(2012-12#5)(2012-2#6)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#2)
the activation or##2##3##(1996-8#1)(2008-5#1)
the activation parameters for the interconversion between the alpha- and beta-conformations of fac-Re(CO)(3)(dpknph)Cl##2##13##(2008-10#2)
the activation parameters##3##3##(1996-2#1)(2008-10#2)
the activation pathway##2##3##(1995-8#1)(2008-4#1)
the activation process##5##3##(1991-4#1)(1991-8#1)(1993-6#1)(1997-6#1)(2008-4#1)
the activation spreads##2##3##(2008-7#2)
the activation state of##4##4##(1995-6#1)(2008-1#1)(2008-10#1)(2008-9#1)
the activation status of##2##4##(2008-11#1)(2008-7#1)
the activation status##3##3##(1997-7#1)(2008-11#1)(2008-7#1)
the activation##469##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#7)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#2)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#2)(1991-2#5)(1991-3#2)(1991-4#1)(1991-5#4)(1991-6#3)(1991-7#1)(1991-8#7)(1991-9#1)(1992-1#2)(1992-11#4)(1992-12#3)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#3)(1992-9#5)(1993-11#5)(1993-12#4)(1993-3#8)(1993-4#1)(1993-6#7)(1993-7#1)(1993-8#4)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#8)(1994-3#4)(1994-5#3)(1994-6#7)(1994-8#5)(1994-9#3)(1995-10#1)(1995-11#4)(1995-12#6)(1995-2#5)(1995-3#7)(1995-5#6)(1995-6#8)(1995-8#7)(1996-1#1)(1996-10#3)(1996-11#1)(1996-12#1)(1996-2#8)(1996-3#1)(1996-5#9)(1996-7#7)(1996-8#3)(1996-9#2)(1997-1#3)(1997-2#7)(1997-3#4)(1997-4#4)(1997-5#2)(1997-6#5)(1997-7#6)(2003-11#1)(2005-10#3)(2005-11#4)(2005-7#1)(2005-8#1)(2006-10#9)(2006-12#3)(2006-2#1)(2006-3#2)(2006-6#2)(2007-11#7)(2007-12#5)(2007-5#1)(2007-7#1)(2008-1#12)(2008-10#20)(2008-11#3)(2008-3#2)(2008-4#22)(2008-5#9)(2008-6#5)(2008-7#14)(2008-8#10)(2008-9#3)(2009-1#1)(2009-10#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-8#6)(2010-10#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#5)(2011-3#2)(2012-1#4)(2012-12#7)(2012-2#8)(2012-3#4)(2013-1#9)(2013-7#1)(2013-8#2)
the activation-deactivation cycle##2##3##(1990-7#2)
the activator of##2##3##(1990-9#1)(1993-8#1)
the activator protein##3##3##(1992-5#1)(1994-3#1)(2008-9#1)
the activator##21##2##(1990-9#1)(1992-5#2)(1992-9#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-3#1)(1997-1#1)(1997-4#3)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-3#1)
the activators##7##2##(1993-12#1)(1993-3#1)(1995-3#1)(1997-2#1)(2008-10#1)(2008-9#1)(2013-8#1)
the active agent in##2##4##(2006-12#1)(2008-11#1)
the active agent##4##3##(1993-10#1)(2006-12#1)(2007-11#1)(2008-11#1)
the active and##8##3##(1990-3#1)(1990-8#1)(1994-11#1)(2006-10#2)(2007-11#1)(2008-2#1)(2012-3#1)
the active area##2##3##(2008-2#1)(2008-3#1)
the active avoidance test##2##4##(2013-1#2)
the active binding##2##3##(1995-8#1)(2008-8#1)
the active c-erbB-2 protein##2##4##(1991-12#1)(1991-7#1)
the active center of##3##4##(1990-7#1)(1994-11#1)(2007-8#1)
the active center##9##3##(1990-11#1)(1990-7#1)(1991-6#1)(1994-11#1)(1995-11#2)(1996-2#1)(2007-8#1)(2008-8#1)
the active centre of the##2##5##(1990-10#1)(2008-5#1)
the active channel##2##3##(1997-8#2)
the active chemical##2##3##(2008-10#1)(2008-8#1)
the active component##2##3##(2010-12#1)(2011-1#1)
the active components of##3##4##(2008-10#2)(2013-1#1)
the active components##5##3##(1996-2#1)(2008-10#3)(2013-1#1)
the active compound##3##3##(2008-10#2)(2008-12#1)
the active compounds in##2##4##(1991-3#1)(2007-8#1)
the active compounds##8##3##(1991-3#1)(1994-9#1)(2007-8#1)(2008-10#2)(2008-3#1)(2010-7#1)(2012-2#1)
the active conformation##4##3##(1996-5#1)(1997-2#1)(2011-1#2)
the active constituents##3##3##(2007-1#1)(2008-10#1)(2012-11#1)
the active drug and the##2##5##(1990-10#1)(2012-2#1)
the active drug##5##3##(1990-10#1)(2005-7#1)(2012-1#1)(2012-2#2)
the active enantiomer of##2##4##(1993-11#1)(2006-2#1)
the active enzyme##9##3##(1992-12#1)(1992-2#1)(1994-12#1)(1995-3#1)(1995-5#1)(1996-5#3)(1997-4#1)
the active form of vitamin D##3##6##(2008-3#1)(2008-5#1)(2010-12#1)
the active form of##7##4##(1991-6#1)(1992-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-12#1)(2012-2#1)
the active form##10##3##(1990-2#1)(1991-6#1)(1992-12#1)(1995-2#1)(2006-7#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-12#1)(2012-2#1)
the active formation##2##3##(1997-2#1)(2013-7#1)
the active group##2##3##(2008-10#1)(2012-12#1)
the active immunoglobulin heavy chain gene##2##6##(2008-11#2)
the active ingredient##9##3##(2008-10#1)(2008-5#5)(2011-2#3)
the active ingredients in##2##4##(2008-1#1)(2010-9#1)
the active ingredients##7##3##(2008-1#1)(2008-5#3)(2009-6#1)(2010-2#1)(2010-9#1)
the active material##5##3##(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)
the active medium of##3##4##(2008-2#2)(2008-3#1)
the active medium##6##3##(2007-12#2)(2008-2#3)(2008-3#1)
the active metabolite of molsidomine##2##5##(1990-6#2)
the active metabolite of the##2##5##(1995-2#1)(2009-10#1)
the active metabolite of##6##4##(1990-6#2)(1995-2#1)(2005-1#1)(2007-11#1)(2009-10#1)
the active metabolite##7##3##(1990-6#2)(1991-8#1)(1995-2#1)(2005-1#1)(2007-11#1)(2009-10#1)
the active molecule##3##3##(2007-7#1)(2008-4#1)(2008-5#1)
the active oxygen##2##3##(1994-5#1)(2008-8#1)
the active participation of##6##4##(1993-3#1)(2006-4#1)(2008-10#2)(2009-4#1)(2010-5#1)
the active phase##2##3##(2006-2#1)(2008-4#1)
the active principle of##2##4##(1991-2#1)(1991-8#1)
the active principle##7##3##(1991-2#1)(1991-8#1)(1992-3#2)(2008-10#3)
the active principles##2##3##(1992-2#1)(2008-10#1)
the active region##4##3##(2007-11#1)(2007-12#1)(2008-8#2)
the active ret##2##3##(1993-8#2)
the active self-concept##3##3##(2008-5#3)
the active site and##6##4##(1991-2#1)(1992-6#1)(1994-8#1)(1995-10#2)(2012-2#1)
the active site are##3##4##(1991-8#1)(1992-11#1)(1995-5#1)
the active site by##3##4##(1995-3#1)(1997-1#1)(1997-6#1)
the active site cavity##2##4##(1997-4#2)
the active site cysteine residue##2##5##(1995-2#2)
the active site cysteine##3##4##(1995-2#2)(1995-5#1)
the active site for##2##4##(1993-3#1)(1995-2#1)
the active site histidine##3##4##(1991-2#1)(1992-12#1)(1993-8#1)
the active site in the##4##5##(1992-5#1)(1992-6#1)(1994-8#1)(1996-7#1)
the active site in##7##4##(1990-7#1)(1992-2#1)(1992-5#1)(1992-6#1)(1994-8#1)(1996-7#1)(2006-12#1)
the active site is##5##4##(1990-12#1)(1990-5#1)(1992-5#2)(1993-6#1)
the active site loop##2##4##(1994-2#1)(1994-8#1)
the active site may##2##4##(1995-5#1)(1996-5#1)
the active site nucleophile##3##4##(1995-2#1)(1995-6#2)
the active site of PKC##2##5##(1992-6#2)
the active site of the enzyme##13##6##(1990-9#1)(1991-5#1)(1992-11#1)(1992-6#1)(1992-7#1)(1993-3#1)(1993-4#1)(1994-5#1)(1994-8#1)(1996-10#1)(1997-6#1)(2008-4#1)(2009-9#1)
the active site of the##23##5##(1990-9#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-11#2)(1994-5#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-10#1)(1996-11#1)(1997-6#1)(2007-6#1)(2008-4#1)(2008-8#1)(2009-9#1)
the active site of this enzyme##3##6##(1990-5#1)(1991-8#1)(1994-3#1)
the active site of##74##4##(1990-2#3)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#2)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#4)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#3)(1994-11#3)(1994-3#1)(1994-5#7)(1994-8#4)(1995-11#4)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#1)(1997-4#1)(1997-6#1)(2007-6#1)(2008-3#2)(2008-4#1)(2008-8#2)(2009-3#1)(2009-9#1)(2010-2#1)
the active site or##2##4##(1997-2#1)(1997-6#1)
the active site peptide of##2##5##(1992-5#1)(1994-2#1)
the active site pocket##2##4##(1994-8#1)(2009-12#1)
the active site region##2##4##(1990-2#1)(1994-6#1)
the active site residues##3##4##(1990-3#1)(1997-4#1)(2007-6#1)
the active site serine##8##4##(1991-2#2)(1991-4#1)(1992-12#1)(1992-6#2)(1994-8#2)
the active site structure##2##4##(1992-6#1)(2009-3#1)
the active site to##3##4##(1994-5#1)(1995-6#1)(1997-1#1)
the active site were##2##4##(1991-6#1)(1993-11#1)
the active site while##2##4##(1991-4#1)(1993-11#1)
the active site zinc##2##4##(1995-5#1)(2004-12#1)
the active site##251##3##(1990-12#3)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#5)(1990-7#2)(1990-8#3)(1990-9#2)(1991-11#1)(1991-2#7)(1991-3#2)(1991-4#6)(1991-5#4)(1991-6#3)(1991-7#1)(1991-8#4)(1992-10#1)(1992-11#7)(1992-12#6)(1992-2#2)(1992-3#5)(1992-4#2)(1992-5#4)(1992-6#12)(1992-7#2)(1992-8#2)(1992-9#4)(1993-11#4)(1993-3#2)(1993-4#1)(1993-6#8)(1993-8#1)(1994-11#7)(1994-12#1)(1994-2#4)(1994-3#2)(1994-5#11)(1994-6#1)(1994-8#12)(1994-9#2)(1995-10#3)(1995-11#4)(1995-2#6)(1995-3#1)(1995-5#6)(1995-6#7)(1995-8#10)(1996-1#1)(1996-10#1)(1996-11#2)(1996-5#1)(1996-7#5)(1996-8#1)(1997-1#4)(1997-2#2)(1997-4#6)(1997-6#4)(1997-7#2)(2004-12#1)(2005-11#1)(2006-12#3)(2007-6#2)(2008-3#2)(2008-4#5)(2008-8#3)(2009-11#1)(2009-12#1)(2009-3#4)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2012-2#3)(2013-1#1)(2013-8#2)
the active site(s)##2##3##(1994-8#1)(1995-8#1)
the active sites of the##2##5##(1991-5#1)(1995-5#1)
the active sites of these##2##5##(1992-8#1)(2009-8#1)
the active sites of##13##4##(1990-8#1)(1991-3#1)(1991-5#1)(1992-8#2)(1994-11#1)(1994-12#1)(1994-8#1)(1995-5#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)
the active sites##18##3##(1990-8#1)(1991-11#1)(1991-3#1)(1991-5#1)(1992-8#3)(1994-11#1)(1994-12#1)(1994-8#1)(1995-5#2)(2008-10#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-12#1)
the active species##6##3##(1990-10#1)(1990-5#1)(1993-6#1)(1994-3#1)(1995-3#1)(2006-11#1)
the active state##3##3##(1990-8#1)(1994-9#1)(2008-11#1)
the active substance of##2##4##(2008-10#1)(2008-6#1)
the active substance##7##3##(1990-5#1)(1992-2#1)(1993-10#1)(2008-10#3)(2008-6#1)
the active surface##2##3##(2008-10#1)(2010-3#1)
the active surveillance##2##3##(2008-4#1)(2012-12#1)
the active to##2##3##(1996-5#1)(2008-5#1)
the active transport of##2##4##(1990-9#1)(2011-2#1)
the active treatment##2##3##(2008-5#1)(2012-3#1)
the active zone##3##3##(1994-8#1)(2007-10#1)(2007-11#1)
the active##614##2##(1990-10#3)(1990-11#2)(1990-12#3)(1990-2#5)(1990-3#3)(1990-4#1)(1990-5#7)(1990-6#3)(1990-7#3)(1990-8#7)(1990-9#3)(1991-11#2)(1991-12#1)(1991-2#8)(1991-3#5)(1991-4#6)(1991-5#7)(1991-6#6)(1991-7#2)(1991-8#6)(1991-9#3)(1992-10#1)(1992-11#7)(1992-12#10)(1992-2#5)(1992-3#7)(1992-4#2)(1992-5#5)(1992-6#15)(1992-7#3)(1992-8#5)(1992-9#5)(1993-10#2)(1993-11#6)(1993-3#5)(1993-4#2)(1993-5#1)(1993-6#9)(1993-8#4)(1993-9#1)(1994-11#12)(1994-12#6)(1994-2#6)(1994-3#7)(1994-5#13)(1994-6#1)(1994-8#16)(1994-9#4)(1995-10#3)(1995-11#7)(1995-2#8)(1995-3#5)(1995-5#10)(1995-6#8)(1995-8#13)(1996-1#1)(1996-10#2)(1996-11#3)(1996-12#1)(1996-2#2)(1996-5#7)(1996-7#5)(1996-8#3)(1996-9#1)(1997-1#4)(1997-2#5)(1997-4#7)(1997-6#5)(1997-7#4)(1997-8#3)(2004-12#1)(2004-3#1)(2004-9#1)(2005-1#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#7)(2006-11#1)(2006-12#4)(2006-2#3)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#3)(2007-1#1)(2007-10#2)(2007-11#8)(2007-12#8)(2007-2#1)(2007-5#1)(2007-6#3)(2007-7#2)(2007-8#4)(2008-1#3)(2008-10#37)(2008-11#8)(2008-12#2)(2008-2#9)(2008-3#9)(2008-4#9)(2008-5#19)(2008-6#2)(2008-7#3)(2008-8#13)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#4)(2009-4#1)(2009-6#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#5)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-9#2)(2011-1#5)(2011-2#8)(2012-1#5)(2012-11#1)(2012-12#5)(2012-2#11)(2012-3#3)(2013-1#8)(2013-7#2)(2013-8#5)
the active-site cysteine##4##3##(1993-11#1)(1994-2#2)(1995-2#1)
the active-site serine##3##3##(1991-2#2)(1993-11#1)
the active-site##27##2##(1991-2#5)(1991-4#3)(1992-5#1)(1993-11#2)(1993-3#1)(1994-2#2)(1994-3#1)(1994-5#2)(1995-2#1)(1995-3#2)(1995-6#3)(1996-11#1)(1996-4#1)(1997-4#1)(2009-9#1)
the actively##2##2##(2010-3#1)(2012-3#1)
the activin##3##2##(1992-3#1)(1992-6#1)(1994-9#1)
the activin-induced##2##2##(1992-4#2)
the activin/TGF-beta##2##2##(2010-2#2)
the activities and##6##3##(1994-5#1)(2008-1#2)(2008-2#1)(2008-4#1)(2008-5#1)
the activities in##3##3##(1992-8#1)(1995-3#1)(2004-11#1)
the activities of DNA polymerase##2##5##(1994-2#1)(2008-5#1)
the activities of DNA##3##4##(1992-6#1)(1994-2#1)(2008-5#1)
the activities of NADPH-cytochrome##2##4##(1995-3#1)(2008-8#1)
the activities of all##2##4##(1997-4#1)(2008-7#1)
the activities of both##2##4##(2008-10#1)(2011-2#1)
the activities of catalase and glutathione##2##6##(1990-4#1)(2008-7#1)
the activities of its##2##4##(2005-5#1)(2008-11#1)
the activities of key##4##4##(1990-2#1)(1995-3#1)(2008-11#1)(2011-2#1)
the activities of lipoprotein lipase##2##5##(2008-7#1)(2013-1#1)
the activities of plasma##2##4##(1993-9#1)(2008-7#1)
the activities of respiratory enzymes##2##5##(2008-10#2)
the activities of respiratory##3##4##(2005-8#1)(2008-10#2)
the activities of soil betaG##2##5##(2013-8#2)
the activities of soil##3##4##(2011-12#1)(2013-8#2)
the activities of superoxide dismutase (SOD)##2##6##(1994-6#1)(2007-9#1)
the activities of superoxide dismutase##3##5##(1990-3#1)(1994-6#1)(2007-9#1)
the activities of the enzyme complexes of the##3##8##(1996-9#3)
the activities of the##32##4##(1990-12#1)(1990-2#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-3#1)(1994-8#1)(1995-5#1)(1996-3#1)(1996-8#1)(1996-9#3)(2004-11#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
the activities of these enzymes##3##5##(1990-12#1)(1994-8#1)(1995-11#1)
the activities of these##6##4##(1990-12#1)(1993-4#1)(1994-8#1)(1995-11#1)(2008-6#1)(2008-9#1)
the activities of##142##3##(1990-12#3)(1990-2#2)(1990-3#2)(1990-4#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#3)(1991-11#1)(1991-12#2)(1991-4#1)(1991-8#5)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#3)(1995-1#1)(1995-10#2)(1995-11#1)(1995-3#2)(1995-5#2)(1995-9#1)(1996-2#1)(1996-3#2)(1996-8#1)(1996-9#3)(1997-2#2)(1997-4#1)(1997-5#2)(1997-8#1)(2004-11#2)(2005-5#1)(2005-8#2)(2006-3#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#2)(2009-2#1)(2010-2#3)(2010-8#2)(2011-12#1)(2011-2#4)(2012-12#3)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#5)
the activities that##3##3##(2006-5#1)(2007-5#1)(2008-7#1)
the activities##176##2##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#2)(1990-4#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#3)(1991-11#1)(1991-12#2)(1991-4#1)(1991-8#5)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#2)(1993-4#2)(1993-9#1)(1994-1#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#3)(1995-1#2)(1995-10#2)(1995-11#1)(1995-3#3)(1995-5#2)(1995-9#1)(1996-2#1)(1996-3#2)(1996-8#1)(1996-9#3)(1997-2#2)(1997-4#1)(1997-5#2)(1997-8#1)(2004-11#3)(2004-4#1)(2005-5#1)(2005-8#2)(2006-2#1)(2006-3#1)(2006-5#3)(2006-8#1)(2007-10#2)(2007-11#3)(2007-2#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-1#3)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#2)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#8)(2008-8#2)(2008-9#3)(2009-12#1)(2009-2#1)(2009-7#1)(2010-2#3)(2010-4#1)(2010-8#3)(2011-12#1)(2011-2#4)(2011-3#1)(2012-12#3)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#5)
the activity against##2##3##(1997-1#1)(2006-8#1)
the activity and expression of##2##5##(1996-12#1)(2008-11#1)
the activity and toxicity of a##2##6##(2006-6#2)
the activity and toxicity of##3##5##(1994-8#1)(2006-6#2)
the activity and##22##3##(1994-11#1)(1994-6#1)(1994-8#1)(1995-1#1)(1996-12#1)(1996-5#2)(1997-5#1)(1997-6#1)(1997-8#2)(2005-11#1)(2006-6#2)(2008-10#1)(2008-11#2)(2008-7#1)(2009-10#1)(2011-2#1)(2013-1#1)(2013-7#1)
the activity as##2##3##(1990-3#1)(2007-2#1)
the activity at##3##3##(1990-7#1)(1994-12#1)(2008-4#1)
the activity by##8##3##(1990-10#1)(1990-5#2)(1990-9#1)(1991-1#1)(2006-8#3)
the activity change##2##3##(1990-10#1)(1997-7#1)
the activity coefficient##3##3##(2006-10#2)(2008-10#1)
the activity coefficients of glycine##2##5##(2006-10#2)
the activity coefficients of##6##4##(1990-8#1)(1991-5#1)(2006-10#2)(2008-10#2)
the activity coefficients##8##3##(1990-8#1)(1991-5#1)(2006-10#2)(2008-10#4)
the activity during the##2##4##(2008-11#1)(2010-8#1)
the activity for##2##3##(2008-5#1)(2010-3#1)
the activity in the##3##4##(1990-10#1)(1992-6#1)(2012-1#1)
the activity in##9##3##(1990-10#2)(1992-6#1)(1993-3#1)(1996-12#1)(2008-11#1)(2008-4#1)(2012-1#1)(2013-1#1)
the activity increased##2##3##(1990-7#1)(1991-10#1)
the activity is##10##3##(1990-2#1)(1990-8#1)(1991-8#1)(1994-2#1)(1995-6#1)(1996-7#1)(2008-7#1)(2009-2#1)(2009-3#1)(2013-1#1)
the activity level of##2##4##(1991-12#1)(2011-12#1)
the activity level the##2##4##(2007-11#1)(2008-8#1)
the activity level##4##3##(1991-12#1)(2007-11#1)(2008-8#1)(2011-12#1)
the activity levels of##2##4##(1993-9#2)
the activity observed##3##3##(1990-9#1)(1997-8#1)(2009-2#1)
the activity of 2##2##4##(1996-11#1)(2008-10#1)
the activity of DNA polymerase alpha##2##6##(1994-2#2)
the activity of DNA##4##4##(1994-2#2)(2005-8#1)(2009-8#1)
the activity of HIV-RT##2##4##(2011-1#2)
the activity of NK cells##2##5##(2008-10#2)
the activity of SOD##3##4##(1997-8#1)(2009-5#1)(2012-2#1)
the activity of a range of##2##6##(2005-8#1)(2010-5#1)
the activity of a##16##4##(1990-8#1)(1993-12#1)(1995-2#2)(1996-10#1)(1997-6#1)(2005-11#1)(2005-8#1)(2007-11#1)(2008-4#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-3#1)(2012-3#1)(2013-8#1)
the activity of an##5##4##(1991-12#1)(1991-5#1)(2007-8#1)(2008-10#1)(2010-11#1)
the activity of antioxidant enzymes##5##5##(1990-4#3)(2008-1#1)(2011-12#1)
the activity of antioxidant##7##4##(1990-4#3)(1996-1#1)(2008-1#1)(2011-12#1)(2011-2#1)
the activity of any of the##2##6##(1993-4#1)(2012-12#1)
the activity of at least##2##5##(1996-10#1)(2007-7#1)
the activity of both##4##4##(1995-1#1)(2008-10#1)(2008-11#1)(2010-2#1)
the activity of cells##2##4##(1995-5#1)(2007-11#1)
the activity of complex III##3##5##(1994-10#1)(2005-8#2)
the activity of cytochrome c with##2##6##(1995-2#2)
the activity of cytochrome##4##4##(1995-2#2)(1996-8#1)(1997-2#1)
the activity of cytosolic##4##4##(1990-5#1)(1991-5#1)(1991-9#1)(1992-5#1)
the activity of different##3##4##(1992-5#1)(1995-4#1)(2009-3#1)
the activity of endogenous##2##4##(2008-5#1)(2009-12#1)
the activity of enzymes##4##4##(1991-5#1)(2008-10#1)(2008-2#1)(2010-8#1)
the activity of exogenously##2##4##(1993-3#1)(2009-8#1)
the activity of glutathione##2##4##(1990-4#1)(1991-1#1)
the activity of growth factor##2##5##(2008-12#1)(2012-1#1)
the activity of hepatic glucose-6-phosphatase##2##5##(1991-9#1)(2008-11#1)
the activity of heterotrophic microorganism in membrane bioreactor##2##8##(2013-1#2)
the activity of human##2##4##(1992-4#1)(2008-5#1)
the activity of its##2##4##(2009-3#1)(2010-5#1)
the activity of lysine-ketoglutarate reductase##2##5##(1994-3#2)
the activity of multiple##2##4##(1996-2#1)(2003-11#1)
the activity of native##2##4##(1990-2#1)(1991-2#1)
the activity of neurons and muscles##3##6##(2007-12#3)
the activity of noradrenergic neurons##2##5##(1994-2#2)
the activity of one##3##4##(2004-12#1)(2007-8#1)(2012-12#1)
the activity of other##2##4##(1996-1#1)(2013-7#1)
the activity of phospholipase A2##3##5##(1992-5#1)(1994-5#2)
the activity of phospholipase##5##4##(1991-1#1)(1992-5#1)(1994-5#2)(2011-2#1)
the activity of protein kinase C##2##6##(1994-8#1)(1996-5#1)
the activity of protein kinase##3##5##(1993-12#1)(1994-8#1)(1996-5#1)
the activity of quinolones##2##4##(2008-3#1)(2008-5#1)
the activity of rat##2##4##(1994-8#1)(2008-5#1)
the activity of recombinant##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
the activity of several##2##4##(2007-9#1)(2008-10#1)
the activity of single##3##4##(1990-2#1)(1994-3#1)(1996-12#1)
the activity of some##3##4##(2006-8#1)(2008-5#1)(2012-2#1)
the activity of specific##2##4##(1994-6#1)(2009-8#1)
the activity of superoxide dismutase (SOD) and##2##7##(1997-2#1)(2012-2#1)
the activity of superoxide dismutase (SOD)##4##6##(1997-2#1)(2011-1#1)(2012-2#2)
the activity of superoxide dismutase##6##5##(1991-1#1)(1997-2#1)(1997-6#1)(2011-1#1)(2012-2#2)
the activity of the androgen receptor##2##6##(2009-4#1)(2012-12#1)
the activity of the anoxic stress protein##2##7##(1993-12#2)
the activity of the disease##3##5##(1996-1#1)(2006-10#1)(2013-1#1)
the activity of the endogenous##2##5##(1996-12#1)(2006-11#1)
the activity of the enzyme in##2##6##(1995-11#1)(1996-2#1)
the activity of the enzyme##11##5##(1994-2#1)(1994-6#1)(1994-9#1)(1995-11#1)(1996-2#1)(1997-6#1)(2006-9#1)(2007-11#1)(2008-9#1)(2009-6#1)(2013-1#1)
the activity of the enzymes##2##5##(1996-8#1)(2008-7#1)
the activity of the immobilized##2##5##(2008-10#2)
the activity of the phosphate carrier##5##6##(1990-8#1)(1992-1#4)
the activity of the promoter##2##5##(1995-6#1)(1996-7#1)
the activity of the purified##2##5##(1991-8#1)(1994-5#1)
the activity of the reconstituted##2##5##(1995-2#1)(1997-7#1)
the activity of the respiratory##2##5##(1992-8#1)(1994-6#1)
the activity of the##157##4##(1990-10#1)(1990-11#2)(1990-2#2)(1990-3#1)(1990-5#2)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#4)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#4)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#5)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#6)(1994-8#2)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#4)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#4)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#3)(1997-4#1)(1997-6#3)(1997-7#2)(2005-12#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#2)(2007-7#3)(2008-1#2)(2008-10#6)(2008-11#2)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#5)(2012-3#2)(2013-1#7)(2013-8#1)
the activity of these two##2##5##(1997-5#1)(2007-1#1)
the activity of these##8##4##(1991-1#1)(1997-5#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-3#1)
the activity of this drug##2##5##(1997-2#1)(2008-6#1)
the activity of this enzyme##4##5##(1990-12#1)(1991-10#1)(1991-9#1)(1994-6#1)
the activity of this receptor##2##5##(1994-8#1)(2005-11#1)
the activity of this##13##4##(1990-12#1)(1990-5#1)(1991-10#1)(1991-6#1)(1991-9#1)(1993-9#1)(1994-6#1)(1994-8#1)(1996-5#1)(1997-2#1)(1997-3#1)(2005-11#1)(2008-6#1)
the activity of three different##2##5##(2008-10#1)(2008-5#1)
the activity of three##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
the activity of two##4##4##(1991-3#1)(1994-6#1)(2006-8#2)
the activity of type##2##4##(1991-4#1)(2008-8#1)
the activity of various##3##4##(1994-12#1)(1994-8#1)(2010-12#1)
the activity of which is##4##5##(1990-7#1)(1990-9#1)(1994-6#1)(1995-7#1)
the activity of##610##3##(1990-10#3)(1990-11#5)(1990-12#1)(1990-2#6)(1990-3#2)(1990-4#5)(1990-5#7)(1990-7#9)(1990-8#5)(1990-9#2)(1991-1#7)(1991-10#1)(1991-12#2)(1991-2#5)(1991-3#3)(1991-4#2)(1991-5#8)(1991-6#2)(1991-7#3)(1991-8#4)(1991-9#6)(1992-1#4)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#1)(1992-3#3)(1992-4#2)(1992-5#5)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#8)(1993-2#1)(1993-3#5)(1993-4#3)(1993-6#1)(1993-8#2)(1993-9#5)(1994-10#2)(1994-11#3)(1994-12#8)(1994-2#7)(1994-3#3)(1994-5#5)(1994-6#13)(1994-7#1)(1994-8#11)(1994-9#6)(1995-1#10)(1995-10#1)(1995-11#4)(1995-12#5)(1995-2#8)(1995-3#4)(1995-4#1)(1995-5#5)(1995-6#5)(1995-7#2)(1995-8#1)(1995-9#1)(1996-1#3)(1996-10#3)(1996-11#1)(1996-12#5)(1996-2#6)(1996-3#2)(1996-4#2)(1996-5#11)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#2)(1997-1#4)(1997-2#10)(1997-3#2)(1997-4#3)(1997-5#3)(1997-6#8)(1997-7#3)(1997-8#2)(2003-11#1)(2004-12#2)(2005-1#1)(2005-11#4)(2005-12#1)(2005-4#1)(2005-7#2)(2005-8#6)(2006-10#2)(2006-11#2)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#5)(2006-9#2)(2007-1#1)(2007-11#9)(2007-12#5)(2007-7#5)(2007-8#6)(2007-9#3)(2008-1#10)(2008-10#29)(2008-11#11)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#13)(2008-5#15)(2008-6#6)(2008-7#6)(2008-8#11)(2008-9#10)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#5)(2009-4#3)(2009-5#3)(2009-6#1)(2009-8#9)(2010-11#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-5#3)(2010-8#2)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#5)(2011-3#3)(2012-1#3)(2012-12#8)(2012-2#8)(2012-3#8)(2013-1#15)(2013-7#2)(2013-8#3)
the activity or##2##3##(1994-2#1)(2012-12#1)
the activity profile during the host infection process and the effect of lipase activity inhibitor ebelactone B on infection##2##19##(2010-10#2)
the activity profile##3##3##(1996-12#1)(2010-10#2)
the activity recovery##2##3##(2011-2#2)
the activity status of PKC##2##5##(1994-12#2)
the activity status of##3##4##(1994-12#2)(2010-6#1)
the activity therapies##2##3##(1993-2#2)
the activity to##3##3##(1992-7#1)(1994-5#1)(1994-9#1)
the activity was found##2##4##(1992-8#1)(2008-10#1)
the activity was inhibited by##2##5##(1993-4#1)(1994-12#1)
the activity was##19##3##(1990-10#1)(1990-2#1)(1991-10#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-4#2)(1994-11#2)(1994-12#2)(1995-11#1)(1996-5#1)(2008-10#1)(2009-2#1)(2013-1#1)
the activity with##5##3##(1990-11#1)(1993-8#1)(1994-8#1)(1995-3#1)(1996-9#1)
the activity##816##2##(1990-10#8)(1990-11#6)(1990-12#2)(1990-2#8)(1990-3#3)(1990-4#5)(1990-5#9)(1990-6#1)(1990-7#12)(1990-8#7)(1990-9#4)(1991-1#8)(1991-10#5)(1991-11#1)(1991-12#4)(1991-2#5)(1991-3#5)(1991-4#3)(1991-5#12)(1991-6#3)(1991-7#3)(1991-8#6)(1991-9#6)(1992-1#4)(1992-10#1)(1992-11#5)(1992-12#5)(1992-2#2)(1992-3#5)(1992-4#2)(1992-5#6)(1992-6#6)(1992-7#2)(1992-8#4)(1992-9#3)(1993-11#2)(1993-12#8)(1993-2#3)(1993-3#6)(1993-4#5)(1993-5#2)(1993-6#1)(1993-8#3)(1993-9#7)(1994-10#2)(1994-11#7)(1994-12#16)(1994-2#10)(1994-3#3)(1994-5#6)(1994-6#15)(1994-7#1)(1994-8#18)(1994-9#11)(1995-1#11)(1995-10#1)(1995-11#5)(1995-12#7)(1995-2#9)(1995-3#7)(1995-4#1)(1995-5#5)(1995-6#6)(1995-7#2)(1995-8#1)(1995-9#1)(1996-1#3)(1996-10#4)(1996-11#1)(1996-12#8)(1996-2#6)(1996-3#3)(1996-4#2)(1996-5#14)(1996-6#1)(1996-7#3)(1996-8#3)(1996-9#6)(1997-1#7)(1997-2#10)(1997-3#2)(1997-4#3)(1997-5#4)(1997-6#10)(1997-7#6)(1997-8#5)(2003-11#1)(2004-12#2)(2005-1#1)(2005-11#6)(2005-12#1)(2005-4#1)(2005-7#2)(2005-8#6)(2006-10#6)(2006-11#2)(2006-12#2)(2006-2#1)(2006-6#2)(2006-7#1)(2006-8#9)(2006-9#2)(2007-1#1)(2007-11#11)(2007-12#5)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#5)(2007-8#6)(2007-9#3)(2008-1#11)(2008-10#37)(2008-11#16)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#17)(2008-5#19)(2008-6#6)(2008-7#9)(2008-8#15)(2008-9#10)(2009-10#2)(2009-12#1)(2009-2#6)(2009-3#7)(2009-4#3)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#9)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#8)(2011-12#2)(2011-2#9)(2011-3#3)(2012-1#4)(2012-11#2)(2012-12#9)(2012-2#8)(2012-3#8)(2013-1#20)(2013-7#3)(2013-8#5)
the actor effect##2##3##(2013-8#2)
the actor##5##2##(2008-11#2)(2013-8#3)
the acts##4##2##(1995-1#1)(2009-6#1)(2010-12#1)(2011-1#1)
the actual capacity (equipment##3##4##(2008-10#3)
the actual cause of death##3##5##(1996-7#3)
the actual cause##4##3##(1996-7#4)
the actual chemical##2##3##(1992-9#1)(2008-4#1)
the actual concentrations##2##3##(2008-10#2)
the actual daily##2##3##(2008-10#1)(2013-7#1)
the actual distribution of##3##4##(2007-10#1)(2007-5#1)(2008-10#1)
the actual effects##3##3##(2008-1#1)(2012-2#2)
the actual evidence##2##3##(2006-10#1)(2011-2#1)
the actual image##3##3##(1995-8#2)(2010-5#1)
the actual impact of##3##4##(1994-1#1)(1997-3#1)(2013-8#1)
the actual lesion##2##3##(2006-7#1)(2007-11#1)
the actual level of##4##4##(1993-2#1)(2004-12#1)(2009-5#1)(2012-3#1)
the actual location of the##2##5##(2006-6#1)(2010-8#1)
the actual measurement##2##3##(2007-12#1)(2010-8#1)
the actual mechanism##3##3##(1991-1#1)(1993-6#1)(2008-11#1)
the actual mechanism(s)##2##3##(2007-11#1)(2008-10#1)
the actual number of##5##4##(1993-12#1)(2008-1#1)(2008-2#1)(2008-8#1)(2012-3#1)
the actual outcome##2##3##(2007-8#1)(2007-9#1)
the actual phase##3##3##(2008-3#3)
the actual rate of transport##2##5##(1990-3#2)
the actual rate of##3##4##(1990-11#1)(1990-3#2)
the actual rate##4##3##(1990-11#1)(1990-3#2)(1997-6#1)
the actual role of##3##4##(1996-5#1)(2007-5#1)(2011-2#1)
the actual sample##2##3##(1990-11#1)(2008-10#1)
the actual use of medicines##2##5##(2008-11#2)
the actual use of##4##4##(1995-3#1)(2008-11#2)(2008-9#1)
the actual use##5##3##(1995-3#1)(1997-8#1)(2008-11#2)(2008-9#1)
the actual values of the##2##5##(2007-11#1)(2008-3#1)
the actual##235##2##(1990-11#2)(1990-12#2)(1990-3#3)(1991-1#1)(1991-12#2)(1991-2#1)(1991-5#2)(1992-11#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#2)(1993-10#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-11#2)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#4)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#4)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-12#1)(2005-1#1)(2005-11#3)(2006-10#8)(2006-12#2)(2006-2#1)(2006-5#2)(2006-6#4)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#6)(2007-3#1)(2007-4#1)(2007-5#2)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#19)(2008-11#8)(2008-12#2)(2008-2#10)(2008-3#19)(2008-4#5)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#4)(2009-5#3)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-12#2)(2011-2#4)(2012-1#3)(2012-2#6)(2012-3#3)(2013-7#1)(2013-8#2)
the actuarial survival##2##3##(1990-9#1)(2011-2#1)
the actuarial##5##2##(1990-6#1)(1990-9#1)(1997-8#1)(2011-2#2)
the actuation##5##2##(2005-10#1)(2006-12#1)(2009-11#1)(2010-4#2)
the actuator##9##2##(2008-2#1)(2008-3#2)(2010-2#2)(2010-4#2)(2012-1#2)
the actuators##5##2##(2008-2#1)(2009-9#1)(2010-2#2)(2011-1#1)
the acuity##2##2##(1992-7#1)(2007-8#1)
the aculeus apex##2##3##(2008-6#2)
the aculeus##3##2##(2008-6#3)
the acupoints of left HM##3##5##(2008-9#3)
the acupoints of##4##3##(2008-9#4)
the acupuncture group##2##3##(1995-9#2)
the acupuncture##4##2##(1995-9#2)(2011-1#2)
the acute and chronic##4##4##(1991-9#1)(1997-1#1)(2008-5#1)(2013-1#1)
the acute and late##2##4##(2008-6#1)(2009-3#1)
the acute and long-term##2##4##(2004-2#1)(2007-8#1)
the acute and subacute##4##4##(2005-8#1)(2007-9#1)(2008-3#2)
the acute and the chronic##2##5##(1994-2#1)(1995-12#1)
the acute and the##3##4##(1994-2#1)(1995-12#1)(1997-7#1)
the acute and##18##3##(1991-9#1)(1994-2#1)(1995-12#1)(1997-1#1)(1997-7#1)(2004-2#1)(2005-8#1)(2007-8#1)(2007-9#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2013-1#1)
the acute care setting##2##4##(2008-3#1)(2011-1#1)
the acute care##12##3##(1996-2#2)(1996-3#1)(1997-1#1)(1997-4#1)(2008-3#2)(2010-4#1)(2011-1#1)(2012-11#1)(2013-1#2)
the acute coronary ischemic syndromes##3##5##(2008-10#3)
the acute coronary syndromes of unstable angina##2##7##(2007-11#1)(2010-12#1)
the acute coronary syndromes##3##4##(2007-11#1)(2008-3#1)(2010-12#1)
the acute coronary##7##3##(2007-11#1)(2008-10#3)(2008-3#2)(2010-12#1)
the acute effect of##5##4##(1996-6#1)(1996-9#1)(2008-3#1)(2008-6#1)(2009-12#1)
the acute effect##6##3##(1996-6#1)(1996-9#2)(2008-3#1)(2008-6#1)(2009-12#1)
the acute effects of a##2##5##(1997-5#1)(2011-2#1)
the acute effects of##14##4##(1990-5#1)(1990-8#1)(1991-11#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-11#1)(1997-2#1)(1997-5#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2011-2#1)
the acute episode##3##3##(1991-8#1)(1993-10#1)(2010-10#1)
the acute form##2##3##(2006-2#1)(2006-6#1)
the acute hospital##4##3##(2005-8#1)(2007-10#1)(2007-9#2)
the acute infection##2##3##(2008-4#1)(2009-8#1)
the acute management of migraine##3##5##(2007-10#1)(2008-3#2)
the acute management of##4##4##(2007-10#1)(2008-3#3)
the acute medical##2##3##(2010-12#1)(2010-5#1)
the acute phase of ischemic stroke##2##6##(2007-9#1)(2010-2#1)
the acute phase of stroke##2##5##(1991-11#1)(2007-10#1)
the acute phase of the disease##2##6##(2007-7#1)(2013-1#1)
the acute phase of the##5##5##(1997-3#1)(1997-5#1)(2007-7#1)(2008-8#1)(2013-1#1)
the acute phase of##26##4##(1991-11#1)(1992-11#1)(1997-3#1)(1997-5#6)(2005-8#1)(2006-9#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-1#1)(2010-2#1)(2012-2#1)(2013-1#3)
the acute phase response to##2##5##(1993-12#1)(1994-9#1)
the acute phase response##14##4##(1992-9#1)(1993-12#2)(1994-6#1)(1994-9#4)(1995-2#3)(1996-2#3)
the acute phase responsive##2##4##(1991-7#1)(1992-12#1)
the acute phase##59##3##(1991-11#2)(1991-7#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-12#3)(1993-5#1)(1994-6#1)(1994-8#1)(1994-9#4)(1995-2#3)(1996-2#3)(1996-9#2)(1997-3#1)(1997-5#6)(2005-8#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-1#1)(2009-5#1)(2010-1#1)(2010-2#1)(2012-2#2)(2013-1#4)(2013-7#1)
the acute respiratory distress syndrome (ARDS)##3##6##(2005-8#3)
the acute respiratory distress syndrome##4##5##(2005-8#4)
the acute setting##3##3##(2007-10#1)(2007-9#1)(2013-1#1)
the acute stage of##7##4##(1990-9#1)(1995-5#2)(1997-6#1)(2005-1#1)(2006-10#1)(2008-12#1)
the acute stage##21##3##(1990-12#1)(1990-9#1)(1991-9#1)(1995-5#3)(1997-6#1)(2005-1#1)(2006-10#1)(2007-10#6)(2007-9#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-11#1)
the acute state##2##3##(1996-2#1)(1996-3#1)
the acute to the chronic##2##5##(1996-4#1)(1997-8#1)
the acute toxicity of##2##4##(2004-4#1)(2008-7#1)
the acute toxicity##4##3##(2004-4#1)(2005-10#1)(2008-10#1)(2008-7#1)
the acute treatment of##2##4##(2005-7#1)(2006-10#1)
the acute treatment##3##3##(1997-7#1)(2005-7#1)(2006-10#1)
the acute##251##2##(1990-10#1)(1990-12#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-11#3)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#4)(1992-9#1)(1993-10#1)(1993-12#3)(1993-5#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-6#1)(1994-8#2)(1994-9#4)(1995-11#1)(1995-12#5)(1995-2#4)(1995-5#3)(1995-6#1)(1995-9#2)(1996-12#3)(1996-2#6)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#8)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#7)(1997-6#1)(1997-7#2)(1997-8#2)(2004-2#1)(2004-4#1)(2005-1#1)(2005-10#2)(2005-11#1)(2005-7#1)(2005-8#7)(2006-10#6)(2006-11#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#14)(2007-11#7)(2007-2#1)(2007-7#3)(2007-8#3)(2007-9#8)(2008-10#8)(2008-12#2)(2008-3#15)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#4)(2009-1#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-5#2)(2011-1#1)(2011-2#3)(2012-11#3)(2012-2#5)(2013-1#9)(2013-7#1)
the acute-phase reaction##2##3##(1993-8#1)(1994-3#1)
the acute-phase response##5##3##(1990-2#1)(1990-3#1)(1994-10#2)(2006-2#1)
the acute-phase##8##2##(1990-2#1)(1990-3#1)(1993-8#1)(1994-10#2)(1994-3#1)(1995-11#1)(2006-2#1)
the acutely##11##2##(1991-2#2)(1994-6#1)(1995-2#2)(1996-10#1)(1996-9#1)(1997-3#2)(1997-5#1)(2007-12#1)
the acyclic##7##2##(1990-9#2)(1992-3#1)(1996-5#1)(2005-7#1)(2008-10#1)(2008-5#1)
the acyl CoA##2##3##(1991-3#2)
the acyl chain length of##2##5##(1990-7#1)(1994-5#1)
the acyl chain region##3##4##(1994-11#2)(1994-3#1)
the acyl chain##11##3##(1990-7#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-5#1)(1996-5#1)(2005-11#1)
the acyl chains of the phospholipid##3##6##(1990-3#1)(1993-9#1)(1995-8#1)
the acyl chains of the##4##5##(1990-3#2)(1993-9#1)(1995-8#1)
the acyl chains of##6##4##(1990-3#2)(1992-9#1)(1993-9#1)(1995-8#1)(2008-10#1)
the acyl chains##11##3##(1990-3#3)(1991-2#1)(1992-1#1)(1992-9#2)(1993-9#1)(1994-11#1)(1995-8#1)(2008-10#1)
the acyl transfer##2##3##(1991-5#2)
the acyl##34##2##(1990-3#3)(1990-4#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#3)(1991-4#2)(1991-5#2)(1992-1#1)(1992-9#3)(1993-11#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-3#1)(1994-5#1)(1995-8#1)(1996-5#2)(2005-11#1)(2008-10#2)(2009-2#1)
the acyl-CoA oxidase##2##3##(1994-6#1)(1995-3#1)
the acyl-CoA##5##2##(1990-2#1)(1990-5#1)(1994-6#1)(1995-3#1)(1995-5#1)
the acyl-coenzyme A binding protein##2##5##(1995-5#2)
the acyl-enzyme##3##2##(1991-5#2)(2008-7#1)
the acylated##3##2##(1990-2#2)(1994-3#1)
the acylation of##3##3##(1990-5#2)(1997-4#1)
the acylation process##2##3##(1990-11#1)(1990-8#1)
the acylation##8##2##(1990-11#1)(1990-5#2)(1990-8#2)(1995-8#1)(1997-4#2)
the acyltransferase##3##2##(1991-2#2)(1996-5#1)
the ad libitum##2##3##(2008-7#1)(2013-7#1)
the ad##3##2##(2008-7#2)(2013-7#1)
the adaptability of##4##3##(1991-8#1)(1995-4#1)(2007-12#1)(2012-11#1)
the adaptation and##2##3##(2008-10#1)(2010-1#1)
the adaptation of a##2##4##(1990-12#1)(1996-8#1)
the adaptation of the##8##4##(1995-7#1)(2005-10#1)(2006-10#1)(2006-7#1)(2008-10#1)(2008-2#1)(2008-8#1)(2012-3#1)
the adaptation of##22##3##(1990-12#1)(1991-11#1)(1992-2#1)(1994-8#1)(1995-7#1)(1996-8#1)(1997-2#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-3#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-6#1)(2011-1#1)(2012-3#1)(2013-8#1)
the adaptation period##3##3##(1992-10#3)
the adaptation potential##2##3##(2006-6#1)(2010-12#1)
the adaptation##38##2##(1990-12#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-10#3)(1992-2#1)(1994-8#1)(1995-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-7#1)(2007-3#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-8#1)(2009-6#1)(2010-1#1)(2010-12#1)(2011-1#2)(2012-3#2)(2013-8#1)
the adapted##4##2##(1992-10#1)(1997-1#1)(2008-7#1)(2013-8#1)
the adaptive changes of##2##4##(2005-12#1)(2010-10#1)
the adaptive changes##3##3##(2005-12#2)(2010-10#1)
the adaptive effect was found##2##5##(1992-10#2)
the adaptive effect was##3##4##(1992-10#3)
the adaptive effect##4##3##(1992-10#4)
the adaptive gain theory##2##4##(2011-1#2)
the adaptive immune response by##3##5##(2007-11#1)(2008-3#1)(2008-4#1)
the adaptive immune response##12##4##(2006-10#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-6#1)(2010-12#1)(2010-2#1)(2012-12#1)(2013-8#1)
the adaptive immune##14##3##(2006-10#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-6#1)(2010-12#1)(2010-2#1)(2012-12#1)(2013-8#2)
the adaptive mechanisms##2##3##(2012-2#1)(2012-3#1)
the adaptive nature of##2##4##(2008-7#1)(2012-2#1)
the adaptive response on##2##4##(1997-1#1)(2008-7#1)
the adaptive response##6##3##(1997-1#3)(2008-7#2)(2013-1#1)
the adaptive responses of##2##4##(1994-12#1)(2011-1#1)
the adaptive responses##3##3##(1994-12#1)(1994-2#1)(2011-1#1)
the adaptive significance of##3##4##(1993-12#1)(2008-9#1)(2010-8#1)
the adaptive system##2##3##(2006-10#1)(2008-2#1)
the adaptive value of##2##4##(2008-8#1)(2009-8#1)
the adaptive##74##2##(1992-10#4)(1993-12#1)(1994-12#1)(1994-2#1)(1995-12#1)(1997-1#3)(1997-2#2)(2005-12#2)(2006-10#2)(2007-11#3)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#7)(2008-3#8)(2008-4#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
the adaptor protein Grb2##2##4##(1995-3#1)(2006-12#1)
the adaptor protein##6##3##(1995-3#1)(1997-6#1)(2006-12#1)(2012-3#1)(2013-1#2)
the addAB##2##2##(1995-8#2)
the added advantage of##2##4##(2008-2#1)(2008-4#1)
the added amount##3##3##(2004-9#1)(2008-10#2)
the added benefit of##4##4##(2008-8#1)(2010-4#1)(2010-8#1)(2012-1#1)
the added copper##2##3##(1990-8#1)(1997-8#1)
the added flexibility##2##3##(1997-6#1)(2008-3#1)
the added petroleum hydrocarbons##2##4##(2006-12#2)
the added value of the##2##5##(2009-4#1)(2012-1#1)
the added value of##4##4##(2009-4#1)(2010-2#1)(2011-2#1)(2012-1#1)
the added##55##2##(1990-5#1)(1990-8#2)(1991-12#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-3#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-1#1)(1996-12#1)(1996-7#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-12#1)(2006-12#2)(2006-3#3)(2006-4#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#3)(2013-1#1)
the addictive##3##2##(1995-4#1)(2007-3#1)(2013-1#1)
the adding##2##2##(2008-10#1)(2008-3#1)
the addition and removal of##2##5##(1996-7#1)(2008-2#1)
the addition and##3##3##(1995-3#1)(1996-7#1)(2008-2#1)
the addition of &quot##2##4##(1991-10#1)(2005-11#1)
the addition of 0##10##4##(1990-10#1)(1990-5#1)(1993-12#1)(1997-8#1)(2008-10#2)(2008-5#2)(2012-12#1)(2013-1#1)
the addition of 1 mM calcium ions##2##7##(2005-11#2)
the addition of 1 mM##4##5##(1992-2#1)(1997-1#1)(2005-11#2)
the addition of 1##6##4##(1991-4#1)(1992-2#1)(1992-8#1)(1997-1#1)(2005-11#2)
the addition of 10 mM##2##5##(1993-9#1)(1994-3#1)
the addition of 10##3##4##(1993-9#1)(1994-3#1)(2008-10#1)
the addition of 200##2##4##(1993-2#1)(2008-10#1)
the addition of 5 microM##2##5##(1991-2#1)(1995-6#1)
the addition of 5##3##4##(1991-2#1)(1995-6#1)(1996-6#1)
the addition of ATP##3##4##(1992-12#1)(1993-9#1)(2008-8#1)
the addition of B##2##4##(2007-3#2)
the addition of CO##2##4##(1995-5#1)(2010-12#1)
the addition of Ca2+##3##4##(1990-8#1)(1992-8#1)(1993-11#1)
the addition of Con A##2##5##(1990-3#2)
the addition of Cremophor EL##2##5##(2008-3#2)
the addition of Cu##3##4##(2004-9#1)(2008-11#2)
the addition of D-glucose anomer##2##5##(1994-8#2)
the addition of EDTA##6##4##(1992-12#1)(1993-4#1)(2008-10#3)(2008-4#1)
the addition of HSA##2##4##(1994-9#2)
the addition of IL-2##2##4##(2007-11#1)(2008-4#1)
the addition of N-linked oligosaccharides##2##5##(1990-3#2)
the addition of NaCl##2##4##(2005-11#1)(2008-10#1)
the addition of a known##2##5##(2008-10#1)(2008-9#1)
the addition of a small amount of##2##7##(2008-3#1)(2008-5#1)
the addition of a##36##4##(1990-7#1)(1993-3#1)(1995-5#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-9#1)(2009-12#2)(2010-12#1)(2011-1#1)(2013-1#1)
the addition of actinomycin D##3##5##(1992-8#1)(1997-2#1)(2008-11#1)
the addition of ammonium##3##4##(1991-5#1)(2008-10#1)(2011-1#1)
the addition of an##11##4##(1992-9#1)(1993-2#1)(1996-6#1)(1996-9#1)(2005-11#1)(2008-10#2)(2008-2#2)(2011-1#1)(2011-2#1)
the addition of antibiotics##2##4##(2007-7#1)(2013-8#1)
the addition of apyrase##2##4##(2008-4#2)
the addition of chemotherapy##2##4##(2011-1#1)(2012-3#1)
the addition of cytochrome b(5)##2##5##(2011-2#2)
the addition of dexamethasone##2##4##(2008-11#1)(2008-5#1)
the addition of different##3##4##(2008-6#1)(2011-2#1)(2012-12#1)
the addition of either##3##4##(1996-9#1)(2008-5#1)(2010-4#1)
the addition of excess##3##4##(1992-2#1)(1994-9#1)(2008-10#1)
the addition of exogenous genes##2##5##(2012-3#2)
the addition of exogenous growth factors##2##6##(2008-11#1)(2008-9#1)
the addition of exogenous##7##4##(1991-4#1)(1992-8#1)(1997-1#1)(2008-11#1)(2008-9#1)(2012-3#2)
the addition of gentamycin##2##4##(2007-12#1)(2013-8#1)
the addition of glucose##3##4##(1990-2#1)(2006-10#1)(2008-10#1)
the addition of glycerol##4##4##(1993-9#1)(1995-4#1)(1997-6#1)(2008-10#1)
the addition of human##3##4##(1992-2#1)(1992-5#1)(1994-3#1)
the addition of ketamine##2##4##(1996-8#2)
the addition of labeled##2##4##(1993-3#1)(1993-9#1)
the addition of more##2##4##(2008-10#1)(2008-6#1)
the addition of multiple##2##4##(2008-3#1)(2010-11#1)
the addition of muramyl##2##4##(2008-11#2)
the addition of one##2##4##(1993-12#1)(2008-3#1)
the addition of proteins##3##4##(2008-10#2)(2013-7#1)
the addition of salt##4##4##(2005-11#1)(2008-10#3)
the addition of serum##2##4##(1995-9#1)(2008-11#1)
the addition of small amounts##2##5##(1991-2#1)(2008-10#1)
the addition of small##4##4##(1991-2#1)(2008-10#3)
the addition of sodium##4##4##(1991-7#1)(2008-10#3)
the addition of steroids##2##4##(1990-2#1)(2006-10#1)
the addition of the##34##4##(1990-1#1)(1990-7#1)(1990-8#2)(1991-10#1)(1992-12#1)(1993-6#1)(1994-10#1)(1994-2#1)(1994-3#3)(1994-8#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-8#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-11#3)(2008-8#1)(2009-2#1)(2013-8#1)
the addition of this##3##4##(1991-1#1)(2009-7#2)
the addition of triethylamine##2##4##(1996-5#1)(2008-7#1)
the addition of urea##2##4##(1995-4#1)(2004-12#1)
the addition of various##2##4##(2007-11#1)(2008-10#1)
the addition of vitamin##2##4##(1993-6#1)(2008-10#1)
the addition of water##2##4##(2008-10#1)(2009-8#1)
the addition of yeast telomeric##2##5##(1990-5#1)(1991-9#1)
the addition of yeast##3##4##(1990-5#1)(1991-9#1)(2008-11#1)
the addition of##562##3##(1990-1#1)(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#5)(1990-3#8)(1990-5#2)(1990-6#1)(1990-7#3)(1990-8#4)(1991-1#3)(1991-10#4)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#3)(1991-5#1)(1991-6#2)(1991-7#3)(1991-8#4)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#5)(1992-2#4)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#8)(1992-9#3)(1993-11#4)(1993-12#4)(1993-2#2)(1993-3#5)(1993-4#2)(1993-6#6)(1993-8#5)(1993-9#7)(1994-10#1)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#7)(1994-5#3)(1994-6#2)(1994-8#5)(1994-9#7)(1995-1#3)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#5)(1995-4#2)(1995-5#5)(1995-6#3)(1995-8#3)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#3)(1996-7#5)(1996-8#2)(1996-9#6)(1997-1#6)(1997-2#5)(1997-4#5)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#3)(2004-12#1)(2004-4#1)(2004-8#1)(2004-9#2)(2005-11#13)(2005-4#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#8)(2006-11#2)(2006-12#1)(2006-3#1)(2006-6#1)(2007-10#1)(2007-11#12)(2007-12#7)(2007-3#4)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#76)(2008-11#29)(2008-12#1)(2008-2#7)(2008-3#13)(2008-4#9)(2008-5#25)(2008-6#5)(2008-7#4)(2008-8#5)(2008-9#4)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#4)(2009-8#2)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#9)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#4)(2011-12#3)(2011-2#5)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#8)(2013-7#2)(2013-8#4)
the addition or##3##3##(2006-6#1)(2009-8#2)
the addition to##2##3##(2007-11#1)(2008-11#1)
the addition##575##2##(1990-1#1)(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#5)(1990-3#8)(1990-5#2)(1990-6#1)(1990-7#3)(1990-8#4)(1991-1#3)(1991-10#4)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#3)(1991-5#1)(1991-6#3)(1991-7#3)(1991-8#4)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#5)(1992-2#4)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#8)(1992-9#3)(1993-11#4)(1993-12#4)(1993-2#2)(1993-3#5)(1993-4#2)(1993-6#6)(1993-8#5)(1993-9#7)(1994-10#1)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#8)(1994-5#3)(1994-6#2)(1994-8#5)(1994-9#7)(1995-1#3)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#6)(1995-4#2)(1995-5#5)(1995-6#3)(1995-8#3)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#3)(1996-7#6)(1996-8#2)(1996-9#6)(1997-1#6)(1997-2#5)(1997-4#5)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#3)(2004-12#1)(2004-4#1)(2004-8#1)(2004-9#2)(2005-11#13)(2005-4#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#9)(2006-11#2)(2006-12#1)(2006-3#1)(2006-6#2)(2007-10#1)(2007-11#13)(2007-12#7)(2007-3#4)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#77)(2008-11#30)(2008-12#1)(2008-2#9)(2008-3#13)(2008-4#9)(2008-5#25)(2008-6#5)(2008-7#4)(2008-8#5)(2008-9#4)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#4)(2009-8#4)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#9)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#4)(2011-12#3)(2011-2#5)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#8)(2013-7#2)(2013-8#4)
the additional advantage##2##3##(2008-10#2)
the additional advantages of##2##4##(1996-3#1)(2012-1#1)
the additional benefit of##2##4##(2007-2#1)(2008-9#1)
the additional benefits##2##3##(2006-8#1)(2011-2#1)
the additional factors##2##3##(1991-11#1)(1997-4#1)
the additional presence of##2##4##(1992-10#1)(1996-3#1)
the additional requirement of##2##4##(2007-12#1)(2009-12#1)
the additional##91##2##(1991-11#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-9#3)(1993-3#1)(1993-5#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-3#4)(1997-4#2)(1997-7#1)(2005-10#3)(2006-10#1)(2006-12#2)(2006-5#1)(2006-6#1)(2006-8#2)(2007-10#2)(2007-11#3)(2007-12#4)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#4)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-2#2)(2010-6#1)(2010-8#1)(2011-2#3)(2012-1#2)(2012-2#1)(2013-1#1)(2013-7#1)
the additive and##5##3##(1996-5#1)(2005-11#1)(2007-8#2)(2012-3#1)
the additive effect of##2##4##(1996-12#1)(2006-7#1)
the additive effects of##4##4##(1994-9#1)(1996-12#1)(2008-11#1)(2013-7#1)
the additive genetic##2##3##(2008-8#1)(2013-1#1)
the additive noise##2##3##(2007-12#1)(2008-2#1)
the additive score##2##3##(2007-8#2)
the additive##38##2##(1994-3#1)(1994-9#1)(1996-10#1)(1996-12#2)(1996-5#1)(2004-9#1)(2005-11#1)(2006-7#1)(2007-12#1)(2007-8#7)(2008-10#4)(2008-11#1)(2008-2#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#1)(2011-12#1)(2011-2#1)(2012-3#3)(2013-1#1)(2013-7#1)
the additives##2##2##(2008-12#1)(2009-11#1)
the additivity##2##2##(1992-3#1)(2008-10#1)
the adduct by##2##3##(1992-3#1)(1995-2#1)
the adduct formation##2##3##(2008-10#2)
the adduct formed##2##3##(1991-2#1)(2008-10#1)
the adduct was##3##3##(1992-3#1)(2008-10#2)
the adduct##23##2##(1991-2#1)(1991-5#2)(1992-3#2)(1992-7#1)(1993-12#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-2#2)(1996-7#1)(2007-11#1)(2008-10#6)(2008-5#2)
the adductor pollicis##4##3##(1996-9#2)(2006-3#1)(2008-9#1)
the adductor##8##2##(1996-9#2)(2006-3#1)(2008-9#1)(2009-10#3)(2013-7#1)
the adducts##8##2##(1990-11#1)(1992-7#1)(1993-11#1)(1996-9#2)(1997-7#1)(2008-10#2)
the adenine nucleotide pool##2##4##(1993-2#1)(1995-8#1)
the adenine nucleotide##3##3##(1993-2#1)(1994-6#1)(1995-8#1)
the adenine nucleotides##2##3##(1990-8#1)(1992-8#1)
the adenine ring##2##3##(1992-6#1)(1993-6#1)
the adenine##19##2##(1990-12#1)(1990-8#1)(1992-6#3)(1992-8#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-8#1)(2008-10#1)(2008-3#1)(2008-9#2)
the adenine-ribose bond##2##3##(1990-5#2)
the adenocarcinoma##4##2##(1995-9#1)(2006-10#1)(2008-4#1)(2013-8#1)
the adenohypophysis##3##2##(1991-5#1)(2008-4#2)
the adenoma##5##2##(1990-11#1)(1996-11#1)(2006-10#1)(2010-2#1)(2013-8#1)
the adenoma-carcinoma sequence##2##3##(1993-5#1)(2008-8#1)
the adenomas and##2##3##(1990-11#1)(2008-5#1)
the adenomas##8##2##(1990-11#1)(2008-5#5)(2013-8#2)
the adenomatous##4##2##(2006-12#1)(2008-1#1)(2008-10#1)(2010-5#1)
the adenosine A1 receptor##2##4##(1995-5#1)(2006-12#1)
the adenosine A2 receptor##2##4##(1990-12#1)(1990-5#1)
the adenosine analogue##3##3##(1993-6#1)(1994-9#2)
the adenosine concentration##2##3##(1993-12#1)(1993-3#1)
the adenosine moiety of##3##4##(1990-5#1)(1991-4#1)(1993-11#1)
the adenosine moiety##5##3##(1990-5#1)(1991-4#1)(1993-11#1)(1994-11#1)(1997-4#1)
the adenosine receptor antagonist##2##4##(1992-8#1)(1996-12#1)
the adenosine receptor##8##3##(1992-8#1)(1993-3#1)(1994-5#1)(1995-8#2)(1996-12#1)(2008-4#1)(2013-7#1)
the adenosine triphosphate##2##3##(1995-6#1)(2011-1#1)
the adenosine##36##2##(1990-12#1)(1990-5#2)(1991-11#1)(1991-4#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-3#3)(1993-6#1)(1994-11#2)(1994-5#1)(1994-9#2)(1995-5#1)(1995-6#1)(1995-8#3)(1996-12#1)(1996-7#1)(1997-4#1)(1997-5#1)(2006-12#1)(2008-10#1)(2008-4#4)(2010-2#1)(2011-1#1)(2013-7#1)
the adenovirus E1A##5##3##(1994-3#1)(1997-4#2)(2008-11#2)
the adenovirus major late promoter##2##5##(1997-2#1)(2008-11#1)
the adenovirus type##2##3##(1992-9#1)(1994-2#1)
the adenovirus##14##2##(1990-7#1)(1991-12#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-2#1)(1994-3#1)(1997-2#1)(1997-4#2)(1997-7#1)(2008-11#3)
the adenovirus-2 major late promoter##2##5##(1990-4#2)
the adenovirus-2##3##2##(1990-4#2)(1993-2#1)
the adenylate cyclase##11##3##(1990-5#1)(1990-7#2)(1991-7#1)(1993-2#1)(1993-7#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-8#1)
the adenylate##17##2##(1990-5#1)(1990-7#2)(1991-7#1)(1992-3#1)(1993-2#1)(1993-7#1)(1994-5#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#3)(1996-6#1)(1997-2#1)(1997-8#1)
the adenylyl cyclase Cyr1##2##4##(2009-8#1)(2010-12#1)
the adenylyl cyclase##5##3##(1994-12#2)(1994-5#1)(2009-8#1)(2010-12#1)
the adenylylated##2##2##(1995-3#2)
the adequacy of a##2##4##(1990-11#1)(2008-11#1)
the adequacy of the##8##4##(1990-3#1)(1997-2#1)(2005-11#1)(2005-7#1)(2007-1#1)(2007-9#1)(2008-11#1)(2011-1#1)
the adequacy of##28##3##(1990-11#1)(1990-3#1)(1991-1#1)(1992-1#1)(1992-12#1)(1992-2#1)(1995-1#1)(1996-1#1)(1996-3#2)(1997-2#1)(1997-6#1)(2005-11#1)(2005-7#1)(2007-1#1)(2007-4#1)(2007-9#1)(2008-11#2)(2008-5#1)(2010-5#1)(2011-1#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
the adequacy##29##2##(1990-11#1)(1990-3#1)(1991-1#1)(1992-1#1)(1992-12#1)(1992-2#1)(1994-3#1)(1995-1#1)(1996-1#1)(1996-3#2)(1997-2#1)(1997-6#1)(2005-11#1)(2005-7#1)(2007-1#1)(2007-4#1)(2007-9#1)(2008-11#2)(2008-5#1)(2010-5#1)(2011-1#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
the adequate##17##2##(1993-6#1)(1995-3#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-2#1)(2010-6#1)(2011-2#3)(2012-12#1)(2013-8#1)
the adherence and##2##3##(2007-2#1)(2008-10#1)
the adherence of the##2##4##(2006-8#1)(2008-10#1)
the adherence of##7##3##(1993-9#1)(1997-4#1)(2006-8#2)(2008-10#1)(2008-3#1)(2012-2#1)
the adherence to##2##3##(2011-2#1)(2012-3#1)
the adherence##17##2##(1993-9#1)(1997-4#1)(2006-10#1)(2006-8#2)(2007-2#1)(2008-10#2)(2008-3#2)(2009-4#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#2)
the adherent and nonadherent##2##4##(1992-8#1)(2008-10#1)
the adherent cells##4##3##(1992-8#2)(2008-11#2)
the adherent layer##2##3##(1995-1#1)(1995-12#1)
the adherent##15##2##(1990-8#1)(1992-8#3)(1995-1#1)(1995-12#1)(2006-8#2)(2008-10#3)(2008-11#3)(2009-7#1)
the adhesion and growth of##2##5##(2006-5#1)(2013-1#1)
the adhesion and the##2##4##(2004-9#1)(2005-11#1)
the adhesion and##8##3##(2004-9#1)(2005-11#1)(2006-3#1)(2006-5#1)(2008-11#1)(2008-5#1)(2010-4#1)(2013-1#1)
the adhesion force##4##3##(2005-11#2)(2008-10#1)(2008-11#1)
the adhesion molecule##2##3##(1990-8#1)(2006-6#1)
the adhesion molecules##2##3##(1995-8#1)(2007-11#1)
the adhesion of cells to##2##5##(1996-5#1)(2011-11#1)
the adhesion of leukocytes and##2##5##(2008-5#2)
the adhesion of platelets to##2##5##(1997-7#2)
the adhesion of the##4##4##(2004-9#1)(2005-11#1)(2008-10#1)(2012-2#1)
the adhesion of##25##3##(1990-9#1)(1993-11#1)(1993-8#1)(1994-6#1)(1996-5#1)(1997-7#4)(2004-9#1)(2005-11#1)(2006-11#1)(2006-12#1)(2006-5#1)(2008-10#1)(2008-4#1)(2008-5#2)(2009-8#1)(2010-4#1)(2011-11#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
the adhesion strength##2##3##(2012-1#2)
the adhesion to the##2##4##(2008-11#1)(2012-3#1)
the adhesion to##3##3##(1991-5#1)(2008-11#1)(2012-3#1)
the adhesion##64##2##(1990-8#1)(1990-9#1)(1991-5#1)(1992-1#1)(1993-11#1)(1993-8#1)(1994-6#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-7#4)(2004-9#2)(2005-11#6)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#2)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#6)(2008-4#1)(2008-5#5)(2008-8#1)(2009-11#1)(2009-8#1)(2010-4#2)(2011-11#1)(2012-1#3)(2012-12#1)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
the adhesions##4##2##(1992-7#1)(1995-7#1)(2012-3#2)
the adhesive and invasive##2##4##(2008-8#2)
the adhesive and##3##3##(1994-9#1)(2008-8#2)
the adhesive cells##2##3##(1995-1#1)(2008-9#1)
the adhesive function##2##3##(1990-11#2)
the adhesive joint##2##3##(2010-4#2)
the adhesive was##2##3##(2013-8#2)
the adhesive##29##2##(1990-11#2)(1990-8#1)(1994-9#1)(1995-1#1)(1997-2#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2010-4#4)(2012-2#1)(2013-7#3)(2013-8#5)
the adhesiveness of##2##3##(1992-9#1)(1995-12#1)
the adiabatic##2##2##(1992-7#1)(2007-11#1)
the adipocere##2##2##(1996-6#2)
the adipocyte differentiation##2##3##(2008-11#1)(2008-3#1)
the adipocyte lipid binding protein##2##5##(1992-12#1)(1992-9#1)
the adipocyte##9##2##(1992-12#1)(1992-9#1)(1994-12#1)(1997-1#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-5#2)
the adipocyte-derived##2##2##(1990-4#1)(2006-1#1)
the adipocytes##2##2##(1994-8#1)(2010-4#1)
the adipogenic program##2##3##(2012-2#2)
the adipogenic##4##2##(1997-4#1)(2012-2#3)
the adiponectin concentration##2##3##(2011-1#2)
the adiponectin##6##2##(2007-8#1)(2008-3#1)(2011-1#4)
the adipose eyelid##4##3##(2010-8#4)
the adipose tissue##13##3##(1990-4#1)(1995-12#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#2)(2010-8#1)(2012-2#1)(2013-8#2)
the adipose##22##2##(1990-4#1)(1992-9#1)(1994-12#1)(1995-12#1)(2006-2#2)(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#3)(2010-8#5)(2012-2#1)(2013-8#2)
the adiposity##2##2##(1997-2#1)(2007-11#1)
the adjacency##3##2##(2008-3#2)(2008-8#1)
the adjacent anterior or posterior cerebral artery territories##2##8##(2007-9#2)
the adjacent histologically##2##3##(2008-3#1)(2010-12#1)
the adjacent muscle##2##3##(1992-9#1)(2008-10#1)
the adjacent normal##2##3##(1993-4#1)(2007-2#1)
the adjacent subunit##2##3##(1995-8#2)
the adjacent teeth##2##3##(2007-12#1)(2013-1#1)
the adjacent vertebrae##2##3##(2007-8#1)(2012-12#1)
the adjacent##82##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#3)(1995-8#2)(1996-10#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-3#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-8#1)(2012-1#2)(2012-12#1)(2013-1#3)
the adjective##4##2##(2008-11#3)(2009-2#1)
the adjunct##2##2##(2008-3#1)(2013-1#1)
the adjunctive treatment##3##3##(2006-12#2)(2007-9#1)
the adjunctive##4##2##(2006-12#2)(2007-9#1)(2013-1#1)
the adjustable##4##2##(1991-4#1)(2007-11#1)(2008-10#1)(2008-5#1)
the adjusted##8##2##(1993-3#1)(1993-9#1)(1996-5#1)(2005-10#1)(2006-6#1)(2007-4#1)(2008-10#1)(2013-1#1)
the adjustment of initially random configural stimuli##2##7##(1993-12#2)
the adjustment of the##6##4##(2005-11#1)(2006-5#1)(2008-2#3)(2008-7#1)
the adjustment of##14##3##(1993-12#2)(1994-6#1)(1996-7#1)(2005-11#1)(2006-5#1)(2007-12#1)(2007-4#1)(2008-2#4)(2008-3#1)(2008-7#1)
the adjustment##21##2##(1991-1#1)(1992-12#2)(1993-1#1)(1993-12#2)(1994-6#1)(1996-7#1)(2005-11#1)(2006-5#1)(2007-12#1)(2007-4#1)(2008-2#4)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2013-8#1)
the adjustments##4##2##(1991-1#1)(1991-9#1)(1992-12#1)(1993-1#1)
the adjuvant chemotherapy##2##3##(1996-6#1)(2013-8#1)
the adjuvant effect of##2##4##(1996-10#2)
the adjuvant effect##3##3##(1996-10#3)
the adjuvant setting##8##3##(1997-5#1)(2006-9#1)(2007-11#3)(2007-3#1)(2008-5#1)(2008-6#1)
the adjuvant treatment of early breast cancer##2##7##(2008-5#1)(2010-7#1)
the adjuvant treatment of early##3##5##(2008-5#1)(2009-5#1)(2010-7#1)
the adjuvant treatment of##5##4##(2008-5#1)(2009-4#2)(2009-5#1)(2010-7#1)
the adjuvant##31##2##(1992-8#1)(1996-1#1)(1996-10#3)(1996-6#1)(1997-5#1)(2006-9#1)(2007-11#4)(2007-3#1)(2008-5#4)(2008-6#2)(2009-4#2)(2009-5#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-7#1)(2012-1#2)(2012-2#1)(2013-8#1)
the adjuvanted vaccine##3##3##(2007-11#3)
the adjuvanted##4##2##(2007-11#4)
the administered dose of the##2##5##(1990-5#1)(2006-6#1)
the administered dose##5##3##(1990-5#1)(1995-3#2)(2006-6#1)(2008-5#1)
the administered##15##2##(1990-3#3)(1990-5#1)(1991-12#1)(1991-2#1)(1995-3#2)(1996-3#1)(1997-8#1)(2006-6#1)(2008-1#1)(2008-5#1)(2008-8#1)(2010-12#1)
the administration and##3##3##(1991-12#1)(1991-3#1)(2006-10#1)
the administration of PRN##2##4##(2007-3#2)
the administration of RS extract##2##5##(2008-11#2)
the administration of a##15##4##(1993-10#1)(1993-9#1)(1994-3#1)(1997-2#1)(1997-3#1)(2005-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-8#1)(2012-11#1)(2012-2#1)
the administration of an##4##4##(1997-3#1)(2007-11#1)(2008-1#1)(2008-11#1)
the administration of chemotherapy##2##4##(2007-7#1)(2008-7#1)
the administration of contrast material##2##5##(2007-10#1)(2008-7#1)
the administration of corticosteroids##3##4##(1993-8#1)(2006-4#1)(2006-8#1)
the administration of cytotoxic##2##4##(2008-6#1)(2008-9#1)
the administration of either##2##4##(1990-7#1)(1996-6#1)
the administration of general##2##4##(2006-10#1)(2009-8#1)
the administration of medication##4##4##(1996-8#1)(2006-10#1)(2009-5#1)(2011-2#1)
the administration of medications##2##4##(2005-8#1)(2011-2#1)
the administration of oral##2##4##(1991-12#1)(2010-12#1)
the administration of oxygen##2##4##(1994-3#1)(2008-10#1)
the administration of radiotherapy##2##4##(2010-3#1)(2012-2#1)
the administration of recombinant human##2##5##(1993-7#1)(2012-2#1)
the administration of the first##2##5##(2006-10#1)(2007-11#1)
the administration of the##13##4##(1993-1#1)(1993-2#1)(1993-5#1)(1995-12#1)(1996-6#1)(2005-8#1)(2006-10#1)(2006-12#2)(2007-11#1)(2008-12#1)(2013-1#2)
the administration of this##2##4##(1994-8#1)(2008-8#1)
the administration of##174##3##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#2)(1990-7#2)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-3#2)(1994-6#2)(1994-8#5)(1995-12#3)(1995-3#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#2)(1997-2#3)(1997-3#3)(1997-8#1)(2005-1#1)(2005-11#2)(2005-7#1)(2005-8#3)(2006-10#12)(2006-12#2)(2006-4#3)(2006-6#2)(2006-8#3)(2006-9#2)(2007-10#3)(2007-11#5)(2007-3#3)(2007-5#2)(2007-7#2)(2007-8#2)(2008-1#6)(2008-10#3)(2008-11#4)(2008-12#3)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#6)(2012-11#2)(2012-2#7)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
the administration##194##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#2)(1990-5#2)(1990-7#2)(1991-12#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-6#3)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#1)(1994-3#2)(1994-6#2)(1994-8#5)(1995-12#3)(1995-3#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#2)(1997-2#3)(1997-3#3)(1997-8#1)(2005-1#1)(2005-11#2)(2005-7#1)(2005-8#3)(2006-10#13)(2006-12#2)(2006-4#3)(2006-6#2)(2006-8#4)(2006-9#2)(2007-10#3)(2007-11#5)(2007-3#3)(2007-5#2)(2007-7#2)(2007-8#2)(2008-1#6)(2008-10#3)(2008-11#4)(2008-12#3)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#6)(2012-11#2)(2012-12#2)(2012-2#11)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#4)
the administration's##2##2##(1991-1#1)(1996-11#1)
the administrative and##4##3##(2009-2#1)(2013-8#3)
the administrative##23##2##(1990-5#1)(1991-12#1)(1992-3#1)(1993-2#1)(1994-3#2)(1995-12#1)(1996-2#1)(1997-2#1)(2005-5#1)(2007-2#1)(2008-1#1)(2009-2#1)(2012-3#3)(2013-8#7)
the administrator##3##2##(1992-2#1)(1994-2#1)(2006-8#1)
the administrators##3##2##(1993-1#1)(2008-5#1)(2009-6#1)
the admission electrocardiogram##2##3##(2008-3#1)(2013-7#1)
the admission of##3##3##(1991-2#2)(2006-6#1)
the admission to the hospital##2##5##(1990-9#1)(1993-8#1)
the admission##12##2##(1990-9#1)(1991-2#2)(1992-1#1)(1993-8#1)(1997-2#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-7#1)(2013-7#1)
the admissions##7##2##(1990-10#1)(1990-5#1)(1991-1#1)(1996-2#1)(2006-8#1)(2007-7#1)(2012-12#1)
the adolescent age group##3##4##(2008-6#1)(2008-7#2)
the adolescent girls##2##3##(2008-1#1)(2011-1#1)
the adolescent in##2##3##(2008-9#1)(2010-9#1)
the adolescent period##2##3##(2005-3#1)(2010-12#1)
the adolescent population##2##3##(2007-11#1)(2009-7#1)
the adolescent with##3##3##(2006-9#1)(2007-6#1)(2011-1#1)
the adolescent years##4##3##(1994-2#1)(2008-7#1)(2009-7#2)
the adolescent##51##2##(1990-12#3)(1990-6#1)(1990-7#1)(1990-8#2)(1993-10#1)(1993-3#1)(1994-2#2)(2004-12#1)(2005-3#1)(2006-9#1)(2007-11#1)(2007-2#2)(2007-6#2)(2008-1#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#9)(2008-9#1)(2009-7#4)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#2)(2013-1#2)
the adolescent's and##2##3##(2008-7#1)(2010-9#1)
the adolescent's##4##2##(2008-7#1)(2009-7#1)(2010-9#2)
the adolescents reported##2##3##(1993-3#1)(2010-11#1)
the adolescents##17##2##(1990-2#1)(1990-5#2)(1991-8#2)(1993-3#1)(1993-5#1)(1994-2#1)(2007-3#1)(2008-2#1)(2008-9#3)(2009-4#1)(2010-11#1)(2011-1#1)(2012-12#1)
the adolescents'##5##2##(1990-5#2)(2007-2#1)(2009-7#1)(2010-7#1)
the adopted##2##2##(2008-10#1)(2008-2#1)
the adoption of a##9##4##(1995-1#1)(1995-9#1)(1997-4#1)(2004-7#1)(2007-12#1)(2008-10#1)(2008-12#1)(2009-9#1)(2010-5#1)
the adoption of insulin therapy##2##5##(2007-5#2)
the adoption of modern##2##4##(2006-8#1)(2008-12#1)
the adoption of new##6##4##(2007-12#5)(2011-2#1)
the adoption of strategies to##2##5##(2007-12#1)(2013-1#1)
the adoption of such##2##4##(2008-3#1)(2011-1#1)
the adoption of the##7##4##(1991-7#1)(1993-3#1)(1996-3#1)(1997-7#1)(2008-1#1)(2008-8#1)(2012-3#1)
the adoption of##62##3##(1991-12#2)(1991-7#1)(1993-3#1)(1995-1#1)(1995-3#1)(1995-9#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-7#2)(2004-7#1)(2005-10#1)(2005-11#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-12#10)(2007-2#1)(2007-4#1)(2007-5#2)(2008-1#1)(2008-10#2)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
the adoption##65##2##(1991-12#2)(1991-7#1)(1993-3#1)(1995-1#1)(1995-3#2)(1995-9#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-7#2)(2004-7#1)(2005-10#1)(2005-11#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-12#10)(2007-2#1)(2007-4#1)(2007-5#2)(2008-1#1)(2008-10#2)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-9#1)(2010-11#2)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
the adoptive transfer of##3##4##(2008-4#1)(2011-2#1)(2012-12#1)
the adoptive transfer##6##3##(1991-12#2)(2008-11#1)(2008-4#1)(2011-2#1)(2012-12#1)
the adoptive##7##2##(1991-12#2)(2008-11#1)(2008-4#1)(2009-11#1)(2011-2#1)(2012-12#1)
the adrenal cortex by##2##4##(1997-5#1)(2007-11#1)
the adrenal cortex##19##3##(1990-10#1)(1990-11#1)(1990-5#2)(1991-8#2)(1994-2#1)(1994-9#1)(1995-12#1)(1996-11#1)(1997-5#2)(2006-10#1)(2007-11#1)(2008-4#2)(2011-1#2)(2011-2#1)
the adrenal gland in##4##4##(1990-5#2)(1995-7#1)(1996-10#1)
the adrenal gland is##3##4##(1992-8#1)(2013-1#2)
the adrenal gland##23##3##(1990-5#3)(1991-6#1)(1992-3#1)(1992-8#1)(1993-3#2)(1995-7#1)(1996-10#1)(1997-5#2)(2007-9#1)(2008-12#1)(2008-4#3)(2011-2#3)(2012-2#1)(2013-1#2)
the adrenal glands of##2##4##(1995-10#1)(1997-8#1)
the adrenal glands##10##3##(1990-2#1)(1993-5#1)(1995-10#1)(1995-12#1)(1997-8#1)(2009-2#4)(2011-2#1)
the adrenal medulla and##2##4##(1995-5#1)(1996-12#1)
the adrenal medulla##12##3##(1990-2#1)(1990-5#2)(1991-8#1)(1995-12#4)(1995-5#1)(1996-12#1)(1997-8#1)(2006-9#1)
the adrenal steroids##2##3##(1993-11#1)(1995-12#1)
the adrenal##89##2##(1990-10#2)(1990-11#1)(1990-2#2)(1990-5#7)(1991-10#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#5)(1992-3#1)(1992-8#2)(1993-11#1)(1993-3#2)(1993-5#1)(1994-2#4)(1994-9#1)(1995-10#4)(1995-11#1)(1995-12#9)(1995-5#1)(1995-7#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-5#1)(1997-5#4)(1997-8#2)(2005-8#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-9#1)(2008-12#2)(2008-4#5)(2009-2#4)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#2)
the adrenals and##3##3##(1990-3#1)(1994-2#1)(2008-4#1)
the adrenals##14##2##(1990-2#2)(1990-3#3)(1993-5#1)(1994-2#1)(1994-5#1)(1995-10#1)(1995-3#1)(2008-4#1)(2010-12#1)(2011-1#1)(2012-2#1)
the adrenergic system##2##3##(1990-3#1)(1993-5#1)
the adrenergic##8##2##(1990-3#1)(1991-2#1)(1993-5#1)(1994-2#1)(1995-3#1)(1997-7#1)(2005-10#2)
the adrenoceptor##2##2##(1996-2#1)(2008-3#1)
the adrenocortical response to##2##4##(1994-2#1)(2006-3#1)
the adrenocortical##4##2##(1994-2#1)(1995-10#1)(2006-3#1)(2007-9#1)
the adrenocorticotropic hormone (ACTH)##2##4##(1992-8#1)(1993-7#1)
the adrenocorticotropic hormone##3##3##(1992-8#1)(1993-5#1)(1993-7#1)
the adrenocorticotropic hormone-releasing##2##3##(1990-2#2)
the adrenocorticotropic##5##2##(1990-2#2)(1992-8#1)(1993-5#1)(1993-7#1)
the adrenogenital syndrome##4##3##(2009-2#4)
the adriamycin-perfused##2##2##(1990-5#2)
the adsorbate and##2##3##(2007-12#1)(2008-10#1)
the adsorbate##5##2##(2005-11#2)(2007-12#1)(2008-10#2)
the adsorbed amount##4##3##(2005-11#3)(2008-10#1)
the adsorbed elements##2##3##(2008-10#2)
the adsorbed protein##3##3##(2005-11#2)(2008-5#1)
the adsorbed species##3##3##(2005-11#1)(2008-10#2)
the adsorbed##38##2##(1990-12#1)(1993-2#1)(1994-2#1)(2005-11#11)(2007-8#1)(2008-10#15)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-11#1)(2010-2#1)(2011-2#1)
the adsorbent surface##2##3##(2008-10#2)
the adsorbent##24##2##(1996-6#1)(1996-8#2)(2005-11#6)(2007-10#1)(2008-10#11)(2008-4#2)(2008-7#1)
the adsorbents##7##2##(1996-8#1)(1997-2#1)(2005-11#2)(2008-10#3)
the adsorbing polycation##2##3##(2005-11#2)
the adsorbing##5##2##(1994-12#1)(2005-11#3)(2008-10#1)
the adsorption and desorption of decanethiol##2##6##(2008-10#2)
the adsorption and desorption of##4##5##(2005-11#2)(2008-10#2)
the adsorption and##8##3##(2005-11#3)(2008-10#3)(2008-5#1)(2008-7#1)
the adsorption behavior of##5##4##(2005-11#5)
the adsorption behavior##7##3##(2005-11#7)
the adsorption capacities##3##3##(2005-11#1)(2008-10#2)
the adsorption chamber##3##3##(2008-7#3)
the adsorption characteristics##2##3##(2005-11#1)(2008-10#1)
the adsorption constant##2##3##(2008-10#2)
the adsorption constants of##2##4##(2005-11#2)
the adsorption constants##4##3##(2005-11#4)
the adsorption equilibrium##2##3##(2008-10#2)
the adsorption excess##2##3##(1996-4#2)
the adsorption from##2##3##(2005-11#1)(2008-10#1)
the adsorption isotherms revealed##2##4##(2005-11#2)
the adsorption isotherms##3##3##(2005-11#3)
the adsorption kinetics of##2##4##(2005-11#1)(2008-10#1)
the adsorption layer##2##3##(2008-2#2)
the adsorption mechanism##2##3##(2005-11#1)(2005-4#1)
the adsorption of BSA onto##2##5##(2005-11#2)
the adsorption of Cr(VI) ion##2##5##(2005-11#2)
the adsorption of atrazine onto a##2##6##(2008-10#2)
the adsorption of fibrinogen##2##4##(2005-11#1)(2010-4#1)
the adsorption of some##2##4##(2005-4#1)(2008-10#1)
the adsorption of talin##2##4##(2006-10#2)
the adsorption of the##8##4##(1991-5#1)(1996-1#1)(2005-11#3)(2008-10#3)
the adsorption of##66##3##(1991-5#1)(1992-7#1)(1996-1#1)(1997-3#1)(2005-11#30)(2005-4#2)(2006-10#3)(2007-10#1)(2008-10#21)(2008-6#1)(2008-7#1)(2010-4#2)(2013-8#1)
the adsorption process and##2##4##(2005-11#2)
the adsorption process of##3##4##(2005-11#2)(2008-10#1)
the adsorption process##10##3##(2005-11#8)(2008-10#2)
the adsorption properties of##3##4##(1993-12#1)(2005-11#1)(2008-10#1)
the adsorption rate##2##3##(2005-11#2)
the adsorption##157##2##(1991-5#1)(1992-7#1)(1993-12#1)(1996-1#2)(1996-4#2)(1997-2#2)(1997-3#1)(1997-4#1)(2005-11#73)(2005-4#3)(2006-10#3)(2007-10#1)(2008-10#48)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#6)(2010-4#3)(2011-2#1)(2013-1#1)(2013-8#2)
the adsorptive##5##2##(2008-10#4)(2008-11#1)
the adult CNS##6##3##(1991-3#1)(1995-5#1)(2007-10#1)(2008-1#2)(2008-11#1)
the adult age##3##3##(2006-8#1)(2008-3#1)(2013-7#1)
the adult and the##2##4##(2006-11#1)(2007-4#1)
the adult and##11##3##(1991-12#1)(1993-7#1)(1995-5#1)(2006-11#1)(2006-2#1)(2007-12#2)(2007-4#1)(2008-4#2)(2013-7#1)
the adult animal##3##3##(1995-10#1)(1997-2#1)(2008-9#1)
the adult are##2##3##(1993-6#1)(2007-3#1)
the adult brain##11##3##(1993-12#1)(1994-11#1)(1995-7#1)(1996-12#1)(1997-5#1)(1997-6#1)(2008-1#2)(2008-7#2)(2010-8#1)
the adult female##2##3##(1990-11#1)(2009-5#1)
the adult forebrain##2##3##(1995-12#1)(1997-4#1)
the adult hippocampus##3##3##(1993-2#1)(1996-4#1)(2008-10#1)
the adult human striatum##3##4##(1990-2#3)
the adult human##8##3##(1990-2#3)(1991-6#1)(1995-12#1)(1996-10#1)(2007-8#1)(2012-12#1)
the adult is##3##3##(1996-3#1)(2008-10#1)(2012-12#1)
the adult mammalian brain##2##4##(2008-7#1)(2012-12#1)
the adult mammalian##4##3##(1994-12#1)(2008-11#1)(2008-7#1)(2012-12#1)
the adult mice##2##3##(2008-9#1)(2012-3#1)
the adult mouse##7##3##(1994-2#1)(1995-2#1)(2008-11#2)(2010-11#1)(2012-12#2)
the adult nervous system##2##4##(1994-10#1)(1994-12#1)
the adult organism##2##3##(2008-8#1)(2009-3#1)
the adult patients##4##3##(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
the adult pattern##2##3##(1993-12#1)(1996-9#1)
the adult phase##2##3##(2008-6#1)(2011-1#1)
the adult plant##5##3##(2008-10#5)
the adult population in##3##4##(1992-2#1)(2008-11#1)(2013-8#1)
the adult population##32##3##(1992-10#1)(1992-2#1)(1992-5#1)(1996-6#1)(1997-2#1)(2006-1#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-2#2)(2007-6#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-8#3)(2009-7#1)(2010-4#1)(2010-7#1)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#5)
the adult rat spinal cord##3##5##(1991-9#1)(1992-8#1)(1995-12#1)
the adult rat striatum##6##4##(1995-11#2)(1996-12#3)(1996-3#1)
the adult rat testis##2##4##(2009-10#1)(2012-2#1)
the adult rat##33##3##(1991-12#1)(1991-9#2)(1992-1#1)(1992-7#1)(1992-8#2)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#2)(1995-11#2)(1995-12#2)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-3#2)(1996-4#1)(1996-6#1)(1996-9#1)(1997-3#2)(2008-11#1)(2009-10#1)(2012-2#1)
the adult stage of##2##4##(2004-11#1)(2008-10#1)
the adult stage##11##3##(1990-3#2)(1993-7#1)(2004-11#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-5#1)
the adult stages##2##3##(2007-11#1)(2011-12#1)
the adult value##3##3##(1991-4#1)(1996-4#1)(1996-5#1)
the adult with##2##3##(2008-12#2)
the adult worms##2##3##(1996-12#1)(2006-10#1)
the adult##350##2##(1990-11#1)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#2)(1991-9#4)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#2)(1992-8#3)(1992-9#1)(1993-1#1)(1993-10#2)(1993-12#7)(1993-2#1)(1993-3#2)(1993-6#3)(1993-7#2)(1993-9#1)(1994-10#4)(1994-11#4)(1994-12#3)(1994-2#6)(1994-3#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#5)(1995-12#6)(1995-2#2)(1995-5#4)(1995-7#1)(1995-8#3)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#9)(1996-2#1)(1996-3#6)(1996-4#6)(1996-5#4)(1996-6#3)(1996-8#1)(1996-9#5)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#2)(2004-10#2)(2004-11#1)(2005-12#2)(2005-8#1)(2006-1#1)(2006-10#4)(2006-11#3)(2006-2#1)(2006-5#3)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#15)(2007-2#3)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#8)(2008-10#13)(2008-11#10)(2008-12#2)(2008-3#3)(2008-4#5)(2008-5#7)(2008-6#2)(2008-7#10)(2008-8#5)(2008-9#3)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#13)(2012-2#5)(2012-3#4)(2013-1#9)(2013-7#3)(2013-8#6)
the adults and##2##3##(2006-12#1)(2013-8#1)
the adults in##3##3##(1993-2#1)(2006-4#1)(2010-8#1)
the adults##30##2##(1990-5#1)(1993-2#2)(1996-1#1)(2006-12#1)(2006-4#1)(2007-12#3)(2008-12#1)(2008-6#1)(2008-9#3)(2009-2#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#4)
the advance in##2##3##(1991-9#1)(1994-4#1)
the advance of##5##3##(2008-3#1)(2008-5#1)(2008-9#2)(2012-3#1)
the advance##9##2##(1991-9#1)(1994-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#2)(2010-8#1)(2012-3#1)
the advanced management##3##3##(2008-1#1)(2010-12#2)
the advanced stage of##2##4##(1990-4#1)(1991-10#1)
the advanced stage##3##3##(1990-4#1)(1991-10#1)(2005-1#1)
the advanced stages of##3##4##(2007-12#1)(2008-10#1)(2008-11#1)
the advanced##26##2##(1990-4#1)(1991-10#1)(1991-9#1)(1992-12#1)(1994-12#1)(2005-1#1)(2005-10#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#2)(2010-12#2)(2010-5#1)(2011-12#1)(2012-2#1)
the advancement of the##2##4##(2008-4#1)(2011-2#1)
the advancement of##18##3##(1993-12#1)(1995-9#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-2#4)
the advancement##19##2##(1993-12#1)(1995-9#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#4)
the advances achieved##2##3##(1992-10#1)(2010-3#1)
the advances in the field##3##5##(2006-8#1)(2008-5#1)(2012-2#1)
the advances in the##4##4##(2006-8#1)(2008-5#1)(2012-11#1)(2012-2#1)
the advances in##19##3##(1996-2#1)(2005-10#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-11#1)(2008-5#3)(2008-6#1)(2009-12#1)(2009-2#1)(2011-12#1)(2012-11#1)(2012-2#2)(2013-1#2)
the advances made in##4##4##(2005-8#1)(2009-8#1)(2010-11#1)(2010-3#1)
the advances of the##2##4##(2008-5#1)(2010-8#1)
the advances of##3##3##(2008-1#1)(2008-5#1)(2010-8#1)
the advances##37##2##(1992-10#1)(1996-2#1)(2005-10#1)(2005-8#1)(2006-10#4)(2006-6#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-11#1)(2010-3#2)(2010-8#1)(2011-12#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#2)
the advancing##2##2##(1992-5#1)(2005-11#1)
the advantage of a##6##4##(2006-10#1)(2008-10#1)(2008-3#2)(2008-5#1)(2013-1#1)
the advantage of being##12##4##(1990-6#1)(1997-3#1)(2006-10#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2009-6#1)(2013-1#1)
the advantage of low##2##4##(2006-5#1)(2008-1#1)
the advantage of providing##2##4##(2008-4#1)(2008-5#1)
the advantage of reduced##3##4##(2011-2#2)(2012-3#1)
the advantage of specificity##3##4##(2005-8#1)(2008-10#2)
the advantage of the##7##4##(1990-10#1)(1992-6#1)(2006-12#1)(2007-12#1)(2008-4#1)(2008-9#1)(2009-4#1)
the advantage of this##2##4##(2006-3#1)(2007-12#1)
the advantage of total body##2##5##(2007-11#1)(2010-3#1)
the advantage of using##7##4##(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-9#1)
the advantage of##120##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#2)(1991-1#1)(1991-3#1)(1992-6#1)(1994-3#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-7#1)(2005-3#1)(2005-8#1)(2005-9#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#2)(2006-5#3)(2007-11#1)(2007-12#5)(2007-8#2)(2008-1#3)(2008-10#18)(2008-11#4)(2008-2#9)(2008-3#9)(2008-4#5)(2008-5#5)(2008-7#1)(2008-9#5)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-6#1)(2010-12#3)(2010-2#1)(2010-3#1)(2011-2#4)(2012-2#2)(2012-3#3)(2012-5#1)(2013-1#3)
the advantage that a##2##4##(2004-9#1)(2007-8#1)
the advantage that the##5##4##(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)
the advantage that##21##3##(1990-9#1)(1992-3#1)(1995-8#1)(1996-12#1)(2004-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#1)(2010-5#1)
the advantage to##4##3##(2007-5#1)(2008-11#1)(2009-11#1)(2009-3#1)
the advantage##154##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-1#1)(1991-3#1)(1992-3#1)(1992-6#1)(1994-10#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-7#2)(2004-9#1)(2005-3#1)(2005-8#1)(2005-9#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#2)(2006-5#3)(2007-11#3)(2007-12#6)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#21)(2008-11#6)(2008-2#10)(2008-3#12)(2008-4#6)(2008-5#5)(2008-7#3)(2008-9#6)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#4)(2012-5#1)(2013-1#3)
the advantages and disadvantages in##2##5##(2008-10#1)(2012-11#1)
the advantages and disadvantages of each##9##6##(1992-2#1)(2004-2#1)(2005-5#1)(2006-10#1)(2007-4#1)(2008-2#1)(2009-3#1)(2011-2#1)(2013-8#1)
the advantages and disadvantages of flow##2##6##(2008-10#1)(2008-9#1)
the advantages and disadvantages of the##4##6##(2007-5#1)(2008-10#2)(2009-5#1)
the advantages and disadvantages of using##2##6##(2007-5#1)(2007-6#1)
the advantages and disadvantages of various##2##6##(2008-4#1)(2008-9#1)
the advantages and disadvantages of##27##5##(1990-10#1)(1991-1#1)(1992-2#1)(1996-3#1)(2004-2#1)(2005-5#1)(2006-10#1)(2007-10#1)(2007-4#1)(2007-5#2)(2007-6#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-9#2)(2009-3#1)(2009-5#2)(2011-2#2)(2013-8#3)
the advantages and disadvantages##34##4##(1990-10#1)(1990-8#1)(1991-1#1)(1992-2#1)(1996-3#1)(2004-2#1)(2005-5#1)(2006-10#1)(2007-10#1)(2007-4#1)(2007-5#2)(2007-6#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#2)(2009-3#2)(2009-5#2)(2009-9#1)(2011-2#2)(2012-1#1)(2012-11#1)(2013-8#3)
the advantages and drawbacks of##3##5##(2007-11#1)(2008-3#2)
the advantages and limitations of each##3##6##(2007-10#1)(2008-9#1)(2010-8#1)
the advantages and limitations of the##4##6##(2008-10#1)(2008-3#1)(2008-9#1)(2013-7#1)
the advantages and limitations of these##2##6##(2005-7#1)(2012-3#1)
the advantages and limitations of this##2##6##(1996-11#1)(2009-5#1)
the advantages and limitations of##13##5##(1996-11#1)(2005-7#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-9#2)(2009-5#1)(2010-8#1)(2012-3#1)(2013-7#1)
the advantages and limitations##16##4##(1994-1#1)(1996-11#1)(2005-7#1)(2006-12#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-9#2)(2009-5#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-7#1)
the advantages and possible##2##4##(2006-10#1)(2008-11#1)
the advantages and the limitations##2##5##(2008-10#1)(2008-2#1)
the advantages and the##3##4##(1992-8#1)(2008-10#1)(2008-2#1)
the advantages and##65##3##(1990-10#1)(1990-12#1)(1990-8#1)(1991-1#1)(1992-2#1)(1992-8#1)(1994-1#1)(1996-11#1)(1996-3#1)(2004-2#1)(2005-5#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-4#1)(2007-5#2)(2007-6#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-9#4)(2009-3#2)(2009-5#3)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#4)
the advantages of a##7##4##(1990-7#1)(1994-3#1)(1997-1#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-12#1)
the advantages of being##4##4##(2006-7#1)(2008-11#1)(2008-3#1)(2008-7#1)
the advantages of both##3##4##(2008-2#2)(2008-8#1)
the advantages of each##3##4##(2008-12#1)(2008-7#1)(2013-1#1)
the advantages of low resistance##2##5##(2008-10#2)
the advantages of low##4##4##(2007-12#1)(2008-10#2)(2008-3#1)
the advantages of minimally invasive techniques##3##6##(2007-5#1)(2012-12#2)
the advantages of simplicity##3##4##(2007-11#1)(2008-10#2)
the advantages of such##2##4##(1992-1#1)(2008-2#1)
the advantages of the proposed##4##5##(2007-12#1)(2008-2#1)(2008-3#1)(2012-12#1)
the advantages of the##25##4##(1990-12#1)(1990-5#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-7#1)(1996-3#1)(2004-2#1)(2005-9#1)(2006-12#1)(2007-11#1)(2007-12#3)(2008-12#1)(2008-2#3)(2008-3#4)(2011-1#1)(2011-2#1)(2012-12#1)
the advantages of this##9##4##(1991-2#1)(1993-1#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-2#1)
the advantages of using##4##4##(1992-8#1)(2008-3#2)(2012-12#1)
the advantages of##156##3##(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#2)(1991-3#1)(1992-1#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-5#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-7#1)(1996-1#1)(1996-11#2)(1996-3#1)(1997-1#1)(1997-3#1)(1997-6#1)(2004-10#1)(2004-2#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#3)(2006-2#2)(2006-5#2)(2006-7#2)(2007-11#4)(2007-12#8)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-10#16)(2008-11#2)(2008-12#2)(2008-2#17)(2008-3#14)(2008-4#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2011-1#1)(2011-2#3)(2012-12#7)(2012-2#3)(2012-3#1)(2013-1#2)
the advantages offered by##3##4##(1990-9#1)(2010-12#1)(2012-2#1)
the advantages over##2##3##(2007-12#1)(2008-10#1)
the advantages that##4##3##(1997-6#1)(2008-4#2)(2011-1#1)
the advantages##251##2##(1990-10#1)(1990-12#3)(1990-5#1)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-4#1)(1992-1#1)(1992-2#1)(1992-8#2)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-5#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-7#1)(1996-1#1)(1996-11#3)(1996-3#4)(1997-1#1)(1997-3#1)(1997-6#2)(2004-10#1)(2004-2#2)(2005-5#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#5)(2006-12#4)(2006-2#2)(2006-5#2)(2006-6#1)(2006-7#2)(2007-10#2)(2007-11#6)(2007-12#9)(2007-2#2)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#3)(2008-1#2)(2008-10#30)(2008-11#3)(2008-12#2)(2008-2#19)(2008-3#17)(2008-4#5)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#5)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#5)(2009-9#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#8)(2012-2#6)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#4)
the advent of better##2##4##(2005-10#1)(2006-2#1)
the advent of genomics##2##4##(2007-4#1)(2010-5#1)
the advent of highly##2##4##(2007-11#1)(2009-4#1)
the advent of managed care##3##5##(1996-12#1)(1997-2#1)(2007-8#1)
the advent of new drugs##4##5##(2006-6#4)
the advent of new therapies##2##5##(2007-10#1)(2009-10#1)
the advent of new##9##4##(2006-6#4)(2007-10#1)(2008-5#1)(2009-10#1)(2010-12#1)(2010-7#1)
the advent of newer##2##4##(2011-1#1)(2011-2#1)
the advent of recombinant##2##4##(2006-9#1)(2009-2#1)
the advent of the##6##4##(1991-2#1)(1993-2#1)(1996-11#1)(2008-4#1)(2008-5#1)(2008-7#1)
the advent of##91##3##(1991-2#1)(1993-2#1)(1994-2#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-2#1)(2003-11#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#1)(2006-6#4)(2006-8#4)(2006-9#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-10#2)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
the advent##92##2##(1991-2#1)(1993-2#1)(1994-2#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-2#1)(2003-11#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#1)(2006-6#4)(2006-8#4)(2006-9#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-10#2)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
the adventitia##5##2##(1991-8#1)(1997-3#1)(1997-8#3)
the adventitial##4##2##(1992-12#1)(1997-1#1)(2010-4#2)
the adventitious root##4##3##(2008-12#4)
the adverse consequences of##3##4##(1993-3#1)(2007-4#1)(2008-11#1)
the adverse consequences##5##3##(1992-2#1)(1993-3#1)(2007-4#1)(2008-11#1)(2010-5#1)
the adverse drug reaction##2##4##(1997-5#1)(2010-5#1)
the adverse drug##3##3##(1997-5#1)(2010-5#1)(2011-2#1)
the adverse effect of##6##4##(1993-7#1)(2008-7#1)(2009-4#1)(2009-8#1)(2012-3#1)(2013-1#1)
the adverse effect##7##3##(1993-7#1)(2008-7#1)(2009-4#1)(2009-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
the adverse effects are##2##4##(2005-11#1)(2007-11#1)
the adverse effects of##19##4##(1995-5#1)(1996-6#1)(1996-9#1)(2005-10#1)(2006-10#2)(2006-2#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#1)(2011-12#1)(2012-12#1)
the adverse effects on the##2##5##(2007-2#1)(2008-4#1)
the adverse effects##27##3##(1992-3#1)(1995-5#1)(1996-6#1)(1996-9#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-11#2)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#1)(2011-12#1)(2012-12#1)(2013-7#1)
the adverse event##4##3##(1991-12#1)(2006-6#1)(2012-1#2)
the adverse events##5##3##(2006-10#1)(2008-11#1)(2008-5#1)(2010-1#1)(2013-8#1)
the adverse health effects of##2##5##(2007-8#1)(2013-1#1)
the adverse health effects##3##4##(1993-6#1)(2007-8#1)(2013-1#1)
the adverse impact##2##3##(2008-7#1)(2008-8#1)
the adverse outcomes##2##3##(2008-11#1)(2009-9#1)
the adverse reaction##2##3##(2006-5#1)(2008-2#1)
the adverse reactions of##2##4##(1991-9#1)(2008-8#1)
the adverse reactions##3##3##(1991-9#1)(2008-8#1)(2011-1#1)
the adverse##74##2##(1991-12#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-11#1)(1995-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-2#3)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
the advertisement call of##2##4##(2013-7#2)
the advertisement##4##2##(1995-9#1)(2013-7#3)
the advice of a##2##4##(1994-7#1)(2007-12#1)
the advice to##2##3##(2010-12#1)(2012-12#1)
the advice##5##2##(1994-7#1)(2004-7#1)(2007-12#1)(2010-12#1)(2012-12#1)
the advisability of##5##3##(1992-12#1)(1992-2#1)(1995-1#1)(1996-2#1)(2008-6#1)
the advocacy##4##2##(2007-2#1)(2008-11#1)(2011-1#1)(2012-12#1)
the aeciospores##2##2##(2008-10#2)
the aedeagus##2##2##(2007-12#1)(2008-8#1)
the aeration rate was##2##4##(2008-5#1)(2010-11#1)
the aerial image##2##3##(2007-12#1)(2008-3#1)
the aerial parts of Xanthium strumarium##2##6##(2007-1#2)
the aerial parts of##20##4##(2006-12#2)(2007-1#12)(2007-11#1)(2007-3#1)(2008-11#1)(2008-4#1)(2011-1#1)(2013-1#1)
the aerial parts##23##3##(2006-12#2)(2007-1#14)(2007-11#1)(2007-3#1)(2008-11#2)(2008-4#1)(2011-1#1)(2013-1#1)
the aerial##29##2##(2005-11#1)(2006-12#2)(2007-1#14)(2007-11#1)(2007-12#1)(2007-3#1)(2008-11#3)(2008-3#1)(2008-4#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-1#1)
the aero-medical##2##2##(2012-12#2)
the aero-optic linking equation##2##4##(2008-3#2)
the aerobic and##2##3##(2009-12#1)(2013-8#1)
the aerobic##16##2##(1990-8#2)(1994-8#1)(1994-9#1)(1996-6#1)(2006-8#3)(2007-10#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-12#1)(2013-8#1)
the aerodynamic size##2##3##(1992-3#2)
the aerodynamic##4##2##(1992-3#2)(2008-11#1)(2008-3#1)
the aerogels##3##2##(2010-4#3)
the aerosol and##2##3##(1991-1#1)(1992-3#1)
the aerosol backscattering##4##3##(2008-3#4)
the aerosol bolus##2##3##(1997-1#2)
the aerosol complex index of refraction and size distribution from scattering measurements of polarized light##2##15##(2008-2#2)
the aerosol concentration##2##3##(2008-3#2)
the aerosol extinction coefficient##3##4##(2008-2#1)(2008-3#2)
the aerosol extinction profile##3##4##(2008-3#3)
the aerosol extinction##6##3##(2008-2#1)(2008-3#5)
the aerosol optical properties##2##4##(2008-2#2)
the aerosol optical thickness##5##4##(2008-2#3)(2008-3#2)
the aerosol optical##9##3##(2008-2#7)(2008-3#2)
the aerosol phase function##2##4##(2008-2#2)
the aerosol properties##2##3##(2008-3#2)
the aerosol refractive index##4##4##(2008-2#1)(2008-3#3)
the aerosol single-scattering albedo and##2##5##(2008-2#2)
the aerosol single-scattering albedo##3##4##(2008-2#3)
the aerosol size distribution##2##4##(2008-3#2)
the aerosol size##3##3##(2008-3#3)
the aerosol volume##2##3##(2008-2#1)(2008-3#1)
the aerosol was##2##3##(1992-2#1)(1994-12#1)
the aerosol##79##2##(1991-1#2)(1992-2#1)(1992-3#4)(1994-12#3)(1995-3#2)(1996-2#2)(1996-3#1)(1997-1#2)(2008-10#3)(2008-2#28)(2008-3#30)(2013-1#1)
the aerosols##6##2##(1992-2#1)(2008-10#2)(2008-2#1)(2008-3#2)
the aesthetic##11##2##(1990-9#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-5#1)(2012-11#1)(2012-12#1)(2013-1#2)
the aetiologic##3##2##(1996-7#1)(2008-5#2)
the aetiological agent##2##3##(1997-7#1)(2008-5#1)
the aetiological diagnosis of##2##4##(1990-3#1)(1992-10#1)
the aetiological factors##2##3##(1996-12#1)(2006-7#1)
the aetiological##10##2##(1990-3#1)(1990-5#1)(1992-10#1)(1996-12#1)(1997-7#1)(2006-3#1)(2006-7#1)(2008-5#1)(2008-7#1)(2010-1#1)
the aetiologies##2##2##(1995-10#1)(2008-12#1)
the aetiology and the##2##4##(2007-10#1)(2007-9#1)
the aetiology and treatment of##2##5##(2006-9#1)(2011-2#1)
the aetiology and##14##3##(1993-11#1)(1993-7#1)(1997-1#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-12#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-2#1)
the aetiology of dental##2##4##(2006-2#1)(2013-8#1)
the aetiology of human##2##4##(1991-5#1)(1997-4#1)
the aetiology of the##3##4##(1996-11#1)(2006-3#1)(2008-3#1)
the aetiology of this##2##4##(2009-4#1)(2009-7#1)
the aetiology of##56##3##(1990-8#1)(1991-5#2)(1991-9#1)(1992-4#1)(1992-5#2)(1993-11#1)(1993-2#2)(1993-9#1)(1996-11#4)(1997-1#1)(1997-4#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-3#1)(2007-11#3)(2007-4#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-7#1)(2010-8#2)(2011-2#5)(2012-2#1)(2013-8#3)
the aetiology##75##2##(1990-8#1)(1991-5#2)(1991-9#1)(1992-4#1)(1992-5#2)(1993-11#2)(1993-2#2)(1993-7#1)(1993-9#1)(1996-11#4)(1997-1#2)(1997-4#1)(1997-8#1)(2005-11#1)(2006-10#3)(2006-2#1)(2006-3#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-2#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-2#7)(2012-2#1)(2013-8#3)
the aetiopathogenesis of schizophrenia##2##4##(1996-5#2)
the aetiopathogenesis of##3##3##(1992-2#1)(1996-5#2)
the aetiopathogenesis##4##2##(1990-9#1)(1992-2#1)(1996-5#2)
the affect of##3##3##(1994-2#1)(2008-2#1)(2010-3#1)
the affect##5##2##(1993-6#1)(1994-2#1)(2008-11#1)(2008-2#1)(2010-3#1)
the affected and##2##3##(1992-10#1)(2007-8#1)
the affected area##8##3##(1996-6#1)(2006-7#1)(2007-2#1)(2008-1#1)(2008-10#1)(2012-2#1)(2013-8#2)
the affected areas##7##3##(1995-2#1)(2005-7#1)(2007-7#2)(2009-6#1)(2011-2#2)
the affected bowel segment##2##4##(1992-5#1)(2006-10#1)
the affected children##3##3##(1990-11#1)(1993-12#1)(2012-2#1)
the affected domains of##2##4##(2006-11#1)(2010-5#1)
the affected eye##3##3##(1996-3#2)(2007-2#1)
the affected families##2##3##(1997-5#1)(2008-8#1)
the affected finger##2##3##(2006-3#1)(2009-5#1)
the affected individuals##4##3##(1997-3#1)(1997-4#1)(2010-8#1)(2011-1#1)
the affected knee##4##3##(2007-8#1)(2008-12#1)(2012-1#1)(2013-1#1)
the affected limb##6##3##(2006-10#1)(2007-7#1)(2008-7#1)(2009-3#2)(2010-9#1)
the affected limbs##2##3##(1991-7#1)(1991-8#1)
the affected members##4##3##(1991-7#1)(1995-1#1)(1997-8#1)(2010-3#1)
the affected organ##2##3##(2006-2#1)(2011-2#1)
the affected part of the##2##5##(1994-12#1)(2008-1#1)
the affected patients##5##3##(1996-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2009-4#1)
the affected people in##2##4##(2011-1#2)
the affected people##3##3##(1992-1#1)(2011-1#2)
the affected population##5##3##(2008-7#1)(2010-5#3)(2012-2#1)
the affected region##3##3##(1990-6#1)(1994-12#1)(2007-8#1)
the affected side##5##3##(2007-7#1)(2009-5#1)(2010-2#2)(2013-1#1)
the affected teeth##3##3##(2007-2#1)(2008-12#1)(2013-1#1)
the affected thumb##2##3##(2006-3#2)
the affected tissue##5##3##(1993-3#1)(1997-8#1)(2007-11#1)(2007-7#2)
the affected tissues##3##3##(1990-3#1)(2011-2#1)(2012-12#1)
the affected zone##2##3##(2008-10#1)(2008-2#1)
the affected##169##2##(1990-11#2)(1990-2#1)(1990-3#2)(1990-6#2)(1991-3#1)(1991-7#2)(1991-8#1)(1992-1#1)(1992-10#3)(1992-5#2)(1992-7#1)(1993-12#1)(1993-3#1)(1994-12#2)(1994-5#1)(1994-6#1)(1995-1#2)(1995-2#1)(1996-12#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-8#2)(2005-7#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#3)(2006-7#2)(2006-8#2)(2007-10#4)(2007-11#2)(2007-12#2)(2007-2#3)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#9)(2007-8#3)(2007-9#2)(2008-1#5)(2008-10#4)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2009-3#4)(2009-4#2)(2009-5#3)(2009-6#2)(2010-10#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#11)(2012-1#3)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#6)(2013-8#3)
the affection##3##2##(1993-5#1)(2007-8#1)(2012-2#1)
the affective and##3##3##(1996-2#1)(2009-2#1)(2012-12#1)
the affective##5##2##(1996-2#1)(2009-2#1)(2009-9#1)(2012-12#1)(2013-8#1)
the afferent and efferent##2##4##(2009-2#1)(2010-4#1)
the afferent input##2##3##(1990-5#1)(1991-10#1)
the afferent##13##2##(1990-5#1)(1991-10#1)(1994-6#1)(1995-12#1)(1996-9#2)(1997-3#1)(2006-10#1)(2008-10#1)(2008-7#2)(2009-2#1)(2010-4#1)
the affiliated##2##2##(1991-2#1)(2007-9#1)
the affine##2##2##(1997-8#1)(2008-2#1)
the affinities for##3##3##(1990-7#1)(1993-9#1)(1996-7#1)
the affinities of the##3##4##(1992-3#1)(1993-3#1)(2008-10#1)
the affinities of these##2##4##(1991-4#1)(1995-12#1)
the affinities of##10##3##(1991-4#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-8#1)(1995-12#1)(1996-5#1)(1996-9#1)(2008-10#1)
the affinities##16##2##(1990-7#1)(1991-4#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(2008-10#1)
the affinity and##3##3##(1994-5#1)(1995-10#1)(2007-11#1)
the affinity between the##2##4##(1990-2#1)(2008-10#1)
the affinity between##6##3##(1990-2#2)(1991-10#1)(2005-11#1)(2008-10#2)
the affinity constant of the##2##5##(2008-10#2)
the affinity constant##7##3##(1991-5#1)(1992-1#1)(2008-10#5)
the affinity for binding##2##4##(1990-4#1)(1990-8#1)
the affinity for heme##2##4##(1990-8#1)(1994-8#1)
the affinity for the##5##4##(1990-7#1)(1991-2#2)(1994-9#2)
the affinity for##15##3##(1990-3#2)(1990-4#1)(1990-7#1)(1990-8#2)(1991-2#2)(1991-3#1)(1994-8#1)(1994-9#2)(1995-3#1)(1997-6#1)(2006-12#1)
the affinity labeling##2##3##(1990-12#1)(1994-11#1)
the affinity of CP 96##3##5##(1994-9#3)
the affinity of Ca2+ for the high-affinity sites##2##8##(1992-3#2)
the affinity of P1 for DNA##2##6##(1992-6#2)
the affinity of a##2##4##(1992-4#1)(2008-4#1)
the affinity of agonists for##3##5##(1990-5#2)(1996-2#1)
the affinity of protein kinase C for##2##7##(1994-5#2)
the affinity of sIL-1R for##2##5##(1995-2#2)
the affinity of the enzyme for Mg2+##2##7##(1990-8#2)
the affinity of the enzyme for##4##6##(1990-8#2)(1991-2#1)(1994-11#1)
the affinity of the enzyme##5##5##(1990-8#2)(1991-2#1)(1993-6#1)(1994-11#1)
the affinity of the receptor for##4##6##(1991-3#1)(1992-12#1)(1994-5#1)(1995-3#1)
the affinity of the##37##4##(1990-2#1)(1990-7#1)(1990-8#2)(1991-2#1)(1991-3#1)(1992-12#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-6#2)(1993-8#1)(1994-11#2)(1994-5#1)(1994-6#2)(1994-9#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-11#2)(1996-3#1)(1996-5#1)(1997-4#3)(2006-12#1)(2008-4#2)(2008-8#2)(2010-2#1)
the affinity of this##5##4##(1990-4#1)(1990-7#1)(1990-8#1)(1994-11#1)(1995-8#1)
the affinity of##91##3##(1990-1#1)(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#4)(1990-7#3)(1990-8#4)(1991-2#2)(1991-3#1)(1991-9#1)(1992-12#2)(1992-3#3)(1992-4#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-6#3)(1993-8#1)(1994-11#3)(1994-12#1)(1994-5#3)(1994-6#3)(1994-9#6)(1995-1#2)(1995-2#4)(1995-3#3)(1995-5#2)(1995-8#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#3)(1997-2#1)(1997-4#3)(1997-7#1)(2006-12#1)(2008-11#1)(2008-4#3)(2008-8#2)(2009-12#1)(2010-2#1)
the affinity purification of##2##4##(1990-8#1)(1995-2#1)
the affinity reaction##2##3##(2007-9#1)(2008-12#1)
the affinity tag##3##3##(2008-4#2)(2008-7#1)
the affinity to##4##3##(1992-9#1)(1994-2#1)(1995-8#1)(1997-4#1)
the affinity##166##2##(1990-1#1)(1990-12#3)(1990-2#5)(1990-3#2)(1990-4#3)(1990-5#4)(1990-7#4)(1990-8#9)(1991-10#1)(1991-11#1)(1991-2#4)(1991-3#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#3)(1992-4#2)(1992-6#3)(1992-8#1)(1992-9#2)(1993-1#2)(1993-2#1)(1993-4#1)(1993-6#4)(1993-8#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#4)(1994-6#4)(1994-8#1)(1994-9#11)(1995-1#2)(1995-10#2)(1995-11#1)(1995-2#5)(1995-3#4)(1995-5#2)(1995-8#2)(1996-11#3)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#3)(1997-2#1)(1997-4#4)(1997-6#1)(1997-7#2)(1997-8#1)(2005-11#1)(2005-12#1)(2006-12#2)(2007-11#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-4#8)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#1)(2010-2#1)(2012-2#1)
the affinity-purified##2##2##(1994-5#1)(2008-7#1)
the afflicted##3##2##(1991-6#1)(2011-2#1)(2013-1#1)
the affluent##3##2##(1997-7#1)(2007-9#1)(2008-3#1)
the aflatoxin moiety was##2##4##(1995-10#2)
the aflatoxin moiety##4##3##(1995-10#4)
the aflatoxin production##2##3##(1992-9#1)(2009-3#1)
the aflatoxin##8##2##(1992-9#2)(1995-10#5)(2009-3#1)
the afore##2##2##(2007-12#1)(2008-8#1)
the afore-mentioned##3##2##(1995-4#1)(2007-8#1)(2009-10#1)
the aforementioned##36##2##(1993-12#1)(1993-2#1)(1993-4#1)(1994-12#2)(1994-8#1)(1994-9#1)(1996-11#1)(1997-1#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-4#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-2#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
the african american##3##3##(2010-8#3)
the african##5##2##(1996-11#2)(2010-8#3)
the after load##2##3##(2006-6#1)(2012-2#1)
the after##3##2##(1991-12#1)(2006-6#1)(2012-2#1)
the afterglow in##2##3##(2008-5#2)
the afterhyperpolarization in##2##3##(1996-1#1)(1996-8#1)
the afterhyperpolarization##6##2##(1991-8#1)(1993-2#1)(1996-1#2)(1996-8#1)(2009-2#1)
the aftermath of##9##3##(1993-12#1)(2008-4#1)(2008-7#1)(2008-9#2)(2010-11#1)(2010-6#1)(2012-1#1)(2013-8#1)
the aftermath##10##2##(1993-12#1)(2008-4#1)(2008-7#1)(2008-9#2)(2010-11#1)(2010-6#1)(2012-1#1)(2012-3#1)(2013-8#1)
the afternoon##10##2##(1993-10#1)(1993-12#1)(1995-1#1)(2005-8#1)(2006-2#1)(2008-3#1)(2008-5#2)(2010-5#1)(2013-8#1)
the agar diffusion method##2##4##(2007-11#1)(2011-1#1)
the agar diffusion##3##3##(2007-11#1)(2008-5#1)(2011-1#1)
the agar dilution method for##2##5##(2006-5#1)(2008-10#1)
the agar dilution method##4##4##(2006-5#1)(2006-8#1)(2008-10#1)(2012-12#1)
the agar dilution##7##3##(1994-11#1)(2006-10#1)(2006-5#1)(2006-8#2)(2008-10#1)(2012-12#1)
the agar surface##5##3##(2008-10#4)(2008-8#1)
the agar##24##2##(1994-11#1)(1994-8#1)(2006-10#1)(2006-5#1)(2006-8#2)(2007-11#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#3)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)
the agarose gel##3##3##(1990-11#1)(2008-10#2)
the agarose##6##2##(1990-11#1)(1997-4#1)(2008-10#2)(2008-4#1)(2008-8#1)
the agate industry##2##3##(2009-12#2)
the age and sex##4##4##(1990-8#1)(2006-10#1)(2009-3#1)(2012-3#1)
the age and##17##3##(1990-8#1)(1991-9#1)(1994-12#1)(2004-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-6#1)(2009-3#1)(2011-2#2)(2012-3#2)
the age at onset##2##4##(2007-7#1)(2013-8#1)
the age at the time of##2##6##(2011-2#1)(2012-2#1)
the age at the##3##4##(1991-6#1)(2011-2#1)(2012-2#1)
the age at which##7##4##(1994-7#1)(2007-2#1)(2008-10#2)(2008-8#1)(2009-5#1)(2012-12#1)
the age at##17##3##(1991-6#1)(1994-7#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-8#1)(2009-5#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
the age distribution of##6##4##(1996-1#1)(1997-8#1)(2007-9#2)(2009-10#1)(2009-7#1)
the age distribution##7##3##(1993-9#1)(1996-1#1)(1997-8#1)(2007-9#2)(2009-10#1)(2009-7#1)
the age group 15-20 years##2##5##(1991-8#1)(2007-11#1)
the age group of 21-30 years##2##6##(2007-7#1)(2007-8#1)
the age group of 31-40 years##2##6##(2007-7#1)(2008-3#1)
the age group of##25##4##(2006-4#3)(2007-2#1)(2007-7#5)(2007-8#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-5#2)(2011-1#2)(2012-12#1)(2013-8#5)
the age group##49##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-8#1)(1991-9#1)(1993-11#1)(1995-9#1)(2006-4#4)(2006-6#1)(2007-11#2)(2007-2#1)(2007-7#7)(2007-8#2)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-5#2)(2011-1#4)(2012-12#1)(2012-3#2)(2013-8#6)
the age groups of##2##4##(1991-12#1)(2008-7#1)
the age groups##17##3##(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-6#1)(1996-5#1)(2006-1#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-3#1)(2008-7#2)(2008-9#1)(2013-8#1)
the age of 1##3##4##(1995-4#1)(2006-2#1)(2007-7#1)
the age of 10 and##2##5##(2006-10#1)(2008-9#1)
the age of 10##6##4##(2006-10#1)(2006-4#1)(2008-5#1)(2008-9#2)(2010-3#1)
the age of 12 months##2##5##(2007-3#1)(2012-1#1)
the age of 12 years##2##5##(2008-9#1)(2012-12#1)
the age of 12##4##4##(2007-3#1)(2008-9#1)(2012-1#1)(2012-12#1)
the age of 14 years##2##5##(2007-7#1)(2012-1#1)
the age of 14##3##4##(1993-5#1)(2007-7#1)(2012-1#1)
the age of 15##4##4##(1993-3#1)(1996-6#1)(2008-1#1)(2008-9#1)
the age of 16 years##7##5##(1993-10#1)(1995-6#1)(1997-2#1)(2007-3#2)(2010-4#1)(2011-12#1)
the age of 16##11##4##(1991-8#1)(1993-10#1)(1994-8#1)(1995-6#1)(1997-2#1)(2007-3#2)(2008-7#1)(2010-4#1)(2011-12#1)(2012-2#1)
the age of 17 to##2##5##(1993-4#1)(2012-2#1)
the age of 17 years##4##5##(1992-4#1)(1996-6#1)(2005-9#1)(2006-1#1)
the age of 17##7##4##(1992-4#1)(1993-4#1)(1996-6#1)(1997-3#1)(2005-9#1)(2006-1#1)(2012-2#1)
the age of 18 months##3##5##(1991-11#1)(1993-5#1)(1994-6#1)
the age of 18##8##4##(1990-5#1)(1991-11#1)(1993-5#1)(1994-6#1)(1997-1#1)(2008-12#1)(2011-2#2)
the age of 2 years and##2##6##(1997-3#1)(2005-8#1)
the age of 2 years##4##5##(1997-3#1)(1997-6#1)(2005-8#1)(2006-8#1)
the age of 2##6##4##(1990-10#1)(1997-3#1)(1997-6#1)(2005-8#1)(2006-8#1)(2007-10#1)
the age of 20 years##3##5##(1996-2#1)(1997-3#1)(2007-3#1)
the age of 20##6##4##(1992-2#1)(1996-2#1)(1996-9#1)(1997-3#1)(2007-3#1)(2013-8#1)
the age of 21##2##4##(2009-5#1)(2010-4#1)
the age of 27##3##4##(1997-2#1)(2013-1#2)
the age of 3 months##3##5##(2007-11#1)(2012-1#1)(2013-7#1)
the age of 3##8##4##(2007-11#1)(2008-10#1)(2008-5#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-7#1)
the age of 30 days##2##5##(2009-2#1)(2012-1#1)
the age of 30 years##2##5##(2008-6#1)(2013-7#1)
the age of 30##9##4##(1991-8#1)(1995-9#1)(2006-4#1)(2008-11#1)(2008-6#1)(2009-10#1)(2009-2#1)(2012-1#1)(2013-7#1)
the age of 38 and##2##5##(2008-5#1)(2011-2#1)
the age of 4 months##3##5##(1995-12#1)(2006-8#1)(2007-11#1)
the age of 4##5##4##(1995-12#1)(1996-11#1)(2006-11#1)(2006-8#1)(2007-11#1)
the age of 40 years##7##5##(2004-2#1)(2006-6#1)(2007-2#3)(2008-5#2)
the age of 40##17##4##(2004-2#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-2#4)(2008-5#2)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#3)
the age of 45 years##2##5##(1991-3#1)(2005-8#1)
the age of 45##3##4##(1991-12#1)(1991-3#1)(2005-8#1)
the age of 5 years##5##5##(1997-3#1)(2007-8#1)(2008-8#1)(2008-9#1)(2013-8#1)
the age of 5##9##4##(1995-1#1)(1997-3#1)(2006-12#1)(2007-8#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#1)(2013-8#1)
the age of 50 years##7##5##(1990-4#1)(1992-3#1)(1993-12#1)(1994-12#1)(2007-2#1)(2007-7#1)(2008-4#1)
the age of 50##18##4##(1990-4#1)(1992-3#1)(1993-10#1)(1993-12#1)(1994-12#2)(1995-9#2)(1997-1#1)(2006-9#1)(2007-2#1)(2007-7#1)(2008-4#1)(2008-5#2)(2009-3#1)(2011-2#1)(2013-1#1)
the age of 51##2##4##(1991-12#1)(2007-12#1)
the age of 55##4##4##(1990-9#2)(1996-11#1)(2012-2#1)
the age of 6 weeks##2##5##(2006-8#1)(2008-7#1)
the age of 6 years##3##5##(1997-3#1)(2007-7#1)(2008-6#1)
the age of 6##9##4##(1991-1#2)(1994-6#1)(1997-3#1)(2006-8#1)(2007-7#1)(2008-6#1)(2008-7#1)(2013-1#1)
the age of 60##3##4##(1990-4#1)(2006-4#1)(2011-2#1)
the age of 65##5##4##(1990-11#1)(1992-10#1)(2007-8#1)(2008-3#1)(2009-4#1)
the age of 70##5##4##(1990-8#1)(1991-4#1)(1996-3#1)(1997-8#1)(2012-1#1)
the age of 75##3##4##(1997-8#1)(2011-2#1)(2013-7#1)
the age of 8 years##2##5##(2007-2#1)(2012-12#1)
the age of 85##5##4##(1991-10#1)(1994-5#1)(1996-11#1)(1996-3#1)(2008-11#1)
the age of 90##2##4##(1991-10#1)(1997-5#1)
the age of a##6##4##(1996-3#1)(1996-7#1)(2008-10#2)(2008-8#1)(2008-9#1)
the age of eight years##3##5##(2006-10#3)
the age of eighteen##2##4##(1991-10#1)(2006-2#1)
the age of five years##2##5##(1991-12#1)(2006-8#1)
the age of five##5##4##(1991-12#1)(1992-2#1)(1997-3#1)(2006-8#1)(2007-7#1)
the age of four##3##4##(1993-10#1)(2006-10#1)(2012-11#1)
the age of one month##3##5##(1992-11#1)(2006-8#1)(2007-1#1)
the age of one year##3##5##(1990-12#1)(1991-4#1)(1994-6#1)
the age of one##8##4##(1990-12#1)(1991-4#1)(1992-11#2)(1994-6#1)(1997-3#1)(2006-8#1)(2007-1#1)
the age of onset##2##4##(2007-6#1)(2008-1#1)
the age of six##2##4##(2007-2#1)(2007-7#1)
the age of the child##3##5##(2006-10#1)(2007-11#1)(2011-1#1)
the age of the common ancestor of##5##7##(1996-5#4)(1997-6#1)
the age of the girl##2##5##(1995-6#2)
the age of the mother##2##5##(1990-6#1)(2009-5#1)
the age of the patient (39##2##6##(1990-10#1)(2010-2#1)
the age of the patient##9##5##(1990-10#1)(1990-11#1)(1990-9#1)(2004-2#3)(2008-5#1)(2008-7#1)(2010-2#1)
the age of the patients##3##5##(1994-6#1)(2007-10#1)(2008-7#1)
the age of the population##2##5##(2011-2#2)
the age of the##52##4##(1990-10#1)(1990-11#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-5#1)(1993-1#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-6#3)(1996-5#5)(1996-6#1)(1997-6#2)(2004-11#1)(2004-2#3)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-2#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
the age of three months and##2##6##(1991-11#1)(1993-6#1)
the age of three months##3##5##(1991-11#1)(1991-6#1)(1993-6#1)
the age of three years##2##5##(2007-7#1)(2010-10#1)
the age of three##6##4##(1991-11#1)(1991-6#1)(1993-6#1)(2007-7#1)(2010-10#1)(2013-1#1)
the age of two##5##4##(1991-4#1)(1993-1#1)(1993-11#1)(1995-8#1)(2006-7#1)
the age of##353##3##(1990-10#2)(1990-11#2)(1990-12#1)(1990-4#2)(1990-5#1)(1990-6#2)(1990-8#2)(1990-9#3)(1991-1#2)(1991-10#3)(1991-11#3)(1991-12#3)(1991-3#2)(1991-4#4)(1991-6#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#1)(1993-1#2)(1993-10#3)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#1)(1993-9#2)(1994-11#3)(1994-12#2)(1994-5#2)(1994-6#4)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#3)(1995-3#1)(1995-4#1)(1995-6#5)(1995-8#2)(1995-9#3)(1996-11#4)(1996-2#1)(1996-3#6)(1996-5#5)(1996-6#3)(1996-7#2)(1996-9#3)(1997-1#2)(1997-2#2)(1997-3#7)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#2)(2004-11#3)(2004-2#4)(2005-10#1)(2005-12#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#8)(2006-11#1)(2006-12#1)(2006-2#5)(2006-3#1)(2006-4#4)(2006-6#1)(2006-7#6)(2006-8#9)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#7)(2007-3#4)(2007-5#1)(2007-6#1)(2007-7#13)(2007-8#3)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#9)(2008-6#4)(2008-7#10)(2008-8#2)(2008-9#9)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#4)(2010-6#1)(2011-1#3)(2011-12#2)(2011-2#12)(2012-1#6)(2012-11#1)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#8)(2013-7#4)(2013-8#3)
the age range of##5##4##(2006-8#1)(2008-4#1)(2008-7#1)(2012-12#1)(2013-8#1)
the age range##13##3##(1992-7#1)(2006-5#1)(2006-8#1)(2008-4#1)(2008-7#4)(2009-4#1)(2012-12#1)(2013-1#1)(2013-8#2)
the age related changes##2##4##(2008-12#1)(2011-2#1)
the age related##3##3##(2006-12#1)(2008-12#1)(2011-2#1)
the age rule is used to handle age-specific code assignment in ICD-10-CM##2##12##(2013-1#2)
the age specific##2##3##(2006-8#1)(2010-10#1)
the age when##2##3##(1990-8#1)(2009-7#1)
the age##521##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#1)(1990-4#2)(1990-5#3)(1990-6#3)(1990-8#4)(1990-9#3)(1991-1#2)(1991-10#3)(1991-11#3)(1991-12#6)(1991-3#2)(1991-4#4)(1991-5#1)(1991-6#4)(1991-7#1)(1991-8#4)(1991-9#3)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#2)(1993-1#2)(1993-10#4)(1993-11#2)(1993-12#1)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#1)(1993-9#3)(1994-11#3)(1994-12#3)(1994-5#3)(1994-6#4)(1994-7#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#3)(1995-3#1)(1995-4#1)(1995-6#5)(1995-8#2)(1995-9#4)(1996-1#1)(1996-11#4)(1996-2#1)(1996-3#7)(1996-5#6)(1996-6#3)(1996-7#2)(1996-9#3)(1997-1#2)(1997-2#2)(1997-3#7)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#3)(2004-11#4)(2004-2#4)(2005-10#1)(2005-12#1)(2005-8#3)(2005-9#1)(2006-1#2)(2006-10#10)(2006-11#1)(2006-12#2)(2006-2#5)(2006-3#1)(2006-4#8)(2006-5#1)(2006-6#2)(2006-7#6)(2006-8#12)(2006-9#2)(2007-1#2)(2007-10#3)(2007-11#8)(2007-12#2)(2007-2#9)(2007-3#4)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#23)(2007-8#8)(2007-9#4)(2008-1#4)(2008-10#13)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#9)(2008-5#12)(2008-6#5)(2008-7#18)(2008-8#3)(2008-9#10)(2009-10#2)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#5)(2009-7#2)(2009-9#1)(2010-10#3)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#4)(2010-5#2)(2010-6#1)(2011-1#8)(2011-11#1)(2011-12#2)(2011-2#19)(2012-1#6)(2012-11#1)(2012-12#7)(2012-2#9)(2012-3#7)(2013-1#18)(2013-7#4)(2013-8#17)
the age-1##2##2##(2008-3#2)
the age-adjusted death##2##3##(1997-7#1)(2008-10#1)
the age-adjusted##5##2##(1997-7#1)(2008-10#1)(2008-8#1)(2012-3#2)
the age-associated decline in##3##4##(1995-12#2)(2010-2#1)
the age-associated##6##2##(1990-5#1)(1995-12#2)(1996-12#1)(1996-7#1)(2010-2#1)
the age-corrected##2##2##(1996-5#1)(2007-2#1)
the age-dependent decrease##2##3##(1991-2#1)(1991-4#1)
the age-dependent##11##2##(1990-3#1)(1991-2#1)(1991-4#2)(1992-12#1)(1995-8#1)(1996-3#1)(2006-6#1)(2008-3#1)(2008-7#1)(2011-1#1)
the age-matched controls##2##3##(1990-3#1)(1996-5#1)
the age-matched normal##2##3##(1993-1#1)(2006-8#1)
the age-matched##4##2##(1990-3#1)(1993-1#1)(1996-5#1)(2006-8#1)
the age-related changes in##3##4##(1990-3#1)(1994-6#1)(2013-8#1)
the age-related changes##5##3##(1990-3#1)(1991-6#1)(1994-6#1)(2008-7#1)(2013-8#1)
the age-related decline in##3##4##(1992-12#1)(1992-8#1)(1995-12#1)
the age-related decline of##2##4##(1992-1#1)(2008-7#1)
the age-related decline##6##3##(1992-1#1)(1992-12#1)(1992-8#1)(1995-12#1)(2008-7#2)
the age-related decrease in##2##4##(1994-5#1)(1995-9#1)
the age-related decrease##3##3##(1994-5#2)(1995-9#1)
the age-related increase##2##3##(1995-9#1)(1996-2#1)
the age-related##28##2##(1990-3#1)(1991-10#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#1)(1994-5#3)(1994-6#1)(1995-12#2)(1995-6#1)(1995-9#2)(1996-2#1)(1996-7#1)(1996-9#2)(2008-5#1)(2008-7#3)(2011-2#2)(2013-1#1)(2013-8#1)
the age-specific incidence##3##3##(1994-11#2)(1996-3#1)
the age-specific##9##2##(1992-5#1)(1993-5#1)(1994-11#2)(1996-3#1)(2008-7#2)(2012-2#1)(2013-1#1)
the age-standardized##2##2##(1996-3#1)(2006-8#1)
the aged and##2##3##(1990-4#2)
the aged cements##2##3##(2010-8#2)
the aged group##3##3##(1997-2#3)
the aged in##3##3##(1990-4#1)(1994-1#1)(2011-1#1)
the aged population##2##3##(1996-6#1)(2009-10#1)
the aged rat##5##3##(1992-12#1)(1994-2#1)(1995-7#2)(1997-1#1)
the aged rats##3##3##(1992-8#1)(1997-1#2)
the aged##71##2##(1990-11#1)(1990-12#5)(1990-2#1)(1990-3#5)(1990-4#3)(1990-5#3)(1991-1#1)(1991-11#2)(1991-6#2)(1991-8#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-1#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-7#2)(1995-8#2)(1995-9#1)(1996-2#3)(1996-3#1)(1996-6#2)(1996-7#1)(1997-1#3)(1997-2#4)(1997-6#1)(2007-8#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-10#1)(2009-5#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-2#1)
the aged-care##2##2##(2010-10#2)
the aged]##8##2##(1990-11#1)(1990-3#1)(1991-11#1)(1991-7#1)(1991-8#1)(1992-10#1)(1995-10#1)(1996-2#1)
the ageing of##3##3##(2008-11#1)(2008-5#1)(2008-9#1)
the ageing process##5##3##(1991-1#1)(1992-11#1)(2008-5#1)(2008-7#1)(2009-12#1)
the ageing##17##2##(1991-1#1)(1992-11#1)(1995-3#1)(1995-8#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-5#4)(2008-7#1)(2008-9#1)(2009-12#1)(2010-8#1)(2011-1#1)
the agencies##2##2##(1997-2#1)(2011-12#1)
the agency that had##2##4##(1994-2#2)
the agency##8##2##(1992-1#1)(1993-1#1)(1994-2#2)(1995-3#1)(1996-11#1)(2007-9#2)
the agency's##4##2##(1992-8#1)(1995-6#1)(2007-2#1)(2007-9#1)
the agenda##3##2##(1996-6#1)(2011-1#1)(2013-8#1)
the agenda?##2##2##(2008-2#1)(2013-1#1)
the agent being##2##3##(2008-2#1)(2010-9#1)
the agent has##3##3##(2007-11#1)(2009-2#1)(2009-8#1)
the agent in##3##3##(1995-10#1)(1995-2#1)(2007-11#1)
the agent is##2##3##(1996-8#1)(2008-4#1)
the agent of##4##3##(2005-8#1)(2006-10#1)(2007-8#1)(2008-8#1)
the agent##33##2##(1990-11#1)(1991-12#1)(1991-3#2)(1992-3#1)(1995-10#1)(1995-2#1)(1996-5#1)(1996-8#1)(1997-3#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#1)(2009-11#1)(2009-2#1)(2009-8#2)(2010-9#1)
the agent's##3##2##(1994-8#1)(2008-7#2)
the agents involved##2##3##(2008-10#1)(2008-5#1)
the agents of##3##3##(2008-5#1)(2011-2#1)(2012-3#1)
the agents that##2##3##(1992-8#1)(2012-12#1)
the agents used##2##3##(1991-12#1)(2005-11#1)
the agents##37##2##(1990-6#1)(1991-12#2)(1991-2#1)(1992-8#1)(1993-12#1)(1994-6#1)(1996-11#1)(1997-2#1)(1997-7#1)(2005-11#2)(2006-5#1)(2006-9#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#5)(2008-8#2)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
the agents'##3##2##(2008-1#2)(2008-5#1)
the ages of 10 and##3##5##(1995-8#1)(2009-4#1)(2012-12#1)
the ages of 20##2##4##(1992-7#1)(2012-2#1)
the ages of 45 and 65##2##6##(2009-11#1)(2009-5#1)
the ages of the##2##4##(2008-7#1)(2009-2#1)
the ages of two##2##4##(2008-6#1)(2013-8#1)
the ages of##41##3##(1990-2#1)(1990-4#1)(1991-12#1)(1992-2#1)(1992-7#1)(1994-3#1)(1995-12#1)(1995-6#1)(1995-8#1)(1997-5#1)(2006-10#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-4#2)(2007-8#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
the ages##45##2##(1990-2#1)(1990-4#1)(1991-12#1)(1992-2#1)(1992-7#1)(1993-2#1)(1994-3#1)(1995-12#1)(1995-6#1)(1995-8#1)(1997-5#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#2)(2007-8#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-1#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
the agglutination of##3##3##(1991-8#1)(1994-9#2)
the agglutination##4##2##(1991-8#1)(1994-9#2)(2011-1#1)
the aggravation of##2##3##(2008-10#1)(2008-6#1)
the aggravation##4##2##(2008-10#1)(2008-5#1)(2008-6#1)(2011-2#1)
the aggrecan mRNA##2##3##(1992-1#1)(2008-11#1)
the aggrecan##6##2##(1992-1#5)(2008-11#1)
the aggregate level##2##3##(1996-3#1)(2012-3#1)
the aggregate##19##2##(1991-7#1)(1994-5#1)(1996-3#1)(2006-10#3)(2006-12#1)(2008-1#1)(2008-10#2)(2008-6#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)
the aggregated peptide##2##3##(1991-11#1)(1995-3#1)
the aggregated##15##2##(1991-11#2)(1995-3#1)(1996-5#1)(2005-11#2)(2008-10#2)(2008-3#1)(2008-8#1)(2009-10#2)(2010-11#1)(2010-4#1)(2012-11#1)
the aggregates and##2##3##(2005-11#2)
the aggregates are##3##3##(2005-11#1)(2008-4#2)
the aggregates##16##2##(1990-12#1)(1991-2#1)(1992-2#1)(1997-6#1)(2005-11#5)(2008-10#2)(2008-4#2)(2010-8#1)(2011-2#2)
the aggregating##2##2##(1992-3#1)(1995-10#1)
the aggregation and##3##3##(2004-9#1)(2006-5#1)(2008-5#1)
the aggregation is##3##3##(1995-5#1)(1997-1#1)(2005-11#1)
the aggregation number##2##3##(2005-11#1)(2007-8#1)
the aggregation of insulin B chain##2##6##(1995-5#2)
the aggregation of pancreatic cancer in##2##6##(2006-10#2)
the aggregation of##26##3##(1990-2#1)(1990-4#1)(1994-9#1)(1995-5#4)(1996-2#1)(1996-5#1)(2005-11#4)(2006-10#2)(2008-1#1)(2008-10#4)(2008-11#2)(2009-8#1)(2010-6#1)(2013-1#2)
the aggregation process##3##3##(1997-3#1)(2005-11#2)
the aggregation rate##2##3##(1996-1#1)(2005-11#1)
the aggregation##55##2##(1990-2#1)(1990-4#2)(1994-12#1)(1994-9#1)(1995-5#5)(1995-8#1)(1996-1#2)(1996-2#1)(1996-5#1)(1997-1#1)(1997-3#1)(2004-9#1)(2005-11#13)(2005-4#1)(2006-10#2)(2006-2#2)(2006-5#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-6#1)(2009-8#1)(2010-6#1)(2010-7#1)(2011-1#1)(2013-1#3)
the aggression of##2##3##(1990-3#1)(1992-12#1)
the aggression##3##2##(1990-3#1)(1992-12#1)(2008-10#1)
the aggressive forms of##2##4##(2007-11#1)(2011-2#1)
the aggressive nature of##2##4##(2006-12#1)(2012-1#1)
the aggressive##16##2##(1991-6#1)(2005-5#1)(2006-12#1)(2007-11#1)(2008-10#6)(2009-3#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#2)
the aggressiveness and##2##3##(2007-7#1)(2008-10#1)
the aggressiveness of treatment##2##4##(2007-11#1)(2012-3#1)
the aggressiveness of##7##3##(1994-12#1)(2007-11#1)(2007-8#1)(2008-10#2)(2011-12#1)(2012-3#1)
the aggressiveness##9##2##(1994-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#3)(2011-12#1)(2012-3#1)
the aging brain##4##3##(1994-5#1)(1996-11#1)(2008-7#2)
the aging hippocampus##2##3##(1993-11#2)
the aging male##6##3##(1990-6#1)(2006-6#3)(2006-9#1)(2008-6#1)
the aging of the population and##2##6##(1996-3#1)(2013-1#1)
the aging of the population##3##5##(1992-1#1)(1996-3#1)(2013-1#1)
the aging of the##7##4##(1992-1#1)(1996-11#1)(1996-3#1)(2005-2#1)(2008-12#1)(2009-9#1)(2013-1#1)
the aging of##14##3##(1992-1#2)(1993-11#1)(1996-11#1)(1996-3#1)(2005-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2009-9#1)(2010-2#1)(2013-1#1)(2013-8#1)
the aging population##5##3##(1991-12#1)(1996-8#1)(2008-12#1)(2011-2#2)
the aging process and##6##4##(1990-4#1)(1994-10#1)(2008-5#1)(2009-12#1)(2009-5#1)(2012-2#1)
the aging process is##2##4##(1995-6#1)(2008-9#1)
the aging process of##2##4##(1994-6#1)(2010-3#1)
the aging process##41##3##(1990-4#2)(1990-5#1)(1992-12#1)(1993-11#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-6#2)(1997-2#4)(1997-3#1)(2005-8#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-12#1)(2009-5#1)(2010-2#1)(2010-3#2)(2012-2#2)(2013-8#1)
the aging processes##2##3##(2008-7#1)(2013-7#1)
the aging rat##2##3##(1993-11#1)(2008-7#1)
the aging##96##2##(1990-12#1)(1990-4#2)(1990-5#1)(1990-6#1)(1991-12#2)(1992-1#2)(1992-12#2)(1993-11#6)(1993-7#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-5#4)(1994-6#4)(1994-8#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#2)(1996-3#2)(1996-6#2)(1996-8#1)(1997-2#4)(1997-3#1)(2005-2#1)(2005-8#1)(2006-6#4)(2006-9#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-9#1)(2009-12#2)(2009-5#1)(2009-9#1)(2010-11#4)(2010-2#3)(2010-3#2)(2011-2#2)(2012-2#3)(2013-1#2)(2013-7#2)(2013-8#2)
the agitation##4##2##(2005-11#2)(2008-10#1)(2013-1#1)
the aglycone##3##2##(1995-7#1)(2007-1#1)(2008-11#1)
the agmatine treatment group##2##4##(2010-12#2)
the agonist concentration##3##3##(1994-6#3)
the agonist##27##2##(1990-2#1)(1990-7#3)(1991-2#1)(1991-7#1)(1992-3#1)(1992-5#1)(1992-9#1)(1994-2#1)(1994-6#3)(1995-1#1)(1995-11#1)(1995-12#1)(1996-2#2)(1996-5#1)(1996-9#1)(1997-1#1)(2004-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-2#2)
the agonist-induced##4##2##(1994-6#1)(1996-5#1)(1996-6#1)(1997-5#1)
the agonistic##2##2##(1992-7#2)
the agonists for##2##3##(1995-12#2)
the agonists##8##2##(1995-11#2)(1995-12#3)(1997-5#1)(1997-7#1)(2008-9#1)
the agouti gene##2##3##(1994-3#2)
the agranular##4##2##(1991-8#1)(1994-2#1)(2008-5#2)
the agreement between the##3##4##(2006-8#1)(2007-11#1)(2008-3#1)
the agreement between##10##3##(1992-1#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2012-1#1)
the agreement was##2##3##(2006-8#1)(2008-3#1)
the agreement with##2##3##(2008-10#2)
the agreement##23##2##(1992-1#1)(1994-3#1)(1995-6#1)(1997-2#1)(2005-8#1)(2006-7#2)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-3#2)(2010-2#1)(2011-1#1)(2012-1#2)
the agricultural industry##2##3##(2008-11#1)(2013-1#1)
the agricultural##10##2##(1991-6#1)(1996-3#1)(2006-4#1)(2008-10#2)(2008-11#1)(2008-12#3)(2013-1#1)
the agriculture##2##2##(2008-1#1)(2008-12#1)
the agrochemical##2##2##(1997-7#1)(2008-10#1)
the agroecological##2##2##(2008-10#1)(2013-8#1)
the agronomically important##2##3##(1992-8#1)(2006-12#1)
the aid of a##15##4##(1990-12#1)(1991-7#1)(1993-10#1)(1993-8#1)(1997-6#1)(2006-5#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-5#1)
the aid of an##10##4##(1990-5#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-3#3)(2009-3#1)(2010-5#1)(2012-2#1)
the aid of crutches##2##4##(2007-11#2)
the aid of special##3##4##(2006-5#1)(2008-2#1)(2008-7#1)
the aid of specific##2##4##(1995-6#1)(2008-4#1)
the aid of suitable##2##4##(1993-8#1)(2006-11#1)
the aid of the##19##4##(1990-4#1)(1991-6#1)(1991-8#1)(1992-9#2)(1994-12#1)(2006-6#5)(2007-12#1)(2007-7#1)(2008-10#2)(2008-2#4)
the aid of##109##3##(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-11#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-8#2)(1994-11#1)(1994-12#1)(1995-6#1)(1996-6#2)(1997-6#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#2)(2006-6#5)(2007-1#2)(2007-11#3)(2007-12#3)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#24)(2008-11#2)(2008-2#6)(2008-3#7)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
the aim is to compare##2##5##(1994-6#1)(2008-10#1)
the aim is to##8##4##(1991-12#1)(1994-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2011-12#1)(2011-3#1)
the aim of analyzing the##2##5##(1993-6#1)(2004-9#1)
the aim of developing an##2##5##(2005-7#2)
the aim of developing##4##4##(2005-7#2)(2007-10#1)(2011-2#1)
the aim of investigating##2##4##(1995-3#1)(2012-3#1)
the aim of our##2##4##(2006-6#1)(2008-10#1)
the aim of reducing##7##4##(2005-8#1)(2006-8#1)(2008-2#1)(2008-3#1)(2011-1#1)(2012-12#1)(2013-1#1)
the aim of studying the##2##5##(1995-12#1)(2007-6#1)
the aim of studying##4##4##(1995-12#1)(2007-12#1)(2007-6#1)(2010-3#1)
the aim of testing##2##4##(2008-10#1)(2008-5#1)
the aim of the present study was to investigate##2##9##(2011-12#1)(2012-12#1)
the aim of the present study was to##6##8##(2008-12#1)(2008-5#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
the aim of the present study##7##6##(2008-12#1)(2008-5#1)(2009-10#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
the aim of the present work was to##2##8##(1996-5#1)(2011-1#1)
the aim of the present##9##5##(1996-5#1)(2008-12#1)(2008-5#1)(2009-10#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
the aim of the##12##4##(1996-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
the aim of this paper##3##5##(1994-5#1)(2006-12#1)(2006-6#1)
the aim of this review##3##5##(2005-7#1)(2009-11#1)(2012-12#1)
the aim of this study to##2##6##(1990-11#1)(2008-11#1)
the aim of this study was to compare##2##8##(2008-12#1)(2013-7#1)
the aim of this study was to examine##2##8##(2008-7#1)(2012-11#1)
the aim of this study was to##9##7##(2007-1#1)(2007-11#1)(2008-12#1)(2008-7#1)(2012-11#1)(2012-2#1)(2012-3#2)(2013-7#1)
the aim of this study##12##5##(1990-11#1)(1996-11#1)(2007-1#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-11#1)(2012-2#1)(2012-3#2)(2013-7#1)
the aim of this work was to##2##7##(2010-12#1)(2012-12#1)
the aim of this work##3##5##(2008-8#1)(2010-12#1)(2012-12#1)
the aim of this##24##4##(1990-11#1)(1994-5#1)(1996-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-11#1)(2010-12#1)(2011-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-7#1)
the aim of which is to##2##6##(2007-4#1)(2012-3#1)
the aim of which##3##4##(2007-4#1)(2009-4#1)(2012-3#1)
the aim of##162##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#2)(1990-8#2)(1991-2#1)(1992-2#2)(1992-8#1)(1993-11#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#3)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#1)(2004-1#1)(2004-12#1)(2004-9#2)(2005-6#1)(2005-7#3)(2005-8#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#3)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#1)(2008-10#14)(2008-11#3)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#3)(2010-3#3)(2010-4#2)(2010-6#1)(2011-1#4)(2011-12#2)(2011-2#5)(2012-11#2)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#5)
the aim to develop##2##4##(2007-4#1)(2011-2#1)
the aim to##37##3##(1990-9#1)(1992-6#1)(1996-1#1)(2005-10#1)(2005-11#1)(2006-4#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#3)
the aim was to assess##2##5##(2004-2#1)(2005-11#1)
the aim was to##5##4##(2004-2#1)(2005-11#1)(2008-10#1)(2010-9#1)(2012-1#1)
the aim##216##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#1)(1992-2#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#2)(1996-11#3)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#1)(2004-1#1)(2004-12#1)(2004-2#1)(2004-9#2)(2005-10#1)(2005-11#3)(2005-6#1)(2005-7#3)(2005-8#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#4)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#20)(2008-11#5)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#6)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2010-11#2)(2010-12#4)(2010-3#3)(2010-4#2)(2010-6#1)(2010-9#1)(2011-1#4)(2011-12#4)(2011-2#10)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#6)(2012-2#4)(2012-3#4)(2013-1#4)(2013-7#4)(2013-8#5)
the aiming component##2##3##(1992-9#2)
the aims of this study were to investigate the##2##9##(2010-12#1)(2011-2#1)
the aims of this study were to##3##7##(2010-12#1)(2010-2#1)(2011-2#1)
the aims of this##6##4##(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#1)
the aims of##14##3##(1997-7#1)(2006-10#1)(2007-4#2)(2008-10#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)
the aims##16##2##(1997-7#1)(2006-10#1)(2007-4#2)(2008-10#1)(2008-4#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)
the air gap##2##3##(2008-10#1)(2008-3#1)
the air in the##3##4##(1995-6#1)(1997-4#1)(2010-8#1)
the air kerma##2##3##(2007-11#2)
the air of##4##3##(1992-6#1)(2008-10#1)(2010-4#2)
the air passage##2##3##(1991-11#1)(2010-4#1)
the air pollutant##2##3##(2007-4#1)(2008-10#1)
the air quality##2##3##(2008-11#1)(2010-9#1)
the air sample##3##3##(2008-10#3)
the air samples##5##3##(2008-10#5)
the air superficial##2##3##(2008-6#2)
the air temperature was##2##4##(2008-6#2)
the air temperature##4##3##(2008-10#1)(2008-6#3)
the air to##3##3##(1995-9#1)(2005-11#1)(2008-11#1)
the air##103##2##(1990-3#1)(1990-8#2)(1991-11#1)(1992-11#1)(1992-4#1)(1992-6#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-10#1)(2005-11#4)(2005-4#1)(2006-11#1)(2006-6#3)(2006-7#1)(2007-11#3)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#30)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#6)(2008-6#5)(2009-7#1)(2010-2#1)(2010-4#5)(2010-8#2)(2010-9#3)(2011-2#1)(2013-1#1)(2013-8#2)
the air-acetylene flame##2##3##(2008-10#2)
the air-acetylene##3##2##(2008-10#3)
the air/water interface were studied##2##5##(1993-3#1)(2005-4#1)
the air/water interface##26##3##(1990-11#2)(1991-3#1)(1993-3#1)(1995-8#1)(2005-11#18)(2005-4#2)(2008-10#1)
the air/water##30##2##(1990-11#2)(1991-3#1)(1993-3#1)(1995-8#1)(2005-11#22)(2005-4#2)(2008-10#1)
the airbag was##2##3##(2007-1#1)(2007-4#1)
the airbag##3##2##(2007-1#1)(2007-4#2)
the airborne cobalt##2##3##(1994-6#2)
the airborne##18##2##(1994-6#2)(2006-12#3)(2007-2#1)(2007-4#1)(2008-10#2)(2008-2#3)(2008-3#3)(2011-1#3)
the aircraft##12##2##(1996-12#3)(2008-2#1)(2008-3#3)(2009-9#4)(2012-12#1)
the airglow emissions##2##3##(2008-2#2)
the airline##2##2##(1997-5#1)(2011-1#1)
the airspaces##2##2##(1991-9#1)(2008-10#1)
the airway and##4##3##(1992-2#1)(1997-1#1)(2006-10#1)(2008-8#1)
the airway circulation##4##3##(1996-1#1)(1997-1#3)
the airway epithelium##3##3##(1994-3#1)(1997-2#2)
the airway have been established##2##5##(2007-8#1)(2008-10#1)
the airway is##5##3##(1996-1#1)(2005-11#1)(2007-12#2)(2010-7#1)
the airway of##2##3##(2005-11#1)(2007-8#1)
the airway sealing pressure##3##4##(2010-7#3)
the airway##65##2##(1992-11#1)(1992-2#5)(1993-7#1)(1994-2#1)(1994-3#4)(1994-6#1)(1995-12#1)(1996-1#3)(1996-12#1)(1997-1#6)(1997-2#2)(1997-3#1)(2005-11#6)(2005-8#1)(2006-10#4)(2006-4#1)(2007-12#5)(2007-8#3)(2007-9#1)(2008-10#1)(2008-12#3)(2008-5#1)(2008-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-7#5)(2011-1#1)(2012-2#1)(2013-8#1)
the airways and the lung parenchyma##2##6##(2009-1#1)(2012-2#1)
the airways and the##3##4##(1996-12#1)(2009-1#1)(2012-2#1)
the airways and##5##3##(1991-7#1)(1996-12#1)(2005-11#1)(2009-1#1)(2012-2#1)
the airways of the##3##4##(1997-1#2)(2008-3#1)
the airways of##6##3##(1992-5#1)(1993-1#1)(1994-2#1)(1997-1#2)(2008-3#1)
the airways##43##2##(1991-7#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1996-12#1)(1996-2#1)(1996-7#2)(1997-1#10)(1997-2#2)(2005-11#4)(2006-10#1)(2007-11#2)(2007-6#2)(2008-3#2)(2008-7#1)(2009-1#1)(2009-4#1)(2010-7#1)(2012-2#2)(2013-8#1)
the alane decomposition and##2##4##(2010-4#2)
the alane##3##2##(1996-2#1)(2010-4#2)
the alanine##5##2##(1991-1#1)(2005-11#1)(2006-12#1)(2008-11#2)
the alarm##2##2##(1997-8#1)(2006-10#1)
the alarming obesity epidemic##2##4##(2013-1#2)
the alarming##5##2##(1996-1#1)(2008-8#1)(2013-1#3)
the albino locus in the mouse##2##6##(1992-8#1)(1995-1#1)
the albino locus##3##3##(1992-8#1)(1995-1#2)
the albino##6##2##(1992-7#1)(1992-8#1)(1994-8#2)(1995-1#2)
the albumin concentration##2##3##(1993-8#1)(2008-10#1)
the albumin secretion##3##3##(2008-11#3)
the albumin##10##2##(1990-7#1)(1990-8#1)(1993-8#1)(1996-11#1)(2008-10#1)(2008-11#4)(2013-8#1)
the albumin-fixed membrane was##3##4##(2008-5#3)
the alcohol abusers##2##3##(1990-5#2)
the alcohol in the##2##4##(2008-10#1)(2008-7#1)
the alcohol to a##2##4##(1994-5#1)(2009-8#1)
the alcohol was##2##3##(2008-10#1)(2008-5#1)
the alcohol##35##2##(1990-4#1)(1990-5#2)(1991-1#1)(1991-2#1)(1992-7#1)(1993-12#1)(1993-4#1)(1994-11#1)(1994-5#2)(1994-6#1)(1996-10#1)(1996-6#1)(1996-9#1)(1997-8#1)(2005-11#1)(2007-11#1)(2008-10#7)(2008-5#2)(2008-7#2)(2009-8#1)(2010-7#2)(2011-1#1)(2012-12#1)(2013-8#1)
the alcohol-induced##3##2##(1992-6#1)(1993-4#1)(2012-2#1)
the alcoholic group##3##3##(2007-9#2)(2008-10#1)
the alcoholic patients##4##3##(1991-12#3)(2011-2#1)
the alcoholic##14##2##(1991-1#1)(1991-12#3)(1995-2#1)(2007-11#1)(2007-9#2)(2008-10#2)(2011-2#2)(2012-1#2)
the alcoholics##2##2##(1990-4#2)
the alcohols##10##2##(1990-11#2)(1990-4#2)(1992-6#1)(1996-5#1)(2008-10#1)(2012-12#3)
the aldehyde##19##2##(1990-2#2)(1991-5#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-2#2)(1995-7#2)(1996-7#4)(1997-2#1)(2008-10#2)(2008-4#1)
the aldehydes by##2##3##(2010-12#2)
the aldehydes##3##2##(2008-10#1)(2010-12#2)
the aldo-keto reductase superfamily##4##4##(1994-3#2)(1994-8#1)(1996-11#1)
the aldo-keto reductase##5##3##(1994-3#2)(1994-6#1)(1994-8#1)(1996-11#1)
the aldol##3##2##(2007-11#1)(2008-3#1)(2011-2#1)
the aldolase A##2##3##(1994-12#2)
the aldolase##5##2##(1992-1#1)(1994-12#3)(1995-8#1)
the aldose reductase##2##3##(1992-3#1)(2008-1#1)
the aldosterone##3##2##(1990-5#1)(1992-7#1)(2007-8#1)
the alert line##2##3##(1992-5#2)
the alert##9##2##(1991-12#1)(1991-5#1)(1992-5#5)(1995-12#1)(2012-2#1)
the aleurone##2##2##(1990-12#1)(2008-10#1)
the alfalfa##6##2##(2008-10#4)(2008-5#1)(2009-4#1)
the alga##6##2##(1994-6#1)(2005-11#1)(2008-10#1)(2008-6#2)(2009-8#1)
the algae##6##2##(2007-8#1)(2008-10#4)(2008-5#1)
the algal##5##2##(2008-10#1)(2008-6#1)(2012-1#1)(2012-12#2)
the algebraic##3##2##(1997-8#1)(2008-3#2)
the alginate##4##2##(2008-11#2)(2008-7#1)(2012-1#1)
the algorithm and the##2##4##(2008-2#1)(2008-3#1)
the algorithm and##10##3##(2008-1#1)(2008-12#1)(2008-2#3)(2008-3#3)(2010-8#1)(2011-1#1)
the algorithm are##3##3##(2008-2#2)(2008-3#1)
the algorithm can be##4##4##(1997-2#1)(2006-10#1)(2008-2#1)(2008-3#1)
the algorithm can##6##3##(1997-2#1)(2006-10#1)(2008-2#2)(2008-3#1)(2008-6#1)
the algorithm for##5##3##(2008-2#3)(2008-3#1)(2008-7#1)
the algorithm in a##2##4##(2007-12#1)(2013-1#1)
the algorithm in##4##3##(2007-12#1)(2013-1#3)
the algorithm includes##2##3##(2008-3#1)(2011-1#1)
the algorithm is##13##3##(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#4)(2008-3#4)(2008-6#1)(2011-1#1)
the algorithm of##6##3##(1992-4#1)(1996-4#1)(2005-1#1)(2008-1#1)(2008-6#1)(2009-4#1)
the algorithm on##2##3##(2008-2#1)(2009-2#1)
the algorithm proposed##2##3##(2008-2#1)(2012-3#1)
the algorithm solves##2##3##(2009-12#1)(2012-1#1)
the algorithm that##2##3##(2008-3#2)
the algorithm to##7##3##(1997-6#1)(2007-12#1)(2008-2#2)(2008-5#1)(2010-9#1)(2013-1#1)
the algorithm was##2##3##(2008-3#1)(2010-8#1)
the algorithm we propose##2##4##(1991-12#1)(2008-3#1)
the algorithm with##2##3##(2008-2#2)
the algorithm##117##2##(1991-12#1)(1992-4#1)(1994-6#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-1#1)(2006-10#2)(2007-12#5)(2007-7#1)(2008-1#3)(2008-10#3)(2008-12#1)(2008-2#36)(2008-3#25)(2008-5#2)(2008-6#6)(2008-7#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-8#2)(2010-9#1)(2011-1#5)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)
the algorithm's performance in##2##4##(2008-2#2)
the algorithm's performance##4##3##(2008-2#3)(2008-3#1)
the algorithm's##5##2##(2008-2#4)(2008-3#1)
the algorithms and##3##3##(2006-5#1)(2007-11#1)(2008-3#1)
the algorithms are##4##3##(2008-2#2)(2008-3#1)(2013-1#1)
the algorithms for##2##3##(2007-6#1)(2008-3#1)
the algorithms of##4##3##(2008-2#1)(2008-3#1)(2008-6#1)(2013-8#1)
the algorithms##25##2##(1997-6#1)(2006-5#1)(2007-11#1)(2007-6#1)(2008-11#1)(2008-2#6)(2008-3#6)(2008-6#1)(2008-7#2)(2008-9#1)(2010-5#1)(2010-8#1)(2013-1#1)(2013-8#1)
the alien chromosome in##2##4##(2008-5#2)
the alien fragment##2##3##(2008-10#2)
the alien##8##2##(2008-10#2)(2008-5#5)(2013-1#1)
the alienated##2##2##(2008-2#1)(2009-10#1)
the aligned##6##2##(2006-5#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#1)
the aligning forces for quality initiative##3##6##(2013-1#3)
the alignment of the##6##4##(1994-8#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-4#1)
the alignment of##9##3##(1994-8#1)(1997-4#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#1)(2008-3#1)(2008-4#1)
the alignment tolerance##2##3##(2008-2#2)
the alignment##26##2##(1990-8#1)(1994-8#1)(1995-8#1)(1996-11#1)(1997-4#1)(2007-11#1)(2007-12#4)(2007-5#1)(2008-10#2)(2008-2#3)(2008-3#5)(2008-4#3)(2012-3#1)(2013-1#1)
the alimentary canal##3##3##(1991-4#1)(2008-10#1)(2008-7#1)
the alimentary tract##8##3##(1992-12#3)(1993-1#2)(2008-5#3)
the alimentary##16##2##(1991-4#1)(1992-12#3)(1993-1#2)(2008-10#1)(2008-5#4)(2008-7#1)(2008-9#1)(2010-4#1)(2013-7#2)
the aliphatic##6##2##(1994-8#1)(1995-1#1)(1995-3#1)(1996-5#1)(2005-12#1)(2010-4#1)
the aliquot##2##2##(2008-3#1)(2010-7#1)
the alkali metal##5##3##(2008-10#5)
the alkali##9##2##(1992-8#1)(2008-10#7)(2010-5#1)
the alkaline Bohr effect##2##4##(1994-8#1)(1994-9#1)
the alkaline comet assay##3##4##(1997-1#1)(1997-4#2)
the alkaline elution##3##3##(1992-3#1)(1993-12#2)
the alkaline hydrolysis of##2##4##(1991-7#1)(2005-11#1)
the alkaline hydrothermal conversion of##2##5##(2008-10#2)
the alkaline phosphatase gene##2##4##(1993-11#1)(1997-1#1)
the alkaline phosphatase##7##3##(1990-12#1)(1992-1#1)(1992-3#1)(1993-11#1)(1997-1#1)(2008-4#1)(2008-5#1)
the alkaline pond##4##3##(2011-12#4)
the alkaline treatment##2##3##(2008-10#1)(2013-1#1)
the alkaline unwinding technique##2##4##(1997-1#2)
the alkaline##44##2##(1990-10#1)(1990-12#2)(1991-7#3)(1992-1#1)(1992-3#3)(1993-11#1)(1993-12#2)(1993-3#1)(1994-8#1)(1994-9#1)(1995-10#1)(1997-1#4)(1997-4#3)(2005-11#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#2)(2008-9#1)(2011-12#4)(2013-1#1)(2013-7#1)
the alkalinization of the##2##4##(1990-11#1)(1994-8#1)
the alkalinization##3##2##(1990-11#1)(1992-4#1)(1994-8#1)
the alkaloid##6##2##(2006-12#2)(2007-1#2)(2007-11#1)(2008-5#1)
the alkaloids##2##2##(2007-11#2)
the alkanediyl-alpha##2##2##(2005-11#2)
the alkene##2##2##(1996-5#2)
the alkoxide ions##2##3##(2005-11#2)
the alkoxy##2##2##(1993-11#1)(1996-2#1)
the alkyl chain length##5##4##(1996-11#1)(2005-11#3)(2008-10#1)
the alkyl chain of the##2##5##(2005-11#1)(2006-10#1)
the alkyl chain of##4##4##(1995-11#1)(1996-11#1)(2005-11#1)(2006-10#1)
the alkyl chain##19##3##(1990-11#1)(1995-11#1)(1996-11#4)(2005-11#7)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)
the alkyl chains##5##3##(1993-4#1)(2005-11#2)(2006-10#1)(2008-5#1)
the alkyl group##3##3##(1990-3#1)(2005-11#1)(2005-12#1)
the alkyl groups##3##3##(1994-12#1)(1997-2#1)(2008-11#1)
the alkyl side chain##3##4##(2005-11#3)
the alkyl##41##2##(1990-11#1)(1990-3#1)(1993-4#1)(1994-12#1)(1994-2#1)(1995-11#1)(1996-11#4)(1996-2#1)(1997-1#1)(1997-2#1)(2005-11#14)(2005-12#1)(2006-10#2)(2007-11#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#3)(2010-4#1)
the alkyl-lysophospholipid##3##2##(1993-4#3)
the alkylating##3##2##(1992-3#1)(1995-8#1)(1997-2#1)
the alkylation of##2##3##(2008-10#1)(2008-5#1)
the alkylation##5##2##(1993-11#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-5#1)
the alkylene##2##2##(1996-8#1)(2005-7#1)
the alkylphenols##4##2##(2008-10#2)(2008-11#2)
the all##9##2##(1990-12#1)(1991-2#1)(1993-10#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-12#1)
the all-important##2##2##(2010-2#1)(2012-2#1)
the all-optical##4##2##(2008-2#1)(2008-3#2)(2013-8#1)
the all-trans##8##2##(1991-5#1)(1991-7#1)(1992-9#1)(1995-10#1)(2006-3#1)(2006-6#1)(2010-2#2)
the alleged##6##2##(1996-5#1)(2006-4#1)(2007-1#1)(2008-10#3)
the allele##9##2##(1993-3#1)(1995-1#1)(2006-2#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-2#1)(2012-3#1)
the alleles##6##2##(1991-1#1)(1994-8#1)(1997-8#1)(2005-10#1)(2007-2#1)(2008-8#1)
the allelic diversity##3##3##(2006-4#1)(2008-10#1)(2008-5#1)
the allelic##9##2##(1994-9#1)(1995-5#1)(2006-4#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)
the allelism##2##2##(2007-7#1)(2008-10#1)
the allergen##4##2##(1991-7#1)(2008-10#2)(2010-5#1)
the allergenic##4##2##(2006-12#1)(2007-2#1)(2008-11#1)(2012-12#1)
the allergenicity of##3##3##(1995-2#1)(2006-12#2)
the allergenicity##4##2##(1995-2#1)(2006-12#2)(2012-3#1)
the allergic##8##2##(1991-10#1)(1992-3#1)(2005-7#1)(2006-10#1)(2007-11#1)(2010-4#1)(2012-12#1)(2012-2#1)
the alleviation of the##2##4##(2007-2#1)(2008-2#1)
the alleviation of##7##3##(1993-2#1)(2005-8#1)(2006-3#1)(2007-2#1)(2008-2#1)(2010-4#1)(2011-1#1)
the alliance##3##2##(2005-8#1)(2006-5#1)(2009-2#1)
the alliances'##2##2##(2013-1#2)
the alligator gar##3##3##(2008-7#3)
the alligator##6##2##(2007-9#2)(2008-7#3)(2010-3#1)
the allocation of resources##2##4##(2007-8#1)(2008-8#1)
the allocation of##18##3##(1990-12#1)(1991-6#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-2#1)(2005-5#1)(2006-10#1)(2006-5#1)(2007-8#1)(2008-11#2)(2008-7#1)(2008-8#4)(2012-2#1)
the allocation##20##2##(1990-12#1)(1991-6#1)(1992-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-2#1)(2005-5#1)(2006-10#1)(2006-5#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#4)(2012-2#1)
the allodynia##2##2##(1996-1#2)
the allogeneic##3##2##(1995-2#1)(2006-7#1)(2008-1#1)
the allograft and##2##3##(2006-8#1)(2007-11#1)
the allograft group##2##3##(2009-3#1)(2012-3#1)
the allograft is##2##3##(1992-12#1)(2006-10#1)
the allograft kidney##2##3##(2008-1#1)(2008-10#1)
the allograft##19##2##(1992-12#1)(1995-2#2)(2006-10#1)(2006-8#1)(2007-11#4)(2007-7#1)(2008-1#3)(2008-10#1)(2008-4#1)(2008-6#1)(2009-3#1)(2012-3#2)
the allografts##3##2##(1992-12#1)(1995-2#1)(2006-10#1)
the alloimmune response##2##3##(1995-2#1)(2007-8#1)
the allometric##3##2##(2008-5#1)(2008-8#1)(2010-8#1)
the alloscutum##3##2##(2007-12#3)
the allosteric activator##3##3##(1990-5#1)(1994-9#1)(1995-2#1)
the allosteric behavior of##2##4##(1990-8#1)(1995-2#1)
the allosteric control of##2##4##(1994-8#2)
the allosteric inhibitor##3##3##(1995-2#1)(1996-2#1)(2008-4#1)
the allosteric interaction##4##3##(1995-11#4)
the allosteric mechanism of##2##4##(1995-11#1)(1995-2#1)
the allosteric mechanism##3##3##(1995-11#2)(1995-2#1)
the allosteric properties of##3##4##(1990-8#2)(1991-2#1)
the allosteric regulation of##2##4##(1990-3#1)(1995-5#1)
the allosteric transition##3##3##(1990-8#2)(1995-5#1)
the allosteric transitions##2##3##(1995-5#1)(2012-1#1)
the allosteric##41##2##(1990-12#2)(1990-3#1)(1990-5#2)(1990-8#6)(1991-2#1)(1992-6#2)(1992-9#1)(1994-11#1)(1994-8#2)(1994-9#1)(1995-11#6)(1995-2#4)(1995-5#3)(1995-8#1)(1996-10#3)(1996-2#1)(1997-1#1)(2008-4#1)(2012-1#2)
the allowable##3##2##(2008-2#3)
the allowed range##3##3##(2005-11#3)
the allowed##5##2##(1996-12#1)(2005-11#3)(2010-7#1)
the alloy##6##2##(2004-9#2)(2008-10#1)(2009-7#2)(2010-4#1)
the alloys##2##2##(2009-7#1)(2013-1#1)
the allozyme##2##2##(2008-10#1)(2008-9#1)
the almond##3##2##(2008-10#2)(2008-11#1)
the almost##9##2##(1992-12#1)(1995-2#1)(2005-7#1)(2006-12#1)(2006-8#1)(2008-1#1)(2009-8#1)(2010-2#1)(2013-1#1)
the alopecia##3##2##(1990-9#1)(2006-2#1)(2012-11#1)
the alpha 1 (I) promoter##2##5##(1991-5#2)
the alpha 1 (I)##4##4##(1991-5#3)(1994-2#1)
the alpha 1 and alpha##2##5##(1992-11#1)(1995-3#1)
the alpha 1 and beta 1##3##6##(1990-7#2)(1994-3#1)
the alpha 1 and##6##4##(1990-7#2)(1992-11#2)(1994-3#1)(1995-3#1)
the alpha 1 beta 1 dimer##3##6##(1993-8#3)
the alpha 1 subunit##6##4##(1994-2#1)(1994-5#2)(1994-6#1)(1995-2#1)(1996-2#1)
the alpha 1##36##3##(1990-2#2)(1990-7#2)(1991-5#3)(1991-9#2)(1992-11#4)(1992-7#1)(1993-8#3)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#1)(1994-9#1)(1995-11#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#1)(1996-2#1)(1996-9#1)
the alpha 1-AT##3##3##(1997-8#3)
the alpha 1/alpha 2##2##4##(1995-3#2)
the alpha 2 beta 2 complex##3##6##(1996-8#3)
the alpha 2 beta 2 gamma 2 component##2##8##(1995-10#2)
the alpha 2 beta 2##7##5##(1991-10#1)(1995-10#2)(1995-3#1)(1996-8#3)
the alpha 2##11##3##(1991-10#1)(1992-8#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-10#2)(1995-3#1)(1996-8#3)
the alpha 2(I) promoter##2##4##(1991-5#2)
the alpha 2(I)##3##3##(1991-5#3)
the alpha 2-adrenergic agonist##2##4##(1991-3#1)(1995-3#1)
the alpha 2-adrenergic receptor##2##4##(1991-3#1)(2008-3#1)
the alpha 2-adrenergic##4##3##(1991-3#2)(1995-3#1)(2008-3#1)
the alpha 3 beta 3 oligomer##4##6##(1992-11#4)
the alpha 3 beta 3##5##5##(1990-9#1)(1992-11#4)
the alpha 3 beta##7##4##(1990-9#1)(1992-11#4)(1995-11#2)
the alpha 3##9##3##(1990-9#1)(1991-7#1)(1991-9#1)(1992-11#4)(1995-11#2)
the alpha 4 beta 2##3##5##(1995-11#3)
the alpha 4##4##3##(1991-9#1)(1995-11#3)
the alpha 5 subunit##2##4##(1990-7#1)(1997-7#1)
the alpha 5##6##3##(1990-7#1)(1991-9#1)(1992-2#1)(1993-9#1)(1995-11#1)(1997-7#1)
the alpha 5/beta 1 FnR##2##5##(1993-9#2)
the alpha 5/beta 1##3##4##(1993-9#3)
the alpha 7##4##3##(1996-12#3)(2010-8#1)
the alpha and beta chains of##3##6##(1990-7#1)(1992-12#1)(1994-8#1)
the alpha and beta chains##4##5##(1990-7#1)(1992-12#1)(1993-6#1)(1994-8#1)
the alpha and beta subunits of luciferase##2##7##(1990-1#1)(1990-7#1)
the alpha and beta subunits of##11##6##(1990-1#1)(1990-7#2)(1990-9#1)(1991-10#1)(1992-11#1)(1993-2#2)(1993-6#1)(1995-11#1)(1996-2#1)
the alpha and beta subunits##16##5##(1990-1#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1992-11#2)(1992-6#1)(1993-2#2)(1993-6#1)(1994-12#1)(1994-6#1)(1995-11#1)(1996-2#1)
the alpha and beta##28##4##(1990-1#1)(1990-12#1)(1990-5#1)(1990-7#3)(1990-8#1)(1990-9#2)(1991-10#1)(1992-11#3)(1992-12#1)(1992-6#1)(1992-9#1)(1993-2#2)(1993-6#2)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-10#1)(1996-2#1)(1997-6#1)(2008-10#1)
the alpha and the##2##4##(2007-12#1)(2007-6#1)
the alpha and##33##3##(1990-1#1)(1990-12#1)(1990-5#1)(1990-7#3)(1990-8#1)(1990-9#2)(1991-10#1)(1992-11#3)(1992-12#1)(1992-6#1)(1992-9#1)(1993-2#2)(1993-6#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-2#1)(1997-6#1)(2007-12#1)(2007-6#1)(2008-10#1)
the alpha beta##3##3##(1992-6#1)(1994-8#1)(1996-11#1)
the alpha carbon##2##3##(1996-5#1)(1997-2#1)
the alpha chain of the##3##5##(1991-2#1)(1994-6#2)
the alpha chain of##6##4##(1991-2#1)(1992-12#1)(1994-6#3)(2005-11#1)
the alpha chain##10##3##(1990-12#1)(1991-2#1)(1992-12#4)(1994-6#3)(2005-11#1)
the alpha donor##2##3##(1991-5#2)
the alpha haems##2##3##(1991-5#2)
the alpha isoenzyme##2##3##(1994-12#2)
the alpha isoform##3##3##(1994-12#2)(2012-12#1)
the alpha or##2##3##(1995-3#1)(2008-6#1)
the alpha part of the gigantocellular reticular nucleus##2##8##(1996-9#2)
the alpha subunit of Go##2##5##(1990-5#1)(1992-2#1)
the alpha subunit of calcium/calmodulin-dependent protein kinase II##2##8##(1995-2#2)
the alpha subunit of calcium/calmodulin-dependent##3##5##(1995-2#2)(1996-12#1)
the alpha subunit of the##11##5##(1991-5#1)(1992-11#1)(1994-2#1)(1994-3#1)(1995-1#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-6#1)(2006-9#1)(2008-8#1)
the alpha subunit of tryptophan synthase##3##6##(1990-2#3)
the alpha subunit of##31##4##(1990-2#4)(1990-5#1)(1990-7#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#2)(1995-2#2)(1996-12#1)(1996-4#1)(1996-5#3)(1997-2#1)(1997-4#1)(1997-6#2)(2006-9#1)(2008-7#1)(2008-8#1)(2012-2#1)
the alpha subunit##45##3##(1990-2#4)(1990-5#1)(1990-7#3)(1991-5#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-6#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-8#3)(1995-1#2)(1995-2#2)(1995-8#1)(1995-9#1)(1996-12#1)(1996-4#1)(1996-5#3)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#2)(2006-9#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-2#1)
the alpha subunits in##2##4##(1997-5#1)(2007-12#1)
the alpha subunits of Gq and G11 G proteins##2##9##(1995-8#2)
the alpha subunits##9##3##(1990-7#2)(1992-11#1)(1992-2#2)(1995-8#2)(1997-5#1)(2007-12#1)
the alpha v##2##3##(1995-6#1)(1997-7#1)
the alpha##283##2##(1990-1#1)(1990-11#2)(1990-12#3)(1990-2#7)(1990-5#3)(1990-7#18)(1990-8#3)(1990-9#4)(1991-1#1)(1991-10#3)(1991-11#1)(1991-2#2)(1991-3#2)(1991-5#14)(1991-7#1)(1991-8#1)(1991-9#6)(1992-11#13)(1992-12#5)(1992-2#5)(1992-3#2)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#4)(1993-3#1)(1993-6#3)(1993-8#5)(1993-9#4)(1994-11#3)(1994-12#8)(1994-2#6)(1994-3#10)(1994-5#7)(1994-6#6)(1994-8#6)(1994-9#3)(1995-1#3)(1995-10#2)(1995-11#9)(1995-2#7)(1995-3#10)(1995-5#2)(1995-6#2)(1995-8#4)(1995-9#2)(1996-10#2)(1996-11#1)(1996-12#5)(1996-2#2)(1996-4#1)(1996-5#5)(1996-8#5)(1996-9#3)(1997-1#2)(1997-2#4)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#3)(2004-2#1)(2005-11#1)(2005-12#1)(2006-12#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#2)(2010-8#1)(2012-12#1)(2012-2#1)
the alpha- and beta-anomers##2##4##(1996-6#1)(2007-11#1)
the alpha- and beta-globin genes##2##5##(1990-8#1)(1994-8#1)
the alpha- and beta-globin##3##4##(1990-8#1)(1991-5#1)(1994-8#1)
the alpha- and beta-subunits##3##4##(1990-10#1)(1991-12#1)(1996-9#1)
the alpha- and##20##3##(1990-10#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-3#1)(1994-8#1)(1995-3#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-8#2)(2007-11#1)(2008-10#4)(2008-5#1)(2010-8#1)
the alpha-##24##2##(1990-10#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-3#2)(1993-3#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-3#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-8#2)(2007-11#1)(2008-10#4)(2008-5#1)(2010-8#1)
the alpha-1##5##2##(1993-12#1)(1995-5#2)(1997-5#2)
the alpha-2 subunit##4##3##(1997-5#4)
the alpha-2##7##2##(1993-12#2)(1995-3#1)(1997-5#4)
the alpha-3##2##2##(1993-11#2)
the alpha-MHC##2##2##(1991-9#2)
the alpha-MSH##4##2##(1990-2#1)(1993-5#2)(2008-5#1)
the alpha-[PMo(12)O(40)](3-) complex##2##3##(2008-10#2)
the alpha-[PMo(12)O(40)](3-)##3##2##(2008-10#3)
the alpha-adrenoceptor##2##2##(1991-6#1)(1996-12#1)
the alpha-amino##6##2##(1990-7#1)(1992-6#1)(1992-8#2)(1994-9#1)(2005-11#1)
the alpha-aminoacrylate##3##2##(1996-8#3)
the alpha-amylase from##2##3##(1992-8#1)(2008-10#1)
the alpha-amylase##4##2##(1990-7#1)(1992-8#1)(1997-3#1)(2008-10#1)
the alpha-chain of H+##3##4##(1995-6#3)
the alpha-chain of the interleukin-2 receptor##2##6##(1990-5#1)(2007-11#1)
the alpha-chain of##6##3##(1990-5#1)(1995-6#4)(2007-11#1)
the alpha-chain##11##2##(1990-5#1)(1991-6#1)(1992-5#1)(1995-6#6)(2007-11#2)
the alpha-chymotrypsin-catalyzed acyl transfer##3##4##(1991-5#3)
the alpha-chymotrypsin-catalyzed##4##2##(1991-5#3)(2008-7#1)
the alpha-crystallin B chain##3##4##(1992-9#3)
the alpha-cycloadduct##2##2##(1996-5#2)
the alpha-factor receptor##2##3##(1995-1#1)(1997-2#1)
the alpha-factor##5##2##(1992-2#2)(1995-1#2)(1997-2#1)
the alpha-fetoprotein gene##2##3##(1992-11#1)(1994-11#1)
the alpha-fetoprotein##3##2##(1992-11#2)(1994-11#1)
the alpha-globin genes##4##3##(1990-8#4)
the alpha-helical domain of##2##4##(1994-5#1)(1995-4#1)
the alpha-helical domain##3##3##(1994-5#2)(1995-4#1)
the alpha-helical##9##2##(1993-9#1)(1994-3#1)(1994-5#3)(1995-11#1)(1995-4#1)(1995-6#1)(1995-8#1)
the alpha-helices and##3##3##(1991-10#1)(2008-10#2)
the alpha-helices of##3##3##(1994-6#1)(1995-11#1)(1995-8#1)
the alpha-helices##10##2##(1991-10#1)(1993-3#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-8#1)(1997-2#1)(2008-10#2)
the alpha-helix##13##2##(1990-5#1)(1990-8#1)(1991-2#2)(1992-6#1)(1993-3#2)(1994-11#1)(1995-5#1)(1997-2#1)(2006-10#1)(2008-7#2)
the alpha-hydroxy##3##2##(1992-1#1)(2008-5#2)
the alpha-hydroxylation##2##2##(1996-11#2)
the alpha-ketoglutarate dehydrogenase complex##2##4##(1994-2#1)(2010-2#1)
the alpha-meso##2##2##(1994-5#2)
the alpha-myosin heavy chain##3##4##(1991-9#3)
the alpha-pheromone receptor##2##3##(1994-12#2)
the alpha-phosphate##2##2##(1993-8#2)
the alpha-receptor##2##2##(1993-2#1)(1995-3#1)
the alpha-relaxation##2##2##(1995-3#1)(2005-11#1)
the alpha-smooth muscle actin expression##2##5##(2006-9#2)
the alpha-subunit of##15##3##(1990-11#1)(1991-3#2)(1991-6#1)(1991-7#2)(1992-11#1)(1992-8#1)(1993-4#1)(1995-2#1)(1995-3#2)(1996-5#2)(2008-5#1)
the alpha-subunit##28##2##(1990-11#3)(1990-9#1)(1991-2#1)(1991-3#4)(1991-6#1)(1991-7#3)(1992-11#1)(1992-8#1)(1993-11#1)(1993-4#1)(1994-8#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-5#2)(1996-8#1)(1996-9#1)(2008-5#1)(2010-2#1)
the alpha-subunits of##2##3##(1990-7#1)(1995-6#1)
the alpha-subunits##3##2##(1990-7#1)(1995-6#2)
the alpha-tocopherol##3##2##(2005-8#1)(2007-8#1)(2008-5#1)
the alpha-tocopheroxyl radical##3##3##(1996-2#2)(2008-5#1)
the alpha-toxin gene##2##3##(2010-6#2)
the alpha-toxin##7##2##(2006-8#3)(2010-6#4)
the alpha/alpha'##2##2##(1992-6#2)
the alpha/beta and alpha'/beta' divisions##2##5##(2007-12#2)
the alpha1##4##2##(1997-4#1)(1997-5#1)(2008-4#1)(2008-7#1)
the alpha1-adrenoceptor##3##2##(1995-12#3)
the alpha2##4##2##(1997-5#1)(2008-11#3)
the alpha2-macroglobulin##2##2##(1996-5#2)
the alpha2AAR##3##2##(1996-5#3)
the alpha2M conformation##2##3##(1997-6#2)
the alpha3 subunit mRNA##2##4##(1997-8#2)
the alpha3##3##2##(1997-8#3)
the alphabeta-tubulin dimer##2##3##(2010-7#2)
the already known##4##3##(1993-6#1)(1994-6#1)(2008-12#1)(2011-2#1)
the already long##2##3##(2009-5#1)(2009-6#1)
the already##18##2##(1990-10#1)(1993-6#1)(1994-6#2)(2006-12#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#2)(2008-4#1)(2009-5#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
the als##2##2##(2008-6#2)
the alteration in the##2##4##(1996-10#1)(2007-1#1)
the alteration in##8##3##(1993-3#1)(1994-12#1)(1996-10#1)(2007-1#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-1#1)
the alteration of growth##2##4##(1992-9#1)(1994-5#1)
the alteration of the##8##4##(1992-11#1)(1993-8#1)(1996-3#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2011-1#1)
the alteration of##21##3##(1991-1#1)(1991-12#1)(1992-11#1)(1992-9#1)(1993-8#1)(1994-2#1)(1994-5#1)(1996-3#1)(2006-5#2)(2008-1#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#2)(2008-9#1)(2011-1#1)(2011-2#2)
the alteration##32##2##(1991-1#1)(1991-12#1)(1992-11#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1996-10#1)(1996-3#1)(2006-5#2)(2007-1#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#4)(2008-9#2)(2011-1#2)(2011-2#2)(2013-1#2)
the alterations and##2##3##(1992-12#1)(2013-1#1)
the alterations in the##4##4##(2008-2#1)(2008-7#1)(2009-2#1)(2009-5#1)
the alterations in##12##3##(1991-9#2)(1994-3#1)(1995-6#1)(1996-10#1)(2007-11#1)(2008-2#1)(2008-7#3)(2009-2#1)(2009-5#1)
the alterations observed##2##3##(1990-4#1)(1996-3#1)
the alterations of the##2##4##(1994-5#1)(2007-8#1)
the alterations of##11##3##(1991-3#1)(1993-5#1)(1994-5#1)(1995-1#1)(1997-8#1)(2007-8#1)(2008-4#1)(2008-7#1)(2010-4#1)(2013-8#2)
the alterations##36##2##(1990-2#1)(1990-4#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-9#2)(1992-12#1)(1992-5#1)(1993-5#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-6#1)(1996-10#1)(1996-3#1)(1996-5#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#4)(2009-2#1)(2009-5#1)(2010-4#1)(2012-12#1)(2013-1#2)(2013-8#2)
the altered enzyme##3##3##(1992-1#2)(1995-2#1)
the altered expression of##3##4##(1994-10#1)(1997-8#1)(2011-1#1)
the altered mineral metabolism of CKD##2##6##(2009-1#2)
the altered mineral metabolism of##3##5##(2009-1#3)
the altered mineral metabolism##4##4##(2009-1#4)
the altered##58##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1991-3#1)(1991-4#1)(1992-1#2)(1992-10#1)(1992-3#1)(1992-6#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-2#2)(1995-2#2)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-8#2)(2006-10#1)(2006-2#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-1#4)(2010-10#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
the alternata##2##2##(2008-10#2)
the alternate protocol##3##3##(2008-2#1)(2008-4#2)
the alternate protocols##2##3##(2008-4#2)
the alternate##22##2##(1993-12#1)(1995-1#1)(1995-6#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-2#3)(2008-4#5)(2011-2#1)(2012-1#1)(2013-1#1)
the alternating current##2##3##(2006-12#2)
the alternating k-star##2##3##(2008-3#2)
the alternating least squares##2##4##(2007-12#1)(2008-10#1)
the alternating##14##2##(1990-10#1)(1997-3#1)(1997-4#1)(2004-9#1)(2006-12#2)(2007-12#2)(2008-10#2)(2008-3#2)(2009-6#1)(2012-2#1)
the alternative complement##2##3##(1991-7#1)(2010-12#1)
the alternative food source##2##4##(2008-8#2)
the alternative food##3##3##(2008-8#3)
the alternative methods##3##3##(1993-3#1)(2008-8#1)(2010-5#1)
the alternative oxidase (AOX)##2##4##(2008-9#1)(2009-8#1)
the alternative oxidase##5##3##(1991-5#1)(1993-8#2)(2008-9#1)(2009-8#1)
the alternative pathway by##2##4##(1994-11#1)(2005-8#1)
the alternative pathway of##4##4##(1995-9#1)(1997-1#2)(2009-8#1)
the alternative pathway##10##3##(1994-11#2)(1994-8#1)(1995-9#1)(1997-1#2)(2005-8#2)(2007-1#1)(2009-8#1)
the alternative procedure##5##3##(1997-6#1)(2008-10#2)(2008-11#2)
the alternative splicing of##2##4##(1994-9#1)(1996-5#1)
the alternative splicing##4##3##(1993-8#1)(1994-9#1)(1995-12#1)(1996-5#1)
the alternative to##2##3##(1993-2#1)(2005-11#1)
the alternative##80##2##(1990-4#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-5#1)(1991-7#1)(1992-6#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#3)(1994-11#2)(1994-12#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-9#1)(1996-12#1)(1996-5#2)(1997-1#2)(1997-3#1)(1997-6#2)(2005-11#2)(2005-8#2)(2006-10#1)(2006-5#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-8#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#4)(2008-5#1)(2008-8#5)(2008-9#2)(2009-5#1)(2009-8#3)(2010-12#2)(2010-5#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
the alternatively spliced##3##3##(1997-8#1)(2007-11#1)(2008-7#1)
the alternatives to##2##3##(2008-6#1)(2008-9#1)
the alternatives##10##2##(1994-3#1)(1996-2#1)(1997-3#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)
the altitude of the##2##4##(2007-1#1)(2008-3#1)
the altitude range##3##3##(2008-2#1)(2008-3#2)
the altitude##6##2##(2007-1#1)(2008-2#2)(2008-3#3)
the altitudes covered by the##2##5##(2008-3#2)
the altitudes##3##2##(2008-2#1)(2008-3#2)
the altitudinal##3##2##(2008-5#2)(2013-7#1)
the alumina##4##2##(2005-11#3)(2006-12#1)
the aluminium matrix##2##3##(2008-10#2)
the aluminium##7##2##(2005-4#1)(2008-10#6)
the aluminum##9##2##(1992-4#2)(1995-5#1)(1996-3#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2010-4#1)
the alveolar bone##5##3##(2005-3#2)(2011-1#1)(2012-11#1)(2013-1#1)
the alveolar cleft##3##3##(2007-12#1)(2009-8#1)(2012-12#1)
the alveolar epithelium##4##3##(1995-8#3)(2006-10#1)
the alveolar ridge##3##3##(1996-8#1)(2007-12#2)
the alveolar##33##2##(1991-1#1)(1992-12#2)(1992-5#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-8#3)(1996-12#1)(1996-8#1)(1997-1#1)(1997-4#1)(2005-3#2)(2006-10#1)(2007-12#3)(2008-1#1)(2009-8#2)(2010-12#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#2)(2013-1#1)
the alveolar-capillary##4##2##(2005-11#1)(2006-10#1)(2008-8#1)(2012-11#1)
the alveoli and##3##3##(2005-8#1)(2006-10#1)(2012-12#1)
the alveoli##6##2##(2005-11#1)(2005-8#1)(2006-10#1)(2007-8#2)(2012-12#1)
the alveus##2##2##(1991-6#1)(1997-5#1)
the amalgam##2##2##(2006-8#1)(2008-10#1)
the amalgamation of##2##3##(1996-2#1)(2008-11#1)
the amaranth method for##2##4##(2008-10#2)
the amaranth method##3##3##(2008-10#3)
the amaranth##4##2##(2008-10#3)(2008-11#1)
the amaranthin##2##2##(2008-4#2)
the ambidentate##3##2##(2008-5#1)(2010-5#2)
the ambient air##3##3##(1993-9#1)(1995-3#1)(2008-10#1)
the ambient atmosphere##3##3##(1997-4#1)(2008-11#2)
the ambient medium and the##2##5##(2008-3#2)
the ambient medium##3##3##(2008-3#2)(2008-7#1)
the ambient temperature##4##3##(1996-11#1)(2007-12#1)(2008-10#2)
the ambient thermal conditions##2##4##(2008-6#2)
the ambient water##2##3##(2004-4#1)(2010-8#1)
the ambient##42##2##(1990-2#1)(1992-6#1)(1992-8#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-3#1)(1996-11#1)(1997-4#1)(2004-4#2)(2005-11#2)(2006-12#1)(2006-4#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#2)(2008-3#5)(2008-6#2)(2008-7#1)(2010-7#1)(2010-8#1)(2012-12#1)(2013-8#1)
the ambiguities##2##2##(2007-12#1)(2008-2#1)
the ambiguity function##4##3##(2007-11#2)(2008-2#1)(2008-3#1)
the ambiguity in##2##3##(1992-4#1)(2008-2#1)
the ambiguity of##3##3##(2007-8#1)(2008-12#1)(2008-7#1)
the ambiguity##13##2##(1992-4#1)(2006-3#1)(2007-11#2)(2007-8#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-7#1)(2010-11#1)(2012-2#1)
the ambiguous##6##2##(2008-11#1)(2008-5#1)(2008-7#1)(2012-1#1)(2013-1#2)
the ambulance and##2##3##(2007-9#1)(2013-1#1)
the ambulance staff alone##2##4##(1991-9#2)
the ambulance staff##3##3##(1991-9#3)
the ambulance##11##2##(1991-9#5)(2007-9#1)(2008-3#1)(2011-1#2)(2013-1#2)
the ambulatory and##2##3##(1991-11#1)(2010-9#1)
the ambulatory care setting##8##4##(2006-1#6)(2006-10#1)(2012-3#1)
the ambulatory care##9##3##(2006-1#6)(2006-10#2)(2012-3#1)
the ambulatory measures##2##3##(2008-3#2)
the ambulatory setting##4##3##(1996-3#1)(2006-1#1)(2006-10#1)(2008-9#1)
the ambulatory##25##2##(1991-1#1)(1991-11#1)(1996-2#1)(1996-3#1)(1997-3#1)(2006-1#7)(2006-10#6)(2006-7#1)(2008-3#2)(2008-9#1)(2010-9#1)(2012-3#1)(2013-1#1)
the amelioration of##4##3##(1992-6#1)(2008-11#1)(2010-2#1)(2010-4#1)
the amelioration##5##2##(1992-6#1)(2008-10#1)(2008-11#1)(2010-2#1)(2010-4#1)
the amendment##2##2##(1995-6#1)(1996-5#1)
the american##16##2##(2006-10#1)(2006-9#3)(2008-10#8)(2008-3#1)(2008-8#1)(2011-2#1)(2013-1#1)
the amide I##5##3##(1991-9#2)(1993-6#1)(1997-7#1)(2010-5#1)
the amide and##2##3##(2007-6#1)(2009-1#1)
the amide bond##3##3##(2007-7#1)(2008-12#1)(2010-12#1)
the amide nitrogen##2##3##(1994-9#1)(2008-6#1)
the amide proton##2##3##(1997-4#1)(2012-12#1)
the amide##27##2##(1991-3#1)(1991-9#2)(1993-6#1)(1994-9#2)(1995-2#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-7#1)(2006-11#1)(2007-6#2)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-6#1)(2009-1#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)
the amide-(15)N##4##2##(2008-5#4)
the amido##2##2##(1995-4#2)
the amidohydrolase##2##2##(1994-8#1)(2008-7#1)
the amidolytic activity##5##3##(1991-8#2)(1993-12#1)(1995-5#1)(1995-6#1)
the amiloride-sensitive 22Na+##2##3##(1991-9#2)
the amiloride-sensitive##3##2##(1991-9#2)(1994-9#1)
the amination of##2##3##(2007-11#1)(2013-8#1)
the amine and##3##3##(2006-10#1)(2008-10#2)
the amine group##3##3##(2008-10#3)
the amine##25##2##(1990-5#2)(1992-1#1)(1993-12#1)(1995-1#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-7#2)(2006-10#1)(2006-9#1)(2007-8#1)(2008-10#9)(2010-12#1)(2010-4#1)(2010-6#1)
the amines under##2##3##(1995-6#1)(2006-10#1)
the amines##6##2##(1994-9#1)(1995-6#1)(1996-5#1)(2006-10#1)(2007-12#1)(2010-8#1)
the amino acid (aa)##5##4##(1990-9#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#1)
the amino acid and##2##4##(2005-11#1)(2008-10#1)
the amino acid at position 309##2##6##(1995-7#2)
the amino acid at position##8##5##(1990-12#2)(1994-8#1)(1995-5#1)(1995-7#2)(2008-10#2)
the amino acid composition of the##4##6##(1990-8#1)(1993-8#1)(1994-5#1)(2008-9#1)
the amino acid composition of##6##5##(1990-8#1)(1993-8#1)(1994-5#1)(1994-9#1)(2008-9#1)(2012-1#1)
the amino acid composition##12##4##(1990-7#1)(1990-8#1)(1992-3#1)(1992-8#2)(1993-8#1)(1994-5#1)(1994-9#1)(1997-2#1)(2008-10#1)(2008-9#1)(2012-1#1)
the amino acid compositions of these##2##6##(1990-10#1)(1993-9#1)
the amino acid compositions##3##4##(1990-10#1)(1993-9#1)(2007-7#1)
the amino acid content##2##4##(1994-8#1)(2008-11#1)
the amino acid level##15##4##(1990-8#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-7#1)(2006-8#1)(2007-1#1)(2008-7#1)(2008-8#1)
the amino acid position##5##4##(1990-3#1)(1991-11#1)(1996-8#1)(2010-7#1)(2013-8#1)
the amino acid residue##3##4##(1992-6#1)(1997-6#1)(2009-3#1)
the amino acid residues in##2##5##(2008-10#1)(2010-7#1)
the amino acid residues that##2##5##(1993-3#1)(1995-5#1)
the amino acid residues##9##4##(1990-12#1)(1992-4#1)(1993-3#1)(1995-5#1)(1995-8#1)(1997-2#1)(2008-10#1)(2009-8#1)(2010-7#1)
the amino acid sequence data##2##5##(1991-9#1)(2011-2#1)
the amino acid sequence deduced##2##5##(1991-9#1)(1992-4#1)
the amino acid sequence is##2##5##(1992-2#1)(1994-2#1)
the amino acid sequence level##2##5##(1991-4#1)(1997-4#1)
the amino acid sequence of HVR1##2##6##(1992-11#2)
the amino acid sequence of a##3##6##(1990-5#1)(1991-10#1)(1994-8#1)
the amino acid sequence of the N-terminal##2##7##(1990-7#2)
the amino acid sequence of the protein##2##7##(1991-2#1)(1993-8#1)
the amino acid sequence of the rat##2##7##(1990-12#1)(1996-12#1)
the amino acid sequence of the##18##6##(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#2)(1991-1#1)(1991-12#1)(1991-2#3)(1992-12#2)(1993-8#1)(1996-12#1)(1997-1#1)(1997-6#1)(2008-10#1)(2008-4#1)
the amino acid sequence of this peptide##3##7##(1994-12#1)(1997-8#2)
the amino acid sequence of##43##5##(1990-12#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#4)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#3)(1992-10#1)(1992-11#3)(1992-12#3)(1992-3#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-2#1)(1996-12#2)(1996-7#1)(1997-1#1)(1997-6#1)(1997-8#2)(2005-11#1)(2008-10#1)(2008-4#1)(2008-9#1)
the amino acid sequence was##2##5##(1990-11#1)(1994-9#1)
the amino acid sequence with##2##5##(1990-12#1)(2009-2#1)
the amino acid sequence##86##4##(1990-11#2)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#4)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#4)(1991-4#1)(1991-9#2)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#3)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-7#2)(1997-1#1)(1997-4#1)(1997-6#1)(1997-8#2)(2005-11#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-2#1)(2010-4#1)(2011-2#3)(2013-8#2)
the amino acid sequences of the##7##6##(1991-12#1)(1993-3#1)(1994-12#1)(2005-8#1)(2006-5#1)(2007-6#1)(2008-10#1)
the amino acid sequences of##19##5##(1990-7#1)(1991-12#2)(1991-2#1)(1992-11#1)(1992-3#1)(1992-7#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#1)(2005-8#1)(2006-5#1)(2007-6#1)(2008-10#3)(2008-12#1)(2008-4#1)
the amino acid sequences##28##4##(1990-7#1)(1991-1#1)(1991-12#2)(1991-2#2)(1992-11#1)(1992-3#1)(1992-7#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#1)(1995-4#1)(1997-4#1)(2005-8#1)(2006-5#1)(2006-8#1)(2007-6#2)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2009-9#1)(2010-5#1)
the amino acid side chain##3##5##(1991-8#1)(1996-5#1)(1997-3#1)
the amino acid side chains##2##5##(1991-2#1)(1992-3#1)
the amino acid side##6##4##(1991-2#1)(1991-8#1)(1992-3#1)(1996-5#1)(1997-3#1)(2012-3#1)
the amino acid substitutions##3##4##(1990-8#1)(1997-9#1)(2008-10#1)
the amino acid##243##3##(1990-10#1)(1990-11#2)(1990-12#5)(1990-2#1)(1990-3#3)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#6)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#4)(1991-2#7)(1991-4#2)(1991-8#1)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#4)(1992-12#5)(1992-2#3)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#3)(1992-7#3)(1992-8#4)(1992-9#1)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#3)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#4)(1994-8#8)(1994-9#5)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-7#2)(1995-8#3)(1996-12#2)(1996-2#1)(1996-5#1)(1996-7#4)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#3)(1997-9#1)(2005-11#3)(2005-8#1)(2006-10#1)(2006-12#2)(2006-5#1)(2006-7#2)(2006-8#3)(2007-1#1)(2007-11#2)(2007-12#1)(2007-6#2)(2007-7#1)(2008-10#19)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-8#2)(2009-9#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#2)(2013-8#3)
the amino acids (aa)##2##4##(1995-12#1)(2005-11#1)
the amino acids by##2##4##(2007-8#1)(2008-10#1)
the amino acids in the##2##5##(1995-2#1)(2012-2#1)
the amino acids in##4##4##(1992-8#1)(1995-2#1)(2006-10#1)(2012-2#1)
the amino acids of the##2##5##(1993-6#1)(1996-11#1)
the amino acids of##3##4##(1993-6#1)(1994-12#1)(1996-11#1)
the amino acids that##2##4##(1991-5#1)(2008-11#1)
the amino acids with##2##4##(2006-10#1)(2008-10#1)
the amino acids##48##3##(1990-7#2)(1991-2#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-4#1)(1992-8#2)(1993-11#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-11#1)(2005-11#1)(2006-10#11)(2007-12#1)(2007-8#4)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#2)(2012-2#1)
the amino and carboxyl termini##2##5##(1995-10#1)(2006-10#1)
the amino and##5##3##(1992-6#1)(1995-10#1)(2006-10#1)(2006-12#1)(2008-10#1)
the amino group of the##3##5##(1992-3#1)(1994-11#1)(2008-10#1)
the amino group of##6##4##(1992-3#2)(1994-11#1)(2008-10#2)(2009-9#1)
the amino group##12##3##(1991-3#1)(1991-7#1)(1992-3#2)(1994-11#1)(1994-8#2)(2006-10#1)(2008-10#3)(2009-9#1)
the amino groups##5##3##(1995-1#1)(2006-10#3)(2008-10#1)
the amino or carboxyl##3##4##(1995-3#2)(2008-4#1)
the amino portion##2##3##(1991-5#1)(1997-1#1)
the amino side##2##3##(1990-10#1)(1992-6#1)
the amino terminal and##2##4##(1991-7#1)(1996-7#1)
the amino terminal end of##2##5##(1995-5#1)(2005-11#1)
the amino terminal region of the##2##6##(1994-11#1)(1995-11#1)
the amino terminal region##4##4##(1994-11#3)(1995-11#1)
the amino terminal##13##3##(1990-11#1)(1991-7#1)(1992-6#1)(1993-3#1)(1994-11#3)(1995-11#1)(1995-5#1)(1996-7#2)(2005-11#1)(2006-4#1)
the amino terminus and the##2##5##(1996-10#1)(1996-8#1)
the amino terminus and##5##4##(1990-5#1)(1994-9#1)(1995-4#1)(1996-10#1)(1996-8#1)
the amino terminus of an##2##5##(1994-9#1)(1995-4#1)
the amino terminus of the##5##5##(1991-5#1)(1991-9#1)(1992-8#1)(1993-6#1)(1995-2#1)
the amino terminus of##14##4##(1990-3#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-5#1)(1992-8#1)(1993-6#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-5#1)(1996-8#1)
the amino terminus was##2##4##(1992-7#1)(2008-11#1)
the amino terminus##38##3##(1990-3#1)(1990-5#2)(1991-10#1)(1991-2#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-5#1)(1992-7#1)(1992-8#3)(1993-6#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-4#2)(1996-10#1)(1996-12#2)(1996-5#1)(1996-7#1)(1996-8#3)(1997-5#1)(1997-8#1)(2008-10#1)(2008-11#2)
the amino##382##2##(1990-10#2)(1990-11#3)(1990-12#5)(1990-2#1)(1990-3#4)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#8)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#3)(1991-11#2)(1991-12#4)(1991-2#9)(1991-3#1)(1991-4#2)(1991-5#3)(1991-7#2)(1991-8#4)(1991-9#6)(1992-1#1)(1992-10#1)(1992-11#5)(1992-12#5)(1992-2#4)(1992-3#6)(1992-4#3)(1992-5#2)(1992-6#6)(1992-7#4)(1992-8#9)(1992-9#1)(1993-11#2)(1993-12#5)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#5)(1993-8#2)(1993-9#1)(1994-11#5)(1994-12#4)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#6)(1994-8#11)(1994-9#8)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#4)(1995-4#3)(1995-5#5)(1995-6#1)(1995-7#2)(1995-8#4)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-5#3)(1996-7#9)(1996-8#4)(1997-1#4)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#4)(1997-9#1)(2005-11#6)(2005-8#1)(2006-10#17)(2006-12#3)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#3)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-6#2)(2007-7#1)(2007-8#4)(2008-10#28)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-8#2)(2009-9#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#2)(2013-8#3)
the amino- and carboxyl-terminal domains of##2##6##(1991-11#1)(1995-8#1)
the amino- and carboxyl-terminal regions##2##5##(1992-6#1)(1996-5#1)
the amino- and carboxyl-terminal##6##4##(1991-11#1)(1992-6#1)(1995-8#1)(1996-5#3)
the amino- and##8##3##(1991-11#1)(1991-5#1)(1992-6#1)(1995-6#1)(1995-8#1)(1996-5#3)
the amino-##10##2##(1990-12#1)(1991-11#1)(1991-5#1)(1992-6#1)(1995-6#1)(1995-8#1)(1996-5#4)
the amino-acid sequence of##3##4##(1990-5#1)(1994-12#1)(1997-3#1)
the amino-acid sequence##5##3##(1990-5#1)(1993-6#1)(1994-12#1)(1997-3#1)(1997-5#1)
the amino-acid##6##2##(1990-5#1)(1993-6#1)(1994-12#2)(1997-3#1)(1997-5#1)
the amino-terminal cleavage peptide of procalcitonin (PAS-57)##2##7##(1991-2#2)
the amino-terminal domain of the##2##5##(1990-11#1)(1994-12#1)
the amino-terminal domain of##4##4##(1990-11#1)(1994-11#1)(1994-12#1)(1996-5#1)
the amino-terminal domain##6##3##(1990-11#1)(1990-5#1)(1991-9#1)(1994-11#1)(1994-12#1)(1996-5#1)
the amino-terminal extension##2##3##(1995-3#1)(1996-7#1)
the amino-terminal portion of the##3##5##(1991-2#2)(1994-12#1)
the amino-terminal portion of##5##4##(1990-6#1)(1991-2#3)(1994-12#1)
the amino-terminal presequence of##2##4##(1991-12#1)(1992-7#1)
the amino-terminal region of the##3##5##(1991-8#1)(1992-11#1)(1994-9#1)
the amino-terminal region of##6##4##(1990-6#1)(1991-8#1)(1992-11#1)(1994-3#1)(1994-9#1)(1995-5#1)
the amino-terminal sequence of##2##4##(1990-3#1)(1995-6#1)
the amino-terminal sequences##3##3##(1992-8#1)(1995-11#1)(1996-8#1)
the amino-terminal##56##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#2)(1991-10#1)(1991-12#1)(1991-2#5)(1991-3#1)(1991-5#3)(1991-8#3)(1991-9#2)(1992-11#1)(1992-12#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-11#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-9#4)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#3)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-7#1)
the amino-terminus of the##2##4##(1990-12#1)(1993-11#1)
the amino-terminus of##3##3##(1990-12#1)(1992-8#1)(1993-11#1)
the amino-terminus##5##2##(1990-12#2)(1992-8#1)(1993-11#1)(1993-8#1)
the aminoacid##5##2##(1991-3#1)(1992-9#2)(2007-11#1)(2008-11#1)
the aminoacylation of##3##3##(1990-2#2)(1994-8#1)
the aminoacylation##4##2##(1990-2#3)(1994-8#1)
the aminocaproic##2##2##(1996-8#1)(2008-10#1)
the aminoglycosides##5##2##(1990-10#1)(1990-4#2)(1991-12#2)
the aminopeptidase N##3##3##(1990-11#2)(1990-8#1)
the aminopeptidase##7##2##(1990-11#2)(1990-2#1)(1990-8#1)(1991-5#1)(1992-5#1)(1995-8#1)
the ammine-complexes##2##2##(2008-10#2)
the ammonia##11##2##(1994-5#1)(1997-7#1)(2005-11#1)(2005-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2011-1#1)
the ammonia-oxidizing bacteria##2##3##(2005-11#2)
the ammonia-oxidizing##3##2##(2005-11#3)
the ammonium##8##2##(1992-9#1)(1993-2#1)(1994-12#1)(2008-10#3)(2008-12#1)(2011-12#1)
the amnesic and anxiolytic actions of chlordiazepoxide##3##7##(1993-12#3)
the amnesic and anxiolytic##4##4##(1993-12#4)
the amnesic##5##2##(1993-12#5)
the amnion##4##2##(1996-12#1)(2008-4#3)
the amnioserosa and##4##3##(2012-12#4)
the amnioserosa##8##2##(2012-12#8)
the amniotic fluid and##2##4##(2006-10#1)(2008-9#1)
the amniotic fluid##11##3##(1990-12#1)(1990-9#1)(2005-11#1)(2006-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-9#1)(2012-12#1)
the amniotic membrane##5##3##(2007-1#4)(2008-10#1)
the amniotic##19##2##(1990-12#1)(1990-9#1)(1992-2#1)(2005-11#1)(2006-10#1)(2007-1#4)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#2)(2009-4#1)(2009-9#1)(2012-12#1)
the amoeba##3##2##(1994-8#1)(2006-10#1)(2010-9#1)
the amorphous content of a##2##5##(2008-10#2)
the amorphous content of##4##4##(2008-10#4)
the amorphous content##6##3##(2007-11#1)(2008-10#5)
the amorphous##13##2##(1991-12#1)(2005-11#2)(2007-11#1)(2008-10#7)(2008-3#1)(2010-8#1)
the amount and composition of##2##5##(2005-1#1)(2007-1#1)
the amount and distribution of##2##5##(1995-5#1)(2011-2#1)
the amount and percentage of soil##2##6##(2013-8#2)
the amount and the##2##4##(2006-12#1)(2008-2#1)
the amount and##24##3##(1990-5#1)(1993-9#1)(1995-11#1)(1995-5#1)(1996-8#1)(2005-1#1)(2005-10#1)(2005-11#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-8#2)
the amount of A beta##2##5##(1994-11#1)(1995-3#1)
the amount of B-GOx##2##4##(2008-10#2)
the amount of Ca2+##2##4##(1995-3#1)(1997-2#1)
the amount of DNA injected##2##5##(1992-2#1)(1996-5#1)
the amount of DNA isolated##2##5##(1996-12#2)
the amount of DNA##10##4##(1992-2#1)(1996-12#2)(1996-5#1)(1997-5#1)(2008-10#1)(2008-4#2)(2009-12#1)(2010-2#1)
the amount of ET-1##2##4##(1991-1#1)(1992-7#1)
the amount of TGF-beta1##2##4##(2009-4#2)
the amount of a specific##2##5##(1994-2#1)(2008-2#1)
the amount of a##4##4##(1992-4#1)(1994-2#1)(1995-3#1)(2008-2#1)
the amount of active ingredient delivered to the scalp##2##9##(2008-5#2)
the amount of active##4##4##(1995-2#1)(2008-5#2)(2010-7#1)
the amount of activity##2##4##(1990-9#1)(1993-2#1)
the amount of added##3##4##(1991-8#1)(1997-8#1)(2008-10#1)
the amount of adsorbed##3##4##(2005-11#2)(2008-10#1)
the amount of albicidin produced in vitro##3##7##(2008-10#3)
the amount of alpha##2##4##(1994-3#1)(2009-7#1)
the amount of anesthetic medicine to be applied##2##8##(2010-8#2)
the amount of antibody per sample##2##6##(2008-10#2)
the amount of antibody##5##4##(1994-5#1)(1996-5#1)(2008-10#2)(2008-4#1)
the amount of aromatase##2##4##(1993-8#2)
the amount of arsenic##2##4##(2008-10#2)
the amount of available##2##4##(1990-2#1)(2010-12#1)
the amount of biomass##2##4##(2006-8#1)(2008-6#1)
the amount of black carbon##2##5##(2008-3#2)
the amount of blood##4##4##(1994-3#2)(2005-10#1)(2006-10#1)
the amount of both##4##4##(1994-2#1)(1995-8#1)(2008-10#1)(2011-1#1)
the amount of bound##2##4##(1990-12#1)(2008-4#1)
the amount of calmodulin##2##4##(1990-8#1)(1993-6#1)
the amount of cell##2##4##(2007-10#1)(2008-11#1)
the amount of change in##2##5##(2012-2#1)(2013-8#1)
the amount of chemical##3##4##(2008-10#2)(2013-8#1)
the amount of circulating##2##4##(1991-2#1)(2011-2#1)
the amount of community##2##4##(1997-1#1)(2008-11#1)
the amount of data##4##4##(2007-11#1)(2007-12#1)(2008-2#1)(2009-9#1)
the amount of dentin##2##4##(2008-11#1)(2013-8#1)
the amount of disease##3##4##(2008-10#3)
the amount of drug##3##4##(1997-2#1)(2006-8#1)(2010-4#1)
the amount of dust##2##4##(1992-12#1)(2008-11#1)
the amount of empty##2##4##(2007-3#2)
the amount of energy delivered##3##5##(2008-9#1)(2013-1#2)
the amount of energy##7##4##(1991-11#1)(2006-10#1)(2008-9#2)(2010-3#1)(2013-1#2)
the amount of enzyme##3##4##(1991-10#1)(1992-3#1)(2008-10#1)
the amount of extra-metabolic energy##2##5##(2012-2#2)
the amount of extractable##2##4##(2008-11#1)(2008-12#1)
the amount of fibrous tissue##2##5##(1990-3#1)(2008-9#1)
the amount of food##6##4##(1995-1#1)(2006-1#1)(2008-5#1)(2008-9#2)(2013-8#1)
the amount of fresh water##2##5##(2008-6#2)
the amount of growth##2##4##(2012-11#1)(2012-3#1)
the amount of immobilized##2##4##(2007-8#1)(2008-10#1)
the amount of incorporated##2##4##(1994-12#1)(2008-10#1)
the amount of information##4##4##(1994-2#1)(1996-3#1)(1997-3#1)(2008-7#1)
the amount of inorganic##3##4##(2012-2#1)(2013-8#2)
the amount of intracellular##2##4##(2008-11#2)
the amount of lead##2##4##(1995-11#1)(2008-10#1)
the amount of lipid##2##4##(1994-11#1)(2009-2#1)
the amount of mRNA##2##4##(1995-6#1)(1996-6#1)
the amount of material recovered##2##5##(2008-10#1)(2008-4#1)
the amount of misalignment##3##4##(2008-2#1)(2008-3#2)
the amount of ozone##3##4##(1992-8#1)(2008-10#1)(2008-2#1)
the amount of pain##2##4##(1996-2#1)(2008-11#1)
the amount of pathogen DNA present in the##2##8##(2008-10#2)
the amount of pathogen DNA##3##5##(2008-10#3)
the amount of pathogen##4##4##(2008-10#4)
the amount of phospholipids##3##4##(1990-2#1)(1993-6#1)(2008-11#1)
the amount of plant##3##4##(1991-11#1)(2006-12#1)(2008-10#1)
the amount of polymer##2##4##(1991-8#1)(2011-2#1)
the amount of prior information##2##5##(1995-4#2)
the amount of protein##8##4##(1990-9#1)(1992-7#1)(1994-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-12#1)(2012-12#1)
the amount of reagent##2##4##(2008-10#2)
the amount of released##4##4##(2005-12#1)(2008-4#1)(2009-8#2)
the amount of residual##3##4##(2005-11#1)(2008-10#1)(2009-7#1)
the amount of resources##2##4##(2008-10#1)(2008-8#1)
the amount of sample available##2##5##(2008-10#1)(2010-4#1)
the amount of sample##5##4##(2007-12#1)(2008-10#3)(2010-4#1)
the amount of secreted##2##4##(1997-3#1)(2008-10#1)
the amount of spread##2##4##(2008-10#2)
the amount of surface##2##4##(2005-11#1)(2008-4#1)
the amount of surfactant##2##4##(1992-5#1)(2005-11#1)
the amount of the enzyme##3##5##(1990-2#1)(1994-3#1)(1996-7#1)
the amount of the##33##4##(1990-11#1)(1990-12#1)(1990-2#1)(1991-9#1)(1992-3#1)(1992-6#3)(1992-8#1)(1993-6#1)(1994-12#4)(1994-3#2)(1996-7#1)(1997-2#1)(2004-4#1)(2005-11#1)(2005-8#1)(2007-9#1)(2008-10#7)(2008-8#1)(2009-2#1)(2009-8#1)(2010-10#1)
the amount of this##2##4##(1994-12#1)(2007-6#1)
the amount of time elapsed between##2##6##(1996-3#1)(2008-11#1)
the amount of time##9##4##(1996-3#1)(2007-5#1)(2008-11#3)(2008-12#2)(2011-2#2)
the amount of total##6##4##(1990-2#1)(1996-12#1)(2008-12#1)(2008-5#1)(2010-2#1)(2011-1#1)
the amount of trunk##2##4##(2006-6#2)
the amount of type##2##4##(1991-1#1)(2008-9#1)
the amount of virus##2##4##(1992-6#1)(2008-10#1)
the amount of walking##2##4##(2013-1#2)
the amount of waste##2##4##(2005-11#1)(2008-6#1)
the amount of water in the##2##6##(2007-6#1)(2008-10#1)
the amount of water##5##4##(1995-3#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#1)
the amount of which##2##4##(2006-8#1)(2008-10#1)
the amount of yeast##2##4##(2008-10#1)(2008-5#1)
the amount of##668##3##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#7)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#2)(1991-1#2)(1991-10#3)(1991-11#4)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#3)(1991-5#3)(1991-7#1)(1991-8#4)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#4)(1992-5#2)(1992-6#9)(1992-7#5)(1992-8#4)(1992-9#1)(1993-11#2)(1993-2#3)(1993-3#2)(1993-4#3)(1993-6#5)(1993-8#2)(1993-9#3)(1994-11#4)(1994-12#9)(1994-2#3)(1994-3#11)(1994-5#1)(1994-6#5)(1994-8#3)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#6)(1995-4#2)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#3)(1996-1#2)(1996-10#1)(1996-12#6)(1996-2#2)(1996-3#4)(1996-4#2)(1996-5#4)(1996-6#5)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#6)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#2)(2004-1#1)(2004-11#1)(2004-12#1)(2004-3#1)(2004-4#2)(2005-10#1)(2005-11#18)(2005-12#1)(2005-4#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#5)(2006-12#5)(2006-2#1)(2006-3#6)(2006-4#1)(2006-5#1)(2006-6#4)(2006-8#6)(2006-9#2)(2007-10#3)(2007-11#5)(2007-12#9)(2007-2#2)(2007-3#4)(2007-4#2)(2007-5#1)(2007-6#4)(2007-7#1)(2007-8#6)(2007-9#2)(2008-1#7)(2008-10#113)(2008-11#23)(2008-12#7)(2008-2#12)(2008-3#10)(2008-4#18)(2008-5#12)(2008-6#8)(2008-7#5)(2008-8#7)(2008-9#12)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#4)(2009-8#7)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#8)(2011-1#4)(2011-12#1)(2011-2#10)(2012-1#5)(2012-11#2)(2012-12#8)(2012-2#7)(2012-3#3)(2013-1#8)(2013-8#10)
the amount or##3##3##(1991-12#1)(1992-3#1)(2006-10#1)
the amount##717##2##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#5)(1990-2#7)(1990-3#3)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#2)(1991-1#2)(1991-10#3)(1991-11#4)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#3)(1991-5#3)(1991-7#1)(1991-8#4)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#4)(1992-4#4)(1992-5#2)(1992-6#9)(1992-7#5)(1992-8#4)(1992-9#1)(1993-11#2)(1993-2#3)(1993-3#3)(1993-4#3)(1993-6#5)(1993-8#2)(1993-9#4)(1994-11#4)(1994-12#9)(1994-2#4)(1994-3#11)(1994-5#2)(1994-6#5)(1994-8#3)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#2)(1995-3#6)(1995-4#2)(1995-5#5)(1995-6#3)(1995-7#1)(1995-8#4)(1996-1#2)(1996-10#1)(1996-12#6)(1996-2#2)(1996-3#5)(1996-4#2)(1996-5#5)(1996-6#5)(1996-7#2)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#6)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#2)(2004-1#1)(2004-11#1)(2004-12#1)(2004-3#1)(2004-4#2)(2005-1#1)(2005-10#2)(2005-11#19)(2005-12#1)(2005-3#1)(2005-4#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#7)(2006-12#6)(2006-2#2)(2006-3#6)(2006-4#2)(2006-5#1)(2006-6#4)(2006-8#6)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#10)(2007-2#2)(2007-3#4)(2007-4#3)(2007-5#1)(2007-6#4)(2007-7#1)(2007-8#7)(2007-9#2)(2008-1#7)(2008-10#116)(2008-11#23)(2008-12#9)(2008-2#13)(2008-3#10)(2008-4#19)(2008-5#13)(2008-6#8)(2008-7#6)(2008-8#8)(2008-9#13)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#4)(2009-8#7)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#8)(2011-1#4)(2011-12#1)(2011-2#11)(2012-1#5)(2012-11#2)(2012-12#8)(2012-2#8)(2012-3#4)(2013-1#9)(2013-8#12)
the amounts in##3##3##(1990-1#1)(2008-6#1)(2010-8#1)
the amounts of 3##2##4##(2004-11#1)(2008-10#1)
the amounts of immunoreactive##2##4##(1991-8#2)
the amounts of iron transferred to the palm##2##8##(2008-10#2)
the amounts of the##7##4##(1990-3#1)(1991-8#1)(1992-9#1)(2004-11#1)(2008-10#1)(2008-12#1)(2008-6#1)
the amounts of##61##3##(1990-3#1)(1991-10#1)(1991-11#1)(1991-8#3)(1992-9#1)(1993-2#1)(1994-11#2)(1994-3#4)(1995-2#2)(1995-8#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-2#2)(1997-3#2)(1997-7#1)(1997-8#2)(2004-11#2)(2005-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#11)(2008-11#2)(2008-12#3)(2008-5#3)(2008-6#3)(2008-8#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
the amounts##72##2##(1990-1#1)(1990-3#1)(1991-10#1)(1991-11#1)(1991-8#3)(1992-9#1)(1993-2#1)(1993-9#1)(1994-11#2)(1994-3#5)(1995-1#1)(1995-2#2)(1995-8#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-2#2)(1997-3#2)(1997-7#1)(1997-8#2)(2004-11#2)(2005-12#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#13)(2008-11#2)(2008-12#4)(2008-5#3)(2008-6#4)(2008-8#1)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
the amperometric detection of##7##4##(2008-10#7)
the amperometric detection##8##3##(1990-11#1)(2008-10#7)
the amperometric response of##2##4##(2008-10#2)
the amperometric response##4##3##(2008-10#4)
the amperometric##28##2##(1990-11#1)(1992-11#1)(2007-8#1)(2008-10#25)
the amphetamine##5##2##(1991-6#1)(1996-10#2)(2006-4#1)(2008-10#1)
the amphetamine-induced##5##2##(1991-6#2)(1997-7#1)(2013-1#2)
the amphibian Xenopus laevis##2##4##(1990-12#1)(2008-9#1)
the amphibian##8##2##(1990-12#1)(1991-7#2)(1994-12#1)(1996-2#1)(1997-3#1)(2008-12#1)(2008-9#1)
the amphid##2##2##(1995-3#1)(2007-12#1)
the amphimeric##2##2##(1996-7#2)
the amphipathic helices of the plasma apolipoproteins##3##7##(1993-9#3)
the amphipathic helices##4##3##(1993-9#4)
the amphipathic##12##2##(1990-2#2)(1990-5#1)(1993-9#4)(1994-3#1)(1995-3#1)(1995-5#1)(1997-2#1)(2008-10#1)
the amphiphiles##6##2##(2005-11#5)(2012-2#1)
the amphiphilic character##2##3##(1994-5#1)(1994-8#1)
the amphiphilic porphyrin##2##3##(2005-4#2)
the amphiphilic##13##2##(1990-2#1)(1990-5#1)(1991-10#1)(1993-4#1)(1994-11#1)(1994-5#2)(1994-8#1)(2005-4#2)(2008-10#1)(2008-5#1)(2010-4#1)
the ampholytic nature of##2##4##(2010-8#2)
the ampicillin##2##2##(2008-10#1)(2011-1#1)
the amplicon with##2##3##(1996-4#1)(1996-6#1)
the amplicon##6##2##(1994-11#1)(1996-4#2)(1996-6#1)(2007-1#1)(2008-10#1)
the amplification C3 and C5 convertases##2##6##(2008-4#2)
the amplification and##3##3##(1990-11#1)(1997-6#1)(2006-10#1)
the amplification of a##4##4##(1993-7#1)(1993-9#1)(2008-10#2)
the amplification of the##4##4##(2008-10#1)(2008-5#1)(2009-5#1)(2010-4#1)
the amplification of##29##3##(1991-6#1)(1993-2#1)(1993-7#1)(1993-9#1)(1994-3#1)(1994-9#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-9#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-4#1)(2008-5#2)(2009-5#1)(2010-4#1)
the amplification process##3##3##(2007-12#2)(2008-3#1)
the amplification##57##2##(1990-11#1)(1990-12#1)(1991-6#2)(1992-11#1)(1993-2#1)(1993-7#1)(1993-9#1)(1994-3#1)(1994-9#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-6#2)(1997-7#3)(2005-9#1)(2006-10#1)(2006-8#2)(2007-1#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-10#10)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#2)(2009-5#2)(2010-4#1)(2010-5#1)(2012-2#1)
the amplified DNA##7##3##(1990-12#1)(1991-5#1)(1993-12#1)(1997-6#1)(2008-5#1)(2011-2#2)
the amplified cDNA##2##3##(1990-7#1)(2005-11#1)
the amplified fragment length polymorphism##3##5##(2008-10#3)
the amplified fragment was##2##4##(2005-11#1)(2008-12#1)
the amplified fragment##7##3##(1990-4#1)(1996-8#1)(2005-11#1)(2008-10#3)(2008-12#1)
the amplified fragments##4##3##(1992-8#1)(2008-10#1)(2008-2#1)(2012-2#1)
the amplified gene##3##3##(2008-10#1)(2008-11#2)
the amplified products##7##3##(1990-3#1)(1995-12#1)(1996-2#1)(2008-10#2)(2008-4#1)(2012-2#1)
the amplified signal and idler##2##5##(2007-11#1)(2007-12#1)
the amplified signal and##4##4##(2007-11#3)(2007-12#1)
the amplified signal##5##3##(2007-11#3)(2007-12#1)(2008-2#1)
the amplified spontaneous emission##7##4##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#1)
the amplified yeast##2##3##(1997-6#2)
the amplified##60##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-1#2)(1991-5#1)(1992-11#1)(1992-7#1)(1992-8#1)(1993-12#1)(1995-12#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-6#4)(2005-11#2)(2007-11#4)(2007-12#7)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#2)(2012-2#2)(2013-1#1)
the amplifier chain##3##3##(2008-2#3)
the amplifier output##2##3##(2007-12#1)(2008-2#1)
the amplifier spacing##2##3##(2007-12#1)(2008-1#1)
the amplifier stage##3##3##(2007-12#3)
the amplifier##31##2##(2007-11#2)(2007-12#15)(2008-1#4)(2008-10#1)(2008-2#6)(2008-3#3)
the amplitude and duration of the##4##6##(1990-12#1)(1992-3#1)(1995-9#1)(2008-9#1)
the amplitude and duration of##5##5##(1990-12#1)(1991-5#1)(1992-3#1)(1995-9#1)(2008-9#1)
the amplitude and frequency of##2##5##(2009-12#1)(2010-3#1)
the amplitude and latency of##2##5##(1990-2#1)(2009-11#1)
the amplitude and phase of the mean measurements##2##8##(1993-1#2)
the amplitude and phase of the##3##6##(1991-12#1)(1993-1#2)
the amplitude and phase of##6##5##(1991-12#1)(1993-1#2)(2007-12#2)(2008-1#1)
the amplitude and phase##10##4##(1991-12#1)(1993-1#2)(2007-12#5)(2008-1#1)(2008-3#1)
the amplitude and the phase of the##2##7##(2007-11#1)(2008-2#1)
the amplitude and the phase of ultrashort##2##7##(2007-12#2)
the amplitude and the phase of##5##6##(2007-11#1)(2007-12#3)(2008-2#1)
the amplitude and the phase##7##5##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#1)
the amplitude and the##12##4##(1996-2#1)(2007-11#3)(2007-12#5)(2008-2#2)(2008-3#1)
the amplitude and##40##3##(1990-12#1)(1990-2#1)(1991-11#1)(1991-12#1)(1991-5#2)(1991-6#1)(1992-3#1)(1993-1#2)(1993-12#1)(1995-9#1)(1996-2#1)(1996-3#1)(2007-11#3)(2007-12#11)(2008-1#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-3#1)(2011-2#1)(2012-1#1)
the amplitude matrix for a nonspherical particle in##2##8##(2008-3#2)
the amplitude modulation##2##3##(2007-12#1)(2008-2#1)
the amplitude of a##4##4##(1996-5#1)(1997-1#1)(2007-12#1)(2008-2#1)
the amplitude of temperature##2##4##(2010-6#2)
the amplitude of the NANC##2##5##(1997-4#2)
the amplitude of the refractive-index modulation##2##6##(2008-3#2)
the amplitude of the##54##4##(1990-2#1)(1990-7#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-7#3)(1992-8#2)(1993-1#1)(1993-12#1)(1993-3#1)(1994-2#2)(1994-6#1)(1995-12#1)(1995-3#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-8#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-12#2)(2007-8#2)(2008-10#1)(2008-2#5)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#1)(2009-1#1)(2009-4#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-8#1)(2012-1#1)
the amplitude of##87##3##(1990-2#1)(1990-7#3)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-7#4)(1992-8#2)(1993-1#1)(1993-12#1)(1993-3#1)(1994-2#3)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-5#6)(1997-7#1)(1997-8#2)(2005-12#1)(2005-8#1)(2006-12#1)(2006-4#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-12#5)(2007-8#2)(2008-10#1)(2008-2#6)(2008-3#5)(2008-4#5)(2008-5#1)(2008-7#1)(2009-1#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-8#1)(2012-1#1)(2012-12#1)
the amplitude or##2##3##(1991-9#1)(1992-3#1)
the amplitude ratio and phase difference##2##6##(2007-12#2)
the amplitude ratio and##3##4##(2007-12#2)(2008-2#1)
the amplitude ratio##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
the amplitude transmittance##2##3##(2008-2#2)
the amplitude##159##2##(1990-12#1)(1990-2#2)(1990-7#3)(1991-11#2)(1991-12#3)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-3#3)(1992-7#4)(1992-8#2)(1993-1#3)(1993-12#3)(1993-3#1)(1994-2#3)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-5#6)(1997-7#1)(1997-8#2)(2005-12#1)(2005-8#1)(2006-12#1)(2006-4#2)(2006-8#3)(2007-1#1)(2007-11#6)(2007-12#22)(2007-8#2)(2008-1#2)(2008-10#1)(2008-2#16)(2008-3#12)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-9#1)(2010-3#3)(2010-5#1)(2010-6#2)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#1)
the amplitude-modulated##2##2##(2006-6#1)(2008-2#1)
the amplitudes of the##5##4##(1992-8#1)(1996-7#1)(2008-10#1)(2008-2#1)(2008-3#1)
the amplitudes of##12##3##(1992-8#1)(1996-7#1)(1997-2#3)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)
the amplitudes##13##2##(1992-8#1)(1996-7#1)(1997-2#3)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#1)
the ampulla of Vater##2##4##(1990-9#1)(2004-11#1)
the ampulla of##3##3##(1990-9#1)(2004-11#1)(2008-11#1)
the ampulla##4##2##(1990-9#1)(2004-11#1)(2007-3#1)(2008-11#1)
the amputated##2##2##(2007-7#1)(2008-6#1)
the amputation##4##2##(1991-3#1)(2009-12#2)(2011-2#1)
the amputee##2##2##(2010-3#1)(2013-1#1)
the amygdala and hippocampus##2##4##(1993-6#1)(2008-6#1)
the amygdala and inferior temporal cortex##2##6##(1997-5#2)
the amygdala and the##7##4##(1990-7#1)(1994-2#1)(1995-6#1)(1996-10#1)(2007-11#1)(2007-12#1)(2008-7#1)
the amygdala and##16##3##(1990-7#2)(1993-6#2)(1994-2#1)(1995-6#1)(1996-10#1)(1997-5#2)(1997-7#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)
the amygdala does##2##3##(1993-6#1)(2008-11#1)
the amygdala in the##4##4##(1994-12#1)(1996-6#1)(2008-11#1)(2008-7#1)
the amygdala in##11##3##(1991-1#2)(1992-6#1)(1993-12#1)(1994-12#1)(1996-6#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#1)
the amygdala is##4##3##(1992-6#1)(1994-8#1)(2008-11#2)
the amygdala or##3##3##(1996-12#1)(1997-5#1)(2007-10#1)
the amygdala##128##2##(1990-7#3)(1991-1#5)(1991-10#2)(1991-11#1)(1991-5#2)(1992-10#1)(1992-6#3)(1992-7#3)(1992-8#4)(1993-12#13)(1993-6#8)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#5)(1994-8#3)(1995-1#1)(1995-11#8)(1995-12#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-4#1)(1996-5#2)(1996-6#3)(1996-9#2)(1997-5#3)(1997-7#3)(1997-8#1)(2004-11#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-11#10)(2008-4#5)(2008-6#3)(2008-7#4)(2008-9#1)(2009-10#1)(2009-2#6)(2010-2#1)(2011-2#2)(2013-8#2)
the amygdala/pyriform region##3##3##(1993-12#3)
the amygdala/pyriform##4##2##(1993-12#4)
the amygdalohippocampal area##2##3##(1995-12#1)(1995-5#1)
the amygdaloid complex##2##3##(1995-5#2)
the amygdaloid nuclei##2##3##(1997-3#1)(1997-7#1)
the amygdaloid##5##2##(1995-5#2)(1997-3#1)(1997-7#1)(2008-10#1)
the amylase from##2##3##(2008-10#2)
the amyloid A##2##3##(1996-2#2)
the amyloid beta A4 protein##2##5##(1992-8#1)(1992-9#1)
the amyloid beta##7##3##(1992-8#1)(1992-9#1)(1994-6#1)(1995-3#1)(1996-5#1)(1996-6#1)(2004-11#1)
the amyloid beta-protein##4##3##(1991-1#1)(1991-11#1)(1991-2#1)(1992-12#1)
the amyloid deposits##5##3##(1990-3#1)(1990-9#1)(1991-1#1)(1991-11#1)(2008-5#1)
the amyloid fibrils##3##3##(1991-3#1)(1995-1#1)(1997-7#1)
the amyloid precursor protein (APP) gene##3##6##(1993-11#1)(1994-2#1)(1996-6#1)
the amyloid precursor protein (APP)##6##5##(1993-11#2)(1994-2#1)(1996-6#1)(1996-9#1)(1997-1#1)
the amyloid precursor protein gene##2##5##(1992-1#1)(1992-3#1)
the amyloid precursor protein##15##4##(1992-1#1)(1992-12#2)(1992-3#3)(1993-11#3)(1994-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-7#1)
the amyloid precursor##16##3##(1992-1#1)(1992-12#2)(1992-3#4)(1993-11#3)(1994-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-7#1)
the amyloid protein##3##3##(1991-9#1)(1993-3#1)(2011-2#1)
the amyloid##52##2##(1990-3#2)(1990-9#2)(1991-1#3)(1991-11#4)(1991-2#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-12#4)(1992-3#7)(1992-8#1)(1992-9#1)(1993-11#3)(1993-3#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-3#1)(1996-2#2)(1996-5#2)(1996-6#2)(1996-9#2)(1997-1#1)(1997-7#2)(2004-11#1)(2008-5#2)(2010-11#1)(2011-2#1)
the amyloid-β protein##2##3##(2010-8#1)(2012-12#1)
the amyloid-β##4##2##(2010-8#1)(2011-1#1)(2012-12#2)
the amyloidogenic##4##2##(1994-5#1)(1995-10#2)(2011-2#1)
the amylose##2##2##(2008-10#2)
the anabolic action of PTH##2##5##(2009-3#2)
the anabolic action of##4##4##(2009-3#4)
the anabolic##7##2##(1992-6#1)(2008-11#1)(2009-3#4)(2010-2#1)
the anaemia of chronic renal failure##2##6##(1995-3#1)(2007-11#1)
the anaemia of##3##3##(1995-3#2)(2007-11#1)
the anaemia##6##2##(1995-3#2)(2006-2#1)(2006-4#1)(2007-11#1)(2012-12#1)
the anaerobes##2##2##(2007-8#1)(2008-12#1)
the anaerobic bacterium##2##3##(1990-12#1)(2010-2#1)
the anaerobic reactor##2##3##(2006-8#1)(2008-1#1)
the anaerobic threshold##4##3##(2005-1#3)(2013-1#1)
the anaerobic treatment of##2##4##(2011-2#1)(2013-1#1)
the anaerobic##33##2##(1990-12#1)(1990-3#1)(1991-12#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-5#1)(1996-9#1)(2005-1#3)(2006-3#1)(2006-8#6)(2007-12#1)(2007-8#1)(2008-1#2)(2008-9#1)(2009-10#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-2#3)(2013-1#2)
the anaesthesia##3##2##(2006-6#1)(2007-9#1)(2012-2#1)
the anaesthesiological##2##2##(2006-10#1)(2009-3#1)
the anaesthesiologist must##2##3##(2006-10#1)(2013-1#1)
the anaesthesiologist##7##2##(2006-10#5)(2013-1#1)(2013-8#1)
the anaesthesiologists##2##2##(1992-8#1)(2010-7#1)
the anaesthetic and##2##3##(1993-7#1)(2010-7#1)
the anaesthetic management of a##3##5##(2010-7#2)(2011-2#1)
the anaesthetic management of##6##4##(2010-7#3)(2011-1#1)(2011-2#1)(2013-1#1)
the anaesthetic vapours##2##3##(1991-6#1)(1997-3#1)
the anaesthetic##24##2##(1990-4#1)(1991-6#1)(1992-11#1)(1993-2#1)(1993-7#1)(1994-5#1)(1997-3#1)(2006-10#4)(2007-9#1)(2010-7#6)(2011-1#2)(2011-2#1)(2013-1#3)
the anaesthetist to##4##3##(1993-4#2)(2006-10#2)
the anaesthetist##10##2##(1993-4#2)(2006-10#4)(2009-10#1)(2009-3#1)(2012-12#2)
the anaesthetized rat##4##3##(1992-3#1)(1993-11#2)(1996-12#1)
the anaesthetized##5##2##(1992-3#1)(1993-11#2)(1995-11#1)(1996-12#1)
the anagen hair percentage##2##4##(2008-5#2)
the anagen##3##2##(2008-5#3)
the anal canal##17##3##(1994-4#1)(2007-4#1)(2010-5#5)(2011-2#8)(2013-1#2)
the anal fin##4##3##(2008-5#1)(2013-7#3)
the anal sphincter##5##3##(1992-10#1)(2008-8#1)(2011-2#3)
the anal##35##2##(1990-6#1)(1992-10#1)(1994-4#1)(1997-8#1)(2007-4#1)(2008-5#2)(2008-8#1)(2010-12#1)(2010-5#7)(2011-2#11)(2012-12#1)(2013-1#4)(2013-7#3)
the analgesic activity of ketorolac##2##5##(1990-2#2)
the analgesic activity of##3##4##(1990-2#2)(2013-1#1)
the analgesic activity##4##3##(1990-2#2)(2008-5#1)(2013-1#1)
the analgesic effect of corticotropin-releasing factor##2##6##(2012-1#2)
the analgesic effect of morphine##2##5##(1996-2#2)
the analgesic effect of##5##4##(1996-2#2)(1996-7#1)(2012-1#2)
the analgesic effect##7##3##(1991-2#1)(1996-2#3)(1996-7#1)(2012-1#2)
the analgesic effectiveness of##2##4##(2010-4#2)
the analgesic effects of the##2##5##(2008-10#1)(2010-1#1)
the analgesic effects of##10##4##(1992-11#1)(1997-5#3)(2006-12#1)(2008-10#2)(2008-3#1)(2010-1#1)(2012-2#1)
the analgesic effects##11##3##(1992-11#1)(1997-5#3)(2006-12#2)(2008-10#2)(2008-3#1)(2010-1#1)(2012-2#1)
the analgesic efficacy##2##3##(1993-1#1)(2010-7#1)
the analgesic ladder##2##3##(2006-10#1)(2008-7#1)
the analgesic properties of##2##4##(1995-12#1)(2011-2#1)
the analgesic##41##2##(1990-2#2)(1990-6#1)(1991-2#2)(1992-11#1)(1993-1#1)(1993-5#1)(1994-2#1)(1995-12#1)(1996-2#3)(1996-7#1)(1997-2#1)(1997-5#3)(2006-10#1)(2006-12#4)(2007-11#2)(2007-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-4#2)(2010-7#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#1)
the analog depth of the##2##5##(2008-2#2)
the analog is very##2##4##(1991-5#1)(1995-10#1)
the analog is##3##3##(1991-5#1)(1995-10#1)(1997-6#1)
the analog##26##2##(1990-4#1)(1991-5#1)(1992-5#1)(1992-6#1)(1995-1#1)(1995-10#2)(1995-5#1)(1996-7#1)(1997-5#1)(1997-6#2)(2005-11#1)(2007-12#1)(2008-2#11)(2008-7#1)
the analogous enzyme##2##3##(1992-3#1)(1996-7#1)
the analogous zinc##2##3##(1991-2#1)(1996-2#1)
the analogous##28##2##(1990-5#2)(1990-7#1)(1991-11#1)(1991-2#1)(1992-3#1)(1993-12#1)(1994-5#1)(1996-2#1)(1996-5#2)(1996-7#1)(1997-4#1)(2004-9#1)(2005-10#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2009-3#1)(2010-5#2)(2010-7#2)
the analogs##8##2##(1990-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-2#1)(1997-8#1)
the analogue##8##2##(1990-8#1)(1991-7#2)(1992-6#1)(1994-11#1)(1994-8#2)(1996-11#1)
the analogues of##3##3##(2008-1#1)(2008-10#1)(2011-2#1)
the analogues##10##2##(1990-2#1)(1991-7#1)(1992-6#1)(1994-8#1)(2005-11#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
the analogy between##2##3##(2007-12#1)(2008-3#1)
the analogy##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
the analysed samples in the##2##5##(2008-10#2)
the analysed samples##6##3##(2008-10#4)(2013-8#2)
the analysed##17##2##(1993-9#1)(1996-9#1)(2007-1#1)(2007-7#1)(2008-10#7)(2010-8#2)(2011-2#1)(2013-1#1)(2013-8#2)
the analyser##3##2##(1990-8#1)(2008-10#2)
the analyses are##3##3##(1995-4#1)(2006-10#1)(2008-10#1)
the analyses of the##2##4##(2005-4#1)(2008-10#1)
the analyses of##22##3##(1995-5#1)(1995-8#1)(2005-4#1)(2008-10#13)(2008-7#1)(2009-9#1)(2010-12#1)(2011-12#1)(2013-1#1)(2013-7#1)
the analyses used##2##3##(1994-12#1)(2005-5#1)
the analyses##57##2##(1991-7#1)(1994-12#1)(1995-4#1)(1995-5#1)(1995-8#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-4#1)(2005-5#1)(2006-1#1)(2006-10#1)(2006-8#1)(2007-12#2)(2007-5#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#4)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
the analysis accuracy of the##2##5##(2008-3#2)
the analysis accuracy##3##3##(2008-3#3)
the analysis and isolation of##2##5##(1996-8#1)(2009-4#1)
the analysis and the##2##4##(1994-6#1)(2008-3#1)
the analysis and##21##3##(1992-3#1)(1993-2#1)(1994-6#1)(1996-7#1)(1996-8#2)(2007-12#1)(2008-10#4)(2008-3#1)(2008-4#2)(2008-7#1)(2009-10#1)(2009-4#1)(2010-4#1)(2010-7#1)(2013-1#1)(2013-8#1)
the analysis are##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
the analysis by##5##3##(1996-1#1)(2008-10#2)(2008-9#1)(2012-3#1)
the analysis can be##2##4##(2008-10#1)(2008-3#1)
the analysis for##3##3##(1994-6#1)(2008-10#2)
the analysis in##4##3##(1995-5#1)(2009-4#1)(2011-2#1)(2013-7#1)
the analysis is##9##3##(1992-9#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)
the analysis of 1##3##4##(1995-1#2)(2008-10#1)
the analysis of 10##2##4##(2007-8#1)(2008-10#1)
the analysis of DNA sequences##2##5##(1994-6#1)(2008-4#1)
the analysis of DNA##5##4##(1994-6#1)(2007-10#1)(2008-12#1)(2008-4#1)(2012-3#1)
the analysis of a large number of##2##7##(1992-2#1)(1994-3#1)
the analysis of a number of##2##6##(2007-11#1)(2008-10#1)
the analysis of a series of##2##6##(2007-1#1)(2008-3#1)
the analysis of a##22##4##(1992-1#1)(1992-2#1)(1994-3#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-8#2)(2008-10#5)(2008-3#1)(2008-4#2)(2009-4#1)(2012-2#1)
the analysis of aroma##2##4##(2008-10#2)
the analysis of biological samples##3##5##(1996-5#1)(2008-10#1)(2010-9#1)
the analysis of biological##5##4##(1996-5#1)(2008-10#2)(2008-7#1)(2010-9#1)
the analysis of both##5##4##(2007-8#1)(2008-10#2)(2008-3#1)(2011-2#1)
the analysis of cancer##2##4##(1994-2#1)(2009-12#1)
the analysis of cells##2##4##(2008-11#1)(2008-9#1)
the analysis of certified reference material##2##6##(2008-10#2)
the analysis of certified reference materials and##3##7##(2008-10#3)
the analysis of certified reference materials##8##6##(2008-10#8)
the analysis of certified reference##11##5##(2008-10#11)
the analysis of certified##12##4##(2008-10#12)
the analysis of clinical trials data##2##6##(1995-6#2)
the analysis of clinical trials##3##5##(1995-6#2)(1997-7#1)
the analysis of clinical##5##4##(1992-10#1)(1995-6#2)(1997-7#1)(2006-8#1)
the analysis of commercial##2##4##(2007-8#1)(2008-10#1)
the analysis of common##2##4##(2007-6#1)(2012-3#1)
the analysis of complex matrices##2##5##(2008-10#2)
the analysis of complex##7##4##(1997-2#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-2#1)
the analysis of data from##3##5##(1994-11#1)(2006-10#1)(2011-8#1)
the analysis of data##8##4##(1994-11#1)(1997-2#1)(2005-10#1)(2006-10#1)(2007-4#1)(2008-10#1)(2011-8#1)(2012-12#1)
the analysis of different##4##4##(1993-9#1)(2007-8#1)(2008-10#2)
the analysis of drugs##4##4##(1996-5#1)(1997-8#1)(2008-10#1)(2010-11#1)
the analysis of dynamic##3##4##(2008-1#1)(2008-3#2)
the analysis of each of##2##5##(1992-3#1)(2007-8#1)
the analysis of each sample##2##5##(2008-10#2)
the analysis of each##4##4##(1992-3#1)(2007-8#1)(2008-10#2)
the analysis of environmental##3##4##(2008-10#2)(2012-3#1)
the analysis of first##2##4##(1995-12#1)(1995-8#1)
the analysis of five##4##4##(1991-8#1)(2005-11#1)(2005-4#1)(2010-12#1)
the analysis of four certified reference##2##6##(2008-10#2)
the analysis of fringe##2##4##(2008-3#2)
the analysis of gene expression##3##5##(2008-11#2)(2008-2#1)
the analysis of gene##4##4##(2008-11#2)(2008-2#1)(2008-7#1)
the analysis of high##2##4##(2008-10#1)(2008-11#1)
the analysis of large##3##4##(2008-10#1)(2008-2#1)(2008-4#1)
the analysis of life##2##4##(1994-11#1)(2011-1#1)
the analysis of longitudinal##4##4##(1993-9#1)(1996-12#1)(1997-8#1)(2011-1#1)
the analysis of major##3##4##(2008-10#2)(2012-2#1)
the analysis of measurement##2##4##(1993-5#1)(2008-3#1)
the analysis of mixed##2##4##(2008-10#1)(2008-12#1)
the analysis of multiple##2##4##(1997-4#1)(2008-4#1)
the analysis of natural##6##4##(1991-8#1)(2008-10#4)(2008-3#1)
the analysis of one##4##4##(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)
the analysis of organic##3##4##(2008-10#2)(2008-11#1)
the analysis of other##2##4##(2008-10#1)(2008-2#1)
the analysis of patients##3##4##(2007-11#1)(2011-2#1)(2013-1#1)
the analysis of perchlorate in##2##5##(2007-8#2)
the analysis of pharmaceutical##4##4##(2008-10#4)
the analysis of phosphorus##2##4##(2008-10#1)(2008-12#1)
the analysis of plasma samples##2##5##(2008-10#1)(2010-12#1)
the analysis of potable##2##4##(2008-10#2)
the analysis of protein##3##4##(1994-9#1)(2008-10#1)(2010-4#1)
the analysis of proteins and##2##5##(2008-10#1)(2008-9#1)
the analysis of proteins##3##4##(2008-10#1)(2008-4#1)(2008-9#1)
the analysis of rare variants##4##5##(2012-3#4)
the analysis of rare##5##4##(2012-3#5)
the analysis of real samples##3##5##(2008-10#3)
the analysis of real##7##4##(2008-10#6)(2008-2#1)
the analysis of regulatory##2##4##(1991-9#1)(2006-7#1)
the analysis of relatively##2##4##(2008-10#1)(2008-4#1)
the analysis of samples##2##4##(2007-8#1)(2008-10#1)
the analysis of selected##3##4##(1993-9#1)(2008-10#2)
the analysis of serum##2##4##(2008-10#2)
the analysis of several##3##4##(2008-10#2)(2009-10#1)
the analysis of shape##2##4##(1995-8#1)(2008-6#1)
the analysis of small##3##4##(2008-10#2)(2010-2#1)
the analysis of some##10##4##(2008-10#10)
the analysis of spiked##6##4##(2006-12#1)(2007-8#1)(2008-10#4)
the analysis of standard reference materials##2##6##(2008-10#2)
the analysis of such data##2##5##(1993-9#1)(2012-2#1)
the analysis of such##6##4##(1993-9#1)(1996-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)
the analysis of survival data##4##5##(1990-2#1)(1994-4#1)(1997-3#1)(2012-3#1)
the analysis of survival##5##4##(1990-2#1)(1994-4#1)(1997-3#1)(2012-12#1)(2012-3#1)
the analysis of synthetic##8##4##(2008-10#6)(2008-2#1)(2008-4#1)
the analysis of systems##2##4##(2006-10#2)
the analysis of the bulk##2##5##(2008-10#2)
the analysis of the changes##2##5##(2008-11#1)(2013-8#1)
the analysis of the combined##2##5##(1992-9#1)(1997-3#1)
the analysis of the data##3##5##(1995-8#1)(2007-2#1)(2010-10#1)
the analysis of the genetic##2##5##(2008-10#1)(2011-2#1)
the analysis of the##121##4##(1990-11#2)(1990-5#2)(1990-7#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-9#2)(1993-12#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-5#2)(1995-8#1)(1996-12#1)(1997-3#2)(1997-4#1)(1997-8#1)(2004-11#1)(2005-4#2)(2006-10#3)(2006-6#1)(2006-7#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#33)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-6#1)(2008-8#3)(2008-9#4)(2009-6#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#3)
the analysis of their##3##4##(1992-6#1)(1992-7#1)(2008-9#1)
the analysis of these compounds##2##5##(2008-10#2)
the analysis of these herbicides in spiked##2##7##(2008-10#2)
the analysis of these herbicides in##3##6##(2008-10#3)
the analysis of these##11##4##(1995-1#1)(2008-10#7)(2008-2#1)(2011-12#1)(2012-11#1)
the analysis of this type of##2##6##(2008-10#1)(2010-8#1)
the analysis of this##7##4##(2008-10#6)(2010-8#1)
the analysis of three##3##4##(2008-10#2)(2012-3#1)
the analysis of tissue##2##4##(2007-8#1)(2008-5#1)
the analysis of total##3##4##(2008-10#2)(2012-2#1)
the analysis of toxic metal##2##5##(2008-10#2)
the analysis of trace metals##2##5##(2007-8#1)(2008-10#1)
the analysis of trace##8##4##(1997-2#1)(2007-8#2)(2008-10#5)
the analysis of trihalomethanes##2##4##(2007-8#1)(2008-10#1)
the analysis of two##8##4##(1995-6#1)(2006-11#1)(2007-12#1)(2008-10#4)(2008-3#1)
the analysis of urine samples##4##5##(1993-2#1)(1996-6#1)(2008-10#2)
the analysis of urine##5##4##(1993-2#1)(1996-6#1)(2008-10#3)
the analysis of variance (ANOVA)##2##5##(2008-10#1)(2013-1#1)
the analysis of variance##4##4##(1990-8#1)(1994-8#1)(2008-10#1)(2013-1#1)
the analysis of various##3##4##(1992-2#1)(2007-12#1)(2008-10#1)
the analysis of volatile##3##4##(1997-8#2)(2008-10#1)
the analysis of water samples##2##5##(2008-10#2)
the analysis of##876##3##(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#3)(1991-11#1)(1991-2#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#5)(1992-3#3)(1992-4#1)(1992-6#3)(1992-7#2)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#4)(1993-3#1)(1993-5#2)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#5)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#1)(1994-4#2)(1994-6#2)(1994-8#3)(1994-9#2)(1995-1#4)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#2)(1995-5#4)(1995-6#3)(1995-8#3)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#4)(1996-5#7)(1996-6#4)(1996-7#1)(1996-8#4)(1996-9#1)(1997-2#4)(1997-3#5)(1997-4#4)(1997-7#2)(1997-8#5)(2004-11#1)(2005-10#1)(2005-11#1)(2005-12#6)(2005-4#6)(2005-7#1)(2005-8#1)(2006-10#11)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#1)(2007-1#3)(2007-10#3)(2007-11#9)(2007-12#13)(2007-2#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#31)(2007-9#1)(2008-1#6)(2008-10#352)(2008-11#19)(2008-12#5)(2008-2#25)(2008-3#23)(2008-4#29)(2008-5#4)(2008-6#3)(2008-7#8)(2008-8#5)(2008-9#10)(2009-10#2)(2009-11#1)(2009-12#2)(2009-4#3)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#6)(2010-12#5)(2010-2#6)(2010-3#4)(2010-4#3)(2010-5#6)(2010-6#1)(2010-8#3)(2010-9#3)(2011-1#11)(2011-12#1)(2011-2#10)(2011-8#1)(2012-1#4)(2012-11#3)(2012-12#5)(2012-2#6)(2012-3#18)(2013-1#8)(2013-7#1)(2013-8#3)
the analysis presented here##2##4##(2005-11#1)(2006-5#1)
the analysis presented##3##3##(2005-11#1)(2006-5#1)(2008-3#1)
the analysis results##4##3##(2005-12#1)(2008-2#1)(2008-3#1)(2013-1#1)
the analysis showed##2##3##(2008-12#1)(2008-5#1)
the analysis time and##2##4##(2008-10#2)
the analysis time is##2##4##(2008-10#2)
the analysis time was##2##4##(2008-10#1)(2008-3#1)
the analysis time##7##3##(1991-8#1)(2008-10#5)(2008-3#1)
the analysis to##5##3##(2008-10#1)(2008-6#1)(2008-9#1)(2009-11#1)(2010-7#1)
the analysis using##2##3##(2008-2#1)(2011-2#1)
the analysis was performed##2##4##(2008-10#1)(2012-12#1)
the analysis was##14##3##(1992-12#1)(1993-12#1)(1994-12#1)(1995-6#1)(2008-10#6)(2008-8#1)(2010-10#1)(2012-12#1)(2013-8#1)
the analysis were##5##3##(1997-3#1)(2007-10#1)(2008-11#2)(2010-5#1)
the analysis with##2##3##(2008-10#1)(2008-7#1)
the analysis##1118##2##(1990-11#4)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#2)(1990-7#2)(1990-8#3)(1991-11#1)(1991-2#2)(1991-5#2)(1991-6#2)(1991-7#3)(1991-8#5)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#5)(1992-3#5)(1992-4#1)(1992-6#3)(1992-7#2)(1992-8#1)(1992-9#3)(1993-11#2)(1993-12#4)(1993-2#5)(1993-3#1)(1993-5#2)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#5)(1994-11#2)(1994-12#5)(1994-2#6)(1994-3#1)(1994-4#2)(1994-6#5)(1994-8#3)(1994-9#3)(1995-1#4)(1995-10#1)(1995-12#2)(1995-2#2)(1995-3#3)(1995-4#3)(1995-5#5)(1995-6#4)(1995-8#3)(1996-1#1)(1996-11#3)(1996-12#8)(1996-2#2)(1996-3#4)(1996-5#7)(1996-6#4)(1996-7#3)(1996-8#7)(1996-9#1)(1997-2#6)(1997-3#7)(1997-4#5)(1997-7#3)(1997-8#5)(2004-11#1)(2004-12#1)(2005-10#2)(2005-11#2)(2005-12#7)(2005-4#6)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#12)(2006-11#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#4)(2007-1#3)(2007-10#5)(2007-11#9)(2007-12#16)(2007-2#1)(2007-4#2)(2007-5#1)(2007-6#4)(2007-7#4)(2007-8#35)(2007-9#1)(2008-1#7)(2008-10#398)(2008-11#21)(2008-12#8)(2008-2#39)(2008-3#44)(2008-4#33)(2008-5#10)(2008-6#5)(2008-7#12)(2008-8#7)(2008-9#16)(2009-10#3)(2009-11#3)(2009-12#2)(2009-3#1)(2009-4#5)(2009-5#4)(2009-6#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#7)(2010-12#6)(2010-2#7)(2010-3#5)(2010-4#4)(2010-5#8)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#3)(2011-1#12)(2011-12#1)(2011-2#16)(2011-8#1)(2012-1#4)(2012-11#3)(2012-12#9)(2012-2#13)(2012-3#23)(2012-6#1)(2013-1#16)(2013-7#2)(2013-8#8)
the analyst##3##2##(1996-5#1)(2008-10#1)(2012-12#1)
the analyte and the##4##4##(2008-10#3)(2010-7#1)
the analyte and##12##3##(1995-3#1)(1996-8#1)(2006-12#1)(2008-10#8)(2010-7#1)
the analyte at##2##3##(2008-10#2)
the analyte by##4##3##(2008-10#3)(2009-8#1)
the analyte concentration##7##3##(2007-8#1)(2008-10#5)(2008-7#1)
the analyte concentrations##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#1)
the analyte elements were##4##4##(2008-10#4)
the analyte elements##6##3##(2008-10#6)
the analyte from the##4##4##(2008-10#4)
the analyte from##5##3##(1996-5#1)(2008-10#4)
the analyte in the##10##4##(2008-10#7)(2009-8#1)(2010-5#1)(2011-1#1)
the analyte in##15##3##(2007-8#1)(2008-10#11)(2009-8#1)(2010-5#1)(2011-1#1)
the analyte is present##2##4##(1995-2#1)(2008-10#1)
the analyte is##6##3##(1995-2#1)(2008-10#5)
the analyte pulse perturbation##3##4##(2008-10#3)
the analyte pulse##4##3##(2008-10#4)
the analyte signal from the##2##5##(2008-10#2)
the analyte signal##3##3##(2007-8#1)(2008-10#2)
the analyte solution##8##3##(2008-10#8)
the analyte to##5##3##(2008-10#5)
the analyte was retained##2##4##(2008-10#2)
the analyte was##9##3##(2008-10#8)(2012-12#1)
the analyte were##2##3##(2008-10#2)
the analyte##168##2##(1995-2#1)(1995-3#1)(1996-5#1)(1996-8#2)(1997-3#1)(2006-12#3)(2007-10#1)(2007-12#1)(2007-8#9)(2008-10#131)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-8#2)(2010-5#1)(2010-7#1)(2011-1#2)(2012-12#3)(2013-1#1)(2013-8#2)
the analyte's##2##2##(2008-10#2)
the analytes and##5##3##(2007-8#1)(2008-10#4)
the analytes are##7##3##(2008-10#6)(2013-1#1)
the analytes from the##2##4##(2008-10#2)
the analytes from##5##3##(1997-2#1)(2008-10#4)
the analytes in##7##3##(2007-8#1)(2008-10#6)
the analytes of interest##2##4##(2008-10#2)
the analytes was##5##3##(1993-2#1)(2005-12#1)(2008-10#3)
the analytes were detected by##2##5##(2011-1#1)(2013-1#1)
the analytes were##21##3##(1997-8#1)(2005-12#1)(2007-8#1)(2008-10#14)(2011-1#1)(2012-1#1)(2013-1#1)(2013-7#1)
the analytes with##4##3##(2007-8#1)(2008-10#3)
the analytes##114##2##(1993-2#1)(1996-5#1)(1997-2#3)(1997-3#1)(1997-5#1)(1997-8#1)(2005-12#2)(2007-8#5)(2008-1#1)(2008-10#87)(2008-3#3)(2010-5#1)(2011-1#2)(2012-1#1)(2013-1#3)(2013-7#1)
the analytes' concentrations##3##3##(2007-8#3)
the analytic expression##2##3##(2007-10#1)(2012-11#1)
the analytic hierarchy process (AHP)##2##5##(2008-10#1)(2010-8#1)
the analytic hierarchy process##4##4##(2008-10#1)(2010-8#1)(2011-2#2)
the analytic model##3##3##(2008-2#1)(2013-1#2)
the analytic##16##2##(1995-2#2)(2006-10#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2010-8#1)(2011-2#2)(2012-11#1)(2012-12#1)(2013-1#2)
the analytical and preparative##2##4##(1990-12#1)(1991-11#1)
the analytical and##3##3##(1990-12#1)(1991-11#1)(1997-6#1)
the analytical application##2##3##(2007-8#1)(2008-10#1)
the analytical approach##2##3##(2005-11#1)(2008-10#1)
the analytical capabilities of##3##4##(2008-10#1)(2008-3#1)(2010-11#1)
the analytical characteristics of the procedure##2##6##(2008-10#2)
the analytical characteristics of the##3##5##(2008-10#3)
the analytical characteristics of##6##4##(2008-10#6)
the analytical characteristics##11##3##(2008-10#11)
the analytical chemical##2##3##(2008-10#2)
the analytical chemistry##2##3##(2008-10#2)
the analytical column##10##3##(1990-8#2)(1992-2#1)(1993-2#2)(1997-3#1)(2008-10#4)
the analytical community##3##3##(2007-5#1)(2008-10#2)
the analytical concentration##2##3##(2008-10#1)(2010-12#1)
the analytical conditions##3##3##(2008-10#2)(2011-1#1)
the analytical curve was##2##4##(2008-10#2)
the analytical curve##4##3##(2008-10#4)
the analytical curves##3##3##(2008-10#3)
the analytical data##4##3##(1995-5#1)(2008-10#3)
the analytical design of##2##4##(2007-12#1)(2008-3#1)
the analytical design##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
the analytical determination of##2##4##(2008-10#2)
the analytical determination##3##3##(2008-10#3)
the analytical expressions##2##3##(2007-12#1)(2008-2#1)
the analytical figures of merit were##2##6##(2008-10#1)(2010-11#1)
the analytical figures of merit##4##5##(2008-10#3)(2010-11#1)
the analytical formula##2##3##(2008-2#2)
the analytical information##2##3##(1992-2#1)(2007-8#1)
the analytical method##9##3##(1992-2#1)(1997-3#1)(2008-10#3)(2010-11#1)(2010-12#1)(2012-2#1)(2013-7#1)
the analytical methods used##2##4##(1996-12#1)(2007-8#1)
the analytical methods##4##3##(1996-12#1)(2007-8#1)(2008-4#1)(2010-7#1)
the analytical minimalism concept##2##4##(2008-10#2)
the analytical performance of the method##2##6##(2008-10#2)
the analytical performance of the##6##5##(2008-10#6)
the analytical performance of##7##4##(2008-10#7)
the analytical performance##9##3##(2008-10#9)
the analytical performances of the##3##5##(2007-8#1)(2008-10#2)
the analytical performances of##4##4##(2007-8#1)(2008-10#3)
the analytical performances##5##3##(2007-8#1)(2008-10#4)
the analytical procedure##10##3##(2008-10#9)(2008-6#1)
the analytical recovery##2##3##(1991-1#1)(2008-10#1)
the analytical response##3##3##(2008-10#2)(2011-1#1)
the analytical results were in good agreement with##2##8##(2008-10#2)
the analytical results were##5##4##(2008-10#5)
the analytical results##11##3##(2007-11#1)(2008-10#7)(2008-3#2)(2012-1#1)
the analytical sensitivity and##2##4##(2008-10#2)
the analytical sensitivity##6##3##(2008-10#4)(2011-2#1)(2012-12#1)
the analytical signal from##2##4##(2008-10#2)
the analytical signal is##2##4##(2008-10#2)
the analytical signal of##3##4##(2008-10#3)
the analytical signal showed a very good linearity in the range##2##11##(2008-10#2)
the analytical signal to##2##4##(2008-10#2)
the analytical signal versus concentration dependence was linear##2##8##(2008-10#2)
the analytical signal##27##3##(2008-10#25)(2011-1#2)
the analytical signals##6##3##(2008-10#5)(2008-3#1)
the analytical solution##6##3##(2005-11#1)(2007-11#1)(2008-10#1)(2008-3#2)(2011-2#1)
the analytical system##4##3##(2006-2#1)(2008-10#3)
the analytical techniques##2##3##(2010-11#2)
the analytical time was##2##4##(2008-10#2)
the analytical##245##2##(1990-11#1)(1990-12#1)(1990-8#2)(1991-1#1)(1991-11#1)(1992-2#4)(1993-2#3)(1995-5#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-3#3)(1997-6#1)(2005-10#1)(2005-11#2)(2005-4#1)(2006-10#1)(2006-2#1)(2007-11#4)(2007-12#2)(2007-5#1)(2007-8#6)(2007-9#3)(2008-10#157)(2008-2#5)(2008-3#10)(2008-4#1)(2008-6#2)(2008-9#1)(2010-1#1)(2010-10#1)(2010-11#5)(2010-12#2)(2010-4#1)(2010-7#2)(2011-1#4)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
the analytically##2##2##(2007-11#1)(2008-2#1)
the analyzed##33##2##(1997-2#1)(2006-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#9)(2008-12#1)(2008-3#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#2)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#2)
the analyzer with##2##3##(2007-11#1)(2008-3#1)
the analyzer##9##2##(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)
the analyzing of the EXAFS##2##5##(2005-4#2)
the analyzing##4##2##(2005-4#2)(2008-10#1)(2008-3#1)
the anamorphic##3##2##(1996-9#1)(2008-3#2)
the anastomosis site##2##3##(2007-8#1)(2012-2#1)
the anastomosis was##3##3##(2005-9#1)(2006-6#1)(2007-8#1)
the anastomosis##24##2##(1990-6#1)(1991-3#1)(1993-2#3)(1993-6#1)(2005-9#1)(2006-6#5)(2007-8#5)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2012-2#1)
the anastomotic##3##2##(2006-6#1)(2007-8#1)(2013-7#1)
the anatase TiO2 particles##3##4##(2005-11#3)
the anatase nanoparticles##3##3##(2005-11#3)
the anatase##6##2##(2005-11#6)
the anatomic and##3##3##(1992-4#1)(2006-10#1)(2007-12#1)
the anatomic basis##2##3##(2012-2#1)(2012-3#1)
the anatomic data##2##3##(2007-4#1)(2008-7#1)
the anatomic landmarks##2##3##(2006-12#1)(2007-7#1)
the anatomic location of the##2##5##(1994-6#1)(2010-11#1)
the anatomic##25##2##(1990-9#1)(1991-9#1)(1992-4#1)(1994-3#1)(1994-6#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-12#1)(2012-11#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
the anatomical and##7##3##(2006-11#1)(2006-3#1)(2007-11#1)(2008-2#1)(2009-1#1)(2009-7#1)(2013-1#1)
the anatomical axis of the##2##5##(1990-6#1)(2012-2#1)
the anatomical basis##2##3##(2007-11#1)(2013-1#1)
the anatomical features of the##2##5##(2008-11#1)(2011-1#1)
the anatomical features of##3##4##(2008-11#1)(2011-1#1)(2013-1#1)
the anatomical features##4##3##(1996-9#1)(2008-11#1)(2011-1#1)(2013-1#1)
the anatomical location of##4##4##(1996-12#1)(2008-1#1)(2013-1#2)
the anatomical location##5##3##(1996-12#1)(2008-1#1)(2013-1#2)(2013-8#1)
the anatomical origin of the##2##5##(1994-12#1)(2009-5#1)
the anatomical reconstruction##2##3##(2010-12#2)
the anatomical relationships##2##3##(1991-11#1)(2006-5#1)
the anatomical resolution##2##3##(1993-2#1)(2008-4#1)
the anatomical##85##2##(1990-10#1)(1990-6#2)(1991-11#1)(1991-6#1)(1992-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-12#1)(1996-3#1)(1996-9#1)(1997-6#1)(2004-9#1)(2006-11#8)(2006-3#1)(2006-5#2)(2007-1#1)(2007-11#3)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#2)(2009-5#1)(2009-7#2)(2010-12#3)(2010-2#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#8)(2013-8#3)
the anatomy and function##2##4##(1993-6#1)(2008-5#1)
the anatomy and physiology of the##4##6##(2005-11#1)(2006-8#1)(2007-8#1)(2010-9#1)
the anatomy and##10##3##(1993-6#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-6#1)(2010-9#1)
the anatomy is##3##3##(2006-6#1)(2007-7#1)(2013-1#1)
the anatomy of the##9##4##(1990-11#1)(2006-11#1)(2007-12#1)(2008-10#1)(2009-10#1)(2009-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
the anatomy of this region##3##5##(1994-3#1)(1996-9#1)(2006-12#1)
the anatomy of##13##3##(1990-11#1)(1994-3#1)(1996-9#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2009-10#1)(2009-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
the anatomy##33##2##(1990-11#1)(1990-8#1)(1993-6#1)(1994-3#1)(1996-9#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-10#2)(2008-5#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-6#1)(2010-8#1)(2010-9#1)(2012-2#1)(2013-1#4)
the ancestor of##5##3##(2008-1#1)(2008-9#2)(2009-10#1)(2010-6#1)
the ancestor##7##2##(1991-3#1)(2008-1#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-6#1)
the ancestors of##2##3##(2009-2#1)(2009-8#1)
the ancestral condition##2##3##(2008-7#1)(2013-8#1)
the ancestral gene##2##3##(1991-6#1)(1992-12#1)
the ancestral##23##2##(1991-6#1)(1992-12#1)(1994-3#1)(1995-11#1)(1995-8#1)(1996-10#1)(1996-3#1)(1997-4#1)(2006-5#2)(2007-12#1)(2008-12#1)(2008-7#1)(2008-8#4)(2009-5#1)(2011-2#1)(2013-1#3)(2013-8#1)
the anchor cell##4##3##(1994-12#1)(2007-12#3)
the anchor##8##2##(1994-12#1)(1997-6#1)(1997-7#1)(2007-12#3)(2008-10#1)(2010-10#1)
the anchorage for forced##2##4##(2008-7#2)
the anchorage##4##2##(1992-2#1)(2008-7#3)
the anchored##2##2##(2008-10#1)(2011-2#1)
the ancient and##3##3##(2008-1#1)(2008-10#1)(2012-2#1)
the ancient##11##2##(1991-2#1)(2006-10#1)(2008-1#1)(2008-10#4)(2008-11#1)(2009-10#1)(2012-2#1)(2013-1#1)
the ancillary##3##2##(1994-6#1)(2008-4#1)(2011-7#1)
the and##2##2##(2008-9#1)(2012-2#1)
the androgen receptor (AR)##10##4##(1990-11#2)(1992-5#1)(1996-11#1)(1996-5#1)(1997-1#1)(1997-7#1)(2004-1#1)(2011-2#1)(2012-12#1)
the androgen receptor and##4##4##(1996-5#1)(2006-10#1)(2008-4#1)(2010-3#1)
the androgen receptor gene##4##4##(1992-1#2)(2006-10#2)
the androgen receptor##33##3##(1990-11#2)(1990-8#1)(1991-3#1)(1992-1#2)(1992-5#2)(1993-3#1)(1995-11#1)(1995-3#2)(1996-11#1)(1996-5#2)(1997-1#1)(1997-7#1)(2004-1#1)(2006-10#5)(2008-4#3)(2009-4#2)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the androgen##38##2##(1990-11#2)(1990-8#1)(1991-3#1)(1992-1#2)(1992-5#2)(1993-3#1)(1993-6#1)(1995-11#1)(1995-3#2)(1996-11#2)(1996-5#2)(1997-1#1)(1997-7#1)(2004-1#1)(2006-10#5)(2008-4#3)(2008-9#2)(2009-10#1)(2009-4#2)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the androgen-dependent##2##2##(1994-5#1)(2007-6#1)
the androgenic status##3##3##(1994-12#3)
the androgenic steroid##3##3##(1990-11#2)(1993-1#1)
the androgenic##10##2##(1990-11#2)(1991-9#1)(1993-1#1)(1994-12#3)(1996-5#1)(2010-1#1)(2010-3#1)
the androgens##3##2##(1990-9#1)(1992-5#1)(2008-7#1)
the android and##2##3##(2008-11#1)(2009-7#1)
the anecdotal##2##2##(1997-8#1)(2006-8#1)
the anemia of##4##3##(1990-2#1)(1992-2#1)(2010-12#1)(2012-2#1)
the anemia##10##2##(1990-2#1)(1991-10#1)(1992-2#1)(1996-8#1)(2006-10#1)(2007-4#1)(2007-7#1)(2010-12#1)(2011-2#1)(2012-2#1)
the anesthesia and##3##3##(2010-8#2)(2012-12#1)
the anesthesia team##2##3##(2006-6#1)(2013-7#1)
the anesthesia##11##2##(1994-3#1)(2006-10#1)(2006-6#1)(2010-8#4)(2011-2#1)(2012-12#2)(2013-7#1)
the anesthesiologist with##2##3##(1993-7#1)(2006-10#1)
the anesthesiologist##13##2##(1993-7#1)(2006-10#6)(2006-2#1)(2007-11#2)(2009-4#1)(2012-12#1)(2013-8#1)
the anesthesiologist's##2##2##(2006-6#1)(2007-11#1)
the anesthetic management of these patients##2##6##(2006-10#1)(2011-1#1)
the anesthetic management of these##3##5##(2006-10#1)(2011-1#1)(2013-1#1)
the anesthetic management of##5##4##(1993-7#1)(2006-10#1)(2011-1#1)(2013-1#1)(2013-8#1)
the anesthetic management##8##3##(1993-7#1)(2006-10#1)(2009-4#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
the anesthetic nitrous oxide##2##4##(1994-9#2)
the anesthetic technique used##2##4##(2007-8#1)(2009-4#1)
the anesthetic technique##3##3##(2007-8#1)(2009-4#2)
the anesthetic##29##2##(1990-12#1)(1990-2#3)(1991-6#1)(1993-7#1)(1994-9#2)(2006-10#4)(2007-12#2)(2007-7#1)(2007-8#1)(2008-3#1)(2009-4#4)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
the anesthetist##2##2##(2006-10#1)(2009-9#1)
the anesthetized rat##4##3##(1991-2#2)(1993-2#1)(1993-4#1)
the anesthetized##7##2##(1991-2#2)(1993-2#1)(1993-4#1)(2008-4#2)(2008-8#1)
the aneurysm and##4##3##(1991-6#1)(2007-8#2)(2013-8#1)
the aneurysm can##2##3##(2005-9#1)(2012-1#1)
the aneurysm sac##2##3##(2005-9#1)(2008-11#1)
the aneurysm was##3##3##(2006-10#1)(2008-1#1)(2012-2#1)
the aneurysm##42##2##(1991-6#1)(1991-9#1)(1993-10#1)(1997-3#1)(1997-6#2)(2005-10#1)(2005-9#2)(2006-10#1)(2006-11#1)(2006-12#2)(2007-8#6)(2008-1#1)(2008-11#1)(2008-12#3)(2008-7#2)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#3)
the aneurysmal sac##3##3##(1997-3#2)(2008-11#1)
the aneurysmal##10##2##(1997-3#3)(1997-6#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-2#1)
the aneurysms were##3##3##(1995-11#1)(1997-3#1)(2010-12#1)
the aneurysms##7##2##(1990-10#1)(1995-11#1)(1997-3#1)(2005-5#1)(2009-8#1)(2010-12#1)(2013-8#1)
the angR gene##3##3##(1990-1#3)
the anger##2##2##(1997-5#1)(2010-7#1)
the angiogenesis of CMECs##2##4##(2013-8#2)
the angiogenesis of##3##3##(2013-8#3)
the angiogenesis##6##2##(1991-12#1)(1996-6#1)(2011-2#1)(2013-8#3)
the angiogenic and##2##3##(1990-4#1)(2008-1#1)
the angiogenic potential of biomaterials##2##5##(2008-5#2)
the angiogenic potential of##3##4##(2008-5#2)(2011-2#1)
the angiogenic process##2##3##(2008-1#2)
the angiogenic##18##2##(1990-4#1)(1992-3#1)(2006-4#1)(2006-9#1)(2008-1#5)(2008-5#2)(2009-11#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
the angiogenin##2##2##(1991-4#1)(1995-2#1)
the angiographic findings##5##3##(1997-8#3)(2006-10#2)
the angiographic##12##2##(1990-6#1)(1992-9#1)(1994-11#1)(1996-6#1)(1997-2#1)(1997-8#3)(2006-10#3)(2008-7#1)
the angiography##5##2##(1990-8#1)(1991-11#1)(2007-5#1)(2007-7#1)(2008-7#1)
the angioplasty##4##2##(2007-7#1)(2008-4#1)(2008-5#1)(2013-1#1)
the angiotensin AT1##2##3##(1995-12#1)(1996-12#1)
the angiotensin II receptor type##2##5##(1990-6#1)(2010-6#1)
the angiotensin II receptor##7##4##(1990-6#1)(1994-8#1)(1995-11#1)(1997-7#1)(2005-7#1)(2007-1#1)(2010-6#1)
the angiotensin II##11##3##(1990-6#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-6#1)(1997-7#1)(2005-7#1)(2007-1#1)(2008-1#1)(2008-8#1)(2010-6#1)
the angiotensin II-induced mobilization of##2##5##(1990-2#1)(1991-7#1)
the angiotensin II-induced##8##3##(1990-2#2)(1991-7#1)(1994-9#2)(1995-11#1)(1996-12#1)(1996-8#1)
the angiotensin converting enzyme##3##4##(1990-1#1)(1990-12#1)(1990-5#1)
the angiotensin receptor##2##3##(1992-5#1)(2010-6#1)
the angiotensin receptors##4##3##(1991-9#1)(1994-2#2)(2010-6#1)
the angiotensin type-1 (AT1) receptor##2##5##(1992-5#1)(2005-7#1)
the angiotensin##37##2##(1990-1#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-5#2)(1994-2#2)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#2)(1995-12#2)(1995-6#2)(1996-12#2)(1996-4#1)(1996-8#1)(1997-7#1)(2005-7#2)(2007-1#1)(2008-1#2)(2008-8#1)(2010-6#3)
the angiotensin-converting enzyme (ACE) inhibitor##3##5##(1990-2#1)(1991-5#1)(2008-7#1)
the angiotensin-converting enzyme gene##2##4##(1990-3#1)(2008-12#1)
the angiotensin-converting enzyme##7##3##(1990-2#1)(1990-3#1)(1991-5#1)(2006-6#2)(2008-12#1)(2008-7#1)
the angle and##3##3##(2007-8#1)(2008-3#1)(2008-9#1)
the angle between the##3##4##(2007-12#1)(2008-3#2)
the angle between##7##3##(2006-4#1)(2007-12#2)(2008-2#1)(2008-3#3)
the angle formed by the##2##5##(1995-6#1)(2008-1#1)
the angle of incidence and the##3##6##(2007-12#1)(2008-2#1)(2008-3#1)
the angle of incidence of light##3##6##(2008-2#2)(2008-3#1)
the angle of incidence of the##4##6##(2007-2#1)(2008-1#1)(2008-2#1)(2008-3#1)
the angle of incidence of##7##5##(2007-2#1)(2008-1#1)(2008-2#3)(2008-3#2)
the angle of incidence with##4##5##(2008-2#2)(2008-3#2)
the angle of incidence##23##4##(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#10)(2008-3#8)
the angle of polarization##2##4##(2008-3#2)
the angle of reflection##3##4##(2007-12#1)(2008-2#2)
the angle of the##7##4##(2007-11#2)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2013-7#1)
the angle of total##3##4##(2008-2#1)(2008-3#2)
the angle of##47##3##(2006-8#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#16)(2008-3#15)(2010-12#1)(2013-7#2)
the angle range##2##3##(2008-3#2)
the angle##78##2##(1995-11#1)(1995-3#3)(1995-6#1)(2006-4#1)(2006-8#1)(2007-11#3)(2007-12#7)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-2#19)(2008-3#27)(2008-4#1)(2008-9#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
the angles between the##2##4##(2008-3#1)(2013-8#1)
the angles between##3##3##(2008-10#1)(2008-3#1)(2013-8#1)
the angles of##3##3##(2008-2#1)(2009-5#1)(2013-7#1)
the angles##7##2##(2008-10#1)(2008-2#1)(2008-3#2)(2009-5#1)(2013-7#1)(2013-8#1)
the angry##2##2##(1990-11#1)(2004-3#1)
the anguibactin##2##2##(1990-1#1)(2011-2#1)
the angular and the spectral selectivities##2##6##(2008-2#2)
the angular deflection##2##3##(2008-3#2)
the angular dependence of the##2##5##(2008-2#1)(2008-3#1)
the angular displacement of the##2##5##(1996-1#1)(2008-2#1)
the angular displacement##4##3##(1996-1#1)(2008-2#3)
the angular distribution of##7##4##(2007-11#2)(2008-2#4)(2008-3#1)
the angular distribution##10##3##(2007-11#3)(2007-12#1)(2008-2#4)(2008-3#2)
the angular frequency##2##3##(2008-2#1)(2008-3#1)
the angular range##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
the angular sensitivity of the##2##5##(2007-11#1)(2008-2#1)
the angular size of the##2##5##(2008-3#2)
the angular spectrum of##2##4##(2008-2#1)(2008-3#1)
the angular##66##2##(1995-5#1)(1996-1#1)(2007-11#6)(2007-12#5)(2007-6#1)(2007-8#1)(2008-10#2)(2008-2#21)(2008-3#25)(2008-6#1)(2008-7#1)(2009-4#1)
the anharmonic##2##2##(2009-12#1)(2010-2#1)
the anhydride##2##2##(1995-11#1)(2008-10#1)
the anhydrides were##2##3##(1993-11#1)(1995-11#1)
the anhydrides##4##2##(1993-11#3)(1995-11#1)
the anhydrous##3##2##(2008-10#2)(2010-5#1)
the aniline ring##2##3##(1991-4#2)
the aniline##4##2##(1991-4#2)(2008-10#2)
the animal and##6##3##(1991-3#1)(2004-11#1)(2007-2#1)(2009-6#1)(2011-1#1)(2013-8#1)
the animal can be easily handled and restrained##2##8##(2008-4#2)
the animal can##3##3##(2008-4#2)(2008-9#1)
the animal cap##5##3##(2008-5#5)
the animal feed##2##3##(2005-5#1)(2012-12#1)
the animal feeds##2##3##(2007-3#1)(2008-10#1)
the animal hemisphere of##2##4##(1993-6#2)
the animal in##3##3##(1993-2#1)(2005-10#1)(2008-4#1)
the animal industry##3##3##(2005-5#3)
the animal is##3##3##(1993-12#1)(2007-12#1)(2008-11#1)
the animal kingdom##9##3##(1990-12#1)(1990-8#1)(1991-8#1)(1992-7#1)(1996-12#1)(2007-12#3)(2009-8#1)
the animal model of##2##4##(2008-5#1)(2008-9#1)
the animal model##4##3##(2008-4#1)(2008-5#1)(2008-9#2)
the animal models of##3##4##(2008-3#1)(2008-7#1)(2009-12#1)
the animal models##7##3##(2007-11#2)(2008-3#1)(2008-7#1)(2009-12#1)(2010-4#1)(2010-6#1)
the animal showed##3##3##(2007-2#1)(2008-5#1)(2012-1#1)
the animal species##2##3##(2010-11#1)(2012-2#1)
the animal test species##2##4##(2010-11#2)
the animal to respond##2##4##(1995-8#1)(2008-4#1)
the animal to##8##3##(1992-10#1)(1992-12#1)(1995-8#1)(2007-5#1)(2008-4#1)(2008-5#1)(2010-3#1)(2012-12#1)
the animal##158##2##(1990-12#1)(1990-2#1)(1990-4#2)(1990-5#1)(1990-8#1)(1991-11#1)(1991-3#3)(1991-5#1)(1991-8#1)(1992-10#1)(1992-12#3)(1992-6#1)(1992-7#1)(1993-12#1)(1993-2#2)(1993-6#2)(1994-10#3)(1994-12#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-12#2)(1995-8#3)(1996-12#2)(1996-2#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-6#3)(1997-7#1)(2004-11#1)(2005-10#1)(2005-5#5)(2006-2#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#9)(2007-2#3)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#23)(2008-5#13)(2008-7#3)(2008-8#3)(2008-9#3)(2009-12#1)(2009-2#1)(2009-6#1)(2009-8#3)(2010-1#1)(2010-11#3)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#3)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
the animal's behavior##2##3##(2008-11#2)
the animal's head and##2##4##(1993-2#1)(1995-8#1)
the animal's##14##2##(1992-11#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-6#2)(1995-12#1)(1995-8#2)(1996-10#1)(2008-11#2)(2009-11#1)(2011-2#1)
the animal-sourced proteins##2##3##(2008-11#2)
the animals and##2##3##(2008-10#1)(2013-8#1)
the animals are##5##3##(1994-8#1)(2007-3#1)(2008-4#2)(2013-8#1)
the animals at##3##3##(1991-11#1)(1997-4#1)(2010-1#1)
the animals developed##2##3##(1997-2#1)(1997-7#1)
the animals exhibited##2##3##(1990-5#1)(2008-10#1)
the animals for##2##3##(1990-12#1)(1996-10#1)
the animals from##2##3##(1993-5#1)(2008-5#1)
the animals had been##2##4##(1990-11#1)(2008-12#1)
the animals had##6##3##(1990-11#1)(1990-5#1)(1993-12#1)(1997-8#1)(2008-12#1)(2008-4#1)
the animals in the##3##4##(1992-3#1)(1993-12#1)(1993-9#1)
the animals in##4##3##(1992-3#1)(1993-12#1)(1993-9#1)(2006-12#1)
the animals involved should be procured in good health##2##9##(2008-4#2)
the animals kept##2##3##(2008-7#2)
the animals received##5##3##(1993-12#1)(1993-3#1)(1995-12#1)(1996-1#1)(2004-9#1)
the animals showed##3##3##(1994-6#1)(1994-8#1)(1996-12#1)
the animals that received##2##4##(1995-5#2)
the animals that##6##3##(1995-5#2)(2006-12#1)(2008-11#1)(2008-7#1)(2010-7#1)
the animals to##2##3##(2012-1#1)(2013-1#1)
the animals treated with##3##4##(2011-2#2)(2013-8#1)
the animals treated##4##3##(1991-9#1)(2011-2#2)(2013-8#1)
the animals were allowed##2##4##(2009-3#2)
the animals were anaesthetized##3##4##(1995-9#1)(2008-4#1)(2011-2#1)
the animals were anesthetized##2##4##(2011-2#2)
the animals were evaluated##2##4##(1992-3#1)(1997-5#1)
the animals were given##2##4##(1995-9#2)
the animals were placed##2##4##(1993-4#1)(2010-2#1)
the animals were prepared for##2##5##(2007-9#1)(2008-7#1)
the animals were randomly divided into two groups##2##8##(2013-1#2)
the animals were sacrificed and##2##5##(2007-1#1)(2008-7#1)
the animals were sacrificed##5##4##(2007-1#1)(2008-7#1)(2011-2#1)(2013-1#2)
the animals were trained##2##4##(1994-5#1)(1994-6#1)
the animals were##45##3##(1991-1#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-2#1)(1993-4#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-9#4)(1996-1#1)(1996-12#1)(1997-5#1)(2006-7#1)(2007-1#2)(2007-3#1)(2007-9#2)(2008-12#1)(2008-4#2)(2008-7#4)(2009-3#2)(2009-4#1)(2010-2#2)(2010-8#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#4)
the animals which##2##3##(1990-3#1)(1996-12#1)
the animals with##5##3##(1991-1#2)(1991-11#2)(1993-2#1)
the animals##180##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-3#2)(1990-5#3)(1990-7#1)(1991-1#3)(1991-10#1)(1991-11#3)(1991-2#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-7#1)(1993-12#5)(1993-2#2)(1993-3#1)(1993-4#2)(1993-5#1)(1993-7#1)(1993-9#2)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#3)(1994-8#2)(1995-11#1)(1995-12#4)(1995-5#3)(1995-6#1)(1995-8#1)(1995-9#4)(1996-1#3)(1996-10#1)(1996-12#3)(1996-4#1)(1996-6#1)(1997-2#2)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#2)(2004-11#2)(2004-4#3)(2004-9#1)(2006-10#1)(2006-12#3)(2006-7#1)(2006-8#1)(2007-1#2)(2007-2#1)(2007-3#2)(2007-5#1)(2007-9#3)(2008-10#3)(2008-11#2)(2008-12#4)(2008-2#1)(2008-4#10)(2008-5#7)(2008-6#1)(2008-7#9)(2008-8#1)(2009-2#1)(2009-3#3)(2009-4#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#9)(2012-1#1)(2012-3#2)(2013-1#7)(2013-8#7)
the animals'##5##2##(1990-4#1)(1993-5#1)(1994-2#2)(1996-1#1)
the anion and cation##3##4##(2007-12#1)(2007-8#1)(2012-1#1)
the anion and##4##3##(1994-5#1)(2007-12#1)(2007-8#1)(2012-1#1)
the anion exchange##3##3##(2005-12#2)(2008-11#1)
the anion of the##2##4##(1991-10#1)(2010-5#1)
the anion of##5##3##(1991-10#1)(1996-5#1)(2006-10#1)(2008-10#1)(2010-5#1)
the anion##29##2##(1990-3#1)(1991-10#1)(1991-6#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-11#1)(1996-5#1)(2005-12#2)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-5#1)(2009-10#1)(2010-5#1)(2011-1#1)(2012-1#1)
the anion-binding exosite##4##3##(1990-7#1)(1991-6#3)
the anion-binding##5##2##(1990-7#1)(1991-6#3)(1995-1#1)
the anion-exchange selectivity##2##3##(2007-8#1)(2008-10#1)
the anion-exchange##7##2##(2007-8#1)(2008-10#6)
the anionic additive##3##3##(2008-10#3)
the anionic dye##2##3##(1990-3#1)(2008-10#1)
the anionic exchanger##2##3##(2008-10#2)
the anionic form of the##2##5##(2008-10#2)
the anionic form of##3##4##(1995-6#1)(2008-10#2)
the anionic form##4##3##(1995-6#1)(2008-10#2)(2009-6#1)
the anionic surfactant sodium##3##4##(2008-10#3)
the anionic surfactant##6##3##(2005-11#1)(2008-10#5)
the anionic##35##2##(1990-3#1)(1990-5#1)(1991-4#1)(1992-9#1)(1995-11#2)(1995-6#1)(1996-5#1)(1997-1#1)(2005-11#1)(2007-8#1)(2008-10#19)(2008-11#1)(2008-5#1)(2009-6#1)(2010-5#1)(2012-12#1)
the anions##11##2##(1990-5#1)(1995-5#1)(2005-11#1)(2008-10#6)(2010-4#1)(2010-5#1)
the anisotropic molecule dope method##2##5##(2008-3#2)
the anisotropic nonlocal response##2##4##(2007-12#2)
the anisotropic##21##2##(1992-1#1)(1995-5#1)(1997-8#1)(2006-12#1)(2007-12#3)(2008-2#4)(2008-3#8)(2009-5#1)(2010-4#1)
the anisotropies in##2##3##(1994-11#1)(2008-10#1)
the anisotropies##3##2##(1994-11#2)(2008-10#1)
the anisotropy factor##2##3##(2007-11#1)(2008-3#1)
the anisotropy of the##2##4##(2008-3#1)(2008-6#1)
the anisotropy of##6##3##(1997-1#1)(2008-10#1)(2008-3#2)(2008-6#1)(2009-11#1)
the anisotropy##19##2##(1991-5#1)(1997-1#1)(1997-3#2)(1997-8#2)(2007-11#2)(2008-10#2)(2008-2#1)(2008-3#6)(2008-6#1)(2009-11#1)
the ankle and foot##4##4##(2006-1#3)(2011-2#1)
the ankle and##13##3##(1995-8#1)(2006-1#3)(2006-4#2)(2008-4#2)(2009-11#1)(2011-2#3)(2012-1#1)
the ankle joint in##3##4##(1993-3#1)(2007-1#1)(2007-11#1)
the ankle joint##21##3##(1991-10#3)(1993-3#1)(2007-1#3)(2007-11#1)(2007-8#1)(2008-12#2)(2008-4#1)(2009-7#2)(2010-3#2)(2010-5#1)(2011-2#2)(2012-2#2)
the ankle were##2##3##(1991-4#1)(1992-2#1)
the ankle##71##2##(1991-10#4)(1991-4#1)(1992-2#1)(1993-11#1)(1993-3#2)(1995-11#1)(1995-12#2)(1995-8#1)(2006-1#3)(2006-10#1)(2006-4#3)(2007-1#5)(2007-11#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-12#3)(2008-4#4)(2008-8#2)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#2)(2010-3#3)(2010-4#2)(2010-5#1)(2011-2#7)(2012-1#2)(2012-2#8)(2012-3#1)(2013-1#3)
the ankle/foot complex##4##3##(2006-12#4)
the ankle/foot##7##2##(2006-12#7)
the ankyrin##2##2##(1991-7#1)(2008-8#1)
the ankyrin-binding domain##2##3##(1995-3#2)
the anlage of the##4##4##(1991-9#2)(1992-8#1)(1994-4#1)
the anlagen of the##2##4##(1995-11#1)(2011-2#1)
the annealing of the##2##4##(2008-5#1)(2009-5#1)
the annealing step##3##3##(1994-12#2)(2007-11#1)
the annealing##9##2##(1994-12#3)(2007-11#1)(2007-12#1)(2008-5#2)(2009-2#1)(2009-5#1)
the annexin repeat##2##3##(1990-7#2)
the annexin##12##2##(1990-7#2)(1993-4#1)(1993-8#1)(1993-9#1)(1994-3#2)(1995-11#2)(1995-8#1)(1997-6#1)(2008-11#1)
the annotation agreement across our team of annotators is high##2##10##(2013-1#2)
the annotation of the##4##4##(2007-11#1)(2008-4#1)(2008-7#1)(2008-9#1)
the annotation of##9##3##(2007-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-11#1)(2013-1#2)
the annotation##13##2##(2007-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-11#1)(2012-3#1)(2013-1#4)
the annotations##3##2##(2008-4#1)(2013-1#2)
the annual Saudi Urological##2##4##(2007-3#2)
the annual frequency##2##3##(1996-3#1)(1997-8#1)
the annual incidence##5##3##(1991-4#1)(1996-11#2)(2008-7#1)(2011-2#1)
the annual meeting of the##2##5##(2005-7#1)(2007-1#1)
the annual meeting##3##3##(2005-7#1)(2007-1#1)(2008-5#1)
the annual meetings of the##2##5##(2008-8#1)(2009-8#1)
the annual mortality rate##2##4##(1995-3#2)
the annual number of##2##4##(2011-2#2)
the annual precipitation##2##3##(2013-8#2)
the annual reports##2##3##(1990-4#1)(2012-12#1)
the annual values of suicide incidence##2##6##(2011-1#2)
the annual##73##2##(1990-12#1)(1990-4#1)(1991-4#1)(1991-6#2)(1992-2#4)(1992-3#1)(1993-12#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-8#1)(1995-9#1)(1996-11#2)(1996-3#1)(1996-6#2)(1997-8#1)(2005-7#3)(2006-10#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-3#2)(2007-5#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-10#3)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-12#3)(2012-2#1)(2012-5#1)(2013-8#5)
the annualized##2##2##(2007-8#2)
the annular##4##2##(1993-4#1)(2007-12#1)(2008-10#1)(2008-4#1)
the annulus and##2##3##(1996-6#1)(2006-8#1)
the annulus##14##2##(1996-6#3)(2006-10#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-8#3)(2008-5#1)(2008-9#1)(2011-2#1)
the anode and##2##3##(1996-5#1)(2012-12#1)
the anode surface##3##3##(2007-12#3)
the anode##13##2##(1996-5#1)(1997-8#2)(2007-11#1)(2007-12#3)(2007-9#1)(2008-10#2)(2010-4#2)(2012-12#1)
the anodic oxidation##2##3##(2008-10#2)
the anodic peak##5##3##(2007-8#1)(2008-10#4)
the anodic stripping voltammetric##2##4##(2008-10#2)
the anodic stripping##5##3##(2007-8#1)(2008-10#4)
the anodic##21##2##(1995-6#1)(2004-9#1)(2007-8#2)(2008-10#16)(2012-12#1)
the anodized##2##2##(2009-7#2)
the anogenital lesion##2##3##(2010-12#2)
the anogenital##4##2##(1994-1#1)(2010-12#2)(2011-1#1)
the anolyte##4##2##(2012-12#1)(2013-1#3)
the anomalies##8##2##(1991-9#1)(1993-5#1)(1996-12#1)(2008-5#1)(2010-1#1)(2012-3#1)(2013-1#2)
the anomalous coronary artery##2##4##(1991-3#1)(2007-8#1)
the anomalous diffraction approximation##2##4##(2008-2#1)(2008-3#1)
the anomalous diffraction##4##3##(2008-2#3)(2008-3#1)
the anomalous vein##2##3##(2007-8#2)
the anomalous##20##2##(1991-3#1)(1996-4#1)(2005-11#1)(2006-4#1)(2007-11#1)(2007-8#4)(2007-9#1)(2008-2#5)(2008-3#1)(2008-7#2)(2010-1#1)(2012-3#1)
the anomaly zone##3##3##(2010-6#3)
the anomaly##7##2##(2006-10#1)(2007-12#1)(2008-11#1)(2009-9#1)(2010-6#3)
the anomeric configuration##2##3##(1991-9#1)(1992-3#1)
the anomeric preference of##2##4##(1991-10#2)
the anomeric preference##3##3##(1990-11#1)(1991-10#2)
the anomeric##7##2##(1990-11#1)(1991-10#2)(1991-9#2)(1992-3#1)(2007-11#1)
the anorectal##6##2##(1991-12#1)(1994-4#1)(2006-11#1)(2007-11#3)
the anorectum##2##2##(2010-5#1)(2012-12#1)
the anorexia##2##2##(1996-2#1)(2006-10#1)
the anoxia-induced increase in mEPSC frequency##2##6##(1994-2#1)(1997-5#1)
the anoxic##4##2##(1993-12#2)(2005-12#1)(2007-5#1)
the answer is##3##3##(2007-8#1)(2009-4#1)(2012-2#1)
the answer to##8##3##(1991-11#1)(1992-11#1)(1993-5#1)(1996-8#1)(1997-3#1)(2006-9#1)(2007-4#2)
the answer##25##2##(1991-11#1)(1992-11#1)(1993-5#1)(1994-11#1)(1994-12#2)(1995-1#1)(1996-8#2)(1997-3#1)(2006-12#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-4#2)(2007-8#1)(2008-10#1)(2008-8#1)(2009-12#1)(2009-4#1)(2012-2#3)(2012-3#1)
the answers##9##2##(1990-5#1)(1994-1#1)(1996-2#1)(1996-3#1)(1996-9#1)(2008-9#1)(2009-5#1)(2012-2#1)(2013-1#1)
the ant sex ratio##2##4##(2008-8#2)
the ant##8##2##(2007-12#3)(2008-5#1)(2008-6#1)(2008-8#3)
the ant's##2##2##(2007-12#1)(2012-3#1)
the antagonism of##3##3##(1990-2#1)(1992-10#1)(2008-10#1)
the antagonism##8##2##(1990-2#1)(1991-12#1)(1991-9#1)(1992-10#1)(2007-12#1)(2008-10#2)(2008-8#1)
the antagonist and the pathogen##2##5##(2008-10#2)
the antagonist and the##3##4##(1996-12#1)(2008-10#2)
the antagonist and##6##3##(1996-12#1)(2008-10#4)(2008-7#1)
the antagonist effects of naloxonazine were##2##6##(1996-2#2)
the antagonist effects of naloxonazine##3##5##(1996-2#3)
the antagonist on##2##3##(2008-10#2)
the antagonist was##2##3##(2008-10#1)(2011-2#1)
the antagonist##45##2##(1990-7#1)(1991-3#1)(1992-6#1)(1993-2#1)(1994-10#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#3)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#26)(2008-4#1)(2008-7#1)(2011-2#1)
the antagonist's##2##2##(1995-11#1)(2008-10#1)
the antagonistic Fusarium oxysporum##2##4##(2008-10#1)(2008-4#1)
the antagonistic activity of##2##4##(2008-10#1)(2008-12#1)
the antagonistic effect of##2##4##(1991-12#1)(2008-4#1)
the antagonistic effect##3##3##(1991-12#1)(2008-4#1)(2012-12#1)
the antagonistic effects of##3##4##(1994-2#1)(1996-12#1)(2008-12#1)
the antagonistic process##2##3##(2008-10#2)
the antagonistic##24##2##(1991-12#1)(1991-7#1)(1994-2#1)(1996-12#1)(2007-12#2)(2008-10#10)(2008-12#2)(2008-4#2)(2008-8#1)(2008-9#1)(2010-3#1)(2012-12#1)
the antagonists of##2##3##(2008-8#1)(2010-9#1)
the antagonists were##2##3##(1995-7#1)(2008-10#1)
the antagonists##13##2##(1990-11#3)(1993-9#1)(1994-6#1)(1995-11#1)(1995-7#1)(1996-6#1)(2007-7#1)(2008-10#1)(2008-8#2)(2010-9#1)
the antecedent##8##2##(1994-9#1)(2007-3#1)(2007-8#2)(2008-2#2)(2010-12#1)(2012-1#1)
the antecedents and consequences of binge eating##2##7##(2007-7#2)
the antecedents and consequences of##3##5##(2007-7#2)(2008-11#1)
the antecedents and consequences##4##4##(2007-7#3)(2008-11#1)
the antecedents of##2##3##(1996-3#1)(2006-8#1)
the antecedents##6##2##(1996-3#1)(2006-8#1)(2007-7#3)(2008-11#1)
the antegrade##2##2##(1991-3#1)(2007-8#1)
the antemortem##2##2##(1996-6#1)(2010-2#1)
the antenatal clinic##2##3##(2012-2#1)(2013-1#1)
the antenatal##13##2##(2004-10#1)(2007-2#2)(2007-7#2)(2008-1#3)(2008-11#1)(2009-2#1)(2012-2#2)(2013-1#1)
the antenna base##2##3##(2007-12#2)
the antenna elements##2##3##(2007-12#1)(2008-3#1)
the antenna is##5##3##(2007-12#3)(2008-2#1)(2008-3#1)
the antenna of the grasshopper Schistocerca gregaria##3##7##(2007-12#3)
the antenna of the##4##4##(2007-12#3)(2008-10#1)
the antenna of##6##3##(1994-5#1)(2007-12#4)(2008-10#1)
the antenna##36##2##(1991-7#1)(1993-11#1)(1994-5#1)(1995-6#1)(2007-12#22)(2008-10#1)(2008-2#5)(2008-3#3)(2008-5#1)
the antennae##3##2##(2007-12#3)
the antennal glands##3##3##(2007-12#3)
the antennal lobe and##2##4##(2007-12#2)
the antennal lobe##15##3##(1997-6#2)(2007-12#13)
the antennal lobes##2##3##(1992-5#1)(2007-12#1)
the antennal##27##2##(1992-5#1)(1997-6#2)(2007-12#23)(2008-7#1)
the antennular##2##2##(2007-12#2)
the anterior DNLL##2##3##(1996-9#2)
the anterior abdominal wall##5##4##(1991-1#2)(2011-2#1)(2012-12#1)(2013-8#1)
the anterior abdominal##7##3##(1991-1#2)(2006-10#1)(2011-2#1)(2012-12#1)(2013-8#2)
the anterior and lateral walls##2##5##(2008-7#2)
the anterior and lateral##4##4##(2007-11#1)(2008-7#3)
the anterior and posterior##18##4##(1993-12#1)(1995-12#1)(1995-2#1)(1995-7#1)(1997-2#1)(1997-3#1)(2003-11#1)(2006-11#1)(2007-11#1)(2007-7#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
the anterior and##29##3##(1991-8#1)(1992-12#1)(1993-12#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-7#1)(1996-4#1)(1997-2#1)(1997-3#1)(2003-11#1)(2006-11#1)(2006-7#1)(2007-11#2)(2007-7#1)(2008-7#4)(2008-8#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
the anterior approach##18##3##(2006-8#5)(2007-11#8)(2007-7#4)(2008-8#1)
the anterior arch of C-1##2##5##(2006-9#2)
the anterior arch##3##3##(2006-9#3)
the anterior aspect of the##5##5##(1994-12#1)(2006-4#1)(2008-10#1)(2009-3#2)
the anterior aspect of##6##4##(1994-12#1)(2006-4#1)(2006-7#1)(2008-10#1)(2009-3#2)
the anterior border of the Fl1-Fl6 flagellomeres##2##7##(2007-12#2)
the anterior cerebral artery##6##4##(1994-4#1)(1997-3#1)(1997-6#1)(2006-11#1)(2007-10#1)(2008-7#1)
the anterior cerebral##9##3##(1994-4#1)(1997-3#1)(1997-6#1)(2006-11#1)(2007-10#1)(2008-7#2)(2008-9#1)(2012-12#1)
the anterior cervical##2##3##(2006-10#1)(2006-6#1)
the anterior chamber##8##3##(1991-5#1)(1992-8#1)(1995-7#1)(2008-5#1)(2009-8#1)(2011-2#3)
the anterior chest wall is##2##5##(2006-4#1)(2007-8#1)
the anterior cingulate cortex##12##4##(1994-3#1)(1994-6#1)(1996-9#1)(2008-4#7)(2009-10#1)(2011-2#1)
the anterior cingulate##16##3##(1994-3#3)(1994-6#1)(1996-9#1)(2008-4#7)(2009-10#1)(2009-2#1)(2011-2#1)(2012-12#1)
the anterior clinoid##2##3##(2006-12#1)(2011-2#1)
the anterior commissure##3##3##(1991-4#1)(1997-3#1)(2013-7#1)
the anterior communicating artery##2##4##(2008-7#2)
the anterior compartment of the##2##5##(2007-8#1)(2008-6#1)
the anterior compartment##3##3##(2007-8#1)(2008-6#2)
the anterior cranial base##3##4##(2011-2#2)(2012-12#1)
the anterior cruciate ligament (ACL)##5##5##(2007-4#1)(2007-8#1)(2008-4#1)(2013-1#2)
the anterior cruciate ligament of the knee##2##7##(2013-1#2)
the anterior cruciate ligament##22##4##(1996-11#1)(2006-6#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#8)(2008-4#2)(2009-1#1)(2009-9#1)(2013-1#5)
the anterior cruciate##23##3##(1996-11#1)(2006-3#1)(2006-6#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#8)(2008-4#2)(2009-1#1)(2009-9#1)(2013-1#5)
the anterior descending branch of the left coronary artery##2##9##(1991-9#1)(2008-4#1)
the anterior end##3##3##(1995-8#1)(2007-12#2)
the anterior fontanelle##2##3##(2008-5#1)(2011-1#1)
the anterior half of the##2##5##(2007-12#1)(2008-7#1)
the anterior half##3##3##(1996-8#1)(2007-12#1)(2008-7#1)
the anterior horn##4##3##(1990-9#1)(1995-6#1)(2008-7#1)(2011-1#1)
the anterior horns##2##3##(2008-7#1)(2009-3#1)
the anterior hypothalamic-preoptic area##2##4##(1994-8#2)
the anterior hypothalamus (AH)##2##4##(1991-8#1)(1994-10#1)
the anterior hypothalamus##7##3##(1991-8#2)(1994-10#1)(1995-11#2)(1997-5#1)(2008-9#1)
the anterior inferior cerebellar artery##2##5##(2006-11#1)(2007-9#1)
the anterior inferior##3##3##(2006-11#2)(2007-9#1)
the anterior knee##2##3##(2007-6#1)(2013-1#1)
the anterior lateral##4##3##(1995-5#1)(2006-5#1)(2007-7#1)(2012-12#1)
the anterior lobe of the##2##5##(1990-2#1)(1996-5#1)
the anterior lobe##8##3##(1990-2#1)(1991-5#1)(1992-9#3)(1995-11#2)(1996-5#1)
the anterior longitudinal ligament##3##4##(2006-8#1)(2007-4#1)(2008-12#1)
the anterior mandible##2##3##(2010-10#1)(2013-1#1)
the anterior maxilla##8##3##(2007-12#2)(2008-5#2)(2009-8#2)(2012-2#1)(2013-1#1)
the anterior mediastinum##4##3##(2007-8#2)(2008-7#2)
the anterior mesenteron##2##3##(2008-7#2)
the anterior mitral leaflet##2##4##(2007-8#1)(2008-10#1)
the anterior of##3##3##(1993-12#1)(2007-11#1)(2007-12#1)
the anterior olfactory nucleus##2##4##(1993-12#1)(1995-5#1)
the anterior or##3##3##(2005-5#1)(2007-9#1)(2008-3#1)
the anterior part of the##9##5##(1994-2#1)(1996-2#1)(1996-6#2)(2008-5#1)(2010-12#1)(2010-5#1)(2012-2#1)(2013-7#1)
the anterior part##10##3##(1994-2#1)(1996-2#1)(1996-6#2)(2008-5#1)(2009-4#1)(2010-12#1)(2010-5#1)(2012-2#1)(2013-7#1)
the anterior pelvic##4##3##(1990-12#1)(2008-6#3)
the anterior pituitary gland##5##4##(1992-11#1)(1996-11#1)(1997-2#2)(2008-1#1)
the anterior pituitary##21##3##(1990-10#1)(1990-4#1)(1992-10#1)(1992-11#1)(1993-5#2)(1994-6#1)(1995-10#1)(1995-12#1)(1996-11#2)(1997-2#4)(2006-9#1)(2007-11#1)(2008-1#1)(2008-5#2)(2010-2#1)
the anterior pole of the##3##5##(1994-12#1)(2007-12#1)(2008-12#1)
the anterior pole##6##3##(1991-11#1)(1994-12#1)(2007-12#3)(2008-12#1)
the anterior portion of the##3##5##(1991-8#1)(2006-12#1)(2009-1#1)
the anterior portion of##4##4##(1991-8#1)(2006-12#1)(2008-4#1)(2009-1#1)
the anterior region of the##6##5##(2008-7#1)(2009-1#2)(2010-2#1)(2013-1#2)
the anterior region of##7##4##(2007-12#1)(2008-7#1)(2009-1#2)(2010-2#1)(2013-1#2)
the anterior region##8##3##(2007-12#1)(2008-5#1)(2008-7#1)(2009-1#2)(2010-2#1)(2013-1#2)
the anterior segment of the eye##3##6##(2010-1#1)(2011-7#2)
the anterior segment of the##4##5##(2010-1#1)(2011-7#3)
the anterior segment##7##3##(2007-3#1)(2010-1#1)(2010-12#1)(2010-9#1)(2011-7#3)
the anterior side##2##3##(1997-8#1)(2013-2#1)
the anterior spinal canal##3##4##(2006-8#3)
the anterior spinal column##2##4##(1997-8#1)(2007-7#1)
the anterior spinal##8##3##(1997-6#1)(1997-8#1)(2006-8#3)(2007-7#2)(2007-9#1)
the anterior spiracular glands of##2##5##(1994-3#2)
the anterior spiracular glands##5##4##(1994-3#5)
the anterior spiracular##6##3##(1994-3#6)
the anterior surface of the##2##5##(1996-9#1)(2007-12#1)
the anterior surface of##3##4##(1996-9#1)(2007-12#1)(2012-2#1)
the anterior teeth##3##3##(2004-3#1)(2012-12#1)(2013-7#1)
the anterior temporal##3##3##(2006-12#1)(2009-4#2)
the anterior thigh##2##3##(2008-6#1)(2011-2#1)
the anterior vagina##2##3##(2007-12#2)
the anterior wall of the maxillary sinus##4##7##(2011-1#1)(2011-7#1)(2012-12#2)
the anterior wall of the rectum and##2##7##(2011-2#1)(2012-12#1)
the anterior wall of the third ventricle##2##7##(1997-8#2)
the anterior wall of the##13##5##(1997-8#2)(2006-12#2)(2007-8#2)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#3)
the anterior wall of##14##4##(1997-8#2)(2006-12#2)(2007-8#2)(2011-1#1)(2011-2#3)(2011-7#1)(2012-12#3)
the anterior wall##15##3##(1997-8#2)(2006-12#2)(2007-8#2)(2008-10#1)(2011-1#1)(2011-2#3)(2011-7#1)(2012-12#3)
the anterior wedge index##2##4##(2008-5#2)
the anterior##434##2##(1990-10#3)(1990-12#1)(1990-2#1)(1990-4#2)(1990-9#2)(1991-1#2)(1991-11#3)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#5)(1991-9#1)(1992-10#3)(1992-11#2)(1992-12#1)(1992-5#1)(1992-7#1)(1992-8#2)(1992-9#3)(1993-12#4)(1993-2#1)(1993-5#2)(1994-10#1)(1994-12#3)(1994-2#1)(1994-3#9)(1994-4#1)(1994-6#2)(1994-8#2)(1995-10#1)(1995-11#5)(1995-12#2)(1995-2#1)(1995-5#3)(1995-6#1)(1995-7#2)(1995-8#3)(1996-11#3)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#7)(1997-2#6)(1997-3#3)(1997-5#1)(1997-6#2)(1997-8#5)(2003-11#1)(2004-3#2)(2005-5#2)(2005-9#3)(2006-10#2)(2006-11#5)(2006-12#9)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#2)(2006-6#2)(2006-7#3)(2006-8#12)(2006-9#6)(2007-1#1)(2007-10#4)(2007-11#13)(2007-12#26)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#12)(2007-8#17)(2007-9#4)(2008-1#1)(2008-10#8)(2008-12#5)(2008-2#2)(2008-3#2)(2008-4#12)(2008-5#13)(2008-6#9)(2008-7#18)(2008-8#5)(2008-9#2)(2009-1#4)(2009-10#1)(2009-2#4)(2009-3#4)(2009-4#3)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#14)(2011-7#4)(2012-1#1)(2012-12#16)(2012-2#7)(2013-1#13)(2013-2#1)(2013-7#5)(2013-8#2)
the anterior-posterior and right-left directions##2##5##(2007-1#2)
the anterior-posterior and##3##3##(2006-11#1)(2007-1#2)
the anterior-posterior##6##2##(1993-2#1)(2006-11#1)(2007-1#2)(2007-3#1)(2008-5#1)
the antero-lateral submandibular##2##3##(2007-11#2)
the antero-lateral##4##2##(2007-11#3)(2007-8#1)
the antero-posterior##4##2##(1997-4#1)(2007-8#1)(2010-12#2)
the anterograde direction##2##3##(1996-2#1)(2012-12#1)
the anterograde tracer Phaseolus##2##4##(1993-12#1)(1995-5#1)
the anterograde tracer##3##3##(1993-12#1)(1995-5#1)(1996-9#1)
the anterograde##9##2##(1991-9#1)(1993-12#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-9#1)(2012-12#1)(2013-1#1)
the anterolateral approach##4##3##(2011-2#2)(2012-3#2)
the anterolateral##10##2##(1997-1#1)(2006-7#3)(2007-8#1)(2011-2#2)(2012-3#2)(2013-8#1)
the anteromedial##5##2##(1992-10#1)(1995-11#1)(2006-12#1)(2013-1#1)(2013-8#1)
the anteroposterior##4##2##(2007-4#2)(2008-10#2)
the anteroventral##8##2##(1991-8#1)(1992-7#2)(1992-8#2)(1993-11#2)(1995-5#1)
the anthelmintic##2##2##(2005-7#1)(2011-1#1)
the anther##4##2##(2008-8#2)(2013-7#2)
the anthracnose pathogen Colletotrichum##2##4##(2008-10#2)
the anthropogenic##4##2##(2007-9#1)(2008-10#1)(2008-11#2)
the anthropometric##5##2##(2006-11#1)(2006-6#1)(2007-7#1)(2011-1#2)
the anthropometry of the##2##4##(2006-11#1)(2007-4#1)
the anthropometry of##3##3##(2006-11#1)(2007-4#2)
the anti conformation##4##3##(1993-11#1)(1994-8#1)(1995-1#1)(2007-11#1)
the anti##10##2##(1990-11#1)(1990-8#1)(1993-11#1)(1994-8#1)(1995-1#1)(1997-8#1)(2006-4#1)(2007-11#1)(2008-3#1)(2010-2#1)
the anti-FLAG##3##2##(1997-3#3)
the anti-Gi2alpha##2##2##(1996-5#2)
the anti-HIV activity of##4##4##(1991-7#2)(1991-8#1)(2008-4#1)
the anti-HIV##6##2##(1990-10#1)(1991-3#1)(1991-7#2)(1991-8#1)(2008-4#1)
the anti-IL-6##2##2##(2008-10#2)
the anti-Stokes##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
the anti-TNP antibody##3##3##(2008-10#3)
the anti-aging##3##2##(1990-3#1)(2008-5#1)(2010-2#1)
the anti-alpha-NE##2##2##(1996-5#2)
the anti-angiogenic agents and##2##4##(1995-5#2)
the anti-angiogenic agents##6##3##(1995-5#6)
the anti-angiogenic##8##2##(1993-4#1)(1995-5#6)(2008-11#1)
the anti-apoptotic gene##2##3##(2008-11#1)(2010-1#1)
the anti-apoptotic##9##2##(2008-11#4)(2010-1#1)(2010-12#1)(2012-12#2)(2013-1#1)
the anti-atherogenic potential of losartan##2##5##(2011-2#2)
the anti-atherosclerotic##2##2##(1991-11#1)(2008-1#1)
the anti-cancer##3##2##(1996-5#1)(2009-3#1)(2009-9#1)
the anti-estrogens##2##2##(2008-2#1)(2008-5#1)
the anti-gluconeogenic##2##2##(1994-8#2)
the anti-histamine antibody##4##3##(2007-8#4)
the anti-hypertensive##2##2##(2008-10#1)(2008-7#1)
the anti-idiotypic##3##2##(1991-12#3)
the anti-immobility effects of##2##4##(1990-5#1)(1996-12#1)
the anti-inflammatory actions of##3##4##(1993-4#2)(2011-2#1)
the anti-inflammatory activity of##3##4##(1990-3#1)(2007-1#1)(2008-10#1)
the anti-inflammatory and##2##3##(1990-5#1)(2006-10#1)
the anti-inflammatory drug##4##3##(2008-10#3)(2009-11#1)
the anti-inflammatory effect of##4##4##(1995-7#1)(2006-12#1)(2008-10#1)(2012-11#1)
the anti-inflammatory properties of HDL##2##5##(2008-5#2)
the anti-inflammatory properties of##3##4##(2008-5#2)(2012-2#1)
the anti-inflammatory##30##2##(1990-3#1)(1990-5#1)(1990-6#1)(1993-4#2)(1995-7#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-1#1)(2008-10#7)(2008-2#1)(2008-5#2)(2009-1#1)(2009-11#1)(2010-1#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
the anti-microbial##2##2##(2008-10#1)(2008-2#1)
the anti-neoplastic effects of##2##4##(2008-4#2)
the anti-oxidant##3##2##(2005-7#1)(2008-10#1)(2008-5#1)
the anti-oxidative##2##2##(2005-7#1)(2008-10#1)
the anti-proliferative effect##2##3##(1995-5#1)(2009-9#1)
the anti-proliferative effects of##4##4##(2008-10#1)(2009-3#2)(2013-1#1)
the anti-proliferative##7##2##(1995-5#1)(2008-10#2)(2009-3#2)(2009-9#1)(2013-1#1)
the anti-rheumatic##2##2##(1993-12#2)
the anti-sense##6##2##(1991-12#1)(1992-7#2)(1994-12#1)(1995-2#1)(1996-4#1)
the anti-sigma##2##2##(1992-4#1)(2009-8#1)
the anti-subunit antibodies##2##3##(1997-7#2)
the anti-synthetase syndrome##2##3##(2006-10#2)
the anti-tumor activity of##5##4##(1993-7#1)(1994-11#1)(1995-5#1)(2007-3#1)(2009-3#1)
the anti-tumor and##2##3##(1992-7#1)(2008-10#1)
the anti-tumor effect of##2##4##(1992-9#1)(2010-11#1)
the anti-tumor##12##2##(1992-7#1)(1992-9#1)(1993-7#1)(1993-9#1)(1994-11#1)(1995-5#1)(1996-6#1)(2007-3#1)(2008-10#1)(2008-11#1)(2009-3#1)(2010-11#1)
the anti-tumour##3##2##(2007-11#2)(2009-7#1)
the antiadipogenic effect of retinol##2##5##(2008-5#2)
the antiaggregating drug picotamide##2##4##(2008-7#2)
the antiangiogenic##3##2##(1994-12#1)(1996-10#1)(2006-11#1)
the antiapoptotic##3##2##(2008-2#2)(2013-1#1)
the antiarrhythmic##4##2##(1990-5#1)(1994-3#1)(2004-11#2)
the antibacterial activity of the##2##5##(2008-3#1)(2011-2#1)
the antibacterial activity of##5##4##(1994-8#1)(2008-3#1)(2010-11#1)(2010-5#1)(2011-2#1)
the antibacterial activity##8##3##(1993-4#1)(1994-8#1)(2008-2#1)(2008-3#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-2#1)
the antibacterial properties##3##3##(2008-5#2)(2009-5#1)
the antibacterial##25##2##(1990-6#1)(1993-4#1)(1994-8#1)(1996-8#1)(2006-12#2)(2007-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#5)(2009-1#1)(2009-5#1)(2010-11#2)(2010-5#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-11#1)
the antibiogram##3##2##(2013-1#3)
the antibiotic 2##6##3##(2008-10#6)
the antibiotic chloramphenicol##2##3##(2008-10#2)
the antibiotic drug##2##3##(1990-2#1)(2007-10#1)
the antibiotic susceptibility##4##3##(1992-10#1)(2005-8#1)(2009-5#1)(2013-8#1)
the antibiotic treatment##2##3##(1990-2#1)(2008-10#1)
the antibiotic##62##2##(1990-2#2)(1991-11#1)(1991-12#2)(1991-2#1)(1992-10#1)(1992-12#3)(1993-12#1)(1993-2#1)(1993-5#1)(1994-5#1)(1994-6#2)(1995-6#1)(1996-12#1)(1996-3#1)(1997-2#4)(2005-8#2)(2006-12#1)(2006-8#1)(2007-10#1)(2007-7#3)(2007-8#1)(2008-10#12)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#4)
the antibiotics produced by the##2##5##(2008-10#2)
the antibiotics##17##2##(1991-1#1)(2006-10#2)(2006-8#1)(2008-10#5)(2009-8#1)(2010-8#1)(2012-12#2)(2012-3#1)(2013-8#3)
the antibodies against palmitoyl-CoA ligase inhibited##2##6##(1993-9#2)
the antibodies against##7##3##(1990-8#1)(1993-9#2)(2008-4#3)(2008-8#1)
the antibodies and##6##3##(1997-2#1)(1997-5#1)(2008-10#2)(2008-4#1)(2008-7#1)
the antibodies as##2##3##(2006-12#1)(2008-10#1)
the antibodies in##2##3##(1991-7#1)(1996-10#1)
the antibodies of all cloned enzymes tested##2##7##(2006-8#2)
the antibodies of##4##3##(2006-8#4)
the antibodies to##3##3##(1992-11#1)(1995-10#1)(2007-8#1)
the antibodies were##3##3##(1993-8#1)(1995-10#1)(2008-9#1)
the antibodies##67##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-5#1)(1993-2#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-10#2)(1995-11#2)(1995-3#2)(1995-6#1)(1996-10#1)(1996-11#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#2)(2005-11#2)(2006-12#1)(2006-8#4)(2007-8#3)(2008-1#1)(2008-10#8)(2008-4#5)(2008-7#1)(2008-8#4)(2008-9#1)(2009-2#1)(2009-6#1)(2011-2#1)
the antibody against##4##3##(1992-12#1)(1992-3#2)(1997-8#1)
the antibody and##4##3##(1993-9#1)(1997-4#1)(2008-10#1)(2009-3#1)
the antibody concentration##3##3##(1995-4#1)(2008-10#1)(2008-11#1)
the antibody directs the##2##4##(2008-5#1)(2009-8#1)
the antibody for##4##3##(1990-7#1)(1995-8#1)(2008-10#1)(2008-4#1)
the antibody in the##4##4##(1992-8#1)(2008-7#3)
the antibody in##6##3##(1992-8#1)(1993-7#1)(2008-7#3)(2010-4#1)
the antibody is##7##3##(1992-11#1)(1994-3#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)
the antibody levels##2##3##(2007-8#1)(2013-1#1)
the antibody on the sensor##3##5##(1997-2#1)(2008-10#2)
the antibody on##4##3##(1990-2#1)(1997-2#1)(2008-10#2)
the antibody or##3##3##(1992-8#2)(2008-4#1)
the antibody production##2##3##(1992-12#2)
the antibody response to##2##4##(1994-5#1)(2008-10#1)
the antibody response##7##3##(1991-3#1)(1994-5#1)(2008-10#4)(2008-4#1)
the antibody responses##2##3##(2008-4#1)(2012-12#1)
the antibody titers##2##3##(1995-5#1)(1997-7#1)
the antibody to the##2##4##(1990-3#1)(1991-2#1)
the antibody to##6##3##(1990-3#1)(1991-2#1)(1991-5#1)(1994-12#1)(2005-10#1)(2007-11#1)
the antibody was##10##3##(1991-1#1)(1991-5#1)(1996-1#1)(1996-5#1)(1997-2#1)(1997-5#1)(2008-10#2)(2008-4#1)(2012-12#1)
the antibody were##4##3##(1991-5#1)(2005-8#1)(2008-10#1)(2008-8#1)
the antibody with##2##3##(2008-10#2)
the antibody##142##2##(1990-10#1)(1990-2#2)(1990-3#1)(1990-4#2)(1990-7#3)(1991-1#1)(1991-2#1)(1991-3#1)(1991-5#4)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#3)(1993-4#2)(1993-7#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-2#4)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#17)(2008-11#6)(2008-4#9)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#4)(2009-3#1)(2009-4#1)(2009-8#1)(2010-4#2)(2011-1#1)(2012-12#3)(2012-2#1)(2013-1#4)(2013-8#1)
the antibody-antigen interaction is destabilized by brief exposure to##2##9##(2008-4#2)
the antibody-antigen##5##2##(2008-4#5)
the anticancer PG##2##3##(2008-11#2)
the anticancer activity of##2##4##(2008-5#1)(2009-4#1)
the anticancer activity##3##3##(2008-5#1)(2009-12#1)(2009-4#1)
the anticancer alkaloids##2##3##(2009-8#2)
the anticancer benefits##2##3##(2009-12#2)
the anticancer drug cis-diamminedichloroplatinum (II)##2##5##(1994-10#2)
the anticancer drug##9##3##(1990-7#1)(1994-10#2)(1994-3#1)(1996-5#1)(2005-11#1)(2008-10#1)(2008-7#2)
the anticancer##23##2##(1990-7#1)(1994-10#2)(1994-3#1)(1996-5#1)(2005-11#1)(2007-1#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#2)(2009-12#3)(2009-4#1)(2009-8#2)(2009-9#1)(2012-11#1)(2012-12#1)
the anticholinergic##2##2##(2008-11#1)(2008-3#1)
the anticipated##23##2##(1992-3#1)(1993-10#1)(1993-12#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(2006-10#1)(2006-9#1)(2007-2#2)(2007-5#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-7#2)(2009-12#1)(2009-9#1)(2012-2#1)(2012-3#1)
the anticipation of##3##3##(2009-7#1)(2010-8#1)(2011-2#1)
the anticipation##5##2##(2007-11#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-1#1)
the anticoagulant activity of warfarin##3##5##(1990-12#3)
the anticoagulant effect##3##3##(2008-10#2)(2009-8#1)
the anticoagulant##17##2##(1990-12#3)(1990-5#1)(1995-4#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-7#1)(2008-10#4)(2009-11#1)(2009-8#1)(2010-7#1)(2012-11#1)
the anticodon loop##3##3##(1992-7#1)(1992-9#1)(1997-3#1)
the anticodon##14##2##(1991-4#2)(1992-12#1)(1992-7#2)(1992-9#3)(1995-2#1)(1995-3#1)(1996-4#1)(1997-3#1)(2006-11#1)(2008-4#1)
the anticonvulsant activity of##2##4##(1992-3#1)(1995-12#1)
the anticonvulsant activity##3##3##(1992-3#1)(1995-12#1)(2010-12#1)
the anticonvulsant drug##3##3##(1994-8#1)(1995-7#1)(2010-12#1)
the anticonvulsant effect of##4##4##(1990-5#1)(1992-3#1)(1995-7#1)(2010-3#1)
the anticonvulsant effects of##3##4##(1993-4#1)(1994-2#1)(1995-12#1)
the anticonvulsant effects##4##3##(1990-5#1)(1993-4#1)(1994-2#1)(1995-12#1)
the anticonvulsant##22##2##(1990-5#2)(1991-3#1)(1992-3#2)(1993-4#1)(1994-2#2)(1994-8#3)(1995-12#3)(1995-7#3)(2008-3#1)(2008-5#1)(2010-12#2)(2010-3#1)
the anticonvulsive action of phenobarbital##2##5##(1997-5#2)
the anticonvulsive activity of##2##4##(1993-11#1)(1997-5#1)
the anticonvulsive##5##2##(1993-11#1)(1997-5#4)
the antidandruff climbazole##2##3##(2008-5#2)
the antidandruff##3##2##(2008-10#1)(2008-5#2)
the antidepressant activity##2##3##(2010-12#2)
the antidepressant drug##4##3##(2008-10#2)(2008-6#2)
the antidepressant##16##2##(1990-2#1)(1993-2#1)(1996-12#1)(2004-3#1)(2005-7#1)(2008-10#4)(2008-6#3)(2010-12#2)(2011-2#1)(2012-12#1)
the antidepressant-like effects of##2##4##(1990-2#1)(1996-12#1)
the antidepressant-like##3##2##(1990-2#1)(1996-12#2)
the antidepressants##5##2##(2008-11#1)(2008-9#1)(2010-5#2)(2013-8#1)
the antidiabetic effects of##2##4##(2008-11#1)(2009-8#1)
the antidiabetic##3##2##(2008-11#2)(2009-8#1)
the antidipsotropic activity of the##2##5##(1996-4#2)
the antidiuretic hormone arginine vasopressin##2##5##(1997-3#1)(2008-8#1)
the antidote##3##2##(1990-6#2)(1991-11#1)
the antielectroshock##2##2##(1993-11#2)
the antiemetic efficacy of##2##4##(2008-7#1)(2010-12#1)
the antiemetic##4##2##(1991-11#1)(2006-10#1)(2008-7#1)(2010-12#1)
the antiepileptic drug##3##3##(1991-3#1)(1996-8#2)
the antiepileptic##6##2##(1991-3#1)(1993-11#1)(1996-8#2)(2008-6#1)(2013-1#1)
the antiestrogen binding site##4##4##(1990-2#4)
the antiestrogen binding##5##3##(1990-2#4)(2008-11#1)
the antiestrogen tamoxifen (TAM)##2##4##(1993-1#1)(1995-10#1)
the antiestrogen tamoxifen##4##3##(1990-2#1)(1993-1#1)(1995-10#1)(2007-11#1)
the antiestrogen##13##2##(1990-2#5)(1991-1#1)(1993-1#1)(1995-10#1)(1996-11#2)(2007-11#1)(2008-11#2)
the antiestrogenic activity of##2##4##(1991-3#1)(2007-11#1)
the antiestrogenic##3##2##(1991-3#1)(2007-11#1)(2008-7#1)
the antiferromagnetic##3##2##(2008-5#1)(2010-5#1)(2012-2#1)
the antifolate##3##2##(1993-12#1)(1994-11#2)
the antifouling agent##2##3##(2008-10#2)
the antifouling##4##2##(2008-10#2)(2008-11#2)
the antifreeze##2##2##(1994-9#2)
the antifungal activities##2##3##(2008-10#1)(2013-1#1)
the antifungal activity of##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
the antifungal activity##5##3##(2008-10#2)(2008-5#1)(2009-2#1)(2011-2#1)
the antifungal compound##2##3##(1996-7#1)(2008-5#1)
the antifungal compounds##2##3##(2008-10#2)
the antifungal effect of##3##4##(2008-5#1)(2009-2#1)(2011-2#1)
the antifungal properties of##2##4##(2008-10#1)(2012-2#1)
the antifungal properties##3##3##(2008-10#2)(2012-2#1)
the antifungal##25##2##(1990-3#1)(1992-11#1)(1996-7#1)(2008-10#11)(2008-5#4)(2009-2#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
the antigen and##4##3##(1993-12#1)(1994-11#1)(2007-2#1)(2008-10#1)
the antigen by##4##3##(1990-12#2)(1994-2#1)(2008-4#1)
the antigen from##5##3##(1992-8#1)(1995-11#2)(2008-4#1)(2008-5#1)
the antigen in##2##3##(1991-12#1)(2008-5#1)
the antigen is##5##3##(1990-12#1)(1992-8#1)(1994-11#1)(2007-11#1)(2008-8#1)
the antigen receptor##4##3##(1995-6#2)(2008-4#1)(2012-1#1)
the antigen specificity of the##2##5##(2007-11#1)(2008-4#1)
the antigen specificity of##3##4##(1991-2#1)(2007-11#1)(2008-4#1)
the antigen to be##2##4##(1994-3#1)(2008-5#1)
the antigen to##4##3##(1994-3#1)(1997-7#1)(2008-11#1)(2008-5#1)
the antigen was##2##3##(1992-7#1)(1994-6#1)
the antigen##79##2##(1990-12#6)(1991-12#4)(1991-2#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-12#1)(1993-8#2)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1995-11#2)(1995-2#1)(1995-6#2)(1996-2#1)(1997-7#3)(2005-11#2)(2005-7#1)(2007-11#4)(2007-2#5)(2007-7#1)(2008-10#7)(2008-11#4)(2008-3#1)(2008-4#6)(2008-5#3)(2008-8#2)(2012-1#1)(2012-2#1)
the antigen-antibody reaction##2##3##(2008-10#2)
the antigen-antibody##6##2##(2008-10#4)(2008-4#1)(2009-11#1)
the antigen-binding##4##2##(1995-5#1)(1995-8#1)(2007-11#1)(2008-10#1)
the antigen-coated##2##2##(1990-12#1)(1995-12#1)
the antigen-combining site##5##3##(1995-5#5)
the antigen-induced##3##2##(1992-7#2)(1996-12#1)
the antigen-presenting cell##2##3##(2006-10#1)(2007-11#1)
the antigen-presenting##6##2##(1995-8#1)(2006-10#1)(2007-11#2)(2008-4#1)(2008-8#1)
the antigen-specific##4##2##(1990-3#1)(2006-10#1)(2008-10#1)(2008-11#1)
the antigenic peptide##3##3##(1994-11#1)(2007-11#1)(2009-9#1)
the antigenic properties of##2##4##(1995-6#1)(1996-3#1)
the antigenic stimulation of##2##4##(1992-3#1)(2008-4#1)
the antigenic target##2##3##(1993-1#1)(2008-4#1)
the antigenic targets##2##3##(1990-12#1)(2007-8#1)
the antigenic##33##2##(1990-12#1)(1990-8#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-7#1)(1994-11#1)(1994-3#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-3#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-2#1)(2008-4#2)(2009-9#1)(2011-1#3)(2011-2#1)(2013-1#1)(2013-8#2)
the antigenicity of##2##3##(1994-9#1)(2008-4#1)
the antigenicity##5##2##(1994-5#1)(1994-9#1)(2008-10#1)(2008-4#1)(2013-8#1)
the antigens of##3##3##(1997-1#1)(2008-5#1)(2009-5#1)
the antigens##17##2##(1990-12#2)(1994-3#1)(1995-5#2)(1996-2#1)(1997-1#2)(2006-10#2)(2007-2#1)(2008-2#1)(2008-4#1)(2008-5#2)(2009-5#1)(2013-1#1)
the antigingivitis##2##2##(2006-2#1)(2012-3#1)
the antiglobulin##3##2##(1993-3#1)(1993-6#1)(1994-3#1)
the antigravitational muscles##3##3##(2007-8#3)
the antigravitational##4##2##(2007-8#4)
the antiherpetic activity of##3##4##(1996-2#1)(2006-12#1)(2010-3#1)
the antiherpetic##4##2##(1995-6#1)(1996-2#1)(2006-12#1)(2010-3#1)
the antihyperglycemic##2##2##(1995-11#1)(2012-2#1)
the antihypertensive effect of##2##4##(2009-4#1)(2010-4#1)
the antihypertensive efficacy and##2##4##(1993-9#1)(2008-3#1)
the antihypertensive treatment##2##3##(1992-12#1)(2012-3#1)
the antihypertensive##14##2##(1990-8#1)(1991-5#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-9#1)(1995-10#1)(1997-5#1)(2008-10#2)(2008-3#1)(2009-4#1)(2010-4#1)(2012-3#1)
the antiinflammatory##4##2##(1993-11#1)(2006-10#1)(2008-11#1)(2012-1#1)
the antiischemic action of##2##4##(1994-6#2)
the antimalarial##7##2##(1993-2#1)(1994-12#1)(1994-8#1)(1995-3#1)(2006-12#1)(2008-10#1)(2010-1#1)
the antimetamorphic action of JH##2##5##(2012-2#2)
the antimicrobial activities##3##3##(2005-10#1)(2011-12#1)(2012-2#1)
the antimicrobial activity of some##2##5##(2007-11#1)(2009-6#1)
the antimicrobial activity of the##3##5##(2007-11#1)(2008-11#1)(2013-8#1)
the antimicrobial activity of##11##4##(2007-11#2)(2008-11#1)(2008-5#1)(2009-6#1)(2010-5#2)(2011-1#2)(2012-12#1)(2013-8#1)
the antimicrobial activity##14##3##(2007-11#2)(2008-11#1)(2008-5#1)(2009-6#2)(2010-5#2)(2011-1#3)(2012-12#1)(2012-3#1)(2013-8#1)
the antimicrobial agents##3##3##(2006-8#1)(2008-4#1)(2008-5#1)
the antimicrobial and##2##3##(2005-7#1)(2013-1#1)
the antimicrobial peptide##2##3##(1990-2#1)(2010-12#1)
the antimicrobial properties of##2##4##(2010-4#1)(2012-12#1)
the antimicrobial resistance patterns of the##2##6##(1991-8#1)(2007-7#1)
the antimicrobial resistance patterns##3##4##(1991-8#1)(2007-7#1)(2012-2#1)
the antimicrobial resistance##6##3##(1991-8#1)(2006-8#1)(2007-12#1)(2007-7#1)(2012-12#1)(2012-2#1)
the antimicrobial susceptibility##3##3##(2006-8#1)(2007-8#2)
the antimicrobial##47##2##(1990-2#1)(1991-8#1)(1992-11#1)(1994-11#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-8#5)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-6#2)(2010-12#1)(2010-4#1)(2010-5#2)(2011-1#3)(2011-12#1)(2011-2#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
the antimitogenic##3##2##(1990-8#1)(1991-9#2)
the antimodes##2##2##(2007-12#2)
the antimony##4##2##(2004-4#2)(2008-10#2)
the antimutagenic system##2##3##(2008-7#2)
the antimutagenic##3##2##(2008-4#1)(2008-7#2)
the antineoplastic drug##3##3##(1991-11#1)(1992-9#1)(1994-3#1)
the antineoplastic##6##2##(1991-11#1)(1992-1#1)(1992-9#1)(1994-3#1)(1995-8#1)(2011-2#1)
the antinociception##3##2##(1996-2#2)(1997-8#1)
the antinociceptive and ventilatory effects of##2##6##(1996-2#2)
the antinociceptive and##4##3##(1996-2#2)(2008-11#1)(2008-7#1)
the antinociceptive effect of buprenorphine##2##5##(2008-11#2)
the antinociceptive effect of morphine on the##2##7##(1996-12#1)(1996-2#1)
the antinociceptive effect of morphine##3##5##(1996-12#1)(1996-2#2)
the antinociceptive effect of##6##4##(1994-10#1)(1996-12#1)(1996-2#2)(2008-11#2)
the antinociceptive effect##8##3##(1994-10#1)(1996-1#1)(1996-12#1)(1996-2#2)(2008-11#2)(2010-5#1)
the antinociceptive effects of##5##4##(1990-2#2)(1991-1#1)(1991-5#1)(2006-10#1)
the antinociceptive##20##2##(1990-2#3)(1991-1#1)(1991-5#1)(1994-10#1)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#4)(2006-10#1)(2008-11#3)(2008-7#1)(2010-5#1)
the antiobesity##2##2##(2008-10#1)(2013-1#1)
the antioxidant N-acetyl-L-cysteine##2##3##(1997-3#2)
the antioxidant activities of##2##4##(2005-12#1)(2007-11#1)
the antioxidant activity and##2##4##(1995-5#1)(2010-2#1)
the antioxidant activity of the plant##2##6##(2009-6#1)(2010-4#1)
the antioxidant activity of the##3##5##(2009-6#1)(2010-4#2)
the antioxidant activity of##17##4##(1992-9#1)(1995-5#1)(2008-10#5)(2008-11#1)(2008-4#1)(2009-3#1)(2009-6#1)(2010-4#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
the antioxidant activity##21##3##(1992-9#1)(1995-5#2)(2008-10#6)(2008-11#1)(2008-4#1)(2009-3#1)(2009-6#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
the antioxidant and##3##3##(1996-1#1)(2007-8#1)(2011-2#1)
the antioxidant capacity of the##3##5##(2009-8#1)(2010-4#1)(2012-1#1)
the antioxidant capacity of##6##4##(2008-10#3)(2009-8#1)(2010-4#1)(2012-1#1)
the antioxidant capacity##7##3##(2008-10#3)(2009-8#1)(2010-4#1)(2012-1#1)(2012-2#1)
the antioxidant defence##2##3##(2009-6#1)(2013-1#1)
the antioxidant defense system##5##4##(2009-4#1)(2010-12#1)(2010-4#2)(2011-1#1)
the antioxidant defense##8##3##(2005-1#2)(2009-4#1)(2010-12#2)(2010-4#2)(2011-1#1)
the antioxidant effect##3##3##(1995-12#1)(2008-10#1)(2010-2#1)
the antioxidant enzyme##2##3##(1997-8#1)(2013-8#1)
the antioxidant enzymes##3##3##(1994-6#1)(2013-8#2)
the antioxidant network##2##3##(2008-2#2)
the antioxidant potential##2##3##(2008-10#1)(2012-2#1)
the antioxidant properties of stevia##2##5##(2013-1#2)
the antioxidant properties of##6##4##(2008-10#2)(2010-1#1)(2011-2#1)(2013-1#2)
the antioxidant status of the##2##5##(1996-6#1)(1997-6#1)
the antioxidant status of##4##4##(1991-9#1)(1996-6#1)(1997-6#1)(2009-10#1)
the antioxidant status##6##3##(1991-9#1)(1996-6#1)(1997-6#1)(2009-10#1)(2009-4#1)(2013-8#1)
the antioxidant substances##2##3##(2008-10#1)(2009-4#1)
the antioxidant system##6##3##(1990-4#1)(2006-6#2)(2008-7#1)(2010-5#1)(2012-6#1)
the antioxidant##114##2##(1990-4#1)(1991-9#1)(1992-5#1)(1992-9#3)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-6#2)(1995-1#1)(1995-12#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-3#2)(1997-6#1)(1997-8#1)(2005-1#2)(2005-12#1)(2006-10#1)(2006-6#2)(2007-11#1)(2007-8#1)(2008-10#17)(2008-11#3)(2008-2#3)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#5)(2009-6#2)(2009-8#2)(2010-1#1)(2010-12#3)(2010-2#2)(2010-4#6)(2010-5#2)(2010-8#5)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#4)(2012-6#1)(2013-1#5)(2013-8#5)
the antioxidants##12##2##(1992-9#1)(1993-2#1)(1997-8#2)(2008-10#4)(2008-5#2)(2013-8#2)
the antioxidative potential of##2##4##(1995-6#1)(2008-11#1)
the antioxidative##11##2##(1991-12#1)(1995-6#1)(1996-11#1)(2007-9#1)(2008-11#4)(2008-3#1)(2008-5#1)(2011-2#1)
the antiparallel##2##2##(1992-4#1)(1997-1#1)
the antiphase##2##2##(1990-11#1)(2008-3#1)
the antiphospholipid antibody syndrome##2##4##(2006-10#2)
the antiphospholipid antibody##3##3##(1993-1#1)(2006-10#2)
the antiphospholipid syndrome##2##3##(2006-10#2)
the antiphospholipid##5##2##(1993-1#1)(2006-10#4)
the antiplatelet##4##2##(1990-11#1)(1996-12#1)(2011-2#2)
the antiport##2##2##(1991-4#1)(1992-10#1)
the antiproliferative action of##5##4##(1990-2#1)(1991-8#1)(1992-11#1)(1994-3#1)(1996-5#1)
the antiproliferative activity of##2##4##(1991-4#1)(1997-5#1)
the antiproliferative activity##4##3##(1990-12#1)(1991-4#1)(1997-5#1)(2008-5#1)
the antiproliferative effect of GC7##2##5##(1997-1#2)
the antiproliferative effect of##6##4##(1990-11#1)(1990-12#1)(1994-2#1)(1995-2#1)(1997-1#2)
the antiproliferative effects of##6##4##(1994-10#2)(1996-5#2)(1996-8#1)(2007-11#1)
the antiproliferative##24##2##(1990-11#1)(1990-12#2)(1990-2#1)(1991-4#1)(1991-8#1)(1992-11#1)(1994-10#2)(1994-2#1)(1994-3#1)(1995-2#1)(1996-5#4)(1996-8#1)(1997-1#2)(1997-5#1)(2007-11#1)(2008-5#2)(2010-12#1)
the antipsychotic##5##2##(1996-7#1)(1997-7#1)(2008-11#1)(2008-6#1)(2008-8#1)
the antipyretic##2##2##(1990-10#1)(2006-10#1)
the antiretroviral agent##2##3##(1990-6#1)(2007-11#1)
the antiretroviral##6##2##(1990-6#1)(1991-7#1)(1992-6#1)(2007-11#1)(2010-7#1)(2012-12#1)
the antisaccade task has##2##4##(1995-1#1)(2006-4#1)
the antisaccade task##5##3##(1995-1#2)(2006-4#3)
the antisense oligodeoxynucleotide##2##3##(1995-3#1)(1996-1#1)
the antisense strand##4##3##(1992-8#2)(2006-12#2)
the antisense transcript##2##3##(1992-8#1)(1994-11#1)
the antisense##20##2##(1991-9#1)(1992-8#4)(1994-10#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-5#1)(2005-8#1)(2006-12#3)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)
the antisense-Rb oligomer##4##3##(1991-8#4)
the antisera only##2##3##(2008-10#1)(2008-5#1)
the antisera##8##2##(1991-8#1)(1993-8#1)(1994-6#1)(1995-8#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-6#1)
the antiserum against##2##3##(1997-5#2)
the antiserum##14##2##(1990-6#1)(1991-3#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-8#1)(1994-9#2)(1997-5#2)(2007-11#1)(2007-12#1)(2008-4#2)
the antisymmetric##3##2##(1991-5#1)(1995-5#1)(2007-12#1)
the antithetic##2##2##(2009-6#1)(2011-2#1)
the antithrombotic activity##3##3##(1997-7#1)(2006-6#2)
the antithrombotic##6##2##(1990-12#1)(1997-7#1)(2006-6#2)(2007-11#1)(2008-10#1)
the antitrust laws##4##3##(1992-12#1)(1993-1#2)(1994-2#1)
the antituberculosis action of new##2##5##(2007-9#2)
the antituberculosis##4##2##(1994-4#1)(2007-9#3)
the antitumor activity of the##2##5##(1995-11#1)(1996-10#1)
the antitumor activity of##8##4##(1992-7#1)(1995-11#1)(1996-10#1)(2006-6#1)(2008-1#1)(2008-4#2)(2008-5#1)
the antitumor activity##10##3##(1992-7#1)(1995-11#1)(1996-10#1)(2005-4#1)(2006-6#1)(2008-1#1)(2008-4#2)(2008-5#2)
the antitumor agent##4##3##(1994-9#1)(1995-2#1)(1995-3#1)(2013-1#1)
the antitumor drug##3##3##(1991-6#1)(1993-8#1)(1995-1#1)
the antitumor effect##2##3##(2010-2#1)(2012-1#1)
the antitumor effects and##2##4##(2011-1#1)(2013-7#1)
the antitumor effects of##4##4##(1991-12#1)(1996-10#1)(2008-4#1)(2013-1#1)
the antitumor effects##6##3##(1991-12#1)(1996-10#1)(2008-4#1)(2011-1#1)(2013-1#1)(2013-7#1)
the antitumor##34##2##(1991-12#2)(1991-4#1)(1991-6#1)(1992-7#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-10#2)(2004-1#1)(2005-4#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-4#3)(2008-5#4)(2010-2#1)(2011-1#1)(2012-1#1)(2013-1#3)(2013-7#1)
the antitumoral##2##2##(1991-8#1)(1992-5#1)
the antitumour##3##2##(1990-6#1)(2008-5#2)
the antitussive activity of DAMGO##2##5##(1993-3#2)
the antitussive##4##2##(1991-2#1)(1993-3#3)
the antiulcer activity of##2##4##(2009-5#2)
the antiulcer##3##2##(2005-11#1)(2009-5#2)
the antivenoms##3##2##(2008-5#3)
the antiviral activity of the##2##5##(1990-2#1)(1992-5#1)
the antiviral activity of##5##4##(1990-2#2)(1992-5#1)(1994-11#1)(1996-8#1)
the antiviral activity##7##3##(1990-2#2)(1992-5#1)(1994-11#1)(1996-8#1)(1997-1#1)(1997-2#1)
the antiviral drug##3##3##(1994-6#1)(1995-6#1)(2008-5#1)
the antiviral##23##2##(1990-10#1)(1990-2#2)(1992-5#1)(1994-11#4)(1994-3#1)(1994-6#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(2008-3#1)(2008-5#1)(2009-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
the antral##3##2##(1991-4#1)(2007-12#1)(2013-1#1)
the antrum and corpus##2##4##(2005-12#1)(2010-5#1)
the antrum and##3##3##(2005-12#1)(2006-10#1)(2010-5#1)
the antrum##6##2##(1992-8#1)(2005-12#1)(2006-10#1)(2008-5#1)(2010-5#1)(2013-8#1)
the antrum]##2##2##(1991-3#1)(1991-4#1)
the ants were##2##3##(2008-6#1)(2011-12#1)
the ants##8##2##(2006-12#1)(2007-12#2)(2008-6#3)(2011-1#1)(2011-12#1)
the anurans##2##2##(1997-3#2)
the anus##5##2##(2004-11#1)(2007-2#1)(2008-4#1)(2013-1#2)
the anxiety##11##2##(1991-2#1)(1993-10#1)(1994-2#1)(2007-6#1)(2008-11#2)(2009-7#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-7#1)
the anxiolytic effects of##2##4##(1992-7#1)(1994-2#1)
the anxiolytic##5##2##(1992-7#1)(1994-2#1)(2008-10#1)(2008-11#2)
the aorta and its branches##6##5##(1997-8#2)(2006-10#1)(2008-6#3)
the aorta and its##7##4##(1997-8#3)(2006-10#1)(2008-6#3)
the aorta and##14##3##(1991-11#1)(1997-8#3)(2006-10#1)(2007-8#3)(2008-3#1)(2008-6#3)(2009-8#1)(2012-1#1)
the aorta at##2##3##(1991-9#1)(2007-4#1)
the aorta of##5##3##(1991-9#2)(2005-12#2)(2009-11#1)
the aorta to supply##2##4##(2007-12#2)
the aorta##74##2##(1990-2#1)(1991-11#2)(1991-9#4)(1993-5#1)(1993-6#2)(1996-11#1)(1997-1#1)(1997-8#5)(2005-12#2)(2006-10#3)(2006-4#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-3#2)(2007-4#4)(2007-8#15)(2008-3#2)(2008-4#1)(2008-6#3)(2008-7#1)(2009-11#1)(2009-2#1)(2009-7#1)(2009-8#2)(2010-4#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-3#1)
the aortic and mitral valves##2##5##(2006-10#1)(2007-8#1)
the aortic and##3##3##(2005-12#1)(2006-10#1)(2007-8#1)
the aortic aneurysm##2##3##(1991-10#1)(2010-12#1)
the aortic annulus##4##3##(2007-8#2)(2010-9#2)
the aortic arch and##3##4##(1997-8#1)(2008-8#1)(2013-1#1)
the aortic arch was##2##4##(2007-8#2)
the aortic arch##18##3##(1997-8#1)(2006-2#1)(2007-8#7)(2008-8#4)(2010-7#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
the aortic isthmus##2##3##(1997-6#1)(2007-8#1)
the aortic pre-ejection time##2##4##(2008-10#2)
the aortic root##6##3##(2007-8#4)(2009-4#1)(2012-11#1)
the aortic valve replaced##2##4##(1993-5#2)
the aortic valve##15##3##(1990-11#1)(1993-5#3)(1997-5#1)(2006-4#1)(2007-8#5)(2008-1#1)(2009-5#1)(2010-9#1)(2012-2#1)
the aortic wall##8##3##(1991-3#1)(1997-8#1)(2007-8#2)(2009-5#2)(2009-7#1)(2010-8#1)
the aortic##81##2##(1990-11#1)(1990-7#1)(1991-10#1)(1991-3#1)(1991-5#1)(1991-9#1)(1993-5#3)(1995-1#1)(1997-5#1)(1997-6#1)(1997-8#2)(2005-12#2)(2006-1#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-4#1)(2007-7#1)(2007-8#29)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#4)(2009-4#1)(2009-5#5)(2009-7#1)(2010-12#1)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#1)
the aortomitral angle##2##3##(2008-10#2)
the apaH##2##2##(2006-8#2)
the apatite##2##2##(2008-5#1)(2010-8#1)
the ape chromosomes##2##3##(1997-6#2)
the ape##3##2##(1997-6#2)(2007-3#1)
the aperture field##2##3##(2011-2#2)
the aperture size of the##2##5##(2008-2#2)
the aperture size##3##3##(2007-12#1)(2008-2#2)
the aperture to##5##3##(2008-2#1)(2008-3#4)
the aperture##35##2##(1996-3#1)(2007-11#2)(2007-12#6)(2008-2#15)(2008-3#8)(2009-12#1)(2011-2#2)
the aperture-focus distance##2##3##(2008-3#2)
the aperture-interface distance##2##3##(2008-3#2)
the apertured##2##2##(2008-3#2)
the apertures##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
the apex of a##2##4##(1997-6#1)(2007-12#1)
the apex of the bifurcation##2##5##(2007-9#2)
the apex of the##10##4##(1995-8#1)(2007-11#1)(2007-7#1)(2007-9#2)(2008-4#1)(2008-7#1)(2009-5#1)(2012-2#2)
the apex of##18##3##(1995-8#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2012-2#2)
the apex##33##2##(1995-8#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#5)(2007-9#3)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#3)(2009-5#1)(2010-2#1)(2012-12#2)(2012-2#2)(2013-1#2)
the apheresis##3##2##(1994-12#2)(2012-12#1)
the aphicidal activity##2##3##(2010-10#2)
the aphid Acyrthosiphon pisum##2##4##(1996-12#1)(2007-12#1)
the aphid Rhopalosiphum##2##3##(2008-10#2)
the aphid that inoculated the##2##5##(2008-10#2)
the aphid vector##2##3##(2008-10#2)
the aphid##23##2##(1996-12#4)(2004-2#4)(2007-12#3)(2008-10#10)(2008-5#1)(2011-2#1)
the aphid-transmitted isolates##2##3##(2008-10#2)
the apical ES##8##3##(2012-2#8)
the apical and basal##3##4##(1990-6#1)(2007-12#1)(2012-2#1)
the apical and##6##3##(1990-6#1)(2007-12#1)(2007-8#1)(2008-9#1)(2012-2#2)
the apical but not the basolateral##2##6##(1991-8#1)(2008-3#1)
the apical cell membrane##3##4##(2007-12#3)
the apical cell##7##3##(1993-6#2)(2007-12#3)(2008-9#1)(2009-8#1)
the apical compartment##2##3##(1997-4#1)(2012-2#1)
the apical dendrite##4##3##(1994-10#2)(1996-3#1)(1997-5#1)
the apical ectoplasmic specialization##3##4##(2012-2#3)
the apical ectoplasmic##4##3##(2012-2#4)
the apical end##2##3##(2008-7#1)(2010-12#1)
the apical membrane of the RPE##2##6##(2008-3#2)
the apical membrane of the##6##5##(1990-4#1)(1992-5#1)(2008-3#2)(2008-4#1)(2008-6#1)
the apical membrane of##13##4##(1990-11#3)(1990-4#1)(1992-5#1)(1994-12#1)(2006-10#1)(2006-8#1)(2008-3#2)(2008-4#2)(2008-6#1)
the apical membrane##19##3##(1990-11#4)(1990-4#1)(1992-11#1)(1992-3#1)(1992-5#1)(1994-12#1)(2006-10#3)(2006-8#1)(2008-3#2)(2008-4#3)(2008-6#1)
the apical portion of the##3##5##(1996-3#1)(2007-12#1)(2013-1#1)
the apical position##3##3##(1994-9#1)(1997-7#1)(2007-12#1)
the apical region of##5##4##(1995-11#2)(2006-11#1)(2013-1#2)
the apical side of the##2##5##(1997-8#1)(2008-11#1)
the apical side of##3##4##(1997-8#1)(2008-11#2)
the apical surface of the##2##5##(2007-12#1)(2010-2#1)
the apical surface of##3##4##(1995-8#1)(2007-12#1)(2010-2#1)
the apical surface##6##3##(1991-12#1)(1995-8#1)(2007-12#2)(2008-1#1)(2010-2#1)
the apical##131##2##(1990-11#4)(1990-4#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-8#2)(1992-11#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-8#1)(1993-6#3)(1994-10#3)(1994-12#1)(1994-9#2)(1995-11#2)(1995-8#1)(1996-11#1)(1996-3#2)(1997-1#1)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#6)(2006-11#1)(2006-8#1)(2007-11#1)(2007-12#11)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-3#4)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#3)(2009-7#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2012-1#3)(2012-2#18)(2013-1#7)(2013-8#2)
the apo B##4##3##(1993-9#1)(1994-3#1)(1997-8#2)
the apo E deficient mice##2##5##(1997-7#2)
the apo E##3##3##(1990-4#1)(1997-7#2)
the apo and##2##3##(1991-12#1)(2009-7#1)
the apo form##2##3##(1993-8#1)(1996-7#1)
the apo structure##4##3##(1991-12#1)(1995-10#1)(2010-10#2)
the apo##20##2##(1990-4#2)(1991-12#2)(1992-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-10#3)(1996-7#1)(1997-7#2)(1997-8#2)(2009-7#1)(2010-10#2)
the apo(a)##2##2##(1992-3#1)(1993-3#1)
the apo(a)-EIA##2##2##(1993-2#2)
the apo-E gene##2##3##(2008-10#2)
the apo-E##3##2##(2008-10#3)
the apo-MT##2##2##(2008-5#2)
the apoA-IV-1##2##2##(1990-8#1)(1991-8#1)
the apoA-IV-3 allele##2##3##(1990-8#1)(1991-8#1)
the apoB gene##2##3##(1990-7#1)(2006-10#1)
the apoB##4##2##(1990-7#1)(1994-8#1)(2006-10#1)(2010-12#1)
the apoB100##2##2##(1994-9#2)
the apoE gene##2##3##(1995-6#1)(1997-4#1)
the apoE##6##2##(1994-9#1)(1995-1#1)(1995-6#3)(1997-4#1)
the apocrine##2##2##(2004-1#1)(2008-5#1)
the apodization##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
the apoenzyme##8##2##(1990-11#1)(1991-2#1)(1992-11#1)(1993-6#1)(1994-8#1)(1994-9#1)(1997-7#2)
the apolar##3##2##(1993-9#1)(1996-9#1)(2008-10#1)
the apolipoprotein B gene##4##4##(1990-7#1)(1995-2#1)(1997-8#1)(2007-2#1)
the apolipoprotein B##5##3##(1990-7#1)(1995-2#1)(1995-3#1)(1997-8#1)(2007-2#1)
the apolipoprotein E (apoE)-deficient##2##4##(1995-8#1)(1997-4#1)
the apolipoprotein E locus##2##4##(1995-3#1)(1996-5#1)
the apolipoprotein E##10##3##(1995-11#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-5#2)(1997-4#1)(2008-4#1)(2008-7#1)(2008-8#1)
the apolipoprotein##22##2##(1990-7#1)(1991-2#1)(1992-12#1)(1993-6#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-5#2)(1997-4#2)(1997-8#1)(2005-7#1)(2007-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-11#1)
the apolipoproteins##4##2##(1991-2#2)(1993-9#1)(2008-5#1)
the apomictic parent##2##3##(2008-5#2)
the apomorphine-induced##2##2##(1990-2#2)
the aponeurosis##2##2##(2008-10#1)(2009-3#1)
the apoplast##2##2##(2008-5#1)(2009-8#1)
the apoprotein##12##2##(1990-2#3)(1990-8#2)(1991-12#1)(1991-2#2)(1992-10#1)(1993-8#1)(1994-11#1)(1997-7#1)
the apoptosis and##3##3##(2008-11#1)(2012-2#1)(2013-7#1)
the apoptosis induced##2##3##(1995-8#1)(2011-2#1)
the apoptosis observed##2##3##(1994-5#1)(2011-2#1)
the apoptosis of##7##3##(2008-11#2)(2009-4#1)(2009-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
the apoptosis process##3##3##(2006-2#1)(2008-11#2)
the apoptosis program##2##3##(1996-8#1)(2008-11#1)
the apoptosis rate##2##3##(2007-2#1)(2012-2#1)
the apoptosis##31##2##(1994-5#1)(1995-6#2)(1995-8#1)(1996-7#1)(1996-8#1)(2006-2#1)(2006-4#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#7)(2008-5#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
the apoptotic cell##3##3##(2010-10#1)(2011-1#1)(2011-2#1)
the apoptotic cells##4##3##(1992-8#2)(2008-5#1)(2010-1#1)
the apoptotic effects of##2##4##(1995-2#1)(2008-11#1)
the apoptotic machinery##2##3##(2008-8#1)(2009-12#1)
the apoptotic pathways##2##3##(2006-5#1)(2010-12#1)
the apoptotic process##5##3##(2003-11#2)(2006-11#1)(2008-9#1)(2009-3#1)
the apoptotic program in##2##4##(2008-1#1)(2012-1#1)
the apoptotic program##3##3##(1995-2#1)(2008-1#1)(2012-1#1)
the apoptotic response##2##3##(1991-11#1)(1997-6#1)
the apoptotic##41##2##(1991-11#1)(1992-8#2)(1995-12#2)(1995-2#2)(1995-6#1)(1997-6#1)(2003-11#4)(2006-11#1)(2006-5#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#2)(2011-1#3)(2011-2#1)(2012-1#1)(2013-1#1)
the apothecaries##2##2##(2010-12#2)
the apothecaryâs profession##2##3##(2010-12#2)
the apparatus can##2##3##(2012-1#2)
the apparatus for##2##3##(1997-6#1)(2007-8#1)
the apparatus were##2##3##(1990-10#1)(2012-1#1)
the apparatus with the weight bearing lift##2##7##(2012-1#2)
the apparatus with##3##3##(2012-1#3)
the apparatus##28##2##(1990-10#1)(1990-8#1)(1993-8#1)(1993-9#1)(1995-12#1)(1997-6#1)(2006-5#1)(2007-12#1)(2007-8#3)(2008-2#1)(2008-3#7)(2008-4#1)(2012-1#8)
the apparent K(m) for exogenous ADP##2##6##(2008-7#2)
the apparent K(m) for##3##4##(2008-7#3)
the apparent K(m)##5##3##(2008-7#5)
the apparent Km for##3##4##(1990-11#1)(1991-4#1)(1995-10#1)
the apparent Km##10##3##(1990-11#1)(1990-3#1)(1991-4#1)(1991-8#1)(1992-3#1)(1992-6#2)(1995-10#1)(1995-5#1)(1997-2#1)
the apparent Mr##2##3##(1990-11#1)(1990-7#1)
the apparent activation##2##3##(1991-2#1)(1992-3#1)
the apparent affinity for##2##4##(1992-11#1)(1995-1#1)
the apparent affinity of##4##4##(1990-7#1)(1995-11#1)(1995-12#1)(1996-9#1)
the apparent affinity##7##3##(1990-7#1)(1992-11#1)(1995-1#1)(1995-11#1)(1995-12#2)(1996-9#1)
the apparent association##2##3##(1997-1#1)(2008-8#1)
the apparent binding affinity##2##4##(1990-7#1)(1991-5#1)
the apparent binding##7##3##(1990-7#1)(1991-5#1)(1994-3#1)(1997-2#1)(1997-7#1)(2008-10#2)
the apparent changes in##2##4##(1997-2#1)(1997-8#1)
the apparent contrast between##2##4##(1993-2#1)(2008-8#1)
the apparent diffusion coefficient (ADC)##4##5##(1996-5#1)(2006-1#1)(2007-12#1)(2008-11#1)
the apparent diffusion coefficient##8##4##(1996-5#1)(2005-11#1)(2006-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2010-12#1)
the apparent diffusion##10##3##(1996-5#1)(2005-11#2)(2006-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-3#1)(2010-12#1)
the apparent discrepancy##2##3##(1993-9#1)(1997-1#1)
the apparent dissociation constant##3##4##(1995-1#1)(1996-7#1)(1997-6#1)
the apparent dissociation##6##3##(1990-8#2)(1995-1#1)(1996-7#1)(1997-6#1)(2009-4#1)
the apparent distance distribution##2##4##(1994-8#2)
the apparent distance##3##3##(1994-8#2)(2009-8#1)
the apparent enthalpy##2##3##(2006-10#2)
the apparent equilibrium##2##3##(1996-11#2)
the apparent infection rate##3##4##(2008-10#3)
the apparent molar##7##3##(2006-10#2)(2008-10#5)
the apparent molecular mass of the##4##6##(1990-7#1)(1991-10#1)(1995-6#2)
the apparent molecular mass of##7##5##(1990-5#1)(1990-7#1)(1991-10#1)(1992-10#1)(1995-6#2)(1997-2#1)
the apparent molecular##8##3##(1990-5#1)(1990-7#2)(1991-10#1)(1992-10#1)(1995-6#2)(1997-2#1)
the apparent optical properties of##2##5##(2008-2#1)(2008-3#1)
the apparent optical properties##3##4##(2008-2#2)(2008-3#1)
the apparent permeability was##2##4##(1990-11#1)(2010-1#1)
the apparent permeability##3##3##(1990-11#2)(2010-1#1)
the apparent presence of##2##4##(2003-11#1)(2008-10#1)
the apparent rate constant of the##2##6##(1994-12#1)(1997-4#1)
the apparent rate constant##3##4##(1994-12#2)(1997-4#1)
the apparent rate##4##3##(1992-6#1)(1994-12#2)(1997-4#1)
the apparent relationship##2##3##(1991-8#1)(2008-11#1)
the apparent resistance##2##3##(1991-7#1)(2008-10#1)
the apparent simplicity of##2##4##(2006-5#1)(2011-1#1)
the apparent specific##2##3##(2008-10#2)
the apparent viscosity and##2##4##(2008-5#1)(2011-2#1)
the apparent viscosity##4##3##(2008-5#3)(2011-2#1)
the apparent##214##2##(1990-11#6)(1990-12#2)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#6)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#4)(1991-2#1)(1991-4#1)(1991-5#2)(1991-7#2)(1991-8#3)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-3#2)(1992-5#2)(1992-6#3)(1992-9#1)(1993-11#1)(1993-2#2)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-8#3)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#2)(1995-3#2)(1995-5#1)(1995-6#2)(1996-1#1)(1996-11#4)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#4)(1996-9#1)(1997-1#2)(1997-2#6)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2003-11#1)(2004-12#1)(2004-3#1)(2005-11#4)(2006-1#1)(2006-10#9)(2006-11#1)(2006-3#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#35)(2008-11#5)(2008-2#6)(2008-3#4)(2008-5#4)(2008-7#5)(2008-8#3)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-2#2)(2013-8#1)
the apparently##13##2##(1991-9#1)(1993-2#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-8#2)(2010-6#1)(2012-3#1)
the appeal##2##2##(1991-1#1)(1994-11#1)
the appeals court##4##3##(1996-11#1)(1996-5#2)(1996-6#1)
the appeals##5##2##(1995-6#1)(1996-11#1)(1996-5#2)(1996-6#1)
the appearance and disappearance of##2##5##(1995-2#1)(1996-7#1)
the appearance and the##2##4##(1996-4#1)(1997-8#1)
the appearance and##7##3##(1991-7#1)(1995-2#1)(1996-4#1)(1996-7#1)(1997-8#1)(2006-10#2)
the appearance in##2##3##(1994-12#1)(1997-8#1)
the appearance of ACA##2##4##(1991-2#2)
the appearance of a &quot##2##5##(1994-5#1)(2009-2#1)
the appearance of a new##4##5##(1992-8#1)(2008-10#1)(2008-3#1)(2008-9#1)
the appearance of a second##2##5##(1992-10#1)(2008-3#1)
the appearance of a##29##4##(1990-3#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-8#1)(1993-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1996-1#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-10#2)(2007-12#2)(2007-9#1)(2008-10#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)
the appearance of an##8##4##(1990-2#1)(1991-7#1)(1993-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(2006-8#1)(2007-12#1)
the appearance of autoantibodies##2##4##(1995-1#1)(2013-1#1)
the appearance of degenerative changes##2##5##(1997-3#1)(2007-8#1)
the appearance of large numbers of##2##6##(1992-8#1)(2007-11#1)
the appearance of large##3##4##(1992-6#1)(1992-8#1)(2007-11#1)
the appearance of more##2##4##(2009-2#1)(2012-12#1)
the appearance of new##6##4##(1990-10#1)(2007-11#1)(2008-10#1)(2009-2#1)(2011-2#2)
the appearance of novel##2##4##(2006-9#1)(2008-1#1)
the appearance of resistant strains##2##5##(2008-10#1)(2008-4#1)
the appearance of several##3##4##(2007-7#1)(2008-1#1)(2011-12#1)
the appearance of single##2##4##(1995-10#1)(1997-2#1)
the appearance of skin##2##4##(2008-5#1)(2008-7#1)
the appearance of the corresponding##2##5##(1990-4#1)(2008-10#1)
the appearance of the first##4##5##(2007-7#1)(2008-10#2)(2012-2#1)
the appearance of the##35##4##(1990-4#2)(1991-6#1)(1992-3#1)(1993-5#1)(1993-9#1)(1994-11#3)(1995-9#1)(1996-4#1)(1996-6#1)(1997-2#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#3)(2009-12#1)(2009-5#1)(2010-2#1)(2012-2#2)(2013-7#1)
the appearance of this##2##4##(1992-5#1)(1995-7#1)
the appearance of two##4##4##(1991-7#1)(1993-8#1)(2006-12#1)(2008-10#1)
the appearance of##236##3##(1990-10#2)(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#4)(1991-3#2)(1991-5#1)(1991-6#2)(1991-7#2)(1991-9#2)(1992-10#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#2)(1992-8#5)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-5#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#3)(1995-10#3)(1995-11#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#6)(2006-12#2)(2006-2#2)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#5)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#5)(2008-10#18)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#8)(2008-4#2)(2008-5#10)(2008-6#5)(2008-7#5)(2008-8#2)(2008-9#4)(2009-12#1)(2009-2#5)(2009-3#2)(2009-4#1)(2009-5#4)(2010-1#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#4)(2013-7#2)
the appearance ofa##2##3##(2008-11#1)(2013-8#1)
the appearance##257##2##(1990-10#2)(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#4)(1991-3#2)(1991-5#1)(1991-6#2)(1991-7#3)(1991-9#2)(1992-10#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#2)(1992-8#5)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-5#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#3)(1995-10#3)(1995-11#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-6#3)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#3)(2005-11#1)(2005-8#1)(2006-10#8)(2006-12#2)(2006-2#2)(2006-5#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#9)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#5)(2008-10#19)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#8)(2008-4#2)(2008-5#10)(2008-6#5)(2008-7#5)(2008-8#2)(2008-9#4)(2009-12#1)(2009-2#5)(2009-3#3)(2009-4#1)(2009-5#4)(2010-1#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#1)
the appearence of##3##3##(1997-9#1)(2008-2#1)(2008-6#1)
the appendage##2##2##(2007-12#1)(2007-8#1)
the appendiceal wall##2##3##(2009-7#1)(2011-2#1)
the appendicular skeleton##3##3##(2010-3#1)(2011-2#1)(2013-1#1)
the appendicular##8##2##(1991-11#1)(2007-11#1)(2007-12#2)(2010-3#1)(2011-2#2)(2013-1#1)
the appendix##27##2##(1990-10#1)(1990-8#1)(1992-2#1)(1993-12#2)(1993-6#1)(1997-8#1)(2004-10#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-5#1)(2008-9#2)(2009-7#4)(2011-2#4)(2013-1#2)(2013-8#1)
the applanating and intraocular pressures##2##5##(2007-9#2)
the applanating##3##2##(2007-9#3)
the applanation##3##2##(2008-3#3)
the apple domain##2##3##(1991-2#2)
the apple maggot fly##2##4##(2006-5#2)
the apple pectin##2##3##(2008-10#2)
the apple proliferation##3##3##(2008-10#3)
the apple sooty blotch##2##4##(2008-10#2)
the apple##18##2##(1991-2#2)(1996-2#1)(2006-5#2)(2008-10#10)(2008-11#2)(2009-8#1)
the applicability and effectiveness of##2##5##(2011-1#1)(2012-1#1)
the applicability of a##2##4##(2008-10#1)(2013-1#1)
the applicability of an##2##4##(1997-4#1)(2008-5#1)
the applicability of such##2##4##(1993-6#1)(2007-8#1)
the applicability of the method to##2##6##(2008-10#2)
the applicability of the method##4##5##(2008-10#3)(2008-3#1)
the applicability of the proposed method##3##6##(2008-10#3)
the applicability of the proposed##4##5##(1997-8#1)(2008-10#3)
the applicability of the theory##2##5##(2007-8#1)(2008-8#1)
the applicability of the three##2##5##(2008-10#1)(2013-8#1)
the applicability of the##25##4##(1993-1#1)(1997-8#1)(2006-10#2)(2007-12#1)(2007-8#1)(2008-10#10)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2013-8#1)
the applicability of this method##2##5##(2008-10#1)(2009-12#1)
the applicability of this technique##2##5##(2005-7#1)(2008-3#1)
the applicability of this##9##4##(1994-2#1)(1995-9#1)(2004-1#1)(2005-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-12#1)(2012-1#1)
the applicability of##76##3##(1990-7#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-2#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-9#1)(1996-1#1)(1996-7#1)(1997-4#1)(1997-8#1)(2004-1#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-8#2)(2008-10#15)(2008-2#5)(2008-3#4)(2008-5#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-12#2)(2009-3#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#2)(2010-8#2)(2011-1#2)(2011-9#1)(2012-1#1)(2013-1#2)(2013-8#2)
the applicability to##2##3##(2008-10#1)(2008-3#1)
the applicability##82##2##(1990-7#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-2#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-9#1)(1996-1#1)(1996-7#1)(1997-4#1)(1997-8#1)(2004-1#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-8#2)(2008-10#16)(2008-2#6)(2008-3#6)(2008-5#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-12#2)(2009-3#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#2)(2010-8#2)(2011-1#3)(2011-9#1)(2012-1#2)(2013-1#2)(2013-8#2)
the applicable##8##2##(1991-1#1)(1991-2#1)(1992-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)
the applicant##2##2##(1992-5#1)(1995-5#1)
the applicants##5##2##(1992-5#1)(1995-5#1)(1997-3#2)(2010-12#1)
the application and##6##3##(1996-12#1)(2007-10#1)(2008-10#1)(2008-5#1)(2013-1#2)
the application are##2##3##(2006-12#1)(2013-1#1)
the application domain##2##3##(2008-2#1)(2012-3#1)
the application for##3##3##(1992-5#1)(2008-10#1)(2008-3#1)
the application in the##2##4##(2007-11#1)(2009-10#1)
the application in##6##3##(1994-3#1)(2007-11#2)(2009-10#1)(2013-8#2)
the application of AMPH##2##4##(1991-8#2)
the application of Bayesian##2##4##(1997-6#1)(2009-10#1)
the application of Fourier methods##2##5##(2008-2#2)
the application of SPA technology to##2##6##(2008-4#2)
the application of VSFG to the study of##2##8##(2012-1#2)
the application of a##45##4##(1991-7#1)(1992-2#1)(1993-2#1)(1993-9#1)(1995-5#1)(1995-9#1)(2005-11#3)(2006-12#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#8)(2008-2#4)(2008-3#5)(2008-5#2)(2008-7#3)(2008-9#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#4)
the application of acetone##2##4##(2008-2#1)(2009-12#1)
the application of an electric field##2##6##(2005-10#1)(2008-11#1)
the application of an external##3##5##(2008-2#1)(2008-7#2)
the application of an##17##4##(1993-3#1)(1996-5#1)(2005-10#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-5#2)(2008-7#2)(2012-1#1)(2013-1#1)
the application of analytical##3##4##(2006-3#1)(2010-4#1)(2011-2#1)
the application of any##2##4##(2008-5#1)(2011-2#1)
the application of artificial neural##2##5##(2006-12#1)(2008-10#1)
the application of biotechnology to forest trees##2##7##(2006-12#2)
the application of both##2##4##(1996-12#1)(2008-10#1)
the application of cancer control science##2##6##(1997-1#2)
the application of capillary electrophoresis to##2##6##(1996-5#1)(2008-10#1)
the application of capillary##3##4##(1996-5#2)(2008-10#1)
the application of continuous##2##4##(1995-4#1)(2008-7#1)
the application of data##2##4##(2008-10#1)(2008-9#1)
the application of different##2##4##(2008-10#2)
the application of drug##2##4##(2009-7#1)(2011-1#1)
the application of either##2##4##(2008-2#1)(2013-1#1)
the application of functional##2##4##(2007-11#1)(2009-4#1)
the application of general##2##4##(2010-5#1)(2013-8#1)
the application of genetic##3##4##(1991-7#1)(1994-9#1)(2007-7#1)
the application of health##2##4##(1997-8#1)(2008-10#1)
the application of immunohistochemistry##2##4##(1997-3#1)(2010-8#1)
the application of light##2##4##(1992-8#1)(2008-2#1)
the application of mechanical##2##4##(2006-12#1)(2008-3#1)
the application of molecular##3##4##(2006-10#1)(2008-10#1)(2011-1#1)
the application of more##2##4##(2007-4#1)(2010-5#1)
the application of negative##2##4##(1994-4#1)(2007-8#1)
the application of new##4##4##(2008-10#1)(2008-11#1)(2009-8#1)(2010-11#1)
the application of our##2##4##(2012-1#1)(2013-1#1)
the application of physicochemical##2##4##(2008-5#1)(2012-2#1)
the application of preoperative##2##4##(2008-5#1)(2010-3#1)
the application of robust##2##4##(1995-6#1)(2008-11#1)
the application of sequential##2##4##(1996-12#1)(2008-10#1)
the application of simple##2##4##(1993-6#1)(2006-10#1)
the application of standard##3##4##(1994-6#1)(2008-2#1)(2008-4#1)
the application of such##3##4##(2008-2#1)(2009-12#1)(2010-10#1)
the application of the HPGPC-LALLS method to##2##7##(1993-7#2)
the application of the formula##2##5##(1993-10#1)(2008-5#1)
the application of the guidelines##2##5##(2010-11#2)
the application of the hybrid method##2##6##(2008-3#2)
the application of the method to the##2##7##(2006-3#1)(2008-2#1)
the application of the method##4##5##(1997-7#1)(2006-3#1)(2007-10#1)(2008-2#1)
the application of the methods##2##5##(2006-10#1)(2008-10#1)
the application of the new##3##5##(1992-9#1)(1997-8#1)(2008-7#1)
the application of the proposed##3##5##(2008-10#2)(2010-2#1)
the application of the rules##2##5##(1995-6#1)(2007-10#1)
the application of the##82##4##(1990-9#1)(1991-11#1)(1991-7#1)(1992-10#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-7#2)(1995-6#1)(1995-9#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-10#2)(2007-11#1)(2007-3#1)(2007-8#2)(2008-1#2)(2008-10#9)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#6)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-9#1)(2010-11#2)(2010-2#2)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#5)(2013-1#5)(2013-8#1)
the application of theory##2##4##(2008-11#1)(2011-1#1)
the application of these methods##2##5##(2008-8#1)(2008-9#1)
the application of these techniques to##3##6##(2006-7#1)(2008-8#1)(2010-9#1)
the application of these techniques##5##5##(1993-6#1)(2006-7#1)(2008-7#1)(2008-8#1)(2010-9#1)
the application of these##15##4##(1992-2#1)(1993-6#1)(2006-7#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-4#1)(2010-9#1)(2012-2#1)
the application of this new##2##5##(1990-3#1)(2007-12#1)
the application of this technique in##2##6##(1993-10#1)(2013-1#1)
the application of this technique to##3##6##(2007-12#1)(2007-8#1)(2012-1#1)
the application of this technique##6##5##(1993-10#1)(2007-12#2)(2007-8#1)(2012-1#1)(2013-1#1)
the application of this technology##2##5##(1995-7#1)(1996-1#1)
the application of this##26##4##(1990-3#1)(1993-10#1)(1994-3#1)(1994-5#1)(1995-7#1)(1996-1#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
the application of total##2##4##(2007-8#1)(2008-12#1)
the application of traditional##2##4##(1997-7#1)(2011-2#1)
the application of##582##3##(1990-3#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#1)(1992-10#1)(1992-12#3)(1992-2#2)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-10#2)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-7#2)(1993-9#2)(1994-2#2)(1994-3#1)(1994-4#2)(1994-5#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-4#2)(1995-5#2)(1995-6#2)(1995-7#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#3)(1996-3#3)(1996-5#3)(1996-8#1)(1996-9#1)(1997-1#3)(1997-3#2)(1997-4#1)(1997-6#3)(1997-7#2)(1997-8#4)(2004-11#1)(2004-12#1)(2005-10#3)(2005-11#4)(2005-4#1)(2005-5#1)(2005-8#2)(2005-9#1)(2006-10#11)(2006-12#7)(2006-3#2)(2006-5#2)(2006-6#3)(2006-7#3)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#18)(2007-12#6)(2007-2#3)(2007-3#1)(2007-4#3)(2007-5#3)(2007-6#4)(2007-7#9)(2007-8#15)(2008-1#5)(2008-10#76)(2008-11#24)(2008-12#6)(2008-2#32)(2008-3#23)(2008-4#11)(2008-5#14)(2008-6#3)(2008-7#17)(2008-8#8)(2008-9#10)(2009-10#5)(2009-11#1)(2009-12#3)(2009-2#4)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#5)(2010-12#5)(2010-2#4)(2010-3#2)(2010-4#6)(2010-5#5)(2010-6#2)(2010-7#2)(2010-8#5)(2010-9#4)(2011-1#10)(2011-12#1)(2011-2#17)(2012-1#8)(2012-11#3)(2012-12#11)(2012-2#5)(2012-3#8)(2013-1#12)(2013-8#10)
the application on##2##3##(2007-8#1)(2010-5#1)
the application point of view##2##5##(2012-12#1)(2012-2#1)
the application scope of##2##4##(2008-10#1)(2011-1#1)
the application to##5##3##(2006-10#1)(2008-10#3)(2009-10#1)
the application##648##2##(1990-3#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#1)(1992-10#1)(1992-12#3)(1992-2#2)(1992-5#3)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-10#2)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-7#2)(1993-9#2)(1994-2#2)(1994-3#2)(1994-4#2)(1994-5#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-4#2)(1995-5#2)(1995-6#2)(1995-7#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#4)(1996-3#3)(1996-5#3)(1996-8#1)(1996-9#1)(1997-1#3)(1997-3#2)(1997-4#1)(1997-6#3)(1997-7#2)(1997-8#4)(2004-11#1)(2004-12#1)(2005-10#3)(2005-11#5)(2005-4#1)(2005-5#1)(2005-8#2)(2005-9#1)(2006-10#12)(2006-12#8)(2006-3#2)(2006-5#2)(2006-6#3)(2006-7#3)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#20)(2007-12#6)(2007-2#3)(2007-3#1)(2007-4#3)(2007-5#4)(2007-6#4)(2007-7#11)(2007-8#16)(2008-1#5)(2008-10#89)(2008-11#24)(2008-12#6)(2008-2#34)(2008-3#27)(2008-4#11)(2008-5#17)(2008-6#3)(2008-7#18)(2008-8#9)(2008-9#13)(2009-10#7)(2009-11#2)(2009-12#3)(2009-2#4)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#4)(2009-7#3)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#5)(2010-12#5)(2010-2#4)(2010-3#2)(2010-4#6)(2010-5#6)(2010-6#2)(2010-7#2)(2010-8#6)(2010-9#4)(2011-1#11)(2011-12#1)(2011-2#18)(2012-1#8)(2012-11#3)(2012-12#13)(2012-2#6)(2012-3#9)(2013-1#21)(2013-8#12)
the applications and##2##3##(2005-4#1)(2008-1#1)
the applications in##3##3##(2006-6#1)(2008-3#1)(2008-5#1)
the applications of the##4##4##(1991-4#1)(1996-5#1)(2008-2#1)(2013-8#1)
the applications of these##2##4##(2008-7#1)(2011-2#1)
the applications of this##2##4##(2004-4#1)(2013-8#1)
the applications of##29##3##(1990-8#1)(1991-4#1)(1996-5#1)(1997-6#1)(2004-4#1)(2005-8#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-7#1)(2011-2#1)(2011-7#1)(2013-8#4)
the applications##44##2##(1990-8#1)(1991-4#1)(1992-5#1)(1994-1#1)(1996-5#1)(1997-6#1)(2004-4#1)(2005-4#1)(2005-8#1)(2006-6#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#2)(2009-2#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#1)(2011-7#1)(2013-7#1)(2013-8#5)
the applied electric field##4##4##(2005-11#3)(2009-12#1)
the applied electric##5##3##(2005-11#3)(2009-12#1)(2013-1#1)
the applied field##4##3##(1991-8#1)(2007-9#1)(2008-7#2)
the applied potential##6##3##(2008-10#6)
the applied pressure##4##3##(2006-12#1)(2007-6#1)(2010-12#1)(2010-4#1)
the applied strain##4##3##(2006-11#1)(2007-1#1)(2007-12#1)(2008-2#1)
the applied treatment##3##3##(2007-8#1)(2008-10#2)
the applied voltage and##2##4##(2008-2#1)(2009-7#1)
the applied voltage##10##3##(1996-5#1)(2008-10#2)(2008-2#3)(2009-7#2)(2013-8#2)
the applied##87##2##(1991-8#1)(1994-9#1)(1995-3#2)(1996-2#1)(1996-5#1)(1997-7#2)(2005-11#5)(2006-10#1)(2006-11#2)(2006-12#1)(2006-6#1)(2007-1#2)(2007-11#1)(2007-12#3)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#26)(2008-11#2)(2008-2#4)(2008-3#4)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#1)(2009-12#1)(2009-5#1)(2009-7#2)(2010-12#3)(2010-4#1)(2013-1#1)(2013-8#2)
the appliqués##2##2##(2008-3#2)
the appointment of##2##3##(1992-12#1)(1997-8#1)
the appointment##5##2##(1992-12#1)(1993-6#1)(1997-8#1)(2013-1#1)(2013-8#1)
the apportionment of##2##3##(2008-8#1)(2013-1#1)
the appraisals of daily##2##4##(2012-1#2)
the appreciation of the##2##4##(2006-10#1)(2008-1#1)
the appreciation of##8##3##(1993-12#1)(2006-10#1)(2006-3#3)(2008-1#1)(2008-8#1)(2008-9#1)
the appreciation##11##2##(1993-12#1)(2006-10#1)(2006-3#3)(2007-5#2)(2008-1#1)(2008-8#1)(2008-9#1)(2012-2#1)
the apprentice's##2##2##(2008-7#2)
the appressoria##3##2##(2008-10#3)
the approach allows##2##3##(2008-9#1)(2009-10#1)
the approach and##7##3##(1993-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(2006-5#1)(2008-3#1)(2013-1#1)
the approach are##2##3##(1994-4#1)(1997-8#1)
the approach as goal-directed##2##4##(2008-7#2)
the approach as well##3##4##(2012-12#1)(2013-1#2)
the approach as##5##3##(2008-7#2)(2012-12#1)(2013-1#2)
the approach can be##2##4##(2005-4#1)(2008-4#1)
the approach can##4##3##(2005-4#1)(2008-4#1)(2010-7#1)(2013-1#1)
the approach described in##3##4##(1991-4#1)(2008-2#1)(2010-2#1)
the approach gives##2##3##(2008-3#1)(2012-2#1)
the approach has##2##3##(2007-11#1)(2008-10#1)
the approach in the##2##4##(2005-5#1)(2008-7#1)
the approach is##9##3##(1996-5#1)(2004-4#1)(2008-10#3)(2008-12#1)(2008-3#2)(2012-2#1)
the approach may##2##3##(2007-9#1)(2008-11#1)
the approach of Liang and Zeger##2##6##(1993-9#2)
the approach of the##6##4##(1994-9#1)(2008-10#1)(2008-5#1)(2010-11#1)(2011-2#1)(2012-2#1)
the approach of##17##3##(1993-9#2)(1994-9#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-5#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#1)
the approach presented##3##3##(2008-3#1)(2008-7#1)(2010-10#1)
the approach taken##3##3##(1991-12#1)(2006-4#1)(2008-11#1)
the approach to a##2##4##(1993-6#1)(2008-11#1)
the approach to the##5##4##(1992-8#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-7#1)
the approach to this##2##4##(2009-2#1)(2010-11#1)
the approach to##37##3##(1991-2#1)(1992-8#1)(1993-6#1)(1995-1#1)(1997-8#1)(2004-10#1)(2004-3#1)(2005-8#1)(2006-10#2)(2006-5#1)(2006-7#1)(2007-12#2)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-4#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
the approach used in##3##4##(1996-8#1)(2006-10#1)(2008-3#1)
the approach used##5##3##(1996-8#1)(2006-10#1)(2006-3#1)(2007-8#1)(2008-3#1)
the approach using##4##3##(2008-9#1)(2013-1#2)(2013-7#1)
the approach with##4##3##(1995-2#1)(1996-8#1)(2008-10#1)(2009-9#1)
the approach##151##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-9#2)(1994-1#1)(1994-4#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-2#1)(1996-5#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#2)(2004-10#1)(2004-3#1)(2004-4#1)(2005-4#1)(2005-5#1)(2005-8#1)(2006-10#3)(2006-3#2)(2006-4#1)(2006-5#2)(2006-7#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-8#5)(2007-9#3)(2008-10#9)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#6)(2008-4#5)(2008-5#2)(2008-7#9)(2008-8#4)(2008-9#3)(2009-10#2)(2009-2#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#5)(2012-2#6)(2012-3#3)(2013-1#8)(2013-7#2)
the approaches of##3##3##(2008-6#1)(2008-8#1)(2012-3#1)
the approaches taken##2##3##(1991-8#1)(1997-3#1)
the approaches that##5##3##(1994-1#1)(2008-11#1)(2009-11#1)(2011-2#1)(2012-12#1)
the approaches to##2##3##(2006-3#1)(2006-8#1)
the approaches used##3##3##(1990-5#1)(2008-12#1)(2013-1#1)
the approaches##31##2##(1990-5#1)(1991-10#1)(1991-8#1)(1994-1#1)(1994-11#1)(1996-12#1)(1997-2#2)(1997-3#1)(2004-2#1)(2006-3#1)(2006-8#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-4#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
the appropriate administrative##2##3##(1994-3#1)(1997-3#1)
the appropriate antibiotic##3##3##(1994-12#1)(1996-6#1)(2013-8#1)
the appropriate authorities##2##3##(2005-8#1)(2008-5#1)
the appropriate choice of##3##4##(2008-2#1)(2012-1#1)(2012-11#1)
the appropriate clinical##4##3##(2007-4#1)(2008-6#1)(2012-1#1)(2012-3#1)
the appropriate combination of##4##4##(1993-11#1)(2007-11#1)(2007-9#1)(2008-10#1)
the appropriate conditions##4##3##(2006-5#1)(2008-1#1)(2009-4#1)(2010-10#1)
the appropriate delivery##2##3##(2007-12#1)(2008-5#1)
the appropriate direction##2##3##(1996-11#1)(2008-10#1)
the appropriate experimental##2##3##(2008-10#1)(2008-9#1)
the appropriate extraction##2##3##(1996-7#1)(2008-10#1)
the appropriate function##2##3##(2006-9#1)(2008-8#1)
the appropriate fusion##2##3##(1990-5#1)(1995-12#1)
the appropriate imaging##2##3##(2008-8#1)(2012-1#1)
the appropriate instrument##2##3##(1992-10#1)(2013-8#1)
the appropriate management of##2##4##(2006-10#1)(2008-1#1)
the appropriate management##3##3##(2006-10#1)(2008-1#1)(2008-9#1)
the appropriate number of##2##4##(1992-9#1)(2013-8#1)
the appropriate patient##3##3##(2008-5#1)(2009-12#1)(2012-2#1)
the appropriate patients##2##3##(1994-12#1)(2011-2#1)
the appropriate reconstruction##2##3##(2009-9#1)(2011-2#1)
the appropriate role of##2##4##(2008-3#1)(2008-5#1)
the appropriate role##3##3##(2008-3#1)(2008-5#1)(2012-11#1)
the appropriate sample size##2##4##(1995-3#1)(2008-10#1)
the appropriate sample##3##3##(1995-3#1)(2008-10#2)
the appropriate selection and##2##4##(2007-11#1)(2012-12#1)
the appropriate selection of##4##4##(2006-10#1)(2006-12#1)(2008-8#1)(2012-11#1)
the appropriate selection##7##3##(1993-12#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-8#1)(2012-11#1)(2012-12#1)
the appropriate setting##2##3##(1994-12#1)(2010-12#1)
the appropriate solutions##2##3##(2008-3#1)(2011-1#1)
the appropriate starting##2##3##(2008-2#1)(2013-1#1)
the appropriate steps to##2##4##(2007-11#1)(2008-9#1)
the appropriate steps##3##3##(2007-11#1)(2008-9#1)(2010-2#1)
the appropriate stimulation##2##3##(2008-9#1)(2012-12#1)
the appropriate surgical##4##3##(2006-11#1)(2007-11#1)(2007-8#1)(2008-7#1)
the appropriate target##2##3##(1991-3#1)(2008-5#1)
the appropriate tests##2##3##(2004-1#1)(2007-12#1)
the appropriate therapy##3##3##(1993-2#1)(2006-10#1)(2006-11#1)
the appropriate time##2##3##(2011-1#1)(2013-8#1)
the appropriate timing##2##3##(1997-4#1)(2011-12#1)
the appropriate treatment##7##3##(1992-10#1)(2006-10#1)(2007-2#1)(2009-3#1)(2011-12#1)(2011-2#1)(2012-2#1)
the appropriate type of##4##4##(2006-8#1)(2007-11#1)(2007-7#1)(2008-4#1)
the appropriate type##5##3##(2006-8#1)(2007-11#1)(2007-7#1)(2008-4#2)
the appropriate use of preventive##2##5##(1994-2#2)
the appropriate use of##13##4##(1994-2#2)(2006-12#1)(2006-2#1)(2006-8#1)(2007-2#2)(2007-7#1)(2008-3#1)(2008-4#1)(2011-2#2)(2012-12#1)
the appropriate use##14##3##(1994-2#2)(2006-12#1)(2006-2#1)(2006-8#1)(2007-2#2)(2007-7#1)(2008-3#1)(2008-4#1)(2010-2#1)(2011-2#2)(2012-12#1)
the appropriate utilization of##2##4##(1994-12#1)(2008-3#1)
the appropriate##314##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-3#3)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#3)(1992-12#2)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-4#1)(1993-7#1)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#2)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-3#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-2#1)(1996-4#1)(1996-5#2)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2004-1#1)(2004-12#1)(2004-9#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#6)(2006-11#4)(2006-12#3)(2006-2#1)(2006-3#1)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#2)(2007-11#12)(2007-12#12)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#4)(2008-1#5)(2008-10#25)(2008-11#5)(2008-12#2)(2008-2#9)(2008-3#15)(2008-4#11)(2008-5#9)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#6)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#2)(2010-7#1)(2011-1#3)(2011-12#2)(2011-2#9)(2012-1#5)(2012-11#3)(2012-12#4)(2012-2#8)(2012-3#1)(2013-1#12)(2013-8#8)
the appropriately##2##2##(2005-11#1)(2007-12#1)
the appropriateness of a##3##4##(2006-2#1)(2008-12#1)(2010-11#1)
the appropriateness of the##8##4##(1991-12#1)(1992-1#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-4#1)(2011-2#1)
the appropriateness of using##2##4##(1995-5#1)(2008-11#1)
the appropriateness of various##2##4##(2008-2#1)(2008-6#1)
the appropriateness of##31##3##(1991-12#1)(1992-1#1)(1993-9#1)(1995-5#1)(1996-2#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#3)(2007-7#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-11#2)(2010-6#1)(2011-2#1)(2013-8#1)
the appropriateness##34##2##(1991-12#1)(1992-1#1)(1993-9#1)(1995-3#1)(1995-5#1)(1996-2#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#3)(2007-7#2)(2007-8#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-11#2)(2010-6#1)(2011-2#1)(2013-8#1)
the appropriation##2##2##(1995-6#2)
the approval and##2##3##(2005-8#1)(2008-10#1)
the approval of the##4##4##(1992-8#1)(2005-5#1)(2007-9#1)(2010-11#1)
the approval of##12##3##(1992-8#1)(1993-12#1)(2005-5#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-3#1)(2008-8#2)(2009-9#1)(2010-11#1)(2010-4#1)
the approval##17##2##(1991-3#1)(1992-8#1)(1993-12#1)(2005-5#1)(2005-8#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#2)(2009-9#1)(2010-11#1)(2010-4#1)
the approved##6##2##(2006-2#1)(2008-12#1)(2008-8#1)(2009-3#1)(2011-1#1)(2013-1#1)
the approximate size##2##3##(1994-9#1)(2008-3#1)
the approximate##33##2##(1991-2#2)(1992-4#1)(1992-6#1)(1993-9#1)(1994-9#2)(1995-12#1)(1995-4#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2004-9#1)(2005-11#1)(2006-1#1)(2008-2#6)(2008-3#3)(2008-4#2)(2008-5#2)(2009-2#1)(2009-9#1)(2012-1#1)
the approximately 2##2##3##(1990-4#1)(1995-2#1)
the approximately 20##2##3##(1990-5#1)(2006-10#1)
the approximately 3##2##3##(1995-8#1)(2008-3#1)
the approximately 50-kDa fragment##3##4##(1990-3#3)
the approximately 69-kDa##2##3##(1991-4#2)
the approximately##28##2##(1990-11#1)(1990-2#1)(1990-3#4)(1990-4#1)(1990-5#1)(1990-8#1)(1991-4#2)(1992-2#1)(1993-8#1)(1993-9#1)(1995-2#1)(1995-8#1)(1997-4#1)(1997-5#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-7#1)(2010-3#1)(2010-5#1)(2011-12#1)
the approximation error##3##3##(2008-2#2)(2011-1#1)
the approximation is##2##3##(2007-12#1)(2008-3#1)
the approximation##18##2##(1990-8#1)(1996-3#1)(1997-4#1)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#4)(2009-9#1)(2011-1#1)(2012-1#1)(2013-1#1)
the approximations##2##2##(2008-2#1)(2008-3#1)
the aprX mutant##2##3##(2008-10#2)
the aprX##3##2##(2008-10#3)
the apricot##2##2##(2008-10#1)(2012-8#1)
the apron and##3##3##(2006-8#3)
the apron##7##2##(2006-8#7)
the aptamer##4##2##(2007-11#1)(2010-5#1)(2011-1#1)(2012-1#1)
the apx III A gene##2##5##(2005-11#2)
the aqua regia extraction##3##4##(2008-10#3)
the aqua regia##4##3##(2008-10#4)
the aqua##5##2##(1994-6#1)(2008-10#4)
the aquaculture##2##2##(2010-4#1)(2012-1#1)
the aquarium##2##2##(2007-3#1)(2007-5#1)
the aquatic environment of##2##4##(2008-11#1)(2012-11#1)
the aquatic environment##15##3##(1993-9#1)(1996-11#1)(2004-4#5)(2008-10#4)(2008-11#1)(2008-7#1)(2010-8#1)(2012-11#1)
the aquatic habitat##3##3##(2008-9#2)(2011-2#1)
the aquatic macrophyte Stratiotes aloides##2##5##(2010-6#2)
the aquatic macrophyte##3##3##(2010-6#2)(2013-7#1)
the aquatic##38##2##(1993-9#1)(1996-11#1)(2004-4#5)(2007-3#1)(2007-7#2)(2008-10#11)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#4)(2010-6#2)(2010-8#2)(2011-12#2)(2011-2#1)(2012-11#1)(2013-7#2)
the aquation process##3##3##(1992-1#1)(2008-10#2)
the aquation##4##2##(1992-1#1)(2008-10#3)
the aqueous and ethanol##2##4##(2010-3#2)
the aqueous and methanol extracts##3##5##(2011-2#3)
the aqueous and organic##3##4##(2007-8#1)(2010-4#2)
the aqueous and##14##3##(1992-6#1)(1994-5#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-8#1)(2008-10#1)(2010-3#2)(2010-4#2)(2011-2#3)
the aqueous environment##4##3##(1995-12#1)(2007-12#1)(2008-10#1)(2009-12#1)
the aqueous extract of the leaves##3##6##(2008-4#2)(2010-3#1)
the aqueous extract of the##5##5##(2008-4#3)(2010-2#1)(2010-3#1)
the aqueous extract of##13##4##(2007-1#1)(2008-4#5)(2008-5#1)(2010-2#3)(2010-3#1)(2011-1#2)
the aqueous extract##17##3##(2007-1#1)(2008-11#1)(2008-4#6)(2008-5#1)(2010-2#3)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#1)
the aqueous extracts##2##3##(2008-11#1)(2009-5#1)
the aqueous glucose##3##3##(2008-2#3)
the aqueous ion-pair formation (K(MLA))##2##5##(2008-10#2)
the aqueous layer##4##3##(2008-10#2)(2009-4#1)(2010-4#1)
the aqueous medium##2##3##(1993-2#1)(2008-10#1)
the aqueous phase and##7##4##(1995-1#1)(2007-6#1)(2008-10#4)(2010-4#1)
the aqueous phase as a##2##5##(2008-10#1)(2008-7#1)
the aqueous phase as##3##4##(2005-11#1)(2008-10#1)(2008-7#1)
the aqueous phase##49##3##(1990-2#1)(1990-4#1)(1990-5#1)(1991-5#1)(1992-3#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-9#1)(1995-1#1)(1997-1#1)(2004-12#2)(2005-11#2)(2005-4#1)(2006-10#1)(2006-12#1)(2007-6#1)(2008-10#21)(2008-5#2)(2008-7#2)(2010-4#1)(2010-5#2)
the aqueous sample##2##3##(2008-10#2)
the aqueous samples##2##3##(2008-10#2)
the aqueous solution was##3##4##(2005-11#1)(2008-10#2)
the aqueous solution##16##3##(1994-11#1)(1996-4#1)(1997-2#1)(2005-11#1)(2005-4#1)(2007-9#1)(2008-10#8)(2008-5#2)
the aqueous solutions were##2##4##(1991-12#1)(2008-10#1)
the aqueous solutions##4##3##(1991-12#1)(2008-10#3)
the aqueous solvent##3##3##(1991-2#1)(2008-10#1)(2009-12#1)
the aqueous subphase##3##3##(1992-12#1)(1994-3#1)(2005-11#1)
the aqueous system##2##3##(2007-10#1)(2008-10#1)
the aqueous to##2##3##(2008-10#2)
the aqueous two-phase##3##3##(1992-11#1)(2008-10#1)(2008-6#1)
the aqueous##186##2##(1990-10#1)(1990-2#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#3)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-5#2)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#1)(2004-12#2)(2005-11#7)(2005-4#2)(2006-10#2)(2006-11#1)(2006-12#2)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#64)(2008-11#2)(2008-12#3)(2008-2#3)(2008-4#6)(2008-5#7)(2008-6#2)(2008-7#2)(2009-12#2)(2009-4#1)(2009-5#1)(2010-2#4)(2010-3#3)(2010-4#10)(2010-5#2)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#2)
the aquifer##3##2##(2004-4#1)(2006-10#1)(2008-10#1)
the aquo-met##3##2##(1995-3#3)
the arabinose strain##2##3##(2008-6#2)
the arachidonate##2##2##(1992-4#1)(1993-7#1)
the arachidonic acid##5##3##(1990-11#1)(1990-4#1)(1990-7#1)(1994-3#1)(2006-8#1)
the arachidonic##6##2##(1990-11#1)(1990-4#1)(1990-7#1)(1991-4#1)(1994-3#1)(2006-8#1)
the arbitrarily##2##2##(1993-12#1)(2007-12#1)
the arbitrary##2##2##(1990-2#1)(2011-2#1)
the arbuscular##2##2##(2008-10#1)(2010-10#1)
the arc discharge composite##3##4##(2008-10#3)
the arc discharge##4##3##(2008-10#4)
the arc##7##2##(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)
the arch of aorta##2##4##(2011-1#2)
the arch##5##2##(2007-11#1)(2007-7#1)(2011-1#2)(2012-12#1)
the archaea##2##2##(2006-10#1)(2009-8#1)
the archaebacteria##2##2##(1990-12#1)(1990-2#1)
the archaebacterial##3##2##(1990-12#1)(1990-3#1)(1994-2#1)
the archaebacterium##6##2##(1990-3#1)(1992-2#1)(1992-7#1)(1994-9#1)(1995-2#2)
the archaeological##5##2##(2006-7#2)(2008-10#2)(2008-3#1)
the archenteron##2##2##(2008-4#1)(2008-5#1)
the archetypal##4##2##(1990-8#1)(1993-2#1)(1997-1#1)(2008-7#1)
the archetype##3##2##(1994-11#1)(1996-2#1)(2007-12#1)
the architectural##4##2##(1995-8#1)(1996-2#1)(1997-7#1)(2008-3#1)
the architecture and##4##3##(2007-12#1)(2008-4#1)(2009-12#1)(2009-5#1)
the architecture of a##2##4##(2007-12#1)(2008-2#1)
the architecture of the##9##4##(1993-5#1)(1994-2#1)(1997-4#1)(2007-11#1)(2007-6#1)(2008-5#1)(2009-6#1)(2011-1#2)
the architecture of##15##3##(1993-5#1)(1994-11#1)(1994-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-2#1)(2008-5#1)(2009-2#1)(2009-6#1)(2010-11#1)(2011-1#2)(2013-7#1)
the architecture##25##2##(1991-11#1)(1993-5#1)(1994-11#1)(1994-2#1)(1997-4#1)(2007-11#1)(2007-12#3)(2007-6#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-11#1)(2011-1#2)(2013-7#1)
the archival##4##2##(1992-1#1)(1996-2#1)(1996-3#1)(2009-9#1)
the archive##4##2##(2005-7#2)(2006-10#1)(2008-10#1)
the archives of the##4##4##(1994-3#2)(1994-6#1)(2008-10#1)
the archives of##6##3##(1994-3#2)(1994-6#1)(2008-10#1)(2008-2#1)(2008-5#1)
the arcjet plume##4##3##(2008-3#4)
the arcjet##6##2##(2008-2#2)(2008-3#4)
the arcjet's##2##2##(2008-3#2)
the arctic##4##2##(1991-11#1)(1991-5#1)(2010-6#1)(2012-3#1)
the arcuate eminence was##2##4##(2006-12#2)
the arcuate eminence##6##3##(2006-12#5)(2008-7#1)
the arcuate nucleus of the hypothalamus##3##6##(1993-5#1)(1996-12#1)(2006-1#1)
the arcuate nucleus of the##4##5##(1993-5#1)(1996-12#1)(1997-3#1)(2006-1#1)
the arcuate nucleus##14##3##(1993-5#5)(1994-2#1)(1996-12#1)(1997-3#2)(2006-1#1)(2010-10#4)
the arcuate##26##2##(1990-11#1)(1993-2#1)(1993-5#5)(1994-2#1)(1995-12#1)(1996-12#1)(1997-3#2)(2006-1#1)(2006-12#6)(2008-4#1)(2008-7#1)(2010-10#5)
the are##2##2##(2006-6#1)(2008-4#1)
the area and the##2##4##(1997-8#1)(2008-2#1)
the area and##6##3##(1994-11#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-2#1)(2009-4#1)
the area are##2##3##(2007-5#1)(2008-12#1)
the area around the##4##4##(1992-1#1)(1993-1#1)(2005-10#1)(2008-5#1)
the area around##5##3##(1992-1#1)(1993-1#1)(2005-10#1)(2008-10#1)(2008-5#1)
the area between the##2##4##(1994-11#1)(2006-10#1)
the area covered##2##3##(1994-6#1)(2008-11#1)
the area from##2##3##(2006-6#1)(2010-9#1)
the area in which##2##4##(1992-11#1)(2012-1#1)
the area in##3##3##(1992-11#1)(2008-6#1)(2012-1#1)
the area into##2##3##(2007-10#1)(2007-12#1)
the area irradiated##2##3##(1997-3#1)(2008-10#1)
the area is##2##3##(2008-10#1)(2008-11#1)
the area occupied by##2##4##(1994-12#1)(2004-9#1)
the area of Toamasina##3##4##(2007-2#3)
the area of artificial##2##4##(2009-11#1)(2012-1#1)
the area of convergence##3##4##(2013-7#3)
the area of interest##3##4##(1990-6#1)(2007-11#1)(2008-10#1)
the area of overlap##2##4##(1995-8#1)(2010-4#1)
the area of pain##2##4##(2006-3#1)(2010-7#1)
the area of primary##2##4##(1993-8#1)(1996-1#1)
the area of sexual##2##4##(1996-12#1)(2010-3#1)
the area of the##44##4##(1991-2#1)(1991-3#3)(1992-3#1)(1992-6#1)(1993-3#1)(1995-8#1)(1997-2#1)(1997-3#2)(2004-11#1)(2006-11#1)(2006-12#1)(2006-6#3)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-9#1)(2009-3#1)(2009-4#1)(2011-1#1)(2011-2#2)(2013-1#1)
the area of##212##3##(1990-12#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#4)(1992-1#1)(1992-2#2)(1992-3#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-11#2)(1995-3#2)(1995-5#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#1)(2004-1#1)(2004-11#1)(2004-12#2)(2004-9#1)(2005-1#1)(2005-7#1)(2005-8#1)(2006-10#18)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#5)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#9)(2007-12#2)(2007-2#4)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#6)(2008-10#11)(2008-11#8)(2008-12#2)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#3)(2009-3#4)(2009-4#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#5)(2013-8#5)
the area or##2##3##(2007-8#1)(2010-2#1)
the area postrema##7##3##(1991-1#1)(1991-11#5)(1997-8#1)
the area the##2##3##(2008-10#2)
the area to##3##3##(1992-2#1)(1995-3#1)(2008-10#1)
the area under the curve (AUC)##3##6##(2008-11#1)(2012-12#1)(2012-3#1)
the area under the curve of##2##6##(2005-8#1)(2008-10#1)
the area under the curve##8##5##(1992-9#1)(2005-8#1)(2006-10#1)(2008-10#2)(2008-11#1)(2012-12#1)(2012-3#1)
the area under the disease progress curve (AUDPC)##3##8##(2008-10#3)
the area under the disease progress curve##6##7##(2008-10#6)
the area under the plasma##2##5##(1991-12#1)(2008-8#1)
the area under the receiver operating characteristic curve##3##8##(2006-6#1)(2010-2#2)
the area under the receiver operating curve##2##7##(2012-3#1)(2013-1#1)
the area under the receiver operating##5##6##(2006-6#1)(2010-2#2)(2012-3#1)(2013-1#1)
the area under the##31##4##(1990-1#1)(1990-7#1)(1991-12#1)(1992-9#1)(2005-8#1)(2006-10#1)(2006-6#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-2#2)(2012-1#2)(2012-12#1)(2012-3#2)(2013-1#1)
the area under##35##3##(1990-1#1)(1990-7#1)(1991-12#1)(1991-7#1)(1992-9#1)(1997-3#1)(2005-8#1)(2006-10#1)(2006-6#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-2#2)(2012-1#2)(2012-12#1)(2012-3#2)(2013-1#1)
the area ventralis##2##3##(1997-6#1)(2008-6#1)
the area was##3##3##(2007-10#1)(2008-5#1)(2011-2#1)
the area were##2##3##(2007-3#1)(2008-5#1)
the area where##4##3##(1993-6#1)(1995-1#1)(2008-10#2)
the area##391##2##(1990-1#1)(1990-11#1)(1990-12#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#5)(1991-12#1)(1991-2#1)(1991-3#4)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-2#4)(1992-3#2)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#3)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#2)(1994-3#2)(1994-6#2)(1994-9#1)(1995-1#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#4)(1997-6#2)(1997-8#3)(2004-1#1)(2004-11#1)(2004-12#2)(2004-3#1)(2004-9#2)(2005-1#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#4)(2006-10#22)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#8)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#7)(2007-11#9)(2007-12#3)(2007-2#5)(2007-3#3)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#4)(2007-8#7)(2007-9#7)(2008-1#3)(2008-10#36)(2008-11#13)(2008-12#5)(2008-2#7)(2008-3#9)(2008-4#3)(2008-5#13)(2008-6#3)(2008-7#7)(2008-8#6)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#3)(2009-12#1)(2009-3#4)(2009-4#2)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#9)(2012-1#5)(2012-12#8)(2012-2#4)(2012-3#3)(2012-9#1)(2013-1#5)(2013-7#7)(2013-8#6)
the areas for##4##3##(1992-2#1)(1995-5#1)(2013-1#2)
the areas of BAP and##2##5##(2007-8#2)
the areas of both##2##4##(1990-12#1)(2010-11#1)
the areas of more##2##4##(2007-11#2)
the areas of potential##2##4##(1991-1#1)(1991-2#1)
the areas of the##6##4##(1995-1#1)(2005-6#1)(2009-4#1)(2011-1#2)(2013-1#1)
the areas of##66##3##(1990-12#1)(1991-1#1)(1991-2#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-8#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-2#1)(2005-6#1)(2005-7#1)(2006-10#3)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#5)(2008-1#1)(2008-11#2)(2008-12#4)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#2)(2012-1#2)(2013-1#3)(2013-8#2)
the areas that##2##3##(2007-1#1)(2009-4#1)
the areas under##2##3##(2008-10#1)(2012-12#1)
the areas was##2##3##(2007-10#1)(2008-6#1)
the areas where##4##3##(1997-8#1)(2006-8#1)(2008-7#2)
the areas with##2##3##(2009-2#1)(2011-1#1)
the areas##105##2##(1990-12#1)(1991-1#1)(1991-2#1)(1992-2#2)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-8#1)(1994-10#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-1#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-8#1)(2005-6#1)(2005-7#1)(2006-10#5)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#2)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#1)(2008-6#3)(2008-7#3)(2009-2#1)(2009-3#1)(2009-4#2)(2009-8#2)(2010-10#1)(2010-11#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#1)(2013-1#5)(2013-8#2)
the arena of##8##3##(1990-5#1)(2005-6#1)(2006-10#1)(2007-5#1)(2007-6#1)(2008-5#1)(2009-3#1)(2012-3#1)
the arena##9##2##(1990-5#1)(2005-6#1)(2006-10#1)(2007-5#1)(2007-6#1)(2008-11#1)(2008-5#1)(2009-3#1)(2012-3#1)
the arginine##9##2##(1990-6#1)(1991-8#1)(1992-4#1)(1995-2#1)(1997-4#2)(2006-2#1)(2008-5#1)(2008-7#1)
the argon beam coagulator##3##4##(1993-12#2)(1994-3#1)
the argon##6##2##(1993-12#2)(1994-3#1)(1995-3#1)(2008-10#1)(2008-5#1)
the argon/water interface##4##3##(1994-3#4)
the argument for##2##3##(1996-1#2)
the argument that the##2##4##(1993-6#1)(1996-6#1)
the argument that##8##3##(1993-6#1)(1995-6#1)(1996-6#1)(1997-1#1)(2008-10#1)(2008-8#2)(2010-3#1)
the argument##20##2##(1993-6#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-6#1)(1997-1#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#3)(2010-3#1)(2012-1#1)(2012-12#1)
the arguments favoring##2##3##(2007-4#2)
the arguments for##2##3##(2007-4#1)(2011-2#1)
the arguments##8##2##(1996-2#1)(2007-4#3)(2008-9#1)(2009-4#1)(2010-11#1)(2011-2#1)
the arithmetic mean##2##3##(1991-8#1)(2009-11#1)
the arithmetic of##2##3##(2007-12#1)(2008-8#1)
the arithmetic##5##2##(1991-8#1)(2007-12#1)(2008-8#1)(2009-11#1)(2010-2#1)
the arm and##3##3##(1990-11#1)(2006-11#1)(2007-12#1)
the arm as##2##3##(2008-7#1)(2011-2#1)
the arm cavity##2##3##(2008-2#2)
the arm was##2##3##(1993-6#1)(2007-11#1)
the arm##40##2##(1990-11#2)(1992-10#1)(1993-12#1)(1993-6#2)(1994-5#1)(1996-9#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#4)(2008-9#1)(2009-12#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#7)(2013-1#1)
the armamentarium of the reconstructive surgeon##2##6##(2007-12#2)
the armamentarium of the##6##4##(2006-2#1)(2007-12#4)(2011-2#1)
the armamentarium of##13##3##(1996-7#1)(2005-7#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#4)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
the armamentarium##17##2##(1996-7#1)(2005-7#1)(2006-10#1)(2006-2#2)(2006-7#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-3#1)
the armed##2##2##(2008-10#1)(2011-1#1)
the arms and##3##3##(1996-7#1)(2006-10#1)(2007-5#1)
the arms of##3##3##(1996-2#1)(2007-7#1)(2012-2#1)
the arms##15##2##(1995-5#1)(1996-2#1)(1996-7#1)(2006-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-2#1)(2009-12#3)(2010-3#1)(2010-6#1)(2012-2#1)
the army##3##2##(2007-9#1)(2013-1#2)
the armyworm larvae##2##3##(1992-1#2)
the armyworm##3##2##(1992-1#2)(1992-6#1)
the aroC gene##2##3##(1990-3#2)
the aroma##4##2##(2006-12#1)(2008-10#3)
the aromatase activity##2##3##(1990-4#1)(1993-8#1)
the aromatase inhibitor##3##3##(1996-8#1)(2004-1#1)(2008-5#1)
the aromatase##8##2##(1990-4#1)(1991-5#1)(1993-8#3)(1996-8#1)(2004-1#1)(2008-5#1)
the aromatic OH group##2##4##(2007-11#2)
the aromatic hydrocarbon receptor##2##4##(1992-12#1)(2008-10#1)
the aromatic nucleus##2##3##(2006-8#1)(2008-10#1)
the aromatic ring and the##2##5##(1995-8#1)(1996-8#1)
the aromatic ring of##2##4##(1993-6#1)(1997-8#1)
the aromatic ring##15##3##(1993-12#1)(1993-6#1)(1995-8#1)(1996-8#1)(1997-2#1)(1997-8#3)(2007-11#1)(2007-8#1)(2009-9#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-2#1)
the aromatic rings of##4##4##(1994-9#1)(2008-5#2)(2010-5#1)
the aromatic rings##6##3##(1994-9#1)(2007-11#1)(2007-12#1)(2008-5#2)(2010-5#1)
the aromatic##49##2##(1991-10#1)(1992-12#3)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#4)(2005-11#1)(2006-12#1)(2006-8#1)(2007-11#5)(2007-12#1)(2007-8#1)(2008-10#7)(2008-5#3)(2009-9#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#1)(2012-2#1)
the arotinoid##3##2##(1993-9#3)
the arrangement of the##2##4##(2008-7#2)
the arrangement of##11##3##(1992-3#1)(1994-5#1)(2005-11#1)(2006-5#1)(2007-4#1)(2008-7#3)(2009-8#1)(2011-2#1)(2012-2#1)
the arrangement##15##2##(1992-3#1)(1993-12#1)(1994-5#1)(1996-3#1)(2005-11#1)(2006-5#1)(2007-4#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#1)
the array and##5##3##(2007-8#1)(2008-10#2)(2008-4#1)(2012-3#1)
the array is##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
the array of##8##3##(1990-8#1)(1991-3#1)(2008-10#1)(2008-11#1)(2009-5#1)(2009-6#1)(2011-12#1)(2011-2#1)
the array surface##2##3##(2007-8#2)
the array to##2##3##(2008-10#1)(2012-3#1)
the array was##2##3##(2008-10#1)(2011-2#1)
the array##52##2##(1990-8#1)(1991-11#1)(1991-3#1)(2007-11#1)(2007-12#5)(2007-8#4)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#8)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-3#3)(2013-7#1)
the arrayed##3##2##(2008-2#1)(2008-3#1)(2010-12#1)
the arrays##5##2##(2006-5#1)(2007-12#1)(2008-10#2)(2008-7#1)
the arrest of##6##3##(1991-5#1)(1992-6#1)(1996-5#1)(2004-11#1)(2007-7#1)(2012-3#1)
the arrest##8##2##(1991-5#1)(1992-6#1)(1995-1#1)(1996-5#1)(2004-11#1)(2007-7#1)(2007-8#1)(2012-3#1)
the arrested polymerase##2##3##(1994-8#2)
the arrested##12##2##(1991-2#1)(1992-3#1)(1994-8#2)(2006-6#1)(2007-12#1)(2007-8#5)(2008-11#1)
the arrhythmia##4##2##(1991-9#1)(1995-6#1)(2009-4#1)(2012-2#1)
the arrhythmogenic##2##2##(1995-4#1)(2008-10#1)
the arrival of##6##3##(1991-3#1)(2007-2#1)(2008-9#1)(2009-8#1)(2010-9#1)(2012-12#1)
the arrival##8##2##(1991-3#1)(2007-2#1)(2008-1#2)(2008-9#1)(2009-8#1)(2010-9#1)(2012-12#1)
the arrythmia-free period in patients suffering from atrial fibrillation##2##9##(2005-7#2)
the arsenal of##3##3##(1992-4#1)(2008-10#1)(2011-12#1)
the arsenal##4##2##(1992-4#1)(2008-10#2)(2011-12#1)
the arsenic and selenium##2##4##(2008-10#2)
the arsenic and##3##3##(2008-10#3)
the arsenic content of##2##4##(1996-7#1)(2008-10#1)
the arsenic content##3##3##(1996-7#1)(2008-10#1)(2013-1#1)
the arsenic species##6##3##(2008-10#6)
the arsenic##27##2##(1996-7#1)(2008-10#17)(2008-4#1)(2009-7#1)(2011-2#2)(2013-1#5)
the arsine##2##2##(2008-10#2)
the art and##10##3##(1993-3#1)(1994-6#1)(2005-10#1)(2006-8#2)(2007-5#1)(2008-11#1)(2010-11#1)(2012-12#1)(2013-1#1)
the art of##24##3##(1991-4#1)(1992-2#1)(1993-3#1)(1996-9#1)(1997-7#2)(2005-10#1)(2006-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
the art##96##2##(1991-12#1)(1991-4#1)(1991-9#1)(1992-2#1)(1993-3#3)(1994-6#2)(1994-8#1)(1995-2#1)(1995-5#2)(1996-3#1)(1996-9#1)(1997-7#2)(2004-2#1)(2005-10#2)(2005-8#1)(2006-10#2)(2006-12#3)(2006-4#1)(2006-6#2)(2006-8#3)(2006-9#1)(2007-12#2)(2007-4#1)(2007-5#3)(2007-8#4)(2007-9#2)(2008-1#4)(2008-10#4)(2008-11#3)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#2)(2009-4#2)(2009-5#1)(2010-11#1)(2010-12#2)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
the arterial and venous##5##4##(1990-10#2)(1993-2#1)(1997-5#1)(2008-2#1)
the arterial and##10##3##(1990-10#2)(1990-2#1)(1993-12#1)(1993-2#1)(1997-5#1)(2005-10#1)(2007-7#1)(2008-2#1)(2008-7#1)
the arterial blood pressure##2##4##(1991-6#1)(1997-5#1)
the arterial blood##10##3##(1990-4#1)(1991-6#1)(1993-12#1)(1994-6#1)(1996-3#1)(1996-7#1)(1997-5#1)(2008-2#2)(2008-4#1)
the arterial intima##4##3##(1992-12#3)(2008-10#1)
the arterial lumen##4##3##(1990-5#1)(1992-12#1)(1997-4#1)(2008-7#1)
the arterial perfusion##2##3##(2008-7#1)(2012-2#1)
the arterial supply##2##3##(2006-6#1)(2013-7#1)
the arterial switch operation for##2##5##(2009-4#1)(2010-6#1)
the arterial switch##3##3##(2007-8#1)(2009-4#1)(2010-6#1)
the arterial system##3##3##(2008-3#1)(2008-9#2)
the arterial thrombotic risk##2##4##(2007-12#2)
the arterial thrombotic##3##3##(2007-12#3)
the arterial vasodilatation##2##3##(1997-7#2)
the arterial wall and##2##4##(2008-6#1)(2008-9#1)
the arterial wall##18##3##(1992-12#3)(1992-4#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-1#1)(2009-4#1)(2011-2#1)(2013-1#2)
the arterial##98##2##(1990-10#3)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#7)(1992-4#1)(1993-1#1)(1993-10#1)(1993-12#2)(1993-2#1)(1994-6#1)(1995-4#1)(1995-8#1)(1996-12#1)(1996-3#2)(1996-7#1)(1997-4#1)(1997-5#2)(1997-7#2)(1997-8#2)(2005-10#1)(2006-6#3)(2007-10#1)(2007-12#3)(2007-7#7)(2007-8#2)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#4)(2009-1#1)(2009-3#1)(2009-4#2)(2010-11#3)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
the arteries of##2##3##(1991-3#1)(2008-2#1)
the arteries##7##2##(1991-3#1)(1993-11#2)(2007-8#2)(2008-2#1)(2008-7#1)
the arterio-venous##2##2##(1997-6#1)(2008-1#1)
the arterioarterial graft##2##3##(2008-1#2)
the arteriovenous fistula (AVF)##2##4##(2007-8#1)(2010-4#1)
the arteriovenous fistula##3##3##(1993-6#1)(2007-8#1)(2010-4#1)
the arteriovenous malformation##2##3##(2008-7#2)
the arteriovenous##6##2##(1993-6#1)(2007-8#1)(2008-7#2)(2010-4#1)(2011-3#1)
the artery and the##2##4##(2007-7#1)(2008-7#1)
the artery and##3##3##(2007-7#1)(2008-4#1)(2008-7#1)
the artery in##2##3##(2007-7#1)(2012-2#1)
the artery was##3##3##(1992-7#1)(2008-7#1)(2012-3#1)
the artery##33##2##(1991-7#1)(1992-3#1)(1992-7#1)(1993-10#1)(1995-12#1)(1996-8#1)(1997-2#1)(2005-1#1)(2006-11#1)(2006-12#1)(2006-6#2)(2007-3#1)(2007-7#4)(2008-10#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2011-2#2)(2012-2#2)(2012-3#1)
the arthritic##3##2##(1996-1#1)(2010-5#1)(2012-2#1)
the arthritides##2##2##(1994-5#1)(2008-9#1)
the arthritis as well as the##2##6##(2006-10#1)(2009-5#1)
the arthritis##8##2##(1992-11#1)(1992-8#1)(2006-10#4)(2006-4#1)(2009-5#1)
the arthrodesis##3##2##(2006-3#1)(2008-6#1)(2012-3#1)
the arthroplasty##4##2##(2007-11#1)(2008-8#1)(2011-2#1)(2012-12#1)
the arthropod fauna of##2##4##(2008-5#1)(2008-6#1)
the arthropod fauna##3##3##(2008-5#2)(2008-6#1)
the arthropod##14##2##(2007-12#5)(2007-5#1)(2008-5#2)(2008-6#3)(2008-9#1)(2011-2#1)(2012-12#1)
the arthroscopic##6##2##(2006-4#1)(2007-11#1)(2007-7#1)(2008-5#1)(2009-9#1)(2013-1#1)
the article &quot##6##3##(1993-7#1)(1995-2#1)(2005-6#1)(2007-2#2)(2008-7#1)
the article also##2##3##(1993-1#1)(2011-2#1)
the article are##2##3##(2010-11#1)(2012-3#1)
the article by##3##3##(1990-8#1)(1995-2#1)(2006-6#1)
the article concludes that##2##4##(2007-4#1)(2012-2#1)
the article concludes##3##3##(1996-6#1)(2007-4#1)(2012-2#1)
the article describes##4##3##(1993-3#1)(1994-1#1)(2010-2#1)(2012-12#1)
the article discusses the##4##4##(1990-12#1)(1994-1#2)(2009-4#1)
the article examines the##2##4##(2007-4#1)(2012-12#1)
the article examines##3##3##(2007-4#1)(2010-7#1)(2012-12#1)
the article explores the##2##4##(2007-4#1)(2010-7#1)
the article focuses on the##2##5##(2005-6#1)(2006-10#1)
the article focuses on##3##4##(1991-2#1)(2005-6#1)(2006-10#1)
the article identifies##3##3##(1997-3#1)(2007-4#1)(2010-7#1)
the article includes##2##3##(1994-1#1)(2008-12#1)
the article on##38##3##(1990-5#1)(2005-12#3)(2005-7#1)(2006-3#3)(2008-11#3)(2008-12#2)(2008-7#5)(2009-3#6)(2009-5#2)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
the article provides an overview of##2##6##(1995-12#1)(2009-4#1)
the article provides##4##3##(1995-12#1)(2007-4#1)(2008-12#1)(2009-4#1)
the article will##2##3##(2008-12#1)(2010-8#1)
the article##142##2##(1990-10#1)(1990-12#4)(1990-5#1)(1990-8#1)(1991-2#1)(1991-4#1)(1993-1#1)(1993-3#3)(1993-6#1)(1993-7#1)(1994-1#5)(1994-12#1)(1995-12#1)(1995-2#3)(1995-3#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-6#1)(2005-12#3)(2005-6#2)(2005-7#2)(2006-10#3)(2006-3#3)(2006-5#1)(2006-6#1)(2006-7#2)(2007-10#1)(2007-12#1)(2007-2#2)(2007-4#5)(2008-1#1)(2008-11#5)(2008-12#5)(2008-2#1)(2008-6#1)(2008-7#6)(2009-10#1)(2009-3#6)(2009-4#4)(2009-5#3)(2009-6#1)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#3)(2010-2#1)(2010-6#2)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#5)(2011-3#1)(2012-11#3)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#5)(2013-8#1)
the articles published in this issue of the Review##2##9##(1997-2#1)(1997-3#1)
the articles published in this##3##5##(1997-2#1)(1997-3#1)(2008-10#1)
the articles that##3##3##(2006-10#1)(2009-4#1)(2011-2#1)
the articles##23##2##(1992-6#2)(1994-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-8#2)(2007-6#1)(2008-10#5)(2009-4#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
the articular capsule##2##3##(2007-11#1)(2007-8#1)
the articular cartilage of the##2##5##(2007-8#2)
the articular cartilage##10##3##(1997-6#1)(2006-11#1)(2006-6#1)(2007-11#1)(2007-8#3)(2008-1#1)(2008-5#1)(2008-8#1)
the articular cavity##4##3##(2007-11#2)(2009-2#1)(2013-1#1)
the articular manifestations##2##3##(2006-10#1)(2010-4#1)
the articular surface and##2##4##(1991-10#1)(2012-2#1)
the articular surface##9##3##(1991-10#1)(2006-3#2)(2007-11#2)(2008-12#1)(2008-8#1)(2010-12#1)(2012-2#1)
the articular surfaces##3##3##(2006-3#1)(2007-11#2)
the articular##37##2##(1991-10#1)(1994-12#1)(1997-6#1)(2006-10#1)(2006-11#1)(2006-3#4)(2006-6#1)(2007-11#9)(2007-8#4)(2008-1#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-2#1)(2010-11#1)(2010-12#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
the articulation between##2##3##(1994-3#1)(2013-1#1)
the articulation of##4##3##(1994-12#1)(1994-6#1)(2006-6#1)(2008-12#1)
the articulation##7##2##(1994-12#1)(1994-3#1)(1994-6#1)(2006-6#1)(2008-12#1)(2010-12#1)(2013-1#1)
the artifact##4##2##(2008-2#1)(2008-3#3)
the artificial and the##3##4##(2009-2#1)(2012-11#2)
the artificial electron##2##3##(1995-2#1)(2008-11#1)
the artificial neural network##3##4##(2006-12#2)(2008-10#1)
the artificial neural##6##3##(2006-12#4)(2008-10#2)
the artificial peptides##2##3##(1991-7#2)
the artificial promotor##2##3##(2007-9#2)
the artificial sandbar opening##2##4##(2013-7#2)
the artificial sandbar##3##3##(2013-7#3)
the artificial seawater##3##3##(2007-8#1)(2008-10#2)
the artificial tendons##2##3##(2012-1#2)
the artificial##57##2##(1990-11#1)(1990-2#1)(1990-7#2)(1991-7#2)(1991-9#2)(1992-12#1)(1992-2#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(2005-10#1)(2005-4#1)(2005-6#1)(2006-12#4)(2006-5#1)(2007-8#2)(2007-9#2)(2008-10#10)(2008-11#1)(2008-3#1)(2008-5#4)(2009-2#1)(2011-12#1)(2011-2#1)(2012-1#4)(2012-11#2)(2012-2#2)(2013-7#3)(2013-8#1)
the artificially##2##2##(1992-8#1)(2008-5#1)
the artisanal##5##2##(2007-5#1)(2008-5#1)(2013-7#3)
the arts##3##2##(2010-7#1)(2011-2#1)(2013-1#1)
the artwork##2##2##(2007-8#2)
the aryepiglottic fold##2##3##(2013-8#2)
the aryl hydrocarbon receptor##6##4##(1995-5#1)(2008-10#2)(2008-7#2)(2013-1#1)
the aryl hydrocarbon##7##3##(1995-11#1)(1995-5#1)(2008-10#2)(2008-7#2)(2013-1#1)
the aryl##8##2##(1992-6#1)(1995-11#1)(1995-5#1)(2008-10#2)(2008-7#2)(2013-1#1)
the arylidene##2##2##(1997-2#2)
the arylpiperazine##2##2##(1997-1#2)
the as-prepared##5##2##(2008-10#1)(2009-7#1)(2010-4#1)(2013-1#1)(2013-7#1)
the asbestos##4##2##(1991-12#2)(2008-2#1)(2010-9#1)
the ascending and descending##2##4##(2007-1#1)(2007-8#1)
the ascending aorta and the##2##5##(1993-5#1)(2008-4#1)
the ascending aorta and##3##4##(1993-5#1)(2008-11#1)(2008-4#1)
the ascending aorta undergoing coronary surgery##2##6##(2007-8#2)
the ascending aorta was##5##4##(1997-5#1)(2007-8#4)
the ascending aorta with a##3##5##(1990-6#1)(2007-8#2)
the ascending aorta with##5##4##(1990-6#1)(2007-8#4)
the ascending aorta##49##3##(1990-6#1)(1993-10#2)(1993-5#1)(1997-5#4)(1997-8#2)(2007-8#29)(2008-11#2)(2008-3#1)(2008-4#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)
the ascending colon##3##3##(1993-9#1)(2006-8#1)(2013-7#1)
the ascending##69##2##(1990-6#1)(1991-8#1)(1992-4#1)(1993-10#2)(1993-5#2)(1993-9#1)(1996-12#1)(1996-9#1)(1997-5#4)(1997-8#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-8#30)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2009-5#1)(2010-10#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#2)(2013-3#2)(2013-7#1)
the ascidian##7##2##(1991-12#1)(1993-6#1)(1996-2#1)(2008-5#2)(2008-6#1)(2008-7#1)
the ascites##8##2##(1991-4#2)(1997-3#1)(2005-9#1)(2008-4#1)(2011-2#1)(2013-1#2)
the ascitic fluid##5##3##(1995-7#1)(2007-12#2)(2008-1#1)(2009-9#1)
the ascitic##6##2##(1992-8#1)(1995-7#1)(2007-12#2)(2008-1#1)(2009-9#1)
the ascomycete fungus##4##3##(1993-3#1)(2006-9#1)(2008-10#1)(2011-1#1)
the ascomycete##7##2##(1993-3#1)(2006-9#1)(2008-10#4)(2011-1#1)
the ascorbate##7##2##(1990-11#1)(1990-2#1)(1990-9#2)(1992-6#2)(1997-6#1)
the ascorbate-glutathione##2##2##(2009-8#1)(2013-8#1)
the ascorbic acid and##2##4##(2008-10#1)(2010-2#1)
the ascorbic acid##6##3##(1992-11#1)(2008-10#3)(2010-2#2)
the ascorbic##8##2##(1992-11#1)(1995-10#2)(2008-10#3)(2010-2#2)
the asd gene##2##3##(1990-9#2)
the asexual form of##2##4##(2008-10#1)(2008-4#1)
the asexual##6##2##(2006-10#1)(2008-10#4)(2008-4#1)
the ash content##2##3##(2008-10#2)
the ash##7##2##(1996-8#3)(2008-10#4)
the ashing##2##2##(2008-10#2)
the asialoglycoprotein receptor##4##3##(1993-11#1)(1995-2#1)(1996-5#1)(2008-8#1)
the asparagine##6##2##(1990-4#1)(1992-2#1)(1993-3#1)(1994-3#1)(1997-7#1)(2009-12#1)
the asparagine207##2##2##(1994-5#2)
the aspartate 63##2##3##(1996-2#2)
the aspartate receptor and the trp repressor##2##7##(1992-8#2)
the aspartate receptor##7##3##(1992-8#6)(1992-9#1)
the aspartate##14##2##(1991-12#1)(1991-7#2)(1992-8#7)(1992-9#1)(1996-2#2)(2005-11#1)
the aspartic acid##2##3##(1990-3#1)(1992-7#1)
the aspartic proteinase##2##3##(1990-8#1)(1993-3#1)
the aspartic##6##2##(1990-12#1)(1990-3#1)(1990-8#1)(1992-7#1)(1993-3#1)(2008-4#1)
the aspect of the##6##4##(1990-11#1)(1996-9#1)(2006-6#1)(2007-9#1)(2008-10#1)(2011-2#1)
the aspect of##21##3##(1990-11#1)(1993-11#1)(1994-4#1)(1995-5#1)(1996-9#1)(2005-1#3)(2006-6#2)(2007-12#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-4#1)(2010-8#1)(2011-2#1)(2013-7#1)(2013-8#1)
the aspect ratio of##3##4##(2005-11#1)(2007-12#1)(2011-1#1)
the aspect ratio##8##3##(2005-11#2)(2006-7#1)(2007-12#1)(2008-2#3)(2011-1#1)
the aspect##31##2##(1990-11#1)(1993-11#1)(1994-4#1)(1995-5#1)(1996-9#1)(2005-1#3)(2005-11#2)(2006-6#2)(2006-7#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-2#3)(2008-4#1)(2008-8#2)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
the aspects of the##3##4##(2011-2#1)(2012-3#1)(2013-8#1)
the aspects of##19##3##(1991-12#1)(1993-1#1)(1994-3#1)(1995-12#1)(1995-7#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-7#1)(2013-8#2)
the aspects##20##2##(1991-12#1)(1993-1#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-7#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-7#1)(2013-8#2)
the aspirated##2##2##(2007-12#1)(2008-10#1)
the aspiration of the##2##4##(2008-10#1)(2008-4#1)
the aspiration##6##2##(2007-6#1)(2008-10#3)(2008-4#1)(2011-12#1)
the aspirin group (relative risk##2##5##(1993-7#2)
the aspirin group##4##3##(1990-6#1)(1991-11#1)(1993-7#2)
the aspirin##7##2##(1990-6#2)(1991-11#1)(1993-7#4)
the assault##2##2##(1994-4#1)(2011-1#1)
the assay and##5##3##(1993-1#1)(2007-9#1)(2008-10#1)(2008-4#1)(2013-7#1)
the assay are##7##3##(1992-4#1)(1992-9#1)(1994-9#1)(1995-3#1)(1995-8#1)(2008-10#1)(2008-9#1)
the assay at##2##3##(1990-12#1)(2011-2#1)
the assay can be used to##2##6##(2008-10#1)(2008-4#1)
the assay can be##3##4##(2008-10#1)(2008-4#1)(2010-5#1)
the assay can##5##3##(1992-9#1)(2008-10#1)(2008-4#2)(2010-5#1)
the assay characteristics##2##3##(1995-2#1)(2007-7#1)
the assay conditions##5##3##(1990-2#1)(1993-11#1)(1993-8#1)(2008-4#1)(2008-9#1)
the assay for##6##3##(1991-4#1)(1992-12#1)(1994-10#1)(2008-4#1)(2010-12#1)(2013-1#1)
the assay from##2##3##(1990-7#1)(2012-3#1)
the assay in the##2##4##(2008-10#1)(2011-1#1)
the assay in this##2##4##(2008-11#1)(2013-8#1)
the assay in##6##3##(2008-10#2)(2008-11#1)(2008-4#1)(2011-1#1)(2013-8#1)
the assay is carried out##2##5##(2008-10#2)
the assay is##19##3##(1990-1#1)(1990-11#1)(1991-8#1)(1992-4#1)(1992-9#1)(1993-2#2)(1997-2#1)(1997-7#1)(2007-8#1)(2008-10#3)(2008-9#2)(2010-12#1)(2010-2#2)(2011-3#1)
the assay medium##4##3##(1990-12#1)(1994-10#1)(1996-5#1)(2008-10#1)
the assay of S-perindopril##2##4##(2008-10#2)
the assay of creatinine##2##4##(1992-11#1)(2008-10#1)
the assay of protein##2##4##(1991-10#1)(1993-11#1)
the assay of this##2##4##(1990-2#1)(2008-11#1)
the assay of##98##3##(1990-11#1)(1990-2#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-3#2)(1991-5#5)(1991-8#1)(1992-11#1)(1992-6#2)(1992-8#1)(1993-11#1)(1994-10#1)(1994-2#1)(1994-7#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-8#2)(2007-8#2)(2008-10#60)(2008-11#1)(2008-4#3)(2008-6#1)(2009-10#1)(2010-2#1)(2011-1#1)
the assay on##2##3##(1995-7#1)(2013-8#1)
the assay results##4##3##(2007-8#1)(2008-10#3)
the assay system##2##3##(1993-12#1)(2008-10#1)
the assay was linear##2##4##(1993-2#1)(1997-8#1)
the assay was##19##3##(1990-12#1)(1991-12#1)(1991-2#1)(1992-6#1)(1992-7#2)(1993-2#1)(1995-1#2)(1996-1#1)(1996-12#1)(1996-9#1)(1997-8#2)(2008-10#3)(2008-11#1)(2010-4#1)
the assay without##2##3##(1990-11#1)(2008-10#1)
the assay##282##2##(1990-1#1)(1990-11#4)(1990-12#7)(1990-2#2)(1990-3#2)(1990-4#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#7)(1991-6#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#2)(1992-6#6)(1992-7#2)(1992-8#1)(1992-9#4)(1993-1#1)(1993-11#5)(1993-12#2)(1993-2#3)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-7#1)(1994-9#1)(1995-1#4)(1995-2#5)(1995-3#1)(1995-7#1)(1995-8#3)(1996-1#4)(1996-12#4)(1996-2#1)(1996-3#2)(1996-5#3)(1996-9#2)(1997-2#2)(1997-3#2)(1997-4#2)(1997-7#1)(1997-8#5)(2007-11#1)(2007-7#2)(2007-8#7)(2007-9#2)(2008-1#1)(2008-10#87)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#14)(2008-6#1)(2008-9#7)(2009-10#1)(2010-11#1)(2010-12#3)(2010-2#3)(2010-4#2)(2010-5#3)(2011-1#3)(2011-2#1)(2011-3#1)(2012-1#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#3)
the assayed##4##2##(2007-11#2)(2008-10#1)(2008-9#1)
the assays for##2##3##(1993-12#1)(2007-11#1)
the assays was##2##3##(2006-7#1)(2008-10#1)
the assays were##4##3##(1992-5#1)(1992-8#1)(2008-10#1)(2011-2#1)
the assays##31##2##(1992-5#1)(1992-8#1)(1993-12#1)(1993-2#1)(1995-5#1)(1997-3#2)(2004-12#1)(2006-7#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#9)(2008-4#4)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-2#1)
the assemblage##7##2##(2006-12#2)(2007-11#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)
the assembled form of##2##4##(1990-5#1)(2005-8#1)
the assembled sequence##2##3##(1996-6#2)
the assembled wild-type##2##3##(1994-11#2)
the assembled##14##2##(1990-5#1)(1991-11#1)(1994-11#4)(1996-10#1)(1996-6#2)(2005-8#1)(2008-10#2)(2008-8#2)
the assembly and function of##2##5##(1995-8#1)(2011-1#1)
the assembly and##6##3##(1990-5#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-8#1)(2011-1#1)
the assembly line##2##3##(2006-9#2)
the assembly of a##4##4##(1997-5#1)(2009-2#1)(2009-8#1)(2012-2#1)
the assembly of focal adhesions and##2##6##(1993-6#1)(2007-8#1)
the assembly of prothrombinase##2##4##(1990-12#2)
the assembly of the acentrosomal##4##5##(2012-12#4)
the assembly of the enzyme##2##5##(1994-8#1)(2008-9#1)
the assembly of the##20##4##(1991-9#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-8#2)(1996-5#1)(1996-8#1)(2006-12#1)(2008-8#1)(2008-9#2)(2011-1#1)(2012-12#4)(2013-1#2)
the assembly of##78##3##(1990-11#1)(1990-12#2)(1991-4#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-12#1)(1993-6#2)(1994-11#1)(1994-12#3)(1994-3#2)(1994-8#2)(1995-1#1)(1995-11#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-8#2)(1996-5#2)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-12#1)(2005-6#1)(2005-7#1)(2006-11#2)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#4)(2008-2#2)(2008-4#1)(2008-8#4)(2008-9#3)(2009-11#1)(2009-2#1)(2009-7#1)(2009-8#2)(2011-1#1)(2011-2#1)(2012-12#6)(2012-2#2)(2013-1#3)
the assembly process into the outer membrane##2##7##(1990-3#2)
the assembly process of##2##4##(1997-4#2)
the assembly process##8##3##(1990-3#2)(1990-5#1)(1994-2#2)(1997-4#2)(2011-2#1)
the assembly##108##2##(1990-11#1)(1990-12#2)(1990-3#2)(1990-5#2)(1991-4#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-12#1)(1993-6#2)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#3)(1994-5#1)(1994-8#2)(1995-1#2)(1995-11#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#3)(1996-5#3)(1996-8#1)(1997-2#3)(1997-4#3)(1997-5#1)(1997-7#1)(2004-12#1)(2005-6#1)(2005-7#1)(2006-11#2)(2006-12#2)(2006-9#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-2#2)(2008-4#1)(2008-8#5)(2008-9#3)(2009-11#1)(2009-2#2)(2009-7#1)(2009-8#2)(2011-1#2)(2011-2#2)(2012-12#6)(2012-2#2)(2013-1#4)
the assertion that##6##3##(1993-12#1)(2006-1#1)(2007-12#1)(2007-8#1)(2010-2#2)
the assesment of##4##3##(2006-1#1)(2006-6#1)(2007-8#1)(2008-5#1)
the assessed##3##2##(2007-9#1)(2008-9#1)(2010-5#1)
the assessment and management of##10##5##(1996-12#1)(1996-6#1)(2006-12#1)(2007-10#1)(2008-3#1)(2009-12#1)(2010-10#2)(2010-12#1)(2013-1#1)
the assessment and treatment of##7##5##(2005-9#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-6#1)(2010-9#1)(2012-2#1)
the assessment and treatment##8##4##(2005-9#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-9#1)(2012-2#1)
the assessment and##29##3##(1992-12#1)(1996-12#1)(1996-6#1)(2005-6#1)(2005-9#1)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-10#3)(2010-12#2)(2010-9#1)(2011-1#1)(2012-2#2)(2013-1#1)
the assessment approach##2##3##(2008-11#1)(2009-2#1)
the assessment of a##2##4##(2008-1#1)(2008-7#1)
the assessment of an individual's##2##5##(2006-10#1)(2008-3#1)
the assessment of body##2##4##(1996-3#1)(2007-12#1)
the assessment of bone##2##4##(2007-8#1)(2009-7#1)
the assessment of brain##2##4##(2007-7#1)(2008-7#1)
the assessment of cardiac function##2##5##(2008-5#1)(2008-7#1)
the assessment of cardiac##4##4##(2008-5#1)(2008-7#1)(2009-1#1)(2012-2#1)
the assessment of clinical competence##2##5##(2006-10#1)(2008-11#1)
the assessment of clinical##3##4##(2006-10#2)(2008-11#1)
the assessment of food##2##4##(2007-1#1)(2012-12#1)
the assessment of learning##2##4##(2008-11#2)
the assessment of left ventricular##2##5##(2008-12#1)(2009-1#1)
the assessment of left##3##4##(2008-12#1)(2009-1#1)(2011-2#1)
the assessment of long-term##2##4##(2008-11#1)(2008-3#1)
the assessment of medical##5##4##(1995-3#1)(1996-12#4)
the assessment of mental health##3##5##(2005-8#1)(2008-11#2)
the assessment of new##2##4##(2008-10#1)(2008-9#1)
the assessment of pain##3##4##(2006-12#1)(2008-9#1)(2010-6#1)
the assessment of patients with##4##5##(1993-11#1)(2007-11#1)(2007-8#1)(2012-11#1)
the assessment of patients##5##4##(1993-11#1)(2007-11#1)(2007-8#1)(2012-11#1)(2012-12#1)
the assessment of personality##2##4##(1991-1#1)(2010-12#1)
the assessment of physiological##2##4##(2006-10#1)(2006-5#1)
the assessment of potential##2##4##(1992-3#1)(2012-2#1)
the assessment of quality of life##2##6##(2007-7#1)(2008-4#1)
the assessment of quality of##4##5##(2007-7#1)(2008-4#1)(2012-2#2)
the assessment of quality##5##4##(2007-7#1)(2008-4#1)(2012-12#1)(2012-2#2)
the assessment of severity##2##4##(1997-7#1)(2007-2#1)
the assessment of the impact of##2##6##(2005-11#1)(2006-5#1)
the assessment of the potential##2##5##(2008-11#1)(2008-8#1)
the assessment of the quality of##3##6##(1994-3#1)(2006-10#1)(2007-8#1)
the assessment of the##50##4##(1990-8#1)(1994-3#1)(1996-12#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-5#1)(2007-1#2)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#4)(2008-8#2)(2009-2#1)(2009-8#1)(2010-12#2)(2010-3#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
the assessment of their##4##4##(1992-10#1)(2008-10#1)(2008-4#1)(2008-7#1)
the assessment of therapeutic##2##4##(2009-11#1)(2010-4#1)
the assessment of treatment##2##4##(1996-6#1)(2010-12#1)
the assessment of visual##2##4##(1992-7#2)
the assessment of##317##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-7#2)(1992-9#1)(1993-10#1)(1993-11#2)(1993-5#1)(1993-6#6)(1994-10#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-11#1)(1996-12#9)(1996-3#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#4)(2004-12#1)(2005-10#1)(2005-11#2)(2005-8#3)(2006-10#9)(2006-11#3)(2006-12#1)(2006-3#2)(2006-4#2)(2006-5#6)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#4)(2007-11#3)(2007-12#2)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#4)(2007-8#8)(2007-9#1)(2008-1#4)(2008-10#21)(2008-11#13)(2008-12#5)(2008-3#4)(2008-4#16)(2008-5#11)(2008-6#2)(2008-7#9)(2008-8#8)(2008-9#4)(2009-1#4)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2010-11#2)(2010-12#9)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#2)(2010-8#2)(2011-1#5)(2011-12#1)(2011-2#10)(2012-1#5)(2012-11#2)(2012-12#7)(2012-2#7)(2012-3#5)(2013-1#4)(2013-7#2)(2013-8#4)
the assessment period##5##3##(2008-10#2)(2012-12#3)
the assessment process##2##3##(2007-3#1)(2013-8#1)
the assessment##384##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-7#2)(1992-9#1)(1993-10#1)(1993-11#2)(1993-5#1)(1993-6#6)(1994-1#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-11#1)(1996-12#10)(1996-2#1)(1996-3#1)(1996-6#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#4)(2004-12#1)(2004-4#1)(2005-10#1)(2005-11#2)(2005-6#1)(2005-8#3)(2005-9#1)(2006-10#10)(2006-11#3)(2006-12#2)(2006-3#2)(2006-4#2)(2006-5#6)(2006-6#2)(2006-7#3)(2006-8#2)(2006-9#1)(2007-1#4)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#4)(2007-3#2)(2007-4#1)(2007-7#5)(2007-8#9)(2007-9#1)(2008-1#4)(2008-10#25)(2008-11#19)(2008-12#5)(2008-3#5)(2008-4#16)(2008-5#11)(2008-6#3)(2008-7#9)(2008-8#9)(2008-9#4)(2009-1#4)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#2)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#1)(2010-10#3)(2010-11#3)(2010-12#11)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#2)(2010-8#2)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#11)(2012-1#7)(2012-11#2)(2012-12#10)(2012-2#10)(2012-3#5)(2013-1#6)(2013-7#2)(2013-8#11)
the assessments of##2##3##(2006-3#1)(2012-1#1)
the assessments##4##2##(2006-3#1)(2007-6#1)(2012-1#1)(2012-12#1)
the asset##2##2##(1995-5#1)(2005-1#1)
the assets##2##2##(2011-1#1)(2011-2#1)
the assigned##11##2##(1990-1#2)(1992-3#1)(1997-4#1)(2008-10#2)(2010-12#1)(2010-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
the assignment of a##4##4##(1991-2#1)(1997-2#1)(2008-10#1)(2009-7#1)
the assignment of the##7##4##(1991-12#1)(1994-6#1)(1994-9#1)(1995-9#1)(1997-2#1)(2008-10#1)(2009-7#1)
the assignment of##23##3##(1990-5#1)(1991-12#1)(1991-2#1)(1994-11#1)(1994-6#1)(1994-9#2)(1995-8#1)(1995-9#1)(1997-2#2)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2009-7#3)(2010-11#1)(2012-3#1)
the assignment##29##2##(1990-5#1)(1991-12#1)(1991-2#1)(1992-2#1)(1994-11#1)(1994-6#1)(1994-9#2)(1995-12#1)(1995-8#1)(1995-9#1)(1997-2#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#2)(2009-7#3)(2010-11#1)(2012-3#1)
the assignments##2##2##(2008-11#2)
the assimilation##2##2##(2008-3#1)(2009-8#1)
the assistance from the##2##4##(2012-1#2)
the assistance of a##2##4##(1993-3#1)(2006-8#1)
the assistance of the##4##4##(1996-1#1)(2007-11#1)(2009-5#1)(2011-1#1)
the assistance of##18##3##(1990-4#1)(1990-6#1)(1993-1#1)(1993-3#1)(1993-6#1)(1996-1#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-12#1)(2009-5#1)(2010-5#1)(2011-1#3)(2012-1#1)
the assistance##25##2##(1990-4#1)(1990-6#1)(1991-1#1)(1992-3#1)(1993-1#1)(1993-3#1)(1993-6#1)(1996-1#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-12#1)(2009-5#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-1#4)
the assistant##3##2##(1992-1#1)(1993-6#1)(2008-8#1)
the assistant's##2##2##(1992-1#1)(2009-4#1)
the assisted##7##2##(2006-3#1)(2007-10#1)(2008-6#2)(2010-8#1)(2011-2#1)(2013-1#1)
the associate##2##2##(2007-8#2)
the associated benefits##2##3##(1997-3#1)(2013-8#1)
the associated complications##2##3##(2006-8#1)(2008-2#1)
the associated costs##2##3##(1997-5#2)
the associated factors##4##3##(2007-7#1)(2008-10#1)(2011-2#1)(2012-2#1)
the associated increase##2##3##(1990-10#1)(2011-2#1)
the associated metabolic##2##3##(1996-9#1)(2008-11#1)
the associated mortality##2##3##(2008-3#1)(2013-1#1)
the associated patent##2##3##(2008-5#2)
the associated risk of##6##4##(1992-8#1)(1995-7#1)(2008-10#1)(2009-9#1)(2013-1#2)
the associated risk##7##3##(1992-8#1)(1995-7#1)(2008-10#1)(2008-7#1)(2009-9#1)(2013-1#2)
the associated risks##3##3##(1995-6#1)(2007-12#1)(2008-3#1)
the associated##153##2##(1990-10#1)(1990-11#2)(1990-5#1)(1991-11#1)(1991-12#2)(1991-3#1)(1992-3#1)(1992-8#1)(1993-3#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#3)(2004-11#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-4#1)(2006-10#5)(2006-2#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-4#1)(2007-7#4)(2007-8#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#9)(2008-4#2)(2008-5#8)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#2)(2010-8#1)(2011-1#4)(2011-2#6)(2012-1#1)(2012-2#6)(2012-3#5)(2013-1#10)(2013-8#4)
the association among##2##3##(2005-9#1)(2012-2#1)
the association and##6##3##(1991-7#1)(1991-8#1)(1996-2#1)(1996-5#1)(2008-8#1)(2010-2#1)
the association between DNA double-strand break repair gene NBS1##2##9##(2011-1#2)
the association between H##2##4##(2006-10#1)(2013-1#1)
the association between MTHFR gene polymorphism and##2##7##(2007-10#2)
the association between alcohol##2##4##(2009-5#1)(2013-1#1)
the association between attachment##3##4##(2006-3#1)(2010-8#2)
the association between autoimmune##2##4##(1991-8#1)(2010-6#1)
the association between blood pressure and##2##6##(2005-10#1)(2008-3#1)
the association between body##2##4##(2007-12#1)(2009-6#1)
the association between chronic##2##4##(2006-2#1)(2013-7#1)
the association between coronary heart disease risk and body mass index##2##11##(2005-10#2)
the association between education and self-assessed health##2##7##(2010-9#2)
the association between education and##3##5##(2010-9#3)
the association between family##2##4##(2010-10#1)(2013-8#1)
the association between health##2##4##(2008-11#1)(2010-9#1)
the association between higher##2##4##(2008-7#1)(2013-1#1)
the association between household characteristics and the presence of hydatid disease##2##11##(2011-2#2)
the association between household characteristics and the presence of##3##9##(2011-2#3)
the association between interparental conflict and##2##6##(2010-1#2)
the association between oral##2##4##(2006-2#1)(2012-2#1)
the association between polymorphisms##2##4##(2008-10#1)(2011-1#1)
the association between serum##3##4##(2010-10#2)(2011-2#1)
the association between sexual##2##4##(2008-6#1)(2009-7#1)
the association between socioeconomic status and##2##6##(2010-3#1)(2011-1#1)
the association between socioeconomic##3##4##(2008-12#1)(2010-3#1)(2011-1#1)
the association between the##19##4##(1990-9#1)(1992-10#1)(1993-10#1)(1994-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
the association between these two##3##5##(1993-12#1)(2010-6#1)(2011-1#1)
the association between these##6##4##(1993-12#1)(2007-10#1)(2010-6#1)(2011-1#1)(2012-12#1)(2013-1#1)
the association between two dimensions of the media (source of information and internalization) and bulimic attitudes/tendencies##2##16##(2008-3#2)
the association between two##3##4##(2008-3#2)(2012-12#1)
the association between##205##3##(1990-9#1)(1991-12#1)(1991-5#1)(1991-8#2)(1992-10#1)(1992-4#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-2#2)(1996-2#1)(1996-3#1)(2005-10#5)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#4)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-9#2)(2007-1#1)(2007-10#6)(2007-12#3)(2007-2#1)(2007-6#2)(2007-8#2)(2008-1#4)(2008-10#6)(2008-11#3)(2008-12#4)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#5)(2009-8#2)(2009-9#1)(2010-1#3)(2010-10#3)(2010-12#5)(2010-2#3)(2010-3#1)(2010-6#3)(2010-7#1)(2010-8#3)(2010-9#6)(2011-1#10)(2011-12#1)(2011-2#11)(2012-1#4)(2012-12#10)(2012-2#7)(2012-3#5)(2013-1#18)(2013-7#1)(2013-8#4)
the association complex##2##3##(2008-10#2)
the association constant for the##2##5##(1997-4#1)(2008-10#1)
the association constant for##3##4##(1997-4#1)(2008-10#1)(2010-2#1)
the association constant of the##2##5##(2008-10#1)(2010-2#1)
the association constant of##3##4##(2008-10#1)(2010-2#2)
the association constant##9##3##(1990-3#1)(1997-4#1)(2008-10#3)(2010-2#4)
the association constants were##2##4##(2008-10#2)
the association constants##4##3##(2008-10#4)
the association in##2##3##(1997-8#1)(2010-12#1)
the association is##7##3##(1991-8#1)(2005-10#1)(2009-5#2)(2010-9#1)(2011-2#2)
the association of adiposity with cardiovascular reactivity in##2##8##(2012-2#2)
the association of adiposity with cardiovascular reactivity##4##7##(2012-2#4)
the association of adiposity with##5##5##(2012-2#5)
the association of both##2##4##(1992-1#1)(1994-11#1)
the association of chronic##2##4##(2011-2#1)(2013-1#1)
the association of epidural##2##4##(2006-10#1)(2013-1#1)
the association of estrogens and progestins with cardiovascular disease##2##9##(1993-6#2)
the association of extralobar sequestration with renal aplasia is very rare##2##11##(2013-1#2)
the association of genotypes and##2##5##(2012-11#1)(2012-12#1)
the association of genotypes##3##4##(2008-12#1)(2012-11#1)(2012-12#1)
the association of individual proteins with specific##3##7##(2008-1#1)(2008-2#2)
the association of individual##4##4##(1990-12#1)(2008-1#1)(2008-2#2)
the association of nutritional##2##4##(2008-1#1)(2008-10#1)
the association of partial##2##4##(2008-1#1)(2008-8#1)
the association of risk factors##2##5##(2007-10#1)(2009-5#1)
the association of the##12##4##(1992-11#1)(1992-5#1)(1993-11#1)(1995-3#1)(1997-6#1)(2005-4#1)(2008-3#1)(2008-5#2)(2010-12#1)(2011-2#1)(2013-1#1)
the association of this##5##4##(1996-8#1)(2008-10#1)(2009-8#1)(2012-12#1)(2013-8#1)
the association of two common##2##5##(2007-10#1)(2008-10#1)
the association of two##8##4##(1990-2#1)(1991-5#1)(1995-2#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-4#1)
the association of##154##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-4#2)(1991-5#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-5#1)(1993-11#1)(1993-12#1)(1993-6#3)(1994-11#1)(1994-6#1)(1994-9#2)(1995-10#1)(1995-2#3)(1995-3#3)(1996-5#3)(1996-8#2)(1997-6#3)(2005-10#2)(2005-11#2)(2005-4#1)(2005-8#1)(2006-10#5)(2006-12#1)(2006-2#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#6)(2008-10#12)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-12#5)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-11#1)(2012-12#4)(2012-2#7)(2012-3#4)(2013-1#10)(2013-7#1)(2013-8#2)
the association paracetamol-sobrerol##2##3##(1990-10#2)
the association parameters##2##3##(2010-2#2)
the association rate##5##3##(1993-8#2)(1994-11#1)(1995-1#1)(2008-10#1)
the association reaction##2##3##(1995-2#1)(1995-8#1)
the association study##3##3##(1997-4#1)(2012-3#2)
the association was##3##3##(1995-5#1)(2007-3#1)(2008-10#1)
the association with cigarette smoking##2##5##(2008-10#2)
the association with the##5##4##(1991-8#1)(2005-8#1)(2008-10#1)(2011-2#1)(2012-3#1)
the association with##22##3##(1990-10#1)(1991-8#1)(1993-12#1)(1996-5#1)(2004-2#1)(2005-7#1)(2005-8#1)(2006-3#1)(2007-5#1)(2008-10#3)(2008-11#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
the association##462##2##(1990-10#4)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-4#3)(1991-5#2)(1991-7#2)(1991-8#5)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#3)(1992-4#1)(1992-5#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-6#3)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-2#6)(1995-3#3)(1995-5#1)(1995-8#1)(1996-1#1)(1996-2#2)(1996-3#1)(1996-5#5)(1996-8#2)(1997-4#2)(1997-5#2)(1997-6#3)(1997-8#2)(2004-2#1)(2005-10#8)(2005-11#3)(2005-4#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#10)(2006-11#1)(2006-12#2)(2006-2#8)(2006-3#2)(2006-4#2)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#3)(2007-1#1)(2007-10#9)(2007-11#1)(2007-12#6)(2007-2#3)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#6)(2008-1#10)(2008-10#36)(2008-11#5)(2008-12#6)(2008-2#3)(2008-3#9)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#5)(2008-8#7)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#2)(2009-5#4)(2009-6#3)(2009-7#7)(2009-8#4)(2009-9#1)(2010-1#3)(2010-10#4)(2010-12#12)(2010-2#13)(2010-3#1)(2010-6#3)(2010-7#1)(2010-8#4)(2010-9#7)(2011-1#13)(2011-12#1)(2011-2#20)(2012-1#6)(2012-11#1)(2012-12#14)(2012-2#16)(2012-3#14)(2013-1#29)(2013-7#3)(2013-8#6)
the association's##3##2##(1990-12#1)(1996-11#1)(2013-7#1)
the associations among##4##3##(2007-6#1)(2008-5#1)(2012-1#1)(2012-12#1)
the associations between sexual##2##4##(2009-5#2)
the associations between##31##3##(1993-7#1)(1996-9#1)(2005-10#1)(2006-6#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-5#2)(2009-7#3)(2009-9#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
the associations of age and##2##5##(2010-10#2)
the associations of##11##3##(1994-7#1)(2005-10#2)(2008-1#1)(2008-7#1)(2008-8#1)(2010-10#2)(2012-1#2)(2013-1#1)
the associations##59##2##(1993-7#1)(1994-7#1)(1995-2#1)(1996-9#1)(1997-8#1)(2005-10#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2007-12#2)(2007-3#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#2)(2009-7#3)(2009-9#1)(2010-10#3)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
the associative##6##2##(2005-11#1)(2012-1#1)(2012-2#2)(2013-1#2)
the assumed fetal mass##3##4##(2008-4#3)
the assumed##20##2##(1993-8#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-2#3)(2008-3#2)(2008-4#3)(2009-11#1)(2009-3#1)(2011-1#1)(2011-2#1)
the assumption of a##12##4##(1995-8#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2010-8#1)(2011-2#1)
the assumption of horizontal homogeneity##2##5##(2008-3#2)
the assumption of normality##2##4##(1997-7#1)(2010-2#1)
the assumption of the##3##4##(1995-12#1)(2010-2#1)(2013-8#1)
the assumption of##45##3##(1992-5#1)(1993-5#1)(1994-2#1)(1995-12#1)(1995-6#1)(1995-8#1)(1997-2#2)(1997-6#1)(1997-7#1)(2005-11#1)(2006-8#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#1)(2008-6#1)(2008-7#2)(2009-2#1)(2010-2#2)(2010-8#1)(2011-2#1)(2012-1#3)(2013-8#3)
the assumption that a##5##4##(1995-9#1)(2006-5#1)(2008-10#1)(2008-12#1)(2008-7#1)
the assumption that each##4##4##(1996-7#1)(1997-7#1)(2008-3#2)
the assumption that the##27##4##(1992-6#1)(1992-8#1)(1993-11#1)(1995-3#1)(1997-2#1)(2005-11#2)(2006-11#1)(2007-4#1)(2007-9#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-8#1)(2012-11#1)(2012-2#2)(2013-1#1)(2013-8#2)
the assumption that##82##3##(1990-5#1)(1990-6#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#3)(1994-12#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#1)(2005-11#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-5#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-11#1)(2009-2#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
the assumption##133##2##(1990-5#1)(1990-6#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-5#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-1#2)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#2)(2005-11#3)(2005-7#1)(2006-11#1)(2006-12#1)(2006-2#2)(2006-5#1)(2006-6#1)(2006-8#3)(2007-11#1)(2007-12#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#8)(2008-3#13)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#4)(2009-11#1)(2009-2#2)(2009-5#2)(2009-7#1)(2009-8#1)(2010-2#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#5)(2012-11#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#5)
the assumptions and##4##3##(1992-2#1)(1993-3#1)(2006-5#1)(2008-7#1)
the assumptions are##2##3##(1997-7#1)(2012-2#1)
the assumptions behind this##2##4##(2008-9#1)(2012-3#1)
the assumptions made in##3##4##(1991-2#1)(1993-9#1)(2008-3#1)
the assumptions of a##2##4##(2008-2#1)(2008-3#1)
the assumptions of the##5##4##(1995-8#1)(2008-10#1)(2008-9#1)(2010-3#1)(2013-7#1)
the assumptions of##19##3##(1994-11#1)(1995-8#1)(1996-5#1)(2008-10#2)(2008-2#3)(2008-3#5)(2008-9#2)(2010-2#1)(2010-3#1)(2013-1#1)(2013-7#1)
the assumptions underlying the##3##4##(1995-4#1)(2007-4#1)(2008-9#1)
the assumptions underlying##5##3##(1995-4#1)(2006-5#1)(2007-11#1)(2007-4#1)(2008-9#1)
the assumptions##44##2##(1991-2#1)(1992-2#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-4#1)(1995-8#1)(1996-5#1)(1997-7#3)(2006-5#2)(2007-11#2)(2007-4#1)(2008-10#2)(2008-2#4)(2008-3#8)(2008-7#1)(2008-9#4)(2009-12#1)(2009-3#1)(2010-2#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
the astaxanthin production rate##3##4##(2006-3#3)
the aster yellows##5##3##(2008-10#5)
the aster##6##2##(2008-10#5)(2008-6#1)
the asteroids##2##2##(2007-5#2)
the asthma guidelines##2##3##(2007-2#2)
the asthma##10##2##(1990-9#1)(1995-6#1)(2005-8#1)(2006-5#1)(2007-2#2)(2008-12#2)(2009-6#2)
the asthmatic children##2##3##(2012-12#2)
the asthmatic patient##2##3##(2005-8#1)(2007-6#1)
the asthmatic patient]##2##3##(2007-6#2)
the asthmatic##11##2##(2005-10#1)(2005-8#1)(2007-2#1)(2007-6#3)(2007-8#1)(2008-10#1)(2012-12#3)
the astigmatic method##2##3##(2008-2#2)
the astigmatic##4##2##(2008-2#4)
the astigmatism of the laser##2##5##(2007-12#1)(2008-3#1)
the astigmatism of the##3##4##(2007-12#1)(2008-3#2)
the astigmatism of##4##3##(2007-12#1)(2008-3#3)
the astigmatism##7##2##(2007-12#1)(2008-3#6)
the astrocyte##8##2##(1990-7#3)(1996-2#2)(1997-6#1)(2008-11#1)(2012-3#1)
the astrocytes##3##2##(1992-8#1)(2006-7#1)(2007-10#1)
the astrocytic##4##2##(1990-7#1)(1996-3#1)(2006-12#1)(2008-11#1)
the astroglial##3##2##(1995-12#1)(1996-10#1)(2012-1#1)
the astute##2##2##(2006-10#1)(2007-11#1)
the asylum model##2##3##(2012-2#1)(2012-3#1)
the asylum##3##2##(2012-2#2)(2012-3#1)
the asylums##2##2##(1990-6#1)(2010-6#1)
the asymmetric distribution of##2##4##(1994-2#1)(2010-4#1)
the asymmetric synthesis of##7##4##(2007-10#1)(2007-11#2)(2008-11#2)(2008-3#1)(2010-6#1)
the asymmetric unit##20##3##(1991-4#1)(1991-7#2)(1992-4#3)(1992-6#1)(1992-9#1)(1993-8#1)(1994-9#2)(1995-2#1)(1995-3#1)(1996-6#1)(2008-8#3)(2008-9#2)(2009-3#1)
the asymmetric##54##2##(1991-4#1)(1991-7#2)(1992-3#1)(1992-4#3)(1992-6#1)(1992-9#1)(1993-8#1)(1994-2#1)(1994-9#4)(1995-12#1)(1995-2#1)(1995-3#2)(1996-6#1)(1996-7#1)(2006-10#1)(2006-4#2)(2007-10#1)(2007-11#5)(2007-6#1)(2007-8#2)(2007-9#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-3#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2012-1#1)
the asymmetrical##2##2##(2006-10#1)(2009-2#1)
the asymmetry factor##3##3##(2008-10#1)(2008-3#2)
the asymmetry in the##2##4##(2007-11#1)(2012-12#1)
the asymmetry in##3##3##(2007-11#1)(2011-12#1)(2012-12#1)
the asymmetry of the##5##4##(1996-7#1)(2004-3#1)(2008-2#1)(2008-3#1)(2011-1#1)
the asymmetry of##7##3##(1996-7#1)(2004-3#1)(2008-2#2)(2008-3#1)(2008-8#1)(2011-1#1)
the asymmetry parameter##6##3##(2008-2#4)(2008-3#2)
the asymmetry##28##2##(1992-2#1)(1992-7#1)(1993-3#1)(1996-7#1)(2004-3#1)(2007-11#1)(2008-10#1)(2008-2#7)(2008-3#5)(2008-5#4)(2008-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-12#1)
the asymptomatic nature of##2##4##(2007-8#1)(2013-1#1)
the asymptomatic period##4##3##(1997-3#3)(2009-2#1)
the asymptomatic##19##2##(1990-7#1)(1990-8#2)(1996-9#1)(1997-3#3)(2006-11#1)(2007-8#3)(2008-10#2)(2008-11#1)(2008-3#3)(2009-2#1)(2013-1#1)
the asymptotic behavior of##2##4##(2007-12#1)(2013-8#1)
the asymptotic behavior predicted for##2##5##(2008-2#2)
the asymptotic behavior##4##3##(2007-12#1)(2008-2#2)(2013-8#1)
the asymptotic normality of the##2##5##(2009-10#1)(2010-2#1)
the asymptotic normality##3##3##(1993-1#1)(2009-10#1)(2010-2#1)
the asymptotic properties of the ANCOVA with equal slopes##2##9##(2012-1#2)
the asymptotic properties of the##3##5##(2012-1#3)
the asymptotic properties of##4##4##(2008-2#1)(2012-1#3)
the asymptotic results##2##3##(2007-12#1)(2008-3#1)
the asymptotic values of##2##4##(2008-2#2)
the asymptotic##36##2##(1992-2#1)(1993-1#1)(1994-2#3)(1994-3#1)(1995-6#1)(1996-3#1)(2005-11#2)(2007-12#2)(2008-2#6)(2008-3#7)(2008-8#1)(2009-10#2)(2010-1#1)(2010-2#1)(2012-1#5)(2013-8#1)
the asynchronous##3##2##(1994-5#1)(1994-9#1)(1996-8#1)
the at-risk group##4##3##(2007-9#3)(2013-1#1)
the at-risk##8##2##(1994-2#1)(1996-6#1)(2006-5#1)(2007-9#4)(2013-1#1)
the atherogenic dyslipidemia##2##3##(2008-3#1)(2008-7#1)
the atherogenic dyslipidemic##2##3##(2008-10#1)(2009-11#1)
the atherogenic lipoprotein##2##3##(2005-10#1)(2013-7#1)
the atherogenic process##3##3##(1995-1#2)(1997-2#1)
the atherogenic##13##2##(1991-11#1)(1994-9#1)(1995-1#2)(1997-2#1)(2005-10#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-11#1)(2013-7#1)
the atheroma##3##2##(2003-11#1)(2008-10#1)(2008-3#1)
the atheromatous plaque##9##3##(2008-5#7)(2009-5#2)
the atherosclerosis##3##2##(2008-10#1)(2012-2#1)(2012-3#1)
the atherosclerotic plaque##7##3##(1993-6#1)(2005-10#1)(2006-6#1)(2007-10#1)(2008-7#1)(2010-9#1)(2011-2#1)
the atherosclerotic process##11##3##(1991-11#2)(1997-3#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-4#1)(2012-11#2)(2013-8#2)
the atherosclerotic##26##2##(1991-11#2)(1991-6#1)(1993-6#1)(1995-10#1)(1997-3#2)(1997-7#1)(2005-10#1)(2005-7#1)(2006-6#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#2)(2009-10#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-11#2)(2013-8#3)
the atherothrombotic##4##2##(2005-10#1)(2005-7#1)(2008-3#1)(2011-1#1)
the athlete has##2##3##(2008-8#1)(2009-5#1)
the athlete to##2##3##(2011-1#1)(2011-2#1)
the athlete##11##2##(2006-3#4)(2008-7#2)(2008-8#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#1)
the athletes##3##2##(1995-6#1)(1995-9#1)(2012-1#1)
the athletic##4##2##(2006-3#2)(2008-7#1)(2009-5#1)
the atlanto-occipital##2##2##(2007-4#1)(2010-2#1)
the atlas is##3##3##(2008-2#1)(2013-1#2)
the atlas##9##2##(1997-4#1)(2008-2#3)(2012-3#1)(2013-1#4)
the atmosphere and the surface##2##5##(2008-2#1)(2008-3#1)
the atmosphere and the##3##4##(1997-1#1)(2008-2#1)(2008-3#1)
the atmosphere and##12##3##(1992-3#1)(1997-1#1)(2007-11#2)(2008-10#1)(2008-2#4)(2008-3#3)
the atmosphere are##4##3##(2008-10#1)(2008-11#1)(2008-3#2)
the atmosphere as##3##3##(1996-8#1)(2007-11#1)(2008-3#1)
the atmosphere below an observer##3##5##(2008-2#3)
the atmosphere by##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)
the atmosphere from##2##3##(2008-11#1)(2008-2#1)
the atmosphere in##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
the atmosphere is##4##3##(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)
the atmosphere of the##4##4##(2008-5#2)(2009-6#1)(2012-3#1)
the atmosphere of##9##3##(2008-10#3)(2008-3#2)(2008-5#2)(2009-6#1)(2012-3#1)
the atmosphere on##2##3##(2008-10#1)(2008-2#1)
the atmosphere that##3##3##(2007-11#1)(2008-3#2)
the atmosphere was##3##3##(1995-3#1)(2008-2#1)(2008-3#1)
the atmosphere with a##3##4##(2008-3#3)
the atmosphere with##7##3##(2008-2#2)(2008-3#5)
the atmosphere##138##2##(1991-11#1)(1991-3#1)(1991-6#1)(1992-3#1)(1995-11#1)(1995-3#2)(1996-1#1)(1996-8#4)(1997-1#1)(2004-9#1)(2006-3#1)(2007-11#6)(2007-12#5)(2007-4#1)(2007-9#4)(2008-10#13)(2008-11#7)(2008-2#32)(2008-3#41)(2008-4#1)(2008-5#5)(2008-8#1)(2009-3#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
the atmosphere-ocean system##2##3##(2008-2#2)
the atmospheric aerosol##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
the atmospheric and##2##3##(1996-12#1)(2008-3#1)
the atmospheric attenuation and##2##4##(2008-2#1)(2008-3#1)
the atmospheric boundary layer##3##4##(2008-3#3)
the atmospheric column##2##3##(2008-3#2)
the atmospheric correction and##2##4##(2008-2#1)(2008-3#1)
the atmospheric correction of##3##4##(2008-2#2)(2013-8#1)
the atmospheric correction##9##3##(2008-2#4)(2008-3#2)(2013-8#3)
the atmospheric diffuse transmittance##2##4##(2008-2#2)
the atmospheric model##2##3##(2008-3#2)
the atmospheric optical##2##3##(2008-2#1)(2008-3#1)
the atmospheric physical parameters##2##4##(2013-8#2)
the atmospheric profile##2##3##(2008-2#2)
the atmospheric propagation of##2##4##(2008-3#2)
the atmospheric spectra##2##3##(2008-3#2)
the atmospheric transmission##2##3##(2008-2#2)
the atmospheric transmittance##2##3##(2008-2#1)(2008-3#1)
the atmospheric turbidity##2##3##(2008-3#2)
the atmospheric##69##2##(1992-1#1)(1996-1#1)(1996-12#1)(2004-4#1)(2007-12#1)(2008-10#3)(2008-2#26)(2008-3#28)(2012-2#1)(2013-8#6)
the atom##8##2##(1996-3#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-12#1)(2010-2#1)(2012-2#1)
the atomic absorption spectrometric determination of##2##6##(2008-10#2)
the atomic absorption spectrometric##3##4##(2008-10#3)
the atomic absorption##12##3##(2007-5#1)(2007-8#1)(2008-10#9)(2011-12#1)
the atomic and##2##3##(2008-10#1)(2010-7#1)
the atomic beam##2##3##(2008-1#1)(2008-3#1)
the atomic bomb survivor##2##4##(2013-1#2)
the atomic bombing##4##3##(2004-11#4)
the atomic force microscope (AFM)##2##5##(2005-11#1)(2008-7#1)
the atomic force microscope##5##4##(2005-11#2)(2006-10#2)(2008-7#1)
the atomic force##6##3##(2005-11#3)(2006-10#2)(2008-7#1)
the atomic model of##2##4##(1996-11#2)
the atomic model##3##3##(1995-6#1)(1996-11#2)
the atomic number##4##3##(2008-10#2)(2008-3#2)
the atomic scale##3##3##(1991-11#1)(1992-1#1)(2010-7#1)
the atomic structure of##2##4##(1994-5#1)(2007-5#1)
the atomic structure##4##3##(1994-5#1)(2007-3#1)(2007-5#1)(2008-7#1)
the atomic##69##2##(1990-12#1)(1990-6#1)(1991-11#1)(1992-1#2)(1994-5#1)(1994-9#1)(1995-6#1)(1996-11#2)(1997-2#1)(2004-11#4)(2005-11#4)(2006-10#5)(2007-12#4)(2007-3#1)(2007-5#3)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#1)(2008-3#6)(2008-7#4)(2009-12#1)(2010-7#2)(2011-1#1)(2011-12#1)(2013-1#2)(2013-8#2)
the atomization of##2##3##(2008-10#2)
the atomization##5##2##(2008-10#5)
the atomizer##5##2##(2007-10#1)(2008-10#4)
the atoms##8##2##(1991-12#1)(1991-5#1)(1994-11#1)(1996-2#1)(2007-12#1)(2007-9#1)(2008-3#1)(2010-12#1)
the atria##5##2##(1994-3#1)(2007-8#1)(2009-5#1)(2012-1#1)(2013-1#1)
the atrial natriuretic##2##3##(1990-9#1)(1991-8#1)
the atrial septal defect##3##4##(2007-8#1)(2008-11#2)
the atrial septal defects##3##4##(2008-11#1)(2010-7#1)(2012-3#1)
the atrial septal##6##3##(2007-8#1)(2008-11#3)(2010-7#1)(2012-3#1)
the atrial##18##2##(1990-9#1)(1991-8#1)(2006-4#1)(2007-8#5)(2008-11#3)(2008-4#1)(2008-5#3)(2010-7#1)(2011-2#1)(2012-3#1)
the atrio-ventricular##2##2##(2007-8#1)(2008-5#1)
the atrioventricular##2##2##(1992-6#1)(2011-1#1)
the atrium##4##2##(1992-5#1)(2007-7#1)(2008-5#1)(2009-6#1)
the atrophic##6##2##(2006-2#1)(2008-4#2)(2008-5#1)(2010-5#1)(2011-7#1)
the atrophy and##2##3##(1992-12#1)(2008-5#1)
the atrophy of##3##3##(2008-7#1)(2009-2#1)(2011-2#1)
the atrophy##5##2##(1992-12#1)(2008-5#1)(2008-7#1)(2009-2#1)(2011-2#1)
the atropine-resistant##2##2##(1990-5#1)(1997-4#1)
the atropine-sensitive##2##2##(1997-4#2)
the atropisomerism##2##2##(2013-8#2)
the atropisomers##2##2##(2013-8#2)
the attached##11##2##(1994-5#1)(1995-2#1)(1995-5#1)(1997-6#1)(2005-10#1)(2006-2#1)(2008-11#1)(2008-5#1)(2010-5#2)(2011-2#1)
the attachment and##2##3##(1994-5#1)(2010-4#1)
the attachment force##2##3##(2005-10#2)
the attachment of the##7##4##(1991-12#1)(1991-6#1)(1994-12#1)(1997-2#1)(2008-10#1)(2008-8#1)(2009-4#1)
the attachment of trypomastigotes to##2##5##(1990-10#2)
the attachment of##23##3##(1990-10#2)(1990-12#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1993-5#1)(1993-9#1)(1994-12#1)(1996-3#2)(1997-2#2)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-4#1)(2010-12#1)
the attachment site##3##3##(1991-9#1)(1992-2#1)(1995-8#1)
the attachment##40##2##(1990-10#2)(1990-12#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-2#1)(1993-5#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-8#1)(1996-3#2)(1997-2#2)(2005-10#3)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-4#2)(2010-12#1)(2010-4#1)(2012-2#1)
the attachments of the##2##4##(2006-12#1)(2006-8#1)
the attacin##2##2##(1991-2#2)
the attack of##4##3##(1993-12#1)(1993-6#1)(1996-4#1)(2008-7#1)
the attack on the##2##4##(2006-10#1)(2009-10#1)
the attack rates##2##3##(1997-3#2)
the attack##12##2##(1993-12#1)(1993-6#1)(1994-6#1)(1996-4#1)(1997-3#2)(2006-10#1)(2007-10#1)(2008-7#1)(2008-9#1)(2009-10#1)(2013-1#1)
the attacked##2##2##(2010-3#1)(2012-3#1)
the attacker##4##2##(2008-2#2)(2009-6#1)(2009-8#1)
the attacking##2##2##(1995-1#1)(2008-9#1)
the attacks##2##2##(1990-3#1)(2007-2#1)
the attainable precision##3##3##(2008-10#2)(2008-3#1)
the attainable##6##2##(2007-12#2)(2008-10#3)(2008-3#1)
the attainment of high##3##4##(1994-3#1)(2007-12#1)(2008-2#1)
the attainment of the##2##4##(1995-1#1)(2008-6#1)
the attainment of##14##3##(1993-2#1)(1994-3#1)(1995-1#1)(2005-10#1)(2005-3#1)(2007-12#1)(2007-4#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-12#1)(2011-1#1)(2012-5#1)(2013-8#1)
the attempt to##7##3##(1992-1#1)(1997-6#2)(2008-2#1)(2009-11#1)(2012-2#1)(2013-1#1)
the attempt##10##2##(1992-1#1)(1997-6#2)(2007-8#1)(2008-2#1)(2009-11#1)(2009-8#1)(2010-4#1)(2012-2#1)(2013-1#1)
the attempts to##3##3##(2008-11#1)(2008-7#1)(2011-1#1)
the attempts##7##2##(1990-12#1)(1991-1#1)(1994-2#1)(2008-11#2)(2008-7#1)(2011-1#1)
the attendance##2##2##(2011-1#1)(2011-2#1)
the attendant##5##2##(1993-4#1)(2005-8#1)(2007-9#1)(2008-6#1)(2011-2#1)
the attendees##6##2##(1991-12#1)(2007-4#1)(2008-10#2)(2008-5#1)(2013-1#1)
the attending physician##2##3##(1992-3#1)(2007-10#1)
the attending##8##2##(1992-3#1)(1996-9#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-8#2)(2011-1#1)
the attention and##3##3##(1993-10#1)(1994-2#1)(1997-3#1)
the attention of an##2##4##(2007-4#1)(2008-6#1)
the attention of researchers##3##4##(2007-9#1)(2008-1#1)(2009-8#1)
the attention of the authors##2##5##(2006-3#1)(2012-2#1)
the attention of the##7##4##(1991-6#1)(1997-2#1)(2006-3#1)(2008-10#2)(2008-3#1)(2012-2#1)
the attention of##27##3##(1990-3#1)(1991-6#1)(1994-2#1)(1997-2#1)(2005-10#1)(2005-12#1)(2006-12#1)(2006-3#1)(2007-1#1)(2007-12#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-6#1)(2009-7#1)(2009-8#1)(2010-3#1)(2012-2#1)(2013-1#1)
the attention to##3##3##(1990-4#1)(1997-3#1)(2012-12#1)
the attention##46##2##(1990-3#1)(1990-4#1)(1991-6#1)(1992-1#1)(1992-12#1)(1993-10#1)(1994-2#2)(1997-2#2)(1997-3#2)(1997-4#1)(2005-10#1)(2005-12#1)(2006-12#1)(2006-3#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-6#1)(2009-7#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
the attentional blink##3##3##(2008-11#1)(2009-4#2)
the attentional##8##2##(1993-11#1)(1997-2#1)(2005-10#1)(2006-10#1)(2008-11#1)(2009-4#2)(2013-8#1)
the attenuated##12##2##(2005-11#1)(2006-12#1)(2007-12#1)(2008-5#1)(2008-7#2)(2008-9#2)(2012-2#1)(2013-8#3)
the attenuating effect of##2##4##(1991-8#1)(1997-5#1)
the attenuating##3##2##(1991-8#1)(1995-12#1)(1997-5#1)
the attenuation coefficient##5##3##(2007-12#1)(2008-2#2)(2008-3#1)(2011-1#1)
the attenuation in##2##3##(1997-8#1)(2007-11#1)
the attenuation of the##7##4##(1991-4#1)(1993-9#1)(1997-5#1)(1997-7#1)(2008-3#2)(2011-1#1)
the attenuation of##14##3##(1991-3#1)(1991-4#1)(1992-3#1)(1993-9#1)(1995-4#2)(1997-5#1)(1997-7#1)(2008-1#1)(2008-2#1)(2008-3#2)(2011-1#1)(2013-8#1)
the attenuation##31##2##(1991-3#1)(1991-4#1)(1992-3#1)(1993-9#1)(1995-4#3)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#4)(2008-3#7)(2008-7#1)(2011-1#3)(2012-3#1)(2013-8#1)
the attine##3##2##(2008-8#3)
the attitude and practice##2##4##(2007-4#1)(2008-1#1)
the attitude of the##5##4##(2006-11#1)(2007-7#1)(2008-1#1)(2010-8#2)
the attitude of##12##3##(1990-6#1)(1991-8#1)(2006-10#1)(2006-11#1)(2007-7#1)(2008-1#1)(2008-8#1)(2009-10#1)(2010-8#2)(2012-1#1)(2012-12#1)
the attitude towards##5##3##(1990-5#1)(1991-4#1)(1992-5#1)(1992-9#1)(2012-2#1)
the attitude##23##2##(1990-5#1)(1990-6#1)(1991-4#1)(1991-8#1)(1992-5#1)(1992-9#1)(2006-10#1)(2006-11#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-8#1)(2009-10#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)
the attitudes and behaviors of##3##5##(2008-7#1)(2010-5#1)(2011-1#1)
the attitudes and beliefs of##2##5##(1995-1#1)(1996-1#1)
the attitudes and##9##3##(1990-11#1)(1995-1#1)(1996-1#1)(1997-3#1)(2007-9#1)(2008-7#1)(2010-5#1)(2011-1#1)(2011-2#1)
the attitudes of the physicians##2##5##(1995-5#1)(2007-7#1)
the attitudes of##16##3##(1991-2#1)(1994-3#1)(1995-1#1)(1995-5#1)(1997-7#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-1#1)(2010-10#1)(2010-12#1)(2011-2#2)
the attitudes toward##2##3##(2009-1#1)(2013-1#1)
the attitudes##30##2##(1990-11#1)(1991-2#1)(1994-3#1)(1995-1#2)(1995-5#1)(1996-1#1)(1997-3#1)(1997-7#1)(2006-7#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-1#2)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#4)(2013-1#1)
the attitudinal##3##2##(1996-2#1)(2007-12#1)(2013-8#1)
the attraction of##2##3##(1994-8#1)(2008-5#1)
the attraction##9##2##(1994-8#1)(2004-11#3)(2007-5#1)(2008-11#1)(2008-5#1)(2011-12#2)
the attractive interactions##2##3##(2005-11#1)(2008-2#1)
the attractive##9##2##(1992-5#1)(2005-11#3)(2006-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)
the attractiveness of the##2##4##(2006-12#1)(2008-10#1)
the attractiveness of##7##3##(2006-12#1)(2007-12#1)(2008-10#2)(2008-5#1)(2009-8#1)(2011-2#1)
the attractiveness##8##2##(2006-12#1)(2007-12#1)(2008-10#2)(2008-5#2)(2009-8#1)(2011-2#1)
the attributable##3##2##(1994-11#2)(2011-1#1)
the attribute##2##2##(2008-2#1)(2012-2#1)
the attributes of a##2##4##(2006-6#1)(2007-4#1)
the attributes of##7##3##(1995-2#1)(1997-8#2)(2006-6#1)(2007-4#1)(2008-1#1)(2012-11#1)
the attributes##13##2##(1990-12#1)(1995-1#1)(1995-2#1)(1997-8#2)(2006-6#1)(2007-4#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-6#1)(2012-11#1)
the attribution of##3##3##(2007-5#1)(2008-10#1)(2010-8#1)
the attribution to##2##3##(2008-2#1)(2008-5#1)
the attribution##5##2##(2007-5#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-8#1)
the atypical antipsychotic drug##2##4##(1995-12#1)(1997-5#1)
the atypical antipsychotic##5##3##(1995-12#1)(1996-11#1)(1997-5#1)(2008-3#1)(2011-1#1)
the atypical clinical##2##3##(1990-5#1)(2008-7#1)
the atypical presentation##2##3##(2009-8#1)(2012-12#1)
the atypical##25##2##(1990-5#1)(1995-12#1)(1996-11#1)(1997-1#1)(1997-5#1)(1997-7#1)(2005-11#1)(2005-8#1)(2007-11#1)(2007-7#1)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-12#1)(2009-8#1)(2011-1#1)(2012-12#3)(2012-2#1)(2013-7#1)
the audience##8##2##(1997-8#1)(2006-9#1)(2008-10#2)(2008-7#1)(2010-2#1)(2013-1#2)
the audio-visual##2##2##(2011-1#1)(2012-2#1)
the audit##7##2##(1993-1#2)(1995-5#1)(2007-11#1)(2008-11#3)
the auditing of##2##3##(1996-1#1)(2007-4#1)
the auditory and visual##3##4##(2008-4#1)(2008-8#2)
the auditory brainstem response##2##4##(2008-4#2)
the auditory brainstem##4##3##(1996-9#2)(2008-4#2)
the auditory cortex##12##3##(1991-3#1)(1993-9#1)(1995-11#2)(2010-12#2)(2010-3#1)(2010-7#3)(2011-2#1)(2012-2#1)
the auditory evoked##2##3##(1991-6#1)(1992-7#1)
the auditory nerve##5##3##(1996-9#1)(2007-3#1)(2008-8#1)(2008-9#2)
the auditory startle response##2##4##(1991-11#2)
the auditory system##8##3##(1995-12#1)(1996-6#1)(1996-9#1)(2006-2#2)(2007-7#1)(2008-9#1)(2013-1#1)
the auditory thalamo-cortical pathway##2##4##(1991-3#2)
the auditory##59##2##(1990-3#1)(1991-1#1)(1991-11#2)(1991-3#3)(1991-6#1)(1992-11#1)(1992-7#1)(1993-9#1)(1995-11#2)(1995-12#1)(1995-5#1)(1996-5#2)(1996-6#1)(1996-9#4)(2006-10#1)(2006-2#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-4#3)(2008-8#3)(2008-9#10)(2009-9#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-7#3)(2011-12#2)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
the augmentation of glucose uptake##2##5##(2008-10#1)(2008-11#1)
the augmentation of the##3##4##(1990-4#1)(1992-11#1)(1992-8#1)
the augmentation of##10##3##(1990-4#1)(1992-11#1)(1992-8#1)(1995-12#2)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2012-12#1)
the augmentation##12##2##(1990-4#1)(1991-8#1)(1992-11#1)(1992-8#1)(1995-12#2)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-1#1)(2012-12#1)
the augmented production of##3##4##(2007-3#3)
the augmented##9##2##(1995-12#1)(1997-8#1)(2006-6#1)(2007-3#3)(2007-8#1)(2008-8#1)(2013-1#1)
the auricle##3##2##(1992-10#1)(2012-3#1)(2013-1#1)
the auricular acupuncture##2##3##(2010-6#1)(2013-1#1)
the auricular##5##2##(2008-4#2)(2010-6#1)(2013-1#2)
the auspices of the##11##4##(1992-4#1)(1994-12#1)(1994-2#1)(1995-3#2)(2005-8#1)(2006-10#2)(2007-5#1)(2008-10#1)(2008-11#1)
the auspices of##13##3##(1992-4#1)(1994-12#1)(1994-2#1)(1995-3#2)(1996-2#1)(2005-8#1)(2006-10#2)(2007-5#1)(2008-10#1)(2008-11#1)(2011-1#1)
the auspices##14##2##(1992-4#1)(1994-12#1)(1994-2#1)(1995-3#2)(1996-2#1)(2005-8#1)(2006-10#2)(2007-5#1)(2008-10#1)(2008-11#1)(2011-1#1)(2013-7#1)
the authentic 5'##2##3##(1994-8#1)(2008-11#1)
the authentic##15##2##(1990-12#1)(1990-2#2)(1991-2#3)(1993-6#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-2#1)(2008-10#2)(2008-11#1)
the authenticity of the cDNA##2##5##(1990-12#1)(1991-5#1)
the authenticity of the##3##4##(1990-12#1)(1991-5#1)(1992-8#1)
the authenticity of##11##3##(1990-12#1)(1991-5#1)(1992-8#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-9#1)(2010-11#1)(2012-1#1)
the author addresses##3##3##(1992-3#1)(2010-3#1)(2010-5#1)
the author analyzes##2##3##(1993-12#1)(1995-5#1)
the author and##5##3##(1991-11#1)(1994-6#2)(1996-12#1)(2008-2#1)
the author concludes that##3##4##(1993-3#1)(1994-3#1)(1997-2#1)
the author considers##2##3##(1992-6#1)(2007-2#1)
the author describes how##2##4##(1992-1#1)(1992-2#1)
the author describes the##10##4##(1991-1#2)(1991-2#1)(1991-3#2)(1991-7#1)(1994-1#1)(2008-11#1)(2008-9#1)(2012-12#1)
the author describes##16##3##(1991-1#3)(1991-2#2)(1991-3#2)(1991-7#1)(1992-1#1)(1992-2#2)(1994-1#1)(2008-11#1)(2008-9#1)(2012-12#1)(2012-2#1)
the author discusses the##5##4##(1991-2#1)(1992-2#1)(1993-2#2)(1994-6#1)
the author discusses##6##3##(1991-2#1)(1992-1#1)(1992-2#1)(1993-2#2)(1994-6#1)
the author encourages##3##3##(2007-2#3)
the author examines how##2##4##(2007-2#1)(2010-3#1)
the author examines the##6##4##(1991-12#1)(1992-1#1)(1994-3#1)(2007-2#2)(2008-2#1)
the author examines##16##3##(1991-12#1)(1992-1#1)(1992-2#1)(1993-1#1)(1994-1#1)(1994-3#1)(1996-1#1)(1996-12#1)(2007-2#3)(2008-2#2)(2010-3#1)(2012-2#2)
the author explores the##2##4##(1995-2#1)(2007-3#1)
the author explores##4##3##(1995-2#1)(1996-2#1)(2007-3#1)(2012-2#1)
the author focuses on##2##4##(2007-2#1)(2007-8#1)
the author found##2##3##(1996-12#1)(2007-2#1)
the author has##4##3##(2008-8#2)(2009-9#1)(2011-3#1)
the author in##4##3##(1992-8#1)(1997-6#1)(2008-12#1)(2010-8#1)
the author introduces##2##3##(2007-2#2)
the author investigates##2##3##(1992-3#1)(1994-3#1)
the author is##2##3##(2007-2#1)(2011-2#1)
the author makes##2##3##(2007-11#1)(2011-2#1)
the author of this article##2##5##(2007-2#1)(2008-12#1)
the author of this case study##2##6##(1991-1#1)(1992-3#1)
the author of this column##2##5##(2007-2#2)
the author of this paper##2##5##(2006-3#1)(2007-2#1)
the author of this##8##4##(1991-1#1)(1992-3#1)(2006-3#1)(2007-2#4)(2008-12#1)
the author of##13##3##(1991-1#1)(1992-3#1)(2006-12#1)(2006-3#1)(2007-2#4)(2007-5#1)(2008-12#2)(2009-4#1)(2010-10#1)
the author offers##3##3##(1992-12#1)(1992-3#1)(2006-5#1)
the author outlines##2##3##(1992-1#1)(2012-2#1)
the author over a##2##4##(2006-9#1)(2008-11#1)
the author performed##2##3##(2006-8#1)(2006-9#1)
the author points##2##3##(1996-6#1)(2008-12#1)
the author presents a##3##4##(1992-12#1)(2008-1#1)(2008-2#1)
the author presents the##2##4##(1991-2#1)(2008-12#1)
the author presents##10##3##(1991-2#1)(1992-12#1)(1994-8#1)(1997-7#1)(2007-2#2)(2008-1#1)(2008-12#2)(2008-2#1)
the author proposes a##2##4##(2008-1#1)(2008-2#1)
the author proposes that##2##4##(1991-1#1)(2008-3#1)
the author proposes##6##3##(1991-1#1)(1993-3#1)(2006-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
the author provides##2##3##(1993-12#1)(2007-2#1)
the author reviews the##4##4##(1992-10#1)(2006-5#1)(2007-11#1)(2007-8#1)
the author reviews##9##3##(1991-3#1)(1992-10#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-2#2)(2007-8#1)
the author suggests that##2##4##(1992-3#1)(1997-3#1)
the author suggests##4##3##(1991-12#1)(1992-3#1)(1997-3#1)(2009-5#1)
the author summarizes four research studies##2##6##(2008-6#1)(2008-9#1)
the author summarizes the##2##4##(2010-5#1)(2010-8#1)
the author summarizes##6##3##(1991-2#1)(2006-5#1)(2008-6#1)(2008-9#1)(2010-5#1)(2010-8#1)
the author to##4##3##(2007-2#1)(2007-6#1)(2009-2#1)(2009-9#1)
the author tries to##2##4##(2007-11#1)(2007-6#1)
the author was##2##3##(1990-5#1)(2004-3#1)
the author##237##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#6)(1991-11#3)(1991-12#3)(1991-2#5)(1991-3#8)(1991-7#2)(1992-1#7)(1992-10#1)(1992-12#2)(1992-2#7)(1992-3#7)(1992-6#1)(1992-8#2)(1993-1#1)(1993-12#2)(1993-2#6)(1993-3#2)(1993-6#1)(1994-1#3)(1994-12#2)(1994-2#1)(1994-3#3)(1994-6#3)(1994-8#1)(1995-2#2)(1995-5#1)(1996-1#2)(1996-12#3)(1996-2#3)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-3#1)(2006-10#1)(2006-12#2)(2006-2#2)(2006-3#1)(2006-5#4)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#3)(2007-11#7)(2007-2#25)(2007-3#1)(2007-5#1)(2007-6#2)(2007-8#6)(2008-1#3)(2008-11#3)(2008-12#8)(2008-2#12)(2008-3#2)(2008-6#1)(2008-8#4)(2008-9#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#2)(2009-7#1)(2009-9#3)(2010-10#1)(2010-3#2)(2010-5#2)(2010-8#3)(2011-2#4)(2011-3#1)(2012-11#1)(2012-12#2)(2012-2#9)(2012-3#1)(2013-1#1)(2013-7#2)
the author's clinical practice##3##4##(2007-7#1)(2013-1#2)
the author's experience##2##3##(1996-1#1)(2007-4#1)
the author's hypothesis that the##2##5##(2007-7#2)
the author's knowledge##11##3##(2006-8#1)(2007-12#3)(2008-10#1)(2008-2#6)
the author's opinion the##2##4##(1994-2#1)(2007-11#1)
the author's opinion##3##3##(1994-2#1)(2006-3#1)(2007-11#1)
the author's own experience##4##4##(1994-3#1)(2007-11#1)(2007-8#1)(2008-12#1)
the author's own##8##3##(1994-3#1)(2007-11#3)(2007-8#1)(2008-10#1)(2008-12#1)(2011-1#1)
the author's practice##2##3##(1996-2#1)(2010-12#1)
the author's technique##2##3##(2007-12#1)(2013-7#1)
the author's##59##2##(1991-1#1)(1991-3#1)(1992-12#2)(1992-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-2#1)(2005-9#1)(2006-10#2)(2006-3#1)(2006-8#1)(2007-11#4)(2007-12#4)(2007-2#3)(2007-4#2)(2007-7#3)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#7)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
the authorities##9##2##(1991-6#1)(2005-5#2)(2008-3#1)(2008-4#1)(2008-9#1)(2009-7#1)(2012-2#1)(2013-7#1)
the authority to##2##3##(1991-12#1)(1994-12#1)
the authority##5##2##(1991-12#1)(1994-1#1)(1994-12#1)(2007-7#1)(2010-3#1)
the authors address##3##3##(2010-10#1)(2010-11#1)(2012-12#1)
the authors affirm that##2##4##(1993-10#1)(2006-2#1)
the authors also##3##3##(1994-7#1)(2012-3#1)(2013-8#1)
the authors analyzed##2##3##(1990-6#1)(2012-3#1)
the authors and the##2##4##(2008-7#1)(2012-2#1)
the authors and##4##3##(2006-2#1)(2008-7#2)(2012-2#1)
the authors are aware of##2##5##(2008-7#1)(2010-1#1)
the authors are aware##6##4##(2006-10#1)(2008-3#1)(2008-7#1)(2010-1#1)(2011-2#2)
the authors are##7##3##(2006-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-1#1)(2011-2#2)
the authors argue that##3##4##(1993-3#1)(1997-3#1)(2008-12#1)
the authors assessed the##3##4##(1991-11#1)(1992-2#1)(2006-2#1)
the authors assessed##5##3##(1991-11#1)(1992-2#1)(2005-1#1)(2006-2#1)(2008-3#1)
the authors attempted to##2##4##(1992-2#1)(2006-11#1)
the authors attempted##3##3##(1992-2#1)(2006-11#1)(2009-4#1)
the authors believe it is##2##5##(2006-7#1)(2007-1#1)
the authors believe it##3##4##(1991-4#1)(2006-7#1)(2007-1#1)
the authors believe that the##3##5##(2007-7#1)(2008-7#1)(2009-3#1)
the authors believe that##9##4##(2006-3#1)(2006-5#1)(2007-4#1)(2007-7#1)(2008-7#1)(2009-2#1)(2009-3#1)(2011-2#1)(2013-8#1)
the authors believe##15##3##(1991-4#1)(1994-1#1)(1994-6#1)(2006-3#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-7#1)(2009-2#1)(2009-3#1)(2011-2#1)(2013-8#1)
the authors call##3##3##(1991-2#1)(1991-4#1)(2008-6#1)
the authors conclude that##4##4##(1994-2#1)(1995-1#1)(2005-10#1)(2008-11#1)
the authors conclude##5##3##(1994-2#1)(1995-1#1)(2005-10#1)(2008-11#1)(2013-8#1)
the authors conducted a##2##4##(2006-12#1)(2007-4#1)
the authors conducted##3##3##(2006-12#1)(2006-7#1)(2007-4#1)
the authors consider the##2##4##(2005-7#1)(2008-5#1)
the authors consider##3##3##(2005-7#1)(2006-3#1)(2008-5#1)
the authors considered##2##3##(1993-1#1)(2007-4#1)
the authors could##2##3##(2005-11#1)(2010-12#1)
the authors describe a##8##4##(2008-1#1)(2008-11#1)(2008-5#1)(2009-9#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)
the authors describe the##9##4##(1990-7#1)(1993-2#1)(2006-5#1)(2006-7#1)(2006-9#2)(2007-11#1)(2008-2#1)(2012-1#1)
the authors describe##27##3##(1990-7#1)(1993-2#2)(1995-1#1)(1995-12#1)(2006-5#1)(2006-7#1)(2006-9#2)(2007-10#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-9#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)
the authors develop a##2##4##(2008-5#1)(2012-2#1)
the authors developed a##3##4##(1994-3#1)(1996-3#1)(2006-3#1)
the authors developed##4##3##(1993-12#1)(1994-3#1)(1996-3#1)(2006-3#1)
the authors discuss the##6##4##(1991-11#1)(2005-10#1)(2006-2#1)(2007-12#1)(2008-2#1)(2008-8#1)
the authors discuss##13##3##(1990-7#1)(1991-11#1)(1993-3#1)(2005-10#1)(2005-7#1)(2006-2#2)(2007-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
the authors emphasise##2##3##(1991-5#1)(1991-6#1)
the authors emphasize the##2##4##(1991-11#1)(2007-11#1)
the authors estimated the##2##4##(2009-7#1)(2013-1#1)
the authors evaluated##4##3##(1991-6#1)(2006-11#1)(2006-5#1)(2011-1#1)
the authors examine the##7##4##(1991-12#2)(1994-3#1)(1995-3#1)(2007-2#1)(2007-7#1)(2008-2#1)
the authors examine##11##3##(1991-12#2)(1992-10#1)(1993-12#1)(1994-3#2)(1995-3#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-2#1)
the authors examined the role of##2##6##(2006-12#1)(2012-3#1)
the authors examined the##5##4##(1992-12#1)(2006-12#1)(2007-1#1)(2007-4#1)(2012-3#1)
the authors examined##10##3##(1991-3#1)(1991-7#1)(1992-12#1)(1993-12#1)(2006-12#2)(2007-1#1)(2007-4#1)(2011-1#1)(2012-3#1)
the authors explain##2##3##(1990-3#1)(2012-3#1)
the authors explore the##2##4##(2010-11#1)(2010-2#1)
the authors explore##6##3##(1991-12#1)(1993-1#1)(1994-3#1)(2010-10#1)(2010-11#1)(2010-2#1)
the authors find that##2##4##(1994-3#1)(2013-7#1)
the authors focus on the##2##5##(2006-11#1)(2006-2#1)
the authors focus##3##3##(2006-11#1)(2006-2#2)
the authors for##3##3##(2007-12#1)(2007-2#1)(2007-6#1)
the authors found that##4##4##(1995-3#1)(1996-1#2)(2007-1#1)
the authors found##11##3##(1994-12#1)(1995-3#1)(1996-1#2)(2005-1#1)(2005-2#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#1)(2011-1#1)
the authors from##2##3##(1990-12#1)(2008-10#1)
the authors give a##2##4##(1990-8#1)(1992-2#1)
the authors give##8##3##(1990-8#1)(1992-2#1)(1996-1#1)(2007-6#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-7#1)
the authors have conducted##2##4##(2006-6#1)(2010-10#1)
the authors have developed a##3##5##(1993-2#1)(2007-11#2)
the authors have##20##3##(1991-7#1)(1992-2#1)(1993-2#1)(1993-3#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#3)(2007-11#4)(2008-10#1)(2008-4#1)(2008-9#1)(2010-10#1)
the authors hypothesize that the##2##5##(1993-9#1)(2006-9#1)
the authors hypothesize that##4##4##(1993-9#1)(2006-9#1)(2008-11#1)(2010-1#1)
the authors hypothesized that##2##4##(2006-9#1)(2010-7#1)
the authors identified##2##3##(2007-11#1)(2010-10#1)
the authors investigated##2##3##(2006-6#1)(2008-6#1)
the authors measured the##2##4##(1996-6#1)(2006-12#1)
the authors measured##3##3##(1996-6#1)(2006-12#1)(2012-3#1)
the authors observed##4##3##(1990-8#2)(1993-10#1)(2010-10#1)
the authors of this##3##4##(2010-3#1)(2011-1#1)(2012-3#1)
the authors of##10##3##(1996-12#1)(2006-2#1)(2006-7#1)(2008-3#1)(2009-2#2)(2010-3#1)(2011-1#1)(2012-3#2)
the authors offer##2##3##(1994-2#1)(2008-5#1)
the authors outline the##2##4##(2006-4#1)(2006-7#1)
the authors outline##4##3##(2006-2#1)(2006-4#1)(2006-7#1)(2010-2#1)
the authors performed##2##3##(2007-4#1)(2011-2#1)
the authors prefer##2##3##(2006-6#1)(2006-7#1)
the authors present a##5##4##(1992-3#1)(2006-4#1)(2008-11#1)(2009-4#1)(2011-2#1)
the authors present an overview of the##2##7##(2005-7#1)(2006-10#1)
the authors present the##6##4##(1993-2#1)(2007-8#3)(2008-2#1)(2012-1#1)
the authors present their##2##4##(1990-5#1)(2009-4#1)
the authors present##22##3##(1990-5#1)(1992-12#1)(1992-3#1)(1993-2#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-8#4)(2007-9#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-4#2)(2011-2#1)(2012-1#1)
the authors propose a##4##4##(2007-7#1)(2008-2#1)(2010-6#1)(2013-7#1)
the authors propose##8##3##(2007-7#1)(2007-8#1)(2008-2#3)(2010-12#1)(2010-6#1)(2013-7#1)
the authors proposed a##2##4##(2008-2#1)(2008-8#1)
the authors provide a##3##4##(2006-8#1)(2008-9#1)(2010-8#1)
the authors provide an##2##4##(2006-5#1)(2006-7#1)
the authors provide examples of##2##5##(2007-2#1)(2008-11#1)
the authors provide##8##3##(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-9#1)(2010-8#1)
the authors recommend that##3##4##(2005-10#1)(2006-9#1)(2009-4#1)
the authors recommend to##2##4##(1990-6#1)(2005-1#1)
the authors recommend##13##3##(1990-3#1)(1990-6#1)(1991-2#1)(2004-9#1)(2005-1#1)(2005-10#1)(2006-11#1)(2006-12#1)(2006-9#1)(2008-9#2)(2009-4#1)(2011-2#1)
the authors reflect on##2##4##(2008-9#1)(2011-2#1)
the authors report a##2##4##(2008-5#1)(2009-6#1)
the authors report on the##2##5##(1996-2#1)(2007-10#1)
the authors report on##3##4##(1994-6#1)(1996-2#1)(2007-10#1)
the authors report the results of##2##6##(1990-9#1)(1997-6#1)
the authors report the##4##4##(1990-9#1)(1997-6#1)(2006-8#1)(2008-7#1)
the authors report##13##3##(1990-9#1)(1994-6#1)(1996-2#1)(1997-6#1)(2005-11#1)(2006-8#1)(2007-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-6#1)(2012-2#1)(2013-7#1)
the authors review the role of##2##6##(2006-2#1)(2007-4#1)
the authors review the##15##4##(1990-2#1)(1996-7#1)(2005-10#1)(2005-2#1)(2005-6#2)(2006-11#2)(2006-2#1)(2006-8#1)(2007-4#1)(2007-8#1)(2008-2#1)(2010-8#1)(2011-2#1)
the authors review their##2##4##(2006-5#2)
the authors review##26##3##(1990-2#1)(1993-12#1)(1996-7#1)(2004-12#1)(2005-10#1)(2005-2#1)(2005-6#2)(2006-11#3)(2006-2#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-4#1)(2007-8#2)(2008-2#1)(2008-5#2)(2009-2#1)(2010-8#1)(2011-2#1)(2013-7#1)
the authors show that##5##4##(1993-1#1)(1993-2#1)(2007-4#1)(2010-5#1)(2010-9#1)
the authors show the##2##4##(1990-3#1)(2010-10#1)
the authors show##9##3##(1990-3#1)(1993-1#1)(1993-2#1)(2007-4#1)(2008-7#1)(2010-10#1)(2010-5#1)(2010-9#1)(2011-2#1)
the authors suggest that the##3##5##(1994-1#1)(1996-1#1)(2007-8#1)
the authors suggest that##4##4##(1994-1#1)(1996-1#1)(2006-12#1)(2007-8#1)
the authors suggest##6##3##(1990-9#1)(1993-12#1)(1994-1#1)(1996-1#1)(2006-12#1)(2007-8#1)
the authors summarize##2##3##(1991-11#2)
the authors surveyed##2##3##(1997-3#1)(2008-5#1)
the authors tested##5##3##(1990-3#1)(1991-3#1)(2005-1#1)(2007-12#1)(2010-2#1)
the authors to##21##3##(1991-2#1)(1991-7#1)(1993-12#1)(1994-2#1)(1995-1#1)(1997-3#1)(2006-12#2)(2006-7#1)(2006-8#1)(2007-9#1)(2008-5#1)(2008-7#3)(2009-4#3)(2009-5#1)(2010-9#1)(2012-2#1)
the authors treated##3##3##(2007-11#1)(2007-8#1)(2010-12#1)
the authors use##2##3##(2008-11#1)(2010-10#1)
the authors were able to##2##5##(2007-4#1)(2010-8#1)
the authors were##3##3##(2007-2#1)(2007-4#1)(2010-8#1)
the authors who##3##3##(2005-1#1)(2008-1#1)(2013-7#1)
the authors will##4##3##(1993-2#1)(2006-10#2)(2008-7#1)
the authors##549##2##(1990-12#3)(1990-2#1)(1990-3#4)(1990-5#1)(1990-6#3)(1990-7#2)(1990-8#3)(1990-9#3)(1991-1#1)(1991-11#6)(1991-12#7)(1991-2#3)(1991-3#2)(1991-4#3)(1991-5#1)(1991-6#2)(1991-7#4)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#5)(1992-2#6)(1992-3#1)(1992-5#1)(1993-1#3)(1993-10#2)(1993-12#6)(1993-2#7)(1993-3#5)(1993-6#1)(1993-9#2)(1994-1#4)(1994-12#2)(1994-2#4)(1994-3#5)(1994-6#2)(1994-7#1)(1995-1#4)(1995-12#3)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#1)(1996-1#4)(1996-12#3)(1996-2#3)(1996-3#1)(1996-6#2)(1996-7#1)(1997-2#1)(1997-3#6)(1997-6#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-1#8)(2005-10#6)(2005-11#2)(2005-2#2)(2005-4#1)(2005-6#2)(2005-7#4)(2006-10#7)(2006-11#8)(2006-12#12)(2006-2#13)(2006-3#5)(2006-4#3)(2006-5#9)(2006-6#8)(2006-7#14)(2006-8#6)(2006-9#7)(2007-1#3)(2007-10#3)(2007-11#18)(2007-12#4)(2007-2#4)(2007-4#16)(2007-5#1)(2007-6#7)(2007-7#5)(2007-8#13)(2007-9#3)(2008-1#3)(2008-10#9)(2008-11#11)(2008-12#1)(2008-2#18)(2008-3#5)(2008-4#6)(2008-5#12)(2008-6#6)(2008-7#14)(2008-8#6)(2008-9#8)(2009-2#4)(2009-3#1)(2009-4#8)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#2)(2010-10#9)(2010-11#2)(2010-12#3)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#6)(2010-9#4)(2011-1#5)(2011-2#13)(2012-1#3)(2012-12#4)(2012-2#8)(2012-3#9)(2013-1#1)(2013-7#7)(2013-8#4)
the authors' clinical##2##3##(2006-10#1)(2007-11#1)
the authors' experience in##2##4##(2007-11#1)(2010-11#1)
the authors' experience of##3##4##(2008-12#1)(2009-11#1)(2012-12#1)
the authors' experience##11##3##(1990-10#1)(2005-1#1)(2006-3#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-12#1)(2009-11#1)(2010-11#1)(2011-3#1)(2012-12#1)
the authors' experiences##2##3##(1992-1#1)(2008-6#1)
the authors' institution##2##3##(1990-12#1)(2006-12#1)
the authors' knowledge##45##3##(1991-12#1)(2007-10#1)(2007-11#3)(2007-12#21)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#1)(2009-5#1)(2010-9#1)(2011-1#2)(2012-12#1)(2012-3#1)
the authors' laboratories##2##3##(2008-6#1)(2008-7#1)
the authors' laboratory##4##3##(2008-10#1)(2008-4#1)(2008-9#2)
the authors' opinion##9##3##(1990-4#1)(1995-2#1)(2005-8#1)(2007-1#1)(2007-8#1)(2008-7#1)(2012-12#2)(2013-7#1)
the authors' own clinical material##2##5##(2007-7#2)
the authors' own experience##4##4##(2007-11#1)(2007-8#2)(2013-1#1)
the authors' own results##2##4##(1992-8#1)(1993-3#1)
the authors' own##12##3##(1992-8#1)(1993-3#1)(2006-2#1)(2007-11#2)(2007-7#2)(2007-8#3)(2008-4#1)(2013-1#1)
the authors' personal experience##5##4##(1991-4#1)(1991-5#1)(1993-10#1)(1993-3#1)(1993-9#1)
the authors' personal##6##3##(1991-4#1)(1991-5#1)(1993-10#1)(1993-3#1)(1993-9#1)(2012-3#1)
the authors'##126##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#2)(1990-9#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-10#2)(1993-3#3)(1993-9#1)(1994-8#1)(1995-2#1)(2004-12#1)(2005-1#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-2#2)(2006-3#2)(2006-5#2)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#10)(2007-12#22)(2007-2#1)(2007-4#1)(2007-7#4)(2007-8#5)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#5)(2008-9#2)(2009-11#1)(2009-5#2)(2010-11#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-3#1)(2012-12#4)(2012-3#2)(2013-1#1)(2013-7#1)
the authors)##2##2##(2007-6#1)(2012-3#1)
the autistic##7##2##(2006-2#1)(2006-8#2)(2007-9#1)(2008-11#2)(2009-9#1)
the autoantibody##2##2##(1992-3#1)(1994-11#1)
the autoantigen##4##2##(1995-2#1)(1996-4#1)(2006-10#1)(2007-5#1)
the autoantigens##2##2##(2005-11#1)(2006-10#1)
the autocatalytic##2##2##(1991-2#1)(1997-7#1)
the autochthonous##2##2##(2008-9#1)(2012-11#1)
the autoclave##2##2##(2005-9#2)
the autoclaved rockwool##2##3##(2008-10#2)
the autoclaved##3##2##(2008-10#3)
the autocorrelation function (ACF)##2##4##(2007-12#1)(2007-8#1)
the autocorrelation function of the##3##5##(1990-5#1)(2008-2#1)(2008-3#1)
the autocorrelation function of##5##4##(1990-5#1)(2008-2#2)(2008-3#1)(2010-8#1)
the autocorrelation function##14##3##(1990-5#1)(1997-8#1)(2007-12#3)(2007-8#1)(2008-2#3)(2008-3#3)(2008-8#1)(2010-8#1)
the autocorrelation of##2##3##(2007-12#1)(2008-8#1)
the autocorrelation##25##2##(1990-5#1)(1994-8#1)(1997-8#1)(2007-11#2)(2007-12#5)(2007-8#1)(2008-2#5)(2008-3#4)(2008-8#2)(2010-8#1)(2013-1#2)
the autocovariance function##2##3##(2010-1#2)
the autocovariance##3##2##(2008-2#1)(2010-1#2)
the autocrine growth factor##2##4##(1993-9#1)(2008-4#1)
the autocrine growth##3##3##(1993-9#1)(2008-11#1)(2008-4#1)
the autocrine##6##2##(1993-3#1)(1993-9#1)(2008-11#1)(2008-4#2)(2013-1#1)
the autocrine/paracrine##2##2##(1993-12#1)(2008-4#1)
the autodistractor##2##2##(2007-8#2)
the autofluorescence of the##3##4##(1990-4#1)(1995-9#1)(2008-2#1)
the autofluorescence signal##2##3##(2007-12#1)(2011-2#1)
the autofluorescence##13##2##(1990-4#1)(1995-9#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#2)(2011-2#1)
the autogenous##3##2##(1996-2#1)(1997-4#1)(2007-12#1)
the autograft root##2##3##(2007-8#2)
the autograft##5##2##(2007-8#3)(2009-3#1)(2012-3#1)
the autoimmune destruction of##2##4##(2006-1#1)(2007-11#1)
the autoimmune response##5##3##(2007-5#1)(2008-1#2)(2013-7#2)
the autoimmune##19##2##(1991-5#1)(1997-2#1)(2006-1#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-5#2)(2008-1#2)(2008-10#2)(2011-1#1)(2013-7#4)(2013-8#1)
the autologous M protein##2##4##(1991-12#2)
the autologous tumor-specific cytotoxicity##3##4##(1991-9#3)
the autologous##16##2##(1991-12#2)(1991-9#3)(1992-1#1)(1995-12#1)(1997-7#1)(2007-10#1)(2007-9#2)(2008-1#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-12#1)
the autolysin##2##2##(1990-5#1)(1997-6#1)
the autolytic lysozyme##2##3##(1991-7#2)
the autolytic##3##2##(1991-7#2)(1992-1#1)
the automated and##3##3##(2006-2#1)(2008-10#2)
the automated assay##2##3##(1993-12#1)(1995-12#1)
the automated detection##2##3##(2006-12#2)
the automated devices##2##3##(2007-7#2)
the automated electronic verification of medications by nurses at the patient bedside##2##12##(2013-1#2)
the automated illustration system was evaluated using 49 previously unseen cardiology discharge instructions##2##13##(2013-1#2)
the automated marine pH sensor (AMpS)##2##6##(2008-10#2)
the automated method##2##3##(2008-10#2)
the automated operation##2##3##(2008-10#1)(2008-7#1)
the automated##48##2##(1991-11#1)(1991-5#1)(1992-2#1)(1992-7#1)(1993-12#1)(1995-12#1)(2006-12#3)(2006-2#1)(2007-11#1)(2007-7#2)(2008-10#18)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-7#1)(2012-10#1)(2012-2#2)(2013-1#4)
the automatic algorithm##3##3##(2008-2#2)(2012-12#1)
the automatic##28##2##(1990-8#1)(2008-10#6)(2008-11#2)(2008-2#5)(2008-3#5)(2008-4#2)(2008-7#1)(2009-11#2)(2012-12#1)(2013-1#2)(2013-7#1)
the automatically##2##2##(2010-4#1)(2012-12#1)
the automation of the##2##4##(2008-10#2)
the automation of##6##3##(2008-10#5)(2008-4#1)
the automation##11##2##(1990-3#1)(2008-10#9)(2008-4#1)
the automatization##2##2##(2007-9#1)(2008-11#1)
the automobile and##2##3##(1996-10#1)(2008-10#1)
the automobile##3##2##(1996-10#1)(2006-9#1)(2008-10#1)
the automotive industry##3##3##(2008-3#1)(2011-2#2)
the automotive##9##2##(2006-11#1)(2007-1#1)(2007-4#3)(2008-3#1)(2008-7#1)(2011-2#2)
the autonomic and##2##3##(2009-2#1)(2013-1#1)
the autonomic nervous modulation in##2##5##(2012-2#2)
the autonomic nervous system (ANS)##7##5##(2006-1#1)(2008-10#1)(2009-11#1)(2009-7#1)(2011-1#2)(2013-8#1)
the autonomic nervous system can##2##5##(2006-11#1)(2008-1#1)
the autonomic nervous system in the##2##6##(1996-12#1)(1997-2#1)
the autonomic nervous system in##4##5##(1996-12#2)(1997-2#1)(2011-12#1)
the autonomic nervous system was##2##5##(1996-12#1)(2008-2#1)
the autonomic nervous system##32##4##(1991-7#1)(1995-12#2)(1996-12#5)(1997-2#1)(2006-1#1)(2006-10#1)(2006-11#1)(2007-10#1)(2008-1#3)(2008-10#2)(2008-2#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-2#1)(2011-1#2)(2011-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
the autonomic nervous##36##3##(1991-7#1)(1995-12#2)(1996-12#5)(1997-2#1)(2006-1#1)(2006-10#2)(2006-11#1)(2007-10#1)(2008-1#3)(2008-10#2)(2008-2#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
the autonomic system##3##3##(2005-1#1)(2008-10#1)(2008-12#1)
the autonomic##50##2##(1991-7#1)(1995-12#3)(1996-12#5)(1997-2#1)(2005-1#1)(2006-1#1)(2006-10#3)(2006-11#1)(2007-10#2)(2008-1#3)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2009-10#1)(2009-11#1)(2009-2#2)(2009-7#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-2#3)(2013-1#3)(2013-8#4)
the autonomous nerve system##2##4##(2008-5#2)
the autonomous##5##2##(2008-3#1)(2008-5#2)(2011-2#1)(2013-1#1)
the autonomy of##2##3##(2005-11#1)(2012-1#1)
the autonomy##3##2##(2005-11#1)(2008-10#1)(2012-1#1)
the autophagic and##2##3##(2008-4#1)(2013-1#1)
the autophagic##5##2##(2008-4#1)(2010-12#1)(2013-1#3)
the autophagy interactome##2##3##(2013-1#2)
the autophagy pathway##2##3##(2013-1#2)
the autophagy##5##2##(2013-1#5)
the autophosphorylation of##3##3##(1990-9#1)(1991-12#1)(1993-8#1)
the autophosphorylation site##5##3##(1991-12#1)(1993-11#1)(1993-12#1)(1994-8#2)
the autophosphorylation##14##2##(1990-3#2)(1990-9#1)(1991-12#2)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-8#2)(1995-2#2)(1995-3#1)
the autopsy##7##2##(1991-9#1)(1992-2#1)(1996-5#1)(2007-11#1)(2007-8#1)(2009-4#1)(2012-12#1)
the autoradiograms##2##2##(1994-2#2)
the autoregressive##3##2##(2008-8#1)(2009-3#1)(2009-4#1)
the autoregulation of##2##3##(1992-4#1)(1993-9#1)
the autosampler cup##3##3##(2008-10#3)
the autosampler##10##2##(1996-8#1)(2008-10#9)
the autosomal dominant##4##3##(1996-12#1)(2008-11#1)(2008-8#1)(2008-9#1)
the autosomal recessive##5##3##(1996-6#1)(2008-11#1)(2008-6#1)(2008-7#1)(2012-12#1)
the autosomal##9##2##(1996-12#1)(1996-6#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#1)
the autosomes##3##2##(2008-12#2)(2008-7#1)
the autumn of 1992##3##4##(1995-9#1)(2008-2#2)
the autumn of##7##3##(1991-11#1)(1995-9#1)(2007-8#2)(2008-2#2)(2010-8#1)
the autumn##13##2##(1991-11#1)(1994-12#1)(1995-9#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#1)(2010-8#2)
the autumnal cooling rate##3##4##(2008-8#3)
the autumnal##6##2##(2008-10#1)(2008-11#1)(2008-8#3)(2010-8#1)
the auxiliary cells##2##3##(2007-12#1)(2008-7#1)
the auxiliary telescope##2##3##(2008-3#2)
the auxiliary##11##2##(1991-2#1)(1995-1#1)(1995-3#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)
the auxin##5##2##(2009-10#1)(2009-6#1)(2009-8#2)(2011-1#1)
the auxins##2##2##(2008-10#1)(2008-12#1)
the auxotroph##2##2##(1994-8#2)
the availability and the##2##4##(1997-8#1)(2013-7#1)
the availability and use of##3##5##(1991-12#1)(1992-12#1)(2008-9#1)
the availability and##12##3##(1991-12#1)(1992-12#1)(1993-10#1)(1993-8#1)(1995-2#1)(1997-8#1)(2006-12#1)(2008-9#1)(2012-12#1)(2013-1#2)(2013-7#1)
the availability in##2##3##(1996-6#1)(2011-1#1)
the availability of a large##2##5##(2008-5#1)(2011-1#1)
the availability of a new##2##5##(2006-10#1)(2007-11#1)
the availability of a##15##4##(1991-11#1)(1994-8#1)(1996-3#1)(2006-10#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-8#3)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
the availability of an##4##4##(2007-11#1)(2008-10#1)(2010-11#1)(2012-2#1)
the availability of certain##2##4##(1992-8#1)(2011-2#1)
the availability of commercial##2##4##(2008-10#1)(2011-2#1)
the availability of diagnostic##2##4##(2006-10#1)(2007-7#1)
the availability of donor##3##4##(2008-1#1)(2008-9#1)(2011-2#1)
the availability of effective##2##4##(2006-10#1)(2012-12#1)
the availability of free##3##4##(1996-11#1)(2008-10#1)(2008-5#1)
the availability of genetic##2##4##(2008-7#1)(2011-2#1)
the availability of hand-washing materials##3##5##(2013-8#3)
the availability of highly effective##2##5##(2012-2#1)(2013-1#1)
the availability of highly##3##4##(2012-1#1)(2012-2#1)(2013-1#1)
the availability of infective eggs in the##2##7##(2008-5#2)
the availability of more##4##4##(1991-12#1)(1992-2#1)(2008-2#1)(2011-2#1)
the availability of novel##2##4##(2004-3#1)(2010-12#1)
the availability of partial##2##4##(1991-1#1)(2013-1#1)
the availability of several##2##4##(2009-5#1)(2010-2#1)
the availability of simple##3##4##(1997-7#1)(2008-10#1)(2009-10#1)
the availability of sufficient##2##4##(2007-9#1)(2008-1#1)
the availability of suitable##3##4##(1994-6#1)(2006-2#1)(2008-10#1)
the availability of technical##2##4##(1993-8#1)(2012-3#1)
the availability of the##16##4##(1991-9#1)(1992-12#1)(1993-12#1)(1994-3#1)(1996-3#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2011-1#2)(2013-1#1)
the availability of these##4##4##(2007-11#1)(2008-12#1)(2008-3#1)(2008-7#1)
the availability of##211##3##(1990-11#1)(1990-12#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-9#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#3)(1993-12#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-7#1)(1994-8#2)(1995-12#2)(1995-3#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-4#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-6#1)(1997-7#1)(2004-11#1)(2004-2#1)(2004-3#1)(2005-12#1)(2005-7#1)(2006-10#7)(2006-12#1)(2006-2#2)(2006-4#2)(2006-7#4)(2006-8#3)(2007-1#3)(2007-10#2)(2007-11#6)(2007-12#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#18)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#7)(2009-10#3)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#10)(2012-1#2)(2012-12#4)(2012-2#7)(2012-3#2)(2013-1#6)(2013-8#3)
the availability on the market##2##5##(1992-3#1)(2012-12#1)
the availability##232##2##(1990-11#1)(1990-12#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-9#2)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-11#3)(1993-12#2)(1993-8#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-7#1)(1994-8#2)(1995-12#2)(1995-2#1)(1995-3#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-4#1)(1996-6#2)(1997-1#1)(1997-2#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-2#1)(2004-3#1)(2005-12#1)(2005-7#1)(2006-10#7)(2006-12#2)(2006-2#2)(2006-4#2)(2006-7#4)(2006-8#3)(2007-1#3)(2007-10#2)(2007-11#6)(2007-12#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#20)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#8)(2009-10#3)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#10)(2012-1#2)(2012-12#8)(2012-2#7)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#3)
the available clinical##3##3##(2006-7#1)(2008-8#1)(2013-8#1)
the available data and##2##4##(2006-2#1)(2010-8#1)
the available data are##2##4##(1996-12#1)(2008-8#1)
the available data from##2##4##(2007-12#1)(2008-10#1)
the available data in the literature##2##6##(1994-11#1)(2009-8#1)
the available data on the##3##5##(2008-8#1)(2012-12#2)
the available data on##8##4##(1991-12#1)(1994-6#1)(2005-8#1)(2008-8#1)(2010-8#1)(2012-12#2)(2013-1#1)
the available data regarding##3##4##(2012-2#1)(2013-1#2)
the available data##42##3##(1991-12#3)(1994-11#1)(1994-6#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-4#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-8#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-8#2)(2012-12#3)(2012-2#1)(2013-1#3)
the available empirical##2##3##(2010-12#1)(2013-8#1)
the available evidence is##2##4##(1992-2#1)(2008-3#1)
the available evidence on the##3##5##(1992-11#1)(2011-2#1)(2012-3#1)
the available evidence on##4##4##(1992-11#1)(2006-9#1)(2011-2#1)(2012-3#1)
the available evidence##19##3##(1992-11#1)(1992-2#1)(1993-12#1)(2006-10#1)(2006-2#1)(2006-7#1)(2006-9#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
the available experimental data##2##4##(1991-3#1)(1996-2#1)
the available information on the##8##5##(1993-1#1)(2005-10#1)(2006-10#1)(2008-5#1)(2008-8#1)(2010-4#1)(2011-2#1)(2013-8#1)
the available information on##10##4##(1993-1#1)(1994-8#1)(2005-10#1)(2006-10#1)(2007-3#1)(2008-5#1)(2008-8#1)(2010-4#1)(2011-2#1)(2013-8#1)
the available information##18##3##(1991-9#1)(1993-1#1)(1994-8#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-4#1)(2011-2#2)(2012-2#2)(2013-8#1)
the available literature on the##5##5##(2008-1#1)(2008-11#1)(2008-4#1)(2011-1#1)(2012-2#1)
the available literature on##12##4##(2004-3#1)(2006-10#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-11#2)(2008-4#1)(2011-1#1)(2012-12#1)(2012-2#1)
the available literature##36##3##(1991-4#1)(1992-2#1)(1993-5#1)(1996-12#1)(2004-3#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#6)(2007-4#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
the available phosphorus content##2##4##(2013-8#2)
the available phosphorus##3##3##(2013-8#3)
the available resources##5##3##(1991-5#1)(1994-3#1)(2007-8#1)(2008-10#1)(2008-11#1)
the available results##3##3##(1993-12#1)(2007-12#1)(2008-10#1)
the available scientific data##3##4##(2006-10#1)(2008-8#2)
the available scientific##5##3##(2006-10#1)(2007-7#1)(2008-11#1)(2008-8#2)
the available space##2##3##(1996-4#1)(2013-7#1)
the available studies##4##3##(2007-6#1)(2007-8#1)(2009-5#1)(2013-1#1)
the available tests##2##3##(1991-11#1)(2013-8#1)
the available therapeutic##3##3##(2007-11#1)(2011-2#1)(2012-2#1)
the available treatment options##3##4##(2006-12#1)(2008-6#1)(2013-7#1)
the available treatment##5##3##(1996-2#1)(2006-12#1)(2008-6#1)(2010-3#1)(2013-7#1)
the available treatments##5##3##(2007-7#1)(2008-7#2)(2011-2#1)(2012-12#1)
the available##266##2##(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#3)(1993-3#1)(1993-5#1)(1994-11#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-5#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-4#1)(1996-6#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-3#1)(2005-10#3)(2005-11#1)(2005-12#1)(2005-4#1)(2005-7#1)(2005-8#2)(2006-10#6)(2006-11#1)(2006-12#1)(2006-2#3)(2006-4#2)(2006-7#3)(2006-8#1)(2006-9#3)(2007-10#1)(2007-11#13)(2007-12#6)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#4)(2008-10#10)(2008-11#8)(2008-12#2)(2008-2#7)(2008-3#12)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#8)(2008-8#8)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-8#2)(2010-10#2)(2010-11#2)(2010-12#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-8#3)(2011-1#3)(2011-12#1)(2011-2#11)(2012-12#10)(2012-2#9)(2012-3#2)(2013-1#7)(2013-7#5)(2013-8#9)
the avascular##6##2##(2007-6#1)(2011-2#3)(2013-1#2)
the avenue##2##2##(2008-10#2)
the average SABP##2##3##(1997-6#2)
the average accuracy##2##3##(2008-2#1)(2008-4#1)
the average age at##2##4##(2008-6#1)(2008-7#1)
the average age of##9##4##(1992-2#2)(2007-11#3)(2007-12#1)(2008-7#1)(2011-1#1)(2011-2#1)
the average age##13##3##(1992-2#2)(2006-10#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-6#1)(2008-7#2)(2011-1#1)(2011-2#1)
the average and median ratios##2##5##(1996-12#2)
the average and##4##3##(1990-9#1)(1996-11#1)(1996-12#2)
the average annual rate of##2##5##(1993-3#1)(2010-9#1)
the average annual##3##3##(1993-3#1)(2010-12#1)(2010-9#1)
the average concentration##3##3##(2005-11#1)(2006-10#1)(2008-3#1)
the average concentrations##2##3##(1996-11#2)
the average cosine##4##3##(2008-3#4)
the average cost of##5##4##(1993-1#1)(1995-12#1)(2008-10#2)(2008-5#1)
the average cost##7##3##(1993-1#1)(1995-12#1)(2004-1#1)(2008-10#2)(2008-5#1)(2013-8#1)
the average daily##4##3##(1992-12#1)(1993-10#1)(2008-12#1)(2008-9#1)
the average degree of substitution of methyl-β-cyclodextrin##2##7##(2011-2#2)
the average degree of##3##4##(1990-5#1)(2011-2#2)
the average detection##2##3##(2008-10#2)
the average diameter and##2##4##(2008-10#1)(2010-8#1)
the average diameter##3##3##(2008-10#1)(2008-5#1)(2010-8#1)
the average diameters of the encapsulated and decapsulated cysts were 230##2##11##(2008-5#2)
the average dispersion##2##3##(2007-11#1)(2007-12#1)
the average distance##2##3##(1991-5#1)(2012-1#1)
the average duration of illness##2##5##(1993-3#2)
the average duration of the##2##5##(1992-4#1)(2011-2#1)
the average duration of##7##4##(1992-4#1)(1993-3#2)(2008-1#1)(2009-4#1)(2011-2#2)
the average duration was##2##4##(2006-5#1)(2007-8#1)
the average duration##9##3##(1992-4#1)(1993-3#2)(2006-5#1)(2007-8#1)(2008-1#1)(2009-4#1)(2011-2#2)
the average efficiency##2##3##(2008-2#1)(2008-3#1)
the average electro-osmotic flow velocity##2##5##(2005-11#2)
the average electro-osmotic##3##3##(2005-11#3)
the average error##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)
the average expenditure per##2##4##(2006-8#2)
the average female##2##3##(2008-3#1)(2008-9#1)
the average flow velocity of##2##5##(2011-2#2)
the average flow##3##3##(2008-3#1)(2011-2#2)
the average for##2##3##(1992-6#1)(1995-11#1)
the average genetic distance##2##4##(2008-10#1)(2011-2#1)
the average genetic##4##3##(2008-10#2)(2008-9#1)(2011-2#1)
the average group##2##3##(1992-6#1)(2012-3#1)
the average helix content##2##4##(1997-7#2)
the average helix##3##3##(1991-4#1)(1997-7#2)
the average improvement in##2##4##(2008-9#2)
the average in##2##3##(1996-11#1)(2008-6#1)
the average increase in##2##4##(2005-10#1)(2011-2#1)
the average inter-annotator kappa statistic for medical events##2##8##(2013-1#2)
the average length of##6##4##(1990-4#1)(1995-1#2)(2006-8#1)(2007-12#1)(2009-10#1)
the average length##9##3##(1990-4#1)(1992-2#2)(1995-1#2)(2006-8#1)(2007-12#1)(2008-7#1)(2009-10#1)
the average level of##4##4##(1990-8#2)(1991-10#1)(2008-8#1)
the average minimum temperature##2##4##(2008-8#2)
the average minimum##5##3##(1993-4#1)(2007-1#1)(2008-10#1)(2008-8#2)
the average molecular weight##2##4##(2007-11#1)(2008-5#1)
the average molecular##5##3##(1996-4#1)(2005-11#1)(2007-11#1)(2008-2#1)(2008-5#1)
the average mortality rate##2##4##(1995-12#1)(2008-7#1)
the average number of visits##2##5##(1991-12#1)(1995-3#1)
the average number of##32##4##(1990-4#2)(1991-12#1)(1991-7#1)(1992-2#1)(1995-3#1)(1996-11#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2012-12#3)(2012-3#2)(2013-1#1)(2013-8#1)
the average number##35##3##(1990-4#2)(1991-12#1)(1991-7#1)(1992-2#1)(1993-3#1)(1995-3#1)(1996-11#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2012-12#3)(2012-3#2)(2013-1#1)(2013-8#1)
the average of 1##2##4##(2011-1#1)(2012-12#1)
the average of all##2##4##(2006-4#1)(2011-1#1)
the average of the##6##4##(2008-2#2)(2008-3#2)(2008-4#1)(2012-2#1)
the average of##19##3##(1992-2#1)(1997-3#1)(2006-4#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)
the average percentages of erythroblasts##2##5##(2008-10#2)
the average period of##2##4##(1991-12#1)(2007-2#1)
the average period##3##3##(1991-12#1)(2007-2#1)(2013-8#1)
the average power and the##2##5##(2007-11#1)(2007-12#1)
the average power##3##3##(2007-11#1)(2007-12#1)(2010-8#1)
the average prediction##2##3##(2008-10#2)
the average quadratic##2##3##(2007-12#2)
the average ranks##2##3##(1992-2#2)
the average rate##4##3##(1990-12#1)(1990-4#1)(1994-12#1)(1996-4#1)
the average rates##2##3##(1990-4#1)(2008-1#1)
the average ratio of##2##4##(1996-3#1)(2010-9#1)
the average ratio##3##3##(1996-3#1)(2008-1#1)(2010-9#1)
the average recoveries of##2##4##(2008-10#1)(2011-1#1)
the average recoveries varied from##2##5##(2008-10#2)
the average recoveries##6##3##(2005-12#1)(2008-10#3)(2011-1#1)(2013-8#1)
the average recovery##4##3##(2008-10#3)(2011-1#1)
the average reduction of crestal bone height around the implants placed##2##11##(2013-1#2)
the average reduction of##3##4##(2013-1#3)
the average relative standard##2##4##(2008-10#2)
the average size of the##5##5##(1996-1#1)(2005-11#1)(2008-2#1)(2008-3#1)(2010-2#1)
the average size of##12##4##(1994-12#1)(1995-8#1)(1996-1#1)(1997-2#1)(2005-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2010-2#1)(2011-1#1)
the average size##15##3##(1994-12#1)(1995-8#1)(1996-1#1)(1997-2#1)(2005-11#1)(2007-5#2)(2008-2#1)(2008-3#2)(2008-5#3)(2010-2#1)(2011-1#1)
the average strain was##2##4##(2007-4#2)
the average structure##3##3##(1994-5#1)(1995-1#1)(1997-5#1)
the average temperature difference##2##4##(2007-7#2)
the average temperature##6##3##(1996-11#1)(2007-7#2)(2008-10#1)(2008-8#2)
the average time between##3##4##(2007-8#1)(2008-3#1)(2012-12#1)
the average time required was##3##5##(2010-6#3)
the average time to##2##4##(2007-8#1)(2008-8#1)
the average time##11##3##(1990-10#1)(2007-8#2)(2008-3#1)(2008-8#1)(2010-6#3)(2011-12#1)(2011-2#1)(2012-12#1)
the average to##2##3##(1993-12#1)(2013-1#1)
the average total##2##3##(2007-3#1)(2008-5#1)
the average treatment##2##3##(1991-6#1)(2005-10#1)
the average value of the##3##5##(2005-11#1)(2007-11#1)(2011-2#1)
the average value of##6##4##(2005-11#2)(2007-11#1)(2008-7#1)(2011-2#1)(2013-7#1)
the average value##10##3##(1993-3#1)(2005-11#2)(2007-11#2)(2008-10#2)(2008-7#1)(2011-2#1)(2013-7#1)
the average values of the reaction##2##6##(2013-8#2)
the average values of##4##4##(2008-7#1)(2012-3#1)(2013-8#2)
the average values##6##3##(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#2)
the average velocity of##2##4##(2005-11#1)(2011-2#1)
the average weight##2##3##(2007-8#1)(2010-4#1)
the average##550##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#6)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-10#2)(1992-12#3)(1992-2#8)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#1)(1993-1#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-3#6)(1993-4#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#4)(1994-12#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-9#1)(1995-1#5)(1995-11#1)(1995-12#3)(1995-3#4)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#10)(1996-12#3)(1996-2#3)(1996-3#2)(1996-4#4)(1996-6#1)(1996-7#2)(1996-8#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#5)(1997-7#2)(1997-8#4)(2004-1#1)(2004-11#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-10#3)(2005-11#13)(2005-12#1)(2006-10#6)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#4)(2007-1#3)(2007-10#1)(2007-11#13)(2007-12#16)(2007-2#2)(2007-3#2)(2007-4#4)(2007-5#2)(2007-7#8)(2007-8#11)(2008-1#4)(2008-10#57)(2008-11#5)(2008-12#5)(2008-2#22)(2008-3#31)(2008-4#4)(2008-5#15)(2008-6#2)(2008-7#13)(2008-8#11)(2008-9#9)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#6)(2009-9#2)(2010-10#1)(2010-12#2)(2010-2#5)(2010-3#1)(2010-4#1)(2010-6#3)(2010-8#5)(2010-9#3)(2011-1#12)(2011-12#2)(2011-2#21)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#6)(2012-3#8)(2013-1#16)(2013-7#1)(2013-8#10)
the averaged CARS temperature##2##4##(2008-2#2)
the averaged growth##2##3##(2010-8#2)
the averaged##16##2##(1992-7#1)(1996-11#3)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-7#1)(2009-5#1)(2010-8#3)(2012-12#1)
the averages##2##2##(2008-10#1)(2011-2#1)
the averaging##3##2##(2008-3#1)(2008-6#1)(2008-9#1)
the aversive##4##2##(1993-12#1)(1993-3#1)(2008-11#1)(2008-2#1)
the avian embryo##3##3##(2008-5#1)(2012-12#2)
the avian homologue of the mammalian##2##6##(1992-1#1)(1995-2#1)
the avian vocal system##2##4##(2009-2#2)
the avian##30##2##(1990-4#1)(1992-1#1)(1993-4#1)(1993-6#3)(1993-8#1)(1994-2#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1996-5#2)(1997-2#1)(1997-4#1)(2005-9#1)(2006-10#1)(2006-7#1)(2008-4#1)(2008-5#2)(2009-2#2)(2010-2#1)(2012-12#2)(2013-8#1)
the avidin##3##2##(1990-12#1)(1991-10#1)(2008-10#1)
the avidin-biotin##5##2##(1990-12#2)(1995-5#1)(1995-7#1)(2008-10#1)
the avidity of##3##3##(1994-2#2)(1996-5#1)
the avidity##5##2##(1991-11#1)(1994-2#2)(1996-5#1)(2009-6#1)
the avirulence gene##5##3##(2008-10#5)
the avirulence##6##2##(2008-10#6)
the avocado##2##2##(2008-10#2)
the avoidance and##2##3##(2006-7#1)(2008-8#1)
the avoidance of iatrogenic##2##4##(1993-10#1)(2006-10#1)
the avoidance of##16##3##(1993-10#1)(1993-3#1)(1996-9#1)(2006-10#5)(2006-3#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-6#1)(2008-10#1)(2009-6#1)(2012-1#1)
the avoidance response##2##3##(1996-10#2)
the avoidance##23##2##(1993-10#1)(1993-3#2)(1994-5#1)(1994-6#1)(1996-10#2)(1996-9#1)(2006-10#5)(2006-3#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-8#1)(2009-6#1)(2012-1#1)
the avoided##2##2##(2010-7#2)
the avrBs1##3##2##(2008-10#3)
the avulsed##3##2##(1996-12#2)(2008-12#1)
the awake freely##2##3##(1994-11#1)(2009-8#1)
the awake##8##2##(1990-7#1)(1991-3#1)(1993-2#2)(1994-11#1)(1995-7#1)(2007-9#1)(2009-8#1)
the awareness and##5##3##(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
the awareness in##2##3##(2008-11#1)(2012-3#1)
the awareness level of diabetes mellitus##2##6##(2008-6#2)
the awareness level of##3##4##(2008-6#3)
the awareness of the##4##4##(1994-5#1)(2006-6#1)(2007-2#1)(2008-8#1)
the awareness of these disorders##2##5##(2007-2#2)
the awareness of these##3##4##(2007-2#2)(2008-5#1)
the awareness of this##3##4##(1997-6#1)(2007-3#1)(2013-8#1)
the awareness of##28##3##(1994-5#1)(1995-3#1)(1997-6#1)(2006-6#2)(2007-11#1)(2007-2#3)(2007-3#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
the awareness on UI in the elderly and##2##8##(2011-1#2)
the awareness##47##2##(1994-1#1)(1994-5#1)(1995-3#1)(1997-6#1)(2006-6#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
the awd gene##2##3##(1990-11#2)
the axes##3##2##(1997-2#1)(2005-11#1)(2008-10#1)
the axial and equatorial##2##4##(1997-7#1)(2010-6#1)
the axial and##3##3##(1997-7#1)(2007-11#1)(2010-6#1)
the axial direction##4##3##(2007-12#1)(2008-3#2)(2009-7#1)
the axial force##4##3##(2007-4#1)(2008-2#3)
the axial intensity distribution##2##4##(2008-3#2)
the axial joints##2##3##(2006-10#1)(2011-2#1)
the axial ligand##3##3##(1990-3#1)(1996-2#1)(1997-7#1)
the axial ligands##2##3##(1997-7#1)(2010-5#1)
the axial pattern##2##3##(1991-6#2)
the axial position of##2##4##(1991-4#1)(2008-3#1)
the axial position##4##3##(1991-4#1)(2008-3#2)(2008-5#1)
the axial profile##3##3##(2005-11#2)(2009-10#1)
the axial skeleton##6##3##(1995-11#1)(1996-6#1)(2009-10#1)(2011-2#2)(2012-12#1)
the axial##75##2##(1990-3#1)(1991-2#1)(1991-4#1)(1991-6#2)(1992-9#1)(1995-11#2)(1995-8#1)(1996-12#1)(1996-2#2)(1996-6#1)(1997-7#5)(2005-10#1)(2005-11#3)(2006-10#1)(2006-11#2)(2006-12#2)(2007-11#4)(2007-12#9)(2007-4#2)(2008-10#1)(2008-2#4)(2008-3#9)(2008-5#1)(2008-6#1)(2008-8#2)(2009-10#2)(2009-6#1)(2009-7#2)(2010-5#2)(2010-6#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-8#1)
the axicon##2##2##(2007-12#1)(2008-3#1)
the axilla in##2##3##(1994-12#1)(2008-5#1)
the axilla is##2##3##(2008-5#2)
the axilla was##2##3##(2007-6#1)(2008-5#1)
the axilla##28##2##(1994-12#1)(1995-9#1)(1996-12#1)(2004-1#1)(2006-12#1)(2007-6#1)(2008-12#1)(2008-5#18)(2008-8#2)(2011-1#1)
the axillary and##2##3##(1993-8#1)(2013-8#1)
the axillary artery##6##3##(2007-8#1)(2008-7#3)(2011-12#2)
the axillary lymph nodes of##2##5##(2004-2#2)
the axillary lymph nodes##6##4##(1992-4#1)(1993-8#1)(1994-12#1)(2004-2#2)(2010-6#1)
the axillary mass##2##3##(1995-10#1)(2010-6#1)
the axillary microflora was##2##4##(2008-5#2)
the axillary microflora##4##3##(2008-5#4)
the axillary nerve##3##3##(2008-8#1)(2008-9#1)(2013-1#1)
the axillary nodes##3##3##(2008-10#2)(2013-1#1)
the axillary region##3##3##(2007-8#1)(2008-7#1)(2010-12#1)
the axillary skin##3##3##(2008-5#3)
the axillary vault##3##3##(2008-5#3)
the axillary##43##2##(1990-10#1)(1992-4#1)(1993-8#3)(1994-12#1)(1995-10#1)(2004-2#2)(2005-8#1)(2006-10#1)(2006-12#1)(2007-8#2)(2008-10#2)(2008-5#12)(2008-7#4)(2008-8#1)(2008-9#1)(2010-12#1)(2010-6#2)(2011-12#2)(2012-12#1)(2013-1#2)(2013-8#1)
the axis of the femur##3##5##(2006-11#3)
the axis of the##11##4##(1996-6#1)(2006-11#3)(2007-12#1)(2007-7#1)(2007-8#1)(2008-2#3)(2008-3#1)
the axis of##21##3##(1996-6#1)(2005-11#1)(2006-11#3)(2007-12#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-2#5)(2008-3#3)(2008-8#1)(2009-8#1)(2013-8#1)
the axis on##2##3##(2008-11#1)(2008-3#1)
the axis perpendicular to the##2##5##(2008-10#1)(2008-3#1)
the axis##33##2##(1996-6#1)(2005-11#1)(2006-11#3)(2006-9#1)(2007-12#2)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#11)(2008-8#1)(2009-8#1)(2013-8#1)
the axolemma##3##2##(1990-11#1)(1990-4#1)(1997-4#1)
the axolotl##3##2##(1991-9#1)(1994-8#1)(1997-9#1)
the axon and the##2##4##(1996-9#1)(2009-7#1)
the axon and##5##3##(1996-9#1)(1997-4#1)(2008-4#1)(2009-7#1)(2013-7#1)
the axon reflex##4##3##(1996-1#1)(2009-12#3)
the axon terminals##5##3##(1995-11#2)(1996-2#1)(2008-4#1)(2013-8#1)
the axon##33##2##(1990-4#1)(1991-10#1)(1991-9#1)(1994-10#1)(1994-11#2)(1994-2#3)(1994-5#1)(1995-11#2)(1995-2#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-9#3)(1997-4#1)(2007-11#1)(2008-4#2)(2009-12#3)(2009-7#1)(2011-1#1)(2012-2#2)(2013-7#1)(2013-8#1)
the axonal##15##2##(1991-11#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-6#1)(2007-12#1)(2007-8#1)(2008-6#1)(2008-7#3)(2009-7#1)(2010-12#2)(2012-2#1)
the axoneme and##2##3##(2007-12#1)(2008-4#1)
the axoneme##8##2##(1991-2#2)(1997-4#1)(2007-12#2)(2008-4#1)(2008-7#2)
the axons of the##2##4##(1993-9#1)(1996-9#1)
the axons of##6##3##(1990-4#1)(1990-5#1)(1991-10#1)(1993-9#1)(1996-9#2)
the axons##13##2##(1990-4#1)(1990-5#1)(1991-10#1)(1993-9#1)(1995-3#2)(1996-9#2)(2008-2#2)(2008-5#1)(2009-7#2)
the aza-BODIPY dyes##2##3##(2009-5#2)
the azetidine##2##2##(1995-3#2)
the azide moiety##2##3##(1993-11#2)
the azide##5##2##(1993-11#2)(1997-4#2)(2008-6#1)
the azido##2##2##(1996-10#1)(2006-12#1)
the azimuth##4##2##(2008-2#1)(2008-3#3)
the azimuthal##5##2##(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
the azo dye##3##3##(2007-12#1)(2008-10#1)(2011-1#1)
the azo##6##2##(1995-6#1)(2007-12#1)(2008-10#3)(2011-1#1)
the azobenzene##5##2##(2007-12#1)(2008-10#4)
the azole##4##2##(1997-4#1)(2008-4#2)(2008-5#1)
the azoxymethane rat carcinogenesis model##2##5##(2011-1#2)
the azygos vein##6##3##(2008-11#1)(2011-2#2)(2012-12#2)(2012-3#1)
the b##11##2##(1994-10#2)(1994-8#1)(1995-2#1)(1995-3#2)(1996-4#1)(2007-11#1)(2008-10#2)(2008-7#1)
the b(1)(psi) orbital##2##3##(1996-2#2)
the b(1)(psi)##3##2##(1996-2#3)
the bFGF##3##2##(2007-10#2)(2008-5#1)
the bHLH##2##2##(2008-7#1)(2009-8#1)
the bR photocycle##2##3##(1992-11#1)(1995-11#1)
the bR##6##2##(1990-10#1)(1990-2#1)(1992-11#1)(1993-11#2)(1995-11#1)
the bSBP obtained with the catheter##3##6##(2013-8#3)
the bSBP obtained with the cuff##3##6##(2013-8#3)
the bSBP obtained with the##6##5##(2013-8#6)
the bSBP obtained##7##3##(2013-8#7)
the bSBP##9##2##(2013-8#9)
the bZIP transcription##2##3##(2008-9#1)(2009-8#1)
the bZIP##3##2##(2008-9#1)(2009-8#1)(2013-8#1)
the babies##5##2##(1994-3#1)(2006-8#1)(2007-7#1)(2011-2#2)
the babies'##2##2##(1991-2#1)(1992-4#1)
the baboon and rabbit##2##4##(2008-9#2)
the baboon and##3##3##(1993-6#1)(2008-9#2)
the baboon##11##2##(1991-12#1)(1992-1#2)(1993-5#1)(1993-6#1)(1994-12#2)(2007-6#1)(2008-9#2)(2013-1#1)
the baby and##4##3##(1996-11#1)(2007-10#1)(2007-2#1)(2008-2#1)
the baby boom generation##2##4##(2008-10#1)(2009-5#1)
the baby boom##3##3##(2008-10#1)(2008-12#1)(2009-5#1)
the baby##33##2##(1992-7#1)(1993-12#1)(1993-5#1)(1994-3#1)(1995-1#1)(1995-8#1)(1996-11#3)(2004-10#1)(2006-2#1)(2006-8#2)(2007-10#1)(2007-2#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)
the baby's##5##2##(2006-10#1)(2007-2#1)(2008-11#1)(2008-2#2)
the baccalaureate graduate##2##3##(1995-2#2)
the baccalaureate##4##2##(1994-12#1)(1994-2#1)(1995-2#2)
the back and##6##3##(1992-9#1)(1997-3#1)(2005-10#1)(2006-8#1)(2008-5#1)(2012-1#1)
the back electrodes##2##3##(2013-1#2)
the back focal plane of a##2##6##(2008-2#2)
the back focal plane of##3##5##(2008-2#2)(2008-3#1)
the back focal plane##4##4##(2008-2#2)(2008-3#2)
the back of a##5##4##(2008-11#2)(2008-2#2)(2008-3#1)
the back of the hand##5##5##(2007-11#2)(2008-2#1)(2008-6#1)(2012-1#1)
the back of the##14##4##(1990-6#1)(1991-6#1)(2007-11#2)(2007-7#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
the back of##23##3##(1990-6#1)(1991-6#1)(1995-2#1)(2006-5#1)(2007-11#2)(2007-7#1)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
the back or##2##3##(1997-4#1)(2008-12#1)
the back plate##3##3##(2006-11#1)(2007-12#2)
the back side of the##2##5##(1995-12#1)(2007-12#1)
the back side of##3##4##(1995-12#1)(2007-12#1)(2013-1#1)
the back skin and##2##4##(1997-7#2)
the back skin##4##3##(1990-2#1)(1997-7#2)(2013-1#1)
the back surface of the##2##5##(2007-12#1)(2008-8#1)
the back surface##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)
the back with##2##3##(2008-11#1)(2008-5#1)
the back##96##2##(1990-2#1)(1990-6#1)(1990-8#1)(1991-6#1)(1992-9#1)(1995-12#1)(1995-2#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-7#3)(2005-10#2)(2005-11#1)(2006-11#1)(2006-4#1)(2006-5#1)(2006-8#4)(2007-1#1)(2007-11#3)(2007-12#4)(2007-4#3)(2007-7#3)(2007-8#3)(2008-11#3)(2008-12#1)(2008-2#9)(2008-3#9)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#9)(2013-7#1)
the back-scattering of visible light##2##5##(2006-7#2)
the back-scattering of##3##3##(2006-7#3)
the back-up device##2##3##(2008-9#2)
the back-up##3##2##(2008-11#1)(2008-9#2)
the backbone and side##2##4##(2009-7#2)
the backbone and side-chain##2##4##(1995-5#1)(2009-7#1)
the backbone and##7##3##(1995-5#1)(1997-7#1)(2007-10#1)(2008-4#1)(2009-7#3)
the backbone atoms of##2##4##(1996-6#1)(2010-7#1)
the backbone atoms##6##3##(1995-1#3)(1996-6#1)(1997-2#1)(2010-7#1)
the backbone dynamics of##3##4##(1992-9#1)(1996-7#1)(1997-5#1)
the backbone of the##4##4##(1995-8#2)(2007-4#1)(2010-5#1)
the backbone of##11##3##(1991-9#2)(1993-12#1)(1995-8#2)(1996-2#1)(2007-4#1)(2008-9#1)(2010-5#2)(2013-1#1)
the backbone##51##2##(1990-7#1)(1991-9#2)(1992-9#1)(1993-12#1)(1993-3#1)(1994-11#2)(1994-5#1)(1994-9#1)(1995-1#3)(1995-2#2)(1995-5#1)(1995-8#3)(1996-2#1)(1996-6#1)(1996-7#2)(1997-2#1)(1997-5#1)(1997-7#3)(2005-11#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-3#1)(2007-4#1)(2008-4#1)(2008-9#1)(2009-2#1)(2009-7#7)(2010-3#1)(2010-5#2)(2010-7#1)(2012-3#2)(2013-1#1)
the backbones##2##2##(2006-12#2)
the backdrop of##3##3##(2012-2#1)(2013-1#2)
the backdrop##4##2##(2006-2#1)(2012-2#1)(2013-1#2)
the background absorbance##2##3##(2008-10#1)(2011-1#1)
the background absorption of##2##4##(2005-4#2)
the background and rationale for the##2##6##(2007-7#1)(2010-12#1)
the background and the##2##4##(2007-6#1)(2008-2#1)
the background and##15##3##(1992-12#1)(1994-3#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-6#1)(2007-7#2)(2008-10#1)(2008-2#1)(2008-4#1)(2009-5#1)(2010-12#1)(2010-4#1)(2013-8#1)
the background current##3##3##(2008-10#2)(2008-2#1)
the background electrolyte##3##3##(2007-8#1)(2008-10#2)
the background for the##2##4##(1996-12#1)(2006-10#1)
the background for##3##3##(1996-12#1)(2006-10#1)(2008-10#1)
the background medium##4##3##(2007-12#1)(2008-2#3)
the background noise##7##3##(1990-9#2)(2008-10#2)(2008-2#1)(2008-3#1)(2012-2#1)
the background of the##10##4##(1991-8#1)(1995-2#1)(1995-8#1)(1996-9#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-7#1)(2012-12#1)(2013-7#1)
the background of this##2##4##(2008-12#1)(2010-10#1)
the background of##43##3##(1990-3#1)(1991-8#1)(1993-1#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-9#1)(2006-6#2)(2007-10#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-2#2)(2009-7#1)(2010-10#1)(2010-12#3)(2011-1#1)(2011-2#1)(2012-1#5)(2012-12#2)(2013-1#3)(2013-7#1)(2013-8#1)
the background population##2##3##(1992-6#1)(2007-12#1)
the background rate of##2##4##(1993-7#1)(2010-3#1)
the background rate##4##3##(1993-7#1)(1994-8#1)(2006-10#1)(2010-3#1)
the background signal##2##3##(2008-10#2)
the background signals##6##3##(2008-10#1)(2008-3#5)
the background to and##2##4##(2008-3#1)(2008-5#1)
the background to the##2##4##(2008-11#1)(2011-1#1)
the background to##4##3##(2008-11#1)(2008-3#1)(2008-5#1)(2011-1#1)
the background were##2##3##(2008-2#1)(2008-3#1)
the background##159##2##(1990-3#1)(1990-9#2)(1991-12#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-7#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-2#2)(1995-8#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#1)(2005-10#1)(2005-11#1)(2005-4#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#8)(2007-5#3)(2007-6#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#18)(2008-11#2)(2008-12#2)(2008-2#13)(2008-3#14)(2008-4#3)(2008-5#6)(2008-7#2)(2008-9#5)(2009-2#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-10#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#4)(2012-1#5)(2012-12#2)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#2)
the backgrounds of##2##3##(2008-2#1)(2013-8#1)
the backgrounds##3##2##(2008-10#1)(2008-2#1)(2013-8#1)
the backing##3##2##(2008-10#1)(2009-5#1)(2009-7#1)
the backpropagation algorithm##2##3##(2008-10#1)(2010-8#1)
the backreflected##2##2##(2007-11#1)(2008-3#1)
the backs of##2##3##(2005-11#1)(2007-9#1)
the backscatter and##2##3##(2008-3#2)
the backscatter##9##2##(2008-2#4)(2008-3#5)
the backscatter-to-extinction ratio##2##3##(2008-2#2)
the backscattered beam##3##3##(2008-2#3)
the backscattered laser pulse##3##4##(2008-3#3)
the backscattered light##7##3##(2008-2#4)(2008-3#3)
the backscattered signal##2##3##(2007-12#1)(2008-3#1)
the backscattered speckle pattern##2##4##(2008-2#2)
the backscattered##26##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#9)(2008-3#13)
the backscattering coefficient b(b)##2##4##(2008-2#1)(2008-3#1)
the backscattering coefficient##9##3##(2008-2#3)(2008-3#6)
the backscattering cross section for##2##5##(2008-3#2)
the backscattering fraction##3##3##(2008-3#3)
the backscattering is##2##3##(2008-3#2)
the backscattering##33##2##(2005-11#2)(2007-11#1)(2007-12#1)(2008-2#8)(2008-3#21)
the backup##2##2##(1997-2#1)(2008-9#1)
the backward direction##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
the backward inversion algorithm##2##4##(2008-3#2)
the backward second-harmonic##2##3##(2007-12#2)
the backward##12##2##(2007-12#4)(2008-2#2)(2008-3#4)(2009-3#1)(2010-10#1)
the bacteria and##2##3##(1995-2#1)(2006-10#1)
the bacteria are##2##3##(2007-12#1)(2010-12#1)
the bacteria on##2##3##(2008-10#2)
the bacteria or##3##3##(2006-6#1)(2008-11#1)(2008-5#1)
the bacteria that##2##3##(1991-11#1)(2006-8#1)
the bacteria to##7##3##(1990-2#1)(1993-11#1)(1995-2#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#1)
the bacteria was##3##3##(1996-12#1)(2008-6#1)(2010-1#1)
the bacteria were##4##3##(1994-11#1)(1996-12#1)(2008-10#2)
the bacteria##81##2##(1990-12#1)(1990-2#1)(1991-11#1)(1992-10#2)(1993-11#1)(1993-2#1)(1994-11#1)(1994-6#1)(1994-8#2)(1995-2#3)(1995-8#1)(1995-9#1)(1996-12#4)(1996-2#1)(1997-2#1)(1997-4#3)(1997-8#1)(2004-4#1)(2006-10#2)(2006-6#1)(2006-8#2)(2007-12#1)(2007-8#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#3)(2008-8#2)(2010-1#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-12#2)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#2)
the bacterial and##2##3##(1993-3#1)(2008-10#1)
the bacterial beta-galactosidase##2##3##(1992-8#1)(1993-12#1)
the bacterial cell membrane##3##4##(1993-12#1)(2008-11#1)(2011-1#1)
the bacterial cell surface##2##4##(1990-3#1)(1997-4#1)
the bacterial cell##11##3##(1990-3#1)(1990-9#1)(1993-12#1)(1997-4#1)(2006-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2011-1#1)
the bacterial cells##7##3##(2005-12#1)(2006-5#1)(2006-8#1)(2008-4#1)(2009-2#1)(2011-1#1)(2013-8#1)
the bacterial chloramphenicol acetyltransferase (CAT) gene##3##6##(1990-9#1)(1991-12#1)(1993-8#1)
the bacterial chloramphenicol acetyltransferase gene##2##5##(1990-12#1)(1993-3#1)
the bacterial chloramphenicol acetyltransferase##5##4##(1990-12#1)(1990-9#1)(1991-12#1)(1993-3#1)(1993-8#1)
the bacterial chloramphenicol##6##3##(1990-12#1)(1990-9#1)(1991-1#1)(1991-12#1)(1993-3#1)(1993-8#1)
the bacterial colonization of##2##4##(1991-3#1)(2006-8#1)
the bacterial communities##2##3##(2007-12#1)(2008-10#1)
the bacterial community##4##3##(2008-10#1)(2010-6#1)(2011-2#1)(2013-8#1)
the bacterial contamination##2##3##(1991-12#1)(2007-3#1)
the bacterial count##2##3##(2008-5#2)
the bacterial cytoplasmic membrane##3##4##(1990-11#3)
the bacterial diversity##2##3##(2011-1#1)(2011-2#1)
the bacterial enzyme##4##3##(1991-2#1)(1995-2#1)(1996-7#1)(1997-6#1)
the bacterial gene##2##3##(1994-2#2)
the bacterial genome##3##3##(2011-1#3)
the bacterial growth##2##3##(2006-8#1)(2008-10#1)
the bacterial infections##2##3##(2007-7#1)(2008-12#1)
the bacterial insertion##2##3##(1990-3#1)(1994-12#1)
the bacterial membrane##3##3##(1993-9#1)(1997-5#1)(2012-11#1)
the bacterial number##4##3##(2008-5#1)(2008-7#3)
the bacterial outer##2##3##(1990-8#1)(1993-4#1)
the bacterial pathogen##3##3##(2007-5#1)(2008-10#2)
the bacterial populations##3##3##(2008-10#3)
the bacterial protein##2##3##(1994-11#1)(1997-1#1)
the bacterial spores##2##3##(2005-9#1)(2011-1#1)
the bacterial spot pathogen##3##4##(2008-10#3)
the bacterial strain##5##3##(2007-1#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)
the bacterial strains##4##3##(2006-3#1)(2008-10#1)(2010-2#1)(2013-8#1)
the bacterial superantigen##2##3##(1991-10#1)(1994-8#1)
the bacterial surface##2##3##(1990-12#1)(2008-1#1)
the bacterial transposon Tn7##2##4##(1991-5#1)(1991-7#1)
the bacterial transposon##4##3##(1991-5#1)(1991-7#1)(1995-8#2)
the bacterial##179##2##(1990-11#4)(1990-12#2)(1990-3#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-3#2)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#4)(1994-5#2)(1994-6#3)(1994-8#1)(1995-2#2)(1995-8#3)(1996-2#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#1)(2004-4#1)(2005-12#1)(2005-9#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-8#9)(2007-1#1)(2007-12#4)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#25)(2008-11#4)(2008-12#1)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#3)(2009-2#2)(2009-6#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-6#2)(2010-7#1)(2011-1#7)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#4)
the bacterially expressed##4##3##(1994-11#2)(1994-3#1)(1994-5#1)
the bacterially##5##2##(1994-11#2)(1994-3#1)(1994-5#1)(2006-10#1)
the bactericidal activity of neutrophils##2##5##(1991-2#1)(1994-3#1)
the bactericidal activity of##4##4##(1991-2#1)(1994-3#1)(2006-11#1)(2006-8#1)
the bactericidal activity##5##3##(1991-2#1)(1994-3#1)(2006-11#1)(2006-8#1)(2008-5#1)
the bactericidal effects of##2##4##(1991-8#1)(1994-9#1)
the bactericidal##10##2##(1991-2#1)(1991-8#1)(1994-3#1)(1994-9#1)(2005-11#1)(2006-11#1)(2006-8#1)(2008-5#1)(2009-2#1)(2010-4#1)
the bactericidality##2##2##(2006-8#2)
the bacteriocin##2##2##(1996-10#1)(2010-10#1)
the bacterioferritins of##2##3##(1991-5#2)
the bacterioferritins##3##2##(1991-5#3)
the bacteriologic##2##2##(2007-9#1)(2012-3#1)
the bacteriological##3##2##(2007-7#1)(2008-9#1)(2012-2#1)
the bacteriology of infected##2##4##(2006-8#2)
the bacteriology of##3##3##(2006-8#2)(2007-7#1)
the bacteriology##4##2##(2006-8#2)(2007-7#1)(2009-2#1)
the bacteriophage P1##2##3##(1990-3#1)(1994-3#1)
the bacteriophage T4 late##2##4##(1992-5#1)(1995-6#1)
the bacteriophage T4##3##3##(1990-5#1)(1992-5#1)(1995-6#1)
the bacteriophage T7##5##3##(1990-4#1)(1991-5#1)(1992-12#2)(1997-5#1)
the bacteriophage lambda##3##3##(1990-11#2)(1991-5#1)
the bacteriophage##22##2##(1990-11#2)(1990-3#1)(1990-4#1)(1990-5#1)(1991-5#2)(1991-6#2)(1992-12#2)(1992-5#1)(1993-12#1)(1994-3#1)(1995-4#1)(1995-6#1)(1996-2#1)(1997-5#1)(1997-7#1)(2008-2#1)(2008-8#1)(2010-10#1)
the bacterium Erwinia##3##3##(2008-10#3)
the bacterium Escherichia coli##3##4##(1990-12#1)(1991-11#1)(1991-8#1)
the bacterium Pseudomonas##2##3##(2008-10#1)(2008-8#1)
the bacterium and##2##3##(2008-5#1)(2008-7#1)
the bacterium into the host##2##5##(1996-12#1)(2013-1#1)
the bacterium to##3##3##(2008-10#2)(2011-1#1)
the bacterium##58##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-11#1)(1991-8#1)(1992-11#1)(1993-6#1)(1993-9#1)(1995-10#1)(1995-5#1)(1996-11#1)(1996-12#1)(1997-4#1)(1997-6#1)(2004-11#1)(2005-11#1)(2006-10#3)(2007-11#1)(2008-1#1)(2008-10#19)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-8#1)(2010-12#1)(2011-1#4)(2012-12#1)(2012-3#1)(2013-1#3)
the bacterium's##3##2##(2006-12#1)(2008-7#1)(2010-12#1)
the baculovirus expression system##10##4##(1991-7#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-8#1)(1995-6#1)(1997-4#1)(2008-2#2)
the baculovirus expression vector system##4##5##(1993-12#1)(1994-9#1)(1997-4#1)(2008-7#1)
the baculovirus expression##15##3##(1991-7#2)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-8#1)(1994-9#1)(1995-6#1)(1997-4#2)(2008-2#2)(2008-7#1)
the baculovirus system##5##3##(1992-6#1)(1993-12#1)(1994-5#1)(2008-11#1)(2008-2#1)
the baculovirus very late##2##4##(1997-3#1)(1997-4#1)
the baculovirus##30##2##(1990-3#1)(1990-4#1)(1991-7#2)(1992-6#2)(1992-8#1)(1993-11#3)(1993-12#2)(1993-8#1)(1994-5#1)(1994-9#1)(1995-6#1)(1997-3#3)(1997-4#3)(2008-11#1)(2008-2#5)(2008-7#2)
the baculovirus-insect cell system##4##4##(1997-4#1)(2008-11#2)(2008-7#1)
the bad limbs##2##3##(1995-5#2)
the bad##11##2##(1993-11#1)(1995-5#3)(2007-3#1)(2008-10#1)(2008-7#3)(2011-2#1)(2013-8#1)
the baffle system##3##3##(1995-3#3)
the bag##4##2##(1996-11#2)(2006-11#1)(2008-4#1)
the bait-lamina test##2##3##(2008-11#2)
the baker's transformation##2##3##(2007-10#2)
the baker's##3##2##(1995-11#1)(2007-10#2)
the baking industry##2##3##(2010-7#2)
the baking##3##2##(1990-3#1)(2010-7#2)
the balance between cell proliferation and##2##6##(2007-4#1)(2008-11#1)
the balance between its##2##4##(2007-11#1)(2009-10#1)
the balance between the##5##4##(1991-9#1)(2006-10#1)(2008-1#1)(2008-7#1)(2009-8#1)
the balance between##46##3##(1991-9#1)(1992-12#1)(1993-1#1)(1994-10#1)(1994-3#1)(1994-8#1)(1995-7#1)(1996-10#1)(1997-7#1)(2005-11#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-4#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-1#2)(2013-7#1)(2013-8#1)
the balance from##2##3##(1993-9#1)(2006-10#1)
the balance in the##2##4##(2008-11#1)(2008-3#1)
the balance in##4##3##(1991-9#1)(2008-11#1)(2008-3#1)(2008-4#1)
the balance of the##5##4##(1997-1#1)(2006-10#2)(2008-5#1)(2008-9#1)
the balance of##29##3##(1992-3#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-5#1)(1996-3#1)(1996-4#1)(1997-1#2)(2006-10#5)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-8#1)(2011-2#1)(2013-8#1)
the balance##88##2##(1991-9#2)(1992-12#1)(1992-3#1)(1993-1#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-5#1)(1995-7#2)(1996-10#1)(1996-3#1)(1996-4#1)(1997-1#2)(1997-7#1)(2005-1#1)(2005-11#1)(2005-8#1)(2006-10#9)(2006-11#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-4#2)(2008-1#3)(2008-10#3)(2008-11#5)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#2)(2009-12#1)(2009-3#2)(2009-8#2)(2010-11#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-1#2)(2012-11#1)(2013-7#1)(2013-8#2)
the balanced##7##2##(1991-11#1)(1993-2#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-7#1)
the balancing##3##2##(1991-9#1)(1992-10#1)(1995-12#1)
the ball from##2##3##(2007-10#1)(2008-6#1)
the ball##14##2##(1993-8#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-6#3)(2009-7#2)(2011-1#3)(2011-2#1)(2012-1#1)
the ballistic component##2##3##(2008-2#1)(2008-3#1)
the ballistic##5##2##(1993-8#1)(2008-2#1)(2008-3#2)(2008-7#1)
the balloon and##2##3##(2008-10#1)(2008-7#1)
the balloon shape cotton swab##2##5##(2006-8#2)
the balloon##14##2##(1990-8#1)(1993-10#1)(1997-6#1)(2006-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-8#1)(2011-2#1)
the ban on##5##3##(1996-5#1)(1996-6#2)(2011-3#1)(2012-1#1)
the ban##12##2##(1993-10#1)(1995-6#3)(1996-1#1)(1996-5#1)(1996-6#3)(2010-9#1)(2011-3#1)(2012-1#1)
the band at##4##3##(2006-10#1)(2007-11#1)(2007-8#1)(2013-7#1)
the band edge##6##3##(1991-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2009-2#1)
the band gap##5##3##(2008-10#2)(2008-2#1)(2009-2#1)(2013-8#1)
the band of##5##3##(1991-9#1)(1994-3#1)(2005-11#1)(2008-3#1)(2008-4#1)
the band positions##2##3##(2008-10#1)(2008-9#1)
the band power is##2##4##(2012-1#2)
the band with##2##3##(1994-11#1)(1997-7#1)
the band##46##2##(1991-6#1)(1991-9#1)(1992-10#1)(1993-11#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-9#1)(1997-7#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#4)(2008-2#3)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#2)(2010-4#1)(2012-1#2)(2012-12#2)(2013-7#1)(2013-8#2)
the bandage##4##2##(2006-4#2)(2008-10#2)
the bandgap of##4##3##(2007-12#3)(2008-3#1)
the bandgap##12##2##(2007-11#1)(2007-12#7)(2008-1#1)(2008-2#1)(2008-3#2)
the bandpass##2##2##(2007-11#1)(2008-2#1)
the bands in##3##3##(2008-10#2)(2008-9#1)
the bands of##3##3##(2006-2#1)(2008-10#1)(2008-4#1)
the bands##16##2##(1993-11#1)(1993-9#1)(1994-6#1)(1995-3#1)(2005-4#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
the bandwidth and##2##3##(2007-12#1)(2008-2#1)
the bandwidth from##2##3##(2007-11#2)
the bandwidth of optical##2##4##(2007-12#1)(2008-3#1)
the bandwidth of the audiogram##2##5##(2007-5#2)
the bandwidth of the optical##2##5##(2007-12#1)(2008-3#1)
the bandwidth of the##13##4##(2007-11#2)(2007-12#2)(2007-5#2)(2008-10#1)(2008-2#3)(2008-3#3)
the bandwidth of##20##3##(2007-11#2)(2007-12#5)(2007-5#3)(2008-10#1)(2008-2#4)(2008-3#5)
the bandwidth##41##2##(1994-8#1)(2007-11#6)(2007-12#8)(2007-5#3)(2008-1#1)(2008-10#2)(2008-2#7)(2008-3#13)
the bandwidths of##2##3##(2007-11#1)(2007-12#1)
the bar target is##2##4##(2008-2#2)
the bar##13##2##(1993-7#1)(2006-12#3)(2007-12#2)(2008-2#3)(2008-5#1)(2012-10#1)(2012-12#1)(2012-3#1)
the barbed##2##2##(2008-1#1)(2012-2#1)
the barbiturate##2##2##(1990-7#1)(1997-5#1)
the barcodes##2##2##(2008-7#1)(2010-4#1)
the bare electrode##4##3##(2008-10#4)
the bare##16##2##(2007-12#2)(2008-10#9)(2008-2#2)(2008-3#1)(2008-5#1)(2013-1#1)
the bariatric##2##2##(2010-8#1)(2013-1#1)
the barium hydroxide##2##3##(2008-10#2)
the barium##4##2##(1992-12#1)(2008-10#3)
the bark of Bischofia javanica##2##5##(2006-12#2)
the bark of##9##3##(2006-12#4)(2007-1#1)(2008-6#3)(2008-7#1)
the bark##13##2##(2006-12#4)(2007-1#3)(2008-10#2)(2008-6#3)(2008-7#1)
the barks of##2##3##(2008-11#1)(2008-6#1)
the barley stripe##2##3##(1997-3#1)(2008-10#1)
the barley##16##2##(1994-5#1)(1997-3#1)(2008-10#10)(2008-5#3)(2008-9#1)
the barn owl##3##3##(1990-5#2)(1996-9#1)
the barn##4##2##(1990-5#2)(1996-9#1)(2008-9#1)
the baroreflex##4##2##(1991-8#2)(2007-10#1)(2010-11#1)
the barotropic behavior of##2##4##(1990-2#2)
the barrel cortex##6##3##(1993-7#1)(1995-11#2)(1995-5#1)(1997-3#1)(2009-5#1)
the barrel##13##2##(1991-3#1)(1993-7#1)(1994-11#1)(1994-3#2)(1994-9#1)(1995-11#2)(1995-5#1)(1997-3#1)(2008-1#1)(2008-10#1)(2009-5#1)
the barrels##2##2##(1992-7#1)(1997-3#1)
the barrier at the##2##4##(1995-10#1)(1997-4#1)
the barrier for##4##3##(1996-2#1)(2007-7#1)(2012-1#1)(2013-1#1)
the barrier function of the skin##2##6##(2008-5#2)
the barrier function of the##4##5##(2008-5#4)
the barrier function of##6##4##(1994-6#1)(2008-5#5)
the barrier function##14##3##(1994-6#1)(1994-8#1)(2006-10#1)(2007-7#1)(2008-5#9)(2008-7#1)
the barrier height##2##3##(2008-8#1)(2013-8#1)
the barrier heights##3##3##(2008-8#2)(2013-8#1)
the barrier in##2##3##(2007-7#1)(2008-3#1)
the barrier is##2##3##(2006-10#1)(2008-10#1)
the barrier##49##2##(1991-4#1)(1992-12#1)(1992-9#1)(1994-6#1)(1994-8#1)(1995-10#1)(1996-2#1)(1997-4#1)(2006-10#2)(2007-11#2)(2007-4#2)(2007-7#3)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#11)(2008-7#2)(2008-8#4)(2010-4#1)(2010-7#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#2)
the barriers in the##2##4##(2008-8#1)(2010-5#1)
the barriers perceived by##2##4##(1994-1#1)(2012-2#1)
the barriers that##5##3##(1994-12#1)(1996-12#1)(2009-5#1)(2011-1#1)(2012-2#1)
the barriers they##2##3##(2008-12#1)(2011-1#1)
the barriers to implementing##2##4##(1994-1#1)(2011-12#1)
the barriers to the##3##4##(1996-5#1)(2008-8#1)(2012-2#1)
the barriers to##14##3##(1991-1#1)(1993-12#1)(1994-1#1)(1996-5#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-9#1)(2011-12#1)(2012-2#1)(2013-1#2)
the barriers##36##2##(1990-11#1)(1991-1#1)(1993-12#1)(1994-1#4)(1994-12#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#2)(2009-5#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#3)(2013-1#3)
the basal ES at the##2##5##(2012-2#2)
the basal ES##5##3##(2012-2#5)
the basal activity of the##3##5##(1991-7#1)(1992-6#1)(2009-11#1)
the basal activity of##5##4##(1991-7#1)(1992-6#1)(1995-6#1)(1997-7#1)(2009-11#1)
the basal activity##8##3##(1990-7#1)(1991-7#1)(1992-6#1)(1992-7#1)(1995-6#1)(1996-6#1)(1997-7#1)(2009-11#1)
the basal and##7##3##(1990-7#1)(1993-3#1)(1994-5#1)(1996-2#2)(2009-10#1)(2010-12#1)
the basal body of the flagellum##2##6##(2008-7#2)
the basal body temperature##2##4##(1991-11#1)(1992-1#1)
the basal body##8##3##(1991-11#1)(1992-1#1)(2008-7#2)(2008-9#1)(2012-12#3)
the basal cell##3##3##(2006-5#1)(2007-12#2)
the basal concentration of##2##4##(1995-6#1)(2008-10#1)
the basal concentration##5##3##(1992-4#1)(1995-6#2)(2007-9#1)(2008-10#1)
the basal diet##3##3##(1992-9#1)(1994-6#1)(2008-10#1)
the basal expression of##2##4##(1992-5#1)(1993-12#1)
the basal expression##4##3##(1991-10#1)(1992-5#1)(1993-12#1)(2008-6#1)
the basal force of contraction and##2##6##(1990-2#2)
the basal forebrain and##3##4##(1991-9#1)(1997-6#2)
the basal forebrain cholinergic neurons##2##5##(1991-12#2)
the basal forebrain cholinergic##3##4##(1991-12#2)(1996-5#1)
the basal forebrain##22##3##(1991-12#2)(1991-9#1)(1992-10#2)(1992-7#1)(1992-8#1)(1993-12#1)(1993-7#1)(1994-10#1)(1996-5#2)(1997-5#1)(1997-6#7)(2007-1#1)(2012-2#1)
the basal ganglia and##5##4##(1995-5#1)(2006-3#1)(2007-10#2)(2008-7#1)
the basal ganglia of amphibians##2##5##(1997-3#2)
the basal ganglia of##3##4##(1997-3#2)(2012-2#1)
the basal ganglia##52##3##(1991-3#1)(1993-12#1)(1994-3#1)(1995-3#2)(1995-5#1)(1995-8#1)(1995-9#3)(1996-12#2)(1996-4#1)(1997-3#2)(2006-3#1)(2007-10#4)(2007-11#1)(2008-1#2)(2008-11#7)(2008-7#8)(2008-8#1)(2009-10#2)(2010-2#2)(2011-1#1)(2012-1#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#2)
the basal lamina##7##3##(1992-9#1)(2007-12#2)(2008-12#2)(2008-5#1)(2009-10#1)
the basal level at##4##4##(1990-2#1)(1991-7#2)(1994-2#1)
the basal level of##7##4##(1991-8#1)(1992-9#1)(1993-8#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-8#1)
the basal level##23##3##(1990-10#1)(1990-2#1)(1990-7#1)(1991-7#2)(1991-8#1)(1992-9#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-7#1)(2008-3#1)(2010-12#1)
the basal medium##5##3##(1996-2#1)(2008-10#1)(2008-11#3)
the basal nuclei of Meynert##2##5##(1995-5#1)(1997-2#1)
the basal or##3##3##(1994-2#1)(1995-2#1)(2008-6#1)
the basal output##2##3##(1993-3#1)(2012-12#1)
the basal part of the##2##5##(1991-9#2)
the basal plane##3##3##(1993-4#1)(1994-9#1)(2008-2#1)
the basal production of##2##4##(1996-3#1)(2005-8#1)
the basal promoter activity##2##4##(1995-3#1)(1997-7#1)
the basal promoter##3##3##(1991-6#1)(1995-3#1)(1997-7#1)
the basal secretion##2##3##(1995-5#1)(2008-7#1)
the basal state##3##3##(1995-6#1)(1997-1#1)(2008-1#1)
the basal transcription machinery##5##4##(1992-2#1)(1995-6#1)(1995-8#2)(2006-11#1)
the basal transcription##8##3##(1992-2#1)(1995-2#1)(1995-6#2)(1995-8#2)(1997-6#1)(2006-11#1)
the basal transcriptional machinery##3##4##(1995-8#1)(2010-11#2)
the basal values##2##3##(1994-2#1)(2008-5#1)
the basal##274##2##(1990-10#3)(1990-2#3)(1990-3#1)(1990-5#2)(1990-7#3)(1991-10#2)(1991-11#2)(1991-12#2)(1991-3#1)(1991-6#1)(1991-7#4)(1991-8#1)(1991-9#4)(1992-1#1)(1992-10#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#6)(1993-12#3)(1993-3#2)(1993-4#1)(1993-7#2)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#4)(1995-5#6)(1995-6#6)(1995-8#5)(1995-9#3)(1996-11#1)(1996-12#6)(1996-2#5)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#8)(1997-7#3)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#2)(2007-1#1)(2007-10#4)(2007-11#1)(2007-12#6)(2007-5#1)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#15)(2008-12#3)(2008-2#1)(2008-3#3)(2008-5#8)(2008-6#2)(2008-7#16)(2008-8#3)(2008-9#5)(2009-10#7)(2009-11#1)(2009-6#1)(2010-1#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#4)(2012-2#11)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#3)
the basalis##2##2##(1994-9#2)
the base N##3##3##(1992-9#3)
the base and##10##3##(1994-9#1)(1997-3#1)(2008-10#2)(2008-2#1)(2008-5#3)(2012-1#1)(2012-2#1)
the base line##4##3##(1991-12#1)(2007-7#1)(2008-10#1)(2011-1#1)
the base moiety##3##3##(1992-8#1)(1995-5#1)(2005-4#1)
the base of a##4##4##(1990-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
the base of skull##2##4##(2006-6#1)(2012-2#1)
the base of support##2##4##(1994-1#2)
the base of the cuticular apparatus##2##6##(2007-12#2)
the base of the food web is##2##7##(2008-9#2)
the base of the food web##3##6##(2008-9#3)
the base of the pole##2##5##(2011-2#2)
the base of the skull##5##5##(1991-3#1)(2007-1#1)(2008-7#1)(2012-2#1)(2013-1#1)
the base of the thumb##6##5##(2006-10#2)(2006-3#2)(2009-5#2)
the base of the##59##4##(1990-9#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-9#3)(1992-4#1)(1995-8#2)(1996-6#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-3#3)(2006-4#1)(2006-6#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#6)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-2#1)(2009-5#2)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)
the base of tongue##11##4##(2012-3#1)(2013-1#10)
the base of##100##3##(1990-11#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-9#3)(1992-4#1)(1992-8#1)(1992-9#1)(1994-1#2)(1994-9#1)(1995-8#2)(1996-3#1)(1996-5#1)(1996-6#1)(2004-10#1)(2005-4#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-3#4)(2006-4#1)(2006-5#1)(2006-6#2)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#6)(2007-2#1)(2007-4#1)(2007-7#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-2#1)(2009-5#2)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#4)(2012-2#2)(2012-3#4)(2013-1#11)(2013-7#2)
the base pair##3##3##(1993-3#3)
the base pairs##3##3##(1992-6#1)(2006-10#2)
the base peaks in##2##4##(1996-6#1)(2008-10#1)
the base recognition##3##3##(1992-4#2)(1995-11#1)
the base sequence##3##3##(1990-3#1)(1991-9#1)(1993-11#1)
the base stacking in##2##4##(1991-5#1)(2006-10#1)
the base to##4##3##(1991-12#1)(1993-11#1)(2008-10#1)(2010-2#1)
the base##181##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#4)(1992-2#1)(1992-4#3)(1992-6#1)(1992-8#2)(1992-9#4)(1993-11#2)(1993-3#3)(1994-1#2)(1994-9#4)(1995-1#1)(1995-11#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-3#1)(1996-5#1)(1996-6#2)(1997-2#2)(1997-3#1)(1997-8#1)(2004-10#1)(2005-11#2)(2005-12#1)(2005-4#2)(2005-7#1)(2006-10#5)(2006-11#1)(2006-3#5)(2006-4#1)(2006-5#2)(2006-6#2)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#6)(2007-2#1)(2007-4#2)(2007-7#5)(2008-10#18)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#10)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#5)(2009-2#1)(2009-5#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-2#4)(2012-3#4)(2013-1#11)(2013-7#2)
the base-acid and water-electrolyte##2##4##(2008-8#2)
the baseline and##6##3##(1992-9#1)(2007-10#1)(2008-10#2)(2008-3#1)(2012-4#1)
the baseline colonoscopy##2##3##(1997-8#2)
the baseline condition##4##3##(1992-7#1)(1993-6#1)(1995-11#1)(2013-1#1)
the baseline drift##2##3##(2008-10#2)
the baseline levels##2##3##(1994-6#1)(1997-4#1)
the baseline noise##2##3##(1990-9#1)(1996-6#1)
the baseline rate##3##3##(1997-6#3)
the baseline scenario without##2##4##(2007-7#2)
the baseline separation of##2##4##(2008-10#2)
the baseline startle##2##3##(2008-11#2)
the baseline value##2##3##(1990-11#1)(2006-6#1)
the baseline values##5##3##(1991-10#1)(1992-8#1)(2006-4#1)(2007-9#1)(2008-7#1)
the baseline week##2##3##(2008-7#2)
the baseline##108##2##(1990-11#1)(1990-3#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-6#1)(1997-2#1)(1997-4#2)(1997-6#4)(1997-8#3)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#2)(2006-6#1)(2006-8#1)(2007-10#3)(2007-2#1)(2007-7#4)(2007-9#3)(2008-10#14)(2008-11#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#6)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#10)
the baselines##2##2##(1992-1#1)(2008-2#1)
the basement membrane and the##2##5##(2009-10#1)(2013-8#1)
the basement membrane and##5##4##(1992-9#2)(2008-5#1)(2009-10#1)(2013-8#1)
the basement membrane of the##3##5##(2007-9#1)(2011-1#1)(2012-2#1)
the basement membrane of##4##4##(2007-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
the basement membrane##29##3##(1991-7#1)(1991-8#1)(1992-7#1)(1992-9#3)(1995-12#1)(2004-1#1)(2005-8#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-4#2)(2008-5#1)(2009-10#5)(2009-3#2)(2011-1#1)(2011-2#1)(2012-2#3)(2013-8#2)
the basement##30##2##(1991-7#1)(1991-8#1)(1992-7#1)(1992-9#3)(1995-12#1)(2004-1#1)(2005-8#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-4#2)(2008-5#1)(2009-10#5)(2009-3#2)(2011-1#1)(2011-2#1)(2012-2#3)(2013-8#2)
the bases of the##4##4##(1990-12#1)(1995-1#1)(2005-11#1)(2008-9#1)
the bases of##16##3##(1990-12#1)(1991-5#1)(1994-3#1)(1995-1#1)(1995-2#1)(1997-4#1)(2005-11#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)
the bases##28##2##(1990-12#1)(1991-5#1)(1994-3#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-5#1)(1997-4#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#2)
the basic Rh system##2##4##(2005-10#2)
the basic amino##3##3##(1992-8#1)(1996-5#1)(2006-8#1)
the basic amphipathic##2##3##(1990-2#2)
the basic and##4##3##(1993-5#1)(1994-12#1)(2008-2#1)(2013-7#1)
the basic aspects of##2##4##(2010-6#1)(2012-1#1)
the basic aspects##3##3##(2008-1#1)(2010-6#1)(2012-1#1)
the basic assumptions of the##3##5##(2006-5#1)(2007-12#1)(2010-9#1)
the basic biology of this##2##5##(2007-1#1)(2008-11#1)
the basic biology of##8##4##(1991-12#1)(2005-10#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-11#1)(2008-4#1)(2010-3#1)
the basic cell##3##3##(1994-9#1)(2007-12#1)(2008-3#1)
the basic cellular##2##3##(1993-4#1)(2005-8#1)
the basic component##2##3##(1995-4#1)(2008-10#1)
the basic components##2##3##(2006-2#1)(2009-12#1)
the basic concepts and##3##4##(2008-11#1)(2010-12#1)(2013-8#1)
the basic concepts of##4##4##(1993-3#1)(1994-3#1)(2008-9#1)(2011-2#1)
the basic concepts##12##3##(1993-3#1)(1994-3#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
the basic domain of##2##4##(1992-2#1)(1996-10#1)
the basic elements##3##3##(2005-5#1)(2007-4#1)(2008-9#1)
the basic features of the##4##5##(1994-8#1)(2007-12#1)(2008-3#1)(2012-1#1)
the basic features of##8##4##(1994-8#1)(1995-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#2)(2012-1#1)
the basic framework of##2##4##(1995-12#1)(2007-12#1)
the basic group in##2##4##(1993-9#2)
the basic helix-loop-helix##2##3##(1990-8#1)(1994-8#1)
the basic information needed to##2##5##(1994-2#1)(2008-7#1)
the basic information##3##3##(1990-12#1)(1994-2#1)(2008-7#1)
the basic knowledge##3##3##(1994-11#1)(2008-10#1)(2011-2#1)
the basic level##2##3##(1994-9#1)(2011-1#1)
the basic mechanism##2##3##(1996-6#1)(2012-12#1)
the basic mechanisms of##6##4##(2006-10#3)(2006-12#1)(2010-9#1)(2012-1#1)
the basic mechanisms underlying the##2##5##(1994-11#1)(2010-10#1)
the basic mechanisms##11##3##(1994-11#1)(2006-10#3)(2006-12#1)(2010-10#1)(2010-9#1)(2012-1#1)(2013-1#2)(2013-7#1)
the basic methodology for##2##4##(2008-10#1)(2008-4#1)
the basic methods of recycling steel cans##2##7##(1996-12#1)(1996-3#1)
the basic methods##4##3##(1994-6#1)(1996-12#1)(1996-3#1)(2007-11#1)
the basic molecular mechanisms##2##4##(2009-4#1)(2011-1#1)
the basic ones##2##3##(1994-9#1)(2008-1#1)
the basic operation of the##2##5##(2007-12#1)(2008-4#1)
the basic performance of##2##4##(2008-10#2)
the basic principles and##2##4##(2011-1#1)(2012-1#1)
the basic principles are##2##4##(2006-10#1)(2008-12#1)
the basic principles of the##4##5##(2008-9#2)(2010-12#1)(2011-7#1)
the basic principles of##12##4##(1997-3#1)(2007-12#2)(2008-2#1)(2008-9#3)(2009-5#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-7#1)
the basic principles##18##3##(1992-2#1)(1997-3#1)(2006-10#1)(2007-12#2)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#3)(2009-5#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-7#1)(2012-1#1)
the basic procedure##2##3##(2008-11#1)(2008-4#1)
the basic procedures##2##3##(2008-4#1)(2008-7#1)
the basic properties of##2##4##(1996-8#1)(2006-10#1)
the basic protocol that##3##4##(2008-4#3)
the basic protocol##13##3##(2008-1#1)(2008-4#11)(2012-12#1)
the basic question is##2##4##(2010-8#2)
the basic question##4##3##(2010-8#2)(2013-1#2)
the basic reproductive number##5##4##(2007-9#1)(2008-10#4)
the basic requirements for##3##4##(1993-12#1)(2008-10#1)(2008-2#1)
the basic requirements of##4##4##(2006-2#1)(2008-5#1)(2012-12#2)
the basic requirements##7##3##(1993-12#1)(2006-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-12#2)
the basic science##6##3##(1994-3#1)(2005-8#1)(2008-6#1)(2010-11#2)(2013-7#1)
the basic side chain##2##4##(1995-11#2)
the basic steps that##2##4##(2008-4#2)
the basic steps##4##3##(2008-4#4)
the basic structure##3##3##(1994-12#1)(1996-8#1)(2006-6#1)
the basic theory##3##3##(1997-2#1)(2011-1#1)(2012-3#1)
the basic##347##2##(1990-10#1)(1990-12#2)(1990-2#2)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-2#3)(1992-8#1)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#2)(1993-5#2)(1993-9#2)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#3)(1995-1#1)(1995-11#3)(1995-12#1)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(2005-1#1)(2005-10#4)(2005-11#1)(2005-4#1)(2005-5#2)(2005-7#1)(2005-8#3)(2006-10#10)(2006-12#1)(2006-2#4)(2006-3#2)(2006-5#1)(2006-6#2)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#6)(2007-12#13)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#7)(2008-10#20)(2008-11#8)(2008-12#3)(2008-2#11)(2008-3#10)(2008-4#27)(2008-5#6)(2008-6#5)(2008-7#4)(2008-8#5)(2008-9#8)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#2)(2010-12#8)(2010-3#3)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#8)(2011-12#2)(2011-2#5)(2011-7#1)(2012-1#5)(2012-12#4)(2012-2#1)(2012-3#4)(2013-1#10)(2013-7#3)(2013-8#4)
the basic-helix-loop-helix##2##2##(1991-12#1)(1995-3#1)
the basicities##2##2##(1996-2#2)
the basicity of the##2##4##(2008-10#1)(2008-5#1)
the basicity of##3##3##(2008-10#2)(2008-5#1)
the basicity##4##2##(2008-10#3)(2008-5#1)
the basics of image##2##4##(2008-4#1)(2008-9#1)
the basics of##10##3##(1995-8#1)(2006-12#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-4#2)(2008-8#1)(2008-9#1)(2013-1#1)
the basics##12##2##(1995-8#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-4#2)(2008-8#1)(2008-9#1)(2010-3#1)(2013-1#1)
the basidiomata of Thelephora sp##2##5##(2013-7#2)
the basidiomycete Coprinus cinereus##2##4##(1993-3#1)(1997-4#1)
the basidiomycete##9##2##(1991-11#1)(1993-12#1)(1993-3#2)(1994-11#1)(1997-4#1)(2005-12#1)(2008-10#1)(2008-6#1)
the basil##3##2##(2008-10#2)(2008-5#1)
the basilar artery and##2##4##(1997-6#1)(2012-12#1)
the basilar artery##24##3##(1996-2#2)(1996-6#1)(1997-6#2)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-9#5)(2008-4#2)(2010-8#1)(2011-2#1)(2012-12#2)(2013-8#2)
the basilar membrane##4##3##(1991-1#2)(2008-9#1)(2012-2#1)
the basilar##33##2##(1991-1#2)(1996-2#3)(1996-6#1)(1997-6#3)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2007-10#2)(2007-9#5)(2008-4#2)(2008-7#2)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#2)
the basin##8##2##(1992-1#1)(1992-6#2)(1997-5#1)(2007-5#2)(2008-11#2)
the basins##2##2##(2008-8#1)(2012-2#1)
the basis and##3##3##(1996-4#1)(2008-12#1)(2011-2#1)
the basis for a new##2##5##(2007-11#1)(2008-2#1)
the basis for a##17##4##(1990-2#1)(1993-6#2)(1994-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-2#1)
the basis for all##2##4##(1990-10#1)(2007-4#1)
the basis for an##6##4##(1992-6#1)(1996-5#1)(2008-11#1)(2008-3#1)(2012-2#2)
the basis for developing##3##4##(2007-12#1)(2008-7#1)(2012-2#1)
the basis for drug##2##4##(1991-10#1)(2007-3#1)
the basis for further##5##4##(1992-11#1)(2007-11#1)(2007-7#1)(2009-7#1)(2012-3#1)
the basis for future studies##2##5##(1995-3#1)(1996-4#1)
the basis for future##4##4##(1995-3#1)(1996-4#1)(2004-11#1)(2008-2#1)
the basis for its##3##4##(1993-6#1)(1994-8#1)(2008-7#1)
the basis for many##2##4##(2008-12#1)(2010-5#1)
the basis for more##2##4##(1992-6#1)(1994-12#1)
the basis for quality##2##4##(1993-5#1)(2013-8#1)
the basis for recommendations to##2##5##(2005-12#1)(2012-12#1)
the basis for selection of##2##5##(1991-5#1)(1992-3#1)
the basis for selection##3##4##(1991-5#1)(1992-3#1)(1995-1#1)
the basis for subsequent##2##4##(2008-7#1)(2008-9#1)
the basis for successful##2##4##(1997-5#1)(2006-12#1)
the basis for the development of##4##6##(1996-1#1)(2009-5#1)(2009-6#1)(2012-1#1)
the basis for the##49##4##(1990-11#1)(1990-5#2)(1990-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-6#1)(1995-1#1)(1995-2#1)(1995-4#1)(1996-1#1)(1996-11#1)(1997-4#1)(1997-6#1)(2004-11#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-2#1)(2006-3#1)(2007-12#2)(2008-10#4)(2008-11#2)(2008-2#4)(2008-7#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-7#1)
the basis for their##4##4##(1994-6#1)(1996-11#1)(2008-12#1)(2010-3#1)
the basis for these##3##4##(1997-7#1)(2009-5#1)(2010-12#1)
the basis for this effect is not##2##7##(2008-10#1)(2012-3#1)
the basis for this##8##4##(1995-6#1)(1996-11#1)(1997-2#1)(2005-8#1)(2008-10#1)(2008-4#1)(2010-3#1)(2012-3#1)
the basis for treatment of##2##5##(1997-4#1)(2008-4#1)
the basis for understanding##2##4##(1991-6#1)(2007-12#1)
the basis for##210##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#4)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#3)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#2)(2005-10#1)(2005-11#2)(2005-12#1)(2005-7#2)(2005-8#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-7#2)(2007-11#2)(2007-12#8)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#5)(2008-12#4)(2008-2#9)(2008-3#5)(2008-4#7)(2008-5#2)(2008-7#7)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#5)(2013-7#2)(2013-8#5)
the basis functions##3##3##(2006-10#1)(2008-2#1)(2008-6#1)
the basis of a comparison of##4##6##(1990-7#1)(1991-7#1)(2008-3#1)(2008-8#1)
the basis of a model##2##5##(2007-6#1)(2008-3#1)
the basis of a number of##3##6##(1993-2#1)(2006-10#1)(2013-1#1)
the basis of a recent##2##5##(1990-9#1)(2007-12#1)
the basis of a##82##4##(1990-2#1)(1990-7#2)(1990-9#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-10#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-9#1)(1997-6#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-6#2)(2007-1#2)(2007-11#1)(2007-12#2)(2007-4#1)(2007-6#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#2)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
the basis of all##3##4##(2006-10#1)(2008-2#1)(2008-5#1)
the basis of amino acid sequence##4##6##(1990-5#1)(1990-7#1)(1992-7#1)(1993-2#1)
the basis of an analysis of##3##6##(2008-10#1)(2008-3#1)(2009-2#1)
the basis of an##19##4##(1992-3#1)(1994-11#1)(1994-6#1)(1995-5#1)(2006-8#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-11#1)(2010-6#1)(2011-2#1)
the basis of analysis of the##3##6##(1997-3#1)(2013-1#1)(2013-8#1)
the basis of binding##2##4##(1992-4#1)(1993-8#1)
the basis of biological##2##4##(1997-6#1)(2008-10#1)
the basis of both##2##4##(1993-9#1)(1995-1#1)
the basis of cell##3##4##(1994-12#1)(1996-4#1)(1997-7#1)
the basis of cellular##2##4##(1997-6#1)(2009-6#1)
the basis of chemical and spectral evidence##3##7##(1994-3#1)(2007-1#2)
the basis of chemical and##4##5##(1994-3#1)(2007-1#3)
the basis of chemical##11##4##(1994-3#1)(1995-2#1)(1996-10#1)(2006-12#1)(2007-1#4)(2008-10#1)(2008-3#1)(2010-5#1)
the basis of clinical and##7##5##(1990-10#1)(1990-5#1)(1993-11#1)(2006-6#1)(2007-8#2)(2008-10#1)
the basis of clinical##23##4##(1990-10#1)(1990-5#1)(1990-6#1)(1992-10#1)(1992-12#1)(1992-7#1)(1993-11#1)(1993-12#1)(2005-7#1)(2006-6#3)(2007-11#1)(2007-8#2)(2008-10#1)(2008-4#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
the basis of comparison##2##4##(2008-10#1)(2008-9#1)
the basis of current##2##4##(2007-8#1)(2010-1#1)
the basis of data obtained from##2##6##(1994-5#1)(2012-2#1)
the basis of data obtained##3##5##(1994-5#1)(2007-5#1)(2012-2#1)
the basis of data##7##4##(1990-9#1)(1994-5#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-2#1)(2012-2#1)
the basis of differences in##2##5##(2008-10#2)
the basis of differences##3##4##(2008-10#2)(2013-1#1)
the basis of disease##3##4##(2006-10#1)(2008-2#1)(2013-1#1)
the basis of elemental analysis##6##5##(2006-9#1)(2007-11#1)(2008-10#1)(2008-5#2)(2010-3#1)
the basis of elemental##7##4##(2006-9#1)(2007-11#1)(2008-10#1)(2008-5#3)(2010-3#1)
the basis of experimental results##4##5##(1995-11#2)(2008-2#2)
the basis of experimental##5##4##(1995-11#2)(2006-11#1)(2008-2#2)
the basis of genetic##2##4##(2008-10#1)(2008-6#1)
the basis of identical##2##4##(1992-12#1)(1993-12#1)
the basis of infrared##2##4##(1997-7#1)(2008-10#1)
the basis of its amino acid composition##2##7##(1991-2#1)(1997-8#1)
the basis of its##23##4##(1990-10#1)(1990-4#1)(1990-7#1)(1991-2#1)(1991-8#1)(1992-12#2)(1992-9#1)(1993-11#1)(1993-3#1)(1993-7#1)(1993-8#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-8#1)(2008-10#3)(2008-3#1)(2008-6#1)
the basis of molecular##6##4##(1991-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
the basis of more##2##4##(2011-2#1)(2012-11#1)
the basis of morphological##3##4##(2006-9#1)(2008-10#1)(2012-2#1)
the basis of multiple##2##4##(1994-8#1)(2008-9#1)
the basis of new##4##4##(1997-6#1)(2006-12#1)(2007-1#1)(2008-2#1)
the basis of our previous##2##5##(1992-12#1)(1997-2#1)
the basis of our results##2##5##(1997-6#1)(2011-1#1)
the basis of our##21##4##(1991-2#2)(1992-12#1)(1993-8#1)(1995-12#1)(1996-11#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-10#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-2#1)(2009-4#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
the basis of personal experience and a review of the literature##2##11##(1992-9#1)(2006-6#1)
the basis of personal experience##4##5##(1990-3#2)(1992-9#1)(2006-6#1)
the basis of preliminary##2##4##(1997-4#1)(1997-7#1)
the basis of present##2##4##(1991-6#1)(2008-12#1)
the basis of previous##5##4##(1990-12#1)(1990-6#1)(1992-9#1)(1996-12#1)(2010-12#1)
the basis of primary##2##4##(2006-2#1)(2008-10#1)
the basis of published##2##4##(2006-11#1)(2007-8#1)
the basis of recent##3##4##(1990-10#1)(1990-6#1)(2010-2#1)
the basis of results from##2##5##(2010-8#1)(2011-2#1)
the basis of results##5##4##(1990-6#1)(2008-10#1)(2008-8#1)(2010-8#1)(2011-2#1)
the basis of sequence##5##4##(1992-12#1)(1994-11#1)(1995-8#1)(1996-6#1)(2008-7#1)
the basis of spectral and##2##5##(2007-1#1)(2010-3#1)
the basis of spectral##5##4##(2007-1#2)(2008-11#1)(2008-6#1)(2010-3#1)
the basis of the altered##3##5##(1994-2#1)(2013-1#2)
the basis of the analysis of##5##6##(2007-4#1)(2007-7#1)(2008-7#1)(2010-5#1)(2013-1#1)
the basis of the authors'##4##5##(1993-3#1)(2007-11#1)(2007-2#1)(2007-7#1)
the basis of the available##6##5##(1991-12#1)(1993-5#1)(2007-11#2)(2007-8#1)(2009-4#1)
the basis of the chemical##2##5##(1996-7#1)(2008-5#1)
the basis of the clinical##5##5##(1990-12#1)(2007-12#1)(2008-10#1)(2012-12#2)
the basis of the company's##2##5##(1990-2#1)(2005-8#1)
the basis of the data obtained##5##6##(1990-3#1)(1991-2#1)(1993-6#1)(2008-10#1)(2010-8#1)
the basis of the data##9##5##(1990-3#1)(1991-2#1)(1993-6#1)(1994-6#1)(2005-4#1)(2008-10#2)(2008-9#1)(2010-8#1)
the basis of the determination of##2##6##(2006-4#1)(2012-12#1)
the basis of the differences in##3##6##(1992-12#1)(1996-5#1)(2008-10#1)
the basis of the hydrolysis of##2##6##(2005-11#2)
the basis of the literature and the##2##7##(1992-8#1)(2007-8#1)
the basis of the literature and##3##6##(1992-8#1)(2007-8#2)
the basis of the mechanism##3##5##(1992-3#1)(2008-10#2)
the basis of the morphologic##2##5##(1992-11#1)(2007-2#1)
the basis of the most##2##5##(1992-6#1)(2006-10#1)
the basis of the relative##2##5##(1991-4#1)(1992-2#1)
the basis of the results of##9##6##(1991-9#1)(1995-12#1)(1995-8#1)(1996-4#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#2)
the basis of the results##18##5##(1990-5#1)(1990-6#1)(1990-7#1)(1991-3#1)(1991-9#2)(1994-3#1)(1995-12#1)(1995-8#1)(1996-3#1)(1996-4#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-6#1)
the basis of the sequence##3##5##(1992-12#1)(1996-4#1)(2005-11#1)
the basis of the well-known##2##5##(1994-6#1)(2005-11#1)
the basis of the##299##4##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#3)(1990-3#2)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-11#4)(1992-12#4)(1992-2#1)(1992-3#4)(1992-5#3)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#5)(1994-8#1)(1994-9#3)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#2)(1995-8#3)(1996-11#2)(1996-3#3)(1996-4#3)(1996-5#1)(1996-6#1)(1996-7#3)(1996-8#2)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#2)(2004-11#1)(2004-9#1)(2005-11#8)(2005-4#1)(2005-8#1)(2006-10#7)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-1#2)(2007-11#12)(2007-12#4)(2007-2#5)(2007-3#1)(2007-4#2)(2007-7#2)(2007-8#8)(2007-9#4)(2008-1#2)(2008-10#31)(2008-11#5)(2008-2#12)(2008-3#11)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#5)(2008-9#2)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-5#2)(2010-8#2)(2011-1#3)(2011-11#1)(2011-12#2)(2012-11#1)(2012-12#7)(2012-2#1)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
the basis of their##69##4##(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-4#1)(1991-7#1)(1991-8#2)(1992-2#1)(1992-6#1)(1992-9#1)(1993-10#2)(1993-11#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-8#2)(2005-10#1)(2005-11#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-1#1)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-3#2)(2010-4#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)
the basis of theoretical##5##4##(2007-11#1)(2008-2#2)(2008-3#1)(2009-2#1)
the basis of these findings##6##5##(1994-8#1)(1997-1#1)(2006-10#1)(2012-1#3)
the basis of these methods##2##5##(2008-10#1)(2008-3#1)
the basis of these observations##3##5##(1995-10#1)(1996-2#1)(2008-7#1)
the basis of these results##25##5##(1990-3#1)(1990-9#1)(1991-7#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1994-11#1)(1994-8#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-10#1)(1997-2#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-3#1)(2013-1#1)
the basis of these studies##2##5##(1994-5#1)(2008-10#1)
the basis of these##63##4##(1990-11#1)(1990-3#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-4#1)(1994-5#1)(1994-8#2)(1995-10#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(2004-12#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-8#1)(2008-10#6)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#1)(2009-3#1)(2012-1#3)(2013-1#1)
the basis of this finding##2##5##(1990-6#1)(2006-12#1)
the basis of this report##2##5##(2007-9#1)(2012-3#1)
the basis of this study##4##5##(1994-5#1)(1994-6#1)(2005-12#1)(2007-2#1)
the basis of this##39##4##(1990-6#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-12#1)(1994-5#1)(1994-6#1)(1995-6#1)(1997-2#1)(2005-11#1)(2005-12#1)(2006-12#2)(2007-2#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#8)(2008-5#2)(2009-2#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#2)
the basis of three-dimensional##2##4##(2008-3#1)(2009-2#1)
the basis of traditional##2##4##(1996-7#1)(1997-1#1)
the basis of various##2##4##(1995-1#1)(2006-2#1)
the basis of which##2##4##(1995-2#1)(2008-3#1)
the basis of##1225##3##(1990-1#1)(1990-10#6)(1990-11#4)(1990-12#8)(1990-2#7)(1990-3#6)(1990-4#7)(1990-5#8)(1990-6#8)(1990-7#7)(1990-8#3)(1990-9#8)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#3)(1991-2#14)(1991-3#7)(1991-4#6)(1991-5#4)(1991-6#2)(1991-7#9)(1991-8#4)(1991-9#7)(1992-1#1)(1992-10#1)(1992-11#5)(1992-12#12)(1992-2#3)(1992-3#6)(1992-4#3)(1992-5#5)(1992-6#7)(1992-7#3)(1992-8#3)(1992-9#7)(1993-1#1)(1993-10#2)(1993-11#8)(1993-12#9)(1993-2#4)(1993-3#5)(1993-4#2)(1993-5#4)(1993-6#4)(1993-7#2)(1993-8#8)(1993-9#5)(1994-1#1)(1994-10#1)(1994-11#8)(1994-12#2)(1994-2#2)(1994-3#6)(1994-4#1)(1994-5#9)(1994-6#9)(1994-7#1)(1994-8#6)(1994-9#3)(1995-1#3)(1995-10#3)(1995-11#5)(1995-12#6)(1995-2#7)(1995-3#3)(1995-4#3)(1995-5#4)(1995-6#4)(1995-8#10)(1995-9#1)(1996-1#1)(1996-10#2)(1996-11#5)(1996-12#7)(1996-2#7)(1996-3#4)(1996-4#4)(1996-5#3)(1996-6#3)(1996-7#6)(1996-8#4)(1996-9#2)(1997-1#10)(1997-2#11)(1997-3#4)(1997-4#5)(1997-5#2)(1997-6#9)(1997-7#5)(1997-8#10)(2004-11#1)(2004-12#1)(2004-3#1)(2004-4#2)(2004-7#1)(2004-9#1)(2005-10#2)(2005-11#15)(2005-12#1)(2005-4#2)(2005-5#1)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#28)(2006-11#4)(2006-12#13)(2006-2#6)(2006-3#3)(2006-4#1)(2006-5#4)(2006-6#9)(2006-7#2)(2006-8#4)(2006-9#5)(2007-1#14)(2007-11#31)(2007-12#15)(2007-2#13)(2007-3#1)(2007-4#5)(2007-5#3)(2007-6#1)(2007-7#13)(2007-8#30)(2007-9#9)(2008-1#11)(2008-10#108)(2008-11#17)(2008-12#3)(2008-2#42)(2008-3#48)(2008-4#21)(2008-5#34)(2008-6#11)(2008-7#19)(2008-8#13)(2008-9#12)(2009-1#2)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#11)(2009-3#2)(2009-4#7)(2009-6#2)(2009-7#5)(2009-8#2)(2009-9#2)(2010-1#3)(2010-11#5)(2010-12#6)(2010-2#2)(2010-3#7)(2010-4#4)(2010-5#4)(2010-6#3)(2010-7#2)(2010-8#6)(2011-1#9)(2011-11#1)(2011-12#3)(2011-2#18)(2011-3#2)(2012-1#8)(2012-11#2)(2012-12#10)(2012-2#11)(2012-3#9)(2013-1#25)(2013-7#4)(2013-8#10)
the basis on##2##3##(1997-8#1)(2010-12#1)
the basis set##3##3##(1994-9#1)(1996-4#1)(2009-12#1)
the basis to##4##3##(1995-11#1)(2007-12#1)(2008-9#1)(2012-1#1)
the basis##1468##2##(1990-1#1)(1990-10#7)(1990-11#6)(1990-12#9)(1990-2#8)(1990-3#6)(1990-4#8)(1990-5#10)(1990-6#8)(1990-7#7)(1990-8#4)(1990-9#8)(1991-1#3)(1991-10#3)(1991-11#2)(1991-12#4)(1991-2#14)(1991-3#7)(1991-4#6)(1991-5#5)(1991-6#3)(1991-7#10)(1991-8#5)(1991-9#8)(1992-1#2)(1992-10#1)(1992-11#7)(1992-12#14)(1992-2#4)(1992-3#7)(1992-4#4)(1992-5#5)(1992-6#9)(1992-7#3)(1992-8#3)(1992-9#7)(1993-1#1)(1993-10#2)(1993-11#8)(1993-12#10)(1993-2#5)(1993-3#5)(1993-4#2)(1993-5#5)(1993-6#8)(1993-7#2)(1993-8#8)(1993-9#5)(1994-1#1)(1994-10#1)(1994-11#9)(1994-12#3)(1994-2#2)(1994-3#7)(1994-4#1)(1994-5#9)(1994-6#10)(1994-7#1)(1994-8#7)(1994-9#5)(1995-1#6)(1995-10#3)(1995-11#6)(1995-12#7)(1995-2#8)(1995-3#4)(1995-4#5)(1995-5#5)(1995-6#5)(1995-8#11)(1995-9#1)(1996-1#3)(1996-10#3)(1996-11#8)(1996-12#7)(1996-2#8)(1996-3#4)(1996-4#7)(1996-5#4)(1996-6#4)(1996-7#6)(1996-8#4)(1996-9#2)(1997-1#12)(1997-2#12)(1997-3#4)(1997-4#8)(1997-5#3)(1997-6#11)(1997-7#6)(1997-8#13)(2004-11#3)(2004-12#1)(2004-3#1)(2004-4#2)(2004-7#1)(2004-9#1)(2005-10#3)(2005-11#17)(2005-12#2)(2005-4#2)(2005-5#1)(2005-7#3)(2005-8#5)(2006-1#1)(2006-10#30)(2006-11#4)(2006-12#14)(2006-2#7)(2006-3#4)(2006-4#1)(2006-5#4)(2006-6#9)(2006-7#4)(2006-8#4)(2006-9#5)(2007-1#14)(2007-11#33)(2007-12#24)(2007-2#14)(2007-3#3)(2007-4#6)(2007-5#4)(2007-6#1)(2007-7#15)(2007-8#31)(2007-9#9)(2008-1#14)(2008-10#121)(2008-11#22)(2008-12#8)(2008-2#54)(2008-3#53)(2008-4#29)(2008-5#37)(2008-6#13)(2008-7#26)(2008-8#14)(2008-9#15)(2009-1#2)(2009-10#1)(2009-11#4)(2009-12#2)(2009-2#12)(2009-3#3)(2009-4#8)(2009-5#3)(2009-6#4)(2009-7#8)(2009-8#3)(2009-9#3)(2010-1#3)(2010-11#7)(2010-12#13)(2010-2#3)(2010-3#9)(2010-4#6)(2010-5#5)(2010-6#4)(2010-7#3)(2010-8#6)(2011-1#11)(2011-11#1)(2011-12#4)(2011-2#21)(2011-3#2)(2012-1#11)(2012-11#2)(2012-12#13)(2012-2#16)(2012-3#14)(2013-1#26)(2013-7#6)(2013-8#15)
the basitarsus##2##2##(2007-12#2)
the basolateral amygdala##11##3##(1990-5#1)(1991-6#1)(1993-12#1)(1993-6#3)(1995-12#2)(1997-6#1)(1997-7#1)(2008-7#1)
the basolateral cell surface##2##4##(1991-12#2)
the basolateral membrane of##2##4##(1992-5#1)(1994-3#1)
the basolateral membrane##6##3##(1992-5#1)(1993-3#1)(1994-3#1)(2006-10#1)(2008-11#1)(2008-3#1)
the basolateral membranes##2##3##(1990-5#1)(1993-6#1)
the basolateral nucleus##3##3##(1991-11#1)(1995-11#2)
the basolateral##36##2##(1990-5#3)(1991-11#1)(1991-12#2)(1991-6#1)(1991-8#2)(1992-1#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-6#4)(1994-3#1)(1995-11#2)(1995-12#2)(1996-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-11#4)(2008-3#1)(2008-7#1)(2008-8#1)
the basophilic cells##2##3##(2008-7#2)
the bat##4##2##(2008-5#2)(2011-1#1)(2012-12#1)
the batch components##2##3##(2011-2#2)
the batch culture##4##3##(1994-8#1)(2008-11#1)(2008-7#1)(2012-2#1)
the batch injection analysis##3##4##(2008-10#3)
the batch method##4##3##(1991-7#1)(2008-10#3)
the batch mode##3##3##(2008-10#2)(2008-5#1)
the batch##32##2##(1991-7#1)(1994-8#1)(2007-10#1)(2008-10#16)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#3)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#1)
the batchculture with medium exchange##2##5##(2008-11#2)
the batchwise method##2##3##(2008-10#2)
the batchwise##3##2##(2008-10#3)
the bath##14##2##(1991-5#2)(1991-8#1)(1992-11#1)(1994-3#1)(1994-5#1)(1995-3#1)(1997-4#3)(1997-7#1)(2008-11#1)(2008-12#1)(2008-4#1)
the bathing medium##3##3##(1990-7#1)(1991-3#1)(1992-8#1)
the bathing solution##2##3##(1994-12#1)(1996-7#1)
the bathing##7##2##(1990-7#1)(1991-3#1)(1992-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-7#1)
the bathtub##7##2##(1995-3#7)
the battery##7##2##(1996-5#1)(1997-1#1)(2007-1#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-9#1)
the battle against##9##3##(1994-10#1)(2005-7#1)(2006-2#1)(2007-11#1)(2008-3#1)(2008-9#1)(2009-5#1)(2012-1#1)(2012-2#1)
the battle##15##2##(1994-10#1)(1995-2#1)(1996-2#1)(1997-7#1)(2005-7#1)(2006-2#2)(2007-11#2)(2008-10#1)(2008-3#1)(2008-9#1)(2009-5#1)(2012-1#1)(2012-2#1)
the bax gene##2##3##(2007-1#2)
the bay##2##2##(2007-5#1)(2008-5#1)
the bc-1(2)##2##2##(2008-10#2)
the bc1 complex##8##3##(1990-5#1)(1992-11#2)(1994-10#1)(1997-3#4)
the bcl-2 and bag-1##2##4##(2008-11#2)
the bcl-2 gene##4##3##(1993-3#1)(1994-3#1)(1996-5#1)(2007-1#1)
the bcl-2 product##3##3##(1994-10#3)
the bcl-2 transfected cells##2##4##(2008-11#2)
the bcl-2 transfected##4##3##(2008-11#4)
the bcl-2##22##2##(1993-3#3)(1994-10#4)(1994-3#1)(1996-10#1)(1996-3#1)(1996-4#1)(1996-5#1)(2007-1#1)(2008-11#8)(2008-5#1)
the beach##11##2##(2006-12#1)(2007-1#3)(2007-5#2)(2007-7#1)(2008-2#1)(2010-2#2)(2010-8#1)
the beacon##3##2##(2008-2#2)(2008-3#1)
the bead injection##2##3##(2008-10#2)
the bead##9##2##(2008-10#3)(2008-11#1)(2008-4#2)(2008-7#1)(2010-12#1)(2012-12#1)
the beads (t1/2 =##2##4##(1994-12#2)
the beads task##3##3##(2012-1#3)
the beads##26##2##(1990-8#2)(1994-12#3)(1995-6#1)(1996-12#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2012-1#3)
the beam and##3##3##(2008-2#3)
the beam at##3##3##(1997-8#1)(2006-5#1)(2008-3#1)
the beam axis##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
the beam collimation of a lens##2##6##(2008-3#2)
the beam divergence and##2##4##(2007-12#1)(2008-3#1)
the beam divergence in##2##4##(2006-5#1)(2007-12#1)
the beam divergence##6##3##(2006-5#1)(2007-12#2)(2008-2#2)(2008-3#1)
the beam fanning##2##3##(2008-3#2)
the beam in##3##3##(2007-12#1)(2008-3#2)
the beam intensity##5##3##(2006-4#1)(2007-12#1)(2008-2#2)(2008-3#1)
the beam is spatially##2##4##(2007-11#1)(2008-3#1)
the beam is##8##3##(2006-4#1)(2007-11#2)(2008-2#1)(2008-3#4)
the beam of a##2##4##(2007-12#1)(2008-2#1)
the beam profile##4##3##(2008-2#2)(2008-3#2)
the beam propagation method##5##4##(2007-11#2)(2008-2#1)(2008-3#2)
the beam propagation##6##3##(2007-11#2)(2008-1#1)(2008-2#1)(2008-3#2)
the beam quality produced by the##2##6##(2008-3#2)
the beam quality was##2##4##(2007-12#2)
the beam quality##8##3##(2007-11#2)(2007-12#3)(2008-3#3)
the beam ratio##3##3##(2008-2#1)(2008-3#2)
the beam shape##2##3##(2008-2#1)(2008-3#1)
the beam size##2##3##(2008-3#2)
the beam splitter is##2##4##(2008-2#1)(2008-3#1)
the beam splitter##13##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#6)(2008-3#4)
the beam that is##2##4##(2007-12#1)(2008-3#1)
the beam that##3##3##(2007-12#2)(2008-3#1)
the beam through##2##3##(2008-2#1)(2012-3#1)
the beam to##2##3##(2007-12#1)(2008-2#1)
the beam waist##2##3##(2007-11#1)(2008-10#1)
the beam width##2##3##(2008-3#2)
the beam##164##2##(1997-8#2)(2006-4#3)(2006-5#4)(2006-8#1)(2007-11#17)(2007-12#22)(2008-1#3)(2008-10#3)(2008-11#1)(2008-2#39)(2008-3#63)(2009-11#1)(2009-7#1)(2011-1#1)(2012-1#2)(2012-3#1)
the beam's transverse##2##3##(2007-11#1)(2008-3#1)
the beam's##6##2##(2006-12#1)(2007-11#2)(2007-12#1)(2008-3#2)
the beam-fanning novelty filter##2##4##(2008-3#2)
the beam-fanning phenomenon##2##3##(2008-3#2)
the beam-fanning##4##2##(2008-3#4)
the beam-pointing jitter error##2##4##(2008-3#2)
the beam-propagation##2##2##(2007-12#1)(2008-3#1)
the beam-quality parameter##2##3##(2008-3#2)
the beam-shape coefficients##2##3##(2008-2#1)(2008-3#1)
the beam-splitter##5##2##(2008-3#5)
the beam-splitting##3##2##(2008-2#1)(2008-3#2)
the beamline##6##2##(2006-4#1)(2006-5#2)(2008-11#2)(2009-12#1)
the beams are##2##3##(2007-12#1)(2008-3#1)
the beams from##2##3##(2007-12#1)(2010-9#1)
the beams##15##2##(2006-4#1)(2007-12#4)(2008-2#6)(2008-3#3)(2010-9#1)
the bean crop##2##3##(2008-10#2)
the bean population##2##3##(2008-8#2)
the bean##11##2##(2008-10#4)(2008-8#2)(2009-8#1)(2010-10#1)(2010-11#2)(2011-10#1)
the beans##4##2##(2008-10#1)(2008-3#3)
the bear family##2##3##(2009-5#2)
the bear##3##2##(2009-5#3)
the beat frequencies##2##3##(2007-11#1)(2008-2#1)
the beat frequency##8##3##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#3)
the beat length##3##3##(2007-12#2)(2008-3#1)
the beat##19##2##(2007-11#2)(2007-12#7)(2008-2#3)(2008-3#6)(2013-7#1)
the beating heart in##2##4##(2006-6#1)(2010-2#1)
the beating heart within##2##4##(2006-6#1)(2007-4#1)
the beating heart##18##3##(2006-6#4)(2007-4#1)(2007-8#8)(2008-5#1)(2009-12#1)(2010-2#2)(2011-2#1)
the beating of##2##3##(1996-3#1)(2010-9#1)
the beating##22##2##(1996-3#1)(2006-6#4)(2007-4#1)(2007-8#8)(2008-11#2)(2008-5#1)(2009-12#1)(2010-2#2)(2010-9#1)(2011-2#1)
the beauty##2##2##(2008-9#2)
the bed and##2##3##(2007-11#1)(2010-10#1)
the bed is##2##3##(2008-6#1)(2009-4#1)
the bed nucleus of the stria terminalis and the##2##9##(1994-2#1)(1995-5#1)
the bed nucleus of the stria terminalis##6##7##(1994-2#1)(1995-5#1)(1995-6#2)(1997-3#1)(1997-8#1)
the bed nucleus of the##7##5##(1994-10#1)(1994-2#1)(1995-5#1)(1995-6#2)(1997-3#1)(1997-8#1)
the bed nucleus of##8##4##(1992-7#1)(1994-10#1)(1994-2#1)(1995-5#1)(1995-6#2)(1997-3#1)(1997-8#1)
the bed of##2##3##(2008-7#1)(2008-9#1)
the bed##24##2##(1992-7#1)(1994-10#1)(1994-2#1)(1995-5#1)(1995-6#2)(1997-3#1)(1997-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-6#1)(2008-7#4)(2008-9#1)(2009-4#1)(2010-10#1)
the bedrock##2##2##(2006-4#1)(2007-8#1)
the beds##3##2##(1990-10#2)(2011-2#1)
the bedside and##3##3##(1993-3#1)(2005-10#1)(2007-3#1)
the bedside to##2##3##(2005-10#1)(2007-7#1)
the bedside##25##2##(1993-3#1)(1996-1#1)(1996-2#1)(1997-6#1)(1997-7#1)(2005-10#2)(2005-2#1)(2006-6#1)(2007-3#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-9#1)(2009-4#2)(2010-2#1)(2011-2#1)(2012-2#2)(2013-1#4)
the bee venom##2##3##(1996-5#1)(2007-2#1)
the bee##6##2##(1993-5#1)(1996-5#1)(2006-12#1)(2007-2#1)(2008-5#1)(2008-7#1)
the beef##2##2##(2010-4#2)
the beet cyst nematode##3##4##(2008-10#1)(2008-12#2)
the beet##6##2##(2008-10#4)(2008-12#2)
the beetle##4##2##(2007-12#1)(2008-5#2)(2008-6#1)
the beginning and end of each##2##6##(2008-5#1)(2012-1#1)
the beginning and end of the##7##6##(2007-8#1)(2008-4#1)(2008-6#2)(2010-12#1)(2012-3#1)(2013-8#1)
the beginning and end of##10##5##(2007-8#1)(2008-4#1)(2008-5#1)(2008-6#2)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
the beginning and the##4##4##(1990-9#1)(1996-12#1)(2007-2#1)(2012-2#1)
the beginning and##19##3##(1990-9#2)(1991-7#1)(1996-1#1)(1996-12#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#2)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
the beginning of a long##2##5##(2004-9#1)(2012-2#1)
the beginning of a new##2##5##(1991-12#1)(2012-2#1)
the beginning of a##9##4##(1991-12#1)(1997-2#1)(2004-9#1)(2006-4#1)(2007-11#1)(2008-10#2)(2012-2#2)
the beginning of each##10##4##(1994-3#1)(2004-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2012-1#1)
the beginning of its##2##4##(1992-2#1)(2009-4#1)
the beginning of our##2##4##(2007-7#1)(2009-10#1)
the beginning of summer##2##4##(2006-12#1)(2008-10#1)
the beginning of the 1980s##2##5##(1994-11#1)(2007-11#1)
the beginning of the 1990s##3##5##(1997-6#1)(2006-10#1)(2008-8#1)
the beginning of the 19th century##3##6##(1994-5#1)(2005-11#1)(2009-2#1)
the beginning of the 19th##4##5##(1994-5#1)(2005-11#1)(2009-2#1)(2010-9#1)
the beginning of the 20th century##5##6##(2006-10#1)(2008-1#1)(2009-7#2)(2010-10#1)
the beginning of the 21st##3##5##(2007-10#1)(2007-3#1)(2007-4#1)
the beginning of the XX century##2##6##(2008-9#1)(2011-1#1)
the beginning of the century##2##5##(1990-3#1)(1992-2#1)
the beginning of the dry season##2##6##(2007-3#1)(2008-5#1)
the beginning of the epidemic##2##5##(2008-1#1)(2008-10#1)
the beginning of the experiment##3##5##(1991-9#1)(2007-11#1)(2013-7#1)
the beginning of the next##2##5##(1997-6#1)(2007-6#1)
the beginning of the second##3##5##(1995-5#1)(2008-7#1)(2012-1#1)
the beginning of the study##3##5##(2006-10#1)(2008-9#1)(2011-1#1)
the beginning of the third millennium##2##6##(2006-10#1)(2008-10#1)
the beginning of the third##3##5##(1997-8#1)(2006-10#1)(2008-10#1)
the beginning of the treatment##3##5##(1991-10#1)(2007-7#1)(2008-4#1)
the beginning of the##110##4##(1990-12#1)(1990-2#1)(1990-3#2)(1991-10#1)(1991-6#1)(1991-7#1)(1991-9#3)(1992-2#1)(1992-5#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-5#1)(1995-6#1)(1996-12#2)(1996-3#1)(1997-6#2)(1997-8#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-10#5)(2006-12#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-3#3)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-2#2)(2009-7#3)(2010-10#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#1)
the beginning of this##3##4##(1997-4#1)(2004-3#1)(2007-2#1)
the beginning of tissue##2##4##(2007-8#1)(2008-10#1)
the beginning of treatment##4##4##(1992-4#1)(1996-1#1)(2011-2#1)(2013-1#1)
the beginning of##217##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-10#2)(1991-12#2)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#3)(1992-11#1)(1992-2#2)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-9#3)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-5#3)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#3)(1997-8#2)(2004-1#2)(2004-10#1)(2004-3#1)(2004-9#2)(2005-10#1)(2005-11#1)(2005-8#2)(2005-9#1)(2006-10#5)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-3#3)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#5)(2008-10#21)(2008-11#7)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#9)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#1)(2009-2#3)(2009-4#1)(2009-7#3)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#3)(2012-12#2)(2012-2#4)(2013-1#5)(2013-7#1)
the beginning to##3##3##(2007-8#1)(2010-1#1)(2010-3#1)
the beginning##272##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#3)(1990-6#1)(1990-7#1)(1990-9#3)(1991-10#2)(1991-12#2)(1991-2#1)(1991-6#1)(1991-7#2)(1991-9#3)(1992-11#1)(1992-2#2)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-9#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#3)(1996-12#3)(1996-3#1)(1996-5#3)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#3)(1997-8#2)(2004-1#2)(2004-10#1)(2004-3#1)(2004-9#2)(2005-10#2)(2005-11#1)(2005-8#2)(2005-9#1)(2006-10#6)(2006-12#2)(2006-2#1)(2006-4#2)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#2)(2007-3#3)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#5)(2007-9#3)(2008-1#6)(2008-10#23)(2008-11#10)(2008-12#4)(2008-2#3)(2008-3#3)(2008-4#6)(2008-5#11)(2008-6#6)(2008-7#6)(2008-8#4)(2008-9#4)(2009-10#1)(2009-2#3)(2009-4#2)(2009-7#3)(2009-8#1)(2010-1#3)(2010-10#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#9)(2012-1#5)(2012-12#2)(2012-2#5)(2012-3#1)(2012-7#1)(2013-1#6)(2013-7#1)(2013-8#1)
the beginnings of##4##3##(1992-7#1)(2008-10#3)
the behaving##3##2##(1993-6#1)(2006-5#1)(2007-12#1)
the behavior and##8##3##(1991-12#1)(2006-2#1)(2007-4#1)(2008-11#1)(2008-8#1)(2009-8#1)(2012-1#1)(2013-1#1)
the behavior appears##2##3##(2007-2#1)(2010-12#1)
the behavior in##2##3##(1996-7#1)(2008-3#1)
the behavior observed##4##3##(2008-10#2)(2008-7#1)(2009-11#1)
the behavior of a heterogeneous##2##5##(2005-11#1)(2008-8#1)
the behavior of a##9##4##(2005-11#2)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
the behavior of an##3##4##(2008-10#1)(2008-2#1)(2008-8#1)
the behavior of cells##3##4##(2006-5#1)(2008-11#1)(2009-12#1)
the behavior of conventional##2##4##(2007-12#2)
the behavior of dispersion-managed solitons##2##5##(2007-12#2)
the behavior of dispersion-managed##3##4##(2007-12#3)
the behavior of individual##2##4##(1994-9#1)(2008-3#1)
the behavior of its##2##4##(2008-8#1)(2009-5#1)
the behavior of migrating##2##4##(2008-11#1)(2008-8#1)
the behavior of some##2##4##(1991-4#1)(2008-3#1)
the behavior of the wild-type##2##5##(1995-6#1)(2008-10#1)
the behavior of the##38##4##(1990-8#1)(1995-10#1)(1995-2#1)(1995-6#1)(1996-5#1)(2005-11#2)(2006-10#1)(2006-11#2)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#5)(2008-3#5)(2008-5#1)(2008-8#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)
the behavior of these pumps##2##5##(2011-2#2)
the behavior of these##8##4##(1996-5#1)(2007-1#1)(2008-3#1)(2009-2#1)(2010-5#1)(2010-7#1)(2011-2#2)
the behavior of##148##3##(1990-8#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-6#1)(1992-4#1)(1993-2#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-10#2)(1995-2#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-5#3)(2004-3#1)(2005-11#4)(2006-10#2)(2006-11#2)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#2)(2007-12#11)(2007-2#1)(2007-5#1)(2007-9#2)(2008-1#1)(2008-10#10)(2008-11#6)(2008-2#9)(2008-3#14)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#8)(2008-9#3)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-5#1)(2010-7#2)(2010-9#2)(2011-1#2)(2011-2#8)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#6)(2013-8#1)
the behavior##185##2##(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-6#1)(1992-4#1)(1993-2#3)(1993-6#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-10#2)(1995-2#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-5#3)(1996-7#1)(2004-3#1)(2005-11#6)(2006-10#2)(2006-11#2)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-12#12)(2007-2#2)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#13)(2008-11#8)(2008-2#10)(2008-3#15)(2008-4#3)(2008-5#3)(2008-7#4)(2008-8#9)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-7#2)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#9)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#6)(2013-8#1)
the behavioral activation##2##3##(1993-12#1)(2011-2#1)
the behavioral and biochemical##3##4##(1993-12#1)(1993-5#1)(1995-12#1)
the behavioral and neurochemical##2##4##(2008-4#1)(2011-2#1)
the behavioral and##16##3##(1991-1#1)(1991-11#1)(1993-12#1)(1993-5#1)(1995-12#2)(2005-8#2)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2011-1#1)(2011-2#1)
the behavioral deficits observed in##2##5##(1991-8#1)(2011-2#1)
the behavioral deficits##3##3##(1991-8#1)(1992-11#1)(2011-2#1)
the behavioral effects of cocaine by##2##6##(1991-1#1)(2008-10#1)
the behavioral effects of##5##4##(1991-1#1)(1991-5#1)(1995-9#1)(2007-1#1)(2008-10#1)
the behavioral effects##6##3##(1991-1#1)(1991-5#1)(1995-9#1)(1996-1#1)(2007-1#1)(2008-10#1)
the behavioral inhibition system##2##4##(2009-9#2)
the behavioral response to##2##4##(1993-2#1)(1995-12#1)
the behavioral response##4##3##(1993-11#1)(1993-2#1)(1995-12#1)(2009-8#1)
the behavioral sciences##2##3##(2008-12#1)(2013-7#1)
the behavioral tasks##2##3##(1997-2#2)
the behavioral##79##2##(1990-2#1)(1991-1#2)(1991-11#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#3)(1994-2#3)(1995-12#6)(1995-9#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-4#1)(1997-2#2)(2005-8#2)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-4#4)(2008-8#5)(2008-9#2)(2009-10#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#4)(2012-2#1)(2013-1#1)(2013-7#1)
the behaviors of##3##3##(2006-11#1)(2008-5#1)(2008-8#1)
the behaviors##9##2##(1993-2#1)(1994-2#1)(1995-12#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)
the behaviour of a##3##4##(2008-10#2)(2008-12#1)
the behaviour of bacteria##2##4##(2007-8#2)
the behaviour of the cornea under##2##6##(2006-7#1)(2008-7#1)
the behaviour of the##14##4##(1990-3#1)(1992-3#1)(1993-7#1)(2005-11#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#1)
the behaviour of this##2##4##(2011-12#1)(2012-2#1)
the behaviour of##57##3##(1990-10#1)(1990-2#1)(1990-3#1)(1990-8#1)(1990-9#2)(1991-5#1)(1992-3#1)(1993-11#1)(1993-7#1)(1996-8#1)(2004-2#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#4)(2008-7#1)(2010-1#1)(2010-12#1)(2011-12#1)(2011-2#3)(2012-2#1)(2012-7#1)
the behaviour##61##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-8#1)(1990-9#2)(1991-5#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-7#1)(1994-3#1)(1996-8#1)(2004-2#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#5)(2008-7#1)(2010-1#1)(2010-12#1)(2011-12#1)(2011-2#3)(2012-2#1)(2012-7#1)
the behavioural and##3##3##(1991-1#1)(1992-7#1)(1993-2#1)
the behavioural consequences of##2##4##(2006-3#2)
the behavioural effect##2##3##(1990-2#1)(1992-11#1)
the behavioural response##2##3##(1990-10#1)(1992-7#1)
the behavioural responses##3##3##(1990-10#2)(2005-7#1)
the behavioural state##2##3##(1991-3#1)(1996-2#1)
the behavioural##30##2##(1990-10#3)(1990-2#1)(1991-1#2)(1991-3#1)(1991-4#1)(1992-11#1)(1992-7#2)(1992-9#1)(1993-11#2)(1993-2#2)(1994-3#1)(1994-8#1)(1995-12#2)(1996-2#1)(2005-7#1)(2006-3#2)(2006-9#1)(2008-9#3)(2009-4#1)(2012-2#1)
the behaviours##2##2##(2008-10#1)(2010-12#1)
the belief that the##2##4##(1994-2#1)(1996-2#1)
the belief that##19##3##(1990-5#1)(1991-6#1)(1994-2#1)(1994-8#1)(1995-6#1)(1996-1#1)(1996-2#1)(2005-10#2)(2005-11#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-9#2)(2009-5#1)(2010-12#1)(2013-1#1)
the beliefs of##2##3##(1991-6#1)(2012-3#1)
the beliefs##6##2##(1991-6#1)(1994-12#1)(2008-11#1)(2011-1#2)(2012-3#1)
the bell-shaped##2##2##(2005-11#1)(2008-11#1)
the bellow##4##2##(2008-11#1)(2008-8#3)
the belly and groin##2##4##(1996-12#2)
the belly##5##2##(1992-9#1)(1996-12#2)(2004-11#2)
the below-knee##2##2##(2011-2#2)
the belt##7##2##(2006-11#3)(2007-12#1)(2007-4#2)(2008-7#1)
the bench##8##2##(1996-2#1)(2005-10#2)(2007-3#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-4#1)
the benchmark##10##2##(1991-2#1)(2005-12#1)(2008-5#1)(2009-5#1)(2010-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
the benchmarking##4##2##(1995-12#3)(2008-11#1)
the bend##6##2##(1992-5#1)(1994-6#2)(1996-2#1)(2007-12#1)(2008-3#1)
the bending region##2##3##(1995-6#1)(2007-11#1)
the bending stiffness##2##3##(2006-11#1)(2007-4#1)
the bending##19##2##(1995-6#1)(2005-11#1)(2006-10#4)(2006-11#1)(2006-5#1)(2007-11#1)(2007-4#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-1#1)(2013-8#1)
the beneficial actions of##2##4##(1995-5#1)(2010-9#1)
the beneficial effect of dietary fish-oil##2##6##(2006-8#2)
the beneficial effect of##18##4##(1990-2#1)(1994-11#1)(1996-1#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-8#3)(2007-11#1)(2008-10#2)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
the beneficial effect##20##3##(1990-2#1)(1990-6#1)(1991-11#1)(1994-11#1)(1996-1#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-8#3)(2007-11#1)(2008-10#2)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
the beneficial effects are##2##4##(1994-10#1)(2007-11#1)
the beneficial effects of a##2##5##(1992-7#1)(2013-7#1)
the beneficial effects of these##2##5##(1993-12#1)(2011-2#1)
the beneficial effects of##29##4##(1992-7#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-6#1)(1996-2#1)(2006-10#3)(2007-11#2)(2008-1#2)(2008-10#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-2#1)(2010-12#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
the beneficial effects##35##3##(1992-7#1)(1993-12#1)(1993-3#1)(1994-10#2)(1994-6#1)(1996-2#1)(2006-10#3)(2006-2#1)(2007-11#3)(2007-5#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#1)(2010-12#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
the beneficial role of##3##4##(2008-1#1)(2010-7#1)(2012-2#1)
the beneficial role##4##3##(2008-1#1)(2010-1#1)(2010-7#1)(2012-2#1)
the beneficial##78##2##(1990-2#1)(1990-6#1)(1991-11#1)(1991-12#1)(1992-7#1)(1993-12#1)(1993-3#1)(1994-10#2)(1994-11#1)(1994-6#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-5#1)(1997-7#1)(2006-10#4)(2006-2#1)(2006-8#3)(2007-11#4)(2007-5#1)(2007-6#1)(2008-1#4)(2008-10#5)(2008-3#1)(2008-4#2)(2008-7#6)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-12#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
the beneficiaries in##2##3##(1991-3#1)(2008-7#1)
the beneficiaries##3##2##(1991-3#1)(1994-3#1)(2008-7#1)
the beneficiary##2##2##(1990-12#1)(1991-3#1)
the benefit and##5##3##(1994-2#1)(1995-3#1)(2006-2#1)(2008-5#1)(2012-3#1)
the benefit for##3##3##(2007-10#1)(2011-2#1)(2013-8#1)
the benefit from##3##3##(1997-3#1)(2006-5#1)(2011-2#1)
the benefit is##2##3##(1995-9#1)(2011-2#1)
the benefit may##2##3##(1991-8#1)(1993-11#1)
the benefit of a##5##4##(1992-12#1)(1996-4#1)(2008-10#1)(2008-12#1)(2008-5#1)
the benefit of adjuvant##3##4##(1992-11#1)(1995-8#1)(2008-5#1)
the benefit of early##2##4##(1996-11#1)(2013-1#1)
the benefit of the##13##4##(1990-7#1)(1992-2#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-11#1)(2007-12#1)(2008-11#1)(2008-7#1)(2010-5#1)(2011-1#1)(2013-1#2)
the benefit of this##2##4##(2007-11#1)(2007-8#1)
the benefit of using##2##4##(2008-10#1)(2010-4#1)
the benefit of##94##3##(1990-7#1)(1992-11#1)(1992-12#1)(1992-2#1)(1994-3#1)(1995-11#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-4#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-10#6)(2006-11#1)(2006-5#1)(2006-7#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#1)
the benefit to##4##3##(1991-1#1)(1992-3#1)(1994-7#1)(2008-8#1)
the benefit##122##2##(1990-7#1)(1991-1#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#2)(1996-11#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-10#6)(2006-11#1)(2006-2#2)(2006-5#2)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#1)
the benefit-risk ratio of##2##4##(2007-11#2)
the benefit-risk ratio##3##3##(2007-11#3)
the benefit-risk##4##2##(2007-11#3)(2013-7#1)
the benefits and challenges of##3##5##(1997-2#1)(2009-4#1)(2011-2#1)
the benefits and costs of##2##5##(1993-1#1)(2009-4#1)
the benefits and costs##3##4##(1993-1#1)(1995-3#1)(2009-4#1)
the benefits and disadvantages of##2##5##(1996-3#1)(2006-10#1)
the benefits and drawbacks of##2##5##(2013-1#2)
the benefits and limitations of the##2##6##(2008-10#1)(2013-1#1)
the benefits and limitations of##9##5##(1996-12#1)(1997-3#1)(2006-6#1)(2007-4#1)(2008-10#1)(2008-6#1)(2010-12#1)(2010-8#1)(2013-1#1)
the benefits and problems##2##4##(1990-2#1)(2008-3#1)
the benefits and risks of##11##5##(1993-1#1)(2006-10#1)(2008-5#1)(2008-6#1)(2009-12#1)(2010-4#2)(2011-2#1)(2012-1#2)(2012-2#1)
the benefits and risks##14##4##(1992-3#1)(1993-1#1)(2006-10#1)(2008-5#1)(2008-6#2)(2009-12#1)(2010-4#2)(2010-5#1)(2011-2#1)(2012-1#2)(2012-2#1)
the benefits and##42##3##(1990-2#1)(1992-3#1)(1993-1#2)(1995-3#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2006-10#2)(2006-6#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#4)(2009-12#1)(2009-4#2)(2010-12#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-2#1)(2013-1#3)
the benefits are##6##3##(1992-3#1)(2005-11#1)(2006-10#1)(2006-2#1)(2009-1#1)(2009-3#1)
the benefits associated with##2##4##(1992-8#1)(2007-4#1)
the benefits for##3##3##(2008-11#1)(2008-12#1)(2012-12#1)
the benefits from##3##3##(1997-7#1)(2009-6#1)(2013-8#1)
the benefits in##4##3##(2007-10#1)(2007-11#2)(2009-4#1)
the benefits obtained##3##3##(2004-10#1)(2007-7#1)(2008-1#1)
the benefits of OPV##2##4##(2004-12#2)
the benefits of a comprehensive##2##5##(1993-1#1)(2008-3#1)
the benefits of a##9##4##(1991-2#1)(1993-1#1)(1994-2#1)(1996-3#1)(2006-4#1)(2008-12#1)(2008-3#1)(2009-4#1)(2012-1#1)
the benefits of both##4##4##(2006-5#1)(2008-5#1)(2008-7#1)(2012-10#1)
the benefits of drug treatment##2##5##(2005-10#1)(2007-1#1)
the benefits of early##4##4##(1992-2#1)(1997-1#1)(2007-7#1)(2012-2#1)
the benefits of implementing##2##4##(2008-3#2)
the benefits of many##2##4##(2007-12#1)(2008-5#1)
the benefits of philopatry##2##4##(2008-8#2)
the benefits of recycling##2##4##(1996-12#1)(1996-3#1)
the benefits of such##2##4##(1992-3#1)(2011-1#1)
the benefits of the##14##4##(1992-12#1)(1993-12#1)(1996-3#1)(1996-8#1)(1997-5#1)(2006-5#2)(2007-2#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-8#1)
the benefits of these##5##4##(1996-3#1)(2005-7#1)(2008-2#1)(2009-4#1)(2009-7#1)
the benefits of using##4##4##(2006-12#1)(2008-4#1)(2009-5#1)(2010-8#1)
the benefits of##160##3##(1990-11#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-12#2)(1994-2#1)(1994-3#1)(1995-12#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-8#1)(1997-1#2)(1997-3#1)(1997-5#1)(1997-6#1)(2004-12#2)(2005-10#2)(2005-7#2)(2006-1#1)(2006-10#3)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#6)(2007-1#3)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#4)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#5)(2008-12#2)(2008-2#6)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#9)(2008-7#4)(2008-8#5)(2008-9#5)(2009-2#1)(2009-4#3)(2009-5#1)(2009-7#1)(2009-9#2)(2010-10#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#2)(2012-1#1)(2012-10#2)(2012-12#1)(2012-2#3)(2013-1#7)(2013-8#1)
the benefits provided##2##3##(2005-10#1)(2008-8#1)
the benefits to be gained from##2##6##(1994-3#1)(2006-10#1)
the benefits to be gained##3##5##(1994-2#1)(1994-3#1)(2006-10#1)
the benefits to##11##3##(1994-2#1)(1994-3#1)(2006-10#1)(2007-8#1)(2008-8#1)(2010-12#3)(2011-2#1)(2012-3#1)(2013-8#1)
the benefits will##2##3##(2005-7#1)(2009-5#1)
the benefits##260##2##(1990-11#1)(1990-2#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-8#2)(1993-1#3)(1993-12#2)(1994-1#1)(1994-2#2)(1994-3#2)(1995-1#1)(1995-12#3)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#5)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-5#1)(1997-6#1)(1997-7#1)(2004-10#1)(2004-12#2)(2005-10#3)(2005-11#1)(2005-7#3)(2006-1#1)(2006-10#7)(2006-12#2)(2006-2#4)(2006-4#1)(2006-5#6)(2006-6#2)(2007-1#3)(2007-10#2)(2007-11#4)(2007-12#4)(2007-2#5)(2007-4#3)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#3)(2008-11#7)(2008-12#3)(2008-2#8)(2008-3#5)(2008-4#3)(2008-5#6)(2008-6#14)(2008-7#5)(2008-8#7)(2008-9#6)(2009-1#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#6)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#2)(2010-10#2)(2010-12#6)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#3)(2011-1#6)(2011-2#6)(2012-1#3)(2012-10#2)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#12)(2013-8#4)
the benign and##2##3##(1990-3#1)(2007-12#1)
the benign category##2##3##(2013-8#2)
the benign nature of the##3##5##(2008-6#1)(2010-12#1)(2011-1#1)
the benign nature of##4##4##(2008-6#1)(2010-12#1)(2011-1#1)(2011-2#1)
the benign nature##5##3##(1990-10#1)(2008-6#1)(2010-12#1)(2011-1#1)(2011-2#1)
the benign ovarian##2##3##(1992-12#2)
the benign##22##2##(1990-10#1)(1990-3#1)(1992-12#2)(1995-8#2)(1997-3#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#3)
the benomyl-resistant##3##2##(1997-2#1)(2008-10#2)
the bent DNA fragment##3##4##(1990-5#3)
the bent##14##2##(1990-5#4)(1993-8#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#4)
the benthic productivity of the##2##5##(2008-5#2)
the benthic##10##2##(2007-5#3)(2008-5#4)(2008-9#1)(2010-6#1)(2011-2#1)
the benzazepine ring##2##3##(1996-8#2)
the benzene dioxygenase##2##3##(2008-3#2)
the benzene molecules##2##3##(1993-11#2)
the benzene ring of##3##4##(1996-1#1)(2005-11#1)(2008-10#1)
the benzene ring##8##3##(1990-8#1)(1996-1#1)(1996-11#1)(1997-2#1)(2004-7#1)(2005-11#1)(2008-10#2)
the benzene sulfonic acid monolayer film##2##6##(2008-10#2)
the benzene##17##2##(1990-8#1)(1993-11#2)(1996-1#1)(1996-11#1)(1996-8#1)(1997-2#1)(2004-7#1)(2005-11#1)(2008-10#6)(2008-3#2)
the benzimidazolato-functionalized##2##2##(2010-5#2)
the benzimidazole##2##2##(1994-9#1)(1997-2#1)
the benzodiazepine antagonist##2##3##(1994-2#1)(1995-7#1)
the benzodiazepine binding site##2##4##(1992-8#1)(1995-11#1)
the benzodiazepine binding##3##3##(1992-8#1)(1995-11#1)(1997-5#1)
the benzodiazepine diazepam##2##3##(1991-3#1)(1997-5#1)
the benzodiazepine receptor antagonist##3##4##(1990-2#1)(1994-12#1)(1994-2#1)
the benzodiazepine receptor##8##3##(1990-2#1)(1991-1#1)(1992-3#1)(1994-12#1)(1994-2#1)(1994-5#2)(1995-11#1)
the benzodiazepine receptors##2##3##(1990-3#1)(1992-8#1)
the benzodiazepine site##2##3##(1995-11#1)(1996-11#1)
the benzodiazepine##29##2##(1990-2#1)(1990-3#1)(1991-1#1)(1991-11#1)(1991-3#1)(1992-10#1)(1992-3#2)(1992-8#2)(1993-12#1)(1993-8#1)(1994-12#1)(1994-2#3)(1994-5#2)(1995-11#5)(1995-7#1)(1996-11#2)(1997-5#2)(2008-10#1)
the benzodiazepine-Gaba receptor complex##2##4##(1991-1#2)
the benzothiazolyl##2##2##(1997-2#2)
the benzoyl groups##2##3##(1990-9#1)(1997-4#1)
the benzoyl peroxide foaming cloth##3##5##(2010-8#3)
the benzoyl peroxide##5##3##(2004-9#1)(2008-10#1)(2010-8#3)
the benzoyl##11##2##(1990-9#1)(1991-3#1)(1997-4#1)(2004-9#1)(2007-11#2)(2008-10#1)(2010-8#4)
the benzyl alcohol##2##3##(2005-11#2)
the benzyl##7##2##(1992-8#3)(2005-11#2)(2012-11#2)
the benzylic##8##2##(1995-3#3)(1996-7#1)(2007-11#1)(2012-12#2)(2013-1#1)
the bereaved##3##2##(1991-2#1)(2006-4#1)(2008-12#1)
the berg balance scale##2##4##(2006-10#2)
the berry surface##2##3##(2008-10#2)
the best accuracy##2##3##(2008-10#1)(2011-2#1)
the best alternative##7##3##(1990-12#1)(1996-2#1)(2008-1#1)(2008-10#2)(2008-4#1)(2011-2#1)
the best analytical performance##2##4##(2008-10#2)
the best analytical##4##3##(2008-10#4)
the best and most##5##4##(1990-4#1)(2006-12#1)(2006-9#1)(2008-3#1)(2011-1#1)
the best and the##2##4##(2007-11#1)(2007-3#1)
the best and##11##3##(1990-4#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-6#1)(2011-1#1)
the best anesthetic technique##2##4##(2007-7#1)(2013-8#1)
the best approach for##3##4##(1996-1#1)(2008-10#1)(2013-7#1)
the best approach to##2##4##(2004-2#1)(2008-10#1)
the best approach##11##3##(1992-2#1)(1995-12#1)(1996-1#1)(2004-2#1)(2005-7#1)(2007-5#1)(2008-10#3)(2009-12#1)(2013-7#1)
the best approaches##2##3##(2006-9#1)(2008-2#1)
the best at##3##3##(1992-8#1)(1995-7#1)(2008-6#1)
the best available data##2##4##(2008-3#1)(2012-1#1)
the best available evidence##7##4##(2005-8#1)(2007-11#1)(2007-4#1)(2008-9#1)(2012-11#1)(2012-2#1)(2013-1#1)
the best available treatment##2##4##(2006-10#1)(2007-11#1)
the best available##26##3##(2005-8#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-4#1)(2007-8#2)(2008-1#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-2#2)(2013-1#1)
the best basis for##3##4##(2008-10#1)(2012-12#1)(2012-3#1)
the best basis##4##3##(2008-10#1)(2010-8#1)(2012-12#1)(2012-3#1)
the best being##2##3##(1994-9#1)(2007-11#1)
the best biochemical##2##3##(1993-8#1)(2008-5#1)
the best candidate for##2##4##(2006-6#1)(2008-4#1)
the best candidate to##2##4##(2006-6#1)(2008-10#1)
the best candidate##4##3##(2006-6#2)(2008-10#1)(2008-4#1)
the best candidates##2##3##(2008-8#1)(2011-1#1)
the best carbon##2##3##(2006-9#1)(2008-5#1)
the best care##3##3##(1992-11#1)(2009-12#1)(2010-11#1)
the best chance for##3##4##(2008-4#1)(2009-2#1)(2010-2#1)
the best chance of survival##2##5##(1994-6#1)(1996-6#1)
the best chance of##5##4##(1994-6#1)(1994-7#1)(1996-6#1)(1997-3#1)(2013-1#1)
the best chance##8##3##(1994-6#1)(1994-7#1)(1996-6#1)(1997-3#1)(2008-4#1)(2009-2#1)(2010-2#1)(2013-1#1)
the best characterized##10##3##(1991-12#1)(1995-8#1)(1997-4#1)(2005-10#1)(2006-10#1)(2008-10#1)(2008-11#1)(2009-12#1)(2010-11#1)(2013-1#1)
the best chemical##2##3##(2008-10#1)(2008-4#1)
the best choice for##8##4##(2008-10#4)(2008-3#1)(2009-10#1)(2011-2#1)(2012-3#1)
the best choice of##4##4##(2007-4#1)(2008-3#2)(2011-2#1)
the best choice##15##3##(1995-8#1)(2007-4#1)(2008-10#5)(2008-3#4)(2009-10#1)(2011-2#2)(2012-3#1)
the best clinical results##2##4##(2007-11#1)(2008-7#1)
the best clinical##6##3##(2007-11#1)(2007-2#1)(2008-7#1)(2010-3#1)(2010-5#1)(2013-1#1)
the best combination for##2##4##(1997-2#1)(2008-10#1)
the best combination of##5##4##(1993-1#1)(1997-2#1)(2008-12#1)(2008-3#1)(2008-7#1)
the best combination##8##3##(1993-1#1)(1997-2#2)(2008-10#1)(2008-12#1)(2008-3#2)(2008-7#1)
the best compromise of##3##4##(1997-7#1)(2008-10#1)(2009-7#1)
the best compromise##4##3##(1997-7#1)(2008-10#2)(2009-7#1)
the best conditions for the##3##5##(2008-10#2)(2011-2#1)
the best conditions for##7##4##(1992-9#1)(2008-10#5)(2011-2#1)
the best conditions##11##3##(1992-9#1)(2008-10#7)(2008-11#1)(2011-2#1)(2013-1#1)
the best control##2##3##(1997-8#1)(2008-10#1)
the best correlation##4##3##(2004-12#1)(2005-10#1)(2006-10#1)(2012-2#1)
the best curative##2##3##(1996-8#1)(2008-1#1)
the best data##2##3##(2008-9#1)(2010-12#1)
the best diagnostic##4##3##(1990-9#1)(1991-2#1)(1992-10#1)(2013-8#1)
the best documented##3##3##(1995-5#1)(1996-1#1)(2004-2#1)
the best dosage##2##3##(2006-6#1)(2007-11#1)
the best enantioselectivity and time-stability##2##5##(2008-10#2)
the best enzyme##2##3##(2008-5#1)(2008-6#1)
the best established##2##3##(2007-8#1)(2008-11#1)
the best estimate##2##3##(1997-8#1)(2013-1#1)
the best evidence to answer the clinical question##45##8##(2007-8#45)
the best evidence to answer the question##3##7##(2007-8#3)
the best evidence to answer the##48##6##(2007-8#48)
the best evidence to##49##4##(2007-8#48)(2009-8#1)
the best evidence##67##3##(2007-4#1)(2007-8#60)(2008-5#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2011-12#1)
the best experiment##2##3##(2008-5#1)(2013-8#1)
the best experimental conditions##3##4##(2007-12#1)(2007-8#1)(2008-10#1)
the best explanation for##2##4##(1996-3#1)(1996-8#1)
the best extraction efficiency##2##4##(2008-10#2)
the best extraction##4##3##(1992-2#1)(2008-10#3)
the best fit for##2##4##(2008-10#2)
the best fit to the##2##5##(1996-12#1)(2012-1#1)
the best fit was obtained##2##5##(1995-5#1)(2006-5#1)
the best fit##10##3##(1995-5#1)(1996-12#1)(2005-11#1)(2006-5#1)(2008-10#4)(2008-2#1)(2012-1#1)
the best focus##2##3##(2006-5#1)(2008-3#1)
the best for our##2##4##(2007-4#1)(2008-10#1)
the best for##8##3##(1994-12#1)(2007-4#1)(2008-10#2)(2008-4#1)(2008-5#2)(2010-2#1)
the best formulation##2##3##(2012-2#2)
the best functional##2##3##(2008-6#1)(2012-12#1)
the best general##2##3##(2008-2#1)(2009-12#1)
the best growth##3##3##(2004-9#1)(2006-5#1)(2008-5#1)
the best imaging technique##2##4##(2007-7#1)(2008-1#1)
the best imaging##3##3##(2007-7#1)(2008-1#1)(2012-12#1)
the best in vitro##3##4##(1995-3#1)(1995-7#1)(2008-5#1)
the best in##7##3##(1995-3#1)(1995-7#1)(2007-4#1)(2008-5#1)(2008-8#1)(2013-1#2)
the best indication remains small##2##5##(2007-9#1)(2008-3#1)
the best indication##3##3##(2007-9#1)(2008-3#1)(2012-12#1)
the best indicator##2##3##(2006-8#1)(2011-12#1)
the best information##4##3##(1990-4#1)(2006-10#1)(2008-9#1)(2011-1#1)
the best initial treatment##2##4##(2006-10#1)(2007-7#1)
the best interest of the##4##5##(1991-7#1)(2008-12#1)(2009-6#1)(2012-3#1)
the best interest of##7##4##(1991-7#1)(1992-12#1)(1997-1#1)(2007-4#1)(2008-12#1)(2009-6#1)(2012-3#1)
the best interests of the##4##5##(1991-6#1)(1992-3#1)(2010-9#2)
the best interests of##6##4##(1991-6#1)(1992-2#1)(1992-3#1)(1995-2#1)(2010-9#2)
the best jump height##2##4##(2009-1#2)
the best known and##2##4##(1991-4#1)(1995-5#1)
the best known of the##2##5##(2006-9#1)(2007-11#1)
the best known of##3##4##(2006-2#1)(2006-9#1)(2007-11#1)
the best known##12##3##(1991-4#1)(1995-5#1)(1996-3#1)(2004-11#1)(2005-10#1)(2006-2#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-12#2)(2008-5#1)
the best level of##2##4##(2008-4#1)(2013-8#1)
the best long-term##6##3##(2006-10#3)(2008-10#1)(2009-5#1)(2009-8#1)
the best management of##2##4##(2007-12#1)(2013-1#1)
the best management##3##3##(2007-12#1)(2010-3#1)(2013-1#1)
the best mean##2##3##(2008-10#1)(2008-3#1)
the best means of##3##4##(1994-7#1)(1996-3#1)(2008-5#1)
the best means##4##3##(1994-7#1)(1996-3#1)(2006-9#1)(2008-5#1)
the best method for##3##4##(2005-1#1)(2006-12#1)(2007-4#1)
the best method of treatment##2##5##(2007-11#1)(2013-1#1)
the best method of##5##4##(2007-11#1)(2007-8#1)(2008-3#1)(2010-2#1)(2013-1#1)
the best method to predict##2##5##(1992-1#1)(2011-2#1)
the best method to##3##4##(1990-12#1)(1992-1#1)(2011-2#1)
the best method##14##3##(1990-12#1)(1992-1#1)(1994-5#1)(2005-1#1)(2006-12#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-2#1)(2011-2#1)(2013-1#1)
the best model for##6##4##(1994-6#1)(1995-3#1)(1996-10#1)(2008-3#1)(2010-4#1)(2011-2#1)
the best model of##2##4##(2008-10#1)(2010-4#1)
the best model##13##3##(1994-6#1)(1995-3#1)(1996-10#1)(2008-10#2)(2008-3#1)(2010-4#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
the best models##3##3##(1992-2#2)(2007-12#1)
the best modifier##2##3##(2008-10#2)
the best of our knowledge the##2##6##(2007-8#1)(2008-2#1)
the best of our knowledge##79##5##(1990-10#1)(1991-9#1)(1992-6#1)(1994-12#1)(1995-5#1)(1996-2#1)(1996-7#1)(2007-11#5)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#5)(2007-8#2)(2008-1#3)(2008-10#3)(2008-12#1)(2008-2#6)(2008-3#6)(2008-6#1)(2009-12#1)(2009-5#2)(2009-7#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#2)
the best of our##81##4##(1990-10#1)(1991-9#1)(1992-6#1)(1994-12#1)(1995-5#1)(1996-2#1)(1996-7#1)(2007-11#5)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#5)(2007-8#3)(2008-1#3)(2008-10#3)(2008-12#1)(2008-2#6)(2008-3#6)(2008-6#1)(2009-12#1)(2009-5#2)(2009-7#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#2)
the best of the##7##4##(1996-7#1)(1996-8#1)(1997-4#1)(2006-8#1)(2008-2#1)(2008-5#1)(2011-1#1)
the best of##101##3##(1990-10#1)(1991-9#1)(1992-6#1)(1994-1#1)(1994-12#1)(1995-5#1)(1996-2#1)(1996-7#2)(1996-8#1)(1997-3#1)(1997-4#1)(2005-6#1)(2006-8#1)(2007-11#5)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#7)(2007-8#3)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#7)(2008-3#6)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-5#2)(2009-7#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#7)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#3)
the best one##4##3##(1991-3#1)(2005-6#1)(2007-12#1)(2011-2#1)
the best opportunity for##2##4##(2006-9#1)(2008-12#1)
the best option to##2##4##(2008-1#1)(2008-9#1)
the best option##7##3##(1996-3#1)(2005-7#1)(2007-7#2)(2008-1#1)(2008-9#1)(2011-2#1)
the best out of##2##4##(2007-5#1)(2013-1#1)
the best outcome for the##2##5##(2008-7#1)(2011-1#1)
the best outcome for##3##4##(2007-11#1)(2008-7#1)(2011-1#1)
the best outcome##6##3##(2007-11#2)(2007-7#1)(2007-8#1)(2008-7#1)(2011-1#1)
the best outcomes##5##3##(2007-11#1)(2007-7#2)(2010-2#1)(2010-5#1)
the best overall##7##3##(1997-8#1)(2006-11#1)(2007-11#1)(2008-2#1)(2010-4#2)(2012-2#1)
the best patient##2##3##(1994-3#1)(2005-7#1)
the best peak##2##3##(2008-10#2)
the best performance in##2##4##(2008-10#2)
the best performance of##3##4##(2008-10#2)(2008-11#1)
the best performance was##2##4##(2008-10#2)
the best performance##17##3##(1994-5#1)(1995-3#1)(1996-7#1)(2007-8#2)(2008-10#7)(2008-11#1)(2008-2#2)(2013-7#1)(2013-8#1)
the best possible care##3##4##(1995-1#1)(2006-10#1)(2013-1#1)
the best possible quality of##2##5##(2007-12#1)(2012-3#1)
the best possible treatment##2##4##(2011-1#1)(2012-2#1)
the best possible way##2##4##(2006-2#1)(2006-9#1)
the best possible##23##3##(1993-12#1)(1994-1#1)(1995-1#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
the best practices##2##3##(1996-3#1)(2008-11#1)
the best prediction results##2##4##(2008-10#2)
the best prediction##3##3##(1992-12#1)(2008-10#2)
the best predictor of the##2##5##(2007-10#1)(2008-10#1)
the best predictor of##13##4##(1993-1#1)(1993-2#1)(1996-3#1)(1996-7#1)(2006-11#1)(2006-2#1)(2007-10#1)(2008-10#1)(2009-8#1)(2011-2#1)(2013-1#2)(2013-7#1)
the best predictor##14##3##(1993-1#1)(1993-2#1)(1995-6#1)(1996-3#1)(1996-7#1)(2006-11#1)(2006-2#1)(2007-10#1)(2008-10#1)(2009-8#1)(2011-2#1)(2013-1#2)(2013-7#1)
the best predictors of##9##4##(2006-10#1)(2006-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-6#1)(2010-12#1)
the best predictors##12##3##(2006-10#1)(2006-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2010-12#1)(2010-3#1)(2013-1#1)
the best present##2##3##(1993-9#1)(2006-5#1)
the best prevention##2##3##(2007-7#1)(2007-8#1)
the best preventive##2##3##(2011-2#1)(2012-12#1)
the best protection against##3##4##(2006-3#1)(2008-10#1)(2008-5#1)
the best protection##5##3##(2006-3#1)(2008-10#1)(2008-5#1)(2009-4#1)(2013-8#1)
the best recoveries##2##3##(2008-10#2)
the best recovery##2##3##(2008-10#2)
the best regimen##4##3##(1991-11#1)(1993-11#1)(2006-6#2)
the best reported##2##3##(1996-9#1)(2008-7#1)
the best response##4##3##(2005-7#1)(2008-10#1)(2008-12#1)(2008-2#1)
the best result##9##3##(2007-1#1)(2007-11#1)(2007-7#1)(2008-10#5)(2011-2#1)
the best results are obtained##5##5##(1990-6#1)(1992-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
the best results are##6##4##(1990-6#1)(1992-12#1)(1994-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
the best results for##2##4##(1996-2#1)(2006-2#1)
the best results have been##2##5##(2007-8#1)(2008-2#1)
the best results in##3##4##(2008-4#1)(2010-4#1)(2011-2#1)
the best results were obtained using##2##6##(2008-10#1)(2013-1#1)
the best results were obtained with##3##6##(1992-12#1)(2007-5#1)(2008-5#1)
the best results were obtained##10##5##(1992-12#1)(2007-5#1)(2008-10#3)(2008-4#1)(2008-5#2)(2012-3#1)(2013-1#1)
the best results were##12##4##(1992-12#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#2)(2012-3#1)(2013-1#1)(2013-8#1)
the best results##48##3##(1990-10#2)(1990-11#1)(1990-6#1)(1992-1#1)(1992-12#2)(1994-11#1)(1994-2#1)(1995-2#1)(1996-2#1)(2006-2#3)(2007-1#1)(2007-5#1)(2007-8#3)(2007-9#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
the best risk-benefit##2##3##(2008-7#1)(2009-6#1)
the best root##2##3##(2008-10#1)(2011-2#1)
the best science and##3##4##(1996-2#1)(2013-1#2)
the best science##4##3##(1996-2#1)(2011-2#1)(2013-1#2)
the best scientific##2##3##(2007-8#1)(2008-4#1)
the best selectivity for the##2##5##(2008-10#2)
the best selectivity in##2##4##(2008-10#2)
the best selectivity##6##3##(2008-10#6)
the best sensitivity##2##3##(2007-2#1)(2008-10#1)
the best separation##6##3##(1992-1#1)(1996-5#1)(2007-8#1)(2008-10#3)
the best signal##2##3##(2008-10#1)(2008-3#1)
the best single##2##3##(1991-12#1)(2008-3#1)
the best solution for##2##4##(1990-3#1)(1991-9#1)
the best solution is##2##4##(2007-8#1)(2011-2#1)
the best solution may be##2##5##(1992-3#1)(2007-8#1)
the best solution##12##3##(1990-3#1)(1991-9#2)(1992-3#1)(1993-2#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-8#1)(2011-2#1)
the best source of##2##4##(1993-3#1)(2004-5#1)
the best start in life##2##5##(2007-2#1)(2010-5#1)
the best storage##2##3##(1996-12#2)
the best strategy to##2##4##(2006-10#1)(2011-2#1)
the best strategy##7##3##(2006-10#1)(2007-11#1)(2008-10#1)(2010-12#1)(2011-2#2)(2011-3#1)
the best studied##3##3##(2008-1#1)(2008-12#1)(2008-3#1)
the best substrate##2##3##(1992-11#1)(1994-12#1)
the best surgical approach##2##4##(2007-8#1)(2008-12#1)
the best surgical strategy##2##4##(2006-10#1)(2010-8#1)
the best surgical##7##3##(2006-10#1)(2007-11#1)(2007-8#1)(2008-12#1)(2009-5#1)(2010-8#1)(2012-2#1)
the best system##3##3##(1991-2#1)(1995-7#1)(2012-2#1)
the best technique##4##3##(2006-10#2)(2007-7#2)
the best temperatures for pyrolysis and atomization were##2##8##(2008-10#2)
the best temperatures for##3##4##(2008-10#3)
the best test##2##3##(1990-5#1)(2011-2#1)
the best therapeutic##7##3##(1991-3#1)(1994-6#1)(1996-9#1)(2006-12#1)(2009-7#1)(2012-11#2)
the best therapy for##2##4##(2006-10#1)(2013-1#1)
the best therapy##4##3##(1993-12#1)(2006-10#1)(2011-2#1)(2013-1#1)
the best time for##2##4##(1994-7#1)(2009-6#1)
the best time to##2##4##(1997-5#1)(2006-10#1)
the best time##5##3##(1994-7#1)(1995-5#1)(1997-5#1)(2006-10#1)(2009-6#1)
the best timing of application##2##5##(2008-10#2)
the best timing##3##3##(2007-8#1)(2008-10#2)
the best tool##2##3##(2007-6#1)(2008-9#1)
the best treatment for##9##4##(2006-2#1)(2006-5#1)(2008-12#1)(2008-7#2)(2010-3#1)(2011-1#2)(2013-1#1)
the best treatment is##3##4##(2006-11#1)(2006-2#1)(2008-1#1)
the best treatment##23##3##(1997-8#1)(2006-11#1)(2006-2#2)(2006-5#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-7#4)(2010-3#1)(2011-1#3)(2012-3#1)(2013-1#1)(2013-8#1)
the best understood##5##3##(2007-12#2)(2008-1#1)(2009-10#1)(2011-1#1)
the best value##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
the best variant##2##3##(2010-2#2)
the best way of##4##4##(1992-9#1)(1993-11#1)(2006-10#1)(2010-12#1)
the best way to integrate##2##5##(1997-2#1)(2008-9#1)
the best way to##18##4##(1991-4#1)(1994-3#1)(1996-1#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-9#2)(2008-3#1)(2008-9#2)(2011-2#1)
the best way##24##3##(1990-12#1)(1991-4#1)(1992-9#1)(1993-11#1)(1994-3#1)(1996-1#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-9#2)(2008-3#1)(2008-9#2)(2010-12#1)(2011-2#1)
the best ways to##3##4##(2007-10#1)(2008-11#1)(2010-4#1)
the best ways##4##3##(2007-10#1)(2008-10#1)(2008-11#1)(2010-4#1)
the best when##2##3##(2007-8#1)(2012-2#1)
the best##1163##2##(1990-10#3)(1990-11#1)(1990-12#6)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#4)(1991-2#4)(1991-3#3)(1991-4#2)(1991-6#3)(1991-7#2)(1991-8#1)(1991-9#3)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#7)(1992-3#4)(1992-6#1)(1992-8#2)(1992-9#3)(1993-1#2)(1993-10#1)(1993-11#4)(1993-12#3)(1993-2#2)(1993-3#4)(1993-8#2)(1993-9#1)(1994-1#2)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#4)(1994-5#3)(1994-6#4)(1994-7#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#4)(1995-3#8)(1995-4#1)(1995-5#6)(1995-6#1)(1995-7#3)(1995-8#3)(1996-1#3)(1996-10#1)(1996-12#3)(1996-2#6)(1996-3#7)(1996-5#2)(1996-6#2)(1996-7#4)(1996-8#5)(1996-9#5)(1997-1#2)(1997-2#4)(1997-3#3)(1997-4#2)(1997-5#3)(1997-7#1)(1997-8#5)(2004-11#2)(2004-12#1)(2004-2#2)(2004-5#1)(2004-9#2)(2005-1#1)(2005-10#5)(2005-11#4)(2005-6#2)(2005-7#5)(2005-8#2)(2005-9#2)(2006-10#25)(2006-11#6)(2006-12#4)(2006-2#9)(2006-3#1)(2006-5#6)(2006-6#6)(2006-8#2)(2006-9#8)(2007-1#5)(2007-10#5)(2007-11#28)(2007-12#18)(2007-2#5)(2007-3#3)(2007-4#13)(2007-5#9)(2007-6#1)(2007-7#22)(2007-8#86)(2007-9#10)(2008-1#15)(2008-10#152)(2008-11#16)(2008-12#16)(2008-2#41)(2008-3#34)(2008-4#17)(2008-5#31)(2008-6#11)(2008-7#17)(2008-8#12)(2008-9#12)(2009-1#3)(2009-10#2)(2009-11#2)(2009-12#6)(2009-2#2)(2009-3#1)(2009-4#4)(2009-5#5)(2009-6#3)(2009-7#6)(2009-8#4)(2009-9#1)(2010-11#3)(2010-12#11)(2010-2#11)(2010-3#5)(2010-4#11)(2010-5#6)(2010-6#2)(2010-7#2)(2010-8#5)(2010-9#4)(2011-1#19)(2011-12#2)(2011-2#37)(2011-3#1)(2012-1#8)(2012-11#4)(2012-12#15)(2012-2#22)(2012-3#16)(2013-1#41)(2013-7#5)(2013-8#20)
the best-characterized##2##2##(2008-8#1)(2009-8#1)
the best-documented##2##2##(2005-11#1)(2006-7#1)
the best-fit##2##2##(2008-4#1)(2012-2#1)
the best-fitting##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
the best-focus frame##2##3##(2008-3#2)
the best-known##2##2##(2008-8#1)(2008-9#1)
the best-performing##3##2##(2007-11#1)(2011-1#1)(2012-2#1)
the best-studied##3##2##(2007-7#1)(2008-7#1)(2009-5#1)
the best-understood##2##2##(2006-10#1)(2010-4#1)
the beta 1 subunit##2##4##(1992-2#1)(1996-10#1)
the beta 1##9##3##(1990-11#1)(1991-2#1)(1992-11#1)(1992-2#2)(1992-3#1)(1994-3#1)(1995-6#1)(1996-10#1)
the beta 1-adrenergic receptor##3##4##(1995-5#3)
the beta 2 dimer##3##4##(1996-8#3)
the beta 2 strand of WW##2##6##(2008-11#2)
the beta 2 strand of##3##5##(2008-11#3)
the beta 2 strand##4##4##(2008-11#4)
the beta 2##12##3##(1992-4#1)(1992-8#1)(1993-6#1)(1994-5#1)(1996-8#3)(2008-11#4)(2010-6#1)
the beta 2-adrenergic receptor##2##4##(1991-2#1)(1995-11#1)
the beta 3 and beta 5 epitopes##2##7##(1991-7#2)
the beta 3##3##3##(1991-7#2)(1994-3#1)
the beta 3-adrenoceptor##3##3##(1995-11#3)
the beta 4##2##3##(1991-9#1)(1997-2#1)
the beta A4##2##3##(1992-8#1)(1992-9#1)
the beta I##3##3##(1993-6#3)
the beta adrenergic##3##3##(1991-1#1)(1994-9#1)(1997-1#1)
the beta and gamma##2##4##(1991-5#1)(1994-9#1)
the beta and##4##3##(1991-5#1)(1994-6#1)(1994-9#1)(1995-6#1)
the beta anomer##2##3##(1990-11#1)(1991-12#1)
the beta cell##2##3##(2008-1#2)
the beta cells of the pancreas##2##6##(1995-10#1)(2007-12#1)
the beta cells##3##3##(1995-10#1)(1996-11#1)(2007-12#1)
the beta chain of the##2##5##(1992-6#1)(1995-1#1)
the beta chain of##5##4##(1992-6#1)(1995-1#1)(1995-3#2)(2008-7#1)
the beta chain##8##3##(1990-12#1)(1992-6#1)(1993-8#1)(1995-1#1)(1995-3#3)(2008-7#1)
the beta chains##3##3##(1990-7#2)(1991-1#1)
the beta function##2##3##(1991-12#1)(2008-10#1)
the beta gamma subunits of##3##5##(1992-9#1)(1994-8#1)(1994-9#1)
the beta gamma subunits##4##4##(1990-7#1)(1992-9#1)(1994-8#1)(1994-9#1)
the beta gamma##9##3##(1990-7#1)(1992-9#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-6#3)
the beta subunit and the##2##5##(1992-11#1)(1995-8#1)
the beta subunit in##2##4##(1996-8#1)(1997-6#1)
the beta subunit of human chorionic gonadotropin##2##7##(1993-6#1)(1994-8#1)
the beta subunit of human##3##5##(1993-5#1)(1993-6#1)(1994-8#1)
the beta subunit of the##6##5##(1991-3#2)(1993-12#1)(1995-8#1)(1996-8#1)(2006-9#1)
the beta subunit of##13##4##(1991-3#2)(1991-8#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-8#2)(2006-9#1)
the beta subunit was found##3##5##(1992-11#2)(1992-9#1)
the beta subunit##42##3##(1990-7#2)(1991-10#1)(1991-3#2)(1991-8#1)(1992-11#4)(1992-2#1)(1992-3#1)(1992-9#3)(1993-12#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-8#3)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#6)(1996-8#3)(1997-1#1)(1997-6#1)(2005-10#1)(2006-9#1)(2008-8#1)
the beta subunits##2##3##(1990-7#1)(1992-2#1)
the beta toxin##4##3##(2006-5#4)
the beta##185##2##(1990-11#3)(1990-12#1)(1990-7#11)(1990-8#1)(1990-9#2)(1991-1#3)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#3)(1991-5#4)(1991-6#1)(1991-7#3)(1991-8#1)(1991-9#2)(1992-11#5)(1992-2#4)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#7)(1993-12#1)(1993-5#2)(1993-6#7)(1993-8#3)(1994-11#3)(1994-12#2)(1994-3#2)(1994-5#2)(1994-6#3)(1994-8#5)(1994-9#4)(1995-1#1)(1995-10#3)(1995-11#6)(1995-2#1)(1995-3#7)(1995-5#3)(1995-6#7)(1995-8#6)(1996-10#1)(1996-11#1)(1996-5#1)(1996-7#1)(1996-8#7)(1997-1#2)(1997-2#1)(1997-3#1)(1997-6#1)(2005-10#1)(2006-1#1)(2006-5#4)(2006-9#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#5)(2008-12#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-12#1)(2010-5#1)(2010-6#1)(2012-3#1)(2013-7#1)
the beta- and##5##3##(1990-8#2)(1993-8#1)(2006-12#1)(2008-10#1)
the beta-##6##2##(1990-8#2)(1992-4#1)(1993-8#1)(2006-12#1)(2008-10#1)
the beta-1##5##2##(1991-12#2)(2008-10#3)
the beta-CD cavity##3##3##(1994-3#1)(2008-10#2)
the beta-CD##6##2##(1994-3#1)(1996-2#1)(2008-10#3)(2008-11#1)
the beta-CGRP gene##2##3##(1992-6#2)
the beta-MyHC gene##2##3##(1995-2#2)
the beta-actin mRNA level##2##4##(1990-4#1)(1994-2#1)
the beta-actin##4##2##(1990-4#1)(1994-2#1)(1996-2#1)(2008-11#1)
the beta-adrenergic agonist isoproterenol##3##4##(1990-3#1)(1994-3#1)(2007-9#1)
the beta-adrenergic agonist##4##3##(1990-3#1)(1994-3#1)(2007-9#1)(2008-9#1)
the beta-adrenergic receptor##5##3##(1993-4#1)(1994-9#1)(1995-1#1)(1995-3#2)
the beta-adrenergic##12##2##(1990-3#1)(1991-2#1)(1993-4#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-3#2)(2007-9#2)(2008-2#1)(2008-9#1)
the beta-adrenoblocker metoprolol##2##3##(2006-6#2)
the beta-adrenoceptor##4##2##(1990-2#1)(1991-11#1)(1995-11#1)(1995-6#1)
the beta-alanine side chain##2##4##(1997-2#2)
the beta-amyloid precursor protein gene##3##5##(1991-10#3)
the beta-amyloid precursor protein##9##4##(1990-3#2)(1991-10#3)(1992-12#2)(1996-2#1)(2005-7#1)
the beta-amyloid precursor##10##3##(1990-3#2)(1991-10#3)(1992-12#2)(1996-2#2)(2005-7#1)
the beta-amyloid protein##2##3##(1992-8#1)(1995-1#1)
the beta-amyloid##14##2##(1990-3#2)(1991-10#3)(1992-12#2)(1992-8#1)(1994-5#1)(1995-1#1)(1996-2#2)(2004-12#1)(2005-7#1)
the beta-barrel##5##2##(1991-5#1)(1994-11#3)(1995-3#1)
the beta-binomial distribution and##2##4##(2008-10#2)
the beta-binomial distribution to##2##4##(2008-10#2)
the beta-binomial distribution##12##3##(2008-10#11)(2010-3#1)
the beta-binomial##21##2##(2008-10#19)(2010-3#2)
the beta-binomial-based function##2##3##(2008-10#2)
the beta-blockers tested##5##3##(1995-6#5)
the beta-bulge##2##2##(1996-6#2)
the beta-carboline##3##2##(1990-2#1)(2008-10#2)
the beta-casein promoter##3##3##(1995-10#2)(2010-5#1)
the beta-catenin##3##2##(2006-8#1)(2007-12#2)
the beta-cell##5##2##(1992-6#1)(1995-7#1)(1997-4#1)(2008-1#1)(2013-1#1)
the beta-cells##5##2##(1990-2#2)(1991-1#1)(1991-8#1)(1994-11#1)
the beta-chain of the receptor##2##5##(1993-5#1)(1995-6#1)
the beta-chain of##6##3##(1992-11#1)(1993-5#2)(1995-3#2)(1995-6#1)
the beta-chain##11##2##(1991-6#1)(1992-11#2)(1992-5#2)(1993-5#2)(1993-8#1)(1995-3#2)(1995-6#1)
the beta-configuration##2##2##(1991-9#1)(1996-6#1)
the beta-cyclodextrin##2##2##(2008-10#2)
the beta-elimination##3##2##(1995-2#1)(2007-8#1)(2009-8#1)
the beta-gal##3##2##(1993-12#1)(1997-8#1)(2008-7#1)
the beta-galactosidase from Lactobacillus delbrückii subsp##2##6##(1994-6#2)
the beta-galactosidase gene##2##3##(1997-8#1)(2007-3#1)
the beta-galactosidase yield##2##3##(1995-1#1)(2008-11#1)
the beta-galactosidase##10##2##(1990-11#1)(1992-12#1)(1994-11#1)(1994-6#2)(1995-1#1)(1997-8#2)(2007-3#1)(2008-11#1)
the beta-galactosidase-binding interface on cathepsin A##2##6##(1995-2#2)
the beta-globin cluster##2##3##(1992-5#1)(1997-4#1)
the beta-globin gene##3##3##(1990-7#1)(1993-3#1)(2008-11#1)
the beta-globin locus control region##2##5##(1994-12#1)(1997-4#1)
the beta-globin##8##2##(1990-7#1)(1992-5#1)(1993-3#1)(1994-12#1)(1997-4#3)(2008-11#1)
the beta-glucuronidase##3##2##(2008-10#2)(2008-9#1)
the beta-hexosaminidase##2##2##(1993-4#2)
the beta-isoform of proteinkinase C##2##5##(1992-3#2)
the beta-lactam##3##2##(1997-1#2)(2010-11#1)
the beta-lactamase inhibitor##2##3##(1994-8#1)(2007-6#1)
the beta-lactamase##6##2##(1992-6#1)(1994-8#1)(1997-4#1)(2007-6#1)(2008-11#1)(2010-2#1)
the beta-lactamase-encoding gene (bla)##2##4##(1990-9#1)(1994-12#1)
the beta-lactams##5##2##(1991-12#2)(1993-8#1)(1996-3#1)(2006-10#1)
the beta-lactoglobulin##2##2##(1991-3#1)(1995-5#1)
the beta-oxidation of##6##3##(1990-5#1)(1994-6#2)(1994-8#1)(1997-7#1)(2012-2#1)
the beta-oxidation##9##2##(1990-5#1)(1994-6#3)(1994-8#1)(1997-7#1)(2008-4#1)(2008-6#1)(2012-2#1)
the beta-peptide##4##2##(1991-1#1)(2008-5#3)
the beta-peptides##2##2##(1992-4#1)(2006-12#1)
the beta-protein##8##2##(1990-3#1)(1991-1#5)(1992-12#2)
the beta-secretase##2##2##(2008-11#2)
the beta-sheet and##2##3##(1991-11#1)(1991-2#1)
the beta-sheet##16##2##(1990-7#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-6#2)(1995-1#4)(1995-11#1)(1995-5#2)(1997-2#1)(2005-11#1)(2006-10#1)
the beta-structure##3##2##(2006-10#2)(2008-9#1)
the beta-subunit of the##3##4##(1991-8#1)(1993-8#1)(1995-3#1)
the beta-subunit of##15##3##(1990-9#1)(1991-8#1)(1993-11#2)(1993-8#2)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-4#1)
the beta-subunit##22##2##(1990-9#1)(1991-8#1)(1992-9#1)(1993-11#2)(1993-8#2)(1994-12#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-7#1)
the beta-subunits##2##2##(1990-4#1)(1997-7#1)
the beta-transducin##3##2##(1994-6#1)(1995-8#2)
the beta-tubulin gene##7##3##(2008-10#5)(2008-4#2)
the beta-tubulin##16##2##(1990-3#2)(1994-3#1)(1995-5#1)(2008-10#7)(2008-4#4)(2010-3#1)
the beta-turn region##2##3##(1993-3#2)
the beta-turn##3##2##(1993-3#2)(1995-1#1)
the beta-type complex of Y-CPApK##2##5##(2008-10#2)
the beta1 subunit##2##3##(1997-8#1)(2008-8#1)
the beta1##3##2##(1997-7#1)(1997-8#1)(2008-8#1)
the beta2 subunit##3##3##(1995-9#2)(1997-5#1)
the beta2##6##2##(1995-9#3)(1996-5#1)(1997-5#1)(2011-2#1)
the beta2-adrenergic receptor##2##3##(1996-8#1)(2005-8#1)
the betaAR##2##2##(2005-7#2)
the better control of##2##4##(2008-10#1)(2008-9#1)
the better efficacy of##2##4##(1994-6#1)(2011-2#1)
the better management of##2##4##(2007-2#1)(2008-10#1)
the better part of##2##4##(2006-8#1)(2009-5#1)
the better performance##2##3##(2007-9#1)(2011-1#1)
the better the##5##3##(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2011-1#1)
the better understanding of the##4##5##(1997-3#1)(2009-6#1)(2010-8#1)(2012-11#1)
the better understanding of##6##4##(1997-3#1)(2009-6#1)(2010-8#1)(2010-9#1)(2012-11#1)(2013-8#1)
the better##62##2##(1993-12#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-6#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#4)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-4#1)(2010-8#4)(2010-9#1)(2011-1#4)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
the between##2##2##(1992-2#2)
the between-class scatter is generalized##2##5##(2008-6#2)
the beverage##4##2##(2006-10#4)
the bi-directional##2##2##(2008-10#1)(2009-3#1)
the bias and the##2##4##(1995-12#1)(2008-3#1)
the bias and##4##3##(1995-12#1)(1996-3#1)(2008-2#1)(2008-3#1)
the bias error##2##3##(2008-10#2)
the bias in##3##3##(2012-1#1)(2012-2#1)(2013-1#1)
the bias is##3##3##(2009-10#1)(2009-9#1)(2013-8#1)
the bias of the Satterthwaite approximation##2##6##(1994-8#2)
the bias of the##3##4##(1994-8#3)
the bias of##6##3##(1994-8#3)(2008-7#2)(2012-2#1)
the bias voltage is##2##4##(2008-10#2)
the bias voltage##4##3##(2007-12#1)(2008-10#2)(2008-2#1)
the bias##34##2##(1994-8#3)(1995-12#1)(1996-12#2)(1996-3#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-2#5)(2008-3#3)(2008-7#2)(2009-10#1)(2009-9#1)(2012-1#2)(2012-2#2)(2013-1#1)(2013-8#1)
the biases##2##2##(2006-8#1)(2012-12#1)
the bibliography##6##2##(1994-3#1)(2007-2#1)(2007-4#1)(2008-10#2)(2013-1#1)
the bicarbonate concentration##2##3##(2004-12#2)
the bicarbonate##3##2##(2004-12#2)(2008-11#1)
the biceps brachii tendon##3##4##(2007-12#1)(2007-2#1)(2013-7#1)
the biceps brachii##4##3##(2007-12#1)(2007-2#1)(2008-12#1)(2013-7#1)
the biceps tendon##5##3##(2006-3#1)(2007-2#1)(2013-7#3)
the biceps##15##2##(1990-8#1)(2006-3#2)(2007-11#1)(2007-12#1)(2007-2#2)(2008-10#1)(2008-12#1)(2013-7#6)
the bicycle##3##2##(1991-2#1)(1991-9#1)(2005-1#1)
the bicyclic##8##2##(1991-8#2)(1994-9#1)(1996-5#1)(1997-2#1)(2007-11#2)(2007-8#1)
the bidentate##4##2##(1996-2#1)(2008-3#1)(2008-5#2)
the bidirectional communication##2##3##(2009-3#1)(2009-5#1)
the bidirectional reflectance distribution function##3##5##(2008-2#2)(2008-3#1)
the bidirectional reflectance##4##3##(2008-2#3)(2008-3#1)
the bidirectional##16##2##(1994-10#1)(1995-6#1)(1996-9#2)(2007-8#1)(2008-2#3)(2008-3#2)(2008-6#1)(2009-3#1)(2009-5#1)(2011-2#2)(2013-1#1)
the biflavanol 1##2##3##(2007-1#2)
the bifunctional fusion protein RM4/TNF##2##5##(1997-2#2)
the bifunctional##6##2##(1990-2#1)(1992-4#1)(1994-11#1)(1997-2#2)(2008-5#1)
the bifurcation of the##2##4##(2007-8#1)(2008-3#1)
the bifurcation##13##2##(2007-12#1)(2007-8#2)(2007-9#6)(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#1)
the big picture##5##3##(1991-4#1)(1995-6#1)(1997-4#1)(2009-4#1)(2013-8#1)
the big##20##2##(1990-9#1)(1991-4#1)(1993-4#1)(1995-1#1)(1995-6#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-4#1)(2007-4#1)(2008-12#1)(2009-4#1)(2009-8#1)(2010-4#1)(2010-9#2)(2012-2#2)(2013-8#2)
the bigger##3##2##(1991-12#1)(2007-9#1)(2008-8#1)
the biggest impact##2##3##(2010-7#1)(2012-12#1)
the biggest##29##2##(1990-2#1)(1991-2#2)(1992-9#1)(2005-10#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-7#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-7#2)(2013-8#2)
the bilateral VNC##3##3##(1996-9#3)
the bilateral cervical##2##3##(2010-12#1)(2012-12#1)
the bilateral filter##4##3##(2008-2#4)
the bilateral frontal##2##3##(1996-5#1)(2007-9#1)
the bilateral##44##2##(1990-9#1)(1993-7#1)(1996-2#1)(1996-5#2)(1996-9#6)(1997-6#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-11#1)(2008-2#4)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#3)(2010-12#1)(2011-3#1)(2012-1#1)(2012-12#3)(2013-1#1)(2013-7#1)
the bilaterally##3##2##(1992-3#1)(2007-12#1)(2008-5#1)
the bilayer and##5##3##(1990-12#1)(1991-5#1)(1993-11#1)(1996-1#1)(2008-10#1)
the bilayer at##3##3##(1991-2#1)(2006-10#2)
the bilayer center##3##3##(1995-10#2)(1995-11#1)
the bilayer is##3##3##(1991-2#1)(1992-5#2)
the bilayer lipid membrane##2##4##(1993-8#1)(1996-1#1)
the bilayer lipid##3##3##(1993-8#1)(1994-2#1)(1996-1#1)
the bilayer normal##3##3##(1992-1#1)(1995-10#2)
the bilayer structure of##2##4##(1990-7#1)(2008-8#1)
the bilayer structure##4##3##(1990-7#1)(1997-4#2)(2008-8#1)
the bilayer surface##3##3##(1994-11#1)(1994-8#2)
the bilayer to hexagonal phase transition##2##6##(1991-9#1)(1994-12#1)
the bilayer##77##2##(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#3)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#5)(1991-5#2)(1991-9#2)(1992-1#1)(1992-3#1)(1992-5#3)(1992-6#1)(1992-9#2)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#1)(1994-8#4)(1995-10#5)(1995-11#2)(1995-2#2)(1995-5#1)(1996-1#2)(1996-7#1)(1997-4#2)(2006-10#4)(2006-5#1)(2008-10#5)(2008-4#1)(2008-8#1)(2008-9#1)(2012-11#1)(2012-2#1)
the bilayers##9##2##(1991-2#1)(1992-11#1)(1992-5#1)(1992-9#1)(2006-10#1)(2006-12#1)(2008-10#2)(2008-8#1)
the bile acid##5##3##(1994-11#2)(1996-7#1)(1997-3#1)(2006-5#1)
the bile acids##3##3##(1991-3#1)(1995-8#1)(1997-3#1)
the bile duct##7##3##(1991-8#1)(2008-5#2)(2008-6#1)(2010-12#1)(2013-1#2)
the bile ducts##5##3##(2006-10#1)(2006-2#2)(2006-6#1)(2010-12#1)
the bile ducts--are##2##3##(2006-10#2)
the bile salt##2##3##(2005-11#1)(2008-11#1)
the bile salts##2##3##(1990-8#1)(2005-11#1)
the bile##40##2##(1990-3#1)(1990-8#1)(1991-3#4)(1991-8#1)(1994-11#2)(1994-12#1)(1995-1#1)(1995-4#1)(1995-8#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-3#2)(2004-11#1)(2005-11#2)(2006-10#3)(2006-2#2)(2006-5#1)(2006-6#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-6#1)(2008-9#1)(2010-12#2)(2012-2#1)(2013-1#2)
the biliary duct or##2##4##(2008-3#2)
the biliary epithelium##3##3##(1992-2#1)(2006-10#1)(2010-12#1)
the biliary flow##2##3##(2012-2#1)(2013-1#1)
the biliary system##6##3##(2004-11#1)(2010-12#4)(2010-9#1)
the biliary tract##22##3##(1990-5#1)(1990-6#2)(1990-8#1)(1991-5#1)(1992-9#5)(1993-5#1)(2006-2#3)(2008-4#4)(2009-7#3)(2010-12#1)
the biliary tree is##2##4##(2006-10#1)(2010-12#1)
the biliary tree##10##3##(2006-10#4)(2008-11#1)(2009-6#1)(2010-12#1)(2012-12#2)(2013-1#1)
the biliary##55##2##(1990-5#1)(1990-6#2)(1990-8#1)(1991-5#1)(1991-6#1)(1992-2#1)(1992-9#5)(1993-5#1)(1996-4#1)(2004-11#1)(2006-10#6)(2006-2#5)(2006-6#1)(2008-11#1)(2008-3#2)(2008-4#4)(2008-9#1)(2009-6#1)(2009-7#3)(2010-12#8)(2010-2#1)(2010-9#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
the bilinear##2##2##(2008-10#1)(2008-6#1)
the bilingual##2##2##(2007-1#1)(2012-1#1)
the biliverdin##2##2##(1992-3#1)(2008-10#1)
the bill##10##2##(1991-10#2)(1992-1#2)(1995-6#3)(1996-5#1)(2007-4#1)(2010-2#1)
the bimodal response##2##3##(2008-10#2)
the bimodal##9##2##(1991-2#1)(2005-11#1)(2008-10#2)(2008-12#1)(2009-7#1)(2010-2#1)(2011-1#1)(2013-8#1)
the bimolecular##6##2##(1991-7#1)(1992-2#1)(1995-11#1)(1996-8#1)(2008-8#1)(2010-5#1)
the binary complex of##4##4##(1995-5#3)(1997-4#1)
the binary complex##8##3##(1990-5#1)(1991-2#1)(1992-12#1)(1993-11#1)(1995-5#3)(1997-4#1)
the binary complexes of##2##4##(2008-10#2)
the binary complexes##3##3##(1994-9#1)(2008-10#2)
the binary form of Taylor's power law##2##7##(2008-10#2)
the binary form of the##2##5##(2008-10#2)
the binary form of##4##4##(2008-10#4)
the binary mixture of##2##4##(2008-10#2)
the binary mixture##3##3##(2008-10#2)(2010-4#1)
the binary power law##4##4##(2008-10#4)
the binary power##5##3##(2008-10#5)
the binary##49##2##(1990-5#1)(1991-2#1)(1992-12#1)(1993-11#1)(1993-3#1)(1993-5#1)(1994-9#1)(1995-5#3)(1997-1#1)(1997-4#1)(2005-11#1)(2006-11#1)(2006-8#1)(2007-12#1)(2008-10#22)(2008-2#3)(2008-3#1)(2008-5#1)(2010-2#1)(2010-4#1)(2012-3#4)
the binder##3##2##(2007-8#1)(2008-10#2)
the binding ability of##3##4##(1995-6#1)(2008-10#2)
the binding ability##4##3##(1990-9#1)(1995-6#1)(2008-10#2)
the binding activities##2##3##(1991-8#1)(1993-6#1)
the binding activity of##5##4##(1992-11#1)(1992-2#1)(1996-10#1)(1997-3#1)(1997-7#1)
the binding activity##10##3##(1990-5#1)(1992-11#1)(1992-2#2)(1992-9#1)(1996-10#1)(1997-3#1)(1997-4#1)(1997-7#2)
the binding affinities of##4##4##(1993-11#1)(1994-2#1)(2006-10#1)(2008-11#1)
the binding affinities##6##3##(1993-11#1)(1994-2#1)(1996-4#1)(1996-5#1)(2006-10#1)(2008-11#1)
the binding affinity for##4##4##(1990-5#1)(1993-11#1)(2006-12#1)(2008-10#1)
the binding affinity of the##9##5##(1990-5#2)(1991-5#1)(1995-1#1)(1995-2#2)(1996-5#2)(2009-12#1)
the binding affinity of##17##4##(1990-2#1)(1990-5#2)(1991-5#1)(1994-11#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-5#2)(1997-2#1)(2009-12#1)
the binding affinity to the##2##5##(1990-2#1)(1997-3#1)
the binding affinity##33##3##(1990-2#2)(1990-5#3)(1990-7#1)(1991-12#1)(1991-5#1)(1993-11#1)(1994-11#1)(1994-9#2)(1995-1#1)(1995-11#2)(1995-2#3)(1995-3#2)(1995-8#1)(1996-4#1)(1996-5#2)(1997-2#3)(1997-3#1)(1997-5#1)(2006-12#1)(2008-10#1)(2009-12#1)(2013-7#1)
the binding and the##2##4##(1994-12#1)(1995-11#1)
the binding and uptake of##2##5##(1994-5#1)(1995-8#1)
the binding and##15##3##(1990-7#1)(1991-11#1)(1991-9#1)(1992-7#1)(1993-11#2)(1994-12#2)(1994-5#1)(1995-11#1)(1995-2#1)(1995-8#1)(2006-12#1)(2008-10#1)(2008-5#1)
the binding between##5##3##(1994-5#1)(1995-3#1)(2006-2#1)(2009-10#1)(2011-2#1)
the binding by##3##3##(1991-7#1)(1996-6#1)(2008-10#1)
the binding capacities##2##3##(1990-12#1)(2005-11#1)
the binding capacity of the##2##5##(1990-12#1)(1993-4#1)
the binding capacity of##7##4##(1990-12#1)(1990-4#1)(1991-11#1)(1991-5#1)(1992-4#1)(1993-4#1)(2008-8#1)
the binding cavity of##2##4##(1992-6#1)(2013-8#1)
the binding cavity##4##3##(1992-6#1)(1995-8#1)(2010-12#1)(2013-8#1)
the binding characteristics of the##3##5##(1990-3#1)(1990-8#1)(1994-5#1)
the binding characteristics of##12##4##(1990-2#1)(1990-3#1)(1990-8#1)(1991-8#1)(1991-9#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-2#1)(2008-10#2)
the binding characteristics##13##3##(1990-2#1)(1990-3#1)(1990-8#1)(1991-8#1)(1991-9#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-2#1)(2008-10#2)
the binding conditions##2##3##(1991-11#1)(1993-12#1)
the binding constant for##2##4##(1992-3#1)(2008-10#1)
the binding constant of the##3##5##(1990-4#1)(2008-10#2)
the binding constant of##5##4##(1990-4#1)(1994-11#1)(1995-2#1)(2008-10#2)
the binding constant##12##3##(1990-4#1)(1991-2#1)(1992-3#1)(1994-11#1)(1994-5#1)(1995-2#2)(2008-10#5)
the binding constants##4##3##(1992-4#1)(2005-11#1)(2006-12#1)(2008-10#1)
the binding domain##4##3##(1991-5#2)(2008-8#2)
the binding energies of##2##4##(2008-3#1)(2010-7#1)
the binding energies##4##3##(2006-8#1)(2008-3#1)(2010-7#2)
the binding energy of the Cr 2P(3/2) level##2##8##(2008-2#2)
the binding energy of##6##4##(1992-5#1)(1993-8#1)(2006-12#1)(2006-8#1)(2008-2#2)
the binding energy##8##3##(1992-5#1)(1993-8#1)(1994-9#1)(2006-1#1)(2006-12#1)(2006-8#1)(2008-2#2)
the binding event##2##3##(1997-4#1)(2008-4#1)
the binding factor##2##3##(1995-3#2)
the binding interaction##3##3##(1992-12#2)(2008-10#1)
the binding interactions of##2##4##(2006-1#1)(2008-9#1)
the binding interactions##4##3##(2006-1#1)(2008-5#1)(2008-9#1)(2010-11#1)
the binding is##6##3##(1990-12#1)(1990-6#1)(1995-10#1)(1995-3#1)(1996-8#1)(2006-10#1)
the binding kinetics between##2##4##(1997-2#1)(2009-10#1)
the binding kinetics of the##2##5##(2008-4#1)(2010-5#1)
the binding kinetics of##3##4##(2008-4#2)(2010-5#1)
the binding kinetics##6##3##(1997-2#1)(2008-10#1)(2008-4#2)(2009-10#1)(2010-5#1)
the binding mode of##2##4##(1997-1#1)(2013-1#1)
the binding modes##3##3##(1994-11#1)(2010-12#1)(2013-7#1)
the binding number##3##3##(2008-10#3)
the binding of 125I-IGF-II to the IGF-II/Man6P receptor##2##8##(1990-5#2)
the binding of 125I-IGF-II to the receptor##3##7##(1990-5#3)
the binding of 125I-IGF-II to the##5##6##(1990-5#5)
the binding of 125I-labeled##2##4##(1992-3#1)(1995-7#1)
the binding of 2##2##4##(1990-8#1)(1996-6#1)
the binding of 3H-D2S to##2##5##(1995-7#2)
the binding of ADP##2##4##(1990-4#1)(1991-9#1)
the binding of ATP to##2##5##(1991-9#1)(1992-12#1)
the binding of ATP##8##4##(1991-4#1)(1991-5#1)(1991-9#1)(1992-12#1)(1993-6#1)(1993-9#1)(1995-2#1)(1995-3#1)
the binding of CREB to CBP##2##6##(1995-3#2)
the binding of Ca2+##3##4##(1992-3#1)(1994-12#1)(1997-6#1)
the binding of CaM##2##4##(1991-1#1)(1993-6#1)
the binding of FSH##2##4##(1995-11#2)
the binding of GTP or##2##5##(1990-7#1)(1995-5#1)
the binding of GTP##4##4##(1990-7#1)(1992-6#1)(1995-5#1)(1997-6#1)
the binding of [3H]MK-801 was increased in pons and medulla and##2##11##(1997-2#2)
the binding of [3H]MK-801##3##4##(1997-2#3)
the binding of [3H]flunitrazepam to##2##5##(1996-2#2)
the binding of [3H]prazosin to##2##5##(1991-6#2)
the binding of a protein##2##5##(1994-8#1)(1995-2#1)
the binding of a water to##2##6##(2006-8#2)
the binding of a##18##4##(1990-8#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-4#1)(1992-6#1)(1994-8#1)(1995-1#1)(1995-2#2)(2006-12#1)(2006-8#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-4#1)
the binding of all##2##4##(1993-9#1)(1995-7#1)
the binding of an##8##4##(1992-6#1)(1995-1#1)(1996-4#1)(2006-12#1)(2008-4#2)(2012-12#2)
the binding of bFGF to FGFR##2##6##(1994-8#2)
the binding of bFGF to##4##5##(1994-8#4)
the binding of biotin##2##4##(1994-9#1)(2009-9#1)
the binding of both##4##4##(1991-9#1)(1994-9#1)(1995-5#1)(1996-2#1)
the binding of casein kinase I##2##6##(1994-11#2)
the binding of exogenous rabphilin-3A##2##5##(1994-12#2)
the binding of fibrinogen to##2##5##(1995-2#1)(2007-11#1)
the binding of fibrinogen##3##4##(1991-10#1)(1995-2#1)(2007-11#1)
the binding of ligands to##2##5##(1993-6#1)(1996-6#1)
the binding of ligands##6##4##(1993-6#1)(1995-6#1)(1996-11#3)(1996-6#1)
the binding of one##3##4##(1991-1#1)(1991-8#1)(1995-1#1)
the binding of other##3##4##(1993-7#1)(1995-11#1)(2007-1#1)
the binding of oxygen by hemoglobin##2##6##(1996-11#1)(1997-1#1)
the binding of oxygen##3##4##(1993-6#1)(1996-11#1)(1997-1#1)
the binding of plasmid DNA to##2##6##(2008-8#2)
the binding of specific##2##4##(1992-8#1)(1995-3#1)
the binding of the murine##2##5##(1991-11#1)(1995-5#1)
the binding of the protein##3##5##(1992-9#2)(1994-12#1)
the binding of the substrate to the active site##2##9##(1993-6#1)(2006-12#1)
the binding of the substrate##4##5##(1990-12#1)(1990-5#1)(1993-6#1)(2006-12#1)
the binding of the##54##4##(1990-10#1)(1990-11#1)(1990-12#2)(1990-5#2)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#2)(1991-4#1)(1992-4#1)(1992-6#2)(1992-9#2)(1993-4#1)(1993-6#3)(1993-8#1)(1994-12#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#2)(1996-2#1)(1997-1#2)(1997-2#3)(1997-4#1)(1997-5#1)(1997-7#1)(2006-12#2)(2007-11#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2013-1#2)
the binding of these##10##4##(1990-2#1)(1990-4#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#1)(1997-1#1)(2005-11#1)(2005-7#1)
the binding of transcription factors to##2##6##(1994-9#1)(1996-5#1)
the binding of transcription factors##3##5##(1994-9#1)(1996-5#1)(2008-7#1)
the binding of tubulin to##2##5##(1990-5#2)
the binding of two##3##4##(1995-1#1)(1995-3#1)(1996-7#1)
the binding of##417##3##(1990-1#1)(1990-10#5)(1990-11#5)(1990-12#12)(1990-2#3)(1990-3#3)(1990-4#2)(1990-5#13)(1990-6#2)(1990-7#6)(1990-8#7)(1990-9#2)(1991-1#2)(1991-10#3)(1991-11#3)(1991-12#2)(1991-2#6)(1991-3#3)(1991-4#5)(1991-5#3)(1991-6#3)(1991-7#4)(1991-8#5)(1991-9#4)(1992-11#3)(1992-12#4)(1992-3#2)(1992-4#2)(1992-6#6)(1992-8#3)(1992-9#3)(1993-11#1)(1993-3#2)(1993-4#2)(1993-6#10)(1993-7#6)(1993-8#4)(1993-9#7)(1994-10#2)(1994-11#3)(1994-12#8)(1994-3#2)(1994-5#5)(1994-6#1)(1994-8#13)(1994-9#17)(1995-1#10)(1995-10#4)(1995-11#10)(1995-12#2)(1995-2#11)(1995-3#6)(1995-5#6)(1995-6#4)(1995-7#4)(1995-8#3)(1996-1#1)(1996-10#2)(1996-11#5)(1996-12#1)(1996-2#7)(1996-4#1)(1996-5#4)(1996-6#3)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#7)(1997-2#7)(1997-4#3)(1997-5#3)(1997-6#2)(1997-7#6)(1997-8#1)(1997-9#1)(2005-11#2)(2005-7#3)(2006-10#1)(2006-12#7)(2006-6#1)(2006-8#5)(2007-1#1)(2007-11#3)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#2)(2009-12#1)(2009-2#3)(2009-9#1)(2010-10#1)(2010-4#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)
the binding parameters of##2##4##(1992-8#1)(1994-2#1)
the binding parameters##3##3##(1990-6#1)(1992-8#1)(1994-2#1)
the binding partners##2##3##(2009-10#1)(2012-2#1)
the binding pocket of##3##4##(1991-8#1)(1995-11#1)(1997-4#1)
the binding pocket##12##3##(1991-7#1)(1991-8#2)(1992-9#1)(1994-5#1)(1995-11#1)(1996-5#2)(1997-4#1)(2008-4#1)(2009-4#1)(2011-1#1)
the binding polynomial##2##3##(1990-8#1)(1996-11#1)
the binding potential##2##3##(1996-11#2)
the binding process##8##3##(1991-12#1)(1994-8#1)(1994-9#2)(1997-2#1)(2007-8#1)(2008-10#2)
the binding properties of##5##4##(1991-4#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-6#1)
the binding protein for dipeptides and beta-lactam antibiotics of##2##9##(1990-11#2)
the binding protein for dipeptides and beta-lactam antibiotics##3##8##(1990-11#3)
the binding protein for##5##4##(1990-11#4)(1991-10#1)
the binding protein##9##3##(1990-11#4)(1991-10#2)(1994-2#1)(2008-11#1)(2009-10#1)
the binding reaction##8##3##(1990-12#1)(1992-12#1)(1992-9#1)(1995-10#1)(1995-8#1)(2008-10#2)(2008-4#1)
the binding site and the##2##5##(1995-1#1)(2008-9#1)
the binding site and##3##4##(1995-1#1)(1997-4#1)(2008-9#1)
the binding site for the##3##5##(1990-12#1)(1990-7#1)(1995-3#1)
the binding site for##9##4##(1990-12#1)(1990-7#2)(1994-6#1)(1995-3#2)(1997-4#1)(2008-10#1)(2010-10#1)
the binding site in##2##4##(1990-8#1)(2008-10#1)
the binding site may##2##4##(1994-12#1)(2005-7#1)
the binding site of the##8##5##(1990-6#1)(1991-7#1)(1992-11#1)(1992-9#1)(1993-3#1)(1994-9#2)(1995-3#1)
the binding site of##13##4##(1990-6#1)(1991-7#1)(1992-11#1)(1992-9#2)(1993-2#1)(1993-3#1)(1994-9#2)(1995-3#1)(2008-10#1)(2008-5#1)(2008-8#1)
the binding site on##2##4##(1994-11#1)(1994-2#1)
the binding site##50##3##(1990-12#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-7#1)(1992-11#1)(1992-6#1)(1992-9#3)(1993-2#1)(1993-3#1)(1994-11#6)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#4)(1995-1#2)(1995-10#1)(1995-11#1)(1995-3#6)(1996-9#1)(1997-4#2)(2005-7#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2012-2#1)
the binding sites for the##3##5##(1991-2#1)(1991-5#1)(1993-3#1)
the binding sites for##6##4##(1991-2#1)(1991-5#2)(1992-2#1)(1993-11#1)(1993-3#1)
the binding sites in##5##4##(1992-7#1)(2008-4#1)(2011-3#2)(2012-3#1)
the binding sites of the##2##5##(1990-12#1)(2008-10#1)
the binding sites of##4##4##(1990-12#1)(1991-12#1)(1993-3#1)(2008-10#1)
the binding sites on##3##4##(1993-8#1)(2008-4#1)(2010-5#1)
the binding sites##34##3##(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#2)(1992-2#1)(1992-6#2)(1992-7#1)(1993-11#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-5#1)(1995-10#1)(1995-12#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)(2010-5#1)(2011-3#2)(2012-2#1)(2012-3#1)
the binding specificity##3##3##(1993-9#1)(2006-10#1)(2011-1#1)
the binding strength of##2##4##(2007-8#1)(2009-12#1)
the binding strength##3##3##(1990-5#1)(2007-8#1)(2009-12#1)
the binding to DNA##2##4##(1994-6#1)(1996-7#1)
the binding to DREF##2##4##(1995-6#2)
the binding to the##6##4##(1990-7#1)(1991-4#1)(1994-12#1)(1994-9#1)(2009-7#1)(2009-8#1)
the binding to##20##3##(1990-7#1)(1991-4#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-7#2)(1997-4#1)(1997-5#1)(2004-11#1)(2005-8#1)(2008-3#1)(2009-7#1)(2009-8#1)
the binding was##10##3##(1991-4#1)(1993-11#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-5#1)(1996-5#1)(2005-11#1)(2008-2#1)(2010-5#1)
the binding with##2##3##(1990-10#1)(1992-12#1)
the binding##830##2##(1990-1#1)(1990-10#6)(1990-11#9)(1990-12#18)(1990-2#6)(1990-3#4)(1990-4#4)(1990-5#19)(1990-6#5)(1990-7#11)(1990-8#12)(1990-9#3)(1991-1#3)(1991-10#5)(1991-11#6)(1991-12#6)(1991-2#8)(1991-3#3)(1991-4#8)(1991-5#10)(1991-6#3)(1991-7#7)(1991-8#9)(1991-9#7)(1992-11#5)(1992-12#10)(1992-2#3)(1992-3#3)(1992-4#5)(1992-5#1)(1992-6#10)(1992-7#2)(1992-8#4)(1992-9#10)(1993-1#1)(1993-11#8)(1993-12#2)(1993-2#1)(1993-3#5)(1993-4#3)(1993-6#12)(1993-7#6)(1993-8#6)(1993-9#8)(1994-10#2)(1994-11#13)(1994-12#13)(1994-2#6)(1994-3#3)(1994-5#12)(1994-6#4)(1994-8#14)(1994-9#28)(1995-1#13)(1995-10#8)(1995-11#16)(1995-12#6)(1995-2#22)(1995-3#22)(1995-5#8)(1995-6#7)(1995-7#4)(1995-8#11)(1995-9#2)(1996-1#1)(1996-10#3)(1996-11#9)(1996-12#3)(1996-2#11)(1996-4#3)(1996-5#12)(1996-6#4)(1996-7#4)(1996-8#2)(1996-9#3)(1997-1#9)(1997-2#18)(1997-3#2)(1997-4#10)(1997-5#5)(1997-6#3)(1997-7#8)(1997-8#1)(1997-9#1)(2004-11#1)(2005-11#6)(2005-7#4)(2005-8#1)(2006-1#2)(2006-10#6)(2006-12#11)(2006-2#1)(2006-6#1)(2006-8#8)(2007-1#1)(2007-11#3)(2007-6#1)(2007-8#4)(2008-1#2)(2008-10#52)(2008-11#8)(2008-12#1)(2008-2#6)(2008-3#5)(2008-4#14)(2008-5#12)(2008-6#1)(2008-7#3)(2008-8#12)(2008-9#5)(2009-10#4)(2009-11#1)(2009-12#3)(2009-2#4)(2009-4#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#3)(2010-7#3)(2011-1#4)(2011-2#2)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
the bindings of##2##3##(1992-6#1)(2008-3#1)
the binge and##2##3##(2006-12#1)(2006-7#1)
the binge##4##2##(2006-12#2)(2006-7#1)(2008-4#1)
the binomial distribution##6##3##(2008-10#6)
the binomial variance method with exact confidence limits##2##8##(1994-5#2)
the binomial variance##3##3##(1994-5#3)
the binomial##13##2##(1994-5#4)(1995-8#1)(2008-10#8)
the binormal assumption##3##3##(1997-3#3)
the binormal model##3##3##(1996-7#2)(1997-3#1)
the binormal##7##2##(1996-7#2)(1997-3#5)
the binuclear center##4##3##(1991-7#1)(1995-1#2)(1995-2#1)
the binuclear centre##2##3##(1997-7#2)
the binuclear derivative##2##3##(1992-9#2)
the binuclear##11##2##(1991-4#1)(1991-7#1)(1992-9#3)(1995-1#2)(1995-2#1)(1997-6#1)(1997-7#2)
the bio-oils##3##2##(2008-5#3)
the bioaccumulation of##2##3##(2008-12#2)
the bioaccumulation##3##2##(2008-11#1)(2008-12#2)
the bioactivation of##2##3##(1994-2#1)(1994-8#1)
the bioactivation##3##2##(1994-2#1)(1994-8#2)
the bioactive conformation of##2##4##(1996-9#1)(2006-12#1)
the bioactive conformation##3##3##(1996-9#1)(1997-1#1)(2006-12#1)
the bioactive form##2##3##(1995-7#1)(2013-1#1)
the bioactive##20##2##(1991-8#1)(1992-12#1)(1994-8#1)(1995-7#1)(1996-9#1)(1997-1#1)(2006-12#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-7#2)(2010-11#1)(2011-1#2)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
the bioactivity of##5##3##(1992-11#1)(2005-8#1)(2008-4#1)(2008-5#1)(2011-3#1)
the bioactivity##8##2##(1990-11#1)(1992-11#1)(1993-4#1)(2005-8#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-3#1)
the bioanalytical##3##2##(2008-10#3)
the bioassay and##2##3##(2008-10#2)
the bioassay with##2##3##(2010-10#1)(2013-7#1)
the bioassay##12##2##(1991-8#1)(1991-9#2)(2007-8#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2010-10#1)(2013-7#1)
the bioavailability and##2##3##(2008-10#1)(2008-11#1)
the bioavailability of plasma uridine##2##5##(1996-6#2)
the bioavailability of the##2##4##(1996-4#1)(2008-10#1)
the bioavailability of##22##3##(1992-1#1)(1993-12#1)(1996-4#2)(1996-6#3)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#2)(2009-12#1)(2010-1#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#2)
the bioavailability##26##2##(1992-1#1)(1993-12#1)(1996-4#2)(1996-6#3)(1997-8#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#2)(2009-12#1)(2010-1#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#2)
the bioavailable##2##2##(1994-10#1)(1995-9#1)
the biobead #1 reactor##2##4##(2007-12#2)
the biobead #2 reactor##2##4##(2007-12#2)
the biobead #2##3##3##(2007-12#3)
the biobead##8##2##(2007-12#8)
the biocatalyst##5##2##(1991-5#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)
the biocatalytic##4##2##(2008-10#3)(2010-4#1)
the biochemical and##11##3##(1993-8#1)(1994-10#1)(1994-11#1)(1994-8#1)(1995-2#1)(1997-2#1)(2008-1#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-2#1)
the biochemical basis for##3##4##(2007-11#1)(2009-8#1)(2009-9#1)
the biochemical basis of##2##4##(1990-8#1)(1997-1#1)
the biochemical basis##5##3##(1990-8#1)(1997-1#1)(2007-11#1)(2009-8#1)(2009-9#1)
the biochemical characteristics of##2##4##(1992-8#1)(1997-6#1)
the biochemical characterization of##2##4##(1995-5#1)(1996-5#1)
the biochemical composition##3##3##(2008-11#1)(2012-12#2)
the biochemical data##2##3##(2008-10#1)(2012-12#1)
the biochemical diagnosis of##4##4##(1994-9#1)(1997-1#2)(2007-5#1)
the biochemical differentiation of##2##4##(1990-7#2)
the biochemical differentiation##3##3##(1990-7#2)(1994-3#1)
the biochemical effects of##4##4##(1993-8#1)(2006-10#1)(2008-5#1)(2010-1#1)
the biochemical function of##2##4##(2011-2#2)
the biochemical function##3##3##(2008-9#1)(2011-2#2)
the biochemical functions of##2##4##(1990-11#1)(2007-8#1)
the biochemical markers of##2##4##(1993-8#1)(2013-8#1)
the biochemical mechanism##3##3##(1995-3#1)(2010-7#2)
the biochemical mechanisms of##3##4##(1993-9#1)(1997-6#1)(2004-11#1)
the biochemical mechanisms##6##3##(1990-6#1)(1993-9#1)(1997-2#1)(1997-6#1)(2004-11#1)(2011-1#1)
the biochemical nature of the##2##5##(1997-2#1)(2008-6#1)
the biochemical parameters of the##2##5##(2008-7#1)(2009-4#1)
the biochemical parameters of##4##4##(1992-1#1)(2008-7#1)(2009-4#1)(2009-6#1)
the biochemical pathways and##2##4##(2011-1#2)
the biochemical pathways##4##3##(2006-8#1)(2011-1#2)(2013-1#1)
the biochemical processes##2##3##(2008-7#1)(2009-8#1)
the biochemical properties and##3##4##(1995-6#1)(1997-7#1)(2008-9#1)
the biochemical properties of the##2##5##(1990-4#1)(2009-3#1)
the biochemical properties of##8##4##(1990-4#1)(1992-11#1)(1994-8#1)(1995-11#1)(1997-4#1)(2006-7#1)(2009-3#1)(2012-12#1)
the biochemical properties##11##3##(1990-4#1)(1992-11#1)(1994-8#1)(1995-11#1)(1995-6#1)(1997-4#1)(1997-7#1)(2006-7#1)(2008-9#1)(2009-3#1)(2012-12#1)
the biochemical##123##2##(1990-11#1)(1990-4#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-5#1)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#4)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-5#1)(1997-1#5)(1997-2#3)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#1)(2006-10#4)(2006-12#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-4#4)(2010-7#2)(2011-1#3)(2011-2#4)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
the biochemistry and physiological role of##2##6##(2008-11#1)(2012-3#1)
the biochemistry and##6##3##(2008-11#1)(2009-6#1)(2010-4#1)(2012-2#2)(2012-3#1)
the biochemistry of##5##3##(1992-3#1)(1995-12#1)(2005-7#1)(2007-12#1)(2008-8#1)
the biochemistry##13##2##(1992-3#1)(1995-12#1)(1997-8#1)(2005-7#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-8#1)(2009-6#1)(2010-4#1)(2012-2#2)(2012-3#1)
the biocide##3##2##(1993-12#1)(2008-7#1)(2013-7#1)
the biocompatibility and##3##3##(2008-5#1)(2010-7#1)(2013-8#1)
the biocompatibility of implantable devices##2##5##(2009-11#2)
the biocompatibility of the##2##4##(2008-5#1)(2012-2#1)
the biocompatibility of##8##3##(2008-11#1)(2008-5#2)(2008-7#1)(2009-11#3)(2012-2#1)
the biocompatibility##13##2##(2007-2#1)(2008-11#1)(2008-5#4)(2008-7#1)(2009-11#3)(2010-7#1)(2012-2#1)(2013-8#1)
the biocompatible##2##2##(2007-6#1)(2008-10#1)
the bioconsolidation##2##2##(2008-5#2)
the biocontrol activity of CHA0##2##5##(2008-10#2)
the biocontrol activity of##5##4##(2008-10#5)
the biocontrol agent Trichoderma##2##4##(2008-10#2)
the biocontrol agent was##2##4##(2008-10#2)
the biocontrol agent##9##3##(2008-10#9)
the biocontrol agents##6##3##(2008-10#6)
the biocontrol fungus Trichoderma##3##4##(2008-10#3)
the biocontrol isolates were##3##4##(2008-10#3)
the biocontrol isolates##5##3##(2008-10#5)
the biocontrol strain##2##3##(2008-10#2)
the biocontrol##37##2##(2008-10#37)
the bioconversion of##2##3##(1994-12#1)(2011-1#1)
the bioconversion##6##2##(1994-12#1)(2008-6#1)(2009-6#1)(2011-1#1)(2012-2#2)
the biodegradability and##2##3##(1992-5#1)(2008-5#1)
the biodegradability of##2##3##(2009-6#2)
the biodegradability##4##2##(1992-5#1)(2008-5#1)(2009-6#2)
the biodegradable##4##2##(2004-12#1)(2008-12#1)(2009-12#2)
the biodegradation of##9##3##(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-3#2)
the biodiesel##2##2##(2008-5#1)(2009-3#1)
the biodistribution##4##2##(2007-10#1)(2008-3#1)(2008-5#2)
the biodiversity community##2##3##(2012-3#2)
the biodiversity of##2##3##(2005-11#1)(2008-8#1)
the biodiversity##8##2##(2005-11#1)(2007-11#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#3)
the bioenergetics of the##2##4##(2008-1#2)
the bioenergetics##3##2##(2008-1#2)(2011-12#1)
the bioengineering##2##2##(2008-5#1)(2010-9#1)
the bioequivalence of two##2##4##(1993-6#1)(2008-6#1)
the bioequivalence of##3##3##(1993-6#1)(1996-2#1)(2008-6#1)
the bioequivalence##4##2##(1993-6#1)(1996-2#1)(2004-12#1)(2008-6#1)
the bioethical##2##2##(2006-8#1)(2007-10#1)
the biofidelic##4##2##(2006-11#4)
the biofidelity of the##3##4##(2006-11#1)(2007-1#1)(2007-4#1)
the biofidelity of##8##3##(2006-11#3)(2007-1#1)(2007-4#4)
the biofidelity tests##4##3##(2006-11#4)
the biofidelity##16##2##(2006-11#10)(2007-1#1)(2007-4#5)
the biofilm formation##3##3##(2009-6#1)(2013-1#1)(2013-8#1)
the biofilm were##2##3##(2008-7#2)
the biofilm##17##2##(1995-12#2)(2008-7#7)(2009-4#1)(2009-6#1)(2012-2#1)(2013-1#3)(2013-8#2)
the biofilms##5##2##(2007-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2013-8#1)
the biofouling##2##2##(2005-11#1)(2008-2#1)
the biogas were##2##3##(2008-5#1)(2013-1#1)
the biogenesis of this organelle##2##5##(2007-8#1)(2008-11#1)
the biogenesis of##10##3##(1991-10#1)(1994-8#1)(1995-3#1)(1997-2#2)(2007-8#1)(2008-11#1)(2010-5#1)(2011-2#1)(2013-1#1)
the biogenesis##12##2##(1991-10#1)(1994-8#1)(1995-3#1)(1997-2#2)(2007-8#2)(2008-11#1)(2009-2#1)(2010-5#1)(2011-2#1)(2013-1#1)
the biogenic##2##2##(1992-3#1)(2008-7#1)
the biogeochemical cycling of##2##4##(2008-10#2)
the biogeochemical##6##2##(2006-3#1)(2008-10#3)(2008-5#2)
the biogeochemistry of##2##3##(1991-11#1)(2008-10#1)
the biogeographical##2##2##(2007-3#1)(2008-9#1)
the biography of##2##3##(2007-8#1)(2008-1#1)
the bioinformatics community##2##3##(2008-4#1)(2008-7#1)
the bioinformatics##5##2##(2008-4#2)(2008-7#3)
the biolistic method##2##3##(2006-12#1)(2010-5#1)
the biolistic##3##2##(2006-12#2)(2010-5#1)
the biologic activity of##3##4##(1991-10#1)(1995-3#1)(1995-5#1)
the biologic##13##2##(1991-10#1)(1991-4#1)(1992-10#1)(1994-6#1)(1995-3#1)(1995-5#1)(1997-3#1)(2006-10#1)(2007-12#1)(2008-9#1)(2013-1#3)
the biological action of##7##4##(1992-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-10#1)(2013-7#1)
the biological actions##2##3##(1990-5#1)(1993-2#1)
the biological activities and##3##4##(1997-2#1)(2006-12#1)(2011-3#1)
the biological activities of the##4##5##(1990-9#1)(2010-5#1)(2013-8#2)
the biological activities of##11##4##(1990-9#1)(1994-11#1)(1996-7#1)(1997-7#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-5#1)(2013-8#2)
the biological activities##16##3##(1990-9#1)(1992-6#1)(1994-11#1)(1995-3#1)(1996-7#1)(1997-2#1)(1997-7#1)(2006-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-3#1)(2013-8#2)
the biological activity and##3##4##(1997-6#1)(2006-8#1)(2008-5#1)
the biological activity of human##2##5##(1991-7#1)(2008-9#1)
the biological activity of the##8##5##(1992-2#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-8#1)(2009-3#2)(2009-4#1)
the biological activity of this##2##5##(1992-2#1)(1992-8#1)
the biological activity of##34##4##(1990-12#2)(1990-5#1)(1990-9#1)(1991-7#1)(1992-2#2)(1992-6#1)(1992-8#2)(1994-3#1)(1994-8#1)(1995-2#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-7#2)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#2)(2009-3#2)(2009-4#1)(2009-8#1)(2012-2#1)
the biological activity##53##3##(1990-12#2)(1990-5#1)(1990-7#1)(1990-9#1)(1991-7#1)(1992-1#1)(1992-2#2)(1992-5#1)(1992-6#1)(1992-8#4)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-4#1)(1997-2#1)(1997-4#3)(1997-6#1)(1997-7#2)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#3)(2008-9#2)(2009-3#3)(2009-4#1)(2009-8#1)(2010-12#1)(2010-6#1)(2012-2#2)
the biological and genetic##2##4##(2008-7#1)(2008-9#1)
the biological and molecular##2##4##(2006-10#1)(2008-10#1)
the biological and social##2##4##(1991-6#1)(2008-2#1)
the biological and##18##3##(1990-7#1)(1990-9#1)(1991-1#1)(1991-6#1)(2005-7#1)(2006-10#1)(2006-7#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2012-2#1)
the biological aspects##2##3##(2012-12#1)(2012-3#1)
the biological basis for##2##4##(2007-11#1)(2007-12#1)
the biological basis of this##2##5##(1994-2#1)(2013-1#1)
the biological basis of##9##4##(1993-9#1)(1994-2#1)(2006-7#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
the biological basis##11##3##(1993-9#1)(1994-2#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
the biological behavior of this disease and##2##7##(1996-6#1)(2013-8#1)
the biological behavior of##9##4##(1995-10#1)(1996-6#1)(2006-10#1)(2007-10#1)(2009-11#1)(2013-1#1)(2013-7#1)(2013-8#2)
the biological behaviour of the##2##5##(1997-2#1)(2008-7#1)
the biological behaviour of##5##4##(1993-6#1)(1997-2#1)(2007-12#1)(2008-5#1)(2008-7#1)
the biological behaviour##6##3##(1993-6#1)(1997-2#1)(2007-12#1)(2008-5#1)(2008-7#1)(2009-4#1)
the biological characteristics of##6##4##(1992-8#1)(2006-10#1)(2007-8#1)(2008-4#1)(2008-5#1)(2013-8#1)
the biological characteristics##7##3##(1992-8#1)(2006-10#1)(2007-8#1)(2008-4#1)(2008-5#1)(2013-8#2)
the biological clock##5##3##(1994-5#1)(1997-5#1)(2008-1#3)
the biological coefficient of variation##2##5##(1993-8#1)(1995-6#1)
the biological consequences of##6##4##(1997-7#1)(2008-4#2)(2008-7#2)(2009-3#1)
the biological control activity##2##4##(2008-10#2)
the biological control agent##3##4##(2008-10#2)(2008-5#1)
the biological control of##12##4##(2006-10#1)(2007-12#1)(2008-10#9)(2008-8#1)
the biological control##21##3##(2006-10#1)(2007-12#1)(2008-10#15)(2008-5#1)(2008-8#2)(2011-2#1)
the biological effect of the##2##5##(2007-8#1)(2008-10#1)
the biological effect of##7##4##(1991-12#1)(1996-12#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-8#1)
the biological effectiveness##2##3##(1991-4#1)(2008-11#1)
the biological effects and##2##4##(1995-2#1)(2011-2#1)
the biological effects of this##2##5##(2008-6#1)(2011-2#1)
the biological effects of##11##4##(1994-3#1)(1995-6#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2011-1#2)(2011-2#1)
the biological effects##14##3##(1994-3#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-8#1)(2011-1#2)(2011-2#2)
the biological environment##2##3##(2008-5#1)(2009-4#1)
the biological factors##2##3##(2006-9#1)(2007-8#1)
the biological fluid##2##3##(1990-11#1)(2007-8#1)
the biological function of the##2##5##(1991-3#1)(2008-7#1)
the biological function of##12##4##(1991-2#1)(1991-3#1)(1994-11#2)(1994-9#1)(1995-1#1)(1995-8#1)(1996-8#1)(2008-7#1)(2009-5#1)(2012-11#1)(2012-3#1)
the biological function##14##3##(1991-2#1)(1991-3#1)(1994-11#2)(1994-9#1)(1995-1#1)(1995-8#1)(1996-5#1)(1996-8#1)(2008-4#1)(2008-7#1)(2009-5#1)(2012-11#1)(2012-3#1)
the biological functions of DC##2##5##(2009-9#2)
the biological functions of##10##4##(1991-5#2)(1992-12#1)(1993-11#1)(1995-5#1)(2008-5#1)(2009-11#1)(2009-9#3)
the biological functions##11##3##(1991-5#2)(1992-12#1)(1993-11#1)(1995-3#1)(1995-5#1)(2008-5#1)(2009-11#1)(2009-9#3)
the biological importance of##5##4##(1990-3#1)(1992-6#1)(2008-10#2)(2012-3#1)
the biological markers##2##3##(1991-11#1)(1993-2#1)
the biological material##2##3##(1993-2#1)(2008-10#1)
the biological mechanisms##2##3##(2007-5#1)(2007-8#1)
the biological monitoring of##3##4##(1990-12#1)(1994-6#1)(2008-10#1)
the biological network##2##3##(2008-11#1)(2010-12#1)
the biological neural##2##3##(2008-11#1)(2008-2#1)
the biological pathways##3##3##(2008-11#1)(2008-4#1)(2010-2#1)
the biological plausibility##2##3##(2006-2#1)(2011-12#1)
the biological processes##6##3##(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-5#1)
the biological properties of##6##4##(1993-9#1)(2004-2#1)(2008-5#1)(2009-7#1)(2010-3#1)(2013-8#1)
the biological properties##7##3##(1993-9#1)(2004-2#1)(2007-11#1)(2008-5#1)(2009-7#1)(2010-3#1)(2013-8#1)
the biological question##2##3##(2006-10#1)(2012-3#1)
the biological rationale for##2##4##(2010-10#1)(2011-2#1)
the biological relevance of##5##4##(1990-2#1)(1995-3#1)(1997-1#1)(2008-7#1)(2009-8#1)
the biological response to##3##4##(1996-8#1)(2007-11#1)(2008-8#1)
the biological response##4##3##(1996-8#1)(2007-11#1)(2008-5#1)(2008-8#1)
the biological role of the##2##5##(2008-5#1)(2011-1#1)
the biological role of##9##4##(1993-6#1)(1995-2#1)(2004-12#1)(2006-2#1)(2008-1#1)(2008-4#2)(2008-5#1)(2011-1#1)
the biological sample##5##3##(1997-8#1)(2007-11#1)(2008-10#2)(2008-7#1)
the biological samples##6##3##(1993-11#1)(1996-5#1)(2008-10#3)(2010-9#1)
the biological sciences##2##3##(1991-5#1)(2008-12#1)
the biological significance of the##6##5##(1996-3#1)(1997-2#1)(1997-5#1)(2007-3#1)(2010-12#1)(2012-3#1)
the biological significance of these##2##5##(2008-7#1)(2010-11#1)
the biological significance of##11##4##(1990-9#1)(1996-3#1)(1997-2#1)(1997-5#1)(2007-3#1)(2008-10#1)(2008-7#1)(2010-11#1)(2010-12#1)(2012-2#1)(2012-3#1)
the biological source##3##3##(1996-8#1)(2008-1#1)(2012-12#1)
the biological study of##2##4##(2008-3#1)(2012-2#1)
the biological system##4##3##(2007-6#1)(2007-9#1)(2008-10#1)(2008-5#1)
the biological##417##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#2)(1990-9#4)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#4)(1991-5#3)(1991-6#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#2)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#6)(1992-9#1)(1993-11#2)(1993-2#4)(1993-6#2)(1993-8#2)(1993-9#2)(1994-11#3)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#2)(1995-10#1)(1995-2#3)(1995-3#4)(1995-5#2)(1995-6#2)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#4)(1997-1#1)(1997-2#5)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#4)(1997-8#1)(2004-12#1)(2004-2#1)(2005-10#1)(2005-11#2)(2005-7#2)(2006-10#6)(2006-12#2)(2006-2#2)(2006-4#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#4)(2007-11#11)(2007-12#5)(2007-2#1)(2007-3#1)(2007-5#2)(2007-6#2)(2007-8#5)(2007-9#2)(2008-1#7)(2008-10#48)(2008-11#9)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#13)(2008-5#20)(2008-6#2)(2008-7#10)(2008-8#10)(2008-9#4)(2009-11#2)(2009-2#2)(2009-3#4)(2009-4#3)(2009-5#4)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#4)(2010-10#2)(2010-11#1)(2010-12#6)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#4)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#10)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#7)(2012-3#7)(2013-1#8)(2013-7#2)(2013-8#11)
the biologically active form##2##4##(1995-3#1)(2008-3#1)
the biologically active##12##3##(1990-12#1)(1992-5#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-3#1)(2006-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-5#1)(2013-8#1)
the biologically important##2##3##(1991-2#1)(2008-4#1)
the biologically##24##2##(1990-12#1)(1991-2#1)(1992-5#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-3#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-8#1)(2008-9#1)(2010-5#1)(2012-3#1)(2013-8#1)
the biologist to##2##3##(2008-11#1)(2008-7#1)
the biologist##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
the biology and ecology of##2##5##(2008-10#1)(2008-5#1)
the biology and ecology##3##4##(2008-10#1)(2008-5#1)(2008-8#1)
the biology and##19##3##(1992-8#1)(1993-11#1)(2006-10#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-6#2)(2008-8#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
the biology of microglia##2##4##(2007-11#2)
the biology of the##17##4##(1991-6#1)(1994-8#1)(2006-10#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-3#1)(2013-7#1)
the biology of this##4##4##(2006-10#1)(2008-6#1)(2008-7#1)(2012-12#1)
the biology of##61##3##(1991-6#1)(1993-12#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-4#1)(1997-3#1)(2005-2#1)(2006-10#4)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#3)(2009-10#2)(2009-5#1)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
the biology underlying##2##3##(2006-10#1)(2006-11#1)
the biology##91##2##(1991-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-4#1)(1997-3#1)(2005-2#1)(2005-9#1)(2006-10#6)(2006-11#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#2)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#5)(2008-8#4)(2009-10#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#2)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)
the bioluminescence inhibition of##3##4##(2008-10#3)
the bioluminescence inhibition##4##3##(2008-10#4)
the bioluminescence##5##2##(2008-10#4)(2011-1#1)
the biomarker##6##2##(2008-11#1)(2008-8#1)(2010-1#1)(2010-5#1)(2010-8#1)(2010-9#1)
the biomass and##5##3##(1991-11#1)(2005-11#1)(2007-12#1)(2008-12#2)
the biomass of##10##3##(2005-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)(2013-8#2)
the biomass##39##2##(1991-11#1)(1996-2#1)(2005-11#2)(2006-5#1)(2006-8#1)(2007-12#1)(2007-6#1)(2008-10#7)(2008-12#2)(2008-3#1)(2008-5#6)(2008-7#5)(2008-8#3)(2008-9#1)(2013-1#2)(2013-8#4)
the biomaterial##3##2##(2008-10#1)(2009-12#1)(2010-6#1)
the biomaterials##3##2##(2006-6#1)(2008-11#1)(2008-5#1)
the biomechanical assessment of##2##4##(2010-9#1)(2012-1#1)
the biomechanical behaviour of the cornea##2##6##(2006-7#1)(2008-7#1)
the biomechanical behaviour of##3##4##(2006-7#1)(2008-7#1)(2011-2#1)
the biomechanical effects of##4##4##(2006-11#1)(2007-4#1)(2013-1#2)
the biomechanical properties of the graft##2##6##(2013-1#2)
the biomechanical properties of the##5##5##(2007-1#1)(2008-9#1)(2009-8#1)(2013-1#2)
the biomechanical properties of##9##4##(2006-8#1)(2007-1#1)(2008-5#1)(2008-9#2)(2009-3#1)(2009-8#1)(2013-1#2)
the biomechanical properties##10##3##(2006-8#1)(2007-1#1)(2008-5#2)(2008-9#2)(2009-3#1)(2009-8#1)(2013-1#2)
the biomechanical response##3##3##(2006-11#3)
the biomechanical##39##2##(1993-3#1)(2006-11#5)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-9#1)(2011-2#2)(2012-1#2)(2013-1#7)
the biomechanics of the##3##4##(2005-7#1)(2007-7#1)(2013-1#1)
the biomechanics of##6##3##(1991-8#1)(2005-7#1)(2007-7#1)(2013-1#3)
the biomechanics##7##2##(1991-8#1)(2005-7#1)(2007-7#1)(2010-3#1)(2013-1#3)
the biomedical domain##4##3##(2008-7#4)
the biomedical field##5##3##(2008-5#2)(2009-12#1)(2011-1#2)
the biomedical literature##4##3##(2008-7#1)(2012-2#1)(2013-1#2)
the biomedical signal##2##3##(2010-8#1)(2013-1#1)
the biomedical##29##2##(1990-12#1)(2006-2#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-5#3)(2008-7#6)(2009-12#1)(2009-6#1)(2010-8#1)(2011-1#2)(2012-2#2)(2012-8#1)(2013-1#6)
the biomes##2##2##(2008-9#1)(2010-3#1)
the biometric##4##2##(2006-10#1)(2009-2#2)(2011-1#1)
the biomolecular##3##2##(1991-9#1)(2008-1#1)(2008-7#1)
the biomolecule##4##2##(2007-10#1)(2007-11#1)(2008-2#1)(2008-5#1)
the biomolecules##6##2##(2008-10#1)(2008-9#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-8#1)
the biomonitoring##2##2##(2008-11#1)(2011-2#1)
the bioparticle##2##2##(2008-6#1)(2008-7#1)
the biopharmaceutical##2##2##(2008-11#1)(2012-2#1)
the biophysical and##2##3##(1995-8#1)(2008-5#1)
the biophysical consequences of the##2##5##(2008-8#2)
the biophysical properties of the##2##5##(1994-5#1)(1997-6#1)
the biophysical properties of##4##4##(1991-4#1)(1994-5#1)(1997-1#1)(1997-6#1)
the biophysical##16##2##(1991-4#1)(1994-5#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-6#1)(2006-11#1)(2006-12#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-8#2)(2009-9#1)
the biopolymer and a##2##4##(1997-8#1)(2005-11#1)
the biopolymer and##3##3##(1997-8#2)(2005-11#1)
the biopolymer##9##2##(1997-8#4)(2005-11#1)(2006-12#1)(2008-10#1)(2008-11#1)(2010-9#1)
the biopolymers##2##2##(1995-2#1)(2005-11#1)
the biopreparation induced##2##3##(2007-12#2)
the biopreparation treatments and the older control treatment##2##8##(2008-10#2)
the biopreparation##4##2##(2007-12#2)(2008-10#2)
the bioprocess##3##2##(1994-2#1)(2008-5#1)(2008-6#1)
the biopsied##2##2##(2008-5#1)(2012-2#1)
the biopsies were##3##3##(1991-11#1)(2005-12#1)(2007-12#1)
the biopsies##16##2##(1990-11#1)(1991-11#1)(1992-10#1)(1994-1#1)(1994-6#1)(1996-12#1)(2005-12#1)(2007-12#1)(2007-7#2)(2008-1#3)(2008-11#1)(2008-9#1)(2010-2#1)
the biopsy material##2##3##(1993-10#1)(2007-5#1)
the biopsy specimen##4##3##(2007-10#1)(2007-8#1)(2009-3#1)(2010-12#1)
the biopsy specimens##2##3##(2004-1#1)(2007-7#1)
the biopsy##23##2##(1990-1#1)(1991-2#3)(1992-1#1)(1993-10#2)(2004-1#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-3#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)
the biopsychosocial model##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
the biopsychosocial##4##2##(2008-10#1)(2008-6#1)(2012-2#1)(2013-8#1)
the bioreactor and##2##3##(2007-1#1)(2007-8#1)
the bioreactor by##2##3##(2008-11#1)(2009-4#1)
the bioreactor was##2##3##(2008-11#1)(2008-6#1)
the bioreactor##30##2##(1994-5#1)(2005-11#1)(2007-1#1)(2007-8#2)(2008-11#17)(2008-6#1)(2008-7#3)(2009-4#1)(2010-5#1)(2011-2#1)(2012-2#1)
the bioremediation of##3##3##(2004-4#1)(2006-12#1)(2011-1#1)
the bioremediation##6##2##(2004-4#3)(2006-12#1)(2011-1#2)
the biosafety##3##2##(2008-11#1)(2008-8#1)(2012-12#1)
the biosensor are##2##3##(2008-10#1)(2008-4#1)
the biosensor for##3##3##(2008-10#3)
the biosensor is##2##3##(2007-8#1)(2008-10#1)
the biosensor performance##2##3##(1994-8#1)(2008-10#1)
the biosensor was##4##3##(2008-10#4)
the biosensor##55##2##(1994-8#1)(2007-8#4)(2008-10#49)(2008-4#1)
the biosensors were##2##3##(2008-10#2)
the biosensors##11##2##(2007-8#2)(2008-10#9)
the biosorbents##3##2##(2005-11#3)
the biosorption##3##2##(2011-2#2)(2012-2#1)
the biosphere##3##2##(1997-4#1)(2006-7#1)(2011-12#1)
the biosynthesis and the##2##4##(1992-11#1)(1997-8#1)
the biosynthesis and##5##3##(1992-11#1)(1992-2#1)(1997-8#1)(2007-5#1)(2007-8#1)
the biosynthesis of a##3##4##(1990-1#1)(1990-5#1)(2008-8#1)
the biosynthesis of active##2##4##(1994-5#1)(2012-3#1)
the biosynthesis of cholesterol##2##4##(1997-1#1)(2008-5#1)
the biosynthesis of plant##2##4##(1996-5#1)(2009-10#1)
the biosynthesis of tetrahydrobiopterin (BH4)##2##5##(1992-12#1)(1997-5#1)
the biosynthesis of tetrahydrobiopterin##4##4##(1991-3#1)(1992-1#1)(1992-12#1)(1997-5#1)
the biosynthesis of the##14##4##(1990-9#1)(1991-12#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-3#2)(1996-3#1)(2008-10#2)(2008-7#1)(2011-2#1)
the biosynthesis of these##4##4##(1990-3#1)(1994-11#1)(1994-8#1)(2006-12#1)
the biosynthesis of this##4##4##(1992-12#2)(2009-8#2)
the biosynthesis of##93##3##(1990-1#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-11#2)(1992-12#4)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-5#1)(1994-8#4)(1994-9#2)(1995-1#2)(1995-2#1)(1995-3#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-5#2)(2006-12#8)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-6#1)(2009-8#3)(2010-5#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
the biosynthesis##105##2##(1990-1#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-11#4)(1992-12#4)(1992-2#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-5#1)(1994-8#4)(1994-9#2)(1995-1#2)(1995-2#1)(1995-3#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-5#2)(1997-8#1)(2005-7#1)(2006-12#9)(2007-5#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-5#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
the biosynthetic and endocytic pathways##2##5##(2008-1#1)(2012-2#1)
the biosynthetic and##4##3##(1994-3#1)(2006-10#1)(2008-1#1)(2012-2#1)
the biosynthetic pathway to the##2##5##(1991-2#1)(1994-8#1)
the biosynthetic pathway##8##3##(1991-2#1)(1993-9#1)(1994-8#1)(1997-4#1)(1997-6#1)(2006-12#1)(2007-5#1)(2008-1#1)
the biosynthetic##24##2##(1990-12#1)(1991-2#1)(1993-11#1)(1993-5#3)(1993-9#1)(1994-3#1)(1994-8#1)(1995-3#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-5#1)(2007-8#2)(2008-1#2)(2010-1#1)(2010-10#1)(2012-2#1)
the biotech industry##2##3##(2008-11#2)
the biotech##3##2##(1996-11#1)(2008-11#2)
the biotechnological##3##2##(2008-6#1)(2011-1#2)
the biotechnology and pharmaceutical industries##2##5##(2005-8#1)(2009-3#1)
the biotechnology industry##5##3##(2007-11#1)(2008-10#2)(2008-7#2)
the biotechnology##9##2##(2005-8#1)(2006-4#1)(2007-11#1)(2008-10#2)(2008-7#2)(2009-3#1)(2010-2#1)
the biotic##4##2##(2008-10#1)(2008-12#1)(2008-7#1)(2009-3#1)
the biotin and##2##3##(1990-2#1)(1997-3#1)
the biotin is##2##3##(2008-10#1)(2008-4#1)
the biotin##14##2##(1990-12#1)(1990-2#1)(1991-10#1)(1992-6#4)(1994-8#2)(1997-3#1)(2008-10#3)(2008-4#1)
the biotin/avidin interaction##2##3##(2008-10#2)
the biotinyl protease##2##3##(1990-12#2)
the biotinylated DNA##2##3##(1995-8#1)(2008-4#1)
the biotinylated polypyrrole/avidin assembly##2##4##(2008-10#2)
the biotinylated protein##2##3##(1992-6#1)(2005-11#1)
the biotinylated target protein##3##4##(1990-12#3)
the biotinylated##15##2##(1990-12#3)(1992-6#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-5#1)(2005-11#1)(2008-10#3)(2008-4#3)
the biotinylation of the cap structure##2##6##(1997-2#2)
the biotinylation of##4##3##(1996-11#1)(1997-2#2)(2008-4#1)
the biotransformation of xenobiotics##2##4##(1990-6#1)(2008-11#1)
the biotransformation of##11##3##(1990-6#1)(1992-1#1)(1992-2#1)(1993-2#1)(1995-6#1)(1996-5#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#2)
the biotransformation##14##2##(1990-6#1)(1992-1#1)(1992-2#1)(1993-2#1)(1995-6#1)(1996-5#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2013-1#1)
the biotrophic fungus##2##3##(2008-10#2)
the biotype of##3##3##(2007-7#2)(2009-8#1)
the biotype##4##2##(2007-7#2)(2009-8#1)(2012-2#1)
the biovolume##3##2##(2008-11#3)
the bipartite##7##2##(1992-3#1)(1994-12#1)(1995-1#1)(2008-10#4)
the biphasic effect##2##3##(1993-7#1)(2006-10#1)
the biphasic##8##2##(1992-1#1)(1993-7#1)(1995-3#1)(1997-3#1)(2005-11#1)(2006-10#1)(2008-4#1)(2008-5#1)
the biphosphonate##2##2##(1991-11#1)(2013-1#1)
the bipolar group##3##3##(1997-8#3)
the bipolar lipid##2##3##(1991-9#2)
the bipolar##14##2##(1991-6#1)(1991-9#2)(1994-3#1)(1995-11#1)(1996-7#1)(1997-2#1)(1997-8#3)(2005-11#1)(2005-7#1)(2008-12#1)(2008-3#1)
the bird to##3##3##(1996-9#1)(2005-9#2)
the bird was##2##3##(1994-2#1)(2007-2#1)
the bird##16##2##(1994-2#1)(1996-9#1)(2005-9#5)(2007-2#1)(2008-5#4)(2008-8#3)(2012-2#1)
the birds were##2##3##(2008-5#1)(2010-2#1)
the birds with##2##3##(2008-8#2)
the birds##21##2##(1991-11#2)(1992-2#1)(1997-3#3)(2005-9#2)(2007-2#1)(2007-6#2)(2008-5#5)(2008-8#2)(2008-9#1)(2010-2#1)(2013-1#1)
the birefringence and##2##3##(2007-12#1)(2010-4#1)
the birefringence of the##5##4##(2007-12#1)(2008-2#1)(2008-3#3)
the birefringence of##11##3##(2007-12#1)(2008-2#1)(2008-3#8)(2009-11#1)
the birefringence vector distribution in a##2##6##(2008-3#2)
the birefringence vector##3##3##(2008-3#3)
the birefringence##27##2##(1990-7#1)(2007-11#3)(2007-12#3)(2008-2#4)(2008-3#14)(2009-11#1)(2010-4#1)
the birefringent blur filter##2##4##(2008-3#2)
the birefringent properties of lens materials##2##6##(2008-3#2)
the birefringent##6##2##(2008-2#2)(2008-3#4)
the birth environment##2##3##(2007-2#2)
the birth experience##3##3##(2007-2#2)(2010-9#1)
the birth of a normal##2##5##(1993-10#1)(2004-12#1)
the birth of a##5##4##(1993-10#1)(2004-12#1)(2008-8#1)(2012-12#1)(2012-2#1)
the birth of the##3##4##(1996-9#1)(2004-10#1)(2013-7#1)
the birth of their child##2##5##(1993-12#1)(2008-9#1)
the birth of their##5##4##(1993-12#1)(2004-3#1)(2007-2#1)(2008-9#1)(2010-2#1)
the birth of##26##3##(1990-12#1)(1990-8#1)(1991-6#1)(1992-11#1)(1993-10#1)(1993-12#1)(1996-8#1)(1996-9#1)(1997-2#1)(2004-10#1)(2004-12#1)(2004-3#1)(2006-6#2)(2007-2#2)(2007-6#1)(2007-8#1)(2008-12#1)(2008-8#1)(2008-9#2)(2010-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
the birth plan##3##3##(2008-6#3)
the birth process##3##3##(2007-2#1)(2013-7#2)
the birth weight##4##3##(1994-2#1)(2008-4#1)(2011-1#2)
the birth##59##2##(1990-12#1)(1990-8#1)(1991-6#1)(1992-11#1)(1992-6#1)(1993-10#1)(1993-12#1)(1994-2#1)(1995-8#1)(1996-8#1)(1996-9#1)(1997-2#1)(2004-10#1)(2004-12#1)(2004-3#1)(2006-10#1)(2006-6#3)(2007-11#1)(2007-2#10)(2007-6#2)(2007-8#1)(2008-11#1)(2008-12#1)(2008-4#3)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#4)(2009-11#1)(2009-2#1)(2010-2#1)(2010-9#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-7#3)
the birthplace of##2##3##(1994-6#1)(2007-8#1)
the births##4##2##(2007-2#1)(2008-1#1)(2012-12#2)
the bis(phenylsulfonyl)diene##2##2##(1996-5#2)
the bis-phosphorylated##2##2##(2010-12#2)
the bis[[(dimethylamino)methyl]furans] in##2##3##(1992-8#2)
the bismuth film electrode##4##4##(2007-8#1)(2008-10#3)
the bismuth##8##2##(2007-8#2)(2008-10#4)(2010-11#1)(2010-8#1)
the bismuth(III)##2##2##(2008-10#2)
the bispecific##2##2##(1990-12#1)(1994-3#1)
the bisphenol S derivative compounds##2##5##(2013-1#2)
the bisphenol##4##2##(2008-10#1)(2013-1#3)
the bisphosphonate##2##2##(2008-11#1)(2010-3#1)
the bisphosphonates##6##2##(1992-11#3)(1996-2#1)(2007-11#1)(2008-3#1)
the bistranded reaction##2##3##(1992-9#2)
the bisubstrate##3##2##(1990-8#1)(1991-4#1)(1996-7#1)
the bit error##3##3##(2008-3#3)
the bit##7##2##(1996-2#1)(2007-12#1)(2008-2#2)(2008-3#3)
the bit-error rate is##2##4##(2008-3#2)
the bit-error rate of a##3##5##(2008-2#3)
the bit-error rate of##4##4##(2008-2#4)
the bit-error rate##10##3##(2007-12#2)(2008-2#6)(2008-3#2)
the bit-error##12##2##(2007-12#3)(2008-2#7)(2008-3#2)
the bitch##5##2##(1996-11#2)(2006-5#3)
the bite of a##2##4##(2010-8#1)(2012-2#1)
the bite of the##3##4##(2006-4#1)(2008-7#1)(2010-1#1)
the bite of##7##3##(2006-4#1)(2008-7#1)(2010-1#2)(2010-8#1)(2011-2#1)(2012-2#1)
the bite##12##2##(1990-4#1)(2006-4#1)(2007-12#1)(2008-6#1)(2008-7#1)(2010-1#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#2)
the bithorax complex##3##3##(1995-8#2)(2012-3#1)
the bits##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)
the bitter taste##2##3##(2008-9#1)(2010-5#1)
the bitumen##4##2##(2005-11#4)
the biuret method##4##3##(2008-10#2)(2008-9#1)(2009-8#1)
the biuret##7##2##(1990-8#1)(2008-10#4)(2008-9#1)(2009-8#1)
the bivalent vaccine##4##3##(2011-2#4)
the bivalent##9##2##(1992-9#1)(2008-4#2)(2011-2#5)(2013-8#1)
the bivalve##3##2##(1991-4#1)(1994-11#1)(2013-7#1)
the bivalves##2##2##(2007-3#1)(2008-5#1)
the bivariate and##2##3##(2008-7#1)(2012-3#1)
the bivariate##10##2##(1994-2#1)(1995-6#1)(1997-3#1)(1997-4#2)(1997-7#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-3#1)
the bizarre##3##2##(1992-4#1)(2010-3#1)(2011-1#1)
the bla gene##3##3##(1990-9#1)(1995-8#1)(1997-2#1)
the black carbon mass##2##4##(2008-3#2)
the black carbon##3##3##(2008-3#3)
the black pixel assumption##4##4##(2008-3#4)
the black porgy##2##3##(2008-7#2)
the black##26##2##(1995-6#1)(2006-4#1)(2007-11#1)(2007-5#1)(2008-3#7)(2008-7#3)(2008-8#2)(2009-4#1)(2009-8#1)(2010-10#1)(2011-2#2)(2012-11#3)(2012-2#1)(2013-1#1)
the black-and-white box behavioral paradigm##2##5##(1992-8#2)
the bladder and##13##3##(1991-1#1)(1995-12#2)(1996-12#1)(1997-7#2)(2006-10#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#1)(2011-2#2)
the bladder cases##2##3##(2008-10#2)
the bladder is a rare##4##5##(1992-12#1)(2010-12#1)(2013-1#2)
the bladder is a##5##4##(1992-12#1)(2008-10#1)(2010-12#1)(2013-1#2)
the bladder is##7##3##(1992-12#1)(2006-6#1)(2008-10#1)(2010-12#1)(2010-2#1)(2013-1#2)
the bladder neck##3##3##(2006-1#1)(2008-10#2)
the bladder of##2##3##(2008-10#2)
the bladder or##2##3##(1996-12#1)(2011-2#1)
the bladder wall##5##3##(1992-12#3)(1993-11#1)(2005-10#1)
the bladder was expanded##2##4##(1992-3#1)(1997-7#1)
the bladder was##6##3##(1992-3#1)(1997-7#3)(2007-11#1)(2010-2#1)
the bladder with##2##3##(2006-9#1)(2008-10#1)
the bladder##119##2##(1990-5#1)(1991-1#1)(1991-11#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#5)(1992-2#2)(1992-3#3)(1992-6#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-12#2)(1995-5#2)(1995-9#1)(1996-12#3)(1997-4#1)(1997-7#6)(2005-10#1)(2006-1#1)(2006-10#3)(2006-6#4)(2006-8#2)(2006-9#8)(2007-10#3)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-9#2)(2008-10#22)(2008-12#1)(2008-3#2)(2008-4#1)(2010-12#2)(2010-2#2)(2010-8#2)(2011-2#5)(2012-12#2)(2012-2#1)(2013-1#10)
the blades##2##2##(1992-1#1)(2008-3#1)
the blank values##2##3##(2008-10#2)
the blank##27##2##(2007-8#1)(2008-10#23)(2008-9#1)(2010-5#1)(2013-7#1)
the blankets##2##2##(2006-6#1)(2007-10#1)
the blast##5##2##(2007-8#1)(2008-10#2)(2008-7#1)(2011-2#1)
the blastocyst stage in##3##4##(2006-5#2)(2008-11#1)
the blastocyst stage##16##3##(1994-3#1)(1995-11#1)(1995-2#1)(2005-8#2)(2006-5#9)(2008-11#1)(2013-1#1)
the blastocyst##22##2##(1992-1#1)(1992-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(2005-8#2)(2006-5#9)(2006-6#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
the blastoderm##3##2##(1993-9#1)(1994-8#1)(1995-8#1)
the blastopore##2##2##(2008-4#1)(2008-7#1)
the blaze angle##3##3##(2008-2#2)(2008-3#1)
the blazed grating##2##3##(2008-2#2)
the bleaching of a##2##4##(2008-10#1)(2008-2#1)
the bleaching of##5##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
the bleaching##12##2##(1992-6#1)(1993-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-4#1)(2012-2#1)(2013-1#2)
the bleeding risk##3##3##(2007-10#1)(2011-2#1)(2013-8#1)
the bleeding source##2##3##(2006-6#2)
the bleeding time##4##3##(1990-11#3)(2008-5#1)
the bleeding vessels##3##3##(2006-6#1)(2010-9#1)(2011-1#1)
the bleeding##23##2##(1990-11#3)(1993-9#1)(1995-11#1)(2006-11#1)(2006-6#3)(2007-10#2)(2007-7#1)(2007-8#1)(2008-5#1)(2008-8#3)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
the blend formulations##2##3##(2010-1#2)
the blend##8##2##(2007-11#1)(2008-5#1)(2009-8#2)(2010-1#3)(2011-1#1)
the blend/PEDOT##2##2##(2010-4#2)
the blended##2##2##(2008-5#2)
the blind##13##2##(1991-9#1)(2005-8#1)(2006-10#1)(2007-2#1)(2008-2#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-12#1)(2010-6#1)
the blinded##2##2##(2007-10#1)(2008-7#1)
the blindness##2##2##(2010-8#1)(2011-2#1)
the blister rust##2##3##(2008-10#2)
the blister##3##2##(2006-10#1)(2008-10#2)
the block copolymer##2##3##(2008-7#1)(2010-4#1)
the block of nAChRs##2##4##(1994-2#2)
the block of##4##3##(1994-2#2)(2008-8#1)(2012-3#1)
the block##27##2##(1994-2#2)(1995-11#3)(1995-3#1)(1996-5#1)(1997-1#1)(2006-10#2)(2006-12#3)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#2)(2010-4#1)(2010-7#1)(2012-1#2)(2012-3#1)(2013-1#1)(2013-7#1)
the blockade of the##3##4##(2005-7#2)(2013-1#1)
the blockade of##15##3##(1990-5#1)(1991-10#1)(1992-12#1)(1994-5#1)(1995-1#1)(2005-7#5)(2008-11#2)(2008-4#1)(2013-1#2)
the blockade##17##2##(1990-5#1)(1991-10#1)(1992-12#1)(1992-5#1)(1993-3#1)(1994-5#1)(1995-1#1)(2005-7#5)(2008-11#2)(2008-4#1)(2013-1#2)
the blockage of##6##3##(1994-8#1)(1996-3#1)(2004-9#1)(2006-10#1)(2011-3#1)(2013-1#1)
the blocked##4##2##(1990-3#1)(1992-11#1)(2008-3#1)(2008-7#1)
the blocking and##2##3##(1994-12#1)(2007-8#1)
the blocking effect of##3##4##(1993-2#1)(1995-5#1)(1996-12#1)
the blocking effect##4##3##(1993-2#1)(1995-5#1)(1996-12#1)(2005-11#1)
the blocking of##3##3##(1993-3#1)(2011-12#1)(2013-8#1)
the blocking##13##2##(1990-12#1)(1992-7#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-5#1)(1996-12#1)(1997-1#1)(2005-11#1)(2007-8#1)(2008-6#1)(2011-12#1)(2013-8#1)
the blocks##3##2##(2008-11#1)(2008-2#1)(2008-9#1)
the blog##2##2##(2007-12#2)
the blood ACh content##2##4##(1997-3#2)
the blood ACh##3##3##(1997-3#3)
the blood and milk##3##4##(2013-8#3)
the blood and plasma##4##4##(1996-5#1)(1997-3#3)
the blood and urine##2##4##(2007-7#1)(2008-10#1)
the blood and##23##3##(1996-5#1)(1996-7#1)(1997-3#3)(2006-6#1)(2007-12#1)(2007-7#1)(2007-9#2)(2008-10#1)(2008-4#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-12#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#3)
the blood as##2##3##(2008-4#1)(2009-4#1)
the blood bank##6##3##(1991-7#3)(1996-6#1)(2005-12#1)(2007-2#1)
the blood brain barrier##2##4##(1995-10#1)(2013-1#1)
the blood by##4##3##(1991-12#1)(1996-5#1)(2005-10#1)(2008-10#1)
the blood cells##5##3##(1990-3#1)(1993-12#1)(1997-3#1)(2007-9#1)(2010-12#1)
the blood circulation##6##3##(1993-9#3)(1994-5#2)(2006-4#1)
the blood coagulation pathway##2##4##(1993-3#1)(2008-10#1)
the blood coagulation##7##3##(1991-2#1)(1993-11#1)(1993-3#1)(2006-6#1)(2007-8#1)(2008-10#1)(2013-7#1)
the blood collected##2##3##(2007-1#1)(2008-5#1)
the blood compartment##2##3##(1990-3#1)(2007-8#1)
the blood compatibility of##2##4##(2008-8#2)
the blood compatibility##3##3##(2008-5#1)(2008-8#2)
the blood culture##4##3##(2007-2#1)(2007-7#1)(2008-5#1)(2010-12#1)
the blood donation##4##3##(1994-3#1)(2005-10#1)(2013-8#2)
the blood flow of##4##4##(2008-10#3)(2008-12#1)
the blood flow through the##2##5##(2005-1#1)(2008-12#1)
the blood flow to the##2##5##(2006-3#1)(2006-5#1)
the blood flow##15##3##(2005-1#1)(2006-3#1)(2006-5#2)(2008-1#1)(2008-10#4)(2008-12#2)(2008-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
the blood for##2##3##(2005-10#1)(2010-11#1)
the blood glucose concentration##2##4##(1993-1#1)(1996-7#1)
the blood glucose level##4##4##(2008-1#1)(2008-10#1)(2008-5#1)(2012-2#1)
the blood glucose levels##3##4##(2008-10#1)(2008-3#1)(2008-4#1)
the blood glucose##15##3##(1992-9#1)(1993-1#1)(1996-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#3)(2008-5#1)(2011-3#1)(2012-12#1)(2012-2#1)
the blood group B##2##4##(1991-12#1)(1996-3#1)
the blood group##3##3##(1990-7#1)(1991-12#1)(1996-3#1)
the blood in##5##3##(1991-1#1)(1992-3#1)(1996-9#1)(2006-7#1)(2008-4#1)
the blood is##6##3##(1991-11#1)(1992-4#1)(1992-5#1)(1993-2#1)(2007-9#1)(2008-10#1)
the blood lead##3##3##(1993-9#2)(2008-3#1)
the blood level of##2##4##(2005-1#1)(2009-6#1)
the blood levels of##3##4##(1990-4#1)(2008-7#1)(2011-2#1)
the blood levels##4##3##(1990-4#1)(2008-7#1)(2011-1#1)(2011-2#1)
the blood lipid metabolism##4##4##(2013-1#4)
the blood loss was##2##4##(2006-5#1)(2007-8#1)
the blood loss##5##3##(2006-10#1)(2006-5#1)(2007-8#1)(2008-7#1)(2008-9#1)
the blood of a##2##4##(2007-12#1)(2008-7#1)
the blood of the##4##4##(1993-12#1)(1994-12#1)(2007-7#1)(2013-8#1)
the blood of##45##3##(1990-12#1)(1991-10#1)(1991-2#2)(1992-1#1)(1993-12#1)(1993-2#1)(1993-9#2)(1994-12#1)(1996-3#1)(1996-6#1)(1996-9#1)(2006-2#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-4#1)(2008-5#1)(2008-7#2)(2009-2#1)(2009-4#1)(2009-6#2)(2010-12#3)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
the blood or##2##3##(1994-5#1)(2008-5#1)
the blood outflow##2##3##(2008-3#2)
the blood oxygen##2##3##(2007-10#1)(2013-8#1)
the blood picture of the brown rats##2##7##(2008-12#2)
the blood picture of##3##4##(2008-12#3)
the blood picture##4##3##(1992-2#1)(2008-12#3)
the blood pressure and##3##4##(1990-5#1)(2008-7#1)(2009-6#1)
the blood pressure has##2##4##(1992-4#1)(1994-12#1)
the blood pressure in the##2##5##(1997-5#2)
the blood pressure in##3##4##(1997-5#2)(2011-2#1)
the blood pressure is##2##4##(1997-5#1)(2008-5#1)
the blood pressure lowering effect##3##5##(1991-9#1)(2009-4#1)(2010-2#1)
the blood pressure of##3##4##(1990-8#1)(1991-12#1)(2005-7#1)
the blood pressure reduction##3##4##(1992-4#1)(2005-10#1)(2013-8#1)
the blood pressure response to##3##5##(1990-7#1)(2008-1#1)(2008-7#1)
the blood pressure response##4##4##(1990-7#1)(2008-1#2)(2008-7#1)
the blood pressure was normal##2##5##(1992-7#1)(2012-3#1)
the blood pressure was##5##4##(1991-12#1)(1992-4#1)(1992-7#1)(2012-3#1)(2013-8#1)
the blood pressure##46##3##(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#2)(1991-9#1)(1992-2#1)(1992-4#3)(1992-7#1)(1994-11#1)(1994-12#1)(1994-8#1)(1997-5#3)(2005-10#2)(2005-7#1)(2007-1#3)(2007-2#1)(2008-1#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-4#1)(2009-6#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
the blood sample##4##3##(1992-4#1)(1994-12#1)(2007-12#1)(2008-4#1)
the blood samples were##3##4##(2008-12#1)(2009-4#1)(2011-1#1)
the blood samples##10##3##(1990-12#1)(1990-7#1)(1992-8#1)(1997-7#1)(2008-12#1)(2008-5#1)(2009-4#1)(2009-6#1)(2011-1#2)
the blood serum and##2##4##(2008-5#1)(2008-7#1)
the blood serum##5##3##(2008-10#1)(2008-5#1)(2008-7#2)(2011-1#1)
the blood stains##2##3##(1990-7#1)(2008-12#1)
the blood stream##3##3##(2006-5#1)(2008-3#1)(2008-7#1)
the blood sugar##3##3##(1994-8#1)(1996-11#1)(2013-8#1)
the blood supply for HIV-1##2##5##(1990-11#1)(1996-9#1)
the blood supply to the##4##5##(1996-2#1)(2007-7#1)(2007-9#1)(2011-1#1)
the blood supply to##6##4##(1996-2#1)(2006-8#1)(2007-7#2)(2007-9#1)(2011-1#1)
the blood supply##14##3##(1990-11#1)(1995-6#1)(1996-2#1)(1996-9#3)(2006-12#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-7#2)(2007-9#1)(2011-1#1)
the blood through the##2##4##(1990-11#1)(2009-3#1)
the blood to##6##3##(1990-2#1)(1991-3#1)(1995-9#1)(2008-10#1)(2009-3#1)(2010-2#1)
the blood type##2##3##(1990-3#1)(2013-8#1)
the blood urea nitrogen##2##4##(1994-5#1)(2008-5#1)
the blood vessel wall##2##4##(1995-8#1)(1996-3#1)
the blood vessel walls##2##4##(1997-7#1)(2007-11#1)
the blood vessel##11##3##(1995-3#1)(1995-8#1)(1996-3#1)(1997-7#1)(2007-11#1)(2007-5#3)(2008-3#2)(2012-12#1)
the blood vessels and##2##4##(1996-3#1)(2008-1#1)
the blood vessels of recipient##2##5##(2008-11#2)
the blood vessels of the##2##5##(2006-11#2)
the blood vessels of##5##4##(2006-11#2)(2008-11#3)
the blood vessels##13##3##(1991-3#1)(1996-3#1)(1997-8#1)(2006-11#2)(2007-11#1)(2008-1#1)(2008-11#4)(2012-1#1)(2013-1#1)
the blood viscosity##2##3##(2006-4#1)(2007-7#1)
the blood which##2##3##(1990-12#1)(2013-8#1)
the blood with##2##3##(1993-7#1)(2008-7#1)
the blood##441##2##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#2)(1990-3#5)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#4)(1990-8#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#5)(1991-2#6)(1991-3#3)(1991-7#3)(1991-8#1)(1991-9#2)(1992-1#1)(1992-2#2)(1992-3#1)(1992-4#6)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#7)(1994-11#1)(1994-12#3)(1994-3#1)(1994-5#4)(1994-8#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-6#2)(1995-8#2)(1995-9#2)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#4)(1996-4#1)(1996-5#2)(1996-6#3)(1996-7#2)(1996-8#1)(1996-9#6)(1997-1#2)(1997-2#1)(1997-3#9)(1997-5#4)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#3)(2005-1#2)(2005-10#5)(2005-12#1)(2005-7#2)(2005-8#3)(2005-9#1)(2006-10#3)(2006-11#2)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#2)(2006-5#4)(2006-6#3)(2006-7#1)(2006-8#4)(2007-1#7)(2007-10#2)(2007-11#5)(2007-12#3)(2007-2#4)(2007-5#3)(2007-7#8)(2007-8#5)(2007-9#8)(2008-1#9)(2008-10#20)(2008-11#7)(2008-12#7)(2008-2#6)(2008-3#9)(2008-4#12)(2008-5#16)(2008-6#3)(2008-7#13)(2008-8#3)(2008-9#2)(2009-2#2)(2009-3#2)(2009-4#6)(2009-6#5)(2009-9#1)(2010-11#2)(2010-12#9)(2010-2#2)(2010-5#1)(2010-6#1)(2011-1#12)(2011-2#9)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#5)(2013-1#13)(2013-7#3)(2013-8#16)
the blood-brain barrier (BBB)##11##4##(1990-5#1)(1993-12#1)(1995-12#1)(1995-3#1)(1996-4#1)(1996-5#1)(2007-11#2)(2008-7#1)(2010-11#1)(2012-2#1)
the blood-brain barrier and##11##4##(1993-12#1)(1994-3#2)(1996-8#1)(1997-2#1)(2007-12#1)(2008-2#1)(2010-12#1)(2012-1#1)(2012-2#1)(2012-3#1)
the blood-brain barrier in the##3##5##(1994-5#1)(1995-12#1)(2007-9#1)
the blood-brain barrier in##8##4##(1990-5#1)(1994-5#1)(1995-12#1)(1996-11#2)(2007-9#2)(2009-4#1)
the blood-brain barrier is##2##4##(1995-2#1)(1996-12#1)
the blood-brain barrier may##2##4##(1995-12#1)(1996-11#1)
the blood-brain barrier to##2##4##(1993-11#1)(2006-12#1)
the blood-brain barrier##71##3##(1990-2#1)(1990-5#2)(1990-7#1)(1992-3#2)(1993-11#1)(1993-12#2)(1993-4#1)(1994-10#2)(1994-3#2)(1994-5#1)(1995-12#5)(1995-2#1)(1995-3#2)(1996-11#4)(1996-12#2)(1996-4#1)(1996-5#1)(1996-8#1)(1997-2#2)(2005-9#1)(2006-12#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-9#3)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2009-4#1)(2010-11#2)(2010-12#2)(2011-2#1)(2012-1#2)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#2)
the blood-brain##73##2##(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#1)(1992-3#2)(1993-11#1)(1993-12#2)(1993-4#1)(1994-10#2)(1994-3#2)(1994-5#1)(1995-12#5)(1995-2#1)(1995-3#2)(1996-11#4)(1996-12#2)(1996-4#1)(1996-5#1)(1996-8#1)(1997-2#2)(2005-9#1)(2006-12#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-9#3)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2009-4#1)(2010-11#2)(2010-12#2)(2011-2#1)(2012-1#2)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#3)
the blood-cerebrospinal fluid##2##3##(2007-11#1)(2008-7#1)
the blood-feeding##2##2##(2004-11#1)(2008-4#1)
the blood-group##2##2##(1992-9#2)
the blood-labyrinth barrier##5##3##(2009-8#4)(2012-2#1)
the blood-nerve barrier##2##3##(1993-7#2)
the blood-nerve##5##2##(1993-7#3)(1997-8#2)
the blood-testis barrier (BTB)##3##4##(2009-10#1)(2012-2#2)
the blood-testis barrier##4##3##(2009-10#2)(2012-2#2)
the bloodstream form of Trypanosoma brucei##2##6##(1992-4#2)
the bloodstream##18##2##(1990-9#1)(1991-10#1)(1992-11#2)(1992-4#2)(1996-1#1)(2005-9#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-4#1)(2008-7#1)(2009-11#1)(2010-12#1)(2012-3#1)(2013-1#2)
the bloom##3##2##(2008-8#3)
the blot##2##2##(1992-8#1)(1996-12#1)
the blots##2##2##(2008-10#1)(2008-4#1)
the blotting##2##2##(2008-4#2)
the bls gene##2##3##(1990-1#2)
the blubber##4##2##(2008-10#4)
the blue copper proteins##3##4##(1990-5#1)(1993-6#1)(1996-8#1)
the blue copper##4##3##(1990-5#1)(1993-6#1)(1996-10#1)(1996-8#1)
the blue crab Callinectes sapidus##2##5##(1994-11#2)
the blue crab##6##3##(1994-11#2)(2007-12#2)(2007-5#2)
the blue end##2##3##(1992-7#1)(2008-2#1)
the blue region of the spectrum##3##6##(2007-12#1)(2008-2#2)
the blue spectral region##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
the blue##55##2##(1990-5#1)(1990-9#1)(1992-11#1)(1992-7#1)(1993-6#1)(1994-11#3)(1994-5#1)(1996-10#1)(1996-8#1)(1997-4#1)(1997-6#1)(2006-12#1)(2007-11#2)(2007-12#10)(2007-5#2)(2007-7#1)(2007-8#1)(2008-10#9)(2008-2#5)(2008-3#7)(2008-5#2)(2009-2#1)(2013-8#1)
the blue-green##7##2##(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)(2013-1#1)
the blunt##4##2##(2007-12#1)(2007-3#1)(2008-7#1)(2013-1#1)
the blur filter##2##3##(2008-2#2)
the blur function##2##3##(2008-3#2)
the blur##4##2##(2008-2#2)(2008-3#2)
the blurred##3##2##(2008-2#1)(2008-8#1)(2010-9#1)
the board of directors##2##4##(1993-1#1)(1995-6#1)
the board##15##2##(1990-12#1)(1991-1#1)(1992-11#1)(1993-1#1)(1993-3#1)(1995-12#3)(1995-6#1)(1997-1#1)(2006-8#1)(2007-9#1)(2010-3#1)(2012-2#1)(2013-7#1)
the board's role in##2##4##(1991-12#1)(2008-11#1)
the board's role##3##3##(1991-12#1)(1995-12#1)(2008-11#1)
the board's##4##2##(1991-1#1)(1991-12#1)(1995-12#1)(2008-11#1)
the boards##2##2##(1994-1#1)(2008-2#1)
the boat##4##2##(1992-7#1)(2007-2#1)(2007-5#1)(2008-5#1)
the bodies of##3##3##(2007-2#1)(2007-8#1)(2008-8#1)
the bodies##7##2##(2007-2#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-4#1)(2013-7#1)
the body against##3##3##(1994-6#1)(2006-7#1)(2011-1#1)
the body and a##3##4##(1992-3#1)(2007-8#1)(2008-9#1)
the body and is##2##4##(2008-10#1)(2011-2#1)
the body and its##3##4##(2011-2#1)(2012-11#1)(2012-12#1)
the body and the##3##4##(2008-11#1)(2008-5#1)(2008-7#1)
the body and##35##3##(1991-6#2)(1992-10#1)(1992-3#1)(1992-5#1)(1993-4#1)(1997-6#1)(2005-11#1)(2006-11#1)(2006-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-12#1)(2011-2#4)(2012-11#1)(2012-12#1)
the body are##4##3##(2008-10#1)(2009-7#1)(2010-4#1)(2011-2#1)
the body as a##3##4##(2007-11#1)(2007-8#1)(2008-2#1)
the body as##5##3##(2007-11#1)(2007-8#2)(2008-2#1)(2012-3#1)
the body at##2##3##(2007-10#1)(2008-7#1)
the body axis##4##3##(1995-8#1)(2007-12#2)(2007-9#1)
the body can##3##3##(1991-2#1)(2006-10#1)(2009-11#1)
the body cavity##4##3##(1996-12#1)(1997-3#1)(2008-8#1)(2008-9#1)
the body composition##2##3##(1990-5#1)(2008-7#1)
the body fat##2##3##(1990-9#1)(2008-1#1)
the body fluids##4##3##(1991-12#1)(2008-10#3)
the body has##2##3##(1991-6#1)(2012-12#1)
the body have##2##3##(2008-5#1)(2012-12#1)
the body image and##2##4##(2007-12#2)
the body image##7##3##(2006-7#1)(2007-12#5)(2011-1#1)
the body in general##2##4##(2008-1#1)(2013-1#1)
the body in order to##2##5##(1991-1#1)(2006-5#1)
the body in##8##3##(1991-1#1)(2006-5#1)(2006-8#1)(2008-1#1)(2008-11#1)(2008-9#1)(2010-6#1)(2013-1#1)
the body is##7##3##(1990-4#1)(2005-4#1)(2005-9#1)(2006-4#1)(2007-6#1)(2007-9#1)(2010-9#1)
the body mass index (BMI)##6##5##(2007-7#1)(2008-12#1)(2008-9#1)(2011-1#1)(2011-11#1)(2013-1#1)
the body mass index##12##4##(1991-11#1)(1993-11#1)(2007-7#1)(2008-12#1)(2008-9#1)(2009-7#1)(2011-1#3)(2011-11#1)(2012-11#1)(2013-1#1)
the body mass##14##3##(1991-11#1)(1993-11#1)(2006-6#1)(2007-7#1)(2008-12#1)(2008-9#1)(2009-7#1)(2011-1#3)(2011-11#1)(2012-11#1)(2013-1#1)(2013-8#1)
the body of a##2##4##(2006-10#1)(2008-3#1)
the body of information##2##4##(1991-2#1)(2012-1#1)
the body of literature##2##4##(2008-6#1)(2009-1#1)
the body of research##2##4##(2007-2#1)(2009-4#1)
the body of the vertebra##2##5##(1992-1#2)
the body of the##19##4##(1992-1#2)(1993-5#1)(1994-8#1)(1995-1#1)(1996-10#1)(1997-2#1)(2006-5#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-5#1)(2011-12#1)
the body of##47##3##(1991-2#1)(1992-1#2)(1993-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-10#1)(1997-2#1)(2005-7#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#1)
the body or the##2##4##(1995-5#1)(2011-2#1)
the body parts##2##3##(2007-12#1)(2010-8#1)
the body plan of the##3##5##(1993-6#1)(1995-8#2)
the body plan##4##3##(1993-6#1)(1995-8#2)(2007-12#1)
the body possess##2##3##(1992-4#1)(2013-1#1)
the body size##4##3##(2012-2#2)(2013-8#2)
the body skin##2##3##(2008-5#2)
the body structure##2##3##(1997-7#1)(2013-8#1)
the body surface##7##3##(1995-10#1)(2006-9#1)(2007-12#2)(2008-7#1)(2010-8#1)(2012-11#1)
the body temperature of##3##4##(1993-3#1)(2004-9#1)(2008-8#1)
the body temperature##7##3##(1991-8#1)(1993-3#1)(1993-4#1)(1997-5#1)(2004-9#1)(2008-6#1)(2008-8#1)
the body that##2##3##(2008-12#1)(2009-4#1)
the body tissues##2##3##(1996-3#1)(2010-2#1)
the body to##12##3##(1995-12#1)(1996-2#1)(1996-7#1)(2005-8#1)(2007-1#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-8#1)(2009-9#1)(2012-12#1)(2012-3#1)
the body using##3##3##(1997-6#1)(2008-10#2)
the body wall##2##3##(1990-11#1)(1996-11#1)
the body was##3##3##(1995-5#1)(1996-1#1)(2013-1#1)
the body weight of##3##4##(2009-8#1)(2010-5#1)(2013-1#1)
the body weight##10##3##(2005-10#1)(2007-8#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#2)(2013-1#1)(2013-8#1)
the body with##3##3##(1992-6#1)(1996-1#1)(2013-1#1)
the body without##2##3##(1994-5#1)(2013-1#1)
the body##452##2##(1990-11#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-6#3)(1991-8#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#8)(1995-3#2)(1995-4#1)(1995-5#4)(1995-8#4)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-9#1)(2005-10#4)(2005-11#1)(2005-4#1)(2005-7#1)(2005-8#1)(2005-9#3)(2006-10#5)(2006-11#2)(2006-12#3)(2006-2#3)(2006-4#2)(2006-5#2)(2006-6#7)(2006-7#2)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#9)(2007-12#20)(2007-2#5)(2007-4#1)(2007-5#1)(2007-6#4)(2007-7#11)(2007-8#11)(2007-9#5)(2008-1#6)(2008-10#21)(2008-11#5)(2008-12#7)(2008-2#4)(2008-3#7)(2008-4#6)(2008-5#19)(2008-6#9)(2008-7#12)(2008-8#5)(2008-9#11)(2009-1#1)(2009-10#1)(2009-11#4)(2009-12#1)(2009-3#1)(2009-4#4)(2009-5#3)(2009-6#4)(2009-7#3)(2009-8#3)(2009-9#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#5)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#5)(2011-1#10)(2011-11#1)(2011-12#1)(2011-2#19)(2012-1#3)(2012-11#4)(2012-12#13)(2012-2#7)(2012-3#4)(2013-1#13)(2013-7#3)(2013-8#7)
the body's immune##2##3##(2010-10#1)(2010-12#1)
the body's natural##3##3##(2008-5#2)(2013-1#1)
the body's response to##2##4##(2006-10#1)(2008-4#1)
the body's##29##2##(1990-10#1)(1990-12#1)(1991-11#1)(1992-11#1)(1993-8#1)(1997-6#2)(2006-10#2)(2007-12#2)(2007-9#1)(2008-2#1)(2008-4#1)(2008-5#3)(2009-11#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#3)
the body]##4##2##(1996-9#1)(1997-7#1)(2008-8#2)
the boiling##2##2##(2008-10#1)(2011-2#1)
the bolometer is##2##3##(2008-2#2)
the bolometer##5##2##(2008-2#4)(2008-3#1)
the bolus##7##2##(1995-12#1)(2008-10#1)(2009-10#2)(2009-8#1)(2011-2#1)(2012-1#1)
the bombing##2##2##(2007-2#2)
the bombyxin##3##2##(1996-6#3)
the bona fide##2##3##(1990-10#1)(1993-11#1)
the bond between##2##3##(1995-2#1)(2013-1#1)
the bond cleavage##2##3##(1994-11#2)
the bond length##2##3##(1996-2#1)(2008-9#1)
the bond strength of##4##4##(2009-8#2)(2013-1#2)
the bond valence##2##3##(1997-7#2)
the bond##19##2##(1991-9#2)(1994-11#2)(1995-2#1)(1996-2#1)(1997-7#2)(2008-9#2)(2009-8#2)(2009-9#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#3)
the bonded##5##2##(1992-6#1)(1997-2#1)(2008-10#1)(2008-2#1)(2013-8#1)
the bonding force between the##2##5##(2008-10#2)
the bonding of##2##3##(1991-7#1)(2008-10#1)
the bonding##17##2##(1991-7#1)(1995-5#1)(2005-4#1)(2007-12#1)(2007-9#3)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-5#1)(2010-6#1)(2013-8#1)
the bonds##2##2##(1996-1#1)(2012-12#1)
the bone and soft##2##4##(2010-6#1)(2011-2#1)
the bone and##13##3##(2005-3#1)(2005-7#1)(2005-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2009-3#1)(2009-6#1)(2010-6#2)(2011-2#1)(2013-1#1)(2013-8#1)
the bone by##2##3##(2008-5#1)(2013-1#1)
the bone chamber##2##3##(2006-9#2)
the bone defect in the mastoid area##2##7##(2008-7#2)
the bone defect##3##3##(2008-7#2)(2010-2#1)
the bone flap##2##3##(2006-11#1)(2008-7#1)
the bone formation##3##3##(2005-3#1)(2008-10#1)(2013-8#1)
the bone grafts##4##3##(2007-11#3)(2008-6#1)
the bone in the##2##4##(2007-8#1)(2009-7#1)
the bone in##6##3##(2007-1#1)(2007-8#1)(2009-7#1)(2010-3#1)(2010-6#1)(2012-2#1)
the bone loss##5##3##(2005-3#1)(2008-12#1)(2008-5#1)(2009-3#1)(2012-2#1)
the bone marrow and##6##4##(1995-1#1)(1995-2#1)(2008-1#1)(2008-4#2)(2012-1#1)
the bone marrow aspirate##2##4##(2008-11#2)
the bone marrow cells##3##4##(1994-12#1)(2009-2#1)(2009-4#1)
the bone marrow microenvironment and##3##5##(2008-3#1)(2009-3#1)(2009-8#1)
the bone marrow microenvironment##12##4##(2006-10#1)(2008-3#1)(2009-3#4)(2009-8#1)(2011-1#3)(2011-2#1)(2013-1#1)
the bone marrow of patients##2##5##(1994-5#1)(2008-5#1)
the bone marrow of##5##4##(1994-5#1)(1995-1#1)(2007-11#1)(2008-5#1)(2010-6#1)
the bone marrow stem cell##2##5##(2010-11#1)(2010-8#1)
the bone marrow##91##3##(1990-5#1)(1990-6#1)(1991-11#1)(1992-5#1)(1993-8#2)(1994-12#1)(1994-5#2)(1995-1#4)(1995-2#1)(1996-10#1)(1996-3#1)(1997-3#1)(2004-2#2)(2005-7#1)(2006-10#4)(2006-2#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-7#1)(2008-1#4)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#4)(2008-9#2)(2009-2#1)(2009-3#7)(2009-4#1)(2009-7#2)(2009-8#1)(2010-11#4)(2010-6#3)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#2)(2012-1#4)(2012-12#5)(2012-3#1)(2013-1#1)
the bone matrix##2##3##(1993-11#1)(2009-3#1)
the bone mineral density (BMD)##2##5##(2006-10#1)(2008-8#1)
the bone mineral density##3##4##(2006-10#1)(2008-6#1)(2008-8#1)
the bone mineral##6##3##(1995-6#2)(2006-10#1)(2008-6#1)(2008-8#1)(2013-1#1)
the bone remodeling##3##3##(1991-11#1)(2007-8#1)(2010-9#1)
the bone resorption##6##3##(1991-7#2)(2005-3#2)(2008-11#1)(2013-8#1)
the bone resorptive##2##3##(1993-9#1)(2011-2#1)
the bone scan##3##3##(2007-11#1)(2010-12#2)
the bone surface##2##3##(2007-4#1)(2010-9#1)
the bone tissue##11##3##(1995-6#3)(2006-6#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-8#1)(2009-3#1)(2013-1#1)
the bone to##3##3##(2007-2#1)(2008-6#1)(2012-12#1)
the bone turnover##2##3##(2012-3#1)(2013-8#1)
the bone union process##2##4##(2007-11#2)
the bone union##7##3##(2007-11#3)(2007-8#4)
the bone volume##2##3##(2009-3#1)(2011-2#1)
the bone##261##2##(1990-10#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#6)(1991-12#1)(1991-3#1)(1991-7#2)(1991-8#2)(1992-5#1)(1992-8#1)(1993-11#2)(1993-8#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#2)(1995-1#4)(1995-2#2)(1995-6#7)(1996-10#1)(1996-11#1)(1996-3#1)(1997-3#1)(2004-2#2)(2004-9#3)(2005-3#5)(2005-7#2)(2005-8#1)(2006-10#5)(2006-11#2)(2006-2#1)(2006-5#1)(2006-6#2)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#18)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#9)(2008-1#8)(2008-10#3)(2008-11#6)(2008-12#3)(2008-3#1)(2008-4#4)(2008-5#5)(2008-6#7)(2008-7#12)(2008-8#2)(2008-9#3)(2009-2#2)(2009-3#15)(2009-4#2)(2009-6#1)(2009-7#4)(2009-8#1)(2010-11#4)(2010-12#3)(2010-2#1)(2010-3#2)(2010-6#6)(2010-8#1)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#10)(2012-1#4)(2012-12#8)(2012-2#3)(2012-3#2)(2013-1#7)(2013-8#10)
the bone-forming##2##2##(1992-7#1)(1993-11#1)
the bone-implant interface##2##3##(2008-5#1)(2009-4#1)
the bone-resorbing activity of mature osteoclasts through##2##7##(2008-11#2)
the bone-resorbing activity of##3##4##(2008-11#3)
the bone-resorbing##4##2##(2008-11#4)
the bones of the##3##4##(1993-12#1)(2008-6#1)(2009-10#1)
the bones of##4##3##(1993-12#1)(2008-6#1)(2009-10#1)(2009-8#1)
the bones with##2##3##(2007-2#1)(2008-9#1)
the bones##23##2##(1992-11#1)(1992-9#1)(1993-12#1)(1995-3#2)(2007-11#1)(2007-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-3#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-1#1)(2013-8#1)
the bony defect##3##3##(2005-9#1)(2007-12#1)(2010-12#1)
the bony structures of the##2##5##(2008-10#1)(2008-6#1)
the bony structures##3##3##(2007-11#1)(2008-10#1)(2008-6#1)
the bony surface##2##3##(2009-3#1)(2011-1#1)
the bony##26##2##(1993-5#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
the book##11##2##(2006-3#1)(2007-6#1)(2008-1#3)(2008-11#1)(2008-4#3)(2008-7#1)(2010-4#1)
the book's##2##2##(2008-4#1)(2013-1#1)
the books##4##2##(1994-3#1)(2008-4#2)(2012-12#1)
the booster##3##2##(1992-7#2)(2011-2#1)
the boosting##2##2##(2008-11#1)(2010-12#1)
the bootstrap analysis##2##3##(2008-10#2)
the bootstrap##5##2##(1996-8#1)(2008-10#3)(2009-3#1)
the border between the##4##4##(2006-2#1)(2007-12#2)(2007-3#1)
the border between##5##3##(2006-2#1)(2007-12#2)(2007-3#1)(2013-1#1)
the border of the##3##4##(1991-6#1)(2007-12#1)(2008-5#1)
the border of##12##3##(1991-6#1)(1991-9#1)(1996-10#1)(2007-12#2)(2008-10#1)(2008-5#1)(2008-9#1)(2012-2#4)
the border zone of##2##4##(2012-12#1)(2012-2#1)
the border##26##2##(1990-11#1)(1991-6#1)(1991-9#1)(1996-10#1)(1997-3#1)(2006-2#1)(2007-12#4)(2007-3#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#5)(2013-1#1)
the border-crossing adjustment##2##3##(1995-12#2)
the borderline of##2##3##(1992-1#2)
the borderline value##2##3##(1990-9#1)(1992-6#1)
the borderline##15##2##(1990-2#2)(1990-9#1)(1992-1#3)(1992-6#1)(1995-4#1)(2007-2#1)(2007-9#1)(2009-8#1)(2010-7#2)(2011-1#1)(2012-1#1)
the borders of the##3##4##(1990-7#1)(1994-3#1)(2008-10#1)
the borders of##9##3##(1990-7#1)(1994-3#1)(2008-1#1)(2008-10#3)(2009-2#1)(2009-9#1)(2012-11#1)
the borders##12##2##(1990-7#1)(1993-11#1)(1994-3#1)(1994-9#1)(2008-1#1)(2008-10#3)(2008-2#1)(2009-2#1)(2009-9#1)(2012-11#1)
the boron##5##2##(1990-3#1)(1992-12#1)(1993-11#2)(1996-2#1)
the boronic acid group##3##4##(2008-10#3)
the boronic acid##4##3##(1996-7#1)(2008-10#3)
the botanical origin of the##2##5##(2008-10#2)
the botanical##5##2##(2006-12#1)(2008-10#3)(2008-4#1)
the botanist##2##2##(2009-2#1)(2009-4#1)
the both the##5##3##(1997-4#1)(2004-11#1)(2007-6#1)(2011-1#1)(2013-1#1)
the both##21##2##(1992-9#1)(1994-11#1)(1996-3#1)(1997-1#1)(1997-4#1)(2004-11#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-12#1)(2013-1#2)
the bottleneck##3##2##(2008-10#1)(2008-2#1)(2010-7#1)
the bottom 15% and 30% of actual##3##7##(2007-9#3)
the bottom and##2##3##(2008-5#2)
the bottom layer##5##3##(2008-2#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-3#1)
the bottom line##4##3##(1994-1#1)(1995-1#1)(1997-6#1)(2007-9#1)
the bottom of a##4##4##(1991-7#1)(1997-5#1)(2006-10#1)(2008-11#1)
the bottom of the atmosphere##3##5##(2008-2#2)(2008-3#1)
the bottom of the##22##4##(1994-11#1)(1995-8#1)(2006-2#1)(2007-1#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-8#1)(2009-12#2)(2009-9#1)(2012-4#1)(2013-8#1)
the bottom of##34##3##(1991-7#1)(1992-4#1)(1994-11#1)(1995-8#1)(1997-5#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#2)(2009-9#1)(2011-1#1)(2011-2#1)(2012-4#1)(2013-8#1)
the bottom phase##3##3##(1992-11#1)(2008-10#2)
the bottom surface of the##3##5##(2007-12#1)(2008-11#2)
the bottom surface of##4##4##(2007-12#1)(2008-11#2)(2011-2#1)
the bottom surface##6##3##(2007-12#1)(2008-11#2)(2008-12#1)(2011-2#1)(2013-8#1)
the bottom##88##2##(1990-3#1)(1991-11#1)(1991-7#1)(1992-11#1)(1992-4#1)(1994-1#1)(1994-11#1)(1995-1#1)(1995-8#1)(1997-5#1)(1997-6#1)(2004-3#1)(2005-3#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2007-1#1)(2007-12#4)(2007-7#1)(2007-9#5)(2008-10#5)(2008-11#5)(2008-12#2)(2008-2#9)(2008-3#10)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#2)(2009-9#2)(2010-2#1)(2011-1#1)(2011-2#5)(2012-3#1)(2012-4#1)(2013-7#1)(2013-8#2)
the bottom-up##3##2##(2008-11#1)(2008-7#1)(2011-12#1)
the botulinum toxin C1 light chain##3##6##(2008-4#3)
the botulinum##6##2##(1990-5#1)(1995-12#1)(2008-4#3)(2011-2#1)
the bound CaD*##2##3##(1994-5#2)
the bound and unbound##2##4##(1994-8#1)(2008-4#1)
the bound and##5##3##(1992-12#1)(1994-11#1)(1994-8#1)(1996-8#1)(2008-4#1)
the bound antigen##3##3##(1990-12#1)(2008-4#2)
the bound dye##2##3##(1996-1#2)
the bound inhibitor is##2##4##(1993-11#1)(2012-2#1)
the bound inhibitor##4##3##(1993-11#2)(2012-2#2)
the bound leading-edge vortex and wake distortion##2##7##(2005-10#2)
the bound leading-edge vortex##4##4##(2005-10#4)
the bound peptide##3##3##(1995-11#1)(1995-3#2)
the bound peptides##2##3##(1997-4#1)(2008-4#1)
the bound protein 4##2##4##(2006-10#2)
the bound protein##4##3##(1995-1#1)(2006-10#2)(2008-4#1)
the bound thymocytes on##2##4##(2008-8#2)
the bound##97##2##(1990-10#2)(1990-12#3)(1990-2#1)(1990-7#6)(1991-4#1)(1991-5#3)(1992-12#2)(1992-6#4)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#3)(1993-3#2)(1993-9#1)(1994-11#1)(1994-5#2)(1994-8#2)(1995-1#2)(1995-10#1)(1995-11#2)(1995-3#2)(1995-5#2)(1995-8#2)(1996-1#2)(1996-12#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#3)(1997-7#1)(2005-10#4)(2005-7#2)(2006-10#6)(2006-12#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-4#6)(2008-7#1)(2008-8#2)(2009-12#1)(2010-12#2)(2010-8#1)(2012-12#1)(2012-2#4)
the boundaries between##3##3##(2006-3#1)(2007-12#1)(2008-11#1)
the boundaries of the##8##4##(1997-1#1)(1997-6#1)(1997-8#1)(2006-5#1)(2006-8#1)(2008-7#1)(2008-9#1)(2010-6#1)
the boundaries of this##3##4##(1991-7#1)(1995-1#1)(2008-7#1)
the boundaries of##14##3##(1991-7#1)(1993-9#1)(1995-1#1)(1997-1#1)(1997-6#1)(1997-8#1)(2006-5#1)(2006-8#1)(2007-12#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-6#1)
the boundaries##27##2##(1991-7#1)(1993-9#1)(1995-1#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-6#1)(1997-8#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
the boundary between the##6##4##(1991-6#1)(1997-8#1)(2008-2#2)(2009-9#1)(2013-1#1)
the boundary between##17##3##(1991-6#1)(1994-12#1)(1995-6#1)(1997-8#2)(2006-11#1)(2007-9#1)(2008-2#2)(2009-9#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
the boundary conditions of the##3##5##(2006-10#1)(2006-4#1)(2013-8#1)
the boundary conditions##8##3##(2006-10#1)(2006-11#1)(2006-4#1)(2008-3#1)(2008-7#1)(2009-12#1)(2012-1#1)(2013-8#1)
the boundary layer##5##3##(2008-11#2)(2008-3#3)
the boundary of the##9##4##(1994-8#1)(1996-12#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-2#3)(2012-1#1)
the boundary of##14##3##(1990-5#1)(1994-8#1)(1996-11#1)(1996-12#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-2#4)(2008-8#1)(2009-8#1)(2012-1#1)
the boundary value and##2##4##(2008-3#2)
the boundary value##4##3##(2008-2#1)(2008-3#3)
the boundary##69##2##(1990-11#1)(1990-5#1)(1991-2#1)(1991-6#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-6#1)(1996-11#1)(1996-12#1)(1997-3#1)(1997-8#2)(2006-10#2)(2006-11#2)(2006-4#1)(2007-11#2)(2007-12#2)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#9)(2008-3#10)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#3)
the boundary-element method (BEM)##2##4##(2008-11#1)(2008-3#1)
the boundary-element method##3##3##(2008-11#1)(2008-3#2)
the boundary-element##4##2##(2007-12#1)(2008-11#1)(2008-3#2)
the bounds##4##2##(2007-9#1)(2008-10#1)(2008-3#1)(2012-2#1)
the bovine BAC##2##3##(2008-7#2)
the bovine NPR-B##2##3##(1994-8#2)
the bovine adrenal##4##3##(1993-3#2)(1994-12#2)
the bovine and human##3##4##(1992-11#2)(1992-7#1)
the bovine and rat##2##4##(1991-5#1)(1993-4#1)
the bovine and##8##3##(1991-10#2)(1991-5#1)(1992-11#2)(1992-6#1)(1992-7#1)(1993-4#1)
the bovine brain##5##3##(1990-7#2)(1991-5#1)(1994-3#1)(1997-2#1)
the bovine cDNA##2##3##(1990-7#1)(1991-10#1)
the bovine chromaffin##3##3##(1990-2#2)(2008-5#1)
the bovine enzyme##2##3##(1995-11#1)(1996-9#1)
the bovine heart mitochondrial F1-ATPase##2##5##(1991-3#2)
the bovine heart##3##3##(1991-3#2)(1992-12#1)
the bovine natriuretic peptide receptor-B##2##5##(1994-8#2)
the bovine protein##2##3##(1994-9#1)(1997-4#1)
the bovine retina##2##3##(1990-7#1)(1991-10#1)
the bovine serum albumin##3##4##(2008-10#1)(2008-5#2)
the bovine tissue##2##3##(1991-12#1)(2008-2#1)
the bovine β-actin gene##2##4##(2012-3#2)
the bovine##107##2##(1990-2#2)(1990-7#4)(1990-8#1)(1990-9#2)(1991-10#6)(1991-12#2)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#5)(1992-12#7)(1992-3#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-10#1)(1993-2#2)(1993-3#3)(1993-4#3)(1993-5#2)(1993-9#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-8#4)(1994-9#1)(1995-11#5)(1996-10#2)(1996-12#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-7#2)(2004-11#1)(2005-8#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#2)
the bowel and##2##3##(1996-3#1)(1996-6#1)
the bowel wall and##3##4##(1992-5#1)(2006-6#1)(2007-5#1)
the bowel wall##10##3##(1992-5#1)(2006-6#1)(2007-5#2)(2008-8#2)(2009-12#2)(2012-2#2)
the bowel##31##2##(1991-3#1)(1992-12#1)(1992-4#1)(1992-5#2)(1993-9#1)(1994-9#1)(1996-3#1)(1996-6#1)(2006-10#2)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#2)(2007-4#1)(2007-5#3)(2008-3#1)(2008-8#2)(2009-12#2)(2009-2#1)(2010-12#1)(2011-11#1)(2012-2#2)
the bowels##3##2##(1996-6#2)(2009-10#1)
the box to##3##3##(2010-11#1)(2012-1#2)
the box##17##2##(1993-9#1)(1995-12#1)(1995-2#1)(1997-3#1)(2006-2#1)(2007-9#1)(2009-12#1)(2010-11#1)(2012-1#9)
the boy and##2##3##(1996-5#1)(2012-2#1)
the boy##9##2##(1995-5#2)(1996-5#3)(2006-2#1)(2008-10#1)(2012-2#2)
the boy/The boy is##2##4##(2008-11#2)
the boys##10##2##(1991-8#1)(1991-9#3)(1993-10#1)(1996-6#1)(2006-7#1)(2007-11#1)(2007-2#1)(2009-8#1)
the boys'##2##2##(2009-10#1)(2011-1#1)
the brace##2##2##(2006-7#1)(2011-2#1)
the brachial artery##6##3##(1997-2#3)(2007-8#1)(2013-1#2)
the brachial plexus and##2##4##(2006-1#1)(2006-3#1)
the brachial plexus##13##3##(2005-8#1)(2006-1#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-8#2)(2007-10#1)(2008-9#2)(2009-3#3)
the brachial##24##2##(1997-2#3)(2005-8#1)(2006-1#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-8#2)(2007-10#1)(2007-8#1)(2008-9#2)(2009-1#3)(2009-3#3)(2010-12#1)(2013-1#2)(2013-8#1)
the brachiation strides characterized by each transition type are mainly associated with speed##2##13##(2012-12#2)
the brachiocephalic##2##2##(1997-6#1)(2006-5#1)
the brachioradialis##2##2##(2006-3#1)(2009-3#1)
the bradycardia##2##2##(1991-5#1)(1993-11#1)
the bradycardic##2##2##(1997-2#2)
the bradykinin##3##2##(1990-3#1)(1993-12#1)(1997-5#1)
the bradykinin-induced activation of##2##4##(1995-3#2)
the bradykinin-induced##5##2##(1991-12#1)(1994-3#1)(1995-3#2)(1996-5#1)
the brain activations##2##3##(2009-2#1)(2012-12#1)
the brain activity##2##3##(2008-10#1)(2008-11#1)
the brain and in the##2##5##(1990-5#1)(1995-3#1)
the brain and in##6##4##(1990-5#1)(1991-11#1)(1992-3#1)(1994-2#1)(1995-3#1)(2008-3#1)
the brain and its##4##4##(1997-2#1)(2010-11#1)(2012-2#1)(2013-8#1)
the brain and liver##2##4##(1992-4#2)
the brain and lungs##2##4##(2008-7#1)(2009-9#1)
the brain and may##2##4##(1995-11#1)(2007-1#1)
the brain and nervous system##2##5##(2007-12#1)(2008-10#1)
the brain and pancreas##2##4##(1995-6#1)(2010-12#1)
the brain and reproductive##2##4##(1990-11#1)(2010-1#1)
the brain and spinal cord of##2##6##(1997-3#1)(2008-11#1)
the brain and spinal cord##12##5##(1995-3#1)(1996-12#1)(1997-3#1)(2006-10#2)(2007-11#1)(2008-11#2)(2008-5#1)(2008-7#1)(2010-12#1)(2010-8#1)
the brain and the##11##4##(1993-5#1)(1994-11#1)(1995-12#2)(1995-4#1)(1996-9#1)(1997-5#1)(2007-4#1)(2008-2#1)(2010-8#1)(2012-3#1)
the brain and##94##3##(1990-11#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#2)(1992-8#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-7#2)(1997-8#1)(2004-1#1)(2004-11#1)(2005-10#1)(2006-10#3)(2006-11#2)(2007-1#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#2)(2009-5#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-8#3)(2011-1#3)(2011-2#1)(2012-1#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the brain are##13##3##(1993-7#1)(1994-11#1)(1995-12#1)(1995-5#1)(1996-4#1)(1997-6#1)(2007-12#1)(2008-11#1)(2008-3#1)(2010-12#1)(2010-9#1)(2013-1#2)
the brain area##4##3##(1994-11#1)(1997-3#1)(2007-8#1)(2011-2#1)
the brain areas activated by##2##5##(1993-7#1)(2008-9#1)
the brain areas##4##3##(1993-7#1)(1995-12#1)(2008-7#1)(2008-9#1)
the brain as a##4##4##(1994-11#1)(2007-9#2)(2009-6#1)
the brain as the##2##4##(1994-5#1)(2010-7#1)
the brain as well as##3##5##(2008-11#1)(2008-6#1)(2009-12#1)
the brain as##12##3##(1994-11#1)(1994-2#1)(1994-5#1)(2005-10#1)(2007-9#2)(2008-11#1)(2008-2#1)(2008-6#1)(2009-12#1)(2009-6#1)(2010-7#1)
the brain at the##3##4##(1995-5#1)(2007-1#2)
the brain at##5##3##(1995-5#1)(1996-4#1)(2007-1#2)(2007-12#1)
the brain but##4##3##(1990-11#1)(1992-6#1)(2007-2#1)(2008-7#1)
the brain by##8##3##(1990-2#1)(1993-7#1)(1994-10#1)(1995-3#1)(1996-12#1)(2008-10#1)(2008-5#1)(2010-5#1)
the brain can be##3##4##(1993-11#1)(2006-11#1)(2008-2#1)
the brain can##5##3##(1991-2#1)(1993-11#1)(2006-11#1)(2007-9#1)(2008-2#1)
the brain cortex##5##3##(1991-4#1)(1991-5#1)(2006-6#1)(2010-12#1)(2012-1#1)
the brain damage##2##3##(1994-2#1)(2011-2#1)
the brain death##3##3##(1995-6#1)(1996-2#1)(2007-11#1)
the brain determine##2##3##(2007-8#1)(2010-5#1)
the brain development##2##3##(1996-2#1)(2011-1#1)
the brain distribution of##2##4##(1996-10#1)(1996-12#1)
the brain during##5##3##(1993-7#1)(1995-2#1)(2007-8#1)(2011-1#1)(2013-1#1)
the brain edema formation##2##4##(2007-10#2)
the brain following##3##3##(1995-12#2)(1996-12#1)
the brain from##5##3##(1995-12#1)(1996-1#1)(2007-11#1)(2008-3#1)(2010-2#1)
the brain functional activity##2##4##(1995-3#1)(2006-6#1)
the brain functional##3##3##(1995-3#1)(2006-6#1)(2009-8#1)
the brain had##4##3##(1991-6#1)(1994-5#1)(1996-4#1)(2008-7#1)
the brain has a unique##2##5##(2008-11#2)
the brain has been##4##4##(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#1)
the brain has##7##3##(2007-12#1)(2008-1#1)(2008-11#4)(2008-4#1)
the brain in a##3##4##(1997-7#1)(2007-12#1)(2009-8#1)
the brain in the##3##4##(1995-1#1)(1997-4#1)(2008-11#1)
the brain in##21##3##(1990-7#1)(1993-7#1)(1995-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-11#1)(2007-12#2)(2008-1#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-1#3)
the brain injury##2##3##(2006-11#1)(2013-1#1)
the brain is still##2##4##(2006-1#1)(2007-12#1)
the brain is##20##3##(1991-11#1)(1991-4#1)(1994-11#1)(1994-2#1)(1994-5#2)(1995-11#1)(1995-12#1)(1996-12#1)(1996-9#1)(1997-3#1)(2006-1#1)(2007-12#1)(2007-8#1)(2008-11#3)(2009-5#1)(2009-6#1)(2012-12#1)
the brain isoform##2##3##(1992-8#1)(1994-12#1)
the brain l-CaD##2##3##(1993-11#2)
the brain lesions##2##3##(1997-3#1)(2011-2#1)
the brain may be##2##4##(1992-3#1)(1995-10#1)
the brain may##5##3##(1992-3#1)(1993-12#1)(1995-10#1)(1996-4#1)(2011-1#1)
the brain must##2##3##(1990-5#1)(2009-8#1)
the brain networks##2##3##(2009-8#1)(2013-8#1)
the brain of a##3##4##(1992-3#1)(1997-3#1)(2009-3#1)
the brain of each rat was harvested and processed to examine several biochemical parameters##2##14##(2008-4#2)
the brain of one-year-old infants##2##5##(2009-2#2)
the brain of the common marmoset##2##6##(1995-5#2)
the brain of the frog Rana pipiens##2##7##(1997-3#2)
the brain of the frog Rana##3##6##(1993-5#1)(1997-3#2)
the brain of the leech Theromyzon tessulatum##2##7##(1996-12#2)
the brain of the transgenic mice##2##6##(1994-2#1)(2007-10#1)
the brain of the##20##4##(1990-4#1)(1991-7#1)(1993-5#2)(1994-2#2)(1995-5#2)(1996-10#1)(1996-12#2)(1997-3#3)(1997-6#1)(2007-10#1)(2007-12#2)(2008-6#2)
the brain of##75##3##(1990-10#1)(1990-4#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-5#2)(1992-9#1)(1993-3#1)(1993-5#4)(1994-2#5)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#3)(1995-6#1)(1995-7#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-5#2)(1997-3#4)(1997-5#1)(1997-6#1)(2007-10#1)(2007-12#3)(2008-1#1)(2008-4#3)(2008-6#4)(2008-7#3)(2008-8#1)(2009-2#3)(2009-3#1)(2010-12#2)(2010-4#1)(2011-11#1)(2012-1#3)
the brain or##3##3##(2006-10#1)(2010-6#1)(2011-1#1)
the brain parenchyma after##2##4##(1993-12#1)(1996-1#1)
the brain parenchyma in##2##4##(2007-9#1)(2009-8#1)
the brain parenchyma##15##3##(1992-12#1)(1993-12#1)(1994-5#1)(1996-1#1)(1996-2#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#2)(2008-8#1)(2009-8#1)
the brain regions##7##3##(1992-9#1)(1994-2#1)(1994-8#1)(1995-5#1)(1996-10#2)(1996-3#1)
the brain reward system##2##4##(2007-8#1)(2011-2#1)
the brain reward##4##3##(2007-8#1)(2008-7#1)(2011-2#1)(2013-8#1)
the brain show##2##3##(1994-12#1)(2010-5#1)
the brain slice##5##3##(2008-11#5)
the brain stem and spinal cord##2##6##(2008-7#2)
the brain stem and##5##4##(1991-6#1)(2008-4#1)(2008-7#2)(2010-10#1)
the brain stem##27##3##(1990-5#1)(1991-6#1)(1993-3#1)(1994-2#1)(1995-12#4)(1996-1#2)(1996-7#1)(2006-1#1)(2006-12#2)(2007-9#1)(2008-4#1)(2008-7#5)(2009-3#1)(2010-10#2)(2011-1#1)(2012-3#1)(2013-1#1)
the brain structure##2##3##(2007-12#1)(2013-8#1)
the brain structures##2##3##(1996-12#2)
the brain surface##3##3##(1990-2#2)(2008-1#1)
the brain that are##2##4##(2006-3#1)(2006-8#1)
the brain that##11##3##(1995-1#1)(1996-12#1)(1996-5#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-12#1)(2008-4#1)(2009-12#1)(2009-3#1)(2009-5#1)
the brain through##2##3##(2010-5#1)(2013-1#1)
the brain tissue was##3##4##(1990-9#1)(1994-3#1)(2007-8#1)
the brain tissue##20##3##(1990-9#1)(1993-2#1)(1994-3#1)(1995-12#1)(1996-5#1)(1996-9#1)(1997-8#1)(2006-11#1)(2007-4#1)(2007-8#2)(2007-9#2)(2008-3#1)(2008-5#1)(2010-11#1)(2010-4#1)(2012-1#2)(2013-8#1)
the brain tissues##2##3##(2006-11#1)(2012-1#1)
the brain to##13##3##(1991-1#1)(1995-12#1)(1996-4#1)(2006-4#1)(2007-1#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-9#1)(2012-1#1)
the brain under normal##2##4##(2006-7#1)(2007-9#1)
the brain under##3##3##(2006-7#1)(2007-1#1)(2007-9#1)
the brain using##2##3##(2007-4#1)(2012-2#1)
the brain via##2##3##(1995-7#1)(2010-5#1)
the brain was##16##3##(1991-2#1)(1992-11#1)(1992-3#2)(1993-12#2)(1994-5#1)(1995-12#1)(1996-3#1)(1997-2#1)(2006-11#2)(2007-9#2)(2010-1#1)(2011-2#1)
the brain were##7##3##(1992-8#1)(1995-11#1)(2005-8#1)(2006-11#1)(2007-1#1)(2008-8#1)(2008-9#1)
the brain where##5##3##(1995-3#1)(1997-8#1)(2007-11#1)(2008-6#1)(2010-8#1)
the brain with##4##3##(2006-11#1)(2011-1#1)(2011-2#1)(2013-8#1)
the brain##1028##2##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#4)(1990-3#2)(1990-4#6)(1990-5#5)(1990-6#1)(1990-7#5)(1990-8#1)(1990-9#2)(1991-1#2)(1991-11#3)(1991-12#2)(1991-2#7)(1991-3#2)(1991-4#2)(1991-5#5)(1991-6#3)(1991-7#2)(1991-8#2)(1991-9#4)(1992-1#2)(1992-10#3)(1992-11#3)(1992-12#8)(1992-2#1)(1992-3#9)(1992-4#2)(1992-5#3)(1992-6#3)(1992-7#1)(1992-8#5)(1992-9#6)(1993-1#1)(1993-10#1)(1993-11#5)(1993-12#8)(1993-2#1)(1993-3#7)(1993-4#5)(1993-5#5)(1993-6#1)(1993-7#7)(1993-8#2)(1993-9#2)(1994-10#6)(1994-11#8)(1994-12#6)(1994-2#21)(1994-3#5)(1994-5#13)(1994-6#4)(1994-8#7)(1994-9#3)(1995-1#8)(1995-10#2)(1995-11#8)(1995-12#33)(1995-2#3)(1995-3#8)(1995-4#2)(1995-5#17)(1995-6#6)(1995-7#3)(1995-9#1)(1996-1#5)(1996-10#8)(1996-12#16)(1996-2#6)(1996-3#10)(1996-4#9)(1996-5#12)(1996-6#3)(1996-7#2)(1996-9#7)(1997-1#1)(1997-2#9)(1997-3#9)(1997-4#5)(1997-5#8)(1997-6#3)(1997-7#4)(1997-8#8)(2004-1#1)(2004-11#1)(2005-10#2)(2005-7#1)(2005-8#2)(2006-1#3)(2006-10#12)(2006-11#17)(2006-12#4)(2006-2#2)(2006-3#3)(2006-4#1)(2006-5#1)(2006-6#6)(2006-7#2)(2006-8#4)(2006-9#1)(2007-1#12)(2007-10#14)(2007-11#22)(2007-12#33)(2007-2#1)(2007-3#1)(2007-4#6)(2007-8#14)(2007-9#14)(2008-1#19)(2008-10#5)(2008-11#35)(2008-12#2)(2008-2#8)(2008-3#7)(2008-4#25)(2008-5#12)(2008-6#14)(2008-7#34)(2008-8#16)(2008-9#8)(2009-10#3)(2009-11#3)(2009-12#6)(2009-2#7)(2009-3#8)(2009-4#1)(2009-5#7)(2009-6#3)(2009-7#5)(2009-8#10)(2009-9#4)(2010-1#4)(2010-10#2)(2010-11#3)(2010-12#13)(2010-2#4)(2010-4#5)(2010-5#7)(2010-6#2)(2010-7#2)(2010-8#8)(2010-9#2)(2011-1#16)(2011-11#1)(2011-2#11)(2012-1#19)(2012-11#1)(2012-12#4)(2012-2#15)(2012-3#3)(2013-1#25)(2013-7#5)(2013-8#8)
the brain's extracellular##2##3##(1994-12#1)(2007-8#1)
the brain's response to##2##4##(1996-3#1)(2006-10#1)
the brain's##18##2##(1992-1#1)(1994-12#1)(1994-2#1)(1995-9#1)(1996-3#1)(2006-10#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-4#1)(2008-6#1)(2009-8#2)(2011-1#1)(2012-12#1)
the brain-dead##2##2##(2006-4#1)(2008-3#1)
the brain-derived##2##2##(1992-11#1)(2007-11#1)
the brain-gut axis##4##3##(2009-10#4)
the brain-gut##5##2##(2009-10#4)(2013-1#1)
the brain-specific##5##2##(1991-1#1)(1992-8#1)(1993-11#1)(1995-12#1)(1995-6#1)
the brain?##2##2##(1995-5#1)(2008-4#1)
the brain]##4##2##(1990-9#1)(1992-10#1)(1992-3#1)(1994-5#1)
the brains and##3##3##(1997-3#1)(2008-6#2)
the brains of Alzheimer's##3##4##(1994-5#1)(1995-5#1)(1996-8#1)
the brains of animals##3##4##(1993-2#1)(1997-3#1)(2006-8#1)
the brains of individuals##2##4##(1996-1#1)(2007-11#1)
the brains of living##2##4##(1995-10#1)(2008-7#1)
the brains of patients with##7##5##(1990-7#1)(1991-1#1)(1992-8#2)(1995-3#1)(2008-1#1)(2011-1#1)
the brains of patients##9##4##(1990-7#1)(1991-1#1)(1992-8#2)(1995-3#1)(1997-5#1)(2008-1#1)(2010-11#1)(2011-1#1)
the brains of##52##3##(1990-11#1)(1990-7#1)(1991-1#1)(1991-5#2)(1992-1#1)(1992-8#2)(1993-2#1)(1994-5#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#3)(1996-1#1)(1996-10#1)(1996-11#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#3)(1997-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-9#1)(2008-1#1)(2008-11#4)(2008-2#1)(2008-4#1)(2008-7#2)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-8#2)
the brains were##3##3##(1993-2#1)(1996-10#1)(2007-1#1)
the brains##61##2##(1990-11#1)(1990-7#1)(1991-1#1)(1991-5#2)(1992-1#1)(1992-12#1)(1992-8#2)(1993-2#2)(1994-5#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#3)(1996-1#1)(1996-10#2)(1996-11#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#4)(1997-5#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#5)(2007-9#1)(2008-1#1)(2008-11#4)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#2)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
the brainstem and##4##3##(1996-11#1)(2006-12#1)(2007-11#1)(2008-4#1)
the brainstem in##2##3##(2005-10#1)(2012-1#1)
the brainstem reticular formation##4##4##(1991-5#1)(1996-11#1)(1997-6#1)(2007-1#1)
the brainstem trigeminal complex##2##4##(1990-4#1)(1991-11#1)
the brainstem##45##2##(1990-4#1)(1990-7#2)(1991-11#4)(1991-12#1)(1991-5#1)(1992-11#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-8#2)(1994-2#1)(1994-3#1)(1996-11#2)(1997-3#1)(1997-6#4)(2005-10#1)(2006-12#2)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-2#1)(2010-2#1)(2011-2#1)(2012-1#2)(2012-3#3)
the branch cuts##3##3##(2008-3#3)
the branch##13##2##(1992-12#1)(1993-11#1)(1994-8#1)(1995-3#1)(2008-2#1)(2008-3#3)(2008-9#1)(2010-6#1)(2011-1#2)(2012-2#1)
the branched alkyl chains##2##4##(1997-1#2)
the branched alkyl##3##3##(1997-1#3)
the branched##9##2##(1990-10#1)(1996-5#2)(1997-1#3)(1997-2#1)(1997-4#1)(2012-3#1)
the branches of the external carotid artery##2##7##(1997-3#2)
the branches of the left##2##5##(1991-11#1)(2007-8#1)
the branches of the##8##4##(1991-11#1)(1995-6#1)(1997-3#2)(2007-8#1)(2008-11#1)(2009-3#1)(2012-3#1)
the branches of##9##3##(1991-11#1)(1995-6#1)(1997-3#2)(2007-8#1)(2008-11#1)(2009-3#1)(2011-1#1)(2012-3#1)
the branches##13##2##(1991-11#1)(1995-6#1)(1997-3#2)(2004-11#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-3#1)(2011-1#1)(2012-3#1)
the branchial heart##5##3##(2008-7#5)
the branchial nerves##2##3##(1995-6#2)
the branchial##14##2##(1993-12#1)(1995-6#2)(1996-5#1)(2006-7#1)(2008-5#1)(2008-7#8)
the branching pattern of##3##4##(1997-3#1)(2011-1#2)
the branching##9##2##(1997-3#1)(2006-10#1)(2007-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#2)(2012-2#1)
the breadth and depth of##2##5##(1995-2#1)(2010-7#1)
the breadth of the##4##4##(2005-7#1)(2008-1#1)(2008-10#1)(2011-2#1)
the breadth of##9##3##(2005-7#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-7#1)(2011-2#2)
the breadth##12##2##(1995-2#1)(2005-6#1)(2005-7#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-7#1)(2010-7#1)(2011-2#2)
the break##6##2##(1990-8#1)(1993-12#1)(1994-3#1)(1994-8#1)(2008-10#1)(2012-2#1)
the break-even##2##2##(1992-12#1)(2007-4#1)
the breakage of##2##3##(1995-5#1)(2008-8#1)
the breakage##3##2##(1995-5#1)(2008-8#1)(2013-8#1)
the breakdown of ATP##2##4##(1990-11#1)(1994-9#1)
the breakdown of##16##3##(1990-11#1)(1991-1#1)(1991-3#1)(1994-9#1)(1995-4#1)(1995-6#1)(1997-4#1)(2006-10#1)(2006-3#1)(2008-10#2)(2008-12#1)(2008-4#1)(2010-3#1)(2011-2#1)(2012-2#1)
the breakdown products of the chemical warfare agent##2##8##(2008-11#2)
the breakdown products of the##3##5##(1994-2#1)(2008-11#2)
the breakdown products##4##3##(1994-2#1)(1996-3#1)(2008-11#2)
the breakdown pulses##2##3##(1991-5#2)
the breakdown threshold##2##3##(2008-1#1)(2008-3#1)
the breakdown zone##2##3##(1996-4#2)
the breakdown##29##2##(1990-11#1)(1991-1#1)(1991-3#1)(1991-5#2)(1992-7#1)(1994-2#1)(1994-9#1)(1995-4#1)(1995-6#1)(1996-3#1)(1996-4#2)(1997-4#1)(2006-10#1)(2006-3#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2010-3#1)(2011-2#1)(2012-2#1)
the breaking activity was##2##4##(1996-2#2)
the breaking of##3##3##(1996-5#1)(2008-3#1)(2011-2#1)
the breaking##10##2##(1996-2#3)(1996-5#1)(2005-11#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
the breakpoint junction of the##2##5##(1996-12#2)
the breakpoint##3##2##(1995-1#1)(1996-12#2)
the breakpoints for##2##3##(1990-5#2)
the breakpoints##6##2##(1990-5#2)(1995-1#1)(2008-5#2)(2013-1#1)
the breakthrough volumes##2##3##(2007-8#1)(2008-10#1)
the breakthrough##5##2##(1997-4#1)(1997-6#1)(2007-8#1)(2008-10#1)(2010-7#1)
the breakup of a##3##4##(2007-12#2)(2008-2#1)
the breakup of##7##3##(2004-3#1)(2007-12#2)(2008-2#1)(2008-7#1)(2009-2#1)(2009-8#1)
the breakup##8##2##(2004-3#1)(2007-12#3)(2008-2#1)(2008-7#1)(2009-2#1)(2009-8#1)
the breast and prostate##3##4##(2006-2#1)(2007-11#1)(2008-11#1)
the breast and##12##3##(1994-12#1)(1994-2#1)(2006-2#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-11#1)(2008-7#1)(2010-7#1)(2012-1#1)(2013-8#1)
the breast are##3##3##(1991-8#1)(1993-12#1)(2012-12#1)
the breast cancer cell line##3##5##(1991-7#1)(1995-8#1)(2008-3#1)
the breast cancer##15##3##(1991-7#1)(1993-11#1)(1993-8#1)(1994-12#1)(1995-8#1)(1996-4#1)(2004-2#1)(2008-3#1)(2008-4#3)(2009-12#1)(2010-12#1)(2012-3#1)(2013-8#1)
the breast epithelial mucin##4##4##(1993-1#4)
the breast feeding##2##3##(1992-2#1)(2011-1#1)
the breast is a##5##4##(1995-4#1)(2005-12#1)(2006-1#1)(2007-6#1)(2008-1#1)
the breast is##14##3##(1990-12#1)(1992-2#1)(1993-8#1)(1995-4#1)(1996-6#1)(2005-12#1)(2006-1#1)(2007-5#1)(2007-6#1)(2008-1#1)(2009-6#1)(2009-9#2)(2011-2#1)
the breast or##2##3##(1992-10#1)(2009-8#1)
the breast tissue##2##3##(2007-11#1)(2010-9#1)
the breast to##3##3##(1993-8#2)(2008-3#1)
the breast which##2##3##(1990-10#1)(2007-5#1)
the breast##179##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-4#4)(1990-6#1)(1991-4#3)(1991-7#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-2#5)(1992-5#1)(1992-8#1)(1993-1#5)(1993-11#1)(1993-12#3)(1993-2#1)(1993-5#2)(1993-6#1)(1993-8#6)(1994-12#4)(1994-2#1)(1994-6#2)(1994-7#6)(1994-8#1)(1995-10#1)(1995-4#5)(1995-8#1)(1995-9#1)(1996-10#1)(1996-3#1)(1996-4#1)(1996-6#7)(1997-3#1)(1997-7#1)(1997-8#2)(2004-1#2)(2004-2#6)(2005-12#1)(2006-1#3)(2006-10#1)(2006-2#1)(2007-10#2)(2007-11#4)(2007-2#2)(2007-4#4)(2007-5#4)(2007-6#4)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#6)(2008-6#2)(2008-7#2)(2008-9#2)(2009-1#1)(2009-12#1)(2009-2#1)(2009-5#3)(2009-6#3)(2009-8#2)(2009-9#2)(2010-12#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#7)
the breastfeeding##5##2##(2006-9#1)(2007-7#1)(2007-9#2)(2009-7#1)
the breasts##4##2##(1992-2#1)(1995-4#1)(2004-2#1)(2007-8#1)
the breath holding task##2##4##(2013-8#2)
the breath##5##2##(2006-2#1)(2008-10#1)(2008-4#1)(2013-8#2)
the breathing cassette##3##3##(1991-3#3)
the breathing##8##2##(1991-3#3)(1995-11#1)(1996-2#1)(1997-4#1)(2007-12#1)(2011-2#1)
the breed##3##2##(2005-9#1)(2006-5#1)(2008-12#1)
the breeding migration##3##3##(2008-5#1)(2008-6#2)
the breeding of##3##3##(1994-8#1)(2007-6#1)(2009-10#1)
the breeding period of##2##4##(2013-7#2)
the breeding period##5##3##(2007-3#2)(2013-7#3)
the breeding program##2##3##(2007-1#1)(2008-10#1)
the breeding season##15##3##(2005-7#1)(2008-5#1)(2008-6#3)(2008-8#4)(2008-9#1)(2009-10#1)(2010-8#3)(2013-7#1)
the breeding sites##2##3##(2006-10#1)(2008-5#1)
the breeding##46##2##(1992-12#1)(1994-8#1)(1995-6#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-1#1)(2007-3#3)(2007-6#1)(2007-9#1)(2008-10#3)(2008-5#5)(2008-6#6)(2008-8#5)(2008-9#3)(2009-10#2)(2010-8#4)(2013-7#4)
the breeds##2##2##(1996-12#1)(2011-2#1)
the brewing##3##2##(2008-10#1)(2013-1#2)
the bridge of the nose##2##5##(1995-4#1)(2013-1#1)
the bridge##12##2##(1995-4#1)(2006-2#1)(2006-6#1)(2008-11#1)(2008-2#4)(2012-2#1)(2013-1#3)
the bridging ligand##3##3##(1997-7#3)
the bridging oxygen##2##3##(1995-10#1)(1995-2#1)
the bridging##13##2##(1991-5#1)(1995-10#1)(1995-2#2)(1997-5#1)(1997-7#5)(2008-10#1)(2011-2#1)(2012-2#1)
the brief period##2##3##(1990-11#1)(1996-3#1)
the brief##14##2##(1990-11#1)(1992-1#1)(1996-11#1)(1996-3#2)(2004-11#1)(2007-7#2)(2008-11#1)(2008-2#1)(2008-9#1)(2009-4#1)(2009-5#1)(2013-1#1)
the bright lesions##2##3##(2010-8#2)
the bright light##2##3##(1996-2#1)(2013-1#1)
the bright spot##2##3##(2008-3#1)(2010-12#1)
the bright##13##2##(1996-2#1)(2006-12#1)(2007-12#2)(2008-1#1)(2008-3#3)(2008-8#1)(2010-12#1)(2010-8#2)(2013-1#1)
the brightest##4##2##(2007-12#2)(2008-1#1)(2012-2#1)
the brightness of the##3##4##(1997-8#1)(2008-2#1)(2008-3#1)
the brightness of##4##3##(1997-8#1)(2008-2#1)(2008-3#2)
the brightness##7##2##(1995-6#1)(1997-8#1)(2007-10#1)(2008-2#2)(2008-3#2)
the brine shrimp Artemia##4##4##(1994-8#1)(2007-12#2)(2008-9#1)
the british##2##2##(2006-11#1)(2012-2#1)
the brittle##2##2##(1991-12#1)(1996-4#1)
the broad field of the##2##5##(2007-7#1)(2009-4#1)
the broad field of##3##4##(1994-12#1)(2007-7#1)(2009-4#1)
the broad host range of##2##5##(2008-10#1)(2008-5#1)
the broad host range##5##4##(2008-10#1)(2008-5#1)(2011-12#1)(2012-2#1)(2013-7#1)
the broad host##6##3##(2008-10#1)(2008-5#1)(2011-12#1)(2012-2#2)(2013-7#1)
the broad range of##5##4##(2007-10#1)(2008-10#1)(2008-5#1)(2009-5#1)(2013-7#1)
the broad spectrum of##7##4##(2006-1#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-12#1)(2012-2#1)
the broad spectrum##8##3##(1992-3#1)(2006-1#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-12#1)(2012-2#1)
the broad##60##2##(1991-10#1)(1992-3#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-8#1)(1997-1#1)(1997-3#2)(1997-5#2)(1997-8#1)(2004-3#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#2)(2007-6#1)(2007-7#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2009-12#1)(2009-4#2)(2009-5#2)(2010-6#1)(2011-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#2)
the broad-spectrum##3##2##(1991-3#1)(2008-5#1)(2011-1#1)
the broadband algorithm##2##3##(2008-3#2)
the broadband##7##2##(2007-11#1)(2008-3#6)
the broadening of the##2##4##(1991-12#1)(2008-3#1)
the broadening of##3##3##(1991-12#1)(2008-3#1)(2012-12#1)
the broadening##10##2##(1991-12#1)(1991-8#1)(2007-11#2)(2008-2#3)(2008-3#2)(2012-12#1)
the broader community##2##3##(1993-1#1)(2007-10#1)
the broader context of##6##4##(2007-12#1)(2008-8#2)(2009-5#2)(2009-8#1)
the broader context##10##3##(1996-8#4)(2007-12#1)(2008-8#2)(2009-5#2)(2009-8#1)
the broader public##2##3##(1993-1#1)(2010-12#1)
the broader social##2##3##(2009-10#1)(2011-2#1)
the broader##40##2##(1993-1#2)(1994-12#2)(1996-8#4)(2006-10#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
the broadest##5##2##(1994-3#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-8#1)
the brochosomal coats##2##3##(2013-8#2)
the broiler##5##2##(1997-3#3)(2008-10#1)(2012-1#1)
the broilers##4##2##(1997-3#1)(2008-5#3)
the broken DNA strands##2##4##(1997-4#1)(2008-4#1)
the broken##5##2##(1990-8#1)(1997-4#1)(2008-4#1)(2012-2#1)(2013-8#1)
the bromate oxidation of N##2##5##(2008-10#2)
the bromate##3##2##(2008-10#2)(2010-5#1)
the bromide ion##2##3##(2008-10#2)
the bromide##4##2##(2008-10#3)(2008-8#1)
the bromination of monochlorodimedone##2##4##(1992-7#2)
the bromination of##3##3##(1992-7#2)(2010-2#1)
the bromination##5##2##(1992-7#2)(2008-10#1)(2010-2#1)(2010-5#1)
the bromine atom##2##3##(1991-3#1)(2010-2#1)
the bromine##3##2##(1991-3#1)(1996-5#1)(2010-2#1)
the bronchi##6##2##(1993-2#1)(2006-6#1)(2008-3#1)(2008-5#1)(2010-8#1)(2012-12#1)
the bronchi]##2##2##(1990-5#1)(1995-5#1)
the bronchial circulation##2##3##(1997-1#2)
the bronchial mucosa##3##3##(1990-9#1)(1991-12#2)
the bronchial resection margin##2##4##(2007-8#2)
the bronchial system##2##3##(1991-11#1)(1991-12#1)
the bronchial tree##6##3##(1994-9#1)(1995-12#2)(1996-1#1)(2005-11#1)(2008-4#1)
the bronchial vasculature##3##3##(1997-1#3)
the bronchial##37##2##(1990-9#2)(1991-11#1)(1991-12#5)(1991-9#1)(1992-2#1)(1994-9#1)(1995-12#3)(1996-1#1)(1997-1#6)(2005-11#1)(2006-6#2)(2007-12#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-4#1)(2009-4#1)(2010-8#2)(2011-2#1)
the bronchiolar##3##2##(2008-1#1)(2013-1#2)
the bronchiolitis obliterans syndrome##3##4##(2011-3#3)
the bronchoalveolar lavage fluid##3##4##(1992-11#1)(1995-12#1)(2005-8#1)
the bronchoalveolar lavage##7##3##(1992-11#1)(1994-6#2)(1995-12#1)(2005-8#2)(2013-8#1)
the bronchodilator##2##2##(1990-5#1)(2004-12#1)
the bronchoscope##4##2##(2008-11#2)(2008-5#1)(2010-8#1)
the bronchoscopic##4##2##(2007-8#1)(2008-5#2)(2010-8#1)
the bronchoscopy##2##2##(2010-10#1)(2010-8#1)
the bronchus##7##2##(1995-11#1)(2006-8#1)(2008-3#1)(2011-2#1)(2012-12#1)(2013-1#2)
the brood##6##2##(2008-12#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-12#2)
the broth microdilution##2##3##(2008-12#1)(2010-12#1)
the broth##5##2##(2008-12#1)(2008-7#1)(2010-12#1)(2010-2#1)(2012-2#1)
the brother##2##2##(1990-9#1)(1997-3#1)
the brow##2##2##(2004-10#1)(2010-8#1)
the brown algal##2##3##(2010-10#1)(2012-2#1)
the brown citrus aphid##2##4##(2008-10#2)
the brown##16##2##(1991-7#1)(1995-8#1)(2005-11#1)(2007-1#1)(2007-12#2)(2008-10#4)(2008-12#2)(2008-5#1)(2010-10#1)(2012-2#1)(2013-1#1)
the brown-headed cowbird##2##3##(2008-9#2)
the brownmillerite##2##2##(2010-12#2)
the brush border membrane of##4##5##(1990-11#3)(1991-12#1)
the brush border membrane##8##4##(1990-11#5)(1991-12#1)(1992-2#1)(2006-10#1)
the brush border of##2##4##(1990-12#1)(1991-8#1)
the brush border##15##3##(1990-11#6)(1990-12#1)(1991-12#1)(1991-8#1)(1992-2#1)(1993-6#1)(1994-12#1)(2006-10#1)(2008-7#2)
the brush phase##3##3##(2005-11#1)(2008-10#2)
the brush##25##2##(1990-11#6)(1990-12#1)(1991-12#2)(1991-8#1)(1992-2#1)(1993-6#1)(1994-12#1)(2005-11#2)(2006-10#1)(2008-10#2)(2008-7#2)(2009-5#2)(2010-4#2)(2012-11#1)
the brush-border membrane##3##3##(1990-11#1)(1994-11#1)(1994-6#1)
the bubble is##2##3##(2008-11#2)
the bubble surface##2##3##(2005-11#1)(2008-11#1)
the bubble##24##2##(1994-3#1)(1996-5#1)(2005-11#5)(2008-11#7)(2008-2#2)(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-11#4)
the bubbles##9##2##(2005-11#6)(2008-2#1)(2009-11#2)
the buccal and##3##3##(1991-7#1)(2007-12#1)(2012-3#1)
the buccal mucosa##13##3##(1991-2#1)(1992-9#1)(1994-4#1)(1995-9#1)(2007-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
the buccal pump##3##3##(2007-12#2)(2011-2#1)
the buccal##24##2##(1991-2#1)(1991-7#1)(1992-9#1)(1994-4#1)(1995-9#1)(2007-12#4)(2007-7#1)(2008-11#1)(2010-10#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
the buck##2##2##(2006-5#2)
the buckling of##2##3##(2008-9#1)(2012-2#1)
the bud site##2##3##(1997-4#2)
the bud##11##2##(1995-6#1)(1997-4#2)(2007-2#1)(2007-3#1)(2008-10#2)(2008-5#1)(2009-8#1)(2011-2#2)
the budded virus##2##3##(1993-11#1)(2008-11#1)
the budding process##2##3##(1997-6#1)(2011-2#1)
the budding yeast Saccharomyces cerevisiae##8##5##(1990-5#1)(1991-8#1)(1992-7#1)(1992-8#1)(1993-8#2)(1996-3#1)(1997-7#1)
the budding yeast##16##3##(1990-5#1)(1990-6#1)(1991-8#1)(1992-7#1)(1992-8#1)(1993-8#3)(1996-3#1)(1996-6#1)(1997-6#1)(1997-7#1)(2008-7#2)(2008-9#2)
the budding##25##2##(1990-5#1)(1990-6#1)(1991-8#1)(1992-7#1)(1992-8#1)(1993-8#3)(1996-3#1)(1996-6#3)(1997-6#2)(1997-7#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-7#2)(2008-9#2)(2011-2#1)(2013-1#1)
the budget of##3##3##(2008-11#2)(2012-2#1)
the budget##10##2##(1991-3#1)(1992-3#2)(1993-1#1)(1994-3#1)(2008-11#2)(2011-2#1)(2012-12#1)(2012-2#1)
the buffer and##2##3##(1992-4#1)(2008-10#1)
the buffer capacity##2##3##(2008-10#2)
the buffer in which##2##4##(2006-10#1)(2008-4#1)
the buffer in##3##3##(2006-10#1)(2008-10#1)(2008-4#1)
the buffer solution at##2##4##(1994-3#1)(2008-10#1)
the buffer solution##8##3##(1990-5#1)(1994-3#1)(2008-10#4)(2008-3#1)(2008-8#1)
the buffer system##2##3##(2008-4#1)(2008-5#1)
the buffer to##2##3##(1992-10#1)(1994-3#1)
the buffer##59##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#2)(1992-10#1)(1992-4#1)(1994-2#1)(1994-3#2)(1996-5#1)(1996-9#1)(1997-8#1)(2006-10#1)(2007-12#2)(2008-10#30)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#2)(2012-12#2)
the buffered##4##2##(1991-12#1)(1991-5#1)(1996-7#1)(2008-10#1)
the buffering capacity of##2##4##(1991-6#1)(2011-2#1)
the buffering##8##2##(1991-6#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2011-2#1)
the buffy coat##5##3##(1996-1#3)(2007-8#2)
the bugs##3##2##(1993-4#1)(2007-3#1)(2009-1#1)
the build up of##3##4##(1994-10#1)(1997-3#1)(1997-7#1)
the build-up##3##2##(1994-8#1)(2008-10#2)
the building block of##2##4##(1992-6#1)(2010-7#1)
the building block##3##3##(1992-6#1)(2006-12#1)(2010-7#1)
the building blocks of##8##4##(1992-11#1)(1996-2#1)(2005-10#1)(2008-1#1)(2008-11#1)(2008-2#1)(2009-5#1)(2011-1#1)
the building blocks##11##3##(1991-3#1)(1992-11#1)(1996-2#1)(2005-10#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-4#1)(2009-5#1)(2011-1#1)
the building of##4##3##(1995-1#1)(2006-2#1)(2007-2#1)(2009-7#1)
the building up##2##3##(2008-11#1)(2009-3#1)
the building##28##2##(1990-10#1)(1991-3#1)(1992-11#1)(1992-2#2)(1992-6#1)(1995-1#1)(1996-12#1)(1996-2#1)(2005-10#1)(2006-12#1)(2006-2#1)(2007-2#1)(2008-1#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-2#1)
the buildings##2##2##(1991-11#1)(2012-2#1)
the buildup of##2##3##(1991-7#1)(1996-12#1)
the buildup##5##2##(1991-7#1)(1996-12#1)(2007-12#1)(2008-2#1)(2010-4#1)
the bulb##7##2##(1992-8#1)(1993-6#1)(1994-10#2)(2007-1#2)(2007-12#1)
the bulbar##5##2##(1991-9#1)(1992-8#1)(1995-5#1)(2006-9#1)(2008-10#1)
the bulbocavernosus (BC)##2##3##(1992-7#1)(1994-5#1)
the bulbocavernosus##10##2##(1992-7#3)(1994-5#2)(1995-5#3)(1996-9#2)
the bulge##6##2##(1990-6#4)(2008-5#2)
the bulgy morph##4##3##(2012-12#4)
the bulk and microprobe##2##4##(1996-8#2)
the bulk and surface##2##4##(1991-8#1)(2010-4#1)
the bulk and##8##3##(1991-8#1)(1992-7#1)(1993-3#1)(1996-8#2)(2005-11#1)(2008-12#1)(2010-4#1)
the bulk aqueous medium and##2##5##(1991-7#2)
the bulk aqueous medium##3##4##(1991-7#3)
the bulk density##3##3##(2008-12#1)(2011-1#2)
the bulk deposition##2##3##(1992-6#2)
the bulk drug##3##3##(2008-10#1)(2012-12#1)(2013-7#1)
the bulk flow##4##3##(2007-10#1)(2008-7#2)(2009-4#1)
the bulk mating experiment##2##4##(2008-10#2)
the bulk of the##26##4##(1992-6#1)(1993-3#1)(1994-8#1)(1994-9#3)(2005-11#1)(2006-7#1)(2007-10#1)(2007-12#3)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2010-8#1)(2012-2#1)
the bulk of variance in academic buoyancy##2##7##(2008-12#2)
the bulk of##52##3##(1990-12#1)(1990-5#1)(1991-6#1)(1992-6#1)(1993-10#1)(1993-3#1)(1994-11#2)(1994-8#1)(1994-9#3)(2005-11#1)(2006-10#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-8#2)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)
the bulk optical properties##2##4##(2008-3#2)
the bulk phase##5##3##(1997-3#1)(2006-10#1)(2008-10#1)(2008-6#1)(2008-7#1)
the bulk solution##9##3##(2005-11#1)(2006-10#1)(2008-10#5)(2008-6#2)
the bulk solvent and##2##4##(1992-7#1)(2006-8#1)
the bulk solvent##4##3##(1992-7#1)(2006-8#1)(2008-10#2)
the bulk suspension##3##3##(2005-11#3)
the bulk water surface##3##4##(2005-11#3)
the bulk water##5##3##(2005-11#3)(2006-10#1)(2010-9#1)
the bulk##166##2##(1990-12#1)(1990-5#1)(1991-10#1)(1991-6#1)(1991-7#3)(1991-8#1)(1992-1#1)(1992-11#1)(1992-6#4)(1992-7#2)(1993-10#1)(1993-3#4)(1994-11#2)(1994-12#1)(1994-8#1)(1994-9#3)(1996-8#3)(1997-3#1)(2005-11#17)(2005-12#1)(2006-10#4)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#2)(2007-11#1)(2007-12#12)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#32)(2008-12#4)(2008-2#4)(2008-3#11)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#5)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-4#5)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#3)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)
the bulking##2##2##(2004-4#1)(2008-12#1)
the bulky##9##2##(1990-4#1)(1993-4#1)(1994-8#1)(1994-9#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-3#1)(2005-11#1)
the bull and##3##3##(2006-5#3)
the bull##4##2##(2006-5#3)(2007-9#1)
the bullet##4##2##(2007-8#2)(2010-9#1)(2013-7#1)
the bullfrog##3##2##(1990-5#1)(1992-3#1)(1993-5#1)
the bundle##7##2##(1993-10#1)(1995-6#1)(1996-7#1)(2008-10#1)(2008-2#2)(2008-3#1)
the bundles##2##2##(1992-2#1)(2007-12#1)
the buoyant density of the##2##5##(1990-5#2)
the buoyant##4##2##(1990-5#2)(1995-6#1)(1996-12#1)
the burden of disease##7##4##(2010-11#1)(2011-2#2)(2012-12#3)(2013-8#1)
the burden of foodborne illness##2##5##(2008-1#2)
the burden of foodborne##3##4##(2007-12#1)(2008-1#2)
the burden of human influenza in##2##6##(2009-5#2)
the burden of human##3##4##(2005-10#1)(2009-5#2)
the burden of illness##3##4##(2006-12#1)(2010-9#1)(2012-12#1)
the burden of malaria##2##4##(2006-4#1)(2007-2#1)
the burden of stroke##6##4##(2008-8#6)
the burden of the disease##2##5##(2006-4#1)(2006-6#1)
the burden of the##6##4##(1996-1#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-6#1)(2011-1#1)
the burden of this disease##2##5##(2007-11#1)(2009-5#1)
the burden of this##3##4##(2007-11#1)(2009-5#1)(2012-12#1)
the burden of##66##3##(1992-4#1)(1994-1#1)(1996-1#1)(1996-11#1)(2005-10#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-4#2)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#4)(2008-11#3)(2008-8#6)(2009-5#3)(2009-9#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#7)(2012-2#1)(2012-3#2)(2013-8#3)
the burden##78##2##(1992-4#1)(1993-3#1)(1994-1#1)(1995-1#1)(1996-1#1)(1996-11#1)(2005-10#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-4#2)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#4)(2008-11#4)(2008-7#1)(2008-8#7)(2009-3#1)(2009-5#3)(2009-9#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-12#7)(2012-2#1)(2012-3#2)(2013-8#5)
the burden-of-illness##2##2##(1994-9#2)
the burdens due to selected NCD (diabetes##2##7##(2013-8#2)
the burdens due to selected##3##5##(2013-8#3)
the burdens due to##7##4##(2013-8#7)
the burdens of##2##3##(2006-10#1)(2013-8#1)
the burdens##9##2##(2006-10#1)(2013-8#8)
the bureaucracy##2##2##(1994-5#1)(1995-3#1)
the bureaucratic##4##2##(1994-11#1)(1995-1#1)(2008-11#1)(2008-6#1)
the burgeoning field of##4##4##(2006-10#1)(2007-1#1)(2008-5#1)(2011-1#1)
the burgeoning##7##2##(1992-2#1)(1994-1#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-5#1)(2011-1#1)
the burial of##2##3##(1995-2#1)(1995-8#1)
the burial##4##2##(1995-2#1)(1995-8#1)(2008-2#1)(2011-1#1)
the buried residues##2##3##(2008-10#2)
the buried##10##2##(1990-12#1)(1991-4#1)(1992-3#2)(1997-2#1)(1997-5#1)(2008-10#2)(2008-2#1)(2010-5#1)
the burn wound and##2##4##(1994-5#1)(2005-10#1)
the burn wound##3##3##(1994-5#1)(2005-10#2)
the burn##6##2##(1993-12#3)(1994-5#1)(2005-10#2)
the burning##5##2##(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)
the burnout##7##2##(1996-2#1)(2010-9#1)(2011-2#4)(2013-1#1)
the burnt area##2##3##(2013-8#2)
the burr hole##2##3##(2006-12#1)(2008-7#1)
the bursa of Fabricius and##2##5##(2008-5#2)
the bursa of Fabricius##4##4##(2008-5#4)
the bursa##5##2##(2007-8#1)(2008-5#4)
the bursae##2##2##(2007-11#1)(2008-5#1)
the burst effect##3##3##(2006-1#1)(2008-5#1)(2011-2#1)
the burst##6##2##(1990-5#1)(1997-3#1)(2006-1#1)(2007-9#1)(2008-5#1)(2011-2#1)
the bursting discharge##3##3##(1992-8#3)
the bursting##4##2##(1992-8#3)(1997-3#1)
the bus##5##2##(1994-6#1)(2008-2#2)(2008-3#1)(2012-12#1)
the bush##3##2##(1995-10#1)(2008-2#2)
the business and##5##3##(1994-3#1)(1996-3#2)(2007-9#2)
the business community##2##3##(1993-3#1)(1995-2#1)
the business of##3##3##(1992-3#1)(1995-2#1)(2007-1#1)
the business sector##3##3##(1994-1#1)(1995-12#1)(2009-4#1)
the business##23##2##(1992-3#1)(1993-1#1)(1993-3#1)(1994-1#3)(1994-3#1)(1995-12#1)(1995-2#2)(1996-3#3)(2004-12#1)(2007-1#1)(2007-4#1)(2007-9#2)(2008-10#1)(2008-4#1)(2009-4#2)(2013-8#1)
the businesses##2##2##(1995-2#1)(1996-11#1)
the butt-coupling##2##2##(2008-2#2)
the butterfly Bicyclus anynana##2##4##(2008-11#1)(2008-9#1)
the butterfly##4##2##(2008-11#2)(2008-3#1)(2008-9#1)
the buttocks and##2##3##(1990-2#1)(2008-5#1)
the buttocks##6##2##(1990-2#1)(2006-10#1)(2007-7#1)(2008-5#1)(2010-9#1)(2013-8#1)
the button##3##2##(1991-2#1)(2013-7#1)(2013-8#1)
the butyltin chloride##2##3##(2008-10#2)
the butyrate##2##2##(1990-6#1)(1993-6#1)
the butyrylcholinesterase##2##2##(1990-3#1)(1995-2#1)
the by##2##2##(2007-7#1)(2010-12#1)
the by-product of##2##3##(2007-9#1)(2011-1#1)
the by-product##3##2##(2007-9#1)(2008-11#1)(2011-1#1)
the by-products##2##2##(2007-8#1)(2008-11#1)
the bypass graft##2##3##(2007-9#1)(2008-7#1)
the bypass##4##2##(2007-9#1)(2008-7#1)(2010-12#1)(2013-7#1)
the bystander effect##3##3##(2008-7#3)
the bystander##5##2##(2008-7#4)(2008-8#1)
the bzip region##2##3##(1992-3#2)
the c -axis##2##3##(2007-12#2)
the c axis and the incident angle##3##7##(2008-3#3)
the c axis##6##3##(1990-4#1)(1996-2#1)(2008-3#4)
the c subunit of##2##4##(1997-7#2)
the c##15##2##(1990-4#1)(1996-2#2)(1997-7#3)(2007-12#2)(2008-10#1)(2008-3#4)(2010-8#1)(2012-1#1)
the c-Jun##5##2##(1995-2#2)(1997-7#1)(2010-3#2)
the c-Ki-ras gene##3##3##(1992-8#2)(1992-9#1)
the c-Ki-ras##4##2##(1992-8#3)(1992-9#1)
the c-Met##3##2##(1991-9#1)(1996-5#1)(2011-2#1)
the c-Myc protein##2##3##(1996-12#1)(2008-8#1)
the c-Myc##4##2##(1996-12#2)(2008-6#1)(2008-8#1)
the c-Src activity##2##3##(1997-6#2)
the c-abl gene##2##3##(1991-6#1)(1995-8#1)
the c-abl##5##2##(1991-6#3)(1992-5#1)(1995-8#1)
the c-axis##2##2##(2004-9#1)(2008-10#1)
the c-erb A beta gene##2##5##(1991-7#2)
the c-erbB-2 gene product##3##4##(1994-11#3)
the c-erbB-2 gene##4##3##(1991-12#1)(1994-11#3)
the c-erbB-2##7##2##(1991-12#2)(1994-11#3)(1995-1#1)(1995-8#1)
the c-fos and##2##3##(1994-8#1)(2008-5#1)
the c-fos promoter##6##3##(1994-11#2)(1994-6#1)(1994-9#2)(1995-6#1)
the c-fos proto-oncogene##3##3##(1990-2#1)(1991-11#1)(1996-9#1)
the c-fos##17##2##(1990-2#1)(1991-11#1)(1992-2#1)(1992-9#1)(1993-6#1)(1994-10#1)(1994-11#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-6#1)(1996-11#1)(1996-9#2)(2008-5#1)
the c-kit gene##6##3##(1995-10#4)(2008-6#2)
the c-kit proto-oncogene##3##3##(1993-5#1)(1993-6#1)(2007-9#1)
the c-kit##13##2##(1993-5#1)(1993-6#1)(1995-10#4)(1997-5#3)(2007-9#1)(2008-6#2)(2009-7#1)
the c-met gene##4##3##(1992-11#4)
the c-met##7##2##(1991-11#1)(1992-11#4)(1995-8#2)
the c-myb protein##3##3##(1992-12#3)
the c-myb##7##2##(1992-12#3)(1994-10#1)(1995-3#3)
the c-myc P2 promoter##2##4##(1993-12#1)(1997-2#1)
the c-myc allele on the translocated chromosome##2##7##(1993-2#2)
the c-myc and c-myb##2##4##(1992-12#2)
the c-myc epitope##2##3##(1997-1#2)
the c-myc gene locus##2##4##(1992-9#2)
the c-myc gene##17##3##(1991-7#1)(1992-7#2)(1992-8#3)(1992-9#3)(1993-12#1)(1993-2#2)(1993-3#2)(1996-5#2)(2008-11#1)
the c-myc nuclease sensitive##2##4##(1992-5#2)
the c-myc promoter##3##3##(1991-4#2)(1992-7#1)
the c-myc protein##3##3##(1992-12#1)(1992-2#1)(1992-6#1)
the c-myc##41##2##(1991-4#5)(1991-7#1)(1992-12#3)(1992-2#1)(1992-5#2)(1992-6#1)(1992-7#3)(1992-8#3)(1992-9#3)(1993-12#2)(1993-2#4)(1993-3#2)(1994-8#1)(1995-9#1)(1996-5#2)(1997-1#2)(1997-2#1)(2006-12#2)(2008-11#2)
the c-ring##4##2##(2008-4#4)
the c1/c1 genotype##3##3##(2008-8#3)
the cAMP accumulation induced by##2##5##(1991-7#1)(2008-4#1)
the cAMP level of brain##2##5##(2008-8#2)
the cAMP level of##3##4##(1992-3#1)(2008-8#2)
the cAMP level##7##3##(1990-10#2)(1990-3#1)(1992-3#2)(2008-8#2)
the cAMP pathway##5##3##(1992-6#3)(1994-12#1)(1996-5#1)
the cAMP response to##2##4##(1991-8#2)
the cAMP response##3##3##(1991-8#2)(1997-4#1)
the cAMP signaling pathway##4##4##(1994-8#1)(1995-3#2)(2008-11#1)
the cAMP##39##2##(1990-10#2)(1990-3#1)(1991-7#1)(1991-8#2)(1992-3#2)(1992-6#5)(1993-3#1)(1993-7#3)(1994-10#1)(1994-12#2)(1994-8#2)(1994-9#1)(1995-10#1)(1995-3#2)(1995-8#2)(1996-5#2)(1997-2#1)(1997-4#1)(1997-6#1)(2008-11#2)(2008-4#1)(2008-8#2)(2012-1#1)
the cAMP-dependent protein kinase (PKA)##3##5##(1992-6#1)(1995-5#1)(2008-8#1)
the cAMP-dependent protein kinase##13##4##(1991-2#1)(1992-6#1)(1993-6#2)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-8#1)(1997-1#1)(1997-8#1)(2008-3#1)(2008-8#1)
the cAMP-dependent##14##2##(1991-2#1)(1992-6#1)(1993-6#2)(1994-11#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-8#1)(1997-1#1)(1997-8#1)(2008-3#1)(2008-8#1)
the cAMP-induced##3##2##(1991-2#2)(1996-5#1)
the cDNA and genomic sequences##2##5##(1994-8#1)(1996-4#1)
the cDNA and genomic##4##4##(1991-9#1)(1993-6#1)(1994-8#1)(1996-4#1)
the cDNA and the##2##4##(1994-5#1)(1996-10#1)
the cDNA and##10##3##(1991-9#1)(1992-5#1)(1993-6#1)(1994-5#2)(1994-8#1)(1996-10#1)(1996-4#1)(2008-11#1)(2008-4#1)
the cDNA as##2##3##(1995-6#1)(2008-9#1)
the cDNA clone##10##3##(1991-12#1)(1991-4#1)(1991-5#1)(1994-11#1)(1995-8#1)(1997-2#2)(2005-8#1)(2008-2#1)(2008-5#1)
the cDNA clones were##2##4##(1996-10#1)(1997-8#1)
the cDNA clones##9##3##(1992-4#1)(1993-6#1)(1994-6#2)(1996-10#1)(1996-2#1)(1997-4#1)(1997-8#1)(2006-12#1)
the cDNA cloning of##4##4##(1992-5#1)(1993-3#1)(1994-11#1)(1994-8#1)
the cDNA encoding bovine##3##4##(1993-2#1)(1997-1#1)(1997-2#1)
the cDNA encoding human##2##4##(1993-6#1)(2008-11#1)
the cDNA encoding the##6##4##(1990-12#1)(1991-6#1)(1992-7#1)(1994-9#1)(1996-4#1)(1997-2#1)
the cDNA encoding##19##3##(1990-12#1)(1991-12#1)(1991-6#1)(1992-7#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1994-9#1)(1995-8#1)(1996-4#1)(1996-7#1)(1997-1#2)(1997-2#2)(2008-11#1)(2008-8#1)
the cDNA for a##2##4##(1993-12#1)(1995-2#1)
the cDNA for the##4##4##(1991-1#2)(1995-8#1)(1996-12#1)
the cDNA for this protein##2##5##(1990-12#1)(1995-8#1)
the cDNA for##16##3##(1990-12#1)(1990-5#1)(1991-1#2)(1991-10#1)(1991-4#1)(1991-9#1)(1992-7#1)(1993-12#1)(1994-11#1)(1995-2#1)(1995-8#2)(1996-12#1)(1996-7#1)(1997-7#1)
the cDNA fragment##2##3##(1992-5#1)(2008-8#1)
the cDNA in##6##3##(1990-12#1)(1992-12#1)(1993-6#1)(1994-10#1)(1994-8#1)(1997-8#1)
the cDNA into##4##3##(1990-5#1)(1991-2#1)(1996-11#1)(2008-10#1)
the cDNA is##3##3##(1992-11#1)(1993-11#1)(2008-8#1)
the cDNA library##7##3##(1990-2#1)(1992-12#1)(1992-2#1)(1995-6#1)(1996-2#1)(2006-8#1)(2008-2#1)
the cDNA nucleotide##3##3##(1993-2#1)(1996-12#2)
the cDNA of the##2##4##(1994-5#1)(2008-12#1)
the cDNA of##7##3##(1990-12#1)(1992-3#1)(1994-5#1)(2008-10#1)(2008-12#2)(2008-8#1)
the cDNA sequence encoding the##2##5##(1992-10#1)(1992-4#1)
the cDNA sequence encoding##3##4##(1992-10#1)(1992-4#1)(1996-10#1)
the cDNA sequence of the##2##5##(1990-8#1)(1992-12#1)
the cDNA sequence of##3##4##(1990-8#1)(1992-12#1)(1995-8#1)
the cDNA sequence##23##3##(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-8#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-4#1)
the cDNA sequences##3##3##(1990-12#1)(1990-5#1)(1992-6#1)
the cDNA was##7##3##(1991-1#1)(1991-5#1)(1993-8#1)(1994-11#1)(1994-8#1)(2007-2#1)(2008-10#1)
the cDNA##194##2##(1990-12#6)(1990-2#1)(1990-5#3)(1990-8#2)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#3)(1991-4#2)(1991-5#4)(1991-6#4)(1991-7#1)(1991-9#3)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#4)(1992-2#2)(1992-3#2)(1992-4#2)(1992-5#5)(1992-6#1)(1992-7#2)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#3)(1993-4#4)(1993-5#1)(1993-6#6)(1993-7#1)(1993-8#3)(1994-10#1)(1994-11#4)(1994-12#3)(1994-5#5)(1994-6#2)(1994-8#9)(1994-9#2)(1995-2#1)(1995-6#3)(1995-8#7)(1996-10#3)(1996-11#1)(1996-12#4)(1996-2#2)(1996-4#3)(1996-5#1)(1996-7#3)(1996-8#1)(1997-1#2)(1997-2#10)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#2)(2005-8#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-2#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#4)(2010-5#1)
the cDNAs encoding##2##3##(1992-11#1)(1993-2#1)
the cDNAs for##3##3##(1994-2#1)(1997-2#1)(2010-5#1)
the cDNAs of##4##3##(1994-11#1)(1994-12#1)(2006-12#1)(2008-7#1)
the cDNAs##17##2##(1990-5#1)(1991-5#1)(1992-11#1)(1993-2#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-8#2)(1997-2#1)(1997-7#1)(2006-12#1)(2008-7#1)(2008-8#1)(2010-5#1)
the cGI-PDE##2##2##(1993-6#2)
the cGMP##2##2##(1992-6#1)(1997-1#1)
the cGMP-PDE##2##2##(1994-12#2)
the cGMP-inhibited cAMP phosphodiesterase##2##4##(1993-6#2)
the cI repressor##4##3##(1995-8#2)(1997-1#2)
the cI##5##2##(1995-8#2)(1997-1#2)(2006-10#1)
the cPCR##2##2##(2012-3#2)
the cPLA2##4##2##(1993-11#4)
the cTAKES##4##2##(2013-1#4)
the cabbage looper##3##3##(1990-8#2)(2008-7#1)
the cabbage##4##2##(1990-8#2)(2008-7#1)(2008-8#1)
the cabin environment##2##3##(1996-12#1)(2007-2#1)
the cabin##8##2##(1990-8#1)(1996-12#6)(2007-2#1)
the cabinet##3##2##(2005-5#1)(2006-7#2)
the cable##5##2##(1991-12#1)(2008-10#1)(2008-9#3)
the cables##2##2##(1995-7#1)(2012-2#1)
the cacao##4##2##(2008-10#4)
the cachexia##2##2##(1992-8#1)(2007-12#1)
the cadaver tests##3##3##(2006-11#3)
the cadaver##8##2##(2006-11#6)(2007-1#1)(2012-1#1)
the cadaveric##4##2##(1997-2#1)(2008-1#1)(2011-2#1)(2012-1#1)
the cadavers##3##2##(1995-11#1)(2007-4#1)(2008-12#1)
the caddisfly Cyrnus trimaculatus and the mayfly Ephoron virgo##2##9##(2004-4#2)
the cadence##3##2##(2013-1#3)
the cadherin family of##2##4##(1990-12#1)(1991-11#1)
the cadherin family##3##3##(1990-12#1)(1991-11#1)(1997-2#1)
the cadherin##9##2##(1990-12#2)(1991-11#4)(1994-9#1)(1997-2#1)(2007-12#1)
the cadmium speciation##2##3##(2008-10#2)
the cadmium##9##2##(1990-3#1)(1992-12#1)(2006-12#1)(2008-10#5)(2012-2#1)
the caecal tonsil##2##3##(1997-6#1)(2008-5#1)
the caecal##4##2##(1997-6#1)(2006-8#1)(2008-3#1)(2008-5#1)
the caecilian tree##2##3##(2010-6#2)
the caecilian##3##2##(2010-6#3)
the caecum##7##2##(1992-8#1)(1993-9#1)(2007-8#1)(2008-5#1)(2011-11#1)(2011-2#1)(2012-2#1)
the caesarean section rate##3##4##(2007-2#1)(2011-12#2)
the caesarean section##4##3##(2007-2#2)(2011-12#2)
the caffeine##3##2##(2008-10#1)(2008-4#1)(2008-5#1)
the caffeine-induced##2##2##(1996-5#1)(2009-3#1)
the cage and##2##3##(2007-4#1)(2008-10#1)
the cage##12##2##(1991-3#1)(1992-9#1)(1995-12#1)(1997-3#1)(2005-11#1)(2006-8#1)(2007-4#2)(2007-8#1)(2008-10#1)(2008-6#1)(2011-12#1)
the caged##3##2##(1990-7#1)(1991-12#1)(1994-6#1)
the cagemates##2##2##(1997-7#2)
the cages were recovered##2##4##(2008-10#2)
the cages were##3##3##(2008-10#3)
the cages##5##2##(2006-8#1)(2008-10#3)(2009-3#1)
the calcaneal##2##2##(2007-11#1)(2012-2#1)
the calcaneus##8##2##(2007-11#2)(2007-9#2)(2008-8#2)(2009-10#1)(2010-11#1)
the calcar##2##2##(2007-11#1)(2008-7#1)
the calcification process##2##3##(2004-9#1)(2013-1#1)
the calcification##6##2##(2004-9#3)(2009-9#2)(2013-1#1)
the calcified cusps##2##3##(2011-2#2)
the calcified##6##2##(1993-5#1)(2007-2#1)(2009-7#1)(2011-2#2)(2013-8#1)
the calcination##4##2##(1996-2#2)(2004-9#1)(2010-4#1)
the calcineurin##4##2##(1993-11#1)(1995-6#2)(2007-11#1)
the calcitonin gene-related peptide##3##4##(1992-3#1)(1992-6#1)(2013-8#1)
the calcitonin##9##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#1)(1992-3#1)(1992-6#1)(2008-7#1)(2013-8#1)
the calcitonin/alpha-CGRP and beta-CGRP genes##2##5##(1992-6#2)
the calcitonin/alpha-CGRP gene##3##3##(1992-6#3)
the calcitonin/alpha-CGRP##5##2##(1992-6#5)
the calcium ATPase of sarcoplasmic reticulum##2##6##(1991-8#1)(1992-11#1)
the calcium and magnesium##2##4##(1995-4#1)(2008-10#1)
the calcium and##3##3##(1995-4#1)(2008-10#1)(2013-8#1)
the calcium antagonists##2##3##(1990-10#1)(1992-9#1)
the calcium binding##5##3##(1991-1#1)(1991-3#1)(1991-7#1)(1991-8#1)(1994-12#1)
the calcium channel blocker##4##4##(1991-6#1)(1994-6#1)(1996-5#1)(2007-9#1)
the calcium channel##7##3##(1991-6#1)(1993-12#1)(1994-6#1)(1996-5#1)(2007-9#1)(2008-8#1)(2012-12#1)
the calcium concentration in the##2##5##(1994-6#1)(2008-10#1)
the calcium concentration needed to support##2##6##(1995-8#2)
the calcium concentration##7##3##(1994-6#1)(1995-8#2)(2006-6#1)(2008-10#1)(2009-8#1)(2011-2#1)
the calcium content##2##3##(1991-9#1)(2012-3#1)
the calcium ion##2##3##(1997-7#1)(2010-8#1)
the calcium ionophore A23187##4##4##(1990-8#1)(1991-3#1)(1992-3#1)(2006-5#1)
the calcium ionophore##11##3##(1990-8#1)(1991-3#1)(1992-3#1)(1993-3#1)(1995-11#1)(1995-12#1)(1996-8#1)(1997-2#1)(2006-5#1)(2012-12#2)
the calcium pump##7##3##(1992-11#1)(1992-12#2)(1993-3#4)
the calcium response##2##3##(2008-4#2)
the calcium##94##2##(1990-10#1)(1990-11#2)(1990-4#1)(1990-5#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-3#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-11#2)(1992-12#3)(1992-3#2)(1992-4#1)(1992-9#1)(1993-12#1)(1993-3#5)(1993-7#2)(1994-12#3)(1994-5#1)(1994-6#2)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-8#2)(1995-9#1)(1996-5#2)(1996-8#2)(1997-1#1)(1997-2#1)(1997-7#2)(2005-1#1)(2005-3#2)(2006-1#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-4#3)(2008-5#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-8#1)
the calcium-binding properties##2##3##(1991-2#1)(1997-6#1)
the calcium-binding protein##2##3##(2007-5#1)(2011-1#1)
the calcium-binding proteins##2##3##(1994-2#1)(1995-11#1)
the calcium-binding##14##2##(1991-2#1)(1991-5#1)(1991-7#1)(1992-8#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1996-8#2)(1997-6#1)(2007-5#1)(2011-1#1)
the calcium-dependent##8##2##(1992-7#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-3#1)(1995-8#1)(2006-10#1)(2008-8#1)
the calcium-induced##2##2##(1990-11#1)(1994-12#1)
the calcium-phosphate##3##2##(1992-5#1)(2012-2#1)(2013-8#1)
the calcium-regulated##2##2##(1990-10#1)(2009-5#1)
the calcium-sensitive dye fura-2##2##4##(1990-7#1)(1994-2#1)
the calcium-transport enzyme##2##3##(1990-3#2)
the calcium/calmodulin-dependent##2##2##(1997-4#1)(2008-10#1)
the calculated activation barriers of##3##5##(2008-10#3)
the calculated and##5##3##(2006-10#1)(2006-4#1)(2008-2#1)(2008-3#2)
the calculated descriptors##2##3##(2008-10#1)(2009-4#1)
the calculated detection##2##3##(2008-10#2)
the calculated distance##2##3##(1992-12#1)(1994-5#1)
the calculated efficiencies##2##3##(2008-2#1)(2008-3#1)
the calculated model##2##3##(1990-10#1)(2008-10#1)
the calculated molecular##2##3##(1992-1#1)(2005-11#1)
the calculated rate##2##3##(1991-3#1)(1997-8#1)
the calculated results##3##3##(1990-5#1)(2007-12#1)(2008-9#1)
the calculated spectra##2##3##(2007-11#1)(2008-3#1)
the calculated spectrum##2##3##(2008-2#1)(2008-3#1)
the calculated times##2##3##(2012-12#2)
the calculated value##3##3##(2008-10#1)(2008-3#1)(2012-12#1)
the calculated values of##2##4##(2007-11#1)(2008-10#1)
the calculated values##4##3##(2007-11#1)(2008-10#1)(2008-3#2)
the calculated##102##2##(1990-10#1)(1990-12#1)(1990-4#1)(1990-5#1)(1991-3#1)(1992-1#1)(1992-12#2)(1992-6#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-5#1)(1995-12#1)(1996-1#1)(1996-5#1)(1996-6#1)(1997-8#2)(2005-11#2)(2006-10#1)(2006-2#1)(2006-4#1)(2007-11#4)(2007-12#4)(2007-7#1)(2008-1#1)(2008-10#18)(2008-2#5)(2008-3#23)(2008-4#2)(2008-5#3)(2008-8#1)(2008-9#1)(2009-1#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#3)(2013-1#1)(2013-8#2)
the calculation of a##8##4##(1992-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)
the calculation of net charge from##2##6##(2008-4#2)
the calculation of partial atomic charges##2##6##(2007-9#2)
the calculation of the effective##3##5##(2008-2#1)(2008-3#1)(2008-8#1)
the calculation of the##27##4##(1993-3#1)(2005-11#2)(2006-10#2)(2006-9#1)(2008-10#5)(2008-2#4)(2008-3#6)(2008-4#1)(2008-8#1)(2010-11#1)(2010-12#1)(2013-7#1)(2013-8#1)
the calculation of##85##3##(1990-12#1)(1990-9#1)(1992-12#1)(1993-3#1)(1994-9#1)(1995-3#1)(1997-3#1)(2005-11#3)(2006-10#5)(2006-9#1)(2007-11#4)(2007-12#3)(2007-6#1)(2007-7#2)(2007-9#2)(2008-1#1)(2008-10#12)(2008-2#13)(2008-3#13)(2008-4#5)(2008-5#2)(2008-8#1)(2009-11#1)(2010-11#1)(2010-12#2)(2010-8#1)(2013-1#2)(2013-7#1)(2013-8#2)
the calculation results are##2##4##(2008-2#1)(2013-1#1)
the calculation results##3##3##(2008-2#1)(2013-1#1)(2013-8#1)
the calculation time##2##3##(2008-3#2)
the calculation##99##2##(1990-12#1)(1990-9#1)(1992-12#1)(1993-3#1)(1994-9#1)(1995-3#1)(1997-3#1)(2005-11#3)(2005-4#1)(2006-10#5)(2006-9#1)(2007-11#4)(2007-12#3)(2007-6#1)(2007-7#2)(2007-9#2)(2008-1#1)(2008-10#15)(2008-12#1)(2008-2#16)(2008-3#17)(2008-4#5)(2008-5#2)(2008-8#1)(2009-11#1)(2010-11#1)(2010-12#2)(2010-8#1)(2013-1#3)(2013-7#1)(2013-8#3)
the calculations for a##2##4##(2008-3#1)(2010-8#1)
the calculations for##3##3##(2008-2#1)(2008-3#1)(2010-8#1)
the calculations of the##2##4##(1991-11#1)(2008-10#1)
the calculations of##5##3##(1990-12#1)(1991-11#1)(2008-10#1)(2008-3#1)(2011-1#1)
the calculations were##2##3##(1991-7#1)(2007-4#1)
the calculations##29##2##(1990-12#1)(1991-11#1)(1991-7#1)(2005-10#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#7)(2008-2#5)(2008-3#5)(2008-8#1)(2010-8#1)(2011-1#2)
the calculus##5##2##(1991-9#2)(1993-10#1)(1996-11#1)(2011-2#1)
the caldesmon-induced##2##2##(1991-2#1)(1992-8#1)
the calendar period##3##3##(1990-4#1)(1993-9#2)
the calendar##4##2##(1990-4#1)(1993-9#2)(2008-10#1)
the calf thymus##3##3##(1995-3#1)(2008-10#1)(2008-5#1)
the calf##18##2##(1990-11#2)(1991-6#1)(1992-2#1)(1995-1#1)(1995-3#1)(1997-3#1)(2007-11#2)(2008-10#1)(2008-5#3)(2009-3#3)(2011-2#1)(2012-2#1)
the caliber##2##2##(1992-1#1)(2010-8#1)
the calibrated##4##2##(1997-2#1)(2008-2#1)(2008-3#1)(2013-8#1)
the calibration accuracy##2##3##(2008-3#2)
the calibration and the##2##4##(2008-10#1)(2008-11#1)
the calibration and##3##3##(1993-1#1)(2008-10#1)(2008-11#1)
the calibration by##3##3##(2008-10#3)
the calibration curve is linear##6##5##(2008-10#6)
the calibration curve is##8##4##(2008-10#8)
the calibration curve of##3##4##(2005-12#1)(2008-10#2)
the calibration curve was##9##4##(1996-8#1)(1997-8#2)(2008-10#6)
the calibration curve##30##3##(1996-6#1)(1996-8#1)(1997-8#2)(2005-12#1)(2008-10#23)(2008-2#1)(2008-5#1)
the calibration curves are linear##2##5##(2008-10#2)
the calibration curves are##4##4##(2008-10#3)(2008-3#1)
the calibration curves##16##3##(2008-10#11)(2008-2#1)(2008-3#3)(2009-8#1)
the calibration for the##3##4##(2008-10#1)(2008-2#2)
the calibration from##2##3##(2008-3#2)
the calibration function##2##3##(2008-10#2)
the calibration graph is linear##3##5##(2008-10#3)
the calibration graph is##8##4##(2008-10#8)
the calibration graph was linear from 0##3##7##(2008-10#3)
the calibration graph was linear in the##2##7##(2008-10#2)
the calibration graph was linear##7##5##(2008-10#7)
the calibration graph was##8##4##(2008-10#8)
the calibration graph##20##3##(2007-8#1)(2008-10#19)
the calibration graphs were linear in the##2##7##(2007-8#1)(2008-10#1)
the calibration graphs were linear##3##5##(2007-8#1)(2008-10#2)
the calibration graphs were##4##4##(2007-8#1)(2008-10#3)
the calibration graphs##12##3##(1992-1#1)(2007-8#2)(2008-10#9)
the calibration in##2##3##(2007-8#1)(2008-10#1)
the calibration is##2##3##(2007-11#1)(2008-2#1)
the calibration line##2##3##(2008-10#2)
the calibration matrix was##2##4##(2008-10#2)
the calibration matrix##7##3##(2008-10#7)
the calibration model is based on absorption spectra in the##2##10##(2008-10#2)
the calibration model is##3##4##(2008-10#3)
the calibration model##7##3##(2007-12#1)(2008-10#6)
the calibration models##6##3##(2007-11#1)(2008-10#4)(2010-12#1)
the calibration of a##2##4##(1997-8#1)(2008-10#1)
the calibration of classification models##4##5##(2013-1#4)
the calibration of the instrument##2##5##(2008-3#2)
the calibration of the##10##4##(1996-12#1)(1997-5#1)(2008-2#1)(2008-3#7)
the calibration of##25##3##(1993-7#1)(1996-12#1)(1997-5#1)(1997-8#1)(2008-10#5)(2008-2#2)(2008-3#9)(2010-12#1)(2013-1#4)
the calibration parameters##3##3##(1995-9#3)
the calibration plot of##2##4##(2008-10#1)(2013-7#1)
the calibration plot##4##3##(2007-8#1)(2008-10#2)(2013-7#1)
the calibration plots##4##3##(2008-10#3)(2011-2#1)
the calibration procedure##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
the calibration procedures##2##3##(2008-2#1)(2008-3#1)
the calibration range##8##3##(2008-10#8)
the calibration recovery##2##3##(2008-10#2)
the calibration set##7##3##(2007-11#2)(2008-10#4)(2010-12#1)
the calibration standards##3##3##(2008-10#3)
the calibration was##2##3##(2008-10#2)
the calibration##219##2##(1992-1#1)(1993-1#1)(1993-7#1)(1995-9#3)(1996-12#1)(1996-6#1)(1996-8#1)(1997-5#1)(1997-8#3)(2005-12#1)(2007-11#4)(2007-12#2)(2007-8#6)(2007-9#2)(2008-10#141)(2008-11#1)(2008-2#12)(2008-3#25)(2008-5#1)(2008-6#1)(2009-8#1)(2010-12#3)(2011-2#1)(2013-1#4)(2013-7#1)
the calibrations##3##2##(1997-8#1)(2008-10#1)(2008-2#1)
the calibrator##6##2##(1995-2#1)(2008-10#5)
the calibre of##2##3##(1991-10#1)(1993-1#1)
the call of the##2##4##(1991-8#1)(1993-2#1)
the call##11##2##(1991-8#1)(1993-2#1)(2007-4#2)(2008-8#2)(2009-11#1)(2009-8#1)(2010-2#1)(2013-1#2)
the calling behavior and in vitro pheromone biosynthesis##2##8##(2006-12#2)
the calling##5##2##(2006-12#2)(2008-3#1)(2010-2#1)(2013-8#1)
the calls##3##2##(1996-9#1)(1997-5#1)(2009-9#1)
the callus of##2##3##(2007-1#1)(2008-12#1)
the callus##6##2##(2007-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-9#1)
the calmodulin antagonist##2##3##(1992-6#1)(1994-6#1)
the calmodulin binding domain of the plasma membrane Ca2+ pump##2##10##(1992-3#1)(1994-9#1)
the calmodulin binding domain of the plasma membrane Ca2+##3##9##(1992-3#1)(1994-9#2)
the calmodulin binding domain of the plasma membrane##4##8##(1992-3#2)(1994-9#2)
the calmodulin binding domain of##5##5##(1992-12#1)(1992-3#2)(1994-9#2)
the calmodulin binding domain##7##4##(1992-12#1)(1992-3#2)(1994-9#4)
the calmodulin binding##8##3##(1992-12#2)(1992-3#2)(1994-9#4)
the calmodulin##17##2##(1990-12#1)(1990-4#1)(1990-8#1)(1991-7#1)(1992-12#2)(1992-3#2)(1992-6#1)(1992-9#1)(1994-6#1)(1994-9#4)(1995-3#1)(2006-8#1)
the calmodulin-binding domain of##5##4##(1991-2#2)(1995-3#1)(1996-11#2)
the calmodulin-binding domain##6##3##(1991-2#2)(1995-3#1)(1996-11#2)(1996-5#1)
the calmodulin-binding##9##2##(1990-11#2)(1991-2#2)(1995-3#2)(1996-11#2)(1996-5#1)
the calmodulin-dependent##2##2##(1991-5#1)(1992-11#1)
the calorimeter##2##2##(2008-10#2)
the calorimetric studies##2##3##(1997-2#2)
the calorimetric transitions##4##3##(1991-2#4)
the calorimetric##11##2##(1990-2#1)(1991-2#5)(1997-2#3)(1997-7#2)
the calpain small subunit##2##4##(1990-6#2)
the calpain##7##2##(1990-4#1)(1990-6#2)(1991-8#1)(1994-9#2)(2010-11#1)
the calvaria##2##2##(2008-10#1)(2008-11#1)
the calvarial##2##2##(2006-12#1)(2008-5#1)
the calvarium##3##2##(2008-4#1)(2008-7#1)(2012-2#1)
the calves were##2##3##(1992-10#1)(1996-3#1)
the calves##8##2##(1991-3#1)(1992-10#1)(1996-3#1)(1997-5#2)(2006-8#1)(2010-2#1)(2012-2#1)
the calycine tube##2##3##(2008-10#2)
the calyptra##3##2##(2008-10#3)
the calyx##8##2##(2008-10#2)(2008-11#6)
the cambium##6##2##(2007-11#1)(2008-10#5)
the camel##4##2##(1993-8#1)(1996-12#1)(2007-2#2)
the camera and##5##3##(2008-2#1)(2008-3#1)(2012-11#2)(2013-1#1)
the camera is##4##3##(2006-6#1)(2007-11#1)(2008-2#1)(2008-3#1)
the camera##31##2##(2006-6#2)(2006-7#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-2#7)(2008-3#3)(2008-6#2)(2008-9#2)(2010-11#2)(2012-11#6)(2012-2#1)(2013-1#1)
the camera's##3##2##(2006-6#1)(2007-12#1)(2008-3#1)
the cameras##3##2##(2008-3#1)(2012-12#2)
the cameras'##2##2##(2008-6#2)
the campaign against##2##3##(1992-12#1)(2011-1#1)
the campaign and##3##3##(1996-8#1)(2004-10#1)(2006-2#1)
the campaign is##2##3##(1995-1#1)(2007-10#1)
the campaign was considered##2##4##(2006-4#1)(2008-12#1)
the campaign was##4##3##(1993-6#1)(2006-4#1)(2008-12#2)
the campaign##27##2##(1990-10#1)(1992-12#1)(1992-2#2)(1993-6#1)(1995-1#3)(1996-8#6)(1997-6#1)(2004-10#1)(2006-2#1)(2006-4#1)(2007-10#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#1)(2008-9#1)(2011-1#1)
the campaign's##2##2##(1995-1#1)(2004-10#1)
the campaigns##2##2##(1997-6#1)(2011-3#1)
the campaniform sensillum##2##3##(2005-10#2)
the camptothecin##3##2##(1993-8#1)(1994-8#1)(1995-5#1)
the campus and the hospital of##2##6##(2012-2#2)
the campus of##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
the campus##5##2##(2008-10#1)(2008-5#1)(2012-2#3)
the canadian##2##2##(2007-7#1)(2013-1#1)
the canal was##2##3##(2007-9#1)(2008-11#1)
the canal##7##2##(2006-10#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-11#1)(2008-5#1)(2013-8#1)
the canalicular ATP-dependent##2##3##(1994-12#2)
the canalicular##7##2##(1990-12#1)(1994-12#3)(1995-2#1)(2008-11#2)
the canals of Hering and##2##5##(2004-11#1)(2008-11#1)
the canals of Hering##3##4##(2004-11#1)(2006-10#1)(2008-11#1)
the canals##7##2##(2004-11#1)(2006-10#1)(2007-3#1)(2007-5#1)(2008-11#1)(2012-2#1)(2013-1#1)
the cancellous##2##2##(2011-2#1)(2012-2#1)
the cancer cell##6##3##(1994-2#1)(1994-3#1)(1994-8#1)(2005-10#1)(2007-6#1)(2010-11#1)
the cancer cells##12##3##(1990-5#1)(1994-8#1)(1995-1#1)(1996-9#1)(1997-4#1)(2008-11#1)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
the cancer genome##2##3##(2009-12#1)(2010-12#1)
the cancer incidence in##2##4##(1995-2#1)(2011-2#1)
the cancer incidence##5##3##(1993-8#1)(1995-2#1)(2008-7#1)(2011-2#2)
the cancer itself##2##3##(1996-6#1)(2009-3#1)
the cancer patient##4##3##(2006-10#2)(2009-10#1)(2011-2#1)
the cancer patients##5##3##(1991-5#1)(2011-1#1)(2011-2#2)(2013-8#1)
the cancer profile##2##3##(2011-2#2)
the cancer registration##2##3##(1996-2#1)(2011-2#1)
the cancer risk##4##3##(2012-12#1)(2012-2#1)(2013-1#2)
the cancer setting##2##3##(2008-7#2)
the cancer stem##3##3##(2009-5#1)(2010-12#1)(2010-4#1)
the cancer was##2##3##(1996-6#1)(2013-1#1)
the cancer##98##2##(1990-5#1)(1990-8#1)(1991-5#1)(1992-1#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-2#1)(1996-2#1)(1996-6#6)(1996-9#1)(1997-4#3)(2005-10#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-10#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#6)(2010-4#1)(2011-1#3)(2011-2#14)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#1)
the cancer-associated##3##2##(1997-4#1)(2005-11#1)(2012-2#1)
the cancer-relevant##2##2##(2008-7#1)(2012-3#1)
the cancer-specific##2##2##(2008-7#1)(2009-9#1)
the cancerous and##2##3##(1992-9#1)(2009-10#1)
the cancerous##6##2##(1992-9#1)(1994-11#1)(1994-7#1)(2006-6#1)(2009-10#2)
the cancers##2##2##(1993-9#1)(2009-12#1)
the candidacy of##2##3##(2006-10#1)(2010-2#1)
the candidate genes for##2##4##(2008-8#1)(2009-10#1)
the candidate genes##5##3##(2008-11#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-3#1)
the candidate markers##2##3##(2010-6#1)(2012-3#1)
the candidate##30##2##(1990-11#1)(1991-10#1)(1991-9#1)(1993-9#1)(1994-1#2)(1994-3#1)(1996-1#1)(1997-4#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-9#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
the candidates for##2##3##(1991-12#1)(2008-9#1)
the candidates##7##2##(1991-12#1)(1991-3#1)(1996-1#1)(2006-10#1)(2008-12#1)(2008-4#1)(2008-9#1)
the canine##25##2##(1990-11#1)(1991-9#1)(1992-3#2)(1993-6#1)(1995-2#1)(1996-12#3)(1996-5#3)(1997-8#1)(2004-12#1)(2005-7#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-12#1)(2013-1#1)
the canker##2##2##(2008-10#2)
the cannabinoid binding site##2##4##(1991-1#1)(1996-2#1)
the cannabinoid receptor##5##3##(1991-1#2)(1992-8#1)(1993-11#1)(2008-7#1)
the cannabinoid receptors in the##2##5##(1991-4#2)
the cannabinoid##12##2##(1991-1#4)(1991-4#2)(1992-8#1)(1993-11#1)(1996-1#1)(1996-2#1)(2008-7#2)
the cannula##3##2##(1990-4#1)(1991-3#1)(1996-12#1)
the cannulation of the##2##4##(2007-8#2)
the cannulation##3##2##(2007-7#1)(2007-8#2)
the canonical##18##2##(1990-8#1)(1992-1#1)(1992-6#1)(1993-8#1)(1995-3#2)(1996-7#1)(1997-9#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-7#2)
the canopy and##2##3##(2008-10#2)
the canopy of##2##3##(2008-10#1)(2008-5#1)
the canopy##14##2##(2008-10#11)(2008-12#1)(2008-5#1)(2008-9#1)
the cantaloupe##3##2##(1996-2#1)(2008-10#2)
the cantilever##7##2##(2005-11#1)(2007-9#1)(2008-10#1)(2008-3#2)(2010-4#1)(2012-2#1)
the cantilevers##2##2##(2008-3#2)
the cap site##7##3##(1990-12#1)(1991-12#1)(1991-4#2)(1991-6#1)(1992-11#1)(1995-6#1)
the cap structure is##2##4##(1997-2#1)(2008-10#1)
the cap structure##7##3##(1997-2#2)(2008-10#4)(2008-9#1)
the cap##20##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-4#2)(1991-6#2)(1992-11#1)(1995-6#1)(1997-2#2)(2005-10#1)(2006-10#1)(2007-4#1)(2008-10#4)(2008-7#1)(2008-9#1)
the capabilities of the##10##4##(2007-12#2)(2007-7#1)(2008-10#1)(2008-2#5)(2011-7#1)
the capabilities of this novel##2##5##(2007-12#1)(2008-3#1)
the capabilities of this##6##4##(1992-2#1)(2006-5#1)(2007-12#1)(2008-3#2)(2008-6#1)
the capabilities of##34##3##(1992-2#1)(1996-1#1)(2006-5#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-2#6)(2008-3#5)(2008-6#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-7#1)(2012-1#1)(2012-12#2)
the capability for##4##3##(1995-12#1)(2008-7#2)(2010-11#1)
the capability of human##2##4##(1994-12#1)(2008-1#1)
the capability of performing##2##4##(1992-3#1)(2008-2#1)
the capability of the method##2##5##(2008-3#1)(2009-7#1)
the capability of the proposed##2##5##(2008-3#1)(2013-1#1)
the capability of the technique##2##5##(2008-1#1)(2008-3#1)
the capability of the##19##4##(1992-4#1)(2006-10#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#4)(2008-4#1)(2009-7#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
the capability of these##2##4##(2008-2#1)(2009-5#1)
the capability of##61##3##(1990-7#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-11#1)(2006-10#4)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-2#4)(2008-3#10)(2008-4#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-7#1)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)
the capability to##26##3##(1992-4#1)(1993-12#1)(1993-3#1)(1996-5#1)(1996-6#1)(2005-12#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#3)(2008-5#2)(2008-7#2)(2011-2#1)
the capability##93##2##(1990-7#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-11#1)(1996-5#1)(1996-6#1)(2005-12#1)(2006-10#4)(2006-2#1)(2006-8#3)(2007-11#4)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-2#8)(2008-3#13)(2008-4#1)(2008-5#2)(2008-7#4)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)
the capacitance##7##2##(1994-2#1)(2005-11#1)(2008-10#2)(2008-11#1)(2010-4#1)(2012-2#1)
the capacitative##2##2##(1991-2#1)(2008-4#1)
the capacities of##5##3##(1991-3#1)(1997-2#1)(2005-11#1)(2008-4#1)(2008-7#1)
the capacities##6##2##(1991-3#1)(1997-2#1)(2005-11#1)(2008-4#1)(2008-7#1)(2012-7#1)
the capacitive##3##2##(1997-1#1)(2008-5#1)(2013-7#1)
the capacitor##2##2##(2008-9#1)(2010-4#1)
the capacity and##2##3##(2008-2#1)(2008-4#1)
the capacity factor##2##3##(1997-8#1)(2008-10#1)
the capacity for binding##2##4##(1992-8#1)(1994-12#1)
the capacity for recognizing a noun in a##2##8##(2007-12#2)
the capacity for##21##3##(1991-4#1)(1991-7#1)(1992-8#1)(1994-12#2)(1995-1#1)(1996-7#1)(1997-2#1)(2006-7#1)(2006-8#1)(2007-12#2)(2008-1#2)(2008-10#2)(2008-11#1)(2009-6#1)(2010-4#1)(2012-11#1)(2012-12#1)
the capacity of MT synthesis##2##5##(1995-3#2)
the capacity of a##6##4##(2008-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)
the capacity of some##2##4##(2010-7#1)(2013-1#1)
the capacity of the channel##2##5##(2008-2#1)(2008-3#1)
the capacity of the health##2##5##(2012-12#1)(2013-8#1)
the capacity of the mammary glands to##4##7##(2012-12#4)
the capacity of the melanotrope cells to produce inositol phosphates##2##10##(1993-5#2)
the capacity of the##42##4##(1992-6#1)(1993-5#2)(1993-7#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-5#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-7#1)(2008-10#3)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-8#1)(2009-8#1)(2012-1#1)(2012-12#6)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
the capacity of these##2##4##(1991-6#1)(2008-10#1)
the capacity of this##3##4##(2006-12#1)(2008-5#1)(2009-10#1)
the capacity of##120##3##(1990-12#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-6#2)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-5#2)(1993-7#1)(1994-3#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-5#2)(1997-1#2)(1997-3#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-4#1)(2006-7#1)(2007-11#2)(2008-1#2)(2008-10#8)(2008-12#3)(2008-2#4)(2008-3#5)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#9)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
the capacity to bind##2##4##(1993-4#1)(1994-8#1)
the capacity to encode##2##4##(1990-10#1)(2012-3#1)
the capacity to generate##5##4##(2008-1#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-9#1)
the capacity to inhibit##3##4##(1992-12#1)(1996-4#1)(2012-1#1)
the capacity to modulate##2##4##(1997-6#1)(2008-11#1)
the capacity to##82##3##(1990-10#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-5#2)(1993-7#1)(1994-1#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-7#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-3#4)(1997-6#2)(1997-8#1)(2005-10#1)(2005-11#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#4)(2008-10#5)(2008-11#5)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2009-3#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
the capacity##237##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-8#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-8#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#4)(1993-7#2)(1994-1#1)(1994-12#2)(1994-3#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#5)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#5)(1997-5#1)(1997-6#2)(1997-8#3)(2005-10#2)(2005-11#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-4#1)(2006-7#2)(2006-8#2)(2007-11#3)(2007-12#3)(2007-4#1)(2008-1#8)(2008-10#18)(2008-11#6)(2008-12#3)(2008-2#8)(2008-3#5)(2008-4#8)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#4)(2009-10#1)(2009-3#3)(2009-6#2)(2009-8#2)(2009-9#2)(2010-10#3)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#4)(2012-11#1)(2012-12#12)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#2)
the capecitabine/RT group##2##3##(2008-7#2)
the capecitabine/RT##3##2##(2008-7#3)
the capillaries##4##2##(1997-2#1)(2005-11#1)(2006-10#1)(2007-12#1)
the capillary column##2##3##(2008-10#2)
the capillary diameter##3##3##(2005-11#3)
the capillary electrophoresis method##2##4##(2008-10#2)
the capillary electrophoretic##2##3##(1994-12#1)(1996-5#1)
the capillary imbibition##2##3##(2005-11#2)
the capillary is##3##3##(2008-10#1)(2008-3#1)(2012-3#1)
the capillary loops##2##3##(2007-8#1)(2011-1#1)
the capillary network##3##3##(1992-12#2)(1995-1#1)
the capillary number##2##3##(2005-11#1)(2007-5#1)
the capillary of a##2##4##(2008-10#2)
the capillary wall##3##3##(1996-11#1)(1996-5#1)(2007-8#1)
the capillary was##2##3##(2007-8#1)(2008-10#1)
the capillary with##2##3##(2007-8#1)(2008-10#1)
the capillary##84##2##(1992-12#2)(1994-12#1)(1994-9#5)(1995-1#1)(1996-11#1)(1996-5#4)(1997-3#1)(2005-11#13)(2006-10#2)(2007-5#1)(2007-8#14)(2007-9#1)(2008-1#1)(2008-10#22)(2008-2#1)(2008-3#5)(2008-4#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
the capital city of##4##4##(2007-10#1)(2007-7#1)(2008-1#1)(2013-1#1)
the capital city##5##3##(1994-9#1)(2007-10#1)(2007-7#1)(2008-1#1)(2013-1#1)
the capital of##7##3##(1994-3#1)(2007-2#2)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)
the capital##22##2##(1991-1#1)(1991-7#1)(1992-12#1)(1993-12#1)(1994-3#1)(1994-9#1)(2007-1#1)(2007-10#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-5#1)(2012-12#1)(2013-1#1)
the capitation##2##2##(1992-12#1)(1994-3#1)
the capped##4##2##(1996-9#1)(2005-11#1)(2008-10#2)
the capping box##5##3##(1994-9#5)
the capping##10##2##(1991-6#2)(1994-9#5)(2009-5#1)(2012-12#2)
the capsaicin##4##2##(1991-9#1)(1992-11#1)(2008-10#1)(2008-11#1)
the capsid has##2##3##(1994-9#1)(2008-8#1)
the capsid polyprotein##2##3##(2008-10#2)
the capsid protein VP60##2##4##(1997-6#2)
the capsid protein##6##3##(1997-6#2)(2007-6#1)(2008-10#2)(2012-2#1)
the capsid surface##2##3##(1994-8#1)(1994-9#1)
the capsid##24##2##(1991-5#2)(1992-8#1)(1994-8#2)(1994-9#4)(1995-1#1)(1997-6#2)(2007-6#1)(2008-10#7)(2008-8#2)(2012-2#1)(2013-8#1)
the capstone course##2##3##(1993-1#2)
the capsular ligament##2##3##(2007-1#1)(2011-1#1)
the capsular polysaccharide of##2##4##(1990-12#1)(2007-10#1)
the capsular polysaccharide##5##3##(1990-12#1)(1991-12#1)(1991-9#1)(2006-8#1)(2007-10#1)
the capsular polyssacharide##2##3##(2007-10#2)
the capsular##13##2##(1990-12#1)(1991-12#1)(1991-9#1)(1994-9#1)(1995-10#1)(1995-5#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-4#1)(2011-1#1)
the capsule and##2##3##(2008-5#1)(2008-9#1)
the capsule in##2##3##(1991-8#1)(2013-7#1)
the capsule of##2##3##(2006-10#1)(2008-5#1)
the capsule##19##2##(1990-10#1)(1990-11#1)(1991-8#1)(1993-10#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-9#1)(2011-2#1)(2012-12#1)(2013-7#3)
the capsules of##2##3##(1990-4#1)(2007-12#1)
the capsules##8##2##(1990-4#1)(1994-2#1)(1997-5#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-5#1)
the caption##2##2##(1992-7#1)(2008-5#1)
the captive##3##2##(1996-12#2)(2005-9#1)
the captopril group##3##3##(1992-5#2)(1993-9#1)
the captopril test##2##3##(1992-7#2)
the captopril##5##2##(1992-5#2)(1992-7#2)(1993-9#1)
the capture agent##2##3##(2007-9#2)
the capture of the##2##4##(1990-12#1)(1996-2#1)
the capture of##12##3##(1990-12#2)(1991-3#1)(1996-2#1)(2006-10#1)(2006-11#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-4#2)(2013-7#1)
the capture##28##2##(1990-12#2)(1991-3#2)(1994-11#1)(1995-2#1)(1996-2#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-9#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#3)(2008-5#1)(2012-2#2)(2013-7#1)
the captured##10##2##(1992-2#1)(1994-12#1)(1996-8#1)(2005-11#1)(2006-10#1)(2007-3#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)
the caput and##2##3##(1992-3#1)(2013-8#1)
the caput##6##2##(1992-3#3)(2007-11#1)(2011-1#1)(2013-8#1)
the car##4##2##(2006-4#1)(2007-4#2)(2010-5#1)
the carbachol##3##2##(1990-10#1)(1990-7#1)(1994-8#1)
the carbachol-induced increase in [Ca2+]i in both phases##2##8##(2004-12#2)
the carbachol-induced##5##2##(1996-12#1)(2004-12#3)(2012-12#1)
the carbamate##3##2##(2009-3#1)(2012-12#2)
the carbamates##2##2##(2008-10#2)
the carbaryl##2##2##(2008-10#2)
the carbethoxy##2##2##(1991-4#1)(1991-7#1)
the carbohydrate antigen 19-9 (CA 19-9) and the carbohydrate antigen 50 (CA 50) have been##2##15##(1990-10#2)
the carbohydrate antigen##5##3##(1990-10#4)(1996-6#1)
the carbohydrate chain##2##3##(1990-5#1)(2009-12#1)
the carbohydrate moieties##3##3##(1991-7#1)(1995-8#1)(1997-4#1)
the carbohydrate moiety of the##2##5##(1991-7#1)(1994-8#1)
the carbohydrate moiety of##6##4##(1991-7#1)(1992-7#1)(1993-11#1)(1994-8#1)(2008-11#1)(2012-1#1)
the carbohydrate moiety##12##3##(1990-11#2)(1990-2#1)(1990-7#1)(1991-7#1)(1992-5#1)(1992-7#1)(1993-11#1)(1994-8#1)(1995-4#1)(2008-11#1)(2012-1#1)
the carbohydrate part of##2##4##(1990-5#1)(1993-7#1)
the carbohydrate part##3##3##(1990-12#1)(1990-5#1)(1993-7#1)
the carbohydrate recognition domain##3##4##(1990-6#1)(2006-10#1)(2011-1#1)
the carbohydrate structure##2##3##(1991-12#1)(1994-9#1)
the carbohydrate structures##2##3##(1996-9#1)(2010-12#1)
the carbohydrate##56##2##(1990-10#4)(1990-11#3)(1990-12#2)(1990-2#1)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-5#1)(1991-7#2)(1991-9#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-7#1)(1994-8#1)(1994-9#1)(1995-4#1)(1995-8#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(2004-11#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-6#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2010-12#1)(2011-1#1)(2012-1#1)(2013-7#1)(2013-8#1)
the carbohydrate-binding##5##2##(1990-11#1)(1990-7#1)(1994-8#1)(1996-5#1)(2005-12#1)
the carbohydrate-restricted##2##2##(2008-3#2)
the carbohydrates in the##3##4##(2008-3#1)(2008-5#2)
the carbohydrates##7##2##(2006-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2013-8#1)
the carbon and##3##3##(1996-3#1)(2008-10#1)(2010-11#1)
the carbon chain##2##3##(2008-6#1)(2009-3#1)
the carbon content##3##3##(2008-10#1)(2008-3#2)
the carbon cycle##3##3##(2006-12#1)(2011-2#1)(2013-8#1)
the carbon dioxide laser##3##4##(1991-12#2)(1993-8#1)
the carbon dioxide##5##3##(1991-12#2)(1993-8#1)(2007-7#1)(2008-5#1)
the carbon fiber##2##3##(1992-11#1)(2008-10#1)
the carbon flux to##2##4##(2008-7#1)(2012-3#1)
the carbon flux##4##3##(1991-11#1)(2008-7#1)(2012-3#1)(2013-1#1)
the carbon from##2##3##(1992-6#1)(2006-8#1)
the carbon monoxide##3##3##(1992-12#1)(1993-10#1)(1996-12#1)
the carbon nanotube surface##2##4##(2007-8#2)
the carbon nanotubes##2##3##(2010-3#1)(2011-2#1)
the carbon number##3##3##(2005-11#2)(2008-11#1)
the carbon paste electrode##5##4##(2008-10#5)
the carbon paste##9##3##(2008-10#9)
the carbon source##13##3##(1990-12#1)(1990-5#1)(1994-9#1)(1995-6#1)(1995-8#1)(1995-9#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-6#2)(2008-7#1)
the carbon sources##2##3##(1997-2#1)(2006-9#1)
the carbon storage and sink ability of mangrove##3##8##(2013-8#3)
the carbon surface##6##3##(2005-11#4)(2008-10#2)
the carbon tetrachloride dose##3##4##(1995-3#3)
the carbon tetrachloride##4##3##(1995-3#3)(2011-2#1)
the carbon##104##2##(1990-12#1)(1990-5#1)(1991-11#1)(1991-12#2)(1991-3#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-10#1)(1993-8#1)(1994-7#1)(1994-9#1)(1995-3#3)(1995-6#2)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-2#1)(2005-11#7)(2005-3#1)(2006-10#1)(2006-12#1)(2006-8#3)(2006-9#1)(2007-7#1)(2007-8#2)(2008-10#25)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#3)(2008-6#5)(2008-7#2)(2008-9#1)(2009-2#2)(2009-3#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#5)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#4)
the carbonaceous materials##3##3##(2005-11#3)
the carbonate##4##2##(2008-10#4)
the carbonic anhydrases##2##3##(1990-8#1)(1993-4#1)
the carbons of##3##3##(1995-11#3)
the carbons##4##2##(1995-11#3)(2005-11#1)
the carbonyl and##2##3##(1995-5#1)(2008-10#1)
the carbonyl group of##3##4##(1992-3#1)(1995-6#1)(2008-5#1)
the carbonyl group##7##3##(1992-3#1)(1994-5#1)(1995-6#1)(1996-2#1)(1997-2#1)(2008-5#2)
the carbonyl oxygen atom##3##4##(1992-9#2)(1996-5#1)
the carbonyl oxygen of##3##4##(1991-3#1)(1992-6#1)(1996-5#1)
the carbonyl oxygen##8##3##(1991-3#1)(1992-6#1)(1992-9#2)(1996-5#2)(1997-1#1)(2008-6#1)
the carbonyl stretching##3##3##(1995-5#2)(2008-8#1)
the carbonyl##34##2##(1990-2#1)(1990-7#1)(1991-3#1)(1992-3#1)(1992-6#2)(1992-9#3)(1993-11#1)(1994-5#2)(1995-5#5)(1995-6#1)(1996-2#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#1)(2007-11#3)(2008-10#2)(2008-5#2)(2008-6#1)(2008-8#1)(2010-5#1)
the carboxy region of the##2##5##(1997-1#2)
the carboxy terminal half of the##2##6##(1990-12#1)(1992-2#1)
the carboxy terminal half of##3##5##(1990-12#1)(1992-2#1)(1997-2#1)
the carboxy terminal half##4##4##(1990-12#1)(1992-2#1)(1997-2#2)
the carboxy terminal tail of##2##5##(1995-3#2)
the carboxy terminal##10##3##(1990-12#1)(1991-6#1)(1992-2#1)(1992-5#1)(1993-6#1)(1995-3#2)(1995-4#1)(1997-2#2)
the carboxy terminals##2##3##(1993-8#2)
the carboxy termini of##2##4##(1991-8#1)(1996-7#1)
the carboxy terminus of##2##4##(1990-7#1)(1993-8#1)
the carboxy terminus##4##3##(1990-7#1)(1992-9#1)(1993-8#1)(1996-7#1)
the carboxy##23##2##(1990-12#1)(1990-7#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-6#1)(1993-8#3)(1995-3#2)(1995-4#1)(1996-7#2)(1997-1#2)(1997-2#2)(1997-8#1)(2006-12#2)
the carboxy-terminal region of the##2##5##(1993-3#1)(1994-6#1)
the carboxy-terminal##18##2##(1991-11#1)(1991-5#1)(1991-9#2)(1992-5#2)(1992-6#1)(1993-11#1)(1993-3#2)(1993-6#1)(1994-6#1)(1995-6#1)(1996-4#2)(2005-11#1)(2008-11#1)(2008-4#1)
the carboxy-terminus##5##2##(1990-12#1)(1991-5#1)(1992-6#1)(1995-4#1)(1995-6#1)
the carboxyl and##3##3##(1995-11#1)(1995-3#1)(2008-10#1)
the carboxyl group of##3##4##(1991-4#1)(1993-3#1)(2005-12#1)
the carboxyl group##10##3##(1991-2#1)(1991-4#1)(1991-8#1)(1993-11#1)(1993-3#2)(2005-12#1)(2007-8#1)(2008-10#1)(2009-9#1)
the carboxyl groups of the##3##5##(1992-3#1)(1993-6#1)(2008-10#1)
the carboxyl groups of##4##4##(1992-3#1)(1993-6#1)(2005-11#1)(2008-10#1)
the carboxyl groups##7##3##(1992-3#1)(1993-6#1)(2005-11#1)(2005-4#1)(2008-10#3)
the carboxyl side##3##3##(1991-5#1)(1994-5#2)
the carboxyl tail##4##3##(1996-2#1)(1996-8#1)(1997-7#2)
the carboxyl terminal of##2##4##(1991-7#1)(1997-7#1)
the carboxyl terminal##10##3##(1990-7#1)(1991-7#3)(1992-8#2)(1993-8#1)(1995-5#1)(1996-8#1)(1997-7#1)
the carboxyl terminus of the##5##5##(1992-8#1)(1995-10#2)(1995-4#1)(1995-8#1)
the carboxyl terminus of##7##4##(1992-6#1)(1992-8#1)(1995-10#2)(1995-4#1)(1995-8#1)(2012-2#1)
the carboxyl terminus##19##3##(1990-3#1)(1991-8#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#3)(1995-10#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-10#1)(1996-5#1)(2012-2#1)
the carboxyl##61##2##(1990-3#1)(1990-7#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#3)(1991-8#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#3)(1993-11#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#2)(1995-10#3)(1995-11#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-8#3)(1997-5#1)(1997-7#3)(2005-11#1)(2005-12#1)(2005-4#1)(2007-8#1)(2008-10#5)(2008-5#1)(2009-9#1)(2012-2#1)
the carboxyl-terminal domain of##2##4##(1995-3#1)(1996-7#1)
the carboxyl-terminal domain##5##3##(1992-2#1)(1994-5#1)(1995-3#1)(1996-5#1)(1996-7#1)
the carboxyl-terminal region of the##3##5##(1990-2#1)(1992-11#1)(1992-6#1)
the carboxyl-terminal region of##4##4##(1990-2#1)(1992-11#1)(1992-6#1)(1997-7#1)
the carboxyl-terminal region##6##3##(1990-2#1)(1992-11#2)(1992-6#1)(1994-5#1)(1997-7#1)
the carboxyl-terminal sequence##2##3##(1991-10#1)(1992-9#1)
the carboxyl-terminal##31##2##(1990-10#1)(1990-2#1)(1991-10#1)(1991-2#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#2)(1995-2#2)(1995-3#3)(1995-8#1)(1996-5#2)(1996-7#1)(1997-7#4)(1997-8#1)
the carboxylase##2##2##(1991-5#1)(1995-8#1)
the carboxylate form##3##3##(1994-8#2)(1997-3#1)
the carboxylate group##3##3##(1991-5#1)(1997-7#1)(2005-11#1)
the carboxylate groups##4##3##(1994-9#1)(2008-10#2)(2008-5#1)
the carboxylate of##2##3##(1995-5#1)(1996-2#1)
the carboxylate##21##2##(1991-5#1)(1992-3#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-5#1)(1996-2#1)(1997-3#1)(1997-7#1)(2005-11#2)(2006-11#1)(2008-10#2)(2008-5#3)(2011-1#1)
the carboxylic acid and##2##4##(1991-9#1)(1995-5#1)
the carboxylic acid group##2##4##(1996-7#1)(2012-11#1)
the carboxylic acid##8##3##(1991-9#1)(1995-5#2)(1996-7#1)(2005-11#2)(2008-10#1)(2012-11#1)
the carboxylic acids##2##3##(2005-11#1)(2008-5#1)
the carboxylic group is##2##4##(2008-10#2)
the carboxylic ionophores##2##3##(1991-1#1)(1992-4#1)
the carboxylic##20##2##(1991-1#2)(1991-9#2)(1992-4#1)(1995-5#2)(1996-7#1)(2005-11#3)(2008-10#5)(2008-5#1)(2008-7#1)(2010-1#1)(2012-11#1)
the carboxyltransferase component##2##3##(1992-9#2)
the carboxymethyl##2##2##(2008-10#2)
the carboxymethylated dextran##2##3##(2008-10#1)(2008-4#1)
the carboxymethylated##3##2##(2008-10#1)(2008-4#1)(2008-5#1)
the carcases##3##2##(1997-5#3)
the carcass and##2##3##(2013-1#2)
the carcass characteristics##2##3##(2008-12#1)(2010-4#1)
the carcass##12##2##(1990-3#1)(2006-12#1)(2008-12#1)(2008-6#2)(2010-4#3)(2011-12#1)(2013-1#3)
the carcasses##2##2##(1997-7#1)(2010-4#1)
the carcinoembryonic antigen (CEA) gene family##2##6##(1990-5#1)(1994-12#1)
the carcinoembryonic antigen (CEA)##3##4##(1990-5#1)(1993-8#1)(1994-12#1)
the carcinoembryonic antigen##4##3##(1990-5#1)(1993-8#1)(1994-12#2)
the carcinogen##10##2##(1990-11#1)(1992-4#2)(1992-5#1)(1992-9#1)(1993-8#1)(1994-5#1)(1995-2#1)(1997-4#1)(2009-9#1)
the carcinogen-initiated##2##2##(1992-9#1)(1993-12#1)
the carcinogenesis##3##2##(2007-11#1)(2012-3#1)(2013-7#1)
the carcinogenic potential of##3##4##(1997-4#1)(2006-10#1)(2008-10#1)
the carcinogenic process##5##3##(1992-7#1)(1996-6#2)(2008-7#1)(2009-5#1)
the carcinogenic##18##2##(1990-5#2)(1991-10#1)(1992-5#1)(1992-7#1)(1993-7#1)(1994-6#1)(1996-6#2)(1997-4#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-1#1)
the carcinogenicity of##10##3##(1990-6#1)(1990-8#1)(1991-12#4)(1991-6#1)(1992-9#1)(1993-8#1)(1994-6#1)
the carcinoid syndrome##2##3##(1995-6#1)(2006-1#1)
the carcinoid##6##2##(1995-6#1)(2006-1#1)(2008-8#1)(2011-2#3)
the carcinoma##11##2##(1990-3#2)(1991-10#2)(1993-9#1)(1994-6#1)(1996-4#1)(1996-6#1)(1997-5#1)(2005-11#1)(2012-12#1)
the carcinomas##5##2##(1990-11#1)(1990-12#1)(1995-9#1)(2008-5#2)
the card##2##2##(2006-8#1)(2008-2#1)
the cardia and##3##3##(1990-4#2)(1992-4#1)
the cardia##9##2##(1990-4#4)(1992-4#3)(2009-3#2)
the cardiac QT(c) interval##3##4##(2007-11#3)
the cardiac activity##2##3##(2008-10#1)(2012-1#1)
the cardiac alpha1-adrenoceptor##2##3##(1995-12#2)
the cardiac and pyloric##2##4##(1994-4#1)(2007-12#1)
the cardiac and##6##3##(1994-4#1)(1995-2#1)(2007-12#1)(2007-7#1)(2007-8#1)(2010-12#1)
the cardiac arrest##3##3##(1990-12#1)(2006-4#1)(2010-8#1)
the cardiac arrhythmia##2##3##(1993-7#1)(2008-4#1)
the cardiac cell cycle##2##4##(1997-6#2)
the cardiac chambers##2##3##(2005-1#1)(2005-12#1)
the cardiac conduction system##2##4##(1996-9#1)(2006-12#1)
the cardiac cycle##7##3##(2006-5#2)(2007-3#1)(2007-8#3)(2008-10#1)
the cardiac effects of##2##4##(1990-3#1)(1995-12#1)
the cardiac function in##2##4##(2008-10#1)(2012-3#1)
the cardiac function##4##3##(1991-3#1)(2008-10#1)(2012-2#1)(2012-3#1)
the cardiac ganglion##2##3##(2008-4#2)
the cardiac muscle##9##3##(1991-12#1)(1992-3#1)(1994-3#1)(2005-1#1)(2008-5#3)(2008-7#1)(2011-1#1)
the cardiac myocyte##2##3##(2008-10#1)(2009-4#1)
the cardiac myocytes##2##3##(1993-3#1)(1994-11#1)
the cardiac output##3##3##(2008-12#1)(2008-2#1)(2012-3#1)
the cardiac surgical##2##3##(1997-8#1)(2008-10#1)
the cardiac sympathetic afferent reflex is##2##6##(2005-10#2)
the cardiac sympathetic afferent reflex##3##5##(2005-10#3)
the cardiac sympathetic##7##3##(1995-6#1)(2005-10#5)(2006-1#1)
the cardiac tissue##3##3##(2006-6#1)(2008-10#1)(2008-8#1)
the cardiac##132##2##(1990-12#2)(1990-3#1)(1990-6#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-2#2)(1993-3#3)(1993-7#1)(1994-11#3)(1994-12#3)(1994-3#1)(1994-4#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#3)(1995-2#1)(1995-6#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#1)(2005-1#3)(2005-10#6)(2005-12#1)(2005-9#1)(2006-1#2)(2006-12#1)(2006-4#1)(2006-5#2)(2006-6#1)(2007-11#3)(2007-12#4)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#4)(2007-9#5)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-4#4)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2010-10#1)(2010-12#4)(2010-5#1)(2010-8#3)(2011-1#6)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#2)
the cardinal temperatures##2##3##(2008-10#2)
the cardinal##8##2##(2006-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-6#1)(2011-2#1)(2012-12#1)
the cardio-respiratory##3##2##(2009-6#2)(2013-1#1)
the cardio-thoracic##2##2##(1991-7#1)(2007-8#1)
the cardio-vascular system##2##3##(2006-9#1)(2011-1#1)
the cardioacceleratory neurons##2##3##(2008-4#2)
the cardioacceleratory##3##2##(2008-4#3)
the cardioinhibitory response to##2##4##(1993-12#2)
the cardiolipin##2##2##(1990-5#1)(2005-8#1)
the cardiologist##2##2##(2006-10#1)(2007-9#1)
the cardiologists##3##2##(2008-11#1)(2008-3#1)(2011-2#1)
the cardiometabolic##2##2##(2008-1#1)(2013-1#1)
the cardiomyocyte cell##2##3##(1997-6#1)(2012-3#1)
the cardiomyocyte##3##2##(1997-6#1)(2009-5#1)(2012-3#1)
the cardiomyocytes##4##2##(1992-9#1)(1994-11#1)(1994-8#1)(2006-6#1)
the cardiomyopathy locus##2##3##(1996-8#2)
the cardiomyopathy##4##2##(1990-9#1)(1996-8#2)(2008-10#1)
the cardioplegia##3##2##(2007-8#2)(2009-4#1)
the cardioprotection##3##2##(1993-3#1)(1996-9#1)(2012-3#1)
the cardioprotective effect of##3##4##(2008-7#1)(2010-12#1)(2012-2#1)
the cardioprotective effect##4##3##(2008-7#1)(2010-12#1)(2012-2#1)(2012-3#1)
the cardioprotective effects of##5##4##(1994-9#1)(2008-1#1)(2008-5#1)(2008-7#1)(2013-7#1)
the cardioprotective role of##2##4##(1991-9#1)(2004-11#1)
the cardioprotective##12##2##(1991-9#1)(1992-5#1)(1994-9#1)(2004-11#1)(2008-1#1)(2008-5#1)(2008-7#2)(2010-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
the cardiopulmonary bypass##3##3##(2007-9#3)
the cardiopulmonary resuscitation (CPR)##2##4##(2009-4#1)(2010-12#1)
the cardiopulmonary##7##2##(1991-8#1)(2007-9#4)(2009-4#1)(2010-12#1)
the cardiorenal##2##2##(1993-3#1)(2011-1#1)
the cardiorespiratory##7##2##(1993-2#3)(2006-10#1)(2007-9#1)(2013-1#2)
the cardiothoracic##4##2##(1991-7#1)(2007-8#1)(2007-9#1)(2012-2#1)
the cardiotoxic##3##2##(1995-1#1)(2008-12#1)(2012-12#1)
the cardiovascular and renal risk##2##5##(2007-12#1)(2008-3#1)
the cardiovascular and renal##4##4##(2007-12#2)(2008-1#1)(2008-3#1)
the cardiovascular and##8##3##(1990-5#1)(1991-1#1)(2005-8#1)(2007-12#2)(2008-1#1)(2008-3#1)(2010-6#1)
the cardiovascular complications of##2##4##(2007-1#1)(2007-12#1)
the cardiovascular complications##3##3##(2007-1#1)(2007-12#1)(2013-7#1)
the cardiovascular disease##5##3##(2005-9#1)(2008-3#1)(2009-4#1)(2010-12#1)(2011-1#1)
the cardiovascular effects of##4##4##(1991-2#1)(1991-4#1)(2008-3#1)(2008-5#1)
the cardiovascular effects##5##3##(1990-5#1)(1991-2#1)(1991-4#1)(2008-3#1)(2008-5#1)
the cardiovascular response to##4##4##(1991-8#1)(1995-12#1)(2006-10#1)(2008-7#1)
the cardiovascular response##5##3##(1991-8#1)(1995-12#1)(1997-2#1)(2006-10#1)(2008-7#1)
the cardiovascular risk associated with the##2##6##(2007-12#1)(2008-1#1)
the cardiovascular risk associated with##3##5##(1996-9#1)(2007-12#1)(2008-1#1)
the cardiovascular risk factors##4##4##(2007-12#1)(2010-12#1)(2012-12#1)(2013-8#1)
the cardiovascular risk in##2##4##(2011-2#1)(2012-12#1)
the cardiovascular risk of the patient##2##6##(2007-12#1)(2008-10#1)
the cardiovascular risk of##5##4##(2007-12#2)(2008-10#1)(2008-3#2)
the cardiovascular risk##23##3##(1995-10#1)(1995-8#1)(1996-9#1)(2007-12#5)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#2)(2013-8#1)
the cardiovascular risks##2##3##(2007-12#1)(2010-4#1)
the cardiovascular status##2##3##(2005-1#1)(2006-4#1)
the cardiovascular system and##4##4##(1993-5#1)(1995-10#1)(2008-4#2)
the cardiovascular system in the##2##5##(1991-2#1)(2013-8#1)
the cardiovascular system in##4##4##(1990-6#1)(1991-2#1)(1995-12#1)(2013-8#1)
the cardiovascular system of the##2##5##(1990-10#1)(2008-4#1)
the cardiovascular system##58##3##(1990-10#1)(1990-6#3)(1991-11#2)(1991-2#1)(1991-4#1)(1991-8#1)(1992-10#1)(1992-3#1)(1993-5#1)(1995-10#1)(1995-12#1)(1995-6#1)(1997-3#1)(1997-4#1)(1997-5#1)(2005-1#1)(2005-10#1)(2005-12#1)(2005-7#2)(2005-8#1)(2006-10#3)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2009-10#3)(2009-3#1)(2009-6#1)(2009-9#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#3)
the cardiovascular toxicity##2##3##(1990-12#1)(2007-12#1)
the cardiovascular##152##2##(1990-10#1)(1990-12#1)(1990-5#2)(1990-6#3)(1990-9#2)(1991-1#1)(1991-11#2)(1991-2#3)(1991-4#2)(1991-8#2)(1992-10#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-4#1)(1993-5#1)(1994-3#1)(1995-10#2)(1995-12#3)(1995-6#1)(1995-8#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(2005-1#2)(2005-10#1)(2005-12#1)(2005-7#4)(2005-8#2)(2005-9#1)(2006-10#6)(2006-4#2)(2006-6#1)(2007-1#1)(2007-10#1)(2007-12#12)(2007-2#1)(2007-4#1)(2007-9#1)(2008-1#4)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#10)(2008-4#3)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#4)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#2)(2010-12#3)(2010-4#3)(2010-5#2)(2010-6#2)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#4)
the cards##3##2##(1992-7#1)(2006-8#1)(2010-2#1)
the care and treatment##2##4##(2007-8#1)(2008-7#1)
the care and##9##3##(1990-12#1)(1992-1#1)(1992-6#1)(2007-8#1)(2008-11#1)(2008-7#2)(2011-2#1)(2012-3#1)
the care for##2##3##(2007-11#1)(2012-3#1)
the care of a##4##4##(2007-7#1)(2008-12#1)(2009-5#1)(2013-1#1)
the care of cancer patients##2##5##(2007-4#1)(2008-1#1)
the care of cancer##3##4##(1992-2#1)(2007-4#1)(2008-1#1)
the care of children##4##4##(1992-3#1)(2006-10#1)(2008-10#1)(2008-11#1)
the care of chronically ill##2##5##(2008-12#1)(2012-3#1)
the care of chronically##3##4##(2008-12#2)(2012-3#1)
the care of elderly##4##4##(1992-3#1)(2006-3#1)(2008-11#1)(2012-3#1)
the care of individuals##3##4##(2010-8#1)(2011-2#2)
the care of older people##5##5##(2010-10#5)
the care of older##6##4##(2010-10#5)(2010-6#1)
the care of patients with##8##5##(1996-2#1)(1997-4#1)(2006-1#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-7#1)(2012-3#1)
the care of patients##12##4##(1992-1#1)(1996-2#1)(1997-4#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-3#1)(2008-7#1)(2012-3#1)
the care of persons with##2##5##(1995-3#1)(1997-1#1)
the care of persons##5##4##(1995-3#1)(1997-1#1)(2007-12#1)(2008-6#2)
the care of survivors of##2##5##(2008-11#1)(2010-7#1)
the care of the chronically##2##5##(1992-1#1)(1997-1#1)
the care of the mentally##2##5##(1992-5#1)(2011-2#1)
the care of the##15##4##(1991-11#2)(1992-1#1)(1992-11#1)(1992-5#1)(1993-12#1)(1997-1#1)(2006-10#1)(2008-11#1)(2008-7#1)(2009-7#1)(2011-2#2)(2012-12#1)(2013-1#1)
the care of their##3##4##(1996-1#1)(2005-7#1)(2008-12#1)
the care of these patients##6##5##(2006-1#1)(2006-12#1)(2006-2#1)(2008-11#1)(2008-7#1)(2012-12#1)
the care of##110##3##(1991-11#2)(1992-1#3)(1992-11#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#2)(1997-1#2)(1997-4#2)(2005-12#1)(2005-7#2)(2005-8#1)(2006-1#2)(2006-10#6)(2006-12#2)(2006-2#1)(2006-3#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-4#2)(2007-7#2)(2008-1#3)(2008-10#1)(2008-11#7)(2008-12#5)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#1)(2009-5#2)(2009-7#1)(2010-10#5)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#7)(2012-11#1)(2012-12#5)(2012-3#3)(2013-1#3)(2013-8#1)
the care plan##5##3##(1993-3#1)(2013-1#4)
the care process##2##3##(2009-4#1)(2011-2#1)
the care provided to the##2##5##(1990-12#1)(1991-3#1)
the care provided to##5##4##(1990-12#1)(1991-3#1)(2006-9#1)(2007-12#1)(2010-8#1)
the care provided##8##3##(1990-12#1)(1991-3#1)(1993-3#1)(2006-9#1)(2007-10#1)(2007-12#1)(2010-8#1)(2013-1#1)
the care provider##4##3##(2006-6#3)(2008-1#1)
the care reform##2##3##(1997-8#2)
the care rendered##3##3##(1994-2#1)(1996-3#1)(2011-2#1)
the care requirements of##2##4##(1994-12#1)(1996-1#1)
the care team##4##3##(2008-3#1)(2011-2#1)(2013-1#2)
the care that we##2##4##(2007-3#1)(2008-7#1)
the care that##7##3##(1995-2#1)(2007-2#1)(2007-3#2)(2007-8#1)(2008-7#1)(2013-1#1)
the care they provided##2##4##(2007-10#1)(2008-11#1)
the care they##4##3##(1997-1#1)(2007-10#1)(2007-9#1)(2008-11#1)
the care to##3##3##(2007-12#1)(2009-8#2)
the care##197##2##(1990-10#1)(1990-12#2)(1991-10#1)(1991-11#2)(1991-3#1)(1992-1#4)(1992-11#1)(1992-2#4)(1992-3#2)(1992-5#1)(1992-6#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-4#1)(1995-2#2)(1995-3#2)(1995-5#1)(1996-1#3)(1996-12#2)(1996-2#2)(1996-3#1)(1997-1#3)(1997-4#2)(1997-6#1)(1997-8#3)(2005-12#1)(2005-7#2)(2005-8#1)(2006-1#2)(2006-10#6)(2006-12#2)(2006-2#1)(2006-3#1)(2006-6#3)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#4)(2007-2#1)(2007-3#2)(2007-4#2)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#1)(2008-11#9)(2008-12#5)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#6)(2008-8#2)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#2)(2010-10#5)(2010-12#1)(2010-2#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#13)(2012-11#1)(2012-12#7)(2012-2#1)(2012-3#7)(2013-1#16)(2013-8#1)
the career of##4##3##(2008-10#1)(2008-5#1)(2009-4#1)(2012-3#1)
the career status of##2##4##(1993-3#1)(2012-3#1)
the career trajectory of a group of##2##7##(2006-5#2)
the career##14##2##(1993-3#1)(1995-12#1)(1997-2#1)(2006-5#2)(2007-12#2)(2007-4#1)(2008-10#1)(2008-5#1)(2009-4#1)(2012-2#1)(2012-3#2)
the careers##2##2##(1993-6#1)(2010-1#1)
the careful##5##2##(1992-9#1)(2007-8#1)(2007-9#1)(2008-10#1)(2013-1#1)
the caregiver and##2##3##(2009-5#1)(2011-2#1)
the caregiver##11##2##(1992-2#1)(1997-3#1)(2006-1#1)(2007-8#1)(2008-6#3)(2009-5#1)(2011-2#3)
the caregivers##6##2##(1992-3#3)(1994-3#1)(2008-10#1)(2008-6#1)
the caregivers'##2##2##(1992-3#1)(2013-1#1)
the caregiving##5##2##(1992-3#2)(1995-3#1)(2008-6#1)(2008-7#1)
the cargo##2##2##(2008-11#1)(2010-10#1)
the caries experience##2##3##(2010-12#2)
the caries##7##2##(2006-10#1)(2010-12#2)(2010-6#2)(2012-12#1)(2013-8#1)
the carina##10##2##(2007-8#5)(2010-7#2)(2012-1#2)(2012-3#1)
the caring##7##2##(1992-1#1)(1992-3#1)(2006-6#1)(2008-11#1)(2008-6#1)(2009-8#1)(2011-1#1)
the carotenogenic##2##2##(1992-8#1)(2010-10#1)
the carotenoid accumulation in##2##4##(1997-1#1)(2006-12#1)
the carotenoid biosynthesis genes##2##4##(1997-1#2)
the carotenoid biosynthesis##3##3##(1997-1#2)(2006-12#1)
the carotenoid##8##2##(1997-1#3)(2006-12#2)(2008-8#1)(2009-10#1)(2011-2#1)
the carotenoids##5##2##(1992-9#2)(2010-2#2)(2012-12#1)
the carotid arteries##16##3##(1990-2#1)(1991-3#1)(1994-5#1)(2006-12#1)(2007-10#2)(2008-7#6)(2008-8#2)(2011-2#1)(2013-7#1)
the carotid artery is##2##4##(1993-3#2)
the carotid artery was##2##4##(2008-7#1)(2010-12#1)
the carotid artery##22##3##(1993-3#2)(1996-5#1)(1997-2#1)(1997-5#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-7#2)(2010-11#1)(2010-12#2)(2011-2#2)
the carotid bifurcation##3##3##(1991-5#1)(2006-11#1)(2006-9#1)
the carotid body##7##3##(1994-10#2)(1994-6#4)(1995-12#1)
the carotid canal and jugular foramen##2##6##(2012-3#2)
the carotid intima-media thickness##2##4##(2007-9#1)(2008-1#1)
the carotid sinus nerve##3##4##(1991-6#1)(1997-5#2)
the carotid sinus##7##3##(1991-6#1)(1993-12#2)(1995-3#1)(1997-5#2)(2010-6#1)
the carotid stenosis##3##3##(2007-9#3)
the carotid##77##2##(1990-2#1)(1990-7#1)(1991-3#2)(1991-5#1)(1991-6#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-3#2)(1994-10#2)(1994-2#1)(1994-5#1)(1994-6#5)(1995-12#1)(1995-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-5#3)(2005-5#1)(2006-11#1)(2006-12#2)(2006-6#1)(2006-9#1)(2007-10#3)(2007-7#2)(2007-8#1)(2007-9#5)(2008-1#1)(2008-2#1)(2008-5#1)(2008-7#9)(2008-8#4)(2009-7#2)(2010-11#1)(2010-12#2)(2010-6#1)(2011-2#4)(2012-3#2)(2013-7#1)(2013-8#2)
the carp##5##2##(2008-5#3)(2008-7#1)(2008-9#1)
the carpal tunnel syndrome##2##4##(1991-8#2)
the carpal tunnel##10##3##(1991-8#2)(2006-3#1)(2008-12#1)(2008-9#2)(2009-9#1)(2010-9#3)
the carpal##14##2##(1991-8#2)(2006-3#2)(2008-12#1)(2008-9#3)(2009-9#1)(2010-9#3)(2012-1#1)(2013-1#1)
the carpenter bee##2##3##(2008-7#2)
the carpus##6##2##(1992-10#1)(1993-3#1)(2006-3#1)(2006-4#1)(2007-11#1)(2008-9#1)
the carrageenan-induced##2##2##(2007-1#1)(2010-2#1)
the carrageenan-treated##2##2##(2006-8#2)
the carriage of##2##3##(2008-11#1)(2008-5#1)
the carrier and##4##3##(2007-12#1)(2008-10#1)(2008-4#1)(2010-12#1)
the carrier buffer##4##3##(1996-5#1)(2008-10#3)
the carrier concentration##4##3##(1992-6#1)(2008-10#2)(2008-3#1)
the carrier density##3##3##(2007-11#1)(2008-2#1)(2008-7#1)
the carrier envelope phase of##2##5##(2007-12#2)
the carrier flow##2##3##(2008-10#2)
the carrier frequency##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
the carrier fringes##2##3##(2008-2#1)(2008-3#1)
the carrier gas flow rate##2##5##(2008-10#2)
the carrier gas##6##3##(2008-10#5)(2008-6#1)
the carrier grating##2##3##(2008-2#2)
the carrier in##2##3##(1996-11#1)(2008-10#1)
the carrier lifetime##2##3##(2007-12#2)
the carrier material and##2##4##(2008-10#2)
the carrier of##2##3##(1994-9#1)(1996-11#1)
the carrier protein##4##3##(1992-3#1)(1993-11#1)(1994-11#1)(1994-4#1)
the carrier recombination##2##3##(2007-11#1)(2009-2#1)
the carrier solution was##2##4##(2008-10#2)
the carrier solution##12##3##(2008-10#12)
the carrier stream##10##3##(2008-10#10)
the carrier was##2##3##(1994-12#1)(1996-9#1)
the carrier##112##2##(1990-11#3)(1990-3#1)(1990-8#1)(1991-5#2)(1992-3#3)(1992-6#2)(1993-11#1)(1994-11#1)(1994-12#2)(1994-4#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-11#2)(1996-5#1)(1996-9#1)(1997-2#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-11#7)(2007-12#8)(2008-1#1)(2008-10#43)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2009-2#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
the carrier-envelope offset frequency##2##4##(2007-11#2)
the carrier-envelope offset phase##3##4##(2007-11#3)
the carrier-envelope offset##5##3##(2007-11#5)
the carrier-envelope phase of##4##4##(2007-11#3)(2007-12#1)
the carrier-envelope phase##7##3##(2007-11#4)(2007-12#3)
the carrier-envelope##14##2##(2007-11#11)(2007-12#3)
the carriers and##2##3##(2008-10#1)(2008-11#1)
the carriers during##2##3##(2005-11#1)(2008-11#1)
the carriers of##2##3##(2005-1#1)(2008-1#1)
the carriers##12##2##(1992-3#1)(1992-8#1)(1994-11#1)(2005-1#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#4)
the carrot##4##2##(2007-12#1)(2008-10#2)(2008-9#1)
the carrying##2##2##(2007-10#1)(2011-2#1)
the carryover##2##2##(2008-10#1)(2013-8#1)
the cartilage and bone##3##4##(2007-11#2)(2008-7#1)
the cartilage and##5##3##(2007-11#3)(2007-8#1)(2008-7#1)
the cartilage matrix##2##3##(1994-2#1)(2007-11#1)
the cartilage tissue##3##3##(2008-1#1)(2008-3#1)(2008-7#1)
the cartilage##26##2##(1990-3#1)(1991-7#1)(1993-2#1)(1994-2#1)(1994-5#1)(2005-12#1)(2006-11#1)(2007-11#8)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#3)(2009-1#1)(2009-2#1)(2010-4#1)(2012-3#1)
the cartilaginous portion of##2##4##(2007-7#1)(2010-8#1)
the cartilaginous region##2##3##(2008-9#2)
the cartilaginous##8##2##(1990-6#1)(2005-12#1)(2007-11#1)(2007-7#1)(2008-9#2)(2010-8#1)(2013-7#1)
the cartridge is##4##3##(2008-10#4)
the cartridge##9##2##(2008-10#9)
the caruncle##4##2##(2013-7#3)(2013-8#1)
the cascade of events that##2##5##(2006-10#1)(2006-11#1)
the cascade of events##3##4##(1993-11#1)(2006-10#1)(2006-11#1)
the cascade of##11##3##(1991-3#1)(1993-11#1)(1994-6#1)(1995-3#1)(2006-10#1)(2006-11#1)(2008-3#1)(2008-8#1)(2009-8#1)(2012-2#1)(2012-3#1)
the cascade##22##2##(1991-3#1)(1992-2#1)(1993-11#1)(1994-6#1)(1995-3#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#2)(2007-12#3)(2008-3#2)(2008-8#1)(2009-10#1)(2009-8#1)(2010-6#1)(2012-2#1)(2012-3#1)
the cascaded phase shift##3##4##(2007-12#3)
the cascaded##9##2##(2007-12#7)(2008-2#1)(2008-3#1)
the cascading##4##2##(2007-12#2)(2008-3#1)(2010-8#1)
the case against##3##3##(1997-5#1)(2007-3#1)(2007-9#1)
the case and review##2##4##(2010-5#1)(2013-1#1)
the case and the##2##4##(2010-12#1)(2013-1#1)
the case and to##2##4##(1996-12#1)(2006-4#1)
the case and##9##3##(1992-6#1)(1994-5#1)(1996-12#1)(2006-4#1)(2009-5#1)(2010-12#1)(2010-5#1)(2013-1#2)
the case by##2##3##(2008-8#1)(2010-2#1)
the case definition##2##3##(1993-6#1)(1994-11#1)
the case described here##2##4##(1994-3#1)(2008-11#1)
the case described##4##3##(1990-3#1)(1994-3#1)(2008-11#1)(2012-2#1)
the case fatality##2##3##(2011-2#1)(2012-1#1)
the case for a##6##4##(1992-1#1)(1995-2#1)(2010-5#1)(2013-1#3)
the case for its##2##4##(2013-1#2)
the case for the##9##4##(1991-6#1)(1993-1#1)(1995-2#1)(2006-10#1)(2006-7#1)(2008-11#2)(2010-8#1)(2012-12#1)
the case for##66##3##(1990-2#1)(1990-5#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-7#1)(1993-1#1)(1993-4#1)(1994-5#1)(1994-7#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#1)(1996-2#1)(1996-9#1)(1997-3#1)(2004-12#1)(2005-11#1)(2006-10#2)(2006-7#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-2#2)(2008-8#2)(2008-9#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#7)(2013-8#1)
the case group and##2##4##(2006-8#2)
the case group##14##3##(1995-4#1)(1995-6#1)(2006-8#2)(2007-2#1)(2011-2#9)
the case history and##3##4##(1993-4#1)(1995-5#1)(2010-4#1)
the case history of a##2##5##(1991-8#1)(2008-6#1)
the case history of##3##4##(1991-8#1)(1994-2#1)(2008-6#1)
the case history##8##3##(1991-8#1)(1993-3#1)(1993-4#1)(1994-2#1)(1995-5#1)(2006-8#1)(2008-6#1)(2010-4#1)
the case if##2##3##(1992-2#1)(1992-3#1)
the case in a##4##4##(1994-9#1)(2005-8#1)(2009-2#1)(2013-1#1)
the case in many##2##4##(2006-10#1)(2007-4#1)
the case in the##5##4##(1995-6#1)(2008-10#2)(2008-3#1)(2008-7#1)
the case in which a##2##5##(2007-8#1)(2008-3#1)
the case in which the##3##5##(2008-2#1)(2008-3#2)
the case in which##8##4##(2007-8#1)(2008-2#1)(2008-3#6)
the case in##40##3##(1990-5#1)(1991-5#1)(1991-9#1)(1992-7#1)(1993-11#1)(1994-2#1)(1994-9#1)(1995-10#1)(1995-6#1)(1997-5#1)(2005-8#1)(2006-10#3)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#7)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2010-11#1)(2011-2#2)(2013-1#1)
the case is considered##3##4##(2008-9#1)(2013-1#2)
the case is##6##3##(1992-10#1)(2006-12#1)(2007-9#1)(2008-9#1)(2013-1#2)
the case management##2##3##(1997-3#1)(2010-2#1)
the case manager##5##3##(2006-1#5)
the case mix##2##3##(1995-2#2)
the case notes##2##3##(1996-9#1)(2008-6#1)
the case of &quot##2##4##(1995-12#1)(2012-2#1)
the case of 37 years old##2##6##(2005-1#1)(2012-3#1)
the case of B##3##4##(1992-2#1)(2008-10#2)
the case of DNA##2##4##(1993-3#1)(1997-6#1)
the case of a 14-year-old##2##5##(2007-8#1)(2010-7#1)
the case of a 20-year-old##3##5##(2008-6#1)(2010-6#1)(2013-1#1)
the case of a 22-year-old##2##5##(2005-11#1)(2006-10#1)
the case of a 27-year-old##2##5##(1996-2#1)(2008-12#1)
the case of a 28 year-old##2##6##(2010-9#1)(2013-1#1)
the case of a 29-year-old##2##5##(2008-12#1)(2013-7#1)
the case of a 30-year-old woman##2##6##(2006-10#1)(2006-11#1)
the case of a 30-year-old##5##5##(2006-10#1)(2006-11#1)(2007-2#1)(2008-11#1)(2013-8#1)
the case of a 33-year-old man with##2##7##(2007-4#1)(2007-8#1)
the case of a 33-year-old man##3##6##(2007-4#1)(2007-8#1)(2012-12#1)
the case of a 35-year-old woman##4##6##(2010-12#1)(2011-2#1)(2013-1#2)
the case of a 35-year-old##5##5##(2010-12#1)(2011-2#2)(2013-1#2)
the case of a 36-year-old##2##5##(1994-4#1)(2006-2#1)
the case of a 38-year-old woman with##2##7##(1992-5#1)(2008-6#1)
the case of a 38-year-old##3##5##(1992-5#1)(2008-6#1)(2009-9#1)
the case of a 41-year-old##2##5##(2010-9#1)(2012-3#1)
the case of a 45-year-old##3##5##(2010-5#1)(2013-1#1)(2013-8#1)
the case of a 46-year-old##2##5##(2008-7#1)(2008-9#1)
the case of a 49-year-old##2##5##(2008-7#1)(2013-8#1)
the case of a 51-year-old##4##5##(2006-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
the case of a 52-year-old##4##5##(2011-2#2)(2012-2#1)(2013-7#1)
the case of a 57-year-old##4##5##(2010-9#1)(2011-1#1)(2011-2#1)(2013-7#1)
the case of a 60-year-old man##2##6##(2007-8#1)(2008-7#1)
the case of a 60-year-old##4##5##(1997-2#1)(2007-8#1)(2008-4#1)(2008-7#1)
the case of a 62-year-old##2##5##(2008-10#1)(2013-1#1)
the case of a 63 years old##2##7##(1991-11#1)(2013-7#1)
the case of a 63-year-old##3##5##(2007-5#1)(2007-8#2)
the case of a 66-year-old##3##5##(2007-8#1)(2008-6#1)(2013-1#1)
the case of a 69-year-old##2##5##(2005-12#1)(2010-6#1)
the case of a 70-year-old male##2##6##(2007-8#1)(2013-7#1)
the case of a 70-year-old woman##2##6##(2012-3#1)(2013-7#1)
the case of a 70-year-old##7##5##(2007-11#1)(2007-8#1)(2012-3#1)(2013-1#2)(2013-7#2)
the case of a 72-year-old woman##3##6##(2007-8#1)(2008-7#1)(2012-12#1)
the case of a 75-year-old##2##5##(1991-10#1)(1991-11#1)
the case of a 79-year-old##2##5##(2007-4#1)(2013-7#1)
the case of a child##5##5##(2007-8#1)(2008-9#1)(2010-12#1)(2012-12#1)(2013-1#1)
the case of a female patient with##2##7##(1992-12#1)(2008-1#1)
the case of a female patient##4##6##(1992-12#1)(2007-7#1)(2007-8#1)(2008-1#1)
the case of a girl##2##5##(1991-6#1)(2011-1#1)
the case of a healthy##2##5##(2007-3#1)(2011-2#1)
the case of a male patient##2##6##(2010-3#1)(2011-2#1)
the case of a male##3##5##(2010-3#1)(2011-2#2)
the case of a man##5##5##(2006-6#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
the case of a middle-aged##2##5##(2006-10#1)(2011-1#1)
the case of a newborn##3##5##(2008-10#2)(2008-4#1)
the case of a patient affected by##2##7##(1991-1#1)(1993-6#1)
the case of a patient affected##3##6##(1991-1#1)(1993-6#2)
the case of a patient who developed##2##7##(1993-8#1)(2008-10#1)
the case of a patient who had##2##7##(1993-8#1)(2005-10#1)
the case of a patient who##8##6##(1993-8#2)(2005-10#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-3#1)
the case of a patient with a##5##7##(1992-10#1)(2007-8#1)(2008-6#1)(2010-12#1)(2010-2#1)
the case of a patient with##29##6##(1992-10#1)(2005-12#2)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-5#1)(2008-6#2)(2010-12#2)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#5)(2013-8#1)
the case of a patient##48##5##(1991-1#1)(1992-10#2)(1993-6#2)(1993-8#2)(2005-10#1)(2005-12#2)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-5#3)(2008-6#3)(2010-12#2)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#1)
the case of a person##3##5##(1990-3#1)(2007-11#1)(2010-12#1)
the case of a previously##2##5##(2008-5#1)(2012-12#1)
the case of a single##3##5##(2006-5#1)(2008-3#2)
the case of a woman who presented##2##7##(2007-6#1)(2008-8#1)
the case of a woman##4##5##(2006-10#1)(2007-6#1)(2008-8#1)(2011-1#1)
the case of a young man##2##6##(1995-12#1)(2008-7#1)
the case of a young woman##2##6##(2006-10#1)(2008-7#1)
the case of a young##8##5##(1991-5#1)(1995-12#1)(2006-10#2)(2007-9#1)(2008-7#2)(2012-2#1)
the case of a##332##4##(1990-3#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-10#2)(1992-12#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-10#1)(1993-6#3)(1993-8#2)(1994-1#1)(1994-4#2)(1995-12#1)(1995-5#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-7#1)(2004-12#1)(2005-10#2)(2005-11#5)(2005-12#5)(2006-10#17)(2006-11#1)(2006-12#1)(2006-2#3)(2006-4#2)(2006-5#2)(2006-6#1)(2007-10#4)(2007-11#3)(2007-2#3)(2007-3#2)(2007-4#2)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#17)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#3)(2008-2#9)(2008-3#14)(2008-4#5)(2008-5#11)(2008-6#7)(2008-7#10)(2008-8#2)(2008-9#5)(2009-1#1)(2009-3#2)(2009-6#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-12#15)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#8)(2011-12#2)(2011-2#25)(2012-1#2)(2012-12#12)(2012-2#11)(2012-3#9)(2013-1#19)(2013-7#8)(2013-8#9)
the case of an 18-year-old##2##5##(2007-11#1)(2010-12#1)
the case of an 81-year-old woman with##2##7##(2007-4#1)(2012-2#1)
the case of an adolescent##2##5##(2007-7#1)(2012-12#1)
the case of an adult male with##2##7##(2007-8#1)(2010-12#1)
the case of an infant who presented##2##7##(1991-2#1)(2006-10#1)
the case of an infant##3##5##(1991-2#1)(2006-10#1)(2006-8#1)
the case of an##32##4##(1990-12#1)(1990-6#1)(1990-8#1)(1991-2#1)(1994-9#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#2)(2009-4#1)(2010-12#3)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
the case of both##3##4##(2007-8#1)(2008-10#1)(2010-5#1)
the case of breast cancer##2##5##(2008-4#1)(2009-1#1)
the case of cancer of##2##5##(1991-12#1)(2013-1#1)
the case of cancer##3##4##(1991-12#1)(2008-11#1)(2013-1#1)
the case of cell##2##4##(1994-6#1)(2008-11#1)
the case of diffuse##2##4##(2008-10#1)(2008-3#1)
the case of high##6##4##(1992-3#1)(2005-11#1)(2007-12#1)(2008-3#2)(2012-2#1)
the case of human##2##4##(1990-4#1)(2010-12#1)
the case of hypertension##2##4##(2009-3#1)(2010-12#1)
the case of liver##2##4##(1990-4#1)(2010-12#1)
the case of malignant##2##4##(1992-10#1)(2008-1#1)
the case of multiple##2##4##(2008-2#1)(2012-2#1)
the case of natural##2##4##(1990-8#1)(2008-10#1)
the case of other##6##4##(1992-10#1)(1993-5#1)(1997-2#1)(1997-3#1)(2010-4#1)(2012-12#1)
the case of patient##2##4##(2011-2#1)(2013-8#1)
the case of patients##2##4##(2006-10#1)(2013-1#1)
the case of ruthenium##2##4##(2008-5#1)(2008-8#1)
the case of such##2##4##(1994-11#1)(2008-7#1)
the case of the biosensor##2##5##(2008-10#2)
the case of the small##2##5##(1990-11#1)(2009-11#1)
the case of the##100##4##(1990-11#1)(1990-12#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#1)(1993-10#1)(1993-6#2)(1993-8#2)(1993-9#2)(1994-11#1)(1994-5#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-11#2)(1996-2#2)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#3)(2005-11#2)(2006-10#3)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#2)(2009-11#2)(2009-12#1)(2009-4#2)(2009-7#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
the case of those##2##4##(1990-8#1)(2011-1#1)
the case of total##2##4##(2007-11#1)(2008-3#1)
the case of two Somali siblings##2##6##(2008-5#2)
the case of two##6##4##(1991-5#1)(1994-5#1)(2008-2#1)(2008-5#2)(2008-9#1)
the case of very##4##4##(2008-10#4)
the case of##1097##3##(1990-11#4)(1990-12#9)(1990-2#2)(1990-3#3)(1990-4#2)(1990-5#3)(1990-6#3)(1990-7#1)(1990-8#4)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#6)(1991-12#2)(1991-2#7)(1991-3#4)(1991-4#3)(1991-5#5)(1991-6#4)(1991-7#3)(1991-8#3)(1991-9#3)(1992-1#3)(1992-10#5)(1992-11#1)(1992-12#4)(1992-2#3)(1992-3#5)(1992-5#3)(1992-6#8)(1992-8#3)(1992-9#1)(1993-1#3)(1993-10#3)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#4)(1993-5#3)(1993-6#7)(1993-8#9)(1993-9#5)(1994-1#2)(1994-11#5)(1994-12#1)(1994-2#2)(1994-3#4)(1994-4#2)(1994-5#4)(1994-6#3)(1994-8#2)(1994-9#3)(1995-1#3)(1995-10#2)(1995-11#4)(1995-12#6)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#2)(1995-9#5)(1996-1#3)(1996-10#1)(1996-11#6)(1996-12#2)(1996-2#5)(1996-3#3)(1996-4#2)(1996-5#3)(1996-7#1)(1996-8#5)(1997-2#5)(1997-3#8)(1997-4#3)(1997-5#2)(1997-6#4)(1997-7#6)(1997-8#2)(2004-12#3)(2004-9#1)(2005-1#1)(2005-10#3)(2005-11#16)(2005-12#5)(2005-5#1)(2005-6#1)(2005-8#1)(2006-10#25)(2006-11#3)(2006-12#7)(2006-2#4)(2006-3#1)(2006-4#7)(2006-5#4)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#4)(2007-1#1)(2007-10#7)(2007-11#17)(2007-12#11)(2007-2#3)(2007-3#2)(2007-4#4)(2007-5#8)(2007-6#2)(2007-7#7)(2007-8#29)(2007-9#6)(2008-1#5)(2008-10#115)(2008-11#19)(2008-12#7)(2008-2#37)(2008-3#50)(2008-4#11)(2008-5#33)(2008-6#11)(2008-7#28)(2008-8#14)(2008-9#10)(2009-1#2)(2009-10#2)(2009-11#2)(2009-12#3)(2009-2#3)(2009-3#3)(2009-4#11)(2009-5#1)(2009-6#4)(2009-7#4)(2009-8#4)(2009-9#3)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#29)(2010-2#5)(2010-3#4)(2010-4#3)(2010-5#9)(2010-6#3)(2010-7#4)(2010-8#2)(2010-9#6)(2011-1#13)(2011-12#8)(2011-2#38)(2012-1#5)(2012-11#4)(2012-12#18)(2012-2#23)(2012-3#12)(2013-1#39)(2013-7#10)(2013-8#15)
the case records of##2##4##(1993-6#1)(2006-2#1)
the case report of a##5##5##(2008-11#1)(2010-6#1)(2010-7#1)(2013-1#2)
the case report of##6##4##(2008-11#1)(2010-6#1)(2010-7#1)(2012-2#1)(2013-1#2)
the case report##10##3##(2007-12#2)(2007-7#1)(2008-11#1)(2008-5#1)(2010-6#1)(2010-7#1)(2012-2#1)(2013-1#2)
the case reported here##2##4##(1991-10#1)(2011-2#1)
the case since##2##3##(2009-7#1)(2011-1#1)
the case studies##3##3##(1990-12#1)(1996-1#1)(2007-10#1)
the case study method##2##4##(1993-3#1)(1994-2#1)
the case study of a##2##5##(2006-2#1)(2012-12#1)
the case study of##3##4##(2006-2#2)(2012-12#1)
the case study##7##3##(1993-3#1)(1994-2#1)(2006-2#2)(2008-11#1)(2012-12#2)
the case that a##2##4##(1993-5#1)(2008-4#1)
the case that##7##3##(1990-11#1)(1991-12#1)(1993-2#1)(1993-5#1)(2008-12#1)(2008-4#1)(2013-8#1)
the case to the##2##4##(1990-4#1)(1997-5#1)
the case was considered##2##4##(2007-10#1)(2008-10#1)
the case was##6##3##(1995-11#1)(2006-2#1)(2007-10#1)(2007-7#1)(2008-10#1)(2012-11#1)
the case when a##2##4##(1994-6#1)(2006-8#1)
the case when the##5##4##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
the case when##11##3##(1991-6#1)(1994-6#1)(1996-8#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#1)
the case where the##6##4##(2005-11#1)(2006-10#1)(2006-2#1)(2008-2#2)(2009-4#1)
the case where##14##3##(1995-9#1)(2005-11#2)(2006-10#1)(2006-2#1)(2008-11#1)(2008-2#2)(2008-6#1)(2008-8#1)(2009-4#1)(2010-2#1)(2012-1#1)(2013-8#1)
the case with the##5##4##(1990-7#1)(1992-5#1)(1997-2#1)(2008-2#1)(2008-8#1)
the case with##27##3##(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#1)(1992-5#1)(1995-3#1)(1997-2#1)(1997-6#1)(2006-10#1)(2006-8#2)(2008-10#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2011-2#3)(2013-1#2)(2013-7#1)
the case without##4##3##(2007-12#1)(2012-3#2)(2013-8#1)
the case##1464##2##(1990-11#6)(1990-12#10)(1990-2#3)(1990-3#4)(1990-4#3)(1990-5#6)(1990-6#4)(1990-7#3)(1990-8#4)(1990-9#3)(1991-1#4)(1991-10#3)(1991-11#6)(1991-12#4)(1991-2#8)(1991-3#4)(1991-4#4)(1991-5#6)(1991-6#6)(1991-7#4)(1991-8#5)(1991-9#4)(1992-1#4)(1992-10#7)(1992-11#1)(1992-12#5)(1992-2#4)(1992-3#6)(1992-5#4)(1992-6#9)(1992-7#2)(1992-8#3)(1992-9#1)(1993-1#5)(1993-10#3)(1993-11#3)(1993-12#4)(1993-2#4)(1993-3#6)(1993-4#2)(1993-5#5)(1993-6#10)(1993-8#10)(1993-9#5)(1994-1#2)(1994-11#6)(1994-12#1)(1994-2#5)(1994-3#6)(1994-4#2)(1994-5#6)(1994-6#4)(1994-7#2)(1994-8#3)(1994-9#4)(1995-1#5)(1995-10#3)(1995-11#5)(1995-12#8)(1995-2#8)(1995-3#5)(1995-4#1)(1995-5#4)(1995-6#8)(1995-8#2)(1995-9#8)(1996-1#4)(1996-10#2)(1996-11#6)(1996-12#4)(1996-2#6)(1996-3#4)(1996-4#2)(1996-5#3)(1996-7#1)(1996-8#6)(1996-9#3)(1997-2#6)(1997-3#10)(1997-4#3)(1997-5#6)(1997-6#5)(1997-7#6)(1997-8#3)(2004-12#4)(2004-9#1)(2005-1#1)(2005-10#3)(2005-11#20)(2005-12#6)(2005-5#1)(2005-6#1)(2005-8#2)(2006-1#5)(2006-10#33)(2006-11#4)(2006-12#9)(2006-2#10)(2006-3#1)(2006-4#8)(2006-5#4)(2006-6#4)(2006-7#2)(2006-8#8)(2006-9#4)(2007-1#1)(2007-10#9)(2007-11#18)(2007-12#17)(2007-2#5)(2007-3#5)(2007-4#6)(2007-5#8)(2007-6#2)(2007-7#9)(2007-8#31)(2007-9#10)(2008-1#11)(2008-10#130)(2008-11#29)(2008-12#9)(2008-2#50)(2008-3#61)(2008-4#14)(2008-5#37)(2008-6#17)(2008-7#33)(2008-8#23)(2008-9#15)(2009-1#2)(2009-10#5)(2009-11#4)(2009-12#5)(2009-2#5)(2009-3#3)(2009-4#12)(2009-5#2)(2009-6#5)(2009-7#6)(2009-8#4)(2009-9#4)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#31)(2010-2#8)(2010-3#6)(2010-4#4)(2010-5#11)(2010-6#5)(2010-7#6)(2010-8#3)(2010-9#7)(2011-1#16)(2011-12#9)(2011-2#61)(2012-1#7)(2012-11#5)(2012-12#22)(2012-2#29)(2012-3#15)(2013-1#57)(2013-7#12)(2013-8#20)
the case-control studies##2##3##(1990-5#1)(2010-10#1)
the case-control study##2##3##(1991-3#1)(1997-6#1)
the case-control##6##2##(1990-5#1)(1991-3#1)(1992-9#1)(1997-6#1)(2010-10#1)(2012-3#1)
the case-fatality##2##2##(1990-9#1)(2011-1#1)
the casein kinase##3##3##(1990-10#1)(1991-2#1)(1994-8#1)
the casein##4##2##(1990-10#1)(1990-8#1)(1991-2#1)(1994-8#1)
the cases analyzed##2##3##(1997-4#1)(2013-1#1)
the cases and the##2##4##(1992-2#1)(2008-5#1)
the cases and##14##3##(1990-6#1)(1992-2#1)(1993-2#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-5#2)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
the cases are##4##3##(1992-2#1)(1995-12#1)(2007-8#1)(2008-1#1)
the cases examined and##2##4##(1996-6#2)
the cases had##4##3##(1992-5#1)(2006-4#1)(2007-2#1)(2011-12#1)
the cases in which the##2##5##(1995-2#1)(2008-3#1)
the cases in##6##3##(1995-10#2)(1995-2#1)(2006-12#1)(2008-10#1)(2008-3#1)
the cases of acute##2##4##(2008-8#1)(2009-4#1)
the cases of##47##3##(1990-4#1)(1991-11#1)(1992-10#1)(1992-3#1)(1992-8#1)(1993-8#1)(1995-8#1)(1996-4#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#4)(2008-10#2)(2008-12#1)(2008-2#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-4#2)(2011-1#1)(2011-12#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#1)
the cases reported here##2##4##(2006-10#1)(2007-11#1)
the cases reported in##3##4##(1990-2#1)(1993-2#1)(2006-11#1)
the cases reported##5##3##(1990-2#1)(1993-2#1)(2006-10#1)(2006-11#1)(2007-11#1)
the cases studied##5##3##(1993-2#1)(2007-11#2)(2008-3#1)(2012-3#1)
the cases that##4##3##(1997-3#1)(1997-6#1)(2008-6#1)(2012-1#1)
the cases the##5##3##(1991-2#1)(1991-9#1)(1993-8#1)(2006-7#1)(2013-1#1)
the cases was##4##3##(1991-8#1)(2007-2#1)(2007-7#1)(2008-10#1)
the cases were##18##3##(1991-4#1)(1993-2#1)(1993-8#1)(1995-12#1)(1996-9#1)(1997-8#1)(2006-4#1)(2007-2#1)(2007-7#5)(2008-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-8#1)
the cases with a##3##4##(1993-8#1)(1996-6#1)(2008-10#1)
the cases with##13##3##(1991-8#1)(1993-8#2)(1996-6#1)(1997-7#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-2#1)(2010-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
the cases without##2##3##(1993-3#1)(2013-8#1)
the cases##364##2##(1990-10#4)(1990-12#4)(1990-2#4)(1990-3#2)(1990-4#3)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#3)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#4)(1991-9#4)(1992-10#2)(1992-11#2)(1992-12#1)(1992-2#4)(1992-3#2)(1992-5#3)(1992-6#3)(1992-8#4)(1992-9#1)(1993-10#1)(1993-2#4)(1993-3#1)(1993-5#4)(1993-8#5)(1994-1#1)(1994-8#1)(1994-9#1)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#5)(1996-9#2)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-5#2)(2006-10#4)(2006-11#1)(2006-12#3)(2006-2#2)(2006-4#5)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#4)(2007-2#6)(2007-3#5)(2007-7#25)(2007-8#10)(2008-1#5)(2008-10#17)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#10)(2008-6#4)(2008-7#5)(2008-8#9)(2008-9#8)(2009-10#1)(2009-2#2)(2009-3#3)(2009-4#3)(2009-5#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-6#1)(2010-7#3)(2010-8#4)(2011-1#7)(2011-12#3)(2011-2#13)(2012-1#1)(2012-12#6)(2012-2#7)(2012-3#3)(2013-1#10)(2013-8#15)
the cases)##5##2##(1992-2#2)(1994-3#1)(2008-9#1)(2013-8#1)
the casino##2##2##(2012-2#2)
the casiragua insulin##3##3##(1992-8#3)
the caspase##3##2##(2008-11#1)(2010-12#1)(2012-2#1)
the caspases##3##2##(2007-8#1)(2008-4#1)(2008-7#1)
the cassava##4##2##(2008-10#1)(2009-6#3)
the cassette##4##2##(1991-3#2)(1993-9#1)(1996-10#1)
the cast of##2##3##(1993-5#1)(2006-10#1)
the cast##12##2##(1993-5#1)(2006-10#1)(2008-11#8)(2008-5#2)
the castration##2##2##(1990-6#1)(2009-10#1)
the casts##2##2##(2012-12#2)
the casual##5##2##(2006-10#1)(2008-10#3)(2010-5#1)
the casualty##2##2##(2009-6#1)(2013-8#1)
the cat adrenal medulla##2##4##(1992-3#2)
the cat as##2##3##(1990-4#1)(1992-7#1)
the cat gene##6##3##(1990-9#3)(1993-6#1)(1995-1#1)(1995-8#1)
the cat reporter gene##2##4##(1990-11#1)(1993-3#1)
the cat that##2##3##(1992-7#1)(2007-9#1)
the cat##60##2##(1990-11#1)(1990-4#2)(1990-7#5)(1990-9#3)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#3)(1991-9#3)(1992-1#1)(1992-10#1)(1992-3#3)(1992-7#2)(1992-8#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#1)(1993-7#1)(1993-9#2)(1994-12#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-5#2)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-6#1)(1996-9#2)(1997-6#1)(2007-12#1)(2007-9#1)(2008-7#1)(2008-8#3)
the cat-86##2##2##(1991-9#2)
the catabolic##6##2##(1990-1#1)(1994-12#1)(2007-8#1)(2008-10#1)(2012-1#1)(2013-1#1)
the catabolism of the##2##4##(1990-7#1)(1996-9#1)
the catabolism of tryptophan##2##4##(2007-12#1)(2008-11#1)
the catabolism of##13##3##(1990-2#1)(1990-7#1)(1991-9#1)(1992-4#1)(1993-12#1)(1993-4#1)(1994-8#1)(1996-9#1)(2007-12#1)(2008-11#1)(2008-6#1)(2009-8#1)(2011-1#1)
the catabolite repression protein##2##4##(2011-2#2)
the cataclysmic##2##2##(1994-7#1)(2012-2#1)
the catalase activity##3##3##(1991-12#2)(2006-8#1)
the catalase##8##2##(1990-12#3)(1991-12#2)(1995-8#1)(2006-8#1)(2008-10#1)
the cataleptic effect of##2##4##(1992-12#1)(1995-12#1)
the catalog of##2##3##(2008-9#2)
the catalysis of##7##3##(1990-12#1)(1993-8#1)(2008-10#4)(2008-4#1)
the catalysis##13##2##(1990-12#1)(1990-5#1)(1991-5#2)(1992-3#1)(1993-11#1)(1993-8#1)(2008-10#4)(2008-11#1)(2008-4#1)
the catalyst and##4##3##(2008-10#3)(2008-12#1)
the catalyst for##3##3##(2008-10#2)(2008-7#1)
the catalyst is##3##3##(2008-10#2)(2010-5#1)
the catalyst##37##2##(1995-2#1)(1995-9#1)(1997-2#1)(2005-11#3)(2005-12#1)(2005-8#1)(2006-4#4)(2006-9#1)(2007-10#1)(2007-11#2)(2008-10#10)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-3#1)(2010-4#2)(2010-5#1)
the catalysts with##2##3##(2005-4#1)(2007-11#1)
the catalysts##8##2##(2005-4#2)(2007-11#2)(2008-10#2)(2008-7#1)(2013-1#1)
the catalytic Zn(II)##2##3##(1992-3#2)
the catalytic active##2##3##(2010-12#1)(2013-1#1)
the catalytic activities##2##3##(1993-8#1)(1995-1#1)
the catalytic activity and##3##4##(1992-7#1)(1996-11#1)(2006-12#1)
the catalytic activity of PLC-gamma 1##3##6##(1990-11#3)
the catalytic activity of the enzyme##6##6##(1991-2#1)(1991-5#1)(1994-8#1)(1996-11#1)(2008-10#1)(2008-7#1)
the catalytic activity of the##9##5##(1991-2#1)(1991-5#1)(1994-8#1)(1994-9#1)(1996-11#1)(2008-10#3)(2008-7#1)
the catalytic activity of##32##4##(1990-11#4)(1990-2#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1996-11#1)(1997-6#1)(1997-7#1)(2004-8#1)(2006-10#1)(2007-10#1)(2008-10#8)(2008-5#1)(2008-7#1)(2009-12#1)(2012-2#1)(2013-8#1)
the catalytic activity##43##3##(1990-11#4)(1990-2#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#3)(1992-3#1)(1992-7#2)(1992-9#1)(1994-8#1)(1994-9#2)(1995-1#1)(1996-11#2)(1997-6#1)(1997-7#1)(2004-8#1)(2005-4#1)(2006-10#1)(2006-12#1)(2007-10#1)(2008-10#8)(2008-5#1)(2008-7#1)(2009-12#2)(2012-2#1)(2013-8#1)
the catalytic alpha-subunit##2##3##(1991-7#1)(1993-11#1)
the catalytic and regulatory subunits##2##5##(1990-8#1)(1995-3#1)
the catalytic and regulatory##3##4##(1990-8#1)(1993-11#1)(1995-3#1)
the catalytic and the##2##4##(1995-11#1)(1997-1#1)
the catalytic and##9##3##(1990-8#1)(1993-11#1)(1993-9#1)(1995-11#1)(1995-3#1)(1997-1#1)(2006-11#1)(2008-7#1)(2009-12#1)
the catalytic center during pRNA synthesis##2##6##(1995-6#2)
the catalytic center##8##3##(1993-8#1)(1994-10#1)(1994-9#1)(1995-6#3)(2009-2#1)(2010-12#1)
the catalytic chains of Escherichia coli aspartate transcarbamoylase##2##8##(1995-6#2)
the catalytic chains##3##3##(1990-8#1)(1995-6#2)
the catalytic cofactor##2##3##(1995-6#1)(1997-5#1)
the catalytic constants##2##3##(1994-5#1)(2007-8#1)
the catalytic core of the##3##5##(2008-4#2)(2012-2#1)
the catalytic core of##4##4##(1996-8#1)(2008-4#2)(2012-2#1)
the catalytic core##9##3##(1991-11#1)(1996-8#2)(2006-12#1)(2008-4#2)(2011-1#2)(2012-2#1)
the catalytic cycle##7##3##(1993-6#1)(1994-10#1)(1995-8#1)(1996-2#1)(1997-4#1)(2009-9#1)(2013-1#1)
the catalytic deposition of##2##4##(2006-12#1)(2008-10#1)
the catalytic domain is##2##4##(1995-8#1)(1996-4#1)
the catalytic domain of##19##4##(1990-5#1)(1991-10#1)(1991-11#1)(1992-11#2)(1993-3#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-8#2)(1995-6#2)(1997-2#1)(2006-8#1)(2008-4#1)(2008-5#2)
the catalytic domain##31##3##(1990-11#1)(1990-5#3)(1991-10#1)(1991-11#1)(1992-11#2)(1993-12#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-11#2)(1994-2#1)(1994-8#2)(1995-6#2)(1995-8#1)(1996-4#2)(1997-2#3)(1997-3#1)(2006-8#1)(2007-3#1)(2008-4#1)(2008-5#2)
the catalytic domains of##9##4##(1991-6#1)(1992-12#1)(1993-11#1)(1993-2#1)(1994-3#1)(1994-8#2)(1995-11#1)(1997-8#1)
the catalytic efficiency of the##2##5##(1992-6#1)(1996-2#1)
the catalytic efficiency of##7##4##(1990-5#1)(1991-7#1)(1992-6#1)(1996-2#1)(1996-8#1)(1997-8#1)(2005-11#1)
the catalytic efficiency##10##3##(1990-5#1)(1991-7#1)(1992-6#2)(1994-9#1)(1995-1#1)(1996-2#1)(1996-8#1)(1997-8#1)(2005-11#1)
the catalytic fragment of##2##4##(1992-12#1)(1995-11#1)
the catalytic function of the##2##5##(1990-7#1)(1994-3#1)
the catalytic function##6##3##(1990-7#1)(1991-8#1)(1992-6#2)(1994-3#1)(2008-9#1)
the catalytic growth of##2##4##(2010-7#2)
the catalytic hydrogen##4##3##(2008-10#4)
the catalytic mechanism and##2##4##(1995-10#1)(2008-4#1)
the catalytic mechanism of this enzyme##2##6##(1995-6#1)(1997-7#1)
the catalytic mechanism of this##3##5##(1995-6#1)(1997-7#1)(2010-7#1)
the catalytic mechanism of##12##4##(1990-2#1)(1992-6#1)(1993-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-6#1)(1997-7#1)(2009-2#1)(2010-7#1)(2013-8#2)
the catalytic mechanism##20##3##(1990-2#1)(1992-11#1)(1992-6#1)(1993-11#2)(1993-12#1)(1994-11#3)(1994-5#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-6#1)(1997-7#1)(2008-4#1)(2009-2#1)(2010-7#1)(2013-8#2)
the catalytic oxidation of##3##4##(2008-10#2)(2010-12#1)
the catalytic pocket of the enzyme##3##6##(1993-3#3)
the catalytic pocket##4##3##(1992-4#1)(1993-3#3)
the catalytic process##5##3##(1992-9#2)(1994-5#1)(2010-12#1)(2012-3#1)
the catalytic properties of the##3##5##(1991-2#2)(1994-11#1)
the catalytic properties of##5##4##(1991-2#2)(1994-11#1)(1994-2#1)(2008-3#1)
the catalytic properties##7##3##(1991-2#2)(1994-11#1)(1994-2#1)(2008-3#1)(2008-4#1)(2010-5#1)
the catalytic rate##2##3##(1990-2#1)(2008-10#1)
the catalytic reaction##6##3##(1990-12#1)(1994-8#1)(2008-10#4)
the catalytic region of##4##4##(1991-2#2)(1991-5#2)
the catalytic residues##4##3##(1990-7#1)(1994-8#1)(1994-9#2)
the catalytic sector of##2##4##(1994-9#2)
the catalytic sector##4##3##(1994-9#4)
the catalytic site and##2##4##(1990-3#1)(1990-5#1)
the catalytic site in##2##4##(1994-8#1)(1995-5#1)
the catalytic site of##7##4##(1990-11#1)(1992-3#1)(1992-8#1)(1993-6#1)(1994-5#2)(1995-2#1)
the catalytic site##30##3##(1990-11#2)(1990-3#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-6#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-6#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#3)(1995-8#1)(1996-2#1)(1997-7#1)(2008-3#1)(2009-7#3)
the catalytic sites##2##3##(1992-3#1)(1996-5#1)
the catalytic step##2##3##(1995-6#1)(1997-5#1)
the catalytic sub-unit of protein kinase A##2##7##(1992-12#1)(1992-7#1)
the catalytic subunit is##2##4##(1993-6#2)
the catalytic subunit of PKA##2##5##(1997-1#1)(2008-8#1)
the catalytic subunit of cAMP-dependent protein kinase##4##7##(1991-10#1)(1994-3#1)(1995-2#1)(1996-4#1)
the catalytic subunit of cAMP-dependent##5##5##(1991-10#1)(1994-3#2)(1995-2#1)(1996-4#1)
the catalytic subunit of protein kinase A##2##7##(1992-12#1)(1996-6#1)
the catalytic subunit of protein##4##5##(1992-12#1)(1994-9#1)(1995-8#1)(1996-6#1)
the catalytic subunit of the enzyme##2##6##(1995-11#1)(1996-8#1)
the catalytic subunit of the##5##5##(1994-5#1)(1994-9#1)(1995-11#1)(1996-8#1)(1997-6#1)
the catalytic subunit of##26##4##(1991-10#1)(1992-12#1)(1993-3#1)(1993-7#1)(1994-3#2)(1994-5#3)(1994-9#2)(1995-11#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-6#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-7#1)
the catalytic subunit##37##3##(1990-8#1)(1991-10#1)(1992-12#1)(1992-8#1)(1993-3#1)(1993-6#4)(1993-7#1)(1994-3#2)(1994-5#3)(1994-9#2)(1995-11#2)(1995-2#4)(1995-3#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-6#1)(1997-7#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-7#1)
the catalytic subunits##4##3##(1991-7#1)(1992-6#1)(1995-2#1)(1997-1#1)
the catalytic triad of##2##4##(1992-3#1)(1995-5#1)
the catalytic triad##7##3##(1992-3#2)(1994-12#1)(1995-3#1)(1995-5#2)(1997-6#1)
the catalytic turnover of##2##4##(2009-11#1)(2012-2#1)
the catalytic turnover##4##3##(1993-6#2)(2009-11#1)(2012-2#1)
the catalytic zinc##3##3##(1992-3#1)(1995-10#1)(1995-5#1)
the catalytic##390##2##(1990-11#7)(1990-12#2)(1990-2#3)(1990-3#2)(1990-5#6)(1990-7#4)(1990-8#5)(1991-1#2)(1991-10#2)(1991-11#4)(1991-12#1)(1991-2#5)(1991-4#1)(1991-5#5)(1991-6#3)(1991-7#4)(1991-8#4)(1991-9#1)(1992-11#4)(1992-12#5)(1992-2#1)(1992-3#10)(1992-4#2)(1992-6#8)(1992-7#3)(1992-8#3)(1992-9#6)(1993-11#7)(1993-12#2)(1993-2#1)(1993-3#5)(1993-6#10)(1993-7#1)(1993-8#3)(1993-9#1)(1994-10#3)(1994-11#6)(1994-12#1)(1994-2#2)(1994-3#4)(1994-5#9)(1994-7#1)(1994-8#11)(1994-9#15)(1995-1#3)(1995-10#5)(1995-11#7)(1995-2#7)(1995-3#4)(1995-5#7)(1995-6#11)(1995-8#4)(1996-11#3)(1996-2#6)(1996-4#3)(1996-5#2)(1996-6#1)(1996-8#5)(1997-1#3)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#5)(1997-8#2)(2004-8#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-11#1)(2006-12#4)(2006-8#1)(2007-10#2)(2007-3#1)(2007-8#1)(2008-10#43)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#5)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#3)(2009-2#4)(2009-7#4)(2009-9#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#4)(2010-8#1)(2011-1#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#3)
the catalytically active##3##3##(2006-12#1)(2006-4#1)(2013-8#1)
the catalytically essential##4##3##(1990-12#1)(1995-10#1)(1995-5#1)(1995-8#1)
the catalytically##10##2##(1990-12#1)(1991-12#1)(1992-12#1)(1994-11#1)(1995-10#1)(1995-5#1)(1995-8#1)(2006-12#1)(2006-4#1)(2013-8#1)
the catalyzed reaction##3##3##(1990-7#1)(2008-10#2)
the catalyzed##5##2##(1990-7#1)(2008-10#3)(2013-1#1)
the catalyzing##2##2##(1990-2#1)(2008-11#1)
the cataract##4##2##(1991-4#1)(2010-8#2)(2013-8#1)
the catastrophic##4##2##(2006-10#2)(2007-3#1)(2012-1#1)
the catatonic##3##2##(1995-11#1)(1997-2#2)
the catch##4##2##(2008-5#2)(2008-6#1)(2009-5#1)
the catch-up##2##2##(2013-1#2)
the catchment##4##2##(1992-6#1)(1994-2#1)(1997-2#1)(2011-2#1)
the catechol 1##2##3##(1997-1#1)(2008-3#1)
the catechol##10##2##(1997-1#1)(1997-7#1)(2006-3#1)(2008-10#4)(2008-3#1)(2009-9#1)(2010-8#1)
the catechol-O-methyltransferase##3##2##(1992-2#2)(2008-3#1)
the catecholamine extraneuronal uptake2##3##4##(1996-6#3)
the catecholamine##8##2##(1990-2#1)(1990-6#1)(1993-3#1)(1995-12#1)(1996-6#3)(2009-12#1)
the catecholaminergic##5##2##(1995-11#1)(1996-5#1)(1996-6#1)(1997-2#2)
the catecholamines##5##2##(1990-8#1)(1991-8#1)(1992-2#1)(1992-7#1)(1997-2#1)
the categorical##6##2##(1995-11#1)(2008-10#1)(2009-8#2)(2010-2#1)(2013-8#1)
the categories of##9##3##(1995-7#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-9#1)(2010-10#1)(2011-1#1)(2012-2#1)(2013-8#1)
the categories##13##2##(1995-7#1)(1997-8#1)(2004-12#1)(2006-10#1)(2007-12#1)(2008-9#1)(2010-10#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-8#1)
the categorization of##5##3##(1993-2#1)(1997-8#1)(2008-11#2)(2010-11#1)
the category membership for##2##4##(2008-9#2)
the category of the##2##4##(2005-8#1)(2008-10#1)
the category of##16##3##(1990-11#1)(1996-2#1)(2004-10#1)(2005-8#1)(2006-8#1)(2006-9#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-9#2)(2011-1#1)(2011-2#1)
the category##25##2##(1990-11#1)(1995-6#1)(1996-2#1)(2004-10#1)(2005-8#1)(2006-8#1)(2006-9#1)(2007-2#1)(2007-6#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-9#4)(2009-10#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)
the catenation##2##2##(1992-11#1)(2008-10#1)
the catfish genome##2##3##(2008-7#2)
the catfish##7##2##(1997-4#1)(2008-5#2)(2008-7#4)
the cathepsin D ERE##2##4##(1994-8#2)
the cathepsin D gene##3##4##(1991-1#1)(1994-8#1)(2009-4#1)
the cathepsin D##6##3##(1991-1#1)(1994-8#4)(2009-4#1)
the cathepsin##10##2##(1990-4#1)(1991-1#1)(1992-9#1)(1994-8#4)(1995-2#1)(1995-6#1)(2009-4#1)
the catheter and##3##3##(1993-5#1)(2011-2#1)(2013-8#1)
the catheter exit site##3##4##(2007-12#1)(2007-7#1)(2008-5#1)
the catheter had to be removed##2##6##(1990-8#2)
the catheter has##2##3##(2008-11#1)(2010-8#1)
the catheter hub##2##3##(2007-7#2)
the catheter material##2##3##(2011-2#2)
the catheter method##4##3##(2013-8#4)
the catheter tip##8##3##(2006-7#1)(2006-9#1)(2007-7#6)
the catheter was##8##3##(1992-3#1)(2007-7#3)(2008-7#1)(2011-2#1)(2013-8#2)
the catheter##72##2##(1990-3#1)(1990-8#2)(1992-3#1)(1993-5#1)(1996-3#1)(1997-3#1)(2006-10#2)(2006-4#1)(2006-7#2)(2006-9#2)(2007-10#1)(2007-12#2)(2007-7#26)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-9#1)(2010-8#4)(2011-2#7)(2013-8#10)
the catheterization laboratory##4##3##(1996-6#1)(2008-3#2)(2011-2#1)
the catheterization##6##2##(1996-6#1)(1997-2#1)(2008-3#2)(2011-2#1)(2011-3#1)
the catheters were##3##3##(2007-7#2)(2008-8#1)
the catheters##10##2##(1997-3#1)(2006-6#1)(2007-7#4)(2007-8#1)(2008-10#1)(2008-8#1)(2011-2#1)
the cathode and the##2##4##(1997-8#1)(2007-9#1)
the cathode and##3##3##(1997-8#1)(2005-11#1)(2007-9#1)
the cathode##12##2##(1996-5#1)(1997-8#2)(2005-11#2)(2007-12#1)(2007-9#1)(2008-10#5)
the cathodic adsorptive stripping##3##4##(2008-10#3)
the cathodic stripping##2##3##(2008-10#2)
the cathodic##14##2##(2008-10#11)(2010-4#1)(2010-6#1)(2012-12#1)
the cation channel##4##3##(1992-11#1)(2007-9#1)(2008-8#2)
the cation exchange##2##3##(2008-10#2)
the cation of the##2##4##(2008-10#2)
the cation of##3##3##(2008-10#3)
the cation was##2##3##(1997-1#1)(2008-10#1)
the cation##27##2##(1992-11#1)(1992-3#1)(1995-7#1)(1996-2#3)(1997-1#1)(2005-4#1)(2006-10#1)(2006-2#1)(2007-9#1)(2008-10#10)(2008-8#3)(2012-12#2)(2012-7#1)
the cation-exchange##2##2##(2008-10#2)
the cationic lipid##2##3##(2006-10#1)(2008-1#1)
the cationic polymer##5##3##(1996-5#1)(2008-11#1)(2008-5#2)(2012-12#1)
the cationic surfactant##9##3##(2005-11#4)(2008-10#2)(2008-5#1)(2008-8#1)(2010-2#1)
the cationic trypsinogen##5##3##(2006-10#5)
the cationic##50##2##(1990-8#1)(1991-7#1)(1992-11#1)(1992-6#4)(1994-12#1)(1996-5#1)(2005-11#4)(2006-10#7)(2006-12#1)(2007-11#2)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-5#5)(2008-8#2)(2009-8#1)(2010-2#1)(2010-4#2)(2011-1#1)(2012-12#1)
the cations and anions##2##4##(2008-10#2)
the cations and##3##3##(2005-11#1)(2008-10#2)
the cations were##2##3##(2008-10#2)
the cations##18##2##(1991-9#1)(2005-11#2)(2006-10#2)(2008-10#11)(2008-5#2)
the cats were##6##3##(1990-4#1)(1993-8#1)(1996-12#1)(1996-9#1)(2012-3#1)(2013-8#1)
the cats##14##2##(1990-4#1)(1990-9#1)(1993-8#1)(1996-12#1)(1996-9#3)(2007-2#2)(2008-8#1)(2012-3#3)(2013-8#1)
the cattle filarial parasite##2##4##(1992-7#1)(1994-11#1)
the cattle population##2##3##(1990-3#1)(2011-2#1)
the cattle tick Boophilus microplus##2##5##(1994-3#1)(1997-7#1)
the cattle tick##3##3##(1994-3#1)(1997-7#1)(2010-10#1)
the cattle##13##2##(1990-3#1)(1991-8#1)(1992-7#1)(1994-11#1)(1994-3#1)(1997-7#1)(2010-10#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
the cauda equina syndrome##2##4##(2006-10#1)(2008-12#1)
the cauda equina##7##3##(2006-10#1)(2006-8#1)(2007-11#1)(2008-12#1)(2008-3#3)
the cauda##8##2##(2006-10#1)(2006-8#1)(2007-11#2)(2008-12#1)(2008-3#3)
the caudal KF##2##3##(1996-5#2)
the caudal end of the##3##5##(1991-3#1)(1993-3#1)(1993-7#1)
the caudal half##2##3##(1991-9#1)(1993-12#1)
the caudal neurosecretory system (CNSS)##2##5##(2008-7#2)
the caudal neurosecretory system##3##4##(2008-5#1)(2008-7#2)
the caudal neurosecretory##5##3##(2008-5#3)(2008-7#2)
the caudal part of the##4##5##(1990-7#1)(1995-11#1)(1997-3#1)(1997-7#1)
the caudal part of##5##4##(1990-7#1)(1995-11#1)(1997-3#1)(1997-7#1)(2007-8#1)
the caudal portion of the spinal cord was##2##8##(2007-2#2)
the caudal raphe##2##3##(1993-7#2)
the caudal##64##2##(1990-3#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-3#1)(1991-9#1)(1992-8#1)(1992-9#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-7#4)(1993-9#1)(1994-2#2)(1995-11#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-5#4)(1997-3#3)(1997-5#1)(1997-7#2)(1997-8#1)(2006-8#2)(2007-1#1)(2007-2#5)(2007-6#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#6)(2008-7#2)(2009-2#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-3#2)(2013-8#1)
the caudate nucleus and putamen##2##5##(1995-5#1)(2008-11#1)
the caudate nucleus in##3##4##(1990-5#1)(2007-8#1)(2008-7#1)
the caudate nucleus##15##3##(1990-5#1)(1991-9#1)(1993-7#1)(1994-12#1)(1995-5#1)(1996-10#1)(1996-8#2)(2006-9#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#2)
the caudate putamen##5##3##(1995-6#1)(1996-12#2)(1997-7#1)(2007-1#1)
the caudate##27##2##(1990-5#1)(1991-4#1)(1991-9#1)(1992-8#2)(1993-7#1)(1994-12#1)(1994-2#2)(1995-5#1)(1995-6#1)(1996-10#1)(1996-12#2)(1996-8#2)(1997-7#2)(2006-9#1)(2007-1#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)
the caudate-putamen of the##2##4##(1990-2#1)(1993-2#1)
the caudate-putamen##12##2##(1990-2#1)(1990-5#1)(1991-8#1)(1993-2#1)(1993-6#3)(1995-12#2)(1996-12#2)(2008-7#1)
the cauliflower mosaic virus##5##4##(1993-7#1)(1997-4#1)(2008-10#2)(2008-5#1)
the cauliflower##6##2##(1993-7#1)(1997-4#1)(2008-10#3)(2008-5#1)
the causal SNP##2##3##(2012-3#2)
the causal SNPs##4##3##(2012-3#4)
the causal agent has not been##2##6##(2008-10#2)
the causal agent has##3##4##(2008-10#3)
the causal agent of Alternaria##2##5##(2008-10#2)
the causal agent of Dutch elm disease##3##7##(2008-10#3)
the causal agent of Fusarium##2##5##(2008-10#2)
the causal agent of bacterial##4##5##(1990-3#1)(2008-10#3)
the causal agent of dollar spot of##2##7##(2008-10#2)
the causal agent of gray mold##2##6##(1997-4#1)(2008-10#1)
the causal agent of late##2##5##(2008-10#2)
the causal agent of maize##2##5##(2008-10#2)
the causal agent of potato and tomato late blight##2##9##(2008-10#2)
the causal agent of potato##5##5##(2008-10#5)
the causal agent of stem canker of oilseed rape##2##9##(2008-10#2)
the causal agent of this##2##5##(2008-10#2)
the causal agent of##76##4##(1990-3#1)(1997-4#1)(2005-1#1)(2008-10#69)(2008-12#1)(2011-1#1)(2011-10#1)(2013-1#1)
the causal agent##85##3##(1990-3#1)(1997-4#1)(2005-1#1)(2006-2#1)(2008-10#77)(2008-12#1)(2011-1#1)(2011-10#1)(2013-1#1)
the causal agents of##4##4##(2005-8#1)(2008-10#3)
the causal effect of##2##4##(2013-1#1)(2013-8#1)
the causal loci##3##3##(2012-3#3)
the causal mechanisms##2##3##(2009-8#2)
the causal organism of##3##4##(2008-10#3)
the causal organism##5##3##(2008-10#5)
the causal relationship between##2##4##(1990-3#1)(2013-8#1)
the causal relationship##4##3##(1990-3#1)(1990-6#1)(1991-5#1)(2013-8#1)
the causal role##3##3##(1994-6#1)(2008-6#1)(2011-2#1)
the causal##144##2##(1990-3#2)(1990-6#1)(1991-5#1)(1994-6#1)(1995-3#1)(1996-2#1)(1997-4#1)(1997-8#2)(2005-1#1)(2005-8#1)(2006-2#2)(2008-10#92)(2008-12#1)(2008-5#1)(2008-6#2)(2009-8#2)(2010-12#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#3)(2011-10#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#13)(2013-1#3)(2013-8#2)
the causality##2##2##(2008-2#1)(2009-5#1)
the causation##5##2##(1991-5#1)(1991-9#1)(1994-6#1)(2008-1#1)(2013-7#1)
the causative agent and##2##4##(2008-5#1)(2011-2#1)
the causative agent in##3##4##(2007-7#1)(2007-8#1)(2008-5#1)
the causative agent is##3##4##(2005-11#1)(2006-4#1)(2008-5#1)
the causative agent of a##3##5##(1992-8#1)(2012-12#1)(2013-8#1)
the causative agent of the##2##5##(2008-8#1)(2011-1#1)
the causative agent of tuberculosis##2##5##(2010-10#1)(2013-1#1)
the causative agent of##33##4##(1990-12#1)(1992-8#3)(2007-12#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-7#1)(2010-10#1)(2010-12#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#3)
the causative agent##46##3##(1990-12#1)(1990-7#1)(1992-8#3)(1994-5#1)(2005-11#1)(2006-4#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-5#3)(2008-8#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#3)
the causative agents of the##2##5##(2006-3#1)(2007-6#1)
the causative agents##4##3##(1997-5#1)(2006-3#1)(2007-6#1)(2008-10#1)
the causative factors##3##3##(1994-12#1)(2008-7#1)(2010-12#1)
the causative organism##4##3##(1990-2#1)(1993-7#2)(1997-3#1)
the causative##78##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-5#1)(1992-8#3)(1993-7#2)(1994-12#1)(1994-5#2)(1996-8#1)(1997-3#1)(1997-5#1)(2005-10#1)(2005-11#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#2)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#4)(2008-5#3)(2008-7#3)(2008-8#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#3)(2011-1#3)(2011-12#1)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#5)
the cause and##9##3##(1991-11#1)(1992-3#1)(1995-4#1)(2005-4#1)(2006-10#1)(2007-10#2)(2007-5#1)(2011-2#1)
the cause for an##2##4##(2005-10#1)(2008-10#1)
the cause for the##3##4##(1991-2#1)(2006-7#1)(2010-1#1)
the cause for##11##3##(1991-2#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-10#1)(2008-10#1)(2008-7#1)(2010-1#2)(2011-2#1)(2013-1#1)
the cause in##2##3##(1993-5#1)(2008-1#1)
the cause of Cushing's##2##4##(2011-2#2)
the cause of ESRD##2##4##(2007-8#1)(2008-4#1)
the cause of PD##2##4##(1995-5#1)(2008-10#1)
the cause of a##8##4##(1991-1#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-4#2)(2011-1#1)(2011-2#1)
the cause of cervical##2##4##(2010-12#1)(2011-2#1)
the cause of chronic##4##4##(1991-2#1)(2006-10#1)(2006-12#1)(2006-6#1)
the cause of citrus##2##4##(2008-10#2)
the cause of death is##2##5##(2006-6#1)(2012-2#1)
the cause of death of the##2##6##(2011-2#1)(2012-2#1)
the cause of death of##4##5##(2007-2#1)(2008-4#1)(2011-2#1)(2012-2#1)
the cause of death was##4##5##(1994-11#1)(1995-11#1)(2005-7#1)(2011-2#1)
the cause of death##17##4##(1990-11#1)(1994-11#1)(1995-11#1)(1995-3#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-2#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-4#1)(2011-2#2)(2012-2#2)(2013-1#1)
the cause of enhanced XPA##2##5##(1996-11#2)
the cause of fatal##2##4##(2007-2#2)
the cause of individual##2##4##(2008-5#1)(2010-7#1)
the cause of pain##3##4##(2006-3#1)(2007-11#1)(2013-1#1)
the cause of renal##2##4##(2008-1#1)(2008-10#1)
the cause of the altered##2##5##(1994-11#1)(1997-8#1)
the cause of the disease##5##5##(1990-11#1)(2008-10#1)(2009-3#1)(2011-2#1)(2012-12#1)
the cause of the##39##4##(1990-11#1)(1990-2#1)(1991-11#1)(1992-1#1)(1992-3#1)(1993-10#1)(1994-11#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-8#1)(2006-12#1)(2006-2#2)(2006-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#2)(2009-3#1)(2010-11#1)(2011-2#3)(2012-12#1)
the cause of their##3##4##(1996-3#1)(2006-8#1)(2008-4#1)
the cause of these##4##4##(2006-8#1)(2007-2#1)(2008-1#1)(2011-2#1)
the cause of this##11##4##(1990-11#1)(1991-12#1)(1992-12#1)(1995-9#1)(2006-5#1)(2008-11#1)(2008-7#1)(2010-2#1)(2010-3#1)(2011-1#1)(2013-1#1)
the cause of which##2##4##(2005-9#1)(2007-9#1)
the cause of##227##3##(1990-11#3)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#3)(1990-6#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#4)(1995-6#1)(1995-8#2)(1995-9#2)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#2)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#2)(1997-7#1)(1997-8#1)(2005-12#1)(2005-7#1)(2005-9#2)(2006-10#7)(2006-12#2)(2006-2#4)(2006-3#2)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#4)(2007-2#6)(2007-3#2)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#2)(2008-1#7)(2008-10#19)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#5)(2008-5#4)(2008-6#2)(2008-7#6)(2008-9#1)(2009-3#3)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#13)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#1)
the cause was##2##3##(1996-9#1)(2006-7#1)
the cause##278##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#3)(1990-6#2)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#2)(1991-2#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-5#1)(1993-6#1)(1994-11#3)(1994-12#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#4)(1995-6#1)(1995-8#2)(1995-9#2)(1996-11#3)(1996-12#2)(1996-2#2)(1996-3#1)(1996-6#2)(1996-8#2)(1996-9#3)(1997-1#2)(1997-2#2)(1997-7#1)(1997-8#1)(2005-10#1)(2005-12#1)(2005-4#1)(2005-7#1)(2005-9#2)(2006-10#11)(2006-12#2)(2006-2#4)(2006-3#2)(2006-4#2)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#3)(2007-1#1)(2007-10#4)(2007-11#4)(2007-2#6)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#2)(2008-1#10)(2008-10#23)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#5)(2008-5#4)(2008-6#3)(2008-7#7)(2008-9#1)(2009-3#3)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#2)(2010-7#3)(2010-8#1)(2011-1#6)(2011-12#1)(2011-2#18)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#10)(2013-7#2)(2013-8#1)
the cause-effect##2##2##(1997-5#1)(2009-4#1)
the cause]##2##2##(1996-11#1)(2011-12#1)
the causes and consequences of##8##5##(2007-4#1)(2008-1#1)(2008-8#2)(2010-2#2)(2010-3#1)(2013-7#1)
the causes and##17##3##(1990-7#1)(1990-9#1)(1994-11#1)(1995-1#1)(2006-7#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-8#2)(2009-10#1)(2010-2#2)(2010-3#1)(2013-7#1)(2013-8#1)
the causes for##8##3##(1990-10#1)(1990-2#1)(1996-11#1)(2009-3#1)(2009-4#1)(2010-12#1)(2012-12#1)(2012-3#1)
the causes of hospitalization##2##4##(2007-7#1)(2012-12#1)
the causes of postoperative##2##4##(2007-12#1)(2010-7#1)
the causes of sudden##2##4##(2009-4#1)(2011-2#1)
the causes of the##4##4##(1990-10#1)(1996-8#1)(2008-8#1)(2012-12#1)
the causes of this##2##4##(2005-7#1)(2008-10#1)
the causes of which##2##4##(1991-11#1)(2008-11#1)
the causes of##73##3##(1990-10#1)(1990-12#1)(1990-7#1)(1990-8#1)(1991-11#1)(1992-12#1)(1994-6#1)(1994-7#1)(1995-5#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-1#1)(2004-10#1)(2005-1#2)(2005-7#1)(2006-10#2)(2006-5#2)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#2)(2007-5#1)(2007-7#3)(2007-8#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#2)(2009-10#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-7#2)(2010-8#3)(2011-11#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#4)(2012-3#2)(2013-1#2)(2013-8#1)
the causes underlying##2##3##(1996-2#1)(2008-10#1)
the causes##118##2##(1990-10#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-6#1)(1992-12#1)(1994-11#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-5#1)(1996-11#1)(1996-2#2)(1996-6#1)(1996-8#1)(1997-1#1)(2004-10#1)(2005-1#3)(2005-7#1)(2006-1#1)(2006-10#3)(2006-5#2)(2006-6#2)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#3)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#5)(2009-10#2)(2009-3#1)(2009-4#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#4)(2011-1#1)(2011-11#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#5)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#4)
the caustic##7##2##(2008-2#6)(2008-6#1)
the caveolae##2##2##(1995-2#1)(1997-6#1)
the cavernous segment of the internal carotid artery##2##8##(2006-12#1)(2012-3#1)
the cavernous sinus and##3##4##(1990-12#1)(2009-6#1)(2011-2#1)
the cavernous sinus##14##3##(1990-12#3)(1993-9#1)(2006-12#2)(2008-7#2)(2009-6#2)(2011-2#3)(2012-3#1)
the cavernous##20##2##(1990-12#3)(1993-9#1)(1996-9#1)(2006-12#3)(2006-5#1)(2008-7#2)(2009-10#1)(2009-6#2)(2011-2#3)(2012-3#2)(2013-8#1)
the cavitation##3##2##(2008-2#1)(2013-8#2)
the cavities of##2##3##(2010-5#1)(2012-2#1)
the cavities##7##2##(2007-11#1)(2008-10#1)(2008-3#3)(2010-5#1)(2012-2#1)
the cavity Fresnel number##2##4##(2007-12#1)(2008-3#1)
the cavity and the##5##4##(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)
the cavity and##9##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)
the cavity by##2##3##(2007-12#1)(2008-3#1)
the cavity center##2##3##(2008-3#2)
the cavity is##5##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
the cavity length of the##2##5##(2007-12#2)
the cavity length##11##3##(2007-11#4)(2007-12#6)(2008-1#1)
the cavity loss##3##3##(2008-2#1)(2008-3#2)
the cavity mode##4##3##(2007-12#2)(2008-1#1)(2008-2#1)
the cavity of a##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
the cavity of an adjacent##2##5##(1991-12#1)(1996-2#1)
the cavity of the##3##4##(2006-10#1)(2007-8#1)(2008-10#1)
the cavity of##11##3##(1991-12#1)(1996-2#2)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#3)
the cavity optics##2##3##(2008-2#1)(2008-3#1)
the cavity output##2##3##(2007-11#2)
the cavity size##2##3##(2008-10#1)(2010-4#1)
the cavity to##3##3##(2007-12#2)(2008-3#1)
the cavity were##2##3##(1995-2#1)(2007-12#1)
the cavity with##2##3##(2007-11#1)(2007-2#1)
the cavity##134##2##(1991-12#1)(1991-2#1)(1992-7#1)(1995-2#3)(1996-2#2)(1996-5#2)(1997-5#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-10#3)(2007-1#1)(2007-11#11)(2007-12#37)(2007-2#1)(2007-8#2)(2008-1#3)(2008-10#4)(2008-11#1)(2008-2#17)(2008-3#36)(2008-7#2)(2009-9#1)(2010-4#1)
the cavity's##2##2##(2007-12#1)(2008-3#1)
the cavo-tricuspid isthmus##4##3##(2007-8#4)
the cdc2##2##2##(1993-5#1)(1994-9#1)
the cdc2+ gene##2##3##(1993-9#1)(1997-6#1)
the cecal wall##2##3##(2008-11#2)
the cecal##3##2##(2008-11#2)(2008-4#1)
the cecum and##3##3##(1992-10#1)(2007-12#1)(2007-2#1)
the cecum##13##2##(1992-10#1)(2006-1#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-11#2)(2008-12#4)(2008-4#1)(2008-9#1)
the ceiling##2##2##(1996-12#1)(2008-11#1)
the celebrated##2##2##(2005-11#1)(2008-2#1)
the celiac artery##3##3##(1990-10#1)(1995-12#1)(2008-12#1)
the celiac##11##2##(1990-10#1)(1992-10#2)(1995-12#1)(2005-10#1)(2007-5#1)(2008-12#3)(2008-7#1)(2012-2#1)
the cell adhesion and##2##4##(1994-11#1)(2008-9#1)
the cell adhesion molecule##5##4##(1990-11#1)(1992-9#1)(1995-3#1)(1997-5#1)(2009-9#1)
the cell adhesion##8##3##(1990-11#1)(1992-9#1)(1994-11#1)(1995-3#1)(1997-4#1)(1997-5#1)(2008-9#1)(2009-9#1)
the cell affinity of##2##4##(2008-5#2)
the cell against##2##3##(1991-9#1)(1996-10#1)
the cell alone##2##3##(2008-11#2)
the cell and##22##3##(1990-11#1)(1990-8#1)(1991-9#1)(1994-6#1)(1996-9#1)(1997-4#1)(2005-8#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-5#1)(2010-12#1)(2010-4#1)(2013-1#1)(2013-8#1)
the cell apoptosis##3##3##(2008-9#1)(2011-1#1)(2013-1#1)
the cell are##3##3##(1997-1#1)(2005-11#1)(2006-10#1)
the cell as##4##3##(1991-6#1)(1994-8#1)(1997-6#1)(2008-1#1)
the cell at##2##3##(1994-9#1)(2005-12#1)
the cell attachment domain of##2##5##(1990-2#1)(1992-3#1)
the cell attachment##5##3##(1990-2#1)(1991-5#1)(1992-3#1)(1994-6#1)(2010-2#1)
the cell biology##3##3##(2006-11#1)(2008-11#1)(2009-12#1)
the cell bodies and##3##4##(1993-12#1)(1994-2#1)(2007-9#1)
the cell bodies of the##3##5##(1991-5#1)(1992-9#1)(2009-2#1)
the cell bodies of##4##4##(1991-3#1)(1991-5#1)(1992-9#1)(2009-2#1)
the cell bodies##11##3##(1990-7#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-9#1)(1993-12#1)(1994-2#2)(2007-9#1)(2009-2#1)
the cell body and##2##4##(1990-7#1)(2008-7#1)
the cell body##19##3##(1990-7#1)(1992-10#1)(1994-10#3)(1994-6#2)(1995-6#1)(1996-8#1)(1997-4#1)(2006-12#1)(2007-5#1)(2008-11#1)(2008-7#5)(2013-1#1)
the cell boundaries##6##3##(2008-5#2)(2008-7#1)(2009-2#1)(2010-6#1)(2011-1#1)
the cell by##2##3##(2007-12#1)(2012-12#1)
the cell concentration##3##3##(2008-11#2)(2008-7#1)
the cell cortex##6##3##(1997-6#4)(2009-10#2)
the cell culture medium##4##4##(2008-11#2)(2010-4#1)(2013-1#1)
the cell culture method##2##4##(2012-2#2)
the cell culture was##2##4##(2008-11#1)(2008-5#1)
the cell culture##24##3##(1991-6#1)(1996-2#1)(1996-7#1)(2007-1#1)(2008-10#1)(2008-11#7)(2008-5#2)(2008-8#1)(2009-10#2)(2009-11#1)(2010-4#2)(2012-1#1)(2012-2#2)(2013-1#1)
the cell cycle and apoptosis##2##5##(1995-6#1)(2012-1#1)
the cell cycle and that##2##5##(1993-11#1)(1996-4#1)
the cell cycle and the##3##5##(1993-6#1)(2006-10#1)(2012-12#1)
the cell cycle and to##2##5##(1994-5#1)(2008-3#1)
the cell cycle and##21##4##(1990-8#1)(1993-11#1)(1993-6#2)(1994-12#1)(1994-3#1)(1994-5#1)(1995-6#1)(1996-2#1)(1996-4#1)(1997-6#1)(2004-11#1)(2006-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2011-1#1)(2012-1#1)(2012-12#1)
the cell cycle arrest##2##4##(1997-3#1)(2008-11#1)
the cell cycle by##5##4##(1994-3#1)(1995-8#1)(1997-1#1)(2007-8#1)(2010-4#1)
the cell cycle during##2##4##(2009-8#1)(2012-3#1)
the cell cycle in synchronized##2##5##(1992-4#1)(1992-8#1)
the cell cycle in the##2##5##(1996-3#1)(2008-4#1)
the cell cycle in##16##4##(1990-10#1)(1992-4#2)(1992-8#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-6#1)(1996-3#1)(1996-5#1)(2007-1#1)(2008-11#1)(2008-4#3)(2008-9#1)
the cell cycle is##4##4##(1991-8#1)(2007-9#1)(2008-1#1)(2011-2#1)
the cell cycle machinery##3##4##(1994-9#1)(1997-6#1)(2008-9#1)
the cell cycle of##2##4##(2008-5#1)(2008-7#1)
the cell cycle or##2##4##(1996-10#1)(2003-11#1)
the cell cycle progression##5##4##(1991-5#1)(1994-12#1)(2008-11#1)(2009-8#1)(2011-2#1)
the cell cycle regulation##3##4##(2006-10#1)(2008-11#1)(2008-5#1)
the cell cycle regulatory##2##4##(1992-11#1)(1996-4#1)
the cell cycle was##4##4##(1992-8#1)(1994-9#1)(2008-10#1)(2008-11#1)
the cell cycle which##2##4##(1995-8#1)(2007-9#1)
the cell cycle with##2##4##(1993-6#1)(2009-9#1)
the cell cycle##197##3##(1990-10#3)(1990-2#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-5#5)(1991-7#1)(1991-8#3)(1991-9#1)(1992-10#1)(1992-11#2)(1992-4#3)(1992-6#2)(1992-8#3)(1992-9#1)(1993-11#4)(1993-12#1)(1993-6#6)(1993-8#2)(1993-9#2)(1994-12#6)(1994-3#5)(1994-5#3)(1994-6#1)(1994-8#2)(1994-9#5)(1995-1#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#5)(1995-9#1)(1996-1#1)(1996-10#1)(1996-2#2)(1996-3#1)(1996-4#4)(1996-5#5)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#1)(2003-11#1)(2004-11#3)(2004-9#1)(2006-10#2)(2007-1#1)(2007-11#2)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#3)(2008-11#19)(2008-3#2)(2008-4#8)(2008-5#4)(2008-7#3)(2008-8#3)(2008-9#6)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#3)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#5)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#1)
the cell cytoplasm##5##3##(1997-6#1)(2007-12#1)(2008-10#2)(2008-4#1)
the cell damage##2##3##(2005-3#1)(2008-8#1)
the cell death machinery##2##4##(2008-11#2)
the cell death program##2##4##(1996-7#1)(2013-7#1)
the cell death##15##3##(1993-8#1)(1996-5#1)(1996-7#1)(2007-11#1)(2007-12#1)(2008-11#4)(2008-8#1)(2009-8#1)(2012-3#1)(2013-1#2)(2013-7#1)
the cell density and##2##4##(2010-10#1)(2012-1#1)
the cell density at the##2##5##(1994-2#1)(1995-1#1)
the cell density in##2##4##(1991-7#1)(2010-10#1)
the cell density of##2##4##(2005-11#1)(2008-7#1)
the cell density on the##2##5##(2008-11#2)
the cell density##20##3##(1991-1#1)(1991-7#1)(1993-12#1)(1994-2#1)(1995-1#1)(2005-11#2)(2008-11#8)(2008-5#1)(2008-7#1)(2010-10#2)(2012-1#1)
the cell differentiation##2##3##(1992-5#1)(2008-9#1)
the cell division cycle##7##4##(1991-6#1)(1995-2#1)(1995-3#2)(1997-6#1)(2005-8#2)
the cell division site##2##4##(2009-10#1)(2009-8#1)
the cell division##11##3##(1990-7#1)(1991-6#1)(1995-2#1)(1995-3#2)(1997-6#1)(2005-8#2)(2006-5#1)(2009-10#1)(2009-8#1)
the cell entered##2##3##(2008-8#2)
the cell envelope##3##3##(1996-1#1)(1996-10#1)(2012-2#1)
the cell extract##4##3##(1990-11#1)(1990-2#1)(1995-10#1)(1997-1#1)
the cell fraction##2##3##(2008-11#1)(2009-3#1)
the cell free system##2##4##(1991-2#1)(1993-12#1)
the cell free##4##3##(1991-2#1)(1993-12#1)(2006-10#2)
the cell from##2##3##(2005-11#1)(2009-10#1)
the cell growth and##4##4##(2008-11#1)(2008-7#1)(2009-8#1)(2013-1#1)
the cell growth in##4##4##(1994-2#1)(1994-6#1)(2008-11#2)
the cell growth inhibitory factor##2##5##(1992-9#2)
the cell growth of##2##4##(1997-5#1)(2008-11#1)
the cell growth rate##2##4##(2008-7#1)(2012-12#1)
the cell growth##23##3##(1992-9#2)(1994-2#1)(1994-6#1)(1997-5#1)(2005-11#1)(2008-11#9)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2012-12#1)(2013-1#2)
the cell have##2##3##(2008-3#1)(2012-12#1)
the cell homogenates##2##3##(2006-12#1)(2008-11#1)
the cell in##3##3##(1997-4#1)(2005-12#1)(2008-11#1)
the cell interior##2##3##(2008-10#1)(2012-2#1)
the cell into##4##3##(2007-11#1)(2007-12#1)(2008-11#1)(2012-2#1)
the cell is##13##3##(1993-8#1)(1994-8#1)(1995-3#1)(1996-7#1)(1997-1#1)(1997-2#1)(2006-3#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-10#1)
the cell killing##2##3##(1993-8#1)(2008-8#1)
the cell line##28##3##(1990-5#1)(1991-12#1)(1991-6#2)(1992-1#1)(1992-10#1)(1992-2#1)(1992-8#1)(1994-5#1)(1995-3#1)(1997-1#1)(2007-1#2)(2008-11#11)(2008-4#1)(2010-11#1)(2013-8#2)
the cell lineage of##2##4##(2007-12#1)(2012-3#1)
the cell lineage##4##3##(1993-2#1)(2007-12#1)(2008-9#1)(2012-3#1)
the cell lines tested##2##4##(1990-10#1)(1991-5#1)
the cell lines to##2##4##(2008-11#2)
the cell lines used##2##4##(2008-11#1)(2013-1#1)
the cell lines with##2##4##(1992-9#1)(2005-6#1)
the cell lines##30##3##(1990-10#1)(1991-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-7#1)(1994-12#1)(1995-12#1)(1995-8#1)(1996-11#1)(1997-1#1)(2005-6#1)(2008-11#7)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-3#1)(2013-1#1)(2013-8#1)
the cell lysate was##2##4##(1992-8#1)(2010-11#1)
the cell lysate##6##3##(1992-8#1)(1994-12#1)(1997-1#1)(1997-4#1)(2008-10#1)(2010-11#1)
the cell lysates##2##3##(2008-7#2)
the cell membrane and##8##4##(1991-2#1)(1991-9#2)(2005-12#1)(2006-12#1)(2008-1#1)(2009-2#1)(2012-3#1)
the cell membrane by##3##4##(1990-9#1)(1993-9#2)
the cell membrane fraction##3##4##(1992-9#1)(1995-7#2)
the cell membrane is##2##4##(1990-11#1)(2009-11#1)
the cell membrane may##3##4##(1991-12#1)(1991-5#1)(2013-8#1)
the cell membrane of##7##4##(1990-5#1)(1995-6#1)(2007-8#1)(2008-11#1)(2008-8#1)(2009-2#1)(2010-2#1)
the cell membrane potential##2##4##(1997-7#1)(2007-8#1)
the cell membrane preparation##3##4##(1995-7#3)
the cell membrane to##2##4##(1990-12#1)(1991-5#1)
the cell membrane##92##3##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#4)(1990-5#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#2)(1991-5#3)(1991-9#2)(1992-12#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-9#2)(1994-8#3)(1995-10#1)(1995-3#1)(1995-6#2)(1995-7#5)(1996-2#1)(1997-1#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(2005-12#1)(2006-12#1)(2007-8#3)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-8#2)(2008-9#2)(2009-11#2)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#3)(2011-12#1)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
the cell membranes and##2##4##(1995-12#1)(2011-12#1)
the cell membranes of##2##4##(1991-12#1)(2013-1#1)
the cell membranes##8##3##(1990-9#1)(1991-12#1)(1994-9#1)(1995-12#1)(1997-2#1)(2009-2#1)(2011-12#1)(2013-1#1)
the cell morphology##2##3##(2008-9#1)(2011-12#1)
the cell multiplication##3##3##(1996-11#1)(2006-8#1)(2008-11#1)
the cell nucleus##7##3##(1990-4#1)(1991-1#2)(1991-2#1)(1991-9#1)(2008-4#1)(2011-2#1)
the cell number##7##3##(1992-3#1)(1994-3#1)(1994-5#1)(2008-10#1)(2008-11#2)(2011-2#1)
the cell numbers##2##3##(1996-12#1)(2004-9#1)
the cell of origin##3##4##(2010-3#2)(2013-1#1)
the cell of##5##3##(2008-10#1)(2009-2#1)(2010-3#2)(2013-1#1)
the cell or##3##3##(1991-10#2)(2008-7#1)
the cell path length##2##4##(2008-2#1)(2008-4#1)
the cell periphery##9##3##(1990-8#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-2#1)(2009-8#1)(2012-2#2)
the cell plasma membrane##2##4##(2009-7#1)(2012-2#1)
the cell population##13##3##(1990-5#1)(1991-4#1)(1992-9#1)(1994-3#1)(1996-7#1)(2008-11#3)(2008-5#1)(2008-7#3)(2013-1#1)
the cell proliferation##12##3##(1990-12#2)(1991-1#1)(1997-2#3)(2008-4#2)(2008-5#1)(2008-9#2)(2012-3#1)
the cell protein content##2##4##(1995-9#2)
the cell samples##2##3##(1990-12#1)(1994-9#1)
the cell seeding##2##3##(2008-11#1)(2009-8#1)
the cell size##6##3##(1995-9#3)(2008-10#1)(2008-7#2)
the cell soma##2##3##(1990-7#1)(1991-10#1)
the cell surface FcepsilonRI expression##2##5##(2008-11#2)
the cell surface and a##2##5##(1990-12#1)(1995-2#1)
the cell surface and in##2##5##(1993-6#1)(2008-4#1)
the cell surface and##12##4##(1990-12#1)(1992-11#1)(1993-5#1)(1993-6#1)(1994-6#1)(1995-2#1)(1996-5#1)(2008-4#1)(2008-8#1)(2010-11#1)(2010-4#1)(2012-12#1)
the cell surface as##2##4##(1994-11#1)(1996-11#1)
the cell surface by##2##4##(1995-1#1)(2008-4#1)
the cell surface during##2##4##(1992-12#1)(2011-1#1)
the cell surface expression of##2##5##(1994-12#1)(2008-11#1)
the cell surface following##4##4##(1994-12#1)(1995-3#1)(2012-12#2)
the cell surface hydrophobicity##2##4##(2013-8#2)
the cell surface in##4##4##(1995-11#1)(1996-5#1)(2012-12#2)
the cell surface is##4##4##(1993-6#1)(1994-8#1)(2008-11#1)(2008-4#1)
the cell surface of the##3##5##(1991-5#1)(1995-3#1)(2008-10#1)
the cell surface of##17##4##(1990-12#1)(1990-7#1)(1991-12#1)(1991-5#2)(1991-9#1)(1992-6#1)(1993-8#1)(1994-8#2)(1995-3#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)
the cell surface or##2##4##(1991-1#1)(2008-4#1)
the cell surface receptor##2##4##(1995-2#1)(1995-8#1)
the cell surface that##2##4##(1992-2#1)(2009-8#1)
the cell surface to##2##4##(1990-12#1)(2009-8#1)
the cell surface with##4##4##(1991-11#1)(1995-2#1)(1996-5#1)(2008-4#1)
the cell surface##150##3##(1990-11#1)(1990-12#5)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-9#4)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#3)(1993-12#2)(1993-4#1)(1993-5#2)(1993-6#4)(1993-8#2)(1994-11#4)(1994-12#5)(1994-3#1)(1994-5#1)(1994-6#4)(1994-8#5)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#2)(1996-11#1)(1996-5#4)(1996-8#2)(1997-1#2)(1997-6#1)(2005-7#2)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#11)(2008-12#1)(2008-2#1)(2008-4#11)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-12#1)(2009-8#2)(2009-9#4)(2010-1#1)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#5)(2013-8#3)
the cell surface-located##2##3##(2008-4#2)
the cell survival##2##3##(1996-5#1)(2012-3#1)
the cell suspension##7##3##(1996-1#2)(2006-3#1)(2008-11#4)
the cell system##2##3##(1990-7#1)(1997-1#1)
the cell through##2##3##(2008-4#1)(2008-7#1)
the cell to potentials more##2##5##(1993-3#2)
the cell to respond##2##4##(2008-2#1)(2011-2#1)
the cell to##12##3##(1992-9#1)(1993-3#2)(1995-2#1)(1996-10#2)(2006-7#1)(2008-11#1)(2008-2#1)(2008-4#1)(2011-1#1)(2011-2#1)
the cell type and##2##4##(1993-8#1)(1996-5#1)
the cell type in##3##4##(1993-8#1)(1997-6#1)(2008-2#1)
the cell type used##2##4##(1997-3#1)(2008-2#1)
the cell type##13##3##(1990-4#1)(1990-9#1)(1992-6#1)(1993-8#2)(1996-5#1)(1997-3#1)(1997-6#1)(2005-11#1)(2008-2#3)(2008-7#1)
the cell types of IGF-I-expressing cells and##2##7##(2008-5#2)
the cell types##5##3##(2008-2#1)(2008-4#1)(2008-5#2)(2008-9#1)
the cell via##2##3##(2008-4#1)(2008-8#1)
the cell viability##4##3##(2006-8#1)(2008-11#2)(2013-7#1)
the cell volume##4##3##(1994-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
the cell wall and##3##4##(2007-2#1)(2008-4#1)(2009-8#1)
the cell wall of##2##4##(2008-5#2)
the cell wall##43##3##(1990-5#2)(1992-11#1)(1992-8#1)(1994-2#1)(1995-6#1)(1996-2#1)(1997-4#1)(2006-12#1)(2007-2#2)(2008-10#12)(2008-11#2)(2008-2#1)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#2)(2009-8#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#2)
the cell wall-associated##2##3##(2006-3#1)(2008-10#1)
the cell walls of##5##4##(2008-10#2)(2008-11#1)(2008-5#1)(2009-3#1)
the cell walls##7##3##(2008-10#4)(2008-11#1)(2008-5#1)(2009-3#1)
the cell was##5##3##(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2010-12#1)
the cell water content##3##4##(2008-5#3)
the cell water##4##3##(2008-5#4)
the cell were##2##3##(1996-8#1)(2008-11#1)
the cell which##2##3##(1990-9#1)(2007-12#1)
the cell with##3##3##(1992-4#1)(2008-4#1)(2009-6#1)
the cell##1279##2##(1990-10#4)(1990-11#6)(1990-12#11)(1990-2#7)(1990-3#5)(1990-4#3)(1990-5#7)(1990-6#1)(1990-7#7)(1990-8#6)(1990-9#7)(1991-1#8)(1991-10#8)(1991-11#3)(1991-12#5)(1991-2#5)(1991-3#2)(1991-4#1)(1991-5#15)(1991-6#8)(1991-7#2)(1991-8#3)(1991-9#17)(1992-1#2)(1992-10#3)(1992-11#4)(1992-12#2)(1992-2#2)(1992-3#4)(1992-4#5)(1992-5#6)(1992-6#6)(1992-7#1)(1992-8#8)(1992-9#11)(1993-11#7)(1993-12#11)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#3)(1993-6#12)(1993-7#1)(1993-8#11)(1993-9#4)(1994-10#3)(1994-11#7)(1994-12#16)(1994-2#6)(1994-3#8)(1994-5#6)(1994-6#12)(1994-8#13)(1994-9#12)(1995-1#5)(1995-10#4)(1995-11#5)(1995-12#2)(1995-2#7)(1995-3#13)(1995-4#1)(1995-5#2)(1995-6#8)(1995-7#7)(1995-8#11)(1995-9#8)(1996-1#5)(1996-10#7)(1996-11#3)(1996-12#3)(1996-2#5)(1996-3#1)(1996-4#7)(1996-5#13)(1996-6#2)(1996-7#6)(1996-8#5)(1996-9#1)(1997-1#15)(1997-2#7)(1997-3#8)(1997-4#13)(1997-5#2)(1997-6#15)(1997-7#3)(1997-8#2)(2003-11#1)(2004-11#3)(2004-8#1)(2004-9#2)(2005-10#2)(2005-11#8)(2005-12#7)(2005-3#1)(2005-6#1)(2005-7#4)(2005-8#5)(2006-10#8)(2006-11#1)(2006-12#4)(2006-3#3)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#4)(2007-1#4)(2007-10#2)(2007-11#10)(2007-12#18)(2007-2#4)(2007-3#2)(2007-4#2)(2007-5#1)(2007-8#5)(2007-9#7)(2008-1#13)(2008-10#56)(2008-11#131)(2008-12#3)(2008-2#14)(2008-3#10)(2008-4#52)(2008-5#35)(2008-6#8)(2008-7#45)(2008-8#25)(2008-9#29)(2009-10#10)(2009-11#3)(2009-12#4)(2009-2#9)(2009-3#3)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#3)(2009-8#17)(2009-9#8)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#5)(2010-2#3)(2010-3#3)(2010-4#14)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#15)(2011-12#3)(2011-2#15)(2011-3#1)(2012-1#7)(2012-12#19)(2012-2#16)(2012-3#9)(2013-1#17)(2013-7#3)(2013-8#10)
the cell's machinery to##2##4##(2006-6#1)(2008-4#1)
the cell's sensitivity to MMS treatment##2##6##(1991-10#2)
the cell's##13##2##(1990-5#1)(1991-10#2)(1996-12#1)(2006-10#2)(2006-6#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-3#1)(2009-8#1)
the cell)##5##2##(1990-5#1)(2006-10#3)(2008-10#1)
the cell-associated matrix##4##3##(1994-12#4)
the cell-associated##9##2##(1992-4#1)(1992-5#1)(1992-9#1)(1993-6#1)(1994-12#4)(1997-3#1)
the cell-based##4##2##(2008-5#1)(2010-2#2)(2011-1#1)
the cell-binding##2##2##(1995-2#1)(2004-9#1)
the cell-cell##4##2##(1996-8#1)(2008-9#2)(2009-8#1)
the cell-free culture##2##3##(2006-5#1)(2008-10#1)
the cell-free extracts##2##3##(1990-3#1)(1994-6#1)
the cell-free system##2##3##(2008-5#1)(2008-8#1)
the cell-free##13##2##(1990-3#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-8#1)(2006-5#1)(2008-10#1)(2008-5#2)(2008-8#1)(2011-2#3)
the cell-material##3##2##(2010-1#1)(2012-11#2)
the cell-specific expression of##2##4##(1995-10#1)(1997-7#1)
the cell-specific##5##2##(1991-7#1)(1993-5#1)(1995-10#1)(1997-7#1)(2008-11#1)
the cell-surface##6##2##(1990-12#1)(1994-6#1)(2008-4#1)(2009-6#1)(2010-12#1)(2013-1#1)
the cell-to-cell movement of##2##4##(2008-10#2)
the cell-to-cell##4##2##(2007-12#1)(2008-10#3)
the cell-wall##2##2##(1995-8#1)(2008-2#1)
the cellobiose##2##2##(1996-11#1)(2008-5#1)
the cells after 4##2##4##(2008-5#2)
the cells after##4##3##(1991-1#1)(2008-5#2)(2008-6#1)
the cells against##2##3##(1996-8#1)(2008-7#1)
the cells and not##2##4##(1990-8#1)(2012-1#1)
the cells and the##4##4##(1993-9#1)(1995-2#1)(2008-4#1)(2008-7#1)
the cells and was##5##4##(1991-12#1)(1994-11#1)(2008-10#1)(2008-11#2)
the cells and##32##3##(1990-3#1)(1990-8#1)(1991-12#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-9#2)(1997-7#1)(2007-12#1)(2008-10#4)(2008-11#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-1#1)(2013-7#1)
the cells are grown##3##4##(2005-7#1)(2008-11#1)(2008-4#1)
the cells are lysed##2##4##(2008-4#1)(2012-1#1)
the cells are##22##3##(1991-5#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-12#1)(1995-7#1)(1995-8#1)(1997-3#1)(2005-7#1)(2007-9#1)(2008-11#5)(2008-4#2)(2009-8#1)(2012-1#1)(2012-2#1)
the cells as##3##3##(1991-2#1)(2008-11#1)(2008-4#1)
the cells at a##3##4##(2008-11#1)(2011-2#1)(2012-7#1)
the cells at##10##3##(1993-4#1)(1993-8#1)(1996-9#1)(2008-11#4)(2008-9#1)(2011-2#1)(2012-7#1)
the cells became##3##3##(1994-6#1)(1995-3#1)(1996-5#1)
the cells become##2##3##(1991-5#1)(1995-3#1)
the cells but##2##3##(1991-9#1)(2006-10#1)
the cells by##9##3##(1992-5#1)(1993-3#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-10#1)(1996-1#1)(2008-11#1)
the cells can be##2##4##(1990-12#1)(1990-2#1)
the cells can##3##3##(1990-12#1)(1990-2#1)(2008-11#1)
the cells changed##2##3##(1992-2#1)(2008-11#1)
the cells could##2##3##(2008-11#2)
the cells during##2##3##(1997-1#1)(2008-11#1)
the cells examined##2##3##(1992-8#1)(2008-11#1)
the cells exposed to##4##4##(2006-7#1)(2008-9#1)(2012-11#2)
the cells expressing the c-myb protein##2##6##(1992-12#2)
the cells expressing the##3##4##(1992-12#2)(1992-2#1)
the cells expressing##7##3##(1990-10#1)(1992-12#2)(1992-2#1)(1994-3#1)(1995-2#1)(1996-2#1)
the cells for##4##3##(1990-3#1)(1991-5#1)(2007-6#1)(2008-8#1)
the cells from the##3##4##(1992-6#1)(1994-11#1)(2009-8#1)
the cells from##14##3##(1990-8#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-12#1)(1994-11#1)(1996-5#1)(2005-10#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-8#1)
the cells grown##5##3##(1991-9#1)(2005-12#1)(2008-11#2)(2008-5#1)
the cells had##6##3##(1990-3#1)(1994-5#1)(1994-8#1)(1997-4#1)(2008-5#1)(2008-9#1)
the cells in a##3##4##(1991-6#1)(1991-7#1)(1992-9#1)
the cells in culture##2##4##(1991-1#1)(1994-5#1)
the cells in the presence of##3##6##(1993-6#1)(1994-3#1)(1997-1#1)
the cells in the##18##4##(1993-11#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-9#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-11#3)(2010-2#1)
the cells in which##2##4##(2008-4#1)(2011-1#1)
the cells in##43##3##(1990-11#1)(1990-9#1)(1991-1#1)(1991-6#1)(1991-7#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-9#1)(1996-12#1)(1996-2#3)(1996-6#1)(1997-1#1)(1997-2#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-9#2)(2008-11#9)(2008-4#2)(2010-2#1)(2011-1#1)(2012-12#1)
the cells increased linearly##2##4##(2008-11#1)(2011-2#1)
the cells increased##3##3##(1993-9#1)(2008-11#1)(2011-2#1)
the cells incubated##3##3##(1994-3#1)(1996-11#1)(2008-11#1)
the cells into the##3##4##(1994-8#1)(2008-1#1)(2008-4#1)
the cells into##5##3##(1994-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)
the cells is##4##3##(1995-2#1)(2007-12#1)(2008-10#1)(2008-8#1)
the cells isolated from##2##4##(1993-9#1)(2006-8#1)
the cells lining the##3##4##(1990-4#1)(2006-10#1)(2011-2#1)
the cells more##3##3##(1992-11#1)(1995-11#1)(2005-7#1)
the cells of a##2##4##(2006-8#1)(2013-8#1)
the cells of interest##4##4##(2008-11#3)(2008-9#1)
the cells of origin##3##4##(2006-12#1)(2013-1#2)
the cells of the female germ unit and##2##8##(2008-11#2)
the cells of the##19##4##(1991-9#1)(1995-5#1)(1996-9#1)(1997-8#1)(2004-11#1)(2005-1#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#2)(2012-12#2)(2012-3#1)
the cells of##45##3##(1991-3#1)(1991-9#1)(1994-11#1)(1995-5#1)(1996-9#1)(1997-8#1)(2004-11#1)(2005-1#1)(2005-6#1)(2006-12#1)(2006-8#2)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-2#2)(2010-3#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-3#3)(2013-1#3)(2013-8#2)
the cells on##4##3##(1991-12#1)(1992-6#1)(2008-11#2)
the cells rather than##3##4##(1990-5#1)(1994-8#1)(2008-10#1)
the cells remained##2##3##(1991-8#1)(1994-12#1)
the cells retained##2##3##(2008-10#1)(2012-1#1)
the cells that##7##3##(1992-6#1)(2007-12#1)(2008-11#1)(2012-3#1)(2013-7#2)(2013-8#1)
the cells through##5##3##(1990-11#1)(1993-11#1)(1994-8#1)(2004-11#1)(2008-4#1)
the cells to a##4##4##(1990-5#1)(1993-6#1)(1995-3#1)(2008-11#1)
the cells to be##3##4##(1994-9#1)(2007-7#1)(2008-4#1)
the cells to the##5##4##(1990-8#1)(1992-11#1)(1992-3#1)(1996-2#1)(2004-9#1)
the cells to##40##3##(1990-10#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-3#3)(1995-7#1)(1996-2#2)(1997-4#1)(1997-7#1)(2004-9#1)(2007-7#1)(2008-11#5)(2008-4#3)(2008-8#1)(2008-9#1)(2010-4#1)(2012-12#1)
the cells transfected with the##2##5##(1994-12#1)(2008-8#1)
the cells transfected with##3##4##(1994-12#1)(1994-9#1)(2008-8#1)
the cells treated with##4##4##(1991-10#1)(1994-3#1)(2008-11#1)(2010-12#1)
the cells treated##5##3##(1991-10#1)(1994-3#1)(2008-11#2)(2010-12#1)
the cells under the##2##4##(2008-11#1)(2008-4#1)
the cells underwent apoptosis##2##4##(2008-10#1)(2008-11#1)
the cells underwent##3##3##(1995-3#1)(2008-10#1)(2008-11#1)
the cells using##2##3##(1991-10#1)(2008-11#1)
the cells was observed##2##4##(1996-2#1)(2008-11#1)
the cells was##22##3##(1990-8#1)(1991-1#1)(1991-12#1)(1992-3#1)(1993-7#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#5)(2008-5#1)(2010-12#1)(2012-11#2)(2013-1#1)(2013-7#1)
the cells were cultivated##2##4##(1990-12#1)(2008-11#1)
the cells were cultured in##2##5##(1996-12#1)(2008-5#1)
the cells were cultured##7##4##(1991-8#1)(1994-12#1)(1995-3#1)(1996-12#1)(1997-2#1)(2008-5#1)(2008-6#1)
the cells were exposed to##3##5##(1993-8#1)(1994-6#1)(1997-1#1)
the cells were fused##2##4##(1991-5#1)(2005-11#1)
the cells were resuspended in##2##5##(1996-1#1)(2008-11#1)
the cells were resuspended##3##4##(1996-1#1)(2008-11#2)
the cells were strongly##2##4##(2007-5#1)(2008-11#1)
the cells were subjected to##2##5##(2008-11#2)
the cells were treated with##2##5##(1991-9#1)(1997-6#1)
the cells were##56##3##(1990-12#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#2)(1991-9#2)(1992-6#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-3#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-7#1)(1997-1#2)(1997-2#2)(1997-6#2)(1997-8#1)(2004-9#1)(2005-11#1)(2007-3#1)(2007-5#2)(2007-9#1)(2008-11#14)(2008-5#2)(2008-6#2)(2008-7#1)(2011-2#1)
the cells with a##5##4##(1993-2#1)(1994-3#1)(1994-8#1)(2008-11#1)(2008-7#1)
the cells with the##6##4##(1992-6#1)(1992-8#1)(1996-5#1)(1997-7#1)(2008-11#2)
the cells with##58##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-7#2)(1991-10#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-6#2)(1992-8#1)(1993-2#1)(1993-4#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-3#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#4)(1996-6#2)(1997-1#5)(1997-4#1)(1997-7#1)(2008-1#1)(2008-11#6)(2008-2#1)(2008-4#3)(2008-7#2)(2012-3#1)(2013-1#1)
the cells within##3##3##(1995-1#1)(1995-2#1)(2008-12#1)
the cells##786##2##(1990-10#3)(1990-11#6)(1990-12#6)(1990-2#6)(1990-3#4)(1990-4#4)(1990-5#4)(1990-7#5)(1990-8#6)(1990-9#2)(1991-1#5)(1991-10#6)(1991-12#5)(1991-2#3)(1991-3#2)(1991-5#5)(1991-6#4)(1991-7#3)(1991-8#4)(1991-9#8)(1992-1#4)(1992-11#4)(1992-12#5)(1992-2#6)(1992-3#6)(1992-5#1)(1992-6#10)(1992-8#15)(1992-9#5)(1993-11#2)(1993-12#5)(1993-2#1)(1993-3#4)(1993-4#5)(1993-6#4)(1993-7#3)(1993-8#5)(1993-9#12)(1994-10#4)(1994-11#11)(1994-12#12)(1994-2#4)(1994-3#15)(1994-5#3)(1994-6#4)(1994-8#13)(1994-9#9)(1995-1#4)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#8)(1995-3#9)(1995-5#1)(1995-7#2)(1995-8#7)(1995-9#1)(1996-1#2)(1996-11#5)(1996-12#3)(1996-2#11)(1996-3#2)(1996-4#1)(1996-5#9)(1996-6#3)(1996-7#4)(1996-8#1)(1996-9#5)(1997-1#11)(1997-2#5)(1997-3#2)(1997-4#4)(1997-6#5)(1997-7#8)(1997-8#3)(2003-11#1)(2004-11#4)(2004-12#1)(2004-9#3)(2005-1#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-6#1)(2005-7#2)(2006-10#3)(2006-12#2)(2006-2#1)(2006-5#2)(2006-6#1)(2006-7#3)(2006-8#5)(2007-11#2)(2007-12#9)(2007-2#1)(2007-3#2)(2007-5#2)(2007-6#3)(2007-7#1)(2007-8#2)(2007-9#5)(2008-1#9)(2008-10#20)(2008-11#119)(2008-12#2)(2008-2#5)(2008-3#3)(2008-4#20)(2008-5#16)(2008-6#8)(2008-7#17)(2008-8#13)(2008-9#8)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#6)(2010-11#3)(2010-12#4)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#1)(2010-7#1)(2011-1#4)(2011-12#2)(2011-2#10)(2011-3#2)(2012-1#7)(2012-11#5)(2012-12#10)(2012-2#2)(2012-3#5)(2012-7#1)(2013-1#9)(2013-7#4)(2013-8#4)
the cells'##12##2##(1990-3#1)(1991-12#1)(1991-6#1)(1992-3#1)(1994-12#1)(1995-12#1)(1995-4#1)(2008-7#2)(2008-8#1)(2012-2#1)(2013-8#1)
the cells)##2##2##(1990-12#1)(1993-3#1)
the cellular RNA##2##3##(2008-8#1)(2011-1#1)
the cellular accumulation of##3##4##(1993-8#1)(1995-5#1)(2013-1#1)
the cellular adaptation##2##3##(1991-5#1)(2009-3#1)
the cellular and humoral##2##4##(1991-10#1)(2011-1#1)
the cellular and molecular biology of##2##6##(2007-11#1)(2008-5#1)
the cellular and molecular events##3##5##(1991-3#1)(1994-6#1)(1995-8#1)
the cellular and molecular levels##3##5##(2006-5#1)(2008-7#1)(2009-5#1)
the cellular and molecular mechanisms of##3##6##(1996-8#1)(2009-10#1)(2009-8#1)
the cellular and molecular mechanisms that regulate##2##7##(2008-4#1)(2013-1#1)
the cellular and molecular mechanisms that##3##6##(2007-12#1)(2008-4#1)(2013-1#1)
the cellular and molecular mechanisms underlying the##2##7##(2008-7#1)(2008-8#1)
the cellular and molecular mechanisms##9##5##(1996-8#1)(2006-10#1)(2007-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2013-1#1)
the cellular and molecular##25##4##(1991-3#2)(1993-10#1)(1994-6#1)(1995-8#1)(1996-8#1)(2006-10#2)(2006-11#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
the cellular and nuclear##3##4##(2005-10#1)(2008-7#1)(2013-1#1)
the cellular and tissue##3##4##(2008-7#1)(2010-2#1)(2013-1#1)
the cellular and##38##3##(1990-4#1)(1991-10#1)(1991-3#2)(1992-12#1)(1993-10#1)(1994-6#1)(1995-8#1)(1996-8#1)(2005-10#1)(2006-10#3)(2006-11#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#2)(2009-10#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#3)
the cellular antioxidant##3##3##(1990-4#1)(1992-3#1)(2008-11#1)
the cellular basis of##5##4##(1996-3#1)(2007-8#2)(2008-10#1)(2008-7#1)
the cellular basis##7##3##(1992-8#1)(1996-3#1)(1996-5#1)(2007-8#2)(2008-10#1)(2008-7#1)
the cellular changes##3##3##(1994-3#1)(2008-10#1)(2009-12#1)
the cellular components of the##2##5##(1990-2#1)(1992-12#1)
the cellular components##4##3##(1990-2#1)(1992-12#1)(2005-11#1)(2008-10#1)
the cellular composition##4##3##(1996-10#1)(2008-7#1)(2009-12#2)
the cellular concentration of##2##4##(1995-8#1)(2008-7#1)
the cellular concentrations of##2##4##(1991-10#1)(1992-4#1)
the cellular content of##2##4##(1990-2#1)(1995-3#1)
the cellular content##3##3##(1990-2#1)(1995-3#1)(2008-9#1)
the cellular context##2##3##(2006-11#1)(2008-4#1)
the cellular damage##2##3##(1993-12#1)(2007-11#1)
the cellular distribution of iron##2##5##(1996-5#2)
the cellular distribution of##6##4##(1995-11#1)(1995-2#1)(1996-5#2)(2008-11#1)(2012-2#1)
the cellular distribution##7##3##(1995-11#1)(1995-2#1)(1996-5#2)(2006-10#1)(2008-11#1)(2012-2#1)
the cellular effects##3##3##(1995-3#1)(1995-7#1)(2008-7#1)
the cellular environment##7##3##(1994-12#1)(1996-10#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
the cellular enzyme##4##3##(1995-8#1)(1996-5#2)(2008-5#1)
the cellular expression of##3##4##(1996-12#1)(2006-9#1)(2008-5#1)
the cellular expression##4##3##(1996-12#1)(2006-9#1)(2008-5#1)(2010-1#1)
the cellular fatty acid composition of##2##6##(2011-1#2)
the cellular fatty acids##2##4##(2011-1#2)
the cellular fatty##4##3##(2011-1#4)
the cellular function of the##3##5##(1990-2#1)(1992-2#1)(1992-4#1)
the cellular function of##4##4##(1990-2#1)(1992-2#1)(1992-4#1)(2009-8#1)
the cellular functions##3##3##(2007-12#1)(2008-1#1)(2008-2#1)
the cellular growth rate##2##4##(2006-10#1)(2008-7#1)
the cellular growth##4##3##(1993-11#1)(2006-10#1)(2008-7#1)(2011-2#1)
the cellular hydration state##2##4##(1997-4#2)
the cellular interactions##4##3##(1992-12#1)(1995-11#1)(2009-6#1)(2011-1#1)
the cellular level of the##2##5##(1991-12#1)(2013-1#1)
the cellular level of##4##4##(1991-12#1)(1992-1#1)(2005-7#1)(2013-1#1)
the cellular level##45##3##(1990-7#1)(1991-12#1)(1992-1#1)(1993-11#1)(1994-2#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-8#1)(1995-9#2)(1996-4#1)(1996-8#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-5#1)(2007-8#2)(2008-1#3)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2010-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
the cellular levels of##2##4##(1991-12#1)(1992-8#1)
the cellular lipid##2##3##(1991-4#1)(1991-9#1)
the cellular localization of the##2##5##(1994-10#1)(1997-1#1)
the cellular localization of##7##4##(1994-10#1)(1994-3#2)(1995-5#1)(1996-6#1)(1997-1#1)(2008-2#1)
the cellular location of a protein##2##6##(1997-2#2)
the cellular location of##3##4##(1997-2#2)(2008-5#1)
the cellular machinery##3##3##(2007-8#1)(2008-1#1)(2008-7#1)
the cellular mechanism##4##3##(2007-2#1)(2008-11#1)(2008-7#1)(2011-2#1)
the cellular mechanisms underlying##2##4##(1993-2#1)(2007-8#1)
the cellular mechanisms##9##3##(1993-2#1)(1994-8#1)(1995-6#1)(1997-2#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-8#1)(2011-12#1)
the cellular melanin content##2##4##(2013-1#2)
the cellular melanin##3##3##(1992-2#1)(2013-1#2)
the cellular membrane##6##3##(1993-12#1)(2006-12#1)(2008-9#2)(2009-8#1)(2010-11#1)
the cellular metabolism##4##3##(1995-11#1)(1995-5#1)(2008-11#2)
the cellular morphology##4##3##(1992-4#1)(1994-3#1)(2008-11#2)
the cellular origin of##2##4##(1996-2#2)
the cellular prion protein##4##4##(1993-2#1)(1995-11#2)(1995-12#1)
the cellular processes##3##3##(2007-12#1)(2008-7#1)(2010-2#1)
the cellular proliferation##3##3##(2008-11#2)(2008-5#1)
the cellular protein##2##3##(1994-12#1)(2012-12#1)
the cellular receptors##3##3##(2006-4#1)(2008-1#1)(2011-2#1)
the cellular response to DNA damage##3##6##(1992-4#1)(1994-2#1)(2011-2#1)
the cellular response to##6##4##(1992-4#1)(1994-2#1)(2008-1#1)(2008-2#1)(2008-4#1)(2011-2#1)
the cellular response##10##3##(1992-4#1)(1994-2#1)(2008-1#1)(2008-2#1)(2008-4#1)(2010-2#1)(2011-2#3)(2013-1#1)
the cellular responses to##2##4##(1997-8#1)(2006-8#1)
the cellular slime mold Dictyostelium discoideum##2##6##(1995-3#2)
the cellular slime mold##3##4##(1995-3#2)(1995-6#1)
the cellular slime mould Dictyostelium discoideum##2##6##(1992-11#1)(1995-8#1)
the cellular slime##5##3##(1992-11#1)(1995-3#2)(1995-6#1)(1995-8#1)
the cellular stress response##2##4##(2012-12#1)(2012-2#1)
the cellular structure of##2##4##(2004-11#1)(2007-12#1)
the cellular structure##3##3##(2004-11#1)(2007-12#2)
the cellular transcription factor##3##4##(1992-8#1)(1996-10#2)
the cellular transport##2##3##(2008-11#2)
the cellular uptake of##8##4##(1991-2#1)(1992-5#1)(1996-8#1)(1997-1#1)(2008-11#2)(2008-4#1)(2012-11#1)
the cellular uptake##11##3##(1991-2#1)(1992-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(2008-11#2)(2008-2#1)(2008-4#1)(2012-11#1)(2012-12#1)
the cellular##398##2##(1990-2#4)(1990-4#2)(1990-7#1)(1991-10#2)(1991-12#3)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#5)(1992-2#3)(1992-3#2)(1992-4#5)(1992-5#1)(1992-8#4)(1993-10#1)(1993-11#3)(1993-12#3)(1993-2#2)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#4)(1994-3#5)(1994-5#2)(1994-6#4)(1994-8#5)(1994-9#1)(1995-1#2)(1995-11#7)(1995-12#2)(1995-2#2)(1995-3#5)(1995-5#3)(1995-6#3)(1995-7#2)(1995-8#7)(1995-9#2)(1996-10#5)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#5)(1996-6#4)(1996-8#3)(1997-1#4)(1997-2#4)(1997-3#3)(1997-4#3)(1997-8#2)(2003-11#1)(2004-11#1)(2004-12#2)(2004-9#1)(2005-10#1)(2005-11#3)(2005-7#2)(2006-10#10)(2006-11#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#5)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#8)(2007-2#1)(2007-5#1)(2007-8#6)(2007-9#1)(2008-1#7)(2008-10#7)(2008-11#24)(2008-2#5)(2008-3#3)(2008-4#10)(2008-5#14)(2008-6#1)(2008-7#17)(2008-8#5)(2008-9#7)(2009-10#2)(2009-12#7)(2009-3#3)(2009-5#2)(2009-6#1)(2009-8#6)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#5)(2011-1#7)(2011-12#2)(2011-2#8)(2012-1#1)(2012-11#2)(2012-12#6)(2012-2#9)(2012-3#2)(2013-1#11)(2013-7#3)
the cellularity was##2##3##(2005-12#2)
the cellulase##4##2##(2006-8#1)(2008-10#1)(2008-6#1)(2013-7#1)
the cellulose and##2##3##(2008-5#1)(2013-8#1)
the cellulose##14##2##(2005-11#1)(2006-8#1)(2008-10#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2010-4#1)(2013-1#1)(2013-8#1)
the cellulosome of##3##3##(1991-2#2)(1995-2#1)
the cellulosome##7##2##(1991-2#2)(1995-2#2)(2006-8#3)
the cement liquid##2##3##(2004-9#1)(2009-7#1)
the cement mantle##2##3##(2004-9#1)(2007-7#1)
the cement with##2##3##(2004-9#1)(2009-9#1)
the cement##13##2##(2004-9#4)(2006-8#1)(2007-7#1)(2008-5#2)(2009-3#1)(2009-7#1)(2009-9#1)(2010-2#1)(2013-1#1)
the cemented##2##2##(1993-8#1)(2009-3#1)
the cementoenamel junction##2##3##(2008-12#1)(2009-8#1)
the cements##2##2##(2010-8#1)(2013-1#1)
the censoring mechanism##2##3##(1997-7#1)(2010-8#1)
the censoring##6##2##(1995-11#1)(1997-7#1)(2008-10#1)(2008-7#1)(2010-8#1)(2012-3#1)
the centenarians##4##2##(2008-7#3)(2010-12#1)
the center and##5##3##(2004-9#1)(2007-11#1)(2008-2#2)(2008-4#1)
the center at##2##3##(1991-2#1)(2008-8#1)
the center frequency##2##3##(2007-12#2)
the center is##2##3##(2008-8#2)
the center line##2##3##(2008-3#2)
the center of a##8##4##(2007-8#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-3#1)(2010-12#1)(2012-2#1)
the center of origin of##2##5##(2008-10#2)
the center of origin##3##4##(2008-10#3)
the center of pressure##2##4##(2010-9#1)(2012-2#1)
the center of the bilayer at##2##6##(1991-2#1)(2006-10#1)
the center of the bilayer##3##5##(1991-2#2)(2006-10#1)
the center of the city##2##5##(2008-10#1)(2008-5#1)
the center of the helix##2##5##(1995-3#1)(2006-12#1)
the center of the##67##4##(1990-5#1)(1991-1#1)(1991-2#2)(1992-12#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-9#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-5#1)(2006-9#1)(2007-12#3)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#11)(2008-5#2)(2008-6#2)(2008-7#1)(2009-3#1)(2009-7#1)(2010-2#2)(2011-2#3)(2012-1#1)
the center of this##2##4##(1995-2#1)(2012-12#1)
the center of##104##3##(1990-5#1)(1991-1#1)(1991-10#1)(1991-2#3)(1991-3#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-9#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-5#2)(2006-9#1)(2007-12#6)(2007-3#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#6)(2008-3#14)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-3#2)(2009-7#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2013-7#2)(2013-8#1)
the center position and##2##4##(2007-12#1)(2008-3#1)
the center position##3##3##(1994-12#1)(2007-12#1)(2008-3#1)
the center stage of##2##4##(2010-1#1)(2010-12#1)
the center to##2##3##(1994-3#1)(2006-3#1)
the center wavelength of the rectified THz radiation##2##8##(2007-11#2)
the center wavelength of the##3##5##(2007-11#2)(2007-12#1)
the center wavelength of##5##4##(2007-11#3)(2007-12#2)
the center wavelength##6##3##(2007-11#3)(2007-12#2)(2008-2#1)
the center##173##2##(1990-5#1)(1991-1#1)(1991-10#1)(1991-2#5)(1991-3#1)(1991-8#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#3)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-5#2)(2004-9#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-3#1)(2006-5#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#13)(2007-3#1)(2007-4#1)(2007-8#2)(2008-1#2)(2008-10#12)(2008-11#2)(2008-2#12)(2008-3#20)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#8)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-9#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#2)(2013-8#1)
the centered##3##2##(2008-2#3)
the centering of the femoral neck##2##6##(2007-8#2)
the centerline of a##2##4##(2005-11#1)(2008-2#1)
the centerline of the##2##4##(2006-12#1)(2008-3#1)
the centerline of##4##3##(2005-11#1)(2006-12#1)(2008-2#1)(2008-3#1)
the centerpiece of##2##3##(1996-3#1)(2011-2#1)
the centers of the##2##4##(2008-11#1)(2009-7#1)
the centers of##6##3##(1991-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-7#1)
the centers that##2##3##(2011-2#2)
the centers##14##2##(1990-10#2)(1991-10#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)
the centiles are##2##3##(1994-11#1)(1996-12#1)
the centiles##3##2##(1994-11#1)(1996-12#1)(1997-2#1)
the central Chilean##2##3##(2008-8#1)(2009-2#1)
the central United States##2##4##(2008-10#1)(2008-11#1)
the central airways##4##3##(1990-6#1)(1994-12#1)(1996-3#1)(2005-8#1)
the central amygdaloid nucleus##3##4##(1996-1#3)
the central and autonomic nervous systems##2##6##(2009-9#1)(2011-1#1)
the central and northern##3##4##(2007-1#1)(2008-10#1)(2010-3#1)
the central and peripheral nervous system##11##6##(1993-9#1)(1996-12#1)(1996-5#1)(2007-11#1)(2008-3#1)(2008-7#3)(2008-8#1)(2013-7#1)(2013-8#1)
the central and peripheral nervous systems##6##6##(1990-8#1)(1996-8#1)(1997-2#1)(1997-6#1)(2008-11#1)(2008-4#1)
the central and peripheral nervous##17##5##(1990-8#1)(1993-9#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-6#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2013-7#1)(2013-8#1)
the central and peripheral##23##4##(1990-8#1)(1992-8#2)(1993-9#1)(1996-12#2)(1996-5#1)(1996-8#1)(1997-2#1)(1997-6#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2010-6#1)(2012-1#2)(2013-7#1)(2013-8#1)
the central and##33##3##(1990-8#1)(1991-1#1)(1992-11#1)(1992-8#2)(1993-9#1)(1996-12#2)(1996-5#1)(1996-8#1)(1997-2#1)(1997-6#2)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-9#1)(2010-3#1)(2010-6#1)(2011-1#1)(2012-1#2)(2013-7#1)(2013-8#1)
the central anterior skull base##2##5##(2006-12#2)
the central area of cat retina##2##6##(1990-12#2)
the central area of##4##4##(1990-12#2)(2008-10#1)(2008-2#1)
the central area##5##3##(1990-12#2)(1997-1#1)(2008-10#1)(2008-2#1)
the central autonomic##2##3##(1992-1#1)(1995-12#1)
the central axis of the##2##5##(2009-2#1)(2013-1#1)
the central axis of##3##4##(2008-10#1)(2009-2#1)(2013-1#1)
the central axis##5##3##(2007-10#1)(2008-10#2)(2009-2#1)(2013-1#1)
the central benzodiazepine##2##3##(1991-10#1)(1996-11#1)
the central blood pressure##2##4##(2013-8#2)
the central branches of##2##4##(1990-4#2)
the central canal in the##2##5##(1995-5#1)(1996-12#1)
the central canal##7##3##(1991-5#1)(1995-5#3)(1996-12#1)(1996-5#1)(2006-5#1)
the central cardiovascular##2##3##(1991-8#1)(1996-11#1)
the central catalytic##2##3##(1991-7#1)(2008-9#1)
the central cavity of##2##4##(1997-4#1)(2008-8#1)
the central cavity##4##3##(1990-8#1)(1997-4#1)(2008-8#2)
the central cell and primary endosperm##2##6##(2008-9#2)
the central cell and##3##4##(2008-9#3)
the central cell##9##3##(2007-12#1)(2008-11#2)(2008-9#6)
the central cells of the##2##5##(2008-5#2)
the central cholinergic system##3##4##(1991-12#1)(2008-10#2)
the central complex##4##3##(1995-5#1)(2007-12#3)
the central component of the##2##5##(2008-7#1)(2012-2#1)
the central core of the##2##5##(1995-3#1)(2012-3#1)
the central core of##4##4##(1991-4#1)(1995-3#1)(1997-4#1)(2012-3#1)
the central core##9##3##(1991-4#1)(1991-5#1)(1995-3#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-9#1)(2008-7#1)(2012-3#1)
the central corneal thickness##2##4##(2013-8#2)
the central cylinder##2##3##(2012-2#2)
the central domain of##3##4##(1996-8#1)(1997-2#1)(2006-12#1)
the central domain##5##3##(1990-4#1)(1996-8#1)(1997-2#1)(2006-12#1)(2008-9#1)
the central dopaminergic system##2##4##(2008-10#1)(2008-11#1)
the central dopaminergic##5##3##(2008-10#4)(2008-11#1)
the central effects of##2##4##(1994-10#1)(1996-12#1)
the central elements of##2##4##(1994-11#1)(2008-5#1)
the central fold of##2##4##(1993-11#2)
the central grey of##2##4##(1990-5#1)(1995-12#1)
the central helix##5##3##(1991-7#3)(1992-3#1)(1995-2#1)
the central hospital##3##3##(1993-3#1)(2010-6#1)(2010-8#1)
the central hydrophobic cavity##2##4##(2006-10#2)
the central hydrophobic##3##3##(1992-11#1)(2006-10#2)
the central level##3##3##(1990-11#1)(1993-3#1)(2009-10#1)
the central lumen##3##3##(2008-6#2)(2008-7#1)
the central metabolism of##3##4##(1994-11#1)(2008-7#2)
the central metabolism##7##3##(1994-11#3)(2008-7#4)
the central metal##2##3##(2008-10#1)(2008-5#1)
the central nervous depressive##2##4##(1995-12#2)
the central nervous system (CNS) and##5##6##(1995-12#1)(1995-5#2)(2007-11#1)(2007-7#1)
the central nervous system (CNS) from##2##6##(2007-11#1)(2008-1#1)
the central nervous system (CNS) is##5##6##(2006-12#1)(2008-4#1)(2008-7#1)(2013-1#1)(2013-8#1)
the central nervous system (CNS) of the##2##7##(1991-3#1)(1997-2#1)
the central nervous system (CNS) of##3##6##(1991-3#1)(1997-2#1)(2005-9#1)
the central nervous system (CNS) that##3##6##(2006-10#1)(2008-11#1)(2010-12#1)
the central nervous system (CNS)##64##5##(1990-3#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1992-12#1)(1994-2#1)(1995-12#1)(1995-5#3)(1996-12#3)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#8)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#4)(2008-7#5)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
the central nervous system and is##2##6##(2008-10#1)(2011-2#1)
the central nervous system and periphery##2##6##(1996-12#1)(2008-1#1)
the central nervous system and the##2##6##(2007-11#1)(2008-1#1)
the central nervous system and##26##5##(1991-11#1)(1992-4#1)(1993-11#1)(1995-12#1)(1996-12#2)(1997-5#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-7#1)
the central nervous system are##6##5##(1995-12#1)(1995-2#1)(1996-5#1)(2006-10#1)(2007-8#1)(2012-2#1)
the central nervous system by##5##5##(1997-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)
the central nervous system can be##3##6##(2007-8#1)(2008-4#1)(2008-9#1)
the central nervous system can##4##5##(1995-8#1)(2007-8#1)(2008-4#1)(2008-9#1)
the central nervous system have##2##5##(1991-6#1)(2008-4#1)
the central nervous system in the##2##6##(2005-10#1)(2013-1#1)
the central nervous system in##5##5##(1991-8#1)(2005-10#1)(2006-10#1)(2007-10#1)(2013-1#1)
the central nervous system including##3##5##(1990-5#1)(2006-10#1)(2007-8#1)
the central nervous system is##8##5##(1990-7#1)(1990-8#1)(1995-12#1)(1995-9#1)(1997-5#1)(1997-6#1)(2006-10#1)(2009-10#1)
the central nervous system may be##2##6##(1996-2#1)(2005-8#1)
the central nervous system may##4##5##(1996-2#1)(2005-8#1)(2006-10#1)(2013-1#1)
the central nervous system of##15##5##(1990-5#1)(1991-3#1)(1992-6#1)(1993-12#1)(1993-7#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-3#1)(2007-12#1)(2008-11#1)(2013-8#1)
the central nervous system that##2##5##(1991-3#1)(1996-6#1)
the central nervous system through##2##5##(1993-12#1)(2007-11#1)
the central nervous system##348##4##(1990-11#1)(1990-3#4)(1990-4#1)(1990-5#2)(1990-7#3)(1990-8#3)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#5)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#4)(1993-2#2)(1993-3#3)(1993-6#1)(1993-7#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-5#2)(1994-8#1)(1994-9#5)(1995-11#3)(1995-12#7)(1995-2#3)(1995-3#2)(1995-4#2)(1995-5#6)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#9)(1996-2#2)(1996-4#3)(1996-5#2)(1996-6#3)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#3)(1997-6#3)(1997-7#2)(1997-8#2)(2005-10#5)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#14)(2006-11#2)(2006-12#2)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#16)(2007-12#9)(2007-2#1)(2007-3#1)(2007-6#2)(2007-7#1)(2007-8#5)(2007-9#4)(2008-1#5)(2008-10#7)(2008-11#7)(2008-2#3)(2008-3#3)(2008-4#8)(2008-5#7)(2008-6#1)(2008-7#19)(2008-8#1)(2008-9#7)(2009-10#3)(2009-2#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-12#7)(2010-2#2)(2010-8#3)(2011-1#1)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#7)(2013-1#9)(2013-7#2)(2013-8#5)
the central nervous system]##2##4##(1994-4#1)(2006-6#1)
the central nervous tissue##2##4##(1994-11#1)(2008-5#1)
the central nervous##355##3##(1990-11#1)(1990-3#4)(1990-4#1)(1990-5#2)(1990-7#3)(1990-8#3)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#5)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#4)(1993-2#2)(1993-3#3)(1993-6#1)(1993-7#2)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#3)(1994-4#1)(1994-5#2)(1994-8#1)(1994-9#5)(1995-1#1)(1995-11#3)(1995-12#9)(1995-2#3)(1995-3#2)(1995-4#2)(1995-5#6)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#9)(1996-2#2)(1996-4#3)(1996-5#2)(1996-6#3)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#3)(1997-6#3)(1997-7#2)(1997-8#2)(2005-10#5)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#14)(2006-11#2)(2006-12#2)(2006-6#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#16)(2007-12#9)(2007-2#1)(2007-3#1)(2007-6#2)(2007-7#1)(2007-8#5)(2007-9#4)(2008-1#5)(2008-10#7)(2008-11#7)(2008-2#3)(2008-3#3)(2008-4#8)(2008-5#8)(2008-6#1)(2008-7#19)(2008-8#1)(2008-9#7)(2009-10#3)(2009-2#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-12#7)(2010-2#2)(2010-8#3)(2011-1#1)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#7)(2013-1#9)(2013-7#2)(2013-8#5)
the central nicotinic##2##3##(1996-12#1)(1996-2#1)
the central nuclear complex##3##4##(1997-6#3)
the central nucleus of the amygdala (CeAX)##2##7##(1993-12#2)
the central nucleus of the amygdala##11##6##(1993-12#5)(1994-11#1)(1994-2#2)(1995-11#1)(1996-9#2)
the central nucleus of the##14##5##(1993-12#5)(1993-2#1)(1994-11#1)(1994-2#2)(1995-11#1)(1995-12#1)(1996-9#2)(2012-3#1)
the central nucleus of##15##4##(1993-12#5)(1993-2#1)(1994-11#1)(1994-2#2)(1995-11#1)(1995-12#1)(1996-9#2)(2010-12#1)(2012-3#1)
the central nucleus##22##3##(1992-6#1)(1993-12#5)(1993-2#1)(1994-11#1)(1994-2#2)(1995-11#2)(1995-12#1)(1995-5#1)(1996-1#1)(1996-9#4)(2009-2#1)(2010-12#1)(2012-3#1)
the central part of the##10##5##(1993-12#1)(1994-10#1)(1994-3#2)(2008-10#1)(2008-3#1)(2008-5#1)(2009-3#1)(2012-2#1)(2013-8#1)
the central part of##11##4##(1992-11#1)(1993-12#1)(1994-10#1)(1994-3#2)(2008-10#1)(2008-3#1)(2008-5#1)(2009-3#1)(2012-2#1)(2013-8#1)
the central part##14##3##(1992-11#1)(1993-12#1)(1994-10#1)(1994-3#4)(2008-10#1)(2008-3#1)(2008-5#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
the central pathophysiological##2##3##(2008-3#1)(2011-2#1)
the central pattern generator##3##4##(1994-10#1)(1997-7#1)(2008-2#1)
the central point##2##3##(2008-10#1)(2008-5#1)
the central portion of the##4##5##(1996-8#1)(2009-3#1)(2010-12#1)(2011-2#1)
the central portion of##6##4##(1995-6#1)(1995-8#1)(1996-8#1)(2009-3#1)(2010-12#1)(2011-2#1)
the central posterior/prepacemaker nucleus (CP/PPn)##2##5##(1995-12#1)(1996-5#1)
the central posterior/prepacemaker nucleus##4##4##(1995-12#2)(1996-5#2)
the central processes of##2##4##(1991-9#1)(2008-4#1)
the central processing##2##3##(1994-8#1)(2008-3#1)
the central region of the perikaryon##2##6##(2008-7#2)
the central region of the##6##5##(1991-12#1)(1997-1#1)(2008-10#1)(2008-7#2)(2008-9#1)
the central region of##9##4##(1991-12#1)(1993-6#1)(1997-1#2)(2005-5#1)(2008-10#1)(2008-7#2)(2008-9#1)
the central region##13##3##(1991-12#1)(1993-6#1)(1994-9#1)(1996-5#1)(1997-1#2)(1997-8#1)(2005-5#1)(2008-1#1)(2008-10#1)(2008-7#2)(2008-9#1)
the central regulation of##2##4##(1992-6#1)(1996-11#1)
the central regulator of##2##4##(2007-11#1)(2008-9#1)
the central role of the##3##5##(1994-5#1)(1997-1#1)(2008-11#1)
the central role of##16##4##(1994-5#1)(1997-1#1)(1997-4#1)(2008-1#3)(2008-11#2)(2008-3#1)(2008-7#1)(2009-11#1)(2009-8#2)(2011-2#1)(2013-1#2)
the central spot##2##3##(2008-2#1)(2008-3#1)
the central sulcus##2##3##(2006-10#1)(2008-7#1)
the central themes##2##3##(1997-2#1)(2008-7#1)
the central venous catheter##3##4##(2007-7#2)(2012-12#1)
the central venous##5##3##(1990-3#1)(2007-7#3)(2012-12#1)
the central vertical##2##3##(1996-6#1)(2007-7#1)
the central wavelength of the##2##5##(2007-12#2)
the central wavelength of##3##4##(2007-12#2)(2008-3#1)
the central wavelength##4##3##(2007-12#2)(2008-3#2)
the central##834##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#6)(1990-4#4)(1990-5#3)(1990-6#1)(1990-7#3)(1990-8#5)(1990-9#2)(1991-1#2)(1991-10#2)(1991-11#5)(1991-12#6)(1991-2#3)(1991-3#5)(1991-4#2)(1991-5#4)(1991-6#3)(1991-7#8)(1991-8#2)(1991-9#2)(1992-1#3)(1992-11#5)(1992-12#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#5)(1992-7#2)(1992-8#3)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#9)(1993-12#15)(1993-2#3)(1993-3#6)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#2)(1994-10#3)(1994-11#10)(1994-12#5)(1994-2#5)(1994-3#4)(1994-4#1)(1994-5#4)(1994-7#1)(1994-8#3)(1994-9#6)(1995-1#2)(1995-10#2)(1995-11#6)(1995-12#16)(1995-2#4)(1995-3#3)(1995-4#3)(1995-5#14)(1995-6#3)(1995-7#4)(1995-8#4)(1995-9#1)(1996-1#8)(1996-10#1)(1996-11#3)(1996-12#15)(1996-2#5)(1996-3#1)(1996-4#3)(1996-5#7)(1996-6#4)(1996-7#1)(1996-8#7)(1996-9#9)(1997-1#6)(1997-2#10)(1997-3#4)(1997-4#7)(1997-5#4)(1997-6#8)(1997-7#3)(1997-8#3)(2005-10#8)(2005-11#4)(2005-3#1)(2005-5#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#21)(2006-11#4)(2006-12#5)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#3)(2006-8#1)(2007-1#3)(2007-10#4)(2007-11#18)(2007-12#24)(2007-2#1)(2007-3#3)(2007-6#4)(2007-7#7)(2007-8#8)(2007-9#7)(2008-1#11)(2008-10#42)(2008-11#15)(2008-12#1)(2008-2#8)(2008-3#17)(2008-4#12)(2008-5#18)(2008-6#4)(2008-7#37)(2008-8#13)(2008-9#19)(2009-10#4)(2009-11#1)(2009-2#6)(2009-3#3)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#1)(2010-10#2)(2010-12#9)(2010-2#3)(2010-3#2)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#5)(2011-1#5)(2011-12#2)(2011-2#12)(2012-1#5)(2012-11#3)(2012-12#5)(2012-2#9)(2012-3#10)(2013-1#18)(2013-7#5)(2013-8#16)
the centrality of##6##3##(1995-1#1)(2007-9#1)(2013-1#4)
the centralized##4##2##(2008-3#1)(2008-5#1)(2008-7#1)(2011-7#1)
the centrally##3##2##(1996-7#1)(2008-10#1)(2008-5#1)
the centre had##2##3##(1996-6#1)(2007-3#1)
the centre is##2##3##(1995-5#1)(1996-4#1)
the centre of a##2##4##(1995-12#1)(1996-11#1)
the centre of an epileptic focus##2##6##(1990-3#2)
the centre of an##3##4##(1990-3#2)(2007-9#1)
the centre of the##7##4##(1993-9#1)(1997-2#1)(2007-12#1)(2008-7#1)(2010-11#1)(2010-8#1)(2012-2#1)
the centre of##30##3##(1990-3#2)(1993-9#2)(1995-12#2)(1996-11#2)(1997-2#2)(1997-4#1)(2005-11#2)(2006-6#1)(2007-12#2)(2007-9#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-10#1)(2010-11#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-7#1)
the centre##47##2##(1990-3#2)(1991-11#2)(1992-12#1)(1993-9#2)(1995-12#3)(1995-3#1)(1995-5#2)(1996-11#2)(1996-4#2)(1996-6#2)(1997-2#2)(1997-4#1)(2005-10#1)(2005-11#2)(2006-6#1)(2007-12#2)(2007-3#3)(2007-9#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-10#1)(2010-11#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-7#1)
the centre's##2##2##(1996-4#1)(1996-6#1)
the centres##6##2##(1990-3#1)(1996-12#1)(2008-10#1)(2009-4#1)(2009-5#1)(2012-12#1)
the centrifugal projection to the##2##5##(1994-2#2)
the centrifugal projection##3##3##(1994-2#3)
the centrifugal##6##2##(1994-2#3)(1995-11#3)
the centrifugation##3##2##(2008-10#1)(2008-5#1)(2010-5#1)
the centrioles##2##2##(2008-7#2)
the centroid is##2##3##(2007-12#2)
the centroid of the##4##4##(2007-11#1)(2008-2#2)(2008-3#1)
the centroid of##6##3##(2007-11#1)(2008-2#2)(2008-3#3)
the centroid potential##2##3##(2009-9#2)
the centroid##12##2##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#4)(2009-9#2)
the centromere of chromosome##2##4##(1990-10#1)(2012-3#1)
the centromere of##4##3##(1990-10#1)(2008-5#2)(2012-3#1)
the centromere on the##2##4##(1996-3#1)(2008-10#1)
the centromere on##3##3##(1996-3#1)(2008-10#2)
the centromere##11##2##(1990-10#1)(1991-2#1)(1996-3#1)(1997-3#1)(2008-10#2)(2008-5#2)(2008-8#1)(2009-5#1)(2012-3#1)
the centromeric region of##3##4##(1996-8#1)(2008-10#1)(2008-5#1)
the centromeric region##4##3##(1996-8#1)(2008-10#1)(2008-5#1)(2010-8#1)
the centromeric regions##2##3##(1997-6#1)(2011-12#1)
the centromeric##10##2##(1990-11#1)(1994-9#1)(1996-8#1)(1997-6#1)(2008-10#1)(2008-5#1)(2009-3#1)(2010-12#1)(2010-8#1)(2011-12#1)
the centrosome and##2##3##(2008-8#1)(2009-7#1)
the centrosome cycle##3##3##(2008-5#1)(2008-8#2)
the centrosome##16##2##(1991-5#5)(2008-5#2)(2008-8#4)(2008-9#2)(2009-7#1)(2012-12#2)
the centrosomes##3##2##(2008-5#1)(2008-8#1)(2008-9#1)
the centuries##3##2##(2007-9#1)(2008-12#1)(2011-2#1)
the century of##3##3##(1990-10#1)(1991-11#1)(2008-8#1)
the century since##2##3##(2008-7#1)(2010-8#1)
the century##26##2##(1990-10#2)(1990-3#1)(1991-11#1)(1992-2#1)(1993-11#1)(1994-5#1)(1994-9#1)(1996-3#1)(1997-3#1)(1997-6#1)(2006-10#3)(2006-6#1)(2007-4#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-8#1)(2013-1#1)(2013-7#1)
the cephalic vein##3##3##(2007-7#3)
the cephalic##8##2##(2007-12#2)(2007-7#3)(2008-5#2)(2011-2#1)
the cephalosporin##4##2##(1990-8#1)(1996-4#1)(2011-1#2)
the cephalosporins##2##2##(1994-8#1)(2013-8#1)
the ceramic particle##2##3##(2005-11#1)(2006-2#1)
the ceramic surface##2##3##(2008-5#1)(2008-8#1)
the ceramic##10##2##(2005-11#2)(2006-2#2)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-2#1)
the ceramics##2##2##(2007-5#1)(2008-5#1)
the ceramide dispersions##2##3##(1994-5#2)
the ceramide##9##2##(1990-7#1)(1992-8#1)(1993-11#1)(1994-5#2)(1997-8#1)(2008-5#3)
the ceramide-mediated proapoptotic##2##3##(2013-1#2)
the cereal##5##2##(2006-12#1)(2008-10#1)(2008-7#1)(2012-2#2)
the cerebellar cortex##17##3##(1991-1#1)(1991-11#2)(1991-3#1)(1992-11#1)(1992-6#1)(1993-12#1)(1994-2#2)(1995-11#2)(1995-8#1)(1996-5#3)(2010-12#1)(2013-8#1)
the cerebellar interpositus nucleus##3##4##(1990-4#3)
the cerebellar lesion##2##3##(1993-7#1)(2013-1#1)
the cerebellar motor##2##3##(1994-2#2)
the cerebellar vermis##5##3##(1996-10#3)(2008-5#1)(2010-11#1)
the cerebellar##53##2##(1990-4#3)(1990-7#1)(1991-1#1)(1991-11#2)(1991-3#3)(1991-6#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-2#4)(1995-10#1)(1995-11#3)(1995-12#1)(1995-8#1)(1995-9#1)(1996-10#3)(1996-5#4)(1996-9#1)(1997-3#1)(2006-9#1)(2007-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-2#1)(2010-11#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
the cerebellopontine angle (CPA)##2##4##(2006-12#1)(2012-3#1)
the cerebellopontine angle and##2##4##(2006-12#1)(2008-7#1)
the cerebellopontine angle##11##3##(2006-11#1)(2006-12#3)(2006-5#2)(2008-7#3)(2011-2#1)(2012-3#1)
the cerebellum and the##2##4##(1991-6#1)(1993-7#1)
the cerebellum and##8##3##(1991-12#1)(1991-6#1)(1993-6#1)(1993-7#1)(1995-11#1)(1996-10#1)(1997-6#1)(2013-8#1)
the cerebellum in the##2##4##(1992-6#1)(2013-1#1)
the cerebellum in##4##3##(1992-6#1)(2008-4#1)(2010-12#1)(2013-1#1)
the cerebellum of the##5##4##(1992-9#1)(1994-10#1)(1996-7#1)(2010-12#1)(2010-8#1)
the cerebellum of##7##3##(1992-9#1)(1994-10#1)(1996-7#1)(2010-12#3)(2010-8#1)
the cerebellum or##2##3##(1994-3#1)(2006-4#1)
the cerebellum to##2##3##(1991-1#1)(1992-11#1)
the cerebellum was##4##3##(1994-10#1)(1996-7#1)(1997-5#1)(2007-8#1)
the cerebellum were##4##3##(1993-7#1)(1996-4#1)(2010-12#1)(2011-1#1)
the cerebellum##104##2##(1990-7#1)(1990-8#1)(1991-1#3)(1991-11#2)(1991-12#1)(1991-6#2)(1991-8#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-4#2)(1993-6#1)(1993-7#4)(1993-8#3)(1994-10#3)(1994-11#1)(1994-2#3)(1994-3#1)(1995-11#4)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#3)(1996-10#1)(1996-12#5)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#3)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2006-11#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-8#6)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-1#1)(2009-5#1)(2009-8#1)(2010-12#8)(2010-8#2)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
the cerebral and##3##3##(1992-4#1)(2008-5#1)(2012-3#1)
the cerebral aqueduct##3##3##(1997-1#1)(2006-5#1)(2012-3#1)
the cerebral arteries##4##3##(2006-11#1)(2007-9#1)(2008-7#1)(2009-4#1)
the cerebral blood flow##2##4##(1995-1#1)(1996-9#1)
the cerebral capillary network##2##4##(1995-1#2)
the cerebral circulation##3##3##(2007-11#1)(2007-9#1)(2008-7#1)
the cerebral collateral circulation##3##4##(2010-11#3)
the cerebral cortex and the##3##5##(1991-9#1)(1996-12#1)(2008-11#1)
the cerebral cortex and##13##4##(1990-7#1)(1991-9#1)(1995-7#1)(1996-12#1)(1996-9#1)(1997-2#3)(2008-11#1)(2008-7#2)(2012-12#1)(2012-2#1)
the cerebral cortex in the##2##5##(1990-7#1)(1997-6#1)
the cerebral cortex in##4##4##(1990-7#1)(1995-11#1)(1997-6#1)(2007-1#1)
the cerebral cortex of nucleus basalis magnocellularis lesioned rats##2##9##(1993-12#2)
the cerebral cortex of##10##4##(1990-4#1)(1993-12#3)(1994-2#1)(1995-6#1)(1996-8#1)(1997-2#1)(1997-5#1)(2008-7#1)
the cerebral cortex was##3##4##(1990-7#1)(1992-3#1)(1995-6#1)
the cerebral cortex##79##3##(1990-4#1)(1990-7#4)(1991-2#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-12#5)(1993-7#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#4)(1995-12#1)(1995-6#4)(1995-7#2)(1996-12#3)(1996-5#2)(1996-8#2)(1996-9#1)(1997-2#6)(1997-4#1)(1997-5#2)(1997-6#1)(2006-8#1)(2007-1#1)(2007-8#3)(2007-9#1)(2008-11#6)(2008-7#9)(2008-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)
the cerebral hemisphere##7##3##(2007-12#3)(2008-7#2)(2013-1#1)(2013-8#1)
the cerebral hemispheres##2##3##(1996-12#1)(2008-7#1)
the cerebral neocortex##2##3##(2008-11#2)
the cerebral vascular##2##3##(2006-6#1)(2013-1#1)
the cerebral vasculature##3##3##(2006-11#1)(2007-10#2)
the cerebral vessels##3##3##(1997-6#1)(2006-10#1)(2006-11#1)
the cerebral white matter##3##4##(2008-7#1)(2010-12#2)
the cerebral##165##2##(1990-4#1)(1990-5#1)(1990-7#4)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-12#5)(1993-7#2)(1994-10#2)(1994-12#1)(1994-2#4)(1994-5#1)(1994-8#1)(1995-1#4)(1995-11#4)(1995-12#1)(1995-6#4)(1995-7#2)(1996-1#1)(1996-12#5)(1996-5#2)(1996-6#1)(1996-8#2)(1996-9#5)(1997-1#1)(1997-2#7)(1997-3#1)(1997-4#1)(1997-5#4)(1997-6#3)(1997-8#1)(2006-10#2)(2006-11#3)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#6)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#3)(2007-9#6)(2008-11#8)(2008-5#2)(2008-7#20)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#3)(2010-12#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
the cerebro-spinal fluid##2##3##(1992-11#2)
the cerebroside##2##2##(1991-9#1)(2008-10#1)
the cerebrospinal fluid (CSF) and##3##5##(1993-4#1)(1995-12#1)(2008-7#1)
the cerebrospinal fluid (CSF) of##4##5##(1996-3#1)(2008-3#1)(2011-2#2)
the cerebrospinal fluid (CSF)##10##4##(1993-4#1)(1995-12#1)(1996-12#1)(1996-3#1)(2005-7#1)(2006-12#1)(2008-3#1)(2008-7#1)(2011-2#2)
the cerebrospinal fluid of##2##4##(1995-12#1)(2008-12#1)
the cerebrospinal fluid##31##3##(1990-10#2)(1991-12#1)(1991-2#1)(1993-4#1)(1994-10#1)(1995-12#2)(1995-5#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-5#1)(2005-7#1)(2006-12#1)(2007-11#1)(2008-12#1)(2008-3#2)(2008-7#2)(2009-11#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#3)(2012-2#1)(2013-1#1)
the cerebrospinal##32##2##(1990-10#2)(1991-12#1)(1991-2#1)(1993-4#1)(1994-10#1)(1995-12#2)(1995-5#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-5#1)(2005-7#1)(2006-12#1)(2006-9#1)(2007-11#1)(2008-12#1)(2008-3#2)(2008-7#2)(2009-11#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#3)(2012-2#1)(2013-1#1)
the cerebrovascular##9##2##(1991-6#1)(1992-2#1)(1993-12#1)(1996-9#1)(2006-10#1)(2006-7#1)(2012-3#3)
the cerebrum and##3##3##(2006-12#1)(2008-9#2)
the cerebrum##10##2##(1993-12#1)(1995-10#1)(1995-8#1)(1996-1#1)(1997-8#1)(2006-12#1)(2008-9#4)
the certain##8##2##(1994-12#1)(1997-6#1)(2005-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2011-2#1)(2013-1#1)
the certainty of##2##3##(2010-12#1)(2013-8#1)
the certification of##3##3##(1996-7#1)(2007-2#1)(2008-10#1)
the certification process##2##3##(2007-7#1)(2007-9#1)
the certification##5##2##(1996-7#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#1)
the certified and##2##3##(2008-10#2)
the certified range##2##3##(2008-10#2)
the certified reference material##4##4##(2008-10#4)
the certified reference materials##4##4##(2008-10#4)
the certified reference##9##3##(2008-10#9)
the certified value and##2##4##(2008-10#2)
the certified value of##4##4##(2008-10#3)(2008-3#1)
the certified value##17##3##(2008-10#16)(2008-3#1)
the certified values and##7##4##(2007-8#1)(2008-10#6)
the certified values##27##3##(1993-11#1)(2005-4#1)(2007-8#2)(2008-10#23)
the certified##76##2##(1993-11#1)(2005-4#1)(2006-3#2)(2007-8#2)(2008-10#66)(2008-12#2)(2008-3#2)
the ceruloplasmin##2##2##(1993-12#1)(2006-8#1)
the cervical and lumbar##3##4##(2006-7#2)(2007-11#1)
the cervical and thoracic spine##4##5##(2007-11#2)(2008-12#1)(2009-8#1)
the cervical and thoracic##5##4##(2007-11#2)(2008-12#2)(2009-8#1)
the cervical and##11##3##(2006-7#2)(2007-11#3)(2008-12#2)(2009-8#1)(2011-12#1)(2013-1#1)(2013-8#1)
the cervical canal##4##3##(1992-1#1)(1992-2#1)(1993-12#1)(1994-9#1)
the cervical cancer##6##3##(1992-10#1)(2007-8#2)(2011-3#1)(2012-3#1)(2013-7#1)
the cervical cord##3##3##(1992-3#1)(1997-6#1)(2008-7#1)
the cervical epithelium##2##3##(1992-9#1)(2007-5#1)
the cervical esophagus##5##3##(2011-2#1)(2013-1#4)
the cervical facet##3##3##(2007-1#2)(2007-4#1)
the cervical line##2##3##(2011-2#2)
the cervical lymph nodes##6##4##(1991-9#1)(1995-2#1)(2008-2#1)(2010-7#1)(2013-8#2)
the cervical musculature##2##3##(2007-4#2)
the cervical region##4##3##(2011-12#2)(2013-1#2)
the cervical segment of the##2##5##(2007-11#1)(2007-8#1)
the cervical segment##3##3##(2007-11#1)(2007-8#1)(2008-7#1)
the cervical spinal cord##8##4##(1991-5#1)(1992-7#1)(1995-3#2)(2006-8#2)(2010-5#2)
the cervical spinal##10##3##(1991-5#1)(1992-7#1)(1995-3#2)(2006-8#2)(2010-5#2)(2013-8#2)
the cervical spine and##6##4##(1995-11#1)(2007-1#1)(2007-11#2)(2007-7#1)(2012-2#1)
the cervical spine are discussed##2##5##(2007-11#1)(2011-2#1)
the cervical spine are##5##4##(1990-12#1)(1997-4#1)(2007-11#1)(2008-9#1)(2011-2#1)
the cervical spine in a##2##5##(2008-12#1)(2011-2#1)
the cervical spine in##5##4##(2006-10#1)(2008-12#1)(2008-4#1)(2009-3#1)(2011-2#1)
the cervical spine is##5##4##(2006-11#1)(2006-8#1)(2007-11#2)(2011-2#1)
the cervical spine may##2##4##(2007-11#2)
the cervical spine was##3##4##(2007-1#1)(2007-11#1)(2009-3#1)
the cervical spine with##2##4##(2007-11#2)
the cervical spine##94##3##(1990-12#2)(1991-6#1)(1995-11#1)(1997-4#1)(2006-10#2)(2006-11#5)(2006-8#4)(2006-9#1)(2007-1#3)(2007-11#29)(2007-4#5)(2007-6#2)(2007-7#5)(2007-8#5)(2008-12#3)(2008-4#4)(2008-9#1)(2009-3#5)(2010-12#3)(2011-2#4)(2012-12#5)(2012-2#1)(2013-1#2)
the cervical vertebrae##2##3##(2007-1#1)(2007-4#1)
the cervical##190##2##(1990-11#1)(1990-12#3)(1990-6#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#2)(1992-3#2)(1992-7#1)(1992-9#2)(1993-12#1)(1993-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#5)(2006-11#5)(2006-7#3)(2006-8#6)(2006-9#1)(2007-1#6)(2007-11#34)(2007-4#9)(2007-5#1)(2007-6#3)(2007-7#5)(2007-8#11)(2008-12#7)(2008-2#1)(2008-4#5)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#5)(2009-8#1)(2010-12#4)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#3)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#10)(2013-7#1)(2013-8#5)
the cervix and the##2##4##(1996-2#1)(1997-7#1)
the cervix and##5##3##(1993-1#1)(1996-2#1)(1997-7#1)(2006-10#1)(2013-7#1)
the cervix in##11##3##(1991-3#1)(1994-5#2)(1996-6#1)(2006-10#5)(2007-11#1)(2009-5#1)
the cervix##67##2##(1990-12#2)(1990-8#3)(1991-3#1)(1992-12#1)(1992-2#4)(1993-1#1)(1993-10#1)(1993-8#2)(1994-1#1)(1994-2#1)(1994-3#2)(1994-5#2)(1995-4#1)(1995-5#1)(1996-12#3)(1996-2#1)(1996-6#1)(1997-7#2)(2004-10#5)(2005-12#1)(2006-10#19)(2007-11#1)(2007-12#1)(2008-11#1)(2008-7#1)(2009-5#3)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
the cesarean section##3##3##(1991-6#1)(2011-2#1)(2012-12#1)
the cesium D(2) line##2##4##(2008-3#2)
the cesium##6##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
the cessation of##12##3##(1994-6#2)(1995-6#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-4#1)(2008-11#1)(2008-4#1)(2009-12#1)(2010-3#1)(2011-2#1)
the cessation##14##2##(1994-6#2)(1995-6#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-4#1)(2008-11#1)(2008-4#1)(2009-12#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-12#1)
the cestode Taenia##2##3##(2011-2#2)
the cestode##3##2##(2010-8#1)(2011-2#2)
the chain and the##2##4##(1991-5#1)(2008-12#1)
the chain and##3##3##(1991-5#1)(2008-12#1)(2009-9#1)
the chain is##3##3##(1994-3#2)(1995-9#1)
the chain length of the alkyl##2##6##(2005-11#2)
the chain length of the##4##5##(1993-11#1)(1993-3#1)(2005-11#2)
the chain length of##5##4##(1993-11#1)(1993-3#1)(2005-11#2)(2009-3#1)
the chain length##17##3##(1992-11#1)(1993-11#1)(1993-3#1)(1995-11#1)(1996-2#1)(1997-8#1)(2005-10#1)(2005-11#6)(2007-9#1)(2008-12#1)(2008-2#1)(2009-3#1)
the chain of biochemical##2##4##(2007-9#1)(2008-7#1)
the chain of##10##3##(1994-2#1)(1995-8#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-8#1)(2011-1#1)(2013-1#1)
the chain##58##2##(1990-2#1)(1991-2#2)(1991-5#1)(1991-7#1)(1992-11#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-3#3)(1995-10#1)(1995-11#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-2#2)(1997-8#1)(2005-10#1)(2005-11#7)(2006-10#2)(2006-12#1)(2007-11#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-12#6)(2008-2#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-3#1)(2009-9#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
the chain-length inequivalence##2##3##(1990-7#2)
the chain-length##4##2##(1990-11#1)(1990-7#2)(1993-4#1)
the chains of##2##3##(1991-2#1)(1997-6#1)
the chains##10##2##(1991-2#2)(1995-6#1)(1997-6#1)(2005-11#2)(2010-2#1)(2010-4#1)(2013-1#2)
the chair and##2##3##(2008-4#1)(2008-5#1)
the chair##4##2##(2007-5#1)(2007-8#1)(2008-4#1)(2008-5#1)
the chalcogenide##4##2##(2007-11#1)(2008-10#3)
the challenge and##3##3##(2008-6#1)(2011-12#1)(2013-1#1)
the challenge for the##2##4##(1996-3#1)(2008-1#1)
the challenge for##5##3##(1992-12#1)(1996-1#1)(1996-3#1)(2008-1#1)(2008-11#1)
the challenge is to##2##4##(1996-2#1)(2006-8#1)
the challenge is##7##3##(1996-2#1)(2006-10#1)(2006-8#1)(2009-12#1)(2010-12#1)(2013-1#2)
the challenge of a##2##4##(1994-7#1)(1997-2#1)
the challenge of creating##2##4##(2007-2#1)(2009-4#1)
the challenge of integration##2##4##(1997-3#1)(2013-7#1)
the challenge of the##2##4##(2008-11#1)(2012-1#1)
the challenge of##52##3##(1991-12#2)(1991-6#1)(1992-3#1)(1994-7#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#2)(1997-6#1)(2004-3#1)(2005-8#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-2#2)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-8#1)(2009-10#1)(2009-4#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-12#1)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#2)
the challenge to##2##3##(1996-5#1)(2006-10#1)
the challenge with##3##3##(2007-2#1)(2008-8#1)(2012-2#1)
the challenge##94##2##(1991-12#2)(1991-6#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-2#1)(1994-7#2)(1995-12#1)(1995-3#1)(1996-1#2)(1996-12#4)(1996-2#2)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-6#1)(2004-3#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-2#3)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#2)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-12#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#2)
the challenges ahead##2##3##(1990-12#1)(2007-11#1)
the challenges and opportunities##2##4##(2008-1#1)(2013-1#1)
the challenges and the##2##4##(1997-2#1)(2008-4#1)
the challenges and##15##3##(1996-2#1)(1997-2#1)(2005-10#1)(2005-8#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-4#1)(2009-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#2)
the challenges are##3##3##(2008-1#1)(2010-6#1)(2011-2#1)
the challenges associated with##4##4##(2008-12#1)(2008-4#1)(2010-2#1)(2012-3#1)
the challenges faced by##7##4##(1994-3#1)(2008-3#1)(2010-6#1)(2012-1#1)(2012-11#2)(2012-12#1)
the challenges faced##12##3##(1994-3#1)(2007-10#1)(2008-3#1)(2009-11#1)(2010-6#1)(2012-1#2)(2012-11#2)(2012-12#1)(2013-1#2)
the challenges facing##5##3##(1996-1#1)(1996-2#1)(1997-3#1)(2008-1#1)(2008-7#1)
the challenges for##2##3##(2008-11#1)(2012-2#1)
the challenges in the diagnosis and management##2##7##(2006-8#1)(2012-12#1)
the challenges in the##3##4##(2006-8#1)(2008-10#1)(2012-12#1)
the challenges in##6##3##(1996-4#1)(2006-8#1)(2007-4#1)(2008-10#1)(2008-8#1)(2012-12#1)
the challenges inherent in##2##4##(1995-2#1)(1995-3#1)
the challenges involved##2##3##(1996-2#1)(2010-12#1)
the challenges of including##2##4##(2009-9#1)(2010-9#1)
the challenges of integrating##2##4##(2007-5#1)(2008-7#1)
the challenges of the##9##4##(1990-4#1)(1991-3#1)(1992-12#1)(1993-2#1)(1994-2#1)(2005-5#1)(2006-8#1)(2008-5#1)(2011-2#1)
the challenges of##59##3##(1990-4#1)(1991-3#1)(1992-1#2)(1992-12#1)(1993-2#1)(1994-2#1)(1995-1#1)(1996-1#1)(2005-5#2)(2006-1#2)(2006-10#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-11#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#1)(2011-9#1)(2012-3#1)(2012-8#1)(2013-1#4)(2013-7#1)
the challenges posed by##2##4##(2008-12#1)(2012-12#1)
the challenges presented by##3##4##(1992-1#1)(1993-2#1)(2005-9#1)
the challenges related to##2##4##(1995-1#1)(2008-2#1)
the challenges that##5##3##(2006-5#1)(2007-4#1)(2009-8#1)(2011-2#2)
the challenges they face##3##4##(2009-4#1)(2011-1#2)
the challenges to##2##3##(2009-11#1)(2009-12#1)
the challenges##159##2##(1990-12#1)(1990-4#1)(1991-3#1)(1992-1#3)(1992-12#1)(1993-2#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-2#1)(1995-3#1)(1996-1#2)(1996-2#3)(1996-4#1)(1997-2#1)(1997-3#1)(2005-10#1)(2005-5#2)(2005-6#1)(2005-8#2)(2005-9#1)(2006-1#2)(2006-10#2)(2006-11#1)(2006-5#2)(2006-8#2)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#2)(2007-4#4)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#1)(2008-11#7)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#4)(2009-12#1)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-5#1)(2010-6#3)(2010-8#1)(2010-9#2)(2011-1#8)(2011-12#1)(2011-2#6)(2011-9#1)(2012-1#2)(2012-11#2)(2012-12#5)(2012-2#2)(2012-3#3)(2012-8#1)(2013-1#11)(2013-7#1)(2013-8#1)
the challenging problems##2##3##(2007-7#1)(2008-9#1)
the challenging##13##2##(1997-2#1)(2007-5#1)(2007-7#1)(2008-7#1)(2008-9#1)(2009-9#4)(2010-12#1)(2011-12#1)(2012-2#1)(2013-1#1)
the chamber and##3##3##(2006-8#1)(2008-10#1)(2008-11#1)
the chamber##13##2##(2006-8#3)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-7#2)
the chambers##3##2##(2008-10#1)(2008-11#1)(2012-12#1)
the chance of a##3##4##(1993-1#1)(2010-1#1)(2010-12#1)
the chance of survival##3##4##(1995-8#1)(2004-10#1)(2007-6#1)
the chance of##36##3##(1990-10#1)(1990-2#2)(1991-12#1)(1993-1#2)(1995-12#1)(1995-6#1)(1995-8#1)(1996-9#1)(2004-10#1)(2006-8#1)(2006-9#2)(2007-6#1)(2007-8#1)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)
the chance that##4##3##(1995-1#1)(1996-6#1)(2007-2#1)(2008-7#1)
the chance to have an infection was##2##7##(1990-12#2)
the chance to learn##2##4##(2008-12#1)(2013-1#1)
the chance to##16##3##(1990-12#2)(1993-2#1)(1993-5#1)(1997-7#1)(2006-6#1)(2007-7#1)(2008-12#1)(2008-2#2)(2009-8#1)(2010-6#1)(2012-3#1)(2013-1#3)
the chance##62##2##(1990-10#1)(1990-12#3)(1990-2#2)(1991-12#1)(1992-10#2)(1993-1#2)(1993-2#1)(1993-5#1)(1995-1#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-6#2)(1996-9#1)(1997-7#1)(2004-10#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)
the chances for##2##3##(2008-9#1)(2012-12#1)
the chances of a##2##4##(1993-8#1)(2005-12#1)
the chances of an##2##4##(2006-11#1)(2013-8#1)
the chances of success##3##4##(1993-11#1)(2008-1#1)(2012-2#1)
the chances of##21##3##(1991-12#2)(1993-10#1)(1993-11#1)(1993-8#1)(2005-12#1)(2005-9#1)(2006-11#1)(2006-6#1)(2007-1#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#1)
the chances##26##2##(1991-12#2)(1993-10#1)(1993-11#1)(1993-8#1)(1996-3#1)(1996-9#1)(2005-12#1)(2005-9#1)(2006-11#1)(2006-6#1)(2007-1#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
the change for##2##3##(1990-8#1)(2008-3#1)
the change from the##2##4##(1990-8#1)(2009-8#1)
the change from##6##3##(1990-8#1)(1992-3#1)(1995-11#1)(2008-5#1)(2008-6#1)(2009-8#1)
the change in absorbance##5##4##(2008-10#5)
the change in average##2##4##(2008-11#2)
the change in effective##2##4##(2008-2#2)
the change in enthalpy##2##4##(1990-5#1)(2006-10#1)
the change in fluorescence intensity##2##5##(1995-11#1)(2008-10#1)
the change in heat capacity##2##5##(1990-5#1)(1996-11#1)
the change in loss##2##4##(2008-3#2)
the change in optical##2##4##(1996-4#1)(2008-2#1)
the change in potential##2##4##(1991-9#1)(2008-10#1)
the change in the absorption coefficient##2##6##(2008-2#2)
the change in the number of##2##6##(2008-10#1)(2008-2#1)
the change in the retention times was generally greater for amino acids##2##12##(2005-12#2)
the change in the##41##4##(1990-2#1)(1990-5#1)(1992-11#1)(1994-3#1)(1995-11#1)(1995-3#1)(1997-2#1)(2005-11#1)(2005-12#2)(2005-8#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#5)(2008-2#7)(2008-3#5)(2008-4#1)(2008-5#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-12#2)(2013-8#1)
the change in transfer##3##4##(1991-2#1)(1997-2#1)(2008-3#1)
the change in##143##3##(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#3)(1990-8#2)(1991-2#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-11#1)(1993-12#1)(1994-3#1)(1994-5#2)(1995-1#1)(1995-11#4)(1995-3#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-4#1)(1996-9#1)(1997-2#3)(1997-4#1)(2004-8#1)(2005-11#4)(2005-12#2)(2005-3#2)(2005-8#1)(2006-10#2)(2006-11#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#19)(2008-11#4)(2008-2#12)(2008-3#15)(2008-4#4)(2008-5#3)(2008-7#2)(2008-8#1)(2009-12#2)(2009-2#1)(2009-5#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#4)(2012-2#1)(2013-1#4)(2013-8#3)
the change is##4##3##(1993-3#1)(1994-1#1)(2008-11#1)(2008-3#1)
the change of free energy##3##5##(2008-10#1)(2010-7#2)
the change of osteoblast proliferation by PTHrP##2##7##(1991-8#2)
the change of osteoblast proliferation by##4##6##(1991-5#2)(1991-8#2)
the change of the##10##4##(1995-7#1)(2006-10#2)(2007-12#1)(2007-5#2)(2007-8#1)(2008-10#1)(2008-8#1)(2013-8#1)
the change of##60##3##(1990-2#1)(1991-5#2)(1991-8#2)(1992-6#1)(1993-5#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-7#1)(1996-5#1)(1997-2#2)(1997-8#1)(2004-9#1)(2005-11#3)(2005-4#4)(2006-10#2)(2006-2#1)(2006-6#1)(2007-12#1)(2007-5#2)(2007-8#3)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#3)(2009-3#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-8#3)
the change over##2##3##(1996-1#1)(2007-12#1)
the change process##4##3##(1995-3#2)(1996-12#1)(2008-11#1)
the change to##6##3##(1990-10#1)(1992-1#1)(1996-1#1)(1997-2#1)(2008-11#1)(2008-7#1)
the change was##3##3##(2007-3#1)(2008-11#1)(2008-5#1)
the change with age of##2##5##(1997-1#1)(2008-5#1)
the change with##3##3##(1997-1#1)(2008-5#1)(2008-7#1)
the change would##2##3##(2008-12#1)(2012-12#1)
the change##257##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#3)(1990-8#4)(1991-2#1)(1991-3#1)(1991-5#4)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#4)(1992-11#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#2)(1993-5#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#2)(1995-1#2)(1995-11#5)(1995-3#6)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-4#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#6)(1997-4#2)(1997-8#2)(2004-8#1)(2004-9#1)(2005-11#7)(2005-12#2)(2005-3#2)(2005-4#4)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-3#1)(2007-5#3)(2007-6#1)(2007-8#5)(2007-9#1)(2008-10#27)(2008-11#9)(2008-12#3)(2008-2#13)(2008-3#20)(2008-4#4)(2008-5#7)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#3)(2011-3#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#6)
the changed##7##2##(1996-2#1)(1997-4#1)(2005-11#1)(2005-8#1)(2007-11#1)(2008-5#1)(2010-6#1)
the changes are##3##3##(1990-2#1)(1993-2#1)(1996-6#1)
the changes at##3##3##(2010-3#1)(2013-1#2)
the changes found in the##3##5##(1991-2#1)(1995-1#1)(2008-1#1)
the changes in [Ca2+]i##3##4##(1993-3#2)(1996-8#1)
the changes in absorption##2##4##(2008-10#1)(2008-2#1)
the changes in cell##3##4##(1994-3#1)(2007-11#1)(2008-9#1)
the changes in free##2##4##(1991-6#1)(2005-3#1)
the changes in gene expression##5##5##(1997-8#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-4#1)
the changes in growth##2##4##(2008-7#1)(2009-4#1)
the changes in lipid##2##4##(1996-9#1)(2008-1#1)
the changes in mechanical properties##2##5##(2008-6#1)(2009-4#1)
the changes in serum##3##4##(1994-10#1)(1994-3#1)(1995-4#1)
the changes in sialylation pattern of##2##6##(2008-11#2)
the changes in stress##2##4##(1996-4#1)(2007-12#1)
the changes in the fluorescence##2##5##(2008-10#2)
the changes in the intestinal##2##5##(1993-9#1)(1996-6#1)
the changes in the levels of##2##6##(1996-11#2)
the changes in the radiometric##2##5##(2008-3#2)
the changes in the##63##4##(1990-12#1)(1990-2#2)(1990-8#1)(1991-12#1)(1991-6#1)(1993-11#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-11#2)(1996-6#1)(1997-1#1)(1997-4#2)(2005-7#1)(2006-10#1)(2006-11#1)(2007-11#2)(2007-8#2)(2008-10#7)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-4#2)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#1)
the changes in##212##3##(1990-12#3)(1990-2#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#3)(1992-3#1)(1993-11#3)(1993-2#3)(1993-3#3)(1993-5#1)(1993-9#1)(1994-1#1)(1994-10#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#3)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#2)(1996-1#1)(1996-10#2)(1996-11#3)(1996-3#1)(1996-4#3)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-10#3)(2005-11#1)(2005-3#1)(2005-7#2)(2006-10#3)(2006-11#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-11#3)(2007-12#2)(2007-2#2)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#16)(2008-11#4)(2008-12#3)(2008-2#4)(2008-3#9)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#2)(2009-11#2)(2009-4#6)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#3)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#4)(2012-1#3)(2012-12#3)(2012-2#3)(2013-1#1)(2013-7#2)(2013-8#7)
the changes induced in the##3##5##(1994-3#1)(2008-2#2)
the changes induced in##4##4##(1991-5#1)(1994-3#1)(2008-2#2)
the changes introduced##2##3##(2008-11#1)(2012-3#1)
the changes made##2##3##(1994-1#1)(1997-3#1)
the changes may##2##3##(1990-12#1)(2007-7#1)
the changes observed in##4##4##(1990-9#1)(1994-10#1)(2004-9#2)
the changes observed##7##3##(1990-9#1)(1994-10#1)(2004-9#2)(2008-1#1)(2008-11#1)(2008-7#1)
the changes occurring in the##2##5##(2011-12#1)(2012-3#1)
the changes occurring##5##3##(2006-10#1)(2008-4#1)(2011-12#1)(2012-2#1)(2012-3#1)
the changes of mechanical properties##2##5##(2004-9#1)(2008-3#1)
the changes of the##12##4##(1992-1#2)(1996-10#1)(1997-2#1)(2006-10#1)(2006-11#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-8#1)
the changes of##43##3##(1992-1#2)(1993-3#1)(1994-6#1)(1995-2#1)(1996-10#1)(1996-6#1)(1997-2#1)(1997-6#1)(2004-9#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#5)
the changes that are##2##4##(1996-2#1)(2008-7#1)
the changes that have occurred##2##5##(1991-2#1)(2008-11#1)
the changes that have##3##4##(1991-2#1)(2007-12#1)(2008-11#1)
the changes that occur in##3##5##(1991-12#1)(2008-2#1)(2008-7#1)
the changes that occur##5##4##(1991-12#1)(2005-7#1)(2008-2#1)(2008-7#1)(2009-3#1)
the changes that the##3##4##(2007-11#1)(2008-12#1)(2011-12#1)
the changes that##18##3##(1991-12#1)(1991-2#1)(1995-1#1)(1996-2#1)(2005-7#1)(2007-11#2)(2007-12#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#2)(2009-3#1)(2011-12#1)
the changes was##2##3##(1992-8#1)(2007-11#1)
the changes were##11##3##(1992-10#1)(1992-6#1)(1993-4#1)(1994-3#1)(1994-9#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-5#1)(2010-12#2)
the changes##359##2##(1990-12#4)(1990-2#3)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-5#3)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#6)(1992-10#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#3)(1993-2#4)(1993-3#4)(1993-4#1)(1993-5#1)(1993-9#1)(1994-1#3)(1994-10#3)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#5)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#3)(1996-1#1)(1996-10#3)(1996-11#3)(1996-12#3)(1996-2#1)(1996-3#2)(1996-4#3)(1996-5#2)(1996-6#3)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(1997-9#1)(2004-12#1)(2004-9#3)(2005-10#3)(2005-11#2)(2005-3#1)(2005-7#3)(2006-1#1)(2006-10#7)(2006-11#2)(2006-12#2)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-11#9)(2007-12#6)(2007-2#3)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#5)(2008-10#21)(2008-11#11)(2008-12#5)(2008-2#8)(2008-3#12)(2008-4#5)(2008-5#7)(2008-6#2)(2008-7#11)(2008-8#4)(2008-9#3)(2009-11#2)(2009-3#2)(2009-4#8)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#7)(2010-2#2)(2010-3#1)(2010-4#3)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#6)(2011-12#2)(2011-2#7)(2012-1#3)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#3)(2013-7#3)(2013-8#12)
the changing health care##3##4##(1996-12#1)(1996-2#1)(2007-11#1)
the changing health##4##3##(1996-12#1)(1996-2#1)(2007-11#1)(2008-1#1)
the changing healthcare##2##3##(1996-2#1)(1997-6#1)
the changing landscape of##3##4##(2013-1#3)
the changing landscape##4##3##(2013-1#4)
the changing nature of the##2##5##(2008-1#1)(2008-12#1)
the changing nature of##4##4##(2007-11#1)(2007-4#1)(2008-1#1)(2008-12#1)
the changing trends##2##3##(2006-10#1)(2012-3#1)
the changing##65##2##(1990-12#1)(1991-2#2)(1992-3#1)(1992-4#1)(1993-3#1)(1994-2#1)(1994-6#1)(1995-11#2)(1995-6#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-7#1)(1997-2#1)(1997-6#1)(2004-3#1)(2005-4#2)(2005-5#1)(2006-10#3)(2006-2#1)(2006-4#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-4#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#2)(2009-11#1)(2009-2#2)(2010-2#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#3)
the channel axis##4##3##(2006-10#1)(2006-12#1)(2006-4#2)
the channel complex##3##3##(1995-8#2)(2005-7#1)
the channel entrance##4##3##(1995-10#1)(2006-10#2)(2008-1#1)
the channel in the##2##4##(1990-11#1)(1994-10#1)
the channel inactivation##2##3##(1993-8#1)(2008-8#1)
the channel is##4##3##(1990-11#1)(2006-10#1)(2008-2#1)(2009-11#1)
the channel models##4##3##(2008-3#4)
the channel molecule by the agonist##2##6##(2012-2#2)
the channel pore##3##3##(1995-1#1)(2006-10#2)
the channel properties of##2##4##(1994-9#1)(2008-8#1)
the channel protein##4##3##(1992-11#1)(1993-12#1)(1994-9#1)(1997-4#1)
the channel to##3##3##(1990-11#1)(1995-3#1)(2008-8#1)
the channel wall##2##3##(2009-11#1)(2010-8#1)
the channel walls##6##3##(2006-12#1)(2007-9#1)(2008-12#2)(2008-5#1)(2010-12#1)
the channel waveguide##2##3##(2007-12#1)(2008-2#1)
the channel##119##2##(1990-11#4)(1990-8#1)(1991-3#2)(1991-9#3)(1992-11#2)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-5#2)(1994-9#3)(1995-1#1)(1995-10#3)(1995-3#1)(1995-5#2)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-2#2)(1997-4#1)(2005-11#2)(2005-7#1)(2006-10#8)(2006-12#2)(2006-4#2)(2007-11#1)(2007-12#4)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-2#10)(2008-3#8)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#10)(2009-11#3)(2010-12#1)(2010-8#1)(2011-1#1)(2012-1#2)(2012-2#2)
the channel-forming##3##2##(1990-11#1)(1990-2#1)(1996-5#1)
the channels and##3##3##(1991-12#1)(2008-10#1)(2008-8#1)
the channels have##2##3##(1995-6#1)(2007-12#1)
the channels of##3##3##(2008-3#2)(2010-4#1)
the channels were##2##3##(1994-11#1)(2008-7#1)
the channels##28##2##(1991-12#2)(1992-7#2)(1994-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(2006-12#1)(2007-12#3)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#5)(2008-7#1)(2008-8#2)(2010-4#1)(2010-8#1)(2012-1#1)
the chaos of the##3##4##(2007-11#1)(2007-9#2)
the chaos of##4##3##(2007-11#1)(2007-9#2)(2012-2#1)
the chaos##5##2##(2007-11#1)(2007-9#2)(2010-8#1)(2012-2#1)
the chaotic oscillation##2##3##(2007-11#1)(2007-12#1)
the chaotic output of##2##4##(2007-11#1)(2007-12#1)
the chaotic##15##2##(1993-2#1)(2007-11#7)(2007-12#5)(2008-8#1)(2010-1#1)
the chaotropic##4##2##(1990-5#2)(1991-3#1)(1994-8#1)
the chaperone##6##2##(1996-4#1)(2008-11#2)(2008-7#2)(2012-2#1)
the chaperone-like activity of##2##4##(1995-5#2)
the chaperone-like##4##2##(1995-5#2)(1997-8#2)
the chaperonin##8##2##(1991-7#1)(1993-9#1)(1994-5#3)(1994-9#1)(1995-3#2)
the chaplain's role##2##3##(1994-12#1)(2010-2#1)
the chapter##3##2##(2007-12#1)(2007-5#1)(2008-4#1)
the character and##4##3##(1995-11#1)(2006-10#1)(2007-10#1)(2012-3#1)
the character of the##8##4##(1996-5#1)(2005-10#1)(2006-9#1)(2007-8#1)(2008-3#2)(2008-9#1)(2013-7#1)
the character of##15##3##(1991-8#1)(1994-3#1)(1996-5#1)(1997-7#1)(2005-10#1)(2006-9#1)(2007-3#1)(2007-8#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2012-2#1)(2013-7#1)
the character##25##2##(1991-8#1)(1994-3#1)(1995-11#1)(1996-5#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
the characterisation and##5##3##(2007-8#1)(2008-10#2)(2008-5#1)(2012-2#1)
the characterisation of##19##3##(1990-12#1)(1993-11#1)(1995-3#1)(2007-2#1)(2008-10#8)(2008-11#2)(2008-4#1)(2008-8#1)(2012-11#2)(2012-2#1)
the characterisation##25##2##(1990-12#1)(1993-11#1)(1994-6#1)(1995-3#1)(2007-2#1)(2007-8#1)(2008-10#10)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2012-11#2)(2012-2#2)
the characteristic CT##3##3##(2008-1#1)(2009-9#1)(2012-2#1)
the characteristic and##2##3##(2005-6#1)(2010-10#1)
the characteristic appearance of##2##4##(1992-12#1)(2008-4#1)
the characteristic clinical##7##3##(2005-11#1)(2006-2#1)(2006-3#1)(2008-6#1)(2010-6#1)(2011-2#2)
the characteristic dimensions of##2##4##(2008-2#1)(2011-2#1)
the characteristic dyslipidemia in the metabolic syndrome X##2##8##(2008-3#2)
the characteristic features of a##2##5##(1990-11#1)(1997-6#1)
the characteristic features of the##4##5##(1990-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
the characteristic features of##13##4##(1990-11#1)(1990-12#1)(1996-12#1)(1997-6#1)(2005-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#3)(2010-7#1)(2011-1#1)
the characteristic features##16##3##(1990-11#1)(1990-12#1)(1996-12#1)(1997-6#1)(2005-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2009-11#1)(2010-12#1)(2010-7#1)(2011-1#1)
the characteristic frequency##2##3##(2005-11#1)(2008-11#1)
the characteristic mass (m(o)) was of##2##6##(2008-10#2)
the characteristic mass of##2##4##(2008-10#2)
the characteristic mass##5##3##(2008-10#5)
the characteristic of negative phototropism when##2##6##(2008-9#2)
the characteristic of##8##3##(1990-6#1)(2008-2#1)(2008-9#4)(2011-2#1)(2013-8#1)
the characteristic time##2##3##(2007-11#1)(2007-12#1)
the characteristic##161##2##(1990-10#1)(1990-11#3)(1990-12#3)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#1)(1991-3#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-10#1)(1993-2#1)(1993-4#1)(1994-11#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-4#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#4)(2005-12#1)(2005-4#1)(2005-6#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-2#3)(2006-3#1)(2006-4#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#4)(2008-2#5)(2008-3#10)(2008-4#4)(2008-5#6)(2008-6#3)(2008-7#2)(2008-9#5)(2009-11#1)(2009-12#1)(2009-2#2)(2009-9#1)(2010-10#2)(2010-12#1)(2010-5#2)(2010-6#2)(2010-7#2)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#5)
the characteristics and management of postmenopausal women##2##7##(2011-1#2)
the characteristics and##11##3##(1995-8#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2010-11#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-8#1)
the characteristics of a##12##4##(1990-11#2)(1992-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2013-1#1)
the characteristics of an##4##4##(1994-8#1)(2006-1#1)(2008-3#1)(2008-5#1)
the characteristics of different##2##4##(2008-7#1)(2012-1#1)
the characteristics of each##5##4##(1991-12#1)(2006-8#1)(2008-3#2)(2010-8#1)
the characteristics of human##2##4##(2008-9#1)(2011-1#1)
the characteristics of male##2##4##(1997-7#1)(2009-5#1)
the characteristics of several##2##4##(2008-3#1)(2008-9#1)
the characteristics of the system##2##5##(2007-11#1)(2008-2#1)
the characteristics of the##82##4##(1992-12#1)(1992-5#1)(1993-10#1)(1993-12#2)(1993-6#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-9#3)(1997-7#1)(1997-8#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-4#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-2#9)(2008-3#6)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#2)
the characteristics of their##2##4##(2006-7#1)(2013-1#1)
the characteristics of therapy in medical##2##6##(2006-6#2)
the characteristics of these##4##4##(1994-12#1)(2006-12#1)(2008-2#1)(2011-12#1)
the characteristics of this##7##4##(1990-3#1)(2005-7#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-12#1)
the characteristics of which##2##4##(1991-6#1)(1994-2#1)
the characteristics of##209##3##(1990-11#3)(1990-3#1)(1990-5#1)(1991-12#2)(1991-5#1)(1991-6#2)(1991-7#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-10#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-7#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-9#3)(1997-3#1)(1997-7#3)(1997-8#1)(2004-11#2)(2004-12#1)(2005-10#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#2)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#7)(2007-12#6)(2007-2#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#8)(2008-12#1)(2008-2#15)(2008-3#15)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#6)(2009-12#2)(2009-5#2)(2009-6#1)(2009-7#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#3)
the characteristics that##8##3##(1996-3#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2011-2#1)
the characteristics##237##2##(1990-11#3)(1990-3#1)(1990-5#1)(1991-12#2)(1991-5#1)(1991-6#2)(1991-7#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-10#1)(1993-12#2)(1993-3#1)(1993-6#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-7#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#3)(1997-3#1)(1997-7#3)(1997-8#1)(2004-11#2)(2004-12#1)(2005-10#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#7)(2007-12#9)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#13)(2008-11#8)(2008-12#1)(2008-2#15)(2008-3#18)(2008-4#5)(2008-5#6)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#6)(2009-12#2)(2009-5#2)(2009-6#1)(2009-7#2)(2010-11#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#6)(2011-12#1)(2011-2#8)(2011-3#1)(2012-1#3)(2012-11#2)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#4)
the characterization and identification of##2##5##(2008-7#1)(2008-9#1)
the characterization and the##2##4##(2008-3#2)
the characterization and##15##3##(1993-5#1)(2005-8#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-12#1)(2011-12#1)
the characterization of a new##2##5##(1996-9#1)(2008-10#1)
the characterization of a##6##4##(1990-12#1)(1996-9#1)(1997-4#1)(2008-10#1)(2009-7#1)(2012-3#1)
the characterization of an##2##4##(1994-2#1)(2009-4#1)
the characterization of biological##2##4##(2008-3#1)(2011-12#1)
the characterization of both##2##4##(1996-5#1)(2008-10#1)
the characterization of materials##2##4##(2008-10#2)
the characterization of optical##3##4##(2008-2#2)(2008-3#1)
the characterization of patterns of##2##5##(2006-10#1)(2008-2#1)
the characterization of recombinant##3##4##(1995-6#1)(2008-4#2)
the characterization of the##26##4##(1990-6#1)(1991-2#1)(1991-5#2)(1992-2#1)(1992-9#1)(1994-3#1)(1994-5#1)(1995-8#2)(1996-10#1)(1996-2#1)(2005-11#1)(2006-5#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2010-4#1)(2011-1#3)(2013-7#1)
the characterization of these##2##4##(2007-1#1)(2008-8#1)
the characterization of this##3##4##(1994-3#1)(1995-3#1)(2008-10#1)
the characterization of two##3##4##(1991-9#1)(2006-10#1)(2011-1#1)
the characterization of##120##3##(1990-11#1)(1990-12#1)(1990-6#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#2)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#1)(1995-3#2)(1995-6#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-2#1)(1996-5#3)(1996-9#1)(1997-1#1)(1997-4#1)(2005-11#2)(2006-10#2)(2006-12#1)(2006-5#2)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#3)(2008-2#6)(2008-3#6)(2008-4#7)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#6)(2011-12#2)(2012-3#1)(2013-7#1)
the characterization##140##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#2)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#1)(1995-3#2)(1995-6#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-2#1)(1996-5#3)(1996-9#1)(1997-1#1)(1997-4#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-12#1)(2006-5#2)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#6)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#3)(2008-2#7)(2008-3#10)(2008-4#8)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#2)(2009-4#1)(2009-5#2)(2009-7#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#6)(2011-12#3)(2012-3#1)(2013-7#1)
the characters##6##2##(1997-1#1)(2007-5#1)(2008-11#1)(2011-2#1)(2013-8#2)
the charge and##3##3##(1991-4#1)(1994-9#1)(2008-10#1)
the charge density##3##3##(1991-5#1)(2008-10#2)
the charge distribution##6##3##(1993-3#1)(1993-4#1)(1994-3#1)(1997-6#1)(2007-11#1)(2007-12#1)
the charge of the##4##4##(1994-9#1)(2008-10#1)(2008-7#1)(2012-1#1)
the charge of##7##3##(1994-9#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-1#1)(2013-1#1)
the charge on##3##3##(1992-3#1)(1992-8#1)(2005-11#1)
the charge separation##3##3##(1994-12#1)(2008-8#2)
the charge transfer##5##3##(1993-6#1)(2008-10#3)(2010-5#1)
the charge##60##2##(1991-4#1)(1991-5#2)(1991-9#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-3#2)(1993-4#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-9#2)(1995-2#2)(1995-5#2)(1996-1#1)(1996-11#2)(1997-1#1)(1997-4#1)(1997-6#1)(2005-11#3)(2006-8#1)(2007-11#3)(2007-12#1)(2008-10#14)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2010-5#1)(2012-1#1)(2013-1#1)
the charge-coupled device (CCD)##2##4##(2007-12#1)(2008-5#1)
the charge-coupled device##3##3##(2007-12#1)(2008-5#1)(2012-2#1)
the charge-solvated structure##3##3##(2006-2#3)
the charge-solvated##5##2##(2006-2#5)
the charge-transfer##4##2##(1993-6#1)(2007-8#1)(2008-10#2)
the charged groups##2##3##(2005-11#1)(2006-10#1)
the charged residues##2##3##(1990-8#1)(1994-9#1)
the charged##22##2##(1990-4#1)(1990-8#2)(1991-11#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-11#1)(1994-8#1)(1994-9#1)(1996-11#1)(2005-11#2)(2006-10#4)(2007-8#1)(2008-10#1)(2008-11#1)(2009-12#1)(2010-4#1)
the charges of##3##3##(1990-7#1)(2007-11#1)(2008-10#1)
the charges##9##2##(1990-7#1)(1991-3#1)(1992-12#1)(1992-8#1)(1993-5#1)(2005-11#1)(2007-11#1)(2007-9#1)(2008-10#1)
the charging##5##2##(2006-12#1)(2007-11#2)(2008-10#1)(2008-8#1)
the charts of##3##3##(1990-12#1)(1995-2#1)(2007-10#1)
the charts##7##2##(1990-12#1)(1995-2#1)(1997-3#1)(2007-10#1)(2007-3#1)(2013-1#2)
the cheapest##2##2##(1993-11#1)(2008-10#1)
the check##2##2##(1994-3#1)(2008-12#1)
the checkerboard##2##2##(2007-7#1)(2009-6#1)
the checklist##2##2##(2005-8#1)(2007-3#1)
the checkpoint##5##2##(1997-6#5)
the cheek and the##2##4##(2008-5#1)(2010-11#1)
the cheek of##2##3##(2008-5#2)
the cheek##19##2##(1995-9#1)(2008-4#2)(2008-5#14)(2009-9#1)(2010-11#1)
the cheeks##5##2##(2007-7#1)(2007-8#1)(2008-5#3)
the chelate##9##2##(1995-8#1)(2008-10#7)(2008-4#1)
the chelate-modified Fenton reaction##2##4##(2010-4#2)
the chelates##2##2##(2005-11#1)(2008-10#1)
the chelating 1##2##3##(1996-2#1)(2008-5#1)
the chelating agent-metal##2##3##(2008-10#2)
the chelating agents##2##3##(1994-5#1)(2008-3#1)
the chelating fiber##3##3##(2008-10#3)
the chelating sites##3##3##(2008-10#3)
the chelating##25##2##(1994-5#1)(1996-2#2)(2008-10#16)(2008-3#4)(2008-5#2)
the chelation of##2##3##(2008-10#2)
the chelation##3##2##(2008-10#2)(2008-3#1)
the chelator##4##2##(1992-12#1)(1996-8#1)(2008-10#2)
the chemical analysis##4##3##(2008-10#3)(2013-1#1)
the chemical and biological diversity of##2##6##(2008-8#2)
the chemical and biological##3##4##(1994-12#1)(2008-8#2)
the chemical and pharmaceutical industries##3##5##(2008-10#1)(2008-9#2)
the chemical and physical##5##4##(1997-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2010-7#1)
the chemical and##22##3##(1990-7#1)(1994-11#1)(1994-12#1)(1997-5#1)(2007-11#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2010-5#1)(2010-7#1)
the chemical availability##2##3##(2008-10#2)
the chemical characteristics of##2##4##(2008-10#2)
the chemical composition and##2##4##(2008-7#1)(2012-2#1)
the chemical composition of the##11##5##(1991-5#1)(1994-12#1)(2007-1#1)(2008-11#1)(2008-3#2)(2008-5#1)(2010-4#2)(2011-1#1)(2013-8#1)
the chemical composition of these##2##5##(2006-12#2)
the chemical composition of##23##4##(1991-5#1)(1994-12#1)(2004-9#1)(2006-12#2)(2006-5#1)(2007-1#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2009-7#1)(2010-4#2)(2010-7#1)(2011-1#2)(2013-1#1)(2013-7#1)(2013-8#1)
the chemical composition##28##3##(1991-12#1)(1991-5#1)(1994-12#1)(2004-9#1)(2006-12#2)(2006-5#1)(2007-1#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2009-7#1)(2010-4#3)(2010-7#1)(2011-1#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
the chemical compositions of the##2##5##(2005-11#1)(2006-8#1)
the chemical compositions##3##3##(2005-11#1)(2006-8#1)(2007-11#1)
the chemical constituents from the##4##5##(2008-10#1)(2011-1#3)
the chemical constituents from##5##4##(2008-10#1)(2011-1#4)
the chemical constituents of##3##4##(2008-11#1)(2011-1#1)(2012-2#1)
the chemical constituents##11##3##(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#6)(2012-2#1)(2013-8#1)
the chemical context (pH)##2##4##(2008-10#2)
the chemical effect of direct current arc plasma##2##8##(2013-8#2)
the chemical energy##3##3##(1993-12#1)(2009-12#1)(2010-8#1)
the chemical environment and##2##4##(2010-11#1)(2012-2#1)
the chemical environment##4##3##(2008-10#2)(2010-11#1)(2012-2#1)
the chemical equilibrium##2##3##(2006-12#1)(2008-10#1)
the chemical form##2##3##(2008-10#1)(2008-3#1)
the chemical inducer##2##3##(2008-10#2)
the chemical industry##5##3##(1994-6#1)(2006-12#1)(2006-5#1)(2008-11#1)(2008-6#1)
the chemical information##2##3##(2013-8#2)
the chemical interaction between##2##4##(2010-4#1)(2010-7#1)
the chemical markers##2##3##(2012-3#2)
the chemical master##2##3##(2006-10#1)(2010-10#1)
the chemical model##4##3##(2005-11#2)(2008-10#2)
the chemical modification##4##3##(1995-6#1)(2005-4#1)(2008-10#1)(2008-3#1)
the chemical modifier##4##3##(2008-10#4)
the chemical nature of the lesions##2##6##(2008-11#2)
the chemical nature of the##5##5##(1992-11#1)(2006-10#1)(2008-11#2)(2010-4#1)
the chemical nature of##8##4##(1990-4#1)(1992-11#1)(1995-5#1)(2006-10#1)(2008-11#2)(2008-6#1)(2010-4#1)
the chemical nuclease##2##3##(2008-3#2)
the chemical potential of##2##4##(2008-10#1)(2011-1#1)
the chemical potential##3##3##(2008-10#1)(2009-2#1)(2011-1#1)
the chemical properties of the##2##5##(1992-6#1)(1997-2#1)
the chemical properties of##7##4##(1990-7#1)(1992-6#2)(1997-2#1)(2007-9#1)(2008-10#2)
the chemical reaction##6##3##(2006-12#1)(2008-10#5)
the chemical reactions##3##3##(2006-12#1)(2008-10#1)(2011-1#1)
the chemical reduction##2##3##(2008-6#1)(2012-2#1)
the chemical shift data##2##4##(1995-1#2)
the chemical shift of some##2##5##(1993-11#1)(2008-10#1)
the chemical shift of the##3##5##(1990-7#1)(1991-1#1)(2008-10#1)
the chemical shift of##5##4##(1990-7#1)(1991-1#1)(1993-11#1)(2008-10#2)
the chemical shift##13##3##(1990-7#1)(1991-1#1)(1992-4#1)(1993-11#2)(1994-5#1)(1995-1#2)(1995-3#1)(2006-1#1)(2008-10#3)
the chemical shifts of the##2##5##(1991-7#1)(2009-3#1)
the chemical shifts of##4##4##(1991-7#1)(1991-8#1)(1995-8#1)(2009-3#1)
the chemical shifts##6##3##(1991-5#1)(1991-7#1)(1991-8#1)(1992-4#1)(1995-8#1)(2009-3#1)
the chemical speciation##2##3##(2008-10#2)
the chemical species##4##3##(2008-10#3)(2008-3#1)
the chemical stability of composites##2##5##(2008-5#2)
the chemical stability of##4##4##(2007-8#1)(2008-10#1)(2008-5#2)
the chemical stability##5##3##(2007-8#1)(2008-10#2)(2008-5#2)
the chemical step##5##3##(1991-7#3)(1993-6#1)(1995-10#1)
the chemical structure of the surfactant##2##6##(1991-2#1)(2008-5#1)
the chemical structure of the##13##5##(1991-2#1)(1992-5#1)(1997-4#1)(2005-3#1)(2005-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2010-4#1)(2011-1#1)(2012-12#1)
the chemical structure of this##2##5##(1994-11#1)(1996-1#1)
the chemical structure of##17##4##(1991-2#1)(1992-5#1)(1994-11#1)(1996-1#1)(1997-4#1)(2005-3#1)(2005-4#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-10#1)(2010-4#1)(2011-1#1)(2012-12#1)
the chemical structure##24##3##(1990-4#1)(1991-2#1)(1991-6#2)(1992-5#1)(1994-11#1)(1994-7#1)(1995-11#1)(1996-1#1)(1997-4#1)(2005-3#1)(2005-4#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-10#1)(2010-4#2)(2011-1#1)(2012-12#1)(2012-3#1)
the chemical structures of##6##4##(1996-12#1)(1997-3#2)(2005-11#1)(2007-8#1)(2008-10#1)
the chemical structures##7##3##(1996-12#1)(1997-3#2)(2005-11#1)(2007-10#1)(2007-8#1)(2008-10#1)
the chemical synthesis of##7##4##(1990-2#1)(1992-3#1)(1993-11#1)(1995-7#1)(1995-8#1)(2008-4#2)
the chemical variables##3##3##(2008-10#3)
the chemical warfare agent##3##4##(2006-7#1)(2008-11#2)
the chemical##338##2##(1990-12#1)(1990-2#1)(1990-4#2)(1990-7#3)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#2)(1991-7#4)(1991-8#1)(1992-11#1)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#4)(1992-7#1)(1993-11#3)(1993-12#2)(1993-2#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#3)(1996-1#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(2004-4#1)(2004-9#1)(2005-11#6)(2005-3#1)(2005-4#3)(2006-1#1)(2006-10#3)(2006-12#8)(2006-3#1)(2006-5#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-10#85)(2008-11#9)(2008-12#1)(2008-2#6)(2008-3#15)(2008-4#4)(2008-5#9)(2008-6#4)(2008-7#4)(2008-8#4)(2008-9#7)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-4#7)(2010-5#2)(2010-7#3)(2010-8#1)(2011-1#11)(2011-2#2)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#2)(2013-7#3)(2013-8#9)
the chemical-physical##2##2##(2008-2#1)(2013-7#1)
the chemically modified##4##3##(1990-12#1)(1994-8#1)(2008-10#2)
the chemically synthesized##2##3##(1990-5#1)(1994-5#1)
the chemically##9##2##(1990-12#1)(1990-5#1)(1991-9#1)(1994-5#1)(1994-8#2)(2008-10#2)(2008-2#1)
the chemicals as##2##3##(1995-6#1)(2013-1#1)
the chemicals##11##2##(1990-9#1)(1994-6#1)(1995-6#2)(1996-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#1)
the chemiluminescence (CL) intensity##2##4##(2008-10#2)
the chemiluminescence (CL)##8##3##(2008-10#7)(2010-4#1)
the chemiluminescence determination of##2##4##(2008-10#2)
the chemiluminescence emission##3##3##(2008-10#3)
the chemiluminescence intensity##4##3##(2007-8#1)(2008-10#3)
the chemiluminescence produced##2##3##(2008-10#2)
the chemiluminescence reaction##5##3##(2008-10#5)
the chemiluminescence##43##2##(1990-2#1)(1991-5#1)(1992-6#2)(2007-8#2)(2008-10#35)(2010-4#1)(2012-1#1)
the chemiluminescent behaviour of phenols and polyphenols##2##7##(2008-10#2)
the chemiluminescent behaviour of##3##4##(2008-10#3)
the chemiluminescent##9##2##(2008-10#9)
the chemiluminometric##3##2##(2008-10#3)
the chemistry of the##2##4##(2008-10#1)(2008-11#1)
the chemistry of##12##3##(1992-6#1)(1993-12#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-2#1)(2011-1#1)(2012-12#1)(2013-1#2)
the chemistry or##2##3##(2006-8#1)(2008-3#1)
the chemistry required for##2##4##(1995-11#1)(2013-1#1)
the chemistry##20##2##(1992-6#1)(1993-12#1)(1995-11#1)(1996-8#1)(2006-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#2)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#3)
the chemo-enzymatic##2##2##(2008-5#1)(2011-2#1)
the chemokine receptor##2##3##(2008-1#1)(2011-2#1)
the chemokine##19##2##(1994-3#1)(1994-9#1)(2005-7#3)(2008-1#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-8#2)(2009-12#1)(2010-11#1)(2011-2#2)(2012-12#1)(2013-1#1)
the chemokines##2##2##(1994-3#1)(2008-5#1)
the chemometric approach##3##3##(2008-10#3)
the chemometric treatment##2##3##(2008-10#1)(2012-12#1)
the chemometric##11##2##(2008-10#7)(2008-3#2)(2010-11#1)(2012-12#1)
the chemoprevention##3##2##(1995-9#1)(1996-12#1)(2007-4#1)
the chemoradiotherapy##2##2##(2007-8#1)(2012-1#1)
the chemoresistance##2##2##(2010-3#1)(2011-2#1)
the chemosensory##4##2##(1991-2#1)(1992-8#2)(2007-12#1)
the chemostat##4##2##(2008-6#1)(2008-7#3)
the chemotactic activity##5##3##(1991-10#1)(1991-3#1)(1991-8#1)(1992-7#2)
the chemotactic peptide##4##3##(1990-7#1)(1992-1#1)(1992-12#1)(1997-8#1)
the chemotactic response##2##3##(1997-3#1)(2006-10#1)
the chemotactic##17##2##(1990-7#1)(1990-9#1)(1991-10#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-7#2)(1993-11#1)(1994-9#1)(1995-8#2)(1997-3#1)(1997-8#1)(2006-10#1)
the chemotaxis of##2##3##(1993-6#2)
the chemotaxis##6##2##(1991-2#1)(1993-6#2)(1994-8#2)(2006-10#1)
the chemotherapeutic drug##2##3##(2008-7#1)(2012-3#1)
the chemotherapeutic##12##2##(1991-6#1)(1992-10#1)(1995-5#1)(2006-10#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-3#1)(2013-1#1)
the chemotherapy group##3##3##(1991-8#1)(2008-6#2)
the chemotherapy of##10##3##(1990-11#1)(1990-5#2)(1990-9#1)(2005-8#1)(2005-9#2)(2006-10#1)(2008-2#1)(2008-7#1)
the chemotherapy##30##2##(1990-11#1)(1990-5#2)(1990-9#2)(1991-12#1)(1991-3#1)(1991-8#2)(1992-1#1)(2005-11#2)(2005-8#1)(2005-9#2)(2006-10#1)(2006-6#1)(2008-11#1)(2008-2#1)(2008-6#2)(2008-7#4)(2008-8#2)(2009-12#1)(2010-3#1)(2012-12#1)
the chemotherapy-induced##2##2##(2008-11#1)(2012-1#1)
the chest CT##2##3##(2012-12#1)(2013-1#1)
the chest X-ray##6##3##(2005-11#1)(2007-10#1)(2007-7#1)(2008-4#1)(2013-1#2)
the chest and abdomen##4##4##(2006-10#1)(2006-11#1)(2007-6#1)(2010-8#1)
the chest and##12##3##(2006-10#1)(2006-11#1)(2007-11#1)(2007-6#1)(2007-8#2)(2010-6#1)(2010-8#1)(2012-12#1)(2012-2#3)
the chest cavity##2##3##(2006-6#1)(2008-5#1)
the chest pain center##4##4##(2008-3#4)
the chest pain##5##3##(1996-3#1)(2008-3#4)
the chest radiograph##6##3##(2005-11#1)(2005-8#1)(2006-10#1)(2007-3#1)(2011-1#1)(2013-1#1)
the chest wall and##4##4##(1994-10#1)(2007-8#1)(2010-6#1)(2012-2#1)
the chest wall is a rare##2##6##(2007-8#2)
the chest wall is##4##4##(2007-8#4)
the chest wall##41##3##(1991-12#1)(1992-10#1)(1992-2#1)(1994-10#1)(2004-1#1)(2007-8#13)(2008-5#1)(2008-6#5)(2009-1#1)(2009-3#1)(2010-6#1)(2010-8#1)(2012-2#11)(2013-1#2)
the chest##112##2##(1990-5#1)(1990-6#1)(1991-12#2)(1991-9#1)(1992-10#1)(1992-2#1)(1994-10#1)(1994-2#1)(1995-8#1)(1996-3#1)(1996-6#1)(2004-1#1)(2005-11#3)(2005-12#1)(2005-8#1)(2006-10#3)(2006-11#5)(2006-6#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#19)(2008-1#1)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#6)(2008-7#1)(2009-1#1)(2009-2#1)(2009-3#1)(2010-12#2)(2010-2#1)(2010-6#2)(2010-8#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#14)(2013-1#8)(2013-7#1)
the chestnut blight fungus##4##4##(2008-10#3)(2008-9#1)
the chestnut blight##5##3##(2008-10#4)(2008-9#1)
the chewing##2##2##(2008-1#1)(2011-2#1)
the chi 1##2##3##(1992-6#2)
the chi##7##2##(1992-6#2)(1993-6#1)(1995-10#1)(2006-10#1)(2007-11#1)(2009-7#1)
the chi((2))##2##2##(2007-12#1)(2008-2#1)
the chi((3))##2##2##(2007-12#1)(2008-3#1)
the chi(3)##2##2##(2008-3#2)
the chi-square test##5##3##(2007-8#1)(2008-12#1)(2010-9#1)(2011-1#1)(2013-8#1)
the chi-square##7##2##(1996-1#1)(2007-8#1)(2008-12#1)(2008-2#1)(2010-9#1)(2011-1#1)(2013-8#1)
the chick brain##4##3##(1991-7#2)(1995-11#1)(1997-6#1)
the chick embryo##14##3##(1991-3#2)(1994-5#1)(1996-12#1)(1996-5#1)(2003-11#1)(2006-11#3)(2006-4#2)(2008-1#2)(2008-11#1)
the chick##38##2##(1990-4#1)(1990-5#2)(1990-6#2)(1991-3#2)(1991-7#3)(1991-9#1)(1992-12#1)(1994-2#1)(1994-5#1)(1995-11#2)(1995-5#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-5#2)(1997-6#1)(1997-8#1)(2003-11#1)(2006-11#3)(2006-4#2)(2008-1#3)(2008-11#2)(2012-12#2)
the chicken H3 histone-encoding gene family##2##6##(1991-6#2)
the chicken T-cell receptor alpha chain constant region##2##8##(1997-9#2)
the chicken Z##3##3##(2008-5#2)(2010-3#1)
the chicken anaemia##2##3##(1991-3#1)(2008-5#1)
the chicken and##3##3##(1992-2#1)(1994-8#1)(1996-5#1)
the chicken anxI cDNA##2##4##(1993-8#2)
the chicken brain##5##3##(1995-3#3)(1996-4#2)
the chicken embryo model##2##4##(2008-12#2)
the chicken embryo related##2##4##(2007-6#2)
the chicken embryo##8##3##(1992-11#1)(1992-3#1)(2007-6#2)(2008-11#1)(2008-12#2)(2008-5#1)
the chicken genome##4##3##(1996-4#1)(2008-8#3)
the chicken homologue##2##3##(1994-12#1)(1995-8#1)
the chicken is##2##3##(2008-4#1)(2008-5#1)
the chicken skin##3##3##(2007-12#3)
the chicken spinal cord##3##4##(1994-11#2)(1996-12#1)
the chicken stomach##2##3##(2008-5#2)
the chicken transferrin receptor##2##4##(1991-6#2)
the chicken##120##2##(1990-4#1)(1990-8#1)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#5)(1991-8#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#6)(1993-8#4)(1993-9#1)(1994-11#2)(1994-12#3)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#3)(1995-3#3)(1995-8#1)(1995-9#1)(1996-10#2)(1996-12#1)(1996-4#4)(1996-5#3)(1997-1#1)(1997-3#3)(1997-4#2)(1997-6#2)(1997-7#1)(1997-9#6)(2005-9#2)(2006-11#1)(2007-12#3)(2007-6#2)(2008-11#3)(2008-12#2)(2008-4#2)(2008-5#17)(2008-7#3)(2008-8#4)(2010-12#1)(2010-3#1)(2013-1#1)(2013-8#1)
the chickens##10##2##(1997-6#2)(2008-5#6)(2013-8#2)
the chickpea##5##2##(2008-10#5)
the chicks##4##2##(2008-12#2)(2008-5#1)(2008-6#1)
the chief executive officer##2##4##(1990-12#1)(1994-1#1)
the chief##24##2##(1990-12#1)(1991-3#1)(1993-11#1)(1994-1#1)(1995-5#1)(1995-6#1)(1996-1#1)(1997-8#1)(2005-10#1)(2007-6#1)(2007-7#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#4)
the child and family##6##4##(2007-2#1)(2007-6#1)(2008-11#2)(2012-1#1)(2012-12#1)
the child and the##7##4##(2005-10#1)(2006-10#1)(2007-11#1)(2009-4#1)(2009-8#1)(2011-1#1)(2013-1#1)
the child and##24##3##(1995-5#1)(1996-2#1)(1996-7#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-2#2)(2007-6#1)(2008-11#2)(2008-12#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
the child but##2##3##(1995-5#1)(2006-10#1)
the child could##2##3##(1997-8#1)(2007-9#1)
the child from##4##3##(1991-6#1)(1995-5#2)(2010-7#1)
the child has a##2##4##(2005-11#1)(2010-3#1)
the child has##3##3##(2005-10#1)(2005-11#1)(2010-3#1)
the child in##4##3##(1990-10#1)(1995-5#1)(2007-2#1)(2010-6#1)
the child is##8##3##(1991-10#1)(1993-10#1)(2005-11#1)(2008-11#1)(2008-4#1)(2010-8#1)(2012-1#1)(2013-1#1)
the child poverty rate##2##4##(2008-11#2)
the child should be##2##4##(1990-2#1)(2006-4#1)
the child should##3##3##(1990-2#1)(2006-4#1)(2010-2#1)
the child spine##2##3##(2006-11#1)(2007-4#1)
the child to##8##3##(1991-7#1)(1995-5#1)(2004-12#1)(2005-8#1)(2009-4#1)(2010-3#1)(2011-2#1)(2012-3#1)
the child was##9##3##(1990-12#1)(1993-12#1)(2005-8#1)(2006-11#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-9#1)(2010-6#1)
the child welfare system##2##4##(2008-4#2)
the child who##7##3##(2005-8#1)(2006-5#5)(2007-8#1)
the child with##12##3##(1990-10#1)(1993-1#1)(2005-9#1)(2006-10#2)(2006-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2010-9#1)(2013-8#1)
the child##206##2##(1990-10#2)(1990-12#4)(1990-2#1)(1990-3#1)(1990-8#1)(1991-10#1)(1991-6#3)(1991-7#4)(1992-12#1)(1992-4#1)(1992-5#1)(1992-9#2)(1993-1#1)(1993-10#2)(1993-12#3)(1993-3#1)(1994-12#1)(1994-6#1)(1995-5#11)(1996-2#2)(1996-5#1)(1996-7#1)(1997-2#2)(1997-8#1)(2004-12#2)(2005-10#2)(2005-11#5)(2005-7#1)(2005-8#5)(2005-9#1)(2006-10#6)(2006-11#2)(2006-2#1)(2006-4#5)(2006-5#5)(2006-6#1)(2006-7#1)(2007-11#2)(2007-12#3)(2007-2#3)(2007-4#3)(2007-6#5)(2007-7#1)(2007-8#6)(2007-9#1)(2008-10#2)(2008-11#12)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-7#1)(2008-9#2)(2009-10#3)(2009-11#3)(2009-4#3)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#4)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#3)(2010-6#4)(2010-7#1)(2010-8#1)(2010-9#7)(2011-1#4)(2011-2#4)(2012-1#5)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#5)(2013-8#4)
the child's age##5##3##(2007-7#2)(2008-10#1)(2009-12#1)(2013-8#1)
the child's illness##3##3##(2005-10#2)(2008-12#1)
the child's parent##2##3##(1993-2#1)(2008-11#1)
the child's physical##2##3##(2007-2#1)(2010-9#1)
the child's testimony##4##3##(2011-2#4)
the child's##58##2##(1990-10#1)(1990-12#2)(1991-12#1)(1991-7#1)(1992-1#2)(1992-2#2)(1993-2#4)(1995-1#1)(1995-12#1)(2005-10#3)(2005-8#1)(2005-9#1)(2006-10#1)(2006-3#1)(2006-4#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-2#2)(2013-8#3)
the childbearing and##2##3##(1992-2#1)(2007-2#1)
the childbearing##12##2##(1992-2#1)(1993-6#1)(2006-5#1)(2007-2#3)(2008-4#1)(2013-1#2)(2013-8#3)
the childbirth educator to##2##4##(2007-2#2)
the childbirth educator##6##3##(2007-2#6)
the childbirth experience##3##3##(2007-2#2)(2013-1#1)
the childbirth##12##2##(2007-2#10)(2012-2#1)(2013-1#1)
the childhood obesity epidemic##2##4##(2012-2#2)
the childhood obesity##3##3##(2008-12#1)(2012-2#2)
the childhood##12##2##(1993-11#1)(1994-11#1)(1995-5#1)(1996-3#1)(2007-8#2)(2008-12#1)(2008-7#1)(2011-1#1)(2012-2#2)(2013-1#1)
the children and their parents##2##5##(1991-2#1)(1995-6#1)
the children and their##3##4##(1991-2#1)(1995-6#1)(2007-12#1)
the children and##11##3##(1991-2#1)(1992-7#1)(1995-6#1)(1997-1#1)(2007-12#1)(2008-11#1)(2011-11#1)(2011-12#1)(2012-12#2)(2013-1#1)
the children at##4##3##(1994-1#1)(2007-7#1)(2008-2#1)(2012-2#1)
the children did not##2##4##(1993-5#1)(2010-2#1)
the children from##2##3##(2007-11#1)(2012-12#1)
the children had been##2##4##(2006-10#1)(2008-9#1)
the children had##10##3##(1991-12#1)(1993-1#1)(1997-4#1)(2006-10#2)(2006-2#1)(2007-7#1)(2008-9#1)(2012-12#1)(2012-2#1)
the children in the##3##4##(2008-3#1)(2008-4#1)(2012-2#1)
the children in##5##3##(1992-2#1)(2007-8#1)(2008-3#1)(2008-4#1)(2012-2#1)
the children included in the study##2##6##(2012-12#1)(2013-1#1)
the children of the##3##4##(2009-1#1)(2013-1#2)
the children of##9##3##(1994-4#1)(2007-3#1)(2009-1#1)(2009-11#1)(2010-9#1)(2013-1#3)(2013-8#1)
the children to##2##3##(2010-8#1)(2012-2#1)
the children was##2##3##(2006-10#1)(2006-4#1)
the children were##21##3##(1990-12#2)(1993-6#1)(1995-6#1)(1996-1#1)(1997-5#1)(2006-10#3)(2006-2#1)(2006-3#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-2#1)(2008-9#1)(2012-12#2)(2013-8#2)
the children who received##2##4##(2010-4#1)(2011-1#1)
the children who were##4##4##(1994-6#1)(2006-10#3)
the children who##7##3##(1994-6#1)(2006-10#3)(2010-4#1)(2011-1#1)(2012-2#1)
the children with low##2##4##(2010-8#1)(2011-2#1)
the children with##25##3##(1992-7#1)(1995-5#1)(1996-1#3)(2005-10#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-2#2)(2008-4#2)(2010-8#2)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
the children##176##2##(1990-11#1)(1990-12#5)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#2)(1991-8#2)(1992-2#1)(1992-3#1)(1992-7#2)(1993-1#1)(1993-5#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-4#1)(1994-6#2)(1995-5#3)(1995-6#2)(1996-1#4)(1996-12#1)(1996-3#1)(1996-9#1)(1997-1#2)(1997-4#2)(1997-5#2)(1997-6#1)(2004-12#1)(2004-3#1)(2005-10#2)(2005-8#1)(2006-10#13)(2006-2#2)(2006-3#3)(2006-4#2)(2006-8#2)(2007-11#3)(2007-12#2)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#7)(2007-8#2)(2008-1#3)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#3)(2008-8#1)(2008-9#11)(2009-1#1)(2009-11#1)(2009-2#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#4)(2010-9#2)(2011-1#4)(2011-11#1)(2011-12#2)(2011-2#4)(2012-12#9)(2012-2#7)(2012-3#1)(2013-1#6)(2013-8#4)
the children's hospital##2##3##(2006-7#1)(2009-8#1)
the children's speech##2##3##(2008-9#1)(2011-1#1)
the children's usual prehospital##2##4##(1991-2#2)
the children's##32##2##(1990-12#1)(1990-2#1)(1991-10#1)(1991-2#3)(1991-6#1)(1993-1#1)(1993-6#2)(1994-6#1)(1995-12#1)(1995-6#2)(1996-1#1)(1996-12#1)(2005-10#1)(2005-9#1)(2006-2#1)(2006-3#1)(2006-7#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-5#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#2)
the chimaera##3##2##(1994-6#2)(1995-12#1)
the chimaeric##2##2##(1994-6#1)(1994-9#1)
the chimeric antibody##2##3##(1996-11#1)(2006-10#1)
the chimeric virus##2##3##(1995-8#2)
the chimeric##23##2##(1991-5#1)(1991-7#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-8#2)(1996-11#1)(1997-2#3)(1997-3#1)(2006-10#1)(2006-3#1)(2007-12#1)(2008-1#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-8#1)
the chimpanzee##3##2##(1997-4#2)(1997-6#1)
the chin and##2##3##(2007-5#1)(2009-1#1)
the chin##5##2##(2007-3#1)(2007-5#1)(2009-1#1)(2011-2#1)(2012-2#1)
the chin]##2##2##(1993-9#1)(2008-4#1)
the chip surface##2##3##(2008-10#1)(2010-1#1)
the chip##19##2##(2006-12#1)(2008-10#5)(2008-11#2)(2008-2#5)(2008-3#2)(2008-4#1)(2010-1#2)(2012-3#1)
the chips##4##2##(1994-1#1)(2008-2#1)(2008-3#2)
the chiral monolithic column##2##4##(2005-12#2)
the chiral recognition##3##3##(2008-10#3)
the chiral selector##4##3##(1996-5#1)(2008-10#2)(2013-1#1)
the chiral separation##2##3##(1996-5#1)(2008-10#1)
the chiral##30##2##(1995-2#1)(1995-6#2)(1996-5#2)(1997-2#1)(2005-12#2)(2006-12#1)(2007-11#3)(2008-10#13)(2008-5#1)(2008-9#1)(2009-5#1)(2010-4#1)(2013-1#1)
the chirality of the##3##4##(1997-2#1)(2008-5#1)(2008-7#1)
the chirality of##6##3##(1990-12#1)(1997-2#1)(2006-12#1)(2008-10#1)(2008-5#1)(2008-7#1)
the chirality##7##2##(1990-12#1)(1997-2#1)(2006-12#2)(2008-10#1)(2008-5#1)(2008-7#1)
the chiropractic profession embrace the doctrine of informed##2##8##(2009-8#2)
the chiropractic profession##5##3##(2007-6#3)(2009-8#2)
the chiropractic##8##2##(1992-9#1)(2007-11#1)(2007-6#4)(2009-8#2)
the chiropractors##2##2##(1992-9#1)(2007-6#1)
the chirp amplitude##2##3##(2008-2#2)
the chirp and the##3##4##(2007-11#1)(2007-12#2)
the chirp of##3##3##(2007-11#1)(2007-12#2)
the chirp##13##2##(2007-11#2)(2007-12#6)(2008-1#1)(2008-2#3)(2008-3#1)
the chit33 gene##2##3##(2008-10#2)
the chitin##5##2##(2007-12#1)(2008-10#2)(2008-7#1)(2009-8#1)
the chitinase##3##2##(2008-10#2)(2010-10#1)
the chitinous##2##2##(2007-12#1)(2008-7#1)
the chitobiase gene##2##3##(1992-10#2)
the chitosan##8##2##(2007-2#2)(2007-8#2)(2008-10#3)(2012-12#1)
the chloramphenicol acetyl transferase (CAT) gene##3##6##(1992-12#1)(1992-8#1)(1995-10#1)
the chloramphenicol acetyl transferase (CAT)##5##5##(1992-12#2)(1992-8#1)(1994-8#1)(1995-10#1)
the chloramphenicol acetyl transferase##6##4##(1992-12#2)(1992-8#1)(1994-8#1)(1995-10#1)(1995-5#1)
the chloramphenicol acetyltransferase (CAT) gene##5##5##(1990-12#1)(1992-5#1)(1992-6#1)(1994-9#1)(1997-8#1)
the chloramphenicol acetyltransferase (CAT) reporter gene##2##6##(1991-2#1)(1992-9#1)
the chloramphenicol acetyltransferase (CAT)##10##4##(1990-12#1)(1990-8#1)(1991-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-4#1)(1994-9#1)(1997-8#1)(2008-4#1)
the chloramphenicol acetyltransferase gene##3##4##(1991-2#1)(1995-3#1)(1996-8#1)
the chloramphenicol acetyltransferase reporter gene##2##5##(1995-2#1)(1996-5#1)
the chloramphenicol acetyltransferase##16##3##(1990-12#1)(1990-8#1)(1991-2#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-4#1)(1993-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-5#1)(1996-8#1)(1997-8#1)(2008-4#1)
the chloramphenicol##24##2##(1990-12#1)(1990-8#1)(1991-2#2)(1992-12#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-4#1)(1993-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-5#1)(1996-8#1)(1997-8#1)(2008-11#1)(2008-4#1)
the chloride channel##3##3##(1990-5#1)(1997-3#1)(2007-7#1)
the chloride conductance in##3##4##(1995-11#3)
the chloride##23##2##(1990-5#1)(1993-6#1)(1994-5#1)(1995-11#3)(1997-3#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-10#8)(2008-4#2)(2008-8#1)(2011-1#1)(2011-3#1)
the chlorinated##5##2##(2004-4#2)(2008-10#2)(2008-3#1)
the chlorination##3##2##(2008-10#2)(2008-9#1)
the chlorine concentration##3##3##(1992-11#2)(2008-10#1)
the chlorine##10##2##(1992-11#2)(1992-6#1)(1996-2#1)(1997-2#1)(2004-4#1)(2008-10#3)(2010-4#1)
the chloro and##2##3##(1990-3#1)(2008-5#1)
the chloroform extraction##2##3##(2008-10#2)
the chloroform##5##2##(1993-9#1)(2008-10#3)(2012-2#1)
the chlorophyll a/b-light harvesting complex II##2##6##(1994-12#2)
the chlorophyll##11##2##(1992-4#1)(1994-12#3)(1995-1#1)(1997-6#1)(2008-2#1)(2008-3#3)(2010-6#1)
the chlorophylls##2##2##(1994-8#1)(2008-10#1)
the chloroplast envelope membrane##2##4##(1995-2#1)(2009-10#1)
the chloroplast envelope##3##3##(1994-11#1)(1995-2#1)(2009-10#1)
the chloroplast genome##6##3##(1990-9#1)(1994-12#2)(1997-2#1)(2008-12#1)(2010-6#1)
the chloroplast##33##2##(1990-12#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-4#1)(1992-6#2)(1993-11#1)(1993-12#1)(1994-11#2)(1994-12#2)(1995-2#1)(1997-2#2)(2008-10#1)(2008-12#1)(2008-8#1)(2009-10#2)(2009-5#1)(2009-7#2)(2010-10#1)(2010-6#1)(2012-3#3)
the choice and duration of##2##5##(1990-6#1)(2013-1#1)
the choice and##6##3##(1990-6#1)(1997-4#1)(2008-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
the choice between these##2##4##(1991-10#1)(2012-3#1)
the choice between##8##3##(1990-3#1)(1991-10#1)(1993-2#1)(1995-12#1)(1995-5#1)(1995-8#1)(2011-12#1)(2012-3#1)
the choice is##2##3##(1992-12#1)(2009-8#1)
the choice of a particular##2##5##(1996-12#1)(2011-1#1)
the choice of a##8##4##(1992-10#1)(1995-5#1)(1996-12#1)(2006-12#1)(2007-11#1)(2008-9#1)(2010-3#1)(2011-1#1)
the choice of an##4##4##(1990-3#1)(2007-11#1)(2008-7#1)(2010-2#1)
the choice of anesthetic technique##2##5##(2006-10#1)(2007-8#1)
the choice of appropriate##2##4##(2008-10#1)(2008-6#1)
the choice of both##2##4##(2009-2#1)(2011-1#1)
the choice of contraceptive##2##4##(1996-11#1)(2008-3#1)
the choice of matrix##2##4##(2007-12#1)(2008-9#1)
the choice of operating##2##4##(2008-2#1)(2008-7#1)
the choice of operative##3##4##(2006-10#1)(2007-7#1)(2010-2#1)
the choice of strategy##2##4##(2006-10#1)(2007-8#1)
the choice of suitable target antigens becomes more challenging to design studies and to assess optimal efficacy of CAR##2##19##(2012-12#2)
the choice of suitable##3##4##(2009-11#1)(2012-12#2)
the choice of surgical##2##4##(2006-10#1)(2007-11#1)
the choice of the appropriate##3##5##(2008-9#1)(2009-9#1)(2011-2#1)
the choice of the best##4##5##(2007-5#1)(2008-10#1)(2008-3#1)(2011-2#1)
the choice of the treatment##2##5##(2012-12#1)(2013-8#1)
the choice of the##33##4##(1990-2#1)(1990-3#1)(1991-11#1)(1995-5#1)(1996-3#1)(1996-6#1)(1997-3#1)(2005-11#1)(2006-11#1)(2006-5#1)(2006-6#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-11#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#1)
the choice of treatment##5##4##(1991-3#1)(1991-6#1)(2005-12#1)(2010-12#1)(2011-2#1)
the choice of which##3##4##(2007-11#1)(2008-4#1)(2012-3#1)
the choice of##184##3##(1990-11#1)(1990-2#1)(1990-3#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-5#2)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#2)(1995-5#3)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-6#2)(1996-7#1)(1997-3#1)(1997-8#1)(2004-3#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-11#7)(2007-12#4)(2007-5#1)(2007-7#3)(2007-8#4)(2008-1#2)(2008-10#13)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#13)(2008-4#5)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#4)(2009-11#1)(2009-2#2)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#2)(2010-2#3)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#9)(2013-7#2)(2013-8#4)
the choice to##4##3##(1994-1#1)(2005-12#1)(2007-6#1)(2009-4#1)
the choice##221##2##(1990-11#1)(1990-2#1)(1990-3#3)(1990-6#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#2)(1992-12#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-5#2)(1993-9#1)(1994-1#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#3)(1995-5#4)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-6#2)(1996-7#1)(1997-3#2)(1997-4#1)(1997-8#1)(2004-3#1)(2005-11#1)(2005-12#2)(2005-8#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-11#7)(2007-12#4)(2007-2#1)(2007-5#3)(2007-6#2)(2007-7#3)(2007-8#4)(2008-1#2)(2008-10#17)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#13)(2008-4#5)(2008-5#6)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#4)(2009-11#1)(2009-2#2)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#3)(2010-12#2)(2010-2#3)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#5)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#12)(2013-7#2)(2013-8#4)
the choices of##4##3##(1991-12#1)(2008-8#1)(2009-8#1)(2012-12#1)
the choices##10##2##(1991-12#1)(1991-2#1)(1991-3#1)(1994-3#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-11#1)(2012-12#2)
the cholecystokinin##5##2##(1992-3#1)(1992-9#1)(1996-12#1)(1997-2#1)(2006-10#1)
the cholera to##2##3##(1992-6#2)
the cholera toxin B subunit (CTB)##2##6##(1997-7#1)(2006-12#1)
the cholera toxin B subunit##3##5##(1990-4#1)(1997-7#1)(2006-12#1)
the cholera toxin B##4##4##(1990-4#1)(1997-7#1)(2006-12#1)(2009-2#1)
the cholera##8##2##(1990-4#1)(1992-6#2)(1993-3#2)(1997-7#1)(2006-12#1)(2009-2#1)
the cholestasis##3##2##(1991-2#1)(1993-3#1)(2004-11#1)
the cholestatic##3##2##(1993-5#1)(2005-10#1)(2010-2#1)
the cholesterol biosynthetic##2##3##(1994-8#1)(1997-1#1)
the cholesterol content of##2##4##(1990-4#1)(2008-6#1)
the cholesterol content##3##3##(1990-4#1)(2008-10#1)(2008-6#1)
the cholesterol##24##2##(1990-2#1)(1990-4#1)(1992-6#2)(1993-3#2)(1994-8#1)(1994-9#1)(1997-1#3)(1997-2#1)(2005-11#1)(2005-9#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-5#1)(2008-10#4)(2008-4#1)(2008-6#1)
the cholesterol-fed rabbits with TTRF##2##5##(2005-12#2)
the cholesterol-fed rabbits##5##3##(1996-12#1)(2005-12#4)
the cholesterol-lowering effect of##2##4##(2004-11#1)(2005-9#1)
the cholesteryl ester transfer##2##4##(1996-4#2)
the cholesteryl ester##4##3##(1990-5#1)(1992-3#1)(1996-4#2)
the cholesteryl##6##2##(1990-5#2)(1992-3#1)(1996-4#2)(1996-5#1)
the choline acetyltransferase##2##3##(1993-4#1)(1996-6#1)
the choline and serine headgroups##2##5##(1990-7#2)
the choline and##3##3##(1990-7#2)(1997-1#1)
the choline function##2##3##(1990-3#2)
the choline##11##2##(1990-2#2)(1990-3#2)(1990-7#2)(1993-4#1)(1994-3#1)(1995-3#1)(1996-6#1)(1997-1#1)
the cholinergic agonist##3##3##(1990-3#1)(1990-7#1)(1993-3#1)
the cholinergic and GABAergic systems##2##5##(1996-6#2)
the cholinergic and##5##3##(1994-6#1)(1996-6#2)(1997-5#1)(2008-8#1)
the cholinergic antagonist##2##3##(1997-5#1)(2008-7#1)
the cholinergic deficit characteristic of Alzheimer's disease##2##7##(1992-3#1)(1992-8#1)
the cholinergic neurons of the nucleus basalis of Meynert##2##9##(2010-8#2)
the cholinergic neurons##3##3##(1997-6#1)(2010-8#2)
the cholinergic system##3##3##(1993-12#1)(1994-8#1)(2008-10#1)
the cholinergic##38##2##(1990-3#1)(1990-7#3)(1992-3#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-8#2)(1996-1#1)(1996-6#4)(1997-2#1)(1997-5#3)(1997-6#2)(1997-8#2)(2005-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-3#1)(2010-8#2)(2013-8#1)
the cholinesterase inhibitor##3##3##(1991-1#1)(1993-11#1)(2011-12#1)
the cholinesterase inhibitors##4##3##(1993-11#2)(2005-6#2)
the cholinesterase##8##2##(1991-1#1)(1992-4#1)(1993-11#3)(2005-6#2)(2011-12#1)
the chondral surface##2##3##(2007-7#1)(2011-2#1)
the chondral##4##2##(2007-11#1)(2007-7#1)(2008-5#1)(2011-2#1)
the chondrocyte##3##2##(1991-11#1)(1992-6#1)(2008-11#1)
the chondrocytes##6##2##(1993-12#1)(1994-11#1)(1994-12#1)(2007-11#2)(2008-7#1)
the chondrogenic potential of##2##4##(2007-11#2)
the chondrogenic##5##2##(1994-11#1)(2007-11#2)(2008-11#2)
the chondroitin sulfate##2##3##(1990-5#1)(2007-10#1)
the chopstick##2##2##(2011-2#2)
the chorda tympani##2##3##(1992-8#2)
the chorion of human term placenta##2##6##(2012-12#2)
the chorion s15 promoter##2##4##(1993-6#2)
the chorion##11##2##(1993-1#1)(1993-6#2)(2007-12#2)(2008-12#4)(2012-12#2)
the choroid and##2##3##(2007-11#1)(2009-4#1)
the choroid plexus and##3##4##(1993-12#1)(1994-10#1)(1996-12#1)
the choroid plexus of the lateral##2##6##(1996-3#2)
the choroid plexus of the##3##5##(1994-9#1)(1996-3#2)
the choroid plexus of##4##4##(1994-9#1)(1996-2#1)(1996-3#2)
the choroid plexus##29##3##(1992-8#1)(1993-12#2)(1994-10#3)(1994-12#1)(1994-9#1)(1996-12#4)(1996-2#2)(1996-3#5)(1996-5#4)(1997-5#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-12#1)
the choroid with##2##3##(2011-7#2)
the choroid##47##2##(1992-8#2)(1993-12#2)(1994-10#3)(1994-12#1)(1994-9#1)(1996-12#4)(1996-2#2)(1996-3#5)(1996-5#4)(1997-3#1)(1997-5#1)(1997-8#1)(2007-11#2)(2008-10#1)(2008-7#1)(2009-4#3)(2010-12#1)(2011-7#3)(2012-12#4)(2013-1#5)
the choroidal##2##2##(2006-4#1)(2009-4#1)
the choroids##3##2##(2009-2#3)
the chosen level of confidence##2##5##(2008-10#2)
the chosen##21##2##(1991-12#1)(1997-3#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#3)(2008-8#2)(2010-8#1)(2011-1#1)(2012-1#1)
the chromaffin##3##2##(1995-8#1)(1996-9#1)(2008-5#1)
the chromate anion##2##3##(2008-10#2)
the chromatic aberration##3##3##(2007-12#2)(2008-3#1)
the chromatic dispersion of the##2##5##(2007-11#1)(2008-2#1)
the chromatic dispersion of##4##4##(2007-11#1)(2007-12#2)(2008-2#1)
the chromatic##9##2##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#3)
the chromaticity coordinates##2##3##(2008-3#2)
the chromaticity of the scene illuminant##2##6##(2008-2#2)
the chromaticity thresholds##3##3##(2008-2#3)
the chromaticity##9##2##(2008-2#7)(2008-3#2)
the chromatin of##2##3##(1994-8#1)(2008-8#1)
the chromatin structure##4##3##(1992-3#1)(1997-2#1)(2011-2#1)(2012-1#1)
the chromatin texture##3##3##(2010-8#1)(2012-1#2)
the chromatin##26##2##(1991-2#1)(1992-3#1)(1992-9#1)(1994-5#1)(1994-8#1)(1995-11#1)(1996-11#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-8#1)(2011-2#1)(2012-1#3)(2012-3#1)(2013-1#1)
the chromatogram##7##2##(1990-12#1)(1990-6#1)(1991-5#1)(1996-9#1)(2008-10#3)
the chromatograms##5##2##(1996-9#1)(2007-8#1)(2008-10#3)
the chromatographic behavior of##6##4##(2004-12#1)(2008-10#4)(2012-1#1)
the chromatographic behavior##7##3##(1996-8#1)(2004-12#1)(2008-10#4)(2012-1#1)
the chromatographic behaviour of##2##4##(1996-5#1)(2007-8#1)
the chromatographic column##4##3##(1991-5#1)(2008-10#3)
the chromatographic conditions##8##3##(1990-8#1)(1992-2#1)(1996-8#2)(2005-12#1)(2008-10#2)(2013-7#1)
the chromatographic determination##3##3##(2008-10#3)
the chromatographic methods##3##3##(2008-10#2)(2010-4#1)
the chromatographic resolution##3##3##(1996-9#1)(2008-10#2)
the chromatographic response##2##3##(2008-10#2)
the chromatographic separation##4##3##(1992-2#1)(2008-10#2)(2013-8#1)
the chromatographic system##3##3##(1996-6#1)(2008-10#1)(2010-11#1)
the chromatographic##66##2##(1990-8#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-2#2)(1994-11#1)(1996-5#1)(1996-6#1)(1996-8#3)(1996-9#1)(2004-12#1)(2005-12#1)(2007-11#1)(2007-8#4)(2008-10#37)(2008-5#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-1#2)(2012-1#1)(2013-7#1)(2013-8#1)
the chromatography of##2##3##(2005-12#1)(2008-4#1)
the chromatography##9##2##(1991-12#1)(1992-1#1)(1993-2#1)(2005-12#1)(2008-10#2)(2008-4#2)(2010-7#1)
the chromatomembrane cell##3##3##(2008-10#3)
the chromatomembrane##5##2##(2008-10#5)
the chromium in DCG has##2##5##(2008-2#2)
the chromium isotope ratios was##2##5##(2008-10#2)
the chromium##13##2##(1995-6#1)(2008-10#7)(2008-2#5)
the chromium(VI) concentration##2##3##(2008-10#2)
the chromium(VI)##4##2##(2008-10#3)(2008-4#1)
the chromogen##3##2##(1991-3#1)(1991-8#1)(1994-2#1)
the chromogenic reaction of##2##4##(2008-10#2)
the chromogenic reaction##4##3##(2008-10#4)
the chromogenic reagent##5##3##(2008-10#5)
the chromogenic##12##2##(1990-2#1)(1997-2#1)(2007-8#1)(2008-10#9)
the chromogranins##2##2##(1991-2#1)(2010-11#1)
the chromoionophore##2##2##(2008-10#1)(2008-5#1)
the chromophore and the perturber##2##5##(1993-3#2)
the chromophore and##6##3##(1991-3#1)(1991-7#1)(1992-8#1)(1993-3#2)(2008-10#1)
the chromophore group##2##3##(1990-7#2)
the chromophore in##3##3##(1990-12#1)(2008-10#1)(2008-8#1)
the chromophore is already##2##4##(1995-10#1)(2006-6#1)
the chromophore is##4##3##(1990-2#1)(1995-10#2)(2006-6#1)
the chromophore of##2##3##(1994-12#1)(1995-10#1)
the chromophore##36##2##(1990-12#1)(1990-2#2)(1990-7#2)(1991-3#1)(1991-7#2)(1992-8#1)(1993-3#2)(1994-11#3)(1994-12#2)(1994-5#1)(1995-10#5)(1996-5#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-11#1)(2006-6#1)(2008-10#4)(2008-3#2)(2008-8#1)(2009-9#1)
the chromophores##4##2##(1994-9#1)(1996-5#1)(2008-3#1)(2009-9#1)
the chromophoric##4##2##(1990-2#2)(1993-3#1)(2008-2#1)
the chromosomal DNA##5##3##(1991-4#1)(1993-9#1)(2005-11#1)(2009-6#1)(2011-2#1)
the chromosomal abnormalities##4##3##(1994-12#1)(2006-10#1)(2007-2#1)(2011-2#1)
the chromosomal gene##2##3##(2008-10#2)
the chromosomal instability##4##3##(1995-1#1)(2008-7#2)(2008-8#1)
the chromosomal level##2##3##(2008-12#1)(2011-12#1)
the chromosomal location of the##4##5##(1997-2#1)(2008-10#2)(2008-11#1)
the chromosomal location of##6##4##(1997-2#1)(2008-10#4)(2008-11#1)
the chromosomal location##7##3##(1997-2#1)(2008-10#4)(2008-11#1)(2008-4#1)
the chromosomal region##2##3##(1997-5#1)(2008-4#1)
the chromosomal replication origin##2##4##(1994-12#1)(1995-8#1)
the chromosomal target##3##3##(1995-1#2)(1996-10#1)
the chromosomal##55##2##(1990-9#2)(1991-4#1)(1991-5#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#2)(1994-9#1)(1995-1#3)(1995-8#1)(1996-10#1)(1996-3#1)(1996-7#2)(1997-2#1)(1997-4#1)(1997-5#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#3)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-6#1)(2010-12#1)(2010-3#2)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
the chromosomally##2##2##(1994-12#1)(2012-12#1)
the chromosome and##3##3##(2007-6#2)(2011-3#1)
the chromosome number##3##3##(1990-8#1)(2006-5#1)(2013-1#1)
the chromosome of Pseudomonas putida##2##5##(1997-2#2)
the chromosome of S##3##4##(1990-3#1)(2008-8#2)
the chromosome of##19##3##(1990-3#3)(1990-9#2)(1991-7#2)(1991-9#1)(1993-11#1)(1993-9#1)(1997-2#4)(1997-4#1)(2008-10#2)(2008-8#2)
the chromosome partition protein Spo0J##2##5##(1997-4#2)
the chromosome to##2##3##(1997-4#1)(2008-6#1)
the chromosome##95##2##(1990-3#3)(1990-5#2)(1990-8#2)(1990-9#5)(1991-5#1)(1991-7#5)(1991-8#3)(1991-9#1)(1992-11#1)(1993-11#3)(1993-12#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-5#2)(1994-9#1)(1995-2#1)(1995-8#1)(1996-10#2)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#7)(1997-4#8)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-6#1)(2006-5#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-6#2)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2011-3#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
the chromosomes of the##5##4##(1996-9#1)(1997-6#1)(1997-8#1)(2006-5#1)(2008-7#1)
the chromosomes of##8##3##(1990-4#1)(1996-9#1)(1997-6#1)(1997-8#1)(2006-5#1)(2007-12#1)(2008-7#1)(2010-8#1)
the chromosomes##23##2##(1990-4#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-5#1)(2007-12#2)(2007-6#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)
the chronic and##2##3##(2006-10#1)(2008-3#1)
the chronic course of##2##4##(1991-2#1)(2007-11#1)
the chronic disease##4##3##(1997-2#1)(2004-4#1)(2008-3#1)(2010-5#1)
the chronic inflammation##3##3##(1991-3#1)(2006-9#1)(2009-1#1)
the chronic inflammatory##5##3##(2006-2#1)(2007-6#1)(2008-5#1)(2008-6#1)(2012-1#1)
the chronic pain##3##3##(1996-1#1)(2006-8#1)(2011-1#1)
the chronic phase of CML##2##5##(1997-3#1)(2009-3#1)
the chronic phase of##3##4##(1997-3#1)(2008-12#1)(2009-3#1)
the chronic phase##6##3##(1992-11#1)(1994-2#1)(1996-4#1)(1997-3#1)(2008-12#1)(2009-3#1)
the chronic progressive##2##3##(1997-6#1)(2007-11#1)
the chronic renal failure patients and##2##6##(1992-2#1)(2007-7#1)
the chronic renal##3##3##(1992-2#1)(2007-7#2)
the chronic stage of##5##4##(1992-8#1)(2007-10#3)(2013-8#1)
the chronic stage##10##3##(1991-9#1)(1992-8#1)(1997-8#1)(2007-10#4)(2009-11#1)(2012-3#1)(2013-8#1)
the chronic stages of##3##4##(1997-8#1)(2006-10#1)(2006-12#1)
the chronic stages##4##3##(1997-8#1)(2006-10#1)(2006-12#1)(2008-3#1)
the chronic use of##2##4##(1996-5#1)(2012-12#1)
the chronic##104##2##(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-8#1)(1993-2#1)(1994-2#1)(1994-6#1)(1995-12#3)(1995-2#2)(1995-3#1)(1996-1#1)(1996-10#3)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(2004-12#1)(2004-4#1)(2005-1#1)(2006-10#5)(2006-12#1)(2006-2#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#4)(2007-11#2)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-12#3)(2011-2#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-8#3)
the chronically ethanol fed rats was##2##6##(1993-11#2)
the chronically ethanol fed rats##3##5##(1993-11#3)
the chronically ill##9##3##(1994-6#1)(1995-2#1)(1997-1#1)(1997-6#1)(2004-4#1)(2005-7#1)(2006-1#1)(2006-2#1)(2008-1#1)
the chronically mentally ill##4##4##(1992-1#1)(1997-2#2)(1997-8#1)
the chronically##20##2##(1992-1#1)(1993-11#3)(1994-6#1)(1995-2#1)(1997-1#1)(1997-2#2)(1997-6#2)(1997-8#1)(2004-4#1)(2005-7#1)(2006-1#1)(2006-2#1)(2008-1#1)(2008-3#1)(2008-9#1)(2011-1#1)
the chronicity##5##2##(2007-7#2)(2008-1#1)(2008-4#1)(2012-1#1)
the chronoamperometric##2##2##(2008-10#2)
the chronolog##4##2##(1991-10#4)
the chronological##6##2##(1991-8#1)(1992-5#1)(1997-4#1)(2008-7#1)(2012-2#1)(2012-3#1)
the chronology of##4##3##(1993-12#1)(1996-11#1)(2008-10#1)(2013-1#1)
the chum salmon##2##3##(1993-3#1)(2008-5#1)
the church##4##2##(1990-8#4)
the chyluria##2##2##(2008-1#2)
the cibarial armature and##2##4##(2008-5#2)
the cibarial armature##4##3##(2004-11#1)(2008-5#3)
the cibarial##7##2##(2004-11#1)(2007-12#2)(2008-5#4)
the cicatricial##5##2##(1991-10#1)(2012-1#4)
the cicatrix##3##2##(2012-1#3)
the cichlid Hemichromis bimaculatus##2##4##(2008-7#2)
the cichlid Pelvicachromis taeniatus##2##4##(2010-8#2)
the cichlid##4##2##(2008-7#2)(2010-8#2)
the cigarette##4##2##(1996-3#1)(2008-1#1)(2008-5#1)(2013-4#1)
the ciliary body##2##3##(2011-2#2)
the ciliary membrane##2##3##(1994-12#1)(2006-12#1)
the ciliary##14##2##(1992-8#1)(1993-12#1)(1994-12#1)(1995-12#1)(1997-1#1)(2006-12#1)(2007-12#3)(2008-2#1)(2011-2#2)(2012-12#2)
the ciliated protozoan##4##3##(1994-12#2)(1995-3#1)(1996-1#1)
the ciliated##5##2##(1994-12#2)(1995-3#1)(1996-1#1)(2005-11#1)
the cilium has been##2##4##(2011-1#1)(2013-1#1)
the cilium##5##2##(2008-7#1)(2011-1#1)(2013-1#3)
the cine loop##2##3##(2013-1#2)
the cingulate cortex and##2##4##(1995-7#1)(2013-7#1)
the cingulate cortex##11##3##(1991-11#2)(1994-2#1)(1995-7#1)(1996-10#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-5#1)(2013-7#1)(2013-8#1)
the cingulate gyrus##3##3##(1996-5#1)(2006-3#1)(2012-1#1)
the cingulate##19##2##(1991-11#2)(1994-2#1)(1995-7#2)(1996-1#1)(1996-10#1)(1996-5#2)(1996-8#1)(1997-3#1)(1997-5#3)(2006-3#1)(2009-9#1)(2012-1#1)(2013-7#1)(2013-8#1)
the cinnamyl moiety of both##2##5##(1993-6#2)
the cinnamyl##3##2##(1993-6#2)(2006-12#1)
the circadian BP##2##3##(2008-3#2)
the circadian amplitude##2##3##(2008-11#2)
the circadian clock and##3##4##(1995-2#1)(2009-8#2)
the circadian clock in the##2##5##(1996-9#1)(1997-5#1)
the circadian clock##8##3##(1995-2#2)(1996-9#1)(1997-5#1)(2006-1#1)(2009-8#3)
the circadian modulation of##2##4##(1992-10#1)(2007-12#1)
the circadian oscillator##3##3##(1993-12#2)(2008-7#1)
the circadian pacemaker##5##3##(1994-2#1)(1995-12#1)(1997-5#1)(2008-5#2)
the circadian rhythm of locomotor activity##2##6##(1992-3#2)
the circadian rhythm of neuronal##2##5##(1994-2#1)(1996-6#1)
the circadian rhythm of##6##4##(1991-2#1)(1992-3#2)(1994-2#2)(1996-6#1)
the circadian rhythm##12##3##(1991-2#1)(1992-12#2)(1992-3#2)(1993-6#1)(1994-2#3)(1996-6#1)(1997-6#1)(2008-5#1)
the circadian system##4##3##(1995-9#1)(2006-1#2)(2008-8#1)
the circadian##57##2##(1991-12#1)(1991-2#1)(1992-10#1)(1992-12#2)(1992-3#2)(1992-8#1)(1993-12#2)(1993-5#1)(1993-6#1)(1994-2#6)(1995-12#1)(1995-2#3)(1995-7#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-5#2)(1997-6#1)(2006-1#4)(2007-12#1)(2008-11#5)(2008-3#3)(2008-5#4)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#3)(2012-1#1)
the circle of Willis##4##4##(1993-12#1)(1995-11#1)(2006-11#1)(2008-7#1)
the circle of##7##3##(1993-12#1)(1995-11#1)(2006-11#1)(2008-2#2)(2008-3#1)(2008-7#1)
the circle##12##2##(1993-1#1)(1993-12#1)(1995-11#1)(2006-11#1)(2008-2#3)(2008-3#2)(2008-7#1)(2008-8#1)(2009-2#1)
the circuit##15##2##(1990-4#1)(2008-11#3)(2008-2#6)(2008-3#1)(2009-9#1)(2010-11#1)(2010-9#2)
the circuitry##4##2##(1995-5#1)(2008-11#1)(2008-4#1)(2010-2#1)
the circuits##3##2##(1992-1#1)(1995-3#1)(2013-8#1)
the circular dichroism of the##2##5##(1991-9#1)(1995-6#1)
the circular dichroism spectra##2##4##(1990-10#1)(1992-5#1)
the circular dichroism##8##3##(1990-10#1)(1991-9#1)(1992-5#1)(1994-11#1)(1995-6#1)(2005-4#1)(2006-10#1)(2008-2#1)
the circular muscle layer##2##4##(1993-12#1)(1996-12#1)
the circular muscle of the##6##5##(1991-10#2)(1996-12#2)(1997-4#2)
the circular muscle of##9##4##(1991-10#2)(1996-12#3)(1997-4#3)(1997-5#1)
the circular muscle##13##3##(1991-10#2)(1993-11#1)(1993-12#1)(1996-12#4)(1997-3#1)(1997-4#3)(1997-5#1)
the circular##45##2##(1990-10#1)(1991-10#2)(1991-2#1)(1991-9#1)(1992-5#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-12#5)(1996-6#1)(1997-3#1)(1997-4#3)(1997-5#1)(2005-4#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#5)(2008-3#4)(2008-6#2)(2010-2#1)(2011-1#1)
the circularly polarized##2##3##(2006-12#1)(2008-2#1)
the circularly##4##2##(1991-11#1)(2006-12#1)(2007-12#1)(2008-2#1)
the circulating IR light##2##4##(2007-12#2)
the circulating blood and##2##4##(2008-1#1)(2008-7#1)
the circulating concentration of##2##4##(1992-1#1)(1994-8#1)
the circulating form##2##3##(1990-10#1)(2007-2#1)
the circulating levels of##4##4##(1991-12#1)(1996-11#1)(1997-8#1)(2004-11#1)
the circulating reagent solution##3##4##(2008-10#3)
the circulating##30##2##(1990-10#1)(1991-10#2)(1991-12#1)(1992-1#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-7#1)(1996-11#1)(1997-6#1)(1997-8#1)(2004-11#1)(2006-6#2)(2007-12#2)(2007-2#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-10#1)
the circulation and##8##3##(1994-3#1)(1994-8#1)(1995-2#1)(2008-4#2)(2009-2#1)(2009-6#1)(2010-9#1)
the circulation in the##2##4##(1990-4#1)(2005-10#1)
the circulation in##3##3##(1990-4#1)(1992-7#1)(2005-10#1)
the circulation is##4##3##(1992-11#1)(1995-1#1)(2005-10#1)(2007-5#1)
the circulation of a##2##4##(2010-4#1)(2012-2#1)
the circulation of the virus vaccine##2##6##(2007-10#2)
the circulation of the##8##4##(1991-2#1)(1992-7#1)(2007-10#3)(2008-10#1)(2008-3#1)(2009-10#1)
the circulation of##23##3##(1990-12#1)(1991-2#2)(1992-3#1)(1992-7#1)(1995-2#3)(1997-2#1)(1997-4#1)(2007-10#3)(2008-1#3)(2008-10#1)(2008-3#1)(2009-10#1)(2009-11#1)(2010-4#1)(2012-1#1)(2012-2#1)
the circulation were##2##3##(1990-12#1)(1995-1#1)
the circulation##83##2##(1990-12#3)(1990-3#1)(1990-4#1)(1991-2#2)(1991-4#1)(1991-8#4)(1992-11#1)(1992-3#1)(1992-7#2)(1993-11#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-1#4)(1995-2#4)(1995-5#1)(1996-1#1)(1996-5#2)(1997-2#3)(1997-4#1)(1997-7#1)(2005-1#1)(2005-10#2)(2006-1#1)(2006-10#1)(2006-6#1)(2007-10#3)(2007-11#2)(2007-5#1)(2008-1#3)(2008-10#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-8#1)
the circulatory system##9##3##(1991-2#1)(1996-5#1)(2005-8#1)(2007-12#2)(2008-7#2)(2012-11#1)(2013-8#1)
the circulatory##13##2##(1991-2#1)(1996-5#1)(2005-8#1)(2006-10#1)(2007-12#3)(2007-5#1)(2008-10#1)(2008-7#2)(2012-11#1)(2013-8#1)
the circulus arteriosus##3##3##(2011-1#3)
the circumference of the knee and hip##2##7##(2007-8#2)
the circumference of the##8##4##(2007-11#2)(2007-8#2)(2008-6#1)(2010-12#1)(2010-2#1)(2013-1#1)
the circumference##9##2##(2007-11#2)(2007-8#2)(2008-6#1)(2008-7#1)(2010-12#1)(2010-2#1)(2013-1#1)
the circumferential##7##2##(2006-3#1)(2007-4#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-4#1)(2011-2#1)
the circumflex artery##3##3##(1991-3#1)(2007-8#1)(2013-1#1)
the circumflex coronary artery system##2##5##(2007-8#2)
the circumflex##7##2##(1991-3#1)(2007-8#5)(2013-1#1)
the circumstance is##2##3##(2008-6#2)
the circumstances in which##2##4##(1996-8#1)(2009-4#1)
the circumstances leading##2##3##(1996-12#1)(2006-5#1)
the circumstances of##6##3##(2006-10#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-2#1)(2010-8#1)
the circumstances under which##3##4##(1994-3#1)(1997-2#1)(2008-11#1)
the circumstances##21##2##(1992-9#1)(1994-3#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-2#1)(2006-10#1)(2006-5#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-11#1)(2009-4#1)(2010-8#1)(2012-2#1)(2013-1#1)
the circumventricular organs##2##3##(1994-10#1)(1996-12#1)
the cirrhosis##3##2##(1993-9#1)(1996-4#1)(2009-3#1)
the cirrhotic##2##2##(2006-10#1)(2011-2#1)
the cis and trans##2##4##(1990-9#1)(1996-11#1)
the cis and##3##3##(1990-9#1)(1996-11#1)(2008-7#1)
the cis isomer##7##3##(1990-8#1)(1993-2#1)(1996-5#1)(2007-12#1)(2008-5#1)(2010-2#2)
the cis peptide bond##2##4##(1992-12#1)(2008-9#1)
the cis regulatory element##2##4##(1995-2#2)
the cis state##2##3##(2007-12#2)
the cis##20##2##(1990-8#1)(1990-9#1)(1992-12#1)(1993-2#1)(1995-1#1)(1995-2#2)(1995-6#1)(1996-11#1)(1996-5#1)(2007-12#3)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#4)
the cis- and trans-acting##2##4##(1996-5#1)(2008-10#1)
the cis- and##3##3##(1996-5#1)(2008-10#1)(2012-3#1)
the cis-Golgi##2##2##(2009-7#1)(2012-2#1)
the cis-acting##4##2##(1990-8#1)(1991-12#1)(1991-4#1)(2006-12#1)
the cis-isomer##2##2##(1994-8#1)(2008-10#1)
the cis-regulatory##3##2##(1995-1#1)(1995-8#1)(2008-9#1)
the cis-to-trans##2##2##(1996-5#1)(2006-6#1)
the cis/trans##2##2##(1991-5#1)(2008-7#1)
the cisplatin and##2##3##(1990-6#1)(2008-7#1)
the cisplatin resistant##2##3##(1992-2#1)(2008-5#1)
the cisplatin##7##2##(1990-12#1)(1990-6#2)(1991-2#1)(1992-2#1)(2008-5#1)(2008-7#1)
the cisterna magna and##2##4##(2007-1#1)(2013-1#1)
the cited##5##2##(2008-10#3)(2013-1#2)
the cities of##6##3##(1992-3#1)(2008-9#1)(2012-12#2)(2013-8#2)
the cities##16##2##(1990-6#1)(1992-3#1)(1995-9#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-6#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#2)
the citizens of##3##3##(2007-3#1)(2008-12#1)(2009-3#1)
the citizens##5##2##(1993-8#1)(2007-3#1)(2008-12#1)(2009-3#1)(2012-3#1)
the citrate##9##2##(1990-4#2)(1992-9#2)(1996-9#1)(2008-7#1)(2011-1#1)(2012-5#1)(2013-1#1)
the citric acid cycle##3##4##(1990-12#1)(2008-4#1)(2011-1#1)
the citric##4##2##(1990-12#1)(2008-10#1)(2008-4#1)(2011-1#1)
the citrus industry##2##3##(2008-10#1)(2013-8#1)
the citrus strains from all##2##5##(2008-10#2)
the citrus tristeza virus##2##4##(2008-10#1)(2008-5#1)
the citrus##9##2##(2008-10#5)(2008-5#1)(2010-10#2)(2013-8#1)
the citrus-leafminer##2##2##(2008-6#2)
the city and##2##3##(1992-6#1)(2008-9#1)
the city as well as##3##5##(1997-4#1)(2008-1#1)(2008-10#1)
the city center##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
the city of Buenos Aires##2##5##(2007-3#1)(2009-10#1)
the city of Rio de Janeiro##8##6##(1993-3#1)(1994-3#2)(2009-7#1)(2011-1#2)(2011-2#1)(2012-3#1)
the city of São##2##4##(1993-6#1)(2011-2#1)
the city of##85##3##(1991-6#1)(1991-7#1)(1991-9#1)(1992-4#1)(1992-8#1)(1993-3#4)(1993-6#1)(1994-2#1)(1994-3#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-5#1)(1997-1#1)(2005-8#2)(2006-1#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-2#3)(2007-3#1)(2007-5#1)(2007-7#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2009-10#4)(2009-7#4)(2010-11#1)(2010-12#1)(2011-1#4)(2011-2#8)(2012-12#6)(2012-3#2)(2013-1#6)(2013-8#1)
the city##124##2##(1990-11#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-4#1)(1992-6#5)(1992-8#1)(1993-1#1)(1993-3#5)(1993-6#1)(1994-2#1)(1994-3#3)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#2)(1996-5#1)(1997-1#1)(1997-4#1)(2004-10#2)(2005-8#2)(2006-1#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-2#3)(2007-3#1)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#4)(2009-4#1)(2009-6#1)(2009-7#5)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#4)(2011-2#9)(2012-12#8)(2012-2#1)(2012-3#2)(2013-1#7)(2013-8#2)
the city's##7##2##(1995-12#2)(1996-5#1)(2008-11#1)(2009-7#1)(2011-2#1)(2013-1#1)
the city-specific##2##2##(2010-9#2)
the civil registry##2##3##(2011-2#1)(2013-1#1)
the civil war in##2##4##(1995-4#1)(2005-9#1)
the civil war##4##3##(1994-9#1)(1995-4#1)(1997-6#1)(2005-9#1)
the civil##9##2##(1994-9#1)(1995-4#1)(1996-12#1)(1996-5#1)(1997-6#1)(2005-9#1)(2006-5#1)(2011-2#1)(2013-1#1)
the civilian population##2##3##(2007-12#1)(2008-4#1)
the civilian##5##2##(1992-3#1)(2004-7#1)(2007-10#1)(2007-12#1)(2008-4#1)
the cladding and the##2##4##(2007-12#1)(2008-2#1)
the cladding and##4##3##(2007-11#2)(2007-12#1)(2008-2#1)
the cladding layer##2##3##(2008-10#1)(2010-8#1)
the cladding mode is##2##4##(2007-11#1)(2007-12#1)
the cladding mode##4##3##(2007-11#2)(2007-12#2)
the cladding of a##3##4##(2007-12#2)(2008-3#1)
the cladding of##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
the cladding##31##2##(2007-11#9)(2007-12#11)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#4)(2010-8#1)
the clade##3##2##(2008-8#1)(2009-5#1)(2012-12#1)
the claim of##2##3##(2007-4#1)(2008-9#1)
the claim that the##2##4##(1992-2#1)(2008-4#1)
the claim that##16##3##(1990-12#1)(1990-2#1)(1992-2#1)(1993-12#1)(1996-11#1)(1997-4#1)(1997-6#1)(2005-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2012-2#1)(2013-8#1)
the claim##19##2##(1990-12#1)(1990-2#1)(1992-2#1)(1993-12#1)(1995-6#1)(1996-11#1)(1997-4#1)(1997-6#1)(2005-8#1)(2007-4#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-4#1)(2012-2#1)(2013-8#1)
the claimed minimum reflectivity##2##4##(2008-2#2)
the claimed##7##2##(1997-4#1)(2007-4#1)(2008-10#3)(2008-2#2)
the claims of##7##3##(1996-3#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2013-8#1)
the claims##14##2##(1993-3#1)(1996-3#1)(2006-3#1)(2006-5#1)(2007-9#1)(2008-1#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2010-3#1)(2012-3#1)(2013-8#1)
the clamp##6##2##(1994-12#3)(2007-9#1)(2008-10#1)(2011-2#1)
the clamping point##2##3##(2007-12#1)(2011-2#1)
the clamping##3##2##(2007-12#1)(2008-10#1)(2011-2#1)
the clams##3##2##(2007-10#2)(2008-5#1)
the clarification of the##3##4##(2008-10#1)(2010-5#1)(2011-1#1)
the clarified cell extract##2##4##(1996-2#1)(1997-1#1)
the clarified##5##2##(1996-2#1)(1997-1#1)(2008-10#2)(2008-7#1)
the clarity and##5##3##(1996-1#1)(2007-12#1)(2013-1#2)(2013-8#1)
the clarity of the##2##4##(2008-2#1)(2013-7#1)
the clarity of##7##3##(1990-12#1)(2008-2#2)(2009-3#1)(2012-2#2)(2013-7#1)
the clarity##12##2##(1990-12#1)(1996-1#1)(2007-12#1)(2008-2#2)(2009-3#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
the clash##2##2##(1993-7#1)(2009-4#1)
the class 3##3##3##(2006-6#1)(2006-8#1)(2007-12#1)
the class Actinomycetes##2##3##(2008-10#2)
the class I MHC protein##2##5##(1995-1#2)
the class I heavy chain and##2##6##(1991-5#1)(1993-12#1)
the class I heavy chain##4##5##(1991-5#3)(1993-12#1)
the class I major histocompatibility complex##2##6##(1995-1#1)(2007-8#1)
the class I molecule##2##4##(1993-12#1)(2008-4#1)
the class I##18##3##(1990-11#2)(1991-2#1)(1991-5#3)(1993-12#2)(1995-1#3)(1995-12#1)(1996-9#1)(1997-4#1)(2007-8#1)(2008-4#2)(2010-7#1)
the class II##6##3##(1991-9#1)(1992-7#1)(1994-2#1)(1995-3#2)(1996-9#1)
the class III##7##3##(1990-10#1)(1997-6#2)(2008-4#2)(2008-7#1)(2008-8#1)
the class identity of##2##4##(2008-10#2)
the class in##3##3##(2007-5#1)(2008-11#1)(2008-2#1)
the class of compounds##2##4##(2008-10#1)(2008-5#1)
the class of##29##3##(1990-5#1)(1991-12#1)(1991-6#1)(1994-5#2)(1995-1#1)(1995-12#1)(1996-5#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#3)(2009-4#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
the class##103##2##(1990-10#1)(1990-11#2)(1990-5#1)(1990-9#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#1)(1991-9#1)(1992-6#1)(1992-7#1)(1993-12#2)(1994-2#2)(1994-5#2)(1995-1#4)(1995-12#2)(1995-3#3)(1995-5#1)(1995-8#1)(1996-5#1)(1996-9#2)(1997-4#1)(1997-6#2)(1997-7#4)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#3)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#9)(2008-11#4)(2008-2#3)(2008-3#3)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#3)(2009-4#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#1)(2013-1#1)(2013-8#1)
the classes of##7##3##(2006-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-3#1)(2010-7#1)
the classes##10##2##(2006-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-3#1)(2010-7#1)
the classic intraosseous ameloblastoma of the jaws##2##7##(2011-1#2)
the classic method##2##3##(2008-2#1)(2008-5#1)
the classic model##2##3##(2008-10#1)(2010-4#1)
the classic nuclear##2##3##(1992-12#1)(2008-4#1)
the classic##76##2##(1990-7#1)(1990-8#1)(1990-9#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-10#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-4#1)(1996-3#1)(2005-10#2)(2006-1#1)(2006-10#3)(2006-2#1)(2006-3#1)(2006-8#2)(2007-12#6)(2007-3#1)(2007-7#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-9#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#5)
the classical SLN##2##3##(2008-5#2)
the classical and##3##3##(2007-1#1)(2008-4#1)(2012-2#1)
the classical anti-DNA ELISA##3##4##(1994-3#3)
the classical biuret##2##3##(1990-8#1)(2008-10#1)
the classical continuous##2##3##(1990-4#1)(2008-10#1)
the classical features of##2##4##(2008-10#1)(2010-12#1)
the classical features##3##3##(2008-10#1)(2010-12#1)(2012-2#1)
the classical gene-for-gene##2##3##(2008-10#1)(2008-8#1)
the classical glucocorticoid##2##3##(1990-12#1)(1996-4#1)
the classical joint transform correlator##2##5##(2008-2#2)
the classical mixed effects##2##4##(2012-3#2)
the classical pathway of complement##2##5##(2005-8#1)(2008-4#1)
the classical pathway##7##3##(1994-11#1)(2005-8#1)(2007-1#1)(2008-4#4)
the classical problem of##2##4##(1996-7#1)(2009-8#1)
the classical symptoms##2##3##(1991-9#1)(2008-10#1)
the classical triad of##3##4##(1996-5#1)(2007-7#1)(2013-1#1)
the classical##178##2##(1990-12#4)(1990-2#1)(1990-3#2)(1990-4#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#5)(1995-11#1)(1995-12#2)(1995-5#2)(1996-11#3)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-8#1)(2005-11#3)(2005-8#2)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#6)(2007-12#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#18)(2008-11#6)(2008-2#12)(2008-3#5)(2008-4#8)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-2#2)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#1)(2013-8#1)
the classically defined##2##3##(1996-1#1)(2012-11#1)
the classically##4##2##(1992-9#1)(1996-1#1)(2008-2#1)(2012-11#1)
the classification accuracies##2##3##(2010-2#2)
the classification accuracy##4##3##(2008-2#1)(2008-6#1)(2008-8#1)(2010-2#1)
the classification analysis##2##3##(2007-8#1)(2008-10#1)
the classification and##9##3##(1990-2#1)(2007-11#1)(2008-10#2)(2008-8#1)(2009-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the classification of new##2##4##(2008-10#1)(2009-11#1)
the classification of the##13##4##(1990-6#2)(1991-5#1)(2004-9#1)(2005-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-7#1)(2009-3#1)(2011-2#1)
the classification of tumors##2##4##(1990-2#1)(2010-7#1)
the classification of##62##3##(1990-2#2)(1990-3#1)(1990-6#2)(1991-5#1)(1992-1#3)(1993-5#1)(1993-7#1)(1994-2#2)(1996-3#1)(2004-9#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-8#2)(2008-1#2)(2008-10#11)(2008-12#1)(2008-3#3)(2008-4#2)(2008-7#3)(2009-11#1)(2009-3#1)(2009-6#1)(2010-12#2)(2010-5#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
the classification performance##2##3##(1994-5#1)(2008-10#1)
the classification systems##2##3##(2007-8#1)(2010-9#1)
the classification was##2##3##(1991-9#1)(2007-5#1)
the classification##123##2##(1990-2#3)(1990-3#1)(1990-6#3)(1991-12#2)(1991-5#1)(1991-9#1)(1992-1#3)(1993-5#1)(1993-7#1)(1994-2#2)(1994-3#1)(1994-5#1)(1996-11#1)(1996-3#1)(2004-9#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-5#1)(2007-8#4)(2008-1#3)(2008-10#19)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-12#2)(2010-2#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#4)(2013-1#8)(2013-7#1)(2013-8#3)
the classifications##2##2##(2011-2#2)
the classifier##9##2##(2006-2#1)(2009-10#1)(2010-5#1)(2013-1#6)
the classifiers##2##2##(2009-3#1)(2010-8#1)
the classroom and##6##3##(2007-8#1)(2008-11#1)(2008-12#2)(2009-7#1)(2012-2#1)
the classroom environment##3##3##(2008-12#3)
the classroom setting##2##3##(2008-11#2)
the classroom##25##2##(2004-12#1)(2005-10#1)(2006-12#1)(2007-4#1)(2007-8#1)(2008-11#5)(2008-12#11)(2009-7#1)(2010-6#1)(2012-2#1)(2012-3#1)
the classrooms##2##2##(1993-6#2)
the classwide##2##2##(2013-1#2)
the clathrin assembly protein AP-2##2##5##(1992-8#2)
the clathrin##3##2##(1992-8#2)(2012-2#1)
the clavicle##11##2##(1993-10#1)(2006-4#1)(2007-1#1)(2007-7#1)(2007-8#3)(2009-3#1)(2009-6#2)(2012-3#1)
the claw##4##2##(2011-1#1)(2011-2#3)
the claws##4##2##(2005-7#1)(2007-12#1)(2011-2#2)
the clay##8##2##(1993-8#1)(2005-11#2)(2008-10#1)(2008-5#1)(2010-5#2)(2012-12#1)
the clay's##2##2##(2005-11#2)
the clean##6##2##(2005-11#1)(2007-11#2)(2008-10#1)(2008-2#1)(2010-4#1)
the clean-up of##3##3##(1992-2#1)(2008-10#1)(2008-11#1)
the clean-up##4##2##(1992-2#1)(2008-10#2)(2008-11#1)
the cleanest##2##2##(2007-11#1)(2008-10#1)
the cleaning##4##2##(2007-7#1)(2008-10#2)(2008-2#1)
the cleansing agents##2##3##(1990-8#1)(2013-1#1)
the cleansing##3##2##(1990-8#1)(2008-3#1)(2013-1#1)
the cleanup of##2##3##(2008-10#1)(2008-4#1)
the clear relationship between##2##4##(2008-10#1)(2011-2#1)
the clear##22##2##(1993-12#1)(1995-12#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#2)(2009-10#2)(2009-4#1)(2009-7#1)(2010-5#1)(2011-2#3)(2012-12#2)
the clearance of soluble and##2##5##(1996-1#1)(2007-11#1)
the clearance of##22##3##(1990-12#1)(1990-2#1)(1990-9#1)(1994-3#1)(1995-2#3)(1996-1#1)(1996-4#2)(1996-5#1)(1997-6#1)(2007-11#5)(2008-6#1)(2009-4#1)(2012-1#1)(2012-3#1)(2013-1#1)
the clearance rate##2##3##(1990-12#1)(1991-2#1)
the clearance##27##2##(1990-12#2)(1990-2#1)(1990-9#1)(1991-2#1)(1992-3#1)(1994-3#1)(1995-2#3)(1996-1#1)(1996-4#2)(1996-5#1)(1997-6#1)(2007-11#5)(2008-5#1)(2008-6#1)(2009-4#1)(2012-1#2)(2012-3#1)(2013-1#1)
the clearest##2##2##(2008-5#1)(2008-9#1)
the cleavable##3##2##(1990-2#1)(1995-3#1)(1995-5#1)
the cleavage at##2##3##(1992-6#1)(1994-5#1)
the cleavage of Beclin 1##2##5##(2011-1#2)
the cleavage of the##12##4##(1990-3#1)(1990-7#1)(1990-8#1)(1992-11#1)(1992-7#1)(2003-11#1)(2004-4#1)(2008-10#3)(2008-4#1)(2008-8#1)
the cleavage of##27##3##(1990-3#1)(1990-7#1)(1990-8#1)(1992-11#1)(1992-12#1)(1992-7#1)(1994-5#1)(1994-9#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-4#1)(2003-11#1)(2004-4#1)(2008-10#5)(2008-4#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-6#1)(2011-1#2)
the cleavage pattern##2##3##(1990-10#1)(2008-4#1)
the cleavage patterns##2##3##(1990-2#1)(1995-10#1)
the cleavage products of##2##4##(1993-11#1)(1996-5#1)
the cleavage products##3##3##(1993-11#1)(1996-5#1)(1996-7#1)
the cleavage site of the fusion##2##6##(2005-9#1)(2007-6#1)
the cleavage site of the##4##5##(2005-9#1)(2007-6#1)(2008-5#2)
the cleavage site of##7##4##(1991-12#1)(1995-8#1)(2005-9#2)(2007-6#1)(2008-5#2)
the cleavage site##11##3##(1991-10#1)(1991-12#1)(1991-3#1)(1993-3#1)(1993-6#1)(1995-8#1)(2005-9#2)(2007-6#1)(2008-5#2)
the cleavage to##2##3##(1995-3#1)(1996-7#1)
the cleavage##68##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-10#2)(1995-11#3)(1995-3#1)(1995-6#3)(1995-8#1)(1996-2#2)(1996-5#1)(1996-7#2)(1996-9#1)(1997-2#1)(1997-4#2)(2003-11#1)(2004-4#1)(2005-9#2)(2007-6#1)(2008-10#6)(2008-4#3)(2008-5#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#3)(2010-6#1)(2011-1#2)(2013-1#1)
the cleavage-ligation##2##2##(1991-11#1)(1995-3#1)
the cleavages##2##2##(1991-9#1)(1994-9#1)
the cleaved##9##2##(1991-9#1)(1993-12#1)(1993-3#1)(1994-8#1)(1995-1#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-4#1)
the cleft patient##2##3##(2007-12#2)
the cleft##16##2##(1991-4#2)(1992-3#1)(1993-11#1)(1995-8#1)(1996-7#3)(2007-12#4)(2009-7#1)(2009-8#1)(2012-12#2)
the click##4##2##(2007-8#1)(2009-11#3)
the client with##3##3##(2008-11#1)(2012-3#2)
the client##17##2##(1991-3#1)(1994-2#1)(2004-2#1)(2006-4#1)(2007-10#1)(2007-6#1)(2008-11#2)(2008-2#3)(2009-6#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-8#1)
the client's##5##2##(1996-3#1)(2007-1#1)(2008-2#1)(2010-8#1)(2011-1#1)
the clientele as well as##2##5##(1994-3#1)(2008-2#1)
the clientele##6##2##(1991-12#1)(1994-3#1)(2008-2#4)
the clients##5##2##(1993-1#1)(2007-7#1)(2008-2#1)(2012-1#1)(2013-8#1)
the climate conditions##2##3##(2006-5#1)(2012-9#1)
the climate of##4##3##(2008-2#1)(2012-11#1)(2012-3#1)(2012-5#1)
the climate system##3##3##(1990-3#1)(1990-8#1)(2007-9#1)
the climate##14##2##(1990-3#1)(1990-8#1)(1996-3#2)(2006-5#1)(2007-9#1)(2008-2#1)(2009-4#1)(2012-1#1)(2012-11#1)(2012-3#1)(2012-5#2)(2012-9#1)
the climatic conditions##2##3##(2008-10#1)(2013-1#1)
the climatic##5##2##(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#1)(2013-8#1)
the climbazole##3##2##(2008-5#3)
the climbing fiber##2##3##(1994-2#1)(1995-11#1)
the climbing##4##2##(1992-6#1)(1994-2#1)(1995-11#1)(2010-8#1)
the clinic and##9##3##(2006-2#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
the clinic are##2##3##(2005-7#1)(2010-8#1)
the clinic as##3##3##(2008-11#1)(2012-12#2)
the clinic for treatment##2##4##(1991-12#1)(1995-9#1)
the clinic for##5##3##(1991-12#1)(1992-2#1)(1995-9#1)(1996-12#1)(2005-6#1)
the clinic group##2##3##(2006-3#2)
the clinic or##2##3##(1995-5#1)(2007-8#1)
the clinic over##2##3##(1996-3#1)(2006-10#1)
the clinic setting##2##3##(2008-1#1)(2011-7#1)
the clinic##111##2##(1990-12#1)(1990-3#1)(1991-12#1)(1991-9#1)(1992-2#2)(1992-3#2)(1993-11#1)(1993-2#1)(1993-9#1)(1994-1#1)(1994-3#1)(1995-2#1)(1995-5#3)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-6#1)(1997-3#1)(1997-7#1)(2005-6#2)(2005-7#1)(2005-8#4)(2006-10#4)(2006-2#3)(2006-3#3)(2007-10#1)(2007-11#6)(2007-4#2)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#4)(2008-11#7)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-2#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#3)(2010-8#2)(2011-1#2)(2011-2#2)(2011-7#1)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#3)(2013-8#1)
the clinical accuracy##2##3##(2006-12#1)(2010-12#1)
the clinical activity##2##3##(1995-4#1)(2009-2#1)
the clinical analysis of##3##4##(1991-9#1)(2007-5#1)(2008-2#1)
the clinical anatomy and biomechanics##2##5##(2006-12#2)
the clinical anatomy##3##3##(2006-12#2)(2013-8#1)
the clinical and biochemical##4##4##(1991-12#1)(1996-6#1)(1997-1#2)
the clinical and biologic##2##4##(2007-12#1)(2010-12#1)
the clinical and economic burden of##2##6##(2011-2#2)
the clinical and economic##4##4##(1997-2#1)(2007-11#1)(2011-2#2)
the clinical and epidemiological characteristics##2##5##(2008-7#1)(2013-1#1)
the clinical and epidemiological##5##4##(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#2)
the clinical and histological##3##4##(1993-10#1)(1996-10#1)(2005-11#1)
the clinical and histopathologic##2##4##(2006-10#1)(2013-1#1)
the clinical and histopathological##2##4##(2008-1#1)(2010-6#1)
the clinical and imaging##2##4##(2007-9#1)(2008-11#1)
the clinical and instrumental##2##4##(2007-7#1)(2008-5#1)
the clinical and laboratory characteristics##2##5##(2006-10#1)(2012-12#1)
the clinical and laboratory features of##2##6##(1992-10#1)(2011-2#1)
the clinical and laboratory findings of##2##6##(2007-2#1)(2008-1#1)
the clinical and laboratory##12##4##(1990-2#1)(1992-10#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-2#1)(2008-1#1)(2009-11#1)(2009-8#1)(2011-2#2)(2012-12#1)
the clinical and molecular##2##4##(1996-3#1)(2008-6#1)
the clinical and morphological##3##4##(1997-6#1)(2007-11#1)(2009-8#1)
the clinical and pathologic##2##4##(1991-8#1)(2008-1#1)
the clinical and pathological features of this##2##7##(1991-6#1)(2007-6#1)
the clinical and pathological features of##6##6##(1991-12#1)(1991-6#1)(2005-8#1)(2007-6#1)(2007-8#1)(2011-2#1)
the clinical and pathological##11##4##(1991-12#1)(1991-6#1)(1991-8#1)(1995-10#1)(1995-3#1)(2005-8#1)(2007-6#1)(2007-8#1)(2011-2#2)(2013-8#1)
the clinical and radiographic findings##2##5##(1997-1#1)(2006-9#1)
the clinical and radiographic##4##4##(1997-1#1)(2006-8#1)(2006-9#1)(2013-1#1)
the clinical and radiologic##2##4##(2007-12#1)(2011-2#1)
the clinical and radiological features of##2##6##(2005-8#1)(2010-2#1)
the clinical and radiological manifestations##3##5##(1991-11#1)(2007-4#1)(2012-12#1)
the clinical and radiological##10##4##(1991-11#1)(1997-3#1)(2005-8#1)(2006-12#1)(2006-7#1)(2007-4#1)(2008-6#1)(2009-9#1)(2010-2#1)(2012-12#1)
the clinical and research##2##4##(2007-6#1)(2013-1#1)
the clinical and the##2##4##(2008-5#1)(2008-8#1)
the clinical and##114##3##(1990-2#2)(1990-6#1)(1991-11#1)(1991-12#2)(1991-5#1)(1991-6#2)(1991-8#2)(1992-10#1)(1992-5#1)(1992-8#1)(1993-10#1)(1993-12#1)(1994-5#1)(1995-10#1)(1995-3#1)(1996-10#1)(1996-3#1)(1996-6#2)(1997-1#3)(1997-2#2)(1997-3#1)(1997-6#1)(2005-11#1)(2005-8#2)(2005-9#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-11#3)(2007-12#3)(2007-2#2)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-2#8)(2011-7#1)(2012-12#4)(2012-3#3)(2013-1#6)(2013-8#1)
the clinical appearance of##2##4##(1995-10#1)(2012-3#1)
the clinical applicability of this##2##5##(2011-1#1)(2011-2#1)
the clinical applicability of##6##4##(1994-1#1)(2007-9#1)(2008-1#1)(2010-5#1)(2011-1#1)(2011-2#1)
the clinical application of mesenchymal stem cells for musculoskeletal regeneration##2##10##(2012-12#2)
the clinical application of the##2##5##(2008-1#1)(2008-10#1)
the clinical application of##13##4##(1990-2#1)(1997-6#1)(2006-10#1)(2006-11#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-4#1)(2011-12#1)(2012-12#3)
the clinical application##16##3##(1990-2#1)(1997-6#1)(2006-10#1)(2006-11#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2009-6#1)(2010-8#1)(2011-12#1)(2012-12#3)
the clinical applications of##6##4##(2006-10#1)(2008-4#1)(2008-5#1)(2010-11#1)(2010-12#1)(2012-2#1)
the clinical applications##7##3##(2006-10#1)(2008-4#1)(2008-5#1)(2010-11#1)(2010-12#1)(2010-2#1)(2012-2#1)
the clinical area##7##3##(2008-11#5)(2008-12#1)(2010-9#1)
the clinical arena##7##3##(2006-10#1)(2007-4#1)(2007-8#1)(2008-5#1)(2009-5#1)(2012-12#2)
the clinical aspect##3##3##(2007-7#1)(2008-9#1)(2011-1#1)
the clinical aspects of the##2##5##(1991-4#1)(2006-3#1)
the clinical aspects of##4##4##(1991-4#1)(1992-6#1)(1995-1#1)(2006-3#1)
the clinical assessment of##3##4##(1991-4#1)(2008-5#1)(2010-6#1)
the clinical assessment##5##3##(1991-12#1)(1991-4#1)(2007-3#1)(2008-5#1)(2010-6#1)
the clinical attachment##2##3##(2010-4#1)(2013-8#1)
the clinical behavior of##2##4##(1994-8#1)(2007-2#1)
the clinical behaviour of##2##4##(2008-4#1)(2013-1#1)
the clinical behaviour##5##3##(1997-6#1)(2004-2#1)(2008-4#1)(2012-2#1)(2013-1#1)
the clinical benefit of##5##4##(1997-4#1)(1997-7#2)(2008-12#1)(2011-12#1)
the clinical benefit##6##3##(1997-4#1)(1997-7#2)(2008-10#1)(2008-12#1)(2011-12#1)
the clinical benefits of##4##4##(1993-12#1)(2007-8#1)(2009-6#1)(2011-2#1)
the clinical benefits##6##3##(1993-12#1)(1996-9#1)(2007-8#1)(2009-6#1)(2010-6#1)(2011-2#1)
the clinical care of##4##4##(2006-10#2)(2006-12#1)(2012-12#1)
the clinical care##6##3##(1997-2#1)(2006-10#2)(2006-12#1)(2012-1#1)(2012-12#1)
the clinical case of a##4##5##(2011-2#1)(2012-2#1)(2013-1#2)
the clinical case##5##3##(1994-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
the clinical cases##2##3##(1990-3#1)(2008-5#1)
the clinical characteristics of the disease##2##6##(1995-4#1)(2008-4#1)
the clinical characteristics of the##3##5##(1992-2#1)(1995-4#1)(2008-4#1)
the clinical characteristics of these##2##5##(2007-10#1)(2007-7#1)
the clinical characteristics of##10##4##(1992-2#1)(1993-12#1)(1994-12#1)(1995-4#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-4#2)(2011-2#1)
the clinical characteristics##12##3##(1992-2#1)(1993-12#1)(1994-12#1)(1995-4#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-3#1)(2008-4#2)(2011-2#1)(2013-1#1)
the clinical characterization of##2##4##(2008-9#1)(2010-6#1)
the clinical charts of##2##4##(2004-1#1)(2006-12#1)
the clinical chemistry##3##3##(1996-9#1)(2005-12#1)(2008-10#1)
the clinical classification##2##3##(1990-2#1)(2008-7#1)
the clinical condition and##3##4##(1992-1#1)(2010-12#1)(2013-8#1)
the clinical condition of the##4##5##(1990-8#1)(1991-3#1)(2006-10#1)(2008-11#1)
the clinical condition of##5##4##(1990-8#1)(1991-3#1)(2006-10#1)(2006-6#1)(2008-11#1)
the clinical condition##10##3##(1990-8#1)(1991-3#1)(1992-1#1)(2006-10#1)(2006-6#1)(2006-7#1)(2008-11#1)(2010-12#1)(2012-2#1)(2013-8#1)
the clinical consequences##2##3##(2006-10#1)(2013-1#1)
the clinical context##5##3##(2008-6#1)(2009-7#2)(2013-1#2)
the clinical course and prognosis##2##5##(2009-5#1)(2010-6#1)
the clinical course and##7##4##(1997-6#1)(2008-3#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-6#1)(2012-12#1)
the clinical course in##4##4##(1991-8#1)(1994-10#1)(2007-12#1)(2011-2#1)
the clinical course of a##3##5##(2007-12#1)(2009-2#1)(2013-7#1)
the clinical course of the disease##6##6##(1990-11#1)(1995-4#1)(2006-10#1)(2008-7#1)(2011-2#1)(2013-7#1)
the clinical course of the##7##5##(1990-11#1)(1993-6#1)(1995-4#1)(2006-10#1)(2008-7#1)(2011-2#1)(2013-7#1)
the clinical course of these##2##5##(2010-7#1)(2011-2#1)
the clinical course of##27##4##(1990-11#1)(1990-6#1)(1991-5#1)(1993-6#1)(1994-7#2)(1995-4#1)(1996-11#1)(1997-5#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-12#1)(2008-7#1)(2009-2#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-12#1)(2011-2#2)(2013-1#1)(2013-7#2)(2013-8#1)
the clinical course was##2##4##(1990-4#1)(2005-3#1)
the clinical course##53##3##(1990-11#1)(1990-4#1)(1990-6#1)(1991-5#1)(1991-8#1)(1992-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-7#2)(1995-4#1)(1996-11#2)(1996-12#1)(1997-3#1)(1997-5#1)(1997-6#1)(2005-3#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-11#2)(2007-12#2)(2007-3#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#3)(2009-2#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-6#1)(2010-7#1)(2011-12#1)(2011-2#3)(2012-12#2)(2013-1#1)(2013-7#2)(2013-8#1)
the clinical criteria##2##3##(2006-10#1)(2009-4#1)
the clinical cut-off##2##3##(2008-6#2)
the clinical data and##3##4##(2008-7#1)(2013-1#2)
the clinical data available##2##4##(2008-5#1)(2008-7#1)
the clinical data of##3##4##(1991-3#1)(1997-7#1)(2011-2#1)
the clinical data##14##3##(1991-3#1)(1993-11#1)(1993-12#1)(1997-7#1)(2005-6#1)(2007-12#3)(2008-5#1)(2008-7#2)(2011-2#1)(2013-1#2)
the clinical decision##3##3##(2010-12#1)(2012-12#1)(2013-1#1)
the clinical demonstration of##2##4##(2012-1#1)(2012-2#1)
the clinical development of the##3##5##(1996-9#1)(2008-5#1)(2009-4#1)
the clinical development of##12##4##(1996-9#1)(2007-5#1)(2008-10#1)(2008-3#3)(2008-5#2)(2008-8#1)(2009-4#1)(2009-8#1)(2013-7#1)
the clinical diagnosis of AD##2##5##(1994-2#1)(2012-2#1)
the clinical diagnosis of##11##4##(1992-12#1)(1994-2#1)(1996-11#1)(1996-2#1)(2006-10#1)(2007-8#2)(2008-3#1)(2009-11#1)(2011-1#1)(2012-2#1)
the clinical diagnosis was##2##4##(2008-5#1)(2012-12#1)
the clinical diagnosis##22##3##(1992-12#1)(1993-2#1)(1994-2#1)(1996-11#1)(1996-2#2)(2006-10#1)(2006-9#1)(2007-7#3)(2007-8#4)(2008-3#1)(2008-5#1)(2009-11#1)(2011-1#2)(2012-12#1)(2012-2#1)
the clinical diagnostic##2##3##(2008-5#1)(2010-12#1)
the clinical effect of##5##4##(1997-5#1)(2008-12#1)(2009-2#1)(2011-1#1)(2013-8#1)
the clinical effect##7##3##(1997-5#1)(2006-12#1)(2008-12#1)(2009-2#1)(2011-1#1)(2012-12#1)(2013-8#1)
the clinical effectiveness of##4##4##(1993-1#1)(2007-8#1)(2008-7#1)(2013-1#1)
the clinical effectiveness##5##3##(1993-1#1)(2007-8#1)(2008-11#1)(2008-7#1)(2013-1#1)
the clinical effects of##2##4##(1990-5#1)(1997-1#1)
the clinical efficacy and tolerability of##2##6##(1990-3#1)(1990-7#1)
the clinical efficacy and##3##4##(1990-3#1)(1990-7#1)(1991-12#1)
the clinical efficacy of##13##4##(1993-12#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-7#1)(2008-11#1)(2008-3#1)(2009-8#1)(2010-7#1)(2012-12#1)(2012-2#1)
the clinical efficacy##18##3##(1990-3#1)(1990-7#1)(1991-12#1)(1993-12#1)(2005-10#1)(2006-10#2)(2006-8#1)(2007-11#2)(2007-7#1)(2008-11#1)(2008-3#1)(2009-8#1)(2010-7#1)(2012-12#2)(2012-2#1)
the clinical entity of##2##4##(1992-8#1)(2005-8#1)
the clinical entity##3##3##(1992-8#1)(2005-8#1)(2012-2#1)
the clinical environment##6##3##(1997-6#1)(2008-11#2)(2008-12#2)(2008-7#1)
the clinical evaluation of the##2##5##(2007-11#1)(2008-5#1)
the clinical evaluation of##8##4##(1991-8#1)(1992-7#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-7#1)(2012-2#1)
the clinical evaluation##11##3##(1991-8#1)(1992-7#1)(1997-2#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#1)(2012-2#1)
the clinical evidence for##3##4##(2008-10#1)(2011-2#1)(2012-2#1)
the clinical evidence##8##3##(2007-10#1)(2008-10#1)(2010-12#1)(2011-2#2)(2012-2#2)(2013-1#1)
the clinical evolution##3##3##(2008-7#1)(2008-8#1)(2011-2#1)
the clinical examination and##2##4##(2010-9#1)(2012-2#1)
the clinical examination##6##3##(1993-5#1)(1994-6#1)(2006-4#1)(2010-4#1)(2010-9#1)(2012-2#1)
the clinical experience of##2##4##(2005-10#1)(2007-8#1)
the clinical experience with##2##4##(2006-8#1)(2007-11#1)
the clinical experience##9##3##(2005-10#2)(2006-8#1)(2007-11#3)(2007-8#1)(2008-11#1)(2012-12#1)
the clinical expression##2##3##(1997-5#1)(2012-12#1)
the clinical features and treatment of##2##6##(2006-10#1)(2007-12#1)
the clinical features and##9##4##(2006-10#1)(2007-12#1)(2007-3#2)(2008-5#1)(2008-9#1)(2010-5#1)(2011-1#1)(2012-2#1)
the clinical features are##2##4##(1992-4#1)(2007-7#1)
the clinical features of patients with##2##6##(2005-9#1)(2013-8#1)
the clinical features of the syndrome##2##6##(2006-10#1)(2007-11#1)
the clinical features of the##6##5##(1993-12#1)(1993-5#1)(2006-10#1)(2007-11#1)(2008-3#1)(2008-5#1)
the clinical features of##30##4##(1993-12#1)(1993-5#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-2#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-3#1)(2010-6#2)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#3)
the clinical features##59##3##(1992-4#1)(1993-12#1)(1993-5#1)(1993-9#1)(2005-7#1)(2005-9#1)(2006-10#4)(2006-2#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#2)(2007-7#3)(2007-8#1)(2007-9#4)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#2)(2011-1#2)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#5)
the clinical findings and the##2##5##(2007-7#1)(2008-3#1)
the clinical findings and##3##4##(1997-4#1)(2007-7#1)(2008-3#1)
the clinical findings in##3##4##(1997-1#1)(2006-9#1)(2010-8#1)
the clinical findings##16##3##(1990-12#1)(1992-2#1)(1995-5#1)(1997-1#1)(1997-4#1)(2004-1#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-3#1)(2007-7#1)(2008-3#1)(2010-8#2)(2013-1#2)
the clinical follow-up##2##3##(1996-9#1)(2007-1#1)
the clinical form of the##2##5##(1996-5#1)(2011-2#1)
the clinical form of##3##4##(1996-5#1)(2006-6#1)(2011-2#1)
the clinical forms of##2##4##(2008-5#1)(2008-6#1)
the clinical hematology##2##3##(2008-9#2)
the clinical history and##2##4##(1996-9#1)(2013-8#1)
the clinical history of##3##4##(2007-11#1)(2012-12#1)(2012-2#1)
the clinical history##11##3##(1992-10#1)(1992-5#1)(1995-11#1)(1996-9#1)(2004-10#1)(2007-10#1)(2007-11#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
the clinical impact of the##2##5##(2008-7#1)(2013-1#1)
the clinical impact of##5##4##(2004-9#1)(2008-7#1)(2009-12#1)(2013-1#2)
the clinical impact##7##3##(2004-9#1)(2005-11#1)(2008-1#1)(2008-7#1)(2009-12#1)(2013-1#2)
the clinical implication of##2##4##(2008-1#1)(2008-5#1)
the clinical implications of the##2##5##(2005-11#1)(2012-12#1)
the clinical implications of##6##4##(1995-10#1)(2005-11#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-12#1)
the clinical implications##9##3##(1995-10#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
the clinical importance of##5##4##(1992-4#1)(1994-11#1)(1997-8#1)(2005-8#1)(2012-12#1)
the clinical improvement##2##3##(2011-1#1)(2013-1#1)
the clinical indication of##2##4##(2006-12#1)(2012-3#1)
the clinical indications for##2##4##(2006-9#1)(2008-3#1)
the clinical indications##4##3##(1997-8#1)(2005-12#1)(2006-9#1)(2008-3#1)
the clinical information##2##3##(2008-3#1)(2008-9#1)
the clinical interview]##2##3##(1993-11#1)(1993-3#1)
the clinical investigation of##2##4##(1993-11#1)(2005-8#1)
the clinical investigation##4##3##(1991-9#1)(1993-11#1)(2005-8#1)(2011-1#1)
the clinical isolates of##4##4##(2007-8#1)(2012-2#1)(2013-8#2)
the clinical isolates##8##3##(2006-8#1)(2007-7#1)(2007-8#1)(2008-5#1)(2012-2#1)(2013-8#3)
the clinical laboratory for##2##4##(1996-6#1)(2008-6#1)
the clinical laboratory##16##3##(1992-12#1)(1993-12#1)(1994-1#2)(1994-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(2008-10#1)(2008-12#1)(2008-6#2)(2008-7#1)(2008-9#1)(2013-1#1)
the clinical learning environment and##2##5##(2008-11#1)(2008-12#1)
the clinical learning environment##7##4##(2007-10#1)(2008-11#1)(2008-12#4)(2009-12#1)
the clinical learning##9##3##(2007-10#1)(2008-11#2)(2008-12#5)(2009-12#1)
the clinical literature##3##3##(1992-12#1)(1993-12#2)
the clinical management of patients##5##5##(1996-9#1)(2006-10#1)(2008-11#1)(2009-7#1)(2012-1#1)
the clinical management of these##2##5##(2006-10#1)(2009-3#1)
the clinical management of##22##4##(1996-9#1)(2006-10#5)(2007-11#2)(2007-12#2)(2007-5#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2012-1#1)(2013-8#1)
the clinical management##25##3##(1996-9#1)(2006-10#6)(2007-11#2)(2007-12#2)(2007-5#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2011-2#1)(2012-1#1)(2013-8#1)
the clinical manifestation of##3##4##(2007-11#2)(2011-2#1)
the clinical manifestation##4##3##(2007-11#2)(2011-2#1)(2012-2#1)
the clinical manifestations of the disease##3##6##(2007-3#1)(2008-5#1)(2011-2#1)
the clinical manifestations of the##4##5##(1994-11#1)(2007-3#1)(2008-5#1)(2011-2#1)
the clinical manifestations of these##2##5##(1990-8#1)(2007-8#1)
the clinical manifestations of##11##4##(1990-8#1)(1994-11#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-3#1)(2007-3#1)(2007-8#1)(2008-5#1)(2011-2#2)
the clinical manifestations##20##3##(1990-8#1)(1991-3#1)(1994-11#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-2#1)
the clinical material##2##3##(2007-11#1)(2007-8#1)
the clinical nurse specialist in##2##5##(1991-7#1)(2008-11#1)
the clinical observation##2##3##(2008-1#1)(2012-12#1)
the clinical observations##4##3##(1994-11#1)(1995-1#1)(2008-3#1)(2009-4#1)
the clinical outcome for##2##4##(2006-10#1)(2012-1#1)
the clinical outcome of patients##2##5##(2005-7#1)(2006-8#1)
the clinical outcome of##12##4##(1990-6#1)(1993-11#1)(1996-11#1)(2005-7#1)(2006-5#1)(2006-8#1)(2007-8#1)(2008-6#1)(2010-4#1)(2010-5#1)(2013-1#1)(2013-8#1)
the clinical outcome##23##3##(1990-6#1)(1991-2#1)(1993-11#1)(1996-11#1)(1997-3#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-8#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#3)(2013-8#1)
the clinical outcomes##5##3##(2008-10#1)(2008-12#1)(2008-3#1)(2012-3#1)(2013-1#1)
the clinical parameters##4##3##(2008-10#1)(2010-2#1)(2011-1#1)(2012-12#1)
the clinical pathology##2##3##(1994-12#1)(2007-2#1)
the clinical pathway##5##3##(2006-1#2)(2010-8#1)(2013-1#2)
the clinical patterns##2##3##(1994-6#2)
the clinical periodontal parameters and oxidative stress/damage indices##2##8##(2008-8#2)
the clinical pharmacokinetics##2##3##(2007-11#1)(2010-11#1)
the clinical pharmacology and##2##4##(2007-11#1)(2007-8#1)
the clinical pharmacology##3##3##(2007-11#1)(2007-8#1)(2009-4#1)
the clinical phase of##3##4##(1992-6#1)(2008-10#1)(2008-4#1)
the clinical phenotype and##3##4##(2007-7#1)(2011-2#1)(2012-3#1)
the clinical phenotype of##2##4##(2010-10#1)(2012-1#1)
the clinical phenotype##9##3##(1996-6#1)(2007-7#1)(2008-5#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
the clinical phenotypes##2##3##(2008-11#1)(2010-1#1)
the clinical picture and##3##4##(1997-7#1)(2007-10#1)(2007-11#1)
the clinical picture is##2##4##(1990-8#1)(1993-1#1)
the clinical picture may##2##4##(2007-7#1)(2008-8#1)
the clinical picture of ACD##2##5##(2005-11#2)
the clinical picture of##9##4##(1990-5#1)(1990-6#1)(1993-1#1)(1993-8#1)(2005-11#2)(2006-6#1)(2007-11#1)(2008-7#1)
the clinical picture was##2##4##(1990-2#1)(2009-5#1)
the clinical picture##35##3##(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1992-9#1)(1993-1#3)(1993-8#1)(1997-4#1)(1997-6#2)(1997-7#1)(2005-11#2)(2006-10#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-6#1)(2007-7#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-2#1)(2010-6#1)(2012-12#1)(2013-1#1)
the clinical placement##2##3##(2008-11#1)(2008-12#1)
the clinical point of view##2##5##(1992-12#1)(2008-10#1)
the clinical population##3##3##(1997-8#2)(2008-4#1)
the clinical potential of##6##4##(2005-7#2)(2006-1#1)(2007-10#1)(2007-11#1)(2011-1#1)
the clinical potential##7##3##(2005-7#2)(2006-1#1)(2007-10#1)(2007-11#1)(2011-1#2)
the clinical practice of the##2##5##(1993-11#1)(2012-2#1)
the clinical practice of##7##4##(1990-10#1)(1993-11#1)(2008-12#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
the clinical practice##21##3##(1990-10#1)(1993-11#1)(2006-2#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
the clinical presentation and##10##4##(1991-12#1)(1993-5#1)(2007-7#1)(2007-8#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
the clinical presentation is##3##4##(2005-11#1)(2006-8#1)(2009-9#1)
the clinical presentation of##11##4##(1990-6#1)(2005-10#1)(2006-10#2)(2006-6#1)(2007-9#1)(2009-12#1)(2010-12#1)(2012-11#1)(2013-7#1)(2013-8#1)
the clinical presentation was##2##4##(1996-3#1)(2007-9#1)
the clinical presentation##47##3##(1990-6#1)(1991-12#1)(1993-5#1)(1996-3#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#2)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#2)
the clinical presentations of##3##4##(1994-11#1)(2008-2#1)(2008-8#1)
the clinical problems##3##3##(2007-11#1)(2007-12#1)(2010-10#1)
the clinical profile and##2##4##(1996-8#1)(2012-2#1)
the clinical profile of##2##4##(2006-10#1)(2012-3#1)
the clinical profile##5##3##(1996-8#1)(2006-10#1)(2009-11#1)(2012-2#1)(2012-3#1)
the clinical prognosis##2##3##(1997-8#1)(2006-10#1)
the clinical question##47##3##(2007-8#46)(2012-2#1)
the clinical records of##3##4##(1993-11#1)(2006-10#1)(2007-7#1)
the clinical records##5##3##(1992-9#1)(1993-11#1)(2006-10#1)(2006-12#1)(2007-7#1)
the clinical relevance of such##2##5##(1993-12#1)(1997-3#1)
the clinical relevance of the##2##5##(1997-3#1)(2007-1#1)
the clinical relevance of##10##4##(1993-12#1)(1997-3#2)(2005-10#1)(2006-10#2)(2007-1#1)(2008-10#1)(2008-4#1)(2012-3#1)
the clinical relevance##11##3##(1993-12#1)(1997-3#2)(2005-10#1)(2006-10#2)(2006-12#1)(2007-1#1)(2008-10#1)(2008-4#1)(2012-3#1)
the clinical research enterprise##2##4##(2005-11#1)(2012-12#1)
the clinical research##4##3##(1992-10#1)(2005-11#1)(2005-8#1)(2012-12#1)
the clinical response of##4##4##(1991-3#1)(2008-5#1)(2008-8#1)(2013-1#1)
the clinical response##6##3##(1991-3#1)(1991-6#1)(2007-11#1)(2008-5#1)(2008-8#1)(2013-1#1)
the clinical result##2##3##(1993-5#1)(2007-11#1)
the clinical results of##3##4##(1994-7#1)(2008-6#1)(2013-7#1)
the clinical results##5##3##(1994-7#1)(2007-11#1)(2008-5#1)(2008-6#1)(2013-7#1)
the clinical samples##2##3##(2007-11#1)(2008-2#1)
the clinical scenario##2##3##(2008-11#1)(2011-2#1)
the clinical setting of##6##4##(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2010-12#1)(2011-2#1)
the clinical setting##51##3##(1990-9#1)(1991-11#1)(1992-3#1)(1993-3#1)(2004-3#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#4)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-4#1)(2009-9#1)(2010-12#1)(2011-2#3)(2012-12#2)(2013-1#2)
the clinical settings##3##3##(2012-12#1)(2013-1#2)
the clinical severity of##4##4##(1997-6#1)(2007-6#1)(2011-1#1)(2012-12#1)
the clinical severity##8##3##(1997-6#1)(2007-6#1)(2009-6#2)(2011-1#1)(2012-12#1)(2013-1#2)
the clinical significance of YAP1##2##5##(2013-1#2)
the clinical significance of##15##4##(1994-8#1)(1994-9#1)(2004-11#1)(2006-10#1)(2007-11#3)(2008-1#1)(2008-2#2)(2008-6#2)(2012-3#1)(2013-1#2)
the clinical significance##17##3##(1994-8#1)(1994-9#1)(2004-11#1)(2006-10#1)(2007-11#3)(2008-1#1)(2008-2#2)(2008-6#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-2#1)
the clinical signs and symptoms of##3##6##(1992-1#1)(1994-7#1)(2008-8#1)
the clinical signs and symptoms##4##5##(1992-1#1)(1994-7#1)(2008-8#1)(2013-1#1)
the clinical signs of##4##4##(1994-7#1)(2005-11#1)(2008-11#1)(2012-3#1)
the clinical signs##10##3##(1992-1#1)(1993-7#1)(1994-7#2)(2005-11#1)(2008-11#1)(2008-8#1)(2012-3#1)(2013-1#2)
the clinical situation and##2##4##(1996-9#1)(2008-10#1)
the clinical situation##11##3##(1990-12#1)(1990-2#1)(1993-5#1)(1996-9#1)(1997-1#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-1#1)(2013-1#1)
the clinical spectrum of these##2##5##(2006-8#1)(2007-7#1)
the clinical spectrum of##4##4##(1996-12#1)(2006-8#1)(2007-2#1)(2007-7#1)
the clinical spectrum##8##3##(1996-12#1)(2006-10#1)(2006-8#2)(2007-2#1)(2007-7#1)(2008-10#1)(2008-7#1)
the clinical staff##2##3##(1991-12#1)(2007-8#1)
the clinical stage IV##2##4##(2008-1#2)
the clinical stage of the##2##5##(1990-6#1)(2008-10#1)
the clinical stage of##4##4##(1990-6#1)(1990-9#1)(2008-10#1)(2012-1#1)
the clinical stage##9##3##(1990-6#1)(1990-9#1)(2008-1#2)(2008-10#1)(2008-5#2)(2012-1#1)(2012-12#1)
the clinical stages##3##3##(2008-1#1)(2008-7#2)
the clinical state##3##3##(1990-8#1)(1995-12#1)(2006-5#1)
the clinical status and##2##4##(2006-10#1)(2013-1#1)
the clinical status of patients##2##5##(2006-10#1)(2009-5#1)
the clinical status of the patient##2##6##(2008-7#1)(2009-10#1)
the clinical status of the##4##5##(1995-11#1)(2005-11#1)(2008-7#1)(2009-10#1)
the clinical status of##6##4##(1995-11#1)(2005-11#1)(2006-10#1)(2008-7#1)(2009-10#1)(2009-5#1)
the clinical status##10##3##(1995-11#1)(2005-11#1)(2006-10#2)(2006-4#1)(2008-7#1)(2009-10#1)(2009-5#1)(2013-1#2)
the clinical studies and##2##4##(2006-6#1)(2013-7#1)
the clinical studies that have##2##5##(2006-6#1)(2010-5#1)
the clinical studies that##3##4##(2006-6#1)(2007-8#1)(2010-5#1)
the clinical studies##13##3##(2006-10#1)(2006-6#2)(2007-11#2)(2007-8#1)(2008-11#2)(2008-5#1)(2010-5#3)(2013-7#1)
the clinical study of##2##4##(1993-2#1)(2006-10#1)
the clinical study##5##3##(1992-10#1)(1993-2#1)(2006-10#2)(2008-5#1)
the clinical subtype of periodic catatonia##2##6##(1995-11#2)
the clinical success of##2##4##(2005-10#1)(2007-11#1)
the clinical suspicion of the##2##5##(1992-8#1)(2011-2#1)
the clinical suspicion of##5##4##(1992-2#1)(1992-8#1)(2006-10#2)(2011-2#1)
the clinical symptoms and##5##4##(1994-6#1)(2005-11#1)(2006-8#1)(2008-12#1)(2012-12#1)
the clinical symptoms of##3##4##(2008-5#1)(2008-8#1)(2011-1#1)
the clinical symptoms##19##3##(1990-11#1)(1991-8#1)(1994-6#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-5#2)(2008-8#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
the clinical syndrome of##2##4##(2006-10#1)(2008-1#1)
the clinical syndrome##4##3##(1997-8#1)(2006-10#1)(2008-1#1)(2008-11#1)
the clinical syndromes##2##3##(2007-9#1)(2012-2#1)
the clinical target volume##2##4##(2008-2#1)(2008-6#1)
the clinical target##3##3##(2008-2#1)(2008-6#1)(2009-5#1)
the clinical testing##2##3##(1997-6#1)(2007-11#1)
the clinical topics that were extracted and used to augment the SAPS-I algorithm significantly improved the performance of the baseline algorithm##2##21##(2013-1#2)
the clinical trial methods##2##4##(2008-8#1)(2012-3#1)
the clinical trial system##2##4##(2007-4#2)
the clinical trial##11##3##(1991-3#1)(1992-9#1)(2007-4#3)(2008-7#1)(2008-8#1)(2010-6#1)(2010-8#1)(2012-3#1)(2013-8#1)
the clinical trials of##3##4##(2005-8#1)(2005-9#1)(2010-12#1)
the clinical trials##18##3##(1994-2#1)(1996-8#1)(1997-5#1)(1997-8#1)(2005-8#1)(2005-9#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#2)(2009-6#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
the clinical type##2##3##(2007-8#1)(2013-1#1)
the clinical use of these##2##5##(1995-12#1)(2007-11#1)
the clinical use of##24##4##(1990-10#1)(1990-3#1)(1991-12#1)(1992-3#1)(1995-12#1)(2006-10#1)(2006-11#1)(2006-6#2)(2007-11#3)(2007-4#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#3)(2012-2#1)(2013-7#1)
the clinical use##25##3##(1990-10#1)(1990-3#1)(1991-12#1)(1992-3#1)(1995-12#1)(2006-10#1)(2006-11#1)(2006-6#2)(2007-11#4)(2007-4#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#3)(2012-2#1)(2013-7#1)
the clinical usefulness of the##3##5##(1991-1#1)(1992-10#1)(2008-5#1)
the clinical usefulness of these##2##5##(1995-1#1)(2013-1#1)
the clinical usefulness of##10##4##(1991-1#1)(1992-10#1)(1995-1#1)(1996-9#1)(2008-5#2)(2009-1#2)(2011-2#1)(2013-1#1)
the clinical utility of this##2##5##(1995-2#1)(2013-8#1)
the clinical utility of##9##4##(1995-2#1)(2006-8#1)(2007-8#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
the clinical utility##11##3##(1995-2#1)(2006-8#1)(2007-8#1)(2008-7#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#2)
the clinical value of##8##4##(2007-11#2)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-2#1)
the clinical variables##3##3##(2006-2#1)(2007-9#1)(2012-3#1)
the clinical work-up##2##3##(2013-8#2)
the clinical##1460##2##(1990-10#4)(1990-11#2)(1990-12#3)(1990-2#6)(1990-3#4)(1990-4#1)(1990-5#3)(1990-6#7)(1990-7#1)(1990-8#4)(1990-9#4)(1991-1#1)(1991-11#5)(1991-12#8)(1991-2#3)(1991-3#6)(1991-4#2)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#5)(1991-9#3)(1992-1#3)(1992-10#7)(1992-11#1)(1992-12#6)(1992-2#3)(1992-3#4)(1992-4#3)(1992-5#2)(1992-6#8)(1992-7#1)(1992-8#3)(1992-9#3)(1993-1#4)(1993-10#1)(1993-11#7)(1993-12#11)(1993-2#2)(1993-3#2)(1993-5#7)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-1#3)(1994-10#2)(1994-11#4)(1994-12#7)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#7)(1994-7#5)(1994-8#2)(1994-9#2)(1995-1#3)(1995-10#3)(1995-11#5)(1995-12#4)(1995-2#2)(1995-3#4)(1995-4#3)(1995-5#2)(1995-6#2)(1996-1#1)(1996-10#1)(1996-11#5)(1996-12#3)(1996-2#4)(1996-3#5)(1996-5#1)(1996-6#6)(1996-8#2)(1996-9#9)(1997-1#7)(1997-2#4)(1997-3#10)(1997-4#3)(1997-5#4)(1997-6#9)(1997-7#4)(1997-8#8)(2004-1#3)(2004-10#1)(2004-11#2)(2004-2#1)(2004-3#1)(2004-9#2)(2005-10#7)(2005-11#11)(2005-12#2)(2005-3#1)(2005-6#1)(2005-7#7)(2005-8#11)(2005-9#4)(2006-1#3)(2006-10#59)(2006-11#5)(2006-12#11)(2006-2#5)(2006-3#2)(2006-4#2)(2006-5#5)(2006-6#11)(2006-7#5)(2006-8#16)(2006-9#7)(2007-1#4)(2007-10#13)(2007-11#53)(2007-12#16)(2007-2#8)(2007-3#8)(2007-4#8)(2007-5#8)(2007-6#7)(2007-7#24)(2007-8#77)(2007-9#13)(2008-1#22)(2008-10#23)(2008-11#38)(2008-12#21)(2008-2#13)(2008-3#19)(2008-4#20)(2008-5#41)(2008-6#19)(2008-7#31)(2008-8#23)(2008-9#19)(2009-1#2)(2009-10#2)(2009-11#4)(2009-12#6)(2009-2#4)(2009-3#4)(2009-4#9)(2009-5#8)(2009-6#8)(2009-7#3)(2009-8#6)(2009-9#4)(2010-1#2)(2010-10#5)(2010-11#4)(2010-12#18)(2010-2#5)(2010-3#3)(2010-4#3)(2010-5#6)(2010-6#11)(2010-7#2)(2010-8#6)(2010-9#3)(2011-1#22)(2011-12#3)(2011-2#46)(2011-7#1)(2012-1#10)(2012-11#1)(2012-12#43)(2012-2#38)(2012-3#18)(2013-1#84)(2013-2#1)(2013-7#8)(2013-8#32)
the clinical-epidemiological##2##2##(1991-12#1)(1996-4#1)
the clinically important##5##3##(1993-12#1)(2005-7#1)(2008-5#1)(2009-10#1)(2012-3#1)
the clinically relevant##6##3##(1996-6#1)(2008-3#1)(2009-10#1)(2012-2#3)
the clinically significant##4##3##(2008-8#1)(2009-2#1)(2011-2#1)(2012-1#1)
the clinically useful##2##3##(2007-11#1)(2008-7#1)
the clinically##30##2##(1990-5#1)(1991-11#1)(1993-12#1)(1995-3#2)(1996-6#1)(1997-2#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#2)(2009-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#4)(2012-3#1)
the clinician and the##2##4##(2009-8#1)(2013-1#1)
the clinician and##5##3##(1992-9#1)(1993-1#1)(2009-8#1)(2011-2#1)(2013-1#1)
the clinician as##3##3##(2008-5#1)(2011-2#1)(2013-1#1)
the clinician can##2##3##(2004-3#1)(2009-8#1)
the clinician in the##3##4##(2006-7#1)(2011-2#1)(2012-3#1)
the clinician in##8##3##(2005-8#1)(2006-11#1)(2006-12#1)(2006-7#1)(2007-12#1)(2008-12#1)(2011-2#1)(2012-3#1)
the clinician must be##2##4##(2008-8#1)(2013-8#1)
the clinician must##9##3##(1993-2#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-8#1)(2012-2#1)(2013-8#2)
the clinician should##2##3##(2005-7#1)(2006-10#1)
the clinician to##17##3##(1991-2#1)(1994-12#1)(1996-12#1)(1996-9#1)(2004-3#1)(2006-10#2)(2006-4#1)(2007-9#1)(2008-12#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#1)(2010-8#1)(2013-1#1)
the clinician with a##6##4##(1990-4#1)(1993-11#1)(2005-10#1)(2005-11#1)(2012-2#2)
the clinician with##8##3##(1990-4#1)(1993-11#1)(2005-10#1)(2005-11#1)(2006-10#1)(2008-6#1)(2012-2#2)
the clinician##100##2##(1990-10#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-2#2)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1996-12#2)(1996-9#1)(1997-3#1)(2004-3#2)(2005-10#1)(2005-11#3)(2005-7#3)(2005-8#1)(2006-10#8)(2006-11#2)(2006-12#3)(2006-2#2)(2006-4#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-4#2)(2007-9#1)(2008-1#2)(2008-12#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-12#1)(2009-4#1)(2009-8#2)(2009-9#2)(2010-12#1)(2010-2#1)(2010-8#3)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#7)(2012-3#4)(2013-1#4)(2013-8#2)
the clinician's##10##2##(2006-10#1)(2006-12#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-1#1)(2012-2#1)
the clinicians and the##2##4##(1990-12#1)(2013-8#1)
the clinicians and##3##3##(1990-12#1)(1997-6#1)(2013-8#1)
the clinicians##17##2##(1990-12#1)(1994-12#1)(1995-1#1)(1997-6#1)(2005-8#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-7#1)(2008-9#1)(2010-9#1)(2013-1#2)(2013-8#1)
the clinicians'##3##2##(2011-1#2)(2013-7#1)
the clinicopathologic characteristics of##2##4##(2013-1#2)
the clinicopathologic characteristics##3##3##(2013-1#3)
the clinicopathologic features of##2##4##(2009-5#1)(2010-1#1)
the clinicopathologic features##3##3##(2008-11#1)(2009-5#1)(2010-1#1)
the clinicopathologic##8##2##(1991-6#1)(2008-11#1)(2009-5#1)(2010-1#1)(2011-2#1)(2013-1#3)
the clinicopathological and##2##3##(2007-8#1)(2011-1#1)
the clinicopathological significance of##2##4##(2008-12#1)(2010-12#1)
the clinicopathological##14##2##(1997-3#1)(2004-1#1)(2006-9#1)(2007-8#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2010-12#1)(2011-1#1)(2012-2#2)
the clinicopathology of T1DM##2##4##(2007-5#2)
the clinics##12##2##(1991-1#1)(1991-10#1)(1994-1#2)(1996-1#1)(2006-2#1)(2007-3#1)(2007-7#1)(2008-1#2)(2008-5#1)(2011-1#1)
the clip##5##2##(2006-6#2)(2008-12#1)(2010-3#1)(2011-1#1)
the clivus##9##2##(2006-12#3)(2006-6#2)(2006-9#1)(2008-12#1)(2013-8#2)
the cloaca##7##2##(2006-8#1)(2007-12#1)(2007-2#1)(2008-5#3)(2008-6#1)
the clock##7##2##(1991-12#1)(1996-11#1)(1997-1#1)(1997-5#1)(2006-1#1)(2007-9#1)(2008-9#1)
the clonal lineage##2##3##(2008-10#2)
the clonal##24##2##(1991-10#1)(1992-7#1)(1992-9#1)(1994-11#1)(1996-10#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#2)(2009-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
the clonally##2##2##(1992-7#1)(2009-2#1)
the clone from a##2##4##(1990-10#1)(1994-11#1)
the clone was inserted into the pSVL vector (pUDPGTh2) and expressed in COS 1 cells##2##15##(2008-11#2)
the clone was##5##3##(1991-2#1)(2008-10#1)(2008-11#2)(2008-5#1)
the clone##27##2##(1990-10#1)(1990-11#4)(1990-2#1)(1990-5#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#2)(1996-7#1)(1997-2#1)(2008-10#2)(2008-11#4)(2008-5#1)(2008-8#2)
the cloned DNA fragment##2##4##(1990-11#1)(1991-9#1)
the cloned DNA##6##3##(1990-11#1)(1991-1#1)(1991-9#1)(1997-4#2)(2008-10#1)
the cloned cDNA##7##3##(1991-7#1)(1991-9#1)(1992-12#1)(1993-12#1)(1994-11#1)(1994-9#1)(1997-1#1)
the cloned embryos##2##3##(2008-9#2)
the cloned fragment##6##3##(1991-6#2)(1994-12#1)(1996-12#1)(1996-4#1)(1996-7#1)
the cloned fragments##3##3##(2008-10#3)
the cloned gene product##6##4##(1990-3#1)(1994-3#5)
the cloned gene was the##2##5##(1990-10#1)(2005-11#1)
the cloned gene##15##3##(1990-10#1)(1990-3#2)(1990-4#1)(1990-6#1)(1991-12#1)(1991-9#2)(1994-3#5)(1995-6#1)(2005-11#1)
the cloned human##5##3##(1991-12#1)(1993-11#1)(1993-8#1)(1995-11#1)(1996-5#1)
the cloned receptor##4##3##(1990-8#1)(1992-11#1)(1992-3#2)
the cloned sequence##2##3##(1997-5#1)(2008-8#1)
the cloned sequences##3##3##(1992-2#1)(1993-12#1)(2006-8#1)
the cloned thrombin##2##3##(1996-8#2)
the cloned##117##2##(1990-1#1)(1990-10#2)(1990-11#2)(1990-2#2)(1990-3#4)(1990-4#3)(1990-6#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#4)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-6#2)(1992-7#2)(1993-11#3)(1993-12#4)(1993-3#2)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-3#5)(1994-9#4)(1995-10#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#2)(1996-4#3)(1996-5#1)(1996-7#1)(1996-8#2)(1997-1#2)(1997-4#4)(1997-5#1)(1997-6#2)(1997-8#1)(2005-11#1)(2006-12#1)(2006-8#2)(2008-10#10)(2008-11#1)(2008-5#2)(2008-8#2)(2008-9#2)(2009-4#1)
the clones were##2##3##(1990-9#1)(1997-2#1)
the clones##33##2##(1990-1#1)(1990-9#1)(1991-6#1)(1992-2#1)(1992-8#1)(1993-3#2)(1993-5#1)(1993-6#1)(1994-6#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-3#1)(1996-10#2)(1997-2#3)(1997-4#2)(1997-8#2)(2006-10#1)(2006-8#1)(2007-1#2)(2007-3#1)(2008-11#2)(2008-9#2)
the cloning and characterization of a##2##6##(1993-7#1)(1995-3#1)
the cloning and characterization of##6##5##(1993-12#1)(1993-7#1)(1995-3#1)(1995-8#1)(1997-4#2)
the cloning and expression of##4##5##(1992-7#2)(1993-6#1)(1997-4#1)
the cloning and identification of##2##5##(1993-5#1)(1997-3#1)
the cloning and sequencing of a##2##6##(1994-12#1)(1995-3#1)
the cloning and sequencing of##6##5##(1994-12#2)(1995-3#1)(1996-9#1)(1997-2#1)(2008-4#1)
the cloning and##24##3##(1991-12#1)(1992-3#1)(1992-7#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1994-12#2)(1995-3#2)(1995-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#3)(2005-11#1)(2008-4#3)
the cloning of a full-length cDNA encoding##2##7##(1991-2#1)(1994-12#1)
the cloning of a##8##4##(1990-5#1)(1991-2#1)(1994-12#1)(1994-9#2)(1995-8#1)(1996-5#1)(2006-10#1)
the cloning of the human##3##5##(1995-11#1)(1996-5#1)(2007-11#1)
the cloning of the##17##4##(1990-11#1)(1993-10#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-6#1)(1996-5#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-11#1)(2009-3#1)
the cloning of##39##3##(1990-11#1)(1990-5#1)(1991-2#1)(1991-7#2)(1993-10#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-5#2)(1997-6#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-3#1)
the cloning site##2##3##(1991-7#1)(1993-11#1)
the cloning##72##2##(1990-11#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-7#3)(1992-3#2)(1992-7#2)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#5)(1994-3#2)(1994-5#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-6#1)(1995-8#2)(1996-5#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#1)(1997-9#1)(2005-11#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-12#1)(2009-3#1)(2013-1#1)
the clonogenic survival##2##3##(1991-7#1)(2007-10#1)
the clonogenic##4##2##(1990-12#1)(1991-7#1)(1995-12#1)(2007-10#1)
the close association of##2##4##(1994-9#1)(1995-8#1)
the close association##3##3##(1994-9#1)(1995-8#1)(1997-1#1)
the close collaboration##3##3##(2008-10#1)(2009-9#1)(2012-2#1)
the close of the 20th century##4##6##(2006-10#2)(2007-5#1)(2008-1#1)
the close of the##6##4##(2006-10#2)(2007-5#1)(2008-1#1)(2009-4#2)
the close phylogenetic relationship of##2##5##(1994-11#1)(1996-12#1)
the close proximity of the##2##5##(1995-10#1)(2008-3#1)
the close proximity of##3##4##(1995-10#1)(2008-3#1)(2013-1#1)
the close proximity##4##3##(1995-10#1)(2008-3#1)(2012-2#1)(2013-1#1)
the close relationship between##2##4##(2007-5#1)(2009-3#1)
the close relationship of##3##4##(2006-3#1)(2008-10#1)(2008-5#1)
the close relationship##5##3##(2006-3#1)(2007-5#1)(2008-10#1)(2008-5#1)(2009-3#1)
the close##43##2##(1990-11#1)(1991-6#1)(1993-11#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-6#1)(2006-10#2)(2006-2#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-4#2)(2009-9#1)(2010-6#1)(2012-2#2)(2012-3#1)(2013-1#2)
the closed and##3##3##(1997-1#2)(1997-7#1)
the closed group##4##3##(2007-8#4)
the closed##24##2##(1992-3#1)(1996-11#3)(1997-1#2)(1997-7#1)(1997-8#1)(2005-4#1)(2006-3#1)(2006-7#1)(2007-8#5)(2008-7#2)(2008-8#3)(2011-12#1)(2011-2#1)(2012-12#1)
the closed-loop##2##2##(2008-1#1)(2008-2#1)
the closed-mouth##3##2##(2007-1#1)(2010-2#2)
the closely linked##3##3##(1990-12#1)(1990-5#1)(1996-5#1)
the closely related##16##3##(1991-5#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-11#1)(1994-5#1)(1995-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2012-5#1)
the closely##24##2##(1990-12#1)(1990-5#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-11#1)(1994-5#1)(1995-8#1)(1996-2#1)(1996-5#1)(2006-10#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2012-2#1)(2012-5#1)
the closeness of##2##3##(2007-1#1)(2009-5#1)
the closeness##3##2##(1996-5#1)(2007-1#1)(2009-5#1)
the closer the##3##3##(1993-3#1)(2008-2#1)(2011-2#1)
the closer##9##2##(1993-3#1)(1996-6#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#3)
the closest living##2##3##(1991-5#1)(1994-3#1)
the closest relative for the##2##5##(2008-10#2)
the closest relative##4##3##(2006-8#1)(2008-10#3)
the closest relatives to the##2##5##(2010-11#2)
the closest relatives to##3##4##(2010-11#3)
the closest relatives##4##3##(1991-5#1)(2010-11#3)
the closest to the##3##4##(2006-12#1)(2006-6#1)(2008-6#1)
the closest##33##2##(1990-12#1)(1991-5#2)(1993-12#1)(1993-5#1)(1994-3#1)(1994-8#1)(1997-8#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-9#1)(2008-10#8)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-11#3)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
the closing of##3##3##(1991-8#1)(1993-3#1)(2007-3#1)
the closing##5##2##(1991-8#1)(1993-3#1)(1996-12#1)(2006-9#1)(2007-3#1)
the clostridial lysozyme##2##3##(1991-7#2)
the closure of the##3##4##(1994-9#1)(1997-3#1)(2007-8#1)
the closure of##12##3##(1994-9#1)(1996-3#1)(1996-4#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-4#2)(2008-5#1)(2009-9#1)(2010-5#1)(2012-1#1)
the closure##18##2##(1993-3#1)(1994-9#1)(1996-3#1)(1996-4#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-9#1)(2010-5#1)(2012-1#1)(2013-7#1)
the clot##6##2##(1990-11#3)(1997-3#1)(1997-4#1)(2007-7#1)
the cloth##3##2##(2004-11#1)(2008-10#1)(2008-2#1)
the clothing##2##2##(1990-2#1)(2008-10#1)
the clotting time##3##3##(1997-2#1)(2007-7#2)
the clotting##7##2##(1993-11#1)(1997-2#1)(2005-12#1)(2007-7#2)(2008-9#1)(2011-2#1)
the cloud base##3##3##(2008-2#2)(2008-3#1)
the cloud is##3##3##(2008-3#3)
the cloud optical depth##2##4##(2008-2#1)(2008-3#1)
the cloud particles##2##3##(2008-2#1)(2008-3#1)
the cloud point extraction##2##4##(2008-10#2)
the cloud point temperature##2##4##(2005-11#1)(2008-10#1)
the cloud point##5##3##(2005-11#1)(2008-10#4)
the cloud top##2##3##(2008-2#2)
the cloud##36##2##(1991-5#1)(1992-3#2)(1992-7#1)(2005-11#1)(2008-10#4)(2008-2#12)(2008-3#14)(2013-7#1)
the clouds##3##2##(1992-7#1)(2008-2#2)
the clue to the##2##4##(1991-4#1)(2008-4#1)
the clue to##3##3##(1991-4#1)(2008-4#1)(2012-2#1)
the clue##4##2##(1991-4#1)(2008-4#1)(2012-2#2)
the cluster adjusted MH##2##4##(2012-3#2)
the cluster analysis##2##3##(2008-10#2)
the cluster in##2##3##(2007-10#1)(2009-2#1)
the cluster is##2##3##(1996-8#1)(2009-5#1)
the cluster of##3##3##(1996-5#1)(2007-12#1)(2009-12#1)
the cluster##39##2##(1990-2#1)(1990-5#1)(1992-5#1)(1993-11#1)(1993-4#1)(1993-5#1)(1996-2#1)(1996-5#1)(1996-6#3)(1996-8#1)(1997-4#1)(1997-8#2)(2005-11#3)(2007-1#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-6#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-10#1)(2012-3#3)(2013-1#1)
the clustered##4##2##(1994-9#1)(1997-4#1)(2008-1#1)(2008-11#1)
the clustering of##6##3##(1991-11#1)(1996-1#1)(2008-10#1)(2008-3#1)(2010-6#1)(2012-1#1)
the clustering##15##2##(1990-5#1)(1991-11#1)(1996-1#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-6#1)(2010-6#1)(2011-2#1)(2012-1#1)(2013-1#2)
the clusters of##4##3##(1994-2#1)(1995-6#1)(2004-7#1)(2008-10#1)
the clusters##18##2##(1990-12#1)(1994-2#1)(1995-6#1)(1997-5#2)(2004-7#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-6#1)(2008-7#2)(2009-2#1)(2011-1#1)
the clutch##3##2##(2008-8#1)(2008-9#1)(2009-10#1)
the cly5 and cly7##2##4##(1997-3#2)
the cmc of the##2##4##(2005-11#2)
the cmc##9##2##(2005-11#8)(2008-10#1)
the cmcH##2##2##(1995-8#2)
the cnidarian sequence##2##3##(1996-10#2)
the cnidarian##5##2##(1996-10#4)(2008-7#1)
the co- polymer trimethylamine microcarriers##2##5##(2008-11#2)
the co-administration of##2##3##(1992-8#1)(1996-3#1)
the co-evolution of##4##3##(2009-3#1)(2011-10#2)(2013-8#1)
the co-existence of both##2##4##(2007-4#1)(2010-11#1)
the co-existence of##7##3##(1995-12#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-9#1)(2010-11#1)(2012-3#1)
the co-existence##8##2##(1995-12#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-9#1)(2010-11#1)(2012-3#2)
the co-expression of##5##3##(1990-12#1)(1995-10#1)(1995-3#1)(2006-11#1)(2008-7#1)
the co-infection##2##2##(2007-7#1)(2011-1#1)
the co-ligands##2##2##(1996-2#2)
the co-localization of##3##3##(2008-10#1)(2010-12#1)(2013-8#1)
the co-migration##2##2##(2008-10#2)
the co-morbidity##2##2##(2006-6#1)(2013-1#1)
the co-occurrence of##4##3##(1994-6#1)(2008-8#1)(2009-12#1)(2013-7#1)
the co-occurrence##6##2##(1994-6#1)(2008-2#2)(2008-8#1)(2009-12#1)(2013-7#1)
the co-ordination##2##2##(2008-4#1)(2013-8#1)
the co-polymer trimethylamine microcarriers##2##4##(2008-11#2)
the co-researchers##2##2##(2008-11#2)
the co-solvent##2##2##(2008-10#1)(2013-1#1)
the co-stimulatory##2##2##(2007-11#1)(2008-10#1)
the co-transfected##2##2##(1995-6#1)(1996-8#1)
the co-transformed genes##2##3##(2006-12#2)
the coaches'##2##2##(1995-3#2)
the coadministration of a##2##4##(1995-2#1)(2008-5#1)
the coadministration of##3##3##(1995-2#1)(1997-6#1)(2008-5#1)
the coaggregation of##2##3##(2008-5#2)
the coaggregation##3##2##(1997-5#1)(2008-5#2)
the coagulase-negative##3##2##(2005-8#1)(2008-3#1)(2009-6#1)
the coagulation and fibrinolytic systems##2##5##(1993-12#1)(2005-11#1)
the coagulation assay##2##3##(1994-9#2)
the coagulation cascade##7##3##(1995-8#1)(2004-11#3)(2005-11#1)(2005-7#1)(2008-7#1)
the coagulation system##7##3##(1990-11#1)(1991-8#1)(1996-6#1)(2005-8#1)(2006-10#2)(2007-10#1)
the coagulation##26##2##(1990-11#2)(1991-8#1)(1993-12#1)(1994-9#2)(1995-8#2)(1996-6#1)(2004-11#3)(2005-11#3)(2005-7#1)(2005-8#1)(2006-10#3)(2006-4#1)(2007-10#2)(2008-10#1)(2008-7#1)(2012-12#1)
the coal surface##5##3##(2005-11#5)
the coal##7##2##(2005-11#6)(2008-10#1)
the coalescence##2##2##(2005-11#2)
the coalition##4##2##(1996-1#1)(2009-10#1)(2009-11#1)(2009-4#1)
the coarctation##3##2##(1990-8#1)(2007-8#2)
the coarse-grained##4##2##(2007-9#1)(2008-8#1)(2008-9#2)
the coarsening##3##2##(2004-9#1)(2008-3#1)(2008-7#1)
the coast and##4##3##(1990-6#1)(1996-4#1)(2007-5#1)(2010-8#1)
the coast of Guerrero##3##4##(2007-3#3)
the coast of##13##3##(1993-7#1)(1996-7#1)(2007-2#1)(2007-3#3)(2007-8#1)(2008-5#2)(2011-1#2)(2011-12#1)(2012-1#1)
the coast##24##2##(1990-6#1)(1993-7#1)(1996-4#1)(1996-7#1)(2007-2#1)(2007-3#3)(2007-5#6)(2007-8#1)(2008-5#4)(2010-8#1)(2011-1#2)(2011-12#1)(2012-1#1)
the coastal and##3##3##(2007-1#1)(2008-8#2)
the coastal area##2##3##(2008-10#1)(2010-9#1)
the coastal plain of##3##4##(2008-5#1)(2011-2#2)
the coastal region##2##3##(2007-8#1)(2010-8#1)
the coastal saline##2##3##(2010-4#2)
the coastal upwelling##2##3##(2007-5#1)(2008-5#1)
the coastal waters##2##3##(2007-5#1)(2008-5#1)
the coastal##29##2##(2007-1#1)(2007-10#1)(2007-5#2)(2007-8#1)(2008-10#3)(2008-3#3)(2008-5#3)(2008-8#5)(2010-4#2)(2010-8#2)(2010-9#2)(2011-2#2)(2013-1#1)(2013-8#1)
the coasts of##3##3##(2007-3#1)(2008-5#1)(2013-7#1)
the coasts##4##2##(2007-3#1)(2008-5#1)(2011-2#1)(2013-7#1)
the coat color##2##3##(1997-5#1)(2006-5#1)
the coat initiator##2##3##(1997-4#2)
the coat protein (CP) and##3##5##(2008-10#3)
the coat protein (CP) gene of##4##6##(2008-10#4)
the coat protein (CP) gene##8##5##(2005-11#1)(2008-10#6)(2008-8#1)
the coat protein (CP)##15##4##(2005-11#1)(2008-10#13)(2008-8#1)
the coat protein gene of##5##5##(1997-1#1)(1997-2#1)(1997-6#1)(2008-10#2)
the coat protein gene##10##4##(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#1)(2008-10#5)
the coat protein of##3##4##(1992-9#1)(1997-2#1)(2008-10#1)
the coat protein##41##3##(1991-5#3)(1992-9#1)(1995-1#1)(1997-1#3)(1997-2#4)(1997-4#1)(1997-6#1)(2005-11#1)(2008-10#25)(2008-8#1)
the coat##54##2##(1991-5#3)(1992-9#1)(1995-1#1)(1997-1#3)(1997-2#4)(1997-4#5)(1997-5#1)(1997-6#1)(2005-11#1)(2006-5#1)(2008-10#31)(2008-8#1)(2012-2#1)
the coated##21##2##(1992-11#1)(1995-2#1)(1995-6#2)(2004-9#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-4#1)(2009-11#1)(2009-4#1)(2010-1#1)(2010-5#1)
the coating and##2##3##(2008-10#1)(2008-3#1)
the coating is##2##3##(2008-3#1)(2010-4#1)
the coating of the##2##4##(1993-3#1)(2008-2#1)
the coating of##4##3##(1993-3#1)(1997-4#1)(2008-2#1)(2013-1#1)
the coating on##2##3##(2006-2#1)(2009-7#1)
the coating or film##2##4##(2008-10#2)
the coating process##3##3##(2004-12#1)(2005-11#1)(2008-2#1)
the coating surface##2##3##(2008-3#2)
the coating thickness##3##3##(2008-3#3)
the coating was##2##3##(2008-5#2)
the coating##46##2##(1993-3#1)(1995-12#1)(1995-2#1)(1997-4#1)(2004-12#3)(2004-9#1)(2005-11#1)(2006-2#1)(2007-12#1)(2008-10#8)(2008-2#3)(2008-3#10)(2008-5#3)(2009-11#1)(2009-6#2)(2009-7#1)(2010-4#4)(2010-5#1)(2013-1#2)
the coatings##7##2##(2004-9#1)(2007-12#1)(2008-3#2)(2008-7#1)(2010-4#2)
the coaxial##3##2##(2005-11#1)(2007-11#1)(2008-6#1)
the cobalt##10##2##(1993-3#1)(1994-6#2)(2006-4#1)(2007-10#1)(2008-10#2)(2008-3#1)(2010-7#2)
the cocaine##11##2##(1996-1#1)(1996-10#3)(1996-4#1)(1997-2#5)(1997-5#1)
the cocaine-ethanol groups##5##3##(1997-2#5)
the cocaine-induced##2##2##(1995-12#1)(2008-10#1)
the cochlea and the##4##4##(2011-1#1)(2012-2#3)
the cochlea and##5##3##(2008-9#1)(2011-1#1)(2012-2#3)
the cochlea##20##2##(1991-1#2)(1995-12#1)(1996-3#3)(2007-3#1)(2008-9#4)(2009-5#2)(2009-9#1)(2011-1#1)(2012-2#5)
the cochlear implant##11##3##(2008-9#8)(2012-2#3)
the cochlear nerve##2##3##(2006-12#1)(2008-9#1)
the cochlear nucleus and##2##4##(1997-1#2)
the cochlear nucleus##7##3##(1992-9#2)(1993-12#1)(1995-12#1)(1997-1#3)
the cochlear spiral##2##3##(1995-12#1)(1996-3#1)
the cochlear##27##2##(1992-9#2)(1993-12#1)(1995-12#2)(1995-3#1)(1996-3#1)(1997-1#3)(2006-12#1)(2008-9#9)(2009-5#1)(2009-8#1)(2012-2#5)
the cochleostomy site##2##3##(2008-9#2)
the cockatoo##2##2##(1997-3#2)
the cockroach##7##2##(1990-4#1)(1995-11#1)(2007-12#2)(2008-8#1)(2011-12#1)(2012-12#1)
the cocktail##3##2##(2006-2#1)(2008-11#1)(2009-5#1)
the cocoon##2##2##(2011-12#2)
the coculture##4##2##(1993-4#1)(2008-11#1)(2008-5#1)(2008-7#1)
the cod β1 globin##2##4##(2012-12#2)
the cod##3##2##(1995-6#1)(2012-12#2)
the code of##2##3##(2011-2#1)(2013-7#1)
the code##14##2##(1990-5#1)(1995-4#1)(2006-5#1)(2007-4#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-7#1)
the coded##4##2##(2008-10#1)(2010-12#1)(2010-8#1)(2012-3#1)
the codes##7##2##(2007-12#1)(2013-1#6)
the coding and classification systems##2##5##(1994-2#2)
the coding and non-coding regions##3##5##(2007-6#1)(2008-7#1)(2012-2#1)
the coding and##7##3##(1990-11#1)(1992-9#1)(1994-2#2)(2007-6#1)(2008-7#1)(2012-2#1)
the coding capacity of a##2##5##(1995-8#1)(2008-1#1)
the coding domain##3##3##(1991-6#1)(1994-5#2)
the coding gain##3##3##(2008-2#3)
the coding gene##2##3##(1990-3#1)(2008-3#1)
the coding region and##5##4##(1990-6#1)(1993-4#1)(1993-6#1)(1996-4#1)(2008-12#1)
the coding region for the##2##5##(1990-12#1)(1990-7#1)
the coding region for##4##4##(1990-12#1)(1990-7#2)(1993-11#1)
the coding region of lambdaN gene##3##6##(2008-8#3)
the coding region of the human##2##6##(1992-7#1)(2008-4#1)
the coding region of the##14##5##(1990-11#1)(1990-5#2)(1992-11#1)(1992-7#1)(1993-6#2)(1994-3#1)(1994-8#1)(1996-1#1)(1997-7#1)(2006-12#1)(2007-1#1)(2008-4#1)
the coding region of##33##4##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-8#1)(1991-8#1)(1992-11#1)(1992-7#2)(1992-8#2)(1993-2#1)(1993-6#2)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-7#1)(2006-11#1)(2006-12#1)(2007-1#1)(2008-4#1)(2008-6#1)(2008-8#3)
the coding region was##2##4##(1991-6#1)(1997-2#1)
the coding region##70##3##(1990-11#1)(1990-12#3)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#1)(1991-10#2)(1991-12#2)(1991-2#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-7#2)(1992-8#2)(1993-11#1)(1993-2#3)(1993-4#1)(1993-5#1)(1993-6#4)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-11#1)(2006-12#2)(2007-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#4)(2010-5#1)(2013-8#1)
the coding regions of##2##4##(1991-12#1)(1997-4#1)
the coding regions##9##3##(1991-12#2)(1991-9#1)(1993-11#1)(1993-5#1)(1995-1#1)(1995-8#1)(1997-4#1)(2008-10#1)
the coding sequence for the##4##5##(1990-10#1)(1994-3#1)(1995-8#1)(1997-3#1)
the coding sequence for##5##4##(1990-10#1)(1991-9#1)(1994-3#1)(1995-8#1)(1997-3#1)
the coding sequence of the##10##5##(1990-5#1)(1991-12#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-12#1)(1996-11#2)(1996-2#1)(1997-8#1)
the coding sequence of##16##4##(1990-5#1)(1991-12#1)(1992-10#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-11#2)(1996-2#1)(1997-8#1)(2008-1#1)
the coding sequence was##2##4##(1997-4#1)(2008-8#1)
the coding sequence##28##3##(1990-10#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-9#2)(1992-10#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-8#2)(1996-11#2)(1996-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-8#1)
the coding sequences of the##5##5##(1994-8#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-2#1)
the coding sequences of##11##4##(1994-8#1)(1995-8#2)(1996-10#2)(1996-2#3)(1997-2#1)(1997-4#1)(2007-5#1)
the coding sequences##12##3##(1992-3#1)(1994-8#1)(1995-8#2)(1996-10#2)(1996-2#3)(1997-2#1)(1997-4#1)(2007-5#1)
the coding##155##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-3#2)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#1)(1991-10#2)(1991-12#5)(1991-2#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#3)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#2)(1992-8#4)(1992-9#1)(1993-11#3)(1993-12#1)(1993-2#5)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#4)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#3)(1994-8#3)(1994-9#1)(1995-1#1)(1995-12#1)(1995-6#2)(1995-8#7)(1996-1#1)(1996-10#2)(1996-11#3)(1996-2#5)(1996-4#1)(1996-6#2)(1996-7#2)(1997-2#2)(1997-3#2)(1997-4#3)(1997-7#3)(1997-8#2)(2006-11#1)(2006-12#2)(2007-1#1)(2007-5#1)(2007-6#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-5#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
the codon for##6##3##(1990-11#2)(1993-8#1)(1993-9#1)(2008-10#2)
the codon usage##4##3##(1990-9#2)(1995-4#1)(1997-8#1)
the codon##20##2##(1990-11#2)(1990-9#2)(1991-11#1)(1992-11#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-8#1)(1995-4#1)(1997-6#1)(1997-8#1)(2005-8#1)(2006-11#1)(2008-10#2)(2013-8#1)
the codons for the##2##4##(1994-12#1)(1994-2#1)
the codons##3##2##(1994-12#1)(1994-2#1)(1997-4#1)
the coefficient of determination##2##4##(2008-10#1)(2011-2#1)
the coefficient of the##2##4##(2004-2#1)(2008-2#1)
the coefficient of variation (CV) of##2##6##(2008-10#1)(2008-8#1)
the coefficient of variation for##2##5##(1990-2#1)(2008-10#1)
the coefficient of variation was##5##5##(1994-3#1)(2005-4#1)(2007-8#1)(2008-10#1)(2008-3#1)
the coefficient of variation##19##4##(1990-2#1)(1992-3#1)(1994-3#1)(1996-5#1)(2005-4#1)(2007-8#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)
the coefficient of##32##3##(1990-2#1)(1992-3#1)(1994-3#1)(1996-5#1)(2004-2#1)(2005-11#2)(2005-4#1)(2007-8#1)(2008-10#12)(2008-2#5)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
the coefficient##36##2##(1990-2#1)(1992-3#1)(1994-3#1)(1996-5#1)(2004-2#1)(2005-11#2)(2005-4#1)(2007-8#1)(2008-10#12)(2008-2#7)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
the coefficients of the linear##2##5##(1994-4#1)(2008-3#1)
the coefficients of the##10##4##(1994-4#1)(1997-6#1)(2007-9#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-6#1)(2010-2#1)
the coefficients of variation##5##4##(1991-8#1)(1996-3#2)(2008-10#2)
the coefficients of##21##3##(1990-12#1)(1991-8#1)(1994-4#1)(1996-3#2)(1997-3#1)(1997-6#1)(2007-9#2)(2008-10#4)(2008-2#3)(2008-3#2)(2008-6#2)(2010-2#1)
the coefficients to##2##3##(2008-2#1)(2010-2#1)
the coefficients##31##2##(1990-12#1)(1991-8#1)(1993-5#1)(1994-4#1)(1996-3#2)(1997-3#1)(1997-6#1)(2006-4#1)(2007-7#1)(2007-9#2)(2008-10#4)(2008-2#7)(2008-3#3)(2008-6#2)(2008-8#1)(2010-2#2)
the coelacanth Latimeria##2##3##(1991-5#2)
the coelacanth##3##2##(1991-5#3)
the coelomic fluid##2##3##(1990-5#1)(1993-12#1)
the coelomic##7##2##(1990-5#1)(1993-12#1)(1994-10#1)(2007-6#1)(2008-5#2)(2011-2#1)
the coenzyme in##2##3##(1992-6#1)(2013-8#1)
the coenzyme specificity##2##3##(1990-7#2)
the coenzyme##18##2##(1990-7#2)(1991-11#1)(1991-2#2)(1991-7#2)(1992-6#4)(1994-8#1)(1995-10#1)(1996-8#2)(2008-10#1)(2013-1#1)(2013-8#1)
the coercive##2##2##(1996-11#1)(2007-12#1)
the coevolution between##2##3##(2008-8#2)
the coevolution of##3##3##(1994-2#1)(2008-1#1)(2008-8#1)
the coevolution##6##2##(1994-2#1)(2008-1#1)(2008-10#1)(2008-8#3)
the coevolutionary dynamics##2##3##(2008-10#2)
the coevolutionary##4##2##(1995-5#1)(2008-10#2)(2010-10#1)
the coexistence of a##2##4##(2007-12#1)(2008-9#1)
the coexistence of both##2##4##(2008-9#1)(2013-8#1)
the coexistence of competitors##2##4##(2008-8#1)(2008-9#1)
the coexistence of the##2##4##(2008-1#1)(2008-10#1)
the coexistence of these two##2##5##(2007-4#1)(2012-2#1)
the coexistence of these##5##4##(1997-1#1)(2007-3#1)(2007-4#1)(2012-2#1)(2013-8#1)
the coexistence of three##2##4##(1994-9#1)(2005-11#1)
the coexistence of two distinct##2##5##(2006-10#1)(2010-6#1)
the coexistence of two##3##4##(1994-9#1)(2006-10#1)(2010-6#1)
the coexistence of##41##3##(1990-4#1)(1992-10#1)(1992-6#1)(1994-9#2)(1995-1#1)(1997-1#1)(2005-11#1)(2005-8#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-4#1)(2008-6#1)(2008-8#4)(2008-9#4)(2010-4#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
the coexistence##43##2##(1990-4#1)(1992-10#1)(1992-6#1)(1992-8#1)(1994-9#2)(1995-1#1)(1997-1#1)(2005-11#1)(2005-8#1)(2006-10#3)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-4#1)(2008-6#1)(2008-8#4)(2008-9#4)(2010-4#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
the coexisting##6##2##(1990-2#1)(2006-10#1)(2007-12#1)(2008-10#1)(2012-12#1)(2012-2#1)
the coexpression of##4##3##(2007-3#1)(2008-9#1)(2011-2#2)
the cofactor and##2##3##(1994-5#1)(1997-7#1)
the cofactor for##3##3##(1993-12#1)(1995-8#1)(1997-5#1)
the cofactor requirement##2##3##(1990-7#1)(2008-11#1)
the cofactor##39##2##(1990-4#1)(1990-5#1)(1990-7#4)(1991-2#1)(1991-4#1)(1991-9#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-11#2)(1994-5#4)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-5#1)(1996-7#2)(1997-4#2)(1997-5#1)(1997-7#3)(2008-11#1)(2009-3#1)
the cofactor-binding##2##2##(1990-12#1)(1994-9#1)
the cofactors##3##2##(1992-11#1)(1994-8#2)
the coffee##2##2##(2006-10#1)(2008-10#1)
the cognate mRNA##2##3##(2008-9#2)
the cognate##20##2##(1990-3#1)(1991-2#1)(1991-4#1)(1993-12#1)(1994-11#1)(1995-1#1)(1995-8#1)(1996-5#2)(1997-2#1)(2006-12#1)(2007-11#2)(2008-10#3)(2008-4#1)(2008-9#3)
the cognition##2##2##(2009-10#2)
the cognitive and brain sciences##2##5##(2011-12#2)
the cognitive and##12##3##(1991-6#1)(1993-1#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-7#1)(2008-9#2)(2009-7#1)(2011-12#2)
the cognitive characteristics##2##3##(2008-2#1)(2012-2#1)
the cognitive decline##4##3##(1991-6#1)(2008-7#2)(2013-8#1)
the cognitive deficits##4##3##(1993-11#1)(1993-12#1)(1995-11#1)(2008-11#1)
the cognitive function of##2##4##(1996-3#1)(2010-10#1)
the cognitive function##4##3##(1996-3#1)(2009-10#1)(2010-10#1)(2013-8#1)
the cognitive functions##4##3##(2008-4#2)(2008-7#1)(2010-10#1)
the cognitive impairment##2##3##(2008-2#1)(2010-11#1)
the cognitive impairments##2##3##(1990-8#1)(1993-11#1)
the cognitive map##4##3##(2008-11#4)
the cognitive performance##3##3##(2005-8#2)(2006-3#1)
the cognitive processes##3##3##(1994-5#1)(2009-3#1)(2009-7#1)
the cognitive sciences##2##3##(2008-1#1)(2008-2#1)
the cognitive status of##2##4##(1993-11#1)(2007-2#1)
the cognitive symptoms of##2##4##(2007-7#1)(2008-4#1)
the cognitive##88##2##(1990-3#1)(1990-8#1)(1991-6#3)(1991-8#1)(1993-1#1)(1993-11#3)(1993-12#1)(1994-2#1)(1994-5#1)(1994-6#2)(1995-11#1)(1995-12#2)(1996-11#1)(1996-3#1)(2005-8#2)(2006-3#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#8)(2008-12#1)(2008-2#6)(2008-4#3)(2008-7#4)(2008-9#2)(2009-10#4)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#2)(2010-10#2)(2010-11#1)(2010-2#1)(2010-3#1)(2011-1#3)(2011-12#3)(2012-1#4)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
the cohered structures##2##3##(1991-7#2)
the cohered##4##2##(1991-7#4)
the coherence function##6##3##(2007-12#1)(2008-2#1)(2008-3#4)
the coherence length of the light source##2##7##(2007-12#1)(2008-3#1)
the coherence length of the##4##5##(2007-11#1)(2007-12#2)(2008-3#1)
the coherence length of##6##4##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
the coherence length##11##3##(2006-7#2)(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#4)
the coherence of the##4##4##(2006-4#1)(2007-11#1)(2010-7#1)(2012-2#1)
the coherence of##7##3##(2006-4#1)(2007-11#1)(2008-3#2)(2008-7#1)(2010-7#1)(2012-2#1)
the coherence properties of##3##4##(2007-12#1)(2008-1#1)(2008-2#1)
the coherence##31##2##(1991-4#1)(2006-4#1)(2006-5#2)(2006-7#2)(2007-11#3)(2007-12#5)(2008-1#1)(2008-2#3)(2008-3#10)(2008-7#1)(2010-7#1)(2012-2#1)
the coherent and the incoherent combinations##2##6##(2008-3#2)
the coherent and the incoherent##4##5##(2008-3#4)
the coherent and##5##3##(2008-10#1)(2008-3#4)
the coherent beam##4##3##(2008-1#3)(2008-2#1)
the coherent noise##2##3##(2008-3#2)
the coherent optical##2##3##(2007-11#1)(2007-12#1)
the coherent speckle##2##3##(2007-11#2)
the coherent sum##2##3##(2008-2#2)
the coherent##33##2##(2006-4#1)(2007-11#6)(2007-12#6)(2008-1#3)(2008-10#1)(2008-2#5)(2008-3#10)(2009-5#1)
the cohesive ends of##2##4##(1993-11#2)
the cohesive##6##2##(1993-11#2)(1993-4#1)(2005-11#1)(2010-4#2)
the cohesiveness##2##2##(1996-3#1)(2009-8#1)
the cohort had##3##3##(2006-8#1)(2007-10#1)(2010-4#1)
the cohort of##4##3##(2006-10#1)(2006-8#2)(2008-6#1)
the cohort was##7##3##(1991-5#1)(1995-9#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-8#1)(2013-1#1)
the cohort with##2##3##(1994-2#1)(2008-7#1)
the cohort##34##2##(1990-10#1)(1991-5#2)(1993-12#1)(1994-12#1)(1994-2#1)(1994-4#1)(1995-8#1)(1995-9#2)(2006-10#1)(2006-8#4)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-9#2)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-4#2)(2011-1#1)(2012-12#2)(2013-1#1)
the coil and##2##3##(2008-10#2)
the coil to##2##3##(2010-7#1)(2012-2#1)
the coil##13##2##(1995-4#1)(1996-9#1)(2008-10#3)(2008-2#1)(2008-9#1)(2010-7#3)(2012-2#1)(2013-7#2)
the coil's##2##2##(2005-11#1)(2008-4#1)
the coiled coil##4##3##(1992-9#1)(1993-11#1)(1997-7#2)
the coiled##6##2##(1992-9#1)(1993-11#1)(1997-7#2)(2008-2#1)(2011-2#1)
the coiled-coil pitch##2##3##(1992-9#2)
the coiled-coil structure and##2##4##(1993-3#2)
the coiled-coil structure##3##3##(1993-3#3)
the coiled-coil##11##2##(1992-6#1)(1992-9#3)(1993-3#5)(1995-6#2)
the coils were##2##3##(1990-5#1)(1996-9#1)
the coils##5##2##(1990-5#1)(1995-11#1)(1996-9#1)(2008-4#1)(2013-7#1)
the coin##5##2##(1995-12#1)(2007-9#1)(2008-4#2)(2010-12#1)
the coincidence of the##2##4##(2008-8#1)(2011-1#1)
the coincidence of##8##3##(1996-6#1)(2008-4#1)(2008-8#1)(2009-2#1)(2011-1#1)(2012-2#1)(2013-1#2)
the coincidence##11##2##(1996-6#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-2#1)(2011-1#1)(2012-2#1)(2013-1#2)
the coincident##2##2##(1995-5#1)(2008-3#1)
the col-36##2##2##(1993-12#2)
the col-6##2##2##(1993-12#2)
the colchicine##2##2##(1993-6#2)
the cold and##2##3##(2007-4#1)(2012-12#1)
the cold chain##3##3##(1994-9#2)(2008-1#1)
the cold vapor mercury##2##4##(2008-10#2)
the cold war##2##3##(2008-11#1)(2011-2#1)
the cold##39##2##(1991-2#2)(1993-2#1)(1994-12#1)(1994-2#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-6#1)(2005-11#1)(2006-10#1)(2006-12#5)(2007-11#1)(2007-12#1)(2007-4#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2009-8#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)
the cold-exposed##2##2##(1995-3#1)(2008-7#1)
the cold-hardiness strategies##2##3##(2008-8#2)
the cold-shock response in mammalian##2##5##(2008-11#2)
the cold-shock##3##2##(1997-7#1)(2008-11#2)
the cold-treated gels##2##3##(2005-11#2)
the colder##2##2##(2007-2#1)(2009-4#1)
the collaboration of##3##3##(2007-11#1)(2007-4#1)(2008-2#1)
the collaboration##7##2##(1994-12#1)(2007-11#1)(2007-4#1)(2008-2#2)(2010-3#1)(2010-5#1)
the collaborative efforts of##4##4##(1994-9#1)(1996-1#1)(2010-10#1)(2013-1#1)
the collaborative encoding deficit##4##4##(2013-1#4)
the collaborative study##2##3##(1997-2#1)(2008-10#1)
the collaborative##26##2##(1992-1#1)(1994-9#1)(1995-2#1)(1996-1#1)(1997-2#1)(1997-3#1)(2005-8#1)(2006-2#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-11#3)(2008-12#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#5)
the collage##2##2##(2008-2#2)
the collagen content was##2##4##(1990-5#1)(1991-9#1)
the collagen fiber##2##3##(2008-5#1)(2013-1#1)
the collagen fibril##2##3##(1992-7#1)(2013-8#1)
the collagen gel##2##3##(1994-6#2)
the collagen in##2##3##(2004-2#1)(2012-12#1)
the collagen is##2##3##(1992-6#1)(2010-8#1)
the collagen network##2##3##(2008-5#1)(2008-7#1)
the collagen of##2##3##(1992-6#1)(2006-4#1)
the collagen sheets##3##3##(2010-8#3)
the collagen##46##2##(1990-5#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-6#6)(1992-7#1)(1993-3#1)(1994-6#2)(1995-5#1)(1997-7#1)(2004-2#1)(2006-12#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-5#6)(2008-7#2)(2008-8#1)(2009-7#1)(2010-8#5)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#4)
the collagen-like domain of##2##4##(1991-6#1)(1993-3#1)
the collagenase##6##2##(1994-2#1)(1996-8#3)(2004-12#1)(2007-10#1)
the collagenous##5##2##(1996-8#1)(2007-12#1)(2008-11#1)(2008-7#2)
the collapse of the Soviet Union##2##6##(1992-5#1)(2008-12#1)
the collapse of the##6##4##(1992-5#1)(1993-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)
the collapse of##13##3##(1991-9#1)(1992-3#1)(1992-5#1)(1993-4#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-8#1)
the collapse##17##2##(1991-9#1)(1992-3#1)(1992-5#1)(1993-4#1)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-8#1)
the collapsed##3##2##(2006-10#1)(2012-12#1)(2012-3#1)
the collapsing method and the##2##5##(2012-3#2)
the collapsing method##3##3##(2012-3#3)
the collapsing##4##2##(2008-11#1)(2012-3#3)
the collar and cuff sling##2##5##(2006-9#2)
the collar and##3##3##(2006-9#2)(2009-3#1)
the collar##8##2##(1995-12#2)(2005-10#2)(2006-9#2)(2008-10#1)(2009-3#1)
the collateral circulation of the##2##5##(1990-4#1)(2010-11#1)
the collateral circulation##4##3##(1990-4#1)(1994-1#1)(2007-9#1)(2010-11#1)
the collateral##14##2##(1990-4#1)(1991-2#1)(1992-9#1)(1994-1#1)(1995-8#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2010-11#1)(2012-2#1)
the colleagues##2##2##(2006-10#1)(2007-8#1)
the collected data##11##3##(1992-1#1)(1992-3#1)(1994-1#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2010-8#2)
the collected information##2##3##(2007-1#1)(2011-2#1)
the collected power##2##3##(2008-2#2)
the collected##31##2##(1991-2#1)(1991-4#1)(1992-1#1)(1992-3#1)(1994-1#1)(1994-8#1)(2005-11#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#3)(2008-5#2)(2008-6#2)(2008-9#1)(2009-6#1)(2010-8#2)(2011-2#1)(2012-1#1)
the collecting lens aperture##3##4##(2008-2#3)
the collecting##10##2##(1996-3#1)(2007-3#1)(2007-9#1)(2008-2#4)(2008-5#1)(2008-6#1)(2011-2#1)
the collection and analysis of##3##5##(1994-2#1)(2008-1#1)(2010-8#1)
the collection and##7##3##(1994-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2010-1#1)(2010-8#1)
the collection at##2##3##(2008-10#1)(2008-5#1)
the collection efficiency for##2##4##(2008-2#1)(2011-1#1)
the collection efficiency##3##3##(2007-11#1)(2008-2#1)(2011-1#1)
the collection of blood##2##4##(1992-8#1)(2008-2#1)
the collection of data##8##4##(1990-12#1)(1991-3#1)(1995-12#1)(1997-3#2)(1997-4#1)(2007-6#1)(2010-3#1)
the collection of large##2##4##(2008-11#1)(2010-12#1)
the collection of sexual network data##2##6##(2010-2#2)
the collection of the##4##4##(2004-11#1)(2006-12#1)(2007-11#1)(2008-6#1)
the collection of##62##3##(1990-12#1)(1991-3#1)(1992-8#1)(1995-12#1)(1996-10#1)(1996-3#1)(1997-3#3)(1997-4#1)(1997-5#1)(2004-11#1)(2006-12#2)(2007-11#2)(2007-12#3)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#2)(2008-6#2)(2008-9#1)(2009-12#1)(2009-5#2)(2010-12#2)(2010-2#5)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#4)
the collection##103##2##(1990-12#1)(1991-3#1)(1992-1#1)(1992-8#1)(1994-2#2)(1995-12#1)(1996-10#1)(1996-3#1)(1996-6#1)(1997-3#3)(1997-4#1)(1997-5#1)(2004-11#2)(2005-10#1)(2006-12#2)(2007-11#4)(2007-12#3)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#21)(2008-11#2)(2008-12#2)(2008-2#6)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#2)(2008-9#1)(2009-12#1)(2009-5#2)(2010-1#1)(2010-12#2)(2010-2#6)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-11#1)(2012-12#2)(2013-1#4)(2013-7#1)
the collections of##4##3##(2007-11#1)(2007-5#2)(2008-5#1)
the collections were##2##3##(2007-3#1)(2008-10#1)
the collections##6##2##(2007-11#1)(2007-3#1)(2007-5#2)(2008-10#1)(2008-5#1)
the collective knowledge of##2##4##(2008-10#1)(2008-5#1)
the collective knowledge##3##3##(2008-10#1)(2008-5#1)(2010-10#1)
the collective##22##2##(1991-11#1)(1992-6#1)(1994-1#1)(1995-3#1)(1997-3#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-10#1)(2012-11#1)(2012-3#1)
the collector##4##2##(2008-10#4)
the college student population##2##4##(2012-1#2)
the college##7##2##(1992-1#1)(1996-1#1)(2007-3#1)(2012-1#2)(2013-8#2)
the collembola-biotest##2##2##(2008-11#2)
the collinear##2##2##(2007-12#1)(2009-9#1)
the collision##5##2##(1993-3#2)(2007-12#1)(2008-1#1)(2008-10#1)
the collision-induced frequency shift##3##4##(2007-12#3)
the collision-induced##4##2##(1991-10#1)(2007-12#3)
the collisional quenching##2##3##(2006-10#1)(2007-12#1)
the collisional##6##2##(1995-8#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-2#2)
the collisions between##3##3##(2005-11#2)(2007-12#1)
the collisions##4##2##(2005-11#2)(2007-12#2)
the colloid##10##2##(2005-11#1)(2005-4#2)(2008-10#3)(2008-2#4)
the colloidal particles##3##3##(2005-11#3)
the colloidal##17##2##(2005-11#7)(2006-5#2)(2008-10#5)(2008-3#1)(2008-5#1)(2008-8#1)
the colloids##3##2##(2006-5#1)(2008-10#1)(2010-7#1)
the colocalization of##5##3##(1993-12#1)(1995-11#1)(1996-4#1)(2011-2#1)(2012-12#1)
the colocalization##6##2##(1993-12#1)(1995-11#1)(1996-4#1)(1997-6#1)(2011-2#1)(2012-12#1)
the colon and rectum##7##4##(1992-8#1)(1993-10#1)(2006-2#1)(2011-2#2)(2012-12#1)(2013-1#1)
the colon and the##2##4##(2006-8#1)(2008-12#1)
the colon and##17##3##(1990-2#1)(1992-8#1)(1993-10#1)(1993-5#1)(1993-7#1)(2006-10#1)(2006-2#2)(2006-8#1)(2008-12#2)(2011-2#4)(2012-12#1)(2013-1#1)
the colon during##2##3##(1992-6#1)(2011-2#1)
the colon in##4##3##(1991-6#2)(2006-8#2)
the colon of##5##3##(2008-12#4)(2011-3#1)
the colon was##4##3##(2007-5#1)(2008-11#1)(2009-1#1)(2009-2#1)
the colon with a##3##4##(1990-3#1)(2007-5#1)(2012-11#1)
the colon with##4##3##(1990-3#1)(2007-5#1)(2008-11#1)(2012-11#1)
the colon##112##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#2)(1990-4#3)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#4)(1991-8#2)(1992-2#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-10#2)(1993-11#1)(1993-5#1)(1993-7#1)(1993-8#2)(1993-9#2)(1994-12#1)(1994-2#2)(1994-9#1)(1995-9#1)(1996-11#1)(1996-2#1)(1997-5#1)(1997-8#2)(2006-10#2)(2006-2#5)(2006-5#1)(2006-6#1)(2006-8#4)(2007-5#2)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#8)(2008-4#3)(2008-6#1)(2009-1#2)(2009-12#4)(2009-2#2)(2009-3#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-6#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
the colon)##2##2##(2006-10#1)(2010-12#1)
the colon]##2##2##(1990-6#1)(2009-2#1)
the colonial##6##2##(1994-8#1)(1995-9#1)(2006-2#1)(2006-7#1)(2008-7#1)(2008-8#1)
the colonic mucosa##6##3##(1992-8#2)(2006-4#1)(2006-8#1)(2009-9#1)(2011-3#1)
the colonic##22##2##(1990-7#1)(1991-10#1)(1991-12#2)(1992-4#1)(1992-8#2)(1995-8#1)(1995-9#1)(1997-8#1)(2006-10#1)(2006-4#1)(2006-8#2)(2007-4#1)(2008-4#1)(2009-1#1)(2009-9#1)(2010-8#1)(2011-2#1)(2011-3#1)(2013-1#1)
the colonies on the##2##4##(2006-8#2)
the colonies on##3##3##(1997-4#1)(2006-8#2)
the colonies##11##2##(1991-9#1)(1997-4#1)(2006-8#2)(2008-10#2)(2008-11#1)(2008-5#2)(2008-9#1)(2010-1#1)
the colonisation of##2##3##(2006-7#1)(2008-11#1)
the colonization effect##2##3##(2008-8#2)
the colonization of the##2##4##(2006-8#1)(2008-10#1)
the colonization of##11##3##(1992-4#1)(1996-3#1)(2006-5#1)(2006-8#1)(2008-10#6)(2009-9#1)
the colonization##21##2##(1992-4#1)(1993-9#1)(1996-3#1)(2006-5#1)(2006-8#1)(2008-10#8)(2008-8#4)(2009-9#1)(2013-1#1)(2013-8#2)
the colonized##2##2##(2005-11#1)(2008-10#1)
the colonoscope##3##2##(2007-5#3)
the colons##4##2##(2006-8#2)(2008-11#1)(2008-7#1)
the colony and##2##3##(2008-10#1)(2009-5#1)
the colony counting method##2##4##(2008-10#2)
the colony##24##2##(1991-12#1)(1996-11#1)(2004-11#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#4)(2009-5#2)
the colony-forming units##3##3##(1994-3#1)(2007-10#1)(2013-1#1)
the colony-forming##5##2##(1991-5#1)(1994-3#1)(1995-6#1)(2007-10#1)(2013-1#1)
the colony-stimulating##3##2##(1991-6#1)(1992-10#1)(2008-4#1)
the color and##6##3##(1996-7#1)(1997-1#2)(2008-3#2)(2008-5#1)
the color center##2##3##(2008-2#2)
the color centers##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
the color of a##2##4##(2007-12#1)(2012-2#1)
the color of the##5##4##(2008-10#2)(2008-3#1)(2011-2#1)(2012-11#1)
the color of##14##3##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-8#3)(2010-1#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-2#1)
the color pigment genes##2##4##(1993-3#1)(1993-6#1)
the color pigment##3##3##(1993-3#2)(1993-6#1)
the color reaction##4##3##(1995-1#1)(2008-10#3)
the color similarity##3##3##(2008-2#3)
the color stability of##3##4##(2010-3#1)(2012-7#1)(2013-1#1)
the color##80##2##(1993-3#2)(1993-6#3)(1995-1#1)(1996-7#1)(1997-1#5)(2005-4#1)(2007-10#1)(2007-12#5)(2008-1#2)(2008-10#13)(2008-2#11)(2008-3#14)(2008-5#1)(2008-6#1)(2009-8#4)(2010-1#1)(2010-3#1)(2010-4#2)(2010-5#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#1)(2012-7#1)(2013-1#1)
the colorants##4##2##(2008-10#4)
the colorectal carcinoma##4##3##(1990-8#1)(1991-5#1)(1992-8#1)(2006-6#1)
the colorectal##9##2##(1990-4#1)(1990-8#2)(1991-5#1)(1992-8#1)(2006-6#1)(2008-10#1)(2008-5#2)
the colorectum##3##2##(1990-11#1)(2008-4#2)
the colored##8##2##(2007-3#1)(2007-8#1)(2008-10#4)(2008-4#1)(2009-2#1)
the colorimetric method##6##3##(1991-10#1)(1994-3#2)(2008-10#3)
the colorimetric reaction between##2##4##(2008-10#2)
the colorimetric##15##2##(1991-10#1)(1994-3#2)(2008-10#10)(2008-5#1)(2012-2#1)
the colors##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
the colour induced##2##3##(2008-5#2)
the colour of the##3##4##(1996-1#1)(2008-10#2)
the colour of##4##3##(1996-1#1)(2008-10#3)
the colour##19##2##(1990-12#1)(1992-11#4)(1996-1#1)(2006-2#1)(2008-10#7)(2008-5#3)(2010-4#2)
the coloured##9##2##(2008-10#7)(2008-5#1)(2010-2#1)
the colposcopy directed biopsy##3##4##(2008-11#3)
the colposcopy directed cytology##2##4##(2008-11#2)
the colposcopy directed##6##3##(2008-11#6)
the colposcopy##7##2##(2006-10#1)(2008-11#6)
the column and the##2##4##(1991-3#1)(2012-12#1)
the column and##6##3##(1991-3#1)(2008-10#2)(2008-9#1)(2010-12#1)(2012-12#1)
the column by##2##3##(1990-12#1)(2008-4#1)
the column could tolerate##2##4##(2008-10#2)
the column could##3##3##(2008-10#3)
the column eluate##2##3##(2008-10#2)
the column for##2##3##(2008-10#1)(2008-4#1)
the column method##3##3##(2008-10#3)
the column temperature##5##3##(2005-12#1)(2008-10#3)(2011-1#1)
the column void volume##2##4##(1990-12#1)(1993-6#1)
the column was##5##3##(1992-6#1)(2008-10#4)
the column with##7##3##(1990-12#1)(2008-10#5)(2008-3#1)
the column##112##2##(1990-11#1)(1990-12#7)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-5#1)(1992-6#1)(1993-6#1)(1996-2#1)(1996-8#3)(1997-1#1)(1997-8#3)(2004-12#1)(2005-12#2)(2007-2#1)(2007-8#1)(2008-10#56)(2008-2#2)(2008-3#2)(2008-4#6)(2008-6#4)(2008-9#2)(2010-11#1)(2010-12#1)(2011-1#1)(2012-12#3)(2013-8#1)
the columnar aerosol##2##3##(2008-2#2)
the columnar metaplasia##2##3##(2007-8#2)
the columnar##10##2##(2006-2#1)(2006-5#1)(2007-3#1)(2007-8#2)(2008-2#2)(2008-3#1)(2008-4#1)(2009-10#1)
the columnar-lined mucosa##2##3##(2009-3#2)
the columnar-lined##3##2##(2006-2#1)(2009-3#2)
the columns were##4##3##(1990-8#1)(1991-3#1)(2008-10#1)(2011-1#1)
the columns##16##2##(1990-3#1)(1990-8#1)(1991-3#1)(2005-12#1)(2007-8#3)(2008-10#6)(2008-8#1)(2009-5#1)(2011-1#1)
the coma aberration##2##3##(2008-3#2)
the coma##5##2##(1991-8#1)(2008-3#4)
the comb of##2##3##(2007-12#1)(2008-3#1)
the comb##8##2##(2007-12#7)(2008-3#1)
the combination and##3##3##(2007-8#2)(2012-2#1)
the combination group##3##3##(2008-12#2)(2008-7#1)
the combination index##2##3##(1992-4#1)(2011-3#1)
the combination of BG + STZ##2##6##(1994-11#2)
the combination of BG +##3##5##(1994-11#3)
the combination of BG##4##4##(1994-11#4)
the combination of DTPA and BHT##2##6##(2008-5#2)
the combination of IdUrd and AG-331##2##6##(1995-6#2)
the combination of Nep1 and P##2##6##(2008-10#2)
the combination of a##16##4##(1997-1#1)(2007-11#3)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)
the combination of agents##2##4##(2007-9#2)
the combination of an##5##4##(1992-2#1)(1992-8#1)(2007-12#1)(2010-2#1)(2012-12#1)
the combination of band depth analysis and PLSR##3##8##(2013-8#3)
the combination of both##7##4##(1991-7#1)(1995-5#1)(1996-12#1)(2007-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
the combination of carboplatin##2##4##(1991-10#2)
the combination of clozapine##2##4##(2008-12#2)
the combination of different##4##4##(2008-10#3)(2009-4#1)
the combination of high##3##4##(2007-11#1)(2008-10#1)(2012-3#1)
the combination of insulin##2##4##(2008-3#1)(2009-9#1)
the combination of intravenous##2##4##(2007-11#1)(2013-1#1)
the combination of octreotide and tamoxifen##2##6##(1994-8#2)
the combination of radiation##2##4##(1991-2#1)(2010-3#1)
the combination of radiotherapy##2##4##(1991-2#1)(1997-6#1)
the combination of the two##6##5##(1990-12#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-5#1)(2012-5#1)
the combination of the##22##4##(1990-12#1)(1990-5#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-4#2)(2010-5#1)(2012-3#1)(2012-5#1)
the combination of these drugs with##2##6##(1995-5#1)(2013-8#1)
the combination of these drugs##3##5##(1995-5#1)(2008-7#1)(2013-8#1)
the combination of these##9##4##(1995-5#1)(2008-7#1)(2008-9#1)(2009-1#2)(2009-2#1)(2010-2#1)(2013-8#2)
the combination of two##5##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-4#1)
the combination of##293##3##(1990-1#1)(1990-10#2)(1990-12#1)(1990-2#3)(1990-5#1)(1990-8#2)(1990-9#1)(1991-10#2)(1991-2#2)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-8#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#4)(1994-2#1)(1994-5#1)(1994-8#3)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#6)(1996-12#3)(1996-4#1)(1997-1#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#2)(2004-1#1)(2004-12#2)(2004-4#1)(2005-11#4)(2005-12#1)(2005-8#1)(2006-10#6)(2006-12#2)(2006-2#1)(2006-4#2)(2006-5#1)(2006-9#1)(2007-11#11)(2007-12#5)(2007-3#1)(2007-5#1)(2007-8#2)(2007-9#5)(2008-1#3)(2008-10#28)(2008-11#4)(2008-12#4)(2008-2#10)(2008-3#9)(2008-4#3)(2008-5#10)(2008-6#3)(2008-7#6)(2008-8#7)(2008-9#9)(2009-1#2)(2009-11#3)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#5)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#7)(2012-3#3)(2012-5#1)(2013-1#7)(2013-7#1)(2013-8#13)
the combination technique##2##3##(2006-10#1)(2008-10#1)
the combination therapy of##2##4##(1995-6#1)(2008-6#1)
the combination therapy##9##3##(1993-2#1)(1995-6#1)(2005-10#1)(2007-8#1)(2008-10#1)(2008-6#2)(2009-3#1)(2012-11#1)
the combination treatment##4##3##(2008-6#1)(2009-6#1)(2012-12#1)(2013-7#1)
the combination vaccine##3##3##(1995-5#1)(2007-11#2)
the combination was##5##3##(1995-6#1)(2005-8#1)(2006-2#1)(2009-4#1)(2010-3#1)
the combination with##4##3##(2006-10#2)(2011-2#1)(2013-8#1)
the combination##370##2##(1990-1#1)(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#1)(1990-8#2)(1990-9#1)(1991-10#2)(1991-12#1)(1991-2#2)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#3)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#2)(1994-11#4)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#3)(1995-12#1)(1995-2#1)(1995-5#8)(1995-6#9)(1995-9#2)(1996-12#3)(1996-4#1)(1997-1#2)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#3)(1997-8#2)(2004-1#1)(2004-12#2)(2004-4#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-8#2)(2006-10#9)(2006-12#2)(2006-2#2)(2006-4#2)(2006-5#1)(2006-9#1)(2007-11#13)(2007-12#7)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#7)(2007-9#6)(2008-1#5)(2008-10#32)(2008-11#5)(2008-12#6)(2008-2#11)(2008-3#10)(2008-4#3)(2008-5#11)(2008-6#6)(2008-7#7)(2008-8#8)(2008-9#11)(2009-1#2)(2009-11#3)(2009-2#3)(2009-3#3)(2009-4#3)(2009-5#1)(2009-6#3)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#4)(2010-2#2)(2010-3#3)(2010-4#5)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#7)(2011-3#1)(2012-1#3)(2012-11#2)(2012-12#5)(2012-2#8)(2012-3#4)(2012-5#1)(2013-1#7)(2013-7#2)(2013-8#14)
the combinations of bupivacaine plus tramadol and bupivacaine plus clonidine##2##10##(2007-2#2)
the combinations of##13##3##(1991-12#1)(1993-7#1)(1996-5#1)(2007-2#2)(2008-10#3)(2008-2#1)(2008-9#2)(2010-10#1)(2013-1#1)
the combinations##17##2##(1991-12#1)(1993-7#1)(1995-9#1)(1996-5#1)(2007-2#2)(2008-10#3)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2011-2#1)(2013-1#1)
the combinatorial##5##2##(1996-3#1)(1997-9#1)(2010-4#1)(2012-1#1)(2013-8#1)
the combined action of##7##4##(1990-12#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-8#1)
the combined actions of##2##4##(1990-7#1)(2008-10#1)
the combined addition of##3##4##(1990-7#1)(1990-8#1)(2008-11#1)
the combined analysis of##2##4##(2008-10#1)(2012-12#1)
the combined analysis##4##3##(2008-10#1)(2012-12#2)(2012-3#1)
the combined application of biochar and inorganic fertilizers##2##8##(2013-8#2)
the combined application of organic and inorganic fertilizers##3##8##(2013-8#3)
the combined application of##5##4##(2013-8#5)
the combined approach##3##3##(2007-8#1)(2013-1#2)
the combined data set##4##4##(2008-10#3)(2008-11#1)
the combined data##6##3##(2008-10#4)(2008-11#1)(2010-4#1)
the combined density of##2##4##(1993-9#1)(2008-9#1)
the combined effect of##17##4##(1990-2#1)(1995-3#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#3)(2008-5#2)(2008-6#1)(2009-8#2)(2010-2#1)(2010-4#1)(2011-1#1)
the combined effect##18##3##(1990-2#1)(1995-3#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-5#2)(2008-6#1)(2009-8#2)(2010-2#1)(2010-4#1)(2011-1#1)
the combined effects of birefringence and diffraction##2##7##(2008-1#2)
the combined effects of energy diffusion##2##6##(2009-2#2)
the combined effects of temperature##2##5##(2008-10#2)
the combined effects of three##2##5##(2008-2#1)(2012-2#1)
the combined effects of##21##4##(1997-7#1)(2005-11#1)(2007-11#1)(2008-1#3)(2008-10#6)(2008-2#1)(2008-3#1)(2009-2#2)(2010-2#1)(2010-4#1)(2011-2#1)(2012-2#2)
the combined effects##22##3##(1997-7#1)(2005-11#1)(2007-11#1)(2008-1#3)(2008-10#6)(2008-2#1)(2008-3#2)(2009-2#2)(2010-2#1)(2010-4#1)(2011-2#1)(2012-2#2)
the combined endpoint##2##3##(1992-9#1)(2007-8#1)
the combined evaluation of##2##4##(1993-10#1)(2006-6#1)
the combined fecal-urinary excreta##2##4##(1990-3#2)
the combined field##2##3##(1997-7#1)(2012-1#1)
the combined group##2##3##(1997-7#1)(2008-8#1)
the combined impact of##3##4##(2006-10#1)(2008-10#1)(2010-7#1)
the combined incidence of##2##4##(2007-11#2)
the combined lipid profile of a high fasting triglyceride level and a low HDL cholesterol level##2##16##(2008-3#2)
the combined measurement##2##3##(1990-10#1)(2008-2#1)
the combined method of ray tracing and diffraction##2##8##(2008-2#2)
the combined method of##4##4##(2008-10#1)(2008-2#2)(2013-1#1)
the combined method##5##3##(2008-10#1)(2008-2#2)(2010-3#1)(2013-1#1)
the combined outcome of coronary death##2##6##(1997-8#2)
the combined outcome of death and##2##6##(2012-2#2)
the combined outcome of##4##4##(1997-8#2)(2012-2#2)
the combined power of##2##4##(2012-2#1)(2012-3#1)
the combined presence of##2##4##(1991-2#1)(1997-5#1)
the combined procedure##2##3##(2007-8#1)(2011-2#1)
the combined processes of##2##4##(2007-12#2)
the combined result of##2##4##(2007-11#1)(2013-1#1)
the combined systems##2##3##(1990-11#2)
the combined techniques##2##3##(1996-3#1)(2008-5#1)
the combined therapy##6##3##(1990-11#1)(1995-6#1)(2008-1#1)(2012-3#1)(2013-1#2)
the combined treatment of##2##4##(1991-9#1)(2009-3#1)
the combined treatment##8##3##(1991-9#1)(2004-12#1)(2006-6#1)(2007-8#1)(2009-3#1)(2012-6#3)
the combined use of##21##4##(1993-3#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#3)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
the combined use##22##3##(1993-3#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#3)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
the combined vaccine##2##3##(2007-11#1)(2008-4#1)
the combined##260##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-7#2)(1990-8#1)(1991-2#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#2)(1995-6#2)(1995-8#2)(1996-12#1)(1996-3#2)(1996-7#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#4)(1997-8#3)(2004-1#1)(2004-10#1)(2004-12#1)(2004-3#1)(2005-11#1)(2005-4#1)(2006-10#5)(2006-12#1)(2006-5#1)(2006-6#4)(2006-9#1)(2007-1#1)(2007-11#8)(2007-12#12)(2007-3#2)(2007-4#3)(2007-5#1)(2007-8#5)(2007-9#1)(2008-1#8)(2008-10#29)(2008-11#4)(2008-12#1)(2008-2#9)(2008-3#13)(2008-4#5)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#5)(2010-7#1)(2011-1#2)(2011-2#5)(2012-1#3)(2012-12#4)(2012-2#6)(2012-3#6)(2012-6#3)(2013-1#10)(2013-8#9)
the combiner##2##2##(2013-7#2)
the combining site of##2##4##(1996-5#1)(1996-7#1)
the combining site##5##3##(1990-10#3)(1996-5#1)(1996-7#1)
the combining##7##2##(1990-10#3)(1990-5#1)(1996-5#1)(1996-7#1)(2008-10#1)
the combs##2##2##(2007-11#1)(2008-6#1)
the combustion of##5##3##(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)
the combustion phase of##2##4##(2008-2#2)
the combustion##18##2##(1996-12#4)(2007-8#3)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#3)(2008-5#1)
the comet assay and##2##4##(1997-4#2)
the comet assay as a##2##5##(1997-4#2)
the comet assay may##2##4##(1997-4#2)
the comet assay to##2##4##(1997-4#2)
the comet assay##17##3##(1997-4#12)(2008-10#2)(2010-5#2)(2013-1#1)
the comet##19##2##(1997-4#12)(1997-5#1)(2008-10#3)(2010-5#2)(2013-1#1)
the comfort of the##2##4##(1994-1#1)(2011-2#1)
the comfort of##3##3##(1994-1#1)(2007-11#1)(2011-2#1)
the comfort##6##2##(1994-1#1)(2007-11#1)(2008-11#1)(2009-8#1)(2011-2#1)(2013-7#1)
the coming decade##2##3##(1995-12#1)(2006-10#1)
the coming of the##2##4##(1993-2#1)(2010-1#1)
the coming years##14##3##(1993-12#1)(1996-1#1)(2005-12#1)(2006-10#2)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-7#1)(2009-10#1)(2010-10#1)(2012-2#1)
the coming##28##2##(1991-11#1)(1993-12#1)(1993-2#1)(1993-7#1)(1995-12#1)(1995-4#1)(1996-1#1)(2005-12#1)(2006-10#3)(2006-9#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-1#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
the commencement of the experiment##2##5##(1992-2#1)(1992-9#1)
the commencement of the##7##4##(1992-2#1)(1992-9#1)(1995-11#1)(2006-4#1)(2007-5#1)(2008-5#1)(2008-6#1)
the commencement of##17##3##(1990-4#1)(1991-12#2)(1992-2#1)(1992-5#1)(1992-9#1)(1995-11#1)(2004-2#1)(2006-4#2)(2007-5#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-6#2)(2009-6#1)
the commencement##18##2##(1990-4#1)(1991-12#2)(1992-2#1)(1992-5#1)(1992-9#1)(1995-11#1)(2004-2#1)(2006-4#2)(2007-5#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-6#2)(2009-6#1)(2012-3#1)
the commentary##6##2##(2007-12#2)(2008-4#4)
the commercial bitumen extraction operation##2##5##(2005-11#2)
the commercial catches##2##3##(2013-7#2)
the commercial enzyme##2##3##(1994-8#1)(1996-12#1)
the commercial kits##2##3##(2007-2#2)
the commercial product##3##3##(2005-11#1)(2008-10#1)(2010-4#1)
the commercial production of##2##4##(2006-5#1)(2008-10#1)
the commercial production##3##3##(2006-5#1)(2008-10#1)(2013-8#1)
the commercial##70##2##(1990-5#1)(1990-7#1)(1994-8#1)(1996-12#2)(1996-8#1)(1997-2#1)(1997-5#1)(1997-6#1)(2004-1#1)(2004-9#1)(2005-11#5)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-4#1)(2007-6#1)(2007-8#2)(2008-10#13)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#5)(2008-9#1)(2009-3#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#2)(2013-8#5)
the commercialization of##2##3##(2011-2#1)(2012-1#1)
the commercialized one##2##3##(2007-8#2)
the commercialized##3##2##(2007-8#2)(2008-10#1)
the commercially available##16##3##(1991-12#1)(1994-9#1)(1997-3#1)(2007-1#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#2)(2010-4#1)(2012-11#1)(2013-7#1)
the commercially important##2##3##(2005-7#1)(2008-10#1)
the commercially##19##2##(1991-12#1)(1994-9#1)(1997-3#1)(2005-7#1)(2007-1#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#2)(2010-4#1)(2011-1#1)(2012-11#1)(2013-7#1)
the commissural##4##2##(1993-7#1)(1994-10#1)(1997-2#1)(1997-5#1)
the commissures##2##2##(2007-12#1)(2008-4#1)
the commitment of the##2##4##(2007-12#1)(2011-12#1)
the commitment of##5##3##(1996-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2011-12#1)
the commitment on##2##3##(1990-12#1)(1996-5#1)
the commitment to##4##3##(1995-10#1)(2007-4#1)(2007-9#1)(2011-2#1)
the commitment##14##2##(1990-12#1)(1992-12#1)(1995-10#1)(1996-10#1)(1996-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-11#1)(2009-10#1)(2011-12#1)(2011-2#1)
the committee reached consensus that the##2##6##(2007-6#2)
the committee reached consensus that##4##5##(2007-6#4)
the committee reviewed 55 articles - all of which pertained to the Activator##2##13##(2007-6#2)
the committee to##2##3##(2004-12#1)(2007-6#1)
the committee##15##2##(1994-2#1)(2004-12#1)(2007-10#1)(2007-6#7)(2007-9#1)(2010-11#1)(2011-12#1)(2011-2#1)(2012-2#1)
the common alpha##2##3##(1994-3#2)
the common alphabeta##3##3##(2009-8#3)
the common amino##2##3##(1992-5#1)(1996-11#1)
the common ancestor of##9##4##(1991-11#1)(1996-5#4)(1997-6#1)(2007-12#1)(2009-8#1)(2010-4#1)
the common and comet##2##4##(2010-8#2)
the common and##5##3##(2009-12#1)(2010-8#2)(2012-2#1)(2013-1#1)
the common approach##2##3##(2008-11#1)(2013-1#1)
the common bean##5##3##(2008-10#5)
the common belief that##2##4##(1990-12#1)(2005-12#1)
the common bile duct##16##4##(1990-5#2)(1990-6#1)(1990-9#2)(1991-3#1)(1993-5#1)(1993-9#1)(1996-11#1)(2007-4#2)(2007-5#1)(2008-3#1)(2008-6#1)(2009-9#1)(2012-1#1)
the common binding##2##3##(1995-5#1)(2013-8#1)
the common brush-tailed possum##2##4##(1997-8#2)
the common carotid artery in##2##5##(2008-7#1)(2010-12#1)
the common carotid artery##7##4##(2008-7#2)(2009-12#1)(2010-12#2)(2012-11#1)(2013-8#1)
the common carotid##9##3##(2007-10#2)(2008-7#2)(2009-12#1)(2010-12#2)(2012-11#1)(2013-8#1)
the common carp##3##3##(2007-3#2)(2008-12#1)
the common causes of##4##4##(2007-7#1)(2007-8#1)(2012-12#1)(2012-3#1)
the common characteristics##2##3##(2008-10#1)(2009-12#1)
the common cold##8##3##(1992-3#1)(1997-1#1)(2008-10#4)(2008-5#1)(2012-3#1)
the common core##2##3##(1994-9#2)
the common diagnostic##3##3##(1991-8#1)(2010-5#1)(2011-1#1)
the common disease/common variant##2##4##(2012-3#2)
the common disease/rare variants##2##4##(2012-3#2)
the common disease/rare##3##3##(2012-3#3)
the common domain##2##3##(1993-11#1)(1994-2#1)
the common feature##2##3##(2006-12#1)(2008-7#1)
the common femoral artery##2##4##(1996-2#1)(2008-10#1)
the common goal of##2##4##(1991-2#1)(2008-6#1)
the common good##2##3##(1993-2#1)(2009-4#1)
the common hepatic artery##3##4##(2008-3#1)(2012-12#1)(2012-2#1)
the common hepatic duct##3##4##(2008-3#2)(2009-2#1)
the common hepatic##6##3##(2008-3#3)(2009-2#1)(2012-12#1)(2012-2#1)
the common human##2##3##(1994-5#1)(2006-10#1)
the common law##4##3##(1995-12#1)(2004-12#1)(2007-10#1)(2008-8#1)
the common marmoset##6##3##(1990-5#2)(1991-9#2)(1995-5#2)
the common mechanisms of##2##4##(2010-7#1)(2013-1#1)
the common methods##4##3##(1992-8#2)(2007-8#1)(2008-4#1)
the common morning glory Ipomoea purpurea##4##6##(2008-9#4)
the common mutation##2##3##(1994-3#1)(2008-7#1)
the common obstacles##2##3##(1994-2#1)(2008-4#1)
the common occurrence of##2##4##(2008-8#1)(2010-8#1)
the common origin of the##2##5##(1991-9#1)(2005-10#1)
the common origin of##3##4##(1990-1#1)(1991-9#1)(2005-10#1)
the common pathway##2##3##(2006-10#1)(2010-11#1)
the common pathways##2##3##(1993-12#1)(2011-2#1)
the common pitfalls in##2##4##(1993-1#1)(2007-8#1)
the common pitfalls##3##3##(1993-1#1)(2007-8#1)(2010-5#1)
the common practice of##5##4##(2008-10#1)(2008-3#1)(2010-2#1)(2011-12#1)(2012-2#1)
the common precursor##3##3##(1993-4#1)(1994-2#1)(2012-3#1)
the common region##5##3##(1990-11#1)(2008-10#3)(2008-8#1)
the common sense##4##3##(1996-3#1)(2008-1#1)(2010-3#1)(2010-4#1)
the common vole##2##3##(1991-8#2)
the common##350##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#4)(1990-6#1)(1990-7#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#5)(1991-9#4)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#3)(1992-8#5)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#4)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#3)(1995-6#2)(1995-8#1)(1995-9#1)(1996-11#4)(1996-12#1)(1996-2#1)(1996-3#4)(1996-5#5)(1996-7#2)(1997-1#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2004-11#1)(2004-12#1)(2005-10#1)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-6#1)(2006-8#1)(2006-9#4)(2007-1#2)(2007-10#5)(2007-11#3)(2007-12#5)(2007-2#4)(2007-3#2)(2007-4#2)(2007-5#3)(2007-7#6)(2007-8#3)(2008-1#5)(2008-10#39)(2008-11#4)(2008-12#3)(2008-2#3)(2008-3#13)(2008-4#6)(2008-5#5)(2008-6#4)(2008-7#9)(2008-8#4)(2008-9#7)(2009-1#1)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#5)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#4)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#7)(2012-1#1)(2012-11#3)(2012-12#4)(2012-2#4)(2012-3#10)(2013-1#12)(2013-7#1)(2013-8#4)
the commonalities##2##2##(1994-12#1)(2008-10#1)
the commoner##2##2##(2007-5#1)(2008-9#1)
the commonest benign##2##3##(1993-9#1)(2008-12#1)
the commonest cause of##8##4##(1992-4#1)(2006-10#1)(2007-7#2)(2008-1#1)(2008-4#1)(2008-7#1)(2013-8#1)
the commonest cause##10##3##(1992-4#1)(2006-10#1)(2007-7#2)(2008-1#3)(2008-4#1)(2008-7#1)(2013-8#1)
the commonest causes of##6##4##(2006-8#1)(2007-7#1)(2008-7#1)(2009-6#1)(2010-9#1)(2013-1#1)
the commonest complication##2##3##(2006-8#1)(2008-1#1)
the commonest form##3##3##(2007-11#1)(2008-5#1)(2011-11#1)
the commonest lesion##2##3##(2007-7#2)
the commonest offending drug##2##4##(2008-8#2)
the commonest offending##3##3##(2007-8#1)(2008-8#2)
the commonest primary##4##3##(2007-7#1)(2008-1#1)(2010-11#1)(2013-1#1)
the commonest secondary##3##3##(2007-7#1)(2008-1#1)(2010-4#1)
the commonest site of##2##4##(2008-5#1)(2011-2#1)
the commonest species##5##3##(2007-7#2)(2008-5#3)
the commonest##102##2##(1990-2#1)(1990-6#1)(1991-8#1)(1992-4#1)(1993-9#1)(1997-8#1)(2004-10#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-8#2)(2007-11#1)(2007-6#1)(2007-7#25)(2007-8#1)(2008-1#12)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#3)(2009-10#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-9#1)(2011-1#3)(2011-11#1)(2011-12#2)(2011-2#3)(2012-3#2)(2013-1#4)(2013-8#3)
the commonly accepted##6##3##(1997-7#1)(2006-4#1)(2006-6#1)(2006-8#1)(2008-1#1)(2008-11#1)
the commonly encountered##2##3##(2008-10#1)(2008-7#1)
the commonly observed##2##3##(1995-8#1)(2008-8#1)
the commonly performed##2##3##(1992-2#1)(2013-1#1)
the commonly seen##2##3##(2007-10#1)(2012-1#1)
the commonly used##36##3##(1991-7#1)(1992-6#1)(1992-8#1)(1995-11#1)(1996-1#1)(1996-10#1)(1997-6#1)(2005-12#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-8#3)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-9#1)(2010-11#1)(2010-4#1)(2010-7#1)(2012-1#1)(2012-12#1)(2013-1#1)
the commonly##62##2##(1991-7#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-8#1)(1995-11#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#1)(1997-6#1)(1997-7#1)(2005-12#1)(2006-10#1)(2006-12#2)(2006-4#2)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#4)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-1#2)(2012-12#3)(2012-2#2)(2013-1#4)
the communication and##2##3##(2008-11#1)(2008-12#1)
the communication between the##3##4##(1997-6#1)(2008-3#1)(2008-4#1)
the communication between##6##3##(1997-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-8#1)
the communication of critical##3##4##(2007-4#1)(2013-1#2)
the communication of emotions##2##4##(2008-12#2)
the communication of##8##3##(1990-12#1)(2007-4#1)(2007-9#1)(2008-12#2)(2010-4#1)(2013-1#2)
the communication system##3##3##(1990-12#1)(2008-2#1)(2008-3#1)
the communication with##4##3##(2008-10#1)(2010-3#2)(2011-2#1)
the communication##49##2##(1990-12#2)(1997-6#2)(2005-7#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-2#4)(2008-3#6)(2008-4#1)(2008-6#3)(2008-7#2)(2009-10#1)(2009-11#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-3#3)(2010-4#1)(2011-2#1)(2012-3#3)(2013-1#4)
the communications##8##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#2)
the communicative##3##2##(1992-7#1)(2010-5#1)(2012-1#1)
the communities in which they##3##5##(1995-3#1)(1996-3#1)(2006-9#1)
the communities in which##5##4##(1995-3#1)(1996-3#2)(2006-9#1)(2008-1#1)
the communities in##7##3##(1995-3#1)(1996-3#2)(2006-9#1)(2007-2#1)(2008-1#1)(2009-4#1)
the communities of##3##3##(2008-1#1)(2008-10#1)(2012-3#1)
the communities that##2##3##(1991-12#1)(2009-2#1)
the communities they serve##3##4##(2007-11#1)(2008-11#1)(2009-11#1)
the communities##22##2##(1990-10#1)(1991-12#1)(1995-3#1)(1996-3#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#3)(2008-1#3)(2008-10#1)(2008-11#1)(2009-11#1)(2009-2#1)(2009-4#1)(2012-1#1)(2012-12#1)(2012-3#1)
the community about##2##3##(1992-12#1)(2011-2#1)
the community and the hospital##2##5##(1996-2#1)(2006-10#1)
the community and the##5##4##(1994-1#1)(1995-3#1)(1996-2#1)(2006-10#1)(2007-12#1)
the community and##24##3##(1990-9#1)(1991-2#1)(1991-4#1)(1994-1#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-2#2)(2005-8#1)(2006-10#1)(2006-5#2)(2007-12#1)(2007-7#1)(2008-8#2)(2009-5#1)(2010-5#1)(2010-7#1)(2012-12#1)(2013-1#2)(2013-8#1)
the community approach##3##3##(1992-1#2)(1993-10#1)
the community as a##4##4##(1995-2#1)(2006-8#1)(2008-7#1)(2008-8#1)
the community as well as##3##5##(2005-12#1)(2007-3#1)(2012-12#1)
the community as##9##3##(1995-2#1)(2005-12#1)(2006-8#1)(2007-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#2)
the community burden of##2##4##(2008-10#1)(2008-11#1)
the community by##3##3##(2008-8#2)(2011-2#1)
the community care##2##3##(1997-8#1)(2010-10#1)
the community health care##2##4##(1991-3#1)(2004-10#1)
the community health centers##2##4##(1996-2#1)(2008-1#1)
the community health##9##3##(1991-3#1)(1996-2#1)(1997-2#2)(2004-10#1)(2006-2#1)(2008-1#2)(2013-8#1)
the community in##6##3##(1996-3#1)(1997-1#1)(2008-7#1)(2009-6#1)(2013-1#2)
the community is##5##3##(1993-7#1)(2006-10#1)(2006-8#1)(2008-8#1)(2010-8#1)
the community of##7##3##(1995-3#1)(2006-10#1)(2006-12#1)(2007-9#1)(2008-1#1)(2008-2#1)(2011-2#1)
the community or hospital##2##4##(2005-11#1)(2008-11#1)
the community served##3##3##(1993-1#1)(1993-2#1)(2006-4#1)
the community setting##4##3##(1993-7#1)(2008-11#2)(2012-12#1)
the community structure of##2##4##(2008-6#1)(2008-8#1)
the community that##3##3##(2007-9#1)(2008-4#1)(2008-8#1)
the community to##6##3##(1992-1#1)(1995-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2009-10#1)
the community volunteers##2##3##(1997-8#2)
the community was##3##3##(2009-6#1)(2009-7#1)(2012-2#1)
the community were##4##3##(1993-8#1)(2007-4#1)(2007-6#1)(2008-3#1)
the community will##2##3##(1991-12#1)(2006-10#1)
the community with a##2##4##(2007-8#1)(2009-7#1)
the community with##4##3##(2007-8#1)(2008-11#1)(2009-7#1)(2011-2#1)
the community##310##2##(1990-10#1)(1990-12#3)(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#2)(1991-12#2)(1991-2#3)(1991-3#2)(1991-4#1)(1992-1#5)(1992-12#1)(1992-5#3)(1993-1#3)(1993-10#1)(1993-11#1)(1993-2#2)(1993-7#2)(1993-8#1)(1994-1#6)(1994-12#2)(1994-3#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-2#7)(1995-3#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#4)(1996-6#1)(1996-7#2)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#3)(1997-8#4)(2004-10#1)(2004-12#1)(2005-11#2)(2005-12#2)(2005-8#1)(2006-10#10)(2006-11#2)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#3)(2006-8#3)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#2)(2007-3#5)(2007-4#3)(2007-6#1)(2007-7#6)(2007-8#3)(2007-9#3)(2008-1#7)(2008-10#2)(2008-11#13)(2008-12#5)(2008-2#7)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#8)(2008-8#13)(2008-9#3)(2009-10#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#6)(2010-1#2)(2010-10#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#4)(2011-1#8)(2011-2#16)(2012-1#1)(2012-12#7)(2012-2#9)(2012-3#7)(2013-1#13)(2013-8#3)
the community's##3##2##(2007-8#1)(2008-12#1)(2012-3#1)
the community)##2##2##(2007-4#1)(2008-8#1)
the community-based##3##2##(1992-5#1)(2008-6#1)(2008-7#1)
the community-dwelling elderly##2##3##(1996-7#1)(2008-7#1)
the community-dwelling##3##2##(1996-7#1)(2008-7#1)(2010-8#1)
the comorbid##2##2##(1993-12#1)(2007-6#1)
the comorbidities##3##2##(2006-10#1)(2006-9#1)(2011-2#1)
the comorbidity of##2##3##(2009-7#2)
the comorbidity##4##2##(2009-7#2)(2011-2#2)
the compact bone##2##3##(2007-4#1)(2008-1#1)
the compact myelin##2##3##(2008-7#2)
the compact##16##2##(1990-12#1)(1992-7#1)(1993-7#1)(1995-2#1)(1995-4#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#2)(2008-8#1)
the compacted##2##2##(1997-4#1)(2006-5#1)
the compactibility##2##2##(2010-5#2)
the compaction of##2##3##(2009-12#1)(2011-1#1)
the compaction##4##2##(2009-12#2)(2011-1#1)(2011-2#1)
the compactness of##2##3##(1991-2#1)(2008-10#1)
the companies##4##2##(1997-5#2)(2005-7#1)(2012-12#1)
the companion##4##2##(1991-6#1)(1991-8#1)(1993-2#1)(2008-6#1)
the company submitted an NDA##2##5##(2005-7#1)(2008-5#1)
the company##31##2##(1992-12#1)(1992-3#1)(1994-4#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#2)(1997-1#1)(1997-7#1)(2005-6#2)(2005-7#2)(2005-8#6)(2008-10#1)(2008-11#4)(2008-5#2)(2010-4#1)(2012-3#1)(2013-1#1)
the company's##11##2##(1990-2#1)(1992-3#1)(1993-12#1)(1995-6#1)(2005-8#1)(2008-10#1)(2008-5#2)(2010-9#1)(2011-2#2)
the comparability of results##2##4##(1996-7#1)(2012-12#1)
the comparability of##8##3##(1990-6#1)(1996-7#1)(2008-10#2)(2008-5#1)(2008-8#1)(2012-12#1)(2012-2#1)
the comparability##9##2##(1990-6#1)(1996-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2012-12#1)(2012-2#1)
the comparable##9##2##(1991-8#1)(1994-11#1)(2005-11#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-10#1)(2010-8#1)
the comparative analysis of##6##4##(2007-7#1)(2008-10#1)(2008-7#1)(2009-4#1)(2011-1#1)(2012-3#1)
the comparative group##2##3##(2011-2#2)
the comparative##39##2##(1990-6#1)(1991-7#1)(1991-9#1)(1994-5#1)(1995-2#1)(1997-2#2)(1997-3#1)(1997-8#1)(2005-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#4)(2008-8#2)(2009-4#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#2)
the comparator##4##2##(2007-4#1)(2008-11#1)(2009-11#1)(2013-1#1)
the compared##3##2##(1992-1#1)(2011-1#1)(2013-8#1)
the comparison among##2##3##(2008-10#1)(2011-2#1)
the comparison as##2##3##(1991-9#2)
the comparison between experimental##2##4##(2008-11#1)(2008-2#1)
the comparison between##7##3##(1994-2#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2011-1#1)
the comparison group was##2##4##(1995-12#2)
the comparison group##10##3##(1995-1#1)(1995-12#2)(1995-3#1)(1996-1#1)(2006-8#2)(2007-12#2)(2008-11#1)
the comparison groups##4##3##(1996-1#1)(2006-3#2)(2011-1#1)
the comparison is##4##3##(1994-9#1)(1996-3#1)(2006-12#1)(2013-1#1)
the comparison of the results of##2##6##(2005-11#1)(2011-2#1)
the comparison of the two##2##5##(1996-10#1)(2008-10#1)
the comparison of the##21##4##(1990-8#1)(1991-12#1)(1993-6#4)(1996-10#1)(1996-7#1)(1997-4#1)(2005-11#1)(2008-10#4)(2008-2#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#2)
the comparison of two##5##4##(1994-9#1)(1995-2#1)(1995-4#1)(2005-10#1)(2008-10#1)
the comparison of##53##3##(1990-8#1)(1991-12#1)(1992-11#1)(1993-6#4)(1994-6#1)(1994-9#2)(1995-2#1)(1995-4#1)(1996-10#1)(1996-7#1)(1997-4#1)(2005-10#1)(2005-11#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-2#2)(2008-5#1)(2008-6#1)(2008-8#1)(2010-2#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-11#1)(2013-1#4)(2013-8#3)
the comparison purpose##2##3##(2008-10#1)(2009-12#1)
the comparison was##2##3##(2006-12#1)(2008-10#1)
the comparison with##4##3##(1990-5#1)(2007-4#1)(2008-5#1)(2012-3#1)
the comparison##104##2##(1990-5#1)(1990-8#1)(1991-12#1)(1991-9#2)(1992-11#1)(1992-6#1)(1993-6#4)(1994-2#1)(1994-6#1)(1994-9#3)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1996-1#3)(1996-10#1)(1996-11#1)(1996-3#2)(1996-7#1)(1997-4#1)(2004-11#2)(2005-10#1)(2005-11#2)(2006-12#2)(2006-3#2)(2006-8#2)(2007-11#1)(2007-12#3)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#2)(2008-2#7)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-2#2)(2010-3#1)(2010-7#1)(2011-1#4)(2011-12#1)(2011-2#3)(2012-11#1)(2012-3#1)(2013-1#5)(2013-8#3)
the compartment##4##2##(1991-5#1)(2007-11#1)(2008-1#1)(2009-3#1)
the compartmental##3##2##(2008-10#2)(2013-8#1)
the compartmentalization of##5##3##(1994-8#1)(2008-11#1)(2009-12#1)(2010-5#1)(2012-2#1)
the compartmentalization##6##2##(1994-11#1)(1994-8#1)(2008-11#1)(2009-12#1)(2010-5#1)(2012-2#1)
the compartmentalized##3##2##(2006-10#2)(2010-11#1)
the compartmentation of##2##3##(1995-8#1)(1997-6#1)
the compartmentation##3##2##(1995-8#1)(1997-6#1)(2009-4#1)
the compartments##2##2##(1992-8#1)(1994-12#1)
the compass##2##2##(2006-12#1)(2008-1#1)
the compatibility of SHLI with##2##5##(2011-2#2)
the compatibility of the##2##4##(2008-3#1)(2013-1#1)
the compatibility of##12##3##(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2010-9#1)(2011-2#3)(2012-12#2)(2013-1#1)
the compatibility##14##2##(1995-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-3#1)(2010-9#1)(2011-2#3)(2012-12#2)(2013-1#1)
the compatible and incompatible interactions##3##5##(2008-10#3)
the compatible interaction##3##3##(2008-10#3)
the compatible##6##2##(2008-10#6)
the compelling##2##2##(2007-8#1)(2008-11#1)
the compensated##4##2##(1991-2#1)(2008-2#2)(2009-7#1)
the compensation of##5##3##(1991-2#2)(1993-5#1)(2008-2#1)(2009-6#1)
the compensation##16##2##(1990-7#1)(1991-2#2)(1991-3#1)(1993-5#1)(1996-2#1)(2008-10#2)(2008-2#1)(2008-3#3)(2009-6#1)(2011-1#1)(2012-1#2)
the compensator##2##2##(2008-3#2)
the compensatory head##2##3##(1995-8#2)
the compensatory processes##2##3##(2008-8#1)(2009-2#1)
the compensatory##11##2##(1995-8#2)(2005-8#1)(2006-10#1)(2008-1#2)(2008-11#1)(2008-8#1)(2009-2#1)(2011-2#1)(2012-2#1)
the competence and##2##3##(1993-4#1)(2010-9#1)
the competence of nurses##2##4##(2008-12#2)
the competence of##8##3##(1996-2#1)(1997-4#1)(2005-5#1)(2006-10#1)(2007-2#1)(2008-12#2)(2008-4#1)
the competence set##2##3##(2008-2#2)
the competence to##3##3##(1992-3#1)(1994-4#1)(2009-6#1)
the competence##15##2##(1992-3#1)(1993-4#1)(1994-4#1)(1996-2#1)(1997-4#1)(2005-5#1)(2006-10#1)(2007-2#1)(2008-12#2)(2008-2#2)(2008-4#1)(2009-6#1)(2010-9#1)
the competencies of##2##3##(2007-10#1)(2012-1#1)
the competencies##7##2##(2006-8#1)(2007-10#1)(2007-11#1)(2011-2#1)(2012-1#1)(2012-12#2)
the competency of##3##3##(2007-5#1)(2008-11#1)(2011-2#1)
the competency##6##2##(2007-11#1)(2007-5#1)(2008-1#1)(2008-11#1)(2011-2#2)
the competency-based movement##2##3##(2008-12#2)
the competent authority##2##3##(2005-5#1)(2011-2#1)
the competent##6##2##(1990-10#1)(1991-8#1)(2004-3#1)(2005-5#1)(2006-12#1)(2011-2#1)
the competing models##2##3##(2006-5#1)(2007-9#1)
the competing risks problem##2##4##(1995-9#1)(1997-4#1)
the competing##13##2##(1993-3#1)(1995-9#1)(1996-12#1)(1997-4#1)(2006-5#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-12#1)
the competition between the##3##4##(1997-2#1)(2008-10#1)(2010-5#1)
the competition between##16##3##(1991-2#1)(1993-12#1)(1993-6#3)(1994-8#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-7#1)(2010-2#1)(2010-4#1)(2010-5#1)
the competition of two##2##4##(2008-10#1)(2012-2#1)
the competition of##4##3##(1995-5#1)(1996-5#1)(2008-10#1)(2012-2#1)
the competition with##4##3##(1997-1#1)(2008-10#1)(2008-11#1)(2009-2#1)
the competition##41##2##(1991-2#1)(1992-2#1)(1993-12#1)(1993-6#3)(1994-8#2)(1995-5#1)(1996-1#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#7)(2008-7#2)(2009-2#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
the competition-colonization##3##2##(2008-8#1)(2008-9#2)
the competitive NMDA receptor antagonist##2##5##(1992-8#1)(1996-9#1)
the competitive NMDA##3##3##(1990-7#1)(1992-8#1)(1996-9#1)
the competitive ability of##2##4##(1997-7#1)(2008-12#1)
the competitive adsorption of##2##4##(2008-10#2)
the competitive antagonist##4##3##(1991-7#3)(1995-1#1)
the competitive inhibition##3##3##(1991-7#1)(1996-10#1)(2008-10#1)
the competitive inhibitor##4##3##(1991-7#1)(1992-8#1)(1995-8#1)(2008-10#1)
the competitive reaction##3##3##(2008-10#3)
the competitive##60##2##(1990-12#1)(1990-7#1)(1991-7#6)(1992-8#2)(1993-6#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-8#1)(1996-10#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-7#1)(2004-11#1)(2005-11#1)(2007-4#1)(2007-8#1)(2008-10#23)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#3)(2008-9#1)(2009-7#1)(2009-8#1)(2011-1#1)(2012-2#1)
the competitor##2##2##(2007-4#1)(2010-5#1)
the compilation of the##2##4##(2008-10#1)(2008-3#1)
the compilation##3##2##(2008-10#2)(2008-3#1)
the compiled##4##2##(1991-6#1)(1996-10#2)(2006-8#1)
the complaint of##3##3##(2008-1#1)(2008-5#1)(2012-3#1)
the complaint##4##2##(2008-1#1)(2008-5#1)(2012-12#1)(2012-3#1)
the complaints of##3##3##(2011-2#1)(2013-1#1)(2013-8#1)
the complaints##8##2##(1990-11#1)(1996-3#1)(2005-10#1)(2006-3#1)(2011-2#2)(2013-1#1)(2013-8#1)
the complement activation##3##3##(2005-11#1)(2005-8#1)(2008-10#1)
the complement cascade##3##3##(2007-8#1)(2011-2#1)(2012-2#1)
the complement component##3##3##(1990-6#1)(1991-3#1)(1996-5#1)
the complement of##3##3##(1996-7#1)(2008-5#1)(2010-12#1)
the complement system##17##3##(1991-2#1)(1995-1#1)(1995-9#1)(1997-1#1)(2007-1#2)(2007-7#1)(2008-1#1)(2008-10#1)(2010-4#2)(2012-1#3)(2012-12#2)(2012-3#1)
the complement##46##2##(1990-6#1)(1991-2#1)(1991-3#2)(1992-12#1)(1993-11#1)(1994-6#2)(1995-1#1)(1995-9#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#2)(1997-4#1)(2005-11#1)(2005-8#2)(2007-1#2)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-4#3)(2008-5#1)(2010-12#1)(2010-4#2)(2011-2#2)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#1)
the complement-dependent##2##2##(2005-8#1)(2008-9#1)
the complementarity of the##2##4##(1991-2#1)(2009-7#1)
the complementarity of these##2##4##(1996-5#1)(2006-3#1)
the complementarity of##4##3##(1991-2#1)(1996-5#1)(2006-3#1)(2009-7#1)
the complementarity##6##2##(1991-2#1)(1996-5#1)(1996-8#1)(1997-4#1)(2006-3#1)(2009-7#1)
the complementarity-determining region##2##3##(1995-2#2)
the complementarity-determining##3##2##(1992-8#1)(1995-2#2)
the complementary and alternative##2##4##(1991-3#1)(2008-10#1)
the complementary and##3##3##(1991-3#1)(2008-10#1)(2013-1#1)
the complementary strand##10##3##(1992-9#1)(1994-12#1)(1994-8#2)(1995-10#2)(1995-4#1)(1996-9#1)(1997-3#1)(2008-4#1)
the complementary strands of##2##4##(1994-11#1)(1995-3#1)
the complementary strands##6##3##(1994-11#2)(1995-3#1)(2006-12#3)
the complementary target##3##3##(2008-10#3)
the complementary##48##2##(1990-12#2)(1991-3#1)(1992-4#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-6#1)(1994-8#4)(1995-1#1)(1995-10#2)(1995-3#1)(1995-4#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-3#1)(2005-11#1)(2006-12#3)(2007-8#1)(2008-1#3)(2008-10#10)(2008-2#2)(2008-4#2)(2008-9#1)(2013-1#1)
the complementation of##2##3##(1997-4#1)(2008-6#1)
the complementation test##2##3##(2007-11#2)
the complementation##5##2##(1996-3#1)(1997-4#1)(2007-11#2)(2008-6#1)
the complemented##4##2##(1991-5#1)(1995-8#1)(1997-2#1)(2010-12#1)
the complementing##2##2##(1995-4#1)(1997-2#1)
the complete 3'-untranslated region##2##4##(1991-4#1)(1992-2#1)
the complete Arabidopsis##2##3##(2007-12#1)(2008-7#1)
the complete ITS##3##3##(2008-10#3)
the complete amino acid sequence of##2##6##(1990-5#1)(1997-6#1)
the complete automation of##2##4##(1991-5#1)(2008-10#1)
the complete cDNA##2##3##(1996-12#1)(2005-11#1)
the complete characterization of an##2##5##(2007-12#2)
the complete coding region of##2##5##(1990-5#1)(1992-11#1)
the complete coding region##4##4##(1990-5#1)(1992-11#1)(1994-2#1)(1997-7#1)
the complete coding sequence of##4##5##(1991-2#1)(1991-6#1)(1993-12#1)(1993-2#1)
the complete coding sequence##7##4##(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1993-12#1)(1993-2#1)(1994-12#1)
the complete coding##11##3##(1990-5#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1997-7#1)
the complete depletion##2##3##(1992-9#1)(1995-3#1)
the complete distribution of##2##4##(2008-10#1)(2012-3#1)
the complete excision of##2##4##(2006-10#1)(2006-12#1)
the complete gene##3##3##(1993-2#1)(1993-8#1)(1994-2#1)
the complete genome of##3##4##(2007-6#1)(2008-10#1)(2012-3#1)
the complete genome sequence of the##2##6##(2008-8#1)(2008-9#1)
the complete genome sequence of##3##5##(2008-8#1)(2008-9#1)(2013-8#1)
the complete genome sequence##26##4##(2008-8#1)(2008-9#1)(2011-2#23)(2013-8#1)
the complete genome sequences##2##4##(2008-10#2)
the complete genome##32##3##(2007-6#1)(2008-10#3)(2008-8#2)(2008-9#1)(2011-2#23)(2012-3#1)(2013-8#1)
the complete genomic##3##3##(1997-6#1)(2008-10#1)(2008-8#1)
the complete human##3##3##(1991-3#1)(2008-10#1)(2008-8#1)
the complete lack of##4##4##(1994-2#1)(1995-2#1)(1996-11#1)(1996-6#1)
the complete loss of##6##4##(1992-12#1)(1994-3#1)(1995-1#1)(1995-6#1)(2008-11#1)(2012-2#1)
the complete nucleotide sequence of a cDNA##2##7##(1993-3#1)(1997-1#1)
the complete nucleotide sequence of a##6##6##(1993-3#1)(1994-12#1)(1995-9#1)(1997-1#1)(1997-4#1)(2008-10#1)
the complete nucleotide sequence of the gene##4##7##(1990-4#1)(1993-11#1)(1994-12#2)
the complete nucleotide sequence of the##8##6##(1990-4#1)(1992-11#1)(1993-11#1)(1994-12#2)(1994-2#1)(1996-7#1)(1997-7#1)
the complete nucleotide sequence of##15##5##(1990-4#1)(1992-11#1)(1993-11#1)(1993-3#1)(1994-12#3)(1994-2#1)(1995-9#1)(1996-10#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-7#1)(2008-10#1)
the complete nucleotide sequence##19##4##(1990-4#1)(1992-11#1)(1993-11#1)(1993-3#1)(1994-12#3)(1994-2#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#2)
the complete nucleotide sequences of##2##5##(2008-10#1)(2013-8#1)
the complete nucleotide##23##3##(1990-1#1)(1990-4#1)(1992-11#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#3)(1994-2#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#3)(2013-8#1)
the complete open reading frame##2##5##(1993-3#1)(1993-9#1)
the complete polarization##2##3##(2008-2#1)(2008-3#1)
the complete procedure of##2##4##(2008-10#1)(2013-1#1)
the complete procedure##3##3##(2006-8#1)(2008-10#1)(2013-1#1)
the complete regression of##2##4##(1990-3#1)(1996-4#1)
the complete release of the##2##5##(2008-10#1)(2009-8#1)
the complete release of##3##4##(1996-4#1)(2008-10#1)(2009-8#1)
the complete removal of##4##4##(1994-11#1)(2008-4#1)(2011-1#1)(2012-12#1)
the complete resistance##3##3##(2008-10#3)
the complete resolution of##2##4##(1992-1#1)(2008-11#1)
the complete resolution##3##3##(1992-1#1)(1996-5#1)(2008-11#1)
the complete response##2##3##(2006-10#1)(2006-6#1)
the complete separation of the##2##5##(1990-12#2)
the complete separation of##3##4##(1990-12#2)(2008-10#1)
the complete sequence and##3##4##(1994-3#1)(2008-7#1)(2011-2#1)
the complete sequence of the##5##5##(1991-12#1)(1991-5#1)(1993-2#1)(1995-3#1)(2009-5#1)
the complete sequence of##9##4##(1990-2#1)(1991-12#1)(1991-5#1)(1993-2#2)(1995-3#1)(2007-12#1)(2009-5#1)(2010-5#1)
the complete sequence##13##3##(1990-2#1)(1991-12#1)(1991-5#1)(1993-2#2)(1994-3#1)(1994-6#1)(1995-3#1)(2007-12#1)(2008-7#1)(2009-5#1)(2010-5#1)(2011-2#1)
the complete set of##5##4##(1997-7#1)(2008-4#2)(2008-6#1)(2012-3#1)
the complete system##5##3##(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#2)
the complete tear group##3##4##(2009-9#3)
the complete##285##2##(1990-1#2)(1990-10#2)(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#3)(1990-7#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#3)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#3)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#5)(1993-3#4)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#5)(1994-2#4)(1994-3#2)(1994-6#3)(1995-1#1)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#4)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#3)(1997-6#2)(1997-7#7)(2004-2#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#6)(2007-2#1)(2007-5#2)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#35)(2008-11#4)(2008-2#2)(2008-3#8)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#5)(2008-9#4)(2009-10#1)(2009-2#1)(2009-5#2)(2009-8#1)(2009-9#3)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#4)(2011-2#27)(2012-12#4)(2012-2#2)(2012-3#5)(2013-1#1)(2013-8#7)
the completed##4##2##(1992-3#2)(2010-6#1)(2012-12#1)
the completely conserved##2##3##(1991-2#1)(1992-11#1)
the completely sequenced genome##2##4##(2007-8#1)(2008-7#1)
the completely sequenced##5##3##(1990-5#1)(1994-9#2)(2007-8#1)(2008-7#1)
the completely##16##2##(1990-5#1)(1991-2#1)(1992-11#1)(1994-9#2)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-8#1)(2012-11#2)
the completeness of##8##3##(1992-3#1)(1997-2#1)(2006-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-2#1)(2012-2#1)
the completeness##11##2##(1990-11#1)(1992-3#1)(1997-2#1)(2006-6#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2010-2#1)(2012-2#1)(2013-7#1)
the completion of a##2##4##(1991-6#1)(2008-10#1)
the completion of mitosis##2##4##(1995-6#1)(1996-4#1)
the completion of the##17##4##(1992-3#1)(1993-9#1)(1996-11#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-12#1)(2011-2#1)(2012-12#1)(2013-8#2)
the completion of treatment##3##4##(1990-12#1)(2007-12#1)(2010-5#1)
the completion of##51##3##(1990-12#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-9#2)(1994-2#1)(1995-10#1)(1995-6#1)(1996-11#1)(1996-4#1)(1996-8#1)(1997-7#1)(2005-11#1)(2006-10#2)(2007-12#3)(2007-7#1)(2008-10#3)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
the completion##52##2##(1990-12#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-9#2)(1994-2#1)(1995-10#1)(1995-6#1)(1996-11#1)(1996-4#1)(1996-8#1)(1997-7#1)(2005-11#1)(2006-10#2)(2007-12#3)(2007-7#1)(2008-10#3)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
the complex ML(2)##2##3##(2008-10#2)
the complex amplitude of the##4##5##(2007-11#1)(2007-12#3)
the complex amplitude of##5##4##(2007-11#1)(2007-12#4)
the complex amplitude##10##3##(2007-11#2)(2007-12#6)(2008-2#1)(2008-3#1)
the complex amplitudes of the##2##5##(2008-2#1)(2008-3#1)
the complex anatomy##3##3##(2008-1#1)(2010-12#1)(2012-2#1)
the complex and##13##3##(1991-3#1)(1991-6#1)(1995-2#1)(2005-11#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-2#1)
the complex are##7##3##(1990-7#1)(1991-8#1)(1995-2#1)(2008-10#3)(2009-10#1)
the complex array of##2##4##(1994-8#1)(2013-1#1)
the complex at##3##3##(2007-8#1)(2008-10#2)
the complex between##7##3##(1992-3#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-1#1)(1997-1#1)(2006-12#1)
the complex biological##3##3##(2008-4#1)(2008-5#1)(2008-9#1)
the complex biology##2##3##(2005-8#1)(2008-6#1)
the complex by##3##3##(1995-2#1)(2006-12#1)(2009-10#1)
the complex can##2##3##(1993-9#1)(2008-10#1)
the complex cascade of##2##4##(1995-11#1)(2008-11#1)
the complex cellular and molecular##2##5##(1995-6#1)(2007-12#1)
the complex cellular##3##3##(1995-6#1)(2007-12#1)(2013-1#1)
the complex changes##2##3##(1997-7#1)(2006-10#1)
the complex could be##2##4##(1993-3#1)(1993-8#1)
the complex coupling##2##3##(2008-3#2)
the complex craniofacial##2##3##(2006-12#1)(2010-6#1)
the complex during##3##3##(1992-8#1)(1994-12#1)(2010-5#1)
the complex effects of##3##4##(1994-8#1)(1996-5#1)(2005-12#1)
the complex formation between##4##4##(1997-6#1)(2008-10#2)(2008-7#1)
the complex formation of##3##4##(2008-10#2)(2008-3#1)
the complex formation##17##3##(1992-11#1)(1997-2#1)(1997-6#1)(2008-10#11)(2008-3#1)(2008-7#1)(2010-5#1)
the complex formed between##4##4##(1990-4#1)(1994-11#1)(1994-5#1)(2008-10#1)
the complex formed by the##3##5##(1992-3#1)(2006-12#1)(2009-8#1)
the complex formed by##4##4##(1992-3#1)(1996-11#1)(2006-12#1)(2009-8#1)
the complex formed##11##3##(1990-4#1)(1991-2#1)(1992-3#1)(1994-11#1)(1994-5#1)(1995-3#1)(1996-11#1)(2006-12#1)(2008-10#2)(2009-8#1)
the complex genetic##4##3##(2009-10#1)(2009-3#1)(2012-1#1)(2012-3#1)
the complex has##3##3##(1992-12#1)(2008-10#2)
the complex hydrogels##3##3##(2013-7#3)
the complex impedance##3##3##(2008-10#2)(2008-7#1)
the complex in the##2##4##(1991-4#1)(2008-10#1)
the complex in vivo environment##2##5##(2006-5#1)(2008-11#1)
the complex in vivo##3##4##(2006-5#1)(2008-11#1)(2013-1#1)
the complex in##8##3##(1991-4#1)(2006-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2013-1#1)
the complex index of refraction and size distribution of aerosols##2##10##(2008-3#2)
the complex index of refraction and the size distribution##2##9##(2008-2#2)
the complex index of refraction and##5##6##(2008-2#3)(2008-3#2)
the complex index of refraction##10##5##(2008-2#8)(2008-3#2)
the complex interaction between##2##4##(2008-4#1)(2009-3#1)
the complex interaction of##4##4##(2006-1#1)(2008-11#1)(2009-8#1)(2010-6#1)
the complex interaction##6##3##(2006-1#1)(2008-11#1)(2008-4#1)(2009-3#1)(2009-8#1)(2010-6#1)
the complex interactions between##5##4##(2006-10#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#1)
the complex interactions##8##3##(1993-8#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-3#1)
the complex interdependence##2##3##(2007-6#1)(2009-8#1)
the complex interplay between the##3##5##(2006-12#1)(2008-8#1)(2013-7#1)
the complex interplay between##4##4##(2006-12#1)(2007-12#1)(2008-8#1)(2013-7#1)
the complex interplay##6##3##(1993-4#1)(2006-12#1)(2007-12#2)(2008-8#1)(2013-7#1)
the complex is a##2##4##(2007-12#1)(2008-5#1)
the complex is discussed##2##4##(1993-3#1)(2007-12#1)
the complex is not##2##4##(1991-8#1)(2006-12#1)
the complex is##28##3##(1990-2#1)(1990-8#1)(1991-8#1)(1992-3#1)(1993-3#1)(1995-12#1)(1995-2#1)(1996-2#1)(2005-4#2)(2006-12#1)(2007-12#2)(2008-10#9)(2008-2#1)(2008-4#1)(2008-5#3)(2010-12#1)
the complex mechanism of##2##4##(1995-12#1)(2010-3#1)
the complex mechanisms regulating##2##4##(2008-10#1)(2008-4#1)
the complex mechanisms underlying##2##4##(2008-11#1)(2010-12#1)
the complex mechanisms##6##3##(2006-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-12#1)(2011-2#1)
the complex mixture##2##3##(1992-1#1)(1994-8#1)
the complex molecular##3##3##(2007-12#1)(2008-10#1)(2012-1#1)
the complex morphology of the##2##5##(2007-12#2)
the complex nature of the##3##5##(1994-8#1)(2006-10#1)(2008-6#1)
the complex nature of these##3##5##(2005-10#1)(2006-12#1)(2007-5#1)
the complex nature of##10##4##(1993-6#1)(1994-8#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-6#1)
the complex needs of##2##4##(2006-5#1)(2011-2#1)
the complex non-linear##2##3##(2006-10#1)(2008-10#1)
the complex of profilin##2##4##(1990-3#2)
the complex of the##3##4##(1991-2#1)(2008-10#2)
the complex of##24##3##(1990-3#2)(1991-2#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-8#4)(1996-11#1)(1996-7#1)(1996-8#1)(1997-1#1)(2005-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-1#2)
the complex or##2##3##(1997-6#1)(2008-2#1)
the complex process of##2##4##(1995-12#1)(2009-6#1)
the complex process##5##3##(1995-12#1)(2009-6#2)(2011-2#1)(2013-1#1)
the complex properties of##2##4##(1993-12#1)(2010-11#1)
the complex reaction##2##3##(2005-4#1)(2012-11#1)
the complex reflection spectrum##2##4##(2008-3#2)
the complex refractive index of##5##5##(2008-2#2)(2008-3#3)
the complex refractive index##18##4##(2008-10#1)(2008-2#7)(2008-3#10)
the complex refractive indices##3##4##(2007-11#2)(2008-3#1)
the complex refractive##21##3##(2007-11#2)(2008-10#1)(2008-2#7)(2008-3#11)
the complex regulation##3##3##(2007-12#1)(2010-9#1)(2011-1#1)
the complex regulatory##2##3##(2007-9#1)(2008-7#1)
the complex relationship between##6##4##(2008-1#1)(2008-11#1)(2009-5#1)(2011-2#2)(2012-12#1)
the complex relationship##7##3##(2008-1#1)(2008-11#1)(2009-5#1)(2011-2#3)(2012-12#1)
the complex relationships##2##3##(2006-6#1)(2008-10#1)
the complex role##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
the complex samples##2##3##(2012-12#1)(2012-3#1)
the complex set of##2##4##(1993-8#1)(2007-4#1)
the complex shows##2##3##(2008-4#2)
the complex spatial##2##3##(2008-2#1)(2008-8#1)
the complex spectral##4##3##(2007-11#1)(2008-10#1)(2008-3#2)
the complex structure of##3##4##(1994-9#1)(1995-9#1)(2011-1#1)
the complex structure##5##3##(1994-9#1)(1995-9#1)(2008-10#2)(2011-1#1)
the complex to be##2##4##(1990-2#1)(2008-5#1)
the complex to##7##3##(1990-2#1)(1993-11#2)(1996-8#1)(2007-12#1)(2008-5#2)
the complex treatment of##2##4##(2008-9#1)(2011-1#1)
the complex type of##3##4##(1994-8#3)
the complex type##5##3##(1990-12#1)(1994-8#3)(1997-4#1)
the complex was observed##2##4##(1993-3#1)(1996-11#1)
the complex was##17##3##(1990-5#2)(1992-6#1)(1993-3#1)(1994-11#2)(1996-11#1)(2007-12#1)(2008-10#6)(2008-5#1)(2009-10#2)
the complex with the##3##4##(1994-10#1)(1997-4#1)(2011-1#1)
the complex with##12##3##(1991-2#1)(1992-2#1)(1993-3#1)(1994-10#1)(1995-2#1)(1996-11#1)(1997-4#1)(2008-10#3)(2009-2#1)(2011-1#1)
the complex##633##2##(1990-12#3)(1990-2#2)(1990-3#3)(1990-4#4)(1990-5#4)(1990-6#1)(1990-7#3)(1990-8#2)(1991-10#1)(1991-12#1)(1991-2#4)(1991-3#5)(1991-4#3)(1991-5#1)(1991-6#1)(1991-8#2)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#5)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#3)(1993-12#1)(1993-3#7)(1993-4#1)(1993-6#1)(1993-8#7)(1993-9#3)(1994-1#1)(1994-10#3)(1994-11#7)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#5)(1994-8#9)(1994-9#3)(1995-1#5)(1995-11#3)(1995-12#3)(1995-2#8)(1995-3#2)(1995-4#2)(1995-6#1)(1995-7#2)(1995-8#4)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#5)(1996-12#1)(1996-2#6)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#6)(1997-2#3)(1997-3#2)(1997-4#3)(1997-6#4)(1997-7#2)(2004-4#1)(2005-10#1)(2005-11#5)(2005-12#1)(2005-4#3)(2005-8#2)(2006-1#2)(2006-10#10)(2006-12#7)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#2)(2006-9#1)(2007-10#1)(2007-11#11)(2007-12#24)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#6)(2007-9#1)(2008-1#10)(2008-10#106)(2008-11#11)(2008-12#1)(2008-2#28)(2008-3#30)(2008-4#15)(2008-5#18)(2008-6#3)(2008-7#7)(2008-8#7)(2008-9#3)(2009-10#7)(2009-2#2)(2009-3#5)(2009-4#1)(2009-5#1)(2009-6#3)(2009-8#7)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#5)(2010-3#2)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#8)(2011-12#1)(2011-2#12)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#7)(2013-1#9)(2013-7#5)(2013-8#5)
the complex-formation##2##2##(2008-10#2)
the complex-valued##3##2##(2006-5#1)(2008-3#2)
the complexation and##2##3##(2008-10#1)(2013-1#1)
the complexation between##2##3##(2008-10#2)
the complexation constant of##2##4##(2005-11#1)(2008-10#1)
the complexation constants of##2##4##(2008-10#2)
the complexation equilibria##2##3##(2008-10#2)
the complexation in water##2##4##(2008-10#2)
the complexation in##3##3##(2008-10#3)
the complexation of the##3##4##(1994-3#1)(2008-10#2)
the complexation of##13##3##(1994-3#1)(2006-11#1)(2007-8#2)(2008-10#8)(2008-7#1)
the complexation reaction is##2##4##(2008-10#2)
the complexation reaction of##2##4##(2008-10#2)
the complexation reaction##12##3##(2006-11#2)(2008-10#8)(2008-5#2)
the complexation with##3##3##(2008-10#3)
the complexation##50##2##(1994-3#1)(2005-11#1)(2006-11#3)(2006-12#1)(2007-8#4)(2008-10#36)(2008-5#2)(2008-7#1)(2013-1#1)
the complexed##7##2##(1996-6#1)(1996-7#1)(2007-9#1)(2008-10#3)(2008-5#1)
the complexes and##6##3##(1990-12#1)(1992-9#1)(1995-1#1)(2006-10#2)(2008-10#1)
the complexes are##6##3##(1995-5#1)(2008-10#1)(2008-5#2)(2008-6#1)(2009-8#1)
the complexes between##3##3##(1996-11#1)(1996-7#1)(2006-10#1)
the complexes formed between##2##4##(1991-11#1)(2008-10#1)
the complexes formed by##2##4##(1993-12#1)(1996-2#1)
the complexes formed##8##3##(1991-11#1)(1993-12#1)(1996-2#1)(2006-10#1)(2008-10#3)(2008-3#1)
the complexes have been##4##4##(2008-5#2)(2010-5#2)
the complexes have##6##3##(2008-3#1)(2008-5#3)(2010-5#2)
the complexes is##5##3##(1996-2#1)(2005-4#1)(2008-10#1)(2008-5#2)
the complexes of the##3##4##(1996-9#1)(2008-3#1)(2008-5#1)
the complexes of##16##3##(1993-11#1)(1996-8#1)(1996-9#1)(1997-3#1)(2005-11#1)(2005-4#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-3#2)(2008-5#1)
the complexes show##3##3##(2008-3#1)(2008-5#1)(2010-5#1)
the complexes to##3##3##(1991-4#1)(2008-5#1)(2009-5#1)
the complexes were##7##3##(1990-12#1)(1994-5#1)(2004-9#1)(2006-10#1)(2008-10#2)(2010-5#1)
the complexes with##8##3##(1991-2#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)
the complexes##136##2##(1990-12#2)(1990-2#2)(1991-10#1)(1991-11#1)(1991-2#3)(1991-4#1)(1991-9#1)(1992-6#1)(1992-9#2)(1993-11#2)(1993-12#1)(1993-4#1)(1993-6#2)(1993-9#3)(1994-11#2)(1994-5#2)(1994-8#2)(1995-1#2)(1995-11#1)(1995-5#1)(1995-8#3)(1996-11#1)(1996-2#6)(1996-7#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-7#1)(2004-9#1)(2005-11#1)(2005-4#2)(2006-10#7)(2007-11#4)(2007-8#1)(2008-10#25)(2008-3#8)(2008-4#1)(2008-5#21)(2008-6#3)(2008-7#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-5#4)(2010-7#2)(2012-12#1)(2013-1#1)
the complexing agent##9##3##(2007-8#1)(2008-10#8)
the complexing properties of##2##4##(2008-10#2)
the complexing##18##2##(1993-12#1)(1997-8#1)(2007-8#1)(2008-10#14)(2008-3#1)
the complexities associated with##2##4##(1992-6#1)(2010-9#1)
the complexities of the##2##4##(1992-11#1)(2008-12#1)
the complexities of##17##3##(1992-11#1)(1996-2#1)(2005-7#1)(2005-8#1)(2006-7#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-5#1)(2011-2#1)(2013-1#4)(2013-8#1)
the complexities##25##2##(1992-11#1)(1992-6#1)(1994-1#1)(1996-2#1)(2005-7#1)(2005-8#1)(2006-7#1)(2007-4#1)(2008-10#2)(2008-12#1)(2008-4#3)(2008-5#1)(2008-8#1)(2009-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#4)(2013-8#1)
the complexity and##3##3##(2006-4#1)(2011-2#2)
the complexity of human##2##4##(1995-12#1)(1996-3#1)
the complexity of maintaining##2##4##(1993-3#1)(2011-2#1)
the complexity of the apparatus##2##5##(2008-3#2)
the complexity of the feeding apparatus##2##6##(2010-8#2)
the complexity of the models##2##5##(2008-11#1)(2009-4#1)
the complexity of the system##2##5##(2008-10#1)(2008-4#1)
the complexity of the##60##4##(1991-7#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1995-5#1)(1996-3#1)(1997-3#4)(1997-6#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-12#2)(2009-3#1)(2009-4#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the complexity of these##2##4##(2008-5#1)(2008-9#1)
the complexity of##131##3##(1991-7#1)(1992-8#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-2#1)(1995-12#1)(1995-5#1)(1996-3#2)(1996-4#1)(1996-8#1)(1997-3#4)(1997-5#1)(1997-6#2)(1997-8#1)(2004-4#1)(2005-7#2)(2006-10#1)(2006-12#1)(2006-4#3)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#4)(2007-12#3)(2007-4#1)(2007-6#1)(2007-8#4)(2007-9#2)(2008-10#10)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-5#2)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#6)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#1)
the complexity##146##2##(1991-7#1)(1992-8#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-2#1)(1995-12#1)(1995-5#1)(1996-3#2)(1996-4#1)(1996-8#1)(1997-3#4)(1997-5#1)(1997-6#2)(1997-8#1)(2004-4#1)(2005-7#2)(2006-10#1)(2006-12#1)(2006-4#4)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#5)(2007-12#3)(2007-4#2)(2007-6#1)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-6#2)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-5#2)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#8)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#1)
the complexometric##2##2##(2008-10#2)
the compliance of the##3##4##(1996-3#1)(2005-7#1)(2011-2#1)
the compliance of##6##3##(1996-3#1)(2005-7#1)(2006-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
the compliance rate of decisions is not 100%##2##8##(2013-1#2)
the compliance with##3##3##(1996-2#1)(2008-10#1)(2012-3#1)
the compliance##17##2##(1996-2#1)(1996-3#1)(2005-7#1)(2006-8#3)(2007-7#1)(2008-10#2)(2008-5#1)(2009-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
the complicated interactions between##2##4##(2006-8#1)(2008-3#1)
the complicated nature of##2##4##(2006-5#1)(2007-5#1)
the complicated##16##2##(2006-5#1)(2006-8#1)(2007-5#1)(2008-11#1)(2008-3#2)(2008-7#1)(2009-6#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-3#3)(2013-8#1)
the complication of##4##3##(1993-8#1)(1995-8#1)(2009-3#1)(2012-2#1)
the complication rate was##3##4##(2006-8#1)(2007-8#1)(2009-10#1)
the complication rate##7##3##(1991-4#1)(2006-8#1)(2007-11#1)(2007-8#1)(2009-10#1)(2013-1#1)(2013-8#1)
the complication rates of##2##4##(2008-8#1)(2011-2#1)
the complication rates##4##3##(2007-9#1)(2008-8#1)(2011-2#2)
the complication##31##2##(1990-9#1)(1991-4#1)(1992-5#1)(1993-1#1)(1993-8#1)(1995-8#1)(1997-3#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#1)(2010-8#3)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
the complications and mortality##2##4##(1997-3#1)(2013-8#1)
the complications and##5##3##(1990-4#1)(1997-3#1)(2007-5#1)(2008-6#1)(2013-8#1)
the complications associated with##4##4##(2005-10#1)(2006-8#1)(2008-3#1)(2009-10#1)
the complications of the##5##4##(2006-2#1)(2007-11#1)(2008-8#1)(2008-9#1)(2011-2#1)
the complications of##38##3##(1991-10#1)(1991-8#1)(1992-2#1)(1993-10#1)(1993-5#1)(1994-2#1)(1995-8#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-2#1)(2006-8#1)(2007-11#1)(2007-5#1)(2007-7#2)(2008-1#3)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)
the complications rate##2##3##(2007-8#1)(2009-3#1)
the complications that may##3##4##(2006-2#1)(2007-11#1)(2012-2#1)
the complications that occurred in##2##5##(2006-11#1)(2008-10#1)
the complications that##6##3##(1994-6#1)(2006-11#1)(2006-2#1)(2007-11#1)(2008-10#1)(2012-2#1)
the complications##80##2##(1990-4#2)(1990-6#2)(1991-10#1)(1991-8#1)(1992-2#1)(1992-5#1)(1993-10#1)(1993-5#1)(1994-2#1)(1994-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-3#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-2#3)(2006-6#1)(2006-8#3)(2007-10#1)(2007-11#4)(2007-5#3)(2007-7#3)(2007-8#1)(2008-1#4)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-2#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#1)
the complimentary##2##2##(1996-5#1)(2008-11#1)
the component of the##4##4##(1991-10#1)(2008-10#1)(2008-2#1)(2011-1#1)
the component of##7##3##(1990-4#1)(1991-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-1#1)(2013-1#1)
the component##45##2##(1990-4#2)(1991-10#1)(1991-12#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-5#1)(1995-10#1)(1995-2#2)(1995-6#1)(1996-12#1)(1997-8#1)(2006-10#1)(2006-11#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#6)(2008-7#1)(2008-8#1)(2009-3#1)(2010-2#1)(2011-1#1)(2012-1#3)(2012-12#1)(2013-1#1)(2013-8#2)
the components and##4##3##(2008-10#2)(2008-3#1)(2013-1#1)
the components are##3##3##(2008-10#1)(2008-3#2)
the components involved in##2##4##(1991-12#1)(1992-12#1)
the components involved##3##3##(1991-12#1)(1992-12#1)(2008-9#1)
the components is##4##3##(1992-9#1)(1994-11#1)(2006-11#1)(2008-10#1)
the components of a##7##4##(1993-1#1)(1993-3#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#2)
the components of the##36##4##(1990-12#1)(1991-12#1)(1991-2#1)(1991-4#1)(1993-11#1)(1993-2#1)(1996-12#2)(1997-6#1)(2005-4#1)(2006-3#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#2)(2009-10#1)(2010-1#1)(2010-4#1)(2013-1#1)
the components of##69##3##(1990-12#1)(1991-12#1)(1991-2#1)(1991-4#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-12#3)(1996-2#2)(1997-6#2)(2005-10#1)(2005-11#1)(2005-4#1)(2006-12#1)(2006-3#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#3)
the components that##2##3##(2006-12#1)(2008-11#1)
the components##122##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-4#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-5#2)(1995-7#1)(1995-8#1)(1996-12#3)(1996-2#3)(1996-5#1)(1997-6#2)(2005-10#1)(2005-11#1)(2005-4#1)(2006-11#1)(2006-12#2)(2006-3#1)(2006-8#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#25)(2008-11#3)(2008-12#2)(2008-3#8)(2008-4#5)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-1#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#4)
the composite OWG##2##3##(2008-10#2)
the composite end point##2##4##(2007-10#1)(2008-10#1)
the composite face illusion##2##4##(2009-4#2)
the composite film##3##3##(2008-3#1)(2008-7#1)(2010-4#1)
the composite hydrogel##2##3##(2008-5#1)(2009-7#1)
the composite interval mapping##2##4##(2008-10#2)
the composite materials##3##3##(2004-9#1)(2008-10#1)(2009-7#1)
the composite nanofiber mat electrospun from##2##6##(2009-11#2)
the composite nanofiber mat##3##4##(2009-11#3)
the composite was##3##3##(2008-10#1)(2008-5#1)(2010-2#1)
the composite##60##2##(1994-3#1)(2004-9#1)(2007-10#2)(2007-11#2)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#10)(2008-2#5)(2008-3#3)(2008-5#9)(2008-7#1)(2008-8#1)(2009-11#3)(2009-2#1)(2009-4#2)(2009-6#1)(2009-7#4)(2010-2#2)(2010-4#2)(2010-8#2)(2012-12#1)(2013-1#1)
the composites##12##2##(1991-4#1)(2004-9#1)(2005-11#2)(2008-3#1)(2008-5#3)(2009-11#2)(2010-4#2)
the composition and structure of the##2##6##(2008-10#1)(2012-2#1)
the composition and structure of##3##5##(2005-4#1)(2008-10#1)(2012-2#1)
the composition and##18##3##(1992-12#1)(1996-9#1)(2005-4#1)(2005-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)
the composition change of##3##4##(2007-8#1)(2008-10#2)
the composition in##3##3##(1990-5#1)(2008-2#1)(2008-3#1)
the composition of a##5##4##(1990-9#1)(1994-11#1)(2008-10#2)(2008-7#1)
the composition of evacuees who##2##5##(2011-2#2)
the composition of the intestinal microbiota##2##6##(2010-9#2)
the composition of the natural enemy community##2##7##(2008-8#2)
the composition of the##50##4##(1990-10#1)(1991-11#1)(1992-1#1)(1994-12#1)(1995-3#2)(1995-4#1)(1996-6#1)(2005-11#2)(2006-10#3)(2006-8#1)(2007-1#2)(2007-8#1)(2008-10#18)(2008-5#1)(2008-7#1)(2008-8#4)(2010-12#2)(2010-9#2)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)
the composition of these##3##4##(1993-2#1)(2008-2#1)(2013-8#1)
the composition of##121##3##(1990-10#1)(1990-9#1)(1991-11#1)(1991-9#1)(1992-1#1)(1992-6#1)(1993-2#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-6#1)(1995-12#1)(1995-3#3)(1995-4#1)(1996-4#1)(1996-6#1)(1997-3#1)(1997-7#2)(2004-9#1)(2005-11#3)(2006-10#3)(2006-2#1)(2006-8#1)(2007-1#3)(2007-10#1)(2007-11#1)(2007-8#2)(2008-10#36)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#6)(2008-7#4)(2008-8#4)(2008-9#1)(2009-11#1)(2009-7#1)(2010-12#2)(2010-4#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#4)(2012-1#1)(2012-11#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#3)
the composition range##3##3##(1996-5#1)(2007-12#1)(2008-10#1)
the composition with##2##3##(2004-9#1)(2008-8#1)
the composition##170##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-2#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#3)(1995-4#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-7#2)(2004-9#2)(2005-11#5)(2005-4#1)(2005-8#1)(2006-10#4)(2006-2#1)(2006-8#1)(2007-1#3)(2007-10#1)(2007-11#1)(2007-12#4)(2007-8#4)(2008-1#1)(2008-10#45)(2008-11#1)(2008-2#4)(2008-3#8)(2008-4#1)(2008-5#8)(2008-7#6)(2008-8#5)(2008-9#1)(2009-11#1)(2009-7#1)(2010-12#2)(2010-4#2)(2010-7#1)(2010-9#3)(2011-1#4)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#4)
the compositional##11##2##(1992-1#1)(1992-6#1)(1993-11#1)(1994-12#2)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#2)
the compositions of the##2##4##(2005-4#1)(2012-1#1)
the compositions of##6##3##(1995-8#1)(2005-4#1)(2008-10#1)(2008-8#1)(2012-1#1)(2012-2#1)
the compositions##11##2##(1991-4#1)(1993-8#1)(1995-8#1)(2005-4#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2012-1#1)(2012-2#1)
the compost mix##7##3##(2008-10#7)
the compost##16##2##(2008-10#14)(2008-12#2)
the compound action potential##3##4##(1990-2#1)(1990-7#1)(1992-3#1)
the compound eye##3##3##(2007-12#3)
the compound fertilizer##2##3##(2008-10#2)
the compound had##3##3##(1992-8#1)(1993-9#1)(2005-7#1)
the compound has##4##3##(1993-11#1)(1993-9#1)(2005-8#1)(2012-12#1)
the compound in##7##3##(1996-6#1)(2005-7#1)(2005-9#1)(2007-11#1)(2008-10#2)(2011-1#1)
the compound stimulus##6##3##(1997-8#6)
the compound that##4##3##(1990-5#1)(2008-2#1)(2008-8#2)
the compound to be##2##4##(2005-8#1)(2008-10#1)
the compound to##7##3##(2005-7#1)(2005-8#2)(2008-10#2)(2008-5#1)(2010-12#1)
the compound was in phase III trials##2##7##(2005-6#1)(2005-8#1)
the compound was removed and replaced with water##2##8##(2008-10#2)
the compound was##15##3##(1995-7#1)(2005-6#1)(2005-7#2)(2005-8#1)(2006-12#3)(2007-8#1)(2008-10#3)(2009-6#1)(2010-2#1)(2011-1#1)
the compound with##2##3##(1993-6#1)(1996-2#1)
the compound##132##2##(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1991-10#1)(1992-3#1)(1992-5#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#3)(1993-4#2)(1993-6#1)(1993-9#2)(1994-6#3)(1995-11#1)(1995-3#1)(1995-7#2)(1995-8#1)(1996-10#1)(1996-2#2)(1996-5#1)(1996-6#2)(1996-7#1)(1997-8#6)(2004-12#2)(2005-11#1)(2005-6#4)(2005-7#9)(2005-8#9)(2005-9#2)(2006-12#4)(2007-11#2)(2007-12#4)(2007-8#3)(2008-1#1)(2008-10#17)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#7)(2008-8#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-12#2)(2010-2#1)(2011-1#2)(2011-12#1)(2011-2#1)(2011-3#2)(2012-12#1)(2013-1#2)
the compound's##2##2##(2008-5#1)(2009-4#1)
the compounds 5##2##3##(2008-5#1)(2012-11#1)
the compounds acylated on nitrogen by an##2##7##(1995-3#2)
the compounds and the##4##4##(1996-6#1)(2005-11#1)(2007-1#1)(2012-12#1)
the compounds and##7##3##(1996-6#1)(2005-11#1)(2005-6#2)(2007-1#1)(2008-10#1)(2012-12#1)
the compounds are##8##3##(1992-11#2)(1997-1#1)(1997-3#1)(2008-10#2)(2008-5#1)(2009-8#1)
the compounds at the##2##4##(1996-10#1)(2008-10#1)
the compounds at##5##3##(1996-10#1)(2007-3#1)(2008-10#2)(2011-3#1)
the compounds bind##2##3##(1991-12#1)(1992-11#1)
the compounds described##2##3##(1997-2#1)(2006-12#1)
the compounds examined##3##3##(1990-5#1)(1995-5#1)(2006-12#1)
the compounds except##2##3##(1994-8#1)(2008-10#1)
the compounds having##3##3##(1992-12#1)(2008-10#1)(2008-5#1)
the compounds in##4##3##(1995-6#1)(1996-6#1)(2008-10#1)(2010-12#1)
the compounds inhibited##3##3##(1996-4#1)(1996-8#1)(2006-8#1)
the compounds obtained##2##3##(2008-5#1)(2008-6#1)
the compounds of##2##3##(2008-11#1)(2011-1#1)
the compounds present in the##2##5##(2006-12#1)(2008-10#1)
the compounds present##4##3##(2006-12#1)(2007-11#1)(2008-10#2)
the compounds studied were##2##4##(1994-11#1)(2008-10#1)
the compounds studied##9##3##(1990-9#1)(1994-11#2)(1994-8#1)(1996-11#1)(1997-3#1)(2007-8#1)(2008-10#2)
the compounds tested##15##3##(1990-12#1)(1990-7#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-5#1)(1995-6#1)(1996-6#1)(1997-2#1)(2008-3#1)(2009-8#1)(2010-12#1)
the compounds to##4##3##(1992-8#1)(1996-8#1)(1997-1#1)(1997-7#1)
the compounds used##2##3##(2008-10#1)(2008-5#1)
the compounds using##3##3##(1996-6#1)(1997-3#1)(2008-10#1)
the compounds was##10##3##(1993-11#1)(1995-2#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#2)
the compounds were measured##2##4##(1993-1#1)(2012-11#1)
the compounds were##19##3##(1993-1#1)(1993-2#1)(1994-3#1)(1995-3#1)(1996-8#1)(2005-9#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-5#3)(2010-12#1)(2012-11#1)
the compounds which##2##3##(1990-11#1)(2008-1#1)
the compounds with##4##3##(1993-4#1)(1997-7#1)(2008-10#1)(2008-5#1)
the compounds##200##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1990-9#2)(1991-12#1)(1991-3#1)(1992-11#4)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#4)(1993-2#2)(1993-4#3)(1993-6#1)(1994-11#3)(1994-3#1)(1994-8#3)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#2)(1996-10#1)(1996-11#1)(1996-2#3)(1996-4#1)(1996-5#4)(1996-6#4)(1996-8#4)(1997-1#5)(1997-2#4)(1997-3#5)(1997-4#2)(1997-6#1)(1997-7#2)(2004-11#1)(2004-12#1)(2004-2#1)(2005-11#2)(2005-6#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-12#3)(2006-2#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#7)(2007-3#1)(2007-8#3)(2008-1#1)(2008-10#42)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#16)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#2)(2010-12#6)(2010-5#1)(2011-1#2)(2011-3#1)(2012-11#3)(2012-12#1)(2012-3#1)
the comprehension of##7##3##(1994-11#1)(1996-7#1)(1997-3#1)(2007-10#1)(2009-8#1)(2011-1#1)(2012-2#1)
the comprehension##12##2##(1994-11#1)(1996-7#1)(1997-3#1)(2007-10#2)(2007-9#1)(2009-8#2)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
the comprehensive and##2##3##(2007-8#1)(2011-1#1)
the comprehensive health##2##3##(1994-1#1)(2011-2#1)
the comprehensive medical##2##3##(2007-12#1)(2007-5#1)
the comprehensive##29##2##(1992-2#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-1#1)(1995-12#1)(2006-12#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-5#2)(2009-2#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-8#1)
the comprehensiveness of##2##3##(2007-1#1)(2008-12#1)
the compressed pulses##3##3##(2007-12#1)(2008-2#1)(2012-11#1)
the compressed##14##2##(2007-12#3)(2008-1#2)(2008-2#7)(2010-3#1)(2012-11#1)
the compressibility##2##2##(2006-11#1)(2010-5#1)
the compression effect##2##3##(2013-8#2)
the compression index##3##3##(2008-5#3)
the compression of the##3##4##(2005-11#1)(2007-8#1)(2008-2#1)
the compression of##7##3##(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#3)
the compression##29##2##(1992-6#1)(1993-3#1)(1996-1#1)(1996-4#1)(2005-11#1)(2006-11#2)(2006-3#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#4)(2008-8#1)(2008-9#3)(2013-8#3)
the compressive failure##2##3##(2006-11#2)
the compressive strength##4##3##(2004-9#3)(2007-9#1)
the compressive##16##2##(2004-9#4)(2006-11#5)(2007-9#1)(2008-1#1)(2008-11#1)(2009-7#4)
the compressor##5##2##(2007-12#1)(2008-2#4)
the compromise between##2##3##(2008-3#1)(2009-3#1)
the compromise##4##2##(2007-7#1)(2008-10#1)(2008-3#1)(2009-3#1)
the compromised##3##2##(2005-7#1)(2007-11#1)(2008-3#1)
the compulsive##2##2##(2009-6#2)
the compulsory##3##2##(1991-6#1)(1994-1#1)(2008-11#1)
the computation and##2##3##(1992-9#1)(2011-1#1)
the computation of a##2##4##(2008-3#1)(2010-2#1)
the computation of optical##2##4##(1992-9#1)(2008-3#1)
the computation of the connectivity##2##5##(2008-2#2)
the computation of the##11##4##(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#4)(2008-3#2)(2008-4#1)(2011-1#1)
the computation of##32##3##(1992-9#1)(1993-5#1)(1996-7#1)(1997-8#2)(2007-12#1)(2007-9#1)(2008-10#3)(2008-2#6)(2008-3#10)(2008-4#2)(2008-8#1)(2009-3#1)(2010-2#1)(2011-1#1)
the computation time of the##2##5##(2008-3#1)(2012-3#1)
the computation time of##3##4##(2008-3#1)(2010-2#1)(2012-3#1)
the computation time##8##3##(2008-2#1)(2008-3#4)(2010-2#2)(2012-3#1)
the computation##48##2##(1992-9#2)(1993-5#1)(1996-7#1)(1997-8#2)(2007-12#1)(2007-9#1)(2008-10#3)(2008-2#10)(2008-3#15)(2008-4#2)(2008-6#1)(2008-8#1)(2009-3#1)(2010-2#3)(2011-1#2)(2012-3#1)(2013-8#1)
the computational burden##2##3##(2008-2#1)(2009-9#1)
the computational complexity##2##3##(2009-10#1)(2012-2#1)
the computational domain##2##3##(2008-3#1)(2008-7#1)
the computational effort##2##3##(2008-8#1)(2011-2#1)
the computational methodology for##2##4##(2008-10#1)(2008-3#1)
the computational power##2##3##(2008-2#2)
the computational time##3##3##(2008-2#2)(2008-3#1)
the computational##41##2##(1990-11#1)(1992-9#1)(1996-12#1)(2005-4#1)(2008-10#2)(2008-2#9)(2008-3#7)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
the computationally##2##2##(2008-11#1)(2008-8#1)
the computations##5##2##(1997-7#1)(2008-2#1)(2008-3#2)(2012-2#1)
the computed result##2##3##(1996-12#1)(2008-3#1)
the computed tomography (CT)##2##4##(2009-8#1)(2011-2#1)
the computed##19##2##(1991-12#1)(1991-2#1)(1995-1#1)(1996-12#1)(2007-11#1)(2007-8#1)(2008-2#3)(2008-3#3)(2008-7#1)(2009-8#1)(2009-9#2)(2010-2#1)(2010-5#1)(2011-2#1)
the computer and##3##3##(1995-12#1)(2012-12#1)(2013-8#1)
the computer database##2##3##(1993-9#1)(2004-10#1)
the computer program##11##3##(1995-12#3)(1997-2#1)(2005-11#1)(2005-8#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)
the computer screen##3##3##(2007-7#1)(2008-10#1)(2012-1#1)
the computer simulations##2##3##(1992-12#1)(2008-3#1)
the computer system##5##3##(1990-3#2)(1992-4#1)(1997-3#1)(2006-8#1)
the computer##65##2##(1990-3#2)(1991-9#1)(1992-12#3)(1992-4#3)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1995-12#4)(1995-2#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-2#2)(1997-3#1)(2004-10#1)(2005-11#1)(2005-8#1)(2006-11#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-5#1)(2007-6#1)(2007-7#3)(2008-10#6)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2009-10#1)(2010-5#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
the computer-aided##3##2##(2008-11#1)(2010-8#1)(2013-1#1)
the computer-assisted##2##2##(2006-6#2)
the computer-based##3##2##(1993-12#1)(1994-2#1)(1994-6#1)
the computing time##2##3##(2008-3#2)
the computing##4##2##(2008-2#1)(2008-3#2)(2009-11#1)
the concatenated##3##2##(1996-10#1)(2012-1#1)(2012-3#1)
the concatenation can##2##3##(2007-12#2)
the concatenation##3##2##(2006-8#1)(2007-12#2)
the concave side of the##3##5##(1996-5#1)(2007-8#1)(2012-2#1)
the concave side of##4##4##(1996-5#1)(2007-8#1)(2012-2#2)
the concentrate##4##2##(2008-10#1)(2010-4#2)(2012-2#1)
the concentrated feedlot area##3##4##(2008-5#3)
the concentrated##16##2##(1990-6#1)(1992-11#1)(2008-10#6)(2008-5#4)(2008-6#1)(2010-7#1)(2010-9#1)(2012-2#1)
the concentrating##2##2##(2008-10#1)(2013-1#1)
the concentration and the##2##4##(2008-10#1)(2008-3#1)
the concentration and##25##3##(1990-2#1)(1991-5#1)(1991-8#1)(1993-12#1)(1994-8#1)(1995-1#1)(1997-2#1)(2005-11#1)(2007-11#1)(2008-10#9)(2008-2#2)(2008-3#1)(2008-5#1)(2009-2#1)(2010-4#1)(2011-2#1)
the concentration at which the##2##5##(2006-10#2)
the concentration at which##4##4##(2004-11#1)(2006-10#2)(2008-10#1)
the concentration corresponding to##2##4##(2008-10#1)(2012-2#1)
the concentration dependence of the##8##5##(1990-11#1)(1994-8#1)(1995-6#1)(2005-11#3)(2007-8#1)(2008-10#1)
the concentration dependence of##11##4##(1990-11#1)(1991-8#1)(1994-8#1)(1995-12#1)(1995-4#1)(1995-6#1)(2005-11#3)(2007-8#1)(2008-10#1)
the concentration gradient##2##3##(2012-1#1)(2012-2#1)
the concentration in the##3##4##(1990-4#1)(2007-2#1)(2011-1#1)
the concentration in##5##3##(1990-4#1)(2007-2#1)(2008-10#2)(2011-1#1)
the concentration increases##2##3##(2005-11#1)(2008-10#1)
the concentration is##3##3##(2008-10#1)(2008-3#1)(2010-11#1)
the concentration level of##4##4##(2008-10#3)(2012-1#1)
the concentration level##6##3##(2008-10#5)(2012-1#1)
the concentration levels of##3##4##(2008-10#2)(2008-11#1)
the concentration levels##6##3##(2008-10#5)(2008-11#1)
the concentration limit of detection##2##5##(1997-2#1)(2007-8#1)
the concentration necessary to induce##2##5##(1993-12#1)(1997-3#1)
the concentration of 0##2##4##(2008-10#2)
the concentration of 1##5##4##(1990-9#1)(1994-11#1)(2008-11#1)(2008-5#1)(2010-5#1)
the concentration of 10##3##4##(1991-7#1)(2008-10#1)(2008-11#1)
the concentration of 100##3##4##(1992-1#1)(1996-2#1)(2008-5#1)
the concentration of 5##3##4##(2008-10#1)(2011-1#1)(2012-3#1)
the concentration of 5-hydroxyindoleacetic acid##2##5##(1996-1#1)(2010-12#1)
the concentration of AA in the range##2##7##(2008-10#2)
the concentration of ATP##2##4##(1991-1#2)
the concentration of CV and##2##5##(2008-10#2)
the concentration of Ca2+ in the##2##6##(1990-5#1)(1991-12#1)
the concentration of Ca2+##3##4##(1990-5#1)(1991-12#1)(1992-5#1)
the concentration of Cr(VI)##2##4##(2008-10#2)
the concentration of FP-IX##2##4##(1994-8#2)
the concentration of IAA##3##4##(2006-10#1)(2008-9#2)
the concentration of Mn##2##4##(2008-10#2)
the concentration of NO##2##4##(1993-8#1)(2008-10#1)
the concentration of STA ion##2##5##(2008-10#2)
the concentration of TCE in the##2##6##(2008-10#1)(2010-4#1)
the concentration of Zn(2+)##2##4##(2008-10#2)
the concentration of a particular##4##5##(2008-4#1)(2008-9#2)(2011-1#1)
the concentration of a##10##4##(1992-8#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-9#2)(2011-1#1)
the concentration of active##3##4##(1991-2#1)(2008-11#1)(2010-7#1)
the concentration of ammonia reached##2##5##(2008-10#2)
the concentration of ammonia##3##4##(2008-10#2)(2008-11#1)
the concentration of an##2##4##(2007-12#1)(2011-2#1)
the concentration of analyte##2##4##(2008-10#2)
the concentration of ascorbic acid##3##5##(2008-10#3)
the concentration of both##2##4##(1991-2#1)(2008-10#1)
the concentration of bupivacaine##4##4##(2006-12#1)(2008-8#3)
the concentration of chlorophyll##2##4##(2008-3#1)(2011-12#1)
the concentration of cobalt##2##4##(1994-6#2)
the concentration of each##5##4##(2008-10#4)(2008-2#1)
the concentration of either##2##4##(1992-3#1)(1992-8#1)
the concentration of extracellular##2##4##(1997-2#1)(2012-12#1)
the concentration of free DAPI##2##5##(2008-2#2)
the concentration of free##9##4##(1994-12#1)(2005-11#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#2)(2011-2#1)
the concentration of glucose##2##4##(2008-10#1)(2008-11#1)
the concentration of glutamate##2##4##(2007-9#1)(2008-7#1)
the concentration of guanidine##2##4##(1992-6#1)(1995-3#1)
the concentration of hemin##2##4##(1993-12#1)(2008-10#1)
the concentration of hormones##2##4##(1997-4#1)(2008-8#1)
the concentration of hydrogen##2##4##(2008-10#2)
the concentration of intracellular Ca(2+)##2##5##(2007-10#1)(2012-3#1)
the concentration of intracellular##4##4##(1990-8#1)(1993-3#1)(2007-10#1)(2012-3#1)
the concentration of iron##2##4##(2008-10#2)
the concentration of lead##2##4##(1997-4#1)(2007-10#1)
the concentration of ligand##2##4##(2008-10#2)
the concentration of macromolecules##2##4##(2006-9#1)(2008-4#1)
the concentration of mast cells in##2##6##(2011-2#2)
the concentration of metal##2##4##(2008-10#2)
the concentration of methanol in##2##5##(1996-5#2)
the concentration of nitrite##4##4##(2005-4#1)(2006-3#1)(2008-10#2)
the concentration of nucleic acids in the range of##2##9##(2008-10#1)(2008-3#1)
the concentration of nucleic acids in the range##3##8##(2008-10#2)(2008-3#1)
the concentration of nucleic acids##5##5##(2008-10#4)(2008-3#1)
the concentration of orthophosphate##2##4##(2008-10#2)
the concentration of oxygen##3##4##(2008-10#2)(2009-2#1)
the concentration of plasma##2##4##(1996-6#2)
the concentration of poverty##2##4##(1992-1#1)(2008-1#1)
the concentration of protein##3##4##(1992-3#1)(1994-12#1)(1995-6#1)
the concentration of proteins##3##4##(2008-10#2)(2008-4#1)
the concentration of reactive carbonyl residues in plasma proteins##2##9##(2004-11#2)
the concentration of serum##2##4##(2008-1#1)(2008-11#1)
the concentration of sodium##3##4##(1991-2#1)(2005-12#2)
the concentration of surface##2##4##(2008-10#1)(2008-5#1)
the concentration of the active##2##5##(1993-10#1)(2011-2#1)
the concentration of the free##2##5##(2008-10#2)
the concentration of the substrate##2##5##(1990-4#1)(1991-8#1)
the concentration of the sulfate ion##2##6##(2008-10#2)
the concentration of the surfactant##3##5##(1997-8#1)(2008-10#1)(2008-7#1)
the concentration of the##77##4##(1990-2#1)(1990-4#1)(1990-5#2)(1991-5#1)(1991-8#1)(1992-12#1)(1992-4#1)(1992-7#1)(1993-10#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-3#2)(1996-12#2)(1996-5#1)(1997-7#1)(1997-8#1)(2004-12#2)(2005-11#3)(2006-10#1)(2007-8#1)(2008-10#28)(2008-12#3)(2008-5#2)(2008-6#2)(2008-7#1)(2009-12#1)(2009-8#1)(2010-3#1)(2010-4#3)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
the concentration of these molecules##2##5##(1994-8#1)(2008-5#1)
the concentration of these##5##4##(1994-3#1)(1994-8#1)(2007-12#1)(2008-5#1)(2009-4#1)
the concentration of this##2##4##(1994-9#1)(1997-6#1)
the concentration of total##3##4##(1993-4#1)(1995-1#1)(2008-10#1)
the concentration of urea##3##4##(2008-10#2)(2008-4#1)
the concentration of vanadium##4##4##(1990-5#1)(2008-10#3)
the concentration of water in##2##5##(2008-3#1)(2012-12#1)
the concentration of which##2##4##(2008-10#2)
the concentration of##619##3##(1990-1#1)(1990-11#2)(1990-12#2)(1990-2#3)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#3)(1991-10#3)(1991-12#4)(1991-2#4)(1991-3#1)(1991-4#2)(1991-5#2)(1991-7#2)(1991-8#4)(1991-9#1)(1992-1#3)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#4)(1992-4#3)(1992-5#3)(1992-6#3)(1992-7#4)(1992-8#3)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#4)(1994-8#4)(1994-9#3)(1995-1#5)(1995-12#2)(1995-2#2)(1995-3#3)(1995-4#2)(1995-5#2)(1995-6#2)(1996-1#1)(1996-11#2)(1996-12#5)(1996-2#2)(1996-3#1)(1996-5#6)(1996-6#3)(1996-7#1)(1996-8#1)(1997-2#5)(1997-3#2)(1997-4#5)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2004-11#2)(2004-12#3)(2004-2#1)(2005-10#1)(2005-11#9)(2005-12#4)(2005-4#3)(2005-6#1)(2006-1#1)(2006-10#3)(2006-12#2)(2006-3#2)(2006-5#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#6)(2007-7#1)(2007-8#9)(2007-9#5)(2008-1#4)(2008-10#218)(2008-11#10)(2008-12#6)(2008-2#11)(2008-3#11)(2008-4#8)(2008-5#14)(2008-6#3)(2008-7#6)(2008-8#7)(2008-9#10)(2009-11#3)(2009-12#1)(2009-2#1)(2009-4#2)(2009-6#2)(2009-8#1)(2010-12#6)(2010-3#4)(2010-4#4)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#7)(2011-12#1)(2011-2#9)(2012-1#4)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#3)(2012-6#1)(2013-1#4)(2013-7#2)(2013-8#10)
the concentration profiles##2##3##(2008-10#1)(2010-2#1)
the concentration range 0##28##4##(1990-9#1)(1993-2#1)(1995-3#1)(1996-5#1)(2008-10#23)(2013-7#1)
the concentration range 1##8##4##(2008-10#7)(2008-5#1)
the concentration range 10(-6)-10(-3)##2##4##(2008-10#2)
the concentration range 2##4##4##(1992-2#1)(2008-10#3)
the concentration range 5##4##4##(2008-10#4)
the concentration range between##6##4##(1990-12#1)(1992-3#1)(2008-10#4)
the concentration range from 0##4##5##(2007-8#1)(2008-10#2)(2012-12#1)
the concentration range from 5##6##5##(2008-10#6)
the concentration range from 50 to##3##6##(2008-10#3)
the concentration range from##27##4##(1995-1#1)(2007-8#1)(2008-10#24)(2012-12#1)
the concentration range of 0##34##5##(1990-12#1)(1997-3#1)(2006-10#1)(2008-10#26)(2011-1#1)(2011-3#1)(2012-12#2)(2013-8#1)
the concentration range of 1##7##5##(1995-11#1)(2008-10#5)(2008-5#1)
the concentration range of 1-10##2##5##(2008-10#1)(2010-2#1)
the concentration range of 10(-6) to##2##6##(2006-12#1)(2008-10#1)
the concentration range of 1x10(-6) to 1x10(-5)M##2##7##(2008-10#2)
the concentration range of 2##6##5##(2007-8#1)(2008-10#4)(2008-5#1)
the concentration range of 3##2##5##(2008-10#1)(2008-12#1)
the concentration range of 5##3##5##(2008-10#3)
the concentration range of the##2##5##(2005-4#1)(2008-10#1)
the concentration range of##97##4##(1990-12#1)(1990-5#1)(1995-11#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-3#2)(2005-4#1)(2006-10#1)(2006-12#2)(2007-8#3)(2008-10#68)(2008-12#1)(2008-5#2)(2010-12#2)(2010-2#3)(2010-5#1)(2011-1#1)(2011-3#1)(2012-12#2)(2013-8#1)
the concentration range studied##4##4##(1991-5#1)(1997-6#1)(2008-10#2)
the concentration range##238##3##(1990-12#2)(1990-5#1)(1990-7#1)(1990-9#1)(1991-5#1)(1992-2#1)(1992-3#1)(1993-2#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#1)(1997-3#3)(1997-6#1)(2005-4#1)(2006-10#2)(2006-12#2)(2007-8#4)(2008-10#183)(2008-12#1)(2008-5#5)(2008-6#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#4)(2013-7#1)(2013-8#1)
the concentration ranges of##9##4##(1996-8#1)(2007-8#1)(2008-10#7)
the concentration ranges##18##3##(1992-7#1)(1994-3#1)(1996-8#1)(2007-8#1)(2008-10#13)(2008-5#1)
the concentration ratio of##5##4##(2005-11#1)(2008-10#2)(2011-1#1)(2013-7#1)
the concentration ratio##7##3##(2005-11#2)(2008-10#3)(2011-1#1)(2013-7#1)
the concentration required##2##3##(1990-5#1)(1997-5#1)
the concentration sensitivity##2##3##(2008-10#1)(2010-7#1)
the concentration was##6##3##(1995-6#1)(1996-12#1)(2008-10#3)(2011-2#1)
the concentration##1025##2##(1990-1#1)(1990-11#3)(1990-12#4)(1990-2#4)(1990-4#2)(1990-5#7)(1990-6#1)(1990-7#3)(1990-8#2)(1990-9#2)(1991-1#3)(1991-10#3)(1991-12#4)(1991-2#4)(1991-3#1)(1991-4#2)(1991-5#4)(1991-7#3)(1991-8#6)(1991-9#1)(1992-1#3)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#5)(1992-4#3)(1992-5#3)(1992-6#3)(1992-7#5)(1992-8#3)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#5)(1993-2#3)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#3)(1994-2#4)(1994-3#2)(1994-5#1)(1994-6#5)(1994-8#7)(1994-9#3)(1995-1#7)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#4)(1995-4#3)(1995-5#2)(1995-6#4)(1996-1#1)(1996-11#2)(1996-12#7)(1996-2#2)(1996-3#1)(1996-5#9)(1996-6#4)(1996-7#2)(1996-8#3)(1997-2#7)(1997-3#6)(1997-4#5)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#1)(2004-11#3)(2004-12#3)(2004-2#1)(2005-10#1)(2005-11#21)(2005-12#4)(2005-4#4)(2005-6#1)(2005-8#1)(2006-1#1)(2006-10#8)(2006-12#4)(2006-3#2)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#6)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#16)(2007-9#5)(2008-1#5)(2008-10#473)(2008-11#11)(2008-12#8)(2008-2#14)(2008-3#17)(2008-4#8)(2008-5#23)(2008-6#4)(2008-7#6)(2008-8#7)(2008-9#10)(2009-11#3)(2009-12#2)(2009-2#3)(2009-4#2)(2009-6#2)(2009-8#2)(2010-11#2)(2010-12#8)(2010-2#4)(2010-3#4)(2010-4#5)(2010-5#3)(2010-7#2)(2010-8#1)(2011-1#11)(2011-12#1)(2011-2#12)(2011-3#1)(2012-1#7)(2012-11#1)(2012-12#9)(2012-2#8)(2012-3#3)(2012-6#1)(2013-1#4)(2013-7#4)(2013-8#11)
the concentration-dependent##4##2##(1991-4#1)(1993-8#1)(1995-4#1)(2008-2#1)
the concentration-response curve for##6##4##(1990-12#1)(1993-11#3)(1996-10#1)(1996-12#1)
the concentration-response curve##10##3##(1990-12#1)(1992-8#1)(1993-11#3)(1996-10#1)(1996-12#3)(1997-5#1)
the concentration-response##11##2##(1990-12#1)(1992-8#1)(1993-11#3)(1996-10#1)(1996-12#3)(1997-5#1)(2008-10#1)
the concentration-time profiles of##3##4##(1994-11#1)(2008-10#2)
the concentration-time profiles##4##3##(1994-11#1)(2008-10#2)(2008-5#1)
the concentration-time##7##2##(1994-11#1)(1995-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-1#1)
the concentrations and##3##3##(1996-12#1)(2008-11#1)(2010-3#1)
the concentrations found in urine ranged from##2##7##(1992-2#2)
the concentrations found##4##3##(1992-2#2)(2008-10#2)
the concentrations in patients with##2##5##(1992-11#1)(2007-3#1)
the concentrations in the##4##4##(2008-10#1)(2013-8#3)
the concentrations in##9##3##(1990-11#1)(1992-11#1)(1993-7#1)(1995-3#1)(2007-3#1)(2008-10#1)(2013-8#3)
the concentrations obtained##2##3##(2007-8#1)(2008-10#1)
the concentrations of 1##2##4##(1990-10#1)(2007-2#1)
the concentrations of all chemokines##2##5##(2012-1#2)
the concentrations of all##4##4##(1995-2#1)(2008-10#1)(2012-1#2)
the concentrations of both##4##4##(1994-12#1)(2006-10#1)(2008-10#1)(2009-5#1)
the concentrations of extracellular##2##4##(2008-11#1)(2013-8#1)
the concentrations of the analytes##2##5##(2008-10#2)
the concentrations of the##23##4##(1990-6#1)(1990-8#1)(1991-10#1)(1992-9#1)(1994-9#1)(1995-3#1)(1996-11#2)(1996-5#1)(1996-9#1)(1997-8#1)(2004-4#1)(2008-1#1)(2008-10#9)(2012-12#1)
the concentrations of their##2##4##(2010-4#1)(2011-1#1)
the concentrations of these##6##4##(1991-9#1)(1997-4#1)(2004-11#1)(2008-10#2)(2009-6#1)
the concentrations of toxic##2##4##(1992-6#1)(1996-12#1)
the concentrations of unconjugated estrogens in##2##6##(2006-5#2)
the concentrations of##167##3##(1990-10#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-2#2)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-12#3)(1993-2#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-6#2)(1996-11#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-4#3)(1997-6#2)(1997-8#2)(2004-11#2)(2004-4#2)(2005-11#1)(2005-12#2)(2005-4#1)(2005-7#1)(2006-10#2)(2006-4#1)(2006-5#3)(2006-9#1)(2007-10#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#42)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#4)(2010-4#2)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#8)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
the concentrations ranged##2##3##(2008-10#2)
the concentrations ranging from##2##4##(1996-5#1)(2008-4#1)
the concentrations tested##6##3##(1995-10#1)(2004-9#1)(2008-10#2)(2008-11#1)(2008-7#1)
the concentrations used##4##3##(1993-9#1)(2008-10#2)(2008-11#1)
the concentrations##224##2##(1990-10#1)(1990-11#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#3)(1992-2#4)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-12#3)(1993-2#1)(1993-7#1)(1993-9#5)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#4)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#2)(1996-11#2)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-4#3)(1997-6#2)(1997-8#2)(2004-11#2)(2004-4#3)(2004-9#1)(2005-11#1)(2005-12#2)(2005-4#1)(2005-7#1)(2006-10#2)(2006-4#1)(2006-5#3)(2006-9#1)(2007-1#1)(2007-10#2)(2007-2#1)(2007-3#1)(2007-5#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#61)(2008-11#7)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#4)(2010-3#1)(2010-4#2)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#8)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#5)
the concentrator##4##2##(2007-8#1)(2008-3#3)
the concentric mosaic##2##3##(2008-2#2)
the concentric##3##2##(2008-2#2)(2008-3#1)
the concept &quot##2##3##(2013-1#2)
the concept and the##2##4##(2009-12#1)(2009-2#1)
the concept and##11##3##(1993-2#1)(1994-2#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-2#1)(2011-2#1)(2013-8#1)
the concept behind##2##3##(2008-1#1)(2008-2#1)
the concept in##3##3##(2008-3#1)(2012-12#1)(2013-1#1)
the concept is##5##3##(1992-12#1)(2006-4#1)(2008-3#1)(2008-9#1)(2009-8#1)
the concept of &quot##12##4##(1991-12#1)(1997-1#1)(2004-9#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-10#1)(2010-4#1)(2012-12#2)(2012-2#1)(2012-3#1)
the concept of HC-transcomplementation##2##4##(2008-10#2)
the concept of a##26##4##(1990-3#1)(1991-1#1)(1992-1#2)(1992-12#1)(1992-2#1)(1994-3#1)(1995-12#1)(1996-1#1)(2005-9#1)(2006-10#2)(2006-6#1)(2007-12#2)(2007-9#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-2#1)(2009-5#1)(2011-1#1)(2012-2#2)
the concept of active##2##4##(2008-6#1)(2008-7#1)
the concept of acute##2##4##(1996-9#2)
the concept of an##5##4##(1994-11#1)(1997-8#1)(2007-9#1)(2008-3#1)(2013-1#1)
the concept of caring##2##4##(2009-8#2)
the concept of competence##2##4##(2006-10#1)(2011-2#1)
the concept of control##2##4##(2009-1#1)(2009-2#1)
the concept of differential optical##2##5##(2008-2#2)
the concept of disease##3##4##(1993-12#1)(1997-6#1)(1997-7#1)
the concept of healthy##2##4##(2006-10#1)(2006-12#1)
the concept of impulsivity##2##4##(2013-7#2)
the concept of net##2##4##(2007-4#1)(2008-10#1)
the concept of nursing##2##4##(2009-12#1)(2010-3#1)
the concept of partnership##2##4##(1992-1#1)(2008-2#1)
the concept of reconstructing##2##4##(2010-10#1)(2013-1#1)
the concept of restorative volume##2##5##(2012-12#2)
the concept of self##2##4##(2010-8#1)(2011-2#1)
the concept of standard##2##4##(2009-7#1)(2012-1#1)
the concept of stewardship in health##2##6##(2012-2#2)
the concept of the &quot##3##5##(1993-6#1)(2006-5#1)(2008-2#1)
the concept of the##21##4##(1990-6#1)(1991-9#1)(1992-12#1)(1993-6#1)(1997-6#1)(2005-11#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-12#1)(2008-2#3)(2008-3#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)
the concept of##280##3##(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#1)(1991-1#1)(1991-12#3)(1991-9#1)(1992-1#4)(1992-12#2)(1992-2#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-1#1)(1996-12#1)(1996-3#3)(1996-6#1)(1996-7#1)(1996-9#4)(1997-1#3)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(2004-8#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-9#1)(2006-10#10)(2006-12#2)(2006-5#3)(2006-6#4)(2006-7#6)(2007-11#6)(2007-12#5)(2007-3#1)(2007-4#4)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#7)(2008-11#5)(2008-12#6)(2008-2#21)(2008-3#15)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#5)(2008-9#6)(2009-1#1)(2009-10#3)(2009-12#2)(2009-2#2)(2009-4#2)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-3#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#12)(2012-1#4)(2012-11#1)(2012-12#9)(2012-2#13)(2012-3#4)(2013-1#12)(2013-7#3)(2013-8#2)
the concept that leptin##2##4##(2006-10#2)
the concept that some##2##4##(2008-10#1)(2012-2#1)
the concept that the##12##4##(1992-3#1)(1994-2#1)(1995-11#1)(1995-5#1)(1996-5#1)(1997-8#1)(2006-12#1)(2008-3#3)(2008-5#1)(2008-7#1)
the concept that##58##3##(1990-11#1)(1990-12#1)(1990-7#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-9#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-5#3)(1996-9#1)(1997-4#2)(1997-5#1)(1997-8#1)(2004-12#2)(2005-10#1)(2005-7#1)(2006-10#3)(2006-12#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#6)(2008-8#1)(2009-10#1)(2009-4#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#1)
the concept was##4##3##(2006-8#1)(2007-5#1)(2008-2#1)(2009-6#1)
the concept##400##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#2)(1991-1#1)(1991-12#3)(1991-9#2)(1992-1#4)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#4)(1995-5#3)(1995-6#1)(1996-1#2)(1996-12#1)(1996-3#3)(1996-5#3)(1996-6#1)(1996-7#1)(1996-9#5)(1997-1#4)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2004-12#2)(2004-5#1)(2004-8#1)(2004-9#1)(2005-10#2)(2005-11#2)(2005-7#1)(2005-9#1)(2006-10#15)(2006-12#3)(2006-4#1)(2006-5#3)(2006-6#4)(2006-7#7)(2006-8#1)(2007-11#7)(2007-12#7)(2007-3#1)(2007-4#5)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#10)(2008-11#5)(2008-12#7)(2008-2#24)(2008-3#27)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#12)(2008-8#2)(2008-9#8)(2009-1#2)(2009-10#4)(2009-12#3)(2009-2#3)(2009-4#3)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#15)(2012-1#4)(2012-11#2)(2012-12#10)(2012-2#17)(2012-3#6)(2013-1#25)(2013-7#3)(2013-8#4)
the conception of##3##3##(1995-5#1)(2008-3#1)(2011-2#1)
the conception rate##3##3##(1992-7#1)(2013-1#2)
the conception##8##2##(1992-7#1)(1994-6#1)(1995-5#1)(2008-3#1)(2009-2#1)(2011-2#1)(2013-1#2)
the concepts and##3##3##(2007-9#1)(2008-9#1)(2009-10#1)
the concepts of &quot##2##4##(2010-7#1)(2013-8#1)
the concepts of the##2##4##(2008-2#2)
the concepts of wave propagation through##2##6##(2007-12#2)
the concepts of##33##3##(1993-6#1)(1994-12#1)(1996-1#1)(2005-10#1)(2007-12#4)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-9#1)(2009-10#1)(2010-3#1)(2010-7#2)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-8#2)
the concepts they##2##3##(1995-1#1)(2010-2#1)
the concepts##52##2##(1992-1#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-1#2)(1996-1#1)(2004-9#1)(2005-10#1)(2006-3#1)(2006-8#1)(2007-12#4)(2007-3#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#2)(2008-6#1)(2008-9#3)(2009-10#2)(2009-4#1)(2010-2#1)(2010-3#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-8#2)
the conceptual basis##2##3##(2006-10#1)(2012-11#1)
the conceptual framework of##2##4##(2008-7#1)(2011-2#1)
the conceptual framework that##2##4##(1997-2#1)(2011-1#1)
the conceptual framework##9##3##(1994-12#1)(1997-2#2)(1997-3#1)(2008-7#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
the conceptual model##2##3##(2012-1#1)(2013-8#1)
the conceptual understanding of##2##4##(2007-8#1)(2012-1#1)
the conceptual##36##2##(1991-6#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-4#1)(1997-2#4)(1997-3#1)(1997-6#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-12#1)(2010-2#1)(2010-3#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#2)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#2)
the conceptualization##3##2##(1995-1#1)(2004-12#1)(2009-9#1)
the concern for##4##3##(2008-4#1)(2008-8#1)(2010-4#1)(2013-1#1)
the concern of##2##3##(2007-12#1)(2011-1#1)
the concern that##2##3##(2008-5#2)
the concern##11##2##(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-3#1)(2010-4#2)(2011-1#1)(2013-1#1)
the concerned##3##2##(2008-11#1)(2008-7#1)(2010-7#1)
the concerns of##6##3##(1993-12#1)(1996-5#1)(2006-4#1)(2006-5#1)(2008-1#1)(2008-10#1)
the concerns raised by##2##4##(2005-7#1)(2012-11#1)
the concerns that##3##3##(2005-5#1)(2006-10#1)(2007-12#1)
the concerns##20##2##(1993-12#1)(1994-1#1)(1994-2#1)(1996-3#1)(1996-5#1)(2005-5#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2010-11#1)(2012-11#1)(2012-12#1)
the concerted action of##4##4##(1991-5#1)(1995-6#1)(2007-9#1)(2009-5#1)
the concerted##8##2##(1991-5#1)(1991-9#1)(1994-8#1)(1995-6#1)(1996-4#1)(2007-9#1)(2009-5#1)(2013-8#1)
the conclusion drawn##2##3##(2008-10#1)(2008-3#1)
the conclusion of a##5##4##(1992-3#1)(1994-1#1)(1994-11#1)(2005-7#1)(2010-8#1)
the conclusion of standard co-axial phacoemulsification##2##6##(2007-1#2)
the conclusion of the study##3##5##(1995-1#1)(2008-11#1)(2013-8#1)
the conclusion of the##11##4##(1995-1#1)(1997-4#2)(2006-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2012-3#1)(2013-8#1)
the conclusion of##27##3##(1990-10#1)(1990-3#1)(1991-3#1)(1992-3#2)(1994-1#1)(1994-11#1)(1995-1#1)(1997-4#2)(2005-7#1)(2006-10#2)(2007-1#3)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
the conclusion that a##4##4##(1991-2#1)(1992-12#1)(1993-6#1)(1996-9#1)
the conclusion that food##2##4##(2008-1#1)(2008-9#1)
the conclusion that it##3##4##(1990-3#1)(2006-10#1)(2009-9#1)
the conclusion that some##2##4##(1995-11#1)(1995-12#1)
the conclusion that the##31##4##(1990-7#1)(1991-8#1)(1992-2#1)(1992-6#1)(1992-9#1)(1995-11#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-7#1)(2007-1#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#2)(2009-3#1)(2009-4#1)(2011-1#2)(2013-1#1)(2013-8#2)
the conclusion that these##2##4##(1990-12#1)(2008-3#1)
the conclusion that this##3##4##(1995-3#1)(1995-4#1)(2007-11#1)
the conclusion that##100##3##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#2)(1991-2#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-4#1)(1997-7#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-1#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#5)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-9#1)(2010-12#1)(2011-1#3)(2011-2#1)(2012-11#1)(2012-12#2)(2013-1#1)(2013-8#3)
the conclusion##134##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#4)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-4#3)(1997-7#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#5)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#6)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-9#1)(2010-12#2)(2010-8#1)(2011-1#3)(2011-2#2)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#4)
the conclusions and##2##3##(2006-11#1)(2007-8#1)
the conclusions drawn from##3##4##(2008-2#1)(2010-7#1)(2011-2#1)
the conclusions drawn##4##3##(1993-9#1)(2008-2#1)(2010-7#1)(2011-2#1)
the conclusions from##2##3##(2010-9#1)(2012-1#1)
the conclusions of the##4##4##(1993-12#1)(2008-3#1)(2013-1#1)(2013-8#1)
the conclusions of##9##3##(1991-2#1)(1993-12#2)(1996-11#1)(2008-3#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
the conclusions reached##2##3##(2008-8#1)(2010-5#1)
the conclusions that can be##2##5##(2006-11#1)(2008-10#1)
the conclusions that##3##3##(1993-4#1)(2006-11#1)(2008-10#1)
the conclusions were##4##3##(1993-6#1)(2012-3#1)(2013-7#2)
the conclusions##34##2##(1991-12#1)(1991-2#1)(1993-12#2)(1993-4#1)(1993-6#1)(1993-9#1)(1995-11#1)(1996-11#1)(1996-12#1)(1997-7#1)(2006-11#2)(2006-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#1)
the conclusive identification of##2##4##(1993-2#1)(2010-6#1)
the conclusive##5##2##(1993-2#1)(2007-11#1)(2007-2#1)(2009-2#1)(2010-6#1)
the concomitant administration of##2##4##(2007-11#1)(2008-5#1)
the concomitant determination of##2##4##(1990-8#1)(1995-1#1)
the concomitant presence of##2##4##(2008-9#1)(2012-12#1)
the concomitant reduction##2##3##(2008-10#1)(2011-1#1)
the concomitant use of MTX##2##5##(2008-8#2)
the concomitant use of##5##4##(2008-10#1)(2008-8#2)(2011-2#2)
the concomitant##41##2##(1990-8#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-3#3)(1995-6#1)(1996-10#1)(1996-2#2)(1996-8#1)(1997-2#1)(2005-12#1)(2006-4#1)(2007-11#1)(2007-2#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
the concordance between##5##3##(1991-2#1)(1992-3#1)(2007-8#1)(2008-5#1)(2008-8#1)
the concordance of the##2##4##(1990-5#1)(2013-8#1)
the concordance of##4##3##(1990-5#1)(2010-3#1)(2013-1#1)(2013-8#1)
the concordance##14##2##(1990-5#1)(1991-2#1)(1992-3#1)(1992-8#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-3#1)(2013-1#1)(2013-8#2)
the concordant group##2##3##(1992-6#2)
the concordant##3##2##(1992-6#2)(1995-8#1)
the concurrent processing##2##3##(2007-11#1)(2013-8#1)
the concurrent##21##2##(1990-8#1)(1992-5#1)(1992-8#2)(1993-12#1)(1993-5#2)(1994-11#1)(1997-3#1)(1997-5#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-9#2)(2008-10#2)(2008-12#1)(2008-5#1)(2012-2#1)(2013-8#1)
the condensate##3##2##(1997-4#1)(2005-11#2)
the condensation of the amino##2##5##(1992-3#1)(2011-1#1)
the condensation of##15##3##(1991-8#1)(1992-3#1)(1993-4#1)(2005-11#1)(2007-11#3)(2007-3#1)(2008-10#2)(2008-3#1)(2009-2#1)(2010-5#1)(2011-1#2)
the condensation product##2##3##(2008-10#2)
the condensation products##3##3##(1996-8#1)(2007-11#1)(2010-12#1)
the condensation reaction between##3##4##(2005-11#1)(2008-10#1)(2008-8#1)
the condensation reaction of##2##4##(2008-10#1)(2008-3#1)
the condensation reaction##5##3##(2005-11#1)(2008-10#2)(2008-3#1)(2008-8#1)
the condensation##26##2##(1991-8#1)(1992-3#1)(1993-4#1)(1996-5#1)(1996-8#1)(2005-11#2)(2007-11#4)(2007-3#1)(2008-10#6)(2008-3#2)(2008-8#1)(2009-2#1)(2010-12#1)(2010-5#1)(2011-1#2)
the condensed phase##3##3##(1996-8#1)(2008-10#2)
the condensed##7##2##(1990-2#1)(1996-8#1)(2005-11#1)(2008-10#4)
the condenser##4##2##(2008-3#1)(2010-6#3)
the condition and##5##3##(1992-4#1)(1992-5#1)(1996-6#1)(2012-2#1)(2013-1#1)
the condition appears##2##3##(1996-11#1)(2007-7#1)
the condition are##2##3##(2008-6#1)(2010-1#1)
the condition being##2##3##(2004-11#1)(2013-1#1)
the condition can##2##3##(1996-11#1)(2007-8#1)
the condition for##2##3##(2006-7#1)(2008-3#1)
the condition in##3##3##(2005-9#1)(2007-10#1)(2009-5#1)
the condition is##8##3##(1990-2#1)(2006-9#1)(2008-1#1)(2008-3#1)(2009-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
the condition of a##3##4##(2004-4#1)(2008-2#1)(2008-9#1)
the condition of group-velocity matching##2##5##(2007-11#1)(2008-1#1)
the condition of the patient##5##5##(1990-4#1)(1991-3#1)(1992-10#1)(2007-8#1)(2008-7#1)
the condition of the##17##4##(1990-4#1)(1990-6#2)(1991-3#1)(1991-7#1)(1992-10#1)(1992-4#1)(2006-10#1)(2006-7#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-8#1)
the condition of##47##3##(1990-4#1)(1990-6#2)(1991-3#1)(1991-7#1)(1992-10#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-2#1)(1994-7#1)(1996-6#1)(1997-3#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-7#2)(2007-11#2)(2007-12#3)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-8#1)(2011-2#2)(2013-8#1)
the condition or##2##3##(2006-10#1)(2008-9#1)
the condition that##4##3##(2005-4#1)(2008-1#1)(2008-10#1)(2008-2#1)
the condition was##4##3##(1990-4#1)(1994-7#1)(1994-8#1)(2008-6#1)
the condition where##3##3##(1991-2#2)(1995-8#1)
the condition##167##2##(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#2)(1990-9#1)(1991-10#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-7#1)(1992-10#1)(1992-4#2)(1992-5#1)(1992-7#1)(1992-8#1)(1993-1#2)(1993-2#1)(1993-9#1)(1994-4#1)(1994-7#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-8#2)(1996-11#4)(1996-3#1)(1996-6#2)(1997-3#1)(1997-8#1)(2004-10#1)(2004-11#1)(2004-4#1)(2005-11#1)(2005-4#1)(2005-8#2)(2005-9#2)(2006-10#7)(2006-4#2)(2006-5#1)(2006-6#2)(2006-7#6)(2006-9#2)(2007-10#1)(2007-11#4)(2007-12#4)(2007-3#2)(2007-6#3)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#5)(2008-11#4)(2008-2#4)(2008-3#6)(2008-5#4)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#2)(2012-11#2)(2012-2#2)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#5)
the conditional and##2##3##(1992-2#1)(2008-7#1)
the conditional formation##2##3##(2008-10#2)
the conditional probability of##2##4##(1997-6#1)(2008-10#1)
the conditional##24##2##(1992-2#2)(1992-6#1)(1993-6#2)(1993-8#1)(1995-1#1)(1995-9#1)(1996-4#1)(1997-6#1)(2006-6#1)(2008-10#6)(2008-2#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-7#1)(2010-8#1)(2012-3#1)
the conditioned emotional response##2##4##(1993-5#1)(2008-4#1)
the conditioned medium of##6##4##(1990-12#1)(1992-6#1)(1993-11#1)(1994-12#1)(1997-1#1)(1997-2#1)
the conditioned medium##16##3##(1990-11#1)(1990-12#1)(1990-2#1)(1991-4#1)(1991-9#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-12#3)(1997-1#1)(1997-2#1)(2008-11#2)
the conditioned place preference paradigm##2##5##(1990-2#1)(1996-10#1)
the conditioned place preference##5##4##(1990-2#4)(1996-10#1)
the conditioned stimulus##5##3##(1995-11#1)(1995-12#1)(1997-7#1)(2009-2#1)(2013-8#1)
the conditioned suppression##4##3##(1993-5#2)(1996-12#2)
the conditioned##38##2##(1990-11#1)(1990-12#1)(1990-2#5)(1991-4#1)(1991-9#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-5#3)(1993-6#1)(1993-9#1)(1994-12#3)(1994-6#1)(1995-11#1)(1995-12#1)(1996-10#1)(1996-12#2)(1997-1#1)(1997-2#1)(1997-7#1)(2008-11#3)(2008-4#1)(2008-5#1)(2009-2#1)(2012-2#1)(2013-8#1)
the conditioning effects of##3##4##(2008-5#3)
the conditioning of##3##3##(1992-11#1)(2008-10#1)(2009-11#1)
the conditioning##16##2##(1992-11#1)(1992-9#1)(1997-5#3)(2007-11#1)(2008-10#3)(2008-11#1)(2008-5#4)(2009-11#1)(2010-4#1)
the conditions and##6##3##(1995-12#1)(2005-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-5#1)
the conditions are##4##3##(1997-4#1)(2010-3#1)(2011-2#1)(2012-2#1)
the conditions employed##8##3##(1992-7#1)(1994-9#1)(1995-10#1)(1997-7#1)(2008-10#4)
the conditions for the##11##4##(1992-1#1)(2007-10#1)(2007-7#1)(2008-10#6)(2008-3#1)(2008-9#1)
the conditions for visual experience in##2##6##(2011-2#2)
the conditions for##51##3##(1990-11#1)(1991-4#1)(1992-1#1)(1994-12#1)(1995-6#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#16)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#5)(2008-9#4)(2010-8#1)(2010-9#2)(2011-2#3)(2012-2#1)
the conditions in which##3##4##(2008-5#1)(2008-7#1)(2009-4#1)
the conditions in##6##3##(2007-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2011-2#1)
the conditions leading##2##3##(2008-5#1)(2009-12#1)
the conditions necessary##2##3##(2008-2#1)(2010-8#1)
the conditions of a##2##4##(2008-2#1)(2008-3#1)
the conditions of the present##2##5##(1992-8#1)(2008-10#1)
the conditions of the##8##4##(1990-8#1)(1991-3#1)(1992-8#2)(1995-2#1)(2008-10#1)(2008-5#1)(2009-7#1)
the conditions of these##6##4##(1990-7#1)(1993-3#1)(2008-9#4)
the conditions of this##10##4##(1990-6#1)(1995-2#1)(2008-10#1)(2008-8#1)(2008-9#5)(2013-1#1)
the conditions of##74##3##(1990-6#1)(1990-7#1)(1990-8#1)(1991-3#1)(1992-8#2)(1993-3#1)(1993-8#2)(1994-9#1)(1995-2#2)(1995-3#1)(1996-2#1)(1997-4#1)(2005-10#1)(2005-12#1)(2006-12#2)(2006-6#1)(2007-11#1)(2007-8#2)(2008-10#11)(2008-11#1)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#9)(2009-2#1)(2009-7#1)(2010-12#1)(2010-7#2)(2010-9#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#4)(2013-8#2)
the conditions required for##2##4##(2007-9#1)(2008-1#1)
the conditions required to##3##4##(1996-10#1)(2006-12#1)(2008-4#1)
the conditions required##5##3##(1996-10#1)(2006-12#1)(2007-9#1)(2008-1#1)(2008-4#1)
the conditions studied##2##3##(1994-9#1)(2008-7#1)
the conditions that are##2##4##(1990-12#1)(2006-5#1)
the conditions that##9##3##(1990-12#1)(1991-5#1)(1993-11#1)(1995-11#1)(1996-8#1)(2006-12#1)(2006-5#1)(2009-7#1)(2013-1#1)
the conditions under which the##4##5##(1995-12#1)(2008-2#2)(2012-2#1)
the conditions under which##24##4##(1990-12#1)(1993-7#1)(1994-11#1)(1995-12#1)(1995-8#1)(1997-2#1)(2005-11#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#3)(2008-7#1)(2008-8#2)(2010-7#1)(2011-1#1)(2012-2#1)
the conditions under##25##3##(1990-12#1)(1993-7#1)(1994-11#1)(1995-12#1)(1995-8#1)(1997-2#1)(2005-11#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#3)(2008-7#1)(2008-8#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
the conditions used in##3##4##(1992-7#1)(1994-9#1)(1995-1#1)
the conditions used##12##3##(1990-12#1)(1991-2#1)(1992-7#1)(1992-9#1)(1994-9#1)(1995-1#1)(1995-5#1)(1996-2#1)(1997-1#1)(2007-11#1)(2008-10#1)(2009-12#1)
the conditions were##2##3##(2007-8#1)(2008-5#1)
the conditions when##3##3##(1990-8#1)(2008-11#1)(2008-2#1)
the conditions where##3##3##(1990-8#1)(2005-11#1)(2008-8#1)
the conditions which##4##3##(2004-10#1)(2008-11#1)(2008-4#1)(2010-3#1)
the conditions##246##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#3)(1991-10#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#2)(1993-3#2)(1993-6#1)(1993-7#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#1)(2004-10#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-8#1)(2006-1#1)(2006-12#4)(2006-5#3)(2006-6#2)(2007-10#2)(2007-11#6)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#35)(2008-11#7)(2008-12#1)(2008-2#10)(2008-3#7)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#10)(2008-9#15)(2009-12#3)(2009-2#2)(2009-4#1)(2009-7#2)(2010-12#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#2)(2010-9#4)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#2)
the condom and##3##3##(1997-7#1)(2007-7#2)
the condom in##2##3##(1997-7#2)
the condom is##2##3##(1990-6#2)
the condom##15##2##(1990-6#3)(1992-2#1)(1997-7#3)(2006-7#1)(2007-7#4)(2008-10#2)(2012-3#1)
the conducive##2##2##(2008-10#1)(2009-3#1)
the conduciveness of the environment##2##5##(2008-10#2)
the conduciveness of##3##3##(2008-10#3)
the conduct and##2##3##(2008-10#1)(2010-5#1)
the conduct of a##2##4##(1991-8#1)(1992-2#1)
the conduct of human##2##4##(2008-9#1)(2009-4#1)
the conduct of research##2##4##(2007-11#1)(2007-4#1)
the conduct of the##2##4##(2008-10#1)(2008-7#1)
the conduct of##21##3##(1991-8#1)(1992-2#1)(1995-9#1)(1997-5#1)(2004-3#1)(2006-1#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-10#1)(2013-8#1)
the conduct##26##2##(1991-8#1)(1992-1#1)(1992-10#1)(1992-2#1)(1995-9#1)(1997-5#1)(2004-3#1)(2006-1#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-10#1)(2010-3#1)(2010-5#1)(2013-8#1)
the conductance of BLM##2##4##(1993-8#2)
the conductance of the##3##4##(1992-7#1)(1993-9#1)(2013-1#1)
the conductance of##9##3##(1992-7#1)(1993-8#2)(1993-9#1)(2008-7#2)(2009-11#1)(2009-8#1)(2013-1#1)
the conductance##14##2##(1992-7#1)(1993-12#1)(1993-8#3)(1993-9#1)(1995-11#1)(1995-5#1)(2008-7#3)(2009-11#1)(2009-8#1)(2013-1#1)
the conducting airways##4##3##(1991-12#2)(2013-1#2)
the conducting##11##2##(1991-12#2)(1991-6#1)(1994-12#1)(2006-7#1)(2008-10#2)(2008-11#1)(2013-1#3)
the conduction band##4##3##(2005-11#3)(2009-2#1)
the conduction mechanism##2##3##(1991-3#1)(2009-11#1)
the conduction system##2##3##(1993-9#1)(2010-12#1)
the conduction##14##2##(1991-3#1)(1992-1#1)(1993-9#1)(1996-3#1)(2005-11#3)(2007-11#1)(2007-12#1)(2008-7#1)(2009-11#1)(2009-2#1)(2010-12#1)(2011-2#1)
the conductive##3##2##(2008-11#1)(2008-2#1)(2013-8#1)
the conductivity and##4##3##(2006-2#1)(2008-10#1)(2010-4#2)
the conductivity of the##3##4##(2008-10#2)(2013-1#1)
the conductivity##16##2##(1990-8#1)(1996-4#1)(2006-2#1)(2008-10#6)(2009-11#1)(2009-8#1)(2010-4#2)(2010-9#2)(2013-1#1)
the conductor##2##2##(2008-10#2)
the conduit##3##2##(2007-7#1)(2007-8#1)(2007-9#1)
the conduits of##3##3##(2008-10#3)
the condylar##10##2##(1996-9#1)(2006-3#1)(2007-7#5)(2012-12#3)
the cone ERG##4##3##(2006-8#4)
the cone beam CT imaging##2##5##(2007-12#2)
the cone biopsy and##2##4##(1992-3#1)(2006-10#1)
the cone biopsy##3##3##(1992-3#1)(2006-10#2)
the cone bipolar cells##2##4##(1990-12#2)
the cone##25##2##(1990-12#4)(1991-1#1)(1992-3#1)(1994-3#1)(1997-1#1)(1997-4#1)(2006-10#2)(2006-8#6)(2007-12#3)(2008-2#2)(2008-3#1)(2011-1#1)(2013-1#1)
the cones##2##2##(2007-5#1)(2008-12#1)
the conference was##4##3##(2005-7#1)(2005-8#1)(2007-7#1)(2008-1#1)
the conference##32##2##(1993-12#1)(1994-3#2)(1996-6#1)(2005-7#3)(2005-8#5)(2007-5#2)(2007-7#1)(2008-1#1)(2008-12#5)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2010-11#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-7#1)
the confidence in the##2##4##(1996-2#1)(2008-9#1)
the confidence interval for the##3##5##(1996-1#3)
the confidence interval for##4##4##(1996-1#3)(2008-10#1)
the confidence interval##8##3##(1994-2#1)(1996-1#3)(1997-6#1)(2008-10#3)
the confidence intervals##3##3##(1991-2#1)(1997-4#1)(2011-1#1)
the confidence of the##4##4##(1994-3#1)(2007-6#1)(2008-11#1)(2009-9#1)
the confidence of##11##3##(1991-10#1)(1993-5#1)(1994-3#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-10#1)(2009-9#1)(2012-12#1)
the confidence that##2##3##(2008-10#1)(2008-5#1)
the confidence##28##2##(1991-10#1)(1991-2#1)(1993-5#1)(1994-2#1)(1994-3#1)(1996-1#3)(1996-2#1)(1997-4#1)(1997-6#1)(2007-6#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-2#1)(2011-1#1)(2012-12#1)
the confidentiality of the##2##4##(1997-5#1)(2007-11#1)
the confidentiality of##6##3##(1991-12#1)(1991-3#1)(1997-5#1)(2007-11#1)(2008-7#1)(2010-8#1)
the configural##3##2##(2008-1#1)(2008-11#1)(2012-12#1)
the configuration at##3##3##(1996-2#1)(2006-12#1)(2007-11#1)
the configuration of the##9##4##(1992-8#1)(1995-3#1)(2005-8#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#1)(2012-1#1)
the configuration of##21##3##(1992-8#1)(1993-3#1)(1995-2#1)(1995-3#1)(1996-6#1)(2005-8#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2009-6#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#1)
the configuration##43##2##(1990-11#1)(1992-8#1)(1993-3#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-2#1)(1996-6#1)(2005-11#2)(2005-4#1)(2005-8#1)(2006-12#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-8#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#2)
the configurations##3##2##(1996-1#1)(2008-3#1)(2008-5#1)
the confined water##2##3##(2008-10#2)
the confined##5##2##(2005-11#1)(2006-12#1)(2007-11#1)(2008-10#2)
the confinement##6##2##(1991-3#2)(1995-5#1)(2005-11#1)(2006-12#1)(2008-7#1)
the confines of the##3##4##(2008-10#2)(2011-2#1)
the confines of##9##3##(2006-6#1)(2007-4#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-9#1)(2011-2#1)
the confirmation of##8##3##(1991-8#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-10#1)(2010-9#1)(2011-2#1)(2013-7#1)
the confirmation that##2##3##(1991-9#1)(2008-1#1)
the confirmation##13##2##(1991-8#1)(1991-9#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-10#1)(2010-9#1)(2011-2#1)(2013-1#2)(2013-7#1)
the confirmatory##2##2##(2010-4#1)(2011-2#1)
the confirming##2##2##(1993-12#1)(2008-12#1)
the conflict area##2##3##(2008-11#1)(2012-12#1)
the conflict between##2##3##(2008-2#1)(2010-7#1)
the conflict##17##2##(1992-9#1)(2004-7#1)(2006-10#1)(2008-11#2)(2008-2#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-9#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#3)
the conflicting results##2##3##(2007-5#1)(2011-2#1)
the conflicting##11##2##(1990-12#1)(1995-1#1)(2006-2#1)(2006-6#1)(2007-5#1)(2008-2#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
the conflicts##9##2##(1995-12#1)(1996-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
the confluence of the##2##4##(2008-7#1)(2013-1#1)
the confluence of##4##3##(1996-1#1)(2007-5#1)(2008-7#1)(2013-1#1)
the confluence##8##2##(1996-1#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2013-1#1)
the confocal##8##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)(2009-4#2)
the conformation and the##2##4##(1995-10#1)(2008-3#1)
the conformation and##10##3##(1992-12#1)(1994-12#1)(1995-10#1)(1995-3#1)(1996-11#1)(1996-7#1)(2008-3#1)(2008-8#1)(2009-3#2)
the conformation in the##2##4##(2008-10#1)(2008-4#1)
the conformation of a##2##4##(1994-3#1)(2011-2#1)
the conformation of each##2##4##(1991-6#1)(1997-2#1)
the conformation of proteins##3##4##(1993-6#2)(2008-10#1)
the conformation of the peptide##2##5##(1995-6#1)(2008-8#1)
the conformation of the protein##3##5##(1992-12#1)(1993-3#1)(2008-7#1)
the conformation of the##37##4##(1990-3#1)(1990-4#1)(1990-5#1)(1991-4#2)(1992-11#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-3#2)(1994-12#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-7#1)(2005-11#2)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-9#1)(2012-12#1)(2012-2#2)
the conformation of these##3##4##(1991-12#1)(1992-7#1)(1993-11#1)
the conformation of##78##3##(1990-10#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#2)(1992-12#2)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-6#3)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#4)(1995-1#3)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#1)(2004-9#1)(2005-11#2)(2005-4#1)(2006-12#1)(2008-10#4)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#3)
the conformation or##2##3##(1992-9#1)(1995-10#1)
the conformation##100##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#2)(1992-12#3)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-3#2)(1993-6#3)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#4)(1995-1#3)(1995-10#2)(1995-11#1)(1995-3#2)(1995-6#1)(1995-8#2)(1996-11#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#4)(1997-6#2)(1997-7#1)(2004-9#1)(2005-11#2)(2005-4#2)(2006-10#1)(2006-12#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-3#2)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#3)
the conformational behavior of##2##4##(1993-11#1)(2006-10#1)
the conformational change in##3##4##(1992-12#2)(1994-11#1)
the conformational change of the##3##5##(1991-12#1)(2008-5#1)(2009-3#1)
the conformational change of##8##4##(1991-12#1)(1993-3#1)(1997-7#1)(2005-4#1)(2008-11#1)(2008-5#1)(2009-3#2)
the conformational change that##2##4##(1990-5#1)(2008-8#1)
the conformational change##16##3##(1990-5#1)(1991-12#1)(1992-12#2)(1993-3#1)(1994-11#1)(1995-6#2)(1997-7#1)(2005-4#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-3#2)(2009-5#1)
the conformational changes in##2##4##(1992-6#1)(2006-12#1)
the conformational changes of immobilized##2##5##(2008-10#2)
the conformational changes of the##2##5##(2008-9#1)(2009-3#1)
the conformational changes of##5##4##(1993-8#1)(2008-10#2)(2008-9#1)(2009-3#1)
the conformational changes##10##3##(1992-6#1)(1992-8#1)(1993-6#1)(1993-8#1)(2006-12#1)(2008-10#2)(2008-4#1)(2008-9#1)(2009-3#1)
the conformational dynamics of the##2##5##(1992-6#1)(2006-2#1)
the conformational entropy##2##3##(1996-8#2)
the conformational preferences##3##3##(1990-10#1)(1997-2#1)(2008-10#1)
the conformational properties of the##3##5##(1992-6#1)(1993-8#1)(1996-8#1)
the conformational properties of##4##4##(1992-6#1)(1993-8#1)(1996-8#1)(2008-4#1)
the conformational properties##5##3##(1990-3#1)(1992-6#1)(1993-8#1)(1996-8#1)(2008-4#1)
the conformational search##2##3##(1991-4#1)(2010-7#1)
the conformational space##2##3##(2008-7#1)(2010-7#1)
the conformational stability##2##3##(1997-6#1)(2008-4#1)
the conformational state##2##3##(1991-9#2)
the conformational substate##2##3##(1994-12#1)(1997-1#1)
the conformational transition##2##3##(1995-11#1)(1996-2#1)
the conformational variability##2##3##(1991-2#1)(1995-6#1)
the conformational##78##2##(1990-10#2)(1990-3#1)(1990-5#2)(1990-7#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-9#2)(1992-12#2)(1992-6#3)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-6#3)(1996-2#1)(1996-8#3)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#2)(1997-7#1)(2005-4#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-9#2)(2008-10#5)(2008-11#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#3)(2009-5#1)(2010-7#2)
the conformationally##7##2##(1990-12#1)(1992-1#1)(1993-4#1)(1994-11#1)(1995-11#1)(1997-4#1)(2008-5#1)
the conformations of the##5##4##(1993-3#1)(1993-4#1)(1994-11#1)(1995-11#1)(1996-8#1)
the conformations of##14##3##(1990-10#1)(1990-5#1)(1991-4#1)(1993-3#2)(1993-4#1)(1994-11#1)(1995-11#1)(1996-8#4)(2005-11#1)(2008-8#1)
the conformations##17##2##(1990-10#2)(1990-5#1)(1991-4#1)(1993-3#2)(1993-4#1)(1994-11#1)(1995-11#2)(1996-2#1)(1996-8#4)(2005-11#1)(2008-8#1)
the confounding effects of body##2##5##(2009-5#2)
the confounding effects of##4##4##(1995-11#1)(2008-9#1)(2009-5#2)
the confounding factors that##2##4##(2008-7#1)(2013-1#1)
the confounding factors##4##3##(2008-7#1)(2010-9#1)(2011-1#1)(2013-1#1)
the confounding##11##2##(1995-11#1)(1995-12#1)(2007-6#1)(2008-7#1)(2008-9#1)(2009-5#3)(2010-9#1)(2011-1#1)(2013-1#1)
the confrontation##3##2##(1991-2#1)(2007-3#1)(2012-3#1)
the confusion with##2##3##(2006-10#1)(2011-1#1)
the confusion##8##2##(1991-12#1)(2006-1#1)(2006-10#2)(2006-12#1)(2008-1#1)(2011-1#1)(2013-1#1)
the confusion?##2##2##(2007-9#1)(2010-4#1)
the congenital##8##2##(1993-2#1)(2005-11#1)(2006-3#1)(2007-11#1)(2008-3#1)(2009-3#3)
the congress##5##2##(2005-8#1)(2006-4#1)(2007-9#1)(2008-5#1)(2008-8#1)
the congruence angle##3##3##(2007-8#3)
the congruence##6##2##(1996-1#1)(2007-8#3)(2010-12#1)(2010-6#1)
the congruity of the joint##2##5##(2007-8#2)
the conic##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
the conical##7##2##(1993-5#1)(2006-4#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-5#1)
the conically sculpted##3##3##(1995-2#3)
the conidia germinated##2##3##(2008-10#2)
the conidia germination##2##3##(2008-10#2)
the conidia were##3##3##(2008-10#3)
the conidia##10##2##(2008-10#10)
the conidial##4##2##(2008-10#4)
the conization group (4##2##4##(1992-3#2)
the conjecture that##2##3##(1995-8#1)(2007-11#1)
the conjugate beam##3##3##(2007-12#2)(2008-2#1)
the conjugate catalytic acid##2##4##(1995-10#2)
the conjugate gradient method##2##4##(2007-12#1)(2010-4#1)
the conjugate image and the zero-order image##2##7##(2008-3#2)
the conjugate image##3##3##(2008-3#3)
the conjugate of##2##3##(2007-10#1)(2007-12#1)
the conjugate was##5##3##(1990-9#2)(1996-1#1)(2008-10#1)(2008-11#1)
the conjugate##31##2##(1990-9#4)(1993-11#1)(1993-3#1)(1994-11#1)(1995-10#2)(1996-1#1)(1997-3#1)(2007-10#1)(2007-12#5)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2008-7#1)(2009-11#1)(2010-4#1)(2010-6#1)(2013-8#1)
the conjugate-gradient method##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
the conjugated retinal##2##3##(1995-1#2)
the conjugated##10##2##(1991-5#2)(1992-3#1)(1993-11#1)(1995-1#2)(1995-3#1)(1997-8#1)(2008-10#1)(2009-3#1)
the conjugates are##2##3##(1994-8#1)(2008-4#1)
the conjugates of##2##3##(1991-3#2)
the conjugates were##3##3##(1994-8#1)(1997-8#1)(2012-12#1)
the conjugates##12##2##(1991-3#2)(1992-11#1)(1993-3#1)(1994-11#1)(1994-8#2)(1997-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-12#1)
the conjugation of##8##3##(1992-7#1)(2007-6#1)(2008-4#2)(2009-9#2)(2010-2#2)
the conjugation##12##2##(1992-7#1)(1995-8#1)(1996-4#1)(1997-8#1)(2007-6#1)(2008-11#1)(2008-4#2)(2009-9#2)(2010-2#2)
the conjugative##3##2##(1991-7#1)(1992-5#1)(2008-10#1)
the conjunction of##4##3##(1990-10#1)(1997-1#1)(2008-10#1)(2009-2#1)
the conjunctiva and##5##3##(2006-11#1)(2007-1#1)(2008-11#1)(2011-1#2)
the conjunctiva##20##2##(1990-5#2)(1992-11#1)(2006-11#3)(2007-1#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-8#4)(2011-1#3)(2013-1#1)
the conjunctival##5##2##(1992-11#1)(2007-9#1)(2008-11#2)(2012-3#1)
the conjunctive##2##2##(1991-11#1)(2011-1#1)
the connecting peptide##4##3##(2008-9#4)
the connecting tubule##2##3##(2012-12#2)
the connecting##8##2##(1993-6#1)(2008-3#1)(2008-9#4)(2012-12#2)
the connection between the##10##4##(1992-1#1)(1996-12#1)(2006-7#1)(2007-10#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-10#2)
the connection between these two##2##5##(1990-10#1)(2008-4#1)
the connection between these##3##4##(1990-10#1)(2007-12#1)(2008-4#1)
the connection between##23##3##(1990-10#1)(1992-1#1)(1992-8#1)(1994-10#1)(1996-12#1)(2005-12#1)(2006-1#1)(2006-7#1)(2007-10#1)(2007-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#2)(2012-1#1)(2012-2#2)(2013-1#2)
the connection of the##3##4##(1992-1#1)(2006-6#1)(2008-3#1)
the connection of##9##3##(1992-1#1)(2005-4#1)(2006-6#1)(2008-11#1)(2008-3#3)(2010-7#1)(2011-2#1)
the connection strengths##3##3##(1997-8#1)(2008-3#2)
the connection with##2##3##(1996-11#1)(2010-9#1)
the connection##44##2##(1990-10#1)(1992-1#2)(1992-8#1)(1994-10#1)(1996-11#1)(1996-12#1)(1997-1#2)(1997-8#1)(2005-12#1)(2005-4#1)(2006-1#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-12#2)(2007-2#1)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#2)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#4)
the connections between the##2##4##(2008-2#1)(2012-5#1)
the connections between these##2##4##(2006-2#1)(2010-8#1)
the connections between##8##3##(2006-2#1)(2006-5#1)(2008-11#1)(2008-12#1)(2008-2#1)(2010-8#1)(2012-3#1)(2012-5#1)
the connections of##2##3##(1991-11#1)(1991-6#1)
the connections##14##2##(1991-11#1)(1991-6#1)(1996-9#1)(1997-4#1)(2006-2#1)(2006-5#1)(2008-11#2)(2008-12#1)(2008-2#1)(2010-8#1)(2012-3#2)(2012-5#1)
the connective tissue disorders##2##4##(2007-8#1)(2007-9#1)
the connective tissue extracellular matrix##2##5##(2009-2#1)(2012-1#1)
the connective tissue matrix##2##4##(1990-2#1)(1992-4#1)
the connective tissue##28##3##(1990-2#1)(1992-4#1)(1996-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-5#3)(2009-2#3)(2010-12#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#5)(2013-8#1)
the connective tissues##2##3##(1990-2#2)
the connective##31##2##(1990-2#3)(1992-4#1)(1996-3#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-5#3)(2009-2#3)(2010-12#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#5)(2013-8#1)
the connectivity of##2##3##(1995-6#1)(2008-7#1)
the connectivity to##2##3##(2008-11#1)(2009-2#1)
the connectivity##11##2##(1995-6#1)(2007-11#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-12#1)(2009-2#1)
the connexin 26##2##3##(2006-10#1)(2008-4#1)
the conscious rat##6##3##(1990-7#1)(1991-1#1)(1993-11#1)(1995-12#1)(1996-9#1)(2008-11#1)
the conscious##19##2##(1990-7#1)(1991-1#1)(1992-10#1)(1993-11#1)(1993-4#2)(1994-2#2)(1995-1#1)(1995-12#1)(1996-9#1)(1997-8#2)(2004-8#1)(2006-10#1)(2007-5#1)(2008-11#1)(2010-4#2)
the consciousness##2##2##(1990-9#1)(2012-11#1)
the consecutive##9##2##(1990-7#1)(2006-8#1)(2008-10#2)(2008-4#2)(2009-5#1)(2009-9#1)(2012-2#1)
the consensus E##2##3##(1990-3#1)(1995-3#1)
the consensus binding##2##3##(1991-11#1)(1995-6#1)
the consensus of##3##3##(1991-2#1)(1993-11#1)(2012-2#1)
the consensus sequence found in##2##5##(1994-9#1)(2008-10#1)
the consensus sequence of##6##4##(1990-3#1)(1992-4#1)(1992-8#1)(1996-6#1)(1997-4#2)
the consensus sequence##21##3##(1990-12#1)(1990-3#1)(1991-7#2)(1992-4#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-2#2)(1995-7#1)(1996-6#1)(1997-2#1)(1997-4#2)(2006-8#1)(2008-1#1)(2008-10#1)(2009-6#1)
the consensus sequences##3##3##(1994-11#1)(1994-9#1)(1997-4#1)
the consensus statement##2##3##(2006-9#1)(2008-3#1)
the consensus statements##3##3##(2009-8#1)(2011-2#2)
the consensus##69##2##(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#2)(1991-11#1)(1991-2#1)(1991-5#1)(1991-7#2)(1991-9#1)(1992-11#1)(1992-4#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-6#3)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-4#3)(1997-7#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-4#1)(2008-1#1)(2008-10#7)(2008-3#2)(2008-5#1)(2008-8#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#1)
the consent for donation##2##4##(2011-2#2)
the consent of the patient's##2##5##(1991-6#1)(1992-12#1)
the consent process##5##3##(2008-8#5)
the consent##13##2##(1991-3#1)(1991-6#1)(1992-12#1)(2008-8#5)(2009-4#2)(2010-11#1)(2011-2#2)
the consequence of a weak##2##5##(1992-8#1)(2008-10#1)
the consequence of a##6##4##(1992-8#1)(1994-12#1)(1997-5#1)(2008-10#2)(2009-9#1)
the consequence of an##2##4##(1995-12#1)(1996-3#1)
the consequence of the presence of##2##6##(1990-8#1)(1994-2#1)
the consequence of the##10##4##(1990-8#1)(1993-12#1)(1994-2#2)(2006-10#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
the consequence of##48##3##(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-2#2)(1995-12#2)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-5#1)(2005-1#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
the consequence##53##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-2#2)(1995-12#2)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-5#1)(2005-1#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#1)
the consequences and##2##3##(2007-11#1)(2011-2#1)
the consequences are##2##3##(2007-11#1)(2010-12#1)
the consequences for patients##2##4##(2008-6#1)(2010-8#1)
the consequences for##9##3##(1990-4#1)(1993-1#1)(2008-6#1)(2008-8#2)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
the consequences of a##2##4##(1994-2#1)(2008-10#1)
the consequences of an##3##4##(2007-12#1)(2007-9#1)(2013-1#1)
the consequences of being##2##4##(1991-11#1)(2012-1#1)
the consequences of elevated##2##4##(1993-12#1)(2008-2#1)
the consequences of its##3##4##(1990-4#1)(1993-12#1)(1994-9#1)
the consequences of stroke##2##4##(2008-2#1)(2013-1#1)
the consequences of such##5##4##(1996-12#1)(2005-10#1)(2007-8#1)(2008-7#1)(2011-2#1)
the consequences of the##12##4##(1991-2#1)(1993-3#1)(1994-11#1)(2005-10#1)(2006-12#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-10#1)(2011-1#1)(2012-12#1)
the consequences of their##3##4##(2008-11#1)(2010-1#1)(2011-2#1)
the consequences of these##4##4##(1992-3#1)(1994-2#1)(1997-5#1)(2007-2#1)
the consequences of this##6##4##(1990-8#1)(1993-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2013-8#1)
the consequences of those##2##4##(2009-10#1)(2010-4#1)
the consequences of##121##3##(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-2#2)(1992-1#1)(1992-2#1)(1992-3#2)(1992-8#1)(1993-10#1)(1993-12#2)(1993-3#1)(1994-11#1)(1994-2#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-5#1)(2004-4#1)(2005-1#1)(2005-10#2)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#2)(2007-9#2)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#9)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#10)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
the consequences on##3##3##(1993-4#1)(2008-2#1)(2013-8#1)
the consequences to##3##3##(1992-12#1)(2012-12#1)(2013-1#1)
the consequences##151##2##(1990-2#1)(1990-4#2)(1990-5#2)(1990-8#1)(1991-11#2)(1991-2#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#1)(1993-1#1)(1993-10#1)(1993-12#2)(1993-3#1)(1993-4#1)(1994-11#1)(1994-2#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-5#1)(2004-4#1)(2005-1#1)(2005-10#2)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#6)(2008-12#1)(2008-2#10)(2008-3#2)(2008-4#4)(2008-6#2)(2008-7#2)(2008-8#12)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#2)(2010-4#2)(2010-8#2)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
the consequent loss of##2##4##(1992-9#1)(2008-10#1)
the consequent loss##3##3##(1992-9#1)(2008-10#1)(2008-3#1)
the consequent##24##2##(1990-2#1)(1990-4#1)(1992-12#1)(1992-9#1)(1997-7#1)(1997-8#1)(2005-10#1)(2007-12#1)(2008-1#4)(2008-10#4)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-12#1)(2013-1#1)(2013-8#1)
the consequential##3##2##(2008-3#1)(2013-1#2)
the conservation and##3##3##(2007-11#1)(2010-2#1)(2013-1#1)
the conservation of the##3##4##(1991-6#1)(2008-3#1)(2008-8#1)
the conservation of this##3##4##(1991-7#1)(2008-5#1)(2008-8#1)
the conservation of##21##3##(1991-6#1)(1991-7#1)(1992-4#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-3#1)(1996-12#1)(1997-1#1)(2006-10#1)(2007-2#1)(2007-3#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#2)(2009-10#1)(2013-1#1)(2013-7#1)
the conservation state of##3##4##(2008-10#3)
the conservation##33##2##(1991-6#1)(1991-7#1)(1992-4#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-3#1)(1996-12#1)(1997-1#2)(2006-10#1)(2007-11#2)(2007-2#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-8#3)(2009-10#1)(2010-2#1)(2013-1#2)(2013-7#2)
the conservative and surgical treatment of##2##6##(2007-7#1)(2013-1#1)
the conservative and surgical##3##4##(2007-1#1)(2007-7#1)(2013-1#1)
the conservative group##2##3##(2007-8#1)(2013-1#1)
the conservative management##2##3##(1993-3#1)(1993-9#1)
the conservative treatment of##7##4##(1994-4#1)(2007-11#2)(2007-7#2)(2007-8#1)(2013-1#1)
the conservative treatment##10##3##(1994-4#1)(2007-11#4)(2007-6#1)(2007-7#2)(2007-8#1)(2013-1#1)
the conservative##31##2##(1990-2#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-4#1)(1996-6#1)(1997-8#1)(2005-11#1)(2007-1#1)(2007-11#4)(2007-6#1)(2007-7#3)(2007-8#3)(2008-5#1)(2008-8#1)(2008-9#3)(2009-7#1)(2012-1#1)(2013-1#3)
the conserved C-terminal##3##3##(1993-8#2)(1997-2#1)
the conserved P-loop##2##3##(1996-8#2)
the conserved amino acid sequence##2##5##(1997-7#1)(2005-11#1)
the conserved amino acid##4##4##(1991-2#1)(1992-3#1)(1997-7#1)(2005-11#1)
the conserved breast##3##3##(1990-12#3)
the conserved carboxy-terminal##2##3##(1990-6#1)(2012-12#1)
the conserved cysteine##2##3##(1992-2#1)(1994-11#1)
the conserved elements##2##3##(1990-5#1)(1995-6#1)
the conserved motif##2##3##(1996-11#1)(2008-10#1)
the conserved motifs##3##3##(2008-10#2)(2011-1#1)
the conserved region##5##3##(1992-11#1)(1992-6#1)(1996-12#1)(2006-11#1)(2008-8#1)
the conserved regions##4##3##(1991-9#1)(1995-5#1)(1997-4#1)(2008-3#1)
the conserved residues##4##3##(1992-6#1)(1993-6#1)(1994-8#1)(1994-9#1)
the conserved sequence of##2##4##(1990-4#1)(1993-3#1)
the conserved sequence##5##3##(1990-4#1)(1993-3#1)(1995-6#1)(2008-10#1)(2009-5#1)
the conserved sequences of##2##4##(1997-4#1)(2013-8#1)
the conserved sequences##3##3##(1995-8#1)(1997-4#1)(2013-8#1)
the conserved##100##2##(1990-12#3)(1990-4#1)(1990-5#2)(1990-6#3)(1991-2#2)(1991-4#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-8#2)(1994-9#6)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#4)(1995-8#4)(1996-10#1)(1996-11#2)(1996-12#1)(1996-5#3)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#2)(1997-9#1)(2005-11#1)(2006-11#1)(2006-2#1)(2006-8#1)(2007-12#3)(2008-10#8)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
the considerable advantages##2##3##(2007-12#1)(2008-2#1)
the considerable difference##2##3##(2008-10#2)
the considerable risk of##2##4##(2004-2#1)(2010-5#1)
the considerable##20##2##(1990-11#2)(1993-10#1)(1995-1#1)(1995-12#1)(1995-6#1)(2004-2#1)(2006-5#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-3#1)
the consideration of##9##3##(1990-8#1)(1993-2#1)(1995-6#1)(1996-1#1)(2005-11#1)(2006-12#1)(2008-7#1)(2009-9#1)(2011-2#1)
the consideration##11##2##(1990-8#1)(1993-2#1)(1995-1#1)(1995-6#1)(1996-1#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-7#1)(2009-9#1)(2011-2#1)
the considerations##2##2##(2008-11#1)(2008-12#1)
the considered##20##2##(1992-2#2)(1994-3#1)(1997-2#1)(2005-11#1)(2007-10#1)(2007-9#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-6#1)(2011-1#1)(2011-12#1)(2013-8#1)
the consistency and##4##3##(1991-5#1)(2008-10#2)(2012-2#1)
the consistency index##3##3##(2006-5#3)
the consistency of the##3##4##(1997-6#1)(2008-2#2)
the consistency of##9##3##(1993-1#1)(1997-6#1)(2008-11#2)(2008-2#2)(2008-9#1)(2012-2#1)(2012-3#1)
the consistency##20##2##(1991-5#1)(1993-1#1)(1997-6#1)(2006-5#3)(2008-10#2)(2008-11#3)(2008-2#2)(2008-3#1)(2008-9#1)(2011-2#1)(2012-2#3)(2012-3#1)
the consistent##6##2##(1995-6#1)(2005-5#1)(2007-7#1)(2008-7#1)(2009-5#1)(2012-3#1)
the consolidation of##8##3##(1993-7#1)(1995-6#1)(1996-1#1)(2005-8#1)(2006-3#1)(2009-7#1)(2010-12#1)(2013-8#1)
the consolidation##12##2##(1993-7#1)(1994-2#2)(1994-3#1)(1994-5#1)(1995-6#1)(1996-1#1)(2005-8#1)(2006-3#1)(2009-7#1)(2010-12#1)(2013-8#1)
the consonant##2##2##(2007-7#1)(2009-12#1)
the consortium##4##2##(1996-1#1)(2008-7#1)(2010-5#2)
the conspecific##3##2##(2009-5#1)(2009-9#1)(2013-8#1)
the conspicuous##4##2##(1997-4#1)(2007-3#1)(2008-7#1)(2009-8#1)
the constancy of the##3##4##(2005-11#1)(2008-10#1)(2008-4#1)
the constancy of##4##3##(2005-11#1)(2008-10#1)(2008-4#1)(2009-2#1)
the constancy##5##2##(1993-2#1)(2005-11#1)(2008-10#1)(2008-4#1)(2009-2#1)
the constant capacitance model##2##4##(2005-11#2)
the constant comparative method##3##4##(2005-10#1)(2008-11#1)(2008-12#1)
the constant component of the##2##5##(2008-3#2)
the constant current##2##3##(2008-10#2)
the constant intraresonator intensity##2##4##(2008-2#2)
the constant ratio method##3##4##(2008-10#3)
the constant region of##2##4##(1990-5#2)
the constant region##4##3##(1990-5#2)(1991-4#1)(1992-7#1)
the constant regions of##2##4##(1994-9#1)(2007-11#1)
the constant##51##2##(1990-11#1)(1990-5#3)(1991-1#1)(1991-4#1)(1991-7#1)(1992-7#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(1996-4#1)(1997-2#1)(1997-6#2)(2005-10#1)(2005-11#2)(2005-5#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-2#1)(2010-4#1)(2011-2#1)(2013-1#3)
the constant-statistics##2##2##(2008-2#2)
the constantly changing##2##3##(2008-10#1)(2013-8#1)
the constantly##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
the constants for##2##3##(2008-10#2)
the constants##8##2##(2008-10#5)(2008-3#1)(2008-7#1)(2011-2#1)
the constellation of##3##3##(2006-10#1)(2009-7#1)(2010-9#1)
the constituent cells of##2##4##(1994-3#1)(1997-6#1)
the constituent equilibrium constants##3##4##(2008-10#3)
the constituent##27##2##(1990-2#2)(1990-7#1)(1991-11#1)(1992-9#1)(1994-3#1)(1994-8#1)(1996-5#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-8#1)(2009-7#1)(2012-2#3)
the constituents of the##6##4##(2007-8#2)(2008-10#1)(2009-4#1)(2009-8#1)(2012-2#1)
the constituents of##10##3##(1993-7#1)(2007-1#1)(2007-8#2)(2008-10#1)(2008-5#1)(2009-4#1)(2009-8#1)(2010-3#1)(2012-2#1)
the constituents responsible for##2##4##(2008-11#1)(2011-2#1)
the constituents##26##2##(1993-7#1)(2006-12#1)(2007-1#2)(2007-8#7)(2008-10#1)(2008-11#1)(2008-5#1)(2009-4#1)(2009-7#5)(2009-8#1)(2010-2#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-2#1)
the constitution of a##2##4##(1994-6#1)(2009-5#1)
the constitution of##9##3##(1994-6#2)(2005-4#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-5#2)(2012-2#1)
the constitution##12##2##(1994-6#2)(2005-4#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-5#2)(2009-7#1)(2011-2#1)(2012-2#1)
the constitutional##11##2##(1991-6#1)(1995-10#1)(1995-3#1)(1995-5#1)(1996-9#1)(1997-5#1)(1997-6#1)(2011-2#1)(2012-3#1)(2013-8#2)
the constitutionality of##2##3##(1990-2#1)(1996-5#1)
the constitutive activation of the##2##5##(2012-12#1)(2013-1#1)
the constitutive activation of##3##4##(2012-12#2)(2013-1#1)
the constitutive and##2##3##(1990-3#1)(2012-1#1)
the constitutive expression and##2##4##(1994-6#1)(2009-3#1)
the constitutive expression of TfR mRNA in##2##7##(1995-5#2)
the constitutive expression of TfR mRNA##3##6##(1995-5#3)
the constitutive expression of the##2##5##(1997-2#1)(1997-8#1)
the constitutive expression of##7##4##(1995-5#3)(1996-5#1)(1997-2#1)(1997-8#1)(2007-11#1)
the constitutive expression##9##3##(1994-6#1)(1995-5#3)(1996-5#1)(1997-2#1)(1997-8#1)(2007-11#1)(2009-3#1)
the constitutive form of##2##4##(1992-12#1)(2008-4#1)
the constitutive isoform of##2##4##(1992-6#1)(1995-12#1)
the constitutive law##3##3##(1996-4#3)
the constitutive pathway##4##3##(1990-3#1)(1992-12#1)(1994-11#1)(1996-4#1)
the constitutive##52##2##(1990-10#1)(1990-3#2)(1991-5#1)(1991-9#1)(1992-12#3)(1992-5#1)(1992-6#2)(1993-8#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-5#3)(1995-8#1)(1996-10#1)(1996-4#6)(1996-5#2)(1997-2#1)(1997-3#1)(1997-8#1)(2005-11#2)(2006-11#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-6#1)(2009-3#1)(2010-11#1)(2011-12#1)(2012-1#1)(2012-12#2)(2013-1#4)
the constitutively##5##2##(1995-3#3)(1996-4#1)(2009-8#1)
the constrained liner##2##3##(2009-3#2)
the constrained##6##2##(1994-12#1)(2007-4#1)(2008-10#1)(2009-3#2)(2009-8#1)
the constraint of##4##3##(1993-1#1)(1994-9#1)(2008-1#1)(2008-8#1)
the constraint##9##2##(1993-1#1)(1994-9#1)(2008-1#1)(2008-2#2)(2008-8#1)(2009-5#1)(2012-2#1)(2012-3#1)
the constraints and##3##3##(2007-10#1)(2008-3#1)(2008-7#1)
the constraints imposed by the##2##5##(2006-10#1)(2008-3#1)
the constraints imposed by##5##4##(1996-4#1)(2006-10#1)(2008-3#2)(2008-9#1)
the constraints of the##2##4##(2010-5#1)(2012-2#1)
the constraints of##8##3##(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2010-5#1)(2012-2#1)
the constraints that##2##3##(2007-10#1)(2013-8#1)
the constraints##28##2##(1991-11#1)(1996-4#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#2)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
the constriction##2##2##(1991-9#1)(1996-10#1)
the construct is##2##3##(2008-12#1)(2008-5#1)
the construct of##4##3##(2008-2#1)(2008-5#1)(2012-12#1)(2013-1#1)
the construct validity of eye-tracking assessments of RJA##2##8##(2013-1#2)
the construct validity of the##2##5##(2007-12#2)
the construct validity of##5##4##(2007-12#2)(2013-1#3)
the construct##23##2##(1992-12#2)(1996-3#1)(1997-6#1)(2004-3#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#1)
the constructed lexicon##2##3##(2008-7#2)
the constructed##11##2##(1990-11#1)(2008-10#1)(2008-3#1)(2008-7#2)(2010-1#1)(2011-1#1)(2012-1#2)(2012-3#1)(2013-1#1)
the construction and application of a##2##6##(1990-9#1)(2008-10#1)
the construction and application of##3##5##(1990-9#1)(2008-10#1)(2008-2#1)
the construction and performance##2##4##(2008-10#1)(2008-2#1)
the construction and testing of##2##5##(2011-1#1)(2011-2#1)
the construction and use of##3##5##(1990-3#1)(1997-1#1)(2008-9#1)
the construction and##21##3##(1990-3#1)(1990-8#1)(1990-9#1)(1993-9#1)(1994-3#1)(1995-2#1)(1995-8#1)(1997-1#1)(2007-2#1)(2008-10#3)(2008-2#2)(2008-4#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)
the construction industry##3##3##(1991-12#1)(2013-1#2)
the construction of BAC##2##4##(2006-12#1)(2013-8#1)
the construction of a critical##2##5##(1990-12#1)(2008-11#1)
the construction of a##43##4##(1990-12#1)(1990-8#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1994-5#1)(1994-6#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-4#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-9#1)(2012-3#1)
the construction of an##6##4##(1996-11#1)(1997-4#1)(2007-12#1)(2010-6#1)(2013-8#2)
the construction of calibration##2##4##(2008-10#2)
the construction of complex##2##4##(2006-12#1)(2008-4#1)
the construction of confidence##2##4##(1990-7#1)(1994-5#1)
the construction of expression##2##4##(1993-2#1)(2008-8#1)
the construction of gene##2##4##(1990-11#1)(2008-9#1)
the construction of infectious clones##2##5##(1996-4#2)
the construction of large##2##4##(1991-12#1)(1994-12#1)
the construction of models##2##4##(2006-10#1)(2008-1#1)
the construction of the new##2##5##(1993-11#1)(2005-11#1)
the construction of the##22##4##(1992-6#1)(1993-11#1)(1996-8#1)(2005-11#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-8#2)
the construction of three##3##4##(2008-11#1)(2013-1#2)
the construction of two##2##4##(2008-7#1)(2013-1#1)
the construction of##184##3##(1990-11#1)(1990-12#1)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-10#1)(1992-6#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-12#4)(1994-5#2)(1994-6#1)(1994-8#1)(1995-2#2)(1995-6#1)(1995-7#1)(1996-11#1)(1996-4#2)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#3)(1997-8#1)(2004-9#2)(2005-11#1)(2006-10#1)(2006-12#5)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2007-11#5)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#18)(2008-11#6)(2008-12#1)(2008-2#9)(2008-3#4)(2008-4#11)(2008-5#3)(2008-6#1)(2008-7#12)(2008-8#5)(2008-9#4)(2009-2#1)(2009-3#1)(2009-4#5)(2009-5#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#6)
the construction##214##2##(1990-11#1)(1990-12#1)(1990-3#3)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-10#1)(1992-6#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#4)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-2#3)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-4#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-8#1)(2004-9#2)(2005-11#1)(2006-10#1)(2006-12#5)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2007-11#6)(2007-12#3)(2007-2#1)(2007-5#2)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#21)(2008-11#6)(2008-12#1)(2008-2#12)(2008-3#4)(2008-4#12)(2008-5#3)(2008-6#1)(2008-7#12)(2008-8#5)(2008-9#5)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#5)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#5)(2013-8#7)
the constructive##6##2##(1992-12#5)(2004-9#1)
the constructor##2##2##(2007-11#1)(2008-9#1)
the constructs##8##2##(1993-3#1)(1995-10#1)(1996-5#1)(2008-11#1)(2008-8#2)(2011-2#1)(2013-1#1)
the consultant##3##2##(1990-2#1)(1996-2#1)(2012-3#1)
the consultation and##3##3##(1992-3#1)(2008-1#1)(2012-12#1)
the consultation is##2##3##(1992-2#1)(2011-2#1)
the consultation##12##2##(1992-2#1)(1992-3#2)(1993-8#1)(1994-4#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
the consulting##4##2##(1993-12#2)(2010-4#1)(2012-2#1)
the consumed##3##2##(2008-10#2)(2011-2#1)
the consumer or##2##3##(2008-5#1)(2011-2#1)
the consumer perspective##2##3##(1996-1#1)(2006-5#1)
the consumer##30##2##(1992-1#1)(1992-12#1)(1994-12#1)(1994-2#1)(1995-7#1)(1996-1#1)(1997-3#1)(2006-10#1)(2006-3#1)(2006-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#5)(2008-8#4)(2008-9#2)(2010-4#3)(2011-2#1)(2013-1#1)
the consumer's##5##2##(1997-2#1)(2007-1#1)(2008-10#1)(2008-5#1)(2012-12#1)
the consumers of##2##3##(1993-9#1)(2010-8#1)
the consumers##9##2##(1992-10#1)(1993-9#1)(1994-5#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-8#1)(2010-4#1)(2010-8#1)
the consumers'##2##2##(2012-12#1)(2013-1#1)
the consummatory##3##2##(1990-7#1)(1991-1#1)(1993-12#1)
the consumption of a##3##4##(1995-4#1)(1996-2#1)(2010-4#1)
the consumption of an##2##4##(1990-6#1)(1996-2#1)
the consumption of food##3##4##(2008-10#1)(2008-5#1)(2012-2#1)
the consumption of fruits and vegetables##2##6##(2012-1#1)(2012-2#1)
the consumption of the probiotic##2##5##(2012-1#1)(2013-1#1)
the consumption of the##3##4##(2008-4#1)(2012-1#1)(2013-1#1)
the consumption of vegetables##2##4##(2008-10#1)(2012-2#1)
the consumption of##59##3##(1990-6#1)(1990-8#1)(1992-8#2)(1993-2#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-4#1)(1996-1#1)(1996-2#2)(1997-7#1)(2004-11#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2010-4#1)(2010-8#3)(2011-1#2)(2011-2#2)(2012-1#3)(2012-12#2)(2012-2#6)(2013-1#1)(2013-7#2)
the consumption##65##2##(1990-6#1)(1990-8#1)(1992-8#2)(1993-2#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-4#1)(1996-1#1)(1996-2#2)(1997-7#1)(2004-11#2)(2005-10#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2010-4#2)(2010-8#3)(2011-1#2)(2011-2#2)(2012-1#3)(2012-12#2)(2012-2#6)(2013-1#2)(2013-7#2)
the contact angle between the liquid##2##6##(2005-11#2)
the contact angle##15##3##(2005-11#11)(2008-5#1)(2009-11#1)(2009-7#1)(2013-1#1)
the contact angles##2##3##(2005-11#2)
the contact area of##2##4##(1996-8#1)(2013-1#1)
the contact area##6##3##(1990-10#1)(1996-8#1)(2005-11#2)(2013-1#2)
the contact impedance between the two##2##6##(2013-1#2)
the contact impedance##3##3##(2013-1#3)
the contact of the##3##4##(2006-12#1)(2008-10#1)(2008-7#1)
the contact of##7##3##(1991-5#1)(1996-6#2)(2006-12#1)(2008-10#2)(2008-7#1)
the contact pressure##3##3##(2007-6#3)
the contact time##4##3##(2007-10#1)(2008-10#2)(2010-9#1)
the contact with the##2##4##(2007-8#1)(2008-5#1)
the contact with##4##3##(1991-2#1)(2007-8#1)(2008-5#1)(2011-1#1)
the contact##80##2##(1990-10#1)(1990-11#2)(1991-2#1)(1991-5#2)(1993-1#1)(1993-9#1)(1994-12#1)(1995-2#2)(1995-5#1)(1996-11#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-3#1)(2005-11#16)(2006-11#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-6#3)(2007-7#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2009-11#2)(2009-7#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-4#1)(2013-1#7)
the contacting##2##2##(2005-11#1)(2008-10#1)
the contacts between##2##3##(1994-5#1)(2008-7#1)
the contacts with##2##3##(2009-2#1)(2012-3#1)
the contacts##10##2##(1991-8#1)(1993-5#1)(1993-9#1)(1994-5#1)(1995-8#1)(2006-7#1)(2008-7#1)(2009-2#1)(2010-5#1)(2012-3#1)
the container##2##2##(2004-9#1)(2011-2#1)
the containers##4##2##(1993-10#1)(2006-5#1)(2007-5#1)(2008-10#1)
the containment of##2##3##(1994-6#1)(2006-10#1)
the containment##3##2##(1994-6#1)(2006-10#1)(2011-3#1)
the contaminant##3##2##(1996-5#1)(2008-3#2)
the contaminants##6##2##(1997-4#1)(2004-4#2)(2007-11#1)(2008-10#1)(2008-11#1)
the contaminated##6##2##(1993-9#2)(2008-10#2)(2008-4#1)(2012-3#1)
the contamination of the##2##4##(1997-5#1)(2011-11#1)
the contamination of##16##3##(1991-11#2)(1992-6#1)(1992-8#1)(1994-3#1)(1996-12#1)(1997-5#1)(1997-6#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-11#1)(2011-2#1)
the contamination risk##2##3##(2008-10#1)(2012-2#1)
the contamination source##2##3##(2008-10#2)
the contamination##25##2##(1991-11#2)(1992-3#1)(1992-6#1)(1992-8#1)(1994-3#1)(1996-12#1)(1997-5#1)(1997-6#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-5#1)(2011-11#1)(2011-2#1)(2012-2#1)
the contemporaneous##2##2##(1991-10#1)(1991-2#1)
the contemporary literature on##2##4##(2008-8#1)(2011-2#1)
the contemporary literature##4##3##(2007-12#1)(2008-8#1)(2011-2#2)
the contemporary practice of##2##4##(2007-4#1)(2008-1#1)
the contemporary##32##2##(1990-11#1)(1991-3#1)(1994-12#1)(1996-1#1)(1997-1#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-4#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-2#3)(2013-1#1)(2013-8#2)
the content analysis##2##3##(2012-12#2)
the content and process of##2##5##(2007-3#1)(2008-11#1)
the content and process##3##4##(2007-10#1)(2007-3#1)(2008-11#1)
the content and structure of the##3##6##(2009-12#1)(2013-1#2)
the content and structure of##4##5##(2009-12#1)(2012-12#1)(2013-1#2)
the content and##23##3##(1990-5#1)(1991-6#1)(1994-10#1)(1996-6#1)(2007-10#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#2)(2009-5#1)(2010-11#1)(2012-11#1)(2012-12#1)(2013-1#2)
the content for##2##3##(1995-3#1)(2005-4#1)
the content in##2##3##(1990-4#1)(2008-5#1)
the content of (NH(4))(2)Cr(2)O(7)##3##4##(2008-2#3)
the content of CS##2##4##(2008-5#2)
the content of Mn##2##4##(2008-10#1)(2010-12#1)
the content of P4502E1 as##2##5##(1994-8#2)
the content of P4502E1##3##4##(1994-8#3)
the content of a##2##4##(1992-2#1)(2011-2#1)
the content of both##2##4##(1993-12#1)(1995-5#1)
the content of estragole##2##4##(2007-1#2)
the content of free##2##4##(2012-2#1)(2013-7#1)
the content of phosphorus##2##4##(2008-10#2)
the content of some##2##4##(2008-10#1)(2010-12#1)
the content of the##16##4##(1993-4#1)(1994-12#1)(1994-7#1)(1995-2#1)(2007-10#1)(2008-10#4)(2008-2#1)(2008-6#1)(2009-9#1)(2010-2#1)(2011-3#1)(2012-1#1)(2012-12#1)
the content of these##4##4##(2006-12#1)(2008-7#1)(2009-10#1)(2013-8#1)
the content of various##2##4##(2008-5#1)(2011-12#1)
the content of vitamin E in##2##6##(1992-9#1)(1994-6#1)
the content of##156##3##(1990-12#1)(1990-5#1)(1990-6#1)(1991-10#3)(1991-3#2)(1991-4#1)(1991-6#1)(1992-2#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-10#1)(1993-12#1)(1993-4#2)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#2)(1995-2#1)(1995-5#1)(1996-1#1)(1996-7#2)(1997-1#1)(1997-7#2)(1997-8#1)(2004-8#1)(2005-10#1)(2005-11#1)(2005-4#5)(2005-8#1)(2005-9#1)(2006-12#1)(2006-6#1)(2007-1#5)(2007-10#1)(2007-12#1)(2008-10#25)(2008-11#4)(2008-12#3)(2008-2#6)(2008-4#4)(2008-5#8)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#9)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#5)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
the content validity of the##3##5##(2007-10#1)(2007-8#1)(2013-1#1)
the content validity of##4##4##(2007-10#1)(2007-8#1)(2010-9#1)(2013-1#1)
the content validity##5##3##(2007-10#1)(2007-8#1)(2010-9#1)(2011-1#1)(2013-1#1)
the content word##2##3##(2008-2#2)
the content##207##2##(1990-12#1)(1990-4#1)(1990-5#2)(1990-6#1)(1991-10#3)(1991-3#2)(1991-4#1)(1991-6#2)(1992-2#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-4#2)(1993-6#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#2)(1996-6#1)(1996-7#2)(1997-1#1)(1997-7#2)(1997-8#1)(2004-8#1)(2005-10#1)(2005-11#1)(2005-4#6)(2005-8#1)(2005-9#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-1#6)(2007-10#3)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#26)(2008-11#5)(2008-12#4)(2008-2#8)(2008-4#4)(2008-5#10)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#2)(2009-12#2)(2009-5#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#9)(2010-2#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#6)(2012-2#2)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#4)
the contention that the##4##4##(1994-3#1)(1996-12#1)(1997-6#1)(2005-7#1)
the contention that##14##3##(1990-12#1)(1994-3#1)(1995-11#1)(1996-12#1)(1996-5#1)(1997-6#1)(2005-7#1)(2007-12#1)(2008-4#1)(2008-9#1)(2009-7#1)(2010-6#1)(2011-2#1)(2012-12#1)
the contents in##2##3##(1997-3#1)(2009-3#1)
the contents of the##12##4##(1992-11#1)(1993-2#1)(1995-5#1)(1996-7#1)(2006-12#1)(2007-1#1)(2007-11#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-2#1)(2011-7#1)
the contents of##42##3##(1990-2#1)(1991-1#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-2#1)(1993-6#1)(1994-6#1)(1995-5#1)(1996-7#1)(1997-8#1)(2004-11#1)(2005-4#1)(2006-10#1)(2006-12#1)(2007-1#2)(2007-11#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#1)(2013-1#1)(2013-8#4)
the contents were##2##3##(2007-1#1)(2010-8#1)
the contents##53##2##(1990-2#1)(1991-1#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-5#1)(1996-12#1)(1996-7#1)(1997-3#1)(1997-8#1)(2004-11#1)(2005-4#1)(2006-10#1)(2006-12#1)(2007-1#3)(2007-11#1)(2007-8#1)(2008-10#6)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-4#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#2)(2011-3#1)(2011-7#1)(2012-12#1)(2013-1#1)(2013-8#4)
the contest##6##2##(1991-4#1)(1995-12#1)(2009-10#1)(2012-3#2)(2013-1#1)
the context and##4##3##(2007-11#1)(2009-9#1)(2010-2#1)(2011-1#1)
the context for##3##3##(1991-3#1)(1997-6#1)(2005-2#1)
the context in which the##2##5##(1993-2#1)(2007-7#1)
the context in which##6##4##(1993-2#1)(2005-10#1)(2007-7#1)(2008-1#1)(2008-2#1)(2009-6#1)
the context in##7##3##(1993-2#1)(2005-10#1)(2007-7#1)(2008-1#1)(2008-2#2)(2009-6#1)
the context of a single##2##5##(2008-11#1)(2011-1#1)
the context of a##59##4##(1991-12#1)(1992-10#1)(1993-12#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-2#1)(1996-3#2)(1997-4#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-12#3)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#2)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#7)
the context of an##12##4##(1992-1#1)(1994-12#1)(1996-1#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-3#1)(2011-2#1)(2012-3#1)
the context of care##2##4##(2005-7#1)(2006-6#1)
the context of climate##4##4##(2009-5#2)(2010-8#1)(2012-8#1)
the context of clinical##4##4##(2007-10#1)(2007-4#1)(2009-8#1)(2009-9#1)
the context of current##9##4##(1991-2#1)(2006-10#2)(2007-3#1)(2007-4#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-1#1)
the context of family and##2##5##(2007-2#1)(2010-8#1)
the context of family##5##4##(2005-11#1)(2007-2#1)(2008-9#1)(2010-8#1)(2012-3#1)
the context of health##5##4##(2008-1#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-12#1)
the context of his##2##4##(2008-11#1)(2009-2#1)
the context of its##3##4##(2006-7#1)(2008-7#1)(2013-8#1)
the context of learning##2##4##(1995-5#1)(2010-2#1)
the context of local##2##4##(1994-11#1)(2006-8#1)
the context of other##2##4##(2005-10#1)(2012-3#1)
the context of previous##4##4##(1995-8#1)(2008-9#2)(2012-2#1)
the context of recent##5##4##(1993-2#1)(1996-11#1)(2008-8#1)(2009-8#1)(2009-9#1)
the context of rehabilitation##2##4##(2007-12#1)(2009-8#1)
the context of the current##5##5##(1994-1#1)(2006-12#1)(2008-3#1)(2008-8#1)(2013-7#1)
the context of the new##3##5##(1991-3#1)(2010-10#1)(2011-1#1)
the context of the##90##4##(1990-12#1)(1991-3#2)(1991-4#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-3#2)(1994-5#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-10#2)(1996-9#1)(1997-2#1)(2005-7#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#4)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
the context of their##9##4##(1994-3#1)(2005-8#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-6#1)(2010-10#1)(2012-2#2)
the context of##550##3##(1990-11#1)(1990-12#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#4)(1991-4#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#4)(1993-4#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#5)(1994-4#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-10#2)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#4)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-12#1)(2004-7#1)(2005-10#6)(2005-11#2)(2005-2#1)(2005-7#2)(2005-8#3)(2006-10#16)(2006-11#1)(2006-12#1)(2006-2#3)(2006-4#2)(2006-5#6)(2006-6#2)(2006-7#2)(2006-8#4)(2006-9#4)(2007-1#1)(2007-10#3)(2007-11#10)(2007-12#19)(2007-2#7)(2007-3#3)(2007-4#3)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#9)(2008-10#13)(2008-11#18)(2008-12#6)(2008-2#15)(2008-3#15)(2008-4#7)(2008-5#8)(2008-6#12)(2008-7#15)(2008-8#13)(2008-9#11)(2009-1#2)(2009-10#5)(2009-11#6)(2009-12#3)(2009-2#3)(2009-4#10)(2009-5#2)(2009-6#3)(2009-7#4)(2009-8#8)(2009-9#6)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#5)(2010-2#7)(2010-3#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#9)(2010-9#5)(2011-1#13)(2011-2#16)(2011-7#1)(2012-1#8)(2012-11#1)(2012-12#11)(2012-2#14)(2012-3#15)(2012-8#1)(2013-1#20)(2013-7#3)(2013-8#7)
the context within which##2##4##(1995-1#1)(2007-12#1)
the context##580##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#5)(1991-4#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#4)(1993-4#1)(1993-9#2)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#5)(1994-4#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#2)(1995-2#3)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-10#2)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#4)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#1)(2004-12#1)(2004-7#1)(2005-10#7)(2005-11#2)(2005-2#2)(2005-7#2)(2005-8#3)(2006-10#16)(2006-11#2)(2006-12#1)(2006-2#3)(2006-4#2)(2006-5#6)(2006-6#2)(2006-7#2)(2006-8#4)(2006-9#4)(2007-1#1)(2007-10#4)(2007-11#11)(2007-12#20)(2007-2#7)(2007-3#3)(2007-4#3)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#3)(2008-1#10)(2008-10#13)(2008-11#19)(2008-12#8)(2008-2#17)(2008-3#15)(2008-4#7)(2008-5#8)(2008-6#12)(2008-7#15)(2008-8#14)(2008-9#11)(2009-1#2)(2009-10#5)(2009-11#6)(2009-12#3)(2009-2#3)(2009-4#10)(2009-5#2)(2009-6#4)(2009-7#4)(2009-8#8)(2009-9#7)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#5)(2010-2#8)(2010-3#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#10)(2010-9#5)(2011-1#14)(2011-2#16)(2011-7#1)(2012-1#8)(2012-11#1)(2012-12#12)(2012-2#15)(2012-3#15)(2012-8#1)(2013-1#20)(2013-7#3)(2013-8#8)
the contexts in which##2##4##(2009-5#1)(2013-1#1)
the contexts of##2##3##(2008-3#1)(2011-2#1)
the contexts##8##2##(1991-11#2)(2006-7#1)(2008-3#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#1)
the contextual##6##2##(2008-11#1)(2008-7#1)(2009-2#1)(2012-2#1)(2013-1#2)
the contig##2##2##(2008-7#2)
the continent and##2##3##(2007-9#1)(2008-10#1)
the continent##15##2##(1990-6#1)(1991-11#2)(1994-3#1)(1996-4#1)(2005-5#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-8#1)
the continent's##2##2##(2006-7#1)(2010-8#1)
the continental US##2##3##(1995-6#1)(2011-2#1)
the continental shelf of the##2##5##(2008-5#1)(2010-8#1)
the continental shelf##4##3##(2007-5#1)(2008-5#2)(2010-8#1)
the continental slope##4##3##(1993-2#2)(2008-5#1)(2010-8#1)
the continental##13##2##(1993-2#2)(1995-6#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-5#3)(2010-8#2)(2011-2#1)
the continents##2##2##(2009-2#1)(2011-2#1)
the contingent##2##2##(2007-7#1)(2010-2#1)
the continual reassessment method##2##4##(1994-9#2)
the continual##6##2##(1994-9#2)(1995-3#1)(2008-5#1)(2009-6#1)(2010-11#1)
the continuation of##13##3##(1994-8#1)(1996-2#1)(1996-7#1)(1997-7#1)(2007-5#1)(2008-4#1)(2009-4#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)
the continuation##17##2##(1994-8#1)(1996-2#1)(1996-7#1)(1997-3#1)(1997-7#1)(2007-5#1)(2008-4#1)(2009-4#1)(2009-9#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)
the continued elucidation of##2##4##(2005-2#1)(2006-1#1)
the continued existence of##2##4##(1992-2#1)(1993-12#1)
the continued need to##2##4##(2008-11#1)(2009-11#1)
the continued presence of##3##4##(1991-10#1)(1991-8#1)(1991-9#1)
the continued use of##4##4##(1992-6#1)(1994-11#1)(2012-2#1)(2013-1#1)
the continued##40##2##(1990-11#1)(1990-4#1)(1991-10#1)(1991-12#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-6#1)(1993-12#3)(1993-2#1)(1994-11#1)(1995-12#1)(1995-7#1)(1996-2#1)(1997-3#1)(1997-7#1)(2005-2#1)(2006-1#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-3#2)(2008-5#2)(2009-11#1)(2009-9#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
the continuing development of##2##4##(2005-5#1)(2012-1#1)
the continuing education of##2##4##(1994-12#1)(1997-8#1)
the continuing education##3##3##(1992-3#1)(1994-12#1)(1997-8#1)
the continuing##23##2##(1990-3#1)(1992-3#1)(1993-3#1)(1994-12#2)(1994-2#1)(1997-8#1)(2005-5#1)(2006-10#1)(2007-11#3)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-4#1)(2012-1#1)(2012-3#2)(2013-8#1)
the continuity and##2##3##(2008-11#1)(2008-7#1)
the continuity of care##3##4##(1993-1#1)(1994-3#1)(2009-3#1)
the continuity of the##3##4##(1991-7#1)(1994-12#1)(2007-8#1)
the continuity of##14##3##(1991-7#1)(1993-1#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-3#1)(2006-3#1)(2007-8#1)(2008-9#1)(2009-3#1)(2012-11#1)(2012-12#2)(2012-2#1)
the continuity##19##2##(1991-7#1)(1993-1#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-7#1)(1995-3#1)(2006-12#1)(2006-3#1)(2007-8#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-3#1)(2012-11#1)(2012-12#2)(2012-2#1)
the continuous ER morphology##2##4##(2009-8#2)
the continuous and##2##3##(1991-11#1)(2008-10#1)
the continuous culture of##2##4##(2008-11#1)(2008-7#1)
the continuous culture##3##3##(2008-11#2)(2008-7#1)
the continuous education##2##3##(1992-11#1)(1996-2#1)
the continuous extraction##3##3##(2008-10#3)
the continuous improvement##2##3##(1993-12#1)(2007-7#1)
the continuous increase in##2##4##(1993-11#1)(2009-2#1)
the continuous phase##3##3##(2005-11#1)(2008-10#1)(2012-11#1)
the continuous spectrum##2##3##(2008-3#1)(2013-8#1)
the continuous wave##3##3##(1995-6#1)(2008-2#1)(2011-1#1)
the continuous wavelet transform##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
the continuous##113##2##(1990-6#1)(1991-11#1)(1991-3#1)(1992-10#1)(1992-11#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#1)(2005-11#1)(2005-12#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-10#25)(2008-11#5)(2008-12#1)(2008-2#7)(2008-3#10)(2008-4#1)(2008-6#3)(2008-7#5)(2008-8#3)(2009-11#1)(2009-2#1)(2009-6#1)(2009-8#3)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#2)(2013-1#1)(2013-7#2)(2013-8#1)
the continuous-time##2##2##(2008-2#1)(2008-8#1)
the continuous-wave##2##2##(2007-11#1)(2008-2#1)
the continuum of care##12##4##(1991-1#1)(1992-12#1)(1994-12#3)(1996-1#1)(1996-12#1)(1997-2#1)(1997-3#3)(2010-9#1)
the continuum of##18##3##(1991-1#1)(1992-12#1)(1994-12#3)(1996-1#1)(1996-12#1)(1997-2#1)(1997-3#4)(2006-2#1)(2006-7#1)(2008-11#1)(2010-10#2)(2010-9#1)
the continuum##34##2##(1991-1#1)(1992-12#1)(1994-12#3)(1996-1#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#4)(2005-8#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-11#3)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2010-10#2)(2010-9#1)(2012-2#1)
the contour group##2##3##(1991-2#2)
the contour##16##2##(1991-2#3)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#5)(2008-3#2)(2008-5#2)(2012-12#1)
the contours##2##2##(2007-12#1)(2008-5#1)
the contraceptive##5##2##(1992-7#1)(1994-8#1)(1996-11#1)(2008-10#1)(2008-11#1)
the contract negotiation##3##3##(1992-2#1)(2007-4#2)
the contract##13##2##(1992-2#1)(1993-12#2)(1994-2#1)(1996-12#1)(2007-4#5)(2007-9#2)(2008-11#1)
the contracted form of##2##4##(2006-10#2)
the contracted form##3##3##(2006-10#3)
the contracted##5##2##(1990-5#1)(2006-10#3)(2013-1#1)
the contractile action of##5##4##(1990-8#1)(1991-9#1)(1993-11#1)(1996-12#1)(1997-4#1)
the contractile activity of the##2##5##(1997-8#1)(2006-6#1)
the contractile activity of##3##4##(1992-2#1)(1997-8#1)(2006-6#1)
the contractile activity##5##3##(1992-2#1)(1997-4#1)(1997-8#1)(2006-6#1)(2008-4#1)
the contractile effect of##4##4##(1990-12#1)(1994-11#2)(1995-12#1)
the contractile properties of##2##4##(2008-3#1)(2013-7#1)
the contractile proteins##2##3##(1991-6#1)(2010-2#1)
the contractile response induced by##2##5##(1996-12#1)(2008-2#1)
the contractile response to electrical##2##5##(1990-5#1)(1993-11#1)
the contractile response to phenylephrine##2##5##(1994-2#2)
the contractile response to##7##4##(1990-5#1)(1990-7#1)(1993-11#1)(1994-2#2)(1997-5#1)(2009-5#1)
the contractile response##12##3##(1990-5#1)(1990-7#2)(1993-11#1)(1994-2#2)(1996-12#2)(1997-5#1)(2008-2#2)(2009-5#1)
the contractile responses induced by##2##5##(1993-11#1)(1996-12#1)
the contractile responses of human omental arteries##2##7##(1993-11#2)
the contractile responses of##4##4##(1993-11#4)
the contractile responses to##3##4##(1993-11#1)(1996-12#1)(1997-5#1)
the contractile responses##12##3##(1990-5#1)(1993-11#7)(1996-12#2)(1997-5#1)(2005-11#1)
the contractile##54##2##(1990-12#1)(1990-5#4)(1990-7#2)(1990-8#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-2#1)(1993-11#9)(1993-3#1)(1994-11#2)(1994-2#2)(1995-12#1)(1995-3#1)(1996-12#5)(1997-4#2)(1997-5#2)(1997-7#2)(1997-8#1)(2005-11#1)(2006-6#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-2#1)(2010-6#1)(2011-2#1)(2013-7#1)
the contractility of##2##3##(1991-4#1)(1997-7#1)
the contracting##4##2##(1994-1#1)(1994-12#1)(1996-9#1)(2007-4#1)
the contraction and##2##3##(2009-4#1)(2011-2#1)
the contraction induced by##3##4##(1991-2#2)(1993-3#1)
the contraction of the##4##4##(1996-12#1)(1997-5#1)(2005-11#1)(2008-6#1)
the contraction of##8##3##(1993-3#1)(1994-11#1)(1996-12#1)(1997-5#1)(2005-11#1)(2008-12#1)(2008-6#1)(2010-12#1)
the contraction was inhibited##2##4##(1993-3#1)(1996-12#1)
the contraction was##4##3##(1991-8#1)(1993-3#1)(1995-12#1)(1996-12#1)
the contraction##30##2##(1990-8#1)(1991-2#2)(1991-8#2)(1993-3#3)(1994-11#1)(1995-12#1)(1996-12#4)(1996-9#1)(1997-5#1)(2005-11#1)(2006-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-4#1)(2009-7#1)(2010-12#1)(2011-2#2)(2013-8#1)
the contractions due to##2##4##(1993-11#1)(1993-3#1)
the contractions of the##2##4##(1996-9#1)(2008-3#1)
the contractions##12##2##(1992-1#1)(1993-11#1)(1993-3#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-9#1)(1997-7#1)(2006-7#2)(2008-3#2)
the contractive##2##2##(2008-2#1)(2011-1#1)
the contradictory##3##2##(1996-6#1)(1997-1#1)(2008-9#1)
the contraindications##2##2##(2008-7#1)(2008-8#1)
the contralateral SI##2##3##(1995-12#2)
the contralateral and ipsilateral##2##4##(1994-2#1)(2011-2#1)
the contralateral and##3##3##(1991-9#1)(1994-2#1)(2011-2#1)
the contralateral auditory##2##3##(1996-5#1)(2008-2#1)
the contralateral breast##5##3##(1990-12#1)(1994-12#1)(1996-3#1)(2007-10#1)(2013-1#1)
the contralateral eye##3##3##(1992-7#1)(2005-11#1)(2011-2#1)
the contralateral hand##2##3##(1990-5#1)(1996-1#1)
the contralateral hemisphere##7##3##(1993-12#1)(1995-12#1)(2007-10#2)(2009-11#1)(2009-2#1)(2012-1#1)
the contralateral hindpaw##4##3##(1991-8#1)(1991-9#3)
the contralateral kidney##3##3##(1992-8#1)(2006-7#1)(2012-2#1)
the contralateral limb##3##3##(1993-7#2)(2012-1#1)
the contralateral lower##2##3##(1995-11#1)(2007-5#1)
the contralateral ovary##3##3##(1992-3#1)(2004-10#1)(2008-3#1)
the contralateral paw##2##3##(1992-10#1)(2008-9#1)
the contralateral primary##2##3##(1990-4#1)(2008-11#1)
the contralateral side of the##2##5##(1991-8#1)(1995-7#1)
the contralateral side of##3##4##(1991-8#1)(1995-12#1)(1995-7#1)
the contralateral side was##3##4##(1991-2#1)(1997-8#1)(2011-12#1)
the contralateral side##23##3##(1991-2#1)(1991-6#2)(1991-8#1)(1993-12#1)(1993-7#1)(1994-2#1)(1995-12#1)(1995-7#2)(1996-9#1)(1997-8#2)(2004-9#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-7#1)(2008-8#2)(2008-9#2)(2011-12#1)
the contralateral stimulation was##2##4##(1993-3#2)
the contralateral stimulation##3##3##(1993-3#3)
the contralateral striatum##2##3##(1996-3#1)(1996-9#1)
the contralateral ventral##4##3##(1990-4#1)(1993-12#2)(1993-2#1)
the contralateral##148##2##(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-5#2)(1991-6#2)(1991-8#2)(1991-9#5)(1992-10#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#11)(1993-2#1)(1993-3#3)(1993-7#5)(1994-10#1)(1994-12#1)(1994-2#4)(1995-11#3)(1995-12#7)(1995-7#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#4)(1996-9#7)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#2)(2004-10#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-8#1)(2006-11#2)(2006-12#1)(2006-3#1)(2006-7#1)(2007-10#6)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#5)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-2#1)(2011-12#1)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#1)
the contralesional##3##2##(1996-2#1)(2009-4#2)
the contrary the##2##3##(1991-12#1)(2011-2#1)
the contrary##136##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-6#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#3)(1995-12#1)(1995-2#2)(1995-5#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2003-11#1)(2005-11#2)(2006-1#1)(2006-2#2)(2006-4#1)(2006-7#3)(2007-1#1)(2007-10#2)(2007-11#2)(2007-2#2)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-3#3)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-8#3)(2011-2#7)(2012-12#2)(2012-2#1)(2013-1#6)(2013-7#1)(2013-8#2)
the contrast agent##3##3##(1993-9#1)(2008-7#2)
the contrast and the##4##4##(1997-6#1)(2007-11#1)(2008-3#1)(2011-1#1)
the contrast and##7##3##(1997-6#1)(2007-11#1)(2008-3#2)(2011-1#1)(2013-1#2)
the contrast between##5##3##(1990-4#1)(2006-3#1)(2007-3#1)(2008-6#1)(2008-8#1)
the contrast deterioration##2##3##(2008-3#2)
the contrast in images##2##4##(2007-11#1)(2008-1#1)
the contrast in the##4##4##(2006-4#1)(2008-3#3)
the contrast in##8##3##(2006-4#1)(2007-11#1)(2008-1#1)(2008-3#3)(2009-4#1)(2010-3#1)
the contrast is##2##3##(2008-2#1)(2008-3#1)
the contrast medium##4##3##(2008-7#4)
the contrast of a##3##4##(2007-11#1)(2008-1#1)(2008-3#1)
the contrast of the##7##4##(2007-12#3)(2008-2#1)(2008-3#3)
the contrast of##15##3##(1996-2#1)(2007-11#2)(2007-12#3)(2008-1#2)(2008-2#2)(2008-3#4)(2008-5#1)
the contrast parameter##2##3##(2008-6#1)(2011-1#1)
the contrast ratio##2##3##(2008-2#1)(2008-3#1)
the contrast with##2##3##(1990-2#1)(2008-2#1)
the contrast##76##2##(1990-2#1)(1990-4#1)(1991-1#1)(1992-7#1)(1993-9#1)(1996-2#1)(1997-4#2)(1997-6#1)(1997-8#1)(2006-3#1)(2006-4#1)(2007-11#7)(2007-12#5)(2007-3#1)(2008-1#3)(2008-10#1)(2008-2#8)(2008-3#16)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#9)(2008-8#1)(2008-9#1)(2009-4#1)(2010-3#1)(2011-1#2)(2011-2#1)(2013-1#3)
the contrasting##2##2##(2008-5#1)(2013-1#1)
the contrasts##2##2##(1991-2#1)(2012-3#1)
the contribution by##2##3##(1990-5#1)(2008-3#1)
the contribution from displacement##2##4##(2007-12#2)
the contribution from the##4##4##(2008-2#1)(2008-3#3)
the contribution from##9##3##(1992-5#1)(2007-12#2)(2008-2#2)(2008-3#4)
the contribution made by##2##4##(1991-12#1)(2009-4#1)
the contribution of DNA repair to##2##6##(2008-11#2)
the contribution of DNA##3##4##(1994-3#1)(2008-11#2)
the contribution of NMDA##2##4##(1992-8#1)(1994-10#1)
the contribution of Raman scattering to the water-leaving radiance in##2##10##(2008-3#2)
the contribution of Sir Henry Thompson##2##6##(2007-10#2)
the contribution of a##3##4##(2008-10#2)(2008-11#1)
the contribution of an##3##4##(2008-10#1)(2008-3#1)(2012-1#1)
the contribution of astrocytes to##2##5##(1995-12#1)(2008-7#1)
the contribution of astrocytes##3##4##(1995-12#1)(2008-7#1)(2013-7#1)
the contribution of bone marrow cells to##2##7##(2009-4#2)
the contribution of both##2##4##(2008-4#1)(2012-2#1)
the contribution of different##3##4##(1996-1#1)(2008-10#1)(2008-5#1)
the contribution of disease-induced root##2##5##(2008-10#2)
the contribution of each##5##4##(1992-1#1)(1993-9#1)(2008-10#1)(2008-5#1)(2010-11#1)
the contribution of genetic##2##4##(1994-2#1)(2008-10#1)
the contribution of migration##2##4##(2007-8#1)(2010-2#1)
the contribution of stimulation-induced activity##2##5##(1994-6#2)
the contribution of teacher##2##4##(2008-12#2)
the contribution of the Responsive Classroom##2##6##(2008-12#2)
the contribution of the different##2##5##(1992-3#1)(2008-8#1)
the contribution of the hydrophobic##2##5##(1991-4#1)(2005-11#1)
the contribution of the various##2##5##(2008-8#1)(2013-7#1)
the contribution of the##43##4##(1990-7#1)(1990-8#1)(1991-1#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-3#1)(1994-10#1)(1994-11#3)(1994-12#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-4#1)(2005-11#2)(2006-11#1)(2006-5#1)(2006-7#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-8#1)(2013-7#1)
the contribution of these##4##4##(2007-9#1)(2008-6#1)(2010-9#1)(2013-1#1)
the contribution of various##2##4##(1995-5#1)(2007-11#1)
the contribution of##207##3##(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-8#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-12#1)(1993-9#2)(1994-1#1)(1994-10#2)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#3)(1994-6#3)(1994-9#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#2)(1997-1#3)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#2)(2005-11#2)(2005-8#1)(2006-11#1)(2006-12#2)(2006-5#1)(2006-7#2)(2007-10#2)(2007-11#1)(2007-12#5)(2007-2#1)(2007-3#2)(2007-8#1)(2007-9#1)(2008-10#17)(2008-11#9)(2008-12#8)(2008-2#4)(2008-3#13)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#6)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#3)(2013-8#2)
the contribution that##2##3##(1993-2#1)(2008-11#1)
the contribution to the##5##4##(1991-4#1)(2007-12#1)(2008-2#2)(2008-3#1)
the contribution to##10##3##(1991-4#1)(1995-8#1)(1996-12#1)(2005-11#1)(2007-12#1)(2008-2#4)(2008-3#1)
the contribution##239##2##(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#2)(1991-8#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#2)(1994-1#1)(1994-10#2)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#4)(1994-6#3)(1994-9#1)(1995-12#2)(1995-5#1)(1995-8#2)(1996-1#1)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#2)(1997-1#3)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2005-11#3)(2005-8#1)(2006-11#1)(2006-12#2)(2006-5#1)(2006-7#2)(2007-10#3)(2007-11#1)(2007-12#8)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#17)(2008-11#11)(2008-12#8)(2008-2#10)(2008-3#19)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#7)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#3)(2013-8#2)
the contributions from##4##3##(1991-3#1)(1992-5#1)(1997-4#1)(2008-2#1)
the contributions made by##2##4##(1993-9#1)(2007-8#1)
the contributions of technology##2##4##(1992-12#1)(2004-10#1)
the contributions of the##8##4##(1992-6#1)(2005-10#1)(2006-10#1)(2008-12#1)(2008-3#3)(2013-1#1)
the contributions of these##2##4##(2008-10#1)(2008-4#1)
the contributions of##43##3##(1991-7#1)(1992-11#1)(1992-12#1)(1992-6#1)(1994-2#1)(1995-2#1)(1996-4#1)(1997-2#1)(2004-10#1)(2005-10#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
the contributions that##2##3##(2008-10#1)(2008-12#1)
the contributions to##4##3##(1997-1#1)(1997-2#2)(2008-2#1)
the contributions##62##2##(1991-3#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-9#1)(1994-2#1)(1995-2#1)(1996-4#1)(1997-1#1)(1997-2#3)(1997-4#1)(2004-10#1)(2005-10#1)(2006-10#2)(2006-12#1)(2007-11#3)(2007-8#2)(2008-10#4)(2008-11#1)(2008-12#5)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
the contributory##3##2##(2005-10#1)(2011-2#1)(2013-1#1)
the control (0##2##3##(2013-8#2)
the control (n =##2##4##(1996-12#1)(2008-10#1)
the control achievements##2##3##(2011-12#2)
the control after##3##3##(1991-2#1)(1992-4#1)(2013-8#1)
the control agents##2##3##(2006-8#1)(2008-10#1)
the control and eradication of##2##5##(2005-5#1)(2007-8#1)
the control and experimental##2##4##(2007-8#1)(2011-2#1)
the control and prevention of##2##5##(2007-7#1)(2011-1#1)
the control and the experimental groups##2##6##(2009-5#1)(2012-3#1)
the control and the##9##4##(1990-1#1)(1994-3#1)(2007-12#1)(2008-10#1)(2009-4#1)(2009-5#1)(2011-3#1)(2012-3#1)(2013-8#1)
the control and##59##3##(1990-1#1)(1990-3#1)(1991-8#2)(1993-12#1)(1994-2#1)(1994-3#1)(1995-12#2)(1996-12#1)(1996-8#1)(1997-1#2)(1997-6#1)(2004-11#1)(2005-11#1)(2005-5#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-4#2)(2009-5#2)(2010-11#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the control animals##7##3##(1992-11#1)(1992-9#2)(1993-12#1)(1996-6#1)(2008-8#1)(2012-3#1)
the control at##4##3##(2006-12#2)(2008-5#1)(2008-9#1)
the control by##4##3##(1990-3#1)(1994-12#1)(1996-12#1)(1997-2#1)
the control cell##5##3##(1990-8#1)(1993-11#1)(2008-11#2)(2010-7#1)
the control cells##8##3##(1990-12#1)(1994-11#1)(1995-3#1)(1996-2#1)(2008-1#1)(2008-11#2)(2008-9#1)
the control condition##8##3##(1992-12#1)(2008-6#1)(2009-9#1)(2010-2#1)(2010-3#1)(2012-2#2)(2013-8#1)
the control culture##4##3##(1993-12#1)(1994-11#1)(2008-11#2)
the control diet containing##2##4##(1993-12#1)(2010-2#1)
the control diet##5##3##(1993-12#1)(2004-2#1)(2007-2#1)(2010-2#1)(2012-2#1)
the control dose-response##2##3##(1993-12#2)
the control experiments##2##3##(1991-2#1)(2008-11#1)
the control flies##2##3##(1995-6#2)
the control group (0##2##4##(1997-3#1)(2008-7#1)
the control group (18##2##4##(2008-1#1)(2008-7#1)
the control group (P &lt##4##5##(1994-3#1)(2004-11#1)(2008-10#1)(2012-3#1)
the control group (P = 0##2##6##(1992-1#1)(2009-6#1)
the control group (P =##4##5##(1992-1#1)(2009-6#1)(2009-8#1)(2010-12#1)
the control group (P##8##4##(1992-1#1)(1994-3#1)(2004-11#1)(2008-10#1)(2009-6#1)(2009-8#1)(2010-12#1)(2012-3#1)
the control group (P&lt##2##4##(2007-8#1)(2008-3#1)
the control group (n =##3##5##(2010-4#1)(2012-12#1)(2012-3#1)
the control group (p = 0##6##6##(1993-3#1)(1997-2#1)(2006-10#1)(2008-10#1)(2009-10#1)(2011-1#1)
the control group (p##12##4##(1990-11#1)(1993-3#1)(1997-2#1)(2006-10#1)(2007-10#1)(2008-10#1)(2009-10#1)(2009-12#1)(2011-1#3)(2011-2#1)
the control group (p&lt##9##4##(1994-12#1)(2007-6#2)(2008-7#1)(2008-8#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
the control group after##2##4##(2008-10#1)(2011-2#1)
the control group and the##3##5##(2008-5#1)(2009-5#1)(2011-2#1)
the control group and##9##4##(1991-12#1)(2007-6#1)(2007-9#1)(2008-12#1)(2008-5#1)(2009-5#2)(2011-2#1)(2013-1#1)
the control group at##3##4##(2006-10#1)(2008-6#1)(2012-12#1)
the control group decreased##2##4##(2008-5#1)(2012-11#1)
the control group did not##4##5##(2006-9#1)(2007-10#1)(2008-3#1)(2013-1#1)
the control group during the##2##5##(1993-12#1)(2008-3#1)
the control group had##2##4##(2006-10#1)(2013-8#1)
the control group in all##3##5##(2007-11#1)(2007-2#1)(2008-8#1)
the control group in the##2##5##(1997-2#1)(2004-11#1)
the control group in##9##4##(1997-2#1)(2004-11#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-8#1)(2010-6#1)(2011-2#1)
the control group of##7##4##(1991-3#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-6#1)(2007-7#1)(2012-3#1)
the control group only##2##4##(2008-4#1)(2011-2#1)
the control group received##7##4##(2007-11#1)(2007-2#1)(2008-11#1)(2008-12#2)(2009-12#1)(2009-4#1)
the control group showed a##2##5##(2007-10#1)(2009-6#1)
the control group to##2##4##(1992-5#1)(2006-12#1)
the control group was##6##4##(1996-11#1)(2007-10#1)(2008-12#1)(2008-8#1)(2009-10#1)(2011-2#1)
the control group were##10##4##(1995-11#1)(1995-3#1)(2006-4#1)(2006-8#1)(2008-1#1)(2009-4#1)(2009-8#1)(2011-1#1)(2011-2#2)
the control group who##2##4##(2006-10#1)(2012-2#1)
the control group with##4##4##(2007-2#1)(2008-9#1)(2011-1#1)(2011-12#1)
the control group without##3##4##(2006-8#1)(2007-7#1)(2011-2#1)
the control group##418##3##(1990-10#1)(1990-11#2)(1990-9#2)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-4#1)(1991-8#2)(1992-1#3)(1992-12#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-8#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#2)(1994-6#1)(1994-8#4)(1995-1#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-11#2)(1996-12#1)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#4)(1997-3#2)(1997-4#1)(1997-6#4)(1997-7#1)(1997-8#3)(2004-10#2)(2004-11#3)(2004-2#1)(2005-1#1)(2006-10#11)(2006-12#1)(2006-4#3)(2006-5#6)(2006-6#5)(2006-7#1)(2006-8#9)(2006-9#3)(2007-10#12)(2007-11#10)(2007-2#7)(2007-3#1)(2007-6#5)(2007-7#11)(2007-8#12)(2007-9#7)(2008-1#3)(2008-10#12)(2008-11#7)(2008-12#13)(2008-3#9)(2008-4#8)(2008-5#4)(2008-6#4)(2008-7#9)(2008-8#3)(2008-9#7)(2009-1#1)(2009-10#4)(2009-12#5)(2009-2#1)(2009-4#2)(2009-5#5)(2009-6#4)(2009-8#2)(2010-10#1)(2010-12#5)(2010-2#3)(2010-4#4)(2010-6#1)(2010-7#1)(2011-1#17)(2011-12#2)(2011-2#31)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#17)(2012-3#5)(2013-1#15)(2013-7#3)(2013-8#9)
the control groups throughout##6##4##(2008-8#2)(2008-9#4)
the control groups##37##3##(1990-11#2)(1992-8#1)(1993-3#1)(1993-6#1)(1997-6#1)(2006-5#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#15)(2011-2#2)(2012-12#1)(2012-2#2)
the control in##2##3##(2008-10#1)(2010-4#1)
the control individuals##2##3##(1992-11#1)(1992-8#1)
the control level for 3 days##2##6##(1993-2#2)
the control level##18##3##(1992-1#2)(1992-4#1)(1992-5#2)(1992-8#1)(1993-12#1)(1993-2#2)(1994-12#2)(1996-5#1)(2008-11#1)(2008-6#2)(2012-1#2)(2013-8#1)
the control light##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
the control loop##3##3##(2008-2#1)(2008-3#1)(2012-1#1)
the control mature form##2##4##(1990-12#2)
the control mature##3##3##(1990-12#2)(1993-6#1)
the control mean##5##3##(1996-7#4)(2012-2#1)
the control measures##3##3##(2007-6#1)(2008-8#1)(2011-12#1)
the control method was##2##4##(2013-8#2)
the control network##2##3##(2008-2#2)
the control of G1##2##4##(2005-11#1)(2007-8#1)
the control of HIV##2##4##(2012-12#1)(2013-8#1)
the control of a##17##4##(1990-12#1)(1990-7#1)(1991-9#1)(1992-10#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-4#1)(1997-4#1)(2006-11#1)(2006-12#1)(2008-10#2)(2013-8#1)
the control of acute##2##4##(2006-10#1)(2010-7#1)
the control of an##2##4##(2007-12#1)(2009-8#1)
the control of apoptosis##3##4##(2007-1#1)(2008-7#1)(2012-2#1)
the control of arterial##2##4##(2009-5#1)(2011-1#1)
the control of cell growth##3##5##(1994-12#1)(2008-7#1)(2011-2#1)
the control of cell##15##4##(1990-5#1)(1991-3#1)(1992-12#1)(1993-3#1)(1994-12#1)(1995-8#1)(1996-10#1)(2006-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-1#1)(2011-2#1)
the control of cerebral##2##4##(1994-5#1)(2006-10#1)
the control of coccidiosis in the##2##6##(1997-6#1)(2008-5#1)
the control of development##2##4##(1996-8#1)(2010-8#1)
the control of energy##4##4##(2004-12#1)(2008-1#1)(2008-10#1)(2008-4#1)
the control of feeding##3##4##(1992-2#1)(1996-4#2)
the control of glucose##2##4##(1994-2#1)(2008-4#1)
the control of human cytomegalovirus##2##5##(1997-4#1)(2013-1#1)
the control of human##3##4##(1996-10#1)(1997-4#1)(2013-1#1)
the control of infectious diseases##2##5##(2006-10#1)(2007-11#1)
the control of infectious##4##4##(2006-10#1)(2007-11#1)(2012-3#1)(2013-8#1)
the control of insulin secretion##2##5##(2008-4#1)(2009-12#1)
the control of insulin##3##4##(2008-4#1)(2009-12#1)(2013-1#1)
the control of its own##3##5##(1992-12#1)(1995-2#1)(2008-10#1)
the control of its##4##4##(1992-12#1)(1995-2#1)(2007-9#1)(2008-10#1)
the control of other##2##4##(1997-7#1)(2007-11#1)
the control of pain##4##4##(2006-10#2)(2007-11#1)(2007-5#1)
the control of several##4##4##(1994-10#1)(2006-10#1)(2008-7#1)(2010-10#1)
the control of soilborne##2##4##(2008-10#2)
the control of spermatogenesis##2##4##(2009-10#1)(2012-2#1)
the control of such##2##4##(1995-8#1)(2010-5#1)
the control of the early##2##5##(1993-12#1)(2013-1#1)
the control of the frequency##3##5##(1996-11#1)(1996-7#2)
the control of the##98##4##(1990-10#2)(1990-12#1)(1990-4#2)(1991-12#2)(1992-3#1)(1992-8#2)(1993-12#2)(1993-4#1)(1993-5#3)(1993-6#3)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-6#3)(1995-8#1)(1996-11#2)(1996-12#1)(1996-7#3)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-5#2)(2005-10#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-3#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#3)(2009-9#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
the control of these##2##4##(2006-12#1)(2011-2#1)
the control of this disease##2##5##(2008-10#1)(2008-5#1)
the control of this##7##4##(1993-6#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-6#1)(2012-12#1)
the control of transcription##4##4##(1991-11#1)(1996-7#1)(2005-10#1)(2012-2#1)
the control of various##5##4##(1994-2#1)(1996-5#1)(1996-6#1)(2007-8#1)(2011-1#1)
the control of##473##3##(1990-10#3)(1990-11#3)(1990-12#4)(1990-2#1)(1990-4#2)(1990-5#2)(1990-6#2)(1990-7#3)(1990-8#1)(1990-9#1)(1991-11#5)(1991-12#3)(1991-3#2)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-10#1)(1992-12#5)(1992-2#1)(1992-3#4)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#4)(1993-2#2)(1993-3#3)(1993-4#1)(1993-5#4)(1993-6#7)(1993-8#1)(1993-9#4)(1994-10#2)(1994-11#5)(1994-12#6)(1994-2#5)(1994-3#3)(1994-5#4)(1994-6#4)(1994-8#6)(1994-9#2)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#6)(1995-2#4)(1995-3#1)(1995-5#3)(1995-6#5)(1995-8#6)(1996-1#1)(1996-10#3)(1996-11#4)(1996-12#4)(1996-3#2)(1996-4#3)(1996-5#3)(1996-6#2)(1996-7#4)(1996-8#2)(1997-1#2)(1997-3#2)(1997-4#12)(1997-5#2)(1997-6#5)(1997-7#4)(2004-12#2)(2005-10#5)(2005-11#2)(2005-5#1)(2005-7#2)(2006-1#1)(2006-10#12)(2006-11#2)(2006-12#10)(2006-3#1)(2007-1#4)(2007-10#1)(2007-11#9)(2007-12#7)(2007-2#2)(2007-3#1)(2007-5#4)(2007-6#4)(2007-7#2)(2007-8#6)(2007-9#4)(2008-1#6)(2008-10#36)(2008-11#7)(2008-12#2)(2008-2#6)(2008-3#5)(2008-4#8)(2008-5#10)(2008-6#2)(2008-7#10)(2008-8#5)(2008-9#5)(2009-10#3)(2009-12#2)(2009-2#3)(2009-4#1)(2009-5#5)(2009-7#1)(2009-8#5)(2009-9#4)(2010-1#2)(2010-10#2)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#10)(2012-12#4)(2012-2#6)(2012-3#4)(2013-1#7)(2013-7#3)(2013-8#6)
the control one##2##3##(2008-10#1)(2009-6#1)
the control over behaviour by##3##5##(1993-6#3)
the control over##4##3##(1993-6#3)(1996-11#1)
the control patients##2##3##(1990-5#1)(2007-8#1)
the control plants##2##3##(2008-2#2)
the control plots##3##3##(2007-6#2)(2008-10#1)
the control population##8##3##(1994-4#2)(1996-12#1)(1996-3#1)(1997-4#1)(2007-10#1)(2007-2#1)(2009-5#1)
the control program##2##3##(1997-8#1)(2008-11#1)
the control programs and##2##4##(2007-7#1)(2011-2#1)
the control programs##3##3##(2007-7#1)(2011-2#2)
the control rat##2##3##(1991-10#1)(1996-12#1)
the control rats##14##3##(1990-8#1)(1991-5#1)(1992-2#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-5#1)(1995-12#1)(1996-3#1)(1997-2#2)(2008-8#1)(2011-1#2)
the control region (CR)##2##4##(2009-5#2)
the control region##3##3##(1993-9#1)(2009-5#2)
the control samples##2##3##(1992-10#1)(2009-11#1)
the control site##6##3##(2007-5#1)(2008-5#1)(2008-7#4)
the control strain##5##3##(1992-7#1)(2008-8#2)(2013-1#2)
the control strategy##3##3##(2006-10#1)(2012-1#1)(2012-3#1)
the control subjects##12##3##(1996-12#1)(1996-9#2)(2007-10#1)(2008-1#2)(2008-5#1)(2009-6#1)(2010-5#1)(2011-2#1)(2013-8#2)
the control system##4##3##(1994-3#1)(2008-10#1)(2008-2#1)(2008-3#1)
the control systems##2##3##(2007-5#1)(2009-7#1)
the control to##3##3##(2004-9#1)(2008-7#1)(2011-12#1)
the control treatment##5##3##(2008-10#3)(2008-8#1)(2010-9#1)
the control value##12##3##(1990-11#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-6#1)(1992-8#1)(1993-1#1)(1997-8#1)(2008-10#1)(2012-2#1)
the control values obtained from##2##5##(1996-5#1)(2013-1#1)
the control values##10##3##(1993-7#1)(1994-3#1)(1995-10#1)(1995-11#1)(1996-2#1)(1996-5#1)(2006-12#1)(2006-5#1)(2011-2#1)(2013-1#1)
the control volume##2##3##(2013-8#2)
the control was##6##3##(1994-11#1)(1994-12#1)(2007-7#1)(2008-10#1)(2009-5#1)(2012-1#1)
the control waveguide##6##3##(2008-2#1)(2008-3#5)
the control week##2##3##(2008-5#2)
the control with##5##3##(2006-8#1)(2008-10#1)(2008-8#1)(2010-4#2)
the control without any##2##4##(2006-10#1)(2006-8#1)
the control without##3##3##(1992-11#1)(2006-10#1)(2006-8#1)
the control zone##3##3##(1991-12#2)(2008-5#1)
the control##1506##2##(1990-1#1)(1990-10#6)(1990-11#11)(1990-12#9)(1990-2#2)(1990-3#3)(1990-4#2)(1990-5#4)(1990-6#4)(1990-7#7)(1990-8#3)(1990-9#3)(1991-10#4)(1991-11#6)(1991-12#7)(1991-2#4)(1991-3#7)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#6)(1991-9#3)(1992-1#5)(1992-10#2)(1992-11#3)(1992-12#8)(1992-2#4)(1992-3#4)(1992-4#6)(1992-5#4)(1992-6#3)(1992-7#3)(1992-8#8)(1992-9#4)(1993-1#4)(1993-11#4)(1993-12#17)(1993-2#6)(1993-3#10)(1993-4#1)(1993-5#4)(1993-6#12)(1993-7#1)(1993-8#3)(1993-9#5)(1994-10#2)(1994-11#10)(1994-12#16)(1994-2#8)(1994-3#10)(1994-4#3)(1994-5#7)(1994-6#6)(1994-8#12)(1994-9#4)(1995-1#4)(1995-10#3)(1995-11#4)(1995-12#12)(1995-2#5)(1995-3#4)(1995-4#1)(1995-5#4)(1995-6#7)(1995-8#7)(1996-1#2)(1996-10#5)(1996-11#7)(1996-12#11)(1996-2#2)(1996-3#4)(1996-4#3)(1996-5#7)(1996-6#6)(1996-7#11)(1996-8#4)(1996-9#4)(1997-1#8)(1997-2#11)(1997-3#5)(1997-4#14)(1997-5#4)(1997-6#14)(1997-7#7)(1997-8#5)(2004-10#2)(2004-11#5)(2004-12#2)(2004-2#2)(2004-4#2)(2004-9#2)(2005-1#1)(2005-10#7)(2005-11#4)(2005-5#2)(2005-7#2)(2006-1#1)(2006-10#25)(2006-11#2)(2006-12#16)(2006-2#1)(2006-3#1)(2006-4#5)(2006-5#14)(2006-6#6)(2006-7#1)(2006-8#13)(2006-9#4)(2007-1#7)(2007-10#15)(2007-11#21)(2007-12#12)(2007-2#13)(2007-3#2)(2007-5#6)(2007-6#12)(2007-7#18)(2007-8#24)(2007-9#13)(2008-1#13)(2008-10#89)(2008-11#36)(2008-12#21)(2008-2#18)(2008-3#27)(2008-4#22)(2008-5#39)(2008-6#12)(2008-7#38)(2008-8#31)(2008-9#35)(2009-1#1)(2009-10#8)(2009-11#2)(2009-12#7)(2009-2#4)(2009-3#1)(2009-4#6)(2009-5#17)(2009-6#7)(2009-7#2)(2009-8#7)(2009-9#5)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#15)(2010-2#9)(2010-3#5)(2010-4#17)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#27)(2011-12#10)(2011-2#53)(2011-3#1)(2012-1#11)(2012-11#2)(2012-12#16)(2012-2#39)(2012-3#12)(2012-6#2)(2013-1#29)(2013-7#7)(2013-8#42)
the controlateral untreated uterine tissues##2##5##(1997-6#2)
the controlateral##3##2##(1997-6#2)(2007-7#1)
the controllable##3##2##(1992-2#1)(2007-11#1)(2008-2#1)
the controlled and##3##3##(1994-11#1)(2008-10#1)(2011-2#1)
the controlled preparation of##2##4##(2008-7#2)
the controlled release of drugs##2##5##(1991-11#1)(1995-11#1)
the controlled release of##5##4##(1991-11#1)(1995-11#1)(2008-10#1)(2010-4#1)(2012-6#1)
the controlled release##7##3##(1991-11#1)(1995-11#1)(2006-5#1)(2008-10#1)(2010-4#1)(2011-2#1)(2012-6#1)
the controlled##38##2##(1990-11#1)(1991-11#1)(1993-11#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-9#1)(2005-10#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-6#1)(2008-7#2)(2009-10#1)(2009-8#1)(2010-12#2)(2010-4#3)(2011-2#3)(2012-2#1)(2012-6#1)(2013-8#1)
the controller output##3##3##(2008-10#3)
the controller voltage##2##3##(2008-10#2)
the controller##14##2##(2008-10#7)(2008-2#1)(2008-5#1)(2010-5#1)(2012-1#4)
the controlling##7##2##(1994-3#1)(2005-10#1)(2007-11#1)(2008-10#3)(2009-5#1)
the controls (P&lt##4##3##(1997-8#1)(2010-12#2)(2012-12#1)
the controls after##4##3##(2008-7#2)(2008-8#1)(2008-9#1)
the controls and##12##3##(1991-1#1)(1992-8#2)(1994-2#1)(1996-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)(2013-8#2)
the controls in##2##3##(1990-5#1)(2008-7#1)
the controls of##2##3##(1992-10#1)(2008-8#1)
the controls showed##2##3##(1997-2#1)(2013-8#1)
the controls throughout##3##3##(2008-8#1)(2008-9#2)
the controls were##3##3##(1997-2#1)(2012-3#1)(2013-8#1)
the controls##176##2##(1990-2#2)(1990-3#3)(1990-5#2)(1990-7#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#3)(1992-8#3)(1992-9#1)(1993-12#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1995-12#1)(1995-4#1)(1995-8#2)(1995-9#2)(1996-11#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-2#5)(1997-8#2)(2004-11#3)(2005-1#1)(2006-1#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#4)(2006-8#2)(2007-2#1)(2007-3#1)(2007-7#5)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#15)(2008-11#2)(2008-5#6)(2008-6#1)(2008-7#8)(2008-8#5)(2008-9#8)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-4#2)(2010-5#1)(2011-1#4)(2011-2#8)(2012-11#1)(2012-12#7)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#8)
the controversial role of##2##4##(2006-7#1)(2008-12#1)
the controversial subject of the use of##2##7##(2007-12#1)(2008-4#1)
the controversial##13##2##(2006-7#1)(2007-12#1)(2007-5#1)(2008-12#1)(2008-4#1)(2009-3#1)(2010-6#3)(2011-2#1)(2012-12#2)(2012-2#1)
the controversies over##2##3##(2008-11#1)(2008-9#1)
the controversies surrounding the##2##4##(2008-11#1)(2008-3#1)
the controversies surrounding##3##3##(2008-11#2)(2008-3#1)
the controversies##10##2##(1993-12#1)(2006-4#1)(2008-11#4)(2008-3#1)(2008-8#1)(2008-9#1)(2012-2#1)
the controversy about##3##3##(1991-11#1)(2006-10#1)(2012-11#1)
the controversy between##2##3##(2008-3#1)(2008-5#1)
the controversy of##3##3##(1996-8#1)(2006-2#1)(2011-2#1)
the controversy regarding##2##3##(1990-12#1)(1995-11#1)
the controversy surrounding the##3##4##(2006-10#1)(2006-12#1)(2010-8#1)
the controversy##21##2##(1990-12#1)(1991-11#1)(1993-6#1)(1993-9#1)(1995-11#1)(1996-8#1)(2006-10#3)(2006-12#1)(2006-2#1)(2007-4#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-11#1)(2013-1#1)
the controversy's##2##2##(2008-11#2)
the conundrum of##2##3##(2006-9#1)(2009-1#1)
the conundrum##3##2##(2006-9#1)(2007-7#1)(2009-1#1)
the conus medullaris##4##3##(1990-6#1)(2008-7#3)
the conus##5##2##(1990-6#1)(2008-7#3)(2012-2#1)
the convection zone##3##3##(1996-5#3)
the convection##4##2##(1996-5#3)(2009-10#1)
the convective motion##2##3##(2005-11#1)(2008-3#1)
the convective##9##2##(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2010-4#1)
the convenience and##4##3##(1990-11#1)(2007-8#1)(2008-3#2)
the convenience of##5##3##(1994-12#1)(1996-12#1)(2007-4#1)(2008-3#2)
the convenience##10##2##(1990-11#1)(1994-12#1)(1996-12#1)(2007-4#1)(2007-8#1)(2008-12#1)(2008-3#4)
the convenient##5##2##(2008-10#2)(2008-5#2)(2008-9#1)
the conventional &quot##3##3##(1990-8#1)(2008-10#1)(2012-2#1)
the conventional 12-lead##2##3##(2008-3#2)
the conventional CysRS##3##3##(2006-12#3)
the conventional Fourier transform##2##4##(2008-2#1)(2008-3#1)
the conventional PDA##2##3##(2008-3#2)
the conventional analysis##2##3##(2008-10#1)(2008-6#1)
the conventional and##4##3##(2007-11#1)(2007-8#2)(2008-2#1)
the conventional approach with##2##4##(2008-2#2)
the conventional approach##4##3##(2008-2#2)(2009-5#1)(2012-12#1)
the conventional classification##2##3##(1990-2#1)(2008-1#1)
the conventional confocal##2##3##(2008-2#2)
the conventional culture dish##3##4##(2008-11#3)
the conventional group##4##3##(2009-2#1)(2013-1#3)
the conventional method for##2##4##(2008-2#1)(2008-8#1)
the conventional method is##2##4##(2008-10#1)(2008-2#1)
the conventional method of##2##4##(2007-6#1)(2008-11#1)
the conventional method##20##3##(1990-8#1)(2004-9#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#2)(2008-8#1)(2010-6#1)
the conventional methods##8##3##(2007-12#1)(2008-10#2)(2008-2#1)(2009-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
the conventional one##2##3##(2008-3#1)(2011-1#1)
the conventional optical##4##3##(2008-1#1)(2008-2#1)(2008-3#2)
the conventional pellet culture##2##4##(2008-11#2)
the conventional planar##2##3##(1994-1#1)(2008-3#1)
the conventional plasma gel clot model##2##6##(1990-12#2)
the conventional polyol synthesis##2##4##(2008-5#1)(2013-1#1)
the conventional procedure##5##3##(2008-10#3)(2011-2#1)(2011-3#1)
the conventional procedures##2##3##(2008-10#1)(2008-5#1)
the conventional process##2##3##(2008-6#2)
the conventional pure-tone audiometry##2##4##(2008-1#2)
the conventional rigid##2##3##(2012-12#2)
the conventional sample##2##3##(1995-2#1)(2008-10#1)
the conventional surgical##3##3##(1992-6#1)(2006-12#1)(2009-2#1)
the conventional technique##4##3##(2008-3#1)(2008-5#1)(2011-2#1)(2011-7#1)
the conventional test##3##3##(1995-9#1)(1997-6#1)(1997-8#1)
the conventional tests##2##3##(2012-3#1)(2013-8#1)
the conventional therapies##2##3##(2007-6#2)
the conventional treatment##5##3##(2006-6#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)
the conventional type##2##3##(1994-8#1)(2008-2#1)
the conventional variety##2##3##(2011-2#2)
the conventional##353##2##(1990-12#3)(1990-2#1)(1990-8#2)(1991-6#2)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#2)(1995-9#2)(1996-2#2)(1996-6#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-1#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-4#1)(2005-8#1)(2005-9#2)(2006-10#5)(2006-12#5)(2006-2#1)(2006-6#3)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#11)(2007-12#18)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#4)(2007-8#6)(2007-9#3)(2008-1#7)(2008-10#63)(2008-11#12)(2008-12#2)(2008-2#30)(2008-3#30)(2008-4#4)(2008-5#11)(2008-6#6)(2008-7#3)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-5#1)(2009-9#3)(2010-2#1)(2010-3#1)(2010-4#4)(2010-6#2)(2010-7#1)(2010-8#5)(2011-1#3)(2011-2#7)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#4)(2013-1#12)(2013-7#1)(2013-8#7)
the conventionally##9##2##(1993-12#1)(1993-4#1)(2007-12#1)(2007-9#2)(2008-2#1)(2010-10#2)(2012-12#1)
the convergence of the##3##4##(1993-11#1)(2008-1#1)(2013-1#1)
the convergence of##6##3##(1992-6#1)(1993-11#1)(2008-1#1)(2008-7#1)(2009-3#1)(2013-1#1)
the convergence rate##3##3##(2007-12#2)(2008-2#1)
the convergence##13##2##(1992-6#1)(1993-11#1)(2007-12#3)(2008-1#1)(2008-2#2)(2008-3#1)(2008-7#2)(2009-3#1)(2013-1#1)
the convergent##8##2##(1991-8#2)(1995-11#1)(2004-10#1)(2007-1#1)(2007-12#2)(2008-5#1)
the converging##4##2##(2008-2#1)(2008-3#1)(2009-9#1)(2010-5#1)
the conversation##7##2##(2007-11#2)(2008-11#1)(2008-6#1)(2008-9#1)(2012-3#2)
the converse is true##2##4##(2008-8#1)(2010-11#1)
the converse is##3##3##(2008-8#1)(2010-11#1)(2010-12#1)
the converse##5##2##(2008-3#1)(2008-8#1)(2010-11#1)(2010-12#1)(2013-7#1)
the conversion efficiency can be##2##5##(2007-11#1)(2008-2#1)
the conversion efficiency is##2##4##(2007-12#2)
the conversion efficiency of the##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
the conversion efficiency of##6##4##(2007-12#3)(2008-2#1)(2008-3#1)(2013-1#1)
the conversion efficiency was##2##4##(2008-6#2)
the conversion efficiency##17##3##(2007-11#1)(2007-12#6)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#3)(2013-1#1)
the conversion from##3##3##(1994-3#1)(2005-4#1)(2011-2#1)
the conversion of 11-deoxycorticosterone##2##4##(1990-11#1)(2008-4#1)
the conversion of 5-monosubstituted hydantoins to enantiomerically pure L-amino acids##2##10##(1995-3#2)
the conversion of L-arginine##2##4##(1992-3#1)(1995-11#1)
the conversion of a##2##4##(1993-12#1)(1995-10#1)
the conversion of arachidonic acid##2##5##(1993-9#1)(1994-8#1)
the conversion of big endothelin##2##5##(1990-9#1)(1991-1#1)
the conversion of big##5##4##(1990-2#1)(1990-9#1)(1991-1#1)(1991-6#1)(1992-6#1)
the conversion of glucose to glycogen in##2##7##(1995-8#2)
the conversion of glucose to glycogen##3##6##(1995-8#3)
the conversion of the##9##4##(1991-5#1)(1992-12#1)(1995-7#1)(1995-8#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-4#1)
the conversion of##105##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-3#1)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-6#2)(1993-11#2)(1993-12#1)(1993-3#2)(1993-9#3)(1994-12#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#3)(1995-6#1)(1995-7#1)(1995-8#5)(1996-2#2)(1996-5#1)(1996-7#3)(1997-4#2)(1997-7#1)(1997-8#1)(2004-8#1)(2005-10#1)(2005-12#2)(2006-10#1)(2006-3#1)(2006-5#1)(2007-1#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#5)(2008-8#2)(2009-11#1)(2009-12#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-9#1)(2012-11#3)
the conversion to##2##3##(1992-9#1)(2008-12#1)
the conversion##144##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-3#1)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-6#2)(1992-9#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-9#3)(1994-12#1)(1994-3#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-2#2)(1995-3#3)(1995-6#1)(1995-7#1)(1995-8#5)(1996-2#2)(1996-5#1)(1996-7#3)(1997-4#2)(1997-7#1)(1997-8#1)(2004-8#1)(2005-10#2)(2005-12#2)(2005-4#1)(2006-10#2)(2006-3#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-11#2)(2007-12#9)(2007-7#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#8)(2008-6#3)(2008-7#1)(2008-8#2)(2009-11#1)(2009-12#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-2#1)(2012-11#4)(2013-1#2)
the converter##3##2##(2008-10#3)
the converting activity of the##2##5##(1991-7#2)
the converting##3##2##(1991-7#3)
the convex SP##2##3##(2007-8#2)
the convex side of##2##4##(1996-5#1)(2012-2#1)
the convex side##3##3##(1996-5#1)(2007-8#1)(2012-2#1)
the convex##11##2##(1996-5#2)(2007-8#3)(2008-10#1)(2008-2#3)(2008-6#1)(2012-2#1)
the convexity##2##2##(1990-5#1)(2008-6#1)
the conviction##2##2##(1997-5#1)(2013-8#1)
the convolution of the##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
the convolution##10##2##(2007-12#2)(2008-11#1)(2008-2#2)(2008-3#4)(2013-8#1)
the convulsant##4##2##(1990-10#1)(1991-1#1)(1991-11#1)(1996-10#1)
the convulsing##3##2##(1993-4#3)
the cooked##3##2##(2012-12#3)
the cooking##4##2##(2008-5#1)(2008-9#1)(2010-2#1)(2010-4#1)
the cooling rate##2##3##(2006-5#2)
the cooling##6##2##(2006-5#2)(2008-10#1)(2008-3#1)(2013-7#2)
the cooperation of the##2##4##(1991-3#1)(2004-2#1)
the cooperation of##9##3##(1990-5#1)(1991-3#1)(2004-2#1)(2006-10#1)(2008-2#1)(2008-4#1)(2009-12#1)(2011-1#1)(2012-1#1)
the cooperation##14##2##(1990-4#3)(1990-5#1)(1991-3#1)(2004-2#1)(2006-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-12#1)(2011-1#2)(2012-1#1)
the cooperative behavior of##2##4##(1990-8#2)
the cooperative binding of##4##4##(1990-11#1)(1996-4#1)(2006-10#1)(2008-10#1)
the cooperative efforts of##2##4##(1994-7#1)(2007-2#1)
the cooperative nature of##2##4##(1990-8#1)(1995-6#1)
the cooperative unfolding##2##3##(1993-11#1)(2008-4#1)
the cooperative##28##2##(1990-11#1)(1990-8#3)(1991-7#1)(1992-7#1)(1993-11#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-4#1)(1997-6#1)(2006-10#2)(2007-12#1)(2007-2#1)(2008-10#2)(2008-4#2)(2008-8#1)(2009-8#1)(2010-12#2)(2011-1#1)(2013-1#2)
the cooperatively breeding##4##3##(2008-9#2)(2010-2#1)(2010-8#1)
the cooperativity of the##2##4##(1990-5#1)(1994-5#1)
the cooperativity of##4##3##(1990-5#1)(1994-11#1)(1994-5#1)(1997-2#1)
the cooperativity parameter##2##3##(1994-11#1)(1997-7#1)
the cooperativity##9##2##(1990-5#1)(1990-8#1)(1994-11#3)(1994-5#1)(1997-2#1)(1997-7#1)(2006-8#1)
the coordinate regulation of##3##4##(1991-5#1)(1996-7#1)(1997-2#1)
the coordinate##12##2##(1991-5#2)(1991-7#1)(1994-12#1)(1996-7#2)(1997-2#2)(2005-11#1)(2007-9#1)(2008-10#1)(2010-7#1)
the coordinated expression of##2##4##(2008-1#1)(2012-2#1)
the coordinated regulation of##3##4##(1994-3#1)(2008-4#1)(2008-7#1)
the coordinated##19##2##(1993-6#1)(1994-3#1)(1994-5#1)(1995-12#1)(1996-2#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-3#1)(2008-4#2)(2008-7#2)(2009-8#2)(2012-2#1)(2013-1#1)
the coordinates of the##3##4##(1992-4#1)(2006-10#1)(2007-12#1)
the coordinates of##4##3##(1991-6#1)(1992-4#1)(2006-10#1)(2007-12#1)
the coordinates##7##2##(1991-6#1)(1992-4#2)(1995-5#1)(2006-10#1)(2007-1#1)(2007-12#1)
the coordinating##5##2##(1996-8#2)(1997-7#1)(2005-4#1)(2006-6#1)
the coordination chemistry of##2##4##(1994-9#1)(2008-3#1)
the coordination geometry##2##3##(1994-9#1)(2006-4#1)
the coordination of services##2##4##(1990-12#1)(2010-5#1)
the coordination of the##3##4##(1991-5#1)(2006-10#1)(2013-7#1)
the coordination of these##2##4##(2006-1#1)(2013-8#1)
the coordination of##21##3##(1990-12#1)(1990-6#1)(1991-5#1)(1994-8#1)(1997-7#1)(2006-1#1)(2006-10#1)(2006-4#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-1#1)(2010-12#1)(2010-5#1)(2010-9#1)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
the coordination sites##2##3##(1997-7#1)(2008-10#1)
the coordination sphere of the##3##5##(1996-7#1)(1997-7#1)(2010-5#1)
the coordination sphere of##5##4##(1994-11#1)(1996-7#1)(1997-7#1)(2008-3#1)(2010-5#1)
the coordination sphere##6##3##(1994-11#1)(1995-11#1)(1996-7#1)(1997-7#1)(2008-3#1)(2010-5#1)
the coordination structure of##2##4##(1997-4#1)(2005-4#1)
the coordination##50##2##(1990-12#1)(1990-6#1)(1991-5#1)(1992-9#1)(1994-11#1)(1994-8#2)(1994-9#2)(1995-11#1)(1996-7#1)(1997-4#1)(1997-7#3)(2005-4#2)(2006-1#1)(2006-10#1)(2006-4#2)(2006-8#1)(2008-10#6)(2008-2#1)(2008-3#4)(2008-8#1)(2008-9#1)(2009-1#1)(2010-12#2)(2010-5#4)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2013-1#1)(2013-7#1)(2013-8#1)
the copepod##2##2##(2008-5#1)(2010-8#1)
the copepods##2##2##(2007-3#1)(2008-5#1)
the copia-containing##2##2##(1994-8#2)
the copia-free##2##2##(1994-8#2)
the coping##14##2##(1990-10#2)(1991-1#1)(1993-3#1)(1995-5#1)(2005-12#1)(2007-10#1)(2008-6#4)(2009-4#1)(2009-7#1)(2013-8#1)
the copolymer with##2##3##(2008-1#1)(2008-10#1)
the copolymer##10##2##(2005-11#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-7#1)
the copolymerization between EO and##4##5##(2012-12#4)
the copolymerization of##3##3##(2010-2#1)(2012-12#2)
the copolymerization##9##2##(2010-2#1)(2012-12#8)
the copolymers##6##2##(2005-11#2)(2008-10#1)(2010-4#2)(2011-2#1)
the copper center##3##3##(1994-9#2)(2009-3#1)
the copper ions##3##3##(1990-7#1)(2008-10#1)(2008-9#1)
the copper is##2##3##(1992-12#2)
the copper oxide##3##3##(1993-5#1)(2008-10#2)
the copper##43##2##(1990-7#1)(1992-12#2)(1992-2#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-9#4)(1995-3#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-6#1)(2005-4#1)(2006-10#1)(2006-4#1)(2006-7#2)(2008-10#13)(2008-3#1)(2008-5#2)(2008-9#2)(2009-3#1)(2010-5#1)(2012-2#1)
the copper(I)##3##2##(1992-12#1)(1996-2#1)(2006-9#1)
the copper(II) ion##2##3##(2008-10#1)(2008-5#1)
the copper(II)##6##2##(1997-7#1)(2008-10#2)(2008-5#1)(2010-2#1)(2010-5#1)
the copper-modified gold electrode##2##4##(2008-10#2)
the copper-protein complexes##2##3##(2008-10#2)
the copper-protein##3##2##(2008-10#3)
the coprecipitation##3##2##(2008-10#3)
the copy number of MDR1 DNA##2##6##(1995-11#2)
the copy number of the##3##5##(1990-4#1)(1997-3#1)(2008-10#1)
the copy number of##9##4##(1990-4#1)(1991-9#1)(1992-7#1)(1995-11#2)(1997-3#1)(2008-10#1)(2008-11#1)(2010-5#1)
the copy number##13##3##(1990-4#1)(1991-8#1)(1991-9#1)(1992-7#1)(1995-11#3)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-5#1)
the copy of##2##3##(1990-5#1)(1995-8#1)
the copy##15##2##(1990-4#1)(1990-5#1)(1991-8#1)(1991-9#1)(1992-7#1)(1995-11#3)(1995-8#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-5#1)
the copying##2##2##(2008-4#1)(2012-1#1)
the coracoid##8##2##(2007-1#1)(2009-4#1)(2013-1#6)
the coral reefs##2##3##(2007-5#1)(2011-2#1)
the coral##14##2##(2007-3#4)(2007-5#3)(2008-5#1)(2008-6#1)(2010-8#1)(2011-2#4)
the cord and##3##3##(2006-8#1)(2008-7#1)(2009-9#1)
the cord##16##2##(1992-3#1)(2006-8#3)(2008-10#1)(2008-3#1)(2008-7#2)(2009-9#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#2)
the core amino##2##3##(1991-2#1)(1995-8#1)
the core and the cladding modes##2##6##(2007-11#1)(2008-3#1)
the core and the##4##4##(1994-8#1)(2007-11#1)(2008-3#2)
the core and##7##3##(1990-9#1)(1994-8#1)(2007-11#1)(2008-3#2)(2009-3#1)(2010-5#1)
the core binding##2##3##(1996-5#1)(2013-1#1)
the core body temperature##2##4##(2007-10#1)(2013-7#1)
the core coding##2##3##(1995-1#1)(2013-1#1)
the core component##2##3##(2010-1#1)(2011-1#1)
the core consensus and##2##4##(1990-10#2)
the core consensus##6##3##(1990-10#6)
the core functionalities##3##3##(2007-12#3)
the core functions of public health##2##6##(1995-12#2)
the core functions##3##3##(1995-12#2)(1996-2#1)
the core histone##4##3##(1996-4#3)(2008-8#1)
the core information##2##3##(2006-10#1)(2010-11#1)
the core issues in##2##4##(2007-4#2)
the core issues##3##3##(2007-4#2)(2007-7#1)
the core material##4##3##(2007-11#1)(2009-8#3)
the core model##2##3##(1996-11#2)
the core of a##3##4##(1991-2#1)(2007-11#1)(2012-2#1)
the core of any##2##4##(1993-3#1)(1996-12#1)
the core of the protein##3##5##(1995-1#1)(1996-8#1)(1997-7#1)
the core of the##26##4##(1991-2#1)(1992-8#1)(1994-11#1)(1995-1#1)(1995-6#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#2)(2009-12#1)(2010-2#1)(2011-2#1)
the core of##56##3##(1991-2#3)(1992-8#1)(1993-10#1)(1993-2#1)(1993-3#1)(1994-11#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-10#3)(2006-3#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
the core part##3##3##(1994-8#3)
the core promoter##3##3##(1994-12#1)(2008-5#1)(2012-2#1)
the core protein##10##3##(1990-12#1)(1990-9#2)(1991-7#2)(1992-11#1)(1992-2#1)(1992-5#1)(1995-5#1)(2008-8#1)
the core public health functions and##2##6##(1996-2#2)
the core public health##3##4##(1996-2#2)(1997-1#1)
the core region of the##2##5##(1991-4#1)(2012-3#1)
the core region of##5##4##(1991-4#1)(2007-3#1)(2008-8#1)(2009-8#1)(2012-3#1)
the core region##12##3##(1990-4#1)(1991-2#1)(1991-4#1)(1996-2#1)(2005-11#1)(2007-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2012-3#1)
the core sequence##2##3##(1997-1#1)(2008-8#1)
the core sequences##3##3##(1996-2#1)(1996-8#1)(2006-12#1)
the core structure of##2##4##(1992-12#1)(1996-4#1)
the core structure##3##3##(1992-12#1)(1994-5#1)(1996-4#1)
the core temperature##6##3##(2005-8#2)(2006-10#1)(2007-10#1)(2008-2#1)(2010-7#1)
the core##245##2##(1990-10#6)(1990-12#1)(1990-4#2)(1990-9#4)(1991-2#6)(1991-4#3)(1991-7#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-11#2)(1994-12#3)(1994-5#2)(1994-8#7)(1994-9#1)(1995-1#2)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-11#2)(1996-12#1)(1996-2#7)(1996-4#4)(1996-5#2)(1996-8#3)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(2004-12#1)(2004-9#1)(2005-11#3)(2005-8#2)(2006-10#5)(2006-12#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#2)(2007-11#4)(2007-12#12)(2007-2#1)(2007-3#1)(2007-4#3)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#10)(2008-11#5)(2008-12#4)(2008-2#4)(2008-3#7)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#8)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-7#1)(2009-8#6)(2010-1#4)(2010-11#2)(2010-12#1)(2010-2#3)(2010-5#2)(2010-7#1)(2011-1#5)(2011-2#3)(2012-12#3)(2012-2#4)(2012-3#6)(2013-1#9)(2013-7#1)(2013-8#3)
the core-histone genes##3##3##(1990-5#3)
the core-histone##4##2##(1990-5#4)
the core-mantle boundary##2##3##(2007-9#2)
the core-shell##4##2##(2005-11#2)(2007-8#1)(2009-9#1)
the cores of##2##3##(2007-12#1)(2008-10#1)
the cores##4##2##(2007-11#1)(2007-12#2)(2008-10#1)
the corn fiber##2##3##(2008-5#1)(2008-6#1)
the corn oil and lard##2##5##(1990-7#2)
the corn oil##4##3##(1990-7#3)(2008-10#1)
the corn##17##2##(1990-7#3)(1995-2#1)(2007-8#1)(2008-10#3)(2008-5#2)(2008-6#1)(2008-8#1)(2009-4#1)(2009-8#1)(2011-2#3)
the corn-oil##3##2##(2006-8#2)(2008-3#1)
the cornea and conjunctiva##2##4##(2006-11#1)(2008-11#1)
the cornea and the lens##3##5##(2007-12#1)(2008-2#2)
the cornea and the##6##4##(2007-1#1)(2007-12#2)(2007-9#1)(2008-2#2)
the cornea and##11##3##(2006-11#2)(2007-1#1)(2007-12#2)(2007-9#1)(2008-11#1)(2008-2#3)(2011-2#1)
the cornea in##3##3##(2007-9#1)(2011-1#1)(2013-1#1)
the cornea retention time##2##4##(2011-3#2)
the cornea##60##2##(1991-5#1)(1997-3#1)(1997-6#1)(2005-11#1)(2006-11#4)(2006-7#3)(2007-1#4)(2007-12#6)(2007-2#1)(2007-9#3)(2008-11#4)(2008-2#6)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-2#2)(2009-7#1)(2010-1#1)(2010-12#2)(2011-1#1)(2011-2#1)(2011-3#2)(2011-7#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)
the corneal epithelial##2##3##(2008-1#2)
the corneal epithelium and##2##4##(2005-11#1)(2008-5#1)
the corneal epithelium##6##3##(2005-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2012-12#2)
the corneal reflex##2##3##(2007-1#2)
the corneal surface##5##3##(2009-7#2)(2010-10#1)(2011-7#1)(2012-12#1)
the corneal##26##2##(1993-12#1)(2005-11#1)(2006-7#1)(2007-1#3)(2008-1#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2009-7#2)(2010-10#1)(2011-2#5)(2011-7#1)(2012-12#3)
the corneocyte envelope##2##3##(2008-5#2)
the corneocyte##5##2##(2008-5#5)
the corneocytes##2##2##(2008-5#1)(2012-2#1)
the corner stone##2##3##(2006-2#1)(2011-1#1)
the corner##5##2##(2006-2#1)(2007-12#1)(2008-8#2)(2011-1#1)
the cornerstone for##2##3##(2006-10#1)(2008-11#1)
the cornerstone in##2##3##(2006-10#1)(2013-1#1)
the cornerstone of the##4##4##(1994-12#1)(2008-1#1)(2008-3#1)(2010-6#1)
the cornerstone of therapy##2##4##(2006-10#1)(2011-2#1)
the cornerstone of treatment##4##4##(1990-12#1)(2009-5#1)(2011-2#1)(2012-12#1)
the cornerstone of##26##3##(1990-12#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-12#1)(2008-3#2)(2008-6#1)(2009-5#1)(2010-10#1)(2010-6#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)
the cornerstone##30##2##(1990-12#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-10#3)(2006-6#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2009-5#1)(2010-10#1)(2010-6#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
the cornerstones of##5##3##(1994-5#1)(1994-7#1)(1997-3#2)(2008-3#1)
the cornerstones##6##2##(1994-5#1)(1994-7#1)(1997-3#2)(2008-3#1)(2011-1#1)
the corona radiata##2##3##(2007-10#2)
the corona##6##2##(2007-10#2)(2008-2#3)(2010-4#1)
the coronal plane##3##3##(2008-8#2)(2013-1#1)
the coronal##9##2##(1997-3#1)(2005-10#1)(2007-2#1)(2008-8#2)(2008-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
the coronary anastomosis##2##3##(2007-8#2)
the coronary angiography##2##3##(2008-3#1)(2008-7#1)
the coronary arterial##2##3##(2011-2#1)(2013-2#1)
the coronary arteries and##3##4##(2005-10#1)(2008-10#1)(2008-3#1)
the coronary arteries were##4##4##(1991-3#1)(2007-8#1)(2012-3#2)
the coronary arteries##22##3##(1991-3#1)(1993-5#1)(1994-11#2)(2005-10#2)(2007-4#1)(2007-8#2)(2008-10#2)(2008-3#1)(2009-12#1)(2009-5#1)(2011-2#1)(2012-2#2)(2012-3#4)(2013-8#1)
the coronary artery##14##3##(1990-12#1)(1994-2#1)(2006-6#2)(2007-8#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2012-2#1)(2013-2#1)
the coronary bypass##2##3##(2008-10#1)(2008-8#1)
the coronary care unit##4##4##(1990-3#2)(2008-3#1)(2012-2#1)
the coronary circulation##4##3##(1990-8#1)(1994-11#1)(2005-7#1)(2006-10#1)
the coronary heart disease##2##4##(1997-6#1)(2013-8#1)
the coronary ostia##2##3##(2008-5#1)(2011-2#1)
the coronary sinus##6##3##(2007-8#4)(2009-3#1)(2012-2#1)
the coronary stent##2##3##(2008-5#1)(2008-7#1)
the coronary syndromes]##3##3##(2008-10#3)
the coronary vasculature##2##3##(1993-11#1)(2005-12#1)
the coronary venous system##3##4##(2007-8#2)(2013-2#1)
the coronary##99##2##(1990-12#1)(1990-3#2)(1990-6#2)(1990-8#1)(1991-3#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-5#1)(1994-11#4)(1994-2#1)(1995-3#2)(1997-6#1)(2005-10#2)(2005-12#1)(2005-7#1)(2006-10#1)(2006-6#3)(2007-10#1)(2007-4#1)(2007-8#14)(2008-10#13)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#7)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2011-2#4)(2012-2#5)(2012-3#7)(2013-2#3)(2013-8#3)
the coronavirus##2##2##(2008-5#1)(2010-2#1)
the coroner##2##2##(2006-7#1)(2008-6#1)
the coronoid process##4##3##(1991-2#1)(2008-7#2)(2012-3#1)
the corpectomy##2##2##(2006-7#1)(2006-8#1)
the corpora##8##2##(1991-12#1)(1995-11#1)(2008-10#3)(2008-9#2)(2011-2#1)
the corporate##6##2##(1990-4#1)(1991-2#1)(1994-3#1)(2006-12#1)(2010-2#1)(2013-1#1)
the corpse##2##2##(2011-1#2)
the corpus callosum (CC)##4##4##(1992-9#1)(2008-7#1)(2010-12#1)(2013-1#1)
the corpus callosum and##2##4##(1996-1#1)(1996-5#1)
the corpus callosum##32##3##(1991-6#1)(1992-9#1)(1993-7#4)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#5)(1997-2#1)(1997-3#1)(2006-5#1)(2007-10#2)(2008-6#1)(2008-7#3)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
the corpus cavernosum penis##2##4##(2006-5#2)
the corpus cerebelli##3##3##(1993-12#2)(1995-5#1)
the corpus luteum##2##3##(1994-6#1)(1995-12#1)
the corpus vertebrae##3##3##(2007-11#3)
the corpus##55##2##(1991-6#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#3)(1993-7#4)(1994-1#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-5#2)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#5)(1997-2#1)(1997-3#1)(2006-5#3)(2007-10#2)(2007-11#4)(2008-6#1)(2008-7#3)(2009-5#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#5)(2013-7#1)
the correct behavior of##2##4##(2007-12#1)(2008-3#1)
the correct choice of##2##4##(1993-11#1)(2007-7#1)
the correct choice##3##3##(1993-11#1)(2007-7#2)
the correct determination of the##2##5##(1992-2#1)(2007-9#1)
the correct determination of##3##4##(1992-2#1)(2007-9#1)(2008-10#1)
the correct diagnosis and##3##4##(1991-3#1)(1992-8#1)(2006-6#1)
the correct diagnosis in##2##4##(2005-11#1)(2012-2#1)
the correct diagnosis of the##2##5##(1991-2#1)(2013-1#1)
the correct diagnosis of##9##4##(1991-2#1)(1997-5#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-6#1)(2011-2#1)(2013-1#2)
the correct diagnosis was##3##4##(1990-12#1)(1997-5#1)(2006-10#1)
the correct diagnosis##44##3##(1990-12#1)(1990-5#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-8#1)(1993-5#1)(1993-8#1)(1995-4#1)(1995-6#1)(1997-5#2)(2005-11#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-6#1)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#3)(2007-9#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-12#2)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
the correct direction##2##3##(2007-11#1)(2008-8#1)
the correct disulfide##3##3##(1996-7#1)(2008-4#2)
the correct dosage##2##3##(2008-12#1)(2008-8#1)
the correct identification of##2##4##(2008-10#1)(2010-12#1)
the correct management of##4##4##(2007-7#1)(2008-1#1)(2009-8#1)(2012-2#1)
the correct management##5##3##(2007-7#1)(2008-1#1)(2009-2#1)(2009-8#1)(2012-2#1)
the correct method##2##3##(1990-3#1)(2011-2#1)
the correct name##2##3##(2008-3#1)(2013-7#1)
the correct phase key##2##4##(2008-3#2)
the correct phase##3##3##(2008-3#3)
the correct placement of##2##4##(2007-8#1)(2008-7#1)
the correct position for##2##4##(1990-5#1)(1995-5#1)
the correct position##3##3##(1990-5#1)(1995-5#1)(2007-7#1)
the correct positioning of the##3##5##(1992-7#1)(2007-7#1)(2013-1#1)
the correct sequence##2##3##(2005-11#1)(2008-4#1)
the correct specification of##2##4##(2007-4#1)(2013-1#1)
the correct structure is found by repeating the GMDS for several close##2##12##(2008-4#2)
the correct structure must (by definition) accept all of the silent amino acid substitutions##2##14##(2008-4#2)
the correct structure##5##3##(2008-4#4)(2008-9#1)
the correct topology##2##3##(1992-1#1)(1992-12#1)
the correct treatment##2##3##(2006-6#1)(2010-4#1)
the correct use of##9##4##(1990-4#1)(1993-8#1)(1994-9#1)(2007-8#1)(2008-11#1)(2008-4#2)(2008-9#1)(2009-4#1)
the correct value##3##3##(2008-10#1)(2008-2#2)
the correct##214##2##(1990-1#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#3)(1990-6#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-1#2)(1992-12#1)(1992-2#2)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#2)(1993-8#2)(1994-11#1)(1994-12#2)(1994-3#2)(1994-9#1)(1995-4#1)(1995-5#1)(1995-6#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-5#2)(2005-10#1)(2005-11#3)(2005-8#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-2#2)(2006-6#3)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#3)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#10)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#8)(2008-3#9)(2008-4#10)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#7)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#5)(2010-3#1)(2010-4#2)(2010-8#1)(2011-2#10)(2012-11#2)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#6)(2013-7#2)(2013-8#2)
the corrected##12##2##(1993-12#1)(1994-6#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#1)
the correcting##2##2##(2007-12#1)(2013-8#1)
the correction and##2##3##(2007-11#1)(2008-10#1)
the correction device##2##3##(2008-2#1)(2008-3#1)
the correction of a##2##4##(1995-8#1)(2008-3#1)
the correction of the base angle##2##6##(2007-7#1)(2008-6#1)
the correction of the##10##4##(1997-1#2)(2007-7#2)(2008-1#1)(2008-3#2)(2008-6#1)(2009-10#1)(2013-1#1)
the correction of##43##3##(1995-12#1)(1995-8#1)(1996-12#1)(1997-1#2)(1997-8#2)(2005-1#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#3)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#12)(2008-6#1)(2009-10#3)(2010-11#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
the correction##65##2##(1995-12#1)(1995-8#1)(1996-12#1)(1997-1#4)(1997-8#2)(2005-1#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-7#4)(2008-1#1)(2008-10#4)(2008-2#10)(2008-3#15)(2008-6#1)(2009-10#3)(2009-4#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#3)
the corrections##2##2##(2008-2#1)(2009-4#1)
the corrective##4##2##(1990-5#1)(1993-1#1)(1994-8#1)(2013-1#1)
the correctly##2##2##(2006-12#2)
the correctness of the##5##4##(2007-8#1)(2008-2#2)(2013-1#2)
the correctness of##6##3##(2007-8#1)(2008-2#2)(2013-1#3)
the correctness##7##2##(2007-8#1)(2008-2#2)(2009-5#1)(2013-1#3)
the correlated##5##2##(1993-6#1)(2008-10#1)(2008-8#1)(2010-12#1)(2013-8#1)
the correlates of##6##3##(1992-11#1)(1993-1#1)(1995-3#1)(2006-3#1)(2008-8#1)(2012-3#1)
the correlation among##2##3##(1993-6#1)(2010-3#1)
the correlation between clinical##2##4##(1997-7#1)(2008-8#1)
the correlation between fellow eyes##2##5##(1994-5#2)
the correlation between laminin 332##3##5##(2013-8#3)
the correlation between p53##2##4##(2006-6#1)(2008-5#1)
the correlation between the in vitro##2##6##(1997-7#1)(2008-5#1)
the correlation between the##34##4##(1991-1#1)(1992-9#1)(1993-11#1)(1994-9#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-6#1)(1996-9#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-2#4)(2008-3#2)(2008-5#1)(2008-6#2)(2009-10#1)(2010-9#1)(2011-1#1)(2012-3#2)(2013-1#1)(2013-8#2)
the correlation between##111##3##(1991-1#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1994-2#1)(1994-5#2)(1994-6#2)(1994-9#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#2)(2005-7#1)(2005-8#1)(2006-10#2)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#8)(2008-6#3)(2008-7#3)(2008-8#3)(2009-10#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#4)(2013-1#1)(2013-8#6)
the correlation coefficient of 0##2##5##(2008-10#2)
the correlation coefficient of the##2##5##(1995-6#1)(2008-10#1)
the correlation coefficient of##6##4##(1995-6#1)(2008-10#4)(2011-1#1)
the correlation coefficient was 0##3##5##(1990-12#1)(2012-12#1)(2013-8#1)
the correlation coefficient was higher##2##5##(1996-11#1)(2008-3#1)
the correlation coefficient was##7##4##(1990-12#1)(1996-11#1)(2008-10#1)(2008-3#1)(2011-1#1)(2012-12#1)(2013-8#1)
the correlation coefficient##21##3##(1990-12#1)(1993-5#1)(1995-4#1)(1995-6#1)(1996-11#1)(2005-9#1)(2006-10#1)(2008-10#6)(2008-3#2)(2011-1#2)(2011-3#1)(2012-12#2)(2013-8#1)
the correlation coefficients (r2)##2##4##(1996-3#1)(2013-8#1)
the correlation coefficients of##4##4##(2005-12#1)(2008-10#1)(2011-1#2)
the correlation coefficients were##2##4##(2008-10#1)(2011-1#1)
the correlation coefficients##17##3##(1992-3#1)(1996-3#1)(2005-12#1)(2007-8#1)(2008-10#6)(2011-1#4)(2012-12#2)(2013-8#1)
the correlation fringe##2##3##(2008-2#2)
the correlation function##7##3##(2007-8#1)(2008-3#6)
the correlation is##2##3##(1991-2#1)(1993-9#1)
the correlation length of the##3##5##(2007-12#1)(2008-3#2)
the correlation length##4##3##(2007-12#2)(2008-3#2)
the correlation of disease status of plants##2##7##(2008-10#2)
the correlation of the two##2##5##(1995-2#1)(1995-4#1)
the correlation of the##12##4##(1992-2#1)(1995-2#1)(1995-4#1)(2007-10#2)(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-8#1)
the correlation of two##2##4##(2008-3#1)(2012-2#1)
the correlation of##47##3##(1990-12#1)(1990-2#1)(1992-2#1)(1992-3#1)(1994-3#1)(1995-2#1)(1995-4#1)(1996-11#1)(1996-6#1)(1997-2#1)(2005-12#1)(2006-1#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#3)(2013-7#1)(2013-8#1)
the correlation peak##4##3##(2008-2#3)(2008-3#1)
the correlation time function##3##4##(2008-3#3)
the correlation time##7##3##(1992-8#1)(2008-10#2)(2008-3#4)
the correlation was not##2##4##(2006-7#1)(2007-8#1)
the correlation was##5##3##(2006-7#1)(2007-8#1)(2008-10#1)(2009-8#1)(2012-2#1)
the correlation with the##2##4##(2007-7#1)(2008-10#1)
the correlation with##4##3##(1995-4#1)(2007-7#1)(2007-8#1)(2008-10#1)
the correlation##267##2##(1990-12#2)(1990-2#1)(1991-1#1)(1991-2#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#2)(1993-5#1)(1993-6#2)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#3)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#4)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#1)(1996-3#2)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#2)(2004-11#2)(2005-12#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#5)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-10#5)(2007-11#2)(2007-12#7)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#5)(2008-1#2)(2008-10#27)(2008-11#1)(2008-12#3)(2008-2#16)(2008-3#25)(2008-4#2)(2008-5#9)(2008-6#3)(2008-7#5)(2008-8#5)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#13)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#7)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#9)
the correlation-peak##2##2##(2008-2#1)(2008-3#1)
the correlational##4##2##(1991-3#1)(2007-9#2)(2009-1#1)
the correlations among##2##3##(1997-3#1)(2007-12#1)
the correlations and the##2##4##(2008-3#1)(2008-6#1)
the correlations between NaCl and other##2##6##(2009-10#2)
the correlations between the##3##4##(2012-3#1)(2013-8#2)
the correlations between##17##3##(1993-12#1)(1995-2#1)(2007-2#1)(2008-10#1)(2008-12#1)(2009-10#2)(2010-3#1)(2012-3#1)(2012-4#1)(2013-1#2)(2013-7#1)(2013-8#4)
the correlations were##2##3##(2006-4#1)(2007-10#1)
the correlations##32##2##(1993-12#1)(1995-2#1)(1997-3#1)(2005-11#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-6#2)(2009-10#2)(2009-11#1)(2010-3#1)(2010-4#1)(2012-3#2)(2012-4#1)(2013-1#2)(2013-7#2)(2013-8#4)
the correlative##4##2##(2008-10#1)(2008-3#1)(2008-9#1)(2011-3#1)
the correlator##9##2##(2007-12#2)(2008-2#2)(2008-3#5)
the correlograms##2##2##(1996-4#1)(2008-3#1)
the corresponded##4##2##(2008-11#4)
the correspondence between##3##3##(1997-8#1)(2008-5#1)(2011-1#1)
the correspondence of##2##3##(2008-12#1)(2012-1#1)
the correspondence##7##2##(1997-8#1)(2008-12#1)(2008-5#1)(2008-6#2)(2011-1#1)(2012-1#1)
the correspondent##2##2##(1993-1#1)(2008-2#1)
the corresponding 1##5##3##(1997-2#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-5#1)
the corresponding 3-keto##2##3##(1996-5#1)(1996-6#1)
the corresponding FT-IR spectra##2##4##(2007-8#1)(2008-10#1)
the corresponding FTIR spectrum##2##4##(2008-10#2)
the corresponding FTIR##3##3##(2008-10#3)
the corresponding N##3##3##(1995-2#1)(2007-11#1)(2013-8#1)
the corresponding RNAs##2##3##(1995-6#1)(2008-10#1)
the corresponding acids##2##3##(1996-6#1)(2008-10#1)
the corresponding alcohols##2##3##(2007-10#1)(2008-5#1)
the corresponding amines in##2##4##(1995-6#1)(2006-12#1)
the corresponding amines##4##3##(1995-6#1)(1996-10#1)(2005-8#1)(2006-12#1)
the corresponding amino acid in##2##5##(1994-12#1)(1995-8#1)
the corresponding amino acid sequence##3##5##(1990-2#1)(1994-12#1)(1995-8#1)
the corresponding amino acid##6##4##(1990-2#1)(1994-12#2)(1995-7#1)(1995-8#2)
the corresponding amino##7##3##(1990-2#1)(1994-12#2)(1995-7#1)(1995-8#2)(2007-11#1)
the corresponding average##2##3##(1996-3#1)(2010-12#1)
the corresponding avirulence gene##2##4##(2008-10#2)
the corresponding binary complexes##2##4##(2008-10#1)(2008-5#1)
the corresponding binary##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
the corresponding bulk##3##3##(2008-3#2)(2008-7#1)
the corresponding cDNA##7##3##(1991-1#1)(1991-2#1)(1991-9#1)(1993-2#1)(1995-6#1)(1996-5#1)(2008-10#1)
the corresponding carboxylic acids##2##4##(1996-10#1)(2007-10#1)
the corresponding carboxylic##3##3##(1996-10#1)(2007-10#1)(2008-10#1)
the corresponding cell##2##3##(1990-5#1)(2008-10#1)
the corresponding chloride##2##3##(1993-4#1)(2013-7#1)
the corresponding chlorinated##2##3##(2008-3#2)
the corresponding complex##2##3##(2008-10#2)
the corresponding complexes##2##3##(1993-9#1)(1997-7#1)
the corresponding control##3##3##(1990-5#1)(2007-11#1)(2010-4#1)
the corresponding controls##4##3##(1990-4#2)(1995-8#1)(2006-6#1)
the corresponding endogenous##2##3##(1992-8#1)(2008-9#1)
the corresponding enzymes##3##3##(1990-5#1)(1997-3#1)(2009-8#1)
the corresponding figures were##2##4##(1993-9#1)(2004-2#1)
the corresponding figures##3##3##(1993-9#1)(2004-2#1)(2011-1#1)
the corresponding free##3##3##(1994-12#1)(1997-2#1)(2006-10#1)
the corresponding gene from##2##4##(1990-6#1)(2009-8#1)
the corresponding gene in the##2##5##(1997-2#1)(2013-1#1)
the corresponding gene in##4##4##(1997-2#1)(2010-12#1)(2011-1#1)(2013-1#1)
the corresponding gene##19##3##(1990-11#1)(1990-6#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-9#1)(1995-6#1)(1995-8#1)(1997-2#2)(1997-6#1)(2008-5#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#2)
the corresponding genes in##2##4##(1996-4#1)(2008-8#1)
the corresponding genes##14##3##(1993-6#1)(1994-12#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-4#1)(1997-6#1)(2006-12#1)(2008-10#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
the corresponding high##2##3##(1993-7#1)(1995-11#1)
the corresponding human##4##3##(1990-4#1)(1993-11#1)(1997-6#1)(2007-1#1)
the corresponding hydrides##2##3##(2008-10#2)
the corresponding idler##2##3##(2007-12#1)(2008-3#1)
the corresponding logical definition##2##4##(2013-1#2)
the corresponding mRNA##5##3##(1994-12#1)(1995-4#1)(1996-7#1)(1996-9#1)(2011-2#1)
the corresponding mean##2##3##(2007-12#1)(2010-7#1)
the corresponding model##2##3##(1995-1#1)(2007-11#1)
the corresponding monoclonal##2##3##(1997-4#1)(2008-10#1)
the corresponding mouse##3##3##(1992-9#1)(1995-8#1)(2012-1#1)
the corresponding normal##2##3##(1994-2#1)(2007-8#1)
the corresponding nucleoside##2##3##(1991-7#1)(2007-11#1)
the corresponding optical##2##3##(2007-12#1)(2008-2#1)
the corresponding output##2##3##(2008-2#1)(2008-3#1)
the corresponding parent##3##3##(1991-9#1)(1994-5#1)(2008-4#1)
the corresponding part of##3##4##(1992-4#1)(1993-6#1)(2009-10#1)
the corresponding part##4##3##(1992-4#1)(1993-6#1)(2005-10#1)(2009-10#1)
the corresponding phosphatidylcholine##2##3##(1992-5#1)(1992-6#1)
the corresponding plasma##2##3##(1991-12#1)(1996-3#1)
the corresponding position##3##3##(1990-11#1)(1993-3#1)(1996-8#1)
the corresponding product##2##3##(1990-11#1)(2008-2#1)
the corresponding protein##7##3##(1990-12#1)(1990-7#1)(1991-12#1)(1991-7#1)(1994-5#1)(1997-2#1)(2008-8#1)
the corresponding proteins from##2##4##(1990-11#1)(1996-2#1)
the corresponding proteins##7##3##(1990-11#1)(1990-9#1)(1996-2#1)(1997-3#1)(2008-10#1)(2009-8#1)(2011-2#1)
the corresponding quenching##2##3##(2008-10#2)
the corresponding rat sequence##2##4##(1996-10#1)(2008-7#1)
the corresponding rat##3##3##(1991-1#1)(1996-10#1)(2008-7#1)
the corresponding rates##3##3##(1995-9#1)(2008-11#1)(2008-7#1)
the corresponding ratio##2##3##(1992-4#1)(2008-8#1)
the corresponding reduction##2##3##(2008-5#1)(2010-5#1)
the corresponding region of##3##4##(1990-12#1)(1995-12#1)(1997-1#1)
the corresponding region##5##3##(1990-12#1)(1991-6#1)(1995-12#1)(1997-1#1)(2007-11#1)
the corresponding regions in##3##4##(1995-7#1)(2008-7#1)(2009-3#1)
the corresponding regions of the##3##5##(1992-6#1)(1996-5#1)(2008-10#1)
the corresponding regions of##6##4##(1992-6#1)(1994-12#1)(1996-5#1)(1997-2#1)(1997-5#1)(2008-10#1)
the corresponding regions##10##3##(1992-6#1)(1994-12#2)(1995-7#1)(1996-5#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-7#1)(2009-3#1)
the corresponding residue##2##3##(1994-9#1)(2006-12#1)
the corresponding residues##4##3##(1990-10#1)(1994-8#2)(1996-9#1)
the corresponding resistance gene##2##4##(2008-10#2)
the corresponding results##2##3##(2008-10#1)(2008-5#1)
the corresponding semicarbazones##2##3##(2007-11#2)
the corresponding sense##3##3##(1993-5#1)(1994-10#1)(2008-7#1)
the corresponding sequence##3##3##(1995-3#1)(2012-2#1)(2012-3#1)
the corresponding six##2##3##(1995-3#1)(2008-10#1)
the corresponding solution##2##3##(2008-10#1)(2008-9#1)
the corresponding steps for##2##4##(2008-2#2)
the corresponding target##2##3##(1993-4#1)(2008-8#1)
the corresponding tumor##2##3##(1994-7#1)(2007-8#1)
the corresponding value##5##3##(1990-8#1)(1991-9#1)(2007-11#1)(2008-3#1)(2011-1#1)
the corresponding values for##5##4##(1991-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-4#1)
the corresponding values in the bulk sediments##2##7##(2008-10#2)
the corresponding values in the##4##5##(2008-10#2)(2008-2#1)(2008-5#1)
the corresponding values of##3##4##(1990-7#1)(1991-4#1)(2009-9#1)
the corresponding values predicted by##2##5##(2008-2#2)
the corresponding values##16##3##(1990-7#1)(1991-2#1)(1991-4#1)(1992-12#1)(1994-11#1)(2008-10#3)(2008-2#4)(2008-3#1)(2008-5#1)(2009-9#1)(2010-4#1)
the corresponding wild-type strains##2##4##(1995-4#1)(2011-2#1)
the corresponding wild-type##4##3##(1995-4#1)(2006-12#1)(2008-10#1)(2011-2#1)
the corresponding##813##2##(1990-10#1)(1990-11#7)(1990-12#5)(1990-2#1)(1990-3#3)(1990-4#7)(1990-5#5)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#3)(1991-1#3)(1991-10#1)(1991-12#3)(1991-2#9)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#4)(1991-7#4)(1991-8#3)(1991-9#8)(1992-1#1)(1992-11#3)(1992-12#5)(1992-2#5)(1992-3#1)(1992-4#2)(1992-5#2)(1992-6#4)(1992-7#1)(1992-8#3)(1992-9#3)(1993-11#3)(1993-12#2)(1993-2#3)(1993-3#5)(1993-4#3)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#3)(1993-9#5)(1994-10#1)(1994-11#5)(1994-12#12)(1994-2#2)(1994-3#3)(1994-5#5)(1994-6#4)(1994-7#1)(1994-8#7)(1994-9#7)(1995-1#2)(1995-10#1)(1995-11#5)(1995-12#1)(1995-2#6)(1995-3#12)(1995-4#3)(1995-5#2)(1995-6#7)(1995-7#4)(1995-8#11)(1995-9#2)(1996-1#1)(1996-10#6)(1996-11#2)(1996-12#1)(1996-2#6)(1996-3#5)(1996-4#2)(1996-5#17)(1996-6#6)(1996-7#5)(1996-8#5)(1996-9#2)(1997-1#2)(1997-2#14)(1997-3#5)(1997-4#5)(1997-5#1)(1997-6#4)(1997-7#6)(1997-8#2)(2004-1#1)(2004-11#2)(2004-12#1)(2004-2#1)(2004-9#1)(2005-10#2)(2005-11#5)(2005-4#4)(2005-7#1)(2005-8#5)(2006-10#3)(2006-12#20)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#6)(2007-10#11)(2007-11#55)(2007-12#8)(2007-2#3)(2007-3#1)(2007-5#1)(2007-6#2)(2007-8#10)(2007-9#2)(2008-1#2)(2008-10#90)(2008-11#4)(2008-12#2)(2008-2#30)(2008-3#27)(2008-4#16)(2008-5#14)(2008-6#1)(2008-7#11)(2008-8#10)(2008-9#4)(2009-10#7)(2009-12#2)(2009-2#1)(2009-3#3)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#6)(2009-9#1)(2010-11#2)(2010-12#6)(2010-2#4)(2010-4#4)(2010-5#9)(2010-6#7)(2010-7#2)(2010-8#2)(2011-1#8)(2011-2#12)(2012-1#5)(2012-11#2)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#8)(2013-7#2)(2013-8#6)
the corridors##2##2##(2006-11#1)(2006-12#1)
the corrosion inhibition##2##3##(2013-1#2)
the corrosion##13##2##(2004-9#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2010-4#1)(2012-2#1)(2013-1#2)
the corrugated structure##2##3##(2008-3#2)
the corrugated##4##2##(2007-12#1)(2008-3#3)
the corrupted##2##2##(2008-2#2)
the corruption of##2##3##(2008-11#1)(2013-1#1)
the cortex and hippocampus##6##4##(1990-7#1)(1993-11#1)(1993-2#1)(1994-2#1)(1995-7#1)(2013-1#1)
the cortex and nucleus##2##4##(1991-9#1)(1997-8#1)
the cortex and##18##3##(1990-7#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-2#1)(1993-4#1)(1994-2#1)(1995-5#1)(1995-6#1)(1995-7#2)(1997-5#1)(1997-8#1)(2007-9#1)(2008-1#1)(2008-9#1)(2012-12#1)(2013-1#1)
the cortex during##2##3##(2008-5#1)(2008-9#1)
the cortex in the##4##4##(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)
the cortex in vivo##3##4##(1996-3#3)
the cortex in##7##3##(1996-3#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)
the cortex is##3##3##(2008-11#2)(2013-7#1)
the cortex of sour orange##2##5##(2008-10#2)
the cortex of the##9##4##(1992-9#1)(1995-6#1)(1997-6#1)(2006-11#1)(2007-7#1)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#1)
the cortex of trifoliate orange##2##5##(2008-10#2)
the cortex of##16##3##(1992-9#2)(1995-6#1)(1996-5#1)(1997-6#1)(2006-11#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-9#1)(2010-4#1)(2011-2#1)
the cortex or hippocampus##2##4##(1991-9#1)(1996-1#1)
the cortex to##4##3##(2008-11#2)(2008-5#1)(2010-2#1)
the cortex were##3##3##(1994-5#1)(1995-6#1)(1996-9#1)
the cortex##135##2##(1990-11#1)(1990-12#1)(1990-7#2)(1990-9#1)(1991-12#1)(1991-5#3)(1991-8#1)(1991-9#3)(1992-10#2)(1992-11#1)(1992-12#1)(1992-7#2)(1992-8#1)(1992-9#2)(1993-11#2)(1993-2#2)(1993-4#5)(1993-7#3)(1994-2#3)(1994-5#1)(1995-10#1)(1995-11#1)(1995-5#2)(1995-6#3)(1995-7#4)(1996-1#1)(1996-12#3)(1996-3#6)(1996-5#1)(1996-9#2)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#3)(2005-7#1)(2006-11#1)(2007-1#1)(2007-10#3)(2007-7#1)(2007-9#4)(2008-1#1)(2008-10#8)(2008-11#13)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#1)(2008-9#5)(2009-10#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
the cortical activity and##2##4##(2010-7#1)(2013-1#1)
the cortical and basal##2##4##(1991-10#2)
the cortical and medullary##2##4##(1996-10#1)(2008-5#1)
the cortical and subcortical##2##4##(2012-2#2)
the cortical and##6##3##(1991-10#2)(1996-10#1)(2008-5#1)(2012-2#2)
the cortical bone##2##3##(2004-9#1)(2013-1#1)
the cortical cells of##3##4##(2008-10#3)
the cortical input to the##2##5##(1992-7#1)(1996-2#1)
the cortical parenchyma##2##3##(1996-6#2)
the cortical region##2##3##(2008-11#1)(2010-7#1)
the cortical sulci##2##3##(2008-7#1)(2010-12#1)
the cortical tissue##3##3##(1996-12#1)(2008-10#1)(2008-11#1)
the cortical veins##4##3##(2006-5#1)(2007-10#2)(2008-7#1)
the cortical##83##2##(1990-9#2)(1991-10#2)(1991-11#1)(1991-3#1)(1992-7#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1995-12#3)(1995-3#1)(1995-7#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#3)(1996-6#2)(1996-9#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-9#1)(2006-10#1)(2006-5#2)(2007-10#3)(2007-12#3)(2007-9#2)(2008-10#5)(2008-11#6)(2008-5#2)(2008-7#5)(2008-9#1)(2009-10#1)(2009-5#1)(2010-12#2)(2010-7#3)(2011-1#1)(2012-12#2)(2012-2#4)(2013-1#2)
the cortices##2##2##(2008-4#2)
the corticoid##3##2##(1997-2#1)(2010-12#1)(2010-3#1)
the corticomedullary##5##2##(1994-5#1)(2008-4#4)
the corticosteroid##4##2##(1997-8#1)(2006-4#1)(2006-8#1)(2013-7#1)
the corticosteroids##2##2##(2011-2#1)(2013-7#1)
the corticosterone##4##2##(1990-2#1)(1994-6#1)(1995-5#1)(2013-1#1)
the corticotropin-releasing factor##3##3##(1990-3#1)(1995-1#1)(1997-5#1)
the corticotropin-releasing##4##2##(1990-3#1)(1995-1#1)(1995-12#1)(1997-5#1)
the cortisol awakening##3##3##(2008-11#1)(2013-1#2)
the cortisol concentrations##3##3##(2008-5#1)(2008-7#1)(2013-1#1)
the cortisol level##2##3##(2006-2#1)(2011-2#1)
the cortisol response to 1-24 corticotropin##3##6##(2006-2#3)
the cortisol response to##4##4##(1996-2#1)(2006-2#3)
the cortisol response##5##3##(1996-2#1)(2006-2#3)(2006-3#1)
the cortisol##14##2##(1992-5#1)(1996-2#1)(2006-2#4)(2006-3#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#3)
the cos site##2##3##(1996-2#2)
the cos##6##2##(1990-11#3)(1996-2#2)(1996-8#1)
the cosine of the##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
the cosine##6##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)
the cosmetic field##2##3##(2008-5#2)
the cosmetic industry##7##3##(2006-12#1)(2008-5#6)
the cosmetic needs##2##3##(2008-5#2)
the cosmetic outcome##2##3##(1993-9#1)(1996-3#1)
the cosmetic##29##2##(1991-2#1)(1993-9#1)(1994-12#1)(1996-3#1)(2006-12#3)(2007-12#1)(2008-5#17)(2010-8#2)(2012-12#2)
the cosmetics##4##2##(2007-7#1)(2008-5#3)
the cosmic microwave background##2##4##(1994-5#1)(2008-2#1)
the cosmic##4##2##(1991-3#1)(1994-5#1)(1997-5#1)(2008-2#1)
the cosmid##6##2##(1994-2#1)(1995-8#1)(1995-9#1)(1997-2#1)(1997-3#1)(2008-6#1)
the cosmogonic hypothesis##2##3##(2008-12#2)
the cosmopolitan##2##2##(2008-10#1)(2008-12#1)
the cost and size of##2##5##(2008-3#1)(2010-11#1)
the cost and the##3##4##(1992-5#1)(1995-10#1)(2008-2#1)
the cost and##16##3##(1990-12#1)(1991-3#1)(1992-5#1)(1995-10#1)(1996-1#1)(1996-12#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-11#1)(2010-8#1)
the cost containment effects of payment systems##2##7##(1990-12#2)
the cost effectiveness of a##2##5##(1992-2#1)(2007-11#1)
the cost effectiveness of the##2##5##(2008-4#1)(2012-12#1)
the cost effectiveness of##10##4##(1992-2#1)(2006-12#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-8#1)(2012-12#1)
the cost for##3##3##(1991-3#1)(2006-6#1)(2008-7#1)
the cost is##3##3##(2008-8#1)(2010-9#1)(2012-2#1)
the cost of a drug##2##5##(1995-1#1)(1996-2#1)
the cost of a##11##4##(1995-1#2)(1996-2#1)(2007-2#1)(2007-8#1)(2008-3#1)(2008-8#2)(2012-12#2)(2012-2#1)
the cost of an additional##2##5##(2008-10#2)
the cost of back injuries##2##5##(2007-11#2)
the cost of cancer##2##4##(1995-10#1)(2012-11#1)
the cost of care##3##4##(1996-12#1)(2010-8#2)
the cost of caring for##2##5##(1993-3#1)(1997-6#1)
the cost of each##2##4##(1990-2#1)(1991-9#1)
the cost of health care##4##5##(1993-7#1)(1995-3#1)(2006-10#1)(2013-8#1)
the cost of hospitalization##4##4##(2010-12#1)(2013-1#2)(2013-8#1)
the cost of nursing home care##2##6##(1995-2#1)(2010-8#1)
the cost of outpatient##2##4##(1995-12#1)(1995-2#1)
the cost of parasitism##2##4##(2008-8#2)
the cost of prescription drugs##2##5##(2008-11#2)
the cost of providing##3##4##(1993-1#1)(1995-1#1)(2008-2#1)
the cost of reproduction##2##4##(2008-8#1)(2013-1#1)
the cost of the procedure##2##5##(1995-12#1)(2006-10#1)
the cost of the##17##4##(1993-1#2)(1995-12#1)(1996-5#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-4#1)(2012-12#1)(2013-1#1)(2013-8#1)
the cost of their##2##4##(2010-12#1)(2013-8#1)
the cost of these##2##4##(2007-9#1)(2011-2#1)
the cost of transporting##2##4##(2008-5#2)
the cost of treating##2##4##(1994-3#1)(1995-6#1)
the cost of water fluoridation##3##5##(2006-8#3)
the cost of##146##3##(1990-11#1)(1990-2#1)(1990-6#1)(1991-9#1)(1992-12#3)(1992-2#1)(1993-1#4)(1993-2#1)(1993-3#1)(1993-7#1)(1994-1#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-1#3)(1995-10#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#4)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#9)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#10)(2008-9#4)(2009-10#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-8#5)(2011-1#3)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#1)(2013-1#4)(2013-8#4)
the cost per##4##3##(1992-2#1)(1992-5#1)(1997-2#1)(2011-2#1)
the cost to##6##3##(2006-5#1)(2006-6#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-9#1)
the cost##213##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-6#1)(1991-3#2)(1991-9#1)(1992-12#5)(1992-2#3)(1992-5#2)(1993-1#4)(1993-2#1)(1993-3#1)(1993-7#1)(1994-1#1)(1994-10#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-1#4)(1995-10#3)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#3)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-7#1)(2006-10#2)(2006-12#3)(2006-2#1)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#6)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#10)(2008-2#10)(2008-3#5)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#13)(2008-9#6)(2009-10#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-8#7)(2010-9#2)(2011-1#3)(2011-2#4)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#2)(2013-1#5)(2013-8#4)
the cost-benefit##3##2##(2006-2#1)(2006-6#1)(2009-8#1)
the cost-containment##2##2##(1990-12#1)(1992-1#1)
the cost-effective##4##2##(1993-3#1)(1996-11#1)(2006-11#1)(2012-12#1)
the cost-effectiveness of a run-in##2##5##(1993-1#2)
the cost-effectiveness of a##4##4##(1993-1#3)(2006-5#1)
the cost-effectiveness of advanced cancer imaging##2##6##(2008-2#2)
the cost-effectiveness of the##3##4##(1996-6#1)(2006-2#1)(2011-2#1)
the cost-effectiveness of##24##3##(1990-12#1)(1993-1#4)(1996-12#1)(1996-6#1)(2005-12#1)(2006-10#2)(2006-2#1)(2006-5#2)(2008-10#1)(2008-2#2)(2008-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#2)
the cost-effectiveness rate##2##3##(2008-5#2)
the cost-effectiveness##30##2##(1990-12#1)(1993-1#4)(1993-2#1)(1996-12#1)(1996-6#1)(2005-12#1)(2006-10#2)(2006-2#1)(2006-5#2)(2008-10#1)(2008-2#2)(2008-5#2)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#3)
the cost/benefit ratio##2##3##(1991-3#1)(2007-7#1)
the cost/benefit##3##2##(1991-3#2)(2007-7#1)
the costimulatory##4##2##(1995-6#1)(2006-10#1)(2007-11#1)(2008-9#1)
the costing##2##2##(1993-3#1)(1996-9#1)
the costly##3##2##(1991-6#1)(1993-11#1)(2008-11#1)
the costs and benefits##3##4##(1994-12#1)(2008-6#1)(2013-1#1)
the costs and rewards of diabetes and its##2##8##(2010-9#2)
the costs and the##3##4##(2006-10#1)(2008-10#1)(2008-9#1)
the costs and##14##3##(1993-12#1)(1994-12#1)(1994-2#1)(2004-1#1)(2006-10#1)(2007-9#1)(2008-10#2)(2008-6#1)(2008-9#1)(2010-8#1)(2010-9#2)(2013-1#1)
the costs associated with##9##4##(1994-2#1)(1997-3#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-5#1)
the costs of care##4##4##(1995-12#1)(1996-12#1)(2012-11#1)(2013-8#1)
the costs of connecting##2##4##(2011-2#2)
the costs of control##2##4##(2008-10#2)
the costs of health care##2##5##(2008-11#1)(2012-1#1)
the costs of health##3##4##(1997-8#1)(2008-11#1)(2012-1#1)
the costs of medical##2##4##(2007-7#1)(2007-8#1)
the costs of providing##3##4##(1994-2#1)(1995-2#1)(2011-2#1)
the costs of the##6##4##(1990-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-2#1)(2010-9#1)
the costs of this##3##4##(1993-10#1)(2007-1#1)(2008-11#1)
the costs of treating##2##4##(1995-6#1)(2004-1#1)
the costs of treatment##3##4##(2006-5#1)(2008-11#1)(2008-5#1)
the costs of##79##3##(1990-12#1)(1990-8#1)(1990-9#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-10#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#2)(1997-1#1)(1997-8#2)(2004-1#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-4#3)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#8)(2008-9#5)(2009-2#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#1)(2013-1#2)(2013-8#1)
the costs##117##2##(1990-12#1)(1990-8#1)(1990-9#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-10#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#2)(2004-1#2)(2005-8#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#3)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#6)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#9)(2008-9#6)(2009-2#1)(2009-5#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#3)(2011-1#2)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#3)(2013-8#1)
the cotransfection of##3##3##(1993-8#1)(2008-4#2)
the cotransfection##4##2##(1993-8#1)(2008-11#1)(2008-4#2)
the cotransporter##3##2##(1991-4#2)(2008-8#1)
the cotton leafworm##2##3##(2010-10#1)(2013-8#1)
the cotton##11##2##(2006-11#1)(2008-10#3)(2009-3#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-8#1)
the cotton-top tamarin (Saguinus oedipus)##2##5##(1994-2#2)
the cotyledon##2##2##(2008-10#2)
the cotyledonary##3##2##(1991-12#1)(2008-10#1)(2013-8#1)
the cotyledons##5##2##(1990-10#1)(1994-8#1)(2008-10#2)(2013-8#1)
the couch and##2##3##(2007-7#1)(2011-2#1)
the couch##5##2##(2007-7#1)(2011-2#4)
the cough##3##2##(1993-11#1)(1994-10#1)(2008-1#1)
the coulombic interactions##2##3##(2008-10#2)
the counseling##4##2##(1995-9#1)(2006-4#1)(2011-1#1)(2012-12#1)
the counselor##2##2##(2007-3#1)(2008-12#1)
the counselors'##2##2##(2008-6#2)
the count of##6##3##(1992-2#1)(2008-4#3)(2010-12#1)(2012-1#1)
the count##8##2##(1992-2#1)(2007-6#1)(2008-4#3)(2010-12#1)(2010-2#1)(2012-1#1)
the counter drugs##2##3##(1996-3#1)(2008-7#1)
the counter electrode##2##3##(2008-10#2)
the counter##18##2##(1995-5#1)(1996-3#3)(1996-5#1)(2006-12#1)(2006-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#4)(2010-5#1)
the counteracting of the##2##4##(2007-9#1)(2008-8#1)
the counterintuitive##2##2##(2007-9#1)(2008-8#1)
the counterion##8##2##(1994-9#1)(1995-1#1)(2005-11#5)(2008-10#1)
the counterpart##4##2##(1993-8#1)(1994-11#1)(2007-10#1)(2008-9#1)
the counterparts of##2##3##(2008-10#1)(2008-4#1)
the counterparts##3##2##(2008-10#1)(2008-4#1)(2008-8#1)
the counterpropagating##3##2##(2007-11#2)(2008-3#1)
the counties##5##2##(1995-5#1)(2005-5#1)(2010-9#3)
the counting##6##2##(1996-12#1)(2008-10#2)(2012-1#2)(2013-8#1)
the countries of the##2##4##(2005-5#1)(2006-10#1)
the countries of##5##3##(2005-5#1)(2006-10#1)(2007-7#1)(2010-4#1)(2011-2#1)
the countries with the##2##4##(1995-5#1)(2007-3#1)
the countries with##3##3##(1990-12#1)(1995-5#1)(2007-3#1)
the countries##21##2##(1990-12#1)(1990-4#1)(1991-4#1)(1995-5#1)(1996-9#1)(2005-5#1)(2006-10#1)(2007-11#1)(2007-3#2)(2007-7#1)(2008-8#1)(2010-3#1)(2010-4#2)(2010-5#1)(2011-2#3)(2012-11#1)(2012-3#1)
the country and##7##3##(1991-6#1)(1996-1#1)(2006-10#1)(2008-1#1)(2008-2#1)(2011-2#1)(2013-1#1)
the country are##5##3##(1991-12#1)(1992-2#1)(1995-2#1)(2009-12#1)(2011-2#1)
the country as##4##3##(1994-1#1)(1996-4#1)(2005-10#1)(2008-1#1)
the country by the##2##4##(1997-6#1)(2013-1#1)
the country by##3##3##(1997-6#1)(2010-8#1)(2013-1#1)
the country had##2##3##(2007-10#1)(2011-1#1)
the country has##4##3##(1994-3#1)(2006-10#1)(2006-5#1)(2008-4#1)
the country in##4##3##(1997-6#1)(2008-1#1)(2008-8#1)(2009-10#1)
the country is##5##3##(1991-5#1)(1994-1#1)(1995-3#1)(2007-10#1)(2009-6#1)
the country level##3##3##(2011-2#1)(2013-1#2)
the country of##2##3##(1992-8#1)(2005-10#1)
the country to##3##3##(1996-12#1)(2008-11#1)(2012-3#1)
the country was##2##3##(2004-2#1)(2011-2#1)
the country were##3##3##(2008-12#1)(2010-12#1)(2012-12#1)
the country with the##3##4##(1997-1#1)(2007-11#1)(2013-1#1)
the country with##7##3##(1993-5#2)(1997-1#1)(2007-11#1)(2007-7#1)(2007-9#1)(2013-1#1)
the country##166##2##(1990-12#1)(1991-12#1)(1991-5#2)(1991-6#3)(1992-2#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-5#2)(1994-1#2)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-4#1)(1997-1#1)(1997-2#1)(1997-6#5)(1997-8#1)(2004-2#1)(2004-4#1)(2005-10#2)(2005-11#1)(2006-10#4)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#3)(2007-4#1)(2007-7#5)(2007-8#2)(2007-9#4)(2008-1#4)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#3)(2009-5#1)(2009-6#3)(2010-1#1)(2010-12#2)(2010-8#4)(2010-9#3)(2011-1#4)(2011-11#1)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#11)(2013-7#2)
the country's health##2##3##(1997-6#1)(1997-7#1)
the country's##19##2##(1995-12#1)(1997-6#1)(1997-7#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-11#1)(2010-8#1)(2012-3#1)(2013-1#1)
the country)##2##2##(1992-6#1)(2012-2#1)
the counts obtained##2##3##(2007-2#1)(2012-2#1)
the counts of CFU##2##4##(2013-7#2)
the counts of##6##3##(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2013-7#2)
the counts##12##2##(1990-2#1)(1996-3#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-1#1)(2012-2#1)(2013-7#2)(2013-8#1)
the county to##2##3##(1992-2#1)(1997-3#1)
the county##23##2##(1990-4#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-11#1)(1992-2#1)(1993-3#3)(1993-5#1)(1993-6#2)(1994-11#1)(1996-12#1)(1996-4#1)(1996-9#2)(1997-3#1)(2008-8#1)(2010-9#1)(2011-1#1)
the couple##9##2##(1992-3#1)(1993-2#1)(1996-4#1)(1996-9#1)(1997-5#1)(2007-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
the couple's##4##2##(2007-7#1)(2009-4#1)(2012-2#1)(2013-1#1)
the coupled enzyme##2##3##(1992-7#1)(2008-10#1)
the coupled reactions of##2##4##(1997-2#1)(2008-10#1)
the coupled system##5##3##(1996-8#1)(2007-12#1)(2008-10#2)(2008-2#1)
the coupled##32##2##(1992-7#1)(1993-3#2)(1994-12#1)(1994-6#1)(1995-9#1)(1996-1#1)(1996-7#2)(1996-8#1)(1997-2#1)(2006-10#1)(2007-11#3)(2007-12#3)(2008-10#6)(2008-2#3)(2008-3#1)(2009-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
the coupled-dipole approximation##3##3##(2008-1#2)(2008-3#1)
the coupled-dipole method##2##3##(2008-3#2)
the coupled-dipole##5##2##(2008-1#2)(2008-3#3)
the coupled-local-mode##2##2##(2008-3#2)
the coupled-mode theory and##2##4##(2007-12#1)(2008-2#1)
the coupled-mode theory##5##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
the coupled-mode##8##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#4)
the coupled-resonator optical waveguide (CROW)##2##5##(2007-11#1)(2007-12#1)
the coupled-resonator optical##3##3##(2007-11#1)(2007-12#2)
the coupled-wave equations##2##3##(2008-2#1)(2008-3#1)
the coupled-wave##3##2##(2008-2#2)(2008-3#1)
the coupler in##2##3##(2007-11#1)(2008-3#1)
the coupler##17##2##(2007-11#3)(2007-12#3)(2008-2#7)(2008-3#4)
the coupler's##3##2##(2007-12#3)
the couples##7##2##(1994-7#1)(1996-9#2)(2007-2#1)(2012-11#1)(2012-2#1)(2013-8#1)
the coupling among##3##3##(1990-8#1)(1995-11#1)(2008-3#1)
the coupling between the fundamental core mode and the cladding modes##2##11##(2008-2#2)
the coupling between the##7##4##(2005-11#1)(2005-4#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-7#1)
the coupling between##14##3##(1991-1#1)(1991-7#1)(1992-11#1)(1997-5#1)(2005-11#1)(2005-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)
the coupling coefficient##4##3##(2007-11#1)(2008-3#2)(2013-8#1)
the coupling coefficients##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
the coupling efficiency and##3##4##(2008-2#1)(2008-3#2)
the coupling efficiency of a##3##5##(2008-2#2)(2008-3#1)
the coupling efficiency of##4##4##(1992-9#1)(2008-2#2)(2008-3#1)
the coupling efficiency##13##3##(1992-9#1)(2007-12#1)(2008-2#7)(2008-3#4)
the coupling ion##2##3##(1997-7#2)
the coupling is##2##3##(2008-2#1)(2008-3#1)
the coupling length##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
the coupling loss##2##3##(2008-3#2)
the coupling mechanism##2##3##(2005-10#2)
the coupling of a##3##4##(2007-12#1)(2008-10#2)
the coupling of an##3##4##(2008-10#2)(2008-3#1)
the coupling of light between two fiber waveguides##2##8##(2008-2#1)(2008-3#1)
the coupling of light##3##4##(2008-2#1)(2008-3#2)
the coupling of the##5##4##(1991-5#1)(1996-8#1)(1997-8#1)(2008-3#1)(2008-8#1)
the coupling of##39##3##(1990-7#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-5#1)(1993-9#1)(1994-12#1)(1996-8#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-12#3)(2008-10#10)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-2#1)
the coupling procedure has been performed##3##6##(2008-2#1)(2008-4#2)
the coupling process##2##3##(1995-3#1)(2013-8#1)
the coupling ratio##2##3##(1994-8#1)(2008-2#1)
the coupling reaction##4##3##(1990-9#1)(2008-4#3)
the coupling region##2##3##(2008-2#1)(2008-3#1)
the coupling strength##2##3##(2007-12#1)(2008-3#1)
the coupling##132##2##(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-7#3)(1997-8#1)(2005-10#3)(2005-11#1)(2005-4#1)(2006-12#1)(2007-11#6)(2007-12#13)(2008-1#1)(2008-10#16)(2008-2#19)(2008-3#21)(2008-4#8)(2008-5#1)(2008-7#3)(2008-8#1)(2009-11#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2013-8#2)
the course and outcome##2##4##(2007-2#1)(2007-7#1)
the course and##15##3##(1995-5#1)(2006-10#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-11#5)(2008-4#1)(2008-9#1)(2012-12#1)
the course in##2##3##(2008-11#1)(2012-12#1)
the course is##10##3##(2006-10#8)(2010-12#1)(2010-7#1)
the course of 1 year##2##5##(2005-1#1)(2008-10#1)
the course of 24 months##2##5##(2005-11#1)(2008-10#1)
the course of 3 years##2##5##(1993-8#1)(2006-6#1)
the course of a single##2##5##(2008-8#1)(2012-2#1)
the course of a systemic##2##5##(1990-6#1)(2009-2#1)
the course of a year##2##5##(2008-9#1)(2010-8#1)
the course of a##26##4##(1990-6#1)(1990-7#1)(1991-3#1)(1991-5#1)(1991-9#1)(1994-2#1)(1995-3#1)(1995-9#1)(1996-6#1)(2005-11#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-8#1)(2012-2#2)
the course of acute##2##4##(2008-7#1)(2013-1#1)
the course of an investigation of##2##6##(2007-7#1)(2007-9#1)
the course of an investigation##3##5##(1991-5#1)(2007-7#1)(2007-9#1)
the course of an##7##4##(1990-9#1)(1991-5#1)(2006-8#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)
the course of bipolar##2##4##(2005-6#1)(2013-7#1)
the course of both##2##4##(1990-2#1)(2012-2#1)
the course of brain injury##2##5##(1996-9#1)(2008-8#1)
the course of chemotherapy##2##4##(2006-6#1)(2007-11#1)
the course of chronic##4##4##(1990-6#1)(2009-4#1)(2011-2#1)(2013-7#1)
the course of clinical care##2##5##(2008-12#1)(2008-7#1)
the course of development##2##4##(2007-11#1)(2007-8#1)
the course of disease##8##4##(2006-1#1)(2006-10#1)(2007-10#1)(2007-8#1)(2011-2#2)(2012-3#1)(2013-7#1)
the course of distraction osteogenesis##2##5##(2007-8#2)
the course of evolution##3##4##(1992-6#1)(1995-8#1)(1997-6#1)
the course of experimental##2##4##(2010-12#2)
the course of his disease##2##5##(2013-1#2)
the course of human##2##4##(1994-8#1)(2012-2#1)
the course of illness##4##4##(1997-3#1)(2007-2#1)(2008-7#1)(2012-3#1)
the course of infection##4##4##(2006-8#1)(2008-4#1)(2008-5#1)(2008-9#1)
the course of its##3##4##(1992-12#1)(2008-11#1)(2008-5#1)
the course of malignant##3##4##(1990-12#1)(1990-5#1)(2011-2#1)
the course of medical##2##4##(1996-12#1)(2007-11#1)
the course of multiple##4##4##(1994-9#1)(2008-1#1)(2009-12#1)(2012-2#1)
the course of numerous##3##4##(2005-10#1)(2007-11#1)(2007-7#1)
the course of our##4##4##(1996-8#1)(2008-11#1)(2008-2#1)(2012-3#1)
the course of pregnancy##5##4##(1995-12#1)(2012-3#4)
the course of recovery##3##4##(1993-9#1)(2007-7#1)(2012-1#1)
the course of rehabilitation##3##4##(2007-11#1)(2007-8#2)
the course of respiration##5##4##(1996-6#5)
the course of rheumatoid arthritis##3##5##(2007-11#1)(2013-1#2)
the course of schizophrenia##2##4##(1990-11#1)(2011-2#1)
the course of the European##2##5##(1995-4#1)(1995-7#1)
the course of the disease and##3##6##(2006-8#1)(2007-8#1)(2008-1#1)
the course of the disease in##2##6##(1991-4#1)(2007-2#1)
the course of the disease with##2##6##(2006-10#1)(2008-7#1)
the course of the disease##41##5##(1990-6#1)(1990-8#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-11#1)(1993-1#1)(1993-11#1)(1993-12#1)(1996-12#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#3)(2008-9#1)(2009-8#2)(2011-1#1)(2012-12#1)(2012-2#1)
the course of the epidemic##2##5##(1996-5#1)(2008-10#1)
the course of the experiment##4##5##(2004-11#1)(2008-10#2)(2008-7#1)
the course of the illness##3##5##(1992-11#1)(2008-11#1)(2012-2#1)
the course of the last##3##5##(1991-11#1)(2007-11#1)(2012-12#1)
the course of the outbreak and##2##6##(2011-3#1)(2013-1#1)
the course of the procedure##2##5##(2007-7#1)(2007-8#1)
the course of the reaction##2##5##(1991-5#1)(1993-9#1)
the course of the study##9##5##(1991-10#1)(1992-1#1)(2006-10#1)(2006-8#1)(2008-10#3)(2008-7#1)(2013-1#1)
the course of the titration##2##5##(2008-10#2)
the course of the##134##4##(1990-11#1)(1990-4#2)(1990-6#2)(1990-8#2)(1991-10#4)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-3#1)(1994-4#1)(1994-5#1)(1995-3#1)(1995-4#1)(1995-7#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-4#2)(1997-8#1)(2004-1#1)(2004-11#1)(2005-11#2)(2005-8#1)(2006-10#3)(2006-2#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#5)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#6)(2008-8#1)(2008-9#5)(2009-2#2)(2009-8#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#3)
the course of their disease##3##5##(1990-1#1)(2008-10#1)(2010-11#1)
the course of their illness##3##5##(2006-10#1)(2007-2#1)(2013-1#1)
the course of their##18##4##(1990-1#1)(1991-12#1)(1994-4#1)(1995-3#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-12#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)(2012-3#1)(2013-1#1)
the course of therapy##9##4##(1991-10#1)(2005-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-8#1)(2012-2#2)(2013-1#1)
the course of these investigations##2##5##(1993-12#1)(2006-12#1)
the course of these studies##3##5##(1993-11#1)(2008-10#1)(2008-8#1)
the course of these##8##4##(1993-11#1)(1993-12#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2012-12#1)
the course of this study##4##5##(1991-8#1)(1996-3#1)(2008-10#2)
the course of this##9##4##(1991-8#1)(1995-4#1)(1996-12#1)(1996-3#1)(2005-10#1)(2006-4#1)(2008-10#2)(2011-2#1)
the course of treatment and##2##5##(1996-9#1)(2008-12#1)
the course of treatment for##2##5##(2007-7#1)(2008-4#1)
the course of treatment in both##2##6##(1996-7#1)(2007-8#1)
the course of treatment in##3##5##(1996-7#1)(2007-8#1)(2010-11#1)
the course of treatment##19##4##(1991-12#1)(1991-6#1)(1992-3#1)(1995-9#1)(1996-2#1)(1996-7#1)(1996-9#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-4#1)(2009-11#1)(2010-11#1)(2012-2#2)(2013-7#1)(2013-8#1)
the course of two years##2##5##(1995-5#1)(2012-2#1)
the course of two##4##4##(1995-11#1)(1995-5#1)(2007-12#1)(2012-2#1)
the course of##531##3##(1990-1#1)(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#1)(1990-4#2)(1990-5#2)(1990-6#6)(1990-7#1)(1990-8#3)(1990-9#1)(1991-10#6)(1991-11#3)(1991-12#3)(1991-3#4)(1991-4#1)(1991-5#3)(1991-6#2)(1991-8#5)(1991-9#7)(1992-1#2)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#4)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#5)(1993-5#2)(1993-6#2)(1993-8#2)(1993-9#5)(1994-12#1)(1994-2#2)(1994-3#1)(1994-4#2)(1994-5#4)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#5)(1995-4#3)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#2)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#4)(1996-4#1)(1996-5#1)(1996-6#7)(1996-7#1)(1996-8#3)(1996-9#3)(1997-3#2)(1997-4#3)(1997-6#3)(1997-8#1)(1997-9#1)(2004-1#1)(2004-11#1)(2005-1#1)(2005-10#7)(2005-11#6)(2005-12#3)(2005-4#1)(2005-6#1)(2005-8#2)(2006-1#1)(2006-10#9)(2006-12#4)(2006-2#3)(2006-4#1)(2006-5#1)(2006-6#6)(2006-8#8)(2007-1#2)(2007-10#5)(2007-11#19)(2007-12#11)(2007-2#5)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#14)(2007-8#21)(2007-9#3)(2008-1#4)(2008-10#31)(2008-11#14)(2008-12#6)(2008-2#5)(2008-3#1)(2008-4#6)(2008-5#6)(2008-6#4)(2008-7#13)(2008-8#6)(2008-9#11)(2009-11#2)(2009-12#4)(2009-2#4)(2009-3#1)(2009-4#2)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#6)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#3)(2011-1#3)(2011-12#2)(2011-2#19)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#18)(2012-3#10)(2013-1#14)(2013-7#5)(2013-8#5)
the course was##3##3##(1995-5#1)(2008-11#1)(2013-1#1)
the course##622##2##(1990-1#1)(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#1)(1990-4#2)(1990-5#2)(1990-6#6)(1990-7#1)(1990-8#3)(1990-9#1)(1991-10#6)(1991-11#3)(1991-12#3)(1991-3#4)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#5)(1991-9#7)(1992-1#2)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#4)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#5)(1993-5#2)(1993-6#2)(1993-8#2)(1993-9#5)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-4#3)(1994-5#4)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-3#5)(1995-4#3)(1995-5#4)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#2)(1996-3#4)(1996-4#1)(1996-5#1)(1996-6#7)(1996-7#1)(1996-8#3)(1996-9#3)(1997-3#2)(1997-4#3)(1997-6#3)(1997-8#1)(1997-9#1)(2004-1#1)(2004-11#1)(2005-1#1)(2005-10#10)(2005-11#6)(2005-12#3)(2005-4#1)(2005-6#1)(2005-8#2)(2006-1#1)(2006-10#18)(2006-12#5)(2006-2#3)(2006-4#3)(2006-5#2)(2006-6#6)(2006-8#9)(2007-1#2)(2007-10#5)(2007-11#21)(2007-12#12)(2007-2#8)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#17)(2007-8#22)(2007-9#3)(2008-1#4)(2008-10#32)(2008-11#36)(2008-12#8)(2008-2#5)(2008-3#1)(2008-4#7)(2008-5#7)(2008-6#5)(2008-7#13)(2008-8#6)(2008-9#12)(2009-11#2)(2009-12#4)(2009-2#4)(2009-3#1)(2009-4#2)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#8)(2010-2#1)(2010-3#4)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#4)(2011-12#2)(2011-2#22)(2011-3#1)(2012-1#3)(2012-12#9)(2012-2#19)(2012-3#10)(2013-1#15)(2013-7#5)(2013-8#9)
the course's##2##2##(1996-12#1)(2007-11#1)
the courses##5##2##(1991-2#1)(2007-8#1)(2008-11#1)(2012-12#1)(2013-1#1)
the court determined that##2##4##(1993-2#1)(1993-7#1)
the court found that the##2##5##(1991-7#1)(1996-2#1)
the court found##3##3##(1991-10#1)(1991-7#1)(1996-2#1)
the court held##2##3##(1991-6#1)(1994-12#1)
the court to##3##3##(1996-11#1)(1996-2#1)(2006-5#1)
the court##29##2##(1990-11#2)(1990-2#1)(1991-10#1)(1991-6#1)(1991-7#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#1)(1994-12#1)(1995-12#1)(1995-6#2)(1996-11#2)(1996-2#2)(1996-5#1)(1996-6#2)(1997-4#1)(2005-8#1)(2006-4#1)(2006-5#1)(2007-10#1)(2008-11#1)(2009-4#1)(2010-10#1)
the courtroom##4##2##(2006-10#1)(2006-8#1)(2008-10#1)(2013-8#1)
the courts and##2##3##(1996-1#1)(2008-9#1)
the courts##17##2##(1991-3#1)(1992-12#1)(1992-3#1)(1993-2#1)(1996-1#1)(1996-2#1)(2005-8#1)(2005-9#1)(2006-3#3)(2007-3#1)(2007-4#1)(2008-9#1)(2011-2#1)(2012-3#2)
the courtship##3##2##(1990-11#1)(2008-6#2)
the covalency##2##2##(1997-7#2)
the covalent attachment of the##2##5##(1997-4#1)(2013-1#1)
the covalent attachment of##4##4##(1996-5#1)(1997-4#1)(2008-5#1)(2013-1#1)
the covalent binding of##7##4##(1994-5#1)(1995-1#1)(1995-7#2)(1996-11#1)(2005-11#1)(2008-10#1)
the covalent binding##8##3##(1994-5#1)(1995-1#1)(1995-7#2)(1996-11#1)(1996-8#1)(2005-11#1)(2008-10#1)
the covalent linkage of##3##4##(1992-6#1)(1994-3#1)(2008-11#1)
the covalent linkage##5##3##(1990-3#1)(1992-6#1)(1994-3#1)(1995-6#1)(2008-11#1)
the covalent modification of##3##4##(1991-2#1)(2008-2#1)(2008-4#1)
the covalent reaction##2##3##(1992-9#1)(1996-11#1)
the covalent##35##2##(1990-3#1)(1991-2#1)(1991-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1994-3#1)(1994-5#2)(1995-1#2)(1995-2#1)(1995-6#1)(1995-7#2)(1996-11#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-4#1)(2004-9#1)(2005-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
the covalently attached benzo[c]phenanthrenyl ring to##2##6##(1995-1#2)
the covalently attached##7##3##(1991-7#1)(1995-1#2)(1995-6#1)(1996-7#3)
the covalently bound fatty acids##2##5##(1990-10#1)(2008-5#1)
the covalently bound##4##3##(1990-10#1)(1990-7#1)(2008-5#2)
the covalently##16##2##(1990-10#1)(1990-7#1)(1991-7#1)(1995-1#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-7#3)(1997-2#1)(1997-6#1)(2008-5#2)(2010-4#1)
the covariables##2##2##(1995-4#1)(1995-9#1)
the covariance matrix of the##4##5##(1992-6#1)(1993-5#1)(2008-2#1)(2009-4#1)
the covariance matrix##8##3##(1992-6#1)(1993-5#1)(1993-6#1)(1997-3#1)(2008-2#1)(2008-9#1)(2009-4#2)
the covariance of the##2##4##(1997-3#1)(2008-2#1)
the covariance structure##2##3##(1992-9#1)(1994-6#1)
the covariance##17##2##(1992-6#1)(1992-9#1)(1993-5#1)(1993-6#2)(1994-6#1)(1995-4#1)(1997-3#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-9#1)(2009-4#2)
the covariates are##2##3##(1995-6#1)(2009-5#1)
the covariates that##2##3##(2008-8#1)(2009-2#1)
the covariates##17##2##(1994-2#1)(1995-6#3)(1996-7#1)(1997-4#1)(1997-6#1)(2008-8#3)(2009-2#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
the covariation##2##2##(2008-8#1)(2009-4#1)
the cover glass##5##3##(2008-1#2)(2008-11#3)
the cover of##2##3##(2008-1#1)(2011-2#1)
the cover##12##2##(2008-1#3)(2008-10#1)(2008-11#3)(2008-2#3)(2011-2#1)(2012-2#1)
the coverage and##2##3##(2009-8#1)(2013-1#1)
the coverage of the##8##4##(1993-9#1)(1996-1#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-3#1)(2009-3#1)(2011-2#1)
the coverage of##11##3##(1993-9#1)(1996-1#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-3#1)(2011-2#3)
the coverage probability of##2##4##(2008-10#2)
the coverage probability##4##3##(1995-9#1)(2008-10#3)
the coverage rate##2##3##(2012-12#1)(2012-3#1)
the coverage reduction##2##3##(2008-10#2)
the coverage##36##2##(1990-12#1)(1991-6#1)(1993-3#1)(1993-9#1)(1995-9#1)(1996-1#1)(1996-5#1)(2004-9#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-7#1)(2009-3#1)(2009-8#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#1)
the covered indications for##2##4##(2007-4#2)
the covered##4##2##(1991-1#1)(1996-12#1)(2007-4#2)
the covering##2##2##(2008-10#1)(2013-7#1)
the coverslip##2##2##(2007-12#1)(2008-11#1)
the covert##2##2##(2006-4#1)(2012-1#1)
the cow##6##2##(1996-11#1)(2004-11#3)(2005-7#1)(2006-5#1)
the cows##6##2##(1990-6#2)(1991-3#2)(1991-8#1)(2006-5#1)
the coxa and##2##3##(2007-12#1)(2008-5#1)
the coxa##5##2##(2007-12#2)(2008-5#1)(2010-11#2)
the coxal##2##2##(2007-12#2)
the coxibs##3##2##(2007-12#2)(2008-11#1)
the crab Chasmagnathus##2##3##(1996-9#2)
the crab##9##2##(1996-5#2)(1996-9#2)(2008-10#1)(2008-5#1)(2008-6#1)(2010-4#1)(2013-7#1)
the crabzone##4##2##(2008-5#4)
the crack phenomena at a##2##5##(2009-7#2)
the crack propagation##2##3##(1991-8#1)(2009-7#1)
the crack tip##2##3##(2008-8#1)(2009-7#1)
the crack##16##2##(1991-8#1)(2005-10#1)(2008-2#3)(2008-3#1)(2008-8#1)(2009-6#1)(2009-7#5)(2010-4#2)(2012-2#1)
the cranes##2##2##(1990-9#1)(1997-4#1)
the cranial and##3##3##(2007-10#1)(2007-2#1)(2008-7#1)
the cranial base##2##3##(2007-12#2)
the cranial nerves##6##3##(1991-10#1)(2006-12#1)(2008-1#3)(2012-3#1)
the cranial part of the##2##5##(1997-4#1)(2007-8#1)
the cranial vault##3##3##(2007-12#3)
the cranial##31##2##(1991-10#1)(1994-2#1)(1995-11#1)(1995-4#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-12#2)(2006-7#3)(2007-10#1)(2007-12#6)(2007-2#1)(2007-8#1)(2008-1#3)(2008-5#1)(2008-7#1)(2010-12#1)(2012-3#1)(2013-8#1)
the craniocervical junction##8##3##(2006-5#1)(2006-9#2)(2007-12#1)(2011-2#4)
the craniocervical##12##2##(2006-5#2)(2006-9#2)(2007-11#2)(2007-12#1)(2011-2#4)(2012-12#1)
the craniofacial bones##2##3##(2008-6#1)(2011-2#1)
the craniofacial region of##2##4##(1996-6#1)(2008-9#1)
the craniofacial region##6##3##(1996-6#1)(2007-12#1)(2008-9#3)(2012-2#1)
the craniofacial team##2##3##(2007-12#2)
the craniofacial##18##2##(1996-6#1)(2007-12#5)(2008-4#1)(2008-6#1)(2008-9#3)(2010-6#4)(2011-2#1)(2012-12#1)(2012-2#1)
the craniospinal axis##3##3##(1994-4#1)(1994-7#1)(2006-12#1)
the craniospinal##5##2##(1994-4#1)(1994-7#1)(2006-12#1)(2007-10#2)
the craniotomy##2##2##(2008-7#2)
the cranioventral abdomen##2##3##(1993-1#2)
the cranioventral##3##2##(1993-1#3)
the craniovertebral junction and##2##4##(2006-9#2)
the craniovertebral junction##4##3##(2006-9#3)(2013-1#1)
the cranium and face##2##4##(2007-12#1)(2010-6#1)
the cranium##16##2##(1995-10#1)(1996-9#2)(2007-11#1)(2007-12#2)(2007-5#1)(2008-11#1)(2008-7#3)(2009-6#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
the crater lakes##2##3##(2013-1#2)
the crayfish##2##2##(1992-8#1)(2008-7#1)
the cream##6##2##(2006-10#1)(2008-5#4)(2008-8#1)
the creams##3##2##(2008-5#3)
the creatinine clearance##3##3##(1992-7#1)(2006-10#1)(2008-8#1)
the creatinine correction approach##2##4##(2011-2#2)
the creatinine correction##3##3##(2011-2#3)
the creatinine##9##2##(1992-7#1)(1995-3#1)(2006-10#1)(2008-10#2)(2008-8#1)(2011-2#3)
the creation and##8##3##(1997-3#1)(2006-4#1)(2007-12#1)(2009-4#1)(2013-1#4)
the creation of a new##4##5##(2007-11#1)(2008-10#2)(2010-1#1)
the creation of a##43##4##(1991-3#1)(1992-6#1)(1994-3#1)(1995-1#1)(1997-2#3)(1997-3#1)(2005-10#1)(2005-12#1)(2005-5#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#3)(2009-11#1)(2010-1#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#3)(2012-3#2)(2013-1#4)
the creation of an online clinical tasks ontology##2##8##(2013-1#2)
the creation of an##3##4##(1996-12#1)(2013-1#2)
the creation of health##2##4##(1994-12#1)(2008-1#1)
the creation of more##2##4##(2009-10#1)(2010-12#1)
the creation of national##3##4##(2008-12#1)(2013-1#2)
the creation of new##7##4##(1996-12#1)(1997-6#1)(2005-7#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-7#1)
the creation of the##19##4##(1993-9#1)(2006-10#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-2#2)(2008-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-2#1)(2012-3#1)
the creation of truly portable##2##5##(2008-10#2)
the creation of##143##3##(1990-4#1)(1990-5#1)(1991-3#1)(1992-1#1)(1992-4#1)(1992-6#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-7#1)(1996-12#3)(1997-1#2)(1997-2#3)(1997-3#2)(1997-6#2)(2005-10#1)(2005-12#1)(2005-5#1)(2005-7#1)(2006-10#3)(2006-11#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-4#2)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#12)(2008-11#8)(2008-12#2)(2008-2#5)(2008-3#5)(2008-4#2)(2008-5#2)(2008-7#9)(2008-8#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2010-1#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#9)(2013-8#1)
the creation##154##2##(1990-4#1)(1990-5#1)(1991-3#1)(1992-1#1)(1992-4#1)(1992-6#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-7#1)(1996-12#3)(1997-1#2)(1997-2#3)(1997-3#3)(1997-6#2)(2005-10#1)(2005-12#1)(2005-5#1)(2005-7#1)(2006-10#3)(2006-11#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-4#3)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#12)(2008-11#8)(2008-12#2)(2008-2#5)(2008-3#5)(2008-4#2)(2008-5#2)(2008-7#9)(2008-8#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#1)(2010-1#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#13)(2013-8#1)
the creative arts therapies##2##4##(1994-12#1)(1995-1#1)
the creative process##2##3##(1995-1#1)(2010-7#1)
the creative##9##2##(1994-12#1)(1994-3#1)(1995-1#3)(1996-1#1)(1997-1#1)(2008-12#1)(2010-7#1)
the creativity##2##2##(2007-4#1)(2008-7#1)
the creator of##2##3##(2009-2#1)(2013-1#1)
the credentialing##4##2##(1991-12#2)(1991-3#1)(1992-1#1)
the credibility of##3##3##(2006-5#1)(2007-5#2)
the credibility##4##2##(2006-5#1)(2007-5#2)(2011-2#1)
the credit##3##2##(1993-1#1)(2008-2#1)(2013-8#1)
the creep function##2##3##(2006-7#2)
the creep##5##2##(2004-9#1)(2006-7#2)(2009-4#1)(2009-7#1)
the crevice between##2##3##(1995-1#1)(2008-10#1)
the crevice##3##2##(1995-1#1)(2008-10#1)(2008-2#1)
the crew##3##2##(1992-6#1)(2006-10#1)(2011-2#1)
the cribriform plate##3##3##(2008-11#1)(2009-5#1)(2011-2#1)
the cricket##2##2##(2007-12#1)(2008-5#1)
the crime##4##2##(1993-3#1)(1996-11#1)(2004-12#1)(2008-10#1)
the criminal justice system##10##4##(1996-1#2)(1997-2#1)(2006-11#1)(2008-11#3)(2009-11#1)(2012-2#1)(2013-7#1)
the criminal justice##11##3##(1996-1#3)(1997-2#1)(2006-11#1)(2008-11#3)(2009-11#1)(2012-2#1)(2013-7#1)
the criminal##17##2##(1996-1#3)(1996-6#1)(1997-2#1)(2006-11#1)(2006-4#1)(2008-11#3)(2009-11#1)(2009-7#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-7#1)
the crisis of##4##3##(1994-4#1)(1995-8#1)(2011-1#1)(2013-1#1)
the crisis##19##2##(1993-12#1)(1994-3#1)(1994-4#1)(1995-5#1)(1995-8#1)(1996-8#1)(1997-5#1)(2006-4#1)(2007-2#1)(2007-9#1)(2008-2#4)(2011-1#1)(2013-1#1)(2013-7#1)(2013-8#2)
the crista galli##2##3##(2006-12#2)
the crista##3##2##(2006-12#2)(2007-8#1)
the cristae##5##2##(2005-8#4)(2008-7#1)
the criteria adopted##2##3##(2008-7#1)(2013-1#1)
the criteria and##5##3##(1992-3#1)(2008-2#1)(2008-5#1)(2011-2#1)(2013-1#1)
the criteria are##4##3##(1997-8#1)(2007-8#1)(2008-2#2)
the criteria established by the Agency for Healthcare Research and Quality (AHRQ)##2##12##(2006-8#2)
the criteria established by the##5##5##(2006-7#1)(2006-8#3)(2011-2#1)
the criteria for OCD##3##4##(1995-11#3)
the criteria for a##6##4##(1994-9#1)(2007-12#1)(2007-2#1)(2008-12#1)(2008-3#1)(2008-9#1)
the criteria for major##2##4##(2010-2#1)(2011-2#1)
the criteria for obtaining a disability##2##6##(1995-5#1)(1997-6#1)
the criteria for the diagnosis of##3##6##(1993-9#1)(2006-8#1)(2008-3#1)
the criteria for the##7##4##(1990-10#1)(1992-2#1)(1993-9#1)(2006-8#1)(2007-11#2)(2008-3#1)
the criteria for##58##3##(1990-10#1)(1992-11#1)(1992-2#2)(1993-6#1)(1993-9#1)(1994-9#1)(1995-11#3)(1995-2#1)(1995-5#2)(1995-7#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-7#1)(2006-2#3)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-2#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-4#1)(2010-11#2)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#3)
the criteria of a##2##4##(2005-9#1)(2006-8#1)
the criteria of the##11##4##(1991-9#1)(2006-6#2)(2006-8#1)(2007-7#1)(2008-3#2)(2008-4#1)(2010-12#1)(2011-2#1)(2013-8#1)
the criteria of##46##3##(1990-11#1)(1991-3#1)(1991-9#1)(1992-2#1)(1992-4#1)(1995-3#1)(1995-4#1)(1997-2#1)(1997-8#1)(2004-1#1)(2005-12#1)(2005-5#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-6#2)(2006-8#2)(2007-2#1)(2007-7#2)(2007-9#2)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
the criteria proposed##2##3##(2006-11#1)(2008-3#1)
the criteria that##3##3##(2008-3#1)(2008-7#1)(2013-1#1)
the criteria used for##2##4##(2008-1#1)(2010-5#1)
the criteria used to define##2##5##(2010-7#1)(2012-11#1)
the criteria used to##6##4##(1993-12#1)(1996-3#1)(1997-2#1)(2008-4#1)(2010-7#1)(2012-11#1)
the criteria used##9##3##(1993-12#1)(1996-3#1)(1997-2#1)(2007-5#1)(2008-1#1)(2008-4#1)(2010-5#1)(2010-7#1)(2012-11#1)
the criteria with##2##3##(1991-3#1)(1992-2#1)
the criteria##162##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-6#1)(1991-11#1)(1991-3#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#4)(1992-3#1)(1992-4#1)(1992-8#1)(1993-12#2)(1993-6#1)(1993-9#1)(1994-9#1)(1995-11#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-7#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#3)(1997-6#1)(1997-8#4)(2004-1#1)(2004-11#1)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#3)(2006-6#2)(2006-7#2)(2006-8#6)(2007-11#3)(2007-12#2)(2007-2#2)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#10)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-3#1)(2009-4#2)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#3)(2010-5#2)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#8)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2013-1#9)(2013-8#1)
the criterion for##9##3##(1991-4#1)(1996-10#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-2#1)(2010-4#1)(2011-12#1)(2012-9#1)
the criterion of##7##3##(1990-9#1)(1991-2#1)(1993-1#1)(1995-8#1)(2006-8#1)(2010-2#2)
the criterion##22##2##(1990-9#1)(1991-11#1)(1991-2#1)(1991-4#1)(1993-1#1)(1995-8#1)(1996-10#1)(2006-11#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-8#1)(2010-2#3)(2010-4#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-9#1)(2013-1#1)
the criterion-related validity of##2##4##(1995-1#1)(2010-6#1)
the criterium##2##2##(1993-10#1)(2008-10#1)
the critical angle for##2##4##(2008-2#2)
the critical angle##13##3##(2008-2#3)(2008-3#10)
the critical appraisal##2##3##(2007-5#1)(2008-11#1)
the critical areas of##2##4##(1997-3#1)(2008-6#1)
the critical areas##3##3##(1997-3#1)(2008-6#1)(2011-1#1)
the critical aspects of##2##4##(2007-10#1)(2008-9#1)
the critical care unit##3##4##(2006-4#1)(2007-9#1)(2008-3#1)
the critical care##9##3##(1991-1#3)(1996-9#1)(2006-4#1)(2007-9#1)(2008-3#1)(2011-2#1)(2012-12#1)
the critical cis-acting##2##3##(1990-6#1)(2012-3#1)
the critical concentration of##3##4##(1994-5#1)(2008-6#1)(2010-2#1)
the critical concentration##7##3##(1992-3#1)(1993-8#1)(1994-5#1)(2008-10#1)(2008-6#1)(2010-2#2)
the critical current##2##3##(1993-8#1)(2008-7#1)
the critical depth of##3##4##(2008-10#3)
the critical depth##4##3##(2008-10#4)
the critical determinant of##2##4##(1992-9#1)(2009-5#1)
the critical dilution rate##2##4##(1997-2#1)(2008-7#1)
the critical effects##2##3##(1994-6#1)(2008-4#1)
the critical evaluation of##3##4##(2007-9#1)(2008-10#1)(2009-8#1)
the critical event##2##3##(2008-9#1)(2010-9#1)
the critical examination of the##2##5##(2008-10#1)(2008-11#1)
the critical examination of##3##4##(2006-10#1)(2008-10#1)(2008-11#1)
the critical factor in##2##4##(1990-12#1)(1995-8#1)
the critical factor##3##3##(1990-12#1)(1993-4#1)(1995-8#1)
the critical factors##4##3##(2008-1#1)(2008-9#1)(2011-1#1)(2012-12#1)
the critical first##2##3##(2006-10#1)(2008-4#1)
the critical importance of##5##4##(2007-4#1)(2008-11#1)(2008-5#1)(2012-12#1)(2012-2#1)
the critical information##2##3##(2008-5#1)(2010-7#1)
the critical issues##2##3##(2006-6#1)(2013-1#1)
the critical level of##2##4##(2006-1#1)(2008-7#1)
the critical level##3##3##(2006-1#1)(2008-11#1)(2008-7#1)
the critical loads##2##3##(2008-10#1)(2009-7#1)
the critical micellar concentration (CMC)##2##5##(1996-5#1)(2008-10#1)
the critical micellar concentration##3##4##(1996-5#1)(2005-11#1)(2008-10#1)
the critical micelle concentration (CMC) of##2##6##(2004-12#1)(2008-10#1)
the critical micelle concentration (CMC) was##2##6##(2007-11#1)(2011-1#1)
the critical micelle concentration (CMC)##4##5##(2004-12#1)(2007-11#1)(2008-10#1)(2011-1#1)
the critical micelle concentration (cmc)##3##5##(2005-11#2)(2008-10#1)
the critical micelle concentration for##2##5##(2008-10#2)
the critical micelle concentration##15##4##(1990-9#1)(1994-9#1)(2004-12#1)(2005-11#4)(2007-11#1)(2008-10#6)(2011-1#1)
the critical micellization concentration##3##4##(2005-11#3)
the critical need for##5##4##(1992-1#1)(1995-1#1)(2009-8#1)(2012-2#1)(2013-1#1)
the critical need##6##3##(1992-1#1)(1995-1#1)(1995-3#1)(2009-8#1)(2012-2#1)(2013-1#1)
the critical parameters##5##3##(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-2#1)
the critical period for the##3##5##(1993-2#1)(1994-3#1)(2012-2#1)
the critical period##8##3##(1992-1#1)(1993-12#1)(1993-2#1)(1994-3#1)(2011-2#1)(2012-2#3)
the critical point##2##3##(1994-4#1)(2008-3#1)
the critical points##4##3##(2007-12#3)(2013-1#1)
the critical power for self-focusing in##2##6##(2007-12#2)
the critical region##2##3##(1996-6#1)(1997-3#1)
the critical review of##2##4##(2006-2#1)(2008-11#1)
the critical role of the##3##5##(1996-5#1)(2011-1#1)(2012-3#1)
the critical role of##14##4##(1995-2#1)(1996-5#2)(1997-1#1)(1997-3#1)(1997-5#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-11#1)(2011-1#1)(2012-3#1)(2013-1#1)
the critical role##16##3##(1992-3#1)(1995-2#1)(1995-8#1)(1996-5#2)(1997-1#1)(1997-3#1)(1997-5#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-11#1)(2011-1#1)(2012-3#1)(2013-1#1)
the critical stages of##3##4##(1995-11#1)(2008-7#1)(2010-4#1)
the critical steps##4##3##(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)
the critical success factors##3##4##(1993-3#1)(2008-12#1)(2008-9#1)
the critical surface##2##3##(2005-11#1)(2008-5#1)
the critical thinking and##2##4##(2008-12#1)(2012-2#1)
the critical thinking##3##3##(2008-11#1)(2008-12#1)(2012-2#1)
the critical threshold##3##3##(2008-4#1)(2010-10#2)
the critical value##2##3##(2008-7#1)(2012-2#1)
the critical values##2##3##(2010-2#1)(2013-1#1)
the critical wavelength##3##3##(2008-5#3)
the critical##265##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-1#3)(1991-7#1)(1992-1#2)(1992-12#1)(1992-3#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-5#4)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-5#2)(2004-12#1)(2004-4#1)(2004-9#1)(2005-11#13)(2005-5#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#7)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#25)(2008-11#10)(2008-12#3)(2008-2#6)(2008-3#19)(2008-4#5)(2008-5#6)(2008-6#2)(2008-7#10)(2008-8#3)(2008-9#7)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#3)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#4)(2012-1#2)(2012-12#9)(2012-2#10)(2012-3#2)(2013-1#6)
the critically endangered Arakan forest turtle (Heosemys depressa)##2##8##(2013-1#2)
the critically ill patient and##2##5##(2008-11#1)(2008-8#1)
the critically ill patient##23##4##(2005-10#2)(2005-8#1)(2006-10#1)(2006-4#10)(2007-8#3)(2007-9#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-4#1)(2010-11#1)
the critically ill##34##3##(2005-10#2)(2005-8#2)(2006-10#2)(2006-4#13)(2007-8#4)(2007-9#2)(2008-11#1)(2008-3#1)(2008-8#2)(2009-4#1)(2010-11#1)(2011-2#1)(2012-12#2)
the critically##39##2##(2005-10#2)(2005-8#2)(2006-10#3)(2006-4#14)(2007-8#4)(2007-9#2)(2008-11#1)(2008-3#1)(2008-8#2)(2009-4#1)(2010-11#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#1)
the criticism##2##2##(2011-2#1)(2013-7#1)
the cromoglycate##2##2##(2008-10#2)
the crop and##2##3##(2008-5#1)(2008-8#1)
the crop contents##2##3##(2007-8#2)
the crop is##3##3##(2006-4#1)(2008-10#2)
the crop production system##2##4##(2008-10#2)
the crop##28##2##(1991-11#1)(2004-2#1)(2006-12#1)(2006-4#1)(2007-6#1)(2007-8#2)(2008-10#12)(2008-11#1)(2008-5#3)(2008-8#1)(2010-10#1)(2011-12#1)(2012-12#1)(2013-8#1)
the cropping season##2##3##(2008-10#2)
the cropping##5##2##(2008-10#5)
the cross between##7##3##(2008-10#6)(2012-3#1)
the cross clamp##2##3##(1996-9#2)
the cross correlation between##2##4##(1990-5#1)(2007-12#1)
the cross correlation##5##3##(1990-5#1)(2007-12#2)(2008-2#1)(2008-3#1)
the cross language##2##3##(2009-10#2)
the cross of the##3##4##(2008-10#2)(2012-11#1)
the cross of##8##3##(2008-10#7)(2012-11#1)
the cross section of##2##4##(2008-3#2)
the cross section##5##3##(2007-12#2)(2008-3#2)(2010-4#1)
the cross talk between##9##4##(1996-4#2)(2007-12#1)(2008-2#2)(2009-8#1)(2012-12#1)(2013-1#2)
the cross talk of##2##4##(2008-2#1)(2008-3#1)
the cross talk##15##3##(1996-4#2)(2007-12#1)(2008-2#5)(2008-3#2)(2009-12#1)(2009-8#1)(2012-12#1)(2013-1#2)
the cross##78##2##(1990-5#2)(1996-4#2)(1996-7#1)(1996-9#2)(2006-4#2)(2007-12#5)(2008-10#32)(2008-2#7)(2008-3#7)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#3)
the cross-ambiguity##2##2##(2008-2#2)
the cross-bridge cycle##2##3##(1992-3#1)(1995-6#1)
the cross-bridge##5##2##(1992-3#1)(1995-3#1)(1995-5#1)(1995-6#1)(2009-6#1)
the cross-correlation##3##2##(2008-2#1)(2008-3#2)
the cross-cultural##2##2##(2004-12#1)(2008-4#1)
the cross-leg##2##2##(2011-2#1)(2012-12#1)
the cross-link##4##2##(1995-1#1)(2011-1#1)(2012-12#1)(2013-8#1)
the cross-linked##9##2##(1990-8#1)(1992-3#1)(1992-9#1)(1995-1#1)(1995-6#3)(2010-4#2)
the cross-linker##3##2##(2008-10#1)(2010-4#1)(2013-8#1)
the cross-linking density##2##3##(2005-11#1)(2010-4#1)
the cross-linking of##4##3##(1990-8#1)(1991-7#1)(1994-9#1)(2007-12#1)
the cross-linking process##2##3##(1993-11#1)(2007-12#1)
the cross-linking reaction##4##3##(1992-3#1)(1994-5#1)(1995-8#2)
the cross-linking##23##2##(1990-11#1)(1990-8#1)(1991-7#1)(1992-3#1)(1993-11#2)(1993-8#1)(1994-5#1)(1994-9#2)(1995-6#1)(1995-8#2)(2005-11#1)(2007-12#2)(2008-10#1)(2008-5#2)(2010-4#1)(2012-3#1)(2013-1#2)
the cross-polarization##2##2##(2008-3#2)
the cross-polarized##2##2##(2007-12#1)(2008-3#1)
the cross-reactivity of##2##3##(1990-12#1)(2008-11#1)
the cross-reactivity##5##2##(1990-12#1)(1991-9#1)(2008-10#2)(2008-11#1)
the cross-section##5##2##(1992-7#1)(1992-9#1)(1993-9#1)(2005-11#1)(2006-10#1)
the cross-sectional area of##3##4##(1996-6#1)(2008-2#1)(2008-7#1)
the cross-sectional area##4##3##(1996-6#1)(2008-2#1)(2008-7#1)(2013-3#1)
the cross-sectional design of##2##4##(2009-10#1)(2012-5#1)
the cross-sectional design##3##3##(2009-10#1)(2010-2#1)(2012-5#1)
the cross-sectional##17##2##(1991-7#1)(1996-6#1)(1996-8#1)(2007-10#1)(2008-2#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2012-5#1)(2013-3#1)(2013-8#1)
the cross-spectral density##3##3##(2007-11#3)
the cross-talk between##4##3##(1996-8#1)(2008-7#1)(2009-10#1)(2009-8#1)
the cross-talk##5##2##(1996-8#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-8#1)
the cross-validated##2##2##(1995-6#1)(2009-3#1)
the cross-validation##9##2##(1992-2#1)(2008-10#1)(2009-3#1)(2010-3#1)(2010-8#3)(2011-3#1)(2012-3#1)
the crossed##3##2##(1991-9#1)(2008-2#2)
the crosses were##2##3##(2008-10#2)
the crosses##4##2##(2008-10#4)
the crossing of##3##3##(1996-2#1)(2007-11#1)(2009-4#1)
the crossing##6##2##(1993-8#1)(1996-2#1)(2007-11#1)(2009-4#1)(2011-1#1)(2012-11#1)
the crosslinked##3##2##(1995-2#1)(1997-6#1)(2008-5#1)
the crosslinking##3##2##(1991-2#1)(2008-10#1)(2008-4#1)
the crossmodal##2##2##(2012-2#2)
the crossover from##2##3##(2005-11#1)(2008-3#1)
the crossover##9##2##(1997-1#1)(2005-11#3)(2008-10#1)(2008-2#1)(2008-3#3)
the crossroads of##2##3##(2005-10#1)(2013-1#1)
the crossroads##4##2##(1996-1#1)(2005-10#1)(2007-8#1)(2013-1#1)
the crosstalk between##4##3##(2009-12#1)(2012-12#2)(2013-7#1)
the crosstalk##6##2##(2007-11#1)(2008-11#1)(2009-12#1)(2012-12#2)(2013-7#1)
the crown and##2##3##(2008-10#1)(2011-2#1)
the crown ether##5##3##(2008-10#5)
the crown of the##2##4##(2008-5#1)(2013-1#1)
the crown of##6##3##(2008-5#1)(2008-6#2)(2013-1#3)
the crown rust resistance gene##2##5##(2008-10#2)
the crown##26##2##(1996-6#1)(2007-1#2)(2007-12#1)(2008-10#10)(2008-5#2)(2008-6#2)(2008-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)
the crowns##4##2##(1990-11#1)(1995-9#1)(2008-10#1)(2013-1#1)
the crp##2##2##(1996-4#1)(1997-4#1)
the crucial points##2##3##(2006-6#1)(2008-7#1)
the crucial role of##10##4##(1992-3#1)(2005-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-1#1)
the crucial role##12##3##(1992-3#1)(2005-1#1)(2005-10#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-1#1)
the crucial##35##2##(1992-3#1)(1992-6#1)(1992-8#1)(1993-4#1)(1994-3#1)(1995-8#2)(1997-3#1)(2005-1#2)(2005-10#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-11#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
the cruciate##2##2##(2006-9#1)(2013-1#1)
the cruciform-containing##2##2##(1994-11#2)
the crude drug was##2##4##(2008-11#2)
the crude extract and##2##4##(2008-11#2)
the crude extract of##5##4##(2005-11#1)(2006-3#1)(2008-11#1)(2008-12#1)(2011-1#1)
the crude extract##13##3##(1996-4#1)(2005-11#1)(2006-3#1)(2007-1#1)(2007-6#1)(2008-10#1)(2008-11#4)(2008-12#1)(2011-1#1)(2011-2#1)
the crude extracts of##3##4##(2006-12#1)(2008-10#1)(2008-11#1)
the crude extracts##6##3##(2006-12#1)(2008-10#2)(2008-11#2)(2008-8#1)
the crude incidence##2##3##(1996-3#1)(2006-2#1)
the crude membrane##4##3##(1990-3#2)(1992-2#1)(1995-7#1)
the crude methanol##2##3##(2008-12#1)(2008-4#1)
the crude oil##6##3##(2005-11#3)(2006-3#1)(2008-10#2)
the crude preparation##2##3##(1994-9#1)(2008-9#1)
the crude##69##2##(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1991-4#1)(1992-2#1)(1992-5#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-7#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-4#1)(1997-7#2)(2005-11#4)(2005-8#1)(2006-12#1)(2006-2#1)(2006-3#2)(2007-1#3)(2007-10#1)(2007-11#1)(2007-3#1)(2007-6#2)(2007-9#1)(2008-10#10)(2008-11#8)(2008-12#4)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
the crus##2##2##(2006-5#2)
the crush##4##2##(1990-2#1)(1990-4#1)(1996-3#1)(2009-12#1)
the crust##4##2##(1992-1#1)(1994-6#1)(1996-4#1)(1997-5#1)
the crustacean##7##2##(1990-2#2)(1995-11#1)(1996-5#1)(2007-12#1)(2007-3#1)(2008-10#1)
the crux of##2##3##(2008-4#1)(2009-7#1)
the crux##4##2##(2007-8#2)(2008-4#1)(2009-7#1)
the cry1Ab gene##2##3##(2008-9#2)
the cryocomplexes##2##2##(2012-1#2)
the cryogenic##3##2##(2007-12#1)(2008-10#1)(2010-6#1)
the cryopreservation of##4##3##(2006-10#1)(2007-7#1)(2008-5#1)(2008-9#1)
the cryopreservation##7##2##(1996-8#2)(2006-10#1)(2006-5#1)(2007-7#1)(2008-5#1)(2008-9#1)
the cryopreserved##3##2##(2007-7#1)(2008-9#1)(2013-7#1)
the cryoprotective##2##2##(1996-1#1)(2013-7#1)
the crypt##3##2##(2008-8#1)(2011-2#1)(2012-12#1)
the crypt-villus##5##2##(1990-12#3)(1991-12#2)
the cryptic##4##2##(1990-7#1)(1996-12#1)(1996-9#1)(2008-5#1)
the crypts##6##2##(1991-12#1)(1995-8#1)(2008-5#1)(2009-12#1)(2011-2#1)(2013-1#1)
the crystal and the##2##4##(2007-11#1)(2008-2#1)
the crystal and##4##3##(2007-11#1)(2008-2#1)(2012-2#1)(2012-3#1)
the crystal are##4##3##(1992-4#1)(2007-12#1)(2008-3#2)
the crystal becomes##2##3##(2007-11#1)(2008-3#1)
the crystal during##2##3##(2007-12#1)(2008-2#1)
the crystal field##3##3##(2005-4#1)(2008-10#2)
the crystal form##2##3##(2007-11#1)(2012-3#1)
the crystal has##4##3##(1996-5#1)(2006-5#2)(2013-1#1)
the crystal is##5##3##(2006-4#1)(2007-12#1)(2008-3#2)(2013-1#1)
the crystal lattice##6##3##(1992-4#1)(2006-4#2)(2007-12#1)(2008-10#1)(2012-2#1)
the crystal length##2##3##(2008-2#2)
the crystal packing##3##3##(1995-6#1)(2007-11#1)(2010-4#1)
the crystal protein-encoding gene##2##4##(1990-3#1)(1993-12#1)
the crystal size##3##3##(2006-6#1)(2012-11#1)(2013-8#1)
the crystal structure and##2##4##(2008-10#1)(2008-4#1)
the crystal structure is##2##4##(1990-9#1)(1992-12#1)
the crystal structure of allophycocyanin from##2##6##(2008-8#2)
the crystal structure of the##8##5##(1990-7#1)(1994-11#1)(1994-3#1)(1995-1#1)(2007-11#1)(2008-8#1)(2011-1#1)(2012-3#1)
the crystal structure of##34##4##(1990-7#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-4#1)(1992-3#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-1#2)(1995-11#1)(1995-6#2)(1996-5#1)(1996-8#1)(2007-11#2)(2008-8#3)(2008-9#1)(2011-1#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
the crystal structure##50##3##(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-1#2)(1995-11#1)(1995-6#2)(1996-5#2)(1996-8#1)(1997-5#1)(1997-7#1)(2005-7#1)(2007-11#3)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2011-1#4)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
the crystal structures of##10##4##(1994-5#2)(1994-8#1)(1995-1#1)(1995-5#1)(1996-6#1)(2008-3#1)(2009-8#1)(2011-1#1)(2012-2#1)
the crystal structures##13##3##(1994-5#2)(1994-8#1)(1995-1#1)(1995-5#1)(1996-6#1)(1996-7#1)(2008-3#1)(2008-5#1)(2009-11#1)(2009-8#1)(2011-1#1)(2012-2#1)
the crystal surface##3##3##(2007-11#1)(2007-12#1)(2007-8#1)
the crystal temperature##7##3##(2007-11#1)(2007-12#5)(2008-3#1)
the crystal to##4##3##(1992-8#1)(2007-12#2)(2008-3#1)
the crystal violet##2##3##(2008-10#1)(2008-9#1)
the crystal##211##2##(1990-10#1)(1990-3#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#3)(1992-8#2)(1992-9#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#3)(1994-8#1)(1995-1#3)(1995-10#1)(1995-11#1)(1995-5#1)(1995-6#4)(1995-8#1)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#1)(1997-5#2)(1997-7#5)(2005-4#1)(2005-7#1)(2006-10#1)(2006-12#3)(2006-4#6)(2006-5#4)(2006-6#1)(2007-11#16)(2007-12#30)(2007-5#1)(2007-8#3)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#15)(2008-3#26)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-1#5)(2012-11#1)(2012-2#5)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#3)
the crystal's##2##2##(2007-11#1)(2007-12#1)
the crystalline lens##2##3##(2007-12#2)
the crystalline state##5##3##(1995-10#2)(2005-11#1)(2008-10#1)(2011-2#1)
the crystalline##25##2##(1990-9#1)(1991-4#1)(1992-1#1)(1993-3#1)(1993-8#1)(1995-10#2)(1996-2#1)(1996-5#2)(2005-11#3)(2007-12#4)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)
the crystallinity and##3##3##(2008-5#1)(2013-7#1)(2013-8#1)
the crystallinity of the##2##4##(1996-2#1)(2013-1#1)
the crystallinity of##3##3##(1996-2#1)(2008-5#1)(2013-1#1)
the crystallinity##9##2##(1996-2#2)(2008-2#1)(2008-5#2)(2010-4#1)(2013-1#1)(2013-7#1)(2013-8#1)
the crystallite size##2##3##(2005-11#1)(2010-5#1)
the crystallite##5##2##(2005-11#2)(2008-10#1)(2010-4#1)(2010-5#1)
the crystallites##4##2##(2005-11#1)(2006-12#1)(2008-2#1)(2013-8#1)
the crystallization of CaCO(3)##2##4##(2005-11#2)
the crystallization of magnetite##2##4##(2004-9#2)
the crystallization of##7##3##(2004-9#2)(2005-11#3)(2008-2#1)(2008-4#1)
the crystallization##15##2##(1996-2#1)(2004-9#2)(2005-11#3)(2006-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-5#1)(2010-10#1)(2010-4#1)
the crystallographic asymmetric unit##3##4##(1992-12#1)(1992-9#1)(1994-9#1)
the crystallographic##12##2##(1990-7#1)(1992-12#1)(1992-9#1)(1994-9#1)(1995-2#1)(1995-8#1)(1997-5#1)(1997-7#1)(2008-3#1)(2008-5#1)(2010-5#1)(2011-2#1)
the crystals of the##2##4##(2008-10#1)(2010-5#1)
the crystals of##3##3##(2007-11#1)(2008-10#1)(2010-5#1)
the crystals were##4##3##(1990-7#1)(1995-6#1)(2006-10#1)(2010-4#1)
the crystals##23##2##(1990-7#1)(1991-4#1)(1992-7#1)(1992-9#1)(1993-6#1)(1995-10#1)(1995-6#1)(1996-9#2)(1997-2#1)(2006-10#1)(2006-4#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-3#1)(2008-4#1)(2009-8#1)(2010-4#1)(2010-5#1)
the cube of the##2##4##(2005-11#1)(2007-12#1)
the cube##9##2##(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#5)
the cubic##5##2##(1994-9#1)(2007-11#1)(2007-12#1)(2008-3#1)(2010-3#1)
the cue was##2##3##(1996-6#1)(2008-2#1)
the cue##10##2##(1996-6#6)(2008-1#1)(2008-2#1)(2009-8#1)(2013-8#1)
the cue-based retrieval##2##3##(2007-12#2)
the cued side##2##3##(2010-5#2)
the cued##3##2##(1994-8#1)(2010-5#2)
the cues##5##2##(2008-11#1)(2009-3#1)(2009-8#1)(2013-8#2)
the cuff of the##3##4##(2006-10#1)(2008-2#2)
the cuff##21##2##(1991-12#3)(2006-10#1)(2006-6#1)(2007-11#1)(2008-2#2)(2009-9#3)(2013-8#10)
the culmination of##5##3##(2005-7#1)(2006-10#1)(2006-7#1)(2008-6#1)(2009-4#1)
the culprit coronary lesions in##2##5##(2008-5#2)
the culprit##5##2##(2008-12#1)(2008-5#3)(2013-8#1)
the cultivar##11##2##(2008-10#11)
the cultivars were##3##3##(2008-10#3)
the cultivars##16##2##(2008-10#14)(2008-8#1)(2012-11#1)
the cultivated##10##2##(2008-10#4)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#2)(2012-11#1)
the cultivation conditions##2##3##(2006-12#1)(2008-6#1)
the cultivation medium##2##3##(2008-5#1)(2008-6#1)
the cultivation of the##2##4##(2007-12#1)(2008-6#1)
the cultivation of##23##3##(1993-12#1)(1994-11#1)(1994-2#1)(1996-2#1)(2006-11#1)(2007-12#1)(2007-4#1)(2008-11#9)(2008-6#3)(2008-9#1)(2010-4#1)(2011-2#1)(2012-3#1)
the cultivation##38##2##(1993-12#1)(1994-11#2)(1994-2#1)(1996-2#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#13)(2008-12#1)(2008-5#1)(2008-6#7)(2008-9#1)(2010-4#1)(2011-2#1)(2012-3#1)
the culturable##4##2##(2008-10#3)(2013-8#1)
the cultural acceptability of##2##4##(2007-3#1)(2012-12#1)
the cultural and linguistic##2##4##(2008-2#1)(2010-5#1)
the cultural and##12##3##(1997-1#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-8#1)
the cultural context of##3##4##(2004-12#1)(2008-4#1)(2010-8#1)
the cultural diversity##2##3##(2006-2#1)(2008-8#1)
the cultural##50##2##(1994-1#1)(1996-1#1)(1996-8#1)(1997-1#2)(2004-12#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-2#1)(2007-3#1)(2008-1#4)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#2)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#2)(2009-10#2)(2009-9#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-1#2)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
the culturally adapted intervention##3##4##(2010-7#3)
the culturally##4##2##(2005-12#1)(2010-7#3)
the culture and the##2##4##(2008-7#1)(2008-9#1)
the culture and##8##3##(2006-3#1)(2008-11#3)(2008-7#1)(2008-9#2)(2009-10#1)
the culture broth##4##3##(2006-12#1)(2008-11#1)(2008-12#1)(2008-6#1)
the culture conditions for##2##4##(2008-11#1)(2008-4#1)
the culture conditions##10##3##(1995-1#1)(1997-6#1)(2007-12#1)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#1)
the culture confirmed the##2##4##(2008-1#1)(2008-11#1)
the culture dish##3##3##(1991-1#1)(1995-12#1)(2008-11#1)
the culture filtrate of##3##4##(1991-5#1)(2008-10#2)
the culture filtrate##5##3##(1991-5#1)(2008-10#3)(2008-8#1)
the culture fluid of##2##4##(1990-1#1)(1994-8#1)
the culture in the##3##4##(2008-6#1)(2008-7#1)(2013-7#1)
the culture in##6##3##(1994-6#1)(2007-10#1)(2007-12#1)(2008-6#1)(2008-7#1)(2013-7#1)
the culture incubated##2##3##(2008-11#2)
the culture is##2##3##(2007-7#1)(2008-11#1)
the culture media of##4##4##(1991-2#1)(1994-2#1)(2008-5#2)
the culture media showed##2##4##(1990-10#1)(1994-9#1)
the culture media was##2##4##(2008-11#1)(2013-1#1)
the culture media##22##3##(1990-10#1)(1991-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1994-2#1)(1994-9#1)(1995-10#1)(1996-3#1)(2007-6#1)(2008-11#4)(2008-5#3)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
the culture medium and##9##4##(1990-5#1)(1992-12#1)(1994-9#1)(1995-3#1)(1997-4#1)(1997-6#1)(2008-11#1)(2008-7#1)(2012-6#1)
the culture medium as##2##4##(1991-7#1)(2008-11#1)
the culture medium by##3##4##(1993-3#1)(1993-6#1)(1995-10#1)
the culture medium for##4##4##(1991-2#1)(1996-11#1)(2008-11#1)(2013-1#1)
the culture medium in##2##4##(1996-11#1)(2008-5#1)
the culture medium of the##3##5##(1993-4#1)(1993-9#1)(2008-5#1)
the culture medium of##14##4##(1991-2#1)(1991-3#1)(1992-6#1)(1993-4#1)(1993-9#2)(1994-6#1)(1994-8#1)(1997-1#1)(1997-4#1)(1997-7#1)(2008-5#1)(2009-3#2)
the culture medium or##4##4##(1993-9#1)(1995-1#1)(1996-11#1)(1997-4#1)
the culture medium resulted in##3##5##(1993-12#1)(1994-6#1)(2008-11#1)
the culture medium to##2##4##(1990-8#1)(2008-11#1)
the culture medium was##10##4##(1990-7#1)(1992-3#1)(1994-6#1)(1994-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(2008-5#2)
the culture medium were determined by##2##6##(1991-8#1)(1993-9#1)
the culture medium were##3##4##(1991-8#1)(1993-9#1)(2008-11#1)
the culture medium with##2##4##(1996-4#1)(2011-2#1)
the culture medium##144##3##(1990-10#1)(1990-11#1)(1990-5#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-10#2)(1991-2#2)(1991-3#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-12#2)(1992-3#3)(1992-6#2)(1992-8#1)(1992-9#2)(1993-12#2)(1993-3#1)(1993-4#1)(1993-6#4)(1993-9#7)(1994-11#1)(1994-12#2)(1994-3#3)(1994-6#3)(1994-8#3)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#3)(1995-6#1)(1995-9#1)(1996-11#4)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#5)(1997-6#1)(1997-7#1)(1997-8#1)(2004-8#2)(2006-11#2)(2006-12#2)(2006-5#1)(2007-4#1)(2008-1#2)(2008-10#1)(2008-11#20)(2008-4#2)(2008-5#8)(2008-7#6)(2008-8#1)(2008-9#1)(2009-3#2)(2010-10#1)(2011-1#1)(2011-2#2)(2012-6#1)(2013-1#1)
the culture method##2##3##(2009-6#1)(2012-2#1)
the culture of human##3##4##(2008-11#2)(2010-3#1)
the culture of the##4##4##(1994-2#1)(2006-2#1)(2007-7#1)(2008-8#1)
the culture of##33##3##(1993-12#1)(1994-1#1)(1994-2#2)(2005-11#1)(2005-6#1)(2006-2#2)(2006-5#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-11#7)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-1#1)(2013-8#2)
the culture or##2##3##(2008-11#1)(2012-2#1)
the culture pH##2##3##(2006-8#1)(2008-5#1)
the culture period and##3##4##(1991-1#2)(2008-11#1)
the culture period##10##3##(1991-1#3)(1993-3#1)(1997-4#1)(2005-8#1)(2008-11#4)
the culture plate method##2##4##(2008-10#2)
the culture pond water##3##4##(2008-5#3)
the culture pond##4##3##(2008-5#4)
the culture process##4##3##(1997-2#1)(2008-11#2)(2008-7#1)
the culture solution was##2##4##(2010-3#2)
the culture supernatant by##2##4##(1992-2#1)(1992-7#1)
the culture supernatant of##3##4##(1993-11#2)(2008-6#1)
the culture supernatant was##2##4##(1994-8#1)(1997-7#1)
the culture supernatant##11##3##(1990-8#1)(1991-3#1)(1992-2#1)(1992-7#1)(1993-11#2)(1994-8#1)(1997-7#1)(2008-11#2)(2008-6#1)
the culture supernatants##6##3##(1990-2#1)(1990-4#1)(1991-7#1)(1994-12#1)(2006-10#1)(2011-3#1)
the culture system##3##3##(2008-11#1)(2008-7#1)(2010-6#1)
the culture technique##4##3##(2006-10#4)
the culture temperature##3##3##(2008-11#2)(2008-7#1)
the culture time##2##3##(1994-6#1)(2008-11#1)
the culture was##4##3##(1991-1#1)(1996-2#1)(2008-11#1)(2008-7#1)
the culture with##4##3##(2008-11#2)(2011-2#1)(2013-1#1)
the culture##381##2##(1990-1#1)(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#2)(1990-5#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#5)(1991-10#2)(1991-12#2)(1991-2#3)(1991-3#2)(1991-5#4)(1991-7#2)(1991-8#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#3)(1993-3#2)(1993-4#1)(1993-6#4)(1993-8#1)(1993-9#7)(1994-1#1)(1994-11#2)(1994-12#4)(1994-2#3)(1994-3#3)(1994-6#6)(1994-8#5)(1994-9#2)(1995-1#3)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#4)(1995-6#1)(1995-9#1)(1996-11#4)(1996-12#1)(1996-2#2)(1996-3#3)(1996-4#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#7)(1997-6#2)(1997-7#2)(1997-8#1)(2004-11#1)(2004-8#2)(2005-11#1)(2005-6#2)(2005-8#1)(2006-10#5)(2006-11#2)(2006-12#3)(2006-2#2)(2006-3#1)(2006-5#2)(2006-8#3)(2006-9#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#4)(2007-8#1)(2008-1#3)(2008-10#6)(2008-11#86)(2008-12#1)(2008-4#9)(2008-5#19)(2008-6#4)(2008-7#20)(2008-8#5)(2008-9#9)(2009-10#3)(2009-3#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-3#3)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-6#1)(2013-1#4)(2013-7#1)(2013-8#2)
the cultured bovine##3##3##(1993-7#1)(2008-5#2)
the cultured cardiac myocytes##2##4##(1993-3#2)
the cultured cells##10##3##(1992-9#1)(1995-12#1)(1995-3#1)(2008-11#3)(2008-4#1)(2008-6#1)(2009-12#1)(2012-2#1)
the cultured human##3##3##(1993-6#1)(2006-8#1)(2008-5#1)
the cultured neurons##4##3##(1994-10#1)(2008-1#1)(2008-11#2)
the cultured##38##2##(1990-9#1)(1992-6#1)(1992-9#1)(1993-3#3)(1993-6#1)(1993-7#1)(1994-10#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-4#1)(2006-8#1)(2008-1#1)(2008-11#6)(2008-4#2)(2008-5#4)(2008-6#1)(2008-8#2)(2009-12#1)(2009-8#1)(2011-12#1)(2012-12#1)(2012-2#1)
the cultures and##2##3##(1990-2#1)(2006-3#1)
the cultures at##2##3##(1991-2#1)(1995-7#1)
the cultures by##3##3##(1992-11#1)(2008-10#1)(2008-11#1)
the cultures from##2##3##(1991-5#1)(2010-8#1)
the cultures had##2##3##(1992-3#1)(2008-11#1)
the cultures of##4##3##(1996-2#1)(2006-10#1)(2006-8#1)(2008-11#1)
the cultures was##3##3##(1994-5#1)(2008-10#2)
the cultures were##6##3##(1990-12#1)(1991-2#1)(1993-8#1)(1996-5#1)(1997-4#1)(2010-3#1)
the cultures with##6##3##(1992-8#1)(1994-11#1)(1995-12#1)(2008-11#2)(2011-2#1)
the cultures##67##2##(1990-12#1)(1990-2#1)(1991-2#2)(1991-5#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#3)(1993-10#7)(1993-8#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-11#1)(2008-10#6)(2008-11#14)(2008-4#1)(2008-5#2)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
the culturing of##2##3##(2008-11#2)
the culturing##3##2##(2008-11#2)(2008-9#1)
the cumbersome##2##2##(1995-2#1)(2008-9#1)
the cumulant expansion##2##3##(2006-4#1)(2006-5#1)
the cumulant##4##2##(2006-4#2)(2006-5#1)(2007-12#1)
the cumulated##4##2##(1994-6#1)(1995-7#1)(2006-10#1)(2013-7#1)
the cumulative action of multiple##2##5##(1995-5#1)(2012-3#1)
the cumulative amount of##3##4##(2008-5#1)(2008-7#1)(2011-3#1)
the cumulative dose of##2##4##(1991-6#1)(2012-12#1)
the cumulative effect of##7##4##(1992-12#1)(2005-7#1)(2008-10#1)(2012-12#1)(2012-3#2)(2013-8#1)
the cumulative effects of##3##4##(1996-3#1)(2008-6#1)(2008-7#1)
the cumulative effects##4##3##(1996-3#1)(2008-10#1)(2008-6#1)(2008-7#1)
the cumulative incidence of##5##4##(2007-8#1)(2008-7#3)(2013-1#1)
the cumulative incidence##8##3##(1997-4#2)(2007-8#1)(2008-11#1)(2008-7#3)(2013-1#1)
the cumulative mortality##3##3##(2008-10#1)(2008-4#2)
the cumulative number of##4##4##(2008-10#3)(2009-3#1)
the cumulative probability of##4##4##(2008-2#1)(2011-3#2)(2013-8#1)
the cumulative probability##5##3##(2007-12#1)(2008-2#1)(2011-3#2)(2013-8#1)
the cumulative risk of developing##2##5##(1993-9#2)
the cumulative time required for sequential implantation##2##7##(2012-2#2)
the cumulative variance of the##2##5##(2006-11#2)
the cumulative variance##3##3##(2006-11#2)(2007-8#1)
the cumulative##75##2##(1991-6#2)(1992-12#1)(1992-7#1)(1993-9#2)(1994-5#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-3#1)(1997-4#2)(1997-5#1)(2005-11#1)(2005-7#1)(2006-11#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-10#12)(2008-11#2)(2008-2#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#8)(2009-3#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-2#1)(2011-3#3)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#2)
the cup and##2##3##(2004-9#1)(2008-3#1)
the cup##3##2##(2004-9#1)(2006-3#1)(2008-3#1)
the cupping##2##2##(2008-5#1)(2012-1#1)
the cups##4##2##(1996-3#1)(2007-4#1)(2008-10#2)
the curation of##2##3##(2008-7#2)
the curative treatment of##2##4##(1991-9#1)(2012-3#1)
the curative##6##2##(1991-9#1)(1995-1#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
the curd forming ability##2##4##(2010-2#2)
the curd##5##2##(2010-2#5)
the curdlan helix##2##3##(2006-12#2)
the cure and##2##3##(2008-3#1)(2012-3#1)
the cure for all##2##4##(2007-3#1)(2008-4#1)
the cure of##5##3##(1992-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2012-12#1)
the cure rate was##2##4##(2010-3#1)(2012-1#1)
the cure rate##3##3##(2008-1#1)(2010-3#1)(2012-1#1)
the cure##16##2##(1992-12#1)(2005-7#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
the cured##4##2##(2008-4#3)(2010-4#1)
the curing##7##2##(2004-9#1)(2007-12#1)(2008-12#1)(2008-8#2)(2010-4#1)(2012-12#1)
the current &quot##4##3##(1994-3#1)(2008-3#1)(2012-12#1)(2012-2#1)
the current U##3##3##(1994-1#1)(2008-6#1)(2008-9#1)
the current advances##2##3##(2008-1#2)
the current age##2##3##(1994-11#1)(2007-7#1)
the current amplitude##2##3##(1990-7#1)(2006-9#1)
the current analysis##2##3##(2006-7#1)(2010-12#1)
the current and future##4##4##(2006-10#1)(2007-4#1)(2007-8#1)(2008-11#1)
the current and potential future##2##5##(2008-11#1)(2009-4#1)
the current and##12##3##(1996-2#1)(2006-10#2)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#2)(2009-4#2)(2010-5#1)
the current approach to##2##4##(2007-4#1)(2010-12#1)
the current approach##3##3##(2007-4#1)(2008-3#1)(2010-12#1)
the current approaches to##3##4##(2005-7#1)(2007-12#1)(2008-10#1)
the current approaches##4##3##(2005-7#1)(2007-12#1)(2008-10#1)(2010-12#1)
the current article##4##3##(2008-5#1)(2008-9#1)(2013-8#2)
the current available##3##3##(2007-3#1)(2007-5#1)(2013-1#1)
the current body of##2##4##(2007-12#1)(2008-12#1)
the current case study##2##4##(2011-2#1)(2013-1#1)
the current case##5##3##(2006-10#1)(2010-10#1)(2010-7#1)(2011-2#1)(2013-1#1)
the current challenges##3##3##(2007-4#2)(2008-12#1)
the current classification##4##3##(2008-10#2)(2008-4#1)(2013-1#1)
the current climate##2##3##(2007-4#1)(2008-11#1)
the current clinical practice##2##4##(2007-5#1)(2009-12#1)
the current clinical##12##3##(2005-11#1)(2007-5#2)(2008-10#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-12#1)(2010-10#1)(2010-12#1)(2012-12#1)(2012-2#1)
the current concepts of##2##4##(1992-4#1)(2008-7#1)
the current concepts##4##3##(1992-4#1)(1996-12#1)(2008-1#1)(2008-7#1)
the current configuration##2##3##(2008-10#1)(2008-3#1)
the current conservative##2##3##(2007-11#1)(2009-5#1)
the current context of increasing##2##5##(2008-12#1)(2008-2#1)
the current criteria##2##3##(2006-8#2)
the current cultivated soybean##2##4##(2012-11#2)
the current data available##2##4##(2007-2#1)(2010-6#1)
the current data##8##3##(1997-2#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-6#1)(2011-1#1)
the current debate##5##3##(1993-12#1)(1994-12#1)(2006-10#1)(2008-11#1)(2009-5#1)
the current decoded frame##2##4##(2008-2#2)
the current delivery##2##3##(1995-12#1)(2010-12#1)
the current density##3##3##(1996-1#1)(2008-10#1)(2009-2#1)
the current development of##2##4##(2007-8#1)(2008-1#1)
the current dummy##2##3##(2006-11#1)(2007-1#1)
the current during SD was##2##5##(1993-12#2)
the current economic##2##3##(2007-4#1)(2011-2#1)
the current epidemiological##3##3##(2007-2#1)(2008-10#1)(2008-8#1)
the current estimate##2##3##(2010-2#2)
the current evidence base##2##4##(2012-1#1)(2013-1#1)
the current evidence for the##2##5##(2008-2#1)(2008-6#1)
the current evidence for##3##4##(2008-2#1)(2008-6#1)(2009-8#1)
the current evidence in##3##4##(2008-11#1)(2008-6#1)(2012-12#1)
the current evidence regarding##3##4##(2008-1#1)(2013-1#2)
the current evidence##16##3##(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-6#2)(2008-8#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#3)
the current experimental##4##3##(2007-1#1)(2011-1#1)(2011-2#1)(2012-2#1)
the current federal budget##2##4##(1990-12#1)(2007-1#1)
the current findings##4##3##(1994-3#1)(2008-10#1)(2012-12#1)(2013-8#1)
the current first-line##2##3##(2006-2#1)(2009-3#1)
the current formulation##2##3##(1996-1#1)(2010-12#1)
the current gold standard##2##4##(2007-11#1)(2007-12#1)
the current guidelines##2##3##(2005-11#1)(2010-4#1)
the current health care system##2##5##(1996-12#1)(1997-3#1)
the current health care##7##4##(1993-12#1)(1994-2#1)(1996-12#1)(1997-3#2)(2008-8#1)(2011-1#1)
the current health situation##2##4##(2011-2#1)(2013-1#1)
the current health##13##3##(1993-12#1)(1993-3#1)(1994-2#1)(1996-12#1)(1997-1#1)(1997-3#2)(2007-6#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
the current healthcare##3##3##(1996-7#1)(2006-10#1)(2007-4#1)
the current hypotheses##2##3##(2011-1#1)(2012-2#1)
the current hypothesis##2##3##(2008-7#1)(2012-11#1)
the current immunization##2##3##(2010-1#1)(2010-9#1)
the current in the##3##4##(1990-3#1)(1991-9#1)(2009-11#1)
the current in##4##3##(1990-3#1)(1991-9#1)(1992-8#1)(2009-11#1)
the current indications for##3##4##(2006-9#1)(2007-12#1)(2011-2#1)
the current indications##4##3##(2006-9#1)(2007-12#1)(2009-4#1)(2011-2#1)
the current information on##2##4##(2008-4#1)(2011-2#1)
the current information##5##3##(2006-9#1)(2007-1#1)(2008-4#1)(2011-2#1)(2012-3#1)
the current interest in##2##4##(1995-8#1)(2008-10#1)
the current interest##3##3##(1995-8#1)(2008-10#1)(2012-12#1)
the current international##4##3##(2006-8#1)(2008-11#1)(2011-2#1)(2013-8#1)
the current investigation##8##3##(1991-12#1)(1995-3#1)(1996-11#1)(1997-6#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-2#1)
the current is##3##3##(1993-2#1)(1995-12#1)(2008-3#1)
the current knowledge about the##3##5##(2008-11#1)(2008-3#1)(2008-4#1)
the current knowledge about##8##4##(1996-5#1)(2005-10#1)(2006-7#1)(2008-11#1)(2008-3#2)(2008-4#1)(2013-1#1)
the current knowledge of the##4##5##(2007-7#1)(2008-5#1)(2013-1#1)(2013-7#1)
the current knowledge of##16##4##(1995-11#1)(2006-12#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-5#2)(2008-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
the current knowledge on the use of##2##7##(2007-11#1)(2010-12#1)
the current knowledge on the##6##5##(2007-11#1)(2008-1#1)(2008-4#1)(2009-4#1)(2010-12#1)(2011-7#1)
the current knowledge on##13##4##(2006-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-4#1)(2010-12#2)(2011-7#1)(2013-8#1)
the current knowledge##39##3##(1995-11#1)(1996-5#1)(2005-10#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#2)(2008-11#3)(2008-3#2)(2008-4#2)(2008-5#4)(2008-8#1)(2009-4#1)(2010-12#2)(2011-1#2)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
the current lack of##3##4##(2007-6#1)(2009-11#1)(2012-2#1)
the current lack##4##3##(2007-6#1)(2009-11#1)(2010-8#1)(2012-2#1)
the current legal##4##3##(2006-10#1)(2007-12#1)(2008-5#1)(2013-8#1)
the current legislation##2##3##(2007-8#1)(2012-3#1)
the current level of##12##4##(1994-2#1)(1996-12#1)(1996-3#1)(1996-9#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-4#1)(2013-1#1)
the current levels of##2##4##(1996-3#1)(2005-8#1)
the current literature and##5##4##(2008-6#1)(2011-12#2)(2011-2#1)(2012-2#1)
the current literature on the##6##5##(1995-12#1)(2006-10#2)(2008-1#1)(2008-5#1)(2011-2#1)
the current literature on##10##4##(1995-12#1)(2005-8#1)(2006-10#2)(2008-1#1)(2008-5#1)(2009-7#1)(2011-2#3)
the current literature surrounding##2##4##(2007-11#1)(2010-12#1)
the current literature##47##3##(1992-12#1)(1995-12#1)(1997-8#1)(2004-10#1)(2005-11#1)(2005-8#1)(2006-10#4)(2007-11#1)(2007-2#1)(2007-4#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-3#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-12#3)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-7#3)
the current management strategies##3##4##(2006-6#1)(2012-2#1)(2013-8#1)
the current management##5##3##(2006-6#1)(2006-9#1)(2008-1#1)(2012-2#1)(2013-8#1)
the current medical##4##3##(1991-12#1)(1992-8#1)(2010-3#1)(2010-8#1)
the current method##2##3##(2008-5#2)
the current methods of##2##4##(1997-7#1)(2005-4#1)
the current methods used for##2##5##(2008-11#1)(2013-1#1)
the current methods##6##3##(1993-6#1)(1997-7#1)(2005-4#1)(2008-10#1)(2008-11#1)(2013-1#1)
the current model for##2##4##(1994-5#1)(2007-11#1)
the current model##5##3##(1994-11#1)(1994-5#1)(1995-5#1)(2006-3#1)(2007-11#1)
the current national##2##3##(2008-3#1)(2011-1#1)
the current nature##2##3##(1995-12#1)(2007-10#1)
the current need for##2##4##(1994-3#1)(2011-1#1)
the current need##3##3##(1994-3#1)(2006-7#1)(2011-1#1)
the current opinions##3##3##(2007-2#1)(2008-5#1)(2012-3#1)
the current paper is##3##4##(2009-2#2)(2010-10#1)
the current paper##14##3##(1991-5#1)(1993-6#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-12#2)(2008-8#1)(2009-2#2)(2009-4#1)(2009-9#1)(2010-10#1)(2010-3#1)
the current pathophysiological##2##3##(2005-8#1)(2010-12#1)
the current pattern of##2##4##(2005-7#1)(2008-11#1)
the current perspectives##2##3##(2006-8#1)(2010-8#1)
the current policy##3##3##(1995-6#1)(1996-2#1)(2008-11#1)
the current position##3##3##(2004-7#1)(2007-5#1)(2013-1#1)
the current practice of##7##4##(1991-6#1)(2008-10#1)(2008-8#1)(2011-1#1)(2013-1#3)
the current practice##10##3##(1991-6#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-10#1)(2011-1#1)(2013-1#3)
the current problem of##2##4##(2006-8#1)(2008-3#1)
the current problem##3##3##(2006-8#1)(2008-3#1)(2010-5#1)
the current problems##4##3##(1991-2#1)(1997-8#1)(2007-5#1)(2008-1#1)
the current protocol##2##3##(2005-7#1)(2008-11#1)
the current provision of##2##4##(2008-11#1)(2010-4#1)
the current recommendations for##2##4##(1996-9#1)(2008-11#1)
the current recommendations##3##3##(1996-9#1)(2008-11#1)(2008-6#1)
the current regulatory scheme##2##4##(2006-8#2)
the current research on##2##4##(2010-12#1)(2011-12#1)
the current research##13##3##(2004-3#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-5#1)(2010-12#2)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)
the current response##6##3##(1991-11#1)(2008-10#4)(2012-2#1)
the current responses of the alpha##2##6##(1995-3#2)
the current responses##3##3##(1995-3#2)(2008-10#1)
the current results##3##3##(1996-5#1)(2007-12#1)(2010-12#1)
the current review##6##3##(2008-3#1)(2008-4#1)(2008-6#1)(2009-10#1)(2010-8#1)(2013-8#1)
the current role of##2##4##(2006-10#1)(2009-10#1)
the current sensitivity##2##3##(2008-2#1)(2013-8#1)
the current shortage of##6##4##(1994-1#1)(2007-8#1)(2008-11#1)(2008-12#1)(2010-5#1)(2011-1#1)
the current situation in##3##4##(2007-5#1)(2008-4#1)(2009-5#1)
the current situation of##2##4##(2007-7#1)(2013-1#1)
the current situation##10##3##(1991-3#1)(2006-10#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-5#1)(2009-5#1)(2012-12#1)(2013-1#1)
the current standard of care##6##5##(1995-9#1)(2006-10#1)(2010-12#3)(2012-2#1)
the current standard of##7##4##(1995-9#1)(2006-10#1)(2010-12#3)(2010-8#1)(2012-2#1)
the current standard##14##3##(1995-9#1)(2006-10#2)(2006-6#1)(2008-11#1)(2008-4#1)(2010-12#3)(2010-8#1)(2011-12#1)(2011-2#2)(2012-2#1)
the current state and##3##4##(2008-1#1)(2012-11#1)(2013-1#1)
the current state of affairs##2##5##(2009-5#1)(2013-1#1)
the current state of knowledge of##2##6##(2007-12#1)(2010-3#1)
the current state of knowledge on##3##6##(1995-11#1)(2007-11#1)(2012-2#1)
the current state of knowledge regarding the##4##7##(2007-11#2)(2010-2#1)(2013-7#1)
the current state of knowledge regarding##6##6##(2007-11#2)(2009-8#1)(2010-2#1)(2012-2#1)(2013-7#1)
the current state of knowledge##17##5##(1995-11#1)(2007-11#4)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-8#1)(2010-2#1)(2010-3#1)(2012-2#2)(2012-3#1)(2013-7#1)
the current state of our##2##5##(2007-8#2)
the current state of research##3##5##(2009-4#1)(2010-11#1)(2012-2#1)
the current state of the art in##2##7##(2007-12#1)(2008-8#1)
the current state of the art##8##6##(1993-3#1)(2006-8#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-8#1)
the current state of the##16##5##(1993-3#1)(1994-6#1)(1994-9#1)(1997-4#1)(2006-8#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-5#1)(2009-7#1)(2009-9#1)(2011-2#1)
the current state of##62##4##(1993-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1997-1#1)(1997-4#1)(1997-8#1)(2005-8#2)(2006-6#1)(2006-8#2)(2007-11#4)(2007-12#2)(2007-4#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-9#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)
the current state##67##3##(1993-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1997-1#1)(1997-4#1)(1997-8#1)(2005-8#2)(2006-6#1)(2006-8#2)(2007-1#1)(2007-11#4)(2007-12#2)(2007-4#1)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-9#1)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-7#1)
the current state-of-the-art##2##3##(2008-4#1)(2011-7#1)
the current status in##2##4##(1992-10#1)(2006-2#1)
the current status of knowledge##3##5##(2008-11#1)(2012-11#1)(2013-1#1)
the current status of renal transplantation in the##2##8##(2008-4#2)
the current status of research##3##5##(2007-11#1)(2008-11#1)(2010-11#1)
the current status of the##10##5##(1996-8#1)(1997-3#1)(2006-10#1)(2006-12#1)(2009-11#1)(2010-11#1)(2010-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
the current status of these##5##5##(1994-12#1)(1997-1#1)(2006-10#1)(2009-3#1)(2010-9#1)
the current status of various##2##5##(2005-11#1)(2008-10#1)
the current status of##56##4##(1994-12#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-3#1)(2005-11#2)(2005-6#2)(2006-10#3)(2006-12#2)(2006-2#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-4#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#1)(2009-11#1)(2009-3#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-7#1)(2012-11#3)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#1)
the current status##63##3##(1992-10#1)(1994-12#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-3#1)(2005-11#2)(2005-6#2)(2006-10#3)(2006-12#2)(2006-2#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-4#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#1)(2009-11#1)(2009-3#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-11#3)(2012-12#3)(2012-2#3)(2013-1#3)(2013-8#1)
the current strategy##2##3##(2006-10#1)(2006-4#1)
the current studies##4##3##(1996-12#1)(1997-4#1)(2010-7#1)(2013-8#1)
the current study indicated that##2##5##(2008-10#1)(2011-2#1)
the current study investigates open-source JBoss® Drools rules engine for automatic translation of QDM criteria into rules for execution over EHR data##2##22##(2013-1#2)
the current study is##4##4##(1991-4#1)(2007-8#1)(2007-9#1)(2011-2#1)
the current study used##2##4##(2007-12#1)(2012-3#1)
the current study##110##3##(1991-11#1)(1991-4#2)(1993-4#1)(1993-9#1)(1994-6#1)(1995-12#1)(1995-2#3)(1996-1#1)(1996-4#2)(1996-5#2)(1997-2#2)(2004-3#1)(2004-9#1)(2006-10#1)(2007-1#4)(2007-11#1)(2007-12#8)(2007-4#2)(2007-6#3)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#11)(2008-11#6)(2008-2#1)(2008-4#2)(2008-5#2)(2009-2#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-2#3)(2010-3#2)(2010-6#1)(2011-2#8)(2012-12#6)(2012-2#4)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#2)
the current system is##2##4##(2006-8#1)(2008-7#1)
the current system of##3##4##(1990-10#1)(2006-8#1)(2008-12#1)
the current system##14##3##(1990-10#1)(1991-3#2)(1997-2#1)(2006-10#1)(2006-12#1)(2006-8#3)(2008-12#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-1#1)
the current task##2##3##(2009-2#1)(2011-1#1)
the current taxonomy##2##3##(1996-6#1)(2011-12#1)
the current technology##2##3##(2006-12#1)(2008-11#1)
the current that##2##3##(2007-12#2)
the current theory##2##3##(2006-12#1)(2008-8#1)
the current treatment options##2##4##(2007-10#1)(2008-5#1)
the current treatment##5##3##(2006-10#1)(2007-10#1)(2007-11#1)(2008-5#1)(2010-5#1)
the current treatments##3##3##(2006-12#1)(2011-2#1)(2013-8#1)
the current trend##2##3##(2007-11#1)(2012-2#1)
the current trends in##3##4##(2007-4#1)(2010-4#1)(2011-1#1)
the current trends##4##3##(2007-4#1)(2010-2#1)(2010-4#1)(2011-1#1)
the current understanding and##2##4##(2013-1#2)
the current understanding of the##13##5##(1993-9#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-7#3)(2009-12#1)(2010-9#1)(2012-11#1)(2012-12#2)(2012-3#1)
the current understanding of##23##4##(1993-9#1)(1995-12#1)(1996-11#1)(1997-4#1)(1997-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-4#1)(2010-5#1)(2010-9#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)
the current understanding##27##3##(1993-9#1)(1995-12#1)(1996-11#1)(1997-4#1)(1997-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-12#2)(2009-3#1)(2009-4#1)(2010-5#1)(2010-9#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)
the current understandings##3##3##(2009-2#1)(2013-1#2)
the current usage##3##3##(2008-11#1)(2013-1#2)
the current use of##6##4##(1991-4#1)(2007-10#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#1)
the current use##7##3##(1991-4#1)(2007-10#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2011-2#1)
the current version of the##3##5##(2006-11#1)(2007-4#1)(2008-5#1)
the current version of##4##4##(2006-11#1)(2006-12#1)(2007-4#1)(2008-5#1)
the current version##5##3##(2006-11#1)(2006-12#1)(2007-4#1)(2008-5#1)(2011-2#1)
the current view of##4##4##(2006-10#1)(2006-2#1)(2007-8#1)(2011-1#1)
the current view##5##3##(1990-2#1)(2006-10#1)(2006-2#1)(2007-8#1)(2011-1#1)
the current was##7##3##(1991-2#1)(1993-3#1)(1994-3#1)(1994-5#2)(1995-12#1)(1995-7#1)
the current work##9##3##(1995-12#1)(2006-10#1)(2007-9#1)(2008-5#2)(2010-5#1)(2010-8#1)(2013-1#2)
the current##1227##2##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#3)(1991-12#4)(1991-2#4)(1991-3#3)(1991-4#4)(1991-5#1)(1991-6#2)(1991-9#3)(1992-10#1)(1992-12#4)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#3)(1993-10#1)(1993-12#9)(1993-2#5)(1993-3#5)(1993-4#1)(1993-6#3)(1993-9#3)(1994-1#3)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#6)(1994-5#4)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#10)(1995-2#3)(1995-3#5)(1995-4#2)(1995-5#3)(1995-6#2)(1995-7#2)(1995-8#1)(1995-9#2)(1996-1#6)(1996-10#2)(1996-11#2)(1996-12#7)(1996-2#8)(1996-3#3)(1996-4#4)(1996-5#7)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#7)(1997-2#6)(1997-3#5)(1997-4#5)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#3)(2004-10#2)(2004-12#1)(2004-2#1)(2004-3#2)(2004-7#2)(2004-9#1)(2005-10#2)(2005-11#6)(2005-4#1)(2005-6#2)(2005-7#6)(2005-8#5)(2005-9#1)(2006-10#31)(2006-11#7)(2006-12#14)(2006-2#7)(2006-3#2)(2006-4#2)(2006-6#8)(2006-7#3)(2006-8#15)(2006-9#6)(2007-1#12)(2007-10#5)(2007-11#21)(2007-12#31)(2007-2#8)(2007-3#2)(2007-4#26)(2007-5#10)(2007-6#5)(2007-7#6)(2007-8#19)(2007-9#3)(2008-1#23)(2008-10#66)(2008-11#45)(2008-12#13)(2008-2#26)(2008-3#28)(2008-4#15)(2008-5#24)(2008-6#16)(2008-7#17)(2008-8#22)(2008-9#10)(2009-10#5)(2009-11#5)(2009-12#4)(2009-2#9)(2009-3#6)(2009-4#14)(2009-5#12)(2009-6#2)(2009-7#4)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#6)(2010-11#10)(2010-12#22)(2010-2#15)(2010-3#9)(2010-4#9)(2010-5#9)(2010-6#5)(2010-7#2)(2010-8#11)(2010-9#6)(2011-1#25)(2011-12#9)(2011-2#43)(2011-7#3)(2012-1#4)(2012-11#12)(2012-12#29)(2012-2#36)(2012-3#21)(2013-1#50)(2013-7#9)(2013-8#18)
the current-voltage##5##2##(1996-5#1)(1997-5#1)(2005-11#1)(2006-7#1)(2008-7#1)
the currently accepted##5##3##(1995-3#1)(2007-10#1)(2008-1#1)(2008-8#1)(2011-2#1)
the currently available data##4##4##(2008-1#1)(2008-5#1)(2008-7#1)(2013-7#1)
the currently available drugs##3##4##(1993-9#1)(2005-7#1)(2007-7#1)
the currently available evidence##2##4##(2008-6#1)(2008-8#1)
the currently available literature##2##4##(2007-11#1)(2012-2#1)
the currently available methods##2##4##(2007-4#1)(2008-4#1)
the currently available structural##2##4##(1996-9#1)(2008-4#1)
the currently available##37##3##(1993-9#1)(1996-2#1)(1996-9#1)(1997-3#1)(2005-7#1)(2006-10#2)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2010-3#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
the currently characterized##2##3##(1993-6#1)(2007-12#1)
the currently existing##3##3##(1996-12#1)(2009-5#1)(2012-3#1)
the currently known##3##3##(1992-4#1)(2007-12#1)(2012-2#1)
the currently observed##2##3##(2007-5#1)(2008-7#1)
the currently used##10##3##(1992-11#1)(1996-11#1)(2005-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2009-5#1)(2010-12#1)(2010-8#1)(2013-8#1)
the currently##82##2##(1992-11#1)(1992-3#1)(1992-4#1)(1993-6#1)(1993-9#1)(1995-3#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-9#1)(1997-3#1)(2005-7#2)(2006-10#3)(2006-12#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#7)(2008-10#3)(2008-11#1)(2008-2#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2009-5#2)(2010-12#1)(2010-3#2)(2010-4#2)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#3)
the currents##9##2##(1995-5#1)(1995-7#1)(1996-1#2)(1997-5#2)(2007-8#1)(2008-8#1)(2009-8#1)
the curricula of##4##3##(1996-1#1)(2006-2#1)(2008-5#2)
the curricula##7##2##(1990-12#1)(1996-1#1)(2006-2#1)(2008-12#1)(2008-5#3)
the curricular##2##2##(1996-2#1)(2008-11#1)
the curriculum of##3##3##(1996-8#1)(2007-11#1)(2011-2#1)
the curriculum to##3##3##(2007-10#1)(2008-1#1)(2012-3#1)
the curriculum##31##2##(1990-5#1)(1993-2#1)(1994-1#2)(1994-12#1)(1995-2#1)(1996-8#1)(2005-12#2)(2006-10#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-11#5)(2008-12#2)(2008-2#1)(2008-6#1)(2009-4#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#2)
the curse of dimensionality##3##4##(2007-8#1)(2009-3#1)(2013-1#1)
the curvature and##3##3##(2007-12#1)(2008-3#1)(2012-1#1)
the curvature of the##3##4##(1994-6#1)(2007-11#2)
the curvature of##5##3##(1994-6#1)(2007-11#2)(2008-9#1)(2009-11#1)
the curvature properties##2##3##(1996-1#2)
the curvature was##2##3##(2008-2#1)(2008-3#1)
the curvature##31##2##(1994-6#1)(1996-1#2)(1997-2#1)(2006-12#1)(2007-11#3)(2007-12#3)(2007-7#1)(2007-8#2)(2008-2#2)(2008-3#3)(2008-9#2)(2009-11#1)(2009-2#3)(2009-6#1)(2010-2#1)(2010-4#1)(2012-1#1)(2012-2#2)
the curve and##2##3##(2008-10#1)(2008-7#1)
the curve is##2##3##(2007-9#1)(2008-11#1)
the curve obtained by adding the Bohr effects of##2##9##(1994-8#2)
the curve obtained by##3##4##(1994-8#2)(2008-10#1)
the curve of the##3##4##(2007-8#1)(2008-10#1)(2008-4#1)
the curve of##13##3##(1993-1#1)(2005-11#1)(2005-8#1)(2007-8#1)(2008-10#2)(2008-4#2)(2009-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the curve pattern##3##3##(2007-7#3)
the curve values##4##3##(2007-10#1)(2007-2#1)(2008-7#1)(2013-7#1)
the curve was##4##3##(2008-10#1)(2013-1#3)
the curve##76##2##(1992-4#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-7#2)(1994-12#2)(1994-8#2)(1996-1#1)(1996-6#1)(1997-1#1)(2004-1#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-7#2)(2007-10#1)(2007-11#3)(2007-2#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-6#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#1)
the curve-fitting##4##2##(2006-12#3)(2006-5#1)
the curved sequence##2##3##(1996-11#2)
the curved surface##2##3##(1994-9#1)(2008-2#1)
the curved##9##2##(1994-9#1)(1996-11#2)(2006-12#1)(2008-2#2)(2008-3#2)(2009-11#1)
the curvelet##3##2##(2008-2#3)
the curves obtained##2##3##(1990-6#1)(2008-10#1)
the curves of##3##3##(2008-2#1)(2010-12#1)(2012-12#1)
the curves##21##2##(1990-6#1)(1994-3#2)(1995-12#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2010-12#1)(2012-12#1)
the cuscore techniques##3##3##(1997-6#3)
the cuscore##6##2##(1997-6#6)
the cushion was inflated##2##4##(2007-6#2)
the cushion was##3##3##(2007-6#3)
the cusp##2##2##(2008-12#1)(2011-2#1)
the cusps##2##2##(1997-5#1)(2008-5#1)
the custom##5##2##(2008-1#1)(2008-10#2)(2008-9#1)(2010-4#1)
the customary##5##2##(1990-7#1)(1997-8#1)(2005-6#1)(2008-1#1)(2010-12#1)
the customer##5##2##(1992-3#1)(1994-12#1)(1995-1#1)(1996-1#1)(1997-3#1)
the customer's##3##2##(1991-12#1)(1994-12#2)
the customers##4##2##(1994-12#1)(1995-2#1)(1996-1#1)(2008-12#1)
the customized##3##2##(2007-12#1)(2013-1#2)
the cut end was##2##4##(1997-4#1)(2008-4#1)
the cut end##6##3##(1997-4#4)(2008-4#2)
the cut ends##2##3##(1997-4#1)(2008-7#1)
the cut##17##2##(1993-12#1)(1994-12#1)(1997-4#6)(2008-10#1)(2008-4#2)(2008-5#3)(2008-7#1)(2009-12#1)(2011-2#1)
the cut-off point##4##3##(2006-10#3)(2011-1#1)
the cut-off value of##2##4##(2008-3#1)(2013-1#1)
the cut-off value was set at##2##6##(1995-1#1)(1996-6#1)
the cut-off value##8##3##(1995-1#1)(1996-6#1)(1997-3#2)(2005-12#1)(2008-3#1)(2010-4#1)(2013-1#1)
the cut-off values for##2##4##(2008-3#1)(2011-1#1)
the cut-off values##4##3##(1994-12#1)(1995-10#1)(2008-3#1)(2011-1#1)
the cut-off##21##2##(1993-1#1)(1994-12#1)(1995-1#1)(1995-10#1)(1996-6#1)(1997-3#2)(2005-12#1)(2006-10#3)(2008-10#1)(2008-3#2)(2009-3#1)(2010-4#1)(2010-5#1)(2011-1#3)(2013-1#1)
the cutaneous lesions##3##3##(2008-5#2)(2013-8#1)
the cutaneous mass##2##3##(2013-8#2)
the cutaneous##28##2##(1990-4#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-6#1)(1993-8#1)(1996-8#1)(2005-7#1)(2006-12#1)(2006-8#1)(2008-5#6)(2009-1#1)(2010-6#2)(2010-9#1)(2012-12#1)(2012-3#1)(2013-8#4)
the cuticle all##2##3##(2007-12#1)(2007-5#1)
the cuticle and##7##3##(2008-10#5)(2011-1#2)
the cuticle layer##2##3##(2008-10#2)
the cuticle of##4##3##(2006-12#1)(2007-12#1)(2008-10#2)
the cuticle##44##2##(1993-12#2)(2006-12#1)(2007-12#11)(2007-5#1)(2008-10#17)(2008-5#4)(2008-7#1)(2008-8#4)(2011-1#3)
the cuticular apparatus##4##3##(2007-12#4)
the cuticular##19##2##(1993-9#1)(2005-10#1)(2007-12#12)(2008-10#1)(2008-5#2)(2008-9#2)
the cutoff frequency of##2##4##(2007-11#1)(2008-1#1)
the cutoff frequency##3##3##(2007-11#1)(2008-1#1)(2008-2#1)
the cutoff in##3##3##(1991-10#3)
the cutoff wavelength##2##3##(2007-11#1)(2007-12#1)
the cutoff##20##2##(1991-10#3)(1992-6#3)(1995-5#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-2#1)(2008-3#2)(2011-1#2)(2011-2#1)(2013-1#1)
the cuts##5##2##(1996-5#1)(2007-5#1)(2008-3#2)(2011-7#1)
the cutting edge##7##3##(1992-7#1)(1994-1#1)(2008-1#2)(2008-6#1)(2008-7#1)(2008-8#1)
the cutting##9##2##(1992-7#1)(1994-1#1)(2008-1#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-12#1)
the cuvette##5##2##(1992-11#1)(2005-8#2)(2008-3#1)(2009-8#1)
the cv##2##2##(2008-10#1)(2008-6#1)
the cw laser##2##3##(2008-2#1)(2008-3#1)
the cw regime##2##3##(2007-11#1)(2007-12#1)
the cw##18##2##(2007-11#3)(2007-12#6)(2008-2#5)(2008-3#4)
the cya##3##2##(1991-7#1)(1997-4#2)
the cyanelle DNA##2##3##(1995-10#1)(1997-6#1)
the cyanelle##4##2##(1995-10#2)(1997-6#2)
the cyanide complex of##2##4##(1993-8#2)
the cyanide##6##2##(1990-12#1)(1990-4#1)(1993-8#2)(2008-10#2)
the cyanine##2##2##(2008-2#1)(2008-3#1)
the cyano propyl stationary phase##2##5##(2008-10#2)
the cyano propyl stationary##3##4##(2008-10#3)
the cyano##4##2##(2007-11#1)(2008-10#3)
the cyanoacrylates##3##2##(2009-2#3)
the cyanobacteria##2##2##(1997-6#1)(2012-2#1)
the cyanobacterial##3##2##(1990-11#1)(1991-12#1)(2012-2#1)
the cyanobacterium Anabaena##3##3##(1991-4#1)(1991-8#1)(1995-1#1)
the cyanobacterium Synechococcus sp##3##4##(1991-12#1)(1992-3#1)(1996-6#1)
the cyanobacterium Synechococcus##4##3##(1990-5#1)(1991-12#1)(1992-3#1)(1996-6#1)
the cyanobacterium Synechocystis##4##3##(1994-8#1)(1994-9#1)(2009-10#2)
the cyanobacterium##21##2##(1990-5#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-4#1)(1991-8#1)(1992-12#1)(1992-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-12#2)(1996-6#1)(1996-9#2)(2009-10#2)
the cyanogen bromide##2##3##(1991-3#1)(2008-4#1)
the cybotactic region##2##3##(2005-11#2)
the cycA mutants##2##3##(1995-6#2)
the cycA##3##2##(1995-6#3)
the cycad Lepidozamia peroffskyana##2##4##(1994-11#2)
the cycad plant##3##3##(1995-7#2)(1996-6#1)
the cycad##5##2##(1994-11#2)(1995-7#2)(1996-6#1)
the cyclase##3##2##(1991-2#1)(1996-11#1)(2008-7#1)
the cycle of the seminiferous epithelium##2##6##(2009-10#2)
the cycle of the##4##4##(1990-11#1)(1993-3#1)(2009-10#2)
the cycle of##11##3##(1990-11#1)(1993-3#1)(2004-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-10#2)(2010-1#1)(2013-1#1)
the cycle##27##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-11#1)(1991-12#1)(1992-4#1)(1992-7#2)(1992-8#1)(1993-3#1)(1994-9#2)(1996-11#1)(1996-3#1)(1996-4#1)(2004-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-10#3)(2010-1#1)(2013-1#1)
the cycles##5##2##(1994-7#2)(1997-3#1)(2008-3#1)(2012-2#1)
the cyclic AMP##5##3##(1990-12#1)(1993-6#1)(1994-10#1)(1994-11#1)(1997-2#1)
the cyclic GMP content##2##4##(1993-11#2)
the cyclic adenosine##2##3##(1994-8#1)(2006-9#1)
the cyclic lipopeptide massetolide A##2##5##(2008-10#2)
the cyclic lipopeptide##3##3##(2008-10#3)
the cyclic peptide##4##3##(1996-8#2)(1997-2#1)(2006-10#1)
the cyclic##45##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1992-6#2)(1993-11#2)(1993-6#1)(1994-10#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#2)(1997-2#3)(2006-10#2)(2006-12#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#4)(2008-4#1)(2009-1#1)(2009-10#1)(2009-8#3)(2010-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
the cyclin D3 pseudogene##2##4##(1997-4#2)
the cyclin##5##2##(1994-12#1)(1997-4#2)(1997-8#1)(2012-3#1)
the cyclin-dependent kinase inhibitor##5##4##(1997-2#1)(2008-11#2)(2012-12#2)
the cyclin-dependent kinase##7##3##(1994-8#1)(1997-2#1)(2008-11#2)(2010-12#1)(2012-12#2)
the cyclin-dependent kinases##2##3##(1994-12#1)(2007-8#1)
the cyclin-dependent##10##2##(1994-12#1)(1994-8#1)(1997-2#1)(1997-6#1)(2007-8#1)(2008-11#2)(2010-12#1)(2012-12#2)
the cycling of##3##3##(1990-8#1)(1993-8#1)(2009-10#1)
the cycling##6##2##(1990-8#1)(1993-11#1)(1993-8#1)(2008-4#1)(2009-10#1)(2010-5#1)
the cyclist##2##2##(1991-2#2)
the cyclization##5##2##(1995-8#2)(2007-11#2)(2010-2#1)
the cyclized##4##2##(1996-5#1)(1996-7#1)(2007-11#1)(2008-4#1)
the cyclo-oxygenase inhibitor##2##3##(1995-11#1)(2006-6#1)
the cyclo-oxygenase##4##2##(1995-11#1)(1995-6#1)(1997-6#1)(2006-6#1)
the cycloadditions##2##2##(1996-5#2)
the cyclodextrin (CD)##2##3##(2008-10#2)
the cyclodextrin cavity##3##3##(1996-2#1)(2008-10#1)(2008-5#1)
the cyclodextrin##10##2##(1996-2#2)(1996-5#1)(2006-12#1)(2008-10#5)(2008-5#1)
the cyclooxygenase (COX)##2##3##(2008-4#1)(2011-2#1)
the cyclooxygenase inhibitor##2##3##(1993-3#1)(1995-12#1)
the cyclooxygenase##11##2##(1992-3#1)(1993-3#1)(1994-2#1)(1994-5#2)(1995-12#1)(1995-7#1)(2006-10#1)(2008-4#2)(2011-2#1)
the cyclooxygenase-2##2##2##(2007-6#1)(2008-3#1)
the cyclopentadienyl##2##2##(1996-2#1)(2007-11#1)
the cyclophosphamide##2##2##(1995-7#1)(2007-7#1)
the cyclosporin A##2##3##(1991-5#1)(1992-7#1)
the cyclosporin##7##2##(1991-11#1)(1991-5#1)(1992-7#1)(1993-11#1)(2007-11#2)(2007-12#1)
the cyclosporine A-induced##2##3##(1995-12#2)
the cyfluthrin##2##2##(2011-2#2)
the cylinder diameters##2##3##(2009-2#2)
the cylinder model##2##3##(2010-8#2)
the cylinder##25##2##(1995-4#1)(1995-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#8)(2009-2#5)(2010-8#2)
the cylinder's##4##2##(2008-2#1)(2008-3#3)
the cylinders##5##2##(2005-11#3)(2008-3#1)(2012-2#1)
the cylindrical epithelium##2##3##(2007-12#2)
the cylindrical inclusion##2##3##(2008-10#2)
the cylindrical inhomogeneity##2##3##(2008-2#2)
the cylindrical##16##2##(2005-11#1)(2006-10#1)(2007-12#2)(2007-9#1)(2008-10#3)(2008-2#4)(2008-3#4)
the cynomolgus monkey##4##3##(2008-10#4)
the cynomolgus##5##2##(1997-8#1)(2008-10#4)
the cyoE gene in##2##4##(1992-12#2)
the cyoE gene##3##3##(1992-12#3)
the cysG promoter##2##3##(1990-7#2)
the cysG##3##2##(1990-7#3)
the cyst and##9##3##(1991-8#1)(2005-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-1#1)(2012-12#1)(2013-1#2)
the cyst cavity##2##3##(1997-8#1)(2012-2#1)
the cyst has##2##3##(2006-5#1)(2009-9#1)
the cyst is##3##3##(2008-12#1)(2011-2#1)(2012-1#1)
the cyst showed##2##3##(2007-8#1)(2009-7#1)
the cyst wall was##2##4##(2007-1#1)(2008-5#1)
the cyst wall##5##3##(1992-6#1)(2007-1#1)(2008-5#1)(2008-7#1)(2013-8#1)
the cyst was##6##3##(1997-8#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#1)
the cyst##66##2##(1990-6#1)(1991-8#3)(1992-6#1)(1992-8#1)(1993-12#1)(1995-12#1)(1997-6#1)(1997-8#2)(2005-9#1)(2006-10#1)(2006-3#1)(2006-5#5)(2007-1#3)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-5#5)(2008-7#5)(2008-9#1)(2009-5#1)(2009-7#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#1)
the cystathionine##2##2##(1995-2#1)(2008-10#1)
the cystatin superfamily##2##3##(1993-3#2)
the cystatin##3##2##(1991-3#1)(1993-3#2)
the cysteine protease papain##2##4##(1997-4#1)(2007-6#1)
the cysteine protease##4##3##(1990-2#1)(1991-2#1)(1997-4#1)(2007-6#1)
the cysteine residue##4##3##(1990-5#1)(1994-3#1)(1994-9#1)(1995-1#1)
the cysteine residues##6##3##(1992-5#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1996-11#1)
the cysteine##31##2##(1990-2#1)(1990-5#1)(1991-1#1)(1991-2#2)(1991-9#1)(1992-2#1)(1992-3#1)(1992-5#2)(1993-11#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-11#1)(1996-8#1)(1997-4#1)(1997-6#2)(2006-12#1)(2007-6#1)
the cysteine-rich##3##2##(1995-2#1)(1995-6#1)(2008-10#1)
the cysteines##3##2##(1991-2#1)(1994-11#2)
the cysteinyl residue of##2##4##(1991-5#1)(1992-7#1)
the cysteinyl##4##2##(1991-5#2)(1992-7#1)(2005-8#1)
the cystic duct##10##3##(1992-9#3)(2008-12#3)(2008-3#2)(2010-12#2)
the cystic fibrosis transmembrane conductance regulator##6##6##(1994-5#1)(1994-9#1)(1995-11#1)(1997-6#1)(2006-10#2)
the cystic fibrosis transmembrane##7##4##(1994-5#1)(1994-9#1)(1995-11#1)(1997-6#1)(2006-10#3)
the cystic fibrosis##10##3##(1990-8#1)(1994-5#1)(1994-9#1)(1995-11#1)(1997-6#1)(2006-10#4)(2007-6#1)
the cystic lesion##3##3##(2006-10#1)(2008-1#1)(2008-5#1)
the cystic lumen##2##3##(2009-3#2)
the cystic##30##2##(1990-8#1)(1992-9#3)(1993-5#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-11#1)(1997-6#1)(2006-10#5)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-12#3)(2008-3#2)(2008-5#2)(2009-3#2)(2010-12#2)
the cystine##3##2##(1990-5#1)(2007-7#1)(2012-12#1)
the cystocele##2##2##(1990-12#2)
the cysts and##3##3##(1993-1#1)(2006-5#1)(2008-5#1)
the cysts are##2##3##(1993-1#1)(2008-7#1)
the cysts in##2##3##(1992-10#1)(2011-2#1)
the cysts were##3##3##(2008-7#1)(2011-1#1)(2012-3#1)
the cysts##23##2##(1992-10#1)(1993-1#3)(1995-12#1)(1996-12#1)(2006-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-5#2)(2008-7#4)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)
the cyt b gene##3##4##(2009-5#1)(2010-4#2)
the cyt b##4##3##(1992-3#1)(2009-5#1)(2010-4#2)
the cyt bc1 complex##3##4##(1992-3#3)
the cyt bc1##4##3##(1992-3#4)
the cyt##10##2##(1992-3#5)(1995-4#1)(2009-5#1)(2010-4#2)(2011-2#1)
the cytidylyltransferase##2##2##(1991-11#1)(1997-2#1)
the cytoarchitecture of the##2##4##(1995-11#1)(2008-11#1)
the cytoarchitecture##3##2##(1995-11#1)(1995-7#1)(2008-11#1)
the cytobrush##3##2##(1992-1#3)
the cytochrome P-450 monooxygenase##2##4##(1990-7#1)(1992-3#1)
the cytochrome P-450##4##3##(1990-7#1)(1992-11#1)(1992-3#1)(2008-3#1)
the cytochrome P450 enzyme##3##4##(1994-11#1)(2009-6#1)(2012-12#1)
the cytochrome P450##17##3##(1991-10#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-5#1)(1996-3#2)(2005-8#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-6#1)(2012-12#1)(2012-2#1)
the cytochrome P450s##2##3##(1993-6#1)(1994-8#1)
the cytochrome b gene##6##4##(1995-11#1)(1995-8#1)(2008-10#4)
the cytochrome b##9##3##(1994-10#1)(1995-11#2)(1995-8#1)(2008-10#4)(2009-9#1)
the cytochrome b5##2##3##(1990-2#1)(1991-2#1)
the cytochrome b6-f complex##4##4##(1991-3#4)
the cytochrome c oxidase##3##4##(1990-2#1)(1994-8#1)(1997-3#1)
the cytochrome c to##2##4##(1994-12#1)(1995-2#1)
the cytochrome c##7##3##(1990-2#1)(1991-3#1)(1994-12#1)(1994-8#1)(1995-2#1)(1997-3#2)
the cytochrome is oxidized##2##4##(1992-6#1)(1995-8#1)
the cytochrome o##2##3##(1995-6#2)
the cytochrome oxidase##5##3##(1994-8#1)(1995-6#2)(1997-6#1)(2008-11#1)
the cytochrome##89##2##(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-3#5)(1992-11#2)(1992-12#2)(1992-3#1)(1992-6#2)(1992-8#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#6)(1994-6#1)(1994-8#8)(1994-9#1)(1995-11#2)(1995-2#1)(1995-5#3)(1995-6#5)(1995-8#2)(1996-3#2)(1996-8#2)(1996-9#2)(1997-3#2)(1997-6#2)(1997-7#1)(2005-8#1)(2006-2#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-6#1)(2009-9#2)(2012-12#1)(2012-2#1)
the cytochromes##4##2##(1991-4#1)(1994-5#1)(1994-8#1)(2006-8#1)
the cytocompatibility of##2##3##(2004-9#1)(2008-5#1)
the cytogenetic analysis##2##3##(1994-6#1)(2012-3#1)
the cytogenetic##9##2##(1990-8#1)(1992-8#1)(1994-6#1)(1996-3#1)(2008-5#2)(2011-12#1)(2012-3#2)
the cytogenetics##2##2##(1997-3#1)(2008-5#1)
the cytokine and##3##3##(1991-12#1)(1995-2#1)(2011-1#1)
the cytokine cascade##2##3##(2006-10#1)(2007-11#1)
the cytokine interleukin-2##2##3##(2007-11#1)(2012-3#1)
the cytokine levels##3##3##(1994-3#1)(2006-4#1)(2008-10#1)
the cytokine milieu##2##3##(2008-8#1)(2012-1#1)
the cytokine network##4##3##(1991-2#1)(1995-12#1)(2007-11#1)(2007-8#1)
the cytokine receptor superfamily##6##4##(1994-11#2)(1994-5#1)(1996-10#1)(1996-2#2)
the cytokine receptor##8##3##(1994-11#2)(1994-5#1)(1996-10#1)(1996-11#2)(1996-2#2)
the cytokine response##2##3##(1996-12#1)(1996-4#1)
the cytokine secretion##3##3##(2008-10#1)(2008-11#2)
the cytokine transforming growth factor-beta##2##5##(1993-12#1)(2006-10#1)
the cytokine transforming growth##3##4##(1993-12#1)(2006-10#1)(2007-9#1)
the cytokine##55##2##(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1992-3#1)(1993-12#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-10#3)(1996-11#2)(1996-12#1)(1996-2#3)(1996-4#1)(2006-10#3)(2006-4#1)(2007-11#7)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-6#1)(2008-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#2)
the cytokine-induced##3##2##(1994-12#2)(1997-6#1)
the cytokines interleukin 3##2##4##(1992-3#1)(1997-4#1)
the cytokines##16##2##(1990-2#1)(1992-3#1)(1992-8#2)(1993-12#2)(1994-6#2)(1995-12#1)(1995-5#1)(1997-4#1)(2005-3#1)(2006-10#1)(2008-11#1)(2009-12#1)(2010-4#1)
the cytologic##5##2##(1991-2#2)(1994-12#1)(2008-6#1)(2012-1#1)
the cytological grading and typing##2##5##(2013-8#2)
the cytological##14##2##(1991-6#1)(1997-2#1)(2007-9#2)(2008-10#2)(2008-11#1)(2009-10#1)(2009-12#1)(2009-7#1)(2011-2#2)(2013-8#2)
the cytologists in##2##3##(2008-6#2)
the cytology##3##2##(2007-2#1)(2012-12#1)(2013-8#1)
the cytolytic activity##4##3##(1990-10#1)(1990-6#1)(1991-12#1)(2008-10#1)
the cytolytic phase of##2##4##(2008-5#2)
the cytolytic##8##2##(1990-10#1)(1990-6#1)(1991-12#1)(1993-6#1)(1994-3#1)(2008-10#1)(2008-5#2)
the cytomegalic cells##2##3##(2012-3#2)
the cytomegalovirus (CMV) promoter##3##4##(1995-12#1)(2008-11#1)(2009-10#1)
the cytomegalovirus##7##2##(1991-9#1)(1995-12#1)(2007-12#1)(2008-11#3)(2009-10#1)
the cytomorphological##2##2##(2005-12#1)(2006-11#1)
the cytopathic effect of##4##4##(1991-3#1)(1992-5#1)(2008-4#1)(2010-12#1)
the cytopathic effect##7##3##(1991-3#1)(1992-5#1)(1996-4#1)(2007-6#1)(2008-4#2)(2010-12#1)
the cytopathic effects of##2##4##(1992-5#1)(1992-8#1)
the cytopathic##9##2##(1991-3#1)(1992-5#2)(1992-8#1)(1996-4#1)(2007-6#1)(2008-4#2)(2010-12#1)
the cytoplasm and cell membrane##2##5##(1994-10#1)(2008-10#1)
the cytoplasm and nucleus##3##4##(1993-12#1)(1994-12#1)(1996-2#1)
the cytoplasm and the nucleus##3##5##(1997-7#1)(2011-2#2)
the cytoplasm and##23##3##(1991-12#1)(1993-12#1)(1994-10#1)(1994-12#1)(1994-6#1)(1994-8#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-7#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2011-2#3)(2012-2#1)
the cytoplasm at##4##3##(1991-2#1)(1991-9#1)(1992-3#1)(1994-3#1)
the cytoplasm during##2##3##(1995-2#1)(2008-8#1)
the cytoplasm in##3##3##(1994-9#1)(1996-9#1)(2006-6#1)
the cytoplasm of E##2##4##(1995-1#1)(2008-8#1)
the cytoplasm of Escherichia coli K-12##2##6##(1991-11#1)(1995-1#1)
the cytoplasm of Escherichia coli##5##5##(1991-11#1)(1991-5#1)(1994-12#1)(1994-2#1)(1995-1#1)
the cytoplasm of eukaryotic cells##2##5##(1994-8#1)(2010-12#1)
the cytoplasm of oocytes##2##4##(1995-12#1)(2013-1#1)
the cytoplasm of the##10##4##(1991-2#1)(1992-2#1)(1995-5#1)(2005-8#1)(2007-12#1)(2008-11#2)(2008-9#1)(2009-2#1)(2012-2#1)
the cytoplasm of##55##3##(1990-11#1)(1991-11#2)(1991-2#1)(1991-5#1)(1991-7#1)(1992-2#1)(1992-3#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-8#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-5#2)(1995-8#2)(1997-2#1)(1997-4#2)(2005-8#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#4)(2008-2#1)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
the cytoplasm transfer##2##3##(2007-12#2)
the cytoplasm was##5##3##(1991-9#1)(1994-6#1)(1995-3#1)(2008-8#1)(2008-9#1)
the cytoplasm where##2##3##(1995-6#1)(2009-8#1)
the cytoplasm with##4##3##(1995-12#1)(1997-4#1)(2008-5#1)(2008-7#1)
the cytoplasm##192##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#2)(1991-11#7)(1991-12#1)(1991-2#2)(1991-5#3)(1991-7#2)(1991-9#2)(1992-1#1)(1992-11#2)(1992-2#1)(1992-3#2)(1992-8#1)(1993-12#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-10#3)(1994-11#3)(1994-12#3)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#4)(1995-12#2)(1995-2#6)(1995-3#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#3)(1996-11#4)(1996-2#1)(1996-3#3)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#5)(1997-7#1)(1997-8#2)(2005-8#2)(2006-10#2)(2006-12#1)(2006-6#2)(2006-7#2)(2007-10#2)(2007-12#4)(2008-1#3)(2008-10#11)(2008-11#10)(2008-2#1)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#6)(2009-10#1)(2009-2#2)(2009-8#3)(2010-12#2)(2011-1#2)(2011-2#8)(2012-12#1)(2012-2#3)(2012-7#2)(2013-1#4)(2013-8#1)
the cytoplasmic TF mutant##2##4##(1995-8#2)
the cytoplasmic and nuclear##2##4##(1990-10#1)(2008-9#1)
the cytoplasmic and##6##3##(1990-10#1)(1992-10#1)(1994-2#1)(1994-5#1)(1995-1#1)(2008-9#1)
the cytoplasmic domain of the receptor##3##6##(1994-5#1)(1996-5#1)(2008-5#1)
the cytoplasmic domain of the##14##5##(1992-5#1)(1994-5#1)(1994-9#3)(1995-3#1)(1996-5#5)(1996-8#1)(1997-6#1)(2008-5#1)
the cytoplasmic domain of##20##4##(1991-1#1)(1992-5#1)(1994-5#1)(1994-9#4)(1995-2#1)(1995-3#1)(1995-8#1)(1996-5#6)(1996-8#1)(1997-4#1)(1997-6#1)(2008-5#1)
the cytoplasmic domain##27##3##(1991-1#1)(1992-11#2)(1992-5#1)(1994-5#1)(1994-9#4)(1995-2#1)(1995-3#1)(1995-8#2)(1996-5#6)(1996-8#3)(1997-4#1)(1997-6#2)(2008-5#1)(2013-1#1)
the cytoplasmic domains of the##3##5##(1994-2#1)(1996-5#1)(2011-1#1)
the cytoplasmic domains of##4##4##(1994-2#1)(1996-5#2)(2011-1#1)
the cytoplasmic face of the##2##5##(1991-1#1)(2013-1#1)
the cytoplasmic face of##3##4##(1991-1#1)(2009-7#1)(2013-1#1)
the cytoplasmic matrix of flagella##2##5##(1997-4#2)
the cytoplasmic matrix of##3##4##(1997-4#3)
the cytoplasmic matrix##6##3##(1992-8#1)(1997-4#4)(2007-9#1)
the cytoplasmic membrane and##3##4##(1991-10#2)(2011-2#1)
the cytoplasmic membrane of Escherichia coli##2##6##(1990-11#1)(1991-5#1)
the cytoplasmic membrane of##6##4##(1990-11#1)(1990-3#1)(1990-4#1)(1991-5#1)(1994-2#1)(2009-10#1)
the cytoplasmic membrane##19##3##(1990-11#1)(1990-3#1)(1990-4#1)(1990-8#2)(1991-10#2)(1991-5#1)(1992-7#1)(1992-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(2008-5#1)(2008-9#1)(2009-10#2)(2011-2#1)
the cytoplasmic portion of the##2##5##(1992-5#1)(2007-12#1)
the cytoplasmic receptor domain##2##4##(1997-7#2)
the cytoplasmic region of##4##4##(1994-3#1)(1994-6#1)(1997-2#1)(2008-5#1)
the cytoplasmic region##5##3##(1994-3#1)(1994-6#1)(1997-2#1)(2008-5#2)
the cytoplasmic regions of##3##4##(1997-2#3)
the cytoplasmic side of the platelet membranes##2##7##(1992-6#2)
the cytoplasmic side of the##5##5##(1990-8#1)(1992-12#1)(1992-6#2)(2009-8#1)
the cytoplasmic side##7##3##(1990-8#1)(1992-12#1)(1992-6#3)(1995-3#1)(2009-8#1)
the cytoplasmic surface of the##2##5##(1991-9#1)(1992-12#1)
the cytoplasmic tail of the HIV-1 envelope glycoprotein##2##8##(1997-4#2)
the cytoplasmic tail of the##3##5##(1991-11#1)(1997-4#2)
the cytoplasmic tail of##7##4##(1991-11#1)(1991-7#1)(1994-9#1)(1997-4#2)(2008-9#1)(2011-1#1)
the cytoplasmic tail##11##3##(1991-10#1)(1991-11#1)(1991-7#1)(1992-5#2)(1994-9#1)(1997-4#2)(2008-9#2)(2011-1#1)
the cytoplasmic##153##2##(1990-10#5)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-8#3)(1991-1#3)(1991-10#3)(1991-11#2)(1991-3#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-4#2)(1992-5#4)(1992-6#3)(1992-7#1)(1992-8#2)(1993-11#1)(1993-3#3)(1994-12#1)(1994-2#5)(1994-3#3)(1994-5#2)(1994-6#2)(1994-9#7)(1995-1#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#5)(1996-5#9)(1996-8#4)(1997-2#4)(1997-4#7)(1997-6#3)(1997-7#3)(2005-12#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-9#7)(2009-10#2)(2009-11#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)
the cytoprotective effect of##3##4##(2008-11#1)(2008-7#1)(2010-12#1)
the cytoprotective##5##2##(1990-9#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-6#1)
the cytosine##2##2##(2008-10#1)(2008-9#1)
the cytoskeletal component##2##3##(1994-9#2)
the cytoskeletal fraction##3##3##(1997-2#3)
the cytoskeletal structure##4##3##(1994-11#1)(1997-1#1)(2007-9#1)(2008-11#1)
the cytoskeletal##17##2##(1992-3#1)(1993-8#1)(1994-11#1)(1994-9#2)(1996-10#1)(1997-1#2)(1997-2#3)(2004-12#1)(2007-12#1)(2007-9#1)(2008-11#1)(2011-1#1)(2013-8#1)
the cytoskeleton and##7##3##(1992-11#1)(1997-3#1)(1997-6#1)(2008-11#1)(2011-2#1)(2012-11#2)
the cytoskeleton in##2##3##(1994-12#1)(2008-1#1)
the cytoskeleton to##3##3##(1992-6#1)(2012-2#1)(2012-3#1)
the cytoskeleton##39##2##(1990-12#1)(1991-1#1)(1992-11#1)(1992-6#2)(1993-11#1)(1994-11#1)(1994-12#3)(1994-9#2)(1995-3#1)(1996-4#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#1)(2006-10#2)(2006-6#1)(2008-1#1)(2008-10#2)(2008-11#3)(2009-10#1)(2009-8#1)(2010-2#1)(2011-2#2)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#1)
the cytosol and the nucleus##2##5##(1997-4#1)(2008-11#1)
the cytosol and the##5##4##(1990-2#1)(1991-2#1)(1997-4#1)(2008-11#1)(2009-8#1)
the cytosol and##20##3##(1990-2#2)(1990-5#2)(1991-2#1)(1992-3#1)(1992-6#1)(1993-9#2)(1996-6#1)(1997-3#1)(1997-4#1)(2008-11#1)(2008-4#1)(2009-10#2)(2009-8#2)(2010-2#2)
the cytosol by##2##3##(1995-11#1)(2007-9#1)
the cytosol fraction of##2##4##(1991-1#1)(1992-1#1)
the cytosol fraction##9##3##(1990-11#2)(1990-7#1)(1991-1#1)(1992-1#1)(1992-6#1)(1997-6#2)(2008-10#1)
the cytosol from##2##3##(1990-5#1)(1994-5#1)
the cytosol in##3##3##(1990-6#1)(1991-10#1)(2005-8#1)
the cytosol is##2##3##(1992-6#1)(2009-8#1)
the cytosol of resting##2##4##(1992-7#2)
the cytosol of the##3##4##(1995-11#1)(1996-2#1)(2010-12#1)
the cytosol of##21##3##(1990-11#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-12#2)(1992-3#1)(1992-7#2)(1993-12#1)(1993-6#1)(1995-11#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-4#1)(2008-9#1)(2010-12#1)(2011-1#1)(2013-1#1)
the cytosol to##18##3##(1990-4#1)(1991-4#3)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1994-12#1)(1994-9#1)(1995-11#2)(1996-2#1)(1996-3#1)(1996-5#2)(1997-1#1)(2011-2#1)
the cytosol with##2##3##(1992-6#1)(1994-12#1)
the cytosol##141##2##(1990-11#3)(1990-2#4)(1990-3#1)(1990-4#2)(1990-5#4)(1990-6#2)(1990-7#1)(1991-1#2)(1991-10#1)(1991-12#2)(1991-2#2)(1991-4#4)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#5)(1992-7#3)(1992-8#1)(1993-12#2)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#4)(1995-3#1)(1995-9#1)(1996-2#2)(1996-3#2)(1996-5#5)(1996-6#1)(1996-7#1)(1997-1#2)(1997-3#1)(1997-4#3)(1997-6#5)(1997-7#2)(2005-8#2)(2006-8#1)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#3)(2009-11#1)(2009-2#3)(2009-3#1)(2009-8#3)(2010-10#1)(2010-12#1)(2010-2#2)(2010-6#1)(2011-1#2)(2011-2#3)(2012-11#4)(2012-12#1)(2013-1#2)
the cytosolic PLA2##2##3##(1996-8#2)
the cytosolic and particulate fractions##2##5##(1991-7#1)(1996-5#1)
the cytosolic and##7##3##(1991-7#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#2)(1996-5#1)
the cytosolic calcium concentration in single##2##6##(1992-4#1)(1994-11#1)
the cytosolic compartment##4##3##(1994-8#1)(1995-11#1)(1995-5#1)(2005-8#1)
the cytosolic enzyme is##2##4##(1991-4#2)
the cytosolic enzyme was##2##4##(1990-5#1)(1996-5#1)
the cytosolic enzyme##6##3##(1990-5#1)(1991-4#2)(1992-11#1)(1996-5#1)(1997-2#1)
the cytosolic form of##3##4##(1992-11#2)(1996-3#1)
the cytosolic fraction of##3##4##(1992-6#1)(1994-3#1)(1995-5#1)
the cytosolic fraction##15##3##(1991-1#3)(1991-2#2)(1991-3#1)(1991-7#1)(1992-11#1)(1992-6#1)(1994-3#1)(1994-5#1)(1995-5#1)(1996-5#2)(1996-8#1)
the cytosolic fractions##3##3##(1990-7#1)(1992-5#1)(1996-2#1)
the cytosolic free Ca2+##2##4##(1990-2#1)(1990-8#1)
the cytosolic free##3##3##(1990-2#1)(1990-8#1)(1992-6#1)
the cytosolic glutathione##3##3##(1995-9#2)(2008-8#1)
the cytosolic level##2##3##(1991-3#1)(1995-12#1)
the cytosolic proteins##2##3##(1997-6#1)(2009-12#1)
the cytosolic side of##2##4##(1995-3#1)(2012-2#1)
the cytosolic side##3##3##(1990-3#1)(1995-3#1)(2012-2#1)
the cytosolic space##2##3##(2007-12#2)
the cytosolic transport##2##3##(1994-6#2)
the cytosolic##95##2##(1990-12#2)(1990-2#4)(1990-3#2)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#3)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#2)(1991-7#2)(1991-8#1)(1992-11#5)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#2)(1993-8#2)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#4)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-9#2)(1996-2#1)(1996-3#2)(1996-5#4)(1996-8#3)(1997-2#1)(1997-3#1)(1997-6#3)(2005-8#2)(2006-12#1)(2007-12#2)(2008-4#1)(2008-8#1)(2009-11#1)(2009-12#1)(2012-12#1)(2012-2#1)
the cytosols##2##2##(1992-9#1)(1995-11#1)
the cytostatic and##2##3##(1996-4#1)(2006-6#1)
the cytostatic effects of##3##4##(1991-5#1)(2012-12#2)
the cytostatic##10##2##(1990-4#1)(1991-5#1)(1996-4#1)(2006-6#1)(2008-5#1)(2008-7#3)(2012-12#2)
the cytotoxic T##2##3##(1993-9#1)(2010-12#1)
the cytotoxic action of the##2##5##(1994-2#1)(1995-3#1)
the cytotoxic action of##6##4##(1994-2#1)(1994-3#1)(1995-1#1)(1995-3#1)(2012-12#2)
the cytotoxic action##7##3##(1994-2#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-3#1)(2012-12#2)
the cytotoxic activities of##3##4##(1994-12#1)(1996-8#2)
the cytotoxic activity of human natural killer cells##3##8##(1990-12#3)
the cytotoxic activity of the##2##5##(1994-9#1)(1997-4#1)
the cytotoxic activity of##12##4##(1990-12#3)(1991-3#1)(1992-9#1)(1994-9#2)(1995-8#1)(1997-4#1)(2006-6#1)(2008-10#1)(2008-3#1)
the cytotoxic activity##14##3##(1990-12#3)(1991-3#1)(1992-5#1)(1992-9#1)(1994-9#2)(1995-8#1)(1997-4#1)(2006-6#1)(2008-10#1)(2008-3#1)(2011-2#1)
the cytotoxic and##3##3##(1993-8#1)(2008-4#1)(2011-2#1)
the cytotoxic effect of bee venom##2##6##(2013-1#2)
the cytotoxic effect of the##2##5##(1993-12#1)(2013-1#1)
the cytotoxic effect of##9##4##(1993-12#1)(2008-12#1)(2009-4#1)(2010-12#2)(2012-12#1)(2013-1#3)
the cytotoxic effect##11##3##(1993-12#1)(1995-8#1)(2008-10#1)(2008-12#1)(2009-4#1)(2010-12#2)(2012-12#1)(2013-1#3)
the cytotoxic effects of MPP+##2##5##(1996-9#2)
the cytotoxic effects of##11##4##(1990-2#1)(1991-9#1)(1995-3#1)(1996-6#1)(1996-9#2)(2007-11#2)(2008-11#1)(2012-3#1)(2013-1#1)
the cytotoxic effects##12##3##(1990-2#1)(1991-9#1)(1995-3#1)(1996-6#1)(1996-9#2)(2007-11#2)(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
the cytotoxic potential of##2##4##(1992-11#1)(2010-12#1)
the cytotoxic response to##2##4##(1994-5#1)(1995-5#1)
the cytotoxic response##7##3##(1992-10#1)(1994-5#1)(1995-5#1)(1995-8#2)(1997-5#1)(2013-8#1)
the cytotoxic##81##2##(1990-12#4)(1990-2#1)(1990-4#2)(1990-8#1)(1991-3#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-3#2)(1995-5#1)(1995-8#5)(1996-3#1)(1996-4#2)(1996-6#1)(1996-8#3)(1996-9#3)(1997-4#1)(1997-5#1)(2005-10#1)(2006-6#1)(2006-9#1)(2007-11#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2009-4#1)(2010-12#4)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
the cytotoxicity against##2##3##(1997-1#1)(2011-3#1)
the cytotoxicity of some##2##4##(2013-1#1)(2013-7#1)
the cytotoxicity of the##7##4##(1991-7#1)(2008-11#1)(2008-5#1)(2008-8#3)(2009-4#1)
the cytotoxicity of##36##3##(1991-5#1)(1991-7#1)(1992-3#1)(1992-8#2)(1993-3#1)(1994-12#1)(1994-5#1)(1995-5#1)(1995-6#1)(1996-6#1)(1996-9#1)(2005-10#1)(2006-12#1)(2007-11#2)(2008-10#2)(2008-11#3)(2008-5#1)(2008-8#5)(2009-4#2)(2012-1#1)(2012-12#2)(2013-1#3)(2013-7#1)
the cytotoxicity##48##2##(1990-2#1)(1991-5#1)(1991-7#1)(1992-3#1)(1992-8#2)(1993-3#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-5#1)(1995-6#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#1)(2005-10#1)(2006-12#2)(2007-11#3)(2008-10#2)(2008-11#4)(2008-5#1)(2008-8#6)(2009-4#2)(2010-12#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-12#2)(2013-1#3)(2013-7#1)
the d##4##2##(1993-11#1)(1996-2#1)(2008-10#1)(2008-11#1)
the dA##2##2##(1991-1#1)(2005-11#1)
the dA-dT##2##2##(1992-6#2)
the dLGN##3##2##(1992-10#2)(1995-11#1)
the dRTA was##2##3##(2008-1#2)
the dRTA##3##2##(2008-1#3)
the da Vinci surgical system##2##5##(2007-5#1)(2008-10#1)
the da Vinci system##2##4##(2006-6#2)
the da Vinci##5##3##(2006-6#2)(2007-5#2)(2008-10#1)
the daily activities##2##3##(2008-9#1)(2010-5#1)
the daily activity##2##3##(2006-4#1)(2009-12#1)
the daily and##3##3##(2008-11#1)(2008-2#1)(2013-8#1)
the daily dietary intake##2##4##(1996-7#1)(2013-7#1)
the daily disposable##2##3##(2005-11#2)
the daily dose of##2##4##(1994-6#1)(2013-1#1)
the daily dose##6##3##(1992-10#1)(1994-6#1)(1995-9#1)(2008-5#1)(2011-2#1)(2013-1#1)
the daily intake of##3##4##(1991-5#1)(1992-9#1)(2013-1#1)
the daily life of##2##4##(2008-11#1)(2010-10#1)
the daily life##5##3##(2006-5#1)(2008-10#1)(2008-11#1)(2010-10#1)(2012-1#1)
the daily lives of##3##4##(2008-2#2)(2012-1#1)
the daily number of##2##4##(2008-10#1)(2011-1#1)
the daily pattern of##2##4##(2008-10#1)(2009-9#1)
the daily photoperiod##2##3##(1994-6#1)(1996-3#1)
the daily practice of medicine##2##5##(1993-3#1)(2012-1#1)
the daily practice of##3##4##(1993-3#1)(2010-9#1)(2012-1#1)
the daily routine##4##3##(1993-12#1)(2007-9#1)(2008-11#1)(2011-2#1)
the daily use of##2##4##(2008-8#1)(2013-8#1)
the daily work##3##3##(1992-2#1)(1994-1#1)(2013-8#1)
the daily##90##2##(1990-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1992-10#1)(1992-2#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-6#2)(1995-12#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-7#1)(1997-3#1)(2005-11#2)(2006-2#2)(2006-4#1)(2006-5#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#6)(2011-2#3)(2012-1#3)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#9)
the dairy##4##2##(1992-10#1)(2006-10#1)(2011-2#1)(2012-2#1)
the dam##5##2##(1991-4#1)(1992-9#1)(2005-10#2)(2013-1#1)
the damage and##3##3##(2007-8#1)(2007-9#1)(2011-1#1)
the damage caused by##8##4##(1992-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-8#1)(2010-12#1)(2013-1#1)
the damage caused##9##3##(1992-3#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-8#1)(2010-12#1)(2013-1#1)
the damage induced by##3##4##(2008-11#1)(2008-4#1)(2011-2#1)
the damage of the##2##4##(1996-7#1)(1997-8#1)
the damage of##4##3##(1996-7#1)(1997-8#1)(2013-8#2)
the damage or##2##3##(2008-1#1)(2008-10#1)
the damage process##2##3##(2008-10#1)(2008-2#1)
the damage threshold of##3##4##(2008-3#3)
the damage threshold##8##3##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#3)(2013-8#1)
the damage to the##3##4##(1996-12#1)(2008-1#1)(2013-8#1)
the damage to##7##3##(1991-9#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-9#1)(2013-8#2)
the damage which is##2##4##(1991-9#1)(2013-8#1)
the damage which##3##3##(1991-9#1)(2008-5#1)(2013-8#1)
the damage##69##2##(1990-4#1)(1990-5#1)(1991-9#3)(1992-3#1)(1992-9#2)(1996-12#1)(1996-7#1)(1997-4#1)(1997-8#2)(2005-4#1)(2005-7#1)(2007-11#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#8)(2008-11#2)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-8#2)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#6)
the damaged area##2##3##(2012-1#2)
the damaged cells##2##3##(2006-7#1)(2012-3#1)
the damaged epidermis##2##3##(1993-5#1)(2008-5#1)
the damaged tissue##2##3##(2006-2#1)(2007-7#1)
the damaged tissues##2##3##(2007-11#1)(2010-8#1)
the damaged##30##2##(1990-11#2)(1990-2#1)(1991-2#1)(1993-11#1)(1993-5#1)(1995-8#1)(2006-2#2)(2006-3#1)(2006-7#1)(2007-11#2)(2007-7#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#2)(2009-3#1)(2009-6#1)(2010-1#1)(2010-8#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
the damages##3##2##(1990-11#1)(1995-6#1)(2009-8#1)
the damaging effects of##7##4##(1994-6#1)(1996-5#1)(1997-7#1)(2006-10#1)(2010-7#1)(2013-1#1)(2013-8#1)
the damaging##9##2##(1993-11#1)(1994-6#1)(1996-5#1)(1997-7#1)(2006-10#1)(2008-10#1)(2010-7#1)(2013-1#1)(2013-8#1)
the damped linear oscillator##2##4##(2009-10#2)
the damped linear##3##3##(2009-10#3)
the damped##4##2##(2008-10#1)(2009-10#3)
the damping is##2##3##(2006-10#1)(2006-11#1)
the damping##4##2##(1991-12#1)(2006-10#2)(2006-11#1)
the damselfish##2##2##(2008-5#2)
the dance##5##2##(2007-2#2)(2009-3#2)(2009-9#1)
the dandruff density##2##3##(2008-5#2)
the dandruff##3##2##(2008-5#3)
the danger of a##2##4##(1994-8#1)(2007-8#1)
the danger of##20##3##(1990-11#1)(1990-12#2)(1992-9#1)(1994-8#1)(1997-4#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
the danger##28##2##(1990-11#1)(1990-12#2)(1992-9#1)(1994-8#1)(1996-11#1)(1997-4#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-12#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
the dangerous##2##2##(2009-10#1)(2010-12#1)
the dangers inherent in##2##4##(1992-3#1)(2007-2#1)
the dangers of AIDS##2##4##(1992-2#1)(1997-6#1)
the dangers of##9##3##(1992-2#1)(1995-6#1)(1997-6#1)(2005-7#1)(2008-10#1)(2009-2#1)(2010-12#1)(2010-5#1)(2013-1#1)
the dangers##15##2##(1990-9#1)(1992-2#1)(1992-3#1)(1995-6#1)(1996-3#1)(1997-6#1)(2005-7#1)(2007-2#2)(2008-10#1)(2009-2#1)(2010-12#1)(2010-5#1)(2013-1#1)(2013-8#1)
the dansyl group##2##3##(1994-5#2)
the dansyl##16##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-7#1)(1992-3#1)(1994-5#5)(1996-5#2)(1997-3#1)(2008-10#3)
the dansylation##2##2##(2008-10#2)
the dark compartment##2##3##(1992-10#1)(1992-8#1)
the dark control##2##3##(2006-3#2)
the dark count##2##3##(2008-3#1)(2010-9#1)
the dark current##2##3##(1992-8#1)(2008-3#1)
the dark or light##2##4##(1993-5#1)(2009-10#1)
the dark or##5##3##(1991-12#1)(1992-7#1)(1993-5#1)(2008-5#1)(2009-10#1)
the dark period##6##3##(1990-7#1)(1994-6#1)(1995-11#1)(1997-2#2)(2008-11#1)
the dark phase##4##3##(1991-2#1)(1993-12#1)(1994-2#1)(2008-5#1)
the dark polymerization studies##2##4##(2008-3#2)
the dark polymerization##3##3##(2008-3#3)
the dark port of##2##4##(2008-1#1)(2008-3#1)
the dark##111##2##(1990-2#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#2)(1992-10#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#3)(1993-12#1)(1993-5#1)(1993-6#1)(1994-2#1)(1994-3#2)(1994-6#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-1#1)(1997-2#2)(1997-4#1)(2006-11#2)(2006-12#2)(2006-3#2)(2006-5#1)(2007-11#4)(2007-12#5)(2008-1#2)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#13)(2008-5#6)(2008-6#1)(2008-8#2)(2009-10#10)(2009-2#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
the data about##3##3##(2008-10#1)(2009-5#1)(2010-12#1)
the data acquired with an##2##5##(2008-3#1)(2010-2#1)
the data acquired##3##3##(2008-10#1)(2008-3#1)(2010-2#1)
the data acquisition and##2##4##(2007-3#1)(2013-7#1)
the data acquisition##4##3##(2007-3#1)(2008-2#1)(2008-7#1)(2013-7#1)
the data also suggest that##2##5##(1993-9#1)(1994-3#1)
the data also##3##3##(1993-9#1)(1994-3#1)(2008-10#1)
the data analysis of##2##4##(1990-3#1)(2008-10#1)
the data analysis was##2##4##(2010-12#1)(2013-8#1)
the data analysis##13##3##(1990-3#1)(1990-8#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-6#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-8#1)
the data analyzed##3##3##(2008-2#1)(2012-12#2)
the data and the##5##4##(1995-6#1)(2007-1#1)(2008-8#1)(2013-8#2)
the data and##30##3##(1992-3#1)(1994-6#1)(1995-11#1)(1995-4#2)(1995-6#1)(1996-12#1)(1996-3#1)(1997-2#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-2#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-2#1)(2010-8#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#2)
the data are also consistent with##3##6##(1993-11#1)(1996-7#1)(2006-3#1)
the data are analyzed##2##4##(1992-11#1)(1994-2#1)
the data are consistent with##3##5##(1992-2#1)(2008-8#1)(2011-2#1)
the data are##33##3##(1990-7#1)(1990-8#1)(1992-11#1)(1992-2#2)(1993-11#1)(1993-12#1)(1993-5#1)(1994-2#2)(1994-9#1)(1995-12#3)(1996-3#1)(1996-5#1)(1996-7#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-2#1)(2010-5#1)(2011-2#1)(2013-8#1)
the data as well as##3##5##(2008-3#1)(2009-8#1)(2013-8#1)
the data as##4##3##(1994-9#1)(2008-3#1)(2009-8#1)(2013-8#1)
the data at##3##3##(1990-8#1)(2008-2#1)(2012-3#1)
the data available from##2##4##(1996-8#1)(2013-8#1)
the data available in the literature##2##6##(1994-6#1)(2012-12#1)
the data available##9##3##(1994-6#1)(1996-8#1)(2007-1#1)(2007-4#1)(2008-11#1)(2008-7#1)(2009-4#1)(2012-12#1)(2013-8#1)
the data base##5##3##(1991-2#1)(1993-12#2)(1993-4#1)(1994-3#1)
the data because of##2##4##(1995-6#1)(2008-2#1)
the data better than the##2##5##(1997-7#1)(2008-10#1)
the data by using##2##4##(2008-3#1)(2008-6#1)
the data by##6##3##(2008-10#1)(2008-3#3)(2008-6#1)(2008-7#1)
the data can be##5##4##(2008-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2012-3#1)
the data can##6##3##(2008-7#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2012-3#1)
the data collected from##2##4##(1991-12#1)(2012-1#1)
the data collected##9##3##(1990-8#1)(1991-12#1)(1992-2#1)(1997-4#1)(2006-12#1)(2008-9#1)(2009-10#1)(2012-1#1)(2013-8#1)
the data collection##6##3##(1993-12#1)(1994-6#1)(1997-2#1)(2007-12#1)(2007-4#1)(2008-11#1)
the data concerning##2##3##(2008-12#1)(2013-1#1)
the data demonstrate that##2##4##(1996-8#1)(2006-8#1)
the data demonstrate##3##3##(1995-1#1)(1996-8#1)(2006-8#1)
the data demonstrated##3##3##(1994-9#1)(1996-6#1)(2010-10#1)
the data derived from##2##4##(2008-11#1)(2008-3#1)
the data do not##5##4##(1992-11#1)(1993-9#1)(2006-10#1)(2008-8#1)(2010-1#1)
the data elements##2##3##(1997-3#1)(2008-6#1)
the data file and##2##4##(1996-12#1)(2008-9#1)
the data file##4##3##(1996-12#2)(2008-9#2)
the data for both##3##4##(2008-10#1)(2008-2#1)(2008-9#1)
the data for each##2##4##(1992-9#1)(2011-2#1)
the data for the##3##4##(2008-11#1)(2008-3#1)(2008-4#1)
the data for##21##3##(1990-11#1)(1992-4#1)(1992-9#1)(1996-1#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-7#2)(2008-9#2)(2011-2#1)(2012-1#1)(2012-3#1)
the data from a##2##4##(1992-6#1)(2008-3#1)
the data from all##2##4##(2006-11#1)(2008-10#1)
the data from the first##2##5##(1996-7#1)(2008-10#1)
the data from the##15##4##(1990-7#1)(1992-11#1)(1996-7#1)(1997-3#1)(2005-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-3#1)
the data from this study##2##5##(1992-5#1)(2008-1#1)
the data from this##3##4##(1992-5#1)(2008-1#1)(2010-6#1)
the data from##37##3##(1990-7#1)(1991-9#1)(1992-11#2)(1992-5#1)(1992-6#1)(1996-7#1)(1997-3#1)(2005-11#1)(2006-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2009-11#1)(2010-12#1)(2010-5#1)(2010-6#2)(2011-1#2)(2011-2#2)(2012-3#1)
the data gathered##2##3##(1997-4#1)(2008-9#1)
the data generated by##3##4##(2008-3#1)(2010-12#1)(2011-2#1)
the data generated##6##3##(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)
the data have been##3##4##(1994-6#1)(2008-10#2)
the data have##4##3##(1994-11#1)(1994-6#1)(2008-10#2)
the data hider##2##3##(2008-2#2)
the data in the##3##4##(1995-8#1)(2007-12#1)(2008-10#1)
the data in##22##3##(1990-8#1)(1995-3#1)(1995-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#2)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
the data indicate that the##3##5##(1990-8#1)(2006-9#1)(2008-10#1)
the data indicate that##11##4##(1990-8#1)(1992-8#1)(1994-12#1)(1996-10#1)(1997-2#1)(2006-9#1)(2008-10#2)(2008-5#1)(2009-8#1)(2011-2#1)
the data indicate##14##3##(1990-8#1)(1992-8#1)(1994-12#1)(1996-10#1)(1997-2#1)(2006-12#1)(2006-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2009-8#1)(2011-2#1)
the data indicated that the##2##5##(2004-12#1)(2008-10#1)
the data indicated that##3##4##(2004-12#1)(2008-10#2)
the data indicated##4##3##(2004-12#1)(2008-10#3)
the data informed##2##3##(2006-5#2)
the data into##3##3##(2007-11#1)(2008-10#1)(2012-12#1)
the data is that##2##4##(2008-6#1)(2012-1#1)
the data is##16##3##(1990-3#1)(1991-12#1)(1994-5#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-9#1)(2010-8#1)(2012-1#2)
the data matrix##3##3##(1992-11#1)(2007-3#1)(2008-10#1)
the data may be##2##4##(2008-1#1)(2013-8#1)
the data may##3##3##(2008-1#1)(2013-8#2)
the data model##2##3##(1997-3#1)(2008-7#1)
the data necessary for##2##4##(1994-3#1)(2006-10#1)
the data obtained at the##2##5##(2011-1#1)(2013-1#1)
the data obtained at##3##4##(1994-8#1)(2011-1#1)(2013-1#1)
the data obtained by the##2##5##(2004-9#1)(2005-11#1)
the data obtained by##9##4##(1991-6#1)(1994-5#1)(1996-5#1)(2004-9#1)(2005-11#1)(2007-7#1)(2008-10#3)
the data obtained from the##2##5##(1990-11#1)(1994-12#1)
the data obtained from##6##4##(1990-11#1)(1994-12#1)(2008-10#1)(2010-8#2)(2012-11#1)
the data obtained in##4##4##(1992-3#1)(1993-3#1)(2007-1#1)(2008-5#1)
the data obtained using the##3##5##(2004-9#1)(2008-10#2)
the data obtained using##4##4##(1995-1#1)(2004-9#1)(2008-10#2)
the data obtained with##3##4##(1994-9#1)(2008-2#1)(2008-5#1)
the data obtained##40##3##(1990-11#1)(1990-3#1)(1991-2#1)(1991-6#1)(1992-3#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1996-5#1)(2004-9#2)(2005-11#1)(2007-1#1)(2007-7#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#1)
the data of a##2##4##(2008-10#1)(2008-2#1)
the data of the##14##4##(1997-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-10#4)(2008-3#2)(2009-7#1)(2009-8#1)(2013-1#1)
the data of##40##3##(1990-8#1)(1991-7#1)(1994-7#1)(1996-12#1)(1997-8#1)(2004-3#1)(2005-4#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#2)(2008-10#7)(2008-2#4)(2008-3#5)(2008-8#1)(2009-4#1)(2009-7#1)(2009-8#2)(2012-2#4)(2012-3#1)(2013-1#1)
the data on the##3##4##(1990-11#1)(2008-11#1)(2011-2#1)
the data on##21##3##(1990-11#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-4#1)(1996-3#1)(1996-4#2)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2013-1#2)
the data or##5##3##(1990-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)
the data page##2##3##(2007-12#1)(2008-3#1)
the data points##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
the data presented in this##3##5##(1994-12#1)(2005-2#1)(2008-7#1)
the data presented in##4##4##(1994-12#1)(2005-2#1)(2005-8#1)(2008-7#1)
the data presented##11##3##(1990-7#1)(1994-12#1)(1994-6#1)(1995-1#1)(2005-2#1)(2005-8#1)(2006-12#1)(2008-10#1)(2008-5#1)(2008-7#2)
the data prior to##2##4##(2008-2#1)(2008-4#1)
the data produced by##2##4##(1996-10#1)(2008-4#1)
the data provide a##2##4##(1994-6#1)(2008-11#1)
the data provide##4##3##(1994-5#1)(1994-6#1)(2008-11#1)(2009-8#1)
the data provided by##2##4##(1991-5#1)(1996-8#1)
the data provided##3##3##(1991-5#1)(1996-8#1)(2008-10#1)
the data quality##2##3##(2007-12#1)(2008-10#1)
the data recorded in##2##4##(2008-10#1)(2012-3#1)
the data regarding the##4##4##(2006-2#1)(2007-11#1)(2010-8#1)(2011-2#1)
the data regarding##6##3##(2006-2#1)(2007-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)
the data related to##2##4##(2011-2#1)(2013-1#1)
the data reported##3##3##(2007-12#1)(2008-2#1)(2009-4#1)
the data required##3##3##(2006-7#1)(2007-12#1)(2008-10#1)
the data reveal that##2##4##(2007-8#1)(2008-7#1)
the data reveal##3##3##(1995-1#1)(2007-8#1)(2008-7#1)
the data set of##2##4##(2007-12#1)(2008-10#1)
the data set##21##3##(1997-6#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#1)(2010-5#1)(2012-3#3)
the data sets of##3##4##(2005-8#1)(2008-10#1)(2010-12#1)
the data sets##16##3##(2005-8#1)(2008-10#9)(2008-2#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2012-11#1)
the data show##3##3##(1990-5#1)(1991-9#1)(1994-6#1)
the data showed##5##3##(1993-3#1)(2007-2#1)(2010-4#1)(2011-1#1)(2012-3#1)
the data shows that##2##4##(1997-2#1)(2008-11#1)
the data sources##5##3##(1991-2#1)(2009-11#1)(2010-12#1)(2013-1#2)
the data structure##2##3##(2008-10#2)
the data suggest a##2##4##(1995-6#1)(2008-5#1)
the data suggest that the##7##5##(1990-7#1)(1994-9#1)(1995-10#1)(1995-8#1)(1996-12#1)(1997-6#1)(2005-10#1)
the data suggest that##20##4##(1990-2#1)(1990-4#1)(1990-7#1)(1992-3#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-10#2)(1995-12#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-6#1)(1997-8#1)(2005-10#1)(2008-1#1)(2008-5#1)(2008-8#1)(2012-2#1)
the data suggest##23##3##(1990-2#1)(1990-4#1)(1990-7#1)(1992-3#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-10#2)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-6#1)(1997-8#1)(2005-10#1)(2008-1#1)(2008-5#2)(2008-8#2)(2012-2#1)
the data suggested##2##3##(1990-6#1)(1997-2#1)
the data suggests##2##3##(2006-11#1)(2010-2#1)
the data supporting##2##3##(2008-10#1)(2008-11#1)
the data system##2##3##(1994-2#1)(1994-3#1)
the data that the##2##4##(1990-9#1)(2006-2#1)
the data that##8##3##(1990-9#1)(1995-6#1)(2006-2#1)(2007-5#1)(2008-11#1)(2008-9#1)(2012-2#1)(2012-3#1)
the data themselves##2##3##(1995-4#1)(2010-12#1)
the data to a##2##4##(2006-10#1)(2007-12#1)
the data to inform##2##4##(2008-11#1)(2008-12#1)
the data to the##3##4##(1997-6#1)(2008-10#1)(2010-4#1)
the data to##23##3##(1993-9#1)(1994-12#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#2)(2009-12#1)(2009-2#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-8#1)
the data uninformed##2##3##(2006-5#2)
the data used and##2##4##(1994-12#1)(1995-6#1)
the data used##4##3##(1994-12#1)(1995-6#1)(2008-10#1)(2008-8#1)
the data via an##2##4##(2008-10#1)(2012-12#1)
the data volume##2##3##(2008-2#1)(2008-3#1)
the data was##10##3##(1995-5#1)(1995-8#1)(2007-10#1)(2008-10#2)(2008-11#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
the data we##2##3##(1992-12#1)(2012-3#1)
the data were analyzed##4##4##(1993-9#1)(2008-10#1)(2008-12#1)(2009-8#1)
the data were used to##2##5##(2008-10#1)(2008-8#1)
the data were##20##3##(1992-7#1)(1993-12#1)(1993-9#1)(1994-1#1)(2005-3#1)(2006-10#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-8#1)(2009-7#1)(2009-8#1)(2011-1#2)(2012-1#1)(2013-8#1)
the data which##2##3##(1994-11#1)(2012-12#1)
the data will be##2##4##(1997-1#1)(2008-1#1)
the data will##3##3##(1997-1#1)(2008-1#1)(2009-6#1)
the data with a##3##4##(2008-7#1)(2009-11#1)(2009-6#1)
the data with the##2##4##(1994-3#1)(2008-2#1)
the data with those##3##4##(2006-4#1)(2008-10#2)
the data with##10##3##(1994-3#1)(2006-4#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#1)(2009-6#1)
the data within##2##3##(1995-1#1)(2008-4#1)
the data##935##2##(1990-11#3)(1990-2#2)(1990-3#4)(1990-4#1)(1990-5#2)(1990-6#3)(1990-7#5)(1990-8#11)(1990-9#1)(1991-12#2)(1991-2#4)(1991-4#1)(1991-5#4)(1991-6#1)(1991-7#1)(1991-9#2)(1992-11#6)(1992-12#1)(1992-2#3)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#6)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#4)(1994-1#1)(1994-11#3)(1994-12#7)(1994-2#5)(1994-3#7)(1994-5#5)(1994-6#8)(1994-7#1)(1994-8#2)(1994-9#7)(1995-1#5)(1995-10#2)(1995-11#2)(1995-12#5)(1995-3#2)(1995-4#3)(1995-5#1)(1995-6#5)(1995-8#5)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#5)(1996-4#2)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#3)(1997-1#2)(1997-2#8)(1997-3#4)(1997-4#5)(1997-5#3)(1997-6#3)(1997-7#3)(1997-8#4)(2004-12#1)(2004-3#1)(2004-9#3)(2005-10#1)(2005-11#6)(2005-2#1)(2005-3#1)(2005-4#3)(2005-8#4)(2006-10#7)(2006-11#3)(2006-12#3)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#5)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#2)(2007-1#5)(2007-10#6)(2007-11#10)(2007-12#21)(2007-2#4)(2007-3#4)(2007-4#4)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#12)(2008-1#8)(2008-10#109)(2008-11#30)(2008-12#5)(2008-2#49)(2008-3#48)(2008-4#15)(2008-5#16)(2008-6#10)(2008-7#30)(2008-8#18)(2008-9#19)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#7)(2009-5#5)(2009-6#2)(2009-7#4)(2009-8#6)(2009-9#3)(2010-1#1)(2010-10#4)(2010-11#3)(2010-12#11)(2010-2#6)(2010-3#1)(2010-4#3)(2010-5#5)(2010-6#2)(2010-7#1)(2010-8#10)(2010-9#1)(2011-1#12)(2011-12#4)(2011-2#17)(2011-3#2)(2012-1#12)(2012-11#2)(2012-12#18)(2012-2#12)(2012-3#22)(2013-1#28)(2013-7#2)(2013-8#16)
the data-reduction process##2##3##(2008-3#2)
the data?##2##2##(1994-2#1)(1997-1#1)
the database and##3##3##(1994-12#1)(2008-4#1)(2008-7#1)
the database as a##2##4##(1997-3#1)(2008-7#1)
the database as##3##3##(1997-3#1)(2006-10#1)(2008-7#1)
the database for##2##3##(2008-4#1)(2010-5#1)
the database in##2##3##(2008-11#1)(2010-5#1)
the database is##4##3##(1991-3#1)(1993-1#1)(2006-10#1)(2008-7#1)
the database of known##3##4##(1993-8#1)(1994-2#1)(2008-4#1)
the database of the##4##4##(2006-11#1)(2007-8#1)(2008-7#1)(2013-7#1)
the database of##12##3##(1993-8#1)(1994-2#1)(1997-8#1)(2006-11#1)(2007-8#1)(2008-4#1)(2008-7#2)(2010-7#1)(2011-1#1)(2012-2#1)(2013-7#1)
the database to##5##3##(2006-10#1)(2007-12#1)(2008-4#2)(2013-1#1)
the database##77##2##(1990-3#1)(1990-7#1)(1991-12#1)(1991-3#2)(1992-1#1)(1992-12#1)(1993-1#2)(1993-4#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-10#1)(1997-2#1)(1997-3#2)(1997-8#1)(2005-10#1)(2006-10#4)(2006-11#1)(2007-1#2)(2007-10#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#10)(2008-5#1)(2008-7#10)(2008-8#1)(2009-10#1)(2009-4#1)(2010-5#4)(2010-7#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#3)
the databases##14##2##(1995-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#3)(2013-8#1)
the dataset at##2##3##(1996-2#1)(2008-8#1)
the dataset##16##2##(1996-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-7#1)(2010-8#1)(2012-3#1)(2013-1#8)
the datasets##2##2##(2008-2#1)(2012-12#1)
the date of the last##2##5##(1996-12#1)(1997-5#1)
the date of the##4##4##(1991-10#1)(1993-11#1)(1996-12#1)(1997-5#1)
the date of##18##3##(1990-8#1)(1991-10#1)(1991-12#1)(1993-11#2)(1996-12#1)(1997-5#1)(2006-12#1)(2008-10#6)(2008-6#1)(2008-7#1)(2009-11#1)(2013-1#1)
the date##25##2##(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1993-11#2)(1996-12#1)(1997-5#1)(2006-12#1)(2008-10#8)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2013-1#2)(2013-8#1)
the dating##2##2##(1996-7#1)(2008-10#1)
the daughter cells##3##3##(1997-6#1)(2009-2#1)(2009-5#1)
the daughter##8##2##(1995-9#2)(1997-6#1)(2008-3#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)
the dawn of a new era##3##6##(2005-6#1)(2008-7#1)(2011-2#1)
the dawn of a new##4##5##(2005-6#1)(2008-5#1)(2008-7#1)(2011-2#1)
the dawn of the##4##4##(1991-11#1)(2007-12#1)(2008-1#1)(2008-10#1)
the dawn of##11##3##(1991-11#1)(2005-6#1)(2006-12#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-7#1)
the dawn##12##2##(1991-11#1)(2005-6#1)(2006-12#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-7#1)
the day after surgery##2##4##(2007-1#1)(2007-8#1)
the day after the##3##4##(2006-6#1)(2007-10#1)(2007-12#1)
the day after##13##3##(1992-7#1)(1992-9#1)(1993-11#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#2)(2010-2#1)(2011-1#1)(2011-2#1)
the day and night##3##4##(1990-12#1)(2007-8#1)(2008-3#1)
the day and##8##3##(1990-12#1)(1995-1#1)(2007-2#1)(2007-8#2)(2008-3#2)(2011-2#1)
the day before surgery##4##4##(1996-3#1)(2008-8#3)
the day before the##2##4##(1992-6#1)(2007-8#1)
the day before##11##3##(1991-3#1)(1992-6#1)(1994-7#2)(1996-3#1)(2007-8#2)(2008-8#3)(2012-2#1)
the day care##2##3##(1994-6#1)(2013-8#1)
the day following##3##3##(1995-3#1)(2010-6#1)(2010-8#1)
the day hospital##2##3##(2008-7#2)
the day in##4##3##(1991-2#2)(2008-1#1)(2011-1#1)
the day of emergence##2##4##(2007-12#2)
the day of grafting##2##4##(1995-2#2)
the day of surgery##9##4##(1992-3#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-8#3)(2012-2#2)
the day of the##7##4##(1992-1#2)(1996-1#1)(1996-3#1)(2007-10#1)(2008-10#1)(2012-12#1)
the day of##51##3##(1990-2#1)(1992-1#3)(1992-3#1)(1992-6#1)(1992-7#1)(1993-1#1)(1994-3#1)(1995-2#4)(1996-1#2)(1996-3#1)(1996-7#1)(1997-7#1)(2004-2#2)(2006-5#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-8#2)(2008-10#6)(2008-5#1)(2008-6#1)(2008-8#3)(2009-5#1)(2009-6#1)(2010-6#1)(2012-12#1)(2012-2#4)(2013-1#1)
the day##146##2##(1990-10#1)(1990-12#1)(1990-2#1)(1991-2#4)(1991-3#1)(1991-9#1)(1992-1#5)(1992-12#1)(1992-3#3)(1992-6#2)(1992-7#3)(1992-9#1)(1993-1#2)(1993-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#4)(1994-7#2)(1995-1#2)(1995-2#4)(1995-3#1)(1996-1#2)(1996-3#2)(1996-7#1)(1997-1#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-2#2)(2006-12#1)(2006-5#2)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#8)(2007-9#1)(2008-1#1)(2008-10#9)(2008-3#3)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#6)(2009-10#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-12#1)(2010-2#1)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#2)(2013-8#1)
the day-night rhythm of##2##4##(1990-7#2)
the day-to-day work##2##3##(2007-10#1)(2008-2#1)
the day-to-day##5##2##(1995-1#1)(2006-5#2)(2007-10#1)(2008-2#1)
the daylight period##2##3##(2008-10#1)(2010-8#1)
the days and##3##3##(2008-11#1)(2009-6#1)(2010-4#1)
the days##11##2##(1993-2#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-6#1)(2010-2#1)(2010-4#1)(2011-2#1)
the daytime##8##2##(1992-8#1)(1993-8#1)(1995-12#1)(2007-10#1)(2008-3#2)(2008-5#1)(2013-1#1)
the db/db mice##2##3##(2009-8#1)(2012-3#1)
the db/db##5##2##(2008-3#1)(2009-8#2)(2012-3#2)
the dbl oncogene product##2##4##(1991-11#2)
the dc Kerr effect##2##4##(2008-1#2)
the dc##10##2##(2007-11#1)(2007-12#1)(2008-1#3)(2008-2#2)(2008-3#2)(2012-2#1)
the de Broglie##2##3##(2008-1#1)(2008-7#1)
the de facto standard in calibration assessment##2##7##(2013-1#2)
the de facto standard##4##4##(2008-10#1)(2008-7#1)(2013-1#2)
the de novo synthesis of##4##5##(1995-12#1)(1995-3#1)(2007-11#1)(2012-1#1)
the de novo##14##3##(1990-11#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-10#1)(1997-3#1)(2007-11#3)(2008-4#1)(2012-1#1)(2013-8#1)
the de##23##2##(1990-11#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-10#1)(1997-3#1)(2007-11#3)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#2)(2012-1#1)(2013-1#2)(2013-8#1)
the deacetylase##4##2##(1990-12#1)(1991-5#1)(2012-12#2)
the deacetylated##2##2##(1996-2#1)(1997-2#1)
the deacetylation process##2##3##(2011-2#2)
the deacetylation##3##2##(1996-6#1)(2011-2#2)
the deactivation of the##2##4##(1996-4#1)(2008-5#1)
the deactivation of##3##3##(1996-4#1)(2008-5#2)
the deactivation##5##2##(1993-11#1)(1996-4#1)(2008-5#2)(2008-8#1)
the deacylation##2##2##(1991-5#1)(1992-9#1)
the dead and##2##3##(2008-11#1)(2008-2#1)
the dead space##2##3##(2008-10#1)(2008-9#1)
the dead volume##3##3##(2007-10#1)(2008-10#1)(2010-11#1)
the dead##30##2##(1991-11#1)(1991-2#1)(1996-5#1)(1997-3#1)(1997-8#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
the deadline driven algorithm##2##4##(2008-2#2)
the deadline driven##3##3##(2008-2#3)
the deadline##5##2##(1991-11#1)(2008-11#1)(2008-2#3)
the deadly##3##2##(2008-10#1)(2010-1#1)(2010-12#1)
the deaf##5##2##(2006-11#1)(2011-2#4)
the deafferented##3##2##(1991-2#1)(1992-10#1)(1997-3#1)
the deal##3##2##(1990-4#1)(1991-7#1)(1997-5#1)
the deamination of##3##3##(1995-8#2)(2009-8#1)
the deamination##5##2##(1992-8#1)(1995-8#2)(1997-7#1)(2009-8#1)
the dearth of##2##3##(2004-11#1)(2007-9#1)
the death and##4##3##(2008-3#2)(2011-2#2)
the death certificate##4##3##(1991-12#1)(1991-2#1)(1996-6#1)(2011-2#1)
the death domain##2##3##(1997-6#2)
the death of HUVECs##2##4##(1995-6#2)
the death of a grandchild##2##5##(2010-9#2)
the death of a significant##2##5##(2009-7#1)(2013-1#1)
the death of a##12##4##(1991-10#1)(1991-6#1)(2008-11#1)(2008-7#1)(2009-5#2)(2009-7#1)(2010-2#1)(2010-9#2)(2011-2#1)(2013-1#1)
the death of one##3##4##(1990-3#1)(2007-2#1)(2007-3#1)
the death of patients##2##4##(1996-11#1)(2007-11#1)
the death of the##9##4##(1994-11#1)(2004-4#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2011-2#1)(2013-1#2)
the death of##56##3##(1990-3#1)(1991-10#1)(1991-6#1)(1991-8#1)(1992-8#2)(1994-11#1)(1995-11#1)(1995-6#2)(1995-7#1)(1996-11#1)(1996-3#1)(1996-6#1)(2004-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#4)(2007-12#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-9#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#4)
the death programme##3##3##(2007-8#1)(2008-11#2)
the death rate##7##3##(1993-1#1)(2005-9#1)(2008-11#1)(2008-7#1)(2010-9#1)(2012-3#1)(2013-8#1)
the death##93##2##(1990-3#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-8#2)(1993-1#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-6#3)(1995-7#1)(1996-11#1)(1996-3#1)(1996-6#2)(1997-6#2)(1997-7#1)(2004-4#1)(2005-8#3)(2005-9#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#4)(2007-12#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-11#5)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#2)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-9#3)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#1)
the deaths in##2##3##(2009-4#1)(2010-8#1)
the deaths occurred##2##3##(2006-2#1)(2007-2#1)
the deaths of##2##3##(2010-12#1)(2012-2#1)
the deaths##15##2##(1993-8#1)(1995-3#1)(2006-2#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-4#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
the debate about the##3##4##(1994-6#1)(2006-10#1)(2012-3#1)
the debate about##7##3##(1992-2#1)(1994-6#1)(1995-2#1)(1997-6#1)(2005-8#1)(2006-10#1)(2012-3#1)
the debate and##2##3##(2006-11#1)(2010-7#1)
the debate concerning the##2##4##(1996-8#1)(2005-7#1)
the debate in##2##3##(1992-10#1)(1997-1#1)
the debate on the##5##4##(2006-10#3)(2008-11#1)(2008-8#1)
the debate on##12##3##(1993-12#1)(1994-12#1)(1996-6#1)(2006-10#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-11#1)(2012-3#1)
the debate over##7##3##(1994-3#1)(1996-5#2)(2007-4#1)(2008-8#2)(2013-7#1)
the debate surrounding##3##3##(1990-6#1)(1992-1#1)(2008-12#1)
the debate##53##2##(1990-6#1)(1991-3#1)(1992-1#1)(1992-10#1)(1992-2#1)(1993-12#2)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-2#1)(1996-5#2)(1996-6#1)(1996-8#2)(1997-1#1)(1997-6#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-11#2)(2006-12#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-6#1)(2008-8#3)(2010-7#1)(2011-2#1)(2012-11#2)(2012-2#1)(2012-3#3)(2013-7#2)
the debates##3##2##(2007-11#1)(2012-3#1)(2013-1#1)
the debilitating##4##2##(2005-11#1)(2007-11#1)(2011-2#1)(2012-3#1)
the debridement of##2##3##(2010-9#1)(2012-2#1)
the debridement##3##2##(2007-8#1)(2010-9#1)(2012-2#1)
the debriefing##3##2##(2007-5#1)(2008-11#2)
the debris flow##2##3##(2008-2#1)(2013-8#1)
the debris##6##2##(2004-9#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2013-8#1)
the debromination of##2##3##(1994-9#2)
the debt##3##2##(1990-2#1)(1992-5#2)
the decade of##2##3##(2007-10#1)(2009-7#1)
the decade##18##2##(1990-12#1)(1990-5#1)(1992-6#1)(1994-2#2)(1994-9#1)(1995-6#1)(2006-5#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#2)(2009-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
the decades##4##2##(2008-5#1)(2008-7#2)(2012-2#1)
the decapeptide##7##2##(1992-11#1)(1992-12#1)(1995-3#1)(1995-5#1)(1996-4#1)(2008-4#2)
the decarboxylase##2##2##(1990-5#1)(1991-12#1)
the decarboxylated dimer##2##3##(1994-11#1)(1996-8#1)
the decarboxylation of##4##3##(1991-6#2)(1991-8#1)(1993-8#1)
the decarboxylation##6##2##(1990-7#1)(1991-6#2)(1991-8#1)(1993-8#2)
the decay constant of##2##4##(1992-2#1)(2008-8#1)
the decay constant##4##3##(1992-2#1)(2008-10#1)(2008-2#1)(2008-8#1)
the decay in##2##3##(2008-2#1)(2008-3#1)
the decay is##2##3##(1990-7#1)(2007-11#1)
the decay of the##8##4##(1991-4#1)(1992-12#1)(1995-1#1)(1996-4#1)(1997-4#1)(2006-6#1)(2008-3#2)
the decay of##15##3##(1991-4#1)(1992-12#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-4#1)(1997-4#2)(2005-11#1)(2006-6#1)(2008-2#1)(2008-3#2)(2009-8#1)
the decay phase##2##3##(1990-11#1)(2008-2#1)
the decay rate of the##2##5##(1992-3#1)(2008-2#1)
the decay rate of##4##4##(1992-3#1)(2007-11#1)(2008-2#1)(2009-5#1)
the decay rate##5##3##(1992-3#1)(2007-11#1)(2007-12#1)(2008-2#1)(2009-5#1)
the decay time constant##3##4##(2008-2#1)(2008-3#2)
the decay time##5##3##(2007-12#1)(2008-2#1)(2008-3#2)(2009-8#1)
the decay##44##2##(1990-11#1)(1990-7#1)(1991-4#1)(1992-12#1)(1992-2#2)(1992-3#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-5#1)(1996-4#1)(1997-4#2)(2005-11#2)(2006-6#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#6)(2008-3#7)(2008-8#1)(2009-5#1)(2009-8#2)(2011-1#1)
the decaying##4##2##(1996-5#1)(2008-10#3)
the deceased##19##2##(1990-4#1)(1990-9#1)(1992-3#1)(1995-3#2)(1995-6#3)(1997-3#1)(2005-7#1)(2006-2#1)(2007-11#1)(2007-3#1)(2007-7#1)(2009-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#1)
the deceased's##2##2##(1995-11#1)(1996-9#1)
the decedent##3##2##(1995-11#1)(2005-8#1)(2010-8#1)
the deceleration##4##2##(1992-9#1)(2006-11#2)(2008-3#1)
the decentralization process##2##3##(2008-7#1)(2011-2#1)
the decentralization##3##2##(2008-7#1)(2011-2#1)(2012-12#1)
the decentralized##2##2##(2008-7#1)(2011-2#1)
the deciding##2##2##(2005-12#1)(2008-5#1)
the decidua##3##2##(1994-9#1)(2008-10#1)(2012-3#1)
the decidualized uterine tissue##2##4##(1997-6#2)
the deciphering of##2##3##(2008-1#1)(2008-7#1)
the decision as to whether##2##5##(1990-3#1)(1995-11#1)
the decision for##5##3##(1993-12#1)(2008-10#1)(2012-2#1)(2013-1#1)(2013-7#1)
the decision is made##2##4##(2007-8#1)(2011-2#1)
the decision is##3##3##(1995-11#1)(2007-8#1)(2011-2#1)
the decision limit##2##3##(2007-8#1)(2008-10#1)
the decision makers##2##3##(2007-2#1)(2013-1#1)
the decision making process##6##4##(1992-3#1)(1996-6#2)(2012-2#3)
the decision making##8##3##(1992-3#1)(1996-6#2)(2007-11#1)(2007-8#1)(2012-2#3)
the decision of nurses to receive influenza vaccinations##2##8##(2012-3#2)
the decision of the##2##4##(1997-8#1)(2012-2#1)
the decision of women to##2##5##(2013-1#2)
the decision of##16##3##(1997-8#1)(2006-9#1)(2007-7#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
the decision process##5##3##(1996-1#1)(2006-9#2)(2008-10#2)
the decision rule##2##3##(2008-10#1)(2010-2#1)
the decision that##3##3##(2005-12#1)(2007-3#1)(2007-8#1)
the decision to stop##2##4##(1997-2#1)(2012-2#1)
the decision to undertake##2##4##(1991-3#1)(1995-4#1)
the decision to use a##2##5##(2007-8#1)(2010-5#1)
the decision to use##3##4##(2007-8#1)(2008-8#1)(2010-5#1)
the decision to##40##3##(1990-2#1)(1991-3#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-4#1)(1996-12#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-4#1)(2005-10#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#3)(2009-12#1)(2009-5#2)(2009-9#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)
the decision tree##2##3##(2008-10#1)(2012-3#1)
the decision was to##2##4##(2008-4#1)(2012-2#1)
the decision whether to##2##4##(2004-10#1)(2009-3#1)
the decision whether##3##3##(2004-10#1)(2007-8#1)(2009-3#1)
the decision##123##2##(1990-2#1)(1990-3#1)(1991-3#1)(1991-7#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#3)(1994-3#1)(1995-11#2)(1995-12#1)(1995-4#1)(1995-6#2)(1995-9#1)(1996-1#2)(1996-12#1)(1996-6#3)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-10#1)(2005-1#1)(2005-10#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-3#1)(2006-9#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#6)(2007-9#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-9#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-11#1)(2012-12#3)(2012-2#7)(2012-3#8)(2013-1#4)(2013-7#1)
the decision-making process for##2##4##(2008-12#2)
the decision-making process of##4##4##(1993-1#1)(2007-2#1)(2009-1#1)(2009-6#1)
the decision-making process##21##3##(1990-10#1)(1990-12#1)(1993-1#1)(1997-1#1)(2006-1#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-12#3)(2008-7#1)(2009-1#1)(2009-10#1)(2009-6#2)(2010-2#1)(2011-2#1)(2012-2#1)(2013-8#2)
the decision-making##24##2##(1990-10#1)(1990-12#1)(1993-1#1)(1993-2#1)(1994-12#1)(1997-1#1)(2006-1#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-12#3)(2008-7#1)(2009-1#1)(2009-10#1)(2009-6#2)(2010-2#1)(2011-2#2)(2012-2#1)(2013-8#2)
the decisions made##2##3##(2012-1#2)
the decisions##8##2##(1993-3#1)(1993-5#1)(1995-1#1)(2009-5#1)(2009-6#1)(2010-9#1)(2012-1#2)
the decisive role##2##3##(2005-11#1)(2008-9#1)
the decisive##9##2##(1995-8#1)(2005-1#1)(2005-11#1)(2007-12#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-2#1)
the declared##2##2##(2007-5#1)(2008-10#1)
the decline in BMD and##2##5##(2007-8#1)(2010-12#1)
the decline in the##4##4##(1990-6#1)(1991-3#1)(2005-10#1)(2008-4#1)
the decline in##21##3##(1990-3#1)(1990-6#1)(1991-3#1)(1994-3#1)(1994-5#1)(1995-1#1)(1996-4#1)(2005-10#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2010-12#2)(2010-3#1)(2012-12#1)
the decline of the##2##4##(2005-1#1)(2008-10#1)
the decline of##16##3##(1991-5#1)(1992-11#1)(1994-8#1)(1995-3#2)(1996-4#1)(2005-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2012-3#1)(2012-7#2)
the decline was##2##3##(2008-11#1)(2013-1#1)
the decline##53##2##(1990-10#1)(1990-3#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-5#2)(1992-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-3#2)(1996-4#2)(2005-1#1)(2005-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-4#2)(2007-8#1)(2008-10#3)(2008-11#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-2#1)(2009-6#1)(2010-12#2)(2010-3#2)(2011-2#1)(2012-12#1)(2012-3#1)(2012-7#2)(2013-1#1)
the declines##2##2##(1990-4#1)(2012-3#1)
the declining physical##2##3##(2005-7#1)(2012-2#1)
the declining##7##2##(1993-3#1)(1996-1#1)(2005-7#1)(2008-6#1)(2009-4#2)(2012-2#1)
the decoded##5##2##(2007-8#1)(2008-2#1)(2008-3#1)(2012-12#2)
the decoder##2##2##(2008-2#2)
the decoding process##2##3##(1990-5#1)(2012-3#1)
the decoding site##2##3##(1994-12#1)(2006-11#1)
the decoding##7##2##(1990-5#1)(1991-6#1)(1994-12#1)(2006-11#1)(2008-2#1)(2008-3#1)(2012-3#1)
the decoloration of##2##3##(2008-10#1)(2008-11#1)
the decomposition and##2##3##(2007-7#1)(2008-2#1)
the decomposition of ONOO(-)##2##4##(2008-10#1)(2010-5#1)
the decomposition of the##4##4##(1992-12#1)(1994-8#1)(2008-10#1)(2008-3#1)
the decomposition of##21##3##(1990-5#2)(1992-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(2005-11#2)(2006-12#1)(2006-5#1)(2008-10#6)(2008-2#1)(2008-3#2)(2009-11#1)(2010-5#1)
the decomposition plateau##2##3##(2008-10#2)
the decomposition rate##2##3##(2004-12#2)
the decomposition##31##2##(1990-5#2)(1992-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(2004-12#2)(2005-11#2)(2006-12#1)(2006-5#1)(2007-7#1)(2008-10#11)(2008-2#3)(2008-3#2)(2009-11#1)(2010-5#1)
the decompression##4##2##(2006-7#1)(2007-11#1)(2009-9#1)(2010-12#1)
the deconvolution##3##2##(1992-1#1)(2008-3#1)(2010-3#1)
the deconvolved##3##2##(1992-4#1)(2008-10#1)(2008-3#1)
the decorated filament##2##3##(1992-3#1)(1993-12#1)
the decorated##5##2##(1992-3#2)(1993-12#1)(1993-9#1)(2008-4#1)
the decoration of##3##3##(1995-2#1)(2008-10#1)(2009-7#1)
the decoration##4##2##(1995-2#1)(2008-10#2)(2009-7#1)
the decorin##2##2##(1992-11#1)(2007-8#1)
the decorrelation##2##2##(2008-2#1)(2008-3#1)
the decrease in absorbance of##6##5##(2008-10#6)
the decrease in absorbance##8##4##(2008-10#8)
the decrease in activity##3##4##(1997-1#1)(2006-10#1)(2008-10#1)
the decrease in brain glucose utilization##2##6##(1995-3#2)
the decrease in colour##2##4##(1993-12#1)(2008-10#1)
the decrease in fluorescence##2##4##(1990-5#1)(1994-5#1)
the decrease in plasma##2##4##(2008-1#1)(2009-7#1)
the decrease in the absorbance of the##2##7##(2008-10#2)
the decrease in the absorbance of##4##6##(2008-10#4)
the decrease in the##27##4##(1992-5#1)(1992-6#1)(1993-12#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-9#1)(1996-11#1)(1996-5#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#1)
the decrease in total##2##4##(1992-12#1)(1996-12#1)
the decrease in##130##3##(1990-11#1)(1990-2#1)(1990-5#2)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#4)(1993-12#3)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#4)(1994-4#2)(1994-5#2)(1994-6#2)(1995-1#1)(1995-11#3)(1995-12#1)(1995-3#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-8#2)(2004-11#1)(2004-12#2)(2004-9#1)(2005-11#3)(2005-12#1)(2005-3#1)(2006-10#3)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#22)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#2)(2010-2#2)(2010-5#1)(2011-1#1)(2011-12#1)(2012-12#1)(2013-1#2)(2013-7#2)
the decrease of body##2##4##(1990-5#1)(1993-3#1)
the decrease of cardiac##2##4##(2007-8#1)(2013-1#1)
the decrease of its##2##4##(1992-3#1)(2007-11#1)
the decrease of plant##2##4##(2013-8#2)
the decrease of the##16##4##(1990-8#1)(1994-11#1)(1995-11#1)(2005-1#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-8#1)(2009-10#1)(2009-2#1)(2010-4#1)(2011-2#1)(2012-12#1)
the decrease of##75##3##(1990-10#2)(1990-12#2)(1990-2#1)(1990-4#2)(1990-5#1)(1990-8#1)(1991-2#1)(1991-3#2)(1992-3#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-11#1)(1994-2#1)(1995-11#1)(1995-3#1)(1996-5#1)(1997-6#1)(2005-1#1)(2005-11#3)(2005-8#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#3)(2008-8#4)(2009-10#2)(2009-2#1)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#3)(2013-8#2)
the decrease was not##3##4##(1995-2#1)(2008-10#2)
the decrease was##8##3##(1991-8#1)(1995-2#1)(2006-8#1)(2008-10#2)(2008-4#1)(2011-1#1)(2012-3#1)
the decrease##224##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#3)(1990-4#2)(1990-5#3)(1990-8#1)(1991-10#1)(1991-2#3)(1991-3#3)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-12#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#4)(1993-11#1)(1993-12#4)(1993-3#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-4#2)(1994-5#2)(1994-6#2)(1995-1#1)(1995-11#4)(1995-12#1)(1995-2#1)(1995-3#4)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-4#1)(1996-5#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-6#1)(1997-8#2)(2004-11#1)(2004-12#2)(2004-9#1)(2005-1#1)(2005-11#6)(2005-12#1)(2005-3#1)(2005-8#1)(2006-10#4)(2006-6#1)(2006-8#3)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#38)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#1)(2009-10#2)(2009-2#1)(2009-5#1)(2009-7#2)(2010-2#2)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#3)
the decreased CL intensity##2##4##(2008-10#2)
the decreased expression of##2##4##(2012-12#1)(2013-1#1)
the decreased risk of##2##4##(1992-9#1)(2013-1#1)
the decreased risk##3##3##(1992-9#1)(2006-10#1)(2013-1#1)
the decreased##56##2##(1990-10#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-8#1)(2010-1#1)(2010-7#2)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)
the decreases in the##2##4##(1992-5#1)(1997-2#1)
the decreases in##8##3##(1991-8#1)(1992-5#2)(1994-3#1)(1996-10#1)(1996-12#1)(1997-2#1)(2009-4#1)
the decreases##10##2##(1991-8#1)(1992-5#2)(1994-3#1)(1996-10#2)(1996-12#1)(1997-2#1)(2009-3#1)(2009-4#1)
the decreasing of##3##3##(2008-10#1)(2008-9#1)(2010-2#1)
the decreasing##13##2##(1992-12#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
the decrement in##2##3##(1997-2#1)(2007-9#1)
the decrement of CL intensity##2##5##(2008-10#2)
the decrement of the##2##4##(1994-2#1)(2005-1#1)
the decrement of##5##3##(1994-2#1)(2005-1#1)(2008-10#3)
the decrement##8##2##(1994-2#1)(1997-2#1)(2005-1#1)(2007-9#1)(2008-10#3)(2013-8#1)
the decrypted##3##2##(2008-3#3)
the decryption##2##2##(2008-3#2)
the dedicated##2##2##(2008-10#1)(2008-8#1)
the dedifferentiation##3##2##(2008-11#3)
the deduced aa sequence of the##2##6##(1991-7#1)(1995-8#1)
the deduced aa sequence of##5##5##(1991-7#1)(1995-2#1)(1995-8#1)(1997-1#2)
the deduced aa sequence##8##4##(1990-4#1)(1991-6#1)(1991-7#1)(1993-12#1)(1995-2#1)(1995-8#1)(1997-1#2)
the deduced aa sequences of##2##5##(1990-4#1)(1993-6#1)
the deduced aa sequences##3##4##(1990-4#1)(1993-2#1)(1993-6#1)
the deduced aa##11##3##(1990-4#2)(1991-6#1)(1991-7#1)(1993-12#1)(1993-2#1)(1993-6#1)(1995-2#1)(1995-8#1)(1997-1#2)
the deduced amino acid (aa) sequence revealed##2##7##(1991-7#1)(1997-2#1)
the deduced amino acid (aa) sequence##6##6##(1991-7#1)(1993-3#1)(1993-6#1)(1994-12#1)(1997-1#1)(1997-2#1)
the deduced amino acid (aa) sequences##3##6##(1991-6#1)(1995-2#1)(1996-10#1)
the deduced amino acid (aa)##9##5##(1991-6#1)(1991-7#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-2#1)(1996-10#1)(1997-1#1)(1997-2#1)
the deduced amino acid sequence of the##3##7##(1992-12#1)(1994-12#2)
the deduced amino acid sequence of##8##6##(1991-12#1)(1991-7#1)(1992-12#1)(1994-12#2)(1994-8#1)(1994-9#1)(2006-8#1)
the deduced amino acid sequence##23##5##(1991-12#1)(1991-7#1)(1992-12#1)(1993-3#1)(1993-9#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1996-7#1)(1997-2#2)(1997-4#1)(1997-5#1)(2005-11#1)(2006-8#1)(2008-10#2)(2008-8#1)(2008-9#1)
the deduced amino acid sequences of the##6##7##(1992-12#1)(1994-2#1)(1995-3#1)(2008-10#2)(2013-8#1)
the deduced amino acid sequences of##9##6##(1992-12#1)(1993-2#1)(1994-2#1)(1994-9#1)(1995-3#1)(1997-7#1)(2008-10#2)(2013-8#1)
the deduced amino acid sequences##15##5##(1990-12#1)(1992-11#1)(1992-12#2)(1993-11#1)(1993-2#1)(1994-2#1)(1994-9#1)(1995-3#1)(1997-7#1)(2008-10#3)(2008-9#1)(2013-8#1)
the deduced amino acid##48##4##(1990-12#1)(1991-12#1)(1991-6#1)(1991-7#2)(1992-11#1)(1992-12#3)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-12#4)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-3#1)(1996-10#1)(1996-7#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-8#1)(2008-10#5)(2008-8#1)(2008-9#2)(2013-8#1)
the deduced amino##49##3##(1990-12#1)(1991-12#1)(1991-6#1)(1991-7#2)(1992-11#1)(1992-12#3)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-12#4)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-3#1)(1996-10#1)(1996-7#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-8#1)(2008-10#5)(2008-8#1)(2008-9#3)(2013-8#1)
the deduced amino-acid sequence of##2##5##(1996-12#1)(1996-9#1)
the deduced amino-acid sequence##5##4##(1994-12#2)(1996-10#1)(1996-12#1)(1996-9#1)
the deduced amino-acid##6##3##(1994-12#3)(1996-10#1)(1996-12#1)(1996-9#1)
the deduced polypeptides##2##3##(1993-11#1)(1996-11#1)
the deduced protein##4##3##(1991-9#1)(1994-12#1)(1996-4#1)(2008-8#1)
the deduced sequence of the##2##5##(1994-9#1)(1995-6#1)
the deduced sequence##5##3##(1992-8#1)(1992-9#1)(1993-2#1)(1994-9#1)(1995-6#1)
the deduced##94##2##(1990-12#1)(1990-4#2)(1991-12#1)(1991-6#3)(1991-7#3)(1991-9#1)(1992-11#1)(1992-12#3)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#1)(1993-2#4)(1993-3#2)(1993-5#1)(1993-6#3)(1993-9#1)(1994-11#1)(1994-12#9)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#2)(1994-9#3)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-4#1)(1996-7#2)(1996-9#1)(1997-1#3)(1997-2#3)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#2)(2006-8#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-8#3)(2008-9#3)(2013-8#1)
the deduction of the##2##4##(2008-2#1)(2010-12#1)
the deep and##3##3##(1991-11#1)(1993-12#1)(1994-10#1)
the deep breathing##2##3##(1994-3#1)(2012-2#1)
the deep cerebellar nuclei##3##4##(1994-10#1)(1995-11#1)(1996-2#1)
the deep dermis##2##3##(2005-11#1)(2010-6#1)
the deep femoral artery##2##4##(1990-2#1)(1990-7#1)
the deep laminae##2##3##(1995-3#1)(1996-9#1)
the deep layers of the superior colliculus##2##7##(1991-3#1)(1994-2#1)
the deep layers of the##3##5##(1991-3#1)(1994-2#1)(2010-5#1)
the deep layers##4##3##(1991-3#1)(1994-10#1)(1994-2#1)(2010-5#1)
the deep sea##6##3##(1992-1#1)(2007-9#1)(2008-5#3)(2009-8#1)
the deep squat##2##3##(2011-2#2)
the deep venous##2##3##(1993-7#1)(2006-6#1)
the deep water pocket##3##4##(1990-8#3)
the deep water##5##3##(1990-8#4)(1991-11#1)
the deep waters##2##3##(1991-11#1)(2007-5#1)
the deep##86##2##(1990-2#1)(1990-7#1)(1990-8#5)(1991-11#4)(1991-3#1)(1992-1#2)(1992-7#1)(1993-12#4)(1993-7#2)(1994-10#3)(1994-2#1)(1994-3#1)(1994-6#2)(1995-11#1)(1995-3#3)(1995-8#1)(1996-2#1)(1996-9#1)(1997-6#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-12#2)(2006-6#1)(2007-11#2)(2007-12#2)(2007-5#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#5)(2009-10#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#4)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#1)
the deep-sea fish##2##3##(2008-11#2)
the deep-sea##5##2##(1991-6#1)(2008-11#3)(2012-2#1)
the deepening##2##2##(2006-7#1)(2012-3#1)
the deeper furrows##2##3##(2008-5#2)
the deeper layers##3##3##(1990-5#1)(1991-9#1)(2008-5#1)
the deeper sections of the submucosal layer##2##7##(2008-5#2)
the deeper##16##2##(1990-5#1)(1991-11#1)(1991-8#1)(1991-9#1)(1996-5#1)(2007-5#1)(2008-3#1)(2008-5#6)(2009-3#1)(2010-11#2)
the deepest##7##2##(1996-2#1)(2008-5#4)(2011-2#1)(2013-8#1)
the deeply##3##2##(1991-3#1)(2006-6#1)(2006-8#1)
the deer##7##2##(2005-7#2)(2008-5#1)(2009-5#1)(2013-7#3)
the default mode##3##3##(2009-9#1)(2012-1#1)(2013-8#1)
the default##11##2##(1995-11#1)(2006-12#1)(2008-11#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#2)(2012-1#1)(2013-8#1)
the defect and##5##3##(2007-11#1)(2008-5#2)(2009-5#1)(2010-7#1)
the defect by##2##3##(1997-1#1)(2012-1#1)
the defect in the##5##4##(1990-7#1)(1992-5#1)(2008-11#1)(2010-12#1)(2011-1#1)
the defect in##10##3##(1990-7#1)(1992-5#1)(1994-8#1)(1995-3#1)(1997-4#1)(2007-10#1)(2007-7#1)(2008-11#1)(2010-12#1)(2011-1#1)
the defect is##7##3##(1990-8#1)(1996-6#1)(2008-1#1)(2008-7#1)(2012-12#2)(2013-8#1)
the defect mode##2##3##(2007-11#2)
the defect of the##3##4##(2008-4#1)(2009-8#1)(2012-1#1)
the defect of##6##3##(1992-4#1)(1993-9#1)(1997-3#1)(2008-4#1)(2009-8#1)(2012-1#1)
the defect was##6##3##(1994-3#1)(1996-6#1)(2007-8#2)(2008-12#1)(2011-2#1)
the defect with##4##3##(2008-6#1)(2011-12#1)(2011-2#1)(2012-2#1)
the defect##79##2##(1990-7#1)(1990-8#1)(1991-2#1)(1992-4#1)(1992-5#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-3#1)(1996-6#2)(1997-1#1)(1997-3#1)(1997-4#1)(2006-12#1)(2007-10#1)(2007-11#10)(2007-12#3)(2007-2#1)(2007-7#2)(2007-8#4)(2008-1#2)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2009-5#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#4)(2012-1#2)(2012-12#5)(2012-2#2)(2013-1#2)(2013-8#2)
the defect-tolerance##2##2##(2012-2#2)
the defective retrovirus##2##3##(2008-11#2)
the defective##10##2##(1990-12#1)(1992-3#1)(1993-9#1)(1995-9#1)(2006-11#1)(2006-2#1)(2008-10#1)(2008-11#2)(2008-4#1)
the defects and##2##3##(2007-11#2)
the defects in##4##3##(1990-5#1)(1997-4#1)(2007-11#1)(2008-10#1)
the defects##14##2##(1990-5#2)(1996-3#1)(1997-4#1)(2006-8#1)(2007-11#4)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-12#1)
the defence##4##2##(1990-4#1)(1990-9#1)(1992-12#1)(1997-5#1)
the defendant##6##2##(1990-3#1)(1991-6#1)(1991-7#2)(1995-12#1)(2007-4#1)
the defendants'##2##2##(1995-6#2)
the defense against##5##3##(2006-10#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-8#1)
the defense bill##2##3##(1995-6#1)(1996-5#1)
the defense gene##2##3##(2008-10#2)
the defense in##2##3##(1993-2#1)(1996-12#1)
the defense mechanism of##3##4##(1991-10#1)(1993-8#1)(1994-6#1)
the defense mechanisms of##4##4##(2007-12#2)(2008-10#2)
the defense mechanisms##6##3##(1991-9#1)(2007-12#2)(2008-10#3)
the defense of##2##3##(1994-3#1)(2005-11#1)
the defense response of##3##4##(1992-8#1)(2008-10#2)
the defense response##7##3##(1992-8#1)(2008-10#4)(2008-9#1)(2009-8#1)
the defense system of the human lungs##2##7##(1992-12#2)
the defense system of##3##4##(1992-12#2)(2008-10#1)
the defense system##4##3##(1992-12#2)(1994-6#1)(2008-10#1)
the defense##42##2##(1991-10#1)(1991-9#1)(1992-12#3)(1992-8#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-3#1)(1994-6#2)(1995-1#1)(1995-6#1)(1996-12#1)(1996-5#1)(2005-11#1)(2006-10#1)(2007-12#2)(2008-10#12)(2008-8#1)(2008-9#5)(2009-8#3)(2010-7#1)
the defensin##2##2##(1993-11#1)(2007-1#1)
the defensive behavior##2##3##(2007-12#2)
the defensive##6##2##(1993-12#1)(2006-10#1)(2007-12#3)(2009-8#1)
the deficiencies of##3##3##(1996-5#1)(2008-9#1)(2009-9#1)
the deficiencies##4##2##(1996-5#1)(2008-9#1)(2009-9#1)(2011-1#1)
the deficiency of##14##3##(1993-2#1)(1994-3#1)(1997-4#1)(2005-3#1)(2006-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
the deficiency##22##2##(1993-12#1)(1993-2#1)(1994-3#1)(1997-4#1)(2004-11#1)(2005-3#1)(2006-6#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
the deficient##8##2##(1991-8#2)(1992-11#1)(1995-11#1)(2008-2#1)(2012-12#1)(2012-2#2)
the deficit in##5##3##(1991-10#1)(1992-10#1)(1992-11#1)(1992-3#1)(2008-4#1)
the deficit irrigation regime##2##4##(2008-10#2)
the deficit syndrome##3##3##(1995-1#2)(1997-2#1)
the deficit was##2##3##(1997-2#2)
the deficit##18##2##(1990-3#1)(1991-10#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-9#1)(1995-1#2)(1997-2#3)(2007-10#1)(2008-10#2)(2008-4#2)(2008-8#1)
the deficit-of-function##2##2##(2010-2#2)
the deficits in##3##3##(1993-12#1)(1993-2#1)(2009-9#1)
the deficits of##4##3##(2006-8#1)(2007-7#1)(2011-1#1)(2013-1#1)
the deficits were##2##3##(1992-9#1)(1994-10#1)
the deficits##12##2##(1990-10#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-10#1)(2006-8#1)(2007-10#1)(2007-7#1)(2009-9#1)(2011-1#1)(2012-1#1)(2013-1#1)
the defined##11##2##(1993-2#1)(1995-6#1)(1996-1#1)(2006-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#2)(2013-1#1)
the defining characteristics of##3##4##(1997-6#1)(2008-2#1)(2012-1#1)
the defining feature##2##3##(1996-1#1)(2009-7#1)
the defining features##2##3##(2009-5#1)(2010-8#1)
the defining##12##2##(1996-1#1)(1997-6#1)(2006-3#1)(2008-2#1)(2008-7#1)(2009-5#1)(2009-7#1)(2010-5#1)(2010-8#1)(2012-1#1)(2013-1#2)
the definite##6##2##(2006-2#1)(2007-2#1)(2007-8#1)(2008-8#1)(2012-2#2)
the definition and##8##3##(2005-8#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-5#2)(2012-2#1)
the definition of a new##3##5##(2006-10#1)(2007-11#1)(2008-10#1)
the definition of a##8##4##(1993-4#1)(1995-10#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
the definition of novel##2##4##(2009-1#1)(2010-9#1)
the definition of the GTV##2##5##(2008-2#2)
the definition of the adult Chiari malformation##2##7##(2006-5#2)
the definition of the##23##4##(1991-12#1)(1991-4#1)(1993-1#1)(1996-9#1)(2006-2#1)(2006-5#2)(2006-8#2)(2007-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#4)(2010-7#1)(2011-1#1)(2012-2#2)
the definition of##82##3##(1990-9#1)(1991-12#2)(1991-2#1)(1991-4#1)(1993-1#1)(1993-2#2)(1993-4#2)(1995-10#1)(1996-8#1)(1996-9#1)(2005-8#1)(2006-10#7)(2006-11#1)(2006-2#1)(2006-5#2)(2006-8#4)(2007-1#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#6)(2008-3#8)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#4)(2009-1#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#3)(2012-2#3)(2013-8#1)
the definition##99##2##(1990-9#1)(1991-12#2)(1991-2#1)(1991-4#1)(1992-11#1)(1993-1#1)(1993-2#2)(1993-4#2)(1995-10#1)(1996-8#1)(1996-9#1)(2005-8#2)(2006-10#7)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-8#5)(2007-1#3)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#7)(2008-3#8)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#4)(2009-1#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-4#2)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#3)(2012-2#5)(2013-8#1)
the definitions and##2##3##(1992-12#1)(2008-11#1)
the definitions of the##2##4##(2008-1#1)(2011-2#1)
the definitions of##7##3##(1996-9#1)(2008-1#1)(2008-2#1)(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
the definitions##13##2##(1991-2#1)(1992-12#1)(1992-5#1)(1993-2#1)(1996-9#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
the definitive diagnosis of##3##4##(2006-10#1)(2008-1#1)(2012-2#1)
the definitive diagnosis##4##3##(2006-10#1)(2007-9#1)(2008-1#1)(2012-2#1)
the definitive diagnostic##2##3##(2008-6#1)(2011-2#1)
the definitive treatment##2##3##(2007-8#1)(2010-3#1)
the definitive##23##2##(1993-2#1)(1995-8#1)(1996-2#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-6#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)
the deflection of a##2##4##(2008-10#1)(2008-2#1)
the deflection of the##2##4##(2005-11#1)(2012-1#1)
the deflection of##4##3##(2005-11#1)(2008-10#1)(2008-2#1)(2012-1#1)
the deflection signal##3##3##(2008-2#3)
the deflection##10##2##(2005-11#1)(2006-11#1)(2007-1#1)(2008-10#1)(2008-2#4)(2008-3#1)(2012-1#1)
the deflections##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
the defocus##3##2##(2005-11#1)(2008-2#2)
the defocused##2##2##(2007-12#1)(2008-2#1)
the deformability of RBC##2##4##(1993-3#2)
the deformability of the##2##4##(1997-6#1)(2006-6#1)
the deformability of##6##3##(1993-3#4)(1997-6#1)(2006-6#1)
the deformable mirror##8##3##(2007-11#1)(2008-2#4)(2008-3#1)(2010-5#2)
the deformable mirrors##2##3##(2007-11#1)(2007-12#1)
the deformable##11##2##(2006-6#1)(2007-11#2)(2007-12#1)(2008-2#4)(2008-3#1)(2010-5#2)
the deformable-mirror drive signals##2##4##(2008-2#2)
the deformable-mirror##3##2##(2008-2#3)
the deformation and##2##3##(2005-11#1)(2009-6#1)
the deformation energy##2##3##(1996-1#2)
the deformation of a##2##4##(1995-12#1)(2008-3#1)
the deformation of the##2##4##(2005-11#1)(2008-2#1)
the deformation of##9##3##(1993-11#1)(1995-12#1)(2005-11#1)(2006-6#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-4#1)(2009-7#1)
the deformation##31##2##(1993-11#1)(1995-12#1)(1996-1#3)(2005-11#2)(2006-6#1)(2007-1#2)(2007-7#1)(2008-10#1)(2008-2#3)(2008-3#7)(2008-5#1)(2008-7#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
the deformational##3##2##(1992-7#1)(2006-6#2)
the deformations of##2##3##(2007-9#1)(2008-3#1)
the deformations##4##2##(2007-9#1)(2008-2#1)(2008-3#1)(2009-10#1)
the deformed##4##2##(2005-11#1)(2006-4#1)(2008-3#1)(2008-5#1)
the deforming##4##2##(2005-11#2)(2008-3#2)
the deformities in##2##3##(2006-3#1)(2007-12#1)
the deformities##4##2##(2006-3#1)(2007-11#1)(2007-12#1)(2007-7#1)
the deformity##17##2##(2005-2#1)(2006-3#1)(2006-8#3)(2007-12#1)(2007-7#3)(2007-8#2)(2008-4#1)(2008-8#2)(2009-10#1)(2009-3#1)(2012-2#1)
the degUh##2##2##(1997-4#2)
the degeneracy##4##2##(1995-5#1)(2008-2#1)(2008-8#1)(2010-7#1)
the degenerate primers##4##3##(1994-12#2)(1996-8#1)(2008-10#1)
the degenerate##10##2##(1994-12#2)(1996-8#1)(1996-9#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#1)
the degenerated##2##2##(2007-12#1)(2008-2#1)
the degeneration of the intervertebral disc##2##6##(2007-11#2)
the degeneration of the##6##4##(1990-5#1)(2007-11#2)(2010-5#1)(2011-1#1)(2011-2#1)
the degeneration of##16##3##(1990-5#3)(1991-9#1)(1992-12#1)(1995-3#1)(2007-11#2)(2008-7#1)(2008-9#1)(2009-12#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#1)
the degeneration##18##2##(1990-5#3)(1991-9#1)(1992-12#1)(1994-8#1)(1995-3#1)(2007-11#2)(2007-12#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#1)
the degenerative changes##5##3##(1990-3#1)(1994-11#1)(2007-11#1)(2013-1#2)
the degenerative process of##2##4##(2006-8#1)(2013-1#1)
the degenerative process##4##3##(2006-8#1)(2008-5#1)(2008-9#1)(2013-1#1)
the degenerative##15##2##(1990-3#1)(1994-11#1)(1997-6#1)(2006-8#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#2)(2013-1#3)
the degradable##3##2##(1990-3#1)(2006-12#1)(2010-2#1)
the degradation due to the##2##5##(2008-11#1)(2008-2#1)
the degradation of IkappaBalpha##2##4##(2008-8#2)
the degradation of a mutant##2##5##(1996-2#1)(1996-9#1)
the degradation of both##3##4##(1997-8#1)(2006-10#1)(2008-10#1)
the degradation of phenol##2##4##(2006-8#2)
the degradation of protein C precursor##2##6##(1995-1#2)
the degradation of the old##2##5##(2008-7#2)
the degradation of the##17##4##(1991-5#1)(1992-11#1)(1992-12#1)(1994-12#1)(1994-2#1)(1996-2#1)(2007-11#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-9#1)(2009-12#1)(2009-3#1)
the degradation of these##2##4##(1995-8#1)(2008-5#1)
the degradation of this##2##4##(1996-9#1)(2008-10#1)
the degradation of##97##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1991-1#2)(1991-11#1)(1991-5#1)(1991-7#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-6#1)(1992-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#3)(1995-6#2)(1995-8#3)(1996-2#2)(1996-5#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-8#1)(2005-11#2)(2006-10#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#11)(2008-11#2)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-12#1)(2009-3#1)(2010-12#1)(2011-12#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
the degradation pathway##3##3##(1990-10#1)(2008-10#1)(2010-4#1)
the degradation process##3##3##(2004-4#1)(2009-11#1)(2009-6#1)
the degradation product##2##3##(1991-5#1)(2008-10#1)
the degradation products of##5##4##(1996-5#1)(2005-12#1)(2008-10#2)(2010-11#1)
the degradation products##14##3##(1990-8#1)(1996-5#1)(2004-12#1)(2005-12#1)(2006-8#1)(2008-10#7)(2010-11#1)(2013-7#1)
the degradation rate##5##3##(1996-9#1)(2008-10#1)(2008-11#2)(2008-6#1)
the degradation rates##3##3##(2004-11#2)(2008-11#1)
the degradation##154##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-4#1)(1991-5#2)(1991-7#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-6#1)(1992-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#4)(1995-6#2)(1995-8#3)(1996-2#3)(1996-5#3)(1996-8#1)(1996-9#4)(1997-1#1)(1997-8#1)(2004-11#2)(2004-12#1)(2004-4#1)(2004-9#1)(2005-11#2)(2005-12#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#24)(2008-11#7)(2008-2#3)(2008-3#7)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#3)
the degradations##4##2##(2008-3#2)(2013-1#2)
the degradative##2##2##(1995-8#1)(2008-5#1)
the degraded##6##2##(1991-7#1)(2007-12#1)(2008-10#2)(2009-3#1)(2013-8#1)
the degranulation##2##2##(1996-2#1)(2007-10#1)
the degree and##7##3##(1997-3#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-1#1)(2012-12#1)
the degree distribution##2##3##(2008-3#1)(2008-5#1)
the degree of DNA superhelicity##2##5##(1992-11#2)
the degree of DNA##4##4##(1992-11#2)(1995-1#1)(2008-11#1)
the degree of activation##3##4##(1994-3#1)(1995-8#1)(1996-8#1)
the degree of aggregation##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
the degree of airway inflammation##2##5##(2007-11#2)
the degree of association##2##4##(1996-2#1)(2008-10#1)
the degree of bacterial##2##4##(2008-10#1)(2012-11#1)
the degree of carotid artery stenosis##2##6##(2007-10#1)(2011-2#1)
the degree of carotid artery##3##5##(2007-10#1)(2011-2#2)
the degree of carotid##4##4##(2007-10#2)(2011-2#2)
the degree of clustering of##2##5##(1990-11#1)(2008-12#1)
the degree of coherence##2##4##(2008-2#1)(2008-3#1)
the degree of competition##2##4##(1997-1#2)
the degree of contracture##2##4##(2008-9#2)
the degree of correlation between##2##5##(2007-12#1)(2008-3#1)
the degree of correlation##4##4##(1996-3#1)(2007-12#1)(2008-3#1)(2012-2#1)
the degree of coupling between##2##5##(1994-12#1)(2011-1#1)
the degree of coupling##3##4##(1994-12#1)(2008-9#1)(2011-1#1)
the degree of crystallinity##2##4##(2004-9#1)(2007-11#1)
the degree of dementia##2##4##(2006-7#1)(2008-7#1)
the degree of deprotonation of##2##5##(1992-6#1)(2008-10#1)
the degree of differentiation of##2##5##(2011-2#2)
the degree of discomfort##2##4##(2004-1#1)(2010-8#1)
the degree of disease control##2##5##(2008-10#2)
the degree of disease##3##4##(2008-10#3)
the degree of distinguishability##2##4##(2008-2#2)
the degree of ellipticity##2##4##(2007-11#1)(2007-12#1)
the degree of enhancement##2##4##(1990-7#1)(2007-11#1)
the degree of enzyme##2##4##(1994-3#1)(2010-7#1)
the degree of expertise##2##4##(1990-12#1)(1992-1#1)
the degree of exposure##2##4##(1994-6#1)(2008-4#1)
the degree of expression##2##4##(2008-9#1)(2011-2#1)
the degree of fasting hyperglycemia##2##5##(1991-7#2)
the degree of fiscal autonomy##2##5##(2011-12#2)
the degree of fluorescence##2##4##(1991-3#1)(1995-8#1)
the degree of fungal##2##4##(2008-10#2)
the degree of gravidas' knowledge of##3##6##(1990-8#3)
the degree of heterogeneity##4##4##(2005-11#1)(2008-10#3)
the degree of host specificity##2##5##(2008-10#1)(2013-1#1)
the degree of hydrophobicity##2##4##(1991-5#1)(2008-7#1)
the degree of hypothermia##3##4##(1993-12#1)(1993-8#1)(2005-8#1)
the degree of impairment##2##4##(1991-1#1)(1991-2#1)
the degree of inbreeding##3##4##(2008-12#1)(2009-5#2)
the degree of increase in##2##5##(1995-12#1)(2008-11#1)
the degree of increase##3##4##(1993-6#1)(1995-12#1)(2008-11#1)
the degree of infection##2##4##(2008-10#1)(2009-4#1)
the degree of inhibition of the##2##6##(2008-10#1)(2011-2#1)
the degree of inhibition of##3##5##(1995-2#1)(2008-10#1)(2011-2#1)
the degree of inhibition##5##4##(1995-11#1)(1995-2#1)(2008-10#1)(2008-7#1)(2011-2#1)
the degree of initial##3##4##(1993-9#1)(2007-8#1)(2008-9#1)
the degree of interaction between##2##5##(2008-2#1)(2008-4#1)
the degree of ionization of##2##5##(2005-11#1)(2006-10#1)
the degree of labeling##2##4##(1995-11#1)(2008-7#1)
the degree of lipid##2##4##(1991-7#1)(1997-2#1)
the degree of liver fibrosis##2##5##(2013-1#2)
the degree of liver##3##4##(1996-9#1)(2013-1#2)
the degree of medical##2##4##(1993-3#1)(2012-11#1)
the degree of methylation##3##4##(1991-2#1)(2008-10#1)(2008-4#1)
the degree of microhematuria and##2##5##(2007-2#2)
the degree of neuronal##2##4##(1995-11#1)(2008-7#1)
the degree of obesity##2##4##(2011-1#1)(2013-8#1)
the degree of omnivory##2##4##(2008-9#2)
the degree of order of the##2##6##(2008-5#2)
the degree of order of##3##5##(2008-5#3)
the degree of oxidative modification of##2##6##(2009-8#1)(2010-12#1)
the degree of pain##2##4##(2007-2#1)(2007-5#1)
the degree of peroxidation##2##4##(1990-11#2)
the degree of phosphorylation of##2##5##(1990-2#1)(1990-4#1)
the degree of phosphorylation##3##4##(1990-2#1)(1990-3#1)(1990-4#1)
the degree of platelet inhibition##2##5##(2008-3#2)
the degree of polarization of##2##5##(2008-2#1)(2008-3#1)
the degree of polarization##9##4##(2007-12#2)(2008-2#4)(2008-3#3)
the degree of polyamine##2##4##(1993-4#2)
the degree of purification##2##4##(1990-5#1)(2008-11#1)
the degree of reduction##2##4##(1995-3#1)(2008-10#1)
the degree of renal##2##4##(1993-12#1)(2008-1#1)
the degree of resistance##6##4##(1993-7#1)(1994-3#1)(2008-10#2)(2012-1#1)(2012-12#1)
the degree of resolution##2##4##(1994-8#1)(2008-2#1)
the degree of response##2##4##(1990-12#1)(2008-5#1)
the degree of retardation##2##4##(1990-10#1)(1991-5#1)
the degree of risk##2##4##(2007-12#1)(2011-2#1)
the degree of role conflict##2##5##(1990-2#2)
the degree of salinity of water##2##6##(2008-3#2)
the degree of saturation of##2##5##(2011-1#1)(2013-1#1)
the degree of saturation##5##4##(2006-3#2)(2011-1#1)(2013-1#2)
the degree of scoliosis##2##4##(2007-7#2)
the degree of sedation##2##4##(2008-8#2)
the degree of sialylation##2##4##(1995-3#1)(2008-8#1)
the degree of similarity##3##4##(1990-11#1)(2008-4#1)(2013-8#1)
the degree of size##2##4##(2008-8#2)
the degree of spatial coherence##2##5##(2007-11#1)(2007-12#1)
the degree of specialization of##2##5##(2008-8#2)
the degree of sperm##2##4##(2006-5#1)(2013-1#1)
the degree of spinal cord##2##5##(1996-1#1)(2008-7#1)
the degree of spinal##3##4##(1996-1#1)(2007-8#1)(2008-7#1)
the degree of stenosis##5##4##(1993-8#1)(2007-10#2)(2008-7#2)
the degree of stress##2##4##(2008-12#1)(2008-5#1)
the degree of surgical##2##4##(2008-3#1)(2009-6#1)
the degree of susceptibility to##2##5##(1992-2#1)(2012-3#1)
the degree of technical##2##4##(1990-12#1)(2009-6#1)
the degree of the##14##4##(1993-5#1)(1997-6#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2013-1#1)(2013-7#1)(2013-8#1)
the degree of this##2##4##(2008-10#1)(2008-3#1)
the degree of tolerance to##2##5##(2008-10#1)(2012-11#1)
the degree of tolerance##3##4##(2008-10#2)(2012-11#1)
the degree of variability in##2##5##(2009-11#1)(2009-6#1)
the degree of variability##3##4##(2008-10#1)(2009-11#1)(2009-6#1)
the degree of vascular##2##4##(2007-10#1)(2008-10#1)
the degree of##591##3##(1990-10#1)(1990-11#5)(1990-12#5)(1990-2#4)(1990-3#3)(1990-4#3)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#4)(1990-9#3)(1991-1#2)(1991-10#1)(1991-11#1)(1991-2#7)(1991-3#3)(1991-5#2)(1991-6#1)(1991-7#4)(1991-8#2)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#3)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#5)(1993-4#3)(1993-5#3)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#4)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#5)(1994-4#1)(1994-5#3)(1994-6#3)(1994-8#3)(1994-9#1)(1995-1#4)(1995-11#4)(1995-12#2)(1995-2#5)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#7)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#4)(1996-4#2)(1996-5#3)(1996-8#2)(1996-9#3)(1997-1#3)(1997-2#3)(1997-3#6)(1997-5#1)(1997-6#2)(2004-1#1)(2004-11#2)(2004-12#2)(2004-4#3)(2004-9#1)(2005-10#2)(2005-11#9)(2005-8#2)(2006-1#1)(2006-10#7)(2006-12#2)(2006-2#1)(2006-3#2)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#1)(2007-10#6)(2007-11#17)(2007-12#15)(2007-2#4)(2007-3#1)(2007-4#4)(2007-5#4)(2007-6#1)(2007-7#7)(2007-8#4)(2007-9#2)(2008-1#5)(2008-10#56)(2008-11#11)(2008-12#5)(2008-2#18)(2008-3#24)(2008-4#5)(2008-5#16)(2008-6#3)(2008-7#26)(2008-8#15)(2008-9#13)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#5)(2009-6#3)(2009-7#3)(2009-8#3)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#3)(2010-8#4)(2011-1#6)(2011-12#3)(2011-2#9)(2012-1#3)(2012-11#4)(2012-12#3)(2012-2#9)(2012-3#1)(2012-5#1)(2013-1#12)(2013-7#1)(2013-8#8)
the degree to which the##7##5##(1992-6#1)(1993-5#1)(1996-3#1)(2006-10#1)(2008-2#1)(2010-6#1)(2011-2#1)
the degree to which their##2##5##(1990-5#1)(2009-7#1)
the degree to which they##3##5##(1996-1#1)(2008-3#1)(2008-9#1)
the degree to which##41##4##(1990-5#1)(1992-2#1)(1992-6#1)(1993-3#1)(1993-5#1)(1993-9#1)(1995-1#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-11#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
the degree##645##2##(1990-10#1)(1990-11#5)(1990-12#5)(1990-2#4)(1990-3#3)(1990-4#3)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#4)(1990-9#3)(1991-1#2)(1991-10#1)(1991-11#1)(1991-2#7)(1991-3#3)(1991-5#2)(1991-6#1)(1991-7#4)(1991-8#2)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#3)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#6)(1993-4#3)(1993-5#4)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#5)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#5)(1994-4#1)(1994-5#3)(1994-6#3)(1994-8#3)(1994-9#1)(1995-1#5)(1995-11#4)(1995-12#2)(1995-2#5)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#7)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#5)(1996-4#2)(1996-5#3)(1996-8#2)(1996-9#3)(1997-1#3)(1997-2#4)(1997-3#7)(1997-5#1)(1997-6#2)(1997-8#1)(2004-1#1)(2004-11#2)(2004-12#2)(2004-4#3)(2004-9#1)(2005-10#2)(2005-11#9)(2005-8#2)(2006-1#1)(2006-10#8)(2006-12#2)(2006-2#1)(2006-3#2)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#1)(2007-10#6)(2007-11#17)(2007-12#15)(2007-2#4)(2007-3#1)(2007-4#5)(2007-5#5)(2007-6#1)(2007-7#7)(2007-8#5)(2007-9#2)(2008-1#5)(2008-10#56)(2008-11#13)(2008-12#7)(2008-2#19)(2008-3#26)(2008-4#7)(2008-5#18)(2008-6#3)(2008-7#28)(2008-8#18)(2008-9#15)(2009-10#1)(2009-11#2)(2009-12#2)(2009-4#1)(2009-5#6)(2009-6#3)(2009-7#4)(2009-8#3)(2010-10#2)(2010-11#4)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#5)(2011-1#6)(2011-12#4)(2011-2#12)(2012-1#4)(2012-11#4)(2012-12#5)(2012-2#10)(2012-3#2)(2012-5#1)(2013-1#12)(2013-7#1)(2013-8#9)
the degrees of freedom of the##2##6##(2006-5#1)(2006-6#1)
the degrees of freedom##3##4##(2006-5#1)(2006-6#1)(2007-11#1)
the degrees of##11##3##(1994-6#1)(2005-11#1)(2005-2#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)
the dehiscence##2##2##(2008-5#1)(2008-8#1)
the dehydrated##2##2##(2008-10#2)
the dehydration##4##2##(2006-6#1)(2008-10#2)(2012-2#1)
the dehydrogenase activity##2##3##(1997-7#1)(2006-5#1)
the dehydrogenase##4##2##(1990-11#1)(1997-7#1)(2006-5#1)(2008-11#1)
the dehydrogenating activity##2##3##(1994-9#2)
the dehydrogenation mixture##2##3##(2010-5#2)
the dehydrogenation##4##2##(1992-7#1)(2010-5#3)
the deinstitutionalization##2##2##(1993-1#1)(2011-7#1)
the deiodination of IUH2 to##2##5##(1994-9#2)
the deiodination of##3##3##(1990-12#1)(1994-9#2)
the del/del##2##2##(2007-9#1)(2013-8#1)
the delay and diffusion##2##4##(2013-8#2)
the delay and##4##3##(1990-11#1)(2011-2#1)(2013-8#2)
the delay between##8##3##(1991-2#1)(1991-3#1)(2005-7#1)(2008-12#1)(2008-3#2)(2010-2#1)(2011-2#1)
the delay in diagnosis##2##4##(2007-8#1)(2009-11#1)
the delay in##14##3##(1991-2#1)(1991-9#1)(1992-3#1)(2005-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2009-11#1)(2009-5#1)(2010-3#1)
the delay of ascospore##2##4##(2008-10#2)
the delay of the increment##2##5##(1993-7#2)
the delay of##8##3##(1993-7#2)(2008-10#2)(2008-12#1)(2012-12#2)(2013-8#1)
the delay period##2##3##(1991-3#1)(2010-2#1)
the delay time##4##3##(2007-12#1)(2010-9#1)(2013-8#2)
the delay was##2##3##(1997-2#1)(2009-11#1)
the delay##65##2##(1990-11#1)(1990-7#2)(1991-2#2)(1991-3#2)(1991-9#1)(1992-3#1)(1993-7#2)(1994-5#1)(1996-2#1)(1997-2#2)(1997-6#1)(2005-7#2)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#3)(2008-2#1)(2008-3#3)(2008-5#1)(2009-11#3)(2009-5#1)(2010-2#2)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-3#1)(2013-8#8)
the delay-time dependence##2##3##(2008-3#2)
the delayed copying##2##3##(2008-4#2)
the delayed matching##2##3##(1990-10#1)(1995-5#1)
the delayed##29##2##(1990-10#2)(1991-2#2)(1992-11#1)(1992-6#1)(1993-12#1)(1994-3#1)(1995-5#1)(1997-2#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#3)(2008-7#1)(2009-5#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-12#1)(2013-1#2)(2013-8#2)
the delays##2##2##(1997-2#1)(2008-2#1)
the deleted receptor##2##3##(1997-7#2)
the deleted region##2##3##(1994-3#1)(2008-10#1)
the deleted##13##2##(1990-10#1)(1990-11#1)(1990-12#1)(1991-7#1)(1993-6#1)(1994-3#2)(1995-1#1)(1997-3#1)(1997-7#2)(2008-10#1)(2013-8#1)
the deleterious consequences of##3##4##(1995-9#1)(2008-3#1)(2009-6#1)
the deleterious effect of the##2##5##(1996-7#1)(2010-8#1)
the deleterious effect of##6##4##(1996-11#1)(1996-7#1)(2008-2#1)(2008-3#1)(2010-8#2)
the deleterious effects of the##2##5##(1991-6#1)(1994-6#1)
the deleterious effects of##15##4##(1991-6#1)(1994-11#2)(1994-6#1)(1996-9#1)(2005-12#1)(2006-8#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-3#3)(2008-4#1)(2008-7#1)
the deleterious effects##18##3##(1991-6#1)(1994-11#2)(1994-6#1)(1996-9#1)(2005-12#1)(2006-8#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-4#1)
the deleterious##32##2##(1991-6#1)(1992-3#1)(1994-11#2)(1994-6#1)(1995-9#1)(1996-11#1)(1996-7#1)(1996-9#1)(2004-12#1)(2005-12#1)(2006-8#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-2#1)(2010-4#1)(2010-7#2)(2010-8#2)
the deletion allele##2##3##(2007-11#2)
the deletion mutant##2##3##(1997-3#1)(2012-3#1)
the deletion mutants##2##3##(1990-3#1)(1990-9#1)
the deletion of exon 9##2##5##(1997-5#2)
the deletion of one##2##4##(1992-9#1)(2005-11#1)
the deletion of the##7##4##(1991-9#1)(1994-5#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-12#1)(2013-8#1)
the deletion of##21##3##(1990-12#1)(1991-10#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-5#1)(1995-12#1)(1996-10#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-7#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-8#1)(2013-8#3)
the deletion##53##2##(1990-11#1)(1990-12#3)(1990-3#1)(1990-5#2)(1990-7#2)(1990-9#1)(1991-10#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-12#2)(1996-4#1)(1996-6#1)(1997-2#2)(1997-3#4)(1997-5#2)(1997-7#1)(2005-11#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-8#3)
the deletions##7##2##(1991-2#1)(1991-8#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-11#1)(1996-8#1)
the deliberately##2##2##(2008-11#1)(2011-1#1)
the deliberations of##2##3##(1994-12#1)(2006-10#1)
the deliberations##3##2##(1994-12#1)(2006-10#1)(2007-12#1)
the delineation of mechanisms of##2##5##(2006-10#2)
the delineation of##12##3##(1993-5#1)(1994-11#1)(1994-6#1)(1996-5#1)(2006-10#2)(2007-10#1)(2008-7#1)(2009-11#2)(2009-2#1)(2010-5#1)
the delinquent adolescent##3##3##(1990-12#3)
the delinquent group##2##3##(1990-12#2)
the delinquent##6##2##(1990-10#1)(1990-12#5)
the delirium protocol##2##3##(2010-10#2)
the delivered protein##2##3##(2008-11#2)
the delivered##11##2##(1991-12#1)(1996-2#2)(1997-8#1)(2007-12#1)(2008-11#2)(2008-3#1)(2010-12#1)(2013-1#1)(2013-7#1)
the deliveries##2##2##(1992-2#1)(1994-2#1)
the delivery and financing of health care##2##7##(1992-3#1)(1995-1#1)
the delivery and##9##3##(1992-3#1)(1995-1#2)(1996-3#1)(2006-8#1)(2008-12#1)(2010-2#1)(2010-6#1)(2013-1#1)
the delivery of a##10##4##(1993-2#1)(1994-8#1)(2006-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2011-1#2)(2012-3#1)(2013-1#1)
the delivery of aerosolized##2##4##(1995-3#2)
the delivery of an##4##4##(2006-10#1)(2008-5#2)(2010-8#1)
the delivery of care to##2##5##(2007-12#1)(2011-1#1)
the delivery of care##7##4##(1992-2#1)(2006-2#1)(2007-12#1)(2007-4#1)(2008-11#1)(2009-8#1)(2011-1#1)
the delivery of complex##2##4##(1993-4#1)(2010-8#1)
the delivery of concurrent chemotherapy and radiotherapy##2##7##(2008-6#2)
the delivery of excellent##2##4##(1993-3#1)(2007-12#1)
the delivery of health care in##2##6##(1997-1#1)(2013-8#1)
the delivery of health care services##5##6##(1994-12#1)(1994-3#1)(1995-3#2)(2010-3#1)
the delivery of health care##12##5##(1992-1#1)(1994-12#2)(1994-3#2)(1995-3#2)(1997-1#1)(2006-6#1)(2010-3#1)(2010-8#1)(2013-8#1)
the delivery of health services##6##5##(1993-2#1)(1993-6#1)(2008-1#1)(2009-3#1)(2010-5#1)(2010-8#1)
the delivery of health##20##4##(1992-1#1)(1993-2#1)(1993-6#1)(1994-1#1)(1994-12#2)(1994-3#2)(1995-3#2)(1997-1#1)(2004-12#1)(2006-6#1)(2008-1#1)(2009-3#1)(2010-3#1)(2010-5#1)(2010-8#2)(2013-8#1)
the delivery of mental health services to##2##7##(1994-1#1)(1996-3#1)
the delivery of mental health services##3##6##(1994-1#2)(1996-3#1)
the delivery of nursing care##2##5##(2007-3#1)(2008-11#1)
the delivery of oxygen##2##4##(2005-7#1)(2011-2#1)
the delivery of preventive care##3##5##(2006-2#3)
the delivery of services##4##4##(1991-3#1)(1994-12#1)(1997-2#2)
the delivery of the##2##4##(1990-6#1)(2009-11#1)
the delivery of therapeutic##4##4##(2007-11#1)(2008-5#2)(2008-6#1)
the delivery of##138##3##(1990-4#1)(1990-6#1)(1991-2#1)(1991-3#3)(1992-1#2)(1992-2#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#2)(1994-1#3)(1994-12#4)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#5)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#3)(1997-6#1)(1997-7#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#3)(2006-10#3)(2006-2#4)(2006-5#2)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#5)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#9)(2008-6#4)(2008-7#5)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-8#6)(2011-1#5)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
the delivery system is promising for future in vivo controlled-release biomedical applications##2##12##(2012-11#2)
the delivery system of choice##2##5##(1996-1#1)(1996-2#1)
the delivery system##14##3##(1993-3#1)(1995-1#1)(1996-1#2)(1996-2#1)(1997-2#1)(2008-3#1)(2008-7#1)(2009-5#1)(2012-11#2)(2012-2#2)(2012-6#1)
the delivery##175##2##(1990-4#1)(1990-6#1)(1991-2#1)(1991-3#3)(1992-1#2)(1992-2#2)(1992-3#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#2)(1994-1#3)(1994-12#5)(1994-2#1)(1994-3#4)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#4)(1995-12#1)(1995-3#5)(1995-6#1)(1996-1#2)(1996-2#3)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#4)(1997-6#1)(1997-7#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#3)(2006-10#3)(2006-2#4)(2006-5#2)(2006-6#2)(2006-8#3)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#2)(2008-1#3)(2008-10#1)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#6)(2008-5#11)(2008-6#4)(2008-7#6)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#6)(2011-1#5)(2011-2#2)(2012-1#1)(2012-11#2)(2012-2#3)(2012-3#4)(2012-6#1)(2013-1#4)(2013-8#1)
the delocalization##2##2##(2007-11#1)(2010-4#1)
the delta 12-16##2##3##(1994-12#2)
the delta 2##2##3##(1995-12#2)
the delta G degrees for adding a##2##7##(1996-4#2)
the delta G degrees for##3##5##(1996-4#3)
the delta G degrees value of##2##6##(1993-8#2)
the delta G degrees##6##4##(1993-8#3)(1996-4#3)
the delta G##7##3##(1993-8#3)(1995-1#1)(1996-4#3)
the delta opioid receptor##4##4##(1992-3#1)(1997-2#2)(1997-7#1)
the delta pH##3##3##(1991-2#1)(1996-9#1)(1997-1#1)
the delta receptor##3##3##(1994-9#1)(1995-3#1)(1995-6#1)
the delta##46##2##(1990-11#1)(1990-7#2)(1990-8#1)(1991-2#3)(1991-7#1)(1991-9#1)(1992-3#1)(1993-8#3)(1994-11#1)(1994-12#3)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#2)(1996-4#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#2)(2005-8#1)(2008-10#1)(2008-11#2)(2008-2#2)(2013-8#1)
the delta-9##2##2##(1996-6#2)
the delta-opioid receptor antagonist naltrindole##3##5##(1996-12#3)
the delta-opioid receptor##6##3##(1992-9#1)(1996-12#4)(2009-7#1)
the delta-receptor##3##2##(1991-9#1)(1992-9#2)
the delta-selective##2##2##(1995-12#1)(1995-3#1)
the delta-subunit##2##2##(1992-12#1)(2005-8#1)
the deltarelA mutant##2##3##(2007-12#2)
the deltarshA mutant##2##3##(2007-12#2)
the deltoid muscle##5##3##(2007-12#1)(2009-9#2)(2010-4#1)(2013-8#1)
the deltoid##8##2##(2006-12#1)(2007-12#1)(2009-9#2)(2010-4#2)(2013-8#2)
the delusion##4##2##(1997-8#2)(2006-12#1)(2007-5#1)
the delusional##3##2##(2006-2#2)(2007-7#1)
the demand for health care##2##5##(1996-3#1)(1997-8#1)
the demand for this##2##4##(1995-3#1)(2006-10#1)
the demand for##38##3##(1990-12#1)(1990-2#2)(1990-6#2)(1994-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-8#2)(2006-10#3)(2006-6#1)(2006-7#1)(2006-8#1)(2007-2#1)(2007-4#2)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-1#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#2)
the demand is##2##3##(1994-1#1)(2007-4#1)
the demand of grain filling##2##5##(2008-9#2)
the demand of##3##3##(2008-9#2)(2013-1#1)
the demand##49##2##(1990-12#1)(1990-2#2)(1990-6#2)(1992-2#1)(1994-1#1)(1994-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-8#2)(2006-10#3)(2006-6#1)(2006-7#2)(2006-8#1)(2007-2#2)(2007-4#3)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#3)(2010-1#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#1)
the demanding##3##2##(1993-2#1)(2007-7#1)(2012-1#1)
the demands for##3##3##(2007-5#1)(2008-4#1)(2008-9#1)
the demands of a##2##4##(2006-8#1)(2008-2#1)
the demands of increased##2##4##(2007-7#1)(2011-2#1)
the demands of its##2##4##(1994-9#1)(2011-1#1)
the demands of the patient##2##5##(2009-5#1)(2012-3#1)
the demands of the##6##4##(1990-12#1)(1993-12#1)(1994-2#1)(2008-7#1)(2009-5#1)(2012-3#1)
the demands of##26##3##(1990-12#2)(1991-11#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-2#1)(2005-12#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-5#2)(2010-8#1)(2011-1#2)(2011-2#3)(2012-3#2)(2013-8#1)
the demands on##2##3##(2006-4#1)(2008-3#1)
the demands##41##2##(1990-12#2)(1991-11#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-12#1)(1994-2#3)(1994-9#1)(1995-12#2)(1995-2#1)(2005-12#1)(2006-4#1)(2006-8#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#2)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-3#2)(2013-8#1)
the demented elderly##2##3##(1990-12#1)(1991-7#1)
the demented##3##2##(1990-12#1)(1991-7#1)(2008-7#1)
the demerits of##2##3##(2008-10#1)(2009-6#1)
the demetalization##2##2##(2008-10#2)
the demethylated##2##2##(1991-5#2)
the demethylating##2##2##(2007-11#1)(2013-1#1)
the demise of##5##3##(1993-2#1)(2006-7#1)(2008-11#1)(2008-12#1)(2013-7#1)
the demodulated##4##2##(2007-12#1)(2008-3#3)
the demodulation of the##2##4##(2006-12#1)(2008-3#1)
the demodulation process##3##3##(2008-3#3)
the demodulation##8##2##(2006-12#1)(2008-1#1)(2008-2#1)(2008-3#5)
the demographic and clinical##2##4##(1990-4#1)(2007-3#1)
the demographic and##9##3##(1990-4#1)(1994-3#1)(2006-10#1)(2007-3#2)(2010-12#1)(2012-11#2)(2012-3#1)
the demographic basis of##3##4##(2008-8#3)
the demographic characteristics of##4##4##(1992-1#1)(2007-3#1)(2007-7#1)(2011-1#1)
the demographic data##2##3##(2008-4#1)(2013-1#1)
the demographic factors##2##3##(2008-9#1)(2013-8#1)
the demographic features##2##3##(2006-8#1)(2008-5#1)
the demographic figures##3##3##(1992-5#3)
the demographic parameters##2##3##(2009-2#1)(2011-2#1)
the demographic profile of##2##4##(1995-2#1)(2008-4#1)
the demographic survey##2##3##(2008-8#2)
the demographic##46##2##(1990-4#1)(1992-1#1)(1992-5#3)(1994-3#1)(1995-12#1)(1995-2#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-3#3)(2007-7#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#4)(2009-2#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-3#1)(2013-1#1)(2013-8#1)
the demographics and##3##3##(2007-2#1)(2008-5#1)(2012-2#1)
the demographics of##4##3##(1992-2#1)(2006-10#1)(2008-4#1)(2013-1#1)
the demographics##13##2##(1992-2#1)(2004-3#1)(2006-10#1)(2007-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-2#2)(2013-1#3)
the demography##4##2##(2008-8#3)(2011-11#1)
the demonstrated##11##2##(1992-6#1)(1995-2#1)(1996-5#1)(1996-9#1)(2007-11#3)(2008-11#1)(2008-2#1)(2008-7#1)(2013-1#1)
the demonstration of a##8##4##(1991-8#1)(1992-6#1)(2007-12#3)(2008-1#1)(2008-2#1)(2010-4#1)
the demonstration of the presence of##2##6##(2008-4#1)(2008-5#1)
the demonstration of the##9##4##(1997-6#1)(2007-11#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2011-2#1)(2013-8#1)
the demonstration of two##2##4##(1997-6#1)(2011-2#1)
the demonstration of##41##3##(1991-10#1)(1991-8#1)(1992-6#1)(1993-10#1)(1993-8#1)(1994-4#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-8#1)(1996-12#1)(1997-6#3)(2005-7#1)(2006-1#1)(2007-11#2)(2007-12#7)(2007-7#2)(2008-1#2)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-8#1)
the demonstration that##8##3##(1991-12#1)(1995-8#1)(1996-10#1)(1996-3#1)(2005-10#1)(2006-10#1)(2006-2#1)(2008-10#1)
the demonstration##52##2##(1991-10#1)(1991-12#1)(1991-8#1)(1992-6#1)(1993-10#1)(1993-8#1)(1994-4#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-8#2)(1996-10#1)(1996-12#1)(1996-3#1)(1997-6#3)(2005-10#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-12#7)(2007-7#2)(2008-1#3)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
the demonstrator##3##2##(2008-4#3)
the demyelinated##2##2##(2008-11#1)(2008-7#1)
the denaturant##6##2##(1990-10#1)(1992-8#1)(1992-9#2)(1997-2#1)(2008-4#1)
the denaturation increment##2##3##(2006-10#2)
the denaturation of##5##3##(1990-12#1)(1991-2#1)(1997-7#1)(2006-12#1)(2013-1#1)
the denaturation process##2##3##(1996-11#1)(2008-10#1)
the denaturation##13##2##(1990-12#1)(1991-2#2)(1993-9#1)(1995-2#1)(1996-11#1)(1997-7#1)(2006-10#2)(2006-12#1)(2008-10#2)(2013-1#1)
the denaturational##2##2##(1994-5#1)(1997-7#1)
the denatured state of staphylococcal nuclease##2##6##(1994-9#1)(1995-4#1)
the denatured state of##4##4##(1992-6#1)(1994-9#1)(1995-4#1)(2006-10#1)
the denatured state under##2##4##(1994-9#1)(1997-2#1)
the denatured state##9##3##(1992-6#3)(1994-9#2)(1995-4#2)(1997-2#1)(2006-10#1)
the denatured##20##2##(1990-5#2)(1992-6#3)(1993-11#1)(1994-9#2)(1995-10#1)(1995-4#2)(1996-11#1)(1996-9#1)(1997-2#1)(2006-10#2)(2008-10#2)(2009-9#1)(2011-1#1)
the denaturing agent##2##3##(1997-4#1)(2008-10#1)
the denaturing##3##2##(1997-4#1)(2008-10#1)(2008-4#1)
the dendrite##2##2##(1990-4#1)(1997-7#1)
the dendrites of##4##3##(1996-7#1)(2008-11#1)(2012-12#2)
the dendrites##11##2##(1992-11#1)(1993-2#1)(1995-11#1)(1996-7#1)(2007-12#4)(2008-11#1)(2012-12#2)
the dendritic arbors of##2##4##(1994-2#2)
the dendritic morphology##2##3##(2008-8#1)(2013-1#1)
the dendritic region##3##3##(1997-8#1)(2007-12#2)
the dendritic spines##3##3##(1995-7#1)(1996-2#1)(1996-4#1)
the dendritic trees##2##3##(1996-2#1)(2012-2#1)
the dendritic##33##2##(1990-11#1)(1990-4#1)(1990-5#1)(1991-5#1)(1994-2#5)(1994-5#1)(1995-7#3)(1996-2#2)(1996-4#1)(1997-7#4)(1997-8#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-12#4)(2008-7#1)(2008-8#1)(2010-11#1)(2012-2#1)(2013-1#1)
the denervated##15##2##(1991-11#1)(1994-10#2)(1995-11#1)(1996-9#2)(1997-3#6)(1997-5#2)(1997-8#1)
the dengue##4##2##(2005-12#1)(2008-11#1)(2009-7#1)(2012-2#1)
the denoising##2##2##(2008-2#1)(2009-8#1)
the denominator##7##2##(1992-12#1)(1994-8#1)(1995-3#1)(1996-2#2)(2008-9#1)(2013-1#1)
the dens##4##2##(2006-7#1)(2006-9#2)(2008-4#1)
the dense tubular##5##3##(1992-6#5)
the dense##17##2##(1992-6#5)(1995-6#1)(1997-6#1)(2005-11#2)(2008-10#2)(2008-2#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-9#1)(2013-1#1)
the densely##2##2##(1991-12#1)(2007-7#1)
the denser##4##2##(1990-7#1)(2005-11#1)(2008-1#1)(2009-10#1)
the densest##3##2##(1995-8#1)(2007-8#1)(2008-8#1)
the densities and##3##3##(1995-11#1)(2007-9#1)(2008-10#1)
the densities of##8##3##(1994-2#1)(1997-5#1)(2008-10#3)(2008-3#1)(2008-9#1)(2013-8#1)
the densities##14##2##(1994-2#1)(1995-11#1)(1997-5#1)(2004-9#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-9#1)(2010-7#1)(2013-8#1)
the density (Bmax) of##2##4##(1993-2#1)(2008-6#1)
the density and##9##3##(1990-10#1)(1995-12#1)(1997-1#1)(2006-4#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-11#1)
the density functional theory##2##4##(2009-2#1)(2010-5#1)
the density functional##3##3##(2009-2#1)(2010-5#1)(2013-1#1)
the density in##4##3##(1990-2#1)(2008-2#1)(2008-5#1)(2012-2#1)
the density matrix##3##3##(2007-12#1)(2008-3#1)(2011-1#1)
the density of binding##2##4##(1995-7#1)(2007-8#1)
the density of both##2##4##(1990-5#1)(1993-12#1)
the density of its partner##2##5##(2008-8#2)
the density of opioid receptors##2##5##(2008-11#2)
the density of states##6##4##(1991-6#1)(2008-2#1)(2009-11#4)
the density of the##12##4##(1994-2#1)(1995-3#1)(1995-6#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2009-2#1)(2011-12#1)(2012-12#1)(2013-8#1)
the density of type II pneumocytes is reduced in##2##9##(1994-5#2)
the density of##101##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#3)(1990-7#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-9#2)(1994-10#1)(1994-2#3)(1994-5#3)(1995-11#4)(1995-12#1)(1995-3#1)(1995-6#1)(1995-7#3)(1995-8#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-5#2)(1997-6#1)(2004-11#1)(2004-9#1)(2005-11#1)(2006-12#1)(2006-4#1)(2007-1#2)(2007-12#1)(2007-8#2)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#4)(2009-2#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
the density range of##2##4##(1992-9#1)(1995-1#1)
the density##147##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#3)(1990-7#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-9#2)(1994-10#1)(1994-2#3)(1994-5#3)(1995-1#1)(1995-10#1)(1995-11#4)(1995-12#2)(1995-3#1)(1995-6#1)(1995-7#3)(1995-8#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#3)(1997-6#1)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-4#2)(2007-1#2)(2007-12#2)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#7)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#4)(2009-2#2)(2010-2#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#2)
the density-based EL ratio test##2##5##(2013-1#2)
the dental and##2##3##(2008-12#1)(2011-1#1)
the dental arch##5##3##(2005-9#1)(2008-11#1)(2012-12#3)
the dental arches##3##3##(1991-1#1)(2012-12#1)(2013-8#1)
the dental biofilms of patients with##2##6##(2013-1#2)
the dental clinic##2##3##(2008-7#1)(2012-3#1)
the dental community##2##3##(2012-12#2)
the dental hygiene profession and##3##5##(2006-2#3)
the dental hygiene profession##7##4##(2006-2#7)
the dental hygiene##8##3##(2006-2#8)
the dental hygienist##2##3##(2006-2#2)
the dental office##3##3##(1993-2#1)(2006-2#2)
the dental profession##3##3##(2006-2#1)(2007-9#1)(2013-1#1)
the dental team##4##3##(2012-2#4)
the dental treatment##2##3##(2011-1#1)(2012-12#1)
the dental##82##2##(1990-2#1)(1990-3#1)(1990-9#2)(1991-1#1)(1991-3#1)(1991-4#1)(1991-9#1)(1993-1#1)(1993-2#1)(1993-3#1)(2005-11#1)(2005-9#2)(2006-2#14)(2006-7#1)(2006-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#4)(2008-7#2)(2008-8#1)(2009-8#1)(2011-1#3)(2011-12#2)(2011-2#1)(2012-11#1)(2012-12#9)(2012-2#5)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#6)
the dentate granule##3##3##(1990-7#1)(1995-7#1)(1997-8#1)
the dentate gyrus and##9##4##(1991-2#1)(1992-7#1)(1992-8#1)(1994-8#1)(1995-7#1)(1996-12#2)(2008-11#1)(2009-8#1)
the dentate gyrus as##2##4##(1995-12#1)(1997-6#1)
the dentate gyrus of the rat##3##6##(1991-9#1)(1995-12#1)(1995-7#1)
the dentate gyrus of the##4##5##(1991-9#1)(1994-2#1)(1995-12#1)(1995-7#1)
the dentate gyrus of##13##4##(1991-9#1)(1993-2#2)(1994-2#1)(1994-8#2)(1995-12#2)(1995-7#2)(1997-5#1)(2005-9#1)(2012-12#1)
the dentate gyrus or##2##4##(1996-6#1)(1997-4#1)
the dentate gyrus was##3##4##(1990-5#1)(1992-7#1)(1995-7#1)
the dentate gyrus##63##3##(1990-5#1)(1990-7#4)(1991-2#1)(1991-9#2)(1992-7#5)(1992-8#1)(1993-12#1)(1993-2#2)(1994-11#1)(1994-2#1)(1994-8#3)(1995-1#1)(1995-12#11)(1995-7#6)(1996-12#4)(1996-2#2)(1996-6#1)(1996-9#1)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#1)(2005-9#1)(2008-11#1)(2008-9#1)(2009-8#2)(2011-2#1)(2012-12#1)(2013-8#1)
the dentate line##2##3##(2006-6#1)(2010-5#1)
the dentate molecular layer##4##4##(1990-5#1)(1991-9#1)(1994-2#1)(1996-3#1)
the dentate##79##2##(1990-5#2)(1990-7#5)(1991-2#1)(1991-7#1)(1991-9#3)(1992-7#5)(1992-8#1)(1993-12#1)(1993-2#2)(1994-11#1)(1994-2#3)(1994-8#4)(1995-1#1)(1995-12#12)(1995-7#8)(1996-12#4)(1996-2#2)(1996-3#2)(1996-6#1)(1996-9#1)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#2)(2005-9#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-8#2)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
the dentin##5##2##(2008-12#1)(2008-5#2)(2009-9#1)(2013-8#1)
the dentist to##2##3##(2008-6#1)(2008-7#1)
the dentist##17##2##(1990-10#1)(1992-5#1)(1996-3#1)(2005-11#1)(2006-8#1)(2008-1#1)(2008-6#3)(2008-7#1)(2011-1#3)(2011-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
the dentists##4##2##(1990-5#1)(2006-7#1)(2008-1#1)(2011-1#1)
the dentition of##2##3##(1990-11#1)(2008-6#1)
the dentition##6##2##(1990-11#1)(2008-6#1)(2008-7#1)(2012-11#1)(2012-3#1)(2013-1#1)
the dentoalveolar morphology##2##3##(2012-12#2)
the dentoalveolar##3##2##(2007-12#1)(2012-12#2)
the denture##6##2##(2007-9#1)(2009-4#2)(2012-2#1)(2013-1#2)
the denuder-based##2##2##(2008-10#2)
the deoxy derivative##2##3##(1993-6#2)
the deoxy##7##2##(1990-8#1)(1993-6#2)(1994-11#1)(1994-9#2)(1996-4#1)
the deoxyribonuclease##2##2##(1990-2#1)(1991-7#1)
the deoxyribose##2##2##(1993-3#1)(1995-6#1)
the department and##3##3##(1996-1#1)(1996-3#1)(2011-2#1)
the department for##2##3##(2006-8#1)(2010-3#1)
the department in##2##3##(1997-4#1)(2008-12#1)
the department of veterans affairs experience with the nationwide health information network##2##12##(2013-1#2)
the department of##26##3##(1990-10#1)(1991-3#2)(1991-6#1)(1992-12#1)(1993-3#1)(2006-2#1)(2006-8#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-6#1)(2010-4#1)(2011-1#2)(2012-2#1)(2013-1#4)(2013-8#2)
the department##58##2##(1990-10#3)(1990-12#1)(1991-11#1)(1991-3#2)(1991-6#1)(1991-9#1)(1992-12#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-8#3)(1994-4#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-1#3)(1996-3#1)(1997-4#1)(2006-2#1)(2006-8#2)(2007-3#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#4)(2008-4#1)(2008-6#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#2)
the departmental level) are stable in the context of a relational network##2##12##(2013-1#2)
the departmental##10##2##(1992-6#1)(2007-4#1)(2008-12#2)(2008-6#2)(2012-2#1)(2013-1#2)(2013-8#1)
the departments of##5##3##(1995-12#1)(1997-3#1)(2006-10#1)(2012-12#2)
the departments##16##2##(1990-4#1)(1990-9#1)(1993-10#2)(1993-8#1)(1995-12#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-10#1)(2008-10#1)(2012-12#4)(2013-1#1)
the dependant##2##2##(2008-3#1)(2010-7#1)
the dependence between##2##3##(2008-10#2)
the dependence is##2##3##(1997-4#1)(2007-12#1)
the dependence of K on##2##5##(1996-2#1)(2008-3#1)
the dependence of absorption##2##4##(2008-1#1)(2008-10#1)
the dependence of the efficiency on the##2##7##(2007-12#1)(2008-3#1)
the dependence of the fluorescence##2##5##(2008-2#1)(2008-3#1)
the dependence of the index##2##5##(2008-2#1)(2008-3#1)
the dependence of the intensity##2##5##(2007-12#1)(2008-2#1)
the dependence of the mixing##2##5##(2007-10#1)(2008-2#1)
the dependence of the output power##2##6##(2008-3#2)
the dependence of the peak##2##5##(2008-10#1)(2008-3#1)
the dependence of the specific##2##5##(1993-12#1)(2005-11#1)
the dependence of the##60##4##(1990-12#1)(1990-3#1)(1990-5#1)(1993-12#1)(1994-7#1)(1995-11#1)(1996-5#1)(2005-11#2)(2006-2#1)(2007-10#1)(2007-11#3)(2007-12#9)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-2#11)(2008-3#11)(2009-7#1)(2009-8#1)(2010-8#1)(2012-2#1)
the dependence of this effect on the##2##7##(2007-12#1)(2008-1#1)
the dependence of##101##3##(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-5#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-7#1)(1995-11#1)(1996-2#1)(1996-3#1)(1996-5#2)(2005-11#3)(2006-11#1)(2006-12#1)(2006-2#2)(2007-10#1)(2007-11#4)(2007-12#13)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#10)(2008-2#13)(2008-3#17)(2008-4#1)(2008-7#1)(2008-9#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
the dependence on the##2##4##(1995-3#1)(2008-3#1)
the dependence on##8##3##(1991-11#1)(1993-4#1)(1995-3#1)(2006-10#1)(2007-11#1)(2008-3#2)(2009-7#1)
the dependence relationship##2##3##(2005-4#1)(2010-8#1)
the dependence##116##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-5#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-7#1)(1995-11#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-4#1)(2005-11#3)(2005-4#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2007-10#1)(2007-11#5)(2007-12#14)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#12)(2008-2#13)(2008-3#19)(2008-4#1)(2008-7#1)(2008-9#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#1)
the dependences of##2##3##(1992-2#1)(2006-10#1)
the dependences##3##2##(1992-2#1)(2006-10#1)(2008-2#1)
the dependencies##3##2##(1996-5#1)(2005-11#1)(2008-3#1)
the dependency between the##2##4##(1996-7#1)(2007-8#1)
the dependency of S phase on##2##6##(1991-1#2)
the dependency of the##3##4##(1990-7#1)(1997-2#1)(2007-12#1)
the dependency of##8##3##(1990-7#1)(1991-1#2)(1997-2#1)(2007-12#1)(2008-11#1)(2008-8#1)(2011-2#1)
the dependency##10##2##(1990-7#1)(1991-1#2)(1996-7#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-8#1)(2011-2#1)
the dependent and independent variables##2##5##(2007-7#1)(2011-1#1)
the dependent measures##2##3##(2007-12#1)(2008-12#1)
the dependent variable and##2##4##(2007-12#1)(2012-12#1)
the dependent variable##10##3##(1992-1#1)(1995-4#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-12#1)
the dependent virus##2##3##(2008-10#2)
the dependent##20##2##(1992-1#1)(1995-4#1)(2007-10#1)(2007-12#4)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-4#1)(2011-1#1)(2011-2#2)(2012-12#1)
the dephasing##2##2##(2008-1#1)(2008-8#1)
the dephosphorylated##2##2##(1991-3#1)(1997-2#1)
the dephosphorylation of##11##3##(1991-6#1)(1993-12#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-1#1)(2008-7#1)(2010-2#1)(2013-8#1)
the dephosphorylation##14##2##(1991-6#1)(1993-12#2)(1993-6#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-5#1)(1995-1#1)(2008-7#1)(2010-2#1)(2013-8#1)
the depiction of##2##3##(2005-9#1)(2008-7#1)
the depiction##4##2##(2005-9#1)(2006-4#2)(2008-7#1)
the depigmenting##3##2##(2008-5#3)
the depletion interaction##2##3##(2005-11#1)(2008-2#1)
the depletion of protein##2##4##(1991-8#1)(1992-11#1)
the depletion of the##3##4##(1993-2#1)(2008-7#1)(2009-8#1)
the depletion of##23##3##(1990-4#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-3#1)(1993-2#1)(1994-10#1)(1995-12#1)(1996-12#1)(1996-5#1)(2005-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2009-8#1)(2010-3#1)
the depletion##29##2##(1990-4#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-3#2)(1993-2#1)(1994-10#1)(1994-11#1)(1995-12#1)(1996-12#1)(1996-5#1)(1996-7#1)(2005-10#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2009-8#1)(2010-3#1)(2012-11#1)
the deployment of resistant##2##4##(2008-10#2)
the deployment of##12##3##(2005-11#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#1)(2010-11#1)
the deployment##13##2##(2005-11#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-11#1)
the depolarisation##2##2##(1997-8#1)(2005-7#1)
the depolarization loss##2##3##(2007-12#1)(2008-2#1)
the depolarization of air##2##4##(2008-3#2)
the depolarization of##5##3##(1992-6#1)(1996-11#1)(2007-11#1)(2008-3#2)
the depolarization ratio##3##3##(2008-2#1)(2008-3#2)
the depolarization spectrum##2##3##(2008-3#2)
the depolarization##21##2##(1990-8#1)(1992-5#1)(1992-6#1)(1996-11#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#4)(2008-3#7)(2008-4#1)(2008-7#1)
the depolarizing##3##2##(1991-9#1)(1992-3#1)(2008-5#1)
the depolymerization of##2##3##(1990-6#1)(2008-11#1)
the depopulation of##2##3##(1990-9#1)(2007-6#1)
the deposit of##3##3##(1995-12#1)(2011-2#2)
the deposit##11##2##(1995-12#1)(2008-10#3)(2008-5#1)(2009-9#1)(2010-4#2)(2010-8#1)(2011-2#2)
the deposited layers##2##3##(2008-10#1)(2008-3#1)
the deposited##8##2##(1991-3#1)(1996-12#1)(2007-12#1)(2008-10#3)(2008-3#2)
the depositing film##2##3##(2010-4#2)
the depositing##3##2##(1996-9#1)(2010-4#2)
the deposition of Cd in the##2##6##(1995-3#2)
the deposition of ECM##2##4##(1994-5#1)(2013-8#1)
the deposition of amyloid beta (A beta)##2##7##(1996-1#1)(1996-5#1)
the deposition of amyloid##4##4##(1991-9#1)(1996-1#1)(1996-5#1)(2008-11#1)
the deposition of immune##2##4##(2006-4#1)(2010-4#1)
the deposition of the##6##4##(1995-6#1)(1996-5#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-7#1)
the deposition of##50##3##(1990-8#1)(1991-1#1)(1991-12#1)(1991-9#1)(1992-2#2)(1992-3#1)(1994-12#1)(1994-5#1)(1995-3#2)(1995-6#1)(1996-1#2)(1996-5#2)(1996-8#1)(1997-8#1)(2004-4#1)(2005-10#1)(2005-11#2)(2005-7#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#12)(2008-11#1)(2008-7#2)(2010-4#1)(2010-5#3)(2011-12#1)(2012-3#1)(2013-8#1)
the deposition on the##2##4##(2008-10#2)
the deposition process##2##3##(2005-11#1)(2008-2#1)
the deposition rate##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
the deposition step##3##3##(2008-10#3)
the deposition time##2##3##(2007-8#1)(2008-10#1)
the deposition##78##2##(1990-8#1)(1991-1#1)(1991-12#1)(1991-9#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-3#2)(1995-6#1)(1996-1#2)(1996-5#2)(1996-8#1)(1996-9#1)(1997-8#1)(2004-4#1)(2005-10#1)(2005-11#5)(2005-7#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-8#2)(2007-9#1)(2008-10#22)(2008-11#1)(2008-2#3)(2008-3#2)(2008-7#3)(2010-4#1)(2010-5#3)(2011-12#1)(2012-3#1)(2013-8#1)
the deposits##3##2##(1994-5#3)
the depravity##2##2##(2012-12#2)
the depressant effect##3##3##(1992-3#1)(1996-12#2)
the depressant effects of##4##4##(1995-12#1)(1997-2#2)(2008-8#1)
the depressant##7##2##(1992-3#1)(1995-12#1)(1996-12#2)(1997-2#2)(2008-8#1)
the depressed patients##3##3##(1996-5#2)(1996-7#1)
the depressed##6##2##(1996-5#2)(1996-7#1)(2005-6#1)(2007-9#1)(2008-7#1)
the depression induced by##3##4##(1995-12#2)(1996-1#1)
the depression of synaptic transmission##2##5##(1995-12#2)
the depression of##6##3##(1992-8#1)(1993-3#1)(1995-12#2)(1996-1#1)(2008-9#1)
the depression##16##2##(1992-8#1)(1993-3#1)(1994-2#1)(1995-12#4)(1996-1#2)(1997-3#1)(2004-3#1)(2008-9#1)(2010-5#1)(2011-1#1)(2013-7#2)
the depressive illness##2##3##(1991-10#1)(2009-10#1)
the depressive state##2##3##(2008-8#1)(2011-2#1)
the depressive##11##2##(1991-10#1)(1991-11#1)(1996-3#2)(2007-4#1)(2008-8#2)(2009-10#1)(2011-2#2)(2013-8#1)
the depressor response##4##3##(1991-5#1)(1997-2#3)
the depressor##7##2##(1991-5#2)(1996-11#1)(1996-5#1)(1997-2#3)
the deprivation##2##2##(1996-4#1)(2008-11#1)
the deprived eye##4##3##(1994-3#1)(1994-8#1)(1995-11#1)(2012-2#1)
the deprived neurons##2##3##(1995-11#2)
the deprived##10##2##(1993-2#1)(1994-3#2)(1994-8#1)(1995-11#3)(1995-5#1)(1996-4#1)(2012-2#1)
the deprotonated##7##2##(1990-12#1)(1990-2#1)(1994-12#1)(1995-5#1)(1996-7#1)(2008-5#2)
the deprotonation of the##4##4##(1993-3#1)(1994-2#1)(1995-5#1)(2008-3#1)
the deprotonation of##5##3##(1993-3#1)(1994-2#1)(1995-11#1)(1995-5#1)(2008-3#1)
the deprotonation##8##2##(1993-3#1)(1994-2#1)(1995-11#1)(1995-5#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-3#1)
the depside##2##2##(2008-5#2)
the depth and the##3##4##(2008-3#1)(2009-4#2)
the depth and##8##3##(2007-10#1)(2007-6#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#2)(2010-12#1)
the depth localization##2##3##(2011-1#2)
the depth of anesthesia##3##4##(1996-9#1)(2010-8#2)
the depth of field##3##4##(2007-11#1)(2008-3#1)(2012-2#1)
the depth of focus##5##4##(2007-12#2)(2008-2#1)(2008-3#2)
the depth of penetration of the##2##6##(1990-10#1)(2008-1#1)
the depth of penetration##3##4##(1990-10#1)(2007-10#1)(2008-1#1)
the depth of the avascular plane and##2##7##(2011-2#2)
the depth of the avascular plane##3##6##(2011-2#3)
the depth of the focal point##2##6##(2008-3#2)
the depth of the##17##4##(1993-8#1)(1995-12#1)(2006-5#1)(2007-12#2)(2008-3#5)(2010-12#1)(2010-2#1)(2011-2#3)(2012-2#1)(2013-8#1)
the depth of##57##3##(1990-10#1)(1990-9#1)(1992-9#1)(1993-8#1)(1994-9#1)(1995-12#1)(1996-9#1)(1997-8#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#5)(2008-1#1)(2008-11#1)(2008-2#3)(2008-3#13)(2008-5#2)(2008-8#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-8#2)(2011-2#5)(2012-1#2)(2012-2#2)(2012-3#1)(2013-8#3)
the depth profile##2##3##(2008-3#2)
the depth resolution##3##3##(2008-3#2)(2009-4#1)
the depth##93##2##(1990-10#1)(1990-9#1)(1992-9#1)(1993-8#1)(1994-9#1)(1995-12#1)(1996-9#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#8)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#26)(2008-5#4)(2008-7#1)(2008-8#2)(2009-4#4)(2009-9#1)(2010-12#2)(2010-2#1)(2010-8#2)(2011-1#2)(2011-2#6)(2012-1#2)(2012-2#2)(2012-3#1)(2013-8#4)
the depth-averaged##2##2##(2005-11#1)(2008-8#1)
the depth-measuring range without any decrease in the axial or the lateral resolution##2##13##(2007-12#1)(2008-3#1)
the depth-resolved##2##2##(2007-12#1)(2011-1#1)
the depyrogenation of##2##3##(1997-3#2)
the deregulated##3##2##(1993-2#1)(1994-10#1)(1996-4#1)
the deregulation of##5##3##(2008-6#1)(2009-5#1)(2011-2#2)(2013-1#1)
the derivation and##3##3##(2008-6#1)(2008-8#1)(2008-9#1)
the derivation of the##6##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)
the derivation of##23##3##(2006-10#1)(2006-12#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2012-4#1)
the derivation##30##2##(1990-12#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2012-4#1)(2013-1#2)
the derivatisation reaction##2##3##(2008-10#2)
the derivative and##2##3##(2008-2#1)(2010-7#1)
the derivative method##2##3##(2008-10#2)
the derivative of the##8##4##(1990-8#1)(1996-7#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
the derivative##35##2##(1990-8#2)(1991-7#1)(1996-7#1)(1996-9#1)(1997-6#1)(2005-11#1)(2005-4#4)(2007-11#1)(2007-12#3)(2008-10#12)(2008-2#3)(2008-3#3)(2008-9#1)(2010-7#1)
the derivatives in##2##3##(2008-10#2)
the derivatives is##2##3##(1992-1#1)(2008-5#1)
the derivatives of##2##3##(2008-6#1)(2009-10#1)
the derivatives were##3##3##(1990-8#1)(2008-11#1)(2013-8#1)
the derivatives##23##2##(1990-5#1)(1990-8#1)(1992-1#1)(1993-2#1)(2006-12#1)(2008-10#6)(2008-11#4)(2008-5#1)(2008-6#2)(2008-7#1)(2009-10#1)(2011-2#1)(2013-8#2)
the derivatization of##5##3##(1991-7#1)(1996-2#1)(2008-10#2)(2008-4#1)
the derivatization reaction##5##3##(2008-10#5)
the derivatization reagent##3##3##(2008-10#1)(2010-5#1)(2012-12#1)
the derivatization##21##2##(1991-7#1)(1993-6#1)(1996-2#1)(1996-6#1)(2008-10#14)(2008-4#1)(2010-5#1)(2012-12#1)
the derivatized##6##2##(1992-9#1)(2008-10#3)(2008-7#1)(2013-7#1)
the derivatizing##2##2##(2005-12#1)(2008-10#1)
the derived FPDF##2##3##(2008-2#2)
the derived amino acid sequence##2##5##(1990-12#1)(1994-8#1)
the derived amino-acid sequence##2##4##(1990-7#2)
the derived total ozone##2##4##(2008-2#2)
the derived##42##2##(1990-12#1)(1990-7#2)(1992-12#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1997-2#1)(2005-11#1)(2006-7#1)(2007-12#3)(2007-6#1)(2008-10#4)(2008-2#7)(2008-3#10)(2008-7#2)(2010-1#1)(2010-8#1)(2012-1#1)
the dermal and##5##3##(2008-5#2)(2008-9#1)(2012-12#1)(2013-8#1)
the dermal layer##2##3##(2008-9#1)(2012-3#1)
the dermal##24##2##(1992-12#1)(1992-9#1)(1994-7#1)(2007-9#1)(2008-5#7)(2008-7#1)(2008-9#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#4)
the dermal-epidermal junction##4##3##(1992-6#1)(1996-6#1)(2008-5#1)(2011-2#1)
the dermatitis##5##2##(1990-3#1)(2008-9#4)
the dermatologic##4##2##(2006-10#2)(2010-6#1)(2013-7#1)
the dermatological##3##2##(2005-11#1)(2007-11#1)(2010-6#1)
the dermatologist##6##2##(2006-12#1)(2007-7#2)(2008-5#1)(2009-4#1)(2010-9#1)
the dermatologists##3##2##(2007-7#1)(2007-8#1)(2008-5#1)
the dermis and epidermis##2##4##(1996-12#1)(2008-5#1)
the dermis and subcutis##2##4##(2005-7#1)(2010-6#1)
the dermis and##9##3##(1996-12#1)(2004-9#1)(2005-7#1)(2008-5#4)(2008-9#1)(2010-6#1)
the dermis of##2##3##(1996-11#1)(2008-5#1)
the dermis##41##2##(1990-4#1)(1996-11#1)(1996-12#6)(2004-9#1)(2005-7#1)(2006-12#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#11)(2008-9#6)(2010-6#4)(2011-1#1)(2012-12#1)(2012-3#2)
the desaturation##2##2##(1991-3#1)(1991-7#1)
the descendents of##2##3##(1994-1#1)(2008-10#1)
the descending aorta and##3##4##(2007-8#2)(2012-2#1)
the descending aorta##11##3##(1992-8#1)(1993-10#1)(2007-7#1)(2007-8#6)(2008-11#1)(2012-2#1)
the descending colon##5##3##(1993-9#2)(2006-4#2)(2011-2#1)
the descending thoracic aorta##6##4##(2007-8#2)(2008-5#1)(2010-8#2)(2013-3#1)
the descending thoracic##8##3##(2007-8#3)(2008-10#1)(2008-5#1)(2010-8#2)(2013-3#1)
the descending##31##2##(1990-4#1)(1992-8#1)(1993-10#1)(1993-9#2)(1994-2#1)(2006-4#2)(2007-10#1)(2007-7#2)(2007-8#9)(2008-10#2)(2008-11#1)(2008-5#2)(2010-8#2)(2011-2#2)(2012-2#1)(2013-3#1)
the descent of##2##3##(1993-11#1)(2007-4#1)
the described approach##2##3##(2008-2#1)(2010-8#1)
the described method##3##3##(1990-9#1)(2006-10#1)(2008-10#1)
the described model##2##3##(1996-1#1)(1997-2#1)
the described technique##3##3##(2007-11#1)(2008-10#1)(2008-11#1)
the described##39##2##(1990-9#2)(1991-5#2)(1994-11#1)(1994-12#1)(1995-1#1)(1995-6#1)(1996-1#1)(1997-2#1)(2004-9#1)(2005-1#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-1#1)(2010-10#1)(2010-8#1)(2012-2#2)(2013-8#1)
the describes##2##2##(2008-2#1)(2008-4#1)
the description and##3##3##(2008-3#1)(2012-12#1)(2013-7#1)
the description of a##3##4##(1991-2#1)(2005-1#1)(2008-9#1)
the description of all##2##4##(1993-8#1)(2008-10#1)
the description of many##2##4##(2009-2#1)(2012-3#1)
the description of the illuminating beam##2##6##(2008-2#2)
the description of the##22##4##(1993-9#1)(1994-8#2)(1997-2#1)(2006-12#1)(2007-11#3)(2008-1#1)(2008-11#1)(2008-2#4)(2008-3#1)(2008-9#2)(2009-6#1)(2011-1#1)(2012-1#1)(2013-8#2)
the description of##57##3##(1990-10#1)(1990-12#1)(1990-8#1)(1991-2#1)(1993-8#1)(1993-9#1)(1994-6#1)(1994-8#2)(1996-3#1)(1997-2#1)(2005-1#1)(2006-12#3)(2006-4#1)(2007-10#1)(2007-11#6)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#2)(2008-7#1)(2008-9#4)(2009-2#1)(2009-3#1)(2009-6#2)(2010-12#1)(2010-7#1)(2011-1#2)(2011-7#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#2)
the description##65##2##(1990-10#1)(1990-12#1)(1990-8#1)(1991-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-6#1)(1994-8#2)(1996-3#1)(1997-2#1)(2005-1#1)(2006-12#3)(2006-4#1)(2007-10#1)(2007-11#6)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#4)(2008-4#2)(2008-7#1)(2008-9#4)(2009-2#1)(2009-3#1)(2009-6#2)(2010-1#1)(2010-12#1)(2010-7#2)(2011-1#3)(2011-7#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-7#1)(2013-8#2)
the descriptions of##5##3##(2008-1#3)(2009-3#1)(2010-3#1)
the descriptive data##2##3##(2008-11#1)(2008-7#1)
the descriptive##8##2##(1991-12#1)(1991-6#2)(1993-5#1)(2008-11#1)(2008-7#1)(2009-8#1)(2012-2#1)
the descriptors##4##2##(1997-2#1)(2007-11#1)(2008-10#2)
the desensitization of##5##3##(1990-4#1)(1994-8#1)(1995-12#1)(1997-7#1)(2009-7#1)
the desensitization##8##2##(1990-4#1)(1994-8#1)(1995-12#2)(1997-7#1)(2008-3#1)(2008-4#1)(2009-7#1)
the desert locust##2##3##(2007-12#1)(2012-2#1)
the desert species##2##3##(2008-10#1)(2011-12#1)
the desert##12##2##(1992-6#1)(1996-12#1)(2006-9#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-12#1)(2012-2#1)(2013-1#1)
the desialylated##2##2##(1990-12#1)(1995-2#1)
the desiccation##2##2##(1992-12#1)(2013-7#1)
the design and analysis of##7##5##(1992-6#1)(1993-6#1)(1996-6#1)(2006-2#1)(2008-2#1)(2008-3#1)(2013-7#1)
the design and analysis##8##4##(1992-6#1)(1993-6#1)(1994-2#1)(1996-6#1)(2006-2#1)(2008-2#1)(2008-3#1)(2013-7#1)
the design and characterization of##3##5##(2007-12#1)(2007-8#1)(2008-3#1)
the design and construction of a##2##6##(2008-2#1)(2008-3#1)
the design and construction of##3##5##(2008-2#2)(2008-3#1)
the design and development of an##2##6##(2006-8#1)(2008-2#1)
the design and development of##8##5##(2006-11#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-12#1)(2008-2#1)(2010-12#1)(2010-7#1)
the design and execution of##6##5##(2007-7#1)(2011-2#1)(2012-12#4)
the design and experimental##2##4##(2007-12#1)(2007-6#1)
the design and fabrication of##6##5##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-7#1)
the design and implementation of a##2##6##(1996-2#1)(2012-3#1)
the design and implementation of the##3##6##(2007-2#1)(2008-3#1)(2012-1#1)
the design and implementation of##14##5##(1991-1#1)(1995-1#1)(1996-2#1)(2007-2#2)(2008-1#2)(2008-10#1)(2008-3#1)(2010-11#2)(2012-1#1)(2012-11#1)(2012-3#1)
the design and management of##2##5##(1995-12#1)(2010-4#1)
the design and monitoring of clinical trials##2##7##(1996-6#1)(2006-4#1)
the design and monitoring of##3##5##(1996-6#2)(2006-4#1)
the design and performance of##2##5##(2008-2#1)(2008-3#1)
the design and performance##3##4##(2008-2#1)(2008-3#2)
the design and realization of##3##5##(2007-11#1)(2007-12#1)(2008-2#1)
the design and synthesis of a##2##6##(1994-12#1)(1994-8#1)
the design and synthesis of new drugs##2##7##(2006-4#1)(2008-5#1)
the design and synthesis of##6##5##(1994-12#1)(1994-3#1)(1994-8#1)(2006-4#1)(2008-5#1)(2010-12#1)
the design and the fabrication##2##5##(2008-2#1)(2008-3#1)
the design and the##7##4##(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2011-2#1)
the design and use of##2##5##(1993-12#1)(2008-2#1)
the design and##100##3##(1991-1#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-6#3)(2004-8#1)(2005-5#1)(2006-11#1)(2006-2#1)(2006-4#2)(2006-8#1)(2007-11#4)(2007-12#8)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#12)(2008-3#10)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#2)(2010-11#2)(2010-12#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-1#3)(2012-11#1)(2012-12#4)(2012-3#2)(2013-7#1)(2013-8#1)
the design can##2##3##(2007-11#1)(2008-3#1)
the design characteristics##2##3##(2008-12#1)(2008-3#1)
the design considerations##2##3##(2006-8#1)(2007-12#1)
the design features##2##3##(2007-3#1)(2012-3#1)
the design has##2##3##(2007-4#1)(2008-12#1)
the design in##2##3##(2008-2#1)(2013-7#1)
the design is##3##3##(1995-9#1)(2008-2#2)
the design of Expresso##2##4##(2008-7#2)
the design of a new##3##5##(1996-6#1)(2008-3#1)(2012-1#1)
the design of a##27##4##(1993-3#1)(1996-6#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#5)(2008-3#9)(2008-7#1)(2008-8#1)(2010-2#1)(2012-1#1)(2013-8#2)
the design of active##2##4##(2005-7#1)(2012-2#1)
the design of an information##2##5##(1996-4#1)(2008-2#1)
the design of an##14##4##(1995-2#1)(1996-4#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#2)(2010-5#1)(2012-1#1)(2013-1#1)
the design of binary##2##4##(2005-12#1)(2007-12#1)
the design of bio-inspired##2##4##(2008-2#1)(2009-9#1)
the design of clinical trials##5##5##(1994-8#1)(2008-8#1)(2009-2#1)(2010-11#1)(2011-1#1)
the design of clinical##7##4##(1994-4#1)(1994-8#1)(2005-8#1)(2008-8#1)(2009-2#1)(2010-11#1)(2011-1#1)
the design of diffractive elements##2##5##(2007-11#1)(2007-12#1)
the design of diffractive optical elements##2##6##(2007-12#1)(2008-3#1)
the design of diffractive optical##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
the design of diffractive##6##4##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)
the design of effective##2##4##(2011-2#2)
the design of efficient##5##4##(2008-10#1)(2009-4#1)(2012-12#2)(2013-7#1)
the design of future##7##4##(2008-2#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-3#1)(2012-1#1)(2012-11#1)
the design of improved##2##4##(1992-11#1)(2009-12#1)
the design of medical##2##4##(2006-2#1)(2011-2#1)
the design of molecular##2##4##(2007-3#1)(2010-12#1)
the design of more effective##4##5##(1993-11#1)(1997-3#1)(2008-12#1)(2012-2#1)
the design of more potent##3##5##(2005-11#1)(2012-2#2)
the design of more##8##4##(1993-11#1)(1995-11#1)(1997-3#1)(2005-11#1)(2008-12#1)(2012-2#3)
the design of new##13##4##(1992-11#1)(2006-12#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#2)
the design of novel##8##4##(1991-7#1)(1992-6#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-5#1)(2009-3#1)(2011-1#1)
the design of optimal##3##4##(2006-5#1)(2008-2#2)
the design of potent##2##4##(1992-4#1)(1997-1#1)
the design of potential##2##4##(1994-8#1)(2007-11#1)
the design of such a##2##5##(2008-2#1)(2008-3#1)
the design of such##6##4##(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2012-1#1)
the design of synthetic peptides##2##5##(2005-7#1)(2008-2#1)
the design of synthetic##6##4##(2005-7#1)(2006-12#1)(2008-10#1)(2008-2#1)(2010-12#1)(2012-11#1)
the design of targeted##2##4##(1997-7#1)(2012-2#1)
the design of the system##2##5##(2008-2#1)(2012-3#1)
the design of the##30##4##(1997-2#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-6#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-12#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-1#5)(2012-12#1)(2012-3#1)
the design of these##3##4##(1995-6#1)(2008-2#1)(2011-2#1)
the design of this##4##4##(2007-12#1)(2007-4#1)(2008-12#1)(2008-3#1)
the design of transfemoral prostheses##2##5##(2012-1#2)
the design of two##2##4##(2008-2#1)(2008-3#1)
the design of vascular tree##2##5##(2010-9#2)
the design of##305##3##(1991-7#1)(1992-11#2)(1992-12#3)(1992-4#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-3#2)(1993-6#1)(1994-11#1)(1994-4#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-5#2)(1995-6#2)(1995-7#1)(1996-12#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-6#1)(1997-7#1)(2005-11#3)(2005-12#2)(2005-7#5)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#5)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#14)(2007-12#11)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#2)(2008-1#6)(2008-10#13)(2008-11#4)(2008-12#4)(2008-2#30)(2008-3#33)(2008-4#2)(2008-5#5)(2008-7#9)(2008-8#6)(2008-9#3)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#4)(2010-9#2)(2011-1#5)(2011-2#9)(2011-3#1)(2012-1#15)(2012-11#6)(2012-12#6)(2012-2#9)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#4)
the design optimization of##2##4##(2008-2#1)(2013-1#1)
the design optimization##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
the design parameters of##3##4##(2008-3#3)
the design parameters##6##3##(1995-4#2)(2008-2#1)(2008-3#3)
the design principle for##2##4##(1995-8#2)
the design principles##2##3##(2008-11#1)(2008-3#1)
the design procedure##3##3##(2008-3#3)
the design process##4##3##(2008-2#2)(2008-3#1)(2010-10#1)
the design requirements##4##3##(2006-6#1)(2007-12#1)(2008-3#1)(2013-8#1)
the design to##3##3##(2006-4#1)(2008-2#2)
the design tolerances##3##3##(2008-2#1)(2008-3#2)
the design##536##2##(1990-11#1)(1991-1#1)(1991-7#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-4#1)(1992-6#2)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-6#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-8#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-4#2)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#4)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-8#1)(2005-10#1)(2005-11#3)(2005-12#2)(2005-5#1)(2005-7#5)(2005-8#2)(2006-10#3)(2006-11#3)(2006-12#5)(2006-2#2)(2006-4#5)(2006-5#1)(2006-6#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#19)(2007-12#22)(2007-2#3)(2007-3#2)(2007-4#3)(2007-5#1)(2007-6#3)(2007-7#2)(2007-8#3)(2008-1#8)(2008-10#25)(2008-11#9)(2008-12#9)(2008-2#70)(2008-3#73)(2008-4#5)(2008-5#7)(2008-6#2)(2008-7#12)(2008-8#6)(2008-9#6)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#2)(2009-9#4)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#4)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#6)(2011-12#1)(2011-2#13)(2011-3#1)(2012-1#18)(2012-11#7)(2012-12#10)(2012-2#11)(2012-3#7)(2013-1#11)(2013-7#3)(2013-8#8)
the designated movement##2##3##(2007-6#2)
the designated##10##2##(2006-5#1)(2007-12#1)(2007-4#1)(2007-6#2)(2008-1#1)(2008-10#1)(2009-2#1)(2010-8#1)(2013-8#1)
the designation of##3##3##(2007-7#1)(2008-6#1)(2010-8#1)
the designation##5##2##(1992-5#1)(1995-5#1)(2007-7#1)(2008-6#1)(2010-8#1)
the designed system##2##3##(2008-2#2)
the designed##19##2##(1991-9#2)(1995-1#2)(1997-8#1)(2007-11#1)(2008-10#3)(2008-2#3)(2008-3#5)(2011-2#1)(2013-1#1)
the designer##4##2##(1996-8#2)(2008-2#2)
the designing of##2##3##(2008-3#1)(2011-3#1)
the designs##6##2##(1994-9#1)(1997-2#1)(2008-2#2)(2008-3#1)(2009-7#1)
the desirability function##4##3##(2008-10#4)
the desirability of health technology##2##5##(2009-3#2)
the desirability of##5##3##(2008-3#2)(2008-9#1)(2009-3#2)
the desirability##11##2##(1994-1#1)(2007-8#1)(2008-10#4)(2008-3#2)(2008-9#1)(2009-3#2)
the desirable##8##2##(1992-1#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-7#1)(2012-11#1)
the desire for##5##3##(1993-1#1)(2008-7#1)(2009-4#3)
the desire of##3##3##(1992-9#1)(2008-10#2)
the desire to be##2##4##(2007-12#1)(2009-4#1)
the desire to create##2##4##(2010-2#1)(2011-2#1)
the desire to limit##2##4##(1996-8#1)(2009-5#1)
the desire to##22##3##(1996-8#1)(2005-11#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#2)(2008-3#1)(2008-5#1)(2009-4#2)(2009-5#1)(2010-12#2)(2010-2#2)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
the desire##30##2##(1992-9#1)(1993-1#1)(1996-8#1)(2005-11#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#5)(2009-5#1)(2010-12#2)(2010-2#2)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
the desired accuracy##2##3##(2006-6#1)(2008-10#1)
the desired characteristics##2##3##(1990-8#1)(1993-2#1)
the desired effect##3##3##(1994-11#1)(2007-9#1)(2009-8#1)
the desired field of##2##4##(2008-3#1)(2009-4#1)
the desired final##2##3##(1994-9#1)(2008-7#1)
the desired image##7##3##(2008-2#4)(2008-3#3)
the desired level of##3##4##(2009-6#1)(2010-2#2)
the desired mutation##2##3##(1994-3#2)
the desired number of##2##4##(1992-4#1)(2007-10#1)
the desired outcome##2##3##(2010-8#1)(2013-7#1)
the desired product##7##3##(1994-2#1)(1997-3#1)(2008-10#2)(2009-10#1)(2010-4#1)(2010-5#1)
the desired products##3##3##(2008-4#1)(2009-12#1)(2010-5#1)
the desired property##2##3##(2008-2#1)(2009-10#1)
the desired reduction in##2##4##(2007-12#1)(2010-11#1)
the desired structural##2##3##(2006-6#1)(2008-10#1)
the desired target##3##3##(2006-5#1)(2006-7#1)(2008-4#1)
the desired##158##2##(1990-2#1)(1990-5#1)(1990-8#1)(1992-1#1)(1992-4#2)(1992-6#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-8#1)(1994-9#2)(1995-3#3)(1995-8#1)(1996-10#1)(1996-12#2)(1996-5#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(2006-10#1)(2006-12#3)(2006-5#1)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#11)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#9)(2008-11#3)(2008-2#15)(2008-3#16)(2008-4#7)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#5)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#3)(2012-2#2)(2013-7#1)(2013-8#1)
the desires of##3##3##(1997-1#1)(2007-12#1)(2011-2#1)
the desmoplastic##2##2##(2006-8#1)(2007-6#1)
the desmosome and gap junction##2##5##(2012-2#2)
the desmosome##5##2##(1990-12#1)(1997-2#1)(2008-3#1)(2012-2#2)
the desolvation##3##2##(1991-7#1)(2008-10#1)(2013-8#1)
the desorption of##2##3##(2008-10#1)(2009-12#1)
the desorption##6##2##(1994-3#1)(1996-11#1)(2005-11#1)(2008-10#2)(2009-12#1)
the desquamation process##3##3##(2008-5#3)
the desquamation##6##2##(2008-5#5)(2012-3#1)
the desquamatory enzymes##2##3##(2008-5#2)
the destabilizing effects of##2##4##(1995-5#1)(1996-5#1)
the destabilizing##5##2##(1993-8#1)(1995-5#1)(1996-5#1)(2005-11#1)(2008-5#1)
the destination of the##2##4##(1991-11#1)(2011-2#1)
the destination of##3##3##(1991-11#1)(2011-2#1)(2013-1#1)
the destination##4##2##(1991-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
the destroyed##3##2##(2005-7#1)(2007-8#2)
the destruction of basal##2##4##(1993-11#1)(2013-1#1)
the destruction of the##10##4##(1991-1#1)(1991-3#1)(1992-9#1)(1994-5#1)(1995-10#1)(2005-11#1)(2007-7#1)(2009-10#1)(2012-12#1)(2013-8#1)
the destruction of##28##3##(1991-1#1)(1991-3#1)(1992-5#1)(1992-9#2)(1993-11#1)(1994-5#2)(1994-6#1)(1995-10#1)(1996-4#1)(2005-11#1)(2006-6#1)(2007-11#3)(2007-3#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-10#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
the destruction##34##2##(1991-1#1)(1991-3#1)(1992-5#1)(1992-9#2)(1993-11#1)(1993-9#1)(1994-5#2)(1994-6#1)(1995-10#1)(1996-4#1)(2005-11#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-3#2)(2007-7#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-7#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#1)
the destructive nature of##2##4##(2008-1#1)(2008-7#1)
the destructive##10##2##(1990-6#1)(2007-11#2)(2008-1#3)(2008-10#1)(2008-11#1)(2008-7#1)(2010-11#1)
the deswelling##2##2##(2005-11#2)
the detached##5##2##(1995-1#1)(2007-10#1)(2007-12#1)(2008-10#2)
the detachment of##2##3##(1991-3#1)(1991-9#1)
the detachment##4##2##(1991-3#1)(1991-9#1)(1995-5#1)(2008-11#1)
the detail##5##2##(1993-6#1)(2007-12#1)(2008-2#2)(2008-3#1)
the detailed behavior##2##3##(2005-11#1)(2008-2#1)
the detailed composition of##3##4##(1995-8#1)(2008-3#2)
the detailed description of the##2##5##(2008-9#1)(2010-12#1)
the detailed information##2##3##(2007-10#1)(2011-3#1)
the detailed mechanism of##3##4##(2006-10#1)(2008-9#1)(2013-1#1)
the detailed mechanism##4##3##(2006-10#1)(2008-10#1)(2008-9#1)(2013-1#1)
the detailed mechanisms of##2##4##(1996-4#1)(2008-7#1)
the detailed molecular mechanisms of##2##5##(2007-12#1)(2010-12#1)
the detailed molecular##5##3##(1990-11#1)(2007-12#1)(2009-2#1)(2010-12#2)
the detailed shape##2##3##(1992-6#1)(2008-2#1)
the detailed studies##2##3##(2006-8#1)(2008-10#1)
the detailed study of##4##4##(1992-3#1)(2008-10#1)(2008-11#1)(2008-3#1)
the detailed##65##2##(1990-11#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-4#1)(1997-2#2)(1997-5#1)(2004-9#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-12#3)(2011-1#1)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
the details of the interaction##2##5##(2008-1#1)(2011-1#1)
the details of the##18##4##(1990-5#1)(1992-2#1)(1996-12#1)(1997-2#1)(1997-5#1)(2005-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#2)(2010-9#1)(2011-1#1)(2013-1#1)
the details of##41##3##(1990-5#1)(1992-2#1)(1992-9#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-12#2)(1996-6#1)(1997-2#1)(1997-5#2)(2005-10#1)(2007-11#3)(2007-12#2)(2007-6#1)(2008-1#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#2)(2009-12#1)(2009-2#1)(2009-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#2)
the details##45##2##(1990-5#1)(1992-2#1)(1992-9#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-12#2)(1996-6#1)(1997-2#1)(1997-5#2)(2005-10#1)(2007-11#3)(2007-12#2)(2007-4#1)(2007-6#1)(2008-1#1)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#2)(2009-12#2)(2009-2#1)(2009-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#2)
the detarium##2##2##(1996-4#2)
the detectability of a lung nodule##2##6##(2010-9#2)
the detectability of##7##3##(2007-8#1)(2008-10#3)(2010-9#2)(2011-1#1)
the detectability##10##2##(1996-4#1)(2007-8#1)(2008-10#3)(2008-3#1)(2009-10#1)(2010-9#2)(2011-1#1)
the detectable##8##2##(1996-11#1)(1997-2#1)(2007-2#1)(2007-8#1)(2008-3#1)(2010-11#1)(2011-2#1)(2013-1#1)
the detected fluorescence##4##3##(2008-10#2)(2008-3#2)
the detected light##3##3##(2008-2#1)(2008-3#2)
the detected phase##2##3##(2008-3#2)
the detected pulse##2##3##(2007-11#1)(2007-12#1)
the detected radiation##2##3##(2008-2#1)(2008-3#1)
the detected signal is##2##4##(2008-2#1)(2008-3#1)
the detected signal##5##3##(2008-2#3)(2008-3#2)
the detected signals##2##3##(2008-2#1)(2008-3#1)
the detected##47##2##(1990-5#1)(1990-7#1)(1993-7#1)(1994-1#1)(1995-4#1)(1997-7#1)(2006-12#1)(2007-11#1)(2007-12#3)(2008-10#7)(2008-11#1)(2008-2#9)(2008-3#14)(2008-5#1)(2008-6#1)(2012-11#1)(2012-3#1)(2013-1#1)
the detecting##5##2##(2007-11#1)(2008-10#2)(2008-4#1)(2009-8#1)
the detection and analysis of##3##5##(2008-2#2)(2008-4#1)
the detection and characterization of##5##5##(1995-7#1)(2008-1#1)(2008-10#1)(2008-8#1)(2011-2#1)
the detection and determination of##5##5##(1997-3#1)(2008-10#1)(2008-11#2)(2008-5#1)
the detection and identification of##6##5##(2007-1#1)(2008-10#3)(2008-4#1)(2010-2#1)
the detection and management of##2##5##(1997-8#1)(2013-1#1)
the detection and measurement of##3##5##(2008-2#1)(2008-3#1)(2008-4#1)
the detection and prevention of##4##5##(2006-10#2)(2007-12#1)(2010-10#1)
the detection and quantification limits##3##5##(2008-10#3)
the detection and quantification of##6##5##(1996-6#1)(2007-5#1)(2008-1#1)(2008-10#1)(2012-3#2)
the detection and quantification##9##4##(1996-6#1)(2007-5#1)(2008-1#1)(2008-10#4)(2012-3#2)
the detection and quantitation of##4##5##(1990-12#1)(1996-8#1)(2008-4#1)(2009-3#1)
the detection and treatment of##5##5##(2004-3#1)(2007-10#1)(2008-4#1)(2008-7#1)(2012-2#1)
the detection and##79##3##(1990-12#1)(1990-6#1)(1991-5#1)(1993-12#2)(1995-6#1)(1995-7#1)(1996-6#2)(1996-8#1)(1997-3#1)(1997-8#1)(2004-3#1)(2005-8#2)(2005-9#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-5#1)(2008-1#3)(2008-10#16)(2008-11#3)(2008-2#4)(2008-3#1)(2008-4#5)(2008-5#2)(2008-7#2)(2008-8#1)(2009-3#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
the detection area##5##3##(1993-9#2)(2008-10#2)(2009-6#1)
the detection being##2##3##(2008-10#1)(2012-2#1)
the detection cell##3##3##(2008-10#3)
the detection efficiency##2##3##(2008-9#1)(2013-8#1)
the detection electrode##2##3##(2008-10#2)
the detection end of the capillary##2##6##(2007-8#2)
the detection frequency##2##3##(2008-10#2)
the detection limit (3sigma) of##2##5##(2008-10#2)
the detection limit (3sigma)##6##4##(2007-10#1)(2008-10#5)
the detection limit (S/N=3)##2##4##(2008-10#2)
the detection limit and the##3##5##(2008-10#2)(2008-2#1)
the detection limit and##6##4##(1991-8#1)(2008-10#3)(2008-2#1)(2010-2#1)
the detection limit by##2##4##(2008-10#1)(2008-3#1)
the detection limit for##12##4##(1997-3#1)(2007-8#1)(2008-10#9)(2010-11#1)
the detection limit in##2##4##(2008-10#1)(2008-3#1)
the detection limit is 0##6##5##(2008-10#6)
the detection limit is 1##4##5##(2008-10#4)
the detection limit is 2##3##5##(2005-4#1)(2008-10#2)
the detection limit is##22##4##(2005-4#2)(2007-8#1)(2008-10#18)(2013-1#1)
the detection limit obtained##2##4##(2008-10#1)(2008-3#1)
the detection limit of 0##8##5##(2005-12#1)(2008-10#7)
the detection limit of 1##6##5##(2008-10#5)(2008-11#1)
the detection limit of 2##2##5##(2008-10#2)
the detection limit of the method was##2##7##(2005-4#1)(2008-10#1)
the detection limit of the##10##5##(1992-2#1)(1996-1#1)(1997-2#1)(2005-4#1)(2007-8#1)(2008-10#3)(2008-2#2)
the detection limit of##44##4##(1992-2#1)(1996-1#1)(1997-2#1)(2005-12#1)(2005-4#1)(2007-8#1)(2008-10#31)(2008-11#2)(2008-2#3)(2011-1#1)(2013-8#1)
the detection limit was 0##18##5##(1993-2#1)(1995-1#1)(1997-8#1)(2005-4#2)(2008-10#13)
the detection limit was 1##5##5##(2007-8#1)(2008-10#4)
the detection limit was 3##3##5##(2005-12#1)(2008-10#2)
the detection limit was estimated as 0##2##7##(2008-10#2)
the detection limit was lower than##2##6##(2008-10#2)
the detection limit was##57##4##(1993-2#1)(1995-1#1)(1996-7#1)(1997-8#1)(2005-12#1)(2005-4#2)(2007-8#2)(2008-10#48)
the detection limit##191##3##(1990-9#1)(1991-8#1)(1992-2#1)(1993-1#1)(1993-2#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-5#1)(1996-7#1)(1997-2#2)(1997-3#1)(1997-8#1)(2004-4#1)(2005-12#2)(2005-4#5)(2007-10#1)(2007-12#1)(2007-8#6)(2008-10#144)(2008-11#2)(2008-2#6)(2008-3#3)(2008-7#1)(2010-11#1)(2010-2#1)(2011-1#1)(2013-1#1)(2013-8#1)
the detection limits (DL)##2##4##(2008-10#2)
the detection limits and##2##4##(2008-10#2)
the detection limits are##2##4##(2008-10#2)
the detection limits for##8##4##(2005-12#1)(2008-10#6)(2010-11#1)
the detection limits of the##5##5##(2008-10#3)(2008-2#1)(2013-8#1)
the detection limits of##22##4##(2007-8#2)(2008-10#18)(2008-2#1)(2013-8#1)
the detection limits were##12##4##(1993-2#1)(2008-10#10)(2011-1#1)
the detection limits##72##3##(1993-2#1)(2005-12#1)(2007-8#2)(2008-10#62)(2008-2#2)(2010-11#1)(2011-1#1)(2012-12#1)(2013-8#1)
the detection methods##2##3##(2008-10#1)(2008-5#1)
the detection of 0##3##4##(2007-8#1)(2008-10#2)
the detection of DNA##8##4##(1995-12#1)(1996-4#1)(2006-12#1)(2008-10#5)
the detection of E##2##4##(2008-10#1)(2008-3#1)
the detection of Escherichia##3##4##(2008-10#3)
the detection of F(-)##2##4##(2008-10#2)
the detection of FZ##2##4##(2008-10#2)
the detection of HIV##2##4##(2007-7#1)(2008-4#1)
the detection of HSV##2##4##(2007-12#1)(2007-8#1)
the detection of IgG##3##4##(1994-9#1)(2006-9#2)
the detection of M##2##4##(1992-4#1)(2008-5#1)
the detection of NO##5##4##(2008-10#2)(2008-3#2)(2010-7#1)
the detection of P##4##4##(2008-10#4)
the detection of TNT##2##4##(2008-10#1)(2009-3#1)
the detection of a variety of##2##6##(2008-10#1)(2010-11#1)
the detection of a##11##4##(1990-3#1)(1991-9#1)(1992-2#1)(1993-11#1)(2007-8#1)(2008-10#3)(2008-3#1)(2009-3#1)(2010-11#1)
the detection of aPT##2##4##(2006-10#2)
the detection of an##4##4##(2007-11#1)(2008-10#2)(2011-2#1)
the detection of antibodies##11##4##(1990-12#3)(1991-3#2)(1992-6#1)(1994-9#1)(1997-6#1)(2005-9#2)(2013-8#1)
the detection of antigens##3##4##(1993-2#1)(2007-2#1)(2008-10#1)
the detection of bacterial##3##4##(2007-10#1)(2007-7#1)(2011-2#1)
the detection of blood##2##4##(2007-12#1)(2010-7#1)
the detection of cattle##2##4##(2010-4#1)(2012-3#1)
the detection of causal##2##4##(2012-3#2)
the detection of certain##2##4##(2010-4#1)(2012-2#1)
the detection of changes in##4##5##(1994-2#1)(1997-6#1)(2007-10#1)(2008-9#1)
the detection of cholera antitoxin##2##5##(2008-10#2)
the detection of cholera##3##4##(2007-8#1)(2008-10#2)
the detection of differences##2##4##(2008-10#1)(2008-2#1)
the detection of disease##2##4##(2010-6#1)(2012-2#1)
the detection of dysplasia##2##4##(2009-3#1)(2011-1#1)
the detection of early##4##4##(1991-8#1)(2008-3#2)(2008-7#1)
the detection of fluorescence##2##4##(2010-12#1)(2011-1#1)
the detection of gastrointestinal##3##4##(1993-8#1)(2006-10#1)(2008-5#1)
the detection of heavy metal ions##2##6##(2008-10#1)(2012-12#1)
the detection of hepatitis##2##4##(1990-8#1)(2012-12#1)
the detection of human##4##4##(1992-6#1)(2008-10#1)(2008-2#1)(2008-4#1)
the detection of lipids##2##4##(2008-10#1)(2012-12#1)
the detection of low levels of##2##6##(2008-10#1)(2008-5#1)
the detection of low##4##4##(2008-10#3)(2008-5#1)
the detection of membrane##2##4##(1992-11#2)
the detection of nitric oxide (NO)##2##6##(2008-10#2)
the detection of nitric oxide##5##5##(1994-3#1)(2008-10#3)(2008-2#1)
the detection of nitrite##2##4##(2008-10#2)
the detection of other##2##4##(2008-5#1)(2012-2#1)
the detection of outlier data in chemical analysis##2##8##(2008-10#2)
the detection of pancreatic##3##4##(2007-8#1)(2008-2#2)
the detection of phenolic##2##4##(2008-10#2)
the detection of phosphate##2##4##(2008-10#1)(2008-4#1)
the detection of plasma##2##4##(1994-2#1)(2008-10#1)
the detection of several##3##4##(2008-10#1)(2008-2#1)(2009-3#1)
the detection of short##3##4##(1996-12#2)(2008-10#1)
the detection of small##3##4##(1991-9#1)(2008-2#1)(2008-7#1)
the detection of some##2##4##(1992-7#1)(2008-10#1)
the detection of specific##3##4##(2008-4#1)(2010-6#1)(2011-1#1)
the detection of sulfur##2##4##(2008-10#2)
the detection of tau##2##4##(2008-3#2)
the detection of the mecA gene##2##6##(2008-10#2)
the detection of the##41##4##(1990-11#1)(1990-12#2)(1991-10#1)(1991-5#1)(1992-6#1)(1993-9#1)(1996-6#1)(1997-3#1)(2006-8#2)(2007-11#3)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-1#4)(2013-7#1)(2013-8#1)
the detection of their##2##4##(1991-9#1)(2010-11#1)
the detection of this##3##4##(1997-6#1)(2007-8#1)(2008-11#1)
the detection of trace constituents in sooting combustion##2##8##(2006-12#2)
the detection of trace##9##4##(2006-12#2)(2008-10#7)
the detection of tumors##2##4##(2007-11#1)(2010-12#1)
the detection of##637##3##(1990-11#1)(1990-12#14)(1990-2#2)(1990-3#2)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#2)(1991-10#2)(1991-12#2)(1991-3#4)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#3)(1992-7#2)(1992-8#6)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-5#4)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#7)(1994-6#1)(1994-9#6)(1995-1#1)(1995-12#3)(1995-2#4)(1996-11#1)(1996-12#7)(1996-3#1)(1996-4#3)(1996-5#1)(1996-6#2)(1996-8#2)(1996-9#1)(1997-2#2)(1997-3#4)(1997-4#1)(1997-6#6)(1997-8#2)(2005-1#2)(2005-10#1)(2005-11#2)(2005-12#2)(2005-7#2)(2005-8#2)(2005-9#3)(2006-10#9)(2006-12#6)(2006-6#1)(2006-8#3)(2006-9#3)(2007-1#2)(2007-10#4)(2007-11#8)(2007-12#10)(2007-2#2)(2007-5#1)(2007-7#3)(2007-8#17)(2008-1#7)(2008-10#169)(2008-11#9)(2008-12#2)(2008-2#24)(2008-3#26)(2008-4#18)(2008-5#18)(2008-6#3)(2008-7#13)(2008-8#1)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#5)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#3)(2010-12#7)(2010-2#1)(2010-4#7)(2010-5#6)(2010-6#5)(2010-7#3)(2010-8#2)(2011-1#14)(2011-2#12)(2011-7#1)(2012-1#1)(2012-11#4)(2012-12#6)(2012-2#9)(2012-3#4)(2013-1#9)(2013-7#2)(2013-8#9)
the detection point##3##3##(2008-10#3)
the detection process##3##3##(2008-2#2)(2008-3#1)
the detection rate of CIN##2##5##(1992-10#1)(1994-1#1)
the detection rate of##8##4##(1991-12#1)(1992-10#1)(1994-1#1)(2007-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the detection rate##11##3##(1991-12#1)(1992-10#1)(1994-1#1)(2004-2#1)(2007-8#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the detection scheme##3##3##(1995-6#1)(2007-11#1)(2008-3#1)
the detection sensitivity of##2##4##(2008-10#1)(2008-3#1)
the detection sensitivity##4##3##(2007-9#2)(2008-10#1)(2008-3#1)
the detection step##2##3##(1995-6#1)(2008-10#1)
the detection system##7##3##(2006-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#1)
the detection technique##3##3##(2007-8#1)(2008-10#2)
the detection wavelength was##2##4##(2011-1#1)(2012-3#1)
the detection wavelength##5##3##(1996-5#1)(2008-10#1)(2011-1#1)(2012-12#1)(2012-3#1)
the detection zone##2##3##(2008-10#2)
the detection##1108##2##(1990-11#1)(1990-12#15)(1990-2#2)(1990-3#2)(1990-5#2)(1990-6#3)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#2)(1991-12#3)(1991-3#4)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#3)(1992-1#1)(1992-10#2)(1992-11#4)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#3)(1992-7#2)(1992-8#6)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#6)(1993-2#6)(1993-5#4)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#4)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#7)(1994-6#1)(1994-9#6)(1995-1#2)(1995-12#3)(1995-2#5)(1995-6#5)(1995-7#1)(1996-1#1)(1996-11#2)(1996-12#7)(1996-3#1)(1996-4#3)(1996-5#5)(1996-6#4)(1996-7#1)(1996-8#3)(1996-9#1)(1997-2#4)(1997-3#6)(1997-4#2)(1997-6#7)(1997-8#5)(2004-2#1)(2004-3#1)(2004-4#1)(2005-1#2)(2005-10#1)(2005-11#3)(2005-12#5)(2005-4#5)(2005-7#2)(2005-8#4)(2005-9#4)(2006-10#11)(2006-11#1)(2006-12#7)(2006-2#1)(2006-6#2)(2006-8#3)(2006-9#4)(2007-1#3)(2007-10#6)(2007-11#12)(2007-12#17)(2007-2#2)(2007-5#2)(2007-7#3)(2007-8#31)(2007-9#2)(2008-1#10)(2008-10#433)(2008-11#15)(2008-12#2)(2008-2#48)(2008-3#38)(2008-4#24)(2008-5#23)(2008-6#3)(2008-7#16)(2008-8#2)(2008-9#8)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#6)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#6)(2010-12#9)(2010-2#3)(2010-4#7)(2010-5#7)(2010-6#5)(2010-7#4)(2010-8#2)(2011-1#18)(2011-2#15)(2011-7#1)(2012-1#1)(2012-11#4)(2012-12#11)(2012-2#13)(2012-3#8)(2013-1#14)(2013-7#3)(2013-8#15)
the detector and a##2##4##(2008-10#1)(2008-3#1)
the detector and##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
the detector aperture##2##3##(2008-2#1)(2008-3#1)
the detector array##4##3##(2008-2#1)(2008-3#3)
the detector as well as##2##5##(2008-2#1)(2008-3#1)
the detector as##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
the detector at a##2##4##(2008-10#2)
the detector at##3##3##(2008-10#3)
the detector by##2##3##(2008-2#1)(2008-3#1)
the detector electrode##2##3##(2007-8#2)
the detector field of view##2##5##(2008-2#2)
the detector for the##2##4##(2008-10#2)
the detector in##2##3##(2006-4#1)(2013-7#1)
the detector is##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
the detector plane##5##3##(2007-11#1)(2008-2#3)(2008-3#1)
the detector port##2##3##(2008-3#2)
the detector readings##2##3##(2008-2#2)
the detector response is linear##2##5##(2008-10#2)
the detector response##5##3##(2008-10#5)
the detector signals##2##3##(2008-10#1)(2008-3#1)
the detector surface##2##3##(2008-3#2)
the detector that##3##3##(1995-6#1)(2008-10#1)(2008-3#1)
the detector##125##2##(1993-12#1)(1995-6#1)(1996-5#1)(2006-4#1)(2007-11#2)(2007-12#11)(2007-8#3)(2008-10#39)(2008-11#1)(2008-2#32)(2008-3#27)(2008-4#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-9#1)(2013-7#1)
the detector's##2##2##(2008-3#2)
the detector)##2##2##(1996-5#1)(2008-3#1)
the detectors##8##2##(2008-2#5)(2008-3#2)(2008-9#1)
the detectors' field of view##2##5##(2008-3#2)
the detectors'##3##2##(2007-12#1)(2008-3#2)
the detention##2##2##(2012-11#2)
the detergent and##3##3##(1994-9#1)(1997-6#1)(2011-2#1)
the detergent from##2##3##(1994-12#1)(2008-5#1)
the detergent used##2##3##(1992-6#2)
the detergent##22##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-9#1)(1991-1#1)(1992-6#2)(1993-11#1)(1994-12#2)(1994-8#1)(1994-9#1)(1996-5#1)(1996-7#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-2#1)
the detergent-protein##2##2##(2008-5#2)
the detergents used##2##3##(1991-12#1)(1994-12#1)
the detergents##6##2##(1990-7#1)(1991-12#1)(1992-11#1)(1994-12#2)(1996-9#1)
the deterioration index##2##3##(1994-6#2)
the deterioration of##5##3##(1991-8#1)(2007-12#1)(2008-1#1)(2008-7#1)(2013-1#1)
the deterioration##8##2##(1991-8#1)(1994-6#2)(2006-10#1)(2007-12#1)(2008-1#1)(2008-7#1)(2013-1#1)
the determinant factors of##2##4##(1991-6#1)(1996-9#1)
the determinant##6##2##(1991-6#1)(1995-2#1)(1996-9#2)(2009-7#1)(2012-1#1)
the determinants and##3##3##(2004-2#1)(2006-5#1)(2012-1#1)
the determinants for##3##3##(1995-12#1)(1996-3#1)(1996-9#1)
the determinants of the##3##4##(1995-4#1)(2007-6#1)(2012-11#1)
the determinants of these##2##4##(2008-9#1)(2012-3#1)
the determinants of##30##3##(1991-3#1)(1991-4#1)(1992-2#1)(1992-6#1)(1993-12#1)(1994-8#1)(1995-12#1)(1995-4#1)(1996-1#1)(1996-3#1)(1997-1#1)(2006-10#1)(2006-3#1)(2006-9#2)(2007-10#1)(2007-6#1)(2007-7#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-11#1)(2012-2#1)(2012-3#1)
the determinants##40##2##(1991-3#1)(1991-4#1)(1992-2#1)(1992-6#1)(1993-12#2)(1994-10#1)(1994-8#1)(1995-12#2)(1995-4#1)(1996-1#1)(1996-3#2)(1996-9#1)(1997-1#1)(1997-2#1)(2004-2#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-9#2)(2007-10#1)(2007-6#1)(2007-7#2)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)
the determination and##9##3##(2008-10#7)(2010-11#1)(2012-11#1)
the determination are##3##3##(2005-4#2)(2008-10#1)
the determination by##4##3##(2008-10#2)(2009-2#1)(2012-12#1)
the determination is based on##2##5##(2008-10#1)(2010-6#1)
the determination is##8##3##(2008-10#6)(2008-5#1)(2010-6#1)
the determination limit##2##3##(2008-10#2)
the determination method for##2##4##(2008-10#2)
the determination method##3##3##(2008-10#3)
the determination of 0##8##4##(2008-10#8)
the determination of 1##3##4##(2008-10#3)
the determination of 2-acetyl-1-pyrroline##3##4##(2011-1#3)
the determination of Ag##4##4##(2008-10#4)
the determination of Al##4##4##(2007-8#1)(2008-10#3)
the determination of As and##3##5##(2008-10#3)
the determination of As##6##4##(2008-10#6)
the determination of As(III) and As(V)##2##6##(2008-10#2)
the determination of As(III) in water samples##2##7##(2008-10#2)
the determination of As(III) in##3##5##(2008-10#3)
the determination of As(III)##8##4##(2008-10#8)
the determination of Au##2##4##(2008-10#2)
the determination of BPA in##2##5##(2008-10#1)(2009-8#1)
the determination of Bi in##2##5##(2008-10#2)
the determination of Bi##4##4##(2008-10#4)
the determination of CBZ and CBZ-E in##2##7##(1996-8#1)(2008-10#1)
the determination of Ca##3##4##(2008-10#3)
the determination of Captopril by differential pulse polarography##2##8##(2008-10#2)
the determination of Captopril##4##4##(2008-10#4)
the determination of Cd and Pb##3##6##(2008-10#3)
the determination of Cd##9##4##(2008-10#9)
the determination of Co(II)##2##4##(2008-10#2)
the determination of Cr(III) and Cr(VI) in spiked and##2##9##(2008-10#2)
the determination of Cr(III) and Cr(VI) in##3##7##(2008-10#3)
the determination of Cr(III) and##4##5##(2008-10#4)
the determination of Cr(III)##5##4##(2008-10#5)
the determination of Cr(VI)##3##4##(2008-10#3)
the determination of Cu(II)##6##4##(2008-10#6)
the determination of DMA in##3##5##(2008-10#3)
the determination of DMA##4##4##(2008-10#4)
the determination of DNA##3##4##(1997-4#1)(2008-10#1)(2008-9#1)
the determination of Fe##5##4##(2008-10#4)(2013-8#1)
the determination of Fe(II)##3##4##(2007-8#1)(2008-10#2)
the determination of H(2)O(2)##4##4##(2008-10#4)
the determination of Hg in##2##5##(2008-10#2)
the determination of Hg(II) in##2##5##(2008-10#2)
the determination of Hg(II) is##2##5##(2008-10#2)
the determination of Hg(II)##5##4##(2008-10#5)
the determination of K##3##4##(2005-4#2)(2008-10#1)
the determination of Mg in##2##5##(2008-10#2)
the determination of Mo##3##4##(2008-10#3)
the determination of NAA##2##4##(2008-10#2)
the determination of NAL in##2##5##(2008-10#2)
the determination of NH(4)(+)##2##4##(2008-10#2)
the determination of Ni##4##4##(2008-10#4)
the determination of PA##3##4##(2008-10#3)
the determination of PBDEs##3##4##(2008-10#3)
the determination of Pb##4##4##(2008-1#1)(2008-10#3)
the determination of Pb(2+)##3##4##(2008-10#3)
the determination of Pu##3##4##(2008-10#3)
the determination of QCT in##2##5##(2005-4#2)
the determination of Sb(III) in##2##5##(2008-10#2)
the determination of Se in##3##5##(2008-10#3)
the determination of Se##8##4##(2008-10#8)
the determination of Se(IV)##3##4##(2008-10#3)
the determination of Si-tot##2##4##(2008-10#2)
the determination of V(V)##2##4##(2008-10#2)
the determination of W(VI)##2##4##(2008-10#2)
the determination of a large##2##5##(2008-2#1)(2008-4#1)
the determination of a##13##4##(1990-9#1)(1992-2#1)(1994-11#1)(1997-8#2)(2008-10#5)(2008-2#1)(2008-4#1)(2008-5#1)
the determination of absorbed dose to water##2##7##(2012-1#2)
the determination of acetaminophen in##2##5##(2008-10#2)
the determination of acetylcholine##4##4##(2008-10#4)
the determination of acid volatile##3##5##(2008-10#3)
the determination of acid##4##4##(2008-10#4)
the determination of affinity constants##2##5##(1992-10#1)(1997-2#1)
the determination of aliphatic amines in##2##6##(2008-10#2)
the determination of aliphatic##3##4##(2008-10#3)
the determination of aluminium in water and dialysis fluids##2##9##(1992-7#2)
the determination of aluminium##6##4##(1992-7#2)(2008-10#4)
the determination of ammonia in##3##5##(2008-10#3)
the determination of ammonium ion##2##5##(2008-10#2)
the determination of ammonium##5##4##(2008-10#5)
the determination of an##5##4##(1992-6#1)(2008-10#3)(2008-2#1)
the determination of analytes in##2##5##(2008-10#2)
the determination of andrographolide##2##4##(2005-12#1)(2008-10#1)
the determination of anionic surfactants in river water##2##8##(2008-10#2)
the determination of anionic surfactants in##3##6##(2008-10#3)
the determination of anionic##5##4##(2008-10#5)
the determination of antimony by hydride generation##2##7##(2008-10#2)
the determination of antimony by##4##5##(2008-10#4)
the determination of antimony in##3##5##(2008-10#3)
the determination of antimony##8##4##(2008-10#8)
the determination of any##2##4##(1992-9#1)(1997-5#1)
the determination of arsenic in##7##5##(2008-10#7)
the determination of arsenic##11##4##(2008-10#11)
the determination of ascorbic acid in##3##6##(2008-10#3)
the determination of ascorbic acid##9##5##(2008-10#9)
the determination of atmospheric##3##4##(2008-10#2)(2009-6#1)
the determination of benzo[a]pyrene##4##4##(2008-10#4)
the determination of benzoyl peroxide in wheat flour##3##8##(2005-12#1)(2008-10#2)
the determination of beryllium##2##4##(2005-4#1)(2008-10#1)
the determination of bismuth in##2##5##(2008-10#2)
the determination of bismuth##4##4##(2008-10#4)
the determination of boron in##4##5##(2007-8#1)(2008-10#3)
the determination of boron##11##4##(2007-8#1)(2008-10#6)(2008-3#4)
the determination of both##7##4##(1992-8#1)(2008-10#6)
the determination of bromide in seawater samples##2##7##(2008-10#2)
the determination of bromide in seawater##4##6##(2008-10#4)
the determination of bromide in##5##5##(2008-10#5)
the determination of bromide##8##4##(2008-10#8)
the determination of cadmium and##3##5##(2008-10#3)
the determination of cadmium in##8##5##(2008-10#8)
the determination of cadmium##16##4##(2008-10#16)
the determination of calcium and magnesium##2##6##(2008-10#2)
the determination of calcium##4##4##(2008-10#4)
the determination of carbaryl##3##4##(2007-8#1)(2008-10#2)
the determination of carbon in##3##5##(2007-11#1)(2008-10#1)(2008-3#1)
the determination of carbon##6##4##(2007-11#1)(2008-10#4)(2008-3#1)
the determination of cationic polyelectrolytes such as poly (diallyldimethylammonium chloride) (Cat-floc) by##2##12##(2008-10#2)
the determination of cationic##3##4##(2008-10#3)
the determination of cefadroxil##3##4##(2008-10#3)
the determination of cefixime##3##4##(2008-10#2)(2013-7#1)
the determination of cell##4##4##(1991-3#1)(2008-11#1)(2008-4#2)
the determination of chlorate##2##4##(2008-10#2)
the determination of chloride in##4##5##(2008-10#4)
the determination of chloride##7##4##(2008-10#7)
the determination of chlorinated##3##4##(2007-8#2)(2008-10#1)
the determination of chlorine##2##4##(2007-10#1)(2008-10#1)
the determination of cholesterol in##2##5##(1990-8#1)(2008-10#1)
the determination of chromium in##5##5##(2008-10#5)
the determination of chromium##12##4##(2008-10#12)
the determination of chromium(VI) in##3##5##(2008-10#3)
the determination of chromium(VI)##4##4##(2008-10#4)
the determination of ciprofloxacin in##3##5##(2008-10#3)
the determination of ciprofloxacin##4##4##(2008-10#4)
the determination of clenbuterol##3##4##(1990-9#2)(2008-10#1)
the determination of cobalt and##2##5##(2008-10#2)
the determination of cobalt in##5##5##(2008-10#5)
the determination of cobalt##12##4##(2008-10#12)
the determination of compounds##2##4##(1997-3#1)(2008-10#1)
the determination of copper in the##3##6##(2008-10#3)
the determination of copper in##11##5##(2008-10#11)
the determination of copper##22##4##(2008-10#22)
the determination of creatine##2##4##(1990-8#1)(1992-10#1)
the determination of creatinine##2##4##(2008-10#2)
the determination of cyanide in##2##5##(2008-10#2)
the determination of cyanide##4##4##(2008-10#4)
the determination of different##2##4##(2005-11#1)(2008-10#1)
the determination of dimethyltin chloride##2##5##(2008-10#2)
the determination of dissolved silver##3##5##(2008-10#3)
the determination of dissolved##8##4##(2008-10#8)
the determination of dopamine in injection##2##6##(2008-10#2)
the determination of dopamine in##4##5##(2008-10#3)(2010-5#1)
the determination of dopamine##8##4##(2008-10#7)(2010-5#1)
the determination of doxycycline hydrochloride##3##5##(2008-10#3)
the determination of electroosmotic mobility##2##5##(2008-10#2)
the determination of epinephrine##3##4##(2008-10#3)
the determination of famotidine in##2##5##(2007-9#1)(2008-10#1)
the determination of famotidine##3##4##(2007-9#1)(2008-10#2)
the determination of fluoride in##3##5##(2008-10#3)
the determination of fluoride##6##4##(2008-10#6)
the determination of fluoxetine##2##4##(2008-10#2)
the determination of formaldehyde in##2##5##(2008-10#2)
the determination of formaldehyde##3##4##(2008-10#3)
the determination of free ammonium and##2##6##(2008-10#2)
the determination of free##6##4##(1990-1#1)(1990-8#1)(1996-1#1)(2008-10#3)
the determination of gallium##3##4##(2008-10#3)
the determination of gentamycin##2##4##(2008-10#2)
the determination of glucose in the##2##6##(2008-10#2)
the determination of glucose in##9##5##(2008-10#8)(2010-5#1)
the determination of glucose##12##4##(2008-10#11)(2010-5#1)
the determination of hydrazine##6##4##(2008-10#6)
the determination of hydrochlorothiazide##2##4##(2008-10#2)
the determination of hydrogen peroxide in rainwater##3##7##(2008-10#3)
the determination of hydrogen peroxide in##5##6##(2008-10#5)
the determination of hydrogen peroxide##11##5##(2008-10#11)
the determination of hydrogen##12##4##(2008-10#12)
the determination of hydroquinone in photographic developers##2##7##(2008-10#2)
the determination of hydroquinone in##3##5##(2008-10#3)
the determination of indium##2##4##(2008-10#2)
the determination of inorganic##8##4##(1993-12#1)(1994-6#1)(2005-4#1)(2008-10#4)(2008-3#1)
the determination of iodate and iodide##2##6##(2008-10#2)
the determination of iodate and sulphate in##2##7##(2008-10#2)
the determination of iodate and##4##5##(2008-10#4)
the determination of iodate##5##4##(2008-10#5)
the determination of iodide in##2##5##(2008-10#2)
the determination of iodide##3##4##(2008-10#3)
the determination of iridium in##2##5##(2008-10#2)
the determination of iron and##2##5##(2008-10#2)
the determination of iron in seawater by##2##7##(2007-8#2)
the determination of iron in##11##5##(2007-8#2)(2008-10#9)
the determination of iron##19##4##(2007-8#2)(2008-10#17)
the determination of iron(III) in##2##5##(2008-10#2)
the determination of isoproturon##2##4##(2008-10#2)
the determination of lactic acid in##2##6##(2008-10#2)
the determination of lanthanides in##2##5##(2007-8#1)(2008-10#1)
the determination of lead in##16##5##(2008-10#16)
the determination of lead isotope ratios in wine##2##8##(2008-10#2)
the determination of lead##26##4##(2008-1#1)(2008-10#25)
the determination of lead(II)##5##4##(2008-10#5)
the determination of lithium ion in aqueous solution##2##8##(2008-10#2)
the determination of lithium##5##4##(2008-10#5)
the determination of low levels of##4##6##(2006-12#1)(2008-10#3)
the determination of low levels##5##5##(2006-12#1)(2008-10#4)
the determination of low##9##4##(2006-12#1)(2008-10#7)(2008-2#1)
the determination of magnesium##5##4##(2007-8#2)(2008-10#3)
the determination of major##2##4##(2005-12#1)(2008-10#1)
the determination of manganese in##4##5##(2008-10#4)
the determination of manganese##6##4##(2008-10#6)
the determination of manganese(II)##5##4##(2008-10#5)
the determination of mercury in##3##5##(2008-10#3)
the determination of mercury##9##4##(2008-10#9)
the determination of mercury(II)##2##4##(2008-10#2)
the determination of methionine##2##4##(2008-10#2)
the determination of metoclopramide##2##4##(2008-10#2)
the determination of metrifonate##2##4##(2008-10#2)
the determination of minoxidil##2##4##(2008-10#2)
the determination of molybdenum in##4##5##(2008-10#4)
the determination of molybdenum##10##4##(2008-10#10)
the determination of n##2##4##(2008-2#1)(2008-3#1)
the determination of naproxen##3##4##(2008-10#3)
the determination of nickel in##7##5##(2008-10#7)
the determination of nickel##11##4##(2008-10#11)
the determination of nitrate and##2##5##(2008-10#2)
the determination of nitrate in##4##5##(2008-10#4)
the determination of nitrate##7##4##(2008-10#7)
the determination of nitrite in the##2##6##(2008-10#2)
the determination of nitrite in##8##5##(2008-10#8)
the determination of nitrite##17##4##(2008-10#16)(2008-11#1)
the determination of nitrogen oxides##2##5##(2008-10#2)
the determination of nitrogen##3##4##(2008-10#3)
the determination of norepinephrine##2##4##(2005-4#2)
the determination of nucleic acids##5##5##(2008-10#4)(2008-3#1)
the determination of ochratoxin A in##2##6##(2008-10#2)
the determination of ofloxacin in##2##5##(2008-10#2)
the determination of optical##3##4##(2008-2#2)(2008-3#1)
the determination of organic##2##4##(1994-9#1)(2008-10#1)
the determination of orthophosphate in##2##5##(2008-10#2)
the determination of orthophosphate##3##4##(2008-10#3)
the determination of oxalate##2##4##(2008-10#2)
the determination of oxidizable##2##4##(2008-10#2)
the determination of paracetamol in pharmaceuticals##2##6##(2008-10#2)
the determination of paracetamol in##5##5##(2008-10#5)
the determination of paracetamol##6##4##(2008-10#6)
the determination of paraquat in##2##5##(2008-10#2)
the determination of paraquat##5##4##(2008-10#5)
the determination of partition coefficients of drugs##2##7##(2008-10#2)
the determination of partition coefficients##3##5##(2008-10#3)
the determination of perchlorate in##5##5##(2007-8#2)(2008-10#3)
the determination of perchlorate##7##4##(2007-8#4)(2008-10#3)
the determination of periodate and iodate##2##6##(2008-10#2)
the determination of perphenazine in##2##5##(2008-10#2)
the determination of perphenazine##3##4##(2008-10#3)
the determination of phenols##2##4##(2008-10#2)
the determination of phosphate##3##4##(2008-10#3)
the determination of phosphatidylcholine in sediment##2##6##(2008-10#2)
the determination of phosphatidylcholine##3##4##(2008-10#3)
the determination of phosphorus by##2##5##(2008-10#2)
the determination of phosphorus species##3##5##(2008-10#3)
the determination of phosphorus##9##4##(2008-10#9)
the determination of piroxicam##5##4##(1997-8#2)(2008-10#3)
the determination of plasma##3##4##(1990-12#1)(1991-3#1)(1994-8#1)
the determination of platinum##4##4##(2008-10#4)
the determination of polychlorinated##2##4##(2008-10#2)
the determination of potassium##2##4##(2008-10#2)
the determination of procaine hydrochloride##2##5##(2008-10#2)
the determination of protein in##2##5##(2008-10#2)
the determination of protein##10##4##(1990-12#1)(1990-6#1)(1991-11#1)(1992-8#1)(2008-10#3)(2008-4#2)(2009-12#1)
the determination of proteins in##2##5##(2008-10#2)
the determination of proteins with##3##5##(2008-10#3)
the determination of proteins##8##4##(2008-10#8)
the determination of psilocin and psilocybin##2##6##(2008-10#2)
the determination of purines in##2##5##(1992-2#2)
the determination of pyridoxine hydrochloride##2##5##(2008-10#2)
the determination of pyritinol dihydrochloride in##2##6##(2010-4#2)
the determination of pyritinol dihydrochloride##3##5##(2010-4#3)
the determination of quinolones##3##4##(2007-8#2)(2008-10#1)
the determination of radioactivity##2##4##(1992-5#1)(2007-11#1)
the determination of relative##2##4##(2008-3#1)(2008-5#1)
the determination of rhodium in##2##5##(2008-10#2)
the determination of rhodium##5##4##(2008-10#5)
the determination of rubidate in##2##5##(2008-10#2)
the determination of rutin in##2##5##(2008-10#2)
the determination of rutin##3##4##(2008-10#3)
the determination of salbutamol##4##4##(1992-1#2)(2008-10#2)
the determination of salicylic acid##2##5##(2007-8#2)
the determination of salsalate in##2##5##(2008-10#2)
the determination of salsalate##3##4##(2008-10#3)
the determination of scandium##2##4##(2008-10#2)
the determination of selenium in##2##5##(2008-10#2)
the determination of selenium##5##4##(2008-10#5)
the determination of several##4##4##(2005-4#1)(2008-10#3)
the determination of silicate##2##4##(2008-10#2)
the determination of silicon##2##4##(2008-10#2)
the determination of silver in##5##5##(2007-8#1)(2008-10#4)
the determination of silver##6##4##(2007-8#1)(2008-10#5)
the determination of silver(I)##3##4##(2008-10#3)
the determination of sodium##5##4##(2008-10#5)
the determination of soluble##3##4##(1994-2#1)(2008-10#2)
the determination of studied##2##4##(2008-10#2)
the determination of substances in##2##5##(2008-10#1)(2010-11#1)
the determination of sucrose##2##4##(2008-10#2)
the determination of sulfide in##4##5##(2008-10#4)
the determination of sulfide##6##4##(2007-8#1)(2008-10#5)
the determination of sulfite in##3##5##(2008-10#3)
the determination of sulfite##5##4##(2008-10#5)
the determination of terbium##3##4##(2008-10#3)
the determination of thallium##6##4##(1991-12#2)(2008-10#4)
the determination of the above mentioned##2##6##(2008-10#2)
the determination of the above##4##5##(2008-10#4)
the determination of the absolute##2##5##(2006-12#1)(2008-10#1)
the determination of the analyte in a##2##7##(2008-10#2)
the determination of the analyte in##3##6##(2008-10#2)(2010-5#1)
the determination of the analyte##5##5##(2008-10#4)(2010-5#1)
the determination of the complex index of refraction##3##8##(2008-2#3)
the determination of the components##2##5##(2008-10#1)(2011-1#1)
the determination of the critical##2##5##(1990-3#1)(2004-12#1)
the determination of the drug in capsules and##2##8##(2008-10#2)
the determination of the drug in##6##6##(2008-10#6)
the determination of the drug##7##5##(2008-10#7)
the determination of the drugs in plasma##2##7##(1990-8#1)(2008-10#1)
the determination of the drugs in##6##6##(1990-8#1)(1996-5#1)(2008-10#4)
the determination of the drugs##7##5##(1990-8#1)(1996-5#1)(2008-10#4)(2010-2#1)
the determination of the four##3##5##(2008-10#3)
the determination of the inclusion constant##2##6##(2008-10#2)
the determination of the investigated##3##5##(2008-10#3)
the determination of the levels of##2##6##(2008-10#1)(2011-2#1)
the determination of the metal##2##5##(2008-10#2)
the determination of the molecular##3##5##(1996-5#1)(1996-8#1)(2006-10#1)
the determination of the most##2##5##(2007-8#1)(2008-10#1)
the determination of the nature of##2##6##(1997-1#1)(2010-12#1)
the determination of the optical constants##3##6##(2008-2#3)
the determination of the optical##4##5##(2008-2#4)
the determination of the optimum##2##5##(2007-11#1)(2008-3#1)
the determination of the orientation##2##5##(1994-3#1)(2008-4#1)
the determination of the protein in##2##6##(1995-3#2)
the determination of the refractive##3##5##(2008-3#3)
the determination of the studied##3##5##(2008-10#3)
the determination of the surfactant##2##5##(2008-10#2)
the determination of the total amount of##3##7##(1997-3#1)(2008-10#2)
the determination of the total##4##5##(1997-3#1)(2008-1#1)(2008-10#2)
the determination of the trace##3##5##(2005-4#1)(2008-10#2)
the determination of the two##2##5##(2008-10#2)
the determination of the two-dimensional MTF of digital radiography systems using##2##11##(2010-12#2)
the determination of the##223##4##(1990-12#3)(1990-3#1)(1990-7#1)(1990-8#1)(1991-5#3)(1991-7#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-3#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-4#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(2003-11#1)(2004-12#1)(2005-11#3)(2005-12#1)(2005-4#4)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-5#2)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#107)(2008-11#2)(2008-12#2)(2008-2#17)(2008-3#13)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-11#2)(2012-12#1)(2013-8#1)
the determination of their##5##4##(1995-6#1)(2007-9#1)(2008-10#1)(2009-5#1)(2013-1#1)
the determination of these antioxidants##2##5##(2008-10#2)
the determination of these catecholamines##2##5##(2008-10#2)
the determination of these compounds##6##5##(2008-10#6)
the determination of these ions##3##5##(2008-10#3)
the determination of these parameters##2##5##(2008-10#2)
the determination of these pesticides in##2##6##(2007-8#1)(2008-10#1)
the determination of these##30##4##(2007-8#1)(2008-10#29)
the determination of thiamine in pharmaceutical##2##6##(2008-10#2)
the determination of thiamine##4##4##(2008-10#4)
the determination of thiram##2##4##(2008-10#2)
the determination of this element##3##5##(2008-10#3)
the determination of this##8##4##(1992-11#1)(2008-10#7)
the determination of thorium##2##4##(2008-10#2)
the determination of three##6##4##(2007-8#1)(2008-10#5)
the determination of tin##3##4##(2008-10#3)
the determination of total arsenic##3##5##(2008-10#3)
the determination of total iron##2##5##(2008-10#2)
the determination of total sulfur##3##5##(2008-10#3)
the determination of total urinary##2##5##(1993-1#1)(1994-6#1)
the determination of total##41##4##(1991-10#1)(1992-2#2)(1993-1#1)(1994-6#1)(1996-8#1)(1997-2#1)(2008-10#34)
the determination of trace Cd and Pb##2##7##(2008-10#2)
the determination of trace amount of##13##6##(2005-4#1)(2008-10#12)
the determination of trace amounts of lead##2##7##(2008-10#2)
the determination of trace amounts of##35##6##(2005-4#1)(2007-8#1)(2008-10#33)
the determination of trace cobalt##3##5##(2008-10#3)
the determination of trace elements in##7##6##(2007-8#2)(2008-10#3)(2011-2#1)(2013-8#1)
the determination of trace elements##9##5##(2007-8#2)(2008-10#5)(2011-2#1)(2013-8#1)
the determination of trace lead##4##5##(2005-4#1)(2008-10#1)(2013-8#2)
the determination of trace levels of##9##6##(1990-8#1)(2008-10#8)
the determination of trace manganese##3##5##(2008-10#3)
the determination of trace mercury in water##2##7##(2008-10#2)
the determination of trace mercury in##5##6##(2008-10#5)
the determination of trace mercury##7##5##(2008-10#7)
the determination of trace metals in##3##6##(2008-10#3)
the determination of trace metals##7##5##(2005-4#1)(2008-10#6)
the determination of trace nitrite in##2##6##(2008-10#2)
the determination of trace nitrite##3##5##(2005-4#1)(2008-10#2)
the determination of trace##138##4##(1990-8#1)(1991-8#1)(2005-4#17)(2007-8#4)(2008-10#111)(2011-2#1)(2013-8#3)
the determination of trihalomethanes##3##4##(2007-8#1)(2008-10#2)
the determination of trimethylamine##2##4##(2008-10#2)
the determination of tungsten in##4##5##(2008-10#4)
the determination of tungsten##6##4##(2005-4#1)(2008-10#5)
the determination of uptake rates##2##5##(2008-10#2)
the determination of uranium in synthetic##2##6##(2008-10#2)
the determination of uranium in##5##5##(2008-10#5)
the determination of uranium##7##4##(2008-10#7)
the determination of urea##2##4##(2008-10#2)
the determination of uric acid##4##5##(2008-10#4)
the determination of vanadium in##10##5##(2008-10#10)
the determination of vanadium##16##4##(2008-10#16)
the determination of vitamin##3##4##(2008-10#3)
the determination of yperites##2##4##(2008-10#2)
the determination of zinc and nickel##2##6##(2008-10#2)
the determination of zinc in##3##5##(2007-10#1)(2008-10#2)
the determination of zinc##8##4##(2007-10#1)(2008-10#7)
the determination of zinc(II)##2##4##(2008-10#2)
the determination of##2289##3##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#13)(1990-2#5)(1990-3#2)(1990-6#2)(1990-7#1)(1990-8#13)(1990-9#4)(1991-1#2)(1991-10#4)(1991-11#2)(1991-12#2)(1991-3#2)(1991-5#7)(1991-7#1)(1991-8#3)(1991-9#2)(1992-1#4)(1992-10#2)(1992-11#4)(1992-2#11)(1992-3#1)(1992-5#2)(1992-6#1)(1992-7#5)(1992-8#4)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#3)(1993-2#4)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#5)(1995-4#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-3#2)(1996-5#11)(1996-6#2)(1996-7#2)(1996-8#9)(1996-9#1)(1997-1#2)(1997-2#6)(1997-3#9)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#8)(2003-11#1)(2004-12#1)(2005-10#1)(2005-11#6)(2005-12#8)(2005-4#41)(2005-7#1)(2006-10#3)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#4)(2007-2#1)(2007-3#1)(2007-5#3)(2007-7#1)(2007-8#52)(2007-9#3)(2008-1#5)(2008-10#1725)(2008-11#11)(2008-12#2)(2008-2#34)(2008-3#38)(2008-4#11)(2008-5#11)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-1#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#6)(2010-2#3)(2010-4#8)(2010-5#7)(2010-8#1)(2011-1#15)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#5)(2012-11#4)(2012-12#9)(2012-2#2)(2012-4#1)(2013-1#2)(2013-7#2)(2013-8#5)
the determination range##2##3##(2008-10#2)
the determination results##2##3##(2005-12#1)(2008-10#1)
the determination was performed##2##4##(2008-10#2)
the determination was##13##3##(2008-10#13)
the determination were investigated##2##4##(2008-10#2)
the determination were##4##3##(2007-8#1)(2008-10#3)
the determination##2377##2##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#13)(1990-2#5)(1990-3#2)(1990-6#2)(1990-7#1)(1990-8#13)(1990-9#4)(1991-1#2)(1991-10#4)(1991-11#2)(1991-12#2)(1991-3#2)(1991-5#7)(1991-7#1)(1991-8#3)(1991-9#2)(1992-1#4)(1992-10#2)(1992-11#4)(1992-2#11)(1992-3#1)(1992-5#2)(1992-6#1)(1992-7#5)(1992-8#4)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#3)(1993-2#5)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#5)(1995-4#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-3#2)(1996-5#11)(1996-6#2)(1996-7#2)(1996-8#10)(1996-9#1)(1997-1#2)(1997-2#6)(1997-3#9)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#8)(2003-11#1)(2004-12#1)(2005-10#1)(2005-11#7)(2005-12#9)(2005-4#46)(2005-7#1)(2006-10#3)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#4)(2007-2#1)(2007-3#1)(2007-5#3)(2007-7#1)(2007-8#54)(2007-9#3)(2008-1#5)(2008-10#1792)(2008-11#11)(2008-12#2)(2008-2#34)(2008-3#38)(2008-4#11)(2008-5#13)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-1#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#1)(2010-10#1)(2010-11#4)(2010-12#6)(2010-2#4)(2010-4#8)(2010-5#7)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#15)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#5)(2012-11#5)(2012-12#10)(2012-2#2)(2012-4#1)(2013-1#2)(2013-7#2)(2013-8#5)
the determinations of##10##3##(2007-8#2)(2008-10#8)
the determinations##19##2##(2006-8#1)(2007-8#2)(2008-10#16)
the determined and foreign ions##2##5##(2008-10#2)
the determined values##5##3##(2008-10#5)
the determined##25##2##(1990-9#1)(1994-8#1)(1996-8#1)(1997-2#1)(1997-7#1)(2007-8#1)(2008-10#15)(2008-3#2)(2008-8#1)(2010-12#1)
the determining factor##3##3##(1990-2#1)(1996-7#1)(2008-7#1)
the determining##5##2##(1990-2#1)(1996-7#1)(2008-2#1)(2008-7#1)(2008-9#1)
the deterministic effects##2##3##(1996-6#1)(2007-9#1)
the deterministic models##2##3##(2007-9#2)
the deterministic threshold model##2##4##(1995-8#2)
the deterministic##12##2##(1991-12#2)(1995-8#2)(1996-6#1)(2007-11#1)(2007-9#3)(2008-8#1)(2008-9#1)(2010-9#1)
the detoxication of##2##3##(1995-8#1)(2009-3#1)
the detoxification of##10##3##(1994-12#1)(1994-5#1)(1995-1#1)(1996-1#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)
the detoxification##14##2##(1994-12#1)(1994-5#1)(1995-1#1)(1996-1#1)(1996-5#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
the detrimental effect of##3##4##(2008-10#1)(2008-11#1)(2009-3#1)
the detrimental effects of oxidative##2##5##(2008-5#1)(2009-3#1)
the detrimental effects of##10##4##(1993-12#1)(1994-3#2)(1996-12#1)(2006-5#1)(2007-11#1)(2008-5#1)(2009-3#1)(2009-8#1)(2010-10#1)
the detrimental effects##12##3##(1993-12#1)(1994-3#2)(1996-12#1)(1996-6#1)(2006-5#1)(2007-11#1)(2007-2#1)(2008-5#1)(2009-3#1)(2009-8#1)(2010-10#1)
the detrimental impact on##2##4##(2005-1#1)(2013-8#1)
the detrimental##19##2##(1993-12#1)(1994-3#2)(1996-12#1)(1996-6#1)(2005-1#1)(2006-5#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-3#2)(2009-8#1)(2010-10#1)(2011-2#2)(2013-8#1)
the detrital##2##2##(2005-12#1)(2010-8#1)
the detrusor##5##2##(1995-9#1)(2006-9#1)(2008-10#3)
the detuning##3##2##(2007-11#1)(2007-12#2)
the deuterated##4##2##(1991-9#1)(1993-4#1)(1996-5#1)(2008-4#1)
the deuterium##6##2##(1990-7#1)(1994-5#1)(1994-8#1)(1996-5#1)(2008-10#1)(2008-9#1)
the deutocerebrum##5##2##(2007-12#5)
the devastating##7##2##(2007-12#1)(2008-7#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-7#1)
the developed PCR assay##2##4##(2008-10#1)(2013-1#1)
the developed and developing world##3##5##(1997-7#1)(2006-1#1)(2008-5#1)
the developed and developing##5##4##(1997-7#1)(2005-8#1)(2006-1#1)(2008-10#1)(2008-5#1)
the developed biosensor##3##3##(2007-8#2)(2008-10#1)
the developed countries##11##3##(1992-5#1)(1992-6#1)(2005-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#1)(2010-8#1)(2012-2#1)
the developed immunoassay##3##3##(2007-8#1)(2008-10#1)(2010-5#1)
the developed method are##3##4##(2008-10#3)
the developed method has been##2##5##(2008-10#1)(2012-12#1)
the developed method is##4##4##(2008-10#3)(2011-1#1)
the developed method was##9##4##(2007-8#1)(2008-10#7)(2009-2#1)
the developed method##46##3##(2007-8#3)(2008-10#37)(2008-3#1)(2009-2#1)(2010-5#1)(2011-1#1)(2012-12#2)
the developed methodology was##2##4##(2008-10#2)
the developed methodology##3##3##(2008-10#2)(2011-2#1)
the developed methods were##2##4##(2008-10#1)(2010-2#1)
the developed methods##4##3##(2008-10#2)(2010-2#2)
the developed microscope##2##3##(2008-1#2)
the developed model##8##3##(1997-8#1)(2006-11#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-3#1)(2011-2#1)(2012-3#1)
the developed procedure##10##3##(2008-10#10)
the developed system##6##3##(2006-2#1)(2008-10#2)(2008-3#1)(2010-10#1)(2010-8#1)
the developed world##19##3##(1994-9#1)(2004-10#1)(2006-10#3)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#2)(2009-3#1)(2010-12#2)(2010-8#1)(2012-12#1)
the developed##178##2##(1992-5#1)(1992-6#1)(1993-8#1)(1994-9#1)(1996-2#1)(1996-3#1)(1997-7#2)(1997-8#1)(2004-10#1)(2005-11#3)(2005-8#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-2#1)(2007-11#4)(2007-12#1)(2007-7#2)(2007-8#8)(2008-1#4)(2008-10#87)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#3)(2009-2#1)(2009-3#3)(2010-10#1)(2010-12#2)(2010-2#2)(2010-5#2)(2010-8#4)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2012-6#1)(2013-1#4)(2013-8#1)
the developer##4##2##(2005-8#1)(2006-5#1)(2008-10#1)(2008-2#1)
the developers of the##2##4##(1997-2#1)(2008-7#1)
the developers of##4##3##(1994-1#1)(1997-2#1)(2007-10#1)(2008-7#1)
the developers##5##2##(1994-1#1)(1995-2#1)(1997-2#1)(2007-10#1)(2008-7#1)
the developing CNS##5##3##(1990-5#1)(1993-5#1)(2008-5#1)(2008-7#2)
the developing Mexican##2##3##(1997-9#1)(2007-3#1)
the developing Xenopus##2##3##(1997-4#2)
the developing adult wing##2##4##(2007-12#1)(2007-9#1)
the developing and##11##3##(1994-12#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-4#1)(2007-10#1)(2008-1#2)(2008-10#1)(2008-4#1)
the developing antennal lobe##2##4##(2007-12#2)
the developing brain##13##3##(1994-2#1)(1994-9#1)(1995-12#2)(1996-1#1)(1996-4#1)(1996-6#2)(2005-10#1)(2007-12#1)(2008-7#1)(2010-12#1)(2012-1#1)
the developing cerebellum##4##3##(1995-12#1)(1996-5#2)(2012-3#1)
the developing cervical##2##3##(1996-5#1)(2007-4#1)
the developing chick embryo##2##4##(1993-2#1)(2006-4#1)
the developing chick##3##3##(1993-2#1)(1996-2#1)(2006-4#1)
the developing countries##10##3##(1990-7#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
the developing embryo##6##3##(1993-7#1)(1994-8#1)(1995-10#1)(2008-11#2)(2010-11#1)
the developing eye##2##3##(1993-6#1)(2007-12#1)
the developing fetal##3##3##(1991-4#1)(1995-11#1)(2011-2#1)
the developing fetus##6##3##(1994-4#1)(1994-6#1)(2008-3#1)(2008-7#1)(2010-2#1)(2011-2#1)
the developing field of##2##4##(2009-10#1)(2009-4#1)
the developing fruit##3##3##(2008-10#3)
the developing human fetus##2##4##(1990-7#1)(1994-4#1)
the developing human##4##3##(1990-7#1)(1991-7#1)(1994-4#1)(2008-7#1)
the developing immune system##2##4##(2005-8#1)(2008-10#1)
the developing inner ear##2##4##(1996-3#1)(2012-2#1)
the developing limb##7##3##(2003-11#1)(2006-11#1)(2008-11#3)(2009-3#1)(2010-3#1)
the developing lung##2##3##(1991-12#1)(2009-9#1)
the developing mouse##8##3##(1993-2#1)(1993-4#1)(1994-2#1)(1995-11#1)(1995-8#1)(1996-4#1)(1997-2#1)(2006-11#1)
the developing nervous system##8##4##(1991-3#1)(1992-3#1)(1996-4#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-3#1)(2012-3#1)
the developing neural tube##3##4##(1996-5#1)(2008-11#2)
the developing neural##5##3##(1992-9#1)(1996-12#1)(1996-5#1)(2008-11#2)
the developing oocyte##2##3##(2006-12#1)(2008-10#1)
the developing or##2##3##(1997-3#1)(2013-1#1)
the developing peripheral nervous system##3##5##(1996-3#3)
the developing rat##15##3##(1992-6#1)(1993-11#3)(1993-2#3)(1994-12#1)(1996-12#1)(1996-4#2)(1996-5#2)(1997-2#1)(2012-2#1)
the developing rodent brain##2##4##(1994-2#1)(2008-7#1)
the developing rodent##3##3##(1994-2#1)(1996-4#1)(2008-7#1)
the developing vertebrate nervous system##2##5##(1991-3#1)(1996-3#1)
the developing vertebrate##3##3##(1991-3#1)(1996-3#1)(2007-12#1)
the developing visual system##2##4##(1996-10#1)(1996-2#1)
the developing world##43##3##(1997-3#1)(1997-7#3)(2004-10#2)(2005-8#1)(2006-10#2)(2006-4#2)(2006-9#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-4#1)(2010-12#4)(2010-5#1)(2010-8#1)(2010-9#2)(2011-11#1)(2011-2#2)(2012-2#1)(2013-7#1)(2013-8#3)
the developing##266##2##(1990-5#2)(1990-7#2)(1991-12#3)(1991-3#3)(1991-4#1)(1991-7#2)(1992-3#2)(1992-6#1)(1992-7#2)(1992-9#1)(1993-11#3)(1993-12#1)(1993-2#5)(1993-4#2)(1993-5#3)(1993-6#2)(1993-7#1)(1994-12#2)(1994-2#3)(1994-4#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#4)(1995-12#5)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#3)(1996-10#1)(1996-12#4)(1996-2#2)(1996-3#5)(1996-4#8)(1996-5#7)(1996-6#2)(1996-8#1)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#4)(1997-6#2)(1997-7#4)(1997-9#2)(2003-11#1)(2004-10#2)(2005-10#1)(2005-8#2)(2006-1#1)(2006-10#2)(2006-11#5)(2006-12#1)(2006-4#3)(2006-6#2)(2006-9#2)(2007-10#1)(2007-11#1)(2007-12#15)(2007-2#1)(2007-3#2)(2007-4#3)(2007-5#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#6)(2008-10#10)(2008-11#10)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#3)(2009-10#3)(2009-2#1)(2009-3#1)(2009-4#2)(2009-9#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-11#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#3)
the development and application of a##3##6##(2008-10#2)(2012-2#1)
the development and application of##9##5##(1994-3#1)(1996-3#1)(2008-10#3)(2008-5#1)(2008-8#1)(2010-4#1)(2012-2#1)
the development and applications of##3##5##(2007-8#1)(2008-8#1)(2013-8#1)
the development and assessment of##2##5##(2008-11#1)(2011-8#1)
the development and characterization of a##3##6##(1994-3#1)(2008-3#1)(2013-1#1)
the development and characterization of##5##5##(1994-3#1)(2008-3#2)(2010-4#1)(2013-1#1)
the development and current##3##4##(2006-10#1)(2007-11#1)(2012-2#1)
the development and design of the##2##6##(2012-12#1)(2012-2#1)
the development and dissemination of##2##5##(2011-12#1)(2012-12#1)
the development and evaluation of a##6##6##(2008-11#1)(2008-12#2)(2010-5#1)(2013-1#2)
the development and evaluation of##11##5##(2006-5#1)(2008-11#1)(2008-12#2)(2008-9#1)(2010-5#1)(2012-12#1)(2013-1#4)
the development and evolution of##6##5##(1991-7#1)(1993-4#1)(2007-4#1)(2007-9#1)(2009-5#1)(2011-1#1)
the development and expression of##2##5##(1995-12#1)(2008-11#1)
the development and function of the male##2##7##(2007-4#1)(2012-2#1)
the development and function of the##4##6##(2007-12#1)(2007-4#1)(2008-4#1)(2012-2#1)
the development and function of##6##5##(2007-12#1)(2007-4#1)(2007-5#1)(2008-4#1)(2009-9#1)(2012-2#1)
the development and homeostasis of##2##5##(2006-2#1)(2009-3#1)
the development and implementation of a##4##6##(1993-3#2)(2007-4#1)(2012-1#1)
the development and implementation of##11##5##(1993-3#2)(1994-2#2)(2007-4#1)(2008-11#3)(2009-12#1)(2010-6#1)(2012-1#1)
the development and maintenance of persistent pain##2##7##(2008-7#2)
the development and maintenance of##16##5##(1991-11#1)(1994-8#1)(1996-3#1)(1996-5#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#2)(2011-2#1)
the development and maintenance##17##4##(1991-11#1)(1994-8#1)(1996-3#1)(1996-5#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#2)(2011-2#2)
the development and organization of##2##5##(2008-12#1)(2011-11#1)
the development and outcome of##2##5##(2007-7#1)(2013-7#1)
the development and perpetuation of##5##5##(2006-7#1)(2008-12#3)(2010-12#1)
the development and persistence of##2##5##(1995-9#1)(2006-10#1)
the development and preliminary##2##4##(2006-1#1)(2008-10#1)
the development and progress of##2##5##(2006-10#1)(2010-3#1)
the development and progression of DR##2##6##(2008-1#1)(2011-2#1)
the development and progression of##27##5##(1993-9#1)(1997-5#1)(2004-9#1)(2008-1#3)(2008-10#1)(2008-4#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#3)(2012-12#3)(2012-3#2)(2013-1#5)
the development and registration of##2##5##(2012-2#1)(2013-7#1)
the development and regulation of##3##5##(1996-9#1)(2006-10#1)(2013-1#1)
the development and testing of##5##5##(1992-2#1)(1996-2#1)(1997-5#1)(2007-11#1)(2010-2#1)
the development and the##3##4##(2008-6#1)(2008-8#1)(2012-2#1)
the development and treatment of##3##5##(1997-4#1)(2012-12#2)
the development and use of clinical##2##6##(1993-12#1)(2011-12#1)
the development and use of##12##5##(1992-1#1)(1993-12#1)(1994-10#1)(1995-8#1)(1996-5#1)(2005-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-12#1)(2013-1#1)(2013-8#1)
the development and validation of a##5##6##(2007-12#1)(2008-10#1)(2008-5#1)(2013-1#2)
the development and validation of##7##5##(2007-12#2)(2008-10#1)(2008-5#1)(2009-2#1)(2013-1#2)
the development and##212##3##(1991-11#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-9#1)(1994-10#1)(1994-2#2)(1994-3#2)(1994-8#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-2#2)(1996-3#2)(1996-5#2)(1996-9#1)(1997-4#1)(1997-5#2)(1997-6#1)(2004-9#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-2#1)(2006-5#1)(2006-6#3)(2006-7#1)(2007-11#4)(2007-12#8)(2007-4#4)(2007-5#2)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#6)(2008-10#12)(2008-11#9)(2008-12#8)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#2)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#2)(2011-1#1)(2011-11#1)(2011-12#2)(2011-2#7)(2011-8#1)(2012-1#1)(2012-12#12)(2012-2#7)(2012-3#2)(2013-1#18)(2013-7#3)(2013-8#2)
the development and/or##2##3##(1995-6#1)(2008-6#1)
the development in##4##3##(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
the development is##2##3##(2008-10#2)
the development of &quot##2##4##(2008-4#1)(2012-12#1)
the development of AIDS##2##4##(1994-10#1)(2007-2#1)
the development of ARDS##3##4##(1991-9#1)(2005-11#1)(2005-8#1)
the development of Alzheimer's disease##2##5##(1993-11#1)(1994-5#1)
the development of Burnout Syndrome##2##5##(2013-1#2)
the development of DME and retinal NV##2##7##(2008-1#2)
the development of FHB##2##4##(2011-10#2)
the development of HBBS##2##4##(2005-7#2)
the development of HCC##4##4##(2005-8#1)(2008-5#2)(2008-8#1)
the development of HIV/AIDS##2##4##(2012-12#1)(2013-1#1)
the development of IPA in##2##5##(2011-2#2)
the development of SCLC##2##4##(1992-9#1)(2013-8#1)
the development of SMT##2##4##(2006-12#2)
the development of a capillary electrophoresis method for the##2##9##(2008-10#2)
the development of a capillary##3##5##(2008-10#3)
the development of a complex##2##5##(2007-12#1)(2009-8#1)
the development of a comprehensive##4##5##(1995-3#1)(1997-3#1)(2013-1#2)
the development of a gene##2##5##(1993-12#1)(2005-7#1)
the development of a highly##2##5##(2008-10#1)(2008-3#1)
the development of a laboratory##2##5##(2008-10#2)
the development of a large number of##2##7##(1994-3#1)(2013-1#1)
the development of a malignant##2##5##(1991-9#1)(2005-11#1)
the development of a marketing plan will provide a strategy that will keep the medical group competitive among older consumers##2##20##(1994-3#2)
the development of a method##4##5##(1996-11#1)(2008-10#1)(2008-4#2)
the development of a methodology##2##5##(2007-6#1)(2008-10#1)
the development of a more##5##5##(1994-11#1)(1997-2#1)(2007-8#1)(2008-11#1)(2010-8#1)
the development of a multitude of##2##6##(2006-6#1)(2010-12#1)
the development of a new class of##2##7##(2008-5#1)(2010-4#1)
the development of a new generation of##3##7##(2006-10#1)(2006-4#1)(2011-1#1)
the development of a new##28##5##(1991-10#1)(1992-6#1)(1992-7#1)(1995-2#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-3#1)(2008-5#1)(2009-4#1)(2010-4#2)(2010-6#1)(2011-1#1)(2012-3#1)
the development of a novel##7##5##(2007-5#1)(2008-1#1)(2008-11#2)(2008-5#2)(2009-7#1)
the development of a number of##2##6##(2008-3#1)(2008-4#1)
the development of a programme##2##5##(1996-4#1)(1997-7#1)
the development of a real-time##2##5##(2008-3#1)(2013-8#1)
the development of a robust##2##5##(2008-5#1)(2010-10#1)
the development of a sandwich##2##5##(2007-8#1)(2008-10#1)
the development of a shared##3##5##(1993-12#1)(2005-10#1)(2008-11#1)
the development of a simple##3##5##(2008-10#1)(2008-3#1)(2008-7#1)
the development of a single##3##5##(2008-10#1)(2011-1#1)(2013-1#1)
the development of a standard##2##5##(1996-8#1)(2008-7#1)
the development of a successful##3##5##(1991-3#1)(2008-10#1)(2010-10#1)
the development of a surgical##2##5##(2007-5#1)(2008-8#1)
the development of a system##2##5##(2006-2#1)(2013-1#1)
the development of a vaccine##4##5##(1997-7#1)(2006-10#2)(2011-2#1)
the development of a virtual##2##5##(2008-10#1)(2012-1#1)
the development of a##273##4##(1990-10#1)(1990-12#3)(1990-8#1)(1990-9#1)(1991-10#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#5)(1994-6#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#2)(1997-2#1)(1997-3#3)(1997-4#3)(1997-6#3)(1997-7#2)(2005-1#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#2)(2006-10#6)(2006-11#1)(2006-12#4)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#3)(2007-11#3)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-8#6)(2007-9#1)(2008-1#3)(2008-10#38)(2008-11#12)(2008-12#2)(2008-2#5)(2008-3#9)(2008-4#4)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#3)(2009-2#1)(2009-4#3)(2009-6#1)(2009-7#3)(2009-8#2)(2010-10#2)(2010-12#3)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#9)(2011-7#1)(2012-1#4)(2012-11#3)(2012-12#6)(2012-2#3)(2012-3#6)(2013-1#7)(2013-7#1)(2013-8#1)
the development of abnormal##2##4##(1996-8#1)(2013-1#1)
the development of accurate##2##4##(1993-11#1)(2008-10#1)
the development of acquired##2##4##(2006-11#1)(2008-4#1)
the development of acute##3##4##(2007-2#1)(2008-1#1)(2009-8#1)
the development of adolescent##2##4##(2008-7#1)(2010-2#1)
the development of adverse events##2##5##(2008-7#1)(2010-12#1)
the development of adverse##3##4##(2006-10#1)(2008-7#1)(2010-12#1)
the development of agents##4##4##(2007-1#1)(2008-1#1)(2009-12#1)(2012-2#1)
the development of alcohol##2##4##(2008-1#1)(2012-3#1)
the development of alternative methods##2##5##(1997-1#1)(2007-8#1)
the development of alternative##9##4##(1994-12#1)(1994-3#1)(1997-1#1)(1997-7#1)(2007-8#1)(2008-10#1)(2010-12#1)(2010-2#1)(2012-12#1)
the development of an appropriate##2##5##(2008-10#1)(2012-2#1)
the development of an effective##2##5##(2006-10#1)(2006-12#1)
the development of an in##2##5##(1990-12#1)(2008-3#1)
the development of an integrated##6##5##(1996-7#1)(2006-9#1)(2008-10#2)(2008-6#1)(2011-1#1)
the development of an##68##4##(1990-12#1)(1991-1#2)(1993-1#1)(1993-12#1)(1993-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(2005-12#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-7#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#6)(2008-6#2)(2008-7#1)(2008-8#2)(2009-4#1)(2009-5#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)
the development of analytical methods for the determination of rhodium has increased##2##12##(2008-10#2)
the development of analytical##5##4##(2008-10#3)(2011-1#1)(2011-2#1)
the development of animal##3##4##(1992-9#1)(2008-11#1)(2011-2#1)
the development of anticancer drugs##2##5##(1994-4#1)(2006-12#1)
the development of antiviral##4##4##(1991-10#1)(1993-3#1)(2008-1#1)(2011-2#1)
the development of appropriate##5##4##(1991-5#1)(2007-10#1)(2008-1#1)(2008-5#1)(2011-2#1)
the development of arterial hypertension in##2##6##(2011-2#2)
the development of artificial##3##4##(2008-5#1)(2011-1#1)(2013-1#1)
the development of assays##2##4##(2005-8#1)(2008-4#1)
the development of asthma##4##4##(2005-8#1)(2008-3#1)(2010-5#1)(2012-3#1)
the development of atherosclerosis##13##4##(1991-11#3)(1991-8#1)(1995-1#1)(1995-8#1)(1997-2#1)(2006-6#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-5#1)(2012-3#1)
the development of atherosclerotic lesions##2##5##(1996-3#1)(2010-8#1)
the development of atherosclerotic##5##4##(1996-3#1)(2006-10#1)(2010-2#1)(2010-4#1)(2010-8#1)
the development of atrial##2##4##(2012-12#2)
the development of autism##2##4##(2012-3#2)
the development of autoimmune##4##4##(1991-7#1)(2008-10#2)(2013-7#1)
the development of autoimmunity in##2##5##(2008-10#1)(2008-4#1)
the development of autoimmunity##4##4##(2008-10#2)(2008-4#1)(2010-5#1)
the development of automated##3##4##(2008-10#1)(2008-11#1)(2012-12#1)
the development of bacterial##4##4##(2005-11#1)(2005-9#1)(2008-10#1)(2009-5#1)
the development of basic##2##4##(1993-12#1)(2007-4#1)
the development of behavioral##2##4##(1993-4#1)(2004-3#1)
the development of better##5##4##(1995-3#1)(1995-4#1)(2005-7#1)(2008-7#1)(2011-1#1)
the development of bioethics in##2##5##(2008-4#2)
the development of biological##2##4##(1990-2#1)(2006-6#1)
the development of biosensors##2##4##(2007-8#1)(2008-10#1)
the development of bone##4##4##(2005-1#1)(2007-11#1)(2008-5#1)(2009-2#1)
the development of both##8##4##(1991-8#1)(1992-12#1)(2007-11#1)(2008-1#4)(2012-12#1)
the development of breast cancer##3##5##(1994-12#1)(2008-12#1)(2013-8#1)
the development of breast##5##4##(1994-12#1)(1997-4#1)(2008-12#1)(2008-3#1)(2013-8#1)
the development of cancer##7##4##(1990-12#1)(2005-10#1)(2007-10#2)(2008-8#1)(2009-5#1)(2013-1#1)
the development of cardiovascular disease##9##5##(1996-9#1)(1997-8#1)(2005-10#1)(2005-8#1)(2007-1#1)(2008-1#2)(2009-9#1)(2011-1#1)
the development of cardiovascular##13##4##(1996-9#1)(1997-8#1)(2005-10#1)(2005-8#1)(2007-1#1)(2008-1#3)(2008-7#1)(2009-9#1)(2010-6#1)(2011-1#1)(2013-7#1)
the development of case##2##4##(1995-2#1)(2008-11#1)
the development of cell-based##2##4##(2007-11#1)(2008-10#1)
the development of cellular##2##4##(1990-5#1)(2010-12#1)
the development of central##3##4##(1991-11#1)(2008-7#1)(2008-9#1)
the development of cerebral##5##4##(1990-6#1)(1995-6#1)(1996-1#1)(2007-9#1)(2008-9#1)
the development of chronic kidney disease##2##6##(2008-8#1)(2010-10#1)
the development of chronic##7##4##(1997-5#1)(2006-10#1)(2008-10#1)(2008-8#1)(2010-10#1)(2011-2#1)(2013-1#1)
the development of clinical practice guidelines##2##6##(1993-12#1)(2006-9#1)
the development of clinical symptoms##3##5##(1997-3#1)(2011-12#1)(2013-8#1)
the development of clinical##18##4##(1993-12#1)(1996-1#1)(1997-2#2)(1997-3#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#1)(2013-8#2)
the development of colon##2##4##(1993-11#1)(2013-8#1)
the development of colorectal##3##4##(1991-9#1)(1993-8#1)(2011-2#1)
the development of community##2##4##(1990-8#1)(2011-2#1)
the development of competence in##3##5##(1991-7#1)(1992-2#1)(2006-9#1)
the development of competencies##2##4##(2008-12#1)(2012-3#1)
the development of competent practitioners##2##5##(2008-11#1)(2008-12#1)
the development of complete##2##4##(2006-5#1)(2008-5#1)
the development of complex##3##4##(2006-7#1)(2007-12#1)(2008-10#1)
the development of complications##3##4##(2005-11#1)(2011-3#1)(2013-8#1)
the development of compounds##2##4##(2007-11#1)(2010-5#1)
the development of computational##3##4##(2007-11#1)(2008-11#1)(2009-8#1)
the development of coronary heart disease (CHD)##2##7##(2007-1#1)(2008-3#1)
the development of coronary##5##4##(1995-12#1)(2007-1#1)(2008-10#1)(2008-3#1)(2008-7#1)
the development of critical##2##4##(2007-9#1)(2008-11#1)
the development of depressive symptoms##2##5##(2012-1#2)
the development of diabetes and##2##5##(1996-6#1)(2008-4#1)
the development of diabetes in##2##5##(1993-11#1)(2008-1#1)
the development of diabetes##6##4##(1992-5#1)(1993-11#1)(1996-6#1)(2008-1#1)(2008-4#1)(2011-2#1)
the development of diabetic complications##4##5##(1997-2#1)(1997-7#1)(2008-1#1)(2009-11#1)
the development of diabetic nephropathy##3##5##(1996-12#1)(2005-10#1)(2008-1#1)
the development of diabetic##11##4##(1996-12#1)(1997-2#1)(1997-7#1)(2005-10#1)(2006-6#1)(2008-1#4)(2009-11#1)(2012-2#1)
the development of diagnostic##2##4##(2006-10#1)(2013-7#1)
the development of different##2##4##(2010-8#2)
the development of disease symptoms##2##5##(2007-11#1)(2009-8#1)
the development of disease##5##4##(2007-11#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-8#1)
the development of diseases##4##4##(1992-12#1)(2008-7#1)(2010-12#1)(2013-1#1)
the development of drug resistance and##2##6##(2007-11#2)
the development of drug resistance to##2##6##(1992-11#2)
the development of drug resistance##6##5##(1992-11#2)(1993-9#1)(1997-6#1)(2007-11#2)
the development of drug##9##4##(1992-11#2)(1993-9#1)(1997-6#1)(2007-11#2)(2008-6#1)(2012-12#1)(2012-2#1)
the development of drugs that##2##5##(2005-8#1)(2006-4#1)
the development of drugs##8##4##(1994-12#1)(1997-6#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-4#1)(2012-2#1)
the development of dysplasia##2##4##(2006-10#1)(2007-6#1)
the development of early##10##4##(1990-2#1)(1991-7#1)(1992-12#1)(1994-2#2)(2008-1#1)(2008-10#1)(2009-1#1)(2012-12#1)(2012-2#1)
the development of educational programs##2##5##(2006-12#1)(2008-1#1)
the development of educational##3##4##(2006-12#1)(2008-1#1)(2008-12#1)
the development of effective therapies##2##5##(2008-1#2)
the development of effective##9##4##(1993-12#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-4#1)(2011-1#1)(2012-1#1)(2012-12#1)
the development of efficient##5##4##(2008-10#1)(2010-8#1)(2012-2#1)(2013-1#2)
the development of emphysema##4##4##(1991-12#2)(1994-11#1)(2006-9#1)
the development of estrogen##2##4##(2008-4#1)(2013-1#1)
the development of experimental allergic encephalomyelitis##3##6##(2007-11#1)(2008-4#2)
the development of experimental atherosclerosis##2##5##(1991-11#1)(2005-3#1)
the development of experimental##10##4##(1991-11#1)(1996-12#1)(2005-3#1)(2005-7#1)(2006-11#1)(2007-11#1)(2008-4#2)(2008-5#1)(2008-7#1)
the development of fast##2##4##(2008-10#1)(2008-11#1)
the development of fibrosis##3##4##(1997-3#1)(2005-8#1)(2012-12#1)
the development of further##4##4##(2007-9#1)(2008-11#1)(2008-5#1)(2012-2#1)
the development of future therapeutic agents##2##6##(2008-4#1)(2011-1#1)
the development of future##9##4##(2007-11#1)(2007-12#1)(2007-5#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
the development of gastric##2##4##(1995-2#1)(2008-12#1)
the development of gene transfer##2##5##(2008-9#1)(2013-7#1)
the development of gene##4##4##(2005-7#1)(2008-11#1)(2008-9#1)(2013-7#1)
the development of genomic##3##4##(2008-7#2)(2008-8#1)
the development of guidelines for##2##5##(2008-7#1)(2013-1#1)
the development of guidelines##3##4##(2008-7#1)(2009-4#1)(2013-1#1)
the development of health##4##4##(1990-10#1)(1992-1#1)(1995-8#1)(2012-1#1)
the development of heart failure##3##5##(2007-8#1)(2009-4#1)(2010-12#1)
the development of heart##6##4##(1996-2#1)(2007-1#1)(2007-8#1)(2008-8#1)(2009-4#1)(2010-12#1)
the development of hepatic##3##4##(1990-4#1)(1992-11#1)(2005-8#1)
the development of hepatocellular carcinoma (HCC)##2##6##(2005-8#1)(2008-5#1)
the development of hepatocellular carcinoma##5##5##(2005-8#1)(2006-10#1)(2008-5#1)(2009-2#1)(2010-12#1)
the development of high##2##4##(2006-11#1)(2010-4#1)
the development of highly sensitive##4##5##(2006-10#1)(2008-10#1)(2010-7#1)(2011-2#1)
the development of highly##5##4##(2006-10#1)(2008-10#1)(2009-11#1)(2010-7#1)(2011-2#1)
the development of human breast cancer##2##6##(1994-12#1)(1994-6#1)
the development of human resource management skills##2##7##(1995-3#2)
the development of human##12##4##(1991-3#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-3#2)(1996-11#1)(2007-10#1)(2007-11#1)(2008-7#1)(2009-8#1)(2012-2#1)
the development of hyperalgesia in##2##5##(1993-12#1)(1996-5#1)
the development of hyperalgesia##3##4##(1993-12#1)(1996-5#1)(2006-10#1)
the development of hyperplasia##2##4##(1996-4#1)(2012-1#1)
the development of hypertension in##3##5##(1991-6#1)(1997-6#1)(2006-1#1)
the development of hypertension##9##4##(1991-12#1)(1991-6#1)(1997-6#3)(2006-1#1)(2008-1#1)(2010-2#1)(2011-2#1)
the development of immune##2##4##(1994-6#1)(2012-12#1)
the development of immunity to Eimeria##2##6##(2005-9#2)
the development of immunity##3##4##(2005-9#2)(2008-5#1)
the development of implantable##2##4##(2008-7#1)(2009-11#1)
the development of improved##6##4##(1993-6#1)(2005-7#1)(2006-10#2)(2008-11#1)(2011-2#1)
the development of in vitro##3##5##(2008-1#1)(2010-4#1)(2010-5#1)
the development of in-stent restenosis##3##5##(2008-5#3)
the development of increasingly##2##4##(1992-11#1)(2008-7#1)
the development of innovative##3##4##(2005-11#1)(2010-12#2)
the development of insulin resistance and diabetes##2##7##(2008-12#1)(2012-2#1)
the development of insulin resistance##9##5##(2005-10#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-9#1)(2011-1#1)(2012-2#2)(2012-5#1)
the development of insulin##10##4##(2005-10#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#2)(2012-5#1)
the development of interventions##4##4##(2006-10#1)(2008-7#1)(2009-5#1)(2012-1#1)
the development of intestinal##2##4##(2006-10#2)
the development of invasive##2##4##(1991-9#1)(2009-11#1)
the development of irreversible##2##4##(1994-12#1)(2010-12#1)
the development of ischemic##3##4##(1991-3#1)(1995-6#1)(1997-2#1)
the development of latent##3##4##(2008-5#1)(2010-8#1)(2012-2#1)
the development of lesions##4##4##(2005-7#1)(2008-10#2)(2010-12#1)
the development of liver fibrosis##2##5##(2012-12#2)
the development of liver##3##4##(2006-9#1)(2012-12#2)
the development of local##3##4##(2007-4#1)(2008-6#1)(2012-1#1)
the development of long-term potentiation##2##5##(1990-5#2)
the development of long-term##3##4##(1990-5#2)(2008-7#1)
the development of low##2##4##(2007-11#1)(2012-12#1)
the development of lung##3##4##(1991-2#1)(2008-6#1)(2013-1#1)
the development of lupus##2##4##(2007-7#1)(2008-10#1)
the development of major##2##4##(2007-10#1)(2009-4#1)
the development of malignancy##3##4##(1995-6#1)(2009-2#1)(2011-2#1)
the development of malignant##4##4##(2007-8#1)(2009-5#1)(2011-2#2)
the development of mammary##2##4##(1993-4#1)(1993-7#1)
the development of manifest##2##4##(1993-2#1)(1994-12#1)
the development of many of##2##5##(2008-6#1)(2009-2#1)
the development of many##7##4##(1996-4#1)(2006-12#1)(2006-6#1)(2008-6#2)(2009-2#1)(2013-8#1)
the development of mechanical##2##4##(2008-8#1)(2009-12#1)
the development of medical##5##4##(1993-10#1)(1993-2#1)(2010-1#1)(2010-8#1)(2012-3#1)
the development of medicine##3##4##(1993-11#1)(2010-7#1)(2011-2#1)
the development of medulloblastoma##2##4##(2006-8#2)
the development of mental health##3##5##(1994-1#1)(2006-9#1)(2009-6#1)
the development of mental##4##4##(1994-1#1)(2006-9#1)(2009-6#1)(2011-1#1)
the development of metabolic syndrome##2##5##(2008-3#1)(2008-4#1)
the development of metabolic##3##4##(2008-3#2)(2008-4#1)
the development of metastases##3##4##(1991-8#1)(2008-7#1)(2013-8#1)
the development of methodology##2##4##(2005-8#1)(2007-8#1)
the development of methods for##2##5##(2005-11#1)(2008-10#1)
the development of methods##4##4##(2005-11#1)(2008-1#1)(2008-10#1)(2008-7#1)
the development of miniaturized##2##4##(2007-8#1)(2008-10#1)
the development of minimally invasive##4##5##(2007-8#1)(2009-10#1)(2009-4#1)(2011-2#1)
the development of modern##2##4##(1991-11#1)(2007-8#1)
the development of molecular biology##2##5##(1993-9#1)(2006-10#1)
the development of molecular therapies##2##5##(2005-8#1)(2008-2#1)
the development of molecular##8##4##(1993-9#1)(2005-8#1)(2006-10#1)(2007-9#1)(2008-10#2)(2008-2#1)(2011-1#1)
the development of more accurate##2##5##(2008-3#1)(2008-5#1)
the development of more effective##3##5##(2007-7#1)(2008-1#1)(2009-12#1)
the development of more potent##2##5##(1994-5#1)(2008-4#1)
the development of more##18##4##(1994-5#1)(1995-10#1)(1996-9#1)(2007-7#1)(2008-1#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#1)
the development of morphine tolerance##2##5##(1991-8#2)
the development of motor complications##2##5##(2010-12#2)
the development of multiple organ failure##2##6##(2006-6#1)(2008-3#1)
the development of multiple##7##4##(2006-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#1)(2013-1#1)
the development of myocardial##2##4##(1993-12#1)(2006-6#1)
the development of nanosensors##2##4##(2008-10#2)
the development of nasal##2##4##(1992-10#1)(1996-9#1)
the development of neural##2##4##(1994-12#1)(2008-8#1)
the development of neuronal##2##4##(1996-3#1)(2008-11#1)
the development of neuropathic pain##2##5##(1993-4#1)(2006-12#1)
the development of new agents##2##5##(2005-9#1)(2008-4#1)
the development of new and improved methods##2##7##(1994-9#1)(2010-11#1)
the development of new and##4##5##(1994-9#1)(1997-4#1)(2010-11#1)(2012-11#1)
the development of new antimicrobial##2##5##(2006-10#1)(2008-10#1)
the development of new antiviral##2##5##(2006-10#1)(2007-11#1)
the development of new classes of##2##6##(1994-4#1)(2007-3#1)
the development of new clinical##2##5##(2009-1#1)(2009-4#1)
the development of new drugs and##2##6##(2006-6#1)(2007-11#1)
the development of new drugs##6##5##(2006-12#2)(2006-5#1)(2006-6#1)(2007-11#1)(2008-8#1)
the development of new methods##3##5##(1997-1#1)(2008-10#1)(2011-1#1)
the development of new models##2##5##(2008-11#1)(2012-2#1)
the development of new neurological deficits##2##6##(2007-10#2)
the development of new programs##2##5##(1992-1#1)(1994-1#1)
the development of new strategies and##2##6##(2008-11#1)(2011-10#1)
the development of new strategies for##2##6##(2006-10#1)(2010-5#1)
the development of new strategies##7##5##(1997-8#1)(2006-10#1)(2007-6#1)(2008-11#1)(2010-12#1)(2010-5#1)(2011-10#1)
the development of new surgical techniques##2##6##(1994-6#1)(2007-8#1)
the development of new therapeutic modalities##2##6##(1992-3#1)(2005-11#1)
the development of new therapeutic strategies to##2##7##(2008-4#1)(2008-6#1)
the development of new therapeutic strategies##3##6##(2008-4#2)(2008-6#1)
the development of new therapeutic##6##5##(1992-3#1)(2005-11#1)(2007-11#1)(2008-4#2)(2008-6#1)
the development of new therapies will be##2##7##(2007-2#2)
the development of new therapies##8##5##(2007-2#2)(2008-6#1)(2008-8#1)(2009-7#1)(2011-1#2)(2011-2#1)
the development of new treatment##2##5##(2010-12#1)(2013-8#1)
the development of new##123##4##(1991-12#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-3#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-4#1)(1994-6#1)(1994-9#3)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-7#3)(2005-8#1)(2005-9#2)(2006-10#3)(2006-12#2)(2006-3#1)(2006-5#1)(2006-6#1)(2007-10#2)(2007-11#6)(2007-2#3)(2007-3#1)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#7)(2008-11#5)(2008-2#2)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#1)(2009-1#1)(2009-12#1)(2009-4#2)(2009-7#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-5#2)(2010-6#2)(2010-7#2)(2011-1#7)(2011-10#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
the development of newer##4##4##(1993-12#1)(2006-10#1)(2009-1#1)(2010-5#1)
the development of next-generation##2##4##(2008-10#1)(2010-7#1)
the development of non-invasive##2##4##(2010-6#1)(2012-3#1)
the development of non-melanoma skin##2##5##(2008-4#1)(2010-9#1)
the development of nonpeptide##2##4##(1997-2#1)(2005-7#1)
the development of novel and effective##2##6##(2012-12#1)(2013-8#1)
the development of novel anticancer##2##5##(2008-1#1)(2009-4#1)
the development of novel cancer##2##5##(2010-5#1)(2011-2#1)
the development of novel therapeutic approaches##2##6##(2008-10#1)(2012-12#1)
the development of novel therapeutic strategies##2##6##(2008-1#1)(2010-10#1)
the development of novel therapeutic##5##5##(2008-1#1)(2008-10#1)(2008-6#1)(2010-10#1)(2012-12#1)
the development of novel treatment##2##5##(2011-2#1)(2013-1#1)
the development of novel##50##4##(1994-2#1)(2005-7#2)(2006-10#2)(2006-11#2)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#4)(2011-7#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#2)
the development of nursing##5##4##(1996-1#1)(1997-7#1)(2008-12#2)(2009-4#1)
the development of one of##2##5##(2008-10#2)
the development of one##3##4##(2008-10#2)(2012-2#1)
the development of ontogenic resistance##2##5##(2008-10#2)
the development of optical##3##4##(2007-12#1)(2008-10#1)(2010-12#1)
the development of optimal##3##4##(2008-7#1)(2010-12#1)(2010-5#1)
the development of oral##6##4##(1992-8#1)(2006-10#1)(2007-7#1)(2008-8#1)(2012-2#1)(2012-3#1)
the development of organ##3##4##(1993-10#1)(2013-1#2)
the development of other##4##4##(1996-4#1)(2006-10#1)(2006-2#1)(2012-2#1)
the development of our##3##4##(1997-8#1)(2012-2#2)
the development of overt##2##4##(2007-8#1)(2009-1#1)
the development of patient-based measurement systems##2##6##(1994-3#2)
the development of pediatric##2##4##(1992-8#1)(2007-4#1)
the development of periodic##2##4##(2008-10#2)
the development of peripheral arterial disease##2##6##(1997-2#1)(2005-10#1)
the development of peripheral##4##4##(1992-7#1)(1994-11#1)(1997-2#1)(2005-10#1)
the development of pharmacological##2##4##(1993-11#1)(2006-10#1)
the development of physical##3##4##(1991-3#1)(2008-7#1)(2008-8#1)
the development of policies##2##4##(1996-1#1)(2010-7#1)
the development of potential##2##4##(2008-7#1)(2009-10#1)
the development of preeclampsia##4##4##(1996-12#1)(2008-11#2)(2011-2#1)
the development of premature atherosclerosis##4##5##(1997-2#2)(2008-11#2)
the development of premature##5##4##(1997-2#2)(2008-1#1)(2008-11#2)
the development of preventive##3##4##(2009-4#1)(2009-6#1)(2010-12#1)
the development of primary##3##4##(1993-10#1)(1996-1#1)(2009-9#1)
the development of professional##2##4##(2008-11#1)(2009-3#1)
the development of programs##3##4##(1992-8#1)(1995-3#1)(2008-1#1)
the development of proliferative##2##4##(2008-1#1)(2009-4#1)
the development of proteinuria##2##4##(2006-8#1)(2008-1#1)
the development of pulmonary##4##4##(1994-8#1)(2008-8#1)(2009-5#1)(2010-12#1)
the development of quantitative##2##4##(1994-6#1)(2009-5#1)
the development of rapid##3##4##(2008-10#2)(2008-7#1)
the development of recombinant DNA technology##3##6##(2009-2#2)(2011-2#1)
the development of reflective##2##4##(2008-12#2)
the development of reliable##2##4##(2006-12#1)(2010-11#1)
the development of renal impairment without dose adjustment or close monitoring of visual function is likely to have potentiated retinal toxicity##2##21##(2013-1#2)
the development of renal##6##4##(1992-4#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-1#2)
the development of research##3##4##(2007-7#1)(2008-11#1)(2010-2#1)
the development of resistance and the##2##6##(2005-8#1)(2007-2#1)
the development of resistance to the##2##6##(2007-11#1)(2007-7#1)
the development of resistance to##3##5##(2007-11#1)(2007-7#1)(2012-3#1)
the development of resistance##12##4##(1994-8#1)(2005-8#1)(2006-11#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-5#1)(2008-7#1)(2009-11#2)(2011-3#1)(2012-3#1)
the development of resistant##3##4##(2008-1#1)(2009-3#1)(2010-11#1)
the development of respiratory tract lesions##2##6##(2008-5#2)
the development of robust##5##4##(2007-11#1)(2008-10#2)(2008-7#1)(2012-12#1)
the development of safe and effective##2##6##(2007-11#1)(2009-5#1)
the development of safe and##3##5##(2007-11#1)(2009-5#1)(2010-2#1)
the development of safe##5##4##(2006-10#1)(2007-11#1)(2008-5#1)(2009-5#1)(2010-2#1)
the development of scar##2##4##(2008-12#2)
the development of second-generation##2##4##(2009-3#1)(2010-12#1)
the development of selective##2##4##(2005-8#1)(2006-10#1)
the development of sensitization to##2##5##(1996-10#2)
the development of sensitization##3##4##(1996-10#2)(2008-10#1)
the development of sensory maps##2##5##(2007-8#2)
the development of sensory##3##4##(1996-3#1)(2007-8#2)
the development of several##10##4##(2006-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-10#1)(2010-7#1)(2011-2#1)(2013-8#1)
the development of severe##3##4##(1992-4#1)(2007-12#1)(2011-2#1)
the development of sexual##3##4##(1994-6#1)(2008-7#1)(2012-3#1)
the development of sexually dimorphic##2##5##(1997-7#1)(2007-12#1)
the development of short-term##2##4##(1996-9#2)
the development of significant##2##4##(2008-10#1)(2008-7#1)
the development of simple##4##4##(1997-3#1)(2006-10#1)(2008-4#1)(2009-2#1)
the development of skeletal##2##4##(2007-11#1)(2010-4#1)
the development of skills##2##4##(1990-12#1)(2011-2#1)
the development of skin cancer##2##5##(2007-11#2)
the development of small molecule##2##5##(2005-7#1)(2010-7#1)
the development of small##3##4##(2005-10#1)(2005-7#1)(2010-7#1)
the development of social##2##4##(2008-11#2)
the development of specific diagnostic##2##5##(2006-9#1)(2008-10#1)
the development of specific##14##4##(1994-1#1)(1996-12#1)(1996-3#1)(2006-9#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-3#1)(2010-11#1)(2010-7#1)(2010-9#1)(2012-11#1)(2012-2#1)
the development of spontaneous##3##4##(1993-12#1)(1996-8#1)(2008-6#1)
the development of squamous cell##2##5##(2005-11#1)(2006-12#1)
the development of stable##2##4##(2008-11#1)(2008-5#1)
the development of strategies##4##4##(1994-3#1)(1995-6#1)(2009-5#1)(2010-11#1)
the development of subsequent##2##4##(1997-8#1)(2008-7#1)
the development of subtype-selective##2##4##(1990-3#1)(1994-6#1)
the development of such a##2##5##(1992-4#1)(2007-8#1)
the development of such##8##4##(1992-4#1)(1992-9#1)(1995-3#1)(1996-11#1)(2007-8#1)(2008-2#1)(2009-5#1)(2010-5#1)
the development of superior##2##4##(2008-9#1)(2013-8#1)
the development of supra ventricular disorders of##2##7##(2011-1#2)
the development of surgical##4##4##(2007-5#1)(2009-4#1)(2009-5#1)(2010-8#1)
the development of sustainable##2##4##(2008-10#1)(2012-1#1)
the development of symptoms##3##4##(2008-10#1)(2008-7#1)(2009-9#1)
the development of synapses##2##4##(1996-2#1)(1996-9#1)
the development of synaptic plasticity##2##5##(1990-9#1)(2007-8#1)
the development of systems for the##2##6##(1995-7#1)(2008-7#1)
the development of systems##3##4##(1995-7#1)(2008-7#1)(2010-9#1)
the development of targeted##5##4##(2010-12#1)(2010-5#1)(2011-3#1)(2012-11#1)(2012-2#1)
the development of techniques for the##2##6##(2007-8#1)(2011-2#1)
the development of techniques##4##4##(2007-11#1)(2007-8#1)(2008-11#1)(2011-2#1)
the development of technology##4##4##(1997-3#1)(2005-11#1)(2007-11#1)(2008-10#1)
the development of testicular##2##4##(1992-5#1)(2010-5#1)
the development of the Georgia system##2##6##(1996-12#2)
the development of the central##2##5##(1990-8#1)(2008-11#1)
the development of the concept of##2##6##(1996-3#1)(2008-2#1)
the development of the concept##3##5##(1996-3#1)(2008-2#1)(2008-7#1)
the development of the disease##8##5##(1990-6#1)(1997-2#1)(1997-3#1)(2006-2#1)(2007-11#1)(2009-1#1)(2010-9#1)(2013-1#1)
the development of the first##4##5##(1990-6#1)(2006-6#1)(2011-12#1)(2012-12#1)
the development of the guidelines##2##5##(2010-5#1)(2012-2#1)
the development of the immune response##2##6##(1993-12#1)(2012-1#1)
the development of the immune##3##5##(1993-12#1)(1995-12#1)(2012-1#1)
the development of the medical##3##5##(2007-5#1)(2008-11#1)(2011-2#1)
the development of the nervous system##2##6##(1994-2#1)(2008-7#1)
the development of the new##3##5##(1992-12#1)(2006-10#1)(2007-4#1)
the development of the oral##2##5##(1991-8#1)(2006-2#1)
the development of the program##2##5##(1995-3#1)(2007-4#1)
the development of the reaction between##3##6##(2008-10#3)
the development of the roles and responsibilities of the radiologist assistant##2##11##(2007-4#2)
the development of the##217##4##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#2)(1990-8#2)(1991-11#2)(1991-2#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-6#3)(1992-7#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-5#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#3)(1996-5#2)(1996-6#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-12#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-4#1)(2005-8#2)(2006-10#5)(2006-11#2)(2006-2#4)(2006-4#1)(2006-5#1)(2006-6#3)(2006-8#1)(2007-1#1)(2007-11#4)(2007-12#8)(2007-2#1)(2007-4#4)(2007-5#3)(2007-6#2)(2007-7#2)(2007-8#1)(2008-10#15)(2008-11#7)(2008-12#6)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#3)(2011-2#6)(2012-1#3)(2012-12#2)(2012-2#4)(2012-3#4)(2012-5#1)(2013-1#10)(2013-8#6)
the development of their##4##4##(1990-12#1)(2008-11#1)(2008-12#1)(2008-3#1)
the development of theory of mind##2##6##(2006-2#2)
the development of therapeutic strategies##2##5##(2007-8#1)(2008-4#1)
the development of therapeutic##7##4##(1990-6#1)(2007-8#1)(2008-4#1)(2009-6#1)(2011-12#1)(2012-12#1)(2012-2#1)
the development of therapeutics##3##4##(2005-6#1)(2007-11#2)
the development of therapies##2##4##(1995-4#1)(2006-10#1)
the development of thermal##2##4##(2008-7#1)(2009-7#1)
the development of these disorders##2##5##(2008-2#1)(2011-2#1)
the development of these systems##2##5##(1990-12#1)(2011-7#1)
the development of these##17##4##(1990-12#1)(1993-3#1)(1995-12#1)(1996-4#1)(2005-7#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-2#1)(2011-7#1)(2013-8#1)
the development of this disease##3##5##(2008-1#1)(2008-10#1)(2012-3#1)
the development of this type of##3##6##(1997-8#1)(2008-9#1)(2011-2#1)
the development of this##28##4##(1992-2#1)(1994-6#1)(1994-9#1)(1995-9#1)(1996-10#1)(1997-1#1)(1997-2#1)(1997-8#1)(2006-11#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#2)(2009-11#1)(2011-2#1)(2012-3#1)
the development of tissue##4##4##(1995-2#1)(2006-6#1)(2010-5#1)(2011-1#1)
the development of tolerance to these##2##6##(1995-11#1)(2009-7#1)
the development of tolerance##6##4##(1990-11#1)(1991-1#1)(1991-5#1)(1995-11#1)(1996-10#1)(2009-7#1)
the development of treatment##3##4##(1996-2#1)(1997-2#1)(2007-10#1)
the development of tuberculosis##3##4##(1993-7#1)(1994-4#1)(2006-6#1)
the development of tumor##2##4##(1993-9#1)(2012-1#1)
the development of tumors##3##4##(1991-9#1)(2011-1#1)(2013-1#1)
the development of two##5##4##(1994-12#1)(1994-3#1)(1995-11#1)(2005-8#1)(2012-1#1)
the development of type 2 diabetes and##2##7##(2008-10#1)(2008-11#1)
the development of type 2 diabetes##4##6##(2008-1#2)(2008-10#1)(2008-11#1)
the development of type##6##4##(1991-3#1)(1996-9#1)(2008-1#2)(2008-10#1)(2008-11#1)
the development of ultrasensitive##3##4##(2006-6#2)(2008-4#1)
the development of vaccines##4##4##(1994-11#1)(2008-3#1)(2011-1#1)(2013-8#1)
the development of various##4##4##(2009-11#1)(2010-3#1)(2012-2#1)(2013-8#1)
the development of vascular##7##4##(1992-4#1)(1996-12#1)(2004-7#1)(2008-1#1)(2008-9#1)(2009-1#1)(2011-1#1)
the development of vectors##2##4##(1994-5#1)(2008-11#1)
the development of ventricular##2##4##(2004-11#1)(2011-1#1)
the development of visual##3##4##(1991-12#1)(1992-7#1)(1994-5#1)
the development of what we##2##5##(2007-11#1)(2008-9#1)
the development of which is##2##5##(2009-5#1)(2013-1#1)
the development of##2634##3##(1990-10#2)(1990-11#4)(1990-12#13)(1990-2#3)(1990-3#1)(1990-4#5)(1990-5#7)(1990-6#7)(1990-7#3)(1990-8#6)(1990-9#3)(1991-1#6)(1991-10#3)(1991-11#11)(1991-12#8)(1991-2#4)(1991-3#6)(1991-5#3)(1991-6#4)(1991-7#5)(1991-8#8)(1991-9#9)(1992-1#5)(1992-10#3)(1992-11#7)(1992-12#6)(1992-2#5)(1992-3#5)(1992-4#4)(1992-5#2)(1992-6#5)(1992-7#6)(1992-8#5)(1992-9#5)(1993-1#3)(1993-10#4)(1993-11#9)(1993-12#17)(1993-2#9)(1993-3#10)(1993-4#4)(1993-5#2)(1993-6#4)(1993-7#5)(1993-8#2)(1993-9#4)(1994-1#3)(1994-10#1)(1994-11#10)(1994-12#16)(1994-2#9)(1994-3#16)(1994-4#4)(1994-5#5)(1994-6#13)(1994-7#1)(1994-8#3)(1994-9#6)(1995-1#6)(1995-10#1)(1995-11#5)(1995-12#12)(1995-2#8)(1995-3#11)(1995-4#5)(1995-5#4)(1995-6#7)(1995-7#1)(1995-8#4)(1995-9#4)(1996-1#10)(1996-10#8)(1996-11#6)(1996-12#13)(1996-2#9)(1996-3#17)(1996-4#9)(1996-5#8)(1996-6#5)(1996-7#1)(1996-8#8)(1996-9#11)(1997-1#7)(1997-2#20)(1997-3#11)(1997-4#7)(1997-5#4)(1997-6#14)(1997-7#11)(1997-8#10)(2004-11#3)(2004-12#9)(2004-3#2)(2004-7#1)(2005-1#2)(2005-10#13)(2005-11#15)(2005-12#5)(2005-3#1)(2005-4#1)(2005-5#1)(2005-6#1)(2005-7#22)(2005-8#27)(2005-9#6)(2006-1#1)(2006-10#61)(2006-11#15)(2006-12#26)(2006-2#13)(2006-3#4)(2006-4#8)(2006-5#4)(2006-6#26)(2006-7#5)(2006-8#8)(2006-9#10)(2007-1#12)(2007-10#12)(2007-11#55)(2007-12#28)(2007-2#15)(2007-3#6)(2007-4#16)(2007-5#12)(2007-6#7)(2007-7#15)(2007-8#44)(2007-9#14)(2008-1#62)(2008-10#190)(2008-11#91)(2008-12#36)(2008-2#28)(2008-3#45)(2008-4#52)(2008-5#60)(2008-6#22)(2008-7#74)(2008-8#37)(2008-9#29)(2009-1#7)(2009-10#8)(2009-11#13)(2009-12#12)(2009-2#17)(2009-3#17)(2009-4#24)(2009-5#14)(2009-6#9)(2009-7#14)(2009-8#13)(2009-9#13)(2010-1#8)(2010-10#7)(2010-11#12)(2010-12#37)(2010-2#12)(2010-3#11)(2010-4#15)(2010-5#22)(2010-6#10)(2010-7#18)(2010-8#17)(2010-9#9)(2011-1#43)(2011-10#3)(2011-12#10)(2011-2#88)(2011-3#6)(2011-7#3)(2012-1#25)(2012-11#14)(2012-12#54)(2012-2#51)(2012-3#37)(2012-4#1)(2012-5#2)(2013-1#63)(2013-7#8)(2013-8#39)
the development or##4##3##(2004-3#1)(2008-7#1)(2011-1#1)(2013-7#1)
the development period##2##3##(2007-3#1)(2008-7#1)
the development process of##4##4##(2007-10#1)(2009-7#1)(2012-1#1)(2012-12#1)
the development stage of##2##4##(2008-10#1)(2012-12#1)
the development work##3##3##(2006-8#3)
the development##2920##2##(1990-10#2)(1990-11#4)(1990-12#13)(1990-2#4)(1990-3#1)(1990-4#5)(1990-5#7)(1990-6#7)(1990-7#3)(1990-8#6)(1990-9#3)(1991-1#6)(1991-10#3)(1991-11#12)(1991-12#9)(1991-2#4)(1991-3#7)(1991-5#3)(1991-6#4)(1991-7#6)(1991-8#8)(1991-9#9)(1992-1#6)(1992-10#3)(1992-11#7)(1992-12#7)(1992-2#7)(1992-3#5)(1992-4#4)(1992-5#2)(1992-6#5)(1992-7#6)(1992-8#5)(1992-9#5)(1993-1#3)(1993-10#4)(1993-11#10)(1993-12#18)(1993-2#9)(1993-3#12)(1993-4#5)(1993-5#2)(1993-6#4)(1993-7#5)(1993-8#2)(1993-9#5)(1994-1#4)(1994-10#2)(1994-11#10)(1994-12#16)(1994-2#12)(1994-3#18)(1994-4#5)(1994-5#5)(1994-6#13)(1994-7#1)(1994-8#4)(1994-9#6)(1995-1#6)(1995-10#1)(1995-11#6)(1995-12#13)(1995-2#8)(1995-3#11)(1995-4#5)(1995-5#4)(1995-6#8)(1995-7#1)(1995-8#5)(1995-9#5)(1996-1#10)(1996-10#8)(1996-11#6)(1996-12#14)(1996-2#11)(1996-3#19)(1996-4#9)(1996-5#10)(1996-6#5)(1996-7#1)(1996-8#8)(1996-9#12)(1997-1#7)(1997-2#20)(1997-3#11)(1997-4#8)(1997-5#6)(1997-6#15)(1997-7#11)(1997-8#10)(2004-11#3)(2004-12#9)(2004-3#3)(2004-7#1)(2004-9#1)(2005-1#2)(2005-10#13)(2005-11#15)(2005-12#5)(2005-3#1)(2005-4#1)(2005-5#2)(2005-6#1)(2005-7#23)(2005-8#29)(2005-9#6)(2006-1#2)(2006-10#67)(2006-11#16)(2006-12#26)(2006-2#14)(2006-3#4)(2006-4#8)(2006-5#5)(2006-6#30)(2006-7#6)(2006-8#11)(2006-9#10)(2007-1#12)(2007-10#13)(2007-11#60)(2007-12#36)(2007-2#15)(2007-3#8)(2007-4#20)(2007-5#15)(2007-6#7)(2007-7#17)(2007-8#47)(2007-9#16)(2008-1#70)(2008-10#213)(2008-11#104)(2008-12#45)(2008-2#30)(2008-3#48)(2008-4#58)(2008-5#66)(2008-6#26)(2008-7#80)(2008-8#42)(2008-9#33)(2009-1#7)(2009-10#9)(2009-11#13)(2009-12#15)(2009-2#18)(2009-3#18)(2009-4#24)(2009-5#16)(2009-6#9)(2009-7#15)(2009-8#16)(2009-9#14)(2010-1#8)(2010-10#9)(2010-11#12)(2010-12#40)(2010-2#13)(2010-3#13)(2010-4#17)(2010-5#24)(2010-6#12)(2010-7#18)(2010-8#18)(2010-9#9)(2011-1#47)(2011-10#3)(2011-11#1)(2011-12#12)(2011-2#98)(2011-3#6)(2011-7#3)(2011-8#1)(2012-1#27)(2012-11#14)(2012-12#69)(2012-2#60)(2012-3#40)(2012-4#1)(2012-5#2)(2013-1#82)(2013-7#12)(2013-8#43)
the developmental and##3##3##(2006-6#1)(2010-12#1)(2013-1#1)
the developmental barrier between##4##4##(2012-12#4)
the developmental changes in the##2##5##(1996-3#1)(1996-5#1)
the developmental characteristics of##2##4##(1994-4#1)(1995-11#1)
the developmental competence##2##3##(2010-12#1)(2013-1#1)
the developmental dynamics of##2##4##(2007-12#1)(2011-2#1)
the developmental events##2##3##(2008-10#1)(2008-7#1)
the developmental expression of##2##4##(1995-9#1)(2008-8#1)
the developmental expression##3##3##(1995-9#1)(1997-2#1)(2008-8#1)
the developmental origins of##2##4##(2012-2#2)
the developmental pattern##2##3##(2008-11#1)(2008-7#1)
the developmental period##2##3##(1992-12#1)(1995-11#1)
the developmental periods##3##3##(2008-8#1)(2009-11#1)(2011-2#1)
the developmental potential of##2##4##(2006-5#1)(2008-9#1)
the developmental process##4##3##(1993-12#1)(1997-1#1)(2008-3#1)(2010-9#1)
the developmental processes of##2##4##(2008-8#1)(2011-2#1)
the developmental program of##2##4##(1991-9#1)(2007-12#1)
the developmental stage of the##2##5##(1995-8#1)(2008-9#1)
the developmental stage of##4##4##(1991-4#1)(1995-8#1)(2008-10#1)(2008-9#1)
the developmental stage##10##3##(1991-4#1)(1991-9#1)(1993-3#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-11#1)(2008-10#1)(2008-6#1)(2008-9#1)
the developmental stages of##2##4##(2007-11#1)(2008-10#1)
the developmental stages##5##3##(1994-9#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-8#1)
the developmental state of the plant##2##6##(1990-5#1)(2008-11#1)
the developmental toxicity of tributyltin chloride##2##6##(1995-2#2)
the developmental toxicity of##4##4##(1993-12#1)(1995-2#2)(2008-8#1)
the developmental toxicity##5##3##(1993-12#1)(1995-2#2)(2008-8#1)(2010-1#1)
the developmental##105##2##(1990-2#1)(1990-5#1)(1991-10#1)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1993-12#3)(1993-3#1)(1994-4#1)(1994-9#1)(1995-11#2)(1995-2#5)(1995-8#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-6#1)(2006-11#2)(2006-3#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#4)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-9#2)(2011-2#3)(2012-12#5)(2012-2#4)(2013-1#2)
the developmentally disabled##2##3##(1997-6#1)(2008-12#1)
the developmentally regulated##5##3##(1995-1#2)(1995-8#1)(2008-10#1)(2008-7#1)
the developmentally##8##2##(1992-12#1)(1995-1#2)(1995-8#1)(1997-6#1)(2008-10#1)(2008-12#1)(2008-7#1)
the developments in##11##3##(2006-10#2)(2006-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2012-2#1)(2013-8#1)
the developments of##2##3##(1994-6#1)(2006-4#1)
the developments that have##2##4##(2005-7#1)(2011-1#1)
the developments##15##2##(1994-6#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-4#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
the deviance##4##2##(1994-9#2)(1996-3#1)(2010-8#1)
the deviant stimuli##2##3##(1996-1#1)(2008-8#1)
the deviant##4##2##(1996-1#2)(2008-8#2)
the deviation between##3##3##(2008-3#1)(2013-1#2)
the deviation from##4##3##(1991-2#1)(2008-2#1)(2008-3#2)
the deviation of the##6##4##(2005-11#1)(2006-12#1)(2008-12#1)(2008-2#2)(2009-11#1)
the deviation of##8##3##(2005-11#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-2#3)(2009-11#1)
the deviation##21##2##(1991-2#1)(2005-11#3)(2005-4#1)(2006-12#1)(2008-10#3)(2008-12#1)(2008-2#4)(2008-3#4)(2009-11#1)(2013-1#2)
the deviations are##2##3##(1995-7#1)(2008-3#1)
the deviations from the##2##4##(2008-7#1)(2010-2#1)
the deviations from##4##3##(2007-11#1)(2008-3#1)(2008-7#1)(2010-2#1)
the deviations of##2##3##(2009-3#1)(2012-3#1)
the deviations##13##2##(1995-7#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-7#2)(2009-3#1)(2010-2#1)(2012-3#1)
the device after##3##3##(2006-6#1)(2008-11#1)(2012-3#1)
the device and the##2##4##(1997-2#1)(2006-5#1)
the device and##9##3##(1997-2#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-7#1)(2012-3#2)
the device are##5##3##(2006-2#1)(2008-2#3)(2008-3#1)
the device as an##2##4##(2008-2#2)
the device as##6##3##(2006-6#1)(2007-12#1)(2008-2#3)(2008-3#1)
the device at##2##3##(2008-3#1)(2012-1#1)
the device can be##2##4##(2007-12#1)(2008-2#1)
the device can##3##3##(2007-12#1)(2008-2#1)(2013-1#1)
the device for##7##3##(2006-2#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)
the device from the##2##4##(2008-11#1)(2008-7#1)
the device from##3##3##(2007-11#1)(2008-11#1)(2008-7#1)
the device has##2##3##(2008-10#1)(2008-3#1)
the device is##20##3##(2006-6#2)(2007-11#2)(2007-12#4)(2008-1#2)(2008-11#1)(2008-2#4)(2008-3#3)(2009-6#1)(2010-2#1)
the device must be both biocompatible and be permeable to small molecules and proteins##2##14##(2012-11#2)
the device on##2##3##(2008-11#1)(2008-9#1)
the device sensitivity##2##3##(2009-5#2)
the device structure##2##3##(2007-11#1)(2007-12#1)
the device to be##3##4##(2007-11#1)(2008-3#1)(2010-4#1)
the device to the##4##4##(2007-8#1)(2008-11#2)(2009-6#1)
the device to##11##3##(1994-3#1)(2007-11#2)(2007-8#2)(2008-11#3)(2008-3#1)(2009-6#1)(2010-4#1)
the device under test##2##4##(2007-11#1)(2007-12#1)
the device was##13##3##(1992-10#1)(1994-9#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-9#1)(2012-3#1)
the device##226##2##(1991-12#1)(1992-10#3)(1994-11#1)(1994-3#1)(1994-9#2)(1996-2#1)(1996-6#1)(1997-2#1)(2005-8#1)(2006-2#3)(2006-5#1)(2006-6#12)(2007-11#14)(2007-12#19)(2007-5#1)(2007-7#6)(2007-8#7)(2008-1#3)(2008-10#11)(2008-11#37)(2008-12#1)(2008-2#25)(2008-3#23)(2008-4#2)(2008-5#3)(2008-7#3)(2008-9#6)(2009-10#1)(2009-5#2)(2009-6#3)(2009-7#1)(2010-2#1)(2010-4#2)(2010-6#4)(2010-7#3)(2010-8#1)(2012-1#6)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#2)
the device's##5##2##(2004-9#1)(2007-11#1)(2007-12#1)(2008-3#1)(2011-7#1)
the devices and##2##3##(1993-12#1)(2012-3#1)
the devices are##4##3##(2008-11#2)(2008-2#2)
the devices based on the##2##5##(2008-2#1)(2010-6#1)
the devices in##2##3##(2008-11#1)(2011-2#1)
the devices used##3##3##(2008-2#1)(2008-4#1)(2013-7#1)
the devices were##3##3##(1993-12#1)(2007-12#1)(2008-9#1)
the devices##30##2##(1991-3#1)(1993-12#2)(1996-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#8)(2008-2#4)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-7#1)
the dexamethasone suppression test##4##4##(1990-3#1)(1994-11#1)(1995-11#2)
the dexamethasone##7##2##(1990-12#1)(1990-3#1)(1993-1#1)(1994-11#1)(1995-11#2)(2006-10#1)
the dexamethasone-induced inhibition of##2##4##(1994-12#2)
the dexamethasone-induced##3##2##(1994-12#3)
the dexterity##2##2##(2006-6#2)
the dextran##4##2##(1990-11#1)(2008-10#2)(2009-4#1)
the dextrose##2##2##(2008-9#1)(2011-2#1)
the diabetes##17##2##(1992-5#1)(1993-11#1)(1993-12#1)(1996-11#3)(2007-3#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)
the diabetes-associated##2##2##(2006-1#1)(2013-1#1)
the diabetic foot##6##3##(1992-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-2#1)
the diabetic men##3##3##(2008-7#2)(2011-2#1)
the diabetic patient##10##3##(1993-12#1)(2005-11#1)(2007-1#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-7#1)(2008-9#1)(2012-2#1)
the diabetic patients##4##3##(1991-12#1)(1993-11#1)(2006-7#1)(2013-1#1)
the diabetic population##9##3##(2005-10#1)(2008-1#4)(2008-8#1)(2009-5#1)(2012-2#1)(2013-1#1)
the diabetic rat##2##3##(1993-11#1)(1994-3#1)
the diabetic rats##4##3##(1993-11#1)(1994-11#1)(1994-8#1)(2004-11#1)
the diabetic retinal microvascular environment##2##5##(2012-4#2)
the diabetic state##5##3##(1995-10#2)(2006-9#1)(2008-1#2)
the diabetic subjects##2##3##(2011-11#1)(2012-12#1)
the diabetic##69##2##(1990-10#1)(1990-3#1)(1991-12#2)(1992-3#1)(1993-11#3)(1993-12#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#2)(1995-10#2)(1997-2#4)(2004-11#1)(2005-10#1)(2005-11#1)(2006-7#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#10)(2008-10#1)(2008-12#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2011-11#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-4#2)(2013-1#2)(2013-8#1)
the diabetics##5##2##(1990-9#1)(2006-7#1)(2008-3#1)(2009-5#2)
the diacylated##2##2##(1996-5#1)(2004-4#1)
the diacylglycerol##5##2##(1991-1#1)(1991-9#1)(1993-3#1)(1993-8#1)(1995-8#1)
the diafiltration buffer pH for##2##5##(2011-2#2)
the diafiltration buffer##3##3##(2011-2#3)
the diafiltration##4##2##(2011-2#4)
the diagnose##2##2##(2007-11#1)(2013-7#1)
the diagnosed##3##2##(1990-11#1)(2007-11#1)(2012-2#1)
the diagnoses made in##2##4##(1994-6#1)(2011-2#1)
the diagnoses made##3##3##(1994-6#1)(2007-9#1)(2011-2#1)
the diagnoses of##9##3##(1991-9#2)(2006-8#1)(2008-8#2)(2010-9#1)(2011-2#1)(2013-1#2)
the diagnoses were##4##3##(2007-12#2)(2012-12#1)(2013-8#1)
the diagnoses##26##2##(1990-12#1)(1991-9#2)(1994-6#1)(1995-11#2)(1997-8#2)(2006-7#1)(2006-8#1)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-8#2)(2009-3#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
the diagnosis and allows##2##4##(2008-12#1)(2009-2#1)
the diagnosis and detection of##2##5##(2006-10#1)(2013-8#1)
the diagnosis and differential diagnosis of social anxiety disorder##2##9##(2011-2#2)
the diagnosis and differential diagnosis of##7##6##(1992-8#1)(1996-11#1)(2006-2#1)(2006-6#1)(2010-10#1)(2011-2#2)
the diagnosis and differential diagnosis##8##5##(1992-8#1)(1996-11#1)(2006-2#1)(2006-6#1)(2007-5#1)(2010-10#1)(2011-2#2)
the diagnosis and evaluation of##3##5##(1992-5#1)(2007-4#1)(2007-8#1)
the diagnosis and follow-up of patients with##3##7##(2011-1#1)(2012-2#2)
the diagnosis and follow-up of##9##5##(1990-12#1)(2008-11#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#3)
the diagnosis and further##2##4##(1991-8#1)(2011-1#1)
the diagnosis and management of a##2##6##(2008-12#2)
the diagnosis and management of acute##2##6##(2006-4#1)(2008-4#1)
the diagnosis and management of choledocholithiasis##3##6##(2006-10#1)(2007-3#2)
the diagnosis and management of neovascular age-related macular degeneration##2##9##(2011-7#2)
the diagnosis and management of patients with##2##7##(2007-11#1)(2011-2#1)
the diagnosis and management of small bowel##2##7##(2006-10#1)(2012-2#1)
the diagnosis and management of small##3##6##(2006-10#1)(2012-2#2)
the diagnosis and management of the##2##6##(1996-1#1)(2009-4#1)
the diagnosis and management of##57##5##(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-9#1)(1996-1#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-3#4)(2007-7#1)(2008-11#1)(2008-12#3)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-4#2)(2010-12#3)(2010-8#1)(2011-2#3)(2011-7#5)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
the diagnosis and management##59##4##(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-9#1)(1996-1#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-3#4)(2007-7#1)(2008-11#1)(2008-12#3)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-4#2)(2010-12#3)(2010-8#1)(2011-2#3)(2011-7#5)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#2)
the diagnosis and monitoring of the##2##6##(2008-1#2)
the diagnosis and monitoring of##7##5##(2005-11#1)(2006-10#1)(2007-12#1)(2008-1#2)(2008-5#1)(2013-1#1)
the diagnosis and prognosis of##6##5##(1995-9#1)(2006-6#1)(2007-7#1)(2008-11#1)(2008-4#2)
the diagnosis and prognosis##7##4##(1995-9#1)(2006-6#1)(2007-7#1)(2008-11#1)(2008-4#2)(2010-6#1)
the diagnosis and staging of##4##5##(2006-10#2)(2008-9#2)
the diagnosis and surgical management of##2##6##(2007-8#1)(2011-12#1)
the diagnosis and surgical##3##4##(2007-8#1)(2008-10#1)(2011-12#1)
the diagnosis and that##2##4##(2007-6#1)(2008-4#1)
the diagnosis and the therapy of##2##6##(1993-6#1)(2013-8#1)
the diagnosis and the##11##4##(1990-7#1)(1991-3#1)(1993-10#1)(1993-6#1)(1994-3#1)(2007-8#1)(2010-12#1)(2012-12#1)(2013-1#1)(2013-8#2)
the diagnosis and therapeutic##2##4##(2008-1#1)(2011-2#1)
the diagnosis and therapy of##8##5##(1990-2#1)(1992-3#1)(2006-10#2)(2006-6#1)(2008-7#1)(2011-1#1)(2012-3#1)
the diagnosis and treatment of a##2##6##(1990-9#1)(2006-10#1)
the diagnosis and treatment of bronchiolitis obliterans in##2##8##(2013-1#2)
the diagnosis and treatment of depression in##2##7##(1996-12#1)(2010-2#1)
the diagnosis and treatment of patients with##5##7##(1993-8#1)(2006-10#1)(2008-12#1)(2009-2#1)(2011-7#1)
the diagnosis and treatment of patients##6##6##(1993-8#1)(2006-10#1)(2008-12#1)(2008-7#1)(2009-2#1)(2011-7#1)
the diagnosis and treatment of the##7##6##(1996-3#1)(2006-2#1)(2007-5#1)(2008-1#1)(2008-4#1)(2011-12#1)(2012-2#1)
the diagnosis and treatment of these##2##6##(2006-12#1)(2010-5#1)
the diagnosis and treatment of this##5##6##(1992-5#1)(2010-12#1)(2011-7#1)(2013-1#2)
the diagnosis and treatment of##71##5##(1990-9#1)(1991-1#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-10#1)(1996-12#1)(1996-3#2)(1997-5#1)(1997-6#1)(1997-8#1)(2005-7#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#2)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-5#3)(2007-7#2)(2007-8#1)(2008-1#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-2#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#2)(2011-12#1)(2011-7#2)(2012-2#3)(2013-1#7)(2013-7#2)
the diagnosis and treatment##74##4##(1990-9#1)(1991-1#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-10#1)(1995-8#1)(1996-12#1)(1996-3#2)(1997-5#1)(1997-6#1)(1997-8#1)(2005-7#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#2)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-2#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#3)(2011-12#1)(2011-7#2)(2012-2#3)(2013-1#7)(2013-7#2)
the diagnosis and##249##3##(1990-12#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-2#3)(1992-3#3)(1992-5#3)(1992-8#2)(1993-10#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-9#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-9#1)(2006-10#16)(2006-11#1)(2006-12#2)(2006-2#3)(2006-4#2)(2006-6#3)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-11#5)(2007-12#3)(2007-2#1)(2007-3#4)(2007-4#1)(2007-5#6)(2007-6#2)(2007-7#5)(2007-8#4)(2008-1#7)(2008-10#1)(2008-11#4)(2008-12#6)(2008-2#1)(2008-3#5)(2008-4#7)(2008-5#3)(2008-6#3)(2008-7#4)(2008-9#3)(2009-10#2)(2009-2#2)(2009-4#4)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#7)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#13)(2011-7#7)(2012-1#1)(2012-12#5)(2012-2#10)(2012-3#2)(2013-1#12)(2013-7#2)(2013-8#6)
the diagnosis are##4##3##(1997-8#1)(2013-1#2)(2013-8#1)
the diagnosis as##5##3##(1991-12#1)(2007-8#1)(2010-12#1)(2012-3#1)(2013-8#1)
the diagnosis at##2##3##(2006-12#1)(2011-2#1)
the diagnosis because the##2##4##(1991-12#1)(2009-2#1)
the diagnosis but##2##3##(1990-5#1)(1997-3#1)
the diagnosis by##2##3##(2006-10#1)(2008-2#1)
the diagnosis can be##5##4##(1993-1#1)(2005-8#1)(2006-10#1)(2007-4#1)(2012-12#1)
the diagnosis can##7##3##(1992-3#1)(1993-1#1)(2005-8#1)(2006-10#1)(2007-4#1)(2010-8#1)(2012-12#1)
the diagnosis for##2##3##(2008-1#1)(2012-12#1)
the diagnosis has been confirmed by##2##6##(1990-9#1)(2006-2#1)
the diagnosis has##3##3##(1990-9#1)(2006-12#1)(2006-2#1)
the diagnosis in the##2##4##(1993-7#1)(1996-4#1)
the diagnosis in##9##3##(1993-7#1)(1996-4#1)(1997-1#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-5#1)(2011-2#1)
the diagnosis is made at##3##5##(2013-1#2)(2013-8#1)
the diagnosis is made##11##4##(1992-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-6#1)(2011-2#1)(2013-1#2)(2013-8#2)
the diagnosis is not##3##4##(1991-2#1)(1996-12#1)(2013-8#1)
the diagnosis is often delayed##2##5##(2007-7#1)(2012-2#1)
the diagnosis is usually##2##4##(2006-4#1)(2011-2#1)
the diagnosis is##40##3##(1990-12#1)(1991-2#1)(1992-11#2)(1993-10#1)(1993-8#1)(1994-2#1)(1996-12#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-4#1)(2007-7#2)(2008-10#1)(2008-6#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-12#2)(2010-6#1)(2011-2#3)(2012-2#2)(2013-1#4)(2013-8#5)
the diagnosis of &quot##3##4##(1991-12#1)(2011-2#1)(2013-7#1)
the diagnosis of CTEPH##2##4##(2010-6#2)
the diagnosis of HIT##2##4##(2006-12#1)(2010-3#1)
the diagnosis of M##2##4##(2008-5#1)(2011-2#1)
the diagnosis of a##23##4##(1992-5#1)(1992-8#1)(2004-2#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-4#3)(2009-9#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
the diagnosis of active HHV-6 infection##2##6##(2009-10#2)
the diagnosis of acute appendicitis##2##5##(2011-12#1)(2013-1#1)
the diagnosis of acute ischemic stroke##2##6##(2007-10#1)(2007-9#1)
the diagnosis of acute myocardial infarction##5##6##(1992-10#2)(1997-2#1)(2008-3#2)
the diagnosis of acute##20##4##(1991-8#1)(1992-10#2)(1994-9#1)(1997-2#1)(2006-10#1)(2007-10#2)(2007-2#1)(2007-9#1)(2008-3#3)(2008-7#1)(2008-9#1)(2011-12#1)(2012-2#1)(2013-1#3)
the diagnosis of an##7##4##(2006-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2012-12#1)(2012-3#2)
the diagnosis of asthma##2##4##(2005-11#1)(2011-1#1)
the diagnosis of autoimmune bullous##2##5##(2005-11#2)
the diagnosis of autoimmune hepatitis##2##5##(1996-11#1)(2011-1#1)
the diagnosis of autoimmune##5##4##(1996-11#1)(2005-11#2)(2008-11#1)(2011-1#1)
the diagnosis of benign##3##4##(1996-2#1)(2006-1#1)(2010-2#1)
the diagnosis of bone##2##4##(1994-12#1)(2006-10#1)
the diagnosis of brain abscess##2##5##(2005-10#1)(2005-9#1)
the diagnosis of brain##4##4##(1991-11#1)(2005-10#1)(2005-9#1)(2009-11#1)
the diagnosis of breast##10##4##(1991-12#3)(1991-9#1)(2004-1#3)(2008-3#1)(2010-12#1)(2012-2#1)
the diagnosis of cancer##2##4##(1996-11#1)(2012-3#1)
the diagnosis of child abuse##2##5##(2005-10#1)(2006-8#1)
the diagnosis of chordoma##2##4##(2006-12#2)
the diagnosis of chronic granulomatous disease##2##6##(1992-5#1)(1994-3#1)
the diagnosis of chronic pancreatitis##3##5##(1993-5#1)(2006-10#2)
the diagnosis of chronic##12##4##(1992-5#2)(1993-5#1)(1994-11#1)(1994-3#1)(1994-7#1)(2006-10#2)(2006-5#1)(2006-6#1)(2006-7#1)(2010-6#1)
the diagnosis of cleft palate##2##5##(2011-2#2)
the diagnosis of cleft##3##4##(2011-2#3)
the diagnosis of coccidioidomycosis##2##4##(1993-6#2)
the diagnosis of colonic##2##4##(2007-12#1)(2008-7#1)
the diagnosis of congenital##2##4##(2007-7#1)(2008-12#1)
the diagnosis of coronary artery##5##5##(2008-11#1)(2012-1#1)(2012-12#2)(2012-2#1)
the diagnosis of cutaneous leishmaniasis##2##5##(2005-8#1)(2007-8#1)
the diagnosis of cutaneous##3##4##(2005-8#1)(2007-7#1)(2007-8#1)
the diagnosis of cystic##2##4##(2013-1#1)(2013-7#1)
the diagnosis of diabetes##3##4##(2006-10#1)(2008-1#1)(2009-5#1)
the diagnosis of diffuse##3##4##(1991-12#1)(2005-8#1)(2008-7#1)
the diagnosis of disseminated##2##4##(2007-7#1)(2008-5#1)
the diagnosis of early intrauterine inflammation##2##6##(2013-1#2)
the diagnosis of early##4##4##(1991-12#1)(2008-5#1)(2013-1#2)
the diagnosis of endobronchial##2##4##(1992-8#1)(2008-5#1)
the diagnosis of facet joint pain##3##6##(2006-8#3)
the diagnosis of facet joint##4##5##(2006-8#4)
the diagnosis of gout##2##4##(2006-10#2)
the diagnosis of hard metal disease##2##6##(1994-6#2)
the diagnosis of hard metal##3##5##(1994-6#3)
the diagnosis of heart failure##2##5##(2008-3#1)(2009-10#1)
the diagnosis of heart##3##4##(1992-2#1)(2008-3#1)(2009-10#1)
the diagnosis of hepatitis##2##4##(1997-4#1)(2008-10#1)
the diagnosis of hypertension##2##4##(1997-3#1)(2006-7#1)
the diagnosis of idiopathic##2##4##(2005-8#1)(2008-11#1)
the diagnosis of inflammatory##3##4##(2006-8#1)(2013-1#2)
the diagnosis of invasive##2##4##(2011-2#1)(2013-1#1)
the diagnosis of ischemic##2##4##(1990-6#1)(2005-1#1)
the diagnosis of liver fibrosis##2##5##(2010-12#1)(2011-12#1)
the diagnosis of liver##5##4##(1993-10#1)(1995-4#1)(2010-12#1)(2010-7#1)(2011-12#1)
the diagnosis of malaria in##3##5##(2006-4#1)(2007-2#2)
the diagnosis of malaria##8##4##(2006-10#1)(2006-4#1)(2007-12#2)(2007-2#2)(2007-7#2)
the diagnosis of malignancy##3##4##(1991-9#1)(2006-4#1)(2013-8#1)
the diagnosis of malignant##4##4##(1992-8#1)(1993-10#1)(2010-7#1)(2013-8#1)
the diagnosis of metastatic##2##4##(2005-12#1)(2010-9#1)
the diagnosis of mild##2##4##(2012-2#1)(2013-8#1)
the diagnosis of multiple##4##4##(1990-3#1)(2006-7#1)(2008-7#1)(2012-3#1)
the diagnosis of oral lesions##2##5##(2013-1#2)
the diagnosis of osteoporosis##4##4##(2005-3#1)(2006-10#2)(2012-12#1)
the diagnosis of pancreatic##2##4##(1993-5#1)(2006-6#1)
the diagnosis of pelvic##2##4##(2006-6#1)(2009-6#1)
the diagnosis of pheochromocytoma##3##4##(1995-7#2)(1996-12#1)
the diagnosis of posttraumatic##2##4##(1995-11#1)(2007-6#1)
the diagnosis of primary##10##4##(1992-7#1)(1995-12#1)(1996-12#2)(2010-12#1)(2010-3#1)(2013-1#4)
the diagnosis of pulmonary embolism##3##5##(1991-11#1)(2005-10#1)(2007-7#1)
the diagnosis of pulmonary##8##4##(1991-11#1)(1992-4#1)(1993-1#1)(2005-10#1)(2007-3#1)(2007-7#1)(2008-10#1)(2010-12#1)
the diagnosis of renal##4##4##(1990-9#1)(2006-10#1)(2008-1#1)(2011-2#1)
the diagnosis of ruptured##3##4##(1993-1#1)(1996-9#1)(2007-3#1)
the diagnosis of sarcoidosis##5##4##(2006-10#2)(2007-10#1)(2008-1#1)(2013-7#1)
the diagnosis of small##3##4##(1991-12#1)(1992-10#1)(2009-3#1)
the diagnosis of superficial##2##4##(2008-5#1)(2008-9#1)
the diagnosis of the acute##2##5##(1997-3#1)(2007-10#1)
the diagnosis of the disease##2##5##(1990-5#1)(2008-6#1)
the diagnosis of the##25##4##(1990-3#1)(1990-5#1)(1990-6#1)(1993-1#2)(1996-12#1)(1997-3#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-10#1)(2011-2#1)(2013-1#1)(2013-8#2)
the diagnosis of these disorders##2##5##(1993-12#1)(2010-12#1)
the diagnosis of these##6##4##(1990-5#1)(1993-12#1)(2009-3#1)(2010-12#1)(2010-2#1)(2012-2#1)
the diagnosis of this disorder##2##5##(2008-8#1)(2012-2#1)
the diagnosis of this syndrome##2##5##(2006-10#1)(2008-3#1)
the diagnosis of this##12##4##(1993-10#1)(1997-8#1)(2006-10#1)(2006-4#1)(2007-9#1)(2008-3#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-8#1)(2012-12#1)(2012-2#1)
the diagnosis of thyroid cancer##2##5##(2006-9#2)
the diagnosis of toxoplasmosis##2##4##(2008-4#1)(2013-8#1)
the diagnosis of tuberculosis can remain challenging##2##7##(2013-1#2)
the diagnosis of tuberculosis##3##4##(2008-12#1)(2013-1#2)
the diagnosis of upper gastrointestinal##2##5##(2006-8#1)(2007-2#1)
the diagnosis of urinary##2##4##(1997-2#1)(2007-2#1)
the diagnosis of vaginal##2##4##(2007-10#1)(2008-9#1)
the diagnosis of##723##3##(1990-10#4)(1990-11#3)(1990-12#3)(1990-2#2)(1990-3#5)(1990-4#4)(1990-5#3)(1990-6#3)(1990-8#4)(1990-9#4)(1991-11#4)(1991-12#8)(1991-2#1)(1991-3#5)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#2)(1991-9#4)(1992-10#6)(1992-11#1)(1992-2#1)(1992-4#3)(1992-5#4)(1992-6#1)(1992-7#2)(1992-8#4)(1992-9#1)(1993-1#5)(1993-10#8)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#4)(1993-6#2)(1993-9#5)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#5)(1994-7#2)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-4#2)(1995-7#3)(1995-9#3)(1996-1#1)(1996-11#3)(1996-12#8)(1996-2#2)(1996-3#3)(1996-4#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#5)(1997-4#2)(1997-7#3)(1997-8#5)(2004-1#4)(2004-10#1)(2004-2#1)(2005-1#1)(2005-10#4)(2005-11#5)(2005-12#2)(2005-3#1)(2005-5#1)(2005-7#2)(2005-8#9)(2005-9#1)(2006-1#4)(2006-10#28)(2006-12#6)(2006-2#4)(2006-4#6)(2006-5#2)(2006-6#4)(2006-7#5)(2006-8#15)(2006-9#9)(2007-1#1)(2007-10#11)(2007-11#7)(2007-12#8)(2007-2#10)(2007-3#2)(2007-5#2)(2007-6#5)(2007-7#22)(2007-8#12)(2007-9#6)(2008-1#10)(2008-10#11)(2008-11#9)(2008-12#5)(2008-2#2)(2008-3#10)(2008-4#8)(2008-5#13)(2008-6#7)(2008-7#19)(2008-8#5)(2008-9#4)(2009-1#1)(2009-10#3)(2009-11#1)(2009-2#1)(2009-3#6)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#10)(2010-2#4)(2010-3#5)(2010-4#1)(2010-5#2)(2010-6#7)(2010-7#4)(2010-8#2)(2010-9#3)(2011-1#9)(2011-12#6)(2011-2#38)(2011-3#1)(2012-1#4)(2012-11#3)(2012-12#14)(2012-2#17)(2012-3#12)(2013-1#45)(2013-7#8)(2013-8#13)
the diagnosis should##2##3##(2006-10#1)(2013-1#1)
the diagnosis to##2##3##(2006-2#1)(2008-10#1)
the diagnosis was confirmed by##6##5##(1990-2#1)(1990-6#2)(1997-8#1)(2008-7#1)(2012-2#1)
the diagnosis was confirmed with##3##5##(2007-3#1)(2010-5#1)(2012-12#1)
the diagnosis was confirmed##13##4##(1990-2#1)(1990-6#2)(1993-3#1)(1993-5#1)(1997-8#1)(2007-3#1)(2007-8#1)(2008-7#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#1)
the diagnosis was established##5##4##(2007-12#1)(2007-5#1)(2011-2#2)(2012-2#1)
the diagnosis was made##4##4##(1992-1#1)(1993-1#1)(2006-8#1)(2007-7#1)
the diagnosis was not made##2##5##(1992-8#1)(2008-7#1)
the diagnosis was not##4##4##(1992-5#1)(1992-8#1)(2007-8#1)(2008-7#1)
the diagnosis was##47##3##(1990-2#1)(1990-3#2)(1990-6#2)(1991-2#1)(1992-1#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-3#2)(1993-5#2)(1997-8#1)(2004-2#1)(2005-11#1)(2006-8#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-12#4)(2012-2#2)(2012-3#1)
the diagnosis##1287##2##(1990-10#5)(1990-11#4)(1990-12#6)(1990-2#6)(1990-3#8)(1990-4#4)(1990-5#4)(1990-6#6)(1990-7#1)(1990-8#4)(1990-9#7)(1991-1#2)(1991-11#5)(1991-12#12)(1991-2#4)(1991-3#6)(1991-4#1)(1991-5#4)(1991-6#1)(1991-8#4)(1991-9#5)(1992-1#1)(1992-10#6)(1992-11#3)(1992-12#1)(1992-2#5)(1992-3#6)(1992-4#4)(1992-5#9)(1992-6#2)(1992-7#2)(1992-8#10)(1992-9#1)(1993-1#8)(1993-10#11)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#7)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#6)(1994-1#1)(1994-10#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#8)(1994-7#2)(1994-9#2)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#1)(1995-4#2)(1995-7#3)(1995-8#1)(1995-9#4)(1996-1#3)(1996-11#4)(1996-12#11)(1996-2#2)(1996-3#6)(1996-4#2)(1996-6#1)(1996-8#1)(1996-9#5)(1997-1#2)(1997-2#2)(1997-3#10)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#9)(2004-1#4)(2004-10#1)(2004-11#1)(2004-2#2)(2005-1#1)(2005-10#4)(2005-11#9)(2005-12#4)(2005-3#1)(2005-5#1)(2005-7#4)(2005-8#11)(2005-9#4)(2006-1#5)(2006-10#54)(2006-11#1)(2006-12#13)(2006-2#11)(2006-3#1)(2006-4#11)(2006-5#3)(2006-6#8)(2006-7#7)(2006-8#21)(2006-9#11)(2007-1#2)(2007-10#15)(2007-11#15)(2007-12#20)(2007-2#12)(2007-3#7)(2007-4#3)(2007-5#11)(2007-6#7)(2007-7#36)(2007-8#24)(2007-9#9)(2008-1#23)(2008-10#15)(2008-11#13)(2008-12#13)(2008-2#6)(2008-3#17)(2008-4#18)(2008-5#18)(2008-6#16)(2008-7#29)(2008-8#7)(2008-9#12)(2009-1#1)(2009-10#7)(2009-11#1)(2009-12#1)(2009-2#7)(2009-3#7)(2009-4#6)(2009-5#2)(2009-6#4)(2009-7#2)(2009-8#3)(2009-9#4)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#28)(2010-2#5)(2010-3#7)(2010-4#4)(2010-5#7)(2010-6#10)(2010-7#5)(2010-8#7)(2010-9#5)(2011-1#16)(2011-12#9)(2011-2#66)(2011-3#1)(2011-7#7)(2012-1#5)(2012-11#5)(2012-12#29)(2012-2#41)(2012-3#17)(2013-1#75)(2013-7#12)(2013-8#29)
the diagnosis-related group##2##3##(1990-12#1)(1991-3#1)
the diagnosis-related##3##2##(1990-12#1)(1991-3#1)(1993-1#1)
the diagnostic accuracy of##12##4##(2005-1#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-11#1)(2009-4#2)(2010-8#1)(2012-2#2)(2013-1#1)
the diagnostic accuracy##17##3##(2005-1#1)(2006-10#1)(2006-7#1)(2007-6#2)(2008-1#1)(2008-11#1)(2008-12#2)(2009-11#1)(2009-4#2)(2009-7#1)(2010-8#1)(2012-2#2)(2013-1#1)
the diagnostic and prognostic##5##4##(1995-5#1)(1996-9#1)(2005-10#1)(2011-3#1)(2013-1#1)
the diagnostic and therapeutic approach##2##5##(2007-5#1)(2011-2#1)
the diagnostic and therapeutic problems##3##5##(1997-2#1)(2007-8#1)(2008-9#1)
the diagnostic and therapeutic##16##4##(1990-10#1)(1997-2#1)(2006-10#1)(2007-5#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-2#1)(2013-7#1)
the diagnostic and treatment##3##4##(2010-2#1)(2011-2#2)
the diagnostic and##27##3##(1990-10#1)(1990-12#2)(1995-5#1)(1996-12#1)(1996-9#1)(1997-2#1)(2005-10#1)(2006-10#1)(2007-5#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-2#4)(2011-3#1)(2012-2#1)(2013-1#1)(2013-7#1)
the diagnostic approach to##2##4##(2008-1#1)(2010-4#1)
the diagnostic approach##8##3##(1990-4#1)(1992-9#1)(1995-5#1)(2006-10#1)(2008-1#1)(2009-8#1)(2010-4#1)(2010-8#1)
the diagnostic approaches to##2##4##(2007-5#1)(2012-2#1)
the diagnostic approaches##3##3##(2006-8#1)(2007-5#1)(2012-2#1)
the diagnostic armamentarium##3##3##(1996-1#1)(2007-8#1)(2011-2#1)
the diagnostic capabilities of##2##4##(2006-9#1)(2010-12#1)
the diagnostic category##2##3##(2012-2#2)
the diagnostic challenges##3##3##(2013-1#2)(2013-8#1)
the diagnostic criteria for##9##4##(1991-3#1)(1995-6#1)(2005-7#1)(2008-1#1)(2008-7#1)(2011-2#1)(2013-1#2)(2013-8#1)
the diagnostic criteria of##3##4##(1995-8#1)(1997-8#1)(2008-9#1)
the diagnostic criteria##17##3##(1991-3#1)(1994-12#1)(1995-6#1)(1995-8#1)(1997-8#1)(2005-7#1)(2008-1#1)(2008-7#2)(2008-9#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
the diagnostic difficulties##4##3##(1992-5#1)(2008-6#2)(2010-7#1)
the diagnostic dilemma of##3##4##(2012-12#1)(2013-1#2)
the diagnostic dilemma##4##3##(2008-1#1)(2012-12#1)(2013-1#2)
the diagnostic evaluation of##3##4##(1992-12#1)(2006-7#1)(2012-1#1)
the diagnostic evaluation##8##3##(1992-12#1)(1992-3#1)(2006-7#1)(2007-11#1)(2010-11#1)(2012-1#1)(2013-1#2)
the diagnostic expertise of##2##4##(1994-1#1)(2005-5#1)
the diagnostic imaging##2##3##(1994-1#1)(1994-2#1)
the diagnostic laboratory##3##3##(2007-8#1)(2011-1#1)(2013-1#1)
the diagnostic method##2##3##(2010-1#1)(2011-2#1)
the diagnostic modalities##3##3##(1993-9#1)(2008-4#1)(2011-1#1)
the diagnostic possibilities##6##3##(1990-8#1)(1990-9#1)(1993-8#1)(2007-11#1)(2007-2#1)(2011-2#1)
the diagnostic potential of##3##4##(1992-7#1)(1993-1#1)(2007-8#1)
the diagnostic problems##3##3##(1992-8#1)(1994-6#1)(2008-10#1)
the diagnostic procedure##2##3##(1993-3#1)(1993-5#1)
the diagnostic procedures##6##3##(1993-11#1)(1997-4#1)(2008-1#1)(2008-5#1)(2008-7#1)(2013-1#1)
the diagnostic process and##4##4##(1990-9#1)(2005-7#1)(2006-10#1)(2008-10#1)
the diagnostic process of##2##4##(2005-11#1)(2013-7#1)
the diagnostic process##14##3##(1990-10#1)(1990-9#1)(1996-11#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-4#1)(2008-1#1)(2008-10#2)(2013-1#1)(2013-7#1)
the diagnostic recognition of chronic SPs##2##6##(2013-1#2)
the diagnostic relevance of##2##4##(2008-2#1)(2010-8#1)
the diagnostic sensitivity of##2##4##(2006-10#1)(2007-9#1)
the diagnostic sensitivity##3##3##(2006-10#1)(2007-9#2)
the diagnostic test##3##3##(1996-2#1)(2012-12#1)(2013-1#1)
the diagnostic tools##2##3##(2007-2#1)(2008-1#1)
the diagnostic use of##3##4##(1991-3#1)(1992-12#1)(2007-11#1)
the diagnostic usefulness of##2##4##(2006-6#1)(2007-10#1)
the diagnostic utility of##6##4##(1991-2#1)(2008-12#2)(2009-8#1)(2011-2#1)(2012-2#1)
the diagnostic validity of##2##4##(2007-10#1)(2007-9#1)
the diagnostic value of##12##4##(1991-6#1)(1992-3#1)(1996-3#1)(2006-10#1)(2006-12#1)(2007-7#1)(2007-9#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
the diagnostic workup##2##3##(1992-1#1)(2012-2#1)
the diagnostic yield from##2##4##(1997-8#1)(2013-1#1)
the diagnostic yield of##6##4##(1993-7#1)(2008-5#1)(2010-12#1)(2011-2#2)(2012-12#1)
the diagnostic yield##10##3##(1990-3#1)(1993-7#1)(1997-8#1)(2008-5#1)(2010-12#1)(2011-2#3)(2012-12#1)(2013-1#1)
the diagnostic##268##2##(1990-10#3)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#2)(1990-8#1)(1990-9#3)(1991-2#2)(1991-3#2)(1991-4#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#2)(1992-3#2)(1992-5#2)(1992-7#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-4#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-8#4)(2005-1#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-7#2)(2006-10#10)(2006-12#2)(2006-6#2)(2006-7#2)(2006-8#3)(2006-9#1)(2007-10#2)(2007-11#4)(2007-12#3)(2007-2#4)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#3)(2007-8#7)(2007-9#5)(2008-1#8)(2008-10#10)(2008-11#3)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#5)(2008-7#6)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#3)(2009-7#1)(2009-8#2)(2010-1#2)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#16)(2011-3#1)(2012-1#1)(2012-12#7)(2012-2#12)(2013-1#23)(2013-7#2)(2013-8#4)
the diagnostics and##3##3##(2007-11#1)(2007-7#1)(2007-8#1)
the diagnostics of##9##3##(1990-5#1)(2007-11#3)(2008-1#1)(2009-2#3)(2013-8#1)
the diagnostics##12##2##(1990-5#1)(2007-11#4)(2007-7#1)(2007-8#1)(2008-1#1)(2009-2#3)(2013-8#1)
the diagonal and##3##3##(1997-2#1)(2007-4#1)(2008-8#1)
the diagonal band of Broca##6##5##(1993-4#4)(1994-3#1)(1997-8#1)
the diagonal band of##7##4##(1993-4#4)(1994-3#2)(1997-8#1)
the diagonal band##9##3##(1990-7#1)(1993-4#4)(1994-3#2)(1997-3#1)(1997-8#1)
the diagonal branch##2##3##(2007-8#1)(2008-12#1)
the diagonal##21##2##(1990-7#1)(1993-4#4)(1994-3#2)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-8#1)
the diagram##2##2##(2005-11#1)(2012-2#1)
the diagrams##2##2##(1993-2#1)(2008-10#1)
the dialogue##2##2##(1994-3#1)(1997-3#1)
the dialysate from the##2##4##(2008-10#2)
the dialysate from##3##3##(1996-6#1)(2008-10#2)
the dialysate##18##2##(1995-12#2)(1995-7#1)(1996-6#2)(2007-9#2)(2008-1#2)(2008-10#5)(2008-4#1)(2011-2#2)(2012-1#1)
the dialysed##2##2##(1994-8#1)(2007-9#1)
the dialysis centers##2##3##(2008-1#2)
the dialysis fiber##2##3##(1993-7#2)
the dialysis membrane##3##3##(1992-3#1)(1993-12#1)(1994-10#1)
the dialysis patients##2##3##(2007-7#1)(2008-1#1)
the dialysis population##4##3##(2007-7#2)(2008-1#1)(2011-2#1)
the dialysis probe##2##3##(1992-3#1)(1997-2#1)
the dialysis system was##2##4##(2004-8#2)
the dialysis system##3##3##(2004-8#2)(2008-1#1)
the dialysis treatment##2##3##(2007-7#1)(2007-8#1)
the dialysis unit##3##3##(1996-12#1)(2007-7#1)(2007-8#1)
the dialysis was##2##3##(1990-12#1)(2008-10#1)
the dialysis##36##2##(1990-12#1)(1992-3#2)(1993-12#1)(1993-7#2)(1994-10#1)(1996-12#1)(1997-2#1)(2004-8#2)(2006-8#1)(2007-12#1)(2007-7#7)(2007-8#3)(2008-1#6)(2008-10#3)(2008-12#1)(2008-5#1)(2011-2#2)
the dialytic##5##2##(2007-7#5)
the dialyzation solution##3##3##(2006-6#3)
the dialyzation##4##2##(2006-6#4)
the dialyzed##2##2##(1995-2#1)(2005-11#1)
the diamagnetic##9##2##(1990-7#1)(1994-5#1)(1997-7#1)(1997-8#1)(2008-3#4)(2008-9#1)
the diameter and the length of the##2##7##(1997-4#1)(2011-2#1)
the diameter of the ball lens##2##6##(2011-1#2)
the diameter of the particles##2##5##(2005-11#1)(2008-2#1)
the diameter of the##18##4##(1993-12#1)(2005-11#1)(2007-8#1)(2008-1#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#1)(2009-2#1)(2011-1#3)(2013-1#1)(2013-7#1)
the diameter of##31##3##(1992-8#1)(1993-12#1)(1995-1#1)(2005-1#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#4)(2008-5#2)(2008-7#1)(2009-2#1)(2011-1#4)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
the diameter##41##2##(1992-8#1)(1993-12#2)(1995-1#1)(1997-4#1)(2005-1#1)(2005-10#1)(2005-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-3#5)(2008-5#2)(2008-7#1)(2009-2#1)(2010-1#1)(2011-1#5)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
the diameters of the##4##4##(2005-10#1)(2008-2#3)
the diameters of##9##3##(1990-4#1)(2005-10#1)(2005-11#1)(2007-2#1)(2008-10#1)(2008-2#4)
the diameters##12##2##(1990-4#1)(1990-6#1)(2005-10#1)(2005-11#1)(2007-2#1)(2008-10#1)(2008-2#4)(2010-1#2)
the diamine##6##2##(1994-11#2)(1995-11#1)(1996-2#1)(2008-5#1)(2013-8#1)
the diamino##2##2##(1997-1#1)(2007-11#1)
the diamond##10##2##(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)
the diamonds##2##2##(2007-11#2)
the dianion##2##2##(1996-2#1)(2010-5#1)
the dianions##2##2##(1997-1#1)(2008-5#1)
the diapause##2##2##(2008-8#2)
the diaper##3##2##(1990-8#1)(1993-5#2)
the diaphorase##3##2##(1992-3#1)(1992-6#1)(1993-6#1)
the diaphragm and##5##3##(1990-2#1)(2006-10#1)(2010-9#1)(2012-1#1)(2012-2#1)
the diaphragm into the pleural cavity##2##6##(1991-8#1)(2007-12#1)
the diaphragm into the##3##4##(1991-8#1)(2007-12#1)(2008-5#1)
the diaphragm of##4##3##(1994-4#1)(2007-8#1)(2009-6#1)(2010-2#1)
the diaphragm was##6##3##(1994-4#1)(1997-4#1)(1997-5#1)(2007-8#1)(2008-2#1)(2012-1#1)
the diaphragm##54##2##(1990-2#2)(1990-5#1)(1991-3#1)(1991-8#1)(1993-6#1)(1994-4#3)(1996-9#2)(1997-4#1)(1997-5#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-8#12)(2008-11#1)(2008-2#1)(2008-5#1)(2009-6#1)(2009-8#1)(2010-2#2)(2010-5#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#7)(2012-12#2)(2012-2#1)(2013-1#2)
the diaphragmatic incision##3##3##(2007-8#3)
the diaphragmatic##5##2##(1993-10#1)(2007-8#3)(2011-1#1)
the diaphyseal##2##2##(1996-3#1)(2009-2#1)
the diaphysis of the femoral bone##2##6##(2009-2#2)
the diaphysis of the##3##4##(2009-2#3)
the diaphysis##5##2##(2009-2#3)(2009-7#2)
the diarrhea##2##2##(2010-9#2)
the diary##2##2##(1993-5#1)(2008-7#1)
the diastereoisomers##2##2##(1991-5#1)(1997-7#1)
the diastereomeric##4##2##(1990-8#1)(1995-3#1)(2007-11#1)(2008-11#1)
the diastereomers of##3##3##(1991-8#1)(1993-6#1)(2005-12#1)
the diastereomers##5##2##(1991-8#1)(1992-2#1)(1993-6#1)(1996-2#1)(2005-12#1)
the diastereoselective formation of##2##4##(2010-5#2)
the diastereoselective##3##2##(2010-5#2)(2010-6#1)
the diastolic##8##2##(1992-9#1)(1994-6#1)(1996-6#2)(2006-6#1)(2008-10#1)(2008-8#1)(2011-1#1)
the diatom Thalassiosira weissflogii##2##4##(1994-8#1)(2011-2#1)
the diatom##5##2##(1993-3#2)(1994-8#1)(2010-11#1)(2011-2#1)
the diauxic growth pattern##2##4##(2008-7#2)
the diauxic##3##2##(2008-6#1)(2008-7#2)
the diazepam##3##2##(1991-4#1)(1992-10#1)(2008-6#1)
the diazepam-insensitive site##2##3##(1995-11#2)
the diazepam-insensitive##5##2##(1992-3#3)(1995-11#2)
the diazonium salt##2##3##(1992-9#1)(2008-10#1)
the diazonium##3##2##(1992-9#1)(2008-10#2)
the dicarboxylic acid##2##3##(1990-2#1)(2008-10#1)
the dicarboxylic##3##2##(1990-2#1)(2008-10#1)(2013-1#1)
the dication##2##2##(1992-2#2)
the dichloromethane fraction##3##3##(2008-11#3)
the dichloromethane##5##2##(2007-1#2)(2008-11#3)
the dichloropropanols##2##2##(1997-3#2)
the dichotomous trait##2##3##(2012-3#2)
the dichotomous##4##2##(1996-2#1)(2009-12#1)(2012-3#2)
the dichotomy between##2##3##(2006-10#1)(2008-6#1)
the dichotomy of##2##3##(2008-4#1)(2012-2#1)
the dichotomy##5##2##(2006-10#1)(2008-4#1)(2008-6#1)(2012-2#2)
the dichroism##2##2##(2005-11#2)
the dichromate##2##2##(2008-10#1)(2008-3#1)
the dictates of##2##3##(1991-2#1)(2006-12#1)
the dictionary##4##2##(2006-4#1)(2008-4#2)(2012-12#1)
the didactic##2##2##(2007-2#1)(2012-2#1)
the dideoxy##4##2##(1991-7#1)(1992-1#1)(2008-2#2)
the diel##2##2##(2004-4#2)
the dielectric constant and the##2##5##(2005-11#1)(2008-3#1)
the dielectric constant of the medium##2##6##(2008-10#1)(2010-4#1)
the dielectric constant of the##3##5##(2005-11#1)(2008-10#1)(2010-4#1)
the dielectric constant of##4##4##(2005-11#2)(2008-10#1)(2010-4#1)
the dielectric constant##10##3##(1996-5#1)(2005-11#3)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#2)(2010-4#1)
the dielectric function of##2##4##(2008-2#1)(2008-3#1)
the dielectric function##3##3##(2008-2#2)(2008-3#1)
the dielectric properties of the##3##5##(1990-9#1)(1995-1#1)(2006-10#1)
the dielectric properties of##6##4##(1990-9#1)(1995-1#1)(2006-10#3)(2008-3#1)
the dielectric properties##7##3##(1990-9#1)(1995-1#1)(2006-10#4)(2008-3#1)
the dielectric##47##2##(1990-9#1)(1993-5#1)(1995-1#2)(1995-2#1)(1996-5#1)(1997-2#2)(2005-11#5)(2006-10#5)(2007-11#3)(2007-12#5)(2008-10#1)(2008-2#5)(2008-3#8)(2008-7#2)(2009-5#1)(2010-4#1)(2011-2#2)(2013-1#1)
the dielectrophoretic##7##2##(1997-1#1)(2005-11#2)(2006-2#4)
the diencephalic##3##2##(1993-8#1)(1994-9#1)(2008-7#1)
the diencephalon##8##2##(1992-1#1)(1994-2#4)(1994-9#1)(1995-12#1)(2009-2#1)
the diene##2##2##(1991-5#1)(1994-9#1)
the diestrous state##2##3##(1995-7#2)
the diet and##6##3##(1991-11#2)(2004-11#1)(2008-12#1)(2008-4#1)(2009-2#1)
the diet at##2##3##(1994-9#1)(2007-2#1)
the diet did not##2##4##(1995-4#1)(2008-12#1)
the diet for##2##3##(1991-2#1)(1992-3#1)
the diet in##3##3##(1991-6#1)(2006-4#1)(2008-10#1)
the diet is##5##3##(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2013-8#1)
the diet of S##2##4##(1991-2#1)(2010-8#1)
the diet of a##2##4##(1997-3#1)(2010-2#1)
the diet of the##3##4##(2012-2#2)(2013-7#1)
the diet of white-lipped peccary##2##5##(2008-5#2)
the diet of##24##3##(1991-11#1)(1991-2#1)(1994-8#1)(1995-4#1)(1997-3#1)(2004-11#1)(2007-3#3)(2008-1#1)(2008-5#3)(2010-2#2)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#2)(2013-7#1)
the diet was##4##3##(1990-6#1)(1991-11#1)(1995-4#1)(2007-3#1)
the diet with##3##3##(2008-5#1)(2008-7#1)(2009-5#1)
the diet without##2##3##(1993-12#1)(2008-7#1)
the diet##118##2##(1990-12#1)(1990-6#1)(1990-8#2)(1991-11#7)(1991-2#4)(1991-6#1)(1992-3#3)(1992-8#2)(1993-12#2)(1993-7#1)(1993-9#3)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-4#3)(1996-1#1)(1997-3#1)(2004-11#4)(2004-2#1)(2005-10#1)(2005-11#1)(2005-3#1)(2006-10#3)(2006-4#1)(2007-2#1)(2007-3#7)(2007-5#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#6)(2008-9#2)(2009-2#1)(2009-4#3)(2009-5#2)(2009-9#1)(2010-2#2)(2010-4#3)(2010-8#3)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#5)(2013-1#1)(2013-7#2)(2013-8#1)
the diet)##2##2##(2008-3#1)(2009-2#1)
the dietary and##2##3##(1995-9#1)(2008-1#1)
the dietary factors##2##3##(2008-2#1)(2012-2#1)
the dietary fat##2##3##(1994-12#1)(1996-11#1)
the dietary fiber##2##3##(1993-11#1)(2010-8#1)
the dietary intake of##3##4##(1991-12#1)(2006-7#1)(2012-1#1)
the dietary##35##2##(1990-2#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#3)(1993-11#1)(1994-12#1)(1994-6#1)(1995-4#1)(1995-9#1)(1996-11#2)(1997-7#1)(2006-4#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2010-2#2)(2010-6#1)(2010-8#1)(2012-1#2)(2012-2#3)(2013-1#1)(2013-8#1)
the dietetic##2##2##(1994-2#1)(1995-2#1)
the diethyl##2##2##(2008-10#1)(2010-5#1)
the dieting behavior of their adolescent daughters##2##7##(2006-7#2)
the dieting##3##2##(2006-7#3)
the dietitian in the##2##4##(1993-3#2)
the dietitian in##3##3##(1993-12#1)(1993-3#2)
the dietitian##6##2##(1993-12#3)(1993-3#2)(1994-2#1)
the diets of##3##3##(1991-11#1)(2007-3#1)(2011-2#1)
the diets with##2##3##(2008-7#2)
the diets##14##2##(1991-11#1)(1991-12#1)(1991-2#1)(1993-11#1)(2007-2#1)(2007-3#1)(2008-6#2)(2008-7#2)(2010-8#2)(2011-2#1)(2012-12#1)
the dif site##2##3##(1997-2#2)
the diferric##3##2##(1994-3#1)(1997-7#2)
the difference and##2##3##(2008-10#1)(2008-9#1)
the difference being statistically significant##2##5##(1993-7#1)(1997-2#1)
the difference being##4##3##(1993-7#1)(1994-2#1)(1997-2#1)(2008-10#1)
the difference between a##5##4##(1997-6#1)(2006-10#1)(2008-3#1)(2008-4#2)
the difference between an individual's##2##5##(2007-9#1)(2008-4#1)
the difference between the effect of##2##6##(2008-1#1)(2008-10#1)
the difference between the groups##2##5##(1991-2#1)(2008-7#1)
the difference between the measured##3##5##(2007-11#1)(2008-2#1)(2012-1#1)
the difference between the results obtained##2##6##(1992-4#1)(2008-10#1)
the difference between the superficial dimension of the sagging surface of the lower eyelid and the dimension of its##2##19##(2008-5#2)
the difference between the total##2##5##(2005-4#1)(2008-2#1)
the difference between the two groups was##2##7##(1991-3#1)(2008-8#1)
the difference between the two##11##5##(1991-3#1)(1991-5#1)(1996-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2011-12#1)(2012-1#1)(2013-1#1)
the difference between the##60##4##(1990-5#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-4#1)(1993-2#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-1#1)(1996-6#1)(1996-7#1)(1997-6#1)(2005-11#1)(2005-4#1)(2007-11#2)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#2)(2013-1#1)(2013-8#1)
the difference between these##2##4##(1996-3#1)(2012-3#1)
the difference between total inorganic##2##5##(2008-10#2)
the difference between total##4##4##(1994-11#1)(2008-10#3)
the difference between two##4##4##(1997-6#2)(2008-10#1)(2011-2#1)
the difference between##120##3##(1990-12#1)(1990-5#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#1)(1992-2#1)(1992-4#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-6#4)(1997-8#1)(2005-10#1)(2005-11#2)(2005-4#2)(2005-8#1)(2006-10#1)(2007-11#2)(2007-4#2)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#2)(2008-2#10)(2008-3#6)(2008-4#4)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2010-2#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#4)(2012-1#3)(2012-3#2)(2013-1#1)(2013-8#2)
the difference did not##2##4##(2008-1#1)(2008-7#1)
the difference frequency##2##3##(2007-12#2)
the difference in chain length##2##5##(1997-8#1)(2008-5#1)
the difference in energy##2##4##(1993-7#1)(1997-6#1)
the difference in log K(ex)##2##5##(2008-10#2)
the difference in reactivity of##2##5##(1996-2#1)(2008-10#1)
the difference in survival##2##4##(1996-12#1)(2004-1#1)
the difference in the##41##4##(1990-8#1)(1991-8#1)(1993-4#1)(1993-7#1)(1994-12#1)(1995-3#1)(1996-7#1)(1997-2#2)(2003-11#1)(2004-11#2)(2006-6#1)(2007-11#1)(2007-12#2)(2007-8#3)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#4)(2008-3#1)(2008-5#2)(2008-9#1)(2009-6#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-11#2)(2012-2#1)
the difference in their##2##4##(1993-12#1)(2008-2#1)
the difference in##140##3##(1990-11#2)(1990-12#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#3)(1993-4#2)(1993-7#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-3#3)(1995-5#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-2#3)(1997-4#2)(1997-6#2)(1997-8#1)(2003-11#1)(2004-1#1)(2004-11#2)(2004-8#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#19)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-4#2)(2010-5#1)(2011-12#2)(2011-2#4)(2012-11#2)(2012-2#2)(2012-3#1)(2013-8#1)
the difference is##5##3##(1993-2#1)(1994-4#1)(2011-12#1)(2012-1#2)
the difference may##2##3##(1992-4#1)(2008-9#1)
the difference not being significant##2##5##(2009-5#1)(2011-2#1)
the difference of one##2##4##(2008-11#1)(2008-3#1)
the difference of the two##4##5##(1992-11#1)(2008-10#1)(2008-3#2)
the difference of the##14##4##(1992-11#1)(1996-4#1)(1996-7#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#3)(2010-4#1)(2012-2#1)(2012-3#1)
the difference of##35##3##(1990-12#1)(1990-2#1)(1990-4#1)(1990-8#1)(1992-11#1)(1996-4#1)(1996-7#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#4)(2008-8#1)(2008-9#3)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-8#1)
the difference spectra##2##3##(1990-12#1)(1990-8#1)
the difference spectrum of##2##4##(1990-12#1)(1992-11#1)
the difference was not significant (p##2##6##(1992-7#1)(2008-10#1)
the difference was not significant##9##5##(1992-10#1)(1992-11#1)(1992-7#1)(2006-2#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-12#1)(2013-1#1)
the difference was not statistically significant (p = 0##2##9##(1991-4#1)(2007-2#1)
the difference was not statistically significant##9##6##(1991-4#1)(1996-12#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-5#1)(2011-2#1)
the difference was not##19##4##(1991-4#1)(1992-10#1)(1992-11#1)(1992-7#1)(1996-12#1)(2006-10#1)(2006-2#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
the difference was significant##3##4##(2007-2#1)(2007-3#1)(2008-3#1)
the difference was statistically##3##4##(2006-6#1)(2007-2#1)(2012-12#1)
the difference was##33##3##(1991-4#1)(1992-10#1)(1992-11#1)(1992-7#1)(1996-12#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-2#3)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
the difference##383##2##(1990-11#2)(1990-12#5)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#5)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-4#2)(1992-6#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#2)(1993-4#2)(1993-7#3)(1993-9#1)(1994-11#4)(1994-12#2)(1994-2#5)(1994-3#1)(1994-4#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-3#3)(1995-5#2)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-7#3)(1997-2#4)(1997-4#2)(1997-6#6)(1997-8#2)(2003-11#1)(2004-1#1)(2004-10#1)(2004-11#2)(2004-8#1)(2005-10#2)(2005-11#4)(2005-4#2)(2005-8#1)(2006-10#5)(2006-11#2)(2006-2#2)(2006-5#1)(2006-6#2)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#6)(2007-2#4)(2007-3#1)(2007-4#2)(2007-7#4)(2007-8#9)(2007-9#5)(2008-1#4)(2008-10#43)(2008-11#8)(2008-12#5)(2008-2#20)(2008-3#19)(2008-4#6)(2008-5#9)(2008-6#1)(2008-7#7)(2008-8#6)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#4)(2011-2#12)(2012-1#5)(2012-11#2)(2012-12#4)(2012-2#7)(2012-3#4)(2013-1#3)(2013-8#5)
the difference?##3##2##(1993-4#1)(2007-4#1)(2008-2#1)
the differences among the##3##4##(2005-8#1)(2008-10#1)(2008-3#1)
the differences among##5##3##(2005-8#1)(2006-10#1)(2008-10#1)(2008-3#1)(2009-1#1)
the differences and similarities between##2##5##(2009-12#1)(2011-1#1)
the differences and similarities##3##4##(2006-7#1)(2009-12#1)(2011-1#1)
the differences and##4##3##(2006-7#1)(2009-12#1)(2010-8#1)(2011-1#1)
the differences are##2##3##(2008-10#1)(2012-12#1)
the differences between normal##2##4##(2008-7#1)(2010-3#1)
the differences between the two##4##5##(1997-6#1)(2007-11#1)(2008-8#1)(2013-8#1)
the differences between the##21##4##(1990-12#1)(1992-4#1)(1992-9#1)(1993-6#1)(1995-12#1)(1995-5#1)(1997-6#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
the differences between them##2##4##(1995-8#1)(2008-5#1)
the differences between these##3##4##(2008-10#1)(2008-7#1)(2013-8#1)
the differences between this##2##4##(1997-6#1)(2010-5#1)
the differences between##80##3##(1990-12#1)(1990-2#1)(1990-8#1)(1991-11#1)(1992-2#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#2)(1997-4#1)(1997-6#3)(2006-10#1)(2006-11#1)(2006-12#3)(2006-4#1)(2007-1#1)(2007-11#2)(2007-4#1)(2007-6#1)(2008-1#2)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2009-10#2)(2009-2#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-5#3)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#3)
the differences did not reach statistical significance##2##7##(1994-10#1)(2009-4#1)
the differences found##2##3##(2007-7#1)(2008-9#1)
the differences in activity##2##4##(1995-8#1)(2006-12#1)
the differences in care##2##4##(2007-2#2)
the differences in facial##3##4##(2008-5#1)(2010-8#2)
the differences in prevalence##2##4##(1993-10#1)(2012-3#1)
the differences in the##31##4##(1991-9#1)(1992-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-5#2)(1997-2#1)(1997-4#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#3)(2008-8#1)(2008-9#1)(2009-11#2)(2009-12#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#2)
the differences in their##5##4##(1994-3#1)(1996-5#1)(2007-7#1)(2008-10#1)(2013-8#1)
the differences in##114##3##(1991-2#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-10#1)(1993-11#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1997-2#2)(1997-4#1)(1997-7#2)(2005-11#2)(2005-12#1)(2006-10#1)(2006-11#2)(2006-12#2)(2006-4#1)(2006-7#1)(2007-11#3)(2007-12#1)(2007-2#4)(2007-7#1)(2007-8#1)(2008-10#11)(2008-11#3)(2008-2#6)(2008-3#4)(2008-4#2)(2008-5#2)(2008-8#2)(2008-9#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#3)
the differences observed between##3##4##(1997-2#1)(2008-10#1)(2008-5#1)
the differences observed in##3##4##(1997-9#1)(2005-11#1)(2013-8#1)
the differences observed##8##3##(1994-11#1)(1997-2#1)(1997-9#1)(2005-11#1)(2006-8#1)(2008-10#1)(2008-5#1)(2013-8#1)
the differences of##10##3##(2005-4#1)(2007-6#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#2)(2013-8#2)
the differences that may##2##4##(2007-4#1)(2008-3#1)
the differences that##3##3##(2007-4#1)(2008-3#1)(2008-8#1)
the differences were not significant##6##5##(1992-2#1)(2007-3#1)(2007-6#1)(2008-5#2)(2008-9#1)
the differences were not##10##4##(1991-6#1)(1992-2#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-9#1)(2013-7#1)
the differences were small and##2##5##(1994-2#1)(1997-8#1)
the differences were##14##3##(1990-1#1)(1991-6#1)(1992-2#1)(1994-11#1)(1994-2#1)(1997-8#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-9#1)(2013-7#1)
the differences##265##2##(1990-1#1)(1990-12#2)(1990-2#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-6#3)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#4)(1992-3#2)(1992-4#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-10#2)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-3#2)(1995-5#3)(1995-8#2)(1996-1#2)(1996-12#3)(1996-2#2)(1996-3#2)(1996-5#1)(1996-7#1)(1997-2#4)(1997-4#2)(1997-6#3)(1997-7#3)(1997-8#1)(1997-9#1)(2004-11#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-4#1)(2005-8#1)(2006-10#4)(2006-11#3)(2006-12#5)(2006-4#2)(2006-7#2)(2006-8#1)(2007-1#1)(2007-11#5)(2007-12#1)(2007-2#4)(2007-3#1)(2007-4#2)(2007-6#3)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#23)(2008-11#5)(2008-12#1)(2008-2#7)(2008-3#8)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#3)(2009-2#2)(2009-4#3)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#3)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#6)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#4)(2013-1#4)(2013-7#2)(2013-8#9)
the different P##2##3##(1996-2#1)(2008-8#1)
the different SSB binding modes##2##5##(1997-2#2)
the different age##3##3##(1996-3#1)(1997-6#1)(2013-7#1)
the different antibodies##2##3##(1994-12#1)(2007-12#1)
the different approaches##5##3##(2007-12#1)(2008-10#2)(2008-7#1)(2012-3#1)
the different areas of##4##4##(1992-8#1)(2008-10#1)(2009-10#1)(2009-2#1)
the different areas##5##3##(1992-8#1)(2007-6#1)(2008-10#1)(2009-10#1)(2009-2#1)
the different aspects of##9##4##(1992-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-4#1)(2012-12#1)(2013-1#2)
the different aspects##10##3##(1992-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-4#1)(2012-12#2)(2013-1#2)
the different association##3##3##(1990-3#1)(2008-10#1)(2010-2#1)
the different available methods##2##4##(2008-3#1)(2009-1#1)
the different available##3##3##(2007-11#1)(2008-3#1)(2009-1#1)
the different binding sites##2##4##(1990-2#1)(1996-7#1)
the different binding##4##3##(1990-2#1)(1990-7#1)(1996-5#1)(1996-7#1)
the different biological##3##3##(2007-7#2)(2009-3#1)
the different body##2##3##(1994-6#1)(2007-4#1)
the different brands and##2##4##(2008-10#1)(2011-1#1)
the different categories of##3##4##(1990-8#1)(1990-9#1)(1991-6#1)
the different categories##5##3##(1990-8#1)(1990-9#1)(1991-6#1)(2012-12#2)
the different causal##2##3##(1996-2#1)(1997-3#1)
the different cell cycle##2##4##(1995-9#1)(2008-11#1)
the different cell lines##2##4##(2010-7#2)
the different cell##9##3##(1993-7#1)(1995-9#1)(2008-1#1)(2008-11#2)(2008-2#1)(2010-7#2)(2011-1#1)
the different cellular##2##3##(2008-7#1)(2011-12#1)
the different chemometric strategies##2##4##(2011-1#2)
the different classes of##8##4##(1995-7#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2012-12#3)
the different classes##11##3##(1995-7#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-7#1)(2012-12#3)
the different clinical and##2##4##(1991-9#1)(2006-5#1)
the different clinical##7##3##(1991-9#1)(1992-8#1)(1994-6#1)(2006-5#1)(2008-1#1)(2008-8#1)(2012-12#1)
the different components of the##2##5##(2008-6#1)(2008-8#1)
the different components of##3##4##(2008-10#1)(2008-6#1)(2008-8#1)
the different components##4##3##(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#1)
the different compounds##2##3##(1996-2#1)(2008-10#1)
the different concentration of##3##4##(2005-4#1)(2008-10#1)(2010-8#1)
the different concentration##5##3##(2005-4#1)(2008-10#2)(2010-2#1)(2010-8#1)
the different conditions##4##3##(1990-3#1)(1993-11#1)(1995-6#1)(2008-10#1)
the different conformers##3##3##(1991-7#1)(1995-11#1)(2007-10#1)
the different countries##2##3##(1990-11#1)(2008-10#1)
the different cultures##2##3##(2005-7#1)(2008-6#1)
the different detection##2##3##(2008-10#2)
the different developmental##2##3##(2008-3#1)(2011-1#1)
the different diffraction orders##2##4##(2008-2#1)(2008-3#1)
the different diseases##2##3##(2008-10#1)(2010-4#1)
the different districts##2##3##(1994-2#1)(2007-2#1)
the different drugs##3##3##(2005-8#1)(2007-10#1)(2008-3#1)
the different effects##2##3##(2008-6#1)(2013-1#1)
the different elements of##3##4##(1995-5#1)(2008-2#1)(2013-7#1)
the different ethnic groups##2##4##(2008-1#1)(2008-9#1)
the different evolution of##2##4##(2009-10#1)(2013-7#1)
the different experimental##5##3##(1995-3#1)(2008-1#1)(2008-10#2)(2012-12#1)
the different factors##5##3##(2008-10#1)(2008-7#1)(2010-2#1)(2011-1#1)(2012-1#1)
the different forms of##7##4##(1990-12#1)(1997-4#1)(1997-6#1)(2006-7#1)(2010-12#1)(2010-3#1)(2013-8#1)
the different forms##12##3##(1990-12#3)(1990-5#1)(1992-12#1)(1996-7#1)(1997-4#1)(1997-6#1)(2006-7#1)(2010-12#1)(2010-3#1)(2013-8#1)
the different formulations##2##3##(2007-11#1)(2008-5#1)
the different functional##3##3##(2007-12#2)(2008-4#1)
the different genes##2##3##(1991-7#1)(1996-7#1)
the different groups of##3##4##(1992-2#1)(1993-8#1)(2012-2#1)
the different groups##11##3##(1992-2#1)(1992-8#1)(1993-8#1)(1996-12#2)(2006-5#1)(2008-10#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
the different growth##2##3##(2004-4#1)(2008-9#1)
the different histological##2##3##(2007-12#1)(2007-8#1)
the different host##2##3##(2008-10#1)(2008-3#1)
the different imaging techniques##3##4##(2007-5#1)(2011-2#1)(2012-2#1)
the different in##2##3##(2008-5#1)(2013-8#1)
the different issues##2##3##(2006-5#1)(2012-3#1)
the different kinds of##3##4##(1992-3#1)(2007-5#1)(2013-1#1)
the different kinetics##2##3##(1993-2#1)(1995-11#1)
the different layers of the##2##5##(1990-9#1)(2008-3#1)
the different levels of##3##4##(1994-12#1)(2006-6#1)(2012-3#1)
the different lipoproteins##2##3##(1992-3#1)(1996-4#1)
the different local##2##3##(2008-8#1)(2010-8#1)
the different mechanisms##6##3##(1991-9#1)(1992-6#1)(1993-3#1)(2006-12#1)(2008-8#1)(2012-3#1)
the different medical specialties##2##4##(1991-11#1)(2006-8#1)
the different members of the##3##5##(1990-5#1)(1996-3#1)(2005-7#1)
the different methodological approaches##2##4##(2006-4#1)(2010-12#1)
the different methods for##2##4##(2008-10#1)(2011-1#1)
the different methods of##3##4##(2007-10#1)(2007-7#1)(2007-8#1)
the different methods used##2##4##(2008-2#1)(2011-2#1)
the different methods##13##3##(1991-3#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-7#1)(2011-1#1)(2011-2#1)
the different minerals##2##3##(2005-11#1)(2010-5#1)
the different mobility species##2##4##(1991-7#2)
the different modalities of treatment##2##5##(2006-12#1)(2008-7#1)
the different modes of##2##4##(1991-5#1)(2011-1#1)
the different modes##3##3##(1991-5#1)(2010-9#1)(2011-1#1)
the different molecular weight##3##4##(1990-12#2)(1993-9#1)
the different molecular##4##3##(1990-12#2)(1993-9#1)(2010-9#1)
the different operative##2##3##(1991-5#1)(1992-8#1)
the different organic##2##3##(2007-6#1)(2013-8#1)
the different organs##2##3##(2007-10#1)(2008-10#1)
the different orientation of##2##4##(2008-2#1)(2010-5#1)
the different parameters##2##3##(1990-9#1)(2008-10#1)
the different parts of the##2##5##(1997-7#1)(2008-1#1)
the different patterns of##2##4##(1995-11#1)(1995-9#1)
the different patterns##3##3##(1992-10#1)(1995-11#1)(1995-9#1)
the different periods of##2##4##(1993-9#1)(2008-7#1)
the different perspectives of##2##4##(2008-2#1)(2013-1#1)
the different phases of the##2##5##(1991-5#1)(2008-7#1)
the different phases of##3##4##(1991-5#1)(2008-7#1)(2013-1#1)
the different phases##4##3##(1991-5#1)(2008-10#1)(2008-7#1)(2013-1#1)
the different phenotypes##2##3##(1994-12#1)(2008-10#1)
the different phenotypic##2##3##(2007-7#1)(2008-10#1)
the different plant##3##3##(2008-10#2)(2013-7#1)
the different populations##2##3##(1993-6#1)(2009-9#1)
the different portions of the##2##5##(1994-6#1)(2008-5#1)
the different postoperative##2##3##(2006-3#1)(2007-8#1)
the different problems##3##3##(1995-9#1)(2007-5#1)(2009-10#1)
the different procedures##3##3##(1995-8#1)(2008-4#1)(2008-8#1)
the different profiles##2##3##(2004-3#1)(2005-11#1)
the different properties##2##3##(2007-11#1)(2011-12#1)
the different proteins##2##3##(2005-11#1)(2008-7#1)
the different protocols##3##3##(1990-10#1)(2007-7#1)(2012-1#1)
the different receptors##2##3##(1993-6#1)(1995-3#1)
the different regions of the##4##5##(1996-11#1)(2003-11#1)(2007-3#1)(2008-2#1)
the different regions of##6##4##(1992-9#1)(1996-11#1)(2003-11#1)(2007-10#1)(2007-3#1)(2008-2#1)
the different regions##7##3##(1992-9#1)(1996-11#1)(2003-11#1)(2007-10#1)(2007-3#1)(2008-10#1)(2008-2#1)
the different resistances##2##3##(2008-10#1)(2010-12#1)
the different response##3##3##(1993-5#1)(1997-1#1)(2008-3#1)
the different responses##2##3##(1995-11#1)(2013-1#1)
the different retention##4##3##(1990-8#1)(1991-11#1)(2008-11#2)
the different risk factors##2##4##(1990-6#1)(1997-6#1)
the different roles##2##3##(2007-10#1)(2008-5#1)
the different samples##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
the different sectors of##2##4##(1991-3#1)(2007-12#1)
the different senses##2##3##(2010-12#1)(2012-2#1)
the different set##2##3##(2008-2#2)
the different shapes of##3##4##(2012-11#2)(2013-1#1)
the different spatial##3##3##(2007-11#1)(2007-8#1)(2008-3#1)
the different species and##2##4##(1997-2#1)(2008-10#1)
the different species of the##2##5##(2010-10#1)(2010-12#1)
the different species of##3##4##(1994-6#1)(2010-10#1)(2010-12#1)
the different species##16##3##(1993-11#1)(1994-6#1)(1997-2#1)(2008-10#7)(2008-5#1)(2008-8#1)(2010-10#1)(2010-12#2)(2010-7#1)
the different spin##2##3##(2009-5#1)(2010-8#1)
the different stages of the##4##5##(1990-12#1)(1992-3#1)(2008-11#1)(2010-7#1)
the different stages of##6##4##(1990-12#1)(1992-3#1)(2008-11#1)(2010-7#1)(2011-2#1)(2012-1#1)
the different steps of##3##4##(1991-2#1)(2008-2#1)(2011-2#1)
the different strains##2##3##(2012-2#1)(2012-3#1)
the different strategies##2##3##(2005-6#1)(2007-11#1)
the different stress##2##3##(2007-8#1)(2008-11#1)
the different structural##5##3##(1995-6#1)(2005-11#1)(2005-7#1)(2007-11#1)(2008-10#1)
the different structures##2##3##(1993-12#1)(1995-3#1)
the different studies##2##3##(2006-2#1)(2008-1#1)
the different subcellular fractions##2##4##(1990-5#1)(1996-2#1)
the different substrate specificities##2##4##(1990-4#1)(2004-4#1)
the different substrate##3##3##(1990-4#1)(2004-4#1)(2008-10#1)
the different subtypes of##2##4##(2005-7#1)(2012-12#1)
the different subtypes##3##3##(2005-7#1)(2008-6#1)(2012-12#1)
the different subunits##2##3##(2008-7#1)(2008-9#1)
the different surgical approaches##2##4##(1990-4#1)(2007-8#1)
the different surgical##4##3##(1990-4#1)(2006-2#1)(2007-8#1)(2008-8#1)
the different systems##6##3##(1991-2#1)(1993-2#1)(2006-6#1)(2007-4#1)(2007-7#1)(2007-9#1)
the different techniques available##3##4##(2008-10#2)(2009-12#1)
the different techniques##10##3##(1990-10#1)(1991-12#1)(1992-1#1)(1995-5#1)(2006-10#1)(2008-10#3)(2009-12#1)(2012-1#1)
the different test##2##3##(2007-6#1)(2009-9#1)
the different therapeutic##2##3##(2009-2#1)(2011-1#1)
the different tissue##2##3##(1997-7#1)(2010-9#1)
the different treatment modalities##3##4##(1996-1#1)(1996-12#1)(1996-9#1)
the different treatment options##2##4##(2006-10#1)(2009-6#1)
the different treatment##8##3##(1996-1#1)(1996-12#1)(1996-9#1)(2006-10#1)(2008-7#2)(2009-6#1)(2011-2#1)
the different treatments##2##3##(2008-10#2)
the different types of##36##4##(1990-5#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-8#1)(1996-11#1)(1996-9#1)(2006-10#2)(2006-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-4#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-8#1)(2013-1#4)
the different types##39##3##(1990-5#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-8#1)(1996-11#1)(1996-9#1)(1997-2#1)(2006-10#2)(2006-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-4#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-8#1)(2013-1#4)(2013-8#1)
the different units##3##3##(1992-12#1)(2008-1#1)(2008-12#1)
the different variables##3##3##(2007-8#1)(2008-10#1)(2012-3#1)
the different ways##2##3##(1991-2#1)(2007-7#1)
the different##905##2##(1990-10#2)(1990-11#3)(1990-12#10)(1990-2#1)(1990-3#4)(1990-4#3)(1990-5#6)(1990-6#1)(1990-7#2)(1990-8#4)(1990-9#7)(1991-1#3)(1991-10#1)(1991-11#4)(1991-12#3)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#5)(1991-6#2)(1991-7#5)(1991-8#1)(1991-9#5)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#5)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#7)(1992-9#2)(1993-11#6)(1993-12#2)(1993-2#5)(1993-3#1)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#3)(1993-9#4)(1994-10#1)(1994-11#1)(1994-12#5)(1994-2#4)(1994-3#2)(1994-4#1)(1994-6#7)(1994-8#2)(1994-9#1)(1995-11#5)(1995-12#4)(1995-2#2)(1995-3#5)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#1)(1995-9#3)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#7)(1996-2#7)(1996-3#4)(1996-4#3)(1996-5#3)(1996-6#1)(1996-7#4)(1996-8#2)(1996-9#2)(1997-1#5)(1997-2#9)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#5)(1997-7#7)(1997-8#3)(2003-11#1)(2004-12#1)(2004-3#1)(2004-4#3)(2004-9#1)(2005-10#1)(2005-11#11)(2005-4#2)(2005-6#2)(2005-7#5)(2005-8#1)(2006-10#11)(2006-11#7)(2006-12#6)(2006-2#5)(2006-3#2)(2006-4#1)(2006-5#5)(2006-6#4)(2006-7#1)(2006-8#3)(2006-9#2)(2007-10#9)(2007-11#10)(2007-12#16)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#4)(2007-6#4)(2007-7#12)(2007-8#13)(2007-9#1)(2008-1#15)(2008-10#140)(2008-11#20)(2008-12#3)(2008-2#19)(2008-3#20)(2008-4#7)(2008-5#30)(2008-6#8)(2008-7#29)(2008-8#15)(2008-9#8)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#8)(2010-2#8)(2010-3#2)(2010-4#6)(2010-5#3)(2010-7#4)(2010-8#6)(2010-9#4)(2011-1#14)(2011-12#3)(2011-2#10)(2012-1#9)(2012-11#2)(2012-12#13)(2012-2#11)(2012-3#9)(2012-8#1)(2012-9#1)(2013-1#28)(2013-7#9)(2013-8#12)
the differential absorption##4##3##(2006-4#1)(2008-2#1)(2008-3#2)
the differential binding##2##3##(2006-8#1)(2010-7#1)
the differential cultivars##2##3##(2008-10#2)
the differential detection scheme##2##4##(2008-2#1)(2008-3#1)
the differential determination of##2##4##(2008-10#2)
the differential diagnoses##5##3##(1990-10#1)(1993-8#1)(2006-12#1)(2008-7#1)(2010-7#1)
the differential diagnosis and##6##4##(1993-8#1)(2006-5#1)(2007-10#1)(2008-9#1)(2010-12#1)(2012-1#1)
the differential diagnosis are##3##4##(1992-11#1)(2008-11#1)(2009-5#1)
the differential diagnosis between##3##4##(2006-2#1)(2010-12#1)(2013-1#1)
the differential diagnosis for##5##4##(1993-6#1)(2006-10#1)(2007-10#1)(2010-11#1)(2011-2#1)
the differential diagnosis from##2##4##(2005-12#1)(2006-8#1)
the differential diagnosis of a##8##5##(1992-2#1)(2007-12#1)(2007-8#1)(2008-8#1)(2009-1#1)(2010-12#1)(2012-2#1)(2013-7#1)
the differential diagnosis of acute##2##5##(2007-7#1)(2012-12#1)
the differential diagnosis of chronic##2##5##(2006-6#1)(2008-12#1)
the differential diagnosis of dementia##2##5##(1996-11#1)(2008-7#1)
the differential diagnosis of fever##2##5##(2006-10#1)(2007-5#1)
the differential diagnosis of intestinal##2##5##(2006-2#1)(2013-1#1)
the differential diagnosis of mass##2##5##(2007-8#1)(2008-1#1)
the differential diagnosis of the##3##5##(2006-10#1)(2007-10#1)(2008-12#1)
the differential diagnosis of this##3##5##(2006-10#1)(2010-12#1)(2012-12#1)
the differential diagnosis of##104##4##(1990-11#1)(1990-2#1)(1990-6#2)(1990-9#1)(1991-10#1)(1991-11#2)(1991-2#1)(1991-6#1)(1992-2#2)(1994-2#1)(1994-4#1)(1996-11#2)(1996-12#1)(1996-3#1)(1997-3#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#4)(2008-1#1)(2008-11#1)(2008-12#3)(2008-3#2)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#4)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#2)
the differential diagnosis with##3##4##(1990-8#1)(2004-11#1)(2008-9#1)
the differential diagnosis##154##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#2)(1991-2#2)(1991-3#1)(1991-6#1)(1992-11#1)(1992-2#3)(1993-2#2)(1993-6#1)(1993-8#1)(1994-2#1)(1994-4#1)(1996-11#2)(1996-12#1)(1996-3#1)(1997-3#1)(1997-7#1)(2004-11#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-8#1)(2006-1#1)(2006-10#10)(2006-11#1)(2006-12#1)(2006-2#3)(2006-5#1)(2006-6#1)(2006-8#2)(2007-10#4)(2007-11#2)(2007-12#3)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#4)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-3#5)(2009-5#2)(2010-11#1)(2010-12#5)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#9)(2012-1#1)(2012-12#6)(2012-2#6)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#3)
the differential diagnostic##2##3##(1992-3#1)(2011-2#1)
the differential effect of##5##4##(1992-5#1)(2008-10#2)(2010-1#1)(2013-1#1)
the differential effective group index##2##5##(2008-3#2)
the differential effective##3##3##(2008-3#3)
the differential effects of##5##4##(1996-10#1)(1996-12#1)(1997-2#1)(2006-6#1)(2010-2#1)
the differential equations##2##3##(1996-11#1)(2008-10#1)
the differential expression of the##3##5##(1991-7#1)(1993-12#1)(1997-7#1)
the differential expression of##10##4##(1991-7#1)(1992-10#1)(1992-9#1)(1993-12#1)(1996-10#1)(1997-7#1)(1997-8#1)(2010-6#1)(2011-12#1)(2012-12#1)
the differential expression##11##3##(1991-7#1)(1992-10#1)(1992-9#1)(1993-12#1)(1996-10#1)(1997-7#1)(1997-8#1)(2008-7#1)(2010-6#1)(2011-12#1)(2012-12#1)
the differential group delay##7##4##(2007-11#2)(2007-12#5)
the differential hosts##3##3##(2008-10#3)
the differential hybridization##3##3##(1990-11#1)(1991-9#1)(1992-2#1)
the differential impact of##3##4##(1996-3#1)(2009-8#1)(2011-2#1)
the differential migration of##2##4##(1991-2#1)(2010-7#1)
the differential of##2##3##(1994-6#1)(2012-2#1)
the differential optical##2##3##(2007-12#1)(2008-2#1)
the differential piston##2##3##(2007-11#2)
the differential pressure##3##3##(2008-10#3)
the differential pulse voltammetry (DPV)##3##5##(2008-10#3)
the differential pulse##10##3##(2008-10#10)
the differential regulation of##5##4##(1991-5#2)(1992-3#1)(1992-5#1)(2008-11#1)
the differential retention##2##3##(2007-8#1)(2008-4#1)
the differential role of##2##4##(1993-6#1)(1996-8#1)
the differential scanning##2##3##(1991-2#1)(1995-8#1)
the differential sensitivity##2##3##(1990-7#1)(2010-8#1)
the differential spectra##3##3##(2005-11#1)(2005-4#2)
the differential time##2##3##(1993-6#1)(2012-1#1)
the differential toxicity of##2##4##(1996-6#1)(2011-12#1)
the differential tumor growth rates observed##2##6##(1992-7#2)
the differential white blood cell##2##5##(1995-12#1)(2008-4#1)
the differential##349##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#3)(1991-2#5)(1991-3#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#4)(1992-3#2)(1992-5#3)(1992-7#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-4#1)(1993-5#1)(1993-6#4)(1993-8#2)(1994-12#1)(1994-2#1)(1994-4#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-10#2)(1996-11#4)(1996-12#2)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#2)(1997-8#1)(2004-11#1)(2004-8#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-4#2)(2005-8#2)(2006-1#1)(2006-10#12)(2006-11#1)(2006-12#2)(2006-2#3)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#3)(2007-10#4)(2007-11#9)(2007-12#14)(2007-2#2)(2007-4#1)(2007-5#2)(2007-7#4)(2007-8#7)(2008-1#1)(2008-10#35)(2008-11#4)(2008-12#3)(2008-2#8)(2008-3#15)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#9)(2008-8#5)(2008-9#4)(2009-1#1)(2009-10#3)(2009-3#6)(2009-5#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#4)(2010-8#1)(2011-1#3)(2011-12#3)(2011-2#12)(2012-1#2)(2012-12#9)(2012-2#8)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#4)
the differentially expressed##5##3##(1996-2#1)(2008-8#1)(2011-3#3)
the differentially##7##2##(1996-2#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-3#3)
the differentials##3##2##(2006-10#1)(2008-10#2)
the differentiated cells##5##3##(1992-11#1)(1996-7#3)(2008-9#1)
the differentiated phenotype##3##3##(1991-1#1)(1994-11#1)(1994-6#1)
the differentiated state##5##3##(1994-9#2)(1996-1#1)(1996-3#1)(2008-9#1)
the differentiated status of##2##4##(1996-11#1)(2008-11#1)
the differentiated status##3##3##(1996-11#1)(2008-11#2)
the differentiated##27##2##(1991-1#1)(1992-1#1)(1992-11#1)(1993-2#1)(1994-11#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-7#3)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#4)(2008-9#2)(2011-2#1)(2012-12#1)
the differentiating##5##2##(1990-5#2)(2008-3#1)(2008-4#1)(2013-1#1)
the differentiation among##2##3##(1996-3#1)(2008-5#1)
the differentiation and activation##2##4##(1990-9#1)(1995-6#1)
the differentiation and growth of##3##5##(1991-1#1)(2006-10#1)(2008-7#1)
the differentiation and maturation##3##4##(1991-6#1)(2010-12#2)
the differentiation and survival of##2##5##(1995-12#1)(1996-2#1)
the differentiation and##18##3##(1990-9#1)(1991-1#1)(1991-6#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-2#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-10#2)(2010-12#2)(2012-12#1)
the differentiation between the##3##4##(1994-4#1)(1995-11#1)(2013-7#1)
the differentiation between##12##3##(1991-3#1)(1994-4#1)(1995-11#1)(1996-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-6#1)(2012-1#1)(2012-2#1)(2013-7#1)
the differentiation by##2##3##(1992-1#1)(1992-8#1)
the differentiation capacity of##2##4##(2008-11#1)(2010-6#1)
the differentiation from##2##3##(1990-3#1)(2012-12#1)
the differentiation of ES cells##2##5##(2008-1#1)(2008-8#1)
the differentiation of HL-60 cells##3##5##(1991-6#1)(1992-5#1)(1995-5#1)
the differentiation of HL-60##5##4##(1991-6#2)(1992-5#1)(1995-5#1)(2008-11#1)
the differentiation of cells##2##4##(2008-5#1)(2008-8#1)
the differentiation of embryonic stem##2##5##(2008-9#1)(2009-4#1)
the differentiation of embryonic##3##4##(1997-2#1)(2008-9#1)(2009-4#1)
the differentiation of feeding habits##2##5##(2013-7#2)
the differentiation of human##4##4##(1997-7#1)(2008-11#2)(2013-8#1)
the differentiation of keratinocytes##3##4##(2006-12#1)(2010-3#2)
the differentiation of prestalk cells##2##5##(1993-6#2)
the differentiation of the##17##4##(1991-9#1)(1992-8#1)(1994-12#1)(1995-3#1)(1995-8#1)(1996-4#1)(1997-6#1)(2006-10#1)(2008-1#2)(2008-10#5)(2009-3#1)(2012-2#1)
the differentiation of these cells##2##5##(1993-3#1)(1996-8#1)
the differentiation of these##3##4##(1991-10#1)(1993-3#1)(1996-8#1)
the differentiation of##100##3##(1990-11#2)(1990-4#1)(1991-10#2)(1991-11#2)(1991-6#3)(1991-9#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#5)(1994-12#3)(1994-3#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-10#1)(1996-4#2)(1996-5#1)(1996-8#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2003-11#1)(2006-1#2)(2006-10#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#3)(2008-10#7)(2008-11#6)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-9#2)(2010-12#1)(2010-3#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#2)(2013-8#1)
the differentiation ofHL-60##2##3##(2008-11#2)
the differentiation potential of##2##4##(2008-1#1)(2008-11#1)
the differentiation procedure##2##3##(2008-9#1)(2010-8#1)
the differentiation process of##2##4##(2008-5#1)(2010-6#1)
the differentiation process##13##3##(1992-12#1)(1992-3#1)(1994-2#1)(1997-6#1)(2008-10#1)(2008-3#3)(2008-5#2)(2010-6#1)(2010-8#1)(2012-2#1)
the differentiation programs##2##3##(1995-6#1)(2008-8#1)
the differentiation state of##2##4##(1995-1#1)(2008-1#1)
the differentiation##190##2##(1990-11#2)(1990-3#1)(1990-4#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#2)(1991-3#1)(1991-6#5)(1991-7#1)(1991-9#2)(1992-1#2)(1992-12#1)(1992-3#2)(1992-5#2)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#6)(1994-12#3)(1994-2#1)(1994-3#2)(1994-4#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#1)(1996-8#2)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#1)(2003-11#1)(2006-1#2)(2006-10#2)(2006-12#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#13)(2008-11#13)(2008-3#3)(2008-4#3)(2008-5#8)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#4)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-9#2)(2010-12#5)(2010-3#2)(2010-6#2)(2010-8#2)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#5)(2013-1#1)(2013-7#4)(2013-8#1)
the differing effects of##3##4##(2007-9#1)(2008-2#1)(2012-3#1)
the differing##15##2##(1991-3#1)(1995-2#1)(1996-2#1)(2006-11#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-6#1)(2011-2#2)(2012-3#1)
the difficult airway##7##3##(2005-8#1)(2006-10#4)(2006-4#1)(2010-7#1)
the difficult and##3##3##(1990-12#1)(2008-9#1)(2009-9#1)
the difficult diagnosis##2##3##(1992-5#1)(2008-10#1)
the difficult##24##2##(1990-12#2)(1992-12#1)(1992-5#1)(1995-3#1)(2005-8#2)(2006-10#4)(2006-4#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-9#1)(2010-11#1)(2010-7#1)(2012-3#1)(2013-1#1)
the difficulties and##2##3##(2011-2#1)(2012-3#1)
the difficulties associated with##3##4##(1992-3#1)(2005-11#1)(2005-7#1)
the difficulties caused by##2##4##(1995-6#1)(2008-12#1)
the difficulties encountered by##3##4##(2007-11#1)(2007-7#1)(2008-4#1)
the difficulties encountered in##3##4##(1997-3#1)(2008-11#1)(2012-2#1)
the difficulties encountered##11##3##(1996-12#1)(1997-3#1)(2005-10#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-4#1)(2012-2#1)(2013-1#1)
the difficulties faced by##3##4##(1992-3#1)(1993-3#1)(2011-2#1)
the difficulties for##2##3##(2007-12#1)(2011-2#1)
the difficulties in applying adequate##2##5##(2007-6#1)(2008-1#1)
the difficulties in developing##2##4##(2009-12#1)(2009-8#1)
the difficulties in interpreting meta-analyses are clearly demonstrated by two recently published meta-analyses (Rizos et al##2##16##(2013-1#2)
the difficulties in making##3##4##(2005-11#1)(2008-7#1)(2009-7#1)
the difficulties in the##4##4##(2008-1#1)(2008-2#1)(2008-5#1)(2013-8#1)
the difficulties in##23##3##(1990-10#1)(1993-8#1)(1995-12#1)(2004-10#1)(2005-11#1)(2006-10#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-7#1)(2009-8#1)(2012-11#1)(2012-3#1)(2013-1#3)(2013-8#1)
the difficulties inherent in##3##4##(2006-10#2)(2010-8#1)
the difficulties involved in##2##4##(1996-1#1)(2012-2#1)
the difficulties of applying##2##4##(2009-8#1)(2011-2#1)
the difficulties of##22##3##(1990-6#1)(1990-9#1)(1991-6#1)(1994-7#1)(1996-10#1)(1997-3#1)(1997-6#2)(2006-10#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-2#2)(2008-8#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
the difficulties to##2##3##(1994-3#1)(2011-2#1)
the difficulties##97##2##(1990-10#2)(1990-6#1)(1990-9#1)(1991-6#1)(1992-3#2)(1992-5#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(1997-3#2)(1997-6#2)(2004-10#1)(2005-10#1)(2005-11#2)(2005-7#2)(2006-10#4)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#6)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#7)(2013-8#1)
the difficulty in correctly identifying##2##5##(2009-6#1)(2010-5#1)
the difficulty in determining the optimal##2##6##(2007-8#1)(2012-3#1)
the difficulty in determining##4##4##(1996-6#1)(2007-12#1)(2007-8#1)(2012-3#1)
the difficulty in diagnosis##2##4##(2006-12#1)(2010-3#1)
the difficulty in distinguishing##2##4##(1993-10#1)(2013-1#1)
the difficulty in establishing##2##4##(2005-10#1)(2008-3#1)
the difficulty in the##2##4##(2007-7#1)(2008-8#1)
the difficulty in##55##3##(1990-11#1)(1990-12#1)(1990-3#1)(1991-9#1)(1992-8#1)(1993-10#1)(1993-11#1)(1996-6#2)(2005-10#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-6#1)(2010-3#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#1)
the difficulty of access##2##4##(2010-12#1)(2012-12#1)
the difficulty of establishing##2##4##(1990-3#1)(2005-8#1)
the difficulty of the##5##4##(1997-2#1)(2007-7#1)(2009-6#1)(2011-3#1)(2012-2#1)
the difficulty of##36##3##(1990-3#1)(1991-10#1)(1992-12#1)(1994-11#1)(1994-4#1)(1995-2#1)(1997-2#1)(2005-8#1)(2006-2#1)(2007-12#2)(2007-7#1)(2008-10#4)(2008-11#4)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
the difficulty to##6##3##(1993-6#1)(1997-7#1)(2008-12#1)(2008-5#1)(2011-2#1)(2013-8#1)
the difficulty##108##2##(1990-11#1)(1990-12#1)(1990-3#2)(1991-10#1)(1991-5#1)(1991-9#2)(1992-12#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-4#1)(1995-2#1)(1996-6#2)(1997-2#1)(1997-7#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-3#1)(2009-5#3)(2009-6#2)(2010-12#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#1)
the diffracted field##2##3##(2007-11#1)(2008-3#1)
the diffracted light in##2##4##(2008-2#2)
the diffracted light##7##3##(2007-11#1)(2008-2#4)(2008-3#2)
the diffracted orders##2##3##(2007-12#1)(2008-2#1)
the diffracted##21##2##(2006-4#1)(2007-11#2)(2007-12#4)(2008-2#6)(2008-3#8)
the diffracting structure##2##3##(2008-2#2)
the diffracting##4##2##(2007-12#1)(2008-2#3)
the diffraction angle##3##3##(2007-12#2)(2008-3#1)
the diffraction at##2##3##(2008-2#2)
the diffraction data##3##3##(1991-2#1)(1992-9#1)(2008-4#1)
the diffraction efficiency and the##3##5##(2008-3#3)
the diffraction efficiency and##4##4##(2008-2#1)(2008-3#3)
the diffraction efficiency can be##2##5##(2007-12#1)(2008-3#1)
the diffraction efficiency is##2##4##(2008-2#2)
the diffraction efficiency of a##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
the diffraction efficiency of the##7##5##(2007-11#1)(2008-2#4)(2008-3#2)
the diffraction efficiency of##15##4##(2007-11#3)(2007-12#2)(2008-2#6)(2008-3#4)
the diffraction efficiency##42##3##(2007-11#3)(2007-12#6)(2008-1#1)(2008-2#18)(2008-3#14)
the diffraction limit for##2##4##(2007-12#1)(2008-2#1)
the diffraction limit in##2##4##(2008-3#1)(2009-5#1)
the diffraction limit of##2##4##(2008-3#2)
the diffraction limit##20##3##(2007-11#2)(2007-12#6)(2008-2#2)(2008-3#6)(2009-5#3)(2012-2#1)
the diffraction of a##4##4##(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#1)
the diffraction of light from##2##5##(2008-2#1)(2008-3#1)
the diffraction of light##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
the diffraction of##10##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#4)(2008-3#2)(2009-5#1)
the diffraction orders##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
the diffraction pattern of a##2##5##(2008-2#1)(2008-3#1)
the diffraction pattern##13##3##(2005-11#1)(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#6)
the diffraction patterns of##2##4##(1995-8#1)(2008-3#1)
the diffraction patterns##4##3##(1995-8#1)(2008-2#1)(2008-3#2)
the diffraction spot##3##3##(2007-12#1)(2008-3#2)
the diffraction theory##2##3##(2008-3#2)
the diffraction##136##2##(1991-2#1)(1992-4#1)(1992-9#1)(1995-8#1)(2005-11#1)(2006-4#1)(2007-11#8)(2007-12#25)(2008-1#3)(2008-2#41)(2008-3#47)(2008-4#1)(2009-5#4)(2012-2#1)
the diffraction-limited case##2##3##(2007-11#1)(2008-2#1)
the diffraction-limited spot size##2##4##(2007-11#1)(2008-3#1)
the diffraction-limited spot##3##3##(2007-11#1)(2008-3#2)
the diffraction-limited##7##2##(2007-11#2)(2008-2#1)(2008-3#4)
the diffraction-order##2##2##(2008-3#2)
the diffractional divergence of the scattered wave##2##7##(2008-3#2)
the diffractional##3##2##(2008-2#1)(2008-3#2)
the diffractive EPE##2##3##(2008-3#2)
the diffractive optical elements##2##4##(2007-12#1)(2008-2#1)
the diffractive optical##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
the diffractive##14##2##(2007-11#2)(2007-12#2)(2008-2#4)(2008-3#6)
the diffuse and the total##2##5##(2008-3#2)
the diffuse attenuation coefficient##4##4##(2008-2#1)(2008-3#3)
the diffuse attenuation##5##3##(2008-2#2)(2008-3#3)
the diffuse backscattering Mueller matrix##2##5##(2007-12#1)(2008-3#1)
the diffuse backscattering##3##3##(2007-12#1)(2008-3#2)
the diffuse form##2##3##(1995-11#1)(2013-1#1)
the diffuse layer##2##3##(2005-11#2)
the diffuse reflectance and transflectance spectra##2##6##(2007-8#2)
the diffuse reflectance and##3##4##(2007-8#2)(2008-2#1)
the diffuse reflectance spectrum of##2##5##(2008-10#1)(2008-3#1)
the diffuse reflectance spectrum##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
the diffuse reflectance##8##3##(2007-11#1)(2007-8#3)(2008-10#2)(2008-2#1)(2008-3#1)
the diffuse reflection coefficient of##2##5##(2008-2#2)
the diffuse transmittance##2##3##(2008-2#1)(2008-3#1)
the diffuse##43##2##(1992-8#2)(1995-11#1)(2005-11#3)(2006-5#1)(2007-11#1)(2007-12#2)(2007-8#3)(2008-10#4)(2008-2#8)(2008-3#15)(2012-12#2)(2013-1#1)
the diffusely backscattered intensity patterns that arise from##2##8##(2007-12#1)(2008-3#1)
the diffusely##3##2##(2007-12#1)(2008-3#2)
the diffuser##8##2##(2007-11#1)(2008-2#5)(2008-3#2)
the diffusing##3##2##(2007-12#1)(2008-3#2)
the diffusion and##7##3##(1990-7#1)(1995-12#1)(2007-4#1)(2008-10#1)(2008-5#1)(2010-5#1)(2011-1#1)
the diffusion anisotropy##2##3##(2007-5#2)
the diffusion approximation is##2##4##(2007-12#1)(2008-3#1)
the diffusion approximation of the##3##5##(2008-2#2)(2008-3#1)
the diffusion approximation##18##3##(2007-12#1)(2008-2#9)(2008-3#8)
the diffusion coefficient of the##2##5##(2007-10#1)(2008-3#1)
the diffusion coefficient of##8##4##(2005-11#2)(2007-10#1)(2007-12#2)(2008-10#1)(2008-3#1)(2010-9#1)
the diffusion coefficient##17##3##(1994-2#1)(2005-11#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-9#1)
the diffusion coefficients##7##3##(1990-2#1)(1991-5#1)(2005-12#2)(2007-11#1)(2008-10#1)(2008-7#1)
the diffusion constant##3##3##(1996-5#1)(2008-10#1)(2009-4#1)
the diffusion equation and##2##4##(2008-2#2)
the diffusion equation for##5##4##(2008-2#3)(2008-3#1)(2008-7#1)
the diffusion equation##19##3##(2007-11#2)(2007-12#3)(2008-2#9)(2008-3#4)(2008-7#1)
the diffusion in##2##3##(2006-10#1)(2008-10#1)
the diffusion layer##3##3##(1990-12#1)(2008-10#2)
the diffusion length##2##3##(2010-4#2)
the diffusion limit##3##3##(1991-4#1)(1994-12#1)(2008-3#1)
the diffusion model##3##3##(2006-9#1)(2008-10#1)(2008-3#1)
the diffusion of the complex##2##5##(2008-10#2)
the diffusion of the##4##4##(2008-10#3)(2010-8#1)
the diffusion of two##2##4##(2007-12#1)(2008-5#1)
the diffusion of##32##3##(1990-12#1)(1991-9#1)(1993-11#2)(1993-3#1)(1993-8#1)(1994-12#1)(2006-12#1)(2006-5#1)(2007-12#2)(2008-10#6)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2009-11#1)(2010-10#1)(2010-8#1)(2012-2#3)(2013-1#1)(2013-8#1)
the diffusion potential##3##3##(1994-2#1)(1996-8#1)(2008-10#1)
the diffusion process##4##3##(2008-2#3)(2008-5#1)
the diffusion rate##3##3##(1992-9#1)(2008-11#1)(2008-8#1)
the diffusion time##2##3##(2005-11#2)
the diffusion##162##2##(1990-12#2)(1990-2#1)(1990-7#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-8#1)(1994-12#2)(1994-2#2)(1995-12#1)(1996-5#2)(1996-8#1)(1997-6#2)(2005-11#4)(2005-12#2)(2006-10#2)(2006-12#1)(2006-5#1)(2006-9#1)(2007-10#4)(2007-11#4)(2007-12#13)(2007-4#1)(2007-5#2)(2007-8#2)(2008-10#19)(2008-11#5)(2008-2#24)(2008-3#21)(2008-4#1)(2008-5#5)(2008-7#6)(2008-8#1)(2009-11#1)(2009-4#1)(2010-10#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-11#1)(2012-2#5)(2013-1#1)(2013-8#1)
the diffusion-controlled regime##2##3##(2007-3#2)
the diffusion-controlled##3##2##(2007-3#2)(2008-10#1)
the diffusional##6##2##(1994-8#2)(1996-11#1)(2005-11#2)(2008-3#1)
the diffusive##7##2##(1992-9#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)
the digest##5##2##(1991-3#1)(1994-12#1)(1996-8#1)(1997-2#1)(2008-10#1)
the digested sample##2##3##(2008-10#2)
the digested samples##2##3##(2007-8#1)(2008-10#1)
the digested##7##2##(2007-8#1)(2008-10#6)
the digester##4##2##(2008-6#2)(2008-7#1)(2013-1#1)
the digestibility of##3##3##(1993-4#1)(2007-8#1)(2008-5#1)
the digestibility##4##2##(1993-4#1)(2007-8#1)(2008-5#1)(2013-1#1)
the digestion method##2##3##(2008-10#2)
the digestion of the##2##4##(1996-2#1)(2008-10#1)
the digestion of##13##3##(1990-4#1)(1992-7#1)(1994-12#1)(1996-2#1)(2007-10#1)(2007-6#1)(2008-10#5)(2008-4#1)(2010-8#1)
the digestion procedure##2##3##(2008-10#2)
the digestion##34##2##(1990-4#1)(1990-9#1)(1992-7#2)(1993-8#1)(1994-12#1)(1994-8#1)(1996-2#1)(1997-4#1)(2005-10#1)(2007-10#1)(2007-3#1)(2007-6#1)(2008-10#16)(2008-4#2)(2008-5#1)(2010-8#1)(2013-8#1)
the digestive and cardiovascular##2##4##(2008-3#2)
the digestive apparatus##3##3##(2006-2#3)
the digestive cells##2##3##(2007-12#2)
the digestive enzymes##2##3##(2010-1#1)(2013-1#1)
the digestive system##11##3##(1992-3#1)(2006-8#2)(2007-3#2)(2008-10#1)(2008-5#1)(2009-10#2)(2009-6#1)(2010-5#1)
the digestive tract are##2##4##(2007-12#1)(2011-2#1)
the digestive tract in##2##4##(2006-2#1)(2008-4#1)
the digestive tract of the##2##5##(1994-11#1)(2008-5#1)
the digestive tract of##9##4##(1994-11#1)(2006-8#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-5#2)(2012-2#1)
the digestive tract##43##3##(1990-12#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-5#1)(1991-6#1)(1991-9#1)(1993-10#2)(1993-5#1)(1993-8#1)(1994-11#1)(2006-2#2)(2006-8#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#1)(2009-2#1)(2009-5#1)(2010-12#5)(2011-2#3)(2012-2#1)(2013-1#1)
the digestive##75##2##(1990-12#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-5#1)(1993-10#2)(1993-5#1)(1993-8#1)(1994-11#1)(2006-2#5)(2006-8#3)(2007-11#2)(2007-12#4)(2007-3#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#5)(2008-7#1)(2009-10#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-12#6)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#2)
the digit##2##2##(2007-7#1)(2008-9#1)
the digital image##2##3##(2008-10#1)(2008-3#1)
the digital nerve ends##2##4##(2006-3#2)
the digital signal processor##2##4##(2006-6#1)(2008-3#1)
the digital speckle##2##3##(2008-3#2)
the digital##28##2##(1990-2#1)(2004-9#2)(2006-3#2)(2006-6#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#5)(2008-3#4)(2008-4#1)(2008-7#2)(2008-9#2)(2009-11#1)(2012-2#1)
the digitization##2##2##(2007-12#1)(2008-10#1)
the digitized##4##2##(1995-6#1)(2008-10#1)(2008-3#1)(2008-8#1)
the digits##4##2##(1991-1#1)(1996-2#1)(2008-6#2)
the dignity##2##2##(2011-2#1)(2012-2#1)
the dihedral angle of C4-C1-C2-S3##2##5##(1993-8#2)
the dihedral angle##4##3##(1993-8#3)(1997-7#1)
the dihydrofolate reductase (DHFR) gene##2##5##(1994-9#1)(1996-5#1)
the dihydrofolate reductase (DHFR)##4##4##(1994-9#1)(1996-5#1)(2008-11#1)(2008-2#1)
the dihydrofolate reductase##8##3##(1993-12#1)(1994-9#1)(1995-7#1)(1996-5#1)(2005-8#1)(2008-11#2)(2008-2#1)
the dihydrofolate##9##2##(1991-5#1)(1993-12#1)(1994-9#1)(1995-7#1)(1996-5#1)(2005-8#1)(2008-11#2)(2008-2#1)
the dihydrolipoyl##2##2##(1990-7#1)(1991-1#1)
the dihydropyridine calcium##2##3##(1991-9#1)(1993-4#1)
the dihydropyridine receptor##3##3##(1991-1#2)(1991-7#1)
the dihydropyridine##11##2##(1990-7#1)(1991-1#3)(1991-7#1)(1991-9#1)(1993-4#1)(1995-1#1)(1996-3#1)(1996-5#1)(2012-12#1)
the dihydropyridine-sensitive##2##2##(1991-2#1)(1996-9#1)
the dihydropyridine-type##2##2##(1994-9#1)(1995-1#1)
the diiron##6##2##(1991-12#2)(1991-7#1)(1991-8#1)(1995-10#2)
the dilatation of##3##3##(1991-4#1)(2009-2#1)(2011-1#1)
the dilatation##5##2##(1991-4#1)(1996-9#1)(2008-10#1)(2009-2#1)(2011-1#1)
the dilated ureter##2##3##(2008-10#2)
the dilated##6##2##(1991-3#1)(2005-8#1)(2006-2#1)(2008-10#2)(2010-12#1)
the dilation and##2##3##(2006-11#1)(2010-9#1)
the dilation##3##2##(2006-11#1)(2010-9#1)(2011-2#1)
the dilemma of how##2##4##(2010-2#1)(2013-1#1)
the dilemma of whether##2##4##(1991-8#1)(2007-2#1)
the dilemma of##13##3##(1990-12#1)(1991-8#1)(1992-1#1)(1992-3#1)(1996-2#1)(2007-2#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-2#1)(2012-12#1)(2013-1#2)
the dilemma that##2##3##(2007-12#1)(2007-8#1)
the dilemma##18##2##(1990-12#1)(1991-8#1)(1992-1#1)(1992-3#1)(1994-6#1)(1996-2#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-12#1)(2010-2#1)(2012-12#1)(2013-1#2)
the dilemmas##3##2##(1997-3#1)(2008-3#1)(2008-8#1)
the diluent##6##2##(1992-1#1)(1996-2#1)(2007-10#1)(2008-10#3)
the diluents##2##2##(2008-10#2)
the dilute##8##2##(1990-11#1)(2005-11#3)(2008-10#3)(2008-6#1)
the diluted##5##2##(1994-9#1)(2008-10#3)(2008-11#1)
the dilution of the sample##2##5##(1990-4#1)(2008-10#1)
the dilution of the##5##4##(1990-4#1)(1991-2#1)(2008-10#1)(2008-7#1)(2012-1#1)
the dilution of##6##3##(1990-4#1)(1991-2#1)(1995-3#1)(2008-10#1)(2008-7#1)(2012-1#1)
the dilution rates##2##3##(1994-2#1)(2008-6#1)
the dilution##17##2##(1990-4#1)(1991-2#1)(1994-2#1)(1995-3#1)(1996-7#1)(2005-11#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#1)(2010-7#1)(2012-1#1)(2013-8#1)
the dimension of the##5##4##(2007-8#1)(2008-3#1)(2009-9#1)(2012-1#1)(2013-1#1)
the dimension of##18##3##(1996-2#1)(1996-3#1)(2005-4#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#3)(2009-1#1)(2009-11#2)(2009-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
the dimension##22##2##(1993-5#1)(1996-2#1)(1996-3#1)(2005-4#1)(2007-10#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#3)(2009-1#1)(2009-11#2)(2009-9#1)(2011-2#2)(2012-1#1)(2013-1#1)
the dimensional##6##2##(1992-8#1)(2007-12#2)(2008-4#1)(2012-2#2)
the dimensionality of the TSI##2##5##(2012-3#2)
the dimensionality of the##6##4##(2006-7#1)(2008-11#1)(2008-7#1)(2009-11#1)(2012-3#2)
the dimensionality of##9##3##(1994-9#1)(2006-7#1)(2007-9#1)(2008-11#1)(2008-7#1)(2009-11#1)(2012-2#1)(2012-3#2)
the dimensionality##12##2##(1994-9#1)(2006-7#1)(2007-9#1)(2008-11#1)(2008-7#2)(2009-11#1)(2012-1#2)(2012-2#1)(2012-3#2)
the dimensionless##8##2##(2005-11#3)(2007-10#1)(2008-2#2)(2008-7#1)(2009-6#1)
the dimensions and##3##3##(1991-12#1)(2008-11#1)(2008-4#1)
the dimensions of a##2##4##(1996-2#1)(2008-7#1)
the dimensions of the##10##4##(1991-9#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-2#2)(2010-4#1)(2012-2#1)
the dimensions of##22##3##(1991-9#1)(1993-12#1)(1995-3#1)(1996-2#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#2)(2008-9#1)(2009-12#1)(2009-2#2)(2009-5#1)(2010-4#1)(2011-11#1)(2012-2#1)
the dimensions that##2##3##(2004-10#1)(2008-3#1)
the dimensions##31##2##(1991-12#1)(1991-9#1)(1993-12#1)(1995-3#1)(1996-2#1)(2004-10#1)(2005-8#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-2#2)(2009-5#1)(2010-3#1)(2010-4#1)(2011-11#1)(2012-2#1)
the dimer and##3##3##(1990-9#1)(1996-11#1)(2008-10#1)
the dimer interface##5##3##(1992-12#1)(1995-1#1)(1995-5#1)(1995-8#1)(2008-8#1)
the dimer is##4##3##(1991-4#1)(1992-12#1)(1994-11#1)(2008-10#1)
the dimer of the##2##4##(1990-4#1)(1990-5#1)
the dimer of##4##3##(1990-4#1)(1990-5#1)(2006-12#1)(2010-5#1)
the dimer##47##2##(1990-4#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-4#2)(1991-7#1)(1992-1#1)(1992-12#2)(1993-4#1)(1994-11#2)(1994-3#1)(1994-6#1)(1994-8#2)(1995-1#3)(1995-5#3)(1995-8#1)(1996-11#1)(1996-8#2)(1997-7#1)(2006-12#4)(2008-10#4)(2008-5#1)(2008-7#2)(2008-8#3)(2009-4#1)(2010-5#1)(2011-1#1)(2013-1#1)
the dimeric enzyme##2##3##(1992-3#1)(1995-8#1)
the dimeric protein##3##3##(1994-8#1)(1995-5#1)(2008-8#1)
the dimeric structure##3##3##(1990-5#1)(1990-7#1)(1991-4#1)
the dimeric##24##2##(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-4#1)(1992-3#1)(1994-12#1)(1994-8#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-8#1)(1997-2#1)(2006-12#1)(2008-10#4)(2008-3#1)(2008-8#2)(2008-9#1)(2010-2#2)
the dimerisation##2##2##(1996-8#1)(1997-1#1)
the dimerization constant##2##3##(1992-9#1)(2008-10#1)
the dimerization of##5##3##(1992-12#1)(1995-8#1)(1996-2#1)(1997-6#1)(2008-9#1)
the dimerization##14##2##(1992-12#2)(1992-9#1)(1995-8#1)(1996-2#1)(1996-5#2)(1997-6#1)(2008-10#4)(2008-4#1)(2008-9#1)
the dimers##8##2##(1997-1#1)(2005-11#1)(2005-4#1)(2006-12#1)(2006-4#2)(2009-9#2)
the dimethyl##7##2##(1990-12#1)(1991-4#1)(1994-8#2)(2007-10#1)(2008-10#1)(2010-5#1)
the dimethyldibenzothiophenes##2##2##(1992-1#2)
the diminished##8##2##(1990-10#1)(1990-11#1)(1990-3#1)(1993-8#1)(1995-1#1)(1996-3#1)(2007-9#1)(2010-3#1)
the diminishing##4##2##(1996-1#1)(2008-4#1)(2008-8#1)(2009-2#1)
the diminution of##4##3##(1991-6#1)(2005-11#1)(2007-11#1)(2008-1#1)
the dimmer##2##2##(2008-10#1)(2013-1#1)
the dimorphic fungus##3##3##(1991-9#1)(1995-8#1)(2008-5#1)
the dimorphic##6##2##(1991-9#1)(1995-8#1)(1996-6#1)(1997-2#1)(2008-5#1)(2013-7#1)
the dinuclear iron##5##3##(1995-10#3)(1996-7#1)(1997-4#1)
the dinuclear##11##2##(1991-8#1)(1995-10#3)(1995-11#1)(1996-2#3)(1996-7#1)(1997-4#1)(2007-11#1)
the dinucleotide##8##2##(1991-5#1)(1991-8#1)(1993-3#1)(1994-3#1)(1996-7#1)(1997-6#2)(2008-4#1)
the diode laser##9##3##(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#1)(2013-1#1)
the diode pump##2##3##(2007-12#2)
the diode##21##2##(2007-12#6)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#6)(2012-1#1)(2013-1#1)
the diode-laser##3##2##(2008-2#1)(2008-3#2)
the diol substrate##2##3##(2008-7#2)
the diol to the##2##4##(1991-5#1)(2008-10#1)
the diol##7##2##(1991-5#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#3)
the dioptric##3##2##(1992-7#1)(2007-12#1)(2008-2#1)
the dioxane##2##2##(1997-4#2)
the dioxin responsive element##2##4##(1993-11#1)(2006-12#1)
the dioxin##12##2##(1993-11#1)(2006-12#1)(2008-10#10)
the dioxin-responsive##3##2##(1992-8#1)(2006-12#1)(2008-11#1)
the dioxygen concentration in##2##4##(2008-10#2)
the dioxygen##7##2##(1990-10#1)(1997-4#1)(1997-7#1)(2008-10#3)(2010-5#1)
the dip by##2##3##(2008-1#2)
the dip##4##2##(2007-2#2)(2008-1#2)
the dipeptide##7##2##(1990-8#1)(1990-9#1)(1994-9#1)(2006-7#2)(2008-4#2)
the dipeptides are##2##3##(1990-8#2)
the dipeptides##6##2##(1990-8#2)(2004-12#2)(2006-12#1)(2008-10#1)
the diphosphate##2##2##(1992-11#1)(2008-5#1)
the diplexer##2##2##(2008-2#2)
the diploid##10##2##(1991-8#1)(1993-4#1)(2007-12#1)(2008-11#1)(2008-5#3)(2010-3#1)(2013-1#1)(2013-8#1)
the dipolar coupling##2##3##(1991-3#2)
the dipolar##3##2##(1991-3#2)(1994-5#1)
the dipole antenna##3##3##(2007-12#3)
the dipole emits from##2##4##(2008-2#2)
the dipole moment of the##2##5##(1993-3#1)(2008-10#1)
the dipole moment##4##3##(1993-3#1)(2007-11#2)(2008-10#1)
the dipole moments of##2##4##(1997-6#1)(2007-11#1)
the dipole moments##3##3##(1997-6#1)(2007-11#2)
the dipole sources##2##3##(2004-11#2)
the dipole##27##2##(1990-5#1)(1992-12#2)(1992-6#1)(1993-3#1)(1997-1#1)(1997-6#2)(2004-11#3)(2006-12#1)(2007-11#4)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-9#1)(2010-8#1)
the dipole-dipole##3##2##(1996-2#1)(2008-10#1)(2010-4#1)
the dipoles##2##2##(1997-1#1)(2006-8#1)
the dipping##4##2##(2005-11#2)(2008-10#1)(2008-12#1)
the dipstick##2##2##(1991-3#1)(2006-10#1)
the dire##2##2##(1991-5#1)(2008-4#1)
the direct UV detection of non-absorbing inorganic cations##2##8##(2008-10#2)
the direct UV detection of##3##5##(2008-10#3)
the direct action of##3##4##(1990-7#1)(1991-12#1)(2010-8#1)
the direct action##4##3##(1990-7#1)(1991-12#1)(1991-7#1)(2010-8#1)
the direct activation of##2##4##(2003-11#1)(2009-8#1)
the direct addition of##2##4##(1990-9#1)(2008-2#1)
the direct addition##3##3##(1990-9#1)(2008-11#1)(2008-2#1)
the direct analysis of the##2##5##(2008-10#2)
the direct analysis of trace metals in estuarine waters by square-wave anodic stripping voltammetry##2##14##(2008-10#2)
the direct analysis of##11##4##(1993-1#1)(1997-2#1)(2006-10#1)(2008-10#7)(2008-7#1)
the direct analysis##12##3##(1993-1#1)(1997-2#1)(2006-10#1)(2008-10#8)(2008-7#1)
the direct and indirect effects of##3##6##(1997-1#1)(1997-5#1)(2010-8#1)
the direct and indirect##11##4##(1991-5#1)(1992-1#1)(1997-1#1)(1997-5#1)(2008-10#3)(2008-11#2)(2010-8#1)(2012-2#1)
the direct and##22##3##(1990-8#1)(1990-9#1)(1991-5#1)(1992-1#1)(1992-3#1)(1994-5#1)(1997-1#1)(1997-5#1)(2004-12#1)(2008-10#6)(2008-11#2)(2008-4#2)(2010-8#1)(2012-1#1)(2012-2#1)
the direct anti-tumor effect mediated by##2##6##(2005-10#2)
the direct application of the##3##5##(2012-3#1)(2013-1#2)
the direct assay##2##3##(2008-10#2)
the direct binary search##2##4##(2008-2#1)(2008-3#1)
the direct binding of##2##4##(1994-8#1)(2008-9#1)
the direct causation##2##3##(2008-5#2)
the direct cause of##4##4##(1996-12#1)(2006-10#1)(2006-12#1)(2008-1#1)
the direct contact##2##3##(1992-9#1)(2006-12#1)
the direct conversion of##4##4##(1991-6#3)(2008-10#1)
the direct cost of##2##4##(2006-2#1)(2011-2#1)
the direct coupling##2##3##(2008-2#1)(2008-3#1)
the direct cytotoxic##2##3##(1995-8#1)(2010-12#1)
the direct detection and##2##4##(2008-10#2)
the direct detection of##8##4##(1990-5#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)
the direct detection##10##3##(1990-5#1)(2006-8#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)
the direct determination of antimony##2##5##(2008-10#2)
the direct determination of the##10##5##(1990-9#1)(1992-9#1)(2008-10#7)(2008-2#1)
the direct determination of this compound in##2##7##(2008-10#2)
the direct determination of trace##3##5##(2005-4#1)(2008-10#2)
the direct determination of##63##4##(1990-9#1)(1991-12#1)(1992-1#2)(1992-4#1)(1992-9#1)(1993-1#1)(1996-3#1)(2005-4#1)(2007-8#6)(2008-10#46)(2008-2#1)(2008-3#1)
the direct determination##65##3##(1990-9#1)(1991-12#1)(1992-1#2)(1992-4#1)(1992-9#1)(1993-1#1)(1996-3#1)(2005-4#1)(2007-8#6)(2008-10#48)(2008-2#1)(2008-3#1)
the direct effect of##9##4##(1991-12#1)(2007-4#1)(2008-10#2)(2008-8#1)(2009-9#1)(2011-12#1)(2012-1#1)(2012-2#1)
the direct effects of##8##4##(1990-7#1)(1996-2#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#1)(2011-12#1)
the direct effects##9##3##(1990-7#1)(1996-2#1)(2007-3#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#1)(2011-12#1)
the direct electrochemistry of##2##4##(2008-10#2)
the direct evidence for##2##4##(2007-5#1)(2008-8#1)
the direct examination##2##3##(2007-10#1)(2008-5#1)
the direct generation of##2##4##(2008-10#1)(2008-2#1)
the direct identification of##3##4##(1991-7#1)(2008-10#1)(2011-2#1)
the direct infusion##2##3##(2008-10#1)(2010-9#1)
the direct injection of##3##4##(1990-8#1)(1992-2#1)(2008-10#1)
the direct injection##7##3##(1990-12#2)(1990-8#1)(1992-2#1)(2008-10#2)(2012-12#1)
the direct interaction of##4##4##(1992-3#1)(1994-8#1)(1995-1#1)(1997-7#1)
the direct interaction##5##3##(1992-3#1)(1994-8#1)(1995-1#1)(1997-7#1)(2008-11#1)
the direct involvement of##7##4##(1990-11#1)(1991-5#1)(1991-8#1)(1992-11#1)(2006-6#1)(2013-1#2)
the direct irradiance##2##3##(2008-2#2)
the direct measurement of the##3##5##(2007-11#1)(2007-12#2)
the direct measurement of thiamine and its phosphate esters##2##9##(1995-1#2)
the direct measurement of##11##4##(1990-11#1)(1992-3#1)(1995-1#2)(1997-8#1)(2007-11#1)(2007-12#2)(2008-3#1)(2009-8#1)(2012-3#1)
the direct measurement##12##3##(1990-11#1)(1992-3#1)(1995-1#2)(1997-8#1)(2007-11#1)(2007-12#2)(2008-3#2)(2009-8#1)(2012-3#1)
the direct observation of##4##4##(2006-10#1)(2007-12#1)(2008-2#1)(2011-1#1)
the direct or indirect##3##4##(2008-4#1)(2012-12#1)(2013-8#1)
the direct or##4##3##(1990-8#1)(2008-4#1)(2012-12#1)(2013-8#1)
the direct oxidation of##2##4##(2007-8#1)(2008-10#1)
the direct phosphorylation##2##3##(1993-6#1)(2008-2#1)
the direct plate##2##3##(2007-7#2)
the direct potentiometric method##2##4##(2008-10#2)
the direct quantification of##2##4##(2008-10#1)(2013-1#1)
the direct repeat##3##3##(1990-7#1)(1992-9#1)(2008-7#1)
the direct result of##4##4##(1990-11#1)(1992-11#1)(2004-11#1)(2004-3#1)
the direct solar##2##3##(2008-2#2)
the direct solid##2##3##(2007-8#1)(2008-10#1)
the direct space-to-time pulse shaper##2##5##(2007-12#2)
the direct supervision of##2##4##(2006-11#1)(2007-10#1)
the direct transfer of##2##4##(1994-5#1)(2013-1#1)
the direct##390##2##(1990-11#5)(1990-12#4)(1990-5#2)(1990-7#3)(1990-8#3)(1990-9#3)(1991-11#1)(1991-12#4)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#3)(1991-7#2)(1991-8#1)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-8#1)(1992-9#4)(1993-1#2)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#1)(1994-2#2)(1994-5#4)(1994-8#2)(1995-1#3)(1995-10#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-5#1)(1997-7#3)(1997-8#2)(2003-11#1)(2004-11#1)(2004-12#1)(2004-3#1)(2005-10#2)(2005-12#1)(2005-4#1)(2005-8#1)(2006-10#4)(2006-11#4)(2006-12#3)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#9)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#10)(2007-9#2)(2008-1#2)(2008-10#123)(2008-11#8)(2008-2#18)(2008-3#13)(2008-4#6)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#3)(2009-6#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#3)(2012-1#4)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#5)(2013-1#8)(2013-7#1)(2013-8#1)
the direct-binary-search##3##2##(2008-3#3)
the directed migration##2##3##(1990-12#1)(2005-9#1)
the directed##4##2##(1990-12#1)(2005-9#1)(2006-12#1)(2008-3#1)
the direction and magnitude of the##2##6##(1990-8#1)(2007-8#1)
the direction and magnitude of##3##5##(1990-8#1)(1992-2#1)(2007-8#1)
the direction and##9##3##(1990-8#1)(1992-2#1)(2006-11#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-7#1)(2010-7#1)(2012-3#1)
the direction cosines of##2##4##(2008-2#1)(2008-3#1)
the direction in which the##2##5##(2007-4#1)(2008-3#1)
the direction in which##4##4##(2007-4#1)(2007-8#1)(2008-3#1)(2013-8#1)
the direction of a##4##4##(2007-12#1)(2008-1#1)(2011-2#1)(2012-1#1)
the direction of an##2##4##(2006-10#1)(2008-7#1)
the direction of evolution##2##4##(2008-8#1)(2008-9#1)
the direction of film##2##4##(1993-11#1)(2007-12#1)
the direction of light propagation##2##5##(2007-12#1)(2008-3#1)
the direction of motion##5##4##(1997-6#1)(2007-12#1)(2008-2#1)(2008-3#2)
the direction of propagation##7##4##(2007-12#2)(2008-1#1)(2008-2#3)(2008-3#1)
the direction of rotation##2##4##(2008-2#1)(2009-6#1)
the direction of the incident##2##5##(2008-1#1)(2008-3#1)
the direction of the##49##4##(1992-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-2#1)(1995-11#1)(1996-6#1)(2004-11#1)(2005-11#1)(2006-11#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#3)(2009-2#2)(2009-7#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-2#1)(2013-8#2)
the direction of this##2##4##(1997-2#1)(1997-8#1)
the direction of##132##3##(1990-11#2)(1990-9#2)(1991-3#1)(1991-5#1)(1991-8#1)(1992-11#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-2#1)(1995-11#1)(1996-1#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#11)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#5)(2008-11#2)(2008-2#11)(2008-3#15)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#2)(2009-2#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-4#3)(2010-7#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#3)
the direction selectivity##2##3##(2008-8#2)
the direction##177##2##(1990-11#2)(1990-8#1)(1990-9#2)(1991-3#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-2#1)(1995-11#1)(1996-1#2)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-11#2)(2006-10#2)(2006-11#2)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#3)(2007-12#14)(2007-4#3)(2007-6#2)(2007-7#1)(2007-8#5)(2008-1#3)(2008-10#9)(2008-11#4)(2008-2#14)(2008-3#21)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#3)(2008-8#5)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-4#3)(2010-7#2)(2010-8#2)(2010-9#4)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#5)
the directional form of Kirchhoff's##2##5##(2008-2#2)
the directional##13##2##(1995-3#1)(2008-2#4)(2008-3#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-8#1)(2009-9#1)(2012-2#1)
the directionality of the##4##4##(2006-12#1)(2007-12#1)(2008-11#1)(2012-1#1)
the directionality of##6##3##(2006-12#1)(2007-12#2)(2008-11#1)(2008-8#1)(2012-1#1)
the directionality##7##2##(2006-12#1)(2007-12#2)(2008-11#1)(2008-5#1)(2008-8#1)(2012-1#1)
the directions of##7##3##(1990-12#1)(1995-4#1)(2008-2#3)(2008-9#1)(2013-8#1)
the directions##10##2##(1990-12#1)(1995-4#1)(2006-3#1)(2008-2#3)(2008-9#1)(2009-3#1)(2010-9#1)(2013-8#1)
the directive##5##2##(2006-6#2)(2007-6#1)(2007-8#1)(2007-9#1)
the directly measured##2##3##(2007-12#1)(2008-3#1)
the directly##8##2##(1991-7#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#2)(2009-12#1)
the director of mission services##2##5##(1993-12#1)(1994-1#1)
the director of the##3##4##(1990-11#1)(2007-5#1)(2008-2#1)
the director of##8##3##(1990-11#1)(1993-12#1)(1994-1#1)(2007-5#1)(2007-8#1)(2008-2#1)(2008-3#1)(2013-8#1)
the director##9##2##(1990-11#1)(1993-12#1)(1994-1#1)(2007-5#1)(2007-8#1)(2008-2#1)(2008-3#2)(2013-8#1)
the director's##2##2##(1994-3#2)
the directors of##2##3##(1991-5#1)(1994-1#1)
the directors##3##2##(1991-5#1)(1994-1#1)(2008-4#1)
the disability associated with##2##4##(2008-2#1)(2009-12#1)
the disability register at##3##4##(2006-8#3)
the disability register##4##3##(2006-10#1)(2006-8#3)
the disability##18##2##(1991-1#1)(1995-12#1)(1995-3#1)(1997-1#1)(2006-10#2)(2006-8#4)(2007-11#1)(2007-7#1)(2008-2#1)(2008-9#2)(2009-12#1)(2010-12#1)(2011-2#1)
the disabled##16##2##(1992-12#1)(1992-2#1)(1992-3#1)(1994-2#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-4#1)(1997-2#1)(2005-11#1)(2006-2#1)(2006-8#1)(2008-8#1)(2009-6#2)
the disabling##5##2##(2006-8#1)(2008-11#1)(2008-12#1)(2008-8#1)(2013-1#1)
the disaccharide##6##2##(1990-1#1)(1990-2#1)(1992-12#1)(1992-6#1)(1995-11#1)(2006-5#1)
the disadvantage of being##4##4##(1995-5#1)(2007-11#1)(2008-11#1)(2009-8#1)
the disadvantage of##9##3##(1995-5#1)(2005-1#1)(2006-5#1)(2007-11#2)(2007-12#1)(2008-11#1)(2009-8#1)(2011-2#1)
the disadvantage that##3##3##(1990-2#1)(1992-2#1)(2013-1#1)
the disadvantage##12##2##(1990-2#1)(1992-2#1)(1995-5#1)(2005-1#1)(2006-5#1)(2007-11#2)(2007-12#1)(2008-11#1)(2009-8#1)(2011-2#1)(2013-1#1)
the disadvantaged##2##2##(1992-1#1)(2010-3#1)
the disadvantages of##10##3##(1990-11#1)(1991-11#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-7#1)(2009-6#1)(2010-2#1)(2012-3#1)(2013-1#1)
the disadvantages##16##2##(1990-11#1)(1991-11#1)(1994-3#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-3#1)(2009-6#2)(2010-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
the disagreement between##3##3##(1991-6#1)(1996-5#1)(2008-2#1)
the disagreement##4##2##(1991-6#1)(1996-5#1)(2008-2#1)(2008-8#1)
the disappearance of the##11##4##(1990-3#1)(1990-5#1)(1993-4#1)(1993-8#1)(1995-4#1)(1996-11#1)(1996-3#1)(2008-10#1)(2008-3#1)(2009-2#1)(2009-9#1)
the disappearance of##32##3##(1990-3#1)(1990-5#2)(1991-1#3)(1991-7#3)(1992-6#1)(1993-2#1)(1993-4#1)(1993-8#1)(1994-3#1)(1995-3#1)(1995-4#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-2#1)(2009-9#1)(2011-2#2)
the disappearance##33##2##(1990-3#1)(1990-5#2)(1991-1#3)(1991-7#3)(1992-6#1)(1993-2#1)(1993-4#1)(1993-8#1)(1994-3#1)(1995-3#1)(1995-4#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-2#1)(2009-9#1)(2011-2#2)
the disassembly##2##2##(2009-10#1)(2011-2#1)
the disaster##8##2##(1991-2#1)(1992-12#1)(2008-12#1)(2008-2#2)(2008-8#1)(2013-1#2)
the disc and##3##3##(1996-6#1)(2007-1#1)(2007-8#1)
the disc diffusion##2##3##(2008-12#1)(2008-5#1)
the disc harrow##2##3##(2008-10#2)
the disc is##2##3##(2006-8#1)(2012-2#1)
the disc was##3##3##(2006-7#1)(2006-8#2)
the disc##33##2##(1994-11#1)(1995-12#1)(1996-6#2)(2006-7#4)(2006-8#5)(2007-1#1)(2007-11#1)(2007-5#1)(2007-8#3)(2008-10#2)(2008-12#1)(2008-5#1)(2009-4#4)(2009-5#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-2#1)
the disc-cyclide##2##2##(2007-9#2)
the discharge needs and needs satisfaction of frail elders' family caregivers during the##2##13##(2007-10#2)
the discharge needs##3##3##(2007-10#3)
the discharge of##2##3##(2008-10#1)(2008-6#1)
the discharge patterns of##2##4##(1991-9#1)(1995-7#1)
the discharge##24##2##(1991-9#1)(1993-12#1)(1995-7#1)(1997-7#2)(2006-10#1)(2007-10#7)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-3#2)(2008-6#1)(2008-7#1)(2013-8#2)
the discharged##2##2##(1993-1#1)(2008-7#1)
the discharges##3##2##(1990-5#1)(1992-2#1)(2013-8#1)
the disciplinary##2##2##(1992-10#1)(2013-8#1)
the discipline and##2##3##(2008-12#1)(2008-5#1)
the discipline of##5##3##(1991-3#1)(2008-10#1)(2008-12#1)(2009-5#1)(2012-2#1)
the discipline##15##2##(1991-3#1)(1994-2#1)(2007-4#2)(2008-10#1)(2008-12#5)(2008-5#1)(2009-2#1)(2009-5#1)(2010-7#1)(2012-2#1)
the disciplines of##3##3##(2005-12#1)(2008-10#1)(2008-4#1)
the disciplines##7##2##(1991-2#1)(1992-4#1)(1996-3#1)(2005-12#1)(2008-10#1)(2008-4#1)(2012-2#1)
the disclosure of a##2##4##(2005-8#2)
the disclosure of##6##3##(1992-3#2)(2005-8#2)(2008-2#1)(2012-11#1)
the disclosure##12##2##(1991-7#1)(1992-3#2)(1997-3#1)(1997-8#1)(2004-9#1)(2005-8#2)(2008-2#1)(2012-11#1)(2013-1#2)
the discoidal##2##2##(1993-9#1)(1994-9#1)
the discomfort from##3##3##(2007-2#1)(2007-4#1)(2007-7#1)
the discomfort##11##2##(1995-6#1)(1996-9#1)(2006-6#1)(2007-2#1)(2007-4#1)(2007-7#2)(2008-12#1)(2008-4#1)(2008-6#1)(2010-2#1)
the disconnect between##2##3##(2012-12#1)(2012-3#1)
the discontinued##2##2##(2008-11#2)
the discontinuity##3##2##(1995-11#1)(2009-4#1)(2011-2#1)
the discontinuous##4##2##(1996-12#1)(1996-5#1)(1997-8#1)(2008-3#1)
the discourse in##2##3##(2006-2#2)
the discourse of##4##3##(2008-9#1)(2009-4#1)(2013-1#2)
the discourse##13##2##(2006-2#2)(2006-5#1)(2007-12#1)(2007-3#1)(2008-5#3)(2008-9#1)(2009-4#1)(2010-10#1)(2013-1#2)
the discourses##2##2##(1994-1#1)(2012-3#1)
the discovered##3##2##(2008-1#1)(2008-9#1)(2012-2#1)
the discoveries of##3##3##(2007-6#1)(2010-1#1)(2011-2#1)
the discoveries##4##2##(2007-6#1)(2007-9#1)(2010-1#1)(2011-2#1)
the discovery and characterization of##3##5##(1996-6#1)(1997-1#1)(2008-10#1)
the discovery and development of new drugs##3##7##(2005-8#1)(2005-9#1)(2007-2#1)
the discovery and development of new##4##6##(2005-7#1)(2005-8#1)(2005-9#1)(2007-2#1)
the discovery and development of novel##2##6##(2005-7#1)(2010-8#1)
the discovery and development of##7##5##(2005-7#2)(2005-8#1)(2005-9#2)(2007-2#1)(2010-8#1)
the discovery and development##8##4##(2005-7#2)(2005-8#1)(2005-9#2)(2007-2#1)(2008-1#1)(2010-8#1)
the discovery and##23##3##(1996-3#1)(1996-6#1)(1997-1#1)(1997-4#1)(2005-4#1)(2005-7#2)(2005-8#2)(2005-9#2)(2007-2#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-11#1)(2010-8#1)(2011-3#1)
the discovery of a new##3##5##(1996-11#1)(2006-10#1)(2012-3#1)
the discovery of a second##2##5##(1991-10#1)(1992-6#1)
the discovery of a##22##4##(1990-4#1)(1991-10#1)(1991-8#1)(1992-6#1)(1994-11#1)(1995-7#1)(1996-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2008-4#2)(2008-5#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-2#3)(2012-3#1)(2013-8#1)
the discovery of an##2##4##(1994-11#1)(2008-9#1)
the discovery of genes##2##4##(2008-7#1)(2008-8#1)
the discovery of inhibitors##3##4##(2008-7#1)(2013-1#2)
the discovery of multiple##3##4##(2008-10#1)(2009-5#1)(2012-3#1)
the discovery of new##8##4##(2006-12#1)(2007-7#1)(2008-10#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-9#1)(2011-3#1)
the discovery of novel##9##4##(1995-11#1)(2008-10#1)(2008-6#1)(2008-9#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
the discovery of penicillin##2##4##(2011-2#1)(2013-8#1)
the discovery of potential therapeutic##2##5##(2009-12#1)(2010-12#1)
the discovery of potential##5##4##(2009-12#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-3#1)
the discovery of several##2##4##(2010-3#1)(2012-3#1)
the discovery of the first##2##5##(2007-9#1)(2008-11#1)
the discovery of the##30##4##(1991-8#1)(1992-6#1)(1995-8#1)(1996-2#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#2)(2009-9#1)(2010-10#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-3#1)(2012-12#1)(2013-8#1)
the discovery of this##2##4##(2009-2#1)(2009-9#1)
the discovery of##167##3##(1990-4#1)(1990-9#1)(1991-10#1)(1991-8#2)(1992-6#2)(1994-11#3)(1994-12#1)(1994-2#1)(1995-11#2)(1995-7#1)(1995-8#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-12#1)(2005-7#1)(2005-8#2)(2006-10#3)(2006-12#2)(2007-1#1)(2007-11#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#12)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#6)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#6)(2009-10#1)(2009-12#2)(2009-2#2)(2009-4#1)(2009-5#3)(2009-6#4)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#1)(2010-7#3)(2011-1#6)(2011-2#4)(2011-3#3)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#7)(2013-1#5)(2013-7#1)(2013-8#6)
the discovery phase##2##3##(2008-9#1)(2010-5#1)
the discovery process##2##3##(1995-12#1)(2005-8#1)
the discovery that the##2##4##(1997-2#1)(2008-8#1)
the discovery that##10##3##(1994-5#1)(1997-2#1)(1997-3#1)(2006-6#1)(2008-5#1)(2008-8#1)(2010-3#1)(2012-12#1)(2013-1#2)
the discovery##208##2##(1990-4#1)(1990-9#1)(1991-10#1)(1991-8#2)(1992-6#2)(1994-11#3)(1994-12#1)(1994-2#1)(1994-5#1)(1995-11#2)(1995-12#1)(1995-7#1)(1995-8#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#1)(2004-12#1)(2005-4#1)(2005-7#3)(2005-8#5)(2005-9#2)(2006-10#3)(2006-12#2)(2006-6#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#13)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#7)(2008-5#3)(2008-6#4)(2008-7#7)(2008-8#3)(2008-9#8)(2009-10#1)(2009-12#2)(2009-2#2)(2009-4#1)(2009-5#3)(2009-6#4)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#5)(2010-4#1)(2010-5#2)(2010-7#3)(2010-8#1)(2011-1#6)(2011-2#5)(2011-3#4)(2012-1#1)(2012-12#6)(2012-2#3)(2012-3#7)(2013-1#7)(2013-7#1)(2013-8#6)
the discrepancies between##2##3##(2008-9#1)(2011-2#1)
the discrepancies in##2##3##(2008-4#1)(2012-1#1)
the discrepancies##8##2##(1992-2#1)(1994-6#1)(1994-9#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-1#1)
the discrepancy between the##5##4##(1990-8#1)(1991-1#1)(2008-11#1)(2008-2#1)(2008-3#1)
the discrepancy between##14##3##(1990-5#1)(1990-8#1)(1991-1#1)(1991-9#1)(1993-11#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
the discrepancy in##5##3##(1993-9#1)(2008-1#1)(2008-3#1)(2008-6#1)(2013-7#1)
the discrepancy##27##2##(1990-5#1)(1990-8#1)(1991-1#1)(1991-9#2)(1993-11#1)(1993-9#2)(1997-4#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-2#3)(2008-3#3)(2008-6#1)(2008-8#1)(2010-9#1)(2012-2#1)(2013-7#1)
the discrepant results##3##3##(1996-8#2)(1997-6#1)
the discrepant##5##2##(1992-7#1)(1996-8#2)(1997-6#1)(2013-8#1)
the discrete Fourier transform##4##4##(2007-12#1)(2008-2#2)(2008-6#1)
the discrete dipole approximation##2##4##(2008-3#2)
the discrete ordinates method##2##4##(2008-2#1)(2008-3#1)
the discrete##25##2##(1993-6#1)(1995-3#1)(1996-4#1)(2005-11#1)(2006-10#1)(2006-5#1)(2007-12#2)(2008-2#9)(2008-3#5)(2008-6#1)(2008-8#1)(2011-2#1)
the discrete-dipole##2##2##(2008-1#1)(2008-3#1)
the discrete-time##4##2##(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)
the discretion of##3##3##(1996-9#1)(2008-9#1)(2011-2#1)
the discretion##4##2##(1996-9#1)(1997-6#1)(2008-9#1)(2011-2#1)
the discretization##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
the discriminant##6##2##(1990-10#1)(1994-5#1)(2007-9#1)(2008-10#2)(2011-1#1)
the discriminating##2##2##(1996-7#1)(2008-10#1)
the discrimination ability##2##3##(2005-1#1)(2008-2#1)
the discrimination between different##3##4##(2008-10#2)(2011-1#1)
the discrimination between the##3##4##(1994-4#1)(2006-11#1)(2007-11#1)
the discrimination between##13##3##(1990-2#1)(1991-5#1)(1993-1#1)(1994-4#1)(1994-6#1)(1994-9#1)(2006-11#1)(2007-11#1)(2008-10#4)(2011-1#1)
the discrimination of the##2##4##(2008-10#1)(2009-5#1)
the discrimination of##13##3##(2007-1#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-5#1)(2010-4#1)(2010-8#1)(2012-2#1)
the discrimination power of##3##4##(1995-11#1)(2008-12#1)(2011-2#1)
the discrimination power##6##3##(1995-11#1)(2008-12#1)(2008-2#1)(2011-2#1)(2012-2#1)(2012-3#1)
the discrimination task##5##3##(1992-11#1)(1992-7#1)(1993-9#2)(2008-1#1)
the discrimination##51##2##(1990-2#1)(1991-5#1)(1992-11#1)(1992-7#1)(1993-1#1)(1993-2#2)(1993-9#2)(1994-4#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-1#1)(2005-1#1)(2006-11#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)
the discriminations##3##2##(1993-12#2)(1997-8#1)
the discriminative accuracy##3##3##(1992-11#3)
the discriminative stimulus effects of##3##5##(1996-10#1)(1997-5#1)(1997-7#1)
the discriminative##7##2##(1992-11#3)(1996-10#1)(1997-5#1)(1997-7#1)(2010-8#1)
the discriminatory power of##3##4##(2005-8#1)(2008-11#1)(2011-1#1)
the discriminatory power##4##3##(1996-5#1)(2005-8#1)(2008-11#1)(2011-1#1)
the discriminatory##5##2##(1996-5#1)(2005-8#1)(2007-8#1)(2008-11#1)(2011-1#1)
the discursive##3##2##(2008-7#1)(2013-7#2)
the discussed##3##2##(1992-6#1)(1995-2#1)(2007-11#1)
the discussion and##2##3##(2008-12#1)(2011-2#1)
the discussion is##2##3##(1994-4#1)(2008-10#1)
the discussion of arthropod##2##4##(2007-12#2)
the discussion of the##8##4##(1994-3#1)(1996-3#1)(2008-10#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
the discussion of their##2##4##(2008-10#1)(2010-6#1)
the discussion of##23##3##(1991-6#1)(1992-2#1)(1993-3#1)(1994-3#2)(1995-8#1)(1996-3#1)(1997-7#1)(2005-8#1)(2006-10#2)(2007-12#2)(2008-10#2)(2009-8#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#2)
the discussion on how##2##4##(2006-10#1)(2008-10#1)
the discussion on the##2##4##(2008-11#1)(2009-4#1)
the discussion on##4##3##(2006-10#1)(2008-10#1)(2008-11#1)(2009-4#1)
the discussion will##2##3##(2008-10#1)(2008-11#1)
the discussion##54##2##(1990-12#1)(1990-8#1)(1991-6#1)(1992-2#1)(1993-3#1)(1993-9#2)(1994-3#2)(1994-4#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-3#1)(1997-7#1)(1997-8#1)(2005-8#1)(2006-10#5)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#2)
the discussions in##2##3##(1993-9#1)(2012-12#1)
the discussions##10##2##(1993-9#1)(1994-12#1)(1995-5#1)(1996-4#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
the disease (p##2##3##(2006-6#1)(2008-6#1)
the disease -##2##3##(2007-11#1)(2010-12#1)
the disease activity##2##3##(1997-8#1)(2012-2#1)
the disease after##5##3##(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-8#1)
the disease among##3##3##(1993-2#1)(1996-8#1)(2011-2#1)
the disease and in##2##4##(2008-10#1)(2013-8#1)
the disease and its treatment##4##5##(1991-2#1)(1996-3#1)(2006-3#1)(2009-1#1)
the disease and its##9##4##(1991-2#1)(1995-4#1)(1996-3#1)(2006-3#1)(2008-1#1)(2008-2#1)(2008-5#1)(2009-1#1)(2012-12#1)
the disease and reduce##2##4##(2006-8#1)(2011-12#1)
the disease and the##24##4##(1991-6#1)(1992-3#1)(2004-3#1)(2005-8#1)(2006-4#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-8#1)(2010-12#1)(2010-5#1)(2010-9#1)(2012-12#2)(2012-2#1)(2013-7#1)
the disease and to##2##4##(2008-10#1)(2009-9#1)
the disease and##98##3##(1990-3#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-3#1)(1993-1#1)(1993-8#1)(1994-6#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-3#1)(1996-5#1)(1997-8#1)(2004-3#1)(2004-9#1)(2005-11#2)(2005-8#2)(2006-1#1)(2006-10#1)(2006-11#1)(2006-2#2)(2006-3#1)(2006-4#2)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#6)(2007-12#3)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#3)(2009-1#2)(2009-10#1)(2009-2#1)(2009-8#1)(2009-9#2)(2010-12#2)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#4)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#1)
the disease and/or##3##3##(1991-9#1)(2012-2#1)(2012-3#1)
the disease appears to be##3##5##(2007-11#1)(2008-10#1)(2008-5#1)
the disease are recognized##2##4##(2008-11#1)(2011-1#1)
the disease are##22##3##(1990-9#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1993-6#1)(1994-11#1)(2005-7#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-11#1)(2011-1#1)(2012-3#1)(2013-1#1)
the disease as##10##3##(1992-11#1)(1993-11#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-8#1)
the disease at an early stage##3##6##(1991-9#1)(2006-10#1)(2012-3#1)
the disease at an##4##4##(1991-9#1)(2006-10#2)(2012-3#1)
the disease at##12##3##(1991-9#1)(1995-8#1)(2006-10#2)(2007-2#1)(2007-3#2)(2008-10#1)(2008-6#1)(2010-9#1)(2011-1#1)(2012-3#1)
the disease becomes##2##3##(2005-11#1)(2012-3#1)
the disease being##3##3##(2007-11#1)(2007-3#1)(2007-8#1)
the disease burden##5##3##(2006-2#1)(2007-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
the disease but##5##3##(1993-1#1)(2006-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
the disease by the##2##4##(1993-11#1)(1994-9#1)
the disease by##8##3##(1991-12#1)(1993-11#1)(1994-9#1)(2006-1#1)(2008-3#1)(2008-4#3)
the disease can be##8##4##(2005-7#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-9#1)(2010-6#1)(2011-2#1)(2013-8#1)
the disease can##14##3##(2004-11#1)(2005-7#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-9#1)(2010-12#1)(2010-6#1)(2011-2#2)(2013-8#1)
the disease caused by##2##4##(2008-10#1)(2009-5#1)
the disease caused##3##3##(2008-10#1)(2009-5#1)(2011-2#1)
the disease control##2##3##(2008-10#2)
the disease could##2##3##(2007-6#1)(2012-2#1)
the disease course and##2##4##(2006-2#1)(2009-9#1)
the disease course by##2##4##(2007-11#1)(2008-12#1)
the disease course##6##3##(2006-10#1)(2006-2#1)(2007-11#1)(2008-12#1)(2009-9#1)(2013-1#1)
the disease cycle of##2##4##(2008-10#2)
the disease cycle##5##3##(2008-10#5)
the disease development##4##3##(2008-10#3)(2012-12#1)
the disease develops##2##3##(2007-9#1)(2009-10#1)
the disease during the##2##4##(2006-6#1)(2011-2#1)
the disease during##3##3##(1992-9#1)(2006-6#1)(2011-2#1)
the disease for##5##3##(2006-6#1)(2007-7#1)(2007-8#1)(2010-11#1)(2013-7#1)
the disease from##7##3##(2006-12#1)(2006-2#1)(2008-10#2)(2008-8#1)(2009-7#1)(2010-4#1)
the disease gene##6##3##(1992-3#1)(1993-1#1)(1995-5#1)(1997-8#1)(2008-4#1)(2008-7#1)
the disease had been##2##4##(1994-9#1)(2007-7#1)
the disease had##3##3##(1994-9#1)(2007-7#1)(2008-3#1)
the disease has been##9##4##(1995-6#1)(1997-8#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
the disease has##25##3##(1991-9#1)(1993-7#1)(1995-6#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-4#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
the disease have##6##3##(1995-1#1)(2007-7#1)(2007-8#2)(2008-1#1)(2010-7#1)
the disease in Iceland##3##4##(2006-10#2)(2006-8#1)
the disease in a##5##4##(2006-10#1)(2007-7#1)(2008-10#1)(2010-2#1)(2013-8#1)
the disease in its##2##4##(2005-11#1)(2007-11#1)
the disease in the field##2##5##(2008-10#2)
the disease in the##17##4##(1990-9#1)(1992-9#2)(1994-2#1)(1994-9#1)(1996-7#1)(2007-11#2)(2007-2#2)(2008-10#3)(2008-8#1)(2009-12#1)(2009-3#1)(2010-10#1)
the disease in these##3##4##(1995-2#1)(2008-5#1)(2010-7#1)
the disease in three##2##4##(1996-5#1)(2008-7#1)
the disease in##72##3##(1990-11#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-8#1)(1992-6#1)(1992-9#3)(1993-11#3)(1993-2#1)(1993-5#1)(1994-2#1)(1994-9#2)(1995-2#1)(1995-4#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-6#1)(2005-11#1)(2006-10#4)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#3)(2007-6#1)(2007-7#2)(2008-10#13)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-8#1)
the disease incidence was##2##4##(1997-6#1)(2008-10#1)
the disease incidence##7##3##(1990-3#1)(1997-6#1)(2006-4#1)(2008-10#3)(2008-8#1)
the disease intensity##2##3##(2008-10#2)
the disease is an##3##4##(2007-11#1)(2008-10#1)(2011-2#1)
the disease is diagnosed##2##4##(2006-10#1)(2012-1#1)
the disease is not##3##4##(1997-8#1)(2007-7#1)(2008-10#1)
the disease is of##2##4##(2008-10#2)
the disease is spread##2##4##(1993-6#1)(2008-10#1)
the disease is still##3##4##(2008-7#1)(2012-2#2)
the disease is usually##2##4##(2008-1#1)(2011-2#1)
the disease is##84##3##(1991-11#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-10#1)(1992-5#1)(1992-8#1)(1993-6#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-6#1)(1997-5#1)(1997-8#1)(2004-11#1)(2005-1#1)(2005-11#1)(2005-8#2)(2006-10#1)(2006-2#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#4)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#9)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#4)(2008-9#1)(2009-2#1)(2010-3#1)(2010-5#1)(2010-6#3)(2010-8#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#2)
the disease itself##4##3##(1990-6#1)(2005-11#1)(2008-10#1)(2011-1#1)
the disease level##2##3##(2008-10#2)
the disease management##3##3##(2008-10#1)(2012-12#1)(2013-8#1)
the disease may be##4##4##(2005-11#2)(2009-10#1)(2011-2#1)
the disease may##10##3##(1992-12#1)(2005-11#2)(2006-10#1)(2008-1#1)(2008-7#1)(2009-10#1)(2009-2#1)(2011-2#1)(2012-12#1)
the disease of##6##3##(1997-8#1)(2006-9#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-8#1)
the disease on##7##3##(1990-3#1)(2004-9#1)(2008-10#2)(2008-8#1)(2012-1#1)(2012-3#1)
the disease onset##2##3##(2008-10#1)(2012-1#1)
the disease or##6##3##(1994-12#1)(2005-1#1)(2010-2#1)(2010-5#1)(2010-6#1)(2012-2#1)
the disease pathology##3##3##(1993-11#1)(1995-5#1)(2008-9#1)
the disease phenotype##4##3##(2007-7#1)(2008-10#2)(2012-2#1)
the disease process and##8##4##(1997-4#1)(2007-11#1)(2008-3#1)(2010-5#1)(2010-8#1)(2013-1#1)(2013-8#2)
the disease process##31##3##(1991-9#1)(1995-5#1)(1996-4#1)(1996-8#1)(1997-4#1)(1997-8#1)(2006-10#4)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
the disease processes##4##3##(2008-4#1)(2008-5#1)(2010-12#1)(2010-9#1)
the disease progress curve was##2##5##(2008-10#2)
the disease progress curve##24##4##(2008-10#24)
the disease progress##27##3##(2008-10#27)
the disease progressed in##3##4##(2007-11#1)(2008-10#1)(2008-4#1)
the disease progressed##5##3##(2006-12#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-4#1)
the disease progresses##7##3##(2005-10#1)(2007-10#1)(2008-2#1)(2008-8#2)(2012-2#1)(2013-1#1)
the disease progression##7##3##(2007-11#1)(2008-10#1)(2008-11#1)(2010-5#1)(2011-1#1)(2013-8#2)
the disease ratings of the##2##5##(2008-10#2)
the disease resistance##2##3##(2008-10#1)(2008-9#1)
the disease results from mutations in##2##6##(2006-8#2)
the disease risk##2##3##(2008-10#1)(2012-3#1)
the disease severity##9##3##(1994-11#1)(2008-10#6)(2008-9#1)(2013-1#1)
the disease should be considered##2##5##(2008-10#1)(2012-11#1)
the disease should be##3##4##(2008-10#2)(2012-11#1)
the disease should##4##3##(2008-10#2)(2012-11#1)(2013-1#1)
the disease spread##4##3##(2008-10#1)(2008-3#1)(2010-1#1)(2011-2#1)
the disease state##2##3##(1995-12#1)(2006-6#1)
the disease states##2##3##(2008-3#2)
the disease status of patients##2##5##(1992-3#2)
the disease status of##6##4##(1992-3#2)(2008-10#2)(2008-9#1)(2012-3#1)
the disease status##7##3##(1992-3#2)(2008-10#2)(2008-9#1)(2012-3#2)
the disease than##4##3##(2007-7#1)(2008-10#1)(2009-5#1)(2012-3#1)
the disease that##2##3##(2006-10#1)(2008-4#1)
the disease through##9##3##(1993-8#1)(2005-7#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2012-12#1)
the disease to##9##3##(1990-9#1)(1993-7#1)(2005-10#1)(2008-10#1)(2008-2#1)(2009-3#2)(2010-1#1)(2011-2#1)
the disease under##5##3##(1994-12#1)(2008-10#3)(2008-4#1)
the disease using##2##3##(1994-6#1)(2010-8#1)
the disease was established##2##4##(1994-6#1)(1997-8#1)
the disease was not##2##4##(2007-8#1)(2010-12#1)
the disease was observed##3##4##(2007-8#1)(2008-10#2)
the disease was##46##3##(1990-9#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-8#1)(1993-1#1)(1993-9#1)(1994-6#2)(1994-9#1)(1996-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-6#2)(2007-7#1)(2007-8#3)(2008-10#9)(2008-2#1)(2010-12#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
the disease were##9##3##(1990-10#1)(1991-4#1)(1991-5#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)
the disease will##4##3##(2006-2#1)(2007-11#1)(2008-7#1)(2013-8#1)
the disease with##12##3##(1990-2#1)(1990-6#1)(1996-1#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)
the disease##1448##2##(1990-10#3)(1990-11#4)(1990-2#3)(1990-3#4)(1990-4#2)(1990-5#4)(1990-6#9)(1990-8#3)(1990-9#7)(1991-10#1)(1991-11#3)(1991-12#10)(1991-2#6)(1991-3#1)(1991-4#6)(1991-5#5)(1991-6#6)(1991-7#1)(1991-8#6)(1991-9#12)(1992-10#5)(1992-11#5)(1992-12#1)(1992-2#1)(1992-3#5)(1992-4#2)(1992-5#1)(1992-6#6)(1992-8#5)(1992-9#4)(1993-1#6)(1993-10#1)(1993-11#14)(1993-12#2)(1993-2#4)(1993-3#3)(1993-5#2)(1993-6#4)(1993-7#3)(1993-8#6)(1993-9#6)(1994-10#1)(1994-11#4)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#11)(1994-7#1)(1994-8#2)(1994-9#12)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-4#4)(1995-5#4)(1995-6#4)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#5)(1996-10#1)(1996-11#2)(1996-12#5)(1996-2#3)(1996-3#4)(1996-4#1)(1996-5#3)(1996-6#5)(1996-7#1)(1996-8#2)(1996-9#2)(1997-2#3)(1997-3#7)(1997-4#1)(1997-5#2)(1997-6#7)(1997-7#1)(1997-8#13)(2004-11#3)(2004-3#1)(2004-9#2)(2005-1#3)(2005-10#4)(2005-11#16)(2005-12#2)(2005-3#1)(2005-5#1)(2005-7#6)(2005-8#12)(2006-1#5)(2006-10#47)(2006-11#5)(2006-12#8)(2006-2#15)(2006-3#1)(2006-4#8)(2006-6#17)(2006-7#1)(2006-8#12)(2006-9#3)(2007-1#1)(2007-10#6)(2007-11#53)(2007-12#17)(2007-2#14)(2007-3#9)(2007-4#2)(2007-5#8)(2007-6#9)(2007-7#38)(2007-8#31)(2007-9#6)(2008-1#24)(2008-10#196)(2008-11#15)(2008-12#8)(2008-2#7)(2008-3#13)(2008-4#29)(2008-5#23)(2008-6#17)(2008-7#37)(2008-8#22)(2008-9#18)(2009-1#3)(2009-10#12)(2009-11#2)(2009-12#2)(2009-2#6)(2009-3#7)(2009-4#1)(2009-5#6)(2009-6#2)(2009-7#4)(2009-8#4)(2009-9#3)(2010-1#4)(2010-10#4)(2010-11#3)(2010-12#25)(2010-2#4)(2010-3#5)(2010-4#2)(2010-5#8)(2010-6#8)(2010-7#2)(2010-8#7)(2010-9#5)(2011-1#17)(2011-12#5)(2011-2#53)(2011-3#1)(2012-1#11)(2012-11#2)(2012-12#22)(2012-2#23)(2012-3#22)(2013-1#36)(2013-7#7)(2013-8#28)
the disease's##4##2##(1992-2#1)(2006-9#1)(2007-10#1)(2009-1#1)
the disease)##3##2##(2005-1#1)(2006-10#1)(2011-2#1)
the disease-associated##2##2##(1997-7#1)(2008-10#1)
the disease-free survival rate##4##4##(1995-10#1)(1997-7#2)(2011-2#1)
the disease-free##5##2##(1995-10#1)(1997-7#2)(2008-5#1)(2011-2#1)
the disease-modifying##2##2##(2006-10#1)(2007-11#1)
the disease-related##2##2##(1994-8#1)(1996-11#1)
the disease-specific##3##2##(1993-7#1)(1995-3#1)(2008-7#1)
the disease?##2##2##(1994-1#1)(2007-8#1)
the diseased seedlings##2##3##(2008-10#2)
the diseased##17##2##(1992-3#2)(1992-6#1)(1994-11#1)(1996-12#1)(2006-5#1)(2007-11#1)(2008-10#5)(2008-4#1)(2011-2#1)(2012-2#2)(2012-3#1)
the diseases caused by these##2##5##(2008-10#1)(2008-9#1)
the diseases caused by##3##4##(2008-10#1)(2008-9#1)(2010-8#1)
the diseases of the##4##4##(1992-10#1)(1997-1#1)(2006-2#1)(2013-7#1)
the diseases of##6##3##(1992-10#1)(1997-1#1)(2006-2#1)(2008-1#1)(2010-3#1)(2013-7#1)
the diseases that##3##3##(1991-8#1)(1997-2#1)(2008-10#1)
the diseases themselves##2##3##(2008-10#1)(2011-1#1)
the diseases they##2##3##(2008-10#1)(2010-11#1)
the diseases##41##2##(1991-6#1)(1991-8#1)(1992-10#2)(1993-11#1)(1996-3#1)(1997-1#1)(1997-2#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-2#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2012-1#2)(2013-7#1)
the diseases?##2##2##(2008-7#2)
the disector##4##2##(1995-8#1)(1996-10#1)(2008-4#2)
the disgust induction##2##3##(2012-2#2)
the dish##9##2##(2008-11#5)(2011-2#4)
the dishes##4##2##(1995-8#1)(1997-4#1)(2004-11#1)(2008-11#1)
the dishing##2##2##(2008-3#2)
the disinfection rates##2##3##(2013-1#2)
the disinfection##5##2##(2008-3#1)(2013-1#2)(2013-8#2)
the disintegration of social##2##4##(2008-11#1)(2011-2#1)
the disintegration of##5##3##(2008-10#1)(2008-11#1)(2010-4#1)(2011-2#2)
the disjoining pressure##2##3##(2005-11#2)
the disk diffusion method##4##4##(2008-5#1)(2011-2#1)(2013-8#2)
the disk is##3##3##(2008-2#1)(2008-3#2)
the disk shedding##2##3##(1996-9#2)
the disk surface##2##3##(2008-2#1)(2008-3#1)
the disk to##3##3##(2008-10#2)(2008-2#1)
the disk##38##2##(1995-11#1)(1996-9#2)(2007-8#2)(2008-10#8)(2008-11#1)(2008-2#7)(2008-3#10)(2008-5#2)(2009-3#1)(2009-5#1)(2011-2#1)(2013-8#2)
the disk's##2##2##(2008-2#2)
the disks with##2##3##(2008-10#1)(2010-1#1)
the disks##5##2##(2008-10#2)(2008-2#1)(2008-3#1)(2010-1#1)
the dislocated femoral##2##3##(2009-4#2)
the dislocated##7##2##(2008-4#2)(2009-4#2)(2011-2#3)
the dislocation density##2##3##(2008-2#2)
the dislocation of the##2##4##(2007-7#1)(2008-10#1)
the dislocation##8##2##(2007-7#1)(2008-10#1)(2008-2#3)(2009-3#1)(2009-4#1)(2011-1#1)
the dismantling of##2##3##(1993-9#1)(2004-4#1)
the dismantling##3##2##(1993-9#1)(2004-4#1)(2007-12#1)
the dismutation of superoxide##3##4##(1996-1#1)(1996-10#1)(1997-8#1)
the dismutation##6##2##(1996-1#1)(1996-10#1)(1996-9#1)(1997-2#2)(1997-8#1)
the disorder and##7##3##(2007-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-11#1)
the disorder are##3##3##(2012-12#1)(2012-3#1)(2013-7#1)
the disorder can##2##3##(1994-11#1)(2007-12#1)
the disorder has##2##3##(2008-11#2)
the disorder in##3##3##(1997-8#1)(2008-1#1)(2013-1#1)
the disorder is##4##3##(2006-8#1)(2007-11#1)(2008-4#1)(2013-8#1)
the disorder was##2##3##(2007-2#1)(2012-2#1)
the disorder##102##2##(1990-10#1)(1991-12#1)(1991-3#1)(1993-11#1)(1993-9#1)(1994-11#4)(1995-5#1)(1996-12#3)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-5#2)(1997-7#1)(1997-8#1)(2004-3#1)(2005-8#1)(2006-10#7)(2006-2#1)(2006-3#1)(2006-8#1)(2006-9#4)(2007-1#1)(2007-11#4)(2007-12#1)(2007-2#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#3)(2008-6#2)(2008-7#6)(2008-9#1)(2009-4#1)(2010-1#1)(2010-11#3)(2010-3#1)(2011-1#3)(2011-12#2)(2011-2#4)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#5)
the disordered##4##2##(1990-2#1)(1995-11#1)(2006-10#1)(2006-3#1)
the disordering##2##2##(1991-2#1)(2008-10#1)
the disorders in##2##3##(2006-3#1)(2012-1#1)
the disorders of##4##3##(1991-12#1)(1996-9#1)(2011-12#1)(2012-3#1)
the disorders that##3##3##(2006-4#1)(2008-3#1)(2009-5#1)
the disorders##18##2##(1991-12#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-5#1)(2006-3#1)(2006-4#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-12#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
the disparities in##3##3##(2008-1#1)(2008-10#1)(2012-12#1)
the disparities##4##2##(2008-1#1)(2008-10#2)(2012-12#1)
the disparity between the##3##4##(2007-9#1)(2008-3#1)(2010-7#1)
the disparity between##4##3##(1991-11#1)(2007-9#1)(2008-3#1)(2010-7#1)
the disparity in##5##3##(1997-1#1)(2007-7#1)(2008-2#1)(2010-11#1)(2010-9#1)
the disparity##12##2##(1990-8#1)(1991-11#1)(1997-1#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-2#1)(2008-3#1)(2010-11#1)(2010-7#1)(2010-9#1)(2012-7#1)
the dispenser cathode##2##3##(2009-10#2)
the dispersal of##10##3##(2008-10#7)(2010-3#1)(2011-12#1)(2012-3#1)
the dispersal rate of the##2##5##(2008-8#2)
the dispersal##20##2##(1991-12#1)(2008-10#10)(2008-5#1)(2008-8#4)(2009-2#1)(2010-3#1)(2011-12#1)(2012-3#1)
the dispersed##10##2##(2005-11#2)(2007-10#1)(2007-12#1)(2008-10#1)(2008-5#2)(2008-7#1)(2012-12#1)(2013-8#1)
the disperser##4##2##(2007-11#2)(2008-5#2)
the dispersion and the##2##4##(2007-11#1)(2007-12#1)
the dispersion and##3##3##(2007-11#1)(2007-12#1)(2012-3#1)
the dispersion characteristics of##2##4##(2007-11#1)(2008-3#1)
the dispersion coefficient##3##3##(1996-8#1)(2008-2#1)(2008-3#1)
the dispersion in the##3##4##(1997-5#1)(2007-12#1)(2008-10#1)
the dispersion in##4##3##(1997-5#1)(2007-12#1)(2008-10#2)
the dispersion map##3##3##(2007-12#1)(2008-1#2)
the dispersion medium is##2##4##(2005-11#1)(2008-2#1)
the dispersion of the group velocity of light in##2##9##(2008-2#2)
the dispersion of the refractive index##3##6##(2008-2#3)
the dispersion of the##10##4##(2007-12#1)(2008-10#1)(2008-2#5)(2008-3#2)(2010-4#1)
the dispersion of##19##3##(1991-4#1)(2005-11#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#6)(2008-3#2)(2010-4#1)(2010-8#1)(2011-12#1)
the dispersion relation for##2##4##(2008-2#1)(2008-3#1)
the dispersion relation##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
the dispersion relationship##2##3##(2007-11#1)(2008-2#1)
the dispersion turning points##3##4##(2007-12#3)
the dispersion##65##2##(1991-4#1)(1996-8#1)(1997-5#1)(2005-11#3)(2007-11#7)(2007-12#17)(2008-1#3)(2008-10#4)(2008-11#1)(2008-2#15)(2008-3#5)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
the dispersions##4##2##(2006-10#1)(2007-12#2)(2013-1#1)
the dispersive and nonlinear##2##4##(2007-12#2)
the dispersive effect##2##3##(2007-12#1)(2008-3#1)
the dispersive##7##2##(2006-10#1)(2007-11#2)(2007-12#3)(2008-3#1)
the displaced##7##2##(1991-9#1)(1995-8#1)(2008-3#1)(2011-12#1)(2012-12#2)(2013-1#1)
the displacement field##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
the displacement of a##3##4##(2008-2#1)(2008-3#1)(2010-12#1)
the displacement of the##4##4##(1996-8#1)(2008-2#1)(2009-10#1)(2010-7#1)
the displacement of##18##3##(1992-9#1)(1996-8#2)(1997-1#1)(1997-2#1)(2008-10#2)(2008-2#3)(2008-3#3)(2009-10#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-1#1)
the displacement##35##2##(1992-9#1)(1995-2#1)(1996-8#2)(1997-1#1)(1997-2#2)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#4)(2008-2#6)(2008-3#6)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-1#1)
the displacements##5##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
the displacer##2##2##(2008-7#2)
the display and selection of##2##5##(1994-11#1)(2008-4#1)
the display and##3##3##(1994-11#1)(2008-4#1)(2008-6#1)
the display exit pupil##2##4##(2008-3#2)
the display of a##2##4##(1991-2#1)(1994-12#1)
the display of##7##3##(1991-2#1)(1992-7#1)(1993-6#1)(1994-12#1)(2006-3#1)(2008-11#1)(2008-4#1)
the display##28##2##(1991-2#1)(1992-7#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#2)(2006-3#1)(2008-11#1)(2008-2#2)(2008-3#9)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-8#1)
the displayed##3##2##(2008-2#1)(2008-4#1)(2008-6#1)
the disposable screen-printed electrode##2##4##(2008-10#2)
the disposable##5##2##(2008-10#2)(2011-1#1)(2011-2#1)(2012-12#1)
the disposal of##4##3##(1991-4#1)(2005-5#1)(2009-10#1)(2009-6#1)
the disposition of##5##3##(1996-4#1)(2005-10#1)(2008-10#1)(2008-5#1)(2013-1#1)
the disposition##7##2##(1996-4#1)(2005-10#1)(2008-10#1)(2008-5#1)(2012-3#1)(2013-1#2)
the dispute mediation system##2##4##(1992-12#1)(1992-3#1)
the dispute##7##2##(1992-12#1)(1992-2#1)(1992-3#1)(2006-5#1)(2009-7#1)(2012-2#1)(2013-1#1)
the disrupted##6##2##(1995-2#1)(1995-4#1)(2008-10#2)(2010-10#1)(2010-11#1)
the disruption of a##2##4##(1997-1#1)(2008-4#1)
the disruption of the##12##4##(1991-12#1)(1992-5#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-9#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-8#1)(2012-2#1)
the disruption of##27##3##(1991-12#1)(1992-5#1)(1993-9#1)(1994-11#3)(1994-3#1)(1994-9#1)(1997-1#2)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#1)(2010-3#1)(2010-7#1)(2012-2#1)
the disruption##30##2##(1991-12#1)(1992-5#1)(1993-3#1)(1993-9#1)(1994-11#3)(1994-3#1)(1994-9#1)(1995-3#1)(1997-1#2)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-8#1)(2010-3#1)(2010-7#1)(2012-2#1)
the dissecting##2##2##(2008-11#1)(2008-6#1)
the dissection and##3##3##(2008-11#1)(2013-1#2)
the dissection of the##6##4##(1992-11#1)(2007-7#1)(2008-11#1)(2011-2#1)(2012-1#1)(2013-1#1)
the dissection of##8##3##(1992-11#1)(2007-7#1)(2007-8#1)(2008-11#2)(2011-2#1)(2012-1#1)(2013-1#1)
the dissection##23##2##(1990-7#1)(1992-11#1)(1993-10#1)(2005-12#1)(2006-10#1)(2006-4#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-11#3)(2008-8#1)(2010-10#1)(2011-2#2)(2012-1#1)(2013-1#3)
the disseminated form##2##3##(2013-7#2)
the disseminated##3##2##(2011-2#1)(2013-7#2)
the disseminating structures are##2##4##(2007-12#2)
the dissemination and##2##3##(1992-2#1)(2013-1#1)
the dissemination of research##2##4##(2008-8#1)(2010-2#1)
the dissemination of the##2##4##(1995-11#1)(2005-9#1)
the dissemination of##15##3##(1993-6#1)(1995-11#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-2#1)(2010-6#1)(2012-2#1)
the dissemination##19##2##(1992-2#1)(1993-12#1)(1993-6#1)(1995-11#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-2#1)(2010-6#1)(2012-1#1)(2012-2#1)(2013-1#1)
the dissipation of##3##3##(1996-5#1)(2006-4#1)(2011-2#1)
the dissipation##5##2##(1996-5#1)(2005-11#2)(2006-4#1)(2011-2#1)
the dissociated##6##2##(1995-3#2)(1995-6#1)(2007-12#1)(2008-10#1)(2008-8#1)
the dissociation and somatization##2##4##(2012-12#2)
the dissociation and##5##3##(1996-8#1)(2005-11#1)(2008-10#1)(2012-12#2)
the dissociation between##2##3##(1994-2#1)(2010-8#1)
the dissociation constant (Kd)##3##4##(1992-8#1)(1994-11#1)(1995-12#1)
the dissociation constant for the##2##5##(1992-5#2)
the dissociation constant of the##2##5##(1990-2#1)(1993-8#1)
the dissociation constant of##4##4##(1990-2#1)(1993-8#1)(1995-2#1)(2008-10#1)
the dissociation constant##19##3##(1990-2#1)(1990-7#1)(1991-8#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-8#3)(1994-11#1)(1995-12#1)(1995-2#1)(1996-7#1)(2007-9#1)(2008-10#3)(2008-6#1)
the dissociation constants (Kd)##2##4##(1994-9#1)(1995-11#1)
the dissociation constants of the##3##5##(1993-8#1)(1996-5#1)(2008-10#1)
the dissociation constants of##5##4##(1993-8#1)(1995-11#1)(1996-5#1)(2008-10#2)
the dissociation constants##15##3##(1990-8#1)(1991-5#1)(1992-3#1)(1993-8#2)(1994-9#1)(1995-11#2)(1996-5#1)(2005-11#1)(2008-10#5)
the dissociation equilibrium##2##3##(2007-11#1)(2008-10#1)
the dissociation is##2##3##(1993-9#1)(2008-11#1)
the dissociation limit##3##3##(2007-11#3)
the dissociation of Asp-tRNA##2##4##(1994-12#2)
the dissociation of GDP from##4##5##(1991-1#1)(1991-11#1)(1991-2#1)(1997-6#1)
the dissociation of the##5##4##(1991-11#1)(1993-6#1)(1994-9#1)(1997-4#1)(2008-4#1)
the dissociation of##30##3##(1990-2#1)(1990-5#1)(1991-1#1)(1991-11#2)(1991-2#1)(1992-3#2)(1993-12#1)(1993-3#1)(1993-6#2)(1994-12#2)(1994-2#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-10#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-4#1)
the dissociation rate constant##5##4##(1990-7#1)(1991-7#2)(1995-1#1)(2008-10#1)
the dissociation rate##7##3##(1990-7#1)(1991-7#2)(1993-8#1)(1995-1#1)(2006-4#1)(2008-10#1)
the dissociation##100##2##(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-11#2)(1991-2#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-3#3)(1992-5#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#6)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-5#1)(1996-7#3)(1996-8#1)(1997-4#1)(1997-6#1)(2005-11#4)(2006-1#1)(2006-10#1)(2006-3#2)(2006-4#3)(2007-11#4)(2007-9#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2010-4#1)(2010-8#1)(2012-12#2)
the dissociative disorders and##2##4##(2009-10#2)
the dissociative##4##2##(1995-7#1)(2006-3#1)(2009-10#2)
the dissolution data##2##3##(2004-12#1)(2011-2#1)
the dissolution of gases in water##2##6##(1996-11#2)
the dissolution of the##5##4##(2005-11#1)(2008-10#2)(2008-12#1)(2009-7#1)
the dissolution of##18##3##(1990-2#1)(1991-8#1)(1996-11#2)(2005-11#1)(2008-10#9)(2008-12#1)(2008-3#1)(2008-5#1)(2009-7#1)
the dissolution rate of mefenamic acid##3##6##(2012-2#3)
the dissolution rate##5##3##(2008-10#1)(2008-5#1)(2012-2#3)
the dissolution results##2##3##(2005-10#1)(2010-12#1)
the dissolution##50##2##(1990-2#1)(1991-8#1)(1996-11#3)(2004-12#1)(2005-10#1)(2005-11#6)(2006-5#1)(2008-10#19)(2008-12#1)(2008-3#1)(2008-5#2)(2009-7#2)(2010-12#3)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#3)(2013-1#2)
the dissolved hydrogen##2##3##(2008-7#2)
the dissolved organic carbon (DOC)##2##5##(2008-10#1)(2011-12#1)
the dissolved organic carbon##3##4##(2008-10#2)(2011-12#1)
the dissolved organic##4##3##(2008-10#2)(2008-3#1)(2011-12#1)
the dissolved oxygen##7##3##(1994-2#1)(1994-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)
the dissolved##27##2##(1994-2#1)(1994-3#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#4)(2009-8#1)(2011-12#1)(2011-2#1)
the distal airways##2##3##(2005-8#1)(2008-8#1)
the distal colon##2##3##(1994-12#1)(2008-4#1)
the distal common bile duct##2##5##(1990-9#1)(2008-9#1)
the distal convoluted##2##3##(1993-4#1)(2007-7#1)
the distal deletion was##2##4##(1993-12#2)
the distal end of a##2##5##(1992-12#1)(2008-8#1)
the distal end of the external carotid artery##2##8##(1997-6#2)
the distal end of the##14##5##(1991-7#1)(1993-11#1)(1997-6#2)(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-9#1)(2011-12#1)
the distal end of this##2##5##(1994-3#1)(2008-6#1)
the distal end of##22##4##(1991-7#1)(1992-12#1)(1993-11#1)(1994-3#1)(1994-9#1)(1997-1#1)(1997-6#2)(2007-10#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2011-12#1)
the distal end##24##3##(1991-7#1)(1992-12#1)(1993-11#1)(1994-3#1)(1994-9#1)(1997-1#1)(1997-6#2)(2007-10#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#2)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#1)(2010-4#1)(2011-12#1)
the distal ends of both##2##5##(1995-6#1)(2007-11#1)
the distal ends of the##2##5##(2008-2#1)(2008-5#1)
the distal ends of##4##4##(1995-6#1)(2007-11#1)(2008-2#1)(2008-5#1)
the distal ends##5##3##(1995-6#1)(2007-11#1)(2008-2#1)(2008-5#1)(2008-8#1)
the distal enhancer##2##3##(1996-11#2)
the distal epiphyses of##2##4##(1995-6#1)(2008-4#1)
the distal esophageal squamous epithelium##2##5##(2009-3#1)(2011-12#1)
the distal esophageal##3##3##(2009-3#1)(2011-12#1)(2013-8#1)
the distal esophagus##6##3##(2006-10#2)(2009-3#2)(2013-1#2)
the distal extremities##3##3##(2005-11#1)(2008-7#2)
the distal femur and##2##4##(1993-8#1)(2012-12#1)
the distal femur##8##3##(1993-8#1)(2006-11#1)(2008-2#1)(2008-6#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
the distal forearm##2##3##(1996-9#1)(2006-3#1)
the distal half of##2##4##(2007-12#1)(2007-8#1)
the distal humerus##5##3##(2007-1#1)(2007-11#2)(2012-2#2)
the distal ileum##3##3##(1993-10#1)(2004-11#2)
the distal interphalangeal##3##3##(2006-3#2)(2011-1#1)
the distal lung##4##3##(1991-12#1)(2005-8#3)
the distal maxillary##2##3##(1991-2#1)(2007-12#1)
the distal muscles##2##3##(2004-11#1)(2010-12#1)
the distal nephron##2##3##(1993-7#1)(2007-7#1)
the distal part of the femur##2##6##(2008-7#1)(2013-1#1)
the distal part of the##16##5##(1993-10#1)(1997-5#1)(1997-8#1)(2006-2#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-1#1)(2013-1#2)
the distal part of##17##4##(1993-10#1)(1997-5#1)(1997-8#1)(2006-2#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-8#2)(2011-2#1)(2012-1#1)(2013-1#2)
the distal part##18##3##(1993-10#1)(1997-5#1)(1997-8#1)(2006-2#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-4#1)(2009-8#2)(2011-2#1)(2012-1#1)(2013-1#2)
the distal portion of the nephron##2##6##(1991-5#1)(2006-6#1)
the distal portion of the##5##5##(1991-5#1)(1996-11#1)(2006-6#1)(2007-12#1)(2007-8#1)
the distal portion of##7##4##(1991-5#1)(1996-11#1)(1996-8#1)(1997-4#1)(2006-6#1)(2007-12#1)(2007-8#1)
the distal portion##10##3##(1991-5#1)(1996-11#1)(1996-8#1)(1997-4#1)(2006-6#1)(2007-12#2)(2007-8#1)(2011-2#2)
the distal portions##2##3##(2007-12#1)(2008-5#1)
the distal program##2##3##(1992-9#2)
the distal radius and##4##4##(2006-3#2)(2008-9#1)(2012-2#1)
the distal radius fracture##2##4##(2006-3#2)
the distal radius##25##3##(2006-3#9)(2006-4#2)(2008-9#7)(2009-3#3)(2012-2#3)(2013-1#1)
the distal region of the##2##5##(1990-5#1)(1991-9#1)
the distal region of##3##4##(1990-5#1)(1991-9#1)(1997-1#1)
the distal region##4##3##(1990-5#1)(1991-9#1)(1997-1#1)(1997-8#1)
the distal right coronary artery##2##5##(1990-4#1)(2010-12#1)
the distal right##3##3##(1990-4#1)(2008-6#1)(2010-12#1)
the distal segment##2##3##(2013-8#2)
the distal segments of the##2##5##(1997-3#1)(2007-7#1)
the distal site of the##2##5##(2012-2#2)
the distal site##3##3##(1993-3#1)(2012-2#2)
the distal stomach##3##3##(1990-4#2)(1997-7#1)
the distal third of the##2##5##(2008-5#1)(2012-1#1)
the distal third##4##3##(2008-1#1)(2008-5#1)(2012-1#1)(2013-8#1)
the distal tip##2##3##(2007-12#2)
the distal tubule##2##3##(1996-8#1)(1997-8#1)
the distal ulna##4##3##(2006-6#1)(2009-3#3)
the distal ureter##2##3##(2006-9#1)(2008-3#1)
the distal urethra##2##3##(2008-10#2)
the distal wall##2##3##(2008-5#1)(2011-2#1)
the distal##292##2##(1990-3#1)(1990-4#5)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-3#1)(1992-9#4)(1993-10#2)(1993-11#2)(1993-12#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#2)(1994-12#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#2)(1996-11#3)(1996-3#1)(1996-5#2)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#4)(2004-11#4)(2005-11#1)(2005-5#1)(2005-8#4)(2006-10#3)(2006-11#2)(2006-12#1)(2006-2#2)(2006-3#14)(2006-4#3)(2006-6#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#17)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#8)(2007-8#16)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#10)(2008-6#3)(2008-7#4)(2008-8#5)(2008-9#15)(2009-3#10)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#3)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#3)(2011-2#7)(2012-1#3)(2012-12#5)(2012-2#10)(2012-3#1)(2013-1#11)(2013-7#1)(2013-8#4)
the distally##2##2##(1996-5#1)(2008-4#1)
the distance between the two##3##5##(1997-8#1)(2008-2#1)(2008-3#1)
the distance between the##33##4##(1993-12#1)(1993-3#1)(1993-6#1)(1995-8#1)(1997-2#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#5)(2008-3#6)(2008-5#1)(2010-2#1)(2013-8#1)
the distance between them##4##4##(1995-2#1)(2008-10#1)(2008-3#1)(2010-9#1)
the distance between these two##2##5##(1993-9#1)(2008-2#1)
the distance between two##2##4##(1995-8#1)(2008-11#1)
the distance between##56##3##(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-8#1)(1995-2#1)(1995-8#2)(1997-2#1)(1997-6#1)(1997-7#3)(1997-8#1)(2006-12#2)(2007-11#2)(2007-12#2)(2007-4#2)(2007-8#1)(2008-10#8)(2008-11#2)(2008-2#8)(2008-3#7)(2008-5#1)(2010-2#1)(2010-4#1)(2010-9#1)(2013-1#1)(2013-8#1)
the distance dependence of##2##4##(1991-5#2)
the distance from the##8##4##(2008-2#2)(2008-3#4)(2008-9#1)(2013-7#1)
the distance from##12##3##(1994-9#1)(1997-7#1)(2008-10#2)(2008-2#2)(2008-3#4)(2008-9#1)(2013-7#1)
the distance geometry program DIANA##2##5##(1997-2#1)(2008-8#1)
the distance in##2##3##(1991-11#1)(2008-2#1)
the distance of the##5##4##(1991-3#1)(1993-7#1)(1997-3#1)(2007-11#1)(2008-12#1)
the distance of##13##3##(1991-2#1)(1991-3#1)(1993-6#1)(1993-7#2)(1994-9#1)(1996-6#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-2#1)
the distance separating##2##3##(2008-10#1)(2011-1#1)
the distance that##2##3##(2008-10#2)
the distance to##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
the distance walked##2##3##(1995-4#1)(2013-1#1)
the distance##121##2##(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#2)(1993-12#1)(1993-3#1)(1993-6#2)(1993-7#2)(1993-8#2)(1993-9#2)(1994-8#1)(1994-9#2)(1995-2#1)(1995-4#1)(1995-6#1)(1995-8#2)(1996-6#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#1)(2006-12#2)(2006-7#2)(2007-11#4)(2007-12#2)(2007-4#3)(2007-8#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-2#14)(2008-3#14)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
the distances and##2##3##(2008-3#1)(2010-8#1)
the distances between the##3##4##(1995-8#1)(2008-6#1)(2008-9#1)
the distances between##8##3##(1994-12#1)(1995-8#1)(2007-9#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-7#1)
the distances from##2##3##(1995-2#1)(2007-3#1)
the distances of##3##3##(2008-2#1)(2010-10#1)(2012-2#1)
the distances##20##2##(1994-12#1)(1995-2#1)(1995-8#1)(2006-7#1)(2007-3#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-7#3)(2010-8#1)(2012-2#1)
the distant spread of##2##4##(2009-2#2)
the distant##13##2##(1991-2#1)(1992-8#1)(1993-1#1)(1993-3#1)(1996-3#1)(1996-5#1)(1997-1#1)(2006-8#1)(2007-12#1)(2009-2#2)(2010-9#1)(2013-1#1)
the distension-induced##2##2##(2011-2#2)
the distinct biological##2##3##(1995-2#1)(2011-1#1)
the distinct characteristics of##2##4##(1995-3#1)(2009-8#1)
the distinct domains##2##3##(1993-8#1)(1996-2#1)
the distinct imaging##2##3##(2010-9#2)
the distinct use of##3##4##(2012-1#1)(2013-1#2)
the distinct##42##2##(1991-2#1)(1991-4#1)(1991-8#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-4#2)(1997-7#1)(2004-4#1)(2005-3#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-2#1)(2010-9#3)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-7#1)
the distinction between ARDS##2##4##(2005-8#2)
the distinction between short-term and long-term##2##6##(1992-11#1)(1996-4#1)
the distinction between the##4##4##(2007-12#1)(2008-10#2)(2008-3#1)
the distinction between##28##3##(1990-3#1)(1992-11#1)(1992-4#1)(1995-2#1)(1995-8#1)(1996-4#1)(1997-3#1)(2005-8#2)(2006-3#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#3)(2009-4#1)(2009-6#1)(2010-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
the distinction of##6##3##(1994-11#1)(1997-5#1)(2005-7#1)(2007-4#1)(2008-10#1)(2013-7#1)
the distinction##36##2##(1990-3#1)(1992-11#1)(1992-4#1)(1994-11#1)(1995-2#1)(1995-8#1)(1996-4#1)(1997-3#1)(1997-5#1)(2005-7#1)(2005-8#2)(2006-3#1)(2006-7#1)(2007-12#1)(2007-4#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#3)(2009-4#1)(2009-6#1)(2010-12#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
the distinctions between##3##3##(1995-4#1)(2008-11#1)(2008-12#1)
the distinctions##4##2##(1995-4#1)(2008-11#1)(2008-12#1)(2013-8#1)
the distinctive features of the##2##5##(1996-12#1)(2013-8#1)
the distinctive features##3##3##(1996-12#1)(2008-6#1)(2013-8#1)
the distinctive##15##2##(1991-7#1)(1992-3#1)(1992-6#1)(1995-2#1)(1996-1#1)(1996-12#2)(2005-10#1)(2005-12#1)(2005-8#1)(2008-10#1)(2008-6#1)(2010-3#1)(2011-2#1)(2013-8#1)
the distinguishing##4##2##(1992-7#1)(1996-1#1)(2010-12#1)(2013-1#1)
the distorted##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2009-7#1)
the distortion amplitude##2##3##(2008-2#2)
the distortion of##2##3##(2007-12#1)(2008-3#1)
the distortion##10##2##(2007-12#2)(2008-2#6)(2008-3#1)(2009-4#1)
the distortions of the##2##4##(1996-2#1)(2008-2#1)
the distortions##9##2##(1996-2#1)(2007-11#2)(2008-2#4)(2008-3#1)(2009-4#1)
the distraction##4##2##(2007-8#1)(2008-4#1)(2011-2#1)(2013-8#1)
the distress associated with the##2##5##(2007-12#2)
the distress##5##2##(2006-3#1)(2006-6#1)(2007-12#2)(2013-8#1)
the distressed##2##2##(2008-1#1)(2012-2#1)
the distressing##2##2##(1996-12#1)(2012-2#1)
the distributed##11##2##(1995-11#1)(2007-11#2)(2007-12#3)(2007-3#1)(2008-3#1)(2012-2#1)(2013-1#2)
the distribution and abundance of##2##5##(2008-8#1)(2013-7#1)
the distribution and composition of##2##5##(2006-5#1)(2008-10#1)
the distribution and ultrastructure of##2##5##(1995-11#1)(1995-7#1)
the distribution and##33##3##(1990-8#1)(1991-10#1)(1991-12#1)(1992-4#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-7#1)(1997-8#2)(2004-11#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#3)(2009-11#1)(2009-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
the distribution between##2##3##(1992-9#1)(2008-5#1)
the distribution characteristics of##2##4##(2007-8#1)(2013-8#1)
the distribution coefficient for##2##4##(2008-10#1)(2009-11#1)
the distribution coefficient##3##3##(2008-10#2)(2009-11#1)
the distribution coefficients##3##3##(2005-11#1)(2008-10#2)
the distribution constants of 16C5##2##5##(2008-10#2)
the distribution constants of##3##4##(2008-10#3)
the distribution constants##4##3##(2008-10#4)
the distribution function##6##3##(2008-2#2)(2008-3#2)(2009-4#2)
the distribution in##3##3##(1995-8#1)(1997-1#1)(2008-3#1)
the distribution is##3##3##(1994-5#1)(2007-12#1)(2008-10#1)
the distribution of RAPD##2##4##(2008-5#2)
the distribution of Snails##2##4##(2011-1#2)
the distribution of TRH-R mRNA in##2##6##(1995-5#2)
the distribution of TRH-R mRNA##3##5##(1995-5#3)
the distribution of a##2##4##(1990-5#1)(2008-4#1)
the distribution of alpha##2##4##(1996-10#1)(2005-11#1)
the distribution of both##2##4##(2008-10#1)(2010-8#1)
the distribution of brain##2##4##(1997-2#1)(2008-1#1)
the distribution of cells##2##4##(1990-7#1)(1997-1#1)
the distribution of changes in pixel value##2##7##(2010-9#2)
the distribution of different##2##4##(1993-2#1)(2013-1#1)
the distribution of expression of##2##5##(1994-10#2)
the distribution of food resources##2##5##(1991-11#1)(2008-8#1)
the distribution of genotypes##2##4##(2011-1#1)(2011-2#1)
the distribution of immunoreactive##2##4##(1993-7#1)(1994-9#1)
the distribution of internal##3##4##(2007-4#1)(2009-10#1)(2010-2#1)
the distribution of iron##2##4##(2008-10#1)(2013-8#1)
the distribution of labeling##2##4##(1997-3#2)
the distribution of paternity##2##4##(2008-8#2)
the distribution of protein kinase C##2##6##(1991-7#1)(1994-3#1)
the distribution of protein##4##4##(1991-7#1)(1994-3#1)(1995-4#1)(2009-2#1)
the distribution of rare variants##2##5##(2012-3#2)
the distribution of resistance##2##4##(2008-10#2)
the distribution of response##2##4##(1995-4#1)(1997-6#1)
the distribution of sex##2##4##(2010-3#1)(2012-2#1)
the distribution of the PS-1##2##5##(1997-1#1)(1997-5#1)
the distribution of the covariates##2##5##(1995-6#1)(2011-1#1)
the distribution of the##79##4##(1990-12#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-9#3)(1992-11#1)(1992-2#2)(1992-3#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-5#2)(1997-8#1)(2005-11#3)(2005-8#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-5#1)(2008-10#7)(2008-11#2)(2008-2#4)(2008-3#3)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#4)(2011-2#1)(2012-12#3)(2012-3#2)(2013-1#3)
the distribution of these two##2##5##(1992-6#1)(2009-9#1)
the distribution of these##9##4##(1990-12#1)(1992-6#2)(1993-2#1)(1995-5#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-9#1)
the distribution of this##5##4##(1994-2#1)(1997-4#1)(2006-2#1)(2008-3#1)(2010-2#1)
the distribution of tree species##3##5##(2007-3#3)
the distribution of variance##2##4##(2008-2#1)(2011-2#1)
the distribution of##409##3##(1990-11#1)(1990-12#4)(1990-2#3)(1990-4#1)(1990-5#5)(1990-6#1)(1990-7#3)(1990-8#1)(1991-1#1)(1991-11#3)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#4)(1992-11#1)(1992-12#1)(1992-2#6)(1992-3#2)(1992-6#4)(1992-7#1)(1992-8#5)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#5)(1993-2#3)(1993-3#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#5)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-4#2)(1995-5#10)(1995-6#2)(1995-7#3)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#4)(1996-5#3)(1996-9#2)(1997-1#7)(1997-2#4)(1997-3#3)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#3)(2004-11#1)(2004-4#1)(2005-11#6)(2005-8#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-3#5)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#32)(2008-11#5)(2008-12#1)(2008-2#10)(2008-3#9)(2008-4#5)(2008-5#9)(2008-6#3)(2008-7#9)(2008-8#18)(2008-9#7)(2009-10#2)(2009-12#3)(2009-2#3)(2009-5#3)(2009-8#2)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#3)(2010-3#3)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#10)(2011-2#11)(2011-7#1)(2012-12#4)(2012-2#7)(2012-3#6)(2013-1#10)(2013-7#3)(2013-8#2)
the distribution pattern of the##3##5##(2008-5#1)(2012-1#1)(2012-3#1)
the distribution pattern of##12##4##(1994-10#1)(1997-4#1)(1997-5#1)(2007-1#1)(2007-10#1)(2008-10#2)(2008-5#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-8#1)
the distribution pattern##13##3##(1994-10#1)(1997-4#1)(1997-5#1)(2007-1#1)(2007-10#1)(2008-10#2)(2008-5#1)(2010-8#1)(2012-1#1)(2012-3#2)(2013-8#1)
the distribution was##2##3##(1993-12#1)(2012-12#1)
the distribution##518##2##(1990-11#1)(1990-12#4)(1990-2#3)(1990-4#1)(1990-5#5)(1990-6#1)(1990-7#3)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#4)(1992-11#2)(1992-12#1)(1992-2#6)(1992-3#3)(1992-4#1)(1992-6#4)(1992-7#1)(1992-8#5)(1992-9#3)(1993-10#1)(1993-11#1)(1993-12#6)(1993-2#3)(1993-3#3)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#6)(1994-11#1)(1994-12#4)(1994-2#4)(1994-3#3)(1994-5#5)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#3)(1995-3#1)(1995-4#2)(1995-5#10)(1995-6#2)(1995-7#4)(1995-8#1)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#4)(1996-5#4)(1996-9#2)(1997-1#8)(1997-2#5)(1997-3#3)(1997-4#3)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#5)(2004-11#2)(2004-4#2)(2005-11#7)(2005-8#2)(2006-10#2)(2006-12#1)(2006-2#2)(2006-4#2)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#4)(2007-12#8)(2007-2#1)(2007-3#5)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#52)(2008-11#7)(2008-12#1)(2008-2#14)(2008-3#15)(2008-4#6)(2008-5#12)(2008-6#4)(2008-7#10)(2008-8#21)(2008-9#8)(2009-10#2)(2009-11#2)(2009-12#4)(2009-2#3)(2009-4#2)(2009-5#4)(2009-8#2)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#3)(2010-3#3)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#10)(2011-2#12)(2011-7#1)(2012-1#1)(2012-12#5)(2012-2#8)(2012-3#9)(2013-1#14)(2013-7#4)(2013-8#4)
the distributions of the simulated values of the residence time##2##10##(2007-9#2)
the distributions of the##4##4##(2007-9#2)(2008-10#1)(2008-2#1)
the distributions of##13##3##(1995-12#1)(2005-11#1)(2007-10#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2010-11#1)(2013-7#1)(2013-8#1)
the distributions##22##2##(1990-7#1)(1992-2#1)(1995-12#1)(1995-8#1)(1996-3#1)(1996-7#1)(1997-8#1)(2005-11#1)(2007-10#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-7#1)(2010-11#1)(2012-2#1)(2013-7#1)(2013-8#1)
the district and##2##3##(2008-9#1)(2012-3#1)
the district court##4##3##(1996-12#2)(1996-6#1)(1997-6#1)
the district health##2##3##(1990-8#1)(2008-1#1)
the district##24##2##(1990-8#1)(1993-10#1)(1993-3#1)(1996-1#1)(1996-12#2)(1996-6#1)(1997-6#2)(2007-2#1)(2007-5#2)(2008-1#1)(2008-2#1)(2008-6#2)(2008-9#1)(2009-5#1)(2009-6#3)(2010-8#1)(2011-2#1)(2012-3#1)
the districts of##2##3##(2007-8#1)(2012-12#1)
the districts##5##2##(1997-5#1)(2007-8#1)(2011-12#2)(2012-12#1)
the disturbance in##2##3##(1995-8#1)(2010-8#1)
the disturbance of##7##3##(1994-5#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-10#1)(2009-12#1)(2010-12#1)
the disturbance##15##2##(1994-5#1)(1995-8#1)(2005-11#2)(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-8#1)(2011-12#1)
the disturbances in##3##3##(1991-12#1)(2008-3#2)
the disturbances of##5##3##(2008-11#1)(2008-12#1)(2008-7#2)(2009-6#1)
the disturbances##8##2##(1991-12#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#2)(2009-6#1)
the disturbed environments##2##3##(2008-5#2)
the disturbed##8##2##(1997-4#1)(2005-11#1)(2006-6#1)(2008-5#2)(2010-2#1)(2012-1#1)(2013-7#1)
the disturbing effect of##2##4##(2008-10#1)(2008-2#1)
the disturbing##5##2##(2008-10#1)(2008-2#1)(2008-3#3)
the disulfide bond##15##3##(1991-1#3)(1993-3#4)(1993-4#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-7#1)(1997-4#1)(2010-5#1)
the disulfide bonds##6##3##(1990-5#1)(1991-2#2)(1993-8#1)(1994-9#1)(1995-6#1)
the disulfide bridge##2##3##(1990-12#1)(1993-3#1)
the disulfide exchange reaction##2##4##(1993-11#2)
the disulfide exchange##3##3##(1993-11#3)
the disulfide is##2##3##(1992-1#1)(1994-5#1)
the disulfide linkage##4##3##(1994-9#2)(1995-6#1)(2008-4#1)
the disulfide##45##2##(1990-12#1)(1990-5#1)(1991-1#4)(1991-2#2)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#3)(1993-3#5)(1993-4#2)(1993-6#1)(1993-8#1)(1994-5#3)(1994-8#1)(1994-9#4)(1995-6#2)(1995-8#1)(1996-7#3)(1997-4#1)(2006-12#1)(2006-4#1)(2008-4#1)(2010-5#1)(2013-7#1)
the disulfide-linked##2##2##(1995-6#1)(2008-4#1)
the disulphide##3##2##(1995-4#1)(2008-10#2)
the dither##3##2##(2007-12#2)(2008-3#1)
the dithiocarbamate##2##2##(2008-10#1)(2008-3#1)
the dithiol##3##2##(2005-11#1)(2008-11#1)(2010-4#1)
the diuretic effect of##2##4##(1995-2#1)(2007-1#1)
the diuretic##8##2##(1992-6#1)(1995-2#1)(2006-6#1)(2007-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-2#1)
the diuretics##2##2##(1994-8#1)(2008-10#1)
the diurnal and##2##3##(1990-8#1)(2013-8#1)
the diurnal pattern of##4##4##(1995-1#1)(1997-8#1)(2013-1#2)
the diurnal rhythm of##3##4##(1993-1#2)(1997-1#1)
the diurnal rhythm##5##3##(1993-1#3)(1997-1#1)(2007-11#1)
the diurnal samplings##2##3##(2008-5#2)
the diurnal schedule of male female-search##2##6##(2008-6#2)
the diurnal schedule of##3##4##(2008-6#3)
the diurnal variation##2##3##(1990-3#1)(1990-8#1)
the diurnal##23##2##(1990-3#1)(1990-8#2)(1993-1#3)(1995-1#1)(1997-1#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-5#2)(2008-6#3)(2011-1#1)(2013-1#4)(2013-8#1)
the divalent cation##4##3##(1993-6#2)(1994-12#1)(1995-8#1)
the divalent cations##2##3##(1990-7#1)(1994-5#1)
the divalent metal##2##3##(1996-7#1)(2008-10#1)
the divalent##13##2##(1990-7#1)(1992-12#1)(1993-6#2)(1994-12#1)(1994-5#1)(1995-8#1)(1996-7#2)(2008-10#3)(2010-5#1)
the divergence between##2##3##(1992-7#2)
the divergence in##5##3##(1996-4#1)(2007-12#2)(2009-12#1)(2012-2#1)
the divergence of the##6##4##(1993-6#1)(2008-2#1)(2008-3#2)(2010-3#1)(2011-1#1)
the divergence of##12##3##(1991-6#1)(1993-6#1)(1994-11#1)(1994-8#1)(2008-2#2)(2008-3#3)(2008-7#1)(2010-3#1)(2011-1#1)
the divergence##21##2##(1991-6#1)(1992-7#2)(1993-6#1)(1994-11#1)(1994-8#1)(1996-4#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#3)(2008-7#1)(2009-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2012-2#1)
the divergent results##2##3##(1990-6#1)(1993-12#1)
the divergent type##2##3##(1995-11#2)
the divergent##14##2##(1990-6#1)(1990-8#1)(1993-12#1)(1995-11#2)(1995-2#1)(1996-11#1)(1996-9#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)
the diverse and##3##3##(2005-11#1)(2012-3#1)(2013-1#1)
the diverse aspects of##2##4##(1994-5#1)(2008-1#1)
the diverse group of##2##4##(2008-3#1)(2012-12#1)
the diverse needs##2##3##(1997-1#1)(2008-1#1)
the diverse range of##3##4##(2009-12#1)(2010-5#1)(2011-3#1)
the diverse##50##2##(1990-8#1)(1991-3#1)(1991-9#1)(1993-5#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-8#1)(2005-10#1)(2005-11#2)(2007-1#1)(2007-10#1)(2007-12#1)(2008-1#3)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-7#2)(2009-8#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#2)
the diversification of the##2##4##(2010-6#1)(2012-2#1)
the diversification of##5##3##(2007-12#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#1)
the diversification##7##2##(1991-1#1)(2007-12#1)(2008-9#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#1)
the diversion of##2##3##(1994-11#1)(2008-9#1)
the diversion##5##2##(1994-11#1)(1996-12#1)(2008-9#1)(2010-11#1)(2012-2#1)
the diversity among##2##3##(2008-10#1)(2008-6#1)
the diversity and##13##3##(1991-3#1)(1993-6#1)(2005-11#1)(2006-1#1)(2007-12#1)(2007-2#1)(2008-5#1)(2009-10#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
the diversity in##6##3##(1992-8#1)(1994-11#1)(1997-8#1)(2008-10#1)(2010-8#1)(2012-3#1)
the diversity of a##2##4##(2008-8#1)(2008-9#1)
the diversity of applications##2##4##(2008-7#1)(2012-1#1)
the diversity of genes##2##4##(1992-2#1)(2006-12#1)
the diversity of the##7##4##(1992-2#1)(1997-5#1)(2007-4#1)(2008-10#2)(2008-5#1)(2008-8#1)
the diversity of these##2##4##(2013-7#2)
the diversity of this##2##4##(1992-3#1)(2008-5#1)
the diversity of##65##3##(1990-12#1)(1990-8#1)(1992-2#2)(1992-3#1)(1992-4#1)(1993-7#1)(1994-7#1)(1996-9#1)(1997-5#1)(1997-6#1)(2006-12#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-3#2)(2011-2#1)(2012-1#2)(2012-12#3)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
the diversity within##2##3##(1997-2#1)(2008-1#1)
the diversity##103##2##(1990-12#1)(1990-8#1)(1991-3#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-8#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-6#1)(2006-1#1)(2006-12#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2008-1#3)(2008-10#17)(2008-11#2)(2008-12#1)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#4)(2013-1#2)(2013-7#6)(2013-8#1)
the diverticular##2##2##(1990-4#1)(2010-2#1)
the diverticulum##8##2##(1991-6#1)(1992-1#1)(1992-8#1)(2008-10#1)(2012-2#4)
the dividing cells##2##3##(2008-9#1)(2012-12#1)
the dividing##3##2##(2008-10#1)(2008-9#1)(2012-12#1)
the divine##2##2##(2004-8#1)(2012-2#1)
the division cycle##3##3##(1994-3#1)(1997-4#1)(2007-9#1)
the division of labor in##2##5##(2008-8#1)(2008-9#1)
the division of the##4##4##(2007-8#1)(2008-1#1)(2008-2#1)(2008-5#1)
the division of##18##3##(1991-2#1)(2005-11#1)(2005-8#1)(2007-10#1)(2007-8#2)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#2)(2012-12#2)(2012-2#1)
the division##30##2##(1991-2#1)(1994-3#1)(1995-8#1)(1997-4#1)(2005-11#1)(2005-8#1)(2007-10#1)(2007-12#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#2)(2009-6#1)(2010-12#1)(2012-12#2)(2012-2#1)
the divisional##3##2##(1990-3#1)(2005-8#1)(2009-6#1)
the divisions of##2##3##(2008-5#1)(2011-1#1)
the dlt operon##2##3##(1995-6#2)
the dnaA region of##3##4##(1994-12#1)(1996-12#2)
the dnaA##4##2##(1994-12#1)(1996-12#3)
the docked##2##2##(1992-9#1)(1997-7#1)
the docking of##3##3##(1995-2#1)(1997-2#1)(2008-11#1)
the docking##12##2##(1994-12#1)(1995-2#2)(1995-3#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-11#1)(2010-12#2)(2010-3#1)(2013-1#1)
the doctor and his##2##4##(1993-7#1)(2011-1#1)
the doctor and##3##3##(1993-7#1)(2011-1#2)
the doctor in##4##3##(1990-4#1)(1997-4#1)(2004-3#1)(2010-1#1)
the doctor on duty##2##4##(1992-11#1)(2007-9#1)
the doctor on##3##3##(1992-11#1)(2007-9#1)(2010-2#1)
the doctor to##2##3##(2008-5#1)(2011-1#1)
the doctor##46##2##(1990-2#3)(1990-4#4)(1990-5#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-12#2)(1993-10#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-3#2)(1996-3#1)(1996-6#1)(1997-4#1)(1997-6#1)(2004-3#2)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-1#2)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#3)(2011-12#1)(2012-3#1)(2013-7#2)
the doctor's office##8##3##(1992-4#2)(1993-1#1)(1996-11#1)(1996-2#1)(2006-10#1)(2009-5#1)(2011-2#1)
the doctor's role##4##3##(1992-6#4)
the doctor's##19##2##(1990-8#1)(1992-3#2)(1992-4#2)(1992-6#4)(1993-1#1)(1993-7#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(2006-10#1)(2009-5#1)(2011-2#1)(2013-1#1)
the doctor-patient relationship##10##3##(1992-12#1)(1993-3#1)(1994-6#1)(1997-2#1)(2008-3#1)(2010-1#2)(2011-2#3)
the doctor-patient##12##2##(1992-12#1)(1993-3#1)(1994-6#1)(1997-2#1)(1997-6#2)(2008-3#1)(2010-1#2)(2011-2#3)
the doctors and##3##3##(1993-5#1)(1997-4#1)(2010-8#1)
the doctors had##2##3##(1993-11#1)(1993-3#1)
the doctors to##2##3##(2008-5#1)(2009-10#1)
the doctors were##2##3##(1990-9#1)(1992-2#1)
the doctors who##4##3##(1990-4#1)(1990-5#1)(1996-8#1)(2010-5#1)
the doctors##38##2##(1990-4#2)(1990-5#1)(1990-9#2)(1991-5#1)(1991-6#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-5#1)(1994-6#1)(1994-7#1)(1995-4#1)(1995-6#1)(1995-9#2)(1996-12#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-2#3)(2007-9#3)(2008-5#1)(2009-10#1)(2010-5#1)(2010-8#1)(2013-7#2)
the doctors'##5##2##(1993-11#1)(1994-6#1)(1997-6#1)(2011-2#2)
the doctrine of double effect##2##5##(2012-2#2)
the doctrine of informed consent##2##5##(2009-8#2)
the doctrine of informed##3##4##(2009-8#3)
the doctrine of##8##3##(1991-3#1)(1994-3#1)(1995-12#1)(2009-8#3)(2012-2#2)
the doctrine##9##2##(1991-3#1)(1994-3#2)(1995-12#1)(2009-8#3)(2012-2#2)
the document and##3##3##(2007-9#1)(2013-1#2)
the document##13##2##(1994-3#1)(1995-9#1)(2006-6#1)(2007-12#1)(2007-9#2)(2011-1#1)(2011-2#1)(2013-1#4)(2013-7#1)
the documentation of##8##3##(1991-12#1)(1993-12#1)(2007-10#1)(2007-7#1)(2010-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
the documentation##16##2##(1991-12#1)(1993-12#1)(1995-6#1)(1997-6#1)(2004-1#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
the documented##8##2##(1992-11#1)(1997-6#1)(2007-2#1)(2007-7#1)(2008-11#1)(2011-3#1)(2012-1#2)
the documents##5##2##(1991-7#1)(1996-2#1)(2007-5#1)(2008-5#1)(2008-9#1)
the dodecamer##2##2##(1994-7#1)(1995-3#1)
the dodecyl##2##2##(1990-11#1)(2005-11#1)
the does##3##2##(1993-7#1)(2006-5#2)
the dog A2 receptor##2##4##(1992-5#2)
the dog is a##2##4##(1995-2#1)(2005-7#1)
the dog is##3##3##(1995-2#1)(1996-11#1)(2005-7#1)
the dog liver##2##3##(1995-11#2)
the dog pancreas##2##3##(1997-8#1)(2004-12#1)
the dog was##2##3##(2008-5#1)(2012-2#1)
the dog##44##2##(1990-12#2)(1990-5#2)(1991-1#1)(1991-3#1)(1992-2#1)(1992-5#2)(1993-2#1)(1993-4#1)(1995-11#4)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-5#2)(1997-8#1)(2004-12#2)(2005-7#2)(2008-10#2)(2008-5#2)(2008-8#3)(2011-1#3)(2012-2#6)(2013-1#1)
the dog's##2##2##(2010-2#1)(2013-1#1)
the dogma of##2##3##(2008-11#1)(2008-12#1)
the dogma##4##2##(2006-10#1)(2008-11#2)(2008-12#1)
the dogs were##2##3##(1991-6#1)(1992-3#1)
the dogs##14##2##(1990-11#1)(1991-6#1)(1992-3#1)(1992-5#3)(1993-7#1)(1996-12#1)(1996-6#1)(2004-9#1)(2007-8#1)(2008-6#1)(2012-3#2)
the dollar##2##2##(1991-1#1)(1993-3#1)
the dolls##3##2##(1992-3#2)(2011-1#1)
the domain is##2##3##(1991-11#1)(1994-12#1)
the domain of the##3##4##(1991-3#1)(1997-4#1)(2008-2#1)
the domain of##22##3##(1991-3#1)(1997-4#1)(1997-6#1)(2005-7#1)(2006-10#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2009-2#1)(2009-5#1)(2009-9#2)(2010-2#1)(2012-1#1)
the domain on the##2##4##(1994-9#1)(1996-8#1)
the domain on##3##3##(1994-9#1)(1996-8#1)(2010-2#1)
the domain related to##2##4##(1994-12#1)(2011-1#1)
the domain responsible for##2##4##(1996-5#1)(1997-4#1)
the domain structure of##3##4##(1991-1#1)(1994-8#1)(2008-1#1)
the domain structure##4##3##(1991-1#1)(1994-12#1)(1994-8#1)(2008-1#1)
the domain wall##3##3##(2008-2#1)(2009-6#2)
the domain##68##2##(1991-1#1)(1991-11#1)(1991-3#1)(1991-8#1)(1991-9#1)(1994-12#4)(1994-8#1)(1994-9#1)(1995-1#4)(1995-2#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-4#2)(1997-6#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-2#2)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#2)(2009-9#3)(2010-2#3)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
the domains and##3##3##(1994-8#1)(1994-9#1)(2012-12#1)
the domains of##8##3##(1994-11#1)(2004-3#1)(2007-5#1)(2007-9#1)(2008-8#1)(2009-4#1)(2009-7#1)(2012-2#1)
the domains##28##2##(1991-7#1)(1991-9#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-6#1)(1996-10#1)(1996-11#1)(1997-6#1)(2004-3#1)(2005-7#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-11#1)(2008-8#1)(2009-4#1)(2009-7#1)(2010-11#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)
the dome and the##2##4##(1991-6#1)(2008-3#1)
the dome of the acetabulum##2##5##(2008-5#2)
the dome of the bladder##2##5##(2008-10#2)
the dome of the##4##4##(2008-10#2)(2008-5#2)
the dome of##5##3##(2008-10#2)(2008-5#2)(2010-5#1)
the dome##9##2##(1991-6#1)(2008-10#2)(2008-3#1)(2008-5#3)(2009-7#1)(2010-5#1)
the domestic cat##2##3##(2008-8#2)
the domestic fowl##2##3##(2005-9#1)(2008-5#1)
the domestic hen (Gallus domesticus)##2##5##(2008-12#2)
the domestic hen##3##3##(2008-12#3)
the domestic##16##2##(1997-2#1)(2005-12#1)(2005-9#1)(2007-12#1)(2007-4#1)(2008-12#3)(2008-5#2)(2008-6#1)(2008-8#3)(2009-2#1)(2011-2#1)
the domestication of forest trees##2##5##(2006-12#2)
the domestication of##4##3##(2006-12#3)(2011-1#1)
the domestication##7##2##(2006-12#3)(2009-10#1)(2011-1#1)(2012-11#1)(2013-1#1)
the dominance of the##3##4##(1994-2#1)(2008-3#1)(2010-5#1)
the dominance of##13##3##(1991-6#1)(1993-9#1)(1994-2#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-4#1)(2009-6#1)(2010-5#1)(2012-2#1)(2013-1#1)
the dominance##16##2##(1991-6#1)(1993-9#1)(1994-2#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-6#1)(2010-5#1)(2012-2#1)(2013-1#1)
the dominant and##3##3##(2010-8#1)(2011-2#1)(2012-3#1)
the dominant causal##2##3##(2008-10#1)(2010-6#1)
the dominant contrast##2##3##(2007-11#1)(2008-3#1)
the dominant contribution to the##3##5##(1992-5#1)(1995-12#1)(2008-3#1)
the dominant contribution to##5##4##(1992-5#1)(1995-12#1)(1996-8#1)(2007-12#1)(2008-3#1)
the dominant factor determining##2##4##(2008-10#2)
the dominant factor##3##3##(1993-1#1)(2008-10#2)
the dominant form of##2##4##(1997-2#1)(2007-1#1)
the dominant gene was##2##4##(2008-10#2)
the dominant gene##4##3##(2008-10#3)(2008-7#1)
the dominant haplotype##2##3##(2008-10#2)
the dominant hemisphere##3##3##(1990-11#1)(2006-3#1)(2006-5#1)
the dominant influence##2##3##(1997-1#1)(2006-11#1)
the dominant mechanisms##2##3##(2004-9#1)(2009-5#1)
the dominant mode of##3##4##(1994-6#1)(1997-2#1)(2006-10#1)
the dominant noise##2##3##(2007-12#1)(2008-2#1)
the dominant or##2##3##(1996-6#1)(2008-10#1)
the dominant organisms in##2##4##(2008-5#2)
the dominant role in##2##4##(2010-11#1)(2011-3#1)
the dominant role of##2##4##(1992-9#1)(2011-2#1)
the dominant role##5##3##(1992-9#1)(1997-1#1)(2010-11#1)(2011-2#1)(2011-3#1)
the dominant source of##2##4##(1995-1#1)(1997-6#1)
the dominant species##6##3##(2007-3#1)(2008-10#2)(2008-5#1)(2011-2#2)
the dominant##165##2##(1990-11#3)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-3#1)(1992-5#2)(1992-7#1)(1992-9#2)(1993-1#1)(1993-8#2)(1994-1#1)(1994-3#2)(1994-5#1)(1994-6#2)(1995-1#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-6#2)(1996-8#1)(1997-1#4)(1997-2#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-9#1)(2005-10#2)(2005-11#2)(2006-1#1)(2006-10#2)(2006-11#1)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#6)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#11)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-5#3)(2010-6#1)(2010-8#3)(2011-1#3)(2011-2#6)(2011-3#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#3)
the dominant-negative##2##2##(1994-12#1)(1994-8#1)
the dominating##13##2##(1992-3#1)(1993-10#1)(1993-8#1)(1996-6#1)(1996-8#1)(2007-11#2)(2008-1#2)(2008-2#1)(2008-3#1)(2008-8#1)(2009-2#1)
the donation of##2##3##(2012-11#2)
the donation##12##2##(2007-7#1)(2011-2#4)(2012-11#2)(2012-12#1)(2013-8#4)
the donor and acceptor##2##4##(1991-3#1)(2008-10#1)
the donor and recipient##2##4##(2006-10#1)(2011-2#1)
the donor and##7##3##(1991-3#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2011-2#1)(2013-8#1)
the donor cells##3##3##(1994-3#1)(2006-5#1)(2010-10#1)
the donor lipid##3##3##(1994-11#3)
the donor membrane##2##3##(1991-11#1)(1997-4#1)
the donor organ##2##3##(2007-11#1)(2008-1#1)
the donor phase##2##3##(2008-10#2)
the donor s portal vein##2##5##(2008-11#2)
the donor s pulmonary artery##2##5##(2008-11#2)
the donor s##5##3##(2008-11#5)
the donor site was##2##4##(2011-2#2)
the donor site##9##3##(2006-3#1)(2009-9#1)(2011-12#1)(2011-2#6)
the donor strains##2##3##(1993-12#2)
the donor vesicles##2##3##(1992-3#1)(1994-5#1)
the donor was##3##3##(1991-7#2)(2012-12#1)
the donor##111##2##(1990-11#1)(1990-2#2)(1990-4#1)(1990-5#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-7#4)(1992-3#1)(1992-6#1)(1993-12#2)(1994-11#3)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-4#1)(1996-6#1)(1997-4#2)(2005-11#2)(2006-10#2)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#6)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-5#1)(2011-12#1)(2011-2#21)(2011-3#1)(2012-12#3)(2013-8#2)
the donor's##3##2##(1990-3#1)(1994-9#1)(2011-2#1)
the donor-recipient##2##2##(2008-1#1)(2011-2#1)
the donors with##2##3##(1990-5#1)(2008-7#1)
the donors##17##2##(1990-5#3)(1991-12#1)(1992-5#1)(1994-9#1)(1997-1#1)(2007-7#1)(2008-10#1)(2008-7#2)(2011-1#1)(2011-2#3)(2013-8#2)
the donut hole##2##3##(2008-11#2)
the donut##3##2##(2008-11#3)
the door to##9##3##(2006-12#1)(2007-11#1)(2007-8#1)(2007-9#2)(2008-4#1)(2009-12#1)(2010-7#1)(2012-1#1)
the door##15##2##(1994-12#1)(1997-5#1)(2006-12#1)(2007-11#1)(2007-8#1)(2007-9#2)(2008-4#1)(2008-9#1)(2009-12#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-2#1)
the doors##2##2##(2008-7#1)(2009-5#1)
the dopamine (DA)##4##3##(1993-2#1)(1997-8#1)(2005-8#1)(2008-7#1)
the dopamine D1 receptor##4##4##(1993-3#1)(1996-10#2)(1996-2#1)
the dopamine D1##5##3##(1993-3#1)(1996-10#2)(1996-2#1)(1996-5#1)
the dopamine D2 receptor gene##2##5##(1990-12#1)(2008-9#1)
the dopamine D2 receptor##8##4##(1990-12#2)(1990-7#1)(1993-11#2)(1995-3#2)(2008-9#1)
the dopamine D3 receptor##5##4##(1995-2#2)(1996-1#1)(1996-12#1)(2008-9#1)
the dopamine D4 receptor##2##4##(1996-5#2)
the dopamine D4##3##3##(1996-5#2)(2005-8#1)
the dopamine agonist##4##3##(1992-9#1)(1993-3#1)(1996-4#1)(2008-7#1)
the dopamine level##3##3##(1995-5#1)(1996-10#1)(2008-10#1)
the dopamine metabolite##2##3##(1995-12#2)
the dopamine receptor##3##3##(1990-5#1)(1995-3#1)(2012-1#1)
the dopamine receptors##3##3##(1995-2#1)(2007-2#1)(2013-1#1)
the dopamine system##2##3##(1994-5#1)(1996-5#1)
the dopamine transporter gene##2##4##(1995-11#1)(2009-4#1)
the dopamine transporter##8##3##(1991-12#1)(1994-12#1)(1994-9#1)(1995-11#2)(1996-4#2)(2009-4#1)
the dopamine uptake system##3##4##(1995-11#3)
the dopamine uptake##4##3##(1990-1#1)(1995-11#3)
the dopamine##76##2##(1990-1#1)(1990-10#1)(1990-12#2)(1990-2#2)(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-2#1)(1993-3#2)(1994-10#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-11#6)(1995-12#3)(1995-2#3)(1995-3#3)(1995-5#1)(1996-1#1)(1996-10#3)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#5)(1996-5#4)(1997-7#1)(1997-8#1)(2005-7#1)(2005-8#2)(2007-2#1)(2007-3#1)(2008-10#3)(2008-7#2)(2008-9#2)(2009-4#1)(2012-1#1)(2012-12#1)(2013-1#1)
the dopamine-denervated##2##2##(2008-11#2)
the dopamine-glutamate interaction##3##3##(1995-11#3)
the dopaminergic and##3##3##(1991-5#1)(1994-2#1)(2008-12#1)
the dopaminergic control of##2##4##(1993-5#1)(1995-5#1)
the dopaminergic function in##2##4##(2008-7#2)
the dopaminergic function##3##3##(2008-7#2)(2012-2#1)
the dopaminergic input is impaired##2##5##(1991-6#2)
the dopaminergic neurons of the##2##5##(1996-12#1)(2008-7#1)
the dopaminergic neurons##6##3##(1990-7#1)(1994-12#1)(1996-12#1)(2008-11#1)(2008-7#2)
the dopaminergic neurotoxicant##2##3##(1990-7#2)
the dopaminergic system in##5##4##(1996-12#1)(1996-5#1)(2008-11#3)
the dopaminergic system##14##3##(1990-2#1)(1994-5#1)(1996-10#1)(1996-12#1)(1996-5#1)(2006-9#1)(2008-11#5)(2008-7#1)(2009-6#1)(2012-1#1)
the dopaminergic##53##2##(1990-2#2)(1990-7#3)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#2)(1992-10#1)(1992-8#1)(1993-5#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-4#2)(1994-5#2)(1995-5#2)(1995-6#1)(1995-7#1)(1996-10#2)(1996-12#2)(1996-3#1)(1996-5#1)(2006-9#1)(2007-10#1)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#6)(2009-2#1)(2009-6#2)(2012-1#1)(2012-2#1)
the dopaminergically denervated neostriatum##2##4##(1994-10#2)
the dopant##3##2##(2007-12#1)(2008-3#1)(2010-11#1)
the doped##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-2#1)
the doping##8##2##(1993-3#1)(2007-12#1)(2008-10#3)(2008-5#1)(2009-11#1)(2009-2#1)
the dorsal and medial raphe##2##5##(1991-12#1)(2008-7#1)
the dorsal and the##2##4##(1991-2#1)(2008-5#1)
the dorsal and ventral##9##4##(1995-11#1)(1996-11#1)(1996-12#2)(1997-7#1)(2007-12#2)(2009-2#1)(2011-2#1)
the dorsal and##17##3##(1991-12#1)(1991-2#1)(1994-2#1)(1995-11#1)(1996-11#1)(1996-12#3)(1996-4#1)(1997-5#1)(1997-7#1)(2007-12#2)(2008-5#1)(2008-7#1)(2009-2#1)(2011-2#1)
the dorsal anterior cingulate cortex (dACC)##2##6##(2008-11#1)(2009-2#1)
the dorsal anterior cingulate##5##4##(1991-1#1)(2008-11#2)(2009-2#1)(2010-2#1)
the dorsal anterior##6##3##(1991-1#1)(2007-12#1)(2008-11#2)(2009-2#1)(2010-2#1)
the dorsal artery of the penis##2##6##(2006-5#2)
the dorsal aspect of the##3##5##(2006-10#1)(2006-3#1)(2010-2#1)
the dorsal caudate-putamen##3##3##(1993-6#2)(1996-12#1)
the dorsal column nucleus##2##4##(1997-1#2)
the dorsal column##4##3##(1997-1#2)(1997-3#2)
the dorsal columns##3##3##(1990-11#1)(1992-9#1)(2006-8#1)
the dorsal duct##2##3##(2007-5#2)
the dorsal fin and##2##4##(2010-8#1)(2013-7#1)
the dorsal fin##9##3##(2008-5#3)(2010-8#1)(2013-7#5)
the dorsal hippocampus of##2##4##(1992-3#1)(1995-12#1)
the dorsal hippocampus##11##3##(1991-2#1)(1991-5#2)(1992-3#1)(1992-8#2)(1993-12#1)(1995-12#1)(1996-12#1)(2008-11#1)(2013-8#1)
the dorsal horn and##3##4##(1991-5#1)(1995-5#1)(1996-12#1)
the dorsal horn of the rat##2##6##(1994-2#1)(1995-12#1)
the dorsal horn of the spinal cord##4##7##(2006-11#1)(2006-12#2)(2008-7#1)
the dorsal horn of the##8##5##(1990-4#1)(1990-7#1)(1994-2#1)(1995-12#1)(2006-11#1)(2006-12#2)(2008-7#1)
the dorsal horn of##10##4##(1990-4#1)(1990-7#1)(1994-2#1)(1995-11#1)(1995-12#1)(2006-11#1)(2006-12#2)(2008-7#1)(2011-2#1)
the dorsal horn that##2##4##(1996-7#1)(1997-3#1)
the dorsal horn##36##3##(1990-4#1)(1990-7#5)(1991-10#1)(1991-5#3)(1993-12#1)(1994-2#1)(1995-11#2)(1995-12#3)(1995-3#2)(1995-5#1)(1995-7#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-3#4)(2006-11#1)(2006-12#3)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)
the dorsal lateral geniculate nucleus##6##5##(1992-10#1)(1992-8#1)(1995-11#1)(1996-12#1)(1997-7#1)(1997-8#1)
the dorsal lateral##7##3##(1991-3#1)(1992-10#1)(1992-8#1)(1995-11#1)(1996-12#1)(1997-7#1)(1997-8#1)
the dorsal motor nucleus of the vagus##2##7##(1993-12#2)
the dorsal motor##3##3##(1993-12#2)(1993-9#1)
the dorsal nucleus of the lateral lemniscus##7##7##(1993-12#1)(1996-9#1)(1997-3#5)
the dorsal nucleus of##8##4##(1991-7#1)(1993-12#1)(1996-9#1)(1997-3#5)
the dorsal olfactory mucosae##2##4##(1993-3#2)
the dorsal pCG##2##3##(2009-4#2)
the dorsal papillae##2##3##(2008-5#2)
the dorsal part of the##4##5##(1994-12#1)(1995-6#1)(1996-2#1)(1996-9#1)
the dorsal portion of the##2##5##(1995-5#1)(2009-12#1)
the dorsal portions of##2##4##(1995-10#1)(2008-4#1)
the dorsal premotor area##2##4##(1995-12#1)(1995-5#1)
the dorsal premotor##5##3##(1995-12#4)(1995-5#1)
the dorsal prestriate##3##3##(1993-9#3)
the dorsal raphe and##2##4##(1994-2#1)(1995-6#1)
the dorsal raphe nucleus##5##4##(1992-3#2)(1993-12#1)(1995-5#1)(1995-6#1)
the dorsal raphe##13##3##(1991-2#1)(1992-3#2)(1993-12#1)(1994-2#3)(1995-5#1)(1995-6#2)(1996-12#1)(1996-4#1)(1997-6#1)
the dorsal region of##2##4##(1991-5#1)(1994-9#1)
the dorsal region##3##3##(1991-5#1)(1994-9#1)(2009-3#1)
the dorsal root ganglia##6##4##(1990-4#1)(1994-2#1)(1996-11#1)(1996-3#1)(1997-3#1)(2008-9#1)
the dorsal root ganglion##17##4##(1993-4#2)(1995-12#2)(1996-3#2)(1996-7#1)(1997-2#2)(2006-12#3)(2006-8#1)(2008-8#1)(2011-2#1)(2012-2#2)
the dorsal root##25##3##(1990-4#1)(1991-5#1)(1993-4#2)(1994-2#1)(1995-12#2)(1996-11#1)(1996-3#3)(1996-5#1)(1996-7#1)(1997-2#2)(1997-3#1)(2006-12#3)(2006-8#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#2)
the dorsal side##7##3##(1995-8#1)(2007-12#1)(2008-5#3)(2008-7#1)(2011-2#1)
the dorsal spine##2##3##(2008-1#1)(2009-9#1)
the dorsal striatum##4##3##(1993-6#1)(1996-2#1)(2010-2#1)(2013-8#1)
the dorsal surface of the foot##2##6##(2012-3#2)
the dorsal surface of the##6##5##(1997-5#1)(2007-11#1)(2008-4#1)(2011-2#1)(2012-3#2)
the dorsal surface of##7##4##(1997-5#1)(2005-5#1)(2007-11#1)(2008-4#1)(2011-2#1)(2012-3#2)
the dorsal surface##9##3##(1997-5#1)(2005-5#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-3#2)
the dorsal third##2##3##(1993-12#1)(1996-3#1)
the dorsal visual stream##2##4##(1995-12#2)
the dorsal##276##2##(1990-11#1)(1990-4#2)(1990-7#6)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#5)(1991-5#8)(1991-7#1)(1992-10#1)(1992-3#3)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#9)(1993-2#2)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#3)(1993-7#2)(1993-9#5)(1994-12#1)(1994-2#6)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#4)(1995-12#13)(1995-3#2)(1995-5#4)(1995-6#3)(1995-7#1)(1995-8#1)(1996-11#2)(1996-12#8)(1996-2#3)(1996-3#4)(1996-4#2)(1996-5#2)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#12)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-12#6)(2006-3#4)(2006-4#3)(2006-5#3)(2006-7#1)(2006-8#3)(2007-11#1)(2007-12#19)(2007-5#2)(2007-8#2)(2008-1#1)(2008-11#3)(2008-2#1)(2008-4#3)(2008-5#12)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#4)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#4)(2010-8#1)(2011-2#5)(2012-12#8)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#5)(2013-8#4)
the dorsogluteal##2##2##(2013-8#2)
the dorsolateral division##2##3##(1996-6#1)(1997-8#1)
the dorsolateral prefrontal cortex (DLPFC)##2##5##(2006-9#1)(2008-10#1)
the dorsolateral prefrontal cortex##4##4##(1995-1#1)(2006-9#1)(2008-10#1)(2010-7#1)
the dorsolateral region##2##3##(1993-9#1)(2008-7#1)
the dorsolateral##22##2##(1991-2#1)(1991-5#1)(1992-1#1)(1992-3#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-5#1)(1996-6#1)(1997-5#1)(1997-8#1)(2006-9#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-7#2)(2010-7#1)(2012-12#2)
the dorsomedial posterior tubercle##2##4##(1997-3#2)
the dorsomedial##14##2##(1992-1#1)(1992-8#1)(1993-12#1)(1994-2#5)(1994-8#1)(1996-5#1)(1997-3#2)(1997-5#1)(2008-4#1)
the dorsoventral plane##3##3##(1990-3#1)(1997-3#2)
the dorsoventral##7##2##(1990-3#1)(1991-5#1)(1994-3#1)(1997-3#2)(1997-4#1)(2010-4#1)
the dorsum of the foot##2##5##(2008-4#1)(2012-3#1)
the dorsum of the tongue##4##5##(1997-4#1)(2006-2#2)(2006-8#1)
the dorsum of the##11##4##(1997-4#1)(2006-2#2)(2006-3#2)(2006-8#1)(2007-7#2)(2008-4#1)(2008-6#1)(2012-3#1)
the dorsum of##13##3##(1996-7#1)(1997-4#1)(2006-2#2)(2006-3#2)(2006-8#1)(2007-7#2)(2008-4#1)(2008-6#1)(2010-3#1)(2012-3#1)
the dorsum##16##2##(1996-7#1)(1997-4#1)(2006-2#2)(2006-3#2)(2006-5#1)(2006-8#1)(2007-12#1)(2007-7#2)(2008-4#1)(2008-6#1)(2010-3#1)(2010-8#1)(2012-3#1)
the dosage and##3##3##(1994-6#1)(2007-11#1)(2013-1#1)
the dosage compensation complex##2##4##(2007-12#2)
the dosage forms##3##3##(2005-10#1)(2008-10#1)(2012-2#1)
the dosage of dietary##2##4##(2012-2#2)
the dosage of the##3##4##(2006-6#1)(2008-8#1)(2011-2#1)
the dosage of##13##3##(1991-2#1)(1994-3#1)(1997-5#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-8#1)(2008-11#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-2#2)
the dosage was##2##3##(1990-5#1)(1997-6#1)
the dosage##34##2##(1990-4#1)(1990-5#1)(1990-9#1)(1991-2#2)(1992-6#1)(1994-3#1)(1994-6#3)(1997-5#1)(1997-6#1)(2005-10#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-2#4)(2013-1#1)
the dosages##4##2##(1993-10#2)(2008-3#1)(2008-8#1)
the dose 1##2##3##(1991-4#1)(2007-3#1)
the dose administered##3##3##(1991-11#1)(1994-3#1)(2008-7#1)
the dose and the##4##4##(1992-4#1)(1993-3#1)(2007-12#1)(2008-2#1)
the dose and##7##3##(1992-4#1)(1993-2#1)(1993-3#1)(1995-12#1)(1997-1#1)(2007-12#1)(2008-2#1)
the dose at 100 cm with##2##6##(2010-9#2)
the dose at 100 cm##3##5##(2010-9#3)
the dose at##6##3##(1994-11#1)(2007-10#1)(2010-9#4)
the dose delivered from the##2##5##(1995-3#1)(1997-2#1)
the dose delivered to the##2##5##(2010-12#2)
the dose delivered##4##3##(1995-3#1)(1997-2#1)(2010-12#2)
the dose for##3##3##(1993-4#1)(1996-10#1)(2010-2#1)
the dose given##2##3##(1997-8#1)(2008-5#1)
the dose in##4##3##(1992-10#1)(1993-6#1)(1994-8#1)(2008-6#1)
the dose is##6##3##(1993-12#1)(1995-3#1)(2008-10#1)(2008-3#1)(2010-8#1)(2011-1#1)
the dose of 0##4##4##(1990-9#1)(1994-2#1)(2011-1#2)
the dose of 1##3##4##(1993-11#1)(1994-5#1)(1996-1#1)
the dose of 2##2##4##(1992-3#1)(1996-2#1)
the dose of 200 and 400 mg/kg significantly##2##8##(2010-3#2)
the dose of 5##2##4##(2011-1#1)(2012-3#1)
the dose of 500 mg/kg##2##5##(2013-1#2)
the dose of the##2##4##(1996-7#1)(2007-11#1)
the dose of##69##3##(1990-11#1)(1990-2#1)(1990-9#2)(1991-2#1)(1991-4#1)(1992-12#2)(1992-3#1)(1993-1#1)(1993-11#2)(1993-3#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-7#1)(1997-3#1)(2005-9#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#2)(2010-2#2)(2010-3#2)(2011-1#3)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#7)(2013-8#3)
the dose range of##4##4##(1991-10#1)(1992-4#1)(1994-8#2)
the dose range##8##3##(1991-10#1)(1992-4#1)(1993-6#1)(1994-8#2)(2005-7#1)(2008-7#2)
the dose received##2##3##(2009-10#1)(2009-11#1)
the dose required##2##3##(2007-12#1)(2008-10#1)
the dose response curve##2##4##(2004-12#1)(2012-1#1)
the dose response##8##3##(1996-11#1)(2004-12#1)(2005-9#1)(2007-3#2)(2008-7#2)(2012-1#1)
the dose that##2##3##(2007-12#1)(2008-4#1)
the dose to OARs##2##4##(2009-5#2)
the dose to##5##3##(2007-11#2)(2009-5#2)(2013-1#1)
the dose used in##2##4##(2011-1#2)
the dose used##3##3##(2008-10#1)(2011-1#2)
the dose was at least##2##5##(1990-5#1)(2007-5#1)
the dose was##8##3##(1990-3#1)(1990-5#1)(1991-2#1)(1991-7#2)(2006-10#1)(2007-5#1)(2007-7#1)
the dose##207##2##(1990-11#1)(1990-2#1)(1990-3#4)(1990-5#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-2#2)(1991-4#2)(1991-7#2)(1992-10#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#2)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#4)(1995-12#3)(1995-2#4)(1995-3#3)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#2)(2004-12#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#3)(2007-12#3)(2007-3#3)(2007-5#1)(2007-7#2)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#12)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#6)(2009-7#1)(2009-8#3)(2010-12#4)(2010-2#4)(2010-3#2)(2010-8#1)(2010-9#4)(2011-1#6)(2011-2#2)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#11)(2013-8#3)
the dose- and time-dependent##2##4##(1992-7#1)(1993-3#1)
the dose- and##3##3##(1990-2#1)(1992-7#1)(1993-3#1)
the dose-##4##2##(1990-2#1)(1992-7#1)(1993-3#1)(2006-9#1)
the dose-dependent##7##2##(1991-12#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-12#2)
the dose-effect##2##2##(1993-6#1)(2008-7#1)
the dose-finding##2##2##(2011-1#2)
the dose-limiting##2##2##(2008-1#1)(2008-8#1)
the dose-related##4##2##(1994-8#1)(2006-2#1)(2008-3#1)(2011-2#1)
the dose-response curve for##5##4##(1990-2#1)(1990-7#1)(1993-6#1)(1996-2#1)(1997-4#1)
the dose-response curve##9##3##(1990-2#1)(1990-7#1)(1993-6#1)(1994-11#2)(1996-2#1)(1997-1#1)(1997-4#1)(2007-9#1)
the dose-response curves and##2##4##(1992-3#1)(1995-12#1)
the dose-response curves##6##3##(1990-8#1)(1992-3#1)(1994-12#1)(1995-10#1)(1995-12#1)(2008-7#1)
the dose-response for##3##3##(1995-3#2)(2008-7#1)
the dose-response relationship between##2##4##(2007-4#1)(2008-10#1)
the dose-response relationship##7##3##(1990-2#1)(1991-7#1)(1992-9#1)(1996-6#1)(2007-4#1)(2008-10#1)(2008-4#1)
the dose-response##32##2##(1990-2#2)(1990-7#1)(1990-8#1)(1991-7#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-11#3)(1994-12#1)(1995-10#1)(1995-12#1)(1995-3#2)(1996-2#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-4#1)(2007-4#1)(2007-9#1)(2008-10#3)(2008-4#1)(2008-7#2)(2009-5#1)(2012-2#1)
the dose-volume##2##2##(2008-3#1)(2009-8#1)
the dose/response##2##2##(1991-2#1)(2008-10#1)
the doses administered##3##3##(1993-4#1)(2008-4#1)(2010-12#1)
the doses and##2##3##(1991-10#1)(2005-11#1)
the doses of the##2##4##(2007-9#1)(2008-7#1)
the doses of##15##3##(1991-12#1)(1991-3#1)(1993-11#1)(2007-11#1)(2007-9#1)(2008-7#3)(2009-6#1)(2010-3#1)(2013-1#3)(2013-8#2)
the doses required##2##3##(1990-5#1)(2008-6#1)
the doses tested##6##3##(1990-11#1)(1994-11#1)(1996-8#1)(1997-2#1)(2005-7#1)(2010-1#1)
the doses used##3##3##(1992-10#1)(1993-11#1)(2013-1#1)
the doses##44##2##(1990-11#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-10#1)(1993-11#3)(1993-4#1)(1993-7#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-8#1)(1997-2#1)(2005-11#1)(2005-7#1)(2007-11#2)(2007-4#1)(2007-9#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-3#2)(2013-1#4)(2013-8#2)
the dosimeters##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
the dosing of##2##3##(2008-10#1)(2011-1#1)
the dosing regimen of##2##4##(2006-8#1)(2007-11#1)
the dosing##12##2##(1992-4#1)(1996-3#1)(1997-2#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#1)(2011-1#1)
the dot##4##2##(1994-1#1)(2006-11#1)(2008-3#1)(2009-11#1)
the dots##4##2##(2007-11#1)(2008-5#1)(2008-7#2)
the double bond of##2##4##(1991-12#1)(2012-11#1)
the double bond##7##3##(1990-2#1)(1991-12#1)(1992-11#1)(1992-6#1)(2005-8#1)(2007-11#1)(2012-11#1)
the double frequency##2##3##(2007-12#2)
the double helix##6##3##(1992-6#1)(1995-6#1)(1995-8#1)(1997-6#2)(2008-7#1)
the double layer##4##3##(2005-11#2)(2008-5#2)
the double layers##2##3##(2005-11#2)
the double lumen tube##2##4##(2006-10#2)
the double lumen##3##3##(2005-12#1)(2006-10#2)
the double mutant receptor##2##4##(1995-6#2)
the double mutant##15##3##(1991-4#1)(1993-3#1)(1995-10#1)(1995-11#1)(1995-6#3)(1995-8#2)(1997-1#1)(1997-4#1)(2006-12#1)(2007-11#1)(2009-8#1)(2012-11#1)
the double mutation##2##3##(1990-5#1)(1996-5#1)
the double positive##2##3##(2008-10#1)(2013-1#1)
the double stranded##6##3##(1991-7#1)(1992-12#1)(2006-10#1)(2007-6#1)(2008-10#2)
the double##92##2##(1990-2#1)(1990-4#1)(1990-5#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-6#2)(1992-8#1)(1993-2#1)(1993-3#1)(1994-5#1)(1995-10#1)(1995-11#1)(1995-6#6)(1995-8#5)(1996-11#1)(1996-12#1)(1996-5#2)(1997-1#2)(1997-4#1)(1997-6#2)(2005-11#4)(2005-12#1)(2005-8#1)(2006-10#3)(2006-12#2)(2007-1#1)(2007-11#2)(2007-12#2)(2007-6#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#4)(2008-5#4)(2008-7#2)(2008-9#2)(2009-10#2)(2009-8#3)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#1)
the double-blind##2##2##(1995-3#1)(2007-11#1)
the double-clad##2##2##(2007-12#2)
the double-deficit hypothesis##2##3##(2007-9#2)
the double-edge molecular technique##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
the double-edge technique##7##3##(2008-2#4)(2008-3#3)
the double-edge##14##2##(2007-12#1)(2008-2#7)(2008-3#6)
the double-labeling##2##2##(1991-8#1)(1996-11#1)
the double-layer interferometer##2##3##(2008-3#2)
the double-layer relaxation##2##3##(2005-11#2)
the double-layer##6##2##(2005-11#2)(2008-2#1)(2008-3#2)(2009-2#1)
the double-lumen tube##3##3##(2006-10#3)
the double-placebo group##3##3##(1995-9#2)(2007-11#1)
the double-stranded DNA##5##3##(1992-3#1)(1993-3#1)(2008-10#1)(2010-5#2)
the double-stranded##12##2##(1992-3#1)(1992-9#1)(1993-3#1)(1996-5#1)(1996-7#1)(2008-10#3)(2008-7#1)(2008-9#1)(2010-5#2)
the doubled haploid##2##3##(2008-10#2)
the doubled##3##2##(2007-11#1)(2008-10#2)
the doublet##4##2##(1994-11#1)(2005-11#1)(2008-3#2)
the doubling crystal##2##3##(2008-3#2)
the doubling##4##2##(1995-7#1)(2008-1#1)(2008-3#2)
the doubly adaptive##2##3##(2008-2#2)
the doubly resonant##2##3##(2008-2#1)(2008-3#1)
the doubly##19##2##(1990-8#2)(1991-3#1)(1991-7#1)(1992-3#1)(1994-10#1)(1995-8#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-2#4)(2008-3#3)(2013-8#1)
the down regulation of##3##4##(1990-3#1)(2006-5#1)(2007-10#1)
the down##7##2##(1990-3#1)(1990-8#2)(2006-5#1)(2007-10#1)(2008-11#2)
the down-regulation of the##2##4##(1991-3#1)(2008-7#1)
the down-regulation of##20##3##(1991-3#1)(1992-11#1)(1992-5#1)(1993-8#1)(1994-3#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-4#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#2)(2011-2#1)(2012-2#1)
the down-regulation##22##2##(1991-3#1)(1992-11#1)(1992-5#1)(1993-8#1)(1994-3#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#2)(1997-4#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#2)(2011-2#1)(2012-2#1)
the downconverted##2##2##(2007-12#2)
the downgrading##2##2##(1990-9#2)
the downregulation of##4##3##(1996-4#1)(2007-10#2)(2012-2#1)
the downsizing process##2##3##(1994-3#1)(1996-12#1)
the downsizing##5##2##(1994-3#1)(1996-12#1)(1997-2#1)(2008-10#1)(2012-3#1)
the downstream NF-kappaB site##3##4##(1997-7#3)
the downstream component of oriLyt##2##5##(1997-3#2)
the downstream component##4##3##(1997-3#4)
the downstream effector of##2##4##(2008-5#1)(2010-5#1)
the downstream gene##2##3##(1995-8#1)(2008-9#1)
the downstream of##2##3##(2007-8#1)(2008-8#1)
the downstream processing of##2##4##(1996-10#1)(2008-4#1)
the downstream region of##2##4##(1992-4#1)(2008-9#1)
the downstream region##3##3##(1992-4#2)(2008-9#1)
the downstream target##2##3##(1997-7#1)(2012-2#1)
the downstream##55##2##(1991-4#1)(1991-5#2)(1991-9#2)(1992-4#2)(1992-9#1)(1993-3#1)(1994-11#2)(1994-2#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-7#4)(2007-11#1)(2007-8#2)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#4)(2009-10#3)(2010-5#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
the downward##8##2##(2007-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2012-12#2)
the downy mildew##3##3##(2008-10#2)(2012-3#1)
the downy##4##2##(2008-10#2)(2008-12#1)(2012-3#1)
the dowsers##2##2##(1997-6#2)
the doxorubicin##2##2##(2011-2#2)
the dozen##2##2##(2007-6#1)(2007-9#1)
the draft##6##2##(2007-1#1)(2008-3#1)(2008-9#2)(2010-3#1)(2012-12#1)
the drag##3##2##(2005-11#3)
the drain of precursors##2##4##(2008-7#2)
the drain##9##2##(1990-10#1)(2008-7#2)(2008-8#1)(2010-7#1)(2011-2#4)
the drainage##8##2##(1991-3#1)(2006-6#1)(2007-10#1)(2007-8#2)(2010-12#1)(2011-1#1)(2011-2#1)
the draining lymph nodes and##2##5##(2008-10#1)(2008-4#1)
the draining lymph nodes##4##4##(1997-2#1)(2008-10#2)(2008-4#1)
the draining vein##2##3##(2006-6#1)(2008-7#1)
the draining veins##4##3##(1997-3#1)(2008-7#2)(2012-3#1)
the draining##12##2##(1997-2#1)(1997-3#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-7#3)(2012-3#1)
the dramatic increase in##4##4##(1997-3#1)(2006-12#1)(2006-5#1)(2013-1#1)
the dramatic increase of##2##4##(1995-10#1)(1997-4#1)
the dramatic increase##6##3##(1995-10#1)(1997-3#1)(1997-4#1)(2006-12#1)(2006-5#1)(2013-1#1)
the dramatic##19##2##(1992-11#1)(1995-10#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-3#1)(2012-12#1)(2013-1#2)
the drastic##5##2##(1992-7#1)(2007-2#1)(2007-8#1)(2008-5#1)(2010-8#1)
the drawback of##4##3##(1992-10#1)(2007-12#1)(2008-12#1)(2008-3#1)
the drawbacks of the##2##4##(2008-10#2)
the drawbacks of##7##3##(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-7#1)(2012-1#1)
the drawbacks##8##2##(1990-2#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-7#1)(2012-1#1)
the drawing##4##2##(2007-10#1)(2007-12#1)(2008-3#1)(2009-9#1)
the drawn##4##2##(2008-3#2)(2009-10#2)
the dreaded##2##2##(1990-11#1)(1993-2#1)
the dream of##4##3##(1993-6#1)(2007-9#1)(2010-8#1)(2011-1#1)
the dream##10##2##(1993-6#1)(2007-9#1)(2008-12#1)(2008-2#3)(2010-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
the dreamer's##2##2##(2008-2#2)
the dried##10##2##(1994-3#1)(2006-12#1)(2007-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-5#2)(2010-4#1)(2012-2#1)
the driest##4##2##(2007-3#1)(2008-10#1)(2008-5#2)
the drift of the##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
the drift of##5##3##(2007-11#1)(2008-10#1)(2008-3#2)(2010-4#1)
the drift##11##2##(1992-6#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#2)(2010-4#1)(2012-2#1)
the drill##2##2##(1996-2#1)(2012-2#1)
the drilling##3##2##(1991-3#1)(2007-5#1)(2011-1#1)
the drinker##3##2##(2005-10#3)
the drinking response to##2##4##(1991-6#1)(1991-8#1)
the drinking water for##4##4##(2008-10#1)(2008-4#1)(2008-9#2)
the drinking water of##2##4##(2008-10#1)(2013-8#1)
the drinking water##26##3##(1990-4#1)(1990-6#1)(1995-12#1)(1995-3#1)(1996-10#1)(1997-2#1)(2007-10#1)(2007-8#2)(2008-10#4)(2008-4#1)(2008-5#3)(2008-9#7)(2013-7#1)(2013-8#1)
the drinking##36##2##(1990-4#1)(1990-6#1)(1991-6#2)(1991-8#1)(1993-12#1)(1994-11#1)(1995-12#2)(1995-3#1)(1996-10#1)(1997-2#1)(2005-10#1)(2007-10#1)(2007-3#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#3)(2008-9#7)(2012-12#1)(2013-7#1)(2013-8#1)
the drip##5##2##(2007-7#1)(2008-10#1)(2010-4#1)(2011-2#1)(2013-8#1)
the drive for muscularity##3##4##(2007-12#3)
the drive for##4##3##(2006-10#1)(2007-12#3)
the drive to##2##3##(2008-1#1)(2010-12#1)
the drive##9##2##(1996-5#1)(2006-10#1)(2007-12#3)(2008-1#1)(2008-11#1)(2009-5#1)(2010-12#1)
the driven##2##2##(1992-4#1)(2012-1#1)
the driver are##2##3##(2007-4#1)(2008-2#1)
the driver##5##2##(2006-11#1)(2007-4#1)(2008-2#1)(2012-12#1)(2013-7#1)
the driver's##3##2##(1994-6#1)(2008-4#1)(2012-1#1)
the drivers##5##2##(1997-2#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-8#1)
the driving force behind##3##4##(1997-6#1)(2010-12#1)(2012-3#1)
the driving force for the##2##5##(1996-2#1)(2008-5#1)
the driving force for##8##4##(1994-2#1)(1996-2#1)(1997-4#1)(2007-8#1)(2008-5#2)(2009-2#1)(2013-8#1)
the driving force of##4##4##(1991-12#1)(2008-5#2)(2010-2#1)
the driving force##16##3##(1991-12#1)(1994-2#1)(1996-2#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-8#1)(2008-5#4)(2009-2#1)(2010-12#1)(2010-2#1)(2012-3#1)(2013-8#1)
the driving forces of##2##4##(2007-11#1)(2008-7#1)
the driving forces##4##3##(1996-2#1)(2005-11#1)(2007-11#1)(2008-7#1)
the driving##32##2##(1991-11#1)(1991-12#1)(1993-1#1)(1994-2#1)(1994-8#1)(1996-2#2)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#1)(2009-2#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
the drop and##3##3##(2005-11#1)(2008-10#1)(2010-4#1)
the drop base and##5##4##(2005-11#5)
the drop base##11##3##(2005-11#11)
the drop profile##2##3##(2005-11#2)
the drop size##2##3##(2005-11#1)(2008-2#1)
the drop volume##4##3##(2005-11#2)(2008-10#2)
the drop##52##2##(1991-5#3)(1995-9#1)(2005-11#31)(2007-11#1)(2007-12#1)(2008-10#9)(2008-2#1)(2008-5#1)(2010-4#2)(2013-1#2)
the drop-out mechanism for the##2##5##(1997-7#2)
the droplet and##3##3##(1995-3#1)(2008-10#1)(2010-4#1)
the droplet diameter##3##3##(2008-10#2)(2008-2#1)
the droplet is##2##3##(1994-9#1)(2008-10#1)
the droplet size##2##3##(2005-11#1)(2008-3#1)
the droplet##29##2##(1994-9#2)(1995-3#1)(2005-11#5)(2006-12#1)(2007-12#4)(2008-1#1)(2008-10#4)(2008-2#5)(2008-3#3)(2008-7#1)(2010-4#1)(2012-2#1)
the droplet's##3##2##(2006-12#1)(2007-12#1)(2008-2#1)
the droplets and the##3##4##(1995-3#1)(2005-11#1)(2008-2#1)
the droplets##15##2##(1995-3#2)(1996-3#1)(2005-11#5)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-2#1)(2013-8#1)
the dropout rate##2##3##(2008-12#1)(2011-1#1)
the dropout##3##2##(2008-12#1)(2011-1#2)
the dropping mercury electrode##5##4##(2008-10#5)
the dropping##6##2##(1991-12#1)(2008-10#5)
the drops##7##2##(1994-2#1)(2005-11#3)(2008-10#1)(2009-5#1)(2013-7#1)
the drought resistance of the##2##5##(2013-8#2)
the drought treatment##2##3##(2009-8#1)(2012-7#1)
the drought##6##2##(2009-8#2)(2012-7#1)(2013-8#3)
the drought-resistance of##2##3##(2013-8#2)
the drought-resistance##4##2##(2013-8#4)
the drug administration##3##3##(1991-4#1)(1992-6#1)(2007-10#1)
the drug and its##2##4##(1990-12#1)(2008-5#1)
the drug and the##3##4##(1990-12#1)(1994-5#1)(2008-10#1)
the drug and##15##3##(1990-12#2)(1990-3#1)(1992-1#1)(1993-6#1)(1994-5#1)(1995-4#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-5#1)(2010-9#1)(2011-2#1)(2012-12#1)
the drug at lower##2##4##(1991-10#1)(2006-10#1)
the drug at##6##3##(1991-10#1)(1993-8#1)(1995-2#1)(2006-10#1)(2008-10#2)
the drug benefit##2##3##(1995-1#1)(2007-9#1)
the drug binding##3##3##(1991-2#1)(1995-5#1)(2008-10#1)
the drug both##3##3##(2005-9#1)(2009-8#1)(2010-12#1)
the drug by##4##3##(2007-11#1)(2008-10#1)(2008-7#1)(2010-8#1)
the drug can be##4##4##(1993-6#1)(2005-9#1)(2007-9#1)(2009-8#1)
the drug can##5##3##(1993-6#1)(1994-3#1)(2005-9#1)(2007-9#1)(2009-8#1)
the drug companies##2##3##(1992-5#1)(1996-5#1)
the drug compartment##3##3##(1994-6#3)
the drug concentration range##2##4##(1990-2#1)(2012-12#1)
the drug concentration time curve##2##5##(1996-3#1)(2008-11#1)
the drug concentration##5##3##(1990-2#1)(1996-3#1)(2008-11#1)(2008-7#1)(2012-12#1)
the drug content##5##3##(2010-2#2)(2010-3#2)(2012-2#1)
the drug delivery##6##3##(2008-2#1)(2009-4#1)(2009-6#1)(2012-2#2)(2012-3#1)
the drug development##2##3##(2008-8#1)(2013-7#1)
the drug discovery and development##2##5##(2005-9#1)(2008-4#1)
the drug discovery and##3##4##(2005-9#1)(2008-4#1)(2011-3#1)
the drug discovery process##4##4##(2005-8#1)(2008-10#1)(2008-7#1)(2010-12#1)
the drug discovery##10##3##(2005-8#1)(2005-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-12#1)(2011-3#1)
the drug disorder diagnosed population##2##5##(1993-12#2)
the drug dose##2##3##(2006-10#1)(2008-7#1)
the drug for the treatment of##2##6##(2005-7#1)(2009-10#1)
the drug for the##4##4##(2005-7#1)(2009-10#1)(2010-2#1)(2012-3#1)
the drug for##9##3##(1992-5#1)(2005-7#1)(2005-8#1)(2007-11#1)(2008-11#1)(2008-8#1)(2009-10#1)(2010-2#1)(2012-3#1)
the drug from its##3##4##(2008-10#2)(2010-5#1)
the drug from##7##3##(1990-11#1)(2008-10#3)(2009-11#1)(2010-12#1)(2010-5#1)
the drug had a##3##4##(1990-10#1)(2005-8#1)(2008-1#1)
the drug has##5##3##(1990-6#1)(1994-2#1)(1995-4#1)(2005-7#1)(2009-10#1)
the drug in a##3##4##(1990-4#1)(2007-8#1)(2008-10#1)
the drug in the##9##4##(1990-11#1)(2005-7#1)(2007-3#1)(2007-9#1)(2008-10#3)(2010-11#2)
the drug in urine and##2##5##(2008-10#2)
the drug in##37##3##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1992-5#1)(1992-9#2)(1993-2#1)(2005-7#1)(2007-11#2)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#16)(2008-8#1)(2009-10#1)(2010-11#2)(2010-12#1)(2013-7#1)
the drug industry##4##3##(1996-2#1)(2006-12#1)(2008-1#1)(2008-5#1)
the drug is taken##2##4##(1996-12#1)(2008-3#1)
the drug is##24##3##(1990-3#1)(1991-5#1)(1992-3#1)(1992-7#1)(1994-12#1)(1994-6#1)(1996-1#1)(1996-12#1)(1997-4#1)(2005-8#2)(2006-4#2)(2007-11#2)(2007-9#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
the drug loading##3##3##(2011-2#1)(2012-11#2)
the drug market##2##3##(1996-5#1)(2008-1#1)
the drug may##2##3##(2007-11#1)(2008-8#1)
the drug of choice for##3##5##(1991-10#1)(1991-12#1)(2008-11#1)
the drug of choice in the##2##6##(1990-7#1)(2011-2#1)
the drug of choice in##6##5##(1990-7#1)(2006-8#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
the drug of choice##13##4##(1990-7#1)(1991-10#1)(1991-12#1)(2006-10#3)(2006-11#1)(2006-8#1)(2008-11#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
the drug of##14##3##(1990-7#1)(1991-10#1)(1991-12#1)(1991-3#1)(2006-10#3)(2006-11#1)(2006-8#1)(2008-11#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
the drug release##10##3##(2006-1#1)(2009-2#1)(2010-1#2)(2011-2#1)(2012-2#4)(2012-3#1)
the drug resistance##2##3##(1994-11#1)(2010-12#1)
the drug should be##3##4##(2010-12#1)(2013-1#2)
the drug should##4##3##(1992-9#1)(2010-12#1)(2013-1#2)
the drug showed##2##3##(1994-6#1)(2008-5#1)
the drug shows##3##3##(1996-10#1)(2008-10#1)(2010-4#1)
the drug significantly##2##3##(2008-5#2)
the drug solution and##2##4##(2008-10#1)(2012-12#1)
the drug solution##3##3##(2008-10#2)(2012-12#1)
the drug structure##2##3##(1991-2#1)(1995-5#1)
the drug substance##7##3##(1992-2#2)(1992-7#1)(1997-2#1)(2008-10#2)(2011-2#1)
the drug that##2##3##(1994-6#1)(2009-1#1)
the drug to be##3##4##(1990-3#1)(1996-1#1)(2008-8#1)
the drug to##8##3##(1990-3#1)(1990-6#1)(1991-2#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)
the drug transport##2##3##(1990-5#1)(2005-8#1)
the drug treatment##8##3##(1990-3#1)(1993-7#1)(1993-9#1)(1997-6#1)(2006-12#1)(2008-10#1)(2008-5#1)(2011-2#1)
the drug used##3##3##(2005-10#1)(2010-4#1)(2011-2#1)
the drug was injected##2##4##(1993-12#1)(2012-1#1)
the drug was##26##3##(1990-6#1)(1991-6#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-5#1)(1996-7#1)(1996-9#1)(2005-11#1)(2005-7#2)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-7#1)(2010-1#1)(2010-5#2)(2012-1#2)(2012-12#1)
the drug were##9##3##(1990-10#1)(1990-9#1)(1997-2#1)(2004-12#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-11#1)
the drug will##2##3##(2007-9#2)
the drug within##2##3##(1992-2#1)(2007-11#1)
the drug##540##2##(1990-10#3)(1990-11#4)(1990-12#2)(1990-2#6)(1990-3#4)(1990-4#2)(1990-5#5)(1990-6#5)(1990-7#2)(1990-9#1)(1991-1#1)(1991-10#3)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#5)(1991-4#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#2)(1992-2#4)(1992-3#3)(1992-5#5)(1992-6#1)(1992-7#4)(1992-9#6)(1993-11#1)(1993-12#3)(1993-2#2)(1993-6#2)(1993-7#1)(1993-8#4)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#8)(1994-8#3)(1994-9#2)(1995-1#3)(1995-11#2)(1995-12#3)(1995-2#1)(1995-4#2)(1995-5#3)(1995-6#2)(1995-7#2)(1995-9#2)(1996-1#3)(1996-10#4)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#4)(1996-7#2)(1996-9#1)(1997-2#6)(1997-3#2)(1997-4#4)(1997-5#2)(1997-6#3)(1997-7#2)(2004-1#1)(2004-12#2)(2005-10#3)(2005-11#2)(2005-12#1)(2005-7#8)(2005-8#9)(2005-9#4)(2006-1#1)(2006-10#14)(2006-11#2)(2006-12#4)(2006-2#1)(2006-4#4)(2006-5#3)(2006-6#3)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#22)(2007-12#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#4)(2007-7#4)(2007-8#2)(2007-9#13)(2008-1#6)(2008-10#63)(2008-11#13)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#24)(2008-6#3)(2008-7#9)(2008-8#13)(2008-9#1)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#2)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#3)(2010-11#3)(2010-12#13)(2010-2#4)(2010-3#3)(2010-4#3)(2010-5#7)(2010-8#3)(2010-9#1)(2011-2#13)(2011-3#1)(2012-1#3)(2012-11#3)(2012-12#9)(2012-2#8)(2012-3#5)(2013-1#4)(2013-7#2)(2013-8#1)
the drug's##13##2##(1991-2#1)(1994-8#1)(2004-3#1)(2005-9#1)(2006-7#1)(2008-5#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
the drug-adsorption mechanism##2##3##(1994-6#2)
the drug-eluting##2##2##(2008-11#1)(2010-4#1)
the drug-induced##3##2##(1992-9#1)(1993-3#1)(2011-2#1)
the drug-loaded##3##2##(2008-5#1)(2009-2#1)(2013-7#1)
the drug-metabolizing system##2##3##(2008-10#2)
the drug-resistance##2##2##(1993-7#1)(2005-4#1)
the drug-sensitive##3##2##(1991-9#1)(1992-8#1)(1994-8#1)
the drugs and##7##3##(1992-12#1)(1996-5#1)(2006-12#1)(2008-10#1)(2009-10#1)(2009-7#1)(2013-8#1)
the drugs are##3##3##(1990-5#1)(1994-9#1)(2005-11#1)
the drugs from##2##3##(2007-8#1)(2008-10#1)
the drugs have##4##3##(2007-11#2)(2010-11#1)(2013-1#1)
the drugs of choice for##2##5##(2005-8#1)(2008-5#1)
the drugs of choice in the##2##6##(1994-6#1)(2008-1#1)
the drugs of choice in##3##5##(1994-6#1)(2007-11#1)(2008-1#1)
the drugs of choice##7##4##(1994-6#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-5#1)
the drugs of##8##3##(1994-6#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-8#1)
the drugs that##3##3##(2007-6#1)(2008-10#1)(2008-8#1)
the drugs themselves##2##3##(1990-1#1)(2010-11#1)
the drugs used to##2##4##(1996-3#1)(2011-1#1)
the drugs used##11##3##(1994-11#1)(1996-1#1)(1996-3#1)(2006-10#1)(2007-7#1)(2007-9#1)(2009-6#2)(2010-12#2)(2011-1#1)
the drugs was##3##3##(2007-8#1)(2008-7#1)(2010-2#1)
the drugs were##5##3##(1992-9#1)(1994-3#1)(2007-7#2)(2010-2#1)
the drugs which##3##3##(1991-11#1)(1991-2#1)(2008-10#1)
the drugs##156##2##(1990-1#2)(1990-11#1)(1990-2#2)(1990-5#1)(1990-8#3)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-8#1)(1991-9#2)(1992-12#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-6#1)(1996-1#2)(1996-10#1)(1996-12#3)(1996-3#1)(1996-5#5)(1997-1#1)(1997-4#3)(1997-5#1)(2005-11#2)(2005-4#1)(2005-8#4)(2005-9#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#7)(2007-2#1)(2007-6#2)(2007-7#8)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#26)(2008-11#3)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#6)(2009-10#1)(2009-6#3)(2009-7#1)(2010-11#3)(2010-12#5)(2010-2#3)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the drugs'##2##2##(1990-1#1)(2006-10#1)
the drum##2##2##(2008-4#1)(2008-9#1)
the dry and rainy seasons##4##5##(2007-5#1)(2007-8#2)(2013-7#1)
the dry and wet seasons##2##5##(2006-4#1)(2007-6#1)
the dry and##6##3##(2006-4#1)(2007-5#1)(2007-6#1)(2007-8#2)(2013-7#1)
the dry chemistry##3##3##(1992-12#3)
the dry forest##2##3##(2008-5#2)
the dry matter##2##3##(2008-10#1)(2008-5#1)
the dry period##3##3##(2005-7#1)(2013-7#2)
the dry season of 1997##2##5##(2007-5#2)
the dry season of##3##4##(2007-5#2)(2008-5#1)
the dry season there##2##4##(2008-5#1)(2013-7#1)
the dry season##41##3##(2005-8#1)(2007-2#1)(2007-3#5)(2007-5#9)(2007-6#1)(2007-8#2)(2008-3#2)(2008-5#15)(2008-6#1)(2008-8#1)(2012-2#1)(2013-7#2)
the dry season)##2##3##(2008-5#1)(2013-7#1)
the dry##84##2##(1990-7#1)(1991-2#2)(1992-12#3)(2004-11#1)(2004-4#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-4#1)(2007-2#1)(2007-3#6)(2007-5#11)(2007-6#2)(2007-8#4)(2008-10#3)(2008-11#2)(2008-3#2)(2008-5#22)(2008-6#2)(2008-7#1)(2008-8#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-7#8)(2013-8#3)
the drying process of the##2##5##(2008-7#1)(2010-2#1)
the drying process of##3##4##(2008-7#1)(2010-2#1)(2011-1#1)
the drying process##8##3##(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-2#2)(2011-1#1)(2012-2#1)
the drying step##3##3##(2004-9#2)(2008-10#1)
the drying temperature##2##3##(2005-11#1)(2011-2#1)
the drying##23##2##(1996-2#1)(2004-9#2)(2005-11#2)(2007-4#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#2)(2010-2#2)(2011-1#1)(2011-2#1)(2012-2#1)
the ds-DNA arrays##2##3##(2007-11#2)
the ds-DNA##3##2##(2007-11#2)(2008-2#1)
the dsDNA##4##2##(1995-2#2)(2008-10#2)
the dsRNA##10##2##(1991-4#1)(2008-10#8)(2008-9#1)
the dsbA##2##2##(1996-10#2)
the dual blood supply to the hand##2##7##(2011-2#2)
the dual functions of##2##4##(1996-7#1)(2008-7#1)
the dual grid##4##3##(2013-1#4)
the dual specificity##2##3##(1994-9#1)(1996-5#1)
the dual##44##2##(1990-2#1)(1990-9#1)(1991-6#1)(1991-8#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-7#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#5)(2013-8#1)
the dual-axis joint##2##3##(2008-2#2)
the dual-isotope protocol##3##3##(2005-1#3)
the dually entitled##3##3##(1995-3#3)
the dually##6##2##(1995-3#3)(2007-8#1)(2008-10#1)(2008-5#1)
the duck##5##2##(1992-12#1)(1995-12#1)(2005-9#2)(2008-3#1)
the duct cells##2##3##(2007-12#2)
the duct##11##2##(1991-9#2)(1994-7#1)(2007-12#5)(2008-3#1)(2008-5#1)(2011-2#1)
the ductal epithelia##2##3##(2013-8#2)
the ductal system##3##3##(1993-5#1)(2006-10#1)(2011-12#1)
the ductal##10##2##(1993-5#1)(2006-10#1)(2007-5#1)(2008-5#2)(2009-4#1)(2011-12#1)(2011-2#1)(2013-8#2)
the ductile part of the##2##5##(1996-4#2)
the ductility##2##2##(2009-7#1)(2010-4#1)
the ducts of##2##3##(2008-6#1)(2011-2#1)
the ducts##5##2##(2007-12#1)(2007-5#1)(2008-5#1)(2008-6#1)(2011-2#1)
the ductus arteriosus##4##3##(1996-3#1)(2008-4#1)(2009-9#1)(2010-12#1)
the ductus##6##2##(1994-9#1)(1996-3#1)(2007-9#1)(2008-4#1)(2009-9#1)(2010-12#1)
the dummies were##2##3##(2007-4#2)
the dummies##7##2##(2006-11#4)(2007-4#3)
the dummy response##3##3##(2006-11#3)
the dummy to##2##3##(2006-11#1)(2007-4#1)
the dummy##17##2##(2006-11#8)(2007-1#2)(2007-4#6)(2009-11#1)
the dummy's##4##2##(2006-11#1)(2007-4#3)
the duodenal bulb##3##3##(2008-5#3)
the duodenal ulcer##2##3##(1992-6#1)(2008-12#1)
the duodenal wall##3##3##(1990-3#1)(2010-12#1)(2012-12#1)
the duodenal##19##2##(1990-3#2)(1990-4#1)(1990-7#1)(1991-6#1)(1992-6#1)(1996-2#1)(1997-3#1)(2004-11#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-5#4)(2010-12#1)(2011-2#1)(2012-12#1)
the duodenum and jejunum##2##4##(1996-11#1)(2013-1#1)
the duodenum and the##2##4##(1990-6#1)(1996-11#1)
the duodenum and##6##3##(1990-6#1)(1996-11#2)(2008-7#1)(2013-1#1)(2013-7#1)
the duodenum by##2##3##(1997-3#1)(2007-5#1)
the duodenum in##3##3##(1995-11#1)(2009-6#1)(2012-1#1)
the duodenum with##2##3##(2008-12#1)(2008-3#1)
the duodenum##46##2##(1990-10#3)(1990-3#1)(1990-6#1)(1992-9#1)(1994-12#1)(1995-11#1)(1996-11#2)(1996-2#1)(1996-8#1)(1997-3#1)(1997-5#1)(2004-11#2)(2006-2#3)(2007-5#1)(2008-12#2)(2008-3#2)(2008-5#5)(2008-7#1)(2008-8#1)(2009-6#1)(2011-12#1)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#5)(2013-7#1)
the duplex DNA and##2##4##(1994-11#1)(2010-2#1)
the duplex DNA##4##3##(1994-11#3)(2010-2#1)
the duplex stability of DNA##2##5##(2006-12#2)
the duplex stability##3##3##(1991-7#1)(2006-12#2)
the duplex was found##2##4##(1994-8#1)(2008-5#1)
the duplex##43##2##(1990-5#1)(1991-7#2)(1992-9#1)(1993-3#3)(1994-11#3)(1994-8#1)(1994-9#1)(1995-1#4)(1995-3#3)(1995-5#1)(2006-10#1)(2006-12#4)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#10)(2010-2#1)(2012-3#1)(2013-8#1)
the duplex-to-coil transition##3##3##(1992-9#3)
the duplex-to-coil##4##2##(1992-9#4)
the duplexes##2##2##(1991-7#1)(2005-11#1)
the duplicate##2##2##(2008-1#1)(2008-10#1)
the duplicated##5##2##(1993-11#1)(1994-10#1)(1996-7#1)(1997-3#1)(2009-10#1)
the duplication event##3##3##(1992-7#1)(1997-8#1)(2009-8#1)
the duplication##5##2##(1992-7#1)(1997-8#1)(2009-8#1)(2012-3#2)
the dura and##2##3##(2008-7#1)(2009-8#1)
the dura mater##12##3##(2006-12#2)(2006-8#1)(2007-12#5)(2007-5#1)(2009-8#1)(2010-12#1)(2013-1#1)
the dura propria of the temporal lobe##2##7##(2011-2#2)
the dura##27##2##(1993-10#1)(1996-9#1)(1997-6#1)(2006-12#3)(2006-6#1)(2006-7#1)(2006-8#2)(2007-12#5)(2007-5#1)(2008-7#2)(2009-8#3)(2010-12#1)(2011-2#2)(2012-2#2)(2013-1#1)
the durability of resistance to##2##5##(2008-10#2)
the durability of resistance##5##4##(2008-10#5)
the durability of the##3##4##(2005-11#1)(2006-10#1)(2007-4#1)
the durability of##15##3##(2005-11#1)(2006-10#1)(2007-4#1)(2008-10#9)(2010-8#1)(2011-1#1)(2012-12#1)
the durability##17##2##(2005-11#1)(2006-10#1)(2006-11#1)(2007-4#1)(2008-10#9)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
the dural defect##4##3##(2006-8#1)(2011-2#1)(2013-7#1)(2013-8#1)
the dural sinuses##2##3##(2008-7#2)
the dural sleeve##9##3##(2006-11#1)(2006-12#8)
the dural##25##2##(2005-5#1)(2006-11#1)(2006-12#8)(2006-8#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-7#6)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
the duration (h)##2##3##(2008-10#2)
the duration and intensity of##4##5##(2005-7#1)(2010-9#1)(2012-1#1)(2012-12#1)
the duration and the##4##4##(1990-7#1)(1993-1#1)(2007-8#1)(2011-2#1)
the duration and##12##3##(1990-7#1)(1993-1#1)(1993-2#1)(1997-2#1)(1997-7#1)(2005-7#1)(2007-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
the duration of BSB##2##4##(1996-4#2)
the duration of a##3##4##(2008-10#1)(2008-7#1)(2009-11#1)
the duration of action potentials##2##5##(1991-5#1)(1993-12#1)
the duration of action##3##4##(1991-5#1)(1993-12#1)(2010-7#1)
the duration of anesthesia##2##4##(2013-7#1)(2013-8#1)
the duration of antibiotic##2##4##(2010-12#2)
the duration of dialysis##2##4##(2007-7#2)
the duration of drug##2##4##(1997-4#1)(2013-1#1)
the duration of each##3##4##(1993-3#1)(2007-6#1)(2010-2#1)
the duration of exposure##4##4##(2008-10#1)(2008-11#1)(2011-12#1)(2011-2#1)
the duration of hospital##2##4##(1992-5#1)(2012-2#1)
the duration of illness##4##4##(2007-11#1)(2009-7#1)(2011-11#1)(2012-2#1)
the duration of individual##2##4##(1995-1#1)(2010-8#1)
the duration of leaf wetness##2##5##(2008-10#2)
the duration of levodopa##2##4##(1994-10#1)(2008-8#1)
the duration of life##2##4##(1990-3#1)(2008-11#1)
the duration of motility##3##4##(2008-7#3)
the duration of neutropenia in patients##2##6##(2007-11#1)(2008-7#1)
the duration of pauses##2##4##(2008-4#2)
the duration of postoperative analgesia##3##5##(2008-8#1)(2010-7#1)(2011-12#1)
the duration of prior##2##4##(1996-5#1)(1997-3#1)
the duration of slow sleep##2##5##(1993-2#2)
the duration of surgery##2##4##(2007-11#1)(2008-8#1)
the duration of symptoms and their severity##2##7##(2008-3#1)(2008-4#1)
the duration of symptoms##5##4##(1991-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2013-1#1)
the duration of the asymptomatic period##2##6##(1997-3#2)
the duration of the disease##3##5##(1994-12#1)(2008-4#1)(2013-1#1)
the duration of the follow-up##2##5##(2008-7#1)(2011-2#1)
the duration of the following##2##5##(1997-2#1)(2008-7#1)
the duration of the infectious period and##2##7##(1996-1#1)(2011-2#1)
the duration of the infectious period##3##6##(1996-1#2)(2011-2#1)
the duration of the inhibition##2##5##(1991-12#1)(1996-2#1)
the duration of the spike##2##5##(1992-3#2)
the duration of the stimuli##2##5##(2008-9#2)
the duration of the study##3##5##(2008-10#1)(2008-5#1)(2008-7#1)
the duration of the surgical procedure##2##6##(2008-8#2)
the duration of the treatment##3##5##(2007-7#1)(2007-8#1)(2008-8#1)
the duration of the trial##3##5##(1993-5#1)(2007-11#1)(2012-3#1)
the duration of the##93##4##(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#2)(1991-4#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-4#1)(1993-5#1)(1994-12#1)(1995-7#1)(1996-1#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(2004-12#1)(2004-2#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#5)(2008-8#4)(2008-9#2)(2009-11#1)(2009-4#1)(2009-6#1)(2010-8#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
the duration of time##3##4##(2008-6#1)(2008-8#1)(2009-11#1)
the duration of treatment##9##4##(1991-6#1)(1993-11#1)(1993-9#1)(1995-3#1)(2006-12#1)(2007-7#1)(2007-8#2)(2011-1#1)
the duration of##244##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1991-11#3)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-3#3)(1992-5#1)(1992-6#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#4)(1993-3#1)(1993-4#1)(1993-5#1)(1993-9#2)(1994-10#3)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-3#3)(1995-6#1)(1995-7#2)(1996-1#2)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#2)(1997-5#1)(2004-12#1)(2004-2#1)(2005-10#2)(2005-11#3)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-7#1)(2007-10#2)(2007-11#10)(2007-12#1)(2007-2#2)(2007-4#1)(2007-6#2)(2007-7#4)(2007-8#6)(2007-9#2)(2008-1#2)(2008-10#17)(2008-11#9)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#5)(2008-5#4)(2008-6#2)(2008-7#16)(2008-8#9)(2008-9#4)(2009-10#1)(2009-11#3)(2009-4#1)(2009-6#2)(2009-7#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#1)(2011-11#1)(2011-12#3)(2011-2#7)(2011-3#1)(2012-1#1)(2012-2#6)(2012-3#2)(2013-1#3)(2013-7#3)(2013-8#3)
the duration on dialysis##3##4##(2008-1#3)
the duration##272##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#2)(1991-11#3)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-3#3)(1992-5#1)(1992-6#2)(1992-8#1)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#5)(1993-3#1)(1993-4#1)(1993-5#1)(1993-9#2)(1994-10#3)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-3#3)(1995-6#1)(1995-7#2)(1996-1#2)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#3)(1997-5#1)(1997-7#1)(2004-12#1)(2004-2#1)(2005-10#2)(2005-11#3)(2005-7#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-7#1)(2007-10#2)(2007-11#10)(2007-12#1)(2007-2#3)(2007-4#1)(2007-6#2)(2007-7#4)(2007-8#8)(2007-9#3)(2008-1#5)(2008-10#19)(2008-11#9)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#5)(2008-5#4)(2008-6#2)(2008-7#17)(2008-8#10)(2008-9#4)(2009-10#1)(2009-11#3)(2009-4#1)(2009-6#2)(2009-7#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#1)(2011-11#1)(2011-12#3)(2011-2#8)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#6)(2012-3#4)(2013-1#3)(2013-7#3)(2013-8#4)
the durations of##5##3##(1992-10#1)(1992-9#1)(2008-8#1)(2012-3#1)(2013-8#1)
the durum##4##2##(2007-8#1)(2008-10#2)(2012-3#1)
the dust of##2##3##(1992-8#2)
the dust##10##2##(1992-8#2)(2008-10#3)(2010-5#2)(2013-8#3)
the duties of##4##3##(1991-12#1)(1993-3#1)(2006-8#1)(2008-7#1)
the duties##6##2##(1991-12#1)(1992-2#1)(1993-3#1)(2006-7#1)(2006-8#1)(2008-7#1)
the duty cycle of the##2##5##(2007-12#1)(2008-2#1)
the duty cycle ratio##2##4##(2008-3#2)
the duty cycle##6##3##(2007-12#1)(2008-2#2)(2008-3#2)(2010-8#1)
the duty of##2##3##(2005-7#1)(2008-5#1)
the duty to research##2##4##(2008-5#2)
the duty to##3##3##(1991-10#1)(2008-5#2)
the duty##15##2##(1991-10#1)(2005-7#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-2#2)(2008-3#3)(2008-5#3)(2010-8#1)(2013-8#1)
the duxil control group##2##4##(2006-4#2)
the dwarf##2##2##(2008-10#1)(2011-12#1)
the dwell time##3##3##(1990-11#1)(2008-10#1)(2009-7#1)
the dwell##4##2##(1990-11#1)(2008-10#1)(2008-3#1)(2009-7#1)
the dwellings of##2##3##(2011-1#1)(2011-2#1)
the dwellings##7##2##(1995-6#2)(2008-1#3)(2011-1#1)(2011-2#1)
the dye and##6##3##(1992-11#1)(1992-6#1)(2008-1#1)(2008-10#1)(2008-2#2)
the dye concentration##2##3##(2008-1#2)
the dye in##2##3##(2008-10#1)(2008-9#1)
the dye is##4##3##(1991-5#1)(1992-10#1)(2008-10#1)(2008-3#1)
the dye methylene blue##2##4##(2008-10#1)(2012-2#1)
the dye molecules##7##3##(1991-5#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-3#1)(2010-4#1)
the dye stability##2##3##(2008-2#2)
the dye to##2##3##(1994-12#1)(2008-8#1)
the dye wastewater##2##3##(2008-1#2)
the dye with##2##3##(1992-6#1)(2008-4#1)
the dye##87##2##(1990-12#2)(1990-3#1)(1991-5#4)(1992-1#1)(1992-10#1)(1992-11#2)(1992-5#1)(1992-6#2)(1993-11#1)(1994-12#3)(1994-3#1)(1994-6#1)(1995-8#1)(1996-1#2)(1996-12#2)(1997-8#1)(2005-11#3)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#20)(2008-2#7)(2008-3#5)(2008-4#1)(2008-8#1)(2008-9#3)(2010-4#5)(2010-5#1)(2012-2#1)
the dye-doped##2##2##(2007-12#2)
the dye-formation##2##2##(2008-5#2)
the dyeability of hair##3##4##(2008-5#3)
the dyeing of##2##3##(2008-5#2)
the dyeing##4##2##(2008-1#1)(2008-5#2)(2011-1#1)
the dyes and nitrite##3##4##(1990-6#3)
the dyes##18##2##(1990-6#3)(1996-1#1)(1996-12#1)(1997-1#2)(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)
the dying patient##3##3##(2004-3#1)(2011-2#2)
the dying process##5##3##(1990-10#4)(2004-3#1)
the dying##20##2##(1990-10#5)(1990-4#1)(1991-12#1)(1991-2#1)(1992-7#1)(1993-12#1)(1993-6#1)(1997-6#1)(2004-3#2)(2007-12#1)(2008-7#1)(2010-10#1)(2010-8#1)(2011-2#2)
the dynamic Franz-Keldysh effect for##2##5##(2007-12#2)
the dynamic Franz-Keldysh effect##3##4##(2007-12#3)
the dynamic and##5##3##(2006-10#1)(2008-3#1)(2008-8#1)(2011-2#2)
the dynamic aspects of##2##4##(1990-5#1)(1995-5#1)
the dynamic baroreflex gain##2##4##(2009-9#1)(2010-5#1)
the dynamic behavior of the##2##5##(2008-2#1)(2009-8#1)
the dynamic behavior of##5##4##(1990-3#1)(2007-12#2)(2008-2#1)(2009-8#1)
the dynamic behavior##6##3##(1990-3#1)(2007-12#2)(2008-10#1)(2008-2#1)(2009-8#1)
the dynamic capacity##2##3##(2008-10#1)(2008-4#1)
the dynamic changes in##2##4##(2005-11#1)(2008-12#1)
the dynamic changes of##2##4##(2008-8#1)(2013-8#1)
the dynamic changes##5##3##(1991-11#1)(2005-11#1)(2008-12#1)(2008-8#1)(2013-8#1)
the dynamic coating##2##3##(2008-10#2)
the dynamic contact angle##4##4##(2005-11#4)
the dynamic deformation##2##3##(2006-11#2)
the dynamic electrophoretic mobility##2##4##(2005-11#2)
the dynamic interactions##2##3##(2008-4#1)(2012-2#1)
the dynamic interplay between##2##4##(1995-2#1)(2013-7#1)
the dynamic model##3##3##(1996-7#2)(2008-9#1)
the dynamic nature of##9##4##(2007-5#1)(2008-10#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#4)
the dynamic neural##2##3##(2008-2#2)
the dynamic of##2##3##(2007-3#1)(2009-4#1)
the dynamic pattern of##2##4##(2007-12#1)(2010-12#1)
the dynamic pattern##3##3##(2004-2#1)(2007-12#1)(2010-12#1)
the dynamic performance##2##3##(2008-7#1)(2012-2#1)
the dynamic phase##2##3##(2008-10#1)(2008-2#1)
the dynamic programming##2##3##(2008-2#1)(2009-3#1)
the dynamic progression##2##3##(2010-6#1)(2013-8#1)
the dynamic properties of the##2##5##(1994-9#1)(1995-6#1)
the dynamic properties of##9##4##(1994-9#1)(1995-1#1)(1995-6#1)(2008-3#2)(2008-5#1)(2009-10#1)(2012-2#2)
the dynamic properties##10##3##(1993-8#1)(1994-9#1)(1995-1#1)(1995-6#1)(2008-3#2)(2008-5#1)(2009-10#1)(2012-2#2)
the dynamic range and##2##4##(2008-10#1)(2008-3#1)
the dynamic range of Cu(II)##2##5##(2008-10#2)
the dynamic range of the##4##5##(2007-11#1)(2008-1#1)(2009-3#1)(2013-8#1)
the dynamic range of##13##4##(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#5)(2009-3#1)(2013-8#1)
the dynamic range was##2##4##(2008-10#1)(2008-2#1)
the dynamic range##33##3##(1997-8#1)(2007-11#2)(2007-12#6)(2008-1#1)(2008-10#9)(2008-2#4)(2008-3#6)(2008-9#1)(2009-3#1)(2011-1#1)(2013-8#1)
the dynamic relationship between##2##4##(2012-1#2)
the dynamic response of the##3##5##(2006-11#1)(2007-4#1)(2008-10#1)
the dynamic response##5##3##(2006-11#2)(2007-4#1)(2008-10#1)(2011-1#1)
the dynamic responses##3##3##(1993-2#1)(2007-4#1)(2008-10#1)
the dynamic stress##2##3##(1996-4#1)(2008-2#1)
the dynamic surface tension detector (DSTD)##2##6##(2008-10#2)
the dynamic surface tension##5##4##(2005-11#1)(2008-10#4)
the dynamic##199##2##(1990-3#2)(1990-5#1)(1991-11#1)(1991-2#1)(1992-11#1)(1992-9#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-4#1)(1996-7#2)(1996-8#2)(1997-5#1)(1997-8#1)(2004-2#1)(2005-11#9)(2006-10#1)(2006-11#5)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#18)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#30)(2008-11#1)(2008-12#1)(2008-2#12)(2008-3#14)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#4)(2009-10#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-1#5)(2012-2#5)(2012-3#1)(2013-1#6)(2013-7#3)(2013-8#4)
the dynamical behaviour of##3##4##(2006-10#1)(2007-9#2)
the dynamical structure of##2##4##(1990-2#1)(1990-5#1)
the dynamical structure##3##3##(1990-2#1)(1990-5#1)(1996-12#1)
the dynamical##16##2##(1990-2#1)(1990-5#1)(1992-1#2)(1993-2#1)(1994-8#1)(1995-8#1)(1996-12#1)(2006-10#2)(2007-12#1)(2007-9#3)(2009-8#1)(2010-10#1)
the dynamically##3##2##(1992-5#1)(2007-11#1)(2011-1#1)
the dynamics and##16##3##(1992-9#1)(1997-4#1)(2008-10#1)(2008-8#3)(2009-10#1)(2009-5#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-8#1)
the dynamics are reduced to##2##5##(2013-8#2)
the dynamics are##4##3##(1996-12#1)(2007-12#1)(2013-8#2)
the dynamics of HIV##2##4##(1997-3#1)(2007-12#1)
the dynamics of a##10##4##(1993-5#1)(1993-9#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-8#1)(2010-7#1)
the dynamics of actin##2##4##(2008-9#1)(2012-2#1)
the dynamics of capillary imbibition##2##5##(2005-11#2)
the dynamics of complex##2##4##(2005-10#1)(2008-9#1)
the dynamics of ecological##2##4##(2008-8#1)(2008-9#1)
the dynamics of gene##2##4##(2008-7#1)(2010-9#1)
the dynamics of host-pathogen interactions##2##5##(2008-9#2)
the dynamics of human##2##4##(1996-4#1)(2011-1#1)
the dynamics of live##2##4##(2008-3#2)
the dynamics of surface##2##4##(2007-11#1)(2007-12#1)
the dynamics of the amplified spontaneous emission##2##7##(2007-12#2)
the dynamics of the disease##2##5##(2006-4#1)(2008-10#1)
the dynamics of the formation of##2##6##(2007-12#1)(2009-2#1)
the dynamics of the process##2##5##(2005-10#1)(2005-11#1)
the dynamics of the protein##2##5##(1994-11#1)(2008-8#1)
the dynamics of the system##3##5##(1994-3#1)(2006-10#1)(2008-5#1)
the dynamics of the##46##4##(1993-2#1)(1994-11#2)(1994-3#1)(1995-11#1)(1997-2#1)(2005-10#1)(2005-11#2)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#4)(2007-6#1)(2008-1#3)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#3)(2008-9#1)(2009-2#1)(2009-3#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the dynamics of their##2##4##(2007-7#1)(2008-10#1)
the dynamics of these##2##4##(2008-3#1)(2010-11#1)
the dynamics of two##2##4##(2006-10#1)(2008-8#1)
the dynamics of##185##3##(1990-10#1)(1990-8#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#2)(1995-11#1)(1995-5#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-6#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-8#1)(2005-10#2)(2005-11#6)(2006-10#4)(2006-12#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#9)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#16)(2008-11#7)(2008-2#4)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#16)(2008-9#11)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-8#2)(2010-10#1)(2010-11#3)(2010-12#1)(2010-3#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#7)
the dynamics that##3##3##(1993-1#1)(2006-11#1)(2007-12#1)
the dynamics##228##2##(1990-10#1)(1990-8#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#2)(1995-11#1)(1995-5#1)(1995-9#2)(1996-1#1)(1996-11#2)(1996-12#2)(1996-4#1)(1996-6#1)(1996-7#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-10#2)(2005-11#7)(2006-10#4)(2006-11#1)(2006-12#2)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#14)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#19)(2008-11#7)(2008-2#5)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#20)(2008-9#13)(2009-10#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#2)(2009-8#2)(2010-10#2)(2010-11#3)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#3)(2012-12#2)(2012-2#7)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#12)
the dynorphin##2##2##(1991-1#1)(1993-6#1)
the dysfunction of the##3##4##(2008-11#1)(2009-6#1)(2011-2#1)
the dysfunction of##8##3##(2008-11#2)(2008-4#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
the dysfunction##11##2##(2006-5#1)(2008-11#2)(2008-4#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
the dyslipidaemia##3##2##(2008-4#1)(2008-6#2)
the dyslipidemia of the metabolic syndrome##2##6##(2008-3#2)
the dyslipidemia##3##2##(2008-1#1)(2008-3#2)
the dysplasia##3##2##(1990-11#1)(2006-2#1)(2013-1#1)
the dysplastic hip##4##3##(2007-11#1)(2007-7#1)(2007-8#2)
the dysplastic##5##2##(2006-12#1)(2007-11#1)(2007-7#1)(2007-8#2)
the dyspnea##2##2##(2008-1#1)(2009-4#1)
the dysregulation of##2##3##(2007-10#1)(2010-12#1)
the dysthymic group and major depression group##3##7##(2011-2#3)
the dystrophin cDNA##2##3##(1993-2#2)
the dystrophin##7##2##(1992-1#1)(1993-2#2)(1994-7#1)(1996-6#1)(1997-3#2)
the dystrophin-associated##2##2##(1993-2#1)(1994-8#1)
the e antigen##3##3##(1994-3#2)(1995-2#1)
the e##7##2##(1994-3#2)(1995-12#3)(1995-2#1)(1997-4#1)
the e-mails were##2##3##(2012-3#2)
the e-portfolio model##2##3##(2009-9#2)
the e-portfolio##3##2##(2009-9#3)
the eFDR##2##2##(2010-3#2)
the eFSHR##2##2##(1994-5#2)
the eHealth Initiative##2##3##(2009-10#2)
the eHealth##3##2##(2007-10#1)(2009-10#2)
the eIF-4E mRNA##2##3##(1995-2#2)
the ePTFE group##6##3##(2007-7#6)
the ePTFE##8##2##(2007-7#8)
the eSRT programme##3##3##(2008-9#3)
the each##5##2##(1997-4#1)(2005-10#1)(2005-12#1)(2007-2#1)(2008-10#1)
the ear canal##2##3##(1995-9#1)(2008-4#1)
the ear is##3##3##(2007-7#1)(2008-4#1)(2011-2#1)
the ear leaf##2##3##(2008-10#2)
the ear##37##2##(1991-1#1)(1991-8#2)(1995-9#1)(1996-11#2)(1996-5#1)(1997-8#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#7)(2008-7#3)(2008-9#3)(2010-8#4)(2011-2#1)(2012-12#2)(2013-7#2)
the earlier detection of##2##4##(1992-12#1)(2008-10#1)
the earlier investigations##2##3##(1991-12#1)(2009-6#1)
the earlier review##2##3##(2007-2#1)(2012-1#1)
the earlier stages##3##3##(1997-8#1)(2006-12#1)(2007-11#1)
the earlier study##3##3##(1994-3#1)(1995-3#1)(2009-2#1)
the earlier the##2##3##(1992-1#1)(2013-1#1)
the earlier work##3##3##(1991-12#1)(2013-1#2)
the earlier years##2##3##(1990-3#1)(2008-8#1)
the earlier##71##2##(1990-3#1)(1990-9#1)(1991-1#1)(1991-12#3)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-7#1)(1994-3#2)(1995-11#1)(1995-3#1)(1995-9#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-1#1)(2005-7#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#1)
the earliest events##2##3##(1995-2#1)(1997-8#1)
the earliest possible##2##3##(1997-3#1)(2008-4#1)
the earliest stage of##2##4##(1990-2#1)(1994-8#1)
the earliest stage##5##3##(1990-2#1)(1994-8#1)(1995-1#1)(2007-10#1)(2012-2#1)
the earliest stages of the##2##5##(2006-6#1)(2008-10#1)
the earliest stages of##8##4##(1995-11#1)(2006-6#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-8#1)(2012-7#1)
the earliest times##2##3##(1990-2#1)(1995-12#1)
the earliest visual areas##2##4##(1995-11#2)
the earliest##80##2##(1990-2#2)(1990-8#1)(1991-11#3)(1992-12#1)(1992-5#2)(1993-3#1)(1994-3#1)(1994-7#1)(1994-8#1)(1995-1#2)(1995-11#4)(1995-12#2)(1995-2#3)(1995-6#1)(1996-12#1)(1996-9#2)(1997-3#1)(1997-6#1)(1997-8#1)(2004-10#1)(2004-12#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-2#2)(2012-3#2)(2012-7#1)(2013-1#4)
the earlobe using a soft splint##2##6##(2008-3#2)
the early 1900s##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2011-1#1)
the early 1930s##2##3##(1990-6#1)(2005-11#1)
the early 1950s##5##3##(2005-10#1)(2006-10#1)(2008-12#1)(2008-9#1)(2010-1#1)
the early 1960s##7##3##(1996-12#1)(2005-11#1)(2005-8#1)(2009-7#2)(2010-7#1)(2011-2#1)
the early 1970's##3##3##(1990-4#1)(2006-2#1)(2008-10#1)
the early 1970s##21##3##(1992-2#1)(1992-4#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-5#1)(1996-3#1)(2004-4#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-12#1)(2009-2#1)(2012-12#1)(2013-8#1)
the early 1980s and##4##4##(1994-6#1)(1997-6#1)(2005-7#1)(2008-5#1)
the early 1980s##28##3##(1990-11#1)(1990-5#1)(1994-2#1)(1994-6#1)(1995-6#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-6#1)(2004-9#1)(2005-10#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-5#2)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
the early 1990s and##2##4##(2006-6#1)(2009-7#1)
the early 1990s##25##3##(1991-6#1)(1993-3#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-10#1)(2010-12#1)(2011-7#1)(2012-1#1)(2012-3#1)(2013-1#1)
the early 19th##2##3##(1993-6#1)(2009-10#1)
the early 20th##2##3##(1997-8#1)(2013-1#1)
the early G1 phase##2##4##(1994-2#1)(1997-6#1)
the early SV40##2##3##(1993-12#1)(1996-9#1)
the early activation of##2##4##(1996-2#1)(2008-4#1)
the early and 1 year postoperative##2##6##(2007-8#2)
the early and late phase##2##5##(1995-11#1)(2010-8#1)
the early and late##7##4##(1995-11#1)(1995-6#1)(1996-1#1)(1996-5#1)(2006-12#1)(2006-4#1)(2010-8#1)
the early and long-term##2##4##(2008-8#1)(2009-8#1)
the early and middle##2##4##(1995-6#1)(2007-4#1)
the early and##20##3##(1995-11#1)(1995-6#3)(1996-1#1)(1996-5#1)(2006-12#1)(2006-4#1)(2007-12#1)(2007-4#1)(2007-8#5)(2008-10#1)(2008-12#1)(2008-8#1)(2009-8#1)(2010-8#1)
the early appearance##2##3##(2008-4#1)(2009-4#1)
the early beta ERD##2##4##(2013-8#2)
the early brain##2##3##(2007-8#2)
the early changes##2##3##(2006-10#1)(2013-8#1)
the early childhood##4##3##(2006-9#1)(2007-8#1)(2009-9#1)(2010-12#1)
the early clinical##2##3##(2007-11#1)(2007-8#1)
the early control##3##3##(2013-1#3)
the early course of##2##4##(1996-12#1)(2009-3#1)
the early days of##6##4##(1990-12#1)(2006-10#2)(2007-5#1)(2008-11#1)(2009-10#1)
the early days##8##3##(1990-12#1)(2006-10#2)(2007-2#1)(2007-5#1)(2008-11#1)(2008-3#1)(2009-10#1)
the early detection of cancer##2##5##(1990-10#1)(1992-10#1)
the early detection of this##2##5##(1992-3#1)(2011-2#1)
the early detection of##37##4##(1990-10#1)(1991-4#1)(1991-6#1)(1992-10#3)(1992-2#1)(1992-3#2)(1994-12#1)(1994-7#1)(1996-9#1)(2006-10#2)(2007-11#2)(2007-4#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-7#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#2)(2013-7#1)
the early detection##41##3##(1990-10#1)(1990-8#1)(1991-4#1)(1991-6#1)(1992-10#3)(1992-2#1)(1992-3#2)(1994-12#1)(1994-7#1)(1996-9#1)(2006-10#2)(2007-11#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-7#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-2#2)(2013-1#1)(2013-7#1)
the early developing##2##3##(1993-11#1)(2008-1#1)
the early development of the##5##5##(1992-12#1)(1992-5#1)(1995-6#1)(2007-11#1)(2008-8#1)
the early development of##11##4##(1992-12#1)(1992-5#1)(1995-6#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-12#1)(2012-1#1)(2012-2#1)
the early development##13##3##(1992-12#1)(1992-5#1)(1995-6#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#1)(2012-1#1)(2012-2#1)
the early diagnosis and treatment##2##5##(2005-11#1)(2008-3#1)
the early diagnosis and##6##4##(1991-7#1)(1992-8#1)(2005-11#1)(2008-3#1)(2013-1#2)
the early diagnosis of cancer##2##5##(1992-10#1)(2010-2#1)
the early diagnosis of prostatic##2##5##(1991-2#1)(2009-5#1)
the early diagnosis of##23##4##(1990-9#1)(1991-2#1)(1991-4#1)(1991-7#2)(1992-10#1)(1993-3#1)(2006-10#2)(2007-11#1)(2007-2#1)(2007-7#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-3#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-9#1)(2011-1#1)
the early diagnosis##32##3##(1990-5#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-7#3)(1992-10#1)(1992-8#1)(1993-3#1)(1994-3#1)(2005-11#1)(2006-10#2)(2007-11#1)(2007-2#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-3#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-9#1)(2011-1#1)(2013-1#2)
the early eighties##4##3##(2006-10#1)(2007-2#1)(2008-10#1)(2008-5#1)
the early embryo##11##3##(1994-3#1)(2007-12#5)(2007-8#1)(2008-10#1)(2009-3#1)(2009-8#1)(2012-3#1)
the early embryonic brain of the grasshopper Schistocerca gregaria##2##9##(2007-12#2)
the early embryonic brain of the grasshopper##3##7##(2007-12#3)
the early embryonic##7##3##(1997-6#1)(2007-12#4)(2008-11#1)(2008-5#1)
the early evening##2##3##(1996-2#1)(2007-12#1)
the early event of cytotoxicity of##2##6##(2009-12#2)
the early events of the##2##5##(1994-2#1)(2008-10#1)
the early events of##6##4##(1994-2#1)(1995-8#1)(1996-5#1)(2008-10#1)(2008-7#1)(2012-2#1)
the early events##9##3##(1992-4#1)(1994-2#1)(1995-8#1)(1996-5#1)(2008-10#1)(2008-7#1)(2012-2#3)
the early experience##2##3##(1993-7#1)(2008-3#1)
the early gastrula stage##2##4##(1996-10#1)(2008-5#1)
the early group##3##3##(2006-5#3)
the early growth##2##3##(1990-11#1)(1993-4#1)
the early history of the discovery of##2##7##(2009-2#2)
the early history of##4##4##(2007-8#1)(2008-1#1)(2009-2#2)
the early identification and##2##4##(2010-12#1)(2011-1#1)
the early identification of patients with##2##6##(1996-4#1)(2008-9#1)
the early identification of##6##4##(1996-4#1)(2006-10#1)(2007-10#1)(2008-9#1)(2010-12#1)(2013-1#1)
the early identification##8##3##(1996-4#1)(2006-10#1)(2007-10#1)(2008-9#1)(2010-12#2)(2011-1#1)(2013-1#1)
the early induction of##2##4##(1990-6#1)(1993-4#1)
the early induction##4##3##(1990-6#1)(1993-4#1)(1996-12#1)(2008-10#1)
the early infection##2##3##(2006-10#1)(2008-11#1)
the early intracellular##2##3##(1993-6#1)(1995-11#1)
the early juvenile##2##3##(2009-2#2)
the early life##4##3##(2009-9#1)(2010-7#1)(2010-8#1)(2012-1#1)
the early management of##3##4##(2006-7#1)(2007-12#1)(2011-2#1)
the early modern period]##2##4##(2008-10#2)
the early modern##13##3##(1991-9#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#4)
the early morning hours##2##4##(2008-10#1)(2013-1#1)
the early morning##6##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2013-1#1)
the early onset of##2##4##(2008-4#1)(2011-2#1)
the early outcome after##2##4##(2007-8#1)(2013-7#1)
the early outcome##4##3##(2006-6#1)(2007-8#2)(2013-7#1)
the early part of the##6##5##(1991-8#1)(1994-2#1)(2008-1#1)(2008-10#1)(2008-9#1)(2013-1#1)
the early part of##8##4##(1991-8#1)(1994-2#1)(1996-11#1)(2008-1#1)(2008-10#1)(2008-9#2)(2013-1#1)
the early period after##3##4##(2007-10#1)(2010-11#1)(2012-3#1)
the early period of##3##4##(1993-3#1)(2008-11#1)(2012-1#1)
the early period##9##3##(1993-3#1)(2007-10#1)(2007-7#3)(2008-11#1)(2010-11#1)(2012-1#1)(2012-3#1)
the early phase of a##2##5##(1990-6#1)(2012-2#1)
the early phase of rehabilitation##2##5##(2007-8#2)
the early phase of the epidemic##2##6##(2007-9#1)(2008-10#1)
the early phase of the##6##5##(1992-3#1)(1996-5#1)(2007-2#1)(2007-9#1)(2008-10#1)(2009-9#1)
the early phase of##33##4##(1990-10#1)(1990-6#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-1#1)(1995-8#1)(1995-9#2)(1996-2#1)(1996-5#1)(1997-6#1)(2003-11#1)(2007-2#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-1#1)(2012-2#1)(2013-1#1)
the early phase##40##3##(1990-10#1)(1990-6#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-1#1)(1995-11#2)(1995-8#1)(1995-9#2)(1996-2#1)(1996-5#1)(1997-6#1)(1997-7#1)(2003-11#1)(2007-2#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
the early phases of##9##4##(1992-1#1)(1995-3#1)(2006-2#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-1#1)(2012-12#1)
the early phases##10##3##(1991-8#1)(1992-1#1)(1995-3#1)(2006-2#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-1#1)(2012-12#1)
the early post-transplant period##2##4##(2007-11#1)(2008-1#1)
the early post-transplant##3##3##(2007-11#2)(2008-1#1)
the early postmenopausal##2##3##(2008-11#1)(2013-8#1)
the early postnatal period##6##4##(1991-1#1)(1991-4#1)(1992-7#1)(1997-2#1)(2008-11#1)(2010-1#1)
the early postnatal##8##3##(1990-5#1)(1991-1#1)(1991-4#1)(1992-7#1)(1997-2#1)(2008-11#1)(2009-2#1)(2010-1#1)
the early postoperative period and##2##5##(1991-2#1)(2011-12#1)
the early postoperative period##18##4##(1991-2#1)(1991-5#1)(1994-3#1)(1995-4#1)(1996-8#2)(2006-9#1)(2007-2#1)(2007-7#1)(2007-8#3)(2009-6#1)(2010-6#1)(2011-12#2)(2011-2#1)(2012-3#1)
the early postoperative##23##3##(1990-6#1)(1991-2#1)(1991-5#1)(1994-3#1)(1995-4#1)(1996-12#1)(1996-8#2)(2006-9#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#3)(2009-6#1)(2010-6#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-3#1)
the early postpartum period##3##4##(2007-10#2)(2009-4#1)
the early pregnancy##2##3##(1991-6#1)(2006-5#1)
the early prereplicative period##2##4##(1994-6#2)
the early psychosis##2##3##(2008-1#2)
the early rapid##2##3##(1993-9#1)(2006-10#1)
the early recognition of##4##4##(1996-11#1)(2006-5#1)(2008-4#1)(2012-12#1)
the early response genes##2##4##(1992-12#1)(1994-8#1)
the early response##3##3##(1992-12#1)(1994-8#1)(1996-5#1)
the early results##2##3##(2009-4#1)(2013-8#1)
the early risk of stroke##2##5##(2008-8#1)(2012-3#1)
the early signs of##2##4##(2008-4#1)(2012-2#1)
the early signs##3##3##(1994-7#1)(2008-4#1)(2012-2#1)
the early solar##2##3##(1996-5#1)(2007-9#1)
the early stage and##2##4##(1997-1#1)(2012-12#1)
the early stage of adult life##2##6##(2008-4#1)(2008-5#1)
the early stage of infection##4##5##(1994-6#1)(2008-10#2)(2008-5#1)
the early stage of the disease##2##6##(1990-6#1)(2012-3#1)
the early stage of the##8##5##(1990-6#1)(1991-12#1)(2005-11#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-2#1)(2012-3#1)
the early stage of##46##4##(1990-10#1)(1990-4#1)(1990-6#2)(1990-8#1)(1991-12#1)(1992-12#1)(1992-5#1)(1993-12#2)(1994-3#2)(1994-6#2)(1995-12#1)(1997-1#1)(1997-3#1)(1997-8#1)(2005-11#2)(2006-12#1)(2006-7#1)(2007-7#1)(2008-10#5)(2008-4#2)(2008-5#3)(2008-9#4)(2009-12#1)(2009-2#1)(2009-6#1)(2010-12#3)(2010-8#1)(2012-3#1)(2013-1#1)
the early stage##54##3##(1990-10#1)(1990-4#1)(1990-6#2)(1990-8#1)(1991-12#1)(1992-12#1)(1992-4#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#2)(1994-3#2)(1994-6#2)(1994-7#1)(1995-12#1)(1995-4#1)(1997-1#2)(1997-3#1)(1997-8#1)(2005-11#2)(2006-12#1)(2006-6#1)(2006-7#1)(2007-7#1)(2008-10#5)(2008-4#2)(2008-5#3)(2008-9#4)(2009-12#1)(2009-2#1)(2009-6#1)(2010-12#3)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
the early stages of development##5##5##(1993-2#1)(1995-12#1)(2008-6#1)(2008-7#1)(2011-2#1)
the early stages of disasters##2##5##(2010-8#2)
the early stages of embryogenesis##2##5##(1995-2#1)(2013-1#1)
the early stages of peritonitis##2##5##(2008-12#2)
the early stages of the disease##2##6##(2006-10#1)(2008-11#1)
the early stages of the##9##5##(2006-10#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
the early stages of##75##4##(1990-11#1)(1991-4#1)(1991-8#1)(1992-1#2)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#1)(1994-10#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(2006-10#2)(2006-11#2)(2006-8#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-12#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-8#1)(2010-3#1)(2010-6#1)(2010-8#4)(2011-1#3)(2011-10#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#4)(2013-8#2)
the early stages##92##3##(1990-11#1)(1991-4#1)(1991-8#1)(1992-1#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-7#1)(1994-10#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#1)(2005-5#1)(2006-10#2)(2006-11#2)(2006-8#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#7)(2008-11#3)(2008-12#3)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#3)(2009-6#1)(2009-8#1)(2010-3#1)(2010-6#1)(2010-8#4)(2011-1#4)(2011-10#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#3)
the early steps in##3##4##(2007-12#1)(2009-8#1)(2011-1#1)
the early steps of##5##4##(1992-2#1)(1993-9#2)(1997-5#1)(2008-2#1)
the early steps##8##3##(1992-2#1)(1993-9#2)(1997-5#1)(2007-12#1)(2008-2#1)(2009-8#1)(2011-1#1)
the early subjective##2##3##(2008-5#2)
the early surgical##4##3##(2006-4#1)(2006-7#1)(2008-8#1)(2008-9#1)
the early to##5##3##(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#1)
the early treatment of##2##4##(2006-12#1)(2011-2#1)
the early twentieth century##7##4##(2007-11#1)(2008-12#1)(2008-7#2)(2009-10#1)(2010-1#1)(2012-12#1)
the early twentieth##8##3##(2007-11#1)(2008-12#1)(2008-7#2)(2009-10#1)(2010-1#1)(2012-12#1)(2013-1#1)
the early use of##2##4##(1991-12#1)(2005-11#1)
the early use##3##3##(1991-12#1)(2005-11#1)(2008-9#1)
the early weeks##2##3##(2007-2#1)(2009-9#1)
the early work##2##3##(1993-11#1)(2006-5#1)
the early years of the##3##5##(1993-12#1)(1995-4#1)(2012-2#1)
the early years of##6##4##(1992-2#1)(1992-3#1)(1993-12#1)(1995-4#1)(2008-1#1)(2012-2#1)
the early years##11##3##(1992-2#1)(1992-3#1)(1993-12#1)(1995-4#1)(2006-5#1)(2008-1#1)(2008-11#1)(2010-12#2)(2010-8#1)(2012-2#1)
the early##890##2##(1990-10#4)(1990-11#5)(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#3)(1990-6#7)(1990-8#3)(1990-9#1)(1991-1#4)(1991-11#2)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#5)(1991-5#2)(1991-6#6)(1991-7#3)(1991-8#3)(1991-9#1)(1992-1#3)(1992-10#5)(1992-12#5)(1992-2#4)(1992-3#5)(1992-4#5)(1992-5#3)(1992-6#1)(1992-7#3)(1992-8#5)(1992-9#5)(1993-1#2)(1993-10#1)(1993-11#5)(1993-12#5)(1993-2#2)(1993-3#4)(1993-4#3)(1993-5#1)(1993-6#4)(1993-7#2)(1993-9#4)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#5)(1994-3#10)(1994-5#2)(1994-6#6)(1994-7#3)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#6)(1995-12#4)(1995-2#2)(1995-3#1)(1995-4#5)(1995-5#1)(1995-6#7)(1995-7#1)(1995-8#8)(1995-9#3)(1996-1#3)(1996-10#1)(1996-11#4)(1996-12#6)(1996-2#3)(1996-3#2)(1996-4#4)(1996-5#7)(1996-8#2)(1996-9#2)(1997-1#3)(1997-2#3)(1997-3#3)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#4)(2003-11#1)(2004-4#1)(2004-9#1)(2005-10#2)(2005-11#9)(2005-12#1)(2005-5#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#21)(2006-11#4)(2006-12#6)(2006-2#3)(2006-4#3)(2006-5#11)(2006-6#3)(2006-7#5)(2006-8#3)(2006-9#3)(2007-1#1)(2007-10#7)(2007-11#14)(2007-12#22)(2007-2#7)(2007-3#3)(2007-4#6)(2007-5#1)(2007-6#3)(2007-7#11)(2007-8#26)(2007-9#4)(2008-1#10)(2008-10#46)(2008-11#27)(2008-12#12)(2008-2#4)(2008-3#9)(2008-4#16)(2008-5#19)(2008-6#9)(2008-7#17)(2008-8#17)(2008-9#20)(2009-10#3)(2009-11#2)(2009-12#3)(2009-2#8)(2009-3#4)(2009-4#3)(2009-5#1)(2009-6#5)(2009-7#4)(2009-8#6)(2009-9#6)(2010-1#6)(2010-10#1)(2010-11#3)(2010-12#14)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#4)(2010-6#3)(2010-7#4)(2010-8#12)(2010-9#2)(2011-1#13)(2011-10#1)(2011-12#2)(2011-2#23)(2011-7#1)(2012-1#11)(2012-11#1)(2012-12#11)(2012-2#22)(2012-3#9)(2013-1#26)(2013-7#3)(2013-8#11)
the early-morning##2##2##(1992-8#1)(2013-1#1)
the early-onset##4##2##(1996-6#1)(1997-5#1)(2004-11#1)(2008-8#1)
the early-stage kinetics of##2##4##(2007-12#2)
the ears of##2##3##(1991-3#1)(1994-2#1)
the ears##6##2##(1991-3#1)(1994-2#3)(2008-8#1)(2010-6#1)
the earth surface##2##3##(2008-10#2)
the earth##9##2##(1990-6#1)(2008-10#2)(2008-12#3)(2008-5#1)(2009-6#2)
the earth's crust##3##3##(1996-4#1)(2008-10#1)(2013-8#1)
the earth's surface##4##3##(1990-3#1)(1996-4#1)(2008-10#1)(2010-5#1)
the earth's##9##2##(1990-3#1)(1990-5#1)(1996-4#2)(2008-10#2)(2008-3#1)(2010-5#1)(2013-8#1)
the earthquake in##2##3##(1996-4#1)(2008-9#1)
the earthquake##21##2##(1996-4#8)(2008-2#1)(2008-9#1)(2011-1#2)(2012-1#2)(2012-2#1)(2013-1#4)(2013-8#2)
the earthworm##11##2##(1991-10#1)(1997-6#3)(2004-4#1)(2008-5#4)(2008-9#1)(2011-1#1)
the ease of application##2##4##(2007-11#1)(2010-7#1)
the ease of scientific##2##4##(2012-2#2)
the ease of use of the##2##6##(1994-3#1)(2012-3#1)
the ease of use of##4##5##(1994-3#1)(2008-7#1)(2012-3#1)(2013-1#1)
the ease of use##5##4##(1994-3#1)(2008-7#1)(2011-12#1)(2012-3#1)(2013-1#1)
the ease of##42##3##(1990-10#1)(1991-12#1)(1991-8#1)(1992-11#1)(1992-2#1)(1994-3#1)(1996-7#1)(1997-3#1)(1997-4#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-4#2)(2008-7#1)(2008-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-12#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#3)
the ease with which##2##4##(2008-3#1)(2008-4#1)
the ease##45##2##(1990-10#1)(1991-12#1)(1991-8#1)(1992-11#1)(1992-2#1)(1994-3#1)(1996-7#1)(1997-3#1)(1997-4#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-7#1)(2008-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-12#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#3)
the easier##2##2##(2008-9#1)(2013-8#1)
the easiest and safest technique for##2##6##(2007-7#2)
the easiest and safest##3##4##(2007-7#3)
the easiest and##5##3##(1996-7#1)(2007-7#3)(2008-1#1)
the easiest##11##2##(1990-3#1)(1996-7#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-1#1)
the easily##2##2##(1996-5#1)(2007-12#1)
the easiness##3##2##(2007-12#1)(2008-5#1)(2008-7#1)
the east and west coasts of##2##6##(2008-10#2)
the east and##3##3##(2008-10#3)
the east coast of##5##4##(1992-5#1)(2007-10#1)(2009-12#1)(2010-8#1)(2012-2#1)
the east coast##6##3##(1991-6#1)(1992-5#1)(2007-10#1)(2009-12#1)(2010-8#1)(2012-2#1)
the east##21##2##(1991-6#1)(1992-2#1)(1992-5#1)(2007-10#1)(2007-2#1)(2007-5#2)(2007-9#1)(2008-10#6)(2008-5#1)(2009-12#1)(2009-7#1)(2010-8#2)(2011-2#1)(2012-2#1)
the eastern Atlantic##3##3##(2008-5#1)(2010-8#2)
the eastern Indian Ocean##2##4##(2010-8#2)
the eastern Pacific Ocean##2##4##(2008-5#1)(2010-8#1)
the eastern Pacific##3##3##(2008-5#2)(2010-8#1)
the eastern United States##9##4##(1992-1#1)(2008-10#7)(2013-8#1)
the eastern coast of##2##4##(2010-8#1)(2011-2#1)
the eastern plains##2##3##(2012-12#2)
the eastern province of##2##4##(2008-10#1)(2012-2#1)
the eastern region of##2##4##(2007-2#1)(2009-2#1)
the eastern region##3##3##(2007-2#1)(2009-2#1)(2011-2#1)
the eastern section##3##3##(2007-5#3)
the eastern subpopulation##2##3##(2012-12#2)
the eastern##53##2##(1992-1#1)(1993-2#1)(1993-5#3)(1996-9#1)(2006-4#1)(2007-2#1)(2007-5#4)(2008-1#1)(2008-10#16)(2008-5#4)(2008-9#1)(2009-2#1)(2009-8#1)(2010-8#7)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-8#1)
the easy##17##2##(1990-5#1)(1990-9#1)(1995-2#1)(1996-12#1)(1996-8#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
the eating disorder##5##3##(2006-7#3)(2008-11#1)(2011-12#1)
the eating##12##2##(1993-12#1)(1993-7#1)(2006-7#3)(2006-8#1)(2008-11#1)(2010-4#2)(2011-12#2)(2012-3#1)
the eccentric##2##2##(2006-11#1)(2013-1#1)
the ecchymosis##4##2##(2012-12#4)
the eccrine sweat gland##2##4##(1991-5#1)(2007-7#1)
the eccrine sweat glands##2##4##(1996-6#1)(2013-7#1)
the eccrine sweat##4##3##(1991-5#1)(1996-6#1)(2007-7#1)(2013-7#1)
the eccrine##5##2##(1991-5#1)(1996-6#1)(2007-7#1)(2010-6#1)(2013-7#1)
the ecdysial##3##2##(2007-5#1)(2008-7#2)
the ecdysis behavior##2##3##(1991-10#2)
the ecdysone pathway##2##3##(2012-12#2)
the ecdysone##3##2##(1995-8#1)(2012-12#2)
the ecdysteroid##2##2##(1991-11#1)(1995-11#1)
the echinocandin##2##2##(2011-2#2)
the echinocandins##3##2##(2008-3#2)(2008-7#1)
the echinoid##3##2##(1992-12#1)(2007-5#1)(2008-6#1)
the echo decay##2##3##(2005-11#2)
the echo##5##2##(2005-11#2)(2007-11#1)(2011-2#1)(2012-3#1)
the echocardiographic##2##2##(1990-8#1)(2008-10#1)
the echocardiography##2##2##(1996-4#1)(2010-12#1)
the eclosion hormone##3##3##(1991-10#3)
the eclosion##4##2##(1991-10#4)
the ecological and economic##2##4##(1992-5#1)(2007-5#1)
the ecological and evolutionary##2##4##(1996-6#1)(2008-8#1)
the ecological and##4##3##(1992-5#1)(1996-6#1)(2007-5#1)(2008-8#1)
the ecological balance of the##3##5##(2006-10#1)(2012-3#2)
the ecological carrying capacity of##2##5##(2013-8#2)
the ecological characteristics of##2##4##(2008-5#1)(2008-8#1)
the ecological demonstration activities##2##4##(2013-8#2)
the ecological factors##2##3##(2007-10#1)(2010-10#1)
the ecological literature##2##3##(2008-8#1)(2008-9#1)
the ecological niche of##2##4##(2006-2#1)(2012-2#1)
the ecological significance of##2##4##(2009-8#2)
the ecological significance##3##3##(2008-10#1)(2009-8#2)
the ecological##54##2##(1992-5#1)(1994-3#1)(1995-11#1)(1996-6#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-3#2)(2007-5#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-5#3)(2008-8#6)(2008-9#1)(2009-8#3)(2010-10#1)(2010-11#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#4)(2012-5#1)(2013-7#2)(2013-8#5)
the ecologically##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
the ecology and epidemiology of##2##5##(2007-10#1)(2008-9#1)
the ecology and evolution of the##2##6##(1996-3#1)(2009-8#1)
the ecology and evolution of##5##5##(1995-8#1)(1996-3#1)(2008-8#1)(2009-8#1)(2012-3#1)
the ecology and##8##3##(1995-8#1)(1996-3#1)(2007-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-3#1)
the ecology of the##2##4##(2007-5#2)
the ecology of this##3##4##(2008-9#1)(2009-4#1)(2012-2#1)
the ecology of##23##3##(1994-6#1)(2006-4#1)(2006-8#1)(2007-5#3)(2008-10#6)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#2)(2009-4#2)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
the ecology##32##2##(1994-6#1)(1995-8#1)(1996-3#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-5#3)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#2)(2008-9#3)(2009-4#2)(2009-5#1)(2009-8#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
the economic and##6##3##(1990-12#1)(1993-2#1)(1995-5#1)(2009-7#1)(2011-2#1)(2013-8#1)
the economic aspects of##2##4##(1993-12#2)
the economic benefit of##2##4##(2005-11#1)(2008-12#1)
the economic burden of multiple sclerosis (MS) in##2##8##(2006-12#2)
the economic burden of##6##4##(1995-11#1)(2006-12#3)(2008-6#1)(2010-3#1)
the economic context##2##3##(2010-3#2)
the economic cost##2##3##(2008-11#1)(2013-8#1)
the economic crisis##3##3##(2010-3#2)(2011-2#1)
the economic downturn on##2##4##(2012-3#2)
the economic downturn##3##3##(2012-3#3)
the economic evaluation##2##3##(2006-5#1)(2010-12#1)
the economic impact of the##3##5##(2007-11#1)(2007-6#1)(2008-10#1)
the economic impact of##5##4##(2007-11#1)(2007-6#1)(2008-10#1)(2008-8#1)(2011-2#1)
the economic impact##8##3##(2007-11#2)(2007-6#1)(2008-10#2)(2008-8#1)(2010-8#1)(2011-2#1)
the economic importance of##2##4##(2008-12#1)(2013-8#1)
the economic success of##2##4##(2004-3#1)(2008-10#1)
the economic##76##2##(1990-12#1)(1992-4#1)(1992-8#1)(1993-10#1)(1993-12#2)(1993-2#1)(1994-3#1)(1995-11#1)(1995-5#2)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(2004-3#1)(2005-11#2)(2006-10#1)(2006-12#3)(2006-5#1)(2006-6#1)(2007-11#2)(2007-6#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-10#2)(2009-5#1)(2009-7#1)(2010-12#1)(2010-3#5)(2010-8#2)(2011-1#4)(2011-2#6)(2012-2#1)(2012-3#3)(2013-8#3)
the economical##5##2##(2006-6#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-4#1)
the economically important##3##3##(2008-10#1)(2008-7#2)
the economically inactive##2##3##(2013-8#2)
the economically##10##2##(2008-10#2)(2008-5#1)(2008-7#2)(2010-3#1)(2012-2#2)(2013-8#2)
the economics of Crohn's disease##2##5##(2007-11#2)
the economics of##6##3##(2006-10#1)(2007-11#2)(2008-11#1)(2008-5#2)
the economy and##2##3##(2007-4#1)(2013-1#1)
the economy of##4##3##(2008-10#2)(2011-2#1)(2013-8#1)
the economy##18##2##(1990-12#1)(1991-1#1)(1992-4#1)(1997-5#1)(1997-6#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-6#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
the ecosystem and##3##3##(1995-11#1)(1997-7#1)(2012-1#1)
the ecosystem services##2##3##(2008-9#1)(2013-8#1)
the ecosystem##20##2##(1995-11#1)(1995-9#1)(1997-7#1)(2006-8#1)(2007-3#2)(2008-12#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-7#1)(2012-1#2)(2013-8#4)
the ecotoxicological effect of##2##4##(2008-10#1)(2008-11#1)
the ecotoxicological##3##2##(2007-8#1)(2008-10#1)(2008-11#1)
the ectatic area##3##3##(1997-3#3)
the ectatic##4##2##(1997-3#3)(2006-12#1)
the ectoderm to form##2##4##(2007-12#1)(2008-4#1)
the ectoderm##5##2##(1990-5#1)(1991-5#1)(2007-12#1)(2008-4#1)(2008-7#1)
the ectodermal##2##2##(1996-6#1)(2008-7#1)
the ectodomain of##2##3##(1997-1#1)(2013-1#1)
the ectomycorrhizal##2##2##(2012-6#2)
the ectoparasitic##2##2##(2008-10#1)(2009-5#1)
the ectopic expression of the##2##5##(2006-11#1)(2008-11#1)
the ectopic expression of##5##4##(1996-5#1)(1997-4#1)(2006-11#1)(2008-11#1)(2008-7#1)
the ectopic meatus##2##3##(2009-5#2)
the ectopic pregnancy##2##3##(1995-7#1)(2004-10#1)
the ectopic##19##2##(1990-12#1)(1990-9#1)(1995-4#1)(1995-7#1)(1996-5#1)(1997-4#1)(2004-10#1)(2006-11#1)(2007-10#1)(2008-11#1)(2008-7#1)(2009-5#2)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)
the eddy##2##2##(2007-12#1)(2008-2#1)
the edema##2##2##(2008-5#1)(2010-2#1)
the edentulous##3##2##(1996-3#1)(2007-12#1)(2012-2#1)
the edge enhancement of objects and edge-enhanced##2##7##(2008-2#2)
the edge enhancement of##5##4##(2008-2#2)(2008-3#3)
the edge enhancement##6##3##(2008-2#3)(2008-3#3)
the edge had##2##3##(2013-7#2)
the edge image waviness##3##4##(2008-3#3)
the edge image##5##3##(2008-3#5)
the edge of a##8##4##(1991-3#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-9#1)(2013-7#1)
the edge of the orchard##2##5##(2008-10#2)
the edge of the##28##4##(1992-3#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-6#1)(1996-5#2)(1996-6#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-3#1)
the edge of##52##3##(1991-2#1)(1991-3#1)(1992-3#1)(1992-4#1)(1993-9#2)(1994-5#1)(1994-9#1)(1995-6#1)(1995-7#1)(1996-3#1)(1996-5#2)(1996-6#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#7)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
the edge##92##2##(1991-2#1)(1991-3#2)(1992-3#1)(1992-4#1)(1993-9#2)(1994-5#1)(1994-9#2)(1995-6#1)(1995-7#1)(1996-3#1)(1996-5#2)(1996-6#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-2#16)(2008-3#19)(2008-4#1)(2008-5#1)(2008-6#3)(2008-8#1)(2008-9#1)(2009-7#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#6)(2013-8#1)
the edge-to-edge##2##2##(2007-8#2)
the edges are##2##3##(2008-3#2)
the edges of a##2##4##(2008-2#2)
the edges of the##8##4##(2006-10#1)(2008-2#2)(2009-12#1)(2010-7#1)(2011-2#1)(2013-1#2)
the edges of##13##3##(1997-3#1)(2006-10#1)(2007-8#1)(2008-2#5)(2009-12#1)(2010-7#1)(2011-2#1)(2013-1#2)
the edges##23##2##(1997-3#1)(2006-10#1)(2006-6#1)(2007-3#1)(2007-8#1)(2008-2#9)(2008-3#3)(2008-5#1)(2009-12#1)(2010-7#1)(2011-2#1)(2013-1#2)
the edible basidiomycete##2##3##(1991-8#2)
the edible mushroom##2##3##(1995-2#1)(2008-11#1)
the edible##10##2##(1991-8#2)(1995-2#1)(2007-5#1)(2008-10#3)(2008-11#1)(2012-12#1)(2013-7#1)
the edited##2##2##(1990-11#1)(1993-9#1)
the editing pathway##2##3##(1994-11#2)
the editing protein##4##3##(1994-8#4)
the editing status##2##3##(1995-5#2)
the editing##13##2##(1992-11#1)(1993-9#1)(1994-11#2)(1994-8#4)(1995-5#2)(1997-2#1)(2006-12#1)(2011-1#1)
the editor##43##2##(1995-8#1)(1995-9#1)(1996-9#1)(1997-3#1)(2005-12#3)(2006-10#2)(2006-12#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-11#4)(2008-12#8)(2008-4#1)(2008-6#1)(2008-9#2)(2010-2#1)(2010-4#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#6)
the editor]##2##2##(1993-10#1)(2008-8#1)
the editorial##4##2##(1990-12#1)(2008-10#1)(2010-8#1)(2013-1#1)
the editors of##2##3##(2006-9#1)(2011-1#1)
the editors##7##2##(1996-12#1)(2005-7#2)(2006-9#1)(2007-12#1)(2011-1#1)(2012-11#1)
the educated##3##2##(2007-11#1)(2007-12#1)(2008-11#1)
the education and training of##4##5##(1996-2#1)(2006-9#1)(2007-4#1)(2008-11#1)
the education and training##8##4##(1991-1#1)(1996-2#1)(1996-6#1)(2006-9#1)(2007-4#1)(2008-11#1)(2008-12#2)
the education and##12##3##(1991-1#1)(1996-2#1)(1996-6#1)(2006-10#1)(2006-3#1)(2006-9#1)(2007-4#1)(2008-11#1)(2008-12#2)(2008-8#1)(2011-1#1)
the education committee##2##3##(1996-1#1)(2006-2#1)
the education group##2##3##(2012-11#2)
the education level of the##2##5##(2008-7#2)
the education level##3##3##(1991-2#1)(2008-7#2)
the education of health care##2##5##(1992-2#1)(2008-12#1)
the education of health##5##4##(1992-2#1)(1993-2#1)(2008-11#2)(2008-12#1)
the education of the##3##4##(2007-4#1)(2007-7#1)(2010-2#1)
the education of##19##3##(1992-2#1)(1992-4#1)(1993-2#2)(1994-12#1)(2006-10#1)(2007-4#2)(2007-7#1)(2008-11#5)(2008-12#2)(2009-4#1)(2010-2#1)(2012-1#1)
the education system##4##3##(2006-2#1)(2008-11#1)(2010-12#2)
the education##53##2##(1991-1#1)(1991-2#1)(1992-2#1)(1992-4#1)(1993-2#2)(1994-12#1)(1996-1#3)(1996-2#1)(1996-6#1)(1997-1#1)(2006-10#2)(2006-2#2)(2006-3#1)(2006-9#1)(2007-4#3)(2007-7#1)(2008-11#7)(2008-12#5)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2010-12#2)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#2)(2013-1#2)
the educational and##3##3##(1996-2#1)(2008-12#1)(2011-2#1)
the educational experience of##2##4##(2008-12#1)(2013-7#1)
the educational infrastructure##2##3##(2004-10#1)(2007-2#1)
the educational materials##2##3##(2006-7#1)(2010-9#1)
the educational needs of##3##4##(1992-12#2)(2008-11#1)
the educational preparation##2##3##(2008-11#1)(2013-1#1)
the educational principles of##2##4##(2009-4#1)(2012-12#1)
the educational process##3##3##(1993-3#1)(2006-2#1)(2008-12#1)
the educational requirements for##3##4##(2006-2#1)(2007-6#2)
the educational requirements##4##3##(1992-1#1)(2006-2#1)(2007-6#2)
the educational system##4##3##(1990-10#1)(2007-7#1)(2007-9#1)(2008-11#1)
the educational value##2##3##(2008-11#1)(2008-12#1)
the educational##54##2##(1990-10#1)(1990-3#1)(1990-4#1)(1992-1#2)(1992-12#2)(1992-3#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-3#1)(1996-2#1)(2004-10#1)(2006-10#1)(2006-2#2)(2006-3#1)(2006-7#1)(2007-2#1)(2007-4#1)(2007-6#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#8)(2008-12#7)(2009-4#2)(2009-7#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
the educator and##2##3##(2007-4#1)(2010-9#1)
the educator##5##2##(1996-3#1)(2007-4#1)(2007-7#1)(2008-12#1)(2010-9#1)
the eel##12##2##(1990-7#3)(1991-10#2)(2005-8#2)(2008-5#5)
the efe gene##9##3##(2008-10#9)
the efe##12##2##(2008-10#12)
the effect and##6##3##(1994-2#1)(1996-12#1)(2007-12#1)(2008-11#1)(2008-3#1)(2009-2#1)
the effect being##3##3##(2006-9#1)(2007-11#1)(2008-11#1)
the effect in##4##3##(1993-11#1)(1997-5#1)(2008-3#1)(2012-2#1)
the effect induced##2##3##(1994-2#1)(2010-6#1)
the effect is mediated by##2##5##(1991-5#1)(2009-7#1)
the effect is more##2##4##(2008-5#2)
the effect is not##2##4##(2008-2#1)(2008-5#1)
the effect is##24##3##(1990-2#2)(1991-5#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-9#1)(1995-4#1)(1996-2#1)(1997-6#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-2#2)(2008-5#3)(2008-9#1)(2009-10#1)(2009-7#1)(2011-2#1)
the effect might be##2##4##(2007-3#1)(2008-4#1)
the effect observed##2##3##(1990-4#1)(2007-12#1)
the effect of 1##2##4##(1994-10#1)(2013-7#1)
the effect of 3##2##4##(2008-5#1)(2013-1#1)
the effect of 6##2##4##(1997-8#1)(2013-8#1)
the effect of CCK##2##4##(1994-10#1)(1994-2#1)
the effect of CCT on the##2##6##(2013-8#2)
the effect of Ca2+##2##4##(1990-10#1)(1993-4#1)
the effect of Cisplatin-liposome on Hela cells##2##7##(2008-10#2)
the effect of EGF on##2##5##(1994-6#2)
the effect of ET-1##3##4##(1994-11#1)(1994-12#2)
the effect of GTP##2##4##(1992-6#1)(1993-3#1)
the effect of Gaussian apodization on##2##6##(2008-2#1)(2008-3#1)
the effect of Gaussian##3##4##(2008-2#2)(2008-3#1)
the effect of Ge alloying on##2##6##(2008-10#2)
the effect of HGF on##2##5##(1991-12#1)(1992-11#1)
the effect of IL-4 on##2##5##(1991-7#1)(1995-5#1)
the effect of LPL-mediated##2##4##(1992-12#1)(1995-6#1)
the effect of MOEE##2##4##(2008-10#2)
the effect of NMDA##3##4##(1994-10#1)(1996-5#1)(2010-4#1)
the effect of PMA##2##4##(1991-4#1)(1996-5#1)
the effect of PO on the clarity of tumor margins were##2##11##(2012-2#2)
the effect of PTH##2##4##(2008-8#2)
the effect of SNP##2##4##(1994-2#1)(1995-5#1)
the effect of SOD##2##4##(1992-11#1)(1997-4#1)
the effect of SP##2##4##(1993-12#2)
the effect of UV##2##4##(2008-2#1)(2012-1#1)
the effect of a 5-min residence time##2##7##(2008-5#2)
the effect of a finite##3##5##(2008-2#1)(2008-3#2)
the effect of a group##2##5##(1995-1#1)(2008-9#1)
the effect of a single##3##5##(1991-8#1)(1997-7#1)(2008-3#1)
the effect of a small##2##5##(2008-7#2)
the effect of a##81##4##(1990-11#1)(1990-12#1)(1990-5#1)(1991-1#1)(1991-2#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-3#2)(1992-6#1)(1993-1#1)(1993-11#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-4#1)(1997-7#2)(1997-8#2)(2004-3#1)(2004-9#1)(2006-10#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-10#6)(2008-11#2)(2008-2#4)(2008-3#4)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2010-1#1)(2010-10#1)(2010-2#3)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
the effect of acupuncture##2##4##(1993-3#1)(2012-3#1)
the effect of acute##10##4##(1991-10#1)(1994-11#1)(1995-7#1)(1996-2#1)(2008-10#1)(2008-4#2)(2008-5#1)(2010-12#1)(2013-1#1)
the effect of adding##3##4##(1997-3#1)(2008-10#1)(2010-4#1)
the effect of additional##2##4##(1992-2#1)(2012-2#1)
the effect of age and##2##5##(2008-7#2)
the effect of age at##2##5##(1996-7#1)(2009-5#1)
the effect of age on##5##5##(2008-1#1)(2008-7#2)(2012-11#2)
the effect of age##9##4##(1996-7#1)(2008-1#1)(2008-7#4)(2009-5#1)(2012-11#2)
the effect of ageing##2##4##(2010-8#1)(2012-2#1)
the effect of aging on the##3##6##(1995-11#1)(2008-7#2)
the effect of aging on##7##5##(1994-6#1)(1995-11#1)(1996-11#1)(2008-7#4)
the effect of aging##8##4##(1994-6#1)(1995-11#1)(1996-11#1)(2008-7#5)
the effect of airbags on##2##5##(2007-4#2)
the effect of alcohol consumption and##2##6##(2005-10#2)
the effect of alcohol consumption##3##5##(1992-9#1)(2005-10#2)
the effect of alcohol##4##4##(1992-9#1)(1994-11#1)(2005-10#2)
the effect of alendronate##3##4##(2005-3#1)(2006-6#1)(2010-10#1)
the effect of all##2##4##(2013-1#1)(2013-8#1)
the effect of alpha-thrombin##2##4##(1993-8#1)(1994-12#1)
the effect of amino##2##4##(1995-3#1)(2010-8#1)
the effect of ampicillin##2##4##(2006-8#1)(2009-12#1)
the effect of an underestimated##2##5##(1997-6#2)
the effect of an##18##4##(1994-2#1)(1994-4#1)(1997-6#3)(2005-12#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)(2009-12#1)(2009-6#1)(2010-2#1)(2010-9#1)(2013-1#1)
the effect of any##2##4##(2008-10#1)(2012-12#1)
the effect of axial##2##4##(2006-11#1)(2007-4#1)
the effect of background##2##4##(2008-2#1)(2008-3#1)
the effect of biologics##2##4##(2012-2#2)
the effect of birth##2##4##(2007-6#1)(2011-1#1)
the effect of blocking##2##4##(2005-11#1)(2006-10#1)
the effect of blood##2##4##(1994-6#1)(2007-11#1)
the effect of both##7##4##(1991-1#1)(1993-6#1)(1996-12#1)(1997-1#1)(2008-1#1)(2008-10#1)(2009-4#1)
the effect of calcium##3##4##(1991-8#1)(1992-1#1)(2011-2#1)
the effect of carbachol##3##4##(1990-10#1)(1996-12#2)
the effect of castor oil##2##5##(2010-12#2)
the effect of cell##5##4##(1995-8#1)(2008-11#3)(2008-7#1)
the effect of certain##2##4##(1996-8#1)(2008-12#1)
the effect of changes in##4##5##(1996-3#1)(1997-2#1)(2006-10#1)(2008-2#1)
the effect of changes##5##4##(1996-3#1)(1997-2#1)(2006-10#1)(2008-2#1)(2012-2#1)
the effect of chloroquine##3##4##(1993-8#1)(1994-3#1)(2012-12#1)
the effect of cholesterol on membrane##2##6##(1996-1#1)(2006-10#1)
the effect of cholesterol on##3##5##(1993-3#1)(1996-1#1)(2006-10#1)
the effect of cholesterol##4##4##(1990-11#1)(1993-3#1)(1996-1#1)(2006-10#1)
the effect of chronic##7##4##(1990-4#1)(1992-10#1)(1993-11#1)(1994-2#1)(1995-11#1)(2008-10#1)(2013-1#1)
the effect of cigarette smoking on##4##6##(1996-3#1)(2006-11#1)(2008-10#1)(2008-12#1)
the effect of cigarette##5##4##(1991-9#1)(1996-3#1)(2006-11#1)(2008-10#1)(2008-12#1)
the effect of cocaine##4##4##(1993-12#1)(2013-8#3)
the effect of colour##2##4##(2008-4#2)
the effect of combined##3##4##(1991-5#1)(2007-1#1)(2009-4#1)
the effect of common##3##4##(2008-10#1)(2008-12#1)(2012-3#1)
the effect of continuous##2##4##(2008-11#1)(2008-12#1)
the effect of conventional##3##4##(2004-10#1)(2008-6#2)
the effect of copper and##2##5##(1997-7#1)(2008-10#1)
the effect of copper##3##4##(1990-8#1)(1997-7#1)(2008-10#1)
the effect of current and future##2##6##(2005-8#1)(2007-11#1)
the effect of cyclic##2##4##(1995-1#1)(2012-7#1)
the effect of cytokines##2##4##(1995-5#1)(2010-11#1)
the effect of dementia##2##4##(2008-7#2)
the effect of diabetes on##2##5##(2008-10#2)
the effect of diabetes##3##4##(1993-11#1)(2008-10#2)
the effect of dietary##4##4##(2006-10#1)(2006-8#1)(2010-2#1)(2013-1#1)
the effect of different##32##4##(1992-9#2)(1995-12#1)(1996-2#1)(2006-1#1)(2007-11#1)(2007-8#2)(2008-10#3)(2008-12#6)(2008-2#2)(2008-5#1)(2008-8#1)(2009-3#1)(2010-4#3)(2011-2#1)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#3)
the effect of dopamine##2##4##(1997-5#2)
the effect of drug treatment##2##5##(1993-1#2)
the effect of drug##5##4##(1993-1#2)(2004-1#1)(2008-7#1)(2011-2#1)
the effect of drugs##3##4##(2008-4#1)(2008-8#1)(2012-2#1)
the effect of duration of##2##5##(2008-10#1)(2010-8#1)
the effect of each##2##4##(2009-9#1)(2012-12#1)
the effect of either##2##4##(1995-6#1)(2012-3#1)
the effect of electric field##2##5##(1996-1#1)(2008-3#1)
the effect of environmental##2##4##(2008-3#1)(2009-4#1)
the effect of estradiol on##3##5##(1990-9#1)(2009-4#2)
the effect of estrogen on##2##5##(1993-4#1)(2008-11#1)
the effect of ethanol##2##4##(1990-10#1)(2006-10#1)
the effect of ethanolic extract of##2##6##(2008-10#1)(2012-2#1)
the effect of exercise##3##4##(2008-8#1)(2012-3#1)(2013-1#1)
the effect of exhaustive treadmill running##2##6##(2012-1#2)
the effect of exogenous##5##4##(1990-11#1)(1990-5#1)(1994-3#1)(2008-11#1)(2008-12#1)
the effect of experimental##2##4##(1990-7#1)(2008-10#1)
the effect of exposure to##4##5##(2007-12#1)(2008-4#1)(2009-12#1)(2012-1#1)
the effect of external##2##4##(1990-11#1)(2007-8#1)
the effect of extracellular##3##4##(1991-8#1)(2008-4#1)(2008-8#1)
the effect of factors##2##4##(2008-10#1)(2009-9#1)
the effect of false##2##4##(2007-5#1)(2008-2#1)
the effect of family##3##4##(2010-9#1)(2011-2#1)(2013-1#1)
the effect of feeding##5##4##(2008-12#1)(2012-2#4)
the effect of fiber tilt##2##5##(2008-2#2)
the effect of finite##2##4##(2008-3#2)
the effect of flow rate##2##5##(2008-10#2)
the effect of fluoride##2##4##(2013-1#1)(2013-8#1)
the effect of folic acid##4##5##(2008-11#2)(2010-5#2)
the effect of foreign ions##3##5##(2008-10#3)
the effect of foreign##5##4##(2007-8#1)(2008-10#3)(2012-2#1)
the effect of four##2##4##(1995-5#1)(2008-12#1)
the effect of free##2##4##(2008-10#1)(2008-5#1)
the effect of gangliosides on the##2##6##(1990-11#1)(1996-5#1)
the effect of gender##3##4##(2004-11#1)(2007-5#1)(2012-2#1)
the effect of gene##2##4##(2008-8#2)
the effect of genetic##2##4##(2005-8#1)(2008-7#1)
the effect of glucose##3##4##(1995-8#1)(1997-4#1)(2007-1#1)
the effect of graded##2##4##(2008-10#1)(2008-4#1)
the effect of growth##3##4##(1991-12#1)(1994-9#1)(2008-10#1)
the effect of harvest time##2##5##(2013-1#2)
the effect of having##2##4##(2010-5#1)(2011-2#1)
the effect of heat stress on##2##6##(2008-12#2)
the effect of heat##5##4##(1993-6#1)(2006-12#1)(2008-12#2)(2013-1#1)
the effect of high##5##4##(1990-10#1)(1991-3#1)(1995-3#1)(2005-12#1)(2008-10#1)
the effect of human##3##4##(1991-9#1)(1993-9#1)(1997-5#1)
the effect of image##3##4##(2008-2#2)(2009-4#1)
the effect of immobilized##2##4##(2010-12#1)(2012-1#1)
the effect of improving system performance##2##6##(2007-1#2)
the effect of in##2##4##(1996-11#1)(2004-4#1)
the effect of increasing the##3##5##(1991-2#1)(2008-2#1)(2008-8#1)
the effect of increasing##7##4##(1991-2#1)(1994-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-8#1)(2013-1#1)
the effect of incubation##2##4##(1991-7#1)(2011-2#1)
the effect of infection##2##4##(1991-8#1)(2011-3#1)
the effect of insoluble##2##4##(2005-11#2)
the effect of insulin##4##4##(1990-11#1)(1991-5#1)(1996-8#2)
the effect of interferences##2##4##(2008-10#2)
the effect of interleukin 1 beta on type II phospholipase A2##2##11##(1994-2#2)
the effect of interleukin 1 beta##3##6##(1994-2#3)
the effect of interleukin 1##4##5##(1992-11#1)(1994-2#3)
the effect of interleukin##5##4##(1990-7#1)(1992-11#1)(1994-2#3)
the effect of intravenous##3##4##(1996-7#1)(2007-10#1)(2007-7#1)
the effect of iodine supplementation##2##5##(2012-1#1)(2012-3#1)
the effect of ionic##2##4##(1996-5#1)(2005-11#1)
the effect of iron##3##4##(1995-2#1)(2004-9#1)(2009-8#1)
the effect of irradiation##2##4##(1996-6#1)(2011-2#1)
the effect of lead##2##4##(1995-3#1)(1997-2#1)
the effect of ligand##2##4##(1992-7#1)(2010-5#1)
the effect of light initiation##2##5##(2008-10#2)
the effect of light##4##4##(1993-12#1)(1997-6#1)(2008-10#2)
the effect of lithium on##2##5##(2009-8#1)(2012-12#1)
the effect of lithium##3##4##(1996-12#1)(2009-8#1)(2012-12#1)
the effect of long-term##3##4##(1997-2#2)(2009-12#1)
the effect of low doses of##2##6##(1993-1#1)(1994-5#1)
the effect of low levels of##2##6##(1993-4#1)(1996-8#1)
the effect of low##8##4##(1993-1#1)(1993-4#1)(1994-5#1)(1996-12#1)(1996-8#1)(2008-7#1)(2010-9#1)(2011-2#1)
the effect of lowering##2##4##(2007-10#1)(2008-5#1)
the effect of massage##2##4##(2008-12#2)
the effect of morphine##6##4##(1990-10#1)(1991-1#1)(1996-2#4)
the effect of mother##2##4##(1996-2#2)
the effect of multiple##3##4##(1993-6#1)(1996-3#1)(2007-12#1)
the effect of mutations##2##4##(1993-6#1)(1997-4#1)
the effect of nano-sized precipitates##2##5##(2009-5#2)
the effect of neuropeptides##2##4##(2007-2#1)(2008-4#1)
the effect of nicotine on naloxone-induced jumping##2##7##(1996-2#2)
the effect of nicotine on##3##5##(1991-1#1)(1996-2#2)
the effect of nicotine##4##4##(1991-1#1)(1996-2#3)
the effect of nitric oxide##2##5##(1996-1#1)(1997-8#1)
the effect of noise##2##4##(2008-3#2)
the effect of non-linear material##2##5##(2006-11#2)
the effect of numerous##2##4##(1995-1#1)(2008-10#1)
the effect of nutrient availability##2##5##(2008-10#2)
the effect of nutritional##2##4##(2011-2#1)(2012-2#1)
the effect of oral##2##4##(1991-10#1)(1992-8#1)
the effect of organic##2##4##(2005-11#1)(2008-10#1)
the effect of other##2##4##(1991-12#1)(2009-12#1)
the effect of oxygen##2##4##(1991-8#1)(1995-3#1)
the effect of pH and##2##5##(2008-10#1)(2008-7#1)
the effect of pH on the peak##2##7##(2008-10#2)
the effect of pH on the##3##6##(2008-10#2)(2008-8#1)
the effect of pH on##5##5##(2008-10#3)(2008-6#1)(2008-8#1)
the effect of pH##17##4##(1992-8#1)(2008-10#12)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
the effect of parameters##2##4##(2008-10#1)(2008-7#1)
the effect of parathyroid hormone##3##5##(1992-6#1)(1994-11#1)(1994-6#1)
the effect of parathyroid##4##4##(1991-8#1)(1992-6#1)(1994-11#1)(1994-6#1)
the effect of parental##3##4##(1994-2#1)(2010-8#1)(2013-8#1)
the effect of particle size on##2##6##(2005-11#1)(2008-7#1)
the effect of peptides##2##4##(1992-3#1)(2008-9#1)
the effect of peripheral##2##4##(2008-11#1)(2010-12#1)
the effect of phentolamine##2##4##(1990-5#2)
the effect of physical##2##4##(2011-2#1)(2013-1#1)
the effect of physiological##2##4##(1995-5#1)(2010-12#1)
the effect of population##2##4##(1995-2#1)(2012-3#1)
the effect of potential##2##4##(2008-10#1)(2011-1#1)
the effect of prenatal##2##4##(1996-5#1)(2010-12#1)
the effect of preoperative##2##4##(2007-8#2)
the effect of pressure on the##2##6##(1991-10#1)(2006-10#1)
the effect of pressure on##3##5##(1991-10#1)(2006-10#1)(2008-10#1)
the effect of pressure##5##4##(1991-10#1)(2006-10#1)(2006-9#1)(2008-10#1)(2008-6#1)
the effect of prolonged##2##4##(1995-12#1)(2009-3#1)
the effect of protein##2##4##(1993-3#1)(1994-11#1)
the effect of quadrat##2##4##(2008-10#2)
the effect of radiation##3##4##(2008-5#1)(2008-7#1)(2013-1#1)
the effect of recombinant hFGF-10 adenovirus on##2##7##(2011-3#2)
the effect of recombinant##4##4##(1992-3#1)(1994-8#1)(2011-3#2)
the effect of reducing##4##4##(2005-11#1)(2006-5#1)(2008-5#1)(2008-9#1)
the effect of relative##2##4##(2008-10#1)(2011-2#1)
the effect of relevant##2##4##(2008-10#1)(2008-7#1)
the effect of residential##2##4##(2009-9#1)(2013-1#1)
the effect of resource##2##4##(2007-12#1)(2008-8#1)
the effect of retention##3##4##(2008-10#2)(2008-12#1)
the effect of salt##2##4##(1991-9#1)(2009-8#1)
the effect of scattering##4##4##(2008-3#3)(2011-1#1)
the effect of selected##2##4##(1997-6#1)(2008-7#1)
the effect of selective##2##4##(1991-3#1)(2012-2#1)
the effect of several##3##4##(1993-9#1)(1995-3#1)(1995-6#1)
the effect of sex##2##4##(1991-3#1)(1997-7#1)
the effect of smoking##2##4##(1996-3#1)(2009-11#1)
the effect of social##4##4##(1995-5#1)(1997-3#1)(2007-1#1)(2007-12#1)
the effect of socioeconomic##2##4##(2007-9#1)(2013-1#1)
the effect of sodium##2##4##(1994-2#1)(1997-6#1)
the effect of soil##5##4##(2008-10#3)(2008-5#2)
the effect of soluble##2##4##(2007-10#1)(2012-12#1)
the effect of solution pH##2##5##(2008-5#2)
the effect of solvents on the##2##6##(1997-4#1)(2008-3#1)
the effect of some##7##4##(1993-7#1)(1996-12#1)(2004-9#1)(2008-10#2)(2008-5#1)(2008-8#1)
the effect of spatial hole burning##3##6##(2007-11#2)(2008-3#1)
the effect of specific##4##4##(2007-11#1)(2008-10#1)(2008-4#1)(2010-10#1)
the effect of spherical aberration##2##5##(2008-2#1)(2009-4#1)
the effect of stress##3##4##(1991-11#1)(2006-12#1)(2009-7#1)
the effect of structured##2##4##(2008-11#1)(2013-7#1)
the effect of substance##2##4##(1990-2#1)(2007-11#1)
the effect of such##8##4##(1993-1#1)(2004-9#1)(2007-10#1)(2008-11#1)(2008-3#1)(2009-6#1)(2012-1#1)(2013-8#1)
the effect of sucrose##2##4##(1994-12#1)(2009-6#1)
the effect of surface##2##4##(2007-5#1)(2012-1#1)
the effect of surfactants on##2##5##(2008-5#2)
the effect of surgical##3##4##(2008-10#1)(2008-7#1)(2009-6#1)
the effect of systemic administration of##3##6##(1994-3#1)(1996-2#1)(1996-9#1)
the effect of systemic##6##4##(1990-7#1)(1994-3#1)(1994-7#1)(1995-7#1)(1996-2#1)(1996-9#1)
the effect of task##2##4##(2008-8#1)(2012-3#1)
the effect of taxon##2##4##(2010-6#1)(2012-2#1)
the effect of temperature and##2##5##(2005-11#1)(2008-10#1)
the effect of temperature on the##2##6##(1992-5#1)(2008-5#1)
the effect of temperature on##9##5##(1992-5#1)(1993-5#1)(2008-10#3)(2008-5#2)(2009-6#1)(2009-8#1)
the effect of temperature##19##4##(1991-2#1)(1991-6#1)(1992-5#1)(1993-5#1)(2005-11#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2009-6#1)(2009-8#1)(2013-7#1)
the effect of the ACE##2##5##(1991-12#1)(2010-6#1)
the effect of the addition of##2##6##(1997-1#1)(2008-6#1)
the effect of the chemical##2##5##(1996-9#1)(2008-6#1)
the effect of the different##2##5##(1996-2#1)(2008-7#1)
the effect of the first##2##5##(1990-2#1)(2008-10#1)
the effect of the following##2##5##(2008-10#1)(2008-7#1)
the effect of the inhibitor on##2##6##(1990-11#1)(2008-4#1)
the effect of the mating system on the##2##8##(2013-1#2)
the effect of the mutations##2##5##(1992-9#1)(1997-2#1)
the effect of the number of##2##6##(2007-8#1)(2011-2#1)
the effect of the particle##2##5##(2008-3#1)(2008-8#1)
the effect of the peptide on##2##6##(1990-2#1)(1996-7#1)
the effect of the presence of##2##6##(1991-10#1)(2008-10#1)
the effect of the time##2##5##(2008-10#1)(2013-1#1)
the effect of the##179##4##(1990-10#1)(1990-11#1)(1990-2#3)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-6#1)(1992-9#3)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-6#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#2)(1995-4#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#1)(1997-3#1)(1997-6#1)(2004-12#1)(2004-4#1)(2005-11#4)(2005-4#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#25)(2008-11#6)(2008-12#2)(2008-2#11)(2008-3#8)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#5)(2009-3#1)(2009-4#2)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#6)(2012-1#2)(2012-11#1)(2012-2#1)(2013-1#6)(2013-7#3)(2013-8#3)
the effect of their##3##4##(1991-8#1)(1994-5#1)(2009-6#1)
the effect of therapeutic##2##4##(1991-4#1)(1995-9#1)
the effect of thermal injury on##2##6##(2008-9#2)
the effect of thermal##3##4##(2008-2#1)(2008-9#2)
the effect of these agents##3##5##(1990-2#1)(1995-6#1)(1996-2#1)
the effect of these modifications##2##5##(1991-12#1)(1997-6#1)
the effect of these mutations on##2##6##(1996-7#1)(2008-11#1)
the effect of these##22##4##(1990-2#1)(1991-12#1)(1991-2#1)(1995-3#1)(1995-6#1)(1996-2#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-6#1)(2004-10#1)(2006-9#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-5#1)(2009-9#2)(2010-4#1)(2012-3#1)(2013-8#1)
the effect of this##15##4##(1990-12#1)(1991-7#2)(1994-3#1)(1996-1#1)(1996-12#1)(1996-5#1)(2005-1#1)(2006-12#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-6#1)(2012-12#1)
the effect of three##2##4##(1995-12#1)(2011-2#1)
the effect of tissue##2##4##(2008-2#1)(2010-8#1)
the effect of transdermal##2##4##(1991-8#1)(1992-12#1)
the effect of treatment##4##4##(1990-5#1)(1992-2#1)(1992-8#1)(1997-3#1)
the effect of two different##3##5##(2004-1#1)(2006-9#1)(2011-1#1)
the effect of two##7##4##(1990-10#1)(1996-9#1)(2004-1#1)(2006-2#1)(2006-9#1)(2011-1#1)(2011-12#1)
the effect of valproic acid (VPA)##2##6##(2010-10#1)(2013-1#1)
the effect of vanadium (V)##2##5##(1993-12#1)(2011-2#1)
the effect of variation in##2##5##(2007-5#1)(2008-4#1)
the effect of various##11##4##(1990-11#2)(1993-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-5#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
the effect of varying the##2##5##(1995-8#1)(2012-2#1)
the effect of varying##5##4##(1995-10#1)(1995-8#1)(2008-1#1)(2008-9#1)(2012-2#1)
the effect of visceral##2##4##(2005-10#1)(2013-8#1)
the effect of vitamin##8##4##(1990-3#1)(1994-12#1)(2007-7#1)(2008-1#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-8#1)
the effect of volatile##2##4##(1990-2#1)(2007-7#1)
the effect of water##4##4##(1996-3#1)(2008-10#3)
the effect of zinc##2##4##(2012-2#1)(2013-7#1)
the effect of##2053##3##(1990-1#1)(1990-10#10)(1990-11#11)(1990-12#5)(1990-2#10)(1990-3#6)(1990-4#3)(1990-5#12)(1990-7#6)(1990-8#5)(1990-9#1)(1991-1#9)(1991-10#7)(1991-11#6)(1991-12#9)(1991-2#15)(1991-3#6)(1991-4#4)(1991-5#7)(1991-6#7)(1991-7#8)(1991-8#11)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#3)(1992-2#4)(1992-3#14)(1992-4#5)(1992-5#2)(1992-6#9)(1992-7#3)(1992-8#9)(1992-9#8)(1993-1#6)(1993-10#1)(1993-11#10)(1993-12#17)(1993-2#2)(1993-3#13)(1993-4#7)(1993-5#3)(1993-6#9)(1993-7#4)(1993-8#6)(1993-9#6)(1994-10#7)(1994-11#13)(1994-12#10)(1994-2#15)(1994-3#12)(1994-4#3)(1994-5#10)(1994-6#11)(1994-7#1)(1994-8#6)(1994-9#5)(1995-1#7)(1995-10#6)(1995-11#10)(1995-12#19)(1995-2#8)(1995-3#15)(1995-4#4)(1995-5#9)(1995-6#5)(1995-7#5)(1995-8#9)(1995-9#2)(1996-1#7)(1996-10#2)(1996-11#3)(1996-12#18)(1996-2#22)(1996-3#6)(1996-4#4)(1996-5#12)(1996-6#4)(1996-7#6)(1996-8#14)(1996-9#6)(1997-1#14)(1997-2#15)(1997-3#7)(1997-4#10)(1997-5#5)(1997-6#11)(1997-7#13)(1997-8#6)(2004-1#3)(2004-10#2)(2004-11#3)(2004-12#3)(2004-3#1)(2004-4#2)(2004-9#7)(2005-1#1)(2005-10#6)(2005-11#21)(2005-12#2)(2005-3#3)(2005-4#1)(2005-6#1)(2005-7#1)(2005-8#4)(2005-9#1)(2006-1#3)(2006-10#22)(2006-11#6)(2006-12#8)(2006-2#6)(2006-3#3)(2006-5#5)(2006-6#3)(2006-7#3)(2006-8#7)(2006-9#8)(2007-1#8)(2007-10#14)(2007-11#24)(2007-12#23)(2007-2#12)(2007-3#2)(2007-4#8)(2007-5#6)(2007-6#4)(2007-7#11)(2007-8#22)(2007-9#13)(2008-1#15)(2008-10#189)(2008-11#45)(2008-12#45)(2008-2#50)(2008-3#70)(2008-4#27)(2008-5#56)(2008-6#20)(2008-7#47)(2008-8#40)(2008-9#21)(2009-10#3)(2009-11#2)(2009-12#9)(2009-2#3)(2009-3#5)(2009-4#15)(2009-5#7)(2009-6#12)(2009-7#2)(2009-8#9)(2009-9#9)(2010-1#3)(2010-10#8)(2010-11#5)(2010-12#18)(2010-2#11)(2010-3#5)(2010-4#14)(2010-5#6)(2010-6#6)(2010-7#2)(2010-8#14)(2010-9#4)(2011-1#16)(2011-11#1)(2011-12#6)(2011-2#46)(2011-3#5)(2012-1#26)(2012-11#6)(2012-12#14)(2012-2#46)(2012-3#21)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#52)(2013-7#12)(2013-8#32)
the effect on HIV##2##4##(1996-12#1)(2008-1#1)
the effect on temperature##2##4##(1996-2#2)
the effect on the##15##4##(1990-8#1)(1993-3#1)(1994-2#1)(1996-1#1)(1996-9#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)
the effect on##59##3##(1990-11#1)(1990-2#1)(1990-8#1)(1991-12#2)(1992-11#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-2#2)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#4)(1996-3#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-2#2)(1997-3#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-3#5)(2008-5#2)(2008-8#1)(2008-9#1)(2009-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
the effect size##5##3##(2006-3#1)(2009-4#1)(2010-4#1)(2012-3#2)
the effect that the##3##4##(2008-8#1)(2013-1#2)
the effect that##22##3##(1992-3#1)(2006-1#1)(2006-3#1)(2006-6#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-7#1)(2011-2#1)(2013-1#4)(2013-7#1)
the effect this##2##3##(2006-10#1)(2013-7#1)
the effect to a##2##4##(2008-5#1)(2010-2#1)
the effect under##2##3##(2008-11#1)(2008-2#1)
the effect was due to##2##5##(2007-9#1)(2011-2#1)
the effect was found##2##4##(1993-6#1)(2008-5#1)
the effect was greater##2##4##(1996-1#1)(2008-10#1)
the effect was less##2##4##(1991-12#1)(2008-9#1)
the effect was more##2##4##(1993-4#1)(2012-1#1)
the effect was much##2##4##(1992-2#1)(2008-10#1)
the effect was not##4##4##(1995-6#1)(2008-11#1)(2013-1#2)
the effect was significantly##2##4##(1991-9#1)(1996-12#1)
the effect was the##2##4##(1993-2#1)(2009-7#1)
the effect was##36##3##(1991-1#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#1)(1997-3#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#2)
the effect##2286##2##(1990-1#1)(1990-10#10)(1990-11#12)(1990-12#5)(1990-2#14)(1990-3#6)(1990-4#4)(1990-5#12)(1990-7#6)(1990-8#6)(1990-9#1)(1991-1#10)(1991-10#7)(1991-11#6)(1991-12#14)(1991-2#16)(1991-3#6)(1991-4#4)(1991-5#8)(1991-6#7)(1991-7#8)(1991-8#11)(1991-9#5)(1992-1#4)(1992-10#1)(1992-11#4)(1992-12#5)(1992-2#5)(1992-3#16)(1992-4#5)(1992-5#3)(1992-6#9)(1992-7#3)(1992-8#11)(1992-9#10)(1993-1#6)(1993-10#1)(1993-11#11)(1993-12#23)(1993-2#3)(1993-3#15)(1993-4#8)(1993-5#3)(1993-6#10)(1993-7#4)(1993-8#6)(1993-9#8)(1994-10#7)(1994-11#13)(1994-12#10)(1994-2#19)(1994-3#12)(1994-4#3)(1994-5#11)(1994-6#11)(1994-7#1)(1994-8#7)(1994-9#6)(1995-1#7)(1995-10#6)(1995-11#10)(1995-12#19)(1995-2#9)(1995-3#15)(1995-4#5)(1995-5#11)(1995-6#6)(1995-7#5)(1995-8#10)(1995-9#2)(1996-1#9)(1996-10#3)(1996-11#3)(1996-12#22)(1996-2#27)(1996-3#7)(1996-4#5)(1996-5#12)(1996-6#4)(1996-7#7)(1996-8#15)(1996-9#8)(1997-1#14)(1997-2#17)(1997-3#9)(1997-4#10)(1997-5#6)(1997-6#12)(1997-7#13)(1997-8#8)(2004-1#3)(2004-10#2)(2004-11#3)(2004-12#3)(2004-3#1)(2004-4#2)(2004-9#8)(2005-1#1)(2005-10#7)(2005-11#22)(2005-12#2)(2005-3#3)(2005-4#1)(2005-6#1)(2005-7#1)(2005-8#4)(2005-9#1)(2006-1#4)(2006-10#25)(2006-11#6)(2006-12#9)(2006-2#6)(2006-3#5)(2006-5#6)(2006-6#5)(2006-7#4)(2006-8#7)(2006-9#9)(2007-1#9)(2007-10#14)(2007-11#29)(2007-12#29)(2007-2#13)(2007-3#5)(2007-4#9)(2007-5#6)(2007-6#4)(2007-7#13)(2007-8#23)(2007-9#15)(2008-1#18)(2008-10#200)(2008-11#55)(2008-12#48)(2008-2#54)(2008-3#82)(2008-4#29)(2008-5#68)(2008-6#20)(2008-7#49)(2008-8#44)(2008-9#31)(2009-10#4)(2009-11#2)(2009-12#9)(2009-2#5)(2009-3#5)(2009-4#16)(2009-5#8)(2009-6#12)(2009-7#4)(2009-8#9)(2009-9#9)(2010-1#3)(2010-10#8)(2010-11#5)(2010-12#18)(2010-2#13)(2010-3#5)(2010-4#17)(2010-5#7)(2010-6#7)(2010-7#3)(2010-8#15)(2010-9#4)(2011-1#17)(2011-11#1)(2011-12#6)(2011-2#49)(2011-3#5)(2012-1#28)(2012-11#6)(2012-12#15)(2012-2#51)(2012-3#23)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#59)(2013-7#15)(2013-8#33)
the effective area##2##3##(2008-3#2)
the effective complex##2##3##(2006-12#1)(2008-2#1)
the effective concentration of##4##4##(1994-9#1)(2005-11#1)(2008-10#1)(2012-3#1)
the effective concentration##7##3##(1993-12#1)(1994-9#1)(2005-11#1)(2008-10#3)(2012-3#1)
the effective delivery of##3##4##(2010-12#1)(2010-6#1)(2013-1#1)
the effective depth for##2##4##(2008-3#2)
the effective diffusion coefficient and the##2##6##(2005-11#1)(2008-2#1)
the effective diffusion coefficient##4##4##(2005-11#2)(2006-10#1)(2008-2#1)
the effective diffusion##5##3##(2005-11#2)(2006-10#2)(2008-2#1)
the effective dose##8##3##(1995-12#1)(1996-11#1)(1997-8#2)(2008-12#1)(2010-9#2)(2013-8#1)
the effective group##6##3##(2006-12#1)(2012-12#5)
the effective head pressure is##2##5##(2006-8#2)
the effective immobilization of##2##4##(2008-10#2)
the effective index of##2##4##(2007-12#1)(2008-2#1)
the effective index##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
the effective medium theory##2##4##(2008-3#2)
the effective medium##3##3##(2007-11#1)(2008-3#2)
the effective migration rate##2##4##(2008-10#1)(2008-8#1)
the effective noise##2##3##(1991-6#1)(2007-12#1)
the effective number of##3##4##(1993-11#1)(2008-2#1)(2010-2#1)
the effective optical##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
the effective pixel size##2##4##(2007-12#2)
the effective population size##3##4##(1997-4#1)(2008-10#1)(2013-1#1)
the effective radius##3##3##(2008-3#3)
the effective reflectivity of##2##4##(2008-2#2)
the effective refractive index##5##4##(2007-11#2)(2007-12#1)(2008-3#2)
the effective removal of##3##4##(1991-9#1)(2005-11#1)(2006-12#1)
the effective shear##2##3##(2006-6#2)
the effective size of a##3##5##(2007-12#2)(2008-8#1)
the effective size of the##3##5##(1990-11#1)(2007-11#1)(2008-10#1)
the effective size of##6##4##(1990-11#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-8#1)
the effective sizes of##2##4##(2008-10#2)
the effective source##2##3##(2008-2#2)
the effective surface area##2##4##(1996-8#1)(2008-10#1)
the effective therapeutic##2##3##(2006-8#1)(2011-2#1)
the effective treatment of##6##4##(1991-12#1)(1996-6#1)(2005-10#1)(2008-4#1)(2013-7#1)(2013-8#1)
the effective use of##6##4##(1992-9#1)(2005-10#1)(2008-6#1)(2009-12#1)(2010-11#1)(2012-11#1)
the effective use##7##3##(1992-2#1)(1992-9#1)(2005-10#1)(2008-6#1)(2009-12#1)(2010-11#1)(2012-11#1)
the effective utilization of##2##4##(2008-10#1)(2010-10#1)
the effective values of##2##4##(2006-5#1)(2008-3#1)
the effective wavelength of the##3##5##(2008-2#2)(2008-3#1)
the effective wavelength##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
the effective##237##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-2#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-4#1)(1993-8#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-7#1)(1996-11#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#2)(2005-10#2)(2005-11#9)(2005-9#1)(2006-10#4)(2006-12#4)(2006-5#2)(2006-6#3)(2006-8#3)(2007-10#1)(2007-11#11)(2007-12#23)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#25)(2008-11#3)(2008-12#3)(2008-2#22)(2008-3#26)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-12#1)(2009-4#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#5)(2012-3#1)(2012-6#1)(2013-1#4)(2013-7#1)(2013-8#5)
the effective-index model##2##3##(2007-12#2)
the effective-index##3##2##(2007-12#2)(2008-2#1)
the effectiveness and cost-effectiveness of##2##5##(2011-2#1)(2013-8#1)
the effectiveness and safety of a##2##6##(1992-10#1)(1993-2#1)
the effectiveness and safety of rituximab##2##6##(2013-1#2)
the effectiveness and safety of##10##5##(1992-10#1)(1993-2#1)(2006-6#1)(2008-3#1)(2010-12#1)(2013-1#4)(2013-8#1)
the effectiveness and the##2##4##(2006-10#1)(2010-8#1)
the effectiveness and tolerance of##4##5##(1990-6#1)(1992-2#1)(1997-1#1)(2008-5#1)
the effectiveness and##28##3##(1990-6#1)(1992-10#1)(1992-2#1)(1993-2#1)(1996-1#1)(1997-1#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#6)(2013-8#2)
the effectiveness of ASPs##2##4##(2013-1#2)
the effectiveness of a given##2##5##(2008-3#1)(2012-3#1)
the effectiveness of a##40##4##(1990-6#1)(1992-1#2)(1992-11#1)(1993-11#1)(1994-12#1)(1994-7#1)(1995-3#1)(1995-4#1)(1996-11#1)(2004-12#1)(2005-10#2)(2006-10#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#5)(2008-9#1)(2009-10#1)(2010-3#1)(2010-6#1)(2012-3#2)
the effectiveness of all##2##4##(2006-8#1)(2012-12#1)
the effectiveness of an intervention##2##5##(2010-10#1)(2011-1#1)
the effectiveness of an##8##4##(1995-2#1)(1997-1#1)(2007-4#1)(2008-8#1)(2010-10#1)(2011-1#1)(2012-2#2)
the effectiveness of anti-inflammatory##2##4##(1996-7#1)(2008-7#1)
the effectiveness of antimicrobially impregnated catheters##2##6##(2007-7#2)
the effectiveness of cardiac##2##4##(2006-10#1)(2012-12#1)
the effectiveness of control##2##4##(1997-7#1)(2008-1#1)
the effectiveness of couple therapy for##2##6##(2012-2#2)
the effectiveness of current##4##4##(1995-2#1)(2007-10#1)(2008-11#1)(2012-2#1)
the effectiveness of different##7##4##(1994-12#1)(2006-10#1)(2008-2#1)(2011-2#1)(2013-1#2)(2013-8#1)
the effectiveness of epidural##2##4##(2006-8#2)
the effectiveness of exercise for##2##5##(2013-1#2)
the effectiveness of five##2##4##(2008-11#1)(2008-4#1)
the effectiveness of inpatient##2##4##(1990-12#1)(1991-2#1)
the effectiveness of interventions##2##4##(1997-2#1)(2011-2#1)
the effectiveness of local##2##4##(2009-3#1)(2013-7#1)
the effectiveness of non-clinician trainers##2##5##(2013-1#2)
the effectiveness of our##9##4##(1995-12#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2010-9#1)
the effectiveness of population replacement strategy##2##6##(2008-11#2)
the effectiveness of routine##2##4##(2011-2#1)(2012-12#1)
the effectiveness of some##2##4##(2006-11#1)(2007-12#1)
the effectiveness of such##2##4##(2005-8#1)(2008-8#1)
the effectiveness of the existing##2##5##(2007-4#1)(2012-2#1)
the effectiveness of the method##3##5##(2007-6#1)(2007-8#1)(2008-3#1)
the effectiveness of the proposed approach##2##6##(2007-11#1)(2008-2#1)
the effectiveness of the proposed method##3##6##(2007-12#2)(2008-3#1)
the effectiveness of the proposed scheme##2##6##(2008-3#1)(2010-6#1)
the effectiveness of the proposed system##2##6##(2008-3#2)
the effectiveness of the proposed##12##5##(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#4)(2010-6#1)
the effectiveness of the strategic##2##5##(1997-1#1)(2007-7#1)
the effectiveness of the##91##4##(1990-5#1)(1991-2#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-9#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1997-1#1)(1997-3#2)(1997-7#1)(2004-3#1)(2005-6#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-4#1)(2007-6#2)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#9)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#1)(2010-1#1)(2010-10#2)(2010-2#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)
the effectiveness of their##6##4##(1997-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)
the effectiveness of these##9##4##(1991-1#1)(1994-6#1)(1996-1#1)(2006-10#1)(2007-11#1)(2008-7#1)(2008-9#1)(2010-6#1)(2012-2#1)
the effectiveness of this method##4##5##(1996-1#1)(2008-11#1)(2008-12#1)(2008-3#1)
the effectiveness of this technique##3##5##(2008-10#1)(2008-11#1)(2008-3#1)
the effectiveness of this treatment##3##5##(1990-4#1)(2007-8#1)(2012-12#1)
the effectiveness of this type of##3##6##(2007-12#1)(2012-2#2)
the effectiveness of this##22##4##(1990-4#1)(1990-8#1)(1996-1#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2010-4#1)(2012-12#1)(2012-2#2)
the effectiveness of treatment##6##4##(1996-3#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-1#1)
the effectiveness of two##3##4##(1992-3#1)(2004-10#1)(2013-1#1)
the effectiveness of using##4##4##(2007-5#1)(2012-12#1)(2013-7#2)
the effectiveness of various##2##4##(1990-8#1)(2013-8#1)
the effectiveness of##474##3##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#3)(1995-3#3)(1995-4#1)(1996-1#2)(1996-11#1)(1996-12#4)(1996-3#1)(1996-6#1)(1996-7#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-7#2)(1997-8#1)(2004-10#2)(2004-12#1)(2004-3#1)(2005-10#3)(2005-6#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#7)(2006-11#2)(2006-12#3)(2006-2#1)(2006-6#3)(2006-8#7)(2006-9#2)(2007-1#2)(2007-10#3)(2007-11#14)(2007-12#7)(2007-2#5)(2007-3#3)(2007-4#3)(2007-5#2)(2007-6#6)(2007-7#14)(2007-8#13)(2007-9#2)(2008-1#4)(2008-10#18)(2008-11#12)(2008-12#7)(2008-2#20)(2008-3#14)(2008-4#6)(2008-5#9)(2008-6#9)(2008-7#14)(2008-8#5)(2008-9#5)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-1#2)(2010-10#3)(2010-2#5)(2010-3#2)(2010-4#3)(2010-5#3)(2010-6#5)(2010-9#3)(2011-1#2)(2011-11#1)(2011-12#4)(2011-2#16)(2011-3#2)(2012-1#6)(2012-10#1)(2012-11#1)(2012-12#13)(2012-2#20)(2012-3#6)(2013-1#44)(2013-7#5)(2013-8#3)
the effectiveness##511##2##(1990-10#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#3)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#3)(1995-3#3)(1995-4#1)(1996-1#3)(1996-11#1)(1996-12#5)(1996-3#1)(1996-6#1)(1996-7#1)(1997-1#4)(1997-2#1)(1997-3#2)(1997-7#2)(1997-8#1)(2004-10#2)(2004-12#1)(2004-3#1)(2005-10#3)(2005-6#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#8)(2006-11#2)(2006-12#3)(2006-2#2)(2006-6#4)(2006-8#7)(2006-9#2)(2007-1#2)(2007-10#3)(2007-11#15)(2007-12#7)(2007-2#5)(2007-3#3)(2007-4#3)(2007-5#2)(2007-6#6)(2007-7#15)(2007-8#13)(2007-9#2)(2008-1#4)(2008-10#20)(2008-11#12)(2008-12#7)(2008-2#20)(2008-3#15)(2008-4#6)(2008-5#10)(2008-6#9)(2008-7#15)(2008-8#5)(2008-9#5)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#2)(2010-1#2)(2010-10#3)(2010-12#1)(2010-2#5)(2010-3#2)(2010-4#3)(2010-5#3)(2010-6#5)(2010-8#1)(2010-9#3)(2011-1#3)(2011-11#1)(2011-12#4)(2011-2#20)(2011-3#2)(2012-1#6)(2012-10#1)(2012-11#1)(2012-12#14)(2012-2#21)(2012-3#6)(2013-1#50)(2013-7#5)(2013-8#5)
the effectivity of the##3##4##(1991-10#1)(2008-5#2)
the effector cells##3##3##(1990-12#1)(1993-6#1)(1995-2#1)
the effector molecule##2##3##(1995-3#1)(2012-3#1)
the effector phase##4##3##(2005-11#1)(2008-10#3)
the effector site##2##3##(1995-2#2)
the effector##26##2##(1990-12#1)(1991-12#1)(1991-9#2)(1992-3#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-9#2)(1995-2#3)(1995-3#1)(1995-6#1)(2005-11#1)(2007-2#1)(2008-10#3)(2008-3#1)(2009-2#1)(2011-2#1)(2012-12#1)(2012-3#1)
the effectors of##2##3##(1996-2#1)(2008-9#1)
the effectors##3##2##(1996-2#1)(2008-8#1)(2008-9#1)
the effects and##14##3##(1995-2#1)(1996-3#1)(2006-10#3)(2006-12#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-9#1)(2011-3#1)(2012-3#1)(2013-1#1)
the effects are##8##3##(1995-6#1)(1997-1#1)(2006-10#2)(2008-3#1)(2008-7#1)(2009-11#1)(2013-1#1)
the effects can be##2##4##(1991-8#1)(2012-1#1)
the effects caused by##4##4##(2007-11#1)(2008-10#1)(2008-2#2)
the effects due to##3##4##(1994-3#1)(2008-2#1)(2008-4#1)
the effects in##4##3##(1995-2#1)(2011-2#1)(2012-12#1)(2013-8#1)
the effects induced by##2##4##(1991-9#1)(1995-12#1)
the effects mediated##2##3##(1996-5#1)(2010-1#1)
the effects observed##6##3##(1991-3#1)(1991-5#2)(1994-6#2)(2011-1#1)
the effects of 1##4##4##(1991-10#1)(1997-3#1)(1997-8#1)(2010-7#1)
the effects of 5##2##4##(1997-6#1)(2008-6#1)
the effects of 5-HT##2##4##(1990-5#1)(1992-9#1)
the effects of 8-OH-DPAT##2##4##(1990-5#1)(1992-7#1)
the effects of Angiotensin##2##4##(2007-9#2)
the effects of CCK-8 on##2##5##(1992-4#1)(1995-11#1)
the effects of CR##4##4##(1994-5#2)(2008-10#1)(2008-11#1)
the effects of ET on##2##5##(2012-3#1)(2013-8#1)
the effects of ET##4##4##(2008-1#1)(2012-3#2)(2013-8#1)
the effects of FGF-20 on established mucositis##2##7##(2008-7#2)
the effects of GABA##2##4##(1994-10#1)(1994-5#1)
the effects of GM-CSF##2##4##(1990-8#1)(1992-3#1)
the effects of IL-1 on##2##5##(1990-7#1)(1994-10#1)
the effects of IL-1##4##4##(1990-7#1)(1994-10#2)(1995-11#1)
the effects of JP-8 exposure on##2##6##(2008-4#2)
the effects of K+##2##4##(1994-9#1)(2008-11#1)
the effects of LDL##2##4##(1994-9#2)
the effects of NA##2##4##(1995-5#2)
the effects of NO##2##4##(1997-7#1)(2007-10#1)
the effects of S##2##4##(2008-5#1)(2010-8#1)
the effects of SP in##2##5##(2008-5#2)
the effects of SP##3##4##(2008-5#3)
the effects of T3##3##4##(1994-3#2)(1996-5#1)
the effects of TNF-alpha##2##4##(1993-6#1)(1997-7#1)
the effects of VIP on##2##5##(1995-11#1)(1997-8#1)
the effects of a DNR order##2##6##(1992-12#1)(1992-3#1)
the effects of a health education program##2##7##(2008-6#2)
the effects of a known##2##5##(2008-1#1)(2013-1#1)
the effects of a novel##2##5##(1997-5#1)(2012-3#1)
the effects of a physical##3##5##(2007-12#2)(2008-12#1)
the effects of a scopolamine-induced deficit##2##6##(1993-11#2)
the effects of a single##2##5##(1995-12#1)(2012-2#1)
the effects of a variety of##3##6##(1991-10#1)(1994-2#1)(2013-1#1)
the effects of a##71##4##(1990-4#1)(1990-9#1)(1991-1#1)(1991-10#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-11#2)(1993-3#1)(1994-2#1)(1994-6#1)(1995-12#1)(1996-11#1)(1996-12#2)(1996-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-12#1)(2006-10#1)(2006-6#1)(2007-12#3)(2007-3#1)(2007-4#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-6#1)(2010-2#3)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#1)
the effects of acetylcholine on##2##5##(1995-11#2)
the effects of acute and##3##5##(1992-5#1)(1996-12#1)(2011-2#1)
the effects of acute##10##4##(1991-9#1)(1992-1#1)(1992-5#1)(1995-7#1)(1996-12#1)(2007-10#1)(2007-2#1)(2008-12#1)(2011-2#1)(2013-1#1)
the effects of additional##2##4##(2008-1#1)(2012-1#1)
the effects of aerosol##2##4##(2008-2#2)
the effects of age and##4##5##(1994-9#1)(1996-5#1)(2006-8#1)(2008-8#1)
the effects of age at##2##5##(2008-9#1)(2011-1#1)
the effects of age##12##4##(1991-12#1)(1992-7#1)(1994-9#1)(1996-3#1)(1996-5#1)(1997-5#1)(2006-12#1)(2006-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-1#1)
the effects of agents##2##4##(1996-2#1)(2008-5#1)
the effects of aggressive##2##4##(2006-10#1)(2008-8#1)
the effects of aging and##2##5##(1992-8#1)(2013-8#1)
the effects of aging on##4##5##(1997-1#1)(2006-9#1)(2007-9#1)(2010-7#1)
the effects of aging##6##4##(1992-8#1)(1997-1#1)(2006-9#1)(2007-9#1)(2010-7#1)(2013-8#1)
the effects of agricultural practices##2##5##(2008-10#2)
the effects of agricultural##3##4##(2008-10#2)(2008-11#1)
the effects of air pollution##2##5##(2010-9#2)
the effects of alcohol##2##4##(2005-7#1)(2009-12#1)
the effects of amino##2##4##(1991-5#1)(1997-5#1)
the effects of amphetamine##3##4##(1991-5#1)(1995-11#1)(2013-7#1)
the effects of amygdala##2##4##(2006-3#1)(2008-7#1)
the effects of an##14##4##(1990-4#1)(1990-5#1)(1994-2#1)(1996-12#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-3#1)(2008-5#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#1)
the effects of angiotensins in##2##5##(1997-7#2)
the effects of antioxidants##2##4##(2005-8#1)(2007-8#1)
the effects of aqueous##2##4##(1992-2#1)(2011-1#1)
the effects of atmospheric##2##4##(2008-3#2)
the effects of auditory##2##4##(1997-7#1)(2008-9#1)
the effects of background##2##4##(2008-3#1)(2009-4#1)
the effects of base time on the diagnosticity of##2##9##(2008-8#2)
the effects of base##3##4##(1992-12#1)(2008-8#2)
the effects of bilateral##2##4##(1994-3#1)(1997-6#1)
the effects of blocking##3##4##(1995-11#1)(2007-12#1)(2010-8#1)
the effects of body mass##2##5##(2007-4#1)(2011-1#1)
the effects of body##3##4##(2007-4#1)(2011-1#1)(2013-7#1)
the effects of bortezomib##2##4##(2011-2#2)
the effects of both##6##4##(1993-4#1)(1994-11#1)(2008-11#1)(2009-4#1)(2009-6#1)(2012-3#1)
the effects of cadmium##2##4##(1994-6#1)(2013-1#1)
the effects of caloric restriction##2##5##(1994-5#1)(2008-10#1)
the effects of cardiac surgery##2##5##(2006-10#1)(2007-8#1)
the effects of cations##2##4##(2008-6#2)
the effects of cell##2##4##(1995-3#1)(2008-7#1)
the effects of ceramide on##3##5##(1996-5#3)
the effects of cetyltriethylammonium bromide (CTAB) on the##2##8##(2008-11#2)
the effects of chain length on the##2##7##(1992-2#1)(1997-4#1)
the effects of changes in##6##5##(1993-11#1)(1993-2#1)(2004-9#1)(2007-12#1)(2008-4#1)(2012-12#1)
the effects of chemical##2##4##(2005-11#1)(2008-10#1)
the effects of chronic##6##4##(1995-12#1)(1996-12#1)(2008-10#1)(2008-12#1)(2010-6#1)(2013-1#1)
the effects of cisapride and BRL 24924##2##7##(1990-5#2)
the effects of climate change##3##5##(2012-12#2)(2013-8#1)
the effects of codeine##2##4##(1993-11#2)
the effects of combined##4##4##(2007-2#1)(2008-8#1)(2013-1#1)(2013-8#1)
the effects of complete##2##4##(2007-12#2)
the effects of concurrent##2##4##(1992-3#1)(2006-10#1)
the effects of constitutive##2##4##(2006-12#1)(2008-8#1)
the effects of contact##2##4##(2006-12#1)(2009-8#1)
the effects of continuous##2##4##(1995-12#1)(2010-6#1)
the effects of corticosteroids##2##4##(1995-12#1)(1997-1#1)
the effects of cultivating##2##4##(2011-2#2)
the effects of cultural##2##4##(1991-12#1)(2008-10#1)
the effects of daily##4##4##(1996-10#1)(2005-11#2)(2008-10#1)
the effects of dexamethasone##5##4##(1991-6#1)(1992-4#1)(1994-10#1)(1994-3#1)(2010-12#1)
the effects of diet and##2##5##(1994-2#1)(2008-10#1)
the effects of diet##3##4##(1994-2#1)(2008-10#1)(2009-4#1)
the effects of dietary##5##4##(1994-2#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-12#1)
the effects of different tillage##2##5##(2013-8#2)
the effects of different types of##2##6##(2008-8#1)(2011-1#1)
the effects of different##33##4##(1992-12#1)(1993-6#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#2)(2010-10#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#7)
the effects of direct##2##4##(1994-8#1)(2010-2#1)
the effects of disease and##2##5##(2009-10#1)(2013-7#1)
the effects of donor cell##2##5##(2008-9#1)(2012-2#1)
the effects of donor knowledge and perceived risk on##2##9##(1994-3#2)
the effects of donor##4##4##(1994-3#2)(2008-9#1)(2012-2#1)
the effects of drug treatment##2##5##(2008-10#1)(2009-9#1)
the effects of drugs on##3##5##(1990-7#1)(2005-9#1)(2010-9#1)
the effects of drugs##6##4##(1990-7#1)(1993-7#1)(1993-8#1)(2005-9#1)(2006-6#1)(2010-9#1)
the effects of dynamic##2##4##(2008-2#1)(2010-9#1)
the effects of each##4##4##(1992-1#1)(2008-12#1)(2008-2#1)(2008-8#1)
the effects of earlier##2##4##(2007-7#1)(2008-7#1)
the effects of early##5##4##(1993-2#1)(1993-7#1)(2010-4#1)(2011-2#1)(2012-2#1)
the effects of either##2##4##(2008-10#1)(2009-12#1)
the effects of electrical##2##4##(1994-5#1)(2009-10#1)
the effects of elevated##4##4##(1993-5#1)(1994-2#1)(2008-5#1)(2012-12#1)
the effects of emotions on##2##5##(2007-2#1)(2008-5#1)
the effects of endogenous##2##4##(1997-5#1)(2008-4#1)
the effects of endogenously##2##4##(1992-6#1)(1997-6#1)
the effects of endothelin-1##2##4##(1991-12#1)(1995-10#1)
the effects of environmental##2##4##(1994-11#1)(2008-9#1)
the effects of estrogen and##2##5##(1996-4#1)(2008-7#1)
the effects of estrogen on##3##5##(2008-11#2)(2008-7#1)
the effects of estrogen##6##4##(1996-4#1)(2008-11#2)(2008-3#1)(2008-7#2)
the effects of ethanol on##2##5##(1994-11#1)(2010-12#1)
the effects of ethanol##4##4##(1994-11#1)(1994-5#1)(2010-12#2)
the effects of excitatory amino acids##2##6##(1992-3#1)(1996-1#1)
the effects of exercise##3##4##(2005-10#2)(2008-11#1)
the effects of exogenous##7##4##(1992-2#1)(1992-8#1)(1994-11#1)(2008-6#1)(2011-1#1)(2011-10#1)(2013-8#1)
the effects of explanatory##2##4##(1997-8#1)(2008-4#1)
the effects of exposure to##3##5##(1993-6#1)(2007-12#1)(2013-7#1)
the effects of external##3##4##(2007-12#1)(2008-3#1)(2008-6#1)
the effects of extracellular ATP##2##5##(2008-4#2)
the effects of extracellular##4##4##(1996-5#1)(2008-4#2)(2008-8#1)
the effects of factors##2##4##(1995-9#1)(2010-10#1)
the effects of feeding##2##4##(1995-3#1)(2010-2#1)
the effects of fiber##2##4##(2007-12#1)(2008-2#1)
the effects of five-level-four-factors and their reciprocal interactions##2##8##(2008-5#2)
the effects of four##2##4##(1996-12#1)(2013-8#1)
the effects of frequent##2##4##(2009-7#1)(2009-8#1)
the effects of gamma-aminobutyric acid (GABA)##2##6##(2008-8#1)(2008-9#1)
the effects of gender and##2##5##(2007-4#1)(2009-7#1)
the effects of gender##3##4##(2006-12#1)(2007-4#1)(2009-7#1)
the effects of genes##3##4##(1997-7#2)(2012-3#1)
the effects of genetic##2##4##(2010-4#1)(2013-1#1)
the effects of gestational##2##4##(1992-12#1)(1996-3#1)
the effects of glucocorticoids##2##4##(1994-9#1)(2008-9#1)
the effects of glutamate##3##4##(1990-2#1)(1996-12#1)(2008-7#1)
the effects of grazing##2##4##(2008-12#1)(2010-2#1)
the effects of group##2##4##(1997-7#1)(2008-8#1)
the effects of growth hormone (GH)##2##6##(1995-10#1)(2010-5#1)
the effects of growth hormone##3##5##(1995-10#1)(1997-8#1)(2010-5#1)
the effects of health care##2##5##(1993-12#2)
the effects of heat##2##4##(2008-7#1)(2013-8#1)
the effects of heavy##2##4##(2008-10#2)
the effects of herbivory on##2##5##(2008-8#1)(2008-9#1)
the effects of high##3##4##(1993-4#1)(1993-7#1)(1995-7#1)
the effects of histamine##3##4##(1995-3#1)(1996-12#1)(1996-5#1)
the effects of honey##2##4##(2013-8#2)
the effects of hospital##2##4##(1991-3#1)(2007-10#1)
the effects of hypoxia##2##4##(1994-3#1)(2011-1#1)
the effects of ibogaine##2##4##(1991-6#2)
the effects of in vitro##2##5##(1995-1#1)(1995-10#1)
the effects of in##3##4##(1991-9#1)(1995-1#1)(1995-10#1)
the effects of increased##2##4##(2008-9#1)(2009-4#1)
the effects of increasing##3##4##(1990-7#1)(2005-12#1)(2008-8#1)
the effects of indirubin-3-monoxime##2##4##(2008-10#2)
the effects of initial##3##4##(2008-10#3)
the effects of inoculum density##3##5##(2008-10#3)
the effects of inoculum##5##4##(2008-10#4)(2008-5#1)
the effects of insulin##5##4##(1990-7#1)(1990-8#1)(1991-5#1)(2008-1#2)
the effects of interaction##2##4##(2005-11#1)(2009-12#1)
the effects of interpixel cross talk##2##6##(2008-2#1)(2008-3#1)
the effects of intracerebral##2##4##(1993-12#1)(1994-5#1)
the effects of intrastriatal##2##4##(1995-5#1)(1997-2#1)
the effects of its##2##4##(1995-11#1)(2007-4#1)
the effects of large-scale##2##4##(2008-3#2)
the effects of lead on the##2##6##(1995-11#1)(1997-2#1)
the effects of lead##4##4##(1995-11#1)(1997-2#1)(1997-4#1)(2011-1#1)
the effects of lesions##2##4##(2004-11#1)(2008-4#1)
the effects of light##5##4##(1995-6#1)(2007-10#1)(2008-10#1)(2008-3#1)(2009-4#1)
the effects of lipopolysaccharide##2##4##(1990-5#1)(1995-12#1)
the effects of local##2##4##(2006-10#1)(2009-7#1)
the effects of long-term##6##4##(1995-12#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-2#1)
the effects of low doses of radiation##2##7##(1996-3#1)(2008-7#1)
the effects of low doses of##3##6##(1996-3#1)(2008-7#1)(2013-1#1)
the effects of low##6##4##(1995-7#1)(1996-3#1)(2006-6#1)(2008-10#1)(2008-7#1)(2013-1#1)
the effects of low-dose##2##4##(1996-9#1)(2009-4#1)
the effects of major##2##4##(1992-4#1)(2011-3#1)
the effects of material##2##4##(2006-3#1)(2007-12#1)
the effects of maternal##3##4##(1992-12#1)(1995-8#1)(2009-7#1)
the effects of measurement##2##4##(2010-2#1)(2010-7#1)
the effects of mechanical##2##4##(2008-11#1)(2010-9#1)
the effects of melatonin##3##4##(1995-11#1)(1996-1#1)(1996-6#1)
the effects of membrane##2##4##(1996-10#1)(2008-5#1)
the effects of metals on##2##5##(1990-4#1)(2005-10#1)
the effects of multiple##3##4##(1993-4#1)(2008-2#1)(2008-3#1)
the effects of muscimol##2##4##(1991-1#2)
the effects of muscle##2##4##(2006-10#1)(2011-2#1)
the effects of music on##3##5##(1991-12#1)(2007-6#1)(2008-5#1)
the effects of mutations in##2##5##(2007-12#1)(2010-4#1)
the effects of national##2##4##(1996-9#1)(2007-2#1)
the effects of natural perturbations##2##5##(2008-10#2)
the effects of natural##5##4##(1996-7#1)(2008-10#2)(2012-1#1)(2013-1#1)
the effects of neurotransmitters##2##4##(1991-12#1)(1994-2#1)
the effects of nicotine on##2##5##(2008-8#1)(2011-1#1)
the effects of nitric oxide on##2##6##(1993-3#1)(1994-7#1)
the effects of nitric##3##4##(1990-8#1)(1993-3#1)(1994-7#1)
the effects of noise##3##4##(2008-3#2)(2008-6#1)
the effects of noncompliance##2##4##(2007-11#2)
the effects of nonlinear polarization##2##5##(2007-12#2)
the effects of noradrenaline##2##4##(1994-5#1)(1995-5#1)
the effects of nutritional##3##4##(1996-9#1)(2006-2#1)(2010-6#1)
the effects of one##2##4##(2008-7#1)(2011-2#1)
the effects of optical##4##4##(2007-12#2)(2008-2#1)(2008-3#1)
the effects of oral##4##4##(2007-5#1)(2007-6#1)(2008-11#1)(2010-8#1)
the effects of other##6##4##(1993-5#1)(2007-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
the effects of oxidative stress##2##5##(2005-10#1)(2007-1#1)
the effects of pH and##4##5##(1991-4#1)(1995-8#1)(2007-10#1)(2008-10#1)
the effects of pH##9##4##(1991-4#2)(1991-5#1)(1995-8#1)(2007-10#1)(2008-10#4)
the effects of pairings##2##4##(2009-11#2)
the effects of perceived##2##4##(2009-7#1)(2010-2#1)
the effects of peripheral##2##4##(1992-2#1)(2007-11#1)
the effects of peripherally administered##2##5##(1992-9#1)(1994-6#1)
the effects of pharmacological agents##2##5##(1993-7#1)(1994-10#1)
the effects of pharmacological##4##4##(1993-7#1)(1994-10#1)(2008-7#1)(2009-4#1)
the effects of phorbol##2##4##(1990-10#1)(1995-5#1)
the effects of photo-induced toxicity of##2##6##(2004-4#2)
the effects of photoperiod##2##4##(2008-11#1)(2009-5#1)
the effects of physical activity##3##5##(2012-12#1)(2013-1#2)
the effects of physical##4##4##(2008-9#1)(2012-12#1)(2013-1#2)
the effects of pollution in Elazig##2##6##(2013-8#2)
the effects of postoperative##2##4##(1993-2#1)(1993-7#1)
the effects of prenatal WIC participation and the use of prenatal care##2##12##(1993-3#2)
the effects of prenatal alcohol exposure on##2##7##(2006-3#1)(2011-2#1)
the effects of prenatal##6##4##(1993-3#2)(2006-3#1)(2008-2#1)(2011-2#1)(2012-2#1)
the effects of pretreatment of##2##5##(1990-11#1)(1992-6#1)
the effects of prior##3##4##(1997-8#1)(2008-10#1)(2008-11#1)
the effects of progesterone##3##4##(1993-2#2)(2007-12#1)
the effects of prostaglandin##2##4##(1995-12#1)(2006-5#1)
the effects of radiation-induced##2##4##(2007-12#1)(2008-2#1)
the effects of reaction##2##4##(1994-11#1)(2008-6#1)
the effects of recombinant##2##4##(1991-10#1)(2008-11#1)
the effects of red-light cameras##2##5##(2009-8#2)
the effects of repeated##5##4##(1995-9#1)(2007-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
the effects of retinoic acid (RA)##2##6##(1992-1#1)(1994-6#1)
the effects of salt##2##4##(2009-12#1)(2012-2#1)
the effects of sample##3##4##(1995-1#1)(2008-10#1)(2009-10#1)
the effects of scattering##2##4##(2008-2#1)(2008-3#1)
the effects of season##2##4##(2007-8#1)(2008-5#1)
the effects of selective##4##4##(1993-7#1)(1994-3#1)(2008-10#1)(2010-1#1)
the effects of serotonin##2##4##(1990-5#1)(1997-5#1)
the effects of several##8##4##(1992-3#1)(1993-2#1)(1995-2#1)(2007-8#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-5#1)
the effects of sex hormones on##2##6##(1996-4#2)
the effects of sex##3##4##(1996-4#2)(2013-1#1)
the effects of single and##2##5##(1993-3#1)(2012-1#1)
the effects of single nucleotide polymorphisms##2##6##(2005-8#2)
the effects of single##5##4##(1993-3#1)(2005-8#2)(2012-1#2)
the effects of smoking##2##4##(2008-8#1)(2009-11#1)
the effects of social##2##4##(2008-1#1)(2010-1#1)
the effects of solvent and##2##5##(2008-10#2)
the effects of solvent##3##4##(1991-7#1)(2008-10#2)
the effects of some##3##4##(1996-8#1)(1996-9#1)(2006-12#1)
the effects of spatial##4##4##(1991-11#1)(1991-12#1)(2008-10#1)(2008-8#1)
the effects of specific##6##4##(2006-10#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)
the effects of spinal##2##4##(1997-2#1)(2006-11#1)
the effects of stress##4##4##(1995-12#1)(2008-5#1)(2008-6#1)(2008-7#1)
the effects of such##8##4##(1993-2#1)(2008-3#1)(2008-9#1)(2010-11#1)(2010-5#1)(2011-1#1)(2013-1#2)
the effects of surgical##2##4##(2006-2#1)(2013-8#1)
the effects of synthetic##4##4##(1990-10#1)(1992-8#1)(1995-12#2)
the effects of systemic##2##4##(1994-10#1)(1994-2#1)
the effects of tail docking on##2##6##(1994-4#2)
the effects of tail##3##4##(1994-4#3)
the effects of temperature and##5##5##(1997-2#1)(2005-11#1)(2007-6#1)(2008-9#1)(2010-8#1)
the effects of temperature on the##2##6##(1991-11#1)(1991-5#1)
the effects of temperature on##3##5##(1991-11#1)(1991-5#1)(2008-10#1)
the effects of temperature##10##4##(1991-11#1)(1991-5#1)(1997-2#1)(2005-11#1)(2007-6#1)(2008-10#2)(2008-9#1)(2010-4#1)(2010-8#1)
the effects of the absence of##2##6##(1992-1#1)(2008-11#1)
the effects of the aforementioned##2##5##(2008-11#1)(2008-5#1)
the effects of the antibiotic##2##5##(1994-6#1)(2010-12#1)
the effects of the atmosphere##2##5##(2008-3#2)
the effects of the drug##3##5##(1990-3#1)(2007-11#1)(2008-11#1)
the effects of the finite##2##5##(2008-2#2)
the effects of the hormone##2##5##(1994-8#1)(2008-1#1)
the effects of the individual##2##5##(2008-11#1)(2011-2#1)
the effects of the interaction of##2##6##(2008-2#1)(2013-7#1)
the effects of the interaction on the##2##7##(2005-11#2)
the effects of the interaction##4##5##(2005-11#2)(2008-2#1)(2013-7#1)
the effects of the intervention on##2##6##(2010-2#2)
the effects of the intervention##3##5##(1997-4#1)(2010-2#2)
the effects of the latter##2##5##(1990-9#1)(1997-2#1)
the effects of the mutations##3##5##(1991-10#1)(1997-2#1)(2013-1#1)
the effects of the novel##2##5##(1996-10#1)(1996-9#1)
the effects of the optical##2##5##(2008-2#2)
the effects of the program##2##5##(1993-1#1)(2010-9#1)
the effects of the treatment##3##5##(1995-12#1)(2008-1#1)(2012-2#1)
the effects of the##167##4##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#3)(1992-1#1)(1992-2#2)(1992-4#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#2)(1995-7#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-2#2)(1997-4#1)(1997-6#1)(2004-3#1)(2005-11#5)(2006-11#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-8#1)(2008-1#4)(2008-10#12)(2008-11#7)(2008-2#9)(2008-3#13)(2008-5#7)(2008-9#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#3)(2010-4#2)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#5)
the effects of therapy##2##4##(1996-2#1)(2012-2#1)
the effects of these agents on##3##6##(1993-3#1)(2008-8#1)(2012-2#1)
the effects of these changes on##2##6##(1992-4#1)(2010-2#1)
the effects of these changes##3##5##(1992-4#1)(2008-6#1)(2010-2#1)
the effects of these mutations##2##5##(1993-3#1)(2008-11#1)
the effects of these peptides on##3##6##(1996-12#2)(1997-7#1)
the effects of these substitutions on the##3##7##(1994-8#1)(1995-2#1)(1997-3#1)
the effects of these two##5##5##(1990-7#1)(1992-2#1)(1996-1#1)(2003-11#1)(2008-3#1)
the effects of these variables##2##5##(2008-4#2)
the effects of these##44##4##(1990-7#1)(1991-7#1)(1992-2#1)(1992-4#1)(1993-3#2)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-10#1)(1996-12#3)(1997-3#1)(1997-7#1)(2003-11#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#2)(2009-5#1)(2010-2#2)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
the effects of thiamine##2##4##(1990-9#1)(1997-5#1)
the effects of this##17##4##(1991-2#2)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-1#1)(1997-1#1)(1997-6#1)(2004-9#1)(2007-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2012-12#1)(2013-7#1)
the effects of three different##2##5##(2007-11#1)(2011-1#1)
the effects of three##8##4##(1996-5#1)(1997-5#1)(1997-7#1)(2007-11#1)(2008-11#1)(2009-12#1)(2011-1#1)(2013-1#1)
the effects of tillage practices on##2##6##(2008-10#2)
the effects of time##2##4##(1996-7#1)(2012-2#1)
the effects of timing and##2##5##(2008-10#1)(2008-12#1)
the effects of treatment##4##4##(1997-5#1)(2005-8#1)(2006-11#1)(2008-6#1)
the effects of tumor##2##4##(1993-6#1)(2012-3#1)
the effects of two factors##2##5##(2008-10#2)
the effects of two novel##2##5##(2007-11#2)
the effects of two##22##4##(1993-1#1)(1994-10#1)(1994-12#1)(1994-5#1)(1994-8#1)(1996-10#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-7#1)(1997-8#1)(2004-4#1)(2006-10#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2012-12#1)
the effects of unilateral##4##4##(1995-12#1)(1997-2#1)(2008-7#1)(2010-2#1)
the effects of using##2##4##(2006-12#1)(2008-3#1)
the effects of variable##2##4##(1997-6#1)(2008-8#1)
the effects of varicella vaccination programs##2##6##(2007-9#2)
the effects of various cationic##2##5##(2008-10#2)
the effects of various factors on##2##6##(2008-5#1)(2013-8#1)
the effects of various##25##4##(1990-10#1)(1990-11#1)(1991-2#1)(1991-7#1)(1992-1#1)(1992-5#1)(1992-6#1)(1994-2#1)(1995-2#1)(1996-12#1)(1997-7#1)(1997-8#1)(2005-12#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2010-4#1)(2011-12#1)(2013-8#1)
the effects of varying##6##4##(2007-8#1)(2008-10#2)(2008-5#1)(2011-12#1)(2011-2#1)
the effects of vascular##2##4##(2009-3#1)(2011-2#1)
the effects of verapamil##2##4##(1990-7#1)(1995-1#1)
the effects of vitamin##2##4##(2008-1#1)(2011-1#1)
the effects of which are##2##5##(1992-8#1)(1993-12#1)
the effects of which##3##4##(1992-5#1)(1992-8#1)(1993-12#1)
the effects of##2102##3##(1990-1#1)(1990-10#8)(1990-11#3)(1990-12#6)(1990-2#10)(1990-3#9)(1990-4#3)(1990-5#12)(1990-6#2)(1990-7#7)(1990-8#11)(1990-9#7)(1991-1#10)(1991-10#7)(1991-11#2)(1991-12#11)(1991-2#9)(1991-3#3)(1991-4#5)(1991-5#12)(1991-6#6)(1991-7#6)(1991-8#7)(1991-9#10)(1992-1#11)(1992-10#3)(1992-11#3)(1992-12#5)(1992-2#8)(1992-3#13)(1992-4#8)(1992-5#5)(1992-6#7)(1992-7#2)(1992-8#10)(1992-9#7)(1993-1#5)(1993-11#13)(1993-12#11)(1993-2#13)(1993-3#15)(1993-4#6)(1993-5#6)(1993-6#9)(1993-7#10)(1993-8#7)(1993-9#4)(1994-1#1)(1994-10#11)(1994-11#12)(1994-12#9)(1994-2#17)(1994-3#21)(1994-4#4)(1994-5#11)(1994-6#11)(1994-7#1)(1994-8#12)(1994-9#9)(1995-1#9)(1995-10#6)(1995-11#17)(1995-12#24)(1995-2#11)(1995-3#12)(1995-4#1)(1995-5#13)(1995-6#1)(1995-7#6)(1995-8#6)(1995-9#3)(1996-1#6)(1996-10#10)(1996-11#6)(1996-12#23)(1996-2#13)(1996-3#6)(1996-4#6)(1996-5#14)(1996-6#5)(1996-7#3)(1996-8#6)(1996-9#9)(1997-1#6)(1997-2#10)(1997-3#6)(1997-4#5)(1997-5#15)(1997-6#7)(1997-7#20)(1997-8#17)(2003-11#1)(2004-11#2)(2004-12#2)(2004-2#2)(2004-3#1)(2004-4#3)(2004-9#2)(2005-10#9)(2005-11#16)(2005-12#3)(2005-7#2)(2005-8#9)(2005-9#2)(2006-10#29)(2006-11#6)(2006-12#10)(2006-2#4)(2006-3#5)(2006-5#4)(2006-6#4)(2006-7#1)(2006-8#3)(2006-9#4)(2007-1#8)(2007-10#13)(2007-11#29)(2007-12#40)(2007-2#9)(2007-3#5)(2007-4#10)(2007-5#5)(2007-6#5)(2007-7#8)(2007-8#16)(2007-9#13)(2008-1#17)(2008-10#134)(2008-11#58)(2008-12#20)(2008-2#49)(2008-3#77)(2008-4#35)(2008-5#56)(2008-6#21)(2008-7#36)(2008-8#36)(2008-9#29)(2009-10#5)(2009-11#9)(2009-12#10)(2009-2#5)(2009-3#4)(2009-4#13)(2009-5#4)(2009-6#4)(2009-7#13)(2009-8#10)(2009-9#8)(2010-1#3)(2010-10#6)(2010-11#7)(2010-12#17)(2010-2#23)(2010-3#1)(2010-4#17)(2010-5#6)(2010-6#5)(2010-7#5)(2010-8#12)(2010-9#9)(2011-1#22)(2011-10#2)(2011-12#4)(2011-2#36)(2011-3#1)(2011-7#1)(2012-1#16)(2012-11#4)(2012-12#29)(2012-2#34)(2012-3#24)(2012-5#2)(2012-7#1)(2013-1#47)(2013-7#13)(2013-8#48)
the effects on blood##2##4##(1994-11#1)(2007-1#1)
the effects on the##11##4##(1991-7#1)(1992-6#1)(2006-2#2)(2008-2#1)(2008-5#2)(2008-8#1)(2010-4#1)(2011-3#2)
the effects on##61##3##(1990-12#1)(1990-3#1)(1991-6#1)(1991-7#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-2#3)(2007-1#1)(2007-4#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-5#1)(2010-2#1)(2010-4#1)(2011-2#3)(2011-3#2)(2012-1#1)(2012-4#1)(2013-1#1)
the effects that##8##3##(1991-2#1)(1996-7#1)(2006-1#1)(2008-10#2)(2008-7#1)(2010-4#1)(2012-3#1)
the effects the framework had on our qualitative methods of inquiry and analysis##2##13##(2013-1#2)
the effects were less##2##4##(1994-10#1)(2009-4#1)
the effects were more##2##4##(2008-10#1)(2010-2#1)
the effects were not##3##4##(1991-1#1)(1994-2#1)(1994-5#1)
the effects were##14##3##(1991-1#1)(1991-6#1)(1992-1#1)(1993-6#1)(1994-10#1)(1994-2#1)(1994-5#1)(1997-3#1)(2005-11#1)(2008-10#1)(2008-4#1)(2009-4#1)(2010-2#1)(2012-12#1)
the effects within##2##3##(2007-11#1)(2012-2#1)
the effects##2281##2##(1990-1#1)(1990-10#8)(1990-11#3)(1990-12#7)(1990-2#11)(1990-3#10)(1990-4#3)(1990-5#12)(1990-6#2)(1990-7#7)(1990-8#12)(1990-9#7)(1991-1#11)(1991-10#7)(1991-11#2)(1991-12#12)(1991-2#11)(1991-3#4)(1991-4#5)(1991-5#14)(1991-6#8)(1991-7#8)(1991-8#8)(1991-9#11)(1992-1#12)(1992-10#3)(1992-11#3)(1992-12#5)(1992-2#8)(1992-3#14)(1992-4#8)(1992-5#5)(1992-6#8)(1992-7#2)(1992-8#10)(1992-9#7)(1993-1#5)(1993-11#13)(1993-12#14)(1993-2#13)(1993-3#15)(1993-4#6)(1993-5#6)(1993-6#10)(1993-7#10)(1993-8#7)(1993-9#5)(1994-1#2)(1994-10#12)(1994-11#13)(1994-12#9)(1994-2#18)(1994-3#22)(1994-4#4)(1994-5#14)(1994-6#13)(1994-7#1)(1994-8#14)(1994-9#10)(1995-1#9)(1995-10#6)(1995-11#17)(1995-12#25)(1995-2#14)(1995-3#12)(1995-4#1)(1995-5#13)(1995-6#3)(1995-7#6)(1995-8#6)(1995-9#3)(1996-1#6)(1996-10#10)(1996-11#7)(1996-12#24)(1996-2#14)(1996-3#8)(1996-4#6)(1996-5#17)(1996-6#6)(1996-7#4)(1996-8#7)(1996-9#9)(1997-1#9)(1997-2#12)(1997-3#8)(1997-4#5)(1997-5#16)(1997-6#7)(1997-7#20)(1997-8#18)(2003-11#1)(2004-11#2)(2004-12#2)(2004-2#2)(2004-3#1)(2004-4#3)(2004-7#1)(2004-9#2)(2005-10#9)(2005-11#17)(2005-12#3)(2005-3#1)(2005-7#2)(2005-8#9)(2005-9#2)(2006-1#1)(2006-10#36)(2006-11#6)(2006-12#13)(2006-2#7)(2006-3#5)(2006-5#4)(2006-6#4)(2006-7#1)(2006-8#3)(2006-9#4)(2007-1#9)(2007-10#13)(2007-11#32)(2007-12#44)(2007-2#10)(2007-3#6)(2007-4#11)(2007-5#5)(2007-6#5)(2007-7#8)(2007-8#16)(2007-9#13)(2008-1#18)(2008-10#147)(2008-11#63)(2008-12#22)(2008-2#54)(2008-3#82)(2008-4#38)(2008-5#60)(2008-6#22)(2008-7#39)(2008-8#39)(2008-9#31)(2009-10#6)(2009-11#10)(2009-12#10)(2009-2#5)(2009-3#4)(2009-4#14)(2009-5#5)(2009-6#4)(2009-7#13)(2009-8#11)(2009-9#8)(2010-1#4)(2010-10#6)(2010-11#7)(2010-12#18)(2010-2#26)(2010-3#1)(2010-4#19)(2010-5#6)(2010-6#5)(2010-7#5)(2010-8#12)(2010-9#9)(2011-1#23)(2011-10#2)(2011-12#4)(2011-2#40)(2011-3#4)(2011-7#1)(2012-1#19)(2012-11#5)(2012-12#33)(2012-2#35)(2012-3#28)(2012-4#1)(2012-5#2)(2012-7#1)(2013-1#52)(2013-7#13)(2013-8#49)
the efferent tear ducts##2##4##(2006-11#2)
the efferent vessel##2##3##(2008-7#2)
the efferent##13##2##(1992-3#1)(1993-8#1)(1994-2#1)(1997-3#1)(2006-11#2)(2006-6#1)(2008-4#3)(2008-7#3)
the efficacies of##3##3##(2006-10#1)(2008-8#1)(2011-2#1)
the efficacy and effectiveness of the##2##6##(2006-7#1)(2012-12#1)
the efficacy and outcome of##2##5##(2007-11#1)(2008-10#1)
the efficacy and safety of a##2##6##(2008-8#1)(2011-2#1)
the efficacy and safety of new##2##6##(2006-10#1)(2007-11#1)
the efficacy and safety of the##4##6##(1996-4#1)(2006-1#1)(2009-4#1)(2013-1#1)
the efficacy and safety of##40##5##(1993-12#1)(1993-7#1)(1996-4#1)(1997-1#1)(2004-3#1)(2005-11#1)(2006-1#2)(2006-10#2)(2007-10#1)(2007-11#1)(2007-7#4)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-11#2)(2009-4#1)(2010-4#2)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
the efficacy and safety##42##4##(1993-12#1)(1993-7#1)(1996-4#1)(1997-1#1)(2004-3#1)(2005-11#1)(2006-1#2)(2006-10#2)(2007-10#1)(2007-11#1)(2007-7#4)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2009-11#2)(2009-4#1)(2010-4#2)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
the efficacy and the safety of##2##6##(2007-8#1)(2008-3#1)
the efficacy and the##4##4##(1990-12#1)(1992-4#1)(2007-8#1)(2008-3#1)
the efficacy and tolerability of the##2##6##(1992-10#1)(2010-12#1)
the efficacy and tolerability of##12##5##(1990-12#1)(1991-9#1)(1992-10#1)(1992-4#1)(2006-2#2)(2007-11#1)(2008-3#1)(2009-11#1)(2010-12#1)(2011-2#2)
the efficacy and tolerance of flutrimazole 1%##2##7##(2007-7#2)
the efficacy and tolerance of##6##5##(1992-2#1)(2007-7#2)(2008-10#1)(2008-5#1)(2010-3#1)
the efficacy and tolerance##7##4##(1992-2#1)(1996-6#1)(2007-7#2)(2008-10#1)(2008-5#1)(2010-3#1)
the efficacy and toxicity of a##2##6##(1990-2#1)(2007-10#1)
the efficacy and toxicity of##6##5##(1990-2#1)(2007-10#1)(2008-6#1)(2010-11#1)(2011-1#2)
the efficacy and##94##3##(1990-12#2)(1990-2#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-4#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-7#1)(1994-8#1)(1996-4#1)(1996-6#1)(1997-1#1)(2004-3#1)(2005-11#1)(2005-7#1)(2006-1#2)(2006-10#4)(2006-2#2)(2006-7#1)(2007-10#2)(2007-11#3)(2007-7#7)(2007-8#2)(2008-10#4)(2008-11#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#2)(2009-11#3)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#4)(2011-2#5)(2012-12#3)(2012-2#2)(2013-1#3)(2013-8#1)
the efficacy and/or##2##3##(1990-2#1)(2008-3#1)
the efficacy of ASRC##2##4##(1996-12#2)
the efficacy of LMWH##2##4##(2007-10#1)(2008-1#1)
the efficacy of a new##4##5##(1997-8#1)(2008-10#1)(2010-9#1)(2012-3#1)
the efficacy of a##28##4##(1993-5#1)(1995-2#1)(1996-5#1)(1997-2#1)(1997-8#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#1)(2009-11#1)(2009-2#1)(2010-4#1)(2010-9#1)(2011-1#1)(2012-3#3)(2013-1#2)
the efficacy of acupuncture##3##4##(2006-10#1)(2007-6#1)(2012-3#1)
the efficacy of acute##2##4##(1992-9#1)(2007-9#1)
the efficacy of an alternative##2##5##(1993-5#1)(2012-12#1)
the efficacy of an##8##4##(1993-5#1)(2004-11#1)(2006-10#1)(2008-4#1)(2008-5#1)(2010-7#1)(2012-1#1)(2012-12#1)
the efficacy of bisoprolol##2##4##(2008-5#2)
the efficacy of bisphosphonates in the##2##6##(1993-11#1)(2012-2#1)
the efficacy of calcium##2##4##(2012-2#1)(2013-1#1)
the efficacy of combination##2##4##(1995-8#1)(2011-2#1)
the efficacy of cosmetics##2##4##(2008-5#2)
the efficacy of cytotoxic##2##4##(2008-1#1)(2008-5#1)
the efficacy of different control##2##5##(1991-12#1)(2008-10#1)
the efficacy of different##3##4##(1991-12#1)(2007-11#1)(2008-10#1)
the efficacy of drug##2##4##(2009-12#1)(2012-2#1)
the efficacy of entomopathogenic nematodes##2##5##(2008-8#1)(2010-12#1)
the efficacy of existing##2##4##(2005-8#1)(2007-11#1)
the efficacy of four##2##4##(1995-3#1)(2008-10#1)
the efficacy of induced##2##4##(2007-2#1)(2008-10#1)
the efficacy of intra##2##4##(2007-11#1)(2012-2#1)
the efficacy of lepirudin in##2##5##(2007-11#1)(2009-8#1)
the efficacy of new##5##4##(2005-9#1)(2006-10#2)(2010-12#1)(2011-2#1)
the efficacy of numerous##2##4##(2005-9#1)(2006-6#1)
the efficacy of oral##3##4##(2007-7#1)(2011-2#1)(2012-2#1)
the efficacy of postoperative##2##4##(2008-6#1)(2008-7#1)
the efficacy of preservatives##2##4##(2008-5#2)
the efficacy of prophylactic##3##4##(1994-2#1)(2010-7#1)(2011-12#1)
the efficacy of resistance elicitors##2##5##(2008-10#2)
the efficacy of resistance##3##4##(2008-10#2)(2011-2#1)
the efficacy of selected##2##4##(2007-8#1)(2010-3#1)
the efficacy of self-tanning##2##4##(2008-5#2)
the efficacy of soil##2##4##(2008-10#2)
the efficacy of such interventions##2##5##(2005-11#1)(2007-1#1)
the efficacy of such##3##4##(2005-11#1)(2007-1#1)(2008-5#1)
the efficacy of surgery##2##4##(2009-10#1)(2012-3#1)
the efficacy of surgical##3##4##(2011-2#1)(2012-1#1)(2013-1#1)
the efficacy of systemic##2##4##(2006-10#1)(2008-8#1)
the efficacy of the 2##2##5##(2011-2#1)(2013-1#1)
the efficacy of the treatment##3##5##(2008-5#1)(2012-3#1)(2013-8#1)
the efficacy of the##61##4##(1991-12#1)(1992-10#1)(1993-1#2)(1993-6#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-3#1)(2004-1#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-6#1)(2007-11#2)(2007-2#1)(2007-6#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2009-8#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#2)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#4)
the efficacy of therapeutic##4##4##(2007-12#1)(2008-1#1)(2010-2#1)(2010-4#1)
the efficacy of these##8##4##(1990-2#1)(2006-10#1)(2006-6#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-5#1)
the efficacy of this procedure##2##5##(2006-9#1)(2011-2#1)
the efficacy of this treatment##2##5##(1995-11#1)(2011-1#1)
the efficacy of this##11##4##(1995-11#1)(1997-4#1)(2006-9#2)(2007-8#1)(2008-3#1)(2009-12#2)(2011-1#1)(2011-2#1)(2012-1#1)
the efficacy of treatment##9##4##(1994-5#1)(1996-2#1)(2004-12#1)(2006-10#1)(2007-11#2)(2008-7#1)(2012-2#1)(2013-1#1)
the efficacy of treatments##3##4##(2008-9#1)(2009-6#1)(2012-1#1)
the efficacy of two different##2##5##(1993-1#1)(2012-2#1)
the efficacy of two##3##4##(1993-1#1)(2012-2#1)(2012-3#1)
the efficacy of using##3##4##(2006-10#1)(2008-2#1)(2008-9#1)
the efficacy of various##3##4##(2006-10#2)(2008-2#1)
the efficacy of##493##3##(1990-12#2)(1990-2#2)(1990-3#2)(1990-6#2)(1990-7#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-7#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-7#1)(1992-9#1)(1993-1#3)(1993-11#3)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#4)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-1#1)(2004-11#1)(2004-12#3)(2004-3#2)(2004-7#1)(2005-10#1)(2005-11#2)(2005-12#2)(2005-7#2)(2005-8#1)(2005-9#2)(2006-1#2)(2006-10#18)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#7)(2006-8#1)(2006-9#3)(2007-1#2)(2007-10#1)(2007-11#14)(2007-12#2)(2007-2#4)(2007-3#3)(2007-4#1)(2007-6#4)(2007-7#7)(2007-8#10)(2007-9#4)(2008-1#9)(2008-10#29)(2008-11#6)(2008-12#3)(2008-2#6)(2008-3#11)(2008-4#5)(2008-5#31)(2008-6#7)(2008-7#16)(2008-8#10)(2008-9#3)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#4)(2009-2#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#7)(2009-9#1)(2010-1#3)(2010-11#1)(2010-12#9)(2010-2#2)(2010-3#4)(2010-4#5)(2010-5#5)(2010-6#1)(2010-7#2)(2010-8#5)(2010-9#2)(2011-1#8)(2011-12#2)(2011-2#20)(2012-1#9)(2012-11#1)(2012-12#5)(2012-2#11)(2012-3#12)(2013-1#31)(2013-7#4)(2013-8#9)
the efficacy or##2##3##(2008-5#1)(2012-3#1)
the efficacy profile of sunscreens##2##5##(2008-5#2)
the efficacy was##3##3##(1991-10#1)(1993-3#1)(1997-4#1)
the efficacy##631##2##(1990-12#4)(1990-2#4)(1990-3#2)(1990-6#2)(1990-7#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-7#2)(1991-9#2)(1992-1#1)(1992-10#2)(1992-2#1)(1992-4#3)(1992-5#1)(1992-7#1)(1992-9#1)(1993-1#4)(1993-11#4)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#4)(1996-2#2)(1996-3#1)(1996-4#3)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-1#1)(2004-11#1)(2004-12#3)(2004-3#3)(2004-7#1)(2005-10#1)(2005-11#3)(2005-12#2)(2005-7#3)(2005-8#1)(2005-9#2)(2006-1#4)(2006-10#22)(2006-12#3)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#8)(2006-7#1)(2006-8#1)(2006-9#3)(2007-1#2)(2007-10#3)(2007-11#17)(2007-12#2)(2007-2#4)(2007-3#3)(2007-4#1)(2007-6#9)(2007-7#15)(2007-8#13)(2007-9#4)(2008-1#10)(2008-10#35)(2008-11#8)(2008-12#3)(2008-2#7)(2008-3#15)(2008-4#8)(2008-5#38)(2008-6#10)(2008-7#19)(2008-8#13)(2008-9#3)(2009-1#1)(2009-10#4)(2009-11#4)(2009-12#4)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#7)(2009-9#1)(2010-1#3)(2010-11#3)(2010-12#13)(2010-2#2)(2010-3#5)(2010-4#7)(2010-5#5)(2010-6#1)(2010-7#2)(2010-8#6)(2010-9#3)(2011-1#12)(2011-12#2)(2011-2#25)(2012-1#9)(2012-11#1)(2012-12#11)(2012-2#13)(2012-3#13)(2013-1#36)(2013-7#4)(2013-8#12)
the efficiencies of##5##3##(1996-11#1)(1996-2#1)(1996-3#1)(2008-3#1)(2008-8#1)
the efficiency and effectiveness of##2##5##(2006-6#1)(2007-9#1)
the efficiency and specificity of the##2##6##(1996-11#1)(1997-2#1)
the efficiency and stability of##2##5##(2008-3#1)(2012-12#1)
the efficiency and the##5##4##(2006-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2011-2#1)
the efficiency and##28##3##(1990-6#1)(1996-11#1)(1997-1#1)(1997-2#1)(2004-4#1)(2006-6#1)(2006-8#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#4)(2008-8#2)(2009-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)
the efficiency curves##2##3##(2008-3#1)(2011-2#1)
the efficiency for##2##3##(1990-12#1)(2008-10#1)
the efficiency of Cre complementation##2##5##(2009-8#2)
the efficiency of DNA repair##3##5##(1996-11#1)(2008-11#1)(2009-5#1)
the efficiency of a new##2##5##(2008-10#1)(2008-5#1)
the efficiency of a##9##4##(1991-9#1)(2004-11#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-5#2)(2011-1#1)
the efficiency of calcium##2##4##(1990-10#1)(2006-10#1)
the efficiency of capture##2##4##(2009-4#2)
the efficiency of different##3##4##(2007-9#1)(2008-10#1)(2008-3#1)
the efficiency of energy##2##4##(1990-8#1)(1992-12#1)
the efficiency of extraction##2##4##(2008-10#2)
the efficiency of gene targeting##2##5##(1995-1#1)(2005-6#1)
the efficiency of gene##3##4##(1990-11#1)(1995-1#1)(2005-6#1)
the efficiency of such##2##4##(2008-2#1)(2010-1#1)
the efficiency of the health##2##5##(1992-2#1)(1996-12#1)
the efficiency of the method##3##5##(2008-2#2)(2008-3#1)
the efficiency of the proposed##2##5##(2008-10#1)(2008-6#1)
the efficiency of the treatment##2##5##(2007-2#1)(2008-2#1)
the efficiency of the##53##4##(1990-3#1)(1992-2#1)(1992-5#1)(1992-9#1)(1994-9#1)(1996-12#1)(1997-2#2)(1997-3#1)(1997-8#2)(2004-11#1)(2006-11#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-2#6)(2008-3#3)(2008-5#2)(2008-6#3)(2009-10#1)(2009-2#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-8#1)
the efficiency of this method##2##5##(2008-10#2)
the efficiency of this##6##4##(1994-5#1)(1996-4#1)(2007-12#1)(2008-10#2)(2009-10#1)
the efficiency of transmission##3##4##(2007-11#1)(2008-10#2)
the efficiency of treatment##4##4##(2008-2#1)(2008-4#1)(2011-2#1)(2013-1#1)
the efficiency of two##2##4##(2008-12#1)(2008-2#1)
the efficiency of##231##3##(1990-10#2)(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#3)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-11#2)(1996-12#1)(1996-4#3)(1996-5#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#3)(2004-4#1)(2005-11#2)(2005-4#1)(2005-6#2)(2005-7#1)(2006-10#3)(2006-11#1)(2006-12#1)(2007-10#2)(2007-11#7)(2007-12#8)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#30)(2008-11#5)(2008-12#5)(2008-2#16)(2008-3#8)(2008-4#3)(2008-5#7)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#6)(2011-1#3)(2011-12#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#5)(2012-8#1)(2013-1#5)(2013-7#1)
the efficiency was##3##3##(1990-8#1)(1997-2#1)(2007-12#1)
the efficiency with which##4##4##(1993-3#1)(2007-12#1)(2010-5#1)(2012-12#1)
the efficiency##294##2##(1990-10#3)(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#2)(1991-2#1)(1991-7#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1994-12#3)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-3#3)(1995-9#1)(1996-11#3)(1996-12#1)(1996-4#4)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#5)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#3)(2004-4#2)(2005-11#2)(2005-4#1)(2005-6#2)(2005-7#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#7)(2007-12#16)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#3)(2007-9#3)(2008-10#35)(2008-11#7)(2008-12#6)(2008-2#21)(2008-3#17)(2008-4#3)(2008-5#7)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#6)(2011-1#4)(2011-12#1)(2011-2#9)(2011-3#1)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#5)(2012-8#1)(2013-1#6)(2013-7#2)
the efficient and robust##2##4##(2008-1#1)(2013-1#1)
the efficient and##4##3##(2008-1#1)(2008-11#1)(2011-2#1)(2013-1#1)
the efficient delivery of##2##4##(2008-11#1)(2010-10#1)
the efficient elimination of##2##4##(1992-8#1)(2008-10#1)
the efficient enrichment##2##3##(1990-11#1)(2005-11#1)
the efficient generation of##2##4##(1997-6#1)(2008-2#1)
the efficient operation of a##2##5##(2008-2#2)
the efficient removal of##2##4##(2011-1#1)(2013-1#1)
the efficient use of##5##4##(1992-2#1)(2006-12#1)(2008-10#1)(2008-2#1)(2013-1#1)
the efficient##59##2##(1990-11#1)(1990-5#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-8#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-8#1)(1996-2#1)(1997-6#1)(2005-11#3)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#5)(2008-3#3)(2008-7#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#5)
the effluent at##2##3##(2008-10#1)(2008-7#1)
the effluent from##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
the effluent is##2##3##(1996-8#1)(2010-5#1)
the effluent of##3##3##(2008-10#2)(2013-1#1)
the effluent was##5##3##(1990-6#1)(2007-8#2)(2008-1#1)(2008-10#1)
the effluent##32##2##(1990-6#1)(1991-2#1)(1992-6#1)(1993-3#1)(1994-6#1)(1996-8#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#10)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2010-5#3)(2013-1#1)
the effluents##3##2##(1996-8#1)(2007-7#1)(2008-10#1)
the efflux and##2##3##(1994-9#1)(2007-11#1)
the efflux of the##2##4##(1990-11#1)(1993-3#1)
the efflux of##10##3##(1990-11#1)(1990-9#1)(1991-1#1)(1991-9#1)(1992-7#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-8#1)(2007-11#1)
the efflux was##2##3##(1991-1#1)(2007-8#1)
the efflux##20##2##(1990-11#1)(1990-9#1)(1991-1#2)(1991-9#2)(1992-12#1)(1992-7#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-8#1)(1994-9#1)(1997-5#1)(2005-8#1)(2007-11#2)(2007-8#2)(2011-12#1)
the effort has been to develop##2##6##(2008-2#2)
the effort of##2##3##(1991-3#1)(2008-10#1)
the effort required##2##3##(2008-3#1)(2013-1#1)
the effort to improve the##2##5##(1996-9#1)(2006-11#1)
the effort to improve##3##4##(1994-3#1)(1996-9#1)(2006-11#1)
the effort to##16##3##(1990-4#1)(1993-12#1)(1994-3#1)(1994-9#1)(1996-12#1)(1996-9#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-7#2)(2012-2#1)(2012-3#1)
the effort will##2##3##(1994-9#1)(2010-2#1)
the effort##32##2##(1990-4#1)(1991-3#1)(1992-3#1)(1993-12#1)(1994-3#1)(1994-9#3)(1996-12#1)(1996-9#1)(1997-1#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#2)(2010-12#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
the efforts by the##2##4##(1991-6#1)(1993-12#1)
the efforts made##3##3##(1990-5#1)(2007-11#1)(2007-8#1)
the efforts of the##4##4##(1991-9#1)(1992-1#1)(1994-9#1)(1996-1#1)
the efforts of##11##3##(1991-9#1)(1992-1#2)(1993-5#1)(1994-9#1)(1995-3#1)(1996-1#1)(2006-5#1)(2007-2#1)(2008-1#1)(2012-2#1)
the efforts to##7##3##(1991-1#1)(1993-3#1)(1996-11#1)(1997-7#1)(2008-10#1)(2008-12#1)(2012-3#1)
the efforts##28##2##(1990-5#1)(1991-1#1)(1991-6#1)(1991-9#1)(1992-1#2)(1993-12#1)(1993-3#1)(1993-5#1)(1994-9#1)(1995-3#1)(1996-1#1)(1996-11#1)(1997-1#1)(1997-7#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2009-12#1)(2011-1#1)(2012-2#1)(2012-3#1)
the egg and##2##3##(2007-8#1)(2008-11#1)
the egg capsule##2##3##(2008-12#2)
the egg cell and##2##4##(2008-11#1)(2008-9#1)
the egg cell##4##3##(1991-5#1)(2008-11#1)(2008-8#1)(2008-9#1)
the egg during##2##3##(2008-11#1)(2008-4#1)
the egg excretion was##2##4##(2008-5#2)
the egg is##3##3##(1994-5#1)(2007-12#1)(2008-11#1)
the egg jelly##3##3##(1992-8#2)(1994-11#1)
the egg maturation rate##2##4##(2008-9#2)
the egg plasma membrane##2##4##(1995-10#1)(1995-6#1)
the egg shell/lipid layer##2##4##(2008-10#2)
the egg stage##4##3##(1990-3#1)(2007-6#1)(2008-4#1)(2008-8#1)
the egg surface##2##3##(1996-5#1)(2010-8#1)
the egg yolk##3##3##(1995-2#1)(2009-4#1)(2010-2#1)
the egg##60##2##(1990-3#1)(1991-5#2)(1992-8#2)(1993-6#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-10#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-6#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#7)(2008-12#5)(2008-4#3)(2008-5#4)(2008-6#1)(2008-8#4)(2008-9#7)(2009-4#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-1#1)
the eggs and##2##3##(2007-5#1)(2010-10#1)
the eggs of S##2##4##(1990-10#1)(2009-2#1)
the eggs of the##4##4##(1990-10#1)(2011-12#3)
the eggs of##11##3##(1990-10#2)(2008-10#1)(2008-3#1)(2008-5#1)(2009-2#1)(2011-12#5)
the eggs were##4##3##(1993-2#1)(2007-3#1)(2008-4#1)(2008-5#1)
the eggs##32##2##(1990-10#2)(1993-2#1)(1993-6#1)(1995-2#1)(1995-3#1)(1997-6#2)(2007-12#1)(2007-3#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-9#1)(2009-2#1)(2010-10#3)(2010-8#1)(2011-12#5)(2012-12#2)
the eggshell##6##2##(2007-12#2)(2008-11#4)
the egl1 gene##3##3##(2008-10#3)
the egocentric##3##2##(1992-9#1)(1993-7#1)(1997-1#1)
the eicosanoids##2##2##(1994-2#1)(1997-4#1)
the eigenmodes of##5##3##(2007-11#1)(2007-12#4)
the eigenmodes##8##2##(1993-7#1)(2007-11#2)(2007-12#4)(2008-3#1)
the eigenvalue##4##2##(2008-3#4)
the eigenvalues##3##2##(2008-2#2)(2008-3#1)
the eigenvectors##5##2##(2007-12#2)(2008-2#2)(2009-9#1)
the eight Ac##2##3##(2012-3#2)
the eight key issues in##2##5##(1992-3#2)
the eight patients##6##3##(1994-9#1)(2004-10#1)(2007-8#2)(2008-6#1)(2011-2#1)
the eight races##3##3##(2008-10#3)
the eight##75##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-3#2)(1993-2#1)(1993-6#2)(1993-8#1)(1994-8#1)(1994-9#2)(1995-6#1)(1996-12#1)(1996-7#2)(1997-3#2)(2004-10#1)(2005-12#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-10#13)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
the eight-arm radial maze##2##4##(1994-6#1)(2012-2#1)
the eight-channel condition##2##3##(2008-9#2)
the eight-channel##3##2##(2008-2#1)(2008-9#2)
the eighteen##4##2##(1997-8#1)(2012-2#1)(2012-3#2)
the eighteenth century##8##3##(2007-5#1)(2008-10#1)(2008-8#4)(2009-2#1)(2010-5#1)
the eighteenth##11##2##(1993-2#1)(2006-2#1)(2007-5#1)(2008-10#1)(2008-8#4)(2009-2#1)(2010-1#1)(2010-5#1)
the eighth day##6##3##(1994-3#1)(2007-12#1)(2008-5#1)(2009-5#1)(2010-7#1)(2011-2#1)
the eighth decade##2##3##(2007-2#2)
the eighth in a series on##2##6##(1992-2#1)(2008-3#1)
the eighth##26##2##(1992-1#1)(1992-2#1)(1994-3#1)(1997-5#2)(2005-8#1)(2007-12#2)(2007-2#2)(2007-9#1)(2008-1#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-6#1)(2010-7#1)(2011-2#3)(2013-1#1)
the eighties##6##2##(1990-2#1)(1994-11#1)(2006-4#1)(2007-5#1)(2008-1#1)(2012-12#1)
the ejaculate##3##2##(1991-11#1)(2006-5#2)
the ejaculatory bulb of##2##4##(1994-3#2)
the ejaculatory duct lumen##2##4##(2008-7#2)
the ejaculatory duct##5##3##(2008-7#5)
the ejaculatory##10##2##(1994-3#2)(1997-8#3)(2008-7#5)
the ejection fraction and the cardiac index##2##7##(1993-2#2)
the ejection fraction and##3##4##(1993-2#2)(2009-5#1)
the ejection fraction##11##3##(1990-9#1)(1993-2#2)(2006-6#1)(2008-10#2)(2008-7#2)(2009-5#1)(2011-1#1)(2013-1#1)
the ejection of##2##3##(1990-2#1)(1994-11#1)
the ejection##16##2##(1990-2#1)(1990-9#2)(1993-2#2)(1994-11#1)(2006-6#1)(2008-10#3)(2008-2#1)(2008-7#2)(2009-5#1)(2011-1#1)(2013-1#1)
the elaboration and implementation of##2##5##(2005-5#1)(2008-9#1)
the elaboration and##3##3##(2005-5#1)(2008-5#1)(2008-9#1)
the elaboration of##15##3##(1996-2#1)(2005-10#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)
the elaboration##20##2##(1996-2#1)(2005-10#1)(2005-5#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-2#5)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)
the elastic and viscous##2##4##(2008-5#2)
the elastic behavior##2##3##(2004-9#1)(2010-4#1)
the elastic modulus and##2##4##(2004-9#1)(2012-2#1)
the elastic modulus of##3##4##(1996-12#1)(2009-7#1)(2010-8#1)
the elastic modulus##8##3##(1996-12#1)(2004-9#2)(2009-7#2)(2010-4#1)(2010-8#1)(2012-2#1)
the elastic properties of##3##4##(2008-10#1)(2009-7#1)(2010-4#1)
the elastic properties##4##3##(2008-10#1)(2009-7#2)(2010-4#1)
the elastic support bandage##2##4##(2006-9#2)
the elastic##39##2##(1992-7#1)(1996-12#1)(2004-9#3)(2005-11#1)(2006-9#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#6)(2008-7#1)(2009-5#3)(2009-7#7)(2010-1#1)(2010-4#3)(2010-8#1)(2012-1#1)(2012-2#1)
the elastically scattered irradiances##2##4##(2008-3#2)
the elasticities##2##2##(1990-7#1)(2008-10#1)
the elasticity of the##3##4##(2006-6#1)(2007-7#1)(2008-5#1)
the elasticity of##4##3##(2006-6#1)(2007-7#1)(2008-5#1)(2009-4#1)
the elasticity parameters##2##3##(2005-11#1)(2007-5#1)
the elasticity##9##2##(2005-11#1)(2006-6#1)(2007-5#1)(2007-7#1)(2008-3#1)(2008-5#2)(2009-4#1)(2010-8#1)
the elastin and##2##3##(1993-10#1)(2008-5#1)
the elastin##4##2##(1990-8#1)(1993-10#1)(1994-8#1)(2008-5#1)
the elbow and##3##3##(1995-6#1)(2008-12#1)(2008-4#1)
the elbow joint##13##3##(1996-9#2)(2006-11#1)(2007-11#3)(2008-9#1)(2012-1#6)
the elbow##47##2##(1992-5#1)(1992-9#2)(1993-11#1)(1995-6#1)(1996-6#1)(1996-9#2)(2006-11#2)(2006-3#1)(2006-4#1)(2007-11#5)(2007-2#1)(2007-7#2)(2008-1#3)(2008-12#2)(2008-4#2)(2008-8#2)(2008-9#6)(2010-11#1)(2012-1#8)(2013-1#1)(2013-8#2)
the elder##2##2##(1996-1#1)(2009-9#1)
the elderly although##2##3##(2005-3#1)(2006-10#1)
the elderly and disabled##2##4##(1996-1#1)(2012-1#1)
the elderly and the##2##4##(1997-6#1)(2008-11#1)
the elderly and their##2##4##(1992-3#1)(2011-1#1)
the elderly and to##2##4##(2007-11#1)(2012-12#1)
the elderly and##31##3##(1991-3#1)(1992-3#1)(1994-6#4)(1995-1#1)(1996-1#1)(1997-6#1)(1997-8#1)(2005-7#2)(2005-8#1)(2006-12#1)(2006-8#1)(2007-1#2)(2007-11#1)(2007-7#3)(2007-8#1)(2008-11#1)(2008-7#2)(2011-1#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
the elderly are discussed##4##4##(1994-12#1)(1995-2#1)(2006-5#1)(2008-2#1)
the elderly are##13##3##(1990-11#1)(1993-10#1)(1994-1#1)(1994-12#1)(1995-2#1)(1996-1#1)(2006-5#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-12#1)
the elderly as##2##3##(1994-1#1)(2006-10#1)
the elderly from the##3##4##(1990-6#1)(1993-5#1)(2007-1#1)
the elderly group##5##3##(1991-12#1)(2006-7#1)(2007-7#1)(2008-7#1)(2012-2#1)
the elderly have##4##3##(1993-12#1)(2005-8#1)(2007-7#1)(2012-2#1)
the elderly in the##4##4##(2007-11#1)(2008-2#1)(2012-12#1)(2013-8#1)
the elderly in##24##3##(1991-2#1)(1993-10#1)(1993-3#1)(1995-5#1)(2006-8#1)(2007-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#3)
the elderly is##9##3##(1990-8#1)(1993-5#1)(1995-10#1)(2006-10#1)(2008-2#1)(2008-3#1)(2009-1#1)(2009-10#1)(2013-8#1)
the elderly living##2##3##(2008-7#2)
the elderly may##2##3##(1990-1#1)(2007-5#1)
the elderly or##3##3##(1994-6#1)(2011-2#1)(2012-1#1)
the elderly patient with a##2##5##(1993-8#1)(2010-1#1)
the elderly patient##15##3##(1990-11#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-8#1)(1994-4#1)(1996-3#1)(1996-7#2)(2006-10#1)(2006-2#1)(2006-7#1)(2008-4#1)(2008-8#1)(2010-1#1)
the elderly patients##8##3##(1992-6#3)(2007-8#1)(2008-10#1)(2008-7#3)
the elderly people##3##3##(2010-8#1)(2011-1#2)
the elderly person##3##3##(2008-11#1)(2011-2#2)
the elderly persons##2##3##(2005-9#1)(2008-6#1)
the elderly population are##2##4##(2007-9#1)(2008-8#1)
the elderly population in##2##4##(2008-7#1)(2011-1#1)
the elderly population##31##3##(1991-3#1)(1993-3#1)(1995-12#1)(2004-3#1)(2006-1#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-12#1)(2010-10#1)(2011-1#2)(2011-12#1)(2011-2#1)(2011-7#1)(2012-2#1)(2012-3#1)
the elderly to##2##3##(1993-5#1)(2009-10#1)
the elderly were##3##3##(1994-1#1)(1995-8#1)(2009-7#1)
the elderly who##3##3##(2006-7#2)(2012-2#1)
the elderly with##8##3##(1991-2#1)(1991-6#1)(1992-4#1)(2006-7#1)(2008-7#2)(2009-10#1)(2009-4#1)
the elderly##468##2##(1990-1#1)(1990-11#3)(1990-2#1)(1990-3#3)(1990-6#3)(1990-8#1)(1990-9#2)(1991-1#3)(1991-12#5)(1991-2#5)(1991-3#6)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#4)(1992-4#2)(1992-6#4)(1992-8#5)(1993-1#3)(1993-10#5)(1993-11#2)(1993-12#13)(1993-2#2)(1993-3#4)(1993-5#4)(1993-8#1)(1993-9#1)(1994-1#7)(1994-12#5)(1994-2#1)(1994-4#2)(1994-5#2)(1994-6#9)(1995-1#1)(1995-10#4)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#3)(1995-5#1)(1995-8#3)(1995-9#4)(1996-1#6)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#3)(1996-9#2)(1997-3#1)(1997-5#2)(1997-6#2)(1997-8#2)(2004-11#1)(2004-3#2)(2005-10#1)(2005-12#1)(2005-3#5)(2005-7#2)(2005-8#2)(2005-9#2)(2006-1#2)(2006-10#14)(2006-12#7)(2006-2#5)(2006-3#4)(2006-5#1)(2006-7#9)(2006-8#4)(2006-9#1)(2007-1#5)(2007-10#3)(2007-11#7)(2007-12#4)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#8)(2007-8#4)(2007-9#4)(2008-1#3)(2008-10#4)(2008-11#8)(2008-12#2)(2008-2#7)(2008-3#5)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#35)(2008-8#11)(2008-9#4)(2009-1#3)(2009-10#6)(2009-12#4)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#4)(2010-1#1)(2010-10#1)(2010-12#5)(2010-2#3)(2010-4#4)(2010-8#6)(2011-1#15)(2011-12#4)(2011-2#16)(2011-7#1)(2012-1#6)(2012-12#8)(2012-2#6)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#5)
the elderly)##4##2##(1992-4#1)(2010-12#1)(2013-1#2)
the elderly?##2##2##(2008-7#1)(2012-1#1)
the elderly?]##3##2##(1993-10#1)(1993-6#1)(2009-9#1)
the elderly]##22##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-8#1)(1992-6#2)(1992-8#2)(1993-1#1)(1993-3#1)(1993-5#1)(1994-5#1)(1994-6#1)(1996-12#1)(2005-10#1)(2005-3#1)(2006-2#1)(2008-4#1)(2011-2#1)(2012-11#1)(2012-2#1)
the elders##2##2##(2007-10#1)(2013-8#1)
the elected##3##2##(1991-1#1)(2005-11#1)(2008-6#1)
the election##2##2##(1996-11#1)(2006-7#1)
the elective period##2##3##(2007-2#2)
the elective##11##2##(1990-8#1)(1990-9#1)(1991-6#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-8#2)
the electorate##2##2##(1991-1#1)(1997-3#1)
the electric current##4##3##(2005-11#1)(2008-10#1)(2013-1#2)
the electric field and##2##4##(2007-12#1)(2008-2#1)
the electric field by##2##4##(2008-3#2)
the electric field in the##2##5##(2008-3#2)
the electric field inside##2##4##(2007-11#1)(2008-3#1)
the electric field of the##3##5##(2007-12#1)(2008-10#1)(2008-3#1)
the electric field of##6##4##(2007-11#1)(2007-12#3)(2008-10#1)(2008-3#1)
the electric field strength##3##4##(2008-10#1)(2008-3#1)(2009-2#1)
the electric field was##2##4##(1996-1#1)(2007-11#1)
the electric field##46##3##(1990-12#1)(1990-4#1)(1990-7#1)(1991-1#1)(1996-1#1)(1996-12#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#2)(2007-11#5)(2007-12#9)(2008-10#5)(2008-2#3)(2008-3#11)(2009-2#1)(2013-8#1)
the electric fields##2##3##(2007-11#1)(2009-12#1)
the electric instability of the ventricular##2##6##(2005-1#2)
the electric organ of##3##4##(1992-6#2)(1997-8#1)
the electric organ##5##3##(1992-6#2)(1995-5#1)(1997-8#2)
the electric##76##2##(1990-12#1)(1990-3#2)(1990-4#1)(1990-7#1)(1991-1#2)(1992-6#3)(1993-8#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-8#1)(1997-8#4)(2005-1#2)(2005-11#4)(2006-10#1)(2006-12#1)(2006-2#2)(2007-11#6)(2007-12#10)(2008-1#1)(2008-10#7)(2008-2#3)(2008-3#11)(2008-4#1)(2008-7#1)(2009-12#1)(2009-2#1)(2010-6#1)(2012-2#1)(2013-1#2)(2013-8#1)
the electric-field##3##2##(2007-12#1)(2008-2#2)
the electric-field-induced reorientation of##2##4##(2007-12#2)
the electrical activity of the brain##2##6##(1992-3#1)(2010-8#1)
the electrical activity of##5##4##(1992-3#1)(1994-2#1)(1996-2#1)(2004-11#1)(2010-8#1)
the electrical activity signals of the heart##3##7##(2010-8#3)
the electrical activity##8##3##(1992-3#1)(1994-2#1)(1996-2#1)(2004-11#1)(2010-8#4)
the electrical and##4##3##(1992-8#1)(1994-8#1)(2008-2#1)(2010-8#1)
the electrical characteristics of##2##4##(1992-2#1)(1995-3#1)
the electrical characteristics##3##3##(1992-2#1)(1995-3#1)(2008-10#1)
the electrical conductivity of composites##2##5##(2010-4#2)
the electrical conductivity of##5##4##(2005-11#2)(2007-8#1)(2010-4#2)
the electrical conductivity##10##3##(2005-11#6)(2007-8#1)(2008-10#1)(2010-4#2)
the electrical current and##2##4##(2008-3#1)(2009-10#1)
the electrical current##3##3##(2005-11#1)(2008-3#1)(2009-10#1)
the electrical double layer##3##4##(2005-11#3)
the electrical double-layer interaction##3##4##(2005-11#3)
the electrical double-layer##4##3##(2005-11#4)
the electrical impedance##2##3##(2007-12#1)(2009-3#1)
the electrical or##2##3##(1995-2#1)(2008-7#1)
the electrical potential##2##3##(2006-10#1)(2008-4#1)
the electrical power##2##3##(2008-1#1)(2008-3#1)
the electrical properties of the##2##5##(1997-7#1)(2005-11#1)
the electrical properties of##4##4##(1997-7#1)(2005-11#1)(2009-8#2)
the electrical resistance##3##3##(1996-5#1)(2010-2#2)
the electrical stimulation##2##3##(1992-9#1)(1993-2#1)
the electrical stimulus##3##3##(1992-9#1)(2009-8#1)(2012-12#1)
the electrical transport##2##3##(2008-7#1)(2010-7#1)
the electrical##83##2##(1990-11#1)(1990-5#2)(1991-5#1)(1992-2#1)(1992-3#2)(1992-8#1)(1992-9#2)(1993-2#1)(1994-2#1)(1994-8#2)(1995-2#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#17)(2006-10#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-8#5)(2010-2#2)(2010-4#2)(2010-7#1)(2010-8#6)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
the electrically charged##2##3##(2005-11#1)(2008-10#1)
the electrically evoked release of##2##5##(1993-2#1)(1995-12#1)
the electrically evoked##4##3##(1991-8#1)(1993-2#1)(1995-12#2)
the electrically stimulated release of##2##5##(1993-2#2)
the electrically stimulated##5##3##(1990-5#2)(1993-2#2)(1997-5#1)
the electrically##14##2##(1990-5#2)(1991-8#1)(1993-2#3)(1995-12#2)(1997-5#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
the electrically-elicited##2##2##(2011-2#2)
the electro##2##2##(2008-10#1)(2012-2#1)
the electro-optic crystal##3##3##(2007-11#1)(2008-3#2)
the electro-optic effect##7##3##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#2)
the electro-optic##16##2##(2007-11#2)(2007-12#5)(2008-2#5)(2008-3#4)
the electro-optical##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
the electro-reduction of the product of the enzyme-catalyzed reaction have been##2##11##(2008-10#2)
the electro-reduction##3##2##(2008-10#3)
the electroabsorption and the electro-optic effects##2##6##(2008-2#2)
the electroactive##9##2##(2007-8#2)(2008-10#6)(2008-5#1)
the electroanalytical##4##2##(2008-10#4)
the electrocardiogram (ECG)##3##3##(1991-5#1)(1995-6#1)(2008-10#1)
the electrocardiogram and##2##3##(1991-12#1)(2012-2#1)
the electrocardiogram##17##2##(1990-5#1)(1991-12#1)(1991-5#1)(1993-11#1)(1994-6#1)(1995-6#1)(1996-4#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2012-2#3)(2013-1#1)
the electrocardiographic##2##2##(2005-8#1)(2010-9#1)
the electrocatalytic effect of##2##4##(2008-10#1)(2010-5#1)
the electrocatalytic oxidation of##2##4##(2008-10#2)
the electrocatalytic process##2##3##(2008-10#2)
the electrocatalytic reduction of##2##4##(2008-10#2)
the electrocatalytic##9##2##(2008-10#8)(2010-5#1)
the electrocautery##2##2##(1994-12#2)
the electrochemical and##2##3##(1992-7#1)(2005-11#1)
the electrochemical behavior of the##2##5##(2008-10#2)
the electrochemical behavior of##6##4##(2008-10#5)(2010-6#1)
the electrochemical cell##3##3##(2006-12#1)(2008-10#1)(2009-2#1)
the electrochemical characteristics##2##3##(1997-8#1)(2008-10#1)
the electrochemical detection of##3##4##(2008-10#1)(2008-12#2)
the electrochemical detection##6##3##(1993-1#1)(2008-10#3)(2008-12#2)
the electrochemical determination of##5##4##(2008-10#5)
the electrochemical hydride generation##4##4##(2008-10#4)
the electrochemical oxidation of##6##4##(2007-8#2)(2008-10#4)
the electrochemical performance of MnO2-based electrodes##2##6##(2010-4#2)
the electrochemical performance##3##3##(2010-4#3)
the electrochemical potential##3##3##(1991-2#1)(2005-11#1)(2006-12#1)
the electrochemical quartz crystal microbalance##5##5##(2005-11#1)(2007-8#2)(2008-10#2)
the electrochemical reaction##2##3##(1990-12#1)(2008-10#1)
the electrochemical reduction of##3##4##(2008-10#3)
the electrochemical response of##3##4##(2008-10#2)(2010-7#1)
the electrochemical response##7##3##(2008-10#6)(2010-7#1)
the electrochemical responses of##2##4##(1996-11#1)(2008-10#1)
the electrochemical responses##3##3##(1996-11#1)(2007-8#1)(2008-10#1)
the electrochemical signal##3##3##(2007-8#1)(2010-5#2)
the electrochemical##87##2##(1990-12#1)(1991-2#1)(1991-8#1)(1992-7#1)(1993-1#1)(1996-1#1)(1996-11#1)(1996-2#1)(1997-8#1)(2005-11#3)(2006-12#3)(2007-8#9)(2008-10#49)(2008-12#2)(2008-8#2)(2009-2#1)(2010-2#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2013-7#1)
the electrochemically##6##2##(2008-10#5)(2009-12#1)
the electrochemiluminescence##2##2##(2008-10#2)
the electrochemistry of##5##3##(2005-11#2)(2007-8#1)(2008-10#2)
the electrochromic##3##2##(1996-4#1)(2007-8#1)(2010-7#1)
the electrocoagulation##2##2##(2005-11#1)(2007-10#1)
the electroconstriction##2##2##(2006-10#2)
the electrode and the##3##4##(2005-11#1)(2008-9#1)(2010-10#1)
the electrode and##12##3##(1990-5#1)(2005-11#1)(2008-10#6)(2008-12#1)(2008-9#1)(2010-10#2)
the electrode as well as##2##5##(2007-11#1)(2008-5#1)
the electrode as##3##3##(2007-11#1)(2008-5#1)(2008-9#1)
the electrode based on##3##4##(2008-10#3)
the electrode by##5##3##(1995-6#1)(2008-10#4)
the electrode can be used##2##5##(2008-10#2)
the electrode can be##4##4##(2008-10#4)
the electrode can##5##3##(2008-10#5)
the electrode exhibited good selectivity##2##5##(2008-10#2)
the electrode exhibited##4##3##(2008-10#4)
the electrode has##2##3##(2008-10#2)
the electrode in a##2##4##(2008-10#2)
the electrode in the##2##4##(2008-10#2)
the electrode in##8##3##(1992-8#1)(2008-10#7)
the electrode is##8##3##(2006-12#1)(2007-8#1)(2008-10#6)
the electrode materials##2##3##(2008-10#2)
the electrode membrane##3##3##(2008-10#3)
the electrode performance##2##3##(2008-10#2)
the electrode potential and##2##4##(2008-10#2)
the electrode potential is##2##4##(2008-10#2)
the electrode potential##8##3##(2008-10#7)(2010-11#1)
the electrode prepared##3##3##(2008-10#3)
the electrode process was##2##4##(2008-10#2)
the electrode process##4##3##(2007-8#1)(2008-10#3)
the electrode reaction was##2##4##(2008-10#2)
the electrode reaction##4##3##(2005-11#1)(2007-8#1)(2008-10#2)
the electrode response##8##3##(2008-10#8)
the electrode responses##2##3##(2008-10#2)
the electrode selectivity##2##3##(2008-10#2)
the electrode shows##2##3##(2008-10#2)
the electrode surface and##6##4##(2007-8#1)(2008-10#5)
the electrode surface by##3##4##(2008-10#3)
the electrode surface such that##2##5##(2008-10#2)
the electrode surface was##3##4##(2008-10#2)(2008-11#1)
the electrode surface##55##3##(2007-8#3)(2008-10#49)(2008-11#1)(2008-5#1)(2009-12#1)
the electrode system##2##3##(2008-3#2)
the electrode to##2##3##(2008-10#1)(2008-3#1)
the electrode was##19##3##(2008-10#18)(2008-9#1)
the electrode were##3##3##(2008-10#3)
the electrode with##4##3##(1997-1#1)(2008-10#3)
the electrode wrapping angle##2##4##(2008-2#2)
the electrode##270##2##(1990-5#1)(1992-8#1)(1994-2#1)(1995-6#1)(1997-1#1)(2005-11#4)(2006-12#3)(2006-2#1)(2006-3#2)(2007-10#1)(2007-11#1)(2007-8#9)(2008-10#210)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#4)(2008-5#3)(2008-7#2)(2008-9#11)(2009-12#1)(2010-10#2)(2010-11#1)(2010-2#2)(2010-5#1)(2012-1#1)
the electrode's position##2##3##(2008-9#1)(2010-8#1)
the electrodeposited##3##2##(2008-10#3)
the electrodeposition of##2##3##(2008-10#2)
the electrodeposition##5##2##(2005-11#1)(2008-10#4)
the electrodes and##4##3##(2008-10#2)(2008-5#1)(2010-2#1)
the electrodes are##8##3##(2008-10#7)(2013-1#1)
the electrodes based on##2##4##(2008-10#2)
the electrodes on the##2##4##(2008-3#2)
the electrodes were##5##3##(2008-10#4)(2008-9#1)
the electrodes##55##2##(1996-2#1)(1997-4#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#32)(2008-2#1)(2008-3#4)(2008-5#1)(2008-9#3)(2009-10#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2013-1#1)
the electrodynamic##2##2##(2005-11#1)(2009-8#1)
the electroencephalogram (EEG)##2##3##(2009-8#1)(2013-1#1)
the electroencephalogram##5##2##(2006-10#1)(2008-5#1)(2009-8#1)(2011-2#1)(2013-1#1)
the electrogenerated##2##2##(2008-10#2)
the electrogenic##3##2##(1990-11#2)(1996-1#1)
the electrokinetic properties of##3##4##(2005-11#3)
the electrokinetic##7##2##(2005-11#6)(2008-10#1)
the electrolyte and the##2##4##(2005-11#1)(2006-10#1)
the electrolyte and##3##3##(2005-11#1)(2006-10#1)(2008-10#1)
the electrolyte balance##2##3##(2010-12#1)(2010-7#1)
the electrolyte composition##2##3##(2008-10#1)(2009-5#1)
the electrolyte concentration##2##3##(1990-3#1)(2009-7#1)
the electrolyte considered##2##3##(2005-11#2)
the electrolyte##24##2##(1990-3#1)(1996-5#1)(2005-11#4)(2005-4#3)(2006-10#1)(2006-6#1)(2007-8#1)(2007-9#1)(2008-10#6)(2009-5#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-7#1)
the electrolytes##4##2##(2005-11#1)(2006-10#1)(2008-10#1)(2013-1#1)
the electrolytic chamber##2##3##(2008-10#2)
the electrolytic##6##2##(2007-12#1)(2008-10#5)
the electromagnetic fields##4##3##(2008-2#2)(2008-3#2)
the electromagnetic power##2##3##(2008-3#2)
the electromagnetic spectrum##4##3##(2008-2#2)(2010-5#1)(2012-12#1)
the electromagnetic wave theory##2##4##(2008-3#2)
the electromagnetic wave##3##3##(2007-11#1)(2008-3#2)
the electromagnetic wavelets##2##3##(2008-2#2)
the electromagnetic##36##2##(2006-6#1)(2007-11#2)(2007-12#6)(2007-8#1)(2008-2#11)(2008-3#10)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
the electromyographic (EMG)##2##3##(2008-10#1)(2008-5#1)
the electromyographic activity of the##3##5##(2010-6#1)(2010-9#2)
the electromyographic signal##2##3##(2010-6#1)(2010-9#1)
the electromyographic##8##2##(2008-10#1)(2008-5#1)(2008-9#1)(2010-6#2)(2010-9#3)
the electron acceptor##4##3##(1992-3#1)(2004-4#1)(2006-8#1)(2007-6#1)
the electron affinities of these##2##5##(1991-10#1)(2010-4#1)
the electron beam##2##3##(2009-10#1)(2009-7#1)
the electron capture detector##2##4##(1990-8#1)(2008-10#1)
the electron densities##2##3##(1995-11#1)(2008-3#1)
the electron density in##2##4##(2006-5#1)(2007-12#1)
the electron density map##2##4##(1993-6#1)(1994-12#1)
the electron density was##2##4##(1990-11#1)(2008-9#1)
the electron density##11##3##(1990-11#1)(1993-6#1)(1994-12#1)(1995-1#1)(1997-2#1)(2006-5#3)(2007-12#2)(2008-9#1)
the electron donor##2##3##(1995-2#1)(2005-8#1)
the electron flux##3##3##(1990-8#1)(2005-8#1)(2009-10#1)
the electron impact##2##3##(2008-10#2)
the electron injection##4##3##(2008-10#3)(2010-5#1)
the electron mediator##2##3##(2007-8#1)(2008-6#1)
the electron microscope##11##3##(1990-12#1)(1990-5#1)(1997-3#1)(1997-6#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-7#2)
the electron microscopic level##7##4##(1990-4#1)(1991-9#1)(1992-8#1)(1995-11#1)(1995-3#1)(1997-8#1)(2008-7#1)
the electron paramagnetic resonance (EPR)##2##5##(1990-2#1)(2008-8#1)
the electron paramagnetic resonance##3##4##(1990-2#1)(1995-5#1)(2008-8#1)
the electron phase space beam model##2##6##(2009-11#2)
the electron spin resonance (ESR)##2##5##(2008-10#1)(2010-4#1)
the electron spin resonance technique##2##5##(2008-10#1)(2008-8#1)
the electron spin resonance##6##4##(1991-6#1)(1992-3#1)(2008-10#2)(2008-8#1)(2010-4#1)
the electron transfer between the##3##5##(1994-8#1)(2005-11#1)(2008-10#1)
the electron transfer between##4##4##(1994-8#1)(2005-11#1)(2008-10#2)
the electron transfer flavoprotein dehydrogenase##2##5##(2011-1#2)
the electron transfer process##3##4##(2006-10#2)(2008-8#1)
the electron transfer rate##3##4##(1991-8#1)(1997-7#1)(2006-10#1)
the electron transfer to##4##4##(1994-12#1)(2008-10#3)
the electron transfer was##2##4##(2008-10#2)
the electron transfer##29##3##(1991-12#1)(1991-8#1)(1994-12#1)(1994-8#1)(1996-8#1)(1997-7#2)(2005-11#4)(2006-10#6)(2008-10#8)(2008-8#1)(2009-9#1)(2011-1#2)
the electron transport chain and##2##5##(2005-8#1)(2008-10#1)
the electron transport chain##10##4##(1995-6#1)(1996-8#1)(1996-9#2)(2005-8#3)(2008-10#1)(2011-1#1)(2013-8#1)
the electron transport##11##3##(1995-6#1)(1996-8#1)(1996-9#2)(2005-8#3)(2006-8#1)(2008-10#1)(2011-1#1)(2013-8#1)
the electron##129##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#2)(1991-10#2)(1991-12#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-6#1)(1994-12#2)(1994-7#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-8#2)(1996-9#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-4#1)(2005-11#4)(2005-4#1)(2005-8#5)(2006-10#6)(2006-4#1)(2006-5#5)(2006-8#2)(2007-12#5)(2007-6#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#25)(2008-11#1)(2008-3#3)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#4)(2009-11#2)(2009-7#1)(2009-9#1)(2010-4#2)(2010-5#1)(2011-1#4)(2013-8#1)
the electron-density profile##3##3##(2007-12#3)
the electron-phonon coupling factor##3##4##(2008-3#3)
the electron-phonon coupling##4##3##(1990-4#1)(2008-3#3)
the electron-phonon##6##2##(1990-4#1)(2006-7#1)(2008-3#3)(2012-2#1)
the electron-transfer reaction##2##3##(1994-8#2)
the electron-transfer##8##2##(1990-5#1)(1994-8#3)(1995-2#1)(2008-10#3)
the electron-transport chain##2##3##(1991-2#1)(2008-8#1)
the electron-withdrawing##2##2##(1992-6#1)(1996-5#1)
the electronic absorption and##2##4##(1997-4#1)(2008-10#1)
the electronic absorption spectra##3##4##(2006-12#1)(2007-11#1)(2008-10#1)
the electronic absorption##5##3##(1997-4#1)(2006-12#1)(2007-11#1)(2008-10#2)
the electronic and##5##3##(1991-7#1)(2007-12#2)(2009-10#1)(2010-4#1)
the electronic coupling between##2##4##(1995-2#1)(2008-10#1)
the electronic coupling##7##3##(1995-2#2)(1997-1#1)(2008-10#1)(2010-2#2)(2012-2#1)
the electronic health record##8##4##(2007-5#1)(2008-5#1)(2013-1#5)(2013-7#1)
the electronic health##10##3##(1994-2#1)(1996-12#1)(2007-5#1)(2008-5#1)(2013-1#5)(2013-7#1)
the electronic medical record system##2##5##(2008-8#2)
the electronic medical record##6##4##(1993-12#1)(1994-3#1)(2006-6#1)(2008-8#2)(2012-11#1)
the electronic medical##7##3##(1993-12#1)(1994-3#1)(2006-6#1)(2008-8#2)(2012-11#1)(2012-3#1)
the electronic patient record##2##4##(1997-1#2)
the electronic properties of##5##4##(1996-2#1)(2006-12#1)(2008-7#3)
the electronic properties##7##3##(1996-2#1)(2006-12#1)(2008-10#1)(2008-7#3)(2010-5#1)
the electronic structure of##3##4##(1993-11#1)(2007-9#1)(2010-7#1)
the electronic structure##6##3##(1993-11#1)(1996-2#1)(2006-10#1)(2007-11#1)(2007-9#1)(2010-7#1)
the electronic structures##2##3##(2006-10#1)(2010-5#1)
the electronic tongue##2##3##(2008-10#2)
the electronic toolkit##4##3##(2013-1#4)
the electronic transfer of patient data across organizations##2##8##(2013-1#2)
the electronic##107##2##(1990-2#1)(1990-8#1)(1991-4#1)(1991-7#1)(1992-2#1)(1993-11#1)(1993-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-2#2)(1996-12#2)(1996-2#2)(1996-6#1)(1997-1#3)(1997-4#1)(1997-5#1)(1997-7#1)(2006-10#3)(2006-12#3)(2006-4#1)(2006-6#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-5#1)(2007-9#3)(2008-10#8)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#7)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-6#1)(2010-2#2)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#1)(2011-2#2)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#15)(2013-7#1)
the electronics##6##2##(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)
the electrons in##2##3##(2008-3#1)(2009-2#1)
the electrons##9##2##(1991-11#1)(2008-3#2)(2008-7#3)(2009-2#1)(2011-1#1)(2012-2#1)
the electroosmotic flow (EOF)##4##4##(1997-2#1)(2007-8#1)(2008-10#2)
the electroosmotic flow##8##3##(1994-9#1)(1996-5#2)(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#2)
the electrophilic##2##2##(1994-3#1)(1996-5#1)
the electrophilicity##2##2##(1996-5#1)(2008-9#1)
the electrophoresis##4##2##(2005-11#1)(2008-10#2)(2009-8#1)
the electrophoretic buffer##2##3##(1997-2#1)(1997-3#1)
the electrophoretic mobilities of the##2##5##(1990-7#1)(2008-10#1)
the electrophoretic mobility and the electrical conductivity##3##7##(2005-11#3)
the electrophoretic mobility and##4##4##(1990-2#1)(2005-11#3)
the electrophoretic mobility of the inhibitor##2##6##(1997-8#2)
the electrophoretic mobility of the##4##5##(1994-11#1)(1997-8#2)(2008-10#1)
the electrophoretic mobility of##8##4##(1992-6#1)(1994-11#1)(1997-2#1)(1997-8#2)(2005-11#2)(2008-10#1)
the electrophoretic mobility shift assay##3##5##(1991-11#1)(1993-12#1)(1995-3#1)
the electrophoretic mobility##18##3##(1990-2#2)(1991-11#1)(1992-6#1)(1993-12#1)(1994-11#1)(1994-9#1)(1995-3#1)(1997-2#1)(1997-8#2)(2005-11#6)(2008-10#1)
the electrophoretic pattern##2##3##(1991-4#1)(1992-9#1)
the electrophoretic separation##2##3##(1997-8#1)(2008-4#1)
the electrophoretic##37##2##(1990-2#2)(1990-3#1)(1990-7#1)(1991-11#2)(1991-4#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-8#1)(1997-2#2)(1997-3#1)(1997-8#4)(2005-11#7)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2010-4#1)
the electrophysiologic properties of the##2##5##(1997-4#1)(2007-9#1)
the electrophysiologic properties of##3##4##(1997-4#1)(2007-9#1)(2008-10#1)
the electrophysiological and##4##3##(1991-6#1)(1993-5#1)(2008-11#1)(2008-9#1)
the electrophysiological properties of##3##4##(1990-2#1)(1994-10#1)(2013-8#1)
the electrophysiological##14##2##(1990-12#1)(1990-2#2)(1990-9#1)(1991-6#1)(1993-5#1)(1993-8#1)(1994-10#2)(1994-2#1)(2008-11#1)(2008-9#1)(2013-1#1)(2013-8#1)
the electrophysiology##2##2##(2006-9#1)(2008-11#1)
the electropolymerization of pyrrole##2##4##(2008-10#2)
the electropolymerization of##4##3##(2008-10#4)
the electropolymerization##9##2##(2007-8#1)(2008-10#8)
the electroporation of##3##3##(2008-1#1)(2008-11#1)(2008-2#1)
the electroporation##5##2##(2006-5#2)(2008-1#1)(2008-11#1)(2008-2#1)
the electroretinogram##3##2##(2012-1#2)(2012-12#1)
the electrospray##4##2##(1997-2#1)(2007-8#1)(2008-10#1)(2008-6#1)
the electrospun PHBV##2##3##(2008-5#2)
the electrospun PLGA scaffolds##2##4##(2010-9#2)
the electrospun TiO2 nanofibers##2##4##(2010-4#2)
the electrospun TiO2##3##3##(2010-4#3)
the electrospun##10##2##(2008-5#4)(2009-7#1)(2010-4#3)(2010-9#2)
the electrostatic attraction between the##2##5##(2005-11#2)
the electrostatic contribution to the##3##5##(2006-10#2)(2008-4#1)
the electrostatic contribution to##4##4##(1996-8#1)(2006-10#2)(2008-4#1)
the electrostatic contribution##5##3##(1996-8#1)(2006-10#2)(2008-4#1)(2008-7#1)
the electrostatic effect##2##3##(1996-7#1)(2008-10#1)
the electrostatic energy##2##3##(2005-11#1)(2008-4#1)
the electrostatic field##2##3##(2008-10#1)(2008-2#1)
the electrostatic force##2##3##(2008-10#2)
the electrostatic free##2##3##(2006-10#1)(2008-4#1)
the electrostatic interaction between##3##4##(2008-5#1)(2012-6#1)(2013-1#1)
the electrostatic interactions between the##2##5##(1991-5#1)(2010-4#1)
the electrostatic interactions##8##3##(1990-12#1)(1991-5#1)(1994-8#1)(2005-11#2)(2006-10#1)(2008-10#1)(2010-4#1)
the electrostatic potential##3##3##(1992-3#1)(2009-5#1)(2010-2#1)
the electrostatic properties of##2##4##(1993-3#1)(2005-11#1)
the electrostatic properties##3##3##(1993-3#1)(2005-11#2)
the electrostatic repulsion between##2##4##(2005-11#2)
the electrostatic##59##2##(1990-12#1)(1991-5#1)(1992-3#1)(1993-3#1)(1994-5#2)(1994-8#1)(1995-10#1)(1996-11#1)(1996-4#1)(1996-7#1)(1996-8#2)(1997-6#1)(2005-11#10)(2006-10#6)(2007-11#1)(2008-10#7)(2008-2#1)(2008-4#4)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#2)(2010-2#1)(2010-4#2)(2010-7#1)(2012-6#1)(2013-1#3)(2013-8#2)
the electrostrictive response in##2##4##(2007-12#2)
the electrostrictive response##3##3##(2007-12#3)
the electrostrictive##8##2##(2007-12#7)(2008-1#1)
the electrosynthesis##2##2##(2007-8#1)(2008-10#1)
the electrothermal atomic absorption spectrometric##2##5##(2008-10#2)
the electrothermal atomic absorption##3##4##(2008-10#3)
the electrothermal atomizer##3##3##(2008-10#3)
the electrothermal##7##2##(2008-10#6)(2008-2#1)
the element can##2##3##(2008-2#1)(2008-3#1)
the element from##2##3##(1992-5#1)(1996-10#1)
the element is##4##3##(1991-5#1)(1994-6#1)(2008-10#1)(2008-3#1)
the element##31##2##(1990-10#1)(1990-3#1)(1991-5#1)(1992-5#2)(1994-6#2)(1995-1#1)(1995-2#1)(1995-8#2)(1996-10#1)(1996-7#1)(2006-12#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-2#3)(2008-3#4)(2009-6#1)(2012-2#1)
the elemental analysis of##3##4##(2008-10#2)(2013-7#1)
the elemental analysis##4##3##(2008-10#3)(2013-7#1)
the elemental composition of##5##4##(2007-9#1)(2008-10#3)(2012-2#1)
the elemental##23##2##(1992-9#1)(1993-6#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-9#1)(2008-10#14)(2012-2#1)(2013-7#2)
the elementary events underlying force generation##2##6##(2012-2#2)
the elementary steps of the##2##5##(1994-8#1)(1997-4#1)
the elementary##9##2##(1992-5#1)(1994-6#1)(1994-8#1)(1996-12#1)(1997-3#1)(1997-4#1)(2007-12#1)(2012-2#2)
the elements and##6##3##(1991-11#1)(1997-1#1)(2008-10#2)(2010-9#1)(2013-1#1)
the elements in the##3##4##(2008-10#2)(2008-2#1)
the elements in##7##3##(2005-4#1)(2006-10#1)(2008-10#4)(2008-2#1)
the elements investigated##2##3##(2008-10#2)
the elements involved in##2##4##(1993-12#1)(1993-2#1)
the elements of a successful##2##5##(1993-2#1)(1997-2#1)
the elements of a##3##4##(1993-2#1)(1997-2#1)(2007-12#1)
the elements of social##2##4##(2006-3#1)(2012-3#1)
the elements of the Mueller matrix##2##6##(2008-3#1)(2009-5#1)
the elements of the metabolic syndrome##2##6##(2008-3#2)
the elements of the##13##4##(1995-12#1)(2007-8#1)(2008-1#1)(2008-2#2)(2008-3#4)(2008-9#1)(2009-5#1)(2013-1#2)
the elements of##35##3##(1993-2#1)(1994-12#1)(1994-3#2)(1995-12#1)(1996-12#1)(1996-9#1)(1997-2#1)(2006-11#1)(2006-2#1)(2006-3#2)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#4)(2008-7#1)(2008-9#1)(2009-5#1)(2009-6#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
the elements required##2##3##(1991-5#1)(1993-12#1)
the elements studied##2##3##(2008-10#2)
the elements that##6##3##(2006-12#1)(2006-8#1)(2007-1#1)(2008-10#1)(2010-7#1)(2013-1#1)
the elements were##5##3##(1996-8#1)(2008-10#4)
the elements##108##2##(1991-11#1)(1991-5#1)(1992-6#3)(1993-12#2)(1993-2#2)(1994-12#1)(1994-3#2)(1995-12#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(2005-4#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#4)(2008-1#1)(2008-10#39)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#4)(2008-7#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#3)
the elevated blood pressure##3##4##(1992-8#1)(1997-5#2)
the elevated blood##4##3##(1992-5#1)(1992-8#1)(1997-5#2)
the elevated level of IgE##2##5##(2009-2#2)
the elevated level of##3##4##(1996-5#1)(2009-2#2)
the elevated levels of##6##4##(1990-10#1)(1990-8#1)(1994-11#1)(1994-3#1)(2011-2#1)(2013-8#1)
the elevated plus maze apparatus##2##5##(1993-9#1)(1995-12#1)
the elevated plus maze##4##4##(1993-7#1)(1993-9#1)(1995-12#1)(2011-2#1)
the elevated plus-maze and the shock-probe burying tests##2##8##(1993-3#2)
the elevated plus-maze and the##3##5##(1993-3#3)
the elevated plus-maze test##7##4##(1991-2#1)(1993-3#2)(1993-9#1)(2008-11#1)(2013-1#2)
the elevated plus-maze##16##3##(1991-2#1)(1992-7#1)(1993-3#5)(1993-7#1)(1993-9#2)(2008-11#3)(2008-4#1)(2013-1#2)
the elevated##69##2##(1990-10#1)(1990-11#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-10#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-3#5)(1993-6#1)(1993-7#3)(1993-9#3)(1994-11#1)(1994-3#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-5#3)(1997-7#1)(2005-10#1)(2005-3#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-11#3)(2008-4#2)(2008-5#2)(2009-2#2)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#5)(2013-1#4)(2013-8#2)
the elevation angle##2##3##(2008-3#2)
the elevation in##2##3##(1990-4#1)(2004-11#1)
the elevation of [Ca2+]i##2##4##(1990-8#1)(2011-3#1)
the elevation of blood##2##4##(2009-7#1)(2010-11#1)
the elevation of intracellular##2##4##(1991-2#1)(2010-2#1)
the elevation of the##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
the elevation of##26##3##(1990-7#1)(1990-8#1)(1991-2#1)(1993-12#1)(1995-10#1)(1995-12#1)(1995-6#1)(1995-7#1)(1996-4#1)(1997-2#2)(2006-11#1)(2006-4#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-1#1)(2009-7#1)(2010-11#1)(2010-2#1)(2011-2#1)(2011-3#1)(2013-1#1)
the elevation##31##2##(1990-4#1)(1990-7#1)(1990-8#1)(1991-2#1)(1993-12#1)(1995-10#1)(1995-12#1)(1995-6#1)(1995-7#1)(1996-4#1)(1997-2#2)(2004-11#1)(2006-11#1)(2006-4#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-8#1)(2009-1#1)(2009-7#1)(2010-11#1)(2010-2#1)(2011-2#1)(2011-3#1)(2013-1#1)
the elevations in##2##3##(1990-12#1)(2004-11#1)
the elevations##4##2##(1990-12#1)(2004-11#1)(2008-10#1)(2013-8#1)
the eleven##7##2##(1990-11#1)(1992-11#1)(1992-3#1)(1994-6#1)(1996-2#1)(2006-12#1)(2008-10#1)
the elicitation of dilemmas##2##4##(2008-8#2)
the elicitation of##8##3##(1994-2#1)(1994-6#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-8#2)
the elicitation phase##4##3##(2005-11#3)(2008-10#1)
the elicitation##13##2##(1994-2#1)(1994-6#1)(1997-2#1)(1997-8#1)(2005-11#3)(2008-10#3)(2008-4#1)(2008-8#2)
the elicited##3##2##(1990-9#1)(1993-2#1)(2008-10#1)
the elicitin family##2##3##(2008-10#2)
the elicitor##2##2##(1997-4#1)(2008-10#1)
the eligibility##2##2##(1997-2#1)(2013-1#1)
the elimination half-life##2##3##(2005-7#1)(2007-2#1)
the elimination of a##2##4##(1990-11#1)(2009-7#1)
the elimination of other##2##4##(2005-7#1)(2011-2#1)
the elimination of the##12##4##(1991-3#1)(1993-11#1)(1994-3#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2012-12#1)(2013-1#2)
the elimination of##59##3##(1990-11#2)(1991-12#1)(1991-3#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-4#1)(1995-6#1)(1996-3#1)(1997-3#1)(2005-11#1)(2005-7#1)(2006-12#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#1)(2008-5#2)(2008-6#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#4)(2013-1#4)
the elimination rate constant##2##4##(2004-12#1)(2012-12#1)
the elimination##69##2##(1990-11#3)(1991-12#1)(1991-3#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-4#1)(1995-6#1)(1996-3#1)(1997-3#1)(2004-11#1)(2004-12#1)(2005-11#1)(2005-7#2)(2006-12#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#1)(2008-5#2)(2008-6#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#2)(2012-12#6)(2013-1#5)
the elite level##4##3##(2007-11#3)(2013-8#1)
the elite##9##2##(2006-12#2)(2007-11#4)(2008-8#1)(2011-2#1)(2013-8#1)
the ellipsoids##2##2##(1997-3#1)(2008-3#1)
the ellipsometer##2##2##(2008-3#2)
the ellipsometric parameter##3##3##(2008-2#2)(2008-3#1)
the ellipsometric parameters##3##3##(2008-2#2)(2008-3#1)
the ellipsometric##12##2##(2007-12#1)(2008-2#6)(2008-3#5)
the ellipsometry##3##2##(2005-11#1)(2008-2#1)(2008-3#1)
the elliptic##3##2##(2007-11#1)(2008-2#1)(2008-5#1)
the elliptical##6##2##(2006-4#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)
the ellipticity##8##2##(1994-3#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)
the elongate##4##2##(2007-12#2)(2008-6#1)(2008-8#1)
the elongated##8##2##(1994-5#1)(1994-8#2)(1995-2#1)(1997-6#1)(2007-12#1)(2009-8#1)(2011-2#1)
the elongating##4##2##(1994-9#1)(2008-10#1)(2011-2#1)(2012-2#1)
the elongation factor 1 alpha##4##5##(1994-12#4)
the elongation factor 1##5##4##(1990-5#1)(1994-12#4)
the elongation factor##7##3##(1990-5#1)(1991-12#1)(1994-12#4)(1995-5#1)
the elongation of the##4##4##(1992-7#1)(2007-11#1)(2011-2#1)(2012-2#1)
the elongation of##9##3##(1992-7#2)(1993-12#1)(1995-5#1)(2007-10#1)(2007-11#1)(2011-2#1)(2012-2#2)
the elongation##24##2##(1990-5#1)(1991-1#1)(1991-12#1)(1992-7#2)(1993-12#1)(1994-12#4)(1995-5#2)(1995-6#1)(1997-5#2)(2007-10#1)(2007-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#2)
the eloquence of##2##3##(2006-2#1)(2007-5#1)
the eluant##3##2##(2008-10#3)
the eluate from##3##3##(1991-10#1)(1991-5#1)(1993-6#1)
the eluate was evaporated##2##4##(2008-10#2)
the eluate was##5##3##(1990-8#1)(2008-10#4)
the eluate##15##2##(1990-8#2)(1991-10#1)(1991-5#1)(1992-9#1)(1993-6#1)(1994-12#1)(2008-10#7)(2010-2#1)
the eluates##3##2##(1992-1#1)(2008-10#2)
the elucidation of its##3##4##(1990-7#1)(1995-11#1)(2009-11#1)
the elucidation of the mechanism##2##5##(1997-4#1)(2013-8#1)
the elucidation of the role##2##5##(1990-11#1)(2007-11#1)
the elucidation of the##13##4##(1990-11#1)(1992-4#1)(1994-10#1)(1996-11#1)(1997-4#1)(2005-7#1)(2007-11#1)(2007-8#1)(2008-8#1)(2009-12#1)(2010-1#1)(2011-2#1)(2013-8#1)
the elucidation of##28##3##(1990-11#1)(1990-7#1)(1992-4#1)(1994-10#1)(1995-11#1)(1996-11#1)(1996-12#1)(1996-4#1)(1997-4#1)(1997-8#1)(2005-7#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-1#1)(2011-2#2)(2012-1#1)(2013-8#1)
the eluent##23##2##(1990-9#1)(1993-2#1)(1995-6#1)(1996-11#1)(1996-6#2)(2005-12#1)(2008-10#15)(2008-7#1)
the eluents##2##2##(2005-12#1)(2010-3#1)
the elusive##5##2##(1991-12#1)(1997-2#1)(2008-10#1)(2008-7#1)(2012-12#1)
the eluted##5##2##(1995-2#1)(1996-2#1)(2008-10#3)
the eluting##5##2##(1990-12#1)(2008-10#3)(2008-2#1)
the elution and##2##3##(2008-10#1)(2008-2#1)
the elution conditions##2##3##(1991-11#2)
the elution of the##2##4##(1990-8#1)(2008-7#1)
the elution of##11##3##(1990-12#1)(1990-8#1)(1991-12#1)(2008-10#5)(2008-4#2)(2008-7#1)
the elution order of##2##4##(2008-10#2)
the elution order##3##3##(1992-1#1)(2008-10#2)
the elution profiles##2##3##(1990-12#1)(2011-1#1)
the elution volume##2##3##(1990-7#1)(2012-12#1)
the elution##39##2##(1990-12#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#1)(1992-1#1)(1992-6#2)(1996-5#1)(1996-8#1)(2008-10#14)(2008-2#1)(2008-4#2)(2008-7#1)(2011-1#1)(2012-12#4)
the embargo##3##2##(1996-11#3)
the embedded##7##2##(1994-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2009-8#1)
the embodied##2##2##(2008-11#1)(2012-11#1)
the embodiment of##2##3##(1996-6#1)(2012-3#1)
the emboli rate##2##3##(2007-9#2)
the emboli##4##2##(2007-10#1)(2007-9#2)(2009-8#1)
the embolic source##2##3##(2007-10#1)(2011-2#1)
the embolization of##2##3##(2006-6#1)(2007-8#1)
the embolization##9##2##(1991-2#1)(2006-6#1)(2007-3#1)(2007-8#2)(2008-7#3)(2012-12#1)
the embryo and##7##3##(1995-8#1)(2005-11#1)(2006-12#1)(2006-7#1)(2007-12#1)(2008-11#2)
the embryo from##2##3##(1995-8#1)(2008-10#1)
the embryo has##4##3##(1995-8#1)(2008-11#1)(2008-4#1)(2012-11#1)
the embryo implantation##2##3##(2008-9#1)(2013-1#1)
the embryo is##5##3##(1997-4#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-11#1)
the embryo sac during##3##4##(2007-4#1)(2008-11#2)
the embryo sac##7##3##(2007-4#1)(2008-11#2)(2008-4#1)(2009-8#3)
the embryo to##4##3##(1995-3#1)(2006-8#1)(2007-12#1)(2008-11#1)
the embryo##88##2##(1990-11#1)(1991-5#1)(1992-12#1)(1993-12#1)(1994-12#1)(1994-9#2)(1995-3#1)(1995-8#3)(1996-10#1)(1996-8#2)(1997-4#2)(2005-11#1)(2006-11#2)(2006-12#3)(2006-7#2)(2006-8#1)(2007-10#4)(2007-12#11)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#6)(2008-11#11)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#4)(2010-7#1)(2011-1#1)(2012-1#1)(2012-11#6)(2012-12#2)(2013-1#2)
the embryo's##2##2##(2008-11#1)(2013-1#1)
the embryo-larval stages of##2##4##(1996-2#2)
the embryo-larval stages##3##3##(1996-2#3)
the embryology##3##2##(1993-5#1)(2008-11#1)(2008-12#1)
the embryonal carcinoma##2##3##(1990-8#1)(1996-5#1)
the embryonal##8##2##(1990-8#1)(1993-6#1)(1994-11#1)(1994-3#1)(1996-5#1)(2008-11#1)(2009-8#1)(2010-12#1)
the embryonic and adult##2##4##(2008-1#1)(2008-10#1)
the embryonic and##5##3##(1995-11#1)(2008-1#1)(2008-10#1)(2012-12#2)
the embryonic brain of the grasshopper Schistocerca gregaria##2##8##(2007-12#2)
the embryonic brain##10##3##(1992-11#1)(1996-6#1)(1997-6#1)(2007-12#6)(2007-3#1)
the embryonic chick##3##3##(1994-8#1)(1995-11#2)
the embryonic development of##4##4##(1992-11#1)(2008-5#1)(2008-6#1)(2010-5#1)
the embryonic development##9##3##(1992-11#1)(1992-6#1)(2007-3#1)(2008-5#1)(2008-6#1)(2010-5#1)(2012-12#2)(2012-2#1)
the embryonic rat##2##3##(1990-8#1)(2008-11#1)
the embryonic stage##3##3##(1990-5#1)(2008-5#1)(2008-8#1)
the embryonic tissues##2##3##(1997-4#1)(2008-5#1)
the embryonic zebrafish model##2##4##(2008-8#2)
the embryonic##69##2##(1990-5#2)(1990-8#1)(1991-5#1)(1992-11#2)(1992-6#1)(1993-6#1)(1994-8#2)(1995-1#1)(1995-11#3)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#2)(1996-9#2)(1997-2#1)(1997-4#1)(1997-6#2)(2006-9#2)(2007-12#9)(2007-3#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-5#3)(2008-6#1)(2008-8#4)(2008-9#2)(2010-12#1)(2010-5#1)(2012-11#1)(2012-12#8)(2012-2#1)
the embryos and##2##3##(1993-2#1)(2008-8#1)
the embryos at##2##3##(1991-2#1)(2006-5#1)
the embryos were##2##3##(1996-5#1)(2006-5#1)
the embryos##23##2##(1990-6#2)(1991-12#1)(1991-2#1)(1993-2#1)(1994-2#1)(1994-3#1)(1996-5#1)(2006-5#4)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2010-7#4)(2010-8#1)
the emergence and##11##3##(1991-11#1)(1992-3#1)(1995-8#1)(2005-8#1)(2008-1#1)(2008-10#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
the emergence of a new##7##5##(1994-1#1)(1994-12#1)(2006-10#1)(2007-12#1)(2008-10#1)(2010-5#1)(2013-1#1)
the emergence of a##20##4##(1990-12#1)(1994-1#1)(1994-12#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-5#1)(2013-1#1)
the emergence of an##3##4##(2008-1#1)(2008-4#1)(2011-2#1)
the emergence of antibiotic resistance##2##5##(2005-8#1)(2006-10#1)
the emergence of comorbid psychiatric diagnoses##2##6##(2006-4#2)
the emergence of drug##2##4##(2007-7#1)(2008-11#1)
the emergence of drug-resistant##5##4##(1991-4#1)(2006-11#1)(2008-5#1)(2011-3#1)(2013-1#1)
the emergence of modern surgery##2##5##(2009-2#2)
the emergence of modern##4##4##(1996-4#1)(2009-2#3)
the emergence of new technologies##2##5##(2008-10#1)(2012-3#1)
the emergence of new##9##4##(1995-12#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-3#1)(2013-8#1)
the emergence of novel##2##4##(2009-6#1)(2011-9#1)
the emergence of resistance to the##3##6##(2005-9#1)(2006-10#1)(2007-11#1)
the emergence of resistant##3##4##(2005-11#1)(2010-11#1)(2013-1#1)
the emergence of the##6##4##(2006-5#1)(2007-12#1)(2007-7#1)(2008-6#1)(2013-8#2)
the emergence of women's health centers has been a nationally growing trend##2##12##(1994-3#2)
the emergence of##148##3##(1990-12#1)(1991-3#1)(1991-4#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-12#1)(1995-2#1)(1996-4#1)(1997-1#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#8)(2006-11#2)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#4)(2009-3#1)(2009-5#4)(2009-6#2)(2009-9#2)(2010-1#1)(2010-11#1)(2010-3#1)(2010-5#4)(2011-1#2)(2011-12#1)(2011-2#3)(2011-3#1)(2011-9#1)(2012-1#2)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#4)
the emergence or##3##3##(2006-10#1)(2010-4#1)(2011-1#1)
the emergence##168##2##(1990-12#1)(1991-11#1)(1991-3#1)(1991-4#1)(1992-3#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-4#1)(1997-1#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#10)(2006-11#2)(2006-2#1)(2006-3#2)(2006-4#2)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#8)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#4)(2009-3#1)(2009-5#4)(2009-6#2)(2009-9#2)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#4)(2011-1#3)(2011-12#1)(2011-2#5)(2011-3#1)(2011-9#1)(2012-1#3)(2012-12#6)(2012-2#5)(2012-3#3)(2013-1#7)(2013-7#3)(2013-8#4)
the emergency care##4##3##(1991-5#2)(1994-4#1)(2009-4#1)
the emergency contraceptive pill##2##4##(2011-1#2)
the emergency department (ED)##11##4##(2007-5#1)(2007-7#3)(2008-3#2)(2009-6#2)(2010-2#1)(2010-8#1)(2012-2#1)
the emergency department after##2##4##(2007-4#1)(2010-11#1)
the emergency department and##2##4##(2008-3#1)(2013-1#1)
the emergency department of##4##4##(2007-7#1)(2008-10#1)(2013-1#2)
the emergency department with a##4##5##(2007-10#1)(2007-7#1)(2013-1#2)
the emergency department with cardiac magnetic resonance imaging##2##8##(2008-3#2)
the emergency department with cardiac magnetic resonance##3##7##(2008-3#3)
the emergency department with##24##4##(2006-4#2)(2007-10#1)(2007-3#1)(2007-5#2)(2007-7#1)(2008-3#8)(2009-6#1)(2009-9#2)(2010-7#1)(2011-2#2)(2013-1#3)
the emergency department##143##3##(1991-12#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-4#2)(2006-5#2)(2006-8#1)(2007-10#4)(2007-2#1)(2007-3#5)(2007-4#3)(2007-5#8)(2007-7#21)(2008-10#2)(2008-11#3)(2008-3#25)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#3)(2009-6#4)(2009-7#1)(2009-8#1)(2009-9#5)(2010-1#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#6)(2011-12#1)(2011-2#5)(2012-2#7)(2012-3#2)(2013-1#12)(2013-7#1)
the emergency medical services##2##4##(2006-10#2)
the emergency medical##4##3##(2006-10#3)(2007-9#1)
the emergency physician##4##3##(1994-3#2)(2007-3#1)(2007-5#1)
the emergency room at##2##4##(2006-8#1)(2007-12#1)
the emergency room for##4##4##(1995-11#1)(2007-8#1)(2011-2#1)(2013-1#1)
the emergency room of##2##4##(2007-3#2)
the emergency room with##7##4##(2007-9#1)(2008-3#1)(2009-3#2)(2010-12#1)(2010-5#1)(2013-1#1)
the emergency room##35##3##(1990-3#2)(1992-1#1)(1993-8#2)(1994-2#1)(1995-11#1)(1996-6#1)(2005-10#1)(2006-8#1)(2007-10#1)(2007-12#5)(2007-3#2)(2007-8#2)(2007-9#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#2)(2010-12#2)(2010-2#2)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
the emergency service of a##2##5##(1994-5#1)(1996-9#1)
the emergency service##5##3##(1991-11#1)(1994-5#1)(1996-9#1)(2007-8#1)(2011-2#1)
the emergency services##2##3##(1993-12#1)(2011-1#1)
the emergency team##2##3##(1995-9#1)(2008-10#1)
the emergency ward##3##3##(1991-2#1)(1992-6#2)
the emergency##237##2##(1990-3#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-1#2)(1992-3#1)(1992-6#2)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#1)(1995-11#1)(1995-9#3)(1996-2#1)(1996-6#1)(1996-9#1)(2005-10#2)(2005-8#1)(2006-10#8)(2006-4#2)(2006-5#4)(2006-8#2)(2007-10#5)(2007-12#5)(2007-2#2)(2007-3#9)(2007-4#4)(2007-5#12)(2007-7#22)(2007-8#3)(2007-9#2)(2008-10#4)(2008-11#4)(2008-3#27)(2008-4#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-3#2)(2009-4#4)(2009-6#4)(2009-7#2)(2009-8#2)(2009-9#5)(2010-1#2)(2010-11#2)(2010-12#4)(2010-2#3)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#9)(2011-12#2)(2011-2#7)(2012-2#10)(2012-3#2)(2013-1#18)(2013-7#1)
the emergent##12##2##(1991-3#2)(2007-9#1)(2008-10#1)(2008-2#2)(2010-1#2)(2011-2#1)(2012-12#2)(2013-8#1)
the emerging and##2##3##(2008-3#1)(2011-1#1)
the emerging concept##2##3##(2008-7#1)(2010-1#1)
the emerging field of##6##4##(2006-2#1)(2008-4#1)(2008-8#1)(2009-5#1)(2009-7#1)(2013-8#1)
the emerging field##7##3##(2006-2#1)(2008-4#1)(2008-8#1)(2009-5#1)(2009-7#1)(2012-2#1)(2013-8#1)
the emerging health##2##3##(1995-12#1)(1997-3#1)
the emerging role of the##2##5##(1992-2#1)(2004-11#1)
the emerging role of##4##4##(1992-2#1)(2004-11#1)(2006-10#1)(2008-4#1)
the emerging story of##2##4##(2007-10#1)(2008-4#1)
the emerging trends in##3##4##(1997-2#1)(2007-8#1)(2008-12#1)
the emerging##69##2##(1991-2#1)(1992-2#1)(1995-12#1)(1995-6#1)(1996-3#2)(1997-2#1)(1997-3#1)(1997-5#1)(2004-11#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#4)(2008-7#4)(2008-8#1)(2008-9#3)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#2)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#2)(2013-7#1)(2013-8#1)
the emetic##2##2##(1993-11#1)(2011-2#1)
the emission from##4##3##(1993-8#1)(2008-1#1)(2008-2#1)(2008-3#1)
the emission intensity for##2##4##(2005-4#1)(2008-10#1)
the emission intensity of##3##4##(1992-6#1)(1995-2#1)(2008-10#1)
the emission intensity##5##3##(1992-6#1)(1995-2#1)(2005-4#1)(2008-10#2)
the emission is##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
the emission maxima##3##3##(1991-4#1)(2007-8#1)(2008-10#1)
the emission maximum of##2##4##(1991-7#1)(2006-12#1)
the emission maximum##3##3##(1990-5#1)(1991-7#1)(2006-12#1)
the emission of a##3##4##(2007-11#1)(2008-1#1)(2008-10#1)
the emission of the##4##4##(1996-8#1)(2007-12#1)(2008-10#2)
the emission of##27##3##(1990-3#1)(1990-5#1)(1995-5#1)(1996-2#1)(1996-8#1)(2005-4#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2012-2#2)
the emission properties of##2##4##(2008-2#1)(2010-2#1)
the emission spectra of the##3##5##(1994-8#1)(2007-12#1)(2008-10#1)
the emission spectra of##6##4##(1990-5#1)(1994-8#1)(2007-12#1)(2008-10#1)(2009-8#1)(2013-8#1)
the emission spectra##10##3##(1990-5#1)(1994-8#1)(2007-12#2)(2008-10#4)(2009-8#1)(2013-8#1)
the emission spectrum of##4##4##(2008-10#1)(2008-3#2)(2013-8#1)
the emission spectrum##15##3##(1991-8#1)(1996-12#1)(1997-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#2)(2013-8#1)
the emission wavelength is##2##4##(2008-10#1)(2008-2#1)
the emission wavelength##8##3##(1997-1#1)(2005-12#1)(2008-10#5)(2008-2#1)
the emission##108##2##(1990-3#1)(1990-5#3)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-6#1)(1993-4#1)(1993-8#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-1#3)(2005-11#1)(2005-12#1)(2005-4#2)(2006-10#2)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#5)(2007-12#8)(2007-8#1)(2008-1#5)(2008-10#34)(2008-11#2)(2008-2#8)(2008-3#7)(2008-7#2)(2009-8#1)(2010-2#1)(2010-7#1)(2012-2#2)(2013-8#2)
the emissions##5##2##(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2010-9#1)
the emissivities of vegetation##2##4##(2013-8#2)
the emissivities##3##2##(2013-8#3)
the emissivity is##2##3##(2008-3#2)
the emissivity of the##2##4##(2007-12#1)(2008-3#1)
the emissivity of##3##3##(2007-12#2)(2008-3#1)
the emissivity##8##2##(2007-12#2)(2008-2#1)(2008-3#5)
the emittance##2##2##(2006-5#1)(2008-2#1)
the emitted and##2##3##(2008-3#2)
the emitted light##2##3##(2008-10#1)(2012-12#1)
the emitted##16##2##(2004-12#1)(2006-5#1)(2007-11#2)(2008-10#4)(2008-2#3)(2008-3#4)(2012-12#1)
the emitter##3##2##(2007-12#1)(2008-3#1)(2010-8#1)
the emitting tryptophan##2##3##(1994-9#1)(1995-1#1)
the emitting##6##2##(1994-9#1)(1995-1#1)(1995-6#1)(2007-11#1)(2008-2#1)(2012-2#1)
the emollient##2##2##(2008-5#2)
the emotion##2##2##(2007-8#1)(2012-12#1)
the emotional climate##3##3##(1990-11#1)(1997-5#1)(2007-1#1)
the emotional content##2##3##(2006-3#1)(2012-12#1)
the emotional distress##2##3##(1991-12#1)(1995-9#1)
the emotional reactions of##2##4##(1993-11#1)(2008-2#1)
the emotional##30##2##(1990-11#1)(1990-8#1)(1991-12#1)(1992-3#1)(1993-11#1)(1994-2#1)(1995-9#1)(1997-1#1)(1997-4#1)(1997-5#1)(2006-3#1)(2006-4#1)(2007-1#1)(2007-12#2)(2007-7#1)(2008-11#2)(2008-2#1)(2008-4#1)(2009-4#2)(2010-8#1)(2011-1#2)(2012-12#3)(2013-1#2)
the emotionality of##2##3##(1993-3#1)(2010-10#1)
the emotionality##3##2##(1993-3#1)(2010-10#2)
the emotionally and##2##3##(2006-2#1)(2013-1#1)
the emotionally##4##2##(1997-1#1)(2006-2#1)(2013-1#1)(2013-7#1)
the emotions in##2##3##(2009-10#1)(2013-8#1)
the emotions of##2##3##(2006-12#1)(2012-2#1)
the emotions##9##2##(2006-12#1)(2008-11#1)(2009-10#1)(2010-1#1)(2012-12#2)(2012-2#1)(2013-8#2)
the emphasis has been on##3##5##(1996-6#1)(2006-10#1)(2010-8#1)
the emphasis is on##3##4##(1992-9#1)(2007-5#1)(2012-2#1)
the emphasis is##5##3##(1992-9#1)(1997-8#1)(2007-5#1)(2010-5#1)(2012-2#1)
the emphasis of##3##3##(2008-12#1)(2008-3#1)(2013-7#1)
the emphasis on##5##3##(1990-12#1)(1991-11#1)(2005-7#1)(2007-2#1)(2008-1#1)
the emphasis placed##2##3##(1996-7#1)(2010-9#1)
the emphasis was##2##3##(2005-8#1)(2008-5#1)
the emphasis##25##2##(1990-12#1)(1991-11#1)(1992-9#1)(1996-6#1)(1996-7#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#2)(2008-5#1)(2010-5#1)(2010-8#1)(2010-9#1)(2012-2#1)(2013-7#1)
the empirical and##2##3##(1993-9#1)(2008-6#1)
the empirical data##4##3##(2007-4#1)(2008-2#2)(2010-3#1)
the empirical evidence for##3##4##(2008-10#1)(2010-4#1)(2013-7#1)
the empirical evidence##6##3##(2008-10#1)(2008-2#1)(2010-12#1)(2010-4#1)(2010-9#1)(2013-7#1)
the empirical literature on the##2##5##(2007-12#1)(2013-1#1)
the empirical literature on##3##4##(2007-12#1)(2008-10#1)(2013-1#1)
the empirical literature##5##3##(2006-9#1)(2007-12#2)(2008-10#1)(2013-1#1)
the empirical relationship between##2##4##(2007-10#1)(2008-10#1)
the empirical relationship##4##3##(2007-10#1)(2007-4#1)(2007-5#1)(2008-10#1)
the empirical results##2##3##(2008-8#1)(2013-1#1)
the empirical studies on##2##4##(2006-5#2)
the empirical studies##3##3##(1995-11#1)(2006-5#2)
the empirical therapy of##2##4##(2006-8#1)(2010-11#1)
the empirical therapy##3##3##(2006-8#1)(2008-5#1)(2010-11#1)
the empirical##63##2##(1992-3#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-9#2)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-2#1)(2006-10#1)(2006-5#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-4#2)(2007-5#1)(2008-10#5)(2008-12#1)(2008-2#5)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
the empirically determined##2##3##(1991-8#1)(1994-8#1)
the empirically observed##2##3##(2008-2#1)(2008-8#1)
the empirically##6##2##(1991-8#1)(1994-8#1)(2008-2#1)(2008-8#1)(2008-9#1)(2013-1#1)
the employed##9##2##(1994-3#1)(1995-6#1)(1995-8#1)(2006-10#1)(2008-2#1)(2009-11#1)(2009-4#2)(2010-2#1)
the employee and##2##3##(1991-2#1)(1996-12#1)
the employee##7##2##(1991-2#1)(1994-2#1)(1995-6#1)(1996-12#2)(1996-5#1)(2011-1#1)
the employee's##2##2##(1996-5#1)(1996-6#1)
the employees at the##2##4##(1991-4#1)(2007-4#1)
the employees at##3##3##(1991-4#1)(1994-4#1)(2007-4#1)
the employees##14##2##(1991-4#1)(1992-5#1)(1994-4#2)(1996-3#1)(1996-9#1)(2007-4#1)(2007-7#1)(2008-12#1)(2010-4#1)(2011-1#1)(2011-2#3)
the employer##6##2##(1991-8#1)(1994-12#1)(1994-6#1)(1995-6#1)(1996-11#1)(1997-2#1)
the employer's##7##2##(1994-12#1)(1994-2#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-2#1)(2008-6#1)
the employment and##2##3##(1992-3#1)(1997-8#1)
the employment of an##2##4##(2007-11#1)(2008-3#1)
the employment of##17##3##(1995-5#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-3#1)(2010-2#2)(2011-2#2)(2013-1#1)
the employment##23##2##(1991-6#1)(1992-3#2)(1994-1#1)(1995-5#1)(1997-8#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-3#1)(2009-3#1)(2010-2#2)(2011-2#2)(2013-1#1)
the empowerment of##2##3##(1995-9#1)(2007-2#1)
the empty capsid##2##3##(1990-5#1)(1992-8#1)
the empty##6##2##(1990-5#1)(1990-7#1)(1991-4#1)(1992-8#1)(2006-12#1)(2010-12#1)
the emptying##2##2##(1997-4#2)
the empyema##2##2##(2007-12#1)(2011-2#1)
the emulsifying##3##2##(2005-11#1)(2008-10#1)(2008-5#1)
the emulsion formulations##3##3##(2008-5#3)
the emulsion solvent##2##3##(2011-2#2)
the emulsion was##2##3##(1994-12#1)(1997-8#1)
the emulsion##24##2##(1991-2#1)(1994-12#1)(1997-8#1)(2005-11#4)(2008-10#4)(2008-11#1)(2008-5#9)(2009-11#1)(2011-2#2)
the emulsions##10##2##(1991-2#1)(2005-11#1)(2008-10#1)(2008-5#6)(2008-8#1)
the enactment of##2##3##(2011-1#1)(2012-12#1)
the enamel and dentin##2##4##(2008-7#1)(2013-8#1)
the enamel and##5##3##(2006-8#2)(2008-7#1)(2009-9#1)(2013-8#1)
the enamel##12##2##(1993-11#1)(2006-8#2)(2008-7#3)(2009-9#1)(2012-2#1)(2013-1#3)(2013-8#1)
the enantiomer##6##2##(1991-3#1)(1994-9#1)(1996-5#1)(2008-10#1)(2008-6#1)(2013-1#1)
the enantiomeric composition of##4##4##(1992-1#1)(2008-10#3)
the enantiomeric composition##6##3##(1991-12#1)(1992-1#1)(2008-10#4)
the enantiomeric ratios of the##2##5##(1993-2#2)
the enantiomeric separation##2##3##(2008-10#2)
the enantiomeric##16##2##(1991-12#1)(1992-1#1)(1992-2#1)(1993-2#2)(1995-6#1)(1997-7#1)(2006-12#1)(2008-10#7)(2009-12#1)
the enantiomers of##13##3##(1990-6#1)(1992-1#1)(1992-2#1)(1993-2#1)(1997-2#1)(1997-3#2)(2008-10#4)(2008-11#1)(2008-8#1)
the enantiomers##21##2##(1990-6#1)(1992-1#1)(1992-2#1)(1993-2#1)(1995-2#1)(1996-8#1)(1997-2#2)(1997-3#2)(2008-10#9)(2008-11#1)(2008-8#1)
the enantiopurity of##4##3##(2008-10#4)
the enantioselective##11##2##(1990-6#1)(2007-10#1)(2007-11#1)(2008-10#5)(2009-10#1)(2009-7#1)(2010-2#1)
the enantioselectivity of the##2##4##(1992-5#1)(1994-9#1)
the enantioselectivity##6##2##(1992-5#1)(1994-9#2)(1996-5#1)(2008-10#1)(2009-3#1)
the enantioseparation of##3##3##(2008-10#1)(2010-4#1)(2013-1#1)
the enantioseparation##5##2##(2008-10#3)(2010-4#1)(2013-1#1)
the encapsulation of##6##3##(2008-10#2)(2008-7#1)(2010-4#2)(2010-6#1)
the encapsulation##10##2##(1990-11#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-1#1)(2010-4#2)(2010-6#1)
the encephalitogenicity of##2##3##(2013-1#2)
the encephalogram##2##2##(1991-11#1)(2006-11#1)
the enchytraeid-biotest##2##2##(2008-11#2)
the enclosed##2##2##(2006-5#1)(2008-2#1)
the enclosure##6##2##(1996-12#1)(2007-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2013-8#1)
the encoded enzyme##3##3##(1990-4#1)(1991-3#1)(1992-5#1)
the encoded protein##5##3##(1990-12#1)(1991-8#1)(1996-10#1)(2006-11#1)(2008-9#1)
the encoded proteins##4##3##(1992-6#1)(1994-12#1)(2008-7#1)(2009-8#1)
the encoded##21##2##(1990-12#1)(1990-4#1)(1991-3#1)(1991-8#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-2#1)(1994-12#1)(1995-2#1)(1995-8#1)(1996-10#1)(1997-7#1)(2006-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-8#1)(2012-12#1)
the encoder##3##2##(2008-2#2)(2008-3#1)
the encoding genes##2##3##(2007-7#1)(2012-3#1)
the encoding of##3##3##(1991-6#1)(2008-11#1)(2013-8#1)
the encoding process##2##3##(2008-2#1)(2008-3#1)
the encoding task##2##3##(2013-1#2)
the encoding##18##2##(1990-5#1)(1991-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#6)(2009-3#1)(2012-3#1)(2013-1#2)(2013-8#1)
the encompassing##2##2##(1993-12#1)(2010-8#1)
the encounter of##3##3##(1994-9#1)(2008-3#1)(2009-4#1)
the encounter##8##2##(1994-4#1)(1994-9#1)(2008-3#1)(2009-2#1)(2009-4#2)(2010-8#1)(2011-1#1)
the encouragement##3##2##(2006-9#1)(2011-2#1)(2013-8#1)
the encouraging##2##2##(2004-1#1)(2008-7#1)
the encrypted image##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
the encrypted##7##2##(2006-10#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
the encryption and##2##3##(2007-12#1)(2008-3#1)
the encryption##5##2##(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#2)
the encyclopedic##2##2##(2008-1#1)(2008-9#1)
the encystment##2##2##(2008-10#2)
the end and##2##3##(1996-6#1)(2008-2#1)
the end effect##2##3##(2008-3#2)
the end goal##2##3##(2008-3#1)(2012-3#1)
the end in##3##3##(1990-3#1)(2005-9#1)(2008-4#1)
the end of 1 week##2##5##(2007-8#1)(2008-7#1)
the end of 1 year##5##5##(1995-2#2)(2006-8#1)(2007-7#1)(2008-8#1)
the end of 1##7##4##(1995-2#2)(2006-8#1)(2007-7#1)(2007-8#1)(2008-7#1)(2008-8#1)
the end of 1993##2##4##(1996-6#1)(2008-2#1)
the end of 1994##4##4##(1996-3#1)(1997-6#2)(2006-5#1)
the end of 1996##2##4##(2006-10#1)(2008-5#1)
the end of 1998##5##4##(2007-11#1)(2007-12#1)(2008-1#1)(2008-5#2)
the end of 1999##3##4##(2006-10#3)
the end of 2003##5##4##(2005-5#1)(2007-4#2)(2007-7#1)(2010-4#1)
the end of 2006##2##4##(2008-10#1)(2011-2#1)
the end of 2008##5##4##(2011-1#2)(2011-12#1)(2012-11#1)(2012-3#1)
the end of 24##3##4##(2007-7#2)(2013-1#1)
the end of 6##2##4##(2007-8#1)(2010-7#1)
the end of 8##2##4##(2007-10#1)(2007-7#1)
the end of August##3##4##(2008-10#1)(2008-2#1)(2008-5#1)
the end of January##2##4##(2008-5#1)(2008-7#1)
the end of June##2##4##(2005-7#1)(2008-10#1)
the end of October##2##4##(2007-5#1)(2011-2#1)
the end of September##2##4##(1997-2#1)(2008-4#1)
the end of World War II##3##6##(2007-8#1)(2008-12#1)(2011-2#1)
the end of a##20##4##(1994-2#1)(1994-6#1)(1994-9#1)(1996-6#1)(1997-1#1)(2006-5#1)(2007-8#2)(2008-10#7)(2008-2#1)(2008-3#2)(2008-8#1)(2013-1#1)
the end of an##3##4##(2007-12#2)(2008-3#1)
the end of each##21##4##(1994-12#1)(1994-3#1)(1995-2#1)(1997-4#3)(1997-6#1)(2005-10#1)(2005-11#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-3#3)(2008-6#1)(2008-9#1)(2009-9#1)(2011-1#1)(2013-1#1)
the end of experimental##2##4##(2008-12#1)(2008-8#1)
the end of exposure##2##4##(1994-6#1)(1995-3#1)
the end of follow up##2##5##(2013-1#2)
the end of follow-up##3##4##(2007-7#1)(2008-10#1)(2008-12#1)
the end of induction##2##4##(2013-8#2)
the end of its##2##4##(2008-12#1)(2009-7#1)
the end of life##18##4##(2005-7#1)(2006-12#1)(2006-4#2)(2007-12#3)(2008-4#2)(2008-7#1)(2010-2#2)(2010-6#2)(2010-7#1)(2011-2#2)(2013-7#1)
the end of one year##2##5##(2008-6#1)(2011-2#1)
the end of one##3##4##(1995-8#1)(2008-6#1)(2011-2#1)
the end of our##4##4##(1992-5#1)(2008-8#1)(2011-1#1)(2011-2#1)
the end of pregnancy##5##4##(1992-12#1)(2008-12#1)(2009-1#1)(2009-6#1)(2011-2#1)
the end of primary school##2##5##(2006-8#1)(2009-12#1)
the end of six##4##4##(2004-9#1)(2009-6#1)(2010-4#2)
the end of study##2##4##(2011-1#1)(2013-1#1)
the end of surgery##3##4##(1990-2#1)(2007-8#1)(2010-3#1)
the end of that##3##4##(1997-3#1)(2006-8#1)(2008-12#1)
the end of the 1980s##5##5##(1993-2#1)(2009-1#1)(2010-12#1)(2011-2#2)
the end of the 19th century##5##6##(1991-6#1)(2006-9#1)(2008-3#1)(2009-7#2)
the end of the 20th century##2##6##(2007-11#1)(2010-1#1)
the end of the PDT##2##5##(2008-5#2)
the end of the assessment period##2##6##(2008-10#2)
the end of the capillary##2##5##(1994-9#1)(2007-8#1)
the end of the century##7##5##(1990-10#2)(1993-11#1)(1994-5#1)(1994-9#1)(1996-3#1)(1997-6#1)
the end of the common##2##5##(2007-12#1)(2008-11#1)
the end of the convulsive##2##5##(1993-2#2)
the end of the course##5##5##(2008-11#3)(2012-12#1)(2013-8#1)
the end of the decade##4##5##(1990-12#1)(1990-5#1)(1994-2#1)(1994-9#1)
the end of the dry##3##5##(2004-11#1)(2005-8#1)(2007-8#1)
the end of the experiment##21##5##(1992-9#1)(1995-7#1)(1996-6#2)(1997-3#1)(1997-6#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-1#2)(2012-12#1)(2013-1#1)(2013-8#1)
the end of the experimental period##3##6##(2007-1#1)(2008-7#1)(2011-2#1)
the end of the experimental##4##5##(2007-1#1)(2008-7#1)(2011-2#1)(2012-2#1)
the end of the exponential##2##5##(2006-7#1)(2008-11#1)
the end of the first stage of labor##2##8##(1994-6#2)
the end of the first stage##3##6##(1994-6#2)(1997-2#1)
the end of the first year##10##6##(1992-7#1)(1996-12#1)(2005-10#4)(2007-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
the end of the first##18##5##(1992-7#1)(1993-10#1)(1994-6#2)(1995-2#1)(1996-12#1)(1996-3#1)(1997-2#1)(2005-10#4)(2006-12#1)(2007-9#1)(2008-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
the end of the follow-up period##3##6##(2008-3#1)(2008-7#2)
the end of the follow-up##5##5##(1992-6#1)(2008-3#1)(2008-7#2)(2008-8#1)
the end of the fourth year##2##6##(1992-12#2)
the end of the fourth##4##5##(1992-12#2)(1995-6#1)(2012-9#1)
the end of the growing season##4##6##(2004-4#1)(2008-10#3)
the end of the growth period##4##6##(2007-7#1)(2007-8#2)(2008-11#1)
the end of the growth##6##5##(2007-7#1)(2007-8#2)(2008-11#3)
the end of the infusion##2##5##(1990-10#1)(2008-7#1)
the end of the nineteenth century##3##6##(2008-2#1)(2009-7#1)(2012-2#1)
the end of the nineteenth##4##5##(2008-2#1)(2008-7#1)(2009-7#1)(2012-2#1)
the end of the observation period##5##6##(2007-7#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-6#1)
the end of the operation##5##5##(1993-9#1)(2006-12#1)(2006-5#1)(2007-8#1)(2009-10#1)
the end of the procedure##5##5##(1996-12#1)(2006-8#2)(2007-2#1)(2012-2#1)
the end of the rainy season##2##6##(2006-2#1)(2013-7#1)
the end of the season##6##5##(2007-5#1)(2008-10#3)(2008-8#2)
the end of the second week of##2##7##(2006-10#1)(2008-8#1)
the end of the second week##3##6##(1997-2#1)(2006-10#1)(2008-8#1)
the end of the second year##2##6##(1996-11#1)(1996-12#1)
the end of the second##13##5##(1995-1#1)(1996-11#1)(1996-12#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-9#1)(2008-10#2)(2008-8#1)(2009-3#1)(2012-12#1)(2013-1#1)
the end of the signal##2##5##(1991-6#1)(2008-3#1)
the end of the stress##7##5##(1992-1#4)(1993-2#1)(1994-2#1)(2008-11#1)
the end of the study period##3##6##(2006-8#1)(2008-4#1)(2010-3#1)
the end of the study##54##5##(1990-9#2)(1991-7#1)(1995-3#1)(1996-1#2)(1997-4#1)(2005-8#1)(2006-10#1)(2006-5#2)(2006-8#1)(2007-1#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#19)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)
the end of the study) and the##2##7##(1993-7#1)(2006-10#1)
the end of the third year##2##6##(1992-12#2)
the end of the third##3##5##(1991-5#1)(1992-12#2)
the end of the treatment period##5##6##(1990-11#1)(1997-5#1)(2007-7#1)(2008-4#1)(2008-5#1)
the end of the treatment##13##5##(1990-10#1)(1990-11#1)(1990-9#1)(1991-8#1)(1993-1#1)(1997-3#1)(1997-5#1)(2007-7#1)(2008-4#1)(2008-5#1)(2013-1#1)(2013-7#1)(2013-8#1)
the end of the trial##6##5##(1991-3#1)(1994-6#2)(1994-9#1)(1997-2#1)(2008-8#1)
the end of the year##4##5##(2007-2#1)(2008-1#1)(2008-12#1)(2008-5#1)
the end of the##395##4##(1990-10#4)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#6)(1991-12#4)(1991-3#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#5)(1992-12#5)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#5)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#2)(1993-9#2)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#7)(1994-7#1)(1994-9#5)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-1#3)(1996-11#1)(1996-12#4)(1996-3#2)(1996-4#1)(1996-6#2)(1996-8#2)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#2)(2004-11#1)(2004-4#1)(2005-10#5)(2005-11#2)(2005-8#3)(2006-10#6)(2006-12#3)(2006-2#1)(2006-5#4)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#5)(2007-10#2)(2007-11#2)(2007-12#6)(2007-2#3)(2007-3#2)(2007-5#5)(2007-7#6)(2007-8#7)(2007-9#4)(2008-1#4)(2008-10#31)(2008-11#15)(2008-12#4)(2008-2#3)(2008-3#5)(2008-4#7)(2008-5#12)(2008-6#3)(2008-7#14)(2008-8#12)(2008-9#24)(2009-1#1)(2009-10#2)(2009-3#2)(2009-5#1)(2009-7#4)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-12#2)(2011-2#8)(2012-1#3)(2012-12#6)(2012-2#10)(2012-7#1)(2012-9#1)(2013-1#5)(2013-7#3)(2013-8#6)
the end of their lives##3##5##(1996-9#1)(2012-12#1)(2013-1#1)
the end of their##14##4##(1996-9#1)(1997-5#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-9#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the end of therapy##11##4##(1991-10#1)(2006-10#2)(2007-11#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-2#2)(2013-1#1)
the end of this article##2##5##(2007-11#1)(2010-5#1)
the end of this period##2##5##(2006-4#1)(2009-2#1)
the end of this##15##4##(1996-1#1)(1997-8#1)(2006-4#1)(2007-11#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-4#1)(2009-2#1)(2010-5#1)(2011-3#1)(2012-12#1)(2013-8#1)
the end of treatment##29##4##(1991-10#1)(1991-2#1)(1991-5#1)(1993-9#1)(1996-1#1)(1997-3#1)(2005-12#1)(2007-11#2)(2007-12#4)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-8#1)(2012-11#1)(2013-1#5)(2013-8#1)
the end of##756##3##(1990-10#4)(1990-11#1)(1990-12#3)(1990-2#2)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#6)(1991-10#2)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#6)(1992-10#1)(1992-12#6)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#5)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#8)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#2)(1993-9#4)(1994-12#1)(1994-2#4)(1994-3#4)(1994-5#1)(1994-6#9)(1994-7#1)(1994-8#1)(1994-9#7)(1995-1#2)(1995-2#6)(1995-3#2)(1995-6#2)(1995-7#2)(1995-8#1)(1996-1#5)(1996-11#1)(1996-12#6)(1996-3#3)(1996-4#2)(1996-5#2)(1996-6#6)(1996-8#3)(1996-9#2)(1997-1#3)(1997-2#7)(1997-3#5)(1997-4#14)(1997-5#3)(1997-6#6)(1997-7#2)(1997-8#1)(2004-11#1)(2004-4#1)(2004-9#2)(2005-10#6)(2005-11#3)(2005-12#1)(2005-5#1)(2005-6#1)(2005-7#3)(2005-8#5)(2006-10#13)(2006-12#4)(2006-2#2)(2006-4#4)(2006-5#7)(2006-7#1)(2006-8#9)(2006-9#1)(2007-1#7)(2007-10#4)(2007-11#9)(2007-12#17)(2007-2#3)(2007-3#3)(2007-4#3)(2007-5#6)(2007-6#1)(2007-7#15)(2007-8#16)(2007-9#9)(2008-1#8)(2008-10#56)(2008-11#17)(2008-12#14)(2008-2#7)(2008-3#16)(2008-4#14)(2008-5#21)(2008-6#8)(2008-7#20)(2008-8#17)(2008-9#30)(2009-1#2)(2009-10#2)(2009-12#2)(2009-2#4)(2009-3#4)(2009-5#1)(2009-6#3)(2009-7#5)(2009-8#1)(2009-9#4)(2010-1#2)(2010-10#1)(2010-12#1)(2010-2#3)(2010-3#3)(2010-4#6)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#4)(2011-1#11)(2011-12#3)(2011-2#22)(2011-3#2)(2012-1#6)(2012-11#2)(2012-12#8)(2012-2#14)(2012-3#3)(2012-7#1)(2012-9#1)(2013-1#27)(2013-7#5)(2013-8#12)
the end point of##2##4##(2005-9#1)(2006-1#1)
the end point##7##3##(2005-9#1)(2006-1#1)(2008-10#4)(2012-12#1)
the end product of##2##4##(1994-12#1)(2007-11#1)
the end product##6##3##(1994-12#1)(2006-8#1)(2007-11#1)(2008-10#2)(2009-2#1)
the end result##5##3##(1996-3#1)(1997-3#1)(2007-12#1)(2009-3#1)(2013-1#1)
the end stage of##4##4##(2005-9#1)(2006-10#1)(2007-11#1)(2009-10#1)
the end stage##5##3##(1996-2#1)(2005-9#1)(2006-10#1)(2007-11#1)(2009-10#1)
the end user##2##3##(1993-3#1)(2007-10#1)
the end users##3##3##(1992-12#1)(2009-9#1)(2012-12#1)
the end##834##2##(1990-10#4)(1990-11#1)(1990-12#4)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#7)(1991-10#2)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#6)(1992-10#1)(1992-12#7)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#5)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#8)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#2)(1993-9#5)(1994-12#3)(1994-2#4)(1994-3#4)(1994-4#1)(1994-5#1)(1994-6#10)(1994-7#1)(1994-8#1)(1994-9#7)(1995-1#2)(1995-2#6)(1995-3#2)(1995-6#2)(1995-7#2)(1995-8#1)(1996-1#6)(1996-10#1)(1996-11#1)(1996-12#6)(1996-2#1)(1996-3#4)(1996-4#2)(1996-5#2)(1996-6#7)(1996-8#3)(1996-9#2)(1997-1#3)(1997-2#7)(1997-3#6)(1997-4#14)(1997-5#3)(1997-6#7)(1997-7#2)(1997-8#1)(2004-11#1)(2004-4#1)(2004-5#1)(2004-9#2)(2005-10#6)(2005-11#4)(2005-12#1)(2005-4#1)(2005-5#1)(2005-6#1)(2005-7#3)(2005-8#5)(2005-9#3)(2006-1#1)(2006-10#14)(2006-12#4)(2006-2#3)(2006-4#4)(2006-5#7)(2006-7#1)(2006-8#10)(2006-9#1)(2007-1#7)(2007-10#5)(2007-11#13)(2007-12#19)(2007-2#3)(2007-3#3)(2007-4#4)(2007-5#6)(2007-6#1)(2007-7#16)(2007-8#17)(2007-9#10)(2008-1#9)(2008-10#63)(2008-11#18)(2008-12#15)(2008-2#9)(2008-3#23)(2008-4#15)(2008-5#22)(2008-6#8)(2008-7#21)(2008-8#17)(2008-9#30)(2009-1#2)(2009-10#3)(2009-12#2)(2009-2#6)(2009-3#5)(2009-5#2)(2009-6#5)(2009-7#5)(2009-8#1)(2009-9#5)(2010-1#4)(2010-10#1)(2010-12#2)(2010-2#3)(2010-3#3)(2010-4#6)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#4)(2011-1#11)(2011-12#3)(2011-2#22)(2011-3#2)(2012-1#6)(2012-11#2)(2012-12#10)(2012-2#15)(2012-3#4)(2012-7#1)(2012-9#1)(2013-1#30)(2013-7#5)(2013-8#12)
the end-effector##2##2##(2012-1#2)
the end-face##2##2##(2008-2#2)
the end-of-life##2##2##(2004-3#1)(2010-4#1)
the end-point of##2##3##(2008-10#1)(2011-2#1)
the end-point##9##2##(2008-10#8)(2011-2#1)
the end-stage of##2##3##(2006-10#1)(2007-11#1)
the end-stage##5##2##(2006-10#1)(2007-11#1)(2007-7#1)(2010-5#1)(2011-3#1)
the end-tidal carbon dioxide value##2##5##(2006-10#2)
the end-to-end##3##2##(2006-3#1)(2008-2#2)
the end-to-side transfer with a patch##2##6##(2006-3#2)
the endeavor##2##2##(1991-12#1)(2007-4#1)
the endeavours##2##2##(1990-12#1)(2010-12#1)
the endemic areas##3##3##(1992-4#1)(1994-3#1)(1996-11#1)
the endemic diet##5##3##(1994-3#5)
the endemic situation##2##3##(2011-12#1)(2012-3#1)
the endemic##26##2##(1992-4#1)(1994-10#1)(1994-3#6)(1994-4#1)(1996-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-12#1)(2008-5#2)(2008-8#1)(2011-12#2)(2011-2#3)(2012-12#3)(2012-3#1)
the endo##6##2##(1996-5#4)(1996-8#1)(2010-6#1)
the endobronchial route##2##3##(1994-9#2)
the endobronchial##6##2##(1994-9#4)(2007-8#1)(2008-5#1)
the endocannabinoid system##4##3##(2007-11#1)(2008-9#2)(2009-8#1)
the endocannabinoid##5##2##(2007-11#1)(2008-9#2)(2009-8#1)(2010-6#1)
the endocardial##2##2##(1991-6#1)(1996-9#1)
the endocardium##3##2##(2007-8#1)(2010-12#1)(2010-5#1)
the endocavitary##2##2##(2007-7#2)
the endocervical##3##2##(1991-2#2)(2006-10#1)
the endocervix##2##2##(1992-3#1)(1994-12#1)
the endocrine action of##2##4##(2008-7#2)
the endocrine and##2##3##(2007-12#1)(2008-5#1)
the endocrine control of##2##4##(1996-4#1)(2006-10#1)
the endocrine effects of subcutaneous##2##5##(1991-6#2)
the endocrine effects of##3##4##(1991-6#2)(1994-10#1)
the endocrine glands##3##3##(1992-5#1)(2008-1#1)(2009-2#1)
the endocrine pancreas##8##3##(1991-7#1)(1994-6#1)(1994-8#1)(1995-10#1)(1997-8#2)(2006-10#1)(2008-1#1)
the endocrine system##6##3##(2006-10#1)(2007-1#1)(2008-11#2)(2008-4#1)(2008-9#1)
the endocrine systems##2##3##(2008-5#1)(2010-5#1)
the endocrine##48##2##(1990-11#1)(1990-3#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-7#1)(1992-5#1)(1992-6#1)(1994-10#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1996-4#2)(1996-6#1)(1997-8#2)(2006-10#3)(2006-12#1)(2006-5#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#2)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#4)(2008-9#2)(2009-2#1)(2009-5#1)(2010-11#2)(2010-5#1)(2011-2#1)(2012-2#1)
the endocrinological and the immune system##2##6##(2008-5#2)
the endocrinological##3##2##(2008-5#3)
the endocrinology##2##2##(2011-2#2)
the endocytic pathway##4##3##(1993-11#1)(1994-9#1)(2008-1#1)(2008-4#1)
the endocytic rate constant##2##4##(1990-11#1)(1994-6#1)
the endocytic rate##3##3##(1990-11#1)(1991-3#1)(1994-6#1)
the endocytic##10##2##(1990-11#1)(1991-3#1)(1993-11#1)(1994-6#2)(1994-9#1)(1996-2#1)(2008-1#1)(2008-4#1)(2009-10#1)
the endocytosis of##3##3##(1995-11#1)(1995-3#1)(2008-1#1)
the endocytosis##5##2##(1990-11#1)(1992-4#1)(1995-11#1)(1995-3#1)(2008-1#1)
the endoderm##5##2##(2008-11#1)(2008-6#2)(2008-7#1)(2012-12#1)
the endodontic management of a##4##5##(2013-1#4)
the endodontic therapy##4##3##(2010-6#1)(2012-3#1)(2013-1#2)
the endodontic treatment##2##3##(2010-4#1)(2012-3#1)
the endodontic##12##2##(2008-7#1)(2009-8#1)(2010-4#1)(2010-6#1)(2012-3#2)(2013-1#6)
the endogenous ADP##3##3##(1996-7#2)(2008-7#1)
the endogenous L-type pyruvate kinase##2##5##(1990-8#1)(1995-5#1)
the endogenous activity##4##3##(1990-10#1)(1990-12#1)(1990-9#1)(1994-9#1)
the endogenous antioxidant network##2##4##(2012-12#2)
the endogenous antioxidant##5##3##(2012-1#2)(2012-12#2)(2013-8#1)
the endogenous circadian##2##3##(1990-5#1)(1997-6#1)
the endogenous component##2##3##(2006-10#2)
the endogenous endonuclease activation##2##4##(1992-7#2)
the endogenous enzyme##2##3##(1992-8#1)(2009-4#1)
the endogenous gene##3##3##(1991-9#1)(1997-4#1)(2008-9#1)
the endogenous levels of##4##4##(1990-7#1)(1995-2#1)(1996-4#1)(1997-3#1)
the endogenous levels##5##3##(1990-7#1)(1995-2#1)(1996-4#1)(1997-3#1)(2006-10#1)
the endogenous ligands##3##3##(1993-3#1)(2008-5#1)(2009-9#1)
the endogenous microbiota##2##3##(2008-10#1)(2010-9#1)
the endogenous mouse##2##3##(1994-3#1)(1996-6#1)
the endogenous neuroactive steroid pregnanolone##2##5##(1997-5#2)
the endogenous neurotransmitter##2##3##(1990-11#1)(1994-5#1)
the endogenous opioid system##4##4##(1996-12#1)(2008-7#1)(2009-7#1)(2012-1#1)
the endogenous release of##2##4##(1992-2#1)(1997-4#1)
the endogenous##140##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-5#4)(1990-7#3)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-2#2)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-9#2)(1994-10#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-3#1)(1996-4#2)(1996-5#6)(1996-6#1)(1996-7#2)(1996-8#1)(1997-3#1)(1997-4#4)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#2)(2006-10#4)(2006-11#1)(2006-8#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#7)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-11#2)(2010-2#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#3)(2012-12#4)(2012-3#1)(2013-7#1)(2013-8#2)
the endogenously##5##2##(1992-6#1)(1993-1#1)(1994-9#1)(1995-12#1)(1997-7#1)
the endoglucanase activity##2##3##(2006-8#1)(2008-10#1)
the endoglucanase##5##2##(1991-7#2)(2006-8#1)(2008-10#1)(2008-6#1)
the endolymphatic sac##3##3##(2006-12#3)
the endometrial cancer##3##3##(1994-9#1)(2008-10#1)(2011-1#1)
the endometrial cavity and##2##4##(1994-9#1)(2009-8#1)
the endometrial##16##2##(1992-6#1)(1994-9#4)(1995-3#1)(1996-2#1)(2006-5#1)(2008-10#1)(2008-6#2)(2008-9#2)(2009-8#1)(2011-1#1)(2013-8#1)
the endometriosis##2##2##(1992-9#1)(1993-5#1)
the endometrium and##3##3##(1991-3#1)(1991-9#1)(2012-3#1)
the endometrium compared to##2##4##(1994-9#1)(2007-2#1)
the endometrium in##3##3##(1994-9#1)(2007-2#1)(2008-9#1)
the endometrium is##3##3##(2011-2#1)(2012-3#2)
the endometrium of##4##3##(1993-12#3)(1994-9#1)
the endometrium##50##2##(1991-12#1)(1991-3#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-12#3)(1993-8#1)(1993-9#1)(1994-5#1)(1994-9#8)(1995-3#1)(1996-2#2)(2006-10#1)(2006-5#1)(2007-2#4)(2008-4#1)(2008-9#2)(2009-6#1)(2010-9#1)(2011-1#2)(2011-2#9)(2012-2#2)(2012-3#4)
the endonuclease activity of terminase##2##5##(1996-8#2)
the endonuclease activity of##3##4##(1990-7#1)(1996-8#2)
the endonuclease##11##2##(1990-3#1)(1990-7#1)(1992-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-8#2)(2008-8#1)
the endopeptidase##2##2##(1990-2#1)(1994-2#1)
the endophyte##3##2##(2008-10#3)
the endoplasmic reticulum (ER) and##3##5##(1990-11#1)(1990-12#1)(1995-3#1)
the endoplasmic reticulum (ER) of##4##5##(1994-11#1)(1996-5#1)(2009-2#1)(2009-8#1)
the endoplasmic reticulum (ER) stress##2##5##(2008-7#1)(2012-2#1)
the endoplasmic reticulum (ER)##23##4##(1990-11#1)(1990-12#1)(1991-2#1)(1992-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-1#1)(2006-11#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
the endoplasmic reticulum and the Golgi apparatus##4##7##(1990-4#1)(1990-7#1)(2008-11#1)(2009-8#1)
the endoplasmic reticulum and the Golgi##5##6##(1990-4#1)(1990-7#1)(1997-5#1)(2008-11#1)(2009-8#1)
the endoplasmic reticulum and##15##4##(1990-4#1)(1990-7#1)(1994-11#1)(1994-9#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-9#1)(1997-5#1)(2006-10#1)(2008-11#1)(2009-7#1)(2009-8#2)(2013-1#1)
the endoplasmic reticulum membrane##6##4##(1991-10#1)(1995-6#4)(1997-7#1)
the endoplasmic reticulum of##2##4##(1996-3#1)(2008-3#1)
the endoplasmic reticulum was##2##4##(1996-8#1)(2008-11#1)
the endoplasmic reticulum##106##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-2#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-6#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#3)(1994-12#3)(1994-6#1)(1994-8#1)(1994-9#4)(1995-1#1)(1995-2#4)(1995-3#3)(1995-5#1)(1995-6#4)(1995-7#1)(1995-8#1)(1996-3#4)(1996-5#1)(1996-8#4)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#2)(2006-10#2)(2006-11#1)(2008-1#3)(2008-10#3)(2008-11#6)(2008-3#1)(2008-4#1)(2008-7#3)(2009-10#2)(2009-2#2)(2009-7#1)(2009-8#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#3)
the endoplasmic##111##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-2#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-6#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#4)(1993-9#1)(1994-11#4)(1994-12#3)(1994-6#1)(1994-8#1)(1994-9#4)(1995-1#1)(1995-2#4)(1995-3#3)(1995-5#1)(1995-6#4)(1995-7#1)(1995-8#1)(1996-3#4)(1996-5#1)(1996-8#4)(1996-9#1)(1997-1#3)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#2)(2006-10#2)(2006-11#1)(2008-1#3)(2008-10#3)(2008-11#6)(2008-3#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-10#2)(2009-2#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#3)
the endoprostheses##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
the endoprosthesis stem##2##3##(2007-7#2)
the endoprosthesis was##2##3##(1992-1#1)(2007-7#1)
the endoprosthesis##7##2##(1992-1#2)(2007-7#3)(2007-8#2)
the endoreduplication##2##2##(2008-5#2)
the endoscope##12##2##(1997-5#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#2)(2008-5#2)(2008-7#1)(2009-8#1)(2012-12#1)(2013-1#1)
the endoscopic and##2##3##(2011-12#1)(2011-2#1)
the endoscopic appearance of##2##4##(2010-12#1)(2011-12#1)
the endoscopic approach##2##3##(2006-10#1)(2006-5#1)
the endoscopic management of##3##4##(2006-10#2)(2006-5#1)
the endoscopic procedure##5##3##(2006-5#4)(2011-2#1)
the endoscopic surgical procedures##2##4##(1994-3#1)(2006-6#1)
the endoscopic technique##3##3##(1992-8#1)(2006-5#1)(2008-3#1)
the endoscopic treatment of##2##4##(2006-2#1)(2007-5#1)
the endoscopic##50##2##(1990-3#1)(1991-3#1)(1992-1#1)(1992-4#1)(1992-8#2)(1993-12#1)(1994-3#1)(1994-9#1)(2006-10#5)(2006-2#1)(2006-5#10)(2006-6#2)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-3#1)(2008-4#1)(2008-5#4)(2009-2#1)(2009-3#1)(2010-12#1)(2010-9#1)(2011-12#3)(2011-2#2)(2012-2#1)(2013-7#1)
the endoscopist##3##2##(2006-10#2)(2010-12#1)
the endoscopy##7##2##(1992-11#1)(1992-5#1)(2006-10#2)(2006-8#1)(2007-5#1)(2008-5#1)
the endosomal compartment##4##3##(1995-11#2)(2009-2#1)(2012-2#1)
the endosomal##6##2##(1995-11#2)(1997-7#1)(2009-2#1)(2012-2#1)(2013-1#1)
the endosome##6##2##(1992-6#1)(1994-5#1)(2008-11#1)(2012-12#3)
the endosomes##4##2##(1990-11#1)(1992-6#1)(1995-11#1)(2009-2#1)
the endosperm and##3##3##(2006-12#2)(2008-10#1)
the endosperm of##4##3##(1992-3#1)(2006-12#2)(2007-1#1)
the endosperm##17##2##(1992-3#1)(1994-3#1)(1994-8#2)(2006-12#8)(2007-1#1)(2008-10#3)(2009-12#1)
the endosymbiont##5##2##(1993-12#1)(1996-12#3)(2012-3#1)
the endothelial P2Y(1) receptor##2##4##(2008-4#2)
the endothelial and##2##3##(1994-11#1)(2012-1#1)
the endothelial cell damage##2##4##(1992-1#2)
the endothelial cell loss and clinical outcome##2##7##(2011-2#2)
the endothelial cell surface##5##4##(1995-2#1)(1996-8#3)(2008-1#1)
the endothelial cell##20##3##(1990-4#1)(1990-9#1)(1991-2#1)(1992-1#2)(1993-3#1)(1993-6#2)(1993-8#1)(1995-2#2)(1996-8#3)(2008-1#3)(2011-2#3)
the endothelial cells and##2##4##(1992-9#1)(2006-11#1)
the endothelial cells in##2##4##(1995-12#1)(1997-5#1)
the endothelial cells##14##3##(1992-9#1)(1994-10#1)(1995-11#1)(1995-12#2)(1997-5#3)(2005-1#1)(2006-11#2)(2007-12#1)(2010-6#1)(2011-12#1)
the endothelial dysfunction##3##3##(2008-1#1)(2008-11#1)(2010-10#1)
the endothelial layer##2##3##(2007-8#1)(2009-12#1)
the endothelial nitric oxide synthase##3##5##(2007-10#2)(2008-7#1)
the endothelial##56##2##(1990-4#1)(1990-9#1)(1991-1#1)(1991-2#1)(1992-1#2)(1992-9#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1995-11#2)(1995-12#2)(1995-2#2)(1996-8#3)(1997-5#3)(2005-1#1)(2005-7#1)(2006-11#2)(2007-10#2)(2007-12#1)(2007-8#2)(2008-1#4)(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#1)(2009-12#1)(2010-10#2)(2010-6#1)(2010-7#2)(2011-12#1)(2011-2#3)(2012-1#1)
the endothelin receptor##3##3##(1991-7#1)(1995-12#1)(2011-2#1)
the endothelin##12##2##(1990-2#2)(1990-6#1)(1991-7#1)(1993-6#1)(1994-12#1)(1995-12#4)(1996-2#1)(2011-2#1)
the endothelin-B receptor gene##2##4##(1994-12#2)
the endothelin-B receptor##4##3##(1994-12#4)
the endothelin-B##5##2##(1994-12#4)(1996-4#1)
the endothelium and perivascular infiltrating inflammatory cells##2##7##(2012-3#2)
the endothelium and##6##3##(1995-2#1)(2008-10#1)(2010-12#1)(2012-1#1)(2012-3#2)
the endothelium in##2##3##(1992-9#1)(2012-12#1)
the endothelium of##7##3##(1994-5#1)(1997-2#1)(2007-11#1)(2009-11#1)(2012-1#1)(2012-3#2)
the endothelium##42##2##(1990-12#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-11#1)(1994-5#2)(1994-9#1)(1995-2#2)(1996-2#1)(1996-9#2)(1997-2#1)(1997-5#2)(2005-11#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-3#2)(2008-5#1)(2009-11#1)(2010-12#1)(2010-4#1)(2012-1#2)(2012-11#1)(2012-12#5)(2012-3#4)
the endothelium-dependent relaxation##3##3##(1995-12#1)(2007-8#2)
the endothelium-dependent##6##2##(1994-11#1)(1995-12#1)(1996-12#1)(2007-8#2)(2007-9#1)
the endothelium-derived##3##2##(1991-3#1)(1992-6#1)(1994-5#1)
the endothermic##3##2##(1995-1#1)(2006-10#1)(2010-5#1)
the endotoxin##2##2##(1990-12#1)(2012-12#1)
the endotracheal tube (ETT) is##2##5##(2007-11#1)(2008-8#1)
the endotracheal tube##5##3##(1996-3#1)(1997-6#1)(2007-11#1)(2008-8#1)(2010-7#1)
the endovascular procedure##5##3##(1996-6#1)(2006-10#1)(2007-8#1)(2008-7#1)(2013-8#1)
the endovascular treatment of##3##4##(1996-9#1)(2006-10#1)(2008-5#1)
the endovascular##15##2##(1995-11#1)(1996-6#1)(1996-9#1)(2006-10#2)(2007-8#4)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2013-8#1)
the endpoint##6##2##(1992-9#1)(2006-10#1)(2007-11#1)(2008-7#2)(2012-2#1)
the endpoints of##2##3##(2007-1#1)(2011-2#1)
the endpoints##3##2##(2007-1#1)(2011-2#1)(2012-2#1)
the ends of IS1##2##4##(1994-9#2)
the ends of chromosomes##2##4##(2006-10#1)(2008-11#1)
the ends of linear##2##4##(1990-9#1)(2008-11#1)
the ends of the##11##4##(1993-11#1)(1993-6#1)(1994-6#1)(1995-6#1)(1995-8#1)(1996-11#1)(1997-4#2)(2007-11#1)(2008-4#1)(2008-8#1)
the ends of##29##3##(1990-8#1)(1990-9#1)(1991-8#1)(1993-11#1)(1993-6#1)(1994-6#2)(1994-9#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-4#1)(1997-2#1)(1997-4#2)(1997-6#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-4#3)(2008-8#1)(2008-9#2)
the ends##37##2##(1990-8#1)(1990-9#1)(1991-8#1)(1993-11#1)(1993-6#2)(1994-6#2)(1994-9#3)(1995-6#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-4#3)(1997-6#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-4#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-9#1)(2013-1#1)
the endurance##2##2##(2007-8#1)(2011-1#1)
the enediyne##2##2##(1994-12#1)(1997-1#1)
the energetic cost of##2##4##(2008-8#2)
the energetic costs##3##3##(1991-11#1)(2008-9#2)
the energetic equivalence rule##2##4##(2008-9#2)
the energetic invariant##2##3##(2008-3#2)
the energetic state##2##3##(2008-7#1)(2012-12#1)
the energetic status of the cell##2##6##(1991-9#1)(2005-8#1)
the energetic status of the##3##5##(1991-9#1)(1994-3#1)(2005-8#1)
the energetic##29##2##(1991-11#1)(1991-9#1)(1992-1#2)(1994-11#2)(1994-3#2)(1995-10#1)(2004-12#1)(2005-11#1)(2005-8#1)(2006-12#1)(2008-10#1)(2008-3#3)(2008-7#1)(2008-8#4)(2008-9#4)(2010-4#1)(2012-12#1)(2013-1#1)
the energetics of protein##2##4##(1997-2#1)(2008-4#1)
the energetics of##7##3##(1992-11#1)(1995-8#1)(1997-2#3)(2008-4#1)(2010-12#1)
the energetics##8##2##(1992-11#1)(1995-8#1)(1997-2#3)(2008-4#2)(2010-12#1)
the energies##3##2##(1992-8#1)(1996-1#1)(2008-10#1)
the energy absorbed##3##3##(1995-10#1)(2005-10#1)(2008-10#1)
the energy and##3##3##(1992-2#1)(2006-4#1)(2007-12#1)
the energy balance##3##3##(2004-12#1)(2007-11#1)(2008-10#1)
the energy barrier##3##3##(1996-11#1)(2005-11#1)(2006-10#1)
the energy barriers##2##3##(2008-4#1)(2009-5#1)
the energy budget##2##3##(2008-9#1)(2012-2#1)
the energy change##2##3##(2007-11#2)
the energy density##4##3##(2007-12#1)(2008-3#2)(2008-6#1)
the energy distribution of##2##4##(2006-4#1)(2008-3#1)
the energy distribution##4##3##(1993-8#1)(2006-4#1)(2008-3#2)
the energy expenditure##2##3##(2006-10#1)(2006-7#1)
the energy for##2##3##(1992-12#1)(2008-11#1)
the energy gap##3##3##(1993-5#1)(2008-3#1)(2012-12#1)
the energy in the##3##4##(2007-11#1)(2008-1#1)(2013-1#1)
the energy in##4##3##(2007-11#1)(2008-1#1)(2012-3#1)(2013-1#1)
the energy intake##2##3##(2007-8#1)(2008-5#1)
the energy levels of the##2##5##(2008-2#2)
the energy levels of##3##4##(2008-2#2)(2008-8#1)
the energy levels##4##3##(2008-2#2)(2008-3#1)(2008-8#1)
the energy losses##2##3##(2005-11#1)(2008-2#1)
the energy metabolism of the##2##5##(1996-8#1)(2008-11#1)
the energy metabolism of##5##4##(1996-8#1)(2006-12#1)(2008-11#1)(2010-10#1)(2011-2#1)
the energy metabolism##8##3##(1992-3#1)(1996-8#1)(2005-1#1)(2006-12#1)(2008-11#2)(2010-10#1)(2011-2#1)
the energy needed##2##3##(2007-9#1)(2008-5#1)
the energy of the##10##4##(1997-7#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#3)(2008-4#1)
the energy of##19##3##(1992-5#1)(1993-9#1)(1995-10#1)(1997-7#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#6)(2008-4#1)(2013-1#1)
the energy production from##2##4##(2012-3#2)
the energy production##4##3##(2008-5#1)(2009-6#1)(2012-3#2)
the energy state of the##2##5##(1997-7#1)(2010-4#1)
the energy state##3##3##(1993-4#1)(1997-7#1)(2010-4#1)
the energy stored in the##3##5##(1991-7#1)(2007-11#1)(2008-2#1)
the energy supply##3##3##(1994-2#1)(2009-8#1)(2012-1#1)
the energy surface##2##3##(2005-11#1)(2009-5#1)
the energy transfer between##2##4##(1991-2#1)(2008-10#1)
the energy transfer##10##3##(1991-2#1)(1993-9#1)(2008-10#4)(2008-8#3)(2009-5#1)
the energy##179##2##(1990-12#1)(1990-6#1)(1991-2#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-2#2)(1994-9#1)(1995-10#2)(1995-11#1)(1995-4#1)(1996-11#1)(1996-12#1)(1996-8#3)(1996-9#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2004-12#1)(2005-1#1)(2005-10#1)(2005-11#3)(2005-8#1)(2006-10#4)(2006-12#2)(2006-4#2)(2006-5#2)(2006-7#1)(2007-11#9)(2007-12#7)(2007-5#1)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#12)(2008-11#6)(2008-12#1)(2008-2#13)(2008-3#23)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#1)(2009-5#3)(2009-6#1)(2009-8#3)(2010-10#1)(2010-4#2)(2010-5#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#2)
the energy-absorbing##2##2##(2005-10#2)
the energy-coupling##3##2##(1992-6#2)(1995-1#1)
the energy-density distribution##2##3##(2008-2#2)
the enforcement of a##2##4##(2007-6#2)
the enforcement of##4##3##(2007-6#2)(2009-7#1)(2010-7#1)
the engagement##3##2##(2007-12#1)(2009-9#1)(2013-1#1)
the engine##7##2##(1992-2#1)(2007-10#4)(2008-2#1)(2008-3#1)
the engineered##8##2##(1994-11#1)(1996-5#1)(2006-12#1)(2008-1#1)(2008-10#1)(2010-12#1)(2013-8#2)
the engineering of##6##3##(1995-3#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-11#1)(2009-5#1)
the engineering##13##2##(1995-3#1)(2006-10#1)(2006-9#1)(2007-8#1)(2008-1#2)(2008-11#2)(2008-3#1)(2009-12#1)(2009-5#1)(2012-3#1)(2013-7#1)
the engineerized enzyme##2##3##(2008-10#2)
the engrailed homeodomain and##2##4##(1990-8#2)
the engrailed protein##4##3##(1990-8#1)(2007-12#3)
the engrailed##6##2##(1990-8#3)(2007-12#3)
the enhanced ECL##5##3##(2008-10#5)
the enhanced RLS intensity##4##4##(2008-10#4)
the enhanced effect of##2##4##(1996-4#1)(2008-8#1)
the enhanced efficacy of##2##4##(2005-8#1)(2008-5#1)
the enhanced expression of##2##4##(1994-3#1)(2013-1#1)
the enhanced expression##3##3##(1994-3#1)(2008-7#1)(2013-1#1)
the enhanced green fluorescent protein##2##5##(2007-8#1)(2008-11#1)
the enhanced growth##3##3##(1992-8#1)(2008-11#1)(2009-8#1)
the enhanced intensity of fluorescence is in proportion to the concentration of##2##12##(2008-10#2)
the enhanced production of##2##4##(1996-6#1)(2008-11#1)
the enhanced ray-optics##2##3##(2008-3#2)
the enhanced recovery##2##3##(2006-11#1)(2013-8#1)
the enhanced resistance##2##3##(2009-8#1)(2011-12#1)
the enhanced resonance light scattering (RLS)##2##6##(2008-10#2)
the enhanced response to##2##4##(1995-11#1)(2006-10#1)
the enhanced speech##2##3##(2007-11#2)
the enhanced stability of the##2##5##(1995-1#1)(2012-12#1)
the enhanced stability of##3##4##(1995-1#1)(2012-12#2)
the enhanced##113##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-4#1)(1991-6#1)(1992-12#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-4#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#2)(2005-8#1)(2006-10#4)(2006-11#2)(2006-12#2)(2007-11#4)(2007-12#2)(2007-4#1)(2007-8#2)(2008-10#24)(2008-11#4)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#3)(2009-9#1)(2010-4#1)(2011-12#2)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#1)
the enhancement and##2##3##(1990-7#1)(2007-11#1)
the enhancement effect of##3##4##(2008-3#1)(2008-9#1)(2013-8#1)
the enhancement effect##6##3##(2005-4#1)(2008-10#2)(2008-3#1)(2008-9#1)(2013-8#1)
the enhancement factor was##5##4##(2007-8#1)(2008-10#4)
the enhancement factor##6##3##(2007-8#1)(2008-1#1)(2008-10#4)
the enhancement in##5##3##(1997-8#1)(2007-11#1)(2008-3#1)(2008-7#1)(2012-12#1)
the enhancement of a##3##4##(1990-3#1)(1996-2#1)(2007-12#1)
the enhancement of antibody##2##4##(1990-12#1)(1995-11#1)
the enhancement of helical propensities##2##5##(1997-2#2)
the enhancement of the##13##4##(1991-2#2)(1993-3#1)(1994-2#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)
the enhancement of##84##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-2#2)(1991-7#1)(1992-1#1)(1992-10#1)(1992-7#1)(1992-8#2)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#4)(1994-5#1)(1994-6#1)(1995-11#1)(1995-3#2)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-4#1)(1997-2#2)(1997-6#1)(1997-8#2)(2005-11#1)(2006-11#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#16)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-6#1)(2013-8#1)
the enhancement or##2##3##(1995-5#1)(2009-11#1)
the enhancement##115##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#2)(1990-7#1)(1991-2#2)(1991-7#1)(1992-1#1)(1992-10#1)(1992-7#1)(1992-8#2)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#4)(1994-5#1)(1994-6#1)(1995-11#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-4#1)(1997-2#2)(1997-6#1)(1997-8#4)(2005-11#1)(2005-4#1)(2006-11#1)(2007-11#3)(2007-12#4)(2007-8#2)(2008-1#3)(2008-10#22)(2008-11#3)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-11#1)(2009-3#1)(2009-5#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-6#1)(2013-7#1)(2013-8#2)
the enhancements##2##2##(1994-8#1)(2006-4#1)
the enhancer activity##3##3##(1991-11#1)(1994-11#1)(1997-4#1)
the enhancer and##2##3##(1992-5#2)
the enhancer region of##2##4##(1990-10#1)(1996-10#1)
the enhancer sequence##3##3##(1994-8#2)(2008-9#1)
the enhancer##21##2##(1990-10#1)(1990-11#1)(1991-11#2)(1991-12#1)(1991-5#1)(1992-10#1)(1992-5#2)(1994-11#1)(1994-8#2)(1994-9#2)(1995-8#1)(1996-10#1)(1996-4#1)(1997-4#1)(2005-11#1)(2008-9#1)(2012-3#1)
the enhancing effect of arginine-vasopressin on##2##6##(1995-12#2)
the enhancing effect of##10##4##(1990-2#1)(1991-10#1)(1994-9#1)(1995-12#3)(2008-10#2)(2008-11#1)(2010-7#1)
the enhancing effect##15##3##(1990-2#1)(1991-10#1)(1994-9#1)(1995-12#3)(1997-2#1)(2006-11#1)(2008-10#3)(2008-11#2)(2009-8#1)(2010-7#1)
the enhancing##17##2##(1990-2#1)(1991-10#1)(1994-9#1)(1995-12#3)(1997-2#1)(2006-11#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#1)(2009-8#1)(2010-7#1)
the enigmatic##3##2##(2007-10#1)(2009-12#1)(2012-12#1)
the enlarged lymph nodes##2##4##(1990-8#1)(2007-7#1)
the enlarged##14##2##(1990-8#1)(1997-7#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#2)(2013-7#2)
the enlargement of the##2##4##(2005-9#1)(2008-3#1)
the enlargement of##5##3##(2005-9#1)(2008-10#1)(2008-3#2)(2009-4#1)
the enlargement##6##2##(2005-9#1)(2008-10#1)(2008-3#3)(2009-4#1)
the enlarging##2##2##(2006-10#1)(2008-10#1)
the enol form##2##3##(2010-2#1)(2010-5#1)
the enol##3##2##(1994-11#1)(2010-2#1)(2010-5#1)
the enolizable##2##2##(2010-2#2)
the enormous amount of data##4##5##(2008-4#2)(2013-1#2)
the enormous amount of##5##4##(2008-4#2)(2008-7#1)(2013-1#2)
the enormous##22##2##(1995-12#1)(2004-2#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-7#2)(2008-9#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
the enquiry##4##2##(2006-12#1)(2008-10#3)
the enriched environment##5##3##(1991-2#1)(1992-11#3)(1993-7#1)
the enriched##12##2##(1991-2#1)(1992-11#3)(1993-7#1)(1994-2#1)(1997-4#1)(2008-10#2)(2008-11#1)(2010-1#1)(2010-2#1)
the enrichment and##2##3##(2008-10#1)(2013-7#1)
the enrichment column##2##3##(2008-10#2)
the enrichment culture and##2##4##(2006-3#2)
the enrichment culture##3##3##(2006-3#3)
the enrichment factor##4##3##(2008-10#4)
the enrichment factors##3##3##(2008-10#2)(2012-12#1)
the enrichment in##2##3##(1990-4#1)(1991-2#1)
the enrichment of the##3##4##(1992-9#1)(1997-3#1)(2008-9#1)
the enrichment of##16##3##(1992-9#1)(1995-10#1)(1997-3#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-7#1)(2011-2#1)(2013-7#1)
the enrichment##40##2##(1990-4#1)(1991-12#1)(1991-2#1)(1992-9#1)(1995-10#1)(1997-3#1)(2006-3#4)(2008-10#18)(2008-11#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-7#1)(2011-2#3)(2012-12#2)(2013-7#2)
the enrolled##2##2##(1996-2#1)(2013-1#1)
the enrollment of##2##3##(1991-1#1)(2007-11#1)
the enrollment##4##2##(1991-1#1)(1991-2#1)(2007-11#1)(2009-6#1)
the ensemble of##2##3##(1995-12#1)(2008-2#1)
the ensemble##7##2##(1995-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-5#1)(2013-1#1)
the ensuing years##2##3##(2006-3#1)(2008-7#1)
the ensuing##24##2##(1991-10#1)(1992-1#1)(1993-3#1)(1996-10#1)(1996-2#2)(2006-3#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#2)
the entA mutant##3##3##(2008-10#3)
the enteral##3##2##(2005-10#1)(2006-10#1)(2012-1#1)
the enteric microflora##2##3##(2006-10#2)
the enteric nervous system (ENS)##2##5##(2008-7#1)(2012-2#1)
the enteric nervous system##7##4##(1992-6#2)(1995-9#1)(2006-10#1)(2008-7#2)(2012-2#1)
the enteric neural##2##3##(2008-7#2)
the enteric##20##2##(1990-5#1)(1992-6#2)(1995-9#1)(2006-10#5)(2006-2#1)(2007-12#2)(2008-7#4)(2012-2#2)(2013-1#2)
the entering##2##2##(2008-8#1)(2009-3#1)
the enterocyte##4##2##(1990-11#1)(1996-5#1)(2006-10#2)
the enterocytes##5##2##(1993-6#1)(1994-6#1)(1997-3#1)(2008-10#2)
the enterohemolysin##2##2##(1993-9#2)
the enterovirus##4##2##(2008-4#1)(2011-1#3)
the enterprise##5##2##(1994-12#1)(1995-2#1)(1996-3#1)(1997-3#1)(2007-4#1)
the enthalpic and entropic##2##4##(1993-3#1)(2008-5#1)
the enthalpic##4##2##(1993-3#1)(1996-2#1)(2005-11#1)(2008-5#1)
the enthalpy and entropy##3##4##(1996-2#1)(2006-10#1)(2008-10#1)
the enthalpy and##5##3##(1990-8#1)(1993-3#1)(1996-2#1)(2006-10#1)(2008-10#1)
the enthalpy change##6##3##(1992-9#1)(1993-3#1)(1993-8#1)(2006-10#1)(2008-10#2)
the enthalpy of binding of##2##5##(1993-3#2)
the enthalpy of binding##4##4##(1993-3#2)(1994-5#1)(2006-10#1)
the enthalpy of micellization##2##4##(2005-11#2)
the enthalpy of##13##3##(1990-8#1)(1992-5#2)(1993-3#2)(1994-5#1)(1996-11#2)(1996-4#1)(2005-11#3)(2006-10#1)
the enthalpy##31##2##(1990-8#2)(1992-10#1)(1992-5#2)(1992-9#1)(1993-3#4)(1993-8#1)(1994-5#1)(1996-11#2)(1996-2#1)(1996-4#1)(1997-2#3)(2005-11#4)(2006-10#5)(2008-10#3)
the enthusiastic##2##2##(2008-3#1)(2013-8#1)
the entire 5'##2##3##(1994-5#1)(1995-5#1)
the entire D-loop##2##3##(2009-5#2)
the entire E##4##3##(1990-10#1)(1994-12#1)(1997-2#1)(1997-4#1)
the entire ITS##3##3##(2008-10#3)
the entire abdomen##2##3##(1997-8#1)(2008-7#1)
the entire area##2##3##(2006-8#1)(2007-3#1)
the entire body##6##3##(1990-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2011-1#1)(2012-2#1)
the entire brain##4##3##(1996-4#1)(1997-5#1)(2008-7#1)(2009-3#1)
the entire cDNA##2##3##(1991-5#1)(1995-6#1)
the entire cell##2##3##(2007-12#1)(2011-1#1)
the entire chromosome 11##2##4##(1990-6#1)(1991-2#1)
the entire chromosome complement of##2##5##(2008-5#2)
the entire chromosome##6##3##(1990-6#1)(1991-2#1)(1997-5#1)(2008-10#1)(2008-5#2)
the entire clinical##2##3##(1996-3#1)(2008-7#1)
the entire coding region of the##3##6##(1990-4#1)(1993-6#1)(1994-12#1)
the entire coding region of##5##5##(1990-4#1)(1990-7#1)(1990-8#1)(1993-6#1)(1994-12#1)
the entire coding region##10##4##(1990-12#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-7#1)(1992-3#1)(1993-6#1)(1994-12#1)(1995-1#1)(1996-2#1)
the entire coding sequence of the##2##6##(1996-2#1)(2011-2#1)
the entire coding sequence of##5##5##(1991-8#1)(1993-9#1)(1994-9#1)(1996-2#1)(2011-2#1)
the entire coding sequence##9##4##(1991-11#1)(1991-12#1)(1991-8#1)(1992-8#1)(1993-9#1)(1994-9#1)(1996-10#1)(1996-2#1)(2011-2#1)
the entire coding##21##3##(1990-12#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-8#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-9#1)(1995-1#2)(1996-10#1)(1996-2#2)(2011-2#1)
the entire cohort##2##3##(2008-3#1)(2008-7#1)
the entire colon##5##3##(1993-10#1)(2006-2#1)(2006-6#1)(2008-1#1)(2009-10#1)
the entire community##3##3##(1996-2#1)(2008-9#1)(2010-2#1)
the entire complex of##2##4##(1990-6#1)(1997-6#1)
the entire control##2##3##(2008-12#2)
the entire course of##4##4##(1995-11#1)(2006-2#1)(2008-10#1)(2008-7#1)
the entire data set##2##4##(2008-10#1)(2008-2#1)
the entire experiment##3##3##(2008-10#2)(2012-9#1)
the entire extracellular##2##3##(1991-9#1)(1992-9#1)
the entire eye##2##3##(2007-12#1)(2010-8#1)
the entire family##2##3##(2009-9#1)(2010-2#1)
the entire flow##2##3##(2008-5#1)(2008-7#1)
the entire gamut of##2##4##(2008-3#1)(2012-2#1)
the entire gene##3##3##(1994-11#1)(2006-5#2)
the entire genome of Drosophila melanogaster using fusion analysis##2##9##(2008-7#2)
the entire genome of##7##4##(1996-11#1)(1996-6#1)(2005-11#1)(2008-10#1)(2008-7#2)(2008-8#1)
the entire genome##18##3##(1996-11#1)(1996-12#1)(1996-6#4)(1996-8#1)(1997-2#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#2)(2011-2#1)
the entire group of##2##4##(1991-12#1)(2008-9#1)
the entire group was##2##4##(2008-1#1)(2008-6#1)
the entire group##11##3##(1991-12#2)(1992-10#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-2#1)(2012-7#1)
the entire health care##2##4##(1991-12#1)(1996-3#1)
the entire human##4##3##(1992-2#1)(1992-7#1)(2008-7#1)(2010-9#1)
the entire length of the##4##5##(1995-4#1)(1997-4#1)(2009-7#1)(2012-2#1)
the entire length of##9##4##(1990-5#1)(1990-6#1)(1991-12#1)(1995-4#1)(1996-10#1)(1997-4#1)(2007-8#1)(2009-7#1)(2012-2#1)
the entire length##11##3##(1990-5#1)(1990-6#1)(1991-12#1)(1995-4#1)(1996-10#1)(1996-6#1)(1997-4#1)(2007-8#1)(2009-7#2)(2012-2#1)
the entire life##2##3##(1996-9#1)(2011-1#1)
the entire lifetime##3##3##(2009-2#2)(2011-2#1)
the entire medical##2##3##(2006-4#1)(2012-2#1)
the entire nucleotide sequence##2##4##(1993-5#1)(1994-9#1)
the entire open reading frame##2##5##(1990-12#1)(1993-6#1)
the entire pH range##2##4##(2008-10#2)
the entire period of##3##4##(1993-6#1)(2008-11#1)(2012-1#1)
the entire period##4##3##(1992-6#1)(1993-6#1)(2008-11#1)(2012-1#1)
the entire polypeptide##2##3##(1994-6#1)(1995-3#1)
the entire population##11##3##(1993-11#1)(1997-6#1)(2005-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-12#2)
the entire posterior##4##3##(2007-11#1)(2007-8#2)(2009-3#1)
the entire practice##2##3##(2009-10#1)(2010-7#1)
the entire procedure was##3##4##(1993-3#1)(2008-10#2)
the entire procedure##12##3##(1993-1#1)(1993-3#1)(1994-8#1)(1997-8#1)(2006-8#1)(2007-8#1)(2008-10#3)(2008-11#1)(2010-6#1)(2010-7#1)
the entire protein##2##3##(2008-7#1)(2009-3#1)
the entire range of##6##4##(1990-4#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-6#1)(2012-2#1)
the entire range##8##3##(1990-4#1)(1992-8#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2012-2#1)
the entire reading frame##2##4##(1990-2#1)(1993-11#1)
the entire region of##3##4##(1993-6#1)(1995-6#1)(2009-7#1)
the entire region##6##3##(1993-6#1)(1994-9#1)(1995-6#1)(1995-8#1)(2008-5#1)(2009-7#1)
the entire respiratory tract##2##4##(2005-8#1)(2011-2#1)
the entire sample##3##3##(1997-8#1)(2007-12#1)(2012-1#1)
the entire section##2##3##(2011-2#2)
the entire sequence of the##2##5##(1991-3#1)(1993-6#1)
the entire sequence of##5##4##(1990-5#1)(1991-3#1)(1993-6#1)(2008-5#1)(2013-8#1)
the entire sequence space##2##4##(1997-6#1)(2007-9#1)
the entire sequence##10##3##(1990-5#1)(1991-3#1)(1992-3#1)(1993-6#1)(1993-8#1)(1995-9#1)(1997-6#1)(2007-9#1)(2008-5#1)(2013-8#1)
the entire set of##5##4##(1991-4#1)(1994-11#1)(2008-10#2)(2008-7#1)
the entire small##2##3##(1993-6#1)(2010-12#1)
the entire spatial##2##3##(2007-12#1)(2008-10#1)
the entire spectral range##2##4##(2008-2#1)(2008-3#1)
the entire spectrum of##5##4##(2008-2#1)(2008-8#1)(2008-9#1)(2010-3#1)(2012-2#1)
the entire spectrum##8##3##(2007-11#1)(2008-2#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-3#1)(2012-2#1)
the entire spleen##2##3##(2006-1#2)
the entire study period##2##4##(1990-5#1)(2008-7#1)
the entire study population##2##4##(2007-8#1)(2011-11#1)
the entire study##5##3##(1990-5#1)(2006-9#1)(2007-8#1)(2008-7#1)(2011-11#1)
the entire surface of the##2##5##(2007-12#1)(2011-2#1)
the entire surface##3##3##(1990-7#1)(2007-12#1)(2011-2#1)
the entire surgical##2##3##(2006-6#1)(2010-12#1)
the entire system##5##3##(2007-11#1)(2008-10#2)(2008-3#1)(2012-12#1)
the entire thickness of the##3##5##(1992-6#1)(2008-8#1)(2012-12#1)
the entire thin##2##3##(2007-12#1)(2008-6#1)
the entire time##4##3##(1990-12#1)(1990-8#1)(1997-4#1)(2009-7#1)
the entire tuning range##4##4##(2007-12#2)(2008-2#2)
the entire visible region##3##4##(2007-11#1)(2008-3#1)(2013-1#1)
the entire visible##4##3##(2007-11#1)(2008-3#1)(2008-7#1)(2013-1#1)
the entire wavelength range##2##4##(2008-2#1)(2010-5#1)
the entire wavelength##3##3##(1994-11#1)(2008-2#1)(2010-5#1)
the entire year##2##3##(2007-3#1)(2008-6#1)
the entire##618##2##(1990-10#3)(1990-12#3)(1990-2#1)(1990-4#3)(1990-5#5)(1990-6#3)(1990-7#2)(1990-8#2)(1991-11#3)(1991-12#8)(1991-2#1)(1991-3#1)(1991-4#3)(1991-5#7)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#5)(1992-4#1)(1992-6#2)(1992-7#3)(1992-8#2)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#2)(1993-3#3)(1993-5#1)(1993-6#9)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#4)(1994-12#5)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#4)(1995-1#4)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#3)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#4)(1996-11#1)(1996-12#4)(1996-2#4)(1996-3#4)(1996-4#5)(1996-6#7)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#8)(1997-4#5)(1997-5#4)(1997-6#4)(1997-8#4)(2004-11#1)(2004-4#1)(2004-8#1)(2004-9#1)(2005-1#1)(2005-11#4)(2005-8#1)(2006-1#3)(2006-10#9)(2006-11#2)(2006-12#3)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#4)(2006-7#1)(2006-8#4)(2006-9#1)(2007-1#3)(2007-11#9)(2007-12#24)(2007-2#2)(2007-3#3)(2007-5#1)(2007-7#3)(2007-8#12)(2007-9#3)(2008-1#3)(2008-10#43)(2008-11#8)(2008-12#5)(2008-2#19)(2008-3#17)(2008-4#5)(2008-5#16)(2008-6#9)(2008-7#23)(2008-8#11)(2008-9#8)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#6)(2009-3#4)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#4)(2009-8#1)(2009-9#3)(2010-11#3)(2010-12#3)(2010-2#2)(2010-3#6)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#6)(2011-11#1)(2011-2#15)(2012-1#5)(2012-11#2)(2012-12#12)(2012-2#13)(2012-3#5)(2012-7#1)(2012-9#1)(2013-1#9)(2013-3#1)(2013-7#2)(2013-8#2)
the entirety of##2##3##(1997-3#1)(1997-5#1)
the entity and##2##3##(1993-12#1)(2006-2#1)
the entity##7##2##(1993-12#1)(1993-8#1)(1996-12#1)(2006-2#1)(2006-8#1)(2008-10#1)(2008-12#1)
the entomological##4##2##(2006-4#1)(2007-3#1)(2008-6#1)(2012-12#1)
the entomopathogenic##3##2##(2007-12#1)(2008-5#1)(2008-6#1)
the entorhinal cortex are##2##4##(1994-3#1)(2011-2#1)
the entorhinal cortex##25##3##(1990-7#1)(1991-9#2)(1994-2#1)(1994-3#5)(1994-8#1)(1995-10#1)(1995-12#1)(1995-5#1)(1997-3#1)(1997-5#1)(1997-7#1)(2004-11#2)(2008-11#4)(2011-2#3)
the entorhinal##32##2##(1990-7#1)(1991-1#2)(1991-9#2)(1992-11#1)(1994-2#1)(1994-3#5)(1994-8#1)(1995-10#1)(1995-12#2)(1995-5#1)(1997-1#1)(1997-3#2)(1997-5#1)(1997-7#2)(2004-11#2)(2008-11#4)(2011-2#3)
the entorhinal-hippocampal loop circuits##2##4##(2008-11#2)
the entrainment##3##2##(1994-2#1)(2008-5#1)(2013-1#1)
the entrance of the##3##4##(1992-12#1)(1994-9#1)(2008-3#1)
the entrance of##4##3##(1992-12#1)(1994-9#1)(2008-10#1)(2008-3#1)
the entrance to the##2##4##(2008-11#1)(2011-2#1)
the entrance##17##2##(1992-12#1)(1992-2#1)(1994-9#1)(1995-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2010-12#2)(2010-9#1)(2011-2#1)
the entrapment of##4##3##(2005-11#1)(2007-8#1)(2008-10#1)(2010-4#1)
the entrapment##7##2##(1993-12#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-8#1)(2010-4#1)
the entrapped##12##2##(1990-2#2)(2004-9#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-2#2)(2012-6#1)
the entropic##3##2##(1996-8#1)(2006-10#1)(2013-8#1)
the entropies of##2##3##(2005-11#1)(2008-5#1)
the entropy contribution##2##3##(1996-12#1)(2008-9#1)
the entropy of the##2##4##(1995-6#1)(2008-2#1)
the entropy of##3##3##(1995-6#1)(2006-10#1)(2008-2#1)
the entropy##8##2##(1995-6#1)(1996-12#1)(2006-10#1)(2006-12#1)(2008-2#2)(2008-9#1)(2009-8#1)
the entry and##2##3##(1994-9#1)(2009-4#1)
the entry criterion##3##3##(1994-4#3)
the entry into##5##3##(1993-11#1)(1993-6#1)(1994-5#1)(2010-5#1)(2012-1#1)
the entry of HIV into##2##5##(2008-1#1)(2011-3#1)
the entry of##15##3##(1990-11#1)(1992-2#1)(1993-3#1)(1994-6#1)(1997-2#1)(1997-6#1)(2005-11#1)(2007-10#1)(2008-1#2)(2008-5#1)(2009-8#1)(2011-3#1)(2012-2#1)(2013-8#1)
the entry point##4##3##(1992-9#1)(2008-11#1)(2012-2#1)(2013-8#1)
the entry##40##2##(1990-11#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-4#3)(1994-5#1)(1994-6#2)(1994-9#1)(1996-9#1)(1997-2#1)(1997-6#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-5#1)(2009-4#2)(2009-8#1)(2010-5#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#3)(2013-8#2)
the enucleated##4##2##(1992-10#1)(2008-9#2)(2011-1#1)
the enumeration of##3##3##(1992-8#1)(2006-8#1)(2007-11#1)
the enumeration##4##2##(1992-8#1)(2006-8#1)(2007-11#1)(2013-8#1)
the env gene##3##3##(1992-3#1)(2007-6#2)
the envelope and##2##3##(1993-12#1)(1996-1#1)
the envelope glycoprotein gp120 of##2##5##(1992-8#1)(1993-3#1)
the envelope glycoprotein##6##3##(1992-8#1)(1993-3#4)(1995-5#1)
the envelope is##2##3##(2007-12#1)(2008-8#1)
the envelope of##3##3##(1990-2#1)(2007-12#1)(2008-3#1)
the envelope##19##2##(1990-2#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-3#4)(1995-5#1)(1996-1#1)(1997-6#1)(2007-12#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#1)
the enveloped##2##2##(1994-8#1)(2008-2#1)
the environment and a##2##4##(2008-9#1)(2012-12#1)
the environment and the use of##2##6##(1995-11#1)(2006-5#1)
the environment and the##5##4##(1995-11#1)(2006-1#1)(2006-5#1)(2008-10#1)(2008-4#1)
the environment and therefore##2##4##(2006-7#1)(2013-8#1)
the environment and##36##3##(1990-9#1)(1992-1#1)(1993-12#1)(1995-11#1)(1997-8#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#4)(2013-8#1)
the environment as##2##3##(2008-10#1)(2008-2#1)
the environment at##3##3##(1990-9#1)(2008-10#2)
the environment can##5##3##(2006-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2013-1#1)
the environment from##2##3##(2006-7#1)(2008-3#1)
the environment has##3##3##(2008-10#2)(2011-2#1)
the environment in the##4##4##(1990-3#1)(1992-3#1)(1996-7#1)(2008-8#1)
the environment in which they##2##5##(2008-8#1)(2013-8#1)
the environment in which##6##4##(1991-12#1)(1994-12#1)(2007-2#1)(2008-6#1)(2008-8#1)(2013-8#1)
the environment in##15##3##(1990-3#1)(1991-12#1)(1992-3#2)(1993-2#1)(1994-12#1)(1996-7#1)(1996-9#1)(2007-2#1)(2008-12#1)(2008-6#1)(2008-8#2)(2009-10#1)(2013-8#1)
the environment is##12##3##(2005-11#1)(2007-3#1)(2007-7#1)(2008-10#4)(2008-3#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-1#1)
the environment of Delhi##2##4##(1992-6#2)
the environment of a##2##4##(1994-11#1)(1995-1#1)
the environment of the##12##4##(1991-6#1)(1992-12#1)(1994-5#1)(1994-9#1)(1995-8#1)(1997-2#1)(2008-10#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
the environment of##23##3##(1990-2#1)(1990-7#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-6#2)(1994-11#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-5#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-4#2)(2008-10#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
the environment on the##3##4##(2006-8#1)(2007-7#1)(2007-8#1)
the environment on##4##3##(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#1)
the environment or##3##3##(2006-10#1)(2008-1#1)(2008-5#1)
the environment requires##2##3##(2008-10#1)(2008-2#1)
the environment surrounding##4##3##(1997-4#1)(2007-10#1)(2008-1#1)(2008-6#1)
the environment through##3##3##(2005-11#1)(2007-12#1)(2010-7#1)
the environment to the##2##4##(2006-10#1)(2008-10#1)
the environment to##5##3##(2006-10#1)(2006-9#1)(2008-10#1)(2012-11#1)(2013-8#1)
the environment where##2##3##(1997-2#1)(2008-10#1)
the environment##336##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-6#1)(1991-7#1)(1992-1#2)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-6#3)(1993-12#2)(1993-2#1)(1994-11#1)(1994-12#2)(1994-3#4)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#2)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-4#4)(1997-7#1)(1997-8#1)(2004-4#2)(2005-11#4)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#7)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#2)(2006-7#4)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#6)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#5)(2008-1#6)(2008-10#49)(2008-11#9)(2008-12#3)(2008-2#7)(2008-3#7)(2008-4#2)(2008-5#16)(2008-6#4)(2008-7#5)(2008-8#15)(2008-9#5)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#5)(2009-5#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-12#4)(2010-2#2)(2010-4#1)(2010-5#4)(2010-7#2)(2010-8#4)(2010-9#3)(2011-1#11)(2011-12#1)(2011-2#5)(2012-1#6)(2012-11#1)(2012-12#3)(2012-2#10)(2012-3#2)(2013-1#5)(2013-8#5)
the environmental 'pressure'##2##3##(1991-6#2)
the environmental and biological##3##4##(2008-10#2)(2011-1#1)
the environmental and##10##3##(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-4#1)(2011-1#1)
the environmental compatibility##2##3##(2008-5#2)
the environmental conditions under which##2##5##(2008-10#1)(2008-5#1)
the environmental conditions##11##3##(1990-6#1)(1996-9#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#2)(2010-10#1)(2013-7#1)
the environmental effects and the##2##5##(2006-10#1)(2008-11#1)
the environmental factors that##3##4##(2006-10#1)(2008-10#1)(2012-12#1)
the environmental factors##8##3##(1993-3#1)(2006-10#1)(2008-10#2)(2008-5#1)(2008-9#1)(2011-3#1)(2012-12#1)
the environmental fate##2##3##(2005-11#1)(2008-5#1)
the environmental health##3##3##(1992-6#1)(2008-1#1)(2012-1#1)
the environmental impact of the##2##5##(2005-11#1)(2008-11#1)
the environmental impact of##6##4##(2005-11#2)(2006-7#1)(2008-10#1)(2008-11#1)(2011-2#1)
the environmental impact##7##3##(2005-11#2)(2006-7#1)(2008-10#1)(2008-11#1)(2010-10#1)(2011-2#1)
the environmental impacts of##2##4##(2008-11#2)
the environmental index##2##3##(2008-10#2)
the environmental monitoring of##4##4##(2008-1#1)(2008-10#2)(2013-8#1)
the environmental pollution##2##3##(2010-7#1)(2013-8#1)
the environmental problems caused by##2##5##(1992-3#1)(2009-3#1)
the environmental problems##3##3##(1992-3#1)(2008-1#1)(2009-3#1)
the environmental regulation of##2##4##(2008-10#1)(2012-2#1)
the environmental risk##2##3##(2008-10#1)(2008-11#1)
the environmental temperature##3##3##(1996-10#1)(2006-6#2)
the environmental variables##2##3##(2007-3#1)(2008-10#1)
the environmental variance##2##3##(2008-8#1)(2008-9#1)
the environmental##132##2##(1990-12#1)(1990-6#1)(1991-12#1)(1991-6#2)(1992-3#2)(1992-6#1)(1993-3#1)(1994-6#1)(1996-1#1)(1996-10#1)(1996-9#1)(1997-3#1)(2005-11#3)(2005-12#1)(2005-9#1)(2006-10#3)(2006-12#2)(2006-6#2)(2006-7#1)(2007-3#1)(2007-5#2)(2007-8#1)(2008-1#3)(2008-10#34)(2008-11#7)(2008-3#3)(2008-5#12)(2008-7#1)(2008-8#9)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-10#2)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#2)(2013-8#3)
the environmentally driven##2##3##(2008-2#1)(2008-8#1)
the environmentally##6##2##(1995-11#1)(2008-2#1)(2008-8#1)(2009-4#1)(2012-2#1)(2013-8#1)
the environments##4##2##(2008-10#2)(2008-9#1)(2010-12#1)
the enzymatic activities of##3##4##(1993-12#1)(1997-7#1)(2008-10#1)
the enzymatic activities##7##3##(1990-3#1)(1991-8#1)(1992-7#1)(1993-12#1)(1997-7#1)(2008-10#1)(2008-4#1)
the enzymatic activity of the##9##5##(1990-2#1)(1991-9#1)(1995-8#1)(1997-6#1)(2008-10#2)(2008-6#2)(2008-8#1)
the enzymatic activity of##30##4##(1990-11#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-9#1)(1992-7#2)(1993-12#1)(1993-3#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-2#1)(1995-8#3)(1996-5#2)(1997-6#1)(2005-7#1)(2008-10#5)(2008-11#1)(2008-6#2)(2008-8#1)
the enzymatic activity was##5##4##(1990-1#1)(1992-6#1)(2008-10#2)(2008-8#1)
the enzymatic activity##52##3##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-6#1)(1992-7#2)(1993-12#2)(1993-3#1)(1994-5#1)(1994-6#1)(1995-1#3)(1995-10#1)(1995-2#1)(1995-5#1)(1995-8#3)(1996-5#2)(1997-6#1)(2005-7#1)(2006-8#1)(2008-10#8)(2008-11#2)(2008-6#3)(2008-7#2)(2008-8#2)(2009-12#1)(2009-2#1)
the enzymatic and##3##3##(1990-12#1)(1994-12#1)(2008-4#1)
the enzymatic cleavage##2##3##(1996-12#1)(2008-7#1)
the enzymatic conversion##2##3##(1990-2#1)(2013-1#1)
the enzymatic degradation of##2##4##(2008-10#1)(2008-4#1)
the enzymatic degradation##4##3##(2008-10#2)(2008-4#1)(2011-1#1)
the enzymatic hydrolysis of compound##2##5##(1991-7#2)
the enzymatic hydrolysis of the##2##5##(2008-5#1)(2013-1#1)
the enzymatic hydrolysis of##13##4##(1991-7#3)(2008-10#4)(2008-5#2)(2008-6#1)(2008-7#1)(2013-1#2)
the enzymatic hydrolysis process##3##4##(2008-10#2)(2013-1#1)
the enzymatic hydrolysis##19##3##(1991-7#3)(2008-10#8)(2008-5#3)(2008-6#1)(2008-7#1)(2013-1#3)
the enzymatic oxidation of##3##4##(1991-1#1)(1992-12#1)(2008-10#1)
the enzymatic probe sonication##2##4##(2008-10#2)
the enzymatic properties of Dnmt1##2##5##(2007-10#2)
the enzymatic properties of##3##4##(2007-10#2)(2008-4#1)
the enzymatic properties##5##3##(1992-9#1)(2007-10#2)(2008-4#2)
the enzymatic reactant##2##3##(2005-11#2)
the enzymatic reaction and##2##4##(2008-10#1)(2011-2#1)
the enzymatic reaction is##2##4##(2008-10#2)
the enzymatic reaction of##4##4##(1991-5#1)(2008-10#3)
the enzymatic reaction##26##3##(1990-2#1)(1990-8#1)(1991-5#1)(1991-7#1)(1994-8#1)(1995-3#1)(1996-4#1)(2008-10#15)(2008-4#1)(2008-6#2)(2011-2#1)
the enzymatic reactor##2##3##(2008-10#2)
the enzymatic synthesis of##2##4##(2007-6#1)(2008-5#1)
the enzymatic##180##2##(1990-1#1)(1990-11#2)(1990-12#4)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-5#3)(1991-7#5)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-7#4)(1992-9#2)(1993-12#3)(1993-3#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#3)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#3)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#4)(1997-6#1)(1997-7#3)(2004-8#1)(2005-11#2)(2005-7#1)(2006-12#2)(2006-8#2)(2007-10#2)(2007-6#1)(2008-10#49)(2008-11#2)(2008-12#1)(2008-4#7)(2008-5#6)(2008-6#8)(2008-7#5)(2008-8#2)(2009-12#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#5)
the enzymatically active##3##3##(1994-6#1)(2011-1#2)
the enzymatically##5##2##(1994-12#1)(1994-6#1)(2008-10#1)(2011-1#2)
the enzyme active site##6##4##(1990-12#1)(1995-6#3)(1997-7#1)(2005-7#1)
the enzyme activities##10##3##(1990-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(1996-5#1)(1996-9#1)(2004-11#1)(2006-5#1)(2008-10#1)(2013-8#1)
the enzyme activity and##6##4##(1991-12#1)(1992-8#1)(1994-6#1)(1996-6#1)(1997-6#1)(2006-1#1)
the enzyme activity by 22##2##5##(1994-8#2)
the enzyme activity by##6##4##(1990-5#2)(1992-11#1)(1994-8#2)(2013-1#1)
the enzyme activity decreased##2##4##(2008-7#1)(2008-8#1)
the enzyme activity in##2##4##(1994-8#1)(2008-7#1)
the enzyme activity inNocardia andRhodococcus##2##5##(2008-11#2)
the enzyme activity of##4##4##(1990-5#1)(1994-12#1)(1995-3#1)(1996-5#1)
the enzyme activity to##2##4##(1991-2#1)(2008-6#1)
the enzyme activity was##8##4##(1990-4#1)(1991-2#1)(1993-9#1)(1996-8#1)(2008-10#3)(2008-5#1)
the enzyme activity were##3##4##(1990-5#1)(1990-9#1)(2005-11#1)
the enzyme activity##75##3##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#6)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#5)(1991-4#1)(1991-6#1)(1991-7#1)(1992-11#2)(1992-12#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-3#2)(1993-9#3)(1994-12#1)(1994-6#2)(1994-8#3)(1995-1#1)(1995-11#1)(1995-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-6#1)(2005-11#1)(2006-1#1)(2006-8#1)(2008-10#7)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#3)(2011-2#1)(2012-2#1)(2013-1#2)
the enzyme after##2##3##(1992-6#2)
the enzyme against inactivation##2##4##(1992-5#1)(1996-7#1)
the enzyme against##3##3##(1990-11#1)(1992-5#1)(1996-7#1)
the enzyme also##2##3##(1992-8#1)(1997-4#1)
the enzyme and its##2##4##(1995-2#1)(1996-5#1)
the enzyme and the##9##4##(1991-1#1)(1993-8#1)(1994-9#1)(1996-8#1)(1996-9#1)(1997-4#1)(2008-10#3)
the enzyme and##32##3##(1990-7#1)(1990-9#2)(1991-1#2)(1991-2#1)(1992-6#2)(1993-11#2)(1993-8#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-2#2)(1995-7#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-4#1)(2008-10#6)(2008-5#1)(2008-6#1)(2013-8#1)
the enzyme appears to be##3##5##(1993-6#1)(1997-4#1)(2008-8#1)
the enzyme are##5##3##(1990-5#1)(1991-6#1)(1992-3#1)(1995-12#1)(2008-7#1)
the enzyme as##3##3##(1991-12#1)(1992-4#1)(2008-9#1)
the enzyme assay##2##3##(1993-2#1)(2008-11#1)
the enzyme at the##3##4##(1990-3#1)(1992-3#1)(1994-6#1)
the enzyme at##9##3##(1990-3#1)(1991-2#1)(1991-5#1)(1992-3#1)(1993-8#1)(1994-6#1)(2008-10#2)(2008-9#1)
the enzyme based##2##3##(1991-12#1)(1995-2#1)
the enzyme before##2##3##(1990-3#1)(1997-4#1)
the enzyme bound via##2##4##(2009-12#2)
the enzyme bound##3##3##(1990-12#1)(2009-12#2)
the enzyme but##2##3##(1991-2#1)(1996-7#1)
the enzyme by##26##3##(1990-2#2)(1990-7#3)(1990-8#1)(1991-1#2)(1991-9#1)(1992-2#1)(1992-4#1)(1992-5#1)(1993-11#2)(1993-9#3)(1994-11#2)(1994-12#1)(1995-1#1)(1995-6#1)(1996-2#1)(1997-8#1)(2008-7#1)(2009-7#1)
the enzyme can##3##3##(1992-8#1)(2007-10#1)(2008-10#1)
the enzyme catalytic##2##3##(1991-9#1)(1993-3#1)
the enzyme catalyzed##2##3##(1990-7#1)(1991-9#1)
the enzyme catalyzing the##2##4##(1994-8#1)(2007-3#1)
the enzyme complex##9##3##(1991-1#1)(1994-12#1)(1996-2#3)(1996-5#1)(2010-12#1)(2012-2#1)(2012-3#1)
the enzyme conjugate##3##3##(2008-7#2)(2011-1#1)
the enzyme could be##2##4##(1991-8#1)(1997-8#1)
the enzyme could##3##3##(1991-8#1)(1997-8#1)(2008-10#1)
the enzyme dilution##2##3##(2008-10#2)
the enzyme does not##2##4##(1990-12#1)(1992-4#1)
the enzyme exhibited##2##3##(1994-11#1)(2012-2#1)
the enzyme from E##2##4##(1992-3#1)(1993-6#1)
the enzyme from inactivation##4##4##(1990-12#1)(1991-7#1)(1994-11#1)(1995-11#1)
the enzyme from the##4##4##(1991-2#1)(1993-9#1)(2008-10#1)(2008-11#1)
the enzyme from##33##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#2)(1991-1#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-3#4)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-9#1)(1995-11#1)(1995-8#1)(1996-2#3)(1996-7#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)
the enzyme has a##2##4##(1990-12#1)(1990-5#1)
the enzyme has been##4##4##(1990-5#1)(1994-8#1)(2008-10#1)(2008-7#1)
the enzyme has##10##3##(1990-12#2)(1990-5#2)(1994-8#1)(1995-5#1)(1996-6#1)(2008-10#1)(2008-7#1)(2011-1#1)
the enzyme in a##6##4##(1990-11#2)(1990-4#1)(1991-2#1)(1995-5#1)(2008-10#1)
the enzyme in an##2##4##(2008-10#1)(2008-5#1)
the enzyme in solution##2##4##(1995-11#1)(2008-10#1)
the enzyme in the presence of##2##6##(1993-6#1)(2008-4#1)
the enzyme in the##11##4##(1990-10#1)(1990-5#1)(1992-2#1)(1992-9#1)(1993-6#3)(2008-10#3)(2008-4#1)
the enzyme in these##2##4##(1996-2#1)(2008-11#1)
the enzyme in##42##3##(1990-10#3)(1990-11#3)(1990-4#1)(1990-5#2)(1990-8#1)(1991-12#1)(1991-2#4)(1992-2#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-6#3)(1994-11#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-2#3)(1996-6#1)(1996-7#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)
the enzyme inactivation##2##3##(1990-5#1)(1992-12#1)
the enzyme increased##3##3##(1990-5#1)(1990-7#1)(1991-2#1)
the enzyme incubation##2##3##(2008-10#1)(2008-11#1)
the enzyme inhibition##2##3##(1991-7#1)(2008-10#1)
the enzyme involved in the##2##5##(1990-11#1)(1997-4#1)
the enzyme involved in##3##4##(1990-11#1)(1994-8#1)(1997-4#1)
the enzyme involved##4##3##(1990-11#1)(1994-11#1)(1994-8#1)(1997-4#1)
the enzyme is activated##3##4##(1990-2#1)(1994-12#1)(2008-4#1)
the enzyme is bound to##2##5##(1995-11#1)(1996-2#1)
the enzyme is inhibited by##2##5##(1991-3#1)(1992-12#1)
the enzyme is probably##2##4##(1992-9#1)(1996-5#1)
the enzyme is suggested##2##4##(1991-3#1)(1996-2#1)
the enzyme is synthesized##2##4##(1990-5#1)(1991-7#1)
the enzyme is##49##3##(1990-11#1)(1990-12#3)(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-3#5)(1991-5#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-4#2)(1992-8#1)(1992-9#3)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-2#2)(1996-5#1)(1996-7#1)(2006-3#1)(2007-6#1)(2008-4#1)(2008-9#1)
the enzyme isolated from##2##4##(1990-3#1)(1992-7#1)
the enzyme isolation method##2##4##(1991-7#2)
the enzyme layer##4##3##(2007-6#1)(2007-8#1)(2008-10#2)
the enzyme loading and time of##2##6##(2008-10#2)
the enzyme loading and##3##4##(2008-10#3)
the enzyme loading##4##3##(2008-10#3)(2008-6#1)
the enzyme may##3##3##(1993-11#1)(1994-12#1)(1995-3#1)
the enzyme microenvironment##2##3##(2008-10#2)
the enzyme molecule##5##3##(1991-5#1)(1992-11#1)(1992-2#1)(1993-8#1)(1994-11#1)
the enzyme molecules##2##3##(2008-10#2)
the enzyme nor##3##3##(1991-12#1)(1993-3#1)(2008-9#1)
the enzyme of##4##3##(1991-9#2)(1996-7#1)(2007-12#1)
the enzyme on the##2##4##(1993-11#1)(2008-10#1)
the enzyme on##5##3##(1990-7#1)(1991-5#1)(1993-11#1)(1995-6#1)(2008-10#1)
the enzyme per se##2##4##(1990-2#1)(1996-4#1)
the enzyme phospholipase A2##2##4##(1990-11#1)(1991-8#1)
the enzyme preparation##4##3##(1990-2#1)(1991-3#1)(1992-2#1)(1995-5#1)
the enzyme preparations##2##3##(1996-6#1)(1997-7#1)
the enzyme prior to##2##4##(1991-2#1)(1993-3#1)
the enzyme product 13-HPODE##2##4##(1995-5#2)
the enzyme production##2##3##(2008-5#2)
the enzyme protein##3##3##(1991-1#1)(1994-2#1)(1996-7#1)
the enzyme purified from##4##4##(1993-8#2)(1995-2#1)(1997-8#1)
the enzyme pyranose##2##3##(1995-2#1)(2008-6#1)
the enzyme reaction##12##3##(1990-5#1)(1992-11#1)(1995-1#1)(1997-2#1)(1997-6#1)(2007-8#1)(2008-10#5)(2011-2#1)
the enzyme reactor##3##3##(2007-8#1)(2008-10#1)(2008-6#1)
the enzyme remains##3##3##(1990-8#1)(1995-2#1)(2012-2#1)
the enzyme responsible for the##6##5##(1990-8#1)(1991-10#1)(1991-8#1)(1992-11#1)(1994-3#1)(2008-11#1)
the enzyme responsible for##11##4##(1990-8#1)(1991-10#1)(1991-6#1)(1991-8#1)(1992-11#1)(1994-3#2)(1996-6#1)(2007-5#1)(2008-11#1)(2012-2#1)
the enzyme secreted by##2##4##(1993-3#2)
the enzyme showed##2##3##(1990-3#1)(2013-1#1)
the enzyme shows##3##3##(1990-9#1)(1991-5#1)(2005-11#1)
the enzyme solution##3##3##(2008-10#3)
the enzyme structure##2##3##(1990-2#1)(2008-7#1)
the enzyme subsites##2##3##(1992-8#1)(2004-12#1)
the enzyme substrate##4##3##(1992-6#1)(1995-5#1)(2007-8#1)(2010-5#1)
the enzyme surface##2##3##(2009-12#1)(2013-8#1)
the enzyme telomerase##2##3##(2007-11#1)(2008-4#1)
the enzyme that catalyzes##2##4##(1991-10#1)(1997-1#1)
the enzyme that is##3##4##(1990-5#1)(2008-7#1)(2009-8#1)
the enzyme that##16##3##(1990-5#2)(1991-10#1)(1991-9#1)(1992-6#1)(1993-9#1)(1995-10#1)(1995-3#1)(1997-1#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-7#1)(2009-8#1)(2010-11#1)(2013-1#1)
the enzyme through##3##3##(1990-4#1)(1994-8#1)(2008-10#1)
the enzyme to the##5##4##(1990-2#1)(1992-12#1)(1993-6#1)(1994-8#1)(1995-8#1)
the enzyme to##20##3##(1990-12#1)(1990-2#2)(1990-3#1)(1991-1#1)(1991-2#2)(1992-12#1)(1993-6#1)(1994-8#1)(1995-2#1)(1995-6#3)(1995-8#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-5#1)(2009-8#1)
the enzyme toward##2##3##(1993-6#1)(1995-6#1)
the enzyme tyrosinase##3##3##(1992-3#1)(2008-5#1)(2012-12#1)
the enzyme undergoes##2##3##(1997-5#1)(2009-5#1)
the enzyme upon the##2##4##(1990-5#1)(1995-5#1)
the enzyme upon##4##3##(1990-5#1)(1990-8#1)(1995-5#1)(1996-8#1)
the enzyme was also##3##4##(1990-2#1)(1992-12#1)(1994-12#1)
the enzyme was expressed in##2##5##(1990-8#1)(1991-4#1)
the enzyme was found##3##4##(1992-12#1)(1997-1#1)(1997-4#1)
the enzyme was incubated with##2##5##(1996-5#1)(1996-7#1)
the enzyme was inhibited by##2##5##(1990-10#1)(1991-12#1)
the enzyme was purified##2##4##(1994-6#1)(1994-8#1)
the enzyme was shown##2##4##(1990-10#1)(2008-9#1)
the enzyme was##52##3##(1990-10#3)(1990-12#1)(1990-2#1)(1990-4#2)(1990-7#1)(1990-8#2)(1991-12#1)(1991-4#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#1)(1992-5#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-5#2)(1996-7#2)(1996-8#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-6#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-6#2)(2008-9#1)(2013-1#1)
the enzyme were##11##3##(1990-12#2)(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-12#1)(1996-5#1)(1996-7#1)(2006-10#1)(2006-8#1)
the enzyme when##2##3##(1993-6#1)(1994-8#1)
the enzyme which catalyzes the##3##5##(1993-8#1)(1995-9#1)(1996-6#1)
the enzyme which##8##3##(1992-9#1)(1993-8#1)(1994-11#1)(1995-1#1)(1995-9#1)(1996-6#1)(2008-11#1)(2008-5#1)
the enzyme with a##6##4##(1990-4#1)(1991-3#1)(1992-5#1)(1993-4#1)(1993-6#1)(1994-5#1)
the enzyme with##25##3##(1990-2#2)(1990-4#1)(1990-7#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#1)(1992-5#1)(1993-11#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-6#2)(1997-6#1)(2008-10#2)(2009-11#1)
the enzyme##1145##2##(1990-10#12)(1990-11#9)(1990-12#24)(1990-2#19)(1990-3#12)(1990-4#8)(1990-5#31)(1990-7#21)(1990-8#19)(1990-9#9)(1991-1#11)(1991-10#7)(1991-11#2)(1991-12#14)(1991-2#38)(1991-3#12)(1991-4#5)(1991-5#24)(1991-6#4)(1991-7#11)(1991-8#11)(1991-9#12)(1992-1#4)(1992-11#13)(1992-12#18)(1992-2#9)(1992-3#18)(1992-4#10)(1992-5#5)(1992-6#18)(1992-7#4)(1992-8#12)(1992-9#7)(1993-11#13)(1993-12#1)(1993-2#2)(1993-3#18)(1993-4#2)(1993-6#11)(1993-8#12)(1993-9#12)(1994-10#2)(1994-11#26)(1994-12#12)(1994-2#4)(1994-3#8)(1994-5#8)(1994-6#11)(1994-8#23)(1994-9#18)(1995-1#11)(1995-10#3)(1995-11#9)(1995-12#4)(1995-2#13)(1995-3#9)(1995-5#12)(1995-6#15)(1995-7#2)(1995-8#8)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#15)(1996-3#1)(1996-4#1)(1996-5#12)(1996-6#10)(1996-7#26)(1996-8#15)(1996-9#6)(1997-1#18)(1997-2#12)(1997-4#20)(1997-5#2)(1997-6#12)(1997-7#7)(1997-8#3)(2004-11#1)(2004-12#1)(2005-11#5)(2005-7#2)(2006-1#1)(2006-10#5)(2006-2#1)(2006-3#2)(2006-5#2)(2006-8#3)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-3#1)(2007-5#1)(2007-6#3)(2007-8#9)(2008-1#3)(2008-10#86)(2008-11#12)(2008-3#1)(2008-4#9)(2008-5#14)(2008-6#13)(2008-7#14)(2008-8#5)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#11)(2009-2#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#3)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#6)(2012-2#7)(2012-3#2)(2013-1#9)(2013-8#4)
the enzyme's active site##6##4##(1992-12#1)(1992-5#1)(1993-8#1)(1995-5#1)(2009-12#2)
the enzyme's active##7##3##(1992-12#1)(1992-5#1)(1993-8#1)(1995-5#1)(1997-4#1)(2009-12#2)
the enzyme's active-site##2##3##(1990-7#1)(1994-8#1)
the enzyme's activity##3##3##(1990-4#1)(1991-12#1)(2011-1#1)
the enzyme's##24##2##(1990-4#1)(1990-7#1)(1991-12#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-11#2)(1993-8#1)(1994-5#1)(1994-8#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-4#1)(2008-10#1)(2008-5#2)(2008-8#1)(2009-12#3)(2011-1#1)(2012-2#1)
the enzyme(s)##3##2##(1990-11#1)(1990-7#1)(1994-8#1)
the enzyme-based##2##2##(2008-10#1)(2010-2#1)
the enzyme-bound coenzyme##2##3##(1992-6#1)(1995-10#1)
the enzyme-bound##8##2##(1991-4#1)(1991-9#1)(1992-3#1)(1992-6#2)(1993-11#1)(1993-6#1)(1995-10#1)
the enzyme-catalyzed##11##2##(1990-2#1)(1991-2#1)(1993-8#1)(2007-8#1)(2008-10#4)(2008-7#1)(2008-9#1)(2010-4#1)
the enzyme-free##2##2##(1994-3#2)
the enzyme-inhibitor complex##3##3##(1993-11#1)(1997-1#1)(1997-6#1)
the enzyme-inhibitor##6##2##(1991-2#1)(1992-6#2)(1993-11#1)(1997-1#1)(1997-6#1)
the enzyme-linked immunosorbent assay (ELISA)##6##5##(1996-9#1)(2005-8#1)(2007-2#1)(2008-10#2)(2008-4#1)
the enzyme-linked immunosorbent assay##7##4##(1996-9#1)(2005-8#1)(2007-2#1)(2008-10#3)(2008-4#1)
the enzyme-linked immunosorbent##9##3##(1996-9#1)(2005-8#1)(2007-2#2)(2008-10#4)(2008-4#1)
the enzyme-linked##11##2##(1991-8#1)(1996-9#1)(2005-8#1)(2007-2#2)(2008-10#4)(2008-4#2)
the enzyme-substrate complex##5##3##(1990-8#1)(1991-7#1)(1994-5#1)(2007-6#1)(2008-5#1)
the enzyme-substrate complexes##2##3##(1990-12#1)(1994-5#1)
the enzyme-substrate##10##2##(1990-12#1)(1990-8#1)(1990-9#1)(1991-7#1)(1994-5#2)(2007-6#1)(2008-10#2)(2008-5#1)
the enzymes and the##2##4##(1993-3#1)(1997-6#1)
the enzymes and##5##3##(1993-3#1)(1993-9#1)(1994-3#1)(1997-6#1)(2007-12#1)
the enzymes expressed##2##3##(1997-8#1)(2008-11#1)
the enzymes from E##2##4##(1991-9#1)(1995-6#1)
the enzymes from##5##3##(1990-11#1)(1991-12#1)(1991-9#1)(1992-7#1)(1995-6#1)
the enzymes in##2##3##(2009-2#1)(2012-2#1)
the enzymes involved in##7##4##(1991-4#1)(1994-9#1)(2007-10#1)(2008-10#1)(2008-5#1)(2011-1#1)(2013-1#1)
the enzymes involved##8##3##(1991-4#1)(1992-8#1)(1994-9#1)(2007-10#1)(2008-10#1)(2008-5#1)(2011-1#1)(2013-1#1)
the enzymes of the##3##4##(1991-4#1)(1997-1#1)(2010-5#1)
the enzymes of##6##3##(1991-4#1)(1997-1#1)(2004-11#1)(2008-3#1)(2010-5#1)(2010-7#1)
the enzymes responsible for the##4##5##(1991-7#1)(1994-3#1)(1997-4#1)(2005-7#1)
the enzymes responsible for##6##4##(1991-7#1)(1994-3#1)(1997-4#1)(2005-7#1)(2008-4#1)(2010-7#1)
the enzymes studied##2##3##(1995-12#1)(2008-5#1)
the enzymes that##4##3##(2007-3#1)(2008-4#1)(2010-2#1)(2011-1#1)
the enzymes were##3##3##(1991-11#1)(1994-12#1)(1997-6#1)
the enzymes with##2##3##(1992-12#1)(1995-5#1)
the enzymes##102##2##(1990-11#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-4#2)(1991-5#4)(1991-7#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#4)(1994-5#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#3)(1997-8#1)(2004-11#1)(2005-7#2)(2005-8#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#2)(2009-2#1)(2010-2#1)(2010-5#2)(2010-7#2)(2011-1#4)(2011-12#1)(2012-2#1)(2013-1#1)
the enzymic##3##2##(1991-5#2)(1995-10#1)
the enzymology##2##2##(1996-6#1)(2008-4#1)
the eosinophil##6##2##(1992-3#1)(1992-6#1)(1994-6#1)(2010-12#1)(2011-2#1)(2012-2#1)
the eosinophilia##2##2##(1990-11#1)(2008-7#1)
the eosinophilic matrix##2##3##(2012-1#2)
the eosinophilic##4##2##(2008-11#1)(2008-5#1)(2012-1#2)
the epicardial##2##2##(1996-9#1)(2012-12#1)
the epicardium##2##2##(2007-8#1)(2008-5#1)
the epicenter of the##3##4##(2005-8#1)(2010-2#1)(2013-1#1)
the epicenter##4##2##(2005-8#1)(2010-2#1)(2011-1#1)(2013-1#1)
the epicondylar area##2##3##(2007-11#2)
the epidemic and##3##3##(1993-3#1)(2007-12#1)(2009-10#1)
the epidemic in##10##3##(1990-12#1)(1992-5#1)(1995-6#1)(1996-11#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-1#1)(2011-1#1)(2011-2#1)
the epidemic of##7##3##(1996-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
the epidemic onset##2##3##(2008-10#2)
the epidemic strains##2##3##(2011-1#2)
the epidemic threshold##2##3##(1996-11#1)(2008-10#1)
the epidemic was##3##3##(2008-10#3)
the epidemic##96##2##(1990-12#3)(1990-6#1)(1991-12#1)(1992-12#1)(1992-5#1)(1993-3#2)(1994-4#1)(1995-12#1)(1995-6#1)(1996-11#4)(1996-3#1)(1996-5#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-7#6)(2007-9#3)(2008-1#4)(2008-10#39)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-1#3)(2011-2#2)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#2)
the epidemic's##3##2##(1997-3#1)(1997-6#1)(2008-8#1)
the epidemics in each##2##4##(2008-10#2)
the epidemics of the##2##4##(2008-10#1)(2012-12#1)
the epidemics of##3##3##(2007-10#1)(2008-10#1)(2012-12#1)
the epidemics##13##2##(2004-11#1)(2007-10#1)(2008-10#7)(2010-12#1)(2012-12#1)(2012-3#2)
the epidemiologic and##2##3##(1994-4#1)(2007-7#1)
the epidemiologic data##3##3##(2006-9#1)(2009-9#1)(2013-8#1)
the epidemiologic##11##2##(1990-12#1)(1990-9#1)(1994-4#1)(2006-9#1)(2007-7#1)(2008-7#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
the epidemiological and clinical aspects of##2##6##(2006-8#1)(2010-7#1)
the epidemiological and clinical##3##4##(2006-8#1)(2008-3#1)(2010-7#1)
the epidemiological and##6##3##(2005-10#1)(2006-8#1)(2008-10#1)(2008-3#1)(2010-7#1)(2013-7#1)
the epidemiological aspects##2##3##(1997-2#1)(2007-2#1)
the epidemiological characteristics of##3##4##(2011-1#1)(2011-2#2)
the epidemiological characteristics##5##3##(2007-7#1)(2011-1#1)(2011-12#1)(2011-2#2)
the epidemiological data of##2##4##(2006-4#1)(2013-1#1)
the epidemiological evidence and the##2##5##(1992-4#1)(2008-5#1)
the epidemiological evidence##8##3##(1992-4#1)(2005-10#2)(2006-2#1)(2008-5#1)(2010-5#1)(2010-6#1)(2013-1#1)
the epidemiological literature##2##3##(2008-8#1)(2013-1#1)
the epidemiological situation in Norway##2##5##(1994-6#1)(1996-6#1)
the epidemiological surveillance system##2##4##(1993-3#1)(1993-6#1)
the epidemiological surveillance##3##3##(1993-3#1)(1993-6#1)(2012-12#1)
the epidemiological##48##2##(1990-6#1)(1991-10#1)(1991-2#1)(1991-9#1)(1992-4#1)(1993-10#1)(1993-3#1)(1993-6#1)(1994-6#1)(1996-6#1)(1997-2#1)(2005-10#4)(2006-10#1)(2006-12#1)(2006-2#2)(2006-4#1)(2006-8#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#1)(2013-1#3)(2013-7#1)
the epidemiologist##4##2##(1994-3#4)
the epidemiology and clinical features of##2##6##(2007-2#1)(2011-1#1)
the epidemiology and clinical##3##4##(2007-2#1)(2009-4#1)(2011-1#1)
the epidemiology and management of soilborne##2##6##(2008-10#2)
the epidemiology and management of##5##5##(2007-12#1)(2008-10#4)
the epidemiology and pathophysiology of##2##5##(2006-10#1)(2006-7#1)
the epidemiology and##23##3##(2005-11#1)(2006-10#1)(2006-7#1)(2006-8#2)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#6)(2008-4#2)(2008-6#1)(2008-9#1)(2009-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
the epidemiology of acute##2##4##(1992-6#1)(2007-8#1)
the epidemiology of malaria##2##4##(2005-8#1)(2008-8#1)
the epidemiology of pediatric##2##4##(1995-12#1)(2013-1#1)
the epidemiology of the disease and##2##6##(2006-4#1)(2008-10#1)
the epidemiology of the##6##4##(2006-4#1)(2008-10#3)(2008-3#1)(2008-9#1)
the epidemiology of##73##3##(1990-12#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-6#1)(1994-8#1)(1995-12#2)(1995-9#1)(1996-9#1)(1997-1#1)(2004-9#1)(2005-10#1)(2005-5#1)(2005-6#1)(2005-8#2)(2006-10#4)(2006-4#1)(2006-8#2)(2007-10#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#2)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#4)(2011-3#1)(2012-12#1)(2013-1#4)
the epidemiology##133##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-6#1)(1994-4#1)(1994-8#1)(1995-12#2)(1995-9#1)(1996-9#1)(1997-1#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-6#1)(2005-8#3)(2005-9#1)(2006-10#11)(2006-4#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#2)(2007-3#1)(2007-6#1)(2007-8#3)(2008-1#2)(2008-10#19)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#4)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-4#5)(2010-12#3)(2010-2#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#7)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#1)
the epidermal cell##3##3##(1991-1#1)(2008-10#1)(2008-7#1)
the epidermal cells##4##3##(2007-12#1)(2008-10#1)(2010-3#1)(2011-1#1)
the epidermal growth factor (EGF) receptor##7##6##(1990-11#1)(1990-5#1)(1992-12#1)(1995-2#1)(1997-2#1)(1997-7#1)(2007-8#1)
the epidermal growth factor (EGF)##10##5##(1990-11#1)(1990-5#1)(1992-12#1)(1995-2#1)(1996-8#1)(1997-2#1)(1997-7#1)(2006-10#1)(2007-8#1)(2011-2#1)
the epidermal growth factor induced##2##5##(1993-3#1)(1993-9#1)
the epidermal growth factor receptor (EGF-R)##3##6##(1994-8#1)(1995-6#1)(2005-7#1)
the epidermal growth factor receptor (EGFR)##6##6##(1990-9#1)(2008-7#1)(2010-12#1)(2010-5#1)(2012-1#2)
the epidermal growth factor receptor##23##5##(1990-5#1)(1990-9#1)(1991-11#1)(1991-9#1)(1993-4#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-11#1)(1996-5#1)(2005-7#1)(2008-7#1)(2010-12#1)(2010-5#1)(2012-1#2)(2012-12#1)(2013-1#2)
the epidermal growth factor##36##4##(1990-11#1)(1990-5#2)(1990-9#1)(1991-11#1)(1991-9#1)(1992-12#1)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-6#2)(1996-11#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-7#1)(2005-7#1)(2006-10#1)(2007-8#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#2)
the epidermal growth##38##3##(1990-11#1)(1990-5#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-9#1)(1992-12#1)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-6#2)(1996-11#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-7#1)(2005-7#1)(2006-10#1)(2007-8#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#2)
the epidermal layer##2##3##(1997-5#1)(2008-10#1)
the epidermal layers of the eschar##2##6##(2013-8#2)
the epidermal##65##2##(1990-11#1)(1990-5#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-6#2)(1996-11#2)(1996-5#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-5#4)(2008-7#2)(2008-9#2)(2010-10#1)(2010-12#1)(2010-3#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#2)(2013-1#3)(2013-8#2)
the epidermis and dermis##6##4##(1996-12#1)(2007-11#1)(2008-5#3)(2008-9#1)
the epidermis and outer cortex tissues##4##6##(2008-10#4)
the epidermis and the dermis##2##5##(2008-1#1)(2008-5#1)
the epidermis and the##5##4##(2008-1#1)(2008-10#1)(2008-5#2)(2008-7#1)
the epidermis and##22##3##(1996-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-5#7)(2008-7#1)(2008-9#2)
the epidermis by##2##3##(2008-4#1)(2010-12#1)
the epidermis in##5##3##(2006-9#1)(2008-1#1)(2010-6#1)(2012-12#2)
the epidermis is##2##3##(2007-12#1)(2010-7#1)
the epidermis of##7##3##(1996-12#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-5#2)
the epidermis or##3##3##(2008-10#1)(2010-12#1)(2010-6#1)
the epidermis##106##2##(1992-11#1)(1992-8#1)(1993-5#2)(1994-5#1)(1995-11#2)(1996-12#4)(1996-2#1)(1996-6#2)(2006-9#2)(2007-11#1)(2007-12#11)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#15)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#19)(2008-7#2)(2008-9#6)(2009-8#2)(2010-12#2)(2010-3#1)(2010-6#6)(2010-7#1)(2011-3#1)(2012-12#13)
the epididymal##4##2##(1997-1#2)(1997-8#1)(2008-4#1)
the epididymis and##3##3##(1992-3#1)(2006-7#1)(2008-9#1)
the epididymis##12##2##(1992-3#2)(1992-9#1)(1996-8#1)(2006-7#1)(2008-9#2)(2011-1#2)(2012-12#1)(2013-8#2)
the epidural space##12##3##(1993-10#5)(2006-10#1)(2006-12#1)(2006-8#3)(2009-3#1)(2010-7#1)
the epidural##24##2##(1993-10#6)(1993-4#1)(1996-12#1)(2006-10#2)(2006-12#4)(2006-7#1)(2006-8#3)(2009-3#1)(2010-7#1)(2012-3#1)(2013-1#3)
the epigenetic influence of##2##4##(2009-3#2)
the epigenetic influence##3##3##(2009-3#3)
the epigenetic##13##2##(2007-10#1)(2008-8#2)(2009-3#4)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
the epigenome is##2##3##(2011-2#1)(2012-2#1)
the epigenome##10##2##(2007-10#1)(2011-1#1)(2011-2#2)(2012-2#6)
the epilepsy patients was##2##4##(2008-8#1)(2010-8#1)
the epilepsy patients##4##3##(2008-8#3)(2010-8#1)
the epilepsy service##2##3##(1997-8#2)
the epilepsy##7##2##(1997-8#2)(2008-8#4)(2010-8#1)
the epileptic##7##2##(1992-9#1)(1995-9#1)(1996-9#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-8#1)
the epileptogenic human neocortex##3##4##(1992-8#3)
the epileptogenic##7##2##(1992-8#3)(1997-3#1)(2008-1#1)(2009-8#1)(2010-5#1)
the epinephrine##4##2##(1994-3#1)(2005-8#1)(2008-10#2)
the epiphyseal growth##2##3##(2007-11#1)(2007-7#1)
the epiphyseal##7##2##(1992-8#1)(1996-11#1)(2007-11#1)(2007-7#2)(2008-4#1)(2011-2#1)
the epiphyses##3##2##(1995-6#1)(2009-2#1)(2009-7#1)
the epiphysis##9##2##(1990-2#1)(1995-6#1)(2007-11#1)(2008-1#1)(2008-8#2)(2009-2#3)
the epiphytic##3##2##(2008-10#1)(2008-5#1)(2013-7#1)
the episode##6##2##(1996-6#1)(2007-2#1)(2007-9#1)(2008-2#1)(2009-3#1)(2011-1#1)
the episodes of##2##3##(2008-1#1)(2008-10#1)
the episodes##3##2##(1996-12#1)(2008-1#1)(2008-10#1)
the epistemic##3##2##(2006-9#1)(2009-2#1)(2013-1#1)
the epistemological crisis in genomics##2##5##(2009-5#2)
the epistemological##6##2##(2007-12#1)(2008-11#1)(2009-5#2)(2010-12#1)(2012-2#1)
the epistemology of##2##3##(2011-2#1)(2013-1#1)
the epitaxial growth of##2##4##(1992-11#1)(2008-7#1)
the epithelia##3##2##(1992-11#1)(2007-11#1)(2008-5#1)
the epithelial barrier##3##3##(2006-10#2)(2008-5#1)
the epithelial cell##8##3##(1991-5#1)(1992-3#1)(1992-5#1)(1993-8#1)(1994-3#1)(1997-6#1)(2006-10#1)(2008-7#1)
the epithelial cells of the##3##5##(1990-12#1)(2008-10#1)(2008-8#1)
the epithelial cells of##7##4##(1990-12#1)(1994-3#1)(1996-5#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-8#1)
the epithelial cells that##2##4##(1995-11#1)(2010-11#1)
the epithelial cells##22##3##(1990-12#1)(1991-2#1)(1991-9#1)(1994-3#1)(1995-11#1)(1996-11#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-12#4)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-11#1)(2013-1#1)
the epithelial component of##2##4##(2007-10#1)(2009-5#1)
the epithelial cycle##7##3##(2009-10#3)(2012-2#4)
the epithelial layer##2##3##(1997-6#1)(2006-10#1)
the epithelial lining fluid##2##4##(2005-11#1)(2010-5#1)
the epithelial lining of the##2##5##(2006-10#1)(2007-12#1)
the epithelial lining##4##3##(2005-11#1)(2006-10#1)(2007-12#1)(2010-5#1)
the epithelial nature of the##2##5##(1991-12#1)(1992-11#1)
the epithelial##75##2##(1990-12#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#2)(1992-1#3)(1992-11#1)(1992-3#1)(1992-5#1)(1993-8#1)(1994-3#2)(1995-11#1)(1996-11#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#5)(1997-8#1)(2005-11#2)(2006-10#7)(2007-10#1)(2007-12#8)(2008-10#2)(2008-12#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#3)(2009-5#1)(2010-11#1)(2010-5#1)(2010-6#1)(2012-1#2)(2012-12#3)(2012-2#4)(2013-1#1)
the epithelial-mesenchymal##2##2##(2008-5#1)(2010-12#1)
the epithelium and in##3##4##(2008-8#1)(2013-1#2)
the epithelium and##6##3##(2005-11#1)(2007-12#1)(2008-8#1)(2013-1#3)
the epithelium during##2##3##(1995-5#1)(2012-2#1)
the epithelium in##4##3##(1994-3#1)(2008-4#1)(2010-12#1)(2013-1#1)
the epithelium lining the##2##4##(1992-6#1)(2007-12#1)
the epithelium of the##8##4##(1996-3#1)(2005-11#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-12#1)(2008-7#1)(2010-11#1)
the epithelium of##12##3##(1991-5#1)(1996-3#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-11#1)(2012-1#1)
the epithelium with##2##3##(1994-5#2)
the epithelium##51##2##(1991-5#2)(1992-6#1)(1994-3#2)(1994-5#2)(1995-5#1)(1995-8#1)(1996-3#1)(1997-1#2)(2005-11#2)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#4)(2007-9#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2009-10#2)(2009-7#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#5)(2013-7#1)
the epitope recognized by the##3##5##(1991-2#1)(1995-4#1)(2008-8#1)
the epitope regions##2##3##(2008-11#2)
the epitope##23##2##(1990-11#2)(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1993-12#1)(1994-6#1)(1995-2#1)(1995-4#1)(1995-5#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-11#3)(2008-8#2)(2009-3#1)
the epitope-tagged##2##2##(1992-9#1)(2008-2#1)
the epitopes are##2##3##(1995-8#1)(2008-10#1)
the epitopes recognized by the##2##5##(1990-12#1)(2008-10#1)
the epitopes##10##2##(1990-12#1)(1992-11#1)(1993-6#2)(1995-6#1)(1995-8#1)(2006-6#1)(2008-10#2)(2008-8#1)
the epizootic##2##2##(2005-9#2)
the epoetin##2##2##(2007-11#1)(2008-7#1)
the epothilones##3##2##(2009-9#1)(2011-12#2)
the epoxidation of##4##3##(1990-12#1)(1992-5#1)(2007-10#1)(2007-11#1)
the epoxidation##5##2##(1990-12#1)(1992-5#1)(1996-5#1)(2007-10#1)(2007-11#1)
the epoxide hydrolase##3##3##(1994-9#2)(1995-8#1)
the epoxide##7##2##(1990-6#1)(1994-9#4)(1995-1#1)(1995-8#1)
the epoxy group##2##3##(2007-11#1)(2008-10#1)
the epoxy##8##2##(1996-5#1)(2007-11#1)(2008-10#2)(2008-3#1)(2010-4#3)
the epsilon 2 allele##2##4##(1991-1#1)(1995-12#1)
the epsilon 2/zeta 1##2##4##(1995-3#2)
the epsilon 4 allele##3##4##(1991-1#1)(1995-12#1)(1996-5#1)
the epsilon subdivision of##2##4##(1997-1#1)(2006-8#1)
the epsilon subunit##4##3##(1994-10#1)(1995-1#2)(1996-4#1)
the epsilon##16##2##(1991-1#2)(1994-10#1)(1995-1#2)(1995-12#2)(1995-3#2)(1996-1#1)(1996-4#1)(1996-5#1)(1997-1#1)(2006-8#1)(2009-7#2)
the epsilon-amino group of lysine##2##5##(1991-4#1)(1996-8#1)
the epsilon-amino##4##2##(1991-4#1)(1992-6#2)(1996-8#1)
the epsp##3##2##(1991-6#3)
the equal##7##2##(1990-9#1)(1997-5#1)(2005-11#1)(2006-1#1)(2008-10#1)(2009-3#1)(2011-2#1)
the equality of##3##3##(1996-3#1)(2006-8#1)(2013-1#1)
the equality##6##2##(1996-3#1)(2005-11#2)(2006-8#1)(2008-3#1)(2013-1#1)
the equalization##2##2##(2008-1#1)(2008-2#1)
the equally##2##2##(2008-3#1)(2010-10#1)
the equation is##3##3##(2008-2#1)(2008-3#2)
the equation of the##2##4##(2008-10#1)(2008-2#1)
the equation of##10##3##(1990-8#1)(1996-5#1)(2005-11#3)(2008-10#1)(2008-2#3)(2011-1#1)
the equation##40##2##(1990-8#1)(1991-2#1)(1995-2#1)(1995-6#1)(1996-5#2)(2004-12#1)(2005-11#5)(2006-10#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#6)(2008-3#3)(2008-7#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#1)
the equations for the##4##4##(1996-12#1)(2007-12#1)(2007-9#1)(2008-10#1)
the equations for##7##3##(1996-12#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-3#1)(2012-3#1)
the equations of motion##2##4##(2007-12#1)(2008-3#1)
the equations of##7##3##(1993-7#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-3#1)(2009-11#1)
the equations to##3##3##(1990-12#1)(2007-12#2)
the equations##30##2##(1990-12#1)(1993-7#1)(1996-12#1)(1996-9#1)(2007-11#1)(2007-12#5)(2007-9#2)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#4)(2008-6#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-3#1)
the equator##3##2##(1992-7#1)(1993-4#1)(2010-6#1)
the equatorial plane##2##3##(1996-2#1)(1997-7#1)
the equatorial position##2##3##(2008-5#1)(2010-5#1)
the equatorial##12##2##(1992-7#1)(1995-11#1)(1996-2#2)(1996-5#1)(1997-7#3)(2007-12#1)(2008-3#1)(2008-5#1)(2010-5#1)
the equilibration of the##2##4##(1996-4#1)(2012-12#1)
the equilibration of##3##3##(1996-4#1)(2010-9#1)(2012-12#1)
the equilibration time##2##3##(2008-10#2)
the equilibration##10##2##(1990-12#1)(1992-6#1)(1996-4#2)(1996-5#1)(2008-10#3)(2010-9#1)(2012-12#1)
the equilibria##4##2##(2005-11#1)(2006-10#1)(2008-10#2)
the equilibrium and##2##3##(2005-11#1)(2006-10#1)
the equilibrium between the##4##4##(1991-4#1)(1993-9#1)(2008-10#2)
the equilibrium between##11##3##(1991-4#1)(1991-7#1)(1992-12#1)(1993-9#1)(1997-2#1)(1997-4#1)(2005-1#1)(2007-11#1)(2008-10#2)(2008-3#1)
the equilibrium concentration of##2##4##(2008-10#2)
the equilibrium concentration##3##3##(1997-1#1)(2008-10#2)
the equilibrium concentrations of the two##2##6##(1994-8#1)(2005-11#1)
the equilibrium concentrations of##3##4##(1993-6#1)(1994-8#1)(2005-11#1)
the equilibrium concentrations##4##3##(1993-6#1)(1994-8#1)(2005-11#1)(2010-9#1)
the equilibrium constant for##4##4##(1991-7#1)(1997-2#2)(2010-2#1)
the equilibrium constant of the##3##5##(1994-8#1)(1995-6#1)(2005-11#1)
the equilibrium constant##13##3##(1991-7#1)(1994-8#2)(1995-6#1)(1997-2#2)(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#3)(2010-2#1)
the equilibrium constants for##3##4##(1990-12#1)(2008-10#1)(2008-2#1)
the equilibrium constants of##2##4##(2008-10#1)(2008-2#1)
the equilibrium constants##10##3##(1990-12#1)(1990-2#1)(1994-11#1)(2005-11#1)(2008-10#4)(2008-2#2)
the equilibrium displacement##2##3##(1991-7#1)(2006-10#1)
the equilibrium dissociation constant##6##4##(1993-3#1)(1993-6#1)(1995-5#1)(1997-2#1)(1997-8#1)(2008-5#1)
the equilibrium dissociation##7##3##(1990-12#1)(1993-3#1)(1993-6#1)(1995-5#1)(1997-2#1)(1997-8#1)(2008-5#1)
the equilibrium distribution of##4##4##(1990-7#1)(1995-2#1)(2008-10#2)
the equilibrium folding pathway##2##4##(1995-4#2)
the equilibrium frequencies of##2##4##(2007-9#1)(2008-10#1)
the equilibrium frequency of##2##4##(2008-9#2)
the equilibrium of##3##3##(2006-11#1)(2008-10#2)
the equilibrium population size##3##4##(2008-8#2)(2008-9#1)
the equilibrium population##4##3##(2008-8#2)(2008-9#2)
the equilibrium potential of##2##4##(2008-10#1)(2008-4#1)
the equilibrium potential##3##3##(1994-2#1)(2008-10#1)(2008-4#1)
the equilibrium state##2##3##(1992-6#1)(2008-10#1)
the equilibrium surface##2##3##(2005-11#2)
the equilibrium temperature##4##3##(2008-2#4)
the equilibrium toward the##2##4##(1990-4#2)
the equilibrium unfolding of##2##4##(1994-8#1)(1995-5#1)
the equilibrium unfolding##3##3##(1990-7#1)(1994-8#1)(1995-5#1)
the equilibrium##127##2##(1990-12#2)(1990-2#1)(1990-4#2)(1990-7#3)(1990-8#1)(1991-4#2)(1991-7#3)(1992-10#1)(1992-12#1)(1992-6#2)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-8#4)(1995-11#1)(1995-2#1)(1995-4#2)(1995-5#2)(1995-6#1)(1996-7#1)(1997-1#2)(1997-2#4)(1997-4#1)(1997-7#1)(1997-8#1)(2004-9#2)(2005-1#1)(2005-11#11)(2006-10#4)(2006-11#1)(2006-4#2)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#29)(2008-12#1)(2008-2#6)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#5)(2008-9#4)(2009-10#1)(2009-5#2)(2010-2#2)(2010-9#1)(2012-2#1)
the equimolar mixture of##2##4##(1990-4#1)(2006-12#1)
the equimolar##5##2##(1990-2#1)(1990-4#1)(2005-11#1)(2006-12#1)(2008-10#1)
the equine##12##2##(1991-7#1)(1994-5#3)(1996-10#2)(2005-7#2)(2008-8#4)
the equipment and the##2##4##(2005-8#1)(2007-5#1)
the equipment and##6##3##(1990-5#1)(2005-8#1)(2007-5#1)(2008-1#1)(2008-4#1)(2013-1#1)
the equipment for##2##3##(2006-12#1)(2006-8#1)
the equipment of the##2##4##(1991-11#1)(2007-11#1)
the equipment of##4##3##(1991-11#1)(2007-11#1)(2008-3#1)(2008-9#1)
the equipment used##3##3##(1992-7#1)(2006-10#1)(2007-8#1)
the equipment##33##2##(1990-5#1)(1991-11#2)(1992-12#1)(1992-3#1)(1992-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-11#1)(2007-5#2)(2007-8#3)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
the equity##4##2##(1992-12#1)(2008-10#1)(2010-5#1)(2011-2#1)
the equivalence of##4##3##(1995-9#1)(1996-12#1)(2009-7#1)(2012-3#1)
the equivalence point (EP)##2##4##(2008-10#2)
the equivalence point##8##3##(2008-10#8)
the equivalence##15##2##(1995-9#1)(1996-12#1)(2008-10#9)(2008-3#1)(2008-4#1)(2009-7#1)(2012-3#1)
the equivalency##2##2##(2006-9#1)(2007-10#1)
the equivalent dose##2##3##(2008-12#1)(2008-3#1)
the equivalent of a##2##4##(2005-10#1)(2007-11#1)
the equivalent of the##2##4##(1991-7#1)(1997-2#1)
the equivalent of##10##3##(1991-7#1)(1997-2#1)(2004-11#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-10#1)(2009-12#1)(2010-2#1)
the equivalent residue##2##3##(1992-11#1)(1995-2#1)
the equivalent##53##2##(1991-2#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-7#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-12#1)(1997-2#1)(1997-6#2)(2004-11#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#9)(2009-12#1)(2009-8#1)(2010-2#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the era of the##4##4##(1993-1#1)(2007-6#1)(2008-5#1)(2009-7#1)
the era of##42##3##(1993-1#3)(1996-1#1)(2005-10#1)(2006-10#2)(2006-2#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#2)(2008-1#4)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#6)
the era##44##2##(1993-1#3)(1996-1#1)(2005-10#1)(2006-10#2)(2006-2#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#4)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#6)
the era's##4##2##(2007-5#2)(2008-7#1)(2009-4#1)
the eradication of Helicobacter pylori##3##5##(2007-3#1)(2008-12#1)(2012-1#1)
the eradication of the##2##4##(2008-4#1)(2008-5#1)
the eradication of##16##3##(1995-5#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-1#1)
the eradication##25##2##(1995-5#1)(2005-5#1)(2006-6#2)(2006-8#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)
the erbB-2##3##2##(1996-4#3)
the erbB2 gene product p185##2##5##(1994-6#2)
the erbB2##4##2##(1990-9#1)(1994-6#2)(1995-2#1)
the erbium##3##2##(2008-1#1)(2008-2#1)(2008-7#1)
the ergonomic##2##2##(2006-6#1)(2013-7#1)
the eriophyid mite-transmitted##2##3##(2008-10#2)
the eriophyid##3##2##(2008-10#3)
the eroding##2##2##(1995-12#1)(2010-12#1)
the erosion of the##2##4##(2008-10#1)(2013-1#1)
the erosion of##5##3##(2008-10#2)(2008-11#1)(2008-12#1)(2013-1#1)
the erosion yield caused by##2##5##(2010-4#2)
the erosion##10##2##(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2010-4#3)(2013-1#1)
the erosive##2##2##(2006-2#1)(2013-1#1)
the erroneous##3##2##(2009-2#1)(2011-12#1)(2012-2#1)
the error associated with##2##4##(2008-3#1)(2008-6#1)
the error between the##2##4##(2006-10#1)(2007-11#1)
the error caused by the##2##5##(2008-3#2)
the error diffusion##4##3##(2008-2#4)
the error estimate##2##3##(2012-2#2)
the error in the##7##4##(1995-8#1)(2008-2#4)(2008-3#2)
the error in##10##3##(1995-8#1)(2008-10#1)(2008-2#6)(2008-3#2)
the error introduced##2##3##(2008-2#1)(2009-4#1)
the error is##4##3##(1995-3#1)(2008-2#1)(2008-3#2)
the error metric##2##3##(2008-2#2)
the error of the retrieved##2##5##(2008-3#2)
the error of the##5##4##(2008-3#3)(2010-4#1)(2012-2#1)
the error of##8##3##(2008-2#2)(2008-3#4)(2010-4#1)(2012-2#1)
the error propagation theory##2##4##(2008-10#2)
the error propagation##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
the error rate for##2##4##(2006-8#1)(2008-2#1)
the error rate in##2##4##(1993-5#1)(2008-4#1)
the error rate##9##3##(1990-3#1)(1993-5#1)(2006-8#1)(2008-2#1)(2008-4#1)(2008-6#1)(2010-12#1)(2012-2#1)(2013-1#1)
the error that is due to##2##6##(2008-2#1)(2008-3#1)
the error that is##3##4##(2008-2#2)(2008-3#1)
the error that results##2##4##(2008-2#1)(2008-3#1)
the error that##5##3##(2008-2#3)(2008-3#2)
the error##102##2##(1990-3#1)(1991-3#1)(1993-5#1)(1995-3#1)(1995-8#1)(1996-8#1)(1997-2#3)(1997-5#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#8)(2008-2#34)(2008-3#26)(2008-4#1)(2008-6#4)(2009-10#1)(2009-4#2)(2009-8#1)(2010-12#1)(2010-4#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
the errors are##3##3##(1992-9#1)(2008-3#2)
the errors caused by the##2##5##(2008-3#2)
the errors caused by##3##4##(2007-12#1)(2008-3#2)
the errors in the##5##4##(2007-12#2)(2008-2#2)(2013-8#1)
the errors in##10##3##(2007-12#2)(2008-2#4)(2008-3#3)(2013-8#1)
the errors into account##2##4##(1992-6#1)(2008-3#1)
the errors of##6##3##(2008-10#1)(2008-2#1)(2008-3#3)(2013-8#1)
the errors were##2##3##(2008-12#1)(2008-3#1)
the errors##40##2##(1992-6#2)(1992-9#1)(2006-8#1)(2007-12#3)(2007-5#1)(2008-10#3)(2008-12#1)(2008-2#10)(2008-3#16)(2013-8#2)
the errors-in-variables context##2##3##(2010-3#2)
the eruption of Mt##2##4##(2008-2#1)(2008-3#1)
the eruption of the##3##4##(2005-9#1)(2011-2#1)(2012-12#1)
the eruption of##7##3##(2005-9#1)(2008-2#3)(2008-3#1)(2011-2#1)(2012-12#1)
the erythemal response was##2##4##(1992-6#2)
the erythemal response##4##3##(1992-6#3)(2010-12#1)
the erythemal##5##2##(1992-6#3)(2010-12#2)
the erythroblastosis##2##2##(1992-7#1)(2012-12#1)
the erythrocyte antioxidant##3##3##(1992-7#1)(2013-8#2)
the erythrocyte membrane lipid##3##4##(1990-11#1)(1990-2#1)(2008-11#1)
the erythrocyte membrane##10##3##(1990-11#1)(1990-2#1)(1991-7#1)(1993-11#1)(1993-4#2)(1995-8#1)(1996-1#2)(2008-11#1)
the erythrocyte membranes##3##3##(1990-2#1)(1991-5#1)(1994-8#1)
the erythrocyte plasma membrane Ca(2+)-ATPase##2##5##(1992-12#1)(1997-1#1)
the erythrocyte plasma##3##3##(1992-12#1)(1997-1#1)(2012-2#1)
the erythrocyte sedimentation rate##3##4##(1990-11#1)(1997-6#1)(2007-7#1)
the erythrocyte##35##2##(1990-11#3)(1990-12#1)(1990-2#3)(1990-7#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-7#1)(1993-11#1)(1993-4#2)(1994-8#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-1#2)(1997-1#1)(1997-6#1)(2007-1#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-8#3)
the erythrocytes of##5##3##(1990-1#1)(1990-11#1)(1990-2#1)(2007-1#1)(2007-9#1)
the erythrocytes##15##2##(1990-1#1)(1990-11#2)(1990-2#1)(1990-8#1)(1993-3#1)(1994-9#1)(1996-1#1)(1997-6#1)(2007-1#1)(2007-9#1)(2008-2#1)(2008-7#1)(2008-8#1)(2013-8#1)
the erythrocytic##3##2##(2006-6#1)(2010-2#1)(2012-12#1)
the erythroid and##2##3##(1990-5#1)(2012-1#1)
the erythroid##6##2##(1990-5#1)(1991-5#1)(1992-12#1)(1994-8#1)(1997-4#1)(2012-1#1)
the erythron##5##2##(1996-4#3)(2008-9#2)
the erythropoietin##2##2##(1991-9#1)(2007-7#1)
the escalating##5##2##(2007-4#2)(2011-1#1)(2012-12#1)(2012-2#1)
the escalation of##2##3##(2006-9#1)(2013-1#1)
the escalation##4##2##(2006-9#1)(2009-10#2)(2013-1#1)
the escape of MeBr##2##4##(1995-3#2)
the escape of##4##3##(1995-3#2)(1996-12#1)(2006-3#1)
the escape##6##2##(1994-2#1)(1995-3#2)(1996-12#1)(2006-3#1)(2008-9#1)
the escape-from-enemy hypothesis##2##3##(2008-8#2)
the eschar (tache noire)##2##4##(2013-8#2)
the eschar##5##2##(2013-8#5)
the esophageal and##2##3##(1992-11#1)(1994-3#1)
the esophageal hiatus##2##3##(2007-8#1)(2011-2#1)
the esophageal lumen##2##3##(1996-9#1)(2007-8#1)
the esophageal mucosa##2##3##(2006-2#1)(2008-5#1)
the esophageal wall##4##3##(2007-8#3)(2009-5#1)
the esophageal##25##2##(1990-4#1)(1992-11#1)(1994-3#1)(1995-3#1)(1996-9#1)(2006-10#1)(2006-2#2)(2007-7#1)(2007-8#7)(2007-9#1)(2008-5#1)(2009-5#1)(2011-2#1)(2013-8#5)
the esophagogastric junction##3##3##(1991-10#1)(1992-9#1)(2006-10#1)
the esophagus and stomach##4##4##(2006-8#2)(2011-2#1)(2012-3#1)
the esophagus and##17##3##(1990-6#1)(1994-4#1)(2005-1#1)(2006-10#2)(2006-2#1)(2006-8#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2009-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
the esophagus in##3##3##(2006-10#1)(2008-5#1)(2011-2#1)
the esophagus or##2##3##(2009-3#1)(2012-2#1)
the esophagus were##2##3##(1992-9#1)(2006-10#1)
the esophagus##95##2##(1990-6#1)(1991-9#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-4#1)(1993-8#2)(1994-4#2)(1995-3#2)(1995-5#1)(1996-9#2)(2005-1#1)(2006-10#12)(2006-2#1)(2006-8#2)(2007-12#1)(2007-2#2)(2007-4#1)(2007-6#3)(2007-7#1)(2007-8#7)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#13)(2009-2#2)(2009-3#3)(2009-7#2)(2010-12#5)(2010-8#1)(2011-2#7)(2012-2#2)(2012-3#1)(2013-7#2)(2013-8#6)
the essay##3##2##(2008-12#2)(2009-10#1)
the essence of the##5##4##(2006-4#1)(2007-9#1)(2008-8#1)(2009-7#1)(2011-1#1)
the essence of##16##3##(1992-2#1)(1994-2#1)(1997-2#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-8#1)(2009-11#1)(2009-7#1)(2011-1#2)
the essence##17##2##(1992-2#1)(1994-2#1)(1997-2#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-7#1)(2011-1#2)
the essential and##2##3##(1995-1#1)(1997-6#1)
the essential characteristics of##2##4##(1995-11#1)(2013-7#1)
the essential component##2##3##(1996-12#1)(1997-6#1)
the essential components of##2##4##(1994-3#1)(1995-1#1)
the essential components##3##3##(1994-3#1)(1994-8#1)(1995-1#1)
the essential downstream component of##2##5##(1997-3#2)
the essential elements for##2##4##(1991-12#1)(2009-6#1)
the essential elements of##4##4##(2006-10#1)(2007-11#2)(2008-4#1)
the essential elements##9##3##(1991-12#1)(2006-10#1)(2007-11#4)(2008-2#1)(2008-4#1)(2009-6#1)
the essential enzyme##2##3##(2008-4#1)(2010-12#1)
the essential features of the##3##5##(1994-12#1)(2008-1#1)(2008-10#1)
the essential features##5##3##(1994-12#1)(2008-1#1)(2008-10#1)(2011-1#1)(2012-2#1)
the essential function##2##3##(1997-6#1)(2010-2#1)
the essential functional##2##3##(1990-3#1)(1994-8#1)
the essential oil and##2##4##(2007-1#1)(2007-8#1)
the essential oil of the fruits##5##6##(2008-11#4)(2008-12#1)
the essential oil of the##7##5##(2008-11#5)(2008-12#1)(2010-12#1)
the essential oil of##14##4##(2007-1#2)(2008-11#7)(2008-12#1)(2008-5#2)(2010-12#2)
the essential oil##30##3##(2007-1#5)(2007-11#2)(2007-8#1)(2008-11#7)(2008-12#2)(2008-5#2)(2010-12#6)(2012-12#1)(2012-3#2)(2013-1#2)
the essential oils and their##2##5##(2008-10#2)
the essential oils and##3##4##(2008-10#2)(2010-4#1)
the essential oils of##5##4##(2006-12#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-5#1)
the essential oils##14##3##(2006-12#1)(2007-1#3)(2007-11#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2010-4#1)(2012-12#1)
the essential requirements##3##3##(2006-6#2)(2008-1#1)
the essential role in##2##4##(1995-12#1)(2008-8#1)
the essential role of the##2##5##(1995-12#1)(2010-5#1)
the essential role of##13##4##(1995-12#1)(1995-2#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
the essential role played by##2##5##(2005-11#1)(2009-4#1)
the essential role##18##3##(1995-12#2)(1995-2#1)(2005-11#1)(2008-1#2)(2008-11#1)(2008-5#1)(2008-8#2)(2009-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
the essential##160##2##(1990-3#1)(1990-5#1)(1991-12#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-3#4)(1997-6#4)(2005-11#1)(2005-12#1)(2005-7#2)(2006-10#1)(2006-12#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#8)(2007-10#1)(2007-11#8)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#7)(2008-10#5)(2008-11#11)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#7)(2010-2#2)(2010-4#3)(2010-5#1)(2011-1#2)(2011-2#3)(2012-1#3)(2012-12#4)(2012-2#4)(2012-3#3)(2013-1#6)(2013-7#2)(2013-8#5)
the essentiality of the##2##4##(2008-7#1)(2010-12#1)
the essentials of##5##3##(1992-12#1)(1994-1#1)(2007-12#1)(2008-7#1)(2008-8#1)
the essentials##6##2##(1992-12#1)(1994-1#1)(2007-12#1)(2008-1#1)(2008-7#1)(2008-8#1)
the established experimental conditions##2##4##(2008-10#2)
the established method##2##3##(2008-10#1)(2011-1#1)
the established standard input function##4##5##(2008-2#4)
the established##58##2##(1990-2#1)(1990-3#1)(1991-12#1)(1992-3#1)(1994-3#1)(1995-12#1)(1996-9#1)(1997-3#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-7#3)(2005-9#1)(2006-10#1)(2006-12#1)(2006-6#2)(2006-7#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#11)(2008-2#4)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
the establishment and development of##2##5##(1991-9#1)(2008-5#1)
the establishment and maintenance of##9##5##(1992-7#1)(1995-1#1)(1995-2#2)(1996-11#1)(1997-2#1)(2006-10#1)(2008-9#1)(2013-1#1)
the establishment and##15##3##(1991-9#1)(1992-7#1)(1995-1#1)(1995-2#2)(1996-11#1)(1996-4#1)(1997-2#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-12#1)(2013-1#1)
the establishment of a state##2##5##(2006-10#1)(2011-2#1)
the establishment of a##35##4##(1991-12#1)(1993-9#1)(1996-2#2)(2006-10#2)(2006-2#1)(2006-6#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
the establishment of an interdisciplinary##2##5##(2006-10#1)(2006-7#1)
the establishment of an##13##4##(1991-9#1)(1993-8#1)(1997-3#1)(1997-7#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-9#1)(2008-2#1)(2008-5#1)(2012-12#2)(2012-3#1)
the establishment of data##2##4##(2008-7#1)(2012-3#1)
the establishment of mirror symmetry##4##5##(2012-12#4)
the establishment of permanent##2##4##(2006-2#1)(2012-2#1)
the establishment of specific##2##4##(2008-8#1)(2010-5#1)
the establishment of such##2##4##(2007-11#1)(2012-12#1)
the establishment of the##24##4##(1991-3#1)(1991-6#1)(1992-3#1)(1992-6#1)(1993-6#1)(1994-5#1)(1996-1#1)(1996-9#1)(1997-2#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-4#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-6#2)(2011-2#3)(2012-3#1)(2013-1#2)
the establishment of this NGO##2##5##(2008-1#2)
the establishment of this##6##4##(1994-6#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#1)
the establishment of three##2##4##(1992-8#1)(1995-12#1)
the establishment of##175##3##(1990-12#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(2005-7#2)(2006-10#6)(2006-11#1)(2006-2#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#5)(2008-10#14)(2008-11#8)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#3)(2009-10#2)(2009-12#2)(2009-4#2)(2009-8#3)(2009-9#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#2)(2011-10#1)(2011-2#8)(2012-1#1)(2012-11#1)(2012-12#11)(2012-2#9)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#1)
the establishment or##2##3##(2011-2#2)
the establishment##195##2##(1990-12#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-4#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#2)(2005-7#2)(2005-8#1)(2006-10#7)(2006-11#1)(2006-2#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#5)(2008-10#15)(2008-11#8)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#4)(2009-10#2)(2009-12#2)(2009-4#2)(2009-8#3)(2009-9#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#3)(2011-10#1)(2011-12#1)(2011-2#10)(2012-1#1)(2012-11#1)(2012-12#11)(2012-2#9)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#1)
the estate of##2##3##(1990-6#1)(1996-12#1)
the ester carbonyl##3##3##(1991-2#2)(2008-10#1)
the ester##10##2##(1991-2#2)(1992-5#2)(2005-4#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-3#1)
the ester-type polyurethane membrane##2##4##(2008-10#2)
the ester-type##3##2##(2008-10#3)
the esterase S gene##3##4##(1995-2#3)
the esterase S##4##3##(1995-2#4)
the esterase gene##2##3##(2008-11#1)(2012-2#1)
the esterase##10##2##(1991-5#1)(1995-2#4)(2008-11#1)(2008-5#1)(2012-2#3)
the esterification of##6##3##(1990-4#1)(1992-6#1)(1994-9#1)(1995-8#1)(2007-10#1)(2008-7#1)
the esterification reaction##2##3##(2008-10#1)(2008-7#1)
the esterification##9##2##(1990-4#1)(1992-6#1)(1994-9#1)(1995-8#1)(2007-10#2)(2008-10#1)(2008-7#2)
the esterified##2##2##(1994-11#2)
the esters##4##2##(2007-10#1)(2012-12#3)
the esthetic##8##2##(1993-8#1)(2008-4#2)(2008-5#1)(2009-8#1)(2011-1#1)(2012-3#1)(2013-7#1)
the estimate of effect##2##4##(1994-2#1)(2012-3#1)
the estimate of the##9##4##(1993-1#1)(1997-6#2)(2007-12#1)(2008-10#1)(2008-2#1)(2010-7#1)(2012-2#2)
the estimate of##17##3##(1992-6#1)(1993-1#1)(1994-2#3)(1997-6#2)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-3#1)(2010-7#1)(2012-2#2)(2012-3#1)
the estimate##24##2##(1992-6#1)(1993-1#1)(1994-2#4)(1997-6#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-2#1)(2010-3#1)(2010-7#1)(2012-2#3)(2012-3#1)
the estimated annual##2##3##(1993-9#1)(1997-4#1)
the estimated average##2##3##(1997-2#1)(2008-10#1)
the estimated convexity is##2##4##(2008-6#2)
the estimated mean##3##3##(1991-6#1)(2008-10#1)(2008-2#1)
the estimated number of##3##4##(2006-10#2)(2012-3#1)
the estimated optical##2##3##(2008-2#2)
the estimated prevalence of##3##4##(2007-7#1)(2011-2#2)
the estimated prevalence##4##3##(2007-7#1)(2011-2#2)(2012-1#1)
the estimated ratios##2##3##(1993-9#1)(1994-2#1)
the estimated regression##2##3##(1995-2#1)(2008-6#1)
the estimated sample size##2##4##(1995-6#1)(2007-7#1)
the estimated sample##3##3##(1994-6#1)(1995-6#1)(2007-7#1)
the estimated total##2##3##(2004-11#1)(2008-10#1)
the estimated##117##2##(1990-10#1)(1990-11#1)(1990-12#1)(1991-11#1)(1991-6#1)(1992-3#2)(1992-6#1)(1993-11#2)(1993-3#1)(1993-9#3)(1994-2#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-11#2)(2004-4#1)(2004-8#1)(2006-10#3)(2006-12#1)(2006-2#2)(2007-10#1)(2007-12#3)(2007-7#2)(2007-8#1)(2008-10#18)(2008-11#1)(2008-2#8)(2008-3#8)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#4)(2009-11#1)(2009-4#1)(2010-12#1)(2010-2#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
the estimates made##2##3##(1996-1#1)(2008-6#1)
the estimates of the##8##4##(1994-8#1)(1995-8#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-2#1)
the estimates of##14##3##(1992-2#1)(1993-1#1)(1994-8#2)(1995-8#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)(2011-2#1)(2012-2#1)(2012-7#1)
the estimates##34##2##(1991-3#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-1#1)(1994-8#2)(1995-8#2)(1996-1#1)(1996-7#1)(1996-8#1)(1997-3#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#3)(2009-5#1)(2010-2#1)(2010-3#2)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-7#1)
the estimation and##4##3##(2006-11#1)(2013-8#3)
the estimation method##3##3##(1997-3#2)(2009-2#1)
the estimation methods##2##3##(1992-6#1)(2012-2#1)
the estimation of a##3##4##(2008-3#1)(2009-5#1)(2012-2#1)
the estimation of growth##2##4##(1997-4#1)(2013-7#1)
the estimation of the activity coefficients##2##6##(2008-10#2)
the estimation of the proportion of##2##6##(1995-6#1)(1997-7#1)
the estimation of the##32##4##(1993-2#1)(1995-4#1)(1995-6#1)(1996-12#1)(1997-7#1)(2005-11#1)(2006-11#1)(2007-11#2)(2007-9#1)(2008-10#7)(2008-2#4)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#2)(2012-12#1)(2013-1#1)
the estimation of##109##3##(1990-5#1)(1990-8#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-9#1)(1995-1#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-11#2)(2006-11#1)(2006-3#1)(2006-5#1)(2007-11#2)(2007-6#2)(2007-8#1)(2007-9#1)(2008-10#25)(2008-11#1)(2008-12#2)(2008-2#10)(2008-3#12)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-12#1)(2009-5#2)(2009-7#1)(2010-12#1)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#2)
the estimation##135##2##(1990-5#1)(1990-8#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-9#1)(1995-1#1)(1995-4#1)(1995-6#1)(1996-12#2)(1996-8#1)(1997-2#1)(1997-3#4)(1997-4#1)(1997-7#1)(2005-11#2)(2006-11#2)(2006-3#1)(2006-5#1)(2007-11#2)(2007-12#2)(2007-6#2)(2007-8#1)(2007-9#1)(2008-10#25)(2008-11#1)(2008-12#2)(2008-2#13)(2008-3#16)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#5)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#2)(2013-8#4)
the estimations of the##2##4##(2006-1#1)(2013-8#1)
the estimations of##4##3##(2006-1#1)(2007-3#1)(2008-10#1)(2013-8#1)
the estimations##6##2##(2006-1#1)(2007-3#1)(2008-10#1)(2008-2#2)(2013-8#1)
the estimator##5##2##(1997-3#1)(2006-5#1)(2008-2#1)(2010-3#1)(2012-1#1)
the estimators of the parameter and asymptotic expansion for the estimators of the nonparametric part##2##15##(2009-5#1)(2010-2#1)
the estimators of the##5##4##(1995-9#1)(2009-5#2)(2010-2#2)
the estrogen and thyroid hormone receptors##2##6##(1991-5#1)(1993-3#1)
the estrogen and##3##3##(1991-5#1)(1993-3#1)(2013-1#1)
the estrogen receptor (ER)##5##4##(1992-7#1)(1996-11#1)(1996-2#1)(2007-5#1)(2008-11#1)
the estrogen receptor and##3##4##(1994-12#1)(1996-8#1)(2008-11#1)
the estrogen receptor in the##2##5##(1994-12#1)(1996-8#1)
the estrogen receptor in##3##4##(1994-12#2)(1996-8#1)
the estrogen receptor is##2##4##(1991-8#1)(2008-11#1)
the estrogen receptor##38##3##(1990-5#1)(1990-7#2)(1991-1#1)(1991-8#1)(1992-7#1)(1993-6#1)(1994-12#6)(1996-11#3)(1996-2#1)(1996-8#6)(2006-5#1)(2007-10#1)(2007-5#1)(2008-11#10)(2010-5#1)(2011-1#1)
the estrogen receptors##2##3##(2009-4#1)(2010-3#1)
the estrogen response element (ERE)##2##5##(1991-2#1)(1992-6#1)
the estrogen response element##4##4##(1991-2#1)(1992-6#2)(1996-8#1)
the estrogen responsive##2##3##(1994-12#1)(1996-2#1)
the estrogen responsiveness of##2##4##(1991-2#2)
the estrogen##62##2##(1990-5#1)(1990-7#2)(1991-1#1)(1991-2#3)(1991-5#1)(1991-7#1)(1991-8#1)(1992-6#2)(1992-7#1)(1993-3#1)(1993-6#1)(1994-12#7)(1996-11#3)(1996-2#2)(1996-5#1)(1996-8#7)(2006-5#1)(2007-10#1)(2007-5#1)(2008-10#2)(2008-11#12)(2008-4#1)(2008-5#2)(2009-4#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#2)
the estrogen-induced##3##2##(1990-7#1)(2004-11#1)(2007-10#1)
the estrogen-primed##2##2##(1997-5#2)
the estrogenic activity##2##3##(1996-3#1)(2004-9#1)
the estrogenic##6##2##(1990-8#1)(1996-3#1)(2004-9#1)(2010-5#2)(2013-1#1)
the estrogens##4##2##(1996-5#1)(2008-11#1)(2008-4#1)(2012-2#1)
the estrous cycle##10##3##(1992-3#3)(1992-9#1)(1993-11#2)(2006-5#2)(2007-2#1)(2012-11#1)
the estrous response##2##3##(2008-12#2)
the estrous##13##2##(1992-3#3)(1992-9#2)(1993-11#2)(2006-5#2)(2007-2#1)(2008-12#2)(2012-11#1)
the estuarine##2##2##(2011-12#1)(2013-1#1)
the estuary##7##2##(2007-3#1)(2008-5#1)(2010-5#1)(2011-12#1)(2013-1#3)
the etalon##17##2##(2007-11#1)(2007-12#1)(2008-1#2)(2008-2#5)(2008-3#8)
the etalons##2##2##(2008-1#1)(2008-3#1)
the etched##4##2##(1997-2#1)(2008-10#2)(2008-3#1)
the etching depth##2##3##(2008-3#2)
the etching process##4##3##(1997-2#1)(2006-5#1)(2008-10#1)(2008-2#1)
the etching rate##2##3##(2008-2#1)(2008-3#1)
the etching solution##3##3##(2008-10#3)
the etching##14##2##(1997-2#1)(2006-5#1)(2008-10#5)(2008-2#3)(2008-3#4)
the ethanol extract of##7##4##(2008-10#2)(2008-11#1)(2010-12#1)(2010-5#1)(2011-3#1)(2013-7#1)
the ethanol extract##8##3##(2008-10#2)(2008-11#1)(2010-12#1)(2010-5#1)(2011-3#1)(2013-1#1)(2013-7#1)
the ethanol extracts of##2##4##(2005-11#1)(2008-6#1)
the ethanol fraction in the##2##5##(1995-4#2)
the ethanol solution of##2##4##(2005-11#2)
the ethanol yield##3##3##(2008-5#1)(2008-6#1)(2013-1#1)
the ethanol##36##2##(1993-11#2)(1995-4#2)(1996-9#1)(1997-2#1)(2005-10#1)(2005-11#5)(2006-3#1)(2006-8#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#3)(2008-6#3)(2010-12#1)(2010-5#1)(2011-3#1)(2013-1#2)(2013-7#1)
the ethanol-associated##3##2##(1996-4#3)
the ethanol-induced##3##2##(1994-5#1)(1994-6#1)(2009-7#1)
the ethanolamine##2##2##(1991-7#1)(1995-3#1)
the ethanolic extract of##3##4##(2007-1#1)(2008-10#2)
the ethanolic extract##5##3##(2007-1#2)(2008-10#3)
the ethanolic##7##2##(2007-1#2)(2007-11#1)(2008-10#3)(2011-2#1)
the ether extract##2##3##(1992-5#1)(2010-2#1)
the ether oxygen##3##3##(2008-3#2)(2008-5#1)
the ether##10##2##(1992-5#1)(1994-8#1)(1995-2#1)(1995-3#1)(1997-4#1)(2008-3#2)(2008-5#1)(2008-8#1)(2010-2#1)
the ethical and##3##3##(2007-12#1)(2007-7#1)(2010-3#1)
the ethical aspects##2##3##(2007-5#1)(2010-11#1)
the ethical framework##2##3##(2006-11#1)(2012-2#1)
the ethical imperative##2##3##(1996-12#1)(2013-8#1)
the ethical implications##2##3##(1990-4#1)(2008-12#1)
the ethical issues are##2##4##(2007-6#1)(2008-9#1)
the ethical issues associated with##2##5##(2007-4#1)(2013-8#1)
the ethical issues involved##3##4##(1990-4#1)(2007-12#1)(2008-9#1)
the ethical issues##15##3##(1990-4#1)(1994-12#2)(2006-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-9#2)(2012-1#1)(2013-7#1)(2013-8#2)
the ethical principles##6##3##(1994-1#1)(2006-1#1)(2007-10#1)(2007-12#1)(2009-6#1)(2013-1#1)
the ethical use of##2##4##(2005-7#1)(2008-5#1)
the ethical##67##2##(1990-4#2)(1991-2#2)(1994-1#1)(1994-12#2)(1994-3#2)(1995-6#1)(1996-12#1)(1996-2#1)(2005-10#1)(2005-7#3)(2006-1#1)(2006-11#2)(2007-10#1)(2007-12#4)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#1)(2009-6#2)(2009-9#1)(2010-11#2)(2010-3#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#4)
the ethics and##3##3##(2006-11#1)(2007-3#1)(2008-9#1)
the ethics committee##3##3##(1993-1#2)(2008-11#1)
the ethics of dual##2##4##(2009-9#2)
the ethics of research##2##4##(2005-11#1)(2010-11#1)
the ethics of##12##3##(1991-3#1)(1995-5#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-11#1)(2009-4#1)(2009-9#3)(2010-11#1)(2013-8#1)
the ethics##20##2##(1991-3#1)(1993-1#2)(1995-5#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-11#2)(2007-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-9#3)(2010-11#1)(2013-8#1)
the ethidium-SRD##2##2##(1997-4#2)
the ethmoidal##3##2##(1995-7#1)(1996-5#1)(2006-12#1)
the ethnic composition of school##2##5##(2010-1#2)
the ethnic composition of##3##4##(2010-1#3)
the ethnic group##3##3##(2008-10#1)(2009-3#1)(2010-2#1)
the ethnic groups##3##3##(2008-1#1)(2008-9#1)(2011-2#1)
the ethnic minority##2##3##(2004-12#2)
the ethnic specific##2##3##(2008-1#2)
the ethnic##28##2##(1991-11#1)(1994-12#1)(2004-12#3)(2007-3#1)(2008-1#4)(2008-10#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-3#1)(2010-1#5)(2010-2#1)(2010-8#5)(2011-2#1)
the ethnicity of##2##3##(2006-7#1)(2008-11#1)
the ethnicity##3##2##(2006-7#1)(2008-11#1)(2013-8#1)
the ethyl acetate extract##5##4##(2007-1#1)(2008-5#3)(2010-2#1)
the ethyl acetate##8##3##(2007-1#2)(2008-10#2)(2008-5#3)(2010-2#1)
the ethyl ester##4##3##(1992-5#2)(2008-5#1)(2008-7#1)
the ethyl##17##2##(1992-5#2)(1995-5#1)(2007-1#2)(2007-11#2)(2008-10#3)(2008-5#4)(2008-7#1)(2010-2#1)(2011-2#1)
the ethylene##9##2##(1991-3#1)(1993-12#1)(1995-2#1)(2007-12#2)(2008-10#1)(2009-8#3)
the ethylene-forming enzyme##2##3##(2008-10#2)
the etiologic agent of adult T cell leukemia##2##8##(1991-8#1)(2008-4#1)
the etiologic agent of##6##4##(1991-8#1)(1997-5#1)(2007-2#1)(2008-4#1)(2008-9#1)(2012-3#1)
the etiologic agent##9##3##(1991-8#1)(1992-3#1)(1997-5#1)(2007-2#1)(2008-4#1)(2008-9#1)(2012-3#3)
the etiologic agents of##4##4##(1991-8#1)(2006-10#1)(2011-12#1)(2011-2#1)
the etiologic diagnosis##3##3##(1990-3#1)(2010-12#2)
the etiologic factors##2##3##(1996-4#1)(2008-4#1)
the etiologic##24##2##(1990-3#1)(1991-2#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-3#1)(1994-4#1)(1996-4#1)(1997-5#1)(2006-10#2)(2007-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-12#2)(2011-12#1)(2011-2#1)(2012-3#3)
the etiological agent of##5##4##(1992-3#1)(1997-4#1)(2007-12#1)(2008-9#1)(2010-12#1)
the etiological agents of##2##4##(2007-12#1)(2011-2#1)
the etiological factors##8##3##(1993-8#1)(1997-4#3)(2006-5#1)(2007-8#1)(2008-5#1)(2011-1#1)
the etiological##24##2##(1992-3#1)(1993-8#1)(1996-2#1)(1997-4#4)(2006-5#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-4#5)(2011-1#1)(2011-2#2)
the etiologies of##2##3##(1990-2#1)(2009-5#1)
the etiology and management##4##4##(2007-2#1)(2009-10#3)
the etiology and pathogenesis of this##3##6##(1993-8#1)(2006-2#1)(2007-7#1)
the etiology and pathogenesis of##8##5##(1990-11#1)(1993-8#1)(2006-10#1)(2006-2#1)(2007-5#1)(2007-7#2)(2013-8#1)
the etiology and the##4##4##(1994-8#1)(1997-3#1)(2008-4#1)(2011-1#1)
the etiology and treatment of depression##2##6##(2008-6#1)(2009-10#1)
the etiology and treatment of##3##5##(2008-6#1)(2009-10#1)(2013-8#1)
the etiology and##30##3##(1990-11#1)(1993-8#1)(1994-8#1)(1997-3#1)(2005-10#2)(2005-8#2)(2006-10#1)(2006-2#1)(2007-10#1)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#4)(2009-9#1)(2011-1#1)(2011-12#1)(2013-8#2)
the etiology is unknown##2##4##(2007-5#1)(2008-12#1)
the etiology is##5##3##(2006-10#1)(2007-5#1)(2008-1#1)(2008-12#1)(2009-3#1)
the etiology of Parkinson's disease##3##5##(1995-3#1)(2008-11#1)(2008-7#1)
the etiology of anxiety##2##4##(1991-2#1)(1995-12#1)
the etiology of autism##3##4##(2009-4#1)(2011-12#1)(2012-2#1)
the etiology of chest pain##2##5##(2008-3#1)(2013-8#1)
the etiology of congenital heart disease##2##6##(2008-10#1)(2010-6#1)
the etiology of disease##2##4##(1993-9#1)(2008-10#1)
the etiology of obesity in Mäori children##2##7##(2008-1#2)
the etiology of obesity##3##4##(2008-1#2)(2008-5#1)
the etiology of pain##2##4##(2006-8#1)(2008-12#1)
the etiology of schizophrenia##2##4##(1996-1#1)(2005-6#1)
the etiology of stuttering##2##4##(2008-2#1)(2012-12#1)
the etiology of the disease and##2##6##(2007-7#1)(2012-1#1)
the etiology of the disease##8##5##(1991-9#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2010-12#1)(2012-1#1)
the etiology of the diseases##2##5##(2008-10#1)(2008-3#1)
the etiology of the shortening##2##5##(2007-11#2)
the etiology of the##26##4##(1991-9#2)(1994-6#1)(1996-11#1)(2005-10#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-12#1)(2012-1#1)(2012-11#1)(2013-1#1)
the etiology of these##4##4##(2007-11#2)(2008-4#1)(2010-5#1)
the etiology of this disease##3##5##(1993-11#1)(2006-8#1)(2007-5#1)
the etiology of this##5##4##(1993-11#1)(2006-8#1)(2007-11#1)(2007-5#1)(2011-2#1)
the etiology of##162##3##(1990-10#1)(1990-7#1)(1990-8#3)(1991-2#1)(1991-9#4)(1992-1#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(2005-10#1)(2005-11#1)(2005-6#1)(2005-9#1)(2006-10#6)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#5)(2007-10#1)(2007-11#7)(2007-12#1)(2007-5#4)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#12)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#5)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-12#2)(2011-2#4)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#3)
the etiology##225##2##(1990-10#1)(1990-11#1)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-2#1)(1991-9#4)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-10#3)(2005-11#2)(2005-6#1)(2005-8#2)(2005-9#1)(2006-10#9)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#1)(2006-6#2)(2006-8#6)(2007-10#2)(2007-11#7)(2007-12#3)(2007-2#3)(2007-5#6)(2007-7#5)(2007-8#6)(2007-9#1)(2008-1#6)(2008-10#13)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#10)(2008-8#2)(2008-9#2)(2009-10#5)(2009-11#2)(2009-3#2)(2009-4#3)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-12#3)(2011-2#5)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#5)
the etiopathogenesis of reactive##2##4##(1990-6#2)
the etiopathogenesis of the##2##4##(1990-2#1)(2006-6#1)
the etiopathogenesis of##16##3##(1990-2#1)(1990-3#1)(1990-6#2)(1991-2#1)(1991-7#1)(1992-2#1)(1993-9#1)(2006-10#1)(2006-6#1)(2007-9#1)(2009-7#1)(2010-1#1)(2013-7#2)(2013-8#1)
the etiopathogenesis##19##2##(1990-2#1)(1990-3#1)(1990-6#2)(1991-2#1)(1991-7#1)(1992-2#1)(1993-5#1)(1993-9#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-9#1)(2009-5#1)(2009-7#1)(2010-1#1)(2013-7#2)(2013-8#1)
the etiopathogenetic##3##2##(1990-9#1)(1991-6#1)(1993-10#1)
the etiopathogenic##4##2##(2008-2#1)(2009-2#1)(2012-12#2)
the etiopathology of##3##3##(2008-7#1)(2013-1#2)
the etiopathology##4##2##(2008-7#1)(2012-12#1)(2013-1#2)
the euarthropod##3##2##(2007-12#3)
the eubacterial##2##2##(1990-3#1)(1992-3#1)
the euchromatic##2##2##(2008-7#1)(2008-8#1)
the eukaryote##4##2##(1997-5#1)(2007-12#1)(2008-7#1)(2008-9#1)
the eukaryotic cell cycle##2##4##(1993-9#2)
the eukaryotic cell##5##3##(1993-9#2)(1996-8#1)(2008-7#1)(2008-9#1)
the eukaryotic transcription factor##3##4##(1991-2#2)(1996-5#1)
the eukaryotic##37##2##(1990-11#2)(1990-2#1)(1991-2#3)(1991-4#1)(1991-9#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-9#2)(1994-12#2)(1994-3#1)(1995-8#1)(1996-2#1)(1996-5#3)(1996-7#1)(1996-8#1)(2008-11#1)(2008-4#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-5#1)(2011-1#1)(2012-1#1)
the euphotic zone##2##3##(1991-11#1)(2008-3#1)
the europium##2##2##(2007-11#1)(2008-10#1)
the eutherian##5##2##(1993-6#3)(1997-8#1)(2010-2#1)
the euthyroid##2##2##(2007-9#1)(2008-11#1)
the eutrophic##2##2##(2004-4#1)(2007-5#1)
the evacuated##2##2##(2006-2#1)(2008-2#1)
the evacuation of a##2##4##(1994-2#1)(2008-7#1)
the evacuation of##6##3##(1994-2#1)(1996-12#1)(2008-7#1)(2010-2#1)(2012-3#1)(2013-1#1)
the evacuation##8##2##(1991-2#1)(1994-2#1)(1996-12#2)(2008-7#1)(2010-2#1)(2012-3#1)(2013-1#1)
the evaluable patients##2##3##(2007-7#1)(2008-3#1)
the evaluated particle##2##3##(2008-3#2)
the evaluated##14##2##(1990-12#1)(1990-9#1)(2007-10#1)(2007-7#1)(2008-3#4)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
the evaluation and diagnosis of##2##5##(2008-6#1)(2010-12#1)
the evaluation and management of##8##5##(2006-5#1)(2006-9#1)(2007-12#1)(2007-8#1)(2010-12#1)(2010-9#1)(2012-12#1)(2013-8#1)
the evaluation and management##10##4##(2006-5#1)(2006-8#1)(2006-9#1)(2007-12#2)(2007-8#1)(2010-12#1)(2010-9#1)(2012-12#1)(2013-8#1)
the evaluation and monitoring of##2##5##(1995-5#1)(2011-3#1)
the evaluation and treatment of children with##2##7##(1993-9#1)(2009-3#1)
the evaluation and treatment of##6##5##(1993-10#1)(1993-9#1)(2006-12#1)(2008-3#1)(2009-1#1)(2009-3#1)
the evaluation and treatment##7##4##(1993-10#1)(1993-9#1)(2006-12#1)(2008-3#1)(2008-9#1)(2009-1#1)(2009-3#1)
the evaluation and##38##3##(1993-10#1)(1993-9#1)(1995-5#1)(2006-12#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-12#3)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-9#2)(2009-1#1)(2009-3#1)(2009-9#1)(2010-12#2)(2010-9#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
the evaluation of a##8##4##(1990-6#1)(1993-1#1)(1997-2#1)(2008-5#1)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#1)
the evaluation of acute##4##4##(2008-7#1)(2010-9#1)(2011-2#1)(2013-1#1)
the evaluation of all##2##4##(2007-3#1)(2013-1#1)
the evaluation of antimicrobial agents##2##5##(2008-7#2)
the evaluation of antimicrobial##3##4##(2008-7#2)(2011-2#1)
the evaluation of brain##2##4##(2008-6#1)(2008-7#1)
the evaluation of changes in##3##5##(2008-4#1)(2008-8#1)(2013-7#1)
the evaluation of children suspected##2##5##(2006-10#1)(2007-2#1)
the evaluation of children##3##4##(2006-10#1)(2006-8#1)(2007-2#1)
the evaluation of coronary artery disease##2##6##(2008-12#1)(2010-11#1)
the evaluation of coronary artery##3##5##(2008-12#1)(2010-11#1)(2011-2#1)
the evaluation of coronary##4##4##(1995-9#1)(2008-12#1)(2010-11#1)(2011-2#1)
the evaluation of factors##2##4##(1993-9#1)(2008-10#1)
the evaluation of health##2##4##(1997-3#1)(2010-10#1)
the evaluation of models##2##4##(2008-8#1)(2011-2#1)
the evaluation of multiple##2##4##(2008-8#1)(2010-11#1)
the evaluation of new##4##4##(1993-11#1)(2008-11#1)(2008-8#1)(2008-9#1)
the evaluation of other##2##4##(2008-10#1)(2013-7#1)
the evaluation of patients with##9##5##(2005-12#1)(2006-5#1)(2006-7#1)(2007-4#1)(2008-3#2)(2008-9#2)(2012-2#1)
the evaluation of patients##12##4##(2005-12#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-4#1)(2008-12#1)(2008-3#2)(2008-9#2)(2009-8#1)(2012-2#1)
the evaluation of possible##2##4##(2009-6#1)(2011-2#1)
the evaluation of potential##3##4##(2008-10#2)(2012-12#1)
the evaluation of rectal polypoid lesions in##3##7##(2013-1#3)
the evaluation of renal##2##4##(1995-2#1)(2007-2#1)
the evaluation of small##2##4##(2009-11#1)(2012-2#1)
the evaluation of some##2##4##(2008-10#2)
the evaluation of such patients##2##5##(2011-2#1)(2012-3#1)
the evaluation of the biliary##2##5##(1991-6#1)(2010-12#1)
the evaluation of the catalytic##2##5##(2008-10#1)(2008-5#1)
the evaluation of the clinical##2##5##(1990-3#1)(2011-2#1)
the evaluation of the effects of##4##6##(2008-10#1)(2010-9#1)(2011-1#1)(2013-1#1)
the evaluation of the impact of##2##6##(2007-11#1)(2013-7#1)
the evaluation of the patient##2##5##(2008-9#1)(2013-8#1)
the evaluation of the quality of##2##6##(2008-7#1)(2008-8#1)
the evaluation of the results##2##5##(1990-9#1)(2011-2#1)
the evaluation of the##82##4##(1990-1#1)(1990-11#2)(1990-3#1)(1990-5#1)(1990-9#2)(1991-10#1)(1991-3#1)(1991-5#1)(1991-6#1)(1993-11#1)(1993-2#1)(1994-5#1)(1995-10#1)(1996-12#1)(1996-4#1)(1997-3#1)(2005-11#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-2#5)(2008-3#1)(2008-4#4)(2008-5#5)(2008-7#6)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#2)
the evaluation of these##4##4##(2005-10#1)(2007-10#1)(2008-10#1)(2008-4#1)
the evaluation of this##5##4##(1991-5#1)(1993-12#1)(2008-12#1)(2008-5#1)(2013-1#1)
the evaluation of treatment##4##4##(2005-3#1)(2007-9#1)(2008-7#1)(2009-8#1)
the evaluation of various##3##4##(2008-11#1)(2010-12#1)(2012-2#1)
the evaluation of##360##3##(1990-1#1)(1990-11#5)(1990-12#1)(1990-3#2)(1990-5#3)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1992-2#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#3)(1993-6#1)(1993-9#1)(1994-10#2)(1994-3#2)(1994-5#1)(1995-10#2)(1995-2#3)(1995-5#1)(1995-9#2)(1996-10#1)(1996-11#2)(1996-12#3)(1996-4#1)(1996-5#3)(1997-2#2)(1997-3#4)(1997-6#1)(1997-8#1)(2004-11#2)(2004-9#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-3#1)(2005-5#1)(2006-10#9)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#6)(2007-11#8)(2007-2#4)(2007-3#4)(2007-4#2)(2007-5#1)(2007-6#4)(2007-7#1)(2007-8#6)(2007-9#5)(2008-1#4)(2008-10#33)(2008-11#4)(2008-12#6)(2008-2#15)(2008-3#5)(2008-4#10)(2008-5#20)(2008-6#3)(2008-7#18)(2008-8#8)(2008-9#7)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#2)(2009-8#2)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#6)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#1)(2010-9#3)(2011-1#2)(2011-12#1)(2011-2#17)(2012-1#2)(2012-12#3)(2012-2#8)(2012-3#3)(2013-1#13)(2013-7#7)(2013-8#4)
the evaluation process##3##3##(2007-10#1)(2008-10#1)(2008-12#1)
the evaluation proved##2##3##(1995-3#1)(2008-5#1)
the evaluation was##2##3##(2007-11#1)(2008-1#1)
the evaluation##443##2##(1990-1#1)(1990-11#5)(1990-12#1)(1990-3#2)(1990-5#3)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#3)(1993-6#1)(1993-9#3)(1994-10#2)(1994-3#2)(1994-5#1)(1995-10#2)(1995-2#3)(1995-3#1)(1995-5#2)(1995-9#2)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-4#1)(1996-5#3)(1997-2#2)(1997-3#4)(1997-6#1)(1997-8#1)(2004-11#2)(2004-9#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-3#1)(2005-5#3)(2005-9#1)(2006-10#9)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#7)(2006-9#1)(2007-1#2)(2007-10#8)(2007-11#10)(2007-12#4)(2007-2#4)(2007-3#5)(2007-4#3)(2007-5#1)(2007-6#5)(2007-7#2)(2007-8#7)(2007-9#5)(2008-1#5)(2008-10#38)(2008-11#8)(2008-12#8)(2008-2#18)(2008-3#9)(2008-4#12)(2008-5#22)(2008-6#4)(2008-7#18)(2008-8#8)(2008-9#9)(2009-1#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#8)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#1)(2010-9#4)(2011-1#2)(2011-12#1)(2011-2#20)(2011-3#1)(2012-1#3)(2012-12#6)(2012-2#8)(2012-3#4)(2013-1#18)(2013-7#7)(2013-8#6)
the evaluations of##4##3##(2008-8#1)(2009-6#1)(2011-2#1)(2012-1#1)
the evaluations##10##2##(2006-10#1)(2007-1#1)(2007-7#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-6#1)(2011-2#1)(2012-1#1)
the evaluative##3##2##(1995-3#1)(2011-1#1)(2012-2#1)
the evanescent field produced##2##4##(2008-3#2)
the evanescent field##6##3##(2007-12#2)(2008-2#1)(2008-3#3)
the evanescent##11##2##(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#5)
the evaporation of##5##3##(1997-1#1)(2008-10#1)(2008-3#1)(2008-5#2)
the evaporation rate and##2##4##(2008-10#2)
the evaporation rate##4##3##(2008-10#3)(2013-8#1)
the evaporation##13##2##(1995-3#1)(1997-1#1)(2006-12#1)(2008-10#4)(2008-3#1)(2008-5#2)(2013-8#3)
the evaporator and the condenser##2##5##(2010-6#2)
the evaporator and##3##3##(2010-6#3)
the evaporator##5##2##(2008-5#1)(2010-6#4)
the even or odd##2##4##(2007-8#1)(2010-7#1)
the even##6##2##(1990-10#1)(1991-1#1)(1994-5#1)(1994-9#1)(2007-8#1)(2010-7#1)
the evening##13##2##(1990-1#1)(1992-2#1)(1992-3#1)(1996-5#2)(1997-6#1)(2007-3#1)(2008-5#3)(2011-2#1)(2012-5#2)
the event and##5##3##(2007-10#1)(2007-9#1)(2008-11#1)(2008-7#1)(2013-8#1)
the event due to the##2##5##(1992-1#1)(1996-7#1)
the event of a##5##4##(1990-9#1)(2008-7#1)(2008-9#1)(2010-9#1)(2013-8#1)
the event of an emergency##4##5##(1992-1#1)(1997-2#1)(2006-10#1)(2010-1#1)
the event of an##7##4##(1992-1#1)(1997-2#1)(2006-10#1)(2007-9#1)(2010-1#1)(2011-12#1)(2013-1#1)
the event of##32##3##(1990-3#1)(1990-4#1)(1990-9#1)(1991-6#1)(1992-1#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-8#1)(1997-2#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-11#3)(2007-9#1)(2008-7#2)(2008-9#1)(2010-1#1)(2010-12#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-1#1)(2013-1#1)(2013-8#1)
the event that the##2##4##(2008-10#1)(2008-2#1)
the event that##7##3##(1997-8#1)(2005-4#1)(2006-9#1)(2008-10#1)(2008-2#1)(2011-2#2)
the event##87##2##(1990-3#1)(1990-4#1)(1990-9#1)(1991-3#1)(1991-6#1)(1992-1#2)(1992-5#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-8#2)(1996-12#1)(1996-7#2)(1997-2#1)(1997-3#1)(1997-8#1)(2005-4#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#4)(2007-12#1)(2007-8#1)(2007-9#5)(2008-1#3)(2008-10#4)(2008-11#2)(2008-2#3)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#4)
the event-marker##2##2##(2012-12#2)
the event-related brain potential##2##4##(1996-5#1)(2008-11#1)
the event-related potential##3##3##(1995-5#1)(1996-1#1)(2013-8#1)
the event-related potentials##2##3##(2008-11#1)(2008-9#1)
the event-related##7##2##(1995-5#1)(1996-1#1)(1996-5#1)(2008-11#2)(2008-9#1)(2013-8#1)
the events and##4##3##(1996-2#1)(2009-10#1)(2009-9#1)(2013-1#1)
the events in##2##3##(1991-3#1)(1995-4#1)
the events leading to the##4##5##(1993-3#1)(1996-8#1)(2008-11#1)(2008-8#1)
the events leading to##6##4##(1993-3#1)(1995-2#1)(1996-8#1)(2008-11#1)(2008-8#1)(2010-9#1)
the events occurring##2##3##(1995-4#1)(2010-9#1)
the events of spermiation and##2##5##(2012-2#2)
the events of##11##3##(1990-6#1)(1993-6#2)(2006-10#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-11#1)(2012-2#3)
the events that##9##3##(1994-12#1)(1997-5#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-9#1)
the events##46##2##(1990-6#1)(1991-3#2)(1993-3#1)(1993-6#2)(1994-12#1)(1995-11#1)(1995-2#1)(1995-4#3)(1995-8#1)(1996-11#1)(1996-2#1)(1996-8#1)(1997-5#1)(2006-10#2)(2006-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-9#2)(2011-12#1)(2011-2#1)(2012-2#3)(2013-1#1)
the eventual effects##2##3##(2008-1#1)(2008-10#1)
the eventual presence of##2##4##(2007-10#1)(2008-10#1)
the eventual##27##2##(1993-3#1)(1994-12#1)(1995-2#1)(1995-9#1)(1996-4#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-5#2)(2010-12#2)(2011-2#2)(2012-12#1)(2012-2#1)
the eventually##2##2##(1993-10#1)(2006-10#1)
the ever expanding##2##3##(1996-5#1)(2011-2#1)
the ever increasing##2##3##(1992-2#1)(2012-2#1)
the ever##6##2##(1992-2#1)(1996-5#1)(2008-1#1)(2009-6#1)(2011-2#1)(2012-2#1)
the ever-increasing##6##2##(1991-4#1)(2006-8#1)(2008-11#1)(2008-7#1)(2013-1#2)
the ever-present##2##2##(2005-11#1)(2008-11#1)
the everyday life of##3##4##(1995-6#1)(2011-2#2)
the everyday##15##2##(1995-1#1)(1995-6#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-2#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)
the evidence about##2##3##(1996-12#1)(2011-1#1)
the evidence and the##2##4##(1993-12#1)(2008-3#1)
the evidence and##7##3##(1993-12#1)(2006-10#2)(2008-3#1)(2008-8#2)(2009-4#1)
the evidence available##2##3##(2008-12#1)(2013-8#1)
the evidence base for##6##4##(2006-1#1)(2008-2#1)(2010-5#1)(2012-12#2)(2013-1#1)
the evidence base##15##3##(2006-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-6#1)(2010-5#3)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
the evidence based##2##3##(2006-10#1)(2008-1#1)
the evidence behind##2##3##(2011-12#1)(2013-8#1)
the evidence for a##4##4##(1990-2#1)(1995-12#1)(2004-4#1)(2008-7#1)
the evidence for an##2##4##(1996-11#1)(2008-6#1)
the evidence for and against##3##5##(2007-8#1)(2008-6#1)(2010-5#1)
the evidence for and##4##4##(2006-10#1)(2007-8#1)(2008-6#1)(2010-5#1)
the evidence for such##2##4##(2008-1#1)(2008-12#1)
the evidence for the effectiveness of##2##6##(2011-12#1)(2013-1#1)
the evidence for the##19##4##(1991-11#1)(1994-5#1)(1994-6#1)(2006-8#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-6#5)(2009-2#1)(2009-4#1)(2010-11#1)(2011-12#1)(2012-12#1)(2013-1#1)
the evidence for these##2##4##(2005-8#1)(2008-10#1)
the evidence for this##2##4##(2007-8#1)(2011-1#1)
the evidence for##59##3##(1990-2#1)(1991-11#1)(1991-12#1)(1992-5#1)(1992-9#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-11#1)(2004-4#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#1)(2008-6#8)(2008-7#3)(2008-8#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#2)(2012-3#2)(2013-1#1)
the evidence from clinical trials is##3##6##(1997-6#1)(2008-5#1)(2010-6#1)
the evidence from clinical trials##4##5##(1997-6#1)(2008-1#1)(2008-5#1)(2010-6#1)
the evidence from##11##3##(1992-4#1)(1993-12#1)(1995-1#1)(1997-6#1)(2005-10#1)(2007-12#1)(2008-1#1)(2008-5#1)(2009-7#1)(2010-6#1)(2012-1#1)
the evidence in support of##3##5##(1990-12#1)(2007-9#1)(2010-5#1)
the evidence in the literature##2##5##(2007-6#1)(2010-1#1)
the evidence in the##4##4##(2007-6#1)(2008-6#2)(2010-1#1)
the evidence in##9##3##(1990-12#1)(1995-5#1)(2007-6#1)(2007-9#1)(2008-6#2)(2010-1#1)(2010-5#1)(2013-1#1)
the evidence is limited##2##4##(2005-10#1)(2008-12#1)
the evidence is not##2##4##(2008-9#1)(2011-12#1)
the evidence is##15##3##(1992-5#1)(1994-12#1)(2005-10#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-8#1)
the evidence of a##4##4##(1990-10#1)(1992-10#1)(2011-2#1)(2013-8#1)
the evidence of effectiveness of##2##5##(2006-8#2)
the evidence of the##2##4##(2008-10#1)(2013-1#1)
the evidence of##17##3##(1990-10#1)(1992-10#1)(2006-5#1)(2006-8#2)(2007-12#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
the evidence on the##5##4##(1995-5#1)(2012-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
the evidence on which##3##4##(2007-1#1)(2008-12#1)(2010-12#1)
the evidence on##12##3##(1995-5#1)(1996-6#1)(2007-1#1)(2008-12#1)(2010-12#2)(2012-10#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
the evidence points to##2##4##(1990-8#1)(2005-10#1)
the evidence presented##2##3##(2004-10#1)(2013-8#1)
the evidence provided by the##2##5##(2006-12#1)(2008-8#1)
the evidence regarding##2##3##(2013-1#1)(2013-8#1)
the evidence shows that##2##4##(2006-9#1)(2008-9#1)
the evidence suggesting that##2##4##(2011-12#1)(2011-2#1)
the evidence suggests that##4##4##(2005-8#1)(2008-1#1)(2008-11#1)(2008-9#1)
the evidence suggests##5##3##(2005-8#1)(2008-1#1)(2008-11#1)(2008-9#1)(2010-12#1)
the evidence supporting the hypothesis that##2##6##(2008-7#1)(2009-10#1)
the evidence supporting the##5##4##(2008-7#1)(2009-10#1)(2011-2#1)(2012-12#2)
the evidence supporting##10##3##(2007-10#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2011-2#2)(2012-12#2)
the evidence surrounding##2##3##(2006-2#1)(2008-8#1)
the evidence that the##3##4##(1991-3#1)(2006-2#1)(2008-10#1)
the evidence that##27##3##(1990-7#1)(1991-3#1)(1994-11#1)(1995-1#1)(1996-5#1)(1997-4#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-2#2)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#1)(2009-8#1)(2010-11#1)(2010-2#1)(2011-2#1)
the evidence to support this##3##5##(2008-6#1)(2008-8#1)(2011-2#1)
the evidence to support##4##4##(2008-11#1)(2008-6#1)(2008-8#1)(2011-2#1)
the evidence to##8##3##(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-1#1)(2011-2#1)(2012-3#1)
the evidence was##2##3##(1996-8#1)(2013-1#1)
the evidence which suggests that##2##5##(1994-11#1)(2010-11#1)
the evidence##272##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-3#1)(1992-10#1)(1992-4#1)(1992-5#2)(1992-9#1)(1993-12#6)(1994-11#2)(1994-12#1)(1994-5#1)(1994-6#1)(1995-1#3)(1995-12#1)(1995-5#2)(1996-11#1)(1996-12#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-6#1)(2004-10#1)(2004-12#1)(2004-4#1)(2005-10#6)(2005-8#2)(2006-1#1)(2006-10#10)(2006-12#3)(2006-2#3)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#2)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#7)(2008-10#8)(2008-11#6)(2008-12#7)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#11)(2008-7#9)(2008-8#12)(2008-9#4)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-11#4)(2010-12#3)(2010-2#2)(2010-5#5)(2010-6#2)(2010-7#2)(2010-8#2)(2011-1#4)(2011-12#4)(2011-2#13)(2012-1#2)(2012-10#1)(2012-11#1)(2012-12#9)(2012-2#4)(2012-3#4)(2013-1#12)(2013-7#1)(2013-8#9)
the evidence-based medicine##3##3##(2006-6#1)(2006-8#1)(2013-8#1)
the evidence-based##13##2##(2006-4#1)(2006-6#1)(2006-8#1)(2008-12#1)(2008-8#2)(2008-9#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
the evidences##3##2##(2008-1#1)(2008-7#1)(2009-6#1)
the evidentiary basis for##2##4##(2010-8#1)(2012-3#1)
the evoked response##3##3##(1992-7#2)(1993-2#1)
the evoked unit responses from##2##5##(1995-12#2)
the evoked##8##2##(1990-9#1)(1991-6#1)(1992-7#2)(1993-2#1)(1995-12#2)(2008-9#1)
the evolution and development of##2##5##(2007-4#1)(2012-1#1)
the evolution and function of##2##5##(1993-2#1)(1996-2#1)
the evolution and persistence of##2##5##(2008-8#1)(2009-5#1)
the evolution and##15##3##(1993-2#1)(1996-2#1)(1996-3#1)(2006-11#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-7#1)(2008-8#2)(2009-5#1)(2009-7#1)(2010-3#1)(2012-1#1)
the evolution in our understanding of##2##6##(2006-10#1)(2011-2#1)
the evolution in##3##3##(2006-10#1)(2008-10#1)(2011-2#1)
the evolution of a##7##4##(1994-11#1)(1995-2#1)(2006-9#1)(2008-10#1)(2009-10#1)(2010-12#1)(2013-1#1)
the evolution of altruism##4##4##(2006-5#1)(2008-10#1)(2008-8#1)(2008-9#1)
the evolution of an RNA##2##5##(1992-7#1)(1997-6#1)
the evolution of an##4##4##(1992-7#1)(1997-6#1)(2008-2#1)(2008-7#1)
the evolution of brain##2##4##(2008-3#1)(2009-8#1)
the evolution of cervical squamous intraepithelial lesions##2##7##(2006-10#2)
the evolution of clinical practice##2##5##(1997-2#1)(2012-2#1)
the evolution of clutch size##2##5##(2008-9#2)
the evolution of cognitive##2##4##(1991-8#1)(2009-8#1)
the evolution of cooperation through reciprocal altruism##2##7##(2008-8#2)
the evolution of cooperation##3##4##(2008-8#2)(2010-4#1)
the evolution of cuticular##2##4##(2007-12#1)(2012-3#1)
the evolution of dispersal##3##4##(2008-8#2)(2008-9#1)
the evolution of emotional communication##2##5##(2008-11#2)
the evolution of endophytism##2##4##(2010-6#2)
the evolution of floral##2##4##(2009-8#1)(2012-2#1)
the evolution of gene families##2##5##(1994-8#1)(2008-8#1)
the evolution of gene##3##4##(1994-8#1)(2008-8#1)(2010-5#1)
the evolution of genes##3##4##(2008-8#1)(2013-1#2)
the evolution of genome##2##4##(2008-4#1)(2010-3#1)
the evolution of guppy##2##4##(2008-8#2)
the evolution of host##2##4##(2008-8#1)(2008-9#1)
the evolution of human language##4##5##(1997-8#1)(2007-3#1)(2012-1#1)(2012-12#1)
the evolution of human##7##4##(1991-11#1)(1997-8#1)(2007-3#1)(2009-8#1)(2012-1#1)(2012-12#1)(2013-8#1)
the evolution of its##3##4##(1992-1#1)(2008-10#1)(2008-12#1)
the evolution of life##4##4##(1991-1#1)(2007-9#1)(2008-4#1)(2008-9#1)
the evolution of mating##2##4##(2008-8#1)(2008-9#1)
the evolution of migration rate##3##5##(2008-8#3)
the evolution of migration##4##4##(2008-8#3)(2008-9#1)
the evolution of migratory##2##4##(2008-3#2)
the evolution of molecular##2##4##(2006-10#1)(2009-11#1)
the evolution of natural##2##4##(2008-10#1)(2008-8#1)
the evolution of new traits##3##5##(2010-4#3)
the evolution of new##5##4##(2008-10#1)(2010-4#3)(2012-1#1)
the evolution of optimal phenotypes##2##5##(2008-8#2)
the evolution of parasite virulence##3##5##(2008-8#3)
the evolution of parasite##4##4##(2008-8#4)
the evolution of plant##3##4##(2006-5#1)(2008-10#1)(2008-8#1)
the evolution of premating##2##4##(2008-9#2)
the evolution of prostate##2##4##(2007-11#1)(2011-1#1)
the evolution of proteins##2##4##(1997-6#1)(2008-7#1)
the evolution of reproductive##2##4##(2008-8#2)
the evolution of resistance##4##4##(1995-6#1)(2008-9#1)(2010-4#1)(2011-2#1)
the evolution of several key##2##5##(1996-11#1)(1997-2#1)
the evolution of sex##5##4##(1990-11#2)(2008-8#1)(2009-2#1)(2010-3#1)
the evolution of sexual dimorphism##3##5##(2008-8#3)
the evolution of sexual##4##4##(2008-8#3)(2013-1#1)
the evolution of sibling pathogens in##3##6##(2008-10#3)
the evolution of sociality##3##4##(2008-8#1)(2013-1#2)
the evolution of specialization and##2##5##(2008-8#2)
the evolution of specialization##3##4##(2008-8#3)
the evolution of strong##2##4##(1996-6#1)(2008-9#1)
the evolution of such##3##4##(2007-12#1)(2007-9#1)(2008-11#1)
the evolution of the disease##4##5##(1991-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
the evolution of the immune system##2##6##(1997-4#1)(2012-12#1)
the evolution of the lesions##2##5##(1992-11#1)(1996-5#1)
the evolution of the polarization##3##5##(2007-11#1)(2007-12#2)
the evolution of the volatile##2##5##(2006-12#1)(2008-3#1)
the evolution of the##100##4##(1990-11#1)(1990-12#1)(1990-3#1)(1991-10#1)(1991-11#1)(1991-6#1)(1992-11#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-1#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-4#1)(1997-5#1)(1997-8#1)(1997-9#1)(2005-11#1)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#9)(2007-2#1)(2007-3#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#7)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2009-2#2)(2009-9#1)(2010-11#1)(2010-7#3)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
the evolution of their##2##4##(2008-10#1)(2013-1#1)
the evolution of these##4##4##(1994-8#1)(2006-10#1)(2006-3#1)(2012-1#1)
the evolution of this##5##4##(2007-12#1)(2008-1#1)(2009-10#1)(2010-6#1)(2011-2#1)
the evolution of virulence##3##4##(2008-10#1)(2008-8#2)
the evolution of viviparity##2##4##(2008-8#2)
the evolution of worker policing##2##5##(2008-8#2)
the evolution of##462##3##(1990-11#3)(1990-12#2)(1990-3#1)(1990-7#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#2)(1992-1#1)(1992-11#3)(1992-7#3)(1993-2#3)(1993-3#2)(1993-8#2)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-11#3)(1995-2#2)(1995-4#1)(1995-5#2)(1995-6#4)(1995-8#2)(1996-1#3)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-8#2)(1997-9#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#7)(2006-11#1)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#7)(2006-6#1)(2006-7#1)(2006-9#3)(2007-10#2)(2007-11#8)(2007-12#22)(2007-2#1)(2007-3#2)(2007-7#1)(2007-9#4)(2008-1#3)(2008-10#26)(2008-11#6)(2008-12#3)(2008-2#11)(2008-3#10)(2008-4#4)(2008-5#1)(2008-6#5)(2008-7#9)(2008-8#77)(2008-9#29)(2009-10#6)(2009-11#1)(2009-2#4)(2009-3#1)(2009-5#2)(2009-6#3)(2009-8#5)(2009-9#3)(2010-11#2)(2010-12#2)(2010-3#7)(2010-4#5)(2010-5#6)(2010-6#6)(2010-7#7)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#6)(2012-12#6)(2012-2#7)(2012-3#13)(2013-1#18)(2013-7#4)(2013-8#6)
the evolution##493##2##(1990-11#3)(1990-12#2)(1990-3#1)(1990-7#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#2)(1992-1#1)(1992-11#3)(1992-6#1)(1992-7#3)(1993-2#4)(1993-3#2)(1993-8#2)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-11#3)(1995-2#2)(1995-4#1)(1995-5#2)(1995-6#4)(1995-8#2)(1996-1#3)(1996-11#2)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-8#2)(1997-9#1)(2004-4#1)(2005-10#1)(2005-11#3)(2005-7#1)(2005-8#2)(2006-10#9)(2006-11#2)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#7)(2006-6#1)(2006-7#1)(2006-9#3)(2007-10#2)(2007-11#8)(2007-12#24)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#1)(2007-9#4)(2008-1#3)(2008-10#29)(2008-11#6)(2008-12#3)(2008-2#11)(2008-3#10)(2008-4#4)(2008-5#1)(2008-6#6)(2008-7#10)(2008-8#79)(2008-9#30)(2009-10#6)(2009-11#1)(2009-2#4)(2009-3#1)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#5)(2009-9#3)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#8)(2010-4#5)(2010-5#6)(2010-6#6)(2010-7#7)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#6)(2012-1#7)(2012-12#6)(2012-2#8)(2012-3#14)(2013-1#19)(2013-7#4)(2013-8#6)
the evolutionarily stable (ES)##2##4##(2008-8#2)
the evolutionarily stable strategy (ESS)##3##5##(2008-8#1)(2008-9#2)
the evolutionarily stable##9##3##(2008-8#5)(2008-9#4)
the evolutionarily##17##2##(1991-10#1)(1992-3#1)(1994-8#1)(1995-8#1)(2008-10#1)(2008-7#1)(2008-8#5)(2008-9#4)(2011-2#2)
the evolutionary advantage of sex##3##5##(2008-11#3)
the evolutionary advantage##4##3##(2007-7#1)(2008-11#3)
the evolutionary and##2##3##(2008-10#1)(2012-1#1)
the evolutionary changes##2##3##(2007-6#1)(2010-4#1)
the evolutionary consequences of##2##4##(2008-8#2)
the evolutionary distance between##2##4##(1996-10#1)(2008-8#1)
the evolutionary dynamics of##4##4##(2008-7#1)(2008-8#2)(2012-3#1)
the evolutionary dynamics##6##3##(2008-7#1)(2008-8#3)(2012-3#1)(2013-1#1)
the evolutionary forces##3##3##(2008-9#1)(2009-6#1)(2012-3#1)
the evolutionary history of the##6##5##(1992-1#1)(1996-3#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-8#1)
the evolutionary history of##11##4##(1992-1#1)(1996-3#1)(1997-4#2)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-2#3)
the evolutionary imperative##2##3##(2008-7#2)
the evolutionary interests##2##3##(2008-8#2)
the evolutionary nature of##2##4##(2007-4#1)(2008-11#1)
the evolutionary origin of##4##4##(2006-5#1)(2007-12#1)(2010-1#1)(2013-1#1)
the evolutionary origin##5##3##(2006-5#1)(2007-12#1)(2008-8#1)(2010-1#1)(2013-1#1)
the evolutionary origins of##3##4##(2006-3#1)(2008-11#1)(2010-6#1)
the evolutionary outcome##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
the evolutionary process##7##3##(1994-3#1)(1994-6#1)(2008-2#1)(2009-12#1)(2010-4#1)(2010-5#1)(2012-3#1)
the evolutionary processes##3##3##(2008-10#1)(2012-12#1)(2013-7#1)
the evolutionary relationships between##2##4##(1991-6#1)(1994-6#1)
the evolutionary relationships##5##3##(1991-6#1)(1993-6#1)(1994-11#1)(1994-6#1)(2008-10#1)
the evolutionary scale##3##3##(1994-6#2)(1997-7#1)
the evolutionary significance of##3##4##(2007-12#1)(2012-2#1)(2012-3#1)
the evolutionary stability of##3##4##(1993-2#1)(2008-8#1)(2012-3#1)
the evolutionary trajectories##2##3##(2008-8#1)(2012-3#1)
the evolutionary transition##2##3##(2008-9#1)(2009-6#1)
the evolutionary tree##2##3##(2008-4#1)(2009-5#1)
the evolutionary##123##2##(1990-11#1)(1990-12#1)(1991-6#1)(1992-1#1)(1992-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#4)(1994-8#1)(1996-10#1)(1996-3#1)(1996-9#1)(1997-4#2)(1997-5#1)(1997-7#2)(1997-9#2)(2006-12#1)(2006-3#1)(2006-5#1)(2006-7#1)(2007-12#6)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-2#2)(2008-4#2)(2008-6#1)(2008-7#6)(2008-8#21)(2008-9#5)(2009-12#1)(2009-2#4)(2009-5#2)(2009-6#3)(2010-1#1)(2010-12#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#7)(2013-1#3)(2013-7#1)(2013-8#2)
the evolvability of##2##3##(2008-7#1)(2010-10#1)
the evolved##11##2##(1995-2#1)(1997-4#2)(2008-10#2)(2008-8#1)(2011-1#4)(2012-12#1)
the evolving health care##3##4##(1990-12#1)(1997-2#1)(2007-4#1)
the evolving role of##8##4##(1993-12#1)(1994-2#1)(1996-9#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-2#1)(2009-5#1)
the evolving role##9##3##(1993-12#1)(1994-2#1)(1996-9#1)(2005-8#1)(2006-10#1)(2007-12#2)(2007-2#1)(2009-5#1)
the evolving##32##2##(1990-12#1)(1991-11#1)(1992-12#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-1#1)(1996-9#1)(1997-2#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-5#1)(2006-8#1)(2007-12#3)(2007-2#1)(2007-4#2)(2008-12#1)(2008-2#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-7#2)(2011-2#1)(2012-1#1)
the ewe##2##2##(1995-10#1)(2006-5#1)
the ewes##2##2##(1991-8#1)(2006-5#1)
the ex situ##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
the ex vivo##7##3##(1992-3#1)(1993-11#1)(1996-6#1)(2008-11#2)(2008-5#1)(2008-9#1)
the ex##12##2##(1992-3#1)(1993-11#1)(1996-6#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-9#1)
the ex-type strain##2##3##(2008-10#2)
the exacerbating##2##2##(2006-12#1)(2010-6#1)
the exacerbation of##2##3##(1993-3#1)(2008-2#1)
the exacerbation##5##2##(1993-3#1)(1996-8#1)(2008-11#2)(2008-2#1)
the exact cause of the##2##5##(2008-1#1)(2010-9#1)
the exact cause##3##3##(1993-1#1)(2008-1#1)(2010-9#1)
the exact conditional test under inverse sampling##2##7##(1996-3#2)
the exact conditional##3##3##(1995-9#1)(1996-3#2)
the exact date of##2##4##(1994-7#1)(2008-10#1)
the exact diagnosis##3##3##(1990-12#1)(2010-3#1)(2012-12#1)
the exact formulation##2##3##(2007-11#1)(2008-3#1)
the exact location of the##3##5##(1995-2#1)(2012-12#2)
the exact location##4##3##(1995-2#1)(1996-6#1)(2012-12#2)
the exact mechanism is##2##4##(2008-7#1)(2012-12#1)
the exact mechanism of##2##4##(2008-7#1)(2009-5#1)
the exact mechanism##7##3##(1992-8#1)(1996-4#1)(2008-1#1)(2008-7#2)(2009-5#1)(2012-12#1)
the exact mechanisms##4##3##(1996-6#1)(2006-10#1)(2012-2#1)(2012-3#1)
the exact molecular mechanism##2##4##(2007-1#1)(2008-10#1)
the exact morphology of the##2##5##(2008-4#2)
the exact nature of the##7##5##(1993-11#1)(1996-11#1)(1996-8#1)(2005-12#1)(2006-2#1)(2008-7#1)(2008-9#1)
the exact nature of##9##4##(1993-11#2)(1996-11#1)(1996-8#1)(2005-12#1)(2006-2#1)(2008-11#1)(2008-7#1)(2008-9#1)
the exact number of##2##4##(2008-11#1)(2009-10#1)
the exact order##2##3##(2008-2#1)(2008-7#1)
the exact pathogenesis of##2##4##(2008-11#1)(2013-1#1)
the exact position of##2##4##(1990-4#1)(2008-3#1)
the exact role and##2##4##(2008-8#1)(2008-9#1)
the exact role##3##3##(2008-8#1)(2008-9#1)(2010-7#1)
the exact same##5##3##(1992-4#1)(1996-4#1)(2007-5#1)(2008-11#2)
the exact site of##2##4##(1992-6#1)(1994-12#1)
the exact size of##2##4##(2008-7#1)(2013-1#1)
the exact solution##3##3##(1991-5#1)(2008-3#2)
the exact structure##2##3##(2008-3#1)(2013-7#1)
the exact time##2##3##(1996-1#1)(2013-1#1)
the exact value of##2##4##(2008-3#1)(2009-9#1)
the exact values##2##3##(2008-2#1)(2008-3#1)
the exact##153##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-3#1)(1991-5#2)(1992-2#1)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1994-12#1)(1994-2#1)(1994-7#1)(1995-11#3)(1995-2#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#3)(1996-4#2)(1996-6#2)(1996-8#1)(1997-4#1)(1997-7#1)(2005-12#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#3)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#6)(2008-2#6)(2008-3#22)(2008-4#2)(2008-7#7)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#2)(2009-9#2)(2010-12#1)(2010-3#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)
the exaggerated sympathetic outflow commonly observed in heart failure##2##9##(2005-10#2)
the exaggerated##6##2##(1993-3#1)(2005-10#2)(2008-5#1)(2008-7#1)(2012-12#1)
the examination and##4##3##(1990-3#1)(1995-11#1)(1996-11#1)(2007-5#1)
the examination at##2##3##(1991-12#1)(1993-10#1)
the examination is##2##3##(2006-5#1)(2006-6#1)
the examination of such##2##4##(1996-4#1)(2008-8#1)
the examination of the##5##4##(1996-8#1)(2006-10#1)(2007-8#1)(2007-9#1)(2013-7#1)
the examination of their##2##4##(2007-11#1)(2008-3#1)
the examination of##42##3##(1990-5#1)(1992-8#1)(1993-1#1)(1995-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-2#1)(2005-6#1)(2005-8#1)(2006-10#3)(2006-6#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#1)(2008-12#2)(2008-3#2)(2008-8#1)(2009-11#1)(2009-2#1)(2010-8#3)(2011-1#1)(2011-12#1)(2012-12#1)(2013-7#1)
the examination system##2##3##(2006-10#1)(2010-6#1)
the examination technique##2##3##(2010-12#2)
the examination was##2##3##(1991-6#1)(2007-12#1)
the examination##86##2##(1990-3#2)(1990-4#1)(1990-5#1)(1991-12#1)(1991-6#2)(1992-8#1)(1993-1#1)(1993-10#1)(1995-11#2)(1995-6#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(2004-2#1)(2005-6#1)(2005-8#1)(2006-10#5)(2006-12#1)(2006-5#1)(2006-6#3)(2006-8#2)(2007-11#5)(2007-12#2)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#1)(2008-12#3)(2008-3#3)(2008-7#1)(2008-8#3)(2009-11#1)(2009-2#1)(2010-12#4)(2010-3#2)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
the examinations were##4##3##(1990-8#1)(1996-9#1)(1997-3#1)(2005-1#1)
the examinations##8##2##(1990-4#1)(1990-8#1)(1992-5#1)(1993-5#1)(1995-5#1)(1996-9#1)(1997-3#1)(2005-1#1)
the examined##34##2##(1990-3#1)(1990-9#1)(1991-2#1)(1991-6#1)(1992-2#1)(1993-5#1)(1994-8#1)(1996-1#1)(2005-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-4#1)(2012-1#1)(2012-11#2)(2012-12#1)(2013-1#2)
the examiner##4##2##(2006-10#1)(2007-11#1)(2011-2#2)
the example of a##3##4##(2005-11#1)(2006-3#1)(2007-4#1)
the example of oxidation of##2##5##(1990-5#1)(2008-10#1)
the example of the##7##4##(2006-12#1)(2007-10#1)(2008-10#1)(2008-3#2)(2008-6#1)(2012-2#1)
the example of##36##3##(1990-5#1)(1990-6#1)(1994-2#1)(1995-1#1)(1997-5#1)(2005-11#1)(2006-12#2)(2006-3#1)(2007-10#2)(2007-11#1)(2007-4#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)
the example##49##2##(1990-5#1)(1990-6#1)(1992-6#1)(1994-2#2)(1995-1#1)(1996-12#1)(1996-6#1)(1997-5#1)(2005-11#1)(2006-12#2)(2006-3#1)(2007-10#2)(2007-11#1)(2007-4#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-6#2)(2008-7#1)(2009-3#1)(2009-9#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#2)
the examples of the##2##4##(2005-5#1)(2007-11#1)
the examples of##6##3##(2005-5#1)(2007-11#1)(2007-8#1)(2008-10#1)(2009-12#1)(2009-5#1)
the examples##14##2##(1991-12#1)(2005-4#1)(2005-5#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-7#1)(2011-12#1)
the exbB-exbD-tonB locus##2##3##(1997-2#2)
the excellent clinical##2##3##(2008-1#1)(2013-1#1)
the excellent compatibility##2##3##(2006-6#1)(2008-5#1)
the excellent performance of the##2##5##(2007-11#1)(2010-10#1)
the excellent performance of##5##4##(2006-4#1)(2007-11#1)(2007-7#1)(2008-10#1)(2010-10#1)
the excellent##34##2##(1990-10#1)(1990-9#1)(1991-6#1)(1993-6#1)(1997-2#1)(2004-12#1)(2004-2#1)(2004-9#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-10#1)(2010-5#1)(2011-2#1)(2013-1#1)
the exception of 1##2##4##(2008-12#1)(2008-5#1)
the exception of a single##2##5##(2008-10#1)(2008-9#1)
the exception of a##7##4##(1991-9#1)(1992-2#1)(1995-11#1)(1996-5#1)(2008-10#1)(2008-12#1)(2008-9#1)
the exception of one##8##4##(1991-12#1)(1993-10#1)(1993-6#1)(1995-11#1)(2008-10#3)(2008-5#1)
the exception of the##35##4##(1990-5#1)(1991-2#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-5#1)(1996-11#1)(1996-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-1#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-8#1)(2010-12#1)(2011-2#2)
the exception of two##2##4##(2008-10#1)(2008-12#1)
the exception of##175##3##(1990-1#1)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-12#4)(1991-2#3)(1991-4#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-10#2)(1993-11#3)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-3#2)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#3)(1995-12#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#2)(1996-12#1)(1996-5#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-1#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-12#3)(2007-2#2)(2007-3#2)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#26)(2008-11#1)(2008-12#4)(2008-3#2)(2008-4#3)(2008-5#7)(2008-7#4)(2008-8#2)(2008-9#3)(2009-11#1)(2009-4#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#6)(2013-8#3)
the exception to##3##3##(1992-1#1)(2007-10#1)(2008-10#1)
the exception##199##2##(1990-1#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-12#4)(1991-2#3)(1991-4#1)(1991-7#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-7#1)(1992-8#2)(1993-10#2)(1993-11#3)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#3)(1995-12#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#2)(1996-12#1)(1996-5#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-1#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#5)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#2)(2007-3#2)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#32)(2008-11#1)(2008-12#4)(2008-3#2)(2008-4#4)(2008-5#7)(2008-7#4)(2008-8#2)(2008-9#3)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#6)(2013-8#3)
the exceptional##6##2##(1995-2#1)(1995-5#1)(1997-1#1)(2007-7#1)(2008-10#1)(2008-2#1)
the exceptionally##2##2##(2007-12#1)(2008-5#1)
the exceptions to this##2##4##(1996-5#1)(2007-11#1)
the exceptions##8##2##(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#3)(2008-8#1)(2010-5#1)
the excess CHOL##2##3##(1995-10#2)
the excess demand argument##2##4##(1995-2#2)
the excess ligand##2##3##(2006-6#2)
the excess of##6##3##(1995-6#1)(2008-10#4)(2012-3#1)
the excess risk in##2##4##(1996-7#1)(2008-7#1)
the excess risk##4##3##(1996-7#1)(2005-10#1)(2008-7#2)
the excess was##2##3##(2010-2#1)(2013-1#1)
the excess##50##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-12#2)(1991-3#1)(1992-9#1)(1993-2#1)(1993-5#1)(1995-10#2)(1995-2#2)(1995-6#1)(1995-8#1)(1996-7#3)(1997-2#1)(1997-7#1)(2005-10#2)(2005-11#2)(2006-10#3)(2006-6#3)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#2)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
the excess-noise factor##3##3##(2007-12#2)(2008-3#1)
the excessive accumulation of##2##4##(1996-6#1)(2009-8#1)
the excessive use of##4##4##(1992-10#1)(1993-2#1)(2008-10#1)(2013-8#1)
the excessive##21##2##(1992-10#1)(1992-11#1)(1993-2#1)(1993-6#1)(1994-3#1)(1996-6#1)(2006-4#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2009-8#1)(2010-9#1)(2011-12#1)(2012-1#2)(2013-8#1)
the exchange and##6##3##(1992-12#1)(1996-12#1)(2005-6#1)(2008-11#1)(2008-3#1)(2010-8#1)
the exchange of information##2##4##(1992-12#1)(2011-2#1)
the exchange of internal##2##4##(1997-1#2)
the exchange of knowledge and##2##5##(2008-9#1)(2012-2#1)
the exchange of knowledge##3##4##(2008-9#1)(2012-2#1)(2013-1#1)
the exchange of protons between the##2##6##(1993-3#2)
the exchange of##32##3##(1990-2#1)(1991-4#1)(1992-12#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-8#1)(1995-8#1)(1996-6#1)(1997-1#2)(1997-2#1)(2006-10#1)(2006-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#2)(2008-9#2)(2010-5#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-7#1)
the exchange process##3##3##(1995-2#1)(2008-12#1)(2010-3#1)
the exchange rate##2##3##(1990-8#1)(2008-7#1)
the exchange##62##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-4#1)(1992-12#2)(1992-4#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-7#3)(2005-11#2)(2005-6#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-9#2)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#4)(2013-7#1)
the exchange/transfer process##2##3##(2010-7#2)
the exchangeable##2##2##(1990-5#1)(1992-1#1)
the exchanger##4##2##(1991-9#1)(2008-10#3)
the excimer##2##2##(1991-3#1)(1992-6#1)
the excimer-to-monomer##2##2##(1992-6#1)(2005-11#1)
the excipients##8##2##(2008-10#5)(2010-5#1)(2011-1#1)(2013-7#1)
the excised tumor##3##3##(1990-12#1)(1996-6#1)(2012-12#1)
the excised##26##2##(1990-12#1)(1991-5#1)(1995-1#2)(1995-4#1)(1995-8#4)(1996-6#1)(2005-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-12#1)(2011-1#2)(2012-12#2)(2012-2#1)
the excision of an##2##4##(1995-8#1)(2007-8#1)
the excision of the##5##4##(1997-1#1)(2007-9#1)(2009-1#1)(2010-2#1)(2013-8#1)
the excision of##13##3##(1995-2#1)(1995-8#1)(1997-1#1)(2006-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2009-1#1)(2010-2#1)(2011-1#2)(2011-12#1)(2013-8#1)
the excision repair##2##3##(1995-9#1)(2009-5#1)
the excision##20##2##(1995-2#1)(1995-8#1)(1995-9#1)(1997-1#1)(2004-2#1)(2006-10#1)(2006-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-3#1)(2009-5#1)(2010-2#1)(2011-1#2)(2011-12#1)(2013-8#1)
the excitability of##6##3##(1992-3#1)(1992-8#1)(1994-3#1)(1997-5#1)(2007-11#1)(2010-7#1)
the excitability##7##2##(1992-3#1)(1992-8#1)(1994-3#1)(1997-5#2)(2007-11#1)(2010-7#1)
the excitable##2##2##(2007-12#1)(2013-7#1)
the excitation and emission##4##4##(2007-11#1)(2008-10#2)(2008-4#1)
the excitation and the##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
the excitation and##11##3##(1990-3#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-4#1)(2008-8#1)
the excitation beam##8##3##(2007-11#3)(2007-12#1)(2008-10#1)(2008-3#3)
the excitation energy density##2##4##(2008-3#2)
the excitation energy##3##3##(2007-12#1)(2008-3#2)
the excitation laser light##2##4##(2006-12#1)(2008-3#1)
the excitation laser##5##3##(2005-11#1)(2006-12#1)(2008-3#3)
the excitation light of##2##4##(2007-11#1)(2013-8#1)
the excitation light##9##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2013-8#1)
the excitation of surface waves##2##5##(2008-2#2)
the excitation of the##2##4##(2007-5#1)(2013-1#1)
the excitation of##16##3##(1996-2#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2010-12#1)(2013-1#1)
the excitation power##2##3##(2008-2#1)(2012-2#1)
the excitation pulse##2##3##(1993-8#1)(2008-3#1)
the excitation spectra##3##3##(1997-1#1)(2008-2#1)(2012-2#1)
the excitation wavelength##5##3##(1990-5#1)(1994-5#1)(2005-12#1)(2008-3#1)(2008-5#1)
the excitation wavelengths##2##3##(1992-8#1)(2008-3#1)
the excitation##91##2##(1990-3#1)(1990-5#1)(1992-8#1)(1993-8#1)(1994-5#1)(1995-3#1)(1996-2#1)(1997-1#1)(2005-11#2)(2005-12#1)(2006-12#1)(2007-11#8)(2007-12#11)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#10)(2008-3#19)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2010-12#2)(2010-5#1)(2012-2#2)(2013-1#1)(2013-8#1)
the excitation-contraction coupling##2##3##(2004-11#1)(2013-8#1)
the excitatory amino acid##8##4##(1990-2#3)(1991-5#1)(1994-2#1)(1996-3#1)(2008-7#2)
the excitatory amino##10##3##(1990-11#1)(1990-2#3)(1990-7#1)(1991-5#1)(1994-2#1)(1996-3#1)(2008-7#2)
the excitatory neurotransmitter glutamate##2##4##(1990-8#1)(2008-4#1)
the excitatory neurotransmitter##3##3##(1990-8#1)(1994-10#1)(2008-4#1)
the excitatory response in##3##4##(1996-1#3)
the excitatory response##4##3##(1996-1#4)
the excitatory##32##2##(1990-11#1)(1990-2#3)(1990-7#1)(1990-8#1)(1991-5#1)(1991-6#1)(1992-3#1)(1993-2#1)(1994-10#1)(1994-2#2)(1995-12#1)(1996-1#4)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#1)(2005-10#3)(2007-1#1)(2008-1#1)(2008-4#1)(2008-7#2)
the excited singlet state##2##4##(1995-6#1)(2005-11#1)
the excited state energy##4##4##(2009-12#2)(2010-2#2)
the excited state of##3##4##(2006-3#1)(2008-10#2)
the excited state##17##3##(1990-3#1)(1995-11#1)(1997-4#1)(2006-10#1)(2006-3#1)(2007-12#1)(2008-10#3)(2008-2#1)(2009-12#2)(2009-6#2)(2010-2#2)(2012-11#1)
the excited states of the##2##5##(2006-12#1)(2007-12#1)
the excited states of##4##4##(2006-12#1)(2007-12#1)(2008-10#1)(2010-7#1)
the excited states##6##3##(2006-12#1)(2006-5#1)(2007-12#1)(2008-10#2)(2010-7#1)
the excited##38##2##(1990-3#1)(1992-12#1)(1995-11#1)(1995-6#1)(1997-1#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-12#6)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#4)(2009-11#1)(2009-12#2)(2009-6#2)(2010-2#2)(2010-7#1)(2012-11#1)(2012-12#1)
the excited-state absorption##6##3##(2007-12#1)(2008-10#2)(2008-3#3)
the excited-state##8##2##(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#3)
the excitement of##2##3##(2008-7#1)(2011-1#1)
the excitement##3##2##(1995-12#1)(2008-7#1)(2011-1#1)
the exciting progress##2##3##(2005-8#1)(2006-10#1)
the exciting radiation##2##3##(2008-3#2)
the exciting##12##2##(1992-12#1)(2005-8#1)(2006-10#1)(2007-12#2)(2008-2#1)(2008-3#4)(2009-10#1)(2010-5#1)
the exciton##3##2##(2006-10#2)(2008-10#1)
the excitonic##2##2##(2007-12#1)(2010-2#1)
the excitotoxic cascade##2##3##(2007-9#2)
the excitotoxic cell death##2##4##(1990-7#2)
the excitotoxic process##2##3##(2008-7#1)(2011-2#1)
the excitotoxic##9##2##(1990-7#2)(1992-1#1)(2006-5#1)(2007-9#2)(2008-7#1)(2009-10#1)(2011-2#1)
the excitotoxin##2##2##(1993-12#1)(1996-6#1)
the excluded##2##2##(1990-8#1)(1995-6#1)
the exclusion criteria##2##3##(2006-12#1)(2008-5#1)
the exclusion of a##2##4##(2005-8#1)(2013-1#1)
the exclusion of all##2##4##(2008-10#1)(2011-2#1)
the exclusion of an##2##4##(1991-6#1)(2010-12#1)
the exclusion of other##3##4##(2006-10#1)(2009-4#1)(2013-1#1)
the exclusion of patients##2##4##(1992-10#1)(2008-3#1)
the exclusion of the##4##4##(2007-8#1)(2010-12#1)(2012-2#1)(2013-7#1)
the exclusion of##29##3##(1991-6#1)(1992-10#1)(1993-2#1)(1995-11#1)(1997-3#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#2)(2009-10#1)(2009-4#1)(2010-12#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
the exclusion##33##2##(1991-6#1)(1992-10#1)(1993-2#1)(1995-11#1)(1997-3#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#2)(2009-10#1)(2009-4#1)(2010-12#2)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)
the exclusive domain of##2##4##(2006-10#1)(2007-4#1)
the exclusive involvement of##2##4##(1995-12#1)(2008-8#1)
the exclusive##20##2##(1991-1#1)(1993-3#1)(1993-6#1)(1994-9#1)(1995-12#1)(1996-5#1)(1997-7#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-8#1)(2010-12#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
the excreted##4##2##(1992-8#1)(1993-2#1)(2008-7#1)(2013-1#1)
the excretion action##2##3##(2011-3#2)
the excretion of the##3##4##(1990-6#1)(2005-12#1)(2006-12#1)
the excretion of##15##3##(1990-6#1)(1991-12#1)(1993-12#1)(1995-1#1)(1996-8#2)(1997-8#1)(2005-12#1)(2006-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2009-5#1)(2009-6#1)(2012-2#1)
the excretion##21##2##(1990-5#1)(1990-6#1)(1991-12#1)(1993-12#1)(1994-5#1)(1994-6#2)(1995-1#1)(1996-8#2)(1997-8#1)(2005-12#1)(2006-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2009-5#1)(2009-6#1)(2011-3#2)(2012-2#1)
the excretory duct##3##3##(2007-12#3)
the excretory##4##2##(2007-12#3)(2008-5#1)
the excursion of the##2##4##(2008-10#1)(2012-2#1)
the excursion##3##2##(1994-8#1)(2008-10#1)(2012-2#1)
the execution of a##2##4##(2007-4#1)(2012-1#1)
the execution of##22##3##(1990-10#1)(1992-9#2)(1993-5#1)(1993-9#1)(1996-8#1)(2007-4#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#3)(2010-12#1)(2012-1#2)(2012-12#1)(2013-1#3)(2013-8#2)
the execution time##3##3##(2008-3#1)(2009-5#1)(2012-2#1)
the execution##27##2##(1990-10#1)(1992-9#2)(1993-12#1)(1993-5#1)(1993-9#1)(1996-8#1)(2006-12#1)(2007-4#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#3)(2010-12#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
the executioner##2##2##(2008-3#1)(2011-2#1)
the executive director##2##3##(1993-1#1)(2006-8#1)
the executive function##2##3##(2008-2#1)(2013-8#1)
the executive##20##2##(1993-1#1)(1993-2#2)(1995-1#1)(1995-3#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-11#1)(2008-2#1)(2008-8#1)(2009-9#1)(2010-6#1)(2012-1#1)(2013-8#1)
the exemption##2##2##(1996-2#2)
the exercise group##10##3##(1992-3#2)(2011-12#1)(2011-2#1)(2012-11#4)(2013-7#2)
the exercise instructor##2##3##(2007-6#2)
the exercise of power##2##4##(2008-11#2)
the exercise of##5##3##(1995-1#1)(2006-4#1)(2008-11#2)(2012-3#1)
the exercise was##6##3##(2008-10#2)(2008-12#1)(2008-5#1)(2012-12#2)
the exercise##50##2##(1991-12#1)(1991-3#2)(1991-8#1)(1992-3#4)(1995-1#3)(1996-4#1)(2006-4#1)(2007-11#1)(2007-6#3)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-5#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-11#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#2)
the exercise-induced increase##2##3##(2005-8#1)(2013-8#1)
the exercises##7##2##(2007-11#4)(2007-9#1)(2012-1#1)(2013-8#1)
the exercising muscle##3##3##(2005-10#1)(2005-12#1)(2012-3#1)
the exercising of jurisdictional##2##4##(2007-10#2)
the exercising##6##2##(2005-1#1)(2005-10#1)(2005-12#1)(2007-10#2)(2012-3#1)
the exertion of##2##3##(2008-12#1)(2013-1#1)
the exhaust##13##2##(2007-10#3)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#5)
the exhaustion of##2##3##(2008-10#1)(2009-2#1)
the exhaustion##3##2##(1993-12#1)(2008-10#1)(2009-2#1)
the exhaustive search##3##3##(2008-2#2)(2011-1#1)
the exhaustive##5##2##(1991-1#1)(2008-2#2)(2011-1#1)(2013-1#1)
the exhibition##3##2##(1994-3#1)(2005-8#1)(2008-10#1)
the exhumation##2##2##(1995-6#1)(2009-2#1)
the exine##2##2##(2011-2#2)
the existance of##2##3##(1992-3#1)(2009-5#1)
the existence and importance of##2##5##(1990-5#1)(2012-12#1)
the existence and nature of##3##5##(2007-9#1)(2011-1#1)(2013-8#1)
the existence and stability of##3##5##(2007-12#2)(2009-8#1)
the existence and stability##4##4##(2007-12#3)(2009-8#1)
the existence and the##2##4##(1993-2#1)(2008-4#1)
the existence and uniqueness of the##2##6##(2008-2#1)(2009-10#1)
the existence and uniqueness of##3##5##(2008-11#1)(2008-2#1)(2009-10#1)
the existence and##21##3##(1990-5#1)(1991-12#1)(1991-8#1)(1993-2#1)(2005-10#1)(2006-8#1)(2007-12#3)(2007-9#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#2)(2009-10#1)(2009-8#1)(2011-1#1)(2012-12#1)(2013-8#2)
the existence of &quot##2##4##(1995-1#1)(2008-11#1)
the existence of 1##2##4##(1990-7#1)(2008-10#1)
the existence of 2##2##4##(1990-7#1)(2010-6#1)
the existence of God##4##4##(2013-1#4)
the existence of a &quot##2##5##(1992-11#1)(1996-9#1)
the existence of a direct##2##5##(1991-1#1)(1995-3#1)
the existence of a distinct##2##5##(1997-1#1)(1997-7#1)
the existence of a family of novel##2##7##(1994-12#1)(1994-6#1)
the existence of a highly##2##5##(1992-3#1)(2013-1#1)
the existence of a large##3##5##(1991-2#1)(1994-8#1)(2007-11#1)
the existence of a mechanism##3##5##(1993-8#1)(1997-6#1)(2005-8#1)
the existence of a new type of##2##7##(1992-6#1)(2008-8#1)
the existence of a new##4##5##(1992-6#1)(2007-12#1)(2008-7#1)(2008-8#1)
the existence of a possible##2##5##(2008-4#1)(2013-1#1)
the existence of a second##3##5##(1991-4#1)(1992-5#1)(2008-10#1)
the existence of a##131##4##(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#2)(1991-2#1)(1991-4#1)(1991-6#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-4#3)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-12#3)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-12#6)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#6)(1994-9#2)(1995-1#1)(1995-11#2)(1995-2#4)(1995-3#1)(1995-4#1)(1995-8#3)(1996-11#1)(1996-2#1)(1996-4#3)(1996-9#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-3#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-6#1)(2007-7#2)(2008-10#6)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-8#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#1)
the existence of additional##2##4##(1991-5#1)(2009-2#1)
the existence of agonist-specific activated states of##2##7##(1997-7#2)
the existence of an endogenous##2##5##(1994-5#1)(2010-8#1)
the existence of an inverse##2##5##(1994-8#1)(2008-8#1)
the existence of an##22##4##(1990-5#1)(1991-11#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-1#2)(1996-12#1)(1996-4#1)(1997-6#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-8#1)(2013-7#1)
the existence of another##2##4##(1991-5#1)(1995-7#1)
the existence of at least three##4##6##(1990-8#1)(1994-8#1)(1994-9#1)(2008-10#1)
the existence of at least two##3##6##(1992-12#1)(1995-10#1)(2008-9#1)
the existence of at least##9##5##(1990-8#1)(1992-12#1)(1994-8#2)(1994-9#1)(1995-10#1)(2008-10#1)(2008-9#1)(2013-1#1)
the existence of both##7##4##(1997-6#1)(2005-10#1)(2006-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#1)
the existence of different##4##4##(1991-8#1)(1996-12#1)(1997-1#1)(2005-10#1)
the existence of diffuse##2##4##(1991-12#1)(2008-2#1)
the existence of discrete##2##4##(2007-11#1)(2007-12#1)
the existence of distinct##3##4##(1991-9#1)(1995-8#1)(2008-10#1)
the existence of four major##2##5##(1997-7#1)(2008-5#1)
the existence of four##3##4##(1997-7#1)(2008-5#1)(2010-12#1)
the existence of functionally##2##4##(1994-10#1)(2008-1#1)
the existence of long-range##2##4##(2005-11#1)(2007-12#1)
the existence of many##2##4##(2008-5#1)(2010-8#1)
the existence of more than one##2##6##(1991-2#1)(2008-10#1)
the existence of more##3##4##(1991-2#1)(2008-10#2)
the existence of multiple mechanisms##2##5##(2007-12#1)(2008-10#1)
the existence of multiple##7##4##(1991-5#1)(1993-9#1)(1995-1#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-7#1)
the existence of one##3##4##(1997-2#1)(1997-7#1)(2008-7#1)
the existence of positive##2##4##(2008-3#1)(2008-9#1)
the existence of several##4##4##(1990-3#1)(1990-4#1)(1993-8#1)(2008-10#1)
the existence of significant##2##4##(1991-11#1)(2007-5#1)
the existence of similar##2##4##(1992-12#1)(2005-8#1)
the existence of stable and##2##5##(1994-8#1)(2008-2#1)
the existence of such##2##4##(1994-3#1)(2010-3#1)
the existence of the latter##2##5##(1995-8#1)(2010-5#1)
the existence of the##35##4##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#2)(1993-11#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-8#1)(1996-3#1)(1997-6#1)(1997-7#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-3#1)(2007-1#1)(2007-12#4)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#1)
the existence of these two##2##5##(1992-12#1)(2006-2#1)
the existence of these##4##4##(1992-12#1)(1997-5#1)(1997-8#1)(2006-2#1)
the existence of this##3##4##(1995-2#1)(2007-5#1)(2007-6#1)
the existence of three##4##4##(1992-8#1)(1993-4#1)(1994-5#1)(2008-10#1)
the existence of two distinct##3##5##(1990-11#1)(1991-5#1)(2004-9#1)
the existence of two types of##2##6##(1993-11#1)(2005-4#1)
the existence of two##22##4##(1990-11#1)(1990-7#1)(1991-1#2)(1991-5#1)(1992-12#1)(1992-5#1)(1993-11#1)(1994-3#1)(1996-6#1)(1997-3#2)(2004-9#1)(2005-4#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)
the existence of##508##3##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#4)(1990-7#5)(1990-8#5)(1990-9#2)(1991-1#4)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#5)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#6)(1992-3#3)(1992-4#3)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#4)(1993-12#5)(1993-2#2)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#4)(1993-9#4)(1994-10#1)(1994-11#4)(1994-12#8)(1994-2#5)(1994-3#2)(1994-5#3)(1994-6#4)(1994-8#11)(1994-9#5)(1995-1#6)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#6)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#7)(1996-11#2)(1996-12#3)(1996-2#5)(1996-3#1)(1996-4#5)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#5)(1997-2#5)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#6)(1997-7#6)(1997-8#3)(1997-9#1)(2004-12#1)(2004-9#2)(2005-10#4)(2005-11#4)(2005-12#1)(2005-4#2)(2005-8#3)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#2)(2006-6#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#3)(2007-11#7)(2007-12#22)(2007-3#1)(2007-4#1)(2007-5#4)(2007-6#2)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#35)(2008-11#11)(2008-12#1)(2008-2#9)(2008-3#9)(2008-4#6)(2008-5#11)(2008-6#2)(2008-7#13)(2008-8#8)(2008-9#7)(2009-1#1)(2009-10#4)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#3)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#5)(2010-2#1)(2010-3#3)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#4)(2010-9#1)(2011-12#1)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#7)(2012-3#2)(2012-7#1)(2013-1#8)(2013-7#3)(2013-8#7)
the existence or not of##4##5##(1993-2#1)(1993-5#1)(2009-9#1)(2013-8#1)
the existence##537##2##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#5)(1990-7#5)(1990-8#5)(1990-9#2)(1991-1#4)(1991-11#2)(1991-12#3)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#5)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#2)(1992-1#1)(1992-11#3)(1992-12#6)(1992-3#3)(1992-4#3)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#4)(1993-12#5)(1993-2#5)(1993-3#2)(1993-4#2)(1993-5#2)(1993-6#2)(1993-7#1)(1993-8#4)(1993-9#4)(1994-10#1)(1994-11#4)(1994-12#8)(1994-2#5)(1994-3#2)(1994-5#3)(1994-6#4)(1994-8#11)(1994-9#5)(1995-1#6)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#6)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#7)(1996-11#2)(1996-12#3)(1996-2#5)(1996-3#1)(1996-4#5)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#5)(1997-2#5)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#6)(1997-7#6)(1997-8#3)(1997-9#1)(2004-12#1)(2004-9#2)(2005-10#5)(2005-11#4)(2005-12#1)(2005-4#2)(2005-8#3)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#2)(2006-6#1)(2006-7#1)(2006-8#4)(2007-1#1)(2007-10#3)(2007-11#7)(2007-12#25)(2007-3#1)(2007-4#1)(2007-5#4)(2007-6#2)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#35)(2008-11#12)(2008-12#1)(2008-2#10)(2008-3#9)(2008-4#7)(2008-5#11)(2008-6#2)(2008-7#13)(2008-8#10)(2008-9#7)(2009-1#1)(2009-10#5)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#3)(2009-7#3)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#5)(2010-2#1)(2010-3#3)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#7)(2012-3#2)(2012-7#1)(2013-1#8)(2013-7#3)(2013-8#10)
the existent##3##2##(1994-6#1)(2010-12#1)(2011-1#1)
the existential##2##2##(2007-10#2)
the existing channels##2##3##(2008-2#2)
the existing conventional procedure##2##4##(2008-10#2)
the existing data##4##3##(1994-1#1)(2008-5#1)(2008-8#1)(2011-2#1)
the existing evidence##5##3##(2005-10#1)(2011-1#1)(2011-2#1)(2013-1#2)
the existing health##2##3##(1995-1#1)(2010-8#1)
the existing infection assay##3##4##(2010-10#3)
the existing literature on the##2##5##(1996-11#1)(2008-5#1)
the existing literature on##7##4##(1993-12#1)(1996-11#1)(2008-5#1)(2010-2#1)(2012-12#3)
the existing literature##22##3##(1993-12#1)(1994-7#1)(1996-11#1)(2006-8#2)(2007-2#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-7#1)(2010-2#1)(2010-8#1)(2012-1#1)(2012-12#4)(2013-1#1)
the existing methods##6##3##(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-6#1)(2013-1#1)
the existing models##2##3##(1992-11#1)(2009-7#1)
the existing problems##2##3##(2010-12#1)(2012-3#1)
the existing process##2##3##(1993-12#1)(2012-3#1)
the existing recommendations##3##3##(2008-11#1)(2008-3#1)(2008-8#1)
the existing relationship between##2##4##(2009-6#1)(2013-7#1)
the existing standard##2##3##(2007-11#1)(2008-10#1)
the existing system##6##3##(1997-4#2)(2007-4#1)(2008-11#1)(2008-7#1)(2012-11#1)
the existing systems##2##3##(2008-7#1)(2010-8#1)
the existing theory##2##3##(2007-11#1)(2008-8#1)
the existing##178##2##(1991-10#1)(1992-1#1)(1992-11#2)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#2)(1994-1#1)(1994-7#2)(1994-9#1)(1995-1#2)(1995-3#1)(1995-6#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#2)(2005-10#2)(2005-11#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-8#2)(2007-11#4)(2007-12#1)(2007-2#1)(2007-4#2)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#12)(2008-11#5)(2008-12#2)(2008-2#10)(2008-3#5)(2008-5#4)(2008-6#1)(2008-7#12)(2008-8#3)(2008-9#2)(2009-1#1)(2009-4#1)(2009-6#3)(2009-7#3)(2009-8#1)(2010-1#1)(2010-10#4)(2010-12#3)(2010-2#1)(2010-3#1)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#8)(2012-2#4)(2012-3#5)(2013-1#8)(2013-7#2)(2013-8#5)
the exit aperture of the##2##5##(2008-3#2)
the exit of##3##3##(1993-11#1)(1995-11#1)(2008-2#1)
the exit pupil##2##3##(2008-3#2)
the exit site##8##3##(2007-12#1)(2007-7#4)(2011-2#3)
the exit slit##2##3##(2008-2#1)(2008-3#1)
the exit##23##2##(1993-11#1)(1994-12#1)(1994-3#1)(1995-11#1)(2007-12#1)(2007-7#4)(2008-2#4)(2008-3#7)(2011-2#3)
the exiting##2##2##(2009-6#1)(2012-12#1)
the exocrine glands##2##3##(1993-7#1)(2007-10#1)
the exocrine pancreas##2##3##(1992-4#1)(2006-10#1)
the exocrine##6##2##(1990-3#1)(1992-4#1)(1993-7#1)(2004-12#1)(2006-10#1)(2007-10#1)
the exocyclic##7##2##(1992-12#1)(1992-9#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#1)(2008-10#1)
the exocytic##2##2##(1994-6#1)(1996-5#1)
the exocytosis##2##2##(1995-11#1)(1997-3#1)
the exocytotic apparatus##2##3##(1996-9#1)(2007-9#1)
the exocytotic process##2##3##(2008-4#1)(2012-2#1)
the exocytotic release of##2##4##(1990-12#2)
the exocytotic##9##2##(1990-12#2)(1993-3#1)(1996-9#1)(2007-9#2)(2008-12#1)(2008-4#1)(2012-2#1)
the exogenous application of##3##4##(1990-5#1)(2008-10#1)(2008-4#1)
the exogenous substrate##2##3##(1990-10#1)(2008-4#1)
the exogenous##22##2##(1990-10#1)(1990-5#2)(1992-7#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-8#1)(1996-2#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#2)(2008-8#2)(2010-10#1)(2010-12#1)(2011-12#1)
the exome sequencing data##2##4##(2012-3#2)
the exome##4##2##(2012-3#4)
the exon 3##2##3##(1990-6#1)(1992-8#1)
the exon 6##2##3##(1993-4#1)(1993-8#1)
the exon 7 and 8##2##5##(1993-8#2)
the exon 8##3##3##(1993-8#2)(2009-10#1)
the exon of##2##3##(1997-8#1)(2005-10#1)
the exon structure##2##3##(1991-9#1)(1994-12#1)
the exon theory##2##3##(1995-8#2)
the exon##31##2##(1990-11#1)(1990-12#2)(1990-6#2)(1991-5#1)(1991-6#1)(1991-9#2)(1992-8#1)(1993-12#1)(1993-4#1)(1993-8#6)(1994-12#3)(1994-3#1)(1995-6#1)(1995-8#2)(1997-8#1)(2005-10#1)(2006-8#1)(2008-9#1)(2009-10#1)(2012-3#1)
the exon-intron organization of the##3##5##(1991-3#1)(1993-6#1)(1997-2#1)
the exon-intron organization of##4##4##(1991-3#1)(1993-6#2)(1997-2#1)
the exon-intron##7##2##(1990-5#1)(1991-3#1)(1993-6#2)(1994-8#1)(1995-1#1)(1997-2#1)
the exons and their##2##4##(1992-3#1)(1993-3#1)
the exons and##3##3##(1991-5#1)(1992-3#1)(1993-3#1)
the exons of##2##3##(1995-1#1)(2008-8#1)
the exons##9##2##(1991-5#1)(1992-3#2)(1993-3#1)(1993-8#1)(1994-3#1)(1995-1#1)(1997-2#1)(2008-8#1)
the exopolysaccharide##3##2##(1991-9#2)(2009-8#1)
the exoskeleton##12##2##(2007-12#4)(2012-1#8)
the exotherm##3##2##(1991-8#3)
the exothermic and spontaneous nature of##2##6##(2008-10#2)
the exothermic##3##2##(2005-11#1)(2008-10#2)
the exotic##2##2##(2009-2#2)
the expanded score##2##3##(1992-6#2)
the expanded survey##3##3##(2012-12#3)
the expanded uncertainty##2##3##(2008-10#2)
the expanded##28##2##(1991-12#1)(1992-6#2)(1996-12#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#3)(2013-1#1)
the expanding field of##2##4##(2007-11#1)(2009-9#1)
the expanding role of##3##4##(2007-12#1)(2009-4#1)(2012-12#1)
the expanding role##4##3##(2007-12#1)(2007-3#1)(2009-4#1)(2012-12#1)
the expanding##15##2##(1997-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#2)(2008-10#1)(2009-4#1)(2009-8#1)(2009-9#1)(2011-1#1)(2012-12#1)(2013-8#1)
the expansion and##3##3##(2008-1#1)(2008-3#1)(2010-2#1)
the expansion of activated##3##4##(2007-11#1)(2008-10#2)
the expansion of the##12##4##(1990-12#1)(1997-1#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-4#1)(2012-1#1)(2013-1#2)
the expansion of##37##3##(1990-12#1)(1992-1#1)(1995-2#1)(1996-2#1)(1997-1#1)(1997-3#1)(2006-12#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-3#1)(2010-7#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
the expansion order##3##3##(2008-2#3)
the expansion##50##2##(1990-12#1)(1992-1#1)(1995-2#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#2)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-2#1)(2010-7#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
the expectancy##2##2##(1993-2#1)(2008-11#1)
the expectation of a##2##4##(1990-10#1)(1997-1#1)
the expectation of##3##3##(1990-10#1)(1997-1#1)(2008-12#1)
the expectation that##12##3##(1992-8#1)(1997-1#1)(2006-10#1)(2006-7#1)(2007-3#1)(2007-8#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-3#1)(2011-1#1)(2012-12#1)
the expectation value of##2##4##(2007-11#1)(2009-9#1)
the expectation##20##2##(1990-10#1)(1992-8#1)(1997-1#2)(1997-6#1)(2005-10#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-9#1)(2010-3#1)(2011-1#1)(2012-12#1)
the expectation-maximization (EM)##3##3##(2008-2#2)(2012-3#1)
the expectation-maximization##4##2##(2008-2#3)(2012-3#1)
the expectations of mothers##2##4##(2008-9#2)
the expectations of##9##3##(1997-1#1)(2007-3#1)(2007-4#1)(2008-9#3)(2011-1#1)(2011-2#1)(2013-1#1)
the expectations##12##2##(1997-1#1)(2007-3#1)(2007-4#1)(2008-7#1)(2008-9#3)(2011-1#1)(2011-12#1)(2011-2#2)(2013-1#1)
the expected and observed##2##4##(2008-9#2)
the expected and##6##3##(1990-12#1)(2008-10#1)(2008-9#2)(2013-1#2)
the expected asparaginyl residue##2##4##(1992-11#2)
the expected behavior##2##3##(1992-9#1)(2008-7#1)
the expected benefits##2##3##(1993-12#1)(2012-2#1)
the expected change##2##3##(1993-1#1)(1996-8#1)
the expected clinical##2##3##(1996-12#1)(2011-2#1)
the expected concentration##2##3##(1990-8#1)(2008-10#1)
the expected decrease in##2##4##(1996-9#1)(2010-4#1)
the expected direction##4##3##(1990-8#1)(2008-11#1)(2010-10#1)(2010-9#1)
the expected effect##2##3##(1997-1#1)(1997-2#1)
the expected experimental##2##3##(1994-11#1)(2013-1#1)
the expected final##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
the expected impact of##2##4##(2010-2#1)(2011-2#1)
the expected improvement in##2##4##(2006-11#1)(2008-9#1)
the expected increase in##2##4##(2011-2#1)(2013-8#1)
the expected number of##2##4##(2008-10#1)(2012-2#1)
the expected outcome##2##3##(1997-1#1)(2009-6#1)
the expected overall##2##3##(1992-7#1)(2009-11#1)
the expected pattern##2##3##(2008-2#1)(2008-5#1)
the expected performance##2##3##(2007-12#1)(2008-3#1)
the expected population##2##3##(2008-10#1)(2008-8#1)
the expected reduction##2##3##(1992-11#1)(2007-12#1)
the expected response of##2##4##(2008-10#1)(2008-9#1)
the expected results##3##3##(2008-10#1)(2008-4#1)(2012-2#1)
the expected runtime of##2##4##(2010-2#2)
the expected runtime##3##3##(2010-2#3)
the expected seasonal##2##3##(2007-11#1)(2008-10#1)
the expected size##4##3##(1993-8#1)(1994-11#1)(2006-12#1)(2008-10#1)
the expected sizes##2##3##(1991-5#1)(1995-12#1)
the expected term date##2##4##(1992-7#2)
the expected theoretical##2##3##(2008-11#1)(2008-9#1)
the expected thermal##2##3##(2007-12#1)(2008-2#1)
the expected time to extinction##3##5##(2007-9#1)(2008-9#2)
the expected time to##4##4##(2007-9#1)(2008-5#1)(2008-9#2)
the expected time until##2##4##(1997-6#1)(2008-10#1)
the expected time##8##3##(1996-8#1)(1997-6#1)(2007-9#2)(2008-10#1)(2008-5#1)(2008-9#2)
the expected value##2##3##(1997-4#1)(2008-10#1)
the expected values of##2##4##(1990-6#1)(1993-1#1)
the expected values##3##3##(1990-6#1)(1993-1#1)(1995-5#1)
the expected weight##2##3##(1992-12#1)(1995-8#1)
the expected##233##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-6#1)(1990-8#2)(1991-12#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#4)(1992-8#1)(1992-9#2)(1993-1#3)(1993-12#1)(1993-8#3)(1994-11#2)(1994-12#2)(1994-2#1)(1994-5#3)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#3)(1995-5#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-5#2)(2006-9#1)(2007-10#5)(2007-11#4)(2007-12#10)(2007-9#3)(2008-1#1)(2008-10#27)(2008-11#4)(2008-2#12)(2008-3#12)(2008-4#1)(2008-5#5)(2008-7#3)(2008-8#7)(2008-9#8)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#2)(2009-6#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-2#4)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#5)(2013-8#1)
the expense of##54##3##(1990-12#1)(1990-9#1)(1991-6#1)(1991-7#1)(1992-5#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-9#2)(1997-1#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#2)(2007-4#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-2#6)(2008-3#3)(2008-6#2)(2008-7#2)(2008-9#2)(2009-2#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2012-9#1)
the expense##55##2##(1990-12#1)(1990-9#1)(1991-6#1)(1991-7#1)(1992-5#1)(1992-6#1)(1993-12#2)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-9#2)(1997-1#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#2)(2007-4#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-2#6)(2008-3#3)(2008-6#2)(2008-7#2)(2008-9#2)(2009-2#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2012-9#1)
the expenses##4##2##(1990-12#1)(2009-10#1)(2012-2#1)(2013-8#1)
the expensive##7##2##(1996-12#1)(1997-6#1)(2008-10#2)(2009-10#1)(2011-1#1)(2011-2#1)
the experience and##7##3##(1994-1#1)(2007-9#2)(2008-2#2)(2008-8#1)(2009-4#1)
the experience gained##4##3##(1995-2#1)(1996-4#1)(2006-4#1)(2010-11#1)
the experience in##3##3##(2007-3#1)(2007-9#1)(2008-6#1)
the experience of King##2##4##(2007-1#1)(2007-3#1)
the experience of a single##2##5##(2006-11#1)(2013-1#1)
the experience of a##7##4##(1994-1#1)(1996-12#1)(2006-11#1)(2006-2#1)(2007-12#1)(2010-7#1)(2013-1#1)
the experience of an##2##4##(2007-2#1)(2008-12#1)
the experience of being a lecturer practitioner##2##7##(2008-12#2)
the experience of being a victim of crime##2##8##(2011-1#2)
the experience of being a##4##5##(2008-12#2)(2011-1#2)
the experience of nurses##3##4##(2007-10#1)(2008-1#1)(2008-7#1)
the experience of one##4##4##(1993-12#1)(2007-2#1)(2008-12#1)(2009-2#1)
the experience of planned##3##4##(2007-2#2)(2010-6#1)
the experience of recovery##2##4##(2008-2#2)
the experience of stress##2##4##(2009-7#1)(2012-1#1)
the experience of the operator##3##5##(1991-6#1)(2007-3#1)(2007-7#1)
the experience of the##26##4##(1991-6#1)(1992-3#1)(1994-1#1)(1994-12#1)(1996-1#1)(1996-12#1)(1996-8#1)(1997-3#1)(2004-11#1)(2005-5#1)(2006-10#1)(2006-8#1)(2007-3#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-6#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#3)(2012-3#1)
the experience of##109##3##(1990-2#1)(1991-4#1)(1991-6#1)(1992-3#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-1#2)(1994-12#2)(1995-1#1)(1996-1#2)(1996-12#2)(1996-3#1)(1996-8#1)(1997-3#1)(2004-10#1)(2004-11#2)(2004-12#1)(2005-5#2)(2006-10#1)(2006-11#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#6)(2007-3#3)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-11#4)(2008-12#7)(2008-2#4)(2008-3#1)(2008-4#1)(2008-6#3)(2008-7#4)(2009-2#1)(2009-7#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#3)(2012-11#2)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#3)
the experience was a##2##4##(2008-1#1)(2008-12#1)
the experience with the##2##4##(2008-10#1)(2012-3#1)
the experience with##9##3##(1995-5#1)(2008-1#2)(2008-10#1)(2008-6#1)(2010-3#1)(2010-6#1)(2012-3#1)(2013-8#1)
the experience##157##2##(1990-2#1)(1991-4#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-1#3)(1994-12#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-7#1)(1996-1#2)(1996-12#2)(1996-3#1)(1996-4#1)(1996-8#1)(1997-3#1)(2004-10#1)(2004-11#2)(2004-12#1)(2005-5#2)(2006-10#1)(2006-11#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#6)(2007-3#4)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#5)(2008-10#1)(2008-11#5)(2008-12#12)(2008-2#8)(2008-3#1)(2008-4#1)(2008-6#5)(2008-7#5)(2008-8#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-7#2)(2010-11#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#3)(2012-11#2)(2012-12#5)(2012-2#1)(2012-3#4)(2013-1#4)(2013-8#2)
the experienced##5##2##(1990-10#1)(2006-6#1)(2007-8#1)(2008-9#1)(2009-11#1)
the experiences and coping strategies of##2##6##(2010-1#2)
the experiences and perceptions##2##4##(2008-11#1)(2010-10#1)
the experiences and##5##3##(2008-11#1)(2010-1#2)(2010-10#1)(2011-1#1)
the experiences of a##4##4##(1997-1#1)(2008-11#1)(2010-4#1)(2012-3#1)
the experiences of nurses studying professional doctorates##2##7##(2013-8#2)
the experiences of the##7##4##(1997-3#1)(2007-9#1)(2008-12#1)(2008-9#1)(2009-7#1)(2010-3#1)(2013-1#1)
the experiences of these##2##4##(1997-7#1)(2009-5#1)
the experiences of two clinical##2##5##(2008-11#2)
the experiences of two##3##4##(2007-11#1)(2008-11#2)
the experiences of##58##3##(1990-6#1)(1991-2#1)(1992-2#1)(1992-3#1)(1994-2#1)(1995-1#1)(1995-3#2)(1997-1#1)(1997-3#1)(1997-7#1)(2005-8#1)(2007-11#1)(2007-2#3)(2007-9#1)(2008-11#4)(2008-12#5)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#4)(2009-7#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#1)(2010-8#1)(2011-1#1)(2012-12#3)(2012-3#2)(2013-1#2)(2013-8#3)
the experiences##74##2##(1990-6#1)(1991-2#1)(1992-2#1)(1992-3#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-3#2)(1995-5#1)(1997-1#1)(1997-3#1)(1997-7#1)(2005-8#1)(2007-11#2)(2007-2#3)(2007-9#1)(2008-10#1)(2008-11#5)(2008-12#7)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#4)(2009-7#3)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2012-12#4)(2012-3#3)(2013-1#4)(2013-8#3)
the experiential##4##2##(1994-9#1)(2008-11#2)(2010-10#1)
the experiment and the##3##4##(1997-3#1)(2008-5#1)(2008-7#1)
the experiment and##11##3##(1992-9#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2012-1#1)(2012-2#2)
the experiment are demonstrated##3##4##(2008-2#1)(2008-3#2)
the experiment are##6##3##(2007-12#2)(2008-2#2)(2008-3#2)
the experiment can##2##3##(2008-4#2)
the experiment in##2##3##(2007-11#1)(2008-10#1)
the experiment is##3##3##(2007-12#1)(2008-3#2)
the experiment on##2##3##(2008-4#1)(2012-2#1)
the experiment the##6##3##(2007-12#1)(2007-3#1)(2008-10#1)(2008-2#1)(2012-1#2)
the experiment was##9##3##(1993-9#1)(2007-4#1)(2008-12#1)(2008-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-9#1)(2013-8#1)
the experiment were##4##3##(2006-4#1)(2008-5#2)(2008-7#1)
the experiment with##2##3##(2006-8#1)(2007-3#1)
the experiment##166##2##(1991-12#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-9#3)(1993-7#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-7#1)(1996-10#1)(1996-2#1)(1996-6#3)(1997-2#1)(1997-3#2)(1997-4#3)(1997-6#2)(2004-11#2)(2004-4#1)(2004-9#1)(2005-10#1)(2005-4#1)(2006-4#1)(2006-8#1)(2007-11#7)(2007-12#7)(2007-3#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#9)(2008-3#16)(2008-4#7)(2008-5#7)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#1)(2012-1#7)(2012-12#1)(2012-2#3)(2012-3#1)(2012-8#1)(2013-1#6)(2013-7#3)(2013-8#4)
the experimental adhesive##3##3##(2013-7#2)(2013-8#1)
the experimental and calculated data##2##5##(2008-2#1)(2008-3#1)
the experimental and calculated##3##4##(2008-2#1)(2008-3#2)
the experimental and clinical##2##4##(2006-6#1)(2007-8#1)
the experimental and control groups##3##5##(1991-12#1)(2011-1#1)(2011-2#1)
the experimental and the##3##4##(2007-2#1)(2008-2#1)(2008-3#1)
the experimental and theoretical##7##4##(1991-7#1)(2007-10#1)(2008-2#1)(2008-3#3)(2013-8#1)
the experimental and##23##3##(1991-12#1)(1991-7#1)(1997-7#1)(2006-6#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-2#4)(2008-3#6)(2010-4#1)(2011-1#2)(2011-2#2)(2013-8#1)
the experimental animal studies and##2##5##(1996-8#1)(2005-7#1)
the experimental animals##4##3##(1994-8#1)(2007-1#1)(2008-4#1)(2012-1#1)
the experimental area##2##3##(2008-10#2)
the experimental basis for##3##4##(2008-7#1)(2012-1#1)(2013-1#1)
the experimental cements##2##3##(2010-8#2)
the experimental condition##2##3##(2008-3#1)(2010-2#1)
the experimental conditions employed##3##4##(2008-10#3)
the experimental conditions for##3##4##(1992-6#1)(2006-5#1)(2008-10#1)
the experimental conditions of##3##4##(1992-4#1)(2006-10#1)(2008-10#1)
the experimental conditions tested##2##4##(1992-5#1)(2008-11#1)
the experimental conditions used##5##4##(1990-2#1)(1994-12#1)(1995-1#1)(2008-10#1)(2010-11#1)
the experimental conditions was##2##4##(2008-10#2)
the experimental conditions##46##3##(1990-2#1)(1992-4#1)(1992-5#1)(1992-6#1)(1994-12#1)(1995-1#1)(1995-4#1)(1995-7#1)(1996-6#1)(1996-8#1)(2006-10#1)(2006-4#1)(2006-5#1)(2008-10#28)(2008-11#2)(2008-3#1)(2010-11#1)(2010-2#1)
the experimental control##2##3##(2006-11#1)(2010-12#1)
the experimental data and the##2##5##(2008-2#1)(2012-1#1)
the experimental data and##4##4##(1995-6#1)(2008-2#1)(2009-6#1)(2012-1#1)
the experimental data for##2##4##(1997-2#1)(2010-2#1)
the experimental data is obtained##2##5##(2008-2#2)
the experimental data of##2##4##(2008-2#1)(2008-7#1)
the experimental data that##2##4##(1994-2#1)(2007-9#1)
the experimental data to##5##4##(1995-2#1)(2008-2#2)(2008-3#1)(2008-7#1)
the experimental data with##4##4##(1996-5#1)(2005-11#1)(2007-12#1)(2008-3#1)
the experimental data##76##3##(1994-2#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-5#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-7#1)(2005-11#4)(2006-10#1)(2006-11#2)(2006-2#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#12)(2008-3#9)(2008-7#4)(2008-8#1)(2009-6#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)
the experimental demonstration##2##3##(2007-12#1)(2008-2#1)
the experimental design and##2##4##(1997-2#1)(2010-6#1)
the experimental design##11##3##(1997-2#1)(2008-10#3)(2008-2#2)(2008-5#1)(2008-7#1)(2010-2#1)(2010-6#1)(2011-1#1)
the experimental determination of##2##4##(1990-8#1)(2008-3#1)
the experimental error##3##3##(1996-4#1)(2008-10#1)(2008-3#1)
the experimental evaluation##2##3##(2008-3#1)(2008-6#1)
the experimental evidence##6##3##(1990-8#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-7#1)(2010-5#1)
the experimental findings##5##3##(1992-3#1)(2005-11#1)(2008-11#3)
the experimental fish##2##3##(2010-8#1)(2013-8#1)
the experimental group and##2##4##(2008-12#2)
the experimental group on##2##4##(1993-12#1)(2006-12#1)
the experimental group received##2##4##(2007-11#1)(2010-12#1)
the experimental group##42##3##(1991-12#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-3#1)(1995-1#1)(2006-12#1)(2006-2#1)(2006-5#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-12#5)(2008-5#1)(2008-9#1)(2009-6#2)(2010-12#3)(2010-4#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#3)
the experimental groups##12##3##(1996-10#1)(2007-3#1)(2008-12#1)(2008-5#4)(2009-5#2)(2012-3#1)(2013-1#2)
the experimental heat capacity data##2##5##(2006-10#2)
the experimental measurements##3##3##(1990-11#1)(2007-12#1)(2008-3#1)
the experimental model of##5##4##(2007-11#1)(2008-12#1)(2010-12#1)(2013-1#2)
the experimental model##9##3##(1991-12#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-7#1)(2010-12#1)(2013-1#2)
the experimental noise##2##3##(2007-11#1)(2009-5#1)
the experimental observation of##8##4##(2007-11#3)(2007-12#4)(2008-1#1)
the experimental observation that##2##4##(1997-7#1)(2008-11#1)
the experimental observation##10##3##(1997-7#1)(2007-11#3)(2007-12#4)(2008-1#1)(2008-11#1)
the experimental observations##4##3##(2007-12#1)(2008-2#2)(2008-7#1)
the experimental ones##2##3##(2008-10#1)(2008-2#1)
the experimental parameters##12##3##(1997-3#1)(2008-10#6)(2008-2#2)(2010-4#1)(2012-12#1)(2013-8#1)
the experimental period (up to 12 h)##2##7##(1990-11#2)
the experimental period##9##3##(1990-11#2)(2007-1#1)(2007-10#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-5#2)
the experimental periods##3##3##(2008-10#2)(2013-1#1)
the experimental procedure##2##3##(2008-11#1)(2008-5#1)
the experimental protocol##3##3##(2007-1#1)(2008-10#1)(2009-8#1)
the experimental result##2##3##(2007-11#1)(2008-11#1)
the experimental results and the##3##5##(2007-11#1)(2008-2#1)(2008-8#1)
the experimental results and##10##4##(1993-11#1)(2007-11#1)(2007-12#1)(2008-2#4)(2008-8#1)(2009-7#1)(2013-8#1)
the experimental results are##6##4##(2006-10#1)(2007-11#1)(2008-2#3)(2008-3#1)
the experimental results for the##2##5##(2006-11#1)(2008-10#1)
the experimental results for##4##4##(2006-11#1)(2007-11#1)(2008-10#1)(2008-3#1)
the experimental results obtained##2##4##(2008-2#2)
the experimental results of##5##4##(2007-11#1)(2007-12#1)(2008-3#3)
the experimental results show that the##2##6##(2008-10#1)(2008-2#1)
the experimental results show##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
the experimental results was##2##4##(2008-10#1)(2010-2#1)
the experimental results were##3##4##(2006-12#1)(2008-10#1)(2008-2#1)
the experimental results##95##3##(1990-12#1)(1993-11#1)(1995-3#1)(1997-7#1)(2005-11#6)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2007-11#7)(2007-12#7)(2007-9#1)(2008-1#2)(2008-10#7)(2008-2#19)(2008-3#16)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#2)(2009-8#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
the experimental samples##2##3##(2008-10#1)(2008-2#1)
the experimental set-up##3##3##(1997-8#1)(2008-10#1)(2008-7#1)
the experimental setup and the##2##5##(2007-11#1)(2008-3#1)
the experimental setup and##3##4##(2007-11#2)(2008-3#1)
the experimental setup##9##3##(2007-1#1)(2007-11#2)(2007-12#1)(2008-3#4)(2010-10#1)
the experimental sorption isotherms##2##4##(2010-4#2)
the experimental spectra##3##3##(2008-3#3)
the experimental stage##2##3##(1996-11#1)(2006-10#1)
the experimental studies##4##3##(1995-3#1)(2005-11#1)(2008-10#1)(2008-3#1)
the experimental study of##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
the experimental study##6##3##(2007-12#1)(2007-4#1)(2008-2#2)(2008-3#1)(2013-8#1)
the experimental system we used##2##5##(1994-10#1)(1996-2#1)
the experimental system##3##3##(1994-10#1)(1996-2#1)(2005-8#1)
the experimental teat dip##2##4##(1990-6#2)
the experimental treatment##4##3##(1995-2#1)(1997-8#1)(2008-1#1)(2010-9#1)
the experimental trees##2##3##(2011-12#2)
the experimental value##2##3##(2006-10#1)(2008-10#1)
the experimental values##5##3##(1995-6#1)(2008-10#2)(2008-2#1)(2008-3#1)
the experimental variables affecting the##2##5##(2008-10#2)
the experimental variables##4##3##(2008-10#4)
the experimental##643##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-6#3)(1990-8#3)(1991-12#3)(1991-3#1)(1991-4#2)(1991-7#2)(1991-8#1)(1992-1#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-11#2)(1993-12#3)(1993-6#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-1#3)(1995-11#1)(1995-2#2)(1995-3#5)(1995-4#1)(1995-6#8)(1995-7#1)(1996-10#3)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#8)(1997-8#3)(2004-12#1)(2005-10#1)(2005-11#16)(2005-7#2)(2005-8#1)(2006-10#9)(2006-11#4)(2006-12#3)(2006-2#4)(2006-4#2)(2006-5#5)(2006-6#2)(2007-1#4)(2007-10#4)(2007-11#25)(2007-12#32)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#4)(2008-1#10)(2008-10#105)(2008-11#16)(2008-12#9)(2008-2#59)(2008-3#69)(2008-4#1)(2008-5#15)(2008-6#4)(2008-7#15)(2008-8#4)(2008-9#4)(2009-12#3)(2009-3#1)(2009-5#4)(2009-6#3)(2009-7#2)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#7)(2010-4#5)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#8)(2011-12#3)(2011-2#10)(2012-1#4)(2012-11#2)(2012-12#3)(2012-2#4)(2012-3#3)(2012-5#2)(2013-1#12)(2013-7#3)(2013-8#8)
the experimentalist##3##2##(2008-4#1)(2008-8#1)(2009-5#1)
the experimentally derived##2##3##(1991-9#1)(1993-3#1)
the experimentally determined values##2##4##(1994-3#1)(2008-1#1)
the experimentally determined##7##3##(1994-3#1)(1996-11#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2012-3#1)
the experimentally measured data##2##4##(2008-2#1)(2008-3#1)
the experimentally measured##13##3##(1992-5#1)(1996-1#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#1)(2009-5#1)(2010-2#1)
the experimentally observed##11##3##(1993-11#1)(1996-2#1)(1997-1#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-10#1)(2008-3#1)(2009-5#1)(2012-2#2)
the experimentally obtained##5##3##(1990-7#1)(1996-11#1)(2006-12#1)(2007-12#1)(2008-3#1)
the experimentally##42##2##(1990-7#2)(1991-9#1)(1992-5#1)(1993-11#1)(1993-3#1)(1994-3#1)(1996-1#1)(1996-11#2)(1996-2#1)(1997-1#1)(1997-6#2)(1997-8#1)(2004-9#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#4)(2008-3#4)(2009-5#3)(2010-2#1)(2012-2#2)(2012-3#1)
the experimentation##3##2##(2008-10#1)(2011-1#1)(2013-1#1)
the experimenter and##3##3##(2007-6#1)(2013-1#1)(2013-8#1)
the experimenter##13##2##(1991-3#2)(2006-12#1)(2006-3#1)(2007-6#3)(2008-11#1)(2008-4#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
the experimenters presented##2##3##(2009-5#2)
the experiments and##2##3##(2006-11#1)(2008-10#1)
the experiments are##2##3##(2008-10#1)(2008-7#1)
the experiments described##5##3##(1991-9#2)(1997-2#1)(2008-3#1)(2013-7#1)
the experiments done##2##3##(1995-8#1)(2007-2#1)
the experiments in##2##3##(2008-3#1)(2008-4#1)
the experiments performed with##2##4##(1994-11#1)(2008-10#1)
the experiments performed##4##3##(1994-11#1)(2006-12#1)(2008-10#1)(2011-12#1)
the experiments reported here##2##4##(1995-2#1)(2008-7#1)
the experiments was##3##3##(1997-7#1)(2007-12#1)(2008-10#1)
the experiments were carried out##3##5##(1995-8#1)(2008-10#2)
the experiments were performed at##2##5##(1996-9#2)
the experiments were##5##3##(1995-8#1)(1996-9#2)(2008-10#2)
the experiments with##4##3##(1991-12#1)(1996-5#1)(2007-11#1)(2012-1#1)
the experiments##98##2##(1990-11#1)(1990-2#1)(1991-12#1)(1991-9#2)(1992-8#1)(1994-11#1)(1994-2#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#3)(1996-10#1)(1996-5#1)(1996-8#2)(1996-9#2)(1997-2#1)(1997-7#2)(2005-11#4)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-10#14)(2008-11#5)(2008-2#6)(2008-3#11)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#7)(2008-9#1)(2010-2#2)(2010-7#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-12#1)(2013-7#2)(2013-8#1)
the expert consensus##2##3##(2005-11#1)(2013-7#1)
the expert##19##2##(1992-1#1)(1994-1#1)(1996-7#3)(1997-8#1)(2005-11#1)(2007-12#1)(2007-4#2)(2008-10#2)(2008-4#1)(2008-5#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-2#1)(2013-7#1)
the expertise of the##2##4##(1997-8#1)(2011-1#1)
the expertise of##8##3##(1993-6#1)(1996-1#1)(1997-8#1)(2008-4#1)(2009-10#1)(2010-5#1)(2011-1#1)(2012-12#1)
the expertise##14##2##(1993-6#1)(1996-1#1)(1996-2#1)(1997-8#1)(2005-7#1)(2008-1#1)(2008-4#1)(2009-10#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-3#1)
the experts##15##2##(1990-3#1)(1996-2#2)(1996-3#2)(2006-5#1)(2008-3#1)(2008-4#1)(2009-8#2)(2010-12#1)(2010-8#1)(2011-10#1)(2011-2#1)(2013-8#1)
the experts'##3##2##(1992-9#1)(2008-6#1)(2013-1#1)
the expiratory##3##2##(1992-9#1)(1996-5#1)(2013-7#1)
the expired air condensate##4##4##(2006-6#4)
the expired air##6##3##(2006-6#6)
the explained variance##4##3##(1993-3#1)(2006-3#1)(2007-10#1)(2008-10#1)
the explained##6##2##(1993-3#1)(2006-3#1)(2007-10#1)(2008-10#2)(2010-4#1)
the explanation for the##2##4##(1993-3#1)(2008-5#1)
the explanation for##3##3##(1993-3#1)(2008-5#1)(2011-2#1)
the explanation of the##5##4##(1993-9#1)(1997-8#1)(2007-12#1)(2008-9#1)(2013-7#1)
the explanation of##7##3##(1993-9#1)(1997-8#1)(2006-7#1)(2007-12#1)(2008-9#1)(2010-2#1)(2013-7#1)
the explanation##12##2##(1993-3#1)(1993-9#1)(1997-8#1)(2006-7#1)(2007-12#1)(2007-5#1)(2008-5#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-1#1)(2013-7#1)
the explanations##5##2##(1993-6#1)(2007-10#1)(2007-9#1)(2009-9#1)(2011-1#1)
the explanatory power of##2##4##(1993-3#1)(2008-10#1)
the explanatory power##3##3##(1993-3#1)(2008-10#1)(2010-10#1)
the explanatory variables in##2##4##(1992-6#1)(1995-2#1)
the explanatory variables##6##3##(1992-6#2)(1995-2#1)(1997-3#1)(2010-8#2)
the explanatory##13##2##(1992-6#2)(1993-3#1)(1993-8#1)(1995-2#1)(1995-6#1)(1997-3#1)(2005-10#1)(2008-10#1)(2010-10#1)(2010-8#2)(2012-2#1)
the explant##4##2##(1996-7#1)(2007-8#1)(2008-11#1)(2011-3#1)
the explanted##6##2##(1996-7#1)(2008-11#1)(2008-9#2)(2010-1#1)(2010-4#1)
the explants##4##2##(1992-6#1)(1996-5#1)(1997-8#1)(2008-8#1)
the explicit goal##2##3##(2008-11#2)
the explicit health guarantees law##2##5##(2011-2#2)
the explicit##14##2##(1995-12#1)(2006-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
the exploitation of the##4##4##(2007-11#1)(2008-3#1)(2008-7#1)(2009-5#1)
the exploitation of##14##3##(2004-3#1)(2005-8#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#1)
the exploration of new##2##4##(2007-12#1)(2008-7#1)
the exploration of the##9##4##(1994-2#1)(2004-2#1)(2007-8#1)(2008-2#1)(2008-5#1)(2008-8#2)(2010-8#1)(2013-8#1)
the exploration of##22##3##(1990-3#1)(1994-2#1)(2004-2#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-2#2)(2008-5#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-12#1)(2010-2#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-5#1)(2013-8#1)
the exploration##25##2##(1990-3#1)(1994-2#1)(2004-2#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-2#3)(2008-5#3)(2008-7#1)(2008-8#3)(2009-10#1)(2009-12#1)(2010-2#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-5#1)(2013-8#1)
the exploration-exploitation trade-off##2##3##(2011-1#2)
the explored##3##2##(1993-2#1)(2009-9#1)(2010-10#1)
the explosion in##3##3##(2005-7#1)(2007-7#1)(2008-4#1)
the explosion of information##2##4##(1993-2#1)(2011-2#1)
the explosion of new knowledge##2##5##(2006-10#2)
the explosion of##7##3##(1993-2#1)(2006-10#2)(2006-7#1)(2008-2#1)(2011-1#1)(2011-2#1)
the explosion##11##2##(1993-2#1)(2005-7#1)(2006-10#2)(2006-7#1)(2007-7#1)(2008-2#1)(2008-4#1)(2009-4#1)(2011-1#1)(2011-2#1)
the explosive##5##2##(1990-11#1)(2006-10#1)(2007-7#1)(2008-11#1)(2012-2#1)
the exponent##3##2##(2005-11#1)(2008-2#1)(2012-2#1)
the exponential epidemic growth rate##2##5##(2008-10#2)
the exponential growth phase##6##4##(1991-12#1)(2008-11#2)(2008-7#2)(2011-2#1)
the exponential growth##10##3##(1991-12#1)(2005-11#1)(2006-7#1)(2008-11#2)(2008-7#3)(2011-2#1)(2012-12#1)
the exponential increase in##3##4##(1995-3#1)(2007-12#1)(2009-11#1)
the exponential model##3##3##(1995-9#1)(2008-10#2)
the exponential phase of cell##2##5##(1991-9#1)(2008-11#1)
the exponential phase of growth##3##5##(1994-8#1)(1997-2#1)(2008-11#1)
the exponential phase of##8##4##(1991-9#1)(1994-8#1)(1997-2#1)(2008-11#5)
the exponential phase##14##3##(1991-9#1)(1994-8#1)(1997-2#1)(2008-11#9)(2011-2#1)(2012-2#1)
the exponential##52##2##(1991-12#1)(1991-9#1)(1993-12#1)(1994-8#1)(1995-3#1)(1995-9#1)(1996-1#1)(1997-2#1)(2005-11#2)(2006-7#3)(2007-12#1)(2008-10#10)(2008-11#12)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#3)(2009-11#1)(2010-4#1)(2011-2#4)(2012-12#1)(2012-2#1)
the export-incompetent##2##2##(1997-1#2)
the exposed and##3##3##(1992-4#1)(2007-4#1)(2008-12#1)
the exposed area##2##3##(2011-1#2)
the exposed group##3##3##(1994-5#1)(1994-6#1)(2009-12#1)
the exposed parts of the body##2##6##(2007-7#1)(2007-8#1)
the exposed parts of the##3##5##(2007-7#1)(2007-8#1)(2008-7#1)
the exposed workers##7##3##(2008-10#1)(2009-12#3)(2009-5#1)(2010-9#2)
the exposed##54##2##(1991-4#1)(1991-8#1)(1992-12#1)(1992-4#1)(1993-12#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-3#1)(1996-2#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#4)(2009-3#2)(2009-5#1)(2010-12#1)(2010-4#1)(2010-9#2)(2011-1#2)(2011-2#2)(2013-1#3)
the exposure conditions##2##3##(1992-11#1)(2007-12#1)
the exposure dose##2##3##(1992-3#1)(2007-12#1)
the exposure levels##2##3##(1994-6#2)
the exposure of fibrinogen receptor in thrombin-stimulated platelets##2##8##(1993-8#2)
the exposure of fibrinogen receptor in##3##6##(1993-8#3)
the exposure of the##9##4##(1991-12#1)(1992-3#1)(2006-12#1)(2007-4#1)(2008-10#3)(2008-8#1)(2011-1#1)
the exposure of##34##3##(1990-5#1)(1991-11#1)(1991-12#1)(1992-3#1)(1993-8#4)(1994-11#1)(1994-6#1)(1995-1#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-8#3)(2009-7#1)(2010-12#2)(2011-1#1)(2012-2#1)(2013-1#1)
the exposure period##5##3##(1997-3#1)(2004-11#1)(2008-11#1)(2008-8#2)
the exposure time is##2##4##(2008-10#1)(2008-3#1)
the exposure time was##2##4##(1993-9#1)(2008-11#1)
the exposure time##11##3##(1993-9#1)(1996-12#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2011-1#1)(2013-7#1)
the exposure to cobalt##3##4##(1994-6#3)
the exposure to the##2##4##(2005-9#1)(2010-6#1)
the exposure to##27##3##(1990-10#1)(1991-10#1)(1991-12#2)(1991-6#1)(1992-2#1)(1993-2#1)(1993-7#1)(1994-6#3)(1995-4#1)(1996-2#1)(1996-3#1)(1997-3#1)(2005-9#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#2)
the exposure##118##2##(1990-10#1)(1990-5#3)(1991-10#1)(1991-11#1)(1991-12#4)(1991-6#1)(1992-11#1)(1992-2#1)(1992-3#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#4)(1993-9#1)(1994-11#1)(1994-2#3)(1994-6#8)(1995-1#1)(1995-12#1)(1995-4#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#2)(1997-4#1)(2004-11#1)(2005-9#1)(2006-10#1)(2006-12#3)(2007-11#1)(2007-12#6)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#10)(2008-11#4)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#6)(2009-11#1)(2009-7#1)(2010-12#2)(2010-6#1)(2011-1#2)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
the express-FIIAA##2##2##(2008-10#2)
the expressed antigen##2##3##(2005-11#1)(2008-5#1)
the expressed enzyme##4##3##(1991-3#1)(1991-5#1)(1992-12#1)(1993-8#1)
the expressed protein was##4##4##(1990-6#1)(1995-1#1)(2006-10#1)(2010-6#1)
the expressed protein##13##3##(1990-11#2)(1990-6#1)(1992-12#1)(1993-6#1)(1995-1#1)(1995-11#1)(2006-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-6#1)(2013-1#1)
the expressed proteins##3##3##(1994-8#1)(1995-11#1)(2012-2#1)
the expressed receptor##2##3##(1990-9#2)
the expressed##45##2##(1990-11#2)(1990-12#1)(1990-6#1)(1990-9#2)(1991-2#1)(1991-3#1)(1991-5#2)(1992-12#2)(1992-5#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-8#3)(1995-1#1)(1995-11#2)(1996-11#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#1)(2008-8#3)(2010-6#1)(2012-2#1)(2013-1#1)
the expression and activity of##5##5##(1994-12#3)(1995-8#1)(2009-8#1)
the expression and distribution of##2##5##(1994-12#1)(2011-12#1)
the expression and function of the##3##6##(1994-8#1)(2007-12#1)(2010-7#1)
the expression and function of##8##5##(1990-9#1)(1993-8#1)(1994-8#1)(1995-6#1)(2007-12#1)(2008-5#1)(2008-6#1)(2010-7#1)
the expression and functional role of##2##6##(2008-4#1)(2009-10#1)
the expression and functional##3##4##(2008-4#1)(2009-10#1)(2010-2#1)
the expression and localization of##2##5##(1993-6#1)(1994-3#1)
the expression and phosphorylation##2##4##(1995-11#1)(2009-3#1)
the expression and purification of##3##5##(2008-4#2)(2009-9#1)
the expression and secretion of##5##5##(1991-9#1)(1996-2#1)(2006-11#2)(2008-5#1)
the expression and secretion##6##4##(1991-9#1)(1996-2#1)(1997-2#1)(2006-11#2)(2008-5#1)
the expression and the##2##4##(1996-2#1)(2005-10#1)
the expression and##51##3##(1990-2#1)(1990-9#1)(1991-7#2)(1991-9#1)(1993-6#1)(1993-8#1)(1994-12#4)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#2)(1996-5#1)(1997-2#1)(2005-10#1)(2006-10#1)(2006-11#2)(2006-2#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
the expression and/or function of the##2##6##(2008-11#1)(2008-3#1)
the expression and/or##4##3##(1995-3#1)(1997-1#1)(2008-11#1)(2008-3#1)
the expression by##2##3##(1993-9#1)(2008-10#1)
the expression cassette##4##3##(1997-4#2)(2008-11#1)(2008-8#1)
the expression data##2##3##(1993-12#1)(2008-7#1)
the expression for the##2##4##(1992-6#1)(2008-3#1)
the expression for##3##3##(1992-6#1)(2008-3#2)
the expression from##2##3##(1996-2#1)(2006-12#1)
the expression in the##2##4##(1996-12#1)(2009-6#1)
the expression in##9##3##(1990-3#1)(1993-6#1)(1994-2#1)(1996-11#1)(1996-12#1)(1996-2#1)(2008-6#1)(2008-8#1)(2009-6#1)
the expression level and##2##4##(2008-9#1)(2010-5#1)
the expression level of recombinant##2##5##(2005-11#1)(2008-7#1)
the expression level of the##6##5##(1993-6#1)(1997-3#1)(1997-8#1)(2006-4#1)(2008-10#1)(2008-9#1)
the expression level of##22##4##(1993-6#1)(1994-11#1)(1995-11#1)(1997-3#1)(1997-8#1)(2005-11#1)(2006-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-12#1)(2009-8#1)(2010-2#1)(2013-7#1)(2013-8#1)
the expression level##32##3##(1991-9#1)(1992-6#1)(1993-6#1)(1994-11#1)(1995-1#1)(1995-11#1)(1996-2#1)(1997-3#1)(1997-8#1)(2005-11#2)(2006-4#1)(2007-2#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-12#1)(2009-8#1)(2010-2#1)(2010-5#1)(2013-7#1)(2013-8#1)
the expression levels of specific##2##5##(2008-1#1)(2008-7#1)
the expression levels of these##2##5##(1993-6#1)(2011-2#1)
the expression levels of##16##4##(1991-5#1)(1993-6#1)(1994-11#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#3)(2008-9#1)(2010-5#1)(2011-2#1)(2013-1#2)
the expression levels were##3##4##(2008-8#1)(2008-9#2)
the expression levels##24##3##(1991-5#1)(1993-6#1)(1994-11#1)(1997-8#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-2#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#2)
the expression occurs##2##3##(1997-4#2)
the expression of 'anxious'##2##4##(1993-3#2)
the expression of 1##2##4##(1994-3#1)(1996-2#1)
the expression of APP##2##4##(1993-3#1)(1996-12#1)
the expression of AR and IGF-1##2##6##(2011-2#2)
the expression of Axl##2##4##(2013-1#2)
the expression of BCL2##2##4##(1996-4#1)(2008-9#1)
the expression of BDNF##4##4##(1995-11#1)(1997-6#1)(2007-11#2)
the expression of Bcl-2##3##4##(2008-10#1)(2010-12#1)(2013-8#1)
the expression of CAT##2##4##(1993-4#1)(1997-4#1)
the expression of CCK and VIP in the##2##8##(2010-12#2)
the expression of CCK and VIP##3##6##(2010-12#3)
the expression of Cu/Zn SOD##2##5##(1996-10#1)(2005-11#1)
the expression of Cx43##2##4##(2008-11#1)(2008-6#1)
the expression of EGFR##2##4##(1992-12#1)(2013-1#1)
the expression of ER##3##4##(1995-4#1)(2005-9#1)(2013-8#1)
the expression of HO-1##3##4##(2008-4#2)(2011-2#1)
the expression of HSP70##2##4##(1992-7#1)(2011-12#1)
the expression of ICAM-1 mRNA##2##5##(2010-1#2)
the expression of ICAM-1##3##4##(1994-2#1)(2010-1#2)
the expression of IGF-I receptor##2##5##(1996-2#1)(2008-11#1)
the expression of IGF-I##4##4##(1994-2#1)(1996-2#1)(2008-11#2)
the expression of IL-10##2##4##(2011-3#2)
the expression of IL-12 p40 and p35 mRNA##2##8##(2008-8#2)
the expression of IL-12##3##4##(2008-8#3)
the expression of IL-2R alpha##2##5##(1994-9#2)
the expression of MEDDF##2##4##(2008-8#2)
the expression of MHC class II molecules##2##7##(1992-1#1)(2008-8#1)
the expression of MHC##3##4##(1992-1#1)(2008-11#1)(2008-8#1)
the expression of MMP-2 and##2##5##(2008-9#1)(2011-2#1)
the expression of MMP-2##3##4##(2008-9#2)(2011-2#1)
the expression of MMPs##2##4##(1990-7#1)(2007-2#1)
the expression of MT##2##4##(2008-10#1)(2013-7#1)
the expression of MyoD1##2##4##(1992-8#2)
the expression of P-glycoprotein##2##4##(1993-9#1)(1995-11#1)
the expression of PKC isoforms##2##5##(1994-6#1)(1996-5#1)
the expression of PrP##2##4##(1994-6#2)
the expression of SSTR2 in the carcinoid cells##2##8##(2011-2#2)
the expression of TGF beta##2##5##(1991-10#1)(1995-5#1)
the expression of TGF-beta##2##4##(1994-11#1)(2008-12#1)
the expression of TH##3##4##(1996-10#1)(1996-12#1)(2008-10#1)
the expression of TOM1L##2##4##(2010-2#2)
the expression of YAP1 and##2##5##(2013-1#2)
the expression of a gene##2##5##(1991-11#1)(1993-6#1)
the expression of a large number of genes##2##8##(2009-6#1)(2010-12#1)
the expression of a number of genes##2##7##(2010-2#1)(2010-8#1)
the expression of a number of##5##6##(1995-11#1)(1997-4#1)(2010-2#1)(2010-8#1)(2012-12#1)
the expression of a protein##2##5##(1994-9#1)(2008-11#1)
the expression of a range of##2##6##(2007-11#1)(2009-8#1)
the expression of a reporter gene##3##6##(1994-12#1)(2009-6#1)(2010-10#1)
the expression of a variety of genes##2##7##(1993-3#1)(1995-12#1)
the expression of a##48##4##(1990-11#1)(1991-11#1)(1991-3#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-5#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-4#2)(2006-12#3)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#2)(2009-8#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-12#2)
the expression of adhesion molecules and##2##6##(2008-1#2)
the expression of adhesion molecules##3##5##(1995-5#1)(2008-1#2)
the expression of airway hyperresponsiveness##3##5##(1996-12#3)
the expression of all##3##4##(2006-12#1)(2009-10#1)(2013-1#1)
the expression of alpha B-crystallin mRNA in##2##7##(1991-12#2)
the expression of alpha-smooth muscle actin##2##6##(2006-9#2)
the expression of an##8##4##(1990-3#1)(1990-5#1)(1992-3#1)(1993-4#1)(1994-11#1)(2006-8#1)(2007-12#1)(2008-5#1)
the expression of any##2##4##(2008-4#1)(2008-8#1)
the expression of beta##3##4##(1991-10#1)(1994-5#1)(1994-8#1)
the expression of both##6##4##(1991-8#1)(1993-12#1)(1996-8#1)(2008-10#1)(2009-12#1)(2009-5#1)
the expression of brain-derived neurotrophic factor (BDNF)##2##7##(1996-1#1)(1997-2#1)
the expression of c-Met receptor##2##5##(2011-2#2)
the expression of c-fos##5##4##(1991-11#1)(1992-9#1)(1993-9#1)(1994-10#1)(1997-8#1)
the expression of c-myc and##2##5##(1992-8#1)(2008-8#1)
the expression of c-myc##3##4##(1992-8#1)(2008-11#1)(2008-8#1)
the expression of cell adhesion molecules##3##6##(1994-3#1)(2007-11#1)(2010-12#1)
the expression of cell##5##4##(1994-3#1)(2007-11#1)(2008-11#1)(2008-4#1)(2010-12#1)
the expression of cellular genes##2##5##(1993-12#1)(1997-6#1)
the expression of cellular##5##4##(1993-12#1)(1994-9#1)(1997-6#1)(2008-11#1)(2010-1#1)
the expression of certain##2##4##(1997-8#1)(2008-9#1)
the expression of conditioned##2##4##(1992-9#1)(1995-10#1)
the expression of cyclin D1 and##2##6##(2007-8#1)(2008-3#1)
the expression of cyclin D1##3##5##(2007-8#1)(2008-3#2)
the expression of cyclins##4##4##(1997-6#1)(2007-8#1)(2008-4#1)(2009-3#1)
the expression of dystrophin in cultured human muscle##2##8##(1991-11#2)
the expression of endothelial##2##4##(1995-8#1)(2004-3#1)
the expression of even integrins αvβ6 and αvβ8 in tumor cell lines is not comprehensively documented##2##16##(2012-12#2)
the expression of exogenous gene##2##5##(2008-9#2)
the expression of extracellular matrix genes##2##6##(1990-5#1)(1991-10#1)
the expression of foreign genes##2##5##(1997-8#1)(2006-12#1)
the expression of foreign proteins in##2##6##(1995-2#1)(1995-5#1)
the expression of foreign##4##4##(1995-2#1)(1995-5#1)(1997-8#1)(2006-12#1)
the expression of four##2##4##(1996-2#1)(2006-12#1)
the expression of functional##2##4##(1992-11#1)(1992-7#1)
the expression of gamma##2##4##(1995-8#1)(2009-5#1)
the expression of genes encoding##2##5##(2009-10#1)(2012-2#1)
the expression of genes in##3##5##(2008-10#2)(2008-11#1)
the expression of genes involved in##4##6##(1995-11#1)(2008-10#1)(2009-5#1)(2012-2#1)
the expression of genes that##2##5##(2009-5#1)(2010-10#1)
the expression of genes##17##4##(1994-8#1)(1994-9#1)(1995-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#2)(2010-10#1)(2012-2#2)
the expression of growth##2##4##(1992-9#1)(2008-11#1)
the expression of heat shock protein##4##6##(1991-8#1)(1994-11#2)(1994-8#1)
the expression of heat shock proteins##3##6##(1992-6#1)(2010-4#1)(2012-1#1)
the expression of heat shock##9##5##(1991-8#1)(1992-6#1)(1994-11#3)(1994-8#2)(2010-4#1)(2012-1#1)
the expression of heterologous antigens##3##5##(1990-3#2)(1990-9#1)
the expression of heterologous##4##4##(1990-3#2)(1990-9#1)(1991-9#1)
the expression of hsps##2##4##(2012-12#2)
the expression of human##8##4##(1992-5#1)(1993-9#1)(1994-3#1)(1996-11#1)(2005-10#1)(2008-10#1)(2008-11#1)(2010-2#1)
the expression of individual##2##4##(1991-3#1)(2008-11#1)
the expression of inducible nitric oxide synthase##3##7##(1996-12#1)(2008-4#1)(2008-5#1)
the expression of inducible##4##4##(1996-12#2)(2008-4#1)(2008-5#1)
the expression of innate##2##4##(2013-1#2)
the expression of intercellular adhesion molecule-1 (ICAM-1)##2##7##(1993-11#1)(2010-1#1)
the expression of intercellular adhesion molecule-1##3##6##(1993-11#1)(1995-5#1)(2010-1#1)
the expression of key##3##4##(2008-10#1)(2008-4#1)(2008-9#1)
the expression of lambdaN gene##2##5##(2008-8#2)
the expression of lamins A and C##3##7##(1992-12#3)
the expression of lamins A##4##5##(1992-12#3)(1992-5#1)
the expression of mRNA for##3##5##(1994-8#1)(2008-4#1)(2009-9#1)
the expression of mRNA##5##4##(1994-12#1)(1994-8#1)(1996-12#1)(2008-4#1)(2009-9#1)
the expression of mRNAs##2##4##(1996-12#2)
the expression of many##3##4##(2008-4#1)(2009-6#1)(2010-7#1)
the expression of matrix##2##4##(2009-5#1)(2013-1#1)
the expression of membrane##3##4##(1992-3#1)(2008-4#1)(2011-1#1)
the expression of more than 100##2##6##(2010-7#1)(2011-2#1)
the expression of more than##3##5##(2007-8#1)(2010-7#1)(2011-2#1)
the expression of multiple##3##4##(2006-5#1)(2009-8#1)(2012-12#1)
the expression of muscle-specific##2##4##(1992-3#1)(1994-2#1)
the expression of myc##2##4##(1991-9#2)
the expression of neural##2##4##(1995-8#1)(2010-12#1)
the expression of neuronal##2##4##(1996-3#1)(2011-2#1)
the expression of neurotrophins##2##4##(1995-11#1)(2008-7#1)
the expression of numerous genes##3##5##(1995-2#1)(1995-8#1)(2008-1#1)
the expression of opioid##2##4##(1993-6#1)(1996-12#1)
the expression of other genes##3##5##(1993-2#1)(2008-7#2)
the expression of other##8##4##(1993-2#1)(1996-11#1)(2006-12#1)(2008-10#2)(2008-7#2)(2008-8#1)
the expression of p-p53##2##4##(2011-2#2)
the expression of p53##4##4##(1995-10#1)(2008-10#1)(2008-6#1)(2013-1#1)
the expression of pathogenesis-related##2##4##(2008-10#1)(2011-10#1)
the expression of pro- and anti-apoptotic##2##6##(2009-12#2)
the expression of protein D##2##5##(1992-3#2)
the expression of proteins##3##4##(1992-3#1)(1994-9#1)(2010-12#1)
the expression of rat##2##4##(1997-1#1)(2008-8#1)
the expression of receptors##2##4##(1994-3#1)(1995-11#1)
the expression of recombinant human##2##5##(1994-5#1)(2008-11#1)
the expression of recombinant proteins##2##5##(2006-12#1)(2008-11#1)
the expression of recombinant##8##4##(1993-4#1)(1994-5#1)(2006-12#1)(2007-11#1)(2008-11#3)(2008-4#1)
the expression of regulatory##2##4##(1994-11#1)(2009-3#1)
the expression of relevant##2##4##(1995-11#1)(2012-12#1)
the expression of select##2##4##(2008-11#1)(2013-1#1)
the expression of several##10##4##(1991-9#1)(1992-3#2)(1994-9#1)(1996-12#1)(2007-5#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-12#1)
the expression of some##7##4##(1990-6#1)(1995-8#1)(1996-5#1)(2007-6#1)(2008-11#1)(2008-9#1)(2012-2#1)
the expression of specific genes##5##5##(1991-12#1)(1994-3#1)(2006-10#1)(2006-6#1)(2008-4#1)
the expression of specific##8##4##(1991-12#1)(1993-2#1)(1994-3#1)(2006-10#1)(2006-6#1)(2008-1#1)(2008-4#1)(2010-12#1)
the expression of survivin##2##4##(2010-1#1)(2010-12#1)
the expression of syndecan-2##2##4##(2009-4#2)
the expression of target genes##2##5##(2009-4#1)(2011-2#1)
the expression of tau##2##4##(1996-3#1)(2011-2#1)
the expression of the H-NHase gene##3##6##(1996-4#3)
the expression of the IL-6##2##5##(1990-5#1)(1995-2#1)
the expression of the conditioned place preference##2##7##(1990-2#2)
the expression of the energy-coupling H+ gradient between localized##2##9##(1992-6#2)
the expression of the enzyme##2##5##(1991-5#1)(2007-11#1)
the expression of the gene was##2##6##(2008-5#2)
the expression of the gene##12##5##(1991-10#1)(1993-1#1)(1994-2#1)(1995-2#3)(1995-3#1)(1995-6#1)(2008-5#2)(2009-10#1)(2012-3#1)
the expression of the genes##5##5##(1991-2#1)(1991-5#1)(1993-4#1)(1996-2#1)(1997-8#1)
the expression of the human##4##5##(1993-12#1)(1994-9#1)(1997-4#1)(1997-7#1)
the expression of the lacZ reporter##2##6##(1997-6#2)
the expression of the major##3##5##(2008-11#1)(2008-5#2)
the expression of the minor##2##5##(1991-6#1)(1993-12#1)
the expression of the platelet-activating factor receptor##2##7##(1993-12#2)
the expression of the reporter gene##2##6##(1992-8#1)(2008-9#1)
the expression of the transgenes##2##5##(1994-5#1)(2006-12#1)
the expression of the two##3##5##(1993-3#1)(1994-12#1)(2008-9#1)
the expression of the##176##4##(1990-11#1)(1990-12#2)(1990-2#3)(1990-5#4)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#4)(1991-6#3)(1991-8#2)(1991-9#2)(1992-1#2)(1992-12#2)(1992-2#1)(1992-6#2)(1992-8#4)(1992-9#1)(1993-1#1)(1993-12#4)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#3)(1994-8#2)(1994-9#2)(1995-10#2)(1995-11#1)(1995-12#3)(1995-2#5)(1995-3#3)(1995-6#1)(1995-7#2)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-4#5)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#3)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-5#1)(2008-10#5)(2008-11#8)(2008-3#1)(2008-4#4)(2008-5#6)(2008-7#1)(2008-8#2)(2008-9#6)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
the expression of these antigens in the##2##7##(1994-7#1)(1997-7#1)
the expression of these enzymes##2##5##(1990-8#1)(1992-8#1)
the expression of these genes in##2##6##(1996-12#1)(2008-11#1)
the expression of these genes##6##5##(1990-7#1)(1991-9#1)(1994-3#1)(1995-12#1)(1996-12#1)(2008-11#1)
the expression of these markers##2##5##(2008-8#1)(2012-1#1)
the expression of these two genes##2##6##(1991-9#1)(2010-3#1)
the expression of these two##4##5##(1991-9#1)(1992-1#1)(1994-5#1)(2010-3#1)
the expression of these##25##4##(1990-7#1)(1990-8#1)(1991-9#2)(1992-1#2)(1992-8#1)(1993-3#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-3#1)(2012-1#1)
the expression of this cytokine##2##5##(1996-4#1)(2009-9#1)
the expression of this protein##2##5##(2008-10#1)(2010-12#1)
the expression of this##14##4##(1991-5#1)(1991-9#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-12#1)(1994-8#1)(1996-2#1)(1996-4#1)(2008-10#1)(2009-9#1)(2010-12#1)(2010-2#1)
the expression of three##5##4##(1992-3#1)(1993-4#1)(1994-6#1)(1995-8#1)(2008-10#1)
the expression of topoisomerase##2##4##(1993-8#2)
the expression of two##3##4##(1993-11#1)(2008-10#1)(2008-8#1)
the expression of type##2##4##(2008-10#1)(2010-6#1)
the expression of various##5##4##(1994-2#1)(1995-8#1)(2008-8#1)(2011-2#1)(2013-1#1)
the expression of which##4##4##(1991-3#1)(1994-2#1)(2007-10#1)(2010-11#1)
the expression of##1121##3##(1990-10#2)(1990-11#5)(1990-12#5)(1990-2#3)(1990-3#7)(1990-4#1)(1990-5#7)(1990-6#2)(1990-7#4)(1990-8#5)(1990-9#1)(1991-1#1)(1991-10#4)(1991-11#5)(1991-12#6)(1991-2#3)(1991-3#5)(1991-5#7)(1991-6#4)(1991-8#7)(1991-9#10)(1992-1#6)(1992-11#4)(1992-12#8)(1992-2#1)(1992-3#14)(1992-5#4)(1992-6#8)(1992-7#3)(1992-8#17)(1992-9#10)(1993-1#1)(1993-11#6)(1993-12#11)(1993-2#3)(1993-3#10)(1993-4#7)(1993-5#2)(1993-6#9)(1993-8#6)(1993-9#8)(1994-10#3)(1994-11#12)(1994-12#13)(1994-2#15)(1994-3#13)(1994-5#9)(1994-6#8)(1994-7#2)(1994-8#15)(1994-9#14)(1995-1#3)(1995-10#5)(1995-11#10)(1995-12#11)(1995-2#15)(1995-3#8)(1995-4#1)(1995-5#7)(1995-6#5)(1995-7#5)(1995-8#14)(1995-9#3)(1996-1#2)(1996-10#3)(1996-11#7)(1996-12#23)(1996-2#10)(1996-3#4)(1996-4#10)(1996-5#8)(1996-7#3)(1996-8#3)(1996-9#2)(1997-1#2)(1997-2#6)(1997-3#2)(1997-4#8)(1997-5#4)(1997-6#13)(1997-7#7)(1997-8#15)(2003-11#1)(2004-3#1)(2005-10#2)(2005-11#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#11)(2006-2#1)(2006-5#1)(2006-6#4)(2006-8#2)(2006-9#3)(2007-10#4)(2007-11#13)(2007-12#8)(2007-2#1)(2007-3#1)(2007-5#2)(2007-6#3)(2007-8#5)(2007-9#1)(2008-1#6)(2008-10#48)(2008-11#44)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#29)(2008-5#16)(2008-6#6)(2008-7#21)(2008-8#36)(2008-9#25)(2009-10#5)(2009-12#4)(2009-3#5)(2009-4#8)(2009-5#7)(2009-6#6)(2009-8#13)(2009-9#5)(2010-1#5)(2010-10#2)(2010-11#2)(2010-12#20)(2010-2#7)(2010-3#4)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#4)(2010-8#1)(2010-9#2)(2011-1#9)(2011-10#1)(2011-11#1)(2011-12#2)(2011-2#27)(2011-3#4)(2012-1#5)(2012-11#1)(2012-12#20)(2012-2#11)(2012-3#7)(2013-1#32)(2013-7#4)(2013-8#19)
the expression or function of##2##5##(2010-11#1)(2012-12#1)
the expression pattern of Xmsx-2B##2##5##(2008-6#2)
the expression pattern of the##4##5##(1992-3#1)(1993-6#1)(2007-12#1)(2008-10#1)
the expression pattern of##16##4##(1992-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-2#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-6#2)(2008-8#1)(2011-2#1)(2012-1#1)
the expression pattern##22##3##(1992-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-5#1)(1996-5#1)(2006-12#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-6#2)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#1)
the expression patterns of##12##4##(1991-5#1)(1992-2#1)(1994-5#1)(1997-1#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-1#1)
the expression patterns##14##3##(1991-5#1)(1992-2#1)(1994-12#1)(1994-5#1)(1994-9#1)(1997-1#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-1#1)
the expression plasmids##3##3##(2008-8#1)(2008-9#2)
the expression product##3##3##(1992-7#1)(2008-8#1)(2008-9#1)
the expression profile of##5##4##(1996-10#1)(1997-7#1)(2008-4#1)(2013-1#1)(2013-8#1)
the expression profile##6##3##(1996-10#1)(1997-7#1)(2008-4#1)(2009-6#1)(2013-1#1)(2013-8#1)
the expression profiles of##2##4##(1996-10#1)(1996-8#1)
the expression signals##2##3##(1990-11#1)(1996-12#1)
the expression time of##2##4##(1997-2#1)(2008-9#1)
the expression time##3##3##(1997-2#1)(2008-9#2)
the expression vector##18##3##(1990-5#1)(1991-9#1)(1993-12#1)(1993-9#1)(1994-3#1)(1994-5#2)(1996-2#1)(1997-6#1)(1997-8#2)(2005-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#1)
the expression vectors##2##3##(1996-2#1)(2008-11#1)
the expression was##5##3##(1997-4#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-4#1)
the expression##1390##2##(1990-10#2)(1990-11#6)(1990-12#5)(1990-2#4)(1990-3#8)(1990-4#1)(1990-5#8)(1990-6#2)(1990-7#4)(1990-8#5)(1990-9#2)(1991-1#1)(1991-10#4)(1991-11#5)(1991-12#6)(1991-2#4)(1991-3#5)(1991-5#9)(1991-6#6)(1991-7#2)(1991-8#7)(1991-9#13)(1992-1#6)(1992-10#1)(1992-11#4)(1992-12#8)(1992-2#2)(1992-3#15)(1992-5#4)(1992-6#10)(1992-7#4)(1992-8#17)(1992-9#10)(1993-1#1)(1993-11#6)(1993-12#13)(1993-2#3)(1993-3#10)(1993-4#7)(1993-5#2)(1993-6#14)(1993-8#7)(1993-9#10)(1994-10#4)(1994-11#17)(1994-12#19)(1994-2#18)(1994-3#15)(1994-5#14)(1994-6#8)(1994-7#2)(1994-8#17)(1994-9#15)(1995-1#4)(1995-10#5)(1995-11#13)(1995-12#11)(1995-2#17)(1995-3#9)(1995-4#2)(1995-5#8)(1995-6#6)(1995-7#5)(1995-8#15)(1995-9#3)(1996-1#2)(1996-10#5)(1996-11#10)(1996-12#25)(1996-2#17)(1996-3#5)(1996-4#10)(1996-5#10)(1996-6#1)(1996-7#4)(1996-8#4)(1996-9#2)(1997-1#4)(1997-2#8)(1997-3#3)(1997-4#16)(1997-5#5)(1997-6#14)(1997-7#8)(1997-8#20)(2003-11#1)(2004-11#1)(2004-3#4)(2005-10#3)(2005-11#5)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#7)(2006-11#3)(2006-12#14)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#4)(2006-8#2)(2006-9#3)(2007-10#4)(2007-11#16)(2007-12#12)(2007-2#2)(2007-3#2)(2007-5#3)(2007-6#3)(2007-8#5)(2007-9#1)(2008-1#10)(2008-10#56)(2008-11#59)(2008-12#2)(2008-2#4)(2008-3#10)(2008-4#37)(2008-5#21)(2008-6#10)(2008-7#29)(2008-8#52)(2008-9#40)(2009-10#7)(2009-12#6)(2009-2#1)(2009-3#7)(2009-4#9)(2009-5#7)(2009-6#8)(2009-8#16)(2009-9#6)(2010-1#5)(2010-10#2)(2010-11#3)(2010-12#21)(2010-2#9)(2010-3#6)(2010-4#3)(2010-5#4)(2010-6#2)(2010-7#5)(2010-8#1)(2010-9#2)(2011-1#10)(2011-10#1)(2011-11#1)(2011-12#3)(2011-2#29)(2011-3#4)(2012-1#7)(2012-11#1)(2012-12#21)(2012-2#15)(2012-3#8)(2013-1#36)(2013-7#5)(2013-8#22)
the expressions for the##2##4##(1995-6#1)(2008-2#1)
the expressions of these##2##4##(2005-11#1)(2008-1#1)
the expressions of##13##3##(1990-2#1)(1995-9#1)(1997-6#1)(2005-11#1)(2008-1#2)(2008-11#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-8#2)
the expressions##21##2##(1990-2#1)(1995-6#1)(1995-9#1)(1997-6#1)(2005-11#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-11#2)(2008-2#1)(2008-3#1)(2010-2#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-8#3)
the expressive##2##2##(2008-6#1)(2008-9#1)
the expulsion of##2##3##(2008-7#1)(2013-8#1)
the exquisitely##2##2##(1991-12#1)(1996-5#1)
the exstrophy-epispadias complex##2##3##(2008-10#2)
the extant##8##2##(2006-10#1)(2007-12#1)(2008-1#1)(2008-6#1)(2010-11#1)(2010-3#1)(2011-1#1)(2013-7#1)
the extended boundary condition method (EBCM)##2##6##(2008-3#2)
the extended boundary condition method##4##5##(2008-3#4)
the extended period of##2##4##(2007-6#1)(2008-5#1)
the extended period##3##3##(1997-3#1)(2007-6#1)(2008-5#1)
the extended##60##2##(1990-10#1)(1990-5#1)(1990-8#1)(1991-3#1)(1991-5#1)(1992-5#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-5#1)(1995-8#1)(1996-10#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2005-5#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#4)(2007-6#1)(2007-8#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
the extending##2##2##(2007-10#1)(2008-5#1)
the extension of the##22##4##(1992-1#1)(1994-4#1)(1995-9#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2010-5#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-7#3)
the extension of##37##3##(1991-12#1)(1991-5#1)(1991-8#1)(1992-1#1)(1994-4#1)(1995-9#1)(1997-6#1)(2005-11#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2010-5#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#3)
the extension phase##5##3##(1997-2#3)(2007-4#1)(2010-4#1)
the extension##48##2##(1991-12#1)(1991-5#1)(1991-8#2)(1992-1#1)(1994-4#1)(1995-9#1)(1997-2#3)(1997-6#1)(2005-11#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2010-10#3)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#3)
the extensive use of##3##4##(1991-10#1)(2008-10#1)(2012-2#1)
the extensive##47##2##(1990-4#1)(1991-10#1)(1991-2#1)(1992-1#1)(1992-12#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-7#1)(1994-8#1)(1995-1#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-12#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#2)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#3)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#2)
the extensor carpi radialis##3##4##(1996-6#1)(2006-3#1)(2008-12#1)
the extensor carpi##7##3##(1996-6#1)(2006-3#1)(2006-4#1)(2007-4#3)(2008-12#1)
the extensor digitorum and##2##4##(1993-11#1)(2007-4#1)
the extensor digitorum##3##3##(1993-11#1)(1993-7#1)(2007-4#1)
the extensor pollicis longus tendon##2##5##(2006-3#2)
the extensor##24##2##(1993-1#1)(1993-11#1)(1993-7#1)(1995-8#1)(1996-6#1)(1997-2#1)(2006-3#4)(2006-4#1)(2007-4#4)(2007-8#2)(2008-12#1)(2009-4#1)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
the extent and nature of##2##5##(1993-11#1)(2013-1#1)
the extent and severity of##2##5##(1997-2#1)(2013-7#1)
the extent and the##3##4##(1997-2#1)(2006-10#1)(2013-8#1)
the extent and timing of##2##5##(1993-12#1)(2008-11#1)
the extent and##38##3##(1991-12#1)(1991-8#1)(1993-11#1)(1993-12#1)(1994-12#1)(1995-7#1)(1995-8#1)(1996-4#1)(1997-2#2)(1997-6#1)(2004-11#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
the extent of Centralization##2##4##(2011-2#2)
the extent of DNA##2##4##(1992-3#1)(1994-8#1)
the extent of a##4##4##(1994-10#1)(2005-5#1)(2006-8#1)(2008-7#1)
the extent of and##2##4##(2009-4#1)(2013-1#1)
the extent of atherosclerotic lesions in coronary vessels##2##8##(2008-7#2)
the extent of atherosclerotic lesions in the aortic##2##8##(1995-1#1)(2012-11#1)
the extent of atherosclerotic lesions in##4##6##(1995-1#1)(2008-7#2)(2012-11#1)
the extent of cell##2##4##(1990-8#1)(2008-10#1)
the extent of coronary artery disease##2##6##(1993-12#1)(2013-8#1)
the extent of coronary disease##2##5##(1997-2#2)
the extent of coronary##5##4##(1993-12#1)(1995-12#1)(1997-2#2)(2013-8#1)
the extent of cross-linking##2##4##(2010-4#1)(2010-8#1)
the extent of cytochrome##2##4##(1992-11#1)(1994-8#1)
the extent of day surgery##4##5##(1996-1#4)
the extent of disease##2##4##(2007-11#1)(2008-4#1)
the extent of drug##2##4##(1991-9#1)(2011-1#1)
the extent of in##2##4##(1991-12#1)(2008-10#1)
the extent of inactivation##2##4##(1991-3#1)(1995-2#1)
the extent of increase##2##4##(2008-7#1)(2012-12#1)
the extent of infection##2##4##(2008-10#2)
the extent of inhibition##4##4##(1990-6#1)(1991-2#1)(1996-5#1)(2011-2#1)
the extent of injury##2##4##(2007-1#1)(2007-12#1)
the extent of invasion##3##4##(2007-6#1)(2008-1#1)(2008-5#1)
the extent of its##3##4##(2008-10#2)(2008-11#1)
the extent of labeling##3##4##(1990-11#1)(2008-4#2)
the extent of lateral##2##4##(2010-5#1)(2013-8#1)
the extent of light##2##4##(1990-2#1)(1993-12#1)
the extent of lipid peroxidation##3##5##(2007-1#1)(2007-8#1)(2008-4#1)
the extent of lipid substitution##4##5##(2010-4#4)
the extent of lipid##8##4##(1997-7#1)(2007-1#1)(2007-8#1)(2008-4#1)(2010-4#4)
the extent of liver##3##4##(1995-9#1)(2008-4#1)(2013-8#1)
the extent of microbial##2##4##(1997-4#1)(2006-3#1)
the extent of morphological##3##4##(2006-6#2)(2010-8#1)
the extent of myocardial damage##2##5##(2007-9#1)(2011-2#1)
the extent of myocardial##3##4##(2007-8#1)(2007-9#1)(2011-2#1)
the extent of penetration##2##4##(2008-10#1)(2010-2#1)
the extent of phosphorylation of##2##5##(1990-5#1)(1991-7#1)
the extent of reaction##2##4##(2008-11#1)(2008-7#1)
the extent of resection or##2##5##(2008-5#2)
the extent of resection##8##4##(2005-12#2)(2006-6#1)(2008-5#2)(2010-11#1)(2010-5#1)(2011-12#1)
the extent of risk##2##4##(1995-6#1)(1996-1#1)
the extent of spinal##2##4##(2007-7#1)(2007-8#1)
the extent of such##2##4##(2008-10#1)(2009-5#1)
the extent of surgical resection##2##5##(2008-7#2)
the extent of surgical##5##4##(2006-10#1)(2008-7#2)(2012-12#1)(2013-1#1)
the extent of the cancer##3##5##(1996-6#3)
the extent of the disease##4##5##(1994-6#1)(1994-9#1)(2010-8#1)(2011-2#1)
the extent of the lesion##3##5##(2007-8#1)(2008-6#1)(2010-6#1)
the extent of the market##2##5##(1993-2#2)
the extent of the problem in##3##6##(2005-8#1)(2006-10#1)(2008-10#1)
the extent of the problem##5##5##(1991-6#1)(1995-12#1)(2005-8#1)(2006-10#1)(2008-10#1)
the extent of the tumor##2##5##(1990-11#1)(2007-8#1)
the extent of the##51##4##(1990-11#1)(1990-7#1)(1991-6#1)(1992-10#1)(1992-9#1)(1993-2#2)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#2)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#3)(1996-8#1)(2005-8#1)(2006-10#3)(2006-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-10#4)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-6#2)(2010-8#1)(2011-2#1)
the extent of their##5##4##(1991-2#1)(1992-6#1)(2008-10#1)(2008-11#1)(2010-8#1)
the extent of these##2##4##(1990-4#1)(1992-3#1)
the extent of this##5##4##(1992-6#1)(2004-10#1)(2009-4#1)(2013-1#2)
the extent of tissue##2##4##(1997-3#1)(2007-3#1)
the extent of tumor##4##4##(2005-5#1)(2006-5#1)(2007-8#1)(2008-11#1)
the extent of tumors##2##4##(1990-6#1)(2013-1#1)
the extent of which##4##4##(1991-9#1)(1992-6#1)(2007-8#1)(2012-11#1)
the extent of##386##3##(1990-11#3)(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#1)(1991-12#3)(1991-2#4)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#3)(1991-9#2)(1992-10#2)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#3)(1992-6#4)(1992-7#1)(1992-8#1)(1992-9#4)(1993-11#1)(1993-12#4)(1993-2#4)(1993-4#1)(1993-5#1)(1993-6#3)(1993-8#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#5)(1994-9#1)(1995-1#2)(1995-10#3)(1995-12#4)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#2)(1995-7#1)(1995-9#2)(1996-1#5)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#3)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#6)(1997-3#3)(1997-4#2)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#3)(2004-10#1)(2005-11#8)(2005-12#2)(2005-5#2)(2005-8#1)(2006-10#6)(2006-12#3)(2006-3#1)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#1)(2007-1#3)(2007-10#2)(2007-11#4)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#4)(2007-8#12)(2007-9#4)(2008-1#2)(2008-10#31)(2008-11#11)(2008-12#5)(2008-2#1)(2008-3#4)(2008-4#11)(2008-5#9)(2008-6#5)(2008-7#15)(2008-8#7)(2008-9#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#6)(2010-5#3)(2010-6#2)(2010-8#4)(2011-1#2)(2011-12#4)(2011-2#8)(2012-1#2)(2012-11#4)(2012-12#5)(2012-2#2)(2012-6#1)(2013-1#8)(2013-8#5)
the extent that a##3##4##(1991-10#1)(2005-9#1)(2006-4#1)
the extent that the##5##4##(1991-4#1)(2005-9#1)(2006-10#1)(2007-10#1)(2007-6#1)
the extent that they##3##4##(2008-1#1)(2008-3#1)(2010-3#1)
the extent that##26##3##(1990-4#1)(1991-10#1)(1991-4#1)(1991-8#1)(1992-1#1)(1993-1#1)(1996-6#1)(1997-4#1)(1997-5#1)(2005-9#2)(2006-10#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-10#1)(2009-7#1)(2010-3#1)(2012-11#1)(2012-3#1)
the extent to which a##5##5##(1997-8#1)(2007-11#1)(2008-11#1)(2013-1#2)
the extent to which an##2##5##(2007-6#1)(2009-12#1)
the extent to which each##2##5##(1995-2#1)(2009-5#1)
the extent to which race##2##5##(2008-11#2)
the extent to which school##2##5##(1992-8#1)(2009-9#1)
the extent to which such##2##5##(2004-4#1)(2009-12#1)
the extent to which the##24##5##(1990-10#1)(1991-12#2)(1995-3#1)(1995-5#1)(2005-11#1)(2006-11#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-7#2)(2009-9#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#1)
the extent to which these##6##5##(1992-2#1)(2006-10#1)(2008-10#1)(2008-3#1)(2009-4#1)(2010-9#1)
the extent to which they are##2##6##(1994-3#1)(2010-2#1)
the extent to which they##7##5##(1992-11#1)(1994-3#1)(1996-2#2)(2010-2#1)(2010-7#1)(2012-2#1)
the extent to which##130##4##(1990-10#1)(1990-2#1)(1991-11#1)(1991-12#2)(1991-6#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#3)(1995-5#1)(1996-12#1)(1996-2#2)(1996-3#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-4#2)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#3)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#9)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#5)(2008-9#3)(2009-12#2)(2009-4#1)(2009-5#3)(2009-7#3)(2009-9#4)(2010-2#4)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
the extent##590##2##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#3)(1990-4#2)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#6)(1991-2#4)(1991-3#1)(1991-4#2)(1991-6#2)(1991-7#4)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#2)(1992-2#3)(1992-3#4)(1992-6#5)(1992-7#1)(1992-8#2)(1992-9#4)(1993-1#1)(1993-11#2)(1993-12#5)(1993-2#5)(1993-4#1)(1993-5#1)(1993-6#3)(1993-8#2)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#4)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#5)(1994-9#2)(1995-1#4)(1995-10#3)(1995-12#4)(1995-2#3)(1995-3#5)(1995-5#2)(1995-6#2)(1995-7#2)(1995-8#1)(1995-9#2)(1996-1#5)(1996-12#3)(1996-2#3)(1996-3#3)(1996-4#2)(1996-5#3)(1996-6#4)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#9)(1997-3#4)(1997-4#3)(1997-5#5)(1997-6#4)(1997-7#4)(1997-8#4)(2004-10#1)(2004-11#1)(2004-12#1)(2004-4#2)(2005-10#1)(2005-11#9)(2005-12#2)(2005-5#2)(2005-7#2)(2005-8#2)(2005-9#3)(2006-1#1)(2006-10#10)(2006-11#2)(2006-12#5)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#5)(2007-1#4)(2007-10#5)(2007-11#6)(2007-12#6)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#4)(2007-6#3)(2007-7#5)(2007-8#13)(2007-9#6)(2008-1#4)(2008-10#38)(2008-11#21)(2008-12#6)(2008-2#1)(2008-3#9)(2008-4#14)(2008-5#15)(2008-6#6)(2008-7#17)(2008-8#12)(2008-9#4)(2009-10#1)(2009-12#2)(2009-2#2)(2009-4#3)(2009-5#6)(2009-6#1)(2009-7#4)(2009-9#5)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#6)(2010-3#2)(2010-4#6)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#2)(2011-12#5)(2011-2#12)(2012-1#3)(2012-11#5)(2012-12#9)(2012-2#7)(2012-3#3)(2012-6#1)(2013-1#11)(2013-7#1)(2013-8#7)
the extents of##4##3##(1990-3#1)(1990-5#1)(1995-1#1)(2008-7#1)
the exterior##4##2##(2006-12#1)(2008-1#1)(2008-7#1)(2008-9#1)
the external aldimine##4##3##(1996-8#4)
the external and internal##5##4##(1993-2#1)(2007-8#1)(2010-4#1)(2012-12#2)
the external appearance##2##3##(2007-1#1)(2008-10#1)
the external application of##2##4##(1990-3#1)(1996-1#1)
the external auditory canal##4##4##(2006-12#1)(2008-7#2)(2008-9#1)
the external auditory##7##3##(1994-2#1)(2006-12#1)(2008-1#1)(2008-7#2)(2008-9#1)(2011-2#1)
the external boundary##2##3##(2008-7#2)
the external carotid artery##12##4##(1990-7#1)(1997-3#2)(1997-6#4)(2006-11#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-7#1)
the external carotid##16##3##(1990-7#1)(1996-9#3)(1997-3#2)(1997-6#4)(2006-11#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-7#1)(2013-1#1)
the external cavity mode##3##4##(2007-12#3)
the external cavity##5##3##(2007-12#3)(2008-2#1)(2008-3#1)
the external diameter measured##3##4##(2005-10#3)
the external diameter##4##3##(2005-10#4)
the external ear canal##5##4##(2010-7#5)
the external ear##9##3##(2010-7#5)(2012-12#3)(2013-1#1)
the external electric field##2##4##(2007-11#1)(2008-2#1)
the external environment and##2##4##(1995-3#1)(2008-5#1)
the external environment##11##3##(1995-3#3)(1995-5#1)(1997-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-6#1)(2009-8#1)(2011-2#1)
the external fixator##3##3##(2006-3#1)(2007-11#2)
the external iliac##3##3##(2008-4#1)(2011-2#2)
the external magnetic##2##3##(1996-6#1)(2008-10#1)
the external medium##7##3##(1991-10#1)(1991-5#1)(2008-3#2)(2008-5#1)(2008-8#1)(2011-12#1)
the external or internal##2##4##(1994-12#1)(2013-8#1)
the external pH##2##3##(1995-6#1)(1997-1#1)
the external pallidum##2##3##(1991-5#1)(2008-11#1)
the external phloem##2##3##(2008-10#2)
the external portion of##2##4##(2007-7#2)
the external segment of the##2##5##(1991-5#1)(2009-8#1)
the external solution##2##3##(1990-4#1)(1996-2#1)
the external surface of the##3##5##(2006-10#1)(2007-7#1)(2008-10#1)
the external surface of##7##4##(1994-11#3)(2005-11#1)(2006-10#1)(2007-7#1)(2008-10#1)
the external surface##11##3##(1994-11#3)(2005-11#2)(2006-10#1)(2007-3#1)(2007-7#1)(2008-10#3)
the external validation##2##3##(2008-10#1)(2009-4#1)
the external vertebral venous plexus##2##5##(2011-2#2)
the external##209##2##(1990-10#1)(1990-11#4)(1990-2#1)(1990-3#3)(1990-4#1)(1990-7#3)(1990-8#1)(1991-10#1)(1991-2#1)(1991-5#3)(1992-8#1)(1993-12#2)(1993-2#1)(1994-11#3)(1994-12#2)(1994-2#3)(1994-6#2)(1995-11#1)(1995-12#1)(1995-3#3)(1995-5#3)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-6#2)(1996-7#2)(1996-8#4)(1996-9#3)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#4)(1997-8#1)(2005-10#4)(2005-11#4)(2006-10#3)(2006-11#1)(2006-12#2)(2006-3#3)(2006-7#1)(2007-1#2)(2007-11#6)(2007-12#8)(2007-3#2)(2007-7#5)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#14)(2008-11#9)(2008-2#5)(2008-3#6)(2008-4#2)(2008-5#3)(2008-7#8)(2008-8#2)(2008-9#2)(2009-10#3)(2009-4#1)(2009-6#1)(2009-8#2)(2010-10#2)(2010-12#2)(2010-4#1)(2010-7#5)(2011-1#1)(2011-12#1)(2011-2#7)(2012-12#8)(2013-1#4)(2013-8#2)
the externally##2##2##(2005-11#1)(2007-11#1)
the extinct##3##2##(1991-5#1)(2007-12#1)(2007-5#1)
the extinction coefficient k##2##4##(2008-2#2)
the extinction coefficient of the##3##5##(2008-10#1)(2008-3#2)
the extinction coefficient of##7##4##(1991-8#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)
the extinction coefficient##16##3##(1990-8#1)(1991-12#1)(1991-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#6)(2008-3#4)
the extinction coefficients##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
the extinction cross sections##2##4##(2008-2#2)
the extinction cross##3##3##(2005-11#1)(2008-2#2)
the extinction of##4##3##(2007-12#1)(2008-5#1)(2008-8#2)
the extinction ratio of the##3##5##(2008-2#1)(2008-3#2)
the extinction ratio of##5##4##(2008-2#2)(2008-3#2)(2010-4#1)
the extinction ratio##9##3##(2007-11#1)(2008-1#1)(2008-2#4)(2008-3#2)(2010-4#1)
the extinction spectrum##3##3##(2008-3#2)(2009-12#1)
the extinction##54##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-8#1)(2005-11#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#2)(2008-2#16)(2008-3#14)(2008-5#1)(2008-8#6)(2009-12#1)(2010-4#1)(2013-8#1)
the extinction-to-backscatter##2##2##(2008-2#1)(2008-3#1)
the extinction-to-backscattering ratio##2##3##(2008-3#2)
the extra domain##2##3##(1995-1#2)
the extra survival time##2##4##(1995-12#2)
the extra##24##2##(1990-4#2)(1990-5#1)(1991-5#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-5#1)(1996-9#1)(2005-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#3)(2008-5#1)(2008-9#1)(2009-12#1)(2010-2#1)(2013-1#1)(2013-8#1)
the extra- and intracellular##3##4##(2010-10#2)(2012-2#1)
the extracellular ATP##2##3##(2008-4#2)
the extracellular Ca2+##5##3##(1990-2#1)(1990-8#1)(1993-12#1)(1993-2#2)
the extracellular DA levels##3##4##(1994-10#3)
the extracellular N-terminal domain##2##4##(1993-12#1)(1995-10#1)
the extracellular TF mutant##2##4##(1995-8#2)
the extracellular alkaline phosphatase activities##2##5##(2007-3#2)
the extracellular and intracellular##2##4##(1994-12#1)(2007-3#1)
the extracellular and##6##3##(1993-12#1)(1994-12#1)(1994-5#1)(1994-9#2)(2007-3#1)
the extracellular cAMP##2##3##(1996-2#1)(1997-3#1)
the extracellular compartment##2##3##(1994-9#1)(2011-12#1)
the extracellular component of the##2##5##(1990-12#1)(1991-9#1)
the extracellular concentration of ATP##2##5##(2008-4#2)
the extracellular concentration of aspartate##2##5##(1996-12#2)
the extracellular concentration of potassium##2##5##(1994-12#1)(1995-11#1)
the extracellular concentration of##9##4##(1994-12#1)(1995-11#1)(1996-12#2)(1997-1#1)(1997-3#2)(2008-4#2)
the extracellular concentrations of##4##4##(1992-7#1)(1994-8#2)(2007-9#1)
the extracellular domain and##4##4##(1992-12#1)(1993-6#1)(1993-8#1)(1995-5#1)
the extracellular domain of human##2##5##(1992-7#1)(1994-9#1)
the extracellular domain of the human##2##6##(1991-5#1)(1995-3#1)
the extracellular domain of the receptor##3##6##(1990-8#1)(1992-12#1)(2008-4#1)
the extracellular domain of the##15##5##(1990-12#1)(1990-8#1)(1991-5#1)(1991-8#2)(1992-12#1)(1993-3#2)(1995-2#1)(1995-3#1)(1996-5#1)(1997-2#1)(2008-4#2)(2008-8#1)
the extracellular domain of##29##4##(1990-12#1)(1990-8#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-12#3)(1992-7#2)(1993-3#2)(1993-6#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#2)(1996-5#3)(1997-2#1)(1997-7#1)(2008-4#2)(2008-8#1)
the extracellular domain##43##3##(1990-12#1)(1990-8#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-11#2)(1992-12#4)(1992-7#2)(1992-9#1)(1993-3#2)(1993-6#2)(1993-8#2)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-5#1)(1996-5#3)(1997-2#1)(1997-7#1)(2008-11#1)(2008-4#3)(2008-8#1)(2009-8#1)
the extracellular domains of the##2##5##(1991-6#1)(1997-6#1)
the extracellular domains of##7##4##(1990-12#1)(1991-6#2)(1994-5#1)(1997-6#1)(2012-12#2)
the extracellular domains##8##3##(1990-12#1)(1991-6#2)(1994-5#1)(1995-11#1)(1997-6#1)(2012-12#2)
the extracellular dopamine levels##2##4##(1994-10#2)
the extracellular dopamine##3##3##(1994-10#3)
the extracellular environment##9##3##(1991-9#1)(1995-3#1)(2008-4#1)(2008-7#2)(2009-3#1)(2010-10#1)(2012-1#2)
the extracellular levels of##2##4##(1994-8#1)(1997-2#1)
the extracellular ligand##2##3##(1993-3#1)(1994-5#1)
the extracellular matrix (ECM)##4##4##(2007-8#1)(2008-11#1)(2009-7#1)(2010-10#1)
the extracellular matrix and the##2##5##(1992-4#1)(2008-5#1)
the extracellular matrix and##9##4##(1992-11#1)(1992-4#1)(1995-8#1)(1996-8#1)(2006-6#1)(2007-11#1)(2008-5#1)(2012-12#2)
the extracellular matrix in##2##4##(2008-1#1)(2008-5#1)
the extracellular matrix is##4##4##(1990-7#1)(1993-9#1)(2008-9#1)(2009-4#1)
the extracellular matrix of the##2##5##(1994-3#1)(2008-5#1)
the extracellular matrix of##7##4##(1991-3#1)(1991-9#2)(1994-3#1)(1996-3#1)(2008-5#1)(2009-8#1)
the extracellular matrix on the##2##5##(1994-8#1)(2008-11#1)
the extracellular matrix on##3##4##(1994-8#1)(2008-11#2)
the extracellular matrix protein##2##4##(2008-1#1)(2009-8#1)
the extracellular matrix##73##3##(1990-5#1)(1990-7#2)(1991-3#2)(1991-8#4)(1991-9#2)(1992-11#2)(1992-4#1)(1992-7#1)(1993-2#1)(1993-6#1)(1993-9#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-3#3)(1996-5#2)(1996-8#1)(1997-3#2)(2006-1#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-8#1)(2008-1#2)(2008-11#3)(2008-4#1)(2008-5#4)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-3#1)(2011-1#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-8#1)
the extracellular medium of##2##4##(1991-10#1)(1996-10#1)
the extracellular medium##15##3##(1990-11#1)(1990-2#1)(1990-3#1)(1991-10#1)(1991-2#1)(1994-11#1)(1996-10#1)(1996-2#2)(2004-11#1)(2007-11#1)(2008-4#2)(2009-8#1)(2012-11#1)
the extracellular membrane##2##3##(2008-4#1)(2011-1#1)
the extracellular milieu##2##3##(2006-7#1)(2009-8#1)
the extracellular part of the molecule##2##6##(1990-11#1)(1997-9#1)
the extracellular part of##3##4##(1990-11#1)(1993-2#1)(1997-9#1)
the extracellular portion of##2##4##(1992-12#1)(1995-3#1)
the extracellular region of##2##4##(1994-5#1)(1997-7#1)
the extracellular signal-regulated##3##3##(1996-5#1)(2009-8#1)(2009-9#1)
the extracellular space and##2##4##(1994-2#1)(2008-4#1)
the extracellular space is##2##4##(1992-11#1)(2008-7#1)
the extracellular space##18##3##(1990-3#1)(1992-11#1)(1994-2#1)(1994-8#1)(2007-10#1)(2008-4#6)(2008-7#2)(2008-8#1)(2009-8#1)(2009-9#1)(2012-2#1)(2012-3#1)
the extracellular##303##2##(1990-11#4)(1990-12#3)(1990-2#3)(1990-3#6)(1990-5#3)(1990-7#2)(1990-8#2)(1991-10#2)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#6)(1991-9#8)(1992-11#5)(1992-12#7)(1992-4#2)(1992-5#2)(1992-6#2)(1992-7#4)(1992-9#1)(1993-12#4)(1993-2#5)(1993-3#4)(1993-4#2)(1993-6#5)(1993-8#2)(1993-9#2)(1994-10#6)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#6)(1994-8#6)(1994-9#5)(1995-10#1)(1995-11#7)(1995-12#1)(1995-2#4)(1995-3#5)(1995-5#1)(1995-8#5)(1996-10#1)(1996-12#2)(1996-2#3)(1996-3#3)(1996-5#6)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#6)(1997-5#2)(1997-6#2)(1997-7#3)(1997-9#1)(2004-11#1)(2006-1#1)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#2)(2007-11#4)(2007-3#3)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#6)(2008-4#19)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#3)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#9)(2009-9#2)(2010-10#3)(2010-3#1)(2010-4#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#4)(2012-11#1)(2012-12#6)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
the extrachromosomal##2##2##(1993-5#1)(2007-12#1)
the extracisternal space##2##3##(1997-7#2)
the extracorporeal circuit##4##3##(1992-1#1)(2008-1#1)(2008-10#2)
the extracorporeal circulation##2##3##(1996-6#1)(2007-8#1)
the extracorporeal##10##2##(1991-11#1)(1991-12#1)(1992-1#2)(1996-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)
the extracranial##12##2##(1992-5#1)(1997-6#1)(2006-8#1)(2007-9#2)(2008-7#4)(2010-10#1)(2012-3#1)(2013-8#1)
the extract and was##2##4##(1994-2#1)(1995-6#1)
the extract and##10##3##(1994-2#1)(1995-6#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)
the extract at##4##3##(1990-2#1)(2008-4#2)(2013-7#1)
the extract can##2##3##(1997-1#1)(2009-6#1)
the extract for##2##3##(2008-10#1)(2008-12#1)
the extract from the##2##4##(1991-1#1)(1996-7#1)
the extract from##6##3##(1991-1#1)(1994-8#1)(1996-7#1)(2009-3#1)(2010-9#1)(2013-8#1)
the extract in##5##3##(2008-10#1)(2008-12#1)(2008-5#1)(2009-5#1)(2010-2#1)
the extract of the##3##4##(1992-3#1)(1994-11#1)(2006-12#1)
the extract of##12##3##(1992-3#1)(1994-11#1)(1996-10#1)(2006-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2013-1#2)(2013-7#2)
the extract showed##3##3##(2008-5#1)(2010-5#1)(2013-7#1)
the extract to##2##3##(2008-10#1)(2009-5#1)
the extract was##12##3##(1996-11#1)(2006-12#1)(2007-1#1)(2008-10#1)(2008-4#2)(2008-5#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-12#2)
the extract were investigated##2##4##(2008-5#2)
the extract were##5##3##(2008-10#2)(2008-5#2)(2010-12#1)
the extract##105##2##(1990-2#1)(1991-1#1)(1992-3#2)(1994-11#1)(1994-2#2)(1994-6#1)(1994-8#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-4#2)(1996-7#1)(1997-1#3)(2005-11#1)(2006-12#3)(2007-1#4)(2007-8#1)(2008-10#20)(2008-11#4)(2008-12#3)(2008-4#6)(2008-5#8)(2008-6#1)(2008-8#1)(2009-3#1)(2009-5#4)(2009-6#4)(2010-12#5)(2010-2#2)(2010-3#1)(2010-5#3)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#5)(2013-8#2)
the extract-treated##3##2##(2008-10#1)(2012-2#2)
the extractability and##2##3##(2007-8#1)(2008-10#1)
the extractability of##6##3##(1994-8#1)(2008-10#4)(2008-7#1)
the extractability##10##2##(1994-8#1)(2007-8#1)(2008-10#7)(2008-7#1)
the extractable##9##2##(1990-12#1)(2008-10#7)(2008-2#1)
the extractant solution##2##3##(2008-10#2)
the extractant##7##2##(2008-10#7)
the extractants##5##2##(2008-10#5)
the extracted DNA##2##3##(2005-10#1)(2008-5#1)
the extracted complex##3##3##(2008-10#3)
the extracted compounds##2##3##(2012-1#2)
the extracted species##8##3##(2008-10#8)
the extracted##47##2##(1990-2#1)(1990-7#1)(1993-6#1)(1994-8#1)(1995-3#1)(1996-2#1)(1996-4#1)(1997-3#1)(1997-4#1)(2005-10#1)(2006-3#1)(2007-12#1)(2008-10#21)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-8#1)(2010-4#1)(2012-1#3)(2012-2#1)(2013-8#1)
the extracting solvent##4##3##(2008-10#3)(2012-12#1)
the extracting##9##2##(2005-4#1)(2007-8#1)(2008-10#6)(2012-12#1)
the extraction ability for##2##4##(2007-6#1)(2008-10#1)
the extraction ability##3##3##(2007-6#1)(2008-10#2)
the extraction and clean-up##2##4##(1992-2#1)(2008-10#1)
the extraction and desorption##4##4##(2007-8#1)(2008-10#3)
the extraction and determination of molybdenum(VI)##2##6##(2008-10#2)
the extraction and determination of##8##5##(2008-10#8)
the extraction and purification of##2##5##(2008-11#1)(2008-4#1)
the extraction and separation of##2##5##(2008-10#2)
the extraction and##29##3##(1992-2#1)(1996-12#1)(1997-1#1)(2006-3#1)(2007-8#1)(2008-10#19)(2008-11#1)(2008-4#1)(2012-1#1)(2012-12#1)(2013-8#1)
the extraction behavior of##2##4##(2008-10#2)
the extraction behavior##3##3##(2008-10#3)
the extraction chromatography method were##2##5##(2008-10#2)
the extraction chromatography method##3##4##(2008-10#3)
the extraction coil##2##3##(2008-10#2)
the extraction conditions##3##3##(2007-8#1)(2008-10#2)
the extraction constant##2##3##(2008-10#2)
the extraction constants##2##3##(2008-10#2)
the extraction efficiency and selectivity##2##5##(2008-10#2)
the extraction efficiency and##3##4##(2008-10#3)
the extraction efficiency of the##6##5##(2008-10#6)
the extraction efficiency of these##2##5##(2008-10#2)
the extraction efficiency of##12##4##(2007-8#1)(2008-10#11)
the extraction efficiency were##3##4##(2008-10#2)(2012-12#1)
the extraction efficiency##26##3##(2007-8#1)(2008-10#23)(2012-1#1)(2012-12#1)
the extraction is##4##3##(2008-10#4)
the extraction mechanism##3##3##(2007-8#1)(2008-10#2)
the extraction media##2##3##(2008-10#2)
the extraction medium##2##3##(2008-10#2)
the extraction membrane##3##3##(2008-10#3)
the extraction of a##6##4##(2008-1#1)(2008-10#5)
the extraction of b(5)##2##4##(2008-7#2)
the extraction of both##2##4##(2008-10#2)
the extraction of fringe skeletons##2##5##(2008-2#2)
the extraction of mercury##2##4##(2008-10#2)
the extraction of metal ions##2##5##(2008-10#2)
the extraction of metals##3##4##(2008-10#2)(2011-2#1)
the extraction of quantitative##3##4##(2007-12#1)(2009-4#2)
the extraction of the##17##4##(1990-1#1)(1992-2#1)(1996-2#1)(2007-8#2)(2008-10#7)(2008-2#1)(2008-3#1)(2008-6#1)(2010-12#1)(2013-8#1)
the extraction of##109##3##(1990-1#1)(1990-9#1)(1991-8#1)(1992-2#1)(1994-10#1)(1996-2#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#60)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#3)(2008-6#1)(2008-7#5)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#5)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
the extraction performance of the##2##5##(2008-10#2)
the extraction procedure##5##3##(1990-5#1)(2008-10#4)
the extraction procedures##3##3##(2008-10#3)
the extraction process and the##2##5##(2008-10#2)
the extraction process and##3##4##(2008-10#3)
the extraction process using##2##4##(2008-10#1)(2012-1#1)
the extraction process was performed##2##5##(2008-10#2)
the extraction process were##2##4##(2008-10#2)
the extraction process##18##3##(1996-11#1)(2008-10#16)(2012-1#1)
the extraction rate##3##3##(2008-10#3)
the extraction recovery##2##3##(1993-2#1)(2008-10#1)
the extraction selectivity for##2##4##(2008-10#2)
the extraction selectivity##3##3##(2008-10#3)
the extraction solution##4##3##(2008-10#4)
the extraction solvent##5##3##(2007-11#1)(2008-10#3)(2012-12#1)
the extraction spectrophotometric##2##3##(2005-4#1)(2008-10#1)
the extraction step##3##3##(2008-10#2)(2008-7#1)
the extraction system##2##3##(2007-8#1)(2008-10#1)
the extraction technique##2##3##(1991-12#1)(2008-10#1)
the extraction temperature##2##3##(2008-10#2)
the extraction time##12##3##(1997-8#1)(2008-10#10)(2012-12#1)
the extraction vessel##5##3##(2008-10#5)
the extraction was##4##3##(2008-10#4)
the extraction with##4##3##(1990-8#1)(2008-10#3)
the extraction yield of##2##4##(2007-1#1)(2008-10#1)
the extraction yield##4##3##(2007-1#1)(2008-10#3)
the extraction##335##2##(1990-1#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-2#2)(1993-1#2)(1993-2#2)(1994-10#2)(1994-2#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-8#1)(2005-4#3)(2006-3#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-6#1)(2007-8#9)(2008-1#1)(2008-10#236)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#2)(2010-12#1)(2011-1#2)(2011-2#2)(2012-1#9)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#3)
the extractive fermentation was##2##4##(2011-2#1)(2013-7#1)
the extractive fermentation##3##3##(2011-2#2)(2013-7#1)
the extractive##8##2##(2008-10#5)(2011-2#2)(2013-7#1)
the extracts and##4##3##(1994-12#1)(2008-10#2)(2010-3#1)
the extracts are##3##3##(1994-9#1)(2010-2#1)(2012-2#1)
the extracts from##5##3##(1996-5#1)(2008-10#2)(2008-11#1)(2008-5#1)
the extracts had a##2##4##(1992-8#1)(2006-9#1)
the extracts obtained##2##3##(1991-8#1)(2012-1#1)
the extracts of##13##3##(1990-11#1)(1990-2#1)(1994-8#1)(1996-9#1)(2007-6#1)(2008-10#4)(2008-4#1)(2008-5#1)(2009-5#1)(2013-8#1)
the extracts was##4##3##(2008-10#2)(2008-4#1)(2013-1#1)
the extracts were##16##3##(1990-12#1)(1994-12#1)(1996-5#1)(1997-3#1)(2007-1#1)(2008-10#8)(2008-5#1)(2009-5#1)(2011-2#1)
the extracts##79##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-8#2)(1992-12#1)(1992-4#1)(1992-5#1)(1992-8#1)(1994-12#3)(1994-8#1)(1994-9#1)(1996-12#2)(1996-5#2)(1996-9#1)(1997-1#1)(1997-3#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-6#1)(2008-10#28)(2008-11#2)(2008-4#2)(2008-5#5)(2008-6#1)(2009-5#2)(2010-2#2)(2010-3#2)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#3)(2013-8#2)
the extracytoplasmic loop##2##3##(1992-11#2)
the extracytoplasmic##3##2##(1992-11#3)
the extradural space##2##3##(2006-12#1)(2008-7#1)
the extradural##3##2##(2006-12#2)(2008-7#1)
the extrahepatic bile ducts##2##4##(2007-4#1)(2007-5#1)
the extrahepatic bile##5##3##(2007-4#1)(2007-5#1)(2010-12#3)
the extrahepatic biliary tree##2##4##(2009-2#2)
the extrahepatic##9##2##(2006-2#1)(2007-4#1)(2007-5#1)(2009-2#2)(2010-12#3)(2012-2#1)
the extramedullary##2##2##(2010-10#1)(2011-2#1)
the extraocular muscle##2##3##(1996-3#1)(1997-3#1)
the extraocular muscles##3##3##(1992-9#1)(1997-3#1)(2011-1#1)
the extraocular##5##2##(1992-9#1)(1996-3#1)(1997-3#2)(2011-1#1)
the extraordinary index##2##3##(2008-1#1)(2008-3#1)
the extraordinary ray##2##3##(2008-2#2)
the extraordinary##12##2##(1995-2#1)(2007-12#1)(2008-1#1)(2008-2#4)(2008-3#4)(2009-4#1)
the extrapleural chest wall##2##4##(2012-2#2)
the extrapolated##2##2##(1995-2#1)(2008-2#1)
the extrapolation##4##2##(1997-8#1)(2008-10#1)(2008-2#1)(2013-1#1)
the extrapyramidal system##3##3##(2008-11#1)(2008-7#2)
the extrapyramidal##5##2##(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#1)
the extrastriate##2##2##(2008-11#1)(2012-2#1)
the extravasation of##2##3##(1991-2#1)(2008-6#1)
the extravasation##4##2##(1991-2#1)(1994-2#2)(2008-6#1)
the extravascular##2##2##(2008-1#1)(2010-2#1)
the extrema of##3##3##(2008-2#1)(2008-3#2)
the extreme broadening##2##3##(1997-7#2)
the extreme cloacal malformation##2##4##(2008-10#2)
the extreme conditions##3##3##(1996-5#1)(2008-10#1)(2009-4#1)
the extreme heterogeneity##2##3##(1991-6#1)(1997-4#1)
the extreme lateral##2##3##(2006-12#2)
the extreme phenotype##2##3##(1994-3#1)(2012-3#1)
the extreme precipitation##2##3##(2013-8#2)
the extreme rarity of##2##4##(2008-5#1)(2008-6#1)
the extreme thermophilic##2##3##(1994-3#1)(1995-2#1)
the extreme ultraviolet with##2##4##(2007-11#1)(2008-3#1)
the extreme ultraviolet##10##3##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#5)
the extreme##67##2##(1990-8#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-6#1)(1994-3#2)(1994-8#1)(1994-9#2)(1995-2#3)(1995-3#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-7#3)(2006-12#3)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#2)(2009-4#1)(2009-6#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-8#2)
the extreme-UV##4##2##(2008-2#1)(2008-3#3)
the extreme-ultraviolet (EUV)##2##3##(2008-3#2)
the extreme-ultraviolet##8##2##(2007-11#1)(2008-2#3)(2008-3#4)
the extremely high##6##3##(1990-12#1)(1994-2#1)(2008-11#1)(2008-3#1)(2009-3#1)(2012-3#1)
the extremely low##7##3##(1991-8#1)(1993-8#1)(2007-11#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-3#1)
the extremely rare##2##3##(2006-2#1)(2007-12#1)
the extremely small##3##3##(1993-2#1)(2007-12#1)(2008-9#1)
the extremely thermophilic archaebacterium Methanothermus fervidus##2##6##(1990-3#1)(1990-5#1)
the extremely thermophilic archaebacterium##3##4##(1990-3#1)(1990-5#2)
the extremely thermophilic##6##3##(1990-3#2)(1990-5#2)(1990-7#1)(1994-2#1)
the extremely##45##2##(1990-12#1)(1990-3#2)(1990-5#2)(1990-7#1)(1991-8#1)(1993-2#2)(1993-8#1)(1994-2#2)(1995-6#1)(1996-3#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-11#3)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-3#2)
the extremes of the##3##4##(2008-5#1)(2008-8#1)(2012-3#1)
the extremes of##8##3##(1997-3#1)(2006-12#1)(2007-9#1)(2008-5#2)(2008-8#1)(2011-1#1)(2012-3#1)
the extremes##10##2##(1997-3#1)(2006-12#1)(2007-9#1)(2008-10#1)(2008-5#2)(2008-8#1)(2011-1#1)(2012-3#2)
the extremities and face##2##4##(2013-1#2)
the extremities and trunk##3##4##(2005-11#1)(2008-6#2)
the extremities and##12##3##(2005-11#1)(2007-12#1)(2007-7#1)(2008-6#3)(2009-10#1)(2009-2#1)(2010-6#1)(2012-1#1)(2013-1#2)
the extremities of##2##3##(1992-3#1)(2007-8#1)
the extremities##50##2##(1990-12#2)(1991-2#1)(1992-3#1)(1992-6#5)(2005-11#1)(2006-10#3)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#4)(2008-3#1)(2008-6#7)(2008-9#2)(2009-10#1)(2009-2#2)(2009-3#3)(2009-4#1)(2009-8#1)(2010-3#2)(2010-6#1)(2011-2#2)(2012-1#2)(2013-1#5)
the extremities]##2##2##(1992-3#1)(2008-9#1)
the extremity function##2##3##(2007-11#1)(2009-2#1)
the extremity of##2##3##(1996-11#1)(2008-3#1)
the extremity##23##2##(1990-12#1)(1992-6#2)(1993-9#1)(1996-11#1)(2007-11#3)(2008-3#1)(2008-6#5)(2009-2#1)(2010-3#4)(2011-2#2)(2013-1#2)
the extrinsic pathway of##2##4##(1995-6#1)(2012-2#1)
the extrinsic risk factors for inpatient falls from##2##8##(2010-10#2)
the extrinsic##12##2##(1995-6#1)(1995-8#1)(1996-8#1)(1997-7#1)(2005-12#1)(2008-3#1)(2009-9#1)(2010-10#2)(2011-2#1)(2012-12#1)(2012-2#1)
the extruded##2##2##(2012-2#2)
the extrusion of a##2##4##(1994-7#1)(2012-12#1)
the extrusion of##5##3##(1994-7#1)(2007-12#1)(2010-12#1)(2012-12#2)
the extrusion##9##2##(1994-7#2)(2005-11#2)(2007-12#1)(2010-12#1)(2012-12#2)(2012-2#1)
the eye and the##2##4##(2006-11#1)(2011-12#1)
the eye and##13##3##(1992-2#1)(1995-3#1)(1995-5#1)(2005-8#1)(2006-11#1)(2007-12#2)(2008-4#2)(2009-8#1)(2011-12#1)(2012-11#2)
the eye are##2##3##(2005-11#1)(2006-11#1)
the eye as##2##3##(1994-5#1)(2010-1#1)
the eye by##2##3##(2007-9#1)(2011-2#1)
the eye field derived##2##4##(2007-12#2)
the eye field##7##3##(2007-12#7)
the eye in##4##3##(1997-8#1)(2008-5#1)(2009-2#1)(2010-8#1)
the eye ipsilateral to the##2##5##(1994-6#1)(2008-7#1)
the eye is##5##3##(1991-3#1)(2007-12#2)(2008-11#1)(2012-2#1)
the eye lens##3##3##(1993-4#1)(1995-5#1)(2008-3#1)
the eye of the beholder##2##5##(1992-9#1)(2011-2#1)
the eye of the##4##4##(1992-9#1)(1994-2#1)(2009-7#1)(2011-2#1)
the eye or##2##3##(1990-9#1)(1995-5#1)
the eye region##2##3##(2009-10#1)(2009-4#1)
the eye surface##2##3##(2007-1#1)(2009-6#1)
the eye's##3##2##(2007-11#1)(2007-12#1)(2010-9#1)
the eye-movement##2##2##(2009-8#1)(2010-5#1)
the eye-safe##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
the eyeball##5##2##(2007-7#1)(2008-6#1)(2009-2#1)(2012-3#2)
the eyeblinks##2##2##(1992-8#2)
the eyelid##4##2##(1992-7#1)(2009-8#1)(2011-2#1)(2013-8#1)
the eyelids##3##2##(1994-3#1)(2006-10#1)(2007-10#1)
the eyes and##5##3##(1996-12#1)(1997-8#1)(2007-10#1)(2008-1#1)(2009-10#1)
the eyes developed##2##3##(2006-10#1)(2007-1#1)
the eyes of the##3##4##(1995-4#1)(2007-12#1)(2008-1#1)
the eyes of##16##3##(1994-3#1)(1995-4#1)(2006-8#1)(2007-1#1)(2007-12#3)(2007-2#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
the eyes to##2##3##(1997-8#2)
the eyes##46##2##(1990-10#1)(1990-2#2)(1992-9#1)(1994-3#1)(1995-4#1)(1995-9#1)(1996-12#1)(1996-5#1)(1997-8#3)(2006-10#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-12#5)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-5#3)(2008-6#1)(2009-10#1)(2009-4#3)(2009-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
the eyespot##6##2##(2008-10#1)(2009-10#1)(2009-6#1)(2012-2#1)(2012-3#2)
the eyestalk neuroendocrine system##2##4##(2007-12#2)
the eyestalk##6##2##(1994-11#1)(1996-5#1)(2007-12#2)(2008-5#2)
the fEPSP##3##2##(1996-8#1)(2008-4#1)(2009-5#1)
the fMRI##5##2##(2009-6#1)(2009-9#2)(2011-12#1)(2012-2#1)
the fabric##2##2##(2008-11#1)(2008-3#1)
the fabricated microspheres##3##3##(2011-2#1)(2013-1#2)
the fabricated##21##2##(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#6)(2008-3#2)(2008-4#1)(2009-11#1)(2011-2#1)(2013-1#3)
the fabrication and characterization of##4##5##(2007-12#2)(2008-10#1)(2008-12#1)
the fabrication and##13##3##(2007-12#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-12#1)(2012-2#1)
the fabrication of a highly##2##5##(2007-12#1)(2010-4#1)
the fabrication of a##11##4##(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2010-4#1)
the fabrication of large areas##2##5##(2008-3#1)(2008-7#1)
the fabrication of metallic nanowires##2##5##(2008-7#1)(2010-7#1)
the fabrication of the##3##4##(2008-10#1)(2008-3#1)(2008-9#1)
the fabrication of##75##3##(2004-9#1)(2006-12#2)(2006-2#2)(2007-11#3)(2007-12#15)(2007-8#3)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#8)(2008-4#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-2#2)(2010-4#4)(2010-7#3)(2012-11#1)(2012-2#2)(2013-1#1)
the fabrication process##9##3##(2008-10#1)(2008-2#3)(2008-3#3)(2010-4#1)(2013-7#1)
the fabrication technique of##2##4##(2008-2#2)
the fabrication##109##2##(2004-9#1)(2006-12#2)(2006-2#2)(2007-11#4)(2007-12#21)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-12#3)(2008-2#10)(2008-3#18)(2008-4#2)(2008-6#1)(2008-7#4)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-2#2)(2010-4#5)(2010-7#3)(2012-11#1)(2012-2#3)(2013-1#1)(2013-7#1)
the facades of##2##3##(2008-2#1)(2008-3#1)
the face and the##3##4##(2004-11#1)(2008-2#1)(2010-6#1)
the face and##24##3##(1991-9#1)(1995-11#1)(1996-11#1)(1996-3#1)(2004-11#1)(2005-5#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-5#3)(2009-4#2)(2009-6#2)(2010-1#1)(2010-12#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-2#1)
the face from##2##3##(2010-1#1)(2010-8#1)
the face have##2##3##(2009-8#1)(2010-11#1)
the face in##3##3##(2007-7#1)(2009-4#1)(2012-12#1)
the face is##7##3##(2007-7#1)(2007-8#1)(2008-3#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-11#1)
the face of a##5##4##(1995-2#1)(2005-10#1)(2005-11#1)(2007-8#1)(2008-2#1)
the face of less##2##4##(2006-8#1)(2008-12#1)
the face of recent##2##4##(2007-2#1)(2008-10#1)
the face of the##4##4##(1990-9#1)(2010-7#1)(2011-2#2)
the face of this##2##4##(1990-4#1)(2011-2#1)
the face of##59##3##(1990-4#1)(1990-9#1)(1991-3#1)(1991-4#1)(1992-1#1)(1993-1#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-4#2)(2006-8#2)(2006-9#1)(2007-11#3)(2007-2#2)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-2#1)(2010-7#3)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#1)(2013-1#1)
the face processing system##2##4##(2008-1#1)(2009-4#1)
the face that##2##3##(2009-4#1)(2009-9#1)
the face##183##2##(1990-4#2)(1990-9#1)(1991-3#2)(1991-4#1)(1991-9#1)(1992-1#1)(1993-1#2)(1994-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#3)(2005-5#1)(2005-8#1)(2006-10#1)(2006-12#4)(2006-4#3)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#3)(2007-6#1)(2007-7#8)(2007-8#4)(2007-9#3)(2008-1#3)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#2)(2008-4#1)(2008-5#12)(2008-7#3)(2008-8#1)(2009-4#9)(2009-6#3)(2009-8#2)(2009-9#2)(2010-1#6)(2010-11#3)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#3)(2010-7#4)(2010-8#1)(2011-1#2)(2011-2#11)(2012-1#1)(2012-12#10)(2012-2#3)(2012-3#4)(2013-1#5)(2013-7#1)
the face-processing##3##2##(2009-4#3)
the faces of##2##3##(1996-4#1)(2007-12#1)
the faces were##3##3##(2009-4#2)(2009-9#1)
the faces##11##2##(1992-5#1)(1996-4#1)(2007-12#1)(2009-4#4)(2009-9#2)(2010-10#2)
the facet joint##5##3##(1996-9#1)(2006-8#1)(2010-12#1)(2011-2#2)
the facet joints##4##3##(1996-9#2)(2009-3#1)(2013-8#1)
the facet##12##2##(1996-9#3)(2006-8#1)(2007-4#2)(2008-3#1)(2009-3#1)(2010-12#1)(2011-2#2)(2013-8#1)
the facets##4##2##(2008-2#2)(2008-3#1)(2008-4#1)
the facial and##2##3##(2006-11#1)(2006-2#1)
the facial bones##2##3##(2009-1#1)(2012-2#1)
the facial canal##2##3##(2008-9#1)(2011-2#1)
the facial defect##2##3##(2007-3#1)(2008-8#1)
the facial expression of##3##4##(1996-2#1)(2012-11#1)(2013-8#1)
the facial nerve and##2##4##(2008-9#1)(2011-2#1)
the facial nerve in the##2##5##(2006-11#1)(2008-7#1)
the facial nerve in##4##4##(2006-11#2)(2008-12#1)(2008-7#1)
the facial nerve##22##3##(1993-10#1)(2006-11#3)(2006-12#5)(2006-5#2)(2008-12#2)(2008-7#1)(2008-9#3)(2010-12#1)(2011-2#3)(2012-3#1)
the facial nucleus##4##3##(1993-12#3)(1996-5#1)
the facial skeleton##7##3##(1992-4#1)(2006-7#1)(2007-12#4)(2012-3#1)
the facial skin##6##3##(1990-4#1)(2008-5#5)
the facial soft tissues##2##4##(2008-7#1)(2009-9#1)
the facial##75##2##(1990-4#1)(1992-4#1)(1993-10#1)(1993-12#3)(1995-6#2)(1996-2#1)(1996-5#2)(1997-8#1)(2005-5#1)(2006-11#4)(2006-12#5)(2006-2#1)(2006-5#2)(2006-7#1)(2007-11#1)(2007-12#5)(2007-3#1)(2007-4#2)(2007-8#1)(2008-12#3)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#4)(2009-1#1)(2009-2#1)(2009-9#1)(2010-11#2)(2010-12#1)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
the facile##6##2##(1997-2#1)(2006-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-2#1)
the facilitated##2##2##(1993-2#1)(2010-5#1)
the facilitation of the##2##4##(1993-11#1)(1996-12#1)
the facilitation of##13##3##(1993-11#1)(1993-12#1)(1996-12#1)(2005-10#1)(2006-10#1)(2008-11#2)(2008-5#1)(2008-7#2)(2010-10#1)(2010-7#1)(2012-3#1)
the facilitation##16##2##(1993-11#1)(1993-12#1)(1996-12#1)(1997-5#1)(1997-7#1)(2005-10#1)(2006-10#1)(2008-11#2)(2008-5#1)(2008-7#2)(2010-10#1)(2010-7#1)(2011-12#1)(2012-3#1)
the facilitative##3##2##(1991-12#1)(2008-11#1)(2008-9#1)
the facilitator##4##2##(1993-12#1)(2008-11#1)(2008-12#2)
the facilitatory effect of##3##4##(1991-2#2)(1994-5#1)
the facilitatory effect##4##3##(1991-2#2)(1994-5#1)(1995-11#1)
the facilities##6##2##(1995-2#1)(2007-5#1)(2007-9#1)(2008-8#1)(2011-2#1)(2012-3#1)
the facility management staff##2##4##(1992-2#2)
the facility of##2##3##(1991-4#1)(2013-8#1)
the facility with which##4##4##(1997-5#1)(2008-7#1)(2013-1#2)
the facility##35##2##(1991-12#3)(1991-4#1)(1992-12#2)(1992-2#4)(1992-3#1)(1992-5#1)(1994-12#2)(1994-3#2)(1996-11#1)(1996-2#1)(1997-5#1)(2007-4#1)(2007-6#2)(2008-2#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
the fact is##2##3##(1995-2#1)(1996-8#1)
the fact of##4##3##(2008-10#1)(2008-2#1)(2008-4#1)(2012-3#1)
the fact that a fluorescent##2##5##(1993-9#1)(1997-2#1)
the fact that a number of papers appear to have been plagiarized from other previously published papers##3##17##(2008-10#3)
the fact that a##15##4##(1990-11#1)(1991-2#1)(1993-4#1)(1993-9#1)(1996-5#1)(1997-2#1)(2007-8#2)(2008-10#4)(2008-2#1)(2008-3#1)(2010-12#1)
the fact that all##3##4##(2006-10#1)(2007-5#1)(2008-1#1)
the fact that almost 40% of##2##6##(1990-9#1)(2009-5#1)
the fact that almost##3##4##(1990-9#1)(2007-10#1)(2009-5#1)
the fact that an##2##4##(1990-4#1)(2008-3#1)
the fact that both##6##4##(1991-7#1)(1996-3#1)(1997-5#1)(2008-10#1)(2009-10#1)(2009-7#1)
the fact that current##3##4##(2006-9#1)(2007-12#1)(2008-11#1)
the fact that different##2##4##(2008-11#1)(2008-2#1)
the fact that each##2##4##(1995-8#1)(2008-11#1)
the fact that few##2##4##(2006-12#1)(2007-11#1)
the fact that fitness/wellness programs##2##5##(1991-4#2)
the fact that for##2##4##(1994-6#1)(2011-2#1)
the fact that in##9##4##(1991-6#1)(1996-4#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2013-8#1)
the fact that it has##2##5##(1994-4#1)(2008-10#1)
the fact that it is##9##5##(1992-12#1)(1992-2#1)(1994-9#1)(2008-10#1)(2008-2#1)(2009-1#1)(2012-12#3)
the fact that it##17##4##(1990-3#1)(1992-12#1)(1992-2#1)(1994-4#1)(1994-9#1)(1997-8#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-1#1)(2012-12#3)(2012-2#1)
the fact that its##3##4##(1991-6#1)(1992-9#1)(2008-1#1)
the fact that many of these##2##6##(2006-10#1)(2010-3#1)
the fact that many of##3##5##(1995-11#1)(2006-10#1)(2010-3#1)
the fact that many##4##4##(1995-11#1)(2006-10#1)(2009-4#1)(2010-3#1)
the fact that most##3##4##(2008-1#2)(2008-10#1)
the fact that no##2##4##(1994-8#1)(2008-10#1)
the fact that only##2##4##(2008-10#1)(2011-2#1)
the fact that patients##2##4##(1992-8#1)(2008-6#1)
the fact that several##4##4##(1994-5#1)(2009-8#2)(2011-2#1)
the fact that some of##2##5##(1996-4#1)(2008-3#1)
the fact that some##11##4##(1992-10#1)(1996-4#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-4#1)(2012-12#2)(2013-8#2)
the fact that the cell##2##5##(2008-11#1)(2008-4#1)
the fact that the core##2##5##(1990-10#1)(2006-5#1)
the fact that the disease##2##5##(2006-10#1)(2007-5#1)
the fact that the number of##2##6##(2010-6#1)(2013-1#1)
the fact that the number##3##5##(1996-11#1)(2010-6#1)(2013-1#1)
the fact that the presence of##2##6##(2006-9#1)(2011-2#1)
the fact that the relevant##2##5##(2006-6#1)(2008-10#1)
the fact that the subject##2##5##(1990-2#1)(2008-12#1)
the fact that the two##2##5##(2007-9#1)(2008-5#1)
the fact that the##116##4##(1990-10#1)(1990-2#1)(1990-8#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-8#1)(1992-9#2)(1993-6#1)(1994-4#1)(1994-8#1)(1995-7#1)(1996-11#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-6#1)(2004-9#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-4#2)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#3)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#3)(2008-10#9)(2008-11#9)(2008-12#1)(2008-2#6)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2010-2#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-11#1)(2012-3#1)(2013-1#4)
the fact that their##2##4##(2010-10#1)(2013-1#1)
the fact that there are no##2##6##(2007-12#1)(2008-10#1)
the fact that there are##7##5##(2005-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#3)
the fact that there is no##3##6##(2006-2#1)(2013-1#2)
the fact that there is##6##5##(1993-9#1)(2006-2#1)(2007-7#1)(2009-8#1)(2013-1#2)
the fact that there##15##4##(1993-9#1)(2005-8#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-9#1)(2009-8#1)(2013-1#2)
the fact that these##12##4##(1990-2#1)(1992-10#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2011-1#1)(2013-7#1)(2013-8#4)
the fact that they are##5##5##(1992-3#1)(2006-10#1)(2008-11#1)(2008-3#1)(2010-9#1)
the fact that they##18##4##(1990-11#1)(1992-3#1)(1994-2#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2010-9#1)(2011-12#1)(2012-2#2)(2012-3#2)
the fact that this##6##4##(1994-3#1)(1996-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2011-1#1)
the fact that##452##3##(1990-10#2)(1990-11#3)(1990-12#1)(1990-2#3)(1990-3#2)(1990-4#2)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#3)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#5)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#1)(1992-1#2)(1992-10#2)(1992-12#3)(1992-2#1)(1992-3#4)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-11#1)(1993-3#1)(1993-4#3)(1993-5#1)(1993-6#1)(1993-9#5)(1994-12#1)(1994-2#2)(1994-3#3)(1994-4#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#3)(1995-5#2)(1995-6#2)(1995-7#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#1)(2004-9#2)(2005-10#1)(2005-11#2)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#10)(2006-11#1)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#5)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#12)(2007-2#3)(2007-3#1)(2007-5#5)(2007-6#3)(2007-7#3)(2007-8#10)(2007-9#4)(2008-1#7)(2008-10#40)(2008-11#19)(2008-12#1)(2008-2#13)(2008-3#10)(2008-4#9)(2008-5#10)(2008-6#4)(2008-7#7)(2008-8#5)(2008-9#10)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#4)(2009-5#1)(2009-7#1)(2009-8#5)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#5)(2011-12#3)(2011-2#10)(2011-3#1)(2012-1#3)(2012-11#2)(2012-12#5)(2012-2#11)(2012-3#3)(2013-1#13)(2013-7#1)(2013-8#8)
the fact##462##2##(1990-10#2)(1990-11#3)(1990-12#1)(1990-2#3)(1990-3#2)(1990-4#2)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#3)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#5)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#1)(1992-1#2)(1992-10#2)(1992-12#4)(1992-2#1)(1992-3#4)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-11#1)(1993-3#1)(1993-4#3)(1993-5#1)(1993-6#1)(1993-9#5)(1994-12#1)(1994-2#2)(1994-3#3)(1994-4#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#3)(1995-2#1)(1995-5#2)(1995-6#2)(1995-7#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#1)(2004-9#2)(2005-10#1)(2005-11#2)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#10)(2006-11#1)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#5)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#12)(2007-2#3)(2007-3#1)(2007-5#5)(2007-6#3)(2007-7#4)(2007-8#10)(2007-9#4)(2008-1#7)(2008-10#41)(2008-11#19)(2008-12#1)(2008-2#15)(2008-3#10)(2008-4#10)(2008-5#10)(2008-6#4)(2008-7#7)(2008-8#5)(2008-9#10)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#4)(2009-5#1)(2009-7#1)(2009-8#5)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#5)(2011-12#3)(2011-2#11)(2011-3#1)(2012-1#3)(2012-11#2)(2012-12#5)(2012-2#11)(2012-3#4)(2013-1#13)(2013-7#1)(2013-8#8)
the factitious disorders##4##3##(2006-3#4)
the factor IX##3##3##(1990-11#2)(1990-5#1)
the factor VIII gene##5##4##(1991-12#1)(1992-10#1)(2008-12#2)(2012-2#1)
the factor VIII##6##3##(1991-12#2)(1992-10#1)(2008-12#2)(2012-2#1)
the factor Va##2##3##(1990-11#1)(1994-5#1)
the factor X(a) cleavage site##2##5##(1996-2#2)
the factor X(a)##3##3##(1996-2#3)
the factor analysis##2##3##(2008-10#1)(2008-6#1)
the factor is##3##3##(1990-11#1)(1993-6#1)(2008-2#1)
the factor of##3##3##(1995-12#1)(2008-10#1)(2008-11#1)
the factor responsible for##2##4##(1995-12#1)(2008-11#1)
the factor score of##2##4##(1997-8#2)
the factor scores##3##3##(2004-11#1)(2010-12#2)
the factor sera##3##3##(1994-5#3)
the factor structure of the##3##5##(2008-10#1)(2009-5#1)(2012-1#1)
the factor structure##4##3##(2008-10#1)(2009-5#1)(2012-1#2)
the factor that##2##3##(2007-8#1)(2008-1#1)
the factor##64##2##(1990-11#5)(1990-2#2)(1990-5#1)(1990-7#1)(1991-10#1)(1991-12#2)(1991-3#1)(1992-10#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-6#2)(1994-11#1)(1994-3#1)(1994-5#4)(1995-10#1)(1995-12#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#4)(1996-3#1)(1996-7#1)(1997-8#2)(2004-11#1)(2006-10#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#2)(2012-1#2)(2012-2#1)
the factor(s) that##2##3##(1993-11#1)(2006-9#1)
the factor(s)##6##2##(1990-10#1)(1992-12#2)(1993-11#2)(2006-9#1)
the factorial structure of the##2##5##(2010-9#1)(2012-1#1)
the factorial##3##2##(2010-9#2)(2012-1#1)
the factories in the##2##4##(1994-6#2)
the factories in##3##3##(1994-6#2)(2008-8#1)
the factors affecting the##12##4##(1996-7#1)(1997-6#1)(2008-10#5)(2008-3#1)(2008-7#2)(2013-7#1)(2013-8#1)
the factors affecting their##3##4##(2007-8#1)(2008-10#1)(2010-4#1)
the factors affecting##22##3##(1990-12#1)(1990-6#1)(1996-7#1)(1997-6#1)(2007-10#1)(2007-8#1)(2008-10#7)(2008-3#1)(2008-7#3)(2010-4#1)(2011-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
the factors and mechanisms##2##4##(2007-12#1)(2010-3#1)
the factors and##5##3##(2007-12#1)(2008-10#2)(2010-3#1)(2011-1#1)
the factors associated with it##2##5##(2011-2#1)(2012-2#1)
the factors associated with the##4##5##(1994-12#1)(2008-1#1)(2011-2#1)(2013-1#1)
the factors associated with their##2##5##(1995-3#1)(2009-7#1)
the factors associated with##18##4##(1991-9#1)(1994-12#1)(1995-3#1)(2007-10#1)(2007-12#1)(2008-1#1)(2009-7#1)(2010-4#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
the factors contributing to the##3##5##(1991-1#1)(2009-12#1)(2009-4#1)
the factors contributing to##11##4##(1991-1#1)(1994-12#1)(2007-3#1)(2008-10#1)(2008-4#1)(2009-12#1)(2009-4#1)(2011-1#1)(2012-12#2)(2012-3#1)
the factors determining the##2##4##(1996-11#1)(2006-10#1)
the factors determining##3##3##(1992-3#1)(1996-11#1)(2006-10#1)
the factors driving##3##3##(1991-3#1)(2005-8#1)(2008-8#1)
the factors for##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
the factors in##3##3##(1997-8#1)(2009-5#1)(2009-6#1)
the factors influencing the##4##4##(1990-8#1)(2007-1#1)(2008-2#1)(2010-12#1)
the factors influencing##15##3##(1990-8#1)(1996-2#1)(2004-10#1)(2007-1#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)(2013-1#1)
the factors involved in the##6##5##(1993-2#1)(1995-1#1)(1996-9#1)(1997-6#1)(2009-6#1)(2011-2#1)
the factors involved in##11##4##(1992-9#1)(1993-2#1)(1995-1#1)(1996-9#1)(1997-6#1)(2004-12#1)(2008-1#1)(2008-2#1)(2008-6#1)(2009-6#1)(2011-2#1)
the factors involved##15##3##(1992-2#1)(1992-9#1)(1993-2#1)(1995-1#1)(1996-9#1)(1997-6#1)(2004-12#1)(2005-10#1)(2008-1#1)(2008-2#1)(2008-6#1)(2009-5#1)(2009-6#2)(2011-2#1)
the factors limiting##2##3##(2008-2#1)(2008-7#1)
the factors of##5##3##(1996-3#1)(2008-10#2)(2010-1#1)(2010-2#1)
the factors responsible for the##3##5##(2006-12#1)(2008-12#1)(2009-4#1)
the factors responsible for##9##4##(1992-12#1)(1995-12#1)(1997-4#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-12#1)(2009-4#1)(2013-8#1)
the factors that are important for##2##6##(2008-8#1)(2012-1#1)
the factors that are important##3##5##(2007-6#1)(2008-8#1)(2012-1#1)
the factors that are##9##4##(1992-2#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-8#1)(2011-2#1)(2012-1#1)(2013-1#2)
the factors that can lead to##2##6##(1992-1#1)(2012-10#1)
the factors that can##4##4##(1992-1#1)(2007-3#1)(2012-10#1)(2013-1#1)
the factors that contribute to the##2##6##(2006-10#1)(2011-1#1)
the factors that contribute to##6##5##(2006-10#2)(2007-7#1)(2007-8#1)(2008-12#1)(2011-1#1)
the factors that determine the##2##5##(1997-4#1)(2011-1#1)
the factors that determine##3##4##(1997-4#1)(2008-7#1)(2011-1#1)
the factors that distinguish##2##4##(2008-4#1)(2010-8#1)
the factors that have##3##4##(1996-2#1)(2012-2#1)(2013-1#1)
the factors that influence the##11##5##(1991-11#1)(1992-2#1)(1995-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-6#1)(2010-10#1)(2011-1#1)(2012-12#1)
the factors that influence this##2##5##(2007-3#1)(2008-8#1)
the factors that influence##18##4##(1991-11#1)(1992-2#1)(1995-2#1)(1997-3#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-3#1)
the factors that influenced the##2##5##(1990-10#1)(1991-2#1)
the factors that influenced##3##4##(1990-10#1)(1991-2#1)(2006-9#1)
the factors that initiate##2##4##(2007-8#1)(2008-9#1)
the factors that led##2##4##(2006-11#1)(2008-8#1)
the factors that may##5##4##(1993-1#1)(1997-2#1)(2007-1#1)(2007-9#1)(2010-2#1)
the factors that predispose##2##4##(2008-10#1)(2013-8#1)
the factors that will##2##4##(1997-1#1)(2006-12#1)
the factors that##95##3##(1990-10#1)(1991-11#1)(1991-2#1)(1992-1#1)(1992-2#2)(1993-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-3#3)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#5)(2009-10#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-1#2)(2012-10#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#1)
the factors were##2##3##(2006-7#1)(2012-1#1)
the factors which influence##4##4##(1995-4#1)(2007-6#1)(2007-8#1)(2010-9#1)
the factors which may##3##4##(1990-12#1)(1996-3#1)(2005-11#1)
the factors which were##2##4##(1992-1#1)(2011-2#1)
the factors which##20##3##(1990-12#1)(1992-1#1)(1992-6#1)(1995-4#1)(1996-3#1)(1996-7#1)(2005-11#1)(2007-10#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-7#2)(2010-2#1)(2010-9#2)(2011-2#1)(2013-1#2)(2013-8#1)
the factors##272##2##(1990-10#1)(1990-12#3)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#4)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#2)(1994-6#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-4#1)(1996-11#1)(1996-2#2)(1996-3#2)(1996-7#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#3)(1997-8#1)(2004-10#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-4#1)(2006-7#2)(2006-9#1)(2007-1#2)(2007-10#5)(2007-11#3)(2007-12#4)(2007-3#4)(2007-6#2)(2007-7#3)(2007-8#7)(2007-9#3)(2008-1#7)(2008-10#22)(2008-11#1)(2008-12#3)(2008-2#4)(2008-3#5)(2008-4#6)(2008-5#3)(2008-6#2)(2008-7#9)(2008-8#7)(2008-9#6)(2009-10#1)(2009-12#1)(2009-4#3)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#5)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#8)(2011-2#8)(2012-1#4)(2012-10#1)(2012-12#12)(2012-2#4)(2012-3#3)(2013-1#13)(2013-7#1)(2013-8#4)
the factory##7##2##(1993-6#1)(2004-4#1)(2005-4#1)(2006-8#1)(2007-9#1)(2008-10#1)(2009-3#1)
the facts that##4##3##(1993-11#1)(2007-2#1)(2008-10#1)(2010-7#1)
the facts##14##2##(1992-3#1)(1993-11#1)(1994-1#1)(1995-1#1)(2006-4#1)(2007-2#1)(2007-4#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-1#1)
the factual##2##2##(1994-2#1)(2006-7#1)
the facultative##4##2##(1990-5#1)(1991-2#1)(1991-8#1)(2008-12#1)
the faculty members##2##3##(2007-4#1)(2012-2#1)
the faculty##13##2##(1992-1#1)(1993-2#1)(1996-1#1)(2004-12#1)(2006-10#1)(2006-5#2)(2007-4#1)(2009-10#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-8#1)
the fade##2##2##(2008-2#2)
the fading##2##2##(1991-3#1)(2008-2#1)
the faecal occult blood test##3##5##(1993-8#2)(2011-1#1)
the faecal occult blood##4##4##(1993-8#3)(2011-1#1)
the faecal##7##2##(1993-8#3)(2008-11#1)(2008-5#2)(2011-1#1)
the faeces of##8##3##(1993-2#1)(1996-12#1)(2005-7#1)(2006-5#1)(2006-8#1)(2008-11#1)(2008-5#2)
the faeces##14##2##(1993-2#1)(1995-4#1)(1996-12#1)(2005-11#1)(2005-7#1)(2006-5#1)(2006-8#2)(2008-11#1)(2008-5#3)(2008-7#1)(2010-8#1)
the failed##7##2##(1993-12#1)(1995-2#1)(2006-10#2)(2008-11#1)(2008-12#1)(2008-6#1)
the failing heart in##2##4##(2005-10#1)(2011-2#1)
the failing heart##11##3##(1994-3#1)(2005-10#2)(2005-7#1)(2008-10#1)(2009-10#1)(2009-12#1)(2010-11#1)(2010-8#1)(2011-2#2)
the failing##15##2##(1994-3#1)(2005-10#3)(2005-7#1)(2007-9#1)(2008-10#1)(2009-10#1)(2009-12#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-2#3)
the failure and##2##3##(2009-2#1)(2013-8#1)
the failure of a##2##4##(1991-2#1)(2005-8#1)
the failure of many##3##4##(2006-11#1)(2013-1#2)
the failure of one or more##2##6##(1996-4#1)(2012-1#1)
the failure of the##10##4##(1990-11#1)(1990-9#1)(1991-1#1)(1995-5#1)(1996-2#1)(2007-11#1)(2008-5#1)(2008-8#2)(2010-12#1)
the failure of##54##3##(1990-11#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#2)(1991-7#1)(1992-12#2)(1992-7#1)(1994-3#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#2)(1996-4#2)(1997-3#2)(2004-11#1)(2004-9#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#2)(2010-10#1)(2010-12#3)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
the failure or##2##3##(1990-12#1)(2008-11#1)
the failure to find evidence##2##5##(2007-5#2)
the failure to identify##3##4##(1996-2#1)(2008-2#1)(2008-3#1)
the failure to treat##2##4##(2008-11#1)(2012-12#1)
the failure to##15##3##(1991-12#1)(1996-2#1)(2007-5#2)(2007-7#1)(2008-11#2)(2008-2#1)(2008-3#1)(2009-2#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#2)
the failure##87##2##(1990-11#1)(1990-12#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-7#1)(1992-12#2)(1992-7#1)(1994-3#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#3)(1996-3#1)(1996-4#2)(1997-3#2)(2004-11#1)(2004-9#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-4#2)(2007-5#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#6)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#4)(2008-9#2)(2009-2#3)(2009-3#1)(2009-7#2)(2010-10#1)(2010-12#4)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#2)
the faint##2##2##(2008-10#1)(2008-2#1)
the fair##3##2##(1993-3#1)(2006-4#1)(2008-4#1)
the fairly##3##2##(1991-4#1)(2009-5#1)(2011-1#1)
the faith##2##2##(2008-1#1)(2008-12#1)
the falciform ligament##5##3##(2008-3#3)(2009-2#1)(2012-1#1)
the fall and rise of##2##5##(1990-7#1)(2007-11#1)
the fall and##3##3##(1990-7#1)(2007-11#1)(2008-8#1)
the fall in##7##3##(1991-5#1)(1992-2#1)(1993-11#1)(1995-5#1)(2008-7#1)(2013-1#2)
the fall of 1994##3##4##(1995-5#1)(2008-10#2)
the fall of 1995 and 1996##2##6##(2008-10#2)
the fall of 2002##2##4##(2007-2#1)(2008-8#1)
the fall of 2009##2##4##(2010-12#1)(2011-9#1)
the fall of the##2##4##(2007-8#1)(2008-5#1)
the fall of##18##3##(1991-2#1)(1995-5#1)(1996-1#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-9#1)(2012-2#1)(2012-3#1)
the fall prevention##4##3##(2013-1#4)
the fall##52##2##(1990-2#1)(1990-7#1)(1991-2#2)(1991-5#1)(1992-2#1)(1993-11#1)(1994-2#1)(1995-2#2)(1995-5#2)(1996-1#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#3)(2008-10#9)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#3)(2009-11#1)(2010-10#1)(2010-12#1)(2011-9#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#1)
the fallacy of##2##3##(1995-1#1)(2009-4#1)
the fallacy##4##2##(1995-1#1)(2006-12#1)(2009-4#1)(2011-2#1)
the falling##3##2##(1996-2#1)(2005-11#1)(2012-1#1)
the fallopian tube##11##3##(1991-3#1)(1992-1#2)(1992-12#1)(1993-2#1)(1994-7#1)(2007-9#1)(2008-6#1)(2009-6#1)(2013-8#2)
the fallopian##14##2##(1991-12#1)(1991-3#1)(1992-1#2)(1992-12#1)(1993-2#1)(1994-7#1)(2007-9#1)(2008-6#2)(2008-7#1)(2009-6#1)(2013-8#2)
the fallout##3##2##(1992-4#1)(2009-12#2)
the false discovery rate##2##4##(2012-3#2)
the false lumen##4##3##(2007-8#1)(2008-11#2)(2011-2#1)
the false positive results##2##4##(1997-4#1)(2007-11#1)
the false positive##5##3##(1997-4#2)(2006-4#1)(2007-11#1)(2011-1#1)
the false##19##2##(1997-4#2)(2006-4#1)(2007-11#1)(2007-5#2)(2007-8#2)(2008-11#2)(2008-3#2)(2008-6#1)(2011-1#2)(2011-2#1)(2012-3#3)
the false-negative##2##2##(2006-10#1)(2012-2#1)
the false-positive reactions or cross-reactions##2##5##(2005-10#2)
the false-positive##4##2##(2005-10#2)(2008-7#1)(2012-3#1)
the familial aggregation of MS##2##5##(2011-1#2)
the familial form of##2##4##(1996-10#1)(1997-3#1)
the familial##20##2##(1990-3#1)(1990-9#1)(1992-12#1)(1992-3#1)(1996-10#1)(1997-3#1)(1997-5#2)(2004-12#1)(2007-10#1)(2008-6#1)(2008-7#1)(2010-4#1)(2011-1#3)(2012-12#1)(2012-3#2)(2013-1#1)
the familiar##17##2##(1990-11#1)(1991-9#1)(1994-1#1)(1995-12#1)(1997-6#1)(2006-12#1)(2007-3#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-4#1)(2010-2#2)(2012-3#2)
the familiarity of the##2##4##(1993-3#1)(2011-1#1)
the familiarity of##5##3##(1993-3#1)(2008-1#1)(2009-4#2)(2011-1#1)
the families of Type II alcoholics##2##6##(1994-2#2)
the families of Type##3##4##(1994-2#3)
the families of##13##3##(1991-8#1)(1994-2#4)(1996-6#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-4#1)(2010-1#1)(2010-10#1)(2011-2#1)
the families##39##2##(1991-11#1)(1991-8#1)(1992-3#1)(1994-2#4)(1996-5#2)(1996-6#1)(1997-2#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-4#3)(2008-5#1)(2008-6#1)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-8#2)
the family Actinomycetaceae##2##3##(2011-2#2)
the family Amaranthaceae##2##3##(2008-10#2)
the family Aquificaceae##2##3##(2011-2#2)
the family Araceae##5##3##(2008-10#5)
the family Comoviridae##2##3##(2008-10#2)
the family Cucurbitaceae##7##3##(2008-10#7)
the family Enterobacteriaceae##6##3##(2008-10#2)(2008-11#1)(2008-4#1)(2010-6#2)
the family Ferrimonadaceae##2##3##(2011-2#2)
the family Intrasporangiaceae##2##3##(2011-2#2)
the family Nocardiopsaceae##2##3##(2011-2#2)
the family Pasteurellaceae Pohl 1981##2##5##(2008-5#2)
the family Potyviridae##10##3##(2008-10#10)
the family Reoviridae##3##3##(1997-4#1)(2008-10#2)
the family Spirochaetaceae##3##3##(2011-2#3)
the family Synergistaceae##5##3##(2011-2#5)
the family Thermoproteaceae##2##3##(2011-2#2)
the family and its##2##4##(2004-12#1)(2013-1#1)
the family and the patient##2##5##(2009-6#1)(2011-12#1)
the family and the##7##4##(1996-11#1)(2006-1#1)(2007-12#1)(2007-7#1)(2009-12#1)(2009-6#1)(2011-12#1)
the family and those##2##4##(1991-4#1)(2008-4#1)
the family and##25##3##(1990-8#1)(1991-4#1)(1995-1#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-8#1)(2004-12#1)(2005-11#1)(2006-1#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-12#2)(2009-5#1)(2009-6#1)(2011-12#1)(2012-12#2)(2013-1#1)(2013-7#1)
the family are##4##3##(1997-4#1)(1997-6#1)(2008-12#1)(2011-1#1)
the family as a whole##3##5##(2007-7#1)(2008-7#1)(2009-8#1)
the family as a##6##4##(1990-12#1)(2007-7#1)(2008-7#1)(2009-8#3)
the family as##7##3##(1990-12#1)(1993-12#1)(2007-7#1)(2008-7#1)(2009-8#3)
the family context##2##3##(1994-3#1)(2008-9#1)
the family doctor##4##3##(1990-3#1)(1996-9#1)(2006-12#1)(2010-12#1)
the family environment##3##3##(1991-6#1)(2008-7#1)(2012-3#1)
the family health##2##3##(2011-2#1)(2012-3#1)
the family history##7##3##(1993-5#1)(1997-8#1)(2007-2#1)(2008-5#1)(2011-2#1)(2013-1#2)
the family in##5##3##(1991-2#1)(1992-1#1)(2005-7#1)(2008-1#1)(2008-8#1)
the family medicine##3##3##(1995-10#1)(2011-2#2)
the family members of##2##4##(2010-8#1)(2011-2#1)
the family members##9##3##(1990-10#1)(1997-3#1)(2006-8#1)(2006-9#1)(2007-7#1)(2008-11#1)(2010-8#1)(2011-2#1)(2012-2#1)
the family of mammalian##2##4##(1995-3#2)
the family of##57##3##(1990-10#2)(1990-4#1)(1990-8#2)(1991-12#1)(1991-2#2)(1992-11#2)(1992-12#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-2#1)(1995-3#2)(1995-6#4)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-4#1)(1997-7#1)(2004-2#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#2)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)
the family physician and##2##4##(1993-12#1)(1993-3#1)
the family physician##8##3##(1991-2#1)(1993-12#1)(1993-3#1)(1995-11#1)(1995-9#2)(1997-4#2)
the family physician]##2##3##(1996-8#1)(1996-9#1)
the family planning##4##3##(1992-2#1)(2004-10#1)(2006-4#1)(2007-7#1)
the family potyviridae##2##3##(2008-10#2)
the family system##3##3##(2009-11#1)(2013-1#2)
the family to##2##3##(1991-2#1)(2009-8#1)
the family unit is##3##4##(2007-7#2)(2008-11#1)
the family was##2##3##(1997-5#1)(2013-7#1)
the family were##3##3##(1990-8#1)(2006-10#1)(2007-6#1)
the family##428##2##(1990-10#3)(1990-11#1)(1990-12#3)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#4)(1991-11#1)(1991-12#2)(1991-2#5)(1991-4#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#3)(1992-5#1)(1992-6#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#2)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-1#5)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#3)(1995-6#4)(1995-8#3)(1995-9#3)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#2)(1997-2#4)(1997-3#2)(1997-4#8)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-10#1)(2004-12#1)(2004-2#2)(2005-10#1)(2005-11#2)(2005-12#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#4)(2006-12#6)(2006-4#1)(2006-6#1)(2006-8#4)(2006-9#1)(2007-1#2)(2007-10#1)(2007-12#4)(2007-2#2)(2007-3#6)(2007-5#1)(2007-6#4)(2007-7#8)(2007-9#1)(2008-1#3)(2008-10#49)(2008-11#4)(2008-12#5)(2008-2#3)(2008-3#2)(2008-4#8)(2008-5#13)(2008-6#3)(2008-7#7)(2008-8#2)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#7)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#3)(2010-6#5)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#4)(2011-12#3)(2011-2#62)(2012-1#2)(2012-12#10)(2012-2#9)(2012-3#8)(2013-1#6)(2013-7#3)(2013-8#3)
the family's##11##2##(1992-3#1)(1993-12#1)(1994-5#1)(1995-1#2)(2006-4#1)(2008-5#1)(2008-7#1)(2009-6#2)(2010-6#1)
the family)##2##2##(1991-4#1)(2011-2#1)
the family-wise error rate##2##4##(2009-9#1)(2012-3#1)
the famous##7##2##(1991-6#1)(1994-3#3)(2006-9#1)(2009-7#1)(2013-7#1)
the fan-beam DT##2##3##(2008-3#2)
the fan-beam geometry##2##3##(2008-3#1)(2009-5#1)
the fan-beam##4##2##(2008-3#3)(2009-5#1)
the fan-out##2##2##(2008-2#1)(2008-3#1)
the fanning##2##2##(2007-12#1)(2008-3#1)
the fantail and eggfish##3##4##(2010-8#3)
the fantail##4##2##(2010-8#4)
the far field by##2##4##(2007-12#1)(2008-2#1)
the far field is##2##4##(2007-12#1)(2008-3#1)
the far field of a##5##5##(2007-11#2)(2007-12#1)(2008-2#2)
the far field of the##3##5##(2008-2#3)
the far field of##9##4##(2007-11#2)(2007-12#1)(2008-2#6)
the far field##32##3##(2007-11#4)(2007-12#10)(2008-2#13)(2008-3#5)
the far infrared##6##3##(2007-11#1)(2008-1#2)(2008-3#3)
the far##47##2##(1992-1#1)(1992-7#1)(1993-10#1)(2007-11#6)(2007-12#11)(2008-1#2)(2008-10#1)(2008-2#14)(2008-3#9)(2008-7#1)
the far-UV CD##2##3##(1991-4#1)(2009-5#1)
the far-UV region##2##3##(1994-11#2)
the far-UV##4##2##(1991-4#1)(1994-11#2)(2009-5#1)
the far-field beam##2##3##(2008-2#1)(2008-3#1)
the far-field diffraction pattern##2##4##(2008-3#2)
the far-field diffraction##3##3##(2008-3#3)
the far-field expression##2##3##(2008-2#1)(2008-3#1)
the far-field irradiance pattern##2##4##(2008-2#2)
the far-field irradiance##3##3##(2008-2#3)
the far-field pattern##2##3##(2007-11#1)(2007-12#1)
the far-field performance of##2##4##(2007-12#1)(2008-3#1)
the far-field scattering##3##3##(2008-2#1)(2008-3#2)
the far-field##35##2##(2007-11#2)(2007-12#7)(2008-2#11)(2008-3#15)
the far-ultraviolet##2##2##(1992-9#1)(2008-2#1)
the farm that##2##3##(1994-3#1)(2007-7#1)
the farm was##2##3##(1993-2#1)(2007-6#1)
the farm workers##2##3##(2007-7#1)(2011-2#1)
the farm##18##2##(1990-9#1)(1992-10#1)(1993-2#1)(1994-3#1)(1994-7#1)(2007-6#1)(2007-7#3)(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-2#1)(2010-4#1)(2011-1#1)(2011-2#1)
the farmer##4##2##(1995-11#1)(1997-7#1)(2008-12#2)
the farmers##4##2##(1993-8#2)(2011-1#2)
the farming##2##2##(2008-10#1)(2008-12#1)
the farms##4##2##(1992-10#1)(1996-12#2)(2008-4#1)
the farnesylated##2##2##(1992-9#1)(2008-10#1)
the farnesylation of##2##3##(1995-1#1)(1996-4#1)
the fascia and##2##3##(2009-6#2)
the fascia##9##2##(2008-6#1)(2009-1#3)(2009-6#2)(2009-9#1)(2010-7#1)(2012-2#1)
the fascial##3##2##(2008-9#1)(2010-12#1)(2012-2#1)
the fascinating##2##2##(2010-7#1)(2012-2#1)
the fast Fourier transform##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
the fast and slow##2##4##(1995-1#1)(2008-3#1)
the fast and##5##3##(1993-2#1)(1995-1#1)(1996-6#1)(2008-3#1)(2008-7#1)
the fast component##2##3##(2007-12#1)(2008-3#1)
the fast computation of##2##4##(2008-3#2)
the fast decrease##2##3##(1992-5#1)(1993-12#1)
the fast development of##2##4##(2005-10#1)(2011-2#1)
the fast form##2##3##(1991-7#1)(1997-2#1)
the fast phase##3##3##(1990-10#1)(1991-2#1)(1994-11#1)
the fast rate varied from##2##5##(2008-9#2)
the fast rate##4##3##(1997-7#1)(2008-9#3)
the fast relaxation##2##3##(1995-1#1)(2007-3#1)
the fast to slow##2##4##(1991-7#2)
the fast##84##2##(1990-10#1)(1990-2#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-7#3)(1992-11#1)(1992-5#1)(1993-12#1)(1993-2#1)(1994-11#2)(1994-12#1)(1994-6#1)(1995-1#2)(1995-2#1)(1995-3#1)(1996-5#3)(1996-6#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-12#7)(2007-3#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#5)(2008-3#12)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#1)(2010-12#1)(2011-1#4)(2011-2#1)(2012-3#2)(2013-8#1)
the fast-EPSP was elicited in##2##5##(1997-5#2)
the fast-EPSP was##3##3##(1997-5#3)
the fast-EPSP##7##2##(1997-5#7)
the fast-Fourier-transform algorithm##2##3##(2008-2#1)(2008-3#1)
the faster##10##2##(1992-10#1)(1995-3#1)(1996-2#1)(2004-9#1)(2008-10#3)(2008-3#1)(2008-9#1)(2010-5#1)
the fastest growing##9##3##(1994-3#1)(2005-8#2)(2006-10#1)(2006-11#1)(2007-5#1)(2008-1#1)(2008-11#1)(2013-8#1)
the fastest kinetics##2##3##(1993-11#1)(2012-2#1)
the fastest rate##2##3##(2008-10#2)
the fastest##31##2##(1990-4#1)(1990-9#1)(1993-11#1)(1994-3#1)(1995-3#1)(2005-8#2)(2006-10#1)(2006-11#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#2)(2010-3#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
the fastest-growing##2##2##(1997-5#1)(2011-2#1)
the fasting and##2##3##(2008-3#1)(2013-7#1)
the fasting blood glucose##2##4##(2007-2#1)(2009-8#1)
the fasting blood##3##3##(2006-6#1)(2007-2#1)(2009-8#1)
the fasting glucose##2##3##(1991-7#1)(2008-1#1)
the fasting state##3##3##(1991-5#1)(1995-2#1)(2008-6#1)
the fasting##16##2##(1990-4#1)(1991-5#1)(1991-7#1)(1992-6#1)(1995-2#1)(2005-8#1)(2006-6#1)(2007-2#1)(2008-1#2)(2008-3#1)(2008-6#1)(2009-8#1)(2013-7#3)
the fat body of##2##4##(2007-12#2)
the fat body##7##3##(1990-10#2)(1994-12#1)(2007-12#2)(2011-1#1)(2013-1#1)
the fat cells and##2##4##(2007-12#1)(2012-2#1)
the fat content##5##3##(2008-10#4)(2010-4#1)
the fat deposition in the##2##5##(2006-2#1)(2008-3#1)
the fat locus##2##3##(1991-11#2)
the fat reserves##2##3##(2009-5#1)(2013-1#1)
the fat##45##2##(1990-10#2)(1991-10#1)(1991-11#3)(1992-3#1)(1994-12#1)(1995-12#1)(1995-2#3)(1995-4#1)(1995-7#1)(1996-2#1)(1997-3#1)(1997-4#1)(2004-9#1)(2006-2#1)(2007-10#1)(2007-12#3)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#2)
the fatal fungal##2##3##(2010-12#2)
the fatal outcome in the##2##5##(2007-8#1)(2011-2#1)
the fatal outcome##4##3##(2007-3#1)(2007-8#1)(2011-1#1)(2011-2#1)
the fatal##15##2##(1990-2#1)(1992-9#1)(1993-3#1)(2007-12#1)(2007-3#1)(2007-8#2)(2008-7#2)(2010-12#2)(2010-4#2)(2011-1#1)(2011-2#1)
the fatality rate in##2##4##(2007-10#1)(2007-11#1)
the fatality rate##3##3##(2007-10#2)(2007-11#1)
the fatality##5##2##(2007-10#2)(2007-11#1)(2008-12#1)(2012-12#1)
the fate and transport of##2##5##(2005-11#1)(2006-10#1)
the fate and##4##3##(2005-11#1)(2005-12#1)(2006-10#1)(2008-10#1)
the fate of exogenous##2##4##(2005-8#1)(2008-3#1)
the fate of the##4##4##(2006-12#1)(2008-10#3)
the fate of##41##3##(1990-7#2)(1991-11#2)(1991-6#1)(1992-11#1)(1993-11#1)(1994-3#2)(1995-1#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-8#1)(2004-11#1)(2005-8#2)(2006-10#1)(2006-12#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#1)(2012-2#1)
the fate##46##2##(1990-7#2)(1991-11#2)(1991-6#1)(1992-11#1)(1993-11#1)(1994-3#2)(1995-1#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-8#1)(2004-11#1)(2005-11#1)(2005-12#1)(2005-8#2)(2006-10#2)(2006-12#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#1)(2012-2#1)
the fates of##2##3##(1995-8#1)(2009-5#1)
the father of British microbiology##2##5##(2011-1#2)
the father of the##2##4##(1990-11#1)(2012-12#1)
the father of##7##3##(1990-11#1)(2006-6#1)(2008-10#2)(2011-1#2)(2012-12#1)
the father##13##2##(1990-11#1)(1994-12#1)(1996-12#1)(1996-6#1)(2006-12#1)(2006-6#1)(2008-10#2)(2011-1#2)(2012-12#2)(2012-3#1)
the father's##2##2##(1991-7#1)(2007-2#1)
the fathers of the##3##4##(1994-6#2)(2012-2#1)
the fathers##6##2##(1994-6#2)(2009-5#1)(2010-3#2)(2012-2#1)
the fatigue properties of##2##4##(2004-9#1)(2009-7#1)
the fatigue protocol##2##3##(2013-8#2)
the fatigue##9##2##(1992-2#1)(2004-9#1)(2008-7#1)(2009-7#3)(2013-8#3)
the fatty acid composition and##2##5##(1991-7#1)(1996-9#1)
the fatty acid composition of the##5##6##(1991-12#1)(1991-7#1)(1992-10#1)(1994-8#1)(2010-4#1)
the fatty acid composition of##11##5##(1991-12#1)(1991-7#2)(1992-10#1)(1992-12#1)(1994-8#1)(1996-4#1)(1996-9#1)(2010-4#2)(2011-1#1)
the fatty acid composition##17##4##(1991-12#1)(1991-7#3)(1992-10#1)(1992-12#1)(1994-8#1)(1996-4#2)(1996-9#2)(2007-12#1)(2010-4#3)(2010-8#1)(2011-1#1)
the fatty acid compositions of##2##5##(1996-4#1)(2004-11#1)
the fatty acid is##2##4##(1995-8#1)(2005-11#1)
the fatty acid pattern of##2##5##(2010-10#1)(2011-1#1)
the fatty acid profile in rabbits##2##6##(2010-4#2)
the fatty acid profile in##3##5##(2007-8#1)(2010-4#2)
the fatty acid profile##4##4##(2007-8#1)(2010-4#2)(2012-2#1)
the fatty acid##48##3##(1990-11#2)(1990-2#1)(1991-12#2)(1991-3#1)(1991-7#3)(1992-10#1)(1992-11#2)(1992-12#1)(1992-3#1)(1993-2#2)(1993-9#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-3#1)(1996-4#3)(1996-9#2)(2004-11#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-10#1)(2010-12#1)(2010-4#5)(2010-8#1)(2011-1#2)(2012-2#2)(2013-1#1)
the fatty acids##10##3##(1991-6#1)(1991-7#1)(1992-11#1)(1994-5#2)(2007-3#1)(2008-10#2)(2010-9#1)(2011-1#1)
the fatty acyl##4##3##(1991-5#1)(1995-1#1)(1996-5#2)
the fatty tissue##3##3##(1990-10#1)(2012-1#2)
the fatty##68##2##(1990-10#1)(1990-11#2)(1990-2#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#4)(1992-10#1)(1992-11#4)(1992-12#1)(1992-3#1)(1993-2#3)(1993-9#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-3#1)(1996-4#3)(1996-5#2)(1996-9#2)(2004-11#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#3)(2008-5#1)(2010-10#1)(2010-12#1)(2010-4#5)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-1#2)(2012-2#2)(2013-1#1)
the fatty-acid##2##2##(2008-10#1)(2008-7#1)
the fault with an accuracy of##2##6##(2008-3#2)
the fault zone##5##3##(1996-4#5)
the fault##19##2##(1991-12#1)(1991-3#1)(1996-4#13)(2007-9#2)(2008-3#2)
the fauna of##3##3##(2008-5#1)(2009-2#1)(2013-1#1)
the fauna##5##2##(2006-12#1)(2008-5#1)(2009-2#2)(2013-1#1)
the favorable##13##2##(1990-6#1)(1990-8#1)(1993-9#1)(1997-1#1)(2006-11#1)(2006-3#1)(2008-10#3)(2008-3#1)(2009-6#1)(2009-7#1)(2011-2#1)
the favourable##8##2##(1990-8#1)(1991-9#1)(1993-4#1)(2007-8#1)(2008-10#1)(2012-1#1)(2013-1#2)
the favourite##2##2##(1992-11#1)(2011-2#1)
the fd##4##2##(1990-9#1)(1994-12#2)(1997-1#1)
the fdh##2##2##(1995-8#2)
the fear of pain##4##4##(2006-10#1)(2008-1#1)(2012-11#1)(2013-8#1)
the fear of##15##3##(1991-6#1)(1994-1#1)(1994-4#1)(1997-3#1)(2004-11#1)(2006-10#1)(2006-9#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-8#1)(2011-1#2)(2012-11#1)(2013-8#1)
the fear##18##2##(1991-6#1)(1994-1#1)(1994-4#1)(1996-3#1)(1997-3#1)(2004-11#1)(2006-10#1)(2006-9#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-8#1)(2009-9#1)(2010-9#1)(2011-1#2)(2012-11#1)(2013-8#1)
the fears and##3##3##(1995-2#1)(2007-10#1)(2011-2#1)
the fears expressed by##2##4##(2008-12#1)(2011-2#1)
the fears##6##2##(1995-2#1)(1997-1#1)(2007-10#1)(2008-12#1)(2011-2#2)
the feasability of##2##3##(2004-9#1)(2011-2#1)
the feasibility and desirability of##2##5##(1992-2#2)
the feasibility and effectiveness of##4##5##(2009-11#2)(2010-8#1)(2012-1#1)
the feasibility and efficacy of##3##5##(2008-6#1)(2010-9#2)
the feasibility and safety of##7##5##(1992-10#1)(2006-10#1)(2008-10#1)(2012-12#1)(2013-1#2)(2013-8#1)
the feasibility and the##2##4##(2006-6#1)(2008-2#1)
the feasibility and utility of##3##5##(2009-12#1)(2013-1#2)
the feasibility and##35##3##(1991-3#1)(1992-10#1)(1992-2#2)(1996-3#1)(2006-10#1)(2006-6#2)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2009-11#2)(2009-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#7)(2013-8#2)
the feasibility for##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
the feasibility of NeutrAvidin-tagged##2##4##(2008-10#2)
the feasibility of a##20##4##(1990-5#1)(1994-8#1)(1996-12#1)(1996-2#1)(1997-8#1)(2004-9#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-10#1)(2010-12#1)(2012-1#1)(2012-12#2)
the feasibility of an##4##4##(2008-3#1)(2011-2#2)(2012-1#1)
the feasibility of applications##2##4##(2008-3#2)
the feasibility of applying##4##4##(2007-12#1)(2012-3#1)(2013-1#2)
the feasibility of conducting##3##4##(1995-2#1)(2013-1#2)
the feasibility of developing an in vitro##2##7##(2009-7#2)
the feasibility of developing##3##4##(1994-3#1)(2009-7#2)
the feasibility of generating##2##4##(2005-8#1)(2010-10#1)
the feasibility of implementing##2##4##(2007-11#1)(2012-2#1)
the feasibility of large##2##4##(2007-9#1)(2008-3#1)
the feasibility of making##2##4##(2010-12#1)(2012-12#1)
the feasibility of optical##2##4##(1997-5#1)(2007-12#1)
the feasibility of performing##2##4##(2006-8#1)(2007-8#1)
the feasibility of producing##2##4##(1996-5#1)(2008-3#1)
the feasibility of protein##2##4##(2008-10#1)(2013-1#1)
the feasibility of studying##3##4##(1990-3#1)(1992-9#1)(2013-1#1)
the feasibility of such##4##4##(1990-11#1)(2004-9#1)(2008-11#1)(2008-3#1)
the feasibility of the approach##3##5##(2008-2#1)(2008-3#1)(2011-2#1)
the feasibility of the method##3##5##(2008-11#1)(2008-3#2)
the feasibility of the new##2##5##(2008-2#1)(2008-8#1)
the feasibility of the process##2##5##(2005-11#2)
the feasibility of the proposed method##2##6##(2013-1#1)(2013-7#1)
the feasibility of the proposed##3##5##(2008-2#1)(2013-1#1)(2013-7#1)
the feasibility of the use of##2##6##(1995-11#1)(2008-10#1)
the feasibility of the##40##4##(1991-10#1)(1995-11#1)(2005-11#2)(2006-5#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#9)(2008-5#1)(2008-8#2)(2010-11#1)(2010-7#1)(2011-2#2)(2012-1#1)(2013-1#2)(2013-7#1)
the feasibility of these##3##4##(1992-6#1)(2008-10#1)(2008-5#1)
the feasibility of this approach##2##5##(2008-10#1)(2008-2#1)
the feasibility of this technique##2##5##(2007-11#1)(2008-2#1)
the feasibility of this##10##4##(1990-12#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#2)(2012-11#1)(2013-8#1)
the feasibility of using a##3##5##(2006-6#1)(2008-3#1)(2012-1#1)
the feasibility of using the##6##5##(1990-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2012-1#1)
the feasibility of using##28##4##(1990-4#1)(1994-11#1)(1997-5#1)(2005-10#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2008-8#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#2)(2012-1#2)
the feasibility of##228##3##(1990-11#1)(1990-12#3)(1990-3#1)(1990-4#1)(1990-5#1)(1991-10#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1997-5#2)(1997-8#2)(2004-9#2)(2005-10#3)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#2)(2006-5#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-11#5)(2007-12#7)(2007-2#2)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#8)(2007-9#2)(2008-1#2)(2008-10#22)(2008-11#6)(2008-2#14)(2008-3#23)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#3)(2009-5#1)(2009-7#2)(2010-10#2)(2010-11#1)(2010-12#7)(2010-2#2)(2010-3#1)(2010-5#3)(2010-7#2)(2010-9#1)(2011-1#3)(2011-2#7)(2012-1#6)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#9)(2013-7#2)(2013-8#3)
the feasibility##275##2##(1990-11#1)(1990-12#3)(1990-3#1)(1990-4#1)(1990-5#1)(1991-10#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#3)(1992-6#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-5#1)(1997-3#1)(1997-5#2)(1997-8#2)(2004-9#2)(2005-10#3)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#2)(2006-5#1)(2006-6#4)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#7)(2007-2#2)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#9)(2007-9#2)(2008-1#3)(2008-10#25)(2008-11#7)(2008-2#15)(2008-3#23)(2008-5#5)(2008-6#3)(2008-7#1)(2008-8#7)(2008-9#3)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-10#2)(2010-11#1)(2010-12#7)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#3)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#3)(2011-2#10)(2012-1#8)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#16)(2013-7#2)(2013-8#6)
the feasible##4##2##(2007-11#1)(2008-10#1)(2008-9#1)(2011-1#1)
the feather follicle##2##3##(2013-8#2)
the feather follicles##2##3##(2007-12#1)(2008-5#1)
the feather##8##2##(1997-6#1)(2007-12#1)(2007-9#1)(2008-5#3)(2013-8#2)
the feature##21##2##(2008-10#1)(2008-12#1)(2008-2#8)(2008-3#8)(2008-7#1)(2009-10#1)(2012-3#1)
the features and##8##3##(1994-1#1)(2006-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-8#1)(2012-2#1)
the features described##2##3##(2008-7#2)
the features of the##23##4##(1990-11#1)(1991-7#1)(1991-8#3)(1993-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#2)(2008-3#3)(2008-4#1)(2009-10#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-3#1)(2013-8#1)
the features of this##19##4##(2008-12#1)(2011-2#18)
the features of##77##3##(1990-11#1)(1990-6#1)(1991-7#1)(1991-8#3)(1992-4#1)(1993-12#1)(1994-3#1)(1995-5#1)(2004-9#2)(2006-10#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#1)(2008-8#2)(2009-10#1)(2009-4#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#24)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#1)
the features that##4##3##(2006-10#1)(2008-3#2)(2010-12#1)
the features were##4##3##(2008-5#1)(2009-12#1)(2009-9#1)(2013-8#1)
the features##119##2##(1990-10#1)(1990-11#1)(1990-6#1)(1991-7#1)(1991-8#3)(1992-4#1)(1992-9#1)(1993-12#1)(1994-1#1)(1994-3#1)(1995-1#1)(1995-5#1)(1996-3#1)(2004-9#2)(2006-10#5)(2006-8#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#9)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#3)(2009-10#1)(2009-12#2)(2009-4#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#5)(2011-1#2)(2011-2#24)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#3)
the febrile phase##3##3##(2006-7#2)(2012-2#1)
the febrile##5##2##(1997-3#1)(2006-7#2)(2010-8#1)(2012-2#1)
the fecal flora##2##3##(2006-8#1)(2010-2#1)
the fecal microbiota##2##3##(2012-1#2)
the fecal samples were##2##4##(2007-3#2)
the fecal samples##4##3##(2006-8#1)(2007-3#2)(2012-3#1)
the fecal##13##2##(2006-10#1)(2006-6#1)(2006-8#3)(2007-3#2)(2007-8#1)(2008-10#1)(2010-2#1)(2012-1#2)(2012-3#1)
the fecal-oral route##2##3##(1992-2#1)(2007-2#1)
the feces of##4##3##(2007-2#1)(2011-1#1)(2013-1#1)(2013-8#1)
the feces##12##2##(1990-6#1)(1991-12#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-2#1)(2009-4#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
the fecundity of the##2##4##(2004-2#1)(2008-5#1)
the fecundity of##4##3##(1992-12#1)(2004-2#1)(2008-5#1)(2012-3#1)
the fecundity##6##2##(1992-12#1)(2004-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-3#1)
the fed##6##2##(1991-3#1)(1996-5#1)(1997-5#2)(2008-3#1)(2012-2#1)
the fed-batch culture##3##3##(1994-2#1)(2008-11#1)(2008-7#1)
the fed-batch process##2##3##(2008-11#1)(2008-5#1)
the fed-batch##11##2##(1994-2#2)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#3)(2013-1#1)
the federal budget##2##3##(1993-1#1)(2008-7#1)
the federal government and##2##4##(2006-8#1)(2009-4#1)
the federal government has##4##4##(2006-5#1)(2007-4#1)(2008-2#2)
the federal government is##2##4##(1997-2#1)(2007-9#1)
the federal government to##4##4##(1991-1#1)(2008-10#1)(2008-11#1)(2012-1#1)
the federal government##25##3##(1991-1#1)(1991-12#1)(1992-1#1)(1992-12#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-5#2)(2006-8#1)(2007-4#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#3)(2009-4#5)(2012-1#1)
the federal government's##4##3##(1992-3#1)(2007-8#1)(2008-2#1)(2012-3#1)
the federal level##3##3##(1990-12#1)(1994-12#1)(2008-12#1)
the federal patient anti-dumping statute##2##5##(1993-1#1)(1993-2#1)
the federal regulations##2##3##(1995-2#1)(2005-3#1)
the federal republic##2##3##(1993-10#2)
the federal##65##2##(1990-12#2)(1991-1#1)(1991-10#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-1#3)(1993-10#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#1)(1996-1#1)(1997-2#1)(1997-3#1)(2005-3#1)(2006-10#1)(2006-3#1)(2006-5#2)(2006-8#2)(2007-12#1)(2007-2#1)(2007-4#4)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#4)(2008-7#1)(2009-10#1)(2009-4#5)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)
the federally##2##2##(1995-2#2)
the fee schedule together##2##4##(1992-1#2)
the fee schedule##4##3##(1992-1#3)(1994-1#1)
the fee##7##2##(1992-1#3)(1993-3#1)(1994-1#1)(1994-12#1)(2013-8#1)
the fee-for-service (FFS)##2##3##(1997-2#1)(2007-2#1)
the fee-for-service##5##2##(1993-1#1)(1993-3#1)(1997-2#1)(2006-10#1)(2007-2#1)
the feed and##4##3##(1997-3#1)(1997-6#1)(2008-5#1)(2011-2#1)
the feed flow##2##3##(2008-10#1)(2008-5#1)
the feed solution##4##3##(2008-10#4)
the feed stream##3##3##(2004-8#3)
the feed##37##2##(1995-11#1)(1995-4#3)(1997-3#2)(1997-6#2)(2004-8#3)(2005-9#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2009-8#1)(2010-2#1)(2010-4#3)(2011-2#1)(2012-2#1)
the feed-back##2##2##(1993-3#2)
the feed-forward##2##2##(1994-6#1)(2008-2#1)
the feedback from##3##3##(1994-8#1)(2008-8#1)(2009-10#1)
the feedback loop##7##3##(2007-11#2)(2007-12#1)(2008-3#1)(2009-8#1)(2009-9#1)(2010-5#1)
the feedback##33##2##(1992-6#1)(1994-12#1)(1994-8#1)(1996-4#1)(2006-10#2)(2007-10#1)(2007-11#4)(2007-12#5)(2008-2#1)(2008-3#5)(2008-5#1)(2008-8#3)(2009-10#2)(2009-8#1)(2009-9#1)(2010-3#1)(2010-5#1)(2012-1#1)
the feedback-based operation##2##3##(2008-10#2)
the feeder##6##2##(1993-3#1)(1993-9#1)(1997-3#3)(2008-10#1)
the feedforward##2##2##(2008-2#1)(2012-2#1)
the feeding arteries##3##3##(2008-7#2)(2011-2#1)
the feeding artery##3##3##(2007-7#1)(2007-9#1)(2008-7#1)
the feeding induced by##2##4##(1993-7#2)
the feeding of##2##3##(1990-2#1)(2004-11#1)
the feeding period##2##3##(2009-5#1)(2012-2#1)
the feeding response to##3##4##(2011-2#1)(2012-11#2)
the feeding response##4##3##(1995-12#1)(2011-2#1)(2012-11#2)
the feeding##51##2##(1990-2#3)(1990-8#1)(1991-6#1)(1992-10#1)(1993-12#1)(1993-7#2)(1994-12#1)(1995-12#1)(1996-6#1)(2004-11#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#2)(2009-10#1)(2009-5#1)(2010-8#6)(2011-12#1)(2011-2#2)(2012-11#2)(2012-2#3)
the feeding-associated circadian rhythm##2##4##(1997-1#2)
the feedstock##4##2##(2008-5#1)(2008-6#1)(2009-3#1)(2011-2#1)
the feel of##3##3##(2008-5#1)(2012-1#2)
the feeling of##4##3##(1994-1#1)(2007-8#1)(2008-11#1)(2008-2#1)
the feelings and##4##3##(1991-7#1)(2006-2#1)(2008-9#1)(2012-3#1)
the feelings##5##2##(1991-7#1)(2006-2#1)(2008-9#1)(2010-7#1)(2012-3#1)
the feet of##3##3##(1990-5#1)(1992-1#1)(2006-8#1)
the feet##25##2##(1990-5#1)(1992-1#1)(1992-3#1)(1994-12#1)(1996-3#1)(1996-9#1)(1997-8#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-9#2)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
the feline pulmonary vascular bed##2##5##(1991-2#2)
the feline##5##2##(1991-2#2)(1993-3#2)(2010-2#1)
the fellow##2##2##(1996-7#1)(2013-7#1)
the felt##2##2##(2007-8#1)(2008-11#1)
the female and male of##2##5##(2007-3#2)
the female and male##6##4##(1992-3#1)(2006-3#1)(2006-5#1)(2007-3#2)(2013-1#1)
the female and##8##3##(1992-3#1)(2006-3#1)(2006-5#1)(2007-12#1)(2007-3#2)(2008-5#1)(2013-1#1)
the female athlete and##2##4##(2006-3#2)
the female athlete##8##3##(2006-3#8)
the female body##5##3##(1991-6#1)(2007-3#1)(2008-6#1)(2009-10#1)(2009-4#1)
the female breast##2##3##(1992-3#1)(2007-11#1)
the female climacteric##2##3##(2006-6#1)(2006-8#1)
the female condom##5##3##(1997-7#5)
the female elbow joint##2##4##(2007-1#2)
the female gender##2##3##(2008-8#1)(2011-2#1)
the female genital tract##6##4##(2006-10#2)(2009-2#1)(2009-9#1)(2011-2#1)(2012-2#1)
the female genital tracts##2##4##(2008-7#2)
the female genital##10##3##(2006-10#2)(2007-12#1)(2008-7#2)(2009-2#1)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
the female germline##2##3##(1993-2#1)(2006-12#1)
the female group##2##3##(2008-7#1)(2011-1#1)
the female in##3##3##(1993-2#1)(2008-5#1)(2009-2#1)
the female parent##2##3##(2008-10#2)
the female patients##3##3##(2006-10#1)(2007-9#2)
the female rat##3##3##(1992-12#1)(1997-3#2)
the female rats##3##3##(1994-2#1)(1996-4#1)(2013-1#1)
the female reproductive tract##4##4##(1996-12#1)(2004-2#1)(2006-10#1)(2010-3#1)
the female reproductive##8##3##(1996-12#1)(2004-2#1)(2006-1#1)(2006-10#1)(2007-12#1)(2007-7#1)(2009-12#1)(2010-3#1)
the female sex pheromone##2##4##(1990-8#1)(2008-10#1)
the female sex##4##3##(1990-8#1)(1993-11#1)(2008-10#2)
the female sternum##4##3##(1995-6#4)
the female subjects##3##3##(1996-12#1)(2008-4#1)(2008-5#1)
the female##174##2##(1990-11#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-6#2)(1992-12#4)(1992-3#6)(1992-4#2)(1992-6#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-8#1)(1994-2#1)(1994-5#1)(1994-6#4)(1995-11#1)(1995-2#1)(1995-6#4)(1995-8#2)(1995-9#1)(1996-12#3)(1996-4#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#6)(2004-11#1)(2004-2#3)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-3#10)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#4)(2007-11#1)(2007-12#6)(2007-3#3)(2007-7#1)(2007-9#2)(2008-10#11)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#8)(2008-6#4)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#2)(2009-12#2)(2009-2#4)(2009-4#2)(2009-5#3)(2009-7#1)(2009-9#2)(2010-3#1)(2010-5#2)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
the females after##2##3##(1995-3#2)
the females from the##2##4##(2007-3#1)(2009-12#1)
the females of##2##3##(1993-12#1)(2008-7#1)
the females preferred##2##3##(2013-8#2)
the females were##4##3##(2006-9#1)(2007-12#1)(2007-3#1)(2008-4#1)
the females##37##2##(1990-11#1)(1990-8#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-2#2)(1995-3#3)(1996-10#1)(1997-4#2)(2006-9#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-5#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#2)(2009-12#1)(2009-4#1)(2012-12#2)(2012-2#1)(2013-8#3)
the feminine##3##2##(2006-7#1)(2009-10#1)(2013-1#1)
the feminist##2##2##(2007-12#1)(2009-11#1)
the femoral and tibial##2##4##(2007-5#1)(2013-7#1)
the femoral artery to##2##4##(1995-12#1)(2007-10#1)
the femoral artery##13##3##(1993-10#1)(1993-2#1)(1995-12#1)(1996-11#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-3#1)(2009-5#1)(2012-12#2)
the femoral condyle##2##3##(2007-4#1)(2007-8#1)
the femoral condyles##2##3##(2005-7#1)(2006-11#1)
the femoral head in##7##4##(2007-6#1)(2007-7#1)(2008-12#1)(2008-3#1)(2009-10#1)(2009-2#1)(2009-3#1)
the femoral head##58##3##(1991-10#5)(1992-6#1)(1993-5#2)(2004-9#1)(2006-10#2)(2007-6#1)(2007-7#20)(2007-8#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#2)(2009-10#1)(2009-2#1)(2009-3#12)(2009-4#2)(2011-12#1)
the femoral head-neck junction##2##4##(2011-12#2)
the femoral neck and##5##4##(2005-12#1)(2008-6#1)(2011-12#1)(2013-1#2)
the femoral neck fractures##4##4##(2006-6#3)(2009-3#1)
the femoral neck was##2##4##(2007-8#1)(2012-2#1)
the femoral neck##30##3##(2005-12#1)(2006-10#3)(2006-11#1)(2006-6#3)(2007-11#2)(2007-3#1)(2007-8#4)(2008-6#1)(2009-3#5)(2009-4#2)(2010-3#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#2)
the femoral nerve##7##3##(1992-12#1)(1993-12#1)(1994-2#1)(2007-7#1)(2009-3#3)
the femoral quadriceps##3##3##(2005-1#1)(2007-7#2)
the femoral shaft and##2##4##(2006-11#1)(2007-7#1)
the femoral shaft##7##3##(2006-11#2)(2007-7#5)
the femoral vein for acute##2##5##(2007-7#2)
the femoral vein is##4##4##(1991-10#1)(2007-7#3)
the femoral vein##14##3##(1991-10#1)(2006-10#1)(2007-7#9)(2012-2#1)(2013-1#2)
the femoral##184##2##(1991-10#6)(1992-12#1)(1992-3#1)(1992-6#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-5#2)(1994-2#1)(1995-12#1)(1995-6#1)(1996-11#1)(2004-9#2)(2005-1#1)(2005-12#1)(2005-3#1)(2005-7#1)(2006-10#6)(2006-11#5)(2006-6#3)(2007-10#1)(2007-11#4)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#47)(2007-8#9)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-2#9)(2009-3#20)(2009-4#5)(2009-5#1)(2009-7#1)(2010-3#1)(2010-9#1)(2011-12#4)(2011-2#7)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#9)(2013-7#2)
the femoral-tibial##2##2##(2008-4#1)(2013-1#1)
the femtosecond regime##3##3##(2007-11#2)(2007-12#1)
the femtosecond##15##2##(2006-4#1)(2006-5#1)(2007-11#3)(2007-12#7)(2008-2#1)(2008-3#1)(2009-4#1)
the femur and##6##3##(2006-11#1)(2007-11#1)(2007-4#1)(2008-7#1)(2010-12#1)(2013-1#1)
the femur at##2##3##(2006-11#1)(2009-3#1)
the femur of##3##3##(2007-11#1)(2007-2#1)(2009-4#1)
the femur to##2##3##(2008-6#1)(2009-3#1)
the femur was##3##3##(2006-11#1)(2007-11#1)(2007-4#1)
the femur##76##2##(1990-2#1)(1991-11#1)(1992-2#1)(1995-6#1)(2005-9#1)(2006-11#11)(2006-6#2)(2007-1#1)(2007-11#14)(2007-2#2)(2007-3#1)(2007-4#4)(2007-5#1)(2007-7#5)(2007-8#5)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-3#4)(2009-4#2)(2010-12#1)(2010-3#1)(2011-12#1)(2011-2#2)(2012-1#1)(2013-1#5)(2013-8#1)
the fenestrated A1##2##3##(2013-8#2)
the fenestrated##4##2##(2010-12#1)(2013-8#3)
the fermentation broth##7##3##(2004-8#1)(2007-11#1)(2008-6#2)(2008-7#1)(2012-12#1)(2012-2#1)
the fermentation by-product##2##3##(2007-6#1)(2011-1#1)
the fermentation medium##2##3##(1991-8#1)(2008-6#1)
the fermentation of##7##3##(1995-5#1)(2005-11#1)(2008-6#2)(2008-8#1)(2012-1#1)(2013-1#1)
the fermentation performance##2##3##(2008-5#1)(2008-6#1)
the fermentation process##3##3##(2007-11#1)(2008-10#1)(2011-2#1)
the fermentation##35##2##(1991-8#1)(1994-9#1)(1995-5#1)(2004-8#1)(2005-11#1)(2006-8#2)(2007-11#2)(2007-6#2)(2008-10#2)(2008-5#1)(2008-6#7)(2008-7#3)(2008-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
the fermented##2##2##(2008-11#1)(2008-8#1)
the fermenter##4##2##(1994-11#1)(2007-8#1)(2008-5#1)(2008-6#1)
the fermenting##3##2##(2007-12#1)(2008-10#2)
the fern Thelypteris hispidula##2##4##(2006-12#2)
the fern##4##2##(1994-11#2)(2006-12#2)
the ferredoxin-thioredoxin##2##2##(2009-10#2)
the ferret group##2##3##(2008-6#2)
the ferret##12##2##(1991-11#2)(1993-11#2)(1995-5#1)(2008-1#2)(2008-5#1)(2008-6#4)
the ferric ion##3##3##(1991-2#1)(2005-4#1)(2008-10#1)
the ferric reducing##2##3##(2008-11#2)
the ferric siderophore##2##3##(2011-2#2)
the ferric state##2##3##(1990-2#1)(1995-10#1)
the ferric##18##2##(1990-2#2)(1991-2#1)(1992-12#1)(1995-10#2)(1995-5#1)(1996-4#1)(1997-4#1)(1997-7#1)(2005-4#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-2#3)
the ferricyanide##3##2##(2007-8#1)(2008-10#2)
the ferritin##9##2##(1990-5#1)(1994-5#1)(1996-7#1)(2007-7#1)(2008-1#1)(2009-3#2)(2013-8#2)
the ferrocene##4##2##(2005-11#1)(2007-11#2)(2008-10#1)
the ferroelectric##2##2##(2008-2#2)
the ferromagnetic##3##2##(1997-7#1)(2007-11#1)(2008-5#1)
the ferrous##3##2##(1990-2#1)(1990-8#1)(1992-12#1)
the ferrozine method##2##3##(2008-10#2)
the ferryl##2##2##(1991-9#1)(1994-5#1)
the fertile lemmas##2##3##(2008-5#2)
the fertile##5##2##(1996-3#1)(2008-3#1)(2008-5#2)(2013-1#1)
the fertility of##2##3##(2006-5#1)(2012-3#1)
the fertility##11##2##(1992-3#2)(2006-10#1)(2006-5#2)(2009-10#1)(2009-12#1)(2009-4#1)(2010-12#1)(2012-3#1)(2013-8#1)
the fertilization chamber##2##3##(2007-12#2)
the fertilization medium##6##3##(2006-5#6)
the fertilization##14##2##(1994-11#1)(1997-6#1)(2005-10#2)(2006-5#6)(2007-12#2)(2008-9#1)(2010-8#1)
the fertilized eggs##3##3##(2008-5#2)(2010-5#1)
the fertilizer##2##2##(2008-12#1)(2013-8#1)
the fertilizing##2##2##(2006-5#2)
the festival##3##2##(2009-10#2)(2009-9#1)
the fetal circulation##3##3##(1992-1#1)(2005-7#1)(2008-3#1)
the fetal electrocardiogram##2##3##(1994-5#2)
the fetal hydantoin syndrome##3##4##(1990-5#3)
the fetal immune repertoire##2##4##(2008-10#2)
the fetal membranes##2##3##(1992-2#1)(2006-5#1)
the fetal or##2##3##(1995-11#1)(2008-10#1)
the fetal period##4##3##(2009-2#2)(2010-4#1)(2012-12#1)
the fetal rat brain##2##4##(1994-5#1)(1995-9#1)
the fetal rat##5##3##(1992-8#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-9#1)
the fetal sex##9##3##(2013-1#9)
the fetal##85##2##(1990-4#1)(1990-5#3)(1990-7#1)(1991-1#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-4#2)(1994-5#4)(1994-9#1)(1995-11#1)(1995-12#1)(1995-8#2)(1995-9#1)(1996-4#1)(1996-5#3)(1997-2#1)(1997-3#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-7#1)(2008-1#3)(2008-10#7)(2008-11#1)(2008-12#2)(2008-3#2)(2009-10#2)(2009-2#3)(2010-4#1)(2011-1#2)(2011-2#5)(2012-1#3)(2012-12#1)(2012-2#2)(2013-1#10)
the fetus and the newborn##2##5##(2011-12#2)
the fetus and the##4##4##(2007-11#1)(2011-12#2)(2012-3#1)
the fetus and##11##3##(1991-10#1)(1997-6#1)(2004-10#1)(2007-11#2)(2008-3#1)(2010-11#1)(2010-2#1)(2011-12#2)(2012-3#1)
the fetus could be##2##4##(2006-9#1)(2011-1#1)
the fetus during##3##3##(1994-6#1)(2007-10#1)(2011-2#1)
the fetus has a##2##4##(2008-3#1)(2009-9#1)
the fetus has##3##3##(1994-7#1)(2008-3#1)(2009-9#1)
the fetus in the##2##4##(2006-8#1)(2007-11#1)
the fetus is##4##3##(1990-9#1)(1993-6#1)(2008-3#1)(2010-11#1)
the fetus##68##2##(1990-9#1)(1991-10#2)(1993-12#1)(1993-6#1)(1994-5#1)(1994-6#1)(1994-7#2)(1995-8#3)(1996-11#1)(1996-6#1)(1997-6#1)(1997-8#1)(2004-10#1)(2005-10#2)(2005-7#1)(2006-10#1)(2006-11#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2008-2#1)(2008-3#5)(2008-8#1)(2009-10#1)(2009-5#1)(2009-9#4)(2010-11#4)(2010-2#1)(2011-1#2)(2011-12#2)(2011-2#2)(2012-1#3)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#4)
the fetus'##3##2##(1993-12#1)(2009-2#1)(2013-1#1)
the fetuses##7##2##(1991-3#1)(1995-11#1)(1996-12#1)(1996-3#1)(2008-11#1)(2008-12#1)(2012-3#1)
the fever subsided##2##3##(1992-1#1)(2012-12#1)
the fever was##2##3##(2006-11#1)(2013-8#1)
the fever##9##2##(1992-1#1)(1993-7#1)(1994-2#1)(2006-11#1)(2006-4#1)(2009-6#1)(2012-12#1)(2012-2#1)(2013-8#1)
the fevers##2##2##(1996-9#1)(2007-10#1)
the few available studies##2##4##(2007-11#1)(2009-5#1)
the few cases##3##3##(2008-10#2)(2013-7#1)
the few cationic##2##3##(2008-5#2)
the few cells that##2##4##(2007-12#1)(2008-10#1)
the few documented##2##3##(2007-11#1)(2010-2#1)
the few known##2##3##(1997-7#1)(2007-3#1)
the few studies that##3##4##(2008-11#1)(2010-2#1)(2011-2#1)
the few studies##5##3##(1990-8#1)(2008-11#1)(2009-9#1)(2010-2#1)(2011-2#1)
the few##48##2##(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-4#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-10#1)(1997-3#1)(1997-7#1)(2005-8#1)(2006-10#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-3#2)(2007-8#1)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#2)(2009-5#1)(2009-6#1)(2009-9#2)(2010-2#2)(2011-2#1)(2012-3#1)(2013-7#2)
the fewest adverse##2##3##(1992-4#1)(2007-11#1)
the fewest##9##2##(1990-3#1)(1992-4#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)
the fiber Bragg grating##2##4##(2007-11#1)(2008-3#1)
the fiber Bragg##3##3##(2007-11#2)(2008-3#1)
the fiber PMD##2##3##(2007-11#2)
the fiber and the##8##4##(2005-11#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
the fiber are##2##3##(2007-11#1)(2008-2#1)
the fiber array##2##3##(2008-2#2)
the fiber as##3##3##(2005-11#1)(2008-3#1)(2009-7#1)
the fiber axis##6##3##(1994-11#2)(2007-12#1)(2008-2#1)(2008-3#2)
the fiber birefringence##2##3##(2007-12#1)(2010-4#1)
the fiber cells##3##3##(2008-10#3)
the fiber cladding##3##3##(2007-11#1)(2008-3#2)
the fiber continuum pulses by##2##5##(2012-11#2)
the fiber continuum##4##3##(2012-11#4)
the fiber core is##3##4##(2007-11#2)(2007-12#1)
the fiber core##13##3##(2007-11#3)(2007-12#8)(2008-3#2)
the fiber diameter##2##3##(2007-12#1)(2008-2#1)
the fiber dispersion##2##3##(2007-12#1)(2008-2#1)
the fiber does not##2##4##(2007-12#1)(2008-2#1)
the fiber end##3##3##(2008-3#3)
the fiber from##2##3##(2007-12#1)(2008-3#1)
the fiber grating##2##3##(2007-11#1)(2007-12#1)
the fiber input##5##3##(2007-12#2)(2008-2#2)(2008-3#1)
the fiber is bent##2##4##(2007-11#1)(2008-3#1)
the fiber is experimentally##2##4##(2005-11#1)(2008-3#1)
the fiber is##9##3##(2005-11#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#3)(2010-8#1)
the fiber laser##7##3##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#2)
the fiber length##3##3##(2007-11#2)(2007-12#1)
the fiber link##2##3##(2007-12#2)
the fiber optic##5##3##(1990-8#2)(2008-10#3)
the fiber source##2##3##(2004-11#1)(2007-2#1)
the fiber structure##2##3##(2008-1#1)(2008-3#1)
the fiber surfaces and##2##4##(2008-11#1)(2009-11#1)
the fiber tip in##2##4##(1992-1#1)(2008-3#1)
the fiber tip##4##3##(1992-1#1)(1995-2#1)(2008-2#1)(2008-3#1)
the fiber to##6##3##(2007-12#1)(2007-8#1)(2008-2#3)(2008-3#1)
the fiber was pumped##2##4##(2007-11#2)
the fiber was##13##3##(1991-12#1)(1992-1#1)(1997-8#1)(2007-11#2)(2007-12#2)(2008-10#5)(2010-1#1)
the fiber when it##2##4##(2007-12#2)
the fiber##256##2##(1990-8#2)(1991-12#1)(1991-6#1)(1992-1#3)(1994-10#1)(1994-11#2)(1995-2#1)(1997-8#1)(2004-11#1)(2004-9#1)(2005-11#5)(2007-11#37)(2007-12#76)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#24)(2008-11#1)(2008-2#28)(2008-3#48)(2008-5#1)(2008-6#2)(2008-8#2)(2009-11#1)(2009-7#1)(2010-1#1)(2010-4#3)(2010-8#2)(2012-11#4)(2012-12#1)(2013-8#1)
the fiber's##15##2##(2007-11#4)(2007-12#4)(2008-1#1)(2008-2#2)(2008-3#4)
the fiber-optic DNA##2##3##(2008-9#2)
the fiber-optic probe##2##3##(2006-12#1)(2008-10#1)
the fiber-optic sensor##3##3##(2008-10#1)(2008-2#2)
the fiber-optic##14##2##(2006-12#1)(2008-1#1)(2008-10#2)(2008-2#4)(2008-3#3)(2008-9#2)(2011-1#1)
the fiber/epoxy matrix##2##3##(2005-11#2)
the fiberoptic##2##2##(2007-10#1)(2010-8#1)
the fibers are single mode##2##5##(2007-11#1)(2007-12#1)
the fibers are##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
the fibers in the##3##4##(1996-12#1)(2007-12#1)(2008-2#1)
the fibers of##2##3##(1992-7#1)(2007-12#1)
the fibers were##3##3##(2008-10#1)(2008-2#1)(2009-11#1)
the fibers##40##2##(1991-11#1)(1991-12#2)(1992-7#1)(1994-8#1)(1995-11#1)(1996-11#1)(1996-12#1)(2004-9#2)(2005-11#2)(2007-11#1)(2007-12#11)(2008-10#5)(2008-2#3)(2008-3#1)(2008-5#1)(2009-11#1)(2009-2#1)(2009-7#1)(2010-1#2)(2012-3#1)
the fibers'##3##2##(2007-11#1)(2007-12#1)(2010-8#1)
the fibre type composition of the##2##6##(2011-2#2)
the fibre type composition##4##4##(2011-2#4)
the fibre was##2##3##(2006-6#1)(2008-10#1)
the fibre##17##2##(2006-6#1)(2008-10#8)(2008-5#2)(2009-7#1)(2011-2#4)(2013-1#1)
the fibres##4##2##(1996-3#1)(1997-4#1)(2008-5#1)(2008-6#1)
the fibril angle and##2##4##(2008-3#2)
the fibril##7##2##(1994-5#1)(2006-7#1)(2008-3#3)(2009-8#1)(2013-8#1)
the fibrillar material is##2##4##(1994-5#2)
the fibrillar material##3##3##(1994-5#3)
the fibrillar structure of##2##4##(2006-4#1)(2010-4#1)
the fibrillar##8##2##(1994-5#3)(2005-11#1)(2006-4#1)(2008-8#1)(2010-4#2)
the fibrillin##3##2##(1994-3#1)(2013-1#2)
the fibrillin-1##2##2##(1996-3#1)(1997-8#1)
the fibrils of##2##3##(1993-2#1)(2008-5#1)
the fibrils##8##2##(1993-11#1)(1993-2#3)(2008-5#2)(2009-8#2)
the fibrin clot##2##3##(1992-2#1)(2011-1#1)
the fibrin structure##3##3##(2009-4#1)(2011-2#2)
the fibrin##13##2##(1990-11#2)(1991-7#1)(1992-2#1)(1995-3#1)(2008-10#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#1)
the fibrinogen binding##2##3##(1995-2#1)(2006-6#1)
the fibrinogen##11##2##(1990-12#1)(1990-7#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-2#2)(1997-2#1)(2006-6#1)(2008-10#1)(2011-1#1)
the fibrinolytic capacity##2##3##(1990-11#1)(1993-2#1)
the fibrinolytic process##2##3##(2007-7#2)
the fibrinolytic system in##3##4##(1997-1#3)
the fibrinolytic system##6##3##(1990-11#1)(1994-3#1)(1997-1#3)(2008-1#1)
the fibrinolytic##17##2##(1990-11#2)(1992-7#1)(1993-12#1)(1993-2#1)(1994-3#1)(1994-5#1)(1996-5#2)(1996-8#1)(1997-1#3)(2007-7#2)(2008-1#1)(2008-10#1)
the fibroblast form##3##3##(1991-7#3)
the fibroblast growth factor##6##4##(1991-5#1)(1993-6#1)(1994-3#1)(1995-10#1)(2009-7#1)(2010-5#1)
the fibroblast growth##9##3##(1991-5#1)(1993-6#1)(1994-3#1)(1995-10#1)(1997-4#3)(2009-7#1)(2010-5#1)
the fibroblast##18##2##(1991-3#1)(1991-5#1)(1991-7#3)(1991-8#1)(1993-6#1)(1994-3#1)(1995-10#1)(1997-4#3)(2007-3#1)(2008-11#2)(2009-7#1)(2010-5#1)(2012-1#1)
the fibroblasts##8##2##(1991-8#1)(1992-4#1)(1994-11#1)(1996-11#1)(2006-9#1)(2008-11#1)(2008-5#1)(2010-4#1)
the fibronectin##5##2##(1990-7#2)(1992-11#1)(1992-12#1)(1993-12#1)
the fibrosis and##2##3##(2008-9#1)(2013-1#1)
the fibrotic process##2##3##(2005-8#1)(2009-8#1)
the fibrotic##7##2##(2005-8#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-6#1)(2012-12#2)
the fibrous interstitium##2##3##(2008-5#2)
the fibrous matrix##5##3##(2008-11#5)
the fibrous##21##2##(2003-11#1)(2005-11#1)(2006-5#1)(2007-11#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#6)(2008-5#3)(2008-9#1)(2010-4#1)(2011-2#1)(2012-12#1)
the fibula##5##2##(2007-2#1)(2010-12#1)(2010-3#1)(2011-2#2)
the fibular head##2##3##(2008-8#1)(2009-1#1)
the fibular##3##2##(2008-8#1)(2009-1#1)(2009-9#1)
the fideistic probability that God##2##5##(2013-1#2)
the fidelity of supported employment for people with severe mental##2##10##(2010-9#2)
the fidelity of the##3##4##(1996-4#1)(2007-12#1)(2010-9#1)
the fidelity of##14##3##(1993-3#1)(1996-11#1)(1996-4#1)(1996-7#1)(1997-1#1)(2007-12#1)(2008-3#3)(2008-8#1)(2010-9#3)(2013-1#1)
the fidelity##16##2##(1993-3#1)(1994-8#1)(1996-11#1)(1996-4#1)(1996-7#1)(1997-1#2)(2007-12#1)(2008-3#3)(2008-8#1)(2010-9#3)(2013-1#1)
the field EPSP##5##3##(1991-12#1)(1992-7#1)(1994-2#1)(1996-5#1)(1997-5#1)
the field against##2##3##(2004-2#1)(2008-10#1)
the field analysis of##2##4##(2008-10#2)
the field and the##5##4##(1990-3#1)(2008-1#1)(2008-5#1)(2013-1#2)
the field and##31##3##(1990-3#1)(1994-2#1)(2005-7#1)(2006-10#1)(2006-4#1)(2008-1#1)(2008-10#12)(2008-12#1)(2008-5#1)(2009-12#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)
the field are highlighted##2##4##(2005-11#1)(2006-8#1)
the field are##9##3##(1992-3#1)(1992-9#1)(2004-11#1)(2005-11#1)(2005-8#1)(2006-8#1)(2008-1#1)(2008-2#1)(2008-4#1)
the field as a whole##2##5##(1996-2#1)(2005-6#1)
the field as a##3##4##(1996-2#1)(2005-6#1)(2008-10#1)
the field as##5##3##(1996-2#1)(2005-6#1)(2007-12#1)(2008-10#2)
the field at##3##3##(2007-12#1)(2008-10#2)
the field by##8##3##(1992-7#1)(1995-12#1)(2006-10#1)(2008-10#1)(2008-3#1)(2010-1#1)(2011-1#1)(2012-12#1)
the field distribution of##3##4##(2007-11#1)(2007-12#2)
the field distribution##5##3##(2007-11#1)(2007-12#3)(2008-3#1)
the field distributions##2##3##(2007-12#1)(2008-3#1)
the field experiment##5##3##(2008-10#5)
the field experiments##3##3##(2008-10#2)(2008-9#1)
the field for##8##3##(2008-10#2)(2008-5#1)(2008-8#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)
the field from##2##3##(2008-10#2)
the field has##5##3##(2007-11#1)(2008-10#1)(2008-4#1)(2013-1#1)(2013-8#1)
the field in the##6##4##(2007-11#1)(2008-2#1)(2008-3#3)(2010-8#1)
the field in##17##3##(2005-5#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-5#1)(2010-12#1)(2010-8#1)(2012-11#1)
the field is##10##3##(1993-6#1)(2006-10#1)(2007-1#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-9#1)
the field isolates##3##3##(2008-10#2)(2008-5#1)
the field of anticancer##3##4##(2008-1#1)(2008-5#1)(2010-5#1)
the field of applied##2##4##(2009-4#1)(2012-2#1)
the field of bioinformatics##4##4##(2007-12#1)(2008-4#2)(2008-7#1)
the field of clinical##2##4##(1993-3#1)(2005-8#1)
the field of dental hygiene##2##5##(2006-2#2)
the field of diagnostic##2##4##(1994-1#1)(2007-4#1)
the field of emerging##2##4##(2008-7#1)(2011-1#1)
the field of environmental##3##4##(1993-8#1)(2008-10#2)
the field of food##2##4##(2007-8#1)(2010-7#1)
the field of health care##2##5##(1993-2#1)(2006-8#1)
the field of health education##2##5##(2010-12#2)
the field of health insurance##2##5##(1992-3#2)
the field of health##10##4##(1992-3#2)(1993-1#1)(1993-2#1)(1994-6#1)(2005-8#1)(2006-8#1)(2010-12#2)(2011-2#1)
the field of interventional cardiology##2##5##(2006-6#1)(2013-8#1)
the field of interventional endoscopy##3##5##(2006-10#3)
the field of interventional##6##4##(2006-10#4)(2006-6#1)(2013-8#1)
the field of mechanotherapy##2##4##(2008-12#2)
the field of metabonomics##2##4##(2010-11#2)
the field of molecular biology##4##5##(2006-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
the field of molecular##7##4##(1991-9#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)
the field of oral##2##4##(2007-12#1)(2008-9#1)
the field of pediatric heart transplantation##2##6##(2008-4#2)
the field of pediatric##3##4##(2006-10#1)(2008-4#2)
the field of periodontology##2##4##(2012-3#2)
the field of practice##3##4##(1994-12#1)(1995-1#2)
the field of psychiatry##2##4##(2008-6#1)(2013-8#1)
the field of radiology##5##4##(1991-1#1)(1992-1#1)(2007-4#3)
the field of routine##2##4##(2008-10#1)(2011-2#1)
the field of science##2##4##(2008-11#1)(2011-2#1)
the field of synthetic##3##4##(2008-4#2)(2009-5#1)
the field of the##4##4##(2006-2#1)(2008-12#1)(2008-5#1)(2013-8#1)
the field of view is##4##5##(2007-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
the field of view of the##3##6##(2008-2#1)(2008-3#2)
the field of view of##4##5##(2007-11#1)(2008-2#1)(2008-3#2)
the field of view##21##4##(2007-11#3)(2008-2#4)(2008-3#10)(2008-5#2)(2008-9#1)(2013-1#1)
the field of##425##3##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#1)(1991-1#2)(1991-12#1)(1991-6#3)(1991-8#1)(1991-9#1)(1992-1#2)(1992-2#1)(1992-3#3)(1993-1#2)(1993-10#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#2)(1995-1#3)(1995-11#1)(1995-9#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#2)(2004-12#1)(2005-11#1)(2005-5#1)(2005-6#3)(2005-7#5)(2005-8#9)(2005-9#2)(2006-1#1)(2006-10#28)(2006-11#1)(2006-12#1)(2006-2#4)(2006-4#2)(2006-5#3)(2006-6#5)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#3)(2007-11#10)(2007-12#5)(2007-2#4)(2007-4#7)(2007-5#2)(2007-7#4)(2007-8#6)(2007-9#4)(2008-1#8)(2008-10#25)(2008-11#8)(2008-12#10)(2008-2#12)(2008-3#18)(2008-4#12)(2008-5#14)(2008-6#6)(2008-7#13)(2008-8#3)(2008-9#8)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#3)(2009-5#3)(2009-6#3)(2009-7#3)(2009-8#2)(2010-10#4)(2010-11#5)(2010-12#7)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#3)(2010-8#3)(2010-9#3)(2011-1#7)(2011-12#1)(2011-2#11)(2011-3#1)(2011-7#1)(2012-1#5)(2012-11#3)(2012-12#10)(2012-2#11)(2012-3#6)(2013-1#5)(2013-7#2)(2013-8#12)
the field on##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
the field population##2##3##(2007-6#1)(2008-12#1)
the field results##3##3##(2008-10#2)(2010-8#1)
the field size##2##3##(2008-3#2)
the field soil##2##3##(2008-10#2)
the field strength of the##2##5##(1997-7#1)(2008-10#1)
the field strength##4##3##(1997-7#1)(2005-11#1)(2008-10#1)(2008-2#1)
the field study##2##3##(2004-11#1)(2008-10#1)
the field test##2##3##(2008-10#1)(2008-5#1)
the field that results from##2##5##(2007-12#1)(2008-2#1)
the field that##3##3##(2007-12#1)(2008-2#2)
the field the##4##3##(2008-10#1)(2011-2#3)
the field to##11##3##(1995-6#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-9#1)(2010-8#1)(2011-12#1)(2012-2#1)
the field was##4##3##(2008-10#4)
the field were##8##3##(2008-10#6)(2011-12#1)(2011-2#1)
the field with##6##3##(1996-6#1)(2008-10#3)(2008-11#1)(2012-3#1)
the field##947##2##(1990-10#1)(1990-12#2)(1990-3#2)(1990-5#1)(1991-1#2)(1991-12#2)(1991-2#1)(1991-6#3)(1991-8#2)(1991-9#1)(1992-1#3)(1992-12#2)(1992-2#2)(1992-3#4)(1992-6#1)(1992-7#2)(1992-9#1)(1993-1#2)(1993-10#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#1)(1994-1#2)(1994-10#1)(1994-12#2)(1994-2#5)(1994-3#5)(1994-6#2)(1994-9#2)(1995-1#4)(1995-11#1)(1995-12#3)(1995-3#1)(1995-6#1)(1995-9#2)(1996-12#1)(1996-2#5)(1996-5#2)(1996-6#2)(1996-7#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#2)(2004-11#4)(2004-12#1)(2004-2#1)(2004-4#1)(2005-11#4)(2005-5#2)(2005-6#5)(2005-7#8)(2005-8#13)(2005-9#6)(2006-1#1)(2006-10#40)(2006-11#2)(2006-12#1)(2006-2#6)(2006-3#1)(2006-4#3)(2006-5#6)(2006-6#6)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#17)(2007-12#22)(2007-2#5)(2007-3#3)(2007-4#9)(2007-5#4)(2007-6#2)(2007-7#5)(2007-8#8)(2007-9#4)(2008-1#12)(2008-10#214)(2008-11#14)(2008-12#15)(2008-2#29)(2008-3#40)(2008-4#15)(2008-5#28)(2008-6#9)(2008-7#16)(2008-8#11)(2008-9#21)(2009-10#7)(2009-11#1)(2009-12#2)(2009-3#6)(2009-4#7)(2009-5#3)(2009-6#5)(2009-7#3)(2009-8#3)(2009-9#2)(2010-1#2)(2010-10#5)(2010-11#5)(2010-12#10)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-7#6)(2010-8#10)(2010-9#3)(2011-1#11)(2011-12#8)(2011-2#24)(2011-3#1)(2011-7#1)(2012-1#6)(2012-11#7)(2012-12#20)(2012-2#22)(2012-3#8)(2012-8#1)(2013-1#13)(2013-7#3)(2013-8#16)
the field's##2##2##(2009-9#2)
the fields in##4##3##(2007-12#1)(2008-10#2)(2008-3#1)
the fields of##63##3##(1992-2#1)(1995-4#1)(1996-3#1)(1997-1#1)(2005-10#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#2)(2006-9#1)(2007-11#1)(2007-4#3)(2007-6#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#2)
the fields##82##2##(1992-11#1)(1992-2#1)(1995-4#1)(1996-2#1)(1996-3#1)(1997-1#1)(2005-10#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#1)(2006-7#2)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-4#3)(2007-6#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#3)
the fieldwork##3##2##(2009-5#1)(2013-7#2)
the fierce##2##2##(1995-6#1)(2013-8#1)
the fifteenth##3##2##(2008-8#1)(2013-1#1)(2013-8#1)
the fifth and sixth##3##4##(1994-9#1)(2007-12#1)(2013-7#1)
the fifth and##4##3##(1994-9#1)(2007-12#1)(2008-10#1)(2013-7#1)
the fifth case of##2##4##(2009-7#1)(2010-8#1)
the fifth day after##2##4##(2007-11#2)
the fifth day of##4##4##(1993-1#1)(1993-12#1)(2005-10#1)(2008-12#1)
the fifth day##8##3##(1991-8#1)(1993-1#1)(1993-12#2)(2005-10#1)(2007-11#2)(2008-12#1)
the fifth discipline of##2##4##(1994-3#2)
the fifth fraction##2##3##(2008-10#1)(2008-6#1)
the fifth harmonic of a##4##5##(2007-11#2)(2008-2#2)
the fifth harmonic of##5##4##(2007-11#2)(2008-2#2)(2008-3#1)
the fifth instar##2##3##(1997-8#1)(2007-12#1)
the fifth ligand##2##3##(1991-8#1)(1991-9#1)
the fifth lumbar vertebra##2##4##(1996-6#1)(2006-10#1)
the fifth most##2##3##(1995-9#1)(2013-1#1)
the fifth patient##2##3##(1995-5#1)(1997-3#1)
the fifth position##2##3##(1990-10#1)(2008-11#1)
the fifth postoperative day##3##4##(2007-4#1)(2011-1#1)(2013-1#1)
the fifth subsite##2##3##(1990-7#2)
the fifth to##3##3##(2008-1#2)(2009-5#1)
the fifth year of the##2##5##(1992-12#1)(2008-10#1)
the fifth year##3##3##(1992-12#1)(2008-10#2)
the fifth##104##2##(1990-10#1)(1990-7#2)(1991-4#1)(1991-6#1)(1991-8#2)(1991-9#2)(1992-12#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-12#2)(1994-10#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-9#2)(1995-2#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#2)(2005-10#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-11#4)(2007-12#3)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-1#1)(2009-4#4)(2009-5#1)(2009-7#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-10#1)(2012-12#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
the fifth-order##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
the fiftieth anniversary of##2##4##(2005-11#1)(2012-3#1)
the fight against AIDS##4##4##(1990-10#1)(1990-5#1)(1995-1#1)(2010-12#1)
the fight against domestic##2##4##(1993-12#2)
the fight against the##6##4##(1993-3#1)(1997-3#1)(2008-5#1)(2009-7#1)(2013-1#1)(2013-8#1)
the fight against this##2##4##(2006-10#1)(2007-2#1)
the fight against##32##3##(1990-10#1)(1990-5#1)(1993-12#2)(1993-3#1)(1995-1#1)(1996-1#1)(1997-3#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#3)
the fight to##2##3##(1990-5#1)(2008-1#1)
the fight##37##2##(1990-10#1)(1990-5#2)(1993-12#2)(1993-3#1)(1995-1#1)(1996-1#1)(1997-3#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
the figure of the##2##4##(1995-10#1)(2012-12#1)
the figure of##6##3##(1995-10#1)(2007-12#1)(2008-10#1)(2008-3#2)(2012-12#1)
the figure##12##2##(1990-6#1)(1992-4#1)(1995-10#1)(1995-11#1)(2007-12#2)(2008-10#1)(2008-3#2)(2008-9#1)(2012-12#1)(2012-2#1)
the figure-of-8 construct##3##3##(2009-3#3)
the figure-of-8##4##2##(2009-3#4)
the figure-of-eight##3##2##(2007-8#3)
the figures of merit of the method##2##7##(2008-10#2)
the figures of merit of the##4##6##(2008-10#4)
the figures of merit##8##4##(2007-8#1)(2008-10#7)
the figures of##10##3##(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#7)
the figures were##2##3##(1994-3#1)(2013-8#1)
the figures##18##2##(1993-12#1)(1994-3#1)(1996-1#1)(1996-2#1)(1997-4#1)(1997-6#1)(2005-9#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-3#1)(2013-8#1)
the figuring process##2##3##(2008-3#2)
the filament axis##2##3##(1997-4#1)(1997-7#1)
the filament##6##2##(1990-7#1)(1995-8#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-11#1)
the filamentation of powerful ultrashort laser pulses in air##2##9##(2008-1#2)
the filamentous bacteriophage##3##3##(1994-9#1)(2008-10#1)(2008-8#1)
the filamentous form##2##3##(1992-5#1)(2008-6#1)
the filamentous fungus Aspergillus nidulans##2##5##(1994-9#1)(1997-4#1)
the filamentous fungus Podospora anserina##3##5##(1995-6#1)(1996-2#1)(1996-9#1)
the filamentous fungus##5##3##(1994-9#1)(1995-6#1)(1996-2#1)(1996-9#1)(1997-4#1)
the filamentous shape is deemed the most suitable morphology for design and engineering of drug vehicles for cancer therapy##2##19##(2012-11#2)
the filamentous##21##2##(1992-12#1)(1992-5#1)(1994-9#2)(1995-6#2)(1996-2#1)(1996-9#1)(1997-4#2)(1997-7#1)(2008-10#2)(2008-6#2)(2008-8#1)(2012-11#4)(2012-2#1)
the filaments##8##2##(1990-3#1)(1993-12#1)(1995-1#1)(1997-4#1)(2008-7#1)(2008-8#1)(2011-2#2)
the filarial parasite##2##3##(1991-5#1)(1994-11#1)
the filarial##3##2##(1991-5#2)(1994-11#1)
the file##3##2##(1994-1#1)(2006-6#1)(2008-7#1)
the files and extractors##2##4##(2013-8#2)
the files of the##4##4##(1990-2#1)(1993-8#1)(2008-12#1)(2011-2#1)
the files of##8##3##(1990-2#1)(1993-8#1)(1994-8#1)(1997-8#1)(2007-2#1)(2008-1#1)(2008-12#1)(2011-2#1)
the files##12##2##(1990-2#1)(1993-8#1)(1994-8#1)(1995-12#1)(1997-8#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-8#2)
the filiform##2##2##(1996-9#1)(2008-11#1)
the filing##2##2##(2005-6#1)(2006-7#1)
the filipin##2##2##(1996-1#2)
the fill factor##3##3##(2008-2#2)(2008-3#1)
the fill##4##2##(2008-2#2)(2008-3#2)
the filled##2##2##(1990-7#1)(1994-4#1)
the filler##4##2##(2004-9#1)(2008-8#2)(2009-6#1)
the filling in##2##3##(2008-3#2)
the filling of the##2##4##(1993-8#1)(2008-7#1)
the filling of##3##3##(1993-6#1)(1993-8#1)(2008-7#1)
the filling or##2##3##(1995-9#1)(2008-5#1)
the filling##12##2##(1990-9#1)(1993-6#1)(1993-8#1)(1995-9#1)(2005-11#1)(2006-5#1)(2007-7#1)(2008-3#2)(2008-5#1)(2008-7#1)(2011-2#1)
the film and the##6##4##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)
the film and##9##3##(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#3)
the film becomes##2##3##(2007-12#1)(2010-2#1)
the film by irradiation with##2##5##(2008-2#2)
the film by##4##3##(2007-12#2)(2008-2#2)
the film can be##2##4##(2008-10#1)(2009-2#1)
the film formation##3##3##(2005-11#2)(2010-4#1)
the film forming process##2##4##(2008-5#2)
the film in##2##3##(1994-12#1)(2013-7#1)
the film is also##2##4##(2008-10#1)(2008-7#1)
the film is##10##3##(2005-11#4)(2007-11#1)(2008-10#3)(2008-2#1)(2008-7#1)
the film may##2##3##(2008-10#2)
the film preparation##2##3##(2008-10#2)
the film surface##5##3##(2005-11#1)(2007-12#1)(2008-5#1)(2010-4#1)(2013-1#1)
the film thickness and##2##4##(2006-5#1)(2008-10#1)
the film thickness were##2##4##(2007-12#1)(2008-10#1)
the film thickness##17##3##(2004-12#1)(2005-11#1)(2006-5#4)(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#2)(2008-7#1)
the film was##6##3##(2005-11#1)(2008-10#3)(2010-4#1)(2012-2#1)
the film with##3##3##(2005-11#1)(2008-10#1)(2008-11#1)
the film##146##2##(1991-9#1)(1992-5#2)(1994-12#1)(1996-1#1)(1997-2#2)(2004-12#1)(2005-11#16)(2005-4#1)(2006-5#4)(2007-11#5)(2007-12#12)(2007-2#2)(2008-1#1)(2008-10#36)(2008-11#2)(2008-2#16)(2008-3#16)(2008-5#7)(2008-7#4)(2009-10#1)(2009-11#1)(2009-2#2)(2010-2#1)(2010-4#3)(2010-7#2)(2012-2#1)(2013-1#4)(2013-7#1)
the film's##5##2##(2006-12#1)(2007-12#1)(2008-3#2)(2008-5#1)
the film-substrate##2##2##(2005-11#1)(2008-3#1)
the films and##7##3##(2005-11#3)(2008-10#2)(2008-2#2)
the films are##4##3##(1991-3#1)(2007-12#1)(2008-3#1)(2009-11#1)
the films by##3##3##(2005-11#1)(2008-1#1)(2008-2#1)
the films in the medium##2##5##(2008-10#1)(2008-11#1)
the films in the##3##4##(2008-10#2)(2008-11#1)
the films in##4##3##(2008-10#2)(2008-11#1)(2008-2#1)
the films is##4##3##(2007-12#1)(2008-10#1)(2009-11#2)
the films on the##2##4##(1997-1#1)(2005-11#1)
the films prepared##2##3##(2008-2#1)(2008-5#1)
the films was##7##3##(2005-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)
the films were found to##3##5##(2008-10#2)(2010-4#1)
the films were prepared##2##4##(1991-9#1)(2008-8#1)
the films were##10##3##(1991-9#1)(2005-11#1)(2007-11#1)(2008-10#3)(2008-3#2)(2008-8#1)(2010-4#1)
the films##85##2##(1991-3#2)(1991-9#1)(1992-11#1)(1992-8#1)(1997-1#1)(2005-11#11)(2005-4#1)(2007-11#3)(2007-12#4)(2008-1#1)(2008-10#16)(2008-11#4)(2008-12#2)(2008-2#10)(2008-3#10)(2008-5#5)(2008-8#2)(2009-11#3)(2009-2#1)(2009-4#2)(2010-4#3)(2013-1#1)
the filter and##3##3##(2008-2#1)(2008-3#2)
the filter can be##2##4##(2008-2#2)
the filter coefficients##2##3##(2008-2#2)
the filter is##5##3##(2007-12#2)(2008-2#3)
the filter linewidth##2##3##(2007-11#1)(2007-12#1)
the filter output##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
the filter paper##5##3##(2008-10#1)(2008-5#2)(2010-8#1)(2011-1#1)
the filter parameters##2##3##(2007-12#1)(2008-3#1)
the filter performance##2##3##(2008-3#2)
the filter plane##3##3##(2008-2#1)(2008-3#2)
the filter resonance##2##3##(2008-2#2)
the filter response to##2##4##(2008-2#2)
the filter was##4##3##(1991-12#1)(1992-6#2)(2008-3#1)
the filter##83##2##(1991-12#1)(1992-6#2)(2006-9#1)(2007-11#2)(2007-12#10)(2008-1#1)(2008-10#9)(2008-2#32)(2008-3#19)(2008-5#2)(2010-8#1)(2011-1#2)(2011-2#1)
the filter's##3##2##(2008-2#2)(2008-3#1)
the filtered##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
the filtering##8##2##(1995-3#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#1)
the filters and the##2##4##(2006-5#1)(2008-2#1)
the filters to##2##3##(2007-12#1)(2008-2#1)
the filters were##2##3##(1990-11#1)(1996-12#1)
the filters##14##2##(1990-11#1)(1992-5#1)(1996-12#1)(2006-5#1)(2007-12#2)(2008-10#2)(2008-2#4)(2008-3#2)
the filtrate was##2##3##(1994-5#1)(2008-10#1)
the filtrate##12##2##(1994-5#1)(2008-10#9)(2008-7#2)
the filtrates##3##2##(1992-9#1)(2008-10#2)
the filtration##5##2##(1995-10#1)(2005-11#1)(2008-5#1)(2008-9#1)(2012-1#1)
the fimA and fimF genes##2##5##(2008-10#2)
the fimA and fimF##3##4##(2008-10#3)
the fimA gene of##2##4##(1993-11#2)
the fimA##6##2##(1993-11#2)(2008-10#4)
the fimbria##2##2##(1992-8#1)(1994-2#1)
the fimbrial##2##2##(2008-10#2)
the final Si layer##2##4##(2007-11#2)
the final analysis##8##3##(1992-3#1)(1992-6#1)(1996-3#1)(1997-6#1)(2006-10#1)(2008-4#1)(2010-4#1)(2012-2#1)
the final article##2##3##(1996-3#1)(2008-10#1)
the final cellular##2##3##(2007-3#1)(2012-1#1)
the final ceramics##2##3##(2004-9#1)(2009-7#1)
the final common pathway of platelet aggregation##2##7##(2005-7#1)(2007-11#1)
the final common pathway of##5##5##(2005-11#1)(2005-7#1)(2007-11#1)(2009-8#1)(2012-12#1)
the final concentration of##2##4##(1991-9#1)(2013-1#1)
the final data##2##3##(2008-3#1)(2010-5#1)
the final decision##5##3##(1992-5#1)(1994-3#1)(1995-11#1)(2005-11#1)(2011-1#1)
the final determination of##2##4##(2007-10#1)(2008-10#1)
the final diagnoses##2##3##(2011-2#1)(2013-8#1)
the final diagnosis of##4##4##(2008-1#1)(2008-5#1)(2010-6#1)(2012-3#1)
the final diagnosis##9##3##(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-6#1)(2011-2#1)(2012-3#2)
the final disease intensity##2##4##(2008-10#2)
the final disease##3##3##(2008-10#3)
the final drug##2##3##(1992-2#1)(2008-11#1)
the final equilibrium##2##3##(1990-4#1)(2008-10#1)
the final evaluation##2##3##(1997-3#1)(2008-10#1)
the final events##2##3##(1994-12#1)(2006-10#1)
the final extract##2##3##(1997-8#1)(2008-10#1)
the final follow-up##3##3##(2007-8#1)(2008-9#1)(2011-2#1)
the final germination percentage of##2##5##(2008-10#2)
the final goal##3##3##(2006-10#1)(2008-3#2)
the final height of##2##4##(2006-1#1)(2007-11#1)
the final height##4##3##(2006-1#2)(2007-11#2)
the final histopathological##2##3##(2013-8#2)
the final image##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
the final intermediate##2##3##(1994-8#2)
the final mechanical properties of the##2##6##(2008-5#1)(2009-7#1)
the final model##5##3##(1992-4#1)(1995-8#1)(2008-10#2)(2009-7#1)
the final outcome of##5##4##(1994-11#1)(2007-11#1)(2008-7#1)(2009-5#1)(2010-4#1)
the final outcome##11##3##(1991-6#1)(1993-5#1)(1994-11#1)(2007-11#2)(2007-7#1)(2008-7#2)(2009-5#1)(2010-4#1)(2011-2#1)
the final part of##2##4##(1993-12#1)(2009-8#1)
the final part##3##3##(1993-12#1)(2009-8#1)(2013-1#1)
the final pathological##2##3##(1990-9#1)(2007-12#1)
the final phase of the##3##5##(2007-3#1)(2007-7#1)(2008-10#1)
the final phase of##5##4##(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)
the final phase##7##3##(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-11#1)
the final preparation##2##3##(1990-11#1)(1992-2#1)
the final product and##2##4##(2008-3#1)(2012-2#1)
the final product##25##3##(1990-7#2)(1994-12#1)(1994-6#1)(1994-8#1)(1996-8#1)(2005-11#3)(2008-10#4)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2010-10#1)(2010-4#1)(2012-12#1)(2012-2#3)
the final products##4##3##(1996-5#1)(2008-10#1)(2008-4#1)(2011-2#1)
the final purification step##2##4##(1990-2#1)(2008-5#1)
the final refractive-index##2##3##(2007-11#1)(2007-12#1)
the final report##2##3##(1990-12#1)(2008-8#1)
the final response##2##3##(2006-10#1)(2008-6#1)
the final restoration##2##3##(2007-12#1)(2008-7#1)
the final result of##2##4##(2007-7#1)(2009-2#1)
the final result##7##3##(2007-11#1)(2007-7#1)(2008-3#1)(2009-2#1)(2011-1#1)(2013-1#2)
the final results##4##3##(2007-12#1)(2008-10#2)(2008-6#1)
the final round##2##3##(1996-5#1)(1997-4#1)
the final rule##5##3##(1996-12#1)(2006-8#4)
the final section##2##3##(2006-10#1)(2008-4#1)
the final set##2##3##(2009-2#1)(2010-2#1)
the final stage of##7##4##(1996-5#1)(2006-1#1)(2008-2#1)(2008-7#2)(2010-10#1)(2012-2#1)
the final stage##9##3##(1993-10#1)(1996-12#1)(1996-5#1)(2006-1#1)(2008-2#1)(2008-7#2)(2010-10#1)(2012-2#1)
the final stages of##9##4##(1990-5#1)(1991-9#1)(1992-4#1)(1996-8#1)(1997-8#1)(2007-12#2)(2008-5#1)(2013-8#1)
the final step in##3##4##(1992-12#1)(2005-12#1)(2005-7#1)
the final step of the##2##5##(2008-12#1)(2008-3#1)
the final step of##8##4##(1993-8#1)(1994-11#1)(1995-9#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)
the final step##15##3##(1991-11#1)(1992-12#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-9#2)(2005-12#1)(2005-7#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)
the final steps of##2##4##(1992-12#1)(1997-7#1)
the final steps##3##3##(1992-12#1)(1997-7#1)(2009-12#1)
the final study##3##3##(1995-5#1)(2007-6#2)
the final two##2##3##(1997-4#1)(2009-4#1)
the final year of##2##4##(2008-11#1)(2008-12#1)
the final year##4##3##(1992-10#1)(2008-11#1)(2008-12#1)(2008-4#1)
the final years of the##2##5##(2006-10#1)(2011-2#1)
the final years##3##3##(1990-6#1)(2006-10#1)(2011-2#1)
the final##431##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#3)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#3)(1993-10#1)(1993-12#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-3#2)(1994-6#2)(1994-8#4)(1994-9#1)(1995-1#2)(1995-11#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#3)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#2)(1996-5#6)(1996-8#2)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#4)(2003-11#1)(2004-9#3)(2005-10#4)(2005-11#12)(2005-12#1)(2005-7#3)(2006-1#3)(2006-10#8)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#6)(2007-1#2)(2007-10#4)(2007-11#10)(2007-12#13)(2007-3#3)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#4)(2007-9#3)(2008-1#4)(2008-10#48)(2008-11#16)(2008-12#4)(2008-2#11)(2008-3#24)(2008-4#13)(2008-5#18)(2008-6#3)(2008-7#16)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#3)(2009-8#6)(2010-1#2)(2010-10#3)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#9)(2011-7#1)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#11)(2013-7#1)(2013-8#6)
the financial and##6##3##(1992-2#1)(1995-3#1)(2006-5#1)(2007-3#1)(2008-11#1)(2012-2#1)
the financial burden##2##3##(1990-12#1)(2008-3#1)
the financial impact of##2##4##(2007-4#2)
the financial impact##3##3##(1990-12#1)(2007-4#2)
the financial implications##2##3##(1997-8#2)
the financial performance of##4##4##(1991-3#1)(1994-12#1)(1994-2#1)(1995-1#1)
the financial resources of##2##4##(1990-12#1)(1992-12#1)
the financial risk##2##3##(1990-12#1)(1993-3#1)
the financial support##2##3##(2007-11#1)(2008-11#1)
the financial viability of##2##4##(2006-8#1)(2008-10#1)
the financial world##2##3##(2010-5#2)
the financial##45##2##(1990-12#4)(1991-12#1)(1991-3#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-12#2)(1994-2#1)(1995-1#1)(1995-3#1)(1997-1#1)(1997-8#2)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#2)(2007-8#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#2)(2011-2#2)(2012-2#1)(2013-8#1)
the financing of##4##3##(1992-1#1)(1993-2#1)(2005-9#1)(2008-10#1)
the financing##7##2##(1992-1#1)(1993-2#1)(1993-3#1)(1994-12#1)(2005-9#1)(2008-10#1)(2012-1#1)
the finding in##2##3##(1997-2#1)(2010-4#1)
the finding is##2##3##(1991-4#1)(2008-6#1)
the finding of a##7##4##(1990-11#1)(1992-9#1)(1993-9#1)(1996-12#1)(2008-5#1)(2013-1#1)(2013-8#1)
the finding of increased##2##4##(1991-12#1)(2010-3#1)
the finding of##32##3##(1990-11#1)(1990-2#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-2#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-7#1)(2005-7#1)(2006-1#1)(2006-10#1)(2007-1#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
the finding that a##2##4##(2008-1#1)(2011-12#1)
the finding that patients##2##4##(1996-3#1)(2009-10#1)
the finding that the##12##4##(1992-5#1)(1993-2#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#2)(1996-12#1)(2004-10#1)(2006-9#1)(2008-10#2)
the finding that##57##3##(1990-4#1)(1991-5#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-2#2)(1993-7#1)(1994-2#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#3)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-5#1)(2004-10#1)(2005-8#1)(2006-4#1)(2006-9#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2009-10#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-12#1)(2013-1#3)(2013-7#1)(2013-8#1)
the finding##97##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-2#2)(1993-7#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#3)(1996-11#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-5#1)(2004-10#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-4#1)(2006-9#2)(2007-1#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-10#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#2)
the findings and recommendations##2##4##(2009-10#1)(2009-5#1)
the findings and##8##3##(1996-2#1)(2007-8#1)(2009-10#1)(2009-5#1)(2012-1#1)(2012-3#1)(2013-1#2)
the findings are discussed##6##4##(1995-1#1)(2007-12#2)(2012-1#1)(2012-2#1)(2013-7#1)
the findings are##16##3##(1991-12#1)(1992-12#1)(1995-1#1)(2005-8#1)(2007-12#3)(2008-1#1)(2008-10#2)(2011-2#1)(2012-1#2)(2012-2#1)(2013-7#1)(2013-8#1)
the findings for the##2##4##(2008-10#1)(2009-5#1)
the findings for##9##3##(1993-11#1)(1994-2#1)(1997-1#1)(2006-7#1)(2007-12#1)(2008-10#1)(2009-12#1)(2009-5#1)(2009-9#1)
the findings from a study##2##5##(1992-11#1)(2007-12#1)
the findings from an##2##4##(2007-12#1)(2008-11#1)
the findings from the##5##4##(2006-12#1)(2006-8#1)(2007-9#1)(2012-3#2)
the findings from this study suggest that##2##7##(2004-11#1)(2006-9#1)
the findings from##19##3##(1991-4#1)(1992-11#1)(1996-6#1)(2004-11#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-12#2)(2007-8#1)(2007-9#2)(2008-11#1)(2009-12#1)(2012-1#1)(2012-12#1)(2012-3#3)
the findings have##2##3##(2008-12#1)(2011-1#1)
the findings in the##2##4##(1995-1#1)(1996-7#1)
the findings in this##2##4##(2008-1#1)(2008-7#1)
the findings in##14##3##(1991-8#1)(1994-3#1)(1995-1#1)(1996-7#1)(2006-10#1)(2008-1#2)(2008-7#2)(2009-3#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#1)
the findings may##3##3##(2007-9#1)(2008-11#1)(2013-1#1)
the findings obtained##2##3##(1991-2#1)(2008-5#1)
the findings of a study##3##5##(1997-3#1)(2008-9#1)(2009-4#1)
the findings of a survey##2##5##(2008-1#1)(2008-11#1)
the findings of a##19##4##(1991-12#1)(1993-5#1)(1995-1#1)(1995-2#1)(1996-3#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-9#2)(2009-4#1)(2013-8#1)
the findings of an##3##4##(1994-2#1)(2007-8#1)(2008-9#1)
the findings of recent studies##4##5##(2006-7#1)(2008-10#1)(2008-3#1)(2010-8#1)
the findings of recent##5##4##(2006-7#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-8#1)
the findings of research##2##4##(2008-11#1)(2008-7#1)
the findings of that##2##4##(1991-3#1)(2006-10#1)
the findings of the assessment of##2##6##(1996-11#1)(2007-1#1)
the findings of the study##3##5##(2007-10#1)(2008-12#1)(2011-1#1)
the findings of the##21##4##(1990-8#1)(1996-11#2)(2006-11#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#2)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
the findings of these studies##3##5##(1996-2#1)(2006-12#1)(2008-11#1)
the findings of these##4##4##(1994-9#1)(1996-2#1)(2006-12#1)(2008-11#1)
the findings of this pilot study##2##6##(1993-1#1)(2008-7#1)
the findings of this study##6##5##(2008-11#1)(2008-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
the findings of this##11##4##(1993-1#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)
the findings of##96##3##(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#1)(1993-1#1)(1993-5#1)(1994-2#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-4#1)(1996-1#1)(1996-11#2)(1996-2#1)(1996-3#1)(1997-3#1)(1997-7#1)(2004-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-3#2)(2007-8#2)(2007-9#3)(2008-1#3)(2008-10#2)(2008-11#9)(2008-12#4)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#6)(2009-10#1)(2009-2#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
the findings on the##2##4##(2008-12#1)(2010-9#1)
the findings on##7##3##(1997-3#1)(1997-8#2)(2006-10#1)(2008-11#1)(2008-12#1)(2010-9#1)
the findings presented here##2##4##(1996-12#1)(2010-8#1)
the findings provide##2##3##(1997-3#1)(2008-11#1)
the findings reported##2##3##(1995-5#1)(2006-6#1)
the findings show that##2##4##(2006-7#1)(2008-10#1)
the findings suggest that these fingerprints may be used for classification and discovery of genetic pathways##2##16##(2013-1#2)
the findings suggest that##5##4##(2006-6#1)(2008-7#2)(2013-1#2)
the findings suggest##7##3##(2006-6#1)(2007-11#1)(2008-7#2)(2008-8#1)(2013-1#2)
the findings suggested that the##2##5##(1993-9#1)(2006-4#1)
the findings suggested that##3##4##(1993-9#1)(2006-4#1)(2013-8#1)
the findings that the##3##4##(1990-4#1)(1997-3#1)(1997-5#1)
the findings that##5##3##(1990-4#1)(1997-3#1)(1997-5#1)(2008-6#1)(2012-2#1)
the findings to##4##3##(1994-3#1)(1995-1#1)(2008-12#1)(2008-7#1)
the findings were##4##3##(1997-5#1)(2006-1#1)(2008-11#1)(2013-8#1)
the findings with##5##3##(1991-2#1)(1994-1#1)(1994-3#1)(2007-2#1)(2012-3#1)
the findings##278##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-2#2)(1994-3#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#4)(1995-2#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-3#4)(1997-5#2)(1997-7#1)(1997-8#2)(2004-11#1)(2004-7#1)(2005-11#1)(2005-8#3)(2006-1#2)(2006-10#3)(2006-11#3)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#9)(2007-2#3)(2007-3#2)(2007-4#2)(2007-7#3)(2007-8#4)(2007-9#8)(2008-1#7)(2008-10#7)(2008-11#20)(2008-12#10)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#7)(2008-8#5)(2008-9#8)(2009-10#3)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#4)(2011-10#1)(2011-2#8)(2012-1#6)(2012-12#3)(2012-2#5)(2012-3#8)(2013-1#9)(2013-7#1)(2013-8#10)
the fine and##3##3##(2006-12#1)(2008-3#1)(2012-1#1)
the fine particle mass##2##4##(1996-2#2)
the fine structure of##6##4##(1992-1#1)(1992-3#1)(2006-12#1)(2007-12#2)(2008-7#1)
the fine structure##8##3##(1992-1#1)(1992-3#1)(2006-12#1)(2007-11#1)(2007-12#3)(2008-7#1)
the fine##37##2##(1992-1#1)(1992-3#1)(1992-6#1)(1993-5#1)(1995-1#1)(1996-2#2)(1997-4#1)(1997-5#1)(2004-9#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-12#2)(2006-4#1)(2007-11#3)(2007-12#4)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#2)(2009-5#1)(2009-8#1)(2012-1#2)
the fine-tuning of##3##3##(1995-9#1)(2006-1#1)(2013-8#1)
the fine-tuning##4##2##(1995-9#1)(2006-1#1)(2009-7#1)(2013-8#1)
the finesse of the##2##4##(2008-2#1)(2008-3#1)
the finest##5##2##(1994-12#1)(2007-4#1)(2008-2#2)(2008-4#1)
the finger and##2##3##(2006-3#1)(2008-2#1)
the finger of##2##3##(1993-2#1)(1994-5#1)
the finger##16##2##(1991-4#1)(1992-5#1)(1993-2#1)(1994-5#1)(2006-3#5)(2008-2#1)(2008-9#3)(2009-2#1)(2009-5#1)(2010-6#1)
the fingernails of##3##3##(2006-12#1)(2010-5#2)
the fingernails##4##2##(2006-12#2)(2010-5#2)
the fingerprint##9##2##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2010-7#1)(2010-8#1)(2013-7#2)
the fingerprints of##2##3##(2006-3#1)(2007-1#1)
the fingerprints##7##2##(1997-2#1)(2006-3#1)(2007-1#1)(2008-2#1)(2011-1#2)(2011-2#1)
the fingers and toes##4##4##(2006-10#2)(2008-6#1)(2012-2#1)
the fingers and##9##3##(2006-10#2)(2006-4#1)(2007-12#1)(2008-5#1)(2008-6#1)(2012-1#2)(2012-2#1)
the fingers of a##2##4##(2005-11#1)(2009-5#1)
the fingers of##3##3##(2005-11#1)(2008-5#1)(2009-5#1)
the fingers##22##2##(1993-11#1)(1997-1#1)(2005-11#1)(2006-10#3)(2006-3#2)(2006-4#1)(2007-12#1)(2008-1#2)(2008-5#2)(2008-6#1)(2009-3#1)(2009-5#1)(2012-1#2)(2012-2#2)(2013-7#1)
the finishing##4##2##(2010-2#1)(2010-7#1)(2012-2#1)(2013-1#1)
the finite difference##2##3##(2006-10#1)(2013-8#1)
the finite element method##2##4##(2005-11#1)(2006-10#1)
the finite element##6##3##(2005-11#1)(2006-10#1)(2006-6#1)(2007-2#1)(2007-4#1)(2013-1#1)
the finite outer scale##3##4##(2008-2#2)(2008-3#1)
the finite sample performance##2##4##(2009-10#1)(2012-1#1)
the finite sample##3##3##(2009-10#1)(2010-11#1)(2012-1#1)
the finite size of the##5##5##(2008-2#3)(2008-3#2)
the finite##31##2##(1990-5#1)(2005-11#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2008-1#1)(2008-2#7)(2008-3#6)(2009-10#1)(2009-6#1)(2010-11#1)(2012-1#1)(2013-1#1)(2013-8#1)
the finite-difference time-domain (FDTD) method##2##5##(2007-11#1)(2008-3#1)
the finite-difference time-domain (FDTD)##3##4##(2007-11#1)(2008-3#2)
the finite-difference time-domain method and##2##5##(2008-2#1)(2008-3#1)
the finite-difference time-domain method##9##4##(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#4)
the finite-difference time-domain##15##3##(2007-11#3)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#8)
the finite-difference##18##2##(1996-8#1)(2006-10#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#9)
the fire origin and at##2##5##(1996-12#2)
the fire severity##2##3##(2013-8#2)
the fire##26##2##(1990-5#1)(1995-6#2)(1996-12#11)(1996-2#1)(2005-9#1)(2006-4#1)(2007-12#2)(2007-3#1)(2008-10#1)(2008-2#1)(2010-3#1)(2013-8#3)
the firefly luciferase gene##5##4##(1994-9#2)(1996-2#1)(1997-1#1)(1997-2#1)
the firefly##7##2##(1990-10#1)(1994-9#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#1)
the firing behavior##2##3##(1993-2#1)(1994-10#1)
the firing distance##2##3##(2013-7#2)
the firing frequency##3##3##(1993-2#1)(1996-8#1)(2008-4#1)
the firing of##5##3##(1993-12#1)(1996-12#1)(2007-8#1)(2008-11#1)(2009-3#1)
the firing pattern of##3##4##(1996-8#1)(2008-11#1)(2008-7#1)
the firing pattern##4##3##(1993-2#1)(1996-8#1)(2008-11#1)(2008-7#1)
the firing process##2##3##(2008-10#2)
the firing rate of GPi cells##2##6##(1996-8#2)
the firing rate of##7##4##(1991-8#1)(1993-6#1)(1995-12#1)(1996-8#2)(1997-5#1)(1997-7#1)
the firing rate##14##3##(1991-8#1)(1993-6#1)(1993-7#1)(1995-12#2)(1996-2#1)(1996-8#2)(1997-5#1)(1997-7#1)(2005-8#1)(2008-11#3)
the firing rates of##2##4##(1995-12#1)(1997-7#1)
the firing rates##3##3##(1995-12#1)(1997-7#1)(2008-11#1)
the firing threshold##2##3##(1994-10#2)
the firing##44##2##(1991-8#2)(1992-8#1)(1993-12#1)(1993-2#4)(1993-6#1)(1993-7#1)(1994-10#3)(1995-12#3)(1996-12#1)(1996-2#1)(1996-8#4)(1997-5#1)(1997-7#2)(2005-8#1)(2007-8#2)(2008-10#3)(2008-11#7)(2008-4#1)(2008-6#1)(2008-7#1)(2009-3#1)(2013-7#2)
the firm##4##2##(1992-3#1)(1993-3#2)(1997-1#1)
the firm's##2##2##(1993-3#1)(1996-11#1)
the first &quot##3##3##(1990-4#1)(2007-9#1)(2012-2#1)
the first 10 days to##2##5##(2008-10#2)
the first 10 days##3##4##(1995-2#1)(2008-10#2)
the first 10 h##2##4##(2008-10#1)(2008-7#1)
the first 10##13##3##(1990-3#1)(1991-12#1)(1993-11#1)(1994-2#1)(1995-2#1)(2007-8#1)(2008-10#4)(2008-7#1)(2008-8#1)(2012-2#1)
the first 100 base pairs upstream of the##2##8##(1994-12#1)(1996-7#1)
the first 100##6##3##(1994-12#2)(1996-7#1)(2007-7#2)(2008-10#1)
the first 12 h##2##4##(1990-3#1)(1992-1#1)
the first 12 months after##2##5##(2008-3#1)(2009-10#1)
the first 12 months of##3##5##(1990-2#1)(2005-8#1)(2012-12#1)
the first 12 months##6##4##(1990-2#1)(2005-8#1)(2007-5#1)(2008-3#1)(2009-10#1)(2012-12#1)
the first 12##14##3##(1990-2#1)(1990-3#1)(1990-7#1)(1992-1#1)(1993-7#1)(2005-8#1)(2006-2#1)(2006-8#1)(2007-5#1)(2008-3#1)(2009-10#1)(2011-2#2)(2012-12#1)
the first 120##2##3##(1992-7#1)(1996-6#1)
the first 14##2##3##(1991-4#1)(2008-7#1)
the first 15 days##3##4##(1990-10#1)(1991-6#1)(2008-10#1)
the first 15##10##3##(1990-10#3)(1991-6#1)(1992-8#1)(1993-6#1)(1994-7#1)(2008-10#2)(2008-2#1)
the first 150 patients##2##4##(1995-11#2)
the first 16 weeks##2##4##(2004-11#1)(2006-6#1)
the first 16##3##3##(1996-3#1)(2004-11#1)(2006-6#1)
the first 173##3##3##(1996-5#3)
the first 19 amino acids##2##5##(1990-11#1)(2008-10#1)
the first 2 cases##2##4##(1996-3#1)(2007-7#1)
the first 2 days##3##4##(2008-11#1)(2011-12#1)(2012-12#1)
the first 2 h##3##4##(2008-10#2)(2008-7#1)
the first 2 months##4##4##(1991-7#1)(2006-10#1)(2007-7#1)(2013-8#1)
the first 2 weeks of treatment##3##6##(1997-8#1)(2008-6#2)
the first 2 weeks of##6##5##(1992-7#1)(1992-8#1)(1997-8#1)(2008-10#1)(2008-6#2)
the first 2 weeks##10##4##(1992-7#1)(1992-8#1)(1995-12#1)(1997-8#1)(2008-10#3)(2008-6#2)(2008-7#1)
the first 2 years after##3##5##(1996-12#1)(2007-8#1)(2008-7#1)
the first 2 years of life##3##6##(1993-1#1)(1997-2#1)(2010-5#1)
the first 2 years of##5##5##(1993-1#1)(1995-1#1)(1997-2#1)(2008-10#1)(2010-5#1)
the first 2 years##11##4##(1991-3#1)(1993-1#1)(1995-1#1)(1996-12#1)(1997-2#1)(2004-2#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-5#1)(2013-1#1)
the first 2##41##3##(1991-3#1)(1991-7#1)(1992-7#2)(1992-8#1)(1993-1#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-8#1)(2004-2#1)(2006-10#1)(2006-9#1)(2007-7#2)(2007-8#1)(2008-10#7)(2008-11#1)(2008-6#2)(2008-7#3)(2008-9#1)(2010-4#1)(2010-5#1)(2011-12#1)(2012-12#1)(2013-1#3)(2013-8#1)
the first 2-4 weeks##2##4##(1990-10#1)(2007-8#1)
the first 20 years##2##4##(2009-12#1)(2013-1#1)
the first 20##10##3##(1992-2#1)(1994-3#1)(1995-5#1)(1995-6#1)(2007-3#1)(2007-8#1)(2008-3#1)(2008-4#1)(2009-12#1)(2013-1#1)
the first 200##4##3##(2007-7#2)(2008-2#1)(2011-2#1)
the first 23##2##3##(1995-5#1)(2008-5#1)
the first 24 h of##3##5##(1994-4#1)(1996-3#1)(2008-11#1)
the first 24 h##15##4##(1990-3#1)(1990-7#1)(1994-4#1)(1994-8#2)(1995-12#1)(1996-3#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2012-3#1)(2013-1#1)
the first 24 hours after##6##5##(1992-4#1)(1992-5#1)(2007-10#1)(2007-8#1)(2007-9#2)
the first 24 hours and##3##5##(2006-2#1)(2008-6#1)(2011-2#1)
the first 24 hours of##3##5##(2007-7#1)(2013-1#2)
the first 24 hours##22##4##(1992-11#1)(1992-4#1)(1992-5#1)(2006-10#1)(2006-2#2)(2007-10#2)(2007-7#1)(2007-8#1)(2007-9#6)(2008-6#1)(2011-12#1)(2011-2#1)(2013-1#2)(2013-7#1)
the first 24 residues##2##4##(1991-10#2)
the first 24##48##3##(1990-3#1)(1990-7#1)(1991-10#2)(1992-11#1)(1992-4#1)(1992-5#1)(1994-11#1)(1994-4#1)(1994-6#1)(1994-8#2)(1995-12#1)(1996-3#1)(1996-6#1)(2006-10#2)(2006-2#2)(2007-10#2)(2007-7#1)(2007-8#4)(2007-9#6)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-4#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
the first 24-hour##3##3##(1993-11#1)(2013-1#2)
the first 25##4##3##(1990-6#1)(2008-9#2)(2012-2#1)
the first 271##2##3##(1990-8#2)
the first 28 days##3##4##(1993-7#2)(2010-8#1)
the first 28##4##3##(1993-7#2)(2006-11#1)(2010-8#1)
the first 3 days after##2##5##(2011-2#2)
the first 3 days of##2##5##(2008-11#1)(2010-11#1)
the first 3 days##6##4##(1994-10#1)(1995-3#1)(2008-11#1)(2010-11#1)(2011-2#2)
the first 3 h##4##4##(1990-11#1)(1994-6#1)(2006-3#1)(2010-12#1)
the first 3 hours##3##4##(2011-2#1)(2013-1#2)
the first 3 months after##2##5##(2011-2#1)(2013-1#1)
the first 3 months of life##3##6##(2008-10#1)(2010-6#1)(2011-1#1)
the first 3 months of##9##5##(1991-6#1)(2007-9#1)(2008-10#1)(2008-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
the first 3 months##15##4##(1991-6#1)(2004-12#2)(2006-8#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the first 3 to##2##4##(2007-11#1)(2011-2#1)
the first 3 weeks of life##3##6##(1994-2#1)(2008-5#1)(2013-1#1)
the first 3 weeks of##5##5##(1994-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2013-1#1)
the first 3 weeks##8##4##(1994-2#1)(1996-3#1)(1996-9#1)(2008-11#1)(2008-5#2)(2008-7#1)(2013-1#1)
the first 3 years##3##4##(1991-3#1)(1992-12#1)(2007-9#1)
the first 3##47##3##(1990-11#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-2#1)(1994-10#1)(1994-2#1)(1994-6#1)(1995-3#1)(1996-3#1)(1996-9#1)(1997-1#1)(2004-12#2)(2005-11#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-5#1)(2007-9#2)(2008-10#1)(2008-11#2)(2008-5#3)(2008-7#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#4)
the first 30 days##3##4##(1994-2#1)(2007-10#1)(2007-8#1)
the first 30 min##3##4##(2008-5#2)(2009-10#1)
the first 30 s##2##4##(1990-2#1)(1992-2#1)
the first 30##12##3##(1990-2#1)(1991-8#1)(1992-2#1)(1994-2#1)(1996-8#1)(2007-10#1)(2007-8#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-9#1)
the first 300##2##3##(2008-11#1)(2012-2#1)
the first 32 amino acids##2##5##(1993-9#1)(1994-9#1)
the first 35 amino acids##3##5##(1994-9#1)(1997-6#2)
the first 35##4##3##(1994-9#1)(1996-6#1)(1997-6#2)
the first 4 days##6##4##(1991-1#1)(1995-11#1)(2006-7#1)(2006-8#1)(2008-3#2)
the first 4 months of##2##5##(1991-10#1)(2005-7#1)
the first 4 weeks of##2##5##(2006-9#1)(2008-7#1)
the first 4 weeks##6##4##(1992-12#1)(2004-11#1)(2006-3#1)(2006-9#1)(2008-10#1)(2008-7#1)
the first 4##20##3##(1990-7#1)(1991-1#1)(1991-10#1)(1992-12#1)(1994-8#1)(1995-11#1)(2004-11#1)(2005-7#1)(2006-3#1)(2006-7#1)(2006-8#1)(2006-9#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-2#1)
the first 40 min##2##4##(1991-6#1)(1995-3#1)
the first 48 h after the##2##6##(1991-4#1)(1992-12#1)
the first 48 hours after##2##5##(2007-10#1)(2013-7#1)
the first 48 hours##6##4##(2006-8#1)(2007-10#3)(2013-7#2)
the first 48##10##3##(1991-4#1)(1992-12#1)(1994-12#1)(2006-8#1)(2007-10#3)(2012-2#1)(2013-7#2)
the first 5 days##3##4##(1993-12#1)(1994-4#2)
the first 5 min and##2##5##(1995-11#1)(2007-2#1)
the first 5 min##6##4##(1991-7#2)(1994-2#1)(1995-1#1)(1995-11#1)(2007-2#1)
the first 5 years after##2##5##(1990-12#1)(2008-9#1)
the first 5 years##6##4##(1990-12#1)(1992-1#1)(1994-12#1)(2008-9#1)(2011-2#1)(2012-1#1)
the first 5##22##3##(1990-12#1)(1991-7#2)(1992-1#1)(1993-12#1)(1993-5#1)(1994-12#1)(1994-2#4)(1994-4#2)(1995-1#1)(1995-11#1)(1995-6#1)(2007-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-1#1)
the first 50 days of##2##5##(2006-3#1)(2007-5#1)
the first 50##4##3##(1990-11#1)(2006-3#1)(2007-5#1)(2012-3#1)
the first 55##2##3##(1997-3#1)(2007-12#1)
the first 6 hours of##2##5##(1991-2#1)(2006-2#1)
the first 6 hours##3##4##(1991-2#1)(2006-2#1)(2013-8#1)
the first 6 months after##3##5##(2011-2#2)(2013-8#1)
the first 6 months of life##2##6##(1991-6#1)(1993-2#1)
the first 6 months of treatment##3##6##(2012-3#1)(2013-7#1)(2013-8#1)
the first 6 months of##5##5##(1991-6#1)(1993-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
the first 6 months##13##4##(1991-6#1)(1992-7#1)(1993-2#1)(2005-8#1)(2007-9#2)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
the first 6 postoperative weeks##2##5##(2006-3#1)(2009-3#1)
the first 6 weeks##6##4##(2007-11#3)(2008-11#1)(2010-2#1)(2011-1#1)
the first 6##32##3##(1991-2#1)(1991-6#1)(1992-4#1)(1992-7#1)(1993-2#1)(1993-9#1)(1996-12#1)(2005-8#1)(2006-2#1)(2006-3#1)(2007-11#3)(2007-8#1)(2007-9#2)(2008-10#2)(2008-11#2)(2009-3#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
the first 60##9##3##(1991-9#1)(1992-12#1)(1992-3#3)(1993-3#2)(1994-12#1)(2006-11#1)
the first 7 d##2##4##(1994-5#1)(2008-8#1)
the first 7 days after the##2##6##(2007-7#1)(2010-4#1)
the first 7 days after##4##5##(1992-10#1)(2007-7#1)(2007-8#1)(2010-4#1)
the first 7 days of life##2##6##(1992-10#1)(1997-3#1)
the first 7 days##9##4##(1992-10#2)(1997-3#1)(2007-10#2)(2007-7#2)(2007-8#1)(2010-4#1)
the first 7##12##3##(1992-10#2)(1994-5#1)(1997-3#1)(2007-10#2)(2007-7#2)(2007-8#1)(2008-11#1)(2008-8#1)(2010-4#1)
the first 71##2##3##(1990-11#1)(1996-12#1)
the first 72##2##3##(1991-2#1)(2012-2#1)
the first 8 months of##2##5##(1991-4#1)(1992-1#1)
the first 8##5##3##(1991-4#1)(1992-1#1)(1992-12#1)(1994-9#1)(2004-11#1)
the first AIDS##2##3##(1997-2#1)(2013-1#1)
the first ATG##2##3##(1990-12#1)(1997-4#1)
the first Born approximation##3##4##(2007-12#1)(2008-2#2)
the first Born##4##3##(2007-12#1)(2008-2#3)
the first Canadian##3##3##(1995-3#1)(2007-12#1)(2007-3#1)
the first HIV##2##3##(2004-12#1)(2009-6#1)
the first International##2##3##(2007-2#1)(2009-4#1)
the first MR##2##3##(2007-10#2)
the first National##3##3##(1992-6#1)(2011-12#1)(2013-7#1)
the first Rytov approximation##3##4##(2008-2#3)
the first Stokes power##2##4##(2007-12#2)
the first Stokes##7##3##(2007-12#5)(2008-2#1)(2008-3#1)
the first X-ray##2##3##(1994-8#1)(2006-5#1)
the first a##3##3##(2008-3#1)(2010-12#1)(2012-12#1)
the first access##2##3##(2007-7#1)(2011-2#1)
the first administration of##2##4##(1993-11#1)(2008-7#1)
the first administration##4##3##(1993-11#1)(2007-11#1)(2008-5#1)(2008-7#1)
the first alternate protocol##2##4##(2008-4#2)
the first amino acid##2##4##(1991-2#1)(1992-7#1)
the first amino##3##3##(1991-2#1)(1992-7#1)(1994-12#1)
the first ammunition##2##3##(2013-7#2)
the first analytical##4##3##(2005-11#1)(2007-8#1)(2008-10#2)
the first and fifth##2##4##(1997-7#1)(2008-10#1)
the first and last##11##4##(1993-4#1)(1996-7#1)(1997-3#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-8#1)(2009-4#1)(2012-12#2)
the first and most##2##4##(2007-11#1)(2008-10#1)
the first and only##3##4##(2005-12#1)(2008-8#1)(2013-8#1)
the first and rate-limiting enzyme##2##5##(1992-8#1)(1993-8#1)
the first and rate-limiting step##2##5##(2010-1#1)(2012-3#1)
the first and rate-limiting##4##4##(1992-8#1)(1993-8#1)(2010-1#1)(2012-3#1)
the first and second SH3 domains##2##6##(1997-4#2)
the first and second days##2##5##(2008-5#2)
the first and second period##2##5##(1996-3#2)
the first and second quarters##2##5##(1996-3#1)(2007-5#1)
the first and second years of##2##6##(1995-8#1)(2008-12#1)
the first and second##47##4##(1990-4#1)(1990-8#1)(1991-1#1)(1991-3#1)(1993-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-3#3)(1996-6#1)(1997-2#1)(1997-4#4)(1997-6#1)(2006-1#1)(2006-2#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-7#1)(2010-12#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
the first and sixth##2##4##(1991-2#1)(1995-1#1)
the first and the second##13##5##(1991-9#1)(1992-6#1)(1994-12#1)(1995-3#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#2)(2010-1#1)
the first and the##15##4##(1990-3#1)(1991-9#1)(1992-6#1)(1994-12#1)(1995-3#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#3)(2010-1#1)
the first and##98##3##(1990-3#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-3#3)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-6#1)(1997-7#1)(2004-11#1)(2005-12#1)(2006-1#2)(2006-10#1)(2006-2#1)(2007-11#3)(2007-12#1)(2007-4#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#2)(2008-8#3)(2008-9#1)(2009-4#1)(2009-7#1)(2010-1#2)(2010-12#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
the first annual##2##3##(2007-9#1)(2008-6#1)
the first appearance of##3##4##(1991-11#1)(2012-12#2)
the first application of##8##4##(1994-2#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#3)
the first application##10##3##(1994-2#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#2)(2008-3#4)
the first applications of##2##4##(2007-12#1)(2010-12#1)
the first approach##5##3##(2008-10#1)(2008-3#1)(2008-5#1)(2012-12#1)(2012-3#1)
the first approved##2##3##(2010-12#1)(2011-1#1)
the first assay for##2##4##(1993-2#1)(2008-10#1)
the first assay##3##3##(1993-2#1)(2008-10#1)(2008-5#1)
the first assessment##5##3##(1993-12#1)(1995-5#1)(2008-10#1)(2009-3#1)(2011-2#1)
the first atomic##3##3##(1993-11#1)(2007-11#1)(2008-12#1)
the first attempt at##2##4##(2006-10#1)(2007-12#1)
the first attempt of##3##4##(1993-11#1)(2007-8#1)(2009-6#1)
the first attempt to##6##4##(1993-5#1)(1997-1#1)(2007-6#1)(2008-10#1)(2008-11#1)(2013-8#1)
the first attempt##17##3##(1992-10#1)(1993-11#1)(1993-5#1)(1997-1#1)(1997-6#1)(2004-10#1)(2006-10#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#1)(2010-2#1)(2013-8#1)
the first attempts to##2##4##(2008-10#1)(2011-1#1)
the first attempts##3##3##(1990-6#1)(2008-10#1)(2011-1#1)
the first author##6##3##(2007-12#1)(2007-8#1)(2008-12#1)(2010-3#1)(2013-1#2)
the first available##2##3##(2008-12#1)(2008-7#1)
the first baby##2##3##(2004-10#1)(2013-1#1)
the first base of the codon CAA##2##7##(1992-11#1)(1994-8#1)
the first base##3##3##(1992-11#1)(1994-8#1)(2008-10#1)
the first basic protocol##4##4##(2008-4#4)
the first basic##5##3##(1992-2#1)(2008-4#4)
the first being##4##3##(1994-6#1)(2008-2#1)(2008-9#1)(2011-2#1)
the first biochemical characterization of##2##5##(1992-3#1)(1996-5#1)
the first biochemical characterization##3##4##(1991-6#1)(1992-3#1)(1996-5#1)
the first biochemical##5##3##(1991-6#1)(1992-3#1)(1992-5#1)(1994-11#1)(1996-5#1)
the first biopsy##3##3##(1991-12#1)(2007-2#1)(2007-8#1)
the first born##2##3##(2007-12#1)(2008-2#1)
the first breast##2##3##(2004-1#1)(2007-5#1)
the first breastfeed is##2##4##(2006-9#2)
the first breastfeed##6##3##(2006-9#6)
the first cDNA##3##3##(1992-5#1)(1994-5#1)(2008-11#1)
the first case and##5##4##(2007-10#2)(2008-5#1)(2010-12#1)(2012-1#1)
the first case in our country##2##6##(1993-10#1)(2013-1#1)
the first case in the##2##5##(2012-2#1)(2013-8#1)
the first case in which##2##5##(2007-12#1)(2010-11#1)
the first case in##11##4##(1993-10#1)(2006-10#1)(2007-12#1)(2007-7#2)(2008-4#1)(2008-6#1)(2010-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
the first case of a patient##2##6##(2009-3#1)(2010-2#1)
the first case of a##9##5##(1997-8#1)(2008-12#1)(2009-3#2)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#2)
the first case of an##3##5##(1996-12#1)(2008-5#1)(2010-12#1)
the first case of##56##4##(1991-12#2)(1993-1#1)(1994-6#1)(1996-12#1)(1996-8#1)(1997-7#1)(1997-8#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-7#5)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-3#3)(2009-8#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
the first case report in Poland##2##6##(2012-12#2)
the first case report of##7##5##(2008-12#1)(2008-3#1)(2008-6#1)(2009-2#1)(2009-4#1)(2012-12#1)(2013-1#1)
the first case report##11##4##(2007-8#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-2#1)(2009-4#1)(2012-12#3)(2012-3#1)(2013-1#1)
the first case reported##3##4##(2007-10#1)(2007-7#2)
the first case was##3##4##(1991-4#1)(2010-11#1)(2012-2#1)
the first case where##2##4##(2006-4#1)(2008-10#1)
the first case##118##3##(1991-12#2)(1991-2#1)(1991-4#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-2#1)(1994-6#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-7#1)(1997-8#1)(2005-11#2)(2005-12#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-7#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#3)(2007-7#10)(2007-8#4)(2008-10#4)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#1)(2009-2#1)(2009-3#4)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#2)
the first cases of##3##4##(2007-2#1)(2011-2#1)(2012-2#1)
the first cause of##4##4##(1996-2#1)(2006-6#1)(2008-1#1)(2011-3#1)
the first cause##6##3##(1996-2#1)(2006-6#1)(2008-1#2)(2008-10#1)(2011-3#1)
the first cell##3##3##(1990-11#1)(2008-10#1)(2008-11#1)
the first cellular##2##3##(1996-5#1)(2007-5#1)
the first challenge##2##3##(1996-6#1)(1997-2#1)
the first characterization of##4##4##(1990-2#1)(1997-4#1)(2010-3#1)(2012-12#1)
the first characterization##5##3##(1990-2#1)(1991-8#1)(1997-4#1)(2010-3#1)(2012-12#1)
the first characterized##4##3##(1995-5#1)(1995-6#1)(2008-9#1)(2011-2#1)
the first chemical characterization of##2##5##(1992-9#1)(1996-4#1)
the first chemical##5##3##(1992-9#1)(1996-4#1)(2008-4#1)(2010-12#2)
the first chemotherapy##4##3##(2007-3#1)(2007-7#1)(2013-1#2)
the first child##2##3##(1991-5#1)(1996-12#1)
the first choice for the##2##5##(2005-3#1)(2012-2#1)
the first choice for##4##4##(2005-3#1)(2011-2#2)(2012-2#1)
the first choice in##3##4##(2007-1#1)(2007-7#1)(2013-1#1)
the first choice of treatment##2##5##(1992-9#1)(2008-5#1)
the first choice of##5##4##(1992-9#2)(2007-8#1)(2008-5#1)(2012-2#1)
the first choice##16##3##(1992-9#2)(2005-3#1)(2007-1#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-5#1)(2008-8#1)(2011-2#2)(2012-2#2)(2013-1#2)
the first cladding##2##3##(2008-3#2)
the first class of##3##4##(1994-11#1)(2005-8#1)(2008-1#1)
the first class##4##3##(1994-11#2)(2005-8#1)(2008-1#1)
the first clear case##2##4##(2008-10#1)(2008-9#1)
the first clear evidence##2##4##(1992-1#1)(2007-9#1)
the first clear##4##3##(1992-1#1)(2007-9#1)(2008-10#1)(2008-9#1)
the first clinical application##2##4##(2007-12#1)(2007-8#1)
the first clinical trial##3##4##(2006-11#1)(2008-5#1)(2010-2#1)
the first clinical trials##3##4##(1997-1#1)(2007-11#1)(2008-3#1)
the first clinical##14##3##(1990-12#1)(1997-1#1)(2005-7#1)(2006-11#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2010-2#1)(2012-2#1)
the first clue to##2##4##(2007-7#1)(2010-4#1)
the first coding exon##3##4##(1990-8#3)
the first codon##2##3##(1990-11#1)(1994-10#1)
the first cohort of##2##4##(2008-11#1)(2012-11#1)
the first cohort##4##3##(2008-11#1)(2011-1#1)(2011-2#1)(2012-11#1)
the first column##3##3##(1990-8#2)(2008-10#1)
the first commercial##3##3##(2008-7#1)(2009-11#1)(2011-1#1)
the first committed step in fatty acid synthesis##2##8##(1994-8#1)(2005-11#1)
the first community-based##2##3##(1997-7#1)(2013-1#1)
the first complete genome sequence of##9##6##(2008-10#1)(2011-2#8)
the first complete genome sequence##11##5##(2008-10#1)(2011-2#10)
the first complete remission##2##4##(2007-3#1)(2011-2#1)
the first complete##13##3##(2007-3#1)(2008-10#1)(2011-2#11)
the first completed genome sequence##15##5##(2011-2#15)
the first completed##17##3##(2011-2#17)
the first complex##2##3##(1997-1#1)(2009-12#1)
the first component of##3##4##(2008-10#1)(2009-8#1)(2011-1#1)
the first component##5##3##(1991-4#1)(1997-4#1)(2008-10#1)(2009-8#1)(2011-1#1)
the first comprehensive##9##3##(1996-12#1)(1996-2#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-8#2)(2013-1#2)
the first condition##3##3##(2008-11#1)(2008-8#1)(2010-2#1)
the first consensus##2##3##(2010-7#1)(2013-1#1)
the first constant domain of##2##5##(1993-6#1)(1997-4#1)
the first constant domain##3##4##(1993-6#2)(1997-4#1)
the first constant##4##3##(1993-6#2)(1997-4#1)(2008-10#1)
the first contact##2##3##(2006-8#1)(2012-12#1)
the first covering standardized terminology (e##2##6##(2013-1#2)
the first crystal##3##3##(1994-9#1)(2006-4#1)(2008-8#1)
the first cycle of chemotherapy##2##5##(2008-7#2)
the first cycle of##4##4##(2008-7#3)(2011-2#1)
the first cycle##7##3##(1990-12#1)(1991-12#1)(2008-7#3)(2011-2#1)(2013-8#1)
the first data##5##3##(1995-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
the first day after##5##4##(1990-12#2)(1996-2#1)(2007-12#1)(2007-8#1)
the first day of life##3##5##(1990-12#1)(1993-12#2)
the first day of##17##4##(1990-12#2)(1991-11#1)(1992-5#1)(1993-12#3)(1993-7#1)(2005-11#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-4#1)(2012-12#1)(2013-1#1)
the first day##33##3##(1990-12#5)(1990-4#1)(1991-11#1)(1991-6#1)(1992-5#1)(1993-12#3)(1993-7#1)(1994-6#1)(1996-2#1)(1997-4#1)(2004-4#1)(2005-11#1)(2005-8#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2010-4#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)
the first days of life##2##5##(2008-3#1)(2008-7#1)
the first days of the##2##5##(2007-8#1)(2008-11#1)
the first days of##9##4##(1990-6#1)(1990-9#1)(1992-6#1)(1997-6#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2012-11#1)
the first days##13##3##(1990-6#1)(1990-9#1)(1992-6#1)(1992-7#1)(1992-9#1)(1997-6#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-11#1)(2012-3#1)
the first decade of life##4##5##(2005-8#1)(2007-7#1)(2007-8#2)
the first decade of the 21st##2##6##(2009-4#1)(2011-1#1)
the first decade of##8##4##(2005-8#1)(2007-7#1)(2007-8#2)(2009-4#1)(2011-1#1)(2012-12#1)(2013-8#1)
the first decade##9##3##(2005-8#1)(2007-7#1)(2007-8#2)(2009-4#1)(2011-1#1)(2012-12#2)(2013-8#1)
the first decades of the##5##5##(2008-7#1)(2009-10#1)(2009-4#2)(2011-2#1)
the first definitive evidence##2##4##(1995-2#1)(2008-10#1)
the first definitive##3##3##(1990-7#1)(1995-2#1)(2008-10#1)
the first demonstration of a##14##5##(1990-12#1)(1992-11#1)(1992-8#1)(1993-9#1)(1994-3#1)(1994-9#1)(2007-12#4)(2008-1#1)(2008-2#2)(2010-12#1)
the first demonstration of an##6##5##(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#1)(2013-1#1)
the first demonstration of the##7##5##(1993-6#1)(1994-12#1)(1994-8#1)(2005-10#1)(2007-11#1)(2008-1#1)(2008-8#1)
the first demonstration of##52##4##(1990-12#1)(1991-5#1)(1992-11#1)(1992-5#1)(1992-8#2)(1993-6#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-7#1)(1996-1#1)(1996-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-12#1)(2007-11#3)(2007-12#15)(2008-1#3)(2008-10#3)(2008-2#2)(2008-4#1)(2008-8#1)(2010-12#1)(2013-1#1)
the first demonstration that##9##4##(1991-8#1)(1994-9#1)(1996-10#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#2)(2012-1#1)
the first demonstration##66##3##(1990-12#1)(1991-11#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-5#1)(1992-8#2)(1993-6#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-7#1)(1996-1#2)(1996-10#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-10#1)(2006-12#1)(2007-11#3)(2007-12#16)(2008-1#3)(2008-10#5)(2008-2#2)(2008-4#1)(2008-8#3)(2010-12#1)(2012-1#1)(2013-1#1)
the first derivative of the ratio spectra##2##7##(2008-10#2)
the first derivative of the ratio##3##6##(2008-10#3)
the first derivative of the##7##5##(1991-5#1)(2006-10#1)(2008-10#3)(2008-2#2)
the first derivative of##10##4##(1991-5#1)(2006-10#1)(2008-10#5)(2008-2#2)(2008-6#1)
the first derivative spectra D(lambda) and RVI of canopy##2##9##(2008-12#2)
the first derivative spectra##5##4##(2008-10#2)(2008-12#2)(2008-6#1)
the first derivative##20##3##(1991-5#1)(2006-10#1)(2008-10#11)(2008-12#2)(2008-2#2)(2008-6#3)
the first described##3##3##(1994-3#1)(1995-8#1)(2008-10#1)
the first description of a##2##5##(2008-5#2)
the first description of the##6##5##(1993-12#1)(1994-5#1)(1997-8#1)(2008-10#1)(2009-7#1)(2013-8#1)
the first description of##18##4##(1993-12#1)(1994-5#1)(1996-1#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-9#1)(2009-3#1)(2009-7#1)(2010-8#1)(2013-8#1)
the first design of a##2##5##(2008-11#1)(2008-2#1)
the first detailed study of##2##5##(2007-8#1)(2008-3#1)
the first detailed##9##3##(1992-12#1)(1995-5#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)
the first diagnosis##2##3##(2006-2#1)(2010-12#1)
the first diagnostic##4##3##(1993-10#1)(1993-8#1)(1995-11#1)(2009-4#1)
the first differential of##2##4##(2008-3#2)
the first diffraction order##3##4##(2008-2#2)(2008-3#1)
the first dimension##5##3##(2008-10#2)(2008-4#2)(2008-7#1)
the first direct evidence that the##3##6##(1990-2#1)(1995-10#1)(2008-10#1)
the first direct evidence that##7##5##(1990-2#1)(1995-10#1)(1995-2#1)(1996-12#1)(2007-7#1)(2008-10#2)
the first direct evidence##8##4##(1990-2#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-12#1)(2007-7#1)(2008-10#2)
the first direct##19##3##(1990-2#1)(1992-1#1)(1993-3#1)(1993-7#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-4#1)(2011-1#1)
the first documentation of##3##4##(1997-3#1)(2007-8#1)(2010-12#1)
the first documented case of##3##5##(2010-8#1)(2012-1#1)(2013-1#1)
the first documented case##4##4##(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#1)
the first documented##10##3##(1996-3#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
the first dorsal interosseous##2##4##(2007-11#1)(2008-9#1)
the first dorsal web space##2##5##(2008-9#2)
the first dorsal##5##3##(2007-11#1)(2008-9#3)(2010-9#1)
the first dose of medication##2##5##(2008-7#1)(2012-12#1)
the first dose of##10##4##(1990-1#1)(1995-3#1)(2007-10#1)(2007-11#2)(2007-2#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#1)
the first dose##20##3##(1990-1#1)(1990-7#1)(1991-12#1)(1995-3#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-2#1)(2008-5#1)(2008-7#3)(2008-9#1)(2012-12#4)(2013-1#1)
the first drug##3##3##(2006-8#1)(2008-9#1)(2011-1#1)
the first eating day##2##4##(2013-8#2)
the first edition of##2##4##(2007-7#1)(2012-12#1)
the first edition##3##3##(2007-7#1)(2008-4#1)(2012-12#1)
the first effective drug##2##4##(1993-8#1)(2008-1#1)
the first effective##3##3##(1993-8#1)(2005-7#1)(2008-1#1)
the first eight##5##3##(1990-11#1)(1994-12#1)(1997-1#1)(2008-10#1)(2008-3#1)
the first empirical##2##3##(2008-3#1)(2008-9#1)
the first endoscopic##2##3##(2006-6#1)(2013-1#1)
the first enzyme in the pathway##2##6##(1991-1#1)(2013-1#1)
the first enzyme in the##5##5##(1991-1#1)(1991-2#1)(1997-6#1)(2008-7#1)(2013-1#1)
the first enzyme in##6##4##(1991-1#1)(1991-2#1)(1997-6#1)(2008-7#1)(2009-10#1)(2013-1#1)
the first enzyme of##2##4##(1990-7#1)(2009-10#1)
the first enzyme##11##3##(1990-12#1)(1990-7#1)(1991-1#1)(1991-2#1)(1994-3#1)(1997-6#1)(2008-5#1)(2008-7#1)(2009-10#2)(2013-1#1)
the first episode of##3##4##(2006-9#1)(2007-8#1)(2008-4#1)
the first episode##7##3##(2006-6#1)(2006-9#1)(2007-8#3)(2008-4#1)(2009-4#1)
the first epoch of##3##4##(2012-12#3)
the first event##2##3##(1990-2#1)(2006-9#1)
the first ever##5##3##(2006-12#1)(2008-8#1)(2010-12#1)(2012-12#2)
the first evidence for a##3##5##(1995-6#1)(1996-5#1)(2012-12#1)
the first evidence for the presence of##2##7##(1990-7#1)(1994-3#1)
the first evidence for the##4##5##(1990-7#1)(1991-12#1)(1994-3#1)(2008-10#1)
the first evidence for##8##4##(1990-7#1)(1991-12#1)(1994-3#1)(1995-6#1)(1996-5#1)(2008-10#1)(2012-12#1)(2013-8#1)
the first evidence of a##3##5##(1993-8#1)(1996-12#1)(2011-2#1)
the first evidence of an##2##5##(1992-8#1)(2008-1#1)
the first evidence of the##3##5##(1996-11#1)(2010-7#1)(2012-12#1)
the first evidence of##20##4##(1990-8#1)(1991-3#1)(1992-2#1)(1992-8#1)(1993-8#1)(1996-11#1)(1996-12#1)(2006-5#1)(2007-7#1)(2008-1#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#1)
the first evidence suggesting##2##4##(1994-6#1)(1997-4#1)
the first evidence that the##2##5##(1993-3#1)(2010-2#1)
the first evidence that##17##4##(1990-7#1)(1991-10#1)(1991-3#1)(1991-7#1)(1993-3#1)(1994-5#1)(2006-2#1)(2007-11#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#1)(2012-1#1)(2013-1#1)(2013-7#1)
the first evidence##49##3##(1990-7#2)(1990-8#1)(1991-10#1)(1991-12#1)(1991-3#2)(1991-7#1)(1992-2#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-4#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
the first examination##8##3##(1991-2#1)(1992-3#1)(1995-4#1)(1996-6#1)(2007-8#1)(2008-5#1)(2008-7#1)(2010-2#1)
the first example of a protein##2##6##(1991-2#1)(1994-11#1)
the first example of a##11##5##(1991-2#1)(1993-12#1)(1994-11#1)(1995-2#1)(1996-3#1)(2006-5#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-5#1)(2012-3#1)
the first example of such##2##5##(1992-12#1)(1993-11#1)
the first example of##28##4##(1991-12#1)(1991-2#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-5#2)(1995-2#1)(1996-3#1)(1996-5#1)(2006-5#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-7#1)(2010-12#1)(2010-5#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
the first example##30##3##(1991-12#1)(1991-2#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-5#2)(1995-2#1)(1996-3#1)(1996-5#1)(2006-12#1)(2006-5#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-7#1)(2010-12#1)(2010-5#4)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
the first examples of##2##4##(1992-3#1)(1996-5#1)
the first exon and intron##2##5##(1991-6#1)(1993-2#1)
the first exon and##7##4##(1991-5#2)(1991-6#1)(1993-2#1)(1993-3#1)(1993-6#1)(1995-3#1)
the first exon of##3##4##(1994-12#1)(2009-5#1)(2012-1#1)
the first exon was##2##4##(1991-2#1)(1992-1#1)
the first exon##19##3##(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#2)(1991-9#1)(1992-1#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-12#2)(1995-3#1)(1996-10#1)(2009-5#1)(2012-1#1)
the first experience##3##3##(2007-10#1)(2007-9#1)(2009-2#1)
the first experiences##2##3##(2006-6#1)(2008-11#1)
the first experiment and##2##4##(2008-10#1)(2008-7#1)
the first experiment##20##3##(1990-10#1)(1993-6#1)(1994-2#1)(1996-12#1)(1997-3#1)(2007-3#1)(2007-4#1)(2007-6#1)(2008-10#6)(2008-5#1)(2008-7#1)(2010-8#2)(2013-1#1)(2013-8#1)
the first experimental demonstration of a##2##6##(2007-12#1)(2012-2#1)
the first experimental demonstration of##9##5##(2007-12#7)(2008-1#1)(2012-2#1)
the first experimental evidence for##2##5##(2008-11#1)(2008-7#1)
the first experimental evidence of##4##5##(2007-11#1)(2007-12#2)(2008-7#1)
the first experimental evidence showing##2##5##(2007-11#1)(2007-12#1)
the first experimental evidence that##2##5##(1990-2#1)(1993-11#1)
the first experimental evidence##11##4##(1990-2#1)(1993-11#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-11#1)(2008-7#2)
the first experimental observation of##4##5##(2007-11#1)(2007-12#2)(2008-1#1)
the first experimental observation##5##4##(2007-11#1)(2007-12#2)(2008-1#1)(2008-3#1)
the first experimental results obtained with##2##6##(2007-12#1)(2008-1#1)
the first experimental study##3##4##(2007-11#1)(2007-12#1)(2013-8#1)
the first experimental##34##3##(1990-2#1)(1993-11#1)(2007-11#4)(2007-12#15)(2007-8#1)(2008-1#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2012-2#1)(2012-3#1)(2013-8#1)
the first extracellular loop and third transmembrane domain##2##8##(1991-10#1)(1996-5#1)
the first extracellular loop##6##4##(1991-10#1)(1993-9#2)(1994-9#1)(1995-3#1)(1996-5#1)
the first extracellular##7##3##(1990-6#1)(1991-10#1)(1993-9#2)(1994-9#1)(1995-3#1)(1996-5#1)
the first feed##2##3##(2007-9#1)(2008-5#1)
the first few days after a transient##2##7##(2008-8#2)
the first few days after the##2##6##(1995-11#1)(1997-5#1)
the first few days after##4##5##(1995-11#1)(1997-5#1)(2008-8#2)
the first few days of##5##5##(1990-9#2)(2007-10#1)(2007-11#1)(2008-5#1)
the first few days##10##4##(1990-9#2)(1995-11#1)(1997-5#1)(2006-11#1)(2007-10#1)(2007-11#1)(2008-5#1)(2008-8#2)
the first few hours after##4##5##(1995-5#1)(2007-9#1)(2008-11#1)(2008-6#1)
the first few hours of the##2##6##(2008-10#1)(2011-2#1)
the first few hours of##3##5##(1995-6#1)(2008-10#1)(2011-2#1)
the first few hours##9##4##(1995-5#1)(1995-6#1)(1996-8#1)(1996-9#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)
the first few minutes##3##4##(1994-2#1)(1996-1#1)(2008-7#1)
the first few months of life##3##6##(1992-7#1)(1993-12#1)(2012-2#1)
the first few months of##5##5##(1992-7#1)(1993-12#1)(1996-9#1)(1997-2#1)(2012-2#1)
the first few months##7##4##(1992-10#1)(1992-7#1)(1993-12#1)(1996-9#1)(1997-2#1)(2012-2#1)(2013-7#1)
the first few weeks##2##4##(2004-3#1)(2009-7#1)
the first few years of##3##5##(1990-1#1)(1996-9#1)(2008-9#1)
the first few years##4##4##(1990-1#1)(1996-9#1)(2007-11#1)(2008-9#1)
the first few##46##3##(1990-1#1)(1990-9#2)(1991-4#1)(1991-5#1)(1992-10#1)(1992-7#1)(1992-8#1)(1993-12#1)(1994-2#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-8#1)(1996-9#4)(1997-2#1)(1997-5#1)(2004-3#1)(2006-11#1)(2007-10#1)(2007-11#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-7#1)
the first five years of its##2##6##(1992-2#1)(2006-8#1)
the first five years of##5##5##(1992-2#1)(1993-1#1)(2006-8#1)(2011-2#2)
the first five years##6##4##(1992-2#1)(1993-1#1)(1993-5#1)(2006-8#1)(2011-2#2)
the first five##19##3##(1990-10#1)(1990-3#1)(1991-10#1)(1992-2#1)(1993-1#1)(1993-3#1)(1993-5#1)(1997-8#1)(2006-8#1)(2007-1#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-2#1)(2011-2#2)
the first follow-up##2##3##(2008-8#1)(2010-12#1)
the first four hours##2##4##(2007-2#2)
the first four weeks##2##4##(2008-5#1)(2011-2#1)
the first four years##2##4##(2008-1#1)(2011-1#1)
the first four##18##3##(1990-3#1)(1991-10#1)(1993-8#1)(1994-11#1)(2007-1#1)(2007-2#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#2)(2012-12#1)
the first fully##4##3##(2008-3#1)(2008-5#1)(2010-3#1)(2010-9#1)
the first fusion protein##2##4##(1991-10#1)(2010-12#1)
the first fusion##3##3##(1991-10#1)(2010-12#1)(2011-3#1)
the first gene##4##3##(1991-5#1)(1996-12#1)(2008-8#1)(2012-2#1)
the first generation of##2##4##(2007-10#1)(2009-12#1)
the first generation##7##3##(1991-6#1)(2007-10#1)(2007-11#2)(2008-5#1)(2009-12#1)(2012-1#1)
the first genetic##5##3##(1995-8#1)(2007-9#1)(2008-11#1)(2011-1#1)(2012-3#1)
the first genome sequence##3##4##(2011-2#3)
the first genome##4##3##(2010-8#1)(2011-2#3)
the first glutamatergic##2##3##(2012-2#2)
the first goal##2##3##(2010-8#1)(2012-2#1)
the first grade##2##3##(2008-10#1)(2008-11#1)
the first group of patients##2##5##(1990-1#1)(2011-1#1)
the first group of##5##4##(1990-1#1)(2008-1#1)(2011-1#1)(2011-2#2)
the first group was##2##4##(2008-11#1)(2010-12#1)
the first group##33##3##(1990-1#1)(1990-10#3)(1990-2#2)(1991-5#1)(1992-8#2)(1993-5#1)(1994-12#1)(1994-6#2)(1996-2#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#3)
the first half of 1991##2##5##(1992-3#1)(1993-3#1)
the first half of the 20th century##2##7##(2006-10#1)(2013-8#1)
the first half of the nineteenth century##2##7##(2009-2#1)(2010-1#1)
the first half of the twentieth century##5##7##(2007-11#1)(2009-7#2)(2010-1#1)(2011-2#1)
the first half of the##19##5##(1994-6#1)(1995-2#1)(2004-11#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-2#2)(2009-7#2)(2009-8#1)(2010-1#2)(2011-2#1)(2013-8#1)
the first half of##30##4##(1990-3#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-6#1)(1995-2#1)(2004-11#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-2#2)(2009-7#2)(2009-8#1)(2010-1#2)(2011-2#3)(2013-7#1)(2013-8#1)
the first half year of##2##5##(1992-1#1)(1992-6#1)
the first half##32##3##(1990-3#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-6#1)(1995-2#1)(2004-11#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-2#2)(2009-7#2)(2009-8#1)(2010-1#2)(2011-2#3)(2013-7#1)(2013-8#1)
the first half-reaction##2##3##(1993-6#2)
the first health##2##3##(2007-2#1)(2009-10#1)
the first home##2##3##(1996-5#1)(2010-5#1)
the first hospital##3##3##(1992-12#1)(2008-9#1)(2011-7#1)
the first hour of##4##4##(1992-2#1)(1993-12#1)(2010-8#1)(2012-1#1)
the first hour##8##3##(1992-2#1)(1992-5#1)(1993-12#1)(2007-7#1)(2008-5#1)(2010-8#1)(2012-1#1)(2013-1#1)
the first hours##2##3##(1992-8#1)(1993-10#1)
the first hundred cases##2##4##(2007-7#2)
the first hyperpolarizability##4##3##(1994-7#1)(2007-11#1)(2007-12#2)
the first identified##2##3##(1997-1#1)(2009-9#1)
the first imaging##3##3##(1993-6#1)(2010-6#1)(2012-2#1)
the first in a series of##3##6##(1996-3#1)(2007-6#1)(2008-4#1)
the first in a series##8##5##(1990-12#1)(1993-2#1)(1993-3#1)(1996-3#1)(2005-7#1)(2007-6#1)(2008-2#1)(2008-4#1)
the first in a##12##4##(1990-12#1)(1990-2#1)(1993-2#1)(1993-3#1)(1996-3#1)(2005-7#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)
the first in the##2##4##(2006-10#1)(2012-2#1)
the first in vivo evidence that##2##6##(1990-8#1)(2012-12#1)
the first in vivo study##2##5##(2010-12#1)(2010-5#1)
the first in vivo##8##4##(1990-8#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#1)
the first in##26##3##(1990-12#1)(1990-2#1)(1990-8#1)(1992-10#1)(1992-12#1)(1993-2#1)(1993-3#1)(1996-3#1)(2005-7#1)(2006-10#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)
the first index##2##3##(1995-8#1)(2009-8#1)
the first indication that##2##4##(2009-2#1)(2010-4#1)
the first indications of##2##4##(2006-8#1)(2009-8#1)
the first infestation##2##3##(1996-12#2)
the first influenza##2##3##(2010-4#1)(2012-1#1)
the first injection of##8##4##(1990-12#1)(1992-4#1)(1993-11#1)(1997-2#2)(2005-8#1)(2007-7#1)(2013-8#1)
the first injection##13##3##(1990-12#1)(1992-4#1)(1993-11#1)(1997-2#4)(2005-8#1)(2006-8#1)(2007-7#1)(2009-10#1)(2011-2#1)(2013-8#1)
the first inoculation##2##3##(2008-10#1)(2008-5#1)
the first insights into the##2##5##(2008-9#1)(2010-1#1)
the first instance of a##3##5##(1990-10#1)(2008-12#1)(2010-2#1)
the first instance of##6##4##(1990-10#1)(1993-11#1)(1995-7#1)(2008-11#1)(2008-12#1)(2010-2#1)
the first instance##15##3##(1990-10#1)(1992-11#1)(1992-8#1)(1993-11#1)(1995-7#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
the first international##5##3##(1990-11#1)(2006-9#1)(2012-2#1)(2013-8#2)
the first intervention##3##3##(2007-12#1)(2012-2#1)(2013-1#1)
the first intron and##2##4##(1990-4#1)(1994-12#1)
the first intron of the##7##5##(1990-9#1)(1991-11#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-7#1)(2012-3#1)
the first intron of##10##4##(1990-9#1)(1991-11#1)(1992-6#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-7#1)(2008-3#1)(2008-9#1)(2012-3#1)
the first intron##28##3##(1990-4#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-6#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-5#1)(1997-7#1)(2008-3#1)(2008-9#5)(2010-5#1)(2012-3#2)
the first investigation of##2##4##(2007-12#1)(2009-10#1)
the first investigation##6##3##(1993-10#1)(1996-3#1)(2007-12#1)(2008-6#1)(2009-10#1)(2013-8#1)
the first is##4##3##(1991-9#1)(2008-4#1)(2008-8#1)(2011-2#1)
the first ischemia##2##3##(1996-12#2)
the first isolation of##2##4##(2011-2#1)(2012-12#1)
the first issue of##2##4##(2008-10#1)(2013-8#1)
the first issue##4##3##(1997-2#1)(2008-10#1)(2013-1#1)(2013-8#1)
the first kinetic##2##3##(1997-2#1)(2006-12#1)
the first known case##3##4##(2011-2#1)(2013-1#2)
the first known##12##3##(1992-5#1)(1994-12#1)(1996-6#1)(2007-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#4)
the first large scale##2##4##(2007-10#1)(2008-6#1)
the first large##3##3##(2007-10#1)(2008-6#1)(2008-8#1)
the first larval stage##2##4##(1996-2#1)(2007-12#1)
the first larval##3##3##(1996-11#1)(1996-2#1)(2007-12#1)
the first layer##7##3##(1996-12#1)(2008-12#1)(2008-2#4)(2008-3#1)
the first line and##2##4##(1992-7#1)(2012-1#1)
the first line antibiotic according to the local guidelines##2##9##(2013-8#2)
the first line of defense against##2##6##(1993-12#1)(2008-11#1)
the first line of defense in##2##6##(2007-12#1)(2008-10#1)
the first line of defense##4##5##(1993-12#1)(2007-12#1)(2008-10#1)(2008-11#1)
the first line of host##2##5##(2008-1#1)(2010-9#1)
the first line of treatment##2##5##(2007-11#1)(2013-8#1)
the first line of##18##4##(1993-12#1)(1994-8#1)(2005-11#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
the first line treatment##2##4##(2006-5#1)(2011-2#1)
the first line##35##3##(1992-7#1)(1993-12#1)(1994-8#1)(1996-7#1)(2005-11#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#4)
the first loop##2##3##(1990-7#1)(1997-5#1)
the first major##8##3##(1990-12#1)(2007-11#1)(2007-8#1)(2008-10#3)(2012-1#1)(2013-1#1)
the first mammalian##2##3##(1997-4#1)(2012-2#1)
the first manifestation of the disease##2##6##(2007-2#1)(2008-9#1)
the first manifestation of the##4##5##(2006-10#1)(2007-2#1)(2008-9#1)(2011-2#1)
the first manifestation of##8##4##(1991-3#1)(1996-11#2)(2006-10#1)(2007-2#1)(2008-9#2)(2011-2#1)
the first manifestation##11##3##(1991-3#1)(1996-11#2)(2006-10#1)(2007-2#1)(2008-9#2)(2011-2#2)(2012-2#1)(2013-7#1)
the first meal##2##3##(1994-12#2)
the first measurement##3##3##(2010-5#2)(2012-8#1)
the first measurements of the##3##5##(2007-12#3)
the first measurements of##5##4##(2007-12#3)(2008-2#1)(2008-7#1)
the first measurements##6##3##(1990-8#1)(2007-12#3)(2008-2#1)(2008-7#1)
the first mechanism##3##3##(1993-9#1)(1995-1#1)(1996-4#1)
the first medical##4##3##(1990-12#1)(2007-5#1)(2013-1#2)
the first meeting##2##3##(2009-6#2)
the first member of##4##4##(1990-5#1)(1997-2#1)(2008-10#1)(2008-8#1)
the first member##5##3##(1990-5#1)(1995-8#1)(1997-2#1)(2008-10#1)(2008-8#1)
the first metacarpal##5##3##(1997-1#1)(2006-4#1)(2008-9#3)
the first metatarsal##7##3##(2007-11#1)(2008-12#5)(2013-7#1)
the first metatarsophalangeal joint##5##4##(2008-12#2)(2009-10#1)(2010-5#2)
the first method of##2##4##(1994-2#1)(2010-12#1)
the first method##10##3##(1992-8#1)(1994-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2010-12#2)(2010-5#1)
the first methods##2##3##(1990-8#1)(2008-10#1)
the first minute##2##3##(1990-5#1)(1997-7#1)
the first minutes of##3##4##(1994-3#1)(1996-9#1)(2012-1#1)
the first minutes##4##3##(1994-3#1)(1996-3#1)(1996-9#1)(2012-1#1)
the first mode-locked Yb##2##4##(2007-11#1)(2007-12#1)
the first molecular##3##3##(1997-3#1)(2009-2#1)(2012-12#1)
the first month after##2##4##(1993-2#1)(1996-9#1)
the first month of life##6##5##(1990-8#1)(1992-7#2)(1996-10#1)(2006-10#1)(2008-4#1)
the first month of##13##4##(1990-8#1)(1992-7#2)(1993-2#1)(1996-10#1)(1996-8#1)(1997-8#1)(2006-10#2)(2008-10#1)(2008-4#1)(2008-9#2)
the first month##25##3##(1990-8#1)(1992-7#2)(1993-2#2)(1996-10#1)(1996-8#2)(1996-9#3)(1997-8#1)(2006-10#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-4#1)(2012-2#1)
the first months of##3##4##(1990-10#1)(2007-11#1)(2013-1#1)
the first months##5##3##(1990-10#1)(1996-8#1)(2004-4#1)(2007-11#1)(2013-1#1)
the first movement##3##3##(1993-5#3)
the first national##3##3##(1997-8#1)(2007-4#1)(2011-2#1)
the first new##2##3##(2005-8#1)(2008-2#1)
the first nine##3##3##(1997-4#2)(2006-10#1)
the first nucleotide of the##2##5##(1990-3#1)(2006-11#1)
the first nucleotide of##3##4##(1990-3#1)(1995-3#1)(2006-11#1)
the first objective##2##3##(2008-3#1)(2008-9#1)
the first observation of a##3##5##(2007-11#2)(2007-12#1)
the first observation of##14##4##(1991-5#1)(1993-6#1)(2007-11#4)(2007-12#6)(2008-2#1)(2008-7#1)
the first observation##19##3##(1991-5#2)(1993-6#1)(2007-11#4)(2007-12#7)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)
the first observations##2##3##(2007-11#1)(2010-11#1)
the first of a series of##2##6##(2008-5#1)(2008-9#1)
the first of a##5##4##(1994-12#1)(1995-5#1)(2007-2#1)(2008-5#1)(2008-9#1)
the first of its kind in##2##6##(1990-3#1)(2012-2#1)
the first of its kind##4##5##(1990-3#1)(2008-12#1)(2010-12#1)(2012-2#1)
the first of its##5##4##(1990-3#1)(1995-12#1)(2008-12#1)(2010-12#1)(2012-2#1)
the first of the three##3##5##(1996-6#1)(2012-12#2)
the first of the two##2##5##(1996-3#1)(2010-6#1)
the first of the##8##4##(1994-5#1)(1995-10#1)(1996-3#1)(1996-6#1)(2005-8#1)(2010-6#1)(2012-12#2)
the first of their##2##4##(2008-2#1)(2012-2#1)
the first of these##5##4##(1996-2#1)(2006-11#1)(2006-3#1)(2008-10#1)(2011-1#1)
the first of three##2##4##(1991-4#1)(1997-5#1)
the first of two##3##4##(1993-1#1)(2005-8#1)(2009-3#1)
the first of which##4##4##(1997-5#1)(2005-8#1)(2007-12#1)(2008-4#1)
the first of##43##3##(1990-3#1)(1991-4#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-5#2)(2005-8#3)(2006-10#1)(2006-11#1)(2006-3#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-12#2)(2010-6#1)(2011-1#1)(2012-12#2)(2012-2#2)
the first one in##2##4##(1992-5#1)(2011-2#1)
the first one is the##2##5##(2008-7#1)(2009-10#1)
the first one to##4##4##(1992-6#1)(2007-12#1)(2008-10#1)(2013-1#1)
the first one##28##3##(1992-5#1)(1992-6#1)(1993-2#1)(1994-3#1)(1994-6#1)(1995-8#1)(1997-4#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-11#2)(2011-2#1)(2013-1#1)
the first open##2##3##(1995-2#1)(1997-3#1)
the first operation of##2##4##(2007-12#2)
the first operation##8##3##(1991-3#1)(1996-6#1)(2007-12#2)(2007-7#1)(2008-7#1)(2010-12#1)(2013-8#1)
the first optical##4##3##(2006-4#1)(2007-12#2)(2008-2#1)
the first or second##7##4##(1992-7#1)(2006-5#1)(2007-4#1)(2008-7#2)(2009-10#1)(2012-2#1)
the first or the second##2##5##(1993-4#1)(2008-3#1)
the first or##11##3##(1990-8#1)(1992-7#1)(1993-4#1)(2006-5#1)(2007-4#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-10#1)(2012-2#1)
the first order of##2##4##(2008-2#1)(2008-3#1)
the first order##13##3##(2006-4#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#3)(2009-9#1)
the first orthopedic##2##3##(2007-7#1)(2008-8#1)
the first outbreak##2##3##(2008-5#1)(2011-1#1)
the first overview of##2##4##(1993-2#1)(2009-3#1)
the first oxygen molecule##2##4##(1993-8#1)(1994-9#1)
the first pair##2##3##(1992-11#1)(2007-3#1)
the first part of a##4##5##(1995-12#1)(2005-5#1)(2008-11#1)(2013-8#1)
the first part of the study##3##6##(1992-5#1)(2006-8#1)(2008-1#1)
the first part of the##12##5##(1990-3#2)(1990-9#1)(1992-5#1)(1992-6#1)(1996-6#1)(1997-4#1)(2006-8#1)(2008-1#1)(2008-5#2)(2011-2#1)
the first part of this##10##5##(2006-10#2)(2007-6#1)(2008-1#1)(2008-10#2)(2008-2#1)(2009-6#1)(2010-12#1)(2012-2#1)
the first part of##26##4##(1990-3#2)(1990-9#1)(1992-5#1)(1992-6#1)(1995-12#1)(1996-6#1)(1997-4#1)(2005-5#1)(2006-10#2)(2006-8#1)(2007-6#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#2)(2009-6#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
the first part##31##3##(1990-3#2)(1990-9#1)(1992-5#1)(1992-6#1)(1994-6#1)(1995-12#1)(1996-6#1)(1997-4#1)(2005-5#1)(2006-10#2)(2006-8#1)(2007-6#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#2)(2009-6#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
the first pass##2##3##(2007-11#1)(2007-7#1)
the first passage##5##3##(2006-10#2)(2008-10#2)(2008-7#1)
the first patient who##2##4##(1993-7#1)(1995-11#1)
the first patient##11##3##(1990-4#1)(1990-8#1)(1991-8#1)(1993-7#2)(1995-11#1)(2006-12#1)(2006-7#1)(2007-7#1)(2008-4#1)(2009-1#1)
the first patients##2##3##(1996-7#1)(1997-3#1)
the first peak of##4##4##(1992-11#1)(1992-12#1)(1996-12#2)
the first peak was##2##4##(1991-10#1)(1996-3#1)
the first peak##10##3##(1991-10#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-9#1)(1996-12#2)(1996-3#1)(2008-3#1)(2010-3#1)
the first pediatric case##2##4##(2008-10#1)(2013-1#1)
the first period##7##3##(1992-10#1)(1996-11#1)(2008-10#1)(2011-2#3)(2012-1#1)
the first permanent molars##3##4##(1995-2#1)(2012-12#1)(2013-1#1)
the first permanent##4##3##(1995-2#1)(2012-12#1)(2013-1#2)
the first phase in##2##4##(2007-4#1)(2008-9#1)
the first phase is##2##4##(1994-11#1)(2007-7#1)
the first phase of the##3##5##(1993-3#1)(2007-4#1)(2008-6#1)
the first phase of this##2##5##(2007-5#1)(2008-12#1)
the first phase of##9##4##(1993-3#1)(1993-9#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-6#1)
the first phase##28##3##(1990-12#1)(1992-3#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-12#2)(2006-10#1)(2007-12#1)(2007-4#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-6#1)(2011-3#1)(2012-2#2)
the first phenotype replicate##2##4##(2012-3#2)
the first phenotype##3##3##(2009-8#1)(2012-3#2)
the first place in##2##4##(2007-3#1)(2008-1#1)
the first place##18##3##(1990-9#1)(1996-9#1)(2005-10#1)(2006-10#1)(2007-11#3)(2007-3#1)(2008-1#2)(2008-11#1)(2008-9#3)(2009-11#1)(2009-6#1)(2009-7#1)(2011-2#1)
the first plant##3##3##(1994-6#2)(2009-8#1)
the first point of##3##4##(2008-2#2)(2011-1#1)
the first point##5##3##(2006-6#1)(2008-2#2)(2008-6#1)(2011-1#1)
the first polar body##3##4##(2008-9#1)(2013-1#2)
the first population##2##3##(1990-12#1)(2008-10#1)
the first population-based##2##3##(2007-11#1)(2007-8#1)
the first post-operative day##3##4##(2007-2#2)(2008-1#1)
the first posterior##2##3##(2008-12#1)(2008-8#1)
the first postnatal week but##2##5##(1997-2#2)
the first postnatal week##6##4##(1991-3#1)(1995-3#1)(1996-3#1)(1997-2#3)
the first postnatal##10##3##(1991-3#1)(1992-7#1)(1993-3#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-2#3)(2007-5#1)
the first postoperative day##7##4##(1990-2#1)(2006-6#1)(2007-1#1)(2007-10#1)(2008-8#1)(2010-4#1)(2011-1#1)
the first postoperative hour##2##4##(2006-12#2)
the first postoperative##11##3##(1990-2#1)(1992-3#1)(1993-5#1)(2006-12#2)(2006-6#1)(2007-1#1)(2007-10#1)(2008-8#1)(2010-4#1)(2011-1#1)
the first poststroke week##2##4##(2007-10#2)
the first pregnancy##3##3##(1992-6#1)(2010-12#2)
the first prescription of##2##4##(1996-9#1)(2008-8#1)
the first presentation of##4##4##(2007-8#1)(2008-4#1)(2010-9#1)(2011-2#1)
the first presenting##2##3##(2008-10#1)(2008-3#1)
the first principal##3##3##(2010-12#2)(2013-1#1)
the first priorities##2##3##(2006-8#1)(2008-10#1)
the first priority##4##3##(1992-12#1)(2006-12#1)(2010-7#1)(2010-8#1)
the first procedure##3##3##(1997-8#1)(2006-8#1)(2008-10#1)
the first proof of##2##4##(1997-4#1)(2012-1#1)
the first proof##3##3##(1990-7#1)(1997-4#1)(2012-1#1)
the first proteasome inhibitor to have shown##2##7##(2008-1#2)
the first prototype##2##3##(2006-6#1)(2008-10#1)
the first public##2##3##(2008-7#1)(2009-6#1)
the first publication of##2##4##(2006-7#1)(2008-10#1)
the first publication##3##3##(2006-7#1)(2007-8#1)(2008-10#1)
the first published case of##2##5##(1990-6#1)(2008-5#1)
the first published case##3##4##(1990-12#1)(1990-6#1)(2008-5#1)
the first published##8##3##(1990-12#1)(1990-6#1)(1997-8#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-2#1)
the first quantitative##7##3##(1994-3#2)(1995-3#1)(2008-10#1)(2008-2#1)(2012-2#1)(2012-3#1)
the first quarter of##3##4##(2007-2#1)(2008-5#2)
the first randomized##4##3##(2004-1#1)(2012-2#1)(2013-1#2)
the first rationalistic##2##3##(2008-11#2)
the first reaction##4##3##(2008-10#3)(2010-5#1)
the first real-time##2##3##(2007-12#1)(2008-7#1)
the first realization of##2##4##(2007-12#1)(2011-1#1)
the first record of##6##4##(1997-4#1)(2007-3#2)(2008-10#2)(2010-8#1)
the first record##7##3##(1997-4#1)(2007-3#2)(2008-10#3)(2010-8#1)
the first recorded##3##3##(2005-5#1)(2007-2#1)(2008-5#1)
the first records##2##3##(2011-1#1)(2013-7#1)
the first reflection##2##3##(2008-2#2)
the first report concerning##4##4##(1992-1#1)(1995-11#1)(2008-5#1)(2011-1#1)
the first report from##3##4##(2007-9#1)(2008-10#1)(2013-8#1)
the first report in the##4##5##(2008-5#1)(2009-3#2)(2012-2#1)
the first report in##9##4##(1990-12#1)(2008-1#1)(2008-5#2)(2009-3#2)(2010-3#1)(2012-2#1)(2013-8#1)
the first report of a##25##5##(1992-2#1)(1992-9#1)(1994-10#1)(1995-10#1)(1995-5#1)(1995-9#1)(2006-1#1)(2007-2#1)(2008-10#6)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#2)(2011-2#1)(2012-12#3)(2013-1#1)(2013-8#1)
the first report of an##10##5##(1990-9#1)(1991-9#1)(1992-10#1)(2006-12#1)(2007-8#1)(2008-3#1)(2008-5#1)(2013-1#2)(2013-8#1)
the first report of the##22##5##(1990-7#1)(1992-8#1)(1993-9#2)(1994-11#1)(1996-7#1)(1997-2#1)(2006-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
the first report of this##5##5##(1990-6#1)(1992-3#1)(1994-9#1)(2007-2#1)(2013-7#1)
the first report of##136##4##(1990-3#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-4#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#6)(2006-12#3)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-6#1)(2007-7#2)(2007-8#5)(2008-10#26)(2008-11#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-5#1)(2009-7#2)(2009-8#2)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#6)
the first report on induction of##2##6##(1994-9#1)(2008-10#1)
the first report on##30##4##(1990-4#1)(1993-11#1)(1994-3#1)(1994-9#1)(2007-1#1)(2007-3#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#2)(2009-6#1)(2011-2#2)(2012-12#2)(2012-2#1)
the first report that##15##4##(1991-8#1)(1994-6#2)(1996-5#1)(2005-11#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
the first report to##8##4##(1990-5#1)(1991-8#1)(1992-6#1)(2007-12#1)(2007-3#1)(2009-12#1)(2010-2#1)(2012-2#1)
the first report##229##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#3)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-5#2)(1995-6#2)(1995-9#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-11#2)(2006-1#1)(2006-10#6)(2006-12#5)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#4)(2007-3#2)(2007-6#1)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#44)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#4)(2009-1#1)(2009-12#2)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-2#2)(2010-3#2)(2010-4#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#10)(2012-2#6)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#8)
the first reported case of a##7##6##(2007-12#1)(2007-8#1)(2008-5#1)(2008-7#2)(2012-2#1)(2013-1#1)
the first reported case of such a##2##7##(2010-7#1)(2012-2#1)
the first reported case of such an##2##7##(2008-10#1)(2008-11#1)
the first reported case of such##4##6##(2008-10#1)(2008-11#1)(2010-7#1)(2012-2#1)
the first reported case of##43##5##(1996-3#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
the first reported case##49##4##(1991-2#1)(1991-9#1)(1994-9#1)(1996-3#1)(2006-10#3)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
the first reported##68##3##(1990-12#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-8#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-3#1)(2006-10#5)(2006-7#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
the first reports of##3##4##(2007-8#1)(2008-4#1)(2012-12#1)
the first reports##5##3##(2006-10#1)(2007-8#1)(2008-4#1)(2008-5#1)(2012-12#1)
the first representative of Pfam family##3##6##(2010-10#3)
the first research##2##3##(2010-2#1)(2012-2#1)
the first response##2##3##(1993-5#1)(1994-12#1)
the first results##2##3##(1997-4#1)(2007-5#1)
the first round of##5##4##(1995-12#1)(1997-4#1)(2007-11#2)(2008-3#1)
the first round##8##3##(1991-6#2)(1995-12#1)(1997-4#1)(2007-11#3)(2008-3#1)
the first saccade##3##3##(2009-2#3)
the first sample##2##3##(2008-10#2)
the first sampling##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
the first scan##2##3##(1996-5#1)(2010-8#1)
the first season##2##3##(2008-10#2)
the first second##8##3##(1990-5#1)(2007-8#1)(2010-2#1)(2013-1#2)(2013-8#3)
the first section##3##3##(1992-6#1)(2008-4#1)(2010-4#1)
the first selective serotonin##2##4##(2006-10#1)(2012-2#1)
the first semester nursing##2##4##(2007-10#2)
the first semester of##2##4##(1991-12#1)(2012-3#1)
the first semester##6##3##(1991-12#1)(2007-10#2)(2008-10#1)(2012-3#2)
the first sensor##2##3##(2007-3#1)(2008-10#1)
the first sequence##4##3##(2008-10#1)(2008-4#1)(2011-2#2)
the first series of##2##4##(1994-7#1)(2008-1#1)
the first series##4##3##(1994-7#1)(2008-1#1)(2008-5#1)(2011-2#1)
the first session of##2##4##(2010-8#1)(2012-2#1)
the first session##4##3##(1992-5#1)(2008-5#1)(2010-8#1)(2012-2#1)
the first set of experiments##3##5##(1995-12#1)(1997-2#1)(2004-9#1)
the first set of neurons##2##5##(2012-2#2)
the first set of##6##4##(1995-12#1)(1997-2#1)(2004-9#1)(2008-7#1)(2012-2#2)
the first set##7##3##(1995-12#1)(1997-2#1)(2004-9#1)(2008-7#1)(2012-2#2)(2013-1#1)
the first several##2##3##(2007-8#1)(2013-1#1)
the first shot##2##3##(2012-1#1)(2013-7#1)
the first sign of the problem is observed after careful evaluation of the resting ECG for the hallmark of the disorder##2##21##(2011-2#2)
the first sign of##9##4##(1993-2#1)(1996-1#1)(2005-11#1)(2006-10#2)(2007-11#1)(2011-2#3)
the first signs of##3##4##(2007-9#1)(2008-5#1)(2011-2#1)
the first simulated replicate##2##4##(2012-3#2)
the first simultaneous##2##3##(2007-12#1)(2008-1#1)
the first six months of##5##5##(1991-5#2)(1996-11#1)(2006-8#1)(2007-3#1)
the first six months##10##4##(1991-10#1)(1991-3#1)(1991-5#2)(1991-6#1)(1996-11#2)(2006-8#1)(2007-3#1)(2008-2#1)
the first six weeks##3##4##(1992-1#1)(2007-8#1)(2011-1#1)
the first six##16##3##(1991-10#1)(1991-3#1)(1991-5#2)(1991-6#1)(1992-1#1)(1993-2#1)(1996-11#2)(2006-8#1)(2007-3#1)(2007-8#2)(2008-2#1)(2008-5#1)(2011-1#1)
the first soaking period##2##4##(2006-7#2)
the first sonication##2##3##(2008-10#2)
the first species##3##3##(2007-6#1)(2008-12#1)(2008-5#1)
the first specific##4##3##(1996-4#1)(1997-8#1)(2007-3#1)(2013-8#1)
the first stage and##2##4##(2006-3#1)(2007-8#1)
the first stage involves##2##4##(2012-12#1)(2012-3#1)
the first stage is##2##4##(1997-2#1)(2008-10#1)
the first stage of labor##3##5##(1994-6#2)(2006-10#1)
the first stage of the##5##5##(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#2)
the first stage of##16##4##(1990-2#1)(1992-1#1)(1992-5#1)(1994-6#2)(1997-8#1)(2006-10#1)(2008-10#2)(2008-5#2)(2008-9#1)(2011-2#3)(2012-2#1)
the first stage the##2##4##(2009-5#1)(2012-12#1)
the first stage##35##3##(1990-12#1)(1990-2#1)(1992-1#1)(1992-5#1)(1994-6#3)(1997-2#2)(1997-8#1)(2005-11#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-9#1)(2009-3#1)(2009-5#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#1)
the first stages of the titration##2##6##(2008-10#2)
the first stages of##8##4##(2004-9#1)(2005-5#1)(2008-10#2)(2008-12#1)(2009-8#1)(2011-2#1)(2013-7#1)
the first state##3##3##(1995-12#1)(1996-3#1)(2011-1#1)
the first step at##2##4##(1997-7#1)(2012-2#1)
the first step being##2##4##(1990-7#1)(2009-4#1)
the first step consists in the characterisation of the environmental fungal risk and the second one in proposing risk management methods##2##21##(2012-11#2)
the first step for##6##4##(1993-8#1)(1996-3#1)(2005-10#1)(2008-10#1)(2013-1#2)
the first step in a##5##5##(1991-8#1)(1994-10#1)(1995-12#1)(2006-6#1)(2008-10#1)
the first step in the development of an##2##8##(1995-2#1)(2010-7#1)
the first step in the##13##5##(1994-8#1)(1995-2#2)(1996-1#1)(1997-1#1)(1997-8#1)(2004-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2010-10#1)(2010-7#1)
the first step in##34##4##(1990-7#1)(1991-7#1)(1991-8#1)(1994-10#1)(1994-3#2)(1994-8#1)(1995-12#1)(1995-2#2)(1996-1#1)(1997-1#1)(1997-8#1)(2004-8#1)(2005-10#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-6#2)(2009-2#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-2#1)
the first step is##2##4##(1995-12#1)(2009-8#1)
the first step of a##3##5##(1997-5#1)(2008-10#1)(2010-10#1)
the first step of the##4##5##(1992-8#1)(2008-12#1)(2008-5#1)(2013-8#1)
the first step of##20##4##(1991-2#1)(1992-8#1)(1994-8#1)(1995-8#1)(1996-1#1)(1997-5#1)(2007-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-10#1)(2011-2#1)(2013-8#2)
the first step to##6##4##(1992-12#1)(2004-12#1)(2008-4#1)(2008-9#1)(2011-2#2)
the first step toward the development of##2##7##(2009-1#1)(2009-4#1)
the first step toward##6##4##(1990-11#1)(2005-11#1)(2008-4#1)(2008-6#1)(2009-1#1)(2009-4#1)
the first step towards the##3##5##(2008-4#1)(2012-11#2)
the first step towards##4##4##(2008-4#1)(2008-9#1)(2012-11#2)
the first step##107##3##(1990-11#1)(1990-2#1)(1990-7#2)(1991-2#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-8#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-3#6)(1994-8#2)(1995-12#2)(1995-2#2)(1995-8#1)(1996-1#2)(1996-3#1)(1997-1#1)(1997-5#1)(1997-7#1)(1997-8#2)(2004-12#1)(2004-8#1)(2004-9#1)(2005-10#2)(2005-11#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-3#1)(2007-4#1)(2007-7#2)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#1)(2008-6#4)(2008-9#3)(2009-1#1)(2009-10#2)(2009-2#1)(2009-4#2)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-11#5)(2012-2#1)(2013-1#2)(2013-8#2)
the first steps in the##2##5##(1997-5#1)(2009-9#1)
the first steps in##4##4##(1997-5#1)(2008-1#1)(2009-9#1)(2012-1#1)
the first steps of##4##4##(1991-2#1)(1992-6#1)(2008-2#1)(2009-7#1)
the first steps##14##3##(1991-2#1)(1992-2#1)(1992-6#1)(1995-8#1)(1996-3#1)(1997-2#1)(1997-5#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-2#1)(2009-7#1)(2009-9#1)(2012-1#1)
the first stereoselective step of chiral##2##6##(1994-8#2)
the first structural evidence##2##4##(1991-3#1)(2006-6#1)
the first structural##5##3##(1991-3#1)(1994-12#1)(2006-6#1)(2010-10#1)(2013-8#1)
the first structure##2##3##(1997-7#1)(2008-3#1)
the first studies with##2##4##(1996-7#1)(2007-11#1)
the first studies##3##3##(1996-7#1)(2007-11#1)(2012-1#1)
the first study of##2##4##(2010-2#1)(2010-9#1)
the first study to examine the effects of##2##8##(2007-12#1)(2008-10#1)
the first study to examine the##3##6##(2007-12#1)(2008-10#1)(2009-12#1)
the first study to examine##4##5##(2007-12#1)(2008-10#1)(2008-8#1)(2009-12#1)
the first study to##11##4##(2004-11#1)(2007-1#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#1)(2009-12#1)
the first study##39##3##(1991-4#1)(1992-8#1)(1994-3#1)(1995-12#1)(2004-11#1)(2005-10#1)(2005-7#1)(2007-1#1)(2007-12#1)(2007-5#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#2)(2008-8#3)(2009-12#1)(2009-4#1)(2010-2#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
the first substrate##3##3##(1991-12#1)(1992-3#1)(1995-2#1)
the first successful use of##2##5##(2006-12#1)(2010-11#1)
the first successful##12##3##(1991-10#1)(1992-2#1)(1997-2#1)(2005-8#1)(2006-12#1)(2007-11#2)(2007-4#1)(2007-9#1)(2008-7#1)(2008-9#1)(2010-11#1)
the first such report in##2##5##(1992-2#1)(2012-2#1)
the first such report##4##4##(1992-2#1)(1997-4#1)(2010-4#1)(2012-2#1)
the first such##7##3##(1992-2#1)(1992-6#1)(1997-4#1)(2007-11#1)(2007-2#1)(2010-4#1)(2012-2#1)
the first surgeon to perform##2##5##(2007-11#2)
the first surgery##3##3##(2006-10#1)(2006-12#1)(2008-5#1)
the first surgical##3##3##(1990-8#1)(2007-11#1)(2007-12#1)
the first survey##4##3##(1997-8#1)(2004-11#1)(2007-3#1)(2012-3#1)
the first symptom##6##3##(1990-4#1)(1997-3#1)(2006-1#1)(2007-11#1)(2008-12#1)(2012-2#1)
the first symptoms##2##3##(1990-6#1)(2009-5#1)
the first synapse##2##3##(2012-2#1)(2013-8#1)
the first systematic##3##3##(2004-11#1)(2008-3#1)(2008-4#1)
the first targets##2##3##(1996-12#1)(2013-8#1)
the first ten##5##3##(1991-8#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-9#1)
the first test##3##3##(1991-5#1)(1993-10#1)(2009-5#1)
the first tested##2##3##(1995-5#1)(2008-3#1)
the first third of the##2##5##(2008-10#1)(2008-8#1)
the first thoracic##2##3##(2006-11#1)(2007-4#1)
the first three cases of##2##5##(1997-6#1)(2006-12#1)
the first three cases##4##4##(1993-11#1)(1997-6#1)(2006-12#1)(2011-2#1)
the first three days of##2##5##(2010-4#1)(2012-2#1)
the first three days##3##4##(1990-11#1)(2010-4#1)(2012-2#1)
the first three hours of##2##5##(2008-11#1)(2011-1#1)
the first three months and##2##5##(1990-6#1)(2007-11#1)
the first three months of##7##5##(1992-11#1)(1993-10#1)(2007-7#2)(2010-8#1)(2011-2#1)(2012-12#1)
the first three months##14##4##(1990-6#1)(1992-11#1)(1993-10#1)(1995-11#1)(2007-11#2)(2007-7#3)(2008-1#1)(2008-6#1)(2010-8#1)(2011-2#1)(2012-12#1)
the first three orders of##2##5##(2007-11#1)(2008-3#1)
the first three weeks##3##4##(2008-12#1)(2008-5#1)(2008-9#1)
the first three##55##3##(1990-11#1)(1990-5#1)(1990-6#1)(1992-11#1)(1992-4#1)(1992-5#1)(1993-10#1)(1993-11#1)(1995-11#3)(1995-4#1)(1995-7#1)(1996-6#1)(1997-6#1)(2006-11#1)(2006-12#1)(2007-11#3)(2007-12#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)
the first three-dimensional##2##3##(1996-7#1)(2013-8#1)
the first time a complete##2##5##(1997-2#1)(2007-5#1)
the first time a##21##4##(1992-3#1)(1994-9#1)(1996-8#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#3)(2008-6#1)(2008-7#1)(2009-8#2)(2010-7#1)(2011-1#1)(2012-2#1)
the first time an##3##4##(1996-8#1)(2007-8#1)(2010-3#1)
the first time ever##2##4##(2007-5#1)(2008-10#1)
the first time for##7##4##(2006-12#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2010-4#1)(2010-9#1)
the first time in Hungary##2##5##(1991-4#1)(1996-12#1)
the first time in an##2##5##(2007-12#1)(2009-4#1)
the first time in the##12##5##(1990-5#1)(1992-8#1)(1993-4#1)(1995-6#1)(2005-9#1)(2007-1#1)(2007-7#1)(2008-10#1)(2008-9#1)(2010-10#1)(2010-8#1)(2013-1#1)
the first time in this##5##5##(2007-11#1)(2008-10#1)(2009-9#1)(2011-2#1)(2013-1#1)
the first time in##71##4##(1990-12#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-4#1)(1992-8#1)(1993-2#1)(1993-4#1)(1994-11#2)(1994-12#1)(1995-12#1)(1995-6#1)(1996-12#1)(1997-3#1)(1997-7#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-4#1)(2007-1#2)(2007-11#1)(2007-12#6)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#2)
the first time it was given##2##6##(1993-6#2)
the first time it was##5##5##(1991-2#1)(1993-6#2)(2006-6#1)(2008-7#1)
the first time it##6##4##(1990-3#1)(1991-2#1)(1993-6#2)(2006-6#1)(2008-7#1)
the first time that a##9##5##(1990-7#1)(1994-9#1)(2006-12#1)(2006-3#1)(2007-12#1)(2008-5#2)(2009-8#1)(2011-1#1)
the first time that such##2##5##(1996-1#1)(2012-2#1)
the first time that the##15##5##(1991-8#1)(1992-11#2)(1995-6#1)(1996-6#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
the first time that##71##4##(1990-3#2)(1990-4#1)(1990-7#1)(1990-9#2)(1991-3#1)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(2005-7#1)(2006-12#1)(2006-3#1)(2006-5#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#3)(2008-8#1)(2008-9#3)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#2)
the first time the##34##4##(1991-4#1)(1992-3#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-6#2)(1996-4#1)(1997-8#1)(2005-10#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2012-2#2)(2013-1#1)(2013-8#1)
the first time this##2##4##(2008-9#1)(2013-7#1)
the first time to our knowledge that##2##7##(2008-2#1)(2008-3#1)
the first time to our knowledge##59##6##(2007-11#10)(2007-12#24)(2008-1#2)(2008-2#8)(2008-3#15)
the first time to the author's knowledge##4##7##(2007-12#2)(2008-2#2)
the first time to the authors' knowledge##20##7##(2007-11#2)(2007-12#13)(2008-2#3)(2008-3#2)
the first time to the##25##5##(2007-11#2)(2007-12#15)(2008-10#1)(2008-2#5)(2008-3#2)
the first time to##105##4##(1991-1#1)(1992-9#1)(1994-3#2)(1995-8#1)(2005-11#2)(2005-9#1)(2007-11#13)(2007-12#39)(2008-1#2)(2008-10#4)(2008-2#14)(2008-3#17)(2008-9#2)(2009-7#2)(2010-1#1)(2011-1#1)(2012-2#1)(2013-8#1)
the first time##730##3##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#3)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#1)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#2)(1991-2#3)(1991-3#2)(1991-4#3)(1991-8#2)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#4)(1992-6#1)(1992-7#1)(1992-8#4)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#4)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#3)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#4)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#3)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-7#2)(1997-8#1)(2004-11#2)(2005-10#1)(2005-11#5)(2005-4#3)(2005-7#2)(2005-8#1)(2005-9#2)(2006-10#8)(2006-12#11)(2006-3#1)(2006-4#3)(2006-5#4)(2006-6#1)(2006-8#3)(2007-1#9)(2007-10#1)(2007-11#34)(2007-12#80)(2007-2#1)(2007-3#3)(2007-5#5)(2007-6#1)(2007-7#5)(2007-8#12)(2007-9#3)(2008-1#6)(2008-10#103)(2008-11#6)(2008-12#3)(2008-2#32)(2008-3#34)(2008-4#4)(2008-5#16)(2008-6#6)(2008-7#13)(2008-8#5)(2008-9#8)(2009-1#1)(2009-10#2)(2009-11#3)(2009-2#3)(2009-3#3)(2009-4#5)(2009-5#5)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#4)(2010-1#3)(2010-10#5)(2010-12#5)(2010-2#1)(2010-3#6)(2010-4#6)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#8)(2011-3#3)(2012-1#2)(2012-10#1)(2012-11#1)(2012-12#9)(2012-2#16)(2012-3#4)(2012-8#1)(2013-1#31)(2013-7#5)(2013-8#10)
the first to apply##2##4##(2005-11#1)(2008-3#1)
the first to be##5##4##(1996-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#1)
the first to demonstrate that##3##5##(1997-7#1)(2008-3#1)(2009-12#1)
the first to demonstrate##8##4##(1990-11#1)(1991-12#1)(1994-11#1)(1997-4#1)(1997-7#1)(2008-3#1)(2009-12#1)(2010-11#1)
the first to describe the##3##5##(2006-10#1)(2007-8#1)(2008-6#1)
the first to describe##6##4##(2006-10#1)(2006-8#1)(2007-8#1)(2008-6#1)(2013-1#2)
the first to establish##2##4##(2007-11#1)(2008-10#1)
the first to investigate the##2##5##(2010-11#1)(2012-3#1)
the first to report a##2##5##(1995-7#1)(2007-12#1)
the first to report##4##4##(1995-7#1)(2007-12#1)(2010-4#1)(2013-1#1)
the first to show that##2##5##(1993-7#1)(2011-2#1)
the first to show##5##4##(1993-7#1)(2007-12#1)(2008-11#1)(2011-2#1)(2013-3#1)
the first to the##6##4##(1990-8#1)(1991-6#1)(1991-9#1)(1992-2#1)(2008-12#1)(2010-3#1)
the first to##67##3##(1990-11#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-7#1)(1994-11#1)(1994-2#1)(1995-7#1)(1996-3#1)(1996-7#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-2#3)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#2)(2008-9#1)(2009-12#2)(2009-5#1)(2010-11#2)(2010-3#2)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-3#1)(2013-8#1)
the first transmembrane segment##2##4##(1990-12#1)(1997-2#1)
the first transmembrane##3##3##(1990-12#1)(1992-9#1)(1997-2#1)
the first treatment##8##3##(1991-6#2)(1993-8#1)(1995-1#1)(1996-9#1)(2008-1#1)(2008-3#1)(2013-1#1)
the first trial##5##3##(2004-1#1)(2007-9#1)(2008-5#2)(2008-8#1)
the first trimester of pregnancy##8##5##(1990-3#1)(1992-2#2)(1994-9#1)(1996-12#1)(2008-4#1)(2010-5#1)(2012-1#1)
the first trimester of##9##4##(1990-3#1)(1990-6#1)(1992-2#2)(1994-9#1)(1996-12#1)(2008-4#1)(2010-5#1)(2012-1#1)
the first trimester##22##3##(1990-3#1)(1990-6#1)(1990-9#1)(1992-2#3)(1993-10#1)(1993-3#2)(1994-9#1)(1995-9#1)(1996-12#1)(2008-4#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#3)
the first tumor##3##3##(1992-9#1)(1997-3#2)
the first tunable##2##3##(2007-12#1)(2008-2#1)
the first twelve months##2##4##(2012-3#2)
the first twin##2##3##(1992-12#1)(2004-10#1)
the first two amino acids of##2##6##(1991-10#1)(1992-7#1)
the first two amino acids##3##5##(1991-10#2)(1992-7#1)
the first two cases##3##4##(2007-11#1)(2007-8#2)
the first two components##2##4##(1992-11#1)(2008-10#1)
the first two days of##2##5##(2005-8#1)(2008-6#1)
the first two days##3##4##(2005-8#1)(2006-8#1)(2008-6#1)
the first two decades of life##4##6##(2006-1#1)(2007-3#1)(2008-8#2)
the first two decades of the##2##6##(2008-8#1)(2010-12#1)
the first two decades of##7##5##(2006-1#1)(2007-3#1)(2008-8#3)(2010-12#2)
the first two exons##2##4##(1992-4#1)(1993-8#1)
the first two months##2##4##(1991-10#1)(2013-1#1)
the first two patients##2##4##(1992-4#1)(2006-7#1)
the first two phases of the##3##6##(1996-1#1)(1996-2#1)(2008-3#1)
the first two phases of##4##5##(1996-1#1)(1996-2#1)(2006-10#1)(2008-3#1)
the first two principal components##3##5##(2008-10#1)(2012-1#1)(2013-7#1)
the first two protocols##2##4##(2008-4#2)
the first two rounds##2##4##(2008-10#2)
the first two weeks of the illness##2##7##(1996-2#1)(2009-6#1)
the first two weeks of##6##5##(1993-2#1)(1994-6#1)(1996-2#1)(2008-10#1)(2009-6#1)(2010-3#1)
the first two weeks##11##4##(1991-7#1)(1991-9#1)(1993-2#1)(1994-6#1)(1996-2#1)(2007-1#1)(2007-11#1)(2007-5#1)(2008-10#1)(2009-6#1)(2010-3#1)
the first two years and##2##5##(2007-3#1)(2012-2#1)
the first two years of life##4##6##(1996-7#1)(2006-10#1)(2006-8#1)(2008-1#1)
the first two years of their##3##6##(1996-2#1)(2006-10#1)(2008-11#1)
the first two years of##8##5##(1996-2#1)(1996-7#1)(2006-10#2)(2006-8#1)(2008-1#1)(2008-11#1)(2011-2#1)
the first two years##13##4##(1993-8#1)(1996-2#1)(1996-7#1)(2006-10#2)(2006-8#1)(2007-3#1)(2008-1#1)(2008-11#1)(2011-2#3)(2012-2#1)
the first two##103##3##(1990-10#1)(1990-4#1)(1990-8#1)(1991-10#3)(1991-2#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-4#2)(1992-7#1)(1993-2#1)(1993-8#3)(1994-2#3)(1994-6#1)(1996-1#1)(1996-2#3)(1996-3#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-4#1)(2004-2#1)(2004-9#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-3#2)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#10)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#4)(2009-4#1)(2009-6#1)(2009-7#1)(2010-12#2)(2010-3#1)(2011-2#4)(2012-1#2)(2012-12#4)(2012-2#1)(2013-1#4)(2013-7#1)
the first two-thirds of the##2##5##(1994-12#1)(2008-10#1)
the first type of##3##4##(2007-8#1)(2008-3#1)(2012-2#1)
the first type##10##3##(1997-4#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#1)(2011-2#1)(2012-2#1)
the first upper true leaves at 14 dpi##3##8##(2008-10#3)
the first upper true leaves at 14##4##7##(2008-10#4)
the first upper##5##3##(2008-10#4)(2008-8#1)
the first use of a##3##5##(2007-11#1)(2007-12#2)
the first use of##6##4##(2006-8#1)(2007-11#1)(2007-12#2)(2008-3#1)(2011-2#1)
the first use##8##3##(2006-8#1)(2007-11#1)(2007-12#2)(2008-3#3)(2011-2#1)
the first vaccination##2##3##(1994-9#1)(1995-3#1)
the first vascular access##3##4##(2007-7#3)
the first version of##2##4##(2007-10#1)(2007-4#1)
the first visit##5##3##(1995-9#1)(2006-10#1)(2009-4#2)(2012-2#1)
the first was##2##3##(2006-6#1)(2012-3#1)
the first wave of##3##4##(2007-2#1)(2010-5#1)(2013-8#1)
the first wave##6##3##(2006-8#1)(2007-2#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-8#1)
the first week after birth##4##5##(1990-12#1)(1993-2#1)(1994-2#1)(1996-3#1)
the first week after##9##4##(1990-12#1)(1991-3#1)(1993-2#1)(1994-2#1)(1996-3#1)(1997-5#2)(2007-10#1)(2008-10#1)
the first week and##4##4##(2005-11#1)(2008-3#1)(2008-5#2)
the first week following##2##4##(1991-2#1)(2010-3#1)
the first week in culture##3##5##(1991-2#1)(2008-11#2)
the first week of the##2##5##(2007-11#1)(2008-9#1)
the first week of treatment##4##5##(1991-12#1)(1994-10#2)(2007-11#1)
the first week of##16##4##(1991-12#1)(1994-10#2)(1997-6#1)(2005-10#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-9#1)(2012-2#1)
the first week##42##3##(1990-12#1)(1991-12#1)(1991-2#2)(1991-3#1)(1993-2#1)(1994-10#2)(1994-2#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-5#2)(1997-6#1)(2005-10#1)(2005-11#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-9#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-9#1)(2009-9#1)(2010-3#1)(2012-2#2)(2012-3#1)(2013-8#1)
the first weeks of life##4##5##(1992-7#1)(1993-12#1)(2007-11#1)(2007-7#1)
the first when##2##3##(1996-5#1)(2008-3#1)
the first with the chief nurse##2##6##(2013-1#2)
the first with##6##3##(1992-8#1)(2007-11#1)(2008-4#1)(2011-2#1)(2013-1#2)
the first woman##3##3##(1993-6#1)(2011-2#2)
the first year after discharge##2##5##(1993-7#1)(2008-3#1)
the first year after the##2##5##(2009-5#1)(2011-2#1)
the first year after transplantation##3##5##(2007-11#1)(2007-8#1)(2010-8#1)
the first year after##14##4##(1993-7#1)(2006-11#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-8#2)(2007-9#1)(2008-3#1)(2009-5#1)(2010-8#1)(2011-2#1)(2013-1#1)
the first year but##2##4##(1996-12#1)(2006-8#1)
the first year in##3##4##(1994-12#1)(2005-7#1)(2013-1#1)
the first year of Medicare coverage##2##6##(1995-1#2)
the first year of a##2##5##(1995-3#1)(2008-12#1)
the first year of college##2##5##(2013-1#2)
the first year of life and##3##6##(1992-7#1)(2008-1#1)(2012-2#1)
the first year of life##27##5##(1992-7#1)(1993-1#2)(1994-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#1)(1997-2#1)(2006-8#1)(2008-1#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2011-1#1)(2012-12#2)(2012-2#3)(2013-1#1)
the first year of operation##2##5##(2006-5#2)
the first year of the##13##5##(1991-2#3)(1991-3#1)(1993-11#1)(1993-3#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2011-2#1)
the first year of this##2##5##(1990-11#1)(1997-1#1)
the first year of treatment##3##5##(2008-5#1)(2009-1#1)(2013-1#1)
the first year of##65##4##(1990-11#1)(1991-2#3)(1991-3#1)(1992-7#2)(1993-1#2)(1993-11#1)(1993-3#1)(1994-2#1)(1994-6#1)(1995-1#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#1)(1997-1#1)(1997-2#1)(2005-12#1)(2006-5#2)(2006-8#2)(2007-3#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#6)
the first year##131##3##(1990-11#1)(1990-5#1)(1991-2#4)(1991-3#1)(1991-4#1)(1991-6#1)(1992-6#1)(1992-7#4)(1993-1#2)(1993-11#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#3)(1996-5#1)(1997-1#1)(1997-2#1)(2005-10#4)(2005-12#1)(2005-7#2)(2005-8#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-3#1)(2006-5#2)(2006-7#1)(2006-8#3)(2007-10#1)(2007-11#3)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#4)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-5#1)(2010-1#2)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#10)(2013-8#2)
the first years after##3##4##(1995-4#1)(2007-8#1)(2013-8#1)
the first years of life##6##5##(1995-6#1)(1996-1#1)(2006-1#1)(2008-5#1)(2009-4#1)(2013-1#1)
the first years of the##3##5##(2006-7#1)(2008-5#1)(2009-4#1)
the first years of##11##4##(1995-6#1)(1996-1#1)(2006-1#1)(2006-7#1)(2008-11#1)(2008-5#2)(2009-4#2)(2011-2#1)(2013-1#1)
the first years##15##3##(1995-4#1)(1995-6#1)(1996-1#1)(2006-1#1)(2006-7#1)(2007-8#1)(2008-11#1)(2008-5#2)(2009-4#2)(2011-2#2)(2013-1#1)(2013-8#1)
the first zinc finger##3##4##(1994-6#1)(1994-9#2)
the first##5176##2##(1990-1#3)(1990-10#15)(1990-11#22)(1990-12#27)(1990-2#18)(1990-3#22)(1990-4#11)(1990-5#13)(1990-6#14)(1990-7#18)(1990-8#22)(1990-9#11)(1991-1#8)(1991-10#19)(1991-11#8)(1991-12#21)(1991-2#28)(1991-3#17)(1991-4#18)(1991-5#18)(1991-6#24)(1991-7#15)(1991-8#12)(1991-9#14)(1992-1#15)(1992-10#8)(1992-11#16)(1992-12#16)(1992-2#19)(1992-3#19)(1992-4#10)(1992-5#16)(1992-6#18)(1992-7#22)(1992-8#28)(1992-9#12)(1993-1#8)(1993-10#7)(1993-11#16)(1993-12#17)(1993-2#21)(1993-3#19)(1993-4#5)(1993-5#17)(1993-6#19)(1993-7#9)(1993-8#14)(1993-9#13)(1994-1#2)(1994-10#7)(1994-11#18)(1994-12#35)(1994-2#23)(1994-3#25)(1994-4#3)(1994-5#12)(1994-6#28)(1994-7#4)(1994-8#20)(1994-9#24)(1995-1#13)(1995-10#4)(1995-11#14)(1995-12#21)(1995-2#20)(1995-3#23)(1995-4#6)(1995-5#19)(1995-6#19)(1995-7#4)(1995-8#19)(1995-9#5)(1996-1#14)(1996-10#4)(1996-11#10)(1996-12#26)(1996-2#13)(1996-3#29)(1996-4#8)(1996-5#23)(1996-6#16)(1996-7#14)(1996-8#9)(1996-9#16)(1997-1#14)(1997-2#35)(1997-3#20)(1997-4#31)(1997-5#14)(1997-6#17)(1997-7#19)(1997-8#18)(2004-1#3)(2004-10#3)(2004-11#10)(2004-12#5)(2004-2#4)(2004-3#2)(2004-4#2)(2004-8#1)(2004-9#5)(2005-10#16)(2005-11#25)(2005-12#3)(2005-3#1)(2005-4#3)(2005-5#3)(2005-7#14)(2005-8#19)(2005-9#2)(2006-1#9)(2006-10#71)(2006-11#10)(2006-12#32)(2006-2#17)(2006-3#9)(2006-4#9)(2006-5#18)(2006-6#17)(2006-7#14)(2006-8#32)(2006-9#17)(2007-1#16)(2007-10#32)(2007-11#135)(2007-12#216)(2007-2#37)(2007-3#28)(2007-4#12)(2007-5#28)(2007-6#11)(2007-7#71)(2007-8#89)(2007-9#40)(2008-1#61)(2008-10#418)(2008-11#84)(2008-12#52)(2008-2#121)(2008-3#143)(2008-4#82)(2008-5#120)(2008-6#49)(2008-7#81)(2008-8#66)(2008-9#74)(2009-1#5)(2009-10#22)(2009-11#8)(2009-12#12)(2009-2#17)(2009-3#17)(2009-4#29)(2009-5#18)(2009-6#12)(2009-7#23)(2009-8#20)(2009-9#12)(2010-1#13)(2010-10#12)(2010-11#12)(2010-12#54)(2010-2#21)(2010-3#21)(2010-4#30)(2010-5#27)(2010-6#6)(2010-7#11)(2010-8#30)(2010-9#11)(2011-1#57)(2011-12#11)(2011-2#172)(2011-3#7)(2011-7#2)(2011-8#1)(2012-1#31)(2012-10#1)(2012-11#13)(2012-12#86)(2012-2#107)(2012-3#51)(2012-8#2)(2013-1#172)(2013-3#1)(2013-7#24)(2013-8#73)
the first- and the second-order##3##5##(2008-2#1)(2008-3#2)
the first-choice##2##2##(2006-10#1)(2007-11#1)
the first-derivative##3##2##(2008-10#3)
the first-dimension gel##4##3##(2008-2#2)(2008-4#2)
the first-ever##3##2##(1996-2#1)(2007-8#1)(2010-12#1)
the first-generation##3##2##(2008-11#1)(2008-7#1)(2008-8#1)
the first-line drugs##3##3##(2010-10#1)(2010-12#1)(2012-3#1)
the first-line therapy in##2##4##(2013-7#1)(2013-8#1)
the first-line therapy##5##3##(2009-11#1)(2010-12#2)(2013-7#1)(2013-8#1)
the first-line treatment for##2##4##(2010-12#1)(2013-8#1)
the first-line treatment of##3##4##(2009-3#1)(2011-2#1)(2013-8#1)
the first-line treatment##6##3##(2009-3#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#2)
the first-line##23##2##(1997-2#1)(2007-11#1)(2007-12#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#6)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
the first-order diffracted##2##3##(2008-3#2)
the first-order diffraction efficiency##3##4##(2008-2#2)(2008-3#1)
the first-order diffraction##5##3##(1996-4#1)(2007-12#1)(2008-2#2)(2008-3#1)
the first-order rate constant for##2##5##(1990-5#1)(1997-5#1)
the first-order rate constants##3##4##(1994-3#1)(1995-5#1)(2008-10#1)
the first-order rate##5##3##(1990-5#1)(1994-3#1)(1995-5#1)(1997-5#1)(2008-10#1)
the first-order##40##2##(1990-2#1)(1990-5#1)(1991-4#2)(1994-3#2)(1995-5#1)(1996-4#1)(1997-5#1)(2004-8#1)(2005-11#1)(2007-11#1)(2007-12#4)(2007-6#1)(2008-1#1)(2008-10#2)(2008-2#8)(2008-3#11)(2008-5#1)
the first-pass metabolism##2##3##(1996-6#1)(2010-2#1)
the first-pass##3##2##(1996-6#1)(1997-8#1)(2010-2#1)
the first-phase##2##2##(1990-2#1)(2008-1#1)
the first-round PCR##3##3##(1997-4#2)(2008-10#1)
the first-round##4##2##(1997-4#2)(2008-10#2)
the first-strand cDNA synthesis##2##4##(1997-2#2)
the first-strand cDNA##3##3##(1994-12#1)(1997-2#2)
the fiscal year##2##3##(1991-10#1)(2007-4#1)
the fiscal##7##2##(1991-1#1)(1991-10#1)(1992-2#1)(1994-2#1)(1995-6#1)(1997-2#1)(2007-4#1)
the fish Brycon henni##3##4##(2008-5#3)
the fish and##4##3##(1990-2#1)(1993-12#1)(1996-5#2)
the fish at##2##3##(2008-10#1)(2013-7#1)
the fish exposed##2##3##(1997-3#1)(2008-7#1)
the fish fingerlings of Alepes djidaba were##2##7##(2009-6#2)
the fish fingerlings of Alepes djidaba##4##6##(2009-6#4)
the fish fingerlings##5##3##(2009-6#5)
the fish of about##2##4##(2009-4#2)
the fish of##3##3##(2008-12#1)(2009-4#2)
the fish oil diet##3##4##(1991-2#3)
the fish oil##4##3##(1991-2#3)(1994-2#1)
the fish population##3##3##(2009-6#2)(2013-8#1)
the fish species##2##3##(2011-2#1)(2012-2#1)
the fish were##4##3##(2008-12#1)(2010-8#2)(2013-7#1)
the fish##76##2##(1990-2#1)(1991-2#3)(1991-7#1)(1992-1#1)(1992-8#1)(1993-12#1)(1994-2#1)(1996-2#1)(1996-5#2)(1997-3#1)(1997-4#2)(2006-10#1)(2007-3#3)(2007-5#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#7)(2008-7#7)(2008-8#1)(2009-4#3)(2009-5#1)(2009-6#7)(2010-5#1)(2010-8#5)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#3)(2013-1#1)(2013-7#5)(2013-8#1)
the fish's##2##2##(2008-7#1)(2010-8#1)
the fish-fillet plants##2##3##(2006-10#2)
the fish-oil enriched diet##2##4##(2006-8#2)
the fish-oil##3##2##(2006-8#3)
the fisheries##2##2##(2007-5#1)(2013-8#1)
the fishery##9##2##(2007-3#1)(2007-5#6)(2013-7#1)(2013-8#1)
the fishes##4##2##(2007-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
the fishhook##2##2##(2012-12#2)
the fishing##3##2##(2007-5#2)(2013-7#1)
the fishnet-like##2##2##(2005-11#2)
the fission of peroxisomes and mitochondria##2##6##(2009-10#2)
the fission of##3##3##(1992-12#1)(2009-10#2)
the fission yeast Schizosaccharomyces pombe and the##2##7##(1992-7#1)(2009-3#1)
the fission yeast Schizosaccharomyces pombe##12##5##(1990-2#2)(1992-7#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-8#2)(1995-9#1)(1997-3#1)(2008-9#1)(2009-3#1)
the fission yeast##17##3##(1990-2#2)(1992-7#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-8#2)(1995-9#1)(1997-3#1)(2008-7#4)(2008-9#1)(2009-3#1)
the fission##22##2##(1990-2#2)(1992-12#1)(1992-7#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-8#2)(1995-9#1)(1997-3#1)(2007-5#1)(2008-10#1)(2008-7#4)(2008-9#1)(2009-10#2)(2009-3#1)
the fist##2##2##(2008-4#1)(2011-2#1)
the fistula and##2##3##(1993-5#1)(2013-8#1)
the fistula was##7##3##(1996-9#3)(1997-3#1)(2006-6#1)(2007-11#1)(2007-7#1)
the fistula##35##2##(1990-5#1)(1993-5#1)(1995-11#2)(1996-12#1)(1996-9#5)(1997-3#3)(2006-12#1)(2006-6#2)(2007-11#2)(2007-7#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#3)(2011-3#2)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
the fistulae##2##2##(1992-2#1)(2007-11#1)
the fistulas##7##2##(1993-2#1)(1995-11#2)(2006-12#1)(2007-7#1)(2008-7#1)(2009-2#1)
the fistulous##4##2##(1990-4#2)(2008-4#1)(2009-5#1)
the fit between##2##3##(2005-8#1)(2009-7#1)
the fit of the##4##4##(2008-10#3)(2010-6#1)
the fit of##6##3##(2008-10#3)(2008-12#1)(2010-2#1)(2010-6#1)
the fit parameters##3##3##(2008-3#2)(2009-3#1)
the fit##24##2##(1991-3#1)(1995-6#2)(1996-2#1)(2005-11#1)(2005-8#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2009-3#1)(2009-7#1)(2010-2#1)(2010-6#1)(2013-8#1)
the fitness consequences of##2##4##(2008-8#2)
the fitness gain##3##3##(2007-9#1)(2008-9#2)
the fitness of P##2##4##(2006-3#2)
the fitness of the##3##4##(1993-5#1)(2008-10#1)(2008-8#1)
the fitness of##13##3##(1990-11#1)(1993-5#1)(2006-3#2)(2008-10#4)(2008-8#3)(2008-9#2)
the fitness##26##2##(1990-11#1)(1993-5#1)(1997-1#1)(2006-3#2)(2007-9#1)(2008-10#6)(2008-11#1)(2008-8#7)(2008-9#5)(2013-1#1)
the fitted model##2##3##(2008-10#1)(2008-8#1)
the fitted##9##2##(1994-11#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-12#1)(2012-3#1)
the fitting of the##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
the fitting of##6##3##(1996-1#1)(2006-10#2)(2007-12#1)(2008-10#1)(2008-2#1)
the fitting parameters##2##3##(2005-11#1)(2008-2#1)
the fitting procedure##4##3##(1990-3#1)(2008-10#1)(2008-3#1)(2008-9#1)
the fitting##22##2##(1990-3#1)(1996-1#1)(2005-11#2)(2005-4#1)(2006-10#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#6)(2008-3#1)(2008-8#1)(2008-9#1)(2013-8#2)
the five Cys residues##3##4##(1994-11#1)(1996-7#1)(2008-8#1)
the five candidate genes##2##4##(1996-8#2)
the five clones##2##3##(1997-7#2)
the five components of##2##4##(2010-2#2)
the five constructs##2##3##(2008-10#1)(2012-1#1)
the five days##2##3##(2008-1#1)(2008-5#1)
the five different##2##3##(2007-1#1)(2013-1#1)
the five experiments##2##3##(2005-11#2)
the five groups##3##3##(1991-6#1)(1993-9#1)(2004-9#1)
the five known##3##3##(1995-3#1)(1996-12#1)(2008-4#1)
the five major##4##3##(1990-12#1)(1994-12#1)(2008-10#1)(2011-1#1)
the five most common##2##4##(2008-10#2)
the five most frequently##2##4##(2006-12#1)(2008-11#1)
the five most##6##3##(1993-3#1)(2006-12#1)(2008-10#3)(2008-11#1)
the five patients##3##3##(2006-3#1)(2008-6#1)(2011-1#1)
the five species##4##3##(1996-5#1)(2008-10#1)(2008-11#1)(2008-5#1)
the five stages##2##3##(1990-10#2)
the five states##2##3##(1993-3#1)(2008-10#1)
the five strains with##2##4##(2011-2#2)
the five teacher actions##2##4##(2008-4#2)
the five types of##2##4##(1993-2#1)(2011-2#1)
the five year period##3##4##(1993-8#1)(2006-10#1)(2006-8#1)
the five years##3##3##(2006-2#1)(2007-11#1)(2011-1#1)
the five##183##2##(1990-10#2)(1990-12#4)(1990-2#1)(1990-5#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#2)(1996-12#1)(1996-3#3)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-5#3)(1997-7#4)(1997-8#1)(2004-7#1)(2004-9#1)(2005-11#2)(2005-7#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#3)(2007-11#2)(2007-12#1)(2007-2#2)(2007-8#1)(2008-1#2)(2008-10#38)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#6)(2008-6#1)(2008-8#4)(2008-9#2)(2009-3#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#3)(2010-3#1)(2011-1#5)(2011-2#6)(2012-1#2)(2012-12#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
the five-membered##2##2##(1996-2#1)(2010-6#1)
the five-year##3##2##(1990-5#1)(1995-9#1)(2008-10#1)
the fivefold##2##2##(2008-10#1)(2010-4#1)
the fixation and##4##3##(2006-5#1)(2008-10#1)(2008-8#1)(2010-8#1)
the fixation index##2##3##(2007-8#1)(2008-10#1)
the fixation of the##2##4##(1997-7#1)(2008-10#1)
the fixation of##9##3##(1991-4#1)(1997-2#1)(1997-7#2)(2007-11#1)(2008-10#1)(2008-9#1)(2009-9#1)(2010-12#1)
the fixation point##2##3##(1994-2#1)(1995-8#1)
the fixation##25##2##(1991-4#1)(1994-2#1)(1995-8#1)(1997-2#1)(1997-7#2)(2006-5#1)(2006-8#1)(2007-11#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-8#1)(2012-3#1)(2013-1#1)
the fixator was removed##2##4##(1993-8#1)(2009-2#1)
the fixator##3##2##(1993-8#2)(2009-2#1)
the fixed interference method (FIM)##2##5##(2008-10#2)
the fixed interference##3##3##(2008-10#3)
the fixed time and##2##4##(2008-10#2)
the fixed##20##2##(1991-9#1)(1993-12#1)(1995-1#1)(1995-9#1)(1997-2#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-2#2)(2008-3#3)(2008-7#1)(2009-6#1)
the fixed-pattern noise##3##3##(2008-2#2)(2008-3#1)
the fixed-time##2##2##(2008-10#2)
the fixing process##2##3##(2007-12#1)(2008-2#1)
the fixing##5##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
the fjord##4##2##(1996-3#1)(2010-8#3)
the flag leaf sheath##2##4##(2008-10#2)
the flag leaf##5##3##(2008-10#4)(2008-12#1)
the flag##6##2##(2008-10#5)(2008-12#1)
the flagella##3##2##(2006-12#1)(2007-12#1)(2008-10#1)
the flagellar pocket and##2##4##(2007-5#2)
the flagellar pocket##4##3##(2007-5#3)(2008-10#1)
the flagellar##9##2##(1994-8#3)(1997-4#2)(2007-5#3)(2008-10#1)
the flagellated bacteria##2##3##(2006-8#2)
the flagellated##3##2##(1992-8#1)(2006-8#2)
the flagellins##3##2##(1990-2#3)
the flagellum and##2##3##(2007-12#1)(2008-7#1)
the flagellum##11##2##(2007-12#4)(2008-10#1)(2008-4#1)(2008-7#5)
the flame atomic absorption spectrometer nebulizer##2##6##(2008-10#2)
the flame atomic absorption spectrometer##4##5##(2008-10#4)
the flame atomic absorption##7##4##(2008-10#7)
the flame atomizer##3##3##(2008-10#3)
the flame composition##2##3##(2008-10#2)
the flame structure##3##3##(2008-3#3)
the flame##36##2##(1990-11#2)(2006-12#1)(2008-10#22)(2008-2#2)(2008-3#8)(2012-12#1)
the flame-front##2##2##(2008-2#2)
the flames##3##2##(1994-12#1)(2008-3#2)
the flanking regions of the##3##5##(1990-5#1)(1990-9#2)
the flanking regions##9##3##(1990-5#1)(1990-9#2)(1993-5#2)(1995-3#1)(1997-2#1)(2006-9#1)(2008-8#1)
the flanking sequences##6##3##(1991-7#1)(1993-6#1)(1994-11#1)(1995-2#1)(2007-8#1)(2012-2#1)
the flanking##27##2##(1990-5#1)(1990-9#2)(1991-7#2)(1992-5#1)(1993-5#2)(1993-6#2)(1994-11#1)(1995-2#2)(1995-3#1)(1995-8#1)(1997-2#1)(2006-9#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-8#2)(2008-9#1)(2012-2#1)
the flap and##2##3##(2008-9#1)(2009-12#1)
the flap in##2##3##(1991-5#1)(2011-2#1)
the flap##20##2##(1991-5#3)(1995-1#1)(1996-11#1)(2006-10#1)(2007-12#2)(2007-5#1)(2008-4#2)(2008-6#1)(2008-9#2)(2009-12#1)(2011-2#3)(2012-2#1)(2013-1#1)
the flaps##7##2##(1990-6#1)(2007-12#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-5#1)(2011-2#1)
the flash##5##2##(1992-9#1)(1996-7#1)(1997-2#1)(2006-12#1)(2008-10#1)
the flashbackers##3##2##(1996-10#1)(1996-7#2)
the flat group##3##3##(1991-2#3)
the flat##16##2##(1991-2#3)(1993-4#1)(1995-11#1)(1995-2#1)(2005-11#1)(2006-11#1)(2006-5#1)(2007-6#2)(2008-10#2)(2008-3#2)(2009-11#1)
the flat-field##3##2##(2008-3#3)
the flatness of the##2##4##(1994-8#1)(2008-3#1)
the flatness##6##2##(1994-8#1)(2007-11#1)(2008-2#3)(2008-3#1)
the flattened##2##2##(2007-12#1)(2008-2#1)
the flavin##10##2##(1990-4#2)(1991-2#2)(1992-1#2)(1994-8#1)(1995-10#1)(1995-5#1)(1995-6#1)
the flavodoxin##4##2##(1990-4#2)(1994-5#1)(1994-8#1)
the flavone##2##2##(1996-11#1)(2006-12#1)
the flavonoid radical##2##3##(2012-1#2)
the flavonoid##16##2##(1992-8#1)(1996-6#2)(2007-1#2)(2008-10#5)(2008-4#1)(2008-5#1)(2009-10#1)(2010-6#1)(2012-1#2)
the flavonoids##6##2##(1992-5#1)(2007-11#1)(2008-11#3)(2011-2#1)
the flavonols##2##2##(1997-8#2)
the flavoprotein##3##2##(1991-2#1)(1996-2#1)(1996-8#1)
the flavor##6##2##(1992-5#1)(2006-12#1)(2008-10#1)(2008-5#1)(2012-1#1)(2012-2#1)
the flaws##2##2##(1990-12#1)(1992-1#1)
the fleece##5##2##(1997-5#3)(2007-8#2)
the flesh##4##2##(2008-12#1)(2008-9#1)(2009-10#1)(2012-1#1)
the flexibility and##4##3##(1997-8#1)(2008-5#1)(2009-9#1)(2012-2#1)
the flexibility matrix##2##3##(2007-4#2)
the flexibility of the iliotibial band and##2##7##(2007-7#2)
the flexibility of the##17##4##(1990-12#1)(1990-3#1)(1994-11#1)(1994-9#1)(1995-3#1)(2005-11#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
the flexibility of##29##3##(1990-12#1)(1990-3#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-1#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-2#1)(2011-9#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
the flexibility to##6##3##(1993-12#1)(2008-4#1)(2008-7#1)(2009-8#1)(2009-9#1)(2011-1#1)
the flexibility##51##2##(1990-12#1)(1990-3#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-7#2)(2006-8#1)(2007-12#1)(2007-4#5)(2007-7#3)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-8#1)(2009-9#2)(2010-2#1)(2011-1#2)(2011-9#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-7#1)
the flexible loop##2##3##(1994-8#2)
the flexible moiety of##2##4##(1997-6#2)
the flexible probe##3##3##(2007-10#3)
the flexible##23##2##(1991-9#1)(1992-11#1)(1994-2#1)(1994-8#3)(1996-3#1)(1996-7#1)(1997-6#2)(2006-6#1)(2007-10#4)(2007-8#1)(2008-5#2)(2008-7#2)(2011-1#1)(2011-2#1)(2012-1#1)
the flexion synergy and stretch reflexes##3##6##(2012-1#3)
the flexion synergy##6##3##(2012-1#6)
the flexion##11##2##(1997-2#1)(2007-1#1)(2008-5#1)(2012-1#6)(2012-2#1)(2013-8#1)
the flexor and extensor muscle groups##3##6##(2007-8#3)
the flexor and##4##3##(2007-8#3)(2009-9#1)
the flexor carpi ulnaris##4##4##(2006-3#1)(2007-4#1)(2008-9#1)(2009-5#1)
the flexor digitorum superficialis##4##4##(2006-3#1)(2008-9#2)(2012-2#1)
the flexor digitorum##6##3##(2006-3#1)(2008-12#1)(2008-9#2)(2010-5#1)(2012-2#1)
the flexor hallucis longus tendon##2##5##(2010-7#2)
the flexor hallucis longus##3##4##(2009-10#1)(2010-7#2)
the flexor reflex##4##3##(1996-12#4)
the flexor tendon##4##3##(2006-3#1)(2007-7#3)
the flexor tendons##3##3##(1993-1#1)(2006-10#1)(2008-9#1)
the flexor##31##2##(1993-1#1)(1996-12#4)(2006-10#1)(2006-3#3)(2007-4#1)(2007-7#3)(2007-8#3)(2008-12#1)(2008-9#6)(2009-1#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-5#1)(2010-7#2)(2012-2#1)
the flexural resonance frequency shift of##2##6##(2009-5#2)
the flexural strength of##3##4##(2008-12#1)(2009-7#2)
the flexural strength##5##3##(2008-12#3)(2009-7#2)
the flexural##9##2##(2008-12#3)(2008-5#1)(2009-5#2)(2009-7#2)(2011-2#1)
the flhD operon##2##3##(1997-4#2)
the flight ability##2##3##(2008-6#2)
the flight musculature##2##3##(2007-12#2)
the flight##16##2##(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#2)(2008-6#2)(2008-8#1)(2010-12#1)(2012-12#2)(2012-3#1)
the floatability of coal##2##4##(2005-11#2)
the floater##2##2##(2008-9#2)
the floating##2##2##(1990-2#1)(2008-9#1)
the flocculated##2##2##(2005-11#1)(2008-11#1)
the flocculation##7##2##(1995-4#1)(1995-6#1)(2005-11#2)(2008-7#1)(2009-12#2)
the flock was##2##3##(2008-5#2)
the flock##8##2##(1997-3#1)(1997-6#1)(2008-3#1)(2008-5#5)
the flocks##3##2##(1997-3#1)(1997-6#1)(2008-3#1)
the flocs##2##2##(2008-7#1)(2010-2#1)
the flood##6##2##(1991-2#1)(2007-11#1)(2008-10#2)(2008-2#1)(2009-2#1)
the floodgates##2##2##(2007-9#1)(2012-2#1)
the flooding##2##2##(2008-5#1)(2009-10#1)
the floodplain##4##2##(2008-5#1)(2010-8#1)(2013-7#2)
the floods##2##2##(1996-6#2)
the floor by##2##3##(1997-2#2)
the floor of the middle##2##5##(2008-7#1)(2011-2#1)
the floor of the mouth##3##5##(2005-11#1)(2007-7#1)(2013-1#1)
the floor of the##12##4##(1990-4#1)(1996-5#1)(1996-6#1)(1997-5#1)(2005-11#1)(2006-5#1)(2007-7#1)(2008-7#2)(2009-9#1)(2011-2#1)(2013-1#1)
the floor##28##2##(1990-4#1)(1993-12#1)(1995-6#1)(1996-5#1)(1996-6#1)(1997-2#4)(1997-5#1)(2005-11#1)(2006-5#1)(2006-8#2)(2007-7#1)(2008-11#1)(2008-5#2)(2008-6#2)(2008-7#3)(2009-9#1)(2010-11#2)(2011-2#1)(2013-1#1)
the floral cavity##2##3##(2008-10#2)
the floral organs of Hyacinthus orientalis L##2##7##(2008-8#2)
the floral##12##2##(2006-12#2)(2006-9#1)(2008-10#4)(2008-8#4)(2009-8#1)
the floras of##2##3##(2008-8#2)
the floret##3##2##(2008-10#3)
the floristic##4##2##(2008-8#2)(2012-2#1)(2013-7#1)
the flotation##5##2##(2005-11#1)(2005-4#1)(2008-10#3)
the flow analysis##2##3##(2008-10#2)
the flow and##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
the flow cell and the##2##5##(2008-10#1)(2008-9#1)
the flow cell and##5##4##(2007-8#1)(2008-10#3)(2008-9#1)
the flow cell of##2##4##(2008-10#2)
the flow cell to##2##4##(2008-10#2)
the flow cell##32##3##(2007-8#1)(2008-10#26)(2008-3#3)(2008-9#2)
the flow cells##3##3##(2008-10#2)(2008-9#1)
the flow cytometer##2##3##(2008-9#2)
the flow cytometric analysis##2##4##(2008-11#1)(2008-9#1)
the flow cytometric detection of##2##5##(1996-11#1)(2008-9#1)
the flow cytometric##10##3##(1990-12#1)(1996-11#1)(2008-11#2)(2008-4#2)(2008-9#4)
the flow cytometry method##2##4##(2008-10#1)(2008-8#1)
the flow cytometry##3##3##(1992-8#1)(2008-10#1)(2008-8#1)
the flow direction##2##3##(2008-10#1)(2008-5#1)
the flow field##5##3##(2007-12#1)(2007-9#1)(2008-11#2)(2008-3#1)
the flow initially##2##3##(2008-10#2)
the flow injection analysis (FIA)##3##5##(2008-10#3)
the flow injection analysis##5##4##(2008-10#5)
the flow injection determination##2##4##(2008-10#2)
the flow injection manifold##2##4##(2008-10#2)
the flow injection system##5##4##(2008-10#5)
the flow injection technique##2##4##(2008-10#2)
the flow injection##22##3##(2005-4#1)(2008-10#21)
the flow is##6##3##(1991-3#1)(1991-8#1)(2005-10#1)(2008-2#2)(2008-4#1)
the flow line##6##3##(2008-10#6)
the flow manifold##2##3##(2007-8#1)(2008-10#1)
the flow of a##3##4##(1991-9#1)(2008-11#1)(2008-5#1)
the flow of air towards the heart##2##7##(1991-3#2)
the flow of information from##2##5##(1994-2#1)(1994-6#1)
the flow of information##7##4##(1994-2#1)(1994-6#1)(2006-10#1)(2008-11#1)(2010-2#2)(2013-8#1)
the flow of the carrier solution##2##6##(2008-10#2)
the flow of the##6##4##(1997-3#1)(2006-6#1)(2008-10#4)
the flow of water through a##2##6##(2005-11#1)(2007-8#1)
the flow of water##3##4##(2005-11#1)(2007-8#1)(2009-11#1)
the flow of##48##3##(1990-12#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-9#1)(1994-2#1)(1994-6#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(2005-11#2)(2005-7#1)(2006-1#1)(2006-10#1)(2006-6#1)(2007-8#2)(2008-10#8)(2008-11#3)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-11#1)(2010-2#2)(2010-8#1)(2012-12#3)(2012-2#1)(2013-8#1)
the flow pattern##2##3##(2007-10#1)(2013-1#1)
the flow properties##2##3##(2007-9#1)(2008-2#1)
the flow rate and##3##4##(2008-10#2)(2008-7#1)
the flow rate of 1##2##5##(2008-10#1)(2012-12#1)
the flow rate of the carrier##2##6##(2006-12#1)(2008-10#1)
the flow rate of the##9##5##(1991-9#1)(2004-8#1)(2006-12#1)(2008-10#5)(2012-12#1)
the flow rate of##17##4##(1991-9#1)(1996-6#1)(2004-8#1)(2006-12#1)(2007-8#1)(2008-10#10)(2012-12#2)
the flow rate was##2##4##(2008-10#1)(2011-1#1)
the flow rate##43##3##(1990-12#1)(1991-9#2)(1994-2#1)(1996-6#3)(2004-8#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#25)(2008-11#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-12#2)
the flow rates of##2##4##(2007-8#1)(2008-10#1)
the flow rates##5##3##(2007-2#1)(2007-8#1)(2008-10#2)(2008-7#1)
the flow set-up##2##3##(2008-10#2)
the flow system in##2##4##(2008-10#2)
the flow system were##2##4##(2008-10#2)
the flow system##25##3##(2007-8#1)(2008-10#23)(2008-2#1)
the flow through##2##3##(2007-12#1)(2008-11#1)
the flow velocity and the##3##5##(2008-11#1)(2008-3#2)
the flow velocity##7##3##(2007-10#1)(2008-11#1)(2008-3#3)(2008-7#1)(2011-2#1)
the flow##310##2##(1990-12#3)(1990-8#1)(1991-12#1)(1991-3#3)(1991-5#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-7#1)(1994-2#2)(1994-6#1)(1994-8#1)(1995-3#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-6#4)(1996-9#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-8#1)(2005-10#3)(2005-11#8)(2005-4#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#2)(2007-8#7)(2007-9#2)(2008-1#1)(2008-10#141)(2008-11#12)(2008-2#14)(2008-3#12)(2008-4#5)(2008-5#5)(2008-6#2)(2008-7#10)(2008-8#3)(2008-9#11)(2009-11#1)(2009-7#1)(2010-2#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#5)(2012-2#1)(2013-1#2)(2013-8#2)
the flow-injection determination of##4##4##(2008-10#4)
the flow-injection sandwich ELISA##2##4##(2008-10#2)
the flow-injection##12##2##(2008-10#12)
the flow-line##5##2##(2006-10#5)
the flow-rate##9##2##(1991-8#1)(1991-9#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(2008-10#3)
the flow-through cell##2##3##(2008-10#2)
the flow-through sensor##2##3##(2008-10#2)
the flow-through##7##2##(1990-4#1)(2008-10#6)
the flower hypanthium##3##3##(2008-10#3)
the flower##17##2##(2006-12#3)(2007-1#1)(2007-8#4)(2008-10#5)(2009-12#2)(2009-8#1)(2011-10#1)
the flowering plant Senecio isatideus (Asteraceae)##2##6##(1990-7#2)
the flowering plant##3##3##(1990-7#2)(1996-10#1)
the flowering stage##2##3##(2008-12#2)
the flowering##10##2##(1990-7#2)(1996-10#1)(2006-12#1)(2007-1#1)(2008-10#1)(2008-12#2)(2008-8#2)
the flowers of P##3##4##(2012-3#3)
the flowers of##8##3##(2007-1#4)(2012-3#4)
the flowers##14##2##(2007-1#4)(2007-11#1)(2008-10#1)(2008-12#1)(2008-5#3)(2012-3#4)
the flowing##7##2##(2008-10#6)(2011-2#1)
the flows##3##2##(1997-3#1)(2007-5#1)(2008-2#1)
the flu vaccine##2##3##(2008-11#1)(2009-11#1)
the flu##5##2##(2004-11#1)(2008-11#1)(2009-11#1)(2010-11#1)(2010-4#1)
the fluctuating##4##2##(2005-11#1)(2007-11#1)(2008-2#1)(2008-3#1)
the fluctuation of the##4##4##(1996-12#1)(2007-11#1)(2007-2#1)(2013-8#1)
the fluctuation of##6##3##(1996-12#1)(2007-11#2)(2007-2#1)(2008-10#1)(2013-8#1)
the fluctuation##11##2##(1996-12#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-9#2)(2013-8#1)
the fluctuations in the##5##4##(2008-2#3)(2008-5#1)(2008-8#1)
the fluctuations in##7##3##(1996-4#1)(2008-2#3)(2008-5#1)(2008-8#1)(2008-9#1)
the fluctuations of the##2##4##(1995-6#1)(2005-11#1)
the fluctuations of##6##3##(1992-4#1)(1995-6#1)(1996-4#1)(2005-11#1)(2008-2#1)(2008-9#1)
the fluctuations##20##2##(1992-4#1)(1995-6#2)(1996-4#3)(2005-11#1)(2007-12#2)(2008-11#1)(2008-2#5)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#2)
the flue gas##3##3##(2008-10#2)(2008-3#1)
the fluence##3##2##(2008-2#2)(2008-3#1)
the fluid and##2##3##(1991-8#1)(2012-3#1)
the fluid dynamic##2##3##(1996-8#1)(2005-10#1)
the fluid dynamics of##2##4##(2005-10#1)(2009-9#1)
the fluid dynamics##3##3##(2005-10#1)(2008-7#1)(2009-9#1)
the fluid flow##3##3##(2007-9#1)(2009-11#1)(2010-8#1)
the fluid in##2##3##(2006-11#1)(2007-10#1)
the fluid phase##7##3##(1990-12#1)(1990-3#1)(1990-4#1)(1996-8#1)(2009-11#1)(2010-5#2)
the fluid velocity##2##3##(2005-11#1)(2008-7#1)
the fluid was##2##3##(2006-7#1)(2008-7#1)
the fluid##59##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-8#1)(1994-8#1)(1996-4#1)(1996-5#1)(1996-8#2)(2005-10#2)(2005-11#8)(2006-10#1)(2006-11#1)(2006-2#2)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-9#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#7)(2009-11#3)(2009-9#1)(2010-2#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
the fluid's##2##2##(2007-12#1)(2010-12#1)
the fluidic path##2##3##(2008-11#2)
the fluidic##6##2##(2008-11#4)(2009-5#2)
the fluidics##2##2##(2008-9#2)
the fluidity and##2##3##(1996-5#1)(2008-8#1)
the fluidity of the##3##4##(1996-5#1)(1997-1#1)(2008-7#1)
the fluidity of##9##3##(1991-10#1)(1992-8#1)(1995-8#1)(1996-5#1)(1997-1#1)(2006-7#1)(2007-12#1)(2008-7#1)(2008-9#1)
the fluidity##13##2##(1991-10#1)(1992-8#1)(1994-11#1)(1995-8#1)(1996-5#2)(1997-1#1)(2006-7#1)(2007-12#1)(2008-7#1)(2008-8#2)(2008-9#1)
the fluidized##2##2##(2008-11#2)
the fluids##4##2##(2008-10#2)(2008-7#2)
the fluorescein##10##2##(1990-5#1)(1992-6#2)(1993-3#2)(1995-2#1)(1997-2#1)(2008-10#2)(2012-12#1)
the fluorescence and the##3##4##(2007-11#2)(2008-3#1)
the fluorescence and##5##3##(1992-9#1)(2007-11#2)(2008-3#2)
the fluorescence anisotropy of##4##4##(1994-2#1)(1996-7#1)(1997-1#1)(2008-10#1)
the fluorescence anisotropy##7##3##(1993-3#1)(1994-2#1)(1996-5#1)(1996-7#1)(1997-1#1)(2006-12#1)(2008-10#1)
the fluorescence changes##6##3##(1992-6#1)(1994-11#1)(1994-5#1)(1995-5#1)(1996-12#1)(2008-10#1)
the fluorescence contribution##2##3##(2007-12#1)(2008-3#1)
the fluorescence data##2##3##(2006-10#1)(2008-10#1)
the fluorescence decay of##3##4##(1991-4#1)(1994-9#1)(2005-4#1)
the fluorescence decay##6##3##(1990-7#1)(1991-4#1)(1994-9#1)(1996-11#1)(2005-4#1)(2008-10#1)
the fluorescence detector##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
the fluorescence distribution##2##3##(2008-2#1)(2008-3#1)
the fluorescence emission from##2##4##(2008-9#1)(2009-8#1)
the fluorescence emission intensity of##2##5##(1994-11#1)(2008-10#1)
the fluorescence emission maximum at##2##5##(2008-8#2)
the fluorescence emission maximum##3##4##(1997-8#1)(2008-8#2)
the fluorescence emission of the##3##5##(1990-3#1)(1992-6#1)(2008-10#1)
the fluorescence emission of##10##4##(1990-2#1)(1990-3#1)(1992-2#1)(1992-6#1)(2006-12#1)(2008-10#2)(2008-3#3)
the fluorescence emission spectra##3##4##(1997-4#1)(2005-10#1)(2010-4#1)
the fluorescence emission##30##3##(1990-2#1)(1990-3#1)(1992-2#1)(1992-6#1)(1994-11#1)(1997-4#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#7)(2008-2#1)(2008-3#5)(2008-8#3)(2008-9#1)(2009-8#1)(2010-4#1)
the fluorescence energy transfer##2##4##(1994-2#1)(2008-10#1)
the fluorescence enhancement of##6##4##(1994-11#1)(2007-8#1)(2008-10#4)
the fluorescence enhancement was##2##4##(1991-5#1)(2008-10#1)
the fluorescence enhancement##10##3##(1991-5#1)(1994-11#2)(2007-8#1)(2008-10#5)(2008-7#1)
the fluorescence excitation##4##3##(1997-1#1)(2008-10#2)(2008-2#1)
the fluorescence from a##2##4##(2007-12#1)(2008-2#1)
the fluorescence from##5##3##(1993-9#1)(2007-12#2)(2008-2#1)(2008-3#1)
the fluorescence image##2##3##(2008-3#2)
the fluorescence in##2##3##(1994-9#1)(1996-1#1)
the fluorescence increase of##2##4##(1991-9#1)(1997-4#1)
the fluorescence increase##4##3##(1991-9#2)(1997-4#1)(2008-1#1)
the fluorescence intensities of##2##4##(2005-11#1)(2008-10#1)
the fluorescence intensities##4##3##(2005-11#1)(2008-10#3)
the fluorescence intensity and the##2##5##(2008-10#2)
the fluorescence intensity and##4##4##(2007-8#1)(2008-10#3)
the fluorescence intensity at##2##4##(1994-8#1)(2008-10#1)
the fluorescence intensity by##2##4##(1997-8#1)(2013-8#1)
the fluorescence intensity changes##2##4##(1991-7#1)(2008-4#1)
the fluorescence intensity of pyrene-labeled##2##5##(1992-5#2)
the fluorescence intensity of the##11##5##(1990-12#1)(1991-7#1)(1992-3#1)(1995-6#1)(2005-4#1)(2008-10#5)(2008-5#1)
the fluorescence intensity of##24##4##(1990-12#1)(1991-7#1)(1992-3#1)(1992-5#2)(1992-8#1)(1994-12#1)(1995-6#1)(2005-4#1)(2008-10#11)(2008-11#1)(2008-4#1)(2008-5#1)(2009-11#1)
the fluorescence intensity ratio##4##4##(2008-10#1)(2008-2#2)(2008-3#1)
the fluorescence intensity##53##3##(1990-12#2)(1991-7#2)(1992-3#1)(1992-5#2)(1992-8#1)(1994-12#1)(1994-8#1)(1995-6#1)(1997-8#2)(2005-4#1)(2007-8#1)(2008-10#23)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#1)(2009-11#1)(2013-8#3)
the fluorescence is##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
the fluorescence lifetime of##3##4##(1997-1#1)(2006-10#1)(2007-12#1)
the fluorescence lifetime##7##3##(1997-1#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#3)
the fluorescence lifetimes of##2##4##(2005-4#1)(2007-12#1)
the fluorescence lifetimes##3##3##(2005-4#1)(2007-12#1)(2008-5#1)
the fluorescence of a##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
the fluorescence of the##10##4##(1992-8#1)(1995-2#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-10#3)(2008-5#1)(2008-9#1)
the fluorescence of##42##3##(1990-5#1)(1992-7#1)(1992-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#2)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#15)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#3)(2009-5#1)(2013-8#1)
the fluorescence polarization##2##3##(1993-8#1)(2008-8#1)
the fluorescence probe##2##3##(2005-11#1)(2008-10#1)
the fluorescence properties of##4##4##(1991-7#2)(1992-6#1)(1997-2#1)
the fluorescence properties##8##3##(1991-7#2)(1992-6#1)(1993-9#1)(1994-5#1)(1997-2#1)(2006-10#1)(2009-2#1)
the fluorescence quantum yield##3##4##(2008-3#3)
the fluorescence quenching data##2##4##(2008-10#1)(2008-4#1)
the fluorescence quenching##13##3##(2005-4#1)(2008-10#9)(2008-4#1)(2008-8#1)(2013-8#1)
the fluorescence reaction between##2##4##(2008-10#2)
the fluorescence resonance energy transfer (FRET)##2##6##(2008-10#2)
the fluorescence resonance energy##3##4##(2008-10#2)(2008-9#1)
the fluorescence signal##10##3##(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
the fluorescence signals##3##3##(2008-10#2)(2008-2#1)
the fluorescence spectra of the##3##5##(1993-9#1)(1995-1#1)(1997-4#1)
the fluorescence spectra of##6##4##(1993-9#1)(1995-1#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-5#1)
the fluorescence spectra##8##3##(1993-9#1)(1995-1#1)(1997-4#1)(2005-4#1)(2007-11#1)(2008-10#2)(2008-5#1)
the fluorescence spectral##2##3##(2008-2#1)(2009-12#1)
the fluorescence spectrum of##2##4##(2007-11#1)(2008-10#1)
the fluorescence spectrum##5##3##(1991-9#1)(1994-8#1)(2007-11#1)(2008-10#2)
the fluorescence was##4##3##(1990-8#1)(1991-2#1)(1992-9#1)(2006-5#1)
the fluorescence yield of##2##4##(2008-2#1)(2008-3#1)
the fluorescence yield##4##3##(2008-2#3)(2008-3#1)
the fluorescence##334##2##(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#3)(1990-8#2)(1991-2#1)(1991-4#1)(1991-5#2)(1991-7#4)(1991-9#3)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#2)(1993-3#1)(1993-8#1)(1993-9#3)(1994-11#5)(1994-12#1)(1994-2#2)(1994-5#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-2#1)(1995-5#2)(1995-6#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#2)(1996-7#1)(1997-1#3)(1997-2#3)(1997-4#4)(1997-7#2)(1997-8#6)(2005-10#1)(2005-11#3)(2005-4#6)(2006-10#4)(2006-12#3)(2006-5#1)(2007-11#7)(2007-12#12)(2007-8#6)(2008-1#3)(2008-10#96)(2008-11#4)(2008-2#23)(2008-3#34)(2008-4#7)(2008-5#6)(2008-7#4)(2008-8#5)(2008-9#6)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-4#2)(2013-8#5)
the fluorescence-disappear##2##2##(2005-4#2)
the fluorescent base analog##3##4##(2008-4#3)
the fluorescent calcium##5##3##(1990-3#1)(1992-7#2)(1996-11#1)(1996-3#1)
the fluorescent derivative##2##3##(1991-8#1)(1997-2#1)
the fluorescent dye##12##3##(1990-2#1)(1990-9#1)(1991-11#1)(1992-6#1)(1995-7#1)(1996-1#2)(1997-7#1)(2008-10#1)(2008-4#1)(2009-7#1)(2013-1#1)
the fluorescent indicator##4##3##(1992-7#1)(1992-8#1)(1994-12#1)(1994-6#1)
the fluorescent intensity##4##3##(2005-4#2)(2008-10#1)(2011-2#1)
the fluorescent labeling##2##3##(1990-5#1)(2007-8#1)
the fluorescent light##4##3##(2007-12#2)(2008-3#2)
the fluorescent membrane probe##2##4##(1990-5#2)
the fluorescent membrane##3##3##(1990-5#2)(1996-6#1)
the fluorescent phospholipid##3##3##(1992-3#1)(1993-11#1)(1994-5#1)
the fluorescent probe ADIFAB##2##4##(1994-9#2)
the fluorescent probe##16##3##(1990-11#1)(1990-5#1)(1990-7#1)(1992-3#2)(1992-6#1)(1993-9#1)(1994-9#2)(1995-3#1)(1997-6#1)(1997-7#2)(2008-10#2)(2008-8#1)
the fluorescent reagent##2##3##(1990-8#1)(2008-10#1)
the fluorescent signal of##2##4##(2008-10#1)(2008-11#1)
the fluorescent signal##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
the fluorescent signals##2##3##(1992-8#1)(2007-2#1)
the fluorescent##112##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#4)(1990-7#1)(1990-8#3)(1990-9#2)(1991-11#1)(1991-6#1)(1991-8#1)(1992-3#3)(1992-6#4)(1992-7#3)(1992-8#2)(1993-11#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-5#2)(1994-6#1)(1994-9#2)(1995-1#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-7#1)(1996-1#3)(1996-11#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#3)(1997-7#6)(2005-4#2)(2006-10#2)(2006-4#1)(2007-12#2)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#15)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#6)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#2)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#2)
the fluoride concentration in##2##4##(2008-10#2)
the fluoride##12##2##(1990-9#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-8#1)(2011-1#1)
the fluorimetric method##2##3##(2008-10#2)
the fluorimetric##12##2##(1994-2#1)(2008-10#11)
the fluorinated##8##2##(1997-2#1)(2005-11#1)(2008-10#1)(2009-9#1)(2010-4#3)(2010-8#1)
the fluorine ion##2##3##(2008-10#2)
the fluorine##9##2##(1990-12#1)(1992-3#1)(1997-4#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-5#1)
the fluoro group##2##3##(1991-12#1)(2009-9#1)
the fluoro##3##2##(1990-12#1)(1991-12#1)(2009-9#1)
the fluorochrome##6##2##(1990-2#1)(1991-6#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-12#1)
the fluorogenic##7##2##(1990-11#1)(1990-8#1)(1992-9#1)(2008-10#4)
the fluorometric assay##2##3##(1991-10#2)
the fluorometric##9##2##(1991-10#2)(1993-3#1)(2008-10#6)
the fluorophore concentration##3##3##(2007-12#2)(2008-2#1)
the fluorophore is##2##3##(1996-9#1)(2008-10#1)
the fluorophore##20##2##(1990-2#1)(1991-4#1)(1993-3#1)(1993-9#1)(1994-2#1)(1995-5#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-6#1)(1997-8#1)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#1)
the fluorophores##6##2##(1990-8#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-3#1)
the fluoroquinolone class of##2##4##(2006-10#1)(2007-7#1)
the fluoroquinolone class##3##3##(2006-10#1)(2007-7#1)(2008-3#1)
the fluoroquinolone##6##2##(1991-12#2)(2006-10#1)(2007-2#1)(2007-7#1)(2008-3#1)
the fluoroquinolones were##2##3##(1991-12#1)(2008-10#1)
the fluoroquinolones##11##2##(1991-12#4)(2005-7#1)(2008-10#2)(2012-2#1)(2013-8#3)
the fluorosilicone copolymers are##2##4##(2005-11#2)
the fluorosilicone copolymers##3##3##(2005-11#3)
the fluorous##2##2##(2009-10#2)
the fluoxetine-induced elevation##2##3##(1997-6#2)
the flushing reaction##2##3##(1994-5#2)
the flushing##3##2##(1994-5#2)(2009-11#1)
the flux of##11##3##(1990-12#1)(1990-2#1)(1993-9#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-6#1)(2009-8#1)(2012-2#1)
the flux through the##2##4##(1994-8#1)(2008-3#1)
the flux##27##2##(1990-11#1)(1990-12#1)(1990-2#1)(1993-3#2)(1993-9#1)(1994-8#1)(1995-3#1)(1995-6#1)(1997-5#1)(2004-12#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-2#1)
the fluxes##4##2##(2008-10#1)(2008-6#1)(2008-7#2)
the fly ash precipitates##3##4##(2008-10#3)
the fly ash##8##3##(2008-10#7)(2008-3#1)
the fly is##2##3##(1995-8#1)(2008-10#1)
the fly proteome##2##3##(2008-9#2)
the fly##43##2##(1991-6#1)(1994-2#1)(1995-8#4)(1996-11#1)(1996-5#1)(1997-4#1)(2006-1#1)(2007-12#2)(2008-1#2)(2008-10#10)(2008-11#5)(2008-3#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2011-1#1)(2012-12#3)
the fly's##4##2##(2008-11#3)(2012-3#1)
the fmol##2##2##(2008-10#2)
the foam bilayer is##2##4##(1992-5#2)
the foam bilayer##3##3##(1992-5#3)
the foam fractionation process##2##4##(2008-5#2)
the foam##18##2##(1992-5#3)(2005-11#1)(2006-11#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#3)(2008-6#4)(2012-2#2)
the foams##2##2##(1997-1#1)(2009-7#1)
the focal adhesion kinase##2##4##(1997-7#1)(2006-10#1)
the focal adhesion##3##3##(1997-4#1)(1997-7#1)(2006-10#1)
the focal distance##2##3##(2008-3#2)
the focal length is##2##4##(2008-3#2)
the focal length of a##3##5##(2008-3#3)
the focal length of the##3##5##(2008-2#2)(2008-3#1)
the focal length of##6##4##(2008-2#2)(2008-3#4)
the focal length##9##3##(2008-2#2)(2008-3#7)
the focal lesion##2##3##(2006-6#1)(2007-9#1)
the focal plane of the##4##5##(2007-12#1)(2008-2#1)(2008-3#2)
the focal plane of##7##4##(2007-12#1)(2008-2#1)(2008-3#5)
the focal plane##22##3##(2007-12#1)(2008-1#2)(2008-2#5)(2008-3#13)(2011-2#1)
the focal planes##2##3##(2007-11#1)(2008-3#1)
the focal point of a##2##5##(2008-3#2)
the focal point of the laser##2##6##(2007-12#1)(2008-3#1)
the focal point of the##4##5##(1997-6#1)(2007-12#1)(2008-10#1)(2008-3#1)
the focal point of##9##4##(1992-3#1)(1997-6#1)(2006-8#1)(2007-12#2)(2008-10#1)(2008-3#3)
the focal point##20##3##(1992-3#1)(1997-6#1)(2006-5#2)(2006-8#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#9)
the focal position in##2##4##(2008-2#1)(2008-3#1)
the focal position##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2013-8#1)
the focal region and##2##4##(2007-12#1)(2008-3#1)
the focal region of a lens##2##6##(2007-11#1)(2007-12#1)
the focal region of a##6##5##(2007-11#2)(2007-12#2)(2008-3#2)
the focal region of the##3##5##(2008-3#3)
the focal region of##10##4##(2007-11#2)(2007-12#3)(2008-3#5)
the focal region##19##3##(2007-11#3)(2007-12#5)(2008-2#2)(2008-3#9)
the focal shift in##2##4##(2007-12#2)
the focal shift##4##3##(2007-12#4)
the focal spot of##2##4##(2008-2#1)(2012-2#1)
the focal spot size##2##4##(2008-2#1)(2012-2#1)
the focal spot##10##3##(2007-12#2)(2008-2#2)(2008-3#3)(2011-1#1)(2012-2#2)
the focal volume##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
the focal##121##2##(1992-3#1)(1994-9#1)(1997-4#2)(1997-6#1)(1997-7#1)(2006-10#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-11#5)(2007-12#18)(2007-9#1)(2008-1#2)(2008-10#2)(2008-2#19)(2008-3#49)(2008-4#1)(2008-8#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
the foci of##3##3##(1996-3#1)(2007-12#1)(2008-9#1)
the foci##7##2##(1996-3#1)(2007-11#1)(2007-12#2)(2008-3#1)(2008-5#1)(2008-9#1)
the focus and##3##3##(1992-8#1)(2008-10#1)(2010-8#1)
the focus error##3##3##(2008-2#3)
the focus for##2##3##(2008-12#1)(2010-7#1)
the focus group##3##3##(1992-2#1)(2008-11#1)(2012-12#1)
the focus groups and##2##4##(2008-12#1)(2012-3#1)
the focus groups##6##3##(1997-3#1)(2008-12#1)(2008-4#1)(2012-3#3)
the focus has been##3##4##(2009-4#1)(2010-5#1)(2012-1#1)
the focus has shifted to##2##5##(2010-9#1)(2013-1#1)
the focus has##5##3##(2009-4#1)(2010-5#1)(2010-9#1)(2012-1#1)(2013-1#1)
the focus in##2##3##(2008-10#1)(2008-11#1)
the focus is on##5##4##(1990-5#1)(2005-8#1)(2007-11#1)(2008-9#1)(2010-5#1)
the focus is##7##3##(1990-5#1)(2005-8#1)(2006-2#1)(2006-5#1)(2007-11#1)(2008-9#1)(2010-5#1)
the focus of a##5##4##(1995-1#1)(2005-7#1)(2006-2#1)(2007-12#1)(2008-3#1)
the focus of attention##2##4##(1997-2#1)(2010-7#1)
the focus of intense research##4##5##(2008-1#1)(2009-3#1)(2010-7#1)(2010-9#1)
the focus of intense##7##4##(2008-1#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-7#1)(2010-9#1)(2013-7#1)
the focus of many##4##4##(2009-11#1)(2009-5#1)(2010-3#1)(2011-2#1)
the focus of much research##2##5##(2008-10#1)(2008-11#1)
the focus of much##3##4##(1993-1#1)(2008-10#1)(2008-11#1)
the focus of research##2##4##(2006-10#1)(2007-2#1)
the focus of the##10##4##(1994-3#1)(2005-8#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-5#1)(2010-4#1)(2011-1#1)
the focus of this article is to##3##7##(2012-11#2)(2012-2#1)
the focus of this paper##2##5##(2006-8#1)(2008-2#1)
the focus of this review##13##5##(2006-10#3)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-6#1)(2011-12#1)(2011-2#1)
the focus of this##21##4##(2005-8#1)(2006-10#3)(2006-3#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-11#2)(2012-2#1)
the focus of##95##3##(1991-8#1)(1993-1#1)(1993-12#2)(1994-3#1)(1994-4#1)(1995-1#1)(1996-2#1)(1997-2#1)(1997-4#1)(2005-10#1)(2005-7#1)(2005-8#2)(2006-10#7)(2006-2#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#1)
the focus on the##3##4##(1993-11#1)(2008-10#1)(2008-5#1)
the focus on##12##3##(1993-11#1)(1996-3#1)(2005-10#1)(2005-11#1)(2006-11#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-6#1)(2010-8#1)
the focus should##2##3##(1997-2#2)
the focus to##2##3##(1994-12#1)(2009-9#1)
the focus##178##2##(1990-5#1)(1990-9#1)(1991-12#2)(1991-8#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#3)(1994-12#1)(1994-3#1)(1994-4#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(2005-10#2)(2005-11#1)(2005-7#2)(2005-8#3)(2006-10#7)(2006-11#1)(2006-2#2)(2006-3#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#11)(2007-2#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#15)(2008-11#6)(2008-12#4)(2008-2#11)(2008-3#7)(2008-4#4)(2008-5#4)(2008-6#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#2)(2009-9#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#3)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#4)(2012-11#2)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
the focused Gaussian##2##3##(2008-2#2)
the focused beam##2##3##(2007-12#1)(2008-3#1)
the focused intensity##2##3##(2007-11#1)(2008-2#1)
the focused spot##3##3##(2008-2#2)(2008-3#1)
the focused##20##2##(1995-1#1)(2007-11#2)(2007-12#4)(2008-10#2)(2008-2#8)(2008-3#3)
the focusing and##2##3##(2008-2#2)
the focusing effect##2##3##(2008-10#1)(2008-3#1)
the focusing lens##4##3##(2008-2#1)(2008-3#3)
the focusing properties##2##3##(2008-2#1)(2008-3#1)
the focusing##20##2##(2006-5#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#7)(2008-5#1)(2009-5#1)(2010-4#1)
the foetal brain##2##3##(1995-8#1)(1997-6#1)
the foetal##13##2##(1990-5#3)(1995-11#1)(1995-6#1)(1995-8#1)(1996-11#1)(1997-6#2)(2008-4#1)(2008-5#1)(2008-7#1)(2012-2#1)
the foetus and newborn infant##2##5##(1997-6#1)(2008-5#1)
the foetus and newborn##3##4##(1997-6#1)(2008-5#2)
the foetus##32##2##(1990-4#1)(1991-9#2)(1992-4#5)(1992-5#1)(1993-1#1)(1993-6#1)(1994-2#1)(1996-11#1)(1997-2#2)(1997-6#1)(2006-2#1)(2007-7#2)(2008-3#1)(2008-5#3)(2008-7#2)(2009-8#1)(2010-5#1)(2011-2#1)(2012-2#3)(2012-3#1)
the foil##2##2##(2008-1#1)(2008-11#1)
the folate and methionine cycles##2##5##(2007-11#2)
the folate and##3##3##(1995-2#1)(2007-11#2)
the folate receptor##2##3##(1994-6#2)
the folate##11##2##(1991-2#1)(1993-12#1)(1994-6#3)(1995-2#2)(2007-11#2)(2008-10#1)(2009-4#1)
the fold of the##2##4##(1994-11#2)
the fold of##3##3##(1994-11#2)(2008-4#1)
the fold##6##2##(1994-11#2)(2008-4#1)(2009-6#1)(2009-9#2)
the folded and unfolded##2##4##(1994-8#1)(1997-4#1)
the folded and##4##3##(1993-11#1)(1994-8#1)(1997-4#1)(2009-7#1)
the folded conformation of##2##4##(1990-2#1)(1991-5#1)
the folded conformation##3##3##(1990-2#1)(1991-5#1)(2008-4#1)
the folded protein##3##3##(1993-11#1)(1993-6#1)(1997-4#1)
the folded##22##2##(1990-2#1)(1990-5#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-6#1)(1993-11#3)(1993-6#1)(1993-9#1)(1994-8#1)(1997-4#2)(2006-10#1)(2008-2#1)(2008-4#1)(2009-7#1)(2009-9#1)(2012-3#1)(2013-1#1)
the folding and unfolding##2##4##(1991-6#1)(1994-8#1)
the folding and##9##3##(1991-6#1)(1993-3#1)(1994-12#1)(1994-8#1)(1994-9#1)(2008-4#2)(2009-6#2)
the folding intermediate##4##3##(1997-2#2)(1997-4#2)
the folding kinetics of##2##4##(1997-2#1)(2008-9#1)
the folding of a##4##4##(1992-6#1)(1995-4#2)(1995-6#1)
the folding of barnase##3##4##(1995-4#1)(1996-4#2)
the folding of the##11##4##(1990-12#1)(1990-2#2)(1991-11#1)(1992-11#1)(1994-12#1)(1995-3#1)(1996-5#1)(1997-1#1)(1997-4#1)(2007-11#1)
the folding of##29##3##(1990-12#1)(1990-2#2)(1991-11#1)(1991-4#1)(1992-11#1)(1992-6#2)(1993-3#1)(1994-12#2)(1995-3#1)(1995-4#6)(1995-6#1)(1996-11#1)(1996-4#2)(1996-5#3)(1997-1#1)(1997-4#1)(2007-11#1)(2010-4#1)
the folding pathway of##4##4##(1993-6#1)(1995-1#1)(1997-2#2)
the folding pathway##9##3##(1991-6#1)(1992-3#2)(1993-6#1)(1995-1#2)(1995-6#1)(1997-2#2)
the folding process##4##3##(1991-6#2)(1993-6#1)(2008-1#1)
the folding rate##2##3##(1996-4#1)(1997-2#1)
the folding reaction##3##3##(1992-3#2)(1992-6#1)
the folding transition##2##3##(1991-7#1)(1997-2#1)
the folding##77##2##(1990-12#1)(1990-2#2)(1990-7#1)(1991-11#1)(1991-4#1)(1991-6#4)(1991-7#1)(1992-11#1)(1992-12#1)(1992-3#4)(1992-6#4)(1993-3#2)(1993-6#3)(1994-12#3)(1994-8#1)(1994-9#1)(1995-1#2)(1995-3#1)(1995-4#7)(1995-5#1)(1995-6#2)(1995-8#2)(1996-11#1)(1996-4#3)(1996-5#4)(1997-1#1)(1997-2#7)(1997-4#3)(2007-11#1)(2007-12#1)(2008-1#1)(2008-4#3)(2008-9#2)(2009-6#2)(2010-2#1)(2010-4#1)
the folds##2##2##(1993-6#1)(2007-12#1)
the foliage of##4##3##(2006-3#1)(2008-10#3)
the foliage##9##2##(2006-3#1)(2008-10#8)
the foliar application of##2##4##(2008-10#2)
the foliar##4##2##(2008-10#3)(2008-3#1)
the folic acid biosynthetic pathway##2##5##(1994-9#2)
the folic acid##3##3##(1994-9#2)(2013-8#1)
the folk##2##2##(2008-11#1)(2012-2#1)
the follicle cells##7##3##(1991-5#1)(2007-12#1)(2008-6#4)(2008-7#1)
the follicle##20##2##(1990-6#2)(1990-8#1)(1991-3#1)(1991-5#1)(1992-4#1)(1997-8#1)(2007-12#1)(2008-12#1)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#1)(2011-2#4)
the follicles##7##2##(1990-9#1)(2006-5#1)(2008-12#1)(2009-4#1)(2012-3#2)(2013-7#1)
the follicular epithelium##2##3##(2008-5#1)(2008-7#1)
the follicular phase##4##3##(1992-4#1)(2006-5#1)(2009-4#1)(2011-2#1)
the follicular unit-like wigs##2##4##(2012-3#2)
the follicular wall##2##3##(2008-12#1)(2008-7#1)
the follicular##17##2##(1992-4#2)(1994-4#1)(2006-12#1)(2006-5#1)(2008-12#2)(2008-5#3)(2008-7#2)(2009-4#1)(2011-1#1)(2011-2#1)(2012-3#2)
the follistatin molecule##3##3##(1991-8#3)
the follow up of##4##4##(1996-3#1)(2007-9#1)(2013-8#2)
the follow up##15##3##(1991-5#1)(1996-3#1)(1996-9#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-12#1)(2010-3#1)(2013-1#2)(2013-8#2)
the follow-up assessment##2##3##(2008-11#1)(2012-2#1)
the follow-up examination##4##3##(1997-1#1)(1997-3#1)(2007-7#1)(2008-3#1)
the follow-up of coronary##2##4##(2011-2#2)
the follow-up of patients with##3##5##(1990-6#1)(1994-3#1)(1997-8#1)
the follow-up of patients##5##4##(1990-10#1)(1990-6#1)(1990-9#1)(1994-3#1)(1997-8#1)
the follow-up of the##2##4##(2010-6#1)(2012-12#1)
the follow-up of##22##3##(1990-10#1)(1990-6#1)(1990-9#1)(1991-3#1)(1991-9#1)(1994-11#1)(1994-3#1)(1997-4#1)(1997-8#2)(2006-2#1)(2006-9#1)(2007-4#1)(2008-1#1)(2008-7#1)(2010-6#1)(2011-2#3)(2012-12#2)(2012-3#1)
the follow-up period (mean##4##4##(2007-7#1)(2007-8#1)(2008-3#1)(2008-7#1)
the follow-up period is##2##4##(1996-3#1)(2007-11#1)
the follow-up period of 12 to##2##6##(1995-10#2)
the follow-up period of##4##4##(1995-10#2)(2007-7#1)(2008-6#1)
the follow-up period was##3##4##(1996-12#1)(2007-7#1)(2008-3#1)
the follow-up period##42##3##(1991-6#2)(1994-6#1)(1995-10#2)(1995-2#3)(1996-11#2)(1996-12#1)(1996-3#1)(1997-8#2)(2004-10#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-7#4)(2007-8#3)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#4)(2009-10#1)(2010-5#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
the follow-up study##2##3##(1997-8#1)(2008-9#1)
the follow-up##123##2##(1990-10#3)(1990-6#1)(1990-8#1)(1990-9#2)(1991-3#1)(1991-6#2)(1991-9#2)(1992-6#1)(1992-8#1)(1993-10#1)(1993-5#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-10#2)(1995-2#3)(1995-6#1)(1995-9#1)(1996-11#2)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-8#6)(2004-10#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#9)(2007-8#6)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#6)(2011-3#2)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
the following 10##3##3##(1990-3#1)(2008-10#2)
the following 3##4##3##(2006-8#1)(2007-10#2)(2008-10#1)
the following 4##2##3##(1997-2#1)(2008-5#1)
the following 5##2##3##(1994-6#1)(2006-3#1)
the following activities##2##3##(1996-12#1)(2009-8#1)
the following advantages##4##3##(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)
the following analyses##2##3##(2007-12#1)(2008-10#1)
the following are##4##3##(1992-12#1)(2006-10#1)(2006-6#1)(2006-9#1)
the following areas##2##3##(1996-3#1)(2008-11#1)
the following article##5##3##(1991-3#2)(1996-2#1)(1997-4#1)(2012-2#1)
the following aspects##6##3##(1990-10#1)(1994-12#1)(1994-6#1)(2007-12#1)(2008-4#1)(2011-2#1)
the following case##2##3##(2007-8#1)(2008-7#1)
the following categories##6##3##(1995-2#1)(2004-11#1)(2008-2#1)(2011-3#1)(2012-12#1)(2012-3#1)
the following characteristics of##3##4##(2008-10#1)(2008-3#1)(2011-1#1)
the following characteristics##12##3##(1991-2#1)(1991-9#1)(1993-9#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-3#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)
the following chemical##2##3##(1995-5#1)(2008-10#1)
the following classes##2##3##(1992-5#1)(1997-4#1)
the following clinical##7##3##(1997-1#1)(1997-3#1)(2007-12#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-12#1)
the following combination of characters##2##5##(2008-5#2)
the following combination of##3##4##(2008-5#3)
the following combination##4##3##(2007-11#1)(2008-5#3)
the following complexes##3##3##(2008-10#1)(2008-5#2)
the following components##3##3##(2008-10#1)(2008-3#1)(2010-6#1)
the following compounds##2##3##(2006-8#1)(2011-2#1)
the following concentrations##3##3##(2007-12#1)(2008-10#1)(2013-1#1)
the following conclusion##2##3##(1991-4#1)(1997-1#1)
the following conclusions##13##3##(1990-2#1)(1991-8#1)(1994-5#1)(1994-9#1)(2005-7#2)(2006-12#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-9#1)(2012-12#1)
the following conditions##10##3##(1995-2#1)(1996-5#1)(2007-11#1)(2008-10#3)(2008-5#2)(2008-6#1)(2010-5#1)
the following criteria##6##3##(1992-5#1)(1997-5#1)(2006-10#1)(2007-8#1)(2012-12#1)(2013-1#1)
the following data were##2##4##(2007-8#1)(2011-1#1)
the following data##5##3##(2007-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
the following day##9##3##(1993-12#1)(1996-6#1)(2008-3#3)(2008-7#1)(2009-4#1)(2011-1#1)(2012-2#1)
the following days of##2##4##(1991-9#1)(2008-5#1)
the following days##7##3##(1991-6#1)(1991-9#1)(1994-6#1)(2008-10#1)(2008-5#1)(2009-6#1)(2010-2#1)
the following different##2##3##(2007-8#1)(2010-4#1)
the following effects##3##3##(1991-5#1)(2007-11#1)(2013-1#1)
the following equation##5##3##(2008-10#3)(2012-2#2)
the following experimental##2##3##(2008-10#2)
the following factors##4##3##(2008-2#1)(2008-6#1)(2008-7#1)(2012-12#1)
the following features##2##3##(1991-7#1)(1996-10#1)
the following findings##6##3##(1991-3#1)(1991-6#1)(1992-3#1)(1992-8#1)(2006-12#1)(2012-2#1)
the following five##6##3##(1990-12#1)(1992-12#1)(1994-12#1)(1997-2#1)(2007-8#1)(2013-7#1)
the following four##9##3##(1991-2#1)(1992-2#1)(1994-5#1)(1996-9#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-9#1)(2010-6#1)
the following functions##3##3##(2006-2#1)(2008-2#1)(2011-2#1)
the following general##3##3##(1995-11#1)(1997-2#1)(2008-3#1)
the following goals##2##3##(2007-12#1)(2013-1#1)
the following groups##6##3##(1997-5#1)(2006-5#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
the following hypothesis##2##3##(2008-9#2)
the following in##3##3##(1994-6#1)(1996-12#1)(2013-1#1)
the following independent##2##3##(2007-9#1)(2008-10#1)
the following indications##4##3##(2005-8#1)(2005-9#2)(2007-8#1)
the following information##2##3##(1994-12#1)(2013-1#1)
the following issues##3##3##(2008-1#1)(2008-2#1)(2008-5#1)
the following key words##2##4##(2013-1#1)(2013-8#1)
the following key##3##3##(2008-4#1)(2013-1#1)(2013-8#1)
the following lag phase##2##4##(1997-8#1)(2008-7#1)
the following linear##4##3##(2008-10#4)
the following main##5##3##(1993-12#1)(2006-9#1)(2008-10#1)(2008-7#1)(2011-2#1)
the following markers##2##3##(1990-4#1)(2008-10#1)
the following means##2##3##(1994-8#1)(2008-11#1)
the following measurements##2##3##(1993-12#1)(1994-6#1)
the following measures##2##3##(1990-4#1)(2013-7#1)
the following mechanism##3##3##(1996-4#1)(2008-5#1)(2008-7#1)
the following methods##5##3##(1995-12#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-6#1)
the following model##2##3##(1991-12#1)(2013-1#1)
the following months##6##3##(1991-4#1)(1993-3#1)(1997-3#2)(2008-7#1)(2009-4#1)
the following morning##2##3##(2004-11#1)(2007-3#1)
the following new##3##3##(2008-4#1)(2008-5#1)(2010-5#1)
the following note##2##3##(1991-3#1)(1997-3#1)
the following objectives##3##3##(2005-5#1)(2007-12#1)(2010-9#1)
the following observations##4##3##(1990-9#1)(1995-10#1)(2008-7#1)(2013-1#1)
the following one##2##3##(2008-2#1)(2008-7#1)
the following order of potency##2##5##(1991-2#1)(1995-12#1)
the following order of##7##4##(1991-11#1)(1991-2#1)(1995-12#2)(2007-1#1)(2008-10#1)(2008-3#1)
the following order##30##3##(1990-1#1)(1991-11#1)(1991-2#1)(1992-9#1)(1993-11#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-4#1)(1997-6#1)(2004-9#1)(2005-11#1)(2005-8#3)(2007-1#1)(2008-10#8)(2008-11#1)(2008-3#1)(2010-3#1)(2010-4#2)
the following organisms##2##3##(1992-10#1)(2008-5#1)
the following paper##5##3##(1990-3#1)(1995-5#1)(2008-5#1)(2012-3#1)(2013-1#1)
the following parameters were##4##4##(2006-8#1)(2008-10#2)(2009-6#1)
the following parameters##16##3##(1991-12#1)(1991-4#1)(1995-1#1)(2005-10#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-7#2)(2008-8#1)(2009-6#1)
the following performance##2##3##(1992-2#1)(2008-10#1)
the following points##4##3##(1990-7#1)(2006-12#1)(2010-1#1)(2010-12#1)
the following population##2##3##(2012-2#1)(2013-7#1)
the following principles##2##3##(2008-7#1)(2011-12#1)
the following procedure##3##3##(1990-5#1)(1992-3#1)(2008-10#1)
the following properties##3##3##(1993-3#1)(1997-4#1)(2008-10#1)
the following proposed##2##3##(2008-4#1)(2008-7#1)
the following question##4##3##(2008-6#1)(2012-1#1)(2012-12#1)(2012-3#1)
the following questionnaires##2##3##(2007-7#1)(2008-6#1)
the following questions##14##3##(1993-5#1)(1994-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-4#1)(2006-12#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-4#1)
the following rank order##5##4##(1993-6#1)(1994-3#1)(1995-7#1)(1997-2#1)(2008-9#1)
the following reaction##2##3##(1994-12#1)(2008-10#1)
the following reasons##2##3##(1991-2#1)(1992-11#1)
the following recommendations##2##3##(2008-1#1)(2008-10#1)
the following results were obtained##4##5##(1991-12#1)(2007-2#1)(2008-10#2)
the following results##17##3##(1991-12#2)(1992-6#1)(1996-1#1)(2006-10#1)(2007-2#1)(2007-3#1)(2008-10#3)(2008-2#1)(2008-6#2)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
the following risk factors for##2##5##(2008-5#1)(2013-1#1)
the following risk factors##5##4##(1991-12#1)(2006-6#1)(2008-5#1)(2010-5#1)(2013-1#1)
the following schedules##2##3##(1992-8#1)(2006-6#1)
the following situations##2##3##(1993-1#1)(2013-1#1)
the following six##2##3##(2008-1#1)(2008-4#1)
the following skin parameters##2##4##(2008-5#2)
the following specific##2##3##(2006-12#1)(2008-10#1)
the following spring##4##3##(2008-10#3)(2008-8#1)
the following stages##2##3##(2007-9#1)(2013-1#1)
the following steps##8##3##(1990-4#1)(1991-12#1)(1992-5#1)(1994-12#1)(1996-3#1)(2008-2#1)(2008-8#1)(2010-1#1)
the following strategies##3##3##(2008-1#2)(2008-7#1)
the following structure##6##3##(1990-3#1)(1991-7#1)(1995-11#1)(1995-3#1)(1995-4#1)(1996-10#1)
the following studies##3##3##(1991-3#1)(1995-5#1)(1995-9#1)
the following study##3##3##(2007-2#1)(2008-7#1)(2011-1#1)
the following surgical##2##3##(2006-6#1)(2008-6#1)
the following symptoms##2##3##(2007-9#1)(2008-6#1)
the following techniques##3##3##(1990-3#1)(2008-10#1)(2008-2#1)
the following terms##2##3##(2008-12#1)(2011-12#1)
the following text##3##3##(2006-10#1)(2008-1#1)(2013-1#1)
the following themes##2##3##(2008-12#1)(2012-1#1)
the following three##10##3##(1992-1#1)(1994-2#1)(1996-4#1)(1996-7#1)(2008-1#2)(2008-8#1)(2008-9#1)(2009-6#1)(2013-1#1)
the following topics##6##3##(1994-3#1)(1996-1#1)(1996-3#1)(2007-5#1)(2008-1#1)(2010-9#1)
the following treatment##2##3##(1992-4#1)(1997-2#1)
the following treatments##2##3##(2007-8#1)(2008-3#1)
the following trends##2##3##(2008-7#1)(2008-9#1)
the following two years##2##4##(2008-1#1)(2008-2#1)
the following two##9##3##(1990-3#1)(1994-9#1)(1995-2#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-8#1)
the following types of##2##4##(1997-3#1)(2011-12#1)
the following unit##2##3##(1996-2#1)(2008-9#1)
the following units##2##3##(2008-10#1)(2008-4#1)
the following values##7##3##(1995-11#1)(2005-11#1)(2006-10#1)(2007-8#1)(2008-10#1)(2012-12#1)(2013-1#1)
the following variables##5##3##(2004-10#2)(2006-6#1)(2008-3#1)(2011-2#1)
the following was##2##3##(1994-12#1)(2008-10#1)
the following week##2##3##(2008-5#1)(2008-9#1)
the following were##4##3##(1996-7#1)(1997-8#1)(2008-11#1)(2010-11#1)
the following year##10##3##(1994-7#1)(2004-11#2)(2006-8#1)(2007-12#1)(2008-10#2)(2008-6#1)(2008-9#1)(2011-2#1)
the following years##5##3##(1996-3#1)(2006-5#1)(2007-11#1)(2008-11#1)(2009-2#1)
the following##895##2##(1990-1#1)(1990-10#2)(1990-11#4)(1990-12#5)(1990-2#5)(1990-3#6)(1990-4#5)(1990-5#4)(1990-7#2)(1990-8#1)(1990-9#2)(1991-11#2)(1991-12#8)(1991-2#7)(1991-3#5)(1991-4#4)(1991-5#5)(1991-6#5)(1991-7#3)(1991-8#1)(1991-9#5)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#4)(1992-2#3)(1992-3#2)(1992-4#2)(1992-5#3)(1992-6#3)(1992-7#1)(1992-8#4)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#5)(1993-3#5)(1993-4#1)(1993-5#2)(1993-6#1)(1993-8#4)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#7)(1994-2#1)(1994-3#4)(1994-5#4)(1994-6#8)(1994-7#1)(1994-8#3)(1994-9#2)(1995-1#4)(1995-10#2)(1995-11#6)(1995-12#6)(1995-2#3)(1995-3#6)(1995-4#3)(1995-5#4)(1995-6#5)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#4)(1996-10#2)(1996-12#7)(1996-2#3)(1996-3#6)(1996-4#4)(1996-5#4)(1996-6#3)(1996-7#2)(1996-9#1)(1997-1#4)(1997-2#8)(1997-3#6)(1997-4#7)(1997-5#4)(1997-6#1)(1997-7#1)(1997-8#7)(2004-10#2)(2004-11#6)(2004-12#1)(2004-4#3)(2004-8#1)(2004-9#1)(2005-10#2)(2005-11#4)(2005-12#1)(2005-4#1)(2005-5#2)(2005-7#4)(2005-8#4)(2005-9#2)(2006-10#12)(2006-12#10)(2006-2#3)(2006-3#2)(2006-4#1)(2006-5#8)(2006-6#6)(2006-7#2)(2006-8#6)(2006-9#2)(2007-1#2)(2007-10#6)(2007-11#11)(2007-12#18)(2007-2#7)(2007-3#5)(2007-4#1)(2007-5#3)(2007-7#7)(2007-8#19)(2007-9#5)(2008-1#16)(2008-10#89)(2008-11#14)(2008-12#5)(2008-2#13)(2008-3#16)(2008-4#16)(2008-5#28)(2008-6#15)(2008-7#24)(2008-8#11)(2008-9#18)(2009-10#1)(2009-11#1)(2009-2#3)(2009-4#6)(2009-5#4)(2009-6#5)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#3)(2010-3#3)(2010-4#8)(2010-5#3)(2010-6#4)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#13)(2011-12#5)(2011-2#18)(2011-3#1)(2012-1#6)(2012-11#2)(2012-12#11)(2012-2#12)(2012-3#9)(2013-1#32)(2013-7#5)(2013-8#4)
the followup##4##2##(1991-9#1)(2013-1#3)
the food and nutrition##2##4##(2006-4#2)
the food and##6##3##(1991-11#1)(2005-10#1)(2006-4#2)(2008-11#1)(2008-9#1)
the food bolus##2##3##(2007-12#2)
the food chain##17##3##(1994-3#1)(1995-11#1)(2005-5#1)(2006-12#2)(2007-10#1)(2007-4#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-9#2)(2011-2#1)(2013-8#1)
the food eaten by the demonstrator##2##6##(2008-4#2)
the food industry and##3##4##(2008-5#1)(2013-1#1)(2013-8#1)
the food industry##14##3##(2005-7#1)(2008-10#1)(2008-5#1)(2010-7#1)(2011-2#2)(2012-1#2)(2012-2#2)(2013-1#3)(2013-8#1)
the food intake and the##2##5##(2008-5#1)(2009-8#1)
the food intake##5##3##(1994-6#1)(2008-5#1)(2009-8#1)(2010-6#2)
the food manufacturer has to##2##5##(1994-3#2)
the food production##2##3##(2008-7#1)(2011-12#1)
the food products##3##3##(2009-8#1)(2011-1#1)(2011-12#1)
the food safety##3##3##(2007-1#1)(2010-4#2)
the food supply##8##3##(1990-6#1)(2006-10#1)(2006-4#1)(2007-12#2)(2012-1#1)(2012-2#1)(2013-1#1)
the food utilization##3##3##(2007-3#2)(2011-12#1)
the food was##3##3##(1993-9#1)(2007-3#2)
the food web##8##3##(2007-9#1)(2008-10#1)(2008-8#1)(2008-9#5)
the food##127##2##(1990-6#1)(1990-9#1)(1991-1#2)(1991-11#1)(1992-3#2)(1992-8#1)(1993-9#1)(1994-2#2)(1994-3#8)(1994-6#1)(1995-11#1)(1995-5#1)(1996-3#1)(1997-1#1)(1997-4#2)(2005-10#1)(2005-5#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-12#2)(2006-4#3)(2007-1#1)(2007-10#2)(2007-12#5)(2007-3#4)(2007-4#1)(2007-9#1)(2008-1#2)(2008-10#12)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#8)(2009-11#1)(2009-4#1)(2009-8#2)(2010-4#3)(2010-6#2)(2010-7#3)(2010-8#1)(2011-1#1)(2011-12#3)(2011-2#4)(2012-1#4)(2012-2#6)(2013-1#4)(2013-7#2)(2013-8#3)
the food-based inhibitor##2##3##(2009-11#2)
the food-storing##2##2##(1993-2#1)(1994-3#1)
the foodborne##3##2##(2008-1#1)(2011-2#2)
the foods##4##2##(2006-10#1)(2009-8#1)(2013-1#2)
the foot and ankle are##2##5##(2011-2#2)
the foot and ankle region##3##5##(2007-4#1)(2010-3#1)(2012-2#1)
the foot and ankle##17##4##(2007-4#1)(2008-12#2)(2008-4#2)(2010-3#2)(2010-7#1)(2011-2#4)(2012-2#4)(2012-3#1)
the foot and##23##3##(2006-11#2)(2007-4#1)(2008-12#2)(2008-4#2)(2009-3#1)(2010-3#3)(2010-7#1)(2011-2#4)(2012-1#1)(2012-2#5)(2012-3#1)
the foot is##5##3##(2006-11#1)(2006-8#1)(2009-10#1)(2010-3#1)(2010-5#1)
the foot protein moiety of the##2##6##(1992-3#2)
the foot protein moiety##3##4##(1992-3#3)
the foot protein##8##3##(1992-3#8)
the foot was##2##3##(2007-7#1)(2010-3#1)
the foot##82##2##(1992-3#9)(1995-12#1)(2006-11#3)(2006-6#1)(2006-8#1)(2007-11#2)(2007-4#1)(2007-7#2)(2007-8#2)(2008-12#7)(2008-4#5)(2008-6#1)(2008-7#1)(2009-10#4)(2009-3#3)(2009-9#1)(2010-3#8)(2010-5#3)(2010-7#1)(2010-9#1)(2011-2#7)(2012-1#2)(2012-12#2)(2012-2#8)(2012-3#4)(2013-1#2)
the footpad##3##2##(1995-11#2)(2008-10#1)
the footprints of##2##3##(2008-3#1)(2008-4#1)
the for-profit##3##2##(1993-2#1)(2007-1#1)(2008-12#1)
the forage##3##2##(2008-10#1)(2009-4#1)(2010-8#1)
the foraging behavior of##2##4##(2008-8#2)
the foraging##6##2##(1991-11#1)(2008-8#2)(2008-9#2)(2011-2#1)
the foramen magnum##12##3##(1996-9#2)(2005-9#1)(2006-5#2)(2007-1#2)(2008-5#2)(2008-7#1)(2010-2#1)(2011-2#1)
the foramen of Monro##3##4##(1997-1#1)(2006-12#1)(2006-5#1)
the foramen ovale and##2##4##(1996-3#1)(2005-9#1)
the foramen ovale##4##3##(1992-10#1)(1996-3#1)(2005-9#1)(2007-8#1)
the foramen spinosum##3##3##(2005-9#3)
the foramen transversarium##2##3##(2006-12#2)
the foramen##31##2##(1992-10#1)(1996-3#1)(1996-9#2)(1997-1#1)(2005-9#5)(2006-12#3)(2006-5#3)(2006-8#2)(2006-9#1)(2007-1#2)(2007-8#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-12#3)
the forbidden region##2##3##(2007-12#2)
the forbidden##5##2##(2007-11#1)(2007-12#3)(2008-3#1)
the force and##2##3##(1990-2#1)(2012-1#1)
the force applied##2##3##(2007-5#1)(2009-4#1)
the force balance##2##3##(2005-11#1)(2009-7#1)
the force curve##2##3##(2005-11#2)
the force in##2##3##(2007-11#1)(2009-4#1)
the force is##3##3##(2005-11#1)(2007-11#1)(2012-1#1)
the force of hepatitis A virus##2##6##(2012-12#2)
the force of infection##3##4##(1994-9#1)(2012-12#2)
the force of##9##3##(1994-9#1)(1995-12#1)(2007-6#1)(2008-8#1)(2012-12#5)
the force on##2##3##(2005-11#1)(2008-5#1)
the force plate##2##3##(2010-12#1)(2010-3#1)
the force##44##2##(1990-2#1)(1991-7#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-8#1)(1997-4#1)(2005-11#6)(2006-10#1)(2007-11#3)(2007-5#2)(2007-6#1)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-4#3)(2009-6#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2012-1#3)(2012-12#5)
the force-deflection##2##2##(2007-1#2)
the force-extension curve##2##3##(2012-12#2)
the forced expiratory##2##3##(2012-12#1)(2013-1#1)
the forced expression of##2##4##(2008-11#1)(2011-2#1)
the forced##16##2##(1990-5#2)(1996-12#5)(2005-11#2)(2007-2#1)(2008-11#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the forceps##2##2##(2007-5#1)(2013-7#1)
the forces and##3##3##(2007-5#1)(2008-2#1)(2008-3#1)
the forces are##2##3##(1995-4#1)(2007-5#1)
the forces of##2##3##(2008-9#1)(2009-8#1)
the forces on the##2##4##(2007-6#1)(2008-7#1)
the forces on##3##3##(2005-11#1)(2007-6#1)(2008-7#1)
the forces that have##2##4##(1994-12#1)(2008-8#1)
the forces that##4##3##(1994-12#1)(2008-10#1)(2008-8#1)(2010-4#1)
the forces##26##2##(1990-12#1)(1993-3#1)(1994-12#1)(1995-4#1)(1997-3#1)(2005-11#1)(2005-7#1)(2006-11#1)(2007-5#2)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-3#1)
the fore##7##2##(2006-10#1)(2006-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-2#1)
the fore- and hindwings##2##4##(2008-8#2)
the fore- and##4##3##(1991-9#1)(1995-12#1)(2008-8#2)
the forearm and##7##3##(2006-3#2)(2007-4#1)(2007-7#2)(2008-9#1)(2012-1#1)
the forearm of##3##3##(1992-9#1)(1994-4#1)(1996-7#1)
the forearm##43##2##(1992-9#1)(1994-4#2)(1994-6#1)(1996-1#1)(1996-7#1)(1996-9#1)(2006-11#5)(2006-3#2)(2006-8#1)(2006-9#1)(2007-4#1)(2007-7#4)(2008-10#1)(2008-4#1)(2008-5#9)(2008-9#3)(2009-3#3)(2009-9#2)(2011-2#2)(2012-1#1)
the forearms of##4##3##(2007-12#1)(2007-4#1)(2008-10#1)(2008-5#1)
the forearms##6##2##(2007-12#1)(2007-4#1)(2008-10#1)(2008-5#2)(2008-7#1)
the forebrain and##3##3##(1994-8#1)(1995-7#1)(2007-1#1)
the forebrain regions##2##3##(1991-3#1)(1993-8#1)
the forebrain ventricles##2##3##(1995-7#1)(1997-6#1)
the forebrain##21##2##(1990-7#2)(1991-3#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-7#2)(1997-1#1)(1997-2#1)(1997-6#3)(1997-8#1)(2007-1#1)(2008-11#1)
the forecast##5##2##(1996-4#1)(2008-10#1)(2008-8#2)(2013-8#1)
the forecasting##2##2##(1994-12#1)(1994-6#1)
the forecasts##3##2##(2006-11#1)(2008-1#1)(2008-10#1)
the forefront of the##3##4##(2008-3#1)(2013-1#2)
the forefront of##17##3##(1994-1#1)(2005-7#1)(2005-8#2)(2006-10#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-4#1)(2013-1#5)
the forefront##25##2##(1992-5#1)(1994-1#1)(1995-9#1)(1997-8#1)(2005-7#1)(2005-8#2)(2006-10#3)(2007-7#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-4#1)(2012-1#1)(2013-1#5)
the foreground##3##2##(1994-8#1)(2006-5#1)(2008-4#1)
the foregut and##2##3##(2007-5#1)(2013-7#1)
the foregut##9##2##(1991-8#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2010-8#1)(2011-2#2)(2013-7#1)
the forehead and##4##3##(1994-4#2)(2008-5#1)(2012-12#1)
the forehead of##2##3##(2007-12#1)(2008-5#1)
the forehead than##2##3##(2008-5#2)
the forehead##21##2##(1992-2#1)(1994-4#3)(1997-3#1)(2006-12#1)(2007-12#2)(2008-5#6)(2008-8#3)(2010-6#1)(2011-1#1)(2012-12#1)(2013-7#1)
the foreign bodies##2##3##(2008-7#1)(2013-8#1)
the foreign body response##2##4##(2009-11#2)
the foreign body##6##3##(1990-3#1)(2004-7#1)(2009-11#2)(2010-4#1)(2012-12#1)
the foreign gene expression##2##4##(2008-11#2)
the foreign gene##6##3##(1990-3#2)(1994-12#1)(2008-11#3)
the foreign object##3##3##(2011-2#1)(2012-12#2)
the foreign substances##2##3##(2008-10#2)
the foreign##34##2##(1990-3#3)(1993-6#1)(1994-12#1)(1995-2#1)(1996-12#1)(2004-7#1)(2005-10#1)(2005-12#1)(2007-9#1)(2008-10#7)(2008-11#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#3)(2013-8#1)
the foreign-born##3##2##(1990-12#1)(2005-10#1)(2011-2#1)
the foreleg##2##2##(1990-11#1)(1993-9#1)
the forelegs##2##2##(1990-11#1)(2007-12#1)
the forelimb##2##2##(1997-6#1)(2011-2#1)
the forelimbs##8##2##(1992-12#1)(1992-7#1)(1993-3#1)(1996-6#1)(2005-7#1)(2011-2#2)(2012-3#1)
the foremost##3##2##(1993-5#1)(2008-7#1)(2008-9#1)
the forensic analysis of##3##4##(2008-10#3)
the forensic##14##2##(1991-5#1)(1994-4#2)(1997-2#1)(2005-12#1)(2005-7#1)(2008-10#5)(2010-9#1)(2011-1#1)(2013-7#1)
the forepaw##2##2##(1996-1#2)
the foreseeable future##10##3##(1993-8#1)(1996-1#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)
the foreseeable##11##2##(1991-12#1)(1993-8#1)(1996-1#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)
the forest ecosystem services of##2##5##(2008-9#2)
the forest ecosystem##10##3##(2008-5#1)(2008-9#2)(2013-8#7)
the forest##35##2##(1992-1#1)(2005-12#1)(2006-4#1)(2006-7#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-5#5)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2012-12#2)(2013-8#12)
the forestomach##8##2##(1993-9#1)(2008-9#7)
the forests of##4##3##(1996-11#1)(2007-3#1)(2012-12#1)(2013-7#1)
the forests##7##2##(1992-5#2)(1994-9#1)(1996-11#1)(2007-3#1)(2012-12#1)(2013-7#1)
the forgotten##5##2##(1992-2#1)(2006-4#1)(2008-8#1)(2008-9#1)(2012-2#1)
the fork##4##2##(1990-12#1)(1992-3#1)(1993-3#1)(1996-8#1)
the form and##4##3##(1991-3#1)(2007-6#1)(2010-9#1)(2012-2#1)
the form of a##62##4##(1991-12#1)(1992-12#1)(1992-5#1)(1992-7#1)(1992-8#2)(1994-8#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-6#1)(2007-11#2)(2007-12#3)(2007-9#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
the form of an##11##4##(1992-6#1)(1994-5#1)(1995-8#1)(1996-7#1)(2008-10#3)(2010-5#2)(2011-12#1)(2012-12#1)
the form of either##2##4##(1996-8#1)(2006-11#1)
the form of the##17##4##(1990-5#1)(2006-10#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-8#1)(2008-9#1)(2010-3#1)
the form of##335##3##(1990-10#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#3)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-4#1)(1994-5#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-3#5)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-10#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-8#1)(2004-10#1)(2004-11#1)(2004-12#1)(2005-10#2)(2005-11#2)(2005-4#1)(2005-8#1)(2006-10#3)(2006-11#2)(2006-12#5)(2006-6#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#11)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#6)(2007-8#7)(2007-9#2)(2008-1#4)(2008-10#48)(2008-11#9)(2008-12#4)(2008-2#11)(2008-3#10)(2008-4#6)(2008-5#9)(2008-6#3)(2008-7#13)(2008-8#6)(2008-9#5)(2009-1#1)(2009-10#2)(2009-3#3)(2009-4#2)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#4)(2010-5#2)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#7)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#8)(2012-3#2)(2013-1#9)(2013-7#3)(2013-8#6)
the form proposed by##2##4##(1993-5#1)(1996-12#1)
the form##366##2##(1990-10#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#3)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-4#1)(1994-5#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#5)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-10#1)(1996-12#3)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-8#1)(2004-10#1)(2004-11#1)(2004-12#1)(2005-10#2)(2005-11#3)(2005-4#1)(2005-8#1)(2006-10#4)(2006-11#2)(2006-12#5)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#14)(2007-2#1)(2007-3#1)(2007-6#2)(2007-7#8)(2007-8#8)(2007-9#2)(2008-1#4)(2008-10#50)(2008-11#10)(2008-12#4)(2008-2#13)(2008-3#12)(2008-4#6)(2008-5#10)(2008-6#3)(2008-7#13)(2008-8#6)(2008-9#6)(2009-1#1)(2009-10#2)(2009-3#3)(2009-4#2)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#4)(2010-5#2)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#5)(2011-12#2)(2011-2#8)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#9)(2012-3#2)(2013-1#9)(2013-7#3)(2013-8#6)
the forma specialis##3##3##(2008-10#3)
the formal diagnosis rests on the detection of adenosine phosphorylase secretion by infected cell lines##2##15##(2008-4#1)(2008-9#1)
the formal diagnosis##3##3##(1996-4#1)(2008-4#1)(2008-9#1)
the formal potential of the##2##5##(2008-10#2)
the formal potential of##4##4##(1997-1#1)(2008-10#3)
the formal potential##9##3##(1997-1#1)(2006-12#1)(2008-10#7)
the formal sector##3##3##(2008-7#1)(2010-8#1)(2012-12#1)
the formal##40##2##(1991-9#1)(1995-2#1)(1996-4#2)(1997-1#1)(1997-3#2)(2004-12#1)(2005-12#1)(2005-5#1)(2006-12#1)(2006-4#1)(2008-10#11)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2012-12#2)(2012-3#2)(2013-1#1)
the formaldehyde in##2##3##(2008-10#2)
the formaldehyde##7##2##(2008-1#1)(2008-10#4)(2008-2#2)
the formalin injection##2##3##(1995-11#2)
the formalin test in rats##4##5##(1995-12#1)(2009-6#3)
the formalin test##15##3##(1995-12#3)(1997-5#1)(2006-12#8)(2009-6#3)
the formalin##19##2##(1995-11#2)(1995-12#4)(1997-5#1)(2006-12#8)(2009-6#3)(2011-1#1)
the formalin-induced##2##2##(2010-5#1)(2012-3#1)
the formalism is##2##3##(2008-3#2)
the formalism of##2##3##(2008-10#1)(2008-3#1)
the formalism##6##2##(1997-2#1)(2008-10#1)(2008-3#4)
the format of a##3##4##(2008-9#1)(2009-8#1)(2012-11#1)
the format of##9##3##(1990-2#1)(2005-9#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)
the format##10##2##(1990-2#1)(2005-9#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)
the formate##4##2##(1991-7#2)(1992-6#1)(1997-4#1)
the formation and development of the##2##6##(1996-8#1)(2005-11#1)
the formation and differentiation##2##4##(1992-9#1)(2007-12#1)
the formation and growth of##2##5##(1990-3#1)(2012-2#1)
the formation and maintenance of##5##5##(1990-8#2)(1991-5#1)(2008-7#1)(2012-11#1)
the formation and maturation of##2##5##(2007-3#1)(2012-2#1)
the formation and stability of##3##5##(1997-6#1)(2006-9#1)(2008-4#1)
the formation and stabilization of##2##5##(1994-5#1)(2008-10#1)
the formation and subsequent##2##4##(2008-10#2)
the formation and##48##3##(1990-2#1)(1990-3#1)(1990-8#3)(1991-5#1)(1991-7#1)(1992-9#1)(1994-5#1)(1995-4#1)(1996-7#1)(1996-8#1)(1997-6#1)(2005-11#1)(2005-7#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2010-10#1)(2010-12#1)(2010-4#3)(2010-9#1)(2011-1#1)(2011-3#1)(2012-11#1)(2012-12#2)(2012-2#2)
the formation and/or##2##3##(2007-12#1)(2008-5#1)
the formation constant of##2##4##(2008-10#2)
the formation constant##5##3##(2008-10#4)(2008-3#1)
the formation constants of##5##4##(2005-4#1)(2008-10#4)
the formation constants##7##3##(2005-4#1)(2008-10#6)
the formation mechanism##2##3##(2005-4#1)(2010-4#1)
the formation of &quot##2##4##(1996-5#1)(1996-8#1)
the formation of (dT)n##2##4##(1995-5#2)
the formation of 1##3##4##(2008-10#3)
the formation of 2##3##4##(1996-6#1)(2010-5#1)(2010-7#1)
the formation of 3##3##4##(1992-3#1)(1994-12#1)(2005-11#1)
the formation of As(III)##2##4##(2008-10#2)
the formation of GS and SAG##2##6##(2008-10#2)
the formation of N-acetylglucosamine##2##4##(1997-1#2)
the formation of NO in##2##5##(1992-5#2)
the formation of NO##3##4##(1992-5#2)(1994-2#1)
the formation of R-ibuprofenyl-adenylate##2##4##(1994-8#2)
the formation of TBARS##2##4##(1995-3#1)(1997-8#1)
the formation of [14C]oxalacetate##3##4##(1993-11#3)
the formation of a 1##4##5##(2007-11#1)(2008-10#3)
the formation of a complex with##2##6##(2008-10#2)
the formation of a complex##6##5##(1990-11#1)(1991-2#1)(1995-3#1)(2008-10#2)(2008-4#1)
the formation of a covalent##3##5##(1995-2#1)(2005-11#1)(2008-4#1)
the formation of a curly pattern of##2##7##(2011-1#2)
the formation of a functional##2##5##(1997-6#1)(2008-10#1)
the formation of a new##4##5##(1993-11#1)(1997-2#1)(2008-10#2)
the formation of a significant##2##5##(1997-2#1)(1997-4#1)
the formation of a single##3##5##(1994-8#1)(2007-12#1)(2008-10#1)
the formation of a stable##7##5##(1995-5#1)(2005-11#1)(2007-12#1)(2008-10#1)(2009-7#1)(2010-12#2)
the formation of a ternary complex##3##6##(1993-3#1)(1994-8#1)(2008-10#1)
the formation of a ternary##4##5##(1993-3#1)(1994-8#1)(1996-7#1)(2008-10#1)
the formation of a##148##4##(1990-10#1)(1990-11#1)(1990-3#3)(1990-5#1)(1990-7#2)(1991-11#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-9#3)(1992-11#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#4)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-7#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-9#1)(2005-11#11)(2005-12#1)(2006-1#1)(2006-12#2)(2007-11#3)(2007-12#9)(2007-7#1)(2008-1#2)(2008-10#28)(2008-11#5)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-7#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#4)(2012-2#1)(2013-1#2)
the formation of actin##2##4##(2008-9#1)(2012-2#1)
the formation of additional##4##4##(1995-7#1)(2007-12#1)(2008-10#1)(2013-7#1)
the formation of all##2##4##(1993-11#1)(2007-8#1)
the formation of an adduct##2##5##(1993-12#1)(1996-9#1)
the formation of an enzyme##2##5##(1995-10#1)(1996-7#1)
the formation of an##26##4##(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(2005-11#3)(2007-11#1)(2007-12#2)(2008-10#5)(2008-3#1)(2008-6#1)(2009-10#1)
the formation of antibodies##2##4##(2007-11#1)(2013-1#1)
the formation of apoptotic bodies##4##5##(2008-11#2)(2008-7#1)(2012-3#1)
the formation of ascites##2##4##(1997-7#1)(2011-2#1)
the formation of at least##2##5##(1994-6#1)(1997-4#1)
the formation of axonal##2##4##(1995-12#1)(2005-9#1)
the formation of beta##3##4##(1991-9#1)(1992-6#1)(1995-6#1)
the formation of beta-(pyrazole-1-yl)-L-alanine##3##4##(1993-12#3)
the formation of birthmarks##3##4##(2009-2#3)
the formation of both##10##4##(1992-3#1)(1992-6#2)(1993-11#1)(1993-6#1)(2006-6#1)(2007-8#1)(2008-12#1)(2010-12#1)(2013-1#1)
the formation of collagen##2##4##(2007-11#1)(2012-12#1)
the formation of complex##2##4##(1997-1#1)(2010-7#1)
the formation of complexes##7##4##(1995-3#1)(1995-5#1)(1996-5#1)(2005-4#1)(2006-10#1)(2008-5#1)(2008-7#1)
the formation of covalent##2##4##(1995-12#1)(2009-2#1)
the formation of cytoplasmic##2##4##(2008-5#1)(2009-2#1)
the formation of dependence on##2##5##(2009-2#2)
the formation of diacylglycerol##2##4##(1990-12#1)(1994-2#1)
the formation of different##4##4##(1994-10#1)(2008-10#2)(2008-6#1)
the formation of diglyceride mass##2##5##(1991-6#2)
the formation of discrete##2##4##(1991-4#1)(2009-4#1)
the formation of flat symmetric leaves##2##6##(2012-12#2)
the formation of flower##3##4##(1997-2#1)(1997-8#1)(2012-2#1)
the formation of foam##2##4##(1990-8#1)(1992-5#1)
the formation of free##4##4##(1991-11#1)(1995-8#1)(2008-5#1)(2013-1#1)
the formation of ground state##2##5##(2006-10#1)(2010-2#1)
the formation of high molecular weight##2##6##(1995-3#1)(1997-8#1)
the formation of highly##4##4##(2006-2#1)(2007-12#1)(2008-4#1)(2008-7#1)
the formation of hydrogen bonds##2##5##(1996-5#1)(2008-10#1)
the formation of hydroxyl radicals##2##5##(1990-12#1)(1997-8#1)
the formation of induced premicelles##2##5##(2005-11#2)
the formation of inositol phosphates##3##5##(1990-5#1)(1990-9#1)(1994-2#1)
the formation of inositol##7##4##(1990-5#1)(1990-7#3)(1990-9#1)(1993-8#1)(1994-2#1)
the formation of insoluble##5##4##(1991-6#1)(1994-2#1)(2005-11#1)(2008-4#1)(2008-5#1)
the formation of intracellular##2##4##(1996-7#1)(2008-7#1)
the formation of its##4##4##(1994-9#1)(2008-10#1)(2011-3#1)(2012-1#1)
the formation of large##2##4##(1990-4#1)(2008-10#1)
the formation of lysoPI##2##4##(1991-7#2)
the formation of many##3##4##(2007-12#1)(2008-5#1)(2012-12#1)
the formation of micelles##2##4##(1997-4#1)(2005-11#1)
the formation of microvilli##2##4##(2009-10#1)(2009-8#1)
the formation of more##2##4##(2008-10#1)(2010-10#1)
the formation of multinucleated cells##2##5##(1990-9#2)
the formation of multinucleated##3##4##(1990-9#2)(1995-5#1)
the formation of multiple##2##4##(2006-10#1)(2010-12#1)
the formation of new blood vessels from preexisting##2##8##(2008-1#1)(2010-9#1)
the formation of new blood vessels from##3##7##(2008-1#1)(2010-9#1)(2013-8#1)
the formation of new blood##4##5##(2008-1#1)(2010-9#1)(2013-8#2)
the formation of new##12##4##(1990-11#1)(1991-4#1)(2005-11#1)(2006-12#1)(2008-1#1)(2008-5#1)(2008-9#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#2)
the formation of nitric oxide##2##5##(1990-6#1)(2007-9#1)
the formation of normal##6##4##(1995-3#1)(2006-5#1)(2007-8#1)(2010-5#1)(2010-6#1)(2012-1#1)
the formation of one##2##4##(1990-4#1)(1990-7#1)
the formation of only##2##4##(1992-11#1)(2008-10#1)
the formation of optical##2##4##(2007-12#1)(2008-10#1)
the formation of oxygen##2##4##(2008-10#1)(2009-2#1)
the formation of papillae##2##4##(2008-10#2)
the formation of peritoneal adhesions##2##5##(2008-4#1)(2010-3#1)
the formation of phosphatidylethanol##2##4##(1994-3#1)(1996-4#1)
the formation of physical##3##4##(2008-10#2)(2009-8#1)
the formation of pores##3##4##(1994-2#2)(2008-4#1)
the formation of primary##2##4##(2009-2#1)(2012-2#1)
the formation of prostaglandin##2##4##(1991-3#1)(1996-2#1)
the formation of protein complexes##3##5##(1994-11#1)(2010-10#1)(2010-9#1)
the formation of protein##5##4##(1990-12#1)(1992-6#1)(1994-11#1)(2010-10#1)(2010-9#1)
the formation of psi##2##4##(1993-8#1)(1994-8#1)
the formation of radical species##2##5##(1996-7#1)(2010-5#1)
the formation of reactive oxygen species##4##6##(1992-12#1)(1992-6#1)(1993-4#1)(2010-7#1)
the formation of reactive species##2##5##(2008-11#2)
the formation of reactive##7##4##(1992-12#1)(1992-6#1)(1993-4#1)(2008-11#3)(2010-7#1)
the formation of secondary structure##2##5##(2008-8#1)(2011-2#1)
the formation of secondary##7##4##(1991-10#1)(1995-5#1)(1995-8#1)(2008-11#1)(2008-8#1)(2011-2#1)(2013-7#1)
the formation of several##4##4##(1990-8#1)(1996-5#1)(2006-10#1)(2008-3#1)
the formation of significant amounts of##2##6##(1990-5#1)(1996-5#1)
the formation of significant##3##4##(1990-5#1)(1996-5#1)(2005-11#1)
the formation of silver nanoparticles##2##5##(2009-3#1)(2011-2#1)
the formation of small##3##4##(1992-3#1)(2005-11#1)(2008-6#1)
the formation of spatial##2##4##(2008-1#1)(2012-1#1)
the formation of specific##2##4##(1993-8#1)(2005-12#1)
the formation of stable##6##4##(1995-2#1)(1995-3#1)(1997-4#1)(2007-5#1)(2007-6#1)(2008-3#1)
the formation of strong##2##4##(2008-7#1)(2010-4#1)
the formation of such##4##4##(1990-12#1)(1990-5#1)(1994-2#1)(2008-10#1)
the formation of superoxide anion##2##5##(1995-6#1)(2008-4#1)
the formation of ternary##2##4##(2008-10#2)
the formation of tertiary structure##2##5##(1995-3#1)(1997-4#1)
the formation of tertiary##3##4##(1995-11#1)(1995-3#1)(1997-4#1)
the formation of the complex in##2##6##(1991-4#1)(2008-10#1)
the formation of the complex##6##5##(1990-7#1)(1991-4#1)(2008-10#4)
the formation of the complexes##2##5##(2008-10#1)(2008-5#1)
the formation of the corresponding##4##5##(1990-3#1)(2007-11#2)(2009-10#1)
the formation of the following complexes##2##6##(2008-10#1)(2008-5#1)
the formation of the free##2##5##(1991-5#1)(1996-5#1)
the formation of the ion##2##5##(2008-10#2)
the formation of the ternary complex##2##6##(1994-8#1)(2006-10#1)
the formation of the##165##4##(1990-11#2)(1990-2#3)(1990-3#1)(1990-5#2)(1990-7#2)(1990-9#1)(1991-1#2)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#3)(1991-6#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#3)(1993-2#1)(1993-3#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#6)(1994-9#2)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-12#2)(1996-3#1)(1996-5#5)(1996-6#1)(1996-8#3)(1996-9#2)(1997-2#1)(1997-4#1)(1997-7#2)(1997-8#1)(2005-11#4)(2005-4#1)(2006-10#2)(2006-12#4)(2006-4#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#29)(2008-11#1)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#6)(2008-7#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-5#5)(2010-7#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-11#1)(2012-3#1)(2012-5#1)(2013-7#1)
the formation of these##7##4##(1990-12#1)(1991-5#2)(1993-3#1)(2009-2#1)(2010-7#1)(2012-11#1)
the formation of thiobarbituric acid reactive substances (TBARS)##3##8##(1995-3#1)(1997-8#1)(2004-12#1)
the formation of thiobarbituric acid reactive##4##6##(1995-3#1)(1997-8#1)(2004-12#1)(2012-2#1)
the formation of this##5##4##(1991-1#1)(1992-9#1)(1994-8#1)(2007-12#2)
the formation of three##3##4##(1991-6#1)(1995-10#1)(1997-1#1)
the formation of thromboxane##2##4##(1993-3#1)(1995-2#1)
the formation of tight##2##4##(2005-10#1)(2006-10#1)
the formation of total##3##4##(1991-11#1)(1992-6#1)(1995-5#1)
the formation of two##9##4##(1994-8#1)(1994-9#1)(1997-6#1)(1997-7#1)(2006-12#2)(2008-10#2)(2009-12#1)
the formation of unusual##2##4##(1992-2#1)(2005-11#1)
the formation of various##3##4##(1997-7#1)(2008-3#1)(2010-10#1)
the formation of##1227##3##(1990-10#1)(1990-11#6)(1990-12#14)(1990-2#4)(1990-3#7)(1990-4#5)(1990-5#13)(1990-6#3)(1990-7#10)(1990-8#2)(1990-9#8)(1991-1#5)(1991-10#3)(1991-11#7)(1991-12#1)(1991-2#3)(1991-3#9)(1991-4#4)(1991-5#9)(1991-6#6)(1991-7#3)(1991-8#2)(1991-9#8)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#5)(1992-2#7)(1992-3#8)(1992-4#1)(1992-5#8)(1992-6#11)(1992-7#1)(1992-8#3)(1992-9#6)(1993-11#16)(1993-12#7)(1993-2#1)(1993-3#10)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#8)(1993-9#4)(1994-10#3)(1994-11#4)(1994-12#10)(1994-2#16)(1994-3#7)(1994-5#4)(1994-6#5)(1994-8#25)(1994-9#10)(1995-1#1)(1995-10#6)(1995-11#3)(1995-12#3)(1995-2#7)(1995-3#10)(1995-4#3)(1995-5#14)(1995-6#9)(1995-7#1)(1995-8#8)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#8)(1996-3#7)(1996-4#3)(1996-5#18)(1996-6#7)(1996-7#6)(1996-8#6)(1996-9#3)(1997-1#5)(1997-2#11)(1997-4#11)(1997-5#1)(1997-6#5)(1997-7#11)(1997-8#10)(2004-12#2)(2004-9#4)(2005-1#1)(2005-10#2)(2005-11#42)(2005-12#3)(2005-4#4)(2005-7#2)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#12)(2006-11#2)(2006-12#12)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#25)(2007-12#33)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#7)(2007-9#6)(2008-1#8)(2008-10#166)(2008-11#23)(2008-12#4)(2008-2#7)(2008-3#19)(2008-4#19)(2008-5#29)(2008-6#7)(2008-7#18)(2008-8#8)(2008-9#8)(2009-10#4)(2009-11#7)(2009-12#4)(2009-2#15)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#6)(2009-8#7)(2009-9#1)(2010-1#1)(2010-10#6)(2010-11#2)(2010-12#8)(2010-2#4)(2010-3#5)(2010-4#10)(2010-5#18)(2010-6#3)(2010-7#8)(2010-8#3)(2010-9#3)(2011-1#10)(2011-12#2)(2011-2#21)(2011-3#1)(2012-1#8)(2012-11#3)(2012-12#10)(2012-2#12)(2012-3#3)(2012-5#1)(2013-1#19)(2013-7#4)(2013-8#5)
the formation or##2##3##(1997-2#1)(2007-12#1)
the formation process##2##3##(1994-7#1)(2005-11#1)
the formation##1321##2##(1990-10#1)(1990-11#6)(1990-12#14)(1990-2#5)(1990-3#8)(1990-4#6)(1990-5#13)(1990-6#3)(1990-7#10)(1990-8#5)(1990-9#9)(1991-1#5)(1991-10#3)(1991-11#7)(1991-12#1)(1991-2#3)(1991-3#9)(1991-4#4)(1991-5#10)(1991-6#6)(1991-7#4)(1991-8#2)(1991-9#9)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#5)(1992-2#7)(1992-3#8)(1992-4#2)(1992-5#8)(1992-6#11)(1992-7#1)(1992-8#3)(1992-9#7)(1993-11#16)(1993-12#7)(1993-2#1)(1993-3#10)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#8)(1993-9#4)(1994-10#3)(1994-11#4)(1994-12#10)(1994-2#16)(1994-3#7)(1994-5#5)(1994-6#5)(1994-7#1)(1994-8#25)(1994-9#10)(1995-1#1)(1995-10#6)(1995-11#3)(1995-12#3)(1995-2#7)(1995-3#10)(1995-4#4)(1995-5#14)(1995-6#9)(1995-7#1)(1995-8#9)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#8)(1996-3#7)(1996-4#3)(1996-5#18)(1996-6#7)(1996-7#7)(1996-8#7)(1996-9#4)(1997-1#5)(1997-2#12)(1997-4#11)(1997-5#1)(1997-6#6)(1997-7#11)(1997-8#10)(2004-12#2)(2004-9#4)(2005-1#1)(2005-10#2)(2005-11#45)(2005-12#3)(2005-4#6)(2005-7#3)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#12)(2006-11#2)(2006-12#12)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#2)(2006-8#2)(2006-9#2)(2007-1#4)(2007-10#1)(2007-11#26)(2007-12#37)(2007-3#2)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#8)(2007-9#6)(2008-1#8)(2008-10#190)(2008-11#25)(2008-12#4)(2008-2#7)(2008-3#24)(2008-4#20)(2008-5#30)(2008-6#7)(2008-7#20)(2008-8#8)(2008-9#8)(2009-10#4)(2009-11#7)(2009-12#4)(2009-2#15)(2009-3#3)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#6)(2009-8#7)(2009-9#1)(2010-1#1)(2010-10#7)(2010-11#2)(2010-12#9)(2010-2#4)(2010-3#5)(2010-4#15)(2010-5#18)(2010-6#3)(2010-7#8)(2010-8#3)(2010-9#4)(2011-1#12)(2011-12#3)(2011-2#21)(2011-3#2)(2012-1#8)(2012-11#4)(2012-12#12)(2012-2#15)(2012-3#3)(2012-5#1)(2013-1#19)(2013-7#5)(2013-8#5)
the formative##3##2##(1993-4#1)(2008-5#1)(2011-2#1)
the formed complexes##3##3##(2008-10#3)
the formed##22##2##(1991-2#1)(1991-7#1)(1992-3#1)(1994-3#1)(1995-6#1)(2008-10#16)(2011-2#1)
the former German Democratic Republic##2##5##(1992-1#1)(1995-1#1)
the former Soviet Union##4##4##(1995-3#1)(1997-1#1)(2006-10#2)
the former Soviet##6##3##(1995-3#1)(1997-1#1)(1997-6#1)(2005-10#1)(2006-10#2)
the former VL interface##2##4##(1996-6#2)
the former ammunition plant &quot##2##5##(2008-11#2)
the former and##14##3##(1990-9#1)(1991-2#1)(1995-6#1)(1996-7#1)(1996-9#1)(2005-11#1)(2006-10#3)(2006-9#1)(2007-8#1)(2008-10#2)(2008-7#1)
the former are##3##3##(1994-6#1)(2007-7#1)(2009-8#1)
the former becomes##2##3##(2010-3#1)(2010-8#1)
the former being##4##3##(1995-9#1)(2007-11#1)(2007-12#1)(2011-2#1)
the former case##5##3##(1990-12#1)(2006-10#1)(2008-2#1)(2010-7#1)(2013-7#1)
the former cell types##2##4##(1990-6#1)(2007-12#1)
the former condition##2##3##(1991-3#1)(1997-8#1)
the former enzyme##2##3##(1995-5#1)(1995-7#1)
the former group##5##3##(1993-8#1)(1995-10#1)(1995-4#1)(2008-7#1)(2010-11#1)
the former had##2##3##(2007-4#1)(2012-3#1)
the former in##2##3##(1996-5#1)(2006-10#1)
the former increases##2##3##(1996-4#1)(2008-8#1)
the former is a##2##4##(2008-10#1)(2008-8#1)
the former is##7##3##(1990-12#1)(1993-12#1)(1993-9#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-12#1)
the former one##3##3##(2006-12#1)(2008-10#1)(2009-2#1)
the former procedure##2##3##(1993-6#1)(2011-2#1)
the former rapidly##2##3##(2008-10#1)(2010-11#1)
the former shows a##2##4##(2006-12#1)(2008-2#1)
the former storage##2##3##(2008-10#2)
the former to##4##3##(1991-9#1)(1997-1#1)(2008-1#1)(2009-9#1)
the former two##3##3##(1994-3#1)(2006-12#1)(2008-9#1)
the former was##8##3##(1990-4#1)(1995-3#1)(1996-5#1)(2004-9#1)(2005-12#1)(2006-4#1)(2008-4#1)(2010-8#1)
the former were##4##3##(1996-6#1)(2008-5#1)(2008-6#1)(2008-8#1)
the former##257##2##(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#3)(1991-3#2)(1991-4#2)(1991-9#3)(1992-1#2)(1992-12#1)(1992-4#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#3)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#4)(1995-6#2)(1995-7#1)(1995-9#1)(1996-4#1)(1996-5#4)(1996-6#4)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#4)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-8#1)(2006-10#12)(2006-12#4)(2006-4#3)(2006-6#2)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#19)(2008-11#7)(2008-2#2)(2008-3#7)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-12#2)(2009-2#3)(2009-3#1)(2009-8#1)(2009-9#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#4)(2011-2#9)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#4)(2013-8#1)
the formerly##4##2##(1995-12#1)(1995-8#1)(2008-10#1)(2011-7#1)
the formidable##3##2##(2006-10#1)(2008-7#1)(2010-8#1)
the forming of##5##3##(1991-6#1)(1993-12#1)(2008-8#1)(2011-1#1)(2011-2#1)
the forming##8##2##(1991-6#1)(1993-12#1)(1997-8#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#2)
the formins##2##2##(1990-8#2)
the formosan##2##2##(2007-1#1)(2011-2#1)
the forms of the##2##4##(1990-8#1)(2010-9#1)
the forms of##14##3##(1990-8#1)(1991-3#1)(1992-2#1)(1995-3#1)(1996-1#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-6#1)(2010-9#1)(2012-3#2)(2013-1#1)(2013-8#1)
the forms##23##2##(1990-8#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-8#1)(1992-9#1)(1994-3#1)(1995-3#1)(1996-1#1)(1996-7#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-6#1)(2009-4#1)(2010-9#1)(2011-1#1)(2012-3#2)(2013-1#2)(2013-8#1)
the formula for##2##3##(1996-3#1)(2008-10#1)
the formula of##2##3##(2006-10#1)(2007-1#1)
the formula presented##2##3##(2008-8#2)
the formula used##2##3##(1994-12#1)(2008-2#1)
the formula##27##2##(1993-10#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-2#2)(1996-3#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-5#4)(2008-8#3)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)
the formulae of##2##3##(1995-6#1)(2008-10#1)
the formulae##4##2##(1994-2#1)(1995-6#1)(2007-11#1)(2008-10#1)
the formulas##3##2##(2008-2#1)(2008-3#1)(2008-4#1)
the formulated##5##2##(2006-10#1)(2008-10#2)(2008-2#1)(2008-5#1)
the formulation and##5##3##(1990-9#1)(1996-9#1)(2008-10#1)(2010-1#1)(2011-3#1)
the formulation containing##2##3##(2004-12#1)(2012-12#1)
the formulation development##2##3##(2008-10#1)(2011-1#1)
the formulation is##2##3##(2005-7#1)(2008-5#1)
the formulation of a##7##4##(1996-2#1)(2005-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
the formulation of an##2##4##(2008-2#1)(2013-8#1)
the formulation of the##6##4##(1990-8#1)(2006-8#1)(2008-10#2)(2008-3#1)(2010-1#1)
the formulation of this##2##4##(1990-11#1)(2005-7#1)
the formulation of##40##3##(1990-11#1)(1990-8#1)(1992-8#1)(1993-2#1)(1995-12#1)(1996-1#1)(1996-2#1)(1997-6#1)(2005-10#1)(2005-7#1)(2006-8#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#2)(2008-8#2)(2008-9#1)(2009-7#1)(2010-1#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#3)(2013-8#2)
the formulation##77##2##(1990-11#1)(1990-8#1)(1990-9#1)(1992-8#1)(1993-2#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-6#1)(2004-12#3)(2005-10#1)(2005-7#2)(2006-8#1)(2007-7#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#15)(2008-7#2)(2008-8#3)(2008-9#1)(2009-7#1)(2010-1#2)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#3)(2012-1#1)(2012-12#6)(2013-8#2)
the formulations of##2##3##(2008-5#2)
the formulations was##3##3##(2008-10#1)(2008-5#1)(2012-12#1)
the formulations##26##2##(2004-12#2)(2006-1#1)(2008-10#3)(2008-5#11)(2008-9#1)(2010-2#2)(2010-3#2)(2010-5#2)(2012-12#1)(2013-7#1)
the formulator to##2##3##(2008-5#2)
the formulator##4##2##(2008-10#1)(2008-5#3)
the fornix##8##2##(1991-5#2)(1991-8#1)(1992-11#2)(1993-3#1)(1994-6#2)
the fornix-fimbria##2##2##(1990-10#2)
the forskolin-induced##3##2##(1994-10#1)(1996-12#1)(1997-8#1)
the forthcoming##4##2##(1996-8#1)(2007-8#1)(2012-3#2)
the fortification##5##2##(1991-8#1)(1997-8#1)(2006-4#1)(2008-10#1)(2008-11#1)
the fortified beverage##2##3##(2006-10#2)
the fortified##8##2##(2006-10#8)
the forward and backward##3##4##(1996-11#1)(2007-12#1)(2008-2#1)
the forward and reverse reactions##2##5##(1992-3#1)(1992-6#1)
the forward and reverse##3##4##(1992-3#1)(1992-4#1)(1992-6#1)
the forward and##8##3##(1992-3#1)(1992-4#1)(1992-6#1)(1996-11#1)(2007-12#1)(2008-2#3)
the forward direction##5##3##(1990-5#1)(1996-5#1)(2008-10#1)(2008-2#2)
the forward model##3##3##(2008-2#1)(2008-3#2)
the forward problem##4##3##(1997-6#2)(2007-12#2)
the forward reaction##2##3##(1992-6#1)(1992-9#1)
the forward scattering##3##3##(2008-2#3)
the forward##40##2##(1990-5#1)(1991-12#1)(1991-9#1)(1992-3#1)(1992-4#2)(1992-6#2)(1992-9#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-6#2)(2007-12#4)(2008-10#2)(2008-2#9)(2008-3#5)(2008-5#1)(2009-1#1)(2009-11#1)(2009-3#1)(2010-9#1)(2013-1#1)
the forward-scattering##2##2##(2008-2#2)
the fossa##2##2##(2008-11#1)(2008-5#1)
the fossil record##5##3##(2008-1#1)(2008-6#1)(2008-8#1)(2010-8#1)(2013-1#1)
the fossil##6##2##(1994-3#1)(2008-1#1)(2008-6#1)(2008-8#1)(2010-8#1)(2013-1#1)
the found results##2##3##(2008-10#1)(2008-9#1)
the found values##2##3##(2008-10#2)
the found##7##2##(2008-10#5)(2008-9#1)(2013-7#1)
the foundation for a more##2##5##(2008-10#1)(2010-9#1)
the foundation for a##7##4##(1992-12#1)(2007-11#1)(2008-10#1)(2009-10#1)(2010-9#1)(2011-2#1)(2012-12#1)
the foundation for developing##2##4##(2008-5#1)(2009-10#1)
the foundation for further study##2##5##(2013-8#2)
the foundation for further##4##4##(2010-10#1)(2013-1#1)(2013-8#2)
the foundation for future##2##4##(2008-10#1)(2008-4#1)
the foundation for the development##2##5##(2008-9#1)(2013-8#1)
the foundation for the##11##4##(1995-1#2)(2004-12#1)(2007-4#3)(2008-1#1)(2008-10#1)(2008-9#1)(2012-3#1)(2013-8#1)
the foundation for understanding##2##4##(2007-8#1)(2008-5#1)
the foundation for##42##3##(1992-12#1)(1995-1#2)(1996-3#1)(2004-12#1)(2007-11#2)(2007-2#1)(2007-4#4)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-5#2)(2008-9#1)(2009-10#2)(2009-3#1)(2009-8#1)(2010-10#1)(2010-5#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
the foundation of our##2##4##(2008-5#1)(2009-12#1)
the foundation of the##5##4##(1996-1#1)(1997-2#1)(2006-10#1)(2008-1#1)(2008-2#1)
the foundation of##21##3##(1992-2#1)(1994-1#1)(1994-12#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#1)(2011-1#1)(2012-12#1)(2013-1#1)
the foundation upon which##3##4##(1993-3#1)(1997-3#1)(2011-2#1)
the foundation##74##2##(1991-1#1)(1992-12#1)(1992-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1995-1#2)(1996-1#1)(1996-12#1)(1996-3#2)(1997-2#1)(1997-3#1)(2004-12#1)(2006-10#1)(2006-11#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-4#4)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#4)(2008-7#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
the foundations for##2##3##(2008-11#1)(2011-2#1)
the foundations of##7##3##(2007-2#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-2#1)(2012-10#1)(2012-12#1)
the foundations##9##2##(2007-2#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-2#1)(2011-2#1)(2012-10#1)(2012-12#1)
the founder of##5##3##(2006-6#1)(2007-10#1)(2007-4#1)(2007-5#1)(2008-10#1)
the founder##11##2##(1990-3#1)(1991-9#1)(1995-11#1)(1996-12#1)(1996-3#1)(2006-6#1)(2007-10#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-8#1)
the founders of##4##3##(2006-5#1)(2007-6#1)(2009-2#2)
the founding members of the##2##5##(2007-12#1)(2008-8#1)
the founding of the##6##4##(1994-3#1)(1997-2#1)(2005-9#1)(2007-10#1)(2008-7#1)(2011-2#1)
the founding of##7##3##(1994-3#1)(1996-12#1)(1997-2#1)(2005-9#1)(2007-10#1)(2008-7#1)(2011-2#1)
the founding##13##2##(1994-3#1)(1996-12#1)(1996-6#1)(1997-2#1)(2005-9#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#1)
the four Botrytis spp##2##4##(2008-10#2)
the four E##2##3##(1995-3#1)(1995-6#1)
the four S compounds##2##4##(2008-10#2)
the four Stokes vectors##2##4##(2007-11#2)
the four Stokes##3##3##(2007-11#2)(2007-12#1)
the four arsenic species##2##4##(2008-10#2)
the four basic##4##3##(1992-1#1)(1992-11#1)(2008-10#1)(2008-3#1)
the four brain##2##3##(1996-3#1)(2008-1#1)
the four calcium-binding##2##3##(1991-7#1)(1995-2#1)
the four cardinal directions##2##4##(2008-3#1)(2008-5#1)
the four cardinal##3##3##(2008-3#1)(2008-5#1)(2012-2#1)
the four categories of the##3##5##(1994-12#2)(1995-4#1)
the four cell##3##3##(1990-2#1)(1994-12#1)(2003-11#1)
the four common##2##3##(1991-5#1)(2008-10#1)
the four compounds##2##3##(2008-10#2)
the four countries##3##3##(1990-11#1)(2006-4#2)
the four cultivars##2##3##(2008-10#2)
the four different##7##3##(1992-8#1)(2007-4#1)(2008-10#3)(2009-10#1)(2013-8#1)
the four dimensions of##4##4##(2007-7#1)(2011-2#2)(2012-2#1)
the four drug##2##3##(1994-2#1)(2008-10#1)
the four families of##2##4##(2012-12#1)(2013-8#1)
the four fractions##2##3##(2008-10#1)(2011-2#1)
the four groups##15##3##(1991-8#2)(1992-11#1)(1996-8#1)(1997-1#1)(2006-7#1)(2007-2#1)(2008-10#1)(2008-7#3)(2011-1#2)(2011-2#2)
the four isolated##2##3##(1993-3#1)(2008-10#1)
the four isolates##2##3##(2008-10#1)(2008-5#1)
the four known##2##3##(1994-8#1)(2007-1#1)
the four larval instars##2##4##(2008-5#2)
the four leading##2##3##(2006-2#1)(2012-1#1)
the four main##4##3##(1990-11#1)(1992-2#1)(2006-5#1)(2008-2#1)
the four major##4##3##(1994-9#1)(1995-6#1)(1997-4#1)(2009-3#1)
the four metals##2##3##(1993-9#1)(2008-10#1)
the four methods##5##3##(2007-8#1)(2008-10#2)(2012-3#1)(2013-8#1)
the four most##2##3##(2008-10#2)
the four mutants##2##3##(1994-5#1)(1997-2#1)
the four patients##5##3##(1993-2#1)(2007-2#1)(2008-1#1)(2008-6#1)(2009-4#1)
the four populations##4##3##(1990-9#1)(2008-10#2)(2009-9#1)
the four possible##2##3##(1996-7#1)(2008-8#1)
the four primary##2##3##(1996-1#1)(2012-12#1)
the four proteins##4##3##(1992-9#1)(1993-4#2)(2006-10#1)
the four religious coping##2##4##(2009-11#2)
the four seasons##2##3##(2008-3#1)(2013-8#1)
the four species##5##3##(1992-12#1)(1997-3#1)(2007-12#1)(2008-5#1)(2012-3#1)
the four strains##3##3##(2008-10#3)
the four treatments##2##3##(2004-4#1)(2007-2#1)
the four##386##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-4#2)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#4)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#2)(1992-1#2)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#3)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#3)(1993-4#2)(1993-6#1)(1993-9#2)(1994-11#2)(1994-12#7)(1994-2#3)(1994-3#1)(1994-5#2)(1994-7#1)(1994-8#4)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-1#2)(1996-10#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#1)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#5)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#2)(2003-11#1)(2004-11#3)(2004-4#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#7)(2007-2#4)(2007-4#2)(2007-5#3)(2007-6#1)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#4)(2008-10#84)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#9)(2008-4#5)(2008-5#18)(2008-6#2)(2008-7#7)(2008-8#5)(2008-9#3)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-4#2)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#4)(2012-5#1)(2013-1#4)(2013-3#1)(2013-8#8)
the four-channel##3##2##(1996-1#2)(2008-3#1)
the four-dimensional##2##2##(2007-12#1)(2008-3#1)
the four-factor##2##2##(2009-7#1)(2013-7#1)
the four-flux##3##2##(2008-3#3)
the four-step##2##2##(1990-8#1)(2011-2#1)
the four-stranded beta-pleated sheet##2##4##(1997-9#2)
the four-stranded##3##2##(1997-9#3)
the four-wave coupled-mode theory##2##4##(2008-2#2)
the four-wave mixing##3##3##(2007-12#1)(2008-3#2)
the four-wave##6##2##(2007-12#1)(2008-2#3)(2008-3#2)
the four-year##2##2##(1993-9#1)(1996-2#1)
the fourfold##2##2##(2007-11#1)(2008-1#1)
the fourier-transform##2##2##(2008-3#2)
the fourth Ca(2+)-binding site##2##4##(1991-4#2)
the fourth abdominal##2##3##(2007-12#2)
the fourth and fifth##7##4##(1997-3#2)(2007-12#1)(2008-10#3)(2008-9#1)
the fourth and##10##3##(1997-3#2)(2005-8#1)(2007-12#1)(2008-10#3)(2008-9#1)(2012-3#1)(2012-9#1)
the fourth base##2##3##(1994-12#2)
the fourth case##5##3##(1993-6#1)(2004-4#1)(2007-7#1)(2007-8#1)(2011-2#1)
the fourth day after##2##4##(1993-7#1)(2005-8#1)
the fourth day##10##3##(1993-7#1)(2005-8#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-2#1)(2010-12#2)(2012-2#1)
the fourth decade##3##3##(2005-11#1)(2007-2#1)(2007-8#1)
the fourth generation##2##3##(2006-12#1)(2008-10#1)
the fourth harmonic of a Nd##2##6##(2008-2#1)(2008-3#1)
the fourth harmonic of a femtosecond Ti##2##7##(2007-12#1)(2008-3#1)
the fourth harmonic of a##4##5##(2007-12#1)(2008-2#1)(2008-3#2)
the fourth harmonic of##5##4##(2007-12#2)(2008-2#1)(2008-3#2)
the fourth harmonic##6##3##(2007-12#2)(2008-2#1)(2008-3#3)
the fourth instar##4##3##(2004-2#2)(2007-12#1)(2008-8#1)
the fourth most##4##3##(1992-5#1)(2006-12#1)(2008-6#1)(2010-8#1)
the fourth order##5##3##(2007-12#1)(2008-3#4)
the fourth patient##2##3##(1991-12#1)(2006-6#1)
the fourth postoperative##2##3##(2006-6#1)(2013-1#1)
the fourth step##2##3##(1990-8#1)(1995-4#1)
the fourth type##2##3##(1997-3#1)(2008-4#1)
the fourth ventricle and##2##4##(2006-5#1)(2010-11#1)
the fourth ventricle is##2##4##(1996-5#1)(2006-5#1)
the fourth ventricle##15##3##(1991-11#1)(1996-5#1)(2006-5#5)(2007-2#1)(2008-7#2)(2010-11#1)(2011-2#1)(2013-1#3)
the fourth week##3##3##(1997-2#1)(2006-10#1)(2006-2#1)
the fourth year##4##3##(1992-12#2)(1994-12#1)(2012-3#1)
the fourth##163##2##(1990-10#1)(1990-2#2)(1990-8#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-4#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1993-12#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#4)(1994-2#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#2)(1995-8#2)(1996-12#1)(1996-5#1)(1997-2#2)(1997-3#3)(1997-5#2)(2004-2#2)(2004-4#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-12#2)(2006-2#1)(2006-5#6)(2006-6#3)(2007-10#2)(2007-11#1)(2007-12#9)(2007-2#2)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#4)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2012-9#1)(2013-1#5)
the fourth-order##2##2##(2008-1#1)(2008-3#1)
the fourth-year##2##2##(2009-4#2)
the fovea and##2##3##(1995-11#2)
the fovea##10##2##(1993-7#1)(1995-11#2)(2007-11#1)(2008-4#2)(2009-5#1)(2012-12#2)(2013-1#1)
the foveal##3##2##(1992-7#2)(2008-4#1)
the fowl##2##2##(1997-6#2)
the fox##2##2##(1991-12#1)(2007-9#1)
the fractal dimension in##2##4##(1990-7#1)(2005-11#1)
the fractal dimension##7##3##(1990-7#1)(1992-2#1)(2005-11#3)(2007-12#1)(2011-1#1)
the fractal##14##2##(1990-7#1)(1992-2#1)(2005-11#3)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#4)(2011-1#2)
the fractal-like##2##2##(2008-10#1)(2012-2#1)
the fraction bound to##2##4##(2008-10#2)
the fraction containing##2##3##(1991-2#2)
the fraction of cells expressing##2##5##(1992-8#1)(1994-3#1)
the fraction of cells in the S phase##2##8##(2008-11#1)(2008-9#1)
the fraction of cells##6##4##(1992-8#1)(1994-3#1)(1997-4#1)(1997-7#1)(2008-11#1)(2008-9#1)
the fraction of patients##2##4##(1995-2#1)(1997-5#1)
the fraction of plasmid-carrying cells##2##5##(2008-7#2)
the fraction of the total##2##5##(1992-2#1)(2008-7#1)
the fraction of the##11##4##(1991-10#1)(1991-7#1)(1992-2#1)(1994-3#1)(1995-3#1)(1996-9#1)(2007-12#2)(2008-7#1)(2011-2#1)(2011-3#1)
the fraction of##72##3##(1990-8#1)(1991-10#1)(1991-11#2)(1991-2#1)(1991-7#2)(1992-2#1)(1992-8#1)(1993-11#1)(1994-11#2)(1994-3#2)(1994-5#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#2)(1996-5#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(2005-11#3)(2007-12#2)(2007-5#2)(2008-10#10)(2008-11#4)(2008-2#1)(2008-3#1)(2008-7#5)(2008-8#5)(2008-9#1)(2009-4#2)(2011-12#2)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#3)
the fraction with##2##3##(1990-7#1)(2008-10#1)
the fraction##95##2##(1990-2#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#2)(1991-2#3)(1991-7#3)(1992-2#1)(1992-8#1)(1993-10#1)(1993-11#1)(1994-11#2)(1994-3#3)(1994-5#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-5#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#3)(2004-11#1)(2005-11#3)(2007-12#2)(2007-5#2)(2008-10#14)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#5)(2008-8#6)(2008-9#1)(2009-10#1)(2009-4#3)(2011-12#2)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#3)
the fractional Fourier transform##11##4##(2007-12#1)(2008-2#9)(2008-3#1)
the fractional Fourier##15##3##(2007-12#5)(2008-2#9)(2008-3#1)
the fractional Hilbert transform for two-dimensional##2##6##(2008-2#2)
the fractional Hilbert transform##4##4##(2008-2#3)(2008-3#1)
the fractional Talbot effect##3##4##(2007-11#2)(2008-2#1)
the fractional Talbot##4##3##(2007-11#2)(2008-2#2)
the fractional excretion of##2##4##(2006-10#1)(2009-12#1)
the fractional fourier transform##2##4##(2008-2#1)(2008-3#1)
the fractional quantum Hall##3##4##(1990-4#1)(1993-5#1)(1995-11#1)
the fractional saturation##2##3##(1994-5#1)(1997-1#1)
the fractional##58##2##(1990-4#1)(1990-9#1)(1993-3#1)(1993-5#1)(1994-5#1)(1995-11#1)(1996-4#1)(1996-5#1)(1997-1#2)(1997-4#1)(2006-10#1)(2007-11#3)(2007-12#7)(2008-1#1)(2008-2#21)(2008-3#10)(2008-7#3)(2009-12#1)
the fractionated##4##2##(1990-4#1)(1991-7#1)(1994-4#1)(1997-2#1)
the fractionation of arsenic##2##4##(2008-10#2)
the fractionation of##6##3##(1990-9#1)(2008-10#5)
the fractionation##10##2##(1990-9#1)(2005-11#1)(2008-10#5)(2008-2#1)(2008-7#1)(2013-8#1)
the fractions of##12##3##(1991-7#1)(1991-8#1)(1992-6#1)(1997-2#1)(2008-10#4)(2008-7#1)(2008-9#1)(2010-2#1)(2012-2#1)
the fractions were##3##3##(2007-8#1)(2008-10#1)(2011-2#1)
the fractions with##3##3##(1992-7#1)(1997-4#1)(2008-10#1)
the fractions##32##2##(1990-8#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-6#1)(1992-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-1#1)(2007-8#1)(2008-10#7)(2008-11#3)(2008-7#1)(2008-9#1)(2009-3#1)(2010-2#1)(2011-2#1)(2012-2#2)
the fracture and##7##3##(1993-8#1)(2007-11#1)(2007-5#1)(2007-8#1)(2010-3#1)(2013-1#2)
the fracture is##3##3##(2006-3#2)(2007-11#1)
the fracture load##2##3##(2013-8#2)
the fracture pattern##3##3##(2006-11#3)
the fracture risk##2##3##(2006-11#1)(2007-8#1)
the fracture site##7##3##(2007-11#2)(2008-9#1)(2011-2#3)(2012-12#1)
the fracture strength of In ceram##2##6##(2004-9#2)
the fracture strength##3##3##(2004-9#3)
the fracture threshold##2##3##(1991-11#1)(1993-11#1)
the fracture toughness of the##2##5##(2008-8#2)
the fracture toughness of##3##4##(2008-8#3)
the fracture toughness##5##3##(2004-9#1)(2008-8#3)(2009-6#1)
the fracture was##4##3##(1991-6#1)(1993-8#1)(2007-11#1)(2007-7#1)
the fracture##66##2##(1991-10#1)(1991-11#1)(1991-6#1)(1993-11#1)(1993-8#3)(2004-9#4)(2005-3#1)(2006-10#1)(2006-11#5)(2006-3#2)(2006-8#2)(2007-11#7)(2007-5#1)(2007-7#1)(2007-8#6)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#2)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-3#1)(2011-2#7)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
the fractured##11##2##(2005-11#1)(2006-3#1)(2007-11#2)(2008-12#1)(2008-7#1)(2010-10#1)(2011-2#1)(2013-1#2)(2013-8#1)
the fractures##12##2##(1992-3#1)(1993-8#1)(2006-11#1)(2007-11#2)(2007-8#3)(2008-9#1)(2010-3#1)(2013-1#1)(2013-8#1)
the fragile X site##2##4##(1991-12#1)(1991-5#1)
the fragile X syndrome##2##4##(1991-5#1)(1993-10#1)
the fragile X##6##3##(1991-12#1)(1991-2#1)(1991-5#2)(1993-10#1)(2006-12#1)
the fragile##13##2##(1991-12#1)(1991-2#1)(1991-5#2)(1993-10#1)(2006-12#1)(2007-10#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-5#1)(2013-7#1)
the fragility of##3##3##(1990-5#1)(1992-6#1)(1995-3#1)
the fragility##4##2##(1990-5#1)(1992-6#1)(1995-3#2)
the fragment ends##2##3##(2007-8#1)(2008-2#1)
the fragment is##3##3##(1992-6#2)(1995-6#1)
the fragment of##5##3##(1991-12#1)(2007-7#1)(2008-2#1)(2008-4#1)(2013-1#1)
the fragment was##3##3##(2008-10#2)(2013-1#1)
the fragment##39##2##(1991-12#1)(1991-3#1)(1991-4#2)(1992-6#2)(1993-4#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-6#2)(2005-11#1)(2006-5#1)(2006-7#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-12#1)(2008-2#3)(2008-4#1)(2008-7#2)(2008-8#1)(2011-1#1)(2013-1#2)
the fragmentation of Cu##3##4##(1997-8#3)
the fragmentation of the##3##4##(1996-5#1)(2008-10#1)(2008-5#1)
the fragmentation of##13##3##(1992-2#1)(1992-3#1)(1994-10#1)(1996-5#1)(1997-8#5)(2005-2#1)(2008-10#1)(2008-5#1)(2011-2#1)
the fragmentation##18##2##(1992-2#1)(1992-3#1)(1992-6#1)(1994-10#1)(1996-5#1)(1997-8#7)(2005-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#1)
the fragmented##2##2##(1993-8#1)(2009-10#1)
the fragments of##3##3##(1994-9#1)(2007-11#1)(2008-2#1)
the fragments produced##2##3##(1990-7#1)(1994-6#1)
the fragments were##3##3##(1993-6#1)(2008-7#1)(2008-9#1)
the fragments##31##2##(1990-11#1)(1990-7#1)(1992-3#1)(1992-6#1)(1993-6#1)(1994-10#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-8#1)(1996-8#1)(1997-2#1)(2005-11#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2013-7#2)
the fragrance##11##2##(2006-12#2)(2007-11#1)(2008-5#8)
the frail elderly##14##3##(1991-12#1)(1993-1#3)(1993-3#1)(1994-1#1)(1994-2#1)(1995-1#5)(1995-2#1)(2008-2#1)
the frame of a##5##4##(2006-12#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
the frame of reference##2##4##(1995-3#2)
the frame of the##2##4##(2008-3#1)(2011-2#1)
the frame of##13##3##(1995-3#2)(2005-10#1)(2006-12#1)(2008-10#1)(2008-3#2)(2009-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
the frame was##2##3##(2013-1#2)
the frame##20##2##(1995-3#2)(2005-10#1)(2006-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#3)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#3)
the frames##4##2##(2008-3#3)(2013-1#1)
the framework for##17##3##(1990-12#1)(1991-10#1)(1993-4#1)(1993-9#1)(1995-6#1)(2006-10#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#2)(2012-1#1)(2013-1#2)
the framework in##3##3##(1995-6#1)(2012-2#2)
the framework of a simple##2##5##(1995-11#1)(2007-11#1)
the framework of a##20##4##(1990-12#1)(1990-8#1)(1991-12#1)(1992-1#1)(1994-5#1)(1995-11#1)(1995-5#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-2#4)(2008-3#2)(2009-7#1)(2010-7#1)
the framework of an##7##4##(1990-5#1)(1995-12#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2011-2#1)
the framework of our##3##4##(1993-6#1)(2007-10#1)(2008-2#1)
the framework of the##32##4##(1990-6#2)(1991-7#1)(1994-6#1)(1995-2#1)(1996-8#1)(1996-9#1)(1997-6#1)(1997-7#2)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-11#1)(2008-2#3)(2008-3#6)(2008-7#1)(2012-3#1)(2013-1#1)
the framework of##93##3##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#4)(1990-8#2)(1991-12#2)(1991-3#1)(1991-7#1)(1992-1#1)(1992-3#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#5)(2008-12#1)(2008-2#10)(2008-3#12)(2008-4#1)(2008-7#2)(2009-10#1)(2009-3#1)(2009-7#2)(2010-5#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
the framework on##2##3##(2005-11#1)(2009-5#1)
the framework presented in##2##4##(1996-2#1)(2006-7#1)
the framework to##3##3##(1995-2#1)(2006-10#1)(2012-3#1)
the framework##148##2##(1990-10#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#4)(1990-8#2)(1991-10#1)(1991-12#2)(1991-3#1)(1991-7#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-5#1)(1995-6#3)(1996-1#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-11#2)(2005-8#1)(2006-10#4)(2006-12#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#4)(2008-1#3)(2008-10#2)(2008-11#6)(2008-12#1)(2008-2#10)(2008-3#12)(2008-4#3)(2008-5#1)(2008-7#4)(2009-1#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-7#2)(2010-10#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-1#3)(2012-2#4)(2012-3#3)(2013-1#10)(2013-8#2)
the framing of##2##3##(2008-4#2)
the framing##3##2##(2008-4#3)
the fraud and abuse##2##4##(1993-1#1)(1993-3#1)
the free ADP##2##3##(1992-3#1)(1994-8#1)
the free [Mg2+]##3##3##(1990-7#3)
the free amino acid##2##4##(1990-12#1)(2010-8#1)
the free amino##5##3##(1990-11#1)(1990-12#1)(1990-5#1)(2007-11#1)(2010-8#1)
the free and bound##2##4##(1994-3#1)(1996-6#1)
the free and##9##3##(1993-2#1)(1994-3#1)(1995-3#1)(1996-6#1)(1996-7#1)(2008-10#2)(2008-6#2)
the free bilirubin##2##3##(1996-12#2)
the free carboxyl##2##3##(1992-12#1)(2008-5#1)
the free chains##2##3##(1991-9#2)
the free concentration of taurine##2##5##(2008-10#2)
the free concentration of##4##4##(2008-10#4)
the free cytosolic##2##3##(1990-5#1)(1996-1#1)
the free energies of binding##2##5##(1990-8#1)(1996-12#1)
the free energies of dimer-tetramer assembly##2##6##(1990-8#2)
the free energies of##7##4##(1990-8#4)(1991-7#1)(1996-12#1)(2005-11#1)
the free energies##8##3##(1990-8#4)(1991-7#1)(1992-12#1)(1996-12#1)(2005-11#1)
the free energy change for the##2##6##(1994-8#2)
the free energy change for##3##5##(1994-8#2)(2008-4#1)
the free energy change##7##4##(1990-5#1)(1994-11#2)(1994-8#2)(2008-4#1)(2010-7#1)
the free energy difference##3##4##(1994-11#1)(2006-12#1)(2010-7#1)
the free energy of ATP hydrolysis##2##6##(1993-6#1)(1996-6#1)
the free energy of an electrical double layer##3##8##(2005-11#3)
the free energy of binding##3##5##(1990-11#1)(1994-9#1)(2006-12#1)
the free energy of the##7##5##(1991-4#1)(1991-7#2)(1992-6#1)(1995-11#1)(1996-11#1)(1996-4#1)
the free energy of transfer##2##5##(1992-12#1)(2010-2#1)
the free energy of unfolding##3##5##(1995-10#2)(1995-5#1)
the free energy of##27##4##(1990-11#1)(1990-7#1)(1990-8#1)(1991-4#1)(1991-7#4)(1992-12#1)(1992-6#1)(1993-6#1)(1994-9#1)(1995-10#2)(1995-11#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-4#1)(1996-6#1)(2005-11#3)(2006-10#1)(2006-12#1)(2008-7#1)(2010-2#1)
the free energy##52##3##(1990-11#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-4#1)(1991-7#5)(1992-12#1)(1992-6#1)(1993-6#2)(1994-11#4)(1994-8#3)(1994-9#1)(1995-10#2)(1995-11#2)(1995-2#1)(1995-5#2)(1996-11#1)(1996-12#1)(1996-4#1)(1996-6#1)(2005-11#3)(2006-10#3)(2006-12#2)(2008-4#1)(2008-7#1)(2009-5#1)(2010-2#1)(2010-7#2)(2012-2#1)(2013-1#4)
the free enzyme##6##3##(1993-8#1)(1995-10#1)(1995-5#1)(2008-7#1)(2009-12#1)(2011-2#1)
the free hydrogel##2##3##(2010-2#2)
the free intracellular##2##3##(2007-10#1)(2008-5#1)
the free ligand##5##3##(1993-11#1)(1994-11#2)(2007-8#1)(2008-10#1)
the free ligands##2##3##(1996-8#1)(2008-5#1)
the free market##4##3##(1990-12#1)(1995-1#1)(2007-4#1)(2008-7#1)
the free metal##3##3##(2008-10#2)(2009-3#1)
the free nucleosides##2##3##(1996-8#1)(2006-3#1)
the free parameters of##2##4##(2008-2#2)
the free parameters##3##3##(2008-2#3)
the free peptide##4##3##(1991-2#1)(1995-2#1)(1995-3#1)(2007-11#1)
the free peptides##2##3##(1993-9#1)(2006-10#1)
the free protein##3##3##(1996-7#1)(1997-1#1)(2006-10#1)
the free radical concentration##2##4##(2007-3#2)
the free radical scavenger properties of##2##6##(1994-6#1)(2009-8#1)
the free radical scavenger##5##4##(1994-6#1)(1995-12#1)(1995-8#1)(2007-9#1)(2009-8#1)
the free radical theory##3##4##(1992-6#1)(2009-12#1)(2009-5#1)
the free radical##18##3##(1990-11#1)(1990-4#1)(1992-6#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-8#1)(2006-11#1)(2007-11#1)(2007-3#3)(2007-9#1)(2008-11#1)(2008-6#1)(2009-12#1)(2009-5#1)(2009-8#1)
the free radicals##8##3##(1991-12#1)(1995-1#1)(1996-5#1)(2006-10#1)(2007-9#2)(2008-10#1)(2011-2#1)
the free spectral range of##3##5##(2007-11#1)(2007-12#1)(2008-2#1)
the free spectral range##6##4##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2013-8#1)
the free sulfhydryl##2##3##(1993-11#1)(2009-9#1)
the free surface##3##3##(1994-3#1)(2005-11#1)(2011-2#1)
the free thiol##2##3##(1996-7#1)(2008-2#1)
the free wall of left ventricle##3##6##(2008-7#3)
the free wall of the##2##5##(2007-8#1)(2008-10#1)
the free wall of##5##4##(2007-8#1)(2008-10#1)(2008-7#3)
the free wall##6##3##(2007-8#1)(2008-10#1)(2008-7#3)(2010-10#1)
the free##277##2##(1990-10#1)(1990-11#4)(1990-12#3)(1990-3#1)(1990-4#1)(1990-5#4)(1990-7#5)(1990-8#5)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#3)(1991-5#2)(1991-7#6)(1991-9#2)(1992-12#3)(1992-3#1)(1992-6#3)(1992-7#1)(1993-11#3)(1993-2#1)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#6)(1994-12#1)(1994-3#6)(1994-5#1)(1994-6#1)(1994-8#5)(1994-9#2)(1995-1#3)(1995-10#3)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#3)(1995-5#6)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-4#2)(1996-5#2)(1996-6#2)(1996-7#3)(1996-8#3)(1997-1#4)(1997-2#2)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#6)(2005-5#1)(2005-8#1)(2006-10#6)(2006-11#1)(2006-12#3)(2006-3#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-3#3)(2007-4#1)(2007-8#4)(2007-9#4)(2008-10#24)(2008-11#2)(2008-12#4)(2008-2#5)(2008-3#7)(2008-4#1)(2008-5#6)(2008-6#5)(2008-7#8)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#4)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#1)
the free-electron laser##3##3##(2006-5#1)(2007-12#1)(2012-2#1)
the free-electron##4##2##(2006-5#1)(2007-12#1)(2008-2#1)(2012-2#1)
the free-energy##2##2##(1996-4#1)(2011-2#1)
the free-induction decay##2##3##(2007-12#2)
the free-living stages of S##2##5##(2007-12#2)
the free-living strains##3##3##(2006-3#3)
the free-living##8##2##(1994-12#1)(2006-3#3)(2007-12#2)(2008-7#2)
the free-radical##2##2##(2008-5#1)(2009-12#1)
the free-running mode##4##3##(2008-2#2)(2008-3#2)
the free-running##12##2##(2007-2#1)(2008-2#4)(2008-3#7)
the free-space optical systems and##2##5##(2008-3#2)
the free-space optical##3##3##(2008-3#3)
the free-space##15##2##(2007-12#6)(2008-2#1)(2008-3#6)(2009-5#1)(2013-8#1)
the freedom to##2##3##(1997-2#1)(2010-12#1)
the freedom##3##2##(1994-2#1)(1997-2#1)(2010-12#1)
the freely available##2##3##(2010-2#1)(2013-7#1)
the freely moving rat##2##4##(1993-2#2)
the freely##6##2##(1991-2#1)(1993-2#2)(2009-9#1)(2010-2#1)(2013-7#1)
the freerunning period##2##3##(2008-5#2)
the freerunning##3##2##(2008-5#3)
the freestanding##2##2##(2007-12#1)(2007-8#1)
the freeway##2##2##(2012-12#2)
the freeze-thaw##2##2##(2009-11#1)(2010-4#1)
the freezer##2##2##(1992-3#1)(1996-5#1)
the freezing process##3##3##(2005-11#1)(2007-8#2)
the freezing temperature##2##3##(2006-8#1)(2007-8#1)
the freezing##10##2##(1997-1#1)(2005-11#1)(2006-5#1)(2006-8#1)(2007-8#4)(2009-11#1)(2009-2#1)
the frequencies of the##11##4##(1991-1#2)(1991-12#1)(1992-1#1)(2007-10#1)(2007-9#1)(2008-2#2)(2008-3#1)(2011-2#2)
the frequencies of##33##3##(1990-4#1)(1990-6#1)(1991-1#2)(1991-12#1)(1992-1#1)(1992-6#1)(1993-6#1)(1993-8#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-4#1)(2007-10#1)(2007-9#2)(2008-10#3)(2008-2#3)(2008-3#1)(2008-8#1)(2009-4#1)(2010-2#1)(2011-1#1)(2011-2#2)(2013-1#1)
the frequencies required##2##3##(1993-3#1)(2008-4#1)
the frequencies##38##2##(1990-3#1)(1990-4#1)(1990-6#1)(1991-1#2)(1991-12#1)(1992-1#1)(1992-6#1)(1993-3#1)(1993-6#1)(1993-8#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-4#1)(2007-10#1)(2007-9#2)(2008-10#4)(2008-2#3)(2008-3#1)(2008-4#1)(2008-8#1)(2009-4#1)(2010-2#1)(2011-1#1)(2011-2#2)(2013-1#1)
the frequency and amplitude of##4##5##(1994-10#1)(1995-12#1)(2007-2#1)(2008-2#1)
the frequency and intensity of pain##2##6##(2007-8#1)(2012-2#1)
the frequency and intensity of##5##5##(1995-12#1)(2007-8#1)(2010-2#1)(2011-2#1)(2012-2#1)
the frequency and rate of##3##5##(2006-8#1)(2013-1#2)
the frequency and severity of##4##5##(2005-7#1)(2006-8#1)(2007-11#2)
the frequency and the##7##4##(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-3#2)(2008-7#1)
the frequency and type of##3##5##(1993-11#1)(2004-3#1)(2007-1#1)
the frequency and types of##2##5##(1993-12#1)(1995-1#1)
the frequency and##53##3##(1991-6#1)(1993-11#1)(1993-12#1)(1994-10#1)(1995-1#1)(1995-12#2)(1996-1#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-7#1)(2004-12#1)(2004-3#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-8#2)(2007-1#2)(2007-11#4)(2007-12#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-4#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#3)
the frequency at which the##2##5##(1993-12#1)(1993-9#1)
the frequency at which##3##4##(1993-12#1)(1993-9#1)(2011-1#1)
the frequency at##4##3##(1993-12#1)(1993-9#1)(2008-7#1)(2011-1#1)
the frequency autocorrelation of the differential group delay##2##8##(2007-12#2)
the frequency autocorrelation##3##3##(2007-11#1)(2007-12#2)
the frequency band##2##3##(2006-10#1)(2007-12#1)
the frequency changes##2##3##(2007-12#1)(2008-10#1)
the frequency chirp##2##3##(2008-3#2)
the frequency comb##3##3##(2007-11#1)(2007-12#2)
the frequency composition of##2##4##(2008-9#2)
the frequency conversion##2##3##(2008-3#2)
the frequency dependence of##4##4##(2007-12#2)(2008-2#1)(2013-7#1)
the frequency distribution of the##2##5##(2004-9#1)(2012-12#1)
the frequency distribution of##9##4##(2004-9#1)(2006-12#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#4)
the frequency distribution##10##3##(2004-9#1)(2006-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#4)
the frequency distributions of##2##4##(2008-10#1)(2008-3#1)
the frequency domain##22##3##(1995-11#1)(1995-6#1)(1996-2#1)(2007-1#3)(2007-11#3)(2007-12#3)(2007-8#1)(2008-2#5)(2008-3#3)(2008-8#1)
the frequency modulation##3##3##(2008-2#2)(2008-3#1)
the frequency noise##2##3##(2007-11#1)(2007-12#1)
the frequency of 1##2##4##(2008-9#1)(2012-3#1)
the frequency of Caesarean section##2##5##(1991-9#2)
the frequency of G143A##3##4##(2008-10#3)
the frequency of HPV##3##4##(1997-7#2)(2010-7#1)
the frequency of a##5##4##(1991-11#1)(2007-11#1)(2008-3#2)(2009-10#1)
the frequency of acute pancreatitis##2##5##(2006-6#2)
the frequency of acute##3##4##(2006-6#2)(2007-2#1)
the frequency of adverse effects##2##5##(1997-5#1)(2006-8#1)
the frequency of blood##2##4##(1991-6#1)(1994-3#1)
the frequency of both##2##4##(1994-3#1)(2010-2#1)
the frequency of cannibalism##2##4##(2011-12#2)
the frequency of cardiovascular##2##4##(2007-12#1)(2007-8#1)
the frequency of complications##2##4##(2006-10#1)(2009-2#1)
the frequency of cough##2##4##(1993-12#2)
the frequency of death##2##4##(2003-11#1)(2005-12#1)
the frequency of different##2##4##(1997-7#1)(2007-5#1)
the frequency of each##2##4##(2007-9#1)(2008-8#1)
the frequency of episodes of##2##5##(1994-4#1)(2007-7#1)
the frequency of episodes##3##4##(1994-4#1)(2007-7#2)
the frequency of headache##2##4##(2004-12#1)(2008-8#1)
the frequency of infection##2##4##(2012-12#1)(2012-3#1)
the frequency of infectious##2##4##(2006-10#1)(2011-2#1)
the frequency of light##2##4##(2007-12#1)(2008-3#1)
the frequency of micronucleated erythrocytes##5##5##(2008-9#5)
the frequency of micronucleated##7##4##(1996-12#1)(2008-9#6)
the frequency of new##2##4##(1991-8#1)(1993-11#1)
the frequency of occurrence of the##2##6##(1993-9#1)(2007-12#1)
the frequency of occurrence of##5##5##(1992-8#1)(1993-9#1)(2007-12#1)(2012-12#1)(2012-3#1)
the frequency of positive##3##4##(1992-8#1)(2006-8#1)(2011-2#1)
the frequency of rejection##2##4##(2006-5#1)(2007-11#1)
the frequency of relapse##2##4##(1995-11#1)(1995-6#1)
the frequency of resistant##2##4##(2008-10#1)(2008-8#1)
the frequency of seizures##2##4##(1996-1#1)(2007-2#1)
the frequency of sexual##3##4##(2009-5#1)(2012-3#1)(2013-1#1)
the frequency of specific##2##4##(2004-3#1)(2010-12#1)
the frequency of spike##2##4##(1993-12#1)(2012-1#1)
the frequency of spontaneously##2##4##(2007-12#1)(2010-3#1)
the frequency of subsequent##2##4##(1993-11#1)(1995-2#1)
the frequency of sulfation of tyrosine residues##2##7##(1990-3#2)
the frequency of the ac##2##5##(2007-12#1)(2008-3#1)
the frequency of the applied##2##5##(2005-11#1)(2008-1#1)
the frequency of the epsilon##2##5##(1991-1#2)
the frequency of the incident##2##5##(2008-2#1)(2008-3#1)
the frequency of the oscillations##2##5##(2007-11#1)(2008-3#1)
the frequency of the virulence##2##5##(2008-10#2)
the frequency of the##47##4##(1990-12#1)(1991-1#2)(1991-10#1)(1991-12#1)(1993-11#1)(1993-6#1)(1995-3#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#6)(2008-1#2)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2009-6#1)(2010-2#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#2)
the frequency of this##2##4##(1996-8#1)(2007-3#1)
the frequency of use of##3##5##(1990-8#1)(2006-10#2)
the frequency of##383##3##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#4)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-4#2)(1991-5#2)(1991-6#3)(1991-8#2)(1991-9#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#2)(1992-6#2)(1992-8#5)(1992-9#1)(1993-1#1)(1993-11#5)(1993-12#4)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#3)(1994-4#1)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#2)(1996-11#3)(1996-12#2)(1996-5#1)(1996-6#3)(1996-8#1)(1997-1#3)(1997-2#4)(1997-3#4)(1997-4#3)(1997-5#1)(1997-7#4)(1997-8#3)(2003-11#1)(2004-1#1)(2004-10#1)(2004-12#1)(2004-2#1)(2004-3#3)(2005-11#3)(2005-12#2)(2005-7#1)(2005-8#1)(2006-10#12)(2006-11#1)(2006-2#2)(2006-5#1)(2006-6#4)(2006-7#1)(2006-8#2)(2007-10#4)(2007-11#4)(2007-12#15)(2007-2#7)(2007-3#3)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#2)(2007-9#2)(2008-1#6)(2008-10#30)(2008-11#7)(2008-12#4)(2008-2#3)(2008-3#8)(2008-4#4)(2008-5#4)(2008-7#4)(2008-8#8)(2008-9#10)(2009-10#3)(2009-2#2)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#4)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#3)(2011-2#13)(2012-1#2)(2012-12#5)(2012-2#4)(2012-3#5)(2013-1#11)(2013-7#2)(2013-8#5)
the frequency range of##5##4##(1997-2#1)(2007-11#1)(2008-3#2)(2008-5#1)
the frequency range##12##3##(1997-2#1)(2005-11#2)(2007-11#5)(2008-10#1)(2008-3#2)(2008-5#1)
the frequency response of##4##4##(2008-1#1)(2008-2#1)(2008-3#1)(2009-5#1)
the frequency response##8##3##(1991-2#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)
the frequency shift between##2##4##(2008-1#2)
the frequency shift##12##3##(2007-11#2)(2007-12#3)(2008-1#2)(2008-10#3)(2008-3#2)
the frequency structure##2##3##(2006-5#1)(2007-12#1)
the frequency was##2##3##(2008-11#1)(2009-10#1)
the frequency with which##6##4##(1991-1#1)(1995-3#1)(2005-10#1)(2006-9#1)(2008-11#1)(2008-7#1)
the frequency##599##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#4)(1990-8#2)(1990-9#1)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#2)(1991-5#2)(1991-6#4)(1991-8#2)(1991-9#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#2)(1992-6#2)(1992-8#5)(1992-9#1)(1993-1#1)(1993-11#6)(1993-12#6)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#4)(1994-4#1)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#3)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#2)(1996-11#4)(1996-12#2)(1996-2#2)(1996-5#1)(1996-6#3)(1996-7#2)(1996-8#1)(1997-1#4)(1997-2#5)(1997-3#5)(1997-4#4)(1997-5#1)(1997-7#5)(1997-8#3)(2003-11#1)(2004-1#1)(2004-10#1)(2004-12#2)(2004-2#1)(2004-3#4)(2004-9#1)(2005-10#1)(2005-11#6)(2005-12#2)(2005-7#2)(2005-8#1)(2006-10#15)(2006-11#1)(2006-12#2)(2006-2#3)(2006-5#3)(2006-6#4)(2006-7#1)(2006-8#4)(2006-9#1)(2007-1#5)(2007-10#4)(2007-11#27)(2007-12#36)(2007-2#10)(2007-3#3)(2007-4#1)(2007-5#1)(2007-7#7)(2007-8#4)(2007-9#2)(2008-1#14)(2008-10#45)(2008-11#11)(2008-12#4)(2008-2#23)(2008-3#30)(2008-4#4)(2008-5#7)(2008-6#2)(2008-7#10)(2008-8#12)(2008-9#13)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#2)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#3)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#6)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#3)(2011-2#15)(2012-1#3)(2012-12#10)(2012-2#7)(2012-3#5)(2013-1#14)(2013-7#3)(2013-8#6)
the frequency-dependent behavior of photon density waves##2##7##(2008-3#2)
the frequency-dependent##5##2##(2006-10#1)(2007-12#1)(2008-3#3)
the frequency-domain fluorescence##2##3##(1991-2#1)(2008-2#1)
the frequency-domain##3##2##(1991-2#1)(2008-2#1)(2008-3#1)
the frequency-doubled output of a##2##5##(2007-12#1)(2008-2#1)
the frequency-doubled##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
the frequency-doubling##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
the frequency-resolved optical gating##2##4##(2007-12#1)(2008-2#1)
the frequency-shifted##2##2##(2007-12#2)
the frequent changes##2##3##(2008-9#1)(2011-2#1)
the frequent lack of##2##4##(2008-2#1)(2012-11#1)
the frequent occurrence of##7##4##(1990-2#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-11#1)(2012-3#1)
the frequent use of##5##4##(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-1#1)
the frequent##48##2##(1990-2#1)(1990-6#1)(1992-10#1)(1992-5#1)(1996-12#1)(1996-9#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#2)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#2)
the frequently observed##2##3##(1997-4#1)(2012-12#1)
the frequently##10##2##(1991-4#1)(1996-2#1)(1997-4#1)(2006-6#1)(2007-3#1)(2008-4#1)(2009-10#1)(2011-1#2)(2012-12#1)
the fresh and##3##3##(2005-11#1)(2008-5#1)(2013-8#1)
the fresh material##2##3##(2008-10#2)
the fresh stillbirth rate was##2##5##(1992-5#2)
the fresh water##3##3##(2008-10#1)(2008-7#1)(2013-7#1)
the fresh##25##2##(1992-5#2)(2005-11#1)(2006-12#1)(2006-5#2)(2007-1#1)(2007-3#2)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-7#1)(2010-4#1)(2012-12#2)(2013-7#1)(2013-8#1)
the freshest##2##2##(2004-9#1)(2012-2#1)
the freshly isolated##2##3##(1997-1#2)
the freshly##7##2##(1992-8#1)(1997-1#2)(2008-10#1)(2008-4#2)(2011-2#1)
the freshness of##3##3##(1990-6#2)(2008-10#1)
the freshness##4##2##(1990-6#2)(2008-10#2)
the freshwater fish##2##3##(2007-3#1)(2008-10#1)
the freshwater snail Biomphalaria pfeifferi##2##5##(2008-8#2)
the freshwater##21##2##(1996-3#1)(2004-4#2)(2005-12#1)(2007-3#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-8#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)
the friction behavior##2##3##(2008-5#1)(2010-10#1)
the friction between##2##3##(1994-9#1)(2008-3#1)
the friction coefficient of##2##4##(2008-5#1)(2010-4#1)
the friction##11##2##(1993-3#1)(1994-9#1)(1996-4#1)(2004-9#1)(2008-3#1)(2008-5#3)(2009-9#1)(2010-10#1)(2010-4#1)
the frictional force##3##3##(2008-5#3)
the frictional##8##2##(1997-8#1)(2005-11#1)(2008-5#4)(2010-10#2)
the fringe contrast##2##3##(2006-4#1)(2007-12#1)
the fringe imager##2##3##(2008-2#1)(2008-3#1)
the fringe imaging##2##3##(2008-2#1)(2008-3#1)
the fringe modulation##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
the fringe pattern##3##3##(2008-2#2)(2008-3#1)
the fringe patterns##7##3##(2008-2#3)(2008-3#4)
the fringe spacing is##2##4##(2008-2#1)(2008-3#1)
the fringe spacing##4##3##(2008-2#1)(2008-3#3)
the fringe visibility##7##3##(2007-12#1)(2008-2#4)(2008-3#2)
the fringe##53##2##(2006-4#3)(2007-12#5)(2008-2#19)(2008-3#24)(2008-9#2)
the fringe-adjusted##2##2##(2008-2#2)
the fringe-projection##2##2##(2008-3#2)
the fringes are##3##3##(2008-2#1)(2008-3#2)
the fringes##12##2##(2007-11#2)(2008-2#5)(2008-3#5)
the frog olfactory##3##3##(1994-10#2)(1996-7#1)
the frog retina##2##3##(1997-5#2)
the frog##30##2##(1990-11#1)(1990-5#1)(1992-10#1)(1992-11#3)(1992-3#1)(1993-2#1)(1993-3#1)(1993-5#2)(1994-10#4)(1995-8#1)(1996-7#1)(1997-3#4)(1997-5#2)(2008-4#3)(2008-7#2)(2009-2#1)(2010-3#1)
the front and the##2##4##(2008-3#1)(2012-3#1)
the front and##7##3##(1990-10#1)(2007-12#1)(2008-10#2)(2008-3#2)(2012-3#1)
the front end##2##3##(2006-5#1)(2010-8#1)
the front facet modal reflectivity of##2##6##(2008-3#2)
the front line of##3##4##(2008-1#2)(2011-2#1)
the front line##6##3##(2007-12#1)(2008-1#2)(2008-11#1)(2009-12#1)(2011-2#1)
the front lines##5##3##(1994-1#1)(1995-6#1)(1996-12#1)(2005-6#1)(2009-12#1)
the front of the##6##4##(1993-1#1)(2007-10#1)(2007-4#1)(2008-10#2)(2012-12#1)
the front of##7##3##(1993-1#1)(2007-10#1)(2007-4#1)(2008-10#2)(2008-7#1)(2012-12#1)
the front profile##2##3##(2006-11#1)(2008-10#1)
the front surface##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
the front##50##2##(1990-10#1)(1993-1#1)(1994-1#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-8#1)(1997-4#1)(2005-6#1)(2006-11#1)(2006-5#1)(2007-10#1)(2007-12#4)(2007-4#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#8)(2008-5#1)(2008-7#1)(2009-12#2)(2009-6#2)(2010-5#3)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
the front-end##3##2##(2006-5#1)(2008-3#1)(2008-9#1)
the front-line##2##2##(2012-12#2)
the frontal and temporal##2##4##(1996-12#1)(1996-3#1)
the frontal and the##2##4##(2008-2#1)(2008-5#1)
the frontal and##9##3##(1992-8#1)(1996-12#1)(1996-3#1)(2007-4#2)(2008-2#1)(2008-5#1)(2008-9#1)(2011-1#1)
the frontal area##3##3##(1991-1#1)(2007-9#2)
the frontal assessment battery (FAB)##2##5##(2008-9#1)(2013-8#1)
the frontal bone##6##3##(2007-12#1)(2007-4#1)(2008-7#1)(2009-3#2)(2012-8#1)
the frontal cortex and lateral ventricle##2##6##(1996-4#2)
the frontal cortex and##9##4##(1990-7#1)(1993-4#1)(1994-6#3)(1996-4#2)(2010-7#2)
the frontal cortex were##2##4##(1995-1#1)(2013-7#1)
the frontal cortex##45##3##(1990-10#1)(1990-7#2)(1991-12#1)(1991-3#1)(1991-5#2)(1993-12#1)(1993-4#2)(1994-10#1)(1994-11#1)(1994-6#3)(1995-1#2)(1995-2#2)(1995-3#2)(1995-7#2)(1996-1#1)(1996-4#4)(1997-2#1)(1997-5#7)(2008-11#1)(2009-4#3)(2010-7#2)(2011-2#2)(2013-7#1)
the frontal eye##3##3##(1993-2#2)(2010-5#1)
the frontal hairline##2##3##(2005-11#1)(2012-3#1)
the frontal lobe##10##3##(1995-1#1)(1996-5#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-7#1)(2008-9#3)(2011-2#1)
the frontal lobes##3##3##(2008-6#1)(2008-7#2)
the frontal plane##13##3##(1993-9#1)(2007-10#4)(2007-7#6)(2010-8#2)
the frontal sinus##7##3##(2006-12#3)(2008-6#1)(2011-2#2)(2012-8#1)
the frontal##131##2##(1990-10#1)(1990-7#2)(1991-1#2)(1991-12#1)(1991-3#1)(1991-5#2)(1992-11#1)(1992-8#2)(1993-12#1)(1993-2#2)(1993-4#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#3)(1995-1#3)(1995-2#2)(1995-3#2)(1995-7#2)(1996-1#1)(1996-12#2)(1996-3#1)(1996-4#4)(1996-5#2)(1997-2#2)(1997-3#1)(1997-5#7)(1997-8#1)(2004-3#1)(2005-11#1)(2006-11#1)(2006-12#5)(2007-10#6)(2007-11#1)(2007-12#5)(2007-4#4)(2007-7#6)(2007-8#1)(2007-9#3)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-9#5)(2009-3#2)(2009-4#3)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-8#2)(2013-7#1)(2013-8#1)
the frontier##4##2##(1996-5#1)(2005-11#1)(2008-10#1)(2010-9#1)
the frontiers of##2##3##(1993-2#1)(1996-2#1)
the frontiers##4##2##(1993-2#2)(1996-2#1)(2005-8#1)
the frontline##5##2##(2005-7#1)(2010-11#1)(2011-12#1)(2012-3#2)
the fronto-striatal system##2##3##(1995-12#1)(2007-8#1)
the frontoparietal cortex were##2##4##(1997-8#1)(2007-10#1)
the frontoparietal cortex##5##3##(1997-7#2)(1997-8#2)(2007-10#1)
the frontotemporoparietal combined indirect bypass procedure##2##6##(2006-11#2)
the frozen##4##2##(1991-4#1)(1994-8#1)(1995-8#1)(1996-6#1)
the fruit development##5##3##(2008-9#5)
the fruit fly Drosophila melanogaster and the##2##7##(2008-10#1)(2008-7#1)
the fruit fly Drosophila melanogaster##8##5##(1991-8#1)(1992-3#1)(1995-5#2)(1997-7#1)(2007-12#1)(2008-10#1)(2008-7#1)
the fruit fly Drosophila##9##4##(1991-8#1)(1992-3#1)(1995-5#2)(1997-7#1)(2007-12#2)(2008-10#1)(2008-7#1)
the fruit fly##18##3##(1991-8#1)(1992-3#1)(1995-5#2)(1997-7#1)(2007-10#1)(2007-12#3)(2008-10#1)(2008-7#4)(2008-9#2)(2010-5#1)(2013-8#1)
the fruit is##2##3##(2008-10#2)
the fruit of##7##3##(2008-10#1)(2008-9#1)(2011-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
the fruit tissue##2##3##(2007-1#1)(2008-10#1)
the fruit##62##2##(1991-8#1)(1992-3#1)(1993-3#1)(1995-5#2)(1997-7#1)(2006-12#1)(2007-1#2)(2007-10#1)(2007-12#3)(2008-10#19)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-9#9)(2009-6#1)(2010-12#1)(2010-2#2)(2010-5#1)(2011-1#1)(2011-2#2)(2013-1#3)(2013-7#1)(2013-8#2)
the fruit-feeding butterfly Charaxes fulvescens##2##5##(2009-9#2)
the fruitfly##2##2##(2008-2#1)(2008-9#1)
the fruiting##5##2##(1992-1#1)(2006-12#1)(2007-7#1)(2008-6#2)
the fruits of##9##3##(2006-12#1)(2007-1#3)(2008-11#1)(2008-6#1)(2010-3#1)(2012-2#1)(2012-3#1)
the fruits##24##2##(2006-12#1)(2007-1#4)(2008-10#1)(2008-11#8)(2008-12#1)(2008-5#1)(2008-6#1)(2010-2#3)(2010-3#1)(2012-2#2)(2012-3#1)
the fry##2##2##(2008-5#1)(2010-8#1)
the frying process##2##3##(2008-10#1)(2012-12#1)
the frying##4##2##(2008-10#1)(2008-6#1)(2012-12#2)
the ftz##4##2##(1992-4#2)(1993-9#2)
the fucoidan extracts##3##3##(2008-11#3)
the fucose residue##2##3##(1990-8#1)(2005-7#1)
the fucose##3##2##(1990-8#1)(1997-4#1)(2005-7#1)
the fucosyl##2##2##(1991-12#1)(1993-11#1)
the fuel distribution##2##3##(2006-4#2)
the fuel##8##2##(2006-10#1)(2006-4#2)(2008-3#3)(2011-1#1)(2012-12#1)
the fuel-cost increase scenario##2##4##(2012-12#2)
the fulgimide##3##2##(2009-9#3)
the full and##2##3##(2008-1#1)(2011-2#1)
the full aperture##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
the full beam##2##3##(2008-2#1)(2012-2#1)
the full complement of##2##4##(1995-5#1)(1997-2#1)
the full course of##2##4##(2008-3#1)(2009-11#1)
the full distribution of##4##4##(2006-12#1)(2008-8#1)(2010-2#2)
the full dosage##2##3##(1993-9#1)(2007-11#1)
the full exploitation of##2##4##(2007-11#1)(2011-1#1)
the full expression of##3##4##(1990-2#1)(1990-7#1)(1995-6#1)
the full extent of##3##4##(2007-6#1)(2007-9#1)(2013-1#1)
the full genomic##2##3##(1990-12#1)(2008-7#1)
the full length of##3##4##(1994-10#1)(2005-11#1)(2008-8#1)
the full length##14##3##(1991-10#2)(1991-5#1)(1992-1#1)(1992-11#1)(1992-2#1)(1994-10#1)(1995-12#1)(1997-7#1)(2005-11#1)(2007-11#1)(2008-8#1)(2010-2#1)(2012-2#1)
the full phase compensation method##2##5##(2008-3#2)
the full potential of the##2##5##(2008-3#1)(2011-1#1)
the full potential of##10##4##(1994-3#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#2)(2011-1#1)
the full range of##17##4##(1995-11#1)(1996-8#1)(1997-1#1)(1997-4#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-3#1)(2011-1#1)(2012-2#1)
the full set of reactions##2##5##(2008-10#2)
the full set of##3##4##(2008-10#2)(2010-8#1)
the full spectral##4##3##(2008-2#1)(2011-2#3)
the full spectrum of##9##4##(2005-8#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-7#1)(2010-11#1)(2012-3#1)
the full spectrum##10##3##(2005-8#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-3#1)
the full system##5##3##(2006-10#1)(2007-11#1)(2007-12#2)(2012-1#1)
the full text##2##3##(2005-7#1)(2011-2#1)
the full texts##3##3##(2011-1#1)(2011-2#1)(2013-1#1)
the full width at half-maximum of##2##6##(2008-2#2)
the full width at half-maximum##5##5##(2008-2#3)(2008-3#1)(2013-8#1)
the full width at##6##4##(2008-2#3)(2008-3#1)(2011-2#1)(2013-8#1)
the full width##7##3##(2007-12#1)(2008-2#3)(2008-3#1)(2011-2#1)(2013-8#1)
the full##242##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-1#1)(1991-10#2)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-9#2)(1994-10#2)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#3)(1995-5#1)(1995-6#2)(1996-11#1)(1996-12#2)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#2)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#2)(2006-10#3)(2006-11#2)(2006-12#2)(2006-4#1)(2006-5#3)(2006-6#1)(2007-1#2)(2007-11#11)(2007-12#22)(2007-4#1)(2007-5#2)(2007-6#1)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#15)(2008-11#2)(2008-2#15)(2008-3#17)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-2#4)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#6)(2011-2#10)(2012-1#2)(2012-12#2)(2012-2#7)(2012-3#4)(2013-1#10)(2013-7#1)(2013-8#3)
the full-blown disease##2##3##(1997-4#1)(2008-10#1)
the full-blown##4##2##(1997-4#1)(2008-10#1)(2008-5#1)(2012-2#1)
the full-fledged##2##2##(2004-9#1)(2010-9#1)
the full-length and##2##3##(1994-8#1)(1995-2#1)
the full-length cDNA of##3##4##(1997-7#1)(2008-8#2)
the full-length cDNA##10##3##(1990-2#1)(1992-5#2)(1993-8#1)(1995-3#1)(1996-2#1)(1997-7#2)(2008-8#2)
the full-length enzyme##2##3##(1994-8#1)(1995-2#1)
the full-length protein##2##3##(1995-6#1)(1997-6#1)
the full-length##56##2##(1990-11#1)(1990-2#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-8#4)(1994-9#1)(1995-2#2)(1995-3#3)(1995-5#2)(1995-6#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#2)(2006-11#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-6#1)(2012-12#2)
the full-text of##3##3##(1994-1#1)(2013-1#2)
the full-text##4##2##(1991-2#1)(1994-1#1)(2013-1#2)
the full-time##2##2##(1993-6#1)(2006-8#1)
the fullerenes##3##2##(1994-7#2)(2008-7#1)
the fully active##2##3##(1994-10#1)(1994-9#1)
the fully complementary##2##3##(1993-11#1)(2008-10#1)
the fully oxidized##2##3##(1990-10#1)(1994-9#1)
the fully reduced enzyme##2##4##(1990-10#2)
the fully reduced##4##3##(1990-10#2)(1994-9#1)(1997-4#1)
the fully##38##2##(1990-10#3)(1990-8#2)(1991-2#1)(1991-4#1)(1993-11#1)(1993-2#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#3)(1996-3#1)(1997-1#1)(1997-4#2)(2006-12#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-7#1)(2010-3#1)(2011-2#2)(2012-2#3)
the fume is##3##3##(2008-10#3)
the fume##5##2##(2008-10#5)
the fumonisin##5##2##(1995-3#1)(2008-10#1)(2010-10#2)(2013-1#1)
the function and structure of##2##5##(1997-6#1)(2008-6#1)
the function and the##4##4##(1992-11#1)(1994-5#1)(1997-8#1)(2008-10#1)
the function and##32##3##(1991-1#1)(1992-11#1)(1992-9#1)(1994-5#1)(1994-6#1)(1996-11#1)(1997-6#1)(1997-8#1)(2006-10#2)(2006-7#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#2)
the function of EDRF1##3##4##(2008-8#2)(2008-9#1)
the function of G proteins##3##5##(1990-7#1)(1995-6#1)(2008-9#1)
the function of Smad5##2##4##(2008-8#2)
the function of ZAG##3##4##(1997-4#3)
the function of a gene in the##2##7##(2008-4#1)(2009-5#1)
the function of a gene##3##5##(2008-4#1)(2008-7#1)(2009-5#1)
the function of a novel##2##5##(2006-7#1)(2011-1#1)
the function of a##12##4##(2006-7#1)(2008-1#2)(2008-2#1)(2008-4#3)(2008-7#2)(2009-5#1)(2010-12#1)(2011-1#1)
the function of an##2##4##(1992-5#1)(2012-2#1)
the function of basonuclin##2##4##(2008-9#2)
the function of every##2##4##(1991-10#1)(2009-10#1)
the function of genes##3##4##(1993-2#1)(2008-4#1)(2009-8#1)
the function of human##3##4##(2006-6#1)(2008-11#1)(2012-12#1)
the function of mitochondrial##2##4##(1997-2#1)(2008-6#1)
the function of novel genes##2##5##(2008-7#2)
the function of retinal##2##4##(2008-8#2)
the function of specific##5##4##(2007-1#1)(2008-4#3)(2008-7#1)
the function of the NMDA receptor##2##6##(1993-12#2)
the function of the human##2##5##(1992-4#1)(1997-3#1)
the function of the hypopharyngeal gland##2##6##(2008-6#2)
the function of the protein##2##5##(1997-7#1)(2010-2#1)
the function of the##91##4##(1990-11#1)(1990-12#1)(1990-4#2)(1990-8#2)(1991-12#3)(1991-2#1)(1991-6#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#2)(1993-12#2)(1993-6#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-6#1)(1995-2#2)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#4)(2005-11#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-8#3)(2009-9#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)
the function of these proteins##2##5##(1991-12#1)(2008-11#1)
the function of these##11##4##(1991-12#1)(1991-4#1)(1995-2#1)(2006-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-5#1)(2013-1#1)
the function of this gene##2##5##(1990-11#1)(1991-11#1)
the function of this##8##4##(1990-11#1)(1990-4#1)(1990-8#1)(1991-11#1)(1994-8#1)(2006-12#1)(2009-8#2)
the function of which##3##4##(1994-5#1)(1994-9#1)(2009-5#1)
the function of##322##3##(1990-10#1)(1990-11#2)(1990-12#2)(1990-3#1)(1990-4#3)(1990-6#1)(1990-7#1)(1990-8#4)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#6)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#2)(1992-12#1)(1992-4#1)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-4#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#3)(1994-2#2)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#6)(1995-7#1)(1995-8#5)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-4#1)(1996-5#2)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-6#1)(1997-7#6)(1997-8#1)(2004-1#1)(2005-11#3)(2005-7#2)(2006-10#7)(2006-11#1)(2006-12#1)(2006-6#5)(2006-7#1)(2007-1#2)(2007-10#3)(2007-11#2)(2007-12#4)(2007-2#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#8)(2008-11#6)(2008-2#3)(2008-3#1)(2008-4#12)(2008-5#3)(2008-6#3)(2008-7#12)(2008-8#11)(2008-9#19)(2009-10#1)(2009-3#1)(2009-5#3)(2009-6#2)(2009-8#8)(2009-9#2)(2010-11#1)(2010-12#6)(2010-2#6)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#5)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#15)(2012-2#5)(2012-3#5)(2013-1#6)(2013-8#3)
the function that##3##3##(1990-10#1)(1992-3#1)(2010-3#1)
the function##371##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-3#2)(1990-4#3)(1990-6#1)(1990-7#1)(1990-8#4)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#6)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#2)(1992-11#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-4#1)(1993-6#3)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#3)(1994-2#3)(1994-3#4)(1994-5#3)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#6)(1995-7#1)(1995-8#5)(1996-10#2)(1996-11#2)(1996-12#2)(1996-2#3)(1996-4#1)(1996-5#2)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-6#3)(1997-7#6)(1997-8#2)(2004-1#1)(2005-11#3)(2005-7#2)(2006-10#9)(2006-11#1)(2006-12#1)(2006-6#5)(2006-7#2)(2007-1#2)(2007-10#3)(2007-11#3)(2007-12#6)(2007-2#2)(2007-4#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#9)(2008-11#7)(2008-2#3)(2008-3#2)(2008-4#14)(2008-5#5)(2008-6#5)(2008-7#14)(2008-8#13)(2008-9#20)(2009-10#1)(2009-3#1)(2009-5#3)(2009-6#3)(2009-8#8)(2009-9#3)(2010-11#1)(2010-12#6)(2010-2#6)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#5)(2011-2#6)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#15)(2012-2#5)(2012-3#5)(2013-1#8)(2013-8#6)
the functional 5HT1D alpha gene##2##5##(1993-12#2)
the functional ability of##6##4##(1994-3#1)(2007-2#1)(2007-7#3)(2009-12#1)
the functional activities of##2##4##(1994-12#1)(2008-1#1)
the functional activity of the##6##5##(1990-5#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)
the functional activity of##12##4##(1990-5#1)(1991-8#1)(1995-10#1)(1996-10#1)(1997-6#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)
the functional activity##13##3##(1990-5#1)(1991-8#1)(1995-10#1)(1996-10#1)(1997-6#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2013-1#1)
the functional analysis of microarrays##2##5##(2008-7#2)
the functional analysis of the##2##5##(2008-11#1)(2009-10#1)
the functional analysis of##8##4##(1994-9#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-7#2)(2009-10#1)
the functional and esthetic##2##4##(2007-12#1)(2011-2#1)
the functional and structural##5##4##(1992-3#1)(1994-8#1)(2005-7#1)(2007-12#1)(2012-2#1)
the functional and##18##3##(1990-3#1)(1992-3#1)(1994-11#1)(1994-3#1)(1994-8#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#1)(2005-7#1)(2005-8#1)(2007-12#2)(2008-12#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-2#1)
the functional aspects of the##2##5##(1994-8#1)(2008-5#1)
the functional aspects##3##3##(1994-8#1)(2006-6#1)(2008-5#1)
the functional behavior of the##2##5##(2006-12#1)(2008-9#1)
the functional behavior of##3##4##(1992-12#1)(2006-12#1)(2008-9#1)
the functional capacity of patients in the early period following intracranial aneurysm surgery##3##13##(2007-7#3)
the functional capacity of##6##4##(1991-10#1)(1994-5#1)(1997-3#1)(2007-7#3)
the functional capacity##7##3##(1991-10#1)(1994-5#1)(1997-3#1)(2005-1#1)(2007-7#3)
the functional categories of##2##4##(1997-4#1)(2008-7#1)
the functional characteristics of the##2##5##(1992-4#1)(1992-6#1)
the functional characteristics of##5##4##(1991-8#1)(1992-2#1)(1992-4#1)(1992-6#1)(1997-7#1)
the functional characterization of##2##4##(1995-2#1)(2008-11#1)
the functional class##2##3##(2006-6#1)(2013-1#1)
the functional classification##3##3##(2005-10#1)(2008-7#1)(2012-11#1)
the functional connectivity##3##3##(2006-4#1)(2011-2#2)
the functional consequences of these##2##5##(1995-5#1)(1996-11#1)
the functional consequences of##10##4##(1995-5#1)(1996-11#1)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#1)(2013-1#1)
the functional consequences##11##3##(1995-5#1)(1996-11#1)(2007-12#1)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#1)(2013-1#1)
the functional difference##2##3##(1994-9#1)(1995-6#1)
the functional differences between the two##2##6##(1996-7#1)(2012-2#1)
the functional differences between the##3##5##(1996-7#1)(1997-2#1)(2012-2#1)
the functional differences##4##3##(1996-7#1)(1997-2#1)(2008-1#1)(2012-2#1)
the functional differentiation of##2##4##(1995-9#2)
the functional disruption of##2##4##(1992-9#1)(2008-3#1)
the functional dissection of##2##4##(2009-6#1)(2012-3#1)
the functional diversity of##6##4##(1992-2#1)(2008-10#1)(2008-2#1)(2008-4#2)(2012-1#1)
the functional domain##2##3##(1990-3#1)(2008-9#1)
the functional domains of the##2##5##(1994-5#1)(1997-7#1)
the functional domains of##4##4##(1994-5#1)(1995-8#1)(1997-7#2)
the functional domains##7##3##(1990-7#1)(1993-12#1)(1994-5#1)(1995-8#1)(1997-6#1)(1997-7#2)
the functional effect of##3##4##(1994-11#1)(2008-8#1)(2013-8#1)
the functional effects of##4##4##(1992-10#1)(1994-2#1)(1997-4#1)(2007-12#1)
the functional enzyme##3##3##(1992-2#1)(1996-7#1)(1997-7#1)
the functional expression of the##3##5##(1993-8#1)(1997-6#1)(2008-6#1)
the functional expression of##8##4##(1993-8#1)(1994-12#1)(1994-3#2)(1995-8#1)(1997-6#1)(2008-6#1)(2011-2#1)
the functional features of##2##4##(1991-6#1)(1992-11#1)
the functional fitness##2##3##(2010-12#2)
the functional form of the##5##5##(1992-2#1)(2007-12#1)(2008-7#1)(2009-8#1)(2012-2#1)
the functional form of##7##4##(1992-2#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-2#1)
the functional form##9##3##(1992-2#1)(1992-3#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-2#2)
the functional genomics of##2##4##(2008-7#1)(2008-8#1)
the functional group##3##3##(2005-11#1)(2008-10#2)
the functional groups of##2##4##(2008-10#2)
the functional groups##8##3##(1992-6#1)(2005-11#1)(2006-12#1)(2007-6#1)(2008-10#4)
the functional imaging##3##3##(2006-3#1)(2007-11#1)(2010-1#1)
the functional impact of ET##2##5##(2008-7#2)
the functional impact of##3##4##(2007-11#1)(2008-7#2)
the functional importance of##6##4##(1992-1#1)(1994-5#1)(2009-5#1)(2009-9#1)(2012-6#1)(2013-1#1)
the functional information##3##3##(2007-12#3)
the functional integrity of the##6##5##(1994-6#1)(1996-3#1)(2006-12#1)(2006-7#1)(2008-8#1)(2012-12#1)
the functional integrity of##8##4##(1990-7#1)(1992-8#1)(1994-6#1)(1996-3#1)(2006-12#1)(2006-7#1)(2008-8#1)(2012-12#1)
the functional interaction between##3##4##(1995-8#1)(2007-11#1)(2008-4#1)
the functional interaction##4##3##(1995-8#1)(2007-10#1)(2007-11#1)(2008-4#1)
the functional loss##2##3##(2009-11#1)(2012-1#1)
the functional maturation of the visual##2##6##(2011-2#2)
the functional maturation of the##3##5##(1992-9#1)(2011-2#2)
the functional mechanism of##2##4##(1993-2#1)(2011-1#1)
the functional mechanism##3##3##(1993-2#1)(2006-8#1)(2011-1#1)
the functional mechanisms##2##3##(1997-7#1)(2009-8#1)
the functional monomer##4##3##(2008-10#3)(2013-8#1)
the functional monomers##2##3##(2007-6#1)(2008-10#1)
the functional morphology of the##2##5##(2007-12#2)
the functional morphology of##3##4##(2006-6#1)(2007-12#2)
the functional nature of##3##4##(1992-5#1)(1997-6#1)(2008-4#1)
the functional or##2##3##(2008-11#1)(2010-1#1)
the functional organization of the##4##5##(1997-7#1)(2006-12#1)(2007-9#1)(2008-8#1)
the functional organization of##6##4##(1995-12#1)(1997-7#1)(2006-12#1)(2007-9#1)(2008-8#2)
the functional outcome after##3##4##(2007-7#1)(2008-6#1)(2008-7#1)
the functional outcome of##3##4##(2006-8#1)(2008-1#1)(2008-4#1)
the functional outcome##12##3##(2006-6#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-6#3)(2008-7#1)(2011-12#1)
the functional outcomes##2##3##(2007-7#1)(2007-9#1)
the functional properties of the##3##5##(1991-6#1)(2008-6#1)(2013-8#1)
the functional properties of##15##4##(1990-8#1)(1991-5#1)(1991-6#1)(1994-3#2)(1994-8#1)(1995-12#2)(1995-8#1)(1996-5#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-12#1)(2013-8#1)
the functional properties##16##3##(1990-8#1)(1991-5#1)(1991-6#1)(1994-3#2)(1994-8#1)(1995-12#2)(1995-8#1)(1996-5#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-4#1)(2013-8#1)
the functional reconstitution of##2##4##(1991-4#1)(1991-5#1)
the functional reconstitution##3##3##(1991-4#1)(1991-5#1)(1995-2#1)
the functional recovery of##3##4##(2008-5#1)(2011-3#1)(2012-1#1)
the functional region##2##3##(1990-3#1)(1996-7#1)
the functional relationship between##3##4##(1993-3#1)(1993-6#1)(1994-3#1)
the functional relationship of##2##4##(1997-6#1)(2013-7#1)
the functional relationship##5##3##(1993-3#1)(1993-6#1)(1994-3#1)(1997-6#1)(2013-7#1)
the functional relationships##3##3##(2008-10#1)(2008-2#1)(2008-6#1)
the functional relevance of##4##4##(1994-12#1)(1996-5#1)(2012-3#1)(2013-1#1)
the functional residual capacity##2##4##(1996-5#1)(2006-9#1)
the functional response of##2##4##(2008-10#1)(2008-8#1)
the functional response##3##3##(2008-10#1)(2008-8#2)
the functional responses##2##3##(1995-11#1)(2008-6#1)
the functional results##3##3##(1993-2#1)(1993-8#1)(2009-9#1)
the functional role of PTHrP on their own##2##8##(1993-3#2)
the functional role of the##5##5##(1992-8#1)(1993-6#1)(1994-9#1)(2008-11#1)(2009-2#1)
the functional role of this##2##5##(2008-4#1)(2008-7#1)
the functional role of##33##4##(1991-4#1)(1992-8#1)(1992-9#1)(1993-3#2)(1993-6#2)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-6#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-8#1)(2009-9#1)(2011-2#2)(2012-2#1)
the functional role##34##3##(1991-4#1)(1992-8#1)(1992-9#1)(1993-3#2)(1993-6#2)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-6#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-8#1)(2009-9#1)(2011-2#2)(2012-2#2)
the functional roles of these##2##5##(1994-5#1)(1995-8#1)
the functional roles of##6##4##(1992-6#1)(1993-3#1)(1993-6#1)(1994-5#1)(1995-8#1)(2009-10#1)
the functional significance of such##2##5##(1994-3#1)(1994-8#1)
the functional significance of the##3##5##(1990-9#1)(1995-2#1)(2007-12#1)
the functional significance of these##2##5##(1996-9#1)(2010-2#1)
the functional significance of this##2##5##(1995-2#1)(2012-2#1)
the functional significance of##20##4##(1990-9#1)(1991-3#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-2#2)(1995-6#1)(1996-3#1)(1996-5#1)(1996-9#1)(2004-4#1)(2007-12#1)(2008-7#1)(2009-1#1)(2009-5#1)(2010-2#1)(2012-2#2)(2012-3#1)
the functional significance##21##3##(1990-9#1)(1991-3#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-2#2)(1995-6#1)(1996-3#1)(1996-5#1)(1996-9#1)(2004-4#1)(2007-12#1)(2008-7#1)(2009-1#1)(2009-5#1)(2010-2#1)(2011-1#1)(2012-2#2)(2012-3#1)
the functional site##3##3##(2008-4#2)(2008-8#1)
the functional specificity of##2##4##(1991-5#1)(1995-1#1)
the functional state of the##4##5##(1995-12#1)(2006-6#1)(2010-8#2)
the functional state of##7##4##(1995-12#1)(1995-4#1)(2006-6#1)(2008-4#1)(2010-8#2)(2013-1#1)
the functional status of the neurohypophyseal system in##2##8##(1997-8#2)
the functional status of the##7##5##(1992-4#1)(1995-2#1)(1997-8#2)(2008-4#1)(2008-9#1)(2011-2#1)
the functional status of##12##4##(1992-4#1)(1995-2#2)(1997-8#2)(2008-1#1)(2008-4#3)(2008-7#1)(2008-9#1)(2011-2#1)
the functional status##14##3##(1992-4#1)(1995-2#2)(1997-8#2)(2008-1#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)
the functional##507##2##(1990-12#1)(1990-2#1)(1990-3#3)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#2)(1990-9#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#4)(1992-12#1)(1992-2#4)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#4)(1992-8#2)(1992-9#4)(1993-10#1)(1993-12#5)(1993-2#5)(1993-3#4)(1993-6#4)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#8)(1994-5#5)(1994-6#3)(1994-8#6)(1994-9#4)(1995-1#3)(1995-10#2)(1995-11#3)(1995-12#5)(1995-2#8)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#6)(1995-8#6)(1995-9#3)(1996-10#1)(1996-11#2)(1996-2#1)(1996-3#3)(1996-5#7)(1996-6#1)(1996-7#4)(1996-8#3)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#4)(1997-5#2)(1997-6#8)(1997-7#6)(1997-8#2)(2004-4#1)(2005-1#2)(2005-10#1)(2005-11#3)(2005-7#1)(2005-8#2)(2006-10#2)(2006-11#1)(2006-12#4)(2006-3#1)(2006-4#1)(2006-6#7)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#10)(2007-12#17)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#8)(2007-8#2)(2007-9#3)(2008-1#6)(2008-10#20)(2008-11#7)(2008-12#1)(2008-2#6)(2008-3#2)(2008-4#22)(2008-5#4)(2008-6#11)(2008-7#21)(2008-8#13)(2008-9#5)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#4)(2010-1#2)(2010-10#2)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#11)(2011-3#1)(2012-1#4)(2012-11#2)(2012-12#2)(2012-2#13)(2012-3#6)(2012-6#1)(2013-1#11)(2013-7#1)(2013-8#4)
the functionality of the##12##4##(1990-4#1)(1995-12#1)(1997-2#1)(2006-6#1)(2007-3#1)(2007-8#1)(2008-10#2)(2009-2#1)(2012-12#1)(2012-3#1)(2012-6#1)
the functionality of this##2##4##(1990-5#1)(2009-2#1)
the functionality of##24##3##(1990-4#1)(1990-5#1)(1995-12#1)(1997-2#2)(2004-9#2)(2006-2#1)(2006-6#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#2)(2009-4#1)(2010-5#1)(2012-12#1)(2012-3#1)(2012-6#1)
the functionality##35##2##(1990-4#1)(1990-5#1)(1995-12#1)(1997-2#2)(2004-9#2)(2006-2#1)(2006-6#2)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#3)(2008-4#2)(2008-7#1)(2008-8#1)(2009-2#2)(2009-3#1)(2009-4#1)(2010-5#1)(2012-12#1)(2012-3#1)(2012-6#1)(2013-1#5)(2013-8#2)
the functionalization of##2##3##(2007-11#1)(2008-10#1)
the functionalization##4##2##(2007-11#2)(2008-10#1)(2010-2#1)
the functionalized##2##2##(2008-10#1)(2011-1#1)
the functionally important##2##3##(1996-7#1)(2010-8#1)
the functionally significant##2##3##(1997-7#1)(2006-6#1)
the functionally##18##2##(1990-7#1)(1991-7#1)(1993-11#1)(1994-3#1)(1994-5#1)(1996-7#1)(1997-1#1)(1997-7#1)(2006-3#1)(2006-6#1)(2007-12#1)(2007-9#1)(2008-11#1)(2009-10#1)(2009-2#1)(2009-9#1)(2010-8#1)(2011-1#1)
the functioning of the##16##4##(1992-1#1)(1993-6#1)(1994-6#1)(1997-2#1)(2006-5#1)(2007-11#1)(2007-4#2)(2008-10#1)(2008-11#1)(2008-7#2)(2009-5#1)(2009-9#1)(2011-2#1)(2012-11#1)
the functioning of##26##3##(1991-6#1)(1992-1#1)(1993-6#1)(1994-6#1)(1997-2#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-4#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-7#2)(2009-5#1)(2009-9#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-8#1)
the functioning##29##2##(1991-6#1)(1992-1#1)(1993-6#1)(1994-6#1)(1997-2#1)(2004-4#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-4#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-7#3)(2009-5#1)(2009-9#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-8#1)
the functions and##5##3##(1995-2#1)(2006-10#1)(2008-2#1)(2008-4#1)(2009-5#1)
the functions associated with##2##4##(1996-1#1)(2011-1#1)
the functions of a##3##4##(2007-11#1)(2007-4#1)(2013-8#1)
the functions of all##2##4##(2007-9#1)(2008-7#1)
the functions of an##2##4##(2006-10#1)(2011-2#1)
the functions of genes##2##4##(1993-9#1)(2012-3#1)
the functions of its##2##4##(2007-6#1)(2008-1#1)
the functions of most##2##4##(2007-12#1)(2008-8#1)
the functions of the genes##2##5##(1997-8#1)(2008-9#1)
the functions of the##19##4##(1990-3#1)(1993-11#1)(1994-2#1)(1994-3#2)(1997-2#1)(1997-7#2)(1997-8#1)(2006-7#1)(2007-12#2)(2008-2#1)(2008-9#1)(2010-11#1)(2012-12#1)(2012-3#1)(2013-1#2)
the functions of these##5##4##(1994-9#1)(1995-5#1)(2007-8#1)(2009-8#1)(2013-8#1)
the functions of this##2##4##(1990-5#1)(2004-3#1)
the functions of viral##2##4##(2008-9#1)(2013-1#1)
the functions of##86##3##(1990-10#1)(1990-3#2)(1990-5#1)(1991-7#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-3#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#1)(2009-8#3)(2009-9#2)(2010-11#3)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#2)
the functions##103##2##(1990-10#1)(1990-3#2)(1990-5#1)(1991-7#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-2#2)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-3#1)(2006-10#3)(2006-12#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-2#3)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#5)(2009-10#1)(2009-5#1)(2009-8#3)(2009-9#3)(2010-11#3)(2010-5#1)(2010-7#1)(2011-1#4)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#4)
the fundamental and second-harmonic frequencies##2##5##(2007-11#1)(2007-12#1)
the fundamental and second-harmonic##3##4##(2007-11#1)(2007-12#2)
the fundamental and the second harmonic##2##6##(2007-11#1)(2007-12#1)
the fundamental and the second-harmonic light##2##6##(2007-12#1)(2008-1#1)
the fundamental and the second-harmonic##4##5##(2007-12#1)(2008-1#2)(2008-3#1)
the fundamental and the##8##4##(2007-11#1)(2007-12#2)(2008-1#4)(2008-3#1)
the fundamental and##15##3##(2007-11#2)(2007-12#4)(2008-1#4)(2008-2#2)(2008-3#2)(2013-8#1)
the fundamental aspects##2##3##(1995-8#1)(2007-6#1)
the fundamental beam##2##3##(2007-12#1)(2008-2#1)
the fundamental cause##2##3##(2008-10#1)(2012-1#1)
the fundamental cavity##2##3##(2007-11#1)(2007-12#1)
the fundamental concepts of##3##4##(2007-4#1)(2009-6#1)(2010-5#1)
the fundamental concepts##5##3##(2007-3#1)(2007-4#1)(2009-6#1)(2010-5#1)(2013-8#1)
the fundamental differences##2##3##(2012-7#1)(2013-1#1)
the fundamental equation##2##3##(2005-11#2)
the fundamental frequency and##2##4##(2007-12#1)(2010-2#1)
the fundamental frequency##8##3##(1997-5#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#1)(2010-2#1)
the fundamental limits##2##3##(2008-2#1)(2008-3#1)
the fundamental mechanisms of##3##4##(2007-1#1)(2012-1#1)(2012-3#1)
the fundamental mechanisms##5##3##(2007-1#1)(2007-12#1)(2012-1#2)(2012-3#1)
the fundamental mode is##2##4##(2007-11#1)(2008-3#1)
the fundamental mode of##3##4##(2007-12#1)(2008-3#2)
the fundamental mode##14##3##(2007-11#1)(2007-12#6)(2008-2#1)(2008-3#5)(2012-11#1)
the fundamental modes of##3##4##(2006-10#1)(2007-11#1)(2007-12#1)
the fundamental of a##2##4##(2007-12#2)
the fundamental parameter method##2##4##(2005-4#2)
the fundamental parameter##3##3##(1997-7#1)(2005-4#2)
the fundamental principles of##3##4##(2008-3#1)(2008-4#1)(2008-5#1)
the fundamental principles##4##3##(2006-12#1)(2008-3#1)(2008-4#1)(2008-5#1)
the fundamental process of##2##4##(1992-9#1)(2005-11#1)
the fundamental question of##2##4##(1996-4#1)(2010-7#1)
the fundamental role of##3##4##(1994-6#1)(1996-11#1)(2010-4#1)
the fundamental rovibrational band of CO(2)##2##6##(2007-11#1)(2007-12#1)
the fundamental steps##2##3##(2010-7#1)(2011-1#1)
the fundamental transverse-mode##2##3##(2007-12#1)(2008-3#1)
the fundamental understanding of the##2##5##(2008-3#1)(2008-7#1)
the fundamental understanding of##3##4##(2008-3#1)(2008-4#1)(2008-7#1)
the fundamental understanding##4##3##(2008-3#1)(2008-4#1)(2008-7#1)(2012-3#1)
the fundamental wave##3##3##(2007-12#2)(2008-2#1)
the fundamental wavelength to##3##4##(2007-12#2)(2008-3#1)
the fundamental wavelength##7##3##(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-3#1)
the fundamental##210##2##(1991-3#2)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-11#1)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-7#1)(2005-11#3)(2005-12#1)(2005-4#3)(2006-10#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#18)(2007-12#38)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#1)(2007-9#1)(2008-1#6)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#19)(2008-3#23)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-6#3)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#4)(2012-11#2)(2012-2#2)(2012-3#3)(2012-7#1)(2013-1#3)(2013-8#3)
the fundamentally interesting##2##3##(2009-12#1)(2012-2#1)
the fundamentally##3##2##(2009-12#1)(2011-2#1)(2012-2#1)
the fundamentals of##11##3##(1994-12#3)(1997-6#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-3#1)
the funding of##4##3##(1994-2#1)(1995-12#1)(1997-7#1)(2006-5#1)
the funding##11##2##(1991-12#1)(1992-1#1)(1994-2#1)(1995-12#1)(1995-6#1)(1997-7#1)(2006-5#1)(2007-1#1)(2007-2#1)(2007-4#1)(2010-5#1)
the funds##3##2##(1994-2#1)(2004-2#1)(2007-9#1)
the fundus of the##4##4##(1990-3#1)(1991-12#1)(1993-2#1)(2009-4#1)
the fundus##8##2##(1990-3#1)(1991-12#1)(1993-2#1)(2006-5#1)(2009-4#1)(2010-6#1)(2011-1#1)(2011-2#1)
the fungal cell wall##5##4##(2008-10#4)(2009-8#1)
the fungal genome##5##3##(1997-6#1)(2008-10#3)(2011-1#1)
the fungal isolates##3##3##(2007-7#1)(2008-10#2)
the fungal metabolite##2##3##(1990-12#1)(2008-7#1)
the fungal pathogen Leptosphaeria maculans##3##5##(2008-10#2)(2011-10#1)
the fungal pathogen##11##3##(2008-10#9)(2008-4#1)(2011-10#1)
the fungal pathogens##2##3##(2009-8#1)(2010-12#1)
the fungal penetration##2##3##(2008-10#1)(2010-10#1)
the fungal population was##2##4##(2008-10#1)(2008-12#1)
the fungal population##3##3##(2008-10#2)(2008-12#1)
the fungal##84##2##(1990-12#1)(1991-5#1)(1992-2#1)(1997-4#2)(1997-6#1)(2004-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#49)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#4)(2010-10#3)(2010-12#2)(2011-1#2)(2011-10#2)(2012-2#1)(2013-8#1)
the fungi are##2##3##(2008-10#1)(2008-8#1)
the fungi associated with##2##4##(2008-10#2)
the fungi associated##3##3##(1997-4#1)(2008-10#2)
the fungi were##2##3##(2008-10#2)
the fungi##34##2##(1991-4#1)(1997-4#1)(2006-12#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-10#14)(2008-5#2)(2008-6#2)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#2)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
the fungicide Ridomil Gold plus copper##2##6##(2006-5#2)
the fungicide metalaxyl##5##3##(2008-10#5)
the fungicide significantly##2##3##(2006-5#1)(2008-10#1)
the fungicide was applied##2##4##(2008-10#2)
the fungicide##33##2##(1991-5#2)(2006-5#3)(2008-10#26)(2008-11#2)
the fungicide-targeted##2##2##(2008-10#2)
the fungicides##17##2##(1991-5#1)(2008-10#14)(2008-5#1)(2008-6#1)
the fungus Aspergillus##2##3##(2008-10#1)(2008-9#1)
the fungus Botrytis cinerea##2##4##(1991-5#1)(2011-10#1)
the fungus Chalaropsis##3##3##(1990-3#1)(1990-9#1)(1991-7#1)
the fungus Podospora anserina##3##4##(1995-6#1)(1995-8#2)
the fungus Puccinia triticina##2##4##(2008-10#2)
the fungus Pyrenophora tritici-repentis##2##4##(2008-10#2)
the fungus Trichoderma##2##3##(1992-3#1)(2008-10#1)
the fungus but##3##3##(2006-9#1)(2008-10#1)(2008-11#1)
the fungus from##2##3##(2008-10#2)
the fungus grew##2##3##(2008-10#2)
the fungus had##2##3##(2008-10#2)
the fungus has been##2##4##(2008-10#1)(2008-5#1)
the fungus is##4##3##(2005-11#1)(2008-10#3)
the fungus rapidly colonized the##2##5##(2008-10#2)
the fungus that causes##2##4##(2008-10#2)
the fungus that##3##3##(2008-10#3)
the fungus to##5##3##(2008-10#4)(2008-5#1)
the fungus was##12##3##(2008-10#10)(2008-5#1)(2011-2#1)
the fungus##160##2##(1990-3#1)(1990-9#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-3#1)(1994-11#1)(1995-3#1)(1995-6#1)(1995-8#2)(1997-1#1)(1997-4#1)(2004-8#2)(2005-11#1)(2006-12#2)(2006-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#112)(2008-11#3)(2008-12#1)(2008-5#7)(2008-6#1)(2008-9#1)(2009-2#1)(2009-8#2)(2010-10#2)(2010-3#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-11#1)(2013-7#1)
the fungus-growing termites##2##3##(2013-7#2)
the fungus-growing##4##2##(2012-2#1)(2013-7#3)
the fur##3##2##(2009-6#2)(2010-3#1)
the furan##2##2##(1992-6#1)(2008-4#1)
the furanose##2##2##(1990-9#1)(1995-1#1)
the furnace##6##2##(2005-4#1)(2007-8#2)(2008-10#3)
the furrow##2##2##(2008-10#1)(2008-4#1)
the further analysis of these##2##5##(1992-6#1)(1996-2#1)
the further analysis of##3##4##(1992-6#1)(1994-11#1)(1996-2#1)
the further characterization of##2##4##(2008-10#1)(2008-4#1)
the further characterization##3##3##(1996-2#1)(2008-10#1)(2008-4#1)
the further development of the##2##5##(1997-4#1)(2011-2#1)
the further development of##15##4##(1991-3#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-2#1)(2008-12#1)(2009-12#1)(2009-2#1)(2010-11#1)(2010-12#2)(2011-2#1)(2013-8#1)
the further development##16##3##(1991-3#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-12#1)(2009-12#1)(2009-2#1)(2010-11#1)(2010-12#2)(2011-2#1)(2013-8#1)
the further discovery of##2##4##(2007-8#1)(2013-8#1)
the further removed matrix##2##4##(1994-12#2)
the further study of##3##4##(2007-12#1)(2008-8#1)(2013-1#1)
the further understanding of the##4##5##(1991-12#1)(2008-10#1)(2008-9#1)(2013-8#1)
the further##76##2##(1990-10#1)(1990-12#1)(1990-8#1)(1991-12#1)(1991-3#3)(1991-6#1)(1992-1#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-12#2)(1994-2#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-2#2)(1996-4#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-2#1)(2006-5#1)(2007-11#4)(2007-12#1)(2007-8#2)(2008-10#7)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-2#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#5)
the fused silica##2##3##(2008-2#2)
the fused##15##2##(1991-8#1)(1993-11#1)(1997-2#1)(1997-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)(2013-1#1)
the fused-silica##2##2##(2007-11#1)(2008-10#1)
the fusiform gyrus##2##3##(2007-12#1)(2008-11#1)
the fusiform##7##2##(2007-12#1)(2008-10#2)(2008-11#2)(2008-7#1)(2009-4#1)
the fusion between##2##3##(1994-12#1)(2011-3#1)
the fusion gene##2##3##(2008-9#1)(2013-1#1)
the fusion genes##3##3##(1996-2#1)(2008-8#2)
the fusion of the##4##4##(1991-11#1)(2008-5#2)(2009-12#1)
the fusion of two##2##4##(2008-6#1)(2008-9#1)
the fusion of##25##3##(1990-3#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-1#1)(1993-3#1)(1994-12#1)(1995-10#1)(1997-6#1)(2007-11#1)(2008-11#3)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-9#1)(2011-1#1)(2011-2#1)
the fusion partner##4##3##(1995-2#1)(2008-4#1)(2010-2#1)(2012-2#1)
the fusion pore##3##3##(2008-8#3)
the fusion process##3##3##(1990-11#1)(1991-3#1)(2008-11#1)
the fusion protein into##2##4##(1995-8#1)(1996-7#1)
the fusion protein was##4##4##(1993-9#1)(1994-8#1)(1996-5#1)(2008-6#1)
the fusion protein##35##3##(1991-3#1)(1991-7#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#3)(2005-11#1)(2005-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#1)(2012-2#1)
the fusion proteins##10##3##(1993-5#1)(1994-12#1)(1994-3#1)(1995-2#1)(1997-7#1)(2006-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)
the fusion reaction##2##3##(1996-9#1)(2008-4#1)
the fusion##112##2##(1990-11#1)(1990-3#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-8#1)(1993-3#3)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-3#3)(1994-8#1)(1995-1#1)(1995-10#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#4)(1997-7#1)(2005-11#3)(2005-9#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-2#1)(2008-4#3)(2008-5#7)(2008-6#3)(2008-7#2)(2008-8#10)(2008-9#4)(2009-12#1)(2009-3#1)(2009-9#1)(2010-2#2)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#4)(2013-1#3)
the fusion-pore detection error model##2##5##(1995-8#2)
the fusion-pore model##3##3##(1995-8#3)
the fusion-pore##5##2##(1995-8#5)
the fusionof pOCs into##2##4##(2008-11#2)
the fusions##2##2##(1991-12#1)(2006-9#1)
the fuss##2##2##(2006-10#1)(2013-1#1)
the futile cycle##2##3##(1994-8#1)(1997-4#1)
the future a##4##3##(2006-11#1)(2008-11#1)(2009-5#1)(2009-7#1)
the future and the##2##4##(2011-1#1)(2011-2#1)
the future and##8##3##(1991-1#1)(2006-4#1)(2008-1#1)(2008-12#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
the future as##6##3##(2006-12#1)(2007-4#1)(2008-4#1)(2009-6#1)(2010-11#1)(2012-6#1)
the future certainly##2##3##(1997-1#1)(2009-9#1)
the future course of##2##4##(2006-10#1)(2008-11#1)
the future design of##4##4##(2006-10#1)(2008-4#1)(2010-5#1)(2011-2#1)
the future development of##7##4##(2007-11#1)(2008-11#1)(2008-5#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)
the future development##9##3##(2007-11#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)
the future developments##2##3##(2010-11#1)(2010-9#1)
the future direction of the##2##5##(1995-1#1)(2013-1#1)
the future direction of##3##4##(1995-1#1)(2008-7#1)(2013-1#1)
the future direction##4##3##(1995-1#1)(2008-7#1)(2011-7#1)(2013-1#1)
the future directions of##2##4##(2005-7#1)(2013-1#1)
the future directions##6##3##(1994-2#1)(2005-7#1)(2010-4#1)(2012-2#2)(2013-1#1)
the future environment##2##3##(2012-2#2)
the future following##2##3##(2006-10#1)(2007-5#1)
the future for the##2##4##(2006-5#1)(2013-1#1)
the future for##14##3##(1990-2#1)(1992-1#1)(2006-5#1)(2006-9#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-9#1)(2010-12#1)(2011-2#1)(2013-1#3)
the future has##2##3##(2007-4#1)(2011-12#1)
the future health care##2##4##(1996-1#1)(2008-4#1)
the future health##3##3##(1996-1#1)(1996-3#1)(2008-4#1)
the future holds##3##3##(1996-3#1)(2007-1#1)(2008-10#1)
the future impact of##2##4##(2008-10#1)(2013-8#1)
the future in##7##3##(1995-4#1)(1997-2#1)(2005-10#1)(2006-10#1)(2007-11#1)(2008-12#1)(2008-3#1)
the future is to##3##4##(1993-11#1)(1995-12#1)(2008-10#1)
the future is##11##3##(1990-6#1)(1992-11#1)(1993-11#1)(1993-2#1)(1995-12#1)(1996-2#1)(2006-10#1)(2006-9#1)(2008-10#1)(2008-7#1)(2008-8#1)
the future it##2##3##(1997-1#1)(2012-2#1)
the future of CMBE##2##4##(2012-12#2)
the future of cancer##2##4##(2007-4#2)
the future of health care##6##5##(1991-3#1)(1994-1#1)(1996-2#1)(1996-3#1)(2005-11#1)(2008-1#1)
the future of health##8##4##(1991-12#1)(1991-3#1)(1994-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(2005-11#1)(2008-1#1)
the future of medical##2##4##(2006-6#1)(2011-1#1)
the future of medicine##2##4##(1992-3#1)(2008-8#1)
the future of medicines##2##4##(1993-7#1)(2008-1#1)
the future of nursing##2##4##(2008-1#1)(2008-11#1)
the future of our##2##4##(2008-1#1)(2013-1#1)
the future of peer review##2##5##(1991-1#2)
the future of public health##2##5##(1994-1#1)(1995-12#1)
the future of the##15##4##(1991-1#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-2#1)(2007-4#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2009-7#1)(2011-1#2)(2012-12#1)
the future of##89##3##(1991-1#4)(1991-12#1)(1991-3#1)(1992-10#1)(1992-3#2)(1993-1#1)(1993-2#1)(1993-7#1)(1994-1#2)(1994-3#1)(1994-7#1)(1995-11#1)(1995-12#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-1#2)(1997-2#2)(1997-6#1)(2005-10#1)(2005-11#1)(2005-2#1)(2005-7#1)(2006-10#2)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-4#6)(2007-8#1)(2007-9#2)(2008-1#6)(2008-11#5)(2008-12#1)(2008-2#1)(2008-4#2)(2008-8#2)(2009-12#1)(2009-5#1)(2009-7#1)(2010-3#2)(2011-1#5)(2011-2#2)(2012-12#3)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
the future possibility of##2##4##(1991-5#1)(2013-1#1)
the future potential of the technique##2##6##(2006-4#1)(2009-12#1)
the future potential of##3##4##(2006-4#1)(2009-12#1)(2012-1#1)
the future prospects for##3##4##(2006-10#1)(2008-1#1)(2011-2#1)
the future prospects##6##3##(1991-12#1)(2006-10#1)(2008-1#1)(2008-8#1)(2009-3#1)(2011-2#1)
the future research##5##3##(1993-6#1)(2009-4#1)(2009-5#1)(2012-11#1)(2013-8#1)
the future role of##7##4##(1993-2#1)(1995-4#1)(2006-5#1)(2007-1#1)(2008-1#1)(2008-5#1)(2008-6#1)
the future should##3##3##(2007-12#1)(2008-11#1)(2010-4#1)
the future study of##2##4##(2008-10#1)(2008-3#1)
the future study##3##3##(2008-10#1)(2008-3#1)(2013-8#1)
the future therapy##2##3##(2006-10#1)(2011-2#1)
the future use of these##2##5##(2006-10#1)(2012-2#1)
the future use of##4##4##(2006-10#1)(2012-12#2)(2012-2#1)
the future use##5##3##(2006-10#2)(2012-12#2)(2012-2#1)
the future was##2##3##(1992-2#1)(2013-1#1)
the future will##3##3##(1992-12#1)(1994-12#1)(1994-2#1)
the future with##2##3##(2007-6#2)
the future##659##2##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#3)(1991-1#10)(1991-12#7)(1991-2#3)(1991-3#4)(1991-5#2)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#7)(1992-4#1)(1992-5#1)(1992-6#4)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#4)(1993-12#1)(1993-2#10)(1993-3#5)(1993-6#1)(1993-7#1)(1994-1#3)(1994-12#4)(1994-2#6)(1994-3#3)(1994-4#1)(1994-6#4)(1994-7#1)(1995-1#5)(1995-11#2)(1995-12#5)(1995-2#4)(1995-3#3)(1995-4#2)(1995-7#1)(1996-1#6)(1996-10#1)(1996-11#1)(1996-12#6)(1996-2#8)(1996-3#7)(1996-4#2)(1996-5#1)(1997-1#10)(1997-2#4)(1997-3#4)(1997-5#1)(1997-6#1)(1997-7#1)(2004-11#1)(2004-12#1)(2004-3#2)(2004-7#1)(2005-10#5)(2005-11#2)(2005-12#1)(2005-2#1)(2005-7#8)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#30)(2006-11#1)(2006-12#7)(2006-2#3)(2006-4#2)(2006-5#5)(2006-6#10)(2006-7#3)(2006-8#1)(2006-9#3)(2007-1#5)(2007-10#4)(2007-11#14)(2007-12#10)(2007-2#2)(2007-3#2)(2007-4#18)(2007-5#3)(2007-6#2)(2007-7#3)(2007-8#6)(2007-9#2)(2008-1#20)(2008-10#21)(2008-11#20)(2008-12#7)(2008-2#2)(2008-3#6)(2008-4#14)(2008-5#12)(2008-6#4)(2008-7#10)(2008-8#7)(2008-9#3)(2009-1#1)(2009-10#4)(2009-12#4)(2009-2#1)(2009-3#2)(2009-4#7)(2009-5#4)(2009-6#2)(2009-7#4)(2009-8#1)(2009-9#2)(2010-1#3)(2010-11#6)(2010-12#7)(2010-3#6)(2010-4#4)(2010-5#4)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#8)(2011-12#4)(2011-2#21)(2011-7#1)(2012-1#3)(2012-11#3)(2012-12#14)(2012-2#18)(2012-3#8)(2012-5#1)(2012-6#1)(2013-1#27)(2013-7#4)(2013-8#7)
the future?##10##2##(1992-2#1)(1993-12#1)(1997-2#1)(2005-10#1)(2007-1#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-7#1)
the future]##4##2##(1994-6#1)(1994-8#1)(2007-9#1)(2009-2#1)
the fuzzy controller##2##3##(2008-2#2)
the fuzzy rule##2##3##(2008-2#1)(2009-3#1)
the fuzzy##12##2##(2008-10#2)(2008-2#4)(2008-6#3)(2008-8#2)(2009-3#1)
the g factor and the##2##5##(2008-2#2)
the g factor##3##3##(2008-2#3)
the g##12##2##(1990-3#2)(1991-2#1)(1994-3#1)(1997-1#2)(1997-7#1)(2008-2#4)(2012-1#1)
the gC1q receptor##2##3##(1996-5#2)
the gDcPAL1 gene##2##3##(1997-4#2)
the gabapentin##2##2##(2011-3#2)
the gadd genes##2##3##(1992-12#2)
the gadd##3##2##(1992-12#3)
the gadd153promoter##2##2##(2008-11#2)
the gadolinium##2##2##(1990-10#1)(2008-10#1)
the gag region##2##3##(1990-2#1)(1994-12#1)
the gag rule##2##3##(1991-10#2)
the gag##8##2##(1990-2#1)(1991-10#2)(1991-9#1)(1994-12#1)(1994-8#1)(1997-4#1)(2006-2#1)
the gag-related##2##2##(1995-8#2)
the gain and the##2##4##(2008-2#1)(2008-3#1)
the gain and##8##3##(1990-10#1)(2007-12#2)(2008-2#2)(2008-3#3)
the gain bandwidth of##2##4##(2007-11#1)(2007-12#1)
the gain coefficient##2##3##(2007-12#1)(2008-3#1)
the gain curve##2##3##(2007-12#1)(2008-2#1)
the gain fiber##3##3##(2007-11#1)(2007-12#2)
the gain for##2##3##(1992-10#1)(2012-3#1)
the gain in##3##3##(2008-2#1)(2008-9#1)(2012-2#1)
the gain margin##4##3##(2008-3#4)
the gain material##2##3##(2007-12#1)(2008-2#1)
the gain medium##10##3##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#4)
the gain of##3##3##(2007-12#1)(2008-12#1)(2013-8#1)
the gain saturation##3##3##(2008-1#1)(2008-3#2)
the gain##74##2##(1990-10#1)(1992-10#1)(1995-11#1)(1996-3#1)(2007-11#9)(2007-12#17)(2008-1#5)(2008-12#1)(2008-2#14)(2008-3#17)(2008-4#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
the gains##4##2##(1995-6#1)(1996-5#1)(2008-10#1)(2008-2#1)
the gait parameters##2##3##(2012-1#2)
the gait patterns##2##3##(2012-1#2)
the gait##16##2##(1996-9#1)(2007-10#1)(2012-1#9)(2012-12#2)(2013-1#3)
the galactoglucomannan##2##2##(1991-7#2)
the galactose##9##2##(1991-6#1)(1991-9#2)(1993-11#1)(1993-7#1)(1994-6#1)(1995-3#1)(2006-10#1)(2007-8#1)
the galactose-inducible GAL1 promoter and##2##5##(1995-2#1)(1995-8#1)
the galactose-inducible##3##2##(1995-2#1)(1995-6#1)(1995-8#1)
the galactose-proton symport system##2##4##(2008-7#2)
the galanin receptor antagonist##4##4##(1993-3#3)(1994-8#1)
the galanin##5##2##(1993-3#3)(1994-8#2)
the galanin-induced##4##2##(1990-7#3)(1991-2#1)
the galaxy##3##2##(1996-5#1)(2006-7#1)(2007-9#1)
the gall bladder is##2##4##(1992-6#1)(2010-9#1)
the gall bladder##5##3##(1992-6#1)(2006-9#1)(2007-8#1)(2008-8#1)(2010-9#1)
the gall##6##2##(1992-6#1)(2006-9#1)(2007-12#1)(2007-8#1)(2008-8#1)(2010-9#1)
the gallbladder and the##4##4##(2007-4#3)(2010-12#1)
the gallbladder and##7##3##(2006-10#1)(2007-4#3)(2008-3#1)(2008-8#1)(2010-12#1)
the gallbladder is##4##3##(1991-6#1)(1993-10#1)(2011-2#1)(2013-8#1)
the gallbladder to##2##3##(1993-9#1)(1996-4#1)
the gallbladder wall##8##3##(1991-8#1)(1997-8#3)(2008-3#1)(2010-5#2)(2013-8#1)
the gallbladder was##4##3##(1992-2#1)(1996-4#1)(2008-3#1)(2010-9#1)
the gallbladder##71##2##(1990-6#3)(1990-9#1)(1991-12#4)(1991-4#1)(1991-6#2)(1991-8#2)(1992-2#1)(1992-4#1)(1992-6#3)(1992-9#1)(1993-10#1)(1993-5#1)(1993-9#1)(1996-4#2)(1996-6#1)(1997-7#1)(1997-8#3)(2005-12#2)(2006-10#3)(2006-2#2)(2007-2#2)(2007-4#3)(2007-5#1)(2008-1#1)(2008-3#6)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#4)(2010-12#4)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
the galled##2##2##(2006-10#1)(2008-10#1)
the gallium##2##2##(2008-10#1)(2008-5#1)
the gallstone##2##2##(2008-12#2)
the game##5##2##(2006-7#1)(2008-2#2)(2008-9#1)(2010-4#1)
the games##5##2##(1993-3#1)(2008-1#2)(2012-2#1)(2013-7#1)
the gametes##2##2##(1990-10#1)(2007-11#1)
the gametocyte##2##2##(2008-11#1)(2008-4#1)
the gamma 1##2##3##(1990-9#1)(1994-2#1)
the gamma 2 chain##2##4##(1995-5#2)
the gamma 2 subunit##5##4##(1990-7#1)(1992-11#1)(1994-12#2)(1995-12#1)
the gamma 2##7##3##(1990-7#1)(1992-11#1)(1994-12#2)(1995-12#1)(1995-5#2)
the gamma 2-subunit##3##3##(1990-10#3)
the gamma 3 and/or alpha 5 subunits##2##7##(1994-3#2)
the gamma 3##7##3##(1994-3#6)(1995-11#1)
the gamma band##2##3##(2008-11#1)(2012-2#1)
the gamma c##2##3##(1995-8#2)
the gamma camera##4##3##(1996-2#2)(2008-1#1)(2009-6#1)
the gamma chain gene##3##4##(1995-3#3)
the gamma chain is##2##4##(1995-3#2)
the gamma chain of##2##4##(1990-12#1)(1997-8#1)
the gamma chain##9##3##(1990-12#1)(1994-3#1)(1995-3#5)(1995-5#1)(1997-8#1)
the gamma delta##3##3##(1991-12#2)(1996-11#1)
the gamma distribution##3##3##(2007-9#1)(2008-10#1)(2008-2#1)
the gamma division and##2##4##(2007-12#2)
the gamma division##3##3##(2007-12#3)
the gamma knife##2##3##(2007-5#1)(2008-7#1)
the gamma subunit and##2##4##(1994-11#1)(2005-10#1)
the gamma subunit of##3##4##(1994-11#1)(1994-9#1)(2005-10#1)
the gamma subunit##14##3##(1990-12#1)(1992-11#4)(1994-11#4)(1994-8#1)(1994-9#1)(2005-10#2)(2008-8#1)
the gamma##82##2##(1990-10#3)(1990-11#1)(1990-12#3)(1990-7#1)(1990-8#1)(1990-9#2)(1991-12#2)(1992-11#5)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#2)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#2)(1994-3#7)(1994-5#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#5)(1995-5#3)(1995-8#2)(1996-11#1)(1996-2#2)(1997-8#1)(2005-10#2)(2007-11#1)(2007-12#4)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-7#1)(2008-8#1)(2009-6#1)(2012-2#1)
the gamma(0##3##2##(2008-2#3)
the gamma-##3##2##(1992-6#1)(1997-7#1)(2007-11#1)
the gamma-aminobutyric acid##3##3##(1995-11#1)(1995-6#1)(1996-5#1)
the gamma-amylase in honey##2##4##(2012-12#2)
the gamma-carboxyglutamic acid##2##3##(1992-12#1)(1995-2#1)
the gamma-chain##2##2##(1990-11#1)(1992-12#1)
the gamma-interferon##2##2##(1994-11#1)(2010-4#1)
the gamma-phosphate of##2##3##(1990-12#1)(1994-9#1)
the gamma-phosphate##3##2##(1990-12#1)(1992-11#1)(1994-9#1)
the gamut##3##2##(2008-3#1)(2008-4#1)(2008-8#1)
the ganglia of the##2##4##(1990-2#1)(2009-8#1)
the ganglia of##4##3##(1990-2#1)(1991-5#1)(1991-7#1)(2009-8#1)
the ganglia##10##2##(1990-2#1)(1990-8#2)(1991-5#2)(1991-7#1)(1995-5#1)(1996-5#1)(2008-7#1)(2009-8#1)
the ganglion cell##2##3##(1991-10#1)(1995-7#1)
the ganglion cells##2##3##(1991-3#1)(1995-5#1)
the ganglion midline##2##3##(2007-12#2)
the ganglion##16##2##(1990-7#1)(1991-10#1)(1991-3#1)(1991-9#1)(1995-11#3)(1995-5#2)(1995-7#1)(2006-10#1)(2006-7#1)(2007-12#2)(2008-5#1)(2011-2#1)
the ganglionic##6##2##(1995-6#1)(1996-12#1)(1996-4#1)(1997-6#1)(2006-7#1)(2008-11#1)
the ganglioside GM1##4##3##(1994-11#1)(1994-8#1)(1995-5#1)(1996-4#1)
the ganglioside GM3##2##3##(1991-5#1)(1994-3#1)
the ganglioside##18##2##(1990-8#1)(1991-5#3)(1991-6#1)(1991-9#1)(1992-1#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-3#3)(1994-8#1)(1995-1#1)(1995-5#1)(1996-4#1)(1997-7#1)
the gangliosides##5##2##(1990-11#3)(1990-7#1)(1993-11#1)
the gap and##2##3##(2008-11#1)(2008-3#1)
the gap between basic##2##4##(2006-6#1)(2008-5#1)
the gap between the##11##4##(1997-6#1)(2005-6#1)(2007-4#1)(2008-10#1)(2008-2#1)(2009-8#1)(2011-1#2)(2012-1#2)(2013-1#1)
the gap between these##2##4##(2006-11#1)(2008-3#1)
the gap between##46##3##(1990-2#1)(1990-6#1)(1991-1#1)(1993-12#1)(1994-12#1)(1995-11#1)(1996-3#1)(1997-3#1)(1997-6#1)(2005-10#2)(2005-6#1)(2006-11#1)(2006-4#1)(2006-6#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#2)(2012-1#3)(2013-1#3)
the gap distance##2##3##(2008-1#1)(2008-3#1)
the gap in##6##3##(2007-7#1)(2008-3#1)(2008-5#1)(2010-9#1)(2011-2#1)(2012-1#1)
the gap junction##3##3##(1993-12#2)(2013-8#1)
the gaps in our knowledge##2##5##(2010-12#1)(2011-12#1)
the gaps in the##4##4##(1992-2#1)(1997-6#1)(2006-10#1)(2010-2#1)
the gaps in##8##3##(1992-2#1)(1995-12#1)(1997-6#1)(2006-10#1)(2010-12#1)(2010-2#1)(2011-12#1)(2012-12#1)
the gaps##15##2##(1992-2#1)(1995-12#1)(1997-1#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-5#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-2#1)(2011-12#1)(2012-12#2)(2013-8#1)
the garbage dump##2##3##(2011-2#2)
the garden lizard##2##3##(2008-7#2)
the garden##4##2##(1991-3#1)(2007-1#1)(2008-7#2)
the garment##3##2##(2008-1#2)(2008-6#1)
the gas chromatograph##2##3##(1990-11#1)(2007-8#1)
the gas chromatographic##8##3##(1997-8#1)(2007-7#1)(2007-8#1)(2008-10#5)
the gas chromatography-mass##2##3##(2007-8#1)(2008-10#1)
the gas concentration##4##3##(2005-4#4)
the gas density##3##3##(1992-12#1)(2007-12#2)
the gas flow rate##4##4##(2009-11#1)(2013-8#3)
the gas flow##6##3##(2009-11#2)(2012-1#1)(2013-8#3)
the gas phase and##4##4##(2006-1#1)(2007-9#1)(2008-10#1)(2008-7#1)
the gas phase is##2##4##(2006-10#1)(2008-7#1)
the gas phase##35##3##(1990-8#1)(1991-10#1)(1991-3#1)(1992-9#1)(1996-5#1)(1996-7#1)(2005-11#1)(2006-1#2)(2006-10#1)(2006-2#5)(2006-4#1)(2006-8#1)(2007-12#1)(2007-8#1)(2007-9#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#3)(2009-9#1)(2010-7#1)
the gas pressure##3##3##(1995-11#1)(2008-10#1)(2008-3#1)
the gas temperature##3##3##(2008-3#3)
the gas##101##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-10#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-9#1)(1995-11#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-8#1)(2004-4#1)(2005-11#1)(2005-4#4)(2006-1#2)(2006-10#1)(2006-2#5)(2006-4#1)(2006-8#1)(2007-12#6)(2007-7#1)(2007-8#4)(2007-9#3)(2008-10#21)(2008-11#2)(2008-2#2)(2008-3#11)(2008-6#2)(2008-7#3)(2009-11#2)(2009-8#1)(2009-9#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#3)
the gaseous phase##3##3##(2006-10#2)(2008-10#1)
the gaseous species##2##3##(2008-10#2)
the gaseous##13##2##(1997-1#1)(2005-11#1)(2006-10#2)(2007-12#1)(2008-10#7)(2011-1#1)
the gases##3##2##(1996-12#1)(2008-10#1)(2008-3#1)
the gastric acid##2##3##(1991-2#1)(2008-5#1)
the gastric body##2##3##(1997-1#1)(2009-3#1)
the gastric cancer##2##3##(1990-9#1)(1994-3#1)
the gastric contents##3##3##(1992-12#1)(2012-2#1)(2013-8#1)
the gastric emptying rate of##2##5##(1997-4#2)
the gastric emptying##3##3##(1997-4#3)
the gastric fornix##2##3##(2007-9#2)
the gastric fundus##2##3##(1990-9#1)(1992-4#1)
the gastric inhibitory##2##3##(1997-4#1)(2008-11#1)
the gastric irritancy index and##2##5##(2013-8#2)
the gastric juice##2##3##(1996-6#1)(2008-10#1)
the gastric lesions##2##3##(1997-7#1)(2013-8#1)
the gastric mill##2##3##(1995-11#2)
the gastric mucosa against##2##4##(1993-12#2)
the gastric mucosa in##3##4##(1994-2#1)(2005-1#1)(2008-1#1)
the gastric mucosa##18##3##(1990-3#1)(1991-9#2)(1993-12#3)(1994-2#2)(1996-3#1)(1997-1#1)(1997-7#1)(2005-1#1)(2006-10#1)(2008-1#1)(2008-4#1)(2010-12#1)(2012-12#1)(2013-8#1)
the gastric serosa##3##3##(2012-2#3)
the gastric transplant##4##3##(2010-12#2)(2012-1#2)
the gastric tube##2##3##(2010-12#1)(2012-1#1)
the gastric wall##4##3##(1990-10#1)(2006-6#1)(2009-8#1)(2010-12#1)
the gastric##96##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-9#3)(1991-2#1)(1991-6#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-12#3)(1993-8#1)(1994-2#2)(1994-3#1)(1995-11#3)(1996-10#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#4)(1997-4#5)(1997-6#2)(1997-7#2)(2005-1#1)(2005-11#1)(2006-10#3)(2006-2#1)(2006-6#2)(2007-11#2)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#2)(2010-12#6)(2011-2#4)(2012-1#3)(2012-12#3)(2012-2#5)(2013-8#8)
the gastrin mRNA##3##3##(1992-8#1)(2008-5#2)
the gastrin##6##2##(1992-3#1)(1992-8#2)(1995-11#1)(2008-5#2)
the gastrin/CCK-B receptor##2##3##(1994-6#1)(1997-1#1)
the gastritis##2##2##(2006-2#1)(2008-5#1)
the gastro-intestinal tract##7##3##(1991-10#1)(1991-4#1)(2006-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-8#1)
the gastro-intestinal##9##2##(1991-10#2)(1991-4#1)(2006-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-2#1)
the gastrocnemius and##2##3##(1993-2#1)(1995-2#1)
the gastrocnemius muscle##5##3##(1991-10#1)(1991-3#2)(1992-8#1)(2012-2#1)
the gastrocnemius##11##2##(1991-10#1)(1991-3#2)(1992-8#1)(1993-2#1)(1995-2#1)(2012-2#1)(2013-1#4)
the gastroduodenal artery##2##3##(1990-10#1)(2008-7#1)
the gastroduodenal mucosa##3##3##(2006-10#3)
the gastroduodenal##7##2##(1990-10#1)(2006-10#4)(2008-4#1)(2008-7#1)
the gastroenteric tract##2##3##(2006-2#2)
the gastroenterologic##2##2##(1990-2#1)(2007-5#1)
the gastroenterologist##3##2##(2008-9#1)(2011-2#2)
the gastroepiploic artery##2##3##(1990-4#1)(2005-12#1)
the gastroesophageal junction##5##3##(1990-4#1)(2006-10#2)(2007-8#1)(2009-3#1)
the gastroesophageal##6##2##(1990-4#1)(2006-10#2)(2007-8#1)(2008-11#1)(2009-3#1)
the gastrointestinal (GI) tract##4##4##(2007-5#1)(2012-1#2)(2012-12#1)
the gastrointestinal (GI)##7##3##(2006-2#1)(2006-8#1)(2007-12#1)(2007-5#1)(2012-1#2)(2012-12#1)
the gastrointestinal and##3##3##(1992-6#1)(1993-7#1)(2008-5#1)
the gastrointestinal mucosa##4##3##(1992-9#1)(1996-3#1)(2008-4#1)(2012-1#1)
the gastrointestinal symptoms##2##3##(2008-1#1)(2009-10#1)
the gastrointestinal system##6##3##(1992-12#1)(1997-7#1)(2004-2#2)(2008-11#1)(2012-2#1)
the gastrointestinal tract (GIT)##3##4##(2008-12#1)(2012-2#1)(2013-1#1)
the gastrointestinal tract and the##3##5##(1994-5#1)(1996-8#1)(2008-7#1)
the gastrointestinal tract and##11##4##(1990-3#1)(1994-5#1)(1995-4#1)(1996-1#1)(1996-8#1)(2005-10#1)(2006-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-1#1)
the gastrointestinal tract are##5##4##(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
the gastrointestinal tract is##9##4##(1990-11#1)(1996-11#1)(2006-2#1)(2006-6#1)(2008-7#1)(2009-1#1)(2009-2#1)(2011-2#1)(2013-1#1)
the gastrointestinal tract of the##2##5##(1996-11#1)(2011-2#1)
the gastrointestinal tract of##8##4##(1993-10#1)(1996-11#1)(2008-7#1)(2011-2#2)(2013-1#3)
the gastrointestinal tract were##2##4##(1991-6#1)(2007-2#1)
the gastrointestinal tract##129##3##(1990-10#1)(1990-11#2)(1990-3#1)(1990-8#1)(1991-10#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-10#3)(1994-12#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-4#1)(1995-6#2)(1996-1#1)(1996-11#2)(1996-8#1)(1997-1#1)(1997-4#1)(2004-12#1)(2005-10#1)(2006-10#8)(2006-2#3)(2006-4#2)(2006-6#1)(2007-11#3)(2007-2#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#8)(2008-8#4)(2008-9#2)(2009-1#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-8#1)(2010-12#5)(2011-1#3)(2011-2#8)(2012-1#3)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#11)(2013-7#2)(2013-8#3)
the gastrointestinal tract]##2##3##(1995-11#1)(1995-6#1)
the gastrointestinal tracts##3##3##(1994-6#1)(2006-8#1)(2008-11#1)
the gastrointestinal##183##2##(1990-10#1)(1990-11#2)(1990-3#1)(1990-8#1)(1991-10#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#3)(1993-7#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#3)(1995-4#1)(1995-6#3)(1996-1#1)(1996-11#2)(1996-3#1)(1996-8#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-2#2)(2005-10#1)(2006-10#14)(2006-2#4)(2006-4#2)(2006-6#1)(2006-8#2)(2007-11#4)(2007-12#2)(2007-2#2)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#6)(2008-6#4)(2008-7#9)(2008-8#5)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#6)(2011-1#3)(2011-2#9)(2012-1#8)(2012-12#2)(2012-2#7)(2012-3#5)(2013-1#11)(2013-7#2)(2013-8#3)
the gastroprotective action of capsaicin##2##5##(1993-11#2)
the gastroprotective and antidiarrhoeal##2##4##(2005-11#2)
the gastroprotective##5##2##(1993-11#2)(2005-11#2)(2009-5#1)
the gastrula stage##3##3##(1992-11#1)(1992-12#1)(2010-5#1)
the gate helix##2##3##(2012-2#2)
the gate##16##2##(1991-3#1)(1991-5#2)(1992-11#1)(1995-1#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-11#1)(2009-5#1)(2012-2#2)
the gated##2##2##(2009-3#1)(2010-4#1)
the gatekeeper##2##2##(1996-4#1)(2008-8#1)
the gathered##2##2##(2008-10#1)(2011-2#1)
the gathering of##2##3##(2008-10#1)(2013-1#1)
the gathering##4##2##(1997-3#1)(2008-1#1)(2008-10#1)(2013-1#1)
the gating behaviour of##2##4##(1990-11#1)(2008-7#1)
the gating kinetics##2##3##(2008-8#2)
the gating mechanism of##2##4##(1991-3#1)(2006-2#1)
the gating mechanism##3##3##(1991-3#1)(2006-2#1)(2008-8#1)
the gating of##3##3##(1992-7#1)(1994-3#1)(2010-2#1)
the gating was##2##3##(1990-11#1)(2008-2#1)
the gating##19##2##(1990-11#2)(1991-3#1)(1992-6#1)(1992-7#2)(1994-3#1)(2006-2#1)(2008-2#2)(2008-7#1)(2008-8#6)(2008-9#1)(2010-2#1)
the gauche conformation##2##3##(2008-8#2)
the gauge##2##2##(1992-8#1)(2008-2#1)
the gay community##4##3##(1996-11#1)(2007-12#3)
the gaze of##2##3##(2008-11#1)(2011-12#1)
the gaze##8##2##(1992-9#1)(2007-4#1)(2008-11#5)(2011-12#1)
the gazelle##2##2##(2007-2#2)
the gear##2##2##(2008-3#2)
the gel and##9##3##(1997-8#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-2#2)(2008-4#3)
the gel at##2##3##(2005-11#1)(2008-4#1)
the gel beads##3##3##(2008-10#2)(2008-7#1)
the gel can##2##3##(2007-4#1)(2008-4#1)
the gel complex formation assay##2##5##(1992-12#2)
the gel entrapment carrier##2##4##(2008-7#2)
the gel entrapment##3##3##(2008-7#3)
the gel filtration column##2##4##(1992-1#1)(1992-12#1)
the gel filtration##4##3##(1990-7#1)(1992-1#1)(1992-12#1)(1992-6#1)
the gel in##2##3##(1990-4#1)(2007-1#1)
the gel is##2##3##(2008-4#2)
the gel phase##10##3##(1990-2#1)(1993-8#1)(1994-8#1)(2005-11#1)(2006-10#2)(2008-10#1)(2010-5#3)
the gel rather than##2##4##(2005-11#1)(2012-12#1)
the gel showed##2##3##(2008-11#1)(2010-5#1)
the gel test##5##3##(2011-1#5)
the gel to liquid-crystalline phase transition of##2##7##(1990-2#1)(1997-5#1)
the gel to liquid-crystalline phase transition##4##6##(1990-2#1)(1990-3#2)(1997-5#1)
the gel was##2##3##(2007-8#1)(2008-10#1)
the gel##119##2##(1990-11#1)(1990-2#2)(1990-3#3)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-5#2)(1992-1#1)(1992-12#3)(1992-6#1)(1993-8#4)(1994-12#1)(1994-8#3)(1995-3#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-5#1)(1997-8#1)(2005-11#9)(2006-10#4)(2007-1#1)(2007-4#1)(2007-8#4)(2008-1#3)(2008-10#16)(2008-11#3)(2008-2#3)(2008-3#1)(2008-4#13)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2010-4#2)(2010-5#5)(2011-1#6)(2011-2#2)(2012-12#2)
the gel's##2##2##(1996-9#1)(2005-4#1)
the gel-filtration##2##2##(1990-7#1)(2008-11#1)
the gel-liquid crystalline##2##3##(1990-5#1)(2008-10#1)
the gel-sol##3##2##(2005-11#3)
the gelatin capsule technique##5##4##(2011-2#5)
the gelatin method##3##3##(2008-11#3)
the gelatin##11##2##(1995-5#1)(2008-11#3)(2008-2#2)(2011-2#5)
the gelatinases##2##2##(1993-6#1)(1994-11#1)
the gelation of##2##3##(2005-11#1)(2008-10#1)
the gelation time##2##3##(2005-11#1)(2006-10#1)
the gelation##6##2##(2005-11#3)(2006-10#1)(2008-10#2)
the gels are##2##3##(2008-2#1)(2008-7#1)
the gels for##2##3##(2008-4#1)(2010-4#1)
the gels##17##2##(1990-3#1)(1990-4#1)(1994-11#1)(1995-12#1)(2007-8#3)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-4#3)(2010-3#1)(2010-4#2)
the geminate recombination##2##3##(1990-8#1)(1995-2#1)
the geminis with a two-methylene spacer##2##6##(2005-11#2)
the gender and##4##3##(2006-11#1)(2009-4#1)(2010-2#1)(2013-8#1)
the gender bias in the##2##5##(2006-2#2)
the gender bias##3##3##(2006-2#2)(2008-8#1)
the gender composition##2##3##(1997-2#1)(2011-2#1)
the gender differences##2##3##(1995-12#1)(2007-4#1)
the gender gap##2##3##(1995-5#1)(2010-7#1)
the gender of the##4##4##(1992-3#1)(2009-3#1)(2009-4#1)(2012-3#1)
the gender of##5##3##(1992-3#1)(2009-3#1)(2009-4#1)(2012-3#2)
the gender system##2##3##(2009-4#2)
the gender##28##2##(1991-6#1)(1992-3#1)(1994-2#1)(1995-12#1)(1995-5#1)(1996-12#1)(1997-2#1)(2006-11#1)(2006-2#2)(2007-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#5)(2010-2#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-8#1)
the gender-related##2##2##(2009-11#1)(2011-2#1)
the gendered##5##2##(2006-8#1)(2007-7#2)(2008-11#1)(2008-5#1)
the genders##2##2##(2008-1#1)(2013-1#1)
the gene 32 protein##2##4##(1990-10#1)(1994-9#1)
the gene P12X3C##3##3##(2005-6#3)
the gene and its##2##4##(1994-11#1)(2008-7#1)
the gene and##11##3##(1990-5#1)(1991-2#1)(1993-2#1)(1994-11#1)(1995-8#1)(1996-2#1)(1996-8#1)(1996-9#1)(2008-7#2)(2010-12#1)
the gene are##4##3##(1991-7#1)(1993-2#1)(1995-1#1)(1997-2#1)
the gene as##4##3##(1990-12#1)(1994-9#1)(1997-2#1)(2010-4#1)
the gene being##2##3##(1996-10#1)(2008-10#1)
the gene carriers##2##3##(2006-12#1)(2012-12#1)
the gene causing##2##3##(1991-12#1)(1993-10#1)
the gene cluster##5##3##(1990-7#1)(1993-9#1)(1995-2#1)(1996-4#1)(2008-10#1)
the gene coding for the second-largest subunit of RNA polymerase II##2##11##(1997-2#2)
the gene coding for the##8##5##(1990-2#1)(1992-3#1)(1993-8#1)(1997-2#2)(1997-3#2)(2008-6#1)
the gene coding for##19##4##(1990-2#1)(1990-5#1)(1990-9#1)(1992-2#1)(1992-3#2)(1993-11#1)(1993-8#1)(1994-2#1)(1994-6#1)(1995-11#1)(1996-8#1)(1997-2#3)(1997-3#2)(2008-6#1)(2010-8#1)
the gene coding##21##3##(1990-2#1)(1990-5#1)(1990-9#1)(1992-2#1)(1992-3#2)(1993-11#1)(1993-8#1)(1994-2#1)(1994-6#1)(1995-11#1)(1996-7#1)(1996-8#1)(1997-2#3)(1997-3#2)(2007-10#1)(2008-6#1)(2010-8#1)
the gene delivery##2##3##(2008-11#1)(2010-4#1)
the gene encoding SF-1##2##4##(1995-11#2)
the gene encoding a##8##4##(1990-1#1)(1993-11#1)(1994-12#1)(1994-8#1)(1995-6#1)(1996-4#1)(1996-7#1)(1997-3#1)
the gene encoding for the##3##5##(1992-9#1)(1994-12#1)(1997-6#1)
the gene encoding human##9##4##(1991-6#3)(1992-2#1)(1993-5#1)(1993-7#1)(1994-12#1)(1995-3#1)(1997-7#1)
the gene encoding subunit##4##4##(1995-6#2)(1996-5#1)(2005-8#1)
the gene encoding the antigen of##2##6##(2007-11#2)
the gene encoding the antigen##3##5##(1995-2#1)(2007-11#2)
the gene encoding the##51##4##(1990-10#1)(1990-8#1)(1991-12#1)(1991-8#1)(1991-9#2)(1993-2#1)(1993-3#2)(1993-8#3)(1993-9#1)(1994-12#5)(1994-3#1)(1995-2#3)(1995-4#1)(1995-6#1)(1996-12#2)(1996-3#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-7#2)(2006-12#1)(2007-11#3)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-9#1)(2012-3#1)(2013-1#1)
the gene encoding this##3##4##(1994-10#1)(1995-6#1)(2008-10#1)
the gene encoding yeast protein kinase C##2##7##(1997-3#2)
the gene encoding yeast##3##4##(1991-6#1)(1997-3#2)
the gene encoding##138##3##(1990-1#2)(1990-10#5)(1990-5#1)(1990-8#1)(1991-12#3)(1991-6#4)(1991-8#2)(1991-9#2)(1992-12#3)(1992-2#1)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#2)(1993-2#5)(1993-3#3)(1993-4#1)(1993-5#2)(1993-7#1)(1993-8#4)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#10)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#5)(1995-8#4)(1996-12#2)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-7#3)(1996-8#2)(1997-2#3)(1997-3#7)(1997-4#2)(1997-6#1)(1997-7#3)(2005-8#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-11#3)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#1)(2009-9#1)(2010-10#1)(2012-1#2)(2012-3#1)(2013-1#2)(2013-8#1)
the gene expression and##3##4##(1997-8#1)(2010-5#1)(2010-7#1)
the gene expression in##3##4##(1993-8#1)(1993-9#1)(2008-11#1)
the gene expression level of##2##5##(2008-7#1)(2013-1#1)
the gene expression level##3##4##(2008-10#1)(2008-7#1)(2013-1#1)
the gene expression of the##2##5##(1993-12#1)(2013-1#1)
the gene expression of##16##4##(1991-5#1)(1992-6#1)(1993-12#1)(1993-3#3)(1994-12#1)(1995-2#1)(1997-2#1)(2008-10#1)(2010-3#1)(2011-1#1)(2013-1#3)(2013-7#1)
the gene expression profile##3##4##(1997-6#1)(2006-11#1)(2010-11#1)
the gene expression profiles##5##4##(2008-10#3)(2012-1#1)(2013-7#1)
the gene expression##44##3##(1991-5#2)(1992-5#1)(1992-6#1)(1993-12#1)(1993-3#3)(1993-8#2)(1993-9#1)(1994-12#1)(1995-2#1)(1997-2#1)(1997-6#1)(1997-8#2)(2006-10#1)(2006-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#4)(2013-7#2)
the gene expressions of##2##4##(1990-7#1)(1997-2#1)
the gene family##4##3##(2008-10#2)(2008-8#1)(2010-6#1)
the gene for an##2##4##(1997-4#1)(1997-7#1)
the gene for human##3##4##(1994-11#1)(1994-8#1)(2006-12#1)
the gene for iso-rANP##2##4##(1990-8#2)
the gene for the##6##4##(1990-4#1)(1991-1#1)(1992-11#1)(1994-8#1)(1994-9#1)(2008-7#1)
the gene for##41##3##(1990-11#1)(1990-4#1)(1990-5#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-8#1)(1993-7#2)(1994-11#2)(1994-2#1)(1994-8#3)(1994-9#1)(1995-11#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-4#3)(1997-7#2)(2005-10#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-3#1)(2010-4#1)
the gene fusion##2##3##(1990-7#1)(1991-10#1)
the gene in##12##3##(1991-1#1)(1991-9#1)(1993-2#1)(1993-3#1)(1993-9#1)(1995-3#2)(1995-4#1)(1997-1#1)(2008-10#3)
the gene into##2##3##(1991-7#1)(2008-5#1)
the gene is a##2##4##(1991-12#1)(1993-2#1)
the gene is expressed at the##2##6##(1991-5#1)(1995-1#1)
the gene is expressed at##3##5##(1991-5#1)(1993-2#1)(1995-1#1)
the gene is##28##3##(1990-5#1)(1990-8#1)(1991-12#2)(1991-5#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-2#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)
the gene itself##2##3##(1993-2#1)(2008-4#1)
the gene level##10##3##(1990-2#1)(1991-12#1)(1995-7#1)(2008-10#1)(2008-11#1)(2012-3#5)
the gene locus##2##3##(1994-2#1)(2008-4#1)
the gene mutation##2##3##(2006-10#1)(2007-12#1)
the gene networks##3##3##(2007-12#3)
the gene of P##2##4##(2006-8#2)
the gene of interest and##2##5##(2008-11#1)(2008-2#1)
the gene of interest is##2##5##(2008-2#1)(2008-4#1)
the gene of interest##14##4##(1991-12#1)(2006-12#2)(2007-11#1)(2008-11#2)(2008-2#4)(2008-4#1)(2008-9#3)
the gene of the##2##4##(1995-11#1)(2006-10#1)
the gene of##28##3##(1990-10#1)(1990-12#1)(1991-12#1)(1995-11#1)(1996-7#1)(2006-10#1)(2006-12#2)(2006-8#3)(2007-11#1)(2008-10#1)(2008-11#3)(2008-2#4)(2008-4#1)(2008-7#1)(2008-9#4)(2011-1#1)(2012-1#1)
the gene on##3##3##(2008-10#2)(2011-1#1)
the gene ontology##3##3##(2008-7#2)(2011-2#1)
the gene or genes##2##4##(1995-6#1)(2008-10#1)
the gene or##5##3##(1990-11#1)(1995-6#1)(1996-2#1)(2008-10#1)(2008-4#1)
the gene order##4##3##(1990-5#1)(1996-2#1)(1997-2#1)(2013-8#1)
the gene organization##2##3##(1995-11#1)(1996-6#1)
the gene product of a##2##5##(1991-1#1)(2007-11#1)
the gene product of##5##4##(1991-1#1)(1992-3#1)(1992-9#1)(1997-2#1)(2007-11#1)
the gene product##21##3##(1990-3#1)(1990-4#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-7#1)(1991-8#1)(1992-3#2)(1992-9#1)(1995-3#1)(1996-7#1)(1997-2#2)(1997-4#1)(1997-7#1)(2006-5#1)(2007-11#1)(2008-6#2)
the gene products##5##3##(1991-7#1)(1994-12#1)(1996-10#1)(1997-4#1)(2005-7#1)
the gene region##4##3##(1992-9#2)(1994-8#1)(1997-6#1)
the gene regulating activity of##2##5##(1993-8#1)(1996-4#1)
the gene responsible for the##2##5##(1990-8#1)(2013-8#1)
the gene responsible for##9##4##(1990-8#1)(1996-10#1)(1997-4#1)(2007-2#1)(2008-4#2)(2008-5#1)(2013-8#2)
the gene responsible##10##3##(1990-8#1)(1993-6#1)(1996-10#1)(1997-4#1)(2007-2#1)(2008-4#2)(2008-5#1)(2013-8#2)
the gene sequence for##2##4##(1997-6#2)
the gene sequence##3##3##(1997-6#3)
the gene sequences##2##3##(1997-4#1)(2008-5#1)
the gene sets##2##3##(1992-3#1)(2008-7#1)
the gene targeting##5##3##(1997-6#1)(1997-7#1)(2005-6#2)(2008-11#1)
the gene that encodes the##4##5##(1995-8#1)(2008-4#1)(2013-1#2)
the gene that encodes##8##4##(1995-11#1)(1995-8#1)(2006-11#1)(2006-12#1)(2008-4#1)(2008-8#1)(2013-1#2)
the gene that##9##3##(1994-8#1)(1995-11#1)(1995-8#1)(2006-11#1)(2006-12#1)(2008-4#1)(2008-8#1)(2013-1#2)
the gene therapy##4##3##(1994-5#1)(2005-8#1)(2008-5#1)(2013-8#1)
the gene to a##2##4##(1993-2#1)(2008-10#1)
the gene to be##3##4##(2007-1#1)(2008-2#1)(2008-4#1)
the gene to human chromosome##2##5##(1997-1#1)(1997-6#1)
the gene to the##2##4##(1990-8#1)(1996-2#1)
the gene to##11##3##(1990-8#1)(1993-2#1)(1994-12#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-6#1)(2007-1#1)(2008-10#1)(2008-2#1)(2008-4#1)
the gene transcription##2##3##(1994-12#1)(2008-9#1)
the gene transfer##6##3##(1997-8#1)(2008-9#5)
the gene underlying the##2##4##(2008-8#1)(2009-10#1)
the gene was##28##3##(1990-11#1)(1991-1#1)(1991-11#1)(1991-6#1)(1992-2#1)(1993-9#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-2#3)(1997-6#1)(1997-8#1)(2005-11#1)(2006-12#1)(2006-8#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2010-2#1)
the gene were##5##3##(1990-11#1)(1990-9#1)(1993-10#1)(1995-6#1)(1997-4#1)
the gene with the##2##4##(1990-4#1)(1994-12#1)
the gene with##4##3##(1990-4#1)(1994-12#1)(2008-10#1)(2011-2#1)
the gene##752##2##(1990-1#3)(1990-10#7)(1990-11#7)(1990-12#3)(1990-2#2)(1990-3#2)(1990-4#5)(1990-5#11)(1990-7#3)(1990-8#7)(1990-9#4)(1991-1#6)(1991-10#3)(1991-11#5)(1991-12#14)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#6)(1991-7#6)(1991-8#5)(1991-9#5)(1992-11#3)(1992-12#3)(1992-2#4)(1992-3#8)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#4)(1992-9#6)(1993-1#1)(1993-10#3)(1993-11#6)(1993-12#4)(1993-2#15)(1993-3#13)(1993-4#4)(1993-5#3)(1993-6#6)(1993-7#3)(1993-8#13)(1993-9#8)(1994-10#1)(1994-11#5)(1994-12#23)(1994-2#6)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#7)(1994-9#6)(1995-1#4)(1995-11#13)(1995-2#11)(1995-3#7)(1995-4#5)(1995-5#3)(1995-6#14)(1995-7#2)(1995-8#11)(1996-10#7)(1996-11#3)(1996-12#2)(1996-2#13)(1996-3#5)(1996-4#4)(1996-5#4)(1996-6#1)(1996-7#9)(1996-8#4)(1996-9#1)(1997-1#5)(1997-2#23)(1997-3#12)(1997-4#13)(1997-5#1)(1997-6#12)(1997-7#9)(1997-8#4)(2005-10#1)(2005-11#2)(2005-12#1)(2005-6#6)(2005-7#1)(2005-8#2)(2006-10#4)(2006-11#3)(2006-12#8)(2006-5#3)(2006-8#5)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#5)(2007-2#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#38)(2008-11#8)(2008-2#5)(2008-4#17)(2008-5#10)(2008-6#4)(2008-7#19)(2008-8#12)(2008-9#23)(2009-10#2)(2009-3#1)(2009-4#1)(2009-6#3)(2009-9#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#11)(2011-3#1)(2012-1#5)(2012-12#2)(2012-2#1)(2012-3#7)(2013-1#10)(2013-7#2)(2013-8#7)
the gene's##2##2##(1995-2#1)(2008-7#1)
the gene(s)##2##2##(1991-7#1)(1995-8#1)
the gene-based##2##2##(2012-3#2)
the gene-expression##2##2##(1995-8#1)(2008-6#1)
the gene-for-gene model##2##3##(2008-10#2)
the gene-for-gene relationship##3##3##(2008-10#2)(2011-1#1)
the gene-for-gene##7##2##(2008-10#5)(2011-1#1)(2011-10#1)
the gene-level##2##2##(2007-12#1)(2012-3#1)
the genealogical##2##2##(2008-12#1)(2010-8#1)
the genealogy of the##2##4##(2006-10#1)(2008-7#1)
the genealogy of##5##3##(2006-10#2)(2006-7#1)(2008-5#1)(2008-7#1)
the genera Bacillus##2##3##(2008-5#1)(2013-7#1)
the genera of##3##3##(2007-3#1)(2008-10#2)
the genera##37##2##(1997-4#1)(2007-3#1)(2007-7#1)(2008-10#11)(2008-5#7)(2008-6#2)(2008-7#2)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2013-7#3)(2013-8#4)
the general RRT##2##3##(2007-7#2)
the general US population##2##4##(2005-7#1)(2012-3#1)
the general acceptance##2##3##(2011-2#1)(2011-3#1)
the general acid##2##3##(1994-3#1)(1995-10#1)
the general amino acid control pathway##2##6##(1996-5#2)
the general amino acid permease##3##5##(1990-5#1)(1995-11#1)(1997-6#1)
the general amino acid##6##4##(1990-5#2)(1995-11#1)(1996-5#2)(1997-6#1)
the general anesthesia##2##3##(1990-8#1)(1996-12#1)
the general applicability of##3##4##(2007-10#1)(2008-1#1)(2008-9#1)
the general applicability##4##3##(2007-10#1)(2008-1#1)(2008-10#1)(2008-9#1)
the general availability##2##3##(1992-10#1)(2008-1#1)
the general behavior of##2##4##(2007-11#1)(2008-9#1)
the general belief that##2##4##(2007-2#1)(2008-10#1)
the general case of##5##4##(2008-1#1)(2008-2#3)(2008-9#1)
the general case##6##3##(2008-1#1)(2008-2#4)(2008-9#1)
the general circulation##3##3##(1995-5#1)(1996-8#1)(2009-6#1)
the general class of##3##4##(2008-5#1)(2008-6#1)(2010-2#1)
the general clinical##2##3##(2005-11#1)(2008-7#1)
the general concept##2##3##(1996-3#1)(2008-5#1)
the general concepts##2##3##(2007-12#1)(2009-8#1)
the general condition of the patient##2##6##(2008-9#1)(2011-12#1)
the general condition of the##3##5##(2008-9#2)(2011-12#1)
the general condition##5##3##(1990-9#1)(2005-11#1)(2008-9#2)(2011-12#1)
the general consensus##3##3##(2007-10#1)(2007-8#1)(2008-3#1)
the general dialysis population##3##4##(2007-7#3)
the general economic##2##3##(2008-7#1)(2010-2#1)
the general features of##2##4##(1995-6#1)(2009-10#1)
the general formula##11##3##(1994-9#2)(1996-2#1)(1996-5#1)(2005-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-5#1)
the general health of the##3##5##(1996-8#1)(2004-11#1)(2008-7#1)
the general health of##4##4##(1996-8#1)(2004-11#1)(2006-9#1)(2008-7#1)
the general health questionnaire##2##4##(2011-1#1)(2013-1#1)
the general health status and##3##5##(2008-10#1)(2008-7#1)(2010-9#1)
the general health status##4##4##(2007-2#1)(2008-10#1)(2008-7#1)(2010-9#1)
the general health##11##3##(1993-3#1)(1996-8#1)(2004-11#1)(2006-9#1)(2007-2#1)(2008-10#1)(2008-7#2)(2010-9#1)(2011-1#1)(2013-1#1)
the general hospital will##2##4##(2006-9#2)
the general hospital##10##3##(1990-12#1)(1991-2#1)(2006-9#6)(2010-12#1)(2011-2#1)
the general idea##2##3##(2008-1#1)(2009-12#1)
the general level of##2##4##(2006-3#1)(2008-5#1)
the general male population##2##4##(1996-5#1)(2008-1#1)
the general male##3##3##(1996-5#1)(2007-1#1)(2008-1#1)
the general mechanisms##2##3##(2008-7#1)(2009-5#1)
the general method##3##3##(2006-10#1)(2008-2#1)(2008-9#1)
the general mixed model framework##2##5##(1996-12#2)
the general model##2##3##(1992-9#1)(2012-3#1)
the general opinion##2##3##(1992-8#1)(2008-8#1)
the general organization of the##3##5##(1990-3#1)(1991-2#1)(2008-4#1)
the general organization of##4##4##(1990-3#1)(1991-2#1)(1992-11#1)(2008-4#1)
the general paediatric##2##3##(2008-11#2)
the general pattern of##5##4##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)
the general population and are##2##5##(2008-6#1)(2010-12#1)
the general population and in##2##5##(2007-11#1)(2007-5#1)
the general population and##14##4##(1992-2#1)(1995-12#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-5#1)(2008-6#1)(2009-1#1)(2009-4#1)(2010-12#1)(2011-2#1)(2013-1#3)
the general population are##3##4##(2006-2#1)(2010-2#1)(2012-2#1)
the general population as well as##3##6##(1992-2#1)(2009-10#1)(2011-2#1)
the general population as##5##4##(1992-2#1)(1993-7#1)(2009-10#1)(2011-2#1)(2012-12#1)
the general population but##2##4##(1993-9#1)(2007-7#1)
the general population from##2##4##(1995-9#1)(2011-11#1)
the general population in the##2##5##(2006-11#1)(2010-9#1)
the general population in##6##4##(2006-11#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-3#2)
the general population is##6##4##(1992-11#1)(2005-10#2)(2007-12#1)(2011-1#1)(2013-8#1)
the general population of the same age##2##7##(1991-9#1)(2008-7#1)
the general population of the##6##5##(1990-4#1)(1991-2#1)(1991-9#1)(1993-9#2)(2008-7#1)
the general population of##12##4##(1990-4#1)(1991-2#1)(1991-9#1)(1993-9#2)(2006-6#1)(2007-12#1)(2008-1#1)(2008-7#2)(2012-2#1)(2012-3#1)
the general population or##3##4##(2006-7#1)(2008-1#1)(2012-2#1)
the general population with##2##4##(2006-8#1)(2009-10#1)
the general population##220##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-9#2)(1992-11#1)(1992-2#4)(1992-4#1)(1992-9#2)(1993-1#1)(1993-5#1)(1993-7#1)(1993-9#4)(1994-11#1)(1994-2#1)(1994-6#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-3#3)(1996-6#1)(1997-2#1)(1997-3#4)(1997-8#1)(2005-10#5)(2006-10#13)(2006-11#2)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#6)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#6)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#2)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-10#1)(2010-11#6)(2010-12#5)(2010-2#5)(2010-3#1)(2010-6#2)(2010-8#5)(2010-9#1)(2011-1#7)(2011-11#1)(2011-12#1)(2011-2#11)(2012-12#7)(2012-2#5)(2012-3#5)(2013-1#13)(2013-7#1)(2013-8#5)
the general population]##2##3##(1995-4#1)(2008-4#1)
the general practice##4##3##(2008-9#1)(2009-4#3)
the general practitioner and the##3##5##(1997-6#2)(2011-2#1)
the general practitioner in##2##4##(1990-2#1)(1993-11#1)
the general practitioner to##2##4##(1993-8#1)(1995-9#1)
the general practitioner was##2##4##(1993-8#2)
the general practitioner##25##3##(1990-11#1)(1990-2#1)(1990-3#2)(1992-5#3)(1993-11#1)(1993-2#1)(1993-8#3)(1994-6#1)(1995-11#2)(1995-9#1)(1996-4#1)(1997-4#1)(1997-6#2)(2008-11#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
the general practitioners##12##3##(1991-5#1)(1993-2#4)(1995-5#2)(1997-4#3)(2008-10#1)(2011-2#1)
the general principle##2##3##(1993-9#1)(2008-8#1)
the general principles governing##2##4##(2007-11#2)
the general principles of##2##4##(2007-10#1)(2007-11#1)
the general principles##7##3##(2007-10#1)(2007-11#4)(2007-8#1)(2008-9#1)
the general problem of##2##4##(2007-12#1)(2008-7#1)
the general problem##3##3##(2007-12#1)(2008-4#1)(2008-7#1)
the general public and##4##4##(1990-8#1)(2007-12#1)(2007-6#1)(2013-8#1)
the general public in##3##4##(2008-4#1)(2008-7#1)(2013-1#1)
the general public regarding the##2##5##(2010-12#1)(2012-3#1)
the general public that##2##4##(1996-3#1)(2009-2#1)
the general public##35##3##(1990-8#1)(1991-11#1)(1992-8#1)(1993-2#1)(1996-1#1)(1996-3#1)(2004-3#1)(2005-5#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-12#3)(2007-6#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#3)(2009-2#2)(2010-12#3)(2010-5#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the general rate of induced abortion##2##6##(1991-8#2)
the general situation##2##3##(2006-10#1)(2013-1#1)
the general state##2##3##(2010-12#1)(2013-1#1)
the general strategy##3##3##(2005-7#1)(2007-11#1)(2008-4#1)
the general structure of the##3##5##(2006-2#1)(2007-12#1)(2013-7#1)
the general structure of##4##4##(2006-2#1)(2007-12#1)(2008-5#1)(2013-7#1)
the general structure##5##3##(1992-5#1)(2006-2#1)(2007-12#1)(2008-5#1)(2013-7#1)
the general surgeon##2##3##(1991-4#1)(2011-2#1)
the general tendency##3##3##(2007-12#1)(2008-3#1)(2008-8#1)
the general transcription factors##3##4##(1990-6#1)(1995-3#1)(1997-6#1)
the general transcription##5##3##(1990-6#3)(1995-3#1)(1997-6#1)
the general trend of##2##4##(2008-10#1)(2008-2#1)
the general trend##4##3##(2008-10#1)(2008-2#1)(2008-5#2)
the general usage of##2##4##(2006-8#1)(2010-2#1)
the general use of these##2##5##(2005-12#1)(2008-8#1)
the general use of##4##4##(1992-4#1)(2005-12#1)(2007-5#1)(2008-8#1)
the general view##2##3##(2008-10#1)(2008-8#1)
the general ward##4##3##(1990-3#1)(2006-1#1)(2007-7#1)(2007-8#1)
the general##677##2##(1990-1#1)(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#5)(1990-4#2)(1990-5#2)(1990-6#4)(1990-8#3)(1990-9#1)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#7)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#5)(1992-4#3)(1992-5#5)(1992-6#1)(1992-8#3)(1992-9#4)(1993-1#2)(1993-11#2)(1993-12#3)(1993-2#8)(1993-3#2)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#5)(1994-11#1)(1994-2#3)(1994-3#2)(1994-4#2)(1994-6#4)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#4)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#2)(1995-5#4)(1995-6#1)(1995-9#2)(1996-1#2)(1996-10#3)(1996-11#2)(1996-12#4)(1996-2#1)(1996-3#8)(1996-4#1)(1996-5#4)(1996-6#2)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#4)(1997-4#6)(1997-5#1)(1997-6#4)(1997-8#1)(2004-11#1)(2004-3#1)(2004-4#1)(2005-1#1)(2005-10#6)(2005-11#6)(2005-12#2)(2005-4#1)(2005-5#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#19)(2006-11#3)(2006-12#1)(2006-2#6)(2006-3#3)(2006-4#2)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#7)(2006-9#9)(2007-1#1)(2007-10#7)(2007-11#10)(2007-12#23)(2007-2#3)(2007-3#2)(2007-4#3)(2007-5#2)(2007-6#3)(2007-7#11)(2007-8#7)(2007-9#1)(2008-1#15)(2008-10#15)(2008-11#10)(2008-12#4)(2008-2#11)(2008-3#16)(2008-4#14)(2008-5#12)(2008-6#5)(2008-7#24)(2008-8#14)(2008-9#15)(2009-1#1)(2009-10#5)(2009-11#1)(2009-12#1)(2009-2#3)(2009-4#4)(2009-5#3)(2009-6#5)(2009-7#2)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#6)(2010-12#12)(2010-2#9)(2010-3#1)(2010-5#3)(2010-6#2)(2010-8#7)(2010-9#3)(2011-1#9)(2011-11#1)(2011-12#5)(2011-2#21)(2011-3#1)(2012-1#1)(2012-12#13)(2012-2#12)(2012-3#10)(2013-1#19)(2013-7#2)(2013-8#8)
the generalist Myzus persicae##2##4##(2004-2#1)(2009-8#1)
the generalist##5##2##(1990-12#1)(1993-2#2)(2004-2#1)(2009-8#1)
the generality of the##8##4##(1993-12#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#2)
the generality of##12##3##(1993-12#1)(1993-2#1)(1996-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#4)
the generality##13##2##(1993-12#1)(1993-2#1)(1996-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#4)(2013-1#1)
the generalizability of the##4##4##(1993-3#1)(2006-7#1)(2013-1#1)(2013-8#1)
the generalizability of##9##3##(1993-3#1)(1995-11#1)(2006-7#1)(2007-10#1)(2013-1#3)(2013-8#2)
the generalizability##12##2##(1993-3#1)(1995-11#1)(2006-7#1)(2006-9#1)(2007-10#1)(2013-1#5)(2013-8#2)
the generalization capability for##2##4##(2008-3#2)
the generalization of treatment effects##2##5##(2009-9#2)
the generalization of##6##3##(2008-2#2)(2008-6#1)(2009-9#2)(2010-8#1)
the generalization performance##2##3##(2008-2#2)
the generalization##13##2##(2008-2#4)(2008-3#2)(2008-6#1)(2008-9#1)(2009-9#2)(2010-8#1)(2013-1#2)
the generalized Born##2##3##(2009-12#2)
the generalized Lorenz-Mie theory##7##4##(2008-2#3)(2008-3#4)
the generalized ellipsometric##3##3##(2008-2#2)(2008-3#1)
the generalized estimating equation (GEE)##2##5##(1993-9#1)(1995-9#1)
the generalized estimating equation##4##4##(1993-9#2)(1995-9#1)(2012-12#1)
the generalized multipole technique##2##4##(2007-12#2)
the generalized phase-contrast (GPC) method##2##5##(2007-11#2)
the generalized phase-contrast method##3##4##(2007-11#2)(2007-12#1)
the generalized phase-contrast##6##3##(2007-11#4)(2007-12#1)(2008-3#1)
the generalized scidar##2##3##(2008-2#1)(2008-3#1)
the generalized seeing monitor##2##4##(2008-3#2)
the generalized##77##2##(1990-3#1)(1990-8#1)(1991-9#1)(1992-2#5)(1993-10#1)(1993-9#2)(1994-10#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-9#1)(1996-1#1)(1996-12#4)(1997-2#1)(1997-7#1)(2004-3#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-11#6)(2007-12#4)(2007-7#1)(2008-10#3)(2008-2#13)(2008-3#9)(2008-7#1)(2009-12#2)(2009-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)
the generally accepted##8##3##(1993-9#1)(1994-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-8#1)
the generally##16##2##(1993-5#1)(1993-9#1)(1994-3#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-10#1)(2010-8#1)(2013-1#1)(2013-7#2)(2013-8#1)
the generated blue light##2##4##(2007-12#2)
the generated blue##3##3##(2007-12#3)
the generated##43##2##(1990-7#1)(1992-6#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-8#1)(2004-9#1)(2006-2#1)(2007-11#2)(2007-12#8)(2008-1#1)(2008-10#6)(2008-2#4)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#2)(2011-2#1)(2013-1#4)(2013-8#1)
the generating models have##2##4##(2006-5#2)
the generating##5##2##(2006-5#2)(2007-12#1)(2007-4#1)(2012-3#1)
the generation a##2##3##(2007-3#1)(2008-10#1)
the generation and characterization of##2##5##(2011-2#1)(2012-2#1)
the generation and##21##3##(1993-3#1)(1995-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-8#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-11#2)(2012-2#1)
the generation of F2-isoprostanes##2##4##(1994-3#2)
the generation of IP3##2##4##(1990-12#1)(1991-12#1)
the generation of InsP3##2##4##(1994-11#1)(1994-6#1)
the generation of a##23##4##(1992-6#1)(1992-9#1)(1993-3#1)(1993-8#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-10#1)(1997-8#1)(2006-10#1)(2007-11#3)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#2)(2011-1#2)(2013-1#1)
the generation of action potential-like responses in B104 cells##2##9##(1996-9#2)
the generation of action potentials##2##5##(1996-10#1)(2009-12#1)
the generation of action##4##4##(1996-10#1)(1996-9#2)(2009-12#1)
the generation of amyloidogenic##2##4##(1992-12#1)(1994-12#1)
the generation of an##8##4##(1991-8#2)(1992-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)
the generation of androstenone##3##4##(2008-5#3)
the generation of antigen##2##4##(2012-1#1)(2012-12#1)
the generation of antigen-specific##2##4##(2007-11#1)(2012-12#1)
the generation of arbitrary complex##2##5##(2007-11#1)(2008-3#1)
the generation of data##2##4##(2008-10#1)(2008-5#1)
the generation of femtosecond##2##4##(2007-11#1)(2009-5#1)
the generation of free radicals and##2##6##(2008-5#1)(2013-8#1)
the generation of free radicals in##2##6##(1990-3#1)(2010-7#1)
the generation of free radicals##7##5##(1990-3#2)(1994-12#1)(2008-5#1)(2010-7#1)(2012-2#1)(2013-8#1)
the generation of high-energy##2##4##(2007-11#1)(2007-12#1)
the generation of highly##4##4##(1996-2#1)(2008-2#1)(2009-10#1)(2011-2#1)
the generation of human monoclonal##2##5##(1992-7#1)(2008-11#1)
the generation of human##6##4##(1992-7#3)(1995-12#1)(2008-11#1)(2008-4#1)
the generation of hydroxyl radicals##2##5##(1991-9#1)(1996-6#1)
the generation of inflammatory mediators##2##5##(2010-2#1)(2013-1#1)
the generation of inositol phosphates##3##5##(1990-10#1)(1991-2#1)(1993-6#1)
the generation of inositol##5##4##(1990-10#1)(1991-2#2)(1993-6#1)(2012-3#1)
the generation of intense##2##4##(2007-12#2)
the generation of large##3##4##(1990-3#1)(2008-10#1)(2008-3#1)
the generation of most##2##4##(1992-12#1)(2011-1#1)
the generation of multiple##3##4##(1991-2#1)(1996-6#1)(2007-12#1)
the generation of new DNA##2##5##(2008-4#1)(2011-2#1)
the generation of new##6##4##(2007-10#1)(2008-4#2)(2008-7#1)(2011-2#1)(2012-4#1)
the generation of nitric oxide##2##5##(1990-8#1)(1991-3#1)
the generation of oxygen##2##4##(1992-12#1)(2008-10#1)
the generation of reactive oxygen species (ROS)##2##7##(2008-10#2)
the generation of reactive oxygen species and##2##7##(2006-2#1)(2011-1#1)
the generation of reactive oxygen species by##2##7##(1992-6#1)(2009-3#1)
the generation of reactive oxygen species##7##6##(1992-6#1)(2006-2#1)(2008-1#1)(2008-10#2)(2009-3#1)(2011-1#1)
the generation of reactive##9##4##(1992-6#1)(2006-2#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-3#1)(2011-1#1)
the generation of squeezed light##2##5##(2007-11#1)(2007-12#1)
the generation of stably##2##4##(2008-11#1)(2008-2#1)
the generation of superoxide##3##4##(2005-8#1)(2008-1#1)(2009-8#1)
the generation of synthetic##2##4##(2008-2#1)(2008-3#1)
the generation of the##23##4##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1995-10#1)(1995-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(2006-12#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-4#2)(2010-2#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
the generation of these##2##4##(1996-4#1)(1997-4#1)
the generation of transgenic mice##2##5##(2008-4#2)
the generation of transgenic##5##4##(1997-2#1)(2006-12#1)(2008-11#1)(2008-4#2)
the generation of translocations##2##4##(2008-8#1)(2011-1#1)
the generation of tunable##2##4##(2007-12#1)(2008-2#1)
the generation of##350##3##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#4)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-12#2)(1991-2#3)(1991-3#2)(1991-5#3)(1991-8#2)(1991-9#1)(1992-12#3)(1992-6#2)(1992-7#6)(1992-8#2)(1992-9#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#6)(1994-5#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-7#2)(1995-9#1)(1996-10#6)(1996-2#3)(1996-3#2)(1996-4#2)(1996-6#4)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#3)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2004-11#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#5)(2006-12#7)(2006-2#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#21)(2007-12#24)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#8)(2008-10#16)(2008-11#20)(2008-2#10)(2008-3#11)(2008-4#16)(2008-5#12)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#6)(2009-10#1)(2009-12#1)(2009-2#4)(2009-3#2)(2009-5#5)(2009-6#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#3)(2010-2#3)(2010-4#2)(2010-5#1)(2010-7#4)(2010-9#2)(2011-1#5)(2011-2#5)(2011-9#1)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#3)(2012-4#1)(2012-8#1)(2013-1#2)(2013-8#2)
the generation or##3##3##(1993-12#1)(2006-2#1)(2012-12#1)
the generation time of##4##4##(1991-10#1)(1992-3#1)(2008-6#1)(2008-8#1)
the generation time##5##3##(1991-10#1)(1992-3#1)(2008-6#1)(2008-8#2)
the generation##394##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#4)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#3)(1991-3#2)(1991-5#3)(1991-8#2)(1991-9#1)(1992-12#3)(1992-3#1)(1992-6#2)(1992-7#6)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#6)(1994-5#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-7#3)(1995-9#1)(1996-10#6)(1996-2#3)(1996-3#2)(1996-4#2)(1996-6#5)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#3)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2004-11#1)(2004-5#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#6)(2006-12#7)(2006-2#2)(2006-5#1)(2006-7#1)(2007-10#2)(2007-11#23)(2007-12#28)(2007-3#3)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#8)(2008-10#18)(2008-11#21)(2008-2#12)(2008-3#13)(2008-4#20)(2008-5#13)(2008-6#4)(2008-7#5)(2008-8#6)(2008-9#7)(2009-10#1)(2009-12#1)(2009-2#4)(2009-3#2)(2009-5#5)(2009-6#2)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#3)(2010-2#3)(2010-4#2)(2010-5#1)(2010-7#4)(2010-9#2)(2011-1#5)(2011-2#6)(2011-9#1)(2012-1#2)(2012-11#2)(2012-12#5)(2012-2#2)(2012-3#4)(2012-4#1)(2012-8#1)(2013-1#3)(2013-8#2)
the generational##2##2##(1996-2#1)(2008-8#1)
the generations##4##2##(1992-2#1)(1995-11#1)(2009-10#1)(2010-9#1)
the generative##5##2##(2007-12#1)(2008-10#2)(2009-12#1)(2010-4#1)
the generator##7##2##(1992-5#1)(1997-6#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#2)
the generators of##2##3##(2007-12#1)(2010-12#1)
the generic name##3##3##(1990-7#1)(1996-7#1)(2013-7#1)
the generic term##3##3##(1992-4#1)(2007-2#1)(2012-2#1)
the generic##21##2##(1990-7#1)(1992-4#1)(1996-3#1)(1996-7#1)(2006-2#1)(2007-10#1)(2007-2#1)(2008-10#3)(2008-5#2)(2008-6#1)(2008-7#1)(2009-5#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-7#2)
the generosity of##4##3##(1996-2#1)(2008-10#1)(2009-10#2)
the genes and##7##3##(1996-6#1)(1997-1#1)(2007-8#1)(2008-8#2)(2008-9#2)
the genes are expressed##2##4##(1996-2#1)(2010-12#1)
the genes are##7##3##(1991-2#1)(1992-8#1)(1993-6#1)(1996-2#1)(2008-10#1)(2009-8#1)(2010-12#1)
the genes cloned##2##3##(1991-9#1)(1993-11#1)
the genes coding for the##3##5##(1994-5#1)(1995-2#2)
the genes coding for these##2##5##(1991-2#1)(2008-4#1)
the genes coding for##13##4##(1990-9#1)(1991-2#1)(1991-6#1)(1994-5#1)(1995-12#1)(1995-2#3)(1997-6#1)(2005-8#1)(2008-4#1)(2008-9#1)(2011-1#1)
the genes coding##14##3##(1990-6#1)(1990-9#1)(1991-2#1)(1991-6#1)(1994-5#1)(1995-12#1)(1995-2#3)(1997-6#1)(2005-8#1)(2008-4#1)(2008-9#1)(2011-1#1)
the genes contributing to##2##4##(2008-4#1)(2012-3#1)
the genes encoding cystatin type-2 proteins##2##6##(1993-3#2)
the genes encoding for the##2##5##(2006-4#1)(2009-5#1)
the genes encoding the##9##4##(1990-7#1)(1991-6#1)(1992-9#1)(1994-11#1)(1994-12#1)(1996-2#1)(2008-3#1)(2008-7#1)(2009-10#1)
the genes encoding##30##3##(1990-5#1)(1990-7#1)(1991-6#1)(1992-9#1)(1993-12#1)(1993-3#3)(1994-11#1)(1994-12#1)(1995-3#2)(1995-8#1)(1996-2#1)(1997-1#1)(1997-7#1)(2006-10#1)(2006-4#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-7#1)
the genes for the##3##4##(1996-5#1)(2010-11#1)(2011-2#1)
the genes for these##2##4##(1991-5#1)(2006-10#1)
the genes for##22##3##(1990-2#1)(1991-5#1)(1992-3#1)(1993-12#1)(1993-2#1)(1995-8#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-8#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-11#1)(2011-2#1)
the genes from##3##3##(1990-9#1)(1996-10#1)(2008-4#1)
the genes identified##3##3##(2007-11#1)(2008-9#1)(2010-9#1)
the genes in the##2##4##(1996-2#1)(2008-7#1)
the genes in this##2##4##(1992-3#1)(2010-12#1)
the genes in##10##3##(1990-5#1)(1992-3#1)(1994-8#1)(1996-2#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-8#1)(2010-12#1)
the genes involved in the##3##5##(1990-5#1)(2008-11#1)(2008-9#1)
the genes involved in##10##4##(1990-5#1)(1991-2#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-9#2)(2012-2#1)
the genes involved##15##3##(1990-5#1)(1991-2#1)(1996-6#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-9#2)(2011-1#1)(2012-2#1)(2013-8#1)
the genes may be##2##4##(1993-3#1)(2008-9#1)
the genes of beta-lactamases##2##4##(2008-11#2)
the genes of interest##2##4##(1997-4#1)(2008-8#1)
the genes of the##5##4##(1990-5#2)(1990-8#1)(2006-8#1)(2008-4#1)
the genes of##16##3##(1990-5#2)(1990-8#1)(1993-4#1)(1995-12#1)(1997-4#1)(2006-8#2)(2008-11#3)(2008-4#1)(2008-8#3)(2013-1#1)
the genes on chromosome VI of##2##6##(1997-6#2)
the genes on##3##3##(1997-6#2)(2008-4#1)
the genes participating in##2##4##(1996-6#1)(2012-3#1)
the genes related to##2##4##(2011-2#1)(2012-3#1)
the genes responsible for##5##4##(1992-9#1)(1994-9#1)(2007-11#1)(2008-6#1)(2009-6#1)
the genes that are##2##4##(1994-6#1)(1997-2#1)
the genes that encode##4##4##(1993-9#1)(1994-8#1)(1995-6#1)(2008-11#1)
the genes that play##2##4##(1996-10#1)(2008-7#1)
the genes that##14##3##(1993-6#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-6#1)(1996-10#1)(1997-2#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-4#1)(2012-3#1)
the genes underlying##4##3##(2006-9#1)(2009-10#2)(2012-3#1)
the genes upregulated##2##3##(2008-7#1)(2009-8#1)
the genes were##4##3##(2008-10#3)(2009-10#1)
the genes with##3##3##(1993-2#1)(2008-7#1)(2010-5#1)
the genes##248##2##(1990-11#1)(1990-2#1)(1990-5#6)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#3)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#3)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#4)(1993-4#1)(1993-6#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#2)(1995-10#1)(1995-12#3)(1995-2#4)(1995-3#2)(1995-6#3)(1995-8#2)(1996-10#2)(1996-2#4)(1996-4#1)(1996-5#1)(1996-6#3)(1996-7#2)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#6)(1997-7#3)(1997-8#4)(2005-8#2)(2006-10#3)(2006-11#1)(2006-12#2)(2006-4#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-11#2)(2007-12#3)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#14)(2008-11#10)(2008-3#2)(2008-4#7)(2008-5#3)(2008-6#3)(2008-7#10)(2008-8#8)(2008-9#11)(2009-10#6)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#5)(2010-10#2)(2010-11#1)(2010-12#3)(2010-5#1)(2010-7#3)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#6)(2013-1#1)(2013-7#1)(2013-8#2)
the genesis and##5##3##(1990-11#1)(1991-3#1)(1994-3#1)(2008-10#1)(2011-2#1)
the genesis of high blood pressure##2##6##(2008-10#2)
the genesis of the##3##4##(1990-6#1)(1991-12#1)(2007-11#1)
the genesis of##39##3##(1990-6#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-9#1)(1993-4#1)(1995-6#3)(1995-8#1)(1996-11#1)(1996-8#1)(1996-9#1)(2004-11#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-5#2)(2010-12#1)(2010-2#1)(2011-2#2)(2012-2#3)(2013-8#1)
the genesis##45##2##(1990-10#1)(1990-11#1)(1990-6#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1993-4#1)(1994-3#1)(1995-6#3)(1995-8#1)(1996-11#1)(1996-8#1)(1996-9#1)(2004-11#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-5#2)(2010-12#1)(2010-2#1)(2011-2#3)(2012-2#3)(2013-8#1)
the genetic algorithm##5##3##(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)
the genetic alteration##2##3##(2005-9#1)(2011-1#1)
the genetic alterations present in osteosarcoma##2##6##(2010-3#2)
the genetic analysis of cystic##2##5##(1990-3#2)
the genetic analysis of##11##4##(1990-3#3)(1994-12#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-1#2)(2012-2#1)
the genetic analysis##13##3##(1990-3#3)(1994-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-1#2)(2010-11#1)(2012-2#1)
the genetic and biochemical##3##4##(1994-9#1)(2005-7#1)(2008-9#1)
the genetic and biological diversity of##2##6##(2008-10#2)
the genetic and environmental##2##4##(2008-10#1)(2008-11#1)
the genetic and metabolic##2##4##(2008-11#1)(2008-7#1)
the genetic and molecular basis##2##5##(2008-7#1)(2009-5#1)
the genetic and molecular mechanisms of##2##6##(2010-4#1)(2012-11#1)
the genetic and molecular mechanisms##3##5##(1991-3#1)(2010-4#1)(2012-11#1)
the genetic and molecular##10##4##(1991-3#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-4#1)(2012-11#1)(2012-12#1)
the genetic and phenotypic##2##4##(1994-3#1)(2008-10#1)
the genetic and##32##3##(1991-3#1)(1994-3#1)(1994-9#1)(1997-4#1)(1997-5#1)(2005-7#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-12#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-10#1)(2012-11#1)(2012-12#1)
the genetic architecture of the##2##5##(2009-12#1)(2010-12#1)
the genetic architecture of##7##4##(2008-8#3)(2009-12#1)(2010-12#1)(2012-3#1)(2013-8#1)
the genetic association##4##3##(1995-3#1)(2008-9#1)(2010-2#1)(2012-2#1)
the genetic background of the##3##5##(2006-2#1)(2008-2#1)(2012-3#1)
the genetic background of##10##4##(1997-8#1)(2006-2#1)(2006-6#1)(2007-10#1)(2008-10#2)(2008-2#1)(2009-10#1)(2012-3#2)
the genetic background##13##3##(1995-12#1)(1996-5#1)(1997-8#1)(2006-2#1)(2006-6#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-10#1)(2012-3#2)
the genetic bases##3##3##(2008-8#1)(2012-2#1)(2013-1#1)
the genetic basis and##2##4##(2008-9#1)(2012-11#1)
the genetic basis for##8##4##(1991-8#1)(1995-3#1)(2006-10#1)(2008-10#1)(2008-4#1)(2010-4#1)(2012-11#1)(2012-3#1)
the genetic basis of glucose homeostasis##2##6##(2008-1#2)
the genetic basis of heterosis##3##5##(2008-4#1)(2008-8#1)(2009-10#1)
the genetic basis of the##4##5##(2008-10#1)(2008-12#1)(2008-8#1)(2012-12#1)
the genetic basis of##33##4##(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(2006-10#1)(2007-3#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#5)(2008-5#2)(2008-7#1)(2008-8#4)(2009-10#2)(2009-5#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#3)
the genetic basis##45##3##(1991-8#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(2006-10#2)(2007-3#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-4#6)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#2)(2009-2#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#5)
the genetic cause of##2##4##(2008-5#1)(2012-2#1)
the genetic causes of##2##4##(1995-12#1)(1997-7#1)
the genetic causes##3##3##(1995-12#1)(1997-7#1)(2009-6#1)
the genetic changes in##2##4##(2010-12#1)(2013-1#1)
the genetic changes##4##3##(2007-10#1)(2007-11#1)(2010-12#1)(2013-1#1)
the genetic characteristics of the##2##5##(2007-1#1)(2011-2#1)
the genetic characteristics of viral quasispecies##2##6##(2013-8#2)
the genetic characteristics of##5##4##(2007-1#1)(2011-2#1)(2012-12#1)(2013-8#2)
the genetic code##12##3##(1994-5#1)(1997-5#2)(1997-6#1)(2006-12#2)(2006-5#2)(2008-1#1)(2008-4#1)(2012-2#2)
the genetic component of##2##4##(2006-1#1)(2008-7#1)
the genetic component##3##3##(2006-1#2)(2008-7#1)
the genetic composition of##4##4##(2008-10#3)(2009-8#1)
the genetic composition##5##3##(1995-8#1)(2008-10#3)(2009-8#1)
the genetic consequences of##2##4##(2010-3#1)(2012-3#1)
the genetic constitution of##3##4##(2006-10#1)(2008-10#2)
the genetic contribution##2##3##(2008-3#1)(2011-2#1)
the genetic control of##5##4##(2004-11#1)(2006-10#1)(2008-10#1)(2008-8#2)
the genetic control##6##3##(2004-11#1)(2006-10#1)(2008-10#1)(2008-8#3)
the genetic defect##6##3##(1990-11#1)(1990-5#1)(1995-3#1)(1996-12#1)(2010-9#1)(2011-1#1)
the genetic defects##2##3##(1995-8#1)(2012-11#1)
the genetic determinants of##3##4##(2005-10#1)(2008-10#1)(2009-12#1)
the genetic differences##2##3##(1993-9#1)(2010-4#1)
the genetic dissection of##3##4##(1994-9#2)(2007-12#1)
the genetic distance##3##3##(1997-5#1)(2008-10#2)
the genetic distances between##2##4##(2008-10#1)(2011-1#1)
the genetic distances##3##3##(2008-10#1)(2008-6#1)(2011-1#1)
the genetic diversity among##5##4##(2008-10#5)
the genetic diversity and population##2##5##(2008-10#1)(2013-8#1)
the genetic diversity and##5##4##(2006-4#1)(2008-10#3)(2013-8#1)
the genetic diversity between##2##4##(1995-2#1)(2008-7#1)
the genetic diversity in##2##4##(1995-8#1)(2008-10#1)
the genetic diversity of the##3##5##(2008-10#2)(2008-6#1)
the genetic diversity of##14##4##(2005-11#1)(2006-4#1)(2007-2#1)(2008-10#7)(2008-6#1)(2010-4#1)(2010-7#1)(2012-12#1)
the genetic diversity within a##2##5##(2008-10#1)(2012-1#1)
the genetic diversity within the##2##5##(2008-10#2)
the genetic diversity within##4##4##(2008-10#3)(2012-1#1)
the genetic diversity##35##3##(1995-2#1)(1995-8#1)(2005-11#1)(2006-4#2)(2007-2#1)(2008-10#20)(2008-12#1)(2008-6#1)(2008-7#1)(2010-4#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
the genetic effects of##2##4##(2008-8#1)(2008-9#1)
the genetic effects##4##3##(2008-4#1)(2008-8#1)(2008-9#1)(2010-4#1)
the genetic engineering of##4##4##(2005-7#1)(2006-12#2)(2013-1#1)
the genetic etiology of##2##4##(2006-10#1)(2007-12#1)
the genetic evolution of##2##4##(2006-12#1)(2013-8#1)
the genetic evolution##3##3##(1994-12#1)(2006-12#1)(2013-8#1)
the genetic factors involved in##2##5##(1997-8#1)(2009-5#1)
the genetic factors that##3##4##(2008-4#1)(2010-10#2)
the genetic factors##9##3##(1997-5#1)(1997-8#1)(2006-10#1)(2007-2#1)(2008-4#1)(2009-5#1)(2010-10#2)(2011-1#1)
the genetic heterogeneity of##3##4##(1993-11#1)(1996-4#1)(2011-1#1)
the genetic heterogeneity##5##3##(1993-11#1)(1996-3#1)(1996-4#1)(2007-7#1)(2011-1#1)
the genetic homogeneity##2##3##(2008-10#1)(2012-3#1)
the genetic identification of##2##4##(1997-3#1)(2008-10#1)
the genetic information for##2##4##(1994-3#1)(1996-8#1)
the genetic information##6##3##(1991-5#1)(1994-3#1)(1995-4#1)(1996-8#1)(2008-5#1)(2008-9#1)
the genetic instability##2##3##(1994-6#1)(2008-4#1)
the genetic level##4##3##(1997-4#1)(2012-2#1)(2012-3#2)
the genetic makeup of##2##4##(2006-1#1)(2012-2#1)
the genetic manipulation of##4##4##(1991-8#1)(2006-10#1)(2008-9#2)
the genetic manipulation##5##3##(1991-8#1)(2005-11#1)(2006-10#1)(2008-9#2)
the genetic map by##2##4##(1997-4#1)(2008-7#1)
the genetic map##17##3##(1992-4#1)(1996-10#1)(1996-12#2)(1996-6#1)(1997-4#2)(2008-10#6)(2008-5#2)(2008-7#1)(2012-3#1)
the genetic marker##2##3##(1991-9#1)(2011-1#1)
the genetic material##4##3##(1994-5#1)(2007-11#1)(2008-5#1)(2011-2#1)
the genetic mechanism##2##3##(2008-10#2)
the genetic mechanisms##4##3##(1994-11#1)(2006-11#1)(2008-7#1)(2009-5#1)
the genetic model##2##3##(2008-4#1)(2012-1#1)
the genetic modification of##3##4##(2008-11#1)(2008-7#1)(2012-2#1)
the genetic modification##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
the genetic pathway of##2##4##(2006-2#1)(2008-7#1)
the genetic pathway##3##3##(2006-2#1)(2007-12#1)(2008-7#1)
the genetic pathways##2##3##(2009-10#1)(2009-8#1)
the genetic polymorphism of##4##4##(1996-3#3)(2013-1#1)
the genetic polymorphism##7##3##(1996-3#3)(2006-10#1)(2010-2#1)(2013-1#2)
the genetic predisposition of##2##4##(2007-7#1)(2012-12#1)
the genetic predisposition to##3##4##(1995-11#1)(1997-4#1)(2006-2#1)
the genetic predisposition##5##3##(1995-11#1)(1997-4#1)(2006-2#1)(2007-7#1)(2012-12#1)
the genetic programs##2##3##(2007-12#1)(2008-9#1)
the genetic regulation of##3##4##(2009-2#1)(2009-5#1)(2011-2#1)
the genetic regulation##4##3##(1990-5#1)(2009-2#1)(2009-5#1)(2011-2#1)
the genetic relatedness##3##3##(2006-10#1)(2006-3#1)(2008-5#1)
the genetic relationship between##2##4##(2008-10#1)(2008-9#1)
the genetic relationship##4##3##(2006-9#1)(2008-10#2)(2008-9#1)
the genetic relationships among##2##4##(2008-10#2)
the genetic relationships between##2##4##(2007-2#1)(2008-10#1)
the genetic relationships##6##3##(2007-2#1)(2008-10#3)(2011-2#1)(2012-11#1)
the genetic risk of##3##4##(2008-1#2)(2008-7#1)
the genetic risk##6##3##(1995-11#1)(2008-1#2)(2008-3#1)(2008-7#1)(2010-9#1)
the genetic status of##2##4##(1996-12#2)
the genetic structure and##2##4##(2008-10#2)
the genetic structure of M##2##5##(2008-10#2)
the genetic structure of parasite##2##5##(2008-8#1)(2011-2#1)
the genetic structure of these##2##5##(2008-10#1)(2012-3#1)
the genetic structure of##24##4##(2006-10#1)(2007-12#1)(2008-10#14)(2008-2#1)(2008-8#2)(2011-2#1)(2012-1#1)(2012-3#2)(2013-8#1)
the genetic structure##27##3##(2006-10#1)(2007-12#1)(2008-10#17)(2008-2#1)(2008-8#2)(2011-2#1)(2012-1#1)(2012-3#2)(2013-8#1)
the genetic susceptibility to##3##4##(1996-5#1)(1997-8#1)(2008-9#1)
the genetic test##2##3##(1995-12#1)(2013-8#1)
the genetic testing##2##3##(2005-10#1)(2006-4#1)
the genetic toxicity of##2##4##(1997-2#1)(1997-4#1)
the genetic transcription##2##3##(2005-1#1)(2008-6#1)
the genetic underpinnings of##2##4##(2008-11#1)(2009-8#1)
the genetic variability among##2##4##(2008-10#1)(2008-5#1)
the genetic variability##6##3##(2007-10#1)(2008-10#4)(2008-5#1)
the genetic variance##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
the genetic variation among##2##4##(2008-10#2)
the genetic variation in##2##4##(2008-10#1)(2012-11#1)
the genetic variation of##3##4##(2008-10#2)(2012-1#1)
the genetic variation##14##3##(2008-10#8)(2008-8#1)(2010-1#1)(2010-4#1)(2012-1#1)(2012-11#1)(2013-8#1)
the genetic##519##2##(1990-11#1)(1990-3#3)(1990-5#2)(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-4#1)(1993-11#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#4)(1995-1#1)(1995-11#3)(1995-12#5)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#3)(1996-10#1)(1996-12#6)(1996-3#4)(1996-4#1)(1996-5#4)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#7)(1997-5#6)(1997-6#2)(1997-7#2)(1997-8#4)(2004-11#1)(2005-1#1)(2005-10#3)(2005-11#3)(2005-7#2)(2005-9#1)(2006-1#4)(2006-10#11)(2006-11#1)(2006-12#5)(2006-2#4)(2006-3#1)(2006-4#3)(2006-5#4)(2006-6#2)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#3)(2007-12#8)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#1)(2008-1#8)(2008-10#93)(2008-11#6)(2008-12#5)(2008-2#3)(2008-3#4)(2008-4#16)(2008-5#12)(2008-6#4)(2008-7#15)(2008-8#24)(2008-9#17)(2009-10#4)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#5)(2009-6#1)(2009-8#3)(2010-1#3)(2010-10#4)(2010-11#2)(2010-12#3)(2010-2#3)(2010-3#4)(2010-4#7)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#10)(2011-10#1)(2011-2#7)(2012-1#7)(2012-11#7)(2012-12#8)(2012-2#13)(2012-3#20)(2013-1#9)(2013-8#12)
the genetical##3##2##(2006-10#1)(2007-11#1)(2012-12#1)
the genetically modified##2##3##(2008-8#1)(2013-7#1)
the genetically##14##2##(1991-10#1)(1991-12#1)(1995-10#1)(2006-10#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-8#2)(2012-3#1)(2013-7#2)
the genetics and physiology of##2##5##(2008-10#2)
the genetics and##6##3##(2006-10#1)(2008-10#3)(2008-8#1)(2013-1#1)
the genetics of reproductive isolation##2##5##(2008-8#2)
the genetics of resistance in##3##5##(2008-10#2)(2011-10#1)
the genetics of resistance##4##4##(2008-10#3)(2011-10#1)
the genetics of the##3##4##(2006-10#1)(2006-12#1)(2008-10#1)
the genetics of##29##3##(1993-6#1)(1995-12#1)(1996-5#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-4#1)(2008-8#2)(2009-9#1)(2011-1#1)(2011-10#1)(2012-3#2)
the genetics underlying##2##3##(2008-8#1)(2009-4#1)
the genetics##44##2##(1993-6#1)(1995-12#1)(1996-5#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-11#1)(2006-12#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-4#3)(2008-8#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-3#2)(2013-1#1)
the geniculate ganglion##4##3##(2006-12#2)(2011-2#2)
the geniculate##6##2##(2006-12#2)(2008-11#1)(2011-2#3)
the genital region##3##3##(2010-7#2)(2012-1#1)
the genital ridge##2##3##(1995-11#1)(2010-12#1)
the genital tract of the male rat##2##7##(1991-11#2)
the genital tract of the##3##5##(1991-11#2)(2006-5#1)
the genital tract of##4##4##(1991-11#2)(2006-5#1)(2007-12#1)
the genital tract##10##3##(1991-11#2)(1992-9#1)(1994-3#1)(2006-5#1)(2007-12#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
the genital##26##2##(1991-11#2)(1992-9#1)(1994-3#1)(1995-11#1)(1996-12#1)(2005-8#1)(2006-5#1)(2007-12#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-7#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#3)
the genitalia and##2##3##(1990-8#1)(2010-4#1)
the genitalia##8##2##(1990-8#1)(1997-3#1)(2007-12#1)(2008-10#3)(2010-4#1)(2013-7#1)
the genitourinary tract##2##3##(2007-11#1)(2007-12#1)
the genitourinary##5##2##(1990-6#1)(2006-9#1)(2007-11#1)(2007-12#1)(2013-8#1)
the genome and##12##3##(1990-5#1)(2007-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-3#1)(2012-3#2)(2013-8#1)
the genome are##2##3##(1993-12#1)(2008-10#1)
the genome contains##3##3##(1996-2#1)(2008-10#1)(2011-2#1)
the genome evolution##2##3##(2009-5#1)(2012-3#1)
the genome for##2##3##(1996-6#1)(2006-4#1)
the genome from##2##3##(2006-10#1)(2012-2#1)
the genome have##2##3##(2008-8#1)(2012-3#1)
the genome in##3##3##(1991-8#1)(2008-5#1)(2008-7#1)
the genome is##5##3##(1993-11#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)
the genome of Escherichia coli##2##5##(1994-11#1)(1997-4#1)
the genome of S##2##4##(1992-6#1)(2008-9#1)
the genome of Synechocystis sp##5##5##(1995-8#1)(1996-8#1)(1997-2#1)(1997-6#2)
the genome of a##6##4##(2007-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-5#1)
the genome of the cyanobacterium##2##5##(1995-12#1)(1996-12#1)
the genome of the unicellular cyanobacterium Synechocystis sp##4##8##(1995-6#1)(1995-8#1)(1996-6#2)
the genome of the##21##4##(1990-3#1)(1990-4#1)(1990-5#2)(1991-12#1)(1994-12#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-6#2)(1997-3#1)(2006-10#1)(2007-9#1)(2008-10#2)(2008-4#1)(2010-8#1)(2011-12#1)(2011-2#1)
the genome of this##3##4##(1993-11#1)(2008-5#1)(2009-3#1)
the genome of##68##3##(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#2)(1991-1#1)(1991-12#1)(1992-6#1)(1993-11#2)(1994-11#1)(1994-12#2)(1994-3#1)(1995-12#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-6#2)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#2)(2006-10#2)(2007-12#1)(2007-9#2)(2008-10#6)(2008-4#2)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#1)(2009-5#2)(2010-8#2)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#4)
the genome organization of##2##4##(1997-4#1)(2008-10#1)
the genome organization##3##3##(1997-4#1)(2008-10#1)(2008-9#1)
the genome project##4##3##(1990-6#1)(2007-12#1)(2008-12#1)(2008-8#1)
the genome sequence of##5##4##(1996-8#1)(2006-10#1)(2008-7#2)(2013-1#1)
the genome sequence##8##3##(1996-8#1)(2006-10#1)(2008-4#1)(2008-7#2)(2011-2#1)(2012-11#1)(2013-1#1)
the genome sequences of##2##4##(2008-10#1)(2012-11#1)
the genome structure of##2##4##(1996-12#1)(2012-11#1)
the genome that##7##3##(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-3#1)
the genome to##5##3##(1995-4#1)(1996-5#1)(2008-10#1)(2008-11#1)(2009-3#1)
the genome was##4##3##(1996-6#1)(2008-10#2)(2008-12#1)
the genome were##5##3##(1990-11#1)(1992-9#1)(1996-7#1)(2008-10#2)
the genome##264##2##(1990-10#1)(1990-11#2)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-11#4)(1993-12#2)(1993-9#1)(1994-11#1)(1994-12#3)(1994-3#2)(1994-8#2)(1995-11#2)(1995-12#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#4)(1996-11#1)(1996-12#2)(1996-2#2)(1996-5#1)(1996-6#11)(1996-7#2)(1996-8#3)(1997-1#3)(1997-2#2)(1997-3#4)(1997-4#4)(1997-6#2)(1997-8#1)(2005-8#1)(2006-1#1)(2006-10#6)(2006-12#2)(2006-4#1)(2007-11#1)(2007-12#4)(2007-3#4)(2007-6#4)(2007-9#2)(2008-10#28)(2008-11#7)(2008-12#2)(2008-2#2)(2008-4#9)(2008-5#7)(2008-6#1)(2008-7#13)(2008-8#7)(2008-9#7)(2009-10#1)(2009-3#4)(2009-5#3)(2009-6#2)(2009-8#2)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#3)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#9)(2012-11#5)(2012-12#2)(2012-2#5)(2012-3#11)(2013-1#4)(2013-8#8)
the genome-wide##7##2##(2008-2#1)(2008-7#2)(2009-2#1)(2009-9#1)(2011-2#2)
the genomes of##25##3##(1990-3#1)(1991-12#1)(1991-8#1)(1991-9#1)(1994-8#1)(1997-6#1)(2007-3#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#3)(2011-1#1)
the genomes##29##2##(1990-3#1)(1991-12#1)(1991-8#1)(1991-9#1)(1994-8#1)(1997-6#1)(2007-3#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#3)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
the genomic DNA in##2##4##(1997-1#1)(2008-8#1)
the genomic DNA of##5##4##(1991-11#1)(1992-11#1)(1992-6#1)(1994-8#1)(2008-10#1)
the genomic DNA##21##3##(1990-12#1)(1990-4#1)(1991-11#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-6#1)(1993-8#2)(1994-12#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-6#1)(1996-9#1)(1997-1#1)(2008-10#1)(2008-8#1)(2010-7#1)
the genomic RNA of##4##4##(1997-3#1)(2008-10#3)
the genomic RNA##5##3##(1997-3#2)(2008-10#3)
the genomic and##3##3##(1992-3#1)(2006-10#1)(2010-3#1)
the genomic basis##2##3##(2009-8#1)(2011-2#1)
the genomic clone##3##3##(1991-4#1)(1997-7#1)(2006-12#1)
the genomic clones##3##3##(1990-8#1)(1994-6#1)(1994-9#1)
the genomic information##2##3##(2008-10#1)(2008-7#1)
the genomic library of##2##4##(1991-12#1)(1991-9#1)
the genomic library##5##3##(1991-12#1)(1991-7#1)(1991-9#1)(1992-4#1)(1997-2#1)
the genomic location of a##2##5##(2008-4#1)(2008-9#1)
the genomic location of##3##4##(2008-10#1)(2008-4#1)(2008-9#1)
the genomic location##4##3##(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)
the genomic locus##2##3##(1991-6#1)(1996-6#1)
the genomic organization of the##2##5##(1995-1#1)(2008-4#1)
the genomic organization of##3##4##(1992-3#1)(1995-1#1)(2008-4#1)
the genomic region##4##3##(1995-1#1)(1997-2#3)
the genomic sequence data##2##4##(1995-12#1)(2008-1#1)
the genomic sequence of C##2##5##(2008-4#1)(2008-7#1)
the genomic sequence of##4##4##(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)
the genomic sequence##13##3##(1991-4#1)(1992-3#1)(1993-3#1)(1994-3#1)(1995-12#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)
the genomic sequences##2##3##(1992-6#1)(2005-7#1)
the genomic structure of the##3##5##(1993-12#1)(1995-1#1)(1997-7#1)
the genomic structure of##6##4##(1993-11#1)(1993-12#1)(1993-6#1)(1995-1#1)(1996-2#1)(1997-7#1)
the genomic structure##9##3##(1993-11#1)(1993-12#2)(1993-6#1)(1994-8#1)(1995-1#1)(1996-2#1)(1997-7#1)(2008-7#1)
the genomic##124##2##(1990-12#1)(1990-4#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-4#2)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-3#3)(1992-4#1)(1992-6#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#2)(1994-12#2)(1994-3#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#6)(1995-12#2)(1995-8#2)(1996-12#1)(1996-2#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#3)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#2)(2007-12#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#2)(2009-5#1)(2009-8#2)(2010-10#1)(2010-3#2)(2010-4#3)(2010-5#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#3)
the genomics era##3##3##(2007-10#1)(2008-2#1)(2008-4#1)
the genomics##6##2##(2007-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-12#1)(2011-2#1)
the genotoxic effects of##3##4##(1992-6#1)(2008-8#1)(2010-5#1)
the genotoxic##6##2##(1992-6#1)(1993-9#1)(1995-5#1)(1997-4#1)(2008-8#1)(2010-5#1)
the genotoxicity of##2##3##(1992-6#1)(1996-2#1)
the genotoxicity##4##2##(1992-6#1)(1996-2#1)(2008-8#1)(2013-1#1)
the genotype GG of rs266729##2##5##(2011-1#2)
the genotype and##5##3##(1992-9#1)(2006-12#1)(2008-2#1)(2008-4#1)(2011-2#1)
the genotype distribution of patients with##2##6##(1993-7#2)
the genotype distribution of##3##4##(1993-7#2)(2007-3#1)
the genotype frequencies of##2##4##(2011-1#2)
the genotype frequencies##3##3##(1996-7#1)(2011-1#2)
the genotype frequency of##2##4##(2006-6#1)(2011-1#1)
the genotype frequency##3##3##(1996-7#1)(2006-6#1)(2011-1#1)
the genotype of the##5##4##(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2013-1#1)
the genotype of##7##3##(1990-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#2)(2013-1#1)
the genotype was##3##3##(1997-7#1)(2011-1#1)(2012-3#1)
the genotype##37##2##(1990-12#1)(1992-9#1)(1993-7#2)(1996-7#2)(1997-7#1)(2006-12#1)(2006-6#1)(2007-3#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#4)(2011-1#6)(2011-12#1)(2011-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
the genotypes and allele frequencies##3##5##(2011-1#3)
the genotypes and##5##3##(2007-10#1)(2008-4#1)(2011-1#3)
the genotypes in##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
the genotypes of the##3##4##(1996-3#1)(2004-2#1)(2008-10#1)
the genotypes of##8##3##(1995-6#1)(1996-3#1)(2004-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-5#1)(2012-3#1)
the genotypes##27##2##(1995-6#1)(1996-3#1)(2004-2#1)(2007-10#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-5#1)(2011-1#4)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
the genotypic composition of##2##4##(2008-10#2)
the genotypic##9##2##(2008-10#5)(2008-8#2)(2008-9#1)(2012-2#1)
the genotyping uncertainty score##2##4##(2009-8#2)
the genotyping##6##2##(2008-12#1)(2008-7#1)(2008-9#2)(2009-8#2)
the genre##3##2##(2006-12#1)(2009-10#1)(2011-2#1)
the gentamicin##3##2##(2008-10#1)(2010-3#1)(2013-7#1)
the genuine##6##2##(1990-12#1)(2007-1#1)(2008-8#1)(2010-11#1)(2010-7#1)(2012-3#1)
the genus Anacroneuria##2##3##(2008-5#2)
the genus Astyanax##3##3##(2010-8#3)
the genus Bacillus##2##3##(2008-10#1)(2011-2#1)
the genus Bacteroides##2##3##(1997-2#1)(2006-8#1)
the genus Begomovirus##5##3##(2008-10#5)
the genus Blechnum##2##3##(2013-7#2)
the genus Borrelia##3##3##(2011-2#1)(2013-8#2)
the genus Closterovirus##3##3##(2008-10#3)
the genus Clostridia##2##3##(2006-8#2)
the genus Drosophila##4##3##(1997-4#2)(2008-5#1)(2008-8#1)
the genus Flavobacterium##4##3##(2008-9#1)(2012-2#3)
the genus Gymnodactylus##2##3##(2010-3#2)
the genus Mycobacterium##2##3##(2008-7#1)(2011-1#1)
the genus Notothenia##2##3##(2012-12#2)
the genus Potyvirus##8##3##(2008-10#8)
the genus Puntius Hamilton 1822##5##5##(2008-12#5)
the genus Rymovirus##2##3##(2008-10#2)
the genus Sigmodon##2##3##(2010-4#2)
the genus Solanum##4##3##(2008-10#3)(2008-7#1)
the genus Streptomyces##6##3##(1991-12#1)(1993-9#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-7#1)
the genus Thermocrinis##2##3##(2011-2#2)
the genus Tobamovirus##4##3##(2008-10#4)
the genus Tospovirus##7##3##(2008-10#7)
the genus Trichoderma##3##3##(2008-10#3)
the genus##303##2##(1991-12#1)(1992-7#1)(1993-9#1)(1996-3#6)(1996-8#1)(1997-2#1)(1997-4#7)(2005-11#5)(2006-10#1)(2006-12#1)(2006-8#6)(2007-1#2)(2007-11#1)(2007-12#4)(2007-2#3)(2007-3#6)(2007-7#2)(2008-1#2)(2008-10#79)(2008-11#1)(2008-12#5)(2008-4#5)(2008-5#21)(2008-6#8)(2008-7#9)(2008-8#3)(2008-9#3)(2009-5#5)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#3)(2010-3#6)(2010-4#2)(2010-8#5)(2011-1#2)(2011-12#1)(2011-2#67)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#6)(2013-7#4)(2013-8#4)
the geochemical##2##2##(2008-10#2)
the geogenic##2##2##(2008-11#1)(2010-5#1)
the geographic adjustment##2##3##(1991-3#1)(1992-2#1)
the geographic area##4##3##(1991-3#1)(1997-3#1)(2011-2#1)(2013-1#1)
the geographic distribution of##7##4##(1991-12#1)(1993-9#1)(2007-3#1)(2008-5#1)(2008-7#1)(2010-3#1)(2012-12#1)
the geographic location##2##3##(2008-10#2)
the geographic origin of##3##4##(2008-10#2)(2011-2#1)
the geographic origin##4##3##(2008-10#2)(2010-10#1)(2011-2#1)
the geographic populations##5##3##(2008-10#5)
the geographic range of##2##4##(2004-11#1)(2008-5#1)
the geographic regions##4##3##(2008-10#2)(2008-8#1)(2013-1#1)
the geographic##44##2##(1991-12#1)(1991-3#5)(1992-2#1)(1993-9#1)(1994-1#1)(1994-2#1)(1997-3#1)(2004-11#1)(2007-3#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-2#4)(2012-12#1)(2013-1#2)(2013-7#1)
the geographical distribution of the##3##5##(2010-8#1)(2011-2#1)(2012-12#1)
the geographical distribution of##8##4##(2005-5#1)(2008-10#2)(2009-2#1)(2010-8#1)(2011-2#1)(2012-12#2)
the geographical distribution##9##3##(2005-5#1)(2008-10#2)(2009-2#1)(2010-8#1)(2011-2#1)(2012-12#2)(2013-7#1)
the geographical origin of the##2##5##(2006-3#1)(2008-10#1)
the geographical origin##4##3##(2006-3#1)(2007-8#1)(2008-10#1)(2008-4#1)
the geographical regions##2##3##(1992-3#1)(2008-1#1)
the geographical##29##2##(1992-3#1)(1996-4#1)(2005-5#1)(2006-3#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-2#2)(2010-8#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-7#1)
the geological##10##2##(1992-1#1)(1992-12#1)(1996-6#1)(2005-11#1)(2005-4#1)(2007-10#1)(2008-10#2)(2012-2#1)(2013-8#1)
the geometric and##4##3##(1997-8#1)(2008-3#2)(2010-8#1)
the geometric focus##3##3##(2008-3#3)
the geometric mean as##2##4##(2011-2#2)
the geometric mean##10##3##(1991-5#3)(1993-9#1)(2008-8#1)(2011-2#4)(2013-1#1)
the geometric optical performance##2##4##(2008-2#1)(2008-3#1)
the geometric parameters of##2##4##(2008-2#1)(2008-3#1)
the geometric parameters##5##3##(2008-2#3)(2008-3#2)
the geometric phase##3##3##(1992-12#1)(2007-11#2)
the geometric properties of##4##4##(1994-9#1)(2008-3#2)(2008-6#1)
the geometric shape and the size of the##2##8##(2008-2#2)
the geometric##55##2##(1990-12#1)(1991-5#3)(1992-12#1)(1993-9#1)(1994-9#1)(1997-8#2)(2007-11#3)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#10)(2008-3#16)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#5)(2013-1#1)(2013-7#1)
the geometrical and##4##3##(2006-11#1)(2007-6#1)(2008-2#1)(2012-2#1)
the geometrical cross##2##3##(2007-12#1)(2008-2#1)
the geometrical optics approximation##2##4##(2008-2#1)(2008-3#1)
the geometrical optics##3##3##(2008-2#2)(2008-3#1)
the geometrical structure of##2##4##(1993-2#1)(2008-2#1)
the geometrical##31##2##(1993-2#1)(1995-8#1)(1996-2#1)(1997-4#1)(2005-11#2)(2006-11#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-11#1)(2008-2#5)(2008-3#9)(2009-6#1)(2011-1#1)(2012-2#1)(2013-8#1)
the geometrical-optics approximation##3##3##(2008-2#2)(2008-3#1)
the geometrical-optics##5##2##(2008-2#3)(2008-3#2)
the geometrically##2##2##(1992-11#1)(2008-2#1)
the geometries of##2##3##(1997-6#1)(2012-2#1)
the geometries##4##2##(1997-6#1)(2008-2#1)(2008-3#1)(2012-2#1)
the geometry and##4##3##(2006-5#1)(2008-9#1)(2010-4#2)
the geometry of a##4##4##(2008-10#1)(2008-2#3)
the geometry of its##2##4##(1992-3#1)(1997-3#1)
the geometry of the##24##4##(1990-12#1)(1990-5#1)(1994-7#1)(1995-11#1)(1996-7#1)(2005-7#1)(2007-12#4)(2007-5#1)(2007-8#1)(2008-10#2)(2008-2#3)(2008-3#3)(2009-12#1)(2009-2#1)(2009-4#1)(2009-9#1)
the geometry of##48##3##(1990-12#1)(1990-5#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-9#2)(1993-5#1)(1994-5#1)(1994-7#1)(1995-11#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(2005-11#2)(2005-7#1)(2007-12#4)(2007-5#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-2#6)(2008-3#5)(2008-6#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2012-3#1)
the geometry##61##2##(1990-12#1)(1990-5#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-9#2)(1993-5#1)(1994-5#1)(1994-7#1)(1995-11#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(2005-10#1)(2005-11#2)(2005-7#1)(2006-5#1)(2007-12#4)(2007-5#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-2#9)(2008-3#6)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-4#2)(2012-3#1)(2013-8#1)
the gerbil brain##3##3##(1990-7#1)(1996-1#1)(1997-7#1)
the gerbil##20##2##(1990-7#1)(1992-11#1)(1992-12#1)(1994-2#4)(1994-5#1)(1995-12#3)(1995-5#1)(1995-6#1)(1996-1#1)(1997-1#1)(1997-7#2)(1997-8#1)(2010-12#2)
the gerbils##3##2##(1994-5#2)(2010-11#1)
the geriatric assessment unit##5##4##(1990-5#4)(2008-7#1)
the geriatric patient##4##3##(1990-9#1)(1991-2#1)(2005-10#1)(2006-10#1)
the geriatric population##10##3##(1990-3#1)(1993-5#1)(2006-7#2)(2007-7#1)(2009-8#1)(2010-8#3)(2012-12#1)
the geriatric##25##2##(1990-3#1)(1990-5#4)(1990-9#1)(1991-2#1)(1992-1#1)(1993-5#2)(2005-10#1)(2005-4#1)(2006-10#1)(2006-7#2)(2007-7#1)(2008-7#1)(2009-8#1)(2010-1#1)(2010-8#3)(2011-2#2)(2012-12#1)
the germ cell##3##3##(1995-11#1)(2007-12#1)(2009-10#1)
the germ cells in the testis of matrinxã##2##8##(2008-7#2)
the germ cells in the##3##5##(2008-7#3)
the germ cells##9##3##(1997-1#2)(2007-12#1)(2008-7#3)(2012-12#3)
the germ line##12##3##(1994-3#1)(1995-2#2)(2007-11#1)(2007-12#5)(2009-3#3)
the germ plasm##3##3##(2008-10#3)
the germ theory##2##3##(1994-3#1)(2012-12#1)
the germ##36##2##(1994-3#2)(1995-11#1)(1995-2#2)(1997-1#2)(2006-6#1)(2007-11#1)(2007-12#8)(2008-10#4)(2008-7#5)(2009-10#1)(2009-3#3)(2010-3#1)(2010-4#1)(2012-12#4)
the germ-line##2##2##(1997-5#1)(2009-3#1)
the germanium##2##2##(2007-12#1)(2008-5#1)
the germinal cells##2##3##(1994-6#2)
the germinal vesicle##3##3##(2007-12#1)(2008-7#1)(2013-1#1)
the germinal##9##2##(1992-11#3)(1994-3#1)(1994-6#2)(2007-12#1)(2008-7#1)(2013-1#1)
the germinating##2##2##(2008-10#2)
the germination and##3##3##(2006-12#1)(2008-10#1)(2011-2#1)
the germination of the##2##4##(2008-5#2)
the germination of##11##3##(2007-5#1)(2008-10#3)(2008-12#2)(2008-5#2)(2011-1#1)(2012-2#2)
the germination percentage of##2##4##(2008-10#1)(2008-5#1)
the germination process##2##3##(2004-2#1)(2011-2#1)
the germination##24##2##(2004-2#2)(2006-12#1)(2007-5#1)(2008-10#8)(2008-12#2)(2008-5#3)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#2)
the germline##18##2##(1991-11#1)(1992-10#1)(1993-2#2)(1995-8#4)(2007-10#1)(2007-12#1)(2009-10#1)(2010-5#2)(2012-12#3)(2012-3#1)(2013-8#1)
the gerontological profile##2##3##(2012-12#2)
the gerontological##3##2##(2012-12#2)(2012-3#1)
the gestational age at booking##3##5##(2009-5#3)
the gestational age at##4##4##(2009-5#3)(2010-12#1)
the gestational age of the##2##5##(2008-7#1)(2012-2#1)
the gestational age##12##3##(1994-5#1)(1996-12#1)(2004-10#1)(2008-12#1)(2008-7#1)(2009-5#3)(2010-12#1)(2011-1#2)(2012-2#1)
the gestational period##2##3##(1996-5#1)(2009-1#1)
the gestational##18##2##(1993-6#1)(1994-5#1)(1996-11#1)(1996-12#1)(1996-5#1)(2004-10#2)(2007-4#1)(2008-12#1)(2008-7#1)(2009-1#1)(2009-5#3)(2010-12#1)(2011-1#2)(2012-2#1)
the gfp gene##4##3##(1996-6#2)(2004-4#1)(2008-10#1)
the gfp##6##2##(1996-6#2)(1997-4#2)(2004-4#1)(2008-10#1)
the ghost pulse##3##3##(2007-11#2)(2007-12#1)
the ghost##7##2##(1990-4#1)(2007-11#2)(2007-12#2)(2008-2#1)(2012-2#1)
the giant cells##2##3##(1995-5#1)(2008-10#1)
the giant grouper (Epinephelus lanceolatus)##2##5##(2010-5#2)
the giant grouper##3##3##(2010-5#3)
the giant panda were##2##4##(2008-8#2)
the giant##23##2##(1991-2#1)(1991-5#1)(1993-10#1)(1995-11#1)(1995-5#1)(1997-6#1)(2005-9#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#2)(2010-5#4)(2011-2#1)(2012-2#1)(2013-7#2)
the gibbon HBV##3##3##(1993-8#3)
the gift##4##2##(1995-1#1)(2007-4#1)(2008-11#1)(2013-1#1)
the gigahertz##2##2##(2007-11#1)(2007-12#1)
the gill and##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
the gill##14##2##(1995-2#1)(1995-6#1)(2007-3#1)(2008-10#1)(2008-5#4)(2008-7#6)
the gills and##3##3##(2008-10#1)(2008-12#1)(2012-3#1)
the gills##13##2##(2006-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#4)(2010-8#2)(2012-3#1)(2013-1#1)
the gingiva##9##2##(1991-5#1)(1993-1#2)(2009-8#1)(2012-12#1)(2012-3#2)(2013-7#1)(2013-8#1)
the gingival index (GI)##2##4##(2012-12#1)(2013-8#1)
the gingival surface##2##3##(1990-10#1)(2012-3#1)
the gingival tissues##2##3##(2012-12#1)(2012-3#1)
the gingival veneer##3##3##(2012-12#3)
the gingival##15##2##(1990-10#1)(2004-3#1)(2012-12#6)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
the giraffe that##2##3##(2009-4#2)
the giraffe##3##2##(2009-4#3)
the girl should##2##3##(1995-6#1)(2012-12#1)
the girl##5##2##(1995-6#2)(1995-9#1)(2006-2#1)(2012-12#1)
the girl)##2##2##(2008-11#2)
the girls##9##2##(1991-8#1)(1991-9#1)(1993-10#1)(2006-4#2)(2007-11#1)(2007-2#1)(2007-3#1)(2013-1#1)
the given experimental##2##3##(1991-2#1)(2007-8#1)
the given##32##2##(1991-2#1)(1997-6#1)(2006-11#1)(2006-6#1)(2007-11#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-6#1)(2010-12#1)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
the gizzard and##2##3##(1991-5#1)(2008-5#1)
the gizzard##7##2##(1991-5#1)(2008-5#6)
the gland cells##2##3##(2007-12#1)(2008-7#1)
the gland during##2##3##(2011-1#1)(2013-8#1)
the gland is##2##3##(1992-10#1)(2007-12#1)
the gland opening##4##3##(2007-12#4)
the gland secretion##2##3##(2007-12#1)(2008-7#1)
the gland##33##2##(1991-9#2)(1992-10#1)(1992-5#1)(1992-7#1)(2004-1#1)(2004-2#1)(2006-6#2)(2006-9#1)(2007-12#14)(2007-7#1)(2008-7#3)(2009-12#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
the glands are##3##3##(1996-11#1)(2007-12#2)
the glands##11##2##(1996-11#1)(2006-5#1)(2006-6#2)(2007-12#5)(2008-3#1)(2008-5#1)
the glandular epithelium of the##3##5##(1995-6#1)(2007-9#1)(2008-5#1)
the glandular epithelium##5##3##(1995-6#1)(2007-12#1)(2007-9#1)(2008-5#1)(2012-12#1)
the glandular region##2##3##(2007-12#2)
the glandular tissue of the##2##5##(2007-12#2)
the glandular##19##2##(1992-2#2)(1995-6#1)(1997-1#1)(2005-10#1)(2007-12#8)(2007-9#2)(2008-5#1)(2008-7#1)(2012-12#2)
the glans area##2##3##(2006-5#2)
the glans penis##5##3##(2007-7#4)(2007-8#1)
the glans##8##2##(1991-2#1)(2006-5#2)(2007-7#4)(2007-8#1)
the glass and##4##3##(2007-12#1)(2008-11#2)(2009-7#1)
the glass before##2##3##(2007-12#1)(2008-4#1)
the glass capillary of a##2##5##(2008-10#2)
the glass electrode##4##3##(2008-10#4)
the glass fiber##2##3##(2007-11#1)(2008-10#1)
the glass infiltration mode (under or without vacuum)##2##8##(2009-8#2)
the glass infiltration mode##3##4##(2009-8#3)
the glass pores##2##3##(2008-3#2)
the glass sample##2##3##(2007-12#2)
the glass samples##2##3##(2007-12#1)(2008-10#1)
the glass slide and##2##4##(2006-5#1)(2007-7#1)
the glass slides##2##3##(2007-9#1)(2008-10#1)
the glass substrate##2##3##(2008-4#1)(2010-4#1)
the glass surface##4##3##(1991-5#1)(2008-3#1)(2010-4#1)(2013-1#1)
the glass to##3##3##(2008-10#1)(2010-4#1)(2010-8#1)
the glass transition in##2##4##(1995-3#2)
the glass transition temperature of the##2##6##(2008-3#2)
the glass transition temperature##7##4##(1995-3#1)(2004-9#1)(2005-11#1)(2008-3#3)(2009-3#1)
the glass transition##14##3##(1995-3#3)(2004-9#2)(2005-11#1)(2008-2#1)(2008-3#3)(2009-3#1)(2012-2#2)(2013-7#1)
the glass was##3##3##(2006-7#1)(2007-12#1)(2008-3#1)
the glass were##2##3##(2007-12#2)
the glass##96##2##(1991-5#1)(1995-3#3)(2004-9#4)(2005-11#1)(2005-4#1)(2006-5#1)(2006-7#1)(2007-11#2)(2007-12#17)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#20)(2008-11#4)(2008-2#4)(2008-3#13)(2008-4#2)(2009-3#1)(2009-7#1)(2009-8#3)(2010-2#1)(2010-4#3)(2010-8#2)(2010-9#3)(2012-2#3)(2013-1#1)(2013-7#1)
the glass-ionomers##3##2##(2004-9#3)
the glasses##2##2##(2007-12#2)
the glassy carbon electrode (GCE)##3##5##(2008-10#3)
the glassy carbon electrode##14##4##(1995-6#1)(2008-10#13)
the glassy carbon##15##3##(1995-6#1)(2008-10#14)
the glassy##18##2##(1995-3#2)(1995-6#1)(2008-10#14)(2008-7#1)
the glassy-winged sharpshooter##3##3##(2007-12#2)(2011-12#1)
the glaucoma##3##2##(2010-2#1)(2013-8#2)
the glcA##2##2##(1990-1#2)
the gleaner-opportunist trade-off##2##3##(2008-8#2)
the glenohumeral joint##5##3##(2006-11#1)(2007-10#1)(2007-4#1)(2007-7#1)(2009-3#1)
the glenoid##5##2##(2006-10#1)(2007-11#1)(2007-7#1)(2010-11#1)(2011-2#1)
the glial cell##2##3##(2008-3#1)(2009-8#1)
the glial cells##7##3##(1990-7#1)(1996-12#1)(1996-3#1)(1997-5#1)(2008-1#1)(2008-11#1)(2008-7#1)
the glial##22##2##(1990-7#2)(1993-11#1)(1994-11#1)(1994-5#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-5#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#5)(2009-8#1)
the glibenclamide##2##2##(1994-3#1)(2008-4#1)
the glioblastoma##5##2##(1990-9#1)(1993-11#1)(1995-12#1)(2008-7#1)(2011-2#1)
the glioma##3##2##(2007-10#2)(2007-11#1)
the global analysis##2##3##(2008-7#1)(2011-2#1)
the global and local##2##4##(2008-2#1)(2011-1#1)
the global and##6##3##(1994-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-8#1)(2011-1#1)
the global budget##3##3##(1993-3#1)(1994-12#1)(2008-11#1)
the global budgets##2##3##(1991-12#1)(2008-11#1)
the global burden of##2##4##(2006-9#1)(2012-1#1)
the global burden##3##3##(2006-10#1)(2006-9#1)(2012-1#1)
the global carbon cycle##3##4##(1995-8#1)(2007-9#1)(2008-3#1)
the global community##3##3##(2008-3#1)(2009-4#1)(2012-12#1)
the global context##2##3##(1990-11#1)(2008-7#1)
the global distribution of##2##4##(2009-8#1)(2012-12#1)
the global energy##2##3##(2008-2#1)(2010-2#1)
the global eradication of##3##4##(2007-2#2)(2009-9#1)
the global evolution of##2##4##(1990-9#1)(2008-2#1)
the global features##3##3##(2007-9#1)(2008-2#1)(2008-3#1)
the global gene expression profile of##2##6##(2011-2#2)
the global gene expression##3##4##(2009-12#1)(2011-2#2)
the global genomic##2##3##(2008-11#2)
the global information##2##3##(2009-4#1)(2010-8#1)
the global left ventricular##2##4##(1997-6#1)(2008-12#1)
the global level##4##3##(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
the global maximum##3##3##(2008-8#1)(2010-3#1)(2010-8#1)
the global minimum of##3##4##(1991-4#1)(2008-2#2)
the global minimum##10##3##(1991-4#1)(1991-9#1)(1993-11#1)(1995-10#1)(2008-2#5)(2008-3#1)
the global minimum-energy##3##3##(1991-9#3)
the global optimum can##2##4##(2008-10#2)
the global optimum##3##3##(2008-10#3)
the global pathway##3##3##(2007-12#3)
the global phase angle##2##4##(2007-11#2)
the global polio eradication initiative##2##5##(2004-12#2)
the global population##3##3##(2007-12#1)(2008-8#2)
the global prevalence of##2##4##(1997-3#1)(2013-8#1)
the global regulation of##2##4##(2009-6#2)
the global shape of##3##4##(1995-3#1)(2008-4#1)(2009-4#1)
the global shape##6##3##(1995-3#1)(1997-1#2)(2008-4#2)(2009-4#1)
the global stability of the##2##5##(1997-2#1)(2008-2#1)
the global stability##3##3##(1997-2#1)(2008-10#1)(2008-2#1)
the global sun radiation##2##4##(2011-2#2)
the global trend##2##3##(2006-8#1)(2008-10#1)
the global##216##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-4#2)(1991-6#1)(1991-9#4)(1993-10#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-12#2)(1995-10#1)(1995-3#2)(1995-5#1)(1995-8#2)(1996-12#1)(1996-4#1)(1996-5#2)(1996-7#2)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(2004-12#2)(2004-3#1)(2005-10#1)(2005-11#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#8)(2007-2#2)(2007-4#3)(2007-5#2)(2007-8#2)(2007-9#4)(2008-1#1)(2008-10#13)(2008-11#8)(2008-12#1)(2008-2#21)(2008-3#10)(2008-4#5)(2008-5#1)(2008-7#5)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#5)(2009-5#2)(2009-6#2)(2009-8#3)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#4)(2011-1#2)(2011-2#10)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#3)(2013-7#3)(2013-8#2)
the globalization of##3##3##(1996-12#1)(2008-11#1)(2008-7#1)
the globally distributed##2##3##(2008-10#1)(2011-1#1)
the globe to##2##3##(1990-11#1)(2008-10#1)
the globe##32##2##(1990-11#1)(1996-5#1)(1997-5#1)(2004-8#1)(2005-11#1)(2005-12#1)(2006-11#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-2#1)(2009-6#2)(2010-12#2)(2011-1#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#1)
the globin##5##2##(1990-8#2)(1991-5#1)(2008-10#1)(2008-9#1)
the globular domain and##3##4##(1990-7#1)(1992-7#2)
the globular domain##9##3##(1990-7#2)(1991-1#1)(1992-7#3)(1997-4#2)(2011-1#1)
the globular domains of##2##4##(1990-7#1)(1996-5#1)
the globular##21##2##(1990-7#3)(1991-1#1)(1991-5#1)(1992-7#3)(1995-12#2)(1996-4#1)(1996-5#1)(1997-4#2)(2005-11#1)(2006-10#1)(2009-12#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
the globule##3##2##(1990-7#1)(1991-4#1)(2006-10#1)
the globus pallidus (GP)##4##4##(1990-7#1)(1991-9#2)(1993-12#1)
the globus pallidus and##2##4##(1993-11#1)(2009-2#1)
the globus pallidus##17##3##(1990-7#2)(1991-9#3)(1993-11#3)(1993-12#2)(1994-2#1)(2005-10#1)(2008-11#2)(2009-10#1)(2009-2#1)(2012-2#1)
the globus##18##2##(1990-7#2)(1991-9#3)(1993-11#3)(1993-12#2)(1994-2#1)(1995-5#1)(2005-10#1)(2008-11#2)(2009-10#1)(2009-2#1)(2012-2#1)
the glomerular basement membrane##6##4##(1992-7#1)(2007-7#1)(2007-8#1)(2008-1#1)(2012-2#2)
the glomerular capillary wall##2##4##(1993-4#1)(2007-7#1)
the glomerular filtration rate (GFR)##3##5##(1995-5#1)(2007-2#1)(2011-2#1)
the glomerular filtration rate##8##4##(1995-5#1)(1996-6#1)(2007-2#1)(2007-7#1)(2011-2#2)(2012-12#1)(2013-8#1)
the glomerular filtration##9##3##(1995-5#1)(1996-5#1)(1996-6#1)(2007-2#1)(2007-7#1)(2011-2#2)(2012-12#1)(2013-8#1)
the glomerular##41##2##(1990-2#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-7#2)(1993-4#1)(1995-12#1)(1995-5#1)(1996-3#6)(1996-5#1)(1996-6#2)(1996-7#1)(2007-12#2)(2007-2#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#3)(2009-2#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#1)
the glomeruli and##3##3##(1995-2#1)(2005-1#1)(2007-11#1)
the glomeruli##9##2##(1995-2#2)(2005-1#2)(2007-11#1)(2007-12#4)
the glomerulonephritis##3##2##(1992-7#1)(1993-2#2)
the glomerulus##6##2##(1993-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2012-2#1)
the glomus##2##2##(1990-7#1)(1996-8#1)
the glory##3##2##(2007-11#2)(2010-8#1)
the gloss uniformity##2##3##(2008-3#2)
the gloss##3##2##(2008-3#3)
the glossa##2##2##(2007-12#2)
the glossopharyngeal nerve##2##3##(1995-6#1)(2011-2#1)
the glossopharyngeal##4##2##(1991-9#1)(1995-6#2)(2011-2#1)
the glottis##2##2##(2009-2#1)(2013-8#1)
the gloves##5##2##(1995-6#3)(2012-2#2)
the glow##2##2##(2011-2#1)(2012-2#1)
the glucagon##10##2##(1990-3#1)(1995-11#2)(1997-8#1)(2006-6#1)(2007-5#1)(2010-11#2)(2011-2#1)(2012-3#1)
the glucagon-evoked##2##2##(1996-2#2)
the glucagon-induced increase of NAD(P)H##2##5##(1996-2#2)
the glucagon-induced increase##3##3##(1991-6#1)(1996-2#2)
the glucagon-like##2##2##(1994-11#1)(2010-4#1)
the glucoamylase##2##2##(1996-4#1)(2008-8#1)
the glucocorticoid dexamethasone##2##3##(1993-6#1)(1997-6#1)
the glucocorticoid receptor (GR)##4##4##(1993-12#1)(1994-11#1)(1996-5#1)(2006-10#1)
the glucocorticoid receptor and##3##4##(1990-12#1)(1991-11#1)(1993-12#1)
the glucocorticoid receptor##25##3##(1990-11#1)(1990-12#3)(1991-11#1)(1991-12#1)(1993-11#1)(1993-12#3)(1993-8#2)(1994-11#3)(1994-8#2)(1996-12#3)(1996-5#1)(2005-8#1)(2006-10#1)(2008-11#1)(2008-7#1)
the glucocorticoid##38##2##(1990-11#1)(1990-12#5)(1991-11#1)(1991-12#2)(1991-6#2)(1993-11#1)(1993-12#3)(1993-4#1)(1993-6#1)(1993-8#2)(1994-11#4)(1994-8#2)(1996-12#3)(1996-5#1)(1997-6#1)(1997-7#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-7#1)(2010-10#1)(2012-12#1)
the glucocorticoid-induced##3##2##(1991-6#1)(1994-12#1)(2011-1#1)
the glucocorticoid-receptor complex##2##3##(1994-8#2)
the glucocorticoids##3##2##(2007-11#1)(2007-12#1)(2008-9#1)
the glucokinase gene##3##3##(1992-5#3)
the glucokinase##5##2##(1992-5#5)
the gluconeogenic##2##2##(1991-8#1)(1994-8#1)
the glucose and##4##3##(2008-3#2)(2008-4#1)(2012-2#1)
the glucose biosensor##5##3##(2008-10#3)(2010-5#2)
the glucose concentration in##3##4##(1994-5#1)(2004-9#1)(2008-10#1)
the glucose concentration##11##3##(1994-3#1)(1994-5#1)(2004-9#1)(2008-10#6)(2008-5#2)
the glucose consumption rate##2##4##(2008-11#2)
the glucose consumption##3##3##(2008-11#3)
the glucose group##2##3##(1996-11#2)
the glucose levels##2##3##(2007-8#1)(2008-5#1)
the glucose lowering effect##2##4##(2009-5#2)
the glucose moiety##2##3##(1996-5#1)(2008-10#1)
the glucose oxidase##6##3##(2007-6#1)(2008-10#5)
the glucose residue##2##3##(1993-8#1)(1995-1#1)
the glucose response##2##3##(2008-10#1)(2012-11#1)
the glucose sensors##2##3##(2008-10#2)
the glucose tolerance test##3##4##(2008-10#1)(2011-1#1)(2012-12#1)
the glucose transporter##5##3##(1990-2#1)(1993-6#1)(1994-2#1)(1995-10#1)(2006-10#1)
the glucose uptake##4##3##(2008-11#2)(2008-7#1)(2008-8#1)
the glucose utilization##2##3##(1991-7#1)(1995-3#1)
the glucose##85##2##(1990-2#1)(1990-8#1)(1991-7#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-11#2)(1996-5#1)(2004-11#1)(2004-9#1)(2006-10#1)(2007-6#1)(2007-8#1)(2008-10#26)(2008-11#7)(2008-3#2)(2008-4#1)(2008-5#7)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#2)(2010-5#2)(2011-1#2)(2012-11#2)(2012-12#1)(2012-2#1)(2012-4#1)
the glucose-6-phosphatase##3##2##(1991-2#1)(1993-8#1)(1994-5#1)
the glucose-6-phosphate##3##2##(2008-10#2)(2012-2#1)
the glucose-induced##4##2##(1993-12#2)(1997-4#1)(2008-1#1)
the glucose/gluconic acid conversion##2##4##(2008-5#2)
the glucosidase##3##2##(1995-5#2)(2011-1#1)
the glucuronic##2##2##(2008-10#1)(2012-3#1)
the glucuronidation of##2##3##(2008-11#1)(2008-8#1)
the glucuronide##3##2##(1990-11#1)(1996-6#1)(1996-8#1)
the glutamate agonist N-methyl-D-aspartate (NMDA)##2##5##(1992-7#1)(1995-6#1)
the glutamate agonist##3##3##(1992-7#1)(1995-6#1)(1997-5#1)
the glutamate dehydrogenase##3##3##(1992-11#1)(2008-11#1)(2008-8#1)
the glutamate receptor##4##3##(1995-10#1)(1996-4#1)(1996-5#1)(1997-4#1)
the glutamate transporter##4##3##(1993-3#1)(1995-11#1)(1996-2#1)(1997-7#1)
the glutamate##38##2##(1990-11#1)(1990-2#1)(1990-6#1)(1990-7#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-2#2)(1994-6#1)(1995-10#1)(1995-11#1)(1995-6#1)(1996-1#3)(1996-2#1)(1996-4#1)(1996-5#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-12#1)(2008-11#1)(2008-2#1)(2008-7#6)(2008-8#2)
the glutamate-induced neuronal##2##3##(1994-10#1)(2007-9#1)
the glutamate-induced rise in [Ca2+]i##2##5##(1995-12#2)
the glutamate-induced rise in##3##4##(1995-12#3)
the glutamate-induced##5##2##(1994-10#1)(1995-12#3)(2007-9#1)
the glutamatergic system is##2##4##(2008-7#2)
the glutamatergic system##9##3##(1992-3#1)(1993-2#1)(1996-3#1)(2008-1#1)(2008-7#5)
the glutamatergic##13##2##(1992-3#1)(1993-2#1)(1995-11#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-3#1)(2008-7#5)(2012-1#1)
the glutamic acid residue##3##4##(1996-5#2)(2009-2#1)
the glutamic acid##5##3##(1990-8#1)(1996-5#2)(2008-10#1)(2009-2#1)
the glutaminase##4##2##(1990-7#1)(1991-7#3)
the glutamine##10##2##(1993-8#1)(1994-11#2)(1997-1#1)(2008-10#1)(2008-11#4)(2008-2#1)
the glutaminolysis##2##2##(2008-11#2)
the glutathione (GSH)##2##3##(1990-3#1)(1991-9#1)
the glutathione S-transferase##2##3##(1995-10#1)(1995-8#1)
the glutathione binding site##2##4##(1991-1#1)(1992-9#1)
the glutathione level of##2##4##(1994-6#1)(1996-11#1)
the glutathione peroxidase##3##3##(1994-9#1)(2008-10#1)(2013-1#1)
the glutathione reductase##2##3##(1994-9#1)(2013-8#1)
the glutathione##21##2##(1990-3#1)(1991-1#1)(1991-9#1)(1992-11#1)(1992-9#2)(1993-3#1)(1994-6#1)(1994-9#2)(1995-10#1)(1995-5#1)(1995-8#1)(1996-11#1)(1997-2#1)(2008-10#3)(2008-11#1)(2013-1#1)(2013-8#1)
the gluteal region with##2##4##(1992-2#1)(2011-2#1)
the gluteal region##5##3##(1992-2#1)(2005-11#1)(2009-9#1)(2010-8#1)(2011-2#1)
the gluteal##7##2##(1992-2#1)(2005-11#1)(2009-9#1)(2010-8#1)(2011-2#1)(2013-7#1)(2013-8#1)
the gluten protein##2##3##(2012-1#2)
the gluten##3##2##(2007-5#1)(2012-1#2)
the gluten-free##2##2##(1991-2#1)(2007-5#1)
the glutenin HMW subunit##2##4##(1992-7#2)
the gluteus medius##4##3##(2006-10#2)(2013-7#2)
the gluteus##5##2##(2006-10#2)(2009-3#1)(2013-7#2)
the glutinous cultivars##2##3##(2008-10#2)
the glutinous##3##2##(2008-10#3)
the glycan structures##2##3##(1992-9#1)(2010-2#1)
the glycan##7##2##(1990-4#1)(1990-7#1)(1991-12#1)(1992-9#1)(1997-4#1)(2008-4#1)(2010-2#1)
the glycans##4##2##(1990-5#1)(1994-9#1)(1996-8#1)(2008-4#1)
the glycated albumin##2##3##(1993-6#1)(1995-1#1)
the glycated##3##2##(1993-6#1)(1995-1#2)
the glycation of##4##3##(1991-5#1)(1992-7#1)(1994-6#1)(2007-11#1)
the glycation##5##2##(1991-5#1)(1992-7#1)(1994-6#1)(1994-8#1)(2007-11#1)
the glycemia##2##2##(2008-10#1)(2011-1#1)
the glycemic index and the glycemic load##2##7##(2008-1#2)
the glycemic##6##2##(2007-3#1)(2008-1#4)(2011-2#1)
the glyceraldehyde-3-phosphate##3##2##(1992-1#1)(1995-6#1)(2008-10#1)
the glycerol backbone##3##3##(1990-3#2)(1990-4#1)
the glycerol kinase locus##2##4##(1996-10#2)
the glycerol##10##2##(1990-2#1)(1990-3#2)(1990-4#1)(1996-10#2)(1996-5#1)(1997-3#1)(1997-7#1)(2011-2#1)
the glycerolipid receptor##2##3##(1991-3#2)
the glycerolipid##3##2##(1991-3#2)(1993-6#1)
the glycine binding site##2##4##(1996-12#2)
the glycine cleavage complex##2##4##(1997-1#2)
the glycine cleavage##6##3##(1991-4#2)(1992-10#1)(1996-5#1)(1997-1#2)
the glycine decarboxylase##2##3##(1990-12#2)
the glycine modulatory site of the NMDA receptor##3##8##(1990-2#2)(1991-9#1)
the glycine modulatory##4##3##(1990-2#2)(1991-9#1)(2011-1#1)
the glycine receptor##6##3##(1990-7#1)(1992-11#3)(1996-2#1)(1997-3#1)
the glycine residue##4##3##(1991-2#1)(1994-3#1)(1996-5#1)(1997-6#1)
the glycine residues##2##3##(2010-7#2)
the glycine site of the NMDA receptor complex##2##8##(1991-9#1)(1996-1#1)
the glycine site of the NMDA receptor##4##7##(1991-9#1)(1996-1#2)(1997-2#1)
the glycine site of the##5##5##(1991-9#1)(1996-1#2)(1997-2#2)
the glycine site##8##3##(1991-9#1)(1996-1#2)(1996-12#1)(1997-2#4)
the glycine##43##2##(1990-12#2)(1990-2#2)(1990-7#1)(1991-2#1)(1991-4#2)(1991-9#2)(1992-10#1)(1992-11#3)(1992-6#1)(1994-3#1)(1995-12#1)(1995-8#1)(1996-1#2)(1996-12#3)(1996-2#1)(1996-5#3)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#1)(1997-6#1)(2006-10#1)(2008-4#2)(2010-7#3)(2011-1#1)
the glycine-rich loop and##2##4##(1995-6#1)(2008-5#1)
the glycine-rich sequence##2##3##(1992-11#1)(1994-8#1)
the glycine-rich##10##2##(1992-11#2)(1994-8#1)(1995-6#1)(1997-1#1)(1997-4#1)(1997-7#2)(2008-10#1)(2008-5#1)
the glycogen##2##2##(1993-1#1)(1996-9#1)
the glycogenolytic##2##2##(1992-5#1)(1995-9#1)
the glycol##4##2##(1995-2#1)(2005-11#2)(2007-11#1)
the glycolipid##3##2##(1992-1#1)(1996-4#1)(1997-7#1)
the glycolipids##4##2##(1991-3#1)(1993-9#1)(2005-11#2)
the glycolysis##4##2##(2005-12#1)(2008-11#1)(2009-4#1)(2010-7#1)
the glycolytic enzyme##3##3##(1992-2#1)(1994-9#1)(1995-8#1)
the glycolytic flux##2##3##(1992-3#1)(2008-7#1)
the glycolytic pathway##8##3##(1991-9#1)(1993-3#1)(1996-6#1)(2008-11#1)(2008-7#2)(2010-3#1)(2012-2#1)
the glycolytic##19##2##(1990-7#1)(1991-2#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-8#2)(1994-9#1)(1995-8#1)(1996-6#2)(1997-2#1)(2008-11#1)(2008-7#3)(2010-3#1)(2012-2#1)
the glycopeptide products of##2##4##(2009-12#2)
the glycopeptide##7##2##(1990-5#1)(1990-8#1)(1994-8#1)(1995-2#1)(2008-5#1)(2009-12#2)
the glycopeptidolipid##2##2##(1992-12#2)
the glycophorin##2##2##(1994-12#1)(2008-9#1)
the glycoprotein (GP) IIb/IIIa##2##4##(2005-7#1)(2007-11#1)
the glycoprotein IIb-IIIa receptor##5##4##(1990-5#1)(2005-7#4)
the glycoprotein IIb-IIIa##7##3##(1990-5#2)(2005-7#4)(2006-6#1)
the glycoprotein processing##2##3##(1993-8#2)
the glycoprotein##33##2##(1990-5#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-7#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-12#2)(1993-6#1)(1993-8#3)(1994-8#1)(1995-2#1)(1996-3#1)(2005-7#5)(2006-10#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-7#1)(2010-2#1)(2012-3#1)(2013-8#2)
the glycoproteins##3##2##(2008-10#1)(2008-7#1)(2010-12#1)
the glycosaminoglycan chains##2##3##(1994-8#1)(1997-3#1)
the glycosaminoglycan##12##2##(1990-3#1)(1991-9#2)(1992-6#1)(1994-8#1)(1995-12#1)(1995-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(2011-12#1)(2012-3#1)
the glycoside##3##2##(1992-11#1)(1995-11#1)(2007-5#1)
the glycosides##2##2##(1996-10#1)(2007-1#1)
the glycosidic angle##2##3##(1993-11#1)(1993-3#1)
the glycosidic bond of##2##4##(1997-4#1)(2008-10#1)
the glycosidic bond##5##3##(1995-1#1)(1996-4#2)(1997-4#1)(2008-10#1)
the glycosidic linkage##5##3##(1990-5#1)(1993-11#2)(1996-4#1)(2010-5#1)
the glycosidic torsion##2##3##(1991-9#1)(1995-1#1)
the glycosidic##19##2##(1990-5#1)(1991-9#1)(1992-1#1)(1992-12#1)(1993-11#4)(1993-3#1)(1995-1#3)(1996-4#3)(1997-4#1)(2008-10#1)(2009-12#1)(2010-5#1)
the glycosphingolipid content of##2##4##(1991-8#2)
the glycosphingolipid##5##2##(1991-8#2)(1993-9#1)(1994-9#1)(2011-1#1)
the glycosyl donor##2##3##(1996-10#1)(2009-10#1)
the glycosyl residues of the##2##5##(1990-12#2)
the glycosyl residues##3##3##(1990-12#2)(1994-5#1)
the glycosyl##7##2##(1990-12#2)(1994-10#1)(1994-5#1)(1996-10#1)(2007-8#1)(2009-10#1)
the glycosylated##4##2##(1990-4#2)(1990-7#1)(1996-9#1)
the glycosylation of specific proteins##2##5##(2010-11#2)
the glycosylation of##7##3##(1994-11#1)(1996-4#1)(1997-4#2)(2008-4#1)(2010-11#2)
the glycosylation site##3##3##(1990-5#2)(1992-10#1)
the glycosylation sites##2##3##(2008-7#1)(2010-12#1)
the glycosylation##22##2##(1990-5#2)(1992-10#1)(1992-6#1)(1994-11#2)(1996-4#1)(1996-8#1)(1997-2#1)(1997-4#2)(2006-12#1)(2008-11#3)(2008-4#1)(2008-7#1)(2010-11#2)(2010-12#1)(2010-2#1)(2012-3#1)
the glycosylphosphatidylinositol (GPI)##2##3##(1995-3#1)(2008-9#1)
the glycosylphosphatidylinositol##3##2##(1995-3#1)(2008-4#1)(2008-9#1)
the glyoxal/DMSO method for denaturing gel electrophoresis##3##7##(2008-2#1)(2008-4#2)
the glyoxalase##2##2##(2008-10#1)(2008-11#1)
the glyoxylate cycle is##2##4##(1995-4#2)
the glyoxylate cycle##3##3##(1995-4#2)(2008-10#1)
the glyoxylate##4##2##(1995-4#2)(2008-10#1)(2008-7#1)
the gnd##3##2##(1991-12#3)
the go##2##2##(1991-6#1)(2013-8#1)
the goal has been##2##4##(1992-2#1)(2008-8#1)
the goal is to##5##4##(1994-11#1)(2007-11#1)(2008-2#1)(2009-5#1)(2009-9#1)
the goal is##8##3##(1994-11#1)(1996-4#1)(2007-11#1)(2008-2#1)(2008-4#1)(2009-5#1)(2009-8#1)(2009-9#1)
the goal of achieving##3##4##(1991-4#1)(2009-4#1)(2009-7#1)
the goal of an##2##4##(1996-2#1)(2010-9#1)
the goal of developing##3##4##(2007-11#1)(2008-11#1)(2011-8#1)
the goal of preventing##3##4##(1993-2#1)(2006-10#1)(2008-10#1)
the goal of providing##5##4##(2007-12#1)(2008-10#1)(2008-4#1)(2012-1#2)
the goal of the##2##4##(2011-12#1)(2013-1#1)
the goal of this study##2##5##(2007-6#1)(2009-10#1)
the goal of this##5##4##(2007-6#1)(2008-10#1)(2008-11#1)(2009-10#1)(2012-12#1)
the goal of##98##3##(1990-12#1)(1991-4#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1994-1#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-2#2)(1997-1#2)(2005-11#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#3)(2007-1#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-6#2)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#1)(2011-8#1)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#3)(2013-1#7)(2013-7#1)
the goal to##4##3##(1994-3#1)(1994-8#1)(2007-2#1)(2010-9#1)
the goal##130##2##(1990-12#1)(1991-4#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-2#2)(1994-1#1)(1994-11#3)(1994-2#2)(1994-3#4)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-2#2)(1996-4#1)(1997-1#2)(2005-11#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#3)(2007-1#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#1)(2007-6#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#5)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-12#2)(2010-2#2)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#1)(2011-12#1)(2011-2#1)(2011-8#1)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#7)(2013-7#1)
the goals and objectives of##2##5##(1994-12#1)(2007-4#1)
the goals and outcomes##2##4##(1994-3#1)(2012-12#1)
the goals and##6##3##(1994-1#1)(1994-12#1)(1994-3#1)(1996-1#1)(2007-4#1)(2012-12#1)
the goals of Healthy People##2##5##(1996-2#1)(2007-2#1)
the goals of care##2##4##(1994-3#2)
the goals of the##5##4##(2006-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-5#1)
the goals of this##2##4##(1994-3#1)(2009-8#1)
the goals of##38##3##(1994-1#1)(1994-2#2)(1994-3#3)(1995-1#1)(1996-2#1)(1996-3#1)(1996-7#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#3)(2009-5#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#5)(2013-7#1)
the goals##55##2##(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#5)(1995-1#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-7#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-5#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#5)(2013-7#1)
the goat##2##2##(1993-3#1)(2010-4#1)
the goats##5##2##(1993-1#1)(1997-8#1)(2008-12#1)(2008-5#1)(2010-2#1)
the goblet cells##3##3##(2006-11#1)(2010-8#2)
the goblet##4##2##(2006-11#1)(2010-8#2)(2012-12#1)
the gold electrode and##2##4##(2005-11#1)(2008-10#1)
the gold electrode modified with a self-assembled monolayer of l-cysteine##2##10##(2008-10#2)
the gold electrode surface##3##4##(2008-10#3)
the gold electrode##8##3##(2005-11#1)(2008-10#7)
the gold grating##3##3##(2008-2#1)(2008-3#2)
the gold nanoparticles##4##3##(2007-8#1)(2008-10#1)(2008-7#1)(2009-12#1)
the gold particles##2##3##(2008-9#1)(2009-3#1)
the gold standard approach##2##4##(2011-1#1)(2011-2#1)
the gold standard for detecting##2##5##(1996-2#1)(2011-12#1)
the gold standard for diagnosis of##4##6##(2005-10#1)(2011-2#1)(2013-1#2)
the gold standard for diagnosis##6##5##(1991-10#1)(2005-10#1)(2006-10#1)(2011-2#1)(2013-1#2)
the gold standard for obtaining##2##5##(2008-9#1)(2011-1#1)
the gold standard for the diagnosis of##4##7##(2005-8#1)(2006-2#1)(2008-11#1)(2011-2#1)
the gold standard for the diagnosis##5##6##(2005-8#1)(2006-2#1)(2008-11#1)(2011-2#1)(2012-12#1)
the gold standard for the##6##5##(2005-8#1)(2006-2#2)(2008-11#1)(2011-2#1)(2012-12#1)
the gold standard for##31##4##(1991-10#1)(1996-2#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-2#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-5#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
the gold standard in the diagnosis of##2##7##(2006-8#1)(2011-2#1)
the gold standard in the##4##5##(2006-8#1)(2007-8#1)(2011-2#1)(2012-12#1)
the gold standard in##7##4##(2006-8#1)(2007-8#2)(2008-1#1)(2011-2#1)(2011-3#1)(2012-12#1)
the gold standard investigation##2##4##(2008-10#1)(2009-5#1)
the gold standard is##4##4##(2006-6#1)(2009-2#1)(2011-12#1)(2013-1#1)
the gold standard method##3##4##(2012-2#1)(2013-1#2)
the gold standard of treatment##3##5##(2006-10#2)(2007-12#1)
the gold standard of##7##4##(2004-1#1)(2006-10#2)(2006-2#1)(2007-12#1)(2008-10#1)(2011-2#1)
the gold standard treatment##2##4##(2007-4#1)(2012-2#1)
the gold standard##84##3##(1991-10#1)(1996-2#1)(1996-6#1)(1997-8#1)(2004-1#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-10#6)(2006-2#3)(2006-6#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#2)(2010-12#1)(2011-1#2)(2011-12#2)(2011-2#8)(2011-3#2)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#1)
the gold standard?##2##3##(2006-9#1)(2008-10#1)
the gold surface of a##2##5##(2008-10#2)
the gold surface##7##3##(2007-8#1)(2008-10#5)(2013-8#1)
the gold uptake##2##3##(2008-2#1)(2008-6#1)
the gold##138##2##(1991-10#1)(1994-5#2)(1995-11#1)(1995-3#1)(1996-2#2)(1996-6#1)(1997-8#1)(2004-1#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-8#1)(2005-9#1)(2006-10#6)(2006-2#3)(2006-6#1)(2006-8#2)(2006-9#2)(2007-11#2)(2007-12#6)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#6)(2008-1#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#3)(2009-10#1)(2009-12#3)(2009-2#1)(2009-3#2)(2009-5#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-5#2)(2011-1#2)(2011-12#2)(2011-2#8)(2011-3#2)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#2)
the gold-thiolate/disulfide exchange reaction##2##4##(2008-5#2)
the gold/poly(o-PD) electrode##2##3##(2008-10#2)
the golden standard##6##3##(2006-6#1)(2007-7#2)(2008-11#2)(2008-3#1)
the golden##12##2##(1993-2#1)(1995-12#1)(2006-6#1)(2006-9#1)(2007-7#2)(2008-11#2)(2008-3#1)(2009-2#1)(2010-12#1)(2012-12#1)
the goldfish (Carassius auratus)##2##4##(1995-7#1)(2008-6#1)
the goldfish Carassius auratus##3##4##(2008-1#1)(2008-5#2)
the goldfish brain##2##3##(1995-7#2)
the goldfish##15##2##(1991-2#5)(1995-7#4)(2008-1#1)(2008-5#2)(2008-6#1)(2011-2#2)
the gonad##7##2##(1991-5#1)(1993-2#1)(1995-11#2)(2007-12#2)(2008-5#1)
the gonadal primordium##2##3##(1995-11#2)
the gonadal sex developments in##2##5##(2008-5#2)
the gonadal##11##2##(1995-11#2)(2006-1#1)(2007-12#1)(2008-11#4)(2008-5#2)(2008-6#1)
the gonadosomatic index (GSI)##2##4##(2007-3#1)(2008-7#1)
the gonadosomatic index##4##3##(2007-3#1)(2007-5#1)(2008-5#1)(2008-7#1)
the gonads is##2##3##(2009-11#1)(2009-7#1)
the gonads##8##2##(1994-5#1)(1995-3#1)(1996-12#1)(1996-6#1)(2009-11#3)(2009-7#1)
the gonococcal##2##2##(1992-12#1)(2008-9#1)
the good effects of treatment##2##5##(2007-11#1)(2007-8#1)
the good news##2##3##(2006-4#1)(2009-3#1)
the good of the##2##4##(1993-12#1)(2007-5#1)
the good performance of##3##4##(2008-10#2)(2008-2#1)
the good results##2##3##(1992-10#1)(2008-10#1)
the good side##2##3##(1995-5#2)
the good tolerability##2##3##(1990-11#1)(1990-2#1)
the good##65##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#2)(1991-1#1)(1991-2#1)(1992-10#2)(1992-5#1)(1993-12#1)(1994-3#1)(1995-5#2)(1996-1#1)(1997-6#1)(2006-4#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-6#2)(2007-8#2)(2008-1#1)(2008-10#11)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#1)(2010-11#2)(2010-12#1)(2010-4#1)(2011-2#2)(2012-10#1)(2012-11#2)(2013-1#1)(2013-8#2)
the goodness of the fit##2##5##(2008-10#1)(2013-8#1)
the goodness of the##4##4##(1990-5#1)(2008-10#2)(2013-8#1)
the goodness of##5##3##(1990-5#1)(2008-10#3)(2013-8#1)
the goods##2##2##(2008-10#1)(2011-2#1)
the gorilla##4##2##(1993-8#1)(1995-2#1)(1997-4#1)(2009-10#1)
the gout##2##2##(2006-10#2)
the governance of##2##3##(1996-1#1)(2008-10#1)
the governing equations##3##3##(2005-11#1)(2007-12#1)(2008-2#1)
the governing##5##2##(1995-6#1)(1997-3#1)(2005-11#1)(2007-12#1)(2008-2#1)
the government and the##2##4##(2007-4#1)(2013-1#1)
the government and##8##3##(1994-12#1)(1997-8#1)(2007-4#2)(2007-7#1)(2008-10#1)(2008-11#1)(2013-1#1)
the government for##3##3##(1997-5#1)(2007-7#1)(2008-11#1)
the government has been##2##4##(1995-3#1)(2006-8#1)
the government has##3##3##(1995-3#1)(2006-8#1)(2007-9#1)
the government health##3##3##(2007-7#1)(2008-3#1)(2008-7#1)
the government of Delhi##2##4##(1994-9#2)
the government of Porfirio##2##4##(2011-1#2)
the government of the##2##4##(2006-10#1)(2012-3#1)
the government of##10##3##(1994-9#2)(2006-10#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-3#2)
the government sector##2##3##(2008-1#1)(2009-9#1)
the government to##4##3##(1994-7#1)(1995-3#1)(2010-1#1)(2011-2#1)
the government##65##2##(1991-4#1)(1992-4#1)(1993-1#1)(1993-3#1)(1994-12#3)(1994-7#2)(1994-9#2)(1995-12#1)(1995-3#4)(1995-6#1)(1996-2#1)(1996-4#1)(1997-5#1)(1997-8#1)(2005-5#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-12#2)(2007-4#2)(2007-5#1)(2007-7#3)(2007-9#4)(2008-1#2)(2008-10#1)(2008-11#4)(2008-3#2)(2008-7#4)(2008-9#1)(2009-10#1)(2009-9#1)(2010-1#2)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-3#2)(2013-1#1)
the government's perspective##2##3##(2006-8#1)(2010-12#1)
the government's##19##2##(1990-12#1)(1991-12#1)(1993-1#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#2)(2006-8#1)(2007-9#2)(2008-11#4)(2010-11#1)(2010-12#1)(2011-2#1)
the governmental##3##2##(1997-2#1)(2006-8#1)(2010-11#1)
the gp41##2##2##(1995-3#1)(2011-3#1)
the gracile nucleus##2##3##(1995-6#1)(1997-3#1)
the gracile##3##2##(1995-6#1)(1997-1#1)(1997-3#1)
the grade I##3##3##(1990-9#2)(2013-8#1)
the grade III##4##3##(2008-12#1)(2013-8#3)
the grade of the##2##4##(1997-7#1)(2008-6#1)
the grade of##17##3##(1990-12#1)(1991-11#1)(1995-11#1)(1996-9#1)(1997-7#2)(2007-6#2)(2007-8#2)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#1)(2010-5#1)(2012-2#1)(2013-1#1)
the grade##26##2##(1990-12#1)(1990-9#2)(1991-11#1)(1995-11#1)(1996-9#1)(1997-7#2)(2007-2#1)(2007-6#2)(2007-8#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#5)
the graded##4##2##(1996-4#1)(2007-12#1)(2008-6#1)(2008-9#1)
the grades of##2##3##(2008-10#1)(2008-2#1)
the grades##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
the gradient elution mode with##2##5##(2008-10#2)
the gradient elution##7##3##(1997-8#1)(2005-12#1)(2008-10#2)(2011-1#2)(2012-12#1)
the gradient in##3##3##(1990-8#1)(1992-9#1)(2008-10#1)
the gradient of the Frankfurt plane##2##6##(2013-8#2)
the gradient of the##6##4##(2005-11#1)(2008-1#1)(2008-8#1)(2011-1#1)(2013-8#2)
the gradient of##8##3##(1993-11#1)(2005-11#1)(2008-1#1)(2008-2#1)(2008-8#1)(2011-1#1)(2013-8#2)
the gradient##44##2##(1990-8#3)(1992-9#1)(1993-11#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-12#1)(2007-11#2)(2008-1#1)(2008-10#10)(2008-2#3)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2010-3#1)(2010-8#1)(2011-1#3)(2012-12#1)(2013-7#1)(2013-8#2)
the gradients##6##2##(1990-11#1)(1995-6#1)(2007-12#2)(2008-3#1)(2008-8#1)
the grading##2##2##(1997-8#1)(2008-4#1)
the gradostat##2##2##(2004-4#2)
the gradual decrease of##2##4##(2008-2#1)(2012-2#1)
the gradual decrease##3##3##(2008-11#1)(2008-2#1)(2012-2#1)
the gradual##22##2##(1991-11#1)(1995-9#1)(1996-10#1)(1996-9#1)(2005-5#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-4#1)(2011-12#1)(2011-2#1)(2012-2#1)
the graduate students##2##3##(2008-9#1)(2011-2#1)
the graduate##10##2##(1992-2#1)(1993-2#1)(1995-1#1)(2007-6#1)(2008-11#2)(2008-9#2)(2009-4#1)(2011-2#1)
the graduates##2##2##(2007-11#1)(2010-12#1)
the graduates' PLC##2##3##(2007-11#2)
the graft and the##3##4##(2006-6#1)(2007-11#1)(2007-8#1)
the graft and##7##3##(2006-6#1)(2007-11#1)(2007-8#3)(2008-11#1)(2013-1#1)
the graft by##2##3##(1991-11#1)(2007-7#1)
the graft choice##2##3##(2009-9#2)
the graft copolymers##2##3##(2005-11#2)
the graft implantation##2##3##(2006-6#1)(2013-1#1)
the graft in##3##3##(2007-11#1)(2011-2#2)
the graft is##2##3##(1996-2#1)(2007-7#1)
the graft itself##2##3##(2007-8#1)(2013-1#1)
the graft to##3##3##(2006-6#1)(2007-11#1)(2007-7#1)
the graft with##2##3##(1996-2#1)(2009-10#1)
the graft##71##2##(1990-11#1)(1991-11#2)(1995-2#5)(1995-3#1)(1996-2#3)(1996-3#1)(2004-12#2)(2004-9#1)(2005-11#3)(2006-3#1)(2006-6#3)(2007-11#6)(2007-5#2)(2007-7#5)(2007-8#7)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2009-10#1)(2009-9#2)(2010-3#1)(2010-4#1)(2011-2#4)(2011-3#2)(2012-12#2)(2012-2#1)(2013-1#8)
the graft-versus-host reaction##3##3##(1997-8#1)(2005-11#1)(2008-4#1)
the grafted layers##2##3##(2010-4#2)
the grafted polymer##3##3##(2008-10#2)(2009-10#1)
the grafted##11##2##(1994-11#1)(1997-5#1)(2005-11#1)(2008-10#3)(2009-10#1)(2010-4#3)(2010-7#1)
the grafting of##4##3##(1996-12#1)(1997-1#1)(2004-9#1)(2008-5#1)
the grafting##6##2##(1996-12#1)(1997-1#1)(2004-9#1)(2005-12#1)(2008-10#1)(2008-5#1)
the grafts were##2##3##(2006-6#1)(2013-1#1)
the grafts##18##2##(1994-5#1)(1995-7#1)(1997-8#1)(2006-6#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
the grain yield of##2##4##(2006-12#1)(2012-11#1)
the grain yield##8##3##(2006-12#1)(2008-10#1)(2008-12#1)(2012-11#1)(2013-8#4)
the grain##23##2##(1990-6#1)(1991-12#1)(1993-11#1)(1994-2#1)(1995-2#1)(2005-10#1)(2006-12#1)(2008-10#5)(2008-12#1)(2008-5#2)(2009-7#1)(2010-4#1)(2012-1#1)(2012-11#1)(2013-8#4)
the grains##6##2##(1990-9#1)(2006-4#1)(2007-5#2)(2008-12#1)(2008-2#1)
the gram negative##2##3##(2007-7#1)(2013-8#1)
the gram-negative##5##2##(1990-2#1)(1992-8#1)(2006-8#1)(2007-7#1)(2008-8#1)
the gram-positive##3##2##(2008-10#1)(2008-3#1)(2010-12#1)
the gramicidin channel##4##3##(1995-10#4)
the gramicidin##9##2##(1995-10#4)(1996-7#3)(2007-3#1)(2010-5#1)
the grammatical##5##2##(1991-2#2)(1995-11#2)(2008-4#1)
the grand multiparas##3##3##(1992-12#3)
the grand##4##2##(1992-12#3)(2013-8#1)
the grant##7##2##(1992-12#1)(1995-6#2)(1996-2#1)(2007-4#1)(2007-8#2)
the grants##3##2##(1996-3#2)(2007-8#1)
the granular and pyramidal##2##4##(2008-1#1)(2013-8#1)
the granular and##3##3##(1992-8#1)(2008-1#1)(2013-8#1)
the granular layer##4##3##(1993-12#1)(1994-11#1)(1996-4#1)(2010-12#1)
the granular starch binding domain of glucoamylase##2##7##(1991-5#1)(1996-6#1)
the granular starch binding domain##3##5##(1991-5#1)(1996-6#2)
the granular##18##2##(1991-5#1)(1991-8#1)(1992-11#1)(1992-8#1)(1993-12#1)(1994-11#2)(1995-12#1)(1995-3#1)(1996-4#1)(1996-6#2)(2007-9#1)(2008-1#2)(2008-3#1)(2010-12#1)(2013-8#1)
the granule and##2##3##(1992-6#1)(2006-10#1)
the granule cell layer of the dentate gyrus##2##8##(1992-7#1)(1997-8#1)
the granule cell layer of##4##5##(1990-5#1)(1992-7#1)(1993-9#1)(1997-8#1)
the granule cell layer##11##4##(1990-5#2)(1991-9#1)(1992-7#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-12#1)(1997-8#1)(2009-8#1)(2013-8#1)
the granule cell##15##3##(1990-5#2)(1991-6#1)(1991-9#1)(1992-7#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-8#2)(1995-12#1)(1995-7#1)(1997-8#1)(2009-8#1)(2013-8#1)
the granule cells##9##3##(1990-5#1)(1991-6#1)(1995-11#1)(1995-7#5)(2009-8#1)
the granule membrane##2##3##(1991-1#2)
the granule##37##2##(1990-5#3)(1991-1#2)(1991-6#2)(1991-9#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-8#2)(1995-11#1)(1995-12#1)(1995-7#7)(1995-8#3)(1997-8#1)(2006-10#1)(2008-6#1)(2009-8#2)(2011-2#1)(2012-3#1)(2013-8#1)
the granules of##2##3##(1991-12#1)(1995-2#1)
the granules##11##2##(1991-12#1)(1992-2#1)(1995-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#2)(2010-11#1)(2011-2#1)
the granulin##2##2##(1990-12#2)
the granulocyte count##2##3##(1994-3#1)(2007-11#1)
the granulocyte fraction##2##3##(1996-2#2)
the granulocyte##7##2##(1990-10#1)(1994-11#1)(1994-3#1)(1996-2#2)(2007-11#1)(2012-2#1)
the granulocytic##2##2##(2010-12#1)(2012-1#1)
the granuloma##3##2##(1994-5#2)(2010-2#1)
the granulomas##3##2##(1995-1#1)(2007-2#1)(2008-7#1)
the granulomatous##2##2##(1991-11#1)(2007-11#1)
the granulosa cells##7##3##(1995-11#1)(1996-11#1)(2008-12#1)(2008-5#3)(2008-8#1)
the granulosa##11##2##(1995-11#1)(1996-11#1)(2008-12#4)(2008-5#3)(2008-8#1)(2008-9#1)
the grape powdery mildew pathogen##2##5##(2008-10#2)
the grape##3##2##(2008-10#3)
the grapevine##3##2##(2008-10#2)(2010-9#1)
the graph##6##2##(2008-10#1)(2012-2#2)(2013-1#3)
the graphene sheet##3##3##(2009-11#3)
the graphene##4##2##(2009-11#3)(2012-2#1)
the graphic##2##2##(1993-3#1)(1995-7#1)
the graphical##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
the graphics##2##2##(2008-4#1)(2008-6#1)
the graphite furnace##6##3##(2008-10#6)
the graphite tube and the##2##5##(2008-10#2)
the graphite tube and##3##4##(2008-10#3)
the graphite tube##17##3##(2007-10#1)(2008-10#16)
the graphite##33##2##(1992-2#1)(1992-7#1)(2007-10#1)(2008-10#30)
the graphitic##2##2##(2010-7#1)(2013-1#1)
the graphs##4##2##(1990-11#1)(1992-1#1)(1993-2#1)(2010-2#1)
the grasp##2##2##(1992-9#1)(1996-3#1)
the grass##8##2##(1992-11#1)(1994-3#1)(2005-7#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-4#1)
the grasshopper Schistocerca gregaria##8##4##(2007-12#8)
the grasshopper##12##2##(2007-12#9)(2008-5#1)(2008-9#1)(2013-7#1)
the grasslands##2##2##(2008-5#1)(2013-7#1)
the grating and##8##3##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#3)
the grating are##3##3##(2008-3#3)
the grating by##3##3##(2007-12#2)(2008-3#1)
the grating diffraction##3##3##(2008-2#2)(2008-3#1)
the grating efficiencies##2##3##(2008-2#1)(2008-3#1)
the grating efficiency##3##3##(2008-2#1)(2008-3#2)
the grating for##2##3##(2007-12#2)
the grating formation##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
the grating grooves##3##3##(2007-12#1)(2008-2#2)
the grating in##2##3##(2008-2#1)(2008-3#1)
the grating is##10##3##(1995-11#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#5)
the grating length##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
the grating normal##2##3##(2008-2#2)
the grating or##2##3##(2007-12#1)(2008-3#1)
the grating pair##5##3##(2007-11#2)(2008-2#2)(2008-3#1)
the grating parameters##3##3##(2007-12#1)(2008-3#2)
the grating period##5##3##(2007-12#1)(2008-1#1)(2008-3#3)
the grating plane##3##3##(2007-12#1)(2008-3#2)
the grating response##2##3##(2008-2#2)
the grating scale monitor##2##4##(2008-3#2)
the grating separation##3##3##(2008-3#3)
the grating spacing##2##3##(2007-12#2)
the grating strength##2##3##(2007-11#1)(2007-12#1)
the grating surface##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
the grating to##3##3##(2007-11#1)(2007-12#2)
the grating transmission##2##3##(2007-12#2)
the grating vector direction##2##4##(2008-2#2)
the grating with a##2##4##(2007-11#1)(2008-2#1)
the grating with##3##3##(2007-11#2)(2008-2#1)
the grating##193##2##(1995-11#1)(2006-4#1)(2007-11#21)(2007-12#39)(2008-1#3)(2008-2#44)(2008-3#84)
the grating's##5##2##(2007-11#1)(2007-12#1)(2008-3#3)
the grating-formation process in##2##4##(2008-2#2)
the gratings can be##2##4##(2007-11#1)(2008-3#1)
the gratings to##2##3##(2007-12#1)(2008-2#1)
the gratings##24##2##(2007-11#3)(2007-12#3)(2008-2#7)(2008-3#11)
the grave##2##2##(1993-2#1)(2007-6#1)
the gravid##2##2##(2007-12#1)(2013-1#1)
the gravitational##6##2##(2006-10#2)(2008-2#1)(2008-5#1)(2012-11#2)
the gravitational-wave##2##2##(2008-3#2)
the gravity of the##4##4##(1990-3#1)(1995-9#1)(2006-2#1)(2007-7#1)
the gravity vector##3##3##(2008-11#1)(2009-6#1)(2009-8#1)
the gravity##10##2##(1990-3#1)(1995-9#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#2)(2009-6#1)(2009-8#1)
the gray matter##3##3##(1995-11#1)(1995-6#1)(1997-5#1)
the gray##14##2##(1995-11#1)(1995-6#2)(1997-4#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-1#1)(2008-10#2)(2008-3#1)(2008-6#1)(2009-12#1)(2011-2#1)
the gray-scale fabrication of diffractive optical elements##2##7##(2008-3#2)
the gray-scale##5##2##(2004-9#1)(2007-11#1)(2008-3#3)
the grayscale##2##2##(2008-2#1)(2010-9#1)
the grazing intensity##3##3##(2008-12#3)
the grazing season##8##3##(1991-8#1)(1996-12#2)(2010-2#3)(2012-2#2)
the grazing##20##2##(1991-8#1)(1993-9#1)(1996-12#4)(2007-3#1)(2008-12#3)(2008-2#3)(2008-3#1)(2010-2#3)(2012-2#3)
the grazing-incidence##2##2##(2008-2#1)(2008-3#1)
the great advantage##2##3##(2006-9#1)(2008-10#1)
the great amount of data##2##5##(2007-7#1)(2008-10#1)
the great amount of##5##4##(2007-7#1)(2008-10#1)(2008-7#1)(2009-8#1)(2013-8#1)
the great cardiac vein (GCV)##2##5##(2007-8#1)(2013-2#1)
the great differences##2##3##(1993-12#1)(1995-11#1)
the great diversity in the##2##5##(1993-5#1)(1994-11#1)
the great diversity##4##3##(1993-5#1)(1994-11#1)(2006-10#1)(2008-5#1)
the great extension of##2##4##(2005-1#1)(2010-10#1)
the great interest in##2##4##(1995-5#1)(2007-8#1)
the great majority of cases##2##5##(1996-12#1)(2006-6#1)
the great majority of patients##2##5##(2008-1#1)(2008-8#1)
the great majority of the##2##5##(2009-4#1)(2011-1#1)
the great majority of these##2##5##(2008-11#1)(2008-3#1)
the great majority of##13##4##(1992-12#1)(1996-12#1)(2006-6#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#2)(2011-1#1)
the great majority##17##3##(1992-12#1)(1996-12#1)(1997-2#1)(2006-6#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-4#2)(2010-12#1)(2011-1#1)
the great number of##8##4##(1990-7#1)(1991-11#1)(1991-4#1)(1994-6#1)(2006-2#1)(2008-10#1)(2008-2#1)(2012-12#1)
the great potential for##2##4##(1997-4#1)(2007-5#1)
the great potential of this##2##5##(2008-10#1)(2008-5#1)
the great potential of##4##4##(2008-10#1)(2008-5#1)(2011-2#1)(2012-11#1)
the great potential##6##3##(1997-4#1)(2007-5#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-11#1)
the great sensitivity of##2##4##(1990-12#1)(2008-3#1)
the great tit##3##3##(2004-4#1)(2008-9#2)
the great variability##2##3##(1997-4#1)(2006-10#1)
the great variation##2##3##(1997-3#1)(2008-5#1)
the great variety of##3##4##(2008-2#1)(2008-5#2)
the great vessels##5##3##(1990-11#1)(1996-11#1)(2007-8#1)(2008-8#1)(2012-2#1)
the great##122##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-4#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-11#1)(1994-6#1)(1995-11#2)(1995-5#1)(1996-11#1)(1996-12#2)(1996-4#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#2)(2004-4#1)(2005-1#1)(2006-10#3)(2006-2#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#11)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#3)(2009-10#2)(2009-2#2)(2009-4#4)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-2#1)(2013-8#2)
the greater availability of##3##4##(1997-4#1)(2008-10#1)(2008-7#1)
the greater dependence##2##3##(1992-8#1)(1997-7#1)
the greater distance##2##3##(1994-5#1)(2012-1#1)
the greater number of##3##4##(1993-1#1)(2007-6#1)(2008-10#1)
the greater omentum##3##3##(2006-10#1)(2007-8#1)(2012-1#1)
the greater part of##3##4##(2007-12#1)(2008-10#1)(2008-5#1)
the greater portion of##2##4##(1997-6#1)(2008-5#1)
the greater than additive##2##4##(2008-10#2)
the greater the##10##3##(1993-11#1)(1993-12#1)(2005-11#2)(2007-10#1)(2008-3#1)(2010-10#2)(2010-4#1)(2013-8#1)
the greater trochanter##5##3##(1993-11#1)(2006-10#1)(2007-11#2)(2007-7#1)
the greater use of##2##4##(2008-6#1)(2013-8#1)
the greater was the##3##4##(1996-11#1)(2008-4#1)(2013-7#1)
the greater##111##2##(1990-12#3)(1990-5#1)(1990-8#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-2#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#4)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-6#3)(2007-7#3)(2007-8#1)(2008-10#10)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#9)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-2#2)(2009-4#1)(2009-8#1)(2010-10#2)(2010-2#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
the greatest activity##2##3##(2007-11#1)(2008-10#1)
the greatest amount of##4##4##(1995-12#1)(2007-6#1)(2008-10#1)(2013-7#1)
the greatest and##2##3##(2005-11#1)(2008-8#1)
the greatest barrier to##2##4##(2008-11#1)(2011-2#1)
the greatest benefit##3##3##(1993-12#1)(1993-6#1)(2012-1#1)
the greatest challenge##3##3##(1994-2#1)(2006-2#1)(2008-10#1)
the greatest changes##2##3##(1993-11#1)(2008-8#1)
the greatest contribution to##3##4##(1994-2#1)(2008-10#1)(2013-7#1)
the greatest decrease##2##3##(2007-10#1)(2008-10#1)
the greatest degree of cooperativity##2##5##(1991-2#1)(2005-11#1)
the greatest degree of##5##4##(1991-2#1)(2005-11#1)(2007-4#1)(2007-6#1)(2008-4#1)
the greatest diameter##3##3##(2005-5#1)(2007-7#2)
the greatest diversity##2##3##(2008-10#1)(2008-5#1)
the greatest effect on the##3##5##(1990-3#1)(1991-10#1)(2013-1#1)
the greatest effect on##6##4##(1990-3#1)(1991-10#1)(2006-10#1)(2008-10#1)(2009-4#1)(2013-1#1)
the greatest effect##10##3##(1990-3#1)(1991-10#1)(2006-10#1)(2007-2#1)(2008-10#3)(2009-4#1)(2011-2#1)(2013-1#1)
the greatest genetic##2##3##(2008-10#2)
the greatest growth##2##3##(1993-12#1)(2007-5#1)
the greatest impact in##2##4##(2008-1#1)(2008-8#1)
the greatest impact on the##2##5##(1994-5#1)(2013-1#1)
the greatest impact on##4##4##(1994-5#1)(2008-10#1)(2008-8#1)(2013-1#1)
the greatest impact##9##3##(1994-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#2)(2009-5#1)(2011-2#1)(2013-1#1)
the greatest importance##2##3##(1990-10#1)(2009-4#1)
the greatest improvement in##4##4##(1996-1#1)(2005-7#1)(2009-8#1)(2011-2#1)
the greatest improvements##2##3##(1995-10#1)(2006-10#1)
the greatest increase in##6##4##(1991-2#1)(1994-5#1)(2007-6#1)(2008-10#2)(2008-5#1)
the greatest influence##2##3##(1996-3#1)(2007-3#1)
the greatest inhibition##2##3##(1991-1#1)(2012-3#1)
the greatest likelihood of##3##4##(1992-12#1)(1997-3#1)(2008-8#1)
the greatest loss##2##3##(1995-3#1)(2011-2#1)
the greatest magnitude of##2##4##(1997-2#1)(2007-5#1)
the greatest number of cases##2##5##(1992-9#1)(1995-7#1)
the greatest number of##10##4##(1990-12#1)(1992-9#1)(1995-7#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)
the greatest opportunity for##2##4##(1994-2#1)(2008-4#1)
the greatest potential for##2##4##(1996-6#1)(2008-5#1)
the greatest potential to##3##4##(1996-3#1)(2008-10#1)(2010-6#1)
the greatest potential##6##3##(1993-11#1)(1996-3#1)(1996-6#1)(2008-10#1)(2008-5#1)(2010-6#1)
the greatest proportion of the##2##5##(2008-2#1)(2008-7#1)
the greatest proportion of##4##4##(2007-12#1)(2008-2#1)(2008-7#1)(2011-2#1)
the greatest reduction in##3##4##(2008-10#1)(2008-3#2)
the greatest reduction##5##3##(1990-7#1)(1995-11#1)(2008-10#1)(2008-3#2)
the greatest risk for##2##4##(2008-7#1)(2012-3#1)
the greatest risk of##3##4##(1992-6#1)(2006-10#1)(2013-8#1)
the greatest risk##7##3##(1992-6#1)(1997-3#1)(2006-10#1)(2008-7#2)(2012-3#1)(2013-8#1)
the greatest sensitivity##2##3##(2008-10#2)
the greatest##255##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-2#4)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#3)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-2#3)(1994-5#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-7#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-3#3)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#5)(1997-3#2)(1997-7#1)(2004-11#1)(2004-2#3)(2005-11#4)(2005-12#1)(2005-5#1)(2005-7#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#3)(2007-4#2)(2007-5#5)(2007-6#3)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#42)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#6)(2008-5#8)(2008-6#4)(2008-7#6)(2008-8#7)(2008-9#2)(2009-10#3)(2009-4#4)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#10)(2012-1#1)(2012-11#2)(2012-12#6)(2012-2#1)(2012-3#4)(2012-5#1)(2013-1#5)(2013-7#2)(2013-8#2)
the greatly increased##2##3##(2005-7#1)(2012-2#1)
the greatly##4##2##(1992-3#1)(2005-7#1)(2007-8#1)(2012-2#1)
the green alga Chlamydomonas##6##4##(1992-12#1)(1992-3#1)(1994-12#1)(2006-3#1)(2009-10#1)(2012-3#1)
the green alga Dunaliella##2##4##(1992-1#1)(1997-3#1)
the green alga##14##3##(1991-12#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1994-11#1)(1994-12#1)(1997-3#1)(2004-2#1)(2006-3#1)(2009-10#1)(2010-4#1)(2012-2#1)(2012-3#1)
the green fluorescence was##2##4##(2008-9#2)
the green fluorescent protein (GFP) gene##2##6##(2008-8#1)(2008-9#1)
the green fluorescent protein (GFP)##13##5##(1997-5#1)(2004-4#1)(2005-8#1)(2006-12#2)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)
the green fluorescent protein##18##4##(1997-4#1)(1997-5#1)(2004-4#1)(2005-8#1)(2006-12#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-9#1)
the green fluorescent##19##3##(1997-4#1)(1997-5#1)(2004-4#1)(2005-8#1)(2006-12#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-9#1)
the green light##2##3##(2008-2#1)(2008-7#1)
the green sulfur bacterium Chlorobium tepidum##2##6##(1997-7#2)
the green##76##2##(1991-12#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1994-11#2)(1994-12#1)(1995-1#1)(1995-5#1)(1996-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(2004-2#1)(2004-4#1)(2005-8#1)(2006-12#3)(2006-3#1)(2007-1#1)(2007-12#5)(2007-2#3)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#2)(2009-6#3)(2009-8#1)(2009-9#1)(2010-4#1)(2012-2#2)(2012-3#1)
the green-light##2##2##(2007-12#2)
the green-yellow##2##2##(2008-2#1)(2011-2#1)
the greenhouse effect##6##3##(1991-6#4)(1992-3#2)
the greenhouse or##3##3##(2008-10#2)(2011-2#1)
the greenhouse##76##2##(1990-8#1)(1991-6#4)(1992-3#3)(2008-10#63)(2008-9#1)(2010-10#1)(2011-2#3)
the grey matter##4##3##(1992-9#3)(2013-1#1)
the grey phenotype##2##3##(2008-8#2)
the grey##13##2##(1992-9#3)(1995-6#1)(1997-8#1)(2006-11#2)(2008-8#2)(2008-9#1)(2009-9#1)(2010-8#1)(2013-1#1)
the grid##6##2##(1996-4#1)(2006-12#1)(2008-1#1)(2009-11#1)(2010-5#1)(2010-7#1)
the grief##2##2##(1990-10#1)(2007-2#1)
the grinding of##2##3##(1990-5#1)(2008-10#1)
the grinding##5##2##(1990-5#1)(1994-6#2)(2008-10#2)
the grip and hold strength##2##5##(2008-6#2)
the gripping##2##2##(2008-10#2)
the groEL##2##2##(1990-11#1)(1996-12#1)
the groin##5##2##(1993-7#1)(2007-3#2)(2008-7#2)
the groove depth##4##3##(2008-2#2)(2012-11#2)
the groove profile##2##3##(2008-2#2)
the groove##17##2##(1994-3#1)(1995-1#1)(2007-11#1)(2007-12#1)(2008-2#7)(2008-3#3)(2008-8#1)(2012-11#2)
the grooves of adult hagfishes##2##5##(1995-8#2)
the grooves of##3##3##(1995-8#2)(2008-10#1)
the grooves##11##2##(1995-8#4)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)
the gross domestic product##3##4##(1993-3#1)(1996-2#1)(2006-4#1)
the gross national product##3##4##(1990-12#1)(1993-1#1)(2008-3#1)
the gross tumour volume (GTV)##2##5##(2008-2#2)
the gross##29##2##(1990-12#1)(1993-1#1)(1993-3#1)(1995-12#1)(1995-5#1)(1996-2#1)(2006-10#2)(2006-4#1)(2006-6#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-2#1)(2010-4#1)(2011-12#1)(2011-2#1)(2013-8#2)
the grossly##2##2##(1990-11#1)(2008-3#1)
the ground and##5##3##(2006-12#1)(2007-12#1)(2008-10#3)
the ground is##2##3##(1990-8#1)(2008-3#1)
the ground level##2##3##(2008-6#2)
the ground squirrel jejunum##2##4##(1990-5#2)
the ground squirrel##7##3##(1990-5#2)(2008-8#5)
the ground state##22##3##(1991-5#1)(1994-10#1)(1994-9#2)(1996-7#1)(1997-1#1)(1997-3#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-9#1)(2010-2#2)(2010-5#1)(2012-2#3)(2013-1#1)
the ground states of##2##4##(2008-3#2)
the ground station##3##3##(1994-11#1)(2007-12#1)(2008-2#1)
the ground substance##2##3##(2009-6#2)
the ground to the##2##4##(2008-10#1)(2008-3#1)
the ground to##4##3##(2007-5#1)(2008-10#1)(2008-3#2)
the ground##107##2##(1990-5#2)(1990-8#2)(1991-5#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-9#2)(1995-8#1)(1996-7#1)(1997-1#1)(1997-3#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-3#3)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#11)(2008-2#4)(2008-3#16)(2008-5#1)(2008-6#2)(2008-8#7)(2008-9#1)(2009-5#1)(2009-6#3)(2009-9#1)(2010-2#2)(2010-5#2)(2011-12#2)(2012-1#6)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#2)(2013-7#1)
the ground-based##4##2##(2008-2#2)(2008-3#2)
the ground-state##7##2##(2006-3#1)(2006-5#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-5#1)(2012-2#1)
the grounded theory##2##3##(2008-11#1)(2008-12#1)
the grounds##14##2##(1990-11#1)(1991-12#1)(1991-7#1)(1992-3#1)(1995-12#1)(1996-6#2)(1997-4#1)(2006-7#1)(2007-11#1)(2007-7#1)(2011-1#1)(2011-2#1)(2012-11#1)
the groundwater quality of##2##4##(2007-10#1)(2008-1#1)
the groundwater##4##2##(2006-10#1)(2007-10#1)(2008-1#1)(2011-1#1)
the groundwork for##6##3##(2006-5#1)(2008-12#1)(2009-10#1)(2009-4#1)(2009-6#1)(2013-7#1)
the group &quot##3##3##(2009-10#3)
the group A##5##3##(1997-2#1)(2010-12#2)(2012-11#1)(2012-2#1)
the group B##5##3##(2007-3#1)(2008-5#1)(2010-12#2)(2012-2#1)
the group D##2##3##(1990-6#1)(2007-11#1)
the group I##2##3##(2008-10#1)(2011-2#1)
the group II##5##3##(1997-2#1)(1997-7#3)(2011-2#1)
the group III##2##3##(1991-10#1)(2011-2#1)
the group and##9##3##(1996-6#1)(2008-10#3)(2008-11#1)(2008-9#1)(2011-12#1)(2011-2#2)
the group as a whole##4##5##(1996-1#1)(1997-1#1)(2008-7#1)(2009-4#1)
the group as a##5##4##(1996-1#1)(1997-1#1)(2008-7#2)(2009-4#1)
the group could##2##3##(1993-1#1)(1993-7#1)
the group delay##3##3##(2007-12#2)(2008-1#1)
the group differences##2##3##(1992-6#1)(1994-8#1)
the group fed##2##3##(2004-11#1)(2010-2#1)
the group in##7##3##(1993-5#1)(2006-8#1)(2007-11#1)(2008-11#1)(2008-9#1)(2012-1#1)(2012-2#1)
the group index##2##3##(2007-12#1)(2008-2#1)
the group level##2##3##(2013-1#1)(2013-8#1)
the group mean##2##3##(2011-2#2)
the group of healthy subjects##2##5##(1991-11#1)(2008-4#1)
the group of healthy##4##4##(1990-7#1)(1991-11#1)(2005-8#1)(2008-4#1)
the group of older##2##4##(1994-4#1)(2008-3#1)
the group of patients that##2##5##(2006-8#1)(2013-7#1)
the group of patients treated with##3##6##(1990-3#1)(2007-11#1)(2013-8#1)
the group of patients treated##4##5##(1990-3#1)(2007-11#1)(2007-7#1)(2013-8#1)
the group of patients who##4##5##(1992-11#1)(2011-2#2)(2012-3#1)
the group of patients with high##2##6##(2013-1#1)(2013-8#1)
the group of patients with##14##5##(1990-10#1)(1991-10#1)(1991-4#1)(1992-12#1)(1994-6#1)(2006-6#2)(2008-4#2)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
the group of patients##32##4##(1990-10#1)(1990-3#1)(1990-5#1)(1991-10#1)(1991-4#1)(1992-11#1)(1992-12#1)(1992-8#1)(1994-6#1)(2005-1#1)(2006-10#1)(2006-6#2)(2006-8#1)(2007-11#1)(2007-7#1)(2008-4#2)(2008-5#1)(2011-1#1)(2011-2#6)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
the group of the##5##4##(1992-6#1)(2007-9#1)(2008-11#1)(2008-8#1)(2012-12#1)
the group of women##6##4##(1990-11#2)(1992-3#1)(2006-10#1)(2006-6#1)(2011-2#1)
the group of##146##3##(1990-10#1)(1990-11#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-10#2)(1991-11#2)(1991-4#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-4#1)(1994-5#1)(1994-6#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-7#2)(2004-4#1)(2005-1#1)(2005-8#1)(2006-10#2)(2006-6#6)(2006-8#3)(2007-1#1)(2007-11#5)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#7)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#2)(2009-2#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-6#2)(2010-9#2)(2011-1#2)(2011-2#11)(2012-1#1)(2012-11#1)(2012-12#5)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#5)
the group or##2##3##(1993-1#1)(1997-8#1)
the group practice model##2##4##(1991-1#2)
the group practice##5##3##(1991-1#2)(1994-3#2)(1995-1#1)
the group pretreated with##2##4##(1992-8#1)(1995-12#1)
the group process##3##3##(2007-10#2)(2009-4#1)
the group randomized##2##3##(1996-8#1)(2006-2#1)
the group receiving##5##3##(1990-10#1)(2004-3#1)(2007-11#1)(2008-10#2)
the group refractive index##3##4##(2008-2#2)(2008-3#1)
the group sessions##2##3##(2007-10#1)(2007-2#1)
the group size is##3##4##(2008-8#2)(2012-3#1)
the group size##5##3##(2008-8#2)(2008-9#1)(2012-3#1)(2013-1#1)
the group submitted to neoadjuvant##2##5##(2013-8#2)
the group submitted to##3##4##(2013-8#3)
the group taking##2##3##(1991-11#2)
the group that received##2##4##(1993-1#1)(2008-3#1)
the group that##7##3##(1993-1#1)(2006-8#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-1#1)(2013-1#1)
the group to##3##3##(2008-10#1)(2008-11#1)(2008-6#1)
the group treated by##2##4##(1991-9#1)(2011-2#1)
the group treated with##18##4##(1990-6#1)(1991-2#1)(1992-10#1)(1993-2#1)(1993-9#1)(1995-10#1)(1995-12#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-5#2)(2008-8#2)(2013-1#1)
the group treated##21##3##(1990-6#1)(1991-2#1)(1991-9#1)(1992-10#1)(1993-2#1)(1993-9#1)(1995-10#1)(1995-12#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-2#1)(2008-5#2)(2008-8#2)(2011-2#1)(2013-1#1)
the group tried to turn several local health clubs into sports medicine clinics##2##13##(1994-3#2)
the group velocities of the##3##5##(2007-11#1)(2008-1#1)(2008-2#1)
the group velocity of light in##3##6##(2007-12#1)(2008-2#2)
the group velocity of##4##4##(2007-12#2)(2008-2#2)
the group velocity##8##3##(2007-12#4)(2008-2#4)
the group was##6##3##(1990-9#1)(2004-10#1)(2006-10#1)(2008-11#1)(2008-7#1)(2011-1#1)
the group which started with##2##5##(1991-2#2)
the group which##5##3##(1991-2#2)(1992-7#2)(1997-6#1)
the group who##5##3##(1991-6#1)(1997-3#1)(2008-5#2)(2012-2#1)
the group with no##3##4##(1991-10#1)(1992-2#1)(2007-7#1)
the group with the modified program##2##6##(2007-11#2)
the group with the##4##4##(1995-2#1)(2007-11#2)(2012-12#1)
the group with##48##3##(1990-10#1)(1990-4#1)(1990-8#1)(1991-10#2)(1991-3#1)(1992-1#1)(1992-2#1)(1992-5#2)(1992-8#1)(1993-1#1)(1993-5#1)(1994-12#1)(1994-7#1)(1995-2#2)(1995-8#2)(1997-4#1)(1997-5#1)(1997-8#1)(2007-11#4)(2007-7#2)(2007-8#2)(2008-10#1)(2008-3#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-3#1)(2009-9#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#3)
the group without##9##3##(1992-5#1)(1993-8#1)(1994-12#2)(1994-7#1)(2007-11#1)(2007-8#1)(2008-3#1)(2013-7#1)
the group younger##2##3##(1991-9#1)(2011-2#1)
the group##465##2##(1990-10#3)(1990-11#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#3)(1991-10#5)(1991-11#6)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#3)(1991-6#2)(1991-7#1)(1991-9#3)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#4)(1992-6#4)(1992-7#4)(1992-8#3)(1993-1#5)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#3)(1993-7#2)(1993-8#3)(1993-9#3)(1994-12#3)(1994-2#1)(1994-3#4)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#2)(1996-1#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#5)(1997-8#3)(2004-10#1)(2004-11#1)(2004-3#1)(2004-4#1)(2005-1#2)(2005-8#1)(2005-9#1)(2006-10#5)(2006-2#3)(2006-5#2)(2006-6#9)(2006-7#1)(2006-8#8)(2006-9#1)(2007-1#2)(2007-10#4)(2007-11#17)(2007-12#11)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#6)(2007-8#7)(2007-9#3)(2008-1#2)(2008-10#21)(2008-11#8)(2008-12#4)(2008-2#10)(2008-3#6)(2008-4#3)(2008-5#9)(2008-6#6)(2008-7#12)(2008-8#10)(2008-9#11)(2009-10#4)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-12#6)(2010-2#2)(2010-3#4)(2010-4#1)(2010-6#4)(2010-9#2)(2011-1#7)(2011-12#1)(2011-2#27)(2012-1#3)(2012-11#2)(2012-12#7)(2012-2#7)(2012-3#4)(2013-1#13)(2013-7#3)(2013-8#13)
the group's##16##2##(1993-1#1)(1993-3#2)(1993-9#1)(1994-1#1)(1995-5#1)(1996-3#1)(1997-3#1)(1997-8#1)(2005-9#1)(2007-10#1)(2007-4#2)(2008-5#1)(2010-6#1)(2012-12#1)
the group-delay##2##2##(2007-11#2)
the group-specific##2##2##(1991-7#1)(1995-2#1)
the group-velocity dispersion##2##3##(2007-11#2)
the group-velocity##4##2##(2007-11#4)
the grouped##2##2##(2008-12#1)(2009-2#1)
the grouper##3##2##(2010-5#3)
the grouping of##4##3##(2008-10#2)(2012-12#1)(2013-1#1)
the grouping time##2##3##(1997-3#2)
the grouping##8##2##(1992-10#1)(1997-3#2)(2008-10#2)(2012-12#2)(2013-1#1)
the groupings##2##2##(2006-6#1)(2012-3#1)
the groups and the##2##4##(2007-7#1)(2009-8#1)
the groups and##7##3##(1993-2#1)(2007-7#1)(2008-7#1)(2009-5#2)(2009-8#1)(2011-2#1)
the groups as##3##3##(1995-8#1)(2008-10#1)(2012-3#1)
the groups at##4##3##(1990-9#1)(2006-10#1)(2007-8#1)(2012-11#1)
the groups did not differ##2##5##(1995-11#1)(2005-1#1)
the groups did not##3##4##(1991-2#1)(1995-11#1)(2005-1#1)
the groups fed##2##3##(2004-11#1)(2006-8#1)
the groups for##3##3##(2006-7#1)(2007-9#1)(2008-7#1)
the groups given##3##3##(1993-7#2)(2008-6#1)
the groups in the##4##4##(1990-5#1)(1991-8#1)(2007-9#1)(2008-7#1)
the groups in##10##3##(1990-3#1)(1990-5#1)(1991-8#1)(1993-4#1)(1995-9#1)(2006-10#1)(2006-12#2)(2007-9#1)(2008-7#1)
the groups involved##2##3##(1990-8#1)(1994-3#1)
the groups of##14##3##(1991-9#1)(1996-12#2)(2006-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#2)(2012-12#3)(2013-7#1)(2013-8#1)
the groups regarding##2##3##(2006-9#1)(2007-2#1)
the groups that received##2##4##(2006-10#1)(2007-2#1)
the groups that##5##3##(2005-12#1)(2006-10#1)(2007-2#1)(2009-3#1)(2012-11#1)
the groups treated with##4##4##(1995-2#2)(2006-5#1)(2007-11#1)
the groups treated##5##3##(1995-2#2)(2006-4#1)(2006-5#1)(2007-11#1)
the groups was##3##3##(2007-10#2)(2013-8#1)
the groups were generally##2##4##(2004-2#1)(2009-7#1)
the groups were##10##3##(1990-12#1)(1991-9#1)(2004-2#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-5#1)(2009-7#1)(2010-1#1)(2011-12#1)
the groups with##9##3##(1993-4#1)(1995-4#1)(1995-8#1)(1997-4#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-12#1)(2011-1#1)
the groups##194##2##(1990-12#1)(1990-3#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-8#1)(1991-9#2)(1992-3#1)(1993-2#1)(1993-4#3)(1993-6#1)(1993-7#4)(1994-11#1)(1994-3#2)(1994-8#1)(1995-1#2)(1995-11#1)(1995-2#2)(1995-4#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-12#3)(1996-2#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-7#3)(1997-8#1)(2004-11#1)(2004-2#1)(2005-1#1)(2005-10#2)(2005-12#1)(2006-10#5)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#6)(2006-8#3)(2006-9#2)(2007-10#2)(2007-11#3)(2007-2#3)(2007-5#3)(2007-6#1)(2007-7#4)(2007-8#8)(2007-9#4)(2008-10#6)(2008-11#3)(2008-3#2)(2008-4#3)(2008-5#9)(2008-6#4)(2008-7#4)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#1)(2012-11#2)(2012-12#6)(2012-2#5)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#4)
the grove##5##2##(2008-10#5)
the grower##2##2##(2008-10#2)
the growing and##2##3##(1996-2#1)(2010-2#1)
the growing body of evidence##7##5##(1993-6#1)(1993-7#1)(2008-5#1)(2009-2#1)(2010-5#1)(2013-1#2)
the growing body of##9##4##(1993-1#1)(1993-6#1)(1993-7#1)(2006-10#1)(2008-5#1)(2009-2#1)(2010-5#1)(2013-1#2)
the growing cells##7##3##(1991-2#1)(1992-1#1)(1995-11#1)(1995-2#1)(1996-7#3)
the growing demand for##3##4##(2005-5#1)(2008-10#1)(2010-5#1)
the growing evidence that##2##4##(2007-9#1)(2008-8#1)
the growing evidence##3##3##(2007-9#1)(2008-7#1)(2008-8#1)
the growing importance of##3##4##(1993-12#1)(2007-7#1)(2008-2#1)
the growing interest in##7##4##(2006-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-7#1)(2010-1#1)
the growing interest##8##3##(2006-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-7#1)(2010-1#1)(2013-8#1)
the growing list of##2##4##(1990-10#1)(2006-12#1)
the growing need for##2##4##(1991-10#1)(2013-8#1)
the growing number of##12##4##(1990-12#1)(1991-1#1)(1993-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-10#1)(2011-3#1)(2012-1#1)(2013-1#1)
the growing period##2##3##(2013-1#1)(2013-8#1)
the growing population of##3##4##(1993-10#1)(2007-12#1)(2012-1#1)
the growing population##4##3##(1993-10#1)(2007-12#1)(2012-1#1)(2012-12#1)
the growing pressure on##2##4##(1997-1#1)(2008-12#1)
the growing recognition of the##2##5##(1993-1#1)(2011-1#1)
the growing recognition##3##3##(1993-1#1)(2007-11#1)(2011-1#1)
the growing region##2##3##(2008-10#1)(2008-7#1)
the growing season in the##2##5##(2008-10#2)
the growing season in##3##4##(2008-10#3)
the growing season may##2##4##(2008-10#2)
the growing season##40##3##(2004-4#1)(2008-10#29)(2009-2#7)(2010-8#1)(2011-1#1)(2012-5#1)
the growing shortage of##2##4##(2010-3#1)(2012-2#1)
the growing trend##3##3##(1994-1#1)(2007-7#1)(2007-9#1)
the growing use of##5##4##(1996-2#1)(2005-10#1)(2008-3#1)(2009-11#1)(2013-8#1)
the growing##174##2##(1990-10#1)(1990-12#1)(1991-1#1)(1991-10#1)(1991-2#1)(1992-1#1)(1992-3#1)(1993-1#2)(1993-10#1)(1993-12#4)(1993-2#2)(1993-3#1)(1993-6#1)(1993-7#1)(1994-1#1)(1994-12#1)(1995-11#1)(1995-2#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#4)(1997-1#1)(2004-4#1)(2005-10#1)(2005-11#2)(2005-5#1)(2006-10#4)(2006-11#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-4#3)(2007-7#5)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#37)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#10)(2009-7#1)(2009-9#1)(2010-1#3)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#4)(2010-8#2)(2011-1#2)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#1)(2012-5#2)(2013-1#5)(2013-8#5)
the grown##3##2##(1992-5#1)(2013-1#2)
the growth and development of a##2##6##(2005-5#1)(2008-4#1)
the growth and development of the##2##6##(2005-5#1)(2007-12#1)
the growth and development of##17##5##(1994-1#1)(1996-3#1)(2005-5#2)(2006-12#1)(2006-4#1)(2007-12#1)(2008-12#3)(2008-4#3)(2008-8#1)(2009-4#1)(2010-2#1)(2011-12#1)
the growth and development##19##4##(1994-1#1)(1996-3#1)(2005-5#2)(2006-12#1)(2006-4#1)(2007-12#1)(2007-7#1)(2008-12#3)(2008-4#3)(2008-8#1)(2009-4#1)(2010-2#1)(2011-12#1)(2012-12#1)
the growth and differentiation of##5##5##(1991-6#1)(1995-5#1)(2008-4#1)(2008-5#1)(2010-6#1)
the growth and metabolism of##3##5##(1993-5#1)(2008-11#2)
the growth and proliferation process in##2##6##(2008-5#2)
the growth and survival of the##3##6##(1994-12#1)(2008-11#1)(2013-8#1)
the growth and survival of##6##5##(1991-3#1)(1994-12#1)(2008-1#1)(2008-11#1)(2012-12#1)(2013-8#1)
the growth and the##3##4##(2006-8#1)(2007-3#1)(2009-4#1)
the growth and##78##3##(1991-3#1)(1991-6#1)(1992-5#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-3#1)(1997-4#2)(2004-4#1)(2005-5#2)(2006-12#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-12#2)(2007-3#3)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#9)(2008-12#3)(2008-4#5)(2008-5#3)(2008-7#2)(2008-8#4)(2008-9#1)(2009-4#2)(2009-6#1)(2010-2#2)(2010-6#1)(2010-8#1)(2011-12#1)(2012-12#3)(2012-2#1)(2012-8#1)(2013-1#3)(2013-8#3)
the growth and/or##2##3##(1995-3#1)(2011-2#1)
the growth arrest##3##3##(1992-2#1)(1995-1#1)(2008-11#1)
the growth associated##3##3##(1990-8#1)(1991-9#1)(1997-5#1)
the growth behaviour of##2##4##(2008-11#2)
the growth characteristics of##4##4##(1990-3#1)(2008-11#2)(2013-8#1)
the growth characteristics##5##3##(1990-3#1)(2008-11#3)(2013-8#1)
the growth conditions##4##3##(1990-12#1)(2008-10#1)(2008-8#1)(2009-8#1)
the growth cone##9##3##(1994-11#1)(1995-11#1)(1995-9#1)(1996-3#4)(1997-6#1)(2008-7#1)
the growth cones##2##3##(1995-11#1)(1995-12#1)
the growth control model##3##4##(2008-10#3)
the growth control##5##3##(1995-12#1)(2008-10#4)
the growth curve##3##3##(1991-1#1)(1992-9#1)(1995-1#1)
the growth cycle##5##3##(1991-9#1)(2008-11#1)(2008-5#1)(2009-8#2)
the growth defect of an##2##5##(1997-4#2)
the growth defect of##3##4##(1991-5#1)(1997-4#2)
the growth dynamics of##2##4##(2009-3#1)(2013-8#1)
the growth effects of##2##4##(1996-8#1)(2008-5#1)
the growth factor induced##2##4##(1990-3#2)
the growth factor receptor##3##4##(1994-12#1)(2007-11#1)(2010-3#1)
the growth factor##24##3##(1990-3#3)(1990-8#1)(1991-7#1)(1992-10#1)(1992-8#1)(1993-3#1)(1994-10#1)(1994-12#1)(1997-1#1)(1997-4#1)(1997-7#2)(2007-10#1)(2007-11#2)(2008-1#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-3#1)
the growth factors##5##3##(1993-7#1)(1994-5#1)(1995-12#1)(2007-9#2)
the growth hormone (GH)/insulin-like growth factor##2##6##(2007-11#1)(2007-7#1)
the growth hormone receptor##4##4##(1990-12#1)(2006-9#1)(2008-1#1)(2008-4#1)
the growth hormone secretagogue receptor##2##5##(2006-1#1)(2008-3#1)
the growth hormone##11##3##(1990-12#1)(1995-3#1)(2006-1#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-4#1)(2011-2#1)(2013-1#1)
the growth in a##2##4##(2006-8#1)(2010-4#1)
the growth in hospital##2##4##(1992-1#1)(1992-2#1)
the growth in##16##3##(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#2)(1993-12#1)(1995-6#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-4#1)(2008-10#1)(2009-10#1)(2010-4#1)(2010-5#1)
the growth inhibition of##2##4##(1997-4#1)(2008-5#1)
the growth inhibition##7##3##(1991-12#1)(1991-7#1)(1994-12#1)(1995-2#1)(1997-4#1)(2008-11#1)(2008-5#1)
the growth inhibitory action of##2##5##(1991-3#1)(1995-2#1)
the growth inhibitory activity of N-Ac-4-S-CAP in##2##7##(1992-3#2)
the growth inhibitory effect of##3##5##(1995-2#1)(2007-11#1)(2008-11#1)
the growth inhibitory effects of##5##5##(1991-12#1)(1996-4#1)(1997-3#1)(2008-11#1)(2010-7#1)
the growth inhibitory effects##6##4##(1990-10#1)(1991-12#1)(1996-4#1)(1997-3#1)(2008-11#1)(2010-7#1)
the growth inhibitory##17##3##(1990-10#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-3#3)(1994-3#1)(1995-2#2)(1996-2#1)(1996-4#1)(1997-3#1)(2007-11#1)(2008-11#2)(2010-7#1)
the growth is##2##3##(1992-11#1)(2007-9#1)
the growth kinetics of##2##4##(1995-1#1)(2008-11#1)
the growth kinetics##4##3##(1995-1#1)(2008-11#2)(2008-7#1)
the growth media##3##3##(1995-1#1)(2008-10#1)(2008-6#1)
the growth medium and##2##4##(2008-10#2)
the growth medium##24##3##(1990-6#1)(1991-10#1)(1991-11#2)(1993-4#1)(1994-12#2)(1994-2#1)(1996-6#1)(1997-1#1)(1997-6#2)(2008-10#6)(2008-11#3)(2008-4#1)(2008-6#1)(2009-10#1)
the growth of A##4##4##(2008-10#3)(2010-8#1)
the growth of B##4##4##(1996-2#1)(2008-10#1)(2011-2#2)
the growth of C##3##4##(2005-11#1)(2008-5#1)(2013-1#1)
the growth of Candida albicans##2##5##(2008-5#2)
the growth of Candida##3##4##(2008-5#3)
the growth of E##3##4##(1991-7#1)(2008-10#1)(2008-7#1)
the growth of Escherichia coli##2##5##(2006-10#1)(2008-4#1)
the growth of Escherichia##3##4##(2006-10#1)(2008-10#1)(2008-4#1)
the growth of Gram-positive bacteria##2##5##(2008-6#1)(2012-2#1)
the growth of HeLa cells and##2##6##(1997-1#1)(2008-8#1)
the growth of HeLa##3##4##(1992-11#1)(1997-1#1)(2008-8#1)
the growth of L##2##4##(1996-12#1)(2013-8#1)
the growth of M##3##4##(2008-10#1)(2008-6#1)(2013-1#1)
the growth of P##3##4##(1992-7#1)(2008-10#2)
the growth of PC12 cells##2##5##(1994-9#1)(2008-10#1)
the growth of R##3##4##(2008-10#3)
the growth of SC115##2##4##(1990-11#2)
the growth of a variety of##3##6##(1994-9#1)(2006-10#1)(2008-5#1)
the growth of a##11##4##(1991-4#1)(1994-9#1)(1995-6#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2010-9#1)(2012-3#1)
the growth of all##5##4##(1991-10#1)(1994-12#1)(1997-1#1)(2008-8#2)
the growth of an##4##4##(1995-6#1)(1996-3#1)(2008-10#1)(2008-9#1)
the growth of bacteria##3##4##(2008-5#1)(2008-7#1)(2009-2#1)
the growth of bifidobacteria##2##4##(2006-10#1)(2006-8#1)
the growth of both##5##4##(1997-1#1)(2008-10#3)(2008-5#1)
the growth of breast##2##4##(2008-3#1)(2012-3#1)
the growth of cells in##2##5##(1996-1#1)(1997-2#1)
the growth of cells##4##4##(1990-9#1)(1992-11#1)(1996-1#1)(1997-2#1)
the growth of certain##3##4##(1994-10#1)(2008-1#1)(2008-4#1)
the growth of children##2##4##(2007-11#1)(2008-7#1)
the growth of cultured cells##2##5##(1994-3#1)(2008-11#1)
the growth of health care expenditures##2##6##(1992-1#1)(1995-3#1)
the growth of health care##3##5##(1992-1#1)(1995-1#1)(1995-3#1)
the growth of health##4##4##(1991-2#1)(1992-1#1)(1995-1#1)(1995-3#1)
the growth of human breast cancer cells##2##7##(1991-8#1)(2007-11#1)
the growth of human hepatoma##3##5##(2008-11#1)(2008-8#2)
the growth of human neuroblastoma##2##5##(1992-1#2)
the growth of human##15##4##(1990-7#1)(1991-8#1)(1992-1#2)(1993-9#1)(1994-8#1)(1996-11#1)(2005-8#1)(2007-11#1)(2008-11#3)(2008-8#2)(2010-6#1)
the growth of lactic acid bacteria##4##6##(2008-11#4)
the growth of larger##2##4##(2006-12#1)(2008-4#1)
the growth of lung##2##4##(2008-5#1)(2008-8#1)
the growth of managed care##3##5##(1995-12#1)(1996-2#1)(1997-3#1)
the growth of managed##4##4##(1991-3#1)(1995-12#1)(1996-2#1)(1997-3#1)
the growth of many##2##4##(2008-11#1)(2008-9#1)
the growth of neural##2##4##(1991-11#1)(1994-11#1)
the growth of normal##3##4##(1991-10#1)(1993-6#1)(1994-10#1)
the growth of others##2##4##(2008-10#1)(2008-9#1)
the growth of phytopathogenic##2##4##(1990-6#1)(2007-7#1)
the growth of primary##2##4##(1991-2#1)(1997-7#1)
the growth of public expenditures##3##5##(1994-2#3)
the growth of small cell lung cancer cells##2##8##(1993-12#1)(1994-3#1)
the growth of some human mammary##2##6##(1993-11#1)(1995-3#1)
the growth of some##6##4##(1993-11#1)(1994-10#1)(1995-3#1)(2006-12#1)(2006-8#1)(2008-8#1)
the growth of strain LB400##2##5##(2011-12#2)
the growth of the cell lines##2##6##(2008-8#1)(2013-8#1)
the growth of the cell##3##5##(1990-5#1)(2008-8#1)(2013-8#1)
the growth of the fungus##2##5##(2008-10#1)(2009-2#1)
the growth of the human##3##5##(1991-8#1)(1992-8#1)(1995-8#1)
the growth of the##46##4##(1990-5#1)(1991-4#1)(1991-8#1)(1992-3#1)(1992-8#5)(1992-9#1)(1994-12#1)(1994-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-9#1)(2005-11#2)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#3)(2009-2#1)(2009-9#2)(2011-12#1)(2013-1#2)(2013-8#1)
the growth of these##5##4##(1993-9#2)(1996-3#1)(2006-8#1)(2008-10#1)
the growth of this##4##4##(2008-12#1)(2010-1#1)(2012-2#1)(2013-1#1)
the growth of tumor cells##2##5##(2008-4#1)(2012-3#1)
the growth of tumor##4##4##(2008-3#1)(2008-4#1)(2008-5#1)(2012-3#1)
the growth of tumors##4##4##(1992-1#1)(1992-7#1)(2012-2#1)(2013-8#1)
the growth of vascular smooth muscle cells##2##7##(1990-7#1)(1994-11#1)
the growth of vascular##3##4##(1990-7#1)(1993-3#1)(1994-11#1)
the growth of##396##3##(1990-11#3)(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#3)(1991-10#3)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#2)(1991-7#2)(1991-8#3)(1991-9#2)(1992-1#5)(1992-11#4)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#3)(1992-7#3)(1992-8#6)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#3)(1993-9#3)(1994-10#4)(1994-11#4)(1994-12#3)(1994-2#4)(1994-3#3)(1994-8#4)(1994-9#3)(1995-1#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#5)(1995-5#1)(1995-6#4)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#2)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#1)(1997-3#1)(1997-7#3)(2004-4#1)(2005-11#7)(2005-6#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#3)(2006-7#1)(2006-8#8)(2006-9#2)(2007-1#1)(2007-11#6)(2007-12#1)(2007-2#1)(2007-3#2)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#46)(2008-11#23)(2008-12#5)(2008-2#3)(2008-3#3)(2008-4#7)(2008-5#18)(2008-6#2)(2008-7#8)(2008-8#14)(2008-9#9)(2009-10#1)(2009-2#4)(2009-3#1)(2009-4#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-12#4)(2010-2#2)(2010-4#2)(2010-6#2)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#3)(2011-11#1)(2011-12#3)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#4)(2012-8#1)(2013-1#9)(2013-8#8)
the growth or##3##3##(1992-3#1)(1993-3#1)(2008-9#1)
the growth pattern of##2##4##(2006-8#1)(2007-7#1)
the growth patterns##3##3##(1992-8#1)(2010-12#1)(2010-3#1)
the growth performance##7##3##(2010-2#4)(2012-2#3)
the growth period##5##3##(2007-7#1)(2007-8#2)(2008-11#1)(2010-11#1)
the growth phase and##2##4##(2008-11#1)(2008-8#1)
the growth phase of##3##4##(1994-3#1)(2008-11#2)
the growth phase##9##3##(1994-3#1)(1995-1#1)(2008-11#5)(2008-8#1)(2009-6#1)
the growth plate was##3##4##(2007-11#2)(2012-1#1)
the growth plate##12##3##(1993-4#1)(2007-11#6)(2007-8#3)(2012-1#2)
the growth potential##3##3##(1990-3#2)(1991-12#1)
the growth process of##3##4##(2006-11#1)(2006-12#1)(2010-4#1)
the growth process##4##3##(2006-11#1)(2006-12#1)(2007-11#1)(2010-4#1)
the growth properties of##2##4##(1990-3#1)(1994-5#1)
the growth rate and the##2##5##(2007-12#1)(2008-3#1)
the growth rate and##8##4##(1991-10#1)(1996-3#1)(2007-12#1)(2008-11#2)(2008-3#1)(2013-8#2)
the growth rate of cells##2##5##(1991-11#1)(1995-6#1)
the growth rate of mixed##2##5##(2006-8#2)
the growth rate of the##11##5##(1990-10#1)(1991-10#1)(1992-7#1)(1996-9#1)(2005-11#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)
the growth rate of##29##4##(1990-10#1)(1991-10#1)(1991-11#1)(1992-2#1)(1992-7#1)(1993-9#1)(1995-6#1)(1996-9#1)(2004-1#1)(2004-4#1)(2005-11#3)(2006-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-9#1)(2012-2#1)
the growth rate on##2##4##(1994-11#1)(2008-10#1)
the growth rate##50##3##(1990-10#1)(1991-10#2)(1991-11#1)(1992-2#1)(1992-7#1)(1993-9#1)(1994-11#2)(1995-6#1)(1996-3#1)(1996-9#1)(2004-1#1)(2004-4#1)(2005-11#3)(2006-8#2)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#6)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#4)(2008-9#2)(2009-10#1)(2009-4#1)(2009-6#3)(2009-9#1)(2012-2#1)(2013-8#3)
the growth rates of the##3##5##(2004-4#1)(2008-10#1)(2008-5#1)
the growth rates of##6##4##(2004-4#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-1#1)
the growth regulation of human glioma cells##2##7##(1994-5#2)
the growth response of##3##4##(1994-12#1)(2008-4#1)(2012-2#1)
the growth response##4##3##(1994-12#1)(2008-1#1)(2008-4#1)(2012-2#1)
the growth retardation##2##3##(2006-10#1)(2007-11#1)
the growth step##2##3##(1997-4#2)
the growth stimulation##3##3##(1991-1#1)(1991-6#1)(1992-11#1)
the growth substrate##4##3##(1994-12#1)(2007-11#1)(2008-7#2)
the growth suppressor##2##3##(1991-5#1)(2008-1#1)
the growth surface##2##3##(2008-11#1)(2009-11#1)
the growth temperature##3##3##(1990-11#1)(2008-10#1)(2008-7#1)
the growth zone##3##3##(2008-10#1)(2009-8#2)
the growth##852##2##(1990-10#2)(1990-11#5)(1990-12#4)(1990-3#8)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#4)(1990-8#3)(1990-9#3)(1991-1#3)(1991-10#6)(1991-11#5)(1991-12#5)(1991-2#2)(1991-3#4)(1991-4#2)(1991-5#4)(1991-6#3)(1991-7#5)(1991-8#3)(1991-9#4)(1992-1#6)(1992-10#1)(1992-11#6)(1992-12#1)(1992-2#6)(1992-3#6)(1992-4#1)(1992-5#2)(1992-6#3)(1992-7#5)(1992-8#8)(1992-9#4)(1993-11#1)(1993-12#2)(1993-3#5)(1993-4#3)(1993-5#2)(1993-6#3)(1993-7#2)(1993-9#7)(1994-1#1)(1994-10#5)(1994-11#8)(1994-12#10)(1994-2#5)(1994-3#5)(1994-5#4)(1994-7#1)(1994-8#5)(1994-9#3)(1995-1#7)(1995-10#1)(1995-11#2)(1995-12#5)(1995-2#7)(1995-3#8)(1995-5#2)(1995-6#7)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#6)(1996-3#8)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#2)(1996-9#3)(1997-1#6)(1997-2#1)(1997-3#2)(1997-4#9)(1997-5#1)(1997-6#3)(1997-7#6)(2004-1#1)(2004-4#4)(2005-11#10)(2005-5#2)(2005-6#1)(2005-8#1)(2006-1#2)(2006-10#4)(2006-11#2)(2006-12#7)(2006-2#1)(2006-3#1)(2006-4#2)(2006-7#1)(2006-8#13)(2006-9#4)(2007-1#1)(2007-10#1)(2007-11#23)(2007-12#6)(2007-2#1)(2007-3#7)(2007-4#1)(2007-7#10)(2007-8#7)(2007-9#6)(2008-1#6)(2008-10#70)(2008-11#68)(2008-12#12)(2008-2#4)(2008-3#6)(2008-4#17)(2008-5#30)(2008-6#6)(2008-7#21)(2008-8#22)(2008-9#16)(2009-10#4)(2009-11#2)(2009-2#4)(2009-3#3)(2009-4#4)(2009-6#7)(2009-8#9)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#8)(2010-3#2)(2010-4#4)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#8)(2010-9#2)(2011-1#6)(2011-11#1)(2011-12#5)(2011-2#8)(2012-1#3)(2012-12#6)(2012-2#13)(2012-3#4)(2012-8#2)(2013-1#16)(2013-8#17)
the growth-associated protein GAP-43##2##4##(1996-3#1)(2008-7#1)
the growth-associated protein##4##3##(1994-8#1)(1996-3#1)(1996-9#1)(2008-7#1)
the growth-inhibitory##4##2##(1991-7#2)(1991-9#1)(1997-7#1)
the growth-phase-dependent regulation of##2##4##(1991-12#1)(2009-6#1)
the growth-phase-dependent regulation##3##3##(1991-12#2)(2009-6#1)
the growth-phase-dependent##5##2##(1991-12#3)(2009-6#2)
the growth-promoting##4##2##(1992-4#1)(2006-12#1)(2009-8#1)(2012-12#1)
the growth-related##2##2##(1992-8#1)(1994-12#1)
the growth-stimulating effect##2##3##(1995-8#2)
the growth-stimulating##3##2##(1995-8#3)
the grsB gene##2##3##(1994-2#2)
the gsa-1 gene encoding a G protein##2##7##(1997-7#2)
the gsa-1 gene##3##3##(1997-7#3)
the guanidinium group of##2##4##(1992-9#1)(1995-5#1)
the guanidinium##3##2##(1992-9#1)(1995-5#1)(2008-2#1)
the guanidino nitrogen##2##3##(1995-5#2)
the guanine moiety##2##3##(1991-5#1)(1994-9#1)
the guanine nucleotide exchange factor##2##5##(1991-12#1)(2011-1#1)
the guanine nucleotide##4##3##(1990-2#1)(1991-12#1)(1992-3#1)(2011-1#1)
the guanine##20##2##(1990-12#2)(1990-2#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-3#1)(1992-7#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#3)(2008-10#3)(2008-5#1)(2011-1#2)
the guanine-nucleotide exchange factor##3##4##(1994-12#1)(2006-12#1)(2007-12#1)
the guanosine##6##2##(1992-7#1)(1993-7#1)(2004-12#1)(2006-11#1)(2008-1#1)(2008-3#1)
the guanylyl cyclase inhibitor##2##4##(1996-1#1)(1996-12#1)
the guanylyl cyclase##3##3##(1996-1#1)(1996-12#1)(1996-6#1)
the guarantee of##2##3##(2007-9#1)(2010-8#1)
the guard##3##2##(1991-3#1)(2008-10#1)(2008-8#1)
the guardian of the genome##2##5##(2008-5#1)(2011-2#1)
the guardian##5##2##(1990-11#1)(1992-12#1)(2007-8#1)(2008-5#1)(2011-2#1)
the guards##4##2##(1995-6#4)
the guest molecules##4##3##(2006-12#1)(2008-10#2)(2008-2#1)
the guest##11##2##(1997-7#1)(2006-12#2)(2008-10#5)(2008-2#1)(2013-1#1)(2013-8#1)
the guests##4##2##(2006-8#1)(2008-10#1)(2010-4#1)(2010-7#1)
the guidance of a##3##4##(2008-11#1)(2008-3#2)
the guidance of the##5##4##(2008-1#1)(2008-3#1)(2008-7#1)(2009-3#1)(2009-8#1)
the guidance of##18##3##(1993-1#1)(1993-12#1)(1996-3#2)(2007-4#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#1)(2009-3#1)(2009-8#1)(2011-2#3)(2013-8#1)
the guidance##20##2##(1993-1#1)(1993-12#1)(1996-3#2)(2007-4#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2011-2#3)(2012-3#1)(2013-8#1)
the guide##10##2##(1996-2#3)(1996-9#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-3#3)
the guided light##4##3##(2007-12#1)(2008-10#3)
the guided mode##6##3##(2007-11#2)(2007-12#2)(2008-10#1)(2008-3#1)
the guided modes##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
the guided wave##3##3##(2007-11#1)(2008-3#2)
the guided##23##2##(1990-9#1)(2007-11#4)(2007-12#5)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#5)(2013-1#1)
the guided-mode##2##2##(2007-12#2)
the guideline development##2##3##(2006-12#1)(2012-2#1)
the guideline in##2##3##(1995-6#1)(2013-1#1)
the guideline##19##2##(1995-6#2)(1996-3#1)(1996-9#1)(2006-12#1)(2006-6#1)(2007-4#1)(2008-10#4)(2008-8#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-2#1)(2013-1#2)
the guidelines and##3##3##(2008-10#1)(2008-3#1)(2010-5#1)
the guidelines are##2##3##(2007-8#1)(2012-3#1)
the guidelines defined##2##3##(2011-2#1)(2012-2#1)
the guidelines for the##3##4##(2008-10#1)(2008-7#1)(2012-12#1)
the guidelines for##9##3##(1993-5#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
the guidelines of the##5##4##(1991-4#1)(1997-2#1)(1997-8#1)(2011-2#1)(2013-1#1)
the guidelines of##7##3##(1991-3#1)(1991-4#1)(1993-2#1)(1997-2#1)(1997-8#1)(2011-2#1)(2013-1#1)
the guidelines on##2##3##(1990-12#1)(2012-11#1)
the guidelines to##2##3##(2008-5#1)(2012-2#1)
the guidelines were##2##3##(1990-6#1)(2013-1#1)
the guidelines##61##2##(1990-12#1)(1990-6#4)(1991-3#1)(1991-4#1)(1992-8#1)(1993-2#1)(1993-5#1)(1994-2#3)(1996-9#2)(1997-1#1)(1997-2#1)(1997-8#2)(2006-10#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#3)(2008-9#1)(2009-6#2)(2010-11#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#1)
the guiding principles##4##3##(1995-3#1)(2007-11#1)(2011-1#1)(2012-12#1)
the guiding properties##2##3##(2007-12#2)
the guiding region##3##3##(2007-12#2)(2008-2#1)
the guiding##22##2##(1990-4#1)(1994-12#1)(1995-3#1)(2007-11#4)(2007-12#7)(2007-5#1)(2008-1#1)(2008-2#2)(2008-7#1)(2011-1#2)(2012-12#1)
the guiding-center##2##2##(2007-12#1)(2008-1#1)
the guinea pig ileum##7##4##(1991-5#1)(1992-6#1)(1994-11#1)(1995-12#2)(2008-7#2)
the guinea pig##36##3##(1990-9#1)(1991-11#1)(1991-3#1)(1991-5#4)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-3#2)(1995-10#1)(1995-12#2)(1995-7#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-3#4)(2008-10#2)(2008-4#1)(2008-7#2)
the guinea##37##2##(1990-9#1)(1991-11#1)(1991-3#1)(1991-5#4)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-3#2)(1995-10#1)(1995-12#2)(1995-7#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-3#4)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#2)
the guinea-pig colon##3##3##(1997-1#2)(1997-4#1)
the guinea-pig ileum##5##3##(1990-5#1)(1993-3#1)(1996-3#2)(1997-7#1)
the guinea-pig isolated##2##3##(1997-1#1)(1997-7#1)
the guinea-pig##24##2##(1990-5#2)(1991-2#2)(1992-8#1)(1993-11#2)(1993-3#1)(1994-5#2)(1994-6#1)(1996-10#1)(1996-12#1)(1996-3#2)(1997-1#3)(1997-4#2)(1997-5#1)(1997-7#2)(2004-12#1)
the gulf between##2##3##(2008-5#1)(2010-4#1)
the gulf##11##2##(2007-3#1)(2007-5#4)(2008-5#3)(2010-4#1)(2010-8#2)
the gum##6##2##(2005-11#1)(2006-12#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-11#1)
the gumfoot glue##2##3##(2012-2#2)
the gums and##2##3##(2005-3#1)(2012-3#1)
the guppy##3##2##(1991-9#1)(2008-8#2)
the gurken mRNA localisation signal##4##5##(2012-12#4)
the gustatory and somatosensory##2##4##(1993-12#2)
the gustatory##7##2##(1992-11#3)(1993-12#2)(1996-5#1)(2012-1#1)
the gut and##8##3##(1991-10#1)(2006-10#1)(2006-4#1)(2008-10#1)(2008-5#3)(2012-1#1)
the gut as##2##3##(2006-10#1)(2010-8#1)
the gut barrier##2##3##(2008-10#1)(2010-12#1)
the gut flora##2##3##(2006-10#1)(2011-1#1)
the gut in##2##3##(2008-3#1)(2012-1#1)
the gut is##2##3##(1995-6#1)(2006-10#1)
the gut lumen##2##3##(2007-12#1)(2008-10#1)
the gut microbes##2##3##(2008-11#2)
the gut microbiota##3##3##(2011-2#1)(2012-1#2)
the gut mucosa##3##3##(1995-12#1)(1995-6#1)(2007-12#1)
the gut of the##2##4##(1991-10#1)(1993-8#1)
the gut of##6##3##(1991-10#1)(1993-8#1)(2006-5#1)(2008-10#1)(2010-8#1)(2011-12#1)
the gut to##3##3##(2006-10#1)(2007-12#1)(2008-10#1)
the gut tube on day##3##5##(1993-6#3)
the gut wall##3##3##(1993-8#1)(2008-10#1)(2008-4#1)
the gut##99##2##(1990-11#1)(1990-5#1)(1991-10#2)(1992-6#2)(1992-8#2)(1993-1#1)(1993-5#1)(1993-6#3)(1993-8#4)(1995-12#1)(1995-6#3)(1996-5#2)(2006-10#12)(2006-2#1)(2006-4#1)(2006-5#2)(2007-11#1)(2007-12#5)(2007-3#1)(2007-6#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-4#5)(2008-5#5)(2009-9#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#9)(2012-1#4)(2012-12#1)(2013-7#2)
the gut-associated##3##2##(2006-10#2)(2012-2#1)
the guts of##2##3##(2008-7#1)(2013-7#1)
the guts##3##2##(2004-11#1)(2008-7#1)(2013-7#1)
the gynecologic examination##2##3##(1990-2#1)(1992-12#1)
the gynecologic##4##2##(1990-2#1)(1991-3#1)(1992-12#1)(1993-12#1)
the gynecological##2##2##(1991-2#1)(1996-3#1)
the gynecologist##3##2##(1992-2#3)
the gyrA##3##2##(2011-2#3)
the gyrase##2##2##(1994-9#2)
the gyro is##2##3##(2007-12#2)
the gyro noise##2##3##(2008-1#2)
the gyro##6##2##(2007-12#4)(2008-1#2)
the gyrotron output##3##3##(2007-9#1)(2011-1#2)
the gyrotron##5##2##(2007-9#3)(2011-1#2)
the gyrus dentatus##2##3##(1997-8#1)(2009-2#1)
the gz##2##2##(1994-2#1)(1997-3#1)
the h-lamp-2##3##2##(1994-11#3)
the hAT2R mRNA was##2##4##(1994-11#2)
the hAT2R##3##2##(1994-11#3)
the hCG##2##2##(1991-7#1)(2011-2#1)
the hDRS##3##2##(1994-12#3)
the hESC microenvironment##2##3##(2009-3#2)
the hEp##3##2##(1993-12#1)(1993-6#2)
the hFSH receptor##3##3##(1991-8#3)
the hGR##3##2##(1995-10#1)(1995-3#2)
the hIL-5##2##2##(1997-6#2)
the hIL-6 productivity rate##2##4##(2008-11#2)
the hIL-6##3##2##(2008-11#3)
the hKLK2 promoter##2##3##(1993-6#2)
the hKLK2##3##2##(1993-6#3)
the hMSH2 gene##2##3##(1996-7#2)
the hMSH2##3##2##(1995-6#1)(1996-7#2)
the hMTIIA gene transcription start site##2##6##(1996-8#2)
the hMTIIA promoter in##2##4##(1996-8#2)
the hMTIIA promoter##3##3##(1996-8#3)
the hMTIIA##5##2##(1996-8#5)
the hP2Y(1) receptor##5##3##(2008-4#5)
the hP2Y(1)##6##2##(2008-4#6)
the hSAP##3##2##(1996-6#3)
the hTERT gene##2##3##(2008-11#2)
the hTERT promoter##2##3##(2008-11#2)
the hTERT##7##2##(2008-11#7)
the hTHTg mice##2##3##(1997-5#2)
the habit of smoking##3##4##(1991-4#1)(1991-9#2)
the habit of unilateral mastication##2##5##(2012-2#2)
the habit of##11##3##(1991-4#1)(1991-9#2)(1995-6#1)(2006-8#1)(2007-8#1)(2009-4#1)(2010-12#1)(2012-12#1)(2012-2#2)
the habit##16##2##(1991-4#1)(1991-9#3)(1993-6#1)(1995-6#1)(1996-2#1)(2006-8#1)(2007-8#1)(2008-10#2)(2009-4#1)(2010-12#1)(2012-12#1)(2012-2#2)
the habitat in##2##3##(2008-10#1)(2008-8#1)
the habitat patches##2##3##(2008-8#2)
the habitat preferences##2##3##(2006-5#1)(2008-8#1)
the habitat##19##2##(2006-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-5#3)(2008-8#5)(2009-5#1)(2010-8#1)(2011-12#1)(2011-2#1)(2013-1#1)
the habitats##6##2##(2007-10#1)(2007-3#2)(2008-5#1)(2008-8#1)(2013-7#1)
the habits of##2##3##(2009-10#1)(2012-12#1)
the habituation##2##2##(1997-7#1)(2007-4#1)
the haemagglutination##2##2##(1997-8#1)(2008-5#1)
the haemagglutination-inhibition##2##2##(2008-5#2)
the haemagglutinins##2##2##(2008-5#2)
the haematocrit##4##2##(2007-11#1)(2007-8#1)(2008-7#2)
the haematogenous route##3##3##(2009-2#1)(2009-5#1)(2013-8#1)
the haematogenous##4##2##(2009-2#1)(2009-5#1)(2011-2#1)(2013-8#1)
the haematological parameters##2##3##(2010-4#1)(2013-8#1)
the haematological##6##2##(1993-7#1)(2005-10#1)(2008-2#1)(2010-4#1)(2011-1#1)(2013-8#1)
the haematology##2##2##(2005-10#1)(2010-8#1)
the haematoma##5##2##(1997-3#1)(2008-7#4)
the haematopoietic##2##2##(2013-8#2)
the haemodialysis##5##2##(2007-11#1)(2007-7#2)(2013-8#2)
the haemodynamic##6##2##(1990-6#1)(1993-10#1)(1995-5#1)(2006-12#1)(2011-2#1)(2012-2#1)
the haemoglobin solutions##2##3##(2007-11#2)
the haemoglobin##9##2##(1991-9#1)(1994-6#1)(1997-6#1)(2007-11#4)(2009-5#1)(2013-8#1)
the haemoglobinopathies##2##2##(1995-5#2)
the haemolymph and##2##3##(1991-5#1)(1995-12#1)
the haemolymph##4##2##(1991-5#2)(1995-12#1)(2007-12#1)
the haemolysin activity##2##3##(2005-11#2)
the haemolysin##3##2##(1996-12#1)(2005-11#2)
the haemolytic activity##2##3##(1992-1#2)
the haemolytic##3##2##(1992-1#2)(1995-12#1)
the haemorheological parameters##2##3##(2007-1#2)
the haemostatic system##2##3##(2006-10#1)(2010-7#1)
the hagfish##2##2##(2008-5#2)
the hair and##6##3##(2006-12#1)(2007-12#1)(2008-5#4)
the hair bulb##2##3##(1990-6#1)(2008-5#1)
the hair cell##3##3##(1995-3#1)(2012-2#2)
the hair cells##5##3##(1991-9#1)(1993-9#1)(1995-8#3)
the hair cycle##3##3##(2008-5#3)
the hair eclipse phenomenon##3##4##(2008-5#3)
the hair fiber##2##3##(2008-5#2)
the hair follicle##9##3##(2008-5#6)(2008-8#1)(2010-7#1)(2012-2#1)
the hair loss##2##3##(2005-11#1)(2010-6#1)
the hair samples##2##3##(2008-10#1)(2008-5#1)
the hair shaft##4##3##(2008-5#2)(2012-11#2)
the hair shafts##2##3##(2008-5#1)(2012-11#1)
the hair structure##2##3##(2008-5#2)
the hair types##2##3##(2008-5#2)
the hair##96##2##(1990-6#1)(1991-9#1)(1993-9#1)(1995-3#1)(1995-8#3)(1996-12#1)(1996-7#1)(2004-4#3)(2005-11#1)(2005-4#1)(2006-12#4)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-5#53)(2008-8#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-11#6)(2012-2#3)(2012-3#1)(2013-7#1)
the hairless##2##2##(1996-11#1)(2008-5#1)
the hairpin helix##2##3##(1994-9#2)
the hairpin ribozyme##3##3##(1991-11#1)(1996-7#2)
the hairpin##10##2##(1991-11#1)(1991-7#2)(1994-9#3)(1996-7#2)(2006-10#1)(2008-10#1)
the hairy root culture##2##4##(1994-11#1)(2008-10#1)
the hairy root lines of H##2##6##(2007-1#2)
the hairy root##4##3##(1994-11#1)(2007-1#2)(2008-10#1)
the hairy##7##2##(1990-7#1)(1990-9#1)(1994-11#1)(2007-1#2)(2008-10#1)(2008-7#1)
the half life of the##2##5##(1991-10#2)
the half life of##3##4##(1991-10#2)(2008-10#1)
the half life##4##3##(1991-10#2)(1993-12#1)(2008-10#1)
the half neutralization potential by about##2##6##(2008-10#2)
the half of##2##3##(2007-8#1)(2008-11#1)
the half##16##2##(1991-10#2)(1993-12#1)(1993-5#1)(1995-7#1)(1996-1#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-8#1)
the half-bandgap##2##2##(2007-12#1)(2008-2#1)
the half-coupler##2##2##(2008-2#1)(2008-3#1)
the half-intensity##3##2##(2008-2#3)
the half-life of the viable cell##2##6##(2008-11#2)
the half-life of the##8##4##(1992-4#1)(1993-1#1)(1994-12#1)(1994-6#1)(2005-8#1)(2008-11#2)(2008-8#1)
the half-life of##18##3##(1990-10#1)(1991-5#1)(1992-4#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-6#2)(1996-4#1)(1997-4#1)(2005-8#2)(2007-6#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-4#1)
the half-life##21##2##(1990-10#1)(1991-5#1)(1992-4#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-6#2)(1995-6#1)(1996-4#1)(1997-4#1)(2005-8#2)(2006-12#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-4#1)(2012-3#1)
the half-lives##2##2##(1993-9#1)(2004-11#1)
the half-maximal##2##2##(1991-1#1)(2008-4#1)
the half-saturation##2##2##(1992-6#1)(2007-6#1)
the half-visor group##2##3##(2010-1#2)
the half-visor##4##2##(2010-1#4)
the half-wave##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
the halftone microstructure##2##3##(2008-2#2)
the halftone##7##2##(2008-2#5)(2008-3#2)
the halftoning##2##2##(2008-2#1)(2008-3#1)
the halide ion##3##3##(2006-9#2)(2008-10#1)
the halide##5##2##(2006-9#2)(2008-10#1)(2008-5#1)(2011-1#1)
the halides##2##2##(1996-6#2)
the hallmark of the##5##4##(2005-12#1)(2008-11#1)(2011-2#3)
the hallmark of this##2##4##(1993-4#1)(1994-2#1)
the hallmark of##14##3##(1993-4#1)(1994-2#1)(1995-6#1)(2005-11#1)(2005-12#1)(2006-1#1)(2008-1#1)(2008-11#1)(2010-2#1)(2011-2#3)(2012-2#1)(2013-7#1)
the hallmark##18##2##(1991-8#1)(1993-4#1)(1994-2#1)(1995-6#1)(2005-11#1)(2005-12#1)(2006-1#1)(2006-11#1)(2008-1#1)(2008-11#1)(2010-2#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-7#1)
the hallmarks of a##2##4##(1991-6#1)(2009-5#1)
the hallmarks of##12##3##(1991-5#1)(1991-6#1)(1994-6#1)(1995-8#1)(1997-4#1)(2007-10#1)(2007-6#1)(2008-10#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
the hallmarks##13##2##(1991-5#1)(1991-6#1)(1994-6#1)(1995-1#1)(1995-8#1)(1997-4#1)(2007-10#1)(2007-6#1)(2008-10#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
the hallux valgus deformity##2##4##(2009-10#1)(2012-2#1)
the hallux##4##2##(2007-7#1)(2009-10#2)(2012-2#1)
the halo effect##3##3##(2007-5#2)(2009-9#1)
the halo##8##2##(2006-9#1)(2007-11#1)(2007-5#2)(2008-2#2)(2008-3#1)(2009-9#1)
the halogen##2##2##(2008-12#1)(2008-9#1)
the halogenated##4##2##(1992-9#1)(1997-1#1)(2004-4#2)
the halophilic##2##2##(1994-12#1)(2012-2#1)
the hamster model##2##3##(2008-9#2)
the hamster ova penetration test##2##5##(1995-8#2)
the hamster test##2##3##(1995-8#2)
the hamster trachea##2##3##(1993-3#2)
the hamster##28##2##(1990-7#1)(1992-7#1)(1993-3#2)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#4)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#2)(1996-9#3)(2008-4#2)(2008-9#3)
the hamstring##5##2##(2007-11#2)(2009-5#1)(2009-9#2)
the hamstrings group##2##3##(2009-9#2)
the hamstrings##5##2##(2009-9#5)
the hand and upper extremity##3##5##(2006-3#1)(2006-4#1)(2011-2#1)
the hand and wrist##4##4##(2006-4#1)(2012-2#3)
the hand and##20##3##(1990-10#1)(2006-10#1)(2006-3#1)(2006-4#2)(2007-11#2)(2007-7#1)(2008-2#1)(2008-6#2)(2008-7#1)(2009-3#1)(2010-9#1)(2011-2#2)(2012-2#3)(2013-1#1)
the hand are##2##3##(2007-3#1)(2012-2#1)
the hand function##2##3##(2011-2#1)(2012-1#1)
the hand in##5##3##(1997-8#1)(2007-11#1)(2008-6#1)(2012-1#2)
the hand is##4##3##(1992-9#1)(2007-8#1)(2008-9#1)(2012-2#1)
the hand or foot##3##4##(2008-6#3)
the hand or##5##3##(2008-6#4)(2008-9#1)
the hand to##3##3##(1996-1#1)(2008-6#1)(2008-9#1)
the hand with a##2##4##(1994-11#1)(2011-2#1)
the hand##123##2##(1990-10#1)(1990-4#3)(1991-9#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-3#1)(1993-5#1)(1994-11#1)(1996-1#5)(1996-9#1)(1997-1#1)(1997-8#2)(2006-10#5)(2006-11#1)(2006-3#2)(2006-4#5)(2006-6#1)(2007-11#8)(2007-3#2)(2007-5#1)(2007-7#4)(2007-8#3)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#13)(2008-7#2)(2008-9#9)(2009-10#1)(2009-3#2)(2009-9#2)(2010-1#3)(2010-9#1)(2011-1#2)(2011-2#8)(2012-1#6)(2012-12#1)(2012-2#10)(2013-1#1)(2013-8#1)
the handheld##2##2##(2009-10#1)(2011-7#1)
the handiness##2##2##(2011-2#2)
the handle##4##2##(2006-6#2)(2008-6#1)(2012-1#1)
the handler risks injury from bite wounds or scratches inflicted when the animal becomes fearful or anxious##2##17##(2008-4#2)
the handler##4##2##(2008-4#4)
the handling of the##3##4##(2007-11#1)(2008-10#1)(2008-11#1)
the handling of##12##3##(1992-10#1)(1992-11#1)(1994-6#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-4#1)(2010-8#1)(2012-1#1)
the handling##15##2##(1992-10#1)(1992-11#1)(1994-6#1)(2004-9#1)(2006-10#1)(2007-11#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-4#1)(2010-8#1)(2012-1#1)
the hands and feet##8##4##(2007-7#2)(2008-4#1)(2008-7#1)(2009-9#1)(2011-12#1)(2012-12#1)(2013-1#1)
the hands and##11##3##(2007-7#2)(2008-4#1)(2008-7#1)(2009-9#1)(2010-8#1)(2011-12#1)(2012-10#1)(2012-12#1)(2012-3#1)(2013-1#1)
the hands of the person##2##5##(2008-10#1)(2008-8#1)
the hands of the##6##4##(1996-11#1)(1997-5#1)(2008-10#2)(2008-8#1)(2010-9#1)
the hands of##20##3##(1996-11#1)(1997-2#1)(1997-4#1)(1997-5#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-9#1)(2012-3#1)
the hands##51##2##(1993-11#1)(1994-11#1)(1995-5#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2005-11#1)(2006-10#4)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-10#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-7#1)
the hanging drop##2##3##(1994-9#1)(2008-11#1)
the hanging mercury drop electrode (HMDE)##5##6##(2008-10#5)
the hanging mercury drop electrode was##3##6##(2008-10#3)
the hanging mercury drop electrode##14##5##(2008-10#14)
the hanging mercury##15##3##(2005-11#1)(2008-10#14)
the hanging##18##2##(1994-9#1)(2005-11#1)(2008-10#15)(2008-11#1)
the haploid genome##2##3##(1990-12#1)(1996-12#1)
the haploid##3##2##(1990-12#1)(1996-12#1)(2008-7#1)
the haplotype of##2##3##(1997-8#1)(2008-5#1)
the haplotype##4##2##(1996-11#1)(1997-8#1)(2008-5#1)(2010-2#1)
the haplotypes##5##2##(1997-5#1)(2008-10#1)(2008-12#1)(2012-12#1)(2013-1#1)
the hapten content##2##3##(1997-3#2)
the hapten##11##2##(1990-12#1)(1992-8#1)(1993-8#1)(1994-8#2)(1996-10#1)(1997-3#2)(2008-10#1)(2008-4#2)
the haptenic##2##2##(1990-5#1)(1991-8#1)
the haptic device##4##3##(2012-1#4)
the haptic##6##2##(2012-1#6)
the harbor##2##2##(1996-3#2)
the hard limit on character size for each message limits the full value of exploring SMS communication in health care practices##2##21##(2013-1#2)
the hard tissue##2##3##(2007-4#1)(2009-8#1)
the hard##24##2##(1991-11#3)(1994-5#1)(1994-6#2)(2005-11#1)(2006-4#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-8#1)(2011-2#1)(2013-1#3)
the hardening##4##2##(2004-9#1)(2008-10#3)
the hardest hit##2##3##(2008-2#1)(2008-5#1)
the hardest##5##2##(1992-5#1)(2007-8#1)(2008-2#1)(2008-5#1)(2010-9#1)
the hardness and##2##3##(2008-5#1)(2010-4#1)
the hardness##7##2##(1997-4#1)(2008-10#1)(2008-3#1)(2008-5#2)(2010-4#1)(2013-8#1)
the hardship##2##2##(1995-9#1)(2006-10#1)
the hardware##9##2##(2008-2#7)(2008-9#1)(2012-1#1)
the hare##5##2##(2007-9#4)(2013-1#1)
the harm##6##2##(1990-9#2)(2004-12#1)(2006-10#1)(2008-11#1)(2013-8#1)
the harmful effect##2##3##(2008-5#1)(2011-1#1)
the harmful effects of##6##4##(1991-6#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-9#1)
the harmful effects on the##2##5##(1991-6#1)(2007-10#1)
the harmful effects##9##3##(1991-6#2)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-9#1)
the harmful##19##2##(1991-6#2)(2004-4#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#3)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-2#1)
the harmonic frequencies##2##3##(2007-12#1)(2008-1#1)
the harmonic scalpel##2##3##(2007-8#1)(2011-1#1)
the harmonic##10##2##(2005-4#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#1)(2008-8#1)(2011-1#1)
the harmonics in the##2##4##(2008-3#2)
the harmonics in##3##3##(2008-3#3)
the harmonics##6##2##(2007-12#1)(2008-1#1)(2008-3#4)
the harmonious##4##2##(1993-2#1)(2004-8#1)(2008-10#1)(2008-5#1)
the harmonization##2##2##(2008-10#1)(2010-8#1)
the harmony##2##2##(2012-12#2)
the harms##2##2##(1992-12#1)(2008-5#1)
the harsh##2##2##(2011-1#1)(2012-3#1)
the harshest##2##2##(2008-8#1)(2012-11#1)
the harvest of##2##3##(2008-9#1)(2011-1#1)
the harvest##8##2##(2006-9#1)(2007-3#1)(2007-5#1)(2008-9#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
the harvested##4##2##(1994-5#1)(2006-4#1)(2008-10#1)(2008-11#1)
the harvesting and##2##3##(1990-5#1)(2008-4#1)
the harvesting time##2##3##(2012-2#2)
the harvesting##11##2##(1990-5#1)(2006-10#1)(2007-1#1)(2008-4#2)(2008-8#2)(2012-12#2)(2012-2#2)
the hatchability##2##2##(2008-12#1)(2008-4#1)
the hatched##3##2##(1992-6#1)(1997-3#1)(2008-5#1)
the hatchers##2##2##(1997-3#2)
the hatchery##4##2##(1997-3#4)
the hatching rate and##2##4##(2006-5#2)
the hatching rate##4##3##(2006-5#3)(2010-8#1)
the hatching##5##2##(2006-5#3)(2010-8#2)
the hazard function##2##3##(2007-8#1)(2008-10#1)
the hazard ratio (HR)##2##4##(2013-1#2)
the hazard##10##2##(1996-12#2)(2007-8#1)(2008-10#2)(2008-3#1)(2010-12#1)(2011-2#1)(2013-1#2)
the hazardous wastes##2##3##(2007-10#2)
the hazardous##7##2##(2007-10#2)(2008-5#1)(2010-7#4)
the hazards of##10##3##(1990-11#1)(1991-5#1)(1992-3#1)(1996-2#1)(2008-11#2)(2008-6#1)(2008-8#1)(2010-3#1)(2013-1#1)
the hazards##13##2##(1990-11#1)(1991-5#1)(1992-3#1)(1995-9#1)(1996-12#1)(1996-2#1)(2008-11#3)(2008-6#1)(2008-8#1)(2010-3#1)(2013-1#1)
the head &amp##2##3##(2007-11#1)(2009-10#1)
the head and neck area##2##5##(2006-12#1)(2011-2#1)
the head and neck of the##2##6##(2007-7#1)(2008-12#1)
the head and neck region in##3##6##(2012-2#1)(2013-1#2)
the head and neck region##28##5##(1992-5#1)(1992-9#1)(1993-5#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)(2012-12#4)(2012-2#1)(2013-1#3)(2013-8#4)
the head and neck##76##4##(1990-6#2)(1991-10#1)(1992-10#1)(1992-4#2)(1992-5#1)(1992-9#1)(1993-1#1)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-6#1)(1995-8#2)(1997-6#1)(2005-7#1)(2006-11#1)(2006-12#3)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#4)(2007-3#1)(2007-6#2)(2007-7#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#5)(2008-7#2)(2008-8#1)(2009-9#2)(2010-11#1)(2010-7#2)(2011-2#4)(2012-12#4)(2012-2#1)(2013-1#5)(2013-7#2)(2013-8#7)
the head and the##2##4##(1995-12#1)(2009-6#1)
the head and trunk##2##4##(2007-12#1)(2010-8#1)
the head and##99##3##(1990-6#2)(1991-10#1)(1992-10#1)(1992-4#2)(1992-5#1)(1992-9#1)(1993-1#1)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-8#2)(1997-6#1)(2005-7#1)(2006-11#1)(2006-12#3)(2007-1#4)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#4)(2007-6#2)(2007-7#2)(2007-9#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#5)(2008-7#2)(2008-8#3)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-7#2)(2010-8#1)(2011-2#4)(2012-12#4)(2012-2#2)(2013-1#5)(2013-7#2)(2013-8#8)
the head by##4##3##(1990-5#1)(1993-12#1)(2007-12#1)(2010-12#1)
the head center##2##3##(2006-11#1)(2011-2#1)
the head group region and##2##5##(1993-3#1)(1994-11#1)
the head group region##3##4##(1993-3#1)(1994-11#1)(1994-3#1)
the head group##8##3##(1993-3#1)(1994-11#1)(1994-3#2)(2005-11#3)(2008-8#1)
the head groups##4##3##(1992-9#1)(2005-11#2)(2006-10#1)
the head impact##2##3##(2007-1#1)(2007-4#1)
the head is##4##3##(2006-10#1)(2007-4#1)(2008-9#1)(2009-10#1)
the head of pancreas##4##4##(2008-3#4)
the head of the Department of##4##6##(2008-10#4)
the head of the caudate##2##5##(1996-8#1)(2008-6#1)
the head of the femur##2##5##(1990-2#1)(2006-11#1)
the head of the pancreas and##2##6##(1990-3#1)(1993-5#1)
the head of the pancreas is##2##6##(1991-3#1)(1991-9#1)
the head of the pancreas##11##5##(1990-3#3)(1990-9#1)(1991-3#1)(1991-9#1)(1993-5#2)(2008-8#2)(2013-1#1)
the head of the##33##4##(1990-2#1)(1990-3#3)(1990-9#1)(1991-11#1)(1991-3#1)(1991-9#1)(1993-11#1)(1993-5#2)(1994-6#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-8#1)(2006-11#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-6#1)(2008-8#2)(2009-4#1)(2010-10#1)(2010-2#1)(2013-1#1)
the head of##47##3##(1990-2#1)(1990-3#3)(1990-9#1)(1991-11#1)(1991-3#1)(1991-9#1)(1993-11#1)(1993-5#2)(1994-6#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-3#2)(1996-8#1)(1997-6#1)(2006-10#1)(2006-11#2)(2007-12#2)(2007-5#1)(2007-9#1)(2008-10#6)(2008-12#1)(2008-3#4)(2008-6#1)(2008-8#2)(2009-4#1)(2010-10#1)(2010-2#1)(2012-3#1)(2013-1#1)
the head pad research##2##4##(2007-4#2)
the head portion of the heavy chains of brain myosin##2##10##(1990-6#2)
the head region##4##3##(1992-6#1)(1994-9#1)(2007-12#1)(2008-5#1)
the head to the##3##4##(2010-6#1)(2011-1#2)
the head were significantly##2##4##(1991-11#1)(1995-11#1)
the head were##3##3##(1991-11#1)(1995-11#1)(2008-5#1)
the head##282##2##(1990-2#1)(1990-3#3)(1990-5#2)(1990-6#4)(1990-9#2)(1991-10#1)(1991-11#2)(1991-3#1)(1991-9#1)(1992-10#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#4)(1993-3#2)(1993-4#1)(1993-5#3)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#2)(1994-6#3)(1994-8#2)(1994-9#1)(1995-11#5)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#5)(1996-12#1)(1996-3#2)(1996-4#1)(1996-8#1)(1996-9#2)(1997-3#1)(1997-4#1)(1997-6#2)(2004-11#1)(2005-10#1)(2005-11#5)(2005-7#1)(2006-10#5)(2006-11#7)(2006-12#3)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#7)(2007-10#1)(2007-11#5)(2007-12#21)(2007-2#2)(2007-3#1)(2007-4#21)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#1)(2007-9#2)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#6)(2008-6#7)(2008-7#4)(2008-8#7)(2008-9#2)(2009-10#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#6)(2013-7#5)(2013-8#11)
the head-group##2##2##(2006-10#2)
the head-neck junction##5##3##(2011-2#1)(2013-1#4)
the head-neck kinematics##2##3##(2006-11#1)(2007-1#1)
the head-neck##9##2##(2006-11#1)(2007-1#2)(2011-2#1)(2013-1#5)
the head-pressure reference##2##3##(2006-8#2)
the head/neck##2##2##(1995-11#1)(2007-1#1)
the headache##8##2##(2004-12#3)(2008-4#1)(2008-8#1)(2012-2#2)(2013-7#1)
the header##2##2##(1996-12#1)(2008-3#1)
the headgroup area##3##3##(2005-11#3)
the headgroup of##2##3##(1996-5#2)
the headgroup##10##2##(1990-7#1)(1991-7#1)(1994-11#1)(1996-5#2)(2005-11#5)
the heading of##6##3##(2006-3#1)(2008-11#1)(2008-8#1)(2009-9#1)(2010-7#1)(2013-1#1)
the heading##8##2##(2006-12#1)(2006-3#1)(2007-7#1)(2008-11#1)(2008-8#1)(2009-9#1)(2010-7#1)(2013-1#1)
the headlines##2##2##(2010-11#1)(2013-1#1)
the headquarters##2##2##(2008-10#1)(2008-11#1)
the heads of##2##3##(2006-6#1)(2008-5#1)
the heads##6##2##(2004-4#1)(2005-8#1)(2006-12#1)(2006-6#1)(2008-3#1)(2008-5#1)
the headspace above the##3##4##(2006-12#1)(2008-10#2)
the headspace and##2##3##(2008-10#2)
the headspace of##4##3##(2008-10#3)(2008-11#1)
the headspace solvent microextraction##2##4##(2008-10#2)
the headspace##21##2##(2006-12#1)(2008-10#15)(2008-11#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-12#1)
the healer##2##2##(1997-6#1)(2008-4#1)
the healing of chronic##2##4##(2005-11#1)(2007-11#1)
the healing of the##2##4##(2008-5#1)(2013-1#1)
the healing of##17##3##(2005-11#3)(2005-7#1)(2006-8#1)(2007-1#1)(2007-11#2)(2008-5#2)(2008-9#1)(2009-3#1)(2010-1#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
the healing process and##2##4##(1996-12#1)(2007-5#1)
the healing process is##2##4##(2007-11#1)(2009-5#1)
the healing process##10##3##(1996-12#1)(1996-4#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-5#1)(2008-9#1)(2009-5#1)(2011-2#1)
the healing water##2##3##(1994-3#2)
the healing##46##2##(1994-3#4)(1996-12#1)(1996-4#1)(2005-11#3)(2005-7#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-11#4)(2007-12#1)(2007-5#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#4)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
the health and social##3##4##(2008-2#1)(2008-3#1)(2012-1#1)
the health and welfare of farmed deer##2##7##(2005-7#2)
the health and well being of##2##6##(2006-2#1)(2012-11#1)
the health and well-being of##4##5##(2006-2#1)(2009-5#1)(2010-7#1)(2010-9#1)
the health and##34##3##(1991-3#1)(1992-3#1)(1996-12#1)(1996-3#2)(1997-4#1)(1997-8#1)(2005-7#3)(2006-10#1)(2006-2#2)(2006-7#1)(2007-12#1)(2007-2#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-3#1)(2010-7#1)(2010-9#2)(2012-1#2)(2012-11#1)(2012-2#1)(2013-1#2)(2013-8#1)
the health assessment of##2##4##(2013-8#2)
the health authorities of the##2##5##(1990-6#1)(2012-12#1)
the health authorities##7##3##(1990-6#1)(1993-5#1)(1994-3#1)(1994-6#1)(1995-6#1)(1996-1#1)(2012-12#1)
the health behaviors of##2##4##(2007-2#1)(2008-11#1)
the health benefits of##2##4##(1990-9#1)(2007-2#1)
the health benefits##5##3##(1990-9#1)(2007-2#1)(2009-4#1)(2010-7#1)(2012-1#1)
the health care and##3##4##(1994-12#1)(2011-1#2)
the health care attorney##2##4##(1992-2#2)
the health care community##3##4##(1992-12#1)(1995-12#1)(1996-12#1)
the health care context##4##4##(1997-3#2)(2008-11#1)(2010-2#1)
the health care crisis##2##4##(1991-1#1)(1997-3#1)
the health care delivery system##10##5##(1991-1#1)(1993-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(2007-4#2)(2009-4#1)(2011-1#1)
the health care enterprise##2##4##(1994-12#1)(1996-3#1)
the health care environment##9##4##(1990-12#1)(1991-3#1)(1993-3#2)(1995-1#4)(2007-4#1)
the health care experience##4##4##(1995-3#1)(2008-8#3)
the health care facilities##3##4##(1991-4#2)(1997-8#1)
the health care field has##2##5##(1993-12#2)
the health care field##10##4##(1990-12#1)(1993-12#2)(1994-2#2)(1995-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(2006-4#1)
the health care financing##2##4##(1992-3#1)(1993-2#1)
the health care industry##31##4##(1990-12#3)(1991-1#1)(1991-12#2)(1992-3#1)(1993-12#5)(1994-3#1)(1995-12#1)(1995-3#2)(1996-2#1)(1997-2#2)(1997-3#3)(2005-7#1)(2006-10#1)(2006-8#1)(2007-3#1)(2007-4#1)(2008-11#3)(2010-8#1)
the health care institution##2##4##(1990-12#1)(2008-7#1)
the health care management##3##4##(1994-3#2)(2008-11#1)
the health care needs of##3##5##(1990-12#1)(1994-2#1)(2005-12#1)
the health care needs##5##4##(1990-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(2005-12#1)
the health care of##7##4##(1992-8#1)(1995-3#1)(1996-4#1)(2005-11#1)(2006-5#1)(2010-8#1)(2012-2#1)
the health care organization##4##4##(1993-2#1)(1994-12#1)(1994-3#1)(2010-8#1)
the health care problems of##2##5##(1990-12#1)(2008-7#1)
the health care problems##3##4##(1990-12#1)(1997-8#1)(2008-7#1)
the health care profession##2##4##(1991-2#1)(2011-2#1)
the health care provider should##2##5##(2008-7#1)(2010-1#1)
the health care provider to##2##5##(1992-2#1)(2005-7#1)
the health care provider##6##4##(1992-2#1)(2005-7#1)(2008-7#2)(2010-1#1)(2013-1#1)
the health care quality##2##4##(1994-2#1)(1996-2#1)
the health care reform##3##4##(1994-12#1)(1995-3#1)(1996-12#1)
the health care sector##7##4##(1992-1#1)(1992-2#1)(1994-2#1)(1996-2#1)(2008-11#1)(2008-12#1)(2010-7#1)
the health care setting##2##4##(2005-8#1)(2008-11#1)
the health care system and##7##5##(1993-11#1)(1994-2#1)(1996-2#1)(1997-6#1)(2010-4#1)(2011-1#1)(2012-11#1)
the health care system in the##2##6##(1992-12#1)(1995-4#1)
the health care system in##4##5##(1992-12#1)(1992-2#1)(1995-4#1)(2005-10#1)
the health care system is##2##5##(1997-2#1)(2008-3#1)
the health care system should encourage##2##6##(1994-3#1)(1996-2#1)
the health care system to##4##5##(1994-2#1)(2007-4#1)(2008-8#1)(2013-1#1)
the health care system##69##4##(1990-12#2)(1991-1#1)(1991-2#1)(1991-3#2)(1992-12#2)(1992-2#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-6#1)(1994-12#4)(1994-2#3)(1994-3#3)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#3)(1995-4#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-6#2)(2005-10#2)(2006-10#1)(2006-2#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#3)(2008-3#3)(2008-8#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
the health care systems##3##4##(1994-2#1)(2007-9#1)(2013-8#1)
the health care team and##2##5##(2008-7#1)(2011-1#1)
the health care team##13##4##(1995-2#2)(1995-3#2)(2006-10#1)(2006-5#1)(2008-11#2)(2008-7#2)(2010-4#1)(2011-1#1)(2012-12#1)
the health care use##3##4##(1997-3#1)(2013-1#2)
the health care work force##2##5##(1994-2#2)
the health care##273##3##(1990-12#12)(1991-1#4)(1991-12#3)(1991-2#4)(1991-3#4)(1991-4#2)(1991-7#1)(1992-1#2)(1992-12#4)(1992-2#5)(1992-3#3)(1992-8#1)(1993-11#1)(1993-12#12)(1993-2#4)(1993-3#4)(1993-6#2)(1994-11#1)(1994-12#8)(1994-2#11)(1994-3#9)(1994-6#1)(1994-8#1)(1995-1#6)(1995-12#4)(1995-2#8)(1995-3#8)(1995-4#1)(1995-9#2)(1996-1#1)(1996-12#4)(1996-2#8)(1996-3#6)(1996-4#1)(1997-1#3)(1997-2#5)(1997-3#8)(1997-4#1)(1997-6#2)(1997-8#3)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#2)(2005-8#1)(2006-10#3)(2006-2#2)(2006-4#1)(2006-5#2)(2006-8#3)(2007-2#1)(2007-3#2)(2007-4#5)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-11#11)(2008-12#1)(2008-3#3)(2008-4#1)(2008-7#9)(2008-8#4)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-7#1)(2010-8#3)(2011-1#7)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#3)
the health centers##2##3##(1994-4#1)(2011-2#1)
the health clinics##2##3##(1994-3#2)
the health consequences of##5##4##(1994-6#1)(2006-10#1)(2008-10#1)(2008-2#2)
the health consequences##7##3##(1994-6#1)(2006-10#1)(2008-10#1)(2008-2#2)(2008-7#1)(2009-2#1)
the health domain##2##3##(1990-12#1)(2009-3#1)
the health effects and##2##4##(1990-12#1)(2008-6#1)
the health effects of the##2##5##(2008-4#1)(2013-1#1)
the health effects of##10##4##(1994-6#1)(2007-3#1)(2008-11#1)(2008-4#2)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
the health effects##13##3##(1990-12#1)(1994-6#1)(2007-3#1)(2008-11#1)(2008-4#2)(2008-6#1)(2010-9#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
the health field##8##3##(1991-2#1)(1996-12#1)(2005-7#1)(2008-12#1)(2009-4#1)(2011-1#2)(2012-3#1)
the health impact of##2##4##(1992-4#1)(2013-1#1)
the health information management##2##4##(2007-12#2)
the health information##3##3##(1996-1#1)(2007-12#2)
the health institution##2##3##(2007-1#1)(2013-8#1)
the health insurance industry##3##4##(1992-3#1)(1993-1#1)(2010-5#1)
the health insurance##9##3##(1992-3#1)(1993-1#1)(1995-12#1)(1997-2#1)(1997-8#1)(2007-3#1)(2008-7#1)(2010-5#1)(2013-1#1)
the health maintenance organization (HMO)##3##5##(1994-12#1)(1995-1#1)(1995-12#1)
the health needs of their##3##5##(1994-3#1)(1997-3#1)(2009-8#1)
the health needs of##5##4##(1993-6#1)(1994-3#1)(1997-3#1)(2009-8#1)(2010-3#1)
the health of a##2##4##(1991-1#1)(1993-1#1)
the health of children##4##4##(1995-1#1)(2008-11#2)(2009-8#1)
the health of human beings##2##5##(2008-1#1)(2012-2#1)
the health of individuals and##4##5##(1993-3#1)(2008-1#1)(2010-4#1)(2012-12#1)
the health of individuals##6##4##(1993-3#1)(2008-1#1)(2010-4#2)(2012-12#1)(2012-2#1)
the health of laboratory animals and to provide a stable environment for their maintenance is necessary to reduce unwanted variables or complicating factors in experimentation##2##25##(2008-4#2)
the health of mothers##2##4##(2007-2#1)(2013-1#1)
the health of patients##2##4##(2010-8#1)(2012-11#1)
the health of populations##2##4##(1997-3#1)(2008-7#1)
the health of the nation##2##5##(1994-3#1)(2008-11#1)
the health of the population##3##5##(1990-6#1)(2006-10#1)(2012-12#1)
the health of the public##2##5##(1996-2#1)(2010-6#1)
the health of the##22##4##(1990-6#1)(1990-8#1)(1991-6#1)(1993-3#1)(1994-3#1)(1995-3#1)(1996-2#1)(1997-8#1)(2006-10#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-12#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#1)
the health of users##2##4##(2008-7#1)(2013-8#1)
the health of women##3##4##(2007-12#1)(2008-4#1)(2010-6#1)
the health of young##3##4##(1996-12#1)(2008-9#2)
the health of##84##3##(1990-6#1)(1990-8#1)(1991-1#1)(1991-4#1)(1991-6#1)(1992-5#1)(1993-1#1)(1993-3#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-3#1)(1997-8#1)(2006-10#2)(2006-4#1)(2007-1#1)(2007-12#2)(2007-2#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-8#1)(2010-12#1)(2010-4#2)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#3)
the health plan##3##3##(1994-3#1)(1997-3#1)(2006-8#1)
the health policy process##2##4##(1995-2#1)(2008-7#1)
the health policy##4##3##(1995-2#1)(2007-6#1)(2008-7#1)(2012-2#1)
the health problem##2##3##(1994-12#1)(2011-2#1)
the health process in##2##4##(1993-3#1)(2013-1#1)
the health professional can##2##4##(1994-8#1)(2012-2#1)
the health professional##5##3##(1994-8#1)(1996-9#1)(2008-3#1)(2012-11#1)(2012-2#1)
the health professionals##5##3##(1991-6#1)(2008-11#1)(2008-3#1)(2010-7#1)(2011-2#1)
the health professions##3##3##(1992-3#1)(2006-2#1)(2008-11#1)
the health program##2##3##(1996-2#1)(2011-1#1)
the health promotion##2##3##(2008-1#1)(2008-12#1)
the health risks associated with##2##5##(2007-1#1)(2008-7#1)
the health risks of##3##4##(2008-6#1)(2008-7#1)(2010-2#1)
the health risks##5##3##(2007-1#1)(2008-6#1)(2008-7#2)(2010-2#1)
the health science##2##3##(1994-12#1)(1996-1#1)
the health sciences##6##3##(1990-12#1)(1992-2#1)(1994-12#1)(1994-3#1)(2008-11#1)(2008-12#1)
the health sector is##2##4##(1997-2#1)(2011-2#1)
the health sector##15##3##(1992-1#1)(1993-6#1)(1994-2#1)(1995-3#1)(1997-2#1)(2006-10#1)(2008-7#2)(2008-8#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-8#1)
the health sector]##2##3##(1992-11#1)(1993-6#1)
the health service and##2##4##(1996-3#1)(1997-8#1)
the health service##12##3##(1990-8#1)(1995-6#2)(1996-3#1)(1997-8#1)(2004-7#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-12#1)(2011-1#1)(2012-2#1)
the health services and##2##4##(1990-8#1)(1996-11#1)
the health services in##2##4##(1990-11#1)(2011-2#1)
the health services industry##2##4##(1993-12#1)(2008-12#1)
the health services may##2##4##(1990-8#1)(1995-9#1)
the health services##31##3##(1990-11#1)(1990-4#1)(1990-8#3)(1991-5#1)(1991-6#3)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-12#1)(1994-3#1)(1994-4#1)(1995-9#1)(1996-11#2)(1997-3#2)(2006-3#1)(2008-1#2)(2008-12#1)(2008-4#1)(2008-7#1)(2010-4#1)(2011-2#2)(2012-12#1)
the health setting##2##3##(2007-12#2)
the health staff##2##3##(2007-6#1)(2012-12#1)
the health state scores##2##4##(2008-7#2)
the health state##3##3##(1993-5#1)(2008-7#2)
the health status of the##6##5##(1990-6#2)(1995-2#1)(1996-12#1)(2008-1#1)(2008-10#1)
the health status of##17##4##(1990-6#2)(1994-9#1)(1995-12#3)(1995-2#2)(1996-12#1)(1996-3#1)(1997-2#1)(2005-5#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-10#1)(2010-4#1)
the health status##20##3##(1990-6#3)(1993-6#1)(1994-5#1)(1994-9#1)(1995-12#3)(1995-2#2)(1996-12#1)(1996-3#1)(1997-2#1)(2005-5#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-10#1)(2010-4#1)
the health system in##3##4##(1996-12#1)(2010-8#1)(2012-2#1)
the health system that##2##4##(2010-1#1)(2012-3#1)
the health system to##3##4##(2009-4#1)(2012-12#1)(2013-8#1)
the health system##31##3##(1993-12#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(2006-9#1)(2007-5#1)(2008-1#3)(2009-10#1)(2009-4#2)(2010-1#1)(2010-12#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the health systems in##2##4##(1993-6#1)(2012-3#1)
the health systems##3##3##(1993-6#1)(2011-2#1)(2012-3#1)
the health visitor##3##3##(2008-12#1)(2013-1#2)
the health workers##3##3##(2008-1#1)(2008-2#1)(2012-3#1)
the health##711##2##(1990-11#1)(1990-12#17)(1990-4#1)(1990-6#5)(1990-8#5)(1990-9#1)(1991-1#5)(1991-12#3)(1991-2#5)(1991-3#7)(1991-4#3)(1991-5#1)(1991-6#5)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#4)(1992-11#2)(1992-12#6)(1992-2#6)(1992-3#8)(1992-4#1)(1992-5#2)(1992-8#1)(1993-1#3)(1993-10#1)(1993-11#1)(1993-12#14)(1993-2#4)(1993-3#8)(1993-5#2)(1993-6#9)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#13)(1994-2#12)(1994-3#20)(1994-4#2)(1994-5#2)(1994-6#5)(1994-8#3)(1994-9#1)(1995-1#8)(1995-12#10)(1995-2#13)(1995-3#12)(1995-4#1)(1995-6#4)(1995-9#5)(1996-1#5)(1996-11#2)(1996-12#10)(1996-2#11)(1996-3#13)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#3)(1997-2#10)(1997-3#14)(1997-4#2)(1997-6#2)(1997-8#7)(2004-7#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-5#1)(2005-7#6)(2005-8#1)(2006-10#8)(2006-2#6)(2006-3#1)(2006-4#2)(2006-5#2)(2006-7#1)(2006-8#5)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#1)(2007-12#11)(2007-2#8)(2007-3#4)(2007-4#5)(2007-5#1)(2007-6#4)(2007-7#2)(2007-8#3)(2007-9#3)(2008-1#20)(2008-10#5)(2008-11#20)(2008-12#10)(2008-2#5)(2008-3#7)(2008-4#8)(2008-5#4)(2008-6#3)(2008-7#26)(2008-8#7)(2008-9#3)(2009-10#2)(2009-2#2)(2009-3#1)(2009-4#5)(2009-5#2)(2009-7#1)(2009-8#3)(2010-1#2)(2010-10#2)(2010-12#3)(2010-2#6)(2010-3#2)(2010-4#7)(2010-5#1)(2010-6#2)(2010-7#5)(2010-8#7)(2010-9#5)(2011-1#17)(2011-12#2)(2011-2#18)(2012-1#5)(2012-11#4)(2012-12#13)(2012-2#14)(2012-3#9)(2013-1#21)(2013-7#1)(2013-8#13)
the health-care system and##2##4##(2008-7#1)(2011-2#1)
the health-care system##3##3##(2008-7#2)(2011-2#1)
the health-care team##2##3##(2006-10#1)(2007-2#1)
the health-care##10##2##(1993-3#1)(1993-5#1)(2004-11#1)(2006-10#1)(2007-2#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-12#1)
the health-related attitudes##2##3##(2009-5#1)(2013-7#1)
the health-related quality of life##4##5##(2008-1#1)(2011-1#2)(2011-2#1)
the health-related##11##2##(1996-1#1)(2008-1#1)(2008-11#2)(2008-12#1)(2009-5#1)(2011-1#3)(2011-2#1)(2013-7#1)
the healthcare and##2##3##(1996-3#1)(2008-10#1)
the healthcare community##4##3##(1995-2#2)(2011-2#2)
the healthcare environment##5##3##(1993-12#1)(2006-1#1)(2008-3#3)
the healthcare facility##2##3##(1994-3#1)(2010-9#1)
the healthcare industry in##2##4##(2005-7#1)(2007-12#1)
the healthcare industry##11##3##(1991-2#1)(1992-1#1)(1993-3#1)(1994-2#1)(1995-2#1)(2005-7#1)(2007-12#2)(2009-8#1)(2011-2#1)(2013-8#1)
the healthcare of##2##3##(2005-7#1)(2011-2#1)
the healthcare sector##2##3##(2006-12#1)(2007-12#1)
the healthcare system##21##3##(1991-3#2)(1995-10#1)(2006-1#3)(2006-5#1)(2007-11#1)(2009-4#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-12#1)(2011-2#1)(2011-7#1)(2013-1#2)(2013-8#2)
the healthcare team##2##3##(2007-12#1)(2008-3#1)
the healthcare##87##2##(1991-2#1)(1991-3#2)(1992-1#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-12#2)(1993-3#1)(1994-2#2)(1994-3#1)(1995-10#1)(1995-12#1)(1995-2#3)(1996-12#1)(1996-2#2)(1996-3#1)(1997-3#1)(2005-7#4)(2006-1#4)(2006-12#1)(2006-2#1)(2006-5#2)(2006-8#1)(2007-11#1)(2007-12#6)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#2)(2009-6#3)(2009-8#3)(2010-12#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#8)(2011-7#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#3)
the healthiest##3##2##(2008-5#2)(2012-12#1)
the healthy and diseased##3##4##(2007-11#1)(2012-2#2)
the healthy brain##3##3##(2009-12#1)(2010-11#1)(2012-1#1)
the healthy control group##3##4##(2008-7#2)(2011-1#1)
the healthy control##4##3##(2007-9#1)(2008-7#2)(2011-1#1)
the healthy controls##7##3##(1996-7#1)(1997-8#1)(2008-9#1)(2010-12#1)(2011-2#2)(2013-8#1)
the healthy development of##2##4##(2008-11#1)(2008-4#1)
the healthy eating##2##3##(2007-3#1)(2009-6#1)
the healthy heart##2##3##(1990-6#1)(2005-10#1)
the healthy human##2##3##(2012-2#1)(2012-3#1)
the healthy individuals##3##3##(1992-7#1)(2008-7#1)(2011-11#1)
the healthy persons##2##3##(2010-8#2)
the healthy population##8##3##(1997-8#1)(2006-10#1)(2006-6#1)(2008-1#3)(2012-2#1)(2013-7#1)
the healthy skin microflora##2##4##(2012-3#2)
the healthy subjects##5##3##(1991-10#1)(1991-2#1)(1992-12#1)(2007-9#1)(2008-8#1)
the healthy tissue##3##3##(2012-3#1)(2013-1#2)
the healthy volunteers##3##3##(1997-3#1)(2007-8#1)(2013-8#1)
the healthy##106##2##(1990-6#1)(1991-10#1)(1991-2#1)(1992-12#1)(1992-7#1)(1993-5#1)(1994-3#1)(1994-4#1)(1994-5#1)(1995-12#1)(1995-4#1)(1996-3#1)(1996-7#1)(1997-3#1)(1997-6#1)(1997-8#3)(2005-10#1)(2005-3#1)(2006-10#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#3)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#3)(2008-10#3)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-8#2)(2011-1#2)(2011-11#1)(2011-2#3)(2012-1#3)(2012-11#3)(2012-2#4)(2012-3#5)(2013-1#7)(2013-7#5)(2013-8#2)
the hearing loss##4##3##(2006-10#1)(2007-9#1)(2011-1#1)(2012-2#1)
the hearing##16##2##(1991-10#1)(1991-11#1)(1993-9#1)(1995-5#1)(2006-10#1)(2007-9#1)(2008-4#1)(2008-9#4)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#2)
the heart against##4##3##(2006-10#1)(2007-8#1)(2008-1#1)(2012-3#1)
the heart and lung##5##4##(1991-2#1)(1994-9#1)(2007-8#1)(2008-4#1)(2010-8#1)
the heart and the##4##4##(2005-10#1)(2008-10#1)(2008-5#1)(2013-1#1)
the heart and thoracic aorta##2##5##(2007-8#2)
the heart and##36##3##(1991-2#1)(1991-5#1)(1991-6#1)(1994-2#2)(1994-9#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-7#1)(2007-8#6)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#5)
the heart are##6##3##(1990-1#1)(1990-5#1)(1993-12#1)(2007-12#1)(2009-10#1)(2011-2#1)
the heart at##2##3##(2008-5#1)(2012-1#1)
the heart by##2##3##(2006-7#1)(2010-11#1)
the heart during##5##3##(1991-3#1)(2007-8#2)(2008-1#1)(2010-8#1)
the heart failure##5##3##(2005-10#3)(2008-3#1)(2010-12#1)
the heart from##3##3##(1993-11#2)(2008-5#1)
the heart in the##2##4##(1993-12#1)(2013-1#1)
the heart in##10##3##(1993-12#1)(1995-6#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-4#1)(2010-12#1)(2011-12#1)(2013-1#2)
the heart is a##2##4##(2005-12#1)(2008-4#1)
the heart is the##2##4##(2010-5#1)(2010-9#1)
the heart is##12##3##(1990-3#1)(1994-7#1)(1995-3#1)(1996-6#1)(2005-12#1)(2007-7#1)(2008-4#1)(2008-7#1)(2010-5#2)(2010-9#1)(2011-2#1)
the heart meridian##2##3##(2008-9#2)
the heart muscle and##2##4##(1991-11#1)(2009-4#1)
the heart muscle##17##3##(1990-3#1)(1991-11#1)(1994-7#1)(1995-12#1)(1996-3#1)(2005-1#4)(2007-9#1)(2008-4#5)(2009-4#1)(2011-2#1)
the heart of both##2##4##(2008-5#1)(2012-12#1)
the heart of the##12##4##(1993-11#1)(1994-3#1)(2007-10#1)(2007-8#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-3#1)(2013-1#1)
the heart of##30##3##(1993-11#1)(1994-3#1)(1996-12#1)(1996-3#1)(2004-4#1)(2007-10#1)(2007-4#2)(2007-8#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-8#1)(2008-9#2)(2010-11#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#2)
the heart or##2##3##(1993-1#1)(2007-9#1)
the heart pump##2##3##(2005-8#1)(2007-8#1)
the heart rate##10##3##(1990-5#1)(1990-9#1)(1991-6#2)(2008-4#1)(2008-6#1)(2010-7#1)(2012-1#1)(2012-2#2)
the heart such as##2##4##(2005-7#1)(2012-12#1)
the heart that##2##3##(2004-11#1)(2011-2#1)
the heart through##3##3##(2007-12#1)(2008-8#1)(2010-8#1)
the heart to##7##3##(1994-11#1)(2005-9#1)(2006-6#1)(2008-7#1)(2009-4#1)(2013-1#2)
the heart valves##2##3##(2006-6#1)(2008-8#1)
the heart via the##2##4##(1991-3#1)(1996-3#1)
the heart via##3##3##(1991-3#1)(1996-3#1)(2012-3#1)
the heart was##4##3##(1993-12#1)(2009-11#1)(2013-1#2)
the heart were##3##3##(2006-6#1)(2008-4#1)(2008-7#1)
the heart with##4##3##(1991-3#1)(2004-11#1)(2008-7#1)(2009-1#1)
the heart##346##2##(1990-1#1)(1990-12#2)(1990-3#2)(1990-4#2)(1990-5#4)(1990-8#1)(1990-9#1)(1991-11#4)(1991-2#1)(1991-3#4)(1991-4#2)(1991-5#1)(1991-6#4)(1991-8#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#3)(1993-1#1)(1993-11#4)(1993-12#5)(1993-2#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-6#1)(1994-7#3)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#3)(1995-8#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-5#1)(1996-6#4)(1996-9#3)(1997-1#2)(1997-2#1)(1997-4#1)(1997-8#1)(2004-11#2)(2004-4#1)(2005-1#4)(2005-10#4)(2005-12#1)(2005-7#6)(2005-8#1)(2005-9#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-6#5)(2006-7#1)(2006-9#2)(2007-10#3)(2007-11#1)(2007-12#8)(2007-4#3)(2007-5#1)(2007-7#4)(2007-8#23)(2007-9#6)(2008-1#4)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#16)(2008-5#10)(2008-6#2)(2008-7#11)(2008-8#8)(2008-9#4)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#4)(2009-3#1)(2009-4#2)(2010-10#1)(2010-11#3)(2010-12#7)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#6)(2010-7#3)(2010-8#8)(2010-9#1)(2011-1#6)(2011-12#2)(2011-2#11)(2012-1#4)(2012-12#4)(2012-2#6)(2012-3#4)(2013-1#20)(2013-7#1)
the heart's##4##2##(1991-3#1)(2005-8#1)(2011-1#2)
the heartbeat##8##2##(1997-4#1)(2008-4#3)(2008-5#1)(2009-9#1)(2010-5#1)(2010-8#1)
the hearts of rats##3##4##(1994-5#1)(2013-7#2)
the hearts of##9##3##(1994-5#1)(1995-12#1)(1997-4#2)(2013-7#5)
the hearts##13##2##(1990-2#2)(1994-12#1)(1994-5#1)(1995-12#1)(1997-4#2)(2008-5#1)(2013-7#5)
the heat and##2##3##(1996-2#1)(2013-1#1)
the heat capacities of##2##4##(1997-2#2)
the heat capacity of##5##4##(1997-2#1)(2005-11#1)(2006-10#1)(2007-9#2)
the heat capacity##10##3##(1993-6#1)(1997-2#1)(2005-11#1)(2006-10#5)(2007-9#2)
the heat equation##4##3##(2008-3#2)(2009-4#2)
the heat flow rate##2##4##(2006-12#2)
the heat flow##3##3##(1996-4#1)(2006-12#2)
the heat load increased##2##4##(2010-6#2)
the heat may##2##3##(1996-7#1)(2013-8#1)
the heat of demicellization of##2##5##(2005-11#2)
the heat of solvation##2##4##(2008-10#2)
the heat of##6##3##(1990-8#1)(2005-11#2)(2008-10#3)
the heat resistance of##3##4##(2005-12#1)(2008-10#1)(2008-5#1)
the heat response of##2##4##(1994-2#2)
the heat response##3##3##(1994-2#3)
the heat shock protein 70 homolog##3##6##(2008-10#3)
the heat shock protein 70##5##5##(1995-11#1)(1996-2#1)(2008-10#3)
the heat shock protein##13##4##(1994-11#1)(1994-3#1)(1995-11#1)(1996-12#1)(1996-2#1)(1997-6#2)(2007-11#1)(2008-10#3)(2008-7#1)(2012-12#1)
the heat shock proteins##3##4##(1993-11#1)(2006-10#1)(2012-3#1)
the heat shock response##6##4##(1994-11#1)(1994-8#1)(1997-4#1)(2008-7#2)(2010-2#1)
the heat shock transcription factor##3##5##(1991-7#1)(1994-11#1)(1994-8#1)
the heat shock##32##3##(1991-7#1)(1992-12#1)(1993-11#1)(1993-8#1)(1994-11#3)(1994-3#1)(1994-8#3)(1995-11#1)(1995-2#1)(1995-7#1)(1996-12#1)(1996-2#1)(1997-4#1)(1997-6#2)(2006-10#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-7#3)(2010-2#1)(2012-12#1)(2012-3#1)
the heat stable##2##3##(1992-6#1)(1993-6#1)
the heat stress##3##3##(1992-1#2)(2008-12#1)
the heat transfer##3##3##(2008-10#1)(2009-11#1)(2011-2#1)
the heat treatment##6##3##(1990-3#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-3#1)
the heat wave and##2##4##(2011-1#2)
the heat wave##3##3##(2011-1#3)
the heat##113##2##(1990-3#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-6#2)(1993-8#2)(1994-11#3)(1994-2#3)(1994-3#1)(1994-8#3)(1995-11#1)(1995-2#1)(1995-5#1)(1995-7#1)(1996-12#1)(1996-2#3)(1996-4#1)(1996-7#2)(1997-2#3)(1997-4#1)(1997-6#2)(2005-11#4)(2005-12#1)(2005-4#1)(2006-10#7)(2006-12#4)(2007-11#1)(2007-9#2)(2008-10#10)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#3)(2008-7#3)(2009-11#1)(2009-3#1)(2009-4#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-6#2)(2011-1#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
the heat-induced alterations##2##3##(1995-6#2)
the heat-induced##4##2##(1995-6#2)(1997-3#1)(2012-1#1)
the heat-labile##2##2##(1995-8#2)
the heat-shock protein##4##3##(1993-5#1)(1994-12#2)(1995-4#1)
the heat-shock##5##2##(1991-10#1)(1993-5#1)(1994-12#2)(1995-4#1)
the heat-treated (500 degrees C) film##2##6##(2010-4#2)
the heat-treated##7##2##(1990-3#1)(1991-1#1)(2008-10#2)(2010-4#3)
the heated##6##2##(2007-12#2)(2008-10#2)(2008-2#1)(2010-9#1)
the heating and##2##3##(2007-11#1)(2008-10#1)
the heating of##2##3##(2006-9#1)(2008-2#1)
the heating temperature##2##3##(2008-2#1)(2009-11#1)
the heating time##4##3##(1996-12#2)(2005-11#2)
the heating##18##2##(1996-12#2)(2005-11#3)(2006-9#1)(2007-11#1)(2008-10#5)(2008-2#5)(2009-11#1)
the heavens##2##2##(1994-7#1)(2007-8#1)
the heavier##5##2##(2006-8#1)(2007-4#1)(2008-1#1)(2008-3#1)(2010-5#1)
the heaviest##6##2##(1992-10#1)(2006-6#1)(2008-10#1)(2012-3#1)(2013-1#2)
the heavily##2##2##(1990-12#1)(2005-11#1)
the heavy and light chain##2##5##(1991-8#1)(1995-7#1)
the heavy and light chains##5##5##(1993-5#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#1)
the heavy and light##8##4##(1991-8#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-7#1)(2008-3#1)
the heavy atom induced##2##4##(1993-3#1)(2008-10#1)
the heavy chain and light##2##5##(1992-7#1)(1996-9#1)
the heavy chain and##4##4##(1992-7#1)(1993-6#1)(1995-1#1)(1996-9#1)
the heavy chain of##5##4##(1990-5#1)(1994-3#1)(1994-5#2)(1995-2#1)
the heavy chain##27##3##(1990-2#1)(1990-5#2)(1991-5#3)(1992-7#2)(1993-6#2)(1994-11#1)(1994-3#1)(1994-5#2)(1995-1#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-4#1)(1996-5#2)(1996-9#1)(1997-4#1)(1997-5#1)(1997-9#2)(2012-3#1)
the heavy chains of##4##4##(1990-6#2)(1994-11#1)(1997-4#1)
the heavy chains##6##3##(1990-6#3)(1992-12#1)(1994-11#1)(1997-4#1)
the heavy isotope##2##3##(2008-4#1)(2012-3#1)
the heavy metal ions##2##4##(2008-10#2)
the heavy metal##6##3##(1997-4#1)(2007-8#1)(2008-10#3)(2013-8#1)
the heavy metals are##2##4##(2007-8#1)(2008-10#1)
the heavy metals##8##3##(1994-3#1)(1995-3#1)(1997-2#1)(2007-8#3)(2008-10#1)(2008-12#1)
the heavy##74##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#3)(1991-5#3)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#2)(1993-3#1)(1993-5#1)(1993-6#2)(1994-11#3)(1994-12#1)(1994-3#3)(1994-5#3)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#2)(1996-11#1)(1996-4#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-4#3)(1997-5#1)(1997-9#2)(2006-2#1)(2007-8#4)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2011-7#1)(2012-2#1)(2012-3#2)(2013-8#1)
the heel##4##2##(2006-3#1)(2009-10#1)(2010-3#1)(2011-12#1)
the height and##3##3##(2008-12#1)(2008-3#1)(2008-9#1)
the height of block achieved##2##5##(1993-7#2)
the height of children##2##4##(2006-10#2)
the height of the##13##4##(1992-6#1)(2005-11#2)(2006-3#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-2#3)(2008-9#1)
the height of##25##3##(1992-6#1)(1993-7#2)(2004-3#1)(2005-11#2)(2006-10#3)(2006-3#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-2#3)(2008-5#1)(2008-9#1)(2009-5#1)(2012-1#1)(2013-8#1)
the height##41##2##(1992-6#1)(1993-7#2)(2004-3#1)(2005-11#2)(2006-10#3)(2006-3#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#6)(2008-3#6)(2008-5#3)(2008-6#1)(2008-9#2)(2009-5#1)(2012-1#1)(2013-8#1)
the height-based formula##2##3##(2011-2#2)
the heightened##6##2##(1991-3#1)(1993-6#1)(2007-10#1)(2007-5#1)(2008-7#2)
the heights of these##2##4##(2008-10#1)(2008-3#1)
the heights of##3##3##(2005-9#1)(2008-10#1)(2008-3#1)
the heights##5##2##(2005-9#1)(2007-12#2)(2008-10#1)(2008-3#1)
the helical content##2##3##(1991-4#2)
the helical domain##2##3##(1995-6#1)(1997-7#1)
the helical peptide##2##3##(1992-11#1)(2008-10#1)
the helical propensity of##2##4##(1993-11#1)(1997-2#1)
the helical stability of##2##4##(1993-11#1)(1995-2#1)
the helical structure of##2##4##(2008-10#1)(2013-1#1)
the helical##28##2##(1991-2#1)(1991-4#2)(1992-11#1)(1992-6#2)(1992-9#2)(1993-11#4)(1993-9#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-6#3)(1996-4#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#2)(2008-4#2)(2013-1#1)
the helicase##7##2##(1994-12#2)(1995-3#1)(1995-6#1)(1997-7#1)(2008-11#1)(2012-2#1)
the helices##6##2##(1991-6#2)(1992-12#1)(1995-6#1)(1997-6#1)(1997-7#1)
the helix and##6##3##(1990-5#1)(1994-11#1)(1994-9#1)(1995-1#1)(1996-7#1)(2010-7#1)
the helix axis is##2##4##(1991-4#1)(1992-4#1)
the helix axis##8##3##(1990-2#1)(1991-4#1)(1992-4#2)(1993-3#1)(1995-1#1)(2006-12#2)
the helix ends##2##3##(1991-10#1)(1997-7#1)
the helix is##2##3##(1992-6#1)(1995-1#1)
the helix junctions##2##3##(1997-5#2)
the helix of the ear##2##5##(2010-8#2)
the helix to##3##3##(1995-1#1)(1995-6#1)(2006-12#1)
the helix##56##2##(1990-2#2)(1990-5#2)(1990-8#2)(1991-1#1)(1991-10#1)(1991-4#2)(1992-1#1)(1992-12#1)(1992-4#2)(1992-6#1)(1993-11#2)(1993-3#3)(1993-9#1)(1994-11#2)(1994-5#4)(1994-9#3)(1995-1#5)(1995-3#1)(1995-5#1)(1995-6#1)(1996-7#3)(1997-5#2)(1997-7#2)(2006-12#4)(2008-10#1)(2008-2#3)(2010-7#1)(2010-8#2)
the helix-turn-helix motif##4##3##(1991-1#2)(1991-6#2)
the helix-turn-helix##6##2##(1990-11#1)(1991-1#2)(1991-6#2)(1992-4#1)
the helmeted##2##2##(2007-4#2)
the helminth##7##2##(1994-6#1)(2007-3#4)(2007-7#1)(2011-1#1)
the help of a##22##4##(1990-9#1)(1991-7#1)(2006-6#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#3)(2008-5#1)(2009-5#2)(2010-4#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
the help of an##2##4##(2007-2#1)(2008-2#1)
the help of our##2##4##(2008-8#1)(2010-2#1)
the help of the##10##4##(1993-1#1)(1995-4#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-3#1)(2011-1#2)
the help of##89##3##(1990-9#1)(1991-7#1)(1992-10#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-8#1)(1994-10#1)(1994-3#1)(1995-2#1)(1995-4#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-5#1)(1997-6#1)(2005-11#2)(2005-7#1)(2006-10#4)(2006-2#1)(2006-6#1)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#6)(2008-12#1)(2008-2#5)(2008-3#6)(2008-5#3)(2008-7#4)(2008-8#2)(2009-5#4)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#1)
the help##93##2##(1990-9#1)(1991-7#1)(1992-10#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-8#1)(1994-10#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-4#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-5#1)(1997-6#1)(2005-11#2)(2005-7#1)(2006-10#4)(2006-2#1)(2006-6#1)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#6)(2008-12#1)(2008-2#5)(2008-3#8)(2008-5#3)(2008-7#4)(2008-8#2)(2009-5#4)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#1)
the helper strategy##2##3##(2008-10#2)
the helper virus##4##3##(2008-10#4)
the helper##13##2##(1994-12#1)(1997-4#1)(2008-10#9)(2008-4#2)
the hemagglutination##2##2##(1991-9#1)(1992-9#1)
the hemagglutinin##4##2##(1994-8#2)(1997-6#1)(2011-1#1)
the hemangioma##2##2##(1990-9#1)(2011-2#1)
the hematite##3##2##(2005-11#3)
the hematocrit##5##2##(1997-6#1)(2007-3#1)(2008-1#1)(2008-9#1)(2010-9#1)
the hematologic##2##2##(1992-11#1)(2006-10#1)
the hematological##4##2##(2007-3#1)(2008-1#1)(2008-7#1)(2013-7#1)
the hematoma was##3##3##(2008-7#1)(2009-3#1)(2012-12#1)
the hematoma##9##2##(2007-10#2)(2007-12#1)(2008-7#3)(2008-8#1)(2009-3#1)(2012-12#1)
the hematopoietic growth factor##2##4##(2008-11#1)(2010-12#1)
the hematopoietic growth##3##3##(2008-11#1)(2008-7#1)(2010-12#1)
the hematopoietic stem cell##4##4##(2008-9#1)(2010-4#1)(2012-3#2)
the hematopoietic system##4##3##(1992-9#1)(2008-9#1)(2011-1#1)(2012-12#1)
the hematopoietic##20##2##(1992-3#1)(1992-9#1)(1994-6#1)(1995-12#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#2)(2010-12#1)(2010-4#1)(2011-1#1)(2012-12#2)(2012-3#2)(2013-8#2)
the heme biosynthesis##2##3##(1995-8#1)(2009-10#1)
the heme biosynthetic pathway and##2##5##(1995-4#1)(2007-11#1)
the heme group and##3##4##(1991-2#1)(1994-5#1)(2010-4#1)
the heme group##7##3##(1990-2#1)(1991-2#1)(1994-11#1)(1994-5#2)(2009-9#1)(2010-4#1)
the heme groups##2##3##(1990-8#1)(1992-12#1)
the heme in##5##3##(1991-4#1)(1993-6#2)(1994-5#1)(1997-6#1)
the heme iron##9##3##(1991-8#1)(1991-9#1)(1994-5#1)(1994-8#1)(1995-10#1)(1997-4#2)(1997-7#1)(2008-10#1)
the heme pocket##5##3##(1995-11#1)(1995-5#1)(2009-3#3)
the heme to##2##3##(1990-8#1)(1992-9#1)
the heme##77##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#3)(1991-2#1)(1991-4#2)(1991-7#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-9#2)(1993-11#1)(1993-6#3)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#6)(1994-8#5)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#3)(1995-8#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-4#4)(1997-6#3)(1997-7#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-3#4)(2009-9#2)(2010-4#1)(2011-1#1)
the hemes##5##2##(1990-8#1)(1991-3#1)(1992-3#1)(1993-6#1)(1994-3#1)
the hemicellulose##2##2##(2008-5#1)(2008-6#1)
the hemicelluloses##6##2##(2008-5#6)
the hemicellulosic fraction of##2##4##(2006-8#1)(2008-6#1)
the hemimethylated##3##2##(1990-11#2)(1995-8#1)
the hemin experiments##2##3##(1994-9#2)
the hemin##5##2##(1994-5#2)(1994-9#3)
the hemin-catalyzed##2##2##(1994-9#1)(2008-10#1)
the hemisphere##3##2##(1992-9#1)(1993-2#1)(2007-10#1)
the hemispheric volume##2##3##(1995-8#2)
the hemispherical##3##2##(2008-2#1)(2008-3#2)
the hemizygous male##2##3##(2006-8#2)
the hemocytes##3##2##(2008-5#1)(2008-6#2)
the hemodialysis group##2##3##(2009-2#1)(2011-1#1)
the hemodialysis patient##2##3##(2005-10#1)(2007-7#1)
the hemodialysis patients##3##3##(2007-7#1)(2008-1#2)
the hemodialysis population##2##3##(2007-7#1)(2008-3#1)
the hemodialysis##16##2##(1995-1#1)(2005-10#1)(2007-7#6)(2008-1#4)(2008-10#1)(2008-3#1)(2009-2#1)(2011-1#1)
the hemodialytic procedure##2##3##(2007-7#2)
the hemodynamic changes during##2##4##(2007-9#1)(2008-7#1)
the hemodynamic effects of the##2##5##(1992-3#1)(1996-12#1)
the hemodynamic effects of##4##4##(1992-3#1)(1993-12#1)(1996-12#1)(2011-12#1)
the hemodynamic effects##5##3##(1992-3#1)(1993-12#1)(1996-12#1)(2006-12#1)(2011-12#1)
the hemodynamic timecourse##2##3##(2008-11#2)
the hemodynamic##24##2##(1992-3#1)(1993-12#1)(1996-12#1)(2006-10#2)(2006-12#1)(2007-12#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-11#2)(2008-7#1)(2009-1#1)(2009-6#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-12#1)(2012-1#1)(2013-8#1)
the hemodynamics of##3##3##(2008-12#1)(2010-12#1)(2013-1#1)
the hemodynamics##6##2##(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-3#1)(2013-1#1)
the hemoglobin concentration##5##3##(1990-8#1)(2006-4#1)(2007-8#1)(2008-3#2)
the hemoglobin##22##2##(1990-8#4)(1992-1#1)(1992-4#1)(1993-8#1)(1997-2#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-3#5)(2010-4#1)(2012-12#3)
the hemolymph of the##2##4##(2007-12#1)(2008-10#1)
the hemolymph of##8##3##(1990-5#1)(1997-2#2)(1997-4#1)(2006-10#1)(2007-12#1)(2008-10#2)
the hemolymph##27##2##(1990-10#1)(1990-5#1)(1997-2#2)(1997-4#1)(2006-10#2)(2007-12#2)(2008-10#8)(2008-6#5)(2008-7#3)(2011-1#1)(2012-2#1)
the hemolysis##5##2##(1990-3#1)(1993-9#1)(2005-11#1)(2008-7#2)
the hemolytic##4##2##(1993-4#2)(1994-12#1)(2008-1#1)
the hemopoietic system##2##3##(2007-4#1)(2013-1#1)
the hemopoietic##7##2##(1992-12#1)(1993-9#1)(2007-4#1)(2008-4#1)(2008-5#1)(2011-1#1)(2013-1#1)
the hemorrhage##3##2##(2008-12#1)(2008-9#1)(2012-3#1)
the hemorrhagic##6##2##(1990-6#1)(2007-10#1)(2008-10#1)(2008-7#1)(2010-6#1)(2012-3#1)
the hemostasis system after##2##4##(2011-1#1)(2012-1#1)
the hemostasis##4##2##(2008-10#1)(2011-1#2)(2012-1#1)
the hemostatic##5##2##(1994-3#1)(2005-10#1)(2005-11#1)(2006-10#1)(2012-2#1)
the hen##4##2##(1990-12#1)(1990-3#2)(2007-7#1)
the hens##2##2##(2008-10#1)(2008-7#1)
the heparan sulphate chain##2##4##(1997-3#2)
the heparan sulphate##3##3##(1997-3#3)
the heparan##4##2##(1990-10#1)(1997-3#3)
the heparin binding site and##2##5##(1994-10#1)(1994-11#1)
the heparin binding site##5##4##(1994-10#2)(1994-11#2)(1997-2#1)
the heparin binding##7##3##(1993-6#1)(1994-10#2)(1994-11#2)(1996-5#1)(1997-2#1)
the heparin chain##2##3##(1993-6#1)(1995-2#1)
the heparin##17##2##(1992-3#1)(1993-6#2)(1994-10#2)(1994-11#2)(1995-2#2)(1996-5#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(2010-3#1)(2013-1#1)
the heparin-binding site of##2##4##(1995-2#2)
the hepatic and renal##2##4##(1995-3#1)(2008-11#1)
the hepatic and##3##3##(1995-3#1)(2004-11#1)(2008-11#1)
the hepatic arterial##8##3##(1990-3#1)(2006-6#3)(2013-1#4)
the hepatic artery##6##3##(1997-8#1)(2006-6#2)(2007-7#1)(2008-3#1)(2012-2#1)
the hepatic concentration##2##3##(1994-6#1)(2004-11#1)
the hepatic content of##2##4##(1994-3#1)(1997-2#1)
the hepatic damage induced by##2##5##(1995-6#1)(2011-2#1)
the hepatic damage##3##3##(1995-6#2)(2011-2#1)
the hepatic endoderm##3##3##(2008-6#3)
the hepatic expression of##2##4##(1995-3#1)(2008-6#1)
the hepatic expression##4##3##(1992-8#1)(1995-3#2)(2008-6#1)
the hepatic level of##4##4##(1991-2#1)(1994-12#2)(1996-9#1)
the hepatic levels of##2##4##(1995-3#1)(1996-9#1)
the hepatic microsomal##3##3##(1991-7#1)(1996-3#1)(2008-8#1)
the hepatic parenchyma##4##3##(1997-3#1)(2006-10#1)(2008-9#1)(2012-12#1)
the hepatic pedicle##3##3##(2010-12#3)
the hepatic vein closing pressure##2##5##(1991-5#2)
the hepatic vein##4##3##(1991-5#2)(1996-3#1)(2009-9#1)
the hepatic venous##2##3##(1991-5#1)(2007-8#1)
the hepatic volume increased by 25% in two years##2##9##(2013-1#2)
the hepatic##126##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-5#3)(1991-7#2)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#3)(1993-2#1)(1993-5#1)(1993-9#2)(1994-12#2)(1994-3#4)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#3)(1995-3#4)(1995-6#2)(1995-9#1)(1996-12#3)(1996-3#2)(1996-9#3)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#1)(2004-11#3)(2006-10#2)(2006-2#2)(2006-6#5)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#5)(2008-7#1)(2008-8#5)(2008-9#3)(2009-3#1)(2009-6#1)(2009-9#1)(2010-12#3)(2010-5#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#6)
the hepatitis A virus (HAV)##2##5##(1996-4#1)(2008-7#1)
the hepatitis A virus##3##4##(1996-4#1)(2007-12#1)(2008-7#1)
the hepatitis A##4##3##(1996-4#1)(2006-10#1)(2007-12#1)(2008-7#1)
the hepatitis B surface antigen (HBsAg)##2##6##(2006-12#1)(2008-4#1)
the hepatitis B vaccination##2##4##(1995-2#1)(2007-2#1)
the hepatitis B virus (HBV)##9##5##(1991-11#1)(1997-6#1)(2007-11#1)(2009-11#2)(2009-3#1)(2012-1#1)(2012-12#1)(2012-3#1)
the hepatitis B virus surface antigen##2##6##(1991-9#1)(1997-6#1)
the hepatitis B virus surface##3##5##(1991-9#1)(1997-6#1)(2011-2#1)
the hepatitis B virus##18##4##(1991-11#1)(1991-9#1)(1993-6#1)(1994-7#1)(1996-12#1)(1997-6#2)(2006-8#1)(2007-11#1)(2009-11#2)(2009-3#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)
the hepatitis B##25##3##(1991-11#1)(1991-6#1)(1991-9#1)(1993-6#1)(1994-7#1)(1995-2#1)(1996-12#1)(1997-6#2)(2006-12#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-4#1)(2009-11#3)(2009-3#1)(2009-7#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-3#1)
the hepatitis C virus (HCV)##7##5##(1990-3#1)(1994-8#1)(2006-2#1)(2007-11#1)(2008-8#1)(2009-7#1)(2012-2#1)
the hepatitis C virus##13##4##(1990-3#1)(1994-8#1)(1995-1#1)(1997-7#1)(2006-2#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-7#1)(2012-1#1)(2012-2#1)(2013-8#1)
the hepatitis C##16##3##(1990-3#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-1#1)(1997-7#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-7#1)(2012-1#1)(2012-2#1)(2013-8#1)
the hepatitis##51##2##(1990-3#1)(1991-11#1)(1991-6#1)(1991-9#1)(1992-10#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-4#1)(1997-4#2)(1997-6#2)(1997-7#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-8#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#3)(2009-3#1)(2009-7#2)(2011-2#1)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
the hepatobiliary system##5##3##(2004-11#1)(2005-1#1)(2006-6#1)(2010-9#1)(2013-8#1)
the hepatocellular##5##2##(1990-2#1)(1992-3#2)(2010-2#1)(2013-7#1)
the hepatocyte growth factor##2##4##(1992-6#1)(1993-8#1)
the hepatocyte growth##3##3##(1992-6#1)(1993-8#1)(1996-5#1)
the hepatocyte##22##2##(1990-3#1)(1991-10#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-3#1)(1996-11#1)(1996-5#1)(1997-1#1)(2004-11#1)(2008-11#6)(2008-7#1)(2008-9#3)
the hepatocytes differentiated from ES cells##2##6##(2008-1#2)
the hepatocytes of##5##3##(1993-11#1)(1993-12#1)(1994-9#1)(1995-2#1)(2009-2#1)
the hepatocytes was##4##3##(1993-8#1)(1995-3#1)(2009-2#2)
the hepatocytes were##2##3##(1990-7#1)(1997-2#1)
the hepatocytes with##4##3##(1991-6#1)(1993-3#1)(1995-6#1)(1996-2#1)
the hepatocytes##25##2##(1990-7#1)(1991-1#1)(1991-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-9#1)(1995-2#1)(1995-3#3)(1995-6#1)(1996-2#1)(1997-2#1)(2008-1#2)(2008-11#1)(2009-2#4)(2013-8#1)
the hepatoma cells##4##3##(1993-7#1)(1994-3#1)(2008-11#2)
the hepatoma##8##2##(1992-3#1)(1992-8#1)(1993-7#1)(1994-3#1)(2008-11#4)
the hepatopancreas##4##2##(2008-6#2)(2008-7#2)
the hepatoprotective activity of##2##4##(2010-12#1)(2013-1#1)
the hepatoprotective##3##2##(2008-11#1)(2010-12#1)(2013-1#1)
the hepatotoxic##2##2##(2006-10#1)(2008-7#1)
the hepatotoxicity of##4##3##(1990-12#1)(1995-3#1)(2006-10#1)(2013-8#1)
the heptad repeat##2##3##(1993-11#2)
the heptad##3##2##(1993-11#3)
the heptapeptide##2##2##(1994-2#2)
the herb##4##2##(2007-1#1)(2007-11#1)(2007-8#1)(2011-2#1)
the herbal medicine##3##3##(2011-2#1)(2012-3#2)
the herbal treatment##2##3##(2008-2#2)
the herbal##14##2##(2006-10#2)(2007-1#2)(2008-2#2)(2008-6#1)(2010-12#1)(2010-5#2)(2011-2#1)(2012-3#2)(2013-1#1)
the herbert##2##2##(2006-3#1)(2006-4#1)
the herbicide 2##3##3##(2008-10#3)
the herbicide and##2##3##(1997-8#1)(2006-12#1)
the herbicide##37##2##(1993-3#1)(1994-8#1)(1997-2#3)(1997-8#1)(2006-12#2)(2006-5#3)(2007-11#1)(2007-5#1)(2008-10#18)(2008-2#1)(2008-6#2)(2009-6#2)(2010-1#1)
the herbicides##7##2##(2007-8#1)(2008-10#3)(2008-11#2)(2008-7#1)
the herbs##3##2##(2007-1#1)(2008-10#1)(2013-1#1)
the herd and##2##3##(1996-12#2)
the herd##4##2##(1996-12#2)(2006-5#1)(2010-4#1)
the here##2##2##(1996-7#1)(2004-3#1)
the hereditary##6##2##(2008-3#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-4#1)(2010-8#1)
the heritability of##4##3##(1997-5#1)(2008-2#1)(2008-8#2)
the heritability##6##2##(1997-5#1)(2008-10#1)(2008-2#1)(2008-8#2)(2012-3#1)
the heritable##2##2##(2006-12#1)(2008-6#1)
the hermaphrodite##5##2##(2007-12#5)
the hermaphroditic##3##2##(2008-9#1)(2010-5#1)(2011-2#1)
the hernia sac##2##3##(2011-1#1)(2012-12#1)
the hernia##4##2##(1993-9#1)(2009-8#1)(2011-1#1)(2012-12#1)
the hernial sac##2##3##(2009-6#2)
the hernial##3##2##(2009-6#2)(2011-1#1)
the herniated disc##2##3##(2006-8#1)(2007-1#1)
the herniation of the##2##4##(2006-9#1)(2012-1#1)
the heroin##2##2##(1991-12#1)(2007-9#1)
the herpes simplex virus type 1 (HSV-1)##2##7##(1994-3#1)(1995-3#1)
the herpes simplex virus type 1##3##6##(1994-3#1)(1995-3#2)
the herpes simplex virus type-1##2##5##(1996-8#2)
the herpes simplex virus##10##4##(1991-7#1)(1994-3#1)(1994-9#1)(1995-3#2)(1996-8#2)(2006-10#1)(2007-3#1)(2008-8#1)
the herpes simplex##11##3##(1991-7#1)(1994-3#1)(1994-9#1)(1995-3#3)(1996-8#2)(2006-10#1)(2007-3#1)(2008-8#1)
the herpes virus##2##3##(1990-8#1)(2009-7#1)
the herpes##15##2##(1990-8#1)(1991-7#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-3#3)(1996-8#2)(2006-10#1)(2007-3#1)(2008-8#1)(2009-2#1)(2009-7#1)
the heteroatom##6##2##(2007-11#5)(2010-5#1)
the heterochromatic regions##2##3##(1991-5#1)(2009-10#1)
the heterochromatic##4##2##(1991-5#1)(1993-6#1)(2009-10#2)
the heterochromatin##3##2##(1996-3#1)(1997-6#1)(2008-9#1)
the heterocycle##4##2##(1996-8#1)(2006-12#1)(2007-1#1)(2012-12#1)
the heterocyclic base##2##3##(2008-4#2)
the heterocyclic##13##2##(1991-10#1)(1992-2#1)(1992-6#1)(1995-3#1)(1996-11#1)(2007-11#2)(2008-10#1)(2008-4#2)(2010-2#1)(2010-5#1)(2012-2#1)
the heterocystous##2##2##(1996-9#1)(2006-3#1)
the heterodimer of##2##3##(2010-2#1)(2011-1#1)
the heterodimer##10##2##(1991-4#2)(1993-9#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-4#1)(2008-9#1)(2010-2#1)(2011-1#1)
the heterodimeric##8##2##(1992-5#1)(1993-11#1)(1993-8#1)(1995-8#1)(1996-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
the heteroduplexes obtained##2##3##(2008-10#2)
the heterodyne mixing efficiency##2##4##(2008-2#2)
the heterodyne##12##2##(2007-12#5)(2008-1#1)(2008-2#4)(2008-3#2)
the heterodyned##2##2##(2008-2#1)(2008-3#1)
the heterogeneity between##2##3##(1996-12#1)(2008-8#1)
the heterogeneity in the##2##4##(1991-9#1)(2005-11#1)
the heterogeneity in##3##3##(1991-9#1)(2005-11#1)(2013-3#1)
the heterogeneity of stroke##2##4##(2007-9#2)
the heterogeneity of the test samples##2##6##(2008-10#2)
the heterogeneity of the test##3##5##(2008-10#3)
the heterogeneity of the##18##4##(1991-12#1)(1994-2#1)(1994-7#1)(1996-10#1)(1996-8#1)(2006-10#1)(2008-10#3)(2008-12#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
the heterogeneity of##46##3##(1991-12#1)(1992-4#1)(1994-2#1)(1994-7#1)(1994-9#1)(1995-1#1)(1996-10#1)(1996-8#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-11#2)(2007-6#2)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-3#1)(2009-4#1)(2010-12#4)(2010-4#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
the heterogeneity##59##2##(1991-12#1)(1991-9#1)(1992-4#1)(1992-7#1)(1994-2#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-1#1)(1996-10#1)(1996-12#3)(1996-8#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-6#2)(2007-9#2)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-3#1)(2009-4#1)(2010-12#4)(2010-4#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-3#1)
the heterogeneous electron transfer##3##4##(2008-10#3)
the heterogeneous nature of##6##4##(1993-6#1)(1993-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-5#1)
the heterogeneous populations##2##3##(2008-10#1)(2010-10#1)
the heterogeneous##32##2##(1991-6#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-3#1)(1995-6#3)(1996-6#1)(1997-2#1)(2006-6#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-10#2)(2011-2#1)(2012-3#1)
the heterogenous##3##2##(1992-2#1)(2008-10#1)(2008-11#1)
the heterologous CP coding region##2##5##(2008-10#2)
the heterologous Escherichia coli##2##4##(1995-2#1)(1996-8#1)
the heterologous expression of##3##4##(1995-3#1)(2008-10#1)(2009-9#1)
the heterologous gene##3##3##(1990-11#1)(2008-11#1)(2008-5#1)
the heterologous protein##3##3##(1990-11#1)(1993-3#1)(1994-11#1)
the heterologous##41##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-5#1)(1990-8#1)(1991-9#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-3#2)(1996-7#2)(1996-8#1)(1997-3#1)(1997-4#2)(1997-7#1)(2006-10#1)(2008-10#10)(2008-11#3)(2008-5#2)(2009-9#1)(2011-2#1)
the heterologously expressed reductase##2##4##(1996-3#2)
the heterologously expressed##3##3##(1990-12#1)(1996-3#2)
the heteromeric complex##3##3##(1995-3#1)(1996-5#2)
the heteromeric##5##2##(1994-11#1)(1995-3#2)(1996-5#2)
the heterosexual transmission of HIV##2##5##(2006-10#2)
the heterosexual transmission##3##3##(1991-2#1)(2006-10#2)
the heterosexual##8##2##(1991-2#1)(1991-6#2)(1991-8#2)(2006-10#2)(2006-4#1)
the heterotopic##2##2##(1995-12#1)(2005-12#1)
the heterotrimeric G protein##3##4##(1996-5#3)
the heterotrimeric G##4##3##(1996-5#3)(2008-7#1)
the heterotrophic bacteria##3##3##(2008-5#2)(2009-8#1)
the heterotrophic##5##2##(2008-5#3)(2008-7#1)(2009-8#1)
the heterozygote##7##2##(1996-6#1)(1997-8#1)(2008-10#1)(2008-9#1)(2010-4#1)(2011-2#1)(2013-1#1)
the heterozygotes##3##2##(1991-12#2)(2007-7#1)
the heterozygous##12##2##(1991-6#2)(1992-8#1)(1995-2#1)(1995-5#1)(1996-6#1)(2006-8#2)(2009-5#2)(2010-6#1)(2011-2#1)
the heuristic##2##2##(2009-10#1)(2009-2#1)
the hexagon##3##2##(1997-4#1)(2008-3#1)(2013-8#1)
the hexagonal column##7##3##(2008-3#7)
the hexagonal lattice##2##3##(1995-6#1)(2007-12#1)
the hexagonal##16##2##(1990-2#1)(1990-9#1)(1991-11#1)(1994-10#2)(1995-6#1)(2004-9#1)(2007-12#1)(2008-3#8)
the hexahydrated##2##2##(2006-1#1)(2009-12#1)
the hexamer and##2##3##(1992-3#1)(1997-2#1)
the hexamer motif##3##3##(1997-2#3)
the hexamer##13##2##(1992-3#1)(1994-6#1)(1995-11#3)(1995-3#1)(1995-8#1)(1997-2#6)
the hexane##4##2##(2007-1#1)(2007-11#1)(2008-10#1)(2010-2#1)
the hexanucleotide##3##2##(1990-7#2)(1994-11#1)
the hexapeptide##12##2##(1991-2#2)(1991-9#1)(1992-12#1)(1992-8#4)(1994-5#1)(2008-4#1)(2008-5#2)
the hexokinase##2##2##(1990-2#1)(2009-6#1)
the hexose monophosphate##2##3##(1991-12#1)(1993-3#1)
the hexose transporter##3##3##(1996-12#2)(2010-2#1)
the hexose##6##2##(1991-12#1)(1993-3#1)(1996-12#2)(2010-2#2)
the hfq gene##2##3##(1997-7#2)
the hidden Markov model (HMM)##2##5##(1996-12#1)(1997-2#1)
the hidden Markov model##4##4##(1996-12#2)(1997-2#2)
the hidden Markov##5##3##(1996-12#2)(1997-2#2)(2008-10#1)
the hidden and##5##3##(2008-10#5)
the hidden image##2##3##(2008-3#2)
the hidden layer and the output layer##3##7##(2010-8#3)
the hidden layer and the##4##5##(2008-10#1)(2010-8#3)
the hidden layer and##5##4##(2008-10#1)(2010-8#4)
the hidden layer##7##3##(2008-10#3)(2010-8#4)
the hidden phase##2##3##(2008-3#2)
the hidden platform##2##3##(1994-2#2)
the hidden##33##2##(1991-6#1)(1993-2#1)(1994-2#2)(1995-2#1)(1996-12#2)(1997-2#2)(2008-1#1)(2008-10#10)(2008-2#1)(2008-3#5)(2008-6#1)(2008-7#1)(2010-8#4)(2012-2#1)
the hierarchical structure##2##3##(2007-9#1)(2008-2#1)
the hierarchical##16##2##(1991-6#1)(1992-5#3)(2004-3#1)(2005-5#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-2#2)(2009-11#1)(2009-3#1)(2012-2#1)(2013-1#1)
the hierarchy of selenoprotein expression##2##5##(2012-2#2)
the hierarchy of##6##3##(1990-9#1)(2008-11#1)(2008-6#1)(2011-1#1)(2012-2#2)
the hierarchy##13##2##(1990-9#1)(1993-2#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2009-11#1)(2011-1#1)(2012-2#2)(2013-1#2)
the high SPM##2##3##(2012-2#2)
the high accuracy of the##3##5##(2007-11#1)(2008-10#2)
the high accuracy##4##3##(2007-11#1)(2007-5#1)(2008-10#2)
the high activity##2##3##(1995-3#1)(2007-11#1)
the high affinity ATP-binding sites##2##5##(1996-9#2)
the high affinity ATPase center of gpA##2##7##(1996-8#2)
the high affinity ATPase##3##4##(1996-8#3)
the high affinity NGF receptor##2##5##(1991-5#2)
the high affinity binding of##2##5##(1993-6#1)(2008-3#1)
the high affinity binding##6##4##(1990-5#1)(1991-2#1)(1993-6#1)(1997-4#2)(2008-3#1)
the high affinity of##7##4##(1990-4#1)(1991-7#1)(1992-7#1)(1996-8#1)(2008-4#1)(2008-9#1)(2010-1#1)
the high affinity receptor for##3##5##(1990-7#2)(1994-8#1)
the high affinity receptor##4##4##(1990-5#1)(1990-7#2)(1994-8#1)
the high affinity site##3##4##(1990-3#1)(1990-5#1)(1995-11#1)
the high affinity##48##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#2)(1991-1#1)(1991-11#1)(1991-2#2)(1991-5#2)(1991-6#1)(1991-7#1)(1992-4#1)(1992-7#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#3)(1995-11#1)(1996-5#1)(1996-8#4)(1996-9#2)(1997-2#1)(1997-4#2)(2005-7#1)(2006-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-1#1)
the high and low energy electronic states of DSKNPH##2##9##(2008-10#2)
the high and low##10##4##(1993-12#1)(1995-11#1)(1995-5#1)(1995-7#1)(1997-3#1)(2006-4#1)(2007-3#1)(2008-10#2)(2010-1#1)
the high and##11##3##(1993-12#1)(1995-11#1)(1995-5#1)(1995-7#1)(1997-3#1)(2006-4#1)(2007-3#1)(2008-10#2)(2008-9#1)(2010-1#1)
the high beam##2##3##(2006-5#1)(2008-3#1)
the high burden of##3##4##(2008-3#1)(2011-2#1)(2012-12#1)
the high cell density##2##4##(1994-2#1)(2008-11#1)
the high cholesterol##2##3##(1996-12#1)(2008-5#1)
the high complexity of##2##4##(2008-1#1)(2008-10#1)
the high complexity##3##3##(2008-1#1)(2008-10#1)(2010-11#1)
the high concentrate diets##2##4##(2009-4#2)
the high concentration groups##2##4##(2008-9#2)
the high concentration of##6##4##(1990-5#1)(1994-12#1)(2006-10#1)(2008-10#2)(2008-3#1)
the high concentration##9##3##(1990-5#1)(1994-12#1)(2006-10#1)(2008-10#2)(2008-3#1)(2008-9#2)(2010-12#1)
the high concentrations##2##3##(2008-10#1)(2008-11#1)
the high content of##4##4##(1991-2#1)(1996-11#1)(2008-10#2)
the high cost and##2##4##(2008-2#1)(2008-3#1)
the high cost of the##3##5##(2008-3#1)(2008-7#1)(2011-2#1)
the high cost of##10##4##(1990-12#1)(1990-9#1)(1993-12#1)(2004-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
the high cost##14##3##(1990-12#1)(1990-9#1)(1993-12#1)(2004-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
the high costs of##6##4##(2005-11#1)(2007-1#1)(2007-11#3)(2008-9#1)
the high costs##8##3##(2005-11#1)(2007-1#1)(2007-11#4)(2008-10#1)(2008-9#1)
the high coupling efficiency##2##4##(2007-12#1)(2008-3#1)
the high coupling##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
the high current##2##3##(1990-10#2)
the high degree of##7##4##(1991-9#1)(1994-8#1)(1996-7#1)(2008-2#1)(2009-11#1)(2012-12#1)(2012-2#1)
the high dependency##2##3##(2007-12#1)(2007-8#1)
the high dispersion##2##3##(2007-12#1)(2008-3#1)
the high dissociation##2##3##(2008-10#2)
the high dose of##5##4##(1991-4#1)(1994-8#1)(2008-10#1)(2008-7#2)
the high dose##12##3##(1990-11#1)(1991-4#1)(1994-8#2)(1995-10#1)(1995-11#1)(2008-10#1)(2008-5#1)(2008-7#2)(2010-1#1)(2011-2#1)
the high doses of##2##4##(1993-1#1)(2008-7#1)
the high efficiency of##6##4##(2007-12#1)(2007-8#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)
the high efficiency##7##3##(2007-12#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)
the high elevations##3##3##(2008-10#3)
the high end of the scale##2##6##(2008-8#1)(2008-9#1)
the high end of the##3##5##(2008-8#2)(2008-9#1)
the high energy##2##3##(2008-10#1)(2013-8#1)
the high expectations##2##3##(2006-10#1)(2008-3#1)
the high expression of##5##4##(1991-5#1)(1996-12#1)(1996-5#1)(2008-5#1)(2009-9#1)
the high fat##2##3##(1995-7#1)(1996-12#1)
the high field##2##3##(1997-7#1)(2007-12#1)
the high flexibility##2##3##(1997-1#1)(2008-7#1)
the high frequency of##13##4##(1990-6#2)(1992-5#1)(1993-9#1)(2006-10#1)(2007-3#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
the high frequency##17##3##(1990-6#2)(1990-8#1)(1992-5#1)(1993-9#1)(2006-10#1)(2007-11#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
the high genetic##3##3##(2008-10#1)(2012-1#1)(2013-8#1)
the high group##2##3##(2008-3#2)
the high homology##2##3##(1992-12#1)(1995-6#1)
the high impulsives##2##3##(2010-2#2)
the high incidence of##18##4##(1990-2#1)(1992-2#1)(1993-3#1)(1993-7#1)(1996-11#1)(2005-10#1)(2006-10#2)(2006-2#1)(2006-6#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
the high incidence##19##3##(1990-2#1)(1992-2#1)(1993-3#1)(1993-7#1)(1996-11#1)(2005-10#1)(2006-10#2)(2006-2#1)(2006-6#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)
the high level expression##2##4##(2008-8#2)
the high level of genetic##2##5##(2008-10#1)(2008-8#1)
the high level of##16##4##(1992-12#1)(1994-2#1)(1996-4#1)(1997-7#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#2)(2008-8#2)(2009-3#1)(2013-1#1)
the high level##22##3##(1992-12#1)(1992-8#1)(1994-2#1)(1996-4#1)(1997-7#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#4)(2009-3#1)(2012-2#2)(2013-1#1)
the high levels of##12##4##(2006-10#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-7#1)(2008-8#1)(2011-2#1)
the high levels##13##3##(1990-10#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-7#1)(2008-8#1)(2011-2#1)
the high maternal mortality##2##4##(2010-8#2)
the high maternal##3##3##(1993-10#1)(2010-8#2)
the high mobility##2##3##(1992-6#1)(2008-4#1)
the high molecular weight##8##4##(1991-10#1)(1992-10#1)(1992-3#1)(1995-2#1)(2006-9#1)(2008-10#1)(2008-5#1)(2013-8#1)
the high molecular##9##3##(1991-10#1)(1992-1#1)(1992-10#1)(1992-3#1)(1995-2#1)(2006-9#1)(2008-10#1)(2008-5#1)(2013-8#1)
the high morbidity and mortality##5##5##(2006-10#1)(2008-1#1)(2010-12#2)(2012-3#1)
the high mortality and##2##4##(2005-1#1)(2007-11#1)
the high mortality rate among##2##5##(2006-2#1)(2011-12#1)
the high mortality rate##5##4##(1993-6#1)(2006-2#1)(2007-8#1)(2011-12#1)(2011-2#1)
the high mortality##9##3##(1993-6#1)(2005-1#1)(2006-2#1)(2007-11#2)(2007-8#1)(2011-12#1)(2011-2#1)(2012-12#1)
the high mutation##2##3##(2008-1#1)(2011-2#1)
the high number of##7##4##(1993-6#1)(2007-3#1)(2008-10#1)(2008-6#1)(2008-7#2)(2013-7#1)
the high oxido-reduction potential##3##4##(1994-9#3)
the high pH##3##3##(2007-8#1)(2008-10#2)
the high percentage of##4##4##(1991-7#1)(1993-5#1)(2006-10#1)(2011-1#1)
the high percentage##5##3##(1991-7#1)(1993-5#1)(2006-10#1)(2006-12#1)(2011-1#1)
the high performance liquid chromatography (HPLC)##4##6##(1995-7#1)(2008-10#1)(2011-1#1)(2013-8#1)
the high performance##6##3##(1995-7#1)(2008-10#1)(2011-1#1)(2013-1#2)(2013-8#1)
the high potential of##2##4##(1995-12#1)(2011-1#1)
the high potential##3##3##(1994-8#1)(1995-12#1)(2011-1#1)
the high precision##2##3##(2008-2#1)(2008-3#1)
the high pressure##3##3##(1996-5#1)(2005-8#1)(2008-7#1)
the high prevalence of the##2##5##(2007-11#1)(2011-2#1)
the high prevalence of##26##4##(1991-5#1)(1992-11#1)(1992-5#1)(1993-6#1)(1996-12#1)(2004-1#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-3#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#1)
the high prevalence states##2##4##(2008-3#2)
the high prevalence##32##3##(1991-5#1)(1992-11#1)(1992-5#1)(1993-6#1)(1996-12#1)(1996-2#1)(2004-1#1)(2005-10#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#1)
the high proapo A-I/apo A-I ratio##2##6##(1990-8#2)
the high production##2##3##(2006-10#1)(2006-11#1)
the high productivity##2##3##(2008-5#1)(2012-9#1)
the high proportion of##3##4##(2007-8#1)(2008-8#1)(2011-2#1)
the high proportion##4##3##(2007-8#1)(2008-8#1)(2009-9#1)(2011-2#1)
the high protein##2##3##(1992-9#1)(1997-8#1)
the high quality of the##3##5##(2005-7#1)(2008-5#1)(2009-11#1)
the high quality of##6##4##(2005-7#1)(2008-5#1)(2008-6#1)(2009-11#1)(2010-11#1)(2012-12#1)
the high quality##10##3##(2005-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-11#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-8#2)
the high rate of##22##4##(1991-12#1)(1992-2#1)(1993-1#1)(1993-8#2)(2005-1#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
the high rate##24##3##(1991-12#1)(1992-2#1)(1993-1#1)(1993-8#2)(2005-1#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
the high rates of##7##4##(2008-12#1)(2009-5#1)(2010-2#1)(2011-1#2)(2011-2#2)
the high reactives##2##3##(2006-3#2)
the high recurrence rate##2##4##(1996-12#1)(2007-11#1)
the high reflectivity##2##3##(2007-12#1)(2008-3#1)
the high relaxivity##2##3##(2008-7#2)
the high resistance to##4##4##(1993-4#1)(2007-10#2)(2008-10#1)
the high resolution and##2##4##(2008-2#1)(2008-7#1)
the high resolution##6##3##(1997-4#1)(1997-7#1)(2007-11#1)(2008-2#1)(2008-7#2)
the high risk foetus##2##4##(1993-6#2)
the high risk group in##2##5##(2007-11#1)(2011-1#1)
the high risk group##6##4##(1994-11#1)(2007-11#2)(2009-8#1)(2011-1#1)(2011-2#1)
the high risk groups##2##4##(2010-7#1)(2011-1#1)
the high risk of##11##4##(1990-4#1)(1993-5#1)(1997-7#1)(2005-10#1)(2007-1#1)(2008-5#1)(2010-12#1)(2010-9#1)(2012-1#1)(2012-3#1)(2013-7#1)
the high risk##25##3##(1990-4#1)(1991-6#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-11#2)(1997-7#1)(2005-10#1)(2007-1#1)(2007-11#2)(2007-9#1)(2008-5#1)(2009-8#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-7#1)
the high salt##5##3##(1995-6#2)(1997-8#1)(2008-10#2)
the high school##4##3##(1990-3#1)(2006-4#1)(2008-12#1)(2010-4#1)
the high selectivity of the##3##5##(2008-10#3)
the high selectivity of##6##4##(2008-10#5)(2010-7#1)
the high sensitivity and##2##4##(1995-3#1)(2008-10#1)
the high sensitivity of the##6##5##(1992-2#1)(1992-6#1)(2005-4#1)(2008-10#1)(2008-2#1)(2008-3#1)
the high sensitivity of this##3##5##(1993-12#1)(2008-10#1)(2013-8#1)
the high sensitivity of##12##4##(1992-2#2)(1992-6#1)(1993-12#1)(2005-4#1)(2008-10#3)(2008-2#1)(2008-3#1)(2010-5#1)(2013-8#1)
the high sensitivity##17##3##(1992-1#1)(1992-2#2)(1992-6#1)(1993-12#1)(1995-3#1)(2005-4#1)(2008-10#5)(2008-2#1)(2008-3#1)(2009-5#1)(2010-5#1)(2013-8#1)
the high separation##2##3##(2008-10#1)(2008-11#1)
the high spatial##4##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
the high specificity##3##3##(1995-6#1)(2012-2#1)(2012-3#1)
the high speed##3##3##(1997-6#1)(2008-10#1)(2008-2#1)
the high surface##2##3##(2008-9#1)(2010-4#1)
the high susceptibility of##3##4##(2008-8#1)(2009-7#1)(2012-1#1)
the high system##2##3##(2007-11#1)(2008-2#1)
the high temperature##4##3##(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
the high threshold##2##3##(1990-7#1)(1996-3#1)
the high throughput screening##2##4##(2009-6#2)
the high throughput##6##3##(1997-4#1)(2007-6#1)(2008-4#1)(2008-5#1)(2009-6#2)
the high vacuum and short operating time for separation##2##9##(2008-5#1)(2008-6#1)
the high vacuum##3##3##(2006-5#1)(2008-5#1)(2008-6#1)
the high values##2##3##(1993-11#1)(2011-2#1)
the high voltage##2##3##(2007-11#1)(2008-10#1)
the high water##2##3##(2008-5#1)(2009-9#1)
the high##744##2##(1990-10#3)(1990-11#3)(1990-12#2)(1990-2#3)(1990-3#4)(1990-4#2)(1990-5#6)(1990-6#2)(1990-7#3)(1990-8#5)(1990-9#2)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-4#2)(1991-5#4)(1991-6#2)(1991-7#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#5)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#6)(1993-7#1)(1993-8#3)(1993-9#4)(1994-11#3)(1994-12#2)(1994-2#3)(1994-6#2)(1994-8#9)(1994-9#5)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#4)(1995-7#5)(1995-9#1)(1996-11#2)(1996-12#5)(1996-2#1)(1996-3#4)(1996-4#3)(1996-5#5)(1996-6#2)(1996-7#2)(1996-8#5)(1996-9#3)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#4)(1997-6#2)(1997-7#5)(1997-8#3)(2004-1#1)(2004-11#1)(2004-9#2)(2005-1#2)(2005-10#4)(2005-11#3)(2005-4#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#15)(2006-11#1)(2006-12#6)(2006-2#3)(2006-3#3)(2006-4#2)(2006-5#5)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#5)(2007-10#3)(2007-11#22)(2007-12#16)(2007-3#5)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#5)(2007-8#10)(2007-9#3)(2008-1#11)(2008-10#75)(2008-11#10)(2008-12#3)(2008-2#15)(2008-3#31)(2008-4#8)(2008-5#21)(2008-6#8)(2008-7#24)(2008-8#14)(2008-9#11)(2009-10#1)(2009-11#3)(2009-2#1)(2009-3#5)(2009-4#3)(2009-5#3)(2009-6#4)(2009-7#3)(2009-8#2)(2009-9#5)(2010-1#3)(2010-11#3)(2010-12#7)(2010-2#5)(2010-4#5)(2010-5#4)(2010-6#3)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#14)(2011-12#1)(2011-2#22)(2012-1#6)(2012-12#11)(2012-2#12)(2012-3#6)(2012-4#1)(2012-9#1)(2013-1#14)(2013-7#4)(2013-8#10)
the high- and low-affinity##2##4##(1993-3#1)(1996-7#1)
the high- and##3##3##(1993-3#1)(1996-7#1)(1997-4#1)
the high-##5##2##(1993-3#1)(1996-7#1)(1997-4#1)(2007-12#1)(2008-3#1)
the high-CHO diet##2##3##(2013-8#2)
the high-Km component of transport##2##5##(1991-9#2)
the high-Q##3##2##(2007-12#2)(2008-3#1)
the high-absorption##2##2##(2008-2#1)(2008-3#1)
the high-affinity ATP##2##3##(1990-7#2)
the high-affinity IgE receptor##2##4##(2008-4#1)(2009-6#1)
the high-affinity binding of##3##4##(1990-7#1)(1992-3#1)(1994-5#1)
the high-affinity binding sites##2##4##(1994-11#2)
the high-affinity binding##6##3##(1990-7#1)(1992-3#1)(1994-11#2)(1994-5#1)(1997-6#1)
the high-affinity glutamine permease##2##4##(1996-7#2)
the high-affinity receptor##6##3##(1991-10#1)(1994-3#2)(1995-10#2)(1996-8#1)
the high-affinity sites of##2##4##(1992-3#1)(1997-1#1)
the high-affinity sites##4##3##(1992-3#2)(1995-12#1)(1997-1#1)
the high-affinity##52##2##(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#3)(1991-10#1)(1991-2#1)(1992-12#1)(1992-3#3)(1992-6#1)(1993-2#2)(1994-11#3)(1994-3#4)(1994-5#2)(1994-6#1)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-7#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#3)(1996-8#2)(1997-1#1)(1997-2#1)(1997-6#2)(1997-7#1)(2008-4#2)(2008-7#1)(2009-6#2)(2009-7#1)
the high-altitude##2##2##(2008-3#2)
the high-density lipoprotein (HDL)##2##4##(1990-8#1)(2009-8#1)
the high-density##5##2##(1990-8#1)(1991-12#1)(2008-10#1)(2008-8#1)(2009-8#1)
the high-dispersal##2##2##(2013-1#2)
the high-dose##6##2##(1995-9#1)(2007-9#1)(2008-10#2)(2008-6#1)(2008-7#1)
the high-energy##4##2##(1990-11#1)(2008-3#2)(2008-7#1)
the high-fat##4##2##(1991-2#3)(2010-12#1)
the high-foveation-quality field##2##3##(2009-8#2)
the high-foveation-quality##3##2##(2009-8#3)
the high-frequency part of speech##2##5##(2008-2#2)
the high-frequency##13##2##(1991-10#1)(1992-9#1)(1995-10#1)(2007-12#2)(2008-11#1)(2008-2#5)(2008-3#2)
the high-grade##3##2##(1997-7#1)(2007-10#1)(2013-1#1)
the high-index##3##2##(2007-11#2)(2008-2#1)
the high-level expression of human##2##5##(1992-5#1)(2008-9#1)
the high-level expression of##4##4##(1992-5#1)(1995-1#1)(2008-9#2)
the high-level##12##2##(1991-12#1)(1992-5#1)(1995-1#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#2)(2010-7#1)(2012-3#1)(2013-8#1)
the high-mannose type##2##3##(1990-12#1)(1994-8#1)
the high-order##3##2##(2007-12#1)(2008-2#1)(2012-1#1)
the high-performance liquid chromatographic determination of##2##6##(1990-9#1)(1991-5#1)
the high-performance liquid chromatographic##5##4##(1990-9#1)(1991-5#1)(1996-6#1)(1997-2#1)(1997-8#1)
the high-performance liquid chromatography##2##4##(1990-8#1)(2008-10#1)
the high-performance liquid##8##3##(1990-8#1)(1990-9#1)(1991-5#1)(1996-6#1)(1997-2#1)(1997-8#1)(2008-10#2)
the high-potential##3##2##(1995-6#2)(1996-4#1)
the high-power##2##2##(2007-12#2)
the high-precision##3##2##(2008-3#3)
the high-pressure liquid##2##3##(2008-10#1)(2008-5#1)
the high-pressure##5##2##(1990-8#1)(1995-11#1)(2006-12#1)(2008-10#1)(2008-5#1)
the high-profile##3##2##(2008-7#1)(2009-6#1)(2011-2#1)
the high-purity##3##2##(2005-4#2)(2012-12#1)
the high-quality##2##2##(2009-10#1)(2010-2#1)
the high-resolution##15##2##(1994-3#1)(1994-9#1)(1997-4#1)(2004-9#3)(2005-8#1)(2008-2#1)(2008-3#4)(2010-2#2)(2011-1#1)
the high-risk group##8##3##(2007-2#1)(2007-7#1)(2009-2#4)(2009-8#1)(2011-2#1)
the high-risk groups##3##3##(2007-7#2)(2007-8#1)
the high-risk patients##2##3##(2007-8#2)
the high-risk strategy##2##3##(1991-6#1)(2006-8#1)
the high-risk##23##2##(1991-6#1)(1991-7#1)(1992-7#1)(1995-1#1)(1997-7#2)(2006-8#1)(2007-2#1)(2007-7#3)(2007-8#3)(2009-2#4)(2009-8#1)(2010-2#1)(2011-2#3)
the high-speed##3##2##(2007-12#1)(2008-3#1)(2009-5#1)
the high-spin##7##2##(1991-2#2)(1992-12#1)(1997-4#1)(2008-10#1)(2009-3#2)
the high-temperature##9##2##(1990-5#1)(1992-3#1)(2006-7#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-4#1)
the high-throughput analysis of##2##4##(2007-8#1)(2008-10#1)
the high-throughput##3##2##(2007-8#1)(2008-10#1)(2008-7#1)
the higher activity of##2##4##(1991-7#1)(2007-10#1)
the higher affinity of##2##4##(1992-8#1)(1996-7#1)
the higher affinity##4##3##(1991-7#1)(1992-8#1)(1995-2#1)(1996-7#1)
the higher concentration of##2##4##(2006-8#1)(2008-10#1)
the higher concentration##4##3##(1993-8#1)(1994-8#1)(2006-8#1)(2008-10#1)
the higher concentrations##3##3##(2007-10#1)(2008-5#1)(2013-1#1)
the higher conductivity##2##3##(2005-11#1)(2013-1#1)
the higher degree of##2##4##(2006-10#1)(2008-11#1)
the higher dose of##4##4##(1996-10#2)(1997-4#2)
the higher dose##12##3##(1993-4#1)(1994-2#1)(1995-11#1)(1995-9#1)(1996-1#1)(1996-10#2)(1997-4#2)(2007-11#1)(2008-5#1)(2012-3#1)
the higher doses##2##3##(1993-4#1)(2013-1#1)
the higher education sector##2##4##(2008-11#1)(2008-12#1)
the higher education##3##3##(2008-11#1)(2008-12#1)(2012-3#1)
the higher eukaryotes##3##3##(2008-7#2)(2010-9#1)
the higher free##2##3##(2008-7#1)(2011-2#1)
the higher frequency of##4##4##(1992-12#1)(1996-3#1)(2008-10#1)(2010-8#1)
the higher harmonics##3##3##(1996-11#2)(2008-10#1)
the higher incidence of##6##4##(1993-12#1)(1995-10#1)(2005-10#1)(2007-10#1)(2008-1#1)(2011-12#1)
the higher incidence##7##3##(1993-12#1)(1995-10#1)(2005-10#1)(2006-8#1)(2007-10#1)(2008-1#1)(2011-12#1)
the higher level of##7##4##(1990-2#1)(1994-6#1)(2006-8#1)(2008-10#1)(2010-12#1)(2011-2#2)
the higher levels of##2##4##(1996-12#1)(2007-8#1)
the higher levels##3##3##(1996-12#1)(2007-8#1)(2008-10#1)
the higher motor areas##2##4##(2008-1#2)
the higher number of##3##4##(1993-8#1)(2008-10#1)(2012-3#1)
the higher percentage of##2##4##(2006-2#1)(2011-1#1)
the higher plant##2##3##(1996-5#1)(2008-12#1)
the higher potency##2##3##(1993-3#1)(2008-7#1)
the higher prevalence of##3##4##(2008-5#1)(2011-2#1)(2012-3#1)
the higher prevalence##4##3##(2008-3#1)(2008-5#1)(2011-2#1)(2012-3#1)
the higher production of superoxide##2##5##(1990-12#1)(2007-10#1)
the higher rate of##5##4##(1993-2#1)(2007-7#1)(2008-1#1)(2008-10#2)
the higher rates of##2##4##(2008-7#1)(2013-1#1)
the higher risk of##5##4##(1992-8#1)(1993-3#1)(2008-3#1)(2011-2#2)
the higher risk##7##3##(1992-8#1)(1993-3#1)(2007-1#1)(2008-3#1)(2008-7#1)(2011-2#2)
the higher sensitivity of##3##4##(1993-8#1)(2008-10#2)
the higher sensitivity##4##3##(1993-8#1)(2008-10#2)(2008-11#1)
the higher stability##2##3##(1997-8#1)(2004-12#1)
the higher stomatal##2##3##(2013-7#1)(2013-8#1)
the higher sun radiation##2##4##(2011-2#2)
the higher temperature##3##3##(1990-3#1)(2012-2#1)(2013-8#1)
the higher the resistance##2##4##(2008-10#2)
the higher the##26##3##(1991-8#1)(1993-1#1)(1993-11#1)(1993-8#1)(1994-2#1)(1995-6#1)(1996-1#2)(1996-3#1)(2005-11#3)(2006-12#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#2)(2011-2#1)(2013-8#1)
the higher was the##2##4##(2007-11#1)(2010-12#1)
the higher##263##2##(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#2)(1992-5#2)(1992-8#3)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#2)(1993-4#2)(1993-6#1)(1993-8#5)(1993-9#1)(1994-2#3)(1994-6#2)(1994-8#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#3)(1996-10#2)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-7#1)(1997-2#2)(1997-4#3)(1997-5#1)(1997-8#2)(2004-12#2)(2004-9#1)(2005-10#1)(2005-11#5)(2005-12#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-6#1)(2006-8#3)(2007-1#2)(2007-10#5)(2007-11#5)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#39)(2008-11#8)(2008-12#3)(2008-2#4)(2008-3#9)(2008-5#10)(2008-7#9)(2008-8#4)(2008-9#3)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#12)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#7)(2013-7#2)(2013-8#4)
the higher-order structure of##3##4##(2006-10#3)
the higher-order##13##2##(2006-10#3)(2007-12#2)(2008-11#1)(2008-2#4)(2008-3#2)(2012-3#1)
the highest EFs for##2##4##(2008-10#2)
the highest GUS activity of##2##5##(2008-9#2)
the highest PCB##2##3##(2007-5#1)(2008-10#1)
the highest YAP+##2##3##(2008-9#2)
the highest absolute##3##3##(2007-8#1)(2008-10#1)(2009-4#1)
the highest abundance##4##3##(2008-3#1)(2008-5#2)(2011-2#1)
the highest abundances##2##3##(2007-5#1)(2008-10#1)
the highest accuracy##2##3##(2009-10#1)(2013-8#1)
the highest achievable##2##3##(2008-1#1)(2008-7#1)
the highest activities##2##3##(1990-12#1)(2007-3#1)
the highest activity against##5##4##(1993-4#1)(2007-10#1)(2009-6#1)(2010-3#1)(2012-11#1)
the highest activity among##2##4##(2008-5#1)(2010-4#1)
the highest activity and##2##4##(2005-11#1)(2007-6#1)
the highest activity being##3##4##(2008-5#2)(2009-6#1)
the highest activity##16##3##(1993-4#1)(1994-9#1)(2005-11#1)(2007-10#1)(2007-6#1)(2008-5#3)(2009-6#3)(2010-3#1)(2010-4#1)(2010-5#1)(2012-11#1)(2013-1#1)
the highest affinity for##4##4##(1990-2#1)(1994-9#1)(2008-10#1)(2008-5#1)
the highest affinity##9##3##(1990-2#1)(1994-8#1)(1994-9#1)(1996-8#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-5#1)(2011-1#1)
the highest among##5##3##(1996-3#1)(2008-12#1)(2011-1#1)(2013-1#2)
the highest amount of##5##4##(1996-11#1)(1996-2#1)(1997-2#1)(2008-5#1)(2013-1#1)
the highest amount##6##3##(1996-11#1)(1996-2#1)(1997-2#1)(2008-5#1)(2012-12#1)(2013-1#1)
the highest amounts of##2##4##(1992-9#1)(1997-7#1)
the highest amounts##3##3##(1992-9#1)(1997-3#1)(1997-7#1)
the highest and lowest disease##2##5##(2008-12#2)
the highest and lowest##10##4##(1996-2#1)(1997-1#3)(2008-10#2)(2008-12#2)(2008-7#1)(2012-3#1)
the highest and##13##3##(1996-2#1)(1997-1#3)(1997-2#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-7#1)(2012-3#1)
the highest antioxidant activity##2##4##(2008-10#1)(2013-8#1)
the highest antioxidant##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
the highest average score##2##4##(2007-10#1)(2010-9#1)
the highest average##6##3##(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2010-9#1)(2013-1#1)
the highest being##4##3##(1992-6#1)(2006-11#1)(2008-12#1)(2010-7#1)
the highest cleavage##3##3##(2008-9#2)(2012-2#1)
the highest concentration of##9##4##(1993-11#1)(1995-3#1)(2005-12#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-9#1)(2013-1#1)
the highest concentration tested##3##4##(1996-6#1)(1997-2#1)(2008-5#1)
the highest concentration##23##3##(1992-8#1)(1993-11#1)(1995-3#2)(1996-12#1)(1996-6#1)(1996-8#1)(1997-2#1)(2005-12#1)(2007-1#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-5#3)(2008-9#1)(2009-10#1)(2013-1#1)
the highest concentrations in##2##4##(1997-1#1)(2011-2#1)
the highest concentrations of##3##4##(1990-3#1)(1995-5#1)(2004-4#1)
the highest concentrations were##2##4##(1994-11#1)(2007-5#1)
the highest concentrations##11##3##(1990-3#1)(1991-8#1)(1994-11#1)(1995-5#1)(1997-1#1)(2004-4#1)(2007-5#1)(2008-12#1)(2008-3#1)(2011-2#1)(2013-7#1)
the highest consumption##2##3##(1993-5#1)(2008-5#1)
the highest conversion##3##3##(2007-12#1)(2008-5#1)(2013-1#1)
the highest correlation##4##3##(2007-1#1)(2008-10#3)
the highest current signals##2##4##(2008-10#2)
the highest degree of##8##4##(1991-5#1)(1994-7#1)(1995-6#1)(1997-5#1)(2008-10#2)(2008-7#1)(2008-8#1)
the highest degree##11##3##(1991-5#1)(1994-7#1)(1995-6#1)(1997-5#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-8#1)
the highest density##5##3##(1997-6#1)(2005-8#1)(2008-5#2)(2013-7#1)
the highest disease severity##2##4##(2008-10#2)
the highest disease##5##3##(2008-10#5)
the highest dose to##2##4##(2009-2#2)
the highest dose##14##3##(1991-11#1)(1992-3#1)(1993-6#1)(1996-5#1)(1996-9#1)(2005-7#2)(2008-10#2)(2008-5#2)(2009-2#2)(2013-8#1)
the highest doses##3##3##(1992-11#1)(1996-3#1)(2005-7#1)
the highest efficiency of##2##4##(2008-2#2)
the highest efficiency##5##3##(1991-3#1)(2005-12#1)(2008-10#1)(2008-2#2)
the highest energy##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
the highest enzymatic##2##3##(2008-10#1)(2008-5#1)
the highest expression##6##3##(2006-12#2)(2007-12#1)(2008-9#2)(2012-2#1)
the highest figure##2##3##(2007-7#1)(2011-2#1)
the highest fluorescence##3##3##(2007-11#2)(2008-10#1)
the highest food##2##3##(2012-2#2)
the highest frequency of##4##4##(1991-3#1)(2006-10#1)(2008-10#1)(2012-12#1)
the highest frequency##11##3##(1991-3#1)(1995-5#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-12#1)(2012-12#1)
the highest growth##3##3##(1995-8#1)(2008-10#1)(2008-5#1)
the highest homology to##2##4##(1991-8#1)(1995-6#1)
the highest homology##4##3##(1991-8#1)(1995-6#1)(2008-10#1)(2008-8#1)
the highest impact##2##3##(2005-11#1)(2008-8#1)
the highest in Europe##2##4##(2006-10#1)(2008-11#1)
the highest in the world##7##5##(1990-12#1)(2008-12#1)(2008-7#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-3#1)
the highest in the##11##4##(1990-12#1)(2005-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-3#1)
the highest in##27##3##(1990-12#1)(2005-6#1)(2006-10#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
the highest incidence in##4##4##(1991-11#1)(1992-4#1)(1994-9#1)(2011-2#1)
the highest incidence of##7##4##(1990-3#1)(1992-9#1)(1994-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#1)
the highest incidence##16##3##(1990-3#1)(1991-11#1)(1992-4#1)(1992-9#2)(1993-9#2)(1994-9#2)(2005-8#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)
the highest increase in##2##4##(2008-9#1)(2011-2#1)
the highest infection##2##3##(1996-12#1)(2008-5#1)
the highest inhibitory activity##2##4##(1997-2#1)(2011-12#1)
the highest intake##2##3##(1990-3#1)(1992-10#1)
the highest intensity##2##3##(1994-12#1)(2011-1#1)
the highest level in##3##4##(1993-3#1)(1997-2#1)(2010-4#1)
the highest level of quality##2##5##(1994-2#1)(2007-12#1)
the highest level of virulence##2##5##(2008-10#2)
the highest level of##22##4##(1990-11#1)(1992-9#1)(1993-7#1)(1994-2#1)(1994-9#1)(1996-4#1)(1997-4#2)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-8#4)(2010-3#1)
the highest level##29##3##(1990-11#1)(1991-5#1)(1992-9#1)(1993-3#1)(1993-7#1)(1994-2#1)(1994-9#1)(1995-3#1)(1996-4#1)(1997-2#1)(1997-4#2)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-12#2)(2008-8#4)(2010-3#1)(2010-4#1)
the highest levels of disease##2##5##(2008-10#2)
the highest levels of##21##4##(1991-12#1)(1991-2#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-8#1)(1997-4#1)(2007-1#1)(2007-10#1)(2008-10#7)(2011-1#1)
the highest levels were##2##4##(1997-4#1)(2008-7#1)
the highest levels##29##3##(1991-12#1)(1991-2#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-5#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-8#1)(1997-4#3)(2007-1#1)(2007-10#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-1#1)
the highest lipase##2##3##(2008-10#1)(2012-2#1)
the highest mean##5##3##(1990-2#2)(2007-2#1)(2008-12#1)(2012-12#1)
the highest metal##2##3##(2007-8#1)(2008-10#1)
the highest mortality rate##2##4##(2006-7#1)(2008-4#1)
the highest mortality##5##3##(1992-5#1)(2006-7#1)(2008-4#1)(2010-8#1)(2013-8#1)
the highest number of##12##4##(1991-2#1)(2006-10#1)(2007-2#2)(2007-8#1)(2008-10#1)(2008-6#1)(2010-4#1)(2011-2#3)(2012-2#1)
the highest number##14##3##(1991-2#1)(2006-10#1)(2007-2#2)(2007-8#1)(2008-10#1)(2008-6#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#1)
the highest numbers of##4##4##(2007-2#1)(2007-5#1)(2008-5#1)(2011-2#1)
the highest observed##2##3##(2007-6#1)(2008-10#1)
the highest occupied molecular orbital (HOMO)##2##6##(2007-11#1)(2013-1#1)
the highest ones##2##3##(1990-8#1)(2008-10#1)
the highest output power##2##4##(2007-11#1)(2008-2#1)
the highest overall##5##3##(2007-5#1)(2008-10#1)(2011-2#1)(2012-1#1)(2012-3#1)
the highest peak##3##3##(2007-8#1)(2008-1#1)(2012-2#1)
the highest percentage of##6##4##(1990-8#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-5#2)
the highest percentage##10##3##(1990-8#1)(1996-12#1)(2008-10#2)(2008-12#1)(2008-5#2)(2009-5#1)(2012-7#1)(2013-1#1)
the highest percentages##2##3##(2008-10#1)(2010-6#1)
the highest plasma##2##3##(2007-9#1)(2011-2#1)
the highest point of##2##4##(2009-2#1)(2010-5#1)
the highest possible##5##3##(2007-11#2)(2008-2#1)(2011-2#1)(2012-3#1)
the highest power##3##3##(2008-10#1)(2008-12#1)(2012-3#1)
the highest prevalence of##9##4##(2006-8#1)(2007-12#1)(2007-2#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-8#3)
the highest prevalence rates##2##4##(2005-8#1)(2006-9#1)
the highest prevalence##15##3##(1990-6#1)(2005-8#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#2)(2012-3#1)(2013-8#3)
the highest priority for##2##4##(1994-2#1)(2010-6#1)
the highest priority##4##3##(1994-2#1)(2009-2#1)(2010-6#1)(2012-12#1)
the highest production##2##3##(2008-11#1)(2008-5#1)
the highest proportion##3##3##(1990-11#1)(2013-8#2)
the highest protein##2##3##(1990-11#1)(2008-11#1)
the highest quality##6##3##(1991-12#1)(1996-2#1)(2007-7#1)(2007-8#1)(2011-1#1)(2013-1#1)
the highest quartile of##2##4##(2011-2#2)
the highest rate in##2##4##(2006-2#1)(2011-2#1)
the highest rate of##10##4##(1997-8#1)(2006-2#1)(2006-8#1)(2008-10#2)(2008-12#2)(2009-5#1)(2012-1#1)(2013-1#1)
the highest rate##16##3##(1990-9#1)(1997-8#1)(2006-2#2)(2006-6#1)(2006-8#1)(2007-3#1)(2008-10#2)(2008-12#2)(2009-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
the highest rates of##9##4##(1991-12#1)(2006-3#1)(2006-7#2)(2007-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#1)
the highest rates##14##3##(1990-8#1)(1991-12#1)(1996-9#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-7#2)(2007-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#1)
the highest ratings##2##3##(1993-2#1)(2008-10#1)
the highest ratio##3##3##(1992-12#1)(1993-6#1)(2008-10#1)
the highest ration##2##3##(2010-8#2)
the highest ratios of##2##4##(1996-8#1)(2010-8#1)
the highest ratios##3##3##(1996-8#1)(2010-8#1)(2012-2#1)
the highest recovery##2##3##(1991-1#1)(1993-2#1)
the highest relative##2##3##(1995-8#1)(2008-10#1)
the highest released amount##2##4##(2008-5#2)
the highest reported for##5##4##(1990-12#1)(2008-2#2)(2008-5#1)(2010-3#1)
the highest reported##11##3##(1990-12#1)(2006-10#1)(2007-12#2)(2008-11#2)(2008-2#3)(2008-5#1)(2010-3#1)
the highest results##3##3##(2008-1#1)(2013-1#2)
the highest risk of##9##4##(1996-6#1)(1997-7#1)(2007-1#2)(2010-5#2)(2011-2#1)(2012-2#1)(2013-1#1)
the highest risk##22##3##(1991-5#1)(1991-6#1)(1993-11#1)(1993-9#1)(1995-8#1)(1996-6#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-1#2)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-5#2)(2011-2#1)(2012-2#1)(2013-1#1)
the highest score##4##3##(1991-2#1)(2006-12#1)(2013-1#2)
the highest selectivity##4##3##(1996-8#1)(1997-2#1)(2008-10#2)
the highest sennoside A + B##2##6##(2007-1#2)
the highest sensitivity##11##3##(1990-10#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2011-1#1)(2012-2#1)
the highest similarity##3##3##(2008-10#1)(2012-2#2)
the highest social class##2##4##(1997-2#2)
the highest social##3##3##(1997-2#3)
the highest specific##4##3##(1992-6#1)(1995-6#1)(2008-10#1)(2012-2#1)
the highest stability##2##3##(2008-10#1)(2012-2#1)
the highest standard##2##3##(1995-9#1)(2013-8#1)
the highest success rate##2##4##(1990-6#1)(2007-7#1)
the highest temperature##2##3##(1994-8#1)(2011-2#1)
the highest total##5##3##(2007-1#1)(2008-9#1)(2010-4#1)(2011-2#1)(2013-7#1)
the highest transfection efficiency##2##4##(2006-12#1)(2008-11#1)
the highest tumour##2##3##(1995-2#1)(1996-11#1)
the highest uptake capacity##2##4##(2008-6#1)(2010-12#1)
the highest value ever reported##2##5##(2007-12#1)(2008-12#1)
the highest value in##2##4##(2008-5#1)(2010-4#1)
the highest value##10##3##(1990-9#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-4#2)(2013-1#1)
the highest values in##3##4##(2012-12#1)(2013-7#2)
the highest values of bony block density were##2##8##(2008-4#2)
the highest values of##6##4##(2008-10#2)(2008-4#2)(2012-12#2)
the highest values##16##3##(1994-12#1)(1994-2#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-4#2)(2008-7#1)(2011-2#1)(2012-12#3)(2013-1#1)(2013-7#2)
the highest was##2##3##(1991-11#1)(2008-5#1)
the highest##948##2##(1990-10#2)(1990-11#3)(1990-12#5)(1990-2#5)(1990-3#5)(1990-5#2)(1990-6#3)(1990-8#4)(1990-9#4)(1991-1#1)(1991-11#3)(1991-12#3)(1991-2#5)(1991-3#3)(1991-5#7)(1991-6#1)(1991-8#3)(1992-1#1)(1992-10#3)(1992-11#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#4)(1992-8#1)(1992-9#8)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#6)(1993-7#1)(1993-8#1)(1993-9#5)(1994-11#1)(1994-12#6)(1994-2#6)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#6)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#5)(1995-5#2)(1995-6#3)(1995-8#6)(1995-9#1)(1996-1#2)(1996-11#3)(1996-12#3)(1996-2#5)(1996-3#4)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#6)(1996-9#3)(1997-1#6)(1997-2#12)(1997-3#2)(1997-4#6)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#4)(2004-11#1)(2004-12#1)(2004-4#2)(2005-11#4)(2005-12#3)(2005-6#2)(2005-7#3)(2005-8#4)(2006-1#2)(2006-10#9)(2006-11#1)(2006-12#5)(2006-2#4)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#4)(2006-9#1)(2007-1#8)(2007-10#6)(2007-11#21)(2007-12#16)(2007-2#11)(2007-3#8)(2007-5#8)(2007-6#2)(2007-7#6)(2007-8#13)(2007-9#4)(2008-1#9)(2008-10#124)(2008-11#17)(2008-12#22)(2008-2#19)(2008-3#13)(2008-4#13)(2008-5#54)(2008-6#2)(2008-7#11)(2008-8#16)(2008-9#15)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#3)(2009-4#2)(2009-5#4)(2009-6#6)(2009-7#3)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#9)(2010-2#3)(2010-3#3)(2010-4#15)(2010-5#6)(2010-6#2)(2010-7#2)(2010-8#10)(2010-9#2)(2011-1#13)(2011-12#6)(2011-2#34)(2012-1#4)(2012-11#4)(2012-12#12)(2012-2#22)(2012-3#10)(2012-7#1)(2013-1#36)(2013-7#8)(2013-8#21)
the highest-level##2##2##(2004-3#1)(2008-6#1)
the highest-order##3##2##(2007-11#2)(2008-2#1)
the highlands##9##2##(1991-3#1)(2006-2#4)(2008-10#1)(2008-5#1)(2013-1#2)
the highlights of the##5##4##(2005-7#1)(2005-8#1)(2008-7#1)(2009-3#1)(2010-4#1)
the highlights of this##2##4##(2008-5#2)
the highlights of##9##3##(2005-7#1)(2005-8#1)(2007-11#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-4#1)(2010-4#1)
the highlights##12##2##(2005-7#1)(2005-8#3)(2007-11#1)(2008-5#2)(2008-7#2)(2009-3#1)(2009-4#1)(2010-4#1)
the highly active##3##3##(1991-2#1)(1997-7#1)(2013-8#1)
the highly aggressive##2##3##(2008-10#1)(2013-1#1)
the highly birefringent##2##3##(2007-11#1)(2007-12#1)
the highly chlorinated##2##3##(1993-12#2)
the highly complex##2##3##(2008-11#1)(2012-2#1)
the highly concentrated##2##3##(1997-6#1)(2008-10#1)
the highly conserved aspartate##2##4##(1991-2#1)(1996-2#1)
the highly conserved##23##3##(1990-12#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-2#2)(1992-6#1)(1993-5#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#2)(1995-8#1)(1996-2#1)(1996-8#1)(1997-3#1)(2008-8#2)(2009-5#1)
the highly controversial issue##2##4##(1994-1#2)
the highly cytotoxic##2##3##(1997-2#1)(2009-3#1)
the highly efficient##7##3##(1993-2#2)(1995-1#1)(1996-12#1)(2008-3#1)(2010-11#1)(2012-12#1)
the highly fluorescent##3##3##(1991-9#1)(1992-8#1)(2008-10#1)
the highly homologous##2##3##(1994-9#1)(1995-11#1)
the highly ordered##2##3##(1997-5#1)(2009-5#1)
the highly parallel##2##3##(2008-3#1)(2012-2#1)
the highly pathogenic##3##3##(2005-9#1)(2007-6#1)(2008-4#1)
the highly processive DNA helicase##2##5##(1994-12#2)
the highly purified##2##3##(1995-1#1)(2008-9#1)
the highly reactive##4##3##(1994-9#1)(2006-5#1)(2008-11#2)
the highly religious##2##3##(2012-2#2)
the highly restricted training sample expansion and the structure distance between the temporal expression &amp##2##15##(2013-1#2)
the highly selective ARB valsartan##2##5##(2007-1#2)
the highly selective##13##3##(1990-10#1)(1993-11#1)(1995-7#1)(1996-2#1)(1996-5#1)(1997-2#1)(2007-1#4)(2007-11#1)(2008-10#2)
the highly sensitive##9##3##(1990-8#2)(1992-11#1)(1995-8#1)(2008-10#2)(2008-5#1)(2010-12#1)(2012-3#1)
the highly specialized##2##3##(1992-9#1)(2012-3#1)
the highly specific##4##3##(1996-9#1)(1997-4#1)(2007-11#1)(2008-10#1)
the highly susceptible cv##2##4##(2008-10#2)
the highly susceptible##6##3##(1995-2#1)(2008-10#5)
the highly variable##4##3##(2008-1#1)(2008-4#1)(2011-2#2)
the highly virulent##3##3##(2008-10#2)(2009-6#1)
the highly##183##2##(1990-10#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-2#2)(1991-4#1)(1991-9#2)(1992-11#1)(1992-2#2)(1992-6#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#2)(1993-2#2)(1993-5#3)(1993-8#1)(1994-1#2)(1994-11#2)(1994-12#3)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#4)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-7#2)(1995-8#3)(1996-12#2)(1996-2#2)(1996-5#2)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2005-4#1)(2005-9#1)(2006-10#2)(2006-12#3)(2006-4#1)(2006-5#1)(2007-1#4)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#22)(2008-11#6)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-3#1)(2011-1#4)(2011-2#3)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#6)(2013-8#2)
the highly-conserved##2##2##(1995-5#1)(2009-11#1)
the hilar##2##2##(1990-5#1)(1993-12#1)
the hilum##6##2##(1992-3#1)(1997-1#1)(2007-7#1)(2008-7#1)(2010-12#1)(2012-11#1)
the hilus##2##2##(1990-5#1)(1992-8#1)
the hind leg muscle of##2##5##(1995-2#1)(2008-9#1)
the hind leg##5##3##(1995-2#1)(2007-12#3)(2008-9#1)
the hind legs as##2##4##(2004-11#1)(2007-12#1)
the hind legs##3##3##(2004-11#1)(2007-12#2)
the hind##12##2##(1995-2#1)(1995-8#1)(1996-3#1)(2004-11#1)(2007-12#6)(2007-2#1)(2008-9#1)
the hindbrain##7##2##(1991-3#3)(1993-12#1)(1995-6#1)(2006-5#1)(2008-3#1)
the hindered##3##2##(2005-11#2)(2008-8#1)
the hindgut epithelium##4##3##(2007-12#1)(2008-10#3)
the hindgut of##2##3##(1997-8#1)(2010-8#1)
the hindgut##14##2##(1997-8#1)(2005-12#1)(2007-12#4)(2008-10#5)(2010-8#1)(2012-2#1)(2013-7#1)
the hindlimb##9##2##(1990-11#1)(1991-6#1)(1993-11#1)(1994-2#5)(2006-4#1)
the hindlimbs of##2##3##(1990-4#1)(1996-6#1)
the hindlimbs##3##2##(1990-4#1)(1992-12#1)(1996-6#1)
the hindpaw##6##2##(1990-4#1)(1991-9#1)(1996-1#2)(2009-12#2)
the hindrance##2##2##(2011-2#1)(2013-8#1)
the hinfIR gene##2##3##(1990-3#2)
the hinge region of aPKCζ causes exclusion from the nucleus##2##10##(2012-12#2)
the hinge region of##6##4##(1995-6#1)(2006-10#1)(2012-12#4)
the hinge region##13##3##(1995-11#1)(1995-6#1)(1997-2#1)(1997-7#1)(2006-10#1)(2009-9#1)(2012-12#7)
the hinge##17##2##(1994-2#1)(1995-11#1)(1995-6#1)(1997-2#1)(1997-7#1)(2006-10#1)(2008-7#1)(2009-9#3)(2012-12#7)
the hip and knee joints##2##5##(1991-10#1)(2012-1#1)
the hip and knee##6##4##(1991-10#1)(1995-5#1)(2007-7#1)(2008-5#1)(2012-1#2)
the hip and##15##3##(1991-10#1)(1992-12#1)(1993-11#1)(1995-5#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-5#1)(2009-5#1)(2011-12#1)(2012-1#2)(2012-2#1)(2013-1#1)
the hip is##8##3##(2006-10#1)(2006-11#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-4#1)(2009-3#1)
the hip joint by##2##4##(2007-5#1)(2007-7#1)
the hip joint in##5##4##(2007-11#2)(2007-8#3)
the hip joint is##5##4##(1997-6#1)(2007-11#1)(2007-7#2)(2010-4#1)
the hip joint was##2##4##(2007-8#1)(2013-8#1)
the hip joint##48##3##(1991-10#1)(1992-12#1)(1997-6#2)(2006-10#1)(2006-11#3)(2006-6#1)(2007-11#10)(2007-5#1)(2007-7#9)(2007-8#9)(2008-10#1)(2008-4#1)(2008-6#2)(2008-8#1)(2009-5#1)(2010-2#1)(2010-4#1)(2013-7#1)(2013-8#1)
the hip joints##4##3##(2007-11#3)(2008-6#1)
the hip prosthesis##2##3##(2007-7#2)
the hip was##4##3##(2006-11#1)(2007-11#1)(2009-3#1)(2013-7#1)
the hip##190##2##(1990-2#2)(1991-10#2)(1991-11#1)(1992-12#2)(1992-2#1)(1993-11#8)(1995-5#1)(1997-6#2)(2005-3#1)(2006-10#6)(2006-11#10)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#32)(2007-5#1)(2007-6#1)(2007-7#32)(2007-8#28)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#3)(2008-8#3)(2009-11#1)(2009-3#7)(2009-5#2)(2009-7#1)(2010-10#1)(2010-2#4)(2010-3#1)(2010-4#1)(2011-12#2)(2011-2#4)(2012-1#5)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#6)(2013-8#4)
the hip)##2##2##(2007-4#2)
the hippocampal CA1 area##4##4##(1997-7#2)(2008-11#1)(2009-12#1)
the hippocampal CA1 region##6##4##(1990-2#1)(1990-5#1)(1991-8#1)(1992-12#1)(1995-7#1)(2011-2#1)
the hippocampal CA1##17##3##(1990-2#2)(1990-5#1)(1991-10#1)(1991-8#1)(1992-12#1)(1993-9#1)(1995-7#1)(1996-1#1)(1997-1#1)(1997-7#2)(2008-11#3)(2009-12#1)(2011-2#1)
the hippocampal CA3##2##3##(1995-8#1)(2008-11#1)
the hippocampal area##2##3##(1990-5#1)(2013-1#1)
the hippocampal cholinergic activity##3##4##(1992-8#1)(1994-2#2)
the hippocampal cholinergic##4##3##(1992-8#2)(1994-2#2)
the hippocampal dentate gyrus##3##4##(1994-2#1)(1996-9#1)(2008-7#1)
the hippocampal formation and##7##4##(1993-9#1)(1996-6#1)(1996-9#2)(1997-8#2)(2008-3#1)
the hippocampal formation in##2##4##(1994-12#1)(1997-7#1)
the hippocampal formation of##3##4##(1993-4#1)(1996-3#1)(1996-6#1)
the hippocampal formation##32##3##(1990-10#3)(1992-7#3)(1993-4#1)(1993-5#1)(1993-9#1)(1994-12#2)(1995-12#2)(1996-2#1)(1996-3#2)(1996-6#3)(1996-7#1)(1996-9#3)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#2)(2005-10#1)(2008-3#1)
the hippocampal memory system##2##4##(1997-7#2)
the hippocampal region of the##2##5##(1994-2#1)(1995-5#1)
the hippocampal region of##3##4##(1993-2#1)(1994-2#1)(1995-5#1)
the hippocampal region##9##3##(1990-5#1)(1992-11#1)(1993-2#2)(1994-2#1)(1994-3#3)(1995-5#1)
the hippocampal slice preparation##2##4##(1994-2#1)(2008-4#1)
the hippocampal slice##4##3##(1990-2#1)(1994-11#1)(1994-2#1)(2008-4#1)
the hippocampal##102##2##(1990-10#3)(1990-11#2)(1990-2#3)(1990-4#1)(1990-5#4)(1991-10#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-7#3)(1992-8#3)(1992-9#2)(1993-2#2)(1993-4#1)(1993-5#2)(1993-6#1)(1993-9#3)(1994-11#3)(1994-12#2)(1994-2#5)(1994-3#3)(1994-8#1)(1995-12#3)(1995-3#1)(1995-5#2)(1995-7#1)(1995-8#1)(1996-1#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#4)(1996-7#1)(1996-9#4)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#6)(1997-8#3)(2005-10#1)(2008-11#4)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-12#2)(2011-2#1)(2013-1#1)(2013-8#1)
the hippocampi of##2##3##(1995-12#2)
the hippocampi##3##2##(1995-12#3)
the hippocampus CA1##7##3##(1990-7#2)(1997-7#5)
the hippocampus CA3##2##3##(1996-4#1)(1997-7#1)
the hippocampus after##3##3##(1992-12#1)(1994-12#1)(1997-3#1)
the hippocampus and amygdala##3##4##(2004-11#1)(2010-12#2)
the hippocampus and cortex##2##4##(1996-12#1)(2007-10#1)
the hippocampus and in the##6##5##(1995-5#1)(1997-2#1)(2008-4#1)(2009-4#2)(2011-2#1)
the hippocampus and in##7##4##(1995-5#1)(1997-2#2)(2008-4#1)(2009-4#2)(2011-2#1)
the hippocampus and the entorhinal cortex##2##6##(1994-3#2)
the hippocampus and the entorhinal##3##5##(1992-11#1)(1994-3#2)
the hippocampus and the##13##4##(1991-3#2)(1992-11#1)(1993-6#2)(1993-7#1)(1994-3#2)(1995-12#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-12#1)
the hippocampus and##49##3##(1991-12#1)(1991-3#2)(1991-5#1)(1992-10#1)(1992-11#2)(1992-3#1)(1993-11#1)(1993-12#1)(1993-6#3)(1993-7#2)(1994-10#1)(1994-11#1)(1994-3#3)(1994-8#1)(1995-10#1)(1995-12#1)(1995-5#1)(1995-7#1)(1996-11#1)(1996-12#1)(1997-2#2)(2004-11#2)(2005-9#1)(2007-10#1)(2008-11#1)(2008-4#2)(2008-7#2)(2009-3#1)(2009-4#3)(2009-6#1)(2010-12#3)(2011-2#2)(2012-3#1)
the hippocampus are##4##3##(1993-11#1)(1993-12#2)(2013-8#1)
the hippocampus as well as the##2##6##(2009-12#1)(2013-8#1)
the hippocampus at##2##3##(1993-12#1)(1996-1#1)
the hippocampus during##3##3##(1991-11#1)(2008-11#1)(2010-8#1)
the hippocampus from##3##3##(1993-11#2)(1994-2#1)
the hippocampus have been##3##4##(2008-7#1)(2009-5#1)(2013-8#1)
the hippocampus in a##2##4##(1993-2#1)(1994-2#1)
the hippocampus in##15##3##(1991-9#1)(1993-2#2)(1993-6#1)(1994-2#4)(1994-5#1)(1994-6#1)(1995-5#1)(1996-12#1)(2008-7#1)(2009-2#1)(2013-8#1)
the hippocampus is##3##3##(1993-2#1)(1996-9#1)(2009-5#1)
the hippocampus may reflect##2##4##(1992-7#1)(2009-2#1)
the hippocampus may##3##3##(1992-7#1)(2008-11#1)(2009-2#1)
the hippocampus of the reeler mouse##2##6##(1994-10#2)
the hippocampus of the reeler##3##5##(1994-10#3)
the hippocampus of the##10##4##(1990-7#1)(1992-10#1)(1994-10#3)(1994-11#1)(1995-12#2)(1997-7#1)(2010-12#1)
the hippocampus of##31##3##(1990-7#1)(1992-10#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-10#5)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-12#2)(1995-3#2)(1995-5#2)(1996-12#2)(1996-7#1)(1997-7#2)(2007-9#1)(2008-11#1)(2010-12#1)(2013-1#2)
the hippocampus or parahippocampus##2##4##(1990-11#2)
the hippocampus or##3##3##(1990-11#2)(1996-7#1)
the hippocampus that##3##3##(2008-10#1)(2009-2#1)(2013-1#1)
the hippocampus to##5##3##(1994-11#1)(2007-10#1)(2008-11#2)(2008-12#1)
the hippocampus was##4##3##(1994-5#1)(1994-6#1)(1995-12#1)(2013-1#1)
the hippocampus which##2##3##(1996-12#1)(2010-12#1)
the hippocampus##306##2##(1990-11#3)(1990-4#1)(1990-5#1)(1990-7#6)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#1)(1991-9#1)(1992-10#2)(1992-11#4)(1992-12#1)(1992-3#2)(1992-7#5)(1992-8#5)(1992-9#1)(1993-11#12)(1993-12#9)(1993-2#5)(1993-5#3)(1993-6#10)(1993-7#4)(1993-9#2)(1994-10#7)(1994-11#9)(1994-12#5)(1994-2#7)(1994-3#6)(1994-5#8)(1994-6#5)(1994-8#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#8)(1995-3#4)(1995-5#9)(1995-7#2)(1995-8#1)(1996-1#4)(1996-10#1)(1996-11#1)(1996-12#9)(1996-3#4)(1996-4#1)(1996-7#2)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#2)(1997-4#1)(1997-5#2)(1997-7#9)(1997-8#1)(2004-11#3)(2005-9#1)(2007-10#4)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#18)(2008-12#1)(2008-4#4)(2008-7#10)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#5)(2009-3#1)(2009-4#4)(2009-5#2)(2009-6#3)(2010-12#7)(2010-8#2)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#7)
the hips were##2##3##(2006-10#1)(2007-7#1)
the hips##17##2##(1990-2#1)(1990-5#1)(2006-10#1)(2006-8#1)(2007-11#3)(2007-7#6)(2007-8#2)(2010-1#1)(2013-8#1)
the hiring##3##2##(1992-9#2)(1994-1#1)
the hirudin##2##2##(1990-7#1)(1992-9#1)
the his##3##2##(1990-5#3)
the histamine H1 receptors##2##4##(1992-3#1)(1993-3#1)
the histamine H1##3##3##(1992-11#1)(1992-3#1)(1993-3#1)
the histamine H2 receptor##2##4##(1995-12#1)(1996-12#1)
the histamine##17##2##(1992-11#1)(1992-3#1)(1992-5#2)(1993-11#1)(1993-3#1)(1994-5#1)(1995-12#3)(1996-12#2)(1997-1#1)(2007-1#1)(2008-10#2)(2009-6#1)
the histidine and##2##3##(1993-11#1)(2005-4#1)
the histidine biosynthetic##2##3##(1990-5#1)(2008-10#1)
the histidine decarboxylase##3##3##(1992-4#1)(1992-5#1)(1992-6#1)
the histidine residue##5##3##(1992-7#2)(1994-11#2)(1996-8#1)
the histidine residues##5##3##(1991-4#1)(1991-8#1)(1992-6#1)(1992-8#1)(1996-9#1)
the histidine##24##2##(1990-5#1)(1991-2#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#3)(1992-8#1)(1993-11#1)(1994-11#3)(1994-5#1)(1996-8#1)(1996-9#1)(2005-4#2)(2008-10#1)
the histo-blood group ABH genes##2##5##(1991-3#2)
the histo-blood group##3##3##(1991-3#2)(1994-3#1)
the histochemical##4##2##(1991-6#1)(2006-12#1)(2007-3#1)(2013-8#1)
the histogenesis of the##2##4##(2008-5#1)(2009-2#1)
the histogenesis of this##2##4##(1996-6#1)(2009-3#1)
the histogenesis of##4##3##(1996-6#1)(2008-5#1)(2009-2#1)(2009-3#1)
the histogenesis##6##2##(1996-6#2)(2007-2#1)(2008-5#1)(2009-2#1)(2009-3#1)
the histogram of the##3##4##(2008-2#2)(2008-3#1)
the histogram of##4##3##(2008-2#2)(2008-3#2)
the histogram##10##2##(2008-2#6)(2008-3#2)(2008-6#1)(2013-8#1)
the histograms##4##2##(2008-10#1)(2008-2#2)(2008-6#1)
the histologic diagnosis##2##3##(1991-12#1)(1992-12#1)
the histologic features##2##3##(1991-6#1)(2006-2#1)
the histologic findings were##2##4##(1992-11#1)(2006-10#1)
the histologic findings##3##3##(1992-11#1)(2006-10#1)(2010-6#1)
the histologic grade##2##3##(1997-7#1)(2008-5#1)
the histologic response of the primary##2##6##(1992-6#2)
the histologic type##3##3##(1991-10#2)(2006-6#1)
the histologic##26##2##(1990-3#1)(1991-10#2)(1991-12#1)(1991-6#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-6#2)(1993-8#1)(1995-4#1)(1997-7#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-5#2)(2008-7#1)(2010-6#1)(2011-2#1)(2012-12#1)
the histological and biological##2##4##(1990-2#1)(1994-9#1)
the histological and##5##3##(1990-2#1)(1994-9#1)(2008-9#1)(2009-7#1)(2010-9#1)
the histological appearance##2##3##(2007-5#1)(2012-12#1)
the histological changes of##2##4##(2007-12#1)(2011-3#1)
the histological changes##3##3##(1995-2#1)(2007-12#1)(2011-3#1)
the histological diagnosis has##2##4##(2007-4#1)(2013-1#1)
the histological diagnosis of##2##4##(1991-12#1)(2008-10#1)
the histological diagnosis##10##3##(1990-4#1)(1991-12#1)(2007-4#1)(2008-10#1)(2008-4#1)(2008-9#1)(2011-1#1)(2011-7#1)(2013-1#1)(2013-8#1)
the histological examination of the##2##5##(2010-12#1)(2010-6#1)
the histological examination##4##3##(1992-5#1)(2007-10#1)(2010-12#1)(2010-6#1)
the histological findings in##2##4##(1990-11#1)(2007-8#1)
the histological findings of##4##4##(1995-11#1)(2005-11#1)(2006-4#1)(2008-1#1)
the histological findings##11##3##(1990-11#1)(1990-7#1)(1994-9#1)(1995-11#1)(2005-11#1)(2006-4#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-6#1)(2009-7#1)
the histological subtype##2##3##(1996-6#1)(2010-12#1)
the histological type of##2##4##(1992-10#1)(1993-11#1)
the histological type##3##3##(1992-10#1)(1993-11#1)(2011-2#1)
the histological##75##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-5#1)(1992-8#1)(1993-11#1)(1994-6#1)(1994-9#2)(1995-11#2)(1995-2#1)(1996-6#1)(1997-1#1)(2004-11#1)(2005-11#2)(2006-2#2)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#2)(2009-2#1)(2009-7#2)(2009-8#1)(2010-12#2)(2010-4#1)(2010-6#2)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#5)
the histologically##2##2##(1991-6#1)(2008-6#1)
the histology and##3##3##(1994-9#1)(2008-3#1)(2012-2#1)
the histology of the##3##4##(1994-1#1)(2008-6#1)(2009-1#1)
the histology of##6##3##(1994-1#1)(2007-7#1)(2008-10#1)(2008-6#1)(2009-1#1)(2013-1#1)
the histology##20##2##(1994-1#1)(1994-9#1)(1996-12#1)(2005-11#1)(2005-12#2)(2006-2#1)(2006-6#2)(2007-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-1#1)(2009-10#1)(2010-12#1)(2012-2#1)(2013-1#1)
the histomorphology of##2##3##(1997-3#1)(2013-1#1)
the histomorphology##3##2##(1997-3#1)(2013-1#1)(2013-8#1)
the histone H3-II gene##2##4##(1995-3#2)
the histone deacetylase##3##3##(2009-12#2)(2010-3#1)
the histone kinase##2##3##(1990-7#1)(1992-6#1)
the histone##20##2##(1990-2#1)(1990-4#1)(1990-7#1)(1991-5#1)(1992-2#1)(1992-6#1)(1992-8#1)(1994-9#1)(1995-3#2)(1996-4#1)(1996-8#1)(1997-1#2)(2008-7#1)(2009-12#2)(2009-5#1)(2010-3#1)(2011-1#1)
the histones##2##2##(1992-9#1)(1995-7#1)
the histopathologic examination##2##3##(1990-10#1)(2008-10#1)
the histopathologic##10##2##(1990-10#1)(2004-11#1)(2005-8#1)(2006-2#1)(2007-10#1)(2008-10#1)(2010-3#1)(2013-1#1)(2013-8#2)
the histopathological changes##3##3##(2008-5#1)(2008-8#1)(2013-1#1)
the histopathological diagnosis of##2##4##(2011-2#1)(2013-1#1)
the histopathological diagnosis was##2##4##(1997-8#1)(2007-12#1)
the histopathological diagnosis##5##3##(1997-8#1)(2007-12#1)(2010-11#1)(2011-2#1)(2013-1#1)
the histopathological examination of the##2##5##(2011-12#1)(2012-12#1)
the histopathological examination of##3##4##(2011-12#1)(2011-2#1)(2012-12#1)
the histopathological examination##5##3##(2011-12#1)(2011-2#1)(2012-12#2)(2013-8#1)
the histopathological features of##2##4##(2011-1#1)(2013-1#1)
the histopathological findings##5##3##(2005-11#1)(2007-8#1)(2008-5#1)(2011-2#1)(2012-2#1)
the histopathological##29##2##(1997-8#2)(2005-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-5#2)(2008-6#1)(2008-8#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
the histopathology and##2##3##(2009-3#1)(2012-12#1)
the histopathology of##2##3##(1990-3#1)(2008-6#1)
the histopathology report##2##3##(2010-12#1)(2013-8#1)
the histopathology##10##2##(1990-3#1)(1995-5#1)(2006-12#1)(2008-6#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
the histopatological##2##2##(2006-6#1)(2007-11#1)
the historian##2##2##(2008-10#1)(2010-3#1)
the historic##16##2##(1991-12#1)(1994-3#1)(1995-12#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-4#1)(2010-10#1)(2011-2#2)
the historical and##3##3##(1996-2#1)(2009-10#1)(2012-12#1)
the historical background of the##2##5##(2008-2#1)(2012-1#1)
the historical background of##3##4##(2007-12#1)(2008-2#1)(2012-1#1)
the historical background##6##3##(1994-6#1)(2004-7#1)(2007-12#1)(2008-2#1)(2008-9#1)(2012-1#1)
the historical context of World War II##2##7##(2013-1#2)
the historical development of the##2##5##(2007-2#1)(2008-6#1)
the historical development of##8##4##(1993-3#1)(1996-3#1)(1996-8#1)(2007-2#1)(2008-2#1)(2008-6#1)(2008-9#1)(2013-1#1)
the historical evolution of##4##4##(1996-12#1)(2006-7#1)(2008-10#2)
the historical period##2##3##(1992-6#1)(2013-1#1)
the historical perspective##2##3##(1996-1#1)(2008-6#1)
the historical study##2##3##(2008-1#1)(2012-2#1)
the historical##76##2##(1991-3#1)(1991-6#1)(1992-12#1)(1992-6#1)(1993-3#1)(1994-6#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(2004-10#1)(2004-7#1)(2006-5#1)(2006-7#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#2)(2008-9#2)(2009-10#2)(2010-2#1)(2010-5#2)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#2)
the historically##3##2##(2005-11#1)(2012-3#1)(2013-1#1)
the historicity of##2##3##(2008-8#1)(2013-1#1)
the histories and##2##3##(2008-5#1)(2009-2#1)
the histories##3##2##(1993-7#1)(2008-5#1)(2009-2#1)
the history and physical examination##3##5##(2007-3#1)(2007-7#1)(2010-2#1)
the history and physical##4##4##(2007-3#1)(2007-7#1)(2010-1#1)(2010-2#1)
the history and the##2##4##(1997-3#1)(2007-8#1)
the history and##17##3##(1997-3#1)(2006-5#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#2)(2010-1#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
the history is##2##3##(2005-11#1)(2006-5#1)
the history of American##2##4##(1994-12#1)(2012-3#1)
the history of a##4##4##(1992-4#1)(2008-2#1)(2013-7#1)(2013-8#1)
the history of falls##2##4##(2010-3#2)
the history of healthcare##2##4##(2006-6#1)(2013-8#1)
the history of human##2##4##(2008-12#1)(2008-8#1)
the history of mankind##2##4##(1991-11#1)(2006-12#1)
the history of medical##2##4##(2010-1#2)
the history of medicine##8##4##(1993-11#1)(1993-6#1)(2006-4#2)(2007-5#2)(2008-3#1)(2008-9#1)
the history of nursing##3##4##(2005-12#1)(2009-8#1)(2013-8#1)
the history of science##3##4##(2007-9#1)(2013-1#2)
the history of the development of the##3##7##(1996-12#1)(2006-4#1)(2010-5#1)
the history of the development of##4##6##(1996-12#1)(2006-4#1)(2010-5#1)(2010-8#1)
the history of the discovery##2##5##(1997-1#1)(2009-10#1)
the history of the patient##2##5##(2006-4#1)(2008-12#1)
the history of the##40##4##(1990-11#1)(1990-5#1)(1993-1#1)(1993-5#1)(1996-12#1)(1996-3#1)(1997-1#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-4#2)(2006-6#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-2#1)(2009-4#2)(2010-1#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-5#1)(2013-1#1)
the history of treatment for##2##5##(2007-7#2)
the history of##150##3##(1990-11#1)(1990-5#2)(1990-6#1)(1991-1#1)(1991-11#1)(1992-4#1)(1993-1#1)(1993-11#1)(1993-5#1)(1993-6#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-8#1)(2004-2#1)(2005-12#1)(2005-7#2)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-4#4)(2006-5#2)(2006-6#2)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#3)(2007-5#3)(2007-7#5)(2007-8#3)(2007-9#3)(2008-1#4)(2008-10#1)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#2)(2008-8#4)(2008-9#3)(2009-10#2)(2009-2#6)(2009-4#2)(2009-5#1)(2009-8#1)(2010-1#3)(2010-12#2)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#3)(2011-2#2)(2011-8#1)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#5)(2013-7#1)(2013-8#5)
the history##198##2##(1990-11#1)(1990-5#2)(1990-6#1)(1991-1#1)(1991-11#1)(1992-4#1)(1993-1#1)(1993-11#1)(1993-5#1)(1993-6#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-8#1)(2004-2#1)(2005-11#1)(2005-12#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-4#4)(2006-5#4)(2006-6#2)(2006-8#4)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#3)(2007-5#3)(2007-7#9)(2007-8#4)(2007-9#3)(2008-1#4)(2008-10#1)(2008-11#4)(2008-12#5)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#6)(2008-9#3)(2009-10#4)(2009-2#6)(2009-4#2)(2009-5#1)(2009-8#1)(2010-1#4)(2010-12#2)(2010-2#2)(2010-3#4)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#5)(2011-2#3)(2011-8#1)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#3)(2012-5#1)(2013-1#6)(2013-7#1)(2013-8#7)
the histotype of metastatic cells##2##5##(1990-2#2)
the histotype of##3##3##(1990-2#3)
the hit##3##2##(2008-3#1)(2008-6#1)(2012-3#1)
the hit-miss transform##2##3##(2008-3#2)
the hitherto neglected##2##3##(2007-7#1)(2010-10#1)
the hitherto unknown##2##3##(2009-9#1)(2010-5#1)
the hitherto##12##2##(1990-11#2)(1990-9#1)(1993-3#1)(1994-9#1)(1995-8#1)(1997-4#1)(2007-7#1)(2008-10#1)(2009-9#1)(2010-10#1)(2010-5#1)
the hives##3##2##(2008-5#3)
the hlyA##2##2##(2006-5#2)
the hobo##3##2##(1994-8#1)(1995-2#1)(1997-1#1)
the holding coil to##2##4##(2008-10#2)
the holding coil##5##3##(2008-10#5)
the holding of##2##3##(1990-12#1)(2008-10#1)
the holding##12##2##(1990-12#1)(1993-11#1)(1995-12#1)(1997-7#1)(2007-11#1)(2008-10#7)
the hole at the##2##4##(1991-11#1)(1992-2#1)
the hole was##3##3##(2007-12#1)(2008-2#1)(2012-12#1)
the hole##14##2##(1991-11#1)(1992-2#1)(1993-4#1)(1995-6#1)(2006-3#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-2#2)(2012-1#1)(2012-12#1)
the holes##5##2##(1994-9#1)(2007-11#2)(2007-12#1)(2008-5#1)
the holistic##6##2##(1997-6#2)(1997-8#1)(2008-1#1)(2013-1#1)(2013-7#1)
the hollow sphere##2##3##(1994-2#2)
the hollow waveguide##2##3##(2007-11#1)(2007-12#1)
the hollow##18##2##(1993-7#1)(1994-2#3)(2005-11#1)(2006-12#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-3#2)(2013-8#1)
the holo##3##2##(1994-2#1)(1995-10#2)
the holoenzyme and##3##3##(1990-2#1)(1992-6#1)(1997-7#1)
the holoenzyme##22##2##(1990-2#1)(1990-8#3)(1991-2#2)(1992-11#1)(1992-6#1)(1993-6#2)(1994-3#1)(1994-9#3)(1995-10#1)(1995-2#1)(1995-3#1)(1997-7#4)(2008-11#1)
the hologram is##2##3##(2007-12#1)(2008-3#1)
the hologram plane##2##3##(2007-12#1)(2008-3#1)
the hologram was##2##3##(2007-12#1)(2008-2#1)
the hologram##31##2##(2007-12#7)(2008-2#12)(2008-3#12)
the holograms##7##2##(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#2)
the holographic grating##2##3##(2008-3#2)
the holographic recording##3##3##(2007-12#3)
the holographic reflector##2##3##(2008-3#2)
the holographic##34##2##(2007-11#3)(2007-12#4)(2008-2#10)(2008-3#17)
the holoprotein##7##2##(1990-2#2)(1993-4#1)(1993-8#2)(1994-8#2)
the holoreceptor##2##2##(1990-2#1)(2010-8#1)
the holy##2##2##(2007-4#1)(2008-12#1)
the home and community##2##4##(1991-1#1)(2009-9#1)
the home and##10##3##(1991-1#1)(1992-4#1)(1993-1#1)(1993-7#1)(2007-12#1)(2008-7#1)(2009-5#2)(2009-9#1)(2013-8#1)
the home care industry##2##4##(1995-3#1)(1997-3#1)
the home care##5##3##(1995-3#1)(1997-3#1)(2009-4#1)(2010-5#1)(2011-2#1)
the home environment##4##3##(1991-1#1)(2007-8#1)(2007-9#1)(2012-2#1)
the home health##3##3##(1995-3#2)(1997-2#1)
the home in##3##3##(1991-12#1)(2007-12#2)
the home is##4##3##(1990-10#1)(1991-1#1)(2007-12#2)
the home modalities##3##3##(1995-12#3)
the home or##2##3##(1990-12#1)(2008-12#1)
the home##95##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-4#1)(1990-5#1)(1990-8#1)(1991-1#4)(1991-12#3)(1991-4#1)(1991-5#2)(1991-8#2)(1992-2#2)(1992-4#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-7#3)(1994-12#1)(1994-2#1)(1995-12#3)(1995-2#1)(1995-3#3)(1995-8#1)(1996-2#1)(1997-2#1)(1997-3#2)(2005-10#5)(2005-7#1)(2006-10#1)(2007-10#1)(2007-12#8)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#2)(2009-9#1)(2010-2#1)(2010-5#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
the home-made##2##2##(2008-10#2)
the homebound elderly##2##3##(1995-12#1)(1997-2#1)
the homebound##4##2##(1995-12#1)(1995-2#1)(1996-3#1)(1997-2#1)
the homeless##7##2##(1990-12#1)(1995-9#1)(2005-8#1)(2006-8#1)(2012-11#1)(2013-8#2)
the homeobox transcription factor##2##4##(2009-6#1)(2012-2#1)
the homeobox##3##2##(1994-9#1)(2009-6#1)(2012-2#1)
the homeodomain and##2##3##(1995-1#1)(1997-5#1)
the homeodomain of##3##3##(1996-8#3)
the homeodomain##16##2##(1992-4#1)(1993-5#2)(1994-8#1)(1995-1#3)(1995-5#1)(1996-8#5)(1997-5#3)
the homeopathic remedies##2##3##(2008-10#2)
the homeopathic##4##2##(2008-10#4)
the homeostasis model assessment##3##4##(2005-8#1)(2006-9#1)(2008-3#1)
the homeostasis model##4##3##(2005-8#1)(2006-9#1)(2008-3#2)
the homeostasis of the##8##4##(1996-9#1)(2009-10#2)(2009-2#1)(2009-3#1)(2012-12#1)(2013-7#1)(2013-8#1)
the homeostasis of##17##3##(1992-5#1)(1994-12#1)(1995-12#2)(1995-3#1)(1996-9#1)(2006-2#1)(2007-9#1)(2008-5#1)(2009-10#2)(2009-2#1)(2009-3#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
the homeostasis##23##2##(1992-5#1)(1994-12#1)(1995-12#2)(1995-3#1)(1996-9#1)(2005-8#1)(2006-2#1)(2006-9#1)(2007-9#1)(2008-3#2)(2008-5#1)(2009-10#2)(2009-2#1)(2009-3#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
the homeostatic control##2##3##(2008-7#1)(2009-12#1)
the homeostatic##8##2##(1995-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-12#1)(2009-5#1)
the homes##5##2##(1993-9#1)(1995-6#1)(1997-3#1)(2008-5#1)(2013-1#1)
the homing##2##2##(1990-11#1)(2013-8#1)
the hominid##3##2##(1994-3#1)(1997-4#1)(2008-1#1)
the homo##2##2##(2006-10#1)(2007-3#1)
the homo- and heteromeric##2##4##(1995-11#2)
the homodimeric##2##2##(1990-8#1)(2008-11#1)
the homodyne##2##2##(2008-2#2)
the homogenate and##2##3##(1991-1#1)(1993-12#1)
the homogenate##4##2##(1991-1#1)(1991-2#1)(1992-11#1)(1993-12#1)
the homogenates##2##2##(1990-11#1)(2010-2#1)
the homogeneity of the##4##4##(1992-6#1)(2008-10#2)(2011-1#1)
the homogeneity of##9##3##(1992-6#1)(2006-12#1)(2006-8#1)(2008-10#5)(2011-1#1)
the homogeneity##11##2##(1992-6#1)(1996-9#1)(2006-12#1)(2006-4#1)(2006-8#1)(2008-10#5)(2011-1#1)
the homogeneous##11##2##(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2010-5#1)(2013-7#1)
the homogenization##2##2##(2008-10#2)
the homogenized##2##2##(2005-11#1)(2013-8#1)
the homogenous##2##2##(1994-8#1)(2008-10#1)
the homolog##3##2##(1994-9#2)(1995-1#1)
the homologous antigen##3##3##(1990-5#1)(2008-10#1)(2008-5#1)
the homologous protein##2##3##(1995-1#1)(1995-9#1)
the homologous proteins##2##3##(1993-12#1)(1994-2#1)
the homologous regions were##2##4##(1990-4#1)(2008-8#1)
the homologous regions##4##3##(1990-4#1)(1991-6#1)(1993-5#1)(2008-8#1)
the homologous sequence##2##3##(1996-7#1)(2008-4#1)
the homologous##57##2##(1990-11#1)(1990-2#2)(1990-4#2)(1990-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-4#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-5#1)(1996-7#4)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(2006-11#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-4#1)(2008-5#4)(2008-8#1)(2009-6#1)(2011-1#1)(2011-2#1)
the homologue of the##2##4##(1994-3#1)(2009-2#1)
the homologue of##5##3##(1994-3#1)(1994-5#2)(2007-9#1)(2009-2#1)
the homologues of##2##3##(1997-4#1)(2008-7#1)
the homology between##2##3##(1994-9#1)(2009-10#1)
the homology of the##2##4##(2008-9#2)
the homology of##3##3##(2007-12#1)(2008-9#2)
the homology to##2##3##(1990-12#1)(2008-9#1)
the homology##11##2##(1990-12#1)(1994-9#2)(2007-12#2)(2008-9#3)(2009-10#1)(2012-2#2)
the homopolymer##2##2##(2005-11#1)(2010-4#1)
the homotetrameric##2##2##(1994-5#1)(1994-9#1)
the homozygote##2##2##(1997-8#1)(2008-9#1)
the homozygotes##2##2##(1995-2#1)(2007-7#1)
the homozygous deletion##3##3##(1996-12#2)(2008-12#1)
the homozygous mutants##3##3##(1991-6#1)(1997-4#1)(1997-7#1)
the homozygous##15##2##(1990-5#1)(1991-6#1)(1994-12#1)(1995-1#1)(1996-12#2)(1996-6#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#1)(2010-6#1)(2011-2#1)
the honey bee (Apis mellifera)##4##5##(2007-12#2)(2008-5#1)(2013-1#1)
the honey bee##9##3##(1997-6#2)(2007-12#3)(2008-5#1)(2008-6#1)(2009-5#1)(2013-1#1)
the honey samples##4##3##(2008-10#3)(2008-5#1)
the honey##20##2##(1997-6#2)(2006-12#5)(2007-12#3)(2008-10#4)(2008-5#2)(2008-6#1)(2008-7#1)(2009-5#1)(2013-1#1)
the honeybee##6##2##(1994-8#2)(2008-7#2)(2008-8#2)
the honeycomb##3##2##(1994-2#1)(2006-12#1)(2010-5#1)
the honour of##2##3##(1994-11#1)(2008-12#1)
the hood##4##2##(2006-11#3)(2008-5#1)
the hook effect##3##3##(2008-3#3)
the hook##4##2##(2007-12#1)(2008-3#3)
the hope of improving##2##4##(2006-10#1)(2011-7#1)
the hope of##13##3##(1993-10#1)(1993-12#1)(1996-3#1)(2005-9#1)(2006-10#2)(2008-6#1)(2008-7#1)(2009-6#1)(2010-12#1)(2011-7#1)(2013-8#2)
the hope that other##2##4##(2007-7#1)(2008-11#1)
the hope that##13##3##(1992-12#1)(2006-4#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-2#1)(2012-12#1)(2013-8#1)
the hope##28##2##(1992-12#1)(1993-10#1)(1993-12#1)(1996-3#1)(2005-9#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-2#1)(2011-7#1)(2012-12#2)(2013-8#3)
the hopes of##2##3##(1992-2#1)(2011-2#1)
the horizon of##6##3##(1994-10#1)(2008-12#1)(2008-9#1)(2010-8#1)(2012-2#2)
the horizon##17##2##(1994-10#1)(2006-10#3)(2006-6#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#3)
the horizons##2##2##(2008-4#1)(2008-7#1)
the horizontal and the vertical directions##4##6##(2008-2#1)(2008-3#3)
the horizontal and the vertical##6##5##(1993-7#1)(2008-2#2)(2008-3#3)
the horizontal and vertical##5##4##(1994-2#1)(2004-3#1)(2007-3#1)(2008-8#1)(2008-9#1)
the horizontal and##11##3##(1993-7#1)(1994-2#1)(2004-3#1)(2007-3#1)(2008-2#2)(2008-3#3)(2008-8#1)(2008-9#1)
the horizontal axis##2##3##(2004-11#1)(2008-11#1)
the horizontal component of the##3##5##(1990-5#1)(1991-1#1)(1994-2#1)
the horizontal direction##4##3##(1996-5#1)(2008-2#1)(2008-3#2)
the horizontal distance between##2##4##(2008-3#1)(2008-5#1)
the horizontal nucleus of the diagonal band of##2##8##(1994-3#2)
the horizontal plane##13##3##(2006-5#1)(2007-1#1)(2007-11#2)(2007-7#1)(2008-3#4)(2008-9#1)(2012-2#2)(2013-8#1)
the horizontal##71##2##(1990-5#1)(1990-7#1)(1991-1#2)(1991-3#1)(1992-10#4)(1993-1#2)(1993-7#1)(1994-2#2)(1994-3#2)(1996-5#1)(1997-3#1)(2004-11#1)(2004-3#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#8)(2008-3#13)(2008-5#2)(2008-8#1)(2008-9#3)(2009-6#1)(2009-7#1)(2010-12#1)(2012-11#1)(2012-2#3)(2013-7#1)(2013-8#2)
the hormesis effect of##2##4##(2013-8#2)
the hormesis##3##2##(2008-7#1)(2013-8#2)
the hormetic intensity##2##3##(2008-7#2)
the hormetic response##2##3##(2008-7#1)(2010-12#1)
the hormetic zone##2##3##(2008-7#2)
the hormetic##9##2##(2008-7#8)(2010-12#1)
the hormonal changes##2##3##(2007-2#1)(2008-11#1)
the hormonal effects##2##3##(1991-3#1)(2008-11#1)
the hormonal form of vitamin##2##5##(1992-9#1)(2012-12#1)
the hormonal milieu##2##3##(1994-11#1)(2012-2#1)
the hormonal regulation of##2##4##(2005-10#1)(2011-2#1)
the hormonal status##3##3##(2007-11#2)(2013-8#1)
the hormonal##35##2##(1990-2#1)(1990-4#2)(1990-7#1)(1991-3#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-11#1)(1995-2#1)(2005-10#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-2#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2009-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
the hormone and##2##3##(1994-12#1)(1994-9#1)
the hormone binding domain of the##3##6##(1990-7#1)(1991-7#1)(1996-5#1)
the hormone binding domain of##5##5##(1990-7#2)(1991-7#1)(1995-10#1)(1996-5#1)
the hormone binding##7##3##(1990-7#3)(1991-7#1)(1995-10#1)(1995-2#1)(1996-5#1)
the hormone effect##3##3##(1992-6#1)(1994-9#1)(1995-12#1)
the hormone in##3##3##(1990-2#1)(1993-6#1)(2010-5#1)
the hormone is##4##3##(1990-8#1)(1992-4#1)(2008-10#1)(2008-3#1)
the hormone##64##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#3)(1990-8#1)(1991-10#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#3)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-5#2)(1997-1#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#4)(2008-4#1)(2008-7#1)(2009-5#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2013-8#1)
the hormone's##2##2##(1991-4#1)(2013-8#1)
the hormone-binding domain of##2##4##(1990-7#1)(1997-7#1)
the hormone-binding domain##3##3##(1990-7#1)(1995-10#1)(1997-7#1)
the hormone-binding##4##2##(1990-7#1)(1995-10#1)(1997-7#1)(2012-2#1)
the hormone-dependent transcriptional##2##3##(1993-8#1)(1996-4#1)
the hormone-dependent##4##2##(1993-1#1)(1993-8#1)(1996-4#1)(1996-5#1)
the hormones of the##2##4##(2008-1#1)(2008-6#1)
the hormones of##3##3##(2007-1#1)(2008-1#1)(2008-6#1)
the hormones##13##2##(1993-11#1)(1994-8#1)(1995-11#1)(1995-12#1)(2007-1#1)(2008-1#3)(2008-10#1)(2008-6#1)(2009-12#1)(2009-8#1)(2012-2#1)
the horn##2##2##(2004-11#1)(2011-1#1)
the horse protein##2##3##(1990-7#1)(1997-4#1)
the horse was##3##3##(2004-2#1)(2012-12#2)
the horse##20##2##(1990-7#1)(1992-12#2)(1996-10#1)(1997-4#2)(2004-2#4)(2006-5#1)(2008-10#1)(2008-8#5)(2010-4#1)(2012-12#2)
the horseradish peroxidase##3##3##(1992-11#1)(2006-8#1)(2008-10#1)
the horseradish##4##2##(1991-5#1)(1992-11#1)(2006-8#1)(2008-10#1)
the horses##3##2##(2006-10#1)(2007-2#1)(2012-3#1)
the hospice##5##2##(1990-10#2)(2009-7#1)(2010-2#1)(2012-12#1)
the hospital (P &lt##2##4##(2007-10#1)(2013-8#1)
the hospital and community##2##4##(1995-1#1)(2008-5#1)
the hospital and the##9##4##(1991-1#1)(1993-1#1)(1993-2#1)(1993-8#1)(2007-12#1)(2008-10#1)(2009-4#2)(2011-2#1)
the hospital and to##2##4##(1996-4#1)(2006-10#1)
the hospital and##36##3##(1990-12#1)(1990-8#1)(1991-1#1)(1992-2#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-8#1)(1995-1#2)(1995-2#2)(1995-6#1)(1996-2#1)(1996-4#1)(1996-6#1)(2005-6#1)(2005-9#1)(2006-10#2)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-4#2)(2009-7#1)(2010-7#1)(2011-2#2)
the hospital are##2##3##(1992-2#1)(2007-8#1)
the hospital as a##2##4##(1994-3#1)(1995-2#1)
the hospital as the##2##4##(1996-3#1)(2007-4#1)
the hospital as##5##3##(1994-3#1)(1995-2#1)(1995-9#1)(1996-3#1)(2007-4#1)
the hospital before##2##3##(1990-8#1)(2010-7#1)
the hospital environment##11##3##(1991-1#1)(1992-3#1)(1996-1#1)(2006-9#1)(2007-4#1)(2008-2#1)(2010-11#1)(2010-8#1)(2012-12#2)(2013-8#1)
the hospital experience##2##3##(2011-2#2)
the hospital for the##2##4##(2007-12#1)(2009-6#1)
the hospital for##11##3##(1996-11#1)(2005-6#1)(2006-10#1)(2007-12#1)(2007-7#1)(2009-6#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-1#2)
the hospital had##2##3##(1995-12#1)(2007-4#1)
the hospital immediately##2##3##(1993-12#1)(2009-3#1)
the hospital in good##2##4##(1993-6#1)(2010-12#1)
the hospital in##11##3##(1991-12#1)(1993-6#1)(2006-10#2)(2006-5#1)(2007-11#1)(2008-12#1)(2008-5#1)(2010-12#1)(2010-9#1)(2011-2#1)
the hospital industry has been##2##5##(1992-12#1)(2008-11#1)
the hospital industry##5##3##(1992-12#1)(1994-12#1)(1995-12#1)(2008-11#2)
the hospital information##2##3##(1996-2#1)(2012-3#1)
the hospital is##5##3##(1993-12#1)(1996-4#1)(2008-11#1)(2013-1#2)
the hospital laboratory##2##3##(1997-1#1)(2008-10#1)
the hospital leadership##2##3##(1990-12#1)(2010-8#1)
the hospital of##6##3##(1996-12#1)(2006-8#1)(2007-2#1)(2008-4#1)(2012-2#2)
the hospital or##4##3##(1994-12#1)(2004-9#1)(2006-10#1)(2013-8#1)
the hospital performance##2##3##(1993-3#2)
the hospital received##2##3##(2007-12#1)(2010-9#1)
the hospital record##2##3##(1991-3#1)(2011-1#1)
the hospital records##2##3##(2008-10#1)(2011-1#1)
the hospital security##3##3##(1993-2#1)(1995-2#1)(1997-2#1)
the hospital services and##2##4##(1993-1#1)(1995-2#1)
the hospital services##3##3##(1993-1#1)(1995-2#1)(2012-3#1)
the hospital setting##12##3##(1991-1#1)(1991-12#1)(1994-2#1)(1996-2#1)(2006-10#1)(2007-7#1)(2008-11#1)(2008-3#1)(2010-9#1)(2012-10#1)(2013-1#2)
the hospital stay##7##3##(1990-9#1)(1996-11#1)(2006-10#1)(2006-6#1)(2007-8#1)(2010-8#1)(2012-2#1)
the hospital system##2##3##(1996-12#1)(2009-7#1)
the hospital the##2##3##(1995-11#1)(1997-7#1)
the hospital through the##2##4##(1990-12#1)(2008-3#1)
the hospital through##3##3##(1990-12#1)(1996-2#1)(2008-3#1)
the hospital to##10##3##(1993-7#1)(1994-12#1)(1995-1#1)(1995-12#1)(1996-5#1)(2008-8#2)(2009-4#1)(2010-9#1)(2012-2#1)
the hospital was not##2##4##(1993-1#1)(1995-3#1)
the hospital was##3##3##(1993-1#1)(1995-3#2)
the hospital were##5##3##(2006-8#1)(2007-12#1)(2008-12#1)(2009-5#1)(2012-1#1)
the hospital where##2##3##(1991-7#1)(2008-7#1)
the hospital with##12##3##(1992-3#2)(1996-5#1)(2007-10#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
the hospital within##3##3##(1993-9#1)(2010-12#1)(2012-2#1)
the hospital##448##2##(1990-10#2)(1990-12#8)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#2)(1991-1#6)(1991-11#2)(1991-12#6)(1991-2#2)(1991-3#2)(1991-6#1)(1991-7#3)(1992-1#4)(1992-10#1)(1992-12#3)(1992-2#8)(1992-3#9)(1992-5#3)(1993-1#5)(1993-12#3)(1993-2#6)(1993-3#5)(1993-5#1)(1993-6#5)(1993-7#2)(1993-8#1)(1993-9#1)(1994-1#3)(1994-12#6)(1994-2#3)(1994-3#5)(1994-5#1)(1994-6#1)(1995-1#5)(1995-10#1)(1995-11#2)(1995-12#7)(1995-2#10)(1995-3#3)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#2)(1996-11#4)(1996-12#4)(1996-2#8)(1996-3#5)(1996-4#3)(1996-5#4)(1996-6#2)(1997-1#1)(1997-2#4)(1997-4#2)(1997-7#2)(1997-8#1)(2004-9#2)(2005-10#1)(2005-6#2)(2005-7#1)(2005-9#1)(2006-10#11)(2006-2#1)(2006-4#4)(2006-5#1)(2006-6#3)(2006-8#6)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#2)(2007-12#9)(2007-2#4)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#4)(2007-9#5)(2008-1#2)(2008-10#5)(2008-11#9)(2008-12#5)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#4)(2008-7#6)(2008-8#10)(2009-10#2)(2009-11#1)(2009-3#2)(2009-4#5)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-7#4)(2010-8#6)(2010-9#6)(2011-1#13)(2011-12#3)(2011-2#13)(2011-3#1)(2011-7#1)(2012-1#1)(2012-10#1)(2012-11#1)(2012-12#9)(2012-2#10)(2012-3#5)(2013-1#23)(2013-8#12)
the hospital's medical##2##3##(1994-1#1)(1996-3#1)
the hospital's##37##2##(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1993-1#3)(1993-12#2)(1994-1#2)(1994-12#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(2007-1#1)(2007-11#2)(2007-2#1)(2007-4#1)(2008-12#2)(2008-3#1)(2008-7#1)(2010-4#1)(2011-2#1)(2013-8#2)
the hospital-based model##2##3##(2013-7#2)
the hospital-based##6##2##(1992-5#2)(2007-10#1)(2008-7#1)(2013-7#2)
the hospital?##3##2##(1994-6#2)(2010-9#1)
the hospital]##4##2##(1990-2#1)(1994-6#1)(2010-6#1)(2012-12#1)
the hospitalist##3##2##(2008-3#2)(2013-1#1)
the hospitalization and##2##3##(2006-8#1)(2008-8#1)
the hospitalization##9##2##(1993-3#1)(1995-1#1)(1995-3#1)(2005-7#1)(2006-8#1)(2008-10#1)(2008-8#1)(2010-10#1)(2011-2#1)
the hospitalizations##3##2##(1991-4#1)(1995-12#1)(1996-3#1)
the hospitalized patients##2##3##(1991-4#1)(2007-7#1)
the hospitalized##6##2##(1991-4#1)(1994-12#1)(2007-10#1)(2007-7#1)(2012-12#1)(2012-2#1)
the hospitals and##2##3##(1991-2#1)(1995-8#1)
the hospitals are##2##3##(1991-5#1)(2008-12#1)
the hospitals as##3##3##(2009-5#1)(2011-1#1)(2012-3#1)
the hospitals in##4##3##(1995-1#1)(2006-10#1)(2011-1#1)(2012-3#1)
the hospitals management##2##3##(2010-8#1)(2011-1#1)
the hospitals studied##2##3##(2011-2#2)
the hospitals that##2##3##(1995-1#1)(2007-12#1)
the hospitals to##2##3##(1993-1#1)(2012-3#1)
the hospitals were##2##3##(1997-8#1)(2011-1#1)
the hospitals##42##2##(1990-4#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-9#1)(1992-12#1)(1993-1#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-8#1)(1996-1#1)(1997-2#1)(1997-8#1)(2006-10#2)(2006-8#1)(2007-12#1)(2007-7#2)(2008-12#2)(2008-2#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-1#4)(2011-2#3)(2012-2#1)(2012-3#5)
the host against##5##3##(1995-12#1)(2007-11#1)(2008-12#1)(2009-5#1)(2013-1#1)
the host amidase##3##3##(1990-1#3)
the host and the pathogen##2##5##(2008-8#1)(2013-1#1)
the host and the##5##4##(2006-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#1)
the host and##20##3##(1997-4#1)(2006-10#3)(2006-8#1)(2007-12#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
the host animal##4##3##(1997-4#1)(2008-11#1)(2008-4#2)
the host at##3##3##(2008-10#1)(2013-1#2)
the host by##7##3##(1995-12#1)(2008-1#1)(2008-10#2)(2011-2#1)(2012-2#1)(2013-1#1)
the host cell cytoplasm and##2##5##(2008-7#1)(2011-2#1)
the host cell in##2##4##(2009-6#1)(2013-1#1)
the host cell wall##6##4##(2008-10#5)(2010-3#1)
the host cell##32##3##(1990-2#1)(1992-5#1)(1994-11#1)(1997-4#1)(2006-10#1)(2006-4#1)(2008-1#1)(2008-10#7)(2008-11#6)(2008-7#1)(2008-9#2)(2009-6#2)(2010-1#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#3)
the host cells are##2##4##(1994-12#1)(2012-12#1)
the host cells##9##3##(1991-3#1)(1991-5#1)(1994-12#1)(1994-3#1)(1994-6#1)(1997-1#2)(2008-10#1)(2012-12#1)
the host chromosome##3##3##(1995-2#1)(2008-2#1)(2008-4#1)
the host crop##3##3##(2008-10#3)
the host cytoplasm##4##3##(1996-12#2)(2008-10#1)(2013-1#1)
the host defence system##2##4##(1992-4#1)(2008-8#1)
the host defense system##3##4##(1991-5#1)(1992-10#1)(2013-1#1)
the host defense##8##3##(1991-5#1)(1992-10#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-2#1)(2013-1#2)
the host environment##2##3##(2007-1#1)(2008-8#1)
the host enzyme##2##3##(1996-6#2)
the host factor##2##3##(1997-7#1)(2012-2#1)
the host for##2##3##(2005-9#1)(2008-10#1)
the host from##5##3##(1995-12#1)(2008-10#2)(2008-8#1)(2009-9#1)
the host gene##3##3##(1991-6#1)(2008-10#1)(2013-1#1)
the host genome##7##3##(1990-10#1)(1993-6#2)(2007-11#1)(2008-2#1)(2011-1#1)(2012-12#1)
the host image##2##3##(2008-2#2)
the host immune response##4##4##(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
the host immune system##6##4##(1992-4#1)(2005-7#1)(2006-10#2)(2007-11#1)(2008-1#1)
the host immune##10##3##(1992-4#1)(2005-7#1)(2006-10#2)(2007-11#1)(2008-1#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
the host in##4##3##(2006-2#1)(2008-10#2)(2011-2#1)
the host infection process##4##4##(2010-10#4)
the host innate immune##2##4##(2008-4#1)(2010-1#1)
the host innate##3##3##(2008-4#1)(2010-1#1)(2012-12#1)
the host is##6##3##(1992-1#1)(1996-3#1)(2008-10#2)(2008-4#1)(2008-9#1)
the host membrane##2##3##(1991-10#1)(1997-1#1)
the host might##2##3##(1997-6#1)(2008-8#1)
the host of origin##5##4##(2008-10#3)(2008-4#1)(2008-9#1)
the host of##6##3##(2008-10#3)(2008-4#1)(2008-8#1)(2008-9#1)
the host or##4##3##(2008-10#2)(2008-11#1)(2008-8#1)
the host organism##5##3##(1991-9#2)(1996-3#1)(2006-2#1)(2008-1#1)
the host origin##2##3##(2005-11#1)(2008-10#1)
the host phytoalexin response##2##4##(2008-10#2)
the host plant##16##3##(2007-12#1)(2008-10#11)(2008-8#1)(2009-8#2)(2011-2#1)
the host polymer##2##3##(2008-10#1)(2009-2#1)
the host population##12##3##(1994-2#1)(2008-1#1)(2008-10#4)(2008-8#2)(2008-9#2)(2011-2#2)
the host range and##2##4##(2008-5#1)(2011-1#1)
the host range expanded##2##4##(2008-11#2)
the host range of##6##4##(1990-11#1)(1997-1#1)(1997-4#2)(2006-10#1)(2008-10#1)
the host range##13##3##(1990-11#1)(1997-1#1)(1997-4#2)(2006-10#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#1)(2011-1#1)
the host response to##11##4##(1990-12#1)(1990-2#1)(1991-12#1)(1994-2#1)(1995-2#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)
the host response##18##3##(1990-12#1)(1990-2#1)(1991-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-11#2)(2008-10#1)(2008-4#1)(2008-5#2)(2008-8#1)(2011-1#1)(2011-2#1)
the host shift##3##3##(2008-8#3)
the host species to##2##4##(2005-7#1)(2008-8#1)
the host species##9##3##(2005-7#1)(2007-1#1)(2008-10#3)(2008-8#4)
the host strain##4##3##(1993-3#1)(1994-2#1)(1997-4#1)(2008-9#1)
the host surface##3##3##(2008-10#2)(2010-10#1)
the host system##2##3##(2007-11#1)(2008-3#1)
the host through##2##3##(2008-8#1)(2010-12#1)
the host tissue##3##3##(2005-7#1)(2008-10#2)
the host tissues##4##3##(2008-10#4)
the host to##4##3##(2007-12#1)(2008-10#2)(2009-3#1)
the host wall##2##3##(2008-10#2)
the host was##5##3##(1991-11#1)(2006-7#1)(2007-7#1)(2008-10#2)
the host##478##2##(1990-1#3)(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-7#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-1#1)(1992-10#2)(1992-3#1)(1992-4#2)(1992-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#2)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#3)(1994-8#1)(1995-12#5)(1995-2#5)(1996-10#2)(1996-12#3)(1996-3#2)(1996-4#1)(1996-6#2)(1996-8#1)(1997-1#4)(1997-4#6)(1997-6#2)(1997-7#1)(2005-11#6)(2005-7#3)(2005-9#1)(2006-10#16)(2006-12#2)(2006-2#2)(2006-4#2)(2006-7#1)(2006-8#2)(2007-1#2)(2007-11#7)(2007-12#15)(2007-3#1)(2007-6#2)(2007-7#3)(2007-9#1)(2008-1#6)(2008-10#122)(2008-11#12)(2008-12#2)(2008-2#9)(2008-3#4)(2008-4#14)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#29)(2008-9#13)(2009-11#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#8)(2009-9#3)(2010-1#2)(2010-10#7)(2010-12#5)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#17)(2012-1#4)(2012-11#1)(2012-12#9)(2012-2#8)(2013-1#18)(2013-8#3)
the host's immune response##2##4##(2009-9#1)(2013-7#1)
the host's immune system##8##4##(2006-10#3)(2007-11#2)(2008-5#1)(2010-10#1)(2012-12#1)
the host's immune##10##3##(2006-10#3)(2007-11#2)(2008-5#1)(2009-9#1)(2010-10#1)(2012-12#1)(2013-7#1)
the host's sex##2##3##(2008-5#1)(2008-8#1)
the host's##23##2##(1991-11#1)(2006-10#3)(2006-6#1)(2007-10#1)(2007-11#2)(2007-2#1)(2008-2#1)(2008-5#2)(2008-8#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#1)(2012-12#3)(2013-7#2)
the host)##3##2##(2008-8#1)(2011-2#1)(2012-2#1)
the host-free period##3##3##(2008-10#3)
the host-guest##2##2##(2008-10#1)(2010-4#1)
the host-parasite relationship##3##3##(1997-7#1)(2006-10#1)(2008-10#1)
the host-parasite##8##2##(1996-4#1)(1997-7#1)(2006-10#3)(2008-10#1)(2008-12#1)(2011-2#1)
the host-pathogen interaction##4##3##(2008-10#3)(2013-1#1)
the host-pathogen##6##2##(2008-10#3)(2010-8#1)(2013-1#2)
the host-selective##2##2##(2008-10#2)
the hostage group##2##3##(2008-1#2)
the hostile##3##2##(2005-10#1)(2008-4#1)(2011-2#1)
the hosts and##2##3##(2008-10#1)(2012-3#1)
the hosts of##3##3##(1990-3#1)(2008-10#1)(2008-5#1)
the hosts##14##2##(1990-3#1)(2007-3#1)(2007-6#2)(2008-10#4)(2008-4#1)(2008-5#3)(2011-2#1)(2012-3#1)
the hosts'##3##2##(1996-12#1)(2008-10#2)
the hot and wet season##2##5##(2007-3#2)
the hot and##4##3##(2007-3#2)(2007-7#1)(2008-8#1)
the hot plate test##13##4##(1990-2#2)(1992-3#1)(1993-9#3)(1994-2#5)(1996-2#2)
the hot plate##16##3##(1990-2#2)(1991-2#2)(1992-3#1)(1993-9#3)(1994-2#5)(1996-2#2)(2010-5#1)
the hot##29##2##(1990-2#2)(1991-2#2)(1992-3#1)(1993-9#3)(1994-2#5)(1996-2#2)(2007-12#1)(2007-3#2)(2007-7#1)(2008-10#3)(2008-8#2)(2009-12#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-2#1)
the hot-plate##5##2##(1990-2#1)(1991-8#1)(1993-5#2)(2013-1#1)
the hottest##5##2##(2005-8#1)(2007-1#1)(2008-5#1)(2009-5#1)(2013-8#1)
the hour##8##2##(1990-12#1)(1993-6#2)(2007-7#1)(2008-10#1)(2010-7#1)(2012-1#1)(2012-3#1)
the hourly rate of##2##4##(2004-11#1)(2008-10#1)
the hourly##3##2##(2004-11#1)(2008-10#2)
the hours following##3##3##(1993-5#2)(1994-6#1)
the hours immediately##2##3##(1992-8#1)(2010-6#1)
the hours##8##2##(1992-8#1)(1993-5#2)(1994-6#1)(2006-11#1)(2006-4#1)(2010-6#1)(2013-8#1)
the house and##2##3##(2006-12#1)(2008-1#1)
the house dust mite##3##4##(2008-3#1)(2010-5#2)
the house dust##5##3##(1993-9#1)(2007-2#1)(2008-3#1)(2010-5#2)
the house fly##3##3##(1994-3#3)
the house mouse##2##3##(2009-5#1)(2011-1#1)
the house officers##2##3##(1995-6#2)
the house##23##2##(1993-9#2)(1994-3#3)(1995-6#2)(2006-10#1)(2006-12#1)(2007-2#1)(2007-4#1)(2008-1#2)(2008-3#3)(2009-10#1)(2009-4#1)(2009-5#1)(2010-5#2)(2011-1#1)(2011-2#1)
the house-shrew (Suncus murinus)##2##4##(1992-8#2)
the housefly##3##2##(1994-8#2)(2008-8#1)
the household and##4##3##(1991-12#1)(1993-5#1)(1997-4#1)(2012-3#1)
the household head##2##3##(2009-11#1)(2012-3#1)
the household survey##2##3##(2012-3#2)
the household##24##2##(1991-12#1)(1993-5#1)(1994-6#1)(1995-7#1)(1997-4#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-11#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#5)(2013-8#1)
the households##5##2##(2007-2#2)(2009-9#1)(2011-12#1)(2011-2#1)
the housekeeping##4##2##(1995-11#1)(1997-4#1)(2005-11#1)(2007-10#1)
the houses##6##2##(1993-9#1)(1996-3#1)(2007-10#1)(2008-5#1)(2012-2#2)
the housing system##2##3##(2010-4#1)(2013-1#1)
the housing##4##2##(2009-4#1)(2010-4#1)(2010-8#1)(2013-1#1)
the hph gene##2##3##(1997-2#1)(2008-10#1)
the hph##3##2##(1997-2#1)(2008-10#2)
the hph-1 mouse##4##3##(1996-9#4)
the hprt locus##2##3##(1997-3#2)
the hprt##4##2##(1996-2#1)(1997-3#3)
the hrdDp1##2##2##(1991-7#2)
the hrp##2##2##(2008-10#2)
the hrr25##2##2##(1991-8#2)
the hslTS/ibpAB##2##2##(1993-11#2)
the hsp65##2##2##(1994-11#2)
the hsp70 expression##2##3##(2013-1#2)
the hsp70 promoter##2##3##(1991-12#1)(1994-8#1)
the hsp70##17##2##(1991-12#1)(1993-3#1)(1994-11#3)(1994-8#4)(1995-2#1)(1995-6#2)(1995-7#1)(1996-5#1)(2013-1#3)
the htrA##3##2##(1991-4#3)
the hub of##2##3##(1992-1#1)(2004-3#1)
the hub##4##2##(1992-1#1)(2004-3#1)(2007-1#1)(2012-2#1)
the huge##13##2##(2005-10#1)(2006-4#1)(2006-8#1)(2007-12#2)(2008-10#1)(2008-7#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-2#1)
the human 1##5##3##(1990-12#2)(1993-3#3)
the human 5-HT1D alpha##2##4##(1996-10#1)(1997-5#1)
the human A(3) receptor##3##4##(2008-4#3)
the human A(3)##4##3##(2008-4#4)
the human AT1 receptor##2##4##(1992-2#2)
the human Ah receptor##3##4##(1992-11#1)(1994-8#2)
the human B cell##2##4##(1995-2#1)(1995-5#1)
the human B lymphoma cells##2##5##(1991-3#2)
the human B##4##3##(1991-3#2)(1995-2#1)(1995-5#1)
the human CD2##2##3##(1995-3#2)
the human CEA##2##3##(1991-7#1)(1994-12#1)
the human CNP gene##2##4##(1993-7#2)
the human CNP##3##3##(1993-7#3)
the human CYP1A1 gene##2##4##(1994-6#1)(1995-5#1)
the human CYP1A1##3##3##(1994-6#1)(1995-5#1)(2008-11#1)
the human EEG##2##3##(1992-8#1)(2010-8#1)
the human EGF receptor##2##4##(1990-10#1)(1992-8#1)
the human GM-CSF##2##3##(1994-12#2)
the human HMG2 gene##2##4##(1995-2#2)
the human IFN alpha##2##4##(1992-11#2)
the human IFN gamma##2##4##(1994-9#2)
the human IFN##4##3##(1992-11#2)(1994-9#2)
the human IL4##2##3##(1993-2#1)(2008-7#1)
the human LDL receptor##2##4##(1990-11#1)(2008-8#1)
the human LDL##4##3##(1990-11#1)(1992-5#1)(2008-10#1)(2008-8#1)
the human LPL##2##3##(1995-6#1)(2008-11#1)
the human MEKA gene##2##4##(1990-7#2)
the human MNS##2##3##(2008-11#2)
the human NGF gene##2##4##(1990-8#1)(1993-12#1)
the human NGF##3##3##(1990-8#2)(1993-12#1)
the human PRLR##5##3##(1995-10#5)
the human T cell##3##4##(1996-5#1)(2007-11#1)(2008-4#1)
the human T##7##3##(1991-1#1)(1995-3#2)(1996-5#1)(2007-11#1)(2008-4#1)(2011-1#1)
the human T-cell##2##3##(1992-12#1)(1997-2#1)
the human T-lymphocyte cell line Jurkat##2##6##(1992-2#2)
the human T-lymphocyte cell line##3##5##(1992-2#3)
the human TH transgenic##2##4##(1997-5#2)
the human THP-1 cell##2##4##(1993-6#2)
the human TSH receptor##5##4##(1990-9#1)(1992-2#1)(1993-3#2)(1996-5#1)
the human X chromosome##2##4##(1997-4#1)(2010-5#1)
the human X##4##3##(1995-11#1)(1997-4#1)(2008-7#1)(2010-5#1)
the human acetylcholine receptor##2##4##(1996-4#2)
the human adrenal##3##3##(1990-12#1)(1994-5#1)(1995-12#1)
the human adult##2##3##(1994-9#1)(2007-1#1)
the human alpha##3##3##(1992-11#1)(1995-11#2)
the human alpha-catenin##2##3##(1993-6#2)
the human alpha-globin cluster##2##4##(1992-5#2)
the human anatomical##2##3##(2007-8#1)(2013-1#1)
the human anatomy##3##3##(2007-4#1)(2013-7#1)(2013-8#1)
the human and animal##3##4##(2010-2#1)(2011-2#1)(2012-1#1)
the human and bovine##2##4##(1991-6#1)(1995-11#1)
the human and economic##2##4##(1994-2#1)(2007-12#1)
the human and mouse Ah receptor##2##6##(1992-11#2)
the human and mouse enzymes##2##5##(1990-11#1)(1994-9#1)
the human and mouse##13##4##(1990-11#2)(1992-11#3)(1992-4#1)(1992-8#1)(1993-2#1)(1994-9#1)(1997-7#1)(2008-4#1)(2008-7#1)(2012-3#1)
the human and rat##6##4##(1990-7#1)(1991-12#1)(1995-10#1)(1997-5#1)(2008-4#1)(2011-12#1)
the human and the##3##4##(1991-12#1)(1991-4#1)(1993-4#1)
the human and yeast##2##4##(1993-6#2)
the human and##46##3##(1990-11#2)(1990-7#1)(1991-10#2)(1991-12#2)(1991-4#1)(1991-5#1)(1991-6#1)(1992-11#4)(1992-12#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-4#1)(1993-6#2)(1994-2#1)(1994-9#1)(1995-10#2)(1995-11#1)(1995-2#1)(1996-12#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-12#1)(2007-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-2#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
the human androgen receptor##4##4##(1991-9#1)(1995-3#2)(2008-4#1)
the human apoA-II promoter##4##4##(1997-7#4)
the human apoE##2##3##(1995-6#1)(2008-9#1)
the human apolipoprotein##4##3##(1990-8#2)(1997-7#1)(2007-2#1)
the human arm##3##3##(2012-1#3)
the human attention##2##3##(2010-3#1)(2012-12#1)
the human auditory##5##3##(1993-9#1)(1995-11#1)(1995-12#1)(1997-1#2)
the human axilla##2##3##(2006-12#1)(2008-5#1)
the human bcl-2##2##3##(1997-7#1)(2008-5#1)
the human being##5##3##(2007-8#1)(2007-9#1)(2010-8#1)(2011-1#1)(2013-1#1)
the human beta##3##3##(1991-7#1)(1992-11#1)(1995-5#1)
the human beta-amyloid precursor protein##2##5##(1992-12#2)
the human beta-myosin heavy chain##2##5##(1992-11#2)
the human blood group##2##4##(1991-12#1)(2005-7#1)
the human blood##4##3##(1991-12#1)(2005-7#1)(2007-11#1)(2007-7#1)
the human blue opsin gene##2##5##(1994-3#2)
the human body against##2##4##(2006-7#1)(2008-11#1)
the human body and##7##4##(1991-9#1)(1994-3#1)(2008-10#1)(2008-12#1)(2012-3#2)(2013-1#1)
the human body##59##3##(1990-2#1)(1990-3#1)(1991-9#1)(1994-3#2)(1997-8#2)(2004-8#1)(2005-11#1)(2005-12#1)(2006-6#2)(2006-7#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-2#1)(2008-5#7)(2008-7#1)(2008-8#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#3)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
the human bone##4##3##(1994-2#1)(1996-2#2)(2008-11#1)
the human brain and##5##4##(1992-11#2)(1997-5#1)(2008-7#1)(2012-12#1)
the human brain is##4##4##(1991-5#1)(1996-5#1)(2005-9#1)(2008-8#1)
the human brain than##2##4##(2006-11#2)
the human brain using##2##4##(1992-8#1)(2005-9#1)
the human brain was##2##4##(1996-5#1)(2006-7#1)
the human brain##45##3##(1991-2#1)(1991-5#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#4)(1993-5#1)(1994-2#1)(1994-3#2)(1995-11#1)(1995-12#1)(1996-5#3)(1997-2#1)(1997-5#1)(1997-8#2)(2005-9#2)(2006-11#2)(2006-3#1)(2006-7#1)(2007-1#1)(2008-11#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-5#1)(2010-7#1)(2011-1#1)(2012-11#1)(2012-12#1)
the human breast carcinoma cell##2##5##(1991-5#1)(1991-8#1)
the human breast##8##3##(1991-5#1)(1991-8#1)(1993-9#1)(2004-1#2)(2008-11#1)(2008-2#1)(2008-3#1)
the human c-fos and c-myc proto-oncogene promoters##2##7##(1994-6#2)
the human c-fos gene##2##4##(1991-12#2)
the human c-fos##5##3##(1991-12#3)(1994-6#2)
the human c-myc gene##6##4##(1992-7#1)(1992-8#3)(1997-5#2)
the human c-myc##7##3##(1992-7#1)(1992-8#3)(1997-5#2)(1997-7#1)
the human cDNA##6##3##(1991-6#1)(1994-3#1)(1995-10#1)(1996-4#1)(1996-5#1)(1997-6#1)
the human cancer##2##3##(1997-4#1)(2012-2#1)
the human cancers##2##3##(2009-12#1)(2010-1#1)
the human cell line AGE1##3##5##(2012-3#3)
the human cell line##4##4##(2008-11#1)(2012-3#3)
the human cell##7##3##(1990-11#1)(1994-6#1)(2008-10#1)(2008-11#1)(2012-3#3)
the human central nervous system##5##5##(1991-12#1)(1991-7#1)(2007-11#1)(2011-2#1)(2012-11#1)
the human cerebral cortex##3##4##(1990-4#2)(1996-8#1)
the human cervical##3##3##(2007-1#3)
the human chromosome##3##3##(1996-8#1)(1997-8#1)(2009-9#1)
the human ciliary##3##3##(1995-12#1)(1995-5#1)(1997-1#1)
the human colon cancer cell line##2##6##(1992-8#1)(1997-2#1)
the human colon##7##3##(1990-8#1)(1992-2#2)(1992-8#1)(1997-2#1)(2006-8#2)
the human colonic##3##3##(1990-10#1)(1990-7#1)(1991-7#1)
the human condition and##2##4##(2008-4#1)(2012-3#1)
the human condition is##2##4##(2008-1#1)(2008-10#1)
the human condition##4##3##(2008-1#1)(2008-10#1)(2008-4#1)(2012-3#1)
the human cornea##7##3##(2007-9#3)(2008-2#1)(2013-8#3)
the human cortex##2##3##(1995-12#1)(2012-2#1)
the human development##2##3##(2008-8#1)(2008-9#1)
the human diet##7##3##(1990-9#1)(1991-11#1)(1992-8#1)(1993-11#1)(2008-10#1)(2011-2#1)(2012-12#1)
the human disorder##2##3##(1993-12#1)(2008-4#1)
the human dopamine##3##3##(1991-12#1)(1993-3#1)(1997-5#1)
the human efp##2##3##(1997-7#2)
the human embryo##2##3##(1990-11#1)(2008-9#1)
the human embryonic kidney 293##2##5##(1992-3#1)(2008-11#1)
the human embryonic##5##3##(1992-3#1)(1994-12#1)(2008-11#3)
the human endometrium##5##3##(1994-9#3)(2006-10#1)(2012-3#1)
the human environment##2##3##(2007-3#1)(2013-1#1)
the human enzyme and##4##4##(1994-8#2)(1995-5#1)(1995-8#1)
the human enzyme is##2##4##(1990-3#1)(1994-5#1)
the human enzyme##19##3##(1990-11#4)(1990-3#1)(1991-2#1)(1993-9#1)(1994-5#1)(1994-8#3)(1995-11#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-8#2)
the human epidermal growth factor receptor 2##3##7##(2008-5#1)(2011-2#1)(2013-1#1)
the human epidermal growth factor receptor##4##6##(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
the human epidermis##4##3##(1992-11#3)(2008-5#1)
the human erythrocyte membrane and##2##5##(1990-11#1)(2008-11#1)
the human erythrocyte membrane##4##4##(1990-11#1)(1990-12#1)(2008-11#2)
the human erythrocyte##12##3##(1990-11#3)(1990-12#1)(1991-2#2)(1991-8#1)(1994-5#1)(2006-10#1)(2007-9#1)(2008-11#2)
the human erythrocytes##2##3##(1994-8#1)(1996-12#1)
the human eye##12##3##(2006-11#1)(2007-11#2)(2007-12#4)(2008-2#1)(2008-3#2)(2011-7#1)(2013-8#1)
the human face##2##3##(1993-10#1)(2008-3#1)
the human factor##3##3##(1990-5#1)(1994-11#1)(2008-12#1)
the human femur##4##3##(1995-6#1)(2007-1#1)(2009-7#2)
the human ferredoxin gene##2##4##(1991-5#2)
the human fetus##3##3##(1993-4#1)(1994-10#1)(2008-1#1)
the human fibroblast growth factor receptor (flg)##2##7##(1991-1#2)
the human fibroblast growth factor receptor##3##6##(1991-1#3)
the human forearm##2##3##(1996-9#1)(2008-5#1)
the human gastric##4##3##(1992-8#1)(1995-8#1)(2008-11#1)(2009-4#1)
the human gastrointestinal tract##5##4##(2006-10#1)(2007-12#1)(2008-4#1)(2010-10#1)(2012-2#1)
the human gene##17##3##(1990-11#1)(1990-7#1)(1991-2#1)(1991-6#2)(1991-7#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1995-1#1)(1995-11#1)(1997-6#1)(1997-7#1)(2008-6#1)(2008-7#1)(2009-2#1)
the human genes##2##3##(2007-11#1)(2012-1#1)
the human genome and##6##4##(1991-4#1)(1992-3#1)(1995-6#1)(2006-7#1)(2008-7#1)(2009-9#1)
the human genome is##3##4##(2008-4#1)(2008-8#2)
the human genome project##9##4##(1993-9#1)(1995-8#1)(1997-6#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-8#1)(2008-11#1)
the human genome sequence##2##4##(2007-8#1)(2008-7#1)
the human genome##68##3##(1990-12#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#2)(1992-10#1)(1992-12#1)(1992-3#1)(1993-9#1)(1994-10#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-6#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#2)(2006-5#1)(2006-7#1)(2007-10#3)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-11#2)(2008-4#7)(2008-5#2)(2008-7#8)(2008-8#7)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
the human genomic DNA##4##4##(1992-11#2)(1992-4#1)(1996-2#1)
the human glioma##2##3##(1994-11#1)(1997-7#1)
the human glucagon receptor##2##4##(1995-3#1)(2008-11#1)
the human glucocorticoid receptor##4##4##(1990-11#1)(1995-10#1)(1995-2#2)
the human growth##4##3##(1993-4#1)(1995-3#1)(1997-1#1)(2008-11#1)
the human gut##6##3##(1997-8#2)(2006-10#3)(2010-12#1)
the human head##5##3##(1997-6#1)(2006-11#3)(2008-3#1)
the human health##8##3##(2008-1#2)(2008-10#2)(2010-12#1)(2011-2#1)(2013-1#2)
the human heart in##2##4##(1993-12#1)(1993-7#1)
the human heart##5##3##(1991-9#1)(1993-12#1)(1993-7#2)(1996-2#1)
the human hepatoblastoma##2##3##(1997-2#1)(2008-11#1)
the human hepatocyte growth##2##4##(1991-6#2)
the human hepatoma cell line##3##5##(1991-9#1)(1992-11#1)(1993-9#1)
the human histo-blood group ABO##2##5##(1992-11#1)(1992-8#1)
the human homolog of the##2##5##(1994-8#1)(1996-2#1)
the human homolog of##5##4##(1992-9#1)(1994-8#1)(1996-2#1)(1997-1#1)(2005-8#1)
the human homolog##6##3##(1992-9#1)(1994-8#1)(1996-10#1)(1996-2#1)(1997-1#1)(2005-8#1)
the human homologue of the##2##5##(1991-11#1)(1997-3#1)
the human homologue of##4##4##(1990-4#1)(1991-11#1)(1997-3#1)(1997-7#1)
the human homologue##6##3##(1990-4#1)(1991-11#1)(1995-1#1)(1997-3#1)(1997-7#1)(2009-5#1)
the human host preference##2##4##(2012-12#2)
the human host##7##3##(1996-2#1)(2007-2#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
the human hsp27##4##3##(1992-5#1)(1993-6#3)
the human hypothalamus##3##3##(1993-12#1)(2007-8#1)(2008-9#1)
the human imagination##2##3##(2009-10#1)(2009-8#1)
the human immune defences##2##4##(2012-12#2)
the human immune response##3##4##(1991-5#1)(2006-10#2)
the human immune system##6##4##(1997-3#1)(2008-10#2)(2008-4#2)(2011-2#1)
the human immune##12##3##(1991-5#1)(1997-3#1)(2006-10#2)(2008-10#2)(2008-4#2)(2011-2#1)(2012-1#1)(2012-12#2)
the human immunodeficiency virus (HIV)##16##5##(1990-6#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-12#1)(1993-8#1)(1994-3#1)(1996-1#1)(1996-11#1)(2005-10#1)(2006-8#1)(2007-11#1)(2008-5#1)(2012-2#1)(2013-7#1)
the human immunodeficiency virus and##2##5##(1993-6#1)(1997-7#1)
the human immunodeficiency virus in##2##5##(1990-9#1)(1992-6#1)
the human immunodeficiency virus or##2##5##(1992-2#1)(2006-10#1)
the human immunodeficiency virus type 1 (HIV-1)##3##7##(1992-8#1)(1995-8#1)(2012-1#1)
the human immunodeficiency virus type 1##5##6##(1991-10#1)(1992-8#1)(1993-8#1)(1995-8#1)(2012-1#1)
the human immunodeficiency virus type##6##5##(1991-10#1)(1992-8#1)(1993-12#1)(1993-8#1)(1995-8#1)(2012-1#1)
the human immunodeficiency virus##45##4##(1990-11#1)(1990-6#2)(1990-9#2)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-2#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-6#2)(1993-8#2)(1994-3#1)(1994-8#2)(1995-8#1)(1996-1#2)(1996-11#1)(1997-4#1)(1997-7#1)(2005-10#1)(2006-10#2)(2006-8#2)(2007-11#1)(2007-12#1)(2007-7#3)(2008-1#1)(2008-5#1)(2012-1#1)(2012-2#1)(2013-7#1)
the human immunodeficiency virus]##4##4##(1992-10#1)(1993-10#1)(1996-6#1)(1996-9#1)
the human immunodeficiency##54##3##(1990-11#1)(1990-6#2)(1990-9#2)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-2#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#2)(1993-6#2)(1993-8#2)(1994-12#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-6#1)(1996-9#1)(1997-4#2)(1997-7#1)(2005-10#1)(2006-10#2)(2006-8#2)(2007-11#2)(2007-12#1)(2007-7#3)(2008-1#1)(2008-5#1)(2009-6#1)(2012-1#1)(2012-2#1)(2013-7#1)
the human in vivo##2##4##(2008-3#1)(2010-12#1)
the human in##3##3##(2008-3#1)(2010-12#2)
the human insulin receptor##3##4##(1991-1#2)(1993-4#1)
the human insulin##6##3##(1991-1#2)(1993-4#1)(1996-7#1)(1997-8#1)(2008-11#1)
the human interleukin-1 receptor antagonist##3##5##(1992-3#1)(1994-3#1)(2008-5#1)
the human interleukin-1##4##3##(1992-3#1)(1993-8#1)(1994-3#1)(2008-5#1)
the human internal##2##3##(2010-9#1)(2012-1#1)
the human intestinal##3##3##(1993-8#1)(2006-8#2)
the human kidney##3##3##(1990-8#1)(1991-11#1)(1994-9#1)
the human knee joint##4##4##(2007-4#1)(2009-7#1)(2012-1#2)
the human knee##7##3##(2007-4#1)(2009-7#2)(2012-1#4)
the human large##4##3##(1991-9#1)(1993-9#1)(2006-5#1)(2006-8#1)
the human leg joints##2##4##(2012-1#2)
the human leg##3##3##(2007-4#1)(2012-1#2)
the human leptin gene##3##4##(2006-9#3)
the human leukocyte antigen (HLA)##2##5##(2006-10#1)(2011-1#1)
the human leukocyte antigen##3##4##(2006-10#1)(2008-4#1)(2011-1#1)
the human leukocyte##4##3##(2006-10#1)(2008-11#1)(2008-4#1)(2011-1#1)
the human life history##2##4##(2012-2#2)
the human life##3##3##(2012-2#2)(2013-8#1)
the human lifespan and##2##4##(1992-7#1)(2011-1#1)
the human lifespan##4##3##(1992-7#1)(2011-1#1)(2012-2#2)
the human likeness of##2##4##(2008-11#2)
the human liver##8##3##(1991-10#1)(1991-3#1)(1992-12#1)(1993-3#1)(1993-4#2)(1994-6#1)(1994-8#1)
the human lower limb##5##4##(2007-4#3)(2012-1#2)
the human lower##7##3##(2007-4#5)(2012-1#2)
the human lung##6##3##(1991-5#1)(1992-12#1)(1992-9#1)(1994-6#1)(1994-9#1)(2008-11#1)
the human lysosomal##6##3##(1993-8#1)(1994-11#1)(1994-3#1)(1994-9#1)(1997-8#2)
the human major histocompatibility complex##2##5##(1994-8#1)(2008-4#1)
the human major##3##3##(1994-8#1)(1997-9#1)(2008-4#1)
the human malaria parasite##3##4##(1993-2#1)(1993-4#1)(2012-2#1)
the human malaria##4##3##(1993-2#1)(1993-4#1)(2008-8#1)(2012-2#1)
the human melanocortin MC3 receptor##3##5##(1996-10#3)
the human melanocortin##4##3##(1996-10#3)(1997-6#1)
the human melanoma##2##3##(1994-5#1)(1994-6#1)
the human metallothionein IIA##2##4##(1996-8#2)
the human microbiome##2##3##(2011-1#1)(2012-2#1)
the human mind##2##3##(1990-2#1)(1990-6#1)
the human mitochondrial##4##3##(1991-12#2)(1995-11#1)(1997-1#1)
the human motor cortex##2##4##(1997-6#1)(2008-11#1)
the human multidrug##2##3##(1994-5#1)(2008-11#1)
the human muscle glycogen phosphorylase gene##3##6##(1991-11#3)
the human muscle##6##3##(1991-11#3)(1992-2#3)
the human muscle-tendon system##2##4##(2012-1#2)
the human musculoskeletal system##2##4##(2008-7#1)(2012-1#1)
the human myocardium##3##3##(1993-7#2)(2007-11#1)
the human nail##3##3##(2008-5#3)
the human neuroblastoma cell line##6##5##(1990-4#1)(1992-5#1)(1992-6#1)(1996-9#1)(1997-7#2)
the human neuroblastoma cell##7##4##(1990-4#1)(1992-5#1)(1992-6#1)(1996-10#1)(1996-9#1)(1997-7#2)
the human observer##2##3##(2010-8#1)(2012-1#1)
the human or the murine##2##5##(1990-5#1)(1995-11#1)
the human or##3##3##(1990-5#1)(1995-11#1)(2008-3#1)
the human organism##5##3##(1990-6#1)(1996-6#1)(2004-9#1)(2012-2#1)(2013-7#1)
the human ovarian##3##3##(1994-2#1)(2008-5#2)
the human pancreas##2##3##(2009-4#1)(2010-11#1)
the human pancreatic##2##3##(1996-12#1)(2006-10#1)
the human papillomavirus (HPV)##3##4##(1996-7#1)(1997-4#1)(2010-5#1)
the human papillomavirus##6##3##(1996-4#1)(1996-7#1)(1997-4#1)(2008-12#1)(2010-5#1)(2013-7#1)
the human papillomaviruses##2##3##(2006-10#2)
the human pathogen Candida albicans##2##5##(1992-8#1)(2007-7#1)
the human pathogen##4##3##(1992-8#1)(1995-8#1)(2007-7#1)(2011-2#1)
the human placenta##2##3##(1993-4#1)(1994-9#1)
the human plasma##2##3##(1991-2#1)(1996-7#1)
the human platelet and##2##4##(1992-8#1)(2008-11#1)
the human platelet##4##3##(1992-8#1)(2006-6#2)(2008-11#1)
the human platelet-activating factor receptor##3##5##(1993-12#2)(1996-2#1)
the human plectin gene##2##4##(1996-4#2)
the human population##13##3##(1995-2#1)(2005-12#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-3#1)(2008-5#1)(2009-9#1)(2011-3#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-7#1)
the human prostate##3##3##(1994-11#1)(2009-5#2)
the human protein##12##3##(1990-6#1)(1991-2#1)(1991-6#1)(1991-9#1)(1994-8#1)(1995-8#1)(1997-2#1)(1997-4#3)(1997-6#1)(2009-5#1)
the human receptor##4##3##(1991-1#1)(1995-10#3)
the human recombinant##3##3##(2005-7#1)(2007-11#2)
the human red cell##3##4##(1990-11#1)(1991-5#2)
the human renin##2##3##(1990-7#1)(1994-2#1)
the human resources##3##3##(1996-6#1)(2005-5#2)
the human respiratory tract##5##4##(1995-12#1)(1997-1#1)(2008-11#1)(2011-2#1)(2013-1#1)
the human respiratory##6##3##(1995-12#1)(1997-1#1)(2008-1#1)(2008-11#1)(2011-2#1)(2013-1#1)
the human response##5##3##(1991-12#1)(2006-11#1)(2007-1#1)(2007-4#2)
the human retina##5##3##(1990-7#1)(1994-11#1)(2007-11#3)
the human rights##3##3##(1995-9#2)(2010-12#1)
the human serotonin 5-HT2 and 5-HT1C##2##6##(1991-12#2)
the human serum##5##3##(1993-3#1)(2008-10#2)(2008-5#1)(2010-1#1)
the human services##3##3##(1992-1#1)(2008-11#2)
the human skin##11##3##(2008-5#7)(2009-11#1)(2009-6#1)(2011-2#1)(2012-3#1)
the human sleep##2##3##(2004-11#1)(2009-8#1)
the human species##4##3##(1994-9#1)(1997-4#1)(2013-1#1)(2013-7#1)
the human spermidine/spermine N1-acetyltransferase##2##4##(1991-9#1)(1992-10#1)
the human stomach##3##3##(1994-12#1)(1994-8#1)(2013-1#1)
the human studies##2##3##(2007-4#1)(2010-2#1)
the human subjects##2##3##(2007-4#2)
the human substance P receptor##2##5##(1991-9#2)
the human thyroid hormone receptor##2##5##(1991-2#1)(1997-7#1)
the human thyroid##4##3##(1991-2#1)(1992-1#1)(1994-9#1)(1997-7#1)
the human thyrotropin receptor##5##4##(1990-9#1)(1991-5#1)(1992-2#2)(1995-12#1)
the human thyrotropin##7##3##(1990-9#1)(1991-5#2)(1991-9#1)(1992-2#2)(1995-12#1)
the human tissue##3##3##(1997-4#1)(2010-1#2)
the human tumor##3##3##(1990-12#1)(1997-6#1)(2008-5#1)
the human uterine##3##3##(1994-9#1)(2006-8#1)(2008-3#1)
the human uterus##3##3##(1994-8#2)(2007-4#1)
the human vascular endothelial growth factor##2##6##(1997-5#1)(2006-12#1)
the human vision system##2##4##(2008-2#1)(2008-3#1)
the human visual system##3##4##(2008-2#3)
the human visual##5##3##(1997-7#1)(2008-2#3)(2009-10#1)
the human##1747##2##(1990-10#2)(1990-11#22)(1990-12#9)(1990-2#2)(1990-3#6)(1990-4#6)(1990-5#5)(1990-6#7)(1990-7#9)(1990-8#7)(1990-9#9)(1991-1#8)(1991-10#10)(1991-11#8)(1991-12#25)(1991-2#11)(1991-3#8)(1991-4#5)(1991-5#15)(1991-6#18)(1991-7#10)(1991-8#6)(1991-9#21)(1992-1#6)(1992-10#3)(1992-11#27)(1992-12#15)(1992-2#17)(1992-3#8)(1992-4#3)(1992-5#12)(1992-6#9)(1992-7#5)(1992-8#29)(1992-9#9)(1993-10#2)(1993-11#10)(1993-12#19)(1993-2#6)(1993-3#14)(1993-4#12)(1993-5#5)(1993-6#15)(1993-7#8)(1993-8#7)(1993-9#16)(1994-10#2)(1994-11#11)(1994-12#27)(1994-2#17)(1994-3#19)(1994-5#14)(1994-6#13)(1994-7#1)(1994-8#33)(1994-9#27)(1995-1#6)(1995-10#17)(1995-11#18)(1995-12#12)(1995-2#13)(1995-3#24)(1995-5#7)(1995-6#10)(1995-7#4)(1995-8#12)(1995-9#2)(1996-1#3)(1996-10#14)(1996-11#9)(1996-12#14)(1996-2#17)(1996-4#12)(1996-5#17)(1996-6#7)(1996-7#4)(1996-8#9)(1996-9#7)(1997-1#17)(1997-2#16)(1997-3#2)(1997-4#24)(1997-5#18)(1997-6#15)(1997-7#32)(1997-8#12)(1997-9#5)(2004-1#2)(2004-11#1)(2004-4#1)(2004-8#1)(2004-9#1)(2005-10#7)(2005-11#2)(2005-12#2)(2005-5#2)(2005-7#5)(2005-8#5)(2005-9#3)(2006-1#1)(2006-10#22)(2006-11#15)(2006-12#6)(2006-3#1)(2006-5#2)(2006-6#5)(2006-7#4)(2006-8#8)(2006-9#3)(2007-1#13)(2007-10#4)(2007-11#18)(2007-12#14)(2007-2#2)(2007-3#4)(2007-4#27)(2007-5#4)(2007-6#2)(2007-7#7)(2007-8#13)(2007-9#6)(2008-1#11)(2008-10#18)(2008-11#50)(2008-12#7)(2008-2#10)(2008-3#11)(2008-4#38)(2008-5#36)(2008-6#2)(2008-7#23)(2008-8#25)(2008-9#17)(2009-10#9)(2009-11#1)(2009-12#5)(2009-2#6)(2009-3#3)(2009-4#5)(2009-5#10)(2009-6#2)(2009-7#8)(2009-8#5)(2009-9#3)(2010-1#4)(2010-10#2)(2010-11#1)(2010-12#10)(2010-2#3)(2010-3#4)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#6)(2010-9#2)(2011-1#18)(2011-12#2)(2011-2#26)(2011-3#3)(2011-7#1)(2012-1#24)(2012-11#3)(2012-12#11)(2012-2#20)(2012-3#13)(2013-1#24)(2013-7#7)(2013-8#9)
the humanistic##2##2##(2007-10#1)(2007-5#1)
the humanitarian##2##2##(2008-1#1)(2009-6#1)
the humanities in the education of health professionals##2##8##(2008-11#2)
the humanities##7##2##(2005-4#1)(2006-12#1)(2008-11#4)(2013-8#1)
the humanization##2##2##(1993-3#1)(2005-6#1)
the humeral head##8##3##(2006-10#1)(2008-7#1)(2008-8#2)(2009-3#1)(2010-12#2)(2011-12#1)
the humeral shaft##2##3##(2007-7#2)
the humeral##19##2##(2006-10#1)(2007-11#3)(2007-7#2)(2007-8#1)(2008-7#1)(2008-8#2)(2009-2#3)(2009-3#1)(2010-12#2)(2011-12#1)(2012-1#1)(2012-3#1)
the humerii##3##2##(2013-8#3)
the humerus and the##2##4##(2009-3#1)(2013-8#1)
the humerus and##5##3##(1992-1#1)(2009-3#1)(2012-3#1)(2013-8#2)
the humerus##28##2##(1992-1#1)(1995-6#2)(2006-3#1)(2006-4#1)(2007-11#2)(2007-2#1)(2007-8#4)(2008-7#2)(2009-3#1)(2010-3#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#7)
the humic acid##2##3##(2008-10#1)(2013-8#1)
the humic##6##2##(2005-11#1)(2008-10#4)(2013-8#1)
the humid tropics##3##3##(2007-6#1)(2008-9#1)(2010-7#1)
the humid##8##2##(2007-6#2)(2008-10#2)(2008-5#1)(2008-9#1)(2010-7#1)(2011-12#1)
the humidity##3##2##(2008-10#3)
the humoral immune response to##2##5##(1991-5#1)(2008-4#1)
the humoral immune response##8##4##(1991-5#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)
the humoral immune responses in##2##5##(1990-5#1)(2010-12#1)
the humoral immune responses##4##4##(1990-5#1)(2006-12#1)(2008-11#1)(2010-12#1)
the humoral immune##14##3##(1990-5#1)(1991-5#1)(1996-9#1)(2006-10#1)(2006-12#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)
the humoral response##5##3##(1991-12#1)(2007-10#1)(2008-10#1)(2008-5#2)
the humoral##26##2##(1990-5#1)(1991-12#1)(1991-5#1)(1992-8#1)(1995-2#1)(1996-9#1)(1997-6#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#3)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#1)(2010-12#1)(2011-1#2)(2011-2#1)
the hump responses##2##3##(1990-11#2)
the hump##6##2##(1990-11#2)(2007-7#3)(2012-2#1)
the hunt for##2##3##(1991-8#1)(1992-1#1)
the hupL##2##2##(1995-1#2)
the hurdles that##2##3##(1994-2#1)(2008-4#1)
the hurdles##4##2##(1994-2#1)(2008-4#1)(2009-11#1)(2009-4#1)
the hurricanes##3##2##(2009-4#1)(2011-2#1)(2012-3#1)
the husband or cohabiting partner##2##5##(2012-3#2)
the husband##4##2##(2006-4#1)(2011-2#1)(2012-3#2)
the husbands of women##2##4##(2008-5#2)
the husbands##3##2##(2008-5#2)(2008-9#1)
the hyaline layer##2##3##(1990-2#2)
the hyaline##5##2##(1990-2#2)(1996-12#1)(2007-11#1)(2010-4#1)
the hyaluronan##2##2##(1994-2#1)(2008-9#1)
the hybrid DNA##2##3##(1995-8#2)
the hybrid FBP algorithm##2##4##(2008-2#2)
the hybrid and the##2##4##(2008-3#2)
the hybrid and##5##3##(1994-2#1)(1995-8#1)(2008-3#2)(2008-9#1)
the hybrid gene##2##3##(1994-11#1)(1994-12#1)
the hybrid inhibitors##2##3##(1994-11#2)
the hybrid input-output algorithm##3##4##(2008-3#3)
the hybrid membranes##2##3##(1995-1#2)
the hybrid monolithic column was##2##5##(2013-8#2)
the hybrid was##3##3##(1995-8#1)(2008-8#1)(2010-7#1)
the hybrid zone##2##3##(2008-8#2)
the hybrid##94##2##(1990-1#1)(1990-11#1)(1990-3#1)(1990-9#2)(1991-6#1)(1993-11#2)(1993-9#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#2)(1995-3#1)(1995-8#6)(1997-3#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-2#6)(2008-3#15)(2008-4#1)(2008-5#3)(2008-8#6)(2008-9#2)(2009-2#2)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#3)
the hybridization event##3##3##(2008-10#3)
the hybridization kinetics##2##3##(2010-5#2)
the hybridization of the##2##4##(2008-10#1)(2008-7#1)
the hybridization of##6##3##(2008-10#3)(2008-7#1)(2009-2#1)(2010-7#1)
the hybridization signal##2##3##(1993-5#1)(1994-12#1)
the hybridization solution##2##3##(2007-8#1)(2008-4#1)
the hybridization##25##2##(1993-5#1)(1994-12#1)(1997-6#1)(2007-8#2)(2008-10#12)(2008-4#2)(2008-6#1)(2008-7#1)(2009-2#1)(2010-5#2)(2010-7#1)
the hybridoma cell##4##3##(1994-11#1)(2008-10#1)(2008-11#2)
the hybridoma##13##2##(1994-11#1)(1995-2#2)(2008-10#1)(2008-11#9)
the hybridomas##3##2##(1992-8#1)(2008-11#2)
the hybrids and##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
the hybrids were##2##3##(1992-9#1)(2008-10#1)
the hybrids##16##2##(1990-5#1)(1992-9#2)(1994-11#1)(2007-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#2)(2009-10#1)(2010-4#2)(2010-7#1)
the hydatid cyst##2##3##(1991-8#1)(2007-8#1)
the hydatid##3##2##(1991-8#1)(2007-8#1)(2010-12#1)
the hydrated##9##2##(1990-8#1)(1991-2#1)(1994-8#1)(1996-2#1)(2005-11#1)(2006-1#1)(2006-10#1)(2008-10#2)
the hydration free##2##3##(2006-10#1)(2010-2#1)
the hydration level##2##3##(2008-5#2)
the hydration number of the##2##5##(2006-10#1)(2008-10#1)
the hydration number of##3##4##(2006-10#2)(2008-10#1)
the hydration of the##4##4##(1991-2#1)(1992-8#1)(2006-10#1)(2008-5#1)
the hydration of##9##3##(1991-2#1)(1992-8#1)(1994-9#1)(1995-1#1)(2006-10#3)(2008-5#1)(2010-8#1)
the hydration process##6##3##(2005-11#1)(2008-10#5)
the hydration state of##3##4##(2008-5#2)(2008-7#1)
the hydration##36##2##(1991-2#1)(1992-8#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-4#1)(2005-11#1)(2006-10#7)(2006-5#1)(2006-6#1)(2008-10#7)(2008-5#7)(2008-6#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-8#1)(2012-2#1)
the hydraulic##5##2##(2007-2#1)(2008-10#1)(2008-7#1)(2009-8#1)(2012-1#1)
the hydrazone##2##2##(2008-10#1)(2011-1#1)
the hydride generation##4##3##(2008-10#4)
the hydride transfer##4##3##(1990-5#1)(1994-11#1)(1996-7#1)(2010-5#1)
the hydride##13##2##(1990-5#1)(1994-11#1)(1996-7#1)(2008-10#8)(2010-5#2)
the hydrides##2##2##(2008-10#2)
the hydridoborate##3##2##(2010-5#3)
the hydroalcoholic extract##2##3##(2008-5#1)(2011-2#1)
the hydroalcoholic##3##2##(2008-5#2)(2011-2#1)
the hydrocarbon chain length##2##4##(2005-11#2)
the hydrocarbon chain##7##3##(1990-7#1)(1992-8#1)(2005-11#2)(2007-12#1)(2008-10#1)(2013-7#1)
the hydrocarbon chains##6##3##(1992-9#1)(1993-11#2)(1996-8#1)(2006-10#1)(2007-12#1)
the hydrocarbon core##2##3##(1991-9#1)(1993-4#1)
the hydrocarbon order##2##3##(1992-1#1)(1993-3#1)
the hydrocarbon##27##2##(1990-7#1)(1991-9#1)(1992-1#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-4#1)(1995-1#2)(1996-8#1)(2005-11#3)(2006-10#2)(2007-1#1)(2007-12#2)(2008-10#2)(2008-6#2)(2013-1#2)(2013-7#1)
the hydrocarbons##5##2##(1992-3#1)(1992-7#1)(2008-10#3)
the hydrodynamic behavior of##2##4##(1993-3#1)(2007-10#1)
the hydrodynamic interaction between##2##4##(2005-11#2)
the hydrodynamic radius of##2##4##(1990-5#1)(2008-2#1)
the hydrodynamic radius##3##3##(1990-5#1)(2005-11#1)(2008-2#1)
the hydrodynamic##21##2##(1990-5#1)(1991-7#1)(1993-3#1)(1994-9#1)(1995-1#1)(2005-11#9)(2007-10#1)(2007-6#1)(2008-10#1)(2008-2#3)(2008-5#1)
the hydrogel matrix##2##3##(2005-11#1)(2013-7#1)
the hydrogel##23##2##(2005-11#2)(2007-10#1)(2007-11#1)(2008-11#1)(2008-5#11)(2009-12#1)(2009-7#1)(2010-2#2)(2010-5#1)(2013-1#1)(2013-7#1)
the hydrogels##3##2##(2005-11#1)(2013-7#2)
the hydrogen abstraction##2##3##(1995-10#1)(1996-7#1)
the hydrogen atom abstraction##2##4##(2007-11#1)(2008-8#1)
the hydrogen atom##3##3##(1990-8#1)(2007-11#1)(2008-8#1)
the hydrogen atoms##2##3##(1991-12#1)(2005-11#1)
the hydrogen bond between##2##4##(1992-3#1)(1995-11#1)
the hydrogen bond donating ability of##2##6##(2008-10#2)
the hydrogen bond donor##2##4##(1990-2#1)(2010-7#1)
the hydrogen bond##9##3##(1990-2#1)(1991-7#1)(1992-3#1)(1995-11#1)(2008-10#3)(2010-7#2)
the hydrogen bonding##9##3##(1991-12#1)(1992-6#1)(1996-8#1)(2005-11#1)(2008-2#1)(2009-10#1)(2009-2#2)(2010-7#1)
the hydrogen bonds between##3##4##(1990-8#1)(1992-6#1)(2005-11#1)
the hydrogen bonds##7##3##(1990-8#1)(1992-6#1)(1992-9#1)(2005-11#1)(2008-10#1)(2009-8#1)(2010-3#1)
the hydrogen clearance##2##3##(1993-2#1)(1995-3#1)
the hydrogen exchange##2##3##(1995-2#2)
the hydrogen ion concentration##2##4##(2008-10#2)
the hydrogen molecule##2##3##(1993-8#1)(2008-10#1)
the hydrogen peroxide generated##2##4##(2008-10#2)
the hydrogen peroxide##5##3##(2007-8#1)(2008-10#2)(2008-5#1)(2011-2#1)
the hydrogen production##3##3##(2006-8#1)(2013-1#2)
the hydrogen transfer##2##3##(1992-9#1)(1996-7#1)
the hydrogen##68##2##(1990-2#1)(1990-7#1)(1990-8#2)(1991-12#2)(1991-7#1)(1991-8#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#4)(1993-2#1)(1993-8#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#1)(1996-7#3)(1996-8#1)(2005-11#3)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#14)(2008-2#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-2#2)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#3)(2010-7#3)(2011-2#1)(2013-1#3)
the hydrogen-bond##2##2##(1996-9#1)(2008-8#1)
the hydrogen-bonded##2##2##(1991-8#1)(2009-2#1)
the hydrogen-bonding##6##2##(1990-2#1)(1991-3#1)(1991-7#1)(1995-5#1)(2007-11#1)(2012-2#1)
the hydrogenase##2##2##(2006-8#2)
the hydrogenic##2##2##(2005-4#1)(2010-5#1)
the hydrogenotrophic methanogen##2##3##(2006-8#2)
the hydrolase##3##2##(1991-7#1)(1992-4#1)(1992-8#1)
the hydrolysate##5##2##(1992-3#1)(2008-10#1)(2008-5#2)(2013-1#1)
the hydrolysates##8##2##(1990-7#1)(2005-11#1)(2008-5#1)(2008-6#2)(2008-7#2)(2013-1#1)
the hydrolysis and##3##3##(1997-1#1)(2008-10#2)
the hydrolysis by##2##3##(1990-11#1)(1993-3#1)
the hydrolysis of GTP##2##4##(1992-8#1)(1997-6#1)
the hydrolysis of Reactive Red##2##5##(2008-10#2)
the hydrolysis of a number of##2##6##(1990-8#1)(2008-4#1)
the hydrolysis of a##3##4##(1990-8#1)(1995-8#1)(2008-4#1)
the hydrolysis of an##3##4##(2005-7#1)(2006-5#1)(2011-2#1)
the hydrolysis of inositol phospholipids##2##5##(1990-4#1)(1993-12#1)
the hydrolysis of inositol##3##4##(1990-4#1)(1992-9#1)(1993-12#1)
the hydrolysis of lipid##2##4##(1990-4#1)(1994-3#1)
the hydrolysis of phosphorylated##3##4##(1990-5#1)(1993-8#1)(1996-5#1)
the hydrolysis of several##2##4##(1995-5#1)(2008-10#1)
the hydrolysis of small##2##4##(1991-3#1)(1993-3#1)
the hydrolysis of the##14##4##(1990-3#1)(1990-4#1)(1991-8#1)(1993-11#1)(1994-3#1)(1994-5#2)(1994-9#1)(2008-10#2)(2008-6#1)(2008-8#1)(2010-3#1)(2011-2#1)
the hydrolysis of triglycerides##2##4##(1992-12#1)(1992-3#1)
the hydrolysis of##102##3##(1990-11#2)(1990-12#3)(1990-3#1)(1990-4#4)(1990-5#2)(1990-7#2)(1990-8#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#3)(1994-3#2)(1994-5#7)(1994-8#1)(1994-9#2)(1995-2#1)(1995-3#2)(1995-5#2)(1995-8#1)(1996-5#3)(1996-6#1)(1996-8#1)(1997-6#1)(2005-11#9)(2005-7#1)(2006-5#1)(2007-6#1)(2008-10#9)(2008-4#2)(2008-6#2)(2008-7#5)(2008-8#2)(2009-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#4)(2013-1#2)
the hydrolysis process##4##3##(2005-11#1)(2008-10#2)(2008-11#1)
the hydrolysis product of the##2##5##(1995-1#1)(2013-1#1)
the hydrolysis product##3##3##(1995-1#1)(2008-10#1)(2013-1#1)
the hydrolysis products of##2##4##(1994-11#1)(2008-7#1)
the hydrolysis products##5##3##(1994-11#1)(1994-8#1)(1997-2#1)(2008-7#1)(2010-3#1)
the hydrolysis rate##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
the hydrolysis reaction##3##3##(1992-3#1)(1996-5#1)(2008-10#1)
the hydrolysis##137##2##(1990-11#3)(1990-12#3)(1990-3#1)(1990-4#4)(1990-5#2)(1990-7#2)(1990-8#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-8#3)(1994-11#1)(1994-3#2)(1994-5#7)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-8#1)(1996-5#5)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-6#1)(2005-11#11)(2005-7#1)(2006-10#1)(2006-5#1)(2007-6#1)(2008-10#18)(2008-11#1)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#8)(2008-8#2)(2009-12#1)(2010-3#2)(2010-5#1)(2011-1#1)(2011-2#4)(2013-1#4)
the hydrolytic action of##2##4##(1990-12#1)(1990-7#1)
the hydrolytic activity of##3##4##(1991-8#1)(1995-2#1)(2008-5#1)
the hydrolytic reaction##3##3##(1990-12#1)(1990-7#1)(1995-1#1)
the hydrolytic##19##2##(1990-12#2)(1990-7#3)(1991-3#1)(1991-8#1)(1995-1#1)(1995-2#1)(1996-6#2)(2004-11#1)(2004-8#1)(2005-11#1)(2005-7#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
the hydrolyzed##2##2##(1995-2#1)(2007-8#1)
the hydrolyzing##3##2##(2005-11#1)(2008-5#1)(2009-4#1)
the hydropathy profile of##2##4##(1990-5#1)(1990-8#1)
the hydropathy##5##2##(1990-5#2)(1990-8#2)(2008-1#1)
the hydroperoxide##2##2##(1992-3#2)
the hydroperoxo complex##2##3##(1996-2#2)
the hydroperoxo##3##2##(1996-2#3)
the hydrophilic and##2##3##(1990-2#1)(2004-8#1)
the hydrophilic membrane##3##3##(2004-8#3)
the hydrophilic part of##2##4##(2005-11#2)
the hydrophilic pore edge##2##4##(1990-11#2)
the hydrophilic segments of the membrane surface##3##7##(2006-10#3)
the hydrophilic segments of the##4##5##(2006-10#4)
the hydrophilic##46##2##(1990-11#2)(1990-2#2)(1991-2#1)(1991-3#1)(1992-3#3)(1993-3#1)(1993-6#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-10#1)(1997-2#1)(1997-4#1)(2004-8#4)(2005-11#10)(2006-10#5)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#2)(2009-12#1)(2013-8#1)
the hydrophilicity of the##2##4##(2010-9#2)
the hydrophilicity of##3##3##(2006-10#1)(2010-9#2)
the hydrophilicity##4##2##(1991-2#1)(2006-10#1)(2010-9#2)
the hydrophobic PANI##2##3##(2005-11#2)
the hydrophobic and hydrophilic##2##4##(2004-8#1)(2007-11#1)
the hydrophobic and##5##3##(2004-8#1)(2007-11#2)(2008-10#2)
the hydrophobic binding##4##3##(1991-12#1)(1995-5#2)(2008-5#1)
the hydrophobic cavity of##2##4##(2008-10#2)
the hydrophobic character of the molecule##2##6##(1993-4#1)(2005-11#1)
the hydrophobic core of a##3##5##(1993-3#1)(1997-2#2)
the hydrophobic core of the protein##3##6##(1991-2#1)(1994-5#1)(1995-1#1)
the hydrophobic core of the##7##5##(1991-2#1)(1993-3#1)(1994-12#1)(1994-5#2)(1994-6#1)(1995-1#1)
the hydrophobic core of##12##4##(1991-2#1)(1993-3#2)(1994-12#1)(1994-5#2)(1994-6#1)(1995-1#1)(1995-2#1)(1996-6#1)(1997-2#2)
the hydrophobic core##21##3##(1991-2#1)(1991-5#1)(1991-6#1)(1993-12#1)(1993-3#4)(1994-12#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#2)(1995-2#1)(1996-11#1)(1996-6#1)(1996-8#1)(1997-2#2)
the hydrophobic domain##2##3##(1990-7#1)(1996-10#1)
the hydrophobic effect is##2##4##(1996-1#1)(1996-7#1)
the hydrophobic effect##12##3##(1990-5#1)(1991-4#1)(1993-6#3)(1996-1#1)(1996-7#2)(2006-10#1)(2007-12#1)(2008-10#1)(2008-3#1)
the hydrophobic end##2##3##(1992-3#1)(2008-12#1)
the hydrophobic environment##2##3##(1992-9#1)(1994-9#1)
the hydrophobic interaction of##2##4##(1990-5#1)(2008-10#1)
the hydrophobic interaction##3##3##(1990-5#1)(2008-10#2)
the hydrophobic interactions##4##3##(1992-6#1)(1997-1#1)(2006-10#1)(2011-2#1)
the hydrophobic leader##2##3##(1991-10#1)(1995-6#1)
the hydrophobic lining##2##3##(2006-10#2)
the hydrophobic liquid-solid##2##3##(2011-1#2)
the hydrophobic membrane##5##3##(1994-8#1)(1994-9#1)(2004-8#3)
the hydrophobic moment of the##2##5##(1994-12#2)
the hydrophobic moment##5##3##(1994-12#5)
the hydrophobic part of the##4##5##(1996-1#2)(2005-11#1)(2006-10#1)
the hydrophobic part of##5##4##(1996-1#2)(2005-11#2)(2006-10#1)
the hydrophobic patch##3##3##(1991-11#1)(1993-11#1)(2006-10#1)
the hydrophobic surface##5##3##(1990-5#1)(1994-9#1)(1995-8#2)(2005-11#1)
the hydrophobic surfaces of alpha-crystallin##2##5##(1995-5#2)
the hydrophobic thickness of##2##4##(2006-10#2)
the hydrophobic thickness##3##3##(2006-10#3)
the hydrophobic##155##2##(1990-11#1)(1990-4#1)(1990-5#4)(1990-7#1)(1990-8#2)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#1)(1992-12#2)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#4)(1993-4#1)(1993-6#3)(1993-9#1)(1994-11#1)(1994-12#6)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#3)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#5)(1995-6#1)(1995-8#3)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#1)(1996-6#1)(1996-7#3)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-6#2)(1997-8#1)(2004-8#6)(2005-11#14)(2006-10#11)(2006-12#1)(2007-11#2)(2007-12#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-4#1)(2011-1#2)(2011-2#1)(2013-8#1)
the hydrophobicity of the##15##4##(1990-3#1)(1992-3#1)(1993-11#1)(1993-4#1)(1993-9#1)(1995-5#1)(1995-6#1)(1997-5#1)(2005-11#3)(2008-10#2)(2008-6#1)(2008-7#1)
the hydrophobicity of##16##3##(1990-3#1)(1992-3#1)(1993-11#1)(1993-4#1)(1993-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-5#1)(2005-11#3)(2008-10#2)(2008-6#1)(2008-7#1)
the hydrophobicity##19##2##(1990-3#1)(1992-3#1)(1993-11#1)(1993-4#1)(1993-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-5#1)(2005-11#3)(2008-10#4)(2008-6#1)(2008-7#1)
the hydroquinone##5##2##(1992-11#1)(1993-11#1)(2008-10#2)(2008-6#1)
the hydrothermal##4##2##(2008-10#1)(2009-11#1)(2010-4#1)(2013-8#1)
the hydrous##4##2##(1990-12#1)(2005-11#1)(2008-10#2)
the hydroxamate##3##2##(1995-10#2)(2012-2#1)
the hydroxamic##2##2##(1997-8#1)(2008-10#1)
the hydroxide hydrogen atom##3##4##(1990-8#3)
the hydroxide ion##2##3##(1990-5#1)(2005-11#1)
the hydroxide##11##2##(1990-5#1)(1990-8#4)(2005-11#1)(2007-5#1)(2008-10#4)
the hydroxo complex of##2##4##(2008-5#1)(2009-3#1)
the hydroxo##4##2##(2005-11#1)(2008-5#1)(2009-3#1)(2010-5#1)
the hydroxy groups are##2##4##(1991-5#1)(2008-10#1)
the hydroxy##8##2##(1990-10#1)(1991-5#1)(1992-1#1)(1993-11#1)(2004-7#1)(2007-11#1)(2008-10#1)(2008-5#1)
the hydroxyapatite##4##2##(2005-3#1)(2008-7#1)(2009-7#1)(2011-2#1)
the hydroxyl group is##2##4##(1990-12#1)(1991-12#1)
the hydroxyl group of##6##4##(1990-2#1)(1992-12#1)(1992-6#1)(1994-9#1)(1996-5#1)(2008-4#1)
the hydroxyl group##15##3##(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-12#1)(1992-6#1)(1993-11#1)(1994-9#1)(1995-5#1)(1996-5#1)(1997-7#1)(2007-8#1)(2008-4#1)
the hydroxyl groups of the##3##5##(2007-11#1)(2008-10#1)(2008-8#1)
the hydroxyl groups of##5##4##(2007-11#2)(2008-10#1)(2008-5#1)(2008-8#1)
the hydroxyl groups##7##3##(1992-3#1)(2007-11#2)(2007-9#1)(2008-10#1)(2008-5#1)(2008-8#1)
the hydroxyl radical (##2##4##(1990-5#1)(1997-8#1)
the hydroxyl radical##12##3##(1990-5#2)(1991-9#1)(1992-3#3)(1994-3#1)(1995-2#1)(1997-8#1)(2008-10#2)(2008-4#1)
the hydroxyl##49##2##(1990-12#1)(1990-2#1)(1990-5#2)(1991-12#1)(1991-2#3)(1991-3#1)(1991-9#1)(1992-12#1)(1992-3#4)(1992-6#2)(1993-11#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-5#2)(1996-7#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-11#2)(2007-11#2)(2007-8#1)(2007-9#1)(2008-10#5)(2008-4#3)(2008-5#2)(2008-8#2)(2010-4#1)
the hydroxylamine##2##2##(1995-3#1)(1995-6#1)
the hydroxylase component##2##3##(1997-4#1)(2009-3#1)
the hydroxylated##2##2##(2007-8#1)(2010-2#1)
the hydroxylation of##4##3##(1992-11#1)(1992-6#1)(1996-3#1)(1997-6#1)
the hydroxylation reaction##2##3##(1993-6#1)(2010-5#1)
the hydroxylation##8##2##(1992-11#1)(1992-6#1)(1993-6#1)(1996-3#1)(1997-3#1)(1997-6#1)(2005-11#1)(2010-5#1)
the hydroxyls##2##2##(1991-12#1)(2009-12#1)
the hydroxymethyl##2##2##(2007-11#1)(2008-4#1)
the hygiene##3##2##(1994-6#1)(2006-10#1)(2010-4#1)
the hygienic standards of##2##4##(2008-7#2)
the hygienic##6##2##(2008-4#1)(2008-6#1)(2008-7#2)(2010-8#1)(2011-1#1)
the hygienist##3##2##(2006-2#2)(2009-10#1)
the hygromycin##3##2##(2008-10#2)(2008-11#1)
the hygroscopic effects##2##3##(2013-1#2)
the hygroscopic##3##2##(2009-3#1)(2013-1#2)
the hyoid##3##2##(2008-2#1)(2010-11#2)
the hype##2##2##(2007-9#2)
the hyper-Rayleigh##2##2##(2007-12#2)
the hyperactivity##2##2##(1993-6#1)(1994-5#1)
the hyperaemic FC curve shows a##2##6##(2008-3#2)
the hyperalgesia##2##2##(1996-3#1)(1996-8#1)
the hyperbenthic##2##2##(2008-5#2)
the hypercapnic##2##2##(1993-8#1)(2012-12#1)
the hypercortisolism##2##2##(1995-12#1)(2006-1#1)
the hypercube##2##2##(2008-2#2)
the hyperdynamic circulation##7##3##(1997-7#1)(2006-10#6)
the hyperexcitability of axotomized##2##4##(2006-12#2)
the hyperexcitability##3##2##(1995-6#1)(2006-12#2)
the hyperfine##5##2##(1994-8#1)(1996-7#1)(2006-2#1)(2007-11#1)(2008-3#1)
the hyperfine-shifted##2##2##(1991-2#1)(2009-3#1)
the hyperglycemia##3##2##(1991-7#1)(2007-8#1)(2010-11#1)
the hyperglycemic##6##2##(1990-5#1)(1991-12#1)(1994-2#1)(1994-6#1)(1995-10#1)(2008-11#1)
the hyperinsulinemia##2##2##(1992-8#1)(1996-12#1)
the hyperparasite##5##2##(2008-10#1)(2008-9#4)
the hyperphosphorylation of HSSB p34##2##5##(1994-8#2)
the hyperplastic##3##2##(1994-3#1)(2008-10#1)(2009-12#1)
the hyperpolarization##3##2##(1990-7#1)(1990-8#1)(1992-9#1)
the hyperproliferative##2##2##(1994-5#2)
the hypersensitive reaction and##2##4##(2008-10#2)
the hypersensitive reaction##8##3##(2008-10#7)(2011-1#1)
the hypersensitive response (HR)##6##4##(2008-10#6)
the hypersensitive response##10##3##(2008-10#10)
the hypersensitive##19##2##(2008-10#17)(2008-11#1)(2011-1#1)
the hypersensitivity##3##2##(1995-12#1)(1997-2#1)(2008-7#1)
the hyperstriatum##4##2##(1992-9#4)
the hypertension of##2##3##(1997-6#1)(2008-10#1)
the hypertension##9##2##(1992-4#1)(1993-11#1)(1996-9#1)(1997-6#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-4#2)
the hypertensive cohort of##2##4##(2007-1#2)
the hypertensive group##3##3##(2007-1#1)(2008-1#1)(2012-2#1)
the hypertensive patients in##2##4##(2009-6#1)(2010-12#1)
the hypertensive patients##3##3##(2009-6#2)(2010-12#1)
the hypertensive population##2##3##(1996-9#1)(2006-9#1)
the hypertensive subjects##2##3##(2013-1#1)(2013-8#1)
the hypertensive##27##2##(1990-12#1)(1990-2#1)(1990-4#1)(1991-10#1)(1992-4#1)(1992-8#1)(1993-3#1)(1996-9#1)(1997-5#1)(2006-10#1)(2006-9#1)(2007-1#3)(2007-8#1)(2008-1#2)(2008-7#1)(2009-6#2)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
the hypertensives##4##2##(1991-2#1)(2007-1#1)(2012-2#1)(2013-1#1)
the hyperthermia##2##2##(1996-10#1)(2010-1#1)
the hyperthermic##2##2##(1996-3#1)(2007-11#1)
the hyperthermophilic archaeon Pyrococcus furiosus##3##5##(1993-9#1)(1995-5#1)(2011-12#1)
the hyperthermophilic archaeon Pyrococcus##4##4##(1993-9#1)(1995-5#1)(1997-4#1)(2011-12#1)
the hyperthermophilic archaeon##5##3##(1993-9#2)(1995-5#1)(1997-4#1)(2011-12#1)
the hyperthermophilic##8##2##(1993-9#2)(1994-12#2)(1995-5#1)(1997-4#1)(2008-9#1)(2011-12#1)
the hyperthyroid##2##2##(1990-8#1)(2006-11#1)
the hypertrophic differentiation of chondrocytes##2##5##(2013-8#2)
the hypertrophic differentiation##3##3##(2013-8#3)
the hypertrophic##8##2##(1992-3#1)(2005-11#1)(2008-1#1)(2008-5#1)(2009-4#1)(2013-8#3)
the hypertrophied##2##2##(1996-9#1)(2008-4#1)
the hypertrophy of the##2##4##(1990-3#1)(2008-5#1)
the hypertrophy of##3##3##(1990-3#1)(2008-5#1)(2011-1#1)
the hypertrophy##5##2##(1990-3#1)(1992-9#1)(2008-5#1)(2008-7#1)(2011-1#1)
the hypervariable region of##3##4##(1990-7#1)(2012-12#2)
the hypervariable region##4##3##(1990-7#2)(2012-12#2)
the hypervariable regions##2##3##(1995-7#1)(2008-10#1)
the hypervariable##9##2##(1990-7#2)(1995-2#1)(1995-7#1)(2007-11#1)(2008-10#2)(2012-12#2)
the hyperventilation##2##2##(1991-3#2)
the hyphae of the##2##4##(1997-4#1)(2008-4#1)
the hyphae of##6##3##(1997-4#1)(2008-10#3)(2008-4#2)
the hyphae##11##2##(1997-4#1)(2008-10#7)(2008-4#2)(2008-7#1)
the hyphal##8##2##(1996-6#1)(2008-11#1)(2008-4#1)(2008-7#4)(2009-8#1)
the hyphenated##2##2##(2008-10#1)(2011-1#1)
the hyphenation of##2##3##(2008-10#1)(2008-12#1)
the hypnotic##2##2##(1993-8#1)(2008-11#1)
the hypocotyl of##2##3##(2008-11#1)(2012-11#1)
the hypocotyl##5##2##(2008-11#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-11#1)
the hypodermal connective tissue strands##2##5##(2008-5#2)
the hypodermis##5##2##(2007-12#1)(2008-10#1)(2008-5#2)(2012-12#1)
the hypoglossal canal##2##3##(2011-2#2)
the hypoglossal nerve##4##3##(1993-12#1)(1997-3#2)(2008-2#1)
the hypoglossal##7##2##(1993-12#2)(1997-3#2)(2008-2#1)(2011-2#2)
the hypoglycemic##2##2##(1992-8#1)(2011-1#1)
the hypolimnion##3##2##(2005-12#3)
the hypolipidemic##2##2##(1991-11#1)(2009-8#1)
the hypoperfused##2##2##(1996-9#1)(2007-10#1)
the hypopharyngeal gland##3##3##(2008-6#3)
the hypopharynx##2##2##(1993-9#1)(2007-3#1)
the hypophosphorylated form##2##3##(1993-9#1)(1994-8#1)
the hypophysis##6##2##(1992-12#1)(1997-5#1)(2009-2#3)(2009-8#1)
the hypotension and##2##3##(1996-12#2)
the hypotension##3##2##(1994-11#1)(1996-12#2)
the hypotensive action of##2##4##(1990-1#1)(1994-11#1)
the hypotensive effect##2##3##(1990-7#1)(1992-9#1)
the hypotensive response to APNEA##2##5##(1993-11#2)
the hypotensive response to##3##4##(1993-11#2)(1997-5#1)
the hypotensive response##4##3##(1991-5#1)(1993-11#2)(1997-5#1)
the hypotensive##11##2##(1990-1#1)(1990-7#1)(1990-9#1)(1991-5#1)(1992-9#1)(1993-11#2)(1993-3#1)(1994-11#1)(1997-5#1)(2005-10#1)
the hypothalamic arcuate##2##3##(1993-12#1)(2006-1#1)
the hypothalamic defense area##2##4##(1991-8#2)
the hypothalamic nuclei##3##3##(1990-2#1)(1993-5#1)(2007-8#1)
the hypothalamic paraventricular area##2##4##(1993-12#2)
the hypothalamic paraventricular nucleus (PVN)##3##5##(1994-12#1)(1994-8#1)(1995-7#1)
the hypothalamic paraventricular nucleus##14##4##(1991-3#2)(1993-12#1)(1993-2#2)(1994-12#1)(1994-8#2)(1995-12#1)(1995-7#1)(1996-12#2)(1997-8#1)(2009-2#1)
the hypothalamic paraventricular##16##3##(1991-3#2)(1993-12#3)(1993-2#2)(1994-12#1)(1994-8#2)(1995-12#1)(1995-7#1)(1996-12#2)(1997-8#1)(2009-2#1)
the hypothalamic suprachiasmatic nucleus (SCN)##3##5##(1993-12#1)(1995-11#1)(1996-9#1)
the hypothalamic tachykinin##2##3##(1994-10#2)
the hypothalamic##46##2##(1990-2#2)(1991-3#2)(1991-5#1)(1991-8#3)(1991-9#1)(1993-12#5)(1993-2#2)(1993-4#1)(1993-5#1)(1994-10#3)(1994-12#1)(1994-8#4)(1995-11#1)(1995-12#2)(1995-5#1)(1995-7#1)(1996-12#2)(1996-3#2)(1996-4#1)(1996-9#1)(1997-5#1)(1997-8#1)(2006-1#1)(2007-6#1)(2007-8#1)(2009-2#1)(2009-6#1)(2011-2#1)(2012-3#1)
the hypothalamic-pituitary##3##2##(1993-3#1)(1996-3#1)(2010-2#1)
the hypothalamic-pituitary-adrenal (HPA) axis and##2##5##(1995-12#1)(2007-11#1)
the hypothalamic-pituitary-adrenal (HPA) axis is##3##5##(1994-11#1)(2013-1#2)
the hypothalamic-pituitary-adrenal (HPA) axis##11##4##(1994-11#1)(1995-12#1)(1996-10#1)(1996-12#1)(2007-11#2)(2008-4#1)(2011-2#1)(2013-1#3)
the hypothalamic-pituitary-adrenal (HPA)##12##3##(1994-11#1)(1995-12#1)(1996-10#1)(1996-12#1)(1996-4#1)(2007-11#2)(2008-4#1)(2011-2#1)(2013-1#3)
the hypothalamic-pituitary-adrenal axis and##3##4##(1995-12#1)(2008-4#1)(2013-8#1)
the hypothalamic-pituitary-adrenal axis in##3##4##(1994-11#1)(1995-12#1)(2008-5#1)
the hypothalamic-pituitary-adrenal axis##21##3##(1994-10#1)(1994-11#3)(1994-5#1)(1995-12#7)(1997-2#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
the hypothalamic-pituitary-adrenal##33##2##(1994-10#1)(1994-11#4)(1994-5#1)(1995-12#8)(1996-10#1)(1996-12#1)(1996-4#1)(1997-2#1)(2007-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#4)(2013-8#1)
the hypothalamic-pituitary-gonadal axis##3##3##(1994-9#1)(2006-1#1)(2009-6#1)
the hypothalamo-pituitary adrenal##2##3##(1995-12#1)(2006-10#1)
the hypothalamo-pituitary##3##2##(1995-12#1)(2006-10#1)(2006-6#1)
the hypothalamo-pituitary-adrenal (HPA) axis##2##4##(1994-11#1)(1994-2#1)
the hypothalamo-pituitary-adrenal axis##5##3##(1990-2#2)(1994-10#1)(1994-2#1)(1995-12#1)
the hypothalamo-pituitary-adrenal##7##2##(1990-2#2)(1994-10#1)(1994-11#1)(1994-2#2)(1995-12#1)
the hypothalamo-pituitary-gonadal axis##2##3##(1994-10#1)(1994-8#1)
the hypothalamus and hypophysis##2##4##(1997-5#2)
the hypothalamus and in the##2##5##(1990-4#1)(1996-1#1)
the hypothalamus and the##3##4##(1994-2#1)(1995-12#1)(1997-7#1)
the hypothalamus and##19##3##(1990-4#1)(1990-7#1)(1991-10#1)(1991-11#1)(1993-7#1)(1994-10#2)(1994-2#1)(1995-12#2)(1996-1#1)(1996-12#1)(1997-3#1)(1997-5#2)(1997-7#2)(2010-12#1)(2013-1#1)
the hypothalamus are##3##3##(1991-8#1)(1995-10#1)(1995-5#1)
the hypothalamus in##4##3##(1993-12#2)(1996-9#1)(1997-2#1)
the hypothalamus of##15##3##(1991-11#1)(1991-2#1)(1992-12#1)(1992-3#4)(1993-12#1)(1994-10#3)(1995-12#1)(1995-7#2)(1996-3#1)
the hypothalamus was##3##3##(1994-10#1)(2006-10#1)(2011-1#1)
the hypothalamus##122##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-7#1)(1991-10#1)(1991-11#2)(1991-2#1)(1991-4#1)(1991-8#1)(1992-12#1)(1992-3#4)(1992-8#1)(1993-12#8)(1993-2#4)(1993-5#2)(1993-7#2)(1994-10#8)(1994-11#1)(1994-12#1)(1994-2#8)(1994-5#1)(1994-6#1)(1995-1#1)(1995-10#2)(1995-12#16)(1995-5#2)(1995-7#2)(1995-8#2)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#4)(1996-4#2)(1996-7#1)(1996-9#3)(1997-2#1)(1997-3#1)(1997-5#5)(1997-7#2)(1997-8#3)(2006-1#1)(2006-10#1)(2007-12#1)(2007-5#1)(2008-4#2)(2008-7#2)(2010-10#2)(2010-12#2)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#1)(2013-1#2)
the hypothalamus-pituitary-adrenal axis and##2##4##(2009-6#1)(2011-2#1)
the hypothalamus-pituitary-adrenal axis##3##3##(2007-7#1)(2009-6#1)(2011-2#1)
the hypothalamus-pituitary-adrenal##4##2##(1990-3#1)(2007-7#1)(2009-6#1)(2011-2#1)
the hypothermia##3##2##(1993-12#2)(1995-3#1)
the hypothermic##6##2##(1990-12#1)(1994-2#1)(1996-12#2)(1997-3#1)(2007-10#1)
the hypotheses that the##3##4##(1994-3#1)(2008-10#1)(2011-2#1)
the hypotheses that##15##3##(1993-9#1)(1994-3#1)(1996-4#1)(2004-7#1)(2006-5#1)(2007-10#1)(2008-10#3)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#2)(2012-3#1)
the hypotheses##23##2##(1993-9#1)(1994-3#1)(1996-3#1)(1996-4#1)(2004-7#1)(2006-5#1)(2007-10#1)(2007-5#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)
the hypothesis according to which##2##5##(1990-11#1)(1990-2#1)
the hypothesis and##2##3##(1995-11#1)(2007-3#1)
the hypothesis has been##2##4##(1994-10#1)(2013-1#1)
the hypothesis has##3##3##(1994-10#1)(2013-1#2)
the hypothesis is##3##3##(1994-6#1)(2007-9#1)(2009-4#1)
the hypothesis of a single##2##5##(2008-10#2)
the hypothesis of a##21##4##(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-5#1)(2006-2#1)(2008-10#4)(2009-10#1)(2009-11#1)(2013-1#1)
the hypothesis of an##9##4##(1994-3#1)(2006-12#1)(2006-2#3)(2007-9#1)(2008-10#2)(2011-2#1)
the hypothesis of random mating##2##5##(2008-10#2)
the hypothesis of the##4##4##(1991-12#1)(2008-6#1)(2009-2#1)(2010-12#1)
the hypothesis of##57##3##(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-5#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-5#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-5#1)(2004-11#1)(2006-12#1)(2006-2#4)(2007-5#1)(2007-9#1)(2008-10#11)(2008-5#1)(2008-6#2)(2008-8#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2010-12#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
the hypothesis test##2##3##(1996-8#1)(2008-2#1)
the hypothesis that 1##2##4##(1995-12#1)(2010-7#1)
the hypothesis that IL-1##2##4##(1993-7#1)(1994-10#1)
the hypothesis that a##21##4##(1990-3#1)(1990-5#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-6#1)(1994-3#1)(1995-5#1)(1995-7#1)(2004-11#1)(2007-3#1)(2007-6#1)(2008-10#1)(2008-8#2)(2009-5#1)(2010-12#1)(2010-2#1)(2012-1#1)(2013-8#1)
the hypothesis that activation of##2##5##(2008-8#1)(2011-2#1)
the hypothesis that aging##2##4##(2008-3#1)(2013-1#1)
the hypothesis that an##6##4##(1990-5#1)(1990-9#1)(1997-2#1)(2008-10#1)(2008-11#1)(2009-1#1)
the hypothesis that both the##2##5##(1991-1#1)(2013-7#1)
the hypothesis that both##5##4##(1991-1#1)(1997-1#1)(1997-9#1)(2008-5#1)(2013-7#1)
the hypothesis that changes in##2##5##(1991-8#1)(2011-2#1)
the hypothesis that circulating##2##4##(1993-2#1)(2009-11#1)
the hypothesis that decreased##2##4##(1990-5#1)(2008-1#1)
the hypothesis that dietary##2##4##(1994-2#1)(2006-8#1)
the hypothesis that elevated##3##4##(1991-2#1)(1993-12#1)(1997-5#1)
the hypothesis that enhancement of##2##5##(1994-5#2)
the hypothesis that glutamate##2##4##(1993-12#1)(1997-5#1)
the hypothesis that in##2##4##(2006-5#1)(2007-10#1)
the hypothesis that increased##2##4##(1990-11#1)(2009-12#1)
the hypothesis that insulin##2##4##(1997-6#1)(2008-10#1)
the hypothesis that invasive##2##4##(1991-7#1)(2008-8#1)
the hypothesis that it##3##4##(1990-3#1)(1993-12#1)(2008-10#1)
the hypothesis that local##2##4##(1993-2#1)(2008-5#1)
the hypothesis that modulation of##2##5##(1995-10#1)(1996-1#1)
the hypothesis that nonprofit##2##4##(1992-12#1)(1995-2#1)
the hypothesis that occupational##2##4##(1991-12#1)(2008-10#1)
the hypothesis that oxidative stress##3##5##(1992-9#1)(1994-10#1)(2010-8#1)
the hypothesis that physical##2##4##(1992-6#1)(2009-12#1)
the hypothesis that preservation##2##4##(2008-1#1)(2012-2#1)
the hypothesis that repeated##2##4##(1993-12#1)(2010-12#1)
the hypothesis that selection##2##4##(1996-1#1)(2010-8#1)
the hypothesis that spatial##2##4##(2008-8#1)(2009-5#1)
the hypothesis that specific##2##4##(2009-4#1)(2012-2#1)
the hypothesis that spontaneous##2##4##(1991-7#1)(2009-3#1)
the hypothesis that the central##3##5##(1991-7#1)(1993-3#1)(2008-5#1)
the hypothesis that the cytoplasmic##2##5##(1991-1#1)(2009-2#1)
the hypothesis that the disease##2##5##(2008-10#2)
the hypothesis that the effect of##2##6##(2008-4#1)(2008-7#1)
the hypothesis that the neural##2##5##(1991-2#1)(2012-1#1)
the hypothesis that the relationship##2##5##(2005-10#1)(2007-12#1)
the hypothesis that the specific##2##5##(2012-12#1)(2013-1#1)
the hypothesis that the##106##4##(1990-6#1)(1991-1#2)(1991-11#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-7#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2005-10#1)(2006-2#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-3#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#2)(2009-2#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#6)(2013-8#1)
the hypothesis that there are##2##5##(1997-7#1)(2008-5#1)
the hypothesis that there is a##3##6##(1996-3#1)(2010-5#1)(2011-2#1)
the hypothesis that there is an##2##6##(1996-3#1)(2007-2#1)
the hypothesis that there is##7##5##(1996-3#2)(2006-5#1)(2007-2#1)(2008-12#1)(2010-5#1)(2011-2#1)
the hypothesis that there##12##4##(1993-4#1)(1995-2#1)(1996-3#2)(1997-7#1)(2006-5#1)(2007-2#1)(2008-12#1)(2008-5#1)(2010-5#1)(2011-2#2)
the hypothesis that these##5##4##(1991-11#1)(2007-11#1)(2008-4#1)(2008-9#1)(2010-2#1)
the hypothesis that they##5##4##(1991-10#1)(1992-9#1)(1994-11#1)(2007-12#1)(2008-5#1)
the hypothesis that this##6##4##(1993-11#1)(1994-10#1)(1996-5#1)(2006-4#1)(2008-10#1)(2009-8#1)
the hypothesis that when##2##4##(2009-2#1)(2013-8#1)
the hypothesis that##507##3##(1990-1#1)(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#2)(1990-5#5)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#2)(1991-1#5)(1991-10#3)(1991-11#2)(1991-12#2)(1991-2#4)(1991-3#1)(1991-5#2)(1991-6#4)(1991-7#4)(1991-8#1)(1991-9#6)(1992-1#4)(1992-11#1)(1992-12#3)(1992-2#2)(1992-4#1)(1992-5#2)(1992-6#7)(1992-7#2)(1992-8#4)(1992-9#3)(1993-11#2)(1993-12#6)(1993-2#3)(1993-3#2)(1993-4#3)(1993-5#1)(1993-6#4)(1993-7#5)(1993-8#2)(1993-9#1)(1994-10#6)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#5)(1994-8#5)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#3)(1995-12#7)(1995-2#9)(1995-4#1)(1995-5#1)(1995-7#2)(1995-8#3)(1996-1#5)(1996-11#1)(1996-12#3)(1996-3#5)(1996-4#1)(1996-5#5)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#7)(1997-3#2)(1997-4#3)(1997-5#6)(1997-6#2)(1997-7#4)(1997-8#4)(1997-9#1)(2004-10#1)(2004-11#2)(2004-3#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#2)(2006-10#3)(2006-2#3)(2006-4#1)(2006-5#3)(2006-8#3)(2006-9#2)(2007-1#4)(2007-10#3)(2007-11#4)(2007-12#7)(2007-2#1)(2007-3#5)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#4)(2008-1#6)(2008-10#38)(2008-11#7)(2008-12#3)(2008-3#10)(2008-4#6)(2008-5#12)(2008-6#3)(2008-7#10)(2008-8#13)(2008-9#5)(2009-1#2)(2009-10#3)(2009-11#4)(2009-12#3)(2009-2#2)(2009-3#3)(2009-4#4)(2009-5#3)(2009-6#3)(2009-7#2)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#6)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#3)(2012-12#7)(2012-2#6)(2012-3#2)(2012-5#1)(2013-1#13)(2013-7#3)(2013-8#3)
the hypothesis was tested##2##4##(1995-10#1)(2007-9#1)
the hypothesis was##4##3##(1990-2#1)(1995-10#1)(2005-9#1)(2007-9#1)
the hypothesis##614##2##(1990-1#1)(1990-11#4)(1990-12#2)(1990-2#4)(1990-3#2)(1990-4#3)(1990-5#5)(1990-6#1)(1990-7#2)(1990-8#4)(1990-9#2)(1991-1#6)(1991-10#3)(1991-11#2)(1991-12#4)(1991-2#5)(1991-3#1)(1991-5#3)(1991-6#4)(1991-7#4)(1991-8#1)(1991-9#6)(1992-1#4)(1992-11#1)(1992-12#3)(1992-2#2)(1992-4#1)(1992-5#3)(1992-6#8)(1992-7#2)(1992-8#4)(1992-9#3)(1993-10#1)(1993-11#2)(1993-12#6)(1993-2#3)(1993-3#3)(1993-4#3)(1993-5#2)(1993-6#4)(1993-7#6)(1993-8#2)(1993-9#2)(1994-10#7)(1994-11#2)(1994-12#4)(1994-2#4)(1994-3#3)(1994-5#2)(1994-6#7)(1994-8#6)(1994-9#2)(1995-1#1)(1995-10#3)(1995-11#5)(1995-12#7)(1995-2#9)(1995-3#1)(1995-4#1)(1995-5#4)(1995-7#2)(1995-8#3)(1996-1#5)(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#6)(1996-4#1)(1996-5#5)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#6)(1997-2#8)(1997-3#2)(1997-4#3)(1997-5#7)(1997-6#2)(1997-7#4)(1997-8#4)(1997-9#1)(2004-10#1)(2004-11#3)(2004-3#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#2)(2005-9#1)(2006-10#3)(2006-12#2)(2006-2#7)(2006-4#1)(2006-5#3)(2006-8#3)(2006-9#2)(2007-1#4)(2007-10#3)(2007-11#4)(2007-12#7)(2007-2#1)(2007-3#6)(2007-4#1)(2007-5#3)(2007-6#1)(2007-8#2)(2007-9#7)(2008-1#7)(2008-10#52)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#10)(2008-4#6)(2008-5#14)(2008-6#5)(2008-7#12)(2008-8#15)(2008-9#6)(2009-1#2)(2009-10#4)(2009-11#6)(2009-12#3)(2009-2#3)(2009-3#3)(2009-4#8)(2009-5#3)(2009-6#3)(2009-7#2)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#6)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-12#2)(2011-2#10)(2012-1#4)(2012-12#7)(2012-2#6)(2012-3#4)(2012-5#1)(2013-1#20)(2013-7#3)(2013-8#4)
the hypothesized##18##2##(1992-6#1)(1993-6#1)(1994-2#1)(1997-5#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#1)(2011-1#1)(2012-1#2)(2012-2#1)
the hypothetical##17##2##(1992-1#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-6#1)(1996-6#1)(1997-3#1)(2005-4#1)(2006-11#1)(2007-2#1)(2007-3#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-5#1)(2012-1#1)
the hypothyroid##2##2##(1995-7#1)(2006-11#1)
the hypovirulent phenotype##2##3##(2008-10#2)
the hypovirulent##8##2##(2008-10#8)
the hypoxanthine##3##2##(1990-11#1)(1990-5#1)(1992-8#1)
the hypoxanthine-guanine##2##2##(1994-3#1)(1997-3#1)
the hypoxemia##2##2##(1993-11#1)(1997-4#1)
the hypoxia-induced##4##2##(2011-2#1)(2012-12#2)(2013-1#1)
the hypoxia-inducible factor and##3##4##(2009-3#3)
the hypoxia-inducible factor##7##3##(1997-4#1)(2009-3#6)
the hypoxia-inducible##8##2##(1997-4#1)(2009-3#6)(2012-12#1)
the hypoxic##9##2##(1995-1#1)(1995-6#2)(2006-6#1)(2010-7#1)(2011-12#2)(2012-12#2)
the hysterectomy##2##2##(2004-10#1)(2006-10#1)
the hysteresis loop##3##3##(2008-3#2)(2008-7#1)
the hysteresis of##2##3##(2005-11#1)(2007-11#1)
the hysteresis##10##2##(2005-11#2)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-2#1)(2011-2#1)
the hysteretic behavior of the##2##5##(2010-2#2)
the hysteretic behavior##4##3##(2010-2#4)
the hysteroscopic##2##2##(1992-12#1)(1994-9#1)
the i##22##2##(1990-5#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-8#2)(1993-11#1)(1995-11#1)(1996-2#2)(1996-6#1)(1997-8#2)(2006-6#1)(2007-2#5)(2008-1#1)(2013-1#2)
the i2b2##4##2##(2013-1#4)
the i3##2##2##(1995-3#2)
the iCFA##2##2##(1994-8#2)
the iView-GT##2##2##(2009-11#2)
the iatrogenic##2##2##(2005-8#1)(2010-11#1)
the ibuprofen##2##2##(1993-11#1)(1994-8#1)
the icEEG data##2##3##(2013-8#2)
the ice storm##3##3##(2008-2#3)
the ice##20##2##(2005-11#1)(2006-4#2)(2007-7#1)(2007-9#2)(2008-10#3)(2008-2#5)(2008-3#6)
the ice-like water##2##3##(2008-5#2)
the iceberg##4##2##(1994-2#1)(2006-9#1)(2007-8#1)(2008-7#1)
the icelandic##2##2##(2006-10#2)
the ichthyofauna##2##2##(2008-5#1)(2013-7#1)
the icicle##2##2##(2008-2#2)
the icosahedral##4##2##(1991-6#1)(1994-9#1)(2008-4#1)(2011-12#1)
the idea of a##13##4##(1991-1#1)(1994-12#1)(1995-12#1)(2006-3#1)(2006-5#1)(2007-12#1)(2007-9#1)(2008-3#1)(2008-8#1)(2010-10#1)(2010-7#1)(2012-2#1)(2013-8#1)
the idea of blood##2##4##(2008-12#1)(2009-4#1)
the idea of compassion##2##4##(2007-10#2)
the idea of the##7##4##(1994-3#1)(2004-12#1)(2007-12#2)(2008-3#1)(2008-8#1)(2010-11#1)
the idea of using##4##4##(2006-10#1)(2007-11#1)(2008-5#1)(2011-12#1)
the idea of##63##3##(1990-12#1)(1991-1#1)(1994-12#1)(1994-3#1)(1995-12#1)(2004-12#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#4)(2007-11#1)(2007-12#4)(2007-3#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-12#2)(2008-2#5)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#3)(2011-1#2)(2011-12#1)(2011-2#2)(2012-2#4)(2012-3#1)(2013-8#2)
the idea that a##7##4##(1990-10#1)(1990-5#1)(1991-9#1)(1993-4#1)(2006-10#1)(2006-11#1)(2009-9#1)
the idea that at##2##4##(1990-11#1)(1990-5#1)
the idea that the##21##4##(1990-10#1)(1990-5#2)(1991-2#1)(1993-12#1)(1993-6#1)(1994-10#1)(1995-11#1)(1995-2#1)(1997-2#1)(2005-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-2#1)(2012-1#1)
the idea that this##3##4##(1994-9#1)(2007-5#1)(2008-10#1)
the idea that##102##3##(1990-10#2)(1990-11#2)(1990-2#1)(1990-5#4)(1990-8#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(2005-11#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#2)(2011-1#1)(2011-12#1)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#4)
the idea to##3##3##(2007-4#1)(2007-5#1)(2011-2#1)
the idea##178##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#4)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-10#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-7#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#2)(2004-12#1)(2005-10#2)(2005-11#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#1)(2006-8#2)(2007-10#4)(2007-11#1)(2007-12#4)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#4)(2008-1#2)(2008-10#11)(2008-11#5)(2008-12#3)(2008-2#9)(2008-3#2)(2008-5#4)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#4)(2009-5#1)(2009-8#2)(2009-9#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-7#3)(2011-1#3)(2011-12#2)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#9)(2012-3#2)(2013-1#4)(2013-8#2)
the ideal and##4##3##(2008-11#1)(2008-3#1)(2010-10#1)(2012-2#1)
the ideal body##3##3##(2007-12#3)
the ideal estimate##2##3##(2008-3#2)
the ideal male body marketed to##2##6##(2007-12#2)
the ideal of##5##3##(2008-10#1)(2008-5#4)
the ideal option for##2##4##(2006-10#1)(2011-2#1)
the ideal particle diameter##2##4##(2007-9#2)
the ideal regimen##2##3##(2009-8#1)(2010-12#1)
the ideal time##2##3##(2007-7#1)(2012-7#1)
the ideal weight##2##3##(2007-12#1)(2007-8#1)
the ideal##107##2##(1990-4#1)(1990-7#1)(1992-3#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-3#2)(1997-5#1)(2004-2#1)(2005-11#1)(2005-6#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-7#1)(2006-9#2)(2007-11#1)(2007-12#7)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#4)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#9)(2008-3#4)(2008-5#6)(2008-6#3)(2008-8#2)(2008-9#1)(2009-11#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#2)(2012-7#1)(2013-1#4)(2013-8#1)
the ideas of the##2##4##(2007-9#1)(2012-2#1)
the ideas of##5##3##(1990-12#1)(1994-2#1)(2007-9#1)(2012-1#1)(2012-2#1)
the ideas##13##2##(1990-12#1)(1994-2#1)(1996-1#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-9#1)(2008-11#1)(2010-12#1)(2012-1#1)(2012-2#3)
the identical amino acid##2##4##(1992-8#1)(2008-4#1)
the identical##19##2##(1991-4#1)(1991-8#1)(1992-8#2)(1994-3#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-11#1)(1997-2#1)(2006-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2012-2#1)
the identifiable##2##2##(1991-2#1)(2011-2#1)
the identification and characterization of the##2##6##(2005-2#1)(2008-4#1)
the identification and characterization of##7##5##(1992-8#1)(1994-12#1)(1995-3#1)(1996-10#1)(2005-2#1)(2008-4#2)
the identification and differentiation of##2##5##(2008-10#2)
the identification and management of##2##5##(2008-10#1)(2012-11#1)
the identification and quantification of##4##5##(1990-8#1)(2008-10#2)(2008-5#1)
the identification and subsequent##2##4##(1992-2#1)(2008-2#1)
the identification and##49##3##(1990-7#1)(1990-8#1)(1991-2#2)(1991-8#1)(1992-2#1)(1992-8#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-3#1)(1996-10#1)(2005-2#1)(2005-7#1)(2006-10#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-11#1)(2013-1#1)(2013-8#1)
the identification in##2##3##(2008-10#1)(2009-8#1)
the identification of a high##2##5##(2010-6#1)(2012-3#1)
the identification of a novel##2##5##(2009-6#1)(2009-8#1)
the identification of a single##2##5##(1993-6#1)(1997-7#1)
the identification of a##38##4##(1990-11#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-2#1)(1993-12#2)(1993-6#2)(1994-8#1)(1994-9#1)(1995-8#1)(1996-10#2)(1996-5#1)(1996-9#1)(1997-7#2)(2007-1#2)(2007-2#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-2#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-3#2)(2013-1#1)
the identification of all the##2##5##(2009-2#1)(2011-3#1)
the identification of all##3##4##(2008-9#1)(2009-2#1)(2011-3#1)
the identification of an##2##4##(2012-2#2)
the identification of clinically##2##4##(2006-10#1)(2008-10#1)
the identification of critical##2##4##(2009-10#1)(2011-1#1)
the identification of different##2##4##(1997-2#1)(2008-2#1)
the identification of five##2##4##(1990-5#1)(2007-8#1)
the identification of four##3##4##(1991-5#1)(1994-9#1)(2007-7#1)
the identification of functional##3##4##(1992-12#1)(2008-7#2)
the identification of genes controlling##2##5##(2008-7#1)(2008-8#1)
the identification of genes involved in##3##6##(1997-8#1)(2008-10#1)(2009-12#1)
the identification of genes that##4##5##(2008-4#1)(2008-8#1)(2009-10#1)(2011-2#1)
the identification of genes##10##4##(1997-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-12#1)(2009-8#1)(2011-2#1)
the identification of genomic##2##4##(2012-12#1)(2012-2#1)
the identification of immunotoxicity##2##4##(2008-10#2)
the identification of important##3##4##(2007-10#1)(2008-7#1)(2011-1#1)
the identification of key##3##4##(2008-4#1)(2013-1#2)
the identification of major##3##4##(2013-1#2)(2013-8#1)
the identification of mental##2##4##(2008-8#1)(2011-12#1)
the identification of molecules##2##4##(2008-4#1)(2009-9#1)
the identification of more than##3##5##(2006-10#1)(2007-12#1)(2008-7#1)
the identification of more##4##4##(2006-10#1)(2007-12#1)(2008-7#1)(2011-1#1)
the identification of multiple##2##4##(2008-7#1)(2011-1#1)
the identification of new biomarkers and the development of##2##9##(2011-2#1)(2012-12#1)
the identification of new drug targets##2##6##(2008-7#1)(2010-12#1)
the identification of new##10##4##(1997-3#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#1)
the identification of novel##18##4##(2005-6#1)(2005-7#1)(2006-10#2)(2008-1#2)(2008-10#1)(2008-7#2)(2009-10#1)(2009-4#1)(2010-4#1)(2012-1#1)(2012-12#3)(2013-1#2)
the identification of other##5##4##(1994-9#1)(2006-10#1)(2008-10#1)(2010-12#1)(2010-5#1)
the identification of patients at##2##5##(2004-11#1)(2007-11#1)
the identification of patients##7##4##(1990-12#1)(1991-5#1)(2004-11#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#1)
the identification of peptide##3##4##(2006-10#2)(2012-3#1)
the identification of potential##4##4##(2006-10#1)(2008-10#1)(2008-7#1)(2010-12#1)
the identification of potentially##3##4##(2009-8#1)(2012-12#2)
the identification of proteins##7##4##(1997-2#1)(2008-1#1)(2008-10#1)(2008-4#2)(2010-12#1)(2010-6#1)
the identification of regions##3##4##(1993-3#1)(1994-6#1)(2008-3#1)
the identification of risk factors for##2##6##(2010-11#1)(2012-1#1)
the identification of risk factors##3##5##(2007-11#1)(2010-11#1)(2012-1#1)
the identification of several##2##4##(2007-11#1)(2008-4#1)
the identification of six##2##4##(1993-6#1)(2007-12#1)
the identification of specific##5##4##(1995-7#1)(1997-1#1)(2008-9#1)(2010-4#2)
the identification of such##2##4##(2006-7#1)(2010-5#1)
the identification of the main##2##5##(2006-5#1)(2010-8#1)
the identification of the molecular##2##5##(2006-10#1)(2008-1#1)
the identification of the three##3##5##(1990-7#1)(2008-10#2)
the identification of the##50##4##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-7#1)(1992-2#1)(1995-11#1)(1995-9#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
the identification of their##4##4##(2007-12#1)(2008-5#1)(2009-10#1)(2009-4#1)
the identification of these##2##4##(2008-10#1)(2012-2#1)
the identification of this##6##4##(1991-2#1)(1991-5#1)(1994-3#1)(1996-12#1)(2009-10#1)(2009-4#1)
the identification of those##3##4##(1990-8#1)(1992-10#1)(2006-10#1)
the identification of three##3##4##(1991-8#1)(1996-9#1)(2009-4#1)
the identification of two new##3##5##(1993-6#1)(2008-10#1)(2008-11#1)
the identification of two##12##4##(1991-9#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-11#1)(2005-11#1)(2008-10#1)(2008-11#2)(2011-2#1)
the identification of unknown##4##4##(1995-2#2)(2005-4#1)(2010-5#1)
the identification of##468##3##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#4)(1991-12#4)(1991-2#3)(1991-5#3)(1991-7#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#2)(1992-7#1)(1992-9#2)(1993-12#4)(1993-3#2)(1993-5#1)(1993-6#4)(1993-9#3)(1994-11#2)(1994-12#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#5)(1995-11#2)(1995-2#2)(1995-5#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-5#2)(1996-6#1)(1996-9#2)(1997-1#3)(1997-2#4)(1997-3#1)(1997-4#3)(1997-7#2)(1997-8#2)(2004-11#1)(2004-2#1)(2005-10#1)(2005-11#2)(2005-4#1)(2005-6#1)(2005-7#1)(2005-8#2)(2006-10#18)(2006-12#3)(2006-2#2)(2006-5#1)(2006-7#1)(2007-1#5)(2007-10#4)(2007-11#12)(2007-12#5)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#5)(2008-1#7)(2008-10#48)(2008-11#7)(2008-12#3)(2008-2#5)(2008-3#8)(2008-4#14)(2008-5#7)(2008-6#2)(2008-7#23)(2008-8#8)(2008-9#5)(2009-1#2)(2009-10#7)(2009-12#3)(2009-2#1)(2009-4#5)(2009-5#4)(2009-6#4)(2009-7#1)(2009-8#8)(2009-9#3)(2010-10#3)(2010-11#6)(2010-12#9)(2010-2#1)(2010-3#1)(2010-4#5)(2010-5#5)(2010-6#3)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#12)(2011-12#2)(2011-2#10)(2011-3#1)(2012-1#3)(2012-12#14)(2012-2#14)(2012-3#11)(2013-1#10)(2013-7#2)(2013-8#4)
the identification process##2##3##(1997-8#1)(2008-12#1)
the identification##540##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#2)(1990-8#5)(1991-12#4)(1991-2#5)(1991-5#3)(1991-7#2)(1991-8#2)(1991-9#2)(1992-10#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-5#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-12#4)(1993-3#3)(1993-5#1)(1993-6#4)(1993-9#3)(1994-11#2)(1994-12#3)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#5)(1995-1#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-10#3)(1996-11#1)(1996-12#1)(1996-5#2)(1996-6#2)(1996-9#2)(1997-1#3)(1997-2#4)(1997-3#1)(1997-4#4)(1997-7#2)(1997-8#3)(2004-11#1)(2004-2#1)(2005-10#1)(2005-11#2)(2005-2#1)(2005-4#1)(2005-5#1)(2005-6#1)(2005-7#2)(2005-8#2)(2006-10#20)(2006-12#3)(2006-2#2)(2006-5#1)(2006-7#1)(2007-1#5)(2007-10#4)(2007-11#13)(2007-12#5)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#6)(2008-1#10)(2008-10#60)(2008-11#8)(2008-12#4)(2008-2#7)(2008-3#8)(2008-4#16)(2008-5#9)(2008-6#3)(2008-7#24)(2008-8#9)(2008-9#7)(2009-1#2)(2009-10#7)(2009-12#3)(2009-2#1)(2009-4#5)(2009-5#4)(2009-6#5)(2009-7#1)(2009-8#10)(2009-9#3)(2010-10#3)(2010-11#7)(2010-12#10)(2010-2#1)(2010-3#1)(2010-4#5)(2010-5#5)(2010-6#3)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#13)(2011-12#2)(2011-2#12)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#14)(2012-2#15)(2012-3#13)(2013-1#12)(2013-7#2)(2013-8#8)
the identified genes are##2##4##(2008-7#1)(2011-2#1)
the identified proteins##2##3##(2007-12#1)(2008-7#1)
the identified species##2##3##(2007-3#1)(2012-2#1)
the identified##54##2##(1990-3#1)(1991-11#1)(1991-8#2)(1993-12#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-5#2)(2004-2#2)(2006-10#2)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-7#3)(2010-12#1)(2010-2#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#5)
the identify##2##2##(1990-5#1)(1994-8#1)
the identities of##4##3##(1997-4#1)(2006-8#1)(2007-12#1)(2011-2#1)
the identities##5##2##(1997-4#1)(2006-8#1)(2007-12#1)(2008-8#1)(2011-2#1)
the identity and diversity of##2##5##(2008-10#1)(2012-2#1)
the identity and##12##3##(1990-10#1)(1991-2#1)(1991-5#1)(1991-7#1)(2004-12#1)(2008-10#3)(2008-4#2)(2012-2#2)
the identity crisis##2##3##(1997-3#1)(2008-7#1)
the identity of each##2##4##(1990-2#1)(2007-1#1)
the identity of its##3##4##(1991-11#1)(1991-9#1)(2008-5#1)
the identity of the upcoming tastant##2##6##(2008-11#2)
the identity of the##43##4##(1990-12#1)(1990-7#2)(1991-4#1)(1991-7#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-4#1)(1994-12#1)(1994-8#1)(1995-5#1)(1995-7#1)(1996-8#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-12#2)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#2)(2008-8#2)(2010-3#1)(2011-1#2)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
the identity of##67##3##(1990-12#2)(1990-2#1)(1990-7#3)(1991-11#1)(1991-4#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-4#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-7#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-12#3)(2007-1#2)(2007-3#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#2)(2010-3#1)(2011-1#2)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
the identity##92##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-7#3)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-5#2)(1995-7#1)(1996-5#1)(1996-8#1)(1997-3#2)(1997-4#1)(2004-12#1)(2005-11#1)(2006-12#3)(2007-1#2)(2007-11#1)(2007-3#1)(2008-10#8)(2008-11#3)(2008-3#1)(2008-4#4)(2008-5#3)(2008-7#2)(2008-8#2)(2009-4#1)(2010-3#1)(2011-1#3)(2011-2#3)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#3)
the ideological##6##2##(1991-6#1)(2008-7#1)(2008-9#1)(2010-1#1)(2012-2#1)(2013-1#1)
the ideology of##4##3##(1991-6#1)(2006-7#1)(2007-3#1)(2008-10#1)
the ideology##5##2##(1991-6#1)(2006-10#1)(2006-7#1)(2007-3#1)(2008-10#1)
the idiopathic nature of##2##4##(2005-8#1)(2012-2#1)
the idiopathic scoliosis##3##3##(2007-8#3)
the idiopathic##8##2##(2005-8#2)(2006-5#1)(2007-8#3)(2012-12#1)(2012-2#1)
the idiosyncratic##3##2##(2008-10#1)(2008-4#1)(2012-11#1)
the idler and##3##3##(2007-12#1)(2008-1#1)(2008-2#1)
the idler output##3##3##(2007-11#1)(2007-12#2)
the idler pulses##3##3##(2007-11#1)(2007-12#2)
the idler waves##2##3##(2007-12#1)(2008-3#1)
the idler##32##2##(2007-11#3)(2007-12#20)(2008-1#4)(2008-2#1)(2008-3#4)
the ifenprodil binding site##2##4##(1997-3#2)
the ileal bile acid transport system##3##6##(1994-9#3)
the ileal bile acid##4##4##(1994-9#3)(2008-5#1)
the ileal##9##2##(1991-5#1)(1993-11#1)(1994-9#3)(1996-12#1)(1996-3#1)(2008-5#1)(2009-12#1)
the ileocecal valve##3##3##(1994-5#1)(2010-12#2)
the ileocecal##4##2##(1990-8#1)(1994-5#1)(2010-12#2)
the ileostomy##3##2##(2009-5#3)
the ileum and##2##3##(1994-12#1)(2008-4#1)
the ileum##22##2##(1991-5#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1996-11#3)(1996-3#1)(2006-12#1)(2006-8#2)(2007-4#2)(2008-4#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
the iliac arteries##4##3##(1997-3#1)(2005-10#3)
the iliac artery##5##3##(1996-2#1)(2005-10#1)(2008-3#2)(2012-1#1)
the iliac crest and##2##4##(2006-11#1)(2008-6#1)
the iliac crest##9##3##(1996-8#1)(2006-11#1)(2007-11#1)(2007-7#2)(2008-6#1)(2009-9#2)(2010-8#1)
the iliac wings##2##3##(2006-11#1)(2007-4#1)
the iliac##26##2##(1991-11#1)(1996-2#1)(1996-8#1)(1997-3#1)(2005-10#4)(2006-11#2)(2007-11#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-12#1)(2008-3#2)(2008-6#1)(2009-3#1)(2009-9#2)(2010-3#1)(2010-8#1)(2012-1#1)(2012-2#1)
the iliacus##4##2##(2006-10#1)(2009-3#3)
the iliotibial band##6##3##(2007-7#5)(2012-2#1)
the iliotibial##7##2##(2007-7#5)(2012-2#2)
the ill and##2##3##(2005-9#1)(2008-2#1)
the ill##9##2##(1990-10#1)(2005-9#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-9#1)(2010-2#1)(2011-7#1)
the illicit##2##2##(2008-10#1)(2012-1#1)
the illness and##8##3##(1992-11#1)(1992-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-8#1)(2011-1#1)(2012-2#1)
the illness in##3##3##(1992-12#1)(2007-7#1)(2012-2#1)
the illness is##2##3##(2007-8#1)(2012-3#1)
the illness may be##3##4##(2006-10#1)(2008-11#1)(2013-7#1)
the illness may##5##3##(1997-3#1)(2006-10#1)(2007-11#1)(2008-11#1)(2013-7#1)
the illness##62##2##(1990-9#1)(1991-12#1)(1992-11#1)(1992-12#2)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#2)(1997-3#1)(1997-6#1)(1997-8#1)(2005-8#1)(2006-10#2)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#2)(2007-11#2)(2007-2#1)(2007-7#2)(2007-8#2)(2008-11#2)(2008-4#2)(2008-6#3)(2008-7#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-8#2)(2011-1#3)(2011-2#6)(2012-2#2)(2012-3#2)(2013-7#2)
the illuminated regions##2##3##(2007-8#2)
the illuminated##6##2##(2007-8#2)(2008-2#1)(2008-3#3)
the illuminating beam##5##3##(2008-2#4)(2008-3#1)
the illuminating##13##2##(2008-1#1)(2008-2#7)(2008-3#4)(2012-2#1)
the illumination and##3##3##(2008-2#2)(2008-3#1)
the illumination angle##2##3##(2008-3#2)
the illumination of the##2##4##(2008-1#1)(2008-8#1)
the illumination of##6##3##(2007-12#1)(2008-1#1)(2008-3#2)(2008-4#1)(2008-8#1)
the illumination source##5##3##(2007-11#2)(2008-2#1)(2008-3#1)(2011-1#1)
the illumination was##2##3##(2008-4#1)(2012-3#1)
the illumination wavelength##3##3##(2006-12#1)(2008-2#1)(2008-3#1)
the illumination##41##2##(2006-12#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-2#11)(2008-3#14)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-1#1)(2012-3#1)
the illusion effect##2##3##(1997-1#2)
the illusion of musical suspension##2##5##(2012-2#2)
the illusion of##4##3##(2007-12#1)(2012-2#2)(2013-1#1)
the illusion##10##2##(1995-1#1)(1997-1#2)(2007-12#1)(2012-2#4)(2013-1#1)(2013-8#1)
the iloprost group##3##3##(2009-7#3)
the ilv##2##2##(1992-2#2)
the ilv3##2##2##(1993-12#2)
the image acquisition##2##3##(2007-11#1)(2008-10#1)
the image analysis system##2##4##(2005-11#1)(2010-12#1)
the image analysis##4##3##(2005-11#1)(2008-10#1)(2009-3#1)(2010-12#1)
the image and the##5##4##(2008-3#4)(2010-6#1)
the image and##10##3##(2007-12#1)(2008-2#3)(2008-3#5)(2010-6#1)
the image are##2##3##(2008-2#1)(2010-4#1)
the image at the##2##4##(2007-5#1)(2008-2#1)
the image at##5##3##(2007-5#1)(2008-2#2)(2010-5#2)
the image by using a##2##5##(2008-2#1)(2008-3#1)
the image by##3##3##(2008-2#2)(2008-3#1)
the image center as a function of the number of##2##10##(2007-12#1)(2008-2#1)
the image contrast and##2##4##(2008-3#2)
the image contrast##8##3##(2008-2#1)(2008-3#6)(2011-1#1)
the image data and##2##4##(2008-6#1)(2012-3#1)
the image data##10##3##(1997-8#2)(2006-10#1)(2008-2#2)(2008-3#1)(2008-6#1)(2009-3#1)(2011-2#1)(2012-3#1)
the image distribution##3##3##(2008-2#3)
the image edges##2##3##(2008-2#2)
the image field##2##3##(2008-3#2)
the image in##5##3##(2008-1#1)(2008-2#2)(2008-3#1)(2013-8#1)
the image intensity##3##3##(2008-2#2)(2008-3#1)
the image into##3##3##(2007-11#1)(2008-2#2)
the image is##7##3##(1995-11#1)(1996-2#1)(2008-1#1)(2008-2#2)(2008-3#1)(2013-7#1)
the image itself and##2##4##(2008-2#1)(2008-3#1)
the image of a##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
the image of the object itself##2##6##(2008-3#2)
the image of the object##3##5##(2008-2#1)(2008-3#2)
the image of the pattern##2##5##(2008-3#2)
the image of the##20##4##(1995-1#1)(2006-2#1)(2008-12#1)(2008-2#4)(2008-3#7)(2008-5#1)(2008-6#1)(2009-10#1)(2009-4#1)(2010-8#1)(2011-1#1)
the image of##26##3##(1995-1#1)(1996-12#1)(2006-2#1)(2007-10#1)(2007-12#1)(2008-12#2)(2008-2#5)(2008-3#8)(2008-5#1)(2008-6#1)(2009-10#1)(2009-4#1)(2010-8#1)(2011-1#1)
the image or##2##3##(2008-2#2)
the image plane##12##3##(2007-12#3)(2008-2#4)(2008-3#4)(2011-1#1)
the image processing##2##3##(1995-6#1)(2008-3#1)
the image quality and##2##4##(2004-9#1)(2008-2#1)
the image quality of a##2##5##(2008-2#1)(2008-3#1)
the image quality of##3##4##(2008-2#1)(2008-3#1)(2011-1#1)
the image quality##12##3##(1997-8#1)(2004-9#1)(2006-6#1)(2008-2#4)(2008-3#2)(2010-12#1)(2011-1#2)
the image reconstruction##2##3##(2008-3#2)
the image resolution##3##3##(2007-12#1)(2008-2#1)(2010-4#1)
the image sensor##2##3##(2008-2#2)
the image space##2##3##(2008-6#1)(2011-2#1)
the image that is##2##4##(2008-12#1)(2008-2#1)
the image that##3##3##(1992-10#1)(2008-12#1)(2008-2#1)
the image to##4##3##(2007-12#2)(2008-2#1)(2009-10#1)
the image##242##2##(1991-12#1)(1992-10#1)(1992-9#2)(1993-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#2)(1996-12#1)(1996-2#1)(1997-8#5)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#16)(2007-5#1)(2008-1#4)(2008-10#3)(2008-12#4)(2008-2#85)(2008-3#50)(2008-4#1)(2008-5#2)(2008-6#7)(2009-10#2)(2009-3#2)(2009-4#1)(2010-12#4)(2010-4#3)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#8)(2011-2#3)(2012-3#1)(2013-7#2)(2013-8#2)
the image's##2##2##(2006-10#1)(2008-2#1)
the image-formation process##2##3##(2007-12#1)(2008-9#1)
the image-guided##3##2##(2009-12#1)(2013-1#2)
the image-injected##2##2##(2006-9#2)
the imaged##2##2##(2009-10#1)(2011-2#1)
the imager and##2##3##(2008-3#2)
the imager##4##2##(2008-3#3)(2010-12#1)
the imagery##4##2##(1992-8#1)(2008-2#2)(2013-8#1)
the images and the##2##4##(2007-12#1)(2010-8#1)
the images and##3##3##(2007-12#1)(2008-2#1)(2010-8#1)
the images are in color##2##5##(2012-2#2)
the images are##11##3##(2008-2#2)(2008-3#5)(2011-1#1)(2012-2#3)
the images formed by##3##4##(2008-2#1)(2008-3#2)
the images in##3##3##(2006-10#1)(2008-3#1)(2011-7#1)
the images is##2##3##(2008-2#2)
the images obtained##3##3##(1995-11#1)(2005-9#1)(2008-5#1)
the images of lines##2##4##(2008-2#2)
the images of the##3##4##(2008-2#2)(2011-1#1)
the images of##12##3##(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#1)(2008-9#1)(2009-12#2)(2010-8#1)(2011-1#1)
the images on##2##3##(2006-10#1)(2008-3#1)
the images that##2##3##(2007-11#1)(2008-2#1)
the images to##3##3##(2008-2#2)(2010-8#1)
the images were##5##3##(2006-5#1)(2007-11#1)(2007-12#1)(2008-5#1)(2012-2#1)
the images##80##2##(1991-4#1)(1995-11#1)(2005-9#1)(2006-10#3)(2006-4#2)(2006-5#3)(2007-11#5)(2007-12#4)(2008-10#1)(2008-2#20)(2008-3#16)(2008-4#1)(2008-5#3)(2008-9#1)(2009-12#2)(2009-7#1)(2010-1#1)(2010-8#3)(2011-1#3)(2011-7#1)(2012-2#5)(2012-3#1)(2013-8#1)
the imaginary part of the refractive index##3##7##(2008-2#1)(2008-3#2)
the imaginary part of the##7##5##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)
the imaginary part was##2##4##(2008-3#2)
the imaginary part##15##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#11)
the imaginary##39##2##(2007-11#4)(2007-12#9)(2008-1#1)(2008-10#1)(2008-2#6)(2008-3#18)
the imagination of##2##3##(2006-10#1)(2010-7#1)
the imagination##4##2##(2006-10#1)(2008-8#1)(2009-10#1)(2010-7#1)
the imaging and##4##3##(2006-6#1)(2008-3#1)(2008-5#1)(2009-11#1)
the imaging appearances##2##3##(2006-1#1)(2012-2#1)
the imaging capability##2##3##(2008-3#1)(2011-1#1)
the imaging characteristics of the##2##5##(2006-5#1)(2007-12#1)
the imaging characteristics of##6##4##(1997-8#1)(2006-5#1)(2007-12#1)(2008-2#1)(2012-2#2)
the imaging data##2##3##(2012-2#1)(2013-8#1)
the imaging examinations##2##3##(2008-4#1)(2012-12#1)
the imaging features of##3##4##(2007-6#1)(2008-1#1)(2012-2#1)
the imaging features##4##3##(2007-6#1)(2008-1#1)(2008-7#1)(2012-2#1)
the imaging findings##7##3##(2006-1#1)(2008-2#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
the imaging geometry##2##3##(2007-11#1)(2008-6#1)
the imaging investigations demonstrated large bilateral adrenal masses##2##8##(2013-1#2)
the imaging of apoptosis##2##4##(2008-8#2)
the imaging of the##4##4##(2006-6#1)(2007-5#1)(2010-12#1)(2013-1#1)
the imaging of##19##3##(2006-6#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-2#5)(2008-3#2)(2008-7#1)(2008-8#2)(2010-12#1)(2010-4#1)(2012-2#2)(2013-1#1)
the imaging optics##3##3##(2007-12#1)(2008-3#2)
the imaging performance of##5##4##(2008-2#4)(2008-3#1)
the imaging procedure##4##3##(2007-12#1)(2007-2#1)(2008-4#1)(2010-8#1)
the imaging process from##2##4##(2008-2#1)(2008-3#1)
the imaging process##3##3##(2008-2#2)(2008-3#1)
the imaging properties##2##3##(2008-3#2)
the imaging system##8##3##(2006-12#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)(2009-4#1)
the imaging##118##2##(1991-12#1)(1997-8#1)(2006-1#2)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#3)(2007-11#3)(2007-12#7)(2007-2#2)(2007-5#1)(2007-6#1)(2008-1#4)(2008-10#1)(2008-2#20)(2008-3#18)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#1)(2009-3#2)(2009-4#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#5)(2012-2#10)(2013-1#3)(2013-8#3)
the imbalance between the##2##4##(2007-9#1)(2008-3#1)
the imbalance between##3##3##(2007-9#1)(2008-3#1)(2009-7#1)
the imbalance of##2##3##(1992-8#1)(2010-5#1)
the imbalance##6##2##(1992-8#1)(1994-2#1)(2007-9#1)(2008-3#1)(2009-7#1)(2010-5#1)
the imidazobenzodiazepine Ro 15-4513##2##4##(1990-10#2)
the imidazobenzodiazepine##3##2##(1990-10#2)(1995-7#1)
the imidazole derivative##2##3##(2008-10#2)
the imidazole ring of##2##4##(1995-5#1)(2010-2#1)
the imidazole##9##2##(1995-5#1)(2006-4#1)(2008-10#3)(2008-3#1)(2008-8#2)(2010-2#1)
the imidazolidine##2##2##(1993-6#1)(1996-8#1)
the imidazoline receptor##2##3##(1993-9#1)(2008-5#1)
the imide nitrogen##2##3##(1992-6#1)(2009-9#1)
the imine##4##2##(1991-3#1)(2006-12#1)(2008-5#1)(2010-2#1)
the iminium in equilibrium with enamine##2##6##(1991-9#2)
the imino resonances for the##2##5##(1991-11#2)
the imino##7##2##(1990-7#1)(1991-11#2)(1991-8#1)(2008-3#2)(2008-5#1)
the immature and##4##3##(1996-3#1)(2006-4#1)(2008-11#2)
the immature bone tissue##2##4##(2007-7#2)
the immature brain##3##3##(1996-3#1)(1996-5#2)
the immature stages of##6##4##(2004-11#1)(2007-10#1)(2007-6#2)(2008-5#1)(2012-12#1)
the immature visual system##2##4##(1992-7#2)
the immature##35##2##(1990-11#1)(1992-7#2)(1993-7#1)(1994-3#1)(1995-8#1)(1996-1#1)(1996-3#4)(1996-5#2)(2004-11#1)(2006-4#1)(2007-10#1)(2007-6#2)(2007-7#3)(2008-10#1)(2008-11#2)(2008-5#4)(2008-6#2)(2008-7#1)(2009-2#1)(2010-12#1)(2012-12#2)
the immediate aftermath of##2##4##(2007-11#1)(2013-1#1)
the immediate aftermath##3##3##(2007-11#1)(2012-2#1)(2013-1#1)
the immediate and delayed##2##4##(2005-10#1)(2013-8#1)
the immediate and the long-term##2##5##(1993-12#1)(2008-12#1)
the immediate and##5##3##(1993-12#1)(2005-10#1)(2007-2#1)(2008-12#1)(2013-8#1)
the immediate effects of##4##4##(1991-9#1)(2008-12#1)(2009-10#1)(2010-12#1)
the immediate future##4##3##(1995-1#1)(1995-5#1)(2005-12#1)(2010-2#1)
the immediate outcome of##2##4##(1994-11#1)(1996-9#1)
the immediate post-operative outcome of two##2##6##(2007-8#2)
the immediate post-operative outcome##3##4##(2007-8#3)
the immediate post-operative##7##3##(2007-11#1)(2007-8#4)(2012-2#2)
the immediate postflame zone##2##4##(2008-3#2)
the immediate postoperative period##11##4##(1990-3#1)(2005-10#1)(2006-10#1)(2006-11#2)(2007-11#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-10#1)
the immediate postoperative##15##3##(1990-3#1)(2005-10#1)(2006-10#2)(2006-11#2)(2007-11#2)(2007-12#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-4#1)(2010-10#1)
the immediate postpartum##3##3##(2004-10#1)(2006-10#1)(2009-3#1)
the immediate precursor of##4##4##(1994-10#1)(1995-3#1)(1997-1#1)(2008-10#1)
the immediate precursor to##2##4##(1996-9#1)(2008-10#1)
the immediate precursor##6##3##(1994-10#1)(1995-3#1)(1996-9#1)(1997-1#1)(2008-10#2)
the immediate social##2##3##(2008-6#1)(2013-1#1)
the immediate surgical##2##3##(1994-12#1)(2004-1#1)
the immediate vicinity of the##9##5##(1990-3#1)(1990-4#1)(2006-10#1)(2006-3#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-2#1)
the immediate vicinity of##16##4##(1990-3#1)(1990-4#1)(1996-10#1)(1996-3#1)(2006-10#1)(2006-3#1)(2008-10#3)(2008-3#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-9#1)
the immediate##142##2##(1990-3#3)(1990-4#1)(1991-3#1)(1991-9#2)(1992-4#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-10#2)(1996-2#1)(1996-3#2)(1996-7#3)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#1)(1997-5#1)(2004-1#1)(2004-10#1)(2005-10#3)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#5)(2006-11#2)(2006-12#1)(2006-3#1)(2006-4#1)(2006-8#3)(2007-1#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-3#6)(2008-4#2)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#4)(2010-9#2)(2012-1#3)(2012-2#3)(2013-1#7)(2013-8#1)
the immediate-early##3##2##(1993-12#1)(1997-3#1)(1997-5#1)
the immediately postoperative##2##3##(1991-2#2)
the immense##7##2##(2005-8#1)(2006-10#1)(2006-4#1)(2007-10#1)(2008-11#1)(2010-8#1)(2012-3#1)
the immersed##3##2##(1990-5#1)(2005-11#1)(2011-1#1)
the immersion medium##2##3##(2007-12#2)
the immersion of##2##3##(1995-12#1)(2008-11#1)
the immersion##9##2##(1995-12#1)(2007-12#4)(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
the immigrants##8##2##(1991-4#1)(1992-5#1)(1993-9#1)(1995-5#1)(1997-6#1)(2008-8#2)(2013-1#1)
the immigration##4##2##(1996-11#1)(2006-10#1)(2008-10#1)(2012-2#1)
the imminent##6##2##(1991-3#1)(1993-6#1)(2008-8#1)(2009-4#1)(2011-1#1)(2013-8#1)
the immiscible##2##2##(1990-4#2)
the immobilisation##4##2##(2008-10#3)(2010-5#1)
the immobilised##10##2##(1994-6#1)(1995-2#1)(1997-2#2)(2005-8#1)(2008-10#4)(2013-7#1)
the immobility##3##2##(1991-12#1)(1993-2#1)(2013-1#1)
the immobilization and##3##3##(2007-11#1)(2008-10#1)(2008-8#1)
the immobilization of a##3##4##(2008-10#1)(2009-3#1)(2010-12#1)
the immobilization of antibody##2##4##(2007-8#1)(2008-10#1)
the immobilization of polyphenol oxidase##2##5##(2008-10#2)
the immobilization of the##6##4##(2008-10#4)(2008-4#1)(2010-5#1)
the immobilization of##37##3##(1990-4#1)(1992-8#1)(1993-12#1)(2005-11#2)(2007-8#6)(2008-10#18)(2008-11#2)(2008-4#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-5#1)(2013-8#1)
the immobilization##50##2##(1990-4#1)(1992-8#1)(1993-12#1)(1995-3#1)(2005-11#2)(2007-11#1)(2007-8#8)(2007-9#2)(2008-10#24)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-5#1)(2013-8#1)
the immobilized Chiralpak IA##2##4##(2008-10#2)
the immobilized HRP##3##3##(2007-8#1)(2008-10#2)
the immobilized antibodies##2##3##(2007-8#2)
the immobilized cells##4##3##(2008-10#1)(2008-11#2)(2008-7#1)
the immobilized enzyme was##2##4##(2008-10#1)(2008-7#1)
the immobilized enzyme##5##3##(2008-10#3)(2008-7#1)(2009-10#1)
the immobilized lipase##2##3##(2008-5#1)(2008-7#1)
the immobilized metal ion##2##4##(1990-8#1)(1991-11#1)
the immobilized metal##3##3##(1990-8#1)(1991-11#1)(2008-10#1)
the immobilized oligonucleotide##2##3##(2008-10#2)
the immobilized protein##3##3##(1996-8#2)(2008-10#1)
the immobilized system##2##3##(2004-8#1)(2008-10#1)
the immobilized##70##2##(1990-12#2)(1990-5#1)(1990-8#1)(1991-11#1)(1993-11#2)(1994-3#2)(1996-2#1)(1996-3#1)(1996-8#2)(1996-9#1)(1997-3#1)(1997-4#1)(2004-8#1)(2005-8#1)(2006-12#1)(2007-12#1)(2007-8#4)(2008-10#31)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#6)(2008-8#1)(2009-10#1)(2012-1#1)
the immortalization of##2##3##(1993-11#1)(2008-11#1)
the immortalized cells##2##3##(1995-5#2)
the immortalized##4##2##(1995-5#3)(2008-11#1)
the immune activation##3##3##(2008-5#1)(2008-7#1)(2012-2#1)
the immune and nervous systems##2##5##(2007-2#2)
the immune and other##2##4##(1996-12#2)
the immune and##8##3##(1994-10#1)(1996-12#2)(2007-2#2)(2008-9#1)(2009-6#1)(2012-3#1)
the immune cells##5##3##(1994-5#1)(2007-12#1)(2008-3#2)(2013-1#1)
the immune complex##2##3##(1996-5#1)(2008-4#1)
the immune deficiency##2##3##(2005-10#1)(2008-2#1)
the immune function##4##3##(2006-6#1)(2008-9#1)(2010-12#1)(2011-2#1)
the immune inflammatory response##2##4##(2013-1#2)
the immune response against##3##4##(1994-3#1)(2006-10#1)(2008-9#1)
the immune response and phagocytosis##2##5##(2004-12#2)
the immune response and##10##4##(1990-11#1)(2004-12#2)(2006-10#1)(2008-10#1)(2008-4#2)(2008-5#2)(2008-8#1)
the immune response by##3##4##(2006-7#1)(2007-11#1)(2010-12#1)
the immune response during##2##4##(2008-11#1)(2009-5#1)
the immune response in the spleen##2##6##(2010-12#2)
the immune response in the##4##5##(1994-2#1)(2007-7#1)(2010-12#2)
the immune response in##17##4##(1991-12#1)(1994-2#1)(1995-2#1)(1995-5#1)(2004-12#1)(2005-7#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-7#1)(2008-11#1)(2010-12#2)(2010-3#1)(2012-1#1)(2012-12#1)
the immune response of the host##2##6##(2006-10#1)(2007-7#1)
the immune response of the##3##5##(2006-10#2)(2007-7#1)
the immune response of##6##4##(1992-9#1)(2006-10#2)(2007-7#1)(2008-10#1)(2012-2#1)
the immune response to hepatitis B vaccine##2##7##(2009-12#1)(2013-1#1)
the immune response to the infection##2##6##(2008-4#1)(2008-9#1)
the immune response to the##4##5##(1993-8#1)(1996-10#1)(2008-4#1)(2008-9#1)
the immune response to##23##4##(1993-8#1)(1995-2#2)(1995-5#1)(1996-10#1)(1997-4#1)(2004-12#2)(2006-10#1)(2007-11#1)(2007-2#1)(2008-11#2)(2008-2#1)(2008-4#3)(2008-8#1)(2008-9#1)(2009-12#1)(2010-10#1)(2012-2#1)(2013-1#1)
the immune response under##2##4##(2007-11#1)(2010-12#1)
the immune response##126##3##(1990-11#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-9#1)(1992-9#1)(1993-12#2)(1993-8#1)(1994-2#1)(1994-3#2)(1995-2#3)(1995-5#3)(1996-10#3)(1997-4#1)(2004-12#11)(2005-7#1)(2006-10#8)(2006-2#1)(2006-6#2)(2006-7#1)(2006-8#6)(2007-1#1)(2007-11#11)(2007-12#2)(2007-2#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-2#2)(2008-4#7)(2008-5#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#4)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#4)(2013-1#7)
the immune responses##9##3##(1992-5#1)(1995-5#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
the immune status of the host##2##6##(1996-12#1)(2008-5#1)
the immune status of the##5##5##(1996-12#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-5#1)
the immune status##6##3##(1996-12#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-2#1)(2008-5#1)
the immune stimulatory potential of##2##5##(2008-10#2)
the immune system and have##2##5##(1991-6#1)(2007-11#1)
the immune system and the##4##5##(1994-11#1)(1995-12#1)(2007-11#1)(2010-4#1)
the immune system and##23##4##(1990-11#1)(1990-5#1)(1990-9#1)(1991-6#1)(1994-11#1)(1995-12#1)(1996-11#1)(1996-4#1)(2005-8#1)(2006-10#1)(2007-11#4)(2008-10#2)(2008-12#2)(2008-4#1)(2008-7#1)(2010-4#1)(2012-3#1)(2013-1#1)
the immune system are##5##4##(2008-10#1)(2008-2#1)(2008-5#2)(2010-10#1)
the immune system by##2##4##(1994-11#1)(2007-11#1)
the immune system can##3##4##(2006-10#1)(2008-5#1)(2011-1#1)
the immune system functions##2##4##(2005-7#1)(2012-2#1)
the immune system has been##2##5##(2008-11#1)(2010-12#1)
the immune system has##3##4##(1997-3#1)(2008-11#1)(2010-12#1)
the immune system have##2##4##(2006-10#1)(2010-3#1)
the immune system in##16##4##(1995-1#1)(2006-1#1)(2008-10#1)(2008-12#2)(2008-7#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-1#3)(2012-12#2)(2012-3#1)(2013-1#1)
the immune system is##8##4##(1991-2#1)(1997-4#1)(2007-9#1)(2008-4#1)(2008-7#1)(2012-1#1)(2013-1#2)
the immune system may be##2##5##(2006-5#1)(2007-11#1)
the immune system of##10##4##(1991-10#1)(1993-12#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-12#1)(2012-2#1)
the immune system that##3##4##(2007-11#1)(2007-3#1)(2008-8#1)
the immune system through the##2##5##(1997-7#1)(2008-9#1)
the immune system to##5##4##(1990-3#1)(2008-11#1)(2009-12#1)(2011-2#1)(2013-7#1)
the immune system was##2##4##(1993-12#1)(2007-11#1)
the immune system were investigated##2##5##(1991-10#1)(2008-4#1)
the immune system were##5##4##(1991-10#1)(1993-12#1)(2008-10#2)(2008-4#1)
the immune system##242##3##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#2)(1991-10#2)(1991-2#1)(1991-6#1)(1992-2#1)(1993-11#1)(1993-12#3)(1993-3#3)(1994-11#2)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#5)(1995-3#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-3#1)(1997-4#3)(1997-7#1)(1997-9#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-1#4)(2006-10#17)(2006-11#2)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#1)(2007-11#22)(2007-2#2)(2007-3#3)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#25)(2008-11#3)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#16)(2008-5#7)(2008-7#7)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-10#2)(2010-12#7)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-1#9)(2012-12#7)(2012-2#5)(2012-3#5)(2013-1#6)(2013-7#4)(2013-8#1)
the immune systems of##2##4##(2006-10#1)(2013-1#1)
the immune tolerant##2##3##(2009-11#1)(2012-2#1)
the immune##453##2##(1990-11#2)(1990-12#2)(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#3)(1991-6#1)(1991-9#2)(1992-2#1)(1992-4#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#6)(1993-3#3)(1993-8#1)(1994-10#1)(1994-11#2)(1994-2#3)(1994-3#3)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#6)(1995-2#4)(1995-3#1)(1995-5#4)(1996-1#1)(1996-10#4)(1996-11#1)(1996-12#4)(1996-2#1)(1996-4#1)(1996-5#3)(1997-2#1)(1997-3#1)(1997-4#5)(1997-7#1)(1997-8#1)(1997-9#1)(2004-12#12)(2005-10#2)(2005-11#2)(2005-7#2)(2005-8#1)(2006-1#4)(2006-10#31)(2006-11#2)(2006-2#1)(2006-5#1)(2006-6#7)(2006-7#4)(2006-8#7)(2007-1#1)(2007-11#35)(2007-12#3)(2007-2#8)(2007-3#3)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#3)(2008-10#39)(2008-11#9)(2008-12#4)(2008-2#6)(2008-3#3)(2008-4#24)(2008-5#12)(2008-7#10)(2008-8#4)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#3)(2010-12#12)(2010-3#2)(2010-4#2)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#11)(2012-1#10)(2012-12#9)(2012-2#12)(2012-3#6)(2013-1#18)(2013-7#5)(2013-8#1)
the immunised##2##2##(1992-8#1)(1996-12#1)
the immunity of##5##3##(1995-12#1)(2007-11#1)(2008-2#2)(2008-7#1)
the immunity##11##2##(1990-3#1)(1994-2#1)(1995-12#1)(1996-11#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-7#1)
the immunization of##2##3##(1990-4#1)(1995-12#1)
the immunization schedule##2##3##(1996-3#1)(2008-4#1)
the immunization status of##2##4##(1996-1#1)(2008-4#1)
the immunization##18##2##(1990-12#1)(1990-4#1)(1993-2#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-3#1)(1997-8#1)(2007-2#1)(2008-4#3)(2008-6#1)(2008-9#1)(2009-5#1)(2013-1#2)
the immunized##7##2##(2006-10#1)(2008-11#2)(2008-8#1)(2008-9#2)(2012-2#1)
the immuno-pathogenesis of##3##3##(2008-1#3)
the immunoactive##2##2##(2009-11#1)(2011-1#1)
the immunoaffinity column##3##3##(1992-2#1)(2008-10#1)(2008-11#1)
the immunoaffinity step##2##3##(1992-2#2)
the immunoaffinity##9##2##(1992-2#3)(1997-8#1)(2008-10#2)(2008-11#1)(2008-4#2)
the immunoassay##11##2##(1997-7#2)(2008-10#8)(2010-11#1)
the immunobiology of##2##3##(1995-12#1)(2010-12#1)
the immunoblot##2##2##(1991-7#1)(1992-7#1)
the immunochemical reaction##3##3##(1994-3#1)(2008-10#2)
the immunochemical##8##2##(1991-12#1)(1991-4#1)(1994-2#1)(1994-3#1)(1997-6#1)(2008-10#3)
the immunocompetence##3##2##(2008-8#2)(2012-12#1)
the immunocompetent##3##2##(2008-10#1)(2010-12#2)
the immunocompromised host##2##3##(2006-10#1)(2008-1#1)
the immunocompromised##12##2##(2006-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-9#1)(2010-5#1)(2012-3#1)(2013-1#2)
the immunocytochemical localization of the##2##5##(1994-10#1)(2011-2#1)
the immunocytochemical##8##2##(1992-10#1)(1994-10#1)(1994-6#1)(1996-5#1)(1997-2#1)(2008-9#1)(2009-2#1)(2011-2#1)
the immunodeficiency##2##2##(1995-8#1)(2007-2#1)
the immunodominant##4##2##(1990-12#1)(1990-3#1)(1991-10#1)(1994-8#1)
the immunofluorescence##4##2##(1990-12#1)(1991-3#1)(1994-3#1)(2010-12#1)
the immunofluorescent##2##2##(1992-7#1)(1997-3#1)
the immunogen##4##2##(1997-3#2)(2008-4#2)
the immunogenetics of##3##3##(1995-5#1)(2006-10#2)
the immunogenic potential of##2##4##(2008-10#2)
the immunogenic##3##2##(1994-3#1)(2008-10#2)
the immunogenicity of the##4##4##(1990-12#1)(2005-8#2)(2008-5#1)
the immunogenicity of##20##3##(1990-12#1)(1995-2#1)(1995-5#2)(1997-6#1)(2005-8#2)(2006-12#1)(2007-11#1)(2007-2#1)(2008-10#4)(2008-5#1)(2008-8#3)(2009-4#1)(2009-9#1)
the immunogenicity##23##2##(1990-12#1)(1995-2#1)(1995-5#2)(1997-6#1)(2005-8#2)(2006-12#1)(2007-11#1)(2007-2#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#3)(2009-4#1)(2009-9#1)
the immunoglobulin heavy chain##3##4##(1990-5#2)(2008-11#1)
the immunoglobulin heavy##4##3##(1990-5#2)(2008-11#1)(2008-4#1)
the immunoglobulin superfamily##8##3##(1995-3#1)(1996-8#1)(1997-7#2)(2006-10#1)(2008-7#1)(2009-6#1)(2009-8#1)
the immunoglobulin##31##2##(1990-5#3)(1991-2#1)(1991-9#1)(1993-2#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-6#1)(1997-7#2)(1997-9#1)(2006-10#1)(2008-11#2)(2008-4#4)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2009-9#1)(2011-2#1)
the immunoglobulins##3##2##(1997-7#1)(2008-4#1)(2012-1#1)
the immunohistochemical detection of##2##4##(1994-2#1)(2008-6#1)
the immunohistochemical expression of##2##4##(1992-6#1)(2013-1#1)
the immunohistochemical expression##3##3##(1992-6#1)(2007-2#1)(2013-1#1)
the immunohistochemical localization of##2##4##(1996-4#1)(1997-5#1)
the immunohistochemical method##4##3##(1990-5#1)(1996-5#2)(2008-5#1)
the immunohistochemical##16##2##(1990-5#1)(1992-3#1)(1992-6#1)(1992-7#1)(1994-2#1)(1994-7#2)(1996-4#1)(1996-5#2)(1997-5#1)(1997-6#1)(2007-2#1)(2008-5#1)(2008-6#1)(2013-1#1)
the immunohistological##2##2##(1995-2#1)(2008-4#1)
the immunologic and##2##3##(1992-1#1)(2007-2#1)
the immunologic##12##2##(1990-12#1)(1991-12#1)(1992-1#1)(1995-12#2)(1995-5#1)(2005-10#1)(2007-2#1)(2008-10#1)(2008-4#1)(2013-1#2)
the immunological agglutination##4##3##(1990-12#4)
the immunological barrier##3##3##(2009-10#1)(2012-2#2)
the immunological changes##2##3##(1992-2#1)(2008-4#1)
the immunological function##2##3##(1994-6#1)(2008-1#1)
the immunological mechanisms##3##3##(2008-10#1)(2008-11#1)(2009-5#1)
the immunological response##5##3##(1997-7#1)(2005-7#1)(2007-11#1)(2009-12#1)(2012-2#1)
the immunological##45##2##(1990-12#5)(1991-6#2)(1992-2#1)(1994-6#1)(1996-9#2)(1997-7#2)(2004-9#1)(2005-7#2)(2006-10#2)(2006-4#1)(2006-6#2)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2012-1#2)(2012-2#3)(2013-1#1)
the immunologically##2##2##(2008-4#1)(2008-5#1)
the immunology of schistosomiasis##3##4##(2006-10#2)(2008-4#1)
the immunology of##10##3##(1992-12#1)(1993-12#1)(2006-10#5)(2007-7#1)(2008-4#1)(2013-7#1)
the immunology##11##2##(1992-12#1)(1993-12#1)(2006-10#5)(2007-7#1)(2008-1#1)(2008-4#1)(2013-7#1)
the immunomodulating properties of##2##4##(1991-11#1)(1991-6#1)
the immunomodulating properties##3##3##(1991-11#1)(1991-6#1)(1994-3#1)
the immunomodulating##5##2##(1991-11#1)(1991-6#1)(1994-3#1)(2006-10#1)(2008-10#1)
the immunomodulatory activity##2##3##(1991-1#1)(2008-10#1)
the immunomodulatory##6##2##(1991-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-2#1)
the immunopathogenesis of##12##3##(1995-1#1)(1997-4#1)(2005-11#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-12#1)(2011-2#1)(2013-1#1)
the immunoperoxidase staining##2##3##(1992-8#1)(1997-2#1)
the immunoperoxidase##3##2##(1991-8#1)(1992-8#1)(1997-2#1)
the immunophenotype of##2##3##(1995-3#1)(2006-6#1)
the immunophenotype##4##2##(1991-2#1)(1995-3#1)(2006-6#2)
the immunopositive##2##2##(2008-6#1)(2013-8#1)
the immunoprecipitate##3##2##(1992-8#1)(1994-3#1)(1996-5#1)
the immunoprecipitated##6##2##(1992-9#1)(1994-3#1)(2008-1#1)(2008-2#3)
the immunoprecipitates##4##2##(1992-4#1)(1992-9#1)(1993-8#1)(1997-6#1)
the immunoprecipitation of##3##3##(1992-9#1)(1997-1#1)(2008-4#1)
the immunoprecipitation##5##2##(1992-9#1)(1994-2#1)(1996-5#1)(1997-1#1)(2008-4#1)
the immunopurified##3##2##(1993-12#1)(1994-3#2)
the immunoreaction between##2##3##(2008-10#2)
the immunoreaction##7##2##(1990-7#1)(1991-4#1)(1994-2#1)(1995-1#1)(2008-10#3)
the immunoreactive##9##2##(1990-7#1)(1991-4#1)(1993-8#1)(1994-9#1)(1995-5#1)(1996-10#1)(1996-2#1)(1997-5#1)(2013-1#1)
the immunoreactivity of the##6##4##(1990-12#1)(1993-12#1)(1995-4#1)(1996-1#1)(2006-10#1)(2008-7#1)
the immunoreactivity of##12##3##(1990-12#1)(1993-12#1)(1993-6#1)(1995-11#2)(1995-4#2)(1996-1#1)(1996-8#1)(2006-10#1)(2008-7#1)(2013-8#1)
the immunoreactivity##16##2##(1990-12#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-4#2)(1996-1#1)(1996-8#1)(2006-10#1)(2008-7#1)(2013-8#1)
the immunosensor was##2##3##(2007-8#1)(2008-10#1)
the immunosensor##11##2##(2007-8#2)(2008-10#8)(2008-7#1)
the immunosorbent##2##2##(1996-8#2)
the immunostained##3##2##(1993-12#1)(1994-2#1)(1995-11#1)
the immunostaining of##5##3##(1994-6#1)(1997-5#1)(2012-11#2)(2012-2#1)
the immunostaining##6##2##(1994-6#1)(1995-11#1)(1997-5#1)(2012-11#2)(2012-2#1)
the immunosuppressant##6##2##(1992-6#1)(1993-11#1)(1993-8#1)(1994-12#1)(2010-12#1)(2010-3#1)
the immunosuppressants cyclosporin A##2##4##(1991-9#1)(1995-6#1)
the immunosuppressants##4##2##(1991-9#1)(1995-2#1)(1995-6#1)(2006-5#1)
the immunosuppressed##5##2##(2004-11#1)(2005-11#1)(2006-10#1)(2008-5#1)(2010-4#1)
the immunosuppressive actions of##2##4##(1993-8#1)(2008-10#1)
the immunosuppressive activity of##4##4##(1990-5#2)(1995-1#1)(2008-8#1)
the immunosuppressive agent##2##3##(1995-1#1)(2008-10#1)
the immunosuppressive agents##2##3##(1993-11#1)(2007-11#1)
the immunosuppressive drug cyclosporin A##2##5##(1993-6#1)(2011-2#1)
the immunosuppressive drug##5##3##(1991-10#2)(1993-6#1)(2006-10#1)(2011-2#1)
the immunosuppressive effect of##3##4##(1996-12#1)(2007-11#1)(2011-2#1)
the immunosuppressive effects of CsA##2##5##(1990-12#2)
the immunosuppressive effects of##8##4##(1990-12#2)(1995-2#1)(1996-12#1)(1997-4#1)(2007-11#1)(2008-4#1)(2011-1#1)
the immunosuppressive properties of##2##4##(1991-12#1)(1993-11#1)
the immunosuppressive regimen##2##3##(2007-11#1)(2008-1#1)
the immunosuppressive therapy##2##3##(1995-2#1)(2007-11#1)
the immunosuppressive##41##2##(1990-12#2)(1990-5#3)(1990-8#1)(1991-10#2)(1991-12#2)(1991-9#1)(1992-5#1)(1993-11#2)(1993-6#1)(1993-8#1)(1995-1#2)(1995-2#2)(1996-12#2)(1997-4#1)(2006-10#1)(2006-2#1)(2007-11#5)(2007-8#1)(2008-1#2)(2008-10#2)(2008-4#1)(2008-8#2)(2011-1#1)(2011-2#2)
the immunotherapy of cancer##2##4##(2007-11#1)(2009-10#1)
the immunotherapy##3##2##(2007-11#1)(2009-10#1)(2011-1#1)
the immunotoxic##3##2##(1997-3#1)(2008-10#2)
the immunotoxicity##2##2##(2008-10#1)(2008-7#1)
the immunotoxicological potential of##2##4##(2008-10#2)
the immunotoxin##4##2##(1993-7#2)(2008-5#1)(2010-12#1)
the impact and##10##3##(1993-11#1)(2004-12#1)(2006-10#1)(2006-8#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
the impact factor##2##3##(2011-1#1)(2011-4#1)
the impact force##5##3##(2006-11#1)(2007-4#4)
the impact of ART##2##4##(2007-7#2)
the impact of BS contacts##2##5##(2011-12#2)
the impact of CINV on##3##5##(2008-7#1)(2011-2#2)
the impact of CINV##4##4##(2008-7#1)(2011-2#3)
the impact of HIV/AIDS##3##4##(2007-7#3)
the impact of a community-based##2##5##(1992-1#1)(2012-12#1)
the impact of a single##3##5##(2008-4#1)(2008-7#1)(2009-3#1)
the impact of a##32##4##(1992-1#1)(1993-12#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-7#1)(1997-2#1)(2006-1#1)(2006-10#1)(2006-2#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
the impact of acculturation##2##4##(2007-12#1)(2010-8#1)
the impact of age##4##4##(2006-12#1)(2007-8#1)(2008-3#1)(2008-4#1)
the impact of an increasing##2##5##(1993-8#1)(2007-10#1)
the impact of an##7##4##(1993-8#1)(2005-10#1)(2007-10#1)(2007-7#1)(2007-9#1)(2011-2#1)(2012-3#1)
the impact of atmospheric##2##4##(2008-11#1)(2010-9#1)
the impact of changes in##3##5##(1996-2#1)(2011-2#1)(2013-1#1)
the impact of changes##5##4##(1995-12#1)(1995-3#1)(1996-2#1)(2011-2#1)(2013-1#1)
the impact of cultural##2##4##(2009-12#1)(2009-9#1)
the impact of delivery-centric interventions on clinician workflow##4##8##(2013-1#4)
the impact of dietary##2##4##(2008-9#1)(2012-2#1)
the impact of different##5##4##(1996-3#1)(1996-7#1)(2008-12#1)(2012-1#1)(2012-2#1)
the impact of early##5##4##(2007-8#1)(2008-12#1)(2008-4#1)(2009-5#1)(2013-8#1)
the impact of education##2##4##(2008-11#1)(2008-9#1)
the impact of environmental##2##4##(2008-8#1)(2011-1#1)
the impact of extended##2##4##(2007-8#1)(2013-1#1)
the impact of false-negatives##3##4##(2012-12#3)
the impact of foodborne disease##2##5##(2007-12#2)
the impact of gender##2##4##(2006-2#1)(2011-1#1)
the impact of health##6##4##(1995-2#1)(2009-10#1)(2012-12#1)(2012-3#1)(2013-1#2)
the impact of human##2##4##(2007-1#1)(2008-8#1)
the impact of hypertension##2##4##(1991-11#1)(2007-9#1)
the impact of imaging on##2##5##(2008-2#2)
the impact of imaging##3##4##(2008-2#2)(2009-11#1)
the impact of immunological disturbances as a result of allo-HSCT is not understood well##2##14##(2013-1#2)
the impact of local##2##4##(2006-10#1)(2012-2#1)
the impact of maternal##2##4##(1996-4#1)(1997-7#1)
the impact of medical##2##4##(2008-11#1)(2011-1#1)
the impact of mental##2##4##(2012-3#1)(2013-8#1)
the impact of misreporting on the association between EI and weight status##2##12##(2012-1#2)
the impact of n-3 PUFAs on##3##6##(2013-1#3)
the impact of new##3##4##(2005-11#1)(2008-2#1)(2010-12#1)
the impact of obesity on the##2##6##(2011-2#2)
the impact of obesity on##3##5##(2011-2#2)(2012-2#1)
the impact of pain##2##4##(2006-11#2)
the impact of pandemic influenza##2##5##(2011-2#2)
the impact of parental##2##4##(2011-1#2)
the impact of physician##2##4##(1994-1#1)(2007-4#1)
the impact of prior##2##4##(1995-8#1)(2007-9#1)
the impact of rainfall on##2##5##(2010-2#2)
the impact of selected##2##4##(2007-8#1)(2010-3#1)
the impact of several##4##4##(1996-10#1)(1996-12#1)(2007-8#1)(2009-7#1)
the impact of shaving on##2##5##(2008-5#2)
the impact of smoking##2##4##(1995-6#1)(1997-7#1)
the impact of social##2##4##(1994-2#1)(2008-11#1)
the impact of societal##3##4##(2004-12#1)(2007-2#1)(2011-2#1)
the impact of some##2##4##(2006-2#1)(2007-9#1)
the impact of specific##3##4##(2007-12#1)(2007-8#1)(2008-11#1)
the impact of stigma on##2##5##(2006-9#1)(2007-7#1)
the impact of stigma##3##4##(2006-9#1)(2007-7#2)
the impact of stress on##2##5##(1994-2#1)(2012-3#1)
the impact of stress##3##4##(1994-2#1)(2011-2#1)(2012-3#1)
the impact of such##2##4##(2007-10#1)(2008-7#1)
the impact of surgical##2##4##(1994-12#1)(2008-6#1)
the impact of temperature##2##4##(2011-2#1)(2013-8#1)
the impact of the changes in##2##6##(1994-1#1)(2007-8#1)
the impact of the intervention##3##5##(1996-1#1)(2006-2#1)(2007-7#1)
the impact of the##81##4##(1991-1#1)(1991-12#1)(1991-2#2)(1992-1#2)(1992-3#1)(1992-9#1)(1993-6#1)(1994-1#3)(1994-2#3)(1995-1#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-5#2)(2006-10#2)(2006-11#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-10#4)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-1#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
the impact of their##3##4##(2006-12#1)(2007-8#1)(2010-3#1)
the impact of these programs##2##5##(2007-11#1)(2013-1#1)
the impact of these##19##4##(1991-4#1)(1996-11#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-7#1)(2011-2#1)(2013-1#4)
the impact of this##14##4##(1991-6#1)(1997-7#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-7#1)
the impact of treatment on##5##5##(1992-9#1)(2006-10#1)(2008-7#1)(2013-1#2)
the impact of treatment##8##4##(1992-9#1)(2006-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#3)
the impact of two##3##4##(2008-10#1)(2008-5#1)(2013-1#1)
the impact of using##3##4##(2008-11#1)(2008-12#1)(2010-2#1)
the impact of various##6##4##(1993-12#1)(2006-8#1)(2007-11#1)(2007-8#1)(2009-5#1)(2011-2#1)
the impact of vehicular traffic##2##5##(2007-10#1)(2008-10#1)
the impact of weight##2##4##(2007-12#1)(2013-8#1)
the impact of##629##3##(1990-1#1)(1990-10#1)(1990-2#1)(1990-5#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#3)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#1)(1992-9#3)(1993-12#3)(1993-2#1)(1993-6#3)(1993-8#1)(1994-1#5)(1994-12#1)(1994-2#5)(1994-3#4)(1994-5#1)(1994-6#1)(1994-7#1)(1995-1#3)(1995-12#5)(1995-2#3)(1995-3#4)(1995-6#6)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#3)(1996-4#1)(1996-7#3)(1997-1#2)(1997-2#5)(1997-3#1)(1997-5#4)(1997-6#2)(1997-7#3)(2004-1#1)(2004-10#1)(2004-11#1)(2004-12#1)(2004-4#1)(2005-1#1)(2005-10#2)(2005-11#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#12)(2006-11#3)(2006-12#2)(2006-2#4)(2006-4#3)(2006-5#4)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#10)(2007-11#7)(2007-12#13)(2007-2#5)(2007-3#4)(2007-4#4)(2007-5#1)(2007-7#12)(2007-8#20)(2007-9#7)(2008-1#4)(2008-10#25)(2008-11#29)(2008-12#8)(2008-2#17)(2008-3#10)(2008-4#15)(2008-5#11)(2008-6#3)(2008-7#16)(2008-8#13)(2008-9#12)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#1)(2009-4#5)(2009-5#4)(2009-6#1)(2009-7#5)(2009-8#1)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#7)(2010-2#7)(2010-3#6)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#14)(2011-12#2)(2011-2#30)(2012-1#6)(2012-11#3)(2012-12#17)(2012-2#14)(2012-3#16)(2012-9#1)(2013-1#39)(2013-7#3)(2013-8#17)
the impact on child##2##4##(2011-1#1)(2012-3#1)
the impact on health##2##4##(1991-2#1)(2007-10#1)
the impact on patient##2##4##(1994-3#1)(2010-2#1)
the impact on the##5##4##(1992-2#1)(1993-1#1)(2007-3#1)(2008-2#1)(2008-3#1)
the impact on##37##3##(1991-2#1)(1992-12#1)(1992-2#2)(1993-1#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-5#1)(1996-7#1)(1997-3#1)(2006-10#2)(2007-10#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#2)(2008-9#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
the impact that the##3##4##(1992-1#1)(1997-6#1)(2008-12#1)
the impact that##10##3##(1992-1#1)(1996-3#1)(1997-6#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-8#1)(2010-7#1)(2011-2#1)
the impact these##2##3##(1992-3#1)(2008-9#1)
the impact this##3##3##(2010-12#1)(2012-2#1)(2012-3#1)
the impact to##3##3##(2007-4#1)(2008-10#1)(2011-12#1)
the impact##729##2##(1990-1#1)(1990-10#1)(1990-2#1)(1990-5#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#5)(1992-12#2)(1992-2#3)(1992-3#3)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-6#4)(1993-8#1)(1994-1#6)(1994-12#2)(1994-2#5)(1994-3#5)(1994-5#1)(1994-6#1)(1994-7#2)(1995-1#3)(1995-12#6)(1995-2#3)(1995-3#4)(1995-5#1)(1995-6#6)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#4)(1996-4#1)(1996-7#4)(1997-1#2)(1997-2#5)(1997-3#2)(1997-5#7)(1997-6#3)(1997-7#3)(2004-1#1)(2004-10#1)(2004-11#1)(2004-12#2)(2004-4#1)(2005-1#1)(2005-10#3)(2005-11#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#16)(2006-11#10)(2006-12#2)(2006-2#4)(2006-4#3)(2006-5#4)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#3)(2007-10#12)(2007-11#7)(2007-12#14)(2007-2#6)(2007-3#5)(2007-4#9)(2007-5#1)(2007-7#12)(2007-8#21)(2007-9#7)(2008-1#4)(2008-10#29)(2008-11#33)(2008-12#9)(2008-2#20)(2008-3#12)(2008-4#15)(2008-5#11)(2008-6#3)(2008-7#18)(2008-8#15)(2008-9#14)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#4)(2009-2#2)(2009-3#1)(2009-4#5)(2009-5#4)(2009-6#1)(2009-7#5)(2009-8#2)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#8)(2010-2#8)(2010-3#6)(2010-4#4)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#6)(2010-9#3)(2011-1#17)(2011-12#3)(2011-2#35)(2011-4#1)(2012-1#6)(2012-11#3)(2012-12#18)(2012-2#16)(2012-3#21)(2012-9#1)(2013-1#40)(2013-7#3)(2013-8#17)
the impacted##4##2##(2007-12#1)(2007-4#1)(2010-12#1)(2013-1#1)
the impaction##2##2##(2006-5#1)(2008-3#1)
the impactor##6##2##(2007-1#3)(2007-4#1)(2008-10#1)(2008-3#1)
the impacts of the##2##4##(1996-12#1)(2008-1#1)
the impacts of##25##3##(1992-3#1)(1993-1#1)(1996-12#1)(1997-5#1)(1997-7#1)(2005-8#1)(2007-10#2)(2008-1#2)(2008-12#1)(2008-2#2)(2008-5#2)(2008-9#2)(2010-10#1)(2010-12#1)(2010-9#1)(2011-1#2)(2012-12#1)(2013-1#2)
the impacts on##2##3##(2010-9#1)(2012-2#1)
the impacts##29##2##(1992-3#1)(1993-1#1)(1996-12#1)(1997-5#1)(1997-7#1)(2005-8#1)(2007-10#2)(2007-4#1)(2008-1#3)(2008-12#1)(2008-2#2)(2008-5#2)(2008-9#2)(2010-10#1)(2010-12#1)(2010-9#2)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#2)
the impaired arm##4##3##(2012-1#4)
the impaired##17##2##(1990-4#1)(1994-11#1)(1995-3#1)(1995-9#1)(1996-7#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-9#1)(2009-2#1)(2010-4#1)(2012-1#4)(2013-1#1)(2013-8#1)
the impairment in##3##3##(1992-12#1)(2010-3#1)(2011-1#1)
the impairment induced by##2##4##(1994-5#2)
the impairment of insulin receptor kinase##2##6##(1994-5#1)(1995-3#1)
the impairment of the##4##4##(1990-3#1)(1991-5#1)(1995-11#1)(2010-10#1)
the impairment of##29##3##(1990-3#1)(1991-5#1)(1991-6#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-5#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-7#1)(1997-2#1)(1997-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-10#1)(2011-2#1)(2013-1#1)
the impairment##42##2##(1990-3#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-5#4)(1995-1#2)(1995-11#1)(1995-12#2)(1995-3#2)(1995-6#1)(1995-8#1)(1996-7#1)(1997-2#1)(1997-4#1)(2006-8#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
the impasse##2##2##(2005-10#1)(2008-7#1)
the impedance of the##2##4##(1995-11#1)(2010-10#1)
the impedance of##3##3##(1995-11#1)(2008-10#1)(2010-10#1)
the impedance threshold device##2##4##(2010-12#2)
the impedance##11##2##(1995-11#1)(1996-5#1)(2008-10#2)(2008-3#2)(2009-10#1)(2010-10#1)(2010-12#2)(2012-1#1)
the impeller centrifugal pump##2##4##(1992-1#2)
the impeller##4##2##(1992-1#2)(2008-6#1)(2008-8#1)
the impending##5##2##(1992-3#1)(2007-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
the imperative of##4##3##(1996-2#1)(1997-1#1)(2009-4#1)(2011-1#1)
the imperative to##2##3##(1997-2#1)(2008-11#1)
the imperative##6##2##(1996-2#1)(1997-1#1)(1997-2#1)(2008-11#1)(2009-4#1)(2011-1#1)
the imperfect palindrome##2##3##(1991-2#1)(1997-4#1)
the imperfect##3##2##(1991-2#1)(1996-9#1)(1997-4#1)
the impermeable##2##2##(1994-8#2)
the impetus for research into##2##5##(1996-11#1)(1997-7#1)
the impetus for##9##3##(1996-1#1)(1996-11#2)(1997-1#1)(1997-7#1)(2006-8#1)(2008-12#1)(2008-8#2)
the impetus##10##2##(1996-1#1)(1996-11#2)(1997-1#1)(1997-7#1)(2006-8#1)(2008-12#1)(2008-8#2)(2012-12#1)
the implant and##4##3##(2007-7#1)(2007-8#1)(2011-12#2)
the implant can be##3##4##(2008-1#1)(2009-3#1)(2011-2#1)
the implant in##2##3##(2008-9#1)(2009-11#1)
the implant is##3##3##(1996-2#1)(2008-9#1)(2012-12#1)
the implant or##2##3##(2005-5#1)(2008-4#1)
the implant site##3##3##(2007-10#1)(2008-9#1)(2012-3#1)
the implant surface##2##3##(2004-9#2)
the implant was performed##2##4##(2007-11#1)(2008-6#1)
the implant was##5##3##(2007-11#1)(2007-7#1)(2008-6#1)(2008-9#1)(2013-1#1)
the implant##77##2##(1990-3#1)(1996-2#1)(1997-3#1)(2004-1#1)(2004-9#5)(2005-11#1)(2005-5#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#3)(2007-8#3)(2008-1#1)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#17)(2009-11#2)(2009-3#1)(2009-4#3)(2009-7#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-11#3)(2012-12#4)(2012-3#1)(2013-1#3)(2013-8#1)
the implant/abutment##2##2##(2012-11#1)(2013-1#1)
the implantable##3##2##(2006-9#1)(2008-1#1)(2008-12#1)
the implantation of a##4##4##(1993-10#1)(2006-6#1)(2012-2#1)(2012-3#1)
the implantation of stents##2##4##(1993-10#2)
the implantation of##18##3##(1993-10#3)(2006-6#1)(2006-9#1)(2007-7#1)(2007-8#1)(2009-11#1)(2009-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)
the implantation procedure##2##3##(1995-11#1)(2007-7#1)
the implantation##33##2##(1990-3#1)(1992-2#1)(1993-10#3)(1995-11#3)(1996-2#1)(1996-4#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#4)(2009-11#1)(2009-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
the implanted twin##2##3##(2008-9#2)
the implanted##23##2##(1994-2#1)(1994-9#1)(1995-11#1)(1997-4#4)(2004-9#1)(2006-4#2)(2007-7#1)(2007-8#1)(2008-5#1)(2008-8#1)(2008-9#4)(2009-3#1)(2010-10#1)(2012-12#1)(2012-2#2)
the implants are##3##3##(2007-12#1)(2009-4#1)(2013-1#1)
the implants were##2##3##(2008-6#1)(2013-1#1)
the implants##19##2##(2004-9#2)(2007-12#1)(2007-3#1)(2008-6#2)(2008-7#1)(2009-4#1)(2012-12#1)(2012-2#2)(2013-1#8)
the implementation and evaluation##2##4##(1996-1#1)(2008-3#1)
the implementation and##13##3##(1996-1#1)(2006-2#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-5#1)(2011-2#2)(2013-1#1)
the implementation of a##35##4##(1994-3#1)(1994-6#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-2#1)(2004-2#1)(2005-5#1)(2007-11#4)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#6)(2008-9#1)(2010-10#2)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#3)
the implementation of an##8##4##(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2011-1#1)(2011-2#1)
the implementation of early##2##4##(2007-11#1)(2008-2#1)
the implementation of effective##2##4##(1997-2#1)(2008-10#1)
the implementation of evidence-based##2##4##(2008-11#1)(2008-3#1)
the implementation of health##3##4##(1993-3#1)(2011-1#1)(2013-8#1)
the implementation of new##6##4##(1995-3#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-2#1)
the implementation of preventive##2##4##(2007-2#1)(2012-12#1)
the implementation of programs##2##4##(1994-1#1)(1994-2#1)
the implementation of such##4##4##(1991-5#1)(1993-9#1)(2007-12#1)(2010-3#1)
the implementation of the Boston##2##5##(2008-3#2)
the implementation of the new##3##5##(2008-1#1)(2012-3#2)
the implementation of the##42##4##(1991-1#1)(1991-3#1)(1992-1#1)(1992-3#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-11#1)(1997-3#2)(1997-8#1)(2006-4#1)(2006-6#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#6)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#3)
the implementation of these##4##4##(1994-1#2)(1997-7#1)(2009-12#1)
the implementation of this approach##2##5##(1996-1#1)(2010-8#1)
the implementation of this strategy##2##5##(1996-2#1)(2007-4#1)
the implementation of this##7##4##(1996-1#1)(1996-2#1)(2007-4#1)(2008-11#1)(2008-2#1)(2010-10#1)(2010-8#1)
the implementation of##235##3##(1990-12#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-1#4)(1994-12#1)(1994-2#1)(1994-3#3)(1994-6#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#3)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-2#4)(1997-3#3)(1997-7#2)(1997-8#1)(2004-2#1)(2004-9#1)(2005-12#2)(2005-5#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#2)(2006-6#1)(2006-7#2)(2006-8#3)(2007-1#1)(2007-11#5)(2007-12#5)(2007-2#3)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#13)(2008-11#8)(2008-12#2)(2008-2#17)(2008-3#18)(2008-4#3)(2008-5#2)(2008-7#4)(2008-9#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#4)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-8#2)(2010-9#2)(2011-1#8)(2011-2#11)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#15)(2013-7#2)(2013-8#2)
the implementation process##6##3##(1992-2#1)(1996-1#1)(2007-5#1)(2007-7#1)(2008-11#1)(2013-1#1)
the implementation strategies##4##3##(2013-1#4)
the implementation##279##2##(1990-12#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-2#3)(1992-3#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-1#6)(1994-12#1)(1994-2#1)(1994-3#4)(1994-6#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#3)(1996-1#3)(1996-11#1)(1996-2#2)(1996-3#2)(1996-9#1)(1997-2#6)(1997-3#3)(1997-7#2)(1997-8#1)(2004-2#1)(2004-9#1)(2005-12#2)(2005-5#1)(2006-10#4)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#3)(2006-6#1)(2006-7#2)(2006-8#4)(2007-1#1)(2007-11#5)(2007-12#7)(2007-2#3)(2007-4#2)(2007-5#3)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#14)(2008-11#9)(2008-12#2)(2008-2#22)(2008-3#19)(2008-4#4)(2008-5#2)(2008-7#4)(2008-9#3)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2010-10#4)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-8#2)(2010-9#2)(2011-1#8)(2011-2#14)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#25)(2013-7#2)(2013-8#2)
the implemented##5##2##(2007-9#1)(2008-3#1)(2011-3#1)(2012-12#2)
the implication is that##2##4##(1996-1#1)(2007-12#1)
the implication is##3##3##(1996-1#1)(2007-11#1)(2007-12#1)
the implication of##8##3##(1992-6#1)(2008-11#1)(2008-5#1)(2008-7#2)(2011-2#2)(2013-1#1)
the implication that##3##3##(2007-12#1)(2010-2#1)(2013-7#1)
the implication##15##2##(1992-6#1)(1996-1#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-5#1)(2008-7#2)(2010-2#1)(2011-2#2)(2013-1#1)(2013-7#1)
the implications for experimental##2##4##(2008-2#1)(2010-7#1)
the implications for future##4##4##(1993-11#1)(2004-10#1)(2009-4#1)(2010-8#1)
the implications for health##3##4##(1993-1#1)(1994-3#1)(2008-12#1)
the implications for the##4##4##(1996-1#1)(2008-9#1)(2009-3#1)(2011-2#1)
the implications for##35##3##(1991-11#1)(1993-1#1)(1993-11#1)(1994-3#1)(1995-2#1)(1996-1#1)(1997-3#1)(2004-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-5#1)(2010-7#1)(2010-8#4)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
the implications of a##8##4##(1994-12#1)(1994-2#1)(1995-2#1)(2005-9#1)(2007-6#1)(2007-8#1)(2011-12#1)(2012-12#1)
the implications of our findings##2##5##(2009-4#1)(2010-9#1)
the implications of our##7##4##(2008-12#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-9#1)(2013-1#2)
the implications of such##5##4##(2008-12#1)(2008-8#1)(2009-8#1)(2010-1#1)(2012-3#1)
the implications of the findings##2##5##(2007-12#1)(2008-8#1)
the implications of the##16##4##(1993-1#1)(1995-1#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-3#1)(2008-8#4)(2010-8#1)(2012-1#1)(2013-1#1)
the implications of these changes##2##5##(2008-10#1)(2009-3#1)
the implications of these##12##4##(1991-2#1)(1994-1#1)(1996-2#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2009-3#1)(2010-8#1)(2012-1#1)
the implications of this##9##4##(1991-12#1)(1996-12#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-3#2)(2011-2#1)
the implications of##94##3##(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-10#1)(1992-3#1)(1993-1#1)(1993-12#2)(1994-1#2)(1994-12#2)(1994-2#3)(1995-1#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-8#1)(2005-8#2)(2005-9#1)(2006-10#2)(2006-3#1)(2006-5#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#3)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#3)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#2)(2010-1#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-12#2)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#7)
the implications that##3##3##(1990-2#1)(1991-1#1)(1994-2#1)
the implications with##2##3##(2008-10#1)(2012-11#1)
the implications##144##2##(1990-2#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#2)(1992-10#1)(1992-3#1)(1993-1#2)(1993-11#1)(1993-12#2)(1994-1#2)(1994-12#2)(1994-2#4)(1994-3#1)(1995-1#1)(1995-2#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-3#1)(2004-10#1)(2005-8#2)(2005-9#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-5#2)(2006-8#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-4#3)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#4)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#4)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#1)(2011-12#3)(2011-2#2)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#9)
the implicit##7##2##(2006-8#1)(2007-7#1)(2007-8#1)(2008-7#2)(2010-9#1)(2012-12#1)
the implied##3##2##(1990-7#1)(1991-11#1)(2008-11#1)
the import of##5##3##(1994-8#1)(1997-2#2)(1997-4#1)(2009-8#1)
the import precursor of coupling factor 6##3##7##(1990-9#2)(1991-7#1)
the import precursor of subunit b##2##6##(1990-5#2)
the import precursor of subunit##3##5##(1990-5#3)
the import precursor of##9##4##(1990-5#3)(1990-9#3)(1991-7#3)
the import precursor##10##3##(1990-5#3)(1990-9#3)(1991-7#3)(1992-12#1)
the import##22##2##(1990-5#4)(1990-9#4)(1991-7#4)(1992-12#1)(1992-3#1)(1994-8#1)(1995-6#1)(1997-2#2)(1997-4#1)(2006-12#2)(2009-8#1)
the importance and##12##3##(1995-1#1)(2006-6#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
the importance for##5##3##(1992-4#1)(1992-6#1)(1993-11#1)(2007-6#1)(2008-3#1)
the importance given to the##2##5##(2008-9#1)(2009-8#1)
the importance given to##3##4##(1995-1#1)(2008-9#1)(2009-8#1)
the importance of DNA methylation##2##5##(2007-10#1)(2007-8#1)
the importance of a correct##2##5##(1991-5#1)(2013-1#1)
the importance of a multidisciplinary approach##3##6##(2013-1#3)
the importance of a thorough##2##5##(2006-10#1)(2008-7#1)
the importance of a##32##4##(1991-1#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(1996-1#1)(2006-10#2)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#2)(2009-8#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#5)
the importance of accounting for##2##5##(2012-1#1)(2012-2#1)
the importance of achieving a balance##2##6##(1995-10#1)(2008-11#1)
the importance of adding##2##4##(2008-10#1)(2011-12#1)
the importance of age##2##4##(2009-12#1)(2013-1#1)
the importance of all##2##4##(2007-7#1)(2008-1#1)
the importance of an early##3##5##(1993-12#1)(1993-5#1)(2007-10#1)
the importance of an##9##4##(1990-10#1)(1991-12#1)(1991-2#1)(1993-12#1)(1993-5#1)(1995-11#1)(2007-10#1)(2008-4#1)(2012-12#1)
the importance of appropriate##2##4##(2008-4#1)(2008-7#1)
the importance of assessing##2##4##(2008-10#1)(2011-2#1)
the importance of being aware of the##2##7##(1990-12#1)(2010-10#1)
the importance of being aware##3##5##(1990-12#1)(2005-6#1)(2010-10#1)
the importance of being##4##4##(1990-12#1)(2005-6#1)(2008-11#1)(2010-10#1)
the importance of both##4##4##(1994-8#1)(2006-5#1)(2007-2#1)(2008-3#1)
the importance of careful monitoring##2##5##(2006-10#1)(2006-4#1)
the importance of careful##7##4##(1992-6#1)(1997-3#1)(2006-10#2)(2006-4#1)(2008-11#1)(2012-2#1)
the importance of clinical##3##4##(2006-10#1)(2011-1#1)(2012-2#1)
the importance of competition##2##4##(1993-2#1)(2008-9#1)
the importance of concentration##2##4##(2008-7#1)(2010-5#1)
the importance of considering spatial##2##5##(2008-8#2)
the importance of considering the##6##5##(1993-3#1)(1995-12#1)(2007-12#1)(2011-2#1)(2012-12#1)(2013-7#1)
the importance of considering this##2##5##(2007-3#1)(2008-8#1)
the importance of considering##22##4##(1993-10#1)(1993-3#1)(1995-12#1)(1996-1#1)(1997-3#1)(1997-8#1)(2006-10#2)(2007-12#1)(2007-3#1)(2008-8#3)(2010-2#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#3)(2013-7#1)
the importance of context in##2##5##(2006-7#1)(2009-7#1)
the importance of continuing##2##4##(1996-1#1)(2005-8#1)
the importance of controlling##2##4##(2008-5#1)(2009-11#1)
the importance of correct##3##4##(1990-9#1)(2011-1#1)(2011-2#1)
the importance of creating##2##4##(2006-4#1)(2010-6#1)
the importance of developing##5##4##(2008-11#1)(2008-3#1)(2009-11#1)(2010-12#1)(2012-12#1)
the importance of early diagnosis##4##5##(2008-11#1)(2008-12#1)(2010-4#1)(2013-8#1)
the importance of early recognition and##2##6##(2010-10#1)(2013-1#1)
the importance of early##19##4##(1990-9#1)(1992-10#1)(2005-10#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-3#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
the importance of elements##2##4##(1990-11#1)(1990-5#1)
the importance of emergency services]##2##5##(1997-5#2)
the importance of emergency##3##4##(1997-5#2)(2008-12#1)
the importance of evaluating the##3##5##(1993-3#1)(2008-1#1)(2008-11#1)
the importance of evaluating##5##4##(1993-3#1)(2007-10#1)(2008-1#2)(2008-11#1)
the importance of evaluation##2##4##(2006-8#1)(2012-2#1)
the importance of examining ethnic##2##5##(2009-7#1)(2010-10#1)
the importance of examining##5##4##(1990-8#1)(1993-5#1)(2009-7#1)(2010-1#1)(2010-10#1)
the importance of exogenous##2##4##(1990-8#1)(2010-10#1)
the importance of family##2##4##(1994-8#1)(2007-2#1)
the importance of fully##2##4##(1996-3#1)(2006-10#1)
the importance of genetic##2##4##(2006-10#1)(2011-2#1)
the importance of good##5##4##(1994-5#1)(1997-7#1)(2008-1#2)(2012-3#1)
the importance of having##2##4##(2007-9#1)(2008-12#1)
the importance of health##2##4##(2009-6#1)(2012-1#1)
the importance of high##3##4##(2011-1#1)(2013-1#2)
the importance of identifying##4##4##(1993-9#1)(1996-2#1)(2007-2#1)(2010-8#1)
the importance of including##4##4##(2007-11#1)(2008-7#1)(2008-8#1)(2010-4#1)
the importance of integrating##5##4##(1994-4#1)(2005-8#1)(2010-5#1)(2010-7#1)(2012-3#1)
the importance of investigating##3##4##(1993-7#1)(2011-2#1)(2012-1#1)
the importance of its##2##4##(1995-5#1)(2011-12#1)
the importance of keeping##2##4##(1991-2#1)(2010-4#1)
the importance of lipase activity in M##2##7##(2010-10#2)
the importance of local##3##4##(2008-10#1)(2009-3#1)(2012-2#1)
the importance of long-term##3##4##(2007-8#1)(2009-4#1)(2012-2#1)
the importance of maintaining##3##4##(2007-3#1)(2012-3#1)(2013-1#1)
the importance of major##2##4##(1992-3#1)(1996-6#1)
the importance of making##2##4##(1992-12#1)(2008-9#1)
the importance of managing##3##4##(2009-11#1)(2009-2#1)(2013-8#1)
the importance of matching##3##4##(1995-1#1)(2007-11#1)(2008-3#1)
the importance of model selection##2##5##(2008-2#1)(2011-1#1)
the importance of monitoring##3##4##(1996-7#1)(1997-2#1)(2009-10#1)
the importance of national##2##4##(2011-12#1)(2012-3#1)
the importance of nitric oxide##2##5##(2006-10#1)(2013-1#1)
the importance of oral health##3##5##(2006-2#2)(2010-7#1)
the importance of patient##5##4##(1993-2#1)(2004-1#1)(2006-12#1)(2012-1#1)(2012-2#1)
the importance of performing##2##4##(1991-10#1)(2008-7#1)
the importance of physical##2##4##(2006-7#1)(2008-8#1)
the importance of positive##2##4##(1996-9#1)(2008-11#1)
the importance of prevention##3##4##(1996-1#1)(2011-1#1)(2012-2#1)
the importance of primary##3##4##(1994-6#1)(2008-10#1)(2010-5#1)
the importance of providing##5##4##(2005-11#1)(2007-2#1)(2011-2#2)(2012-1#1)
the importance of public health##2##5##(1996-3#1)(2011-2#1)
the importance of quality control##2##5##(2008-7#1)(2008-9#1)
the importance of quality##3##4##(2008-7#1)(2008-9#1)(2012-12#1)
the importance of rapid##2##4##(2008-10#1)(2008-8#1)
the importance of receptor##2##4##(1996-9#1)(1997-6#1)
the importance of recognizing the##2##5##(1993-12#1)(2013-1#1)
the importance of recognizing##5##4##(1993-12#1)(2005-7#1)(2007-5#1)(2011-1#1)(2013-1#1)
the importance of regular##3##4##(2008-3#1)(2011-2#1)(2013-8#1)
the importance of repeated##2##4##(1992-4#1)(2012-1#1)
the importance of research##2##4##(1992-12#1)(2011-2#1)
the importance of school-based##2##4##(2008-9#1)(2009-7#1)
the importance of screening and##2##5##(2010-8#1)(2012-3#1)
the importance of selecting##2##4##(2008-1#1)(2008-10#1)
the importance of social##5##4##(2008-11#1)(2008-5#1)(2009-7#1)(2010-6#1)(2012-12#1)
the importance of some##3##4##(1997-3#1)(2008-10#1)(2009-6#1)
the importance of spatial##2##4##(2008-10#1)(2008-7#1)
the importance of specific##2##4##(2006-10#2)
the importance of studying both##2##5##(1997-5#1)(2008-5#1)
the importance of studying##3##4##(1997-5#1)(2008-5#1)(2009-2#1)
the importance of such a##2##5##(2008-5#1)(2009-8#1)
the importance of such##5##4##(2007-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-8#1)
the importance of surgical treatment##2##5##(1990-4#1)(1992-6#1)
the importance of surgical##3##4##(1990-4#1)(1992-6#1)(2013-1#1)
the importance of taking into account##2##6##(2005-12#1)(2008-12#1)
the importance of taking into##3##5##(1995-9#1)(2005-12#1)(2008-12#1)
the importance of taking the##2##5##(2010-3#1)(2010-4#1)
the importance of taking##8##4##(1990-8#1)(1995-9#1)(2005-12#1)(2008-12#2)(2010-3#1)(2010-4#1)(2013-8#1)
the importance of testing##2##4##(2009-11#1)(2012-2#1)
the importance of the early diagnosis##2##6##(1991-1#1)(2008-9#1)
the importance of the early##3##5##(1991-1#1)(2008-9#1)(2010-12#1)
the importance of the immune system##2##6##(2010-4#1)(2013-1#1)
the importance of the three##2##5##(1994-9#1)(2006-10#1)
the importance of the##104##4##(1990-12#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#2)(1991-4#1)(1991-6#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-9#1)(2004-11#1)(2005-8#1)(2006-10#5)(2006-12#2)(2006-5#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
the importance of their##3##4##(1992-2#1)(2007-11#1)(2008-11#1)
the importance of these factors##2##5##(2007-8#1)(2008-4#1)
the importance of these molecules##2##5##(2007-5#1)(2008-11#1)
the importance of these##20##4##(1990-12#1)(1990-2#1)(1990-3#1)(1991-2#1)(1991-8#1)(1992-12#1)(1994-12#1)(1995-4#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-4#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-1#1)
the importance of this##18##4##(1990-5#1)(1991-2#1)(1995-6#1)(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#3)
the importance of thorough##2##4##(2007-7#1)(2010-7#1)
the importance of treating##3##4##(2006-5#1)(2009-11#1)(2013-8#1)
the importance of two##2##4##(1992-9#1)(2008-7#1)
the importance of understanding how##2##5##(2008-5#1)(2011-2#1)
the importance of understanding the##7##5##(1996-12#1)(2007-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
the importance of understanding##11##4##(1996-12#1)(2007-8#1)(2008-5#2)(2009-5#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#2)
the importance of using a##2##5##(2006-12#1)(2007-8#1)
the importance of using##12##4##(1991-4#1)(1991-6#1)(2004-4#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2011-2#2)(2012-2#1)
the importance of vaccination against##2##5##(2012-12#1)(2013-1#1)
the importance of##989##3##(1990-10#3)(1990-11#1)(1990-12#4)(1990-2#2)(1990-3#5)(1990-4#3)(1990-5#3)(1990-6#3)(1990-8#7)(1990-9#3)(1991-1#2)(1991-10#2)(1991-12#5)(1991-2#5)(1991-3#2)(1991-4#4)(1991-5#2)(1991-6#7)(1991-8#4)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#5)(1992-2#1)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#5)(1992-7#2)(1992-8#2)(1992-9#1)(1993-1#3)(1993-10#2)(1993-12#6)(1993-2#5)(1993-3#6)(1993-5#2)(1993-6#3)(1993-7#1)(1993-9#3)(1994-1#2)(1994-11#3)(1994-12#4)(1994-2#4)(1994-3#4)(1994-4#1)(1994-5#1)(1994-6#2)(1994-7#2)(1994-8#7)(1994-9#5)(1995-1#2)(1995-10#2)(1995-11#1)(1995-12#5)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#4)(1995-6#2)(1995-7#1)(1995-9#1)(1996-1#7)(1996-12#5)(1996-2#3)(1996-3#5)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#5)(1997-4#1)(1997-5#5)(1997-6#2)(1997-7#4)(1997-8#1)(1997-9#1)(2004-1#1)(2004-11#1)(2004-4#2)(2004-9#1)(2005-1#2)(2005-10#3)(2005-11#3)(2005-12#1)(2005-5#1)(2005-6#2)(2005-7#2)(2005-8#5)(2006-1#1)(2006-10#34)(2006-11#2)(2006-12#6)(2006-2#4)(2006-3#2)(2006-4#5)(2006-5#4)(2006-6#1)(2006-7#4)(2006-8#3)(2007-1#2)(2007-10#9)(2007-11#8)(2007-12#17)(2007-2#14)(2007-3#8)(2007-4#4)(2007-5#3)(2007-7#11)(2007-8#15)(2007-9#4)(2008-1#21)(2008-10#46)(2008-11#43)(2008-12#12)(2008-2#12)(2008-3#18)(2008-4#10)(2008-5#13)(2008-6#4)(2008-7#23)(2008-8#19)(2008-9#18)(2009-10#4)(2009-11#6)(2009-12#3)(2009-2#6)(2009-3#3)(2009-4#7)(2009-5#6)(2009-6#3)(2009-7#11)(2009-8#8)(2009-9#2)(2010-1#2)(2010-10#11)(2010-11#2)(2010-12#12)(2010-2#4)(2010-3#9)(2010-4#10)(2010-5#5)(2010-6#6)(2010-7#4)(2010-8#9)(2010-9#2)(2011-1#22)(2011-12#6)(2011-2#35)(2011-3#1)(2012-1#14)(2012-11#3)(2012-12#18)(2012-2#24)(2012-3#16)(2012-8#1)(2013-1#35)(2013-7#5)(2013-8#13)
the importance that##4##3##(1991-9#1)(1995-1#1)(2007-3#1)(2010-4#1)
the importance to##4##3##(2008-5#2)(2009-12#1)(2012-3#1)
the importance##1024##2##(1990-10#3)(1990-11#1)(1990-12#4)(1990-2#2)(1990-3#5)(1990-4#3)(1990-5#3)(1990-6#3)(1990-8#7)(1990-9#3)(1991-1#2)(1991-10#2)(1991-12#5)(1991-2#5)(1991-3#2)(1991-4#4)(1991-5#2)(1991-6#8)(1991-8#4)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#5)(1992-2#1)(1992-3#3)(1992-4#3)(1992-5#1)(1992-6#6)(1992-7#2)(1992-8#2)(1992-9#1)(1993-1#3)(1993-10#2)(1993-11#1)(1993-12#6)(1993-2#5)(1993-3#6)(1993-5#2)(1993-6#3)(1993-7#1)(1993-9#3)(1994-1#2)(1994-11#3)(1994-12#4)(1994-2#4)(1994-3#4)(1994-4#1)(1994-5#1)(1994-6#2)(1994-7#2)(1994-8#7)(1994-9#5)(1995-1#5)(1995-10#2)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#4)(1995-6#2)(1995-7#1)(1995-9#1)(1996-1#7)(1996-12#5)(1996-2#3)(1996-3#5)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#5)(1997-4#1)(1997-5#5)(1997-6#2)(1997-7#4)(1997-8#1)(1997-9#1)(2004-1#1)(2004-11#1)(2004-4#2)(2004-9#1)(2005-1#2)(2005-10#3)(2005-11#3)(2005-12#1)(2005-5#1)(2005-6#2)(2005-7#2)(2005-8#5)(2006-1#1)(2006-10#34)(2006-11#2)(2006-12#6)(2006-2#4)(2006-3#2)(2006-4#5)(2006-5#4)(2006-6#2)(2006-7#4)(2006-8#3)(2007-1#2)(2007-10#9)(2007-11#8)(2007-12#17)(2007-2#14)(2007-3#9)(2007-4#4)(2007-5#3)(2007-6#1)(2007-7#11)(2007-8#15)(2007-9#4)(2008-1#23)(2008-10#46)(2008-11#44)(2008-12#13)(2008-2#13)(2008-3#21)(2008-4#10)(2008-5#16)(2008-6#4)(2008-7#23)(2008-8#19)(2008-9#19)(2009-10#4)(2009-11#6)(2009-12#4)(2009-2#6)(2009-3#3)(2009-4#7)(2009-5#6)(2009-6#3)(2009-7#11)(2009-8#10)(2009-9#2)(2010-1#2)(2010-10#11)(2010-11#2)(2010-12#12)(2010-2#4)(2010-3#9)(2010-4#11)(2010-5#6)(2010-6#6)(2010-7#4)(2010-8#9)(2010-9#2)(2011-1#22)(2011-12#6)(2011-2#36)(2011-3#1)(2012-1#14)(2012-11#3)(2012-12#19)(2012-2#26)(2012-3#18)(2012-8#1)(2013-1#35)(2013-7#5)(2013-8#13)
the important and##2##3##(2008-7#1)(2009-7#1)
the important aspects##2##3##(2006-8#1)(2013-8#1)
the important clinical##2##3##(2005-10#1)(2012-2#1)
the important considerations##2##3##(1992-3#1)(2006-5#1)
the important contribution of##4##4##(1997-3#1)(2006-7#1)(2007-6#1)(2008-10#1)
the important contribution##5##3##(1997-3#1)(2006-7#2)(2007-6#1)(2008-10#1)
the important determinants##2##3##(1993-12#1)(1997-7#1)
the important factors in##2##4##(1994-8#1)(2007-9#1)
the important factors that##2##4##(2007-12#1)(2008-9#1)
the important factors##7##3##(1994-8#1)(2007-12#1)(2007-9#1)(2008-8#1)(2008-9#2)(2009-2#1)
the important features##2##3##(2008-11#1)(2008-3#1)
the important function of##2##4##(2008-4#1)(2009-10#1)
the important lessons##2##3##(2006-8#1)(2009-8#1)
the important parameters##2##3##(2008-3#1)(2008-4#1)
the important part##2##3##(1994-3#1)(2006-6#1)
the important physiological##2##3##(1992-12#1)(2008-9#1)
the important properties##2##3##(2008-2#1)(2013-1#1)
the important question of##2##4##(1991-9#1)(2007-8#1)
the important regulators of##2##4##(2008-3#1)(2011-12#1)
the important role of the hippocampus in##2##7##(1994-2#1)(2009-2#1)
the important role of the##5##5##(1990-2#1)(1994-2#1)(2006-10#1)(2008-10#1)(2009-2#1)
the important role of##30##4##(1990-2#1)(1991-7#1)(1994-2#1)(1995-12#1)(1995-3#1)(1995-8#1)(1997-1#1)(1997-4#1)(2006-10#3)(2007-9#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-8#2)(2009-2#2)(2009-4#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-7#1)
the important role played by the##2##6##(2006-10#1)(2012-2#1)
the important role##35##3##(1990-2#1)(1991-7#1)(1994-2#1)(1995-12#1)(1995-3#1)(1995-8#1)(1997-1#1)(1997-4#1)(2006-10#4)(2007-9#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-2#2)(2009-4#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#2)
the important roles played by##2##5##(1994-12#1)(2008-5#1)
the important roles##4##3##(1994-12#1)(2008-5#1)(2010-11#1)(2012-3#1)
the important structural##2##3##(2008-10#1)(2012-12#1)
the important##190##2##(1990-12#2)(1990-2#2)(1990-6#1)(1991-11#1)(1991-7#2)(1991-9#1)(1992-12#2)(1992-3#4)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-8#3)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-11#1)(1996-3#1)(1997-1#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#2)(2004-12#1)(2004-9#1)(2005-10#1)(2005-3#1)(2006-10#7)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#3)(2007-10#1)(2007-11#3)(2007-12#6)(2007-3#1)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#10)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#6)(2008-4#10)(2008-5#3)(2008-7#2)(2008-8#5)(2008-9#5)(2009-10#1)(2009-11#1)(2009-2#5)(2009-4#2)(2009-7#2)(2009-8#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#3)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#4)(2011-3#1)(2011-4#1)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#5)(2013-7#3)(2013-8#6)
the importation of##4##3##(2005-5#1)(2007-12#1)(2008-10#1)(2011-1#1)
the imported##3##2##(1997-2#1)(2008-10#2)
the imposition of##3##3##(2007-11#1)(2008-11#1)(2009-8#1)
the impossibility of##8##3##(1991-4#1)(1992-10#1)(1996-11#1)(1996-12#1)(2007-6#1)(2007-7#1)(2009-4#1)(2012-2#1)
the impossibility##9##2##(1990-3#1)(1991-4#1)(1992-10#1)(1996-11#1)(1996-12#1)(2007-6#1)(2007-7#1)(2009-4#1)(2012-2#1)
the impossible return##2##3##(1991-12#2)
the impossible##5##2##(1991-12#2)(1996-1#1)(2006-7#2)
the impression that##4##3##(1990-6#1)(1991-12#1)(1993-9#1)(2006-9#1)
the impression##9##2##(1990-6#1)(1991-12#1)(1993-9#1)(1997-5#1)(2006-9#1)(2008-11#1)(2009-6#1)(2011-1#1)(2012-2#1)
the impressionists##2##2##(2006-10#2)
the impressive##8##2##(1990-12#1)(1991-9#1)(1993-12#1)(1994-12#1)(2007-11#1)(2008-5#2)(2008-8#1)
the imprinted polymer for##2##4##(2008-10#2)
the imprinted polymer##7##3##(2008-10#7)
the imprinted##17##2##(1992-8#1)(1996-10#1)(2008-10#11)(2008-7#1)(2010-12#1)(2012-1#1)(2013-7#1)
the imprinting##4##2##(1996-10#1)(2008-10#3)
the improved DSCM##2##3##(2008-3#2)
the improved algorithm##2##3##(2008-2#1)(2008-3#1)
the improved efficacy of##2##4##(2006-2#1)(2013-1#1)
the improved method##3##3##(2008-10#2)(2008-3#1)
the improved quality of##2##4##(1991-7#1)(2008-2#1)
the improved survival of patients with##2##6##(1994-4#1)(2008-7#1)
the improved survival of##4##4##(1994-4#1)(2008-11#2)(2008-7#1)
the improved##65##2##(1990-11#1)(1991-7#1)(1992-10#1)(1993-11#1)(1993-8#1)(1994-4#1)(1994-9#1)(1996-11#1)(1997-3#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-10#11)(2008-11#3)(2008-2#6)(2008-3#10)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#5)(2013-7#1)(2013-8#1)
the improvement in the##5##4##(2007-8#1)(2008-10#1)(2008-6#1)(2009-6#1)(2013-1#1)
the improvement in##25##3##(1992-10#1)(1994-6#1)(1996-9#1)(1997-8#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#1)(2009-6#1)(2010-11#1)(2010-6#1)(2011-1#2)(2013-1#2)(2013-8#1)
the improvement is##3##3##(1993-11#1)(2008-10#1)(2008-2#1)
the improvement of health care##2##5##(1994-3#1)(2007-6#1)
the improvement of health##3##4##(1994-3#1)(2007-6#1)(2010-9#1)
the improvement of quality of life##2##6##(1991-12#1)(2011-1#1)
the improvement of quality of##3##5##(1991-12#1)(2011-1#1)(2012-1#1)
the improvement of quality##4##4##(1991-12#1)(2009-3#1)(2011-1#1)(2012-1#1)
the improvement of the##21##4##(1991-6#1)(1994-6#1)(2005-11#1)(2005-5#1)(2006-11#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-4#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
the improvement of##79##3##(1990-5#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-1#1)(1993-3#1)(1993-5#1)(1994-2#2)(1994-3#1)(1994-6#1)(1997-8#1)(2004-4#1)(2005-11#1)(2005-5#2)(2006-11#2)(2006-6#1)(2006-8#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-2#5)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#4)(2011-2#2)(2011-7#1)(2012-1#1)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#2)
the improvement over the##2##4##(2008-10#1)(2008-2#1)
the improvement was##5##3##(2007-10#1)(2007-11#1)(2008-5#1)(2010-3#1)(2013-1#1)
the improvement##130##2##(1990-5#1)(1991-12#1)(1991-5#1)(1991-6#2)(1992-1#1)(1992-10#1)(1993-11#1)(1993-3#1)(1993-5#1)(1994-2#2)(1994-3#1)(1994-6#2)(1996-12#1)(1996-2#1)(1996-9#1)(1997-8#2)(2004-4#1)(2005-11#1)(2005-5#2)(2006-11#2)(2006-6#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#3)(2008-2#7)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-6#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#2)(2011-7#1)(2012-1#2)(2012-2#3)(2013-1#9)(2013-7#1)(2013-8#4)
the improvements are##2##3##(2013-1#1)(2013-8#1)
the improvements in##8##3##(1993-7#1)(2004-8#1)(2009-9#1)(2010-12#1)(2010-7#2)(2012-12#2)
the improvements of##2##3##(2006-11#1)(2008-3#1)
the improvements##17##2##(1991-12#1)(1993-7#1)(1996-3#1)(2004-8#1)(2006-11#1)(2006-5#1)(2008-3#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-7#2)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
the impulse response from the##2##5##(2008-3#2)
the impulse response##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
the impulse##8##2##(1990-8#1)(1991-5#1)(2007-11#1)(2008-2#1)(2008-3#4)
the impulses##4##2##(1996-12#3)(2008-2#1)
the impurities were##2##3##(2005-4#1)(2012-2#1)
the impurities##10##2##(2005-4#1)(2007-8#1)(2008-10#3)(2010-2#2)(2010-7#1)(2012-2#1)(2013-1#1)
the imputation##2##2##(2008-6#1)(2012-1#1)
the in hospital##2##3##(2006-10#1)(2009-8#1)
the in silico mapping of##2##5##(2008-7#2)
the in silico prediction of##2##5##(2008-4#1)(2012-3#1)
the in silico prediction##3##4##(2008-4#1)(2012-3#2)
the in silico##5##3##(2008-4#1)(2008-7#2)(2012-3#2)
the in situ activity of##2##5##(1991-2#2)
the in situ analysis of##3##5##(2007-8#1)(2008-10#1)(2008-2#1)
the in situ monitoring of##2##5##(1993-6#1)(2008-3#1)
the in situ spectral distribution of##2##6##(2008-3#2)
the in situ##49##3##(1990-2#1)(1991-2#2)(1991-6#1)(1993-6#1)(1994-2#1)(1996-12#1)(1997-8#1)(2005-10#1)(2006-4#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-2#2)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#2)(2009-12#1)(2009-3#1)(2010-4#1)(2011-2#1)
the in the##2##3##(1997-4#1)(2006-8#1)
the in vitro T##2##4##(1996-7#1)(2009-9#1)
the in vitro activation##2##4##(1996-5#1)(2008-9#1)
the in vitro activities of##3##5##(1994-9#1)(1997-1#1)(1997-7#1)
the in vitro activity and##2##5##(2006-8#1)(2008-5#1)
the in vitro activity of##7##5##(1990-10#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-9#1)(2008-12#1)(2012-2#1)
the in vitro activity##10##4##(1990-10#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-9#1)(2008-12#1)(2008-3#1)(2008-5#1)(2012-2#1)
the in vitro adherence of Candida albicans##2##7##(2008-5#2)
the in vitro and in vivo##14##6##(1990-2#1)(1991-5#1)(1995-12#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-5#1)(2009-12#1)(2009-9#1)(2010-6#1)(2012-11#2)(2012-2#1)(2013-8#1)
the in vitro and in##15##5##(1990-2#1)(1991-5#1)(1995-12#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-5#1)(2009-12#2)(2009-9#1)(2010-6#1)(2012-11#2)(2012-2#1)(2013-8#1)
the in vitro antifungal##2##4##(2008-5#2)
the in vitro antioxidant activity##2##5##(2008-10#1)(2008-5#1)
the in vitro assay##2##4##(1994-9#1)(2006-3#1)
the in vitro assembled U2 snRNPs##2##6##(1993-8#2)
the in vitro assembly of##3##5##(1995-8#2)(2004-12#1)
the in vitro binding of##2##5##(1997-6#1)(2009-12#1)
the in vitro binding##3##4##(1997-5#1)(1997-6#1)(2009-12#1)
the in vitro biological activity of##2##6##(2008-8#2)
the in vitro conditions##2##4##(1997-4#1)(2008-11#1)
the in vitro culture##3##4##(2008-5#3)
the in vitro cytotoxicity##2##4##(1995-3#1)(1997-1#1)
the in vitro development##3##4##(1996-3#1)(2008-11#1)(2008-5#1)
the in vitro differentiation of##2##5##(1992-5#1)(2008-8#1)
the in vitro drug release data##2##6##(2010-5#1)(2012-2#1)
the in vitro drug release##6##5##(2010-2#2)(2010-3#2)(2010-5#1)(2012-2#1)
the in vitro drug##7##4##(1995-7#1)(2010-2#2)(2010-3#2)(2010-5#1)(2012-2#1)
the in vitro effects of##3##5##(1997-1#1)(1997-2#1)(2006-8#1)
the in vitro efficacy of##2##5##(2010-5#1)(2013-8#1)
the in vitro evaluation of##3##5##(2006-8#1)(2007-8#1)(2010-5#1)
the in vitro experiments##3##4##(1994-5#1)(2008-11#1)(2008-5#1)
the in vitro germination##2##4##(2005-10#1)(2008-10#1)
the in vitro growth of##3##5##(1991-9#1)(1992-8#1)(2007-11#1)
the in vitro growth##5##4##(1990-3#1)(1991-3#1)(1991-9#1)(1992-8#1)(2007-11#1)
the in vitro metabolism of##5##5##(1993-11#1)(1996-3#2)(1996-4#1)(1996-8#1)
the in vitro model##3##4##(1992-12#1)(1997-4#1)(2008-5#1)
the in vitro phosphorylation of##3##5##(1990-11#1)(1997-2#2)
the in vitro phosphorylation##4##4##(1990-11#1)(1993-3#1)(1997-2#2)
the in vitro production of##3##5##(1994-8#1)(2007-2#1)(2011-12#1)
the in vitro proliferation of##4##5##(1990-7#1)(1991-12#1)(2008-11#1)(2008-4#1)
the in vitro proliferative response of##2##6##(1991-1#1)(2008-7#1)
the in vitro protein biosynthesis system##3##6##(1995-7#3)
the in vitro reaction##2##4##(1993-12#1)(1997-4#1)
the in vitro release of##2##5##(1992-3#1)(1994-10#1)
the in vitro release##3##4##(1992-3#1)(1994-10#1)(2008-10#1)
the in vitro selection##2##4##(1990-8#1)(2010-5#1)
the in vitro sensitivity of##2##5##(1991-2#1)(1993-1#1)
the in vitro study of##3##5##(2008-11#1)(2008-4#1)(2013-8#1)
the in vitro susceptibility of##2##5##(2006-8#1)(2008-5#1)
the in vitro susceptibility##5##4##(2006-8#1)(2007-7#1)(2008-11#1)(2008-5#1)(2012-12#1)
the in vitro synthesised##2##4##(1990-11#1)(1991-5#1)
the in vitro synthesized##5##4##(1990-11#2)(1996-5#1)(1996-9#1)(2009-6#1)
the in vitro system##6##4##(1991-9#1)(1995-7#1)(1996-5#1)(1997-4#1)(2008-11#1)(2008-6#1)
the in vitro toxicity##2##4##(1993-3#1)(2008-4#1)
the in vitro transcribed mRNA##2##5##(1992-8#1)(1993-8#1)
the in vitro translation##3##4##(1992-2#1)(1994-9#1)(1997-2#1)
the in vitro##249##3##(1990-1#3)(1990-10#1)(1990-11#4)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#2)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#2)(1991-7#1)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-7#2)(1992-8#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-6#1)(1993-7#2)(1993-8#3)(1993-9#2)(1994-10#1)(1994-12#2)(1994-5#1)(1994-8#2)(1994-9#7)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-7#7)(1995-8#2)(1996-10#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#4)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#1)(1997-4#5)(1997-5#3)(1997-6#1)(1997-7#3)(1997-8#1)(2004-12#3)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-3#1)(2006-5#2)(2006-8#5)(2007-11#4)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#11)(2008-11#13)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#24)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-12#3)(2009-4#1)(2009-6#2)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#3)(2010-5#4)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#3)(2013-8#4)
the in vivo EPR##2##4##(1994-5#1)(2008-7#1)
the in vivo activity of antimicrobial agents##2##7##(2008-7#2)
the in vivo activity of##5##5##(1992-4#1)(2007-11#1)(2008-2#1)(2008-7#2)
the in vivo activity##6##4##(1992-4#1)(1997-2#1)(2007-11#1)(2008-2#1)(2008-7#2)
the in vivo and in vitro##4##6##(1994-5#1)(1995-7#1)(2008-5#1)(2011-1#1)
the in vivo application##3##4##(1993-2#1)(2012-11#2)
the in vivo behaviour of##2##5##(2006-10#1)(2008-5#1)
the in vivo effects of##5##5##(1995-12#2)(1995-3#1)(2005-8#1)(2008-10#1)
the in vivo effects##7##4##(1995-1#1)(1995-12#3)(1995-3#1)(2005-8#1)(2008-10#1)
the in vivo efficacy of##2##5##(1995-8#1)(2008-11#1)
the in vivo environment##2##4##(2009-12#2)
the in vivo formation of##2##5##(1991-9#1)(1994-5#1)
the in vivo function of##8##5##(1994-9#1)(2005-6#1)(2008-11#1)(2008-9#1)(2009-2#1)(2009-8#1)(2011-1#1)(2012-2#1)
the in vivo genotoxicity of 7##2##6##(1996-12#2)
the in vivo interaction##2##4##(1996-8#1)(2008-7#1)
the in vivo microenvironment##2##4##(2007-3#1)(2009-12#1)
the in vivo nitrite##2##4##(2008-5#2)
the in vivo performance of##3##5##(2004-9#2)(2008-5#1)
the in vivo performance##4##4##(2004-9#2)(2008-5#1)(2012-2#1)
the in vivo production of##2##5##(1992-3#1)(1994-5#1)
the in vivo rat##2##4##(1995-7#1)(1997-5#1)
the in vivo relevance of##2##5##(1991-9#1)(1996-10#1)
the in vivo role of##3##5##(1991-6#1)(1994-9#1)(1995-2#1)
the in vivo situation##2##4##(1996-1#1)(2008-5#1)
the in vivo study of##3##5##(2004-9#1)(2010-1#1)(2012-11#1)
the in vivo study##4##4##(2004-9#1)(2009-3#1)(2010-1#1)(2012-11#1)
the in vivo tumor##3##4##(1995-5#1)(2009-6#2)
the in vivo##170##3##(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-3#2)(1991-4#2)(1991-6#1)(1991-9#3)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#6)(1994-6#1)(1994-8#1)(1994-9#4)(1995-1#2)(1995-12#4)(1995-2#1)(1995-3#4)(1995-5#2)(1995-7#4)(1995-8#3)(1996-1#1)(1996-10#2)(1996-12#4)(1996-2#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(2004-12#3)(2004-2#1)(2004-9#3)(2005-6#2)(2005-8#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#18)(2008-7#5)(2008-8#1)(2008-9#4)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-2#1)(2010-8#1)(2011-1#5)(2012-11#3)(2012-12#2)(2012-2#2)
the in##489##2##(1990-1#3)(1990-10#1)(1990-11#4)(1990-2#4)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#3)(1991-11#2)(1991-12#1)(1991-2#5)(1991-3#4)(1991-4#3)(1991-5#2)(1991-6#2)(1991-7#1)(1991-9#6)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-7#3)(1992-8#4)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#3)(1993-6#2)(1993-7#3)(1993-8#3)(1993-9#2)(1994-10#1)(1994-12#3)(1994-2#4)(1994-3#3)(1994-5#7)(1994-6#1)(1994-8#4)(1994-9#11)(1995-1#2)(1995-11#1)(1995-12#6)(1995-2#3)(1995-3#6)(1995-5#2)(1995-7#11)(1995-8#5)(1996-1#1)(1996-10#3)(1996-12#5)(1996-2#2)(1996-3#4)(1996-4#2)(1996-5#4)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#6)(1997-3#2)(1997-4#7)(1997-5#4)(1997-6#1)(1997-7#3)(1997-8#2)(2004-12#6)(2004-2#1)(2004-9#3)(2005-10#2)(2005-11#1)(2005-6#2)(2005-7#1)(2005-8#2)(2006-10#4)(2006-12#3)(2006-3#1)(2006-4#1)(2006-5#2)(2006-8#6)(2007-10#1)(2007-11#6)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#5)(2008-10#30)(2008-11#18)(2008-12#1)(2008-2#5)(2008-3#11)(2008-4#8)(2008-5#44)(2008-6#4)(2008-7#11)(2008-8#4)(2008-9#6)(2009-11#1)(2009-12#7)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#5)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-3#3)(2010-4#1)(2010-5#4)(2010-6#1)(2010-8#1)(2011-1#8)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#5)(2012-12#3)(2012-2#5)(2012-3#2)(2013-8#4)
the in-depth##5##2##(1994-3#1)(2006-11#1)(2007-12#1)(2010-4#1)(2012-3#1)
the in-focus##2##2##(2008-2#2)
the in-home##2##2##(1995-3#1)(2010-3#1)
the in-hospital rehabilitation##2##3##(2008-6#2)
the in-hospital##3##2##(1992-1#1)(2008-6#2)
the in-house##2##2##(2005-12#1)(2008-10#1)
the in-line##4##2##(2008-10#3)(2008-2#1)
the in-phase and##3##3##(2006-12#1)(2007-11#1)(2008-3#1)
the in-phase##5##2##(2006-12#1)(2007-11#1)(2007-9#1)(2008-3#2)
the in-plane displacement##2##3##(2008-2#2)
the in-plane##13##2##(1993-11#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#2)(2009-11#1)(2009-7#1)(2012-2#1)(2013-8#1)
the in-situ##5##2##(2008-10#1)(2010-7#1)(2013-8#3)
the in-vitro##6##2##(1990-12#2)(1997-3#1)(1997-6#1)(2008-4#1)(2008-9#1)
the in-vivo dose##2##3##(2008-3#2)
the in-vivo##4##2##(1997-3#1)(2008-3#3)
the inability of the##4##4##(1991-10#1)(1992-7#1)(2006-10#1)(2013-1#1)
the inability of##27##3##(1990-8#1)(1991-10#1)(1992-7#2)(1993-11#1)(1994-2#1)(1995-11#1)(1995-2#1)(1996-7#1)(1997-1#1)(1997-6#1)(2006-10#1)(2006-5#1)(2008-10#3)(2008-4#2)(2009-4#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
the inability to##29##3##(1993-6#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-3#1)(2006-10#1)(2008-1#2)(2008-10#3)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-3#2)(2010-5#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
the inability##56##2##(1990-8#1)(1991-10#1)(1992-7#2)(1993-11#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-7#1)(1997-1#1)(1997-6#1)(2006-10#2)(2006-5#1)(2008-1#2)(2008-10#6)(2008-4#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
the inaccuracy of##2##3##(1991-10#1)(2008-4#1)
the inaccuracy##3##2##(1991-10#1)(2008-1#1)(2008-4#1)
the inactivated enzyme##5##3##(1991-5#1)(1992-7#1)(1997-2#1)(2008-5#1)(2008-8#1)
the inactivated##9##2##(1991-5#1)(1992-7#1)(1996-10#1)(1997-2#2)(2008-11#1)(2008-5#2)(2008-8#1)
the inactivation and##2##3##(1995-3#1)(2007-6#1)
the inactivation by##2##3##(1990-7#1)(1993-9#1)
the inactivation kinetics##3##3##(1990-11#1)(2007-6#1)(2008-8#1)
the inactivation of Na+/K(+)-ATPase by##2##5##(1990-7#2)
the inactivation of the enzyme##5##5##(1990-7#1)(1990-8#1)(1993-8#1)(2009-12#1)(2011-2#1)
the inactivation of the##8##4##(1990-7#1)(1990-8#1)(1991-12#1)(1993-8#1)(1995-8#1)(2006-10#1)(2009-12#1)(2011-2#1)
the inactivation of##39##3##(1990-7#3)(1990-8#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-11#1)(1993-11#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-2#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-6#1)(2005-12#1)(2005-7#1)(2006-10#1)(2007-6#1)(2008-11#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-2#3)
the inactivation process##2##3##(1991-2#1)(1991-9#1)
the inactivation rate##2##3##(1990-7#2)
the inactivation##59##2##(1990-11#2)(1990-7#6)(1990-8#2)(1991-12#1)(1991-2#1)(1991-5#2)(1991-9#1)(1992-1#1)(1992-11#1)(1993-11#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#2)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-6#1)(2005-12#1)(2005-7#1)(2006-10#1)(2007-6#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-2#3)
the inactive X and Y##2##5##(1990-3#2)
the inactive X chromosome##2##4##(1991-6#1)(1994-11#1)
the inactive X##4##3##(1990-3#2)(1991-6#1)(1994-11#1)
the inactive analogue##2##3##(1992-11#1)(1997-1#1)
the inactive conformation##2##3##(1991-11#1)(2008-5#1)
the inactive desulfo##2##3##(1992-3#1)(1993-11#1)
the inactive dimer form##2##4##(1994-11#2)
the inactive form##3##3##(1991-8#1)(1995-5#1)(1997-1#1)
the inactive mutant##3##3##(1995-12#1)(1995-5#1)(1996-4#1)
the inactive product##2##3##(1992-6#2)
the inactive##45##2##(1990-3#2)(1991-11#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1996-4#1)(1996-5#1)(1997-1#3)(2008-5#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
the inadequacies of##3##3##(1996-6#1)(2008-1#1)(2008-7#1)
the inadequacy of the##5##4##(1996-12#1)(2007-7#1)(2007-8#1)(2009-5#1)(2012-3#1)
the inadequacy of##6##3##(1995-11#1)(1996-12#1)(2007-7#1)(2007-8#1)(2009-5#1)(2012-3#1)
the inadequate##9##2##(1992-12#1)(1996-2#1)(1997-8#1)(2005-7#2)(2006-12#1)(2008-10#1)(2008-11#1)(2012-12#1)
the inalienable right to life and##4##6##(2011-2#4)
the inanimate environment##2##3##(2005-8#1)(2007-12#1)
the inappropriate use of##2##4##(2005-12#1)(2006-5#1)
the inappropriate##12##2##(1991-12#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-5#1)(1997-2#1)(2005-12#1)(2006-5#1)(2008-1#1)(2008-10#2)(2011-2#1)
the inaugural##4##2##(1992-5#1)(2005-7#1)(2008-7#1)(2008-8#1)
the inbred lines Mo17##2##4##(2008-10#2)
the inbred lines##3##3##(2008-10#2)(2008-5#1)
the inbred##8##2##(1995-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2012-3#1)
the inbreeding##2##2##(2007-2#1)(2008-5#1)
the incapacity of the##2##4##(1995-5#1)(2013-8#1)
the incarceration of##2##3##(1990-10#1)(2008-11#1)
the incarceration##3##2##(1990-10#1)(2008-11#1)(2008-9#1)
the incentive##6##2##(1991-2#1)(1992-3#1)(1995-1#1)(2008-4#1)(2008-5#1)(2008-7#1)
the incentives of##4##3##(1992-2#1)(1993-12#1)(1995-3#1)(1997-1#1)
the incentives##8##2##(1992-2#2)(1993-12#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-2#1)(2008-7#1)
the inception of the##5##4##(2007-10#1)(2007-4#1)(2007-8#1)(2011-2#2)
the inception of##10##3##(1995-11#1)(1995-12#1)(2005-8#1)(2006-12#1)(2007-10#1)(2007-2#1)(2007-4#1)(2007-8#1)(2011-2#2)
the inception##12##2##(1995-11#1)(1995-12#1)(2005-8#1)(2006-12#1)(2007-10#1)(2007-2#1)(2007-4#1)(2007-8#1)(2011-2#2)(2012-12#2)
the incidence among##3##3##(1996-11#1)(2007-7#1)(2011-2#1)
the incidence and character of##2##5##(1990-6#2)
the incidence and clinical##2##4##(2007-11#1)(2009-6#1)
the incidence and duration of##2##5##(2008-7#2)
the incidence and mortality for##2##5##(2007-11#1)(2011-2#1)
the incidence and mortality##3##4##(2007-11#1)(2010-12#1)(2011-2#1)
the incidence and prevalence of##10##5##(1996-11#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-12#1)(2010-5#1)(2010-9#1)(2011-1#1)
the incidence and severity of##17##5##(1991-12#1)(1993-3#1)(2006-10#2)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-5#3)(2008-7#1)(2012-3#1)
the incidence and the##3##4##(2008-1#1)(2008-2#1)(2012-2#1)
the incidence and treatment of##2##5##(2007-7#1)(2011-2#1)
the incidence and types of##3##5##(2008-4#1)(2012-12#1)(2013-1#1)
the incidence and##66##3##(1990-6#2)(1991-11#1)(1991-12#1)(1993-3#1)(1994-10#1)(1996-11#1)(1997-1#1)(1997-6#1)(2004-10#1)(2005-12#1)(2005-7#1)(2006-10#4)(2006-2#1)(2006-5#1)(2007-11#3)(2007-7#2)(2007-8#3)(2008-1#3)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#4)(2009-12#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-9#2)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
the incidence angle of the##2##5##(2007-11#1)(2008-3#1)
the incidence angle shift##2##4##(2008-10#2)
the incidence angle##7##3##(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#2)
the incidence function model##2##4##(2008-9#2)
the incidence has been##2##4##(1990-11#1)(2008-9#1)
the incidence has##3##3##(1990-11#1)(1993-3#1)(2008-9#1)
the incidence in##6##3##(1990-2#1)(1995-3#1)(2006-7#1)(2008-7#1)(2011-12#1)(2012-3#1)
the incidence increased##2##3##(1996-3#1)(2008-7#1)
the incidence is approximately##2##4##(2008-10#1)(2008-7#1)
the incidence is##15##3##(1993-3#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#3)(2009-3#1)(2011-1#2)(2013-1#2)
the incidence of A##2##4##(2008-10#2)
the incidence of AF##2##4##(2007-8#2)
the incidence of BYDV##3##4##(2008-10#3)
the incidence of HCC is##2##5##(2006-10#1)(2013-1#1)
the incidence of HCC##3##4##(2006-10#2)(2013-1#1)
the incidence of MPM##2##4##(2010-9#2)
the incidence of T2D##2##4##(2009-3#2)
the incidence of TYLCV##2##4##(2008-10#2)
the incidence of accidental pleurotomy##2##5##(2007-8#2)
the incidence of acute and chronic##2##6##(2006-10#1)(2011-1#1)
the incidence of acute myocardial##2##5##(1990-9#1)(1991-9#1)
the incidence of acute rejection##2##5##(2007-11#1)(2008-8#1)
the incidence of acute##13##4##(1990-9#1)(1991-9#1)(1996-6#1)(1996-7#1)(2006-10#1)(2007-11#1)(2007-7#2)(2008-1#2)(2008-8#1)(2011-1#1)(2013-8#1)
the incidence of adverse drug reactions##2##6##(2010-6#1)(2011-2#1)
the incidence of adverse events##3##5##(2007-11#1)(2008-3#1)(2008-7#1)
the incidence of adverse reactions##2##5##(1997-7#1)(2008-2#1)
the incidence of adverse##9##4##(1997-7#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-6#1)(2011-12#1)(2011-2#1)
the incidence of aggression##2##4##(2008-12#1)(2008-7#1)
the incidence of air leak##2##5##(2007-8#2)
the incidence of allergic##2##4##(2006-10#1)(2008-5#1)
the incidence of and risk factors for##2##7##(2012-12#1)(2012-3#1)
the incidence of any##2##4##(2007-8#1)(2011-2#1)
the incidence of apoptosis##2##4##(1995-12#1)(2008-7#1)
the incidence of atrial fibrillation##6##5##(2007-8#6)
the incidence of bacteremia was##2##5##(1990-2#1)(2007-7#1)
the incidence of both vertebral and hip fractures##2##8##(2008-8#2)
the incidence of both##6##4##(1997-4#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-8#2)
the incidence of breast cancer##5##5##(1991-5#2)(2008-7#1)(2013-7#2)
the incidence of cancer and##2##5##(2008-4#1)(2012-12#1)
the incidence of cancer##6##4##(1994-5#1)(2007-2#1)(2008-4#1)(2008-7#1)(2012-1#1)(2012-12#1)
the incidence of cardiovascular disease##2##5##(1990-5#1)(2013-1#1)
the incidence of cardiovascular##4##4##(1990-5#1)(2007-1#1)(2013-1#2)
the incidence of cerebral palsy##2##5##(1995-6#2)
the incidence of cerebral##3##4##(1994-2#1)(1995-6#2)
the incidence of chronic##4##4##(1992-2#1)(2007-11#1)(2008-7#1)(2009-12#1)
the incidence of clinical##2##4##(1993-12#1)(2005-8#1)
the incidence of clinically diagnosed##2##5##(2008-7#1)(2011-2#1)
the incidence of colon##2##4##(1993-11#1)(2006-8#1)
the incidence of colonic##2##4##(1990-6#1)(2010-8#1)
the incidence of complete##3##4##(2007-11#1)(2008-5#2)
the incidence of complications##6##4##(1993-11#1)(1995-4#1)(2007-12#1)(2008-1#1)(2012-2#1)(2013-1#1)
the incidence of congenital##3##4##(1990-9#1)(1995-8#1)(2008-7#1)
the incidence of coronary artery disease##2##6##(1996-9#1)(2006-5#1)
the incidence of coronary events##2##5##(1991-7#1)(1993-12#1)
the incidence of coronary##5##4##(1991-7#1)(1993-12#1)(1996-9#1)(1997-7#1)(2006-5#1)
the incidence of death from cardiovascular##2##6##(1990-5#1)(2011-2#1)
the incidence of death from##3##5##(1990-5#1)(1995-12#1)(2011-2#1)
the incidence of death##5##4##(1990-5#1)(1995-12#1)(2005-7#1)(2006-11#1)(2011-2#1)
the incidence of deep##2##4##(2007-10#1)(2008-8#1)
the incidence of delirium in##2##5##(2007-11#1)(2013-1#1)
the incidence of different types of##2##6##(2008-12#1)(2012-2#1)
the incidence of different##3##4##(2004-3#1)(2008-12#1)(2012-2#1)
the incidence of discolored achenes##2##5##(2008-10#2)
the incidence of distant metastases##2##5##(2006-6#1)(2008-6#1)
the incidence of dysplasia##2##4##(1991-9#1)(1993-8#1)
the incidence of early##4##4##(1991-3#1)(2006-10#1)(2006-4#1)(2007-11#1)
the incidence of ectopic##2##4##(1992-4#1)(1994-3#1)
the incidence of esophageal adenocarcinoma has##2##6##(2006-10#1)(2009-3#1)
the incidence of fire blight in##2##6##(2008-10#2)
the incidence of fire blight##3##5##(2008-10#3)
the incidence of fractures##3##4##(1995-11#1)(2010-10#1)(2013-1#1)
the incidence of fruit##4##4##(2008-10#4)
the incidence of gastric##3##4##(1990-4#1)(2006-10#1)(2008-5#1)
the incidence of heart failure##3##5##(2008-3#1)(2010-8#2)
the incidence of heart##4##4##(2008-1#1)(2008-3#1)(2010-8#2)
the incidence of hepatitis##3##4##(2006-10#1)(2007-12#1)(2007-7#1)
the incidence of human##2##4##(2004-7#1)(2011-2#1)
the incidence of hyaline##2##4##(1991-8#1)(1994-6#1)
the incidence of hypertension##4##4##(1996-9#1)(2006-4#1)(2011-12#1)(2013-1#1)
the incidence of hypo-##2##4##(1991-8#2)
the incidence of hypotension##2##4##(2011-12#2)
the incidence of infection by##2##5##(2008-10#2)
the incidence of infection##5##4##(2007-12#1)(2008-10#3)(2010-10#1)
the incidence of inflammatory##3##4##(2006-10#1)(2011-12#1)(2013-1#1)
the incidence of intestinal##2##4##(1993-10#1)(2013-8#1)
the incidence of late##3##4##(1992-5#1)(2005-12#1)(2011-2#1)
the incidence of leaf##2##4##(2008-10#2)
the incidence of lethal arrhythmias##2##5##(1995-12#2)
the incidence of lung cancer##2##5##(1990-12#1)(1991-4#1)
the incidence of major##2##4##(2006-2#1)(2006-8#1)
the incidence of malaria##5##4##(2007-12#1)(2011-12#1)(2012-12#1)(2012-3#2)
the incidence of malignant melanoma##2##5##(2007-10#1)(2011-2#1)
the incidence of malignant##4##4##(2006-12#1)(2007-10#1)(2008-8#1)(2011-2#1)
the incidence of melanoma increased by##2##6##(2011-2#2)
the incidence of neurological##3##4##(2006-10#1)(2006-9#1)(2011-2#1)
the incidence of neurosurgical complications was##2##6##(2012-3#2)
the incidence of new##3##4##(1990-11#1)(2006-10#1)(2010-7#1)
the incidence of newly##2##4##(2006-10#1)(2008-10#1)
the incidence of occupational##2##4##(2007-4#1)(2008-4#1)
the incidence of opportunistic##2##4##(1993-8#1)(2006-10#1)
the incidence of positive##3##4##(2008-10#1)(2008-9#1)(2013-8#1)
the incidence of post-operative mediastinal##2##5##(2007-8#2)
the incidence of post-operative##5##4##(1991-5#1)(2007-8#4)
the incidence of postoperative atrial##3##5##(2007-8#3)
the incidence of postoperative pulmonary##2##5##(1990-10#1)(2007-8#1)
the incidence of postoperative stroke##2##5##(2007-8#2)
the incidence of postoperative##12##4##(1990-10#1)(1990-12#1)(1991-11#1)(1991-5#1)(2006-10#2)(2007-8#6)
the incidence of pre-term birth in Calabar##2##7##(2007-1#2)
the incidence of pre-term birth in##4##6##(2007-1#4)
the incidence of pre-term##5##4##(2007-1#5)
the incidence of prolonged##2##4##(2007-11#1)(2007-8#1)
the incidence of prostate cancer##2##5##(2006-10#1)(2008-6#1)
the incidence of pulmonary##2##4##(2009-6#1)(2012-1#1)
the incidence of recurrence##2##4##(2006-12#1)(2008-8#1)
the incidence of recurrent##2##4##(1993-2#1)(1997-4#1)
the incidence of rejection episodes##2##5##(1990-11#1)(2007-11#1)
the incidence of renal##4##4##(1994-5#1)(2007-11#1)(2008-6#1)(2011-2#1)
the incidence of rotavirus##2##4##(2007-11#1)(2009-5#1)
the incidence of seed##4##4##(2008-10#4)
the incidence of septic##2##4##(2006-2#1)(2009-8#1)
the incidence of serious##2##4##(2007-2#1)(2012-12#1)
the incidence of severe##4##4##(2006-10#1)(2007-9#1)(2008-1#1)(2008-7#1)
the incidence of shoulder##2##4##(2009-3#1)(2010-7#1)
the incidence of side effects##3##5##(1993-1#1)(1993-4#1)(2006-8#1)
the incidence of small##2##4##(2005-10#1)(2013-1#1)
the incidence of some##2##4##(1992-7#1)(1995-9#1)
the incidence of southern blight##2##5##(2008-10#2)
the incidence of specific##2##4##(2007-12#1)(2012-2#1)
the incidence of stems with ray blight##3##7##(2008-10#3)
the incidence of strawberry##2##4##(2008-10#2)
the incidence of stroke and##2##5##(1993-12#1)(2007-8#1)
the incidence of stroke in##2##5##(2007-8#2)
the incidence of stroke##9##4##(1992-4#1)(1993-12#1)(2006-2#1)(2007-8#4)(2008-1#1)(2008-8#1)
the incidence of subdural fluid collections##2##6##(2006-8#2)
the incidence of such##5##4##(1991-3#1)(1993-3#1)(2004-12#1)(2007-7#1)(2012-2#1)
the incidence of sudden infant death syndrome##2##7##(1991-11#1)(1991-9#1)
the incidence of sudden infant death##3##6##(1991-11#1)(1991-9#1)(1992-4#1)
the incidence of surgical site infections##3##6##(2006-6#1)(2012-3#1)(2013-1#1)
the incidence of surgical site##4##5##(2006-6#1)(2012-3#2)(2013-1#1)
the incidence of symptomatic##2##4##(2008-10#1)(2008-5#1)
the incidence of syphilis##4##4##(1993-3#1)(2007-7#1)(2009-9#2)
the incidence of the disease in##2##6##(1992-9#1)(2006-8#1)
the incidence of the disease##6##5##(1991-4#1)(1992-9#1)(2006-8#1)(2007-1#1)(2007-7#1)(2008-4#1)
the incidence of the##17##4##(1990-10#1)(1990-2#1)(1991-4#1)(1992-9#1)(1993-10#1)(1993-8#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-7#2)(2008-10#1)(2008-4#1)(2010-12#1)(2012-2#1)(2013-8#1)
the incidence of these##2##4##(2007-7#1)(2008-10#1)
the incidence of this##9##4##(1993-10#1)(1993-3#1)(2006-10#2)(2008-11#1)(2010-5#1)(2010-9#1)(2012-11#1)(2013-8#1)
the incidence of thromboembolic complications in##2##6##(2007-11#1)(2007-8#1)
the incidence of thromboembolic##3##4##(1996-4#1)(2007-11#1)(2007-8#1)
the incidence of thyroid##2##4##(2006-4#1)(2013-1#1)
the incidence of tuberculosis in this patient population has increased##2##10##(2013-1#2)
the incidence of tuberculosis##4##4##(1993-7#1)(2008-1#1)(2013-1#2)
the incidence of tumor##2##4##(1992-5#1)(1997-7#1)
the incidence of varicocele##2##4##(1990-3#2)
the incidence of vertebral fractures##2##5##(2008-8#2)
the incidence of vertebral##3##4##(2008-3#1)(2008-8#2)
the incidence of which increases##2##5##(2008-4#1)(2011-2#1)
the incidence of which##3##4##(2007-8#1)(2008-4#1)(2011-2#1)
the incidence of wound##3##4##(1990-3#1)(2006-10#1)(2007-9#1)
the incidence of zoster##3##4##(2008-4#1)(2008-5#2)
the incidence of##692##3##(1990-10#2)(1990-11#3)(1990-12#3)(1990-2#4)(1990-3#3)(1990-4#2)(1990-5#2)(1990-6#3)(1990-7#1)(1990-8#1)(1990-9#3)(1991-11#3)(1991-12#2)(1991-2#1)(1991-3#3)(1991-4#2)(1991-5#4)(1991-7#1)(1991-8#3)(1991-9#4)(1992-10#2)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#4)(1992-5#3)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-10#5)(1993-11#2)(1993-12#5)(1993-2#1)(1993-3#4)(1993-4#1)(1993-7#4)(1993-8#4)(1993-9#2)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#2)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#3)(1996-7#1)(1996-9#2)(1997-2#3)(1997-3#2)(1997-4#3)(1997-5#2)(1997-7#3)(1997-8#2)(2004-10#1)(2004-12#2)(2004-3#1)(2004-7#1)(2005-10#3)(2005-12#2)(2005-7#2)(2005-8#2)(2006-10#37)(2006-11#4)(2006-12#3)(2006-2#8)(2006-3#1)(2006-4#4)(2006-5#1)(2006-6#6)(2006-8#13)(2006-9#2)(2007-1#10)(2007-10#5)(2007-11#24)(2007-12#6)(2007-2#5)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#18)(2007-8#43)(2007-9#6)(2008-1#14)(2008-10#65)(2008-11#5)(2008-12#4)(2008-2#2)(2008-3#5)(2008-4#8)(2008-5#10)(2008-6#7)(2008-7#14)(2008-8#13)(2008-9#9)(2009-12#1)(2009-2#1)(2009-3#5)(2009-4#1)(2009-5#3)(2009-6#6)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#3)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#3)(2010-9#4)(2011-1#2)(2011-12#6)(2011-2#26)(2012-1#5)(2012-11#2)(2012-12#10)(2012-2#12)(2012-3#12)(2013-1#33)(2013-7#2)(2013-8#9)
the incidence or severity of##3##5##(2007-10#1)(2008-10#1)(2012-1#1)
the incidence or##4##3##(2007-10#1)(2008-10#1)(2008-7#1)(2012-1#1)
the incidence rate##11##3##(1992-10#1)(1993-8#2)(1994-11#1)(1995-5#1)(1996-3#1)(1996-7#1)(2007-3#1)(2008-11#1)(2008-12#1)(2011-2#1)
the incidence trend##2##3##(2011-2#2)
the incidence was##2##3##(1992-10#1)(1993-2#1)
the incidence will##2##3##(1992-2#1)(2006-10#1)
the incidence##855##2##(1990-10#2)(1990-11#4)(1990-12#3)(1990-2#5)(1990-3#3)(1990-4#2)(1990-5#2)(1990-6#5)(1990-7#1)(1990-8#1)(1990-9#3)(1991-11#4)(1991-12#3)(1991-2#1)(1991-3#3)(1991-4#2)(1991-5#4)(1991-7#1)(1991-8#3)(1991-9#4)(1992-10#4)(1992-12#3)(1992-2#3)(1992-3#1)(1992-4#4)(1992-5#4)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-10#5)(1993-11#3)(1993-12#5)(1993-2#2)(1993-3#7)(1993-4#1)(1993-5#1)(1993-7#4)(1993-8#6)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#2)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#4)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#1)(1996-11#4)(1996-12#3)(1996-2#1)(1996-3#3)(1996-4#2)(1996-5#1)(1996-6#3)(1996-7#2)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#5)(1997-8#2)(2004-10#2)(2004-12#2)(2004-3#1)(2004-7#1)(2005-10#3)(2005-11#2)(2005-12#3)(2005-7#3)(2005-8#2)(2006-10#43)(2006-11#4)(2006-12#3)(2006-2#10)(2006-3#1)(2006-4#4)(2006-5#2)(2006-6#6)(2006-7#1)(2006-8#13)(2006-9#2)(2007-1#10)(2007-10#6)(2007-11#32)(2007-12#10)(2007-2#5)(2007-3#3)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#22)(2007-8#48)(2007-9#6)(2008-1#18)(2008-10#79)(2008-11#7)(2008-12#6)(2008-2#5)(2008-3#7)(2008-4#10)(2008-5#13)(2008-6#8)(2008-7#27)(2008-8#13)(2008-9#12)(2009-12#2)(2009-2#1)(2009-3#6)(2009-4#1)(2009-5#3)(2009-6#7)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#3)(2010-11#1)(2010-12#7)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#4)(2010-7#3)(2010-8#4)(2010-9#6)(2011-1#5)(2011-12#7)(2011-2#37)(2012-1#6)(2012-11#2)(2012-12#11)(2012-2#14)(2012-3#14)(2013-1#38)(2013-7#3)(2013-8#10)
the incidences of focal##3##4##(2008-9#3)
the incidences of squamous cell papilloma were significantly increased in##2##10##(2008-9#2)
the incidences of squamous cell papilloma were##3##7##(2008-9#3)
the incidences of##19##3##(1992-11#1)(1992-9#1)(2006-10#2)(2008-7#1)(2008-9#11)(2010-12#1)(2011-1#1)(2011-2#1)
the incidences##20##2##(1992-11#1)(1992-9#1)(2006-10#2)(2008-7#1)(2008-9#12)(2010-12#1)(2011-1#1)(2011-2#1)
the incident and the##2##4##(2008-2#1)(2008-3#1)
the incident and##5##3##(2007-12#1)(2008-2#1)(2008-3#1)(2013-1#1)(2013-8#1)
the incident angle of the input beam in##2##8##(2008-3#2)
the incident angle of##3##4##(2008-10#1)(2008-3#2)
the incident angle##8##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#5)
the incident beam and##2##4##(2008-3#2)
the incident beam##20##3##(2007-11#2)(2007-12#6)(2007-5#1)(2008-1#1)(2008-2#3)(2008-3#7)
the incident beams##5##3##(2007-11#1)(2007-12#2)(2008-3#2)
the incident fundamental##2##3##(2007-12#2)
the incident illumination##2##3##(2008-2#1)(2008-3#1)
the incident laser beam##5##4##(2007-12#2)(2008-3#3)
the incident laser##7##3##(2007-12#2)(2008-2#1)(2008-3#4)
the incident light is##3##4##(2007-12#3)
the incident light##26##3##(2007-11#2)(2007-12#6)(2008-1#3)(2008-10#2)(2008-2#5)(2008-3#8)
the incident polarization##2##3##(2007-12#1)(2008-3#1)
the incident power##2##3##(2007-12#1)(2008-3#1)
the incident pump##3##3##(2007-12#2)(2008-3#1)
the incident radiation##8##3##(2008-2#4)(2008-3#4)
the incident ray##2##3##(2008-2#1)(2008-3#1)
the incident wave and##2##4##(2008-3#2)
the incident wave##6##3##(2008-2#2)(2008-3#4)
the incident wavelength and##2##4##(2008-3#2)
the incident wavelength##6##3##(2007-12#1)(2008-2#2)(2008-3#3)
the incident##138##2##(1996-11#1)(1996-12#3)(2006-5#1)(2007-10#1)(2007-11#9)(2007-12#32)(2007-5#1)(2007-8#2)(2008-1#4)(2008-10#5)(2008-11#2)(2008-2#29)(2008-3#44)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
the incidental detection##2##3##(2007-10#1)(2007-12#1)
the incidental##3##2##(2007-10#1)(2007-12#1)(2013-8#1)
the incidents and##2##3##(2009-10#1)(2013-1#1)
the incidents##6##2##(2007-12#1)(2008-12#1)(2009-10#1)(2010-9#1)(2011-1#1)(2013-1#1)
the incipient##3##2##(1997-7#1)(2005-1#1)(2009-5#1)
the incisal##2##2##(2010-3#1)(2012-2#1)
the incision##10##2##(1997-1#3)(2006-4#1)(2007-1#1)(2007-8#1)(2009-8#1)(2012-12#2)(2013-1#1)
the incisor##4##2##(1991-4#1)(1996-3#1)(2009-7#1)(2010-3#1)
the inciting##2##2##(2008-4#1)(2012-3#1)
the inclination of the##2##4##(2008-2#1)(2008-3#1)
the inclination of##3##3##(2008-2#2)(2008-3#1)
the inclination##4##2##(2008-2#2)(2008-3#2)
the included articles##3##3##(2009-4#1)(2011-2#1)(2013-1#1)
the included studies##5##3##(2008-10#1)(2010-11#1)(2012-2#2)(2013-8#1)
the included##11##2##(2006-12#1)(2008-10#2)(2008-9#1)(2009-4#1)(2010-11#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
the inclusion ability of##2##4##(2008-10#2)
the inclusion and exclusion criteria and##2##6##(2007-11#1)(2011-2#1)
the inclusion and exclusion criteria##4##5##(2007-11#1)(2009-10#1)(2011-2#2)
the inclusion complex between##2##4##(2008-10#2)
the inclusion complex##11##3##(2007-8#1)(2008-10#10)
the inclusion complexes##3##3##(2004-12#1)(2008-10#2)
the inclusion constant##3##3##(2008-10#3)
the inclusion criteria and agreed to participate##2##7##(2008-1#1)(2010-6#1)
the inclusion criteria and##3##4##(2008-1#1)(2010-4#1)(2010-6#1)
the inclusion criteria for##2##4##(2008-5#1)(2009-6#1)
the inclusion criteria were##5##4##(2005-8#1)(2010-6#1)(2012-12#1)(2012-3#2)
the inclusion criteria##34##3##(2005-10#1)(2005-8#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-6#3)(2011-1#4)(2011-2#2)(2012-12#3)(2012-3#3)(2013-1#4)(2013-8#2)
the inclusion mechanism of imidazole derivatives in##2##7##(2008-10#2)
the inclusion of a##3##4##(1996-10#1)(2007-12#1)(2008-10#1)
the inclusion of additional##2##4##(2008-9#1)(2013-7#1)
the inclusion of covariates##2##4##(1995-2#1)(2011-2#1)
the inclusion of mental health##2##5##(1995-1#1)(2011-2#1)
the inclusion of patients##2##4##(1994-12#1)(2006-10#1)
the inclusion of the##6##4##(1990-11#1)(2007-12#1)(2008-2#1)(2010-5#1)(2012-12#2)
the inclusion of##69##3##(1990-11#1)(1990-2#1)(1990-8#1)(1991-11#1)(1992-2#1)(1992-3#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-3#1)(1996-9#1)(2005-11#2)(2006-10#2)(2007-11#1)(2007-12#4)(2007-2#1)(2007-6#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#3)(2009-10#1)(2010-1#1)(2010-2#2)(2010-4#2)(2010-5#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)
the inclusion process##3##3##(2008-10#3)
the inclusion##146##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-11#1)(1992-2#1)(1992-3#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-9#1)(2004-12#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-8#1)(2007-11#2)(2007-12#4)(2007-2#2)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#39)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#3)(2009-10#2)(2009-12#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-2#2)(2010-4#3)(2010-5#1)(2010-6#3)(2011-1#7)(2011-2#7)(2012-1#1)(2012-12#6)(2012-2#1)(2012-3#4)(2013-1#5)(2013-7#2)(2013-8#2)
the inclusion/exclusion criteria##2##3##(2008-10#1)(2009-6#1)
the inclusions was##2##3##(2008-10#1)(2008-2#1)
the inclusions##10##2##(1995-9#1)(1996-5#1)(1997-3#1)(2008-10#5)(2008-2#2)
the incoherent optical##2##3##(2007-12#1)(2008-3#1)
the incoherent source##2##3##(2007-12#1)(2008-3#1)
the incoherent##22##2##(2007-12#5)(2008-1#4)(2008-11#1)(2008-2#3)(2008-3#9)
the income##3##2##(2006-4#1)(2008-11#1)(2010-5#1)
the incoming beam##2##3##(1996-4#1)(2008-2#1)
the incoming ligand##2##3##(1995-3#1)(2010-12#1)
the incoming light##2##3##(2008-1#1)(2008-2#1)
the incoming signal##2##3##(2008-2#1)(2011-1#1)
the incoming wave front##2##4##(2007-12#1)(2008-3#1)
the incoming wave##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
the incoming##25##2##(1995-3#1)(1996-4#1)(2006-4#1)(2007-11#2)(2007-12#2)(2008-1#3)(2008-10#2)(2008-2#5)(2008-3#4)(2010-12#1)(2010-7#1)(2011-1#1)(2013-1#1)
the incompatibility of##3##3##(1997-8#1)(2008-1#1)(2013-8#1)
the incompatibility##4##2##(1997-8#1)(2008-1#1)(2012-11#1)(2013-8#1)
the incompatible (i##2##3##(2008-10#2)
the incompatible interaction##3##3##(2008-10#3)
the incompatible##8##2##(1994-9#1)(2008-10#5)(2009-6#1)(2011-2#1)
the incompetent##3##2##(1991-2#1)(1993-3#1)(2006-4#1)
the incomplete##15##2##(1992-6#1)(1995-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-11#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
the incongruence between the##2##4##(1990-10#1)(2008-10#1)
the inconsistency##4##2##(2006-4#1)(2007-7#1)(2008-11#1)(2008-8#1)
the inconsistent##4##2##(2005-10#1)(2008-4#1)(2013-1#2)
the incontinence##2##2##(1992-2#1)(2006-7#1)
the incorporated##6##2##(1991-3#1)(1993-11#1)(1994-12#1)(1997-1#2)(2008-10#1)
the incorporation of 0##2##4##(1990-12#2)
the incorporation of [3H]leucine##2##4##(1991-2#1)(1993-12#1)
the incorporation of [3H]thymidine into DNA##2##6##(1990-9#1)(1995-12#1)
the incorporation of [3H]thymidine into##3##5##(1990-9#1)(1995-12#1)(1995-3#1)
the incorporation of [3H]thymidine##4##4##(1990-9#1)(1994-2#1)(1995-12#1)(1995-3#1)
the incorporation of a##4##4##(1994-6#1)(2007-11#1)(2008-3#1)(2011-1#1)
the incorporation of an##5##4##(1993-8#1)(1994-5#1)(2007-11#1)(2007-12#1)(2009-2#1)
the incorporation of ara-C into DNA##2##6##(1992-4#2)
the incorporation of both##2##4##(1995-2#1)(1996-3#1)
the incorporation of cholesterol##2##4##(1990-12#1)(1990-2#1)
the incorporation of new##2##4##(2007-9#1)(2013-1#1)
the incorporation of radioactive##3##4##(1990-11#1)(1992-9#1)(1994-10#1)
the incorporation of the##8##4##(1992-11#1)(1992-6#1)(1994-5#1)(1994-6#1)(1995-11#1)(1997-2#1)(2008-10#1)(2009-3#1)
the incorporation of these##4##4##(1991-7#1)(1997-2#1)(2008-10#1)(2008-4#1)
the incorporation of##140##3##(1990-10#3)(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-7#2)(1991-8#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-4#3)(1992-6#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-10#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#3)(1994-8#3)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#1)(2005-9#1)(2006-3#2)(2006-4#1)(2007-11#4)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#4)(2008-2#3)(2008-3#1)(2008-4#6)(2008-5#1)(2008-7#3)(2009-12#4)(2009-2#2)(2009-3#2)(2009-6#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
the incorporation rates of##2##4##(1993-9#1)(1994-8#1)
the incorporation reaction of##2##4##(2008-10#2)
the incorporation values##2##3##(1991-6#1)(2008-11#1)
the incorporation was##2##3##(1990-11#1)(1992-4#1)
the incorporation##152##2##(1990-10#3)(1990-11#3)(1990-12#3)(1990-2#3)(1990-3#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-6#1)(1991-7#2)(1991-8#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-4#4)(1992-6#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#3)(1994-8#4)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#1)(2005-9#1)(2006-3#2)(2006-4#1)(2007-11#4)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#5)(2008-2#3)(2008-3#1)(2008-4#6)(2008-5#1)(2008-7#3)(2008-8#1)(2009-12#4)(2009-2#2)(2009-3#2)(2009-6#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)
the incorrect##8##2##(1994-11#1)(1997-5#1)(1997-6#1)(2007-11#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-3#1)
the incoupled light##2##3##(2008-3#2)
the increase and##2##3##(2009-12#1)(2013-1#1)
the increase at##2##3##(2008-5#1)(2009-12#1)
the increase for##2##3##(2007-3#1)(2008-3#1)
the increase in DNA##3##4##(1990-2#1)(1994-12#1)(2008-11#1)
the increase in GFAP##2##4##(1990-7#2)
the increase in [Ca2+]i and##2##5##(1990-7#1)(1994-3#1)
the increase in [Ca2+]i##6##4##(1990-7#2)(1992-7#1)(1993-7#1)(1994-2#1)(1994-3#1)
the increase in [Na+]i##2##4##(1994-8#2)
the increase in absorbance##3##4##(2008-10#2)(2008-3#1)
the increase in activity##4##4##(1990-10#1)(1996-8#1)(2005-11#1)(2008-4#1)
the increase in adenosine##2##4##(1993-3#2)
the increase in apoptosis##2##4##(2008-7#2)
the increase in arterial##3##4##(1995-3#2)(2007-12#1)
the increase in blood pressure##3##5##(1991-2#1)(1993-4#1)(1995-3#1)
the increase in blood##4##4##(1991-2#1)(1993-4#1)(1995-3#1)(2006-10#1)
the increase in body##2##4##(2011-1#1)(2013-1#1)
the increase in calcium##2##4##(1990-12#1)(2011-2#1)
the increase in cardiac##2##4##(2006-1#1)(2012-3#1)
the increase in cell number##2##5##(1995-2#1)(1996-2#1)
the increase in cell##4##4##(1990-8#1)(1995-2#1)(1996-2#1)(2009-12#1)
the increase in cytosolic##2##4##(1995-12#1)(2008-10#1)
the increase in diffraction efficiency##2##5##(2008-3#2)
the increase in extracellular##3##4##(1991-12#1)(1994-2#1)(1996-10#1)
the increase in fluorescence##2##4##(2008-10#1)(2013-7#1)
the increase in gastric##2##4##(1992-6#1)(2005-11#1)
the increase in intracellular##2##4##(1994-3#1)(1995-8#1)
the increase in lipid##2##4##(1994-3#1)(2008-10#1)
the increase in mortality##2##4##(1991-3#1)(2008-8#1)
the increase in number of##2##5##(1990-10#1)(2010-8#1)
the increase in p53##2##4##(1993-4#1)(1997-7#1)
the increase in plasma norepinephrine##3##5##(1993-3#1)(1995-12#2)
the increase in plasma##10##4##(1990-11#1)(1990-5#1)(1991-2#1)(1993-3#1)(1995-12#2)(1997-8#2)(2008-10#1)(2010-10#1)
the increase in protein##3##4##(2005-12#1)(2008-5#1)(2010-12#1)
the increase in renal##3##4##(1991-7#1)(1997-2#1)(2011-2#1)
the increase in resistance##2##4##(1995-7#1)(2008-5#1)
the increase in risk##2##4##(2005-10#1)(2010-12#1)
the increase in sensitivity##2##4##(2008-10#1)(2012-2#1)
the increase in serum##2##4##(2008-10#1)(2008-7#1)
the increase in size##2##4##(1993-12#1)(2013-7#1)
the increase in splenic B7(+) macrophages##2##6##(2008-10#2)
the increase in systemic##2##4##(1996-12#1)(2009-9#1)
the increase in temperature##2##4##(2005-11#1)(2013-8#1)
the increase in the H2O2 concentration##2##6##(1997-1#2)
the increase in the amount of##2##6##(1992-4#1)(1994-11#1)
the increase in the concentration of##2##6##(1993-4#1)(2012-2#1)
the increase in the levels of##2##6##(1997-2#1)(2008-10#1)
the increase in the number of##8##6##(1991-5#1)(1994-5#1)(1995-11#1)(1997-2#1)(2006-10#1)(2008-11#1)(2008-5#2)
the increase in the rate of##4##6##(1993-11#1)(1994-5#1)(1994-9#1)(1995-6#1)
the increase in the volume##2##5##(2009-2#1)(2009-5#1)
the increase in the##69##4##(1990-4#1)(1990-5#1)(1990-6#1)(1991-5#2)(1992-11#1)(1992-12#1)(1992-4#1)(1993-11#1)(1993-4#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-6#1)(1996-1#1)(1996-11#2)(1997-1#2)(1997-2#2)(1997-3#2)(1997-7#1)(2005-11#3)(2005-12#1)(2005-7#1)(2006-10#3)(2006-5#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2009-2#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
the increase in total##3##4##(1990-4#1)(1990-9#1)(2008-11#1)
the increase in tyrosine hydroxylase##2##5##(1997-5#2)
the increase in viscosity##2##4##(1996-5#1)(2008-5#1)
the increase in##356##3##(1990-10#4)(1990-11#3)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#4)(1990-5#4)(1990-6#1)(1990-7#5)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#3)(1991-5#4)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#6)(1993-4#3)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#4)(1994-3#3)(1994-5#4)(1994-6#2)(1994-8#6)(1994-9#3)(1995-11#3)(1995-12#5)(1995-2#2)(1995-3#6)(1995-6#3)(1995-7#1)(1995-8#3)(1996-1#2)(1996-10#3)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#7)(1997-3#4)(1997-4#1)(1997-5#3)(1997-7#3)(1997-8#4)(2004-9#1)(2005-10#1)(2005-11#12)(2005-12#2)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#3)(2007-1#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#24)(2008-11#13)(2008-12#2)(2008-3#6)(2008-4#5)(2008-5#12)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#5)(2010-4#3)(2010-8#2)(2011-1#3)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#7)(2013-7#3)(2013-8#7)
the increase is##2##3##(1996-11#1)(2008-3#1)
the increase may##2##3##(2007-2#1)(2008-7#1)
the increase occurred after##2##4##(1991-2#1)(1993-2#1)
the increase of ATP-citrate lyase##2##5##(1992-11#2)
the increase of [Ca(2+)](i)##2##4##(2008-9#2)
the increase of age##3##4##(2011-1#1)(2012-2#1)(2013-7#1)
the increase of concentration of##2##5##(2008-8#2)
the increase of fluorescence##2##4##(2007-8#1)(2008-10#1)
the increase of intracellular##2##4##(1991-12#1)(2008-11#1)
the increase of its concentration##4##5##(2007-8#1)(2008-10#3)
the increase of obesity##2##4##(2006-1#1)(2006-2#1)
the increase of serum##4##4##(1990-2#1)(1995-3#1)(2005-3#1)(2010-12#1)
the increase of the##30##4##(1991-9#1)(1993-6#1)(1994-3#1)(1995-5#1)(1996-3#1)(1996-4#1)(1997-6#1)(2005-11#2)(2005-4#1)(2007-2#1)(2007-8#1)(2008-10#8)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2010-4#1)(2010-5#1)(2011-3#1)(2013-7#1)
the increase of##153##3##(1990-10#1)(1990-12#1)(1990-2#2)(1990-4#2)(1990-5#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-10#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#4)(1994-3#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#2)(1996-3#2)(1996-4#2)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#3)(2005-10#1)(2005-11#5)(2005-3#2)(2005-4#2)(2006-1#1)(2006-10#1)(2006-2#1)(2006-3#1)(2007-11#1)(2007-2#2)(2007-3#2)(2007-8#4)(2008-1#1)(2008-10#18)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#6)(2008-7#2)(2008-8#7)(2008-9#5)(2009-2#1)(2009-3#1)(2009-7#2)(2010-10#1)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#3)(2011-2#5)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#4)
the increase or decrease##2##4##(1994-6#1)(2011-2#1)
the increase was##12##3##(1992-1#1)(1992-3#1)(1992-5#1)(1997-7#2)(2006-9#2)(2008-10#3)(2009-7#1)(2012-3#1)
the increase with##2##3##(1996-5#1)(2011-1#1)
the increase##569##2##(1990-10#5)(1990-11#3)(1990-12#4)(1990-2#4)(1990-3#1)(1990-4#7)(1990-5#6)(1990-6#1)(1990-7#5)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#5)(1991-2#4)(1991-3#4)(1991-5#5)(1991-7#1)(1991-8#2)(1991-9#4)(1992-1#3)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#4)(1992-4#2)(1992-5#2)(1992-6#4)(1992-7#2)(1992-8#3)(1992-9#2)(1993-10#2)(1993-11#1)(1993-12#3)(1993-2#4)(1993-3#6)(1993-4#3)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#8)(1994-3#4)(1994-5#4)(1994-6#4)(1994-8#6)(1994-9#3)(1995-10#1)(1995-11#4)(1995-12#6)(1995-2#2)(1995-3#7)(1995-5#2)(1995-6#4)(1995-7#1)(1995-8#3)(1996-1#2)(1996-10#3)(1996-11#3)(1996-12#2)(1996-2#3)(1996-3#3)(1996-4#2)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#4)(1997-2#8)(1997-3#4)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#5)(1997-8#8)(2004-9#1)(2005-10#2)(2005-11#18)(2005-12#2)(2005-3#2)(2005-4#2)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#7)(2006-12#1)(2006-2#2)(2006-3#1)(2006-5#1)(2006-8#3)(2006-9#2)(2007-1#1)(2007-11#4)(2007-12#3)(2007-2#5)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#9)(2008-10#47)(2008-11#15)(2008-12#6)(2008-2#2)(2008-3#12)(2008-4#9)(2008-5#22)(2008-6#1)(2008-7#7)(2008-8#11)(2008-9#6)(2009-11#2)(2009-12#5)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#3)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#6)(2010-4#5)(2010-5#2)(2010-8#2)(2011-1#8)(2011-2#14)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#7)(2012-3#5)(2013-1#10)(2013-7#5)(2013-8#11)
the increased X-ray##2##3##(1997-8#1)(2012-2#1)
the increased ability##2##3##(1993-3#1)(2007-5#1)
the increased accumulation of##2##4##(1994-12#1)(2008-5#1)
the increased activity of##2##4##(2009-4#1)(2010-4#1)
the increased activity##4##3##(1990-11#1)(2008-4#1)(2009-4#1)(2010-4#1)
the increased affinity of##2##4##(1995-6#1)(1997-4#1)
the increased aggressiveness of##2##4##(2008-10#2)
the increased body mass index##2##5##(2007-12#1)(2011-1#1)
the increased complexity of##2##4##(1996-2#1)(2009-2#1)
the increased complexity##3##3##(1996-2#1)(2009-2#1)(2011-1#1)
the increased consumption of##2##4##(2011-1#1)(2012-12#1)
the increased demand##2##3##(1990-6#1)(1997-3#1)
the increased expression of the##4##5##(1991-9#1)(1994-3#1)(1995-2#1)(2012-12#1)
the increased expression of##15##4##(1991-9#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-3#1)(1994-9#1)(1995-2#2)(1995-5#1)(1996-7#1)(1997-7#1)(2009-8#1)(2010-12#1)(2012-12#1)(2012-3#1)
the increased expression##17##3##(1991-9#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-12#1)(1996-7#1)(1997-7#1)(2009-8#1)(2010-12#1)(2012-12#1)(2012-3#1)
the increased frequency of##7##4##(1991-5#1)(1991-9#1)(1992-9#1)(1993-5#1)(1994-7#1)(2008-11#1)(2009-5#1)
the increased incidence of##6##4##(1990-12#1)(1992-3#1)(1994-5#1)(1996-3#1)(2008-11#1)(2011-2#1)
the increased level of##3##4##(2005-7#1)(2010-12#1)(2011-2#1)
the increased level##5##3##(2005-7#1)(2008-12#1)(2010-12#1)(2011-2#1)(2012-2#1)
the increased levels of##8##4##(1995-6#1)(1996-3#1)(2008-6#1)(2011-1#1)(2012-11#2)(2012-6#1)(2013-1#1)
the increased levels##9##3##(1995-6#1)(1996-3#1)(1997-4#1)(2008-6#1)(2011-1#1)(2012-11#2)(2012-6#1)(2013-1#1)
the increased mortality##2##3##(1993-1#1)(2004-1#1)
the increased number of patients##2##5##(2007-7#1)(2008-1#1)
the increased number of##16##4##(1991-12#1)(1991-2#1)(1991-3#1)(1993-10#1)(1994-11#1)(1994-6#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)
the increased number##17##3##(1991-12#1)(1991-2#1)(1991-3#1)(1993-10#1)(1994-11#1)(1994-6#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)
the increased oxidative stress##2##4##(1992-1#1)(2007-10#1)
the increased oxidative##3##3##(1992-1#1)(1995-6#1)(2007-10#1)
the increased prevalence of##3##4##(1992-3#1)(2008-2#1)(2009-3#1)
the increased prevalence##4##3##(1992-3#1)(2007-2#1)(2008-2#1)(2009-3#1)
the increased production##4##3##(1992-12#1)(1994-11#1)(1996-6#1)(2012-2#1)
the increased rate of##6##4##(1990-3#1)(1994-3#1)(1996-8#1)(2007-11#1)(2008-3#1)(2009-3#1)
the increased rate##7##3##(1990-3#1)(1994-3#2)(1996-8#1)(2007-11#1)(2008-3#1)(2009-3#1)
the increased resistance##2##3##(2004-4#1)(2008-10#1)
the increased risk of cancer##2##5##(1991-5#1)(2007-11#1)
the increased risk of mortality in##2##6##(2011-2#1)(2012-2#1)
the increased risk of##19##4##(1991-5#1)(1991-8#1)(1994-3#1)(1996-8#1)(2005-10#1)(2006-6#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-7#2)(2010-12#1)(2011-2#2)(2012-2#2)(2013-1#3)
the increased risk##21##3##(1991-5#1)(1991-8#1)(1994-3#1)(1996-8#1)(2005-10#1)(2006-6#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-7#3)(2010-12#1)(2010-9#1)(2011-2#2)(2012-2#2)(2013-1#3)
the increased secretion of##2##4##(1993-12#1)(2008-11#1)
the increased sensitivity##2##3##(1991-8#1)(2008-10#1)
the increased shear stress##2##4##(2008-2#1)(2010-10#1)
the increased size of##2##4##(1991-4#1)(2012-3#1)
the increased stability of the##3##5##(1993-11#1)(1997-2#1)(2008-4#1)
the increased stability##4##3##(1993-11#2)(1997-2#1)(2008-4#1)
the increased surface##2##3##(1994-2#1)(1996-8#1)
the increased susceptibility of##2##4##(1997-5#1)(2008-10#1)
the increased susceptibility to##3##4##(1991-9#1)(2008-10#2)
the increased susceptibility##5##3##(1991-9#1)(1997-5#1)(2008-10#3)
the increased transport of##2##4##(1991-5#1)(2009-8#1)
the increased uptake##2##3##(1994-5#1)(2006-10#1)
the increased use of##15##4##(1991-11#1)(1991-12#1)(1991-3#1)(1995-2#1)(1996-1#1)(1996-9#1)(2005-12#1)(2006-10#2)(2007-4#1)(2008-11#1)(2008-12#1)(2009-8#1)(2012-2#1)(2013-8#1)
the increased##324##2##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#3)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-11#3)(1994-12#3)(1994-2#3)(1994-3#4)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#2)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#3)(1995-6#3)(1995-7#2)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#3)(1996-3#4)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#6)(1996-9#2)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#2)(2004-1#1)(2004-3#1)(2004-4#2)(2005-10#2)(2005-12#1)(2005-5#2)(2005-7#2)(2005-8#1)(2006-10#7)(2006-12#1)(2006-3#1)(2006-6#1)(2006-9#1)(2007-10#3)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#3)(2008-1#5)(2008-10#15)(2008-11#10)(2008-12#3)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#6)(2008-6#4)(2008-7#9)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#2)(2009-4#1)(2009-5#3)(2009-8#5)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#12)(2012-11#3)(2012-12#5)(2012-2#7)(2012-3#5)(2012-5#1)(2012-6#1)(2013-1#5)(2013-8#2)
the increases in plasma##3##4##(1997-5#1)(1997-8#1)(2008-4#1)
the increases in the efficiency of the##2##7##(1997-2#2)
the increases in the##4##4##(1997-2#2)(1997-8#1)(2008-5#1)
the increases in##21##3##(1991-2#1)(1991-5#1)(1993-9#1)(1996-11#1)(1996-12#1)(1997-2#2)(1997-4#1)(1997-5#2)(1997-8#2)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#2)(2010-7#1)(2012-2#1)
the increases of##6##3##(1990-11#1)(2005-11#1)(2008-1#1)(2008-4#1)(2008-9#1)(2011-2#1)
the increases were##2##3##(1991-2#1)(2004-11#1)
the increases##34##2##(1990-11#2)(1991-2#2)(1991-5#1)(1991-7#1)(1993-11#1)(1993-9#1)(1995-12#1)(1996-11#1)(1996-12#1)(1997-2#2)(1997-4#1)(1997-5#2)(1997-8#2)(2004-11#1)(2005-11#1)(2008-1#1)(2008-12#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-2#1)
the increasing amount of##5##4##(2007-6#1)(2008-10#1)(2008-9#1)(2009-11#1)(2013-8#1)
the increasing availability of##4##4##(1992-6#1)(2006-4#1)(2008-3#1)(2012-2#1)
the increasing burden of##2##4##(2007-7#1)(2008-1#1)
the increasing complexity of##2##4##(2005-5#1)(2011-2#1)
the increasing demand for##5##4##(1992-3#1)(2007-4#1)(2008-10#1)(2008-3#1)(2010-4#1)
the increasing demand##6##3##(1992-1#1)(1992-3#1)(2007-4#1)(2008-10#1)(2008-3#1)(2010-4#1)
the increasing demands##3##3##(2006-6#1)(2013-1#2)
the increasing effect of methamphetamine on dopamine in the##2##9##(1996-10#2)
the increasing effect of##3##4##(1990-11#1)(1996-10#2)
the increasing frequency of##3##4##(2006-10#1)(2006-11#1)(2008-8#1)
the increasing importance of##4##4##(1995-8#1)(2008-10#1)(2008-2#2)
the increasing incidence of##8##4##(1992-2#1)(1996-11#1)(1996-6#1)(2005-8#1)(2008-4#1)(2011-2#3)
the increasing incidence##9##3##(1992-2#1)(1993-9#1)(1996-11#1)(1996-6#1)(2005-8#1)(2008-4#1)(2011-2#3)
the increasing knowledge about the##2##5##(2004-11#1)(2008-8#1)
the increasing knowledge about##3##4##(2004-11#1)(2008-5#1)(2008-8#1)
the increasing knowledge##4##3##(2004-11#1)(2008-1#1)(2008-5#1)(2008-8#1)
the increasing levels of##2##4##(1996-12#1)(2012-3#1)
the increasing number of##24##4##(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-3#1)(1997-2#2)(2005-1#1)(2005-8#1)(2006-10#2)(2007-12#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-8#2)(2009-10#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)
the increasing numbers of##4##4##(1990-11#1)(1990-12#1)(1990-5#2)
the increasing of##3##3##(2008-8#1)(2008-9#2)
the increasing pressure##2##3##(1993-2#1)(2007-11#1)
the increasing prevalence and##2##4##(2006-10#1)(2006-2#1)
the increasing prevalence of obesity and##2##6##(2010-8#1)(2010-9#1)
the increasing prevalence of##11##4##(1990-6#1)(2006-10#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-3#2)
the increasing prevalence##13##3##(1990-6#1)(2006-10#2)(2006-2#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-3#2)
the increasing problem of##2##4##(2007-2#1)(2013-1#1)
the increasing trend##3##3##(1997-7#1)(2008-1#1)(2013-1#1)
the increasing use of##17##4##(1990-12#1)(2006-2#1)(2006-5#2)(2007-12#1)(2007-4#2)(2007-7#2)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-3#1)(2011-2#1)
the increasing use##18##3##(1990-12#1)(2006-2#1)(2006-5#2)(2007-12#1)(2007-4#2)(2007-7#2)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-3#1)(2010-12#1)(2011-2#1)
the increasing volume of##2##4##(2005-7#1)(2011-1#1)
the increasing##203##2##(1990-11#2)(1990-12#2)(1990-4#1)(1990-5#2)(1990-6#2)(1991-3#1)(1992-1#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#3)(1993-11#2)(1993-2#4)(1993-3#1)(1993-9#1)(1994-1#1)(1994-3#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-10#2)(1996-11#1)(1996-12#3)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2004-11#1)(2005-1#1)(2005-11#1)(2005-5#1)(2005-7#1)(2005-8#5)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#2)(2006-4#2)(2006-5#2)(2006-6#3)(2006-8#2)(2007-1#1)(2007-11#4)(2007-12#3)(2007-2#2)(2007-4#3)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#9)(2008-9#4)(2009-10#1)(2009-11#2)(2009-3#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#9)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#5)(2013-8#4)
the increasingly complex##2##3##(2010-10#1)(2013-1#1)
the increasingly wide##2##3##(2006-10#1)(2011-12#1)
the increasingly##11##2##(1994-2#1)(2005-8#1)(2006-10#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-10#1)(2010-5#1)(2011-12#1)(2013-1#1)
the increment in##6##3##(1990-5#1)(1997-5#1)(2008-3#1)(2008-4#1)(2010-10#2)
the increment of the##4##4##(2005-11#1)(2007-8#1)(2008-10#1)(2009-8#1)
the increment of##9##3##(1991-4#1)(1996-2#1)(2005-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2009-8#1)(2012-2#1)
the increment was##2##3##(1993-7#1)(1994-3#1)
the increment##24##2##(1990-5#1)(1991-4#1)(1993-7#3)(1994-3#1)(1996-2#1)(1997-2#1)(1997-5#1)(2005-11#2)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2009-8#1)(2010-10#2)(2012-2#1)(2013-8#1)
the incremental cost per##2##4##(2006-12#1)(2013-8#1)
the incremental cost##3##3##(2006-12#1)(2008-5#1)(2013-8#1)
the incremental cost-effectiveness##2##3##(2008-1#1)(2012-12#1)
the incremental value of##2##4##(2005-12#1)(2010-12#1)
the incremental##16##2##(1992-9#1)(2005-11#1)(2005-12#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#4)(2013-8#1)
the incubated##2##2##(1990-4#1)(1991-2#1)
the incubation buffer##3##3##(1992-3#1)(1995-8#1)(2008-10#1)
the incubation distribution##2##3##(1992-9#2)
the incubation media##7##3##(1991-2#1)(1991-9#1)(1992-12#1)(1993-6#1)(1994-2#2)(2008-10#1)
the incubation medium##19##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-7#1)(1992-9#1)(1993-6#2)(1994-8#1)(1995-11#3)(2008-5#1)(2008-8#1)
the incubation mixture of##2##4##(1990-2#1)(1992-6#1)
the incubation mixture##7##3##(1990-2#2)(1992-6#1)(1994-5#1)(1994-9#2)(2011-2#1)
the incubation of##5##3##(1991-3#1)(1993-4#1)(1995-1#1)(2008-11#2)
the incubation period of##2##4##(1991-12#1)(1992-8#1)
the incubation period was##2##4##(2008-10#2)
the incubation period##12##3##(1991-12#1)(1992-6#1)(1992-8#1)(2006-10#1)(2008-10#7)(2008-11#1)
the incubation solution##3##3##(1994-6#1)(1997-1#1)(2008-10#1)
the incubation temperature and the##2##5##(2008-10#1)(2011-2#1)
the incubation temperature##5##3##(2008-10#4)(2011-2#1)
the incubation time of the##2##5##(1995-1#1)(2010-12#1)
the incubation time of##3##4##(1995-1#1)(2008-9#1)(2010-12#1)
the incubation time##12##3##(1990-12#1)(1990-2#1)(1991-11#1)(1991-3#1)(1995-1#1)(1996-11#1)(2006-8#1)(2008-10#1)(2008-7#1)(2008-9#2)(2010-12#1)
the incubation was##2##3##(1994-11#1)(1997-7#1)
the incubation with##6##3##(1992-8#1)(1993-7#1)(1993-8#1)(1994-3#1)(1997-8#1)(2008-11#1)
the incubation##99##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#4)(1990-4#3)(1990-5#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#3)(1993-11#1)(1993-4#1)(1993-6#3)(1993-7#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#4)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1997-1#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-4#1)(2006-8#2)(2007-8#1)(2008-10#16)(2008-11#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-12#1)(2011-2#2)
the incubator and##2##3##(2007-10#2)
the incubator##4##2##(2007-10#3)(2008-8#1)
the incubators##2##2##(2007-10#1)(2008-5#1)
the indentation##3##2##(2005-10#1)(2013-8#2)
the independence of the##2##4##(2008-2#1)(2008-6#1)
the independence of##6##3##(2005-11#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-6#1)
the independence##8##2##(2005-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-6#1)(2011-2#1)
the independent action of##2##4##(2008-10#2)
the independent association between##2##4##(2007-3#1)(2010-5#1)
the independent contrast method##2##4##(1997-4#2)
the independent effects of##3##4##(2007-11#1)(2008-7#1)(2009-7#1)
the independent measurements of##2##4##(2008-3#2)
the independent prognostic##2##3##(2006-10#1)(2012-3#1)
the independent samples##2##3##(1992-2#1)(2008-12#1)
the independent variable##5##3##(2008-10#2)(2008-11#2)(2011-1#1)
the independent variables##8##3##(1992-1#1)(1993-1#1)(1994-12#1)(1995-9#1)(2004-12#1)(2007-12#1)(2008-5#1)(2011-2#1)
the independent##50##2##(1990-8#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-9#1)(1996-3#1)(1997-4#2)(2004-12#1)(2005-11#1)(2006-10#1)(2006-11#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-3#6)(2008-5#1)(2008-7#1)(2009-2#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
the independently determined##2##3##(1997-2#1)(2008-10#1)
the independently##8##2##(1990-11#1)(1990-7#1)(1997-2#1)(2006-5#1)(2008-10#2)(2008-2#1)(2008-3#1)
the indeterminate##2##2##(1991-9#1)(2012-12#1)
the index and##2##3##(2007-12#1)(2008-3#1)
the index case##2##3##(1995-6#1)(2008-7#1)
the index cases##2##3##(1993-1#1)(1996-6#1)
the index event##4##3##(2007-10#1)(2007-6#1)(2008-11#1)(2008-7#1)
the index group##3##3##(2006-8#3)
the index is##2##3##(2007-11#1)(2008-2#1)
the index modulation##2##3##(2007-12#1)(2008-3#1)
the index of dispersion##5##4##(2008-10#5)
the index of individuality##2##4##(1995-7#1)(1996-12#1)
the index of refraction and##3##5##(2007-12#1)(2008-3#2)
the index of refraction in the##3##6##(2007-12#1)(2008-3#1)(2008-7#1)
the index of refraction in##4##5##(2007-12#1)(2008-3#2)(2008-7#1)
the index of refraction of an##2##6##(2008-2#1)(2008-3#1)
the index of refraction of the control waveguide##2##8##(2008-2#1)(2008-3#1)
the index of refraction of the##4##6##(2008-2#1)(2008-3#3)
the index of refraction of water##3##6##(2008-2#3)
the index of refraction of##13##5##(2007-12#1)(2008-2#8)(2008-3#4)
the index of refraction##42##4##(1991-9#1)(2007-12#6)(2008-1#1)(2008-2#17)(2008-3#16)(2008-7#1)
the index of the##2##4##(2008-6#1)(2010-2#1)
the index of##65##3##(1990-11#1)(1991-9#1)(1995-7#1)(1996-12#1)(1996-3#1)(2006-5#1)(2007-12#6)(2007-3#1)(2007-6#1)(2008-1#1)(2008-10#7)(2008-2#17)(2008-3#17)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-2#1)(2012-2#2)(2013-1#1)
the index pregnancy##2##3##(2007-1#1)(2008-3#1)
the index profile##4##3##(2007-11#2)(2008-2#1)(2008-3#1)
the index values of##2##4##(1992-2#2)
the index values##3##3##(1992-2#2)(2008-10#1)
the index variation##2##3##(2008-2#1)(2008-3#1)
the index was##2##3##(1991-7#1)(2011-2#1)
the index##135##2##(1990-10#2)(1990-11#1)(1990-5#1)(1991-7#1)(1991-9#1)(1992-2#2)(1992-9#1)(1993-1#1)(1993-6#1)(1993-9#1)(1995-1#1)(1995-6#2)(1995-7#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-5#1)(2004-11#3)(2005-10#1)(2006-5#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#12)(2007-2#1)(2007-3#1)(2007-6#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#24)(2008-3#26)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#1)(2010-11#1)(2010-2#1)(2011-2#5)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
the indexes of##2##3##(1995-12#1)(2005-8#1)
the indexes##3##2##(1991-12#1)(1995-12#1)(2005-8#1)
the indexing##2##2##(2009-7#2)
the indicated##6##2##(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2010-12#1)(2013-1#1)
the indication and##4##3##(1993-3#1)(1996-12#1)(2008-1#1)(2011-2#1)
the indication for this##2##4##(1997-5#1)(2013-1#1)
the indication for##20##3##(1990-7#1)(1991-9#1)(1993-6#1)(1996-11#1)(1996-9#1)(1997-4#2)(1997-5#1)(2004-10#1)(2005-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2010-12#2)(2011-2#1)(2012-12#1)(2013-1#2)
the indication is##2##3##(2011-2#1)(2013-8#1)
the indication of##6##3##(1992-6#1)(2005-10#1)(2007-8#1)(2008-12#1)(2011-1#1)(2013-1#1)
the indication##40##2##(1990-12#1)(1990-4#1)(1990-7#1)(1991-12#1)(1991-9#1)(1992-6#1)(1993-3#2)(1993-6#1)(1993-9#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-4#2)(1997-5#1)(2004-10#1)(2005-10#2)(2006-10#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2010-12#2)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#3)(2013-8#1)
the indications and contraindications##3##4##(2007-11#2)(2011-2#1)
the indications and the##4##4##(2006-10#2)(2007-7#1)(2008-4#1)
the indications and usage of##2##5##(1996-12#1)(2006-10#1)
the indications and##18##3##(1990-9#1)(1991-4#1)(1992-10#1)(1994-4#1)(1996-12#1)(2006-10#4)(2006-6#1)(2007-1#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-4#1)(2008-7#1)(2011-2#1)
the indications for and##2##4##(1990-12#1)(2007-8#1)
the indications for drug treatment##2##5##(1993-1#1)(2011-10#1)
the indications for surgery##2##4##(1991-8#1)(2008-7#1)
the indications for the use of##4##6##(1990-9#2)(1993-10#1)(2011-2#1)
the indications for use##2##4##(2008-11#1)(2011-2#1)
the indications for##43##3##(1990-11#1)(1990-12#1)(1990-8#1)(1990-9#2)(1991-8#1)(1992-12#1)(1993-1#1)(1993-10#1)(1996-9#1)(2005-8#1)(2006-10#3)(2006-5#1)(2007-4#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-10#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
the indications of##6##3##(2006-10#1)(2007-11#1)(2008-10#1)(2009-4#1)(2012-2#1)(2013-7#1)
the indications to##2##3##(1990-4#1)(1991-3#1)
the indications were##2##3##(1992-10#1)(2007-8#1)
the indications##86##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-8#1)(1990-9#3)(1991-3#1)(1991-4#1)(1991-8#1)(1992-10#2)(1992-12#1)(1993-1#1)(1993-10#1)(1994-4#1)(1996-12#1)(1996-9#1)(2005-8#1)(2006-10#8)(2006-2#1)(2006-3#2)(2006-5#1)(2006-6#2)(2007-1#1)(2007-11#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#2)(2009-4#1)(2009-8#1)(2010-11#2)(2010-12#4)(2010-8#1)(2011-10#1)(2011-2#4)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
the indicator electrode##4##3##(2008-10#4)
the indicator in##2##3##(2009-4#1)(2012-3#1)
the indicator reaction##2##3##(2008-10#2)
the indicator##32##2##(1990-12#1)(1990-2#1)(1990-9#1)(1992-12#1)(1997-3#1)(2008-10#17)(2008-4#1)(2008-9#2)(2009-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-8#2)
the indicators for##2##3##(2008-1#1)(2009-8#1)
the indicators of the##2##4##(1994-3#1)(2005-10#1)
the indicators##9##2##(1994-3#1)(1996-2#2)(2005-10#1)(2008-1#1)(2008-10#1)(2009-8#1)(2010-5#1)(2012-12#1)
the indicatrices##2##2##(2008-3#2)
the indices of refraction of##4##5##(2008-2#2)(2008-3#2)
the indices of##9##3##(2007-9#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-8#1)(2013-8#1)
the indices##16##2##(2006-6#1)(2007-11#2)(2007-9#1)(2008-11#2)(2008-2#4)(2008-3#3)(2008-6#1)(2008-8#1)(2013-8#1)
the indigenous##11##2##(1993-3#1)(2006-10#1)(2006-3#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-6#1)(2010-5#1)
the indigenously developed##2##3##(2007-8#1)(2008-11#1)
the indirect antiglobulin test##2##4##(1994-6#1)(1994-9#1)
the indirect benefit of##2##4##(1994-2#1)(2008-8#1)
the indirect defenses of##2##4##(2009-8#2)
the indirect determination of##4##4##(2008-10#4)
the indirect effects of##2##4##(2007-3#1)(2011-2#1)
the indirect method##4##3##(2007-7#1)(2008-10#1)(2008-11#2)
the indirect nature of the##2##5##(2008-10#2)
the indirect pathway##2##3##(1995-2#1)(2008-7#1)
the indirect result of##2##4##(1990-11#1)(2008-10#1)
the indirect##42##2##(1990-11#1)(1991-12#2)(1993-10#1)(1993-11#1)(1994-2#1)(1994-6#1)(1994-9#2)(1995-2#1)(1996-11#1)(2004-12#1)(2005-10#1)(2005-8#1)(2007-3#1)(2007-7#1)(2008-10#11)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-8#2)(2011-2#3)(2012-12#1)(2012-2#1)
the indiscriminate##3##2##(2008-10#1)(2009-10#1)(2011-2#1)
the indium##3##2##(2007-12#1)(2008-10#1)(2009-3#1)
the individual and society##2##4##(2007-3#1)(2008-5#1)
the individual and the##2##4##(1993-12#1)(2012-1#1)
the individual and##18##3##(1993-12#1)(1997-4#3)(2004-12#1)(2006-10#1)(2007-3#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-9#1)(2012-1#1)(2012-3#1)
the individual antioxidants##2##3##(2013-8#2)
the individual are##2##3##(2010-12#1)(2013-8#1)
the individual as##2##3##(1996-1#1)(2010-8#1)
the individual assessment of##2##4##(2009-3#1)(2013-1#1)
the individual bioavailability of n-3 PUFAs along with the highly different study designs and estimations of FAs intake or supplementation dosages in patient populations with different background intake of n-3 PUFAs might be some of the reasons for the inconsistent findings of the studies evaluating the impact of n-3 PUFAs on CVD##2##52##(2013-1#2)
the individual cell##3##3##(1995-2#1)(2007-3#1)(2010-9#1)
the individual characteristics##3##3##(1992-3#1)(2009-12#1)(2009-9#1)
the individual chromatographic##2##3##(2008-10#1)(2008-7#1)
the individual components of the##6##5##(1994-2#1)(1997-2#1)(2008-10#2)(2009-2#1)(2011-12#1)
the individual components of##11##4##(1992-9#1)(1994-2#1)(1997-2#1)(2006-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2009-2#1)(2011-12#1)
the individual components##19##3##(1992-9#1)(1993-6#1)(1994-2#1)(1997-2#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#3)(2009-12#1)(2009-2#1)(2009-8#1)(2011-12#1)
the individual countries##3##3##(1990-12#3)
the individual density and##2##4##(2013-8#2)
the individual diseases##2##3##(1990-8#1)(2008-10#1)
the individual drug##2##3##(2012-2#2)
the individual effects of##2##4##(2008-10#1)(2008-5#1)
the individual effects##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
the individual enantiomers of##2##4##(1990-6#1)(1995-7#1)
the individual enantiomers##4##3##(1990-6#1)(1993-2#1)(1994-9#1)(1995-7#1)
the individual experiencing##2##3##(2007-2#1)(2010-6#1)
the individual factors and##2##4##(1991-11#1)(2008-2#1)
the individual factors##3##3##(1991-11#1)(2008-2#1)(2010-10#1)
the individual genes for##2##4##(2012-2#1)(2013-1#1)
the individual genes##4##3##(1990-8#1)(1993-2#1)(2012-2#1)(2013-1#1)
the individual gratings##3##3##(1997-8#2)(2007-12#1)
the individual has##2##3##(1994-12#1)(2006-10#1)
the individual herbicides##2##3##(2006-5#2)
the individual hospital##2##3##(1992-2#1)(2008-11#1)
the individual hospitals##2##3##(1992-3#1)(2008-8#1)
the individual in##3##3##(2007-7#1)(2008-7#1)(2010-12#1)
the individual increase in##2##4##(2006-7#2)
the individual indications considered##2##4##(1990-5#1)(1993-3#1)
the individual is##7##3##(1990-5#1)(1995-9#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-2#1)(2012-1#1)
the individual level##13##3##(1993-7#1)(1996-8#1)(2007-2#2)(2008-10#1)(2008-3#1)(2008-8#2)(2009-4#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
the individual lower##2##3##(1995-8#1)(2010-2#1)
the individual measures##2##3##(1993-2#1)(2008-10#1)
the individual members##2##3##(2007-4#1)(2008-8#1)
the individual metal##2##3##(1990-5#1)(2007-12#1)
the individual motor##2##3##(1993-9#1)(1995-9#1)
the individual needs of##2##4##(2005-5#1)(2010-1#1)
the individual nurse##2##3##(2010-7#1)(2011-1#1)
the individual or##2##3##(1996-12#1)(2010-4#1)
the individual participant##2##3##(1996-4#2)
the individual patch##2##3##(2008-8#2)
the individual patient and##4##4##(1993-3#1)(1996-8#1)(2007-4#1)(2013-8#1)
the individual patient with##2##4##(2007-12#1)(2008-7#1)
the individual patient##28##3##(1990-4#1)(1992-2#1)(1993-12#1)(1993-3#1)(1996-8#2)(2005-12#1)(2006-10#2)(2006-2#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-4#1)(2008-7#2)(2009-9#1)(2010-12#2)(2010-6#1)(2010-7#1)(2013-1#2)(2013-8#2)
the individual patient's##5##3##(2005-10#1)(2006-10#1)(2007-5#1)(2008-9#1)(2013-8#1)
the individual patients##2##3##(1995-4#1)(2005-3#1)
the individual pulse##2##3##(2007-12#2)
the individual responses##3##3##(1993-6#1)(2008-10#1)(2008-4#1)
the individual risk##2##3##(1990-6#1)(2013-8#1)
the individual sectors##2##3##(1992-3#1)(2009-2#1)
the individual species##4##3##(2008-10#3)(2010-2#1)
the individual steps##2##3##(1994-8#1)(2011-2#1)
the individual student##2##3##(2006-7#1)(2008-11#1)
the individual subunits##2##3##(1991-12#1)(2008-4#1)
the individual treatment of##2##4##(2009-10#1)(2013-1#1)
the individual treatment##4##3##(1997-8#1)(2009-10#1)(2013-1#2)
the individual will##2##3##(2007-8#1)(2011-1#1)
the individual with a##2##4##(1994-1#1)(2006-8#1)
the individual with##4##3##(1994-1#1)(1995-3#1)(2006-8#1)(2011-2#1)
the individual##476##2##(1990-11#1)(1990-12#4)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#4)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#3)(1993-5#2)(1993-6#2)(1993-7#1)(1993-9#2)(1994-1#1)(1994-11#3)(1994-12#5)(1994-2#3)(1994-3#1)(1994-6#3)(1994-8#3)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#1)(1995-7#2)(1995-8#5)(1995-9#3)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#3)(1996-5#2)(1996-8#3)(1997-1#1)(1997-2#2)(1997-4#4)(1997-5#2)(1997-7#1)(1997-8#3)(1997-9#1)(2004-12#1)(2004-3#1)(2005-10#2)(2005-12#1)(2005-3#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#8)(2006-11#1)(2006-12#3)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#5)(2006-7#6)(2006-8#4)(2007-1#2)(2007-10#1)(2007-11#6)(2007-12#11)(2007-2#6)(2007-3#4)(2007-4#2)(2007-5#1)(2007-7#4)(2007-8#9)(2008-1#4)(2008-10#30)(2008-11#11)(2008-12#7)(2008-2#11)(2008-3#14)(2008-4#13)(2008-5#6)(2008-6#3)(2008-7#10)(2008-8#10)(2008-9#6)(2009-10#2)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#2)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#8)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#8)(2010-2#3)(2010-3#1)(2010-4#3)(2010-6#2)(2010-7#3)(2010-8#4)(2010-9#3)(2011-1#2)(2011-12#2)(2011-2#7)(2011-3#2)(2012-1#7)(2012-12#2)(2012-2#8)(2012-3#2)(2013-1#20)(2013-8#13)
the individual's own##2##3##(2007-6#1)(2008-1#1)
the individual's##20##2##(1991-7#1)(1993-7#1)(2006-10#1)(2006-11#2)(2006-2#2)(2007-10#1)(2007-12#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-1#1)(2011-2#1)(2012-3#1)
the individual-based##3##2##(2008-7#1)(2008-9#2)
the individual-level##2##2##(2008-8#2)
the individually##3##2##(2007-8#1)(2008-10#1)(2009-5#1)
the individuals and the##2##4##(2007-4#1)(2007-5#1)
the individuals and##3##3##(2007-4#1)(2007-5#1)(2008-5#1)
the individuals in the##2##4##(2006-8#1)(2009-6#1)
the individuals in##4##3##(2006-8#1)(2007-4#1)(2008-5#1)(2009-6#1)
the individuals of##2##3##(2008-8#1)(2012-2#1)
the individuals with a history of gutkha intake##2##8##(2013-8#2)
the individuals with##8##3##(1994-3#1)(2007-2#1)(2009-2#1)(2012-12#1)(2013-1#1)(2013-8#3)
the individuals within##2##3##(2009-5#1)(2011-1#1)
the individuals##43##2##(1990-7#1)(1994-3#1)(1997-2#1)(1997-5#1)(1997-8#1)(2005-8#1)(2006-12#2)(2006-8#2)(2007-11#1)(2007-2#1)(2007-4#3)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
the individuals'##4##2##(1995-3#1)(2006-2#1)(2012-3#1)(2013-8#1)
the indole ring of##2##4##(1990-4#1)(1992-12#1)
the indole ring##3##3##(1990-4#1)(1991-2#1)(1992-12#1)
the indole side chain##2##4##(1992-12#1)(1995-10#1)
the indole##15##2##(1990-4#1)(1991-2#1)(1992-12#4)(1993-6#1)(1994-3#1)(1994-9#1)(1995-10#3)(1996-3#1)(2008-5#2)
the indoor and outdoor##4##4##(2008-5#2)(2009-4#1)(2010-5#1)
the indoor and##5##3##(2008-5#2)(2009-4#1)(2010-5#2)
the indoor environment##2##3##(1992-4#1)(1995-6#1)
the indoor##9##2##(1992-4#1)(1995-6#1)(2008-5#2)(2009-4#1)(2010-5#4)
the indophenol-type reaction method##2##4##(2008-10#2)
the induced cells##2##3##(1992-1#1)(1993-6#1)
the induced coherence##2##3##(2007-12#2)
the induced differentiation of##2##4##(1991-2#1)(2008-9#1)
the induced differentiation##3##3##(1991-2#2)(2008-9#1)
the induced grating##4##3##(2007-11#3)(2008-3#1)
the induced orientation##2##3##(2008-2#2)
the induced ossicles##2##3##(2008-12#2)
the induced polar order##2##4##(2007-12#2)
the induced refractive index##4##4##(2007-11#1)(2007-12#1)(2008-3#2)
the induced##81##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-10#2)(1991-12#1)(1991-2#2)(1991-5#1)(1991-7#1)(1992-1#2)(1992-9#1)(1993-2#1)(1993-6#2)(1993-9#1)(1996-10#1)(1996-7#1)(1997-1#1)(1997-4#2)(1997-7#1)(2005-11#1)(2007-11#9)(2007-12#12)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#3)(2008-2#5)(2008-3#8)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
the inducer and the##2##4##(1990-7#1)(2008-10#1)
the inducer of##2##3##(1993-6#1)(1994-9#1)
the inducer##15##2##(1990-11#1)(1990-7#1)(1991-9#1)(1992-11#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-8#1)(1996-8#1)(1997-4#1)(1997-7#1)(2004-8#1)(2008-10#1)(2009-8#1)(2012-3#1)
the inducers of##3##3##(1993-4#1)(1994-11#1)(1994-9#1)
the inducers##4##2##(1990-7#1)(1993-4#1)(1994-11#1)(1994-9#1)
the inducibility of##2##3##(1994-11#1)(1997-2#1)
the inducibility##3##2##(1994-11#1)(1997-2#1)(1997-4#1)
the inducible NO synthase##2##4##(1995-11#1)(1997-3#1)
the inducible form of##2##4##(1995-12#1)(1996-6#1)
the inducible isoform##4##3##(1995-11#2)(2005-7#1)(2006-10#1)
the inducible nitric oxide##2##4##(1993-8#1)(1997-3#1)
the inducible##34##2##(1990-10#1)(1991-10#2)(1991-12#1)(1992-4#1)(1992-7#1)(1992-9#2)(1993-12#1)(1993-6#3)(1993-8#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#3)(1995-12#2)(1995-6#1)(1995-8#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-6#1)(2005-7#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2013-1#1)
the inducing (IN) inoculation##2##4##(2008-10#2)
the inducing##6##2##(1993-6#1)(1994-3#1)(2006-8#1)(2008-10#3)
the induction and development of colonic##2##6##(1992-4#2)
the induction and development of##5##5##(1991-12#1)(1992-4#3)(2008-10#1)
the induction and effector stages of relapsing##2##7##(1991-12#2)
the induction and evaluation of##2##5##(2008-4#2)
the induction and expression##2##4##(1991-6#1)(2009-8#1)
the induction and maintenance of##6##5##(2006-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2010-3#1)(2012-2#1)
the induction and the expression##2##5##(1991-6#2)
the induction and the##3##4##(1991-6#2)(2013-7#1)
the induction and##28##3##(1991-12#3)(1991-6#3)(1992-4#3)(1993-2#1)(1993-9#1)(1994-6#1)(1997-8#1)(2006-10#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#4)(2009-8#1)(2010-3#1)(2012-2#1)(2013-7#1)
the induction by##3##3##(1990-9#1)(1992-9#1)(2012-12#1)
the induction chemotherapy##2##3##(1990-6#1)(1991-10#1)
the induction in##2##3##(1994-3#1)(1996-11#1)
the induction medium##3##3##(2008-11#3)
the induction of DNA damage and##2##6##(1997-4#1)(2003-11#1)
the induction of DNA damage##7##5##(1997-1#1)(1997-4#2)(2003-11#1)(2007-11#1)(2008-11#1)(2008-7#1)
the induction of DNA strand breaks##2##6##(1991-12#1)(1997-4#1)
the induction of DNA##13##4##(1990-9#1)(1991-12#1)(1993-7#1)(1997-1#1)(1997-4#4)(2003-11#1)(2007-11#1)(2008-11#1)(2008-7#2)
the induction of HB-EGF##2##4##(1993-11#1)(1997-1#1)
the induction of IFN-gamma production##2##5##(1996-10#1)(2008-4#1)
the induction of IFN-gamma##3##4##(1996-10#2)(2008-4#1)
the induction of JE##2##4##(1994-9#2)
the induction of LTP at##2##5##(1990-4#1)(1995-2#1)
the induction of LTP in the##2##6##(1991-6#1)(1994-2#1)
the induction of LTP##9##4##(1990-4#3)(1991-6#1)(1994-2#1)(1995-12#2)(1995-2#1)(2008-7#1)
the induction of NGF##3##4##(1993-11#1)(1996-9#2)
the induction of NO##2##4##(1992-7#1)(1993-8#1)
the induction of T-cell competence##2##5##(1992-5#2)
the induction of T-cell##3##4##(1992-5#2)(2008-11#1)
the induction of Th1-type cytokine producing cells##2##7##(2008-11#2)
the induction of a specific##2##5##(1994-5#1)(2006-10#1)
the induction of a##9##4##(1991-8#1)(1992-7#1)(1994-5#1)(1995-2#1)(1995-7#1)(1996-8#1)(2006-10#1)(2008-10#1)(2008-4#1)
the induction of anesthesia##2##4##(2006-12#1)(2008-6#1)
the induction of apoptosis in colonic tumour cells##2##8##(1993-9#2)
the induction of apoptosis in##9##5##(1991-7#1)(1993-9#2)(1994-10#1)(1994-3#1)(1996-10#1)(1997-6#1)(2008-11#1)(2011-2#1)
the induction of apoptosis##17##4##(1991-7#1)(1993-9#2)(1994-10#2)(1994-3#1)(1996-10#1)(1997-6#1)(2008-11#2)(2008-9#1)(2009-12#1)(2009-4#1)(2011-2#2)(2012-12#2)
the induction of autogamy##2##4##(2008-12#2)
the induction of autoimmune disease##2##5##(2008-4#2)
the induction of both##3##4##(1990-2#1)(1994-6#1)(2012-12#1)
the induction of bystander##2##4##(2008-7#2)
the induction of c-fos##3##4##(1996-12#1)(1996-3#2)
the induction of cytoskeletal pathology##2##5##(1996-8#2)
the induction of differentiation##3##4##(1993-12#1)(2008-11#1)(2008-4#1)
the induction of genomic instability##2##5##(2008-8#2)
the induction of growth##2##4##(1995-11#1)(1996-10#1)
the induction of hepatic##2##4##(1993-12#1)(1994-6#1)
the induction of hsp70##3##4##(1992-6#1)(1994-11#2)
the induction of immune##3##4##(1997-8#1)(2010-5#1)(2012-3#1)
the induction of immunological##2##4##(2006-10#1)(2008-1#1)
the induction of labor##3##4##(1994-6#1)(1994-9#1)(2008-11#1)
the induction of lipid peroxidation##2##5##(2008-8#2)
the induction of lipid##3##4##(2008-5#1)(2008-8#2)
the induction of long-term potentiation (LTP) in##2##7##(1991-3#1)(2008-7#1)
the induction of long-term potentiation (LTP)##3##6##(1991-3#1)(1995-12#1)(2008-7#1)
the induction of long-term potentiation in##3##6##(1992-3#1)(1995-12#1)(1997-8#1)
the induction of long-term potentiation##9##5##(1991-3#2)(1992-3#1)(1994-2#2)(1995-12#2)(1997-8#1)(2008-7#1)
the induction of long-term##10##4##(1991-3#2)(1992-3#1)(1994-2#2)(1995-12#2)(1997-8#1)(2008-7#1)(2011-2#1)
the induction of lung##2##4##(1991-12#1)(2013-1#1)
the induction of metallothionein by cadmium(II) and##2##7##(1991-5#2)
the induction of metallothionein by##3##5##(1991-5#3)
the induction of molecular##2##4##(2008-7#1)(2012-2#1)
the induction of nitric oxide##2##5##(1992-7#2)
the induction of oxidative stress##2##5##(2008-10#1)(2009-12#1)
the induction of oxidative##3##4##(1994-6#1)(2008-10#1)(2009-12#1)
the induction of peroxisome proliferation##2##5##(1995-3#1)(2009-8#1)
the induction of programmed cell death##3##6##(1993-9#1)(1994-9#1)(2003-11#1)
the induction of protective immunity##2##5##(2011-2#2)
the induction of protective##3##4##(1997-6#1)(2011-2#2)
the induction of specific##3##4##(1997-4#1)(2004-11#1)(2007-11#1)
the induction of systemic resistance##2##5##(2008-10#2)
the induction of systemic##3##4##(2008-10#3)
the induction of terminal differentiation##2##5##(1990-11#1)(1991-5#1)
the induction of the##22##4##(1990-8#1)(1991-12#2)(1991-6#1)(1991-9#1)(1992-4#1)(1992-8#2)(1992-9#1)(1994-12#1)(1994-8#1)(1994-9#1)(1996-10#1)(2005-12#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-4#1)(2008-5#1)(2009-8#1)(2012-3#1)(2013-1#1)
the induction of these##4##4##(1992-4#1)(1994-6#1)(1996-3#1)(2006-10#1)
the induction of this##5##4##(1992-12#2)(1992-4#1)(1993-2#1)(1997-2#1)
the induction of tissue TG##2##5##(1991-2#2)
the induction of tissue##3##4##(1991-2#3)
the induction of tyrosine aminotransferase##2##5##(1994-12#1)(1997-4#1)
the induction of##384##3##(1990-10#1)(1990-11#2)(1990-2#2)(1990-4#4)(1990-5#2)(1990-8#4)(1990-9#2)(1991-12#7)(1991-2#4)(1991-3#3)(1991-4#2)(1991-5#4)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-3#2)(1992-4#4)(1992-5#2)(1992-6#2)(1992-7#4)(1992-8#4)(1992-9#5)(1993-11#4)(1993-12#3)(1993-2#1)(1993-4#4)(1993-7#3)(1993-8#2)(1993-9#3)(1994-10#3)(1994-11#4)(1994-12#5)(1994-2#4)(1994-3#5)(1994-5#1)(1994-6#6)(1994-8#4)(1994-9#7)(1995-1#3)(1995-11#2)(1995-12#7)(1995-2#5)(1995-3#5)(1995-5#2)(1995-6#4)(1995-7#1)(1995-8#3)(1996-10#7)(1996-11#2)(1996-12#1)(1996-3#3)(1996-4#2)(1996-5#1)(1996-7#3)(1996-8#4)(1996-9#5)(1997-1#4)(1997-2#3)(1997-4#8)(1997-6#2)(1997-8#4)(2003-11#2)(2004-11#1)(2005-11#1)(2005-12#1)(2005-9#1)(2006-10#10)(2006-12#2)(2006-4#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#13)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#20)(2008-11#18)(2008-12#4)(2008-4#14)(2008-5#4)(2008-6#3)(2008-7#9)(2008-8#10)(2008-9#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#4)(2010-11#2)(2010-12#1)(2010-5#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-12#7)(2012-2#4)(2012-3#3)(2013-1#8)(2013-8#1)
the induction or##3##3##(2008-10#2)(2008-11#1)
the induction period##5##3##(1994-8#1)(2007-8#1)(2008-10#3)
the induction phase##3##3##(1993-11#1)(1996-10#1)(2008-10#1)
the induction process##2##3##(1992-4#2)
the induction was##4##3##(1992-4#1)(1994-12#1)(1994-5#1)(2008-11#1)
the induction##462##2##(1990-10#1)(1990-11#2)(1990-2#2)(1990-3#1)(1990-4#4)(1990-5#2)(1990-6#1)(1990-8#4)(1990-9#3)(1991-10#3)(1991-12#10)(1991-2#4)(1991-3#3)(1991-4#2)(1991-5#4)(1991-6#6)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-3#2)(1992-4#10)(1992-5#2)(1992-6#2)(1992-7#4)(1992-8#4)(1992-9#6)(1993-11#6)(1993-12#3)(1993-2#2)(1993-4#4)(1993-7#3)(1993-8#2)(1993-9#4)(1994-10#3)(1994-11#4)(1994-12#7)(1994-2#4)(1994-3#6)(1994-5#2)(1994-6#7)(1994-8#6)(1994-9#7)(1995-1#3)(1995-11#2)(1995-12#7)(1995-2#5)(1995-3#5)(1995-5#2)(1995-6#6)(1995-7#1)(1995-8#3)(1996-10#9)(1996-11#3)(1996-12#2)(1996-3#3)(1996-4#2)(1996-5#1)(1996-7#3)(1996-8#4)(1996-9#5)(1997-1#5)(1997-2#3)(1997-4#8)(1997-6#2)(1997-8#5)(2003-11#2)(2004-11#1)(2005-11#1)(2005-12#1)(2005-9#1)(2006-10#13)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#13)(2007-2#1)(2007-6#2)(2007-8#2)(2008-1#3)(2008-10#29)(2008-11#24)(2008-12#5)(2008-4#18)(2008-5#4)(2008-6#3)(2008-7#9)(2008-8#10)(2008-9#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#5)(2010-11#2)(2010-12#2)(2010-3#1)(2010-5#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#8)(2012-12#8)(2012-2#8)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#1)
the inductive effect of##2##4##(1994-12#1)(1997-4#1)
the inductive##7##2##(1991-12#1)(1994-12#1)(1995-5#1)(1997-4#1)(2005-8#1)(2007-11#1)(2008-11#1)
the inductively coupled plasma atomic emission spectrometry##2##7##(2008-10#2)
the inductively coupled plasma##6##4##(2008-10#6)
the inductively coupled plasma-mass spectrometry (ICP-MS)##2##6##(2008-10#2)
the inductively coupled plasma-mass##3##4##(2008-10#3)
the inductively coupled##10##3##(2008-10#9)(2008-3#1)
the industrial production of##4##4##(1992-1#1)(2008-6#1)(2011-2#1)(2012-2#1)
the industrial production##5##3##(1992-1#1)(1992-11#1)(2008-6#1)(2011-2#1)(2012-2#1)
the industrial revolution##2##3##(1992-5#1)(1993-2#1)
the industrial site##2##3##(2007-8#2)
the industrial world##2##3##(2008-10#1)(2013-1#1)
the industrial##30##2##(1990-2#1)(1992-1#1)(1992-11#1)(1992-5#1)(1993-2#1)(2005-11#1)(2006-7#1)(2007-4#1)(2007-6#1)(2007-8#5)(2008-10#4)(2008-11#2)(2008-5#1)(2008-6#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
the industrialised##3##2##(2007-2#1)(2008-11#1)(2009-2#1)
the industrialized countries##3##3##(1990-7#1)(2008-4#1)(2010-5#1)
the industrialized nations##2##3##(2007-4#1)(2010-11#1)
the industrialized world##2##3##(1995-3#1)(2011-2#1)
the industrialized##8##2##(1990-7#1)(1995-3#1)(2007-4#1)(2008-10#1)(2008-4#1)(2010-11#1)(2010-5#1)(2011-2#1)
the industry and##3##3##(1991-1#1)(2005-8#1)(2007-8#1)
the industry by##2##3##(1990-5#1)(2006-8#1)
the industry has##2##3##(2008-11#1)(2008-8#1)
the industry is##8##3##(2005-5#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-4#2)(2011-2#1)
the industry must##2##3##(1996-2#1)(2005-10#1)
the industry standard##2##3##(2008-10#1)(2008-11#1)
the industry##47##2##(1990-4#1)(1990-5#1)(1991-1#1)(1991-3#1)(1992-2#1)(1992-3#1)(1994-2#1)(1995-1#1)(1995-3#1)(1996-2#3)(1996-3#1)(2005-10#1)(2005-5#1)(2005-8#3)(2006-6#1)(2006-8#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#6)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-4#3)(2011-2#2)(2012-2#1)
the inefficiencies##2##2##(1991-3#1)(1996-1#1)
the inefficiency of##3##3##(1996-5#1)(2008-3#2)
the inelastic##4##2##(1991-12#1)(2007-5#1)(2009-9#1)(2010-7#1)
the inert##3##2##(2006-12#1)(2008-10#1)(2009-6#1)
the inertia of##2##3##(1995-1#1)(2006-9#1)
the inertial##6##2##(2007-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-2#1)(2012-1#1)
the inevitable##9##2##(1993-12#1)(2006-7#1)(2007-10#1)(2007-4#1)(2008-3#2)(2008-6#1)(2013-1#1)(2013-8#1)
the inexorable##2##2##(1993-3#1)(2013-1#1)
the inexpensive##2##2##(2008-3#1)(2011-12#1)
the infamous##3##2##(2008-5#1)(2008-7#1)(2009-2#1)
the infant and##2##3##(1994-3#1)(2010-6#1)
the infant brain processes##2##4##(2008-11#2)
the infant brain##3##3##(2008-11#3)
the infant to##2##3##(2008-11#1)(2012-2#1)
the infant was##2##3##(1991-11#1)(2010-10#1)
the infant##49##2##(1990-8#1)(1991-11#2)(1992-11#1)(1992-2#1)(1994-12#1)(1994-3#1)(1994-4#1)(1995-3#2)(1995-6#1)(1996-5#1)(2005-11#1)(2005-6#1)(2006-11#2)(2006-5#1)(2007-1#2)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-2#1)(2008-5#1)(2009-12#1)(2009-9#1)(2010-10#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#5)
the infant's##10##2##(1992-4#2)(1992-7#1)(1993-3#1)(2006-10#1)(2007-11#1)(2009-11#1)(2009-9#1)(2010-2#1)(2012-2#1)
the infantile form of##2##4##(1993-4#1)(2012-12#1)
the infants in##3##3##(1992-11#1)(1992-6#1)(1994-4#1)
the infants were born##2##4##(2006-10#1)(2007-2#1)
the infants were##6##3##(1991-11#1)(1991-2#1)(1993-12#1)(1994-6#1)(2006-10#1)(2007-2#1)
the infants##34##2##(1990-5#1)(1991-11#1)(1991-2#1)(1991-9#2)(1992-11#1)(1992-6#1)(1993-12#2)(1994-4#1)(1994-6#2)(1996-12#1)(2006-10#1)(2006-3#2)(2006-5#1)(2007-2#3)(2007-7#1)(2008-10#1)(2009-9#1)(2010-6#1)(2011-1#4)(2012-1#3)(2012-2#3)
the infants'##7##2##(1991-12#1)(1992-2#1)(1996-5#1)(2006-9#1)(2007-8#1)(2008-10#1)(2011-1#1)
the infarct area##4##3##(1995-12#2)(2007-10#1)(2011-2#1)
the infarct size and the neurological deficit##2##7##(2011-2#2)
the infarct size##6##3##(1997-6#1)(2010-7#1)(2011-2#4)
the infarct volume##3##3##(1992-7#1)(1997-8#1)(2008-7#1)
the infarct##25##2##(1990-6#1)(1992-7#1)(1993-10#1)(1993-8#1)(1995-12#3)(1997-6#1)(1997-8#1)(2007-10#2)(2007-9#2)(2008-10#2)(2008-11#1)(2008-7#1)(2010-7#1)(2011-2#5)(2012-12#1)(2012-2#1)
the infarcted area##3##3##(1993-10#1)(1997-8#1)(2008-4#1)
the infarcted myocardium##2##3##(2012-12#2)
the infarcted##11##2##(1993-10#1)(1993-8#1)(1996-6#1)(1997-8#3)(2006-10#1)(2008-4#1)(2012-12#2)(2013-1#1)
the infarction and##2##3##(1993-8#1)(1997-5#1)
the infarction was##2##3##(1997-3#1)(2008-1#1)
the infarction##11##2##(1993-10#1)(1993-8#1)(1997-3#1)(1997-5#3)(2007-9#1)(2008-1#1)(2008-10#2)(2010-12#1)
the infected animals##3##3##(2007-2#1)(2007-3#1)(2008-5#1)
the infected cell##2##3##(1996-4#1)(2009-6#1)
the infected cells##7##3##(1995-5#1)(1997-1#1)(2006-6#1)(2008-10#1)(2008-11#1)(2009-2#1)(2010-12#1)
the infected host##2##3##(1996-10#1)(2008-7#1)
the infected seeds##2##3##(2008-10#2)
the infected subdural hematoma##2##4##(2008-7#2)
the infected subjects##3##3##(2007-4#3)
the infected tissue was##2##4##(2008-10#2)
the infected tissue##3##3##(2008-10#2)(2011-2#1)
the infected##68##2##(1990-6#1)(1990-9#1)(1991-12#1)(1992-7#1)(1994-2#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-6#1)(2005-11#1)(2005-9#2)(2006-10#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#3)(2007-8#1)(2008-10#17)(2008-11#2)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-2#1)(2009-6#1)(2010-12#3)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
the infecting parasite##2##3##(1992-2#1)(2006-11#1)
the infecting##10##2##(1992-2#1)(2005-8#1)(2006-11#2)(2007-12#2)(2008-10#1)(2008-7#1)(2012-2#2)
the infection and the##4##4##(2006-10#1)(2008-10#1)(2008-5#1)(2008-9#1)
the infection and##14##3##(1990-9#1)(1993-3#1)(1993-8#1)(1994-12#1)(1996-2#1)(2006-10#1)(2006-2#2)(2006-9#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-12#1)
the infection are##2##3##(2007-2#1)(2009-3#1)
the infection by##5##3##(2006-10#1)(2008-10#1)(2008-9#1)(2009-8#1)(2011-2#1)
the infection caused by##2##4##(2008-5#1)(2011-1#1)
the infection control##3##3##(2005-9#1)(2007-2#1)(2008-1#1)
the infection court##3##3##(2008-10#3)
the infection cycle##3##3##(2008-10#2)(2011-1#1)
the infection efficiency##2##3##(2008-10#2)
the infection from##2##3##(1996-11#1)(2008-12#1)
the infection in the##2##4##(2007-2#1)(2013-1#1)
the infection in##8##3##(1990-9#1)(1993-8#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-7#1)(2008-9#1)(2013-1#1)
the infection is endemic##2##4##(2007-2#1)(2011-2#1)
the infection is##4##3##(2007-2#1)(2009-7#1)(2011-2#1)(2012-2#1)
the infection level##2##3##(2008-10#1)(2008-11#1)
the infection of the##8##4##(2007-10#1)(2007-12#1)(2008-3#1)(2008-5#2)(2010-10#2)(2011-2#1)
the infection of##30##3##(1991-3#1)(1994-6#1)(1997-1#2)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-4#3)(2008-5#2)(2008-8#1)(2008-9#1)(2010-10#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
the infection process and##3##4##(1992-12#1)(2008-10#2)
the infection process##9##3##(1992-12#1)(2007-11#1)(2008-10#5)(2009-12#1)(2011-10#1)
the infection rate##4##3##(1990-3#1)(2007-7#1)(2007-8#1)(2012-2#1)
the infection rates of##2##4##(2011-12#1)(2012-3#1)
the infection rates##3##3##(2008-5#1)(2011-12#1)(2012-3#1)
the infection site##4##3##(2006-8#2)(2008-10#2)
the infection stage##2##3##(2008-10#2)
the infection status of##2##4##(1993-2#1)(2013-8#1)
the infection through##2##3##(2007-4#1)(2007-8#1)
the infection to##2##3##(2011-2#1)(2012-11#1)
the infection was##8##3##(1992-6#1)(1996-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2011-1#1)(2012-3#1)
the infection with##3##3##(2006-10#1)(2007-12#1)(2012-12#1)
the infection##208##2##(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#4)(1991-1#2)(1991-12#2)(1991-3#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-4#1)(1992-6#3)(1992-8#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1996-11#2)(1996-2#1)(1997-1#3)(1997-3#2)(1997-7#1)(2005-10#1)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#6)(2006-2#3)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#8)(2007-2#7)(2007-3#1)(2007-4#1)(2007-7#5)(2007-8#7)(2007-9#1)(2008-1#2)(2008-10#37)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#7)(2008-5#7)(2008-7#1)(2008-8#3)(2008-9#6)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#2)(2010-12#2)(2010-4#1)(2011-1#7)(2011-10#1)(2011-12#1)(2011-2#11)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
the infections##7##2##(1994-6#1)(2007-10#1)(2007-2#1)(2008-2#1)(2008-9#1)(2011-2#1)(2012-12#1)
the infectious agent##4##3##(1994-3#1)(1995-5#1)(1996-3#1)(2010-7#1)
the infectious agents##2##3##(2011-2#1)(2012-3#1)
the infectious and##2##3##(2007-11#1)(2007-2#1)
the infectious complications##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
the infectious disease##3##3##(2007-12#1)(2008-7#1)(2010-6#1)
the infectious diseases##4##3##(1995-11#1)(2006-4#1)(2008-10#1)(2009-2#1)
the infectious period##4##3##(1996-1#2)(2008-10#1)(2011-2#1)
the infectious phase##2##3##(1990-7#2)
the infectious process##2##3##(2010-6#1)(2011-2#1)
the infectious##40##2##(1990-7#2)(1994-3#1)(1995-11#1)(1995-5#1)(1996-1#2)(1996-3#1)(2005-9#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#2)(2009-5#1)(2010-6#2)(2010-7#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#1)
the infective agent##2##3##(2008-1#2)
the infective##9##2##(1997-3#1)(2006-10#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-4#1)(2011-2#2)
the infectivity of##6##3##(2007-10#1)(2008-10#3)(2008-9#1)(2013-1#1)
the infectivity##10##2##(1992-9#2)(2007-10#1)(2008-10#3)(2008-5#2)(2008-9#1)(2013-1#1)
the infectoria species-group##2##3##(2008-10#2)
the infectoria##3##2##(2008-10#3)
the inference of##7##3##(1991-2#1)(2008-4#1)(2008-7#2)(2011-1#2)(2012-3#1)
the inference that##2##3##(2008-10#1)(2008-6#1)
the inference##14##2##(1991-2#1)(1991-5#1)(1991-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-3#1)(2011-1#2)(2012-3#2)
the inferences##2##2##(1995-6#1)(2007-7#1)
the inferior alveolar nerve##5##4##(1991-1#1)(2007-12#4)
the inferior alveolar##6##3##(1991-1#1)(2007-12#5)
the inferior colliculus (IC)##4##4##(1990-7#1)(1991-3#1)(1992-11#1)(1997-3#1)
the inferior colliculus##14##3##(1990-7#2)(1991-3#1)(1991-9#2)(1992-11#3)(1995-12#1)(1996-9#1)(1997-3#3)(1997-5#1)
the inferior competitor##6##3##(2007-9#1)(2008-8#5)
the inferior frontal cortex##2##4##(1995-5#1)(2012-2#1)
the inferior frontal gyrus##2##4##(2008-11#1)(2009-1#1)
the inferior frontal##4##3##(1995-5#1)(2008-11#1)(2009-1#1)(2012-2#1)
the inferior margin of##2##4##(2007-8#1)(2008-10#1)
the inferior olivary##2##3##(1991-3#1)(2006-10#1)
the inferior olive##3##3##(1990-9#1)(1993-12#1)(1993-4#1)
the inferior part of the##2##5##(2007-8#1)(2008-12#1)
the inferior surface of the##4##5##(2007-8#2)(2008-8#1)(2013-1#1)
the inferior vena cava (IVC)##2##5##(2007-8#1)(2013-1#1)
the inferior vena cava and##8##5##(1996-3#1)(2008-11#7)
the inferior vena cava##31##4##(1992-1#1)(1993-5#1)(1996-3#1)(2006-6#1)(2007-8#9)(2008-11#11)(2008-4#1)(2008-7#1)(2010-10#1)(2011-2#1)(2013-1#3)
the inferior vena##35##3##(1992-1#1)(1993-5#1)(1996-3#1)(2006-6#1)(2007-8#9)(2008-11#13)(2008-4#1)(2008-7#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#3)
the inferior wall of the##2##5##(2008-10#1)(2008-12#1)
the inferior##113##2##(1990-7#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#2)(1991-9#2)(1992-1#1)(1992-11#4)(1992-12#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#1)(1994-3#1)(1995-11#2)(1995-12#1)(1995-5#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-3#3)(1997-5#1)(2004-9#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-12#5)(2007-2#1)(2007-8#16)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#15)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#6)(2009-1#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2011-2#2)(2012-2#2)(2013-1#5)(2013-8#1)
the inferolateral orbital rim##2##4##(2010-12#2)
the inferolateral##3##2##(2010-12#3)
the inferomedial##3##2##(1990-10#1)(2006-10#1)(2011-2#1)
the inferred amino##2##3##(1994-9#1)(2008-9#1)
the inferred##15##2##(1993-7#1)(1994-9#1)(1996-5#1)(1996-6#1)(2006-10#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-9#1)(2010-10#1)(2010-8#1)(2013-1#2)
the infertile couple##3##3##(2007-8#1)(2011-1#2)
the infertile group##2##3##(1992-1#1)(1994-9#1)
the infertile##9##2##(1992-1#1)(1994-9#1)(2007-8#2)(2008-12#1)(2011-1#4)
the infertility##2##2##(1990-3#1)(2011-1#1)
the infestation with##2##3##(2008-10#2)
the infestation##7##2##(1997-3#1)(2008-10#3)(2008-6#1)(2010-3#1)(2011-2#1)
the infested soil##2##3##(2008-10#2)
the infested##4##2##(2007-6#1)(2008-10#3)
the infiltrated##3##2##(2006-10#1)(2008-9#1)(2009-6#1)
the infiltrates##3##2##(1991-3#1)(2012-2#1)(2013-1#1)
the infiltrating##2##2##(2007-11#1)(2012-3#1)
the infiltration of PMNLs and MPhi##2##6##(2010-1#2)
the infiltration of##7##3##(1996-12#3)(2007-12#1)(2008-5#1)(2010-1#2)
the infiltration##9##2##(1996-12#3)(1996-8#2)(2007-12#1)(2008-5#1)(2010-1#2)
the infinite##7##2##(1994-9#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-3#2)
the infirmary##4##2##(1993-8#1)(2008-10#3)
the inflamed tissue##2##3##(1996-3#1)(2008-1#1)
the inflamed##10##2##(1990-6#1)(1993-8#1)(1994-5#1)(1996-3#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-9#2)(2013-7#1)
the inflammasome##2##2##(2011-1#2)
the inflammation and##2##3##(2008-5#1)(2013-8#1)
the inflammation in##2##3##(2008-11#1)(2013-1#1)
the inflammation of gastric mucosa##2##5##(1991-4#1)(1991-9#1)
the inflammation of the##2##4##(1993-2#1)(2013-8#1)
the inflammation of##4##3##(1991-4#1)(1991-9#1)(1993-2#1)(2013-8#1)
the inflammation process##4##3##(1992-8#1)(1996-6#1)(2008-3#1)(2008-5#1)
the inflammation##27##2##(1991-4#1)(1991-9#1)(1992-8#1)(1993-2#1)(1995-7#1)(1996-6#1)(2003-11#1)(2007-11#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2009-5#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
the inflammatory and immune##2##4##(1992-9#1)(1997-8#1)
the inflammatory arthritides##2##3##(2007-10#2)
the inflammatory bowel disease##3##4##(1994-2#1)(2010-12#1)(2011-1#1)
the inflammatory bowel##4##3##(1994-2#1)(2006-2#1)(2010-12#1)(2011-1#1)
the inflammatory cascade##4##3##(2006-10#1)(2009-12#1)(2010-12#1)(2010-2#1)
the inflammatory cell infiltrates##2##4##(2013-1#2)
the inflammatory cells##2##3##(2007-7#1)(2013-8#1)
the inflammatory changes##4##3##(2008-1#1)(2008-5#1)(2008-7#1)(2010-2#1)
the inflammatory condition##2##3##(2008-1#2)
the inflammatory cytokine##4##3##(1990-5#1)(2008-1#1)(2008-7#1)(2010-8#1)
the inflammatory cytokines##3##3##(1992-8#1)(1995-3#1)(2008-10#1)
the inflammatory disease##2##3##(2010-7#1)(2013-8#1)
the inflammatory infiltrate##2##3##(2006-10#1)(2008-10#1)
the inflammatory lesions##2##3##(2007-7#2)
the inflammatory mechanisms##2##3##(1992-2#1)(2011-1#1)
the inflammatory mediators##3##3##(2011-1#1)(2013-1#2)
the inflammatory process and##4##4##(2006-10#1)(2007-11#1)(2008-1#1)(2010-12#1)
the inflammatory process in##3##4##(2008-5#1)(2008-8#1)(2011-1#1)
the inflammatory process of##4##4##(1995-2#1)(2006-10#1)(2008-10#1)(2008-4#1)
the inflammatory process##28##3##(1992-11#1)(1992-6#3)(1993-1#1)(1995-2#1)(2004-3#1)(2005-10#1)(2005-8#1)(2006-10#3)(2007-11#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-12#1)(2009-5#1)(2010-12#2)(2011-1#1)(2012-1#1)(2012-12#1)
the inflammatory processes##2##3##(2012-12#1)(2012-3#1)
the inflammatory reaction and##2##4##(1996-11#1)(2006-10#1)
the inflammatory reaction in##2##4##(1995-12#1)(2008-11#1)
the inflammatory reaction##13##3##(1990-7#1)(1995-12#1)(1996-11#2)(2005-7#1)(2006-10#1)(2006-9#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-8#1)
the inflammatory response and##5##4##(1997-7#1)(2007-10#1)(2008-2#1)(2010-2#1)(2010-4#1)
the inflammatory response by##3##4##(1993-12#1)(2006-10#1)(2007-9#1)
the inflammatory response in the##3##5##(1994-6#1)(1995-11#1)(2008-7#1)
the inflammatory response in##6##4##(1992-6#1)(1994-6#1)(1995-11#1)(2006-10#1)(2008-7#1)(2012-12#1)
the inflammatory response of##2##4##(1990-8#1)(2009-12#1)
the inflammatory response or##2##4##(2006-10#1)(2008-3#1)
the inflammatory response to##9##4##(1993-12#1)(1994-5#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-9#2)(2008-8#1)(2012-1#1)
the inflammatory response##49##3##(1990-8#1)(1991-8#1)(1992-6#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-5#1)(1997-7#1)(2005-10#2)(2006-10#6)(2006-3#2)(2006-6#1)(2006-9#1)(2007-10#1)(2007-9#3)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-12#1)(2010-2#1)(2010-4#4)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#1)
the inflammatory responses of##3##4##(2008-5#1)(2013-1#2)
the inflammatory responses##4##3##(2008-5#1)(2010-10#1)(2013-1#2)
the inflammatory state##2##3##(1997-8#1)(2005-10#1)
the inflammatory##174##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-6#4)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1996-11#2)(1996-5#1)(1997-7#1)(1997-8#3)(2004-3#1)(2005-10#5)(2005-7#1)(2005-8#1)(2006-10#14)(2006-2#2)(2006-3#2)(2006-5#1)(2006-6#2)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#5)(2007-5#1)(2007-7#4)(2007-9#3)(2008-1#5)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#5)(2008-7#4)(2008-8#5)(2008-9#1)(2009-10#1)(2009-12#4)(2009-3#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#6)(2010-2#3)(2010-3#1)(2010-4#5)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#1)(2012-1#3)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#4)
the inflation group##2##3##(1996-6#2)
the inflation of##2##3##(2010-2#1)(2012-2#1)
the inflation##4##2##(1996-6#2)(2010-2#1)(2012-2#1)
the inflection point of##2##4##(2008-8#1)(2013-8#1)
the inflection point##4##3##(2008-10#2)(2008-8#1)(2013-8#1)
the inflection points##2##3##(2008-10#1)(2008-8#1)
the inflection##7##2##(2008-10#4)(2008-8#2)(2013-8#1)
the inflorescence##6##2##(1990-4#1)(1996-2#1)(2008-10#4)
the inflorescences##3##2##(2007-1#1)(2008-5#1)(2008-8#1)
the inflow##5##2##(1991-11#1)(1994-6#1)(1995-12#1)(2007-12#1)(2007-8#1)
the influence from the##2##4##(2007-12#1)(2008-10#1)
the influence of &quot##2##4##(1991-8#1)(2010-2#1)
the influence of a range of##2##6##(1997-2#1)(2007-12#1)
the influence of a##21##4##(1990-12#1)(1993-12#1)(1996-7#1)(1997-2#1)(1997-6#1)(2005-11#2)(2007-12#1)(2007-6#1)(2008-10#2)(2008-4#1)(2008-5#3)(2008-7#1)(2010-4#1)(2011-12#1)(2012-12#1)(2013-7#1)(2013-8#1)
the influence of age on##5##5##(2006-11#1)(2008-8#2)(2008-9#2)
the influence of age##9##4##(1994-8#1)(2006-11#1)(2006-8#1)(2008-3#1)(2008-8#2)(2008-9#2)(2010-10#1)
the influence of an external##2##5##(2008-3#2)
the influence of an##9##4##(1993-12#2)(1995-7#1)(2008-3#2)(2008-5#1)(2009-12#1)(2010-2#1)(2011-2#1)
the influence of both##2##4##(2007-11#1)(2012-2#1)
the influence of central##2##4##(2006-2#1)(2013-1#1)
the influence of changes in##2##5##(2007-9#1)(2008-2#1)
the influence of circulating##2##4##(2006-9#1)(2012-1#1)
the influence of climate##2##4##(2006-10#1)(2008-11#1)
the influence of complex##2##4##(2008-10#1)(2011-1#1)
the influence of diabetes on##2##5##(2011-2#1)(2012-3#1)
the influence of dietary##5##4##(1991-6#1)(2004-11#1)(2008-11#1)(2009-6#1)(2012-2#1)
the influence of different parameters##2##5##(2008-10#2)
the influence of different##24##4##(1995-7#1)(1996-12#1)(1997-2#1)(2005-11#1)(2007-10#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#2)(2008-8#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)
the influence of drought##2##4##(2012-6#1)(2012-9#1)
the influence of elevated##2##4##(2008-10#1)(2008-3#1)
the influence of environmental##2##4##(2008-7#1)(2009-2#1)
the influence of excess demand##2##5##(1995-2#2)
the influence of external##3##4##(1997-7#1)(2009-4#1)(2012-2#1)
the influence of fluoro group##2##5##(1991-12#2)
the influence of gravity##2##4##(2006-10#1)(2008-2#1)
the influence of harmonics##2##4##(2008-3#2)
the influence of high-dose 6MP infusions##2##6##(1996-3#2)
the influence of hormones##2##4##(1990-8#1)(1997-4#1)
the influence of infection##2##4##(2006-6#1)(2011-12#1)
the influence of ionic strength##2##5##(2007-8#1)(2008-10#1)
the influence of light##2##4##(2008-10#1)(2008-2#1)
the influence of noise on##2##5##(2008-3#1)(2011-1#1)
the influence of noise##3##4##(2006-6#1)(2008-3#1)(2011-1#1)
the influence of other##3##4##(2006-8#1)(2008-10#1)(2008-4#1)
the influence of pH##4##4##(2008-10#2)(2011-2#1)(2013-8#1)
the influence of parental factors##2##5##(2006-8#1)(2009-12#1)
the influence of parental##3##4##(2006-8#1)(2009-10#1)(2009-12#1)
the influence of parents##2##4##(1990-2#1)(2013-7#1)
the influence of percutaneous##2##4##(2004-12#1)(2005-10#1)
the influence of prolonged##2##4##(1995-11#1)(2012-3#1)
the influence of repeated##2##4##(2007-1#1)(2007-8#1)
the influence of sample##3##4##(2005-10#1)(2008-10#1)(2013-8#1)
the influence of several experimental##2##5##(2008-10#2)
the influence of several##6##4##(2008-10#4)(2008-11#1)(2013-1#1)
the influence of sex hormones##3##5##(2007-9#2)(2010-6#1)
the influence of sex##5##4##(1992-3#1)(1994-7#1)(2007-9#2)(2010-6#1)
the influence of social##3##4##(2008-5#1)(2008-9#1)(2011-1#1)
the influence of some genetic##2##5##(1995-6#1)(2006-10#1)
the influence of some##4##4##(1995-6#1)(1997-8#1)(2006-10#2)
the influence of such##2##4##(2008-10#1)(2008-11#1)
the influence of surface##2##4##(2008-3#1)(2008-5#1)
the influence of temperature on##3##5##(1990-11#1)(2008-10#2)
the influence of temperature##4##4##(1990-11#1)(2008-10#3)
the influence of the biological##2##5##(2007-9#1)(2008-10#1)
the influence of the carrier##2##5##(2007-11#1)(2008-7#1)
the influence of the deflection signal on the##2##8##(2008-2#2)
the influence of the different##2##5##(1991-10#1)(2012-9#1)
the influence of the other##2##5##(2008-10#1)(2008-3#1)
the influence of the presence of##2##6##(2008-10#1)(2011-2#1)
the influence of the relative position of the scattering layer on##2##11##(2008-2#2)
the influence of the relative##4##5##(1994-11#1)(2008-2#2)(2008-3#1)
the influence of the system##2##5##(2005-11#1)(2008-3#1)
the influence of the time##2##5##(2007-9#1)(2008-10#1)
the influence of the various##2##5##(2008-10#1)(2008-2#1)
the influence of the wavelength##2##5##(2008-2#1)(2008-3#1)
the influence of the##140##4##(1990-12#1)(1990-2#1)(1991-10#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-9#1)(1995-2#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-7#1)(2004-11#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#6)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#3)(2008-10#15)(2008-11#5)(2008-12#1)(2008-2#15)(2008-3#17)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2012-9#1)(2013-7#1)(2013-8#2)
the influence of these factors##4##5##(1997-8#1)(2005-10#1)(2008-10#1)(2008-3#1)
the influence of these parameters on##2##6##(2008-10#1)(2011-2#1)
the influence of these##14##4##(1994-11#1)(1996-5#1)(1997-8#1)(2005-10#1)(2006-9#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-1#1)(2013-8#1)
the influence of this##4##4##(1995-10#1)(2004-9#1)(2007-12#2)
the influence of three##2##4##(1997-8#1)(2008-10#1)
the influence of time##2##4##(1993-12#1)(2008-10#1)
the influence of two##2##4##(2007-12#1)(2008-5#1)
the influence of various##2##4##(1997-5#1)(2011-2#1)
the influence of visual##3##4##(1990-10#1)(2008-5#1)(2009-2#1)
the influence of women's employment##2##5##(2008-5#2)
the influence of zinc##2##4##(2004-11#1)(2008-7#1)
the influence of##717##3##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-2#2)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#5)(1993-12#6)(1993-2#2)(1993-3#1)(1993-7#1)(1993-9#1)(1994-10#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#2)(1994-7#2)(1994-8#5)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#4)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#4)(1996-4#2)(1996-5#3)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#5)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#3)(2004-11#3)(2004-12#1)(2004-4#2)(2004-9#2)(2005-1#1)(2005-10#4)(2005-11#15)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#7)(2006-11#4)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#3)(2006-8#6)(2006-9#3)(2007-1#3)(2007-10#9)(2007-11#14)(2007-12#16)(2007-2#4)(2007-3#2)(2007-4#2)(2007-5#3)(2007-6#2)(2007-7#1)(2007-8#11)(2007-9#9)(2008-1#1)(2008-10#73)(2008-11#26)(2008-12#8)(2008-2#40)(2008-3#38)(2008-4#2)(2008-5#34)(2008-6#5)(2008-7#15)(2008-8#16)(2008-9#14)(2009-10#3)(2009-11#3)(2009-12#4)(2009-2#6)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#5)(2009-7#5)(2009-8#7)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#9)(2010-3#3)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#12)(2011-12#3)(2011-2#22)(2011-3#1)(2012-1#8)(2012-12#4)(2012-2#8)(2012-3#8)(2012-6#1)(2012-9#2)(2013-1#9)(2013-7#8)(2013-8#15)
the influence on##10##3##(1991-9#1)(1997-1#1)(2005-11#1)(2006-6#1)(2008-10#2)(2008-11#1)(2009-11#1)(2011-2#1)(2012-3#1)
the influence that##5##3##(1995-2#1)(2008-2#1)(2008-9#1)(2009-10#1)(2009-3#1)
the influence##754##2##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-2#2)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#5)(1993-12#6)(1993-2#2)(1993-3#1)(1993-7#1)(1993-9#1)(1994-10#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#3)(1994-6#2)(1994-7#2)(1994-8#5)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#4)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#4)(1996-4#2)(1996-5#3)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#3)(2004-11#3)(2004-12#1)(2004-4#2)(2004-9#2)(2005-1#1)(2005-10#4)(2005-11#17)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#8)(2006-11#4)(2006-12#3)(2006-2#1)(2006-4#2)(2006-5#2)(2006-6#4)(2006-8#6)(2006-9#3)(2007-1#3)(2007-10#9)(2007-11#14)(2007-12#20)(2007-2#4)(2007-3#2)(2007-4#2)(2007-5#3)(2007-6#2)(2007-7#1)(2007-8#12)(2007-9#9)(2008-1#1)(2008-10#78)(2008-11#28)(2008-12#8)(2008-2#43)(2008-3#38)(2008-4#2)(2008-5#34)(2008-6#5)(2008-7#16)(2008-8#16)(2008-9#15)(2009-10#4)(2009-11#4)(2009-12#4)(2009-2#7)(2009-3#4)(2009-4#3)(2009-5#2)(2009-6#5)(2009-7#5)(2009-8#7)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#9)(2010-3#3)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#12)(2011-12#3)(2011-2#24)(2011-3#1)(2012-1#8)(2012-12#4)(2012-2#8)(2012-3#9)(2012-6#1)(2012-9#2)(2013-1#10)(2013-7#8)(2013-8#16)
the influences of age##2##4##(2007-12#1)(2013-8#1)
the influences of different##2##4##(2008-10#1)(2011-2#1)
the influences of##23##3##(1991-11#1)(1994-9#1)(2004-11#1)(2005-6#1)(2007-12#2)(2007-4#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#1)(2013-8#1)
the influences##24##2##(1991-11#1)(1994-9#1)(2004-11#1)(2005-6#1)(2007-12#2)(2007-4#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#1)(2013-8#1)
the influencing factors of tuberculosis among people living with HIV/AIDS##2##10##(2011-1#2)
the influencing factors##3##3##(2011-1#2)(2013-1#1)
the influencing##4##2##(2008-10#1)(2011-1#2)(2013-1#1)
the influent##3##2##(2008-1#1)(2008-10#1)(2010-5#1)
the influenza A (H1N1)##3##4##(2010-4#2)(2010-9#1)
the influenza A##7##3##(1994-9#1)(2007-12#1)(2010-4#2)(2010-9#1)(2013-1#2)
the influenza pandemic of 2009##2##5##(2011-2#2)
the influenza pandemic of##3##4##(2009-7#1)(2011-2#2)
the influenza pandemic##4##3##(2009-7#1)(2011-1#1)(2011-2#2)
the influenza vaccine##3##3##(2008-5#1)(2010-11#1)(2010-4#1)
the influenza virus and##3##4##(2010-7#1)(2012-12#2)
the influenza virus##8##3##(1995-6#1)(1997-6#1)(2007-6#1)(2010-4#1)(2010-5#1)(2010-7#1)(2012-12#2)
the influenza##33##2##(1992-6#1)(1992-9#1)(1994-9#1)(1995-5#1)(1995-6#1)(1997-6#2)(2004-11#1)(2007-12#1)(2007-6#1)(2008-5#1)(2009-4#1)(2009-7#2)(2010-11#1)(2010-4#4)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#4)(2013-1#3)
the influx and efflux##2##4##(2008-5#1)(2012-12#1)
the influx and##3##3##(1995-8#1)(2008-5#1)(2012-12#1)
the influx of Ca2+##4##4##(1990-5#2)(1992-8#1)(1997-2#1)
the influx of##16##3##(1990-5#2)(1990-8#1)(1991-4#1)(1991-9#1)(1992-8#1)(1993-9#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-5#1)(2009-8#1)(2010-9#1)
the influx rate##2##3##(1996-8#1)(1997-5#1)
the influx##23##2##(1990-5#2)(1990-8#1)(1991-1#1)(1991-4#1)(1991-9#1)(1992-8#1)(1993-2#1)(1993-9#1)(1995-8#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-5#1)(2008-5#1)(2009-8#1)(2010-9#1)(2012-12#1)
the informal##5##2##(1994-3#1)(1995-3#1)(2010-1#2)(2012-2#1)
the informants##2##2##(2012-3#2)
the information about the##7##4##(2007-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-2#2)
the information about##12##3##(2007-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#2)(2010-10#1)(2012-12#1)
the information acquired##2##3##(1991-6#1)(2008-10#1)
the information age##5##3##(1994-1#1)(1996-3#1)(2007-11#1)(2008-1#1)(2009-5#1)
the information and##8##3##(1994-2#1)(1995-1#1)(1995-9#1)(1996-3#1)(1997-3#1)(2006-8#1)(2007-4#1)(2008-4#1)
the information appears##2##3##(2007-12#2)
the information available about##2##4##(2006-10#1)(2009-4#1)
the information available##7##3##(2006-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-4#1)(2009-5#1)(2011-2#1)
the information collected from##2##4##(2008-11#1)(2011-2#1)
the information collected##4##3##(1995-2#1)(2008-11#1)(2011-2#1)(2012-3#1)
the information contained in##3##4##(2005-10#1)(2008-7#1)(2009-3#1)
the information contained##4##3##(2005-10#1)(2005-7#1)(2008-7#1)(2009-3#1)
the information content of the##3##5##(2008-2#1)(2008-3#1)(2011-2#1)
the information content of##5##4##(2008-2#2)(2008-3#1)(2010-6#1)(2011-2#1)
the information content##7##3##(1997-4#1)(1997-8#1)(2008-2#2)(2008-3#1)(2010-6#1)(2011-2#1)
the information demands##2##3##(1997-3#1)(2008-2#1)
the information entropy##2##3##(2013-8#2)
the information for##3##3##(1990-11#1)(1996-5#1)(1997-8#1)
the information from the##7##4##(1996-11#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-2#1)(2008-5#1)(2012-12#1)
the information from##10##3##(1996-11#1)(1997-6#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-2#1)(2008-5#1)(2010-12#1)(2012-12#1)(2012-3#1)
the information gained in##2##4##(2008-12#1)(2010-11#1)
the information gained##4##3##(2008-10#1)(2008-12#1)(2010-11#1)(2012-2#1)
the information generated##2##3##(2008-7#1)(2011-2#1)
the information given##3##3##(1993-6#1)(1995-9#1)(2007-8#1)
the information had##3##3##(1995-12#1)(2006-10#1)(2008-5#1)
the information in the##4##4##(1997-5#1)(2008-4#1)(2009-10#1)(2011-2#1)
the information in##8##3##(1993-3#1)(1997-5#1)(2006-5#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2011-2#1)
the information is##6##3##(1992-8#1)(1997-3#2)(2006-8#1)(2007-4#1)(2010-2#1)
the information necessary to##3##4##(1994-1#2)(2013-1#1)
the information necessary##4##3##(1992-1#1)(1994-1#2)(2013-1#1)
the information needed to##2##4##(2005-8#1)(2008-9#1)
the information needed##4##3##(2005-8#1)(2007-8#1)(2008-9#1)(2012-2#1)
the information needs of##7##4##(1991-12#1)(1994-12#1)(1995-1#1)(1997-3#2)(2006-5#1)(2007-7#1)
the information needs##8##3##(1991-12#1)(1994-12#1)(1995-1#1)(1997-3#2)(2006-5#1)(2007-7#1)(2008-3#1)
the information obtained from##3##4##(2008-10#2)(2012-11#1)
the information obtained##8##3##(1994-2#1)(1997-8#1)(2007-1#1)(2008-10#2)(2010-3#1)(2012-11#1)(2012-2#1)
the information of##6##3##(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-3#2)
the information on the##5##4##(2008-10#1)(2008-11#1)(2008-2#1)(2010-1#1)(2012-2#1)
the information on##10##3##(1994-4#1)(2004-10#1)(2006-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2010-1#1)(2012-2#1)
the information present in the##2##5##(2006-10#1)(2008-4#1)
the information processing##2##3##(1997-8#1)(2008-9#1)
the information provided by the##3##5##(2010-3#1)(2010-8#1)(2011-1#1)
the information provided by##9##4##(1993-3#1)(2008-5#2)(2010-3#1)(2010-6#1)(2010-8#2)(2011-1#1)(2012-3#1)
the information provided##10##3##(1993-3#1)(2008-5#2)(2010-3#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-3#1)
the information required to disambiguate this term is extracted from the trained semantic vectors for the terms in this context by reversing the vector transformation to recover the correct sense of the term##2##33##(2013-1#2)
the information required##4##3##(1997-8#1)(2009-10#1)(2013-1#2)
the information retrieval##2##3##(1992-1#1)(2013-8#1)
the information superhighway##2##3##(1995-3#1)(1996-2#1)
the information system##6##3##(1993-6#2)(1994-2#1)(1996-3#1)(2005-5#1)(2010-11#1)
the information systems##3##3##(1993-2#1)(1994-3#1)(2012-3#1)
the information technology##5##3##(1993-2#1)(1994-12#1)(1996-1#1)(1996-3#1)(2008-5#1)
the information that is available##2##5##(2008-2#1)(2008-9#1)
the information that is##4##4##(2007-8#1)(2008-2#2)(2008-9#1)
the information that##12##3##(1992-2#1)(1995-8#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-2#2)(2008-6#2)(2008-9#1)(2013-8#1)
the information they provide##2##4##(2006-2#2)
the information they##6##3##(1993-6#1)(2006-2#2)(2008-9#1)(2009-5#1)(2010-5#1)
the information to the##2##4##(2008-10#1)(2010-10#1)
the information to##8##3##(1993-12#1)(1996-11#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-9#1)(2010-10#1)(2011-2#1)
the information value##2##3##(2005-7#1)(2008-12#1)
the information was##6##3##(2004-10#2)(2011-1#1)(2012-12#1)(2013-1#2)
the information we##2##3##(2007-4#1)(2008-7#1)
the information##293##2##(1990-11#1)(1991-12#1)(1991-6#1)(1992-1#2)(1992-11#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#4)(1994-1#3)(1994-12#3)(1994-2#3)(1994-3#2)(1994-4#1)(1995-1#3)(1995-12#3)(1995-2#2)(1995-3#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-11#3)(1996-12#1)(1996-2#2)(1996-3#9)(1996-5#2)(1997-1#1)(1997-3#11)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#6)(2004-10#4)(2005-10#1)(2005-5#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#6)(2006-2#2)(2006-5#2)(2006-7#1)(2006-8#4)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#7)(2007-2#1)(2007-3#2)(2007-4#4)(2007-5#1)(2007-7#2)(2007-8#7)(2008-1#2)(2008-10#12)(2008-11#6)(2008-12#3)(2008-2#14)(2008-3#16)(2008-4#8)(2008-5#6)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#8)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#2)(2011-2#10)(2011-3#1)(2012-11#2)(2012-12#4)(2012-2#6)(2012-3#7)(2013-1#5)(2013-7#1)(2013-8#5)
the informations##3##2##(1991-3#1)(1997-3#1)(1997-8#1)
the informative value of##3##4##(2008-4#1)(2008-6#2)
the informative##6##2##(1994-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#2)
the informed consent##3##3##(1992-6#1)(2007-11#1)(2010-7#1)
the informed##5##2##(1992-6#1)(1995-12#1)(2007-11#1)(2007-8#1)(2010-7#1)
the infra- and##2##3##(1991-9#1)(1993-9#1)
the infrabuccal cavity##3##3##(2007-12#3)
the infrabuccal##4##2##(2007-12#4)
the infraorbital sinuses##2##3##(2008-5#2)
the infraorbital##4##2##(1995-5#1)(1997-3#1)(2008-5#2)
the infrapatellar fat pad##2##4##(2012-12#1)(2012-3#1)
the infrared (2)F(7/2)-(2)D(5/2)##2##3##(2007-12#2)
the infrared and##3##3##(2005-4#1)(2008-1#1)(2008-3#1)
the infrared detection##3##3##(2007-11#2)(2008-2#1)
the infrared spectra of##6##4##(1990-2#1)(2005-4#1)(2008-2#1)(2008-6#1)(2010-12#1)(2013-8#1)
the infrared spectral##3##3##(2008-2#1)(2008-3#2)
the infrared spectroscopy##2##3##(2005-4#2)
the infrared spectrum##5##3##(1990-8#1)(1991-5#1)(1992-12#1)(2007-8#1)(2013-8#1)
the infrared##63##2##(1990-2#1)(1990-8#1)(1991-1#1)(1991-5#1)(1992-12#1)(1997-7#1)(2005-4#4)(2007-11#4)(2007-12#11)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#11)(2008-3#17)(2008-5#1)(2008-6#1)(2010-12#1)(2013-8#2)
the infrarenal##3##2##(2007-8#1)(2008-7#1)(2009-8#1)
the infraspinatus##2##2##(2008-12#2)
the infrastructural##2##2##(1996-12#1)(2008-11#1)
the infrastructure and##2##3##(1995-12#1)(2008-1#1)
the infrastructure needed to##4##4##(1994-1#1)(1994-9#1)(2007-4#1)(2012-12#1)
the infrastructure##12##2##(1993-9#1)(1994-1#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-12#1)(1997-1#1)(2007-4#1)(2008-1#2)(2012-12#1)
the infratemporal fossa and##2##4##(2009-5#1)(2011-2#1)
the infratemporal fossa##3##3##(2005-9#1)(2009-5#1)(2011-2#1)
the infrequent association of##2##4##(2006-10#1)(2011-1#1)
the infrequent##7##2##(1993-10#1)(2006-10#1)(2006-5#2)(2007-5#1)(2009-5#1)(2011-1#1)
the infrequently##2##2##(2007-7#1)(2008-5#1)
the infundibular##2##2##(2006-5#1)(2007-8#1)
the infundibulum and the##2##4##(1995-7#1)(2008-12#1)
the infundibulum##4##2##(1990-4#1)(1992-6#1)(1995-7#1)(2008-12#1)
the infused##6##2##(1991-5#1)(1992-3#1)(1993-6#1)(1995-5#1)(2007-1#2)
the infusion and##3##3##(1993-7#1)(1997-6#1)(2008-7#1)
the infusion of##6##3##(1996-12#1)(1997-2#1)(2006-5#1)(2007-9#1)(2010-11#1)(2012-11#1)
the infusion was##3##3##(2006-7#1)(2008-6#1)(2010-12#1)
the infusion##39##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-4#1)(1992-10#1)(1992-5#1)(1993-10#2)(1993-7#1)(1995-12#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(2006-5#1)(2006-7#2)(2007-1#2)(2007-10#2)(2007-9#1)(2008-6#1)(2008-7#4)(2010-11#1)(2010-12#5)(2011-2#1)(2012-11#1)(2012-3#1)
the ingenuity of##2##3##(1993-12#1)(2006-9#1)
the ingenuity pathway analysis##2##4##(2010-12#2)
the ingenuity##4##2##(1993-12#1)(2006-9#1)(2010-12#2)
the ingested##7##2##(1997-4#1)(2008-11#2)(2008-5#1)(2008-7#1)(2011-2#2)
the ingestion of specific##2##4##(2007-7#1)(2013-7#1)
the ingestion of the##4##4##(1992-2#1)(1993-4#1)(2007-12#1)(2013-8#1)
the ingestion of##21##3##(1990-5#1)(1992-2#1)(1993-10#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-5#1)(2004-11#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-3#2)(2008-5#1)(2010-6#1)(2012-2#1)(2013-7#1)(2013-8#1)
the ingestion##22##2##(1990-5#1)(1992-2#1)(1993-10#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-5#1)(2004-11#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-3#2)(2008-5#1)(2009-6#1)(2010-6#1)(2012-2#1)(2013-7#1)(2013-8#1)
the ingredient##4##2##(2008-5#3)(2012-2#1)
the ingredients##5##2##(2006-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)
the ingress of##3##3##(1996-2#1)(2008-10#1)(2009-8#1)
the ingrowth of##2##3##(2006-3#1)(2009-2#1)
the inguinal canal##2##3##(2006-7#1)(2011-2#1)
the inguinal lymph nodes##3##4##(1994-12#1)(2006-10#1)(2012-2#1)
the inguinal mass##2##3##(2007-2#2)
the inguinal region##3##3##(1996-9#1)(2011-1#1)(2011-2#1)
the inguinal##18##2##(1990-10#1)(1994-12#1)(1995-5#1)(1996-9#1)(2006-10#1)(2006-7#1)(2007-2#2)(2008-10#1)(2008-7#1)(2008-9#1)(2009-9#2)(2011-1#2)(2011-2#2)(2012-2#1)
the inhabitants of##2##3##(1991-3#1)(2013-8#1)
the inhabitants##6##2##(1991-3#1)(1991-6#1)(2008-1#1)(2013-1#1)(2013-8#2)
the inhalation of##4##3##(1992-6#1)(1994-6#1)(1996-3#1)(2009-6#1)
the inhalation##8##2##(1991-7#1)(1992-6#1)(1994-6#2)(1996-3#1)(2008-10#1)(2008-4#1)(2009-6#1)
the inhaled air##3##3##(1990-8#2)(1993-10#1)
the inhaled route##2##3##(1997-1#1)(2006-10#1)
the inhaled##12##2##(1990-8#2)(1992-3#1)(1993-10#1)(1997-1#1)(2006-10#2)(2007-11#1)(2007-9#1)(2010-6#1)(2013-1#1)(2013-8#1)
the inhaler##2##2##(1991-10#1)(1996-2#1)
the inherent ability##2##3##(1996-4#1)(1997-1#1)
the inherent characteristics of##2##4##(2008-10#1)(2011-2#1)
the inherent complexity of the##2##5##(2008-6#1)(2009-5#1)
the inherent complexity of##3##4##(2008-6#1)(2009-5#1)(2009-8#1)
the inherent optical properties of the##2##6##(2008-3#2)
the inherent optical properties of##6##5##(2008-2#1)(2008-3#5)
the inherent optical properties##10##4##(2008-2#3)(2008-3#7)
the inherent potential of##2##4##(2008-8#1)(2008-9#1)
the inherent problems##2##3##(2009-9#1)(2012-2#1)
the inherent properties##2##3##(2008-11#1)(2010-12#1)
the inherent risks##2##3##(2006-9#1)(2013-1#1)
the inherent value of##2##4##(1995-2#1)(2010-8#1)
the inherent variability in such estimates remains high##2##8##(2013-1#2)
the inherent variability##3##3##(1991-9#1)(2013-1#2)
the inherent##81##2##(1991-2#1)(1991-9#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1995-11#1)(1995-2#1)(1996-11#1)(1996-4#1)(1997-1#1)(2004-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#6)(2008-3#11)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#2)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#5)
the inherently##6##2##(1992-1#1)(1996-4#1)(2007-7#1)(2008-3#1)(2009-12#1)(2009-6#1)
the inheritance of resistance to##2##5##(2008-10#2)
the inheritance of resistance##3##4##(2008-10#3)
the inheritance of schizophrenic##2##4##(2007-1#2)
the inheritance of the##3##4##(2008-10#1)(2008-12#1)(2008-4#1)
the inheritance of##23##3##(1994-9#2)(1996-12#1)(1996-6#1)(2006-12#1)(2007-1#2)(2008-10#7)(2008-12#2)(2008-4#3)(2008-8#1)(2009-5#1)(2012-11#1)(2013-1#1)
the inheritance##25##2##(1994-9#2)(1996-12#1)(1996-6#1)(2006-12#1)(2007-1#2)(2008-10#7)(2008-12#2)(2008-4#3)(2008-8#1)(2009-5#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)
the inherited##7##2##(1990-3#1)(1994-9#1)(1995-1#1)(1997-7#1)(2008-7#2)(2013-7#1)
the inhibited enzyme##2##3##(1994-9#1)(2008-10#1)
the inhibited##7##2##(1990-2#1)(1994-9#1)(2005-11#1)(2006-9#1)(2008-10#2)(2008-4#1)
the inhibiting effect of##2##4##(2008-10#1)(2010-12#1)
the inhibiting effects of##2##4##(2007-3#1)(2008-8#1)
the inhibiting##6##2##(1990-7#1)(2007-3#1)(2008-10#1)(2008-8#2)(2010-12#1)
the inhibition ELISA##2##3##(1992-3#1)(1995-1#1)
the inhibition and##2##3##(1995-12#1)(2008-9#1)
the inhibition by the##2##4##(1994-2#1)(2008-9#1)
the inhibition by##21##3##(1990-12#1)(1990-2#2)(1990-3#1)(1991-3#1)(1992-11#1)(1992-5#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1996-5#1)(1996-9#1)(1997-3#1)(2008-9#4)
the inhibition caused by##3##4##(1990-7#1)(1995-3#1)(2008-10#1)
the inhibition constants of the##2##5##(1995-11#1)(1995-3#1)
the inhibition effect of##5##4##(1995-2#1)(2008-10#3)(2010-12#1)
the inhibition effect##7##3##(1995-2#1)(2008-10#5)(2010-12#1)
the inhibition exerted by##2##4##(1990-7#1)(1996-6#1)
the inhibition mechanism##2##3##(1990-11#1)(1992-6#1)
the inhibition of Acc neurons by DA or MAP was##2##10##(1996-10#2)
the inhibition of CYP3A4##2##4##(2008-10#1)(2008-8#1)
the inhibition of DNA synthesis##2##5##(1991-2#1)(1994-9#1)
the inhibition of DNA##3##4##(1991-2#1)(1994-9#2)
the inhibition of EGF binding to##2##6##(1990-4#2)
the inhibition of FXIa##2##4##(1996-5#2)
the inhibition of GSH-Px##2##4##(1990-4#2)
the inhibition of MAO-A##2##4##(1994-8#1)(1995-7#1)
the inhibition of T-cell##2##4##(1992-5#1)(2011-12#1)
the inhibition of a##2##4##(1990-4#1)(1995-1#1)
the inhibition of adenylate cyclase##3##5##(1990-2#1)(1993-6#1)(1995-6#1)
the inhibition of cholesterol##2##4##(1990-2#1)(1994-8#1)
the inhibition of cyclic AMP##2##5##(1995-11#1)(2008-4#1)
the inhibition of electron transport##2##5##(1990-5#1)(1992-11#1)
the inhibition of factor XIa by##2##6##(1992-7#2)
the inhibition of factor XIa##3##5##(1992-7#2)(1996-5#1)
the inhibition of fungal##2##4##(2008-10#2)
the inhibition of glucagon secretion##2##5##(1994-11#1)(2007-5#1)
the inhibition of glucocorticoid- and cAMP-stimulated PEPCK gene##2##8##(1995-6#1)(1996-2#1)
the inhibition of osteocalcin synthesis##2##5##(1990-2#2)
the inhibition of phospholipase##2##4##(1994-11#1)(1997-1#1)
the inhibition of phosphorylation##2##4##(1990-8#1)(1992-3#1)
the inhibition of protein synthesis##2##5##(1991-10#1)(1994-11#1)
the inhibition of protein##5##4##(1991-10#1)(1994-11#1)(1994-9#1)(1995-8#2)
the inhibition of the formation of##2##6##(1995-12#1)(2012-12#1)
the inhibition of the##34##4##(1990-1#1)(1990-2#1)(1990-7#2)(1990-8#1)(1991-6#1)(1991-8#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-2#2)(2012-12#1)
the inhibition of this##2##4##(1991-2#1)(2009-12#1)
the inhibition of topoisomerase I##2##5##(2008-11#1)(2008-8#1)
the inhibition of trypsin##2##4##(1990-9#2)
the inhibition of##263##3##(1990-1#1)(1990-11#3)(1990-2#8)(1990-3#1)(1990-4#6)(1990-5#4)(1990-7#2)(1990-8#3)(1990-9#3)(1991-10#2)(1991-12#1)(1991-2#5)(1991-4#2)(1991-5#4)(1991-6#1)(1991-8#5)(1992-11#3)(1992-12#1)(1992-3#4)(1992-5#2)(1992-6#3)(1992-7#4)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#2)(1994-3#1)(1994-5#2)(1994-6#3)(1994-8#2)(1994-9#6)(1995-1#3)(1995-11#4)(1995-12#3)(1995-2#3)(1995-3#4)(1995-6#4)(1995-7#1)(1995-8#4)(1996-10#2)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#10)(1996-7#3)(1996-8#2)(1997-1#2)(1997-2#1)(1997-4#3)(1997-5#1)(1997-7#2)(1997-8#3)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#11)(2008-3#1)(2008-4#3)(2008-5#9)(2008-7#3)(2008-8#9)(2008-9#6)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-9#3)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#5)(2013-7#1)
the inhibition produced by##3##4##(1991-9#1)(2007-11#1)(2008-10#1)
the inhibition seen with##2##4##(1990-8#1)(1995-2#1)
the inhibition to##2##3##(1990-10#1)(1996-12#1)
the inhibition was caused##2##4##(2006-3#2)
the inhibition was##17##3##(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#3)(1991-6#1)(1992-3#1)(1992-8#1)(1994-11#1)(1995-5#2)(1997-7#1)(2005-8#1)(2006-12#1)(2006-3#2)
the inhibition zone##2##3##(2008-5#2)
the inhibition##372##2##(1990-1#1)(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#11)(1990-3#4)(1990-4#6)(1990-5#5)(1990-7#4)(1990-8#4)(1990-9#3)(1991-10#2)(1991-12#6)(1991-2#8)(1991-3#1)(1991-4#3)(1991-5#4)(1991-6#2)(1991-8#6)(1991-9#1)(1992-11#5)(1992-12#1)(1992-3#6)(1992-5#3)(1992-6#6)(1992-7#5)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#3)(1993-4#3)(1993-6#3)(1993-7#1)(1993-8#4)(1993-9#2)(1994-10#1)(1994-11#5)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#5)(1994-8#2)(1994-9#6)(1995-1#5)(1995-11#5)(1995-12#5)(1995-2#5)(1995-3#6)(1995-5#2)(1995-6#5)(1995-7#1)(1995-8#5)(1996-10#2)(1996-12#1)(1996-2#4)(1996-3#1)(1996-4#4)(1996-5#11)(1996-6#1)(1996-7#3)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-7#3)(1997-8#3)(2005-8#2)(2006-10#1)(2006-12#2)(2006-2#1)(2006-3#2)(2007-1#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-10#18)(2008-11#11)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#13)(2008-7#3)(2008-8#11)(2008-9#11)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#3)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#6)(2013-7#1)
the inhibitions##2##2##(1993-4#1)(1994-8#1)
the inhibitor and##6##3##(1990-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1995-11#1)
the inhibitor binding##2##3##(1996-7#1)(2012-2#1)
the inhibitor in##3##3##(1990-12#1)(1994-2#1)(2008-7#1)
the inhibitor is##3##3##(1991-3#1)(1992-2#1)(1993-3#1)
the inhibitor of CANP##2##4##(1995-9#2)
the inhibitor of protein tyrosine##2##5##(2008-8#2)
the inhibitor of##11##3##(1991-10#1)(1992-4#1)(1995-9#2)(1997-5#1)(1997-7#1)(2008-8#2)(2012-12#1)(2013-1#1)(2013-8#1)
the inhibitor phenotype##2##3##(1990-12#2)
the inhibitor was##8##3##(1990-2#1)(1990-5#1)(1991-3#1)(1993-3#1)(1994-6#1)(1996-12#1)(1997-8#2)
the inhibitor##105##2##(1990-11#2)(1990-12#4)(1990-2#4)(1990-3#1)(1990-5#1)(1991-10#1)(1991-2#3)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#4)(1993-8#3)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#3)(1994-6#4)(1994-8#2)(1994-9#2)(1995-1#3)(1995-11#2)(1995-2#2)(1995-5#1)(1995-9#2)(1996-12#1)(1996-5#2)(1996-7#2)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#8)(2006-12#1)(2007-7#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-12#1)(2010-10#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
the inhibitors and##2##3##(1995-2#1)(1995-3#1)
the inhibitors for##2##3##(1993-4#1)(1995-2#1)
the inhibitors were##2##3##(1992-10#1)(1996-8#1)
the inhibitors##37##2##(1990-10#1)(1990-7#2)(1991-10#1)(1991-2#4)(1992-10#1)(1992-11#1)(1992-3#2)(1992-4#1)(1992-8#3)(1993-4#1)(1993-8#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-5#2)(1996-6#1)(1996-8#2)(1997-7#1)(1997-8#1)(2005-7#1)(2008-8#1)(2009-11#1)(2009-9#1)
the inhibitory action of the##3##5##(1990-11#1)(1994-8#1)(2008-10#1)
the inhibitory action of##14##4##(1990-11#2)(1990-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-8#1)(1995-1#1)(1995-7#1)(1996-9#1)(1997-5#1)(1997-7#1)(2008-10#1)
the inhibitory action##18##3##(1990-11#2)(1990-2#1)(1990-4#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-8#1)(1995-1#1)(1995-7#1)(1996-2#1)(1996-9#1)(1997-5#1)(1997-7#1)(2008-10#1)(2013-7#1)
the inhibitory actions of##4##4##(1990-2#1)(1995-1#1)(1996-12#1)(2007-11#1)
the inhibitory activity of ochnaflavone##2##5##(1994-11#2)
the inhibitory activity of##8##4##(1994-11#2)(1994-9#1)(1996-11#1)(1996-5#2)(2008-5#1)(2011-1#1)
the inhibitory activity##18##3##(1990-5#1)(1991-12#1)(1991-9#1)(1994-11#2)(1994-2#1)(1994-9#1)(1995-11#1)(1996-11#1)(1996-5#2)(1997-8#2)(2008-2#2)(2008-5#2)(2011-1#1)
the inhibitory effect being##2##4##(1995-1#1)(2006-12#1)
the inhibitory effect is##3##4##(1990-2#1)(1991-9#2)
the inhibitory effect of acetic acid on##2##7##(2008-6#2)
the inhibitory effect of carbachol##2##5##(1990-10#2)
the inhibitory effect of plasma##2##5##(1994-12#2)
the inhibitory effect of the##2##5##(1995-6#1)(2008-9#1)
the inhibitory effect of##73##4##(1990-10#2)(1990-2#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#4)(1991-9#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#3)(1993-12#1)(1993-7#1)(1993-9#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-5#3)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-4#3)(1997-5#3)(1997-7#1)(1997-8#1)(2006-10#1)(2006-4#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-2#2)(2010-8#1)(2011-3#1)(2013-1#1)
the inhibitory effect on##3##4##(1990-12#1)(1996-5#1)(2008-4#1)
the inhibitory effect was more##2##5##(1994-12#1)(1995-11#1)
the inhibitory effect was##7##4##(1990-7#1)(1991-9#1)(1994-12#1)(1995-11#1)(1995-6#1)(2008-10#1)(2008-9#1)
the inhibitory effect##91##3##(1990-10#2)(1990-12#1)(1990-2#2)(1990-7#2)(1991-12#1)(1991-2#2)(1991-6#1)(1991-7#4)(1991-9#4)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#3)(1993-12#1)(1993-7#1)(1993-9#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#3)(1995-6#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-8#1)(1997-4#3)(1997-5#3)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2010-2#2)(2010-8#1)(2011-3#1)(2013-1#1)
the inhibitory effects of amphetamine on##2##6##(2013-1#2)
the inhibitory effects of both##2##5##(1994-3#1)(1996-10#1)
the inhibitory effects of the##3##5##(1991-8#1)(1995-11#1)(2008-11#1)
the inhibitory effects of##38##4##(1990-10#1)(1990-11#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-11#4)(1995-6#1)(1995-7#1)(1996-10#2)(1996-5#1)(1997-5#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-6#1)(2012-3#1)(2013-1#4)
the inhibitory effects on##5##4##(1991-2#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
the inhibitory effects were##2##4##(1995-11#1)(1996-5#1)
the inhibitory effects##46##3##(1990-10#1)(1990-11#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-11#5)(1995-12#1)(1995-6#1)(1995-7#1)(1996-10#2)(1996-5#2)(1997-5#1)(2006-12#2)(2007-11#1)(2008-10#3)(2008-11#3)(2008-4#2)(2008-6#1)(2008-8#1)(2012-3#1)(2013-1#4)
the inhibitory efficiency of##2##4##(1991-2#1)(2006-11#1)
the inhibitory factor##3##3##(1996-2#3)
the inhibitory potencies##2##3##(1994-8#1)(1996-9#1)
the inhibitory potency of##5##4##(1990-4#1)(1992-3#1)(1992-5#1)(2010-12#1)(2011-2#1)
the inhibitory potency##7##3##(1990-4#1)(1992-3#1)(1992-5#1)(2010-11#2)(2010-12#1)(2011-2#1)
the inhibitory potential of##2##4##(1994-6#1)(2008-3#1)
the inhibitory potential##3##3##(1994-6#1)(1997-3#1)(2008-3#1)
the inhibitory properties of##3##4##(1995-3#1)(1996-2#1)(2010-2#1)
the inhibitory properties##4##3##(1995-3#1)(1996-2#1)(2010-2#2)
the inhibitory region##4##3##(1990-4#2)(1991-12#1)(1995-8#1)
the inhibitory role of##3##4##(1990-2#1)(1994-9#1)(2008-11#1)
the inhibitory site##3##3##(1990-11#1)(1990-2#1)(1993-2#1)
the inhibitory##259##2##(1990-10#3)(1990-11#4)(1990-12#4)(1990-2#9)(1990-4#4)(1990-5#1)(1990-7#2)(1991-12#5)(1991-2#5)(1991-3#1)(1991-6#2)(1991-7#5)(1991-8#1)(1991-9#5)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#3)(1992-4#1)(1992-5#3)(1992-6#4)(1992-7#2)(1992-8#2)(1992-9#2)(1993-11#6)(1993-12#1)(1993-2#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#4)(1994-2#3)(1994-3#2)(1994-6#3)(1994-8#4)(1994-9#5)(1995-1#3)(1995-10#1)(1995-11#8)(1995-12#3)(1995-2#1)(1995-3#3)(1995-5#3)(1995-6#6)(1995-7#2)(1995-8#1)(1996-10#2)(1996-11#2)(1996-12#2)(1996-2#7)(1996-3#1)(1996-4#1)(1996-5#7)(1996-8#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-4#3)(1997-5#5)(1997-7#2)(1997-8#3)(2005-10#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-4#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#13)(2008-11#8)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#4)(2008-6#4)(2008-7#3)(2008-8#3)(2008-9#2)(2009-12#1)(2010-11#2)(2010-12#1)(2010-2#5)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#5)(2013-7#1)
the inhomogeneities##2##2##(2008-3#2)
the inhomogeneity of the##5##4##(2008-3#4)(2008-5#1)
the inhomogeneity of##7##3##(1990-9#1)(2008-2#1)(2008-3#4)(2008-5#1)
the inhomogeneity##11##2##(1990-9#1)(1996-4#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#1)
the inhomogeneous##10##2##(1991-7#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#6)
the initial 100##2##3##(1993-2#1)(1994-11#1)
the initial 30 min##2##4##(1994-2#1)(1995-3#1)
the initial CT##2##3##(1993-5#1)(2008-7#1)
the initial F0 is##2##4##(2013-8#2)
the initial Met##2##3##(1993-12#1)(1995-6#1)
the initial activity##6##3##(1990-2#1)(1997-7#2)(2006-10#1)(2008-10#1)(2012-11#1)
the initial amount##2##3##(2007-10#1)(2009-4#1)
the initial analysis##2##3##(2008-10#2)
the initial and end##2##4##(2006-10#1)(2008-10#1)
the initial and terminal##3##4##(1993-11#2)(2007-3#1)
the initial and##13##3##(1992-9#1)(1993-11#2)(2005-9#1)(2006-10#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
the initial assessment##7##3##(1992-5#1)(1993-2#1)(2007-1#1)(2008-3#1)(2010-4#1)(2011-1#1)(2012-2#1)
the initial attachment of##3##4##(1991-2#1)(1992-12#1)(1994-9#1)
the initial attachment##4##3##(1991-2#1)(1992-12#1)(1994-9#1)(2009-12#1)
the initial batch##2##3##(1994-5#1)(2008-7#1)
the initial binding##2##3##(1994-9#1)(1995-10#1)
the initial blood##2##3##(2006-4#1)(2007-9#1)
the initial cell concentrations##2##4##(2008-5#2)
the initial cell##4##3##(1997-1#1)(2008-11#1)(2008-5#2)
the initial cleavage of##2##4##(1990-9#1)(2008-8#1)
the initial clinical trials##3##4##(2007-11#2)(2010-12#1)
the initial clinical##9##3##(1997-8#1)(2005-8#1)(2006-5#1)(2007-11#2)(2008-7#1)(2008-9#1)(2009-7#1)(2010-12#1)
the initial concentration of the##2##5##(2008-10#2)
the initial concentration of##10##4##(1996-6#1)(2005-11#3)(2006-10#1)(2007-10#1)(2008-10#4)
the initial concentration##14##3##(1993-3#1)(1996-6#3)(2005-11#3)(2006-10#1)(2007-10#1)(2008-10#5)
the initial conditions##3##3##(2008-11#2)(2008-3#1)
the initial content##2##3##(1990-2#1)(2012-12#1)
the initial damage##3##3##(1992-9#1)(2008-3#1)(2008-7#1)
the initial decrease in##2##4##(1991-9#1)(1996-11#1)
the initial delay##3##3##(2007-12#1)(2011-2#2)
the initial development of##3##4##(2008-12#1)(2008-8#1)(2010-3#1)
the initial development##5##3##(2005-10#1)(2007-12#1)(2008-12#1)(2008-8#1)(2010-3#1)
the initial diagnosis of##5##4##(2007-8#2)(2011-2#1)(2012-11#2)
the initial diagnosis##16##3##(1993-7#1)(1996-3#1)(2005-10#1)(2006-1#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-8#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-11#2)(2012-2#1)(2013-8#1)
the initial disease##3##3##(2008-10#2)(2012-2#1)
the initial distribution of##2##4##(2006-10#1)(2008-3#1)
the initial distribution##3##3##(2006-10#1)(2008-3#2)
the initial dose##4##3##(2007-2#1)(2007-7#1)(2008-11#1)(2008-8#1)
the initial drug##2##3##(1993-12#1)(1993-9#1)
the initial efforts##2##3##(2005-12#1)(2006-5#1)
the initial enzyme##3##3##(1990-6#1)(1992-10#1)(2011-1#1)
the initial evaluation of renal colic##2##6##(2008-1#2)
the initial evaluation of##4##4##(2006-10#1)(2008-1#2)(2008-11#1)
the initial evaluation##11##3##(1996-9#1)(2006-10#2)(2008-1#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2013-1#2)
the initial event##3##3##(2007-10#1)(2007-3#1)(2010-6#1)
the initial events of##2##4##(1990-9#1)(1993-3#1)
the initial examination in##2##4##(2006-9#1)(2007-3#1)
the initial examination##4##3##(2006-9#1)(2007-11#1)(2007-3#1)(2010-3#1)
the initial findings of##2##4##(1997-7#1)(2008-5#1)
the initial findings##3##3##(1997-7#1)(2008-5#1)(2010-8#1)
the initial fitting session and for the following##2##8##(2008-9#2)
the initial fitting session##3##4##(2008-9#3)
the initial formation of a##2##5##(1990-11#1)(2011-2#1)
the initial frequency##2##3##(2007-12#1)(2008-10#1)
the initial functional damage##2##4##(2007-10#2)
the initial glucose concentration##3##4##(2008-6#2)(2008-7#1)
the initial headspace##2##3##(2011-2#2)
the initial hospital##2##3##(1994-2#1)(1996-9#1)
the initial hypothesis##3##3##(1990-7#1)(1993-2#1)(2008-10#1)
the initial identification of##2##4##(2006-3#1)(2008-10#1)
the initial imaging modality##2##4##(2011-2#2)
the initial imaging technique##2##4##(2008-4#1)(2011-2#1)
the initial imaging##5##3##(2008-4#1)(2010-12#1)(2011-2#3)
the initial implementation##2##3##(1996-12#1)(2008-7#1)
the initial increase in##2##4##(1990-11#1)(1990-5#1)
the initial increase##4##3##(1990-11#1)(1990-2#1)(1990-5#1)(2008-10#1)
the initial infection##5##3##(1995-7#1)(2008-10#4)
the initial infestation in##2##4##(1996-12#2)
the initial inoculum density##2##4##(2008-10#2)
the initial inoculum##5##3##(2008-10#5)
the initial insult##2##3##(2005-8#1)(2010-2#1)
the initial intensity##3##3##(2008-2#1)(2008-3#2)
the initial leukocytosis##2##3##(2011-2#2)
the initial level of##2##4##(2006-3#1)(2008-4#1)
the initial level##4##3##(1990-7#1)(2006-3#1)(2008-4#1)(2008-8#1)
the initial manifestation of an undiagnosed##2##6##(2009-2#2)
the initial manifestation of the disease##2##6##(2006-10#1)(2007-11#1)
the initial manifestation of##7##4##(1991-6#1)(2006-10#2)(2007-11#1)(2009-2#2)(2010-9#1)
the initial manifestation##8##3##(1991-6#1)(1993-2#1)(2006-10#2)(2007-11#1)(2009-2#2)(2010-9#1)
the initial microbial##2##3##(1997-4#1)(2006-12#1)
the initial model##2##3##(1997-3#1)(2008-8#1)
the initial number of##2##4##(2007-8#1)(2008-6#1)
the initial oil##2##3##(2008-10#1)(2010-12#1)
the initial operation##8##3##(1994-5#1)(2006-12#1)(2008-7#1)(2011-2#4)(2012-3#1)
the initial pH of the medium##2##6##(2006-3#1)(2008-6#1)
the initial pH of the##4##5##(2006-3#1)(2008-6#3)
the initial pH##6##3##(2006-3#1)(2008-5#1)(2008-6#4)
the initial parameters##2##3##(2005-4#2)
the initial peak of##2##4##(1990-5#1)(1992-9#1)
the initial peak##3##3##(1990-5#1)(1992-9#1)(1996-11#1)
the initial period of##6##4##(1992-2#1)(1996-2#1)(2005-11#1)(2007-8#2)(2011-1#1)
the initial period##10##3##(1992-2#1)(1994-12#1)(1996-2#1)(2005-11#3)(2007-8#2)(2011-1#1)(2011-2#1)
the initial phase and the##2##5##(1990-10#1)(1990-7#1)
the initial phase of treatment##2##5##(2007-7#1)(2013-8#1)
the initial phase of##11##4##(1994-7#1)(2007-2#1)(2007-4#1)(2007-7#2)(2008-10#1)(2008-2#1)(2008-7#1)(2009-6#1)(2012-3#1)(2013-8#1)
the initial phase##19##3##(1990-10#1)(1990-2#1)(1990-6#1)(1990-7#1)(1994-7#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-6#1)(2012-3#1)(2013-8#1)
the initial plating density##2##4##(1990-7#1)(1996-5#1)
the initial population##2##3##(2008-10#1)(2008-8#1)
the initial position of##2##4##(2007-4#1)(2010-4#1)
the initial preparation##2##3##(2007-9#1)(2012-1#1)
the initial presentation of##10##4##(2006-10#3)(2006-9#1)(2007-5#1)(2008-11#1)(2008-6#1)(2009-10#1)(2010-7#1)(2012-12#1)
the initial presentation##15##3##(2006-10#3)(2006-9#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-3#1)(2010-7#1)(2012-12#1)(2012-3#1)
the initial procedure##2##3##(2006-8#1)(2013-7#1)
the initial process##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
the initial product##2##3##(1990-11#1)(1994-2#1)
the initial protein##2##3##(1991-9#1)(1994-11#1)
the initial pulse##5##3##(2007-11#1)(2007-12#3)(2008-3#1)
the initial rapid##3##3##(1990-5#1)(1997-8#1)(2009-11#1)
the initial rate method##2##4##(2008-10#2)
the initial rate of hydrolysis of##2##6##(1990-11#1)(1992-12#1)
the initial rate of the##2##5##(1990-12#1)(2008-10#1)
the initial rate of uptake of##2##6##(1991-3#1)(1992-6#1)
the initial rate of uptake##3##5##(1991-3#1)(1992-6#1)(1995-11#1)
the initial rate of##19##4##(1990-11#1)(1990-12#3)(1991-3#1)(1991-4#1)(1992-12#1)(1992-6#3)(1994-5#2)(1995-11#1)(1995-2#1)(1995-8#1)(2008-10#2)(2008-5#2)
the initial rate##26##3##(1990-11#1)(1990-12#3)(1991-3#1)(1991-4#1)(1992-12#1)(1992-6#3)(1994-5#2)(1995-11#1)(1995-2#1)(1995-8#1)(2008-10#7)(2008-5#3)(2008-7#1)
the initial rates of##2##4##(1994-11#1)(1994-5#1)
the initial rates##3##3##(1993-6#1)(1994-11#1)(1994-5#1)
the initial reaction rate##2##4##(2007-10#1)(2008-7#1)
the initial reactions##2##3##(1991-3#1)(1991-7#1)
the initial reduction of##2##4##(1995-6#1)(2006-8#1)
the initial reduction##4##3##(1995-6#1)(2006-8#1)(2010-7#1)(2011-2#1)
the initial rejection##2##3##(1995-2#1)(1995-5#1)
the initial release##3##3##(1995-1#1)(1996-2#1)(2008-10#1)
the initial report##2##3##(2008-6#1)(2010-12#1)
the initial response##3##3##(1994-3#1)(1996-3#1)(2008-10#1)
the initial results of##3##4##(2008-6#1)(2011-2#1)(2013-1#1)
the initial results##4##3##(2008-2#1)(2008-6#1)(2011-2#1)(2013-1#1)
the initial resuscitation##2##3##(1996-9#1)(2007-3#1)
the initial sample##2##3##(2008-10#1)(2008-7#1)
the initial sampling occasion##2##4##(2004-11#2)
the initial screening##2##3##(1992-8#1)(2007-12#1)
the initial search##2##3##(2008-2#2)
the initial set##2##3##(2008-12#1)(2012-2#1)
the initial sign of##2##4##(1991-2#1)(2011-2#1)
the initial signal##3##3##(2008-4#1)(2008-8#1)(2011-2#1)
the initial site##2##3##(1991-2#1)(2008-6#1)
the initial size of##3##4##(1990-11#1)(2007-9#1)(2008-8#1)
the initial slope of the##3##5##(2005-11#1)(2008-10#1)(2008-3#1)
the initial slope##6##3##(1991-8#3)(2005-11#1)(2008-10#1)(2008-3#1)
the initial stage of the##3##5##(1994-6#1)(2008-6#1)(2008-7#1)
the initial stage of##9##4##(1992-5#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2011-2#1)(2013-1#1)
the initial stage that##2##4##(1995-11#1)(2011-1#1)
the initial stage##15##3##(1992-5#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-6#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2011-1#1)(2011-2#1)(2013-1#1)
the initial stages of the##5##5##(2006-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
the initial stages of##18##4##(1992-9#1)(1993-11#1)(1994-9#1)(1996-4#1)(2004-9#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-12#3)(2008-1#2)(2008-10#1)(2008-3#1)(2009-8#1)(2009-9#1)(2011-2#1)
the initial stages##20##3##(1992-9#1)(1993-11#1)(1994-9#1)(1996-4#1)(2004-9#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-12#3)(2008-1#2)(2008-10#1)(2008-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#1)
the initial state##3##3##(2008-2#1)(2008-3#1)(2008-8#1)
the initial step in##3##4##(1995-8#1)(2004-4#2)
the initial step of the##2##5##(1995-2#1)(2012-2#1)
the initial step of##5##4##(1991-9#1)(1992-12#1)(1995-2#1)(2009-2#1)(2012-2#1)
the initial step##10##3##(1991-9#1)(1992-12#1)(1995-2#1)(1995-8#1)(2004-4#2)(2008-1#1)(2008-10#1)(2009-2#1)(2012-2#1)
the initial steps in##2##4##(1996-10#1)(2009-2#1)
the initial steps of the##2##5##(2009-2#1)(2012-12#1)
the initial steps of##4##4##(2007-12#1)(2009-2#1)(2011-3#1)(2012-12#1)
the initial steps##8##3##(1996-10#1)(2007-12#1)(2008-10#1)(2009-2#2)(2011-3#1)(2012-12#1)(2012-2#1)
the initial stress##3##3##(2008-5#3)
the initial stroke was associated with##2##6##(2007-9#2)
the initial stroke##3##3##(2007-9#3)
the initial study##3##3##(1994-3#1)(1996-2#1)(2010-12#1)
the initial successful##2##3##(1991-3#1)(2008-1#1)
the initial surgery##3##3##(2007-5#1)(2012-12#1)(2013-1#1)
the initial survey##3##3##(1995-9#1)(2012-12#2)
the initial symptoms of##2##4##(1990-12#1)(2007-10#1)
the initial symptoms##3##3##(1990-12#1)(2007-10#1)(2008-10#1)
the initial template##2##3##(1991-9#1)(1994-12#1)
the initial therapeutic##3##3##(1993-11#1)(2008-11#1)(2009-6#1)
the initial trauma##3##3##(2006-4#1)(2008-4#1)(2009-3#1)
the initial treatment and##2##4##(2007-11#1)(2010-2#1)
the initial treatment of choice##2##5##(1990-9#1)(2013-8#1)
the initial treatment of##5##4##(1990-9#1)(1995-9#1)(2007-6#2)(2013-8#1)
the initial treatment##18##3##(1990-9#1)(1992-3#1)(1993-3#1)(1995-9#1)(2006-1#1)(2007-10#1)(2007-11#2)(2007-6#5)(2010-2#1)(2010-8#1)(2012-12#1)(2013-8#2)
the initial uptake##2##3##(1991-7#1)(1992-6#1)
the initial value of##2##4##(1990-9#1)(2008-9#1)
the initial value##7##3##(1990-3#1)(1990-9#1)(1992-1#1)(1992-2#1)(1996-3#1)(2007-11#1)(2008-9#1)
the initial values##3##3##(1990-7#1)(2007-9#1)(2012-1#1)
the initial velocity of the##2##5##(1990-2#1)(1991-8#1)
the initial velocity of##3##4##(1990-2#1)(1991-8#1)(1995-7#1)
the initial velocity##6##3##(1990-2#1)(1991-5#2)(1991-8#1)(1995-7#1)(2008-6#1)
the initial viral##2##3##(2004-11#1)(2008-10#1)
the initial volume##2##3##(2008-1#1)(2008-11#1)
the initial years##2##3##(1993-6#1)(2008-9#1)
the initial##876##2##(1990-10#3)(1990-11#6)(1990-12#6)(1990-2#8)(1990-3#2)(1990-5#6)(1990-6#3)(1990-7#6)(1990-9#5)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#5)(1991-3#4)(1991-4#3)(1991-5#4)(1991-6#2)(1991-7#4)(1991-8#4)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#6)(1992-7#1)(1992-8#3)(1992-9#6)(1993-11#4)(1993-12#3)(1993-2#4)(1993-3#3)(1993-5#3)(1993-6#4)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#3)(1994-2#3)(1994-3#5)(1994-5#6)(1994-6#3)(1994-7#4)(1994-9#4)(1995-1#3)(1995-10#2)(1995-11#5)(1995-12#1)(1995-2#5)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#4)(1995-7#3)(1995-8#3)(1995-9#2)(1996-1#3)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#5)(1996-3#5)(1996-4#2)(1996-5#3)(1996-6#6)(1996-7#1)(1996-8#1)(1996-9#7)(1997-1#3)(1997-3#1)(1997-4#2)(1997-5#3)(1997-7#5)(1997-8#2)(2004-11#4)(2004-12#3)(2004-2#1)(2004-4#2)(2004-9#2)(2005-10#2)(2005-11#13)(2005-12#1)(2005-4#4)(2005-5#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-1#2)(2006-10#17)(2006-11#1)(2006-12#5)(2006-2#2)(2006-3#3)(2006-4#2)(2006-5#4)(2006-7#1)(2006-8#5)(2006-9#2)(2007-1#3)(2007-10#16)(2007-11#12)(2007-12#26)(2007-2#4)(2007-3#6)(2007-4#5)(2007-5#6)(2007-6#7)(2007-7#10)(2007-8#9)(2007-9#9)(2008-1#11)(2008-10#74)(2008-11#17)(2008-12#4)(2008-2#19)(2008-3#19)(2008-4#11)(2008-5#17)(2008-6#19)(2008-7#17)(2008-8#18)(2008-9#11)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#5)(2009-3#2)(2009-4#1)(2009-6#6)(2009-7#2)(2009-8#3)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#11)(2010-2#4)(2010-3#4)(2010-4#5)(2010-5#2)(2010-6#1)(2010-7#5)(2010-8#5)(2010-9#2)(2011-1#11)(2011-12#1)(2011-2#29)(2011-3#2)(2012-1#4)(2012-11#3)(2012-12#20)(2012-2#10)(2012-3#4)(2013-1#17)(2013-7#3)(2013-8#11)
the initially formed##5##3##(1990-2#1)(1991-9#1)(1996-5#1)(2005-11#1)(2008-5#1)
the initially planned treatment##2##4##(2011-2#2)
the initially##24##2##(1990-11#1)(1990-2#1)(1991-9#1)(1993-12#1)(1993-9#2)(1994-11#1)(1995-6#1)(1996-5#1)(1997-5#1)(2004-9#2)(2005-11#2)(2005-7#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-5#1)(2009-7#1)(2010-12#1)(2011-2#2)
the initiated##2##2##(1993-12#1)(1995-2#1)
the initiating event##2##3##(1995-3#1)(2012-12#1)
the initiating##7##2##(1990-7#2)(1995-3#1)(2007-2#1)(2007-9#1)(2010-12#1)(2012-12#1)
the initiation and control of##2##5##(1993-12#1)(2008-4#1)
the initiation and development of##6##5##(1997-4#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-4#1)(2012-3#1)
the initiation and duration of##2##5##(2007-7#1)(2007-9#1)
the initiation and maintenance of##3##5##(1993-3#1)(1993-4#1)(2008-7#1)
the initiation and perpetuation of##2##5##(1994-8#1)(2012-2#1)
the initiation and progression of##7##5##(1994-5#1)(2006-10#1)(2007-11#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-12#1)
the initiation and propagation of disease processes in multicellular organisms##2##10##(2008-2#1)(2008-4#1)
the initiation and propagation of the##2##6##(2009-5#1)(2011-1#1)
the initiation and propagation of##4##5##(2008-2#1)(2008-4#1)(2009-5#1)(2011-1#1)
the initiation and the progression of renal##2##7##(2012-12#2)
the initiation and the progression of##3##6##(2008-7#1)(2012-12#2)
the initiation and the##4##4##(2008-11#1)(2008-7#1)(2012-12#2)
the initiation and##47##3##(1992-5#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-5#1)(1994-8#1)(1997-4#1)(2004-2#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#2)(2009-5#1)(2010-2#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)
the initiation codon##5##3##(1992-11#1)(1992-2#1)(1992-5#1)(1995-3#1)(2005-11#1)
the initiation codons##2##3##(1996-8#2)
the initiation conformation##2##3##(1997-5#2)
the initiation of DNA synthesis##2##5##(1990-11#1)(1996-8#1)
the initiation of DNA##3##4##(1990-11#2)(1996-8#1)
the initiation of PD therapy##2##5##(2011-2#2)
the initiation of a##5##4##(1993-8#1)(1993-9#1)(1996-4#1)(2008-6#1)(2008-8#1)
the initiation of an##2##4##(2008-11#1)(2011-1#1)
the initiation of cancer##2##4##(2008-8#1)(2009-3#1)
the initiation of dialysis##3##4##(2011-1#1)(2011-2#1)(2013-8#1)
the initiation of highly active antiretroviral therapy (HAART)##2##8##(2009-7#1)(2011-2#1)
the initiation of highly active antiretroviral therapy##3##7##(2006-10#1)(2009-7#1)(2011-2#1)
the initiation of insulin##2##4##(2011-1#2)
the initiation of lambda plasmid DNA replication##2##7##(1994-11#2)
the initiation of oocyte##2##4##(2008-5#2)
the initiation of replication##3##4##(1990-3#1)(1991-12#1)(1996-7#1)
the initiation of sporulation##2##4##(1995-6#2)
the initiation of the##14##4##(1992-3#1)(1993-7#1)(1996-3#1)(1996-5#1)(2006-10#1)(2007-7#1)(2008-10#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-3#1)
the initiation of treatment##4##4##(2008-5#1)(2010-2#1)(2010-3#1)(2010-8#1)
the initiation of##128##3##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#2)(1991-11#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#2)(1995-7#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#2)(1997-4#1)(1997-5#1)(1997-8#1)(2005-11#1)(2005-8#2)(2006-10#7)(2006-12#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-7#3)(2008-1#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#4)(2011-1#6)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#1)
the initiation or##2##3##(1993-6#1)(2008-11#1)
the initiation site of the##2##5##(1993-9#1)(2008-6#1)
the initiation site of##4##4##(1991-10#1)(1993-9#1)(2008-6#2)
the initiation sites were##2##4##(1997-6#2)
the initiation sites##3##3##(1996-8#1)(1997-6#2)
the initiation##214##2##(1990-11#2)(1990-12#1)(1990-3#2)(1990-5#1)(1990-6#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#2)(1993-12#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-7#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#5)(1997-2#1)(1997-4#2)(1997-5#3)(1997-6#2)(1997-8#1)(2004-2#1)(2005-10#2)(2005-11#2)(2005-7#1)(2005-8#2)(2006-10#10)(2006-12#3)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-3#1)(2007-7#6)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#9)(2008-6#3)(2008-7#5)(2008-8#6)(2008-9#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-2#3)(2010-3#1)(2010-4#3)(2010-5#2)(2010-8#4)(2011-1#7)(2011-12#1)(2011-2#8)(2012-1#1)(2012-12#5)(2012-2#6)(2012-3#3)(2013-1#5)(2013-8#1)
the initiative of##2##3##(1992-8#1)(2010-1#1)
the initiative to##3##3##(1992-11#1)(1994-3#1)(2007-9#1)
the initiative##14##2##(1992-11#1)(1992-8#1)(1994-12#2)(1994-3#1)(1995-2#1)(2006-7#1)(2007-9#2)(2008-1#1)(2008-11#1)(2008-5#1)(2010-1#1)(2012-2#1)
the initiatives##5##2##(1996-3#1)(2007-7#1)(2010-12#2)(2013-1#1)
the initiator and##2##3##(1995-6#1)(2008-10#1)
the initiator methionine is##2##4##(1992-3#1)(1994-12#1)
the initiator methionine##3##3##(1990-5#1)(1992-3#1)(1994-12#1)
the initiator##22##2##(1990-5#2)(1990-8#1)(1991-12#1)(1991-3#1)(1992-3#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-8#1)(2005-11#1)(2005-12#1)(2006-12#1)(2008-10#1)(2009-3#1)(2012-12#4)
the injectate##3##2##(1990-10#1)(2006-8#1)(2008-10#1)
the injected and##2##3##(1991-10#1)(2005-11#1)
the injected dose of##2##4##(1990-3#1)(2010-1#1)
the injected dose##4##3##(1990-3#1)(1993-11#1)(2010-1#1)(2013-1#1)
the injected gas##3##3##(2005-11#3)
the injected muscle##2##3##(1995-12#2)
the injected sample##4##3##(2007-8#1)(2008-10#3)
the injected substances##2##3##(2012-1#2)
the injected##42##2##(1990-3#1)(1990-4#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-9#2)(1993-11#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-5#1)(1994-9#1)(1995-12#4)(1996-1#1)(1996-10#1)(1996-8#1)(2005-11#4)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-7#1)(2008-8#1)(2010-1#1)(2010-12#1)(2012-1#2)(2013-1#1)
the injection and##3##3##(1990-5#1)(2007-11#1)(2008-9#1)
the injection current##2##3##(2007-12#2)
the injection duration##2##3##(2008-7#2)
the injection in a##2##4##(2008-10#1)(2008-4#1)
the injection of a##4##4##(1993-12#1)(2006-8#1)(2008-10#2)
the injection of blood##2##4##(1993-10#1)(2011-2#1)
the injection of pseudorabies virus into the##2##7##(1992-8#1)(1997-2#1)
the injection of##55##3##(1990-5#1)(1990-7#2)(1991-2#2)(1991-3#1)(1991-4#2)(1991-9#2)(1992-8#2)(1993-10#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-3#1)(1997-2#2)(2006-8#2)(2007-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#7)(2008-3#1)(2008-4#2)(2008-7#4)(2008-8#1)(2009-10#1)(2009-12#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#1)
the injection port of a gas chromatograph##2##7##(1990-8#1)(1997-8#1)
the injection rate##2##3##(2008-10#1)(2008-7#1)
the injection site##22##3##(1990-6#1)(1993-2#1)(1994-5#1)(1995-5#2)(1996-1#1)(1996-12#1)(1996-7#1)(1997-3#2)(2005-11#1)(2006-8#1)(2007-11#2)(2008-12#1)(2008-4#1)(2008-8#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-2#1)
the injection sites##3##3##(1991-6#1)(1993-1#1)(1997-3#1)
the injection the##4##3##(1990-9#1)(1993-7#1)(2007-11#1)(2012-3#1)
the injection volume was 20##2##5##(2005-12#1)(2012-12#1)
the injection volume was##3##4##(2005-12#1)(2011-1#1)(2012-12#1)
the injection volume##4##3##(1994-9#1)(2005-12#1)(2011-1#1)(2012-12#1)
the injection##152##2##(1990-12#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#2)(1991-3#2)(1991-4#4)(1991-6#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-5#1)(1992-8#2)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#2)(1994-2#1)(1994-5#3)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#4)(1996-1#3)(1996-10#1)(1996-12#1)(1996-3#2)(1996-7#1)(1997-2#6)(1997-3#3)(1997-5#2)(1997-7#1)(1997-8#1)(2004-10#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-8#3)(2007-10#1)(2007-11#7)(2007-12#3)(2007-4#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#10)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#2)(2013-8#1)
the injections were##2##3##(1990-7#1)(1997-2#1)
the injections##6##2##(1990-7#1)(1994-8#1)(1997-2#1)(1997-3#2)(2006-12#1)
the injector and##2##3##(1995-6#1)(2008-10#1)
the injector temperature##2##3##(2008-10#2)
the injector##4##2##(1995-6#1)(2008-10#3)
the injunction##2##2##(1995-6#1)(1997-1#1)
the injured brain##5##3##(1997-8#1)(2005-8#2)(2006-10#1)(2008-5#1)
the injured cells##2##3##(1991-10#1)(1991-12#1)
the injured cortex##2##3##(1995-6#1)(1996-1#1)
the injured kidneys##2##3##(1995-2#1)(2010-2#1)
the injured sciatic nerve##2##4##(1991-3#2)
the injured spinal cord##5##4##(1995-3#2)(2007-12#1)(2008-7#2)
the injured##55##2##(1990-6#1)(1991-10#2)(1991-12#2)(1991-3#2)(1991-9#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-5#1)(1994-10#2)(1995-1#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-9#1)(1997-3#2)(1997-8#1)(2005-8#2)(2006-10#3)(2006-11#1)(2006-3#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-10#1)(2012-7#1)
the injuries that##2##3##(2007-12#1)(2009-7#1)
the injuries were##3##3##(1990-6#1)(1991-2#1)(1991-4#1)
the injuries##13##2##(1990-6#1)(1991-2#1)(1991-4#1)(1993-5#1)(1995-8#1)(1997-3#1)(2006-11#1)(2007-12#1)(2007-8#1)(2008-9#1)(2009-4#2)(2009-7#1)
the injurious##2##2##(1990-4#1)(1996-10#1)
the injury and the##2##4##(2007-11#1)(2008-9#1)
the injury and##8##3##(2006-3#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-9#1)(2011-12#1)(2012-12#2)
the injury event##3##3##(2005-10#3)
the injury mechanisms##5##3##(2006-11#2)(2007-4#3)
the injury rate##4##3##(1997-2#1)(2006-5#1)(2008-11#2)
the injury risk##2##3##(2007-1#1)(2007-4#1)
the injury severity##2##3##(2006-11#1)(2007-7#1)
the injury site##2##3##(1990-4#1)(2011-1#1)
the injury tolerance of the##2##5##(2006-11#2)
the injury was##2##3##(2004-1#1)(2007-11#1)
the injury##82##2##(1990-4#1)(1991-10#1)(1991-12#1)(1991-3#1)(1993-11#1)(1993-8#1)(1994-2#2)(1994-5#1)(1995-10#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-2#1)(2004-1#1)(2005-10#3)(2005-12#1)(2005-7#1)(2006-11#9)(2006-3#3)(2006-5#1)(2006-7#1)(2007-1#2)(2007-10#1)(2007-11#4)(2007-4#6)(2007-7#2)(2007-8#5)(2007-9#3)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#2)(2009-5#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-12#3)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
the injustice##2##2##(2007-8#1)(2011-2#1)
the ink##3##2##(1991-7#1)(2008-10#2)
the ink-bottle effect##2##3##(2005-11#2)
the inkjet##2##2##(2005-11#1)(2010-9#1)
the inlet H2S##2##3##(2007-12#2)
the inlet and##3##3##(2007-2#1)(2008-7#2)
the inlet catheter tip##7##4##(2006-8#7)
the inlet of##2##3##(2007-8#2)
the inlet##18##2##(1996-6#1)(2006-8#7)(2007-12#2)(2007-2#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-7#2)
the inmate's##4##2##(1990-2#1)(1991-10#3)
the inmates'##2##2##(2009-11#1)(2012-11#1)
the innate and adaptive immune##4##5##(2005-11#1)(2006-10#1)(2008-4#1)(2009-8#1)
the innate and adaptive##7##4##(2005-11#1)(2006-10#3)(2008-4#1)(2009-8#1)(2010-1#1)
the innate and##9##3##(2005-11#1)(2006-10#4)(2008-4#1)(2009-8#1)(2010-1#1)(2013-8#1)
the innate immune response to##2##5##(2006-10#1)(2010-12#1)
the innate immune response##12##4##(2006-10#2)(2007-11#1)(2008-1#1)(2008-3#1)(2009-6#1)(2010-1#1)(2010-12#2)(2010-9#1)(2011-1#1)(2013-8#1)
the innate immune system and##3##5##(2006-10#1)(2008-11#1)(2010-8#1)
the innate immune system##20##4##(2005-10#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
the innate immune##36##3##(2005-10#1)(2006-10#3)(2007-11#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2009-6#1)(2010-1#2)(2010-12#5)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#2)
the innate immunity##2##3##(2006-10#1)(2012-3#1)
the innate system##3##3##(2006-10#3)
the innate##55##2##(2005-10#1)(2005-11#1)(2006-10#11)(2007-11#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#3)(2009-6#1)(2009-8#1)(2010-1#3)(2010-12#5)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#4)(2013-1#2)(2013-8#3)
the inner OH group##2##4##(2005-11#2)
the inner and outer##10##4##(1990-11#2)(1991-10#1)(1994-12#1)(1997-1#1)(2007-5#1)(2007-7#2)(2012-1#1)(2013-8#1)
the inner aqueous##2##3##(1991-5#1)(2005-11#1)
the inner barrier##2##3##(2009-12#2)
the inner cavity of##2##4##(2008-7#1)(2008-8#1)
the inner cavity##3##3##(2008-7#1)(2008-8#2)
the inner cell mass of##2##5##(2008-9#2)
the inner cell mass##5##4##(2006-5#1)(2008-11#1)(2008-5#1)(2008-9#2)
the inner cell##6##3##(2006-5#1)(2008-11#1)(2008-5#1)(2008-9#2)(2010-11#1)
the inner core##5##3##(1995-3#3)(2008-2#1)(2008-8#1)
the inner ear and##2##4##(1997-6#1)(2008-4#1)
the inner ear##13##3##(1991-9#1)(1993-9#1)(1994-9#1)(1995-5#3)(1997-6#1)(2008-4#2)(2008-9#2)(2011-1#2)
the inner filter effect and##2##5##(2008-10#1)(2008-11#1)
the inner filter effect##4##4##(2008-10#2)(2008-11#2)
the inner layer of the##3##5##(1992-12#1)(2008-10#1)(2008-8#1)
the inner layer of##4##4##(1992-12#1)(2008-10#1)(2008-12#1)(2008-8#1)
the inner layer##5##3##(1992-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-8#1)
the inner layers##2##3##(2008-10#1)(2010-8#1)
the inner leaflet of the##2##5##(1997-4#1)(2009-12#1)
the inner leaflet of##3##4##(1997-4#1)(2008-11#1)(2009-12#1)
the inner leaflet##5##3##(1995-6#1)(1997-4#1)(2008-11#2)(2009-12#1)
the inner lipid##2##3##(1991-5#2)
the inner lumen##2##3##(1997-6#1)(2008-5#1)
the inner membrane and##3##4##(1990-3#1)(1990-9#1)(1994-12#1)
the inner membrane of##2##4##(1992-7#1)(2007-11#1)
the inner membrane##18##3##(1990-2#2)(1990-3#1)(1990-9#1)(1991-10#1)(1992-11#1)(1992-6#1)(1992-7#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-6#1)(1997-8#1)(2005-8#2)(2007-11#1)(2011-2#1)(2013-8#1)
the inner mitochondrial membrane of##2##5##(1990-11#1)(1992-11#1)
the inner mitochondrial membrane##14##4##(1990-11#1)(1991-10#1)(1992-11#1)(1992-3#1)(1993-6#2)(1995-2#1)(1996-2#1)(1997-1#3)(1997-4#1)(2005-8#1)(2012-2#1)
the inner mitochondrial membranes##2##4##(1990-3#1)(1994-5#1)
the inner mitochondrial##16##3##(1990-11#1)(1990-3#1)(1991-10#1)(1992-11#1)(1992-3#1)(1993-6#2)(1994-5#1)(1995-2#1)(1996-2#1)(1997-1#3)(1997-4#1)(2005-8#1)(2012-2#1)
the inner molecular layer of the dentate##2##7##(1992-7#1)(1995-7#1)
the inner monolayer##2##3##(1992-6#1)(1997-1#1)
the inner nuclear layer##6##4##(1990-5#1)(1991-10#1)(1994-2#1)(1994-3#1)(1995-1#2)
the inner nuclear membrane##3##4##(1990-11#1)(2008-9#1)(2011-2#1)
the inner nuclear##9##3##(1990-11#1)(1990-5#1)(1991-10#1)(1994-2#1)(1994-3#1)(1995-1#2)(2008-9#1)(2011-2#1)
the inner or##2##3##(1990-5#1)(2010-5#1)
the inner part of the##2##5##(1995-3#1)(2008-10#1)
the inner plexiform layer of##2##5##(1996-6#1)(2012-3#1)
the inner plexiform layer##8##4##(1990-12#2)(1990-5#2)(1991-10#1)(1996-6#1)(1997-5#1)(2012-3#1)
the inner portion of##2##4##(2006-12#1)(2008-5#1)
the inner region of the##2##5##(1990-4#1)(2005-11#1)
the inner retina is##3##4##(1992-7#2)(1997-3#1)
the inner retina##4##3##(1992-7#2)(1997-3#2)
the inner retinal##2##3##(1997-3#1)(2012-12#1)
the inner sensillum-lymph##2##3##(2007-12#2)
the inner shell##3##3##(2006-1#1)(2008-8#2)
the inner side of the cell##2##6##(1997-6#1)(2008-10#1)
the inner side of the##5##5##(1995-6#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-9#1)
the inner surface of the##8##5##(2005-11#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2011-2#1)
the inner surface of##10##4##(2005-11#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2011-2#1)
the inner surface##12##3##(2005-11#1)(2007-1#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2011-2#1)
the inner surfaces##2##3##(2005-11#1)(2009-2#1)
the inner wall of the##4##5##(2007-8#1)(2008-10#2)(2011-2#1)
the inner wall of##5##4##(2007-8#1)(2008-10#3)(2011-2#1)
the inner wall##7##3##(1997-2#1)(2007-8#1)(2008-10#3)(2008-9#1)(2011-2#1)
the inner walls of##3##4##(1997-2#1)(2008-10#2)
the inner##236##2##(1990-11#6)(1990-12#3)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#6)(1990-7#1)(1990-9#1)(1991-10#5)(1991-11#2)(1991-2#2)(1991-4#2)(1991-5#4)(1991-9#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-6#2)(1992-7#4)(1993-3#2)(1993-6#2)(1993-9#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-3#5)(1995-5#3)(1995-6#4)(1995-7#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-1#5)(1997-2#2)(1997-3#4)(1997-4#3)(1997-5#1)(1997-6#4)(1997-8#2)(2005-1#1)(2005-11#8)(2005-12#1)(2005-8#3)(2006-1#1)(2006-12#2)(2006-5#3)(2007-1#1)(2007-11#2)(2007-12#6)(2007-5#3)(2007-7#4)(2007-8#1)(2008-10#22)(2008-11#6)(2008-12#1)(2008-2#8)(2008-3#2)(2008-4#4)(2008-5#5)(2008-7#1)(2008-8#9)(2008-9#7)(2009-12#3)(2009-2#1)(2009-5#1)(2010-11#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#3)
the inner-edge polarization of##2##4##(2008-2#2)
the inner-edge polarization##3##3##(2008-2#3)
the innermost GlcNAc##2##3##(1994-5#1)(2008-11#1)
the innermost chorionic layer##2##4##(2007-12#2)
the innermost region I##2##4##(1990-3#2)
the innermost##10##2##(1990-3#2)(1990-5#1)(1994-5#1)(1996-5#1)(2007-12#2)(2008-11#1)(2008-7#1)(2011-2#1)
the innervated face##2##3##(1990-11#2)
the innervated##3##2##(1990-11#2)(1995-3#1)
the innervating nerve##2##3##(1990-11#2)
the innervation from##2##3##(2007-12#1)(2009-2#1)
the innervation of the##6##4##(1995-3#1)(1995-5#1)(2006-8#2)(2007-1#1)(2013-8#1)
the innervation of##10##3##(1993-12#1)(1994-9#1)(1995-3#1)(1995-5#1)(2006-8#2)(2007-1#1)(2008-8#1)(2013-8#2)
the innervation##15##2##(1992-6#1)(1993-12#1)(1993-9#1)(1994-9#1)(1995-3#1)(1995-5#1)(2006-8#2)(2007-1#1)(2007-12#2)(2008-8#1)(2009-2#1)(2013-8#2)
the innominate##4##2##(2007-7#1)(2007-8#2)(2008-6#1)
the innovation##4##2##(1993-12#1)(2008-11#1)(2008-5#1)(2011-2#1)
the innovations##3##2##(1992-2#1)(2012-12#1)(2013-1#1)
the innovative technique##2##3##(2006-10#1)(2007-9#1)
the innovative##10##2##(1997-3#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-3#1)(2008-5#1)(2009-12#1)(2010-3#1)(2011-12#1)(2011-2#1)
the innovator##2##2##(1995-1#1)(2004-12#1)
the inocula##4##2##(2008-10#1)(2008-5#3)
the inoculated Fusarium species##2##4##(2008-10#2)
the inoculated control##3##3##(2008-10#3)
the inoculated isolates##2##3##(2008-10#2)
the inoculated leaf##5##3##(2008-10#5)
the inoculated leaves##5##3##(2008-10#3)(2008-5#1)(2008-8#1)
the inoculated plants##2##3##(2008-10#1)(2008-5#1)
the inoculated##45##2##(2004-11#2)(2006-1#1)(2006-10#1)(2008-10#33)(2008-5#5)(2008-8#1)(2008-9#1)(2012-3#1)
the inoculation density##2##3##(2008-10#1)(2012-2#1)
the inoculation of##2##3##(1993-7#1)(2008-8#1)
the inoculation site##5##3##(2008-10#5)
the inoculation sites##3##3##(1992-7#1)(2008-10#2)
the inoculation##22##2##(1992-7#1)(1993-7#1)(2008-10#15)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-2#1)
the inoculum and##2##3##(2008-10#2)
the inoculum density##6##3##(2008-10#6)
the inoculum of##2##3##(2005-6#1)(2008-10#1)
the inoculum was##2##3##(2008-10#2)
the inoculum##29##2##(1991-11#1)(1995-1#1)(2005-6#1)(2008-10#20)(2008-11#1)(2008-5#1)(2008-7#3)(2010-10#1)
the inorganic core##2##3##(2009-2#2)
the inorganic layer##2##3##(2005-11#1)(2010-4#1)
the inorganic phase##2##3##(2005-11#1)(2008-5#1)
the inorganic##32##2##(1990-12#1)(1990-5#1)(1991-11#1)(1991-7#1)(1993-11#1)(1993-4#1)(1994-6#2)(1995-11#1)(2005-11#2)(2007-3#1)(2008-10#9)(2008-5#1)(2008-6#2)(2008-7#2)(2009-2#3)(2010-4#1)(2010-5#1)(2012-2#1)
the inositol 1##6##3##(1991-8#1)(1993-12#1)(1993-7#1)(1995-2#1)(1995-3#1)(2007-9#1)
the inositol phosphate##2##3##(1991-2#1)(1995-3#1)
the inositol ring##3##3##(1993-6#1)(1993-8#1)(2010-9#1)
the inositol triphosphate##4##3##(1995-11#1)(1995-3#1)(2012-12#2)
the inositol##22##2##(1990-7#3)(1991-2#2)(1991-8#1)(1992-8#1)(1993-12#1)(1993-6#2)(1993-7#1)(1993-8#1)(1995-11#1)(1995-2#2)(1995-3#3)(2007-9#1)(2010-9#1)(2012-12#2)
the inositol-1##2##2##(1994-8#1)(1995-2#1)
the inpatient treatment##2##3##(1991-2#1)(1992-3#1)
the inpatient##12##2##(1991-2#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1996-2#1)(2007-1#1)(2008-9#1)(2010-12#1)(2012-11#1)(2013-1#1)
the input along the optical axis##2##6##(2008-3#2)
the input amplitude##2##3##(2007-12#2)
the input and output##9##4##(2007-11#1)(2007-12#1)(2007-4#1)(2008-2#4)(2010-2#1)(2010-8#1)
the input and the Fourier planes##3##6##(2008-2#1)(2008-3#2)
the input and the output of##2##6##(2008-3#2)
the input and the output##4##5##(2007-12#1)(2008-3#3)
the input and the reference##4##5##(2007-12#1)(2008-2#1)(2008-3#2)
the input and the##13##4##(2007-12#2)(2008-2#3)(2008-3#8)
the input and##24##3##(1991-6#1)(2007-11#1)(2007-12#3)(2007-4#1)(2008-2#7)(2008-3#9)(2010-2#1)(2010-8#1)
the input angle##2##3##(2008-2#2)
the input beam##7##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)
the input beams##2##3##(2007-11#1)(2007-12#1)
the input data##7##3##(1992-3#1)(1995-9#1)(2005-8#1)(2008-2#2)(2008-6#1)(2010-8#1)
the input end##2##3##(2007-12#1)(2008-3#1)
the input image##7##3##(2007-12#1)(2008-2#5)(2008-3#1)
the input images##3##3##(2008-2#2)(2008-3#1)
the input is##2##3##(2008-2#2)
the input laser beam##3##4##(2008-2#2)(2008-3#1)
the input laser##4##3##(2008-2#2)(2008-3#2)
the input layer##5##3##(2008-10#2)(2010-8#3)
the input light intensity##2##4##(2007-11#1)(2007-12#1)
the input light##8##3##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#2)
the input noise##2##3##(2007-12#1)(2008-2#1)
the input object##3##3##(2008-2#1)(2008-3#2)
the input of a##2##4##(2009-11#1)(2013-8#1)
the input of##7##3##(1993-2#1)(1996-12#1)(2004-11#1)(2009-11#1)(2010-8#1)(2011-3#1)(2013-8#1)
the input or##3##3##(2008-2#2)(2008-3#1)
the input parameters##4##3##(2008-10#1)(2008-2#3)
the input plane and##3##4##(2007-11#1)(2008-1#1)(2008-3#1)
the input plane of a##2##5##(2008-2#1)(2008-3#1)
the input plane##7##3##(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#4)
the input port##2##3##(2007-12#1)(2008-3#1)
the input power##3##3##(2007-12#2)(2008-2#1)
the input pulse##5##3##(2007-11#2)(2007-12#2)(2008-1#1)
the input pulses##6##3##(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#1)
the input resistance##5##3##(1991-2#1)(1992-3#1)(1993-12#2)(1993-2#1)
the input scene##10##3##(2008-2#8)(2008-3#2)
the input sequences##2##3##(2008-11#1)(2008-9#1)
the input signal##2##3##(2008-3#2)
the input stage##2##3##(2008-11#1)(2008-2#1)
the input surface##2##3##(2008-3#2)
the input to the##3##4##(1991-3#1)(1991-6#1)(2008-6#1)
the input to##4##3##(1991-3#1)(1991-6#1)(1992-9#1)(2008-6#1)
the input variables##3##3##(2008-10#3)
the input wave##2##3##(2007-11#1)(2007-12#1)
the input wavelength##3##3##(2008-2#2)(2009-7#1)
the input##227##2##(1991-2#1)(1991-3#2)(1991-6#4)(1992-3#2)(1992-6#1)(1992-7#1)(1992-9#2)(1993-12#2)(1993-2#2)(1995-2#1)(1995-9#1)(1996-12#1)(1997-8#3)(2004-11#1)(2005-8#1)(2007-11#17)(2007-12#39)(2007-4#1)(2008-1#4)(2008-10#6)(2008-11#4)(2008-2#66)(2008-3#39)(2008-4#1)(2008-6#5)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-2#2)(2010-5#1)(2010-8#6)(2011-3#1)(2012-2#1)(2013-8#1)
the input-output characteristics of##3##4##(1991-6#1)(2007-12#1)(2008-8#1)
the input-output##6##2##(1991-6#1)(2007-12#1)(2008-2#1)(2008-8#2)(2012-2#1)
the inputs and##2##3##(2008-11#1)(2008-3#1)
the inputs are##2##3##(2008-10#1)(2008-3#1)
the inputs to##2##3##(1993-6#1)(2009-10#1)
the inputs##11##2##(1992-2#1)(1993-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2009-10#1)(2010-12#1)
the insane in##2##3##(2007-5#2)
the insane##6##2##(1994-1#1)(2007-5#2)(2012-2#3)
the inscription of##2##3##(2007-11#1)(2007-12#1)
the insect blood sugar##2##4##(1990-10#2)
the insect brain##3##3##(2007-12#3)
the insect cell##2##3##(1993-6#1)(2008-11#1)
the insect cells##2##3##(1994-8#1)(2008-10#1)
the insect organs##2##3##(2008-10#2)
the insect wing##2##3##(2007-12#2)
the insect##53##2##(1990-10#2)(1991-10#2)(1992-11#1)(1992-3#1)(1992-6#1)(1993-6#1)(1994-12#2)(1994-8#2)(1995-11#1)(1995-8#1)(1996-7#1)(1997-8#2)(2007-12#11)(2007-2#1)(2008-10#8)(2008-11#3)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-12#1)(2010-6#1)(2011-12#1)(2012-2#1)(2013-7#1)
the insect's##5##2##(1990-10#1)(2008-10#3)(2012-12#1)
the insecticidal activity of##2##4##(2006-12#1)(2010-10#1)
the insecticidal protein##2##3##(2006-12#1)(2010-10#1)
the insecticidal##5##2##(2006-12#2)(2008-12#1)(2010-10#2)
the insecticide##10##2##(1995-3#1)(1997-2#2)(2004-11#1)(2005-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#2)
the insecticides##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
the insects##6##2##(2006-12#1)(2006-4#1)(2007-3#1)(2007-6#1)(2008-10#1)(2008-9#1)
the insemination of##2##3##(2006-5#1)(2007-9#1)
the insemination##3##2##(2006-5#1)(2007-12#1)(2007-9#1)
the insensitive##2##2##(2008-10#2)
the insensitivity##5##2##(2008-10#2)(2008-7#1)(2009-9#2)
the insert##18##2##(1990-11#1)(1990-9#1)(1991-12#1)(1991-5#1)(1992-6#1)(1994-12#1)(1995-3#1)(1996-10#1)(1996-8#1)(1997-1#1)(1997-5#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)
the inserted DNA##2##3##(1991-12#1)(2008-11#1)
the inserted T-DNA##2##3##(2008-10#2)
the inserted##16##2##(1990-5#1)(1991-12#1)(1993-6#1)(1994-12#1)(1997-2#1)(1997-8#4)(2006-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)
the insertion efficiency of##2##4##(1993-3#2)
the insertion loss of##2##4##(2007-11#1)(2008-3#1)
the insertion loss##3##3##(2007-11#1)(2008-3#2)
the insertion of a##15##4##(1990-9#1)(1991-7#1)(1994-12#1)(1994-3#1)(1994-9#1)(1997-2#1)(1997-8#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#2)(2013-8#1)
the insertion of an##5##4##(1990-3#1)(1993-10#1)(2007-3#1)(2007-8#1)(2008-10#1)
the insertion of the##11##4##(1991-5#1)(1994-11#1)(2006-3#1)(2008-10#2)(2008-7#1)(2008-9#2)(2012-2#2)(2013-1#1)
the insertion of##62##3##(1990-3#2)(1990-4#2)(1990-9#1)(1991-10#1)(1991-5#1)(1991-6#1)(1991-7#3)(1992-9#1)(1993-10#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1997-2#2)(1997-7#1)(1997-8#1)(2006-3#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-2#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#2)(2013-8#1)
the insertion point of the##2##5##(2006-10#1)(2008-12#1)
the insertion point##3##3##(1995-8#1)(2006-10#1)(2008-12#1)
the insertion site##3##3##(1990-11#1)(1995-8#1)(2013-1#1)
the insertion was##2##3##(2008-10#1)(2009-7#1)
the insertion##92##2##(1990-11#1)(1990-3#2)(1990-4#2)(1990-9#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#3)(1991-9#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-3#4)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-8#2)(1996-6#1)(1997-2#2)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-3#2)(2006-8#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-2#1)(2009-7#4)(2010-2#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#5)(2013-1#3)(2013-8#1)
the insertions##2##2##(1991-7#1)(2005-8#1)
the inserts of##3##3##(1995-3#1)(1997-3#1)(2008-10#1)
the inserts##5##2##(1995-3#1)(1997-3#1)(2008-10#2)(2008-5#1)
the inside and##3##3##(2006-8#1)(2008-12#1)(2011-2#1)
the inside needle capillary adsorption trap (INCAT)##2##7##(2008-10#2)
the inside needle capillary adsorption trap##3##6##(2008-10#3)
the inside of a##2##4##(2008-2#2)
the inside of the##12##4##(1991-12#1)(1994-3#1)(2007-10#2)(2007-8#2)(2008-11#2)(2008-2#2)(2008-3#1)(2009-8#1)
the inside of##16##3##(1991-12#1)(1994-3#1)(1994-6#1)(2007-10#2)(2007-8#2)(2008-10#1)(2008-11#2)(2008-2#4)(2008-3#1)(2009-8#1)
the inside out##2##3##(1996-2#1)(2010-12#1)
the inside##32##2##(1991-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1996-1#1)(1996-2#1)(2005-10#1)(2006-8#1)(2007-10#2)(2007-8#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-7#1)
the inside-out patches##2##3##(1994-3#2)
the inside-out##4##2##(1990-10#1)(1994-3#2)(1995-8#1)
the insight into##2##3##(2009-10#1)(2013-8#1)
the insight##3##2##(2008-11#1)(2009-10#1)(2013-8#1)
the insights##4##2##(1991-5#1)(2008-9#1)(2009-5#1)(2012-2#1)
the insignificant##3##2##(2008-10#2)(2009-3#1)
the insoluble monolayer##2##3##(2008-10#2)
the insoluble##18##2##(1990-4#1)(1990-5#2)(1991-8#1)(1992-1#2)(1992-6#1)(1994-11#2)(1994-12#2)(1997-4#1)(2008-1#1)(2008-10#3)(2009-7#1)(2012-12#1)
the inspection of the##2##4##(1990-2#1)(1994-11#1)
the inspection of##3##3##(1990-2#1)(1994-11#1)(2007-12#1)
the inspection##4##2##(1990-2#1)(1993-2#1)(1994-11#1)(2007-12#1)
the inspiratory##6##2##(1990-7#1)(1994-10#1)(1996-5#1)(1997-4#2)(2011-2#1)
the instabilities##3##2##(1990-10#1)(2007-12#1)(2008-3#1)
the instability of the##4##4##(1991-12#1)(2008-10#2)(2011-7#1)
the instability of##12##3##(1991-1#1)(1991-12#1)(1997-8#1)(2005-11#2)(2008-10#2)(2008-11#1)(2008-3#1)(2010-4#1)(2011-2#1)(2011-7#1)
the instability##19##2##(1991-1#1)(1991-12#1)(1996-4#1)(1997-8#1)(2005-11#2)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-4#1)(2011-2#1)(2011-7#1)(2012-3#1)
the installation of a##4##4##(1990-10#1)(2008-10#2)(2010-3#1)
the installation of##9##3##(1990-10#2)(1990-3#1)(1992-11#1)(1994-3#1)(2008-10#2)(2008-6#1)(2010-3#1)
the installation##13##2##(1990-10#2)(1990-3#1)(1992-11#2)(1994-3#2)(2006-8#1)(2008-10#2)(2008-4#1)(2008-6#1)(2010-3#1)
the instances##2##2##(2006-10#1)(2010-7#1)
the instant of exposure##3##4##(2008-2#3)
the instant##4##2##(2008-10#1)(2008-2#3)
the instantaneous##17##2##(1990-11#1)(1996-6#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#3)(2009-9#1)(2010-5#2)(2010-8#2)(2012-2#1)
the instigator of##2##3##(2005-10#1)(2009-6#1)
the instillation of 0##2##4##(2008-7#2)
the instillation##3##2##(1992-1#1)(2008-7#2)
the institute##7##2##(2004-11#1)(2007-11#1)(2007-9#2)(2008-5#1)(2009-10#1)(2011-2#1)
the institution and##4##3##(1992-12#1)(1994-1#1)(2011-2#1)(2012-11#1)
the institution in##3##3##(1991-3#1)(1993-12#1)(2012-2#1)
the institution of##8##3##(1996-12#1)(1997-2#1)(2006-10#1)(2008-7#1)(2010-3#1)(2011-2#3)
the institution to##2##3##(1993-1#1)(2012-12#1)
the institution##38##2##(1990-12#1)(1991-3#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-1#2)(1994-12#1)(1996-12#1)(1997-2#1)(2006-10#2)(2007-7#2)(2007-9#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#2)(2009-7#1)(2010-3#1)(2010-6#1)(2011-2#7)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)
the institution's##5##2##(1991-3#1)(1994-1#1)(1996-2#2)(1996-3#1)
the institutional review board##2##4##(2007-12#1)(2012-3#1)
the institutional setting##2##3##(2008-7#1)(2008-9#1)
the institutional##17##2##(1992-3#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-3#1)(2007-1#1)(2007-12#1)(2008-7#1)(2008-9#1)(2009-4#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
the institutionalization of##5##3##(2006-10#1)(2007-5#1)(2010-1#2)(2013-1#1)
the institutionalized elderly##2##3##(2008-7#1)(2011-2#1)
the institutions##6##2##(1992-2#1)(2009-2#1)(2010-1#1)(2012-12#1)(2012-3#2)
the instruction of##2##3##(2009-11#1)(2011-3#1)
the instruction to##2##3##(1993-8#1)(2012-2#1)
the instruction##9##2##(1993-8#1)(1996-1#1)(2006-2#1)(2007-3#1)(2008-11#1)(2008-2#1)(2009-11#1)(2011-3#1)(2012-2#1)
the instructions of##2##3##(2007-10#1)(2010-9#1)
the instructions##4##2##(2007-10#1)(2007-11#1)(2010-9#1)(2012-12#1)
the instructor##3##2##(1994-7#1)(2007-6#1)(2010-8#1)
the instrument and##7##3##(1994-3#1)(2006-10#1)(2006-6#1)(2008-10#2)(2008-3#2)
the instrument are##2##3##(2008-10#1)(2008-3#1)
the instrument at##2##3##(2008-3#1)(2008-9#1)
the instrument can##5##3##(2006-4#1)(2006-5#1)(2008-2#1)(2008-3#2)
the instrument design##3##3##(2008-2#1)(2008-3#1)(2010-4#1)
the instrument for##4##3##(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)
the instrument function##3##3##(2008-3#3)
the instrument has##2##3##(2004-9#1)(2008-2#1)
the instrument is##9##3##(2007-11#1)(2007-5#1)(2008-10#2)(2008-3#4)(2010-12#1)
the instrument of##2##3##(2009-4#1)(2009-9#1)
the instrument performance##2##3##(2008-3#2)
the instrument residual emission##3##4##(2008-2#3)
the instrument response##2##3##(2008-2#1)(2008-3#1)
the instrument tip##4##3##(2006-6#3)(2008-11#1)
the instrument to be##2##4##(2008-2#1)(2008-3#1)
the instrument to##5##3##(2008-2#2)(2008-3#2)(2011-1#1)
the instrument was developed##2##4##(2009-12#1)(2011-1#1)
the instrument was##5##3##(2007-8#1)(2008-10#1)(2008-11#1)(2009-12#1)(2011-1#1)
the instrument with##2##3##(2008-2#1)(2012-3#1)
the instrument##143##2##(1991-2#1)(1992-6#2)(1993-3#1)(1993-5#1)(1994-11#1)(1994-3#1)(1997-1#1)(2004-9#1)(2005-12#1)(2006-10#2)(2006-4#3)(2006-5#2)(2006-6#8)(2007-11#2)(2007-12#3)(2007-5#2)(2007-8#2)(2008-1#2)(2008-10#17)(2008-11#4)(2008-2#19)(2008-3#45)(2008-9#5)(2009-12#4)(2009-4#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-8#3)
the instrument's reliability##2##3##(2008-10#1)(2011-1#1)
the instrument's##11##2##(2007-11#1)(2008-10#1)(2008-3#7)(2008-6#1)(2011-1#1)
the instrumental colour##2##3##(2007-8#2)
the instrumental detection limit##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
the instrumental##24##2##(1991-3#1)(1991-8#1)(2006-5#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#11)(2008-3#5)(2011-2#1)
the instrumentation##7##2##(2006-5#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-4#1)
the instrumented##3##2##(2006-11#1)(2007-4#1)(2007-7#1)
the instruments and##3##3##(2004-2#1)(2006-6#2)
the instruments are##2##3##(2006-6#1)(2008-3#1)
the instruments have##3##3##(2007-5#1)(2008-2#1)(2008-3#1)
the instruments used##2##3##(2009-12#1)(2010-12#1)
the instruments##37##2##(1992-10#1)(1995-3#1)(1996-12#1)(2004-2#1)(2005-5#1)(2006-6#6)(2006-8#1)(2007-5#1)(2008-10#2)(2008-2#2)(2008-3#5)(2008-5#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-5#2)(2011-1#2)(2011-2#1)(2013-1#6)
the instruments'##3##2##(2005-4#1)(2008-2#1)(2008-3#1)
the insufficient##7##2##(1994-11#1)(2006-2#1)(2008-10#1)(2008-3#1)(2010-2#1)(2011-1#1)(2013-8#1)
the insufflation gas##3##3##(1992-12#2)(2006-6#1)
the insula##4##2##(1996-1#1)(2008-11#1)(2012-12#2)
the insular cortex##8##3##(1991-5#1)(1995-11#6)(2009-2#1)
the insular##10##2##(1991-5#1)(1995-11#6)(2007-10#1)(2009-2#1)(2010-3#1)
the insulator-metal transition in##2##4##(1991-6#1)(1993-6#1)
the insulin analogues##2##3##(2007-11#1)(2011-1#1)
the insulin and##3##3##(1992-8#1)(1996-10#1)(2010-11#1)
the insulin cells##2##3##(2010-11#2)
the insulin family##3##3##(2005-7#1)(2008-6#1)(2009-8#1)
the insulin gene##4##3##(1994-8#1)(2008-1#1)(2008-4#1)(2010-11#1)
the insulin molecule##2##3##(1994-12#2)
the insulin producing##3##3##(1994-8#1)(2010-11#2)
the insulin receptor (IR)##2##4##(1990-8#1)(1996-5#1)
the insulin receptor and##3##4##(1994-12#1)(1997-6#1)(2008-4#1)
the insulin receptor beta##2##4##(1996-10#1)(2008-4#1)
the insulin receptor by##2##4##(1990-8#1)(1991-12#1)
the insulin receptor gene##7##4##(1990-3#1)(1993-7#2)(1994-12#3)(2012-12#1)
the insulin receptor is##4##4##(1990-11#1)(1992-8#1)(1994-12#2)
the insulin receptor to##2##4##(1991-1#1)(1994-12#1)
the insulin receptor tyrosine kinase##5##5##(1990-4#2)(1991-5#1)(1995-11#1)(1995-3#1)
the insulin receptor##61##3##(1990-11#2)(1990-3#1)(1990-4#2)(1990-7#1)(1990-8#4)(1991-1#4)(1991-12#6)(1991-5#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-4#2)(1993-7#3)(1993-8#1)(1994-11#1)(1994-12#13)(1995-11#1)(1995-3#2)(1995-6#1)(1996-10#1)(1996-5#2)(1997-6#1)(2006-10#1)(2007-8#1)(2008-4#3)(2010-11#1)(2010-12#1)(2011-12#1)(2012-12#1)
the insulin resistance syndrome##2##4##(2008-1#1)(2008-3#1)
the insulin resistance##6##3##(1995-3#1)(2008-1#1)(2008-3#1)(2011-1#1)(2011-12#1)(2011-2#1)
the insulin resistant##2##3##(1994-3#1)(2008-1#1)
the insulin secretion##3##3##(2008-11#3)
the insulin secretory response to##2##5##(1990-12#1)(1997-4#1)
the insulin sensitive glucose transporter (GLUT4)##2##6##(1991-5#2)
the insulin sensitivity in##3##4##(2006-6#1)(2008-3#2)
the insulin sensitivity of##2##4##(2007-7#1)(2008-9#1)
the insulin sensitivity##6##3##(2006-6#1)(2007-7#1)(2008-3#3)(2008-9#1)
the insulin signaling pathway##5##4##(2008-1#1)(2008-11#2)(2010-12#2)
the insulin signaling##6##3##(2008-1#1)(2008-11#2)(2010-12#2)(2010-2#1)
the insulin##142##2##(1990-11#2)(1990-12#1)(1990-3#2)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#5)(1991-1#4)(1991-12#7)(1991-2#1)(1991-5#3)(1992-12#1)(1992-3#3)(1992-6#2)(1992-7#1)(1992-8#4)(1993-12#1)(1993-4#2)(1993-6#2)(1993-7#3)(1993-8#1)(1994-11#1)(1994-12#15)(1994-2#1)(1994-3#2)(1994-8#2)(1995-11#3)(1995-3#3)(1995-6#1)(1996-10#3)(1996-3#1)(1996-5#3)(1996-7#1)(1997-4#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-11#6)(2008-3#5)(2008-4#4)(2008-6#1)(2008-9#1)(2009-8#1)(2010-11#10)(2010-12#3)(2010-2#1)(2011-1#2)(2011-12#3)(2011-2#4)(2012-12#1)(2012-3#1)
the insulin-dependent##2##2##(1990-7#1)(1997-2#1)
the insulin-induced down-regulation of IRS-1 in 3T3-L1 adipocytes##4##8##(1995-8#3)(1996-8#1)
the insulin-induced down-regulation of IRS-1 in##5##6##(1995-8#3)(1996-8#2)
the insulin-induced##8##2##(1990-2#1)(1995-8#3)(1996-8#2)(1997-6#1)(2008-10#1)
the insulin-like effects of growth hormone in isolated##2##8##(1994-8#2)
the insulin-like growth factor I receptor##2##6##(1994-12#1)(1995-6#1)
the insulin-like growth factor##6##4##(1990-9#1)(1992-4#1)(1994-12#1)(1995-6#1)(1996-11#1)(2006-9#1)
the insulin-like growth factor-I##2##4##(1997-1#1)(2010-3#1)
the insulin-like growth##9##3##(1990-9#1)(1992-3#1)(1992-4#1)(1994-12#1)(1995-6#1)(1996-11#1)(1997-1#1)(2006-9#1)(2010-3#1)
the insulin-like##13##2##(1990-9#1)(1992-3#1)(1992-4#1)(1994-12#1)(1994-8#3)(1995-6#1)(1996-11#1)(1996-7#1)(1997-1#1)(2006-9#1)(2010-3#1)
the insulin-producing##2##2##(2008-1#1)(2011-2#1)
the insulin-related##2##2##(1995-8#1)(1996-6#1)
the insulin-secreting##3##2##(1997-4#2)(2008-1#1)
the insulin-sensitive##3##2##(1990-7#1)(1990-8#1)(2010-11#1)
the insulin-stimulated##5##2##(1995-11#1)(1995-3#1)(1995-6#1)(2008-11#1)(2008-9#1)
the insult##7##2##(1991-10#1)(1994-2#1)(1996-5#1)(2008-11#1)(2008-7#2)(2010-7#1)
the insurance and##2##3##(1997-8#1)(2008-11#1)
the insurance industry##4##3##(1993-12#1)(1993-9#1)(1997-3#1)(2008-7#1)
the insurance##17##2##(1991-12#1)(1992-1#1)(1992-3#1)(1993-12#3)(1993-3#1)(1993-9#1)(1994-1#1)(1995-1#1)(1997-3#2)(1997-5#1)(1997-8#1)(2008-11#1)(2008-7#1)(2012-12#1)
the int-1##3##2##(1990-8#3)
the intact and##5##3##(1996-1#1)(1996-12#1)(2006-10#1)(2008-5#1)(2010-4#1)
the intact animal##2##3##(1991-2#1)(2008-9#1)
the intact antibody##2##3##(1993-6#1)(1995-2#1)
the intact cell##4##3##(1991-10#1)(1993-4#1)(1994-10#1)(1994-11#1)
the intact cells##7##3##(1992-3#1)(1992-4#1)(1993-9#3)(1997-6#1)(2012-11#1)
the intact condition##2##3##(2007-7#2)
the intact enzyme##3##3##(1991-5#1)(1992-11#1)(2008-8#1)
the intact form##3##3##(1991-10#2)(1992-5#1)
the intact heart##3##3##(1997-4#3)
the intact hemisphere##2##3##(1993-9#1)(2008-11#1)
the intact molecule##3##3##(1992-5#1)(1992-6#1)(2008-10#1)
the intact murine##3##3##(2008-10#3)
the intact peptide##3##3##(1990-11#2)(1994-10#1)
the intact protein and##2##4##(1995-1#1)(2010-12#1)
the intact protein##7##3##(1991-7#1)(1994-5#1)(1995-1#2)(2006-10#1)(2008-12#1)(2010-12#1)
the intact receptor##2##3##(1992-4#1)(1995-3#1)
the intact side of the aged##2##6##(1996-2#2)
the intact side##4##3##(1993-4#1)(1996-2#3)
the intact state##2##3##(2008-8#2)
the intact wings##2##3##(2013-8#2)
the intact##144##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#2)(1990-7#2)(1990-8#1)(1991-10#3)(1991-12#1)(1991-2#3)(1991-3#3)(1991-5#2)(1991-7#3)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#3)(1992-7#3)(1992-8#2)(1993-4#2)(1993-5#1)(1993-6#1)(1993-9#4)(1994-10#2)(1994-11#1)(1994-12#3)(1994-2#3)(1994-5#1)(1994-8#1)(1995-1#4)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#2)(1996-1#2)(1996-12#1)(1996-2#4)(1996-5#2)(1996-8#1)(1996-9#2)(1997-4#5)(1997-6#3)(1997-7#1)(1997-8#2)(2005-11#1)(2006-10#2)(2006-3#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#4)(2009-9#1)(2010-12#1)(2010-4#1)(2011-12#1)(2012-11#1)(2013-1#2)(2013-8#3)
the intake of RS extract##3##5##(2008-11#3)
the intake of a particular##2##5##(2006-10#1)(2007-3#1)
the intake of a##3##4##(1993-12#1)(2006-10#1)(2007-3#1)
the intake of dietary##2##4##(2005-10#1)(2008-5#1)
the intake of saturated fatty acids##2##6##(1990-2#1)(1992-8#1)
the intake of saturated##3##4##(1990-2#1)(1992-8#1)(2005-10#1)
the intake of these##2##4##(2012-1#1)(2013-7#1)
the intake of vitamin D##2##5##(1995-4#1)(2013-7#1)
the intake of##37##3##(1990-2#1)(1991-2#1)(1991-5#3)(1992-8#1)(1993-12#1)(1994-12#1)(1995-4#1)(1996-1#1)(1996-12#1)(2005-10#2)(2006-10#2)(2007-3#1)(2007-8#2)(2008-1#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#2)
the intake was##2##3##(1990-4#1)(2011-2#1)
the intake##42##2##(1990-2#1)(1990-4#2)(1991-11#1)(1991-2#1)(1991-5#3)(1992-8#1)(1993-12#1)(1994-12#1)(1995-4#1)(1996-1#1)(1996-12#1)(2005-10#2)(2006-10#2)(2007-3#1)(2007-8#2)(2008-1#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-5#1)(2009-8#1)(2010-6#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#2)
the integer##5##2##(1990-7#2)(1994-5#1)(2008-2#1)(2010-9#1)
the integral enzyme##2##3##(1991-9#1)(2008-4#1)
the integral equation##2##3##(2005-11#1)(2008-2#1)
the integral membrane protein##2##4##(1993-11#1)(1997-6#1)
the integral membrane##3##3##(1993-11#1)(1997-6#2)
the integral of##2##3##(1994-6#1)(2008-7#1)
the integral relationship between##2##4##(2006-12#1)(2006-4#1)
the integral##29##2##(1991-9#3)(1993-11#1)(1993-3#1)(1994-6#1)(1994-9#1)(1997-6#2)(2005-11#1)(2005-4#1)(2006-12#1)(2006-4#1)(2006-5#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-7#1)(2009-9#1)(2011-2#2)(2012-1#1)(2012-12#1)
the integrase##7##2##(1992-6#1)(1994-9#1)(1995-8#1)(1997-3#2)(2007-12#1)(2008-1#1)
the integrated intensities of##2##4##(2007-11#2)
the integrated intensity of##2##4##(2008-3#1)(2008-9#1)
the integrated intensity##3##3##(2008-3#2)(2008-9#1)
the integrated organ##3##3##(2012-3#3)
the integrated platform##4##3##(2008-10#4)
the integrated stress response##2##4##(2008-4#1)(2012-2#1)
the integrated system##3##3##(2006-8#1)(2008-2#1)(2011-1#1)
the integrated##69##2##(1991-8#1)(1993-5#1)(1995-12#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2005-11#1)(2006-11#2)(2006-2#2)(2006-3#1)(2006-4#1)(2006-8#1)(2007-11#3)(2007-8#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#3)(2009-10#1)(2009-2#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#5)(2013-8#2)
the integration and##4##3##(2006-12#1)(2008-11#2)(2009-11#1)
the integration between##2##3##(1996-1#1)(2008-3#1)
the integration host factor (IHF)##2##5##(1995-2#2)
the integration is##2##3##(2007-11#1)(2008-3#1)
the integration of a##2##4##(1995-8#1)(1996-10#1)
the integration of clinical##2##4##(1996-2#1)(1997-3#1)
the integration of multiple##2##4##(2008-11#1)(2012-3#1)
the integration of organic##2##4##(2008-7#1)(2010-5#1)
the integration of signals##3##4##(2008-4#1)(2012-12#2)
the integration of the##22##4##(1990-9#1)(1993-6#1)(1994-9#1)(1996-2#1)(1997-3#2)(2005-11#1)(2006-12#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2011-1#1)(2012-3#1)(2013-8#1)
the integration of their##2##4##(1992-9#1)(2008-10#1)
the integration of these##2##4##(2008-7#1)(2009-6#1)
the integration of three##2##4##(2008-10#1)(2008-7#1)
the integration of##111##3##(1990-9#1)(1991-2#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-10#2)(1996-2#2)(1997-1#1)(1997-2#2)(1997-3#3)(2004-3#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#2)(2006-2#3)(2006-6#1)(2006-9#2)(2007-11#2)(2007-12#2)(2007-4#1)(2007-5#2)(2007-8#2)(2007-9#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#4)(2008-6#1)(2008-7#9)(2008-8#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#7)(2013-8#3)
the integration pattern##2##3##(2006-11#1)(2007-11#1)
the integration process##2##3##(1997-1#2)
the integration##137##2##(1990-9#2)(1991-2#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#3)(1995-8#1)(1996-1#1)(1996-10#2)(1996-2#2)(1997-1#3)(1997-2#2)(1997-3#3)(2004-3#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-2#3)(2006-6#1)(2006-9#2)(2007-11#5)(2007-12#3)(2007-4#1)(2007-5#2)(2007-8#2)(2007-9#1)(2008-10#9)(2008-11#5)(2008-2#2)(2008-3#10)(2008-4#4)(2008-6#1)(2008-7#10)(2008-8#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#2)(2010-5#1)(2011-1#2)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#7)(2013-8#3)
the integrative##7##2##(1990-11#1)(1992-2#1)(1994-2#1)(1994-3#1)(1996-1#1)(2012-2#1)(2013-8#1)
the integrin alpha##2##3##(1995-6#1)(1997-2#1)
the integrin##15##2##(1990-6#1)(1992-12#1)(1992-2#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-6#2)(1997-2#1)(2005-7#1)(2006-6#1)(2008-1#1)(2008-5#1)
the integrin-dependent##3##2##(1996-5#3)
the integrins##4##2##(1991-5#1)(1991-9#1)(1992-4#1)(2007-12#1)
the integrity and function of the##2##6##(1994-3#1)(1996-2#1)
the integrity and##6##3##(1994-3#1)(1996-2#1)(1997-4#1)(2007-12#1)(2008-4#1)(2010-12#1)
the integrity of 5-HT##2##4##(1993-3#1)(1995-5#1)
the integrity of lipid##2##4##(1997-5#1)(2012-12#1)
the integrity of the disulfide bond cysteine326-cysteine339##2##7##(1991-1#2)
the integrity of the genome##2##5##(2008-5#1)(2012-3#1)
the integrity of the peri-implant soft tissue##2##7##(2012-11#2)
the integrity of the##43##4##(1990-2#1)(1990-5#1)(1990-6#1)(1991-1#2)(1991-9#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-5#1)(1995-5#1)(1995-6#1)(1996-8#1)(1997-7#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2011-2#2)(2012-11#3)(2012-3#2)(2013-1#2)
the integrity of##73##3##(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#2)(1991-9#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1995-2#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-8#1)(1997-1#1)(1997-5#1)(1997-7#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#4)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#2)(2009-3#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-11#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
the integrity##79##2##(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#2)(1991-9#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1994-3#1)(1995-2#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#2)(2009-3#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-11#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
the integument of##2##3##(2007-12#1)(2008-4#1)
the integument##7##2##(1991-2#1)(2004-2#1)(2007-12#3)(2008-4#1)(2008-5#1)
the integumentary##2##2##(2006-12#1)(2007-12#1)
the intein##2##2##(2011-2#1)(2013-1#1)
the intellectual##6##2##(1993-12#1)(2006-7#1)(2011-2#2)(2012-2#2)
the intelligence quotient##2##3##(1992-8#1)(2013-1#1)
the intelligence##3##2##(1992-8#1)(2012-12#1)(2013-1#1)
the intelligentsia##4##2##(2008-12#4)
the intended use##2##3##(1997-1#1)(2010-6#1)
the intended##21##2##(1994-2#1)(1995-6#2)(1996-9#1)(1997-1#1)(1997-3#1)(2007-10#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-8#1)(2010-11#1)(2010-6#1)(2012-12#2)(2013-7#1)
the intense##12##2##(1991-3#1)(1993-12#1)(1994-11#1)(1996-4#1)(2005-11#1)(2005-8#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-7#1)(2012-1#1)
the intensely##2##2##(1990-2#1)(2008-10#1)
the intensification of##4##3##(1992-11#1)(1996-11#1)(2007-9#1)(2009-2#1)
the intensified##2##2##(2008-10#1)(2010-2#1)
the intensifying##2##2##(2008-10#1)(2010-12#1)
the intensities of the spectral line##2##6##(2013-8#2)
the intensities of the##10##4##(1992-7#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-8#2)(2013-8#2)
the intensities of##17##3##(1991-4#1)(1992-7#1)(1994-7#1)(1996-9#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-8#2)(2013-8#2)
the intensities##19##2##(1991-4#1)(1992-7#1)(1994-7#1)(1996-9#1)(2006-4#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#4)(2008-3#2)(2008-8#2)(2013-8#2)
the intensity and duration of##2##5##(1994-2#1)(2008-4#1)
the intensity and the phase of##6##6##(2007-11#1)(2007-12#5)
the intensity and the##11##4##(2007-11#1)(2007-12#6)(2008-10#1)(2008-2#2)(2008-9#1)
the intensity and unpleasantness of perceived dyspnea##2##7##(2008-10#2)
the intensity and unpleasantness of##3##5##(2008-10#2)(2008-5#1)
the intensity and##29##3##(1994-2#1)(2007-11#2)(2007-12#7)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#1)
the intensity at##6##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#2)
the intensity change of the##2##5##(2008-3#2)
the intensity correlation function##2##4##(2008-2#1)(2008-3#1)
the intensity distribution in##2##4##(2007-12#1)(2008-3#1)
the intensity distribution of the##6##5##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
the intensity distribution##16##3##(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#5)(2008-3#5)
the intensity in##2##3##(2008-2#1)(2008-3#1)
the intensity inside the##2##4##(2008-3#2)
the intensity noise##4##3##(2007-12#3)(2008-3#1)
the intensity noises of the amplified signal and##2##8##(2007-11#2)
the intensity noises of the##3##5##(2007-11#2)(2007-12#1)
the intensity of Fos-like##2##4##(1997-2#2)
the intensity of a##2##4##(2008-3#1)(2008-4#1)
the intensity of an##3##4##(1992-12#1)(2008-4#1)(2012-1#1)
the intensity of central pain##3##5##(2006-12#3)
the intensity of fluorescence##2##4##(1993-4#1)(2008-10#1)
the intensity of foraging##2##4##(2008-8#2)
the intensity of gp75LNGFRIR in the##2##6##(1994-2#2)
the intensity of herbivory##2##4##(1995-8#2)
the intensity of infection##3##4##(2007-2#2)(2011-1#1)
the intensity of light scattered##2##5##(1990-8#1)(2008-1#1)
the intensity of light##5##4##(1990-8#1)(2006-2#1)(2007-10#1)(2008-1#1)(2008-3#1)
the intensity of pain##2##4##(1995-12#1)(2006-12#1)
the intensity of prophylaxis##2##4##(2005-1#1)(2007-12#1)
the intensity of staining##3##4##(1992-8#1)(1997-6#1)(2008-5#1)
the intensity of the band##3##5##(2005-4#1)(2007-8#1)(2009-2#1)
the intensity of the contralateral stimulation##2##6##(1993-3#2)
the intensity of the incident light##2##6##(2008-1#1)(2008-3#1)
the intensity of the incident##3##5##(2008-1#1)(2008-3#2)
the intensity of the red colour of##2##7##(2006-12#2)
the intensity of the visual stimulus##2##6##(1992-11#2)
the intensity of the##69##4##(1990-7#1)(1991-3#1)(1991-4#1)(1992-11#2)(1992-4#1)(1992-9#1)(1993-11#1)(1993-3#2)(1994-7#1)(1995-12#1)(2005-4#1)(2006-12#3)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#6)(2008-3#10)(2008-5#3)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
the intensity of their##2##4##(1996-1#1)(1997-8#1)
the intensity of##181##3##(1990-10#1)(1990-12#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-4#1)(1994-2#5)(1994-6#1)(1994-7#1)(1995-12#4)(1995-8#3)(1996-1#1)(1996-5#1)(1997-2#3)(1997-3#2)(1997-6#1)(1997-8#1)(2005-1#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-12#7)(2006-2#2)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#7)(2007-12#8)(2007-2#3)(2007-8#1)(2008-1#5)(2008-10#18)(2008-11#5)(2008-12#1)(2008-2#10)(2008-3#14)(2008-4#3)(2008-5#8)(2008-6#1)(2008-8#3)(2008-9#4)(2009-10#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-1#3)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#2)(2013-8#4)
the intensity profile of the##4##5##(2007-11#1)(2008-2#2)(2008-3#1)
the intensity profile of##5##4##(2007-11#1)(2008-2#2)(2008-3#2)
the intensity profile##9##3##(2007-11#2)(2008-2#3)(2008-3#3)(2009-9#1)
the intensity profiles of##2##4##(2008-2#2)
the intensity profiles##3##3##(2006-5#1)(2008-2#2)
the intensity ratio of##2##4##(2008-1#1)(2008-10#1)
the intensity ratio##3##3##(2008-1#1)(2008-10#1)(2008-3#1)
the intensity spectrum##2##3##(2007-12#2)
the intensity variation of the light source##4##7##(2008-2#1)(2008-3#3)
the intensity variation##5##3##(2008-2#1)(2008-3#4)
the intensity variations##2##3##(2008-2#1)(2008-3#1)
the intensity was##2##3##(1993-7#1)(2008-10#1)
the intensity##319##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-7#1)(1994-2#6)(1994-6#1)(1994-7#1)(1995-12#5)(1995-8#3)(1996-1#1)(1996-5#1)(1997-2#3)(1997-3#2)(1997-6#1)(1997-8#1)(2005-1#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-12#7)(2006-2#3)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#19)(2007-12#35)(2007-2#3)(2007-8#2)(2008-1#8)(2008-10#27)(2008-11#6)(2008-12#1)(2008-2#40)(2008-3#50)(2008-4#4)(2008-5#9)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#5)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#4)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#2)(2013-8#5)
the intensity-modulated##2##2##(1995-5#1)(2008-3#1)
the intensive care environment##2##4##(1993-12#1)(2006-10#1)
the intensive care unit (ICU) is##4##6##(2007-8#1)(2010-11#2)(2011-2#1)
the intensive care unit (ICU)##14##5##(2005-8#2)(2006-5#1)(2007-8#2)(2008-3#1)(2009-6#1)(2010-11#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the intensive care unit after##2##5##(2006-4#2)
the intensive care unit and##3##5##(2006-10#2)(2006-12#1)
the intensive care unit for##3##5##(2006-4#1)(2009-6#1)(2010-12#1)
the intensive care unit of##3##5##(2009-3#1)(2010-11#1)(2013-1#1)
the intensive care unit##88##4##(1991-2#1)(1992-3#1)(1993-3#1)(1993-7#1)(1995-4#1)(1996-9#1)(1997-6#1)(2005-10#2)(2005-8#9)(2006-10#17)(2006-12#1)(2006-4#12)(2006-5#1)(2007-12#1)(2007-7#1)(2007-8#7)(2007-9#1)(2008-3#2)(2008-4#2)(2008-8#1)(2009-3#2)(2009-6#2)(2009-9#1)(2010-11#5)(2010-12#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
the intensive care##102##3##(1991-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-7#1)(1995-1#1)(1995-4#1)(1995-9#1)(1996-9#1)(1997-6#1)(2005-10#2)(2005-8#9)(2006-10#21)(2006-12#1)(2006-4#12)(2006-5#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#7)(2007-9#1)(2008-3#2)(2008-4#3)(2008-8#1)(2008-9#1)(2009-3#2)(2009-6#2)(2009-9#2)(2010-11#5)(2010-12#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
the intensive treatment##4##3##(2005-1#1)(2007-2#1)(2011-2#2)
the intensive##121##2##(1990-8#1)(1991-2#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-7#1)(1995-1#1)(1995-4#1)(1995-9#1)(1996-9#1)(1997-6#1)(2005-1#1)(2005-10#2)(2005-8#9)(2006-10#23)(2006-12#1)(2006-4#12)(2006-5#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#7)(2007-9#1)(2008-10#2)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#2)(2009-6#2)(2009-9#2)(2010-11#5)(2010-12#1)(2011-1#1)(2011-2#7)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#3)
the intensiveness of##2##3##(1991-12#2)
the intensivist##2##2##(2006-4#2)
the intent of the##3##4##(1994-2#1)(2007-4#1)(2009-4#1)
the intent of##10##3##(1994-1#1)(1994-2#1)(1994-3#1)(1996-12#1)(2007-4#1)(2008-12#1)(2008-8#1)(2009-4#1)(2010-5#1)(2012-12#1)
the intent##14##2##(1993-2#1)(1994-1#1)(1994-2#1)(1994-3#1)(1996-12#1)(2006-10#1)(2007-4#1)(2008-12#1)(2008-8#1)(2009-2#1)(2009-4#1)(2010-5#1)(2010-9#1)(2012-12#1)
the intent-to-treat##2##2##(2004-1#1)(2008-7#1)
the intention of##10##3##(1990-5#1)(1995-11#1)(1995-3#2)(2008-10#1)(2008-5#1)(2011-1#1)(2012-2#1)(2013-1#2)
the intention to##8##3##(1993-12#1)(2006-3#1)(2006-8#1)(2007-2#1)(2011-1#2)(2012-12#1)(2013-8#1)
the intention##22##2##(1990-5#1)(1993-12#2)(1995-11#1)(1995-3#2)(2006-3#2)(2006-8#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-5#1)(2011-1#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
the intention-to-treat##2##2##(2007-9#1)(2013-1#1)
the intentional stance##2##3##(2006-3#1)(2008-11#1)
the intentional##9##2##(2006-3#1)(2007-12#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-9#1)(2012-1#1)(2012-12#1)(2012-3#1)
the intentions of##3##3##(1994-3#1)(1995-3#1)(2007-4#1)
the intentions##5##2##(1994-3#1)(1995-3#1)(1996-4#1)(2007-4#1)(2010-2#1)
the inter##3##2##(2008-10#1)(2012-3#2)
the inter- and##2##3##(1996-8#1)(2013-7#1)
the inter-assay##3##2##(1990-6#1)(1991-3#1)(1997-8#1)
the inter-individual##2##2##(1992-2#1)(1994-4#1)
the inter-laboratory##2##2##(1996-6#1)(2008-10#1)
the inter-observer##2##2##(2005-10#1)(2007-7#1)
the inter-pulse interval between##2##4##(2006-5#2)
the inter-pulse interval##4##3##(2006-5#4)
the inter-species differences##2##3##(1997-8#1)(2011-3#1)
the inter-specific##2##2##(2008-5#1)(2012-5#1)
the inter-vertebral venous plexus##2##4##(2009-6#2)
the inter-war period##2##3##(2008-12#2)
the inter-war##3##2##(2008-12#3)
the interacting genes are##2##4##(2007-11#2)
the interacting nonlinear##2##3##(2007-12#1)(2008-1#1)
the interacting surfaces##2##3##(2005-11#1)(2013-1#1)
the interacting##24##2##(1996-8#1)(2005-11#3)(2007-11#4)(2007-12#3)(2008-1#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the interaction among##2##3##(2005-4#1)(2007-5#1)
the interaction and##4##3##(2006-2#1)(2008-3#1)(2008-4#1)(2008-8#1)
the interaction between Bcd molecules##2##5##(1996-8#2)
the interaction between DNA and oppositely charged mixed liposomes##2##9##(2006-10#2)
the interaction between DNA and##3##5##(1996-7#1)(2006-10#2)
the interaction between F##2##4##(2008-10#2)
the interaction between P##2##4##(2008-10#2)
the interaction between RIPs and##2##5##(2008-8#2)
the interaction between a##8##4##(1992-10#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2009-6#1)
the interaction between antibody##2##4##(2008-1#1)(2009-11#1)
the interaction between cell##2##4##(2008-4#1)(2009-5#1)
the interaction between crystalline metals and##2##6##(2010-7#2)
the interaction between hIL-6 and##2##5##(2008-8#2)
the interaction between proteins and##2##5##(1997-2#1)(2008-10#1)
the interaction between proteins##3##4##(1997-2#1)(2008-10#1)(2011-2#1)
the interaction between spheres##2##4##(2005-11#1)(2008-2#1)
the interaction between the drug##2##5##(2006-10#1)(2008-10#1)
the interaction between the nuclear##2##5##(1996-5#1)(2008-10#1)
the interaction between the two##3##5##(1997-6#1)(2008-10#1)(2012-3#1)
the interaction between the##44##4##(1991-3#1)(1993-3#1)(1994-12#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-6#2)(2005-11#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-4#2)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-7#1)(2010-7#1)(2010-8#1)(2012-2#2)(2012-3#1)
the interaction between these##2##4##(2008-11#1)(2013-1#1)
the interaction between two##3##4##(2008-10#2)(2008-2#1)
the interaction between##206##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-7#1)(1991-2#1)(1991-3#2)(1991-7#2)(1992-10#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-6#1)(1993-8#2)(1994-11#2)(1994-12#2)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-8#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-6#4)(1997-7#2)(2005-11#5)(2006-10#8)(2006-12#2)(2006-2#3)(2006-5#1)(2006-6#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#2)(2008-1#1)(2008-10#34)(2008-11#3)(2008-2#4)(2008-3#2)(2008-4#3)(2008-5#4)(2008-7#5)(2008-8#11)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#5)(2010-12#1)(2010-2#1)(2010-5#2)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#2)(2011-3#1)(2012-11#6)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)
the interaction can##3##3##(1994-3#1)(1997-7#1)(2008-1#1)
the interaction effects of##2##4##(2008-10#1)(2008-4#1)
the interaction effects##3##3##(2008-10#2)(2008-4#1)
the interaction energy##2##3##(2006-10#1)(2008-10#1)
the interaction free energy between##2##5##(2006-10#2)
the interaction free energy##3##4##(2006-10#3)
the interaction index##3##3##(2009-12#3)
the interaction is##8##3##(1994-5#1)(1995-3#1)(1996-10#1)(1997-7#1)(1997-8#1)(2008-10#2)(2010-9#1)
the interaction length of##2##4##(2007-12#1)(2008-3#1)
the interaction length##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
the interaction of G##2##4##(1995-6#1)(2008-9#1)
the interaction of P450scc with adrenodoxin##2##6##(1994-2#2)
the interaction of Ral with RalBP1##2##6##(1997-6#2)
the interaction of a##9##4##(1990-6#1)(1992-12#1)(2005-11#1)(2008-10#2)(2008-2#3)(2008-8#1)
the interaction of different##5##4##(1993-2#1)(1995-11#1)(2005-11#1)(2008-10#1)(2008-9#1)
the interaction of functionalized##2##4##(2008-10#1)(2008-12#1)
the interaction of human##2##4##(1992-2#1)(1994-3#1)
the interaction of known##2##4##(2008-11#1)(2008-7#1)
the interaction of ligands with##2##5##(1995-12#1)(2012-2#1)
the interaction of neutral red##2##5##(2008-10#2)
the interaction of protein kinase C##2##6##(1994-5#2)
the interaction of protein##4##4##(1994-5#2)(1995-6#1)(2008-10#1)
the interaction of proteins of##2##5##(1994-5#1)(2011-2#1)
the interaction of proteins##3##4##(1994-5#1)(2008-10#1)(2011-2#1)
the interaction of specific##2##4##(1995-2#1)(2008-4#1)
the interaction of the protein with##2##6##(1991-7#1)(1995-11#1)
the interaction of the two##3##5##(1991-2#1)(1994-9#1)(1995-1#1)
the interaction of the##40##4##(1991-2#1)(1991-5#1)(1991-7#1)(1992-12#1)(1993-11#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#2)(1996-2#1)(1996-8#1)(1997-6#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-6#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#1)(2009-4#1)
the interaction of these##9##4##(1990-10#1)(1990-2#1)(1992-1#1)(1997-2#1)(2004-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2011-1#1)
the interaction of this##2##4##(1991-1#1)(1994-2#1)
the interaction of two##4##4##(2006-10#1)(2008-10#2)(2008-8#1)
the interaction of##287##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#4)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#5)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#2)(1992-8#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#3)(1993-8#3)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#5)(1994-3#2)(1994-5#5)(1994-6#2)(1994-8#4)(1994-9#2)(1995-1#2)(1995-11#5)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#3)(1995-6#4)(1995-8#1)(1996-12#1)(1996-2#3)(1996-4#3)(1996-5#1)(1996-7#3)(1996-8#3)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#5)(1997-7#1)(1997-8#1)(2004-12#1)(2004-9#1)(2005-11#6)(2005-4#1)(2005-8#2)(2006-10#6)(2006-11#1)(2006-12#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-4#1)(2007-5#1)(2007-8#3)(2008-1#3)(2008-10#45)(2008-11#6)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#4)(2008-5#7)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#5)(2009-10#1)(2009-4#4)(2009-7#2)(2009-8#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#3)(2011-1#3)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#4)(2013-1#1)(2013-7#1)(2013-8#1)
the interaction was specific##2##4##(1996-5#2)
the interaction was that##2##4##(1997-2#2)
the interaction was##10##3##(1996-5#4)(1997-2#3)(1997-4#1)(2007-10#1)(2008-10#1)
the interaction with a##2##4##(1996-7#1)(2010-4#1)
the interaction with the guanine nucleotides##2##6##(1990-12#2)
the interaction with the##15##4##(1990-12#2)(1990-2#1)(1994-5#1)(1994-8#1)(1995-6#1)(1995-8#1)(2008-10#3)(2008-3#1)(2008-4#2)(2009-8#1)(2012-3#1)
the interaction with##46##3##(1990-12#2)(1990-2#2)(1990-4#1)(1990-8#1)(1991-1#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-5#2)(1994-8#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-5#2)(1996-7#1)(1996-9#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-4#4)(2008-5#1)(2009-8#2)(2010-12#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
the interaction##644##2##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#6)(1990-3#4)(1990-4#5)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#5)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#2)(1991-4#1)(1991-5#5)(1991-7#4)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#3)(1992-9#2)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#6)(1993-4#1)(1993-6#4)(1993-7#1)(1993-8#5)(1994-10#1)(1994-11#5)(1994-12#7)(1994-2#6)(1994-3#3)(1994-5#8)(1994-6#2)(1994-8#7)(1994-9#4)(1995-1#4)(1995-11#5)(1995-12#2)(1995-2#5)(1995-3#6)(1995-5#4)(1995-6#6)(1995-8#4)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#4)(1996-4#4)(1996-5#10)(1996-7#5)(1996-8#5)(1996-9#2)(1997-1#1)(1997-2#6)(1997-4#3)(1997-6#9)(1997-7#6)(1997-8#4)(2004-12#1)(2004-9#1)(2005-11#14)(2005-4#2)(2005-8#2)(2006-10#20)(2006-11#1)(2006-12#4)(2006-2#4)(2006-5#1)(2006-6#4)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#7)(2007-12#9)(2007-4#3)(2007-5#2)(2007-8#3)(2008-1#6)(2008-10#102)(2008-11#9)(2008-12#1)(2008-2#14)(2008-3#14)(2008-4#16)(2008-5#13)(2008-6#2)(2008-7#6)(2008-8#18)(2008-9#9)(2009-10#1)(2009-11#2)(2009-12#3)(2009-3#1)(2009-4#6)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#9)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-7#6)(2010-8#1)(2010-9#2)(2011-1#11)(2011-2#8)(2011-3#2)(2012-1#2)(2012-11#7)(2012-12#4)(2012-2#11)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#1)
the interactional##2##2##(2010-10#1)(2013-8#1)
the interactions among 2##2##4##(2008-10#2)
the interactions among##9##3##(1993-1#1)(2005-11#1)(2006-6#1)(2008-1#1)(2008-10#4)(2008-11#1)
the interactions and##3##3##(1995-3#1)(2008-5#1)(2012-1#1)
the interactions between a##2##4##(2005-11#1)(2006-10#1)
the interactions between different##2##4##(1996-6#1)(2008-7#1)
the interactions between genes##2##4##(2012-3#2)
the interactions between genetic and##2##5##(2008-3#1)(2009-3#1)
the interactions between genetic##3##4##(2008-3#2)(2009-3#1)
the interactions between the##13##4##(1992-1#1)(1992-7#1)(1994-9#1)(1995-1#2)(2007-4#1)(2008-10#2)(2008-5#1)(2008-8#1)(2012-12#1)(2012-6#1)(2013-8#1)
the interactions between##74##3##(1990-2#1)(1990-4#1)(1992-1#1)(1992-3#1)(1992-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-9#2)(1995-1#3)(1995-4#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-6#1)(2005-10#1)(2005-11#2)(2005-7#1)(2006-10#5)(2007-11#1)(2007-12#2)(2007-4#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#4)(2009-11#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2012-4#1)(2012-6#2)(2013-1#3)(2013-8#3)
the interactions in vitro##2##4##(2008-3#1)(2008-5#1)
the interactions in##5##3##(2006-10#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-5#1)
the interactions of several##2##4##(1991-4#1)(2008-3#1)
the interactions of the##13##4##(1990-8#1)(1993-6#1)(1993-8#1)(1995-1#1)(1995-7#1)(2006-5#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-9#1)(2010-4#1)
the interactions of these##4##4##(1996-3#1)(2008-4#1)(2012-3#1)(2013-1#1)
the interactions of##65##3##(1990-2#2)(1990-7#1)(1990-8#1)(1991-3#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1995-1#2)(1995-10#1)(1995-3#1)(1995-6#2)(1995-7#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-2#2)(1997-3#1)(2005-4#1)(2005-8#1)(2006-5#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-4#1)(2010-11#1)(2010-12#2)(2010-4#2)(2010-9#1)(2012-3#2)(2013-1#1)
the interactions that##3##3##(2006-10#1)(2009-4#1)(2011-2#1)
the interactions with the##2##4##(1992-6#1)(2011-1#1)
the interactions with##4##3##(1992-6#1)(2008-10#1)(2008-5#1)(2011-1#1)
the interactions within##2##3##(2008-7#1)(2012-3#1)
the interactions##186##2##(1990-2#3)(1990-4#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-3#2)(1992-6#2)(1992-7#1)(1993-1#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#3)(1994-11#2)(1994-8#1)(1994-9#2)(1995-1#5)(1995-10#1)(1995-3#2)(1995-4#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(2005-10#1)(2005-11#4)(2005-4#1)(2005-7#1)(2005-8#1)(2006-10#8)(2006-12#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#5)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#22)(2008-11#3)(2008-2#1)(2008-3#5)(2008-4#4)(2008-5#7)(2008-7#3)(2008-8#6)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-8#3)(2010-11#2)(2010-12#2)(2010-4#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#5)(2012-4#1)(2012-6#2)(2013-1#5)(2013-8#3)
the interactive effects of##2##4##(1993-7#1)(1996-8#1)
the interactive effects##3##3##(1993-7#1)(1996-8#1)(2012-12#1)
the interactive nature of the##3##5##(2007-8#1)(2010-11#2)
the interactive##15##2##(1992-2#2)(1993-7#1)(1996-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-6#1)(2010-11#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
the interassay##2##2##(1990-12#1)(1992-1#1)
the interatrial septum##2##3##(2008-11#1)(2009-5#1)
the interatrial##4##2##(2008-11#1)(2009-2#1)(2009-5#1)(2012-2#1)
the interautogamous interval (IAI)##2##4##(2008-12#2)
the interband##3##2##(2007-12#1)(2008-2#2)
the intercalary segment##2##3##(2007-12#2)
the intercalary##3##2##(2007-12#3)
the intercalated##8##2##(1994-5#1)(1995-10#1)(1996-7#1)(1997-7#1)(2008-10#3)(2010-4#1)
the intercalation of##4##3##(1993-8#2)(2008-10#1)(2009-6#1)
the intercalation site##3##3##(1994-8#1)(1997-8#2)
the intercalation##13##2##(1993-8#2)(1994-8#1)(1997-8#2)(2005-11#3)(2008-10#1)(2008-2#1)(2008-5#1)(2009-6#1)(2010-4#1)
the intercapillary distance##2##3##(1992-12#1)(1995-1#1)
the intercellular fluid##2##3##(2008-10#2)
the intercellular space of the##2##5##(2008-10#2)
the intercellular space##3##3##(2008-10#2)(2008-5#1)
the intercellular spaces of the##3##5##(2008-10#3)
the intercellular spaces##5##3##(2006-10#1)(2008-10#4)
the intercellular##21##2##(1993-8#1)(1994-11#1)(1995-1#1)(1996-11#1)(1996-5#1)(2006-10#1)(2008-10#10)(2008-5#2)(2008-7#3)
the intercept of##2##3##(2008-10#1)(2009-8#1)
the intercept##7##2##(2008-10#6)(2009-8#1)
the interchain##3##2##(1990-5#1)(1993-6#1)(1995-5#1)
the interchange##2##2##(1990-8#1)(2012-12#1)
the interchangeability of##2##3##(1990-12#1)(2013-1#1)
the interchangeability##3##2##(1990-12#1)(2011-1#1)(2013-1#1)
the intercistronic region##2##3##(1992-4#1)(1993-6#1)
the intercondylar##2##2##(2007-8#1)(2010-12#1)
the interconnect system##2##3##(2008-3#2)
the interconnect##3##2##(2008-3#3)
the interconnected##2##2##(2007-12#1)(2008-5#1)
the interconnection of##3##3##(1995-3#1)(2008-2#1)(2008-3#1)
the interconnection##6##2##(1995-3#1)(2008-2#3)(2008-3#2)
the interconnections##5##2##(1994-3#1)(2004-9#2)(2009-12#1)(2009-4#1)
the interconversion of##3##3##(1990-9#1)(1994-8#1)(2005-11#1)
the interconversion##5##2##(1990-9#1)(1994-8#1)(2005-11#1)(2008-10#2)
the intercorneocyte##2##2##(2008-5#2)
the intercorrelation##2##2##(2007-5#2)
the intercostal fields were##2##4##(2008-10#2)
the intercostal region##2##3##(2008-10#2)
the intercostal##7##2##(2006-1#1)(2006-8#1)(2008-10#4)(2011-2#1)
the interdependence between##3##3##(1992-3#1)(2009-8#2)
the interdependence of##3##3##(1992-12#1)(2008-2#1)(2009-9#1)
the interdependence##6##2##(1992-12#1)(1992-3#1)(2008-2#1)(2009-8#2)(2009-9#1)
the interdependency##2##2##(2008-4#1)(2010-8#1)
the interdialytic##5##2##(2007-7#1)(2008-1#4)
the interdigital spaces##2##3##(2010-3#2)
the interdigital##3##2##(2003-11#1)(2010-3#2)
the interdigitated##2##2##(2006-10#1)(2008-3#1)
the interdisciplinary team##2##3##(2008-10#1)(2010-3#1)
the interdisciplinary##5##2##(1991-12#1)(2008-10#1)(2010-3#2)(2010-8#1)
the interdomain linker##3##3##(1994-9#2)(2009-7#1)
the interdomain##6##2##(1992-11#1)(1993-2#1)(1994-9#3)(2009-7#1)
the interest and##2##3##(2008-7#1)(2009-5#1)
the interest has##2##3##(1994-8#1)(2008-8#1)
the interest in##11##3##(1992-1#1)(1992-6#1)(1995-2#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-12#1)
the interest is##2##3##(2007-9#1)(2010-2#1)
the interest of##12##3##(1991-4#1)(1993-2#1)(1994-1#2)(2005-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2010-9#1)
the interest##32##2##(1991-4#1)(1992-1#1)(1992-6#1)(1993-2#1)(1994-1#2)(1994-8#1)(1995-2#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-9#1)
the interesterification of##2##3##(2004-8#1)(2008-6#1)
the interesterification##3##2##(2004-8#1)(2008-6#2)
the interesting possibility##2##3##(1991-3#1)(1994-10#1)
the interesting##10##2##(1991-3#1)(1994-10#1)(1995-5#1)(1996-2#1)(1997-8#1)(2007-8#1)(2008-10#1)(2009-9#1)(2011-1#1)(2013-8#1)
the interests and##3##3##(1992-1#1)(2005-7#1)(2008-2#1)
the interests of patients and##3##5##(1994-2#1)(2005-7#1)(2007-4#1)
the interests of##16##3##(1992-3#2)(1993-5#1)(1994-2#1)(2005-7#1)(2006-2#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the interests##20##2##(1992-1#1)(1992-3#2)(1993-5#1)(1994-2#1)(2005-7#3)(2006-2#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the interface Delta G##2##4##(2005-11#2)
the interface and##3##3##(1996-7#1)(2005-11#1)(2010-5#1)
the interface between the##15##4##(1994-11#1)(1994-9#1)(1995-2#1)(2004-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)
the interface between two##5##4##(2007-12#1)(2008-10#2)(2008-3#1)(2010-7#1)
the interface between##41##3##(1990-7#1)(1991-2#1)(1992-2#1)(1994-11#1)(1994-9#1)(1995-2#1)(1996-8#1)(1997-3#1)(2004-12#1)(2004-9#1)(2006-10#1)(2007-11#1)(2007-12#3)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#5)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-7#3)
the interface design##2##3##(2012-12#2)
the interface in##3##3##(1995-8#1)(2005-11#1)(2008-10#1)
the interface is##7##3##(1993-6#2)(2007-12#2)(2007-8#1)(2008-3#1)(2012-2#1)
the interface of the##9##4##(1991-12#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-8#1)(2012-3#1)
the interface of##24##3##(1990-4#1)(1991-12#1)(1992-12#1)(2006-12#1)(2007-12#1)(2008-10#6)(2008-3#3)(2008-4#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-4#1)(2012-3#1)(2013-7#1)
the interface shape##2##3##(2005-11#1)(2007-12#1)
the interface the##2##3##(2005-11#1)(2010-8#1)
the interface was##4##3##(2005-11#2)(2008-10#1)(2010-5#1)
the interface with##3##3##(2004-7#1)(2008-4#1)(2009-6#1)
the interface##149##2##(1990-4#1)(1990-7#1)(1991-12#1)(1991-2#2)(1992-12#2)(1992-2#1)(1992-7#1)(1993-11#1)(1993-6#2)(1994-11#2)(1994-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#2)(1996-7#1)(1996-8#1)(1997-3#1)(2004-12#3)(2004-7#1)(2004-9#1)(2005-11#23)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#2)(2007-12#10)(2007-8#7)(2008-10#16)(2008-11#2)(2008-2#4)(2008-3#11)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#2)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#6)(2010-7#3)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
the interface)##2##2##(2008-3#1)(2012-1#1)
the interfaces of##2##3##(2005-11#1)(2007-11#1)
the interfaces##12##2##(1991-5#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-3#6)(2008-7#2)
the interfacial ac potential##2##4##(2006-12#2)
the interfacial adhesion##3##3##(2005-11#1)(2009-7#2)
the interfacial and##3##3##(2006-10#1)(2008-10#2)
the interfacial area##2##3##(1994-3#1)(2005-11#1)
the interfacial pressure##2##3##(1994-9#1)(2008-10#1)
the interfacial properties of surface-active samples##2##6##(2008-10#2)
the interfacial properties of##3##4##(2008-10#3)
the interfacial properties##5##3##(1990-2#1)(2006-7#1)(2008-10#3)
the interfacial reaction between TiO2 and Al##2##7##(2010-4#2)
the interfacial region##4##3##(2006-10#2)(2008-7#1)(2010-4#1)
the interfacial strength between##2##4##(1997-4#1)(2005-11#1)
the interfacial strength##4##3##(1997-4#1)(2005-11#2)(2006-7#1)
the interfacial substrate##2##3##(1993-6#1)(1995-10#1)
the interfacial tension between the##2##5##(2004-12#1)(2005-11#1)
the interfacial tension between##5##4##(2004-12#2)(2005-11#3)
the interfacial tension##13##3##(1990-3#1)(2004-12#3)(2005-11#7)(2008-10#1)(2008-3#1)
the interfacial##60##2##(1990-2#1)(1990-3#1)(1993-6#2)(1994-3#1)(1994-9#1)(1995-10#1)(1995-8#1)(1997-4#1)(2004-12#3)(2005-11#18)(2006-10#3)(2006-12#2)(2006-7#2)(2007-8#2)(2008-10#10)(2008-2#1)(2008-3#1)(2008-7#1)(2009-5#1)(2009-7#3)(2010-4#3)(2013-1#1)
the interference between the##5##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
the interference between##7##3##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#2)
the interference but##2##3##(2008-10#1)(2008-5#1)
the interference by##5##3##(1996-7#1)(2006-5#1)(2008-10#3)
the interference caused by##2##4##(2008-10#2)
the interference condition of the Stroop Test##2##7##(2006-4#2)
the interference effect of##3##4##(2008-10#3)
the interference effect##4##3##(2007-12#1)(2008-10#3)
the interference effects of##2##4##(2006-10#1)(2008-10#1)
the interference effects##5##3##(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#2)
the interference fringe pattern##2##4##(2008-2#2)
the interference fringe##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
the interference fringes##9##3##(2006-4#1)(2007-12#1)(2008-2#2)(2008-3#4)(2013-8#1)
the interference from other##2##4##(2008-10#2)
the interference from##11##3##(1995-4#1)(1996-6#1)(2008-10#8)(2008-3#1)
the interference is##2##3##(2008-10#1)(2008-2#1)
the interference of an##2##4##(2007-12#1)(2008-10#1)
the interference of ascorbic acid##2##5##(2008-10#2)
the interference of both##2##4##(2008-10#2)
the interference of other##4##4##(2007-8#1)(2008-10#2)(2008-6#1)
the interference of the##11##4##(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2013-1#1)(2013-8#1)
the interference of these##2##4##(2008-10#1)(2008-3#1)
the interference of two##8##4##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#2)
the interference of##62##3##(1995-12#1)(2005-4#1)(2007-11#3)(2007-12#7)(2007-8#1)(2008-1#1)(2008-10#28)(2008-2#7)(2008-3#6)(2008-5#2)(2008-6#1)(2009-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
the interference pattern in##2##4##(2008-1#1)(2008-3#1)
the interference pattern of##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
the interference pattern##17##3##(2007-11#1)(2007-12#2)(2008-1#3)(2008-2#3)(2008-3#8)
the interference patterns##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
the interference signal##5##3##(2007-11#1)(2008-2#2)(2008-3#2)
the interference##168##2##(1995-1#1)(1995-12#1)(1995-4#1)(1996-6#1)(1996-7#1)(2005-4#2)(2006-10#1)(2006-4#3)(2006-5#2)(2007-11#9)(2007-12#19)(2007-8#1)(2008-1#5)(2008-10#51)(2008-2#26)(2008-3#29)(2008-5#4)(2008-6#1)(2008-9#1)(2009-12#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#5)
the interferences caused by##4##4##(2008-10#4)
the interferences from##5##3##(2008-10#5)
the interferences in the##2##4##(2008-10#1)(2013-1#1)
the interferences of##2##3##(2008-10#2)
the interferences##22##2##(1990-12#1)(1990-6#1)(2008-10#16)(2011-1#2)(2013-1#2)
the interfering##8##2##(1995-3#1)(2007-8#1)(2008-10#5)(2013-1#1)
the interferogram segments##2##3##(2006-12#2)
the interferogram##19##2##(2006-12#3)(2007-11#1)(2008-2#7)(2008-3#8)
the interferograms##7##2##(2008-2#4)(2008-3#3)
the interferometer are##5##3##(2007-11#1)(2007-12#1)(2008-2#3)
the interferometer data##2##3##(2008-3#2)
the interferometer is##11##3##(2007-12#1)(2008-2#3)(2008-3#7)
the interferometer##64##2##(2007-11#7)(2007-12#13)(2008-1#2)(2008-2#20)(2008-3#22)
the interferometric method##2##3##(2007-12#1)(2008-3#1)
the interferometric monitor for greenhouse gases##3##6##(2008-2#1)(2008-3#2)
the interferometric signal##5##3##(2007-12#2)(2008-3#3)
the interferometric##15##2##(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#8)
the interferometry##4##2##(2008-2#3)(2008-3#1)
the interferon##6##2##(1992-11#1)(1992-6#1)(1997-1#1)(2007-11#1)(2009-5#1)(2011-2#1)
the interferon-gamma receptor##4##3##(1995-3#2)(1996-5#2)
the interferon-inducible##3##2##(1996-10#2)(2007-1#1)
the interferons and##2##3##(1996-2#1)(2007-11#1)
the interferons##3##2##(1996-2#1)(2007-11#2)
the interfragmentary contact##2##3##(2013-1#2)
the intergenerational transmission of implicit##2##5##(2010-2#2)
the intergenerational transmission of##4##4##(2009-7#1)(2010-2#3)
the intergenerational##7##2##(2009-10#2)(2009-7#1)(2010-10#1)(2010-2#3)
the intergenic region between##2##4##(1996-10#1)(2008-10#1)
the intergenic region##9##3##(1994-11#1)(1996-10#2)(2006-5#1)(2008-10#5)
the intergenic spacer (IGS) of the##2##6##(2008-10#2)
the intergenic spacer (IGS) region of##2##6##(2008-10#2)
the intergenic spacer (IGS)##4##4##(2008-10#4)
the intergenic spacer##8##3##(1991-12#1)(2008-10#6)(2008-5#1)
the intergenic##21##2##(1991-12#1)(1994-11#1)(1996-10#2)(2006-5#1)(2008-10#13)(2008-5#2)(2012-2#1)
the interhelix##2##2##(1993-8#1)(1994-6#1)
the interhyoid muscle##6##3##(2011-2#6)
the interhyoid##7##2##(2011-2#7)
the interictal##3##2##(1995-12#2)(1996-1#1)
the interim and final analyses##2##5##(1996-8#2)
the interim##9##2##(1993-3#1)(1996-8#2)(2007-8#1)(2008-11#3)(2012-2#2)
the interindividual variability##2##3##(1996-9#1)(2008-8#1)
the interindividual variation in##2##4##(1990-4#1)(2010-10#1)
the interindividual##4##2##(1990-4#1)(1996-9#1)(2008-8#1)(2010-10#1)
the interior and##2##3##(2008-9#1)(2013-7#1)
the interior of fragments##3##4##(2013-7#3)
the interior of the cell##2##5##(1991-1#1)(2008-7#1)
the interior of the##16##4##(1991-1#1)(1994-9#1)(2004-4#1)(2005-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-10#1)(2013-1#1)
the interior of##29##3##(1991-1#1)(1991-9#1)(1993-11#1)(1994-11#1)(1994-9#1)(2004-4#1)(2005-10#1)(2006-10#1)(2007-11#3)(2007-12#1)(2007-3#2)(2007-8#1)(2008-10#3)(2008-6#1)(2008-7#1)(2009-7#1)(2010-10#1)(2010-5#1)(2010-6#1)(2012-12#1)(2013-1#1)(2013-7#3)
the interior surface##2##3##(1990-12#1)(2008-10#1)
the interior##54##2##(1990-12#1)(1991-1#1)(1991-11#1)(1991-9#1)(1992-3#1)(1993-11#1)(1994-11#1)(1994-9#1)(1995-11#3)(1996-4#1)(1996-5#1)(1997-4#1)(1997-6#1)(2004-4#1)(2005-10#1)(2006-10#1)(2007-11#3)(2007-12#1)(2007-3#2)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-7#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-6#1)(2012-12#1)(2013-1#1)(2013-7#5)
the interlaboratory study##3##3##(2008-10#1)(2008-5#2)
the interlacing##3##2##(2006-3#1)(2008-2#2)
the interlamellar##2##2##(1997-7#2)
the interlayer space##3##3##(2005-11#3)
the interlayer##10##2##(1991-5#1)(1996-2#1)(1997-7#1)(2005-11#4)(2008-2#1)(2008-6#1)(2010-12#1)
the interleaved##2##2##(2009-9#2)
the interleukin##8##2##(1994-3#1)(1995-3#1)(1995-8#2)(1996-5#3)(2008-11#1)
the interleukin-1 receptor##2##3##(1994-2#2)
the interleukin-1##4##2##(1994-2#2)(1997-5#1)(2013-1#1)
the interleukin-2##5##2##(1990-5#1)(1991-9#1)(1992-5#1)(1997-5#1)(2007-11#1)
the interleukin-6##4##2##(1994-5#1)(1995-3#2)(1996-9#1)
the intermediary##5##2##(1991-1#2)(1991-11#1)(2008-10#2)
the intermediate and##12##3##(1990-9#1)(1993-5#1)(1995-12#1)(1997-4#1)(1997-5#1)(2006-4#1)(2007-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2012-1#1)(2013-7#1)
the intermediate cells were significantly increased##2##6##(1996-3#2)
the intermediate cladding##2##3##(2008-3#2)
the intermediate dose##2##3##(1996-5#1)(2012-11#1)
the intermediate filament##6##3##(1991-3#2)(1991-8#2)(1996-4#1)(2012-2#1)
the intermediate filaments##2##3##(2009-10#1)(2009-8#1)
the intermediate host##3##3##(2006-10#1)(2007-9#1)(2008-8#1)
the intermediate is##2##3##(1991-7#1)(2009-8#1)
the intermediate lobe of the pituitary##2##6##(1993-5#1)(2008-5#1)
the intermediate lobe of the##4##5##(1991-9#1)(1993-5#2)(2008-5#1)
the intermediate lobe##5##3##(1991-9#1)(1992-12#1)(1993-5#2)(2008-5#1)
the intermediate mNTS##2##3##(1995-11#2)
the intermediate pituitary of the toad##2##6##(1993-5#2)
the intermediate precision##2##3##(2008-10#2)
the intermediate region##2##3##(2005-11#1)(2010-8#1)
the intermediate species##2##3##(1991-4#1)(2008-8#1)
the intermediate state##4##3##(1994-8#1)(1995-5#2)(1997-4#1)
the intermediate steps of##2##4##(2008-3#1)(2010-3#1)
the intermediate subnucleus##2##3##(2009-2#2)
the intermediate was converted to##2##5##(1994-6#1)(2009-9#1)
the intermediate##116##2##(1990-8#2)(1990-9#1)(1991-3#2)(1991-4#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#2)(1992-9#2)(1993-12#1)(1993-5#5)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#2)(1994-8#1)(1995-10#1)(1995-11#5)(1995-12#1)(1995-3#2)(1995-5#3)(1996-11#2)(1996-3#2)(1996-4#1)(1996-5#3)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-4#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-9#2)(2008-10#4)(2008-11#1)(2008-2#5)(2008-3#7)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#1)(2010-3#1)(2010-8#1)(2011-12#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
the intermediates in##2##3##(1990-8#1)(2008-10#1)
the intermediates of##4##3##(1992-4#2)(1997-4#2)
the intermediates##21##2##(1990-8#2)(1991-7#2)(1992-4#2)(1994-12#1)(1994-8#2)(1995-3#1)(1995-4#2)(1997-4#4)(2005-7#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-5#1)
the intermediolateral cell column (IML)##2##5##(1995-12#2)
the intermediolateral cell column##5##4##(1991-3#1)(1991-6#1)(1995-12#2)(1995-7#1)
the intermediolateral cell##6##3##(1991-3#1)(1991-6#1)(1993-9#1)(1995-12#2)(1995-7#1)
the intermediolateral##9##2##(1991-3#2)(1991-6#1)(1993-12#1)(1993-9#1)(1995-12#2)(1995-7#1)(1997-8#1)
the intermembrane distance##2##3##(2006-10#1)(2013-8#1)
the intermembrane##4##2##(1990-4#1)(1994-12#1)(2006-10#1)(2013-8#1)
the intermetallic##2##2##(2006-6#1)(2008-10#1)
the intermittent##7##2##(1996-12#1)(2006-12#1)(2007-12#1)(2007-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
the intermolecular alignment##2##3##(2008-10#2)
the intermolecular interactions between the##2##5##(2005-11#1)(2007-11#1)
the intermolecular interactions of##2##4##(1991-2#1)(2005-11#1)
the intermolecular interactions##6##3##(1991-2#1)(2005-11#2)(2007-11#1)(2010-4#2)
the intermolecular##13##2##(1991-2#1)(2005-11#2)(2006-12#1)(2007-11#1)(2008-10#4)(2008-4#1)(2010-4#2)(2011-1#1)
the intermolt##2##2##(2007-5#1)(2008-5#1)
the internal Ca2+ concentration##2##4##(1990-7#2)
the internal aldimine bond##2##4##(1992-6#2)
the internal aldimine##5##3##(1992-6#2)(1996-8#3)
the internal and external##3##4##(1994-3#1)(2008-1#1)(2012-3#1)
the internal and##5##3##(1994-3#1)(1994-9#1)(2008-1#2)(2012-3#1)
the internal auditory canal##4##4##(2006-12#1)(2008-7#2)(2008-9#1)
the internal auditory##5##3##(2006-11#1)(2006-12#1)(2008-7#2)(2008-9#1)
the internal bladder##2##3##(2008-10#2)
the internal calcium##2##3##(1996-3#2)
the internal capsule or##2##4##(1991-5#1)(2008-7#1)
the internal capsule##6##3##(1991-5#2)(1996-12#1)(1996-5#1)(2008-7#1)(2013-7#1)
the internal carotid and##3##4##(2005-10#1)(2006-11#1)(2011-1#1)
the internal carotid artery (ICA)##7##5##(2005-5#1)(2006-12#2)(2007-10#1)(2007-9#3)
the internal carotid artery and##3##5##(2006-11#1)(2006-12#1)(2007-9#1)
the internal carotid artery in##4##5##(1995-12#1)(2006-12#1)(2007-10#1)(2008-7#1)
the internal carotid artery was##3##5##(2006-1#1)(2007-10#1)(2008-7#1)
the internal carotid artery##39##4##(1995-12#1)(1997-3#1)(2005-5#1)(2006-1#2)(2006-11#3)(2006-12#6)(2006-4#4)(2007-10#3)(2007-9#6)(2008-7#6)(2009-2#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#1)
the internal carotid##48##3##(1995-12#1)(1997-3#1)(1997-8#1)(2005-10#2)(2005-5#1)(2006-1#2)(2006-11#4)(2006-12#7)(2006-4#4)(2007-10#3)(2007-9#8)(2008-7#6)(2009-2#1)(2010-12#1)(2011-1#3)(2011-2#2)(2012-3#1)
the internal consistency and##2##4##(2008-10#1)(2012-12#1)
the internal consistency##5##3##(2007-12#1)(2008-10#1)(2010-2#1)(2011-1#1)(2012-12#1)
the internal conversion##2##3##(2006-5#1)(2007-9#1)
the internal energy##3##3##(1993-4#1)(1994-11#1)(2006-4#1)
the internal features of human##2##5##(2013-1#2)
the internal features##3##3##(2008-1#1)(2013-1#2)
the internal field##5##3##(2008-2#4)(2008-3#1)
the internal fixation##2##3##(2007-11#1)(2010-5#1)
the internal inguinal##2##3##(2006-2#1)(2011-2#1)
the internal intensity##2##3##(2007-12#1)(2008-3#1)
the internal jugular or subclavian veins##2##6##(2007-7#2)
the internal jugular vein (IJV)##2##5##(2007-7#2)
the internal jugular vein##10##4##(1992-12#2)(2007-7#7)(2008-9#1)
the internal jugular##15##3##(1992-12#2)(2007-7#9)(2008-9#1)(2012-3#3)
the internal light##2##3##(2008-10#1)(2008-3#1)
the internal loss of##2##4##(2007-11#1)(2007-12#1)
the internal mammary artery##3##4##(2005-12#1)(2006-9#1)(2007-8#1)
the internal mammary##5##3##(1990-4#1)(2005-12#1)(2006-9#1)(2007-8#1)(2013-1#1)
the internal medicine##2##3##(2006-1#1)(2009-10#1)
the internal milieu##4##3##(1990-10#1)(1990-2#1)(2006-5#1)(2009-2#1)
the internal organs##3##3##(1997-8#1)(2006-11#1)(2012-3#1)
the internal osteosynthesis##2##3##(2007-11#2)
the internal pH##4##3##(1990-12#2)(1990-3#1)(1991-9#1)
the internal pallidum##2##3##(1991-5#1)(1994-2#1)
the internal partitioning##2##3##(1991-3#2)
the internal phloem##2##3##(2008-10#2)
the internal rate of return##2##5##(1992-12#1)(2007-4#1)
the internal reflection##3##3##(2008-10#1)(2008-2#2)
the internal region##3##3##(1992-4#1)(1994-9#2)
the internal rotation##2##3##(2009-3#1)(2010-12#1)
the internal rotator##2##3##(2009-9#1)(2012-1#1)
the internal segment of the globus pallidus (GPi)##2##8##(1994-2#1)(2012-2#1)
the internal segment##3##3##(1994-2#1)(2006-5#1)(2012-2#1)
the internal sequence##2##3##(1995-12#1)(2012-3#1)
the internal standard method##4##4##(1993-3#1)(2007-8#1)(2008-10#2)
the internal standard were extracted from##2##6##(1992-2#1)(2008-10#1)
the internal standard were##5##4##(1990-12#1)(1992-2#1)(1996-5#1)(1997-8#1)(2008-10#1)
the internal standard##50##3##(1990-12#3)(1990-6#2)(1990-9#1)(1992-11#1)(1992-2#3)(1993-2#2)(1993-3#1)(1996-5#1)(1996-6#2)(1996-8#2)(1997-3#8)(1997-8#3)(2004-12#1)(2005-12#2)(2007-8#4)(2008-1#1)(2008-10#11)(2008-6#1)(2008-9#1)
the internal structure of the##5##5##(1991-2#1)(1996-5#1)(2008-2#2)(2009-12#1)
the internal structure of##6##4##(1991-2#1)(1996-5#1)(2008-2#3)(2009-12#1)
the internal structure##10##3##(1991-2#1)(1996-5#1)(2008-2#4)(2008-3#2)(2009-12#1)(2013-8#1)
the internal structures of##2##4##(1995-6#1)(2010-8#1)
the internal surface of##3##4##(1994-3#1)(2008-5#1)(2008-8#1)
the internal surface##4##3##(1994-3#1)(2008-5#1)(2008-8#1)(2012-12#1)
the internal surfaces##3##3##(1990-8#1)(2009-2#1)(2012-12#1)
the internal thoracic artery##2##4##(2006-10#1)(2007-8#1)
the internal thoracic##3##3##(2006-10#1)(2007-4#1)(2007-8#1)
the internal transcribed spacer (ITS) and##2##6##(2008-10#1)(2010-10#1)
the internal transcribed spacer (ITS) region##9##6##(2008-10#8)(2008-5#1)
the internal transcribed spacer (ITS) regions of##3##7##(2008-10#3)
the internal transcribed spacer (ITS) regions##5##6##(2008-10#5)
the internal transcribed spacer (ITS)##19##5##(2008-10#17)(2008-5#1)(2010-10#1)
the internal transcribed spacer (ITS)-1##2##5##(2008-10#2)
the internal transcribed spacer 1 region of##2##7##(2008-10#2)
the internal transcribed spacer 1 region##3##6##(2008-10#3)
the internal transcribed spacer 1##5##5##(2008-10#5)
the internal transcribed spacer region of the##2##7##(2008-10#2)
the internal transcribed spacer region of##3##6##(2008-10#3)
the internal transcribed spacer region##7##5##(2008-10#7)
the internal transcribed spacer##42##4##(2007-3#1)(2008-10#39)(2008-5#1)(2010-10#1)
the internal transcribed##44##3##(2007-3#1)(2008-10#40)(2008-5#1)(2009-2#1)(2010-10#1)
the internal vertebral venous plexus##3##5##(2011-2#3)
the internal##412##2##(1990-10#1)(1990-11#1)(1990-12#8)(1990-2#1)(1990-3#4)(1990-4#1)(1990-6#3)(1990-7#2)(1990-8#1)(1990-9#4)(1991-12#1)(1991-2#3)(1991-3#3)(1991-5#4)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#1)(1992-4#2)(1992-6#2)(1993-10#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-2#3)(1994-3#2)(1994-9#3)(1995-12#2)(1995-5#3)(1995-6#1)(1995-8#4)(1996-12#1)(1996-3#2)(1996-5#5)(1996-6#2)(1996-8#7)(1996-9#1)(1997-3#10)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#5)(2004-12#2)(2005-10#3)(2005-11#1)(2005-12#4)(2005-3#1)(2005-5#1)(2006-1#3)(2006-10#3)(2006-11#6)(2006-12#9)(2006-2#1)(2006-3#1)(2006-4#5)(2006-5#4)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#4)(2007-12#11)(2007-3#1)(2007-4#3)(2007-7#13)(2007-8#7)(2007-9#10)(2008-1#5)(2008-10#70)(2008-11#3)(2008-12#2)(2008-2#14)(2008-3#7)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#11)(2008-8#2)(2008-9#5)(2009-10#3)(2009-12#1)(2009-2#4)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#7)(2011-12#1)(2011-2#9)(2012-1#3)(2012-12#4)(2012-2#5)(2012-3#8)(2013-1#3)(2013-7#1)(2013-8#2)
the internalization and##2##3##(1994-6#1)(1995-11#1)
the internalization of sociocultural attitudes##2##5##(2007-12#2)
the internalization of##12##3##(1993-5#1)(1994-8#1)(1997-1#1)(2007-12#3)(2007-9#1)(2008-11#3)(2011-2#1)(2012-1#1)
the internalization##18##2##(1990-11#1)(1993-5#1)(1994-6#1)(1994-8#3)(1995-11#1)(1997-1#1)(1997-7#1)(2007-12#3)(2007-9#1)(2008-11#3)(2011-2#1)(2012-1#1)
the internalized##2##2##(1990-11#1)(1994-6#1)
the international AIDS##2##3##(1990-10#1)(2013-1#1)
the international community and##2##4##(2008-1#1)(2012-11#1)
the international community##7##3##(1992-5#1)(1995-9#1)(2005-5#1)(2006-10#1)(2008-1#1)(2012-11#1)(2013-1#1)
the international level##4##3##(2005-4#1)(2007-10#2)(2008-12#1)
the international literature and##2##4##(2008-10#1)(2008-5#1)
the international literature##12##3##(1991-11#1)(1991-9#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-1#1)(2011-3#1)
the international standards##2##3##(2008-1#1)(2011-1#1)
the international##84##2##(1990-10#1)(1990-12#1)(1991-11#1)(1991-3#1)(1991-9#2)(1992-5#2)(1992-8#1)(1993-1#1)(1993-2#1)(1994-3#1)(1994-8#1)(1995-9#1)(1996-3#1)(1997-7#2)(1997-8#1)(2005-11#1)(2005-4#1)(2005-5#4)(2006-1#1)(2006-10#3)(2006-11#1)(2006-9#2)(2007-10#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-6#1)(2011-1#2)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#3)
the internet and##4##3##(2007-11#2)(2008-4#1)(2011-2#1)
the internet##35##2##(1994-6#1)(2006-10#1)(2006-2#1)(2007-11#3)(2007-2#1)(2007-5#1)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2009-10#1)(2009-5#1)(2010-3#1)(2011-2#2)(2012-3#2)(2013-1#2)(2013-8#3)
the interns##3##2##(1992-11#1)(1995-6#1)(2010-8#1)
the internucleosomal##2##2##(1993-4#1)(1993-8#1)
the interobserver##2##2##(2011-2#1)(2012-12#1)
the interosseous##3##2##(1991-6#1)(2011-2#1)(2012-3#1)
the interparticle depletion##2##3##(2005-11#2)
the interparticle##6##2##(2005-11#2)(2008-10#2)(2009-11#1)(2009-9#1)
the interpeduncular cistern##2##3##(2006-12#2)
the interpeduncular##3##2##(1995-5#1)(2006-12#2)
the interpersonal anxiety type##2##4##(2004-11#2)
the interpersonal competence##2##3##(2012-3#2)
the interpersonal##11##2##(1991-3#1)(2004-11#2)(2009-10#1)(2009-7#2)(2011-2#1)(2012-3#2)(2013-1#2)
the interphalangeal##4##2##(1993-11#1)(2006-10#1)(2007-7#1)(2008-9#1)
the interphase##10##2##(1990-3#1)(1990-4#2)(1991-8#1)(1991-9#1)(1995-8#1)(2008-3#1)(2008-9#1)(2009-6#1)(2010-4#1)
the interphotoreceptor matrix##2##3##(1990-6#2)
the interphotoreceptor##3##2##(1990-6#2)(1994-9#1)
the interplay between multiple genetic##2##5##(2006-10#1)(2008-8#1)
the interplay between the##8##4##(1997-6#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-7#1)(2009-8#1)(2009-9#1)(2011-1#1)
the interplay between##29##3##(1997-6#1)(2006-10#2)(2006-4#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-8#2)(2009-9#1)(2010-2#1)(2010-5#1)(2011-1#2)(2012-3#1)
the interplay of these##2##4##(2006-5#1)(2012-3#1)
the interplay of##11##3##(2006-5#1)(2006-7#1)(2007-3#1)(2008-3#1)(2008-5#2)(2008-9#1)(2011-12#1)(2011-3#1)(2012-3#1)(2013-7#1)
the interplay##42##2##(1997-6#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-7#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-7#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-8#2)(2009-9#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-3#1)(2012-3#3)(2013-7#1)
the interpolar##3##2##(1996-9#1)(1997-1#1)(1997-3#1)
the interpolated##2##2##(2008-10#2)
the interpolation##3##2##(2007-12#1)(2008-2#2)
the interpretability of##2##3##(2006-10#1)(2011-2#1)
the interpretation and use of##2##5##(1993-3#1)(1994-7#1)
the interpretation and##3##3##(1993-3#1)(1994-7#1)(2010-9#1)
the interpretation of CT##2##4##(1997-8#2)
the interpretation of a##3##4##(1994-3#1)(2004-7#1)(2007-6#1)
the interpretation of clinical##2##4##(1992-9#1)(2008-10#1)
the interpretation of data##6##4##(2006-10#1)(2006-12#1)(2007-9#1)(2008-8#1)(2009-6#1)(2010-9#1)
the interpretation of laboratory##2##4##(1994-12#1)(1995-4#1)
the interpretation of results##2##4##(2007-7#1)(2008-10#1)
the interpretation of the experimental results##2##6##(2008-2#1)(2008-7#1)
the interpretation of the obtained results##2##6##(2008-10#2)
the interpretation of the results##3##5##(2004-12#1)(2008-10#1)(2008-4#1)
the interpretation of the##34##4##(1991-11#1)(1993-8#1)(1994-5#1)(2004-12#1)(2005-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-11#2)(2009-6#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#4)
the interpretation of their results##3##5##(2007-8#1)(2009-4#1)(2011-1#1)
the interpretation of their##4##4##(2007-1#1)(2007-8#1)(2009-4#1)(2011-1#1)
the interpretation of these##3##4##(1996-8#1)(1996-9#1)(2008-4#1)
the interpretation of##119##3##(1990-9#1)(1991-11#1)(1991-6#1)(1992-11#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-8#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-8#3)(2004-12#1)(2004-7#1)(2005-10#1)(2005-11#4)(2006-10#2)(2006-11#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#7)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#10)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#2)(2009-2#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-12#2)(2012-2#3)(2013-1#4)
the interpretation that the##5##4##(1993-4#1)(1995-2#1)(1997-9#1)(2008-11#1)(2008-4#1)
the interpretation##131##2##(1990-9#1)(1991-11#1)(1991-6#1)(1992-11#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-8#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-8#3)(1997-9#1)(2004-12#1)(2004-7#1)(2005-10#1)(2005-11#4)(2006-10#2)(2006-11#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#7)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#11)(2008-11#4)(2008-12#2)(2008-2#5)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#2)(2009-2#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-9#2)(2010-2#1)(2010-8#1)(2010-9#2)(2011-1#1)(2012-12#2)(2012-2#3)(2013-1#4)
the interpretations of##2##3##(1997-8#1)(2008-5#1)
the interpreting##2##2##(2007-4#1)(2007-9#1)
the interpretive##2##2##(2009-12#1)(2011-12#1)
the interprofessional cooperation##2##3##(1990-4#2)
the interrelation between##3##3##(2008-11#1)(2008-6#1)(2012-12#1)
the interrelations between##2##3##(1993-12#1)(1997-1#1)
the interrelations##3##2##(1993-12#1)(1993-6#1)(1997-1#1)
the interrelationship among##3##3##(2008-1#1)(2008-10#2)
the interrelationship between##5##3##(1995-2#1)(2006-5#1)(2008-12#1)(2010-12#1)(2011-2#1)
the interrelationship of##4##3##(1992-12#1)(1992-7#1)(2005-12#1)(2007-11#1)
the interrelationship##13##2##(1992-12#1)(1992-7#1)(1994-3#1)(1995-2#1)(2005-12#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-12#1)(2010-12#1)(2011-2#1)
the interrelationships among##4##3##(2008-10#1)(2008-12#1)(2008-7#1)(2009-8#1)
the interrelationships between##5##3##(1992-4#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)
the interrelationships of##3##3##(2006-10#1)(2008-4#1)(2008-7#1)
the interrelationships##13##2##(1992-4#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#2)(2009-8#1)
the interresidue##2##2##(1991-4#1)(1992-12#1)
the interrogation of##2##3##(2008-3#1)(2008-7#1)
the interrogation##3##2##(2008-3#1)(2008-7#1)(2008-9#1)
the interrupter technique##3##3##(2005-11#2)(2008-1#1)
the interruption of##2##3##(2008-11#1)(2012-12#1)
the interruption##4##2##(2008-11#1)(2008-3#1)(2009-11#1)(2012-12#1)
the interscapular region##3##3##(1992-2#1)(2007-8#1)(2010-12#1)
the interscapular##4##2##(1992-2#1)(2007-8#1)(2010-12#1)(2011-2#1)
the intersection between##2##3##(2008-7#1)(2011-1#1)
the intersection of the##6##4##(1993-4#1)(2008-2#1)(2008-3#1)(2009-5#1)(2011-1#1)(2011-2#1)
the intersection of two##2##4##(2007-11#1)(2008-5#1)
the intersection of##15##3##(1993-4#1)(2007-11#2)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-5#2)(2011-1#2)(2011-2#1)(2013-1#2)
the intersection##22##2##(1993-4#2)(2004-11#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-5#2)(2011-1#3)(2011-2#1)(2013-1#2)
the interside difference of the muscle potential latency##2##8##(2008-7#2)
the interspecific differences##2##3##(1992-1#1)(2008-8#1)
the interspecific##7##2##(1992-1#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-12#1)(2011-12#1)(2012-3#1)
the interstimulus interval##2##3##(1993-2#1)(1996-3#1)
the interstitial cell##2##3##(2008-5#2)
the interstitial cells of Cajal##3##5##(1997-6#2)(2008-6#1)
the interstitial cells##4##3##(1997-6#2)(2008-5#1)(2008-6#1)
the interstitial compartment##2##3##(1997-2#1)(2012-7#1)
the interstitial##25##2##(1991-10#1)(1991-12#1)(1994-12#1)(1995-7#1)(1997-2#1)(1997-3#2)(1997-6#2)(2005-8#2)(2006-10#1)(2008-1#1)(2008-10#1)(2008-5#4)(2008-6#1)(2008-8#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-7#1)(2013-8#1)
the interstitium##4##2##(1994-6#1)(2009-10#2)(2012-7#1)
the intertidal zone##3##3##(2007-3#2)(2009-8#1)
the intertidal##9##2##(2007-3#5)(2008-10#1)(2008-5#1)(2009-8#1)(2012-12#1)
the interval between the##3##4##(1993-6#1)(1997-8#1)(2008-10#1)
the interval between##13##3##(1992-7#1)(1993-6#1)(1997-1#1)(1997-8#1)(2006-6#3)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-7#1)
the interval of the##3##4##(2008-5#2)(2013-8#1)
the interval of##9##3##(1991-2#1)(1993-9#1)(2008-5#2)(2008-7#1)(2010-9#1)(2012-2#1)(2013-8#2)
the interval to first estrus##2##5##(2006-5#2)
the interval##37##2##(1991-2#1)(1992-7#1)(1993-10#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-11#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-8#1)(2006-10#1)(2006-5#2)(2006-6#3)(2007-11#2)(2007-8#1)(2008-10#4)(2008-2#2)(2008-5#5)(2008-7#2)(2010-9#1)(2012-2#1)(2013-8#2)
the intervals between##2##3##(2008-10#1)(2008-5#1)
the intervals##4##2##(2008-10#1)(2008-5#2)(2011-2#1)
the intervening DNA##2##3##(1991-4#1)(1995-3#1)
the intervening##19##2##(1991-2#2)(1991-4#1)(1993-3#2)(1994-9#1)(1995-3#3)(1995-8#1)(2008-10#1)(2008-11#2)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
the intervention and control groups##3##5##(1991-10#1)(2006-7#1)(2010-10#1)
the intervention and##10##3##(1991-10#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-1#1)
the intervention are##3##3##(1995-12#1)(2008-12#1)(2013-1#1)
the intervention characteristics##2##3##(2007-9#2)
the intervention did not##3##4##(2006-12#1)(2008-4#1)(2010-2#1)
the intervention effect##3##3##(1991-10#1)(2008-12#1)(2012-11#1)
the intervention group and##4##4##(1991-10#1)(2008-4#1)(2010-12#1)(2010-4#1)
the intervention group##24##3##(1991-10#1)(2006-12#3)(2007-2#1)(2007-5#2)(2008-12#2)(2008-4#1)(2008-9#1)(2009-10#1)(2010-12#4)(2010-4#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
the intervention had##2##3##(2006-12#1)(2008-12#1)
the intervention hospitals##2##3##(1996-1#2)
the intervention model##2##3##(2008-2#2)
the intervention of##3##3##(1991-9#1)(2008-2#1)(2011-9#1)
the intervention period##4##3##(2008-6#2)(2011-1#1)(2012-11#1)
the intervention to##8##3##(1994-4#1)(2007-5#1)(2008-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2012-1#1)(2012-3#1)
the intervention was##7##3##(1990-4#1)(1996-6#1)(2007-2#1)(2007-7#1)(2008-2#1)(2008-8#1)(2011-12#1)
the intervention were compared##2##4##(2010-3#1)(2012-2#1)
the intervention were##6##3##(2008-12#2)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
the intervention with the##2##4##(2007-5#1)(2008-12#1)
the intervention##168##2##(1990-4#1)(1991-10#3)(1991-9#1)(1992-11#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-4#1)(1995-1#2)(1995-12#1)(1996-1#3)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2004-3#1)(2006-10#1)(2006-12#7)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-5#4)(2007-7#4)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#1)(2008-12#17)(2008-2#5)(2008-4#7)(2008-6#5)(2008-8#4)(2008-9#5)(2009-10#2)(2010-10#3)(2010-11#1)(2010-12#4)(2010-2#5)(2010-3#3)(2010-4#4)(2010-7#2)(2011-1#3)(2011-12#1)(2011-2#6)(2011-9#1)(2012-1#5)(2012-11#2)(2012-12#5)(2012-2#9)(2012-3#3)(2013-1#9)(2013-7#1)
the intervention's##2##2##(2008-6#1)(2013-1#1)
the interventional##6##2##(2006-10#1)(2006-6#1)(2006-8#1)(2008-1#1)(2008-11#1)(2011-2#1)
the interventionalist##2##2##(2006-8#1)(2009-5#1)
the interventionist##5##2##(2006-12#1)(2006-5#1)(2006-6#1)(2008-12#1)(2011-2#1)
the interventions and##2##3##(2008-5#1)(2013-1#1)
the interventions in##2##3##(2008-3#1)(2011-11#1)
the interventions of##3##3##(2005-7#1)(2008-4#1)(2010-5#1)
the interventions were##4##3##(2007-12#1)(2009-6#1)(2012-2#2)
the interventions##31##2##(1995-2#1)(1995-3#1)(1996-2#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#2)(2009-6#3)(2009-7#1)(2010-2#1)(2010-5#1)(2011-11#2)(2011-2#1)(2012-2#3)(2013-1#3)
the interventricular septum##3##3##(1990-6#1)(2007-8#1)(2008-7#1)
the interventricular##4##2##(1990-3#1)(1990-6#1)(2007-8#1)(2008-7#1)
the intervertebral disc is##2##4##(1992-1#2)
the intervertebral disc##24##3##(1992-1#5)(2006-11#1)(2006-12#1)(2006-8#1)(2007-11#8)(2007-7#2)(2007-8#4)(2008-11#1)(2012-2#1)
the intervertebral foramen and##2##4##(2006-12#1)(2007-7#1)
the intervertebral foramen##8##3##(2006-12#1)(2006-8#3)(2007-7#1)(2011-2#1)(2013-8#2)
the intervertebral joints##2##3##(2007-7#2)
the intervertebral space##2##3##(2007-1#1)(2007-8#1)
the intervertebral##40##2##(1992-1#5)(2006-11#1)(2006-12#2)(2006-8#4)(2007-1#1)(2007-11#10)(2007-4#1)(2007-7#5)(2007-8#5)(2008-11#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#2)
the interview and##2##3##(1991-9#1)(2012-3#1)
the interview transcripts##6##3##(1993-3#1)(2007-4#1)(2009-5#1)(2013-1#3)
the interview was##3##3##(1990-12#1)(2011-1#1)(2012-3#1)
the interview##35##2##(1990-12#3)(1990-6#1)(1991-6#1)(1991-9#1)(1992-5#1)(1993-3#1)(1993-8#1)(1996-1#1)(1996-3#1)(1996-8#1)(1997-1#1)(2006-10#1)(2007-10#3)(2007-3#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
the interviewed##3##2##(2008-8#1)(2008-9#1)(2013-1#1)
the interviewees##4##2##(2005-11#1)(2007-2#1)(2008-12#1)(2011-2#1)
the interviewer##2##2##(2011-2#1)(2013-1#1)
the interviews were##3##3##(2008-12#1)(2011-1#1)(2011-2#1)
the interviews##15##2##(1997-3#1)(2007-12#2)(2007-2#1)(2008-11#1)(2008-12#1)(2009-10#1)(2011-1#1)(2011-2#2)(2012-11#1)(2013-1#3)(2013-8#1)
the intestinal absorption of##2##4##(2008-11#1)(2009-9#1)
the intestinal and##2##3##(1991-5#1)(1992-12#1)
the intestinal bacteria##2##3##(1991-12#1)(1995-3#1)
the intestinal barrier##4##3##(2007-11#2)(2008-3#1)(2008-4#1)
the intestinal brush border membrane##2##5##(1991-4#1)(1995-11#1)
the intestinal brush-border membrane##2##4##(1992-6#1)(2006-12#1)
the intestinal continuity##2##3##(2011-11#2)
the intestinal epithelial cell##4##4##(2006-10#1)(2008-10#1)(2008-11#1)(2011-1#1)
the intestinal epithelial##6##3##(2006-10#1)(2008-10#2)(2008-11#2)(2011-1#1)
the intestinal epithelium in##2##4##(2006-10#1)(2010-12#1)
the intestinal epithelium##12##3##(2006-10#3)(2008-10#1)(2008-4#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-1#1)
the intestinal flora##2##3##(1995-3#1)(2006-5#1)
the intestinal immune system and##2##5##(2008-5#1)(2009-12#1)
the intestinal immune system##5##4##(2008-11#1)(2008-4#1)(2008-5#2)(2009-12#1)
the intestinal lumen##5##3##(1995-5#1)(1996-6#1)(1997-2#1)(2011-2#2)
the intestinal microbiome##2##3##(2010-5#1)(2012-1#1)
the intestinal microbiota##7##3##(2008-11#1)(2010-12#2)(2010-5#1)(2010-9#2)(2012-12#1)
the intestinal microflora##2##3##(1993-9#1)(2007-11#1)
the intestinal mucosa of##2##4##(1996-2#1)(2006-2#1)
the intestinal mucosa to##2##4##(2006-10#1)(2008-7#1)
the intestinal mucosa##15##3##(1992-12#1)(1994-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(2005-10#1)(2006-10#3)(2006-2#2)(2007-11#1)(2008-7#1)(2009-8#1)(2012-1#1)
the intestinal tract and##2##4##(1993-2#1)(2006-10#1)
the intestinal tract of##5##4##(1990-9#1)(2006-8#1)(2007-6#1)(2011-2#2)
the intestinal tract##14##3##(1990-9#1)(1993-2#1)(1993-9#1)(1996-2#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-6#1)(2008-5#2)(2008-8#1)(2011-2#2)
the intestinal uptake##3##3##(1990-11#1)(1995-3#1)(2007-2#1)
the intestinal villi were##2##4##(1993-6#2)
the intestinal villi##3##3##(1993-6#2)(2008-4#1)
the intestinal wall##8##3##(1993-8#1)(2006-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-12#1)
the intestinal##149##2##(1990-11#1)(1990-2#2)(1990-7#3)(1990-9#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-12#3)(1992-6#1)(1992-8#2)(1993-2#2)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-8#3)(1994-9#2)(1995-11#1)(1995-3#3)(1995-5#1)(1996-10#1)(1996-2#2)(1996-3#1)(1996-6#2)(1997-2#1)(1997-4#1)(1997-8#1)(2004-11#1)(2005-10#2)(2005-11#1)(2005-9#1)(2006-10#12)(2006-12#1)(2006-2#3)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#5)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-3#2)(2008-4#5)(2008-5#6)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#3)(2009-6#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#2)(2010-9#2)(2011-1#3)(2011-11#2)(2011-2#9)(2012-1#6)(2012-12#1)
the intestine and the##2##4##(1995-2#1)(2008-5#1)
the intestine and##11##3##(1990-2#2)(1995-2#1)(1995-5#1)(1996-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
the intestine of##9##3##(1990-4#1)(1992-8#1)(1995-9#1)(2007-9#1)(2008-4#1)(2008-5#1)(2009-5#1)(2012-1#1)(2012-2#1)
the intestine to##3##3##(1992-9#1)(1993-9#2)
the intestine##75##2##(1990-2#2)(1990-4#1)(1992-11#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-8#1)(1993-9#3)(1994-12#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-11#2)(1996-4#1)(1996-6#1)(1997-3#1)(2005-3#3)(2005-9#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#3)(2007-11#2)(2007-12#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-3#4)(2008-4#4)(2008-5#8)(2008-7#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#2)(2013-1#1)(2013-7#1)
the intestines##6##2##(1992-11#1)(2006-10#1)(2006-12#1)(2008-10#2)(2008-8#1)
the intima##6##2##(1997-5#1)(1997-8#1)(2006-11#3)(2008-7#1)
the intimal thickening##2##3##(1995-12#1)(1997-2#1)
the intimal##9##2##(1995-12#1)(1996-12#1)(1997-2#1)(2006-6#2)(2007-8#3)(2010-4#1)
the intimate##5##2##(2005-11#1)(2008-5#1)(2009-10#2)(2009-7#1)
the intolerance##2##2##(2007-3#1)(2008-1#1)
the intonational phrase##3##3##(2008-4#3)
the intonational##4##2##(2008-4#3)(2013-8#1)
the intoxicants##2##2##(1992-8#1)(2009-4#1)
the intoxication##4##2##(1990-9#1)(1995-9#1)(2005-7#1)(2008-10#1)
the intra##3##2##(1993-4#1)(2006-2#1)(2008-4#1)
the intra- and inter-assay##2##4##(1990-6#1)(1992-2#1)
the intra- and##11##3##(1990-5#1)(1990-6#1)(1991-1#1)(1992-2#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-12#1)(2011-2#2)
the intra-##14##2##(1990-5#1)(1990-6#1)(1991-1#1)(1992-2#1)(1994-3#1)(1996-2#2)(1997-2#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#2)
the intra-abdominal##2##2##(1996-11#1)(2008-10#1)
the intra-articular##3##2##(2006-10#1)(2007-3#1)(2013-7#1)
the intra-operative##5##2##(2007-5#1)(2007-8#2)(2008-9#1)(2011-1#1)
the intraabdominal##3##2##(2006-2#1)(2011-2#2)
the intraarticular##2##2##(1992-8#1)(2009-2#1)
the intracardiac##2##2##(1995-6#1)(2007-8#1)
the intracavitary##2##2##(2008-4#1)(2010-12#1)
the intracavity dispersion##4##3##(2007-11#1)(2007-12#3)
the intracavity power##2##3##(2008-10#1)(2008-3#1)
the intracavity##22##2##(2007-11#3)(2007-12#8)(2008-10#1)(2008-2#1)(2008-3#9)
the intracellular Ca(2+)##2##3##(1996-2#1)(2008-7#1)
the intracellular Ca++ level##2##4##(1991-9#2)
the intracellular Ca++##3##3##(1991-9#3)
the intracellular Ca2+ chelator##2##4##(1994-2#1)(1994-3#1)
the intracellular Ca2+ concentration ([Ca2+]i)##3##5##(1994-12#1)(1994-2#1)(1994-6#1)
the intracellular Ca2+ concentration##10##4##(1990-2#1)(1990-4#1)(1990-7#1)(1992-11#1)(1992-8#2)(1994-12#1)(1994-2#1)(1994-6#1)(1997-7#1)
the intracellular Ca2+##14##3##(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#1)(1992-11#1)(1992-8#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1996-5#1)(1997-7#1)
the intracellular accumulation of##10##4##(1992-1#1)(1992-4#1)(1994-11#1)(1994-3#1)(1995-6#1)(1997-3#1)(1997-5#1)(2008-11#1)(2008-7#1)(2013-1#1)
the intracellular accumulation##11##3##(1992-1#1)(1992-4#1)(1994-11#1)(1994-3#1)(1995-6#1)(1997-3#1)(1997-5#1)(2008-11#2)(2008-7#1)(2013-1#1)
the intracellular and extracellular##2##4##(1994-12#1)(1996-7#1)
the intracellular and##3##3##(1990-12#1)(1994-12#1)(1996-7#1)
the intracellular calcium##5##3##(1992-6#1)(1994-9#1)(1995-8#1)(2008-4#1)(2010-8#1)
the intracellular compartment##3##3##(1990-7#1)(1991-11#1)(2010-10#1)
the intracellular concentration of##12##4##(1990-10#1)(1990-11#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-3#1)(1993-6#1)(1995-3#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-4#1)
the intracellular concentration##16##3##(1990-10#1)(1990-11#1)(1990-5#2)(1990-9#1)(1991-1#1)(1991-3#1)(1993-6#1)(1995-3#1)(1996-5#1)(1997-2#1)(2007-11#2)(2008-4#1)(2008-5#1)(2008-7#1)
the intracellular concentrations of##8##4##(1991-12#1)(1991-7#1)(1992-2#1)(1992-6#1)(1996-6#1)(2008-11#1)(2008-7#1)(2013-1#1)
the intracellular content of##2##4##(1994-6#1)(2008-11#1)
the intracellular contents of##3##4##(1994-12#2)(1994-6#1)
the intracellular degradation of##2##4##(1990-4#1)(2008-4#1)
the intracellular distribution of##2##4##(2008-11#2)
the intracellular domain##3##3##(1992-11#1)(1993-8#1)(1995-3#1)
the intracellular drug##2##3##(1991-7#1)(1996-1#1)
the intracellular dye##3##3##(1992-8#1)(1997-8#1)(2008-4#1)
the intracellular environment##2##3##(1995-1#1)(2008-11#1)
the intracellular enzyme##4##3##(1993-3#2)(1994-6#1)(1995-7#1)
the intracellular fluorescent##2##3##(2008-4#1)(2008-9#1)
the intracellular form of##2##4##(1991-5#1)(1994-9#1)
the intracellular free calcium concentration ([Ca2+]i)##3##6##(1992-7#1)(1994-10#1)(1994-2#1)
the intracellular free calcium concentration##4##5##(1992-7#1)(1993-9#1)(1994-10#1)(1994-2#1)
the intracellular free drug concentration##2##5##(1996-1#2)
the intracellular free##9##3##(1991-5#1)(1992-7#1)(1993-11#1)(1993-9#1)(1994-10#1)(1994-2#1)(1995-8#1)(1996-1#2)
the intracellular glutamine##2##3##(1990-3#1)(2008-11#1)
the intracellular kinase##2##3##(1993-3#1)(1995-3#1)
the intracellular level of##2##4##(1991-9#1)(1994-11#1)
the intracellular levels of##4##4##(1990-3#1)(1992-3#1)(2009-3#1)(2012-1#1)
the intracellular localization of##2##4##(1993-2#1)(1996-4#1)
the intracellular mechanisms##2##3##(1990-4#1)(2008-3#1)
the intracellular milieu##2##3##(2006-10#1)(2008-9#1)
the intracellular nucleotide pools##2##4##(2008-11#2)
the intracellular nucleotide##3##3##(2008-11#3)
the intracellular pH##3##3##(1995-7#1)(2008-10#1)(2008-11#1)
the intracellular pathogen##4##3##(1992-7#1)(1995-2#1)(2009-8#1)(2013-1#1)
the intracellular pathways of##2##4##(1995-5#1)(2008-7#1)
the intracellular pathways##4##3##(1995-5#1)(1996-3#1)(1996-5#1)(2008-7#1)
the intracellular peroxide##2##3##(1997-6#1)(2008-11#1)
the intracellular pool##2##3##(1994-12#1)(2008-5#1)
the intracellular protein##4##3##(1990-11#1)(1991-4#1)(2007-9#1)(2008-11#1)
the intracellular reduction##2##3##(1991-7#1)(1994-9#1)
the intracellular region adjacent to##2##5##(1994-3#2)
the intracellular region##4##3##(1994-3#3)(2008-5#1)
the intracellular signal##3##3##(1993-3#1)(1995-11#1)(1997-3#1)
the intracellular signaling pathways##4##4##(1995-1#1)(1995-6#1)(2008-11#1)(2011-12#1)
the intracellular signaling##6##3##(1995-1#1)(1995-6#1)(2008-11#1)(2008-9#1)(2009-4#1)(2011-12#1)
the intracellular signalling##4##3##(1992-11#1)(1996-2#1)(2008-1#1)(2012-1#1)
the intracellular sodium concentration##3##4##(1991-9#1)(1992-11#1)(2008-5#1)
the intracellular sodium##5##3##(1991-9#1)(1992-11#1)(1992-7#1)(1994-3#1)(2008-5#1)
the intracellular trafficking and##2##4##(1991-1#1)(1994-8#1)
the intracellular trafficking##4##3##(1991-1#1)(1994-8#1)(1995-5#1)(2009-8#1)
the intracellular transport and secretion of##2##6##(2007-12#2)
the intracellular transport and##3##4##(1991-3#1)(2007-12#2)
the intracellular transport##4##3##(1991-3#1)(1992-5#1)(2007-12#2)
the intracellular##275##2##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#3)(1990-4#3)(1990-5#2)(1990-7#4)(1990-9#1)(1991-1#4)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#4)(1991-7#4)(1991-9#7)(1992-1#1)(1992-11#4)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#4)(1992-8#3)(1992-9#2)(1993-11#2)(1993-2#1)(1993-3#7)(1993-6#2)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#7)(1994-2#3)(1994-3#6)(1994-5#1)(1994-6#6)(1994-8#2)(1994-9#5)(1995-1#2)(1995-11#3)(1995-2#1)(1995-3#5)(1995-5#3)(1995-6#3)(1995-7#2)(1995-8#5)(1996-1#4)(1996-12#2)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#1)(2004-12#1)(2005-12#1)(2005-8#2)(2006-10#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#23)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#5)(2008-7#7)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#1)(2013-1#3)(2013-8#2)
the intracellularly##2##2##(1994-6#1)(2008-4#1)
the intracerebral infusion##3##3##(2008-7#3)
the intracerebral##6##2##(1996-1#1)(2008-7#3)(2012-12#2)
the intraclass correlation##2##3##(2008-10#1)(2011-1#1)
the intracluster correlation coefficient##2##4##(1992-9#1)(2008-10#1)
the intracluster correlation##3##3##(1992-9#1)(2008-10#2)
the intracoronary##2##2##(1990-12#1)(2012-2#1)
the intracortical##3##2##(1996-2#1)(2004-9#1)(2008-11#1)
the intracranial and##2##3##(2007-4#1)(2011-2#1)
the intracranial pressure]##2##3##(1997-6#2)
the intracranial tumor##2##3##(2006-7#1)(2012-2#1)
the intracranial##22##2##(1990-9#1)(1995-11#1)(1997-3#1)(1997-6#3)(2005-10#1)(2006-11#3)(2006-12#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-12#1)(2008-7#2)(2011-2#1)(2012-2#1)
the intracytoplasmic##2##2##(1994-12#1)(2012-1#1)
the intradermal route##2##3##(1992-8#1)(2007-11#1)
the intradermal##3##2##(1990-6#1)(1992-8#1)(2007-11#1)
the intradialytic##3##2##(2008-1#2)(2012-12#1)
the intradural##3##2##(2006-10#1)(2006-12#1)(2008-7#1)
the intraepithelial##2##2##(2008-4#2)
the intraerythrocytic##2##2##(1990-12#1)(1993-8#1)
the intrahelical##2##2##(1995-1#1)(1995-2#1)
the intrahepatic and extrahepatic##2##4##(2004-11#1)(2006-4#1)
the intrahepatic bile ducts##3##4##(2004-11#1)(2012-12#1)(2012-2#1)
the intrahepatic biliary##3##3##(1992-2#1)(2006-10#1)(2006-2#1)
the intrahepatic##10##2##(1992-2#1)(2004-11#2)(2006-10#1)(2006-2#1)(2006-4#1)(2012-12#1)(2012-2#2)(2013-1#1)
the intraluminal##2##2##(2007-10#1)(2007-12#1)
the intramedullary canal##2##3##(2007-7#1)(2008-5#1)
the intramedullary nailing##2##3##(2007-11#1)(2013-8#1)
the intramedullary##6##2##(2007-11#2)(2007-7#1)(2008-5#1)(2013-1#1)(2013-8#1)
the intramembrane##3##2##(1992-9#1)(1994-12#1)(1997-1#1)
the intramolecular energy transfer##2##4##(2005-4#1)(2008-10#1)
the intramolecular interaction##2##3##(1991-8#1)(2009-8#1)
the intramolecular##17##2##(1991-8#1)(1992-9#1)(1993-2#1)(1996-5#2)(2005-11#1)(2005-4#1)(2006-12#1)(2008-10#2)(2008-5#2)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#1)(2013-1#1)
the intramural##5##2##(2008-10#1)(2008-8#2)(2011-2#1)(2013-8#1)
the intramuscular connective tissue##3##4##(2010-2#1)(2013-1#2)
the intramuscular##10##2##(1992-11#1)(1997-4#1)(2008-5#1)(2008-8#1)(2010-2#1)(2010-4#3)(2013-1#2)
the intranuclear##6##2##(1994-11#1)(1994-2#1)(1995-5#1)(1996-8#1)(2006-12#2)
the intraobserver##2##2##(2011-1#1)(2011-2#1)
the intraocular pressure and##2##4##(2011-2#1)(2013-1#1)
the intraocular pressure##8##3##(1993-1#1)(2008-11#1)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
the intraocular##17##2##(1993-1#1)(1995-5#1)(1996-2#1)(2007-3#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-3#1)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)
the intraoperative and postoperative##2##4##(2007-12#1)(2013-1#1)
the intraoperative and##3##3##(2007-12#1)(2008-10#1)(2013-1#1)
the intraoperative period in##2##4##(2010-5#1)(2010-7#1)
the intraoperative period##4##3##(2010-5#1)(2010-7#1)(2011-3#1)(2013-1#1)
the intraoperative##29##2##(1993-1#1)(1996-1#1)(2006-12#1)(2006-6#2)(2006-7#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2010-12#2)(2010-5#1)(2010-7#4)(2011-2#1)(2011-3#1)(2011-7#1)(2012-2#1)(2013-1#3)(2013-7#1)
the intraoral##2##2##(1993-12#1)(2007-12#1)
the intraparietal sulcus (IPS)##2##4##(1996-9#1)(2008-4#1)
the intraparietal sulcus##3##3##(1996-9#1)(2008-4#1)(2010-5#1)
the intraparietal##4##2##(1990-12#1)(1996-9#1)(2008-4#1)(2010-5#1)
the intraperitoneal administration of##3##4##(1995-12#2)(2013-1#1)
the intraperitoneal##9##2##(1990-9#1)(1991-8#1)(1995-12#2)(1996-2#1)(2007-12#1)(2008-5#1)(2011-2#1)(2013-1#1)
the intraprotein##2##2##(2006-10#2)
the intrapulmonary##2##2##(1997-1#1)(2008-1#1)
the intrarenal##2##2##(2006-7#1)(2008-1#1)
the intraspecific##3##2##(2010-10#1)(2010-12#1)(2013-7#1)
the intrasubunit##2##2##(1992-12#1)(1992-3#1)
the intrathecal injection##2##3##(2006-10#1)(2008-12#1)
the intrathecal##6##2##(1997-2#1)(2006-10#1)(2006-12#1)(2007-10#1)(2008-12#1)(2012-3#1)
the intrathoracic goitre##2##3##(1993-5#2)
the intrathoracic##7##2##(1993-5#3)(1994-10#1)(2005-11#1)(2007-8#2)
the intrathymic##3##2##(2007-11#2)(2008-5#1)
the intratumoral##2##2##(1996-11#1)(1997-7#1)
the intrauterine##10##2##(1991-2#1)(1994-3#1)(1994-4#1)(1994-9#2)(1996-12#1)(2009-11#2)(2009-9#1)(2013-1#1)
the intravascular##4##2##(1997-3#1)(2008-11#1)(2008-7#1)(2010-8#1)
the intravenous injection of##5##4##(1991-5#1)(1992-3#2)(1995-12#1)(2008-5#1)
the intravenous route##3##3##(2006-10#1)(2007-11#1)(2008-4#1)
the intravenous##16##2##(1991-5#1)(1992-3#2)(1992-8#1)(1993-3#1)(1995-12#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-4#1)(2008-5#2)(2011-2#3)(2013-7#1)
the intraventricular##5##2##(1992-5#1)(1992-9#1)(1995-7#1)(1997-7#1)(2006-5#1)
the intravesical ureter##2##3##(1997-4#1)(2008-10#1)
the intravesical##7##2##(1992-3#1)(1993-11#1)(1997-4#2)(2006-9#1)(2008-10#2)
the intravitreal injection##2##3##(2008-1#1)(2013-1#1)
the intricacies of##2##3##(2008-7#1)(2009-7#1)
the intricate relationship between the##2##5##(1995-12#1)(2012-2#1)
the intricate##13##2##(1992-2#1)(1993-5#1)(1995-12#1)(2005-11#1)(2008-10#2)(2008-9#1)(2009-8#1)(2010-2#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
the intriguing##3##2##(1993-4#1)(2009-3#1)(2012-12#1)
the intrinsic ATPase activity of##2##5##(1992-6#2)
the intrinsic activity of##2##4##(1990-2#1)(1995-4#1)
the intrinsic activity##3##3##(1990-2#1)(1994-8#1)(1995-4#1)
the intrinsic and extrinsic##4##4##(1990-11#1)(2008-1#1)(2009-12#1)(2011-2#1)
the intrinsic and##8##3##(1990-11#1)(1994-12#2)(2008-1#1)(2008-4#1)(2008-5#1)(2009-12#1)(2011-2#1)
the intrinsic binding##2##3##(1994-11#1)(2006-10#1)
the intrinsic complexation constants##2##4##(2008-10#2)
the intrinsic dynamics##2##3##(2008-3#1)(2009-8#1)
the intrinsic fluorescence of the analyte##2##6##(2008-10#2)
the intrinsic fluorescence of##6##4##(1995-6#1)(2008-10#4)(2008-8#1)
the intrinsic fluorescence##15##3##(1990-7#1)(1991-7#1)(1992-6#1)(1995-5#1)(1995-6#1)(1997-2#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-8#1)
the intrinsic limitations of##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
the intrinsic noise##5##3##(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2010-12#1)
the intrinsic properties of the##2##5##(2008-3#1)(2008-7#1)
the intrinsic properties of##5##4##(1997-4#1)(2007-4#1)(2008-1#1)(2008-3#1)(2008-7#1)
the intrinsic rate of change with respect to##2##8##(2008-10#2)
the intrinsic rate of disease##2##5##(2008-10#2)
the intrinsic rate of growth##2##5##(2008-8#2)
the intrinsic rate of##8##4##(1991-5#1)(1993-11#1)(2008-10#4)(2008-8#2)
the intrinsic resistance##2##3##(1993-9#1)(2007-11#1)
the intrinsic viscosity of##2##4##(2008-10#2)
the intrinsic##150##2##(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-6#3)(1992-8#1)(1993-11#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-8#2)(1994-9#1)(1995-1#3)(1995-10#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-6#1)(2004-10#1)(2004-12#1)(2004-4#1)(2005-11#1)(2006-10#6)(2006-2#1)(2006-5#1)(2006-7#1)(2007-11#7)(2007-12#8)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#22)(2008-11#1)(2008-2#6)(2008-3#14)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#6)(2009-11#1)(2009-12#1)(2009-8#1)(2010-12#2)(2010-5#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
the introduced plasmid##3##3##(1994-9#2)(2008-8#1)
the introduced range##2##3##(2008-8#2)
the introduced##17##2##(1994-9#2)(2005-8#1)(2006-3#1)(2008-10#6)(2008-2#1)(2008-5#1)(2008-8#3)(2010-4#1)(2011-12#1)
the introduction and spread of##2##5##(1990-3#1)(2008-10#1)
the introduction and##7##3##(1990-3#1)(1991-4#1)(2008-10#1)(2008-12#2)(2010-5#1)(2011-2#1)
the introduction of DNA##2##4##(1993-9#1)(2008-4#1)
the introduction of a new##3##5##(1996-11#1)(1997-3#1)(2011-1#1)
the introduction of a##29##4##(1990-5#1)(1991-6#1)(1996-11#1)(1997-2#1)(1997-3#3)(1997-4#1)(2004-2#1)(2005-8#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-6#1)(2008-7#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#1)
the introduction of an##8##4##(1990-12#1)(1994-9#1)(2006-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)
the introduction of antibiotics##3##4##(1991-4#1)(1997-2#1)(2008-4#1)
the introduction of artificial##2##4##(2008-1#1)(2009-2#1)
the introduction of chlorpromazine##2##4##(2005-7#1)(2011-7#1)
the introduction of diffractive##2##4##(2008-2#1)(2008-3#1)
the introduction of effective##4##4##(2008-5#1)(2008-7#1)(2010-3#2)
the introduction of endoscopic##3##4##(1990-6#1)(2006-6#2)
the introduction of foreign##2##4##(1997-7#1)(2006-6#1)
the introduction of highly active antiretroviral therapy##2##7##(2007-12#1)(2008-5#1)
the introduction of highly active##3##5##(2007-12#1)(2008-1#1)(2008-5#1)
the introduction of hospital choice in Denmark and Norway##2##9##(2008-7#2)
the introduction of immunosuppressive##2##4##(2007-11#1)(2008-12#1)
the introduction of interferon##2##4##(1992-2#1)(2007-11#1)
the introduction of modern##3##4##(1990-12#1)(2007-11#1)(2008-3#1)
the introduction of molecular##2##4##(1993-6#1)(2010-12#1)
the introduction of more##4##4##(1993-8#1)(1994-11#1)(2006-10#1)(2011-2#1)
the introduction of multiple##2##4##(1992-11#1)(2010-12#1)
the introduction of new##19##4##(1991-3#1)(1993-1#1)(1995-5#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-12#1)(2013-1#1)
the introduction of nonlinearity is shown to provide greater robustness##2##10##(2008-2#2)
the introduction of novel##3##4##(2004-3#1)(2012-12#2)
the introduction of other##2##4##(1994-3#1)(2007-11#1)
the introduction of specific##2##4##(2008-4#1)(2009-7#1)
the introduction of the concept of##2##6##(2008-1#1)(2008-5#1)
the introduction of the concept##3##5##(2008-1#1)(2008-5#1)(2013-1#1)
the introduction of the first##2##5##(1991-9#1)(2008-5#1)
the introduction of the integrated organ system-based curriculum##2##8##(2012-3#2)
the introduction of the new##2##5##(2006-10#1)(2011-1#1)
the introduction of the##55##4##(1990-10#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-12#1)(1994-2#1)(1995-5#1)(1997-4#1)(1997-5#2)(2006-1#1)(2006-10#8)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
the introduction of these##3##4##(2005-11#1)(2008-11#1)(2009-9#1)
the introduction of this##5##4##(1993-2#1)(1997-7#1)(2008-10#1)(2008-7#1)(2009-3#1)
the introduction of two##2##4##(2007-11#1)(2007-8#1)
the introduction of##337##3##(1990-10#1)(1990-12#3)(1990-2#3)(1990-4#2)(1990-5#2)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#4)(1991-4#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-6#2)(1993-8#2)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#2)(1996-11#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#2)(1997-5#2)(1997-7#3)(2004-2#1)(2004-3#1)(2005-10#1)(2005-11#2)(2005-5#2)(2005-7#4)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#20)(2006-11#1)(2006-12#3)(2006-2#2)(2006-5#3)(2006-6#5)(2006-8#3)(2006-9#3)(2007-10#1)(2007-11#9)(2007-12#3)(2007-2#1)(2007-3#2)(2007-6#3)(2007-7#4)(2007-8#7)(2008-1#10)(2008-10#22)(2008-11#12)(2008-12#10)(2008-2#9)(2008-3#12)(2008-4#6)(2008-5#5)(2008-6#3)(2008-7#11)(2008-8#1)(2008-9#1)(2009-11#2)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#1)(2009-7#2)(2009-8#1)(2009-9#3)(2010-1#1)(2010-12#7)(2010-2#1)(2010-3#4)(2010-4#5)(2010-5#1)(2010-7#3)(2010-8#3)(2011-1#4)(2011-12#2)(2011-2#6)(2011-3#1)(2011-7#1)(2012-1#2)(2012-12#5)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#2)
the introduction to##3##3##(1991-3#1)(2007-10#1)(2007-2#1)
the introduction##351##2##(1990-10#1)(1990-12#3)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#5)(1991-4#2)(1991-6#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-6#2)(1993-8#2)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#2)(1996-11#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#2)(1997-5#2)(1997-7#3)(2004-2#1)(2004-3#1)(2005-10#1)(2005-11#2)(2005-5#2)(2005-7#4)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#21)(2006-11#1)(2006-12#3)(2006-2#2)(2006-5#3)(2006-6#5)(2006-8#3)(2006-9#3)(2007-10#2)(2007-11#10)(2007-12#3)(2007-2#2)(2007-3#2)(2007-6#3)(2007-7#4)(2007-8#7)(2008-1#10)(2008-10#23)(2008-11#12)(2008-12#13)(2008-2#9)(2008-3#12)(2008-4#6)(2008-5#5)(2008-6#3)(2008-7#11)(2008-8#1)(2008-9#1)(2009-11#2)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#1)(2009-7#2)(2009-8#1)(2009-9#3)(2010-1#1)(2010-12#7)(2010-2#1)(2010-3#4)(2010-4#5)(2010-5#2)(2010-7#3)(2010-8#3)(2011-1#4)(2011-12#2)(2011-2#7)(2011-3#1)(2011-7#1)(2012-1#2)(2012-12#5)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#2)
the introductory##7##2##(1990-12#1)(1993-12#1)(1997-7#1)(2005-10#1)(2008-10#1)(2008-5#1)(2012-2#1)
the introgression of##2##3##(1994-3#1)(2009-2#1)
the intron downstream of##3##4##(1991-6#1)(1992-5#1)(1993-12#1)
the intron in##2##3##(1995-6#1)(1995-8#1)
the intron##19##2##(1990-2#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-10#1)(1992-5#2)(1993-12#2)(1993-6#1)(1994-12#2)(1995-1#1)(1995-5#1)(1995-6#1)(1995-8#2)(2008-10#1)
the intron-exon junctions##2##3##(1991-5#1)(1994-12#1)
the intron-exon##6##2##(1991-4#1)(1991-5#1)(1994-12#1)(1994-3#2)(1995-1#1)
the intron/exon structure of the##2##5##(1995-12#1)(1996-2#1)
the intron64 splicing accepter site##2##5##(2012-1#2)
the intronic##2##2##(1997-1#1)(2011-1#1)
the intronless##4##2##(1994-8#3)(2010-5#1)
the introns##12##2##(1991-12#1)(1992-12#1)(1993-11#1)(1993-3#1)(1994-12#1)(1995-6#1)(1995-8#1)(1996-4#1)(1997-6#1)(1997-8#1)(2008-7#1)(2010-9#1)
the introns-late##2##2##(1995-8#2)
the intrusion of##2##3##(2008-5#1)(2013-1#1)
the intrusion##3##2##(2005-11#1)(2008-5#1)(2013-1#1)
the intuition##4##2##(2008-3#1)(2009-8#1)(2013-1#2)
the intuitive##3##2##(1995-12#1)(2008-3#2)
the invaded##2##2##(2008-10#1)(2008-12#1)
the invading organism##2##3##(2006-10#1)(2008-10#1)
the invading pathogen##2##3##(2008-10#2)
the invading tumor cells##2##4##(2007-12#2)
the invading##13##2##(1990-10#1)(2006-10#2)(2007-10#1)(2007-12#2)(2008-10#6)(2009-8#1)
the invaginated##2##2##(2008-10#1)(2008-5#1)
the invariance of##2##3##(2010-4#2)
the invariance##3##2##(2010-4#2)(2012-2#1)
the invariant##9##2##(1991-2#1)(1995-2#1)(1995-8#1)(2006-11#2)(2006-12#2)(2012-2#2)
the invasion and metastasis of##2##5##(2012-3#1)(2013-8#1)
the invasion and proliferation of AH109A##2##6##(2008-11#2)
the invasion and##6##3##(1990-11#1)(2008-10#1)(2008-11#2)(2012-3#1)(2013-8#1)
the invasion by##2##3##(2008-10#1)(2012-3#1)
the invasion of AH109A cells##4##5##(2008-11#4)
the invasion of a##2##4##(2008-11#1)(2013-8#1)
the invasion of hepatoma cells##2##5##(2008-11#2)
the invasion of the##2##4##(1991-12#1)(2008-10#1)
the invasion of##25##3##(1991-12#1)(1994-5#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#9)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
the invasion probability##2##3##(2013-8#2)
the invasion##45##2##(1990-11#1)(1991-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(2006-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#13)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#5)
the invasive activity of hepatoma cells by##2##7##(2008-11#2)
the invasive activity of rat hepatoma##2##6##(2008-11#2)
the invasive activity of##4##4##(2008-11#4)
the invasive growth of##2##4##(2008-10#1)(2013-1#1)
the invasive nature of the##2##5##(1992-1#1)(2005-11#1)
the invasive phenotype of##2##4##(1994-5#2)
the invasive phenotype##3##3##(1991-12#1)(1994-5#2)
the invasive plant##2##3##(2008-5#1)(2010-3#1)
the invasive potential##2##3##(2008-10#1)(2013-1#1)
the invasive##29##2##(1991-11#1)(1991-12#1)(1992-1#1)(1993-4#1)(1993-7#1)(1994-5#2)(2005-11#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#2)(2008-10#2)(2008-11#5)(2008-5#1)(2010-12#1)(2010-3#1)(2010-5#1)(2012-3#1)(2013-1#3)(2013-7#1)
the invasiveness of##5##3##(1991-2#1)(1993-4#1)(2006-10#1)(2006-5#1)(2011-2#1)
the invasiveness##7##2##(1991-2#1)(1993-4#1)(2006-10#2)(2006-5#1)(2011-2#1)(2013-8#1)
the invention of##3##3##(2008-2#1)(2009-4#1)(2011-1#1)
the inventory of##3##3##(2007-2#1)(2008-7#1)(2010-2#1)
the inventory##4##2##(2007-2#1)(2008-7#1)(2010-2#1)(2013-1#1)
the inverse Gaussian probability distribution is used to model the heartbeat interval##2##12##(2009-9#1)(2010-5#1)
the inverse PCR##2##3##(1991-12#1)(1997-2#1)
the inverse leafing phenology of##2##5##(2008-5#2)
the inverse of the##8##4##(2005-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-12#1)(2012-1#1)
the inverse of##10##3##(1993-9#1)(2005-11#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2009-12#1)(2012-1#1)
the inverse problem by##2##4##(2008-2#2)
the inverse problem of iterated function systems##2##7##(2008-2#2)
the inverse problem of##3##4##(2008-2#3)
the inverse problem##14##3##(2007-12#2)(2008-2#9)(2008-3#1)(2013-1#2)
the inverse##66##2##(1990-11#1)(1990-7#1)(1991-12#1)(1991-5#1)(1992-7#1)(1993-9#1)(1995-1#1)(1995-11#1)(1997-2#1)(1997-8#1)(2005-11#2)(2006-12#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#5)(2008-2#21)(2008-3#8)(2008-5#5)(2008-8#1)(2009-12#1)(2009-9#1)(2010-1#2)(2010-5#1)(2012-1#1)(2013-1#2)
the inverse-scattering problem##2##3##(2007-12#1)(2008-2#1)
the inversion of the##2##4##(1994-2#1)(2008-3#1)
the inversion of##8##3##(1994-2#1)(2008-2#3)(2008-3#3)(2012-1#1)
the inversion procedure##3##3##(2008-2#1)(2008-3#2)
the inversion results##2##3##(2008-2#1)(2008-7#1)
the inversion##30##2##(1994-2#1)(1994-3#1)(1997-2#1)(2008-2#7)(2008-3#14)(2008-7#1)(2012-1#1)(2013-1#3)(2013-8#1)
the invertase##4##2##(1993-3#2)(2008-10#1)(2008-7#1)
the invertebrate##3##2##(1994-11#1)(2007-12#1)(2008-8#1)
the inverted CCAAT box##2##4##(1994-3#2)
the inverted extinction profile##2##4##(2008-3#2)
the inverted hexagonal (HII) phase##2##5##(1990-2#1)(1992-9#1)
the inverted hexagonal##3##3##(1990-2#1)(1990-5#1)(1992-9#1)
the inverted repeats##3##3##(1990-11#1)(1995-8#2)
the inverted##21##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#1)(1992-4#2)(1992-9#1)(1994-3#2)(1995-8#2)(1996-7#2)(2007-12#1)(2008-2#1)(2008-3#5)(2008-5#1)
the investigated compounds##10##3##(1996-3#1)(1997-1#1)(2007-1#1)(2007-11#1)(2008-10#6)
the investigated organs##2##3##(2008-5#1)(2013-8#1)
the investigated samples##2##3##(2008-10#2)
the investigated species##5##3##(2007-12#4)(2008-4#1)
the investigated##67##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-3#1)(1994-6#1)(1995-11#1)(1995-3#2)(1996-3#1)(1996-6#1)(1997-1#1)(2005-11#2)(2007-1#1)(2007-11#2)(2007-12#5)(2007-8#2)(2008-10#24)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
the investigation and treatment of##2##5##(2007-12#1)(2010-3#1)
the investigation and##9##3##(1992-1#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#1)(2010-3#1)(2010-4#1)
the investigation are##4##3##(1991-3#1)(1991-9#1)(2006-5#1)(2008-3#1)
the investigation carried out##2##4##(2008-2#1)(2009-10#1)
the investigation of a child##2##5##(1991-3#1)(2005-11#1)
the investigation of children with##2##5##(1996-6#1)(2013-1#1)
the investigation of complex##2##4##(1994-6#1)(2008-12#1)
the investigation of human##2##4##(1992-8#1)(2008-11#1)
the investigation of its##2##4##(2008-10#1)(2009-8#1)
the investigation of large##2##4##(2008-11#1)(2010-12#1)
the investigation of many##2##4##(2006-10#1)(2008-9#1)
the investigation of several##2##4##(1991-5#1)(1993-1#1)
the investigation of such##2##4##(2005-9#1)(2008-12#1)
the investigation of the##18##4##(1991-5#1)(1993-3#1)(1995-11#1)(1996-12#1)(1996-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2008-10#5)(2008-11#1)(2008-4#2)(2010-12#1)(2011-1#1)
the investigation of these##3##4##(1991-6#1)(1997-8#1)(2010-9#1)
the investigation of this##2##4##(1996-3#1)(2008-10#1)
the investigation of##124##3##(1990-12#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-3#1)(1993-7#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-11#3)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-11#1)(2005-9#2)(2006-10#4)(2006-11#1)(2006-12#3)(2006-4#1)(2006-5#3)(2007-11#1)(2007-12#4)(2007-5#1)(2007-6#1)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#4)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-11#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#1)
the investigation on##3##3##(2005-12#1)(2008-11#1)(2013-1#1)
the investigation was##14##3##(1990-6#1)(1991-11#1)(1991-12#1)(1992-8#1)(2005-1#1)(2007-11#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-11#1)(2010-9#2)(2011-1#1)
the investigation##183##2##(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-3#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-11#2)(1993-3#2)(1993-7#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-11#3)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-1#1)(2005-1#1)(2005-11#2)(2005-12#1)(2005-9#2)(2006-10#4)(2006-11#1)(2006-12#3)(2006-4#1)(2006-5#4)(2006-6#2)(2006-8#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-5#2)(2007-6#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#18)(2008-11#6)(2008-12#3)(2008-2#4)(2008-3#4)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#2)(2009-4#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-9#3)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#2)(2013-8#1)
the investigational##3##2##(2006-7#1)(2008-11#1)(2012-12#1)
the investigations of##5##3##(1996-5#1)(1997-7#1)(2008-1#1)(2008-10#1)(2013-8#1)
the investigations##18##2##(1990-4#1)(1991-8#1)(1996-5#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2009-4#1)(2009-5#1)(2012-2#1)(2013-1#1)(2013-8#2)
the investigative##2##2##(2007-11#1)(2008-8#1)
the investigator to##5##3##(2008-11#1)(2008-4#3)(2010-12#1)
the investigator##21##2##(1991-1#1)(1993-11#1)(1994-6#1)(2005-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#5)(2008-8#1)(2008-9#1)(2010-12#2)(2011-2#2)
the investigator's##2##2##(2008-4#1)(2008-9#1)
the investigators and##2##3##(1996-8#1)(2012-12#1)
the investigators##10##2##(1990-12#1)(1993-10#1)(1994-5#1)(1996-8#1)(2007-10#1)(2007-2#1)(2008-6#1)(2011-2#1)(2012-12#2)
the investment dimension##2##3##(2007-12#2)
the investment in workers##3##4##(2008-8#3)
the investment of the '90s##2##5##(1994-3#2)
the investment of##3##3##(1994-3#2)(1995-1#1)
the investment##16##2##(1994-3#2)(1995-1#1)(2005-7#1)(2007-12#2)(2008-5#1)(2008-8#3)(2008-9#2)(2010-12#1)(2010-5#1)(2012-12#2)
the invisible hand##2##3##(2007-4#1)(2008-7#1)
the invisible##6##2##(1993-12#1)(2007-10#1)(2007-4#1)(2008-2#1)(2008-7#1)(2011-2#1)
the invitation##2##2##(1992-3#1)(2008-11#1)
the involuntary##4##2##(1990-11#1)(1990-2#1)(2006-9#1)(2008-7#1)
the involved area##2##3##(1990-8#1)(2007-12#1)
the involved bone##2##3##(2008-9#1)(2009-3#1)
the involved leg##2##3##(2008-12#1)(2009-10#1)
the involved mechanism##2##3##(2008-4#1)(2012-2#1)
the involved##44##2##(1990-8#1)(1992-12#1)(1993-6#1)(1994-7#1)(1995-5#1)(1996-12#1)(1996-3#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#3)(2008-7#4)(2008-9#2)(2009-10#1)(2009-3#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-8#1)
the involvement in##3##3##(1993-12#1)(2009-10#2)
the involvement of G proteins in##3##6##(1991-9#2)(1993-3#1)
the involvement of NF-kappaB##2##4##(2007-11#1)(2010-3#1)
the involvement of PKC in##3##5##(1996-12#1)(1997-1#1)(2008-4#1)
the involvement of PKC##5##4##(1994-12#1)(1995-3#1)(1996-12#1)(1997-1#1)(2008-4#1)
the involvement of RNA ligase in##2##6##(1995-3#2)
the involvement of a more##2##5##(2008-10#1)(2008-11#1)
the involvement of a##22##4##(1990-2#1)(1990-6#1)(1991-11#1)(1992-1#1)(1992-3#1)(1992-4#1)(1993-8#1)(1994-3#1)(1995-2#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-9#1)(1997-4#1)(1997-7#1)(2008-10#2)(2008-11#3)(2008-4#1)(2010-2#1)
the involvement of additional##2##4##(1995-3#1)(2009-2#1)
the involvement of an##3##4##(1995-2#1)(1995-3#1)(1997-3#1)
the involvement of cytochrome##2##4##(1991-5#1)(2013-8#1)
the involvement of different##4##4##(1990-3#1)(1992-6#1)(2008-7#1)(2009-2#1)
the involvement of each##2##4##(1995-3#1)(2011-2#1)
the involvement of endogenous##5##4##(1994-8#1)(1995-12#1)(1997-8#1)(2008-11#2)
the involvement of key##2##4##(1990-10#1)(2008-8#1)
the involvement of lipids in##3##5##(1994-2#1)(2008-5#1)(2008-8#1)
the involvement of multiple##3##4##(1991-8#1)(1996-2#1)(2007-3#1)
the involvement of nitric oxide in##2##6##(1996-5#1)(2011-1#1)
the involvement of one##2##4##(2007-8#1)(2008-10#1)
the involvement of other##2##4##(1992-7#1)(2012-12#1)
the involvement of oxidative stress##2##5##(2008-11#2)
the involvement of protein kinase C##2##6##(1991-2#1)(1991-8#1)
the involvement of protein kinases##2##5##(1996-10#1)(1997-1#1)
the involvement of protein##6##4##(1991-2#1)(1991-8#1)(1994-2#1)(1996-10#1)(1997-1#1)(1997-8#1)
the involvement of proteins##2##4##(2008-10#1)(2013-1#1)
the involvement of the frontal lobe##2##6##(2008-9#2)
the involvement of the heme in##2##6##(1993-6#2)
the involvement of the##43##4##(1990-11#1)(1990-12#1)(1991-10#1)(1991-11#1)(1991-6#1)(1992-3#1)(1993-12#1)(1993-6#2)(1993-7#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-9#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-6#2)(2007-8#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-1#1)
the involvement of these##3##4##(1994-5#1)(2005-8#1)(2008-10#1)
the involvement of this gene##2##5##(1990-11#1)(1991-5#1)
the involvement of this##9##4##(1990-11#1)(1990-12#2)(1991-5#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-10#1)
the involvement of two##2##4##(2007-8#1)(2009-8#1)
the involvement of##275##3##(1990-10#3)(1990-11#4)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1991-10#3)(1991-11#2)(1991-2#1)(1991-3#1)(1991-5#4)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#3)(1992-1#1)(1992-11#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#4)(1992-7#2)(1992-8#3)(1992-9#1)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#2)(1993-4#2)(1993-6#2)(1993-7#1)(1993-8#2)(1994-11#1)(1994-12#4)(1994-2#4)(1994-3#4)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#8)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#5)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#3)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#2)(1997-7#2)(1997-8#2)(2003-11#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-8#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-3#1)(2007-5#1)(2007-6#2)(2007-8#5)(2008-1#4)(2008-10#16)(2008-11#14)(2008-12#1)(2008-3#1)(2008-4#7)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#2)(2009-4#1)(2009-6#2)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#5)(2011-2#8)(2012-1#2)(2012-12#2)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#2)
the involvement##281##2##(1990-10#3)(1990-11#4)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1991-10#3)(1991-11#2)(1991-2#1)(1991-3#1)(1991-5#4)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#3)(1992-1#1)(1992-11#2)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#4)(1992-7#2)(1992-8#3)(1992-9#1)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#2)(1993-6#2)(1993-7#1)(1993-8#2)(1994-11#1)(1994-12#4)(1994-2#4)(1994-3#4)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#8)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#5)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#3)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#2)(1997-7#2)(1997-8#2)(2003-11#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-8#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-3#1)(2007-5#1)(2007-6#2)(2007-8#5)(2008-1#4)(2008-10#17)(2008-11#14)(2008-12#1)(2008-3#1)(2008-4#7)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#2)(2009-10#4)(2009-12#1)(2009-2#2)(2009-4#1)(2009-6#2)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#5)(2011-2#8)(2012-1#2)(2012-12#2)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#2)
the involvements of##2##3##(2010-4#1)(2012-2#1)
the inward K(+) current##4##4##(2008-8#4)
the inward current##2##3##(1995-12#1)(1997-5#1)
the inward proton channel##2##4##(1992-11#2)
the inward rectifier##4##3##(1993-12#1)(1995-2#1)(2008-8#1)(2013-7#1)
the inward##14##2##(1990-3#1)(1992-11#2)(1993-12#1)(1995-12#1)(1995-2#1)(1997-2#1)(1997-5#1)(2008-8#5)(2013-7#1)
the inwardly rectifying##3##3##(1994-3#1)(1995-12#1)(2008-6#1)
the iodate##3##2##(2008-10#3)
the iodide electrode##2##3##(2008-10#2)
the iodide##7##2##(1996-2#1)(1996-9#1)(2007-8#2)(2008-10#3)
the iodination##2##2##(1994-9#2)
the iodine administration rate##2##4##(2008-7#2)
the iodine content of salt##2##5##(2006-4#1)(2007-2#1)
the iodine content of##4##4##(2006-4#1)(2007-2#3)
the iodine##13##2##(2005-11#2)(2005-4#1)(2006-4#3)(2007-2#3)(2008-10#1)(2008-7#3)
the iodometric determination##2##3##(2008-10#2)
the iodometric##3##2##(2008-10#3)
the ion associate##5##3##(2008-10#5)
the ion associates##2##3##(2008-10#2)
the ion association##6##3##(2008-10#6)
the ion chamber##2##3##(2009-11#2)
the ion channel##3##3##(1994-2#1)(1996-1#1)(2006-12#1)
the ion complexation##2##3##(2005-11#1)(2008-10#1)
the ion concentration##3##3##(2006-6#1)(2010-2#1)(2012-2#1)
the ion exchange##6##3##(1996-9#1)(1997-7#1)(2008-10#4)
the ion exchanger sites##3##4##(2008-10#3)
the ion exchanger##8##3##(2008-10#8)
the ion motion##2##3##(2008-10#2)
the ion pair##9##3##(2008-10#7)(2008-5#1)(2010-6#1)
the ion permeation##2##3##(2006-10#2)
the ion selectivity##2##3##(1994-6#1)(1995-5#1)
the ion species##2##3##(1990-11#1)(2008-10#1)
the ion transport##3##3##(1996-2#1)(1997-1#2)
the ion##84##2##(1990-11#1)(1990-12#1)(1990-3#1)(1992-6#1)(1994-2#1)(1994-6#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-1#2)(1997-7#1)(2004-9#1)(2005-11#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-6#1)(2008-10#48)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#2)(2010-2#1)(2010-3#1)(2010-6#1)(2012-2#1)(2013-8#1)
the ion-association##2##2##(2008-10#2)
the ion-cycle##2##2##(2008-8#2)
the ion-exchange chromatography##3##3##(1996-6#1)(1996-8#1)(1997-2#1)
the ion-exchange column##2##3##(1996-8#2)
the ion-exchange##13##2##(1996-6#1)(1996-8#4)(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#3)(2008-6#1)(2008-7#1)
the ion-pair complex of##2##4##(2008-10#2)
the ion-pair complex##3##3##(2008-10#3)
the ion-pair extraction constant of##2##5##(2008-10#2)
the ion-pair extraction##4##3##(2008-10#4)
the ion-pair formation##3##3##(2008-10#3)
the ion-pair##17##2##(1992-1#1)(2005-4#1)(2008-10#15)
the ion-pairing reagent##5##3##(1990-1#1)(1997-3#2)(2008-10#2)
the ion-pairing##10##2##(1990-1#1)(1990-11#1)(1997-3#2)(2008-10#6)
the ion-selective##2##2##(2008-10#1)(2013-7#1)
the ion-transporting##2##2##(2008-7#2)
the ionic composition##2##3##(1990-2#1)(2008-11#1)
the ionic conduction##2##3##(2008-10#2)
the ionic current##2##3##(1993-3#1)(2009-5#1)
the ionic liquid##4##3##(2007-10#2)(2008-10#1)(2009-3#1)
the ionic pair##2##3##(2008-10#1)(2010-5#1)
the ionic strength and pH##2##5##(1990-12#1)(1997-3#1)
the ionic strength and##7##4##(1990-12#1)(1990-2#1)(1997-3#1)(2008-10#2)(2009-5#1)(2013-1#1)
the ionic strength but##2##4##(1993-11#1)(2008-10#1)
the ionic strength in##2##4##(1991-2#1)(2008-10#1)
the ionic strength of the solution##2##6##(1990-5#1)(2005-11#1)
the ionic strength of the##8##5##(1990-5#1)(1991-2#1)(1991-7#1)(1992-6#1)(1994-8#1)(1997-2#1)(2005-11#1)(2008-5#1)
the ionic strength of##9##4##(1990-5#1)(1991-2#1)(1991-7#1)(1992-6#1)(1994-8#1)(1997-2#1)(2005-11#1)(2008-10#1)(2008-5#1)
the ionic strength##41##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-2#4)(1991-7#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-8#2)(1995-1#2)(1995-2#2)(1996-9#1)(1997-2#3)(1997-3#1)(2005-11#3)(2008-10#10)(2008-5#1)(2009-4#1)(2009-5#1)(2013-1#1)
the ionic##80##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1991-2#4)(1991-5#1)(1991-7#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-8#2)(1995-1#2)(1995-2#2)(1996-1#1)(1996-2#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-7#1)(2005-11#6)(2007-10#2)(2007-12#1)(2008-10#23)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#2)(2010-4#1)(2010-5#1)(2010-7#1)(2012-2#1)(2013-1#1)
the ionisation of##3##3##(2008-10#3)
the ionisation##5##2##(2008-10#5)
the ionizable##2##2##(1996-5#1)(2008-4#1)
the ionization of a##2##4##(1993-3#1)(1995-5#1)
the ionization of##5##3##(1993-11#1)(1993-3#1)(1995-5#1)(2008-10#2)
the ionization state of the##2##5##(2005-11#1)(2006-10#1)
the ionization state of##3##4##(1991-7#1)(2005-11#1)(2006-10#1)
the ionization##17##2##(1991-7#1)(1993-11#1)(1993-3#1)(1995-5#1)(2005-11#1)(2006-10#2)(2008-10#6)(2008-3#2)(2011-1#1)(2013-8#1)
the ionized##4##2##(1991-5#1)(1993-2#1)(2008-2#1)(2011-1#1)
the ionizing radiation##3##3##(1994-12#1)(1995-1#1)(2008-2#1)
the ionizing##4##2##(1994-12#1)(1995-1#1)(1995-5#1)(2008-2#1)
the ionomer##2##2##(1990-2#1)(2010-4#1)
the ionophore A23187##2##3##(1990-7#1)(1992-4#1)
the ionophore##11##2##(1990-7#1)(1992-4#1)(1993-3#1)(2006-6#1)(2007-8#1)(2008-10#6)
the ionophores##3##2##(2008-10#3)
the ionotropic##3##2##(1993-11#1)(1994-2#1)(1995-7#1)
the ions are##2##3##(2007-12#1)(2008-7#1)
the ions of##3##3##(2006-10#1)(2008-5#1)(2008-9#1)
the ions##17##2##(1993-2#1)(1995-8#1)(2005-11#1)(2005-4#2)(2006-10#2)(2007-12#2)(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2012-11#1)
the ipsative method##2##3##(1992-3#2)
the ipsi- and contralateral##2##4##(1996-9#1)(2007-12#1)
the ipsi- and##3##3##(1996-9#1)(2007-12#1)(2007-8#1)
the ipsilateral SNR##2##3##(1995-12#2)
the ipsilateral and contralateral##4##4##(1996-9#1)(1997-8#1)(2008-6#1)(2008-7#1)
the ipsilateral but not##2##4##(1996-5#2)
the ipsilateral cortex##4##3##(1994-10#1)(1995-12#2)(2008-5#1)
the ipsilateral hemisphere##3##3##(1996-12#1)(2007-10#1)(2009-2#1)
the ipsilateral hippocampus##3##3##(1993-7#1)(1994-10#1)(1996-12#1)
the ipsilateral internal##2##3##(2006-12#1)(2008-12#1)
the ipsilateral knee##3##3##(2009-3#1)(2011-2#1)(2012-12#1)
the ipsilateral limb##2##3##(2008-7#1)(2012-12#1)
the ipsilateral representation in##2##4##(1995-11#2)
the ipsilateral representation##3##3##(1995-11#3)
the ipsilateral side##8##3##(1991-2#1)(1991-8#1)(1993-12#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-8#1)
the ipsilateral striatum and##2##4##(1992-10#2)
the ipsilateral striatum##5##3##(1991-12#1)(1992-10#2)(1995-12#1)(1996-12#1)
the ipsilateral substantia nigra##3##4##(1990-2#2)(1992-10#1)
the ipsilateral superior##2##3##(1991-8#1)(1995-7#1)
the ipsilateral##121##2##(1990-2#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#3)(1991-9#4)(1992-10#3)(1992-11#1)(1992-3#1)(1992-8#2)(1993-12#7)(1993-3#5)(1993-7#1)(1994-10#2)(1994-12#2)(1994-5#1)(1995-10#1)(1995-11#8)(1995-12#6)(1995-7#1)(1996-1#3)(1996-12#4)(1996-2#1)(1996-5#3)(1996-9#4)(1997-3#4)(1997-5#1)(1997-7#2)(1997-8#4)(2004-1#2)(2006-12#2)(2006-3#1)(2006-7#1)(2007-1#1)(2007-10#6)(2007-12#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#3)(2009-2#2)(2009-3#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-12#2)(2013-8#1)
the iridescent##2##2##(2006-7#1)(2008-2#1)
the iridium(III)##2##2##(2008-5#2)
the iris and##5##3##(1993-1#1)(1997-3#1)(1997-6#1)(2008-5#1)(2011-1#1)
the iris##8##2##(1993-1#1)(1996-5#2)(1997-3#1)(1997-6#1)(2008-5#1)(2011-1#2)
the iron and copper##3##4##(2008-10#1)(2012-12#2)
the iron and##7##3##(1994-5#1)(1995-5#1)(2006-4#1)(2008-10#2)(2012-12#2)
the iron atom##5##3##(1991-7#1)(1993-6#1)(1994-5#2)(2007-3#1)
the iron carrier##4##3##(1995-11#3)(2008-5#1)
the iron chalcogenide##4##3##(2008-10#4)
the iron chelator##4##3##(1990-11#1)(1990-4#1)(1995-6#1)(2011-2#1)
the iron concentration in the##2##5##(1992-8#1)(2006-10#1)
the iron concentration in##3##4##(1992-8#1)(2006-10#1)(2006-8#1)
the iron concentration##5##3##(1992-8#1)(2006-10#1)(2006-8#1)(2008-10#2)
the iron content##3##3##(1992-3#1)(1994-8#1)(2008-10#1)
the iron overload##2##3##(2013-8#2)
the iron reduction##2##3##(2006-8#1)(2008-10#1)
the iron regulatory##2##3##(1996-7#2)
the iron site##4##3##(1997-7#4)
the iron##93##2##(1990-1#1)(1990-11#1)(1990-12#1)(1990-3#5)(1990-4#1)(1991-5#2)(1991-6#1)(1991-7#2)(1992-3#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#4)(1994-8#3)(1995-10#2)(1995-11#3)(1995-5#1)(1995-6#1)(1996-7#3)(1996-9#1)(1997-4#1)(1997-7#5)(2005-4#1)(2006-1#1)(2006-10#2)(2006-4#1)(2006-8#2)(2006-9#1)(2007-3#2)(2007-7#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-5#1)(2008-7#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-12#3)(2012-2#2)(2013-8#3)
the iron(III) ISE##2##3##(2008-10#2)
the iron(III)##6##2##(1997-7#2)(2008-10#3)(2010-5#1)
the iron-binding##4##2##(1992-4#1)(1992-7#1)(1996-5#1)(2010-12#1)
the iron-carbonyl##2##2##(1994-12#2)
the iron-histidine##4##2##(1990-5#2)(1993-6#1)(1995-1#1)
the iron-sulfur centers##2##3##(1992-3#2)
the iron-sulfur cluster##2##3##(1991-4#1)(1991-7#1)
the iron-sulfur protein##2##3##(1990-5#1)(1991-2#1)
the iron-sulfur##8##2##(1990-5#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-3#3)(1995-2#1)
the iron-sulphur##2##2##(1994-12#1)(2008-7#1)
the ironic##3##2##(1992-5#1)(2005-4#1)(2007-6#1)
the irradiance and##3##3##(2008-3#2)(2012-3#1)
the irradiance of the##2##4##(2007-11#1)(2008-3#1)
the irradiance of##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
the irradiance responsivity##2##3##(2008-2#1)(2008-3#1)
the irradiance##19##2##(2007-11#1)(2008-2#3)(2008-3#12)(2008-7#1)(2011-1#1)(2012-3#1)
the irradiances from##2##3##(2008-2#2)
the irradiances##4##2##(2008-2#3)(2008-3#1)
the irradiated lung##2##3##(1993-2#1)(1993-6#1)
the irradiated regions##2##3##(2007-8#1)(2008-3#1)
the irradiated solution##2##3##(1992-6#1)(2010-12#1)
the irradiated##26##2##(1992-6#1)(1993-2#1)(1993-6#1)(1995-10#3)(2005-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-3#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
the irradiation of##5##3##(1990-1#2)(1994-5#1)(2008-10#1)(2012-2#1)
the irradiation time##6##3##(2008-10#3)(2008-8#1)(2009-3#1)(2011-2#1)
the irradiation##28##2##(1990-1#2)(1991-2#1)(1992-2#1)(1994-3#1)(1994-5#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-4#1)(2010-5#2)(2011-2#1)(2012-2#1)(2013-8#2)
the irregular##4##2##(2007-1#1)(2007-9#1)(2008-5#1)(2008-9#1)
the irregularly##2##2##(1997-8#1)(2007-8#1)
the irreversibility of the##2##4##(1991-5#1)(1992-11#1)
the irreversibility of##3##3##(1991-5#1)(1991-9#1)(1992-11#1)
the irreversibility##4##2##(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)
the irreversible inhibitor##2##3##(1991-10#1)(1997-6#1)
the irreversible inhibitors##2##3##(1992-8#1)(1995-11#1)
the irreversible thermal denaturation of yeast phosphoglycerate kinase##2##8##(1991-2#2)
the irreversible thermal denaturation of##3##5##(1991-2#2)(2006-10#1)
the irreversible##25##2##(1990-5#1)(1991-10#1)(1991-2#2)(1991-9#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-8#1)(1995-9#1)(1997-6#2)(2006-10#1)(2007-7#1)(2008-1#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
the irrigation season##2##3##(2008-10#2)
the irrigation treatments##2##3##(2008-10#2)
the irrigation##9##2##(2007-3#1)(2008-10#8)
the irritable bowel##3##3##(1990-8#1)(2006-8#1)(2013-1#1)
the irritable##4##2##(1990-8#1)(2006-8#1)(2009-2#1)(2013-1#1)
the irritation potential of##4##4##(2008-5#4)
the irritation##8##2##(1994-6#1)(2007-1#1)(2008-5#5)(2011-3#1)
the isatin##2##2##(1997-3#1)(2005-8#1)
the ischaemic cardiomyopathy group##2##4##(2008-10#2)
the ischaemic period##2##3##(1996-1#1)(2004-12#1)
the ischaemic##13##2##(1996-1#1)(1997-1#1)(2004-12#1)(2005-1#4)(2007-9#1)(2008-10#5)
the ischemia##6##2##(1993-2#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-6#1)(2007-8#1)
the ischemia-induced release of##2##4##(1995-3#2)
the ischemia-induced##4##2##(1992-9#1)(1994-2#1)(1995-3#2)
the ischemia-reperfusion##2##2##(1996-9#1)(2008-1#1)
the ischemia/reperfusion-evoked##2##2##(1997-5#2)
the ischemic and##2##3##(1992-9#1)(1995-6#1)
the ischemic area##2##3##(2007-10#1)(2007-9#1)
the ischemic cardiopathy##2##3##(2008-10#2)
the ischemic cascade##2##3##(2008-2#1)(2009-10#1)
the ischemic focus##2##3##(2010-12#2)
the ischemic injury##3##3##(1995-2#1)(1997-8#1)(2007-9#1)
the ischemic insult##3##3##(1993-3#2)(2008-2#1)
the ischemic myocardium##3##3##(1990-4#1)(2008-10#1)(2008-7#1)
the ischemic penumbra##6##3##(2007-9#5)(2008-2#1)
the ischemic period##4##3##(1994-10#2)(2007-9#1)(2010-3#1)
the ischemic stress##2##3##(1996-12#1)(1996-9#1)
the ischemic zone##2##3##(2008-8#1)(2010-12#1)
the ischemic##58##2##(1990-4#1)(1990-8#1)(1992-9#1)(1993-3#3)(1994-10#2)(1994-2#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#2)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-11#1)(2006-4#1)(2006-6#1)(2007-10#3)(2007-9#10)(2008-1#1)(2008-10#4)(2008-2#3)(2008-7#1)(2008-8#2)(2009-10#1)(2010-12#4)(2010-3#1)(2010-6#1)(2011-2#2)(2013-1#1)
the ischium##3##2##(2008-6#2)(2013-1#1)
the island and##3##3##(1993-7#1)(2008-1#1)(2011-1#1)
the island of##10##3##(1995-6#1)(2008-10#3)(2008-5#1)(2011-1#2)(2011-2#2)(2013-8#1)
the island##33##2##(1993-7#4)(1994-6#1)(1995-6#1)(2006-8#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-2#1)(2011-1#5)(2011-2#3)(2013-8#3)
the island's##3##2##(1993-7#1)(2007-5#1)(2011-2#1)
the islands and##2##3##(2006-5#1)(2007-9#1)
the islands##7##2##(1996-12#2)(2006-5#3)(2007-10#1)(2007-9#1)
the islet cells##2##3##(1996-6#1)(2007-5#1)
the islet##23##2##(1991-7#1)(1992-6#3)(1995-10#1)(1995-3#1)(1995-8#4)(1996-6#2)(2007-5#2)(2008-11#1)(2009-8#1)(2010-10#2)(2010-11#5)
the islets of Langerhans##2##4##(1995-8#1)(1997-4#1)
the islets of##5##3##(1994-8#1)(1995-8#1)(1997-4#1)(2010-12#1)(2011-2#1)
the islets##18##2##(1991-2#2)(1994-8#1)(1995-2#1)(1995-8#1)(1997-4#1)(2008-11#3)(2008-5#1)(2010-11#6)(2010-12#1)(2011-2#1)
the isoalloxazine ring of the##2##5##(1990-4#1)(1992-1#1)
the isoalloxazine ring of##3##4##(1990-4#1)(1992-1#1)(1996-8#1)
the isocenter##6##2##(2007-6#3)(2008-3#2)(2010-9#1)
the isochromatic dye##3##3##(2005-4#3)
the isochromatic fringes##2##3##(2008-3#2)
the isochromatic##7##2##(2005-4#3)(2008-2#1)(2008-3#3)
the isochromatics##2##2##(2008-2#1)(2008-3#1)
the isocitrate dehydrogenase reaction##2##4##(2006-10#2)
the isocitrate##5##2##(1990-5#1)(2006-10#2)(2008-10#2)
the isoclinic##2##2##(2007-12#1)(2008-3#1)
the isocortex##4##2##(1994-8#1)(1997-6#3)
the isocratic##2##2##(2008-10#2)
the isoelectric point of the##2##5##(2005-11#1)(2008-11#1)
the isoelectric point of##3##4##(1990-12#1)(2005-11#1)(2008-11#1)
the isoelectric point##9##3##(1990-12#1)(1990-7#1)(1991-8#1)(1993-4#1)(2005-11#3)(2008-11#1)(2008-7#1)
the isoelectric points of##2##4##(2005-11#2)
the isoelectric points##4##3##(2005-11#2)(2008-10#2)
the isoelectric##14##2##(1990-12#1)(1990-7#1)(1991-8#1)(1993-4#1)(2005-11#5)(2008-10#3)(2008-11#1)(2008-7#1)
the isoenzyme##7##2##(1991-11#1)(1991-8#1)(1992-3#1)(1993-1#2)(1993-11#1)(2008-6#1)
the isoenzymes##4##2##(1991-5#1)(1993-11#2)(2013-1#1)
the isoflavone glucoside was##2##4##(2008-11#2)
the isoflavone##5##2##(1992-3#1)(1993-12#1)(2006-12#1)(2008-11#2)
the isoflavones##4##2##(1991-8#1)(1993-12#1)(1996-3#1)(2010-1#1)
the isoform difference of mammalian metallothionein##2##6##(1996-12#2)
the isoform of##2##3##(1993-4#1)(2008-12#1)
the isoform##7##2##(1993-11#1)(1993-4#1)(1996-12#3)(2008-10#1)(2008-12#1)
the isoforms and##2##3##(1995-10#1)(1995-6#1)
the isoforms##11##2##(1991-1#1)(1992-8#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-3#1)(1995-6#1)(1996-12#1)(2005-8#1)(2008-11#1)
the isogenic wild type##3##4##(1993-11#1)(1993-3#1)(2008-10#1)
the isoka##3##2##(2006-8#3)
the isolate from##2##3##(2008-10#1)(2008-7#1)
the isolate is##2##3##(2005-11#1)(2008-10#1)
the isolate was##4##3##(2007-12#2)(2008-10#2)
the isolate##28##2##(1997-6#1)(2005-11#2)(2007-12#3)(2008-10#17)(2008-5#1)(2008-7#1)(2011-12#1)(2011-2#1)(2012-12#1)
the isolated C-peptide##2##3##(1990-8#2)
the isolated alpha subunit##3##4##(1994-3#3)
the isolated beta##2##3##(1992-3#1)(1994-3#1)
the isolated cDNA##2##3##(1996-5#1)(1997-4#1)
the isolated complex##4##3##(1992-6#1)(1993-3#1)(1994-10#1)(1997-6#1)
the isolated compounds##6##3##(2006-12#1)(2007-1#2)(2008-11#1)(2010-2#1)(2013-1#1)
the isolated enzyme##5##3##(1990-7#1)(1992-3#1)(1993-11#1)(1994-9#1)(1997-6#1)
the isolated enzymes##2##3##(1993-8#1)(1993-9#1)
the isolated gamma subunit##3##4##(2008-8#3)
the isolated guinea pig trachea##2##5##(1993-3#2)
the isolated guinea pig##3##4##(1991-5#1)(1993-3#2)
the isolated guinea-pig##2##3##(1993-3#1)(1997-7#1)
the isolated hepatocytes##2##3##(1990-11#1)(1996-2#1)
the isolated nuclei##2##3##(2008-2#1)(2008-8#1)
the isolated perfused rat liver##2##5##(1996-12#2)
the isolated perfused rat##9##4##(1990-12#1)(1990-3#1)(1991-6#1)(1996-10#3)(1996-12#3)
the isolated perfused##11##3##(1990-12#1)(1990-3#1)(1991-6#1)(1996-10#3)(1996-12#3)(1997-5#1)(2008-4#1)
the isolated protein was##2##4##(1993-11#1)(1993-2#1)
the isolated protein##3##3##(1993-11#1)(1993-2#1)(1994-12#1)
the isolated rabbit##4##3##(1991-9#1)(1996-10#1)(1997-8#2)
the isolated rat heart##2##4##(1991-1#1)(1996-9#1)
the isolated rat hepatocyte##2##4##(1994-8#2)
the isolated rat##5##3##(1991-1#1)(1994-8#2)(1996-8#1)(1996-9#1)
the isolated strains were##2##4##(1991-3#1)(2006-10#1)
the isolated strains##6##3##(1991-3#2)(1992-10#1)(2006-10#1)(2006-8#1)(2007-10#1)
the isolated structures##2##3##(1995-3#1)(2013-8#1)
the isolated##194##2##(1990-10#2)(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#3)(1990-7#3)(1990-8#3)(1991-1#2)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#4)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#5)(1993-12#1)(1993-2#1)(1993-3#5)(1993-4#1)(1993-6#3)(1993-8#3)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#2)(1994-8#3)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-7#2)(1995-8#2)(1996-10#6)(1996-12#7)(1996-2#2)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-5#2)(1997-6#4)(1997-7#1)(1997-8#5)(2004-12#1)(2006-10#2)(2006-12#2)(2006-8#2)(2007-1#4)(2007-10#3)(2007-11#1)(2007-4#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#10)(2008-2#4)(2008-4#2)(2008-5#4)(2008-6#1)(2008-8#6)(2008-9#1)(2009-10#1)(2009-2#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-12#2)(2013-1#2)(2013-8#1)
the isolates adapted to##2##4##(2008-10#2)
the isolates and##3##3##(2008-10#1)(2008-12#2)
the isolates belonged to##3##4##(2008-10#3)
the isolates could be##2##4##(2008-10#2)
the isolates from the##2##4##(2008-10#1)(2008-5#1)
the isolates from##14##3##(1992-2#1)(1997-4#1)(2007-7#1)(2008-10#6)(2008-5#4)(2013-1#1)
the isolates in VCG##4##4##(2008-10#4)
the isolates in##9##3##(2008-10#7)(2008-5#2)
the isolates into two##3##4##(2008-10#3)
the isolates into##6##3##(2008-10#5)(2010-4#1)
the isolates obtained from##2##4##(2006-3#1)(2008-10#1)
the isolates of F##2##4##(2008-10#2)
the isolates of##11##3##(1990-6#1)(1997-6#1)(2006-10#1)(2008-10#6)(2008-12#2)
the isolates tested##3##3##(2008-12#1)(2008-5#2)
the isolates that##4##3##(1995-2#1)(2008-10#3)
the isolates was##3##3##(2006-8#1)(2007-8#1)(2008-10#1)
the isolates were able to##2##5##(2011-2#2)
the isolates were found to##2##5##(2006-5#1)(2007-7#1)
the isolates were found##3##4##(2006-5#1)(2007-7#2)
the isolates were identified##3##4##(2006-8#1)(2007-7#1)(2008-10#1)
the isolates were sensitive to##3##5##(2007-7#1)(2007-8#1)(2008-10#1)
the isolates were susceptible to##6##5##(1993-1#1)(2006-8#1)(2008-11#1)(2008-5#2)(2010-4#1)
the isolates were the##2##4##(1991-8#1)(2008-10#1)
the isolates were##36##3##(1991-8#1)(1993-1#1)(1996-12#1)(2006-5#1)(2006-8#2)(2007-7#4)(2007-8#2)(2008-10#13)(2008-11#1)(2008-5#3)(2008-7#2)(2010-4#1)(2011-2#4)
the isolates##156##2##(1990-6#1)(1991-3#1)(1991-8#1)(1992-2#1)(1993-1#1)(1993-10#1)(1995-2#1)(1996-12#2)(1997-3#1)(1997-4#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-8#3)(2007-1#1)(2007-7#8)(2007-8#3)(2008-10#77)(2008-11#2)(2008-12#7)(2008-5#14)(2008-6#1)(2008-7#3)(2010-10#1)(2010-12#1)(2010-4#3)(2010-8#1)(2011-1#1)(2011-2#8)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
the isolating process of##3##4##(2005-11#3)
the isolating##4##2##(2005-11#3)(2008-8#1)
the isolation and analysis of##2##5##(1993-12#1)(2008-4#1)
the isolation and characterization of a novel##4##7##(1990-12#1)(1991-4#1)(1993-11#1)(1994-9#1)
the isolation and characterization of a##9##6##(1990-12#1)(1991-4#1)(1991-7#1)(1992-2#1)(1993-11#1)(1993-12#1)(1994-6#1)(1994-9#1)(1997-4#1)
the isolation and characterization of##13##5##(1990-12#1)(1991-12#1)(1991-4#1)(1991-7#1)(1992-2#1)(1993-11#1)(1993-12#1)(1994-6#1)(1994-9#1)(1995-8#1)(1997-4#1)(1997-6#1)(2008-7#1)
the isolation and cloning of##2##5##(2006-10#2)
the isolation and culture of##3##5##(2007-11#1)(2008-11#2)
the isolation and identification of##4##5##(1991-1#1)(1991-8#1)(2008-8#1)(2013-1#1)
the isolation and identification##5##4##(1991-1#1)(1991-8#1)(2007-7#1)(2008-8#1)(2013-1#1)
the isolation and initial characterization of##2##6##(1996-5#1)(2008-4#1)
the isolation and molecular##2##4##(1996-2#1)(2008-10#1)
the isolation and purification of##4##5##(2007-11#1)(2008-1#1)(2008-11#1)(2011-1#1)
the isolation and sequencing of##2##5##(1991-6#1)(1997-7#1)
the isolation and##49##3##(1990-12#1)(1990-4#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-2#1)(1993-11#1)(1993-12#3)(1993-6#1)(1994-6#1)(1994-9#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#2)(2006-12#1)(2007-11#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-4#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
the isolation from##2##3##(1995-6#1)(2008-10#1)
the isolation of M##2##4##(2008-9#1)(2011-2#1)
the isolation of a cDNA clone##4##6##(1994-3#1)(1994-8#1)(1995-1#1)(2008-2#1)
the isolation of a cDNA##8##5##(1992-11#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(2008-2#1)
the isolation of a gene##2##5##(1994-3#1)(2008-8#1)
the isolation of a novel cDNA##2##6##(1991-2#1)(1992-2#1)
the isolation of a##28##4##(1990-2#1)(1990-6#1)(1991-2#2)(1991-5#1)(1992-11#1)(1992-2#1)(1994-11#2)(1994-3#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-2#1)(1995-8#1)(2007-1#3)(2008-11#2)(2008-2#1)(2008-8#1)(2009-10#1)(2011-1#1)
the isolation of an##4##4##(1990-7#1)(1996-2#1)(2006-12#1)(2008-5#1)
the isolation of hemicelluloses##2##4##(2008-5#2)
the isolation of several##2##4##(1994-12#1)(2008-4#1)
the isolation of six##2##4##(2010-2#1)(2013-1#1)
the isolation of specific##2##4##(2008-1#1)(2008-11#1)
the isolation of the##15##4##(1991-11#1)(1991-8#2)(1993-9#1)(1994-8#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-7#1)(2006-12#2)(2008-10#3)(2008-2#1)
the isolation of these##2##4##(1995-11#1)(2012-12#1)
the isolation of this##2##4##(1996-5#1)(2008-5#1)
the isolation of two independent##2##5##(1991-12#1)(2006-12#1)
the isolation of two##6##4##(1990-5#1)(1991-12#1)(1997-3#1)(2006-12#1)(2007-1#1)(2010-5#1)
the isolation of##158##3##(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-10#1)(1991-11#4)(1991-12#1)(1991-2#3)(1991-5#3)(1991-7#1)(1991-8#3)(1992-11#1)(1992-2#1)(1992-8#3)(1992-9#1)(1993-4#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-4#2)(1994-6#1)(1994-8#4)(1994-9#3)(1995-1#2)(1995-11#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#2)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2006-12#6)(2006-8#1)(2007-1#6)(2008-1#5)(2008-10#10)(2008-11#7)(2008-12#1)(2008-2#4)(2008-4#11)(2008-5#7)(2008-7#2)(2008-8#1)(2008-9#5)(2009-10#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#5)(2011-2#2)(2012-11#1)(2012-12#2)(2013-1#1)
the isolation procedures##2##3##(2008-1#1)(2008-11#1)
the isolation process##2##3##(2006-12#1)(2009-12#1)
the isolation rate##2##3##(2010-4#1)(2012-3#1)
the isolation##230##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#4)(1991-12#2)(1991-2#3)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#3)(1991-8#4)(1992-11#1)(1992-12#1)(1992-2#2)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#3)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-4#2)(1994-6#2)(1994-8#4)(1994-9#4)(1995-1#2)(1995-11#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#3)(1996-9#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#2)(2006-12#8)(2006-8#1)(2007-1#6)(2007-11#2)(2007-4#1)(2007-7#1)(2008-1#7)(2008-10#15)(2008-11#14)(2008-12#1)(2008-2#4)(2008-4#16)(2008-5#7)(2008-7#3)(2008-8#2)(2008-9#6)(2009-10#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#6)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)
the isomer##4##2##(1990-11#1)(1996-2#1)(2008-5#1)(2009-9#1)
the isomeric##9##2##(1990-10#1)(1991-3#1)(1992-12#1)(1995-10#1)(1996-5#1)(2006-3#1)(2008-10#1)(2009-10#1)(2011-1#1)
the isomerization of##4##3##(1992-6#1)(1995-10#1)(1995-11#1)(1995-3#1)
the isomerization##8##2##(1992-6#1)(1994-8#1)(1995-10#2)(1995-11#1)(1995-3#1)(2008-10#1)(2008-7#1)
the isomers##8##2##(1990-10#1)(1990-5#1)(2006-12#1)(2007-8#1)(2008-10#2)(2011-10#1)(2013-7#1)
the isometric force##2##3##(1995-12#1)(2006-10#1)
the isometric handgrip exercise##2##4##(2013-8#2)
the isometric handgrip##3##3##(1994-3#1)(2013-8#2)
the isometric##7##2##(1994-3#1)(1995-12#1)(2006-10#1)(2006-4#1)(2007-11#1)(2013-8#2)
the isometry of##2##3##(2007-5#2)
the isopod crustacean##2##3##(1991-3#1)(2008-4#1)
the isopod##3##2##(1991-3#1)(2007-12#1)(2008-4#1)
the isostere##2##2##(1992-8#2)
the isosteric heat##2##3##(2010-4#2)
the isosteric##4##2##(1990-6#1)(2010-4#3)
the isotherm##2##2##(2005-11#2)
the isothermal adsorption##2##3##(1997-2#2)
the isothermal##7##2##(1997-2#4)(2004-9#1)(2008-10#1)(2009-7#1)
the isotherms for the##2##4##(1990-8#1)(2005-11#1)
the isotherms of##2##3##(2005-11#2)
the isotherms##6##2##(1990-8#1)(1994-12#1)(2005-11#3)(2008-10#1)
the isotonic solution##2##3##(2008-10#2)
the isotonic##3##2##(2008-10#3)
the isotope dilution method##3##4##(2008-10#3)
the isotope dilution##5##3##(1990-10#1)(2008-10#4)
the isotope effects##2##3##(1991-7#1)(1995-10#1)
the isotope ratio##2##3##(2008-10#2)
the isotope##14##2##(1990-10#1)(1991-7#1)(1992-3#1)(1994-5#1)(1995-10#1)(2008-10#6)(2008-4#1)(2008-9#1)(2009-9#1)
the isotopic analysis of##2##4##(1997-2#1)(2008-10#1)
the isotopic##4##2##(1997-2#2)(2008-10#2)
the isotopomer##2##2##(2008-7#2)
the isotropic##13##2##(1990-2#1)(1991-5#1)(1996-2#1)(2005-11#1)(2008-10#1)(2008-2#2)(2008-3#5)(2009-11#1)
the isotype of the##2##4##(1990-12#1)(1995-2#1)
the isotype of##3##3##(1990-12#2)(1995-2#1)
the isotype##4##2##(1990-12#2)(1995-2#1)(2008-8#1)
the isozyme##8##2##(1990-10#1)(1990-12#2)(1991-12#1)(1994-12#1)(1995-3#1)(2008-10#1)(2012-5#1)
the isozyme-specific##2##2##(1994-2#1)(1996-8#1)
the isozymes##4##2##(1991-11#2)(1992-6#1)(1993-4#1)
the issue and##5##3##(1991-3#1)(1992-1#1)(1993-5#1)(1994-1#1)(2009-6#1)
the issue in##3##3##(2006-12#1)(2008-4#1)(2012-11#1)
the issue is##4##3##(1994-3#1)(1997-8#1)(2008-10#1)(2008-8#1)
the issue of child##2##4##(2006-4#1)(2010-8#1)
the issue of how##3##4##(1995-12#1)(2006-12#1)(2008-9#1)
the issue of specific##2##4##(2007-11#1)(2008-4#1)
the issue of the##10##4##(1991-3#1)(2006-12#1)(2007-11#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2012-2#1)
the issue of whether##5##4##(1992-2#1)(1995-6#1)(2005-6#1)(2010-6#1)(2011-12#1)
the issue of##103##3##(1991-12#1)(1991-3#1)(1992-2#3)(1992-3#1)(1993-1#1)(1993-2#1)(1993-5#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(2005-6#1)(2006-10#5)(2006-12#3)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-4#3)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#4)(2008-12#3)(2008-2#11)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#3)(2008-9#3)(2009-10#2)(2009-4#2)(2009-6#2)(2010-10#1)(2010-12#3)(2010-6#1)(2010-8#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
the issue that##2##3##(1991-11#1)(1992-12#1)
the issue##155##2##(1991-11#1)(1991-12#1)(1991-3#2)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-5#1)(1993-1#1)(1993-2#2)(1993-5#2)(1994-1#3)(1994-3#3)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-3#1)(1997-8#2)(2005-6#1)(2006-10#7)(2006-11#1)(2006-12#4)(2006-2#1)(2006-4#3)(2006-5#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-4#4)(2007-5#1)(2007-8#1)(2008-1#4)(2008-10#4)(2008-11#4)(2008-12#4)(2008-2#14)(2008-3#1)(2008-4#3)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#4)(2009-10#2)(2009-4#2)(2009-6#3)(2009-7#1)(2010-10#1)(2010-12#3)(2010-6#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#1)
the issues addressed##2##3##(1991-3#1)(2008-8#1)
the issues and challenges##2##4##(2007-10#1)(2008-10#1)
the issues and##8##3##(1991-2#1)(1992-1#1)(1992-2#2)(2007-10#1)(2008-10#1)(2009-6#1)(2012-3#1)
the issues are##2##3##(1997-8#1)(2006-2#1)
the issues associated with the##2##5##(2008-11#2)
the issues associated with##3##4##(2008-10#1)(2008-11#2)
the issues concerning##2##3##(1993-11#1)(2007-12#1)
the issues discussed##2##3##(2008-11#1)(2013-1#1)
the issues faced by##2##4##(1993-12#1)(2007-11#1)
the issues facing##2##3##(1994-1#1)(2008-11#1)
the issues in the process of##2##6##(2012-3#2)
the issues in##3##3##(2012-12#1)(2012-3#2)
the issues involved in choosing##2##5##(1993-9#1)(2008-4#1)
the issues involved in##6##4##(1991-12#2)(1993-2#1)(1993-9#1)(1995-1#1)(2008-4#1)
the issues involved##9##3##(1991-12#2)(1993-2#1)(1993-9#1)(1995-1#1)(2005-5#1)(2007-12#1)(2008-4#1)(2008-9#1)
the issues of training##2##4##(1993-2#2)
the issues of##29##3##(1991-1#1)(1991-3#1)(1991-7#1)(1993-2#2)(1995-2#1)(1997-4#1)(2004-7#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-4#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
the issues raised by##2##4##(2005-7#1)(2008-10#1)
the issues raised in##2##4##(2006-2#1)(2006-9#1)
the issues raised##7##3##(1991-2#1)(2005-7#1)(2006-2#1)(2006-9#1)(2007-10#1)(2008-10#1)(2013-1#1)
the issues related to##4##4##(2008-11#1)(2008-3#1)(2008-8#1)(2009-7#1)
the issues relevant to##2##4##(1992-3#1)(2007-2#1)
the issues surrounding the##2##4##(2008-3#1)(2012-2#1)
the issues surrounding##11##3##(2007-1#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-7#1)(2012-2#1)(2013-8#1)
the issues that need to be addressed##8##7##(2013-8#8)
the issues that##22##3##(1991-3#1)(1997-1#1)(2006-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#1)(2011-2#1)(2013-8#8)
the issues##144##2##(1991-1#2)(1991-12#2)(1991-2#2)(1991-3#4)(1991-7#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-7#1)(2005-11#2)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-11#2)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#2)(2007-4#4)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#11)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#6)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#3)(2009-4#2)(2009-6#2)(2009-7#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#2)(2013-8#11)
the isthmic part##2##3##(1993-12#2)
the isthmic region of##2##4##(1996-5#2)
the isthmic##6##2##(1993-12#2)(1996-5#3)(2007-8#1)
the isthmo-optic nucleus##2##3##(1994-2#2)
the isthmo-optic##3##2##(1994-2#2)(1996-1#1)
the isthmus##4##2##(2007-12#1)(2007-4#1)(2009-7#1)(2013-1#1)
the itch associated with dry skin##2##6##(2008-5#2)
the itching##2##2##(2008-5#2)
the item &quot##2##3##(2009-10#1)(2013-1#1)
the item##7##2##(2006-10#1)(2006-12#1)(2009-10#1)(2010-10#1)(2012-2#2)(2013-1#1)
the items was##2##3##(2012-2#1)(2013-1#1)
the items##17##2##(1990-11#1)(1990-4#1)(1994-2#1)(2006-3#2)(2007-12#1)(2008-10#1)(2008-11#1)(2009-12#1)(2010-11#1)(2012-2#2)(2013-1#5)
the iteration##3##2##(2008-2#3)
the iterative Fourier transform algorithm##3##5##(2008-2#2)(2008-3#1)
the iterative error diffusion algorithm##2##5##(2008-2#2)
the iterative method##3##3##(2005-11#1)(2008-10#1)(2008-3#1)
the iterative##25##2##(1996-7#2)(1996-8#1)(2005-10#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#7)(2008-3#8)
the ivory##2##2##(2007-4#2)
the ivyleaf morning glory##2##4##(2008-8#2)
the jackknife##2##2##(2008-10#1)(2011-2#1)
the jasmonic acid##2##3##(1992-8#1)(2009-8#1)
the jaw is##2##3##(2008-1#2)
the jaw##25##2##(1991-1#1)(1996-8#2)(1997-3#1)(2005-3#1)(2005-7#1)(2006-10#1)(2007-2#1)(2008-1#5)(2008-3#1)(2008-7#2)(2010-12#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#1)
the jaws##18##2##(2007-12#3)(2008-1#3)(2008-5#2)(2011-1#2)(2012-12#3)(2013-1#4)(2013-7#1)
the jejunal##9##2##(1991-11#1)(1991-12#1)(1994-6#1)(1996-11#1)(2004-11#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-5#1)
the jejunum and ileum##2##4##(1996-11#1)(2012-2#1)
the jejunum and##5##3##(1996-11#1)(2008-10#1)(2010-12#1)(2012-2#2)
the jejunum in##2##3##(2008-8#1)(2010-12#1)
the jejunum of##2##3##(2008-10#2)
the jejunum was##2##3##(1991-5#1)(1995-3#1)
the jejunum were##2##3##(1996-11#1)(2008-10#1)
the jejunum##29##2##(1990-5#1)(1990-9#1)(1991-5#1)(1992-5#1)(1995-3#2)(1996-11#3)(1997-5#1)(2004-11#1)(2008-10#4)(2008-6#1)(2008-8#1)(2010-12#4)(2010-5#1)(2011-12#2)(2012-2#2)(2013-7#2)(2013-8#1)
the jelly##4##2##(1992-8#2)(2008-8#2)
the jelly-induced##2##2##(1992-8#2)
the jet nebulizer##3##3##(1991-1#3)
the jet##6##2##(1991-1#3)(2007-12#1)(2008-11#1)(2011-1#1)
the jitter##10##2##(2007-11#4)(2007-12#2)(2008-3#4)
the job and##2##3##(1994-6#1)(2004-8#1)
the job of##3##3##(1995-2#1)(1996-1#1)(2012-12#1)
the job satisfaction of##2##4##(1992-3#1)(2013-1#1)
the job##35##2##(1990-2#1)(1991-2#4)(1992-1#1)(1992-3#1)(1993-12#1)(1993-2#4)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-7#1)(2004-3#1)(2004-8#2)(2007-10#1)(2008-12#1)(2008-2#2)(2008-5#1)(2010-3#1)(2011-1#1)(2012-12#1)(2013-1#1)
the joining of##3##3##(1991-5#1)(2007-12#1)(2008-3#1)
the joining process##2##3##(2009-7#1)(2012-2#1)
the joining##7##2##(1991-11#1)(1991-5#1)(1996-5#1)(2007-12#1)(2008-3#1)(2009-7#1)(2012-2#1)
the joint action##2##3##(1994-11#1)(2008-5#1)
the joint and##4##3##(2005-7#1)(2007-11#1)(2008-12#1)(2008-3#1)
the joint capsule##2##3##(2005-7#1)(2013-1#1)
the joint distribution of##3##4##(1993-5#1)(1997-4#1)(2012-3#1)
the joint distribution##4##3##(1993-5#1)(1997-4#2)(2012-3#1)
the joint effect of##2##4##(2008-9#1)(2012-3#1)
the joint effects##2##3##(2006-11#1)(2012-3#1)
the joint fluid##3##3##(2006-10#1)(2007-11#2)
the joint fractional##2##3##(2008-2#1)(2008-3#1)
the joint from##2##3##(1993-3#1)(2007-7#1)
the joint in##2##3##(2007-11#1)(2012-1#1)
the joint is##5##3##(2006-3#1)(2007-11#1)(2007-8#2)(2011-1#1)
the joint meeting of the##3##5##(2005-12#1)(2008-6#1)(2009-11#1)
the joint observing program Intercal_01##2##5##(2008-3#2)
the joint potency of##2##4##(1994-11#2)
the joint power spectrum##2##4##(2008-2#2)
the joint reaction force##2##4##(2007-7#2)
the joint space##2##3##(1996-9#1)(2007-4#1)
the joint surface of##2##4##(2007-11#2)
the joint surface##5##3##(2007-11#4)(2009-3#1)
the joint surfaces##2##3##(2007-11#1)(2007-8#1)
the joint to##2##3##(2005-7#1)(2007-11#1)
the joint transform correlator (JTC)##3##5##(2008-2#1)(2008-3#2)
the joint transform correlator##8##4##(2008-2#4)(2008-3#4)
the joint transform##11##3##(2008-2#5)(2008-3#6)
the joint was##3##3##(2006-3#2)(2007-11#1)
the joint##151##2##(1990-7#1)(1991-12#1)(1991-3#1)(1992-11#2)(1993-3#1)(1993-5#2)(1993-9#1)(1994-11#3)(1994-3#1)(1995-2#1)(1995-4#1)(1995-9#1)(1996-9#1)(1997-4#2)(2005-12#1)(2005-7#4)(2006-10#3)(2006-11#1)(2006-12#2)(2006-3#7)(2007-11#22)(2007-12#2)(2007-4#2)(2007-5#1)(2007-7#7)(2007-8#13)(2008-1#1)(2008-10#2)(2008-12#2)(2008-2#11)(2008-3#10)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-7#3)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#5)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-3#5)(2013-1#5)
the joint-confidence ellipse##2##3##(2008-10#2)
the joints and##3##3##(1990-6#1)(2007-11#1)(2008-10#1)
the joints of the##4##4##(2007-1#1)(2009-3#1)(2011-1#1)(2012-1#1)
the joints of##7##3##(1991-12#1)(1997-3#1)(2007-1#1)(2007-7#1)(2009-3#1)(2011-1#1)(2012-1#1)
the joints##23##2##(1990-6#1)(1990-7#1)(1991-12#1)(1992-5#1)(1993-3#1)(1997-3#1)(2005-7#1)(2006-4#1)(2007-1#1)(2007-11#4)(2007-7#2)(2008-10#1)(2008-5#1)(2009-2#1)(2009-3#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-1#1)
the journal Atención##3##3##(1995-6#1)(1996-2#1)(1996-4#1)
the journal and##3##3##(2007-11#3)
the journal of##3##3##(2007-12#1)(2013-1#1)(2013-7#1)
the journal will##2##3##(2005-9#1)(2007-11#1)
the journal##39##2##(1990-12#1)(1991-2#1)(1992-2#1)(1992-4#1)(1993-8#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-9#1)(2005-7#2)(2005-9#1)(2007-11#5)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#3)(2010-1#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#6)(2013-7#1)
the journal's##3##2##(1993-6#1)(2007-3#2)
the journals##6##2##(2007-3#1)(2011-1#2)(2012-12#3)
the journey##9##2##(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-2#1)(2010-5#1)
the judge##13##2##(1990-12#1)(1997-1#2)(1997-5#1)(1997-6#1)(2007-10#6)(2009-8#2)
the judgement##2##2##(1996-6#1)(2005-5#1)
the judgment of##3##3##(1991-7#1)(2007-10#2)
the judgment##5##2##(1991-7#1)(2006-4#1)(2007-10#2)(2007-9#1)
the judgments of##2##3##(1993-12#1)(2008-1#1)
the judicial review application of##2##5##(2010-12#2)
the judicial##9##2##(1996-12#1)(1997-1#1)(1997-6#1)(1997-8#1)(2007-10#1)(2008-12#1)(2010-12#2)(2011-2#1)
the judiciary##4##2##(1995-1#1)(2010-9#1)(2011-2#2)
the judicious use of##4##4##(2006-10#1)(2008-4#1)(2009-3#1)(2013-8#1)
the judicious##7##2##(1991-9#1)(2006-10#1)(2008-4#1)(2008-6#1)(2009-3#1)(2010-12#1)(2013-8#1)
the jugular foramen##2##3##(2005-5#1)(2011-2#1)
the jugular vein for##2##4##(1990-2#1)(1990-4#1)
the jugular vein is##2##4##(2007-7#2)
the jugular vein##10##3##(1990-2#1)(1990-4#1)(1997-7#1)(2007-7#4)(2009-6#2)(2012-3#1)
the jugular##16##2##(1990-2#1)(1990-4#1)(1994-7#1)(1996-9#1)(1997-7#1)(2005-5#1)(2006-12#1)(2007-7#4)(2009-6#2)(2011-2#2)(2012-3#1)
the juice sac area##6##4##(2008-10#6)
the juice##12##2##(1992-4#1)(1994-12#1)(2008-10#9)(2012-12#1)
the jump sign##2##3##(2008-12#2)
the jump##11##2##(2005-11#1)(2007-12#3)(2008-12#2)(2008-9#3)(2009-1#1)(2009-4#1)
the jumping spider##2##3##(2007-12#1)(2009-9#1)
the jumping##3##2##(2007-12#1)(2008-8#1)(2009-9#1)
the jumps##3##2##(1993-11#1)(2006-4#1)(2011-2#1)
the jumyo mutant##2##3##(1990-7#2)
the junction between the##5##4##(1990-4#1)(2007-12#1)(2010-10#1)(2012-12#1)(2012-3#1)
the junction between##6##3##(1990-4#1)(1996-7#1)(2007-12#1)(2010-10#1)(2012-12#1)(2012-3#1)
the junction of the##7##4##(1994-11#1)(1994-2#1)(2007-12#2)(2007-8#1)(2008-10#1)(2010-12#1)
the junction of##11##3##(1990-5#1)(1993-9#1)(1994-11#1)(1994-2#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-8#1)(2010-12#1)
the junction region (Ser646 to Gly716)##2##6##(1994-12#2)
the junction region##5##3##(1994-12#4)(2007-12#1)
the junction##40##2##(1990-4#1)(1990-5#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#5)(1994-2#1)(1995-2#1)(1996-12#1)(1996-7#1)(1996-8#2)(1996-9#1)(2004-9#1)(2007-11#1)(2007-12#6)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-10#2)(2010-12#1)(2010-7#1)(2012-12#1)(2012-3#1)
the junctional diversity of##2##4##(2008-4#2)
the junctional foot protein##3##4##(1991-7#1)(1995-6#2)
the junctional##12##2##(1990-2#1)(1991-7#1)(1992-1#1)(1992-7#1)(1993-12#1)(1995-6#2)(1996-12#1)(2006-5#1)(2008-4#2)(2012-11#1)
the junctions##6##2##(1990-7#1)(1996-9#1)(2008-10#2)(2008-4#2)
the jungle##3##2##(2008-10#1)(2012-12#2)
the junior doctor##2##3##(1995-9#1)(2009-7#1)
the junior faculty##2##3##(2009-4#2)
the junior##7##2##(1995-9#1)(2005-12#1)(2009-4#3)(2009-7#1)(2012-12#1)
the junk bond##2##3##(1992-11#2)
the junk##3##2##(1992-11#3)
the jury finding##2##3##(1995-6#1)(1996-2#1)
the jury##6##2##(1990-12#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-5#1)
the justification and##2##3##(1995-1#1)(2010-5#1)
the justification for##2##3##(2007-2#1)(2011-2#1)
the justification##4##2##(1995-1#1)(2007-2#1)(2010-5#1)(2011-2#1)
the juvenile PLL##2##3##(2012-11#2)
the juvenile justice system##5##4##(2007-12#1)(2009-7#3)(2009-8#1)
the juvenile stage##2##3##(2007-5#1)(2008-6#1)
the juvenile##20##2##(1991-12#1)(1995-5#1)(1996-5#1)(1996-8#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-7#3)(2009-8#1)(2010-8#1)(2011-2#2)(2012-11#2)
the juveniles##3##2##(2008-10#1)(2008-12#1)(2008-6#1)
the juxtamembrane domain##4##3##(1994-6#3)(2008-5#1)
the juxtamembrane##5##2##(1994-6#3)(2008-5#2)
the juxtaposition of##2##3##(1990-10#1)(2012-2#1)
the k values##2##3##(2005-11#1)(2010-5#1)
the kainate##5##2##(1995-11#1)(1995-5#1)(1997-1#3)
the kainate-induced current in##2##4##(1997-1#2)
the kainate-induced##3##2##(1994-2#1)(1997-1#2)
the kallikrein heavy chain##2##4##(1996-5#2)
the kallikrein##3##2##(1996-5#2)(2007-3#1)
the kan gene##2##3##(1990-5#1)(1991-4#1)
the kaolinite##3##2##(2005-11#3)
the kappa B##2##3##(1993-9#1)(1994-9#1)
the kappa agonists##2##3##(1991-1#2)
the kappa light chain##2##4##(1994-3#1)(1997-8#1)
the kappa opioid receptor##2##4##(1994-9#1)(1997-2#1)
the kappa or delta##2##4##(1994-9#1)(2008-11#1)
the kappa statistic##7##3##(1992-8#1)(1994-4#1)(1995-2#3)(1995-6#2)
the kappa##20##2##(1991-1#2)(1992-8#1)(1993-12#1)(1993-9#1)(1994-3#1)(1994-4#1)(1994-9#3)(1995-2#3)(1995-6#2)(1996-12#1)(1997-2#1)(1997-8#1)(2008-11#1)(2012-11#1)
the kappa-opioid receptor##3##3##(1990-7#2)(1996-12#1)
the kappa-selective##4##2##(1991-1#2)(1995-12#1)(1997-2#1)
the karyosome capsule is##2##4##(2007-12#1)(2008-7#1)
the karyosome capsule##4##3##(2007-12#2)(2008-7#2)
the karyosome in##3##3##(2007-12#2)(2008-7#1)
the karyosome##14##2##(2007-12#6)(2008-7#8)
the karyotype of this species##2##5##(2008-12#1)(2011-12#1)
the karyotype of##4##3##(1993-9#1)(2008-1#1)(2008-12#1)(2011-12#1)
the karyotype was##2##3##(1991-4#1)(2007-4#1)
the karyotype##10##2##(1991-4#1)(1993-9#1)(1995-2#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-12#1)(2010-3#1)(2011-12#1)(2013-8#1)
the karyotypes of##3##3##(1994-11#1)(2008-12#1)(2010-3#1)
the karyotypes##4##2##(1994-11#1)(2007-12#1)(2008-12#1)(2010-3#1)
the karyotypic##3##2##(1993-9#1)(1996-12#1)(2008-5#1)
the katG gene##2##3##(1994-7#2)
the kcat values##3##3##(1994-5#1)(1995-6#1)(1996-11#1)
the kcat was##3##3##(1990-8#1)(1993-9#1)(2005-11#1)
the kcat##9##2##(1990-8#1)(1991-2#1)(1993-9#1)(1994-5#1)(1995-1#1)(1995-6#1)(1996-11#1)(1996-7#1)(2005-11#1)
the kcat/Km##2##2##(1990-12#1)(1991-2#1)
the kdr trait##2##3##(1994-3#2)
the kdr##6##2##(1994-3#5)(2010-2#1)
the keel##3##2##(1997-4#3)
the keratin##6##2##(1991-12#2)(1995-8#1)(2005-7#1)(2008-5#1)(2009-10#1)
the keratinocyte##2##2##(1996-2#1)(2008-9#1)
the keratinocytes##6##2##(1990-3#1)(1993-11#1)(1994-12#1)(1995-11#1)(2008-12#2)
the kernel matrix##3##3##(2008-2#2)(2012-2#1)
the kernel##8##2##(2008-1#1)(2008-2#3)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
the kernels##2##2##(2008-3#1)(2010-4#1)
the ketimine##2##2##(1996-8#1)(2006-4#1)
the keto acid##2##3##(2008-10#2)
the keto##4##2##(1993-11#1)(2008-10#2)(2008-11#1)
the ketone body ratio##2##4##(1996-3#1)(2007-8#1)
the ketone##6##2##(1993-4#1)(1996-3#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-5#1)
the ketones##4##2##(2007-11#1)(2012-12#3)
the key advances in##2##4##(2010-12#1)(2012-1#1)
the key aspects of risk control and##2##7##(2013-1#2)
the key aspects of##4##4##(2007-12#1)(2009-3#1)(2013-1#2)
the key catalytic##2##3##(1992-9#1)(1997-4#1)
the key cell##2##3##(2007-12#1)(2010-5#1)
the key challenges to##3##4##(2011-1#1)(2012-12#2)
the key challenges##4##3##(2010-12#1)(2011-1#1)(2012-12#2)
the key characteristics of##3##4##(1994-3#1)(2012-12#1)(2012-3#1)
the key component##3##3##(2007-12#1)(2008-11#1)(2012-12#1)
the key components##4##3##(2006-4#1)(2007-4#1)(2008-5#1)(2008-7#1)
the key developments##2##3##(2011-2#1)(2012-2#1)
the key drivers##2##3##(2011-2#1)(2013-1#1)
the key element of##2##4##(2007-11#1)(2008-2#1)
the key element##3##3##(2007-11#1)(2008-2#1)(2008-7#1)
the key elements in##3##4##(2009-3#1)(2011-1#1)(2011-2#1)
the key elements of the##2##5##(2008-11#1)(2012-12#1)
the key elements of##3##4##(2008-11#1)(2008-9#1)(2012-12#1)
the key elements to##2##4##(1991-12#1)(2010-8#1)
the key elements##9##3##(1991-12#1)(1993-12#1)(2008-11#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
the key enzyme for##2##4##(1994-9#1)(2008-8#1)
the key enzyme in##2##4##(1995-8#1)(2013-1#1)
the key enzyme of##4##4##(1990-12#1)(2008-10#1)(2008-11#1)(2009-8#1)
the key enzyme##11##3##(1990-12#1)(1992-3#1)(1994-6#1)(1994-9#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)(2012-1#1)(2013-1#1)
the key enzymes in##2##4##(1992-1#1)(2007-9#1)
the key enzymes##9##3##(1992-1#1)(1994-12#1)(1994-3#1)(1995-4#1)(1996-10#1)(1997-2#1)(2007-9#1)(2008-9#2)
the key events##2##3##(2006-11#1)(2011-2#1)
the key factor in##5##4##(1994-5#1)(2005-11#1)(2008-10#1)(2008-3#1)(2010-12#1)
the key factor that##2##4##(2006-2#1)(2008-3#1)
the key factor##9##3##(1994-5#1)(2005-11#1)(2006-2#1)(2008-10#1)(2008-3#2)(2010-12#1)(2010-4#1)(2010-7#1)
the key factors affecting##2##4##(2008-3#1)(2008-5#1)
the key factors for##3##4##(1995-5#1)(2013-1#2)
the key factors that##3##4##(2007-11#1)(2008-11#2)
the key factors##16##3##(1990-2#1)(1993-9#1)(1995-5#1)(2007-11#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
the key feature of##2##4##(2008-3#1)(2009-5#1)
the key feature##3##3##(2008-3#1)(2009-5#1)(2012-2#1)
the key features of the##2##5##(1997-6#1)(2011-2#1)
the key features of##5##4##(1997-6#1)(2007-11#1)(2008-1#1)(2011-2#2)
the key features##8##3##(1994-9#1)(1997-6#1)(2007-11#2)(2008-1#1)(2008-8#1)(2011-2#2)
the key for##2##3##(1993-5#1)(2010-8#1)
the key genes##2##3##(2008-3#1)(2012-12#1)
the key in##3##3##(2006-11#1)(2008-8#1)(2012-1#1)
the key ingredients of##2##4##(1996-4#1)(2009-2#1)
the key intermediate##6##3##(1996-2#1)(2007-10#2)(2007-11#1)(2009-12#1)(2012-2#1)
the key issues in##3##4##(1995-12#1)(1997-8#1)(2008-5#1)
the key issues##10##3##(1995-12#1)(1996-12#1)(1997-2#1)(1997-8#1)(2006-5#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-2#1)(2013-8#1)
the key mechanisms##2##3##(2007-2#1)(2008-11#1)
the key nutrient##2##3##(2008-11#1)(2008-7#1)
the key parameters of##2##4##(2007-11#1)(2008-9#1)
the key parameters##6##3##(1992-9#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-9#1)(2013-8#1)
the key point##2##3##(1995-11#1)(2010-7#1)
the key points##3##3##(1997-8#1)(2008-8#1)(2010-12#1)
the key problems##2##3##(2007-7#1)(2013-8#1)
the key questions that##2##4##(1995-1#1)(1996-8#1)
the key regulator##2##3##(1993-2#1)(2012-2#1)
the key regulatory##2##3##(1995-2#1)(2007-4#1)
the key research##2##3##(2007-12#1)(2010-10#1)
the key results of##2##4##(2008-8#1)(2009-8#1)
the key role of##7##4##(1991-7#1)(1996-10#1)(2008-9#1)(2009-1#1)(2013-1#3)
the key role that##2##4##(2007-6#1)(2012-12#1)
the key role##11##3##(1991-7#1)(1996-10#1)(2007-6#1)(2008-9#1)(2009-1#1)(2011-2#1)(2012-12#2)(2013-1#3)
the key step for the##2##5##(1992-1#1)(2008-11#1)
the key step for##4##4##(1992-1#1)(2008-11#1)(2008-5#1)(2011-1#1)
the key step in##2##4##(1992-8#1)(2006-12#1)
the key step##10##3##(1992-1#1)(1992-11#1)(1992-8#1)(2006-12#2)(2007-11#1)(2007-8#1)(2008-11#1)(2008-5#1)(2011-1#1)
the key steps##4##3##(1992-1#1)(2005-11#1)(2007-12#2)
the key structural##2##3##(2007-8#1)(2009-12#1)
the key studies##3##3##(2008-1#1)(2008-7#1)(2010-11#1)
the key to a good##2##5##(1991-1#1)(2008-4#1)
the key to a##5##4##(1991-1#1)(1995-12#1)(2007-8#1)(2008-4#1)(2010-12#1)
the key to effective##2##4##(1997-3#1)(2008-7#1)
the key to improve##2##4##(2011-2#2)
the key to improvement##2##4##(2007-8#1)(2008-4#1)
the key to its##2##4##(1990-9#1)(2012-2#1)
the key to minimizing##2##4##(1995-12#1)(2013-7#1)
the key to success##3##4##(1994-1#1)(1995-12#2)
the key to survival##2##4##(1994-12#1)(2006-10#1)
the key to the effective##2##5##(2005-10#1)(2008-1#1)
the key to the##11##4##(1990-8#1)(1992-2#1)(1997-1#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-7#1)(2010-5#1)(2011-9#1)
the key to understanding the##3##5##(2008-1#1)(2008-6#1)(2008-9#1)
the key to understanding##4##4##(2006-7#1)(2008-1#1)(2008-6#1)(2008-9#1)
the key to##70##3##(1990-8#1)(1990-9#1)(1991-1#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#4)(1996-1#1)(1996-2#1)(1997-1#1)(1997-3#1)(2005-10#1)(2005-5#1)(2005-7#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-8#5)(2008-1#2)(2008-10#1)(2008-4#2)(2008-6#1)(2008-7#5)(2008-9#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#3)(2011-9#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-7#1)
the key words##4##3##(2006-12#1)(2008-1#1)(2011-1#1)(2012-12#1)
the key##394##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#3)(1991-3#1)(1991-7#1)(1992-1#4)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1992-9#2)(1993-12#2)(1993-2#2)(1993-5#1)(1993-9#1)(1994-1#2)(1994-12#4)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#1)(1994-9#3)(1995-1#2)(1995-11#1)(1995-12#5)(1995-2#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#3)(1996-10#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#2)(2005-10#2)(2005-11#3)(2005-5#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#9)(2006-11#2)(2006-12#6)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#2)(2006-7#2)(2006-9#1)(2007-10#2)(2007-11#8)(2007-12#12)(2007-2#1)(2007-4#3)(2007-6#1)(2007-7#1)(2007-8#9)(2007-9#3)(2008-1#8)(2008-10#9)(2008-11#13)(2008-12#2)(2008-2#5)(2008-3#7)(2008-4#6)(2008-5#5)(2008-6#3)(2008-7#13)(2008-8#7)(2008-9#8)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#4)(2009-6#1)(2009-8#8)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#7)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#4)(2011-1#10)(2011-2#14)(2011-9#1)(2012-1#9)(2012-12#14)(2012-2#9)(2012-3#4)(2013-1#16)(2013-7#3)(2013-8#5)
the keys to success##2##4##(1996-1#1)(2005-8#1)
the keys to##5##3##(1991-12#1)(1996-1#1)(2005-10#1)(2005-8#1)(2011-2#1)
the keys##8##2##(1991-12#1)(1996-1#1)(2005-10#1)(2005-8#1)(2006-2#1)(2007-11#1)(2008-10#1)(2011-2#1)
the keystone species##2##3##(2013-8#2)
the keystone##3##2##(2012-2#1)(2013-8#2)
the keyword##2##2##(2007-11#1)(2010-12#1)
the keywords &quot##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
the keywords##6##2##(2008-10#1)(2008-7#2)(2011-2#1)(2013-1#2)
the kidney and in##4##4##(1992-9#1)(1994-5#1)(1994-6#1)(2008-7#1)
the kidney and liver of##2##5##(1990-7#1)(2008-7#1)
the kidney and liver were##2##5##(1996-12#1)(2007-8#1)
the kidney and liver##8##4##(1990-7#1)(1994-5#1)(1995-3#1)(1996-12#1)(2007-8#1)(2008-12#1)(2008-7#2)
the kidney and lung##2##4##(1997-4#1)(2008-9#1)
the kidney and##32##3##(1990-11#2)(1990-7#1)(1991-11#1)(1992-7#1)(1992-9#1)(1994-5#2)(1994-6#1)(1995-10#1)(1995-3#1)(1996-12#1)(1997-4#1)(1997-7#1)(2006-4#2)(2007-12#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#3)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
the kidney capsule of diabetic##2##5##(2008-11#2)
the kidney capsule##3##3##(2008-11#3)
the kidney function##3##3##(1994-9#1)(2006-6#1)(2011-2#1)
the kidney in a##2##4##(1991-9#1)(2008-10#1)
the kidney in the##2##4##(1996-10#1)(2008-10#1)
the kidney in##8##3##(1991-9#1)(1996-10#1)(1996-8#1)(2007-6#1)(2008-10#2)(2008-7#1)(2012-12#1)
the kidney inner medulla##2##4##(1990-7#1)(1997-1#1)
the kidney is##12##3##(1990-6#1)(1994-5#1)(1994-6#1)(2006-4#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#1)(2010-12#1)(2012-12#1)
the kidney lead concentration##2##4##(1992-12#2)
the kidney may##2##3##(1990-6#1)(2012-3#1)
the kidney medulla of##2##4##(1997-8#2)
the kidney of##8##3##(1990-2#1)(1990-3#1)(1995-12#1)(1996-7#1)(2006-7#1)(2008-7#1)(2009-12#1)(2009-6#1)
the kidney or##2##3##(2008-10#1)(2008-9#1)
the kidney that##2##3##(1991-12#1)(2007-2#1)
the kidney tissue##3##3##(2004-11#1)(2008-8#1)(2010-4#1)
the kidney to##4##3##(1992-9#1)(1995-9#1)(2010-1#1)(2011-2#1)
the kidney was##5##3##(1993-4#1)(1996-7#1)(2008-7#1)(2009-6#1)(2011-2#1)
the kidney with##5##3##(1991-12#1)(1993-9#1)(2006-7#1)(2008-7#1)(2013-1#1)
the kidney##215##2##(1990-11#3)(1990-2#2)(1990-3#2)(1990-4#1)(1990-6#3)(1990-7#2)(1990-8#1)(1991-10#2)(1991-11#1)(1991-12#4)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-12#2)(1992-3#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#3)(1994-2#1)(1994-3#1)(1994-5#4)(1994-6#3)(1994-8#1)(1994-9#1)(1995-10#2)(1995-12#1)(1995-3#3)(1995-9#2)(1996-10#2)(1996-12#3)(1996-7#2)(1996-8#2)(1997-1#2)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#2)(2004-11#1)(2006-10#1)(2006-4#3)(2006-6#1)(2006-7#5)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#8)(2007-8#6)(2008-1#1)(2008-10#8)(2008-11#11)(2008-12#1)(2008-4#2)(2008-7#16)(2008-8#7)(2008-9#3)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#1)(2009-6#4)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#6)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#8)(2012-11#3)(2012-12#9)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
the kidney)##2##2##(1996-12#1)(2007-8#1)
the kidney]##2##2##(1997-3#1)(2006-7#1)
the kidneys and liver##2##4##(1996-11#1)(2008-7#1)
the kidneys and the##2##4##(1990-11#1)(1995-3#1)
the kidneys and##11##3##(1990-11#1)(1991-6#1)(1995-3#1)(1996-11#1)(1997-6#1)(2004-4#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-7#1)(2011-1#1)
the kidneys are##2##3##(2006-10#1)(2012-2#1)
the kidneys from##2##3##(1996-3#1)(2013-7#1)
the kidneys of patients##2##4##(1997-1#1)(2010-6#1)
the kidneys of##14##3##(1990-7#1)(1993-4#1)(1994-5#1)(1996-11#2)(1997-1#1)(1997-6#1)(2007-5#2)(2008-4#1)(2008-5#1)(2009-4#1)(2009-6#1)(2010-6#1)
the kidneys were removed##2##4##(2008-12#1)(2008-8#1)
the kidneys were##3##3##(2008-12#1)(2008-5#1)(2008-8#1)
the kidneys##72##2##(1990-10#1)(1990-11#1)(1990-3#2)(1990-7#1)(1991-6#1)(1992-12#2)(1992-5#1)(1993-3#1)(1993-4#2)(1993-9#1)(1994-5#1)(1995-10#1)(1995-3#3)(1996-11#3)(1996-3#1)(1997-1#1)(1997-3#1)(1997-6#2)(1997-7#1)(2004-4#1)(2005-1#1)(2005-7#1)(2006-10#2)(2006-6#2)(2006-9#1)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#1)(2008-1#2)(2008-12#1)(2008-4#7)(2008-5#4)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-7#1)
the kidneys]##2##2##(1990-9#1)(2005-1#1)
the killed##3##2##(1990-12#1)(2005-11#1)(2008-7#1)
the killer##4##2##(2007-7#2)(2009-4#1)(2011-1#1)
the killing effect##2##3##(1990-7#1)(2008-9#1)
the killing of##4##3##(1992-9#1)(2006-4#1)(2007-1#1)(2008-8#1)
the killing##11##2##(1990-12#1)(1990-7#1)(1992-5#1)(1992-9#1)(1995-8#1)(2006-4#1)(2007-1#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#1)
the kilohertz##2##2##(2005-11#1)(2007-12#1)
the kinase activity of the##2##5##(1990-9#1)(1993-8#1)
the kinase activity##8##3##(1990-11#2)(1990-7#1)(1990-9#1)(1993-12#1)(1993-8#1)(1996-5#1)(1996-8#1)
the kinase at the##2##4##(1990-3#1)(1993-8#1)
the kinase domain of##3##4##(1990-4#1)(2009-3#1)(2009-8#1)
the kinase domain##7##3##(1990-4#1)(1991-12#1)(1995-2#1)(1997-4#1)(2009-3#1)(2009-8#1)(2010-4#1)
the kinase in##3##3##(1990-3#1)(1993-8#1)(2012-3#1)
the kinase inhibitor##4##3##(1992-12#1)(1993-3#1)(1996-8#1)(1997-4#1)
the kinase reaction##2##3##(1992-12#1)(1993-8#1)
the kinase##62##2##(1990-11#5)(1990-12#1)(1990-3#2)(1990-4#2)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-12#3)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#3)(1993-8#5)(1994-3#1)(1995-12#1)(1995-2#5)(1995-3#1)(1995-6#1)(1996-5#3)(1996-8#2)(1997-4#2)(1997-5#2)(1997-6#1)(2005-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-4#1)(2012-3#2)(2013-8#1)
the kinases##7##2##(1993-11#1)(1994-12#1)(1994-8#1)(1996-5#1)(2007-12#1)(2009-8#1)(2011-2#1)
the kind and the##2##4##(2008-3#1)(2012-12#1)
the kind of##34##3##(1990-5#2)(1991-4#1)(1991-6#1)(1992-3#1)(1994-1#1)(1994-8#1)(1995-11#1)(1996-11#1)(1997-8#1)(2005-8#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
the kind##40##2##(1990-5#2)(1990-9#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-3#1)(1994-1#1)(1994-8#1)(1995-11#1)(1996-11#1)(1997-8#1)(2005-8#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#2)
the kindling##4##2##(1991-8#1)(1993-2#3)
the kinds of problems##2##4##(2006-2#1)(2011-2#1)
the kinds of##9##3##(1995-3#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2010-2#1)(2011-2#2)
the kinematic and kinetic responses of##2##6##(2007-4#2)
the kinematic##9##2##(1993-7#1)(1996-3#1)(2007-4#4)(2009-5#1)(2011-2#1)(2012-1#1)
the kinematics and kinetics of the##2##6##(2007-10#1)(2007-4#1)
the kinematics and##3##3##(2007-10#1)(2007-4#2)
the kinematics of the##3##4##(2007-4#3)
the kinematics of##6##3##(1992-9#1)(1993-5#1)(2006-6#1)(2007-4#3)
the kinematics##10##2##(1992-9#1)(1993-5#1)(2006-6#1)(2007-10#1)(2007-4#6)
the kinesin##4##2##(1995-3#2)(1996-6#1)(1997-4#1)
the kinetic analysis##2##3##(1995-10#1)(1997-2#1)
the kinetic and equilibrium##2##4##(1994-9#1)(2008-10#1)
the kinetic and thermodynamic##4##4##(1992-3#1)(2005-10#1)(2007-10#1)(2010-9#1)
the kinetic and##11##3##(1992-3#1)(1992-8#1)(1994-9#1)(1997-1#1)(2005-10#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-4#1)(2010-9#1)
the kinetic behavior of##3##4##(1995-1#1)(2004-9#1)(2008-10#1)
the kinetic behavior##4##3##(1990-8#1)(1995-1#1)(2004-9#1)(2008-10#1)
the kinetic characteristics of##3##4##(1991-9#1)(1992-4#1)(1996-5#1)
the kinetic characteristics##4##3##(1991-9#1)(1992-4#1)(1996-5#1)(1997-4#1)
the kinetic constants for##2##4##(1994-9#1)(2008-10#1)
the kinetic constants##6##3##(1990-12#1)(1991-3#1)(1994-11#1)(1994-9#1)(1996-2#1)(2008-10#1)
the kinetic data for the##2##5##(1990-10#1)(2008-3#1)
the kinetic data to##2##4##(1991-8#1)(1997-4#1)
the kinetic data##7##3##(1990-10#1)(1991-8#1)(1995-5#1)(1997-4#1)(2006-12#1)(2008-10#1)(2008-3#1)
the kinetic determination of##3##4##(2008-10#3)
the kinetic discrimination##2##3##(2008-10#2)
the kinetic energy of impacting##2##5##(2008-10#2)
the kinetic isotope##2##3##(1992-1#1)(1993-8#1)
the kinetic measurements##2##3##(1995-2#1)(2008-10#1)
the kinetic mechanism of the##2##5##(1991-7#1)(1991-9#1)
the kinetic mechanism of##3##4##(1991-7#1)(1991-9#1)(1995-10#1)
the kinetic mechanism##6##3##(1991-7#1)(1991-9#1)(1995-10#1)(1995-2#1)(1995-6#2)
the kinetic method##5##3##(1996-6#1)(1996-7#1)(2008-10#2)(2013-1#1)
the kinetic model##3##3##(1990-11#1)(2007-9#1)(2010-5#1)
the kinetic of##2##3##(1992-11#1)(1996-2#1)
the kinetic parameters for##4##4##(1994-5#1)(1994-6#1)(1995-10#1)(2013-1#1)
the kinetic parameters in##2##4##(1995-12#1)(1997-3#1)
the kinetic parameters of##3##4##(1994-11#1)(2009-11#1)(2011-2#1)
the kinetic parameters##24##3##(1990-11#1)(1990-5#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-2#2)(1992-3#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-12#2)(1997-3#1)(2006-10#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-11#1)(2011-2#1)(2013-1#1)
the kinetic partitioning between##2##4##(1995-3#1)(1995-4#1)
the kinetic properties of the##2##5##(1995-2#1)(2006-10#1)
the kinetic properties of##5##4##(1992-7#1)(1995-2#1)(1997-2#1)(2006-10#1)(2008-1#1)
the kinetic rate processes##2##4##(2012-2#2)
the kinetic rate##3##3##(1994-9#1)(2012-2#2)
the kinetic rates##2##3##(2008-6#1)(2010-10#1)
the kinetic stability of##2##4##(2008-10#1)(2008-4#1)
the kinetic stability##3##3##(2008-10#2)(2008-4#1)
the kinetic studies of##2##4##(1991-8#1)(2008-11#1)
the kinetic studies##3##3##(1991-8#1)(1997-4#1)(2008-11#1)
the kinetic##143##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-5#2)(1990-8#1)(1991-10#1)(1991-3#1)(1991-4#1)(1991-7#3)(1991-8#3)(1991-9#3)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#2)(1995-10#3)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#3)(1996-11#1)(1996-2#3)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-7#2)(2004-9#1)(2005-10#1)(2005-11#2)(2006-10#3)(2006-12#2)(2007-10#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#25)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2010-10#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-2#2)(2013-1#2)
the kinetically derived##2##3##(1990-8#2)
the kinetically determined##2##3##(1991-7#1)(1997-2#1)
the kinetically##6##2##(1990-8#2)(1991-7#1)(1995-1#1)(1997-2#1)(1997-7#1)
the kinetics and stoichiometry of##2##5##(1992-6#1)(2012-2#1)
the kinetics and the##3##4##(1991-5#1)(1995-1#1)(2007-11#1)
the kinetics and##15##3##(1991-5#1)(1992-6#1)(1995-1#2)(1995-12#1)(1997-8#1)(2005-11#1)(2007-11#1)(2008-10#2)(2008-5#3)(2012-2#1)(2013-8#1)
the kinetics are##2##3##(1993-11#1)(1995-5#1)
the kinetics for the##2##4##(1990-5#1)(1990-7#1)
the kinetics in##2##3##(1997-3#1)(2008-8#1)
the kinetics of amyloid##2##4##(1994-12#1)(2012-2#1)
the kinetics of antigen##2##4##(1990-12#1)(2008-9#1)
the kinetics of intracellular##2##4##(2008-9#2)
the kinetics of ligand##2##4##(1990-8#1)(1992-7#1)
the kinetics of recovery from both macroscopic and##2##8##(2008-8#2)
the kinetics of the assay##2##5##(2010-5#2)
the kinetics of the binding##2##5##(1994-8#1)(1995-8#1)
the kinetics of the reaction##5##5##(1993-2#1)(1997-6#1)(2008-10#3)
the kinetics of the##37##4##(1990-11#1)(1990-8#1)(1992-1#1)(1992-6#2)(1993-2#1)(1994-8#2)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-7#1)(1997-3#1)(1997-6#1)(2006-12#1)(2008-10#10)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#3)(2010-5#2)
the kinetics of their##2##4##(1995-4#1)(2009-4#1)
the kinetics of##166##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#3)(1991-1#1)(1991-10#1)(1991-2#2)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#3)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#4)(2004-11#3)(2004-12#1)(2005-11#5)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#20)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#7)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#8)(2008-9#3)(2009-12#1)(2009-4#2)(2009-5#1)(2010-12#1)(2010-2#1)(2010-5#6)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
the kinetics##195##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#3)(1991-1#1)(1991-10#1)(1991-2#2)(1991-5#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#2)(1995-12#5)(1995-2#2)(1995-3#4)(1995-4#2)(1995-5#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#3)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#4)(1997-8#1)(2004-11#3)(2004-12#1)(2005-11#7)(2006-10#2)(2006-12#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#22)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#7)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#9)(2008-9#3)(2009-12#1)(2009-4#2)(2009-5#1)(2010-12#1)(2010-2#1)(2010-5#7)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
the kinetochore to##2##3##(1997-6#2)
the kinetochore##6##2##(1997-6#5)(2009-5#1)
the kinetochores##2##2##(1994-8#2)
the king##2##2##(2007-7#1)(2008-1#1)
the kingdom##5##2##(1997-3#1)(2007-7#1)(2008-1#3)
the kininogen-binding protein p33##2##4##(1996-5#2)
the kink##3##2##(1996-4#1)(2008-11#1)(2008-7#1)
the kinoform size##4##3##(2008-2#4)
the kinoform##10##2##(2008-2#9)(2008-3#1)
the kit criteria##2##3##(1991-9#2)
the kit were##2##3##(1993-1#1)(2007-7#1)
the kit##11##2##(1991-9#3)(1993-1#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-7#1)(2009-8#1)
the kitchen##3##2##(1990-12#1)(1996-11#1)(2007-10#1)
the kits##4##2##(2006-4#1)(2007-2#1)(2007-7#1)(2008-10#1)
the knee after##4##3##(2007-11#1)(2007-4#1)(2007-8#1)(2008-11#1)
the knee along the axis of the femur##2##8##(2006-11#2)
the knee and the##2##4##(2007-11#1)(2009-11#1)
the knee and##11##3##(1995-3#1)(1996-11#1)(2006-8#1)(2007-11#1)(2007-8#4)(2009-11#1)(2012-1#1)(2013-1#1)
the knee are##4##3##(2007-11#1)(2007-8#1)(2009-4#1)(2012-2#1)
the knee at##2##3##(2007-4#2)
the knee can##2##3##(2011-2#1)(2013-1#1)
the knee extensor##3##3##(2007-7#3)
the knee in##11##3##(2006-11#1)(2007-1#1)(2007-11#1)(2007-7#2)(2008-8#2)(2009-3#1)(2012-3#1)(2013-1#2)
the knee is the##3##4##(2006-10#1)(2007-7#1)(2013-1#1)
the knee is##12##3##(1997-8#4)(2006-10#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2010-12#1)(2013-1#2)
the knee itself##2##3##(2007-4#2)
the knee joint are##2##4##(2007-7#1)(2008-1#1)
the knee joint in##7##4##(1993-8#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2011-2#1)
the knee joint is##4##4##(2007-11#2)(2007-7#1)(2007-8#1)
the knee joint were##3##4##(2007-4#1)(2007-7#1)(2008-1#1)
the knee joint with##3##4##(2006-6#1)(2007-11#1)(2007-7#1)
the knee joint##65##3##(1993-8#1)(1994-12#1)(1997-8#1)(2006-6#3)(2007-11#10)(2007-4#4)(2007-7#7)(2007-8#13)(2008-1#4)(2008-3#1)(2008-5#2)(2009-10#1)(2009-2#1)(2009-3#3)(2009-4#2)(2010-12#1)(2011-2#3)(2012-1#2)(2013-1#5)
the knee joint]##2##3##(1990-11#1)(2011-2#1)
the knee joints##7##3##(2007-11#2)(2007-7#1)(2008-4#1)(2010-3#1)(2011-2#2)
the knee or##2##3##(1990-2#1)(2013-1#1)
the knee to##2##3##(2007-1#1)(2012-2#1)
the knee until##2##3##(2006-10#2)
the knee was##12##3##(1997-8#6)(2006-11#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-8#1)(2009-9#1)
the knee##276##2##(1990-11#1)(1990-2#2)(1990-6#1)(1991-6#1)(1992-3#1)(1992-4#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-3#1)(1995-8#2)(1996-11#2)(1996-3#3)(1997-1#1)(1997-8#11)(2006-10#12)(2006-11#7)(2006-5#1)(2006-6#3)(2006-8#2)(2007-1#5)(2007-11#35)(2007-4#13)(2007-5#3)(2007-7#29)(2007-8#32)(2008-1#5)(2008-11#2)(2008-12#4)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#5)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#5)(2009-4#3)(2009-5#4)(2009-9#1)(2010-12#5)(2010-3#3)(2010-4#1)(2011-1#1)(2011-2#12)(2012-1#7)(2012-2#9)(2012-3#1)(2013-1#23)(2013-7#1)
the knees##7##2##(1991-12#1)(1995-2#1)(2006-10#1)(2008-7#1)(2008-8#1)(2009-3#1)(2013-1#1)
the knockout##6##2##(2006-10#2)(2007-10#1)(2010-11#1)(2010-4#1)(2012-12#1)
the knowledge about the##6##4##(2006-6#1)(2007-10#1)(2007-12#1)(2009-8#1)(2011-2#1)(2012-2#1)
the knowledge about##10##3##(1994-2#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2009-8#1)(2011-2#1)(2012-2#1)
the knowledge and attitudes##2##4##(2009-5#1)(2011-2#1)
the knowledge and experience to##2##5##(2008-11#1)(2011-2#1)
the knowledge and experience##4##4##(2006-8#1)(2007-4#1)(2008-11#1)(2011-2#1)
the knowledge and skills needed##2##5##(2005-12#1)(2012-12#1)
the knowledge and skills required##2##5##(1991-1#1)(2013-8#1)
the knowledge and skills##6##4##(1991-1#1)(2005-10#1)(2005-12#1)(2007-1#1)(2012-12#1)(2013-8#1)
the knowledge and understanding of the##2##6##(2007-12#1)(2008-10#1)
the knowledge and##30##3##(1991-1#1)(1995-12#1)(1996-7#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-2#1)(2006-8#2)(2007-1#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-10#1)(2009-5#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#3)(2013-8#1)
the knowledge base##4##3##(2008-10#2)(2011-1#2)
the knowledge gained##3##3##(2008-11#1)(2008-9#1)(2009-4#1)
the knowledge in##2##3##(2009-4#1)(2011-1#1)
the knowledge is##2##3##(1997-8#2)
the knowledge level##2##3##(2011-1#2)
the knowledge of its##2##4##(2008-5#2)
the knowledge of such##3##4##(2013-1#3)
the knowledge of the condom##3##5##(2007-7#3)
the knowledge of the##29##4##(1990-5#1)(1993-11#1)(1997-3#1)(2006-10#1)(2007-12#1)(2007-7#3)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
the knowledge of##71##3##(1990-5#2)(1993-11#1)(1996-12#1)(1996-5#1)(1997-3#2)(2005-1#1)(2005-12#1)(2006-10#2)(2006-2#1)(2007-12#2)(2007-7#4)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#7)(2013-7#1)(2013-8#2)
the knowledge on the##3##4##(1994-2#1)(2012-3#2)
the knowledge on##9##3##(1991-2#1)(1994-2#1)(2007-3#1)(2008-2#1)(2008-8#1)(2012-2#1)(2012-3#2)(2013-1#1)
the knowledge that##6##3##(1997-8#2)(2006-8#1)(2007-8#1)(2008-7#1)(2010-9#1)
the knowledge##180##2##(1990-5#2)(1991-1#1)(1991-2#1)(1993-11#2)(1994-2#2)(1995-12#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-3#2)(1997-8#4)(2004-10#1)(2005-1#1)(2005-10#1)(2005-12#2)(2006-10#3)(2006-12#1)(2006-2#3)(2006-6#1)(2006-7#1)(2006-8#5)(2007-1#1)(2007-10#1)(2007-12#4)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#16)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#6)(2008-8#4)(2008-9#3)(2009-10#1)(2009-2#1)(2009-4#3)(2009-5#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#3)(2010-8#1)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#11)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#5)(2012-3#6)(2013-1#11)(2013-7#1)(2013-8#6)
the knowledge-based##2##2##(1997-8#1)(2008-2#1)
the known &quot##2##3##(2007-3#1)(2008-10#1)
the known FAD##2##3##(1996-6#2)
the known biology of the##2##5##(2008-4#1)(2013-8#1)
the known biology of##3##4##(2008-11#1)(2008-4#1)(2013-8#1)
the known causes##2##3##(2008-4#1)(2009-2#1)
the known compounds##2##3##(2006-12#1)(2007-1#1)
the known crystal structure of##2##5##(1992-3#1)(2013-1#1)
the known effects of these##2##5##(2008-5#1)(2010-2#1)
the known effects of##6##4##(1990-2#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-2#1)
the known functional##2##3##(1990-11#1)(2009-5#1)
the known mechanisms##2##3##(2008-7#1)(2008-9#1)
the known number of##2##4##(1991-1#1)(2008-5#1)
the known ones##2##3##(2007-1#1)(2008-1#1)
the known physical##2##3##(2005-10#1)(2008-2#1)
the known primary##2##3##(1990-3#1)(2012-2#1)
the known proteins##2##3##(1994-12#1)(1996-10#1)
the known role of##3##4##(1990-2#1)(1991-5#1)(2007-12#1)
the known sequence of##2##4##(1990-3#1)(1996-12#1)
the known sequences##3##3##(1990-3#1)(1991-10#1)(1997-4#1)
the known species##2##3##(1995-12#1)(2008-5#1)
the known structures##2##3##(1994-3#1)(2008-7#1)
the known tendency of the##2##5##(1997-7#1)(2007-10#1)
the known vectors of##2##4##(2006-4#2)
the known##226##2##(1990-10#1)(1990-11#2)(1990-2#2)(1990-3#4)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#4)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#5)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-6#4)(1993-8#1)(1993-9#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-8#1)(1996-10#4)(1996-11#1)(1996-12#4)(1996-4#2)(1996-5#2)(1996-6#4)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#5)(1997-8#2)(2005-10#1)(2005-11#2)(2006-10#2)(2006-12#6)(2006-2#1)(2006-4#2)(2007-1#7)(2007-10#1)(2007-11#3)(2007-12#6)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#4)(2008-2#7)(2008-3#4)(2008-4#7)(2008-5#10)(2008-7#9)(2008-8#3)(2008-9#3)(2009-10#3)(2009-11#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
the korean##2##2##(2007-12#1)(2010-1#1)
the kriging##2##2##(1997-6#1)(2012-2#1)
the kringle##2##2##(1993-8#2)
the kuruma prawn##2##3##(2008-5#1)(2008-6#1)
the l-malic acid##2##3##(2008-10#2)
the lab bench##2##3##(2007-3#1)(2008-5#1)
the lab##14##2##(2006-10#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2012-2#2)(2013-8#1)
the label to the##2##4##(2008-11#1)(2008-12#1)
the label to##3##3##(1993-6#1)(2008-11#1)(2008-12#1)
the label##13##2##(1991-4#1)(1991-5#1)(1992-1#1)(1992-6#1)(1993-6#1)(1994-9#1)(1996-3#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2012-12#1)
the label-free##2##2##(2010-7#1)(2012-2#1)
the labeled DNA##2##3##(2008-1#1)(2008-4#1)
the labeled antigen##2##3##(1990-12#1)(1992-7#1)
the labeled compounds##2##3##(1991-9#1)(2007-11#1)
the labeled domain##2##3##(1994-11#2)
the labeled peptides##2##3##(1995-2#1)(2010-1#1)
the labeled rate##3##3##(2008-10#3)
the labeled site##2##3##(1992-3#2)
the labeled##44##2##(1990-12#1)(1990-9#1)(1991-7#3)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#4)(1992-7#1)(1994-11#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-2#2)(1995-3#1)(1996-11#1)(1996-2#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#3)(2008-4#3)(2010-1#1)
the labeling index of##3##4##(2008-4#3)
the labeling index##5##3##(1995-5#1)(1996-11#1)(2008-4#3)
the labeling of the##2##4##(1990-2#1)(2008-2#1)
the labeling of##9##3##(1990-11#1)(1990-2#1)(1991-1#1)(1994-8#1)(1997-2#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-10#1)
the labeling pattern of##3##4##(2008-10#1)(2008-7#2)
the labeling##23##2##(1990-11#1)(1990-2#1)(1991-1#1)(1994-8#1)(1995-5#1)(1996-11#1)(1997-2#1)(2008-10#2)(2008-2#3)(2008-4#4)(2008-7#2)(2008-9#1)(2009-10#2)(2010-8#1)(2013-1#1)
the labelled and unlabelled##2##4##(1994-2#1)(2007-9#1)
the labelled antibodies##2##3##(2008-10#2)
the labelled##22##2##(1990-10#1)(1990-11#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-3#2)(1992-3#1)(1992-6#1)(1994-2#2)(1995-11#1)(1995-12#1)(1995-2#1)(1996-2#2)(2007-9#2)(2008-10#3)(2008-5#1)
the labelling of##7##3##(1990-7#1)(1991-7#2)(1993-12#2)(1995-7#1)(1996-3#1)
the labelling##12##2##(1990-5#1)(1990-7#1)(1991-7#2)(1992-3#1)(1993-12#3)(1995-7#1)(1996-3#1)(1997-1#1)(2012-12#1)
the labels should have##2##4##(1992-2#2)
the labels should##3##3##(1992-2#2)(2011-2#1)
the labels##4##2##(1992-2#2)(2011-2#1)(2012-2#1)
the labial##5##2##(2007-12#4)(2007-7#1)
the lability of the##3##4##(1993-11#1)(1994-11#1)(1994-9#1)
the lability of##8##3##(1991-7#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-9#1)(1996-8#1)(2008-10#1)(2012-12#1)
the labium major##2##3##(2010-6#2)
the labium##4##2##(2007-12#2)(2010-6#2)
the labor force##8##3##(1990-3#1)(1991-1#2)(1997-2#1)(2008-12#1)(2008-9#3)
the labor market and##3##4##(1994-3#1)(2011-2#1)(2012-3#1)
the labor market in##2##4##(2009-4#1)(2013-1#1)
the labor market##11##3##(1994-3#2)(2006-4#1)(2009-4#1)(2010-2#2)(2011-2#3)(2012-3#1)(2013-1#1)
the labor##23##2##(1990-3#1)(1991-1#2)(1994-3#2)(1997-2#1)(2006-10#1)(2006-4#1)(2007-2#1)(2008-12#1)(2008-9#3)(2009-4#1)(2010-2#2)(2011-2#4)(2012-3#2)(2013-1#1)
the laboratories of the##2##4##(2008-2#1)(2011-2#1)
the laboratories of##4##3##(2008-2#1)(2011-1#1)(2011-2#2)
the laboratories##12##2##(1995-4#1)(2007-10#1)(2007-7#1)(2008-10#4)(2008-2#1)(2011-1#1)(2011-2#3)
the laboratory and the field##3##5##(2004-2#1)(2008-10#1)(2008-2#1)
the laboratory and the##8##4##(1993-1#1)(2004-2#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2013-1#2)
the laboratory and##27##3##(1993-1#1)(1994-6#1)(1996-4#1)(2004-11#1)(2004-2#1)(2006-10#3)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#3)(2009-8#1)(2010-10#1)(2011-12#1)(2012-3#1)(2013-1#2)
the laboratory as##2##3##(2008-2#1)(2009-2#1)
the laboratory at##4##3##(2007-3#1)(2008-5#1)(2009-6#1)(2011-12#1)
the laboratory culture of##2##4##(2004-11#1)(2007-7#1)
the laboratory data##3##3##(1993-9#1)(2008-5#1)(2010-4#1)
the laboratory diagnosis of##6##4##(2005-7#1)(2006-10#1)(2008-1#1)(2008-10#1)(2011-1#1)(2012-3#1)
the laboratory diagnosis##7##3##(1997-6#1)(2005-7#1)(2006-10#1)(2008-1#1)(2008-10#1)(2011-1#1)(2012-3#1)
the laboratory for##11##3##(2005-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-6#1)(2012-12#1)(2013-8#1)
the laboratory in##5##3##(2008-10#3)(2008-12#1)(2008-3#1)
the laboratory investigations##2##3##(1992-11#1)(2007-7#1)
the laboratory is##5##3##(1993-7#1)(1996-4#1)(2005-7#1)(2012-11#2)
the laboratory maintenance of##2##4##(2008-9#2)
the laboratory methods##2##3##(1992-10#1)(2006-12#1)
the laboratory mixer##2##3##(2008-5#2)
the laboratory of microbiology##2##4##(2007-12#1)(2010-12#1)
the laboratory of##6##3##(1995-6#1)(2007-12#1)(2009-2#1)(2010-12#1)(2010-3#1)(2011-2#1)
the laboratory on##2##3##(2006-2#1)(2011-12#1)
the laboratory population##3##3##(2008-10#3)
the laboratory prior to##2##4##(2008-2#1)(2010-8#1)
the laboratory results##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
the laboratory should##2##3##(2007-12#1)(2011-2#1)
the laboratory strain##2##3##(2011-2#1)(2012-3#1)
the laboratory there##2##3##(1993-12#1)(1997-8#1)
the laboratory to determine##2##4##(2007-5#1)(2008-3#1)
the laboratory to the##3##4##(2008-10#1)(2008-11#1)(2012-2#1)
the laboratory to##10##3##(2005-7#1)(2006-12#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2010-5#1)(2012-2#1)
the laboratory##261##2##(1990-3#1)(1990-8#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#1)(1993-1#1)(1993-12#2)(1993-5#1)(1993-7#1)(1993-9#2)(1994-2#1)(1994-6#1)(1995-6#1)(1996-4#3)(1996-9#1)(1997-3#1)(1997-6#2)(1997-8#1)(2004-11#5)(2004-2#1)(2004-4#1)(2005-11#1)(2005-12#1)(2005-5#1)(2005-7#4)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#1)(2006-8#1)(2007-10#2)(2007-12#8)(2007-3#2)(2007-4#1)(2007-5#5)(2007-6#3)(2007-7#3)(2007-8#1)(2008-1#5)(2008-10#45)(2008-11#6)(2008-12#1)(2008-2#12)(2008-3#13)(2008-4#10)(2008-5#15)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#10)(2009-12#1)(2009-2#2)(2009-6#2)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#1)(2010-6#2)(2010-8#3)(2011-1#4)(2011-12#4)(2011-2#5)(2012-11#2)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#2)(2013-7#3)(2013-8#4)
the laboratory-rearing experiment##2##3##(2010-8#2)
the laborers##3##2##(2009-12#3)
the laboring##2##2##(2007-2#1)(2008-8#1)
the laborious##2##2##(2008-10#1)(2008-4#1)
the labour force##2##3##(1993-3#1)(2007-7#1)
the labour market##7##3##(1995-5#2)(2006-10#2)(2006-8#2)(2011-2#1)
the labour##12##2##(1991-11#1)(1993-3#1)(1993-6#1)(1995-5#2)(2006-10#2)(2006-8#2)(2007-7#1)(2011-2#1)(2013-8#1)
the labral sensory nerve##2##4##(2007-12#2)
the labral##5##2##(2007-12#5)
the labrum and##2##3##(2007-12#1)(2007-7#1)
the labrum is not##2##4##(2007-12#2)
the labrum is##5##3##(2007-12#5)
the labrum##13##2##(2007-12#11)(2007-7#1)(2013-7#1)
the labs##4##2##(2007-8#2)(2008-10#2)
the labyrinth##3##2##(2012-2#3)
the labyrinthine##4##2##(2006-11#3)(2006-12#1)
the lac operator sequence##2##4##(1990-9#2)
the lac operator##3##3##(1990-9#2)(1997-6#1)
the lac operon##4##3##(1991-12#1)(1991-7#2)(1995-3#1)
the lac repressor##3##3##(1990-9#2)(1991-12#1)
the lac##21##2##(1990-10#1)(1990-5#3)(1990-9#4)(1991-12#2)(1991-7#2)(1991-8#2)(1992-3#1)(1995-2#1)(1995-3#1)(1996-10#1)(1997-5#1)(1997-6#1)(2008-10#1)
the lacF gene was##3##4##(2005-11#3)
the lacF gene##5##3##(2005-11#5)
the lacF##6##2##(2005-11#6)
the lacO sequence##2##3##(1991-12#2)
the lacO##3##2##(1991-12#3)
the lacZ alpha##3##3##(1995-8#1)(1997-4#2)
the lacZ gene was##2##4##(1990-5#1)(1991-9#1)
the lacZ gene##14##3##(1990-5#1)(1991-7#2)(1991-9#1)(1994-3#1)(1994-8#1)(1995-12#3)(1995-7#1)(1995-8#1)(1997-1#2)(2008-11#1)
the lacZ reporter gene##4##4##(1993-3#1)(1997-5#2)(2009-12#1)
the lacZ reporter##6##3##(1993-3#1)(1997-5#2)(1997-6#2)(2009-12#1)
the lacZ##28##2##(1990-5#1)(1991-7#3)(1991-9#1)(1993-12#1)(1993-3#1)(1994-3#2)(1994-8#1)(1995-12#3)(1995-7#1)(1995-8#2)(1997-1#2)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#1)(2008-11#1)(2009-12#1)(2013-1#1)
the lack of a consistent##3##5##(2006-12#1)(2008-9#1)(2010-11#1)
the lack of a reliable##2##5##(2008-10#1)(2009-12#1)
the lack of a specific##3##5##(1993-10#1)(2006-12#1)(2011-2#1)
the lack of a suitable##2##5##(1996-12#1)(2007-11#1)
the lack of a##43##4##(1990-2#1)(1991-10#1)(1993-10#1)(1993-2#1)(1994-11#1)(1994-6#1)(1995-3#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-6#1)(1997-7#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#2)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)
the lack of accuracy##2##4##(1996-11#1)(2008-11#1)
the lack of adequate##8##4##(1996-9#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-2#1)(2010-5#1)
the lack of an efficient##2##5##(2006-2#1)(2008-7#1)
the lack of an##10##4##(1990-5#1)(1993-12#1)(1994-12#1)(1995-2#1)(1997-8#1)(2006-2#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-8#1)
the lack of any##3##4##(1990-2#1)(2008-5#1)(2013-8#1)
the lack of association##2##4##(2007-2#1)(2009-6#1)
the lack of available##4##4##(1990-9#1)(1992-1#1)(2011-2#2)
the lack of awareness of##2##5##(2004-10#1)(2008-10#1)
the lack of awareness##3##4##(2004-10#1)(2008-10#1)(2009-4#1)
the lack of clinical##2##4##(1993-8#1)(2006-5#1)
the lack of controlled##2##4##(2006-10#1)(2007-1#1)
the lack of correlation##3##4##(2008-10#2)(2008-3#1)
the lack of definitive##2##4##(2006-8#1)(2012-12#1)
the lack of disease##2##4##(2008-1#1)(2008-10#1)
the lack of dystrophin##2##4##(1995-12#1)(2012-3#1)
the lack of education##2##4##(2007-10#1)(2013-8#1)
the lack of effect of##2##5##(1993-2#1)(1996-2#1)
the lack of effect##6##4##(1993-2#1)(1995-12#1)(1996-2#1)(2012-2#1)(2013-1#2)
the lack of effective##2##4##(2008-11#1)(2008-6#1)
the lack of evidence##4##4##(2006-10#1)(2008-11#1)(2008-12#1)(2011-2#1)
the lack of existing##2##4##(1990-11#1)(2006-12#1)
the lack of expression of##2##5##(1992-3#1)(2008-9#1)
the lack of homology##2##4##(1995-5#1)(1997-4#1)
the lack of information##2##4##(1992-2#1)(2012-2#1)
the lack of knowledge about##2##5##(1993-10#1)(2008-5#1)
the lack of knowledge and##2##5##(1990-6#1)(2008-11#1)
the lack of knowledge##5##4##(1990-6#1)(1993-10#1)(2006-12#1)(2008-11#1)(2008-5#1)
the lack of local##2##4##(2008-3#1)(2008-5#1)
the lack of methods##2##4##(2008-9#1)(2011-1#1)
the lack of molecular markers##2##5##(2008-10#2)
the lack of one##2##4##(1994-8#1)(1997-4#1)
the lack of other##3##4##(1995-6#1)(2007-3#1)(2008-1#1)
the lack of overlap##2##4##(1991-11#1)(2008-9#1)
the lack of power##2##4##(2008-2#1)(2009-3#1)
the lack of protection##2##4##(1997-6#1)(2008-5#1)
the lack of reliable##4##4##(1994-8#1)(2006-10#1)(2007-10#1)(2013-8#1)
the lack of research in this area##2##7##(2011-2#1)(2013-8#1)
the lack of response##2##4##(2008-8#1)(2013-1#1)
the lack of robust##2##4##(2008-10#1)(2010-12#1)
the lack of significant##3##4##(2005-10#1)(2008-10#2)
the lack of specific##6##4##(1990-3#1)(2006-8#1)(2008-4#2)(2008-9#1)(2013-8#1)
the lack of standardization##2##4##(1992-5#1)(2012-2#1)
the lack of standardized information on promotores programs##2##8##(2012-11#2)
the lack of standardized##4##4##(2010-12#1)(2012-11#2)(2012-2#1)
the lack of standards##2##4##(2008-10#1)(2008-11#1)
the lack of strong evidence##2##5##(2008-5#1)(2012-2#1)
the lack of strong##4##4##(2006-10#1)(2007-7#1)(2008-5#1)(2012-2#1)
the lack of structural##2##4##(2007-7#1)(2009-12#1)
the lack of sufficient##2##4##(2008-5#1)(2012-2#1)
the lack of suitable experimental##2##5##(1990-9#1)(2009-3#1)
the lack of suitable##4##4##(1990-9#1)(2005-7#1)(2009-3#1)(2013-1#1)
the lack of supporting##2##4##(1991-4#1)(1996-3#1)
the lack of the##6##4##(1994-7#1)(1996-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
the lack of true##2##4##(2008-4#1)(2008-9#1)
the lack of understanding##2##4##(2008-11#1)(2010-3#1)
the lack of##395##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#4)(1991-4#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-2#1)(1992-3#3)(1992-4#2)(1992-5#4)(1992-8#2)(1992-9#2)(1993-10#2)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#4)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#3)(1996-6#3)(1996-8#2)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-10#1)(2005-10#3)(2005-11#4)(2005-12#1)(2005-7#1)(2005-8#4)(2006-1#1)(2006-10#8)(2006-11#3)(2006-12#7)(2006-2#4)(2006-4#2)(2006-5#4)(2006-6#3)(2006-8#3)(2007-1#2)(2007-10#5)(2007-11#7)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#33)(2008-11#16)(2008-12#5)(2008-2#1)(2008-3#8)(2008-4#6)(2008-5#15)(2008-6#4)(2008-7#14)(2008-8#6)(2008-9#9)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#3)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#17)(2012-11#2)(2012-12#3)(2012-2#12)(2012-3#3)(2013-1#12)(2013-7#2)(2013-8#10)
the lack##396##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#4)(1991-4#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-2#1)(1992-3#3)(1992-4#2)(1992-5#4)(1992-8#2)(1992-9#2)(1993-10#2)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#4)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#3)(1996-6#3)(1996-8#2)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#1)(2004-10#1)(2005-10#3)(2005-11#4)(2005-12#1)(2005-7#1)(2005-8#4)(2006-1#1)(2006-10#8)(2006-11#3)(2006-12#7)(2006-2#4)(2006-4#2)(2006-5#4)(2006-6#3)(2006-8#3)(2007-1#2)(2007-10#5)(2007-11#7)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#33)(2008-11#16)(2008-12#5)(2008-2#1)(2008-3#8)(2008-4#6)(2008-5#15)(2008-6#4)(2008-7#14)(2008-8#6)(2008-9#9)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#3)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#17)(2012-11#2)(2012-12#3)(2012-2#12)(2012-3#3)(2013-1#12)(2013-7#2)(2013-8#10)
the lacrimal gland and##2##4##(2007-1#2)
the lacrimal gland##10##3##(2007-1#9)(2013-8#1)
the lacrimal sac##2##3##(2006-11#1)(2007-9#1)
the lacrimal##22##2##(1994-7#1)(1995-9#1)(2006-11#3)(2007-1#11)(2007-9#1)(2010-12#1)(2011-1#2)(2011-2#1)(2013-8#1)
the lactam ring##2##3##(1993-8#1)(2007-7#1)
the lactate concentration##3##3##(1997-5#1)(2008-10#1)(2008-6#1)
the lactate dehydrogenase leakage test##2##5##(1992-11#2)
the lactate dehydrogenase##5##3##(1992-11#2)(2008-11#2)(2008-6#1)
the lactate dehydrogenase-B##2##3##(1990-8#2)
the lactate##15##2##(1990-4#1)(1990-8#2)(1992-11#2)(1993-2#1)(1994-9#1)(1997-5#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-6#2)
the lactate-proton symport##2##3##(1996-9#2)
the lactating##6##2##(1991-4#1)(1992-12#1)(1993-2#2)(2007-9#2)
the lactation##4##2##(1991-11#1)(1996-10#1)(2012-1#1)(2012-3#1)
the lactic acid bacteria##2##4##(1997-4#1)(2004-8#1)
the lactic acid productivity of the##2##6##(2008-5#2)
the lactic acid productivity##3##4##(2008-5#3)
the lactic acid##6##3##(1997-4#1)(2004-8#2)(2008-5#3)
the lactic##7##2##(1997-4#1)(2004-8#2)(2008-10#1)(2008-5#3)
the lactone and carboxylate forms of camptothecin##3##7##(1994-8#1)(1997-3#2)
the lactone and carboxylate forms of##5##6##(1994-8#1)(1997-3#4)
the lactone form##2##3##(1994-8#1)(1997-3#1)
the lactone##11##2##(1994-3#1)(1994-8#2)(1997-3#5)(2005-8#1)(2007-1#1)(2007-11#1)
the lactose carrier of##3##4##(1994-9#3)
the lactose permease##4##3##(1991-12#1)(1993-11#1)(1993-3#1)(1995-1#1)
the lactose synthase complex##2##4##(1996-7#2)
the lactose##12##2##(1991-12#1)(1993-11#2)(1993-3#1)(1994-9#3)(1995-1#1)(1996-7#2)(1997-5#1)(2008-5#1)
the lacunary##2##2##(2008-10#1)(2010-6#1)
the ladder##4##2##(1995-2#1)(2006-10#2)(2011-1#1)
the lag and##2##3##(1992-11#1)(2008-11#1)
the lag period##4##3##(1990-11#1)(2008-10#3)
the lag phase of the##3##5##(1990-11#3)
the lag phase of##5##4##(1990-11#3)(1995-12#1)(2005-8#1)
the lag phase was less##2##5##(1997-8#1)(2008-5#1)
the lag phase was##4##4##(1990-12#1)(1997-8#2)(2008-5#1)
the lag phase##17##3##(1990-11#3)(1990-12#1)(1990-7#1)(1995-12#1)(1997-8#4)(2005-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#3)
the lag time between##3##4##(1997-7#1)(2008-10#2)
the lag time##12##3##(1990-8#1)(1996-5#1)(1996-6#1)(1997-7#2)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2009-10#1)(2011-1#1)
the lag##39##2##(1990-11#4)(1990-12#1)(1990-7#1)(1990-8#1)(1992-11#1)(1995-12#1)(1996-5#1)(1996-6#1)(1997-7#2)(1997-8#4)(2005-8#1)(2008-10#5)(2008-11#3)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#4)
the lagging strand##6##3##(1990-12#3)(1993-3#1)(1994-9#2)
the lagging-strand Pol III core##3##5##(1992-3#3)
the lagoon##15##2##(2007-5#6)(2007-8#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-7#3)
the lagoons##2##2##(2010-8#2)
the lake##13##2##(1992-4#1)(1996-6#2)(2004-4#1)(2007-7#2)(2007-9#1)(2008-10#3)(2010-8#1)(2012-2#2)
the lambda##22##2##(1990-1#1)(1990-3#6)(1990-5#1)(1990-8#1)(1991-6#3)(1992-5#1)(1994-2#1)(1995-2#3)(1995-3#2)(1995-8#2)(1997-5#1)
the lambs from##2##3##(1991-8#1)(1994-7#1)
the lambs##5##2##(1991-8#1)(1994-7#3)(1996-12#1)
the lamellae##3##2##(2008-7#2)(2012-2#1)
the lamellar gel phase##2##4##(1991-2#1)(2006-10#1)
the lamellar liquid-crystalline##2##3##(1991-4#1)(2006-10#1)
the lamellar phase##2##3##(1991-2#1)(2008-8#1)
the lamellar scaffold##2##3##(2012-2#2)
the lamellar##28##2##(1990-12#1)(1991-2#5)(1991-4#2)(1993-7#2)(1994-12#1)(1994-2#1)(2005-8#1)(2006-10#4)(2008-2#1)(2008-5#4)(2008-8#1)(2012-2#5)
the lamellate##2##2##(2008-7#1)(2010-10#1)
the lamin A tail##2##4##(2011-2#2)
the lamin A##5##3##(1992-12#1)(1993-8#1)(2011-2#2)(2012-12#1)
the lamin##7##2##(1992-12#1)(1993-8#1)(2008-8#1)(2011-2#3)(2012-12#1)
the lamina propria of##2##4##(2007-2#1)(2009-1#1)
the lamina propria##9##3##(1991-9#1)(1997-1#1)(2007-2#1)(2008-4#1)(2008-5#1)(2009-1#1)(2010-8#1)(2012-2#2)
the lamina terminalis region##2##4##(1991-8#1)(2006-5#1)
the lamina terminalis##4##3##(1991-8#2)(2006-5#1)(2008-4#1)
the lamina##24##2##(1990-7#1)(1991-8#2)(1991-9#1)(1996-6#1)(1997-1#1)(1997-3#1)(2006-5#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-1#1)(2010-8#1)(2011-2#3)(2012-2#2)(2013-7#1)
the laminar distribution##3##3##(1995-11#1)(1997-2#1)(1997-7#1)
the laminar##9##2##(1991-8#1)(1992-10#1)(1993-12#1)(1995-11#1)(1997-2#2)(1997-3#1)(1997-7#1)(2008-3#1)
the laminaria tent##4##3##(1990-12#4)
the laminin A chain##2##4##(1991-2#2)
the laminin##9##2##(1991-2#3)(1991-3#1)(1995-5#1)(1997-1#2)(2013-8#2)
the laminin-coated surface##2##3##(1991-3#2)
the lamp##4##2##(2008-11#1)(2008-2#3)
the lamprey##8##2##(1990-5#2)(1993-3#1)(1997-3#5)
the land cover##3##3##(2013-8#3)
the land surface emissivity##2##4##(2013-8#2)
the land##19##2##(1992-8#1)(1997-1#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-3#1)(2010-9#1)(2013-8#7)
the land-groove recording technique##2##4##(2008-3#2)
the land-groove##3##2##(2008-3#3)
the landings##2##2##(2007-5#2)
the landmark task##2##3##(1992-9#1)(2012-2#1)
the landmark track maneuver##2##4##(2008-2#2)
the landmark##7##2##(1992-9#1)(1996-12#1)(2008-2#2)(2008-9#1)(2009-7#1)(2012-2#1)
the landmarks##2##2##(2010-12#1)(2012-2#1)
the landraces##2##2##(2012-11#2)
the landscape of##10##3##(1994-1#1)(2005-12#3)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#2)(2012-12#1)
the landscape##20##2##(1994-1#1)(2005-12#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-2#1)(2012-12#2)(2012-9#1)(2013-1#1)(2013-8#1)
the language and practices of##2##5##(2008-7#2)
the language and##3##3##(2008-7#3)
the language of degeneration##2##4##(2009-4#2)
the language of the##4##4##(1992-8#1)(2006-7#1)(2007-4#1)(2008-6#1)
the language of##11##3##(1992-8#1)(1997-6#1)(2006-7#1)(2007-3#1)(2007-4#1)(2008-6#1)(2009-4#2)(2010-4#1)(2012-3#1)(2013-1#1)
the language used##4##3##(1996-2#1)(2011-1#1)(2013-1#2)
the language##25##2##(1992-8#1)(1996-2#1)(1996-7#1)(1997-6#1)(2006-7#1)(2007-3#2)(2007-4#1)(2007-7#1)(2007-9#1)(2008-4#1)(2008-6#1)(2008-7#3)(2009-4#2)(2009-9#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-1#3)
the languages##3##2##(2007-9#2)(2008-2#1)
the lanner falcon##2##3##(2011-1#2)
the lanthanide ion##2##3##(1990-11#1)(2012-12#1)
the lanthanide metal ions##2##4##(2008-10#2)
the lanthanide metal##3##3##(2008-10#2)(2008-4#1)
the lanthanide##10##2##(1990-11#1)(1994-8#1)(2008-10#3)(2008-3#3)(2008-4#1)(2012-12#1)
the lanthanides##4##2##(2007-8#1)(2008-10#2)(2010-5#1)
the lanthanum##2##2##(2008-10#2)
the lantibiotic##2##2##(1995-8#1)(2011-1#1)
the lap belt##3##3##(2006-11#2)(2013-1#1)
the lap##4##2##(2006-11#2)(2009-7#1)(2013-1#1)
the laparoscope##4##2##(1991-9#1)(1992-1#1)(1992-12#1)(1996-3#1)
the laparoscopic approach is not##2##5##(2006-5#1)(2008-3#1)
the laparoscopic approach is safe for performing minor liver##2##9##(2007-9#1)(2008-3#1)
the laparoscopic approach is##5##4##(2006-5#1)(2007-9#2)(2008-3#2)
the laparoscopic approach##10##3##(1996-1#1)(2006-5#1)(2006-6#3)(2007-9#2)(2008-3#3)
the laparoscopic cholecystectomy##2##3##(2006-10#1)(2008-5#1)
the laparoscopic operation##2##3##(2006-6#1)(2008-12#1)
the laparoscopic procedure##2##3##(1994-9#1)(2006-6#1)
the laparoscopic##29##2##(1992-3#1)(1994-9#1)(1995-3#1)(1996-1#1)(2006-10#2)(2006-5#2)(2006-6#5)(2007-2#1)(2007-9#4)(2008-12#1)(2008-3#4)(2008-5#1)(2011-2#1)(2013-1#4)
the laparoscopically##2##2##(1993-12#1)(2008-9#1)
the laparoscopy group##2##3##(1996-1#2)
the laparoscopy##11##2##(1995-3#1)(1996-1#2)(2006-6#2)(2006-9#1)(2011-1#5)
the laparotomic placement##2##3##(2007-7#2)
the laparotomy##3##2##(1990-2#1)(1996-1#1)(1997-6#1)
the lapped##3##2##(2008-2#3)
the lapse##2##2##(2007-7#1)(2008-3#1)
the large amount of data##3##5##(2008-1#1)(2008-3#1)(2008-6#1)
the large amount of##9##4##(1991-9#1)(1992-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-2#1)
the large amounts of##4##4##(2006-6#1)(2008-10#1)(2008-7#2)
the large and small subunits of##2##6##(1997-6#1)(2013-8#1)
the large and small##3##4##(1990-9#1)(1997-6#1)(2013-8#1)
the large and##7##3##(1990-9#1)(1997-6#1)(2006-2#1)(2007-11#2)(2011-2#1)(2013-8#1)
the large body of literature##2##5##(2007-6#1)(2008-8#1)
the large body of##4##4##(2007-4#1)(2007-6#1)(2008-8#1)(2012-3#1)
the large body##5##3##(2007-4#1)(2007-6#1)(2008-8#1)(2011-2#1)(2012-3#1)
the large bowel##11##3##(1990-5#1)(1993-8#1)(1993-9#4)(2006-6#2)(2006-8#1)(2007-5#1)(2008-10#1)
the large bubble##2##3##(2008-11#2)
the large difference between##2##4##(1994-6#1)(1995-1#1)
the large difference in##3##4##(2006-2#1)(2008-11#1)(2008-8#1)
the large difference##5##3##(1994-6#1)(1995-1#1)(2006-2#1)(2008-11#1)(2008-8#1)
the large differences between the##2##5##(1997-1#1)(2006-11#1)
the large differences##3##3##(1997-1#1)(2006-11#1)(2007-12#1)
the large dose##2##3##(1990-7#1)(2008-7#1)
the large extracellular domain##3##4##(1994-3#1)(1996-5#1)(2008-4#1)
the large extracellular##6##3##(1993-12#1)(1994-3#1)(1996-5#1)(2008-4#2)(2009-8#1)
the large frequency##2##3##(2007-11#2)
the large hospitals##3##3##(1990-12#1)(2008-4#2)
the large intestine is##4##4##(1990-10#1)(1991-6#1)(1992-4#1)(2009-1#1)
the large intestine##18##3##(1990-10#1)(1990-11#1)(1991-10#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-4#1)(1993-9#2)(1995-10#1)(2006-10#1)(2006-2#2)(2006-8#1)(2007-8#1)(2008-3#1)(2009-1#1)(2011-2#1)
the large literature##2##3##(2008-11#1)(2009-2#1)
the large majority of the##2##5##(2008-3#2)
the large majority of##8##4##(1990-3#1)(1991-9#1)(2005-10#1)(2006-10#1)(2008-10#2)(2008-3#2)
the large majority##9##3##(1990-3#1)(1991-9#1)(2005-10#1)(2006-10#1)(2006-12#1)(2008-10#2)(2008-3#2)
the large negative##2##3##(1991-4#1)(1993-6#1)
the large number of##34##4##(1990-9#1)(1993-2#1)(1995-2#1)(1996-2#1)(1996-8#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-11#1)(2010-11#1)(2010-12#1)(2010-8#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
the large numbers of##3##4##(1995-8#1)(2007-7#1)(2008-11#1)
the large numbers##4##3##(1995-8#1)(1996-9#1)(2007-7#1)(2008-11#1)
the large positive##2##3##(1993-6#1)(2010-9#1)
the large range##2##3##(2006-11#1)(2008-9#1)
the large sample##3##3##(2008-10#1)(2010-2#2)
the large scale##9##3##(1992-7#1)(1996-4#1)(2007-11#1)(2008-10#1)(2008-11#3)(2012-2#1)(2012-3#1)
the large size of the##9##5##(1991-3#1)(1993-2#2)(1995-5#1)(2005-11#1)(2005-9#1)(2006-9#1)(2009-2#1)(2010-3#1)
the large size of##10##4##(1991-3#1)(1993-2#2)(1995-5#1)(2005-11#1)(2005-9#1)(2006-9#1)(2008-1#1)(2009-2#1)(2010-3#1)
the large size##12##3##(1991-3#1)(1993-2#2)(1993-8#1)(1995-5#1)(2005-11#1)(2005-9#1)(2006-9#1)(2007-12#1)(2008-1#1)(2009-2#1)(2010-3#1)
the large species##2##3##(1992-9#1)(2008-7#1)
the large strain##2##3##(2007-4#2)
the large subunit (LSU)##2##4##(1995-8#1)(2008-10#1)
the large subunit of the##3##5##(1992-8#1)(1995-12#1)(2006-12#1)
the large subunit of##10##4##(1991-9#1)(1992-3#1)(1992-8#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-8#1)(2006-12#2)
the large subunit ribosomal##2##4##(1994-12#1)(2010-4#1)
the large subunit##23##3##(1990-10#1)(1990-9#1)(1991-9#1)(1992-3#2)(1992-8#3)(1993-8#1)(1994-12#2)(1995-1#1)(1995-12#1)(1995-8#2)(1996-8#1)(2005-7#1)(2006-12#2)(2006-8#1)(2008-10#1)(2010-4#1)(2013-8#1)
the large tumor##2##3##(1994-8#1)(1995-2#1)
the large variation##2##3##(2007-2#1)(2010-7#1)
the large variations in the##2##5##(2008-10#1)(2010-7#1)
the large variety of##4##4##(2007-1#1)(2007-11#1)(2008-10#1)(2008-3#1)
the large volume of literature##2##5##(2006-10#1)(2008-10#1)
the large volume of##5##4##(2006-10#1)(2008-10#3)(2010-8#1)
the large volume##6##3##(2004-12#1)(2006-10#1)(2008-10#3)(2010-8#1)
the large##368##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-3#3)(1990-5#1)(1990-7#1)(1990-9#5)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#4)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#3)(1993-6#3)(1993-8#4)(1993-9#6)(1994-11#1)(1994-12#4)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#4)(1995-10#2)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#2)(1995-7#1)(1995-8#6)(1996-1#1)(1996-10#1)(1996-2#3)(1996-4#1)(1996-5#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-12#1)(2004-4#1)(2004-9#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#8)(2006-11#2)(2006-12#6)(2006-2#6)(2006-5#1)(2006-6#3)(2006-8#3)(2006-9#1)(2007-1#1)(2007-11#11)(2007-12#16)(2007-2#1)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#21)(2008-11#11)(2008-12#1)(2008-2#8)(2008-3#23)(2008-4#6)(2008-5#2)(2008-6#2)(2008-7#13)(2008-8#4)(2008-9#1)(2009-1#1)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-11#2)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-1#3)(2012-12#4)(2012-2#7)(2012-3#5)(2013-1#7)(2013-8#5)
the large-scale analysis of##2##4##(1994-6#1)(2007-8#1)
the large-scale properties of these##2##5##(1991-11#1)(2008-8#1)
the large-scale##19##2##(1991-11#1)(1994-6#1)(1995-12#1)(1995-6#1)(1997-4#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-9#1)(2010-7#1)(2012-2#1)(2012-3#1)
the largely##5##2##(2006-7#1)(2009-4#1)(2009-8#1)(2012-2#1)(2013-8#1)
the larger and##2##3##(1996-4#1)(2008-11#1)
the larger cavity##2##3##(2005-11#1)(2007-11#1)
the larger community##2##3##(1994-1#1)(2009-8#1)
the larger context of##3##4##(1993-5#1)(2007-6#1)(2010-7#1)
the larger counterpart##2##3##(1993-4#1)(2008-7#1)
the larger cubes##2##3##(1991-3#2)
the larger form of##2##4##(1991-10#1)(1997-4#1)
the larger form##3##3##(1991-10#2)(1997-4#1)
the larger hospitals##3##3##(1991-6#1)(2006-10#2)
the larger number of##3##4##(1992-9#1)(2008-11#1)(2008-6#1)
the larger one##2##3##(1997-7#1)(2013-8#1)
the larger protein##3##3##(1991-10#1)(1996-11#1)(1997-2#1)
the larger social##2##3##(2008-10#1)(2010-12#1)
the larger steric##2##3##(2010-5#2)
the larger the##15##3##(1993-3#1)(1995-11#1)(1995-6#1)(2005-11#2)(2006-12#1)(2006-3#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-8#1)(2010-8#1)
the larger##127##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-10#3)(1991-11#1)(1991-3#2)(1991-4#1)(1991-6#2)(1991-7#3)(1991-9#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#1)(1994-1#2)(1994-12#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#2)(1995-6#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-2#2)(1997-4#2)(1997-5#1)(1997-7#1)(2005-11#7)(2006-10#3)(2006-12#1)(2006-3#2)(2006-4#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#2)(2007-8#2)(2008-10#6)(2008-11#4)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#1)(2013-8#1)
the largest absolute##2##3##(2009-4#1)(2011-2#1)
the largest amount of##5##4##(1993-11#1)(1995-11#1)(2008-6#1)(2009-5#1)(2011-2#1)
the largest and fastest##2##4##(2013-1#1)(2013-8#1)
the largest and most##8##4##(2007-12#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-4#1)(2010-8#1)(2012-3#1)
the largest and##12##3##(2007-12#1)(2008-1#1)(2008-10#3)(2008-8#1)(2009-4#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#2)
the largest body of##2##4##(1994-3#1)(2007-1#1)
the largest change in##3##4##(2004-9#1)(2008-10#1)(2013-8#1)
the largest change##4##3##(2004-9#2)(2008-10#1)(2013-8#1)
the largest chromosome##2##3##(1996-9#1)(2008-10#1)
the largest cluster have relatively##2##5##(2012-3#2)
the largest consumer##2##3##(2007-4#1)(2008-7#1)
the largest contribution to##3##4##(1993-3#1)(2008-5#1)(2010-9#1)
the largest difference##3##3##(1991-7#1)(1995-8#1)(1996-6#1)
the largest effect on##3##4##(2008-10#2)(2012-3#1)
the largest effect##5##3##(1994-6#1)(2008-10#3)(2012-3#1)
the largest error##2##3##(2008-3#1)(2013-8#1)
the largest ever##2##3##(1997-7#1)(2005-11#1)
the largest group of##4##4##(1995-6#1)(2006-10#1)(2011-2#1)(2013-1#1)
the largest group##6##3##(1995-6#1)(1996-8#1)(2006-10#1)(2007-7#1)(2011-2#1)(2013-1#1)
the largest health##2##3##(2007-5#1)(2012-12#1)
the largest hospital in##2##4##(1991-4#1)(2013-8#1)
the largest influence##2##3##(2008-5#1)(2012-2#1)
the largest number of##10##4##(1991-5#1)(1991-8#1)(1994-9#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)
the largest numbers of##2##4##(2007-8#1)(2010-12#1)
the largest of the##2##4##(1991-2#1)(1995-8#1)
the largest of##4##3##(1991-2#1)(1994-12#1)(1995-8#1)(2009-5#1)
the largest percentage of##2##4##(2005-12#1)(2006-1#1)
the largest percentage##3##3##(2005-12#1)(2006-1#1)(2009-4#1)
the largest potential##2##3##(1993-6#1)(2011-2#1)
the largest proportion of##4##4##(2008-10#1)(2008-4#1)(2009-2#1)(2013-8#1)
the largest proportion##5##3##(2008-10#1)(2008-4#1)(2009-2#1)(2010-8#1)(2013-8#1)
the largest relative##2##3##(2008-10#1)(2010-6#1)
the largest reported##3##3##(1996-6#1)(2009-10#1)(2012-12#1)
the largest risk##2##3##(1994-6#1)(2006-8#1)
the largest single##4##3##(1992-1#1)(1992-6#1)(2007-9#1)(2008-11#1)
the largest size##2##3##(2005-11#1)(2008-5#1)
the largest study##2##3##(2006-10#1)(2011-1#1)
the largest subunit of RNA polymerase II##2##7##(1992-5#1)(1997-4#1)
the largest subunit of##6##4##(1992-5#1)(1993-11#1)(1995-6#2)(1997-4#1)(1997-7#1)
the largest##273##2##(1990-11#2)(1990-5#1)(1991-11#1)(1991-2#4)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#2)(1993-11#3)(1993-12#2)(1993-3#2)(1993-6#2)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-2#1)(1995-4#1)(1995-6#5)(1995-8#2)(1996-3#1)(1996-4#1)(1996-6#3)(1996-8#1)(1996-9#2)(1997-2#2)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#1)(2004-4#1)(2004-7#1)(2004-9#3)(2005-11#2)(2005-12#1)(2005-7#1)(2006-1#1)(2006-10#6)(2006-2#1)(2006-5#3)(2006-6#1)(2006-8#2)(2007-1#2)(2007-11#2)(2007-12#7)(2007-2#2)(2007-3#3)(2007-4#3)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#24)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#8)(2008-6#3)(2008-7#4)(2008-8#8)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#3)(2009-5#3)(2009-7#3)(2009-8#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#5)(2011-2#11)(2012-12#3)(2012-2#6)(2012-3#6)(2013-1#9)(2013-7#2)(2013-8#11)
the larva##5##2##(2008-5#4)(2008-8#1)
the larvae and##2##3##(2008-7#1)(2013-1#1)
the larvae in##2##3##(2007-3#1)(2011-12#1)
the larvae of the##4##4##(1992-8#1)(2008-7#1)(2008-8#1)(2010-12#1)
the larvae of##9##3##(1992-8#1)(2007-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-8#1)(2012-12#1)
the larvae were##3##3##(2008-10#1)(2008-11#1)(2010-3#1)
the larvae##36##2##(1992-8#1)(1997-8#2)(2007-12#1)(2007-3#2)(2007-5#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#3)(2011-12#3)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
the larval and##2##3##(2007-11#1)(2011-12#1)
the larval development of##2##4##(2007-12#1)(2008-5#1)
the larval period and##2##4##(2007-12#1)(2008-7#1)
the larval period##4##3##(2007-12#2)(2007-5#1)(2008-7#1)
the larval stage at which##2##5##(2008-10#2)
the larval stage of##4##4##(2006-10#1)(2010-3#1)(2011-2#2)
the larval stage##9##3##(2006-10#1)(2008-10#2)(2008-6#1)(2008-8#2)(2010-3#1)(2011-2#2)
the larval stages##3##3##(1990-3#1)(2007-3#1)(2007-6#1)
the larval##49##2##(1990-3#1)(1991-12#1)(1991-8#1)(1994-3#2)(1995-5#3)(2004-11#1)(2006-10#1)(2007-11#3)(2007-12#8)(2007-3#2)(2007-5#1)(2007-6#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)
the laryngeal cavity##2##3##(2008-5#1)(2013-8#1)
the laryngeal mask airway##8##4##(2006-10#6)(2006-2#1)(2007-7#1)
the laryngeal mask##9##3##(1993-7#1)(2006-10#6)(2006-2#1)(2007-7#1)
the laryngeal##18##2##(1993-7#1)(1996-5#1)(1996-8#1)(2005-7#1)(2006-10#8)(2006-2#1)(2007-7#1)(2008-5#2)(2013-8#2)
the larynx and##5##3##(1993-8#1)(2008-5#2)(2011-1#1)(2011-2#1)
the larynx are very##2##4##(1996-12#1)(2011-2#1)
the larynx has##2##3##(1992-2#1)(1996-12#1)
the larynx is##2##3##(1993-6#1)(2006-4#1)
the larynx##37##2##(1991-4#1)(1992-2#3)(1993-6#3)(1993-8#2)(1994-7#1)(1996-12#2)(2006-4#3)(2007-9#1)(2008-11#1)(2008-5#4)(2009-10#3)(2009-2#1)(2010-7#1)(2011-1#3)(2011-2#4)(2012-2#2)(2013-7#1)(2013-8#1)
the lasB-lacZ fusion was##2##4##(1995-2#2)
the laser Doppler##3##3##(1992-8#1)(2007-11#1)(2008-2#1)
the laser and the##4##4##(2005-4#1)(2007-12#2)(2008-3#1)
the laser and##12##3##(1992-10#1)(1994-12#1)(2005-4#1)(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#3)
the laser are##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
the laser beam intensity##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
the laser beam is##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
the laser beam to##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
the laser beam##43##3##(1993-3#1)(2007-11#4)(2007-12#7)(2008-10#2)(2008-2#10)(2008-3#18)(2008-9#1)
the laser beams##2##3##(2008-3#2)
the laser can##2##3##(2008-2#1)(2012-3#1)
the laser cavities##2##3##(2008-3#2)
the laser cavity and##2##4##(2007-12#1)(2008-3#1)
the laser cavity##16##3##(2007-11#4)(2007-12#7)(2008-2#1)(2008-3#4)
the laser crystal was##2##4##(2007-12#1)(2008-3#1)
the laser crystal##5##3##(2007-12#2)(2008-3#3)
the laser damage threshold##2##4##(2008-2#1)(2008-3#1)
the laser diode and##2##4##(2008-2#1)(2008-3#1)
the laser diode is##2##4##(2007-12#1)(2008-3#1)
the laser diode##14##3##(2007-12#3)(2008-2#4)(2008-3#6)(2010-11#1)
the laser emission##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
the laser energy##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
the laser field##3##3##(2007-12#3)
the laser fluence##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
the laser frequency and##3##4##(2007-12#2)(2008-1#1)
the laser frequency by##2##4##(2008-3#2)
the laser frequency##13##3##(2007-11#1)(2007-12#4)(2008-1#1)(2008-2#3)(2008-3#4)
the laser gain##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
the laser has been##3##4##(2008-3#2)(2008-5#1)
the laser intensity##6##3##(2007-12#2)(2008-2#1)(2008-3#3)
the laser irradiance##2##3##(1993-3#1)(2008-3#1)
the laser irradiation##5##3##(2007-9#1)(2008-3#3)(2013-8#1)
the laser is##8##3##(2007-11#2)(2007-12#4)(2008-2#1)(2008-3#1)
the laser light##10##3##(1992-1#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#3)(2010-8#1)
the laser linewidth##3##3##(2008-2#3)
the laser medium##3##3##(2007-12#2)(2008-3#1)
the laser mode##3##3##(2007-12#3)
the laser output power##4##4##(2007-12#2)(2008-3#2)
the laser output##6##3##(2007-12#4)(2008-3#2)
the laser parameters##2##3##(2007-12#2)
the laser performance of a##2##5##(2007-12#1)(2008-2#1)
the laser performance##6##3##(2007-12#2)(2008-2#2)(2008-3#2)
the laser power##9##3##(1992-12#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)
the laser produces##3##3##(2007-12#2)(2008-3#1)
the laser propagation##2##3##(2007-11#1)(2008-2#1)
the laser pulse and##3##4##(2007-12#2)(2008-3#1)
the laser pulse##12##3##(2007-11#1)(2007-12#5)(2008-1#1)(2008-2#2)(2008-3#3)
the laser pulses##2##3##(2007-11#1)(2007-12#1)
the laser radiation##5##3##(2008-10#1)(2008-2#1)(2008-3#3)
the laser resonator##3##3##(2007-12#1)(2008-2#2)
the laser rod##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
the laser safety standards##2##4##(1993-3#2)
the laser source##7##3##(2007-12#2)(2008-2#2)(2008-3#1)(2008-9#1)(2009-5#1)
the laser spot##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
the laser system##3##3##(2007-11#1)(2008-2#2)
the laser threshold##2##3##(2007-12#2)
the laser through##2##3##(2007-12#2)
the laser was##5##3##(2007-12#2)(2008-3#2)(2012-3#1)
the laser wave front##2##4##(2008-2#2)
the laser wave##3##3##(2008-2#2)(2008-3#1)
the laser wavelength is##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
the laser wavelength##5##3##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
the laser with a##2##4##(2008-2#2)
the laser with##6##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)
the laser##383##2##(1990-12#1)(1991-1#1)(1991-3#1)(1991-4#2)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-8#1)(1993-3#4)(1994-12#1)(1995-2#1)(2004-3#1)(2005-4#2)(2006-10#1)(2006-12#1)(2007-11#32)(2007-12#106)(2007-9#1)(2008-1#2)(2008-10#15)(2008-11#1)(2008-2#78)(2008-3#110)(2008-5#2)(2008-7#1)(2008-9#2)(2009-5#2)(2010-11#1)(2010-8#1)(2011-1#1)(2012-3#3)(2013-8#2)
the laser's##14##2##(2007-11#1)(2007-12#5)(2008-10#1)(2008-2#3)(2008-3#4)
the laser-active dopant##2##3##(2007-12#2)
the laser-active##3##2##(2007-12#3)
the laser-diode##3##2##(2007-12#2)(2008-3#1)
the laser-heated##3##2##(2008-2#2)(2008-3#1)
the laser-induced damage threshold (LIDT)##2##5##(2007-12#1)(2008-3#1)
the laser-induced damage threshold##3##4##(2007-12#1)(2008-3#2)
the laser-induced##8##2##(2006-12#1)(2007-12#2)(2008-3#5)
the lasers to##2##3##(2007-8#1)(2008-3#1)
the lasers##6##2##(2007-11#2)(2007-8#1)(2008-3#2)(2008-7#1)
the lasing frequency##2##3##(2007-12#2)
the lasing mode##2##3##(2007-12#2)
the lasing threshold##4##3##(2007-11#1)(2007-12#2)(2008-1#1)
the lasing wavelength and##2##4##(2007-12#1)(2008-1#1)
the lasing wavelength##7##3##(2007-12#2)(2008-1#1)(2008-2#3)(2008-3#1)
the lasing##28##2##(2007-11#1)(2007-12#12)(2008-1#5)(2008-2#7)(2008-3#3)
the lasso##2##2##(1997-2#1)(2010-1#1)
the last 10 years and##2##5##(2012-12#1)(2012-2#1)
the last 10 years has##2##5##(2005-10#1)(2009-8#1)
the last 10 years in##2##5##(2009-5#1)(2013-1#1)
the last 10 years##34##4##(1991-6#1)(1992-5#1)(1995-12#1)(1995-9#1)(1996-3#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-3#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
the last 10 yr##3##4##(2008-9#1)(2013-8#2)
the last 10##38##3##(1991-6#1)(1992-5#1)(1995-12#1)(1995-9#1)(1996-3#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-3#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
the last 100 years##3##4##(2007-11#1)(2007-2#1)(2008-4#1)
the last 12 months##8##4##(1994-8#1)(1996-9#1)(2007-2#1)(2010-1#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-12#1)
the last 12 years##5##4##(1993-3#1)(1997-3#1)(2006-8#1)(2008-10#1)(2010-12#1)
the last 12##16##3##(1990-10#1)(1993-3#1)(1994-8#1)(1996-9#1)(1997-3#1)(2006-8#1)(2007-2#1)(2008-10#1)(2010-1#1)(2010-11#1)(2010-12#2)(2011-1#1)(2012-12#3)
the last 13##2##3##(1992-2#1)(2006-10#1)
the last 14 years##2##4##(1991-11#1)(2012-3#1)
the last 14##3##3##(1991-11#1)(2008-7#1)(2012-3#1)
the last 15 years##16##4##(1990-8#1)(1991-11#1)(1991-9#1)(1992-10#1)(1992-12#1)(1993-11#1)(1994-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-3#1)(2010-12#3)(2010-3#1)(2012-2#1)
the last 15##18##3##(1990-8#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1993-11#1)(1994-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-3#1)(2010-12#3)(2010-3#1)(2012-2#2)
the last 16 years##2##4##(2007-7#1)(2011-2#1)
the last 18 months##5##4##(1990-6#1)(1996-3#1)(1997-3#1)(2007-7#1)(2008-11#1)
the last 2 decades with##2##5##(2006-2#1)(2009-4#1)
the last 2 decades##11##4##(2005-10#1)(2005-8#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2012-2#1)
the last 2 years##8##4##(1990-6#1)(1993-11#1)(1994-6#1)(2005-9#1)(2006-10#2)(2006-6#1)(2008-3#1)
the last 2##22##3##(1990-6#1)(1993-11#1)(1993-12#1)(1994-6#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-2#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-2#1)
the last 20 years##21##4##(1990-10#1)(1991-4#1)(1992-4#1)(1994-3#1)(2006-1#1)(2006-2#1)(2006-9#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-10#1)(2010-11#1)(2011-2#1)(2011-7#1)(2012-11#1)
the last 20##28##3##(1990-10#1)(1991-4#1)(1992-4#1)(1992-6#1)(1994-12#2)(1994-3#1)(1996-8#1)(2006-1#1)(2006-2#1)(2006-9#2)(2007-2#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-8#1)(2009-10#1)(2010-11#1)(2011-2#1)(2011-7#1)(2012-11#1)
the last 24##3##3##(1996-4#1)(2006-6#1)(2007-7#1)
the last 25 years##15##4##(1996-1#1)(1996-11#1)(1997-5#1)(2006-11#1)(2007-10#1)(2007-12#1)(2007-5#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2012-3#1)(2013-1#1)
the last 3 months##3##4##(2007-8#1)(2008-10#1)(2013-1#1)
the last 3 years##7##4##(2006-5#1)(2006-8#2)(2007-6#1)(2007-8#1)(2008-7#1)(2012-2#1)
the last 3##14##3##(1994-3#1)(2004-3#1)(2004-4#1)(2006-5#1)(2006-8#2)(2007-6#1)(2007-8#2)(2008-10#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
the last 30 years##18##4##(1993-1#1)(1994-12#1)(1997-5#1)(2006-3#2)(2007-11#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
the last 30##24##3##(1993-1#1)(1994-12#1)(1995-6#1)(1997-5#1)(2006-3#2)(2007-11#1)(2007-12#1)(2007-8#5)(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
the last 35##2##3##(1997-7#1)(2010-12#1)
the last 4 years##3##4##(2006-3#1)(2008-10#1)(2011-2#1)
the last 4##7##3##(2006-3#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-3#1)(2011-2#1)
the last 40 years##4##4##(1990-10#1)(2006-2#1)(2007-6#1)(2011-2#1)
the last 40##6##3##(1990-10#1)(1996-7#1)(1997-7#1)(2006-2#1)(2007-6#1)(2011-2#1)
the last 5 years##21##4##(1994-6#1)(1996-11#1)(1997-4#1)(2005-7#1)(2005-8#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-5#1)(2012-3#2)
the last 5##24##3##(1990-4#1)(1994-6#1)(1996-11#1)(1997-4#1)(2005-7#1)(2005-8#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-3#2)
the last 50 years a number of drugs have achieved an established role in the therapy of these infections##2##19##(2005-7#1)(2005-9#1)
the last 50 years##10##4##(1990-6#1)(1995-2#1)(2005-7#1)(2005-8#1)(2005-9#1)(2007-11#1)(2007-7#1)(2008-10#2)(2011-2#1)
the last 50##12##3##(1990-6#1)(1995-2#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-9#1)(2011-2#1)
the last 6 months##3##4##(1997-2#1)(2007-7#1)(2011-2#1)
the last 6 years##6##4##(1990-4#1)(1992-10#1)(1996-9#1)(1997-4#1)(2006-10#1)(2008-8#1)
the last 6##9##3##(1990-4#1)(1992-10#1)(1996-9#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-7#1)(2008-8#1)(2011-2#1)
the last 60 years##3##4##(1991-12#1)(2008-10#1)(2012-12#1)
the last 7##3##3##(1995-6#1)(2011-2#1)(2012-1#1)
the last 8 years##3##4##(1994-1#1)(2006-7#1)(2008-3#1)
the last 90##2##3##(1990-5#1)(2011-12#1)
the last areas of##2##4##(1993-6#1)(2011-2#1)
the last case##5##3##(1991-8#2)(1994-9#1)(2008-3#1)(2008-7#1)
the last century##17##3##(2004-10#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-3#1)(2013-1#1)(2013-7#1)
the last couple of years##2##5##(2005-10#1)(2006-7#1)
the last day of##2##4##(2005-10#1)(2008-6#1)
the last day##3##3##(1992-8#1)(2005-10#1)(2008-6#1)
the last days##2##3##(1992-5#2)
the last decade and##6##4##(1992-1#1)(2005-7#1)(2006-10#1)(2008-11#1)(2008-3#1)(2012-2#1)
the last decade as##4##4##(2006-10#1)(2008-4#1)(2009-3#1)(2012-2#1)
the last decade due to the##2##6##(1990-12#1)(2013-1#1)
the last decade has##3##4##(2007-11#1)(2011-2#2)
the last decade in##6##4##(2005-7#1)(2006-11#1)(2008-1#1)(2008-7#1)(2011-3#1)(2013-1#1)
the last decade is##3##4##(1994-11#1)(1996-11#1)(2008-1#1)
the last decade it has##2##5##(1991-6#1)(2008-4#1)
the last decade the##5##4##(1991-11#1)(1996-3#1)(2007-8#1)(2011-1#2)
the last decade there has been##4##6##(2006-10#1)(2008-12#2)(2009-7#1)
the last decade##168##3##(1990-12#2)(1990-4#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-6#3)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-10#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-4#1)(1997-7#1)(2005-12#1)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#5)(2006-11#1)(2006-2#2)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#2)(2007-11#5)(2007-12#2)(2007-2#1)(2007-5#2)(2007-7#3)(2007-8#1)(2008-1#7)(2008-10#5)(2008-11#4)(2008-12#5)(2008-3#2)(2008-4#4)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#2)(2009-7#4)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-8#4)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#7)(2013-1#10)(2013-7#1)
the last decades##27##3##(1990-10#1)(1994-12#1)(1996-4#1)(2005-11#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-12#1)(2009-4#2)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
the last dose##7##3##(1992-8#2)(1995-3#1)(1996-5#1)(1997-7#1)(2008-7#1)(2013-8#1)
the last egg##2##3##(2008-8#2)
the last eight years##2##4##(2006-8#1)(2008-2#1)
the last eight##3##3##(1991-8#1)(2006-8#1)(2008-2#1)
the last examination##4##3##(2007-11#1)(2007-7#2)(2007-8#1)
the last exposure##3##3##(1991-9#1)(1992-6#1)(2009-2#1)
the last few centuries##2##4##(2005-9#1)(2008-8#1)
the last few decades##18##4##(1992-3#1)(1993-9#1)(1995-1#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2010-12#1)(2012-2#2)(2013-1#1)
the last few years and##2##5##(2010-12#1)(2012-12#1)
the last few years by##2##5##(2011-2#1)(2013-8#1)
the last few years has##2##5##(2010-12#1)(2012-2#1)
the last few years in##2##5##(1992-10#1)(1993-8#1)
the last few years there##2##5##(1993-3#1)(1994-9#1)
the last few years##66##4##(1990-11#1)(1990-3#1)(1990-8#2)(1990-9#1)(1991-3#2)(1992-10#1)(1993-3#2)(1993-5#1)(1993-8#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#6)(2006-12#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-11#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-5#5)(2008-7#1)(2008-8#1)(2009-3#1)(2009-7#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
the last few##89##3##(1990-11#1)(1990-3#1)(1990-8#2)(1990-9#1)(1991-3#2)(1992-10#1)(1992-3#1)(1993-3#2)(1993-5#1)(1993-8#1)(1993-9#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1997-7#1)(2005-10#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#7)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#4)(2006-9#1)(2007-11#3)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#7)(2008-7#1)(2008-8#2)(2009-3#1)(2009-4#1)(2009-7#1)(2010-12#6)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
the last fifteen years##4##4##(2006-6#1)(2007-11#1)(2009-5#1)(2009-7#1)
the last fifteen##5##3##(2006-6#1)(2007-11#1)(2008-1#1)(2009-5#1)(2009-7#1)
the last fifty years##5##4##(1991-3#1)(2007-1#1)(2008-8#1)(2009-2#1)(2010-5#1)
the last five decades##2##4##(1996-3#1)(2013-8#1)
the last five years##11##4##(1991-5#1)(1996-4#1)(1996-7#1)(2006-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-7#1)(2012-2#1)
the last five##15##3##(1991-5#1)(1992-12#1)(1992-6#1)(1996-3#1)(1996-4#1)(1996-7#1)(2006-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-7#1)(2012-2#1)(2013-8#1)
the last follow up##2##4##(2009-11#1)(2013-1#1)
the last follow-up##7##3##(1996-3#1)(1997-3#1)(2008-1#2)(2008-6#2)(2011-1#1)
the last four decades have##2##5##(2005-11#1)(2008-11#1)
the last four decades##6##4##(1997-7#1)(2005-11#1)(2006-12#1)(2008-1#1)(2008-11#1)(2008-3#1)
the last four years##3##4##(1992-8#1)(2006-10#1)(2008-5#1)
the last four##18##3##(1990-10#1)(1992-8#1)(1993-9#1)(1994-2#1)(1996-1#1)(1996-2#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-4#1)(2011-1#2)
the last frontier##2##3##(1995-1#1)(2008-1#1)
the last group##3##3##(2006-7#1)(2007-12#1)(2012-11#1)
the last half of the##2##5##(2008-10#1)(2008-4#1)
the last half of##3##4##(1992-3#1)(2008-10#1)(2008-4#1)
the last half##6##3##(1992-3#1)(1994-1#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-4#1)
the last hour##2##3##(2008-1#1)(2008-12#1)
the last ice##2##3##(2007-8#1)(2007-9#1)
the last in##3##3##(1995-2#1)(1996-2#1)(2007-8#1)
the last injection##9##3##(1994-5#1)(1995-10#1)(1995-5#1)(1996-10#3)(1996-4#1)(2006-10#1)(2010-12#1)
the last larval##3##3##(1992-6#1)(2007-12#2)
the last mentioned##2##3##(1991-7#1)(2008-10#1)
the last month of##4##4##(1996-12#2)(2008-9#1)(2010-8#1)
the last one and##2##4##(1993-2#1)(2007-7#1)
the last one to two##2##5##(2005-8#1)(2006-10#1)
the last one##15##3##(1993-2#1)(1997-3#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-3#3)(2007-7#1)(2007-8#1)(2008-10#1)(2008-8#1)(2012-1#1)
the last part of the##3##5##(1991-12#1)(1994-8#1)(2011-2#1)
the last period of##3##4##(1993-8#1)(1994-3#1)(2011-1#1)
the last period##4##3##(1992-2#1)(1993-8#1)(1994-3#1)(2011-1#1)
the last phases##4##3##(1990-3#2)(1990-6#1)(2008-11#1)
the last product##2##3##(1991-12#1)(2006-12#1)
the last quarter##3##3##(2008-12#1)(2010-8#1)(2013-1#1)
the last question##2##3##(2006-2#1)(2010-12#1)
the last seizure##2##3##(1996-12#1)(2004-11#1)
the last serum##2##3##(1997-5#2)
the last seven years##3##4##(2006-4#1)(2009-8#1)(2013-1#1)
the last seven##6##3##(2006-10#1)(2006-4#1)(2006-7#1)(2007-6#1)(2009-8#1)(2013-1#1)
the last several decades##3##4##(2010-2#1)(2011-2#1)(2012-12#1)
the last several years##17##4##(1992-3#1)(1993-2#1)(1995-2#1)(2006-10#2)(2007-11#2)(2007-4#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-9#1)(2009-3#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-12#1)
the last several##21##3##(1992-3#1)(1993-2#1)(1995-2#1)(1997-4#1)(2006-10#2)(2007-11#2)(2007-4#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-9#1)(2009-3#1)(2010-2#1)(2010-6#1)(2011-12#1)(2011-2#2)(2012-12#2)
the last six months##2##4##(2009-7#1)(2010-12#1)
the last six years##2##4##(2008-10#1)(2009-2#1)
the last six##4##3##(2008-10#1)(2009-2#1)(2009-7#1)(2010-12#1)
the last stage##2##3##(2013-7#1)(2013-8#1)
the last stages of the##2##5##(1996-11#1)(2011-2#1)
the last step in##2##4##(1997-4#1)(2008-4#1)
the last step of##4##4##(1992-5#1)(1996-2#1)(2008-8#1)(2012-2#1)
the last step##9##3##(1992-5#1)(1995-4#1)(1996-2#1)(1997-4#2)(2008-10#1)(2008-4#1)(2008-8#1)(2012-2#1)
the last ten years in##2##5##(2005-9#1)(2013-1#1)
the last ten years the##3##5##(1990-6#1)(1996-3#1)(2007-5#1)
the last ten years##30##4##(1990-11#1)(1990-6#1)(1990-7#2)(1991-9#1)(1992-12#2)(1992-2#1)(1993-3#1)(1993-9#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-7#1)(2005-9#1)(2006-1#1)(2006-6#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-8#3)(2012-2#1)(2012-3#3)(2013-1#2)
the last thirty years##2##4##(2006-8#2)
the last three decades##11##4##(1994-7#1)(2005-11#1)(2006-4#1)(2006-8#1)(2008-6#1)(2008-7#2)(2010-12#1)(2011-2#2)(2012-2#1)
the last three years##8##4##(1990-8#1)(1995-6#1)(2005-10#1)(2006-8#1)(2009-4#1)(2011-2#1)(2012-3#2)
the last three##32##3##(1990-4#1)(1990-8#1)(1991-7#1)(1994-7#1)(1995-6#1)(1997-2#2)(2005-10#1)(2005-11#1)(2006-4#2)(2006-8#2)(2007-1#1)(2007-10#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-4#1)(2010-12#1)(2011-2#5)(2012-2#1)(2012-3#2)(2013-7#1)
the last time##3##3##(1991-3#2)(2012-12#1)
the last to##3##3##(1993-12#1)(1994-8#1)(2013-1#1)
the last trimester of##3##4##(2007-11#2)(2008-5#1)
the last trimester##5##3##(1991-3#1)(1995-8#1)(2007-11#2)(2008-5#1)
the last twelve months##3##4##(2006-10#1)(2011-1#1)(2013-1#1)
the last twelve##4##3##(1993-10#1)(2006-10#1)(2011-1#1)(2013-1#1)
the last twenty years##7##4##(1990-12#1)(1990-5#1)(1992-4#1)(1995-12#1)(1996-2#1)(2006-1#1)(2012-2#1)
the last two abdominal segments##2##5##(2007-12#1)(2013-7#1)
the last two decades have##3##5##(2006-2#1)(2007-12#1)(2010-11#1)
the last two decades of##3##5##(2008-6#1)(2009-4#1)(2013-7#1)
the last two decades or so##3##6##(2007-2#1)(2008-10#1)(2008-8#1)
the last two decades##53##4##(1991-10#1)(1994-3#2)(1995-12#1)(1996-3#1)(2005-12#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#3)(2013-8#1)
the last two parameters##2##4##(2005-11#1)(2008-10#1)
the last two steps of##2##5##(2010-2#1)(2011-1#1)
the last two weeks##2##4##(2006-8#1)(2007-3#1)
the last two years##13##4##(1991-5#1)(1992-3#1)(1993-8#1)(1996-12#1)(1997-8#1)(2005-7#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#1)
the last two##92##3##(1990-8#1)(1991-10#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-8#1)(1994-3#2)(1994-7#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-8#1)(2004-10#1)(2005-11#1)(2005-12#1)(2005-7#2)(2006-10#2)(2006-12#1)(2006-2#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#4)(2013-8#1)
the last visit##2##3##(2006-11#1)(2008-3#1)
the last was##3##3##(2005-8#1)(2007-7#1)(2011-1#1)
the last week of##3##4##(1991-4#1)(1994-6#1)(2012-12#1)
the last week##5##3##(1991-4#1)(1994-6#1)(2012-12#1)(2012-3#2)
the last word on##2##4##(1993-12#1)(2011-1#1)
the last word##3##3##(1993-12#1)(2005-10#1)(2011-1#1)
the last year##24##3##(1990-12#1)(1993-8#1)(1997-3#1)(1997-4#1)(2005-11#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#8)(2007-1#1)(2007-3#1)(2007-8#1)(2008-12#1)(2009-4#1)(2011-1#1)(2012-3#2)
the last years have##2##4##(2008-10#1)(2013-1#1)
the last years##33##3##(1991-4#2)(1993-10#1)(1997-4#2)(1997-5#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#5)(2012-1#1)(2013-1#2)
the last##1208##2##(1990-10#6)(1990-11#3)(1990-12#4)(1990-3#5)(1990-4#4)(1990-5#3)(1990-6#6)(1990-7#4)(1990-8#6)(1990-9#2)(1991-10#2)(1991-11#5)(1991-12#7)(1991-2#2)(1991-3#7)(1991-4#5)(1991-5#2)(1991-6#4)(1991-7#3)(1991-8#4)(1991-9#5)(1992-1#3)(1992-10#4)(1992-11#1)(1992-12#6)(1992-2#4)(1992-3#5)(1992-4#2)(1992-5#5)(1992-6#6)(1992-8#4)(1992-9#1)(1993-1#3)(1993-10#3)(1993-11#3)(1993-12#4)(1993-2#3)(1993-3#4)(1993-5#2)(1993-6#4)(1993-7#1)(1993-8#5)(1993-9#6)(1994-1#2)(1994-11#1)(1994-12#7)(1994-2#3)(1994-3#9)(1994-4#1)(1994-5#1)(1994-6#7)(1994-7#2)(1994-8#4)(1994-9#2)(1995-1#4)(1995-10#2)(1995-11#1)(1995-12#7)(1995-2#4)(1995-3#5)(1995-4#2)(1995-5#2)(1995-6#4)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#4)(1996-10#3)(1996-11#5)(1996-12#8)(1996-2#4)(1996-3#8)(1996-4#7)(1996-5#2)(1996-7#3)(1996-8#1)(1996-9#2)(1997-2#6)(1997-3#5)(1997-4#10)(1997-5#8)(1997-6#2)(1997-7#6)(1997-8#3)(2004-10#2)(2004-11#2)(2004-3#1)(2004-4#1)(2005-10#11)(2005-11#6)(2005-12#2)(2005-6#1)(2005-7#8)(2005-8#10)(2005-9#4)(2006-1#4)(2006-10#43)(2006-11#4)(2006-12#5)(2006-2#12)(2006-3#3)(2006-4#5)(2006-5#5)(2006-6#11)(2006-7#8)(2006-8#18)(2006-9#7)(2007-1#4)(2007-10#4)(2007-11#28)(2007-12#15)(2007-2#8)(2007-3#7)(2007-4#5)(2007-5#10)(2007-6#3)(2007-7#22)(2007-8#29)(2007-9#3)(2008-1#29)(2008-10#51)(2008-11#21)(2008-12#12)(2008-2#8)(2008-3#13)(2008-4#17)(2008-5#20)(2008-6#11)(2008-7#19)(2008-8#26)(2008-9#12)(2009-10#3)(2009-11#1)(2009-12#4)(2009-2#4)(2009-3#7)(2009-4#8)(2009-5#5)(2009-6#1)(2009-7#7)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#23)(2010-2#6)(2010-3#6)(2010-4#7)(2010-5#6)(2010-6#5)(2010-7#2)(2010-8#9)(2010-9#2)(2011-1#20)(2011-12#4)(2011-2#46)(2011-3#4)(2011-7#1)(2012-1#7)(2012-11#3)(2012-12#21)(2012-2#31)(2012-3#22)(2012-7#1)(2013-1#34)(2013-7#8)(2013-8#7)
the late 1800s##2##3##(2008-10#1)(2012-12#1)
the late 1950s##2##3##(2006-7#1)(2010-8#1)
the late 1960s and early 1970s##2##6##(2004-3#1)(2011-2#1)
the late 1960s##5##3##(2004-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)
the late 1970s and 1980s##2##5##(2007-1#1)(2008-12#1)
the late 1970s and##3##4##(1996-5#1)(2007-1#1)(2008-12#1)
the late 1970s##7##3##(1995-3#1)(1996-5#1)(2007-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-3#1)
the late 1980s and 1990s##2##5##(2004-3#1)(2009-8#1)
the late 1980s and early 1990s##2##6##(2008-10#1)(2008-3#1)
the late 1980s and##4##4##(2004-3#1)(2008-10#1)(2008-3#1)(2009-8#1)
the late 1980s##14##3##(1992-2#1)(1992-5#1)(1994-3#1)(1995-12#1)(1997-2#1)(2004-3#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-7#1)
the late 1990s##14##3##(2005-10#1)(2006-4#1)(2007-4#1)(2008-10#3)(2008-7#2)(2009-9#1)(2010-2#1)(2010-5#1)(2012-1#1)(2012-2#1)(2013-1#1)
the late 19th century##4##4##(1993-12#1)(2007-5#1)(2010-12#1)(2013-7#1)
the late afterhyperpolarization##3##3##(1992-8#3)
the late afternoon and##2##4##(1993-12#1)(2012-6#1)
the late afternoon##3##3##(1993-12#1)(2011-2#1)(2012-6#1)
the late blight##6##3##(2008-10#6)
the late eighteenth##2##3##(2009-10#1)(2009-2#1)
the late embryonic##2##3##(2008-11#1)(2008-5#1)
the late group##2##3##(2006-5#2)
the late hypotensive phase##2##4##(1990-7#2)
the late nineteenth century##6##4##(2009-4#1)(2010-1#3)(2011-2#1)(2013-1#1)
the late nineteenth##8##3##(2009-4#1)(2010-1#5)(2011-2#1)(2013-1#1)
the late outcome##2##3##(2006-10#1)(2007-11#1)
the late period following##2##4##(2007-8#1)(2008-6#1)
the late period##7##3##(2007-11#1)(2007-8#3)(2008-4#1)(2008-6#1)(2011-2#1)
the late phase of the##3##5##(1990-6#1)(1992-8#1)(1993-2#1)
the late phase of##8##4##(1990-4#1)(1990-6#1)(1992-8#1)(1993-2#1)(1994-12#1)(1995-12#1)(2009-6#1)(2010-12#1)
the late phase##15##3##(1990-4#1)(1990-6#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-11#2)(1995-12#2)(2009-6#1)(2010-12#4)
the late reflex potential##2##4##(1994-2#2)
the late secretory pathway##2##4##(1997-6#1)(2008-7#1)
the late seventies##2##3##(1991-12#1)(2008-4#1)
the late stage of##10##4##(1991-12#1)(1997-8#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-12#1)
the late stages of##5##4##(1991-4#1)(1991-7#1)(1995-1#1)(2008-10#1)(2012-3#1)
the late stages##8##3##(1991-4#1)(1991-7#1)(1995-1#1)(2008-10#2)(2009-12#1)(2011-3#1)(2012-3#1)
the late summer##2##3##(2007-12#1)(2008-10#1)
the late toxicity##2##3##(1990-4#1)(2006-6#1)
the late##229##2##(1990-11#1)(1990-3#2)(1990-4#4)(1990-6#1)(1990-7#2)(1991-11#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#5)(1992-9#2)(1993-12#2)(1993-2#1)(1993-6#2)(1993-8#1)(1994-12#2)(1994-2#3)(1994-3#2)(1995-1#2)(1995-11#2)(1995-12#3)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-4#2)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#3)(1997-5#3)(1997-6#1)(1997-8#2)(2004-1#1)(2004-3#2)(2005-10#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#4)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-4#1)(2007-5#2)(2007-8#4)(2008-1#5)(2008-10#19)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#9)(2008-6#3)(2008-7#11)(2008-8#3)(2008-9#5)(2009-10#1)(2009-12#2)(2009-2#2)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#5)(2010-11#1)(2010-12#7)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#10)(2011-3#1)(2011-7#1)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#2)(2012-6#1)(2013-1#6)(2013-7#1)
the late-onset##3##2##(1990-5#2)(1991-3#1)
the latencies of##2##3##(1997-7#1)(2011-12#1)
the latencies##4##2##(1996-12#1)(1997-7#1)(2011-12#1)(2013-7#1)
the latency and##2##3##(1996-5#1)(2009-12#1)
the latency of the##6##4##(1991-2#1)(1992-8#1)(1996-1#1)(2008-4#1)(2008-8#1)(2010-7#1)
the latency of##16##3##(1990-7#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-8#1)(1993-3#1)(1994-3#1)(1996-1#1)(1996-5#1)(2008-1#1)(2008-4#1)(2008-8#1)(2010-2#1)(2010-7#1)(2013-1#1)(2013-7#1)
the latency period##2##3##(1997-7#1)(2008-7#1)
the latency to initiate##2##4##(1993-12#2)
the latency to##7##3##(1993-12#2)(1994-2#1)(2005-9#1)(2008-11#1)(2010-2#1)(2010-3#1)
the latency##32##2##(1990-7#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-8#1)(1993-12#2)(1993-3#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-1#1)(1996-5#2)(1997-1#1)(1997-7#1)(2005-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-2#2)(2010-3#1)(2010-7#1)(2010-8#1)(2013-1#1)(2013-7#1)
the latency-associated##2##2##(2006-10#1)(2013-8#1)
the latent form##2##3##(1997-2#1)(2006-9#1)
the latent heat##3##3##(2010-4#1)(2013-8#2)
the latent infection##2##3##(2013-8#2)
the latent period before##2##4##(1990-11#1)(1991-3#1)
the latent period of##2##4##(2008-10#2)
the latent period##8##3##(1990-11#1)(1991-3#1)(2007-12#1)(2008-10#5)
the latent periods and amplitudes of##2##6##(2008-8#2)
the latent variables that are##2##5##(2009-4#1)(2010-2#1)
the latent##37##2##(1990-11#1)(1991-3#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-4#1)(1993-9#1)(1995-3#1)(1997-2#1)(2005-1#1)(2006-10#1)(2006-9#1)(2007-12#2)(2008-10#8)(2008-2#1)(2008-8#2)(2009-10#1)(2009-4#1)(2010-11#1)(2010-2#1)(2010-4#1)(2013-1#1)(2013-8#5)
the later development of##5##4##(2005-6#1)(2006-1#1)(2007-12#1)(2008-3#1)(2012-2#1)
the later of which typically consists of text comments##2##9##(2013-1#2)
the later period##2##3##(2011-2#1)(2013-8#1)
the later stage of##2##4##(2005-3#1)(2008-8#1)
the later stages because##2##4##(1993-9#1)(2013-1#1)
the later stages of##12##4##(1990-5#1)(1996-12#1)(2005-7#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-6#1)(2009-5#1)(2012-3#1)(2013-8#2)
the later stages##18##3##(1990-5#1)(1993-9#1)(1995-12#1)(1996-12#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-5#1)(2012-3#1)(2013-1#1)(2013-8#2)
the later steps##2##3##(1997-7#1)(2009-12#1)
the later##70##2##(1990-10#1)(1990-5#1)(1991-11#1)(1991-4#1)(1992-4#1)(1992-5#1)(1993-9#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-7#1)(1996-12#2)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-12#1)(2005-3#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-1#2)(2007-12#3)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2009-12#1)(2009-5#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#4)
the lateral amygdaloid nucleus##3##4##(1991-9#2)(1996-6#1)
the lateral and medial epicondyle##2##5##(2007-7#1)(2010-12#1)
the lateral and medial##9##4##(1995-5#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-7#1)(2007-7#1)(2009-7#1)(2010-11#1)(2010-12#1)
the lateral and posterior##4##4##(2007-12#1)(2007-8#2)(2013-1#1)
the lateral and the medial##2##5##(1995-5#1)(1996-9#1)
the lateral and third ventricles##4##5##(1996-3#1)(2006-5#3)
the lateral and ventral##2##4##(1995-5#1)(1997-6#1)
the lateral and##22##3##(1990-2#1)(1995-5#3)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-5#3)(2007-12#1)(2007-7#1)(2007-8#2)(2009-7#1)(2010-11#1)(2010-12#1)(2013-1#1)
the lateral angle of the patella##4##6##(2007-8#4)
the lateral aspect of the hip##2##6##(2006-10#2)
the lateral aspect of the##6##5##(1995-7#1)(2006-10#2)(2006-12#1)(2006-5#1)(2013-1#1)
the lateral aspect of##7##4##(1995-7#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-11#1)(2013-1#1)
the lateral balance task##2##4##(2012-1#2)
the lateral canthus##3##3##(2010-12#3)
the lateral cerebellomedullary cistern without dural attachment##2##7##(2008-7#2)
the lateral cerebral ventricle##7##4##(1990-7#1)(1991-6#1)(1993-12#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-7#1)
the lateral chain of##2##4##(2006-10#1)(2008-10#1)
the lateral chain##3##3##(2006-10#2)(2008-10#1)
the lateral chest radiograph##2##4##(1997-8#2)
the lateral collateral ligament##3##4##(2009-7#1)(2013-1#2)
the lateral compartment##2##3##(1992-3#1)(2009-3#1)
the lateral condensation##2##3##(1991-3#1)(2013-1#1)
the lateral cortex##2##3##(1996-1#1)(2010-3#1)
the lateral direction##7##3##(2007-12#2)(2008-2#1)(2009-8#1)(2010-12#1)(2010-2#1)(2012-1#1)
the lateral displacement of##2##4##(1997-3#1)(2008-3#1)
the lateral displacements##2##3##(2008-2#1)(2008-3#1)
the lateral femoral condyle##2##4##(2006-11#1)(2013-7#1)
the lateral film##2##3##(1997-8#2)
the lateral geniculate body##4##4##(2007-3#4)
the lateral geniculate nucleus (LGN) and##2##6##(1995-5#1)(2008-1#1)
the lateral geniculate nucleus##4##4##(1992-9#1)(1993-12#1)(1995-5#1)(2008-1#1)
the lateral geniculate##9##3##(1992-9#1)(1993-12#1)(1995-11#1)(1995-5#1)(2007-3#4)(2008-1#1)
the lateral habenula##2##3##(1997-8#2)
the lateral hypothalamic area##4##4##(1993-6#1)(1994-2#1)(1996-1#1)(1996-9#1)
the lateral hypothalamus (LH)##2##4##(1990-2#1)(1996-1#1)
the lateral hypothalamus in the##2##5##(1994-2#1)(2012-1#1)
the lateral hypothalamus in##5##4##(1994-2#1)(2009-10#1)(2012-1#3)
the lateral hypothalamus##19##3##(1990-2#1)(1991-12#1)(1992-10#1)(1993-6#4)(1994-2#2)(1996-1#1)(1996-2#1)(1996-9#1)(2009-10#1)(2010-10#1)(2012-1#5)
the lateral lemniscus##12##3##(1993-12#1)(1993-9#1)(1996-9#4)(1997-3#6)
the lateral line##7##3##(1995-8#2)(2012-12#2)(2013-7#3)
the lateral localization accuracy##2##4##(2008-3#2)
the lateral lumbar spine in##2##5##(2006-10#2)
the lateral margins##2##3##(1996-9#1)(2010-8#1)
the lateral nucleus are##3##4##(1995-5#3)
the lateral nucleus of the amygdala##4##6##(1993-6#3)(1996-6#1)
the lateral nucleus##15##3##(1993-6#3)(1995-5#6)(1996-6#6)
the lateral or##2##3##(1995-6#1)(1997-2#1)
the lateral orbital rim##2##4##(2006-12#2)
the lateral orbital wall##2##4##(2008-10#1)(2010-10#1)
the lateral orbital##4##3##(2006-12#2)(2008-10#1)(2010-10#1)
the lateral pallidum##2##3##(2008-7#2)
the lateral parabrachial nucleus##4##4##(1991-11#1)(1993-12#2)(1997-8#1)
the lateral part of the##3##5##(1990-10#1)(1991-9#1)(1993-2#1)
the lateral perforant path##3##4##(1993-12#3)
the lateral pontine##2##3##(1993-5#1)(2011-2#1)
the lateral position##2##3##(1993-7#1)(2008-3#1)
the lateral pterygoid muscle##2##4##(2010-2#2)
the lateral pterygoid##3##3##(2010-2#3)
the lateral recess##3##3##(2008-7#1)(2011-2#2)
the lateral rectus muscle##4##4##(1991-3#2)(1993-12#1)(2012-3#1)
the lateral rectus##5##3##(1991-3#2)(1993-12#1)(2012-3#1)(2013-8#1)
the lateral region##2##3##(1994-2#1)(2008-9#1)
the lateral resolution is##2##4##(2008-3#2)
the lateral resolution of the##2##5##(2007-12#1)(2008-3#1)
the lateral resolution##9##3##(2007-11#1)(2007-12#2)(2008-3#6)
the lateral reticular formation of the medulla oblongata##2##8##(1996-1#1)(1996-9#1)
the lateral reticular nucleus##2##4##(1993-12#2)
the lateral reticular##4##3##(1993-12#2)(1996-1#1)(1996-9#1)
the lateral sensillum styloconicum##2##4##(2008-8#2)
the lateral septal##2##3##(1994-2#1)(1997-2#1)
the lateral septum##3##3##(1994-2#1)(1995-1#1)(1997-3#1)
the lateral side of the bifurcation##4##6##(2007-9#4)
the lateral side of the##6##5##(1997-8#1)(2007-12#1)(2007-9#4)
the lateral subdivision##2##3##(1997-6#1)(2010-10#1)
the lateral tegmental field##5##4##(1991-8#2)(1992-7#3)
the lateral tegmental##6##3##(1991-8#2)(1992-1#1)(1992-7#3)
the lateral tunnel##2##3##(2007-8#1)(2010-5#1)
the lateral ventricle (LV)##2##4##(1992-8#1)(2010-12#1)
the lateral ventricle of the##2##5##(1991-3#1)(1996-3#1)
the lateral ventricle of##4##4##(1991-3#1)(1996-3#1)(2010-12#1)(2010-2#1)
the lateral ventricle##20##3##(1991-12#1)(1991-3#1)(1992-3#1)(1992-8#1)(1993-7#1)(1995-12#1)(1996-1#1)(1996-3#2)(1996-7#1)(2006-5#1)(2008-11#2)(2008-7#3)(2010-12#2)(2010-2#1)(2012-2#1)
the lateral ventricles and##2##4##(1994-3#1)(1996-5#1)
the lateral ventricles##12##3##(1991-8#1)(1992-3#1)(1993-12#1)(1994-3#2)(1996-4#1)(1996-5#2)(2006-5#2)(2008-11#2)
the lateral wall of the##3##5##(2006-12#1)(2007-12#1)(2011-2#1)
the lateral wall##7##3##(1997-7#1)(2006-12#1)(2007-12#1)(2008-11#2)(2008-7#1)(2011-2#1)
the lateral##381##2##(1990-10#2)(1990-2#2)(1990-7#2)(1991-11#1)(1991-12#3)(1991-3#5)(1991-6#3)(1991-8#3)(1991-9#5)(1992-1#1)(1992-10#1)(1992-3#3)(1992-7#4)(1992-8#3)(1992-9#1)(1993-12#12)(1993-2#2)(1993-5#1)(1993-6#8)(1993-7#2)(1993-9#2)(1994-2#9)(1994-3#2)(1994-7#1)(1995-1#2)(1995-10#1)(1995-11#4)(1995-12#4)(1995-5#14)(1995-6#2)(1995-7#2)(1995-8#3)(1996-1#5)(1996-11#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#4)(1996-6#8)(1996-7#2)(1996-9#13)(1997-2#3)(1997-3#10)(1997-6#6)(1997-7#4)(1997-8#10)(2004-11#1)(2005-11#1)(2006-10#7)(2006-11#2)(2006-12#5)(2006-3#3)(2006-5#7)(2006-6#2)(2007-1#1)(2007-11#4)(2007-12#14)(2007-3#4)(2007-4#2)(2007-7#2)(2007-8#7)(2007-9#5)(2008-1#1)(2008-10#4)(2008-11#9)(2008-12#1)(2008-2#3)(2008-3#15)(2008-5#3)(2008-6#1)(2008-7#13)(2008-8#4)(2008-9#2)(2009-10#2)(2009-11#2)(2009-2#1)(2009-3#1)(2009-7#2)(2009-8#2)(2010-10#3)(2010-11#3)(2010-12#9)(2010-2#5)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#7)(2012-1#8)(2012-12#5)(2012-2#5)(2012-3#3)(2013-1#8)(2013-7#5)(2013-8#1)
the lateral-to-medial##2##2##(2007-1#2)
the laterality##2##2##(2008-10#1)(2013-1#1)
the lateralization##2##2##(1993-7#1)(2007-8#1)
the laterally##3##2##(1993-12#1)(1994-3#1)(2008-9#1)
the laterodorsal tegmental nucleus##2##4##(1991-11#1)(1995-5#1)
the latest advances in##6##4##(2008-1#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2012-2#1)
the latest advances##7##3##(2008-1#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2011-7#1)(2012-2#1)
the latest data##2##3##(1997-2#1)(2006-10#1)
the latest developments in##5##4##(2005-8#1)(2006-10#1)(2008-1#1)(2008-4#1)(2009-4#1)
the latest developments##7##3##(2005-8#1)(2006-10#1)(2008-1#1)(2008-4#1)(2009-4#1)(2012-1#1)(2013-1#1)
the latest findings##2##3##(2008-1#1)(2009-10#1)
the latest follow-up##5##3##(1992-10#1)(2007-11#1)(2007-8#1)(2008-5#1)(2011-2#1)
the latest in a##2##4##(2007-9#2)
the latest information##2##3##(2006-10#1)(2010-12#1)
the latest literature##2##3##(1991-6#1)(2007-7#1)
the latest research in##3##4##(2008-1#1)(2008-2#1)(2008-5#1)
the latest research on##2##4##(2007-5#1)(2011-12#1)
the latest research##8##3##(2005-8#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2011-12#1)(2013-8#1)
the latest results from##2##4##(2007-8#1)(2011-2#1)
the latest scientific##4##3##(2008-10#1)(2008-7#1)(2011-2#1)(2013-7#1)
the latest studies##2##3##(2006-5#1)(2008-10#1)
the latest trends in##2##4##(2006-2#1)(2008-10#1)
the latest##117##2##(1990-2#1)(1991-12#1)(1991-6#1)(1992-10#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-1#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-10#1)(2004-12#1)(2005-8#3)(2006-10#7)(2006-2#3)(2006-5#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#4)(2007-9#3)(2008-1#4)(2008-10#6)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#6)(2008-5#5)(2008-7#5)(2008-8#1)(2008-9#4)(2009-1#1)(2009-10#2)(2009-12#1)(2009-4#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#6)(2011-7#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#3)
the latex particles##2##3##(2005-11#1)(2008-10#1)
the latex##13##2##(1990-7#1)(2005-11#2)(2008-10#5)(2008-5#1)(2009-3#2)(2010-4#2)
the latexes##3##2##(2004-9#1)(2008-10#1)(2009-3#1)
the latissimus dorsi and##2##4##(2012-2#1)(2013-1#1)
the latissimus dorsi##4##3##(1990-9#1)(2012-2#2)(2013-1#1)
the latter 1980s##2##3##(1996-1#2)
the latter accounting for less structured descriptive statements about norm-deviant states##2##11##(2013-1#2)
the latter analyses##2##3##(2008-10#1)(2009-10#1)
the latter and##4##3##(2008-8#1)(2008-9#1)(2009-8#1)(2010-8#1)
the latter approach##2##3##(1996-5#1)(2008-10#1)
the latter are##13##3##(1996-5#1)(1996-9#1)(1997-4#1)(2006-12#1)(2006-6#1)(2007-12#1)(2008-7#2)(2009-5#1)(2010-2#1)(2011-2#2)(2012-1#1)
the latter being a##4##4##(1990-7#1)(1994-3#1)(2008-4#1)(2013-1#1)
the latter being the most##2##5##(1995-11#1)(2010-12#1)
the latter being the##6##4##(1990-5#1)(1990-9#1)(1995-11#1)(2008-6#1)(2010-12#1)(2012-2#1)
the latter being used##3##4##(1990-11#1)(1996-9#1)(2008-7#1)
the latter being##24##3##(1990-11#1)(1990-5#1)(1990-7#1)(1990-9#1)(1992-2#1)(1992-9#1)(1994-3#1)(1995-11#1)(1996-9#1)(2005-10#1)(2005-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-1#1)(2010-12#1)(2012-2#3)(2013-1#1)
the latter but##2##3##(1990-9#1)(1994-9#1)
the latter by a##2##4##(1992-12#1)(1996-11#1)
the latter by##6##3##(1992-12#1)(1996-11#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-1#1)
the latter can##5##3##(1991-4#1)(2005-10#1)(2007-12#1)(2008-2#1)(2010-12#1)
the latter carries a##2##4##(1992-7#1)(1995-9#1)
the latter case the##4##4##(1995-6#1)(2007-12#1)(2008-1#1)(2013-8#1)
the latter case##32##3##(1990-2#2)(1991-2#2)(1991-5#1)(1991-8#1)(1992-6#1)(1993-9#1)(1995-6#2)(1997-1#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#1)(2012-1#1)(2013-8#1)
the latter cells##2##3##(2007-12#1)(2008-4#1)
the latter combination##2##3##(2007-11#1)(2009-8#1)
the latter complex##2##3##(1994-5#1)(2008-3#1)
the latter compound##3##3##(1990-12#1)(1990-8#1)(1993-4#1)
the latter device##2##3##(1991-10#1)(1992-2#1)
the latter does not##2##4##(2006-12#1)(2011-2#1)
the latter does##3##3##(2006-12#1)(2008-2#1)(2011-2#1)
the latter domain##2##3##(1991-4#1)(1994-9#1)
the latter drug##2##3##(1991-2#1)(1991-4#1)
the latter effect is##3##4##(1996-8#1)(2008-3#1)(2008-5#1)
the latter effect##4##3##(1990-2#1)(1996-8#1)(2008-3#1)(2008-5#1)
the latter enabling##2##3##(2008-11#1)(2008-8#1)
the latter enzyme##2##3##(1992-11#1)(1992-6#1)
the latter from##2##3##(2008-10#1)(2008-9#1)
the latter group of##2##4##(1991-12#1)(1996-12#1)
the latter group##18##3##(1990-11#1)(1990-12#1)(1991-1#1)(1991-12#1)(1995-3#1)(1996-12#1)(1996-9#1)(1997-6#1)(2004-1#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-5#3)(2008-7#1)(2011-1#1)
the latter had##4##3##(1990-4#1)(1993-3#1)(1997-2#1)(2013-1#1)
the latter half of##8##4##(1995-9#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-3#1)(2009-10#2)(2010-7#1)
the latter has been shown##2##5##(1995-1#1)(2006-10#1)
the latter has##3##3##(1995-1#1)(1997-5#1)(2006-10#1)
the latter have##2##3##(1991-12#1)(2006-10#1)
the latter hypothesis##3##3##(1993-2#1)(1994-9#1)(1997-7#1)
the latter in the##2##4##(1991-11#1)(2010-8#1)
the latter in##10##3##(1990-9#1)(1991-11#1)(1991-7#1)(1992-11#1)(1992-8#1)(1996-6#1)(2005-11#1)(2006-10#1)(2008-10#1)(2010-8#1)
the latter including##2##3##(2008-12#1)(2011-1#1)
the latter is a##3##4##(2008-10#1)(2008-5#1)(2010-5#1)
the latter is not##7##4##(1990-5#1)(1994-3#1)(1995-8#2)(2008-10#1)(2008-5#1)(2009-8#1)
the latter is of##2##4##(1997-4#1)(2008-10#1)
the latter is##39##3##(1990-11#2)(1990-3#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-4#1)(1992-1#1)(1993-3#1)(1994-3#1)(1995-4#1)(1995-8#2)(1996-5#1)(1997-4#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#2)(2010-5#1)(2010-6#1)(2011-2#1)(2012-1#2)(2013-1#1)(2013-7#1)
the latter lacking##2##3##(1995-3#1)(2011-12#1)
the latter may be##2##4##(1996-6#1)(2008-1#1)
the latter may##6##3##(1992-4#1)(1994-12#1)(1996-6#1)(2007-5#1)(2008-1#1)(2008-10#1)
the latter method##5##3##(2008-10#2)(2008-3#1)(2011-2#2)
the latter model##2##3##(1993-11#1)(2008-7#1)
the latter mutant##2##3##(1992-3#1)(1995-5#1)
the latter of which##5##4##(1995-1#1)(2008-10#1)(2010-8#1)(2012-2#2)
the latter of##6##3##(1995-1#1)(2008-10#1)(2008-4#1)(2010-8#1)(2012-2#2)
the latter on##3##3##(1997-2#1)(2007-11#1)(2012-2#1)
the latter one##5##3##(1991-4#1)(1995-5#1)(2008-7#1)(2008-8#1)(2009-12#1)
the latter only##2##3##(2013-7#1)(2013-8#1)
the latter part of the##7##5##(1992-3#1)(1994-2#1)(2006-8#2)(2007-12#1)(2008-10#1)(2008-12#1)
the latter part##9##3##(1992-3#1)(1994-2#1)(2006-8#3)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
the latter period##2##3##(2006-8#1)(2010-3#1)
the latter phase##2##3##(2008-10#1)(2009-9#1)
the latter probably##2##3##(2007-7#1)(2009-4#1)
the latter process##4##3##(1995-8#2)(2008-5#1)(2009-8#1)
the latter protein is##2##4##(1990-9#1)(1997-2#1)
the latter provides##2##3##(1991-10#1)(2007-12#1)
the latter represents##2##3##(1993-6#1)(2013-1#1)
the latter show##2##3##(2007-12#1)(2008-5#1)
the latter showing##2##3##(2005-8#1)(2008-5#1)
the latter situation##2##3##(1993-6#1)(2008-8#1)
the latter species is##2##4##(2008-4#1)(2011-2#1)
the latter species##6##3##(2008-10#2)(2008-4#1)(2011-2#3)
the latter stage##2##3##(1991-12#1)(1993-9#1)
the latter technique##4##3##(2005-11#1)(2006-6#1)(2008-10#1)(2008-3#1)
the latter test##2##3##(1992-9#1)(2007-10#1)
the latter the##2##3##(1990-6#1)(1997-8#1)
the latter three##4##3##(1997-4#1)(2008-10#2)(2008-8#1)
the latter to a##2##4##(1997-4#1)(2008-11#1)
the latter to be##2##4##(2008-10#1)(2008-2#1)
the latter to##8##3##(1991-9#1)(1993-11#1)(1993-6#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
the latter treatment##3##3##(1995-5#1)(1996-10#1)(2012-1#1)
the latter two groups##3##4##(1994-2#1)(1996-7#1)(2007-8#1)
the latter two##13##3##(1990-7#1)(1992-1#1)(1994-12#1)(1994-2#1)(1996-7#1)(1997-4#1)(2004-9#1)(2007-8#1)(2008-10#3)(2008-8#1)(2009-7#1)
the latter type of##4##4##(1990-2#1)(1996-7#1)(2007-12#1)(2010-5#1)
the latter type##6##3##(1990-2#1)(1996-7#1)(2007-12#2)(2008-5#1)(2010-5#1)
the latter under conditions##2##4##(1994-11#1)(2006-10#1)
the latter was##15##3##(1991-11#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-5#1)(1994-11#1)(1995-2#1)(1996-5#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-4#1)(2012-2#2)
the latter were##8##3##(1990-8#1)(1996-11#1)(2007-7#2)(2008-1#1)(2008-7#2)(2013-7#1)
the latter when##2##3##(1993-6#1)(2006-10#1)
the latter with##9##3##(1990-5#1)(1992-1#1)(1992-3#1)(1992-9#1)(1996-3#1)(2007-12#1)(2008-6#1)(2011-1#1)(2013-1#1)
the latter##665##2##(1990-10#1)(1990-11#5)(1990-12#4)(1990-2#6)(1990-3#1)(1990-4#3)(1990-5#4)(1990-6#1)(1990-7#5)(1990-8#3)(1990-9#7)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#7)(1991-2#8)(1991-3#1)(1991-4#7)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#4)(1991-9#5)(1992-1#4)(1992-11#3)(1992-12#2)(1992-2#3)(1992-3#7)(1992-4#2)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#3)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#4)(1993-3#4)(1993-4#2)(1993-6#5)(1993-7#1)(1993-8#2)(1993-9#3)(1994-11#4)(1994-12#4)(1994-2#4)(1994-3#4)(1994-4#1)(1994-5#2)(1994-6#1)(1994-9#8)(1995-1#3)(1995-10#3)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#3)(1995-4#2)(1995-5#6)(1995-6#9)(1995-8#5)(1995-9#4)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#5)(1996-6#2)(1996-7#4)(1996-8#2)(1996-9#5)(1997-1#4)(1997-2#4)(1997-3#2)(1997-4#5)(1997-5#2)(1997-6#1)(1997-7#7)(1997-8#3)(2004-1#1)(2004-3#1)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#9)(2005-7#1)(2005-8#2)(2006-10#12)(2006-12#5)(2006-3#2)(2006-4#3)(2006-6#2)(2006-8#8)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#10)(2007-12#17)(2007-3#2)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#8)(2008-10#57)(2008-11#7)(2008-12#5)(2008-2#9)(2008-3#14)(2008-4#14)(2008-5#15)(2008-6#5)(2008-7#20)(2008-8#14)(2008-9#4)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#3)(2009-2#6)(2009-3#2)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#5)(2009-9#4)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#4)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#6)(2011-1#5)(2011-12#2)(2011-2#17)(2012-1#8)(2012-2#15)(2012-3#1)(2012-6#1)(2013-1#12)(2013-7#6)(2013-8#3)
the latter's##7##2##(1994-5#1)(1994-8#1)(1997-5#1)(2008-10#1)(2008-12#1)(2009-2#1)(2012-2#1)
the lattice spacing##2##3##(2008-2#1)(2008-3#1)
the lattice##25##2##(1991-6#1)(1992-4#1)(1993-11#1)(1993-8#1)(1996-12#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#7)(2008-3#1)(2008-5#1)(2010-12#1)(2012-2#2)(2013-8#3)
the lattice-Boltzmann##2##2##(2009-4#2)
the launch of the##3##4##(1996-1#1)(2007-7#1)(2008-2#1)
the launch of##5##3##(1996-1#1)(2007-7#1)(2008-2#1)(2011-2#1)(2013-1#1)
the launch##6##2##(1996-1#1)(2007-7#1)(2008-2#1)(2008-3#1)(2011-2#1)(2013-1#1)
the launched pulse width##2##4##(2008-3#2)
the launched##6##2##(2007-12#2)(2008-3#4)
the launching##2##2##(1991-12#1)(2007-12#1)
the lauric##2##2##(1991-5#1)(2008-10#1)
the lavage##3##2##(1990-9#1)(2008-5#1)(2010-3#1)
the law and##7##3##(1992-12#1)(1993-2#1)(1994-1#1)(1994-5#1)(1997-8#1)(2006-7#1)(2008-3#1)
the law enforcement agencies##2##4##(2005-8#2)
the law enforcement##3##3##(2005-8#3)
the law has##2##3##(1990-12#1)(1997-8#1)
the law in##2##3##(2008-8#2)
the law itself##2##3##(2006-5#1)(2007-10#1)
the law of similars##2##4##(1997-6#2)
the law of##13##3##(1990-7#1)(1991-1#1)(1993-6#1)(1997-6#2)(2005-11#1)(2005-9#1)(2006-6#1)(2007-10#1)(2007-4#1)(2008-11#1)(2011-2#1)(2012-2#1)
the law on##2##3##(1993-5#1)(1993-6#1)
the law regarding##3##3##(1991-1#1)(1992-1#1)(1992-12#1)
the law to##2##3##(2006-12#1)(2006-5#1)
the law was##4##3##(1992-1#1)(1995-9#1)(1997-8#1)(2008-8#1)
the law were##2##3##(1997-1#1)(2010-9#1)
the law##100##2##(1990-12#1)(1990-7#1)(1991-1#2)(1991-10#1)(1991-9#1)(1992-1#2)(1992-12#3)(1993-2#3)(1993-3#2)(1993-5#2)(1993-6#4)(1994-1#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-9#4)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-1#4)(1997-6#3)(1997-8#4)(2005-10#1)(2005-11#3)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#2)(2006-5#2)(2006-6#1)(2006-7#4)(2006-8#2)(2007-10#4)(2007-2#2)(2007-4#3)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#6)(2008-9#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
the law's##2##2##(1993-12#1)(2004-12#1)
the law]##2##2##(1997-3#1)(2008-9#1)
the lawn##2##2##(2007-12#1)(2008-4#1)
the laws of thermodynamics##3##4##(2007-9#1)(2008-3#1)(2008-5#1)
the laws of##7##3##(1992-7#1)(2006-2#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)
the laws##14##2##(1990-12#1)(1992-7#1)(1994-2#1)(2005-11#1)(2006-2#1)(2006-8#1)(2007-4#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-7#3)(2012-12#1)
the lawsuit##7##2##(1992-3#1)(1996-11#3)(1996-5#3)
the lay press##3##3##(2006-10#1)(2009-10#1)(2011-1#1)
the lay public##2##3##(2008-7#1)(2009-3#1)
the lay##9##2##(2006-10#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-10#1)(2011-1#1)(2012-12#1)
the layer and##2##3##(1996-2#1)(2005-11#1)
the layer by##2##3##(2008-2#1)(2013-1#1)
the layer is##3##3##(2005-11#1)(2008-3#2)
the layer of##5##3##(1997-6#1)(1997-7#1)(2008-10#2)(2009-5#1)
the layer structure##2##3##(2008-3#2)
the layer thickness##4##3##(2007-12#1)(2008-10#2)(2010-4#1)
the layer##38##2##(1990-2#1)(1991-5#1)(1994-6#1)(1996-2#2)(1997-6#1)(1997-7#1)(2005-11#4)(2007-12#2)(2008-10#5)(2008-2#4)(2008-3#10)(2008-5#1)(2009-5#1)(2010-4#2)(2013-1#2)
the layer-by-layer (LbL)##2##3##(2005-11#1)(2008-5#1)
the layer-by-layer self-assembly##2##3##(2008-10#1)(2010-4#1)
the layer-by-layer##11##2##(2005-11#1)(2007-8#1)(2008-10#2)(2008-5#1)(2009-12#1)(2009-2#1)(2010-4#2)(2010-7#1)(2010-9#1)
the layered structure##2##3##(2007-12#2)
the layered##7##2##(1997-7#1)(2005-10#1)(2005-11#1)(2007-12#3)(2008-2#1)
the layers are##3##3##(1996-2#1)(2007-12#1)(2008-3#1)
the layers of the##4##4##(1990-5#1)(2007-12#1)(2008-3#1)(2012-12#1)
the layers with##2##3##(2007-11#1)(2008-3#1)
the layers##22##2##(1990-5#1)(1992-8#1)(1993-7#1)(1996-2#1)(1996-3#1)(2005-7#1)(2007-11#1)(2007-12#5)(2008-2#1)(2008-3#7)(2008-6#1)(2012-12#1)
the laying##3##2##(1994-9#1)(2008-9#1)(2012-2#1)
the layout of a##2##4##(2007-7#1)(2008-2#1)
the layout of the##2##4##(2007-12#1)(2008-9#1)
the layout of##6##3##(2007-12#1)(2007-7#1)(2008-2#1)(2008-9#1)(2009-6#1)(2012-2#1)
the layout##10##2##(2007-12#1)(2007-7#1)(2008-2#3)(2008-6#2)(2008-9#1)(2009-6#1)(2012-2#1)
the lazaroid##2##2##(1995-12#2)
the leachates##2##2##(2008-10#2)
the leached##3##2##(2007-10#1)(2008-10#2)
the leaching of##4##3##(1993-9#1)(2004-11#1)(2008-10#2)
the leaching##6##2##(1993-9#1)(1997-4#1)(2004-11#1)(2008-10#3)
the lead and##2##3##(1997-1#1)(2010-10#1)
the lead aprons##2##3##(2006-8#2)
the lead compound##4##3##(1992-12#1)(2005-8#2)(2008-5#1)
the lead concentration##2##3##(2008-10#2)
the lead content of##2##4##(1993-6#1)(2012-12#1)
the lead content##4##3##(1993-6#1)(2008-10#2)(2012-12#1)
the lead determination##2##3##(2008-10#2)
the lead in##7##3##(1992-1#1)(1995-2#1)(1995-3#1)(1997-7#1)(2005-6#1)(2007-7#1)(2012-9#1)
the lead##61##2##(1992-1#1)(1992-12#1)(1992-6#1)(1993-6#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#2)(1997-1#1)(1997-7#1)(2005-6#1)(2005-8#3)(2006-10#1)(2006-8#3)(2007-12#1)(2007-7#1)(2008-10#17)(2008-11#1)(2008-3#3)(2008-5#4)(2008-7#1)(2008-8#1)(2010-10#2)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-9#1)(2013-8#3)
the leader and##3##3##(1992-7#1)(2008-1#1)(2008-8#1)
the leader in##2##3##(1995-1#1)(2008-11#1)
the leader of the##3##4##(1992-8#1)(1996-1#1)(2013-8#1)
the leader region##2##3##(1990-5#1)(1997-1#1)
the leader sequence##3##3##(1992-12#1)(1992-7#1)(2008-9#1)
the leader##25##2##(1990-5#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-7#2)(1992-8#2)(1995-1#2)(1996-1#1)(1997-1#2)(2004-7#1)(2008-1#3)(2008-11#2)(2008-8#3)(2008-9#1)(2012-2#1)(2013-8#1)
the leaders of##2##3##(1991-2#1)(2012-2#1)
the leaders##4##2##(1991-2#1)(1992-5#1)(2006-10#1)(2012-2#1)
the leadership of##2##3##(2009-5#1)(2012-1#1)
the leadership##7##2##(1994-2#1)(1996-2#1)(1997-1#1)(2009-5#1)(2012-1#2)(2013-8#1)
the leading and trailing##2##4##(2008-10#2)
the leading cancers##2##3##(2011-2#1)(2013-7#1)
the leading cause of blindness##3##5##(2007-11#1)(2011-1#1)(2013-1#1)
the leading cause of cancer-related##3##5##(2008-5#1)(2011-9#1)(2012-1#1)
the leading cause of death among##4##6##(1991-8#1)(1996-8#1)(1996-9#1)(2008-4#1)
the leading cause of death and disability in##3##8##(2006-5#1)(2008-8#1)(2011-2#1)
the leading cause of death and disability##4##7##(1995-11#1)(2006-5#1)(2008-8#1)(2011-2#1)
the leading cause of death and##7##6##(1995-11#1)(2005-7#1)(2006-5#1)(2008-3#1)(2008-8#1)(2009-8#1)(2011-2#1)
the leading cause of death in patients##2##7##(2005-8#1)(2008-3#1)
the leading cause of death in the United States##3##9##(1992-7#1)(1993-9#1)(2007-2#1)
the leading cause of death in the##5##7##(1990-7#1)(1992-7#1)(1993-9#1)(2007-2#2)
the leading cause of death in##9##6##(1990-7#1)(1992-7#1)(1993-9#1)(2005-8#1)(2007-2#2)(2008-3#1)(2012-12#1)(2012-2#1)
the leading cause of death worldwide##2##6##(2012-2#1)(2013-8#1)
the leading cause of death##27##5##(1990-12#2)(1990-6#1)(1990-7#1)(1991-8#1)(1992-7#1)(1993-9#1)(1995-11#1)(1996-8#1)(1996-9#1)(1997-1#1)(2005-7#1)(2005-8#1)(2006-5#1)(2007-2#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
the leading cause of morbidity and##3##6##(2007-7#1)(2008-7#1)(2010-4#1)
the leading cause of morbidity##4##5##(2007-7#1)(2008-7#1)(2010-4#1)(2012-12#1)
the leading cause of mortality in##4##6##(2007-11#1)(2008-3#1)(2009-4#1)(2010-6#1)
the leading cause of##70##4##(1990-12#2)(1990-6#1)(1990-7#1)(1991-12#1)(1991-8#1)(1992-7#1)(1993-9#1)(1995-11#1)(1996-8#1)(1996-9#1)(1997-1#1)(2005-7#1)(2005-8#2)(2006-5#1)(2007-11#2)(2007-2#2)(2007-7#4)(2007-8#3)(2008-1#4)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-9#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#1)
the leading causes of death in##3##6##(2006-10#1)(2007-7#1)(2012-3#1)
the leading causes of death##5##5##(2006-10#1)(2007-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
the leading causes of disease##2##5##(2006-10#1)(2010-10#1)
the leading causes of end-stage renal disease##3##7##(2005-10#1)(2007-11#1)(2008-1#1)
the leading causes of morbidity##3##5##(2008-3#1)(2010-9#1)(2012-2#1)
the leading causes of##29##4##(2005-10#2)(2005-8#1)(2006-10#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-3#1)(2010-10#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#3)
the leading edge of the laser##2##6##(2007-12#1)(2008-10#1)
the leading edge of the##5##5##(1996-5#1)(2007-10#1)(2007-12#1)(2008-10#1)(2011-2#1)
the leading edge of##6##4##(1996-5#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2011-2#1)
the leading edge##11##3##(1996-5#1)(2005-10#2)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2011-2#2)(2012-12#2)
the leading risk##2##3##(2008-8#1)(2013-1#1)
the leading strand##3##3##(1990-12#1)(1994-9#2)
the leading symptom##3##3##(1997-2#1)(2007-11#1)(2008-11#1)
the leading##176##2##(1990-12#3)(1990-6#1)(1990-7#1)(1991-12#2)(1991-7#1)(1991-8#1)(1992-7#1)(1993-9#1)(1994-2#1)(1994-9#2)(1995-11#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-10#4)(2005-11#1)(2005-7#2)(2005-8#3)(2005-9#1)(2006-10#5)(2006-5#2)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#2)(2007-2#2)(2007-7#6)(2007-8#3)(2008-1#12)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#3)(2008-7#6)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#4)(2011-1#1)(2011-12#1)(2011-2#10)(2011-9#1)(2012-1#2)(2012-11#1)(2012-12#9)(2012-2#5)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#6)
the leads##5##2##(1997-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-10#1)
the leaf N and P utilization##2##6##(2013-8#2)
the leaf N##4##3##(2013-8#4)
the leaf N/P##2##3##(2008-5#1)(2013-8#1)
the leaf and##2##3##(2008-10#2)
the leaf area##3##3##(2008-10#2)(2013-7#1)
the leaf blade##3##3##(2007-3#1)(2008-10#1)(2008-5#1)
the leaf disks##2##3##(2008-10#2)
the leaf extract##4##3##(2007-1#1)(2008-8#1)(2010-3#1)(2012-11#1)
the leaf extracts##2##3##(2006-12#1)(2009-5#1)
the leaf pathogen##3##3##(2008-10#3)
the leaf scale##2##3##(2008-10#2)
the leaf sheath##2##3##(2008-10#2)
the leaf spot isolates were##2##5##(2008-10#2)
the leaf spot isolates##3##4##(2008-10#3)
the leaf surface##11##3##(1994-11#1)(2008-10#9)(2009-8#1)
the leaf##89##2##(1994-11#1)(2004-4#1)(2006-12#3)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#2)(2008-10#53)(2008-12#2)(2008-5#2)(2008-7#1)(2008-8#3)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2010-3#1)(2010-4#1)(2012-11#1)(2013-7#1)(2013-8#7)
the leaf-drop symptom##3##3##(2008-10#3)
the leafhopper##5##2##(2007-12#1)(2008-10#3)(2011-2#1)
the leaflet and leaf levels##3##5##(2008-10#3)
the leaflet and leaf##5##4##(2008-10#5)
the leaflet and##6##3##(2008-10#5)(2010-8#1)
the leaflet##10##2##(2008-10#9)(2010-8#1)
the leafminer##2##2##(2008-10#1)(2011-2#1)
the leak##4##2##(1994-8#1)(2008-10#1)(2008-7#1)(2010-5#1)
the leakage of lactate dehydrogenase##2##5##(1992-8#1)(2008-10#1)
the leakage of the##2##4##(1997-2#1)(2008-10#1)
the leakage of##5##3##(1992-8#1)(1997-2#1)(2007-8#1)(2008-10#2)
the leakage##10##2##(1992-8#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2012-3#1)
the leaky##2##2##(1997-4#1)(2007-12#1)
the lean##7##2##(1991-12#1)(2007-8#1)(2008-7#1)(2009-8#1)(2010-4#2)(2011-2#1)
the learned##6##2##(2009-11#1)(2009-6#1)(2013-1#4)
the learner to##2##3##(2008-12#1)(2009-4#1)
the learner##4##2##(2007-2#1)(2008-12#1)(2009-4#2)
the learners##3##2##(2013-1#1)(2013-8#2)
the learning algorithm##2##3##(2008-7#1)(2012-1#1)
the learning and##8##3##(1997-2#1)(2008-11#2)(2008-2#3)(2012-12#1)(2012-2#1)
the learning contract marking##2##4##(2008-11#2)
the learning curve for laparoscopic##2##5##(2006-6#1)(2007-7#1)
the learning curve for##4##4##(2006-6#2)(2007-7#1)(2011-2#1)
the learning curve is##2##4##(2006-6#1)(2006-8#1)
the learning curve##8##3##(2006-6#3)(2006-8#1)(2007-7#1)(2010-3#1)(2011-2#1)(2013-1#1)
the learning environment##5##3##(2008-11#3)(2008-12#1)(2012-3#1)
the learning experience##2##3##(2006-8#1)(2008-12#1)
the learning needs of##3##4##(2007-2#1)(2008-12#1)(2010-2#1)
the learning needs##5##3##(2007-2#1)(2008-12#1)(2009-4#2)(2010-2#1)
the learning of##6##3##(1994-1#1)(2007-12#1)(2008-11#3)(2011-2#1)
the learning opportunities##3##3##(2008-11#2)(2010-3#1)
the learning outcomes##4##3##(2008-11#2)(2011-2#1)(2012-12#1)
the learning phase##3##3##(1994-6#1)(2008-2#1)(2013-1#1)
the learning process and##2##4##(2010-8#1)(2012-1#1)
the learning process##9##3##(2008-11#1)(2008-12#1)(2008-8#1)(2010-8#1)(2012-1#2)(2013-1#3)
the learning##85##2##(1992-3#1)(1993-11#1)(1993-12#2)(1994-1#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-8#1)(1997-2#1)(2006-10#1)(2006-6#3)(2006-8#2)(2007-12#1)(2007-2#1)(2007-7#2)(2008-11#17)(2008-12#5)(2008-2#6)(2008-3#2)(2008-7#4)(2008-8#2)(2009-10#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#2)(2010-8#1)(2011-2#4)(2012-1#4)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#2)
the least absolute shrinkage and selection operator (LASSO)##2##8##(2012-3#2)
the least absolute shrinkage and selection operator##3##7##(2012-3#3)
the least abundant##3##3##(2007-5#1)(2008-10#1)(2008-5#1)
the least aggressive##2##3##(2008-10#1)(2012-2#1)
the least amount of##4##4##(2007-11#1)(2007-4#2)(2008-7#1)
the least amount##5##3##(2007-11#1)(2007-4#2)(2008-7#2)
the least common##3##3##(2008-8#1)(2009-5#1)(2012-2#1)
the least developed##2##3##(2007-2#1)(2012-12#1)
the least effective in##2##4##(1995-9#1)(2008-10#1)
the least effective inhibitor in##2##5##(1992-5#2)
the least effective##6##3##(1992-5#2)(1995-9#1)(2008-10#2)(2009-12#1)
the least expensive##2##3##(2008-10#1)(2008-4#1)
the least favourable##2##3##(1991-11#1)(2009-8#1)
the least in##3##3##(1997-3#1)(2007-7#1)(2008-3#1)
the least likely to##2##4##(2007-7#1)(2008-10#1)
the least morbidity##2##3##(2008-12#1)(2010-5#1)
the least number of##3##4##(2008-12#1)(2008-2#1)(2013-1#1)
the least number##4##3##(2008-12#1)(2008-2#1)(2008-4#1)(2013-1#1)
the least of##2##3##(2009-12#2)
the least powerful##2##3##(1993-4#1)(2008-7#1)
the least preferred one##2##4##(2013-8#2)
the least protection##3##3##(1992-2#1)(2008-2#1)(2009-5#1)
the least significant##2##3##(2005-3#1)(2010-5#1)
the least specific##2##3##(1990-12#1)(2008-6#1)
the least square##2##3##(2008-10#1)(2008-6#1)
the least squares##6##3##(1995-4#2)(2008-10#2)(2008-3#1)(2008-6#1)
the least studied##2##3##(1993-6#1)(2013-1#1)
the least surface##2##3##(2005-11#2)
the least well##3##3##(2006-4#1)(2007-11#1)(2008-4#1)
the least##164##2##(1990-12#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-5#2)(1993-2#2)(1993-4#1)(1993-6#2)(1994-8#1)(1995-12#1)(1995-4#2)(1995-9#1)(1996-3#1)(1997-3#1)(2004-4#1)(2005-11#6)(2005-3#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#3)(2007-9#1)(2008-10#25)(2008-11#2)(2008-12#6)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#4)(2008-6#4)(2008-7#4)(2008-8#4)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#4)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#4)(2010-7#2)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#6)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#3)
the least-squares fit##2##3##(2008-3#2)
the least-squares fitting##2##3##(2008-2#2)
the least-squares kernel machine##2##4##(2012-3#2)
the least-squares method##4##3##(2008-2#3)(2008-3#1)
the least-squares##14##2##(2008-2#7)(2008-3#5)(2012-3#2)
the leaves and stems of##2##5##(1991-8#2)
the leaves and##8##3##(1991-8#2)(2007-1#1)(2008-10#3)(2008-4#2)
the leaves increased##2##3##(2008-10#2)
the leaves of Morus alba L##2##6##(2011-3#2)
the leaves of Morus alba##3##5##(2011-3#3)
the leaves of N##2##4##(2010-3#2)
the leaves of the##4##4##(1992-2#1)(2008-10#1)(2008-6#1)(2013-8#1)
the leaves of##37##3##(1990-11#2)(1990-4#1)(1992-2#1)(1997-2#1)(2006-12#2)(2007-1#8)(2007-11#2)(2008-10#3)(2008-11#1)(2008-6#1)(2008-8#1)(2010-2#2)(2010-3#2)(2011-1#1)(2011-2#1)(2011-3#3)(2012-3#1)(2013-1#3)(2013-8#1)
the leaves were##4##3##(2006-12#1)(2008-10#2)(2010-12#1)
the leaves##76##2##(1990-11#2)(1990-4#1)(1991-8#2)(1992-2#1)(1997-2#1)(2006-11#1)(2006-12#7)(2007-1#11)(2007-11#2)(2008-10#16)(2008-11#3)(2008-12#2)(2008-4#2)(2008-6#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-12#3)(2010-2#2)(2010-3#4)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#1)(2011-3#3)(2012-3#1)(2013-1#3)(2013-8#1)
the leaving group##14##3##(1991-7#3)(1993-8#5)(1995-10#3)(1995-5#1)(2008-5#2)
the leaving##15##2##(1991-7#3)(1993-8#5)(1995-10#3)(1995-11#1)(1995-5#1)(2008-5#2)
the lecithin##6##2##(1992-1#1)(1992-2#1)(1995-5#1)(2008-10#2)(2008-5#1)
the lectin and egf domains were##2##6##(1993-8#2)
the lectin and##5##3##(1993-8#2)(1997-8#1)(2008-10#2)
the lectin domain of GMP-140##2##5##(1991-12#2)
the lectin domain of##3##4##(1991-12#2)(1993-3#1)
the lectin from adult##2##4##(1996-5#2)
the lectin from##3##3##(1990-2#1)(1996-5#2)
the lectin pathway of the complement system##2##7##(2010-4#1)(2012-3#1)
the lectin##35##2##(1990-12#1)(1990-2#2)(1990-5#1)(1991-12#2)(1992-6#2)(1992-9#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-5#2)(1997-8#2)(2005-11#1)(2008-10#5)(2008-11#1)(2008-4#1)(2010-2#2)(2010-4#1)(2012-3#1)
the lectins##7##2##(1990-7#2)(1992-5#1)(1995-11#3)(1996-8#1)
the lecture and##2##3##(2007-11#1)(2013-8#1)
the lecture##14##2##(1994-9#2)(2005-10#2)(2007-11#2)(2007-4#1)(2011-1#1)(2013-8#6)
the lecturer in##3##3##(2008-11#3)
the lecturer practitioner role##2##4##(2008-11#2)
the lecturer practitioner##7##3##(2008-11#5)(2008-12#2)
the lecturer##16##2##(2008-11#13)(2008-12#3)
the lecturer's##2##2##(2008-11#2)
the lectures##4##2##(2005-10#1)(2005-7#1)(2005-8#1)(2007-5#1)
the leech##15##2##(1990-8#2)(1991-3#2)(1991-5#2)(1991-9#1)(1996-12#2)(1997-6#2)(2007-7#2)(2008-10#1)(2012-12#1)
the left ACC##2##3##(2009-1#2)
the left AV##2##3##(2008-5#2)
the left BA41/42##2##3##(2008-1#2)
the left DLPFC##3##3##(2008-10#2)(2011-2#1)
the left L5 nerve root##2##5##(2006-10#1)(2012-2#1)
the left MCA##3##3##(2007-10#1)(2007-9#2)
the left adrenal gland##3##4##(1997-3#1)(2007-9#1)(2011-2#1)
the left adrenal##5##3##(1992-2#1)(1997-3#1)(1997-8#1)(2007-9#1)(2011-2#1)
the left and right muscle##3##5##(2011-2#3)
the left and right##27##4##(1991-2#1)(1993-7#1)(1995-8#2)(1996-6#1)(2005-10#1)(2005-9#1)(2006-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#2)(2010-2#2)(2010-7#1)(2011-2#3)(2012-1#1)
the left and the right##5##5##(1994-2#1)(2006-6#1)(2007-8#1)(2008-1#1)(2010-12#1)
the left and##35##3##(1991-2#1)(1993-7#1)(1994-2#2)(1995-8#2)(1996-6#1)(2005-10#1)(2005-9#1)(2006-11#1)(2006-6#1)(2007-10#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#2)(2010-12#1)(2010-2#2)(2010-7#1)(2011-2#3)(2012-1#1)
the left anterior descending (LAD)##4##5##(2005-12#1)(2006-12#1)(2007-8#2)
the left anterior descending artery (LAD)##2##6##(2006-6#1)(2007-8#1)
the left anterior descending artery##10##5##(1994-11#1)(1996-9#2)(2006-10#1)(2006-6#1)(2007-8#4)(2010-9#1)
the left anterior descending coronary artery (LAD)##3##7##(2007-8#1)(2008-7#1)(2013-1#1)
the left anterior descending coronary artery##8##6##(1995-6#1)(2007-8#2)(2008-7#2)(2009-4#1)(2013-1#1)(2013-7#1)
the left anterior descending##23##4##(1994-11#1)(1995-6#1)(1996-9#2)(2005-12#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-8#9)(2008-7#2)(2009-4#1)(2010-9#1)(2013-1#1)(2013-7#1)
the left anterior##32##3##(1991-2#1)(1994-11#1)(1995-12#1)(1995-6#1)(1996-9#2)(2005-12#1)(2006-10#1)(2006-12#2)(2006-6#1)(2006-9#1)(2007-8#11)(2008-6#1)(2008-7#3)(2009-2#1)(2009-4#1)(2010-9#1)(2013-1#1)(2013-7#1)
the left arm of Saccharomyces cerevisiae chromosome##2##7##(1995-9#1)(1996-3#1)
the left arm of chromosome VII of Saccharomyces cerevisiae##3##9##(1995-6#2)(1995-9#1)
the left arm of chromosome VII##5##6##(1995-6#2)(1995-9#1)(1996-6#1)(1996-9#1)
the left arm of chromosome##12##5##(1993-9#1)(1995-6#3)(1995-9#3)(1996-3#2)(1996-6#2)(1996-9#1)
the left arm of##18##4##(1993-2#1)(1993-9#1)(1995-6#3)(1995-9#4)(1996-3#4)(1996-6#4)(1996-9#1)
the left arm##22##3##(1991-3#1)(1993-2#1)(1993-9#1)(1995-11#1)(1995-6#3)(1995-9#4)(1996-3#4)(1996-6#4)(1996-9#1)(2007-12#1)(2009-3#1)
the left atrial appendage was##2##5##(2007-8#1)(2008-4#1)
the left atrial appendage##9##4##(1997-1#1)(2007-8#4)(2007-9#1)(2008-4#2)(2010-12#1)
the left atrial##14##3##(1997-1#2)(1997-8#1)(2007-8#4)(2007-9#1)(2008-11#1)(2008-4#3)(2010-12#1)(2010-9#1)
the left atrium and##3##4##(2007-8#2)(2009-10#1)
the left atrium##20##3##(1993-5#1)(1993-8#1)(2005-12#1)(2007-8#6)(2008-4#4)(2008-7#1)(2009-10#1)(2010-12#1)(2010-9#1)(2012-2#1)(2013-1#2)
the left axilla##3##3##(2006-10#1)(2010-6#1)(2012-12#1)
the left basal ganglia##3##4##(1993-9#3)
the left basal##4##3##(1993-9#3)(2006-11#1)
the left big toe##2##4##(1990-9#2)
the left breast##8##3##(1996-6#2)(2007-7#1)(2008-10#2)(2011-2#2)(2012-3#1)
the left but##2##3##(1990-3#1)(1993-9#1)
the left buttock##2##3##(2012-12#2)
the left cardiac sympathetic nerve##3##5##(2008-9#3)
the left cardiac##4##3##(2007-8#1)(2008-9#3)
the left cerebellum##2##3##(2008-11#1)(2009-1#1)
the left cerebral hemisphere##2##4##(2007-10#1)(2011-1#1)
the left cerebral##3##3##(1991-11#1)(2007-10#1)(2011-1#1)
the left circumflex artery##3##4##(1996-9#1)(2007-8#2)
the left circumflex##5##3##(1996-9#1)(2007-5#1)(2007-8#2)(2008-12#1)
the left colon##6##3##(1990-4#1)(1991-6#1)(1992-6#1)(2006-10#1)(2006-8#1)(2011-2#1)
the left common carotid artery##3##5##(1997-2#2)(2007-8#1)
the left coronary artery##13##4##(1990-3#1)(1991-9#1)(1994-11#1)(1997-1#1)(2007-8#1)(2008-4#3)(2009-7#1)(2010-12#2)(2012-1#1)(2013-2#1)
the left coronary##18##3##(1990-3#1)(1991-9#1)(1994-11#1)(1997-1#1)(2005-12#1)(2006-4#1)(2007-8#3)(2008-4#3)(2009-7#1)(2010-12#3)(2012-1#1)(2013-2#1)
the left dorsolateral prefrontal cortex##2##5##(2008-10#1)(2011-2#1)
the left elbow##5##3##(1992-11#1)(2007-11#1)(2008-4#1)(2008-6#1)(2012-3#1)
the left end of chromosome##2##5##(1996-6#1)(1997-7#1)
the left end of the##3##5##(1991-12#1)(1992-2#2)
the left end of##6##4##(1991-12#1)(1992-2#2)(1994-12#1)(1996-6#1)(1997-7#1)
the left eye##14##3##(1993-12#1)(2007-12#1)(2007-3#2)(2007-7#1)(2010-10#1)(2011-2#5)(2013-1#2)(2013-8#1)
the left femoral artery##2##4##(1997-2#1)(2007-8#1)
the left flank##3##3##(1992-7#1)(2006-10#1)(2008-11#1)
the left forearm##3##3##(2007-4#1)(2010-6#1)(2012-3#1)
the left frontal lobe##3##4##(1995-12#1)(2006-11#1)(2008-12#1)
the left frontal##4##3##(1995-12#1)(2006-11#1)(2008-12#1)(2013-1#1)
the left gastroepiploic artery##2##4##(2006-6#1)(2007-8#1)
the left half of##3##4##(1990-3#1)(2007-8#1)(2008-4#1)
the left hand and##2##4##(2008-4#1)(2012-2#1)
the left hand##8##3##(1990-12#1)(2007-7#1)(2008-4#1)(2012-12#4)(2012-2#1)
the left heart bypass##2##4##(2007-8#2)
the left heart##4##3##(1997-1#1)(2007-8#3)
the left hemidiaphragm##4##3##(2007-8#1)(2013-1#3)
the left hemifield##3##3##(1996-1#1)(1996-5#1)(2008-4#1)
the left hemisphere to##2##4##(1997-8#1)(2009-4#1)
the left hemisphere##13##3##(1993-9#1)(1994-2#1)(1996-2#1)(1996-5#1)(1997-8#1)(2007-7#3)(2008-1#1)(2008-11#1)(2009-2#1)(2009-4#1)(2010-2#1)
the left hemithorax##5##3##(2009-4#1)(2012-2#1)(2013-1#2)(2013-7#1)
the left hepatic lobe##2##4##(2012-2#1)(2012-3#1)
the left hepatic##4##3##(2008-3#1)(2012-2#2)(2012-3#1)
the left hind paw##2##4##(2006-12#1)(2009-6#1)
the left iliac##4##3##(2006-10#1)(2007-11#1)(2008-12#1)(2010-6#1)
the left inferior##4##3##(2008-11#2)(2009-1#1)(2012-3#1)
the left inguinal region##2##4##(1996-9#1)(2013-1#1)
the left internal carotid artery##5##5##(1997-6#1)(2007-9#1)(2008-7#2)(2010-3#1)
the left internal jugular vein##2##5##(2009-9#1)(2012-3#1)
the left internal mammary artery (LIMA)##2##6##(2005-12#1)(2007-8#1)
the left internal mammary artery##7##5##(2005-12#1)(2007-8#6)
the left internal thoracic artery##2##5##(2007-8#2)
the left internal thoracic##3##4##(2007-8#2)(2007-9#1)
the left internal##20##3##(1997-6#1)(2005-12#1)(2007-8#8)(2007-9#2)(2008-7#5)(2009-9#1)(2010-3#1)(2012-3#1)
the left kidney and##7##4##(2008-1#1)(2010-12#1)(2011-2#1)(2013-1#4)
the left kidney was not##2##5##(2006-7#1)(2008-1#1)
the left kidney##25##3##(1990-6#1)(1991-3#1)(1992-7#1)(1997-3#1)(2005-10#1)(2006-4#1)(2006-7#3)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#3)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#5)
the left knee##2##3##(1993-3#1)(2007-11#1)
the left lateral##6##3##(1993-10#1)(1993-12#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)
the left leg##4##3##(1991-3#1)(2007-7#1)(2012-12#1)(2012-2#1)
the left limbs##2##3##(2008-7#2)
the left liver lobe##2##4##(2010-12#2)
the left liver##3##3##(2008-3#1)(2010-12#2)
the left lobe of the##4##5##(2007-8#1)(2012-12#2)(2012-2#1)
the left lobe of##5##4##(2007-8#1)(2008-3#1)(2012-12#2)(2012-2#1)
the left lobe##10##3##(1990-4#1)(1993-5#1)(2007-8#1)(2008-3#1)(2008-5#1)(2009-9#1)(2012-12#2)(2012-2#1)(2013-8#1)
the left lower extremity##4##4##(1993-8#1)(2005-12#1)(2007-10#1)(2008-8#1)
the left lower lobe bronchus##2##5##(2007-8#1)(2008-5#1)
the left lower lobe##13##4##(1991-3#1)(2007-8#7)(2008-1#1)(2008-5#1)(2008-6#2)(2009-8#1)
the left lower##25##3##(1991-3#1)(1991-9#1)(1993-8#1)(2005-12#1)(2007-10#1)(2007-8#7)(2008-1#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-11#3)(2010-12#1)
the left lumbosacral PVM##2##4##(2013-8#2)
the left lung##10##3##(1991-9#1)(2006-10#1)(2007-8#1)(2008-1#2)(2008-4#2)(2010-7#1)(2011-2#1)(2013-8#1)
the left main bronchus##3##4##(2007-8#1)(2008-6#1)(2010-2#1)
the left main coronary artery##6##5##(2007-8#3)(2008-4#1)(2010-9#1)(2011-1#1)
the left main stem##3##4##(1990-9#2)(1991-3#1)
the left main##14##3##(1990-9#2)(1991-3#1)(2007-8#5)(2008-4#1)(2008-6#1)(2010-2#1)(2010-9#1)(2011-1#1)(2013-7#1)
the left maxilla##3##3##(2008-6#1)(2013-1#2)
the left maxillary##4##3##(1991-12#1)(2005-7#1)(2008-2#1)(2010-4#1)
the left middle cerebral artery (MCA) territory##3##7##(2007-10#1)(2007-9#2)
the left middle cerebral artery##6##5##(1990-2#1)(2007-10#1)(2007-9#2)(2008-7#1)(2013-8#1)
the left middle##7##3##(1990-2#1)(2007-10#1)(2007-9#2)(2008-11#1)(2008-7#1)(2013-8#1)
the left one##2##3##(2007-7#1)(2010-2#1)
the left or right##4##4##(1990-10#1)(1997-2#1)(1997-8#1)(2007-4#1)
the left or the right##3##5##(1994-2#1)(1996-1#1)(2008-4#1)
the left or##11##3##(1990-10#1)(1994-2#1)(1996-1#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-4#2)(2008-4#1)(2011-2#1)(2013-1#1)
the left ovary##2##3##(1997-8#1)(2010-12#1)
the left parietal##2##3##(2008-5#1)(2012-12#1)
the left parotid##2##3##(2007-5#1)(2009-5#1)
the left pleural cavity##2##4##(1990-5#1)(2013-7#1)
the left pleural##4##3##(1990-5#2)(2012-3#1)(2013-7#1)
the left posterior##6##3##(1997-6#1)(2008-11#1)(2009-2#1)(2009-8#1)(2011-2#1)(2013-8#1)
the left prefrontal cortex##2##4##(2007-9#2)
the left pulmonary artery##7##4##(2007-8#1)(2008-1#1)(2012-12#4)(2013-7#1)
the left renal artery##6##4##(1990-2#1)(1992-7#1)(2007-5#1)(2008-1#1)(2012-2#2)
the left renal##8##3##(1990-2#1)(1992-7#2)(1995-2#1)(2007-5#1)(2008-1#1)(2012-2#2)
the left sensorimotor cortex##2##4##(1993-9#1)(1995-12#1)
the left shoulder##3##3##(2007-1#1)(2007-11#2)
the left side and##3##4##(2007-8#1)(2008-5#1)(2012-2#1)
the left side of her##2##5##(1991-3#1)(2010-4#1)
the left side of the heart##3##6##(1991-6#1)(1993-6#1)(2007-8#1)
the left side of the neck##4##6##(1990-3#1)(2007-7#1)(2012-12#2)
the left side of the##19##5##(1990-3#1)(1991-6#1)(1993-6#1)(2005-5#1)(2006-7#1)(2007-7#2)(2007-8#1)(2008-12#2)(2008-5#1)(2010-12#2)(2011-1#1)(2011-12#1)(2012-12#2)(2012-3#1)(2013-8#1)
the left side of##23##4##(1990-3#1)(1991-3#1)(1991-6#1)(1993-6#1)(2005-10#1)(2005-5#1)(2006-7#1)(2007-7#2)(2007-8#1)(2008-12#2)(2008-5#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-12#1)(2012-12#3)(2012-3#1)(2013-8#1)
the left side##52##3##(1990-3#2)(1990-4#1)(1991-11#1)(1991-3#1)(1991-6#1)(1993-6#1)(1995-12#1)(2005-10#1)(2005-5#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#2)(2009-7#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#5)(2012-2#2)(2012-3#1)(2013-8#2)
the left subclavian artery##3##4##(2007-7#1)(2008-11#1)(2009-10#1)
the left subclavian##4##3##(2007-7#1)(2008-11#1)(2009-10#1)(2011-2#1)
the left superior temporal##2##4##(1996-2#1)(2012-12#1)
the left superior##5##3##(1996-2#1)(2007-8#1)(2009-9#1)(2011-2#1)(2012-12#1)
the left temporal lobe##4##4##(1995-12#1)(1997-7#1)(2006-8#1)(2008-1#1)
the left temporal##6##3##(1995-12#1)(1997-7#1)(2006-8#1)(2007-9#1)(2008-1#1)(2010-7#1)
the left testis and##2##4##(2008-6#1)(2011-2#1)
the left testis##7##3##(2006-10#2)(2006-2#1)(2008-10#1)(2008-6#2)(2011-2#1)
the left thalamus##3##3##(2006-1#1)(2008-7#1)(2013-8#1)
the left the##2##3##(1992-7#1)(1993-6#1)
the left thigh##7##3##(2007-7#1)(2008-6#3)(2010-8#1)(2013-1#1)(2013-8#1)
the left thorax##2##3##(1990-5#1)(2008-12#1)
the left thumb##3##3##(2010-6#3)
the left upper femur##2##4##(2008-6#2)
the left upper lobe##5##4##(2007-8#1)(2008-1#2)(2010-9#1)(2012-2#1)
the left upper quadrant##2##4##(1991-12#1)(2012-3#1)
the left upper##19##3##(1991-12#1)(1992-5#1)(2006-10#1)(2007-11#1)(2007-8#3)(2008-1#3)(2008-6#2)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
the left ureter##3##3##(1996-3#1)(2008-9#2)
the left ventricle (LV)##2##4##(1991-3#1)(1997-4#1)
the left ventricle and##5##4##(2008-10#1)(2009-10#1)(2011-1#1)(2012-1#1)(2013-8#1)
the left ventricle of##4##4##(1991-2#1)(1996-9#1)(2007-7#1)(2010-3#1)
the left ventricle##54##3##(1991-2#1)(1991-3#1)(1992-9#2)(1993-10#1)(1993-12#2)(1993-9#2)(1996-9#1)(1997-4#1)(1997-8#1)(2006-6#2)(2007-7#2)(2007-8#5)(2007-9#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-12#3)(2009-3#1)(2009-4#1)(2010-3#2)(2010-5#1)(2010-6#1)(2011-1#2)(2012-1#3)(2012-12#1)(2013-1#7)(2013-8#2)
the left ventricular ejection fraction (LVEF)##2##6##(2007-8#1)(2008-10#1)
the left ventricular ejection fraction##3##5##(2007-8#1)(2008-10#1)(2008-12#1)
the left ventricular outflow tract##4##5##(1992-9#1)(2007-9#1)(2008-4#1)(2011-1#1)
the left ventricular systolic function##2##5##(2006-6#1)(2013-1#1)
the left ventricular wall##2##4##(1993-12#1)(1997-6#1)
the left ventricular##29##3##(1990-9#1)(1991-8#1)(1992-2#1)(1992-9#1)(1993-10#1)(1993-12#1)(1995-3#2)(1997-6#1)(2006-6#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#3)(2008-4#1)(2008-9#1)(2009-10#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
the left vertebral artery##2##4##(1996-9#1)(1997-6#1)
the left##871##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#6)(1990-4#3)(1990-5#3)(1990-6#3)(1990-8#1)(1990-9#5)(1991-11#3)(1991-12#3)(1991-2#3)(1991-3#8)(1991-6#3)(1991-8#1)(1991-9#3)(1992-10#1)(1992-11#2)(1992-2#4)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#5)(1992-9#3)(1993-10#3)(1993-12#10)(1993-2#1)(1993-3#1)(1993-5#4)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#11)(1994-11#2)(1994-12#2)(1994-2#4)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#9)(1995-2#1)(1995-3#3)(1995-6#4)(1995-8#3)(1995-9#4)(1996-1#3)(1996-10#1)(1996-2#5)(1996-3#6)(1996-5#2)(1996-6#11)(1996-9#9)(1997-1#7)(1997-2#4)(1997-3#5)(1997-4#2)(1997-6#5)(1997-7#2)(1997-8#8)(2004-11#2)(2005-10#3)(2005-11#1)(2005-12#5)(2005-5#1)(2005-7#1)(2005-9#1)(2006-1#2)(2006-10#13)(2006-11#3)(2006-12#6)(2006-2#2)(2006-4#2)(2006-5#1)(2006-6#7)(2006-7#4)(2006-8#2)(2006-9#2)(2007-1#2)(2007-10#6)(2007-11#9)(2007-12#3)(2007-2#1)(2007-3#2)(2007-4#3)(2007-5#4)(2007-7#22)(2007-8#86)(2007-9#14)(2008-1#21)(2008-10#20)(2008-11#16)(2008-12#12)(2008-2#1)(2008-3#8)(2008-4#25)(2008-5#13)(2008-6#17)(2008-7#25)(2008-8#1)(2008-9#10)(2009-1#5)(2009-10#5)(2009-12#3)(2009-2#8)(2009-3#6)(2009-4#6)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#4)(2009-9#4)(2010-10#1)(2010-11#5)(2010-12#16)(2010-2#6)(2010-3#8)(2010-4#2)(2010-5#1)(2010-6#8)(2010-7#5)(2010-8#2)(2010-9#7)(2011-1#10)(2011-12#2)(2011-2#31)(2012-1#6)(2012-11#1)(2012-12#34)(2012-2#16)(2012-3#11)(2012-7#1)(2013-1#36)(2013-2#1)(2013-7#6)(2013-8#18)
the left-hand column##2##3##(2007-12#2)
the left-handed##2##2##(2006-10#2)
the left-right axis of##2##4##(2007-8#1)(2010-3#1)
the left-right##4##2##(2007-8#1)(2010-3#2)(2011-2#1)
the left-to-right##2##2##(1996-3#1)(2008-3#1)
the leg and##4##3##(2007-4#2)(2008-12#1)(2012-1#1)
the leg at##3##3##(2007-12#1)(2007-8#1)(2008-5#1)
the leg in##3##3##(2007-12#1)(2007-7#1)(2008-12#1)
the leg muscles##3##3##(2007-12#1)(2013-8#2)
the leg was##2##3##(1990-6#1)(2007-8#1)
the leg##49##2##(1990-12#2)(1990-6#1)(1992-3#1)(1993-9#1)(1995-1#1)(1995-2#1)(1996-4#3)(1997-2#1)(2006-10#1)(2006-11#1)(2007-12#6)(2007-4#5)(2007-5#2)(2007-7#2)(2007-8#4)(2007-9#1)(2008-12#2)(2008-5#3)(2008-6#1)(2009-3#1)(2009-5#1)(2010-12#1)(2011-1#1)(2012-1#4)(2013-8#2)
the legacy of##4##3##(1995-1#1)(1995-9#1)(2012-12#1)(2013-1#1)
the legacy##5##2##(1992-3#1)(1995-1#1)(1995-9#1)(2012-12#1)(2013-1#1)
the legal and medical##2##4##(2006-7#1)(2010-9#1)
the legal and##9##3##(1992-3#1)(1993-3#1)(1996-1#1)(2004-12#1)(2006-5#1)(2006-7#1)(2008-11#1)(2008-2#1)(2010-9#1)
the legal aspects of##2##4##(2007-11#1)(2011-2#1)
the legal definition of##2##4##(2005-8#1)(2007-4#1)
the legal foundation for resisting##2##5##(1991-12#1)(1992-3#1)
the legal framework##6##3##(1990-12#1)(1994-12#1)(1996-3#1)(2005-11#1)(2008-10#1)(2011-2#1)
the legal issues##2##3##(1994-3#1)(2007-7#1)
the legal limits of##2##4##(2008-12#1)(2013-1#1)
the legal protection of##2##4##(2005-11#1)(2010-3#1)
the legal requirements for##2##4##(2010-9#1)(2011-2#1)
the legal requirements##3##3##(2008-10#1)(2010-9#1)(2011-2#1)
the legal rights of##2##4##(1995-6#1)(2008-2#1)
the legal status of##2##4##(2006-3#1)(2011-1#1)
the legal system and##2##4##(1995-1#1)(2008-11#1)
the legal system##9##3##(1991-12#1)(1994-2#1)(1995-1#2)(1996-3#1)(2006-8#1)(2008-11#1)(2008-8#1)(2012-2#1)
the legal##78##2##(1990-12#1)(1990-5#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-7#1)(1992-2#2)(1992-3#2)(1992-4#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#3)(1995-6#1)(1996-1#1)(1996-11#1)(1996-3#2)(1997-5#1)(2004-12#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-2#2)(2006-3#4)(2006-5#1)(2006-7#2)(2006-8#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-9#3)(2011-1#2)(2011-12#1)(2011-2#3)(2012-11#2)(2012-2#2)(2013-1#2)
the legalisation of euthanasia##2##4##(2005-2#2)
the legalization##2##2##(2010-12#1)(2011-1#1)
the legally##3##2##(2008-1#1)(2008-10#1)(2010-8#1)
the legislation and##2##3##(2011-2#1)(2012-12#1)
the legislation that##3##3##(2007-1#1)(2007-2#1)(2007-4#1)
the legislation##12##2##(1991-12#1)(1994-1#1)(1996-5#1)(1996-6#1)(1997-3#2)(2007-1#1)(2007-2#1)(2007-4#1)(2007-9#1)(2011-2#1)(2012-12#1)
the legislative process##4##3##(1995-1#1)(1996-1#1)(2009-12#1)(2012-2#1)
the legislative##12##2##(1994-1#1)(1995-1#1)(1996-1#1)(2007-10#2)(2007-5#1)(2008-12#1)(2008-3#1)(2009-12#1)(2010-5#1)(2011-2#1)(2012-2#1)
the legislature##2##2##(2007-10#2)
the legitimacy of##6##3##(1996-12#1)(2007-10#1)(2007-12#1)(2008-5#1)(2008-9#1)(2009-12#1)
the legitimacy##7##2##(1996-12#1)(2007-10#1)(2007-12#1)(2008-5#1)(2008-9#1)(2009-12#1)(2013-1#1)
the legitimate##2##2##(1991-3#1)(2010-8#1)
the legs##25##2##(1990-6#1)(1991-1#1)(1991-6#1)(1992-4#1)(1992-8#1)(1994-8#1)(1997-5#2)(2004-11#1)(2007-12#2)(2007-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
the legume##3##2##(1993-4#1)(2008-10#1)(2009-8#1)
the leishmanin skin test##3##4##(2005-8#3)
the length and weight of##2##5##(2008-5#1)(2008-9#1)
the length and width gradient parameters##2##6##(2008-10#2)
the length and width##3##4##(2008-10#3)
the length and##18##3##(1996-8#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-2#2)(2008-4#1)(2008-5#1)(2008-9#3)(2009-5#1)(2010-7#1)
the length dependence of high-order##2##5##(2007-12#2)
the length of CN##2##4##(2012-2#2)
the length of a##2##4##(2005-11#1)(2008-3#1)
the length of exposure##2##4##(1994-8#1)(1995-3#1)
the length of hospital stay##7##5##(1991-12#1)(1994-5#1)(2008-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
the length of hospitalization##2##4##(1991-2#1)(2006-8#1)
the length of metacarpals and phalanges##2##6##(2012-12#2)
the length of stay in##2##5##(2006-10#1)(2007-12#1)
the length of stay of##2##5##(1991-1#1)(2008-8#1)
the length of stay##8##4##(1991-1#1)(1992-12#1)(1995-3#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-8#1)(2013-8#1)
the length of the 3' untranslated##2##6##(1991-10#1)(1991-2#1)
the length of the adventitious root was##2##7##(2008-12#2)
the length of the alkyl##3##5##(2005-11#2)(2008-10#1)
the length of the intervening##2##5##(1993-3#1)(1994-9#1)
the length of the period##2##5##(2008-5#1)(2009-9#1)
the length of the stem##2##5##(2008-10#2)
the length of the##103##4##(1990-11#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-1#2)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#2)(1994-11#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#3)(2005-11#2)(2005-4#1)(2006-10#1)(2006-12#2)(2007-10#1)(2007-11#3)(2007-12#7)(2007-8#2)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#6)(2008-5#4)(2008-6#1)(2008-7#3)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#3)(2009-3#1)(2009-5#1)(2009-9#2)(2010-1#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
the length of time##9##4##(1994-5#1)(1995-12#1)(1996-12#1)(2006-10#1)(2007-9#2)(2008-7#1)(2011-12#1)(2011-3#1)
the length of##182##3##(1990-11#2)(1990-8#2)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#2)(1994-11#1)(1994-5#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-3#3)(1995-5#2)(1995-8#2)(1995-9#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#4)(1997-7#1)(2004-10#2)(2005-11#3)(2005-4#1)(2006-1#1)(2006-10#3)(2006-12#3)(2006-4#1)(2006-8#2)(2007-10#2)(2007-11#3)(2007-12#8)(2007-7#1)(2007-8#4)(2007-9#3)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#8)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#3)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#7)(2012-2#5)(2013-1#2)(2013-7#1)(2013-8#4)
the length or##3##3##(1994-12#1)(1994-3#1)(2013-8#1)
the length scale of the##2##5##(2008-10#1)(2008-3#1)
the length scale of##3##4##(2008-10#2)(2008-3#1)
the length##227##2##(1990-11#2)(1990-8#2)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#3)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#3)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-3#3)(1995-5#2)(1995-8#2)(1995-9#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#4)(1997-7#1)(2004-10#2)(2004-4#1)(2005-11#4)(2005-4#1)(2006-1#1)(2006-10#4)(2006-12#4)(2006-4#1)(2006-8#2)(2007-10#2)(2007-11#3)(2007-12#12)(2007-7#1)(2007-8#5)(2007-9#3)(2008-1#1)(2008-10#17)(2008-11#2)(2008-12#2)(2008-2#8)(2008-3#9)(2008-4#4)(2008-5#7)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#5)(2009-10#2)(2009-12#1)(2009-2#3)(2009-3#2)(2009-5#2)(2009-7#1)(2009-9#2)(2010-1#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#7)(2012-2#5)(2013-1#2)(2013-7#2)(2013-8#5)
the lengthened##3##2##(2007-8#2)(2010-2#1)
the lengthening index##3##3##(2007-8#3)
the lengthening##9##2##(2007-11#2)(2007-8#4)(2009-2#1)(2011-12#1)(2012-2#1)
the lengths of the##4##4##(2005-10#1)(2007-12#1)(2008-3#2)
the lengths of which##2##4##(1992-12#1)(2007-11#1)
the lengths of##13##3##(1992-12#1)(1993-5#1)(2005-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2012-2#1)(2013-8#1)
the lengths##15##2##(1992-12#1)(1993-5#1)(2005-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2012-2#1)(2013-8#2)
the lengthy##3##2##(1994-8#1)(1996-9#1)(2008-2#1)
the lens and##7##3##(1991-9#1)(1993-9#1)(1995-8#1)(2006-8#1)(2008-11#1)(2008-2#1)(2013-8#1)
the lens aperture##2##3##(2008-2#1)(2008-3#1)
the lens array##5##3##(2007-12#1)(2008-3#4)
the lens in##3##3##(2007-12#1)(2008-3#2)
the lens is##3##3##(2008-2#2)(2008-3#1)
the lens of##8##3##(1991-9#1)(1993-3#1)(2006-5#1)(2008-7#1)(2009-4#1)(2012-11#1)(2012-12#1)(2012-3#1)
the lens to the##2##4##(2007-12#2)
the lens to##3##3##(2007-11#1)(2007-12#2)
the lens was##2##3##(1994-6#1)(2008-5#1)
the lens##76##2##(1990-5#2)(1991-9#3)(1992-12#1)(1993-3#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-8#1)(1997-8#1)(2005-11#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-11#4)(2007-12#9)(2008-11#1)(2008-2#13)(2008-3#17)(2008-5#1)(2008-7#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-8#4)
the lens-free relay system##2##4##(2008-2#2)
the lenses and the##2##4##(2013-8#2)
the lenses and##3##3##(2008-2#1)(2013-8#2)
the lenses##17##2##(1991-9#1)(1993-4#1)(2005-11#1)(2007-12#1)(2008-2#3)(2008-3#6)(2008-5#2)(2013-8#2)
the lensing signal is##2##4##(2008-2#2)
the lensing signal##3##3##(2008-2#3)
the lensing##4##2##(2008-2#4)
the lenslet##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
the lentivirus##2##2##(2008-4#1)(2012-1#1)
the lepidopteran insect##2##3##(1993-12#1)(2008-11#1)
the lepidopteran##3##2##(1993-12#1)(2007-3#1)(2008-11#1)
the leprosy##4##2##(1995-9#2)(2008-3#1)(2011-2#1)
the leptin receptor gene##3##4##(2011-2#3)
the leptin receptor##6##3##(2006-10#1)(2008-4#1)(2011-2#4)
the leptin##8##2##(2006-10#2)(2008-3#1)(2008-4#1)(2011-2#4)
the leptomeningeal##2##2##(2006-10#1)(2008-7#1)
the leptomeninges##4##2##(1993-7#1)(2008-7#1)(2012-2#1)(2013-7#1)
the lesion and the##6##4##(2006-6#1)(2007-9#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)
the lesion and was##2##4##(1995-8#1)(2005-12#1)
the lesion and##30##3##(1990-3#1)(1993-9#1)(1995-11#1)(1995-7#1)(1995-8#1)(1997-6#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2009-1#1)(2009-2#1)(2011-2#2)(2012-12#2)(2012-2#1)
the lesion appeared##2##3##(1994-2#1)(2006-12#1)
the lesion as well as##2##5##(2010-6#1)(2013-8#1)
the lesion as##4##3##(2007-6#1)(2010-6#1)(2012-2#1)(2013-8#1)
the lesion counts##3##3##(2007-7#2)(2008-10#1)
the lesion from##2##3##(2008-5#1)(2012-12#1)
the lesion in the##2##4##(2008-5#1)(2009-6#1)
the lesion in##5##3##(1990-12#1)(1994-12#1)(2008-5#2)(2009-6#1)
the lesion is##10##3##(1990-10#1)(1990-3#1)(2004-1#1)(2006-2#1)(2006-6#1)(2007-8#1)(2009-3#1)(2011-2#1)(2012-2#2)
the lesion morphology##2##3##(2008-5#1)(2009-10#1)
the lesion of##4##3##(1992-7#1)(2006-8#1)(2008-4#1)(2008-8#1)
the lesion revealed##3##3##(1993-3#1)(2007-8#1)(2010-6#1)
the lesion showed##2##3##(1991-9#1)(2007-7#1)
the lesion site##4##3##(1992-9#1)(1996-5#1)(1996-7#1)(2007-11#1)
the lesion size##2##3##(2008-10#1)(2013-8#1)
the lesion to##3##3##(2006-8#1)(2008-5#1)(2008-7#1)
the lesion was found to be##3##6##(2005-5#1)(2009-11#1)(2011-2#1)
the lesion was##34##3##(1991-11#1)(1995-1#1)(1995-10#1)(1996-6#1)(2005-10#1)(2005-5#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-6#2)(2007-7#3)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#4)
the lesion were##4##3##(1996-3#1)(1997-7#1)(2008-5#1)(2012-3#1)
the lesion with##7##3##(1993-12#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)
the lesion##278##2##(1990-10#1)(1990-12#2)(1990-3#3)(1990-4#1)(1990-5#1)(1991-1#3)(1991-11#1)(1991-3#1)(1991-6#1)(1991-9#3)(1992-10#3)(1992-2#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-12#2)(1993-3#3)(1993-8#1)(1993-9#1)(1994-12#3)(1994-2#1)(1994-4#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#3)(1995-11#3)(1995-12#2)(1995-7#1)(1995-8#1)(1996-2#2)(1996-3#5)(1996-5#8)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-6#4)(1997-7#1)(1997-8#1)(2003-11#1)(2004-1#1)(2004-11#1)(2005-10#3)(2005-12#2)(2005-5#1)(2006-10#6)(2006-11#2)(2006-12#1)(2006-2#2)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#5)(2007-11#6)(2007-12#6)(2007-2#1)(2007-6#4)(2007-7#9)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#4)(2008-4#2)(2008-5#13)(2008-6#5)(2008-7#12)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#5)(2010-2#1)(2010-5#2)(2010-6#8)(2011-1#1)(2011-2#14)(2012-1#2)(2012-12#5)(2012-2#8)(2012-3#3)(2013-1#6)(2013-8#14)
the lesion's##2##2##(2007-12#1)(2010-12#1)
the lesioned and##2##3##(1992-11#1)(1994-2#1)
the lesioned group exhibited##2##4##(1997-6#2)
the lesioned hemispheres were##2##4##(1995-12#2)
the lesioned side##3##3##(1991-2#1)(1996-5#1)(1997-2#1)
the lesioned##21##2##(1991-2#1)(1992-11#1)(1993-7#1)(1994-12#1)(1994-2#1)(1995-12#3)(1996-5#1)(1997-2#1)(1997-6#5)(2008-11#1)(2008-7#5)
the lesions and##8##3##(2006-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-8#1)(2011-1#1)(2013-8#1)
the lesions are##10##3##(1992-8#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-8#2)(2008-4#1)(2008-5#1)(2008-8#1)(2011-1#1)
the lesions had##2##3##(2007-9#1)(2013-8#1)
the lesions in##7##3##(1994-7#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2013-8#2)
the lesions is##2##3##(1991-2#1)(2012-3#1)
the lesions of psoriasis##2##4##(2007-7#2)
the lesions of the##2##4##(1991-5#1)(1997-8#1)
the lesions of##7##3##(1991-5#1)(1997-8#2)(2006-8#1)(2007-7#2)(2009-9#1)
the lesions was##5##3##(1992-11#1)(1993-2#1)(1995-4#1)(2008-5#1)(2013-1#1)
the lesions were located at the##2##6##(2005-12#1)(2007-2#1)
the lesions were located##4##4##(1991-8#1)(2005-12#1)(2006-4#1)(2007-2#1)
the lesions were##22##3##(1991-8#1)(1993-7#1)(1995-1#1)(1995-4#2)(1997-6#1)(2004-11#1)(2005-12#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-2#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-5#2)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#1)
the lesions##131##2##(1990-10#1)(1990-5#1)(1991-11#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-8#2)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-7#3)(1993-8#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-4#3)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-6#1)(1997-8#4)(2004-11#1)(2005-11#1)(2005-12#3)(2006-10#2)(2006-12#1)(2006-4#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-11#1)(2007-2#4)(2007-6#1)(2007-7#7)(2007-8#7)(2007-9#3)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-4#3)(2008-5#7)(2008-7#3)(2008-8#3)(2009-10#1)(2009-9#1)(2010-12#1)(2010-6#4)(2011-1#2)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#4)(2013-8#4)
the less abundant##3##3##(1991-2#1)(2007-5#1)(2008-4#1)
the less active##2##3##(1991-3#1)(1996-6#1)
the less aggressive##2##3##(2008-10#2)
the less common##6##3##(1993-10#1)(1995-12#1)(2006-10#1)(2008-10#1)(2008-3#1)(2013-8#1)
the less educated##3##3##(2008-9#1)(2010-8#1)(2013-7#1)
the less frequent causes##2##4##(1993-6#1)(2012-2#1)
the less frequent##3##3##(1993-6#1)(2010-9#1)(2012-2#1)
the less hindered##2##3##(1996-5#1)(2008-10#1)
the less invasive##2##3##(2011-2#1)(2012-12#1)
the less polar##3##3##(1990-2#1)(2006-12#1)(2012-2#1)
the less sensitive##2##3##(2004-4#1)(2008-4#1)
the less stable##4##3##(1997-7#1)(2008-10#1)(2008-4#1)(2009-9#1)
the less toxic##2##3##(1997-4#1)(2007-11#1)
the less##83##2##(1990-2#1)(1990-5#1)(1991-1#1)(1991-2#1)(1991-3#1)(1992-8#1)(1993-10#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-4#1)(1995-1#1)(1995-11#1)(1995-12#2)(1996-2#2)(1996-5#2)(1996-6#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(2004-4#1)(2006-10#2)(2006-12#2)(2006-6#1)(2007-10#1)(2007-11#2)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-12#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
the lesser##9##2##(1995-6#1)(1996-12#1)(1997-5#1)(2007-3#1)(2008-4#1)(2012-2#3)(2013-1#1)
the lession##2##2##(2009-2#2)
the lessons from##2##3##(1995-1#1)(1996-9#1)
the lessons learned and##3##4##(1995-12#1)(2007-12#1)(2009-10#1)
the lessons learned by##2##4##(1994-1#1)(2012-3#1)
the lessons learned from this unsuccessful venture##2##7##(1994-3#2)
the lessons learned from this##3##5##(1994-3#2)(2008-5#1)
the lessons learned from##5##4##(1994-3#2)(2007-4#1)(2008-5#1)(2013-1#1)
the lessons learned##17##3##(1993-3#1)(1994-1#1)(1994-3#2)(1995-12#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2012-3#1)(2013-1#2)
the lessons that have##2##4##(1996-12#1)(2009-6#1)
the lessons that##3##3##(1996-12#1)(2009-6#1)(2010-12#1)
the lessons we##4##3##(2009-1#1)(2012-2#1)(2013-1#2)
the lessons##32##2##(1993-3#1)(1994-1#1)(1994-3#2)(1995-1#1)(1995-12#2)(1996-12#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-5#1)(2008-12#2)(2008-5#1)(2008-7#1)(2009-1#1)(2009-10#1)(2009-6#1)(2010-12#2)(2012-2#1)(2012-3#1)(2013-1#5)
the let-60 gene##3##3##(1990-11#2)(1993-6#1)
the let-60##4##2##(1990-11#3)(1993-6#1)
the let-7##2##2##(2008-1#1)(2012-12#1)
the lethal and##3##3##(1991-10#1)(2008-10#1)(2008-7#1)
the lethal effect of##3##4##(2005-12#1)(2006-10#2)
the lethal effect on##2##4##(1990-7#1)(2005-12#1)
the lethal effect##5##3##(1990-7#1)(2005-12#2)(2006-10#2)
the lethal effects of##5##4##(1995-12#1)(1995-8#1)(1996-1#1)(1997-2#1)(2007-11#1)
the lethal milk mouse##2##4##(2008-10#2)
the lethal potency of##2##4##(1991-3#2)
the lethal potency##4##3##(1991-3#2)(2008-5#2)
the lethal##29##2##(1990-7#1)(1991-10#1)(1991-3#2)(1991-5#1)(1991-8#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-6#1)(1997-2#1)(2005-12#2)(2006-1#1)(2006-10#2)(2006-9#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-7#2)(2013-1#1)
the lethality of the##2##4##(1990-3#1)(1996-8#1)
the lethality of##5##3##(1990-3#1)(1996-8#1)(2005-12#2)(2008-4#1)
the lethality##9##2##(1990-3#1)(1995-12#1)(1996-8#1)(2005-12#2)(2008-10#1)(2008-4#1)(2009-2#1)(2013-1#1)
the letter##5##2##(2005-11#1)(2005-7#1)(2008-4#1)(2008-5#1)(2010-2#1)
the letters##4##2##(2007-12#1)(2008-4#2)(2013-8#1)
the leucine zipper of##2##4##(1994-3#1)(2006-12#1)
the leucine zipper##8##3##(1992-3#3)(1992-8#1)(1993-12#1)(1994-3#2)(2006-12#1)
the leucine##13##2##(1991-1#1)(1991-12#1)(1992-3#3)(1992-8#1)(1993-12#1)(1994-3#2)(2006-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
the leucine-zipper-like##3##2##(1996-10#3)
the leucite##2##2##(2009-7#2)
the leukemia##5##2##(2007-4#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-3#1)
the leukemic cell lines##2##4##(1992-8#1)(2008-9#1)
the leukemic cells##2##3##(2007-2#1)(2008-11#1)
the leukemic##5##2##(1992-8#1)(2007-2#1)(2008-11#1)(2008-9#1)(2012-12#1)
the leukocyte##6##2##(1991-12#1)(1993-3#1)(1994-11#1)(1995-1#1)(1997-4#1)(2006-9#1)
the leukocytes##2##2##(1996-3#1)(2007-3#1)
the leukotriene D4 receptor##2##4##(1993-6#2)
the leukotriene##5##2##(1993-6#2)(1995-8#1)(2007-11#1)(2010-5#1)
the leupeptin treatment##3##3##(1995-9#3)
the leupeptin##4##2##(1995-9#4)
the leupeptin-induced inclusions##2##3##(1995-9#2)
the levator##9##2##(1994-4#5)(2009-8#4)
the level and activity of##2##5##(1996-2#1)(2008-11#1)
the level and duration of##2##5##(1990-5#1)(2008-11#1)
the level and pattern of##2##5##(1990-11#1)(2007-10#1)
the level and the##2##4##(1992-6#1)(1996-2#1)
the level and timing of##2##5##(1990-12#1)(1993-12#1)
the level and##19##3##(1990-11#1)(1990-12#1)(1990-5#1)(1992-1#1)(1992-6#1)(1993-12#1)(1994-4#1)(1994-5#1)(1996-2#2)(2007-10#1)(2007-12#1)(2007-8#1)(2008-11#3)(2010-9#1)(2012-1#1)(2012-12#1)
the level at which the##3##5##(1991-12#1)(2007-11#1)(2007-8#1)
the level at##5##3##(1991-12#1)(1997-2#1)(2006-2#1)(2007-11#1)(2007-8#1)
the level attained##2##3##(2008-10#1)(2008-11#1)
the level for##2##3##(1992-5#1)(1992-6#1)
the level in the##2##4##(2006-12#1)(2008-12#1)
the level in##10##3##(1993-8#1)(1995-4#1)(1996-1#1)(1997-4#1)(2005-3#1)(2006-12#1)(2008-12#1)(2009-5#2)(2010-5#1)
the level observed##4##3##(1993-8#1)(1995-10#1)(1995-3#1)(2011-2#1)
the level of 0##4##4##(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)
the level of CaSR mRNA##2##5##(2008-11#2)
the level of DNA damage##2##5##(1992-3#1)(1996-2#1)
the level of DNA##6##4##(1992-3#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-7#1)
the level of E2##2##4##(2008-9#1)(2012-2#1)
the level of FSH##2##4##(2012-2#2)
the level of IL-6##2##4##(2008-8#1)(2013-1#1)
the level of Ins(1##2##4##(1991-2#2)
the level of MDA##2##4##(2008-7#1)(2009-5#1)
the level of NGF##2##4##(1993-7#1)(1997-6#1)
the level of NO##2##4##(2010-4#1)(2013-1#1)
the level of RNA##6##4##(1990-12#1)(1992-8#1)(1995-6#1)(1997-7#1)(2008-9#1)(2012-3#1)
the level of a single##3##5##(1992-12#1)(2008-4#1)(2008-7#1)
the level of a##6##4##(1990-8#1)(1992-12#1)(1993-11#1)(2007-12#1)(2008-4#1)(2008-7#1)
the level of accuracy##2##4##(1993-5#1)(2008-10#1)
the level of active ingredient within the formulation##2##8##(2008-5#2)
the level of activity##2##4##(2006-6#1)(2008-1#1)
the level of airway##2##4##(2007-11#2)
the level of an##2##4##(2007-1#1)(2010-9#1)
the level of analgesia##2##4##(2007-2#1)(2012-3#1)
the level of annexin I##2##5##(1994-12#2)
the level of antibodies##2##4##(2011-2#1)(2013-1#1)
the level of antibody##3##4##(2007-11#1)(2008-11#1)(2008-4#1)
the level of apoE##2##4##(1995-6#1)(2004-11#1)
the level of aromatase##2##4##(1993-12#1)(1993-8#1)
the level of attention##2##4##(1995-12#1)(2006-2#1)
the level of awareness##3##4##(2007-2#1)(2010-5#1)(2011-1#1)
the level of bacterial##2##4##(2007-6#1)(2008-10#1)
the level of binding of##2##5##(1991-1#1)(1995-3#1)
the level of binding##3##4##(1991-1#1)(1995-3#1)(1997-2#1)
the level of both##5##4##(1995-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)
the level of c-fos mRNA in the caudate-putamen##2##8##(1996-12#2)
the level of c-fos mRNA in the nucleus accumbens shell##2##10##(1996-12#2)
the level of c-fos mRNA in the##5##7##(1996-12#5)
the level of c-fos mRNA was##2##6##(1996-12#2)
the level of c-fos mRNA##9##5##(1996-12#9)
the level of cAMP##2##4##(1991-5#1)(2004-8#1)
the level of calpastatin##2##4##(1994-3#2)
the level of cholesterol##2##4##(1996-2#1)(2008-5#1)
the level of circulating##3##4##(1990-5#1)(2008-1#1)(2011-1#1)
the level of cognitive functioning##2##5##(2010-12#1)(2012-12#1)
the level of cognitive##3##4##(2010-12#1)(2010-3#1)(2012-12#1)
the level of competence##2##4##(2006-9#1)(2007-12#1)
the level of concern##2##4##(2008-10#1)(2008-8#1)
the level of contamination and##2##5##(2008-1#1)(2011-12#1)
the level of contamination in##2##5##(2004-4#1)(2007-6#1)
the level of contamination##8##4##(1996-12#1)(2004-4#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#2)(2011-12#1)
the level of control##9##4##(1997-3#1)(2005-8#1)(2008-10#1)(2008-11#1)(2009-1#2)(2009-11#1)(2010-5#1)(2012-2#1)
the level of cytokine##2##4##(2008-4#2)
the level of depression##2##4##(1990-3#1)(2013-1#1)
the level of discrimination##3##4##(1992-10#2)(2008-10#1)
the level of disease##3##4##(2008-10#2)(2009-1#1)
the level of drug resistance##2##5##(1992-2#2)
the level of education##2##4##(2007-8#1)(2013-1#1)
the level of effort allocated to current reproduction should##2##9##(2008-8#2)
the level of effort##3##4##(1995-1#1)(2008-8#2)
the level of endogenous##2##4##(2006-6#1)(2010-12#1)
the level of environmental##2##4##(2007-7#1)(2008-10#1)
the level of evidence##2##4##(1990-12#1)(2008-8#1)
the level of expression is##2##5##(1991-5#1)(1992-10#1)
the level of expression of the##7##6##(1990-4#1)(1993-9#1)(2006-8#1)(2008-10#1)(2008-11#2)(2011-1#1)
the level of expression of##12##5##(1990-4#1)(1991-4#1)(1992-5#1)(1993-9#1)(1995-2#1)(2006-12#1)(2006-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2011-1#1)
the level of expression##20##4##(1990-4#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-10#1)(1992-5#1)(1993-9#1)(1995-1#1)(1995-2#1)(1996-12#1)(2006-12#1)(2006-8#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-4#1)(2011-1#1)(2012-12#1)(2012-2#1)
the level of functional##4##4##(1995-8#1)(2008-8#1)(2009-8#1)(2011-12#1)
the level of gene expression##9##5##(1994-8#1)(1996-10#2)(1996-11#1)(1997-4#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
the level of gene##12##4##(1994-12#1)(1994-8#1)(1995-1#1)(1996-10#2)(1996-11#1)(1997-4#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
the level of glucose##2##4##(2007-5#1)(2007-8#1)
the level of health care##2##5##(1993-3#1)(1996-3#1)
the level of health##4##4##(1993-3#1)(1996-3#1)(2007-2#1)(2007-7#1)
the level of heme reduction##2##5##(1994-8#2)
the level of immunological complexes##2##5##(2007-11#2)
the level of increased##2##4##(1992-10#1)(2009-6#1)
the level of induction##2##4##(1996-10#1)(1997-1#1)
the level of infection##2##4##(1996-12#1)(1997-1#1)
the level of inhibition of##2##5##(1990-11#1)(1995-3#1)
the level of inhibition##3##4##(1990-11#1)(1990-2#1)(1995-3#1)
the level of insulin##3##4##(1997-4#2)(2012-12#1)
the level of intracellular##4##4##(1992-7#1)(1994-3#1)(2006-10#1)(2010-12#1)
the level of invasion##3##4##(2006-6#1)(2008-5#2)
the level of its##3##4##(1996-3#1)(2008-8#1)(2009-2#1)
the level of knowledge about##2##5##(2006-12#1)(2012-12#1)
the level of knowledge##8##4##(1991-9#1)(2006-12#1)(2008-8#1)(2010-8#1)(2011-2#2)(2012-12#2)
the level of large##2##4##(1994-8#1)(2007-8#1)
the level of latent##2##4##(2008-10#2)
the level of lipid##4##4##(2008-5#2)(2009-6#1)(2009-8#1)
the level of local##2##4##(1993-11#1)(1997-5#1)
the level of mRNA##8##4##(1990-12#1)(1992-3#1)(1993-11#1)(1993-9#1)(1994-11#1)(1995-12#1)(1997-8#1)(2011-1#1)
the level of malondialdehyde##2##4##(2009-6#1)(2012-2#1)
the level of molecular##2##4##(1995-6#1)(2007-11#1)
the level of noise##2##4##(2008-9#2)
the level of normal##2##4##(2012-12#1)(2013-7#1)
the level of occupational therapists' knowledge about patients' rights##3##9##(2013-8#3)
the level of other##2##4##(1995-12#1)(2008-10#1)
the level of oxidative stress##2##5##(1995-6#1)(2009-12#1)
the level of pain##4##4##(1996-2#1)(2006-8#1)(2007-11#1)(2007-8#1)
the level of participation##2##4##(1992-1#1)(2006-2#1)
the level of patient##3##4##(1997-1#1)(2006-1#1)(2011-12#1)
the level of performance of##2##5##(1996-9#1)(1997-8#1)
the level of performance##3##4##(1990-11#1)(1996-9#1)(1997-8#1)
the level of physical activity##7##5##(2011-1#1)(2012-12#4)(2012-2#1)(2013-1#1)
the level of physical##9##4##(1994-4#1)(2011-1#2)(2012-12#4)(2012-2#1)(2013-1#1)
the level of plasma vWF##2##5##(2007-10#2)
the level of plasma##4##4##(2007-1#1)(2007-10#3)
the level of population##2##4##(2008-12#1)(2012-3#1)
the level of post-operative##2##4##(1996-2#1)(2007-8#1)
the level of protection provided by##2##6##(2008-10#1)(2008-5#1)
the level of protection##3##4##(2008-10#2)(2008-5#1)
the level of protein tyrosine phosphorylation##2##6##(2012-3#2)
the level of protein##4##4##(1990-2#1)(2008-5#1)(2012-3#2)
the level of recovered cells##2##5##(2006-8#2)
the level of resistance to##2##5##(2008-10#2)
the level of resistance##5##4##(2008-10#4)(2010-2#1)
the level of satisfaction among the##2##6##(1995-9#1)(2006-4#1)
the level of satisfaction##3##4##(1995-9#1)(1996-3#1)(2006-4#1)
the level of saturated fatty acids in##2##7##(2006-12#2)
the level of saturated fatty acids##3##6##(2006-12#3)
the level of sedation##2##4##(2006-10#1)(2012-2#1)
the level of serum##3##4##(1991-6#1)(1994-7#2)
the level of significance##4##4##(2007-10#1)(2008-10#1)(2010-6#1)(2011-1#1)
the level of social##3##4##(1997-6#1)(2009-4#1)(2013-1#1)
the level of stress##2##4##(2008-11#1)(2009-3#1)
the level of synaptic##2##4##(1997-7#1)(2009-3#1)
the level of the individual##8##5##(1994-2#1)(2006-4#1)(2006-7#1)(2009-12#1)(2010-8#2)(2012-2#1)(2013-8#1)
the level of the##115##4##(1990-12#1)(1990-3#1)(1990-7#2)(1991-12#4)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-5#2)(1994-9#1)(1995-12#1)(1995-3#2)(1995-8#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-1#4)(2005-7#1)(2005-9#2)(2006-10#1)(2006-11#2)(2006-12#3)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#3)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#3)(2008-8#2)(2009-1#1)(2009-12#2)(2009-9#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-2#3)(2011-7#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#2)
the level of their##3##4##(2007-1#1)(2007-6#1)(2008-10#1)
the level of thermal hyperalgesia##2##5##(1995-12#2)
the level of this##3##4##(1994-9#1)(2010-8#1)(2013-1#1)
the level of thyroid cartilage##2##5##(2010-12#1)(2012-12#1)
the level of total##6##4##(1991-11#1)(1996-8#1)(1997-2#1)(2007-1#1)(2010-4#2)
the level of transcription of##2##5##(1996-2#1)(1997-7#1)
the level of transcription##18##4##(1990-7#1)(1993-6#1)(1993-9#3)(1994-11#1)(1994-2#1)(1994-3#2)(1996-2#1)(1996-5#1)(1997-7#1)(2007-12#1)(2008-11#2)(2012-12#2)(2013-1#1)
the level of two##2##4##(1994-3#1)(1997-2#1)
the level of understanding was##2##5##(2008-7#2)
the level of understanding##3##4##(2004-10#1)(2008-7#2)
the level of viral##2##4##(1996-4#1)(2008-4#1)
the level of zinc##2##4##(2008-10#1)(2008-5#1)
the level of α-synuclein##2##4##(2012-1#2)
the level of##984##3##(1990-10#1)(1990-11#3)(1990-12#9)(1990-2#3)(1990-3#3)(1990-4#3)(1990-5#1)(1990-6#3)(1990-7#4)(1990-8#3)(1991-1#3)(1991-10#1)(1991-11#3)(1991-12#5)(1991-2#4)(1991-4#1)(1991-5#5)(1991-6#2)(1991-7#2)(1991-8#3)(1991-9#3)(1992-1#5)(1992-10#5)(1992-11#3)(1992-12#4)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#5)(1992-7#3)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#6)(1993-12#5)(1993-2#2)(1993-3#5)(1993-4#2)(1993-5#3)(1993-6#4)(1993-7#1)(1993-8#3)(1993-9#7)(1994-10#2)(1994-11#2)(1994-12#5)(1994-2#7)(1994-3#12)(1994-4#1)(1994-5#2)(1994-6#4)(1994-7#3)(1994-8#9)(1994-9#4)(1995-1#5)(1995-10#1)(1995-12#9)(1995-2#3)(1995-3#8)(1995-4#3)(1995-5#2)(1995-6#5)(1995-7#3)(1995-8#11)(1995-9#3)(1996-1#3)(1996-10#4)(1996-11#2)(1996-12#17)(1996-2#7)(1996-3#5)(1996-4#3)(1996-5#8)(1996-6#1)(1996-7#3)(1996-8#1)(1996-9#3)(1997-1#7)(1997-2#10)(1997-3#5)(1997-4#7)(1997-5#5)(1997-6#5)(1997-7#10)(1997-8#4)(2004-10#1)(2004-11#1)(2004-12#1)(2004-4#3)(2004-8#1)(2005-1#4)(2005-10#2)(2005-6#1)(2005-7#2)(2005-8#4)(2005-9#2)(2006-1#2)(2006-10#8)(2006-11#5)(2006-12#14)(2006-2#4)(2006-3#1)(2006-4#5)(2006-5#2)(2006-6#7)(2006-7#4)(2006-8#6)(2006-9#2)(2007-1#7)(2007-10#7)(2007-11#10)(2007-12#8)(2007-2#7)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#7)(2007-7#3)(2007-8#15)(2007-9#2)(2008-1#10)(2008-10#73)(2008-11#25)(2008-12#4)(2008-2#7)(2008-3#5)(2008-4#15)(2008-5#22)(2008-6#5)(2008-7#22)(2008-8#29)(2008-9#8)(2009-1#6)(2009-10#1)(2009-11#2)(2009-12#4)(2009-2#5)(2009-3#3)(2009-4#6)(2009-5#3)(2009-6#8)(2009-7#6)(2009-8#9)(2009-9#4)(2010-1#1)(2010-10#3)(2010-12#10)(2010-2#3)(2010-3#2)(2010-4#7)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#7)(2010-9#7)(2011-1#13)(2011-12#5)(2011-2#20)(2011-7#1)(2012-1#4)(2012-12#21)(2012-2#21)(2012-3#12)(2013-1#32)(2013-7#1)(2013-8#16)
the level one##2##3##(1990-8#1)(2012-3#1)
the level or##2##3##(1994-5#1)(2010-5#1)
the level required for##2##4##(1990-8#1)(2008-8#1)
the level set##2##3##(2008-6#1)(2008-9#1)
the level was##4##3##(1992-6#1)(1992-9#1)(2008-11#1)(2010-3#1)
the level##1072##2##(1990-10#1)(1990-11#4)(1990-12#10)(1990-2#3)(1990-3#3)(1990-4#3)(1990-5#2)(1990-6#3)(1990-7#4)(1990-8#7)(1990-9#1)(1991-1#3)(1991-10#2)(1991-11#3)(1991-12#6)(1991-2#4)(1991-4#1)(1991-5#5)(1991-6#3)(1991-7#2)(1991-8#3)(1991-9#3)(1992-1#6)(1992-10#5)(1992-11#3)(1992-12#4)(1992-2#2)(1992-3#6)(1992-4#1)(1992-5#4)(1992-6#8)(1992-7#3)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#7)(1993-12#6)(1993-2#2)(1993-3#5)(1993-4#2)(1993-5#3)(1993-6#4)(1993-7#1)(1993-8#5)(1993-9#7)(1994-10#2)(1994-11#2)(1994-12#5)(1994-2#7)(1994-3#12)(1994-4#2)(1994-5#4)(1994-6#4)(1994-7#3)(1994-8#10)(1994-9#4)(1995-1#5)(1995-10#2)(1995-12#9)(1995-2#3)(1995-3#9)(1995-4#4)(1995-5#2)(1995-6#5)(1995-7#3)(1995-8#11)(1995-9#3)(1996-1#4)(1996-10#4)(1996-11#2)(1996-12#18)(1996-2#10)(1996-3#5)(1996-4#3)(1996-5#9)(1996-6#1)(1996-7#3)(1996-8#1)(1996-9#3)(1997-1#7)(1997-2#11)(1997-3#5)(1997-4#9)(1997-5#5)(1997-6#6)(1997-7#10)(1997-8#4)(2004-10#1)(2004-11#1)(2004-12#1)(2004-4#3)(2004-8#1)(2005-1#4)(2005-10#2)(2005-3#2)(2005-6#1)(2005-7#2)(2005-8#4)(2005-9#2)(2006-1#2)(2006-10#8)(2006-11#5)(2006-12#15)(2006-2#5)(2006-3#1)(2006-4#5)(2006-5#2)(2006-6#8)(2006-7#4)(2006-8#6)(2006-9#2)(2007-1#7)(2007-10#8)(2007-11#11)(2007-12#9)(2007-2#7)(2007-3#1)(2007-4#2)(2007-5#3)(2007-6#7)(2007-7#3)(2007-8#19)(2007-9#2)(2008-1#10)(2008-10#79)(2008-11#31)(2008-12#6)(2008-2#8)(2008-3#6)(2008-4#15)(2008-5#22)(2008-6#6)(2008-7#22)(2008-8#30)(2008-9#10)(2009-1#6)(2009-10#1)(2009-11#2)(2009-12#4)(2009-2#5)(2009-3#3)(2009-4#6)(2009-5#5)(2009-6#8)(2009-7#6)(2009-8#9)(2009-9#4)(2010-1#1)(2010-10#3)(2010-12#10)(2010-2#3)(2010-3#3)(2010-4#7)(2010-5#6)(2010-6#1)(2010-7#2)(2010-8#7)(2010-9#8)(2011-1#13)(2011-12#5)(2011-2#22)(2011-7#1)(2012-1#5)(2012-12#22)(2012-2#21)(2012-3#14)(2013-1#34)(2013-7#1)(2013-8#16)
the level-set##4##2##(2008-6#3)(2010-2#1)
the levels and##5##3##(1990-2#1)(1991-2#1)(1995-3#1)(2008-5#1)(2013-8#1)
the levels attained##2##3##(1992-2#1)(1993-6#1)
the levels decreased##2##3##(1997-6#1)(2008-10#1)
the levels found##2##3##(1993-11#1)(2008-10#1)
the levels in the##4##4##(2007-10#1)(2008-10#1)(2009-12#1)(2011-1#1)
the levels in##9##3##(1990-2#1)(1993-11#1)(1995-1#1)(1995-7#1)(2007-10#1)(2008-10#1)(2009-12#1)(2011-1#1)(2011-2#1)
the levels observed with##2##4##(1997-1#1)(2011-2#1)
the levels observed##4##3##(1995-9#1)(1997-1#1)(2008-10#1)(2011-2#1)
the levels of DDT##2##4##(1992-6#2)
the levels of DNA##2##4##(1994-5#1)(1996-2#1)
the levels of GST##2##4##(1997-7#2)
the levels of HMG-CoA reductase activity##2##6##(1993-6#1)(1994-5#1)
the levels of LH beta mRNA##2##6##(1997-2#2)
the levels of TC##2##4##(2013-1#2)
the levels of TGF beta produced by##2##7##(1992-8#2)
the levels of beta-actin mRNA##2##5##(1991-3#1)(1992-11#1)
the levels of both##6##4##(1992-3#1)(1994-3#1)(1995-10#1)(1995-9#1)(2012-1#1)(2012-12#1)
the levels of cellular##2##4##(2008-11#1)(2013-7#1)
the levels of dopamine##3##4##(1991-2#1)(1996-10#1)(1997-7#1)
the levels of free and##2##5##(1990-7#1)(2008-10#1)
the levels of gene##2##4##(2008-10#1)(2008-9#1)
the levels of glucose##3##4##(1994-3#1)(2008-12#2)
the levels of inositol 1##2##5##(1991-12#1)(1991-5#1)
the levels of mRNA##3##4##(1990-3#1)(1993-5#1)(2009-12#1)
the levels of matrix metalloproteinase-8 and interleukin-1beta##2##7##(2012-12#2)
the levels of matrix##4##4##(2007-1#1)(2008-5#1)(2012-12#2)
the levels of participation##2##4##(1995-2#1)(2010-3#1)
the levels of phosphorylation##2##4##(1995-3#1)(2013-1#1)
the levels of serum##5##4##(1994-12#1)(2006-2#1)(2007-11#1)(2009-12#1)(2011-1#1)
the levels of support##2##4##(2004-12#1)(2008-12#1)
the levels of the antioxidant enzymes##2##6##(2013-8#2)
the levels of the##33##4##(1990-12#1)(1990-5#3)(1991-12#1)(1991-2#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-8#2)(1993-12#1)(1995-5#1)(1995-7#2)(1996-10#1)(1996-2#1)(1997-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-4#1)(2011-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#3)
the levels of their##2##4##(1992-11#1)(2007-1#1)
the levels of these##4##4##(1990-6#1)(1994-12#1)(2008-10#1)(2008-8#1)
the levels of this##3##4##(1993-7#1)(1995-8#1)(2011-2#1)
the levels of total##3##4##(1990-6#1)(1991-7#1)(2010-8#1)
the levels of urinary##4##4##(1996-12#1)(2008-10#2)(2009-6#1)
the levels of various##2##4##(2004-4#1)(2010-12#1)
the levels of vitamin##2##4##(2007-9#1)(2013-8#1)
the levels of which were##2##5##(1992-12#1)(2008-9#1)
the levels of##393##3##(1990-12#2)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#6)(1990-6#3)(1990-7#3)(1990-8#1)(1991-1#2)(1991-12#4)(1991-2#6)(1991-3#1)(1991-4#1)(1991-5#4)(1991-7#2)(1991-9#2)(1992-1#1)(1992-11#6)(1992-12#7)(1992-3#1)(1992-4#5)(1992-5#2)(1992-6#2)(1992-8#6)(1992-9#2)(1993-11#2)(1993-12#3)(1993-2#4)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#5)(1993-9#1)(1994-11#4)(1994-12#5)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#3)(1994-8#3)(1994-9#3)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#4)(1995-8#3)(1995-9#2)(1996-1#1)(1996-10#4)(1996-11#3)(1996-12#2)(1996-2#3)(1996-3#4)(1996-5#2)(1996-6#1)(1996-9#3)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#4)(1997-5#2)(1997-7#4)(1997-8#3)(2003-11#1)(2004-12#1)(2004-4#3)(2005-11#1)(2006-10#2)(2006-11#3)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#1)(2006-9#2)(2007-1#4)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#5)(2008-10#31)(2008-11#8)(2008-12#4)(2008-3#2)(2008-4#7)(2008-5#10)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-10#4)(2009-12#4)(2009-4#3)(2009-6#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-8#3)(2011-1#4)(2011-12#2)(2011-2#10)(2012-1#4)(2012-12#5)(2012-2#8)(2012-3#3)(2013-1#14)(2013-7#3)(2013-8#11)
the levels were significantly##2##4##(2006-8#1)(2008-10#1)
the levels were##8##3##(1993-3#1)(2006-8#1)(2007-6#1)(2007-7#2)(2008-10#1)(2008-12#1)(2012-1#1)
the levels##454##2##(1990-12#2)(1990-2#3)(1990-3#3)(1990-4#1)(1990-5#6)(1990-6#4)(1990-7#3)(1990-8#1)(1991-1#2)(1991-12#5)(1991-2#7)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#1)(1991-7#2)(1991-9#2)(1992-1#1)(1992-11#6)(1992-12#7)(1992-2#1)(1992-3#1)(1992-4#5)(1992-5#3)(1992-6#2)(1992-8#6)(1992-9#2)(1993-11#4)(1993-12#3)(1993-2#4)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#6)(1993-9#1)(1994-11#4)(1994-12#5)(1994-2#3)(1994-3#3)(1994-5#2)(1994-6#5)(1994-8#3)(1994-9#3)(1995-1#2)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#5)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#5)(1995-8#3)(1995-9#3)(1996-1#1)(1996-10#5)(1996-11#3)(1996-12#2)(1996-2#3)(1996-3#4)(1996-5#2)(1996-6#1)(1996-9#3)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#4)(1997-5#2)(1997-6#1)(1997-7#4)(1997-8#3)(2003-11#1)(2004-12#1)(2004-4#3)(2005-10#1)(2005-11#1)(2006-10#3)(2006-11#3)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-8#2)(2006-9#2)(2007-1#5)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#5)(2007-8#5)(2007-9#1)(2008-1#5)(2008-10#37)(2008-11#11)(2008-12#5)(2008-3#4)(2008-4#7)(2008-5#11)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#3)(2009-10#4)(2009-12#5)(2009-4#3)(2009-6#2)(2009-9#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#4)(2011-1#5)(2011-12#2)(2011-2#12)(2012-1#5)(2012-12#6)(2012-2#8)(2012-3#3)(2013-1#14)(2013-7#3)(2013-8#12)
the lever##2##2##(1992-11#1)(1996-4#1)
the levocabastine##2##2##(1997-2#1)(2009-8#1)
the lexical system##2##3##(1991-2#2)
the lexical##7##2##(1991-2#2)(2008-4#1)(2008-7#1)(2009-11#1)(2009-7#1)(2010-2#1)
the lexicon##2##2##(2008-6#1)(2012-12#1)
the lf##2##2##(2008-4#2)
the liability##3##2##(1991-12#1)(1993-12#1)(1994-2#1)
the liaison##3##2##(1991-6#1)(1997-2#1)(2008-11#1)
the liberal use of##3##4##(2006-10#1)(2007-7#1)(2010-2#1)
the liberal##5##2##(2006-10#1)(2007-7#1)(2007-8#1)(2009-9#1)(2010-2#1)
the liberated##4##2##(1990-3#1)(1991-9#1)(2008-10#1)(2013-1#1)
the liberation of##11##3##(1990-4#1)(1990-8#1)(1995-1#1)(1995-11#1)(1995-6#1)(1997-6#1)(1997-7#1)(2007-1#1)(2008-10#2)(2010-7#1)
the librarian##7##2##(1991-3#2)(1992-12#1)(1992-2#1)(1994-2#1)(1994-3#1)(1995-1#1)
the librarian's role##3##3##(1991-3#2)(1992-1#1)
the librarian's##6##2##(1991-3#5)(1992-1#1)
the librarians##2##2##(1992-12#2)
the libraries##5##2##(1991-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-2#1)
the library for##2##3##(2008-4#1)(2008-9#1)
the library of##3##3##(1994-6#1)(1995-12#1)(1995-9#1)
the library to##2##3##(1996-3#2)
the library##31##2##(1990-2#1)(1990-4#1)(1993-1#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#2)(1995-12#1)(1995-3#3)(1995-9#1)(1996-3#2)(1996-7#2)(1997-4#2)(1997-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-3#1)(2010-5#1)(2013-1#1)
the library's##2##2##(1995-3#1)(1996-12#1)
the licensing##2##2##(1996-11#1)(2011-1#1)
the licensure##2##2##(2007-11#1)(2011-2#1)
the lichen Ramalina##3##3##(2008-10#1)(2008-11#2)
the lichen##6##2##(2004-4#1)(2008-10#2)(2008-11#2)(2008-5#1)
the lichenan##2##2##(1992-3#2)
the lichenoid##2##2##(2010-6#2)
the lichens##3##2##(2008-10#3)
the lid was##2##3##(1992-8#1)(1995-12#1)
the lid##8##2##(1992-8#2)(1995-12#2)(2006-11#2)(2009-6#1)(2012-1#1)
the lidar beam##3##3##(2008-3#3)
the lidar data##3##3##(2008-3#3)
the lidar equation##2##3##(2008-2#2)
the lidar measurements##3##3##(2008-2#3)
the lidar receiver##3##3##(2008-2#2)(2008-3#1)
the lidar return signal##3##4##(2008-2#2)(2008-3#1)
the lidar return##6##3##(2008-2#2)(2008-3#4)
the lidar signal power##2##4##(2008-3#2)
the lidar signal##4##3##(2008-2#2)(2008-3#2)
the lidar signals##4##3##(2008-2#1)(2008-3#3)
the lidar system##2##3##(2008-3#2)
the lidar##66##2##(1993-2#1)(2007-11#2)(2008-2#24)(2008-3#39)
the lidocaine##3##2##(2006-8#1)(2012-12#1)(2012-2#1)
the life and##6##3##(2005-8#1)(2007-11#2)(2008-10#1)(2008-4#1)(2009-5#1)
the life course##11##3##(2009-10#2)(2009-3#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-12#4)(2013-1#1)
the life cycle and##2##4##(2004-11#1)(2010-1#1)
the life cycle of the##5##5##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2009-3#1)
the life cycle of this##2##5##(2008-9#1)(2012-2#1)
the life cycle of##16##4##(1992-7#1)(1994-11#1)(1997-4#1)(1997-7#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-2#1)
the life cycle##31##3##(1992-7#1)(1994-11#1)(1995-2#1)(1997-4#1)(1997-7#1)(2004-11#3)(2006-12#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#6)(2008-12#1)(2008-2#1)(2008-4#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#2)(2010-1#1)(2012-2#1)
the life cycles of##3##4##(2008-10#2)(2012-2#1)
the life cycles##4##3##(2008-10#3)(2012-2#1)
the life expectancy of##2##4##(2008-10#1)(2012-12#1)
the life expectancy##5##3##(2008-10#1)(2008-2#1)(2008-7#1)(2009-9#1)(2012-12#1)
the life histories of##2##4##(2008-8#1)(2009-6#1)
the life history of the##4##5##(1995-6#1)(2008-11#2)(2008-8#1)
the life history of##6##4##(1995-6#1)(2008-11#2)(2008-8#1)(2009-10#1)(2013-7#1)
the life history##9##3##(1995-6#1)(2008-11#2)(2008-8#2)(2009-10#1)(2009-12#1)(2012-2#1)(2013-7#1)
the life insurance industry##2##4##(1995-1#1)(1995-12#1)
the life insurance##4##3##(1995-1#2)(1995-12#1)(1996-11#1)
the life of patients with##3##5##(2006-9#1)(2007-8#1)(2009-9#1)
the life of the mother##2##5##(1995-6#1)(2006-10#1)
the life of the##9##4##(1995-6#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-3#1)
the life of##30##3##(1995-5#1)(1995-6#1)(1996-11#1)(1997-7#1)(2005-11#2)(2006-10#2)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-6#1)(2008-7#3)(2008-9#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-7#1)(2010-8#1)(2012-3#2)(2013-1#1)(2013-8#1)
the life quality of the patients##3##6##(2008-8#1)(2013-8#2)
the life quality##4##3##(2007-9#1)(2008-8#1)(2013-8#2)
the life saving##2##3##(2007-10#1)(2008-2#1)
the life sciences##10##3##(2006-6#1)(2006-7#1)(2007-9#1)(2008-5#3)(2008-7#2)(2008-9#1)(2010-7#1)
the life span of High Fivetrade mark cells##2##8##(2008-7#2)
the life span of rats bearing##2##6##(1993-8#2)
the life span of the##3##5##(1991-12#1)(2008-10#1)(2008-7#1)
the life span of##15##4##(1991-12#1)(1992-5#1)(1993-11#1)(1993-8#2)(1996-3#1)(2004-11#1)(2008-10#1)(2008-7#4)(2010-4#1)(2012-11#1)(2012-2#1)
the life span##24##3##(1991-12#1)(1991-6#1)(1992-12#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-8#2)(1994-5#2)(1994-6#1)(1996-3#1)(2004-11#1)(2008-10#2)(2008-7#4)(2010-4#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-7#1)
the life style##4##3##(1990-12#1)(1992-11#1)(2008-11#1)(2008-7#1)
the life world##2##3##(2010-10#2)
the life##174##2##(1990-12#1)(1990-3#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-7#2)(1993-11#1)(1993-8#2)(1994-11#1)(1994-5#2)(1994-6#2)(1995-1#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-11#2)(1996-2#1)(1996-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(2004-11#4)(2005-11#2)(2005-8#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-6#2)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#6)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#13)(2008-8#6)(2008-9#5)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#4)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#4)
the life-course##4##2##(2008-12#1)(2008-6#1)(2008-7#1)(2012-3#1)
the life-cycle##2##2##(2007-12#1)(2008-7#1)
the life-history characteristics of##2##4##(2008-8#1)(2013-1#1)
the life-history traits of the##2##5##(2008-11#1)(2008-8#1)
the life-history traits of##3##4##(2008-11#1)(2008-8#1)(2010-3#1)
the life-history traits##4##3##(2008-11#1)(2008-8#2)(2010-3#1)
the life-history##9##2##(2008-11#1)(2008-8#4)(2009-9#1)(2010-3#1)(2010-8#1)(2013-1#1)
the life-span of##2##3##(1990-9#1)(1993-8#1)
the life-span##3##2##(1990-9#1)(1993-8#1)(2008-8#1)
the life-threatening complication of##2##4##(2006-10#2)
the life-threatening##3##2##(2006-10#2)(2011-2#1)
the lifecycle of a##2##4##(2008-10#1)(2010-5#1)
the lifecycle of##4##3##(2007-8#1)(2008-10#1)(2010-5#1)(2011-1#1)
the lifecycle##5##2##(2007-8#1)(2008-10#1)(2010-5#1)(2011-1#1)(2011-2#1)
the lifespan of the##5##4##(1996-11#2)(2004-1#1)(2010-4#1)(2013-1#1)
the lifespan##15##2##(1996-11#2)(2004-1#1)(2006-2#1)(2007-2#1)(2008-10#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-4#1)(2010-7#1)(2012-1#2)(2013-1#1)
the lifestyle of an##2##4##(1990-9#1)(2006-10#1)
the lifestyle of##3##3##(1990-9#1)(2006-10#1)(2007-4#1)
the lifestyle##6##2##(1990-9#1)(2006-10#1)(2007-10#1)(2007-4#1)(2009-9#1)(2013-8#1)
the lifetime accumulated cadmium intake from food##2##7##(1992-12#2)
the lifetime and##2##3##(1992-7#1)(2008-3#1)
the lifetime decreases from##2##4##(1995-1#1)(2009-9#1)
the lifetime is##2##3##(2008-10#2)
the lifetime of a##2##4##(1993-9#1)(2008-10#1)
the lifetime of the graphite tube##2##6##(2008-10#2)
the lifetime of the##15##4##(1993-1#1)(1995-1#2)(2005-12#1)(2006-12#1)(2008-10#4)(2008-5#1)(2008-7#1)(2009-6#1)(2010-2#2)(2013-8#1)
the lifetime of##27##3##(1992-5#1)(1992-6#1)(1993-1#1)(1993-9#1)(1994-5#1)(1995-1#2)(2005-12#1)(2005-4#1)(2006-12#1)(2007-12#2)(2008-10#5)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#2)(2013-8#1)
the lifetime prevalence of##3##4##(2006-8#1)(2011-1#1)(2012-2#1)
the lifetime prevalence##5##3##(2006-8#1)(2011-1#2)(2012-12#1)(2012-2#1)
the lifetime##55##2##(1992-12#2)(1992-5#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-9#1)(1994-5#1)(1995-1#3)(1995-11#1)(1995-5#1)(2005-12#1)(2005-4#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-2#1)(2008-1#1)(2008-10#11)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-9#2)(2010-12#1)(2010-2#2)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
the lifetimes of##3##3##(2005-11#1)(2007-11#1)(2008-1#1)
the lifting framework##2##3##(2008-2#2)
the lifting##4##2##(2008-2#3)(2008-6#1)
the ligament fibers##2##3##(2009-7#2)
the ligament of Treitz##5##4##(2006-8#1)(2008-6#1)(2009-6#1)(2010-5#1)(2013-1#1)
the ligament##18##2##(2005-7#1)(2006-3#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-5#2)(2007-8#1)(2008-6#2)(2009-6#1)(2009-7#3)(2010-5#1)(2012-1#1)(2013-1#2)
the ligamentous spine##3##3##(2006-11#2)(2007-4#1)
the ligamentous structures##2##3##(2005-7#1)(2007-4#1)
the ligamentous##7##2##(2005-7#1)(2006-11#2)(2006-8#1)(2007-4#3)
the ligaments and##2##3##(2007-7#1)(2008-8#1)
the ligaments##6##2##(2007-7#2)(2008-6#1)(2008-8#1)(2009-7#1)(2010-7#1)
the ligamentum##3##2##(1996-3#1)(2007-4#2)
the ligand and the##3##4##(1991-3#1)(2008-10#1)(2008-3#1)
the ligand and##10##3##(1991-3#1)(1995-1#1)(1995-5#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)
the ligand as##4##3##(2007-11#1)(2008-10#2)(2008-5#1)
the ligand binding domain##5##4##(1991-7#1)(1994-2#1)(1995-3#1)(1996-5#1)(2006-10#1)
the ligand binding kinetics##2##4##(1996-6#1)(2009-3#1)
the ligand binding of##3##4##(1994-3#1)(1995-5#1)(1996-10#1)
the ligand binding site of##3##5##(1994-12#3)
the ligand binding site##6##4##(1991-12#1)(1991-2#1)(1993-3#1)(1994-12#3)
the ligand binding##21##3##(1991-12#1)(1991-2#1)(1991-7#1)(1992-9#1)(1993-3#1)(1994-12#4)(1994-2#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-10#2)(1996-5#1)(1996-6#1)(1997-6#1)(2006-10#1)(2008-8#1)(2009-3#1)
the ligand concentration##4##3##(1992-8#1)(1997-2#1)(2008-10#2)
the ligand field##2##3##(1997-7#2)
the ligand for the##2##4##(1993-5#1)(2008-1#1)
the ligand for##4##3##(1990-5#1)(1992-3#1)(1993-5#1)(2008-1#1)
the ligand has been##2##4##(2008-10#2)
the ligand in##5##3##(1990-11#1)(1994-11#1)(1994-5#1)(2008-10#1)(2008-5#1)
the ligand is##14##3##(1994-11#1)(1995-11#1)(1996-11#1)(1996-6#1)(2008-10#2)(2008-4#5)(2008-7#1)(2010-2#1)(2010-5#1)
the ligand of##3##3##(1991-4#1)(1997-7#1)(2005-7#1)
the ligand specificity of##2##4##(1990-5#1)(1994-12#1)
the ligand structure##2##3##(1993-11#1)(2008-10#1)
the ligand to##7##3##(1990-12#1)(1994-11#1)(1994-9#1)(2008-10#1)(2010-2#1)(2010-5#2)
the ligand was##4##3##(1993-11#1)(1993-8#1)(1994-11#1)(2008-10#1)
the ligand with##3##3##(1995-2#1)(2008-8#1)(2010-5#1)
the ligand##154##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-3#3)(1992-8#2)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#7)(1994-12#5)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-5#2)(1995-8#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#3)(1997-1#3)(1997-2#7)(1997-4#1)(1997-6#1)(1997-7#5)(2005-7#1)(2006-10#3)(2006-6#1)(2007-11#3)(2007-3#3)(2008-1#1)(2008-10#26)(2008-3#2)(2008-4#10)(2008-5#7)(2008-7#1)(2008-8#3)(2009-12#1)(2009-3#2)(2010-12#1)(2010-2#2)(2010-5#5)
the ligand(s)##2##2##(1994-6#1)(1994-8#1)
the ligand-activated##2##2##(1996-8#1)(2006-12#1)
the ligand-binding domain of the##3##5##(1991-12#2)(1992-9#1)
the ligand-binding domain of##4##4##(1991-12#2)(1992-9#1)(2008-8#1)
the ligand-binding domain##11##3##(1991-12#2)(1992-9#1)(1995-10#1)(1995-8#1)(1997-7#1)(2006-11#1)(2008-4#1)(2008-8#3)
the ligand-binding##20##2##(1991-12#2)(1992-9#1)(1993-11#1)(1993-12#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#2)(1997-4#1)(1997-7#1)(2006-11#1)(2008-4#2)(2008-8#3)
the ligand-bound##2##2##(1991-7#1)(1993-6#1)
the ligand-dependent##2##2##(1995-8#1)(2013-1#1)
the ligand-embedded silica##2##3##(2008-10#2)
the ligand-receptor##3##2##(1994-9#1)(2007-3#1)(2011-1#1)
the liganded active site##2##4##(1992-6#2)
the liganded##6##2##(1992-6#4)(1992-8#2)
the ligands and the##4##4##(2008-10#2)(2008-5#2)
the ligands and their##2##4##(2008-3#1)(2008-5#1)
the ligands and##8##3##(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#3)
the ligands in##3##3##(1996-8#1)(2007-11#1)(2010-5#1)
the ligands of##3##3##(1995-2#1)(2008-3#1)(2008-4#1)
the ligands to##3##3##(1991-3#1)(1993-11#1)(2008-4#1)
the ligands##42##2##(1990-10#1)(1990-7#1)(1990-8#1)(1991-3#1)(1993-11#1)(1994-9#1)(1995-2#1)(1996-8#2)(1997-4#1)(1997-6#1)(2007-11#3)(2007-9#1)(2008-1#1)(2008-10#5)(2008-3#4)(2008-4#3)(2008-5#9)(2009-7#1)(2010-5#3)(2013-1#1)
the ligase-AMP##2##2##(1993-3#2)
the ligation of##9##3##(1990-7#1)(1993-3#1)(1995-8#1)(1996-5#1)(1997-1#1)(2008-2#1)(2008-4#1)(2011-3#1)(2013-1#1)
the ligation##13##2##(1990-7#1)(1990-8#1)(1991-2#1)(1993-3#1)(1994-12#1)(1995-8#1)(1996-5#1)(1997-1#1)(2007-8#1)(2008-2#1)(2008-4#1)(2011-3#1)(2013-1#1)
the ligature##2##2##(1992-3#1)(2012-12#1)
the light absorption coefficient##2##4##(2008-3#2)
the light absorption##3##3##(2008-3#3)
the light adaptation##2##3##(1995-1#1)(2006-8#1)
the light and dark phases##2##5##(1997-1#1)(2013-7#1)
the light and dark##5##4##(1991-10#1)(1997-1#1)(2008-10#1)(2009-10#1)(2013-7#1)
the light and electron microscope##2##5##(1995-12#1)(2008-7#1)
the light and electron##5##4##(1993-12#1)(1995-12#1)(2008-4#1)(2008-7#2)
the light and transmission electron##2##5##(2008-7#2)
the light and##20##3##(1991-10#1)(1993-12#1)(1994-3#1)(1994-6#1)(1995-12#2)(1997-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#4)(2009-10#1)(2009-8#1)(2013-1#1)(2013-7#1)
the light beam is##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
the light beam##9##3##(2007-12#3)(2007-3#1)(2008-2#3)(2008-3#2)
the light chain of##4##4##(1990-5#1)(1993-11#2)(1994-5#1)
the light chain phosphorylation##2##4##(1990-11#1)(1990-9#1)
the light chain##15##3##(1990-11#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-3#1)(1992-7#2)(1993-11#2)(1994-11#2)(1994-5#1)(1996-11#1)
the light chains are##2##4##(1993-9#2)
the light chains##5##3##(1990-6#2)(1993-9#2)(1997-5#1)
the light collected by##2##4##(2007-12#1)(2008-3#1)
the light distribution##3##3##(2008-2#1)(2008-3#2)
the light emission##4##3##(1990-8#1)(2008-10#3)
the light energy##3##3##(1991-7#1)(1994-11#1)(2013-1#1)
the light environment##3##3##(2007-3#3)
the light field at the##2##5##(2008-2#1)(2008-3#1)
the light field##9##3##(2007-12#2)(2008-2#1)(2008-3#6)
the light fluence rate##2##4##(2011-1#2)
the light fluence##3##3##(1992-6#1)(2011-1#2)
the light from a##2##4##(2007-11#1)(2008-3#1)
the light from the##2##4##(2007-12#1)(2008-2#1)
the light from##6##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)
the light has##2##3##(1997-6#1)(2008-3#1)
the light in the##3##4##(2007-12#2)(2008-3#1)
the light in##5##3##(2007-12#3)(2008-3#1)(2010-8#1)
the light incident##4##3##(2008-2#2)(2008-3#2)
the light intensities and##2##4##(2008-2#1)(2008-3#1)
the light intensities##3##3##(2008-2#1)(2008-3#1)(2012-3#1)
the light intensity necessary for##2##5##(2007-12#2)
the light intensity##6##3##(2006-2#1)(2007-12#3)(2008-2#1)(2008-3#1)
the light is##5##3##(2007-12#3)(2008-3#1)(2009-10#1)
the light microscope##6##3##(1995-7#2)(2008-4#3)(2008-9#1)
the light microscopic##2##3##(1995-11#1)(2008-8#1)
the light of a##6##4##(1992-9#1)(1993-11#1)(1993-3#1)(1994-3#1)(2008-10#1)(2011-1#1)
the light of current##5##4##(1993-7#1)(1995-6#1)(1996-7#1)(2008-7#1)(2010-8#1)
the light of data##4##4##(1990-9#1)(1991-11#1)(1993-10#1)(1995-12#1)
the light of our##5##4##(1991-4#1)(1993-3#1)(1994-11#1)(1994-9#1)(2008-7#1)
the light of the##40##4##(1990-12#2)(1990-3#2)(1990-5#1)(1990-8#1)(1993-3#2)(1993-9#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-11#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-12#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2010-7#1)(2011-2#1)(2012-2#2)
the light of these findings##2##5##(2005-11#1)(2008-7#1)
the light of these##7##4##(1990-12#1)(2005-11#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-10#1)(2011-1#1)
the light of this##4##4##(1995-11#1)(2006-3#1)(2007-12#1)(2011-1#1)
the light of##133##3##(1990-10#1)(1990-12#3)(1990-3#3)(1990-5#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-2#1)(1991-4#3)(1991-6#2)(1992-10#1)(1992-12#1)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#1)(1993-3#4)(1993-7#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-3#2)(1996-7#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#2)(2004-12#1)(2005-11#2)(2005-12#1)(2006-10#1)(2006-12#2)(2006-3#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#7)(2008-2#6)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-12#1)(2009-8#1)(2010-10#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#3)(2012-2#3)(2012-3#4)
the light output##2##3##(2008-2#1)(2008-3#1)
the light period##4##3##(1994-8#1)(1995-11#1)(1997-2#2)
the light phase##3##3##(1993-12#1)(1997-3#1)(2010-8#1)
the light propagating in the##2##5##(2007-11#1)(2007-12#1)
the light propagating##3##3##(2007-11#1)(2007-12#1)(2010-5#1)
the light pulse##2##3##(1994-2#1)(2008-2#1)
the light pulses##2##3##(2008-5#2)
the light reflected from a##2##5##(2007-12#1)(2008-3#1)
the light reflected##4##3##(2007-12#1)(2008-3#3)
the light response##2##3##(1993-7#1)(1995-1#1)
the light sarcoplasmic reticulum##3##4##(1994-2#3)
the light scattered by the##3##5##(2007-12#1)(2008-3#2)
the light scattered by##4##4##(2007-11#1)(2007-12#1)(2008-3#2)
the light scattered from##3##4##(2006-2#1)(2008-2#1)(2008-3#1)
the light scattered##7##3##(2006-2#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
the light scattering intensity##3##4##(2008-10#2)(2008-3#1)
the light scattering##7##3##(1994-3#1)(2008-10#5)(2008-3#1)
the light source and the##5##5##(2007-12#2)(2008-10#3)
the light source and##7##4##(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#1)
the light source are##3##4##(2008-2#1)(2008-3#2)
the light source in##2##4##(2008-3#2)
the light source is##4##4##(2007-11#1)(2007-12#1)(2007-9#1)(2008-2#1)
the light source to##3##4##(2007-12#1)(2008-2#2)
the light source##55##3##(1993-3#1)(2007-11#3)(2007-12#8)(2007-9#2)(2008-10#6)(2008-12#1)(2008-2#13)(2008-3#19)(2008-5#1)(2010-5#1)
the light that##3##3##(2007-12#1)(2008-3#2)
the light transduction##2##3##(1992-3#1)(1992-8#1)
the light transmitted##2##3##(2008-2#1)(2008-3#1)
the light used##4##3##(2007-12#1)(2008-1#1)(2008-3#1)(2009-5#1)
the light utilization efficiency of##2##5##(2013-8#2)
the light was##2##3##(2008-3#2)
the light wave##2##3##(2008-2#1)(2008-3#1)
the light##466##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#3)(1990-5#2)(1990-6#4)(1990-8#2)(1990-9#3)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#3)(1991-6#2)(1991-7#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#2)(1992-8#3)(1992-9#4)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#4)(1993-3#5)(1993-4#1)(1993-6#1)(1993-7#2)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#4)(1994-12#1)(1994-2#4)(1994-3#5)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#4)(1995-12#4)(1995-3#1)(1995-6#2)(1995-7#2)(1995-8#1)(1996-11#2)(1996-12#1)(1996-3#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#4)(1997-7#2)(2004-12#1)(2004-4#1)(2005-11#3)(2005-12#1)(2005-4#1)(2006-10#1)(2006-12#2)(2006-2#3)(2006-3#1)(2006-5#1)(2006-8#3)(2006-9#1)(2007-11#11)(2007-12#38)(2007-2#1)(2007-3#6)(2007-7#4)(2007-8#1)(2007-9#4)(2008-1#3)(2008-10#35)(2008-11#9)(2008-12#1)(2008-2#55)(2008-3#69)(2008-4#4)(2008-5#9)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#5)(2009-10#6)(2009-12#1)(2009-5#1)(2009-6#4)(2009-8#3)(2010-10#1)(2010-5#2)(2010-7#1)(2010-8#5)(2011-1#5)(2011-2#3)(2012-2#5)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#4)
the light-curing units##2##3##(2008-12#1)(2013-8#1)
the light-curing##3##2##(2008-12#1)(2008-5#1)(2013-8#1)
the light-dark cycle##4##3##(1992-3#1)(1994-6#1)(2007-9#1)(2008-1#1)
the light-dark##9##2##(1990-6#1)(1991-9#1)(1992-10#1)(1992-3#2)(1994-6#1)(2007-9#1)(2008-1#1)(2008-11#1)
the light-dependent##3##2##(1991-9#1)(1995-1#1)(1995-6#1)
the light-harvesting chlorophyll##2##3##(1995-2#1)(2008-4#1)
the light-harvesting##9##2##(1993-3#1)(1994-5#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-4#1)(2010-4#2)(2012-6#1)
the light-induced##5##2##(1995-1#3)(1995-2#1)(2006-12#1)
the light-scattering data##2##3##(2008-3#2)
the light-scattering intensity##2##3##(2005-11#1)(2008-10#1)
the light-scattering pattern##2##3##(2008-2#2)
the light-scattering properties of##4##4##(2007-11#2)(2008-2#1)(2008-3#1)
the light-scattering##16##2##(2005-11#2)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#5)
the light-sensitive channel##2##3##(1994-10#2)
the light-wave##2##2##(2008-2#1)(2008-3#1)
the light-weight lever##2##3##(1990-10#2)
the light/dark transition test##2##4##(2008-8#2)
the light/dark transition##3##3##(1991-11#1)(2008-8#2)
the light/dark##7##2##(1991-11#1)(1993-3#1)(1993-9#1)(1994-6#1)(1995-6#1)(2008-8#2)
the lighter##2##2##(2008-10#1)(2008-12#1)
the lightest##2##2##(1996-5#1)(2005-7#1)
the lightly anesthetized rat##2##4##(1991-3#2)
the lightly pentobarbital-anesthetized##2##3##(1990-7#1)(1992-7#1)
the lightly##5##2##(1990-7#1)(1991-3#2)(1992-7#1)(1996-12#1)
the lignan##3##2##(1990-9#1)(1993-12#1)(2009-10#1)
the lignin##4##2##(1993-4#1)(2005-11#1)(2008-10#1)(2008-6#1)
the lignin-degrading##2##2##(1994-11#1)(1994-12#1)
the ligninolytic##2##2##(2006-3#1)(2011-1#1)
the likelihood for##3##3##(2007-12#2)(2008-8#1)
the likelihood function##3##3##(1992-2#1)(2008-12#1)(2012-1#1)
the likelihood of a re-infarction##2##5##(2009-6#2)
the likelihood of a##6##4##(1993-8#1)(2008-3#1)(2009-5#1)(2009-6#2)(2011-2#1)
the likelihood of adverse events##2##5##(1996-9#1)(2010-12#1)
the likelihood of adverse fetal outcome##2##6##(2007-4#2)
the likelihood of adverse##4##4##(1996-9#1)(2007-4#2)(2010-12#1)
the likelihood of an adverse##2##5##(2009-6#1)(2010-2#1)
the likelihood of an##4##4##(2009-6#1)(2009-8#1)(2010-2#1)(2013-7#1)
the likelihood of being##2##4##(2010-10#1)(2011-2#1)
the likelihood of detecting##2##4##(2008-8#1)(2009-8#1)
the likelihood of having##3##4##(1992-2#1)(2010-10#1)(2010-12#1)
the likelihood of success##2##4##(2006-2#1)(2008-5#1)
the likelihood of successful non-surgical management##2##6##(2011-2#2)
the likelihood of successful##4##4##(2006-9#1)(2008-9#1)(2011-2#2)
the likelihood of the##4##4##(1991-12#1)(2008-1#1)(2008-2#1)(2012-2#1)
the likelihood of their##2##4##(1995-12#1)(2008-9#1)
the likelihood of these##2##4##(2008-8#1)(2010-10#1)
the likelihood of##115##3##(1991-12#1)(1991-2#2)(1992-12#2)(1992-2#2)(1993-11#1)(1993-8#1)(1993-9#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-9#1)(1997-3#2)(1997-8#1)(2004-12#2)(2005-11#1)(2006-10#5)(2006-2#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-9#1)(2007-2#1)(2007-4#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#2)(2008-7#4)(2008-8#7)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-6#4)(2009-7#2)(2009-8#3)(2010-10#3)(2010-12#3)(2010-2#2)(2010-3#3)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#6)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
the likelihood ratio##8##3##(1995-4#1)(1996-12#1)(1996-4#1)(2008-10#3)(2008-12#1)(2008-3#1)
the likelihood surface##2##3##(2008-2#2)
the likelihood that an##2##4##(1993-9#1)(2009-12#1)
the likelihood that the##2##4##(2008-4#1)(2012-12#1)
the likelihood that they will##2##5##(2006-10#1)(2008-9#1)
the likelihood that##19##3##(1993-9#1)(2005-6#1)(2006-10#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-7#1)(2010-10#1)(2010-2#1)(2011-12#1)(2012-12#1)(2013-7#2)
the likelihood##169##2##(1991-12#1)(1991-2#2)(1992-12#2)(1992-2#3)(1993-11#1)(1993-8#1)(1993-9#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-4#1)(1996-12#1)(1996-4#2)(1996-9#1)(1997-2#1)(1997-3#3)(1997-8#1)(2004-12#2)(2005-11#1)(2005-6#1)(2006-10#6)(2006-2#1)(2006-5#1)(2006-6#2)(2006-7#2)(2006-9#1)(2007-12#2)(2007-2#1)(2007-4#3)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#3)(2008-2#9)(2008-3#5)(2008-4#6)(2008-5#2)(2008-7#5)(2008-8#10)(2008-9#5)(2009-10#1)(2009-12#2)(2009-2#1)(2009-5#2)(2009-6#4)(2009-7#3)(2009-8#3)(2010-10#4)(2010-12#3)(2010-2#3)(2010-3#4)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#3)(2013-8#1)
the likelihood-generating function##2##3##(2008-3#2)
the likely cause of##2##4##(1991-12#1)(2008-10#1)
the likely impact of##4##4##(1992-12#1)(1993-1#1)(1996-2#1)(2006-5#1)
the likely time##2##3##(2012-12#1)(2013-7#1)
the likely##41##2##(1991-12#3)(1991-8#1)(1991-9#1)(1992-12#1)(1993-1#1)(1993-11#1)(1996-1#2)(1996-2#1)(1997-6#1)(1997-8#1)(2006-3#1)(2006-5#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#3)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#3)(2013-7#1)
the likewise##2##2##(1991-9#1)(2011-2#1)
the limb and##3##3##(1990-8#1)(1995-8#1)(2007-11#1)
the limb bud##10##3##(1992-8#1)(1993-12#2)(1995-8#3)(2003-11#1)(2006-11#3)
the limb in##2##3##(1993-9#1)(2007-12#1)
the limb is##4##3##(1992-9#1)(2006-11#1)(2007-8#2)
the limb was##3##3##(1994-3#1)(2007-8#1)(2011-3#1)
the limb##60##2##(1990-11#2)(1990-6#2)(1990-8#2)(1991-1#2)(1991-3#1)(1991-9#1)(1992-8#2)(1992-9#1)(1993-12#3)(1993-7#1)(1993-9#2)(1994-3#2)(1995-8#6)(1996-3#2)(2003-11#1)(2006-11#5)(2006-4#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-7#2)(2007-8#7)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-3#2)
the limbal region##3##3##(2008-1#1)(2008-11#1)(2009-8#1)
the limbal vessels##2##3##(2005-11#2)
the limbal##7##2##(2005-11#2)(2008-1#1)(2008-11#1)(2009-8#1)(2012-12#2)
the limbic structures##2##3##(1990-4#1)(1996-5#1)
the limbic system##10##3##(1992-12#4)(1992-8#2)(1997-2#1)(2006-2#1)(2008-6#1)(2011-1#1)
the limbic##19##2##(1990-4#1)(1991-11#1)(1992-12#4)(1992-8#2)(1993-11#1)(1996-10#1)(1996-12#1)(1996-5#1)(1997-2#1)(2006-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-2#1)(2011-1#1)
the limbs##11##2##(1992-6#1)(1996-6#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-3#1)(2010-6#1)(2010-9#1)
the limbus and##2##3##(2007-3#1)(2012-12#1)
the limbus##7##2##(2007-3#1)(2008-11#2)(2011-1#1)(2012-12#3)
the limit imposed##2##3##(2007-12#1)(2008-3#1)
the limit of detection (LOD)##3##5##(1997-3#1)(2008-10#2)
the limit of detection and##3##5##(1992-10#1)(2008-10#2)
the limit of detection for##4##5##(1997-8#1)(2008-10#3)
the limit of detection is 0##4##6##(2008-10#4)
the limit of detection is##7##5##(2008-10#5)(2011-1#1)(2013-1#1)
the limit of detection of##5##5##(2008-10#2)(2008-4#1)(2009-6#1)(2011-2#1)
the limit of detection was 0##3##6##(2008-10#3)
the limit of detection was##11##5##(2007-11#1)(2008-10#9)(2010-4#1)
the limit of detection##52##4##(1992-10#1)(1997-3#1)(1997-8#1)(2007-11#2)(2008-10#37)(2008-4#1)(2009-6#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-8#1)(2013-1#1)(2013-8#1)
the limit of determination##2##4##(2008-10#2)
the limit of quantification in##2##5##(2007-11#1)(2008-10#1)
the limit of quantification was##4##5##(1992-2#1)(2005-12#1)(2008-10#1)(2008-5#1)
the limit of quantification##19##4##(1992-2#1)(1997-8#1)(2005-12#1)(2007-11#1)(2008-10#8)(2008-5#3)(2009-4#1)(2010-2#1)(2012-12#2)
the limit of quantitation##5##4##(1997-3#3)(2008-10#1)(2010-3#1)
the limit of the##3##4##(2007-11#2)(2013-8#1)
the limit of##106##3##(1992-10#1)(1992-2#1)(1995-3#1)(1996-5#1)(1997-3#4)(1997-8#2)(2005-11#3)(2005-12#1)(2006-6#1)(2006-7#1)(2007-11#6)(2007-12#6)(2007-8#1)(2007-9#1)(2008-10#50)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2009-4#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-8#1)(2013-1#1)(2013-8#2)
the limit values##2##3##(2006-11#1)(2013-1#1)
the limit##121##2##(1992-10#1)(1992-2#1)(1993-9#1)(1995-3#1)(1996-5#1)(1996-6#1)(1997-3#4)(1997-8#2)(2005-11#3)(2005-12#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-7#1)(2007-11#6)(2007-12#7)(2007-8#2)(2007-9#1)(2008-10#50)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-8#1)(2013-1#2)(2013-8#4)
the limitation of the##5##4##(1991-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-5#1)
the limitation of using##2##4##(2008-10#1)(2011-1#1)
the limitation of##17##3##(1991-3#1)(1993-10#1)(2005-11#1)(2006-10#2)(2007-11#1)(2007-4#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2010-5#1)(2011-1#1)(2011-2#1)
the limitation##19##2##(1991-3#1)(1993-10#1)(2005-11#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-5#1)(2010-5#1)(2011-1#1)(2011-2#1)
the limitations and##7##3##(1993-11#1)(2005-10#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-7#1)
the limitations associated with##2##4##(2007-6#1)(2008-10#1)
the limitations imposed by##2##4##(2006-12#1)(2010-10#1)
the limitations of a##2##4##(1991-2#1)(2005-2#1)
the limitations of any##2##4##(2007-11#1)(2012-3#1)
the limitations of conventional##4##4##(1996-3#1)(2008-3#1)(2010-11#2)
the limitations of earlier##2##4##(2005-7#1)(2006-5#1)
the limitations of existing##2##4##(2008-10#1)(2008-6#1)
the limitations of our##5##4##(1995-3#1)(2012-3#2)(2013-1#2)
the limitations of the##16##4##(1991-2#1)(1992-3#1)(1992-4#1)(1993-9#1)(1994-2#1)(2006-10#1)(2006-6#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-3#1)(2011-2#1)(2012-11#1)
the limitations of their##2##4##(2008-1#1)(2008-11#1)
the limitations of these##2##4##(2008-2#1)(2008-4#1)
the limitations of this approach##3##5##(2005-12#1)(2008-3#1)(2012-12#1)
the limitations of this study##4##5##(2008-8#1)(2012-2#1)(2013-1#2)
the limitations of this##11##4##(2005-12#1)(2007-1#1)(2008-3#1)(2008-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
the limitations of using##3##4##(2006-2#1)(2008-10#1)(2008-2#1)
the limitations of##83##3##(1990-5#1)(1991-2#2)(1992-3#1)(1992-4#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-3#1)(2004-10#1)(2005-12#1)(2005-2#1)(2005-7#1)(2006-10#3)(2006-2#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-11#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#5)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#5)(2013-7#1)
the limitations##108##2##(1990-11#1)(1990-5#1)(1991-2#2)(1992-3#1)(1992-4#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-3#1)(1996-3#1)(1997-2#1)(2004-10#1)(2005-10#1)(2005-12#1)(2005-2#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-1#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#2)(2007-6#2)(2007-8#1)(2008-1#4)(2008-10#10)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#7)(2013-7#1)
the limited ability##2##3##(1995-12#1)(2009-6#1)
the limited amount of##4##4##(1994-5#1)(1995-2#1)(2009-5#1)(2013-1#1)
the limited availability of human##2##5##(2007-4#1)(2012-12#1)
the limited availability of##5##4##(1991-3#1)(1992-5#1)(2007-4#1)(2011-2#1)(2012-12#1)
the limited availability##6##3##(1991-3#1)(1992-5#1)(1994-12#1)(2007-4#1)(2011-2#1)(2012-12#1)
the limited capacity##2##3##(1993-12#1)(2011-1#1)
the limited data available##2##4##(2012-12#1)(2012-2#1)
the limited data##4##3##(1995-6#1)(1997-2#1)(2012-12#1)(2012-2#1)
the limited information available##2##4##(2006-11#1)(2007-11#1)
the limited information on##2##4##(1992-11#1)(2013-1#1)
the limited information##5##3##(1992-11#1)(1994-12#1)(2006-11#1)(2007-11#1)(2013-1#1)
the limited literature##2##3##(2007-2#1)(2011-2#1)
the limited number of studies##2##5##(2008-10#1)(2011-2#1)
the limited number of##13##4##(1996-3#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)
the limited number##14##3##(1996-3#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
the limited pool of##2##4##(1993-9#1)(2011-2#1)
the limited possibility of##2##4##(2008-11#2)
the limited published data##2##4##(2007-11#1)(2008-11#1)
the limited published##3##3##(2007-11#1)(2008-11#1)(2010-10#1)
the limited resources##3##3##(1996-2#1)(2007-7#1)(2008-10#1)
the limited stability of##2##4##(2005-11#1)(2008-10#1)
the limited success##2##3##(1991-9#1)(2012-1#1)
the limited therapeutic##2##3##(1992-3#1)(2011-2#1)
the limited view##2##3##(2006-12#1)(2009-10#1)
the limited volume##2##3##(2006-11#1)(2008-7#1)
the limited##120##2##(1990-10#1)(1990-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#1)(1993-12#1)(1993-9#1)(1994-12#3)(1994-5#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#2)(1996-2#2)(1996-3#1)(1997-2#1)(1997-7#1)(2004-4#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#8)(2008-11#6)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#2)(2009-3#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#3)(2013-1#4)(2013-7#1)
the limited-fan-out##2##2##(2008-2#2)
the limiting current##3##3##(2005-11#3)
the limiting factor for##2##4##(2008-10#2)
the limiting factor##4##3##(1996-12#1)(2008-10#3)
the limiting factors##2##3##(2008-3#1)(2008-5#1)
the limiting membrane of##2##4##(2007-9#1)(2013-1#1)
the limiting step of##2##4##(2008-10#1)(2008-3#1)
the limiting step##4##3##(1993-6#1)(1994-11#1)(2008-10#1)(2008-3#1)
the limiting##36##2##(1990-11#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-12#1)(1996-11#1)(1996-12#1)(1997-1#1)(2005-11#4)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#5)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#2)
the limitless##2##2##(2009-5#1)(2010-12#1)
the limits and##5##3##(2008-2#2)(2008-3#1)(2008-9#1)(2009-7#1)
the limits for##2##3##(2007-10#1)(2008-10#1)
the limits imposed by the##2##5##(2007-9#1)(2008-3#1)
the limits of Indian Standards##2##5##(2007-10#2)
the limits of adaptive##2##4##(1996-9#1)(2008-8#1)
the limits of detection (LOD)##3##5##(2008-10#3)
the limits of detection (LODs)##2##5##(2008-10#1)(2012-12#1)
the limits of detection and##3##5##(2008-10#3)
the limits of detection for##3##5##(1997-1#1)(2008-10#2)
the limits of detection of##2##5##(1997-3#1)(2008-10#1)
the limits of detection were##6##5##(2008-10#5)(2008-2#1)
the limits of detection##29##4##(1996-11#1)(1997-1#1)(1997-3#1)(2008-10#20)(2008-2#2)(2008-4#1)(2010-5#1)(2012-12#2)
the limits of medical##2##4##(1996-2#1)(2006-8#1)
the limits of quantification were 0##2##6##(2008-10#2)
the limits of quantification##3##4##(2008-10#2)(2011-1#1)
the limits of the experimental##2##5##(2008-10#1)(2008-3#1)
the limits of the##10##4##(1990-4#1)(1994-5#1)(1995-5#1)(1995-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#1)(2011-2#1)(2012-3#1)
the limits of##75##3##(1990-4#1)(1991-6#1)(1993-3#1)(1994-5#1)(1995-5#2)(1995-8#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#3)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#25)(2008-11#1)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-12#3)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
the limits##89##2##(1990-4#1)(1991-6#1)(1993-3#1)(1993-7#1)(1994-5#1)(1995-5#2)(1995-8#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#4)(2007-12#1)(2007-9#2)(2008-1#1)(2008-10#27)(2008-11#1)(2008-2#8)(2008-3#5)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-12#3)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
the line and##4##3##(1997-2#1)(2007-12#1)(2008-2#2)
the line in##2##3##(1991-12#1)(1995-8#1)
the line jitter of##2##4##(2008-3#2)
the line jitter##3##3##(2008-3#3)
the line of sight is##2##5##(2008-2#1)(2008-3#1)
the line of sight of##2##5##(2008-2#1)(2008-3#1)
the line of sight##8##4##(2008-2#4)(2008-3#3)(2008-6#1)
the line of##17##3##(1992-3#1)(1993-5#1)(2007-10#1)(2007-11#1)(2008-2#5)(2008-3#5)(2008-6#1)(2009-4#1)(2009-5#1)
the line shape of##2##4##(2008-2#2)
the line shape##3##3##(2008-2#3)
the line strength of##2##4##(2008-3#2)
the line strength##5##3##(2008-3#5)
the line was##2##3##(1995-8#1)(2008-10#1)
the line with a##2##4##(2006-12#2)
the line with##3##3##(2006-12#3)
the line##77##2##(1990-10#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-3#1)(1992-9#1)(1993-5#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-2#1)(1997-2#1)(1997-4#1)(2006-12#4)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#3)(2008-2#13)(2008-3#22)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
the line-by-line radiances##2##3##(2008-3#2)
the line-by-line##3##2##(2008-3#3)
the lineage leading to##2##4##(1995-11#1)(2010-4#1)
the lineage of##5##3##(1995-3#1)(2007-2#1)(2007-6#1)(2012-2#1)(2013-7#1)
the lineage##13##2##(1995-11#1)(1995-3#1)(1995-8#1)(2007-2#1)(2007-6#1)(2008-11#1)(2008-8#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-7#2)
the lineages##6##2##(1991-9#1)(2008-10#2)(2008-9#1)(2009-2#2)
the linear DNA molecule to##2##5##(1990-8#1)(1997-5#1)
the linear absorption##3##3##(2007-11#1)(2007-12#1)(2009-2#1)
the linear and the##2##4##(2007-11#1)(2008-2#1)
the linear and##7##3##(1995-11#1)(1996-9#1)(2005-11#1)(2006-6#1)(2007-11#1)(2008-2#2)
the linear calibration range##2##4##(2008-10#2)
the linear calibration##4##3##(2008-10#4)
the linear case##2##3##(1994-6#1)(2008-2#1)
the linear combination of the##3##5##(2007-12#1)(2008-10#1)(2012-12#1)
the linear combination of##4##4##(2007-12#1)(2008-10#1)(2012-12#1)(2013-1#1)
the linear combination##5##3##(2006-10#1)(2007-12#1)(2008-10#1)(2012-12#1)(2013-1#1)
the linear concentration range of##3##5##(2008-10#2)(2010-4#1)
the linear concentration range##4##4##(2008-10#3)(2010-4#1)
the linear correlation##2##3##(1997-3#1)(2008-3#1)
the linear determination ranges##2##4##(2008-10#2)
the linear diffusion##2##3##(1994-8#2)
the linear discriminant##2##3##(2007-11#1)(2010-2#1)
the linear dynamic range of##3##5##(2008-10#3)
the linear dynamic range was##2##5##(2008-10#2)
the linear dynamic range##10##4##(2007-8#1)(2008-10#9)
the linear dynamic##11##3##(2007-8#1)(2008-10#10)
the linear electro-optic effect##2##4##(2007-12#1)(2008-2#1)
the linear equation##2##3##(1990-5#1)(2008-10#1)
the linear isotherm approach##2##4##(2008-10#2)
the linear model##3##3##(1992-6#2)(2008-10#1)
the linear no-threshold##2##3##(2013-1#2)
the linear phase##2##3##(2008-2#1)(2008-8#1)
the linear polarization of the##3##5##(2008-2#2)(2008-3#1)
the linear polarization of##4##4##(2008-2#3)(2008-3#1)
the linear polarization##7##3##(2008-2#6)(2008-3#1)
the linear portion##4##3##(1995-1#1)(2008-10#3)
the linear quadratic model##2##4##(1995-9#1)(2007-11#1)
the linear quadratic##3##3##(1994-4#1)(1995-9#1)(2007-11#1)
the linear range and##3##4##(1996-6#1)(2008-10#2)
the linear range for##2##4##(2008-10#2)
the linear range from##2##4##(2008-10#1)(2012-12#1)
the linear range is##5##4##(2008-10#5)
the linear range of the##2##5##(2008-10#2)
the linear range of##6##4##(2008-10#6)
the linear range up to##2##5##(2007-8#1)(2008-10#1)
the linear range was from##2##5##(2008-10#2)
the linear range was##6##4##(2008-10#5)(2010-5#1)
the linear range##40##3##(1992-8#1)(1993-12#1)(1996-6#1)(2005-12#1)(2007-8#1)(2008-10#32)(2008-2#1)(2010-5#1)(2012-12#1)
the linear ranges of the calibration curves were 0##2##9##(2008-10#2)
the linear ranges of##4##4##(2008-10#3)(2011-1#1)
the linear ranges##5##3##(2008-10#4)(2011-1#1)
the linear refractive index of the##2##6##(2007-12#1)(2008-2#1)
the linear regression equation##2##4##(2008-10#1)(2008-7#1)
the linear regression methods##2##4##(2008-10#2)
the linear regression##11##3##(1990-11#1)(1997-2#1)(2008-10#4)(2008-3#1)(2008-7#1)(2010-5#1)(2013-7#1)(2013-8#1)
the linear relationship between the##5##5##(2008-10#5)
the linear relationship between##9##4##(1997-6#1)(2008-10#7)(2010-5#1)
the linear relationship##10##3##(1997-6#1)(2008-10#8)(2010-5#1)
the linear relaxation modulus##2##4##(2007-1#2)
the linear response range##2##4##(2008-10#2)
the linear response##7##3##(2007-12#1)(2008-10#5)(2012-1#1)
the linear strain##2##3##(2008-10#2)
the linear transformation##2##3##(2008-3#1)(2008-6#1)
the linear viscoelastic##2##3##(2007-1#1)(2008-5#1)
the linear##239##2##(1990-11#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-5#3)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#1)(1994-12#3)(1994-2#1)(1994-4#1)(1994-6#1)(1994-7#1)(1994-8#2)(1995-1#2)(1995-11#3)(1995-6#1)(1995-9#1)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#2)(2005-11#2)(2005-12#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-4#1)(2006-6#2)(2006-8#1)(2007-1#3)(2007-11#7)(2007-12#7)(2007-2#1)(2007-6#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#89)(2008-11#1)(2008-2#18)(2008-3#16)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#2)(2009-12#1)(2009-2#1)(2009-3#1)(2010-1#1)(2010-2#4)(2010-4#1)(2010-5#3)(2011-1#2)(2011-12#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#3)
the linear-no threshold theory##3##4##(2008-7#3)
the linear-no threshold##4##3##(2008-7#4)
the linearity and##2##3##(1997-2#1)(2008-2#1)
the linearity is maintained in the concentration##4##7##(2008-10#4)
the linearity of the##6##4##(1992-7#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
the linearity of##8##3##(1992-7#2)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)
the linearity range is##2##4##(2008-10#2)
the linearity range##5##3##(2008-10#4)(2011-1#1)
the linearity was##2##3##(2008-10#2)
the linearity##26##2##(1992-7#2)(1997-2#1)(2005-11#1)(2007-12#1)(2008-10#14)(2008-12#1)(2008-2#3)(2008-3#1)(2011-1#1)(2013-1#1)
the linearization of the##2##4##(2005-11#1)(2008-3#1)
the linearization##3##2##(2005-11#1)(2008-2#1)(2008-3#1)
the linearized##3##2##(1993-7#2)(2008-2#1)
the linearly polarized##3##3##(2006-12#1)(2007-12#1)(2008-2#1)
the linearly transformed##2##3##(2005-11#1)(2008-6#1)
the linearly##7##2##(2005-11#1)(2006-12#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-7#1)
the lined seahorse##5##3##(2010-8#1)(2012-12#4)
the lines homozygous for the##2##5##(2008-10#2)
the lines of the##5##4##(2006-2#1)(2008-2#1)(2008-3#3)
the lines of##14##3##(2006-2#1)(2007-8#2)(2008-2#2)(2008-3#5)(2008-9#1)(2011-1#1)(2012-3#2)
the lines##35##2##(1992-3#1)(1993-11#1)(1993-7#1)(2004-5#2)(2006-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-2#3)(2008-3#8)(2008-8#1)(2008-9#2)(2010-8#2)(2011-1#2)(2012-3#2)
the linewidth of a##4##4##(2007-12#1)(2008-2#3)
the linewidth of the##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
the linewidth of##11##3##(2007-12#4)(2008-2#6)(2008-3#1)
the linewidth##19##2##(2007-12#7)(2008-2#8)(2008-3#4)
the linewidths##2##2##(2007-12#2)
the lingual##5##2##(1991-8#1)(2007-2#1)(2010-3#1)(2012-2#2)
the linguistic and##3##3##(2010-5#2)(2013-8#1)
the linguistic##10##2##(1994-6#1)(2006-2#1)(2007-9#1)(2010-2#1)(2010-5#4)(2012-1#1)(2013-8#1)
the lining of the##2##4##(2006-5#1)(2008-10#1)
the lining of##3##3##(2006-5#1)(2008-10#1)(2010-9#1)
the lining##6##2##(2005-11#1)(2006-5#1)(2007-9#1)(2008-10#1)(2008-5#1)(2010-9#1)
the link between alcohol abuse##2##5##(2007-7#2)
the link between low##2##4##(1997-3#1)(2008-1#1)
the link between maternal##2##4##(2009-7#1)(2012-2#1)
the link between obesity and##2##5##(2007-1#1)(2013-8#1)
the link between obesity##3##4##(2007-1#1)(2013-1#1)(2013-8#1)
the link between personality and##2##5##(2009-12#1)(2012-12#1)
the link between the##9##4##(1990-11#1)(1992-1#1)(1995-1#1)(1995-2#1)(2008-11#2)(2008-4#2)(2008-6#1)
the link between these##4##4##(2005-11#1)(2007-8#1)(2008-10#1)(2012-2#1)
the link between##66##3##(1990-11#1)(1990-6#1)(1992-1#1)(1993-9#1)(1994-5#1)(1995-1#1)(1995-2#1)(1996-11#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#4)(2008-4#2)(2008-5#1)(2008-6#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-2#1)(2010-4#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#5)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#3)
the link of##2##3##(2012-2#2)
the link to##5##3##(2008-10#1)(2008-2#1)(2009-4#1)(2013-1#2)
the link with##3##3##(1990-3#1)(2007-11#1)(2008-10#1)
the link##89##2##(1990-11#1)(1990-3#1)(1990-6#1)(1991-3#1)(1992-1#1)(1993-9#1)(1994-5#1)(1995-1#1)(1995-2#1)(1996-11#1)(1997-2#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#7)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#5)(2012-2#5)(2013-1#7)(2013-7#1)(2013-8#3)
the linkage analyses##2##3##(2012-3#2)
the linkage and exchange model##2##5##(2009-4#2)
the linkage and##3##3##(1997-4#1)(2009-4#2)
the linkage between the##5##4##(1990-8#1)(1993-12#2)(1993-6#1)(1995-1#1)
the linkage between##12##3##(1990-8#1)(1991-12#1)(1993-12#2)(1993-6#1)(1994-12#1)(1995-1#1)(2008-8#1)(2010-11#1)(2010-2#1)(2011-1#1)(2012-3#1)
the linkage disequilibrium##2##3##(2012-3#2)
the linkage map##10##3##(1996-12#4)(1996-6#2)(1997-4#3)(2008-8#1)
the linkage of##6##3##(1990-5#1)(1991-7#2)(2008-10#1)(2011-2#1)(2012-2#1)
the linkage region##2##3##(1990-5#1)(2012-3#1)
the linkage relationships between##2##4##(1995-8#1)(2008-10#1)
the linkage##53##2##(1990-2#2)(1990-5#2)(1990-8#3)(1991-12#1)(1991-7#2)(1993-12#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-12#4)(1996-6#2)(1997-4#4)(1997-5#1)(2008-10#3)(2008-4#1)(2008-8#2)(2009-4#2)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#9)
the linkages between##6##3##(1994-1#1)(1997-2#1)(2005-11#1)(2008-10#1)(2008-2#1)(2009-12#1)
the linkages##9##2##(1990-12#1)(1994-1#1)(1997-2#1)(2005-11#1)(2008-10#1)(2008-2#1)(2009-12#1)(2009-2#1)(2010-11#1)
the linked##4##2##(1994-6#1)(2008-10#2)(2008-8#1)
the linker between the##3##4##(1997-4#2)(2010-5#1)
the linker region of##4##4##(1994-8#1)(1995-10#3)
the linker region##5##3##(1994-8#1)(1995-10#3)(1995-8#1)
the linker##19##2##(1992-6#1)(1993-5#1)(1994-6#1)(1994-8#1)(1995-10#3)(1995-8#3)(1996-7#1)(1997-1#1)(1997-4#2)(2006-12#1)(2009-6#1)(2010-5#1)(2012-12#2)
the linking of##4##3##(2005-9#1)(2008-10#1)(2008-5#1)(2008-6#1)
the linking##7##2##(1996-8#1)(2005-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)
the links between##12##3##(1992-12#2)(1992-4#1)(1995-9#1)(2008-11#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-12#1)(2010-5#1)(2011-1#1)(2013-1#1)
the links##18##2##(1992-12#2)(1992-4#1)(1994-11#1)(1995-9#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
the lion's share of##2##4##(2008-1#1)(2011-12#1)
the lip##11##2##(1991-11#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-6#1)(2009-10#1)(2010-3#1)(2011-2#2)(2012-12#2)
the lipase activity##2##3##(2008-10#2)
the lipase gene##3##3##(1996-5#1)(2006-8#2)
the lipase inhibitor##2##3##(2005-11#1)(2011-1#1)
the lipase##14##2##(1994-3#1)(1995-5#1)(1996-5#1)(1996-7#1)(1996-9#1)(2005-11#1)(2006-8#2)(2008-10#2)(2008-7#1)(2009-8#1)(2011-1#1)(2012-2#1)
the lipid A##5##3##(1990-5#1)(1992-5#2)(1994-12#1)(2011-2#1)
the lipid abnormalities##2##3##(1990-2#1)(1991-12#1)
the lipid anchor##2##3##(1993-3#2)
the lipid and protein##2##4##(2009-8#1)(2012-12#1)
the lipid and##6##3##(2008-3#2)(2009-7#1)(2009-8#1)(2010-4#1)(2012-12#1)
the lipid bilayer and##6##4##(1990-11#1)(1990-4#1)(1991-2#1)(1994-8#1)(1996-9#1)(1997-1#1)
the lipid bilayer membrane##2##4##(2006-10#1)(2009-5#1)
the lipid bilayer of##2##4##(1990-11#1)(1997-1#1)
the lipid bilayer##30##3##(1990-11#3)(1990-2#1)(1990-3#1)(1990-4#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-6#1)(1992-9#1)(1994-2#2)(1994-5#2)(1994-8#1)(1995-11#1)(1996-9#1)(1997-1#3)(2006-10#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-12#1)
the lipid bilayers of##3##4##(1994-8#2)(2008-5#1)
the lipid bilayers##7##3##(1994-8#2)(1996-1#1)(1996-5#1)(2008-5#1)(2009-2#1)(2010-5#1)
the lipid classes##2##3##(2008-11#1)(2013-1#1)
the lipid components##3##3##(1992-9#1)(2006-11#1)(2008-5#1)
the lipid composition of the membrane##2##6##(1994-2#1)(1996-1#1)
the lipid composition of##7##4##(1990-7#2)(1991-9#1)(1993-11#1)(1994-2#1)(1994-6#1)(1996-1#1)
the lipid composition##11##3##(1990-7#2)(1991-9#1)(1992-12#1)(1993-11#1)(1994-2#1)(1994-6#1)(1995-5#1)(1996-1#1)(2008-5#1)(2010-5#1)
the lipid content##3##3##(1997-2#1)(2013-1#1)(2013-7#1)
the lipid core and##2##4##(1990-2#1)(2010-9#1)
the lipid core##5##3##(1990-2#1)(1994-3#1)(1994-9#1)(2007-10#1)(2010-9#1)
the lipid coverage##2##3##(2008-5#2)
the lipid effects of estrogens##2##5##(1993-6#2)
the lipid effects of##3##4##(1993-6#3)
the lipid fluidity of##2##4##(1991-5#1)(1992-11#1)
the lipid has been##2##4##(1992-7#1)(1993-9#1)
the lipid has##3##3##(1990-5#1)(1992-7#1)(1993-9#1)
the lipid head group##2##4##(1990-2#1)(2008-10#1)
the lipid headgroups##2##3##(1990-7#1)(1992-7#1)
the lipid is##2##3##(1990-3#1)(1993-3#1)
the lipid kinase##3##3##(1994-3#1)(1996-2#1)(1996-8#1)
the lipid levels##3##3##(1991-4#1)(2011-11#1)(2011-2#1)
the lipid membrane##9##3##(1990-2#1)(1990-7#1)(1994-5#3)(2005-11#2)(2008-10#1)(2009-12#1)
the lipid metabolism##8##3##(1990-2#1)(1992-11#1)(1994-3#1)(1995-6#1)(1997-7#1)(2008-11#1)(2010-3#1)(2013-1#1)
the lipid mixture##2##3##(1990-3#1)(2006-10#1)
the lipid moiety is##2##4##(1993-8#1)(2008-4#1)
the lipid monolayer##2##3##(1994-3#1)(2009-12#1)
the lipid order##2##3##(2006-10#2)
the lipid packing##2##3##(1994-11#1)(1995-8#1)
the lipid peroxidation and nitrite##2##5##(2010-7#1)(2010-8#1)
the lipid peroxidation induced in the##2##6##(1996-2#1)(1997-8#1)
the lipid peroxidation level##3##4##(1991-9#1)(2008-10#1)(2010-8#1)
the lipid peroxidation of##2##4##(1991-5#1)(2008-5#1)
the lipid peroxidation##19##3##(1991-5#1)(1991-9#1)(1994-11#1)(1996-2#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-5#3)(2010-7#1)(2010-8#2)(2012-11#1)(2013-8#1)
the lipid phase of##3##4##(1991-2#1)(1991-5#1)(2005-8#1)
the lipid phase transition##2##4##(1991-9#1)(1994-3#1)
the lipid phase##11##3##(1990-2#1)(1990-3#1)(1991-2#1)(1991-5#2)(1991-9#1)(1994-3#1)(1994-5#1)(1996-1#1)(2005-8#1)(2012-1#1)
the lipid profile of##2##4##(2006-10#1)(2011-11#1)
the lipid profile##7##3##(1991-2#1)(1993-12#1)(2006-10#1)(2008-4#1)(2011-11#1)(2012-2#2)
the lipid profiles of##2##4##(1991-4#1)(2008-1#1)
the lipid profiles##4##3##(1991-4#1)(2008-1#1)(2008-8#1)(2013-8#1)
the lipid structure of##2##4##(1997-1#2)
the lipid structure##3##3##(1997-1#3)
the lipid surface##2##3##(1994-3#1)(1995-5#1)
the lipid vesicles to##2##4##(2008-11#2)
the lipid vesicles##3##3##(1996-7#1)(2008-11#2)
the lipid##260##2##(1990-11#5)(1990-2#9)(1990-3#4)(1990-4#3)(1990-5#4)(1990-7#4)(1991-12#2)(1991-2#5)(1991-3#1)(1991-4#3)(1991-5#8)(1991-7#1)(1991-9#4)(1992-1#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-5#2)(1992-6#3)(1992-7#2)(1992-9#3)(1993-11#1)(1993-12#1)(1993-3#4)(1993-4#1)(1993-6#4)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#5)(1994-3#9)(1994-5#7)(1994-6#1)(1994-8#4)(1994-9#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#4)(1995-6#1)(1995-8#2)(1996-1#5)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#7)(1997-2#1)(1997-7#1)(1997-8#1)(2005-11#3)(2005-8#2)(2006-10#8)(2006-11#1)(2006-12#2)(2006-6#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#6)(2008-3#4)(2008-4#3)(2008-5#13)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#3)(2009-2#2)(2009-5#1)(2009-7#3)(2009-8#7)(2010-1#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#4)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-11#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#5)(2013-1#4)(2013-7#1)(2013-8#2)
the lipid-##2##2##(1990-2#1)(1994-9#1)
the lipid-associated##2##2##(1992-6#1)(2006-10#1)
the lipid-soluble##2##2##(1991-7#1)(2006-10#1)
the lipid/PVC/DOPP membrane##2##3##(1996-8#2)
the lipidic##4##2##(1990-5#1)(1991-1#1)(1994-3#1)(2007-8#1)
the lipidized membranes##2##3##(1995-2#2)
the lipids are##2##3##(1993-9#1)(2006-10#1)
the lipids in the##2##4##(1992-9#1)(1995-1#1)
the lipids of##3##3##(1991-8#1)(1995-6#1)(1996-1#1)
the lipids##29##2##(1990-2#2)(1991-5#1)(1991-8#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-6#3)(1996-1#1)(1996-5#2)(1996-8#1)(2006-10#1)(2006-9#1)(2007-2#1)(2008-10#1)(2008-5#4)(2008-9#1)(2012-12#1)(2013-1#1)
the lipoamide##2##2##(1996-12#1)(1997-5#1)
the lipodystrophy syndrome##2##3##(2006-10#1)(2008-3#1)
the lipodystrophy##4##2##(2006-10#1)(2007-8#1)(2008-3#1)(2012-12#1)
the lipogenic##2##2##(1994-8#1)(2008-5#1)
the lipoic acid##3##3##(2010-2#3)
the lipolytic response##3##3##(1990-8#1)(1994-6#2)
the lipolytic##5##2##(1990-8#1)(1991-12#1)(1994-6#2)(2012-1#1)
the lipoma##2##2##(1993-9#1)(2012-2#1)
the lipomas##2##2##(2012-12#1)(2012-2#1)
the lipopeptide##5##2##(1990-3#1)(1991-12#1)(1997-2#1)(2011-1#2)
the lipophilic cationic##2##3##(1993-11#1)(2008-10#1)
the lipophilic##32##2##(1990-11#1)(1992-5#1)(1992-9#1)(1993-11#2)(1993-6#1)(1994-11#2)(1996-1#1)(1996-8#1)(2004-12#1)(2006-12#2)(2007-11#1)(2008-10#8)(2008-12#1)(2008-5#5)(2009-2#1)(2009-3#1)(2010-2#1)(2012-12#1)
the lipophilicity of##3##3##(1995-3#1)(2006-12#1)(2010-5#1)
the lipophilicity##5##2##(1995-3#1)(2005-10#1)(2006-12#1)(2007-11#1)(2010-5#1)
the lipopolysaccharide of##3##3##(1991-7#1)(1996-2#1)(2008-10#1)
the lipopolysaccharide##9##2##(1990-2#1)(1991-7#1)(1992-12#1)(1995-12#1)(1996-2#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-3#1)
the lipopolysaccharide-induced##2##2##(1995-12#1)(1997-5#1)
the lipoprotein##16##2##(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-3#1)(1995-3#2)(1996-4#2)(1996-5#1)(2005-8#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-4#1)(2012-2#1)
the lipoproteins were##2##3##(1993-11#1)(1996-5#1)
the lipoproteins##10##2##(1990-8#1)(1991-2#1)(1992-3#1)(1992-5#1)(1993-11#1)(1995-5#1)(1995-8#1)(1996-5#1)(2008-4#1)(2008-5#1)
the liposomal membrane##3##3##(1990-12#1)(1990-2#1)(1994-2#1)
the liposomal surface##3##3##(2008-10#3)
the liposomal vaccine than##3##4##(2007-11#3)
the liposomal vaccine##4##3##(2007-11#4)
the liposomal##15##2##(1990-12#1)(1990-2#1)(1994-2#2)(1996-1#3)(2007-11#4)(2008-10#4)
the liposome membrane##2##3##(1990-11#1)(2008-9#1)
the liposome surface##4##3##(1990-5#2)(2008-10#2)
the liposome##17##2##(1990-11#4)(1990-5#2)(1992-6#1)(1994-12#1)(1994-5#2)(1994-9#1)(1995-5#3)(2008-10#2)(2008-9#1)
the liposomes but##2##3##(1994-11#1)(2010-5#1)
the liposomes##22##2##(1990-2#1)(1990-3#1)(1990-4#1)(1991-5#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-8#1)(1995-2#1)(1996-1#3)(2006-10#1)(2008-5#2)(2008-8#2)(2010-5#3)
the lipoxygenase##4##2##(1990-10#1)(1990-7#1)(1991-7#1)(2008-4#1)
the lipoyl domains of the##2##5##(1996-5#2)
the lipoyl##3##2##(1994-5#1)(1996-5#2)
the lipoylation of##2##3##(1996-5#2)
the lipoylation rate##2##3##(1996-5#2)
the lipoylation site##3##3##(1996-5#3)
the lipoylation##8##2##(1996-5#8)
the liquid and##2##3##(2005-11#1)(2010-8#1)
the liquid chromatographic determination of##2##5##(2007-8#1)(2008-10#1)
the liquid chromatography##4##3##(1996-8#1)(2008-10#3)
the liquid core##2##3##(1994-2#1)(2010-8#1)
the liquid crystal phase##2##4##(1992-1#1)(2006-10#1)
the liquid crystal##11##3##(1992-1#1)(1993-7#1)(1996-1#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-5#1)
the liquid crystalline phase of##2##5##(1992-9#1)(2008-5#1)
the liquid crystalline phase##4##4##(1990-3#1)(1992-9#2)(2008-5#1)
the liquid crystalline phases##2##4##(2005-11#1)(2008-5#1)
the liquid crystalline##10##3##(1990-3#1)(1992-9#2)(2005-11#3)(2007-12#1)(2008-5#2)(2008-7#1)
the liquid flow##3##3##(2005-11#2)(2008-10#1)
the liquid in the##2##4##(2005-11#1)(2010-4#1)
the liquid is##3##3##(1997-6#1)(2010-4#1)(2011-2#1)
the liquid junction potential##2##4##(2008-10#2)
the liquid junction##3##3##(2008-10#3)
the liquid membrane and the##2##5##(2008-10#2)
the liquid membrane and##3##4##(2008-10#2)(2011-1#1)
the liquid membrane##5##3##(2008-10#4)(2011-1#1)
the liquid phase of##2##4##(2007-8#1)(2013-1#1)
the liquid phase using##3##4##(2008-10#2)(2008-4#1)
the liquid phase was##2##4##(2008-10#2)
the liquid phase##12##3##(1991-5#1)(2005-11#2)(2007-12#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-5#1)(2013-1#1)
the liquid propanol##2##3##(2008-3#2)
the liquid sample is##2##4##(2008-10#1)(2008-2#1)
the liquid sample##9##3##(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#1)
the liquid soap and##2##4##(2008-10#2)
the liquid stream##2##3##(2008-10#1)(2008-6#1)
the liquid surface##2##3##(2008-2#1)(2008-3#1)
the liquid to##3##3##(2008-11#1)(2008-3#1)(2010-4#1)
the liquid was##3##3##(2004-9#2)(2008-2#1)
the liquid##137##2##(1990-12#1)(1990-3#1)(1991-5#1)(1992-1#2)(1992-5#2)(1992-6#2)(1992-9#2)(1993-7#1)(1994-2#1)(1995-3#1)(1996-1#1)(1996-8#1)(1997-6#1)(2004-9#2)(2005-11#23)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#2)(2007-12#7)(2007-8#2)(2008-10#34)(2008-11#2)(2008-2#9)(2008-3#9)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2009-10#1)(2009-9#1)(2010-4#7)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
the liquid-air interface of##2##4##(2008-10#2)
the liquid-core##2##2##(2008-10#2)
the liquid-crystal cell##2##3##(2007-11#1)(2007-12#1)
the liquid-crystal layer##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
the liquid-crystal molecules##2##3##(2007-11#1)(2008-3#1)
the liquid-crystal##11##2##(1990-2#1)(2007-11#4)(2007-12#1)(2008-2#2)(2008-3#3)
the liquid-crystalline phase##3##3##(1990-2#1)(1990-7#1)(1996-4#1)
the liquid-crystalline##7##2##(1990-2#1)(1990-3#1)(1990-7#1)(1991-2#1)(1991-4#1)(1996-4#1)(1996-7#1)
the liquid-gas##2##2##(2008-10#1)(2008-3#1)
the liquid-like##2##2##(2006-6#1)(2012-2#1)
the liquid-liquid extraction of##3##4##(2008-10#3)
the liquid-liquid extraction##8##3##(2008-10#6)(2008-5#1)(2012-12#1)
the liquid-liquid##11##2##(2005-11#1)(2008-10#8)(2008-5#1)(2012-12#1)
the liquid-phase##2##2##(2008-10#1)(2008-2#1)
the liquid-solid interface##3##3##(2006-12#1)(2006-4#1)(2006-6#1)
the liquid-solid##6##2##(2006-12#1)(2006-4#1)(2006-6#1)(2008-3#1)(2008-5#1)(2009-8#1)
the liquid-vapor interface##2##3##(2005-11#2)
the liquid/liquid##5##2##(2008-10#2)(2010-5#3)
the liquids##4##2##(1990-3#1)(2005-11#2)(2008-10#1)
the list of potential##2##4##(2006-10#1)(2013-1#1)
the list of the##2##4##(1993-8#1)(2008-2#1)
the list of##36##3##(1991-9#1)(1993-10#1)(1993-8#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-8#1)(1997-3#3)(2006-10#4)(2006-8#1)(2007-10#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-1#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
the list##45##2##(1991-11#3)(1991-9#1)(1993-10#1)(1993-8#1)(1994-6#1)(1995-12#1)(1995-6#1)(1995-7#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-3#3)(1997-5#1)(2006-10#4)(2006-8#1)(2007-10#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2009-1#1)(2009-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
the list-length and strength-based mirror effects##2##6##(2008-6#2)
the listed##3##2##(1997-3#1)(2008-10#1)(2008-5#1)
the listener##2##2##(1997-5#1)(2008-11#1)
the literal##3##2##(2008-11#1)(2008-2#2)
the literary and iconographical##2##4##(2009-2#2)
the literary##3##2##(2008-7#1)(2009-2#2)
the literature about##9##3##(1990-8#1)(1994-8#1)(1995-11#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-8#1)(2010-7#1)(2011-12#1)
the literature addressing##2##3##(1993-2#1)(2010-4#1)
the literature analyzed##2##3##(2012-3#1)(2013-8#1)
the literature and current##2##4##(2007-2#1)(2008-4#1)
the literature and discuss##7##4##(2004-7#1)(2005-10#2)(2007-10#1)(2007-6#1)(2008-1#1)(2008-11#1)
the literature and is##2##4##(1993-12#1)(2006-3#1)
the literature and of##2##4##(1993-11#1)(1994-6#1)
the literature and on##2##4##(1990-3#1)(2006-2#1)
the literature and our##3##4##(2008-2#1)(2009-5#1)(2011-2#1)
the literature and own experience##2##5##(2007-11#2)
the literature and present##3##4##(2005-11#1)(2005-8#1)(2013-1#1)
the literature and research##2##4##(1997-2#1)(2008-9#1)
the literature and suggest##2##4##(2008-9#1)(2012-12#1)
the literature and the authors' own##2##6##(1992-8#1)(2007-11#1)
the literature and the authors'##3##5##(1990-10#1)(1992-8#1)(2007-11#1)
the literature and the##7##4##(1990-10#1)(1992-8#1)(1994-8#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-5#1)
the literature and their##3##4##(2007-11#1)(2008-8#1)(2012-12#1)
the literature and this##2##4##(2006-10#1)(2009-10#1)
the literature and##102##3##(1990-10#1)(1990-12#1)(1990-3#1)(1991-1#1)(1991-3#1)(1991-4#1)(1992-1#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-3#1)(1996-6#1)(1997-2#1)(2004-4#1)(2004-7#1)(2005-10#2)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-2#3)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#2)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#3)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#4)(2009-10#2)(2009-4#1)(2009-5#1)(2010-12#1)(2010-9#2)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#4)
the literature are discussed##2##4##(2008-6#1)(2010-7#1)
the literature are provided##2##4##(2007-11#1)(2008-10#1)
the literature are##18##3##(1992-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1996-7#1)(2006-12#1)(2006-6#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-7#1)(2011-2#1)
the literature as a##7##4##(2006-3#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-7#1)(2013-1#2)
the literature as well as##6##5##(1996-12#1)(2007-2#1)(2008-1#1)(2008-2#1)(2008-3#1)(2009-8#1)
the literature as##19##3##(1996-12#1)(2006-3#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-1#2)
the literature assessing##2##3##(2007-11#1)(2009-5#1)
the literature available##2##3##(2008-10#1)(2008-11#1)
the literature before##2##3##(2010-12#1)(2012-12#1)
the literature between##2##3##(1995-11#1)(2008-4#1)
the literature but##4##3##(1990-3#1)(2006-1#1)(2008-2#1)(2011-2#1)
the literature by##3##3##(2007-10#1)(2008-2#1)(2012-3#1)
the literature concerning the##5##4##(1990-12#1)(1996-8#1)(1996-9#1)(2010-9#1)(2011-2#1)
the literature concerning this##2##4##(2007-9#1)(2008-7#1)
the literature concerning##16##3##(1990-12#1)(1996-3#1)(1996-8#1)(1996-9#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-9#1)(2011-2#3)
the literature data##4##3##(1991-2#1)(2008-10#1)(2008-7#1)(2010-4#1)
the literature demonstrating the##2##4##(1997-3#1)(2010-12#1)
the literature demonstrating##3##3##(1997-3#1)(2010-12#1)(2012-3#1)
the literature describing##6##3##(1997-6#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-3#1)(2009-10#1)
the literature does not##2##4##(2007-5#1)(2008-4#1)
the literature examining##2##3##(2006-12#1)(2013-1#1)
the literature focusing on##2##4##(2006-2#1)(2009-8#1)
the literature for each##2##4##(2008-10#1)(2008-3#1)
the literature for the##3##4##(1992-12#1)(2008-10#1)(2008-11#1)
the literature for##21##3##(1991-3#2)(1992-12#1)(1992-9#1)(1994-9#1)(2005-11#1)(2006-11#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#2)(2011-12#1)(2011-2#1)(2013-1#2)
the literature from##11##3##(1996-2#1)(2006-9#1)(2007-2#1)(2007-5#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)
the literature has been##2##4##(1992-1#1)(2006-12#1)
the literature has not##2##4##(1994-6#1)(2010-8#1)
the literature has##11##3##(1992-1#1)(1994-6#1)(1996-4#1)(2006-12#1)(2007-1#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-9#1)(2010-8#1)
the literature in order to##3##5##(2007-6#1)(2008-10#1)(2008-11#1)
the literature in the##6##4##(1991-3#1)(1995-12#1)(2006-10#1)(2009-10#1)(2012-1#1)(2012-12#1)
the literature in this area##3##5##(2009-3#1)(2010-8#1)(2012-12#1)
the literature in##22##3##(1991-3#1)(1995-12#1)(1995-2#1)(2005-11#1)(2006-10#3)(2007-6#1)(2008-10#2)(2008-11#2)(2009-10#1)(2009-3#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#2)
the literature includes##2##3##(2007-3#1)(2012-2#1)
the literature is also##2##4##(2006-1#1)(2006-12#1)
the literature is given##3##4##(1991-3#1)(1996-9#1)(2008-3#1)
the literature is replete with##2##5##(2007-7#1)(2010-11#1)
the literature is##31##3##(1990-3#1)(1991-3#1)(1995-9#1)(1996-9#1)(1997-8#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-3#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-11#1)(2010-12#2)(2011-1#2)(2011-2#2)
the literature of primary##2##4##(1992-10#1)(2008-6#1)
the literature of the last##2##5##(2006-10#1)(2008-7#1)
the literature of the##6##4##(2006-10#2)(2008-6#1)(2008-7#2)(2009-8#1)
the literature of##32##3##(1992-10#1)(1993-12#1)(1993-2#1)(1996-8#1)(1997-2#1)(1997-4#1)(2006-10#3)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-6#3)(2008-7#3)(2008-9#2)(2009-10#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-7#1)(2012-3#2)(2013-8#1)
the literature on health##2##4##(1993-6#1)(2011-2#1)
the literature on organizational##2##4##(1990-12#1)(2011-2#1)
the literature on spinal##3##4##(2006-2#1)(2009-3#1)(2011-2#1)
the literature on the clinical##2##5##(2008-9#1)(2012-2#1)
the literature on the effects of##4##6##(1992-12#1)(1993-11#1)(2008-7#1)(2010-2#1)
the literature on the effects##5##5##(1992-12#1)(1993-11#1)(1996-3#1)(2008-7#1)(2010-2#1)
the literature on the possible##2##5##(2007-4#1)(2013-8#1)
the literature on the subject and##2##6##(1993-10#1)(2007-6#1)
the literature on the subject##5##5##(1990-5#1)(1992-8#1)(1993-10#1)(2007-6#1)(2009-1#1)
the literature on the topic##3##5##(1991-10#1)(1991-9#1)(2009-6#1)
the literature on the treatment of##2##6##(1992-1#1)(2011-2#1)
the literature on the use of##3##6##(2013-1#3)
the literature on the##43##4##(1990-5#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-6#1)(1994-1#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-8#1)(1997-2#1)(2006-11#1)(2007-11#1)(2007-4#1)(2007-6#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-6#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-2#2)(2013-1#5)(2013-8#1)
the literature on this subject##4##5##(1991-10#1)(1994-9#1)(2006-2#1)(2008-5#1)
the literature on this topic is##2##6##(1992-4#1)(2008-10#1)
the literature on this topic##5##5##(1992-10#1)(1992-4#1)(1993-6#1)(2008-10#1)(2008-11#1)
the literature on this##14##4##(1990-2#1)(1991-10#1)(1992-10#1)(1992-4#1)(1993-6#1)(1994-9#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-8#1)(2013-1#1)
the literature on##126##3##(1990-12#1)(1990-2#1)(1990-5#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-6#3)(1993-9#1)(1994-1#1)(1994-9#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-8#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-11#2)(2006-12#2)(2006-2#3)(2006-3#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#4)(2007-12#1)(2007-3#1)(2007-4#2)(2007-6#7)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#2)(2008-2#3)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-1#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#8)(2012-1#2)(2012-12#1)(2012-2#5)(2013-1#7)(2013-8#1)
the literature or##2##3##(1994-9#1)(2007-3#1)
the literature over the##2##4##(2007-12#1)(2012-12#1)
the literature over##4##3##(2005-9#1)(2007-12#1)(2009-3#1)(2012-12#1)
the literature provides##3##3##(2008-8#1)(2011-2#1)(2013-1#1)
the literature published from##3##4##(2008-12#1)(2009-8#2)
the literature published##8##3##(2007-11#1)(2008-12#1)(2009-4#1)(2009-8#2)(2010-4#1)(2010-8#1)(2012-3#1)
the literature regarding the##4##4##(2008-3#1)(2009-5#1)(2010-2#1)(2012-2#1)
the literature regarding##18##3##(2007-10#1)(2008-3#2)(2008-5#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-2#5)(2013-1#3)(2013-8#1)
the literature related to the##4##5##(2006-10#1)(2007-10#1)(2009-1#1)(2010-2#1)
the literature related to##8##4##(2006-10#1)(2007-10#1)(2007-3#1)(2008-12#1)(2009-1#1)(2010-2#1)(2011-1#1)(2011-2#1)
the literature relating to the##2##5##(2004-4#1)(2005-7#1)
the literature relating to##6##4##(1997-7#1)(2004-4#1)(2005-7#1)(2005-8#1)(2007-8#1)(2010-12#1)
the literature relating##7##3##(1997-7#1)(2004-4#1)(2005-7#1)(2005-8#1)(2007-8#1)(2007-9#1)(2010-12#1)
the literature reveal##2##3##(1990-6#1)(1993-3#1)
the literature revealed that##4##4##(1990-2#1)(1992-12#1)(2004-12#1)(2009-7#1)
the literature revealed##9##3##(1990-2#1)(1992-12#1)(1995-1#1)(2004-12#1)(2006-10#1)(2006-11#1)(2008-12#1)(2008-3#1)(2009-7#1)
the literature reveals##3##3##(2006-10#1)(2006-9#1)(2007-2#1)
the literature review##11##3##(2006-10#1)(2007-10#1)(2007-11#1)(2008-11#3)(2008-4#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
the literature reviewed##4##3##(1993-2#1)(2006-8#1)(2008-7#1)(2012-1#1)
the literature shows that##8##4##(1990-8#1)(2005-10#1)(2008-10#1)(2008-5#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-3#1)
the literature shows##12##3##(1990-6#1)(1990-8#1)(2005-10#1)(2006-10#1)(2008-10#1)(2008-5#1)(2010-3#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)
the literature since##3##3##(2006-10#1)(2008-10#1)(2013-8#1)
the literature suggest##2##3##(1990-6#1)(2009-2#1)
the literature suggests that##5##4##(2006-9#1)(2008-11#2)(2009-3#1)(2013-1#1)
the literature suggests##6##3##(1992-2#1)(2006-9#1)(2008-11#2)(2009-3#1)(2013-1#1)
the literature surrounding the##2##4##(2007-4#1)(2011-2#1)
the literature surrounding##3##3##(2007-4#1)(2008-6#1)(2011-2#1)
the literature that has##2##4##(2012-2#2)
the literature that##15##3##(1992-12#1)(1995-1#1)(2006-10#2)(2006-6#1)(2008-11#1)(2008-3#1)(2009-3#1)(2010-1#1)(2010-3#1)(2012-12#2)(2012-2#3)
the literature the##3##3##(1993-10#1)(2005-2#1)(2008-5#1)
the literature there is##3##4##(2006-12#1)(2007-7#1)(2010-7#1)
the literature there##4##3##(1996-12#1)(2006-12#1)(2007-7#1)(2010-7#1)
the literature through##3##3##(1994-2#1)(2010-9#1)(2012-3#1)
the literature to date##5##4##(1993-4#1)(2005-9#1)(2008-10#1)(2008-11#1)(2013-1#1)
the literature to find##2##4##(1994-2#1)(2006-10#1)
the literature to identify##2##4##(2011-2#2)
the literature to##25##3##(1993-4#1)(1994-2#1)(1997-7#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#2)(2011-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
the literature up to##2##4##(2006-10#1)(2006-12#1)
the literature values reported##2##4##(2008-10#1)(2012-12#1)
the literature values##4##3##(2008-10#3)(2012-12#1)
the literature was reviewed##2##4##(2007-2#1)(2008-6#1)
the literature was##12##3##(1995-5#1)(2006-2#1)(2007-2#1)(2007-6#1)(2008-6#1)(2008-7#1)(2009-5#1)(2012-12#2)(2012-2#1)(2013-1#2)
the literature we##3##3##(1991-4#1)(2007-5#1)(2008-6#1)
the literature where##5##3##(2005-12#1)(2008-3#1)(2008-7#1)(2009-7#1)(2012-1#1)
the literature with particular##2##4##(2007-4#1)(2012-2#1)
the literature with##15##3##(1992-12#1)(1992-4#1)(2006-8#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-3#1)(2010-10#1)(2012-2#1)(2013-1#3)
the literature##1505##2##(1990-10#2)(1990-12#9)(1990-2#4)(1990-3#7)(1990-5#3)(1990-6#8)(1990-8#3)(1990-9#3)(1991-1#3)(1991-10#5)(1991-11#2)(1991-12#7)(1991-2#4)(1991-3#5)(1991-4#4)(1991-5#2)(1991-6#3)(1991-8#1)(1991-9#3)(1992-1#4)(1992-10#4)(1992-11#1)(1992-12#9)(1992-2#3)(1992-4#2)(1992-5#3)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#5)(1993-1#4)(1993-10#4)(1993-11#4)(1993-12#6)(1993-2#5)(1993-3#4)(1993-4#1)(1993-5#4)(1993-6#3)(1993-8#2)(1993-9#3)(1994-1#3)(1994-10#2)(1994-11#3)(1994-2#3)(1994-3#4)(1994-6#9)(1994-7#1)(1994-8#4)(1994-9#4)(1995-1#5)(1995-11#6)(1995-12#2)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#2)(1996-11#3)(1996-12#7)(1996-2#4)(1996-3#9)(1996-4#1)(1996-6#5)(1996-7#1)(1996-8#4)(1996-9#4)(1997-1#1)(1997-2#6)(1997-3#6)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#3)(1997-8#4)(2004-10#2)(2004-12#1)(2004-4#3)(2004-7#1)(2005-1#1)(2005-10#7)(2005-11#9)(2005-12#10)(2005-2#1)(2005-5#1)(2005-7#1)(2005-8#5)(2005-9#5)(2006-1#2)(2006-10#43)(2006-11#13)(2006-12#29)(2006-2#12)(2006-3#3)(2006-4#3)(2006-5#4)(2006-6#7)(2006-7#4)(2006-8#12)(2006-9#7)(2007-1#7)(2007-10#10)(2007-11#32)(2007-12#17)(2007-2#22)(2007-3#16)(2007-4#16)(2007-5#9)(2007-6#22)(2007-7#17)(2007-8#37)(2007-9#7)(2008-1#17)(2008-10#70)(2008-11#47)(2008-12#19)(2008-2#35)(2008-3#33)(2008-4#19)(2008-5#22)(2008-6#34)(2008-7#41)(2008-8#18)(2008-9#26)(2009-1#2)(2009-10#8)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#14)(2009-4#11)(2009-5#12)(2009-6#6)(2009-7#8)(2009-8#6)(2009-9#7)(2010-1#4)(2010-10#4)(2010-11#3)(2010-12#16)(2010-2#11)(2010-3#14)(2010-4#4)(2010-5#2)(2010-6#2)(2010-7#8)(2010-8#8)(2010-9#6)(2011-1#19)(2011-12#3)(2011-2#55)(2011-3#2)(2012-1#12)(2012-12#33)(2012-2#45)(2012-3#20)(2013-1#79)(2013-7#7)(2013-8#13)
the literature)##3##2##(1997-1#1)(2008-2#1)(2008-3#1)
the literatures##6##2##(1996-6#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-8#1)(2011-2#1)
the lithiasis##2##2##(1992-3#1)(2011-2#1)
the lithium ions##2##3##(2008-10#2)
the lithium##17##2##(1991-8#3)(1992-2#2)(1997-7#1)(2008-10#8)(2008-2#2)(2010-5#1)
the lithography##2##2##(2008-10#1)(2008-2#1)
the litigation process##2##3##(1992-2#2)
the litter##8##2##(1994-8#1)(1996-3#1)(2008-11#1)(2008-5#1)(2010-12#2)(2010-3#1)(2011-2#1)
the little finger##4##3##(2008-9#4)
the little##10##2##(2007-5#1)(2007-7#1)(2008-10#2)(2008-9#4)(2009-2#1)(2010-8#1)
the littoral##8##2##(2007-5#1)(2008-4#1)(2008-5#3)(2011-2#1)(2013-7#2)
the live canopy##2##3##(2011-12#2)
the live##18##2##(1995-5#1)(2004-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-7#1)(2011-12#2)(2011-2#3)(2012-12#2)(2013-1#1)(2013-8#1)
the lived experience of##6##4##(2008-11#2)(2008-4#1)(2009-5#2)(2013-1#1)
the lived experience##7##3##(2008-11#3)(2008-4#1)(2009-5#2)(2013-1#1)
the lived##8##2##(2008-11#4)(2008-4#1)(2009-5#2)(2013-1#1)
the livelihood##2##2##(2008-1#1)(2009-2#1)
the liver X##3##3##(2005-11#1)(2006-10#1)(2010-3#1)
the liver after##3##3##(1991-4#1)(2008-11#1)(2009-10#1)
the liver also##2##3##(2008-4#1)(2013-7#1)
the liver and heart##3##4##(2008-1#1)(2008-4#1)(2010-11#1)
the liver and in the##3##5##(1990-11#1)(2007-9#1)(2009-8#1)
the liver and in##4##4##(1990-11#1)(2007-9#1)(2009-8#1)(2011-2#1)
the liver and intestinal##2##4##(2010-12#1)(2012-2#1)
the liver and kidney##10##4##(1990-8#1)(1991-5#1)(1996-6#1)(1997-5#2)(1997-8#1)(2004-4#1)(2007-9#1)(2008-7#1)(2010-11#1)
the liver and kidneys##3##4##(1993-1#1)(1996-6#1)(2005-12#1)
the liver and other##2##4##(1990-3#1)(2008-5#1)
the liver and pancreatic beta-cells##2##5##(2008-1#2)
the liver and small intestine##3##5##(1992-11#3)
the liver and spleen##3##4##(2006-7#1)(2007-2#1)(2010-2#1)
the liver and the lung##3##5##(1994-7#2)(2010-11#1)
the liver and the##11##4##(1990-12#1)(1990-4#1)(1991-10#1)(1993-9#1)(1994-11#2)(1994-7#2)(1995-3#1)(1995-9#1)(2010-11#1)
the liver and##92##3##(1990-11#1)(1990-12#1)(1990-3#2)(1990-4#2)(1990-8#1)(1991-10#1)(1991-12#1)(1991-3#2)(1991-4#1)(1991-5#1)(1992-11#3)(1992-3#1)(1992-6#1)(1993-1#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-11#2)(1994-5#1)(1994-7#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-6#2)(1996-7#1)(1997-3#1)(1997-4#2)(1997-5#2)(1997-8#2)(2004-4#1)(2005-12#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-6#1)(2006-7#1)(2007-2#3)(2007-6#1)(2007-9#2)(2008-1#3)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-6#1)(2009-8#2)(2010-11#3)(2010-12#3)(2010-2#1)(2010-5#2)(2011-1#2)(2011-12#1)(2011-2#4)(2012-2#2)(2013-1#1)(2013-8#1)
the liver are##6##3##(1990-11#1)(1992-10#1)(1994-9#1)(2005-12#1)(2008-4#1)(2010-12#1)
the liver as a##2##4##(2005-12#1)(2010-8#1)
the liver as##6##3##(1994-3#1)(2005-12#1)(2008-8#1)(2009-4#1)(2010-5#1)(2010-8#1)
the liver by##9##3##(1994-3#2)(1995-2#1)(1997-2#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-5#1)
the liver cell##3##3##(1990-3#1)(1991-1#1)(1997-6#1)
the liver cells##3##3##(1990-2#1)(1990-3#1)(2008-11#1)
the liver continues to##2##4##(2006-10#2)
the liver derived##2##3##(1990-12#1)(2012-2#1)
the liver disease##3##3##(1996-5#2)(1996-8#1)
the liver enzyme was##2##4##(1990-7#1)(1992-3#1)
the liver enzyme##5##3##(1990-7#1)(1991-12#1)(1992-3#1)(1996-7#1)(2008-8#1)
the liver fluke##2##3##(1991-7#1)(1992-6#1)
the liver for##2##3##(1993-6#1)(1995-10#1)
the liver from##5##3##(1990-3#1)(1992-9#1)(1995-3#2)(1996-2#1)
the liver has##3##3##(1993-10#1)(2006-10#1)(2006-2#1)
the liver in the metabolism of##2##6##(1994-3#1)(2006-2#1)
the liver in the##3##4##(1993-3#1)(1994-3#1)(2006-2#1)
the liver in##16##3##(1990-11#1)(1991-12#1)(1992-10#1)(1992-12#1)(1992-2#1)(1993-10#1)(1993-3#1)(1994-3#1)(1995-2#1)(1996-5#1)(2006-2#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-5#1)
the liver injury##2##3##(2008-10#1)(2008-8#1)
the liver is a##3##4##(1990-10#1)(1992-1#1)(2008-1#1)
the liver is the##3##4##(1990-1#1)(2009-8#1)(2010-9#1)
the liver is##14##3##(1990-1#1)(1990-10#1)(1991-12#1)(1992-1#1)(1995-3#1)(2004-11#1)(2008-1#1)(2008-9#1)(2009-8#2)(2010-12#1)(2010-7#1)(2010-9#1)(2013-8#1)
the liver macrophages##2##3##(1995-5#2)
the liver mass##2##3##(1990-3#2)
the liver of female##4##4##(1994-12#1)(1995-3#1)(1995-8#1)(1996-11#1)
the liver of rats treated with##2##6##(1992-9#1)(1994-6#1)
the liver of rats with##2##5##(1991-5#1)(1992-9#1)
the liver of rats##8##4##(1991-5#1)(1992-9#2)(1994-3#1)(1994-6#2)(2013-1#2)
the liver of the female##2##5##(2010-5#2)
the liver of the##6##4##(1991-3#1)(1992-12#1)(1992-9#1)(2008-4#1)(2010-5#2)
the liver of##47##3##(1990-12#1)(1990-3#3)(1990-7#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#1)(1992-12#1)(1992-9#3)(1993-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#2)(1995-10#1)(1995-3#3)(1995-6#1)(1995-8#1)(1996-11#1)(2004-4#1)(2008-10#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-12#3)(2010-5#2)(2012-2#1)(2013-1#3)
the liver or kidney##2##4##(1992-7#2)
the liver or##5##3##(1992-7#2)(1994-5#1)(2005-1#1)(2008-7#1)
the liver parenchyma##3##3##(1996-2#1)(2011-2#1)(2012-2#1)
the liver phenotype##2##3##(1992-2#2)
the liver surface##3##3##(2007-2#1)(2012-2#1)(2013-1#1)
the liver that##3##3##(1993-12#1)(2005-12#1)(2009-8#1)
the liver through##2##3##(2006-10#1)(2013-1#1)
the liver tissue##7##3##(1990-11#1)(2008-4#2)(2008-7#1)(2010-5#1)(2012-1#2)
the liver to##13##3##(1993-3#1)(1994-3#1)(1995-6#1)(1995-8#1)(1997-6#1)(2008-11#1)(2008-5#2)(2010-11#1)(2010-9#1)(2012-1#1)(2012-2#2)
the liver transplant##6##3##(2005-10#1)(2007-12#1)(2013-8#4)
the liver under##3##3##(1990-11#1)(1994-9#1)(2012-12#1)
the liver using##4##3##(1990-5#1)(2009-12#1)(2010-7#1)(2012-1#1)
the liver was studied##2##4##(1993-10#1)(2012-1#1)
the liver was##16##3##(1990-11#1)(1990-3#1)(1991-2#1)(1993-10#1)(1993-3#1)(1993-6#1)(1995-6#1)(1997-2#1)(2005-12#1)(2006-6#1)(2008-6#1)(2008-8#1)(2010-12#1)(2011-1#2)(2012-1#1)
the liver were investigated##2##4##(2008-4#1)(2013-1#1)
the liver were##6##3##(1991-2#1)(1991-3#1)(1996-3#1)(2007-11#1)(2008-4#1)(2013-1#1)
the liver with##9##3##(1991-6#1)(1991-7#1)(1996-12#1)(2007-8#1)(2009-1#1)(2010-12#2)(2010-8#1)(2013-1#1)
the liver##660##2##(1990-1#1)(1990-10#4)(1990-11#19)(1990-12#4)(1990-2#4)(1990-3#19)(1990-4#4)(1990-5#5)(1990-7#2)(1990-8#4)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#6)(1991-2#9)(1991-3#6)(1991-4#2)(1991-5#7)(1991-6#4)(1991-7#7)(1991-8#3)(1992-1#1)(1992-10#2)(1992-11#9)(1992-12#4)(1992-2#5)(1992-3#5)(1992-4#2)(1992-5#2)(1992-6#2)(1992-7#3)(1992-8#2)(1992-9#6)(1993-1#1)(1993-10#5)(1993-11#1)(1993-12#2)(1993-3#7)(1993-5#2)(1993-6#2)(1993-7#3)(1993-8#2)(1993-9#4)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#2)(1994-3#7)(1994-5#5)(1994-6#5)(1994-7#2)(1994-8#4)(1994-9#2)(1995-1#3)(1995-10#6)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#14)(1995-4#2)(1995-5#3)(1995-6#3)(1995-8#2)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#3)(1996-7#4)(1996-8#2)(1996-9#2)(1997-2#5)(1997-3#3)(1997-4#6)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#4)(2004-11#5)(2004-4#4)(2005-1#1)(2005-10#3)(2005-11#1)(2005-12#7)(2005-7#1)(2006-1#1)(2006-10#18)(2006-11#1)(2006-12#1)(2006-2#4)(2006-6#3)(2006-7#1)(2006-9#1)(2007-11#5)(2007-12#1)(2007-2#6)(2007-4#1)(2007-5#2)(2007-6#3)(2007-8#4)(2007-9#5)(2008-1#7)(2008-10#14)(2008-11#7)(2008-12#4)(2008-3#11)(2008-4#11)(2008-5#17)(2008-6#5)(2008-7#14)(2008-8#7)(2008-9#8)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#4)(2009-4#5)(2009-6#1)(2009-7#1)(2009-8#9)(2009-9#3)(2010-11#8)(2010-12#22)(2010-2#3)(2010-3#1)(2010-5#11)(2010-7#6)(2010-8#3)(2010-9#5)(2011-1#6)(2011-12#1)(2011-2#9)(2011-3#2)(2012-1#9)(2012-12#4)(2012-2#16)(2012-3#2)(2013-1#19)(2013-7#4)(2013-8#6)
the liver-specific##6##2##(1994-12#2)(1997-1#2)(2011-2#2)
the liver/bone/kidney alkaline phosphatase gene##2##5##(1993-11#1)(2009-11#1)
the liver/bone/kidney##4##2##(1993-11#3)(2009-11#1)
the liver]##8##2##(1991-3#1)(1992-5#1)(1993-1#1)(1993-5#1)(1993-8#1)(1997-7#1)(2009-2#2)
the livers of selenium-deficient##2##4##(1992-11#2)
the livers of##14##3##(1990-7#1)(1992-11#2)(1992-4#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-8#1)(1996-11#1)(1996-7#1)(1997-4#1)(2008-10#2)(2008-5#1)
the livers##22##2##(1990-7#1)(1992-11#2)(1992-4#1)(1993-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-7#1)(1997-2#3)(1997-4#1)(2004-4#1)(2008-10#2)(2008-5#1)(2008-8#1)(2011-12#1)
the liverwort Marchantia polymorpha##4##4##(1996-7#2)(1997-2#2)
the liverwort##6##2##(1996-7#3)(1997-2#2)(2006-3#1)
the lives of children##2##4##(2007-2#1)(2008-11#1)
the lives of more##2##4##(2007-9#1)(2010-8#1)
the lives of people##3##4##(1990-5#1)(1995-6#1)(2007-11#1)
the lives of the##5##4##(1991-2#1)(2006-2#1)(2007-2#1)(2008-2#1)(2009-9#1)
the lives of##40##3##(1990-5#1)(1991-2#1)(1992-6#1)(1993-8#1)(1995-1#1)(1995-6#1)(1997-2#1)(1997-3#1)(2004-8#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-11#2)(2007-2#4)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#3)(2008-2#3)(2008-3#1)(2008-7#3)(2008-8#2)(2009-9#1)(2010-10#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-7#1)
the lives##41##2##(1990-5#1)(1991-2#1)(1992-6#1)(1993-8#1)(1995-1#1)(1995-6#1)(1997-2#1)(1997-3#1)(2004-8#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-11#2)(2007-2#4)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#4)(2008-2#3)(2008-3#1)(2008-7#3)(2008-8#2)(2009-9#1)(2010-10#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-7#1)
the livestock##4##2##(2008-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
the living and##2##3##(2009-7#1)(2013-7#1)
the living are##2##3##(1996-5#1)(2013-7#1)
the living brain##2##3##(1997-5#1)(2011-1#1)
the living cell##4##3##(1991-8#1)(1997-2#1)(2008-5#1)(2012-12#1)
the living cells##2##3##(1996-2#1)(2009-3#1)
the living conditions##2##3##(2008-9#1)(2013-8#1)
the living donation##2##3##(2011-2#2)
the living donor##4##3##(2009-2#1)(2011-2#3)
the living embryo##2##3##(2008-11#1)(2008-9#1)
the living human##5##3##(1992-3#1)(2006-4#1)(2007-11#2)(2008-2#1)
the living organisms##4##3##(2008-10#1)(2008-5#1)(2011-1#1)(2013-8#1)
the living##56##2##(1991-8#1)(1992-3#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-5#1)(2004-4#2)(2006-4#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#3)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#8)(2012-12#1)(2013-7#3)(2013-8#3)
the lizard##8##2##(2006-1#1)(2007-9#3)(2008-8#1)(2010-3#1)(2011-2#2)
the load and##2##3##(2010-6#1)(2013-7#1)
the load applied on the pad##2##6##(2008-5#2)
the load bearing##2##3##(2006-11#2)
the load of##3##3##(1990-11#1)(1997-4#1)(2009-2#1)
the load##29##2##(1990-11#1)(1993-5#2)(1997-4#1)(2005-1#1)(2005-10#2)(2006-11#3)(2007-1#1)(2007-4#4)(2008-10#1)(2008-5#3)(2009-2#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-6#1)(2013-7#3)(2013-8#1)
the loaded##5##2##(2008-10#3)(2008-11#1)(2009-4#1)
the loading and##2##3##(1990-2#1)(2008-10#1)
the loading conditions##4##3##(2006-10#1)(2006-11#1)(2007-1#1)(2007-4#1)
the loading dose##2##3##(1991-9#1)(1997-5#1)
the loading of the##2##4##(1990-12#1)(2008-10#1)
the loading of##5##3##(1990-12#1)(1994-12#1)(1995-11#1)(2006-11#1)(2008-10#1)
the loading rate##2##3##(2008-7#1)(2009-7#1)
the loading##32##2##(1990-12#1)(1990-2#1)(1991-9#1)(1994-12#1)(1995-11#1)(1997-5#1)(2006-10#1)(2006-11#5)(2007-1#2)(2007-12#2)(2007-4#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-6#1)(2008-7#1)(2009-7#2)(2009-9#1)(2010-12#1)(2010-2#1)(2013-1#1)
the loadings##3##2##(2007-8#1)(2008-3#1)(2008-7#1)
the lobe##4##2##(2007-12#3)(2007-9#1)
the loblolly##2##2##(2006-12#1)(2008-10#1)
the lobster##4##2##(1990-2#1)(1993-9#1)(1994-11#1)(2007-12#1)
the lobule##2##2##(2012-11#1)(2012-2#1)
the local DIC##4##3##(2011-1#4)
the local anaesthetic##2##3##(2006-10#1)(2008-10#1)
the local anaesthetics bupivacaine and##2##5##(1995-3#1)(1997-3#1)
the local and distant##2##4##(1991-6#1)(2006-10#1)
the local and regional##3##4##(1992-4#1)(1997-3#1)(2008-10#1)
the local and systemic##3##4##(2006-6#1)(2010-9#1)(2011-2#1)
the local and##13##3##(1990-5#1)(1991-6#1)(1992-4#1)(1997-3#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-12#2)(2010-7#1)(2010-9#1)(2011-2#1)
the local anesthesia##2##3##(1990-5#1)(1992-6#1)
the local anesthetic##11##3##(1990-2#3)(1993-1#2)(1996-8#2)(1997-5#1)(2006-10#1)(2006-8#1)(2012-12#1)
the local application of##2##4##(2006-9#1)(2012-3#1)
the local authorities##4##3##(1992-11#1)(1992-5#1)(2006-8#1)(2008-10#1)
the local birefringence vector##2##4##(2007-12#2)
the local birefringence##3##3##(2007-12#3)
the local chickens and pullets##2##5##(2008-5#2)
the local chickens##3##3##(2008-5#3)
the local circuit##6##3##(1991-10#1)(1991-6#1)(1996-12#1)(2005-10#1)(2008-11#2)
the local community##6##3##(1990-8#1)(1992-6#1)(2007-3#1)(2007-8#1)(2009-6#1)(2013-1#1)
the local concentration of##3##4##(1990-4#1)(1995-1#1)(2009-4#1)
the local control rate##3##4##(2007-11#1)(2008-6#2)
the local control##5##3##(1994-2#1)(2007-11#1)(2008-6#3)
the local density##2##3##(2008-7#1)(2009-9#1)
the local diffusion##2##3##(2007-5#1)(2008-2#1)
the local distribution of##2##4##(1996-4#1)(2007-11#1)
the local economy##2##3##(1994-3#1)(2007-5#1)
the local effects##2##3##(2005-6#1)(2007-5#1)
the local elements##3##3##(2008-4#2)(2009-4#1)
the local environment of a##2##5##(2008-1#1)(2008-11#1)
the local environment##7##3##(2006-12#1)(2008-1#2)(2008-11#2)(2008-8#1)(2012-7#1)
the local environmental health services##2##5##(1996-9#2)
the local environments of##2##4##(1990-8#1)(1992-6#1)
the local ethnic minorities##2##4##(2008-8#2)
the local extent and##2##4##(2008-2#1)(2011-2#1)
the local extinction##4##3##(2008-3#1)(2008-8#3)
the local fringe direction##2##4##(2008-2#2)
the local geometry##2##3##(1996-2#1)(2008-2#1)
the local gradient##3##3##(2008-2#3)
the local health care##2##4##(1994-12#1)(2007-3#1)
the local health##6##3##(1993-8#1)(1994-12#1)(1996-1#1)(2007-1#1)(2007-3#1)(2008-7#1)
the local inhabitants##2##3##(1991-12#1)(1996-8#1)
the local level##14##3##(1992-2#1)(1994-2#1)(1994-3#1)(1996-1#1)(2007-4#3)(2008-1#1)(2008-10#2)(2008-12#1)(2008-9#2)(2011-1#1)
the local lymph node assay##3##5##(1995-2#1)(2008-5#2)
the local lymph node##4##4##(1995-2#1)(2008-3#1)(2008-5#2)
the local market##4##3##(1997-1#1)(2007-2#3)
the local mean##3##3##(2008-3#2)(2012-2#1)
the local motions##2##3##(1995-10#1)(2010-4#1)
the local myocardial##2##3##(1996-9#1)(2007-8#1)
the local optical##3##3##(2007-12#1)(2008-3#2)
the local or##2##3##(1992-2#1)(1995-5#1)
the local oscillator##4##3##(2008-1#1)(2008-2#2)(2008-3#1)
the local pH##2##3##(1990-2#1)(2009-12#1)
the local physician##2##3##(1997-4#1)(2010-12#1)
the local population##14##3##(1990-8#1)(1995-11#1)(2006-6#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-2#1)
the local populations##4##3##(2007-2#1)(2008-10#3)
the local power spectrum##2##4##(2008-2#2)
the local production##2##3##(1993-11#1)(2008-4#1)
the local public health##3##4##(1995-12#1)(1997-3#1)(2007-12#1)
the local recidives##2##3##(2006-6#1)(2008-8#1)
the local recurrence rate##2##4##(2008-2#1)(2008-8#1)
the local recurrence##3##3##(2008-2#1)(2008-6#1)(2008-8#1)
the local reflectance##2##3##(2008-3#2)
the local release##2##3##(1990-11#1)(2012-12#1)
the local renin-angiotensin system##2##4##(1995-9#1)(2008-7#1)
the local rf electric field##2##5##(2013-8#2)
the local scale and##2##4##(2008-6#1)(2010-2#1)
the local scale##4##3##(2007-8#1)(2008-6#1)(2008-8#1)(2010-2#1)
the local separation##2##3##(2005-11#2)
the local sex ratio##2##4##(2008-9#2)
the local shape of the##2##5##(1997-1#1)(2008-2#1)
the local shape##3##3##(1997-1#2)(2008-2#1)
the local situation##2##3##(1990-10#1)(1990-12#1)
the local structure around the##2##5##(1995-10#1)(2005-11#1)
the local structure##8##3##(1992-6#1)(1995-10#1)(1996-6#1)(2005-11#2)(2008-4#1)(2008-6#1)(2008-9#1)
the local surface##2##3##(2008-2#2)
the local temperature##3##3##(2007-12#1)(2008-3#2)
the local treatment of##3##4##(2007-11#1)(2010-3#2)
the local treatment##4##3##(2007-11#1)(2010-3#2)(2011-2#1)
the local uterine immune response##2##5##(1992-1#2)
the local variations##2##3##(2008-2#1)(2013-8#1)
the local##467##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#4)(1990-3#1)(1990-4#4)(1990-5#2)(1990-6#1)(1990-8#3)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#4)(1991-7#1)(1991-9#2)(1992-1#3)(1992-10#2)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#5)(1992-8#1)(1993-1#2)(1993-11#2)(1993-3#1)(1993-5#2)(1993-6#2)(1993-7#1)(1993-8#4)(1994-12#1)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#2)(1995-1#2)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#2)(1995-5#3)(1995-6#1)(1995-9#1)(1996-1#4)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#2)(1996-8#3)(1996-9#5)(1997-1#4)(1997-3#4)(1997-4#1)(1997-5#2)(1997-6#2)(1997-8#2)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#5)(2005-12#1)(2005-5#1)(2005-6#1)(2006-10#6)(2006-12#5)(2006-2#2)(2006-4#2)(2006-5#1)(2006-6#5)(2006-8#3)(2006-9#2)(2007-1#2)(2007-11#6)(2007-12#18)(2007-2#7)(2007-3#4)(2007-4#7)(2007-5#5)(2007-7#1)(2007-8#4)(2007-9#4)(2008-1#4)(2008-10#17)(2008-11#10)(2008-12#7)(2008-2#32)(2008-3#33)(2008-4#8)(2008-5#12)(2008-6#8)(2008-7#8)(2008-8#16)(2008-9#8)(2009-12#2)(2009-2#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-9#2)(2010-1#2)(2010-10#1)(2010-12#6)(2010-2#2)(2010-3#4)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#7)(2011-12#1)(2011-2#9)(2012-12#3)(2012-2#5)(2012-3#2)(2012-7#1)(2013-1#3)(2013-7#2)(2013-8#11)
the local-field factor##2##3##(2007-11#2)
the local-field##3##2##(2007-11#2)(2008-3#1)
the localisation of bicoid RNA during oogenesis##2##7##(2012-12#2)
the localisation of the##3##4##(1997-8#1)(2008-8#1)(2010-4#1)
the localisation of##5##3##(1997-8#1)(2008-8#1)(2010-4#1)(2012-12#2)
the localisation##6##2##(1997-6#1)(1997-8#1)(2008-8#1)(2010-4#1)(2012-12#2)
the localised##2##2##(2006-6#1)(2012-2#1)
the localities##2##2##(1990-3#1)(2007-5#1)
the locality of##2##3##(2007-9#1)(2008-9#1)
the locality##8##2##(2007-11#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-9#1)(2010-4#1)(2012-3#2)
the localization and number of##2##5##(2007-11#1)(2008-8#1)
the localization and##15##3##(1993-9#1)(1994-9#1)(2007-11#3)(2008-1#2)(2008-8#1)(2009-2#1)(2010-9#1)(2012-2#3)(2012-3#1)(2013-1#1)
the localization of a##2##4##(2007-12#1)(2008-4#1)
the localization of one protein relative to another##2##8##(2008-4#2)
the localization of one##4##4##(1997-2#1)(1997-4#1)(2008-4#2)
the localization of proteins##2##4##(2007-12#1)(2009-5#1)
the localization of the##12##4##(1991-12#1)(1992-8#1)(1992-9#1)(1995-6#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-9#2)(2008-7#1)(2008-9#1)(2012-3#1)
the localization of these##2##4##(1993-3#1)(2008-10#1)
the localization of##63##3##(1990-3#1)(1991-10#1)(1991-11#1)(1991-12#2)(1992-10#1)(1992-11#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-5#2)(1995-6#2)(1996-11#1)(1996-3#1)(1997-2#3)(1997-4#2)(1997-6#1)(2006-1#1)(2006-12#1)(2007-11#1)(2007-12#5)(2007-7#1)(2007-9#2)(2008-10#3)(2008-3#4)(2008-4#3)(2008-5#3)(2008-7#2)(2008-9#4)(2009-10#1)(2009-5#1)(2010-7#1)(2012-2#1)(2012-3#1)
the localization##89##2##(1990-3#1)(1991-10#1)(1991-11#1)(1991-12#2)(1992-10#1)(1992-11#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-5#2)(1995-6#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-2#3)(1997-4#2)(1997-6#1)(1997-8#1)(2006-1#1)(2006-12#1)(2007-11#5)(2007-12#5)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#6)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#5)(2009-10#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-6#1)(2010-7#1)(2010-9#1)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#1)
the localized states##2##3##(2009-2#2)
the localized##20##2##(1991-7#1)(1992-5#1)(1993-10#1)(1993-5#1)(1994-2#1)(1996-2#1)(2006-11#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2009-2#2)
the locally##6##2##(2008-2#1)(2008-3#1)(2009-7#1)(2010-4#1)(2012-3#1)(2013-1#1)
the location and extent of##8##5##(1995-11#1)(2006-9#1)(2007-9#1)(2008-2#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
the location and magnitude of##2##5##(2007-5#1)(2007-9#1)
the location and shape of##2##5##(2007-12#1)(2010-7#1)
the location and the##3##4##(2007-8#1)(2008-2#1)(2008-9#1)
the location and##27##3##(1995-11#1)(1995-4#2)(1996-7#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#1)(2009-4#2)(2009-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the location in the##2##4##(2007-11#1)(2008-9#1)
the location of a reversed platform when##2##7##(1992-9#2)
the location of a##8##4##(1992-9#2)(1993-2#1)(1994-3#1)(1995-5#1)(2007-12#1)(2007-7#1)(2008-9#1)
the location of an##3##4##(2008-11#1)(2012-12#2)
the location of objects##2##4##(1995-12#2)
the location of specific##3##4##(2008-1#1)(2008-2#1)(2012-1#1)
the location of the corresponding##2##5##(1993-11#2)
the location of the disulfide##2##5##(1994-5#2)
the location of the metastasis##2##5##(1991-6#1)(2007-11#1)
the location of the neurons##2##5##(1994-10#2)
the location of the nucleotide##2##5##(1991-4#2)
the location of the object##2##5##(1995-2#1)(2008-11#1)
the location of the point##2##5##(2007-7#1)(2008-3#1)
the location of the primary tumour##2##6##(2006-10#2)
the location of the primary##3##5##(1990-5#1)(2006-10#2)
the location of the two##2##5##(1990-8#1)(1992-11#1)
the location of the##73##4##(1990-4#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-4#2)(1991-5#1)(1991-6#2)(1992-11#1)(1992-8#1)(1993-1#2)(1993-11#2)(1993-5#1)(1994-1#1)(1994-10#2)(1994-5#2)(1995-1#1)(1995-2#1)(1995-5#1)(2005-7#1)(2006-10#4)(2006-4#1)(2006-6#2)(2007-11#2)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#4)(2008-2#6)(2008-3#7)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-7#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#3)
the location of these##5##4##(1994-10#1)(1996-7#1)(2005-11#1)(2010-9#1)(2012-12#1)
the location of this##3##4##(1992-7#1)(2008-7#1)(2012-2#1)
the location of##151##3##(1990-12#1)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-6#2)(1992-11#1)(1992-3#1)(1992-7#2)(1992-8#2)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-1#1)(1994-10#3)(1994-3#1)(1994-5#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#2)(1997-3#1)(1997-6#1)(2004-11#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-4#1)(2006-6#2)(2007-11#4)(2007-12#1)(2007-3#2)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#7)(2008-2#8)(2008-3#7)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-8#3)(2010-9#3)(2011-1#1)(2011-2#2)(2012-1#3)(2012-12#4)(2012-2#3)(2013-1#4)(2013-8#3)
the location where the##2##4##(2007-12#1)(2008-2#1)
the location where##3##3##(2007-12#1)(2008-2#1)(2013-1#1)
the location##206##2##(1990-12#2)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-6#3)(1992-11#1)(1992-3#1)(1992-7#2)(1992-8#2)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-1#1)(1994-10#3)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-4#2)(1995-5#2)(1995-6#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#3)(1997-3#1)(1997-6#1)(2004-11#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-4#1)(2006-6#2)(2006-9#1)(2007-11#6)(2007-12#4)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#9)(2008-11#7)(2008-2#11)(2008-3#12)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#3)(2008-9#5)(2009-4#3)(2009-5#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#5)(2010-9#3)(2011-1#1)(2011-2#5)(2012-1#3)(2012-12#6)(2012-2#5)(2013-1#7)(2013-8#4)
the locations and##4##3##(1995-2#1)(2008-10#1)(2010-11#1)(2012-2#1)
the locations of five##2##4##(1994-8#1)(1997-8#1)
the locations of the##6##4##(1996-8#1)(2007-12#1)(2008-2#3)(2010-5#1)
the locations of##26##3##(1990-9#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-8#1)(1996-8#1)(1997-5#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#4)(2008-3#1)(2009-2#2)(2010-5#1)
the locations were##3##3##(1990-8#1)(2013-8#2)
the locations##36##2##(1990-8#1)(1990-9#1)(1992-5#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-2#2)(1995-8#1)(1996-8#1)(1997-5#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#4)(2008-3#1)(2009-2#2)(2010-11#1)(2010-5#1)(2011-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
the loci LDLR##2##3##(1996-7#2)
the loci contributing to##2##4##(2009-4#1)(2012-3#1)
the loci for##3##3##(1993-11#1)(1996-3#1)(2008-10#1)
the loci of##2##3##(1995-5#1)(1996-8#1)
the loci##23##2##(1993-11#1)(1994-8#1)(1995-11#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-7#5)(1996-8#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-4#1)(2012-11#1)(2012-12#1)(2012-3#2)
the lock-in##3##2##(2007-2#1)(2008-10#1)(2010-4#1)
the locked##2##2##(2007-12#1)(2008-3#1)
the locking##7##2##(2007-12#2)(2008-1#1)(2008-2#1)(2008-4#1)(2009-3#2)
the locomotion##4##2##(1993-12#1)(1993-3#1)(2007-7#1)(2012-2#1)
the locomotor activity of the##2##5##(1997-7#1)(2008-5#1)
the locomotor activity##6##3##(1994-2#1)(1997-7#1)(2008-11#1)(2008-5#3)
the locomotor apparatus##6##3##(2007-11#5)(2007-8#1)
the locomotor response to##4##4##(1993-6#3)(1994-11#1)
the locomotor rhythm##3##3##(2008-5#1)(2008-6#2)
the locomotor system##8##3##(1990-6#1)(1995-4#1)(2007-11#3)(2007-8#3)
the locomotor##39##2##(1990-6#1)(1993-12#1)(1993-3#3)(1993-6#4)(1994-11#1)(1994-2#3)(1995-11#1)(1995-4#1)(1997-7#1)(2007-11#9)(2007-8#4)(2008-11#1)(2008-5#5)(2008-6#2)(2011-2#1)(2013-1#1)
the locomotor-stimulating##2##2##(1993-3#1)(1993-6#1)
the locoregional hyperthermic area##3##4##(1996-3#3)
the locoregional##5##2##(1996-3#3)(2011-2#1)(2013-1#1)
the locus coeruleus (LC)##4##4##(1992-9#1)(1993-2#1)(1995-12#1)(1996-12#1)
the locus coeruleus and##4##4##(1991-9#1)(1994-10#1)(1996-10#1)(2008-7#1)
the locus coeruleus in##3##4##(1995-12#1)(1996-10#1)(1997-6#1)
the locus coeruleus##19##3##(1991-9#1)(1992-9#1)(1993-2#1)(1994-10#1)(1995-12#3)(1995-5#1)(1996-10#3)(1996-12#1)(1996-5#1)(1997-6#1)(2007-5#1)(2008-7#4)
the locus control region##3##4##(1994-12#1)(2008-8#2)
the locus of the##3##4##(1990-3#1)(2010-8#1)(2012-11#1)
the locus of this##2##4##(1991-2#1)(1993-2#1)
the locus of##14##3##(1990-3#1)(1991-12#1)(1991-2#1)(1991-9#1)(1993-2#1)(1993-3#1)(2007-12#1)(2007-9#1)(2009-10#1)(2010-8#1)(2012-11#1)(2012-3#1)(2013-1#2)
the locus##59##2##(1990-3#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-9#2)(1992-1#1)(1992-9#1)(1993-11#1)(1993-2#2)(1993-3#1)(1994-10#1)(1994-12#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#2)(1996-10#4)(1996-12#1)(1996-2#2)(1996-5#1)(1997-6#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2009-10#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#2)
the locust##13##2##(1990-2#1)(1994-2#2)(2006-7#2)(2007-12#8)
the lod score##2##3##(1995-11#2)
the log odds##2##3##(1992-10#1)(1997-8#1)
the log of the##6##4##(1991-2#1)(1992-4#1)(1993-11#2)(2008-10#2)
the log of##10##3##(1991-2#1)(1992-4#1)(1993-11#2)(1995-8#1)(2008-10#4)(2008-8#1)
the log##25##2##(1991-2#1)(1992-10#1)(1992-4#1)(1993-11#2)(1993-3#1)(1994-8#1)(1995-3#1)(1995-4#1)(1995-8#1)(1997-2#1)(1997-8#1)(2007-4#1)(2008-1#1)(2008-10#7)(2008-3#1)(2008-7#2)(2008-8#1)
the log-binomial##2##2##(2010-12#2)
the log-likelihood ratio##3##3##(1996-12#2)(2008-10#1)
the log-likelihood##4##2##(1996-12#2)(2008-10#1)(2008-3#1)
the log-log plots##3##3##(2005-11#1)(2008-10#2)
the log-log##5##2##(1996-11#1)(2005-11#1)(2008-10#2)(2008-2#1)
the log-normal model##2##3##(1997-7#2)
the log-normal##6##2##(1997-7#2)(2005-11#2)(2008-10#1)(2008-7#1)
the log-odds##2##2##(1997-6#1)(2008-4#1)
the log-rank test##5##3##(2008-6#1)(2011-2#1)(2012-3#2)(2013-8#1)
the log-rank##6##2##(2007-8#1)(2008-6#1)(2011-2#1)(2012-3#2)(2013-8#1)
the log-transformed data##2##3##(2009-1#1)(2010-2#1)
the log-transformed values of##2##4##(2010-10#2)
the log-transformed##5##2##(2008-10#1)(2009-1#1)(2010-10#2)(2010-2#1)
the logarithm of the concentration of##2##6##(2008-10#2)
the logarithm of the##17##4##(1990-10#1)(1990-2#1)(1994-12#2)(1996-4#2)(1997-4#1)(2005-11#1)(2006-5#1)(2008-10#7)(2008-3#1)
the logarithm of##31##3##(1990-10#1)(1990-2#1)(1991-2#1)(1994-12#2)(1996-4#2)(1997-4#1)(2005-11#1)(2006-5#1)(2007-8#1)(2008-10#16)(2008-3#1)(2008-8#1)(2009-7#2)
the logarithm##34##2##(1990-10#1)(1990-2#1)(1991-2#1)(1994-12#2)(1996-4#2)(1997-4#1)(2005-11#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#16)(2008-3#1)(2008-8#1)(2009-12#1)(2009-7#2)(2013-8#1)
the logarithmic derivative of##2##4##(2005-11#2)
the logarithmic derivative##3##3##(2005-11#3)
the logarithmic transformed AUC(0-infinity)##2##4##(2004-12#2)
the logarithmic transformed##3##3##(2004-12#3)
the logarithmic##14##2##(1990-3#1)(1994-6#1)(1997-2#1)(1997-8#1)(2004-12#3)(2005-11#3)(2008-10#2)(2008-3#1)(2008-5#1)
the loggerhead sea turtle (Caretta caretta)##3##6##(1995-3#2)(2007-2#1)
the loggerhead sea turtle##4##4##(1995-3#3)(2007-2#1)
the logic behind the##2##4##(2006-11#1)(2013-8#1)
the logic of development##2##4##(2009-5#1)(2013-8#1)
the logic of the##2##4##(2008-8#1)(2010-11#1)
the logic of##11##3##(2008-10#1)(2008-12#1)(2008-8#4)(2009-4#1)(2009-5#1)(2010-11#1)(2013-1#1)(2013-8#1)
the logic##18##2##(1995-2#1)(2006-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#5)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#2)(2013-1#1)(2013-8#2)
the logical##8##2##(1997-1#1)(2007-12#1)(2007-3#2)(2008-11#1)(2008-7#2)(2009-9#1)
the logistic EuroSCORE##3##3##(2007-8#3)
the logistic and##2##3##(2007-8#1)(2011-2#1)
the logistic model##7##3##(1994-11#1)(2007-8#2)(2008-10#4)
the logistic probability##3##3##(2007-8#3)
the logistic regression analysis of SSR prevalence##2##7##(2008-10#2)
the logistic regression analysis##3##4##(2008-10#2)(2013-8#1)
the logistic regression model##2##4##(2008-3#1)(2013-1#1)
the logistic regression models##2##4##(1992-2#1)(2008-10#1)
the logistic regression##10##3##(1992-2#2)(2007-8#1)(2008-10#3)(2008-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
the logistic##33##2##(1991-12#1)(1992-2#2)(1992-9#1)(1994-11#1)(2007-8#12)(2008-10#9)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
the logistics of data##2##4##(1995-2#1)(2012-3#1)
the logistics of##6##3##(1993-7#1)(1995-2#1)(2007-12#1)(2007-4#1)(2008-5#1)(2012-3#1)
the logistics##7##2##(1993-7#1)(1995-2#1)(1995-5#1)(2007-12#1)(2007-4#1)(2008-5#1)(2012-3#1)
the lone pair##3##3##(1990-7#1)(2011-2#2)
the lone##4##2##(1990-7#1)(2004-11#1)(2011-2#2)
the long QT syndrome##2##4##(2013-1#2)
the long QT##3##3##(2006-10#1)(2013-1#2)
the long acting##2##3##(1993-6#1)(2007-7#1)
the long and accurate polymerase chain reaction##2##7##(1997-6#2)
the long and the short##2##5##(1996-4#1)(2006-6#1)
the long and##4##3##(1996-4#1)(1997-6#2)(2006-6#1)
the long arm of chromosome 21##2##6##(1996-6#1)(2007-12#1)
the long arm of chromosome 7##3##6##(2006-10#1)(2008-9#1)(2010-3#1)
the long arm of chromosome##17##5##(1993-10#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-7#1)(2008-9#2)(2010-3#1)(2012-12#2)
the long arm of human chromosome##2##6##(1995-11#1)(1997-8#1)
the long arm of the X chromosome##2##7##(2008-12#1)(2012-1#1)
the long arm of the X##3##6##(2008-12#1)(2012-1#1)(2012-2#1)
the long arm of the##4##5##(2008-10#1)(2008-12#1)(2012-1#1)(2012-2#1)
the long arm of wheat chromosome##2##6##(2008-10#2)
the long arm of wheat##3##5##(2008-10#3)
the long arm of##31##4##(1990-7#1)(1993-10#1)(1995-11#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-12#2)(2008-10#8)(2008-12#2)(2008-7#1)(2008-9#2)(2010-3#2)(2012-1#1)(2012-12#2)(2012-2#1)
the long arm##34##3##(1990-7#1)(1990-9#1)(1993-10#1)(1995-11#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-12#2)(2008-10#9)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#2)(2010-3#2)(2012-1#1)(2012-12#2)(2012-2#1)
the long arms of chromosomes##2##5##(1990-9#1)(2008-5#1)
the long arms of##4##4##(1990-9#1)(1997-8#1)(2008-5#1)(2008-7#1)
the long arms##5##3##(1990-9#1)(1997-8#1)(2008-5#2)(2008-7#1)
the long axes of##4##4##(1995-8#2)(1996-7#1)(2008-6#1)
the long axis of the##6##5##(2004-11#1)(2006-11#2)(2009-10#1)(2013-8#2)
the long axis of##8##4##(2004-11#1)(2006-11#2)(2006-12#1)(2008-2#1)(2009-10#1)(2013-8#2)
the long bones of the##4##5##(2007-11#1)(2010-3#2)(2012-2#1)
the long bones##12##3##(1992-3#1)(1996-12#1)(2007-11#3)(2008-12#1)(2008-4#1)(2010-3#2)(2010-6#1)(2012-2#1)(2013-8#1)
the long chain##3##3##(1990-5#1)(1996-7#1)(2012-2#1)
the long cone technique (paralleling technique)##2##6##(1991-4#2)
the long duration of##3##4##(2006-2#1)(2007-7#1)(2012-2#1)
the long form to the short form##2##7##(1994-8#1)(1997-2#1)
the long form##3##3##(1994-8#2)(1997-2#1)
the long history of##2##4##(2008-2#1)(2011-2#1)
the long isoform##2##3##(1996-5#2)
the long lasting##2##3##(1990-9#1)(1992-8#1)
the long latency##3##3##(1991-6#1)(1995-2#1)(2010-9#1)
the long list of##2##4##(2006-4#1)(2008-1#1)
the long range##2##3##(1994-9#1)(2006-2#1)
the long residence time required for##2##6##(2008-5#1)(2008-7#1)
the long run##14##3##(1994-5#1)(1996-1#1)(1996-2#1)(1997-3#1)(1997-5#1)(2008-3#1)(2009-11#1)(2009-12#1)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the long saphenous vein##2##4##(2006-6#2)
the long sought after##2##4##(1991-1#1)(1995-3#1)
the long tail fibres##2##4##(1994-9#2)
the long term effects of##5##5##(1992-8#1)(1995-6#1)(2006-11#1)(2008-11#1)(2008-5#1)
the long term in##4##4##(1994-3#1)(2007-5#1)(2008-8#1)(2013-7#1)
the long term##62##3##(1990-12#1)(1991-10#1)(1991-9#1)(1992-1#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-11#2)(1993-2#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-4#1)(1995-12#1)(1995-6#2)(1995-8#1)(1996-11#1)(2004-9#1)(2006-11#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#2)(2009-6#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-11#2)(2012-12#1)(2013-7#1)(2013-8#1)
the long terminal repeat##6##4##(1991-12#1)(1991-3#1)(1992-2#1)(1993-5#1)(1996-5#1)(2008-5#1)
the long terminal##8##3##(1991-12#1)(1991-3#1)(1992-2#1)(1993-5#1)(1996-5#1)(2008-5#3)
the long time##4##3##(1995-11#1)(2006-9#1)(2007-12#1)(2008-11#1)
the long wavelength##3##3##(1993-3#1)(2007-11#1)(2009-3#1)
the long##258##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#3)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#3)(1993-10#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-5#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-8#2)(1994-9#3)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#3)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-4#2)(1996-5#3)(1996-6#1)(1996-7#2)(1997-2#3)(1997-3#2)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#2)(2004-11#1)(2004-9#1)(2005-4#1)(2006-10#2)(2006-11#3)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#3)(2006-9#1)(2007-10#1)(2007-11#10)(2007-12#6)(2007-3#1)(2007-5#2)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#14)(2008-11#4)(2008-12#4)(2008-2#2)(2008-3#8)(2008-4#2)(2008-5#12)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#5)(2009-10#3)(2009-11#4)(2009-12#1)(2009-3#2)(2009-6#1)(2009-9#1)(2010-11#2)(2010-3#5)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-11#2)(2012-12#5)(2012-2#6)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#6)
the long- and short-term##2##4##(2008-1#1)(2010-5#1)
the long-acting##2##2##(2005-8#1)(2006-1#1)
the long-day##2##2##(2009-8#1)(2013-1#1)
the long-distance transport of##2##4##(2008-10#2)
the long-distance##5##2##(1993-2#1)(2008-10#4)
the long-duration##3##2##(1991-2#2)(2007-12#1)
the long-lasting##6##2##(1992-8#1)(1994-2#1)(1995-12#2)(2008-3#1)(2012-2#1)
the long-lived##7##2##(1991-12#2)(1994-11#1)(1994-5#1)(2008-1#1)(2012-3#2)
the long-period##3##2##(1996-4#1)(2007-12#2)
the long-range interactions##3##3##(2006-10#1)(2007-11#2)
the long-range##8##2##(1992-5#1)(1997-2#1)(2006-10#1)(2007-11#2)(2007-12#2)(2010-2#1)
the long-run##4##2##(2009-4#2)(2010-12#1)(2012-12#1)
the long-scale component of the roughness##2##6##(2007-12#2)
the long-sought##2##2##(1996-5#1)(2007-8#1)
the long-standing##5##2##(1995-8#1)(2006-10#1)(2007-8#1)(2010-2#1)(2012-2#1)
the long-tail form (A beta 1-42/43)##2##6##(1994-11#1)(1994-12#1)
the long-tail form##3##3##(1994-11#1)(1994-12#2)
the long-term care##3##3##(1995-3#1)(1997-1#1)(2011-2#1)
the long-term clinical outcome##2##4##(2012-3#1)(2013-1#1)
the long-term clinical##4##3##(2006-10#1)(2012-3#2)(2013-1#1)
the long-term complications##3##3##(1993-11#1)(1996-11#1)(2010-4#1)
the long-term consequences of##6##4##(1996-6#1)(2006-10#1)(2006-2#1)(2009-8#1)(2010-2#1)(2011-2#1)
the long-term development##2##3##(2007-8#1)(2009-7#1)
the long-term effect of##7##4##(2005-11#1)(2006-4#1)(2007-1#1)(2008-7#1)(2009-6#1)(2010-4#1)(2011-2#1)
the long-term effectiveness of these##2##5##(2007-8#1)(2012-2#1)
the long-term effectiveness of##3##4##(2007-8#1)(2008-11#1)(2012-2#1)
the long-term effectiveness##5##3##(2007-8#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
the long-term effects of acupuncture##2##5##(2008-10#2)
the long-term effects of##17##4##(1992-10#1)(1995-11#1)(1996-12#1)(1996-7#1)(2004-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-1#2)(2009-7#1)(2010-3#1)(2010-8#1)(2012-2#1)(2013-1#2)
the long-term effects##20##3##(1992-10#1)(1995-11#1)(1996-12#1)(1996-7#1)(1997-7#1)(2004-1#1)(2006-8#1)(2006-9#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-1#2)(2009-7#1)(2010-3#1)(2010-8#1)(2012-2#1)(2013-1#2)
the long-term efficacy of##2##4##(2006-12#1)(2006-4#1)
the long-term follow-up of##4##4##(1990-3#1)(2006-10#1)(2006-8#1)(2010-12#1)
the long-term follow-up##6##3##(1990-3#1)(2006-10#1)(2006-8#1)(2006-9#1)(2010-12#1)(2011-2#1)
the long-term goal of##2##4##(2007-8#1)(2012-2#1)
the long-term impact of##2##4##(2006-4#1)(2008-6#1)
the long-term influence of##2##4##(2008-7#1)(2010-5#1)
the long-term management of##7##4##(1990-6#1)(2006-5#1)(2007-6#1)(2008-10#2)(2008-2#1)(2008-8#1)
the long-term management##8##3##(1990-6#1)(2006-5#1)(2007-6#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)
the long-term monitoring of##2##4##(1997-3#1)(2009-4#1)
the long-term monitoring##3##3##(1990-12#1)(1997-3#1)(2009-4#1)
the long-term outcome of##7##4##(1991-6#1)(2006-10#1)(2006-5#1)(2007-7#1)(2008-1#1)(2008-11#1)(2013-8#1)
the long-term outcome##10##3##(1991-6#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-7#1)(2008-1#1)(2008-11#1)(2013-8#1)
the long-term outcomes##3##3##(1997-2#1)(2010-4#1)(2011-2#1)
the long-term patency of##2##4##(1990-4#1)(2007-7#1)
the long-term prognosis is poor##2##5##(1990-2#1)(2006-10#1)
the long-term prognosis of##7##4##(1996-12#1)(2007-8#2)(2008-3#1)(2008-6#1)(2008-9#1)(2011-7#1)
the long-term prognosis##12##3##(1990-2#1)(1991-6#1)(1996-12#1)(2006-10#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-7#1)
the long-term reproducibility##2##3##(2009-8#2)
the long-term response##2##3##(1990-2#1)(2008-8#1)
the long-term results in##2##4##(1994-2#1)(2007-11#1)
the long-term results of##5##4##(1994-5#1)(1995-4#1)(2006-6#1)(2009-8#1)(2011-2#1)
the long-term results##10##3##(1991-3#1)(1992-9#1)(1994-2#1)(1994-5#1)(1995-4#1)(2006-6#1)(2007-11#1)(2009-8#1)(2011-2#1)(2013-1#1)
the long-term risk of##2##4##(2007-7#1)(2011-2#1)
the long-term risk##3##3##(2007-7#1)(2008-11#1)(2011-2#1)
the long-term safety of##2##4##(2005-7#1)(2009-1#1)
the long-term safety outcomes##2##4##(2012-12#2)
the long-term safety##6##3##(2005-7#1)(2008-8#1)(2009-1#1)(2012-12#2)(2012-3#1)
the long-term stability of the##2##5##(2005-11#1)(2008-10#1)
the long-term stability of##5##4##(2005-11#1)(2008-10#2)(2008-11#1)(2008-4#1)
the long-term stability##6##3##(2005-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)
the long-term survival and##3##4##(1992-8#1)(2008-8#1)(2013-1#1)
the long-term survival of##5##4##(1996-12#1)(2006-5#1)(2006-7#1)(2008-10#1)(2008-9#1)
the long-term survival##10##3##(1990-10#1)(1992-8#1)(1996-12#1)(2006-5#1)(2006-7#1)(2008-10#1)(2008-8#2)(2008-9#1)(2013-1#1)
the long-term therapy##3##3##(1990-12#1)(2004-10#1)(2007-8#1)
the long-term treatment of##3##4##(1994-2#1)(2013-1#2)
the long-term treatment with##2##4##(1990-2#1)(1991-12#1)
the long-term treatment##7##3##(1990-2#1)(1991-12#1)(1994-2#1)(2009-11#1)(2011-2#1)(2013-1#2)
the long-term##242##2##(1990-10#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-6#2)(1991-8#1)(1992-10#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1994-12#2)(1994-2#2)(1994-5#1)(1994-6#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2004-1#1)(2004-10#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-9#1)(2006-10#6)(2006-12#3)(2006-2#2)(2006-4#3)(2006-5#4)(2006-6#3)(2006-7#1)(2006-8#2)(2006-9#4)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#4)(2007-8#7)(2008-1#1)(2008-10#12)(2008-11#8)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#4)(2008-6#5)(2008-7#5)(2008-8#9)(2008-9#4)(2009-1#4)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#4)(2010-12#1)(2010-2#3)(2010-3#5)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#11)(2011-7#1)(2012-1#2)(2012-12#6)(2012-2#5)(2012-3#4)(2013-1#12)(2013-7#1)(2013-8#3)
the long-time##5##2##(1992-6#1)(2006-1#1)(2007-12#1)(2008-10#1)(2008-3#1)
the long-wavelength tail##2##3##(2007-12#1)(2008-3#1)
the long-wavelength##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
the longer peptide##2##3##(1992-5#1)(1997-4#1)
the longer term deficit##2##4##(1993-12#2)
the longer term##6##3##(1993-12#2)(1994-8#1)(2004-4#1)(2010-1#1)(2010-11#1)
the longer the##2##3##(1993-1#1)(2011-2#1)
the longer##40##2##(1990-2#1)(1992-5#1)(1993-1#1)(1993-12#2)(1994-10#1)(1994-4#1)(1994-8#1)(1995-10#1)(1995-3#1)(1995-8#3)(1996-2#1)(1996-5#2)(1997-4#2)(1997-7#1)(2004-4#1)(2005-11#2)(2006-8#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#4)(2008-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2011-2#1)(2011-3#1)(2013-1#1)
the longer-chain gangliosides##2##3##(1991-9#2)
the longer-chain##3##2##(1991-9#2)(2009-3#1)
the longest and##2##3##(1991-6#1)(2008-8#1)
the longest##52##2##(1990-8#1)(1991-2#2)(1991-6#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-4#2)(1994-10#1)(1994-3#1)(1994-6#1)(1995-1#1)(1996-10#2)(1996-5#1)(1996-7#1)(1996-9#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-1#1)(2005-11#1)(2006-8#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-9#1)(2010-11#1)(2011-2#5)(2012-12#1)(2012-3#2)(2013-1#1)
the longevity of the##5##4##(1992-5#1)(1993-11#1)(2009-7#1)(2009-9#1)(2012-2#1)
the longevity of##9##3##(1992-5#1)(1993-11#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-7#1)(2009-9#1)(2012-2#1)(2013-1#1)
the longevity##13##2##(1992-5#1)(1993-11#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-5#1)(2009-7#1)(2009-9#1)(2012-2#1)(2013-1#1)
the longissimus##2##2##(2006-12#1)(2010-4#1)
the longitudinal and##2##3##(2007-12#1)(2009-7#1)
the longitudinal axis of the forearm##3##6##(2006-11#3)
the longitudinal axis of the##8##5##(2006-11#3)(2006-3#1)(2007-12#1)(2007-4#1)(2008-7#1)(2011-2#1)
the longitudinal axis of##9##4##(2006-11#3)(2006-3#1)(2007-12#1)(2007-4#1)(2008-7#1)(2008-9#1)(2011-2#1)
the longitudinal component##2##3##(2007-11#1)(2010-8#1)
the longitudinal direction of the##2##5##(2006-10#1)(2009-7#1)
the longitudinal direction##9##3##(2006-10#1)(2007-12#2)(2007-4#1)(2008-3#2)(2008-9#1)(2009-3#1)(2009-7#1)
the longitudinal directions##2##3##(2008-3#2)
the longitudinal effects of##3##4##(2010-2#1)(2010-7#1)(2011-1#1)
the longitudinal glia##2##3##(2008-7#2)
the longitudinal muscle##2##3##(1991-10#1)(1997-3#1)
the longitudinal##67##2##(1991-10#1)(1991-12#1)(1992-12#1)(1995-6#1)(1996-1#1)(1997-3#1)(1997-5#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#3)(2006-3#1)(2006-4#1)(2006-5#1)(2007-11#3)(2007-12#7)(2007-2#1)(2007-4#2)(2008-2#1)(2008-3#7)(2008-6#1)(2008-7#5)(2008-9#3)(2009-11#1)(2009-12#1)(2009-3#2)(2009-7#2)(2009-8#1)(2010-10#1)(2010-2#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
the longitudinally##3##2##(1994-4#1)(2007-12#1)(2008-2#1)
the longstanding##2##2##(2006-10#1)(2007-8#1)
the longterm##4##2##(2006-7#1)(2006-8#1)(2007-7#1)(2013-1#1)
the looming-detector's##3##2##(2006-7#3)
the loop between##2##3##(1995-2#1)(2009-11#1)
the loop is##3##3##(1994-8#1)(1995-10#1)(1995-6#1)
the loop ligation##2##3##(1995-1#2)
the loop ligature##2##3##(1995-1#2)
the loop linking##2##3##(1996-7#2)
the loop of##3##3##(1993-11#1)(1995-2#1)(2008-10#1)
the loop region##4##3##(1993-8#1)(1994-8#1)(2008-4#1)(2011-1#1)
the loop regions##3##3##(1990-7#1)(1992-9#1)(1994-8#1)
the loop to##2##3##(1995-1#1)(2007-12#1)
the loop with##2##3##(2007-12#1)(2008-11#1)
the loop##53##2##(1990-7#1)(1992-1#1)(1992-11#1)(1992-3#2)(1992-9#1)(1993-11#1)(1993-8#1)(1994-8#3)(1995-1#7)(1995-10#1)(1995-2#4)(1995-5#1)(1995-6#2)(1995-8#1)(1996-5#1)(1996-7#2)(1997-2#2)(2007-12#4)(2008-10#2)(2008-11#3)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#2)(2010-8#1)(2011-1#1)(2012-3#1)
the loop-loop helix##3##3##(1997-5#3)
the loops between##2##3##(1994-9#1)(1997-1#1)
the loops of##2##3##(1994-11#1)(1995-3#1)
the loops##7##2##(1994-11#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-8#1)(1997-1#1)(2008-10#1)
the loose bodies##2##3##(2007-7#2)
the loosely##2##2##(2005-11#1)(2008-5#1)
the losing##2##2##(1996-3#1)(2007-9#1)
the loss and##2##3##(2008-3#1)(2013-7#1)
the loss in the##2##4##(2006-9#1)(2007-12#1)
the loss in##9##3##(1994-9#1)(1996-1#1)(2006-9#1)(2007-12#1)(2007-2#1)(2008-9#1)(2009-5#1)(2010-1#1)(2013-1#1)
the loss is##3##3##(1990-11#1)(2007-12#1)(2008-3#1)
the loss level##2##3##(2008-10#1)(2008-2#1)
the loss of B-PE fluorescence in the##2##7##(2008-10#2)
the loss of PLD activity##2##5##(1991-2#1)(1996-5#1)
the loss of a hydrogen bond##2##6##(1990-8#1)(1991-2#1)
the loss of a##14##4##(1990-8#1)(1991-2#1)(1991-9#1)(1992-7#1)(1993-2#1)(1993-3#1)(1993-6#1)(1995-1#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-4#1)(2008-7#1)(2012-3#1)
the loss of activity##2##4##(1995-5#1)(1996-5#1)
the loss of an##2##4##(1993-11#1)(2008-12#1)
the loss of cell##2##4##(1994-3#1)(1997-4#1)
the loss of cellular##2##4##(2008-11#1)(2011-2#1)
the loss of dopaminergic neurons##2##5##(2008-11#2)
the loss of dopaminergic##5##4##(1995-5#1)(1996-10#1)(2008-11#2)(2013-8#1)
the loss of endogenous##2##4##(1996-9#1)(2008-11#1)
the loss of fluorescence##2##4##(2008-10#1)(2008-5#1)
the loss of function of the##2##6##(1996-4#1)(2011-3#1)
the loss of function of##3##5##(1996-4#2)(2011-3#1)
the loss of function##4##4##(1996-4#2)(1997-8#1)(2011-3#1)
the loss of hormone##2##4##(1997-7#2)
the loss of its##2##4##(1997-7#1)(2008-10#1)
the loss of one##4##4##(1990-2#1)(1990-4#1)(2008-7#1)(2008-9#1)
the loss of photosynthetic capacity##2##5##(2006-12#1)(2008-10#1)
the loss of renal##2##4##(1990-2#1)(2011-2#1)
the loss of the NLS only decreases shuttling of aPKCζ##2##10##(2012-12#2)
the loss of the##28##4##(1990-12#2)(1990-8#1)(1991-7#1)(1993-11#1)(1993-9#1)(1994-8#1)(1995-11#1)(1995-5#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-12#2)(2008-10#3)(2008-2#1)(2009-12#1)(2009-8#2)(2011-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
the loss of their##3##4##(1990-11#1)(2005-8#1)(2010-12#1)
the loss of this##5##4##(1996-4#1)(1997-7#1)(1997-8#1)(2010-5#1)(2011-2#1)
the loss of##231##3##(1990-10#1)(1990-11#4)(1990-12#3)(1990-2#3)(1990-4#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#3)(1991-7#3)(1991-9#3)(1992-11#2)(1992-12#2)(1992-2#1)(1992-5#1)(1992-7#2)(1992-8#3)(1993-11#5)(1993-2#3)(1993-3#1)(1993-6#3)(1993-7#1)(1993-9#2)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#2)(1994-7#1)(1994-8#3)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#4)(1995-6#2)(1996-10#1)(1996-11#1)(1996-2#1)(1996-4#3)(1996-5#3)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#6)(1997-8#3)(2005-11#1)(2005-8#2)(2006-10#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#4)(2008-10#15)(2008-11#7)(2008-12#1)(2008-2#6)(2008-3#7)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#4)(2009-10#4)(2009-12#1)(2009-3#2)(2009-8#3)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#2)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#3)
the loss or##2##3##(2007-11#1)(2013-1#1)
the loss##264##2##(1990-10#1)(1990-11#5)(1990-12#3)(1990-2#3)(1990-4#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#3)(1991-7#3)(1991-9#3)(1992-11#2)(1992-12#2)(1992-2#1)(1992-5#1)(1992-7#2)(1992-8#3)(1993-11#5)(1993-2#3)(1993-3#1)(1993-6#3)(1993-7#1)(1993-9#2)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#2)(1994-7#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#4)(1995-6#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-4#3)(1996-5#3)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#6)(1997-8#3)(2005-11#1)(2005-8#2)(2006-10#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#5)(2007-12#6)(2007-2#4)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#16)(2008-11#7)(2008-12#1)(2008-2#8)(2008-3#12)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#5)(2009-10#4)(2009-12#1)(2009-3#2)(2009-5#1)(2009-8#3)(2010-1#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#2)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#2)(2012-11#2)(2012-12#5)(2012-2#3)(2012-3#3)(2013-1#9)(2013-7#2)(2013-8#3)
the losses caused by##2##4##(2008-1#1)(2008-10#1)
the losses of##2##3##(2007-12#1)(2008-10#1)
the losses##13##2##(1997-8#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2013-1#1)(2013-8#1)
the lost of##2##3##(2008-10#1)(2011-2#1)
the lost##8##2##(1994-8#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)(2013-7#1)
the lot##3##2##(2008-10#3)
the lotion##3##2##(2008-5#3)
the lottery##5##2##(2007-10#2)(2013-1#3)
the loud##2##2##(2008-8#1)(2013-1#1)
the low Km##3##3##(1990-11#1)(1994-8#1)(1994-9#1)
the low Mr fraction##2##4##(1990-5#2)
the low Mr##3##3##(1990-5#2)(1991-2#1)
the low abundance of##3##4##(1990-3#2)(1996-12#1)
the low abundance##4##3##(1990-3#2)(1996-12#1)(2013-8#1)
the low activity##4##3##(1995-3#1)(1996-3#1)(1997-7#1)(2008-7#1)
the low affinity binding##2##4##(1990-5#1)(1991-2#1)
the low affinity site##2##4##(1990-3#2)
the low affinity##15##3##(1990-2#1)(1990-3#2)(1990-5#1)(1991-2#2)(1991-5#1)(1992-12#1)(1993-6#1)(1993-9#1)(1994-11#2)(1996-10#1)(2008-7#2)
the low and the##3##4##(2008-3#3)
the low and##5##3##(1991-4#1)(2008-3#3)(2008-6#1)
the low average##2##3##(1996-4#1)(2011-2#1)
the low back##7##3##(2004-10#1)(2006-7#2)(2008-12#3)(2013-8#1)
the low chemical oxygen demand##2##5##(2008-10#2)
the low chromatic sensitivity##2##4##(2008-2#2)
the low concentration and##2##4##(1996-3#1)(2008-6#1)
the low concentration of##2##4##(1992-3#1)(1994-6#1)
the low concentration##8##3##(1992-3#1)(1994-6#1)(1996-3#1)(2008-6#1)(2008-9#1)(2009-8#1)(2011-1#1)(2013-1#1)
the low concentrations of##3##4##(1992-7#1)(2008-10#1)(2010-11#1)
the low concentrations##5##3##(1992-4#1)(1992-7#1)(2005-11#1)(2008-10#1)(2010-11#1)
the low consumption of##2##4##(2008-10#1)(2008-5#1)
the low content of##2##4##(2008-10#1)(2013-8#1)
the low content##3##3##(1997-2#1)(2008-10#1)(2013-8#1)
the low cost of##4##4##(1992-5#1)(1996-2#1)(2008-10#1)(2012-2#1)
the low cost##5##3##(1992-5#1)(1996-2#1)(2008-10#1)(2010-8#1)(2012-2#1)
the low current##2##3##(1990-10#2)
the low density lipoprotein (LDL) receptor##5##6##(1993-9#2)(1995-8#3)
the low density lipoprotein (LDL)##7##5##(1992-5#1)(1993-9#2)(1995-8#3)(2008-5#1)
the low density lipoprotein receptor gene family##2##7##(1994-9#2)
the low density lipoprotein receptor##7##5##(1990-11#1)(1994-9#3)(1995-2#1)(2008-1#1)(2013-1#1)
the low density lipoprotein##14##4##(1990-11#1)(1992-5#1)(1993-9#2)(1994-9#3)(1995-2#1)(1995-8#3)(2008-1#1)(2008-5#1)(2013-1#1)
the low density##20##3##(1990-11#1)(1991-4#1)(1992-5#1)(1993-9#2)(1994-9#4)(1995-10#1)(1995-2#1)(1995-8#3)(1997-5#1)(2005-11#1)(2008-1#1)(2008-5#1)(2012-2#1)(2013-1#1)
the low dose ADR therapy##3##5##(1994-7#3)
the low dose ADR##4##4##(1994-7#4)
the low dose group##2##4##(2008-5#1)(2010-1#1)
the low dose of##2##4##(1996-7#1)(2008-7#1)
the low dose##16##3##(1990-11#1)(1994-7#4)(1994-8#1)(1996-7#1)(2008-5#2)(2008-7#6)(2010-1#1)
the low doses of##3##4##(1995-10#1)(1997-3#1)(2008-7#1)
the low doses##4##3##(1995-10#1)(1997-3#1)(2008-7#2)
the low end of the##2##5##(1995-4#1)(2008-9#1)
the low end of##4##4##(1995-4#1)(2008-9#2)(2011-1#1)
the low energy##4##3##(1993-8#1)(2008-10#1)(2008-12#1)(2009-4#1)
the low fat##2##3##(2004-11#1)(2008-4#1)
the low frequency##2##3##(2008-10#1)(2013-1#1)
the low impulsives##3##3##(2010-2#3)
the low incidence of##12##4##(1990-2#1)(1990-4#1)(1996-11#1)(2006-2#1)(2007-11#2)(2007-12#1)(2008-3#1)(2010-12#1)(2011-2#1)(2013-1#2)
the low level of##12##4##(1991-7#1)(1992-9#1)(1994-3#1)(1995-11#1)(1996-7#1)(2008-10#4)(2008-5#1)(2008-7#1)(2011-7#1)
the low level##14##3##(1991-7#2)(1992-9#1)(1994-3#1)(1995-11#1)(1996-2#1)(1996-7#1)(2008-10#4)(2008-5#1)(2008-7#1)(2011-7#1)
the low levels##2##3##(2005-7#1)(2008-7#1)
the low molecular mass##2##4##(1992-1#1)(1996-8#1)
the low molecular weight HA-based hydrogel##2##6##(2008-5#2)
the low molecular weight form of Hsp70##2##7##(1991-9#2)
the low molecular weight##10##4##(1990-4#1)(1991-9#2)(1995-3#1)(1996-9#1)(2005-7#1)(2008-4#1)(2008-5#2)(2009-4#1)
the low molecular##12##3##(1990-4#1)(1991-9#2)(1992-1#1)(1995-3#1)(1996-8#1)(1996-9#1)(2005-7#1)(2008-4#1)(2008-5#2)(2009-4#1)
the low nanomolar##6##3##(1993-4#1)(1996-8#1)(2004-12#1)(2008-10#2)(2012-2#1)
the low ng##2##3##(2007-8#1)(2008-10#1)
the low operating##2##3##(2007-12#1)(2008-10#1)
the low overall##3##3##(2008-7#1)(2013-1#2)
the low parts##2##3##(2007-12#1)(2007-3#1)
the low percentage of##2##4##(1994-6#1)(2008-10#1)
the low population##2##3##(1995-10#1)(2008-10#1)
the low pressure##2##3##(1996-3#2)
the low prevalence of##3##4##(2008-10#1)(2008-3#1)(2013-8#1)
the low range##2##3##(1993-8#1)(2008-10#1)
the low rate of##8##4##(1991-9#1)(1996-11#1)(2006-5#1)(2007-3#1)(2008-10#1)(2008-8#1)(2013-1#2)
the low risk of##2##4##(2011-2#1)(2012-3#1)
the low risk##5##3##(2007-8#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-3#1)
the low sensitivity of the##2##5##(2006-4#1)(2011-2#1)
the low sensitivity of##4##4##(1990-3#1)(2006-4#1)(2008-5#1)(2011-2#1)
the low sensitivity##6##3##(1990-3#1)(1991-4#1)(2006-4#1)(2008-5#1)(2011-2#1)(2012-12#1)
the low socioeconomic##3##3##(2006-4#1)(2008-4#1)(2010-7#1)
the low spin##2##3##(1990-5#1)(2007-3#1)
the low surface##4##3##(1994-3#1)(2005-11#1)(2010-4#2)
the low temperature##5##3##(1997-2#1)(2005-11#1)(2008-11#1)(2009-2#1)(2012-2#1)
the low value##2##3##(1991-7#1)(1991-8#1)
the low##427##2##(1990-10#3)(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#5)(1990-4#2)(1990-5#5)(1990-8#1)(1991-12#2)(1991-2#3)(1991-4#3)(1991-5#4)(1991-7#3)(1991-8#1)(1991-9#3)(1992-1#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#2)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#2)(1993-6#1)(1993-8#4)(1993-9#4)(1994-1#1)(1994-11#3)(1994-12#2)(1994-3#2)(1994-4#1)(1994-6#2)(1994-7#4)(1994-8#3)(1994-9#6)(1995-1#1)(1995-10#3)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#5)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#4)(1996-10#1)(1996-11#3)(1996-12#4)(1996-2#4)(1996-3#5)(1996-4#3)(1996-5#1)(1996-7#2)(1996-8#5)(1996-9#2)(1997-1#1)(1997-2#4)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#2)(2004-10#1)(2004-11#2)(2004-12#1)(2005-11#5)(2005-7#2)(2005-9#1)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#2)(2007-11#8)(2007-12#9)(2007-3#7)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#7)(2008-1#4)(2008-10#47)(2008-11#3)(2008-12#5)(2008-2#12)(2008-3#14)(2008-4#5)(2008-5#14)(2008-6#3)(2008-7#17)(2008-8#7)(2008-9#7)(2009-2#1)(2009-4#3)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#3)(2010-4#5)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#10)(2011-7#1)(2012-1#2)(2012-12#5)(2012-2#7)(2012-3#3)(2013-1#16)(2013-7#1)(2013-8#7)
the low- and##3##3##(1994-11#1)(2008-3#1)(2009-2#1)
the low-##4##2##(1994-11#1)(2008-10#1)(2008-3#1)(2009-2#1)
the low-CHO diet was##2##4##(2013-8#2)
the low-Km component of transport##3##5##(1991-9#3)
the low-absorption##2##2##(2008-2#2)
the low-affinity ATP binding site##2##5##(1990-7#2)
the low-affinity ATP##3##3##(1990-7#3)
the low-affinity receptor for##2##4##(1991-10#1)(1994-6#1)
the low-affinity site##2##3##(1990-11#1)(1994-3#1)
the low-affinity sites##3##3##(1991-2#1)(1992-3#1)(1995-12#1)
the low-affinity##22##2##(1990-11#1)(1990-3#1)(1990-7#3)(1990-8#1)(1991-10#1)(1991-2#1)(1991-4#1)(1992-3#1)(1992-9#1)(1994-3#2)(1994-5#2)(1994-6#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-4#1)(1997-7#1)(2007-9#1)
the low-coherence##2##2##(2008-3#2)
the low-cost##2##2##(2007-10#1)(2008-3#1)
the low-density lipoprotein (LDL) receptor##2##5##(1991-6#1)(2008-6#1)
the low-density lipoprotein##4##3##(1991-6#1)(2008-6#1)(2013-1#1)(2013-8#1)
the low-density##6##2##(1991-6#1)(2007-12#1)(2008-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
the low-dose##5##2##(1994-5#2)(1997-7#1)(2008-7#1)(2013-8#1)
the low-energy##3##2##(1992-6#1)(2008-7#1)(2012-2#1)
the low-fat##3##2##(1991-2#2)(2013-1#1)
the low-field proton##2##3##(1991-4#1)(1995-5#1)
the low-frequency fluctuations##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
the low-frequency##17##2##(1991-10#1)(1991-7#1)(2006-12#1)(2006-3#1)(2007-11#2)(2007-12#4)(2008-11#1)(2008-2#4)(2008-3#1)(2013-8#1)
the low-gain##4##2##(2007-12#1)(2008-1#1)(2008-3#2)
the low-grade##2##2##(1994-1#2)
the low-level##2##2##(1991-3#1)(1996-5#1)
the low-loss##2##2##(2007-12#1)(2008-3#1)
the low-molecular-weight##4##2##(1992-11#1)(1996-4#1)(2005-11#1)(2008-10#1)
the low-nanomolar range##2##3##(1997-1#1)(2012-2#1)
the low-order##5##2##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)
the low-pass##2##2##(2007-12#1)(2008-2#1)
the low-potential##2##2##(1994-5#1)(1995-8#1)
the low-power##5##2##(2008-1#1)(2008-2#1)(2008-3#2)(2009-5#1)
the low-pressure##5##2##(1995-6#1)(2007-11#1)(2008-2#2)(2008-3#1)
the low-protein##2##2##(2007-2#1)(2007-8#1)
the low-spin heme##2##3##(1990-7#1)(1997-4#1)
the low-spin##5##2##(1990-7#1)(1992-12#1)(1993-8#1)(1997-4#1)(2009-3#1)
the low-temperature##12##2##(1990-8#2)(1991-7#3)(1993-8#1)(1996-2#2)(2008-10#2)(2008-8#1)(2011-2#1)
the lower abdomen##3##3##(1994-2#1)(2008-10#1)(2010-5#1)
the lower affinity##3##3##(1991-2#1)(1995-6#1)(1997-7#1)
the lower and upper##5##4##(1993-2#1)(2005-11#1)(2012-2#2)(2013-1#1)
the lower and##6##3##(1993-2#1)(2005-11#1)(2008-3#1)(2012-2#2)(2013-1#1)
the lower back##4##3##(2006-12#1)(2007-7#1)(2008-5#1)(2009-3#1)
the lower bound##2##3##(1995-3#1)(2007-11#1)
the lower boundary##2##3##(1997-1#1)(2008-3#1)
the lower brainstem and upper cervical##2##6##(2006-12#2)
the lower brainstem##5##3##(1990-9#1)(1994-10#1)(1996-9#1)(2006-12#2)
the lower cell yield##2##4##(2008-11#2)
the lower cell##3##3##(2008-11#3)
the lower cerebral autoregulatory threshold##2##5##(2008-7#2)
the lower cervical spine##9##4##(2006-11#1)(2007-1#6)(2007-4#2)
the lower cervical##12##3##(2006-11#1)(2007-1#6)(2007-4#3)(2007-8#1)(2008-12#1)
the lower concentration of##5##4##(2006-7#1)(2011-12#1)(2012-2#1)(2013-1#2)
the lower concentrations##2##3##(2013-8#2)
the lower cranial nerves##2##4##(2008-7#1)(2011-2#1)
the lower crust##5##3##(1996-4#5)
the lower crustal zone##2##4##(1996-4#2)
the lower detection limit##2##4##(2008-10#2)
the lower dose of##3##4##(1991-6#1)(1994-6#1)(1995-11#1)
the lower dose##7##3##(1990-6#1)(1991-6#1)(1994-6#1)(1995-11#1)(1996-10#1)(2008-10#1)(2012-3#1)
the lower end of the##4##5##(1990-6#1)(2008-10#2)(2011-2#1)
the lower end of##5##4##(1990-6#1)(2007-2#1)(2008-10#2)(2011-2#1)
the lower end##6##3##(1990-6#1)(1996-6#1)(2007-2#1)(2008-10#2)(2011-2#1)
the lower esophageal sphincter (LES)##2##5##(2011-2#1)(2013-8#1)
the lower esophageal sphincter##4##4##(1992-6#1)(2011-2#1)(2013-8#2)
the lower esophageal##5##3##(1992-6#1)(2011-2#2)(2013-8#2)
the lower expression of##2##4##(1992-3#1)(2008-10#1)
the lower extremities and##3##4##(1993-6#1)(2008-4#1)(2011-12#1)
the lower extremities is##2##4##(2007-8#1)(2008-7#1)
the lower extremities##42##3##(1991-7#1)(1991-9#1)(1993-6#1)(1993-7#1)(1994-11#1)(1995-8#1)(1997-3#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-4#3)(2006-8#1)(2007-11#3)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#3)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-2#1)(2009-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-7#1)
the lower extremity and##3##4##(2011-2#1)(2012-2#1)(2013-1#1)
the lower extremity of##2##4##(2006-11#1)(2008-6#1)
the lower extremity##23##3##(2005-10#2)(2006-11#1)(2006-12#1)(2006-7#1)(2007-1#1)(2007-4#1)(2007-7#1)(2008-12#1)(2008-6#3)(2009-1#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
the lower eyelid##9##3##(2008-5#2)(2008-8#1)(2010-11#1)(2010-12#5)
the lower face##3##3##(2007-12#3)
the lower female genital tract##3##5##(1990-2#1)(1994-1#1)(1996-12#1)
the lower female reproductive tract##2##5##(1996-12#2)
the lower female##5##3##(1990-2#1)(1994-1#1)(1996-12#3)
the lower gastrointestinal tract##2##4##(2010-2#1)(2012-1#1)
the lower genital tract##5##4##(1991-2#2)(1994-1#1)(2011-2#2)
the lower half of the##2##5##(2007-7#1)(2008-9#1)
the lower half##3##3##(2007-7#1)(2008-6#1)(2008-9#1)
the lower infant mortality rate##2##5##(2013-1#2)
the lower infant mortality##4##4##(2013-1#4)
the lower jaw##3##3##(2007-5#1)(2008-5#1)(2013-1#1)
the lower leaf layer##2##4##(2008-10#2)
the lower left##2##3##(2008-4#1)(2013-1#1)
the lower leg##19##3##(1990-11#2)(1990-6#1)(1991-3#1)(1994-6#1)(1997-8#2)(2006-11#2)(2007-11#1)(2007-4#1)(2007-8#5)(2009-3#1)(2012-12#2)
the lower level of##6##4##(1993-8#1)(1995-7#1)(2007-12#1)(2008-10#1)(2010-12#1)(2013-1#1)
the lower levels of##2##4##(2008-10#1)(2012-12#1)
the lower limb in##2##4##(2007-4#2)
the lower limb##22##3##(1990-6#1)(1995-2#1)(2007-4#6)(2007-5#2)(2007-8#2)(2008-6#1)(2010-4#1)(2011-2#4)(2012-1#3)(2013-1#1)
the lower limbs in##4##4##(1995-9#1)(2006-10#1)(2006-4#1)(2012-1#1)
the lower limbs using##2##4##(1990-10#1)(2007-11#1)
the lower limbs with##2##4##(1996-4#1)(2009-9#1)
the lower limbs##46##3##(1990-10#1)(1990-11#2)(1990-2#1)(1990-3#2)(1990-6#1)(1991-11#1)(1991-3#1)(1991-4#2)(1991-6#2)(1992-10#1)(1993-5#1)(1995-9#2)(1996-4#1)(1997-3#2)(2006-10#2)(2006-4#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-10#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-9#2)(2012-1#3)(2012-12#2)(2012-2#1)(2013-1#4)
the lower limit for the##2##5##(2006-10#1)(2011-12#1)
the lower limit for##4##4##(1993-11#1)(2006-10#1)(2008-3#1)(2011-12#1)
the lower limit of detection##5##5##(1996-8#1)(1997-3#1)(2008-10#2)(2012-12#1)
the lower limit of the##3##5##(1990-11#1)(2008-2#1)(2010-12#1)
the lower limit of##13##4##(1990-11#1)(1996-8#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-12#1)(2013-1#1)
the lower limit##21##3##(1990-11#1)(1993-11#1)(1996-8#1)(1997-3#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-12#1)(2011-12#1)(2012-12#1)(2013-1#1)
the lower limits of##2##4##(2007-1#1)(2008-10#1)
the lower lip##6##3##(1991-8#2)(2007-2#1)(2007-9#1)(2013-1#2)
the lower lobe of the right lung##2##7##(2007-7#1)(2007-8#1)
the lower lobe##6##3##(2007-7#1)(2007-8#5)
the lower lumbar spine##3##4##(2006-8#1)(2008-6#1)(2009-3#1)
the lower lumbar##5##3##(1992-1#1)(2006-8#1)(2007-11#1)(2008-6#1)(2009-3#1)
the lower nucleus##2##3##(2008-8#2)
the lower number of##2##4##(2007-3#1)(2008-7#1)
the lower pH##2##3##(1992-12#1)(1996-7#1)
the lower part by##2##4##(1993-9#1)(2006-2#1)
the lower part of the##4##5##(2005-10#1)(2007-3#1)(2008-10#1)(2008-2#1)
the lower part of##7##4##(1995-3#1)(2005-10#1)(2006-11#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-2#1)
the lower part##10##3##(1993-9#1)(1995-3#1)(2005-10#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-2#1)
the lower pole of the left testis##2##7##(2006-10#2)
the lower pole of the##4##5##(2006-10#3)(2006-9#1)
the lower pole##6##3##(1992-3#1)(2006-10#3)(2006-9#1)(2008-9#1)
the lower portion of the##2##5##(2004-11#1)(2008-5#1)
the lower posterior##2##3##(2011-2#1)(2013-1#1)
the lower prevalence of##2##4##(2006-1#1)(2007-12#1)
the lower rate of##2##4##(1996-3#1)(2008-10#1)
the lower rectum and##2##4##(2009-5#1)(2010-12#1)
the lower rectum##5##3##(1990-9#1)(1993-5#1)(2009-5#1)(2010-12#2)
the lower rim##3##3##(1996-5#3)
the lower small intestine##3##4##(2006-10#1)(2008-5#2)
the lower spectrum of illness##2##5##(2011-2#2)
the lower spinal##2##3##(2007-12#1)(2007-3#1)
the lower spine##3##3##(2007-4#1)(2007-8#1)(2008-6#1)
the lower stratosphere##4##3##(2008-3#4)
the lower temperature##4##3##(1992-10#1)(2008-10#1)(2008-11#1)(2010-4#1)
the lower temperatures##2##3##(1995-5#1)(2010-2#1)
the lower the##18##3##(1991-12#1)(1991-8#1)(1992-1#1)(1996-6#1)(1997-5#1)(2005-11#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#3)
the lower third of the##4##5##(2006-8#1)(2010-11#1)(2013-7#2)
the lower third of##5##4##(2006-8#1)(2010-11#2)(2013-7#2)
the lower third##6##3##(2006-8#1)(2010-11#2)(2013-7#2)(2013-8#1)
the lower trachea##3##3##(1997-1#1)(2007-8#1)(2013-1#1)
the lower trunk##2##3##(2006-9#1)(2010-2#1)
the lower values##4##3##(2007-3#1)(2008-10#1)(2011-2#2)
the lower##585##2##(1990-10#1)(1990-11#5)(1990-12#3)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#7)(1990-9#2)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#3)(1991-4#4)(1991-6#6)(1991-7#1)(1991-8#3)(1991-9#2)(1992-1#2)(1992-10#3)(1992-12#1)(1992-3#2)(1992-5#2)(1992-6#2)(1992-7#4)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-5#4)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#2)(1994-9#5)(1995-11#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-10#1)(1996-12#5)(1996-3#1)(1996-4#8)(1996-5#3)(1996-6#3)(1996-7#1)(1996-8#3)(1996-9#3)(1997-1#3)(1997-3#4)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#4)(2004-11#1)(2005-1#1)(2005-10#4)(2005-11#4)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#9)(2006-11#7)(2006-12#6)(2006-2#2)(2006-4#5)(2006-6#2)(2006-7#2)(2006-8#6)(2006-9#2)(2007-1#8)(2007-10#3)(2007-11#12)(2007-12#7)(2007-2#4)(2007-3#6)(2007-4#16)(2007-5#4)(2007-6#1)(2007-7#10)(2007-8#21)(2007-9#3)(2008-1#4)(2008-10#48)(2008-11#8)(2008-12#5)(2008-2#9)(2008-3#9)(2008-4#4)(2008-5#11)(2008-6#8)(2008-7#14)(2008-8#7)(2008-9#4)(2009-1#2)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#6)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#4)(2010-11#4)(2010-12#12)(2010-2#4)(2010-4#4)(2010-5#2)(2010-8#5)(2011-1#7)(2011-12#4)(2011-2#22)(2012-1#7)(2012-12#11)(2012-2#8)(2012-3#1)(2013-1#26)(2013-7#3)(2013-8#11)
the lower-bound##2##2##(2007-12#1)(2008-2#1)
the lower-level##2##2##(2008-6#1)(2009-10#1)
the lower-order structure##2##3##(2011-2#2)
the lowered##6##2##(1997-6#1)(2005-7#1)(2005-9#1)(2008-5#2)(2008-7#1)
the lowering of total##2##4##(2005-10#2)
the lowering of##9##3##(1991-12#1)(1993-12#1)(1996-2#1)(2005-10#2)(2005-8#1)(2008-10#1)(2008-11#2)
the lowest and##6##3##(1995-6#1)(2007-11#1)(2008-9#1)(2011-2#2)(2012-11#1)
the lowest at##2##3##(1993-9#1)(2008-2#1)
the lowest average##2##3##(1990-2#1)(2007-5#1)
the lowest blanks##2##3##(2008-10#2)
the lowest body##2##3##(2008-7#1)(2009-2#1)
the lowest concentration of##4##4##(2005-12#1)(2008-10#1)(2010-10#1)(2013-8#1)
the lowest concentration##9##3##(1991-12#1)(1991-9#1)(1994-11#1)(2005-12#1)(2007-1#1)(2008-10#2)(2010-10#1)(2013-8#1)
the lowest cost##3##3##(1996-2#1)(2005-9#1)(2008-5#1)
the lowest density##2##3##(2007-11#1)(2011-2#1)
the lowest detected##2##3##(2008-10#1)(2009-5#1)
the lowest detection##2##3##(2008-10#2)
the lowest effective##4##3##(1994-9#1)(1996-1#1)(2008-3#1)(2009-4#1)
the lowest energy##3##3##(2006-4#1)(2008-5#1)(2011-2#1)
the lowest excited singlet state##4##5##(2008-10#2)(2010-2#2)
the lowest for##2##3##(2007-7#1)(2008-4#1)
the lowest in the##3##4##(1993-8#1)(2008-7#1)(2009-10#1)
the lowest in##10##3##(1991-6#1)(1993-8#1)(1996-8#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-10#1)(2013-1#1)
the lowest incidence of##3##4##(2005-12#1)(2007-11#1)(2007-7#1)
the lowest incidence##6##3##(2005-12#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#2)
the lowest level in##2##4##(2008-10#2)
the lowest level of##6##4##(1994-3#1)(1996-12#1)(2006-7#2)(2008-10#1)(2008-7#1)
the lowest level##14##3##(1994-3#1)(1995-7#1)(1996-12#1)(2006-7#2)(2008-10#4)(2008-7#1)(2008-8#1)(2009-3#1)(2013-1#2)
the lowest levels of##7##4##(1993-11#1)(1995-8#1)(2007-10#1)(2008-10#1)(2010-2#1)(2010-5#1)(2013-1#1)
the lowest limit for##2##4##(2007-9#1)(2008-10#1)
the lowest limit of detection##2##5##(2008-10#2)
the lowest limit##4##3##(2007-9#1)(2008-10#3)
the lowest local extinction probability##2##5##(2008-8#2)
the lowest mean##7##3##(1995-12#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-12#1)(2012-12#1)
the lowest number of##2##4##(2008-3#1)(2012-12#1)
the lowest numbers##2##3##(2008-10#1)(2008-12#1)
the lowest on##2##3##(2008-10#1)(2013-7#1)
the lowest one##2##3##(1990-6#1)(2012-12#1)
the lowest point##2##3##(2008-2#1)(2013-8#1)
the lowest possible dose##4##4##(1991-8#1)(1992-2#1)(2007-11#1)(2007-12#1)
the lowest possible##7##3##(1991-8#1)(1992-2#1)(1995-7#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-6#1)
the lowest prevalence of##3##4##(2006-8#1)(2012-3#2)
the lowest quartile##3##3##(2007-10#1)(2010-8#1)(2011-2#1)
the lowest rate##4##3##(1990-9#1)(2006-2#1)(2013-1#2)
the lowest repetition rate ever##2##5##(2007-11#1)(2007-12#1)
the lowest scores##2##3##(2009-9#1)(2012-3#1)
the lowest sensitivity##3##3##(1990-10#1)(2008-10#2)
the lowest survival##2##3##(2006-7#1)(2010-12#1)
the lowest temperature##2##3##(2005-11#1)(2008-8#1)
the lowest under##2##3##(2008-11#1)(2013-8#1)
the lowest value##3##3##(2008-3#2)(2011-1#1)
the lowest values##5##3##(1996-5#1)(2008-10#1)(2008-11#1)(2010-4#1)(2013-1#1)
the lowest was##5##3##(2008-12#3)(2008-5#1)(2013-8#1)
the lowest##335##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#2)(1993-9#2)(1994-11#2)(1994-3#2)(1994-6#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-7#3)(1995-8#2)(1996-1#2)(1996-12#2)(1996-2#3)(1996-3#3)(1996-5#2)(1996-8#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-7#2)(1997-8#1)(2004-12#1)(2004-4#1)(2005-11#3)(2005-12#2)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#3)(2006-8#3)(2007-1#4)(2007-10#2)(2007-11#7)(2007-12#5)(2007-2#1)(2007-3#2)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#56)(2008-11#3)(2008-12#6)(2008-2#8)(2008-3#15)(2008-4#3)(2008-5#16)(2008-6#3)(2008-7#3)(2008-8#8)(2008-9#3)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#2)(2009-4#5)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#3)(2010-5#3)(2010-7#1)(2010-8#4)(2011-1#2)(2011-12#3)(2011-2#13)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#15)(2013-7#2)(2013-8#7)
the lowest-cost##3##2##(1995-2#1)(2008-2#1)(2008-3#1)
the lowest-energy##2##2##(1991-9#2)
the lowest-order mode##3##3##(2007-12#1)(2008-1#1)(2008-2#1)
the lowest-order##8##2##(2007-12#3)(2008-1#2)(2008-2#1)(2008-3#2)
the ltdh##2##2##(1994-11#2)
the lubrication##2##2##(2005-11#1)(2007-9#1)
the luciferase activity##2##3##(1992-12#1)(2008-11#1)
the luciferase gene under##2##4##(1992-4#1)(1996-11#1)
the luciferase gene##10##3##(1991-2#1)(1992-4#1)(1994-9#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-4#2)(2008-11#2)
the luciferase reporter gene in##2##5##(1994-8#1)(1996-5#1)
the luciferase reporter gene##4##4##(1992-9#1)(1994-8#1)(1996-5#1)(2008-9#1)
the luciferase reporter##5##3##(1992-9#1)(1994-8#1)(1996-5#1)(2008-9#2)
the luciferase##22##2##(1990-10#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-9#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-4#2)(1996-5#1)(1997-2#2)(2008-11#3)(2008-4#1)(2008-9#2)
the luciferases of##2##3##(1990-7#2)
the lucigenin##5##2##(2008-10#5)
the lucigenin-CL system##2##3##(2008-10#2)
the lum and the lux operons##3##6##(1996-2#3)
the lum and##4##3##(1996-2#4)
the lum##5##2##(1996-2#5)
the lumbar and cervical##4##4##(2006-7#2)(2007-8#2)
the lumbar and##5##3##(2006-7#3)(2007-8#2)
the lumbar area##4##3##(1996-3#1)(2007-6#1)(2009-2#1)(2012-2#1)
the lumbar disc##3##3##(2006-2#1)(2006-7#1)(2008-12#1)
the lumbar dorsal horn##2##4##(1993-7#2)
the lumbar region##6##3##(2007-6#1)(2007-7#1)(2008-6#1)(2008-7#1)(2012-2#2)
the lumbar segment##2##3##(2007-8#2)
the lumbar spinal canal##2##4##(2008-7#2)
the lumbar spinal cord##8##4##(1990-4#1)(1990-5#2)(1994-2#2)(1994-5#2)(2008-7#1)
the lumbar spinal##11##3##(1990-4#1)(1990-5#2)(1994-2#3)(1994-5#2)(2008-7#3)
the lumbar spine and##4##4##(1991-11#1)(2007-11#1)(2007-8#1)(2012-2#1)
the lumbar spine were##3##4##(2007-11#1)(2007-8#2)
the lumbar spine##56##3##(1991-11#2)(1992-1#1)(1993-11#1)(2005-2#1)(2006-12#1)(2006-8#8)(2006-9#1)(2007-11#7)(2007-6#1)(2007-7#4)(2007-8#5)(2008-12#1)(2008-4#1)(2009-1#2)(2009-2#1)(2009-5#1)(2010-3#4)(2011-12#2)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-8#1)
the lumbar sympathetic trunk##6##4##(1994-2#1)(2006-7#5)
the lumbar vein##3##3##(2011-2#3)
the lumbar vertebrae##5##3##(1993-11#1)(1996-6#1)(2006-8#1)(2007-7#1)(2008-5#1)
the lumbar##121##2##(1990-4#1)(1990-5#2)(1990-7#1)(1991-11#2)(1991-9#1)(1992-1#2)(1993-11#2)(1993-7#2)(1993-9#1)(1994-2#4)(1994-5#2)(1996-3#1)(1996-6#1)(1997-2#1)(2005-2#1)(2005-3#1)(2006-12#1)(2006-2#1)(2006-7#9)(2006-8#12)(2006-9#1)(2007-11#9)(2007-6#4)(2007-7#8)(2007-8#9)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2009-1#2)(2009-2#2)(2009-5#1)(2010-3#4)(2011-12#2)(2011-2#9)(2012-1#2)(2012-12#2)(2012-2#7)(2012-3#1)(2013-8#1)
the lumbo-sacral spine##5##3##(2007-11#4)(2007-8#1)
the lumbo-sacral##6##2##(2007-11#4)(2007-7#1)(2007-8#1)
the lumbosacral area##5##3##(1992-11#1)(2007-7#1)(2007-8#1)(2010-6#2)
the lumbosacral junction##3##3##(2006-8#1)(2007-1#1)(2009-9#1)
the lumbosacral spinal cord##5##4##(1991-5#2)(1995-6#1)(1997-2#1)(2010-8#1)
the lumbosacral##26##2##(1990-11#1)(1991-5#2)(1992-11#1)(1992-9#1)(1995-5#1)(1995-6#2)(1996-12#1)(1997-2#1)(2006-10#1)(2006-8#2)(2007-1#2)(2007-7#1)(2007-8#1)(2008-12#1)(2008-7#1)(2009-9#1)(2010-6#2)(2010-8#1)(2013-8#3)
the lumen and##2##3##(1996-12#1)(2010-12#1)
the lumen is##2##3##(1997-2#1)(2007-12#1)
the lumen of the endoplasmic reticulum##2##6##(1994-9#1)(2008-4#1)
the lumen of the stylet extension and##2##7##(2008-10#2)
the lumen of the##20##4##(1993-6#2)(1993-8#1)(1994-9#1)(1996-2#1)(1997-1#1)(2006-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2011-2#3)
the lumen of##27##3##(1993-6#2)(1993-8#1)(1994-9#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-6#1)(2006-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-7#2)(2010-12#1)(2010-4#1)(2011-2#3)
the lumen##63##2##(1991-12#1)(1991-3#1)(1992-5#1)(1992-6#3)(1993-12#2)(1993-6#2)(1993-8#1)(1994-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#2)(1997-2#1)(1997-6#1)(2006-10#3)(2006-11#1)(2007-12#6)(2007-3#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#6)(2010-12#2)(2010-4#1)(2011-2#4)(2012-11#1)
the lumenal domain of Sec63p##2##5##(1997-6#2)
the lumenal##4##2##(1997-6#4)
the luminaire##2##2##(2008-3#2)
the luminal and basal##3##4##(2008-5#3)
the luminal and##4##3##(2007-11#1)(2008-5#3)
the luminal surface LDL concentration was##2##6##(2008-9#2)
the luminal surface of the##3##5##(1995-11#1)(2006-5#1)(2008-9#1)
the luminal surface##6##3##(1995-11#1)(2006-5#1)(2008-9#4)
the luminal surfaces of acinar cells##2##6##(1995-11#2)
the luminal surfaces##3##3##(1995-11#2)(2010-2#1)
the luminal##27##2##(1990-6#2)(1991-2#1)(1991-9#1)(1992-9#1)(1993-12#1)(1995-11#3)(1995-3#1)(2006-10#3)(2006-5#2)(2007-11#1)(2007-7#1)(2008-5#4)(2008-8#1)(2008-9#4)(2010-2#1)
the luminance in##2##3##(2008-3#2)
the luminance levels##2##3##(2007-1#1)(2008-3#1)
the luminance##7##2##(2007-1#1)(2008-2#1)(2008-3#4)(2008-4#1)
the luminescence intensity##3##3##(2005-11#1)(2007-12#1)(2008-10#1)
the luminescence of##2##3##(2008-10#1)(2010-7#1)
the luminescence##14##2##(1996-12#1)(2005-11#2)(2007-12#1)(2008-10#4)(2008-2#4)(2008-7#1)(2010-7#1)
the luminescent##10##2##(1990-8#1)(1994-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#1)(2009-11#1)
the luminescing##2##2##(2008-10#2)
the luminol-H(2)O(2)##2##2##(2008-10#2)
the luminous##3##2##(2008-2#2)(2008-3#1)
the lump##3##2##(1991-12#1)(2005-12#1)(2006-1#1)
the lumpectomy##2##2##(1994-8#1)(2009-8#1)
the lunar cycle##3##3##(2011-1#3)
the lunar##7##2##(1992-1#1)(2008-2#1)(2008-3#1)(2011-1#3)(2013-8#1)
the lunate is##2##3##(2012-3#1)(2013-1#1)
the lung after##2##3##(2008-6#1)(2013-7#1)
the lung and other##2##4##(2012-12#1)(2013-8#1)
the lung and##19##3##(1990-12#1)(1990-5#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-3#1)(1997-1#1)(2006-9#2)(2007-8#1)(2008-10#2)(2008-12#1)(2009-10#1)(2010-10#1)(2010-7#1)(2010-9#1)(2012-12#1)(2013-8#1)
the lung are##5##3##(1990-8#1)(2005-11#1)(2007-8#1)(2008-6#1)(2010-12#1)
the lung as##3##3##(1991-2#1)(2012-1#1)(2012-12#1)
the lung at##2##3##(1997-1#1)(2011-2#1)
the lung can be##4##4##(1992-12#2)(2008-7#1)(2013-7#1)
the lung can##5##3##(1992-12#2)(1996-4#1)(2008-7#1)(2013-7#1)
the lung cancer incidence##3##4##(1996-3#2)(2008-7#1)
the lung cancer##8##3##(1991-2#1)(1996-3#2)(2005-10#1)(2008-11#1)(2008-7#1)(2012-12#1)(2013-7#1)
the lung developed##2##3##(1992-2#1)(2007-6#1)
the lung function in mustard gas exposed patients with bronchiolitis##2##10##(2007-2#2)
the lung function##4##3##(2007-2#2)(2008-9#1)(2009-1#1)
the lung has##2##3##(2012-1#1)(2012-12#1)
the lung in##6##3##(1991-12#1)(2005-11#1)(2007-4#1)(2008-2#1)(2010-7#1)(2012-1#1)
the lung interstitium##3##3##(2007-11#1)(2010-10#2)
the lung is a##2##4##(1991-2#1)(2010-5#1)
the lung is##6##3##(1990-7#1)(1991-2#1)(1997-4#1)(2007-8#1)(2008-7#1)(2010-5#1)
the lung parenchyma##10##3##(1991-11#1)(1994-6#1)(2005-8#2)(2007-7#1)(2007-8#1)(2008-5#1)(2009-1#1)(2012-12#1)(2012-2#1)
the lung periphery##3##3##(1994-12#1)(2005-8#1)(2008-7#1)
the lung that##2##3##(2006-10#1)(2008-7#1)
the lung tissue##7##3##(1991-12#1)(1994-6#2)(1996-3#1)(2006-9#1)(2008-10#1)(2011-1#1)
the lung tissues##2##3##(2008-12#1)(2011-2#1)
the lung to##2##3##(1991-12#1)(2005-8#1)
the lung tumor##2##3##(2007-9#1)(2011-2#1)
the lung were##3##3##(1994-7#1)(2008-10#1)(2008-8#1)
the lung with##5##3##(1991-11#1)(1992-11#1)(1997-4#1)(2005-11#1)(2007-8#1)
the lung##302##2##(1990-11#1)(1990-12#3)(1990-3#2)(1990-5#4)(1990-7#2)(1990-8#2)(1991-1#1)(1991-11#2)(1991-12#6)(1991-2#4)(1991-5#1)(1991-6#1)(1991-9#2)(1992-11#2)(1992-12#5)(1992-2#4)(1992-3#2)(1992-4#1)(1992-8#1)(1992-9#3)(1993-10#2)(1993-7#1)(1994-12#6)(1994-2#1)(1994-3#3)(1994-6#6)(1994-7#3)(1995-12#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-11#2)(1996-12#1)(1996-3#4)(1996-4#2)(1996-6#1)(1997-1#7)(1997-2#2)(1997-4#3)(1997-5#1)(2005-10#1)(2005-11#7)(2005-7#1)(2005-8#7)(2005-9#1)(2006-10#3)(2006-6#1)(2006-8#1)(2006-9#4)(2007-11#6)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#18)(2007-9#4)(2008-1#2)(2008-10#14)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#4)(2008-5#3)(2008-6#7)(2008-7#12)(2008-8#3)(2008-9#3)(2009-1#2)(2009-10#1)(2009-3#1)(2009-5#2)(2009-7#1)(2010-10#7)(2010-11#1)(2010-12#3)(2010-3#4)(2010-5#5)(2010-7#3)(2010-8#2)(2010-9#3)(2011-1#2)(2011-2#8)(2011-3#1)(2012-1#8)(2012-11#2)(2012-12#8)(2012-2#3)(2012-3#2)(2013-1#13)(2013-7#3)(2013-8#4)
the lung]##4##2##(1991-9#1)(1994-3#1)(1997-5#1)(2008-1#1)
the lungfish##6##2##(1991-5#1)(1993-5#1)(1995-5#2)(2008-5#2)
the lungs and kidneys##2##4##(1994-3#1)(2008-5#1)
the lungs and other organs##2##5##(1994-5#1)(2009-6#1)
the lungs and other##3##4##(1994-5#1)(1995-8#1)(2009-6#1)
the lungs and the##3##4##(1994-10#1)(1997-4#1)(2012-1#1)
the lungs and to the##2##5##(1992-3#1)(2007-11#1)
the lungs and##25##3##(1991-12#1)(1992-3#1)(1994-10#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-8#1)(1996-3#1)(1997-1#1)(1997-4#1)(2005-11#1)(2005-9#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-3#1)(2008-5#3)(2009-6#1)(2010-12#1)(2011-2#1)(2012-1#2)
the lungs are##4##3##(1991-5#1)(2008-1#1)(2008-5#1)(2010-5#1)
the lungs as##2##3##(1997-1#1)(2007-8#1)
the lungs by##4##3##(1991-9#1)(2005-7#1)(2008-8#1)(2013-1#1)
the lungs can##2##3##(2006-10#1)(2007-8#1)
the lungs during##2##3##(2006-10#1)(2010-12#1)
the lungs have##2##3##(2007-12#1)(2007-8#1)
the lungs in a##2##4##(2007-11#1)(2008-5#1)
the lungs in##6##3##(1994-9#1)(2007-11#1)(2008-5#2)(2010-8#1)(2011-1#1)
the lungs of both##2##4##(2008-10#1)(2008-6#1)
the lungs of children##2##4##(1991-12#1)(1997-1#1)
the lungs of##17##3##(1991-12#1)(1991-8#1)(1994-11#1)(1994-7#1)(1996-8#1)(1997-1#1)(2005-7#1)(2007-11#1)(2008-10#2)(2008-6#1)(2008-8#1)(2010-12#1)(2012-2#1)(2013-1#3)
the lungs or##3##3##(2005-8#1)(2007-8#1)(2008-1#1)
the lungs should##2##3##(2006-10#1)(2007-9#1)
the lungs was##5##3##(1996-3#1)(2007-12#2)(2008-10#1)(2012-12#1)
the lungs were##5##3##(1996-3#1)(2007-2#1)(2008-10#1)(2008-5#1)(2012-3#1)
the lungs with##4##3##(1997-1#1)(2006-8#3)
the lungs##158##2##(1990-10#1)(1990-11#1)(1990-3#2)(1990-5#1)(1991-12#3)(1991-5#3)(1991-8#1)(1991-9#2)(1992-3#1)(1992-5#2)(1992-9#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-3#3)(1994-5#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#6)(1996-8#1)(1997-1#8)(1997-2#1)(1997-4#1)(2005-1#1)(2005-11#2)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#7)(2006-5#1)(2006-6#1)(2006-8#4)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-6#1)(2007-8#9)(2007-9#3)(2008-1#2)(2008-10#6)(2008-3#2)(2008-5#12)(2008-6#1)(2008-8#2)(2009-1#1)(2009-10#2)(2009-3#1)(2009-6#1)(2010-12#3)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#5)
the lupus##2##2##(1990-11#1)(2007-11#1)
the luteal phase##13##3##(1990-8#1)(1991-11#1)(1992-4#1)(1994-9#2)(2006-5#3)(2008-5#1)(2009-4#1)(2011-2#2)(2012-2#1)
the luteal##16##2##(1990-8#1)(1991-11#1)(1992-4#1)(1992-9#1)(1994-4#1)(1994-9#2)(2006-5#3)(2008-5#1)(2009-4#1)(2011-2#2)(2012-2#2)
the luteinized##2##2##(1997-1#1)(2008-5#1)
the lux operon from##3##4##(1993-2#2)(2008-10#1)
the lux##6##2##(1993-2#2)(1996-2#3)(2008-10#1)
the luxA##3##2##(1990-1#1)(1990-7#2)
the lymph node stations##2##4##(1990-3#1)(1997-6#1)
the lymph node##9##3##(1990-3#1)(1990-5#1)(1990-6#1)(1991-12#1)(1996-9#1)(1997-6#1)(2007-6#1)(2008-11#1)(2009-12#1)
the lymph nodes and##2##4##(1990-12#1)(1990-4#1)
the lymph nodes were##2##4##(1990-10#1)(1990-12#1)
the lymph nodes##16##3##(1990-10#1)(1990-12#2)(1990-4#1)(1990-9#1)(1991-11#1)(1992-4#1)(1996-3#1)(2005-1#1)(2007-5#1)(2008-9#1)(2009-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
the lymph system##2##3##(1990-10#1)(2010-4#1)
the lymph##30##2##(1990-10#2)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1992-4#1)(1996-3#1)(1996-9#2)(1997-6#1)(2005-1#1)(2007-5#1)(2007-6#1)(2008-11#1)(2008-9#1)(2009-12#1)(2009-2#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
the lymphatic system##7##3##(2005-11#1)(2008-2#1)(2008-4#1)(2009-8#1)(2010-12#2)(2012-2#1)
the lymphatic vessels##2##3##(2010-1#1)(2013-1#1)
the lymphatic##16##2##(1990-3#1)(1992-7#1)(1992-9#1)(2005-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
the lymphatics##2##2##(2007-11#1)(2013-8#1)
the lymphocyte##21##2##(1990-8#2)(1991-1#2)(1991-10#2)(1991-11#1)(1991-9#1)(1992-2#1)(1993-11#1)(1995-12#2)(1996-1#1)(1997-3#2)(2006-5#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)
the lymphocytes of##3##3##(1990-12#1)(1991-9#1)(1992-12#1)
the lymphocytes was##2##3##(1992-4#1)(2008-10#1)
the lymphocytes##13##2##(1990-12#1)(1991-1#1)(1991-5#1)(1991-9#1)(1992-12#2)(1992-4#1)(1993-12#1)(1994-12#1)(2006-10#1)(2007-11#1)(2008-10#1)(2011-2#1)
the lymphohemopoietic##2##2##(1992-12#2)
the lymphoid cell##2##3##(1991-12#1)(2008-5#1)
the lymphoid cells##3##3##(1993-7#1)(2009-8#1)(2013-8#1)
the lymphoid organs was##2##4##(1996-12#1)(2008-5#1)
the lymphoid organs##3##3##(1996-12#1)(2008-5#2)
the lymphoid patches##2##3##(1992-12#2)
the lymphoid system##3##3##(1991-9#1)(1994-8#1)(2011-2#1)
the lymphoid tissue of##2##4##(2008-5#1)(2010-12#1)
the lymphoid tissue##3##3##(1992-12#1)(2008-5#1)(2010-12#1)
the lymphoid tissues##4##3##(1996-12#2)(2008-10#1)(2008-9#1)
the lymphoid##26##2##(1991-12#1)(1991-9#1)(1992-12#3)(1992-3#1)(1993-7#1)(1994-8#1)(1996-12#3)(2008-10#1)(2008-4#3)(2008-5#4)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#2)(2011-2#1)(2013-8#1)
the lymphokine##2##2##(1990-8#1)(1995-5#1)
the lymphoma##6##2##(1991-5#1)(2005-10#1)(2005-9#1)(2008-7#1)(2010-10#1)(2012-12#1)
the lyn##3##2##(1990-12#1)(1996-4#2)
the lyophilization##2##2##(1996-1#1)(2010-8#1)
the lyophilized##4##2##(1996-7#1)(2006-1#2)(2008-5#1)
the lyotropic##2##2##(1995-5#1)(2005-11#1)
the lysates of##2##3##(1995-6#1)(2010-12#1)
the lysine and isoleucine residues##2##5##(1995-5#2)
the lysine and##3##3##(1995-2#1)(1995-5#2)
the lysine residue##2##3##(1997-6#1)(2012-3#1)
the lysine##15##2##(1991-2#1)(1991-7#1)(1994-10#1)(1995-2#1)(1995-5#2)(1995-8#1)(1997-6#1)(2006-12#1)(2008-4#2)(2008-5#2)(2008-8#1)(2012-3#1)
the lysis of the##2##4##(1995-4#1)(2007-11#1)
the lysis of##4##3##(1992-12#1)(1995-4#1)(2006-8#1)(2007-11#1)
the lysis##13##2##(1990-11#2)(1990-12#1)(1991-9#1)(1992-12#1)(1995-4#1)(1997-1#3)(1997-4#1)(2006-8#1)(2007-11#1)(2008-2#1)
the lysophosphatidic acid##2##3##(1990-8#1)(1991-2#1)
the lysophospholipase activity in##2##4##(1990-2#2)
the lysophospholipid##2##2##(1995-8#1)(2008-1#1)
the lysosomal acid cholesteryl ester hydrolase##2##6##(1994-3#2)
the lysosomal alpha-mannosidase from##2##4##(1997-8#2)
the lysosomal compartment and##2##4##(1990-2#1)(1996-3#1)
the lysosomal compartment##4##3##(1990-2#3)(1996-3#1)
the lysosomal enzyme##6##3##(1990-5#1)(1993-8#1)(1994-3#1)(1996-3#1)(1996-8#1)(1997-7#1)
the lysosomal system##5##3##(1990-2#1)(1992-12#1)(2008-5#1)(2008-7#2)
the lysosomal##47##2##(1990-11#1)(1990-2#5)(1990-4#2)(1990-5#1)(1991-12#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-10#1)(1992-12#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-8#2)(1993-9#2)(1994-3#4)(1994-5#1)(1994-8#1)(1995-10#1)(1996-3#3)(1996-8#1)(1997-1#2)(1997-7#1)(1997-8#2)(2007-8#1)(2008-5#1)(2008-7#3)(2012-12#2)(2012-3#1)
the lysosome##5##2##(1990-4#1)(1993-11#2)(1994-11#1)(2013-1#1)
the lysosomes and##2##3##(1991-4#1)(1992-2#1)
the lysosomes of the##2##4##(1990-5#1)(1991-12#1)
the lysosomes##11##2##(1990-5#1)(1991-12#1)(1991-4#1)(1992-10#1)(1992-2#3)(1996-3#1)(1997-1#2)(2012-12#1)
the lysosomotropic##2##2##(1990-7#1)(1992-9#1)
the lysozyme##2##2##(2008-10#2)
the lysyl##2##2##(1995-3#2)
the lytic activity##2##3##(2013-1#2)
the lytic##8##2##(1990-1#1)(1993-11#2)(1995-2#1)(2008-10#1)(2008-11#1)(2013-1#2)
the m = 2 mode##2##5##(2008-3#2)
the m =##3##3##(2008-2#1)(2008-3#2)
the m##6##2##(2005-1#1)(2007-12#1)(2008-2#1)(2008-3#2)(2013-8#1)
the m-AHP##2##2##(1993-2#2)
the m-OSCE##3##2##(2012-1#3)
the m-RNA level##4##3##(1997-1#4)
the m/z 73##2##3##(2008-10#2)
the m/z##5##2##(2008-10#5)
the m1##3##2##(1996-3#1)(2008-10#1)(2013-1#1)
the mAb##8##2##(1990-12#1)(1992-9#1)(1997-6#1)(1997-7#2)(2008-11#3)
the mAbs##5##2##(1997-6#1)(1997-7#1)(2007-11#1)(2008-11#1)(2008-8#1)
the mCC10##2##2##(1993-11#2)
the mDTC##2##2##(2010-1#2)
the mF plasmid##2##3##(1997-2#2)
the mGlu##3##2##(1995-12#2)(2008-7#1)
the mPFC##15##2##(1991-1#1)(1991-9#4)(2008-11#3)(2008-6#2)(2008-7#3)(2009-2#2)
the mRNA analogues##2##3##(2006-11#2)
the mRNA and protein expression of##2##6##(2012-2#1)(2013-8#1)
the mRNA and protein levels of##3##6##(2010-12#2)(2012-2#1)
the mRNA and protein levels##6##5##(1994-2#2)(1994-8#1)(2010-12#2)(2012-2#1)
the mRNA and protein##10##4##(1994-2#2)(1994-8#2)(1997-7#1)(2010-12#2)(2012-2#2)(2013-8#1)
the mRNA and##15##3##(1990-3#1)(1992-10#1)(1993-4#1)(1994-2#2)(1994-5#1)(1994-8#2)(1995-2#1)(1997-7#1)(2010-12#2)(2012-2#2)(2013-8#1)
the mRNA coding for##4##4##(1990-7#1)(1991-2#1)(1992-1#1)(1993-3#1)
the mRNA content##2##3##(1990-11#1)(2011-2#1)
the mRNA encoding##7##3##(1992-9#1)(1993-6#1)(1994-12#1)(1995-8#1)(1996-7#1)(2008-11#1)(2008-9#1)
the mRNA expression levels of##4##5##(2008-11#2)(2009-8#1)(2012-2#1)
the mRNA expression of the##2##5##(1994-2#1)(2010-10#1)
the mRNA expression of##10##4##(1994-2#2)(1996-12#1)(2008-10#1)(2008-4#1)(2010-10#2)(2010-5#1)(2012-2#1)(2013-1#1)
the mRNA expression##16##3##(1994-2#2)(1996-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-10#2)(2010-5#1)(2012-2#2)(2013-1#1)
the mRNA for the putative##3##5##(1996-12#3)
the mRNA for the##12##4##(1990-11#2)(1990-7#3)(1991-4#1)(1996-12#4)(2005-10#1)(2008-4#1)
the mRNA for##23##3##(1990-11#2)(1990-12#1)(1990-7#5)(1991-12#1)(1991-4#2)(1991-5#1)(1992-12#1)(1992-6#1)(1994-5#1)(1996-12#4)(1997-7#1)(2005-10#1)(2008-11#1)(2008-4#1)
the mRNA is##6##3##(1992-12#1)(1994-10#1)(1994-5#1)(1996-11#1)(1996-12#1)(2008-4#1)
the mRNA level in the TS##2##6##(2008-11#2)
the mRNA level of the##5##5##(1996-12#1)(1997-5#2)(2006-10#1)(2008-11#1)
the mRNA level of##8##4##(1995-11#1)(1996-12#1)(1997-5#3)(2006-10#1)(2008-11#1)(2008-8#1)
the mRNA level##25##3##(1991-1#1)(1991-5#1)(1992-11#1)(1994-6#2)(1995-1#1)(1995-11#1)(1995-5#1)(1996-12#2)(1996-5#1)(1996-6#1)(1997-5#3)(1997-7#1)(2006-10#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#2)
the mRNA levels and##2##4##(1992-8#1)(1995-12#1)
the mRNA levels of these##2##5##(1990-4#1)(1994-12#1)
the mRNA levels of##10##4##(1990-4#2)(1993-3#2)(1994-12#1)(1995-11#1)(1996-10#1)(1997-5#1)(2008-2#1)(2008-4#1)
the mRNA levels##16##3##(1990-4#2)(1991-12#1)(1992-11#1)(1992-8#1)(1993-3#2)(1994-12#1)(1994-9#2)(1995-11#1)(1995-12#1)(1996-10#1)(1997-5#1)(2008-2#1)(2008-4#1)
the mRNA of the##2##4##(1990-3#1)(2010-1#1)
the mRNA of this##2##4##(1994-10#1)(1994-8#1)
the mRNA of##13##3##(1990-3#1)(1991-12#1)(1991-2#1)(1992-2#1)(1994-10#1)(1994-8#1)(1995-11#1)(1995-7#1)(1997-8#1)(2007-12#1)(2008-10#1)(2010-1#1)(2011-2#1)
the mRNA transcription##3##3##(2008-8#1)(2013-1#2)
the mRNA transcripts##2##3##(1991-5#1)(1997-6#1)
the mRNA was##6##3##(1991-5#1)(1992-9#2)(1996-2#2)(1996-7#1)
the mRNA##187##2##(1990-10#1)(1990-11#4)(1990-12#1)(1990-3#4)(1990-4#2)(1990-7#6)(1991-1#1)(1991-12#4)(1991-2#3)(1991-4#2)(1991-5#4)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#2)(1992-2#1)(1992-6#2)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#5)(1993-6#2)(1993-7#1)(1993-8#1)(1994-10#3)(1994-12#3)(1994-2#4)(1994-5#4)(1994-6#2)(1994-8#4)(1994-9#3)(1995-1#2)(1995-11#3)(1995-12#2)(1995-2#1)(1995-5#1)(1995-7#1)(1995-8#2)(1996-10#1)(1996-11#2)(1996-12#9)(1996-2#3)(1996-5#1)(1996-6#1)(1996-7#3)(1996-9#1)(1997-2#2)(1997-5#5)(1997-6#1)(1997-7#4)(1997-8#1)(2005-10#1)(2006-10#1)(2006-11#4)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#8)(2008-2#1)(2008-4#5)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-8#1)(2010-1#1)(2010-10#3)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#5)(2013-1#3)(2013-8#1)
the mRNAs coding for##2##4##(1990-3#1)(1997-7#1)
the mRNAs encoding##3##3##(1993-5#1)(1995-8#1)(1997-7#1)
the mRNAs for##2##3##(1993-11#1)(1996-12#1)
the mRNAs of##3##3##(1997-6#1)(2008-4#1)(2012-12#1)
the mRNAs##18##2##(1990-3#2)(1991-2#2)(1991-3#1)(1991-7#1)(1992-6#1)(1993-11#1)(1993-5#1)(1995-1#1)(1995-7#1)(1995-8#1)(1996-12#1)(1997-6#1)(1997-7#2)(2008-4#1)(2012-12#1)
the mTOR inhibitor##4##3##(2010-12#1)(2013-1#2)(2013-8#1)
the mTOR##8##2##(2009-12#2)(2010-12#1)(2011-2#1)(2013-1#2)(2013-8#2)
the macaque monkey##5##3##(1995-11#2)(1995-12#1)(1996-11#1)(1997-2#1)
the macaque##6##2##(1995-11#2)(1995-12#1)(1996-11#1)(1997-2#1)(2009-10#1)
the macerated##2##2##(2007-2#1)(2008-10#1)
the machine learning##4##3##(2010-12#2)(2013-1#2)
the machine##7##2##(1997-8#1)(2009-11#1)(2010-12#2)(2010-8#1)(2013-1#2)
the machinery for##2##3##(1995-8#1)(2008-7#1)
the machinery of##2##3##(1992-6#1)(2008-4#1)
the machinery##6##2##(1992-6#1)(1995-8#1)(2008-4#1)(2008-7#1)(2010-8#1)(2012-1#1)
the macro and micro##2##4##(2008-11#1)(2008-9#1)
the macro and##3##3##(2008-11#1)(2008-9#1)(2011-1#1)
the macro##5##2##(1994-12#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-1#1)
the macro- and##3##3##(1994-3#1)(1997-1#1)(2013-8#1)
the macro-##4##2##(1994-3#1)(1997-1#1)(2008-11#1)(2013-8#1)
the macroarray##3##2##(2008-11#1)(2012-12#2)
the macrocycle##4##2##(1991-12#1)(2008-10#2)(2009-10#1)
the macrocycles##3##2##(1996-2#1)(2007-11#1)(2008-5#1)
the macrocyclic size and##2##4##(2008-10#2)
the macrocyclic##15##2##(1992-6#1)(1996-2#2)(2006-12#1)(2008-10#6)(2008-5#2)(2008-6#2)(2008-8#1)
the macroion##3##2##(2005-11#3)
the macrolide antibiotic##2##3##(1990-5#1)(2008-11#1)
the macrolide##4##2##(1990-12#1)(1990-5#1)(2007-12#1)(2008-11#1)
the macrolides##2##2##(2008-11#2)
the macromolecular composition of##3##4##(1996-2#2)(2008-7#1)
the macromolecular composition##4##3##(1996-2#2)(2008-11#1)(2008-7#1)
the macromolecular##12##2##(1993-6#1)(1994-12#1)(1994-8#1)(1996-2#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2011-2#1)
the macromolecule##8##2##(1990-8#2)(1992-6#1)(1993-2#1)(1997-2#1)(2005-11#2)(2008-10#1)
the macromolecules##5##2##(1992-6#1)(1996-5#1)(2005-11#2)(2008-10#1)
the macronuclear##3##2##(1991-12#1)(1994-12#2)
the macronucleus##3##2##(1991-12#2)(2008-9#1)
the macrophage in##3##3##(1995-10#1)(1997-4#2)
the macrophage like##2##3##(1995-3#1)(1997-2#1)
the macrophage respiratory burst by##2##5##(1994-6#2)
the macrophage respiratory burst##3##4##(1992-1#1)(1994-6#2)
the macrophage##30##2##(1990-5#1)(1991-12#1)(1991-5#1)(1991-8#4)(1992-1#1)(1992-7#1)(1993-11#1)(1994-2#1)(1994-5#1)(1994-6#3)(1994-8#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-4#3)(1997-5#1)(2008-4#1)(2008-8#1)(2009-5#1)
the macrophage-derived##3##2##(1992-2#1)(1997-4#1)(2006-10#1)
the macrophages##11##2##(1990-7#1)(1992-12#1)(1992-5#2)(1995-5#1)(1996-11#1)(2006-2#1)(2007-2#1)(2007-7#2)(2011-2#1)
the macrophyte##4##2##(2007-3#1)(2013-7#3)
the macropores##2##2##(2004-9#1)(2008-10#1)
the macroporous##3##2##(2008-10#2)(2008-7#1)
the macroscopic and microscopic##3##4##(1996-5#1)(2009-7#1)(2013-1#1)
the macroscopic and##4##3##(1996-5#1)(2008-11#1)(2009-7#1)(2013-1#1)
the macroscopic scale##2##3##(2009-7#2)
the macroscopic##20##2##(1996-4#1)(1996-5#1)(2005-11#1)(2007-11#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#3)(2008-8#1)(2009-7#3)(2012-12#1)(2013-1#1)(2013-7#1)
the macrovascular complications of##2##4##(2007-8#1)(2008-1#1)
the macrovascular complications##4##3##(2007-8#1)(2008-1#3)
the macula and##2##3##(2010-2#1)(2011-2#1)
the macula densa##2##3##(2005-1#2)
the macula##8##2##(2005-1#2)(2008-4#1)(2009-8#1)(2010-2#1)(2011-2#2)(2012-12#1)
the macular degeneration##2##3##(2011-2#2)
the macular##3##2##(2011-2#2)(2012-12#1)
the mad##5##2##(2007-5#3)(2008-7#2)
the magazine##2##2##(2007-11#1)(2009-4#1)
the magic##3##2##(2007-12#1)(2007-8#1)(2008-6#1)
the magnesium##6##2##(2006-12#1)(2007-8#2)(2008-6#1)(2008-8#1)(2010-4#1)
the magnet##7##2##(2008-10#1)(2008-3#1)(2008-9#2)(2009-5#1)(2010-4#2)
the magnetic and##2##3##(2007-12#1)(2009-11#1)
the magnetic anisotropy##4##3##(1990-9#2)(1997-4#1)(2009-5#1)
the magnetic beads##9##3##(1990-12#1)(1995-8#1)(2008-10#7)
the magnetic behavior##2##3##(2008-10#1)(2009-5#1)
the magnetic coupling##2##3##(1996-7#1)(1997-7#1)
the magnetic field in##2##4##(2008-8#2)
the magnetic field to##2##4##(1997-7#1)(2012-1#1)
the magnetic field was##4##4##(1996-1#1)(2008-10#1)(2008-2#1)(2009-5#1)
the magnetic field##27##3##(1991-1#1)(1994-2#1)(1996-1#1)(1997-7#2)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-8#7)(2008-9#1)(2009-5#2)(2012-1#3)
the magnetic orientation##2##3##(2009-5#1)(2009-8#1)
the magnetic resonance (MR)##3##4##(1995-4#1)(2008-7#1)(2012-2#1)
the magnetic resonance imaging (MRI)##4##5##(1996-11#1)(2008-7#2)(2008-8#1)
the magnetic resonance imaging##7##4##(1996-11#1)(2007-11#1)(2007-8#1)(2008-7#2)(2008-8#1)(2010-8#1)
the magnetic resonance##13##3##(1995-4#1)(1996-11#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-7#3)(2008-8#1)(2010-8#1)(2012-2#1)
the magnetic susceptibility##2##3##(1991-7#1)(2012-2#1)
the magnetic##92##2##(1990-12#1)(1990-3#1)(1990-9#3)(1991-1#1)(1991-7#1)(1993-5#1)(1994-2#1)(1995-10#1)(1995-11#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-7#1)(1997-4#1)(1997-7#4)(2005-11#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#13)(2008-12#2)(2008-2#4)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#8)(2008-9#1)(2009-11#2)(2009-5#5)(2009-8#1)(2010-2#1)(2010-5#2)(2010-8#1)(2012-1#3)(2012-11#1)(2012-2#5)(2013-1#1)
the magnetically##2##2##(2008-3#1)(2009-8#1)
the magnetization transfer ratio##2##4##(2006-9#1)(2012-12#1)
the magnetization##12##2##(1996-2#1)(1997-7#1)(2005-11#1)(2006-4#1)(2006-9#1)(2007-9#1)(2008-10#2)(2008-2#1)(2009-6#2)(2012-12#1)
the magneto-optic##4##2##(2008-2#2)(2008-3#2)
the magneto-optical##2##2##(2007-12#1)(2008-1#1)
the magnification factor##2##3##(1993-7#1)(2008-2#1)
the magnification##9##2##(1993-7#1)(2006-6#1)(2007-12#2)(2007-9#1)(2008-2#3)(2008-3#1)
the magnified##2##2##(2008-3#1)(2008-5#1)
the magnitude and breadth of##2##5##(2010-1#2)
the magnitude and correlates of##2##5##(2007-3#1)(2007-7#1)
the magnitude and direction of##4##5##(2008-11#1)(2010-8#2)(2013-1#1)
the magnitude and duration of the##3##6##(1991-2#1)(1993-11#1)(1996-2#1)
the magnitude and duration of##4##5##(1991-2#1)(1993-11#1)(1996-2#1)(1996-5#1)
the magnitude and##27##3##(1991-2#1)(1993-11#1)(1995-5#1)(1995-7#1)(1996-2#1)(1996-5#1)(2007-10#1)(2007-3#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-2#1)(2010-8#3)(2013-1#1)
the magnitude estimation of##2##4##(2012-12#2)
the magnitude of a##3##4##(1993-2#1)(1993-9#1)(2008-3#1)
the magnitude of change##2##4##(1994-8#1)(2009-12#1)
the magnitude of dopamine sensing##3##5##(2008-10#3)
the magnitude of inhibition##2##4##(1992-8#1)(1993-11#1)
the magnitude of n(2)##2##4##(2007-11#1)(2008-2#1)
the magnitude of responses##2##4##(1990-4#1)(1991-2#1)
the magnitude of spectral##2##4##(1996-5#1)(2007-12#1)
the magnitude of the DPD signal##2##6##(2008-2#2)
the magnitude of the bias##2##5##(1994-8#1)(1996-3#1)
the magnitude of the changes were##2##6##(1994-3#1)(1994-9#1)
the magnitude of the changes##3##5##(1992-8#1)(1994-3#1)(1994-9#1)
the magnitude of the exposure##2##5##(1991-12#1)(2008-7#1)
the magnitude of the increase in##2##6##(1995-12#1)(2008-10#1)
the magnitude of the inhibition##2##5##(1995-12#1)(1995-6#1)
the magnitude of the initial perturbation##2##6##(2005-11#1)(2006-10#1)
the magnitude of the initial##3##5##(1990-12#1)(2005-11#1)(2006-10#1)
the magnitude of the problem##4##5##(2007-6#1)(2008-9#1)(2009-4#1)(2010-11#1)
the magnitude of the response##4##5##(2008-10#1)(2008-8#1)(2008-9#1)(2009-8#1)
the magnitude of the responses##2##5##(2006-10#1)(2008-8#1)
the magnitude of the synergistic##2##5##(2008-10#2)
the magnitude of the##117##4##(1990-11#1)(1990-12#1)(1990-5#3)(1991-12#1)(1991-5#1)(1991-8#4)(1992-1#1)(1992-10#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-6#1)(1997-5#2)(1997-7#1)(1997-8#1)(2005-11#2)(2005-2#1)(2005-3#1)(2006-10#4)(2006-2#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#8)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#14)(2008-2#6)(2008-3#9)(2008-5#1)(2008-7#3)(2008-8#5)(2008-9#4)(2009-4#1)(2009-8#1)(2010-11#1)(2010-9#1)(2011-2#3)(2013-8#2)
the magnitude of these effects##2##5##(1995-3#1)(2007-12#1)
the magnitude of these##4##4##(1995-3#1)(1997-2#1)(2007-12#1)(2008-8#1)
the magnitude of this##5##4##(1990-2#1)(1992-12#1)(2006-4#1)(2011-2#1)(2012-12#1)
the magnitude of tissue##2##4##(1991-2#1)(1997-3#1)
the magnitude of which is##2##5##(1995-4#1)(2008-8#1)
the magnitude of which##5##4##(1991-12#1)(1995-4#1)(1996-2#1)(1997-1#1)(2008-8#1)
the magnitude of##249##3##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#3)(1990-8#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#1)(1991-8#4)(1992-1#1)(1992-10#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#3)(1993-1#2)(1993-11#2)(1993-12#3)(1993-2#2)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-5#3)(1997-7#1)(1997-8#1)(2004-4#1)(2005-1#1)(2005-10#1)(2005-11#2)(2005-2#1)(2005-3#1)(2006-10#4)(2006-2#1)(2006-4#1)(2006-6#1)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#11)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#24)(2008-11#2)(2008-2#13)(2008-3#14)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#11)(2008-9#5)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#5)
the magnitude spectrum##2##3##(2007-11#2)
the magnitude##297##2##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#3)(1990-8#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-5#1)(1991-8#4)(1992-1#1)(1992-10#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#3)(1993-1#2)(1993-11#3)(1993-12#3)(1993-2#2)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#3)(1996-5#3)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-5#3)(1997-7#1)(1997-8#1)(2004-4#1)(2005-1#1)(2005-10#1)(2005-11#3)(2005-2#1)(2005-3#1)(2006-10#4)(2006-2#1)(2006-4#1)(2006-6#1)(2007-1#2)(2007-10#2)(2007-11#7)(2007-12#12)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-1#4)(2008-10#25)(2008-11#4)(2008-2#16)(2008-3#16)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#15)(2008-9#5)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#5)(2010-9#1)(2011-1#3)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#5)
the magnitudes of the##4##4##(1995-3#1)(2008-10#1)(2008-2#1)(2008-8#1)
the magnitudes of##8##3##(1994-11#1)(1995-3#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-11#1)
the magnitudes##9##2##(1994-11#1)(1995-3#1)(2007-5#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)(2012-11#1)
the magnocellular basal##2##3##(1995-12#1)(1997-6#1)
the magnocellular part of the paraventricular nucleus##2##7##(1996-9#2)
the magnocellular part of the##3##5##(1993-12#1)(1996-9#2)
the magnocellular##11##2##(1991-3#1)(1993-11#1)(1993-12#1)(1994-10#1)(1995-12#2)(1996-2#1)(1996-9#2)(1997-6#1)(2007-6#1)
the mail##4##2##(1994-2#1)(1994-3#1)(2007-12#2)
the main FAAs were##2##4##(2010-8#2)
the main acidic carboxypeptidase in human platelets##2##7##(2006-6#2)
the main acidic##3##3##(2006-6#2)(2006-8#1)
the main active##2##3##(2008-5#1)(2012-3#1)
the main actors in##3##4##(2006-5#1)(2011-1#2)
the main actors##4##3##(2006-5#1)(2009-5#1)(2011-1#2)
the main advantage of##2##4##(2008-10#1)(2008-3#1)
the main advantage##3##3##(2006-10#1)(2008-10#1)(2008-3#1)
the main advantages of the##3##5##(2008-10#2)(2008-3#1)
the main advantages of##7##4##(2007-11#1)(2008-10#3)(2008-3#1)(2008-7#1)(2013-1#1)
the main advantages##9##3##(2007-11#1)(2008-10#5)(2008-3#1)(2008-7#1)(2013-1#1)
the main aetiological##2##3##(2007-11#1)(2007-4#1)
the main agent##3##3##(1996-3#1)(2012-12#1)(2013-8#1)
the main aim of##3##4##(1992-10#1)(2008-8#1)(2010-11#1)
the main aim##4##3##(1992-10#1)(2008-8#1)(2010-11#1)(2013-8#1)
the main and##4##3##(1991-12#1)(2008-4#1)(2010-5#1)(2011-2#1)
the main applications of##2##4##(2008-2#1)(2012-2#1)
the main arteries of the lower##2##6##(1997-8#1)(2008-7#1)
the main arteries of the##3##5##(1997-8#1)(2008-7#1)(2012-3#1)
the main arteries##5##3##(1997-8#2)(2008-7#2)(2012-3#1)
the main aspects of##4##4##(2006-6#1)(2008-10#1)(2009-7#1)(2011-2#1)
the main axis of##2##4##(2007-9#1)(2008-8#1)
the main beam##2##3##(2008-2#2)
the main binding##2##3##(1994-2#1)(2013-7#1)
the main body of the##3##5##(1990-12#1)(1994-8#1)(2009-5#1)
the main branch##3##3##(1997-3#1)(2005-11#1)(2009-5#1)
the main bronchus##3##3##(2012-12#2)(2013-8#1)
the main bulk of##2##4##(1990-3#1)(1997-4#1)
the main cause for the##3##5##(2012-2#1)(2013-8#2)
the main cause for##4##4##(2008-3#1)(2012-2#1)(2013-8#2)
the main cause of death in##3##6##(1994-5#1)(2008-10#1)(2010-3#1)
the main cause of death##5##5##(1991-12#1)(1994-5#1)(2004-9#1)(2008-10#1)(2010-3#1)
the main cause of morbidity##2##5##(1993-5#1)(2009-2#1)
the main cause of mortality and##2##6##(2012-2#1)(2013-8#1)
the main cause of mortality##3##5##(2006-6#1)(2012-2#1)(2013-8#1)
the main cause of the##3##5##(1996-3#1)(2008-8#1)(2010-12#1)
the main cause of##33##4##(1991-12#1)(1993-5#1)(1994-5#1)(1996-3#1)(2004-9#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-2#1)(2009-5#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-2#2)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
the main cause was##2##4##(2011-1#1)(2013-7#1)
the main cause##42##3##(1991-12#1)(1993-5#1)(1994-5#1)(1996-3#1)(2004-10#1)(2004-9#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-2#1)(2009-5#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#4)(2013-1#1)(2013-7#2)(2013-8#3)
the main causes and the##2##5##(2006-2#1)(2011-1#1)
the main causes of the##2##5##(1996-8#1)(2013-8#1)
the main causes of##11##4##(1996-8#1)(1997-3#1)(2006-11#1)(2008-1#1)(2009-10#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
the main causes##18##3##(1996-8#1)(1997-3#1)(2006-11#1)(2006-2#1)(2006-9#1)(2008-1#1)(2008-9#1)(2009-10#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
the main cellular##2##3##(2007-2#1)(2010-12#1)
the main chain of##3##4##(1995-10#1)(1995-5#1)(1997-1#1)
the main chain##12##3##(1991-7#2)(1995-10#1)(1995-11#3)(1995-5#1)(1997-1#1)(2006-12#1)(2008-9#2)(2009-7#1)
the main changes occurred at a different rate in CD4+##2##10##(1996-3#2)
the main changes##3##3##(1996-3#2)(2011-1#1)
the main characteristics of##7##4##(1991-9#1)(1993-11#1)(2006-5#1)(2008-2#1)(2008-9#1)(2009-8#1)(2013-1#1)
the main characteristics##8##3##(1991-9#1)(1993-11#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-8#1)(2013-1#1)
the main chemical##2##3##(2008-8#1)(2010-12#1)
the main clinical##6##3##(1993-2#1)(2007-12#1)(2009-2#1)(2013-1#2)(2013-8#1)
the main complaint##2##3##(1991-10#1)(2008-7#1)
the main complications##2##3##(2007-12#1)(2007-7#1)
the main component of the##4##5##(1996-9#1)(2007-8#1)(2009-3#1)(2011-2#1)
the main component of##6##4##(1992-12#1)(1996-9#1)(2007-8#1)(2009-3#1)(2011-2#1)(2012-3#1)
the main component##11##3##(1992-12#1)(1996-9#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-8#1)(2009-3#1)(2011-2#1)(2012-3#1)
the main components of the##4##5##(2004-12#1)(2009-5#1)(2010-12#1)(2012-12#1)
the main components of##9##4##(1992-12#1)(1997-2#1)(2004-12#1)(2008-10#1)(2008-4#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#1)
the main components##11##3##(1992-12#1)(1997-2#1)(2004-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
the main compound##2##3##(2008-10#1)(2013-1#1)
the main concepts##4##3##(2008-10#1)(2012-12#2)(2013-1#1)
the main concern##4##3##(2008-1#1)(2008-10#1)(2008-7#1)(2010-12#1)
the main consequences##2##3##(2009-7#1)(2012-2#1)
the main constituent of##4##4##(1992-7#1)(1994-10#1)(1995-10#1)(2005-3#1)
the main constituent##6##3##(1992-7#1)(1994-10#1)(1995-10#1)(2005-3#1)(2007-1#1)(2009-7#1)
the main constituents of##4##4##(2008-10#1)(2008-11#2)(2011-12#1)
the main constituents##5##3##(2008-10#1)(2008-11#3)(2011-12#1)
the main contributions##2##3##(1992-10#1)(2008-10#1)
the main criteria for##2##4##(2007-8#1)(2010-9#1)
the main data and##2##4##(2008-7#1)(2009-4#1)
the main degradation##2##3##(2008-10#2)
the main determinant of the##3##5##(1993-12#1)(2008-8#1)(2013-1#1)
the main determinants of##3##4##(2007-9#1)(2012-3#1)(2013-8#1)
the main determinants##4##3##(1997-2#1)(2007-9#1)(2012-3#1)(2013-8#1)
the main difference##2##3##(2008-2#1)(2008-3#1)
the main disease##2##3##(2007-5#1)(2008-10#1)
the main driving force##2##4##(1992-4#1)(2008-11#1)
the main effect of##6##4##(1990-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)
the main effect##7##3##(1990-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-12#1)
the main effects##2##3##(2008-10#1)(2008-5#1)
the main elements##2##3##(2007-12#1)(2012-2#1)
the main end##2##3##(2004-11#1)(2007-8#1)
the main enzyme##2##3##(1991-3#1)(1997-5#1)
the main epidemiological##2##3##(1991-6#1)(2011-2#1)
the main factor for##2##4##(2008-10#1)(2013-8#1)
the main factor limiting##2##4##(2007-11#1)(2007-3#1)
the main factor##10##3##(1994-5#1)(1996-6#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-10#1)(2012-12#1)(2013-7#2)(2013-8#1)
the main factors affecting the##3##5##(2008-10#1)(2008-6#1)(2013-8#1)
the main factors affecting##4##4##(2008-10#1)(2008-6#1)(2008-8#1)(2013-8#1)
the main factors associated with##2##5##(2007-8#1)(2008-1#1)
the main factors in determining the##2##6##(1994-12#1)(2008-10#1)
the main factors in determining##3##5##(1994-12#1)(2008-10#1)(2010-8#1)
the main factors in##4##4##(1994-12#1)(2008-10#1)(2010-8#1)(2011-1#1)
the main factors influencing the##3##5##(1991-10#1)(2007-8#1)(2008-10#1)
the main factors influencing##4##4##(1991-10#1)(2007-8#1)(2008-10#1)(2008-11#1)
the main factors responsible for##2##5##(1991-6#1)(2008-1#1)
the main factors that##3##4##(2008-10#2)(2012-2#1)
the main factors##30##3##(1991-10#1)(1991-6#1)(1992-1#1)(1994-12#1)(1994-6#1)(2006-2#1)(2006-6#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#2)
the main features of the##6##5##(1994-6#1)(2007-12#2)(2008-10#1)(2008-3#1)(2009-11#1)
the main features of##13##4##(1992-5#1)(1994-6#1)(2005-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-3#2)(2008-5#1)(2009-11#1)(2013-8#1)
the main features##16##3##(1992-5#1)(1994-6#1)(2005-10#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#2)(2009-11#1)(2013-8#1)
the main finding##2##3##(1993-12#1)(1996-7#1)
the main findings of##3##4##(1992-3#1)(2008-8#1)(2010-4#1)
the main findings##6##3##(1992-12#1)(1992-3#1)(2008-8#1)(2010-4#1)(2011-1#1)(2012-12#1)
the main focus of the##2##5##(1995-12#1)(2012-12#1)
the main focus of##3##4##(1995-12#1)(2005-9#1)(2012-12#1)
the main focus##7##3##(1995-12#1)(2005-9#2)(2008-1#1)(2009-5#1)(2012-11#1)(2012-12#1)
the main form of##3##4##(1994-6#1)(2006-2#1)(2013-8#1)
the main function of the##2##5##(2007-12#1)(2008-7#1)
the main functional##2##3##(1991-4#1)(2006-4#1)
the main functions of##2##4##(2007-12#1)(2008-4#1)
the main functions##4##3##(1996-5#1)(2007-11#1)(2007-12#1)(2008-4#1)
the main gastrointestinal##2##3##(2006-2#1)(2010-8#1)
the main genes and##2##4##(2008-10#1)(2009-5#1)
the main goal of##6##4##(1991-3#1)(1991-6#1)(2006-1#1)(2007-11#1)(2011-2#1)(2013-7#1)
the main goal##8##3##(1991-3#1)(1991-6#1)(2006-1#1)(2007-11#1)(2007-12#1)(2009-8#1)(2011-2#1)(2013-7#1)
the main group of##3##4##(1991-9#1)(2008-10#1)(2009-8#1)
the main group##5##3##(1991-9#1)(2008-10#1)(2009-8#1)(2011-1#1)(2012-11#1)
the main groups of##2##4##(1991-6#1)(2004-9#1)
the main groups##4##3##(1991-6#1)(2004-9#1)(2007-3#1)(2008-7#1)
the main heparin-enhanced thrombin inhibitor##2##5##(1990-11#2)
the main histological##2##3##(1996-8#1)(2008-1#1)
the main indication of##2##4##(2008-1#1)(2010-6#1)
the main indication##3##3##(2008-1#1)(2008-11#1)(2010-6#1)
the main indications##4##3##(1990-3#1)(1991-5#1)(1993-3#1)(2007-5#1)
the main interaction##2##3##(1992-6#1)(2008-8#1)
the main interfering##2##3##(2008-10#2)
the main limitation of##3##4##(2008-11#1)(2008-6#1)(2009-10#1)
the main limitation##4##3##(2008-11#1)(2008-6#1)(2009-10#1)(2009-4#1)
the main limiting##3##3##(1997-8#1)(2006-10#1)(2008-1#1)
the main lithogenic##2##3##(2011-2#2)
the main malaria##2##3##(2008-4#1)(2013-1#1)
the main mechanism for##3##4##(1991-7#1)(1996-4#1)(2005-10#1)
the main mechanism of##5##4##(2005-11#1)(2007-11#1)(2008-12#1)(2013-1#1)(2013-7#1)
the main mechanism##13##3##(1991-7#1)(1996-4#1)(2005-10#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2012-1#1)(2013-1#1)(2013-7#1)
the main metabolite##2##3##(1990-11#1)(1993-2#1)
the main metabolites##2##3##(1990-11#1)(1993-12#1)
the main methods for##2##4##(2011-1#1)(2013-8#1)
the main methods of##2##4##(2007-7#1)(2013-1#1)
the main methods##5##3##(1991-7#1)(2007-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
the main mode##3##3##(1991-6#1)(2008-2#2)
the main modes of##2##4##(2008-11#1)(2008-8#1)
the main negative##2##3##(1995-5#1)(2008-11#1)
the main objective of the##2##5##(2010-9#1)(2011-2#1)
the main objective of this work##2##6##(2008-10#1)(2013-7#1)
the main objective of this##3##5##(2008-10#1)(2009-10#1)(2013-7#1)
the main objective of##6##4##(2008-10#1)(2009-10#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-7#1)
the main objective##8##3##(2005-10#1)(2008-10#1)(2009-10#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
the main objectives of##3##4##(1993-3#1)(2006-10#1)(2011-2#1)
the main objectives##5##3##(1993-3#1)(2006-10#1)(2008-11#1)(2011-2#2)
the main obstacle to##3##4##(2007-2#1)(2008-3#1)(2010-5#1)
the main obstacle##4##3##(2007-2#1)(2008-2#1)(2008-3#1)(2010-5#1)
the main olfactory bulb##3##4##(1993-7#1)(1995-5#1)(1996-3#1)
the main optical##2##3##(2008-2#1)(2008-3#1)
the main organs##2##3##(2010-11#1)(2012-12#1)
the main outcome##3##3##(2007-1#1)(2007-7#1)(2012-2#1)
the main oxidation##2##3##(1996-2#1)(2008-10#1)
the main pancreatic duct##5##4##(2009-2#1)(2011-2#2)(2012-2#1)(2013-7#1)
the main parameter determining##2##4##(2007-12#1)(2008-10#1)
the main parameter##3##3##(2007-12#1)(2008-10#1)(2013-8#1)
the main parameters##2##3##(2008-2#1)(2008-5#1)
the main part of the##2##5##(1996-2#1)(2008-3#1)
the main part of##3##4##(1992-8#1)(1996-2#1)(2008-3#1)
the main pathogenetic##2##3##(2006-6#1)(2009-7#1)
the main pathogens of##2##4##(2008-11#1)(2013-8#1)
the main peak and##2##4##(2008-10#1)(2012-12#1)
the main peak##5##3##(2007-12#1)(2008-10#2)(2012-12#1)(2013-7#1)
the main phase transition to lower temperatures##2##7##(2008-10#2)
the main phase transition to lower##3##6##(2008-10#3)
the main phase transition##7##4##(1990-2#1)(1990-7#2)(2006-10#1)(2008-10#3)
the main photoproducts##3##3##(1992-8#2)(2011-1#1)
the main physiological function of##2##5##(1992-7#1)(2010-7#1)
the main physiological##5##3##(1991-11#1)(1992-7#1)(2006-10#1)(2010-7#1)(2013-8#1)
the main plots##2##3##(2008-12#2)
the main points##3##3##(1993-9#1)(2008-11#1)(2011-2#1)
the main portion of##2##4##(1991-2#1)(2008-7#1)
the main portion##3##3##(1991-2#1)(1992-12#1)(2008-7#1)
the main predictors of##2##4##(2008-6#1)(2012-2#1)
the main principle of##2##4##(1997-6#1)(2013-8#1)
the main principles##2##3##(2008-11#1)(2008-9#1)
the main problem##5##3##(1994-6#1)(1995-3#1)(2006-10#1)(2006-6#1)(2007-8#1)
the main problems in the##4##5##(1996-4#1)(2009-2#2)(2011-2#1)
the main problems in##5##4##(1996-4#1)(2008-11#1)(2009-2#2)(2011-2#1)
the main problems##9##3##(1996-10#1)(1996-12#1)(1996-4#1)(1997-6#1)(2008-11#1)(2008-5#1)(2009-2#2)(2011-2#1)
the main processes##3##3##(2010-11#1)(2011-2#1)(2013-8#1)
the main product##3##3##(1990-7#1)(1994-3#1)(2008-10#1)
the main products of##2##4##(2006-8#1)(2008-10#1)
the main prognostic##3##3##(1992-6#1)(1994-6#1)(2011-2#1)
the main properties of the##3##5##(1990-8#1)(2008-10#1)(2008-2#1)
the main protein##3##3##(1995-6#1)(2011-2#1)(2012-2#1)
the main pulmonary trunk##3##4##(2010-7#3)
the main purpose##3##3##(2005-8#1)(2008-4#1)(2008-8#1)
the main purposes##2##3##(1991-2#1)(2006-8#1)
the main reason for admission##2##5##(1990-10#1)(2013-1#1)
the main reason for the##5##5##(1992-2#1)(2007-9#1)(2009-12#1)(2013-8#2)
the main reason for##16##4##(1990-10#1)(1992-2#1)(2006-7#2)(2007-10#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-2#1)(2008-5#1)(2009-11#1)(2009-12#1)(2012-12#1)(2013-1#1)(2013-8#2)
the main reason##23##3##(1990-10#2)(1990-6#1)(1992-2#1)(2006-4#1)(2006-7#2)(2007-10#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
the main reasons for granting sickness benefits##2##7##(2008-9#2)
the main reasons for the##3##5##(2005-11#1)(2008-8#1)(2013-1#1)
the main reasons for##8##4##(1993-5#1)(1997-8#1)(2005-11#1)(2008-2#1)(2008-8#1)(2008-9#2)(2013-1#1)
the main reasons of##3##4##(2011-1#1)(2011-2#1)(2013-8#1)
the main reasons##15##3##(1992-9#1)(1993-5#1)(1997-8#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#3)(2009-11#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
the main regulators of##2##4##(2008-11#1)(2009-8#1)
the main research##3##3##(1991-4#1)(2007-10#1)(2012-12#1)
the main resistance mechanisms##2##4##(2011-2#1)(2012-1#1)
the main responsible##2##3##(1996-3#1)(2013-8#1)
the main results from##2##4##(2010-2#1)(2011-1#1)
the main results##5##3##(1992-9#1)(2008-3#1)(2008-8#1)(2010-2#1)(2011-1#1)
the main risk factor for##5##5##(2006-10#1)(2006-8#1)(2008-1#1)(2011-1#1)(2013-8#1)
the main risk factor##7##4##(2006-10#1)(2006-8#1)(2008-1#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
the main risk factors for##2##5##(2006-10#1)(2012-2#1)
the main risk factors##3##4##(2006-10#1)(2007-2#1)(2012-2#1)
the main risk##11##3##(2006-10#3)(2006-8#1)(2007-2#1)(2008-1#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
the main role in##2##4##(2008-10#1)(2008-4#1)
the main role##4##3##(1990-1#1)(1990-5#1)(2008-10#1)(2008-4#1)
the main route of##4##4##(1993-12#1)(1997-8#1)(2007-7#1)(2013-8#1)
the main sensory##2##3##(1990-4#2)
the main site of##5##4##(2008-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-7#1)
the main source of##19##4##(1991-6#1)(1992-3#1)(1994-6#1)(1997-3#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
the main source##21##3##(1991-1#1)(1991-6#1)(1992-3#1)(1994-6#1)(1997-3#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
the main sources of##10##4##(1996-11#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2013-1#1)
the main species##8##3##(2007-3#1)(2008-10#4)(2008-3#2)(2010-5#1)
the main strategies used to##2##5##(2006-10#1)(2006-12#1)
the main strategies##4##3##(2006-10#1)(2006-12#1)(2008-11#1)(2013-1#1)
the main strategy##2##3##(2006-10#1)(2007-8#1)
the main structural##3##3##(1995-2#1)(1997-4#2)
the main study##6##3##(1997-6#1)(2007-10#1)(2008-2#1)(2010-3#3)
the main substrate##2##3##(1990-5#2)
the main symptom in##2##4##(2007-8#1)(2007-9#1)
the main symptom##5##3##(1996-6#1)(2007-8#1)(2007-9#1)(2008-7#1)(2011-1#1)
the main symptoms of##2##4##(1996-6#1)(1997-3#1)
the main symptoms##5##3##(1996-6#1)(1997-3#1)(2006-6#1)(2007-4#1)(2011-2#1)
the main target of##4##4##(2006-10#1)(2008-5#1)(2013-1#1)(2013-7#1)
the main target organ of##2##5##(1990-5#1)(1992-9#1)
the main target##11##3##(1990-5#1)(1992-2#1)(1992-9#1)(2005-9#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-5#1)(2011-12#1)(2013-1#1)(2013-7#1)
the main targets of##2##4##(1991-4#1)(2011-1#1)
the main targets##4##3##(1991-4#1)(1994-6#1)(2009-8#1)(2011-1#1)
the main theme##4##3##(2008-11#1)(2010-10#3)
the main theoretical##2##3##(2008-2#2)
the main therapeutic##4##3##(2007-5#1)(2008-3#1)(2008-4#1)(2012-12#1)
the main topic of##2##4##(2005-8#1)(2013-7#1)
the main topic##3##3##(2005-8#1)(2011-2#1)(2013-7#1)
the main topics of the##2##5##(2008-10#1)(2012-3#1)
the main topics##3##3##(2005-8#1)(2008-10#1)(2012-3#1)
the main transcription start point##2##5##(1990-5#1)(1991-6#1)
the main transcription start##3##4##(1990-5#1)(1991-6#1)(1997-5#1)
the main transition and##2##4##(2006-10#2)
the main transition temperature##3##4##(1990-3#1)(1991-2#1)(1995-10#1)
the main transition##6##3##(1990-3#2)(1991-2#1)(1995-10#1)(2006-10#2)
the main treatment##2##3##(2007-8#1)(2007-9#1)
the main trunk##2##3##(1996-3#1)(2006-12#1)
the main types of##4##4##(1995-4#1)(1996-12#1)(2008-10#2)
the main variables affecting the results##2##6##(2008-10#1)(2012-12#1)
the main variables affecting the##3##5##(2008-10#2)(2012-12#1)
the main variables##6##3##(2006-2#1)(2008-10#3)(2008-5#1)(2012-12#1)
the main vector##7##3##(2005-8#1)(2008-10#4)(2008-11#1)(2008-5#1)
the main vectors##2##3##(2012-12#1)(2013-8#1)
the main work##2##3##(2008-11#1)(2008-5#1)
the main##1160##2##(1990-1#1)(1990-10#4)(1990-11#5)(1990-12#2)(1990-2#2)(1990-3#8)(1990-4#2)(1990-5#6)(1990-6#1)(1990-7#5)(1990-8#2)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#4)(1991-3#2)(1991-4#4)(1991-5#1)(1991-6#10)(1991-7#4)(1991-9#4)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#5)(1992-2#3)(1992-3#7)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#3)(1992-8#3)(1992-9#4)(1993-11#2)(1993-12#5)(1993-2#3)(1993-3#3)(1993-4#1)(1993-5#4)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#5)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#8)(1994-8#1)(1994-9#2)(1995-10#3)(1995-11#4)(1995-12#3)(1995-2#2)(1995-3#3)(1995-4#1)(1995-5#3)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#7)(1996-4#2)(1996-5#4)(1996-6#5)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#5)(1997-2#5)(1997-3#6)(1997-4#5)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#8)(2003-11#1)(2004-10#2)(2004-11#1)(2004-12#1)(2004-4#1)(2004-9#2)(2005-10#3)(2005-11#7)(2005-12#1)(2005-3#1)(2005-5#1)(2005-6#1)(2005-7#1)(2005-8#6)(2005-9#3)(2006-1#4)(2006-10#20)(2006-11#2)(2006-12#7)(2006-2#10)(2006-4#3)(2006-5#3)(2006-6#10)(2006-7#2)(2006-8#5)(2006-9#1)(2007-1#5)(2007-10#7)(2007-11#15)(2007-12#19)(2007-2#7)(2007-3#9)(2007-4#2)(2007-5#8)(2007-7#15)(2007-8#20)(2007-9#8)(2008-1#21)(2008-10#109)(2008-11#35)(2008-12#12)(2008-2#24)(2008-3#32)(2008-4#16)(2008-5#35)(2008-6#7)(2008-7#24)(2008-8#20)(2008-9#12)(2009-1#1)(2009-10#8)(2009-11#3)(2009-12#1)(2009-2#6)(2009-3#3)(2009-4#4)(2009-5#8)(2009-6#1)(2009-7#5)(2009-8#8)(2009-9#2)(2010-1#1)(2010-10#6)(2010-11#6)(2010-12#21)(2010-2#3)(2010-3#5)(2010-4#4)(2010-5#4)(2010-6#4)(2010-7#6)(2010-8#6)(2010-9#3)(2011-1#26)(2011-12#4)(2011-2#46)(2011-3#1)(2012-1#4)(2012-11#3)(2012-12#23)(2012-2#26)(2012-3#12)(2013-1#30)(2013-7#17)(2013-8#42)
the main-chain##2##2##(1990-7#1)(2008-8#1)
the mainland United States##2##4##(2005-10#1)(2008-10#1)
the mainland##5##2##(1996-6#1)(2005-10#1)(2007-2#1)(2008-10#1)(2011-1#1)
the mainly##3##2##(1993-10#1)(2007-9#1)(2008-6#1)
the mainstay diagnostic##3##3##(2011-2#2)(2012-2#1)
the mainstay for##3##3##(2009-11#1)(2011-1#1)(2013-8#1)
the mainstay in the##5##4##(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-6#1)
the mainstay of asthma##2##4##(2008-7#1)(2013-7#1)
the mainstay of conservative treatment##2##5##(2007-11#1)(2009-5#1)
the mainstay of diagnosis##2##4##(2008-10#1)(2011-1#1)
the mainstay of therapy for##3##5##(2006-4#1)(2010-12#2)
the mainstay of therapy in##2##5##(2006-10#1)(2010-12#1)
the mainstay of therapy##6##4##(2006-10#1)(2006-4#1)(2008-6#1)(2010-12#3)
the mainstay of treatment for##11##5##(2006-9#1)(2007-11#1)(2007-8#1)(2008-4#1)(2009-4#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)
the mainstay of treatment in##4##5##(2008-11#1)(2010-12#1)(2013-1#2)
the mainstay of treatment of##4##5##(1993-9#1)(2006-10#2)(2009-3#1)
the mainstay of treatment##29##4##(1993-9#1)(2006-10#2)(2006-9#1)(2007-11#2)(2007-8#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-3#1)(2009-4#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-5#2)(2011-1#1)(2013-1#3)
the mainstay of##56##3##(1993-9#1)(1995-5#1)(1996-2#1)(1997-1#1)(2005-9#1)(2006-10#3)(2006-4#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-8#3)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#8)(2010-2#1)(2010-4#1)(2010-5#3)(2011-1#2)(2011-12#1)(2011-2#2)(2012-11#1)(2012-2#2)(2013-1#3)(2013-7#1)
the mainstay##67##2##(1993-9#1)(1995-5#1)(1996-2#1)(1997-1#1)(2005-9#1)(2006-10#3)(2006-4#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#8)(2010-2#1)(2010-4#1)(2010-5#3)(2011-1#3)(2011-12#1)(2011-2#4)(2012-11#1)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#1)
the mainstays in##2##3##(1996-2#1)(2007-7#1)
the mainstays of therapy##2##4##(1993-9#1)(2007-11#1)
the mainstays of##4##3##(1993-9#1)(2006-5#1)(2007-11#1)(2008-11#1)
the mainstays##8##2##(1993-9#1)(1996-2#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-9#1)
the mainstem MCA##2##3##(2007-9#2)
the mainstem##3##2##(1997-1#1)(2007-9#2)
the mainstream of##4##3##(1991-11#1)(1994-3#1)(2006-10#1)(2006-9#1)
the mainstream##13##2##(1991-11#1)(1994-3#1)(1994-8#1)(1995-1#1)(1997-3#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-9#1)(2008-6#1)(2011-1#1)(2012-2#1)(2013-7#1)
the maintained##2##2##(1996-11#1)(1996-9#1)
the maintaining##2##2##(2011-1#2)
the maintenance and##9##3##(1995-3#1)(1996-11#1)(2008-2#1)(2008-7#2)(2010-5#1)(2012-12#2)(2013-8#1)
the maintenance of LTP##2##4##(1997-2#2)
the maintenance of PTSD##2##4##(2008-8#1)(2009-11#1)
the maintenance of a healthy skin##2##6##(2008-5#2)
the maintenance of a##7##4##(2008-5#3)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
the maintenance of an##2##4##(2009-6#1)(2013-8#1)
the maintenance of body##2##4##(1997-4#1)(2009-6#1)
the maintenance of bone##2##4##(1997-1#1)(2005-3#1)
the maintenance of cell shape and##2##6##(2008-11#1)(2011-2#1)
the maintenance of cell##3##4##(2008-11#2)(2011-2#1)
the maintenance of certification##2##4##(2007-4#2)
the maintenance of gastric##2##4##(1992-10#1)(2013-8#1)
the maintenance of genetic##2##4##(1996-8#1)(2010-10#1)
the maintenance of genome integrity##2##5##(2012-12#2)
the maintenance of high##3##4##(1997-6#1)(2004-8#1)(2013-1#1)
the maintenance of nodal##2##4##(2008-7#2)
the maintenance of the##26##4##(1991-10#1)(1991-2#2)(1992-3#1)(1993-12#1)(1995-1#2)(1995-12#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-5#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2012-1#2)(2012-12#1)
the maintenance of this##2##4##(1996-5#1)(2007-7#1)
the maintenance of tissue homeostasis##2##5##(2007-10#1)(2009-3#1)
the maintenance of variation under constant selection##2##7##(2012-3#2)
the maintenance of##151##3##(1990-12#1)(1990-7#1)(1991-10#1)(1991-2#2)(1992-10#1)(1992-3#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-12#6)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-5#3)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#2)(2004-12#1)(2004-8#1)(2005-10#1)(2005-3#1)(2005-7#1)(2006-10#5)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-4#4)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#8)(2008-4#5)(2008-5#7)(2008-6#4)(2008-7#9)(2008-8#5)(2008-9#6)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#5)(2012-1#2)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#4)(2013-8#2)
the maintenance phase of##2##4##(1997-2#1)(2008-1#1)
the maintenance phase##3##3##(1997-2#1)(2008-1#1)(2013-8#1)
the maintenance treatment##2##3##(1990-9#1)(2006-10#1)
the maintenance trial##3##3##(2012-2#3)
the maintenance##180##2##(1990-12#1)(1990-7#2)(1990-9#2)(1991-10#1)(1991-2#2)(1992-10#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-12#6)(1995-3#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-5#3)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#2)(2004-12#1)(2004-8#1)(2005-10#1)(2005-3#1)(2005-7#1)(2006-10#6)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#3)(2007-11#4)(2007-4#5)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#10)(2008-2#1)(2008-4#5)(2008-5#7)(2008-6#4)(2008-7#11)(2008-8#5)(2008-9#6)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-8#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#2)(2012-12#7)(2012-2#5)(2012-3#3)(2013-1#5)(2013-7#4)(2013-8#4)
the maize genome and##2##4##(2008-7#2)
the maize genome##5##3##(2008-10#1)(2008-7#3)(2009-10#1)
the maize##22##2##(2006-12#2)(2008-10#6)(2008-12#1)(2008-7#3)(2009-10#4)(2010-10#1)(2011-2#4)(2012-3#1)
the major AT##2##3##(1995-6#2)
the major NORs##3##3##(1993-12#3)
the major PM##2##3##(1991-10#1)(2008-7#1)
the major active##4##3##(1990-6#1)(1996-4#1)(1997-8#1)(2008-4#1)
the major advances##2##3##(2005-11#1)(2005-7#1)
the major advantage##2##3##(1992-9#1)(2007-7#1)
the major agents##2##3##(2008-5#1)(2009-5#1)
the major algal##2##3##(1994-11#1)(2012-2#1)
the major alkaloids##3##3##(2007-1#1)(2008-10#1)(2012-3#1)
the major allergen from##2##4##(1990-10#2)
the major and minor##2##4##(1990-12#1)(2009-4#1)
the major and##4##3##(1990-12#1)(2008-9#1)(2009-4#1)(2009-8#1)
the major apolipoproteins##2##3##(2008-12#1)(2010-12#1)
the major approach##2##3##(1992-6#1)(2008-11#1)
the major arsenic##2##3##(2008-10#2)
the major axis of the##3##5##(2007-12#1)(2008-2#1)(2008-5#1)
the major axis of##4##4##(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
the major axis##5##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#1)
the major barrier to##4##4##(1991-9#1)(1994-1#1)(1997-1#1)(2007-1#1)
the major binding##4##3##(1993-11#1)(1994-2#1)(1995-3#1)(1996-7#1)
the major cancers##2##3##(2006-10#1)(2011-2#1)
the major capsid##4##3##(1994-12#1)(2007-2#1)(2008-5#1)(2009-5#1)
the major cardiovascular##2##3##(2008-1#1)(2011-2#1)
the major carotenoid##2##3##(2008-10#2)
the major causative##2##3##(1997-5#1)(2011-1#1)
the major cause of death in##3##6##(2008-3#1)(2011-2#1)(2013-8#1)
the major cause of death##5##5##(2005-7#1)(2008-3#1)(2011-12#1)(2011-2#1)(2013-8#1)
the major cause of##24##4##(1993-12#1)(1994-3#1)(2005-7#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#2)(2011-12#1)(2011-2#2)(2013-1#2)(2013-8#2)
the major causes for##2##4##(2008-12#1)(2008-4#1)
the major causes of death##3##5##(1993-3#1)(2006-10#1)(2013-7#1)
the major causes of failure of##2##6##(2008-1#1)(2008-11#1)
the major causes of morbidity and mortality in##2##8##(2007-10#1)(2013-7#1)
the major causes of morbidity and##3##6##(1995-9#1)(2007-10#1)(2013-7#1)
the major causes of##19##4##(1990-8#1)(1993-3#1)(1995-9#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-11#3)(2009-12#1)(2009-4#1)(2011-1#1)(2013-7#3)(2013-8#1)
the major causes##25##3##(1990-6#1)(1990-8#1)(1992-9#1)(1993-3#1)(1995-9#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-4#1)(2011-1#1)(2013-7#3)(2013-8#1)
the major cell attachment##2##4##(1990-7#1)(1995-6#1)
the major cell##6##3##(1990-12#1)(1990-7#1)(1994-3#1)(1995-6#1)(2008-4#1)(2012-1#1)
the major cellular##6##3##(1992-11#1)(1992-4#1)(1994-8#1)(1995-8#1)(2008-12#1)(2010-11#1)
the major cellulardeterminant of productivity##2##5##(2008-11#2)
the major challenges in##4##4##(2006-5#1)(2008-4#1)(2011-1#1)(2011-2#1)
the major challenges##9##3##(1990-1#1)(1995-4#1)(2006-5#1)(2007-4#1)(2008-4#1)(2008-7#1)(2009-7#1)(2011-1#1)(2011-2#1)
the major changes in the##2##5##(2006-2#1)(2008-1#1)
the major changes##3##3##(2006-2#2)(2008-1#1)
the major characteristics of##2##4##(2008-4#1)(2013-1#1)
the major classes of##6##4##(1996-9#1)(2008-11#1)(2008-5#3)(2009-3#1)
the major clinical trials of##2##5##(2007-11#1)(2008-3#1)
the major clinical trials##4##4##(2005-7#1)(2007-11#1)(2008-3#1)(2009-11#1)
the major clinical##7##3##(1990-10#1)(2005-7#1)(2006-6#1)(2007-11#1)(2008-3#1)(2008-7#1)(2009-11#1)
the major coat protein##6##4##(1991-5#1)(1994-12#1)(1994-9#2)(1995-2#1)(2009-2#1)
the major coat##9##3##(1991-5#1)(1994-12#1)(1994-9#2)(1995-2#3)(1997-3#1)(2009-2#1)
the major collagen##2##3##(1996-4#1)(2012-2#1)
the major complication of##2##4##(1995-12#1)(2009-8#1)
the major complication##4##3##(1995-12#1)(2008-1#1)(2009-8#1)(2011-12#1)
the major complications of##3##4##(2007-3#1)(2008-1#1)(2011-2#1)
the major complications##10##3##(2006-2#1)(2006-8#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#2)
the major component in##2##4##(1995-3#1)(2006-12#1)
the major component of the deformation##2##6##(1996-1#2)
the major component of the##6##5##(1992-2#1)(1993-3#1)(1996-1#2)(1996-12#1)(2008-10#1)
the major component of##16##4##(1991-1#1)(1991-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-8#1)(1996-1#2)(1996-12#1)(2006-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)
the major component##24##3##(1991-1#1)(1991-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-3#1)(1993-8#1)(1995-1#1)(1995-3#1)(1996-1#2)(1996-12#1)(1997-4#1)(2006-12#3)(2008-10#3)(2008-5#1)(2008-7#1)(2012-2#1)
the major components of the##2##5##(2008-3#1)(2008-6#1)
the major components of##5##4##(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)
the major components##8##3##(2007-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)
the major compound##4##3##(2007-10#1)(2008-10#1)(2008-5#1)(2013-1#1)
the major compounds##2##3##(1990-7#1)(2008-12#1)
the major concern##2##3##(2008-10#1)(2011-2#1)
the major constituent of##3##4##(1990-9#1)(1995-6#1)(2012-2#1)
the major constituent##5##3##(1990-9#1)(1995-6#1)(2007-3#1)(2008-4#1)(2012-2#1)
the major constituents of##3##4##(2008-10#1)(2008-12#1)(2009-8#1)
the major constituents##6##3##(1994-8#1)(1997-2#1)(2008-10#1)(2008-12#1)(2009-8#1)(2011-12#1)
the major constraints##2##3##(2008-10#1)(2008-2#1)
the major contaminants##2##3##(1994-11#2)
the major contribution to the##2##5##(1994-11#1)(2008-2#1)
the major contribution##3##3##(1994-11#1)(2008-2#1)(2012-12#1)
the major contributor to##9##4##(1990-12#1)(1995-10#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-2#1)(2009-4#1)(2011-2#1)(2012-1#1)
the major contributors##3##3##(1993-9#1)(2007-6#1)(2008-1#1)
the major criteria##2##3##(2007-12#1)(2011-2#1)
the major degradation product of##2##5##(1992-1#1)(2008-10#1)
the major degradation product##3##4##(1992-1#1)(2008-10#2)
the major degradation##5##3##(1992-1#1)(2008-10#4)
the major design##2##3##(2008-3#2)
the major determinant of##7##4##(1990-3#1)(1994-6#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)
the major determinant##8##3##(1990-3#1)(1994-11#1)(1994-6#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)
the major determinants of##5##4##(1990-8#1)(1997-2#1)(1997-9#1)(2009-4#1)(2010-10#1)
the major developments##3##3##(2008-5#1)(2008-9#1)(2012-2#1)
the major difference##3##3##(1994-8#1)(2008-10#1)(2010-10#1)
the major differences##2##3##(1997-2#1)(2011-2#1)
the major difficulties in##2##4##(2006-8#1)(2010-9#1)
the major difficulties##3##3##(1996-1#1)(2006-8#1)(2010-9#1)
the major disease##3##3##(1994-5#1)(2008-10#1)(2008-7#1)
the major dose-limiting##2##3##(2005-7#1)(2011-1#1)
the major driving##2##3##(1993-9#1)(2007-12#1)
the major effector##2##3##(1995-12#1)(2007-11#1)
the major electronic##2##3##(1997-3#1)(2009-2#1)
the major elements of the##2##5##(1995-6#1)(2008-6#1)
the major elements##4##3##(1995-6#1)(2005-4#1)(2008-10#1)(2008-6#1)
the major energy source for##2##5##(2008-7#1)(2012-1#1)
the major energy##3##3##(1991-10#1)(2008-7#1)(2012-1#1)
the major enzyme responsible for##2##5##(1994-3#1)(2008-4#1)
the major etiological##2##3##(2008-12#1)(2012-3#1)
the major excitatory neurotransmitter##2##4##(2008-1#2)
the major factor determining##2##4##(2007-8#1)(2008-8#1)
the major factor in##3##4##(1990-3#1)(2008-10#2)
the major factor limiting##2##4##(2006-12#1)(2007-7#1)
the major factor##12##3##(1990-3#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-2#1)(2011-12#1)
the major factors in##3##4##(1994-5#1)(1997-6#1)(2008-10#1)
the major factors##11##3##(1994-5#1)(1997-6#1)(2006-1#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#1)(2010-3#1)(2012-2#1)
the major fatty acids##2##4##(2012-2#1)(2013-1#1)
the major features of the##3##5##(2008-1#1)(2008-3#1)(2010-5#1)
the major findings##4##3##(2006-10#1)(2008-5#1)(2008-9#1)(2011-1#1)
the major focus of##2##4##(1993-2#1)(1997-1#1)
the major forces##2##3##(2007-12#1)(2007-4#1)
the major form in##2##4##(1992-2#1)(1993-2#1)
the major form of##3##4##(1993-5#1)(2008-11#1)(2008-4#1)
the major form##7##3##(1990-5#1)(1992-2#1)(1992-6#1)(1993-2#1)(1993-5#1)(2008-11#1)(2008-4#1)
the major forms of##3##4##(1996-2#1)(2004-4#1)(2005-11#1)
the major forms##4##3##(1992-2#1)(1996-2#1)(2004-4#1)(2005-11#1)
the major fraction##2##3##(1994-2#1)(2008-5#1)
the major fungal##3##3##(2008-10#3)
the major gene##3##3##(2008-10#2)(2013-1#1)
the major groove in the##2##5##(1991-4#1)(1996-7#1)
the major groove of the DNA##2##6##(1991-1#1)(1991-2#1)
the major groove of the##4##5##(1991-1#1)(1991-2#1)(1995-5#1)(1997-5#1)
the major groove of##7##4##(1991-1#1)(1991-2#1)(1992-12#1)(1995-5#1)(1996-4#1)(1997-5#1)(2008-4#1)
the major groove##28##3##(1990-2#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-5#1)(1995-1#3)(1995-10#2)(1995-5#1)(1995-8#1)(1996-4#1)(1996-7#5)(1997-5#2)(2005-11#1)(2008-4#1)
the major groups##3##3##(1991-5#1)(2006-11#1)(2008-10#1)
the major health problems##2##4##(2005-8#1)(2013-1#1)
the major health##4##3##(2005-8#1)(2010-4#1)(2011-2#1)(2013-1#1)
the major histocompatibility complex (MHC)##6##5##(1990-12#1)(1990-5#1)(1997-9#1)(2007-11#1)(2008-1#1)(2013-8#1)
the major histocompatibility complex##16##4##(1990-12#1)(1990-5#2)(1993-4#1)(1994-2#1)(1995-1#1)(1995-2#1)(1997-9#1)(2006-10#3)(2007-11#1)(2008-1#2)(2012-12#1)(2013-8#1)
the major histocompatibility##21##3##(1990-12#1)(1990-5#2)(1991-7#1)(1993-4#1)(1994-2#1)(1995-1#1)(1995-2#1)(1997-9#1)(2006-10#3)(2007-11#1)(2008-1#2)(2008-11#1)(2008-4#2)(2010-12#1)(2012-12#1)(2013-8#1)
the major hospitals in##2##4##(1995-2#1)(2007-3#1)
the major human##5##3##(1991-2#1)(1994-3#1)(1996-11#1)(2006-10#1)(2008-5#1)
the major impact##3##3##(1993-10#1)(1994-1#1)(2007-7#1)
the major increase##2##3##(1991-2#1)(1997-6#1)
the major inducer of##2##4##(1994-3#1)(1997-3#1)
the major influence##2##3##(1997-2#1)(2012-3#1)
the major inhibitory##2##3##(1990-7#1)(1994-10#1)
the major intracellular##3##3##(1991-6#2)(1992-1#1)
the major ions##2##3##(1994-12#1)(2008-10#1)
the major isoform##2##3##(1991-1#1)(2010-12#1)
the major issues##5##3##(1995-1#1)(1996-12#1)(2008-6#1)(2010-9#1)(2013-8#1)
the major late##2##3##(1993-2#1)(1994-8#1)
the major limitation of##2##4##(2008-1#1)(2010-6#1)
the major limitations##3##3##(2008-7#1)(2008-8#1)(2011-2#1)
the major mechanism of##3##4##(1993-3#1)(2005-3#1)(2008-8#1)
the major metabolic##4##3##(1990-6#1)(1996-11#1)(2005-8#1)(2008-3#1)
the major metabolite formed##3##4##(1990-12#1)(1991-7#1)(1991-8#1)
the major metabolite##7##3##(1990-12#1)(1991-12#1)(1991-7#1)(1991-8#1)(1997-2#1)(2005-12#1)(2006-8#1)
the major metabolites of##3##4##(1993-2#1)(2008-10#1)(2013-7#1)
the major metabolites##4##3##(1993-2#1)(1993-4#1)(2008-10#1)(2013-7#1)
the major molecular form##2##4##(1992-7#1)(1993-4#1)
the major noradrenergic##2##3##(1993-7#1)(1996-12#1)
the major obstacles to##3##4##(1996-5#1)(2008-12#1)(2012-3#1)
the major obstacles##7##3##(1990-8#1)(1996-5#1)(2007-6#1)(2008-12#1)(2008-4#1)(2008-5#1)(2012-3#1)
the major occupational##2##3##(1994-3#1)(1995-1#1)
the major one##3##3##(1992-3#1)(2010-3#1)(2011-2#1)
the major outer membrane protein##3##5##(1991-9#2)(2007-8#1)
the major oxygen-consuming tissues##2##4##(1994-12#2)
the major parameters that affect the##2##6##(2008-10#1)(2011-1#1)
the major parameters##4##3##(2007-10#1)(2008-10#1)(2008-2#1)(2011-1#1)
the major part of the##11##5##(1990-5#2)(1993-5#1)(1995-8#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-7#1)(1997-8#1)(2008-5#1)(2013-1#1)
the major part of##14##4##(1990-5#2)(1991-2#1)(1993-5#1)(1995-8#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-7#1)(1997-8#1)(2008-5#1)(2008-6#1)(2009-2#1)(2013-1#1)
the major part##15##3##(1990-5#2)(1991-2#1)(1993-5#1)(1995-8#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-5#1)(2008-6#1)(2009-2#1)(2013-1#1)
the major pathogens##3##3##(2006-10#2)(2013-8#1)
the major pathway for##2##4##(2010-11#1)(2013-8#1)
the major pathway##3##3##(1995-3#1)(2010-11#1)(2013-8#1)
the major peaks##2##3##(1997-7#1)(2008-10#1)
the major pest##2##3##(2007-6#1)(2008-10#1)
the major phase I##3##4##(1997-8#2)(2011-3#1)
the major pneumococcal autolysin##2##4##(1990-5#2)
the major polysaccharide##2##3##(1991-12#1)(1995-6#1)
the major pool of proteoglycans##2##5##(1995-5#2)
the major population of##2##4##(1991-12#1)(1995-11#1)
the major portion of##4##4##(1995-10#1)(1995-5#1)(1996-8#1)(2007-5#1)
the major predisposing##2##3##(2012-3#1)(2013-8#1)
the major primate groups##2##4##(2008-8#2)
the major problem affecting##2##4##(1996-8#1)(2008-5#1)
the major problem in##2##4##(2006-2#1)(2011-2#1)
the major problem##7##3##(1992-3#1)(1996-8#2)(2006-2#1)(2007-11#1)(2008-5#1)(2011-2#1)
the major problems##7##3##(1990-2#1)(1997-2#1)(2006-6#1)(2008-12#1)(2010-8#1)(2012-1#1)(2012-12#1)
the major product##9##3##(1990-12#1)(1990-2#1)(1990-5#1)(1995-3#2)(1996-5#1)(1996-6#1)(2007-11#1)(2009-2#1)
the major products##3##3##(1990-2#1)(1997-2#1)(2005-8#1)
the major protein component of##2##5##(1993-6#1)(1997-8#1)
the major protein##6##3##(1993-6#1)(1993-8#1)(1994-12#1)(1995-7#1)(1997-8#1)(2008-4#1)
the major proteins##4##3##(1991-1#1)(1992-3#1)(2008-5#1)(2008-6#1)
the major reason for##4##4##(1990-4#1)(2008-3#1)(2008-8#2)
the major reason##6##3##(1990-4#1)(2006-7#1)(2008-3#1)(2008-8#2)(2010-12#1)
the major reasons for the##2##5##(2008-1#1)(2010-10#1)
the major reasons##3##3##(2008-1#1)(2009-2#1)(2010-10#1)
the major regulation##2##3##(1993-8#1)(1994-11#1)
the major regulators of##2##4##(1992-5#1)(2011-1#1)
the major regulatory protein of##2##5##(1990-10#1)(2008-8#1)
the major regulatory protein##3##4##(1990-10#1)(1991-12#1)(2008-8#1)
the major research##2##3##(1993-11#1)(2012-2#1)
the major resistance##2##3##(2008-10#2)
the major results##2##3##(2008-1#1)(2008-2#1)
the major risk factors of##3##5##(2008-11#1)(2008-7#1)(2012-12#1)
the major risk factors##5##4##(2007-8#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-12#1)
the major risk##6##3##(2006-10#1)(2007-8#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-12#1)
the major rivers of the##2##5##(2013-1#2)
the major rivers##3##3##(2010-8#1)(2013-1#2)
the major role in the##3##5##(1992-11#1)(1994-8#1)(2009-11#1)
the major role in##4##4##(1992-11#1)(1994-8#1)(1997-9#1)(2009-11#1)
the major role of##4##4##(1996-5#1)(2008-2#1)(2011-1#1)(2012-2#1)
the major role##8##3##(1992-11#1)(1994-8#1)(1996-5#1)(1997-9#1)(2008-2#1)(2009-11#1)(2011-1#1)(2012-2#1)
the major roles##2##3##(1990-3#1)(2008-4#1)
the major second##2##3##(1993-6#1)(2008-11#1)
the major site of action##3##5##(1991-1#1)(1995-12#1)(2011-1#1)
the major site of##11##4##(1990-12#1)(1991-1#1)(1991-5#1)(1992-4#1)(1992-7#1)(1995-12#1)(1995-6#1)(1997-8#1)(2007-8#1)(2010-8#1)(2011-1#1)
the major source for##2##4##(2008-11#1)(2011-1#1)
the major source of the##2##5##(1991-2#1)(1992-9#1)
the major source of##10##4##(1991-2#1)(1992-9#1)(1995-1#1)(1996-1#1)(2008-11#1)(2008-3#2)(2008-5#1)(2010-11#1)(2012-2#1)
the major source##13##3##(1991-2#1)(1992-9#1)(1995-1#1)(1996-1#1)(2008-11#2)(2008-3#2)(2008-5#1)(2010-11#1)(2011-1#1)(2012-2#2)
the major sources of##4##4##(1990-12#1)(1994-3#1)(2008-10#1)(2008-2#1)
the major sources##5##3##(1990-12#1)(1993-9#1)(1994-3#1)(2008-10#1)(2008-2#1)
the major species##5##3##(1990-3#1)(1992-8#1)(2008-1#1)(2008-10#1)(2010-11#1)
the major sperm protein##2##4##(2007-12#2)
the major steps##2##3##(2008-7#1)(2008-9#1)
the major sterol##2##3##(1997-2#1)(2008-10#1)
the major storage##2##3##(1990-4#1)(2009-10#1)
the major strategies##3##3##(2006-10#1)(2008-2#1)(2010-7#1)
the major structural protein of##2##5##(1991-10#2)
the major structural protein##3##4##(1991-10#2)(2005-11#1)
the major studies##2##3##(2005-7#1)(2008-2#1)
the major substrate##2##3##(1994-8#1)(2008-11#1)
the major subtype##2##3##(1991-4#1)(1995-12#1)
the major target for##3##4##(1995-8#1)(1996-10#1)(2005-11#1)
the major target##6##3##(1993-11#1)(1995-8#1)(1996-10#1)(1996-5#1)(2005-11#1)(2007-11#1)
the major therapeutic##2##3##(1993-9#1)(2008-12#1)
the major toxic##2##3##(1990-10#1)(2010-8#1)
the major transcription##2##3##(1992-12#1)(2011-2#1)
the major tyrosine autophosphorylation sites##2##5##(1994-12#2)
the major vault protein##2##4##(1994-12#1)(2008-11#1)
the major vector of visceral leishmaniasis##2##6##(2004-11#2)
the major vector of##3##4##(2004-11#3)
the major##1201##2##(1990-1#1)(1990-10#6)(1990-12#13)(1990-2#4)(1990-3#6)(1990-4#6)(1990-5#13)(1990-6#5)(1990-7#4)(1990-8#4)(1990-9#1)(1991-1#5)(1991-10#6)(1991-12#9)(1991-2#9)(1991-3#2)(1991-4#3)(1991-5#5)(1991-6#6)(1991-7#3)(1991-8#4)(1991-9#7)(1992-1#5)(1992-11#8)(1992-12#6)(1992-2#5)(1992-3#8)(1992-4#5)(1992-5#3)(1992-6#5)(1992-7#5)(1992-8#2)(1992-9#7)(1993-1#2)(1993-10#1)(1993-11#6)(1993-12#6)(1993-2#7)(1993-3#5)(1993-4#3)(1993-5#4)(1993-6#4)(1993-7#2)(1993-8#3)(1993-9#4)(1994-1#2)(1994-10#4)(1994-11#9)(1994-12#14)(1994-2#4)(1994-3#10)(1994-5#6)(1994-6#2)(1994-8#8)(1994-9#6)(1995-1#12)(1995-10#8)(1995-11#1)(1995-12#9)(1995-2#11)(1995-3#12)(1995-4#1)(1995-5#9)(1995-6#9)(1995-7#1)(1995-8#7)(1995-9#2)(1996-1#6)(1996-10#2)(1996-11#4)(1996-12#5)(1996-2#3)(1996-3#3)(1996-4#3)(1996-5#9)(1996-6#2)(1996-7#11)(1996-8#5)(1996-9#3)(1997-1#6)(1997-2#10)(1997-3#6)(1997-4#5)(1997-5#5)(1997-6#5)(1997-7#5)(1997-8#8)(1997-9#3)(2004-10#1)(2004-11#3)(2004-12#1)(2004-3#1)(2004-4#1)(2005-10#2)(2005-11#7)(2005-12#1)(2005-3#1)(2005-4#1)(2005-5#1)(2005-7#6)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#22)(2006-11#2)(2006-12#7)(2006-2#6)(2006-3#2)(2006-4#1)(2006-5#3)(2006-6#4)(2006-7#1)(2006-8#7)(2007-1#6)(2007-10#6)(2007-11#12)(2007-12#14)(2007-2#5)(2007-3#6)(2007-4#3)(2007-5#2)(2007-6#5)(2007-7#6)(2007-8#10)(2007-9#1)(2008-1#29)(2008-10#90)(2008-11#27)(2008-12#17)(2008-2#19)(2008-3#22)(2008-4#34)(2008-5#38)(2008-6#12)(2008-7#26)(2008-8#19)(2008-9#10)(2009-10#5)(2009-11#4)(2009-12#2)(2009-2#5)(2009-3#2)(2009-4#5)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#1)(2010-10#4)(2010-11#5)(2010-12#10)(2010-2#7)(2010-3#3)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#3)(2010-8#7)(2010-9#3)(2011-1#18)(2011-12#8)(2011-2#21)(2011-3#1)(2012-1#6)(2012-11#1)(2012-12#9)(2012-2#17)(2012-3#10)(2013-1#21)(2013-7#6)(2013-8#10)
the majority (53%)##2##3##(2007-2#1)(2008-4#1)
the majority are##3##3##(2006-12#2)(2007-11#1)
the majority being##3##3##(2007-2#1)(2010-2#1)(2013-1#1)
the majority have##2##3##(2007-3#1)(2008-2#1)
the majority in##4##3##(2005-11#2)(2007-11#1)(2009-4#1)
the majority of B cells##2##5##(2008-4#2)
the majority of US##2##4##(2006-10#1)(2010-8#1)
the majority of accessions##2##4##(2008-10#2)
the majority of all##2##4##(1990-7#1)(2008-7#1)
the majority of cardiac##2##4##(2008-12#1)(2010-8#1)
the majority of cases are##2##5##(2008-10#1)(2008-11#1)
the majority of cases of##4##5##(2004-10#1)(2006-10#1)(2007-7#1)(2011-2#1)
the majority of cases##48##4##(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#1)(1993-10#1)(1993-5#1)(1994-6#1)(1995-10#1)(1995-11#1)(1996-6#1)(1997-4#1)(1997-5#1)(2004-10#1)(2006-10#3)(2007-11#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-5#1)(2010-3#1)(2011-2#4)(2012-2#1)(2013-1#3)(2013-8#1)
the majority of cells##5##4##(1992-7#1)(1993-2#1)(1993-8#1)(1994-2#1)(1994-3#1)
the majority of children##4##4##(2006-10#1)(2008-1#1)(2008-11#1)(2009-9#1)
the majority of control##2##4##(2008-9#1)(2009-6#1)
the majority of countries##2##4##(1993-2#1)(2010-9#1)
the majority of experts##2##4##(2007-12#1)(2011-10#1)
the majority of human##2##4##(2007-12#1)(2011-1#1)
the majority of individuals##3##4##(1997-5#1)(2013-7#2)
the majority of infants##2##4##(1992-7#1)(2011-1#1)
the majority of its##2##4##(2006-6#1)(2009-8#1)
the majority of neurons##3##4##(1992-8#1)(2008-11#1)(2009-8#1)
the majority of newly##2##4##(1993-11#1)(1996-5#1)
the majority of our##3##4##(2007-6#1)(2008-11#1)(2013-1#1)
the majority of participants##3##4##(2008-1#1)(2009-8#1)(2012-12#1)
the majority of patients were##3##5##(2006-8#1)(2010-12#1)(2011-1#1)
the majority of patients who##4##5##(1996-4#1)(2006-2#1)(2008-5#1)(2013-1#1)
the majority of patients with chronic##2##6##(2006-6#1)(2007-2#1)
the majority of patients with##15##5##(1991-7#1)(1993-2#1)(1996-2#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-11#1)
the majority of patients##55##4##(1990-10#1)(1990-8#1)(1991-7#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-4#1)(1994-5#1)(1996-2#1)(1996-4#1)(1997-3#1)(2005-7#3)(2006-10#1)(2006-11#2)(2006-12#1)(2006-2#2)(2006-6#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-7#5)(2007-8#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-1#1)(2009-3#1)(2009-5#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
the majority of people##2##4##(2007-2#1)(2008-2#1)
the majority of physicians with##2##5##(2008-8#2)
the majority of rats##3##4##(1995-12#1)(1995-2#1)(2011-2#1)
the majority of research##2##4##(2006-7#1)(2013-1#1)
the majority of residues##3##4##(1990-12#1)(1991-4#1)(1994-9#1)
the majority of samples##5##4##(2006-12#1)(2007-3#1)(2008-10#1)(2011-2#2)
the majority of specimens##2##4##(2007-1#1)(2007-8#1)
the majority of studies are##2##5##(2009-8#1)(2012-2#1)
the majority of studies##6##4##(1997-8#1)(2007-4#1)(2009-10#1)(2009-8#1)(2012-2#1)(2013-1#1)
the majority of subjects##2##4##(1990-9#1)(2010-8#1)
the majority of the authors##2##5##(1996-6#1)(2005-10#1)
the majority of the literature##2##5##(1991-10#1)(2007-11#1)
the majority of the patients##5##5##(1990-12#1)(2006-10#1)(2006-8#1)(2010-11#1)(2010-6#1)
the majority of the samples##3##5##(2007-5#1)(2008-10#1)(2009-5#1)
the majority of the sandflies were##2##6##(2007-6#2)
the majority of the studies##2##5##(1996-9#1)(2011-2#1)
the majority of the world's population##2##6##(2008-5#1)(2008-9#1)
the majority of the world's##4##5##(1993-3#1)(2008-5#1)(2008-8#1)(2008-9#1)
the majority of the##103##4##(1990-11#2)(1990-12#2)(1990-2#1)(1990-4#2)(1990-5#2)(1991-10#1)(1991-11#1)(1991-7#2)(1991-9#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#2)(1996-12#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#2)(1997-7#1)(1997-8#1)(2004-4#1)(2005-10#1)(2006-10#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-3#2)(2007-5#1)(2007-6#2)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#2)(2009-5#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-2#2)(2013-8#1)
the majority of them##7##4##(1995-8#1)(2007-12#1)(2007-5#1)(2008-10#1)(2009-4#1)(2012-1#1)(2012-2#1)
the majority of these children##2##5##(2008-4#1)(2012-11#1)
the majority of these##15##4##(1993-9#1)(1995-12#1)(2005-12#1)(2005-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
the majority of this##4##4##(1997-8#1)(2006-9#1)(2008-6#1)(2013-1#1)
the majority of those living##3##5##(2009-9#1)(2013-1#2)
the majority of those##8##4##(2006-2#1)(2007-7#1)(2008-5#1)(2009-9#1)(2011-1#1)(2012-12#1)(2013-1#2)
the majority of which were##3##5##(1992-8#1)(2006-8#1)(2007-2#1)
the majority of which##8##4##(1991-12#1)(1992-8#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-12#1)
the majority of whom##2##4##(2005-8#1)(2007-8#1)
the majority of women##2##4##(2007-11#1)(2010-9#1)
the majority of##538##3##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#2)(1990-4#3)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#6)(1991-9#5)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-7#4)(1992-8#4)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#4)(1993-3#2)(1993-5#2)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#4)(1994-4#1)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#3)(1995-10#2)(1995-11#4)(1995-12#5)(1995-2#2)(1995-3#3)(1995-5#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#4)(1997-4#1)(1997-5#3)(1997-7#1)(1997-8#6)(2004-10#1)(2004-3#2)(2004-4#1)(2005-10#1)(2005-12#1)(2005-7#3)(2005-8#4)(2006-1#2)(2006-10#11)(2006-11#2)(2006-12#2)(2006-2#4)(2006-5#2)(2006-6#4)(2006-7#1)(2006-8#6)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#11)(2007-12#10)(2007-2#3)(2007-3#6)(2007-4#1)(2007-5#4)(2007-6#5)(2007-7#10)(2007-8#12)(2007-9#5)(2008-1#6)(2008-10#29)(2008-11#10)(2008-12#5)(2008-2#3)(2008-3#3)(2008-4#13)(2008-5#19)(2008-6#8)(2008-7#10)(2008-8#14)(2008-9#10)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#4)(2009-5#4)(2009-6#3)(2009-7#4)(2009-8#7)(2009-9#5)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#6)(2010-2#1)(2010-3#5)(2010-5#2)(2010-6#4)(2010-8#7)(2010-9#2)(2011-1#7)(2011-10#1)(2011-12#3)(2011-2#14)(2012-1#5)(2012-11#1)(2012-12#7)(2012-2#14)(2012-3#4)(2013-1#14)(2013-7#4)(2013-8#6)
the majority were##3##3##(2008-12#1)(2008-4#1)(2011-2#1)
the majority with##2##3##(1997-6#1)(2007-10#1)
the majority##595##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#2)(1990-4#3)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#7)(1991-9#5)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-7#4)(1992-8#4)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#4)(1993-3#2)(1993-5#2)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#4)(1994-4#1)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#3)(1995-10#2)(1995-11#4)(1995-12#5)(1995-2#3)(1995-3#3)(1995-5#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#4)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#6)(2004-10#1)(2004-3#2)(2004-4#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-7#3)(2005-8#4)(2006-1#2)(2006-10#12)(2006-11#2)(2006-12#4)(2006-2#4)(2006-5#2)(2006-6#4)(2006-7#1)(2006-8#6)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#14)(2007-12#10)(2007-2#5)(2007-3#7)(2007-4#1)(2007-5#4)(2007-6#5)(2007-7#13)(2007-8#12)(2007-9#5)(2008-1#7)(2008-10#32)(2008-11#12)(2008-12#8)(2008-2#6)(2008-3#4)(2008-4#16)(2008-5#20)(2008-6#9)(2008-7#10)(2008-8#16)(2008-9#12)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#6)(2009-5#4)(2009-6#4)(2009-7#4)(2009-8#7)(2009-9#5)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#6)(2010-2#2)(2010-3#5)(2010-5#4)(2010-6#4)(2010-8#8)(2010-9#2)(2011-1#7)(2011-10#1)(2011-12#3)(2011-2#16)(2012-1#5)(2012-11#1)(2012-12#8)(2012-2#14)(2012-3#5)(2013-1#15)(2013-7#6)(2013-8#6)
the majors##2##2##(2007-7#1)(2008-11#1)
the make-up of##2##3##(2006-8#1)(2008-7#1)
the make-up##3##2##(2006-8#1)(2008-7#1)(2011-1#1)
the making of##8##3##(1997-2#1)(2007-11#1)(2008-6#1)(2008-7#1)(2009-11#1)(2010-4#1)(2013-1#2)
the making##11##2##(1991-1#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-11#1)(2010-4#1)(2013-1#2)
the malacostracan##2##2##(2007-12#2)
the malar retaining ligament##2##4##(2010-11#2)
the malar##4##2##(2008-5#1)(2010-11#2)(2013-1#1)
the malaria diagnosis network##2##4##(2012-12#2)
the malaria diagnosis##4##3##(2008-3#1)(2011-2#1)(2012-12#2)
the malaria parasite##5##3##(1994-5#1)(2006-10#1)(2008-11#2)(2008-7#1)
the malaria parasites##2##3##(2006-4#1)(2007-12#1)
the malaria##29##2##(1994-5#1)(2005-8#1)(2006-10#4)(2006-2#1)(2006-4#1)(2007-12#2)(2007-2#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2010-1#1)(2010-12#1)(2011-2#3)(2012-12#6)
the malarial##4##2##(1990-9#1)(1993-2#1)(1997-1#1)(2008-1#1)
the male Syrian hamster##3##4##(1992-8#3)
the male and female genital##2##5##(1990-5#1)(2008-7#1)
the male and female reproductive##2##5##(2008-7#1)(2011-2#1)
the male and female##16##4##(1990-5#1)(1992-3#1)(1994-4#1)(1995-8#1)(1997-3#1)(2007-1#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#1)(2013-8#2)
the male and##17##3##(1990-5#1)(1992-3#1)(1994-4#1)(1995-8#1)(1996-12#1)(1997-3#1)(2007-1#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#1)(2013-8#2)
the male gamete##2##3##(1994-5#1)(2012-2#1)
the male genital appendages##2##4##(2008-8#2)
the male genital tract##3##4##(2008-4#1)(2012-1#1)(2012-2#1)
the male genital tracts##2##4##(2008-7#2)
the male genital##8##3##(1993-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2012-1#1)(2012-2#1)
the male genitalia##3##3##(1990-8#2)(2013-7#1)
the male group##3##3##(2005-10#1)(2011-1#2)
the male lambs##2##3##(2010-2#2)
the male mice exposed to##2##5##(1996-11#1)(2008-9#1)
the male mice##3##3##(1996-11#1)(2007-10#1)(2008-9#1)
the male parent##3##3##(2008-10#2)(2008-5#1)
the male population##3##3##(1993-11#1)(1995-11#1)(2006-2#1)
the male rat##6##3##(1991-11#2)(1991-2#2)(1996-10#1)(1996-9#1)
the male rats was##2##4##(1990-11#1)(2008-5#1)
the male rats##9##3##(1990-11#1)(1994-2#1)(1996-4#1)(2008-5#1)(2008-7#1)(2013-1#4)
the male reproductive system##3##4##(1993-3#1)(2009-10#1)(2012-2#1)
the male reproductive tract##6##4##(2011-1#1)(2012-2#1)(2013-8#4)
the male reproductive##12##3##(1993-3#1)(2006-10#1)(2007-12#1)(2007-9#1)(2009-10#1)(2011-1#1)(2012-2#2)(2013-8#4)
the male sex##2##3##(2006-2#1)(2013-1#1)
the male stimulatory ability##2##4##(2008-8#2)
the male three-spined stickleback Gasterosteus aculeatus##2##6##(2010-8#2)
the male##191##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#2)(1991-11#3)(1991-2#2)(1991-5#2)(1992-12#1)(1992-2#2)(1992-3#5)(1992-6#2)(1992-8#3)(1993-11#1)(1993-12#2)(1993-3#2)(1993-6#5)(1993-8#1)(1994-10#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#3)(1995-11#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#2)(1996-9#1)(1997-3#1)(2004-2#1)(2005-10#1)(2006-10#2)(2006-11#2)(2006-2#2)(2006-3#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-12#10)(2007-3#2)(2007-4#1)(2007-6#2)(2007-9#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-4#8)(2008-5#12)(2008-6#4)(2008-7#8)(2008-8#5)(2008-9#3)(2009-10#2)(2009-2#1)(2009-4#1)(2009-8#1)(2010-2#3)(2010-5#2)(2010-8#4)(2011-1#3)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#4)(2013-1#7)(2013-7#2)(2013-8#12)
the male's##2##2##(2008-8#2)
the male-specific expression of the Slp gene##2##7##(1995-2#2)
the male-specific expression##3##3##(1995-2#3)
the male-to-female sex##2##3##(2008-5#1)(2011-2#1)
the male/female ratio was##2##4##(2006-10#1)(2011-3#1)
the male/female##3##2##(2006-10#1)(2011-3#1)(2012-12#1)
the maleimide##2##2##(1994-11#1)(2008-10#1)
the males and females##2##4##(2007-3#1)(2009-4#1)
the males and##3##3##(2007-3#1)(2008-4#1)(2009-4#1)
the males were##3##3##(1995-3#1)(2007-12#1)(2013-7#1)
the males##27##2##(1990-8#1)(1991-2#1)(1993-11#1)(1994-2#2)(1995-3#3)(1996-12#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-8#1)(2009-4#1)(2012-12#2)(2013-7#1)
the malformation##7##2##(1990-8#1)(1990-9#2)(1991-11#1)(1992-5#1)(2006-5#1)(2008-9#1)
the malignancy of##4##3##(1990-10#1)(1992-9#1)(2012-12#1)(2012-2#1)
the malignancy##11##2##(1990-10#1)(1990-8#1)(1992-9#1)(2006-6#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
the malignant cell##2##3##(1996-10#1)(1996-2#1)
the malignant cells##5##3##(1996-5#1)(2007-11#2)(2009-8#1)(2010-1#1)
the malignant nature of##2##4##(1990-6#1)(2008-4#1)
the malignant phenotype##2##3##(2005-7#1)(2008-11#1)
the malignant state##2##3##(1990-2#1)(1991-9#1)
the malignant transformation of##4##4##(1995-8#1)(2008-5#2)(2012-12#1)
the malignant transformation##5##3##(1991-10#1)(1995-8#1)(2008-5#2)(2012-12#1)
the malignant##49##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-2#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-9#1)(1995-4#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(2005-1#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-4#1)(2007-11#2)(2007-3#1)(2007-5#1)(2007-6#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-12#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-9#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#3)
the malnourished##3##2##(1990-3#1)(2006-10#1)(2008-11#1)
the malnutrition##2##2##(2006-4#1)(2011-2#1)
the malolactic##2##2##(1997-6#2)
the malondialdehyde (MDA)##2##3##(1997-7#1)(2008-6#1)
the malondialdehyde##5##2##(1993-9#1)(1994-11#1)(1997-7#1)(2008-10#1)(2008-6#1)
the maltose binding##3##3##(1993-6#3)
the maltose-##2##2##(1996-11#2)
the maltose-binding protein##4##3##(1992-9#1)(1996-11#2)(1997-6#1)
the maltose-binding##5##2##(1992-9#1)(1996-11#2)(1997-4#1)(1997-6#1)
the mammalian CNS##2##3##(1990-12#1)(1994-2#1)
the mammalian DNA methyltransferase##2##4##(1997-4#2)
the mammalian and##4##3##(1991-2#1)(1995-3#1)(2006-12#1)(2009-3#1)
the mammalian brain##15##3##(1990-7#1)(1991-8#1)(1993-5#1)(1994-2#1)(1995-6#1)(1996-4#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-12#2)(2008-11#2)(2008-8#1)(2010-12#1)
the mammalian cell cycle##2##4##(1994-2#1)(2012-2#1)
the mammalian cell##3##3##(1994-2#1)(2010-2#1)(2012-2#1)
the mammalian central nervous system##8##5##(1990-7#1)(1991-5#1)(1993-12#1)(1997-5#1)(2008-11#1)(2008-8#2)(2012-2#1)
the mammalian cochlea##2##3##(1995-3#1)(2013-1#1)
the mammalian genome##4##3##(1991-6#1)(1996-4#1)(2008-1#1)(2008-8#1)
the mammalian homologue of##2##4##(1990-5#1)(1993-9#1)
the mammalian homologue##3##3##(1990-5#1)(1993-9#1)(1997-7#1)
the mammalian host##4##3##(1996-6#1)(2008-9#2)(2011-2#1)
the mammalian immune##2##3##(2008-4#1)(2012-1#1)
the mammalian inner ear##4##4##(1996-3#1)(2009-9#1)(2012-12#2)
the mammalian pineal organ##3##4##(1994-5#3)
the mammalian prefrontal cortex##2##4##(1993-5#2)
the mammalian retina##2##3##(2008-5#1)(2009-2#1)
the mammalian species##3##3##(1990-4#1)(2007-7#1)(2008-10#1)
the mammalian target of rapamycin (mTOR) inhibitor##3##7##(2009-11#1)(2013-1#2)
the mammalian target of rapamycin (mTOR)##4##6##(2008-8#1)(2009-11#1)(2013-1#2)
the mammalian target of rapamycin##6##5##(2006-10#1)(2008-8#1)(2009-11#1)(2013-1#2)(2013-7#1)
the mammalian testis##3##3##(2012-2#3)
the mammalian##168##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-4#2)(1990-5#3)(1990-7#4)(1990-8#1)(1991-10#1)(1991-2#3)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#1)(1992-1#1)(1992-6#1)(1992-7#2)(1993-12#3)(1993-3#1)(1993-5#3)(1993-6#3)(1993-8#1)(1993-9#1)(1994-12#3)(1994-2#4)(1994-3#1)(1994-5#4)(1994-8#2)(1994-9#3)(1995-11#3)(1995-2#2)(1995-3#4)(1995-6#3)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-10#1)(2005-11#1)(2005-9#3)(2006-10#1)(2006-12#2)(2006-5#1)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#7)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#10)(2008-9#3)(2009-11#1)(2009-2#2)(2009-3#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#5)(2013-1#3)(2013-7#2)(2013-8#1)
the mammals##4##2##(1994-12#1)(1997-4#1)(2008-11#1)(2008-5#1)
the mammary epithelium##2##3##(1995-9#1)(2009-12#1)
the mammary gland##29##3##(1990-12#1)(1992-11#1)(1992-9#1)(1993-2#2)(1994-12#1)(1994-3#2)(1995-9#1)(1996-10#2)(1996-4#1)(1996-6#1)(2008-10#1)(2008-4#2)(2008-5#3)(2008-8#1)(2009-12#1)(2011-2#3)(2012-1#1)(2012-2#3)(2013-8#1)
the mammary glands of##2##4##(1990-11#1)(1994-3#1)
the mammary glands##12##3##(1990-11#1)(1993-7#1)(1994-3#1)(2012-1#1)(2012-12#8)
the mammary##51##2##(1990-11#1)(1990-12#1)(1990-5#2)(1992-11#1)(1992-9#1)(1993-2#2)(1993-7#1)(1994-12#1)(1994-3#4)(1995-9#2)(1996-10#2)(1996-2#1)(1996-4#1)(1996-6#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-5#3)(2008-8#1)(2009-12#2)(2011-2#3)(2012-1#2)(2012-12#10)(2012-2#3)(2013-1#1)(2013-8#1)
the mammographic and##2##3##(1990-4#1)(2011-2#1)
the mammographic##3##2##(1990-4#2)(2011-2#1)
the man##10##2##(1994-3#1)(1997-7#1)(2006-9#1)(2007-9#1)(2008-12#3)(2008-6#1)(2008-8#1)(2011-2#1)
the managed care industry##2##4##(1994-12#1)(1994-3#1)
the managed care system##7##4##(1994-2#1)(1996-12#1)(2006-10#5)
the managed care##20##3##(1991-3#1)(1992-2#2)(1994-12#1)(1994-2#2)(1994-3#1)(1995-3#1)(1996-1#1)(1996-12#2)(1996-3#2)(1997-3#1)(2006-10#5)(2009-11#1)
the managed##22##2##(1991-3#1)(1992-2#2)(1994-12#1)(1994-2#2)(1994-3#2)(1995-3#1)(1996-1#1)(1996-12#2)(1996-3#2)(1997-3#1)(2006-10#5)(2008-8#1)(2009-11#1)
the management and outcomes of##2##5##(2005-8#1)(2008-3#1)
the management and##17##3##(1992-12#1)(1993-12#1)(1993-3#1)(1994-4#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-9#1)(2008-3#1)(2008-5#1)(2009-4#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
the management challenge##2##3##(1992-12#1)(2012-12#1)
the management development##2##3##(1995-12#1)(1996-3#1)
the management in##4##3##(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)
the management of AF##2##4##(2008-6#1)(2010-6#1)
the management of CIN##2##4##(1990-12#1)(2006-10#1)
the management of COPD##2##4##(2006-5#1)(2007-11#1)
the management of Fusarium##2##4##(2008-10#2)
the management of HIV##2##4##(2006-10#1)(2008-1#1)
the management of HIV/AIDS##2##4##(2005-7#1)(2007-12#1)
the management of IBD##2##4##(2006-2#1)(2009-8#1)
the management of PCOS##2##4##(2012-11#2)
the management of Parkinson's disease##2##5##(2008-11#1)(2013-8#1)
the management of Type##2##4##(2005-7#1)(2006-7#1)
the management of a case of##3##6##(2009-9#1)(2010-8#1)(2013-1#1)
the management of a diverse##2##5##(1997-2#1)(2007-12#1)
the management of a patient with##2##6##(1991-4#1)(2008-12#1)
the management of a patient##5##5##(1991-4#1)(2008-12#2)(2008-8#1)(2009-4#1)
the management of a##21##4##(1991-4#1)(1993-4#1)(1994-12#1)(1994-2#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-12#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#1)
the management of acute and chronic##2##6##(2007-12#1)(2008-7#1)
the management of acute coronary##3##5##(2008-3#3)
the management of acute ischaemic##3##5##(2005-7#2)(2007-11#1)
the management of acute respiratory##2##5##(2005-8#1)(2012-12#1)
the management of acute##22##4##(1995-8#1)(1995-9#1)(2005-6#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#3)(2007-11#1)(2007-12#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
the management of adult##2##4##(2005-11#1)(2011-1#1)
the management of advanced##3##4##(2006-10#1)(2008-5#1)(2009-4#1)
the management of all##4##4##(1992-2#1)(2007-8#1)(2010-6#1)(2012-3#1)
the management of an##5##4##(1996-11#1)(1997-6#1)(2006-10#1)(2006-4#1)(2008-12#1)
the management of anemia in##2##5##(2008-5#1)(2013-1#1)
the management of anemia##3##4##(2008-5#1)(2013-1#2)
the management of arthritis or periarthritis##2##6##(2006-10#2)
the management of arthritis##3##4##(2006-10#2)(2008-3#1)
the management of asthma##5##4##(2005-7#1)(2008-11#2)(2010-5#2)
the management of atrial fibrillation##4##5##(2008-3#3)(2009-10#1)
the management of atrial##5##4##(2008-3#4)(2009-10#1)
the management of blood##2##4##(1991-1#1)(2008-1#1)
the management of both##4##4##(1991-2#1)(2007-12#1)(2008-7#1)(2009-1#1)
the management of breast cancer##3##5##(2007-11#1)(2013-1#2)
the management of breast##6##4##(2007-11#1)(2010-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
the management of cancer pain##2##5##(2006-12#1)(2008-3#1)
the management of cancer##4##4##(2006-12#1)(2007-4#1)(2008-3#1)(2012-2#1)
the management of cardiac##2##4##(2008-10#1)(2010-8#1)
the management of cardiovascular disease##2##5##(1993-12#1)(2009-1#1)
the management of cardiovascular##3##4##(1993-12#1)(2005-8#1)(2009-1#1)
the management of cerebral##2##4##(2008-7#1)(2013-7#1)
the management of certain##3##4##(1992-6#1)(2008-2#1)(2008-3#1)
the management of cervical anastomotic leakage after##2##7##(2007-8#2)
the management of cervical##3##4##(2007-8#2)(2008-7#1)
the management of chemotherapy-induced emesis##2##5##(2008-7#2)
the management of chemotherapy-induced##3##4##(2005-11#1)(2008-7#2)
the management of chronic hepatitis B##4##6##(2006-10#1)(2008-5#1)(2009-11#1)(2009-8#1)
the management of chronic hepatitis##6##5##(2006-10#1)(2007-11#1)(2008-5#1)(2009-11#1)(2009-8#2)
the management of chronic illness##2##5##(2006-1#1)(2008-4#1)
the management of chronic pain##9##5##(2006-8#4)(2007-2#1)(2008-3#1)(2008-5#2)(2010-8#1)
the management of chronic viral##2##5##(2007-11#1)(2008-8#1)
the management of chronic##44##4##(1990-2#1)(1996-7#2)(1997-1#1)(1997-3#1)(2004-2#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-8#13)(2007-11#3)(2007-2#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#2)(2010-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
the management of common##5##4##(2008-11#1)(2008-7#3)(2010-2#1)
the management of complex##3##4##(2008-4#1)(2009-12#1)(2010-8#1)
the management of complications##3##4##(2007-3#1)(2007-7#1)(2009-9#1)
the management of contaminated##2##4##(2010-5#1)(2011-12#1)
the management of coronary##2##4##(2006-10#1)(2008-8#1)
the management of critical care units##2##6##(1996-2#2)
the management of critical care##3##5##(1996-2#2)(2007-12#1)
the management of critical##4##4##(1994-6#1)(1996-2#2)(2007-12#1)
the management of croup##2##4##(2009-4#2)
the management of deep##2##4##(2005-7#1)(2007-11#1)
the management of depression in##2##5##(2005-6#1)(2011-2#1)
the management of depression##5##4##(1996-12#1)(2005-6#1)(2005-8#1)(2006-4#1)(2011-2#1)
the management of diabetes##5##4##(2007-1#1)(2007-10#1)(2007-8#1)(2009-4#1)(2011-2#1)
the management of diabetic##4##4##(1993-5#1)(2005-12#1)(2008-1#1)(2008-9#1)
the management of diffuse##4##4##(2005-8#2)(2007-9#1)(2010-12#1)
the management of drug##2##4##(2007-12#1)(2013-1#1)
the management of drug-induced agranulocytosis##2##5##(2007-11#2)
the management of dry skin##2##5##(2008-5#2)
the management of dry##3##4##(2007-1#1)(2008-5#2)
the management of dyslipidemia##2##4##(2005-8#1)(2009-11#1)
the management of end-stage##3##4##(2006-10#1)(2007-11#1)(2011-3#1)
the management of exercise-induced asthma##2##5##(2010-5#1)(2011-12#1)
the management of gallbladder cancer##3##5##(2008-3#1)(2010-12#1)(2013-1#1)
the management of gallbladder##4##4##(1991-12#1)(2008-3#1)(2010-12#1)(2013-1#1)
the management of hypertension##3##4##(1990-11#1)(1991-2#1)(2005-8#1)
the management of infertility##2##4##(2005-8#1)(2011-1#1)
the management of insulin resistance##2##5##(2008-3#2)
the management of lung cancer##3##5##(1996-9#1)(2008-5#1)(2010-5#1)
the management of malaria##2##4##(2006-10#1)(2008-2#1)
the management of medical emergencies##2##5##(2008-1#1)(2010-9#1)
the management of medical wastes in##2##6##(1991-4#2)
the management of medical##7##4##(1991-4#2)(1996-6#1)(2006-10#1)(2008-1#1)(2010-4#1)(2010-9#1)
the management of moderate to##2##5##(1996-7#1)(2008-3#1)
the management of needle pain##2##5##(2008-11#2)
the management of neuropathic pain##3##5##(2008-4#1)(2011-1#2)
the management of osteosarcoma##2##4##(2008-6#1)(2010-3#1)
the management of our##2##4##(2007-8#1)(2011-1#1)
the management of pain##12##4##(1996-7#1)(1997-5#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-7#1)(2009-12#1)(2010-12#1)(2010-6#1)
the management of painful##3##4##(2008-7#1)(2008-8#1)(2012-2#1)
the management of patient##4##4##(2006-1#3)(2007-11#1)
the management of patients with acute##2##6##(2006-10#1)(2008-3#1)
the management of patients with chronic##3##6##(2006-10#1)(2010-11#1)(2012-1#1)
the management of patients with unstable##3##6##(2006-8#1)(2007-11#1)(2008-3#1)
the management of patients with##50##5##(1990-8#1)(1991-12#1)(1992-3#1)(1996-11#1)(1996-9#1)(2006-10#3)(2006-7#1)(2006-8#1)(2007-1#2)(2007-11#4)(2007-6#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-1#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
the management of patients##56##4##(1990-8#1)(1991-12#1)(1992-3#1)(1996-11#1)(1996-9#1)(2005-8#1)(2006-10#3)(2006-7#1)(2006-8#1)(2007-1#2)(2007-11#4)(2007-6#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#2)(2009-1#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)
the management of pediatric##7##4##(2006-10#1)(2007-12#2)(2011-1#2)(2012-3#1)(2013-8#1)
the management of post-operative##3##4##(2007-8#2)(2011-1#1)
the management of postmenopausal##2##4##(1991-4#1)(2008-3#1)
the management of postoperative##5##4##(2006-10#1)(2007-8#1)(2008-8#1)(2009-2#1)(2010-2#1)
the management of prostate cancer##2##5##(2006-9#1)(2011-2#1)
the management of psoriasis##2##4##(2005-11#1)(2007-8#1)
the management of pulmonary##2##4##(1997-1#1)(2010-3#1)
the management of rectal cancer##2##5##(1994-4#1)(2007-4#1)
the management of refractory##4##4##(2010-12#1)(2011-2#1)(2013-8#2)
the management of renal cell carcinoma##2##6##(2009-11#1)(2009-8#1)
the management of renal##4##4##(2008-1#1)(2008-7#1)(2009-11#1)(2009-8#1)
the management of severe##9##4##(1991-3#1)(2006-4#1)(2007-1#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-9#2)(2013-7#1)
the management of sleep##2##4##(2007-12#1)(2008-11#1)
the management of some##2##4##(2006-6#1)(2008-12#1)
the management of spasticity##2##4##(2006-12#1)(2007-7#1)
the management of specific##2##4##(2006-10#1)(2009-7#1)
the management of spinal##3##4##(1995-9#1)(2006-2#1)(2006-8#1)
the management of spontaneous##2##4##(2008-7#1)(2012-1#1)
the management of stroke##2##4##(1996-9#1)(2011-1#1)
the management of such patients in##2##6##(2012-2#2)
the management of such patients##4##5##(1995-11#1)(2006-12#1)(2012-2#2)
the management of such##11##4##(1995-11#1)(2005-11#1)(2005-9#1)(2006-12#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)
the management of symptomatic##3##4##(2008-6#1)(2008-8#1)(2012-2#1)
the management of the disease##5##5##(1997-8#1)(2006-10#1)(2008-10#2)(2008-3#1)
the management of the most##2##5##(1996-12#1)(2013-1#1)
the management of the patient##2##5##(2005-3#1)(2006-10#1)
the management of the##43##4##(1990-3#1)(1993-5#1)(1994-12#1)(1996-12#1)(1996-4#1)(1997-3#1)(1997-8#1)(2005-3#1)(2005-5#1)(2005-8#1)(2006-10#4)(2006-2#1)(2007-12#4)(2007-7#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-3#3)(2008-6#1)(2008-8#2)(2008-9#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
the management of their##3##4##(1992-3#1)(2008-8#1)(2009-7#1)
the management of these infections##2##5##(2007-7#1)(2008-7#1)
the management of these patients##10##5##(1991-2#1)(1993-7#1)(2006-2#1)(2006-4#1)(2006-6#1)(2008-3#1)(2010-11#1)(2010-9#1)(2011-2#1)(2013-1#1)
the management of these problems##2##5##(2006-12#1)(2006-3#1)
the management of these##26##4##(1991-2#1)(1993-7#1)(2004-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#2)(2006-7#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
the management of this condition##3##5##(2008-7#1)(2008-8#1)(2013-8#1)
the management of this disease##7##5##(1991-2#1)(1996-9#1)(2007-2#1)(2010-8#1)(2011-2#2)(2012-2#1)
the management of this rare##3##5##(2008-4#1)(2013-1#2)
the management of this##28##4##(1991-2#1)(1996-4#1)(1996-9#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-2#2)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
the management of type 2##3##5##(2008-3#2)(2009-8#1)
the management of unstable angina##3##5##(1991-9#2)(2008-3#1)
the management of unstable##4##4##(1991-9#2)(2006-8#1)(2008-3#1)
the management of urinary##2##4##(2011-1#1)(2012-3#1)
the management of##954##3##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#5)(1991-3#1)(1991-4#5)(1991-7#2)(1991-8#1)(1991-9#2)(1992-10#2)(1992-12#5)(1992-2#1)(1992-3#4)(1992-6#1)(1993-11#1)(1993-12#2)(1993-4#1)(1993-5#3)(1993-7#1)(1993-8#2)(1993-9#2)(1994-10#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#2)(1995-11#2)(1995-12#1)(1995-3#1)(1995-4#1)(1995-8#1)(1995-9#2)(1996-1#4)(1996-11#3)(1996-12#3)(1996-2#2)(1996-3#3)(1996-4#4)(1996-6#1)(1996-7#5)(1996-8#1)(1996-9#4)(1997-1#2)(1997-2#1)(1997-3#6)(1997-5#2)(1997-6#1)(1997-8#3)(2004-1#2)(2004-10#2)(2004-2#2)(2005-10#1)(2005-11#7)(2005-12#2)(2005-3#1)(2005-4#1)(2005-5#1)(2005-6#3)(2005-7#10)(2005-8#16)(2005-9#2)(2006-1#4)(2006-10#50)(2006-11#2)(2006-12#9)(2006-2#9)(2006-3#1)(2006-4#8)(2006-5#2)(2006-6#5)(2006-7#6)(2006-8#17)(2006-9#3)(2007-1#8)(2007-10#4)(2007-11#27)(2007-12#27)(2007-2#7)(2007-3#4)(2007-4#3)(2007-5#3)(2007-6#6)(2007-7#20)(2007-8#19)(2007-9#4)(2008-1#16)(2008-10#26)(2008-11#17)(2008-12#12)(2008-2#5)(2008-3#50)(2008-4#10)(2008-5#19)(2008-6#11)(2008-7#38)(2008-8#15)(2008-9#13)(2009-1#3)(2009-10#4)(2009-11#6)(2009-12#5)(2009-2#1)(2009-3#1)(2009-4#19)(2009-5#2)(2009-6#5)(2009-7#2)(2009-8#9)(2009-9#7)(2010-1#2)(2010-10#2)(2010-11#6)(2010-12#22)(2010-2#3)(2010-3#4)(2010-4#7)(2010-5#10)(2010-6#5)(2010-7#6)(2010-8#7)(2010-9#6)(2011-1#19)(2011-12#2)(2011-2#29)(2011-3#2)(2012-1#7)(2012-10#1)(2012-11#2)(2012-12#12)(2012-2#23)(2012-3#11)(2013-1#35)(2013-7#6)(2013-8#15)
the management options##2##3##(2004-7#1)(2006-9#1)
the management strategies##3##3##(2008-3#1)(2011-1#1)(2011-2#1)
the management team##3##3##(1993-1#2)(1994-3#1)
the management with##3##3##(2008-7#2)(2013-8#1)
the management##1024##2##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#5)(1991-3#1)(1991-4#5)(1991-7#2)(1991-8#1)(1991-9#2)(1992-10#2)(1992-12#8)(1992-2#1)(1992-3#4)(1992-6#1)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#3)(1993-3#2)(1993-4#1)(1993-5#3)(1993-7#1)(1993-8#2)(1993-9#2)(1994-10#2)(1994-12#3)(1994-2#1)(1994-3#3)(1994-4#2)(1994-6#2)(1995-11#2)(1995-12#2)(1995-3#1)(1995-4#1)(1995-8#1)(1995-9#2)(1996-1#4)(1996-11#3)(1996-12#3)(1996-2#3)(1996-3#4)(1996-4#4)(1996-6#1)(1996-7#5)(1996-8#1)(1996-9#4)(1997-1#3)(1997-2#1)(1997-3#7)(1997-5#2)(1997-6#1)(1997-8#3)(2004-1#2)(2004-10#2)(2004-2#2)(2004-7#1)(2005-10#1)(2005-11#7)(2005-12#2)(2005-3#1)(2005-4#1)(2005-5#1)(2005-6#3)(2005-7#10)(2005-8#17)(2005-9#2)(2006-1#4)(2006-10#53)(2006-11#4)(2006-12#9)(2006-2#10)(2006-3#1)(2006-4#8)(2006-5#2)(2006-6#5)(2006-7#6)(2006-8#17)(2006-9#4)(2007-1#8)(2007-10#5)(2007-11#27)(2007-12#27)(2007-2#8)(2007-3#4)(2007-4#3)(2007-5#4)(2007-6#6)(2007-7#20)(2007-8#21)(2007-9#5)(2008-1#18)(2008-10#27)(2008-11#18)(2008-12#13)(2008-2#5)(2008-3#52)(2008-4#10)(2008-5#21)(2008-6#12)(2008-7#40)(2008-8#15)(2008-9#14)(2009-1#3)(2009-10#4)(2009-11#6)(2009-12#5)(2009-2#1)(2009-3#1)(2009-4#21)(2009-5#2)(2009-6#8)(2009-7#2)(2009-8#9)(2009-9#7)(2010-1#2)(2010-10#2)(2010-11#6)(2010-12#22)(2010-2#3)(2010-3#5)(2010-4#7)(2010-5#10)(2010-6#5)(2010-7#7)(2010-8#7)(2010-9#6)(2011-1#21)(2011-12#3)(2011-2#30)(2011-3#2)(2012-1#7)(2012-10#1)(2012-11#2)(2012-12#15)(2012-2#24)(2012-3#13)(2013-1#38)(2013-7#7)(2013-8#17)
the manager##3##2##(1993-12#1)(1995-1#1)(2012-3#1)
the managerial competencies##2##3##(2008-1#1)(2011-2#1)
the managerial##6##2##(1994-12#1)(1994-3#2)(2008-1#1)(2010-10#1)(2011-2#1)
the managers##3##2##(1994-1#1)(2012-12#1)(2012-3#1)
the managing##6##2##(1996-3#1)(2008-11#1)(2008-5#1)(2011-2#2)(2013-1#1)
the manchette##3##2##(2012-2#3)
the mandate##4##2##(1993-3#1)(1997-1#1)(2006-10#1)(2013-7#1)
the mandates of##2##3##(1991-2#1)(2012-2#1)
the mandatory##2##2##(1990-12#1)(2008-7#1)
the mandible and temporomandibular joint##2##5##(2007-12#1)(2010-2#1)
the mandible and##8##3##(2007-12#1)(2007-6#1)(2010-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
the mandible in##4##3##(1996-8#1)(2007-6#1)(2007-7#1)(2010-2#1)
the mandible##43##2##(1996-8#1)(1997-3#1)(2007-12#2)(2007-5#2)(2007-6#2)(2007-7#4)(2008-7#1)(2009-3#1)(2010-2#4)(2010-3#1)(2011-1#5)(2011-12#1)(2011-2#2)(2011-7#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)
the mandibles##2##2##(2007-12#1)(2009-3#1)
the mandibular angle##3##3##(2010-2#1)(2012-12#2)
the mandibular base##2##3##(2004-9#1)(2007-12#1)
the mandibular canal##7##3##(1991-1#1)(2013-8#6)
the mandibular condyle##5##3##(1991-3#1)(1993-1#1)(2007-12#1)(2010-2#1)(2011-12#1)
the mandibular gingiva##2##3##(2012-3#1)(2013-1#1)
the mandibular nerve##2##3##(2011-2#2)
the mandibular##38##2##(1991-1#1)(1991-3#1)(1993-1#1)(1996-5#1)(2004-9#1)(2007-12#6)(2007-7#1)(2008-9#1)(2010-10#1)(2010-2#5)(2011-12#1)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#6)
the maneuvers##2##2##(1997-2#1)(2012-2#1)
the manganese cluster##2##3##(1994-12#1)(1995-8#1)
the manganese##12##2##(1993-8#1)(1994-12#2)(1995-8#1)(1997-7#1)(2008-10#4)(2008-5#1)(2008-8#1)(2010-5#1)
the mangrove crab##3##3##(2008-7#2)(2013-7#1)
the mangrove##11##2##(2007-5#2)(2008-11#1)(2008-5#4)(2008-7#2)(2013-7#2)
the manifestation of a##4##4##(1990-9#1)(1994-2#1)(2008-10#1)(2011-2#1)
the manifestation of the##3##4##(1993-11#1)(1997-8#1)(2008-5#1)
the manifestation of these##2##4##(1994-2#1)(2008-11#1)
the manifestation of this##2##4##(1995-12#1)(1996-12#1)
the manifestation of##27##3##(1990-9#1)(1993-11#1)(1994-2#3)(1995-12#2)(1995-2#1)(1995-5#1)(1996-12#1)(1997-8#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-5#1)(2010-10#1)(2011-2#2)(2011-3#1)(2012-2#1)
the manifestation##29##2##(1990-9#1)(1993-11#1)(1994-2#3)(1995-12#2)(1995-2#1)(1995-5#1)(1996-12#1)(1997-8#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)
the manifestations of##5##3##(1992-12#1)(2006-10#1)(2006-6#1)(2007-6#1)(2009-10#1)
the manifestations##7##2##(1992-12#1)(2006-10#1)(2006-6#1)(2007-6#1)(2009-10#1)(2009-2#1)(2012-11#1)
the manifold##13##2##(1992-2#1)(1993-12#1)(1995-9#1)(2006-10#1)(2006-4#1)(2008-10#7)(2008-11#1)
the manipulation and##3##3##(1995-5#1)(1996-3#1)(2010-7#1)
the manipulation of the##3##4##(2006-12#1)(2008-10#1)(2008-2#1)
the manipulation of##26##3##(1991-12#1)(1994-11#1)(1995-12#1)(1997-2#1)(2006-10#1)(2006-12#3)(2006-3#1)(2007-12#1)(2008-10#1)(2008-11#4)(2008-2#2)(2008-4#2)(2008-7#2)(2009-12#1)(2009-8#2)(2010-11#1)(2011-2#1)
the manipulation##38##2##(1991-12#1)(1994-11#1)(1995-12#1)(1995-5#1)(1996-3#2)(1997-2#1)(2006-10#1)(2006-12#3)(2006-3#1)(2007-12#2)(2008-10#2)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#2)(2010-11#1)(2010-7#1)(2011-2#1)(2012-1#1)
the manipulator##2##2##(2008-10#1)(2012-1#1)
the mannans##3##2##(1991-3#1)(1994-5#2)
the manner and##2##3##(1992-10#1)(2011-2#1)
the manner by which##2##4##(1990-12#1)(1995-12#1)
the manner in which the##11##5##(1992-1#1)(1993-3#1)(1994-2#1)(1996-9#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-7#1)(2009-5#1)(2011-1#1)
the manner in which these##2##5##(1995-3#1)(2012-12#1)
the manner in which##26##4##(1992-1#1)(1993-2#1)(1993-3#1)(1994-2#1)(1995-3#1)(1996-12#1)(1996-9#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-5#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
the manner of death##2##4##(1995-11#1)(2005-8#1)
the manner of##12##3##(1994-11#1)(1995-11#1)(2005-11#1)(2005-8#1)(2006-6#1)(2006-7#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-9#1)(2013-8#1)
the manner##47##2##(1990-12#1)(1990-7#1)(1991-10#1)(1991-8#1)(1992-1#1)(1992-10#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-9#1)(1997-7#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-6#2)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-5#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
the mannitol permease##5##3##(1991-10#5)
the mannitol##7##2##(1991-10#6)(2008-1#1)
the mannolipid-enzyme interaction##2##3##(1994-8#2)
the mannose##4##2##(1995-6#1)(2008-10#2)(2011-2#1)
the mantle##5##2##(1992-1#1)(1993-4#1)(1996-2#1)(1996-4#1)(2013-1#1)
the manual and automated##2##4##(2008-10#2)
the manual and##3##3##(2007-3#1)(2008-10#2)
the manual method##3##3##(2008-10#1)(2012-12#2)
the manual methods##3##3##(1991-3#1)(2008-10#2)
the manual process##3##3##(1996-3#1)(2013-1#2)
the manual visual method##2##4##(2008-10#2)
the manual##38##2##(1990-5#1)(1991-3#1)(1994-6#3)(1995-3#1)(1996-3#1)(2004-10#1)(2007-12#1)(2007-3#1)(2008-10#15)(2008-2#1)(2008-4#2)(2008-7#1)(2010-10#1)(2011-1#1)(2012-12#3)(2012-2#2)(2013-1#2)
the manufacture and##2##3##(2005-8#1)(2008-3#1)
the manufacture of the##2##4##(2008-3#1)(2008-5#1)
the manufacture of vinyl##2##4##(2008-5#1)(2008-9#1)
the manufacture of##26##3##(1994-12#1)(1994-6#1)(1996-10#1)(1996-9#1)(1997-8#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#3)(2008-6#1)(2008-9#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#1)
the manufacture##31##2##(1994-12#1)(1994-6#1)(1996-10#1)(1996-9#1)(1997-8#1)(2005-8#2)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#5)(2008-5#3)(2008-6#1)(2008-9#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#1)
the manufactured##2##2##(2011-2#1)(2013-1#1)
the manufacturer to##3##3##(2008-10#1)(2008-11#1)(2010-6#1)
the manufacturer##17##2##(1991-9#1)(1996-8#1)(2004-12#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-6#1)(2013-1#1)
the manufacturer's instructions##5##3##(1994-1#1)(2008-12#1)(2008-2#1)(2009-7#1)(2012-12#1)
the manufacturer's##15##2##(1994-1#1)(2005-10#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2009-7#1)(2010-9#2)(2012-12#1)
the manufacturer-recommended##3##2##(2007-12#1)(2008-6#1)(2010-9#1)
the manufacturers of##3##3##(2006-10#1)(2007-4#1)(2008-3#1)
the manufacturers##14##2##(1990-4#1)(1994-7#1)(1996-5#1)(1997-3#2)(2004-9#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-3#1)(2010-5#1)
the manufacturing industry##4##3##(1992-2#1)(1994-6#1)(2008-10#1)(2008-2#1)
the manufacturing of##7##3##(2005-8#1)(2006-2#2)(2008-10#1)(2008-11#2)(2008-3#1)
the manufacturing process##10##3##(1995-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2010-8#2)(2012-2#1)
the manufacturing technology##2##3##(2008-3#1)(2009-2#1)
the manufacturing##31##2##(1992-2#1)(1992-3#1)(1994-6#1)(1995-5#2)(2005-8#1)(2006-2#2)(2007-11#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#4)(2008-5#2)(2008-6#1)(2009-2#1)(2010-4#1)(2010-8#3)(2011-2#1)(2012-2#1)
the manure or##2##3##(2008-10#2)
the manure##12##2##(2004-11#2)(2007-7#1)(2008-10#8)(2011-12#1)
the manuscript##3##2##(2009-4#1)(2010-3#1)(2013-1#1)
the many advances in##2##4##(2008-3#1)(2010-3#1)
the many advantages of##4##4##(2007-11#1)(2008-4#1)(2008-5#1)(2010-8#1)
the many applications##4##3##(1991-5#1)(2006-4#1)(2007-12#1)(2009-12#1)
the many challenges##3##3##(1992-1#1)(1996-3#1)(2010-7#1)
the many different##3##3##(2006-10#1)(2008-10#1)(2008-9#1)
the many diverse##2##3##(2006-8#1)(2008-12#1)
the many facets of##3##4##(1994-12#1)(2008-2#1)(2010-4#1)
the many factors##6##3##(1990-12#1)(1995-11#1)(2006-11#1)(2008-11#1)(2010-12#1)(2010-3#1)
the many issues##2##3##(2006-7#1)(2009-12#1)
the many methods available for##2##5##(1996-9#1)(2009-10#1)
the many methods##4##3##(1996-9#1)(2007-11#1)(2007-8#1)(2009-10#1)
the many obstacles##2##3##(2005-10#1)(2008-5#1)
the many paraneoplastic syndromes associated with renal cell carcinoma##2##9##(2006-9#2)
the many possible##2##3##(2005-3#1)(2008-4#1)
the many potential##2##3##(2007-11#1)(2007-4#1)
the many studies##3##3##(2011-1#1)(2012-12#1)(2012-2#1)
the many types of##3##4##(2008-9#2)(2009-3#1)
the many ways##3##3##(2008-5#1)(2013-1#2)
the many##137##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-7#1)(1992-1#2)(1992-2#2)(1993-3#2)(1993-5#1)(1994-12#1)(1995-11#1)(1996-2#1)(1996-3#3)(1996-9#1)(2005-10#2)(2005-3#1)(2005-8#1)(2005-9#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#4)(2007-11#3)(2007-12#2)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#5)(2008-7#8)(2008-8#3)(2008-9#6)(2009-10#2)(2009-12#3)(2009-3#1)(2009-4#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#5)(2013-1#3)(2013-8#1)
the map for##2##3##(1990-10#1)(2007-12#1)
the map of##3##3##(2008-7#1)(2008-8#1)(2012-2#1)
the map##18##2##(1990-10#1)(1994-8#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#1)(2012-11#1)(2012-2#1)(2012-3#2)
the mapped##3##2##(1996-12#1)(2008-10#1)(2008-8#1)
the mapping of the##3##4##(1993-6#1)(2008-11#1)(2012-1#1)
the mapping of##10##3##(1990-5#1)(1993-6#1)(1996-12#1)(2008-10#2)(2008-11#1)(2012-1#1)(2013-1#3)
the mapping population##2##3##(2008-10#2)
the mapping##28##2##(1990-5#1)(1993-6#1)(1994-12#1)(1996-12#1)(1997-7#1)(2007-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-2#1)(2010-9#1)(2012-1#1)(2013-1#7)
the maps of##2##3##(1993-9#1)(2008-7#1)
the maps##7##2##(1991-3#1)(1993-9#1)(2007-5#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-3#1)
the mare##2##2##(2004-2#1)(2006-5#1)
the mares##2##2##(1994-7#1)(2012-3#1)
the margin of a BCS specimen##2##6##(2013-1#2)
the margin of safety##2##4##(1994-3#1)(2008-11#1)
the margin of the##6##4##(1990-12#1)(1990-9#1)(1996-6#2)(2007-7#1)(2008-2#1)
the margin of##13##3##(1990-12#1)(1990-9#1)(1994-3#1)(1996-6#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2012-2#1)(2013-1#2)
the margin##19##2##(1990-12#1)(1990-9#1)(1994-12#1)(1994-3#1)(1995-4#2)(1996-6#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2012-2#1)(2013-1#4)
the marginal and##4##3##(2008-7#2)(2010-2#2)
the marginal distribution of##2##4##(2009-4#2)
the marginal distributions##3##3##(1993-9#1)(2008-7#1)(2012-3#1)
the marginal female##2##3##(2008-8#2)
the marginal sinus##6##3##(1996-9#6)
the marginal survival##2##3##(1995-9#2)
the marginal zone##2##3##(2008-7#1)(2012-1#1)
the marginal##47##2##(1993-6#2)(1993-9#1)(1995-4#1)(1995-9#2)(1996-9#6)(1997-3#2)(2006-8#1)(2008-2#1)(2008-5#1)(2008-7#7)(2008-8#7)(2009-12#2)(2009-4#2)(2009-8#1)(2010-1#1)(2010-2#2)(2010-4#1)(2011-1#2)(2012-1#2)(2012-12#2)(2012-3#1)
the margins of##2##3##(2007-7#1)(2008-9#1)
the margins##11##2##(1995-4#1)(1995-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-9#2)(2012-2#1)
the marinated##2##2##(2010-4#2)
the marine annelid##3##3##(1994-8#1)(1996-2#1)(2012-2#1)
the marine bacterium##4##3##(1990-4#1)(1996-7#1)(2007-11#2)
the marine boundary layer##2##4##(2008-2#1)(2008-3#1)
the marine ciliate##2##3##(1996-4#1)(2012-12#1)
the marine clam Anadara granosa##2##5##(1994-8#2)
the marine clam##3##3##(1994-8#2)(2007-3#1)
the marine environment are##2##4##(2008-10#1)(2008-11#1)
the marine environment##14##3##(1994-9#1)(1997-4#1)(2006-6#1)(2007-5#1)(2008-10#2)(2008-11#7)(2008-5#1)
the marine fish Serranus scriba##3##5##(1991-10#3)
the marine fish##4##3##(1991-10#3)(2008-10#1)
the marine ornamental fish and invertebrate##2##6##(2007-5#2)
the marine ornamental##3##3##(2007-5#3)
the marine sponge Oceanapia sagittaria##2##5##(2008-5#2)
the marine sponge##3##3##(2008-5#3)
the marine##62##2##(1990-4#1)(1991-10#3)(1993-7#1)(1994-3#2)(1994-8#5)(1994-9#1)(1996-2#2)(1996-4#1)(1996-7#1)(1997-4#1)(1997-6#1)(2006-6#1)(2007-11#2)(2007-3#2)(2007-5#5)(2008-10#6)(2008-11#9)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#2)(2008-9#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the marital##2##2##(1996-12#1)(2009-11#1)
the mark##8##2##(1994-1#1)(2008-1#1)(2008-10#1)(2008-2#4)(2013-7#1)
the marked difference in##2##4##(1990-8#1)(2012-11#1)
the marked increase in the##4##5##(1991-11#1)(1994-12#1)(1994-3#1)(2008-3#1)
the marked reduction in##2##4##(1991-2#1)(2004-11#1)
the marked reduction##3##3##(1991-10#1)(1991-2#1)(2004-11#1)
the marked##31##2##(1990-3#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(2004-11#1)(2005-1#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)(2009-4#1)(2012-11#1)(2012-12#1)
the markedly reduced##2##3##(1991-2#1)(1995-2#1)
the markedly##7##2##(1990-5#1)(1991-2#1)(1995-2#1)(1995-4#1)(1995-7#1)(2005-8#1)(2010-10#1)
the marker and the##2##4##(2007-12#1)(2007-9#1)
the marker and##4##3##(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)
the marker data##2##3##(2008-10#1)(2008-5#1)
the marker gene##2##3##(1991-8#1)(2008-11#1)
the marker of##3##3##(1991-2#1)(1993-7#1)(2008-10#1)
the marker protein##2##3##(1995-9#1)(2005-11#1)
the marker##34##2##(1990-6#1)(1991-10#1)(1991-2#1)(1991-8#1)(1993-7#1)(1995-11#1)(1995-8#1)(1995-9#1)(1996-5#2)(2005-11#1)(2007-11#2)(2007-12#2)(2007-9#1)(2008-10#11)(2008-11#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-9#1)(2010-2#1)(2012-3#1)
the markers and##2##3##(1996-5#1)(2008-10#1)
the markers are##3##3##(1994-8#1)(1996-10#1)(2008-4#1)
the markers in##5##3##(1997-5#2)(2008-10#1)(2008-5#2)
the markers of oxidative stress##2##5##(2013-8#2)
the markers of##9##3##(1996-8#1)(1997-7#1)(2008-2#1)(2010-4#1)(2012-11#1)(2013-1#2)(2013-8#2)
the markers##37##2##(1991-4#1)(1994-8#1)(1995-10#1)(1995-6#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-5#2)(1997-7#1)(2006-6#1)(2006-9#1)(2007-4#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-9#1)(2009-2#2)(2010-11#1)(2010-4#1)(2012-11#1)(2013-1#2)(2013-8#4)
the market and##7##3##(1991-1#1)(1995-1#1)(1997-6#1)(2005-9#1)(2006-10#1)(2006-8#1)(2012-1#1)
the market are##2##3##(2007-2#1)(2008-3#1)
the market because##2##3##(2006-10#1)(2008-11#1)
the market can##2##3##(1992-12#1)(2008-10#1)
the market for health##3##4##(1990-12#1)(1994-1#1)(1994-2#1)
the market for medical##2##4##(1990-6#1)(1991-12#1)
the market for##13##3##(1990-12#2)(1990-6#1)(1991-12#1)(1992-3#2)(1993-3#1)(1994-1#1)(1994-2#1)(2007-8#1)(2007-9#1)(2010-1#1)(2012-3#1)
the market in the##4##4##(2006-10#1)(2007-2#1)(2007-9#1)(2009-4#1)
the market in##7##3##(1996-5#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-3#1)(2009-4#1)(2009-8#1)
the market place##2##3##(1996-1#1)(2008-11#1)
the market that drives##2##4##(2008-10#1)(2010-12#1)
the market that##4##3##(2008-10#1)(2008-8#1)(2009-5#1)(2010-12#1)
the market to##2##3##(2006-4#1)(2008-6#1)
the market under##2##3##(1994-3#1)(2006-6#1)
the market##110##2##(1990-12#3)(1990-6#1)(1990-7#1)(1991-1#1)(1991-12#3)(1991-2#2)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-2#2)(1993-3#1)(1993-5#2)(1994-1#1)(1994-2#1)(1994-3#3)(1994-5#1)(1995-1#1)(1996-1#2)(1996-12#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#1)(2005-3#1)(2005-5#2)(2005-7#1)(2005-9#1)(2006-10#7)(2006-4#1)(2006-6#2)(2006-8#2)(2007-11#1)(2007-12#1)(2007-2#4)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#6)(2008-11#6)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-8#1)
the marketable##2##2##(1992-1#1)(2008-10#1)
the marketed formulation##3##3##(2012-12#2)(2013-7#1)
the marketed##11##2##(1993-1#1)(2008-10#1)(2010-1#1)(2010-12#2)(2010-5#1)(2012-12#2)(2012-2#1)(2013-7#2)
the marketing of##2##3##(2006-10#1)(2012-2#1)
the marketing##9##2##(1993-12#2)(1996-1#1)(1996-3#1)(2006-10#1)(2007-1#1)(2008-12#2)(2012-2#1)
the marketplace##22##2##(1991-12#1)(1994-1#2)(1994-3#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-1#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-2#1)(2007-4#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)(2013-1#1)
the marking process##3##3##(2008-11#2)(2013-7#1)
the marking##4##2##(2008-11#2)(2010-8#1)(2013-7#1)
the marks were##2##3##(1995-4#1)(2008-11#1)
the marks##8##2##(1995-4#1)(1996-3#1)(2006-8#1)(2007-11#1)(2008-11#2)(2008-2#1)(2009-4#1)
the marmoset##2##2##(1991-9#1)(2005-9#1)
the marriage of##2##3##(2008-11#1)(2008-6#1)
the marriage##6##2##(2008-11#4)(2008-6#1)(2009-11#1)
the married##4##2##(2007-3#1)(2007-7#1)(2008-8#1)(2012-12#1)
the marrow microenvironment##2##3##(1995-12#1)(2011-1#1)
the marrow##8##2##(1990-12#1)(1991-5#1)(1993-9#1)(1995-12#1)(2011-1#1)(2012-12#3)
the martian atmosphere##2##3##(1995-3#2)
the martian##5##2##(1995-3#2)(1995-6#1)(2007-9#2)
the masculine##3##2##(2008-11#1)(2013-1#2)
the masculinizing##2##2##(1995-12#2)
the mask##15##2##(1995-4#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-2#2)(2008-3#6)(2010-5#1)(2010-7#1)
the masking agent##2##3##(2008-10#2)
the masking agents##3##3##(2008-10#3)
the masking effect##3##3##(2008-10#1)(2008-5#1)(2012-12#1)
the masking##10##2##(2007-12#1)(2008-10#7)(2008-5#1)(2012-12#1)
the mass and the##2##4##(1997-3#1)(2008-3#1)
the mass and##13##3##(1997-3#1)(2005-11#1)(2005-5#1)(2007-8#3)(2008-3#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
the mass by##2##3##(2008-6#1)(2009-4#1)
the mass chromatogram##2##3##(2005-12#2)
the mass concentration##2##3##(2011-1#2)
the mass lesion##2##3##(2007-12#1)(2011-2#1)
the mass media##11##3##(1992-2#1)(1994-11#1)(1994-3#1)(1996-11#1)(2006-7#1)(2007-12#1)(2007-3#2)(2009-4#1)(2012-12#1)(2013-1#1)
the mass of ALP##2##4##(2007-8#2)
the mass of a##2##4##(1991-12#1)(1995-7#1)
the mass of information##2##4##(1997-3#1)(2012-2#1)
the mass of the##8##4##(1990-8#1)(1995-4#1)(2004-9#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)
the mass of##28##3##(1990-8#1)(1991-12#1)(1992-2#1)(1993-3#1)(1994-12#1)(1995-3#1)(1995-4#1)(1995-7#1)(1996-3#1)(1996-4#1)(1997-3#1)(1997-5#1)(2004-9#3)(2006-10#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-9#1)(2012-2#1)
the mass or##2##3##(2007-8#1)(2008-6#1)
the mass ratio of##2##4##(2010-12#1)(2010-4#1)
the mass spectra of the##2##5##(1991-5#1)(2008-10#1)
the mass spectra##6##3##(1991-5#1)(2008-10#3)(2010-5#1)(2013-7#1)
the mass spectral##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
the mass spectrometer##7##3##(2007-8#1)(2008-1#1)(2008-10#3)(2008-4#1)(2010-7#1)
the mass spectrometric##2##3##(2007-8#1)(2008-11#1)
the mass spectrum of##2##4##(2005-12#1)(2013-7#1)
the mass spectrum##4##3##(1990-12#1)(2005-12#1)(2008-6#1)(2013-7#1)
the mass to be##2##4##(2006-5#1)(2010-12#1)
the mass to##3##3##(2006-5#1)(2010-12#1)(2013-1#1)
the mass transfer coefficient was 0##2##6##(2008-7#2)
the mass transfer coefficient##3##4##(2008-7#3)
the mass transfer of##3##4##(1990-12#1)(2008-10#1)(2013-1#1)
the mass transfer##13##3##(1990-12#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-7#3)(2009-11#2)(2011-2#1)(2012-2#1)(2013-1#1)
the mass transport##2##3##(2008-10#1)(2008-9#1)
the mass vaccinations##2##3##(1995-5#2)
the mass was done##3##4##(2008-7#1)(2012-12#1)(2013-8#1)
the mass was found##3##4##(2009-5#1)(2011-2#1)(2013-8#1)
the mass was##15##3##(1990-2#1)(2007-8#1)(2008-7#2)(2009-3#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#3)(2013-1#1)(2013-8#3)
the mass##182##2##(1990-12#2)(1990-2#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-2#3)(1992-3#1)(1992-6#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-3#2)(1995-4#2)(1995-5#2)(1995-7#1)(1996-11#1)(1996-3#1)(1996-4#1)(1997-3#2)(1997-5#1)(1997-8#1)(2004-9#3)(2005-11#2)(2005-12#3)(2005-5#2)(2006-10#2)(2006-12#2)(2006-4#1)(2006-5#1)(2006-7#1)(2007-12#5)(2007-2#2)(2007-3#2)(2007-5#1)(2007-8#13)(2008-1#1)(2008-10#17)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#4)(2008-6#6)(2008-7#8)(2008-9#2)(2009-11#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-9#2)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#6)(2012-1#2)(2012-12#10)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#6)
the mass-per-flexible-bond##2##2##(2008-9#2)
the massage therapy group##2##4##(2006-10#2)
the massage therapy##3##3##(2006-10#2)(2008-12#1)
the massage##10##2##(2006-10#2)(2008-10#4)(2008-12#2)(2010-7#2)
the massaged##2##2##(2008-12#1)(2009-3#1)
the masses of the##2##4##(1993-8#1)(2008-10#1)
the masses of##3##3##(1993-8#2)(2008-10#1)
the masses were removed##2##4##(1991-9#1)(2009-7#1)
the masses were##3##3##(1991-9#1)(2009-7#2)
the masses##10##2##(1990-3#1)(1991-9#1)(1992-6#1)(1993-8#2)(2007-8#1)(2008-10#2)(2009-7#2)
the masseter muscle with##2##4##(1993-12#1)(2012-12#1)
the masseter muscle##17##3##(1992-3#1)(1993-12#1)(1996-2#1)(2008-4#4)(2010-12#2)(2010-6#1)(2010-9#1)(2012-12#1)(2012-2#3)(2013-1#2)
the masseter##21##2##(1990-4#1)(1992-3#1)(1993-12#1)(1996-2#1)(2008-4#5)(2010-12#2)(2010-6#1)(2010-9#1)(2011-12#1)(2012-12#1)(2012-2#3)(2013-1#3)
the massive##11##2##(1993-2#1)(2006-6#1)(2007-10#2)(2007-12#1)(2008-1#1)(2009-5#1)(2010-12#1)(2011-2#2)(2012-12#1)
the mast cell##3##3##(1990-9#1)(2004-12#1)(2008-4#1)
the mast cell-mediated##2##3##(2008-10#1)(2010-12#1)
the mast cells##2##3##(2008-10#1)(2011-2#1)
the mast##7##2##(1990-9#1)(2004-12#1)(2008-10#2)(2008-4#1)(2010-12#1)(2011-2#1)
the mastectomy group and##2##4##(2004-1#2)
the mastectomy##6##2##(2004-1#3)(2011-2#2)(2013-1#1)
the master cast##2##3##(2012-2#2)
the master equation##2##3##(2006-4#1)(2010-7#1)
the master object##2##3##(2007-12#1)(2008-3#1)
the master oscillator##4##3##(2007-12#2)(2008-1#1)(2008-3#1)
the master##19##2##(1992-4#1)(1994-12#1)(1996-7#1)(2006-4#1)(2007-1#1)(2007-12#4)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#2)(2010-2#1)(2010-7#1)(2012-2#2)
the masticatory and##2##3##(2010-9#1)(2012-1#1)
the masticatory system##3##3##(2010-9#2)(2012-12#1)
the masticatory##7##2##(1990-4#1)(1990-9#1)(2010-9#3)(2012-1#1)(2012-12#1)
the mastoid cavity was##2##4##(2006-12#1)(2008-9#1)
the mastoid cavity##3##3##(2006-12#1)(2008-9#2)
the mastoid portion of the facial nerve##2##7##(2008-9#2)
the mastoid process##5##3##(2008-7#4)(2008-9#1)
the mastoid region##2##3##(1990-12#1)(2008-6#1)
the mastoid##20##2##(1990-12#1)(2006-12#1)(2007-2#4)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#5)(2009-1#1)
the mat1-1##3##2##(2008-10#3)
the match between##2##3##(2008-3#1)(2008-8#1)
the match##9##2##(2007-4#5)(2008-3#2)(2008-8#1)(2009-8#1)
the matched##12##2##(1992-6#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-2#2)(2008-3#1)(2010-11#2)(2013-8#1)
the matching of##3##3##(2006-10#1)(2008-10#1)(2009-10#1)
the matching##8##2##(2006-10#1)(2007-4#1)(2007-5#2)(2008-10#2)(2008-2#1)(2009-10#1)
the mate##7##2##(2006-7#1)(2008-8#1)(2008-9#3)(2009-6#2)
the material and the##2##4##(2008-10#1)(2008-3#1)
the material and##8##3##(2004-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-6#1)(2010-10#1)(2010-9#1)
the material constants##2##3##(2008-3#1)(2009-4#1)
the material during##2##3##(1995-2#1)(2008-3#1)
the material for the##3##4##(1994-4#1)(2008-1#1)(2011-2#1)
the material for##6##3##(1994-4#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-7#1)(2011-2#1)
the material from##5##3##(1991-9#1)(1992-3#1)(2004-9#1)(2008-10#2)
the material is separated by SDS-PAGE and the antigens are##2##10##(2008-2#1)(2008-4#1)
the material is##7##3##(1993-8#1)(2006-10#1)(2006-12#1)(2007-12#2)(2008-2#1)(2008-4#1)
the material of choice##2##4##(2010-10#1)(2011-3#1)
the material of the##4##4##(2007-11#1)(2008-7#1)(2010-8#2)
the material of##9##3##(1994-3#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-10#1)(2010-8#2)(2011-1#1)(2011-3#1)
the material or##9##3##(2006-10#8)(2008-1#1)
the material pretreated at##3##4##(2013-1#3)
the material properties and the##2##5##(2004-9#1)(2008-7#1)
the material properties of##5##4##(2005-10#1)(2007-11#1)(2008-3#2)(2009-12#1)
the material properties##10##3##(2004-9#1)(2005-10#1)(2006-11#1)(2006-6#1)(2007-11#1)(2008-3#2)(2008-7#2)(2009-12#1)
the material showed##2##3##(2007-12#1)(2008-3#1)
the material to be##2##4##(2007-12#1)(2008-2#1)
the material was##9##3##(1994-2#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-5#1)(2013-1#1)(2013-8#1)
the material with a##2##4##(2007-12#1)(2013-8#1)
the material##143##2##(1991-12#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-10#1)(1993-8#2)(1994-2#1)(1994-3#1)(1994-4#1)(1995-2#1)(1995-8#1)(1996-8#1)(2004-9#3)(2005-10#2)(2005-11#1)(2006-10#9)(2006-11#1)(2006-12#1)(2006-4#1)(2006-6#3)(2006-7#1)(2007-11#8)(2007-12#8)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#9)(2008-3#15)(2008-4#1)(2008-5#3)(2008-7#6)(2008-8#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2010-10#2)(2010-11#1)(2010-4#1)(2010-8#3)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#4)
the material's##6##2##(2007-4#3)(2008-10#1)(2008-2#1)(2008-3#1)
the materials and methods##4##4##(2008-4#2)(2012-11#2)
the materials and techniques that##2##5##(2011-2#1)(2012-2#1)
the materials and##11##3##(1996-2#1)(2008-2#1)(2008-4#4)(2008-9#1)(2011-2#1)(2012-11#2)(2012-2#1)
the materials are##3##3##(2005-12#1)(2008-11#1)(2013-8#1)
the materials being##2##3##(2004-9#1)(2006-1#1)
the materials obtained##2##3##(1996-2#1)(2009-4#1)
the materials studied##2##3##(2005-11#1)(2008-10#1)
the materials that##2##3##(2008-10#1)(2008-11#1)
the materials used for##3##4##(1994-3#1)(2012-11#2)
the materials used##6##3##(1994-3#1)(2008-5#1)(2012-11#2)(2012-3#2)
the materials were##3##3##(1992-6#1)(2005-11#1)(2010-4#1)
the materials##61##2##(1990-9#1)(1992-6#1)(1994-3#1)(1996-12#1)(1996-2#3)(1997-3#1)(2004-9#2)(2005-11#2)(2005-12#1)(2005-4#1)(2006-1#1)(2007-2#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#6)(2008-5#3)(2008-9#1)(2009-3#2)(2009-4#1)(2010-4#2)(2010-8#1)(2011-2#1)(2012-11#4)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
the maternal age##3##3##(1995-8#1)(1996-12#1)(2013-1#1)
the maternal allele in##2##4##(1994-9#2)
the maternal allele##4##3##(1994-9#2)(2010-12#2)
the maternal and fetal##3##4##(1990-12#1)(1994-6#1)(2008-10#1)
the maternal and##7##3##(1990-12#1)(1992-12#1)(1992-2#1)(1994-6#1)(1995-12#1)(2008-10#1)(2009-1#1)
the maternal circadian system##3##4##(1994-6#3)
the maternal circulation##3##3##(1994-6#2)(2008-1#1)
the maternal environment##2##3##(2011-2#2)
the maternal genome##2##3##(1994-11#2)
the maternal immune##2##3##(2007-7#2)
the maternal mortality##2##3##(2006-4#2)
the maternal parent##3##3##(2008-5#1)(2010-8#2)
the maternal##71##2##(1990-12#1)(1991-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-3#1)(1994-6#7)(1994-9#2)(1995-12#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(2005-10#1)(2006-10#1)(2006-4#2)(2006-9#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#3)(2009-1#1)(2009-10#1)(2009-2#3)(2010-12#2)(2010-5#1)(2010-8#3)(2011-12#1)(2011-2#5)(2012-1#1)(2013-1#4)(2013-8#1)
the maternally##5##2##(1992-8#1)(1997-2#1)(2008-7#2)(2010-12#1)
the maternity ward##2##3##(1992-4#1)(2004-10#1)
the maternity##4##2##(1992-4#1)(2004-10#1)(2006-7#1)(2008-6#1)
the mathematical model of##4##4##(2008-10#1)(2008-3#1)(2009-2#1)(2011-2#1)
the mathematical model##5##3##(1996-12#1)(2008-10#1)(2008-3#1)(2009-2#1)(2011-2#1)
the mathematical models##2##3##(2008-6#1)(2009-8#1)
the mathematical##31##2##(1992-4#1)(1993-7#1)(1994-3#1)(1996-12#1)(2006-5#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-3#4)(2008-4#1)(2008-6#2)(2008-8#1)(2009-2#2)(2009-3#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#1)
the mathematically##2##2##(2008-5#1)(2012-1#1)
the mathematics##4##2##(2005-11#1)(2005-8#1)(2006-5#1)(2008-1#1)
the mating pheromones##2##3##(1990-11#1)(1994-12#1)
the mating propensity of males irradiated with##2##7##(2011-2#2)
the mating response##2##3##(1994-12#1)(1996-2#1)
the mating success of##2##4##(2008-9#2)
the mating system of##2##4##(2008-9#2)
the mating system##8##3##(2008-10#1)(2008-8#1)(2008-9#3)(2013-1#3)
the mating##32##2##(1990-11#1)(1992-9#1)(1994-12#2)(1996-2#1)(1997-4#2)(1997-7#1)(2006-10#1)(2008-10#4)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#6)(2011-2#2)(2012-12#4)(2013-1#3)
the matric potential##2##3##(2008-10#2)
the matrices in the##2##4##(2006-10#1)(2008-2#1)
the matrices##12##2##(1995-12#2)(1996-5#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-2#2)(2010-5#1)(2013-1#1)
the matrix and the##4##4##(2004-9#1)(2008-3#1)(2008-5#1)(2013-7#1)
the matrix and##15##3##(1990-8#1)(2004-9#1)(2005-8#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)(2013-7#1)(2013-8#1)
the matrix are##2##3##(1997-8#1)(2008-8#1)
the matrix effect during the method development##2##7##(2010-11#2)
the matrix effect##9##3##(2008-10#5)(2010-11#4)
the matrix effects##2##3##(1991-8#1)(2008-10#1)
the matrix elements##3##3##(2008-10#2)(2008-2#1)
the matrix for the##2##4##(2008-10#2)
the matrix for##3##3##(1997-8#1)(2008-10#2)
the matrix from##2##3##(2008-3#1)(2008-5#1)
the matrix has##2##3##(2008-10#1)(2008-5#1)
the matrix in##4##3##(2007-10#1)(2008-10#3)
the matrix influence##2##3##(2008-10#2)
the matrix interference##5##3##(2005-4#1)(2008-10#3)(2009-8#1)
the matrix interferences##2##3##(2008-10#2)
the matrix is##5##3##(2006-12#1)(2008-10#3)(2008-4#1)
the matrix metalloproteinases##2##3##(1992-12#1)(2009-4#1)
the matrix method##4##3##(1990-8#1)(2008-2#2)(2008-6#1)
the matrix of the##4##4##(1990-2#1)(1992-6#1)(2008-10#1)(2008-5#1)
the matrix of##14##3##(1990-2#1)(1990-4#1)(1992-6#1)(1997-2#1)(2005-8#2)(2008-10#4)(2008-4#1)(2008-5#1)(2009-7#1)(2013-8#1)
the matrix protein##2##3##(2005-9#1)(2010-1#1)
the matrix side##5##3##(1995-6#1)(1997-1#3)(2005-8#1)
the matrix support##2##3##(2011-2#2)
the matrix with##3##3##(1991-3#1)(2008-10#2)
the matrix##184##2##(1990-11#1)(1990-2#2)(1990-4#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-4#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#2)(1995-6#1)(1997-1#5)(1997-2#1)(1997-8#3)(2004-9#1)(2005-11#1)(2005-4#2)(2005-8#4)(2005-9#1)(2006-1#3)(2006-12#1)(2006-6#1)(2006-7#1)(2006-9#2)(2007-10#1)(2007-11#4)(2007-4#1)(2008-10#57)(2008-2#5)(2008-3#5)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#8)(2009-12#3)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#4)(2010-5#4)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#3)(2013-1#3)(2013-7#4)(2013-8#2)
the matter and##2##3##(2007-8#1)(2010-7#1)
the matter of##4##3##(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)
the matter##17##2##(1992-1#1)(1994-3#2)(1995-6#1)(1996-12#1)(1997-5#1)(2005-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-7#1)(2010-7#1)(2012-12#1)
the maturation and##4##3##(2007-3#1)(2011-1#1)(2011-3#1)(2012-12#1)
the maturation of the##4##4##(1991-9#2)(1992-9#1)(1993-7#1)
the maturation of two##2##4##(1993-7#1)(2008-1#1)
the maturation of##24##3##(1991-10#1)(1991-9#2)(1992-12#1)(1992-9#1)(1993-6#1)(1993-7#2)(1995-6#1)(1996-10#1)(1996-4#1)(1996-5#1)(2006-1#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-8#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
the maturation process##4##3##(1994-8#1)(2007-12#1)(2008-10#1)(2008-5#1)
the maturation##36##2##(1991-10#1)(1991-9#2)(1992-12#1)(1992-9#1)(1993-6#1)(1993-7#2)(1994-8#2)(1995-6#1)(1996-10#1)(1996-4#1)(1996-5#1)(2006-1#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#2)(2013-8#1)
the mature Amy##2##3##(1990-11#2)
the mature and##2##3##(1994-11#1)(1995-12#1)
the mature central auditory system##2##5##(1995-12#2)
the mature central##3##3##(1991-3#1)(1995-12#2)
the mature enzyme##11##3##(1990-10#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-5#1)(1994-12#1)(1996-2#1)(1997-2#1)(2009-11#1)
the mature form of the##2##5##(1990-7#1)(1996-7#1)
the mature form of##4##4##(1990-7#1)(1993-2#1)(1996-7#1)(2008-4#1)
the mature form##10##3##(1990-7#1)(1991-2#1)(1992-6#1)(1993-2#1)(1995-10#1)(1995-8#1)(1996-7#2)(1997-1#1)(2008-4#1)
the mature hormone##2##3##(1990-12#1)(2008-4#1)
the mature macrophages##2##3##(2004-9#2)
the mature part##2##3##(1994-12#1)(1995-6#1)
the mature peptide##4##3##(1991-6#1)(1992-12#1)(1994-12#1)(2008-8#1)
the mature polypeptide##2##3##(1996-10#1)(2009-7#1)
the mature protease##2##3##(1994-12#2)
the mature protein was##3##4##(1990-9#1)(1991-7#1)(1992-1#1)
the mature protein##32##3##(1990-11#1)(1990-12#2)(1990-5#1)(1990-8#2)(1990-9#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#4)(1993-2#1)(1993-3#2)(1994-12#1)(1994-9#2)(1995-8#1)(1996-10#2)(1996-5#1)
the mature region of##2##4##(1990-12#1)(1992-12#1)
the mature sequence##2##3##(1990-12#1)(1993-5#1)
the mature spermatozoa##2##3##(1996-8#1)(2012-2#1)
the mature##153##2##(1990-10#2)(1990-11#5)(1990-12#7)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#4)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#6)(1992-2#1)(1992-3#6)(1992-6#2)(1992-7#1)(1993-2#3)(1993-3#2)(1993-5#2)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#7)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#4)(1995-10#1)(1995-12#4)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#2)(1996-10#3)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#2)(1996-8#2)(1997-1#1)(1997-2#1)(1997-6#2)(1997-7#1)(2004-9#3)(2006-12#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#4)(2008-10#3)(2008-11#1)(2008-4#3)(2008-5#3)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)
the matured leaves C##2##4##(2013-8#2)
the matured leaves N/P ratio was##2##6##(2013-8#2)
the matured leaves##4##3##(2013-8#4)
the matured##7##2##(1990-7#1)(2012-12#1)(2013-8#5)
the maturing of the##2##4##(1995-8#1)(2007-11#1)
the maturing of##3##3##(1995-8#1)(2007-11#1)(2011-2#1)
the maturing##8##2##(1994-5#1)(1995-5#1)(1995-8#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#1)(2011-2#1)
the maturity of social problem-solving skills##2##6##(2009-10#2)
the maturity of the##2##4##(1995-5#1)(2008-3#1)
the maturity of##5##3##(1995-5#1)(2006-2#1)(2008-3#1)(2009-10#2)
the maturity##6##2##(1995-5#1)(2006-2#1)(2008-3#1)(2009-10#2)(2012-11#1)
the maxi-K channel##4##3##(1995-8#4)
the maxilla and mandible##3##4##(1991-1#1)(2007-12#1)(2008-12#1)
the maxilla##15##2##(1991-1#1)(2007-12#3)(2008-12#1)(2008-6#1)(2009-5#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
the maxillae##2##2##(1995-9#1)(2008-6#1)
the maxillary and mandibular arches##2##5##(2010-2#1)(2012-3#1)
the maxillary arch##2##3##(2007-12#1)(2008-12#1)
the maxillary central##4##3##(2008-5#1)(2009-8#2)(2013-7#1)
the maxillary sinus##18##3##(1991-12#1)(1993-1#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-7#1)(2012-1#1)(2012-12#3)(2013-1#3)(2013-7#1)
the maxillary##45##2##(1991-12#1)(1993-1#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-7#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-12#6)(2012-2#1)(2012-3#2)(2013-1#7)(2013-7#2)
the maxillofacial surgeon##2##3##(2005-5#1)(2012-11#1)
the maxillofacial##6##2##(2005-5#1)(2010-8#1)(2011-12#1)(2012-11#1)(2013-7#2)
the maxima of##3##3##(2005-11#1)(2008-10#1)(2010-8#1)
the maxima##6##2##(1994-6#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-8#1)
the maximal accumulation##2##3##(2005-8#1)(2006-11#1)
the maximal activity##2##3##(2007-12#1)(2008-5#1)
the maximal amount of##2##4##(1994-11#1)(2008-5#1)
the maximal cell##2##3##(2008-11#2)
the maximal concentration##2##3##(1994-11#1)(1995-12#1)
the maximal effect of##2##4##(1994-6#1)(1996-8#1)
the maximal effect##9##3##(1990-10#2)(1993-3#1)(1994-11#1)(1994-6#1)(1996-11#1)(1996-12#1)(1996-8#1)(2008-4#1)
the maximal growth##2##3##(2008-6#1)(2011-1#1)
the maximal increase##3##3##(1993-4#1)(1994-6#1)(2009-6#1)
the maximal inotropic response##2##4##(1993-11#2)
the maximal level##4##3##(1993-6#1)(1994-11#2)(2008-9#1)
the maximal nonirritating##2##3##(2008-9#2)
the maximal number of##3##4##(1991-11#1)(1995-7#1)(1996-2#1)
the maximal oscillation amplitude##2##4##(2005-11#2)
the maximal possible##2##3##(2008-3#1)(2008-7#1)
the maximal principal stress##2##4##(2008-7#2)
the maximal rate of##3##4##(1992-9#1)(1996-11#1)(2006-9#1)
the maximal respiratory##2##3##(1995-11#1)(2013-1#1)
the maximal response##6##3##(1992-4#1)(1995-12#1)(1996-12#1)(1997-7#1)(2004-12#1)(2008-3#1)
the maximal tolerated load##3##4##(2005-1#3)
the maximal tolerated##5##3##(1997-7#1)(2005-1#3)(2008-6#1)
the maximal voluntary contraction of##2##5##(2005-1#2)
the maximal##124##2##(1990-10#4)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#4)(1991-1#1)(1991-11#1)(1991-2#2)(1991-5#2)(1992-4#1)(1992-6#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-11#6)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-12#3)(1995-7#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#4)(1997-7#4)(2004-11#1)(2004-12#1)(2005-1#7)(2005-10#1)(2005-11#2)(2005-8#1)(2006-11#1)(2006-9#1)(2007-12#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#4)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#3)(2009-6#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-3#1)(2013-1#2)
the maximally##3##2##(1993-6#1)(2008-6#1)(2008-7#1)
the maximization of the##5##4##(2007-9#2)(2008-7#1)(2012-2#1)(2013-8#1)
the maximization of##9##3##(1991-11#1)(2006-7#1)(2007-9#2)(2008-3#1)(2008-7#2)(2012-2#1)(2013-8#1)
the maximum RLS wavelength##2##4##(2008-10#2)
the maximum RLS##3##3##(2008-10#3)
the maximum a posteriori##3##4##(2008-2#3)
the maximum achievable##4##3##(1996-8#1)(2007-12#1)(2008-2#1)(2012-11#1)
the maximum activity##3##3##(1994-8#1)(1995-1#1)(1997-2#1)
the maximum adsorption##2##3##(2005-11#1)(2013-8#1)
the maximum allowable##3##3##(1993-9#1)(2006-10#1)(2011-12#1)
the maximum amount of information##3##5##(2008-2#1)(2008-7#2)
the maximum amount of##11##4##(2005-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#2)(2010-5#1)(2011-2#1)
the maximum amount##12##3##(1995-2#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#2)(2010-5#1)(2011-2#1)
the maximum amplitude##2##3##(1995-7#1)(1997-4#1)
the maximum and minimum##3##4##(2007-12#1)(2008-10#2)
the maximum and##5##3##(2007-12#1)(2008-10#2)(2008-2#2)
the maximum at##5##3##(2006-10#1)(2008-10#1)(2008-4#1)(2008-9#1)(2013-8#1)
the maximum average##2##3##(2007-12#1)(2008-3#1)
the maximum binding##2##3##(2008-10#2)
the maximum biomass##2##3##(2007-12#1)(2008-7#1)
the maximum cell density##3##4##(1993-8#1)(2008-11#1)(2008-7#1)
the maximum cell##4##3##(1993-8#1)(2008-11#2)(2008-7#1)
the maximum concentration of##2##4##(1992-3#1)(2007-8#1)
the maximum concentration##8##3##(1990-7#1)(1992-3#1)(2004-9#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-2#2)
the maximum contrast##2##3##(2008-2#2)
the maximum current##2##3##(2008-10#1)(2009-10#1)
the maximum degree of protonation of the##2##7##(2008-10#2)
the maximum degree of##3##4##(2008-10#2)(2008-3#1)
the maximum density of tumor enhancement##2##6##(1996-3#2)
the maximum density of tumor stain##2##6##(1996-3#2)
the maximum density of tumor##4##5##(1996-3#4)
the maximum density of##5##4##(1996-3#4)(2008-10#1)
the maximum density##6##3##(1996-3#4)(2008-10#1)(2008-9#1)
the maximum distance##4##3##(1995-8#1)(2004-11#1)(2006-12#1)(2008-2#1)
the maximum dose of##2##4##(2008-5#1)(2012-2#1)
the maximum dose##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
the maximum effect##4##3##(1996-10#1)(2006-12#1)(2008-10#1)(2008-4#1)
the maximum efficiencies##2##3##(2008-3#2)
the maximum efficiency##2##3##(2005-11#1)(2008-10#1)
the maximum emission wavelength##2##4##(2005-4#1)(2008-10#1)
the maximum expected##2##3##(2008-6#1)(2011-1#1)
the maximum fluorescence##4##3##(1995-5#1)(2008-10#1)(2008-3#1)(2013-8#1)
the maximum force##2##3##(1995-12#1)(2007-8#1)
the maximum gain##2##3##(2007-11#1)(2008-2#1)
the maximum growth rate##2##4##(2008-8#1)(2011-2#1)
the maximum growth##3##3##(2008-8#2)(2011-2#1)
the maximum in##5##3##(1995-5#1)(1997-7#1)(2008-10#1)(2010-5#1)(2013-8#1)
the maximum increase in##2##4##(1997-3#1)(2008-5#1)
the maximum increase##3##3##(1991-8#1)(1997-3#1)(2008-5#1)
the maximum information density##2##4##(2008-3#2)
the maximum information##3##3##(2008-2#1)(2008-3#2)
the maximum intensity of##3##4##(2008-2#1)(2009-5#1)(2013-1#1)
the maximum intensity##5##3##(2008-2#2)(2008-3#1)(2009-5#1)(2013-1#1)
the maximum length##2##3##(1997-8#1)(2006-3#1)
the maximum levels##2##3##(1994-5#1)(2010-4#1)
the maximum likelihood approach##3##4##(1993-9#1)(1994-5#2)
the maximum likelihood estimators##2##4##(2008-7#1)(2012-3#1)
the maximum likelihood method##3##4##(2007-12#1)(2008-10#1)(2008-6#1)
the maximum likelihood methods##2##4##(2008-10#1)(2008-6#1)
the maximum likelihood##16##3##(1991-12#1)(1993-9#1)(1994-5#2)(1997-8#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-6#3)(2008-7#1)(2012-1#1)(2012-3#1)
the maximum linear##2##3##(2006-4#1)(2008-10#1)
the maximum load##4##3##(2013-1#4)
the maximum local##2##3##(2008-2#1)(2009-7#1)
the maximum luminance##2##3##(2010-9#2)
the maximum magnification of##2##4##(2008-2#2)
the maximum metal##2##3##(2008-10#1)(2008-6#1)
the maximum number of cases##2##5##(2013-8#2)
the maximum number of##13##4##(1990-8#1)(1991-7#1)(1991-8#1)(1992-8#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-5#1)(2013-8#2)
the maximum number##15##3##(1990-8#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-8#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-7#1)(2013-8#2)
the maximum of the##9##4##(1991-2#1)(1992-8#1)(1995-5#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-3#1)
the maximum of##13##3##(1991-2#1)(1992-8#1)(1995-5#1)(1996-5#2)(1997-1#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2010-3#1)
the maximum output##2##3##(2007-12#1)(2008-2#1)
the maximum oxidation rate##2##4##(1996-6#2)
the maximum pain##2##3##(2007-11#1)(2011-2#1)
the maximum percent##2##3##(1997-2#1)(2007-10#1)
the maximum performance##2##3##(2008-10#1)(2008-9#1)
the maximum permissible##5##3##(1993-3#1)(2008-10#2)(2008-5#1)(2013-1#1)
the maximum possible##5##3##(1996-8#1)(2008-10#2)(2008-3#1)(2008-8#1)
the maximum power##5##3##(1992-9#1)(2007-4#2)(2012-2#1)(2013-7#1)
the maximum principal strain##2##4##(2007-4#2)
the maximum principal##3##3##(2006-11#1)(2007-4#2)
the maximum pump power##2##4##(2007-12#2)
the maximum rate of##4##4##(1990-7#1)(2004-11#1)(2008-8#2)
the maximum rate##7##3##(1990-10#1)(1990-11#1)(1990-7#1)(2004-11#1)(2008-10#1)(2008-8#2)
the maximum recovery##2##3##(2007-8#1)(2008-12#1)
the maximum relative errors##3##4##(2005-11#3)
the maximum relative##4##3##(2005-11#3)(2008-10#1)
the maximum residue limits##3##4##(2007-8#1)(2008-7#1)(2013-8#1)
the maximum residue##4##3##(2007-8#1)(2008-10#1)(2008-7#1)(2013-8#1)
the maximum response##3##3##(1993-12#1)(2008-11#1)(2008-2#1)
the maximum screw withdrawal resistance value##3##6##(2009-3#3)
the maximum signal##2##3##(2008-10#1)(2008-3#1)
the maximum size##2##3##(1990-7#1)(1991-2#1)
the maximum spatial resolution##2##4##(2008-3#2)
the maximum spatial##4##3##(1991-2#1)(2008-2#1)(2008-3#2)
the maximum specific growth rate##2##5##(2008-10#1)(2008-7#1)
the maximum specific##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
the maximum speed##2##3##(1996-9#1)(2012-1#1)
the maximum statistics method##3##4##(2012-3#3)
the maximum strength##2##3##(2004-9#1)(2007-8#1)
the maximum temperature and##2##4##(2005-11#1)(2008-8#1)
the maximum temperature##8##3##(1995-6#1)(2005-11#1)(2008-8#1)(2011-1#4)(2012-12#1)
the maximum theoretical##3##3##(1990-7#1)(2007-11#1)(2008-5#1)
the maximum thermal##2##3##(2006-5#1)(2008-3#1)
the maximum tolerable##3##3##(2006-6#1)(2010-12#1)(2013-1#1)
the maximum tolerated dose (MTD)##2##5##(2005-8#1)(2007-11#1)
the maximum tolerated dose##3##4##(1994-9#1)(2005-8#1)(2007-11#1)
the maximum tolerated##5##3##(1994-9#1)(2005-10#1)(2005-8#1)(2006-8#1)(2007-11#1)
the maximum transverse trapping##2##4##(2008-2#2)
the maximum value at##2##4##(1997-2#1)(2010-1#1)
the maximum value of##2##4##(2005-11#2)
the maximum value##6##3##(1997-2#1)(2005-11#2)(2007-12#1)(2008-11#1)(2010-1#1)
the maximum values##3##3##(1992-4#1)(2007-5#1)(2008-3#1)
the maximum velocity and Michaelis constant##2##6##(1991-5#2)
the maximum velocity##5##3##(1991-5#2)(1995-11#1)(2006-10#1)(2010-7#1)
the maximum width of##2##4##(2006-4#1)(2007-12#1)
the maximum yield of##2##4##(2008-12#1)(2008-4#1)
the maximum##496##2##(1990-10#4)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#5)(1990-8#1)(1991-1#1)(1991-10#2)(1991-12#3)(1991-2#3)(1991-3#1)(1991-5#2)(1991-7#1)(1991-8#3)(1991-9#1)(1992-3#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-10#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-4#4)(1993-5#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#5)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#2)(1996-10#2)(1996-2#1)(1996-3#5)(1996-5#2)(1996-6#2)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#3)(1997-8#3)(2004-11#3)(2004-12#1)(2004-9#2)(2005-10#2)(2005-11#18)(2005-4#3)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#8)(2007-12#22)(2007-3#1)(2007-4#5)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#7)(2008-1#4)(2008-10#77)(2008-11#10)(2008-12#4)(2008-2#42)(2008-3#21)(2008-4#5)(2008-5#13)(2008-6#10)(2008-7#9)(2008-8#9)(2008-9#5)(2009-10#1)(2009-3#4)(2009-4#1)(2009-5#2)(2009-7#2)(2010-1#1)(2010-12#2)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#7)(2011-12#1)(2011-2#6)(2012-1#4)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#6)(2013-1#13)(2013-7#2)(2013-8#15)
the maximum-likelihood (ML)##2##3##(2008-2#1)(2010-8#1)
the maximum-likelihood estimator is unbiased and efficient##2##7##(2008-2#2)
the maximum-likelihood estimator is##3##4##(2008-2#3)
the maximum-likelihood estimator##4##3##(2008-2#4)
the maximum-likelihood##16##2##(1994-5#1)(2007-12#2)(2008-10#1)(2008-2#7)(2008-3#2)(2008-4#1)(2010-6#1)(2010-8#1)
the maze##9##2##(1990-7#2)(1993-12#1)(1993-5#1)(1993-6#1)(1995-1#1)(2007-2#1)(2008-10#1)(2008-11#1)
the mdx##2##2##(1996-6#1)(2012-3#1)
the meal##8##2##(1995-4#1)(1996-12#1)(2007-11#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-2#1)(2011-2#1)
the meals##4##2##(2008-3#1)(2013-1#1)(2013-7#2)
the mean (+/-##3##3##(1995-12#1)(2005-8#1)(2011-2#1)
the mean (+/-SD)##3##3##(1993-10#1)(2008-10#1)(2008-7#1)
the mean +/-##2##3##(1991-10#1)(2011-2#1)
the mean 24-hour##2##3##(1990-11#2)
the mean CBF##3##3##(2007-9#1)(2008-7#2)
the mean DGD##2##3##(2007-12#2)
the mean GSH##4##3##(1990-2#1)(1994-2#3)
the mean Hb##2##3##(2007-7#2)
the mean QTc##2##3##(2008-8#2)
the mean VAS##2##3##(2008-7#1)(2009-3#1)
the mean absolute error##2##4##(2006-12#1)(2008-11#1)
the mean accuracy of##3##4##(2005-4#2)(2008-5#1)
the mean age of onset was 12##2##7##(2007-3#2)
the mean age of##10##4##(1992-2#1)(2006-10#1)(2007-3#2)(2007-4#1)(2007-7#1)(2007-9#2)(2008-7#1)(2012-2#1)
the mean age was##10##4##(2004-2#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-10#1)(2008-1#1)(2009-10#1)(2010-4#1)(2011-2#1)(2012-2#1)
the mean age##24##3##(1992-2#1)(2004-2#1)(2005-10#1)(2006-10#2)(2006-7#1)(2007-10#1)(2007-3#2)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-11#1)(2008-7#1)(2009-10#1)(2010-4#1)(2011-2#1)(2012-2#2)(2013-8#1)
the mean ages of the##2##5##(2008-12#1)(2009-5#1)
the mean ages of##3##4##(1997-7#1)(2008-12#1)(2009-5#1)
the mean amplitude##2##3##(2009-11#1)(2013-8#1)
the mean and standard deviation of the##4##7##(1994-11#1)(2008-10#1)(2008-3#2)
the mean and standard deviation were 0##2##7##(2007-5#2)
the mean and standard deviation##6##5##(1994-11#1)(2007-5#2)(2008-10#1)(2008-3#2)
the mean and the##2##4##(2008-3#1)(2013-1#1)
the mean and variance of##3##5##(1996-1#1)(2007-11#1)(2011-2#1)
the mean and##14##3##(1993-9#1)(1994-11#1)(1994-5#1)(1996-1#1)(2007-11#1)(2007-5#2)(2008-10#1)(2008-3#3)(2011-1#1)(2011-2#1)(2013-1#1)
the mean angle was##3##4##(2007-7#3)
the mean angle##4##3##(2007-7#3)(2009-12#1)
the mean arterial pressure from##2##5##(2007-9#2)
the mean arterial pressure##5##4##(1994-3#1)(2007-9#2)(2008-7#1)(2013-8#1)
the mean arterial##6##3##(1992-6#1)(1994-3#1)(2007-9#2)(2008-7#1)(2013-8#1)
the mean blood##2##3##(1993-9#1)(2013-8#1)
the mean body weight##2##4##(2008-5#1)(2008-9#1)
the mean body##3##3##(2008-5#1)(2008-9#2)
the mean cadaver response##3##4##(2006-11#3)
the mean cell numbers##2##4##(2008-11#1)(2012-1#1)
the mean cell##3##3##(1996-3#1)(2008-11#1)(2012-1#1)
the mean concentration of##5##4##(1991-9#1)(2007-8#1)(2007-9#1)(2012-3#1)(2013-8#1)
the mean concentration##8##3##(1991-9#1)(2007-8#2)(2007-9#1)(2008-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
the mean content of##2##4##(2008-10#1)(2008-8#1)
the mean daily##3##3##(1990-12#1)(2004-3#1)(2008-7#1)
the mean degree##2##3##(2007-7#1)(2008-10#1)
the mean density##2##3##(2008-5#2)
the mean detector response##2##4##(2010-3#2)
the mean diameter##3##3##(1992-7#1)(2008-11#1)(2008-7#1)
the mean difference was##2##4##(2011-1#1)(2011-2#1)
the mean difference##5##3##(1992-9#1)(2008-10#1)(2010-8#1)(2011-1#1)(2011-2#1)
the mean differences##3##3##(2004-11#1)(2010-3#1)(2011-1#1)
the mean differential group delay of##2##6##(2007-11#2)
the mean disease##4##3##(2008-10#2)(2008-4#1)(2012-2#1)
the mean distance##4##3##(2004-11#1)(2007-12#1)(2008-10#2)
the mean dose of##2##4##(2012-3#1)(2013-7#1)
the mean dose##3##3##(1991-2#1)(2012-3#1)(2013-7#1)
the mean duration of##12##4##(1993-5#1)(1996-3#1)(1997-5#1)(2006-7#1)(2006-8#1)(2007-3#2)(2007-7#1)(2007-8#1)(2008-7#1)(2010-7#1)(2011-1#1)
the mean duration##13##3##(1993-5#1)(1996-3#1)(1997-5#1)(2006-7#1)(2006-8#1)(2007-3#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-7#1)(2010-7#1)(2011-1#1)
the mean error##2##3##(2006-10#1)(2012-12#1)
the mean estimate##2##3##(2012-2#2)
the mean field##2##3##(1991-2#1)(2009-8#1)
the mean flow##2##3##(2008-11#1)(2011-2#1)
the mean flux##2##3##(2010-10#2)
the mean follow-up period of##2##5##(2007-8#1)(2010-12#1)
the mean follow-up period##3##4##(2006-5#1)(2007-8#1)(2010-12#1)
the mean follow-up##6##3##(1990-6#1)(2006-5#1)(2007-7#1)(2007-8#1)(2010-12#1)(2011-2#1)
the mean for##2##3##(2005-7#1)(2008-3#1)
the mean free path of the##2##6##(2008-3#2)
the mean free path##4##4##(2008-2#1)(2008-3#3)
the mean free##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
the mean hair shaft##2##4##(2008-5#2)
the mean height##2##3##(2006-10#1)(2011-1#1)
the mean intensity of##3##4##(2008-2#2)(2008-6#1)
the mean intensity##5##3##(2008-2#2)(2008-6#1)(2008-9#1)(2009-5#1)
the mean intraclass correlation##2##4##(2008-10#2)
the mean length of the##2##5##(1991-12#1)(2011-12#1)
the mean length of##5##4##(1991-12#1)(2007-1#1)(2007-5#1)(2008-7#1)(2011-12#1)
the mean level of##4##4##(1993-11#1)(1994-2#1)(1994-6#1)(2006-12#1)
the mean level##7##3##(1992-11#1)(1993-11#1)(1994-2#1)(1994-6#1)(2006-12#1)(2010-12#2)
the mean levels of##2##4##(1997-2#1)(2008-1#1)
the mean levels##3##3##(1992-8#1)(1997-2#1)(2008-1#1)
the mean lifetime##3##3##(2008-8#3)
the mean number of years of##2##6##(1994-6#1)(2011-1#1)
the mean number of##20##4##(1990-5#1)(1991-6#1)(1992-3#2)(1992-7#1)(1994-6#1)(1997-2#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
the mean number##23##3##(1990-5#1)(1991-6#2)(1992-3#2)(1992-7#1)(1994-6#1)(1997-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
the mean of scores for the##2##6##(2011-1#2)
the mean of the##10##4##(1993-1#1)(1994-3#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-8#1)
the mean of##25##3##(1993-1#1)(1994-3#1)(1995-8#1)(1996-5#1)(2004-12#1)(2005-11#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-8#1)(2011-1#2)(2011-2#1)(2012-2#1)
the mean or##2##3##(1993-5#1)(2008-3#1)
the mean orientation angle and angular distribution width were##2##9##(2008-10#2)
the mean orientation angle##4##4##(2008-10#4)
the mean output##2##3##(1996-12#2)
the mean particle size##2##4##(2008-5#1)(2012-3#1)
the mean percent##2##3##(1991-8#1)(1996-3#1)
the mean percentage of##3##4##(1994-1#1)(1994-2#1)(2007-9#1)
the mean plasma##2##3##(1996-3#1)(2008-4#1)
the mean production of##2##4##(2007-2#2)
the mean range of fusion was##2##6##(2007-7#2)
the mean rate of##4##4##(2008-3#2)(2008-5#1)(2011-2#1)
the mean ratio of##2##4##(2007-7#1)(2008-2#1)
the mean reading level##2##4##(2011-1#2)
the mean recovery was##2##4##(1997-3#2)
the mean recovery##5##3##(1990-11#1)(1997-3#2)(2008-10#2)
the mean response parameters##2##4##(2010-2#2)
the mean response##4##3##(1990-2#1)(1996-9#1)(2010-2#2)
the mean score##3##3##(1995-4#1)(1996-5#1)(2013-8#1)
the mean scores of##2##4##(2006-4#1)(2009-10#1)
the mean serum##4##3##(1996-1#1)(2007-7#1)(2008-1#2)
the mean size of particles##2##5##(2005-11#2)
the mean size of the##2##5##(2005-11#1)(2011-12#1)
the mean size of##6##4##(2005-11#3)(2008-9#1)(2011-12#1)(2012-3#1)
the mean speckle intensity##3##4##(2008-2#3)
the mean square displacement##2##4##(1992-9#1)(2008-3#1)
the mean square##3##3##(1992-9#1)(2008-3#1)(2012-2#1)
the mean squared error##4##4##(2006-10#1)(2008-10#1)(2008-2#2)
the mean surface roughness##2##4##(2009-11#1)(2011-2#1)
the mean surface##3##3##(2009-11#1)(2011-2#2)
the mean systolic##2##3##(2008-4#1)(2010-7#1)
the mean temperature##2##3##(2008-2#1)(2008-8#1)
the mean time of##5##4##(1997-4#1)(2007-12#2)(2008-11#1)(2009-3#1)
the mean time to##4##4##(2004-3#1)(2008-8#2)(2012-12#1)
the mean time##14##3##(1991-6#1)(1992-11#1)(1992-12#1)(1997-4#1)(2004-3#1)(2007-12#2)(2008-11#1)(2008-8#2)(2008-9#1)(2009-3#1)(2012-12#1)(2012-2#1)
the mean times##2##3##(2008-10#1)(2012-12#1)
the mean total##7##3##(1997-5#1)(2009-10#1)(2010-12#1)(2011-2#2)(2012-1#1)(2013-1#1)
the mean value and##2##4##(2008-3#2)
the mean value for##2##4##(2007-2#1)(2008-11#1)
the mean value in##3##4##(2007-12#1)(2008-10#2)
the mean value of the##5##5##(1994-10#1)(2006-5#1)(2008-3#1)(2011-1#1)(2012-12#1)
the mean value of##13##4##(1991-7#1)(1993-8#1)(1994-10#1)(1997-1#1)(2006-11#1)(2006-5#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
the mean value theorem##2##4##(2008-2#2)
the mean value##25##3##(1991-7#1)(1993-8#1)(1994-10#1)(1997-1#1)(2006-11#1)(2006-5#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
the mean value)##2##3##(2013-1#2)
the mean values obtained##2##4##(1990-1#1)(1990-12#1)
the mean values of##6##4##(1993-1#1)(1993-9#1)(2006-10#1)(2007-1#1)(2008-11#1)(2009-9#1)
the mean values##11##3##(1990-1#1)(1990-12#1)(1991-8#1)(1993-1#1)(1993-9#1)(2006-10#1)(2007-1#1)(2008-10#1)(2008-11#1)(2009-11#1)(2009-9#1)
the mean velocity##4##3##(1993-12#2)(1996-9#1)(2008-2#1)
the mean weekly##2##3##(2007-7#1)(2011-2#1)
the mean weight of##3##4##(2008-12#1)(2008-3#1)(2009-5#1)
the mean weight##4##3##(2006-10#1)(2008-12#1)(2008-3#1)(2009-5#1)
the mean yield of##2##4##(1992-7#1)(2008-10#1)
the mean yield##3##3##(1992-7#1)(1997-6#1)(2008-10#1)
the mean##646##2##(1990-1#1)(1990-11#3)(1990-12#2)(1990-2#3)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-10#1)(1991-12#3)(1991-2#3)(1991-4#3)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#3)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#1)(1992-7#3)(1992-8#2)(1992-9#2)(1993-1#7)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-5#5)(1993-7#1)(1993-8#1)(1993-9#3)(1994-1#1)(1994-10#2)(1994-11#1)(1994-12#3)(1994-2#6)(1994-3#3)(1994-4#2)(1994-5#2)(1994-6#2)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#3)(1996-10#1)(1996-12#3)(1996-3#4)(1996-5#5)(1996-7#1)(1996-9#2)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#5)(2004-11#4)(2004-12#1)(2004-2#1)(2004-3#2)(2004-4#1)(2004-9#1)(2005-1#1)(2005-10#3)(2005-11#5)(2005-4#2)(2005-7#1)(2005-8#1)(2006-10#8)(2006-11#6)(2006-12#3)(2006-3#1)(2006-4#1)(2006-5#5)(2006-7#2)(2006-8#4)(2006-9#3)(2007-1#3)(2007-10#2)(2007-11#7)(2007-12#13)(2007-2#8)(2007-3#5)(2007-4#3)(2007-5#3)(2007-6#3)(2007-7#22)(2007-8#18)(2007-9#10)(2008-1#9)(2008-10#56)(2008-11#14)(2008-12#3)(2008-2#18)(2008-3#34)(2008-4#5)(2008-5#17)(2008-6#3)(2008-7#14)(2008-8#16)(2008-9#7)(2009-10#4)(2009-11#5)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#3)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#3)(2010-12#5)(2010-2#2)(2010-3#4)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#16)(2011-12#3)(2011-2#25)(2012-1#2)(2012-12#8)(2012-2#13)(2012-3#7)(2013-1#15)(2013-7#3)(2013-8#12)
the mean-field##3##2##(2007-12#2)(2008-2#1)
the mean-free-path##2##2##(2008-1#1)(2008-3#1)
the mean-square displacement##2##3##(2006-10#1)(2009-4#1)
the mean-square##3##2##(2006-10#1)(2007-11#1)(2009-4#1)
the mean-squared error##2##3##(2008-3#2)
the meander tail mutant mouse##3##5##(1991-8#1)(1992-9#2)
the meaning and##5##3##(1992-2#1)(2008-11#3)(2009-6#1)
the meaning of a##4##4##(1995-2#1)(1996-9#1)(2008-7#1)(2011-3#1)
the meaning of being##2##4##(2012-3#1)(2013-8#1)
the meaning of beta lambda alpha iota sigma ó zeta##2##10##(2012-2#2)
the meaning of the##4##4##(2008-2#2)(2008-7#1)(2012-3#1)
the meaning of this content cannot be easily understood without some associated text##2##13##(2013-1#2)
the meaning of##40##3##(1990-12#1)(1993-1#1)(1993-2#2)(1994-9#1)(1995-2#1)(1996-1#2)(1996-9#1)(2004-5#1)(2006-12#1)(2007-3#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-2#3)(2008-6#1)(2008-7#2)(2009-2#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
the meaning##47##2##(1990-12#1)(1992-2#1)(1993-1#1)(1993-2#2)(1994-9#1)(1995-2#1)(1996-1#2)(1996-9#1)(2004-5#1)(2006-12#1)(2007-3#1)(2008-1#1)(2008-11#6)(2008-12#3)(2008-2#3)(2008-6#1)(2008-7#2)(2009-2#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
the meaningful##3##2##(1996-2#1)(2009-10#1)(2011-1#1)
the meanings attributed to##2##4##(1995-1#1)(2011-2#1)
the meanings of premature mother-child skin-to-skin contact##2##7##(2011-2#2)
the meanings of##4##3##(2008-7#1)(2011-2#2)(2013-7#1)
the meanings##7##2##(1995-1#1)(2008-5#1)(2008-7#1)(2011-2#3)(2013-7#1)
the means by which health##2##5##(1997-2#1)(1997-3#1)
the means by which the##2##5##(2007-5#1)(2008-10#1)
the means by which##9##4##(1996-1#1)(1997-2#1)(1997-3#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-7#1)(2012-3#1)(2013-8#1)
the means for a##2##4##(2006-12#1)(2006-7#1)
the means for##10##3##(1991-6#1)(1992-6#1)(1993-3#1)(1994-2#1)(2004-9#1)(2006-12#1)(2006-5#1)(2006-7#1)(2008-3#1)(2013-8#1)
the means of the##3##4##(2008-2#1)(2011-1#1)(2011-2#1)
the means of##16##3##(1991-8#1)(1992-10#1)(1997-5#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)
the means to achieve##2##4##(2007-12#1)(2010-4#1)
the means to##21##3##(1990-11#1)(1994-6#1)(1995-5#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2010-10#1)(2010-4#1)(2011-12#3)(2013-1#2)(2013-8#1)
the means##66##2##(1990-11#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-6#2)(1993-3#1)(1994-2#1)(1994-6#1)(1995-5#1)(1996-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-12#1)(2004-9#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-12#3)(2007-2#2)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#1)(2010-10#1)(2010-2#1)(2010-4#2)(2010-5#2)(2011-1#1)(2011-12#3)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
the meantime##17##2##(1992-3#1)(1995-12#1)(1996-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2009-1#1)(2010-12#2)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#2)
the meanwhile##3##2##(2004-11#1)(2008-11#2)
the measles##6##2##(1996-12#1)(1997-4#1)(2006-8#1)(2007-2#1)(2010-10#1)(2012-12#1)
the measurable##6##2##(1990-8#1)(1992-9#1)(1997-5#1)(2006-6#2)(2008-5#1)
the measurand##3##2##(1992-4#1)(2008-3#2)
the measure and##2##3##(2008-11#1)(2012-2#1)
the measure of multilocus correlation##2##5##(2008-10#2)
the measure of multilocus##3##4##(2008-10#3)
the measure of##11##3##(1992-12#1)(1994-9#1)(2007-3#1)(2008-1#1)(2008-10#5)(2008-7#1)(2012-3#1)
the measure##27##2##(1990-2#1)(1992-12#1)(1993-3#1)(1994-9#1)(1995-6#2)(1996-3#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-7#1)(2010-10#1)(2011-1#1)(2012-2#1)(2012-3#1)
the measured Doppler##2##3##(2008-3#1)(2011-1#1)
the measured absorption and the##2##5##(2008-3#2)
the measured absorption##4##3##(2008-2#1)(2008-3#3)
the measured and predicted datasets##2##5##(2010-8#2)
the measured and predicted##3##4##(2008-2#1)(2010-8#2)
the measured and the##4##4##(2007-11#2)(2008-2#1)(2008-3#1)
the measured and theoretical##3##4##(2008-10#1)(2008-3#2)
the measured and##11##3##(2007-11#3)(2008-10#1)(2008-2#2)(2008-3#3)(2010-8#2)
the measured body##2##3##(2007-12#1)(2008-7#1)
the measured cell##2##3##(2008-4#1)(2011-1#1)
the measured concentration##2##3##(1995-1#1)(2008-3#1)
the measured data with##2##4##(2008-3#2)
the measured data##17##3##(2006-10#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#7)(2008-5#1)(2008-7#1)(2013-8#1)
the measured differences in##2##4##(2008-5#2)
the measured frequency##2##3##(2008-2#1)(2008-3#1)
the measured image##2##3##(2008-2#1)(2008-3#1)
the measured intensity data##2##4##(2007-12#2)
the measured intensity##5##3##(2007-12#2)(2008-2#2)(2008-3#1)
the measured intrinsic vector##2##4##(2008-3#2)
the measured optical##2##3##(2008-3#2)
the measured ozone##2##3##(2008-3#2)
the measured parameters##7##3##(1991-9#1)(1994-8#1)(2008-3#2)(2009-4#2)(2009-5#1)
the measured phase distribution##2##4##(2008-2#2)
the measured phase##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
the measured polarization##2##3##(2008-2#1)(2008-3#1)
the measured potential##2##3##(2008-10#2)
the measured profile##2##3##(2008-3#2)
the measured radiance##4##3##(2008-2#4)
the measured reflectance##4##3##(2008-2#1)(2008-3#3)
the measured response##4##3##(2006-11#1)(2007-12#1)(2008-2#1)(2008-4#1)
the measured results##6##3##(2007-12#1)(2008-2#1)(2008-3#4)
the measured shape##4##3##(2008-2#1)(2008-6#3)
the measured signal##2##3##(2008-10#1)(2008-2#1)
the measured spectra##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
the measured spectral##4##3##(2008-2#1)(2008-3#3)
the measured spectrum##4##3##(2007-12#1)(2008-2#2)(2010-5#1)
the measured speed of sound is too##2##7##(2008-3#2)
the measured surface##3##3##(2008-3#2)(2011-2#1)
the measured transmission##2##3##(2007-12#1)(2011-2#1)
the measured value##2##3##(2008-3#2)
the measured values and##2##4##(1994-11#1)(2012-2#1)
the measured values##9##3##(1991-7#1)(1992-4#1)(1994-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2012-2#1)
the measured variables##2##3##(2013-7#2)
the measured wave front##2##4##(2007-12#1)(2008-2#1)
the measured wave fronts##2##4##(2008-2#2)
the measured wave##5##3##(2007-12#2)(2008-2#3)
the measured zeta potential##2##4##(2005-11#2)
the measured##291##2##(1991-7#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-2#1)(1994-11#2)(1994-12#3)(1994-3#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#1)(1997-7#1)(2004-4#1)(2005-10#1)(2005-11#10)(2006-10#2)(2006-11#2)(2006-12#1)(2007-11#12)(2007-12#25)(2007-8#2)(2008-1#1)(2008-10#19)(2008-11#5)(2008-12#1)(2008-2#61)(2008-3#75)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#2)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
the measurement accuracy and##2##4##(2008-3#1)(2012-3#1)
the measurement accuracy##10##3##(2005-11#1)(2008-2#3)(2008-3#5)(2012-3#1)
the measurement and the##2##4##(2008-3#2)
the measurement and##11##3##(1995-2#1)(1995-4#1)(2008-1#1)(2008-10#3)(2008-3#4)(2010-4#1)
the measurement by##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
the measurement data##4##3##(2008-10#1)(2008-2#1)(2013-8#2)
the measurement error is##2##4##(2008-3#1)(2008-7#1)
the measurement error##11##3##(1993-5#1)(1993-6#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#1)(2010-2#1)(2011-12#1)
the measurement errors##3##3##(1995-4#1)(1997-8#1)(2007-11#1)
the measurement in##2##3##(2008-10#1)(2008-2#1)
the measurement interferometer##2##3##(2008-3#2)
the measurement is##2##3##(2008-10#1)(2008-2#1)
the measurement method##3##3##(2007-12#2)(2008-2#1)
the measurement methods##2##3##(2008-10#1)(2009-9#1)
the measurement of a##8##4##(2008-10#2)(2008-2#2)(2008-3#3)(2010-2#1)
the measurement of anomalous##2##4##(2006-2#1)(2006-4#1)
the measurement of benzo[a]pyrene hydroxylase activity and CO reducible cytochrome P450##2##11##(1994-6#2)
the measurement of blood##2##4##(2008-1#1)(2013-1#1)
the measurement of both the##2##5##(2008-2#1)(2008-5#1)
the measurement of both##3##4##(2008-2#1)(2008-3#1)(2008-5#1)
the measurement of fluorescence##2##4##(2008-10#1)(2008-9#1)
the measurement of its##2##4##(1993-2#1)(2008-5#1)
the measurement of maximum##2##4##(1994-10#1)(2007-8#1)
the measurement of optical##4##4##(2008-10#1)(2008-3#3)
the measurement of oxygen##3##4##(1993-1#1)(2007-8#1)(2008-11#1)
the measurement of protein##2##4##(1991-3#1)(2008-9#1)
the measurement of serum##2##4##(2009-6#1)(2012-12#1)
the measurement of surface##2##4##(2008-2#2)
the measurement of the concentration of##2##6##(1994-9#1)(2008-10#1)
the measurement of the effective##2##5##(2006-12#1)(2007-12#1)
the measurement of the fluorescence##2##5##(2008-10#2)
the measurement of the serum##2##5##(1996-4#1)(2007-2#1)
the measurement of the##53##4##(1990-7#1)(1991-1#1)(1992-8#1)(1994-9#1)(1996-4#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-10#13)(2008-11#1)(2008-2#7)(2008-3#8)(2008-4#4)(2008-5#3)(2008-6#1)(2010-11#1)(2010-5#1)(2010-8#1)(2013-8#1)
the measurement of this##4##4##(1990-6#1)(1992-4#1)(1993-2#1)(1996-10#1)
the measurement of total##4##4##(1991-3#1)(1996-4#1)(1997-6#1)(2008-10#1)
the measurement of urinary##2##4##(1996-12#1)(2012-2#1)
the measurement of##300##3##(1990-11#4)(1990-12#1)(1990-2#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#4)(1991-1#2)(1991-3#2)(1991-7#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-7#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-2#5)(1993-6#1)(1994-10#2)(1994-2#1)(1994-3#2)(1994-6#2)(1994-9#1)(1995-2#2)(1995-7#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-4#2)(1996-6#1)(1996-9#1)(1997-4#3)(1997-6#3)(2004-9#1)(2005-11#2)(2006-10#3)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#2)(2006-6#4)(2007-10#1)(2007-11#7)(2007-12#5)(2007-2#1)(2007-4#1)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#53)(2008-11#5)(2008-2#25)(2008-3#46)(2008-4#11)(2008-5#8)(2008-6#3)(2008-7#4)(2008-9#5)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-11#2)(2010-2#2)(2010-5#4)(2010-8#2)(2010-9#2)(2011-1#4)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
the measurement plane##3##3##(2008-2#2)(2008-3#1)
the measurement precision##2##3##(2008-2#2)
the measurement process##3##3##(2008-10#3)
the measurement range##9##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#2)
the measurement results##7##3##(2005-4#1)(2008-10#2)(2008-3#2)(2009-11#1)(2012-3#1)
the measurement sensitivity##3##3##(2008-3#2)(2008-9#1)
the measurement spots##3##3##(2013-8#3)
the measurement step##2##3##(2008-10#2)
the measurement system##6##3##(1996-2#1)(2008-10#1)(2008-3#4)
the measurement uncertainty of analytical assays##2##6##(2008-10#2)
the measurement uncertainty of##3##4##(2008-10#3)
the measurement uncertainty##8##3##(2008-10#5)(2008-3#3)
the measurement volume##7##3##(2007-11#1)(2008-2#3)(2008-3#2)(2010-4#1)
the measurement was##7##3##(2005-10#2)(2008-10#5)
the measurement##479##2##(1990-11#4)(1990-12#1)(1990-2#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#4)(1991-1#2)(1991-3#2)(1991-7#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-2#5)(1993-5#1)(1993-6#2)(1994-10#2)(1994-2#1)(1994-3#2)(1994-6#2)(1994-9#1)(1995-2#3)(1995-4#2)(1995-7#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#2)(1996-6#1)(1996-9#1)(1997-4#3)(1997-6#4)(1997-8#1)(2004-9#1)(2005-10#2)(2005-11#4)(2005-4#1)(2006-10#4)(2006-11#1)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#2)(2006-6#4)(2007-10#2)(2007-11#13)(2007-12#10)(2007-2#1)(2007-4#2)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#90)(2008-11#7)(2008-12#1)(2008-2#62)(2008-3#94)(2008-4#11)(2008-5#9)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#6)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-11#2)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#4)(2010-8#2)(2010-9#2)(2011-1#4)(2011-12#2)(2012-12#4)(2012-2#2)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#8)
the measurement-volume effect##3##3##(2008-3#3)
the measurements and##2##3##(2008-3#2)
the measurements are##5##3##(1991-8#1)(2008-3#2)(2008-4#1)(2013-7#1)
the measurements at##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
the measurements being##2##3##(2008-10#1)(2008-3#1)
the measurements could be##2##4##(2008-2#1)(2008-3#1)
the measurements could##3##3##(2008-2#1)(2008-3#2)
the measurements from##2##3##(2008-12#1)(2008-3#1)
the measurements made by##2##4##(1990-4#1)(2008-10#1)
the measurements made##4##3##(1990-4#1)(1996-1#1)(2008-10#2)
the measurements of the##2##4##(2008-1#1)(2008-6#1)
the measurements of##15##3##(1990-12#1)(1996-12#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#4)(2008-3#2)(2008-6#1)(2008-7#1)(2009-12#1)(2012-1#1)
the measurements to##3##3##(1997-6#1)(2007-12#1)(2008-10#1)
the measurements was##3##3##(2008-10#2)(2012-12#1)
the measurements were carried out##2##5##(2007-8#1)(2010-5#1)
the measurements were repeated##2##4##(2007-3#1)(2007-9#1)
the measurements were##11##3##(1993-11#1)(2005-10#1)(2007-3#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-3#2)(2010-5#1)
the measurements with##3##3##(1990-2#1)(2008-2#1)(2008-3#1)
the measurements##98##2##(1990-12#1)(1990-2#1)(1990-4#1)(1991-8#1)(1992-7#1)(1993-11#1)(1994-11#2)(1995-2#1)(1996-1#1)(1996-12#1)(1997-3#1)(1997-6#1)(2005-10#1)(2005-11#4)(2006-10#1)(2007-11#1)(2007-12#5)(2007-3#2)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#16)(2008-12#1)(2008-2#4)(2008-3#27)(2008-4#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-12#1)(2009-5#1)(2010-5#2)(2010-7#2)(2011-2#1)(2012-1#2)(2012-12#1)(2013-7#1)
the measures are##3##3##(1990-2#1)(2007-12#1)(2008-11#1)
the measures for##2##3##(2008-8#1)(2011-1#1)
the measures of multilocus correlation and association##2##7##(2008-10#2)
the measures of##11##3##(1990-3#1)(1996-12#1)(2006-4#1)(2008-10#4)(2008-11#1)(2013-1#3)
the measures taken to##2##4##(1996-6#1)(2011-2#1)
the measures taken##4##3##(1996-6#1)(2006-11#1)(2008-11#1)(2011-2#1)
the measures used to##2##4##(2007-12#1)(2010-11#1)
the measures##35##2##(1990-2#1)(1990-3#1)(1994-6#1)(1996-12#2)(1996-6#1)(1996-8#1)(2006-11#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-11#3)(2008-4#1)(2008-6#1)(2008-8#1)(2009-1#1)(2009-11#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#4)
the measuring conditions##2##3##(2007-11#1)(2008-10#1)
the measuring range of the##2##5##(2008-10#2)
the measuring range of##4##4##(2008-10#4)
the measuring range##6##3##(2008-10#6)
the measuring system##2##3##(2008-10#1)(2008-2#1)
the measuring##22##2##(1990-2#1)(1993-8#1)(2007-11#2)(2007-12#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-4#1)(2010-12#1)
the meat samples##2##3##(2010-4#2)
the meat##22##2##(1991-11#1)(2005-5#1)(2008-10#5)(2010-4#13)(2013-1#2)
the meat-type##2##2##(2008-5#2)
the meatal##2##2##(1995-5#1)(2006-11#1)
the mechanical and degradation##2##4##(2012-2#2)
the mechanical and thermal##3##4##(1996-3#1)(2007-9#1)(2012-1#1)
the mechanical and##13##3##(1996-3#1)(2005-10#1)(2006-12#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-2#2)(2011-2#1)(2012-1#1)(2012-2#2)
the mechanical aspects of##2##4##(2008-3#1)(2012-12#1)
the mechanical behavior of##8##4##(2004-9#2)(2008-11#1)(2009-7#1)(2011-1#1)(2012-1#1)(2012-2#2)
the mechanical behaviour of the##3##5##(2006-7#1)(2009-7#2)
the mechanical behaviour of##4##4##(2006-7#1)(2009-7#3)
the mechanical behaviour##5##3##(2006-7#1)(2009-7#4)
the mechanical components of##2##4##(2006-11#1)(2007-12#1)
the mechanical effect##2##3##(1991-5#1)(2004-9#1)
the mechanical energy of##2##4##(2005-8#1)(2010-8#1)
the mechanical energy##3##3##(2005-8#1)(2007-9#1)(2010-8#1)
the mechanical forces of##2##4##(2007-8#1)(2009-8#1)
the mechanical forces##3##3##(1995-9#1)(2007-8#1)(2009-8#1)
the mechanical function##3##3##(2007-11#1)(2008-3#1)(2009-7#1)
the mechanical hypothesis of excitation-contraction##2##5##(1993-12#2)
the mechanical hypothesis##3##3##(1993-12#2)(2009-2#1)
the mechanical parameters##2##3##(2008-11#1)(2008-5#1)
the mechanical properties and color change of acrylic denture base resin##2##11##(2013-8#2)
the mechanical properties and##7##4##(2005-11#1)(2006-11#1)(2008-5#1)(2010-4#1)(2012-2#1)(2013-8#2)
the mechanical properties of cartilage##2##5##(2007-11#1)(2007-4#1)
the mechanical properties of the##15##5##(1996-4#1)(2004-9#1)(2005-11#1)(2007-1#2)(2008-5#1)(2008-6#1)(2009-7#3)(2009-8#1)(2010-4#1)(2011-2#1)(2013-1#2)
the mechanical properties of##44##4##(1996-3#1)(1996-4#1)(2004-9#2)(2005-11#1)(2007-1#2)(2007-11#1)(2007-12#2)(2007-4#2)(2007-5#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#2)(2009-7#6)(2009-8#2)(2010-4#3)(2010-7#2)(2010-8#1)(2011-2#2)(2013-1#2)(2013-8#1)
the mechanical properties##61##3##(1996-3#1)(1996-4#1)(2004-9#4)(2005-11#2)(2006-11#1)(2007-1#2)(2007-11#1)(2007-12#2)(2007-4#2)(2007-5#1)(2007-9#1)(2008-10#1)(2008-3#2)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-5#2)(2009-7#7)(2009-8#2)(2010-4#4)(2010-7#2)(2010-8#1)(2011-2#2)(2012-2#3)(2013-1#2)(2013-8#4)
the mechanical property of##2##4##(2007-9#1)(2013-8#1)
the mechanical property##3##3##(2007-9#1)(2010-12#1)(2013-8#1)
the mechanical response of the##3##5##(2006-8#1)(2008-3#1)(2008-7#1)
the mechanical response##5##3##(1996-11#1)(2006-7#1)(2006-8#1)(2008-3#1)(2008-7#1)
the mechanical stability of##3##4##(1991-12#1)(2008-7#1)(2008-8#1)
the mechanical stimulus##3##3##(1990-8#1)(2006-2#1)(2008-7#1)
the mechanical strain##2##3##(2007-12#2)
the mechanical strength of##3##4##(2009-7#1)(2010-2#2)
the mechanical strength##6##3##(2004-9#1)(2009-3#1)(2009-7#1)(2010-2#2)(2010-4#1)
the mechanical stress##4##3##(2007-12#1)(2008-3#2)(2010-7#1)
the mechanical trauma##2##3##(2005-11#1)(2007-10#1)
the mechanical##182##2##(1990-8#2)(1991-12#1)(1991-5#1)(1992-3#1)(1993-12#2)(1993-9#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-11#1)(1996-3#2)(1996-4#1)(2004-9#9)(2005-10#1)(2005-11#4)(2005-8#1)(2006-11#3)(2006-12#1)(2006-2#1)(2006-7#2)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#6)(2007-4#2)(2007-5#2)(2007-7#2)(2007-8#6)(2007-9#4)(2008-1#3)(2008-10#3)(2008-11#2)(2008-2#7)(2008-3#9)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#6)(2008-8#2)(2009-11#1)(2009-2#2)(2009-3#1)(2009-5#2)(2009-7#14)(2009-8#4)(2010-12#1)(2010-2#3)(2010-4#5)(2010-6#1)(2010-7#3)(2010-8#5)(2011-1#3)(2011-2#5)(2012-1#4)(2012-12#1)(2012-2#7)(2013-1#2)(2013-8#7)
the mechanically##4##2##(1994-12#1)(2007-8#1)(2008-3#1)(2010-5#1)
the mechanics of the##5##4##(1994-3#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-1#1)
the mechanics of##15##3##(1992-4#1)(1994-3#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-7#4)(2008-9#1)(2009-4#1)(2010-1#1)(2011-2#1)(2012-1#1)
the mechanics##19##2##(1992-4#1)(1994-3#1)(2006-11#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-7#5)(2008-9#1)(2009-4#1)(2010-1#1)(2011-2#1)(2012-1#1)
the mechanism and function of##2##5##(2008-2#1)(2010-12#1)
the mechanism and the##3##4##(1991-7#1)(2005-4#1)(2012-2#1)
the mechanism and##17##3##(1990-11#1)(1991-7#1)(2005-4#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)(2012-2#1)
the mechanism behind the##2##4##(1997-5#1)(2008-9#1)
the mechanism behind##4##3##(1997-5#1)(2008-1#1)(2008-3#1)(2008-9#1)
the mechanism by which NRT works##2##6##(2012-3#2)
the mechanism by which it##3##5##(1995-3#1)(2011-1#1)(2012-2#1)
the mechanism by which the##10##5##(1990-11#1)(1990-2#1)(1991-11#1)(1992-2#1)(1993-2#1)(1994-3#1)(2005-8#1)(2007-8#1)(2008-10#1)(2008-5#1)
the mechanism by which these##3##5##(1994-11#1)(2007-4#1)(2008-11#1)
the mechanism by which this occurs##4##6##(1992-9#1)(1996-8#1)(2008-11#1)(2013-1#1)
the mechanism by which this##9##5##(1990-7#1)(1990-9#1)(1992-3#1)(1992-9#1)(1995-8#1)(1996-8#1)(2008-11#1)(2010-11#1)(2013-1#1)
the mechanism by which##63##4##(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-11#1)(1994-3#2)(1994-5#2)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#2)(1996-8#1)(1997-1#1)(1997-2#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#2)(2010-11#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
the mechanism driving##2##3##(2008-8#1)(2009-4#1)
the mechanism for such##2##4##(2006-10#1)(2012-3#1)
the mechanism for the##10##4##(1994-2#1)(1994-5#1)(1995-3#1)(1996-12#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-3#3)
the mechanism for this##4##4##(2008-11#1)(2008-6#1)(2009-10#1)(2009-5#1)
the mechanism for##36##3##(1990-11#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-12#2)(1997-2#1)(2005-12#1)(2006-10#3)(2006-5#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-6#1)(2008-8#2)(2009-10#1)(2009-5#1)(2012-12#1)(2012-3#1)(2013-8#1)
the mechanism governing the##2##4##(2008-7#1)(2008-8#1)
the mechanism governing##4##3##(1990-8#1)(2008-7#1)(2008-8#1)(2009-8#1)
the mechanism how##2##3##(1994-10#1)(2011-2#1)
the mechanism in##2##3##(2009-8#2)
the mechanism involved in the##3##5##(1997-8#1)(2008-7#1)(2012-12#1)
the mechanism involved in##5##4##(1994-2#1)(1995-2#1)(1997-8#1)(2008-7#1)(2012-12#1)
the mechanism involved##8##3##(1994-2#1)(1995-2#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-7#1)(2009-5#1)(2012-12#1)
the mechanism is##4##3##(2008-8#1)(2011-1#1)(2012-1#1)(2013-8#1)
the mechanism leading to##2##4##(2006-9#1)(2008-3#1)
the mechanism of T##2##4##(1991-12#2)
the mechanism of TGF-beta in the scarring and##2##8##(2008-12#2)
the mechanism of action and##3##5##(1992-9#1)(1993-12#1)(2008-1#1)
the mechanism of action is##2##5##(2009-12#1)(2012-1#1)
the mechanism of action of a##2##6##(1991-3#1)(2006-10#1)
the mechanism of action of psychotropic##2##6##(1995-12#1)(2005-9#1)
the mechanism of action of silicone sheeting##2##7##(2008-9#2)
the mechanism of action of the##7##6##(1993-6#1)(2007-4#1)(2008-10#2)(2008-5#1)(2008-7#1)(2013-8#1)
the mechanism of action of these##6##6##(1991-4#1)(2005-7#1)(2008-11#1)(2008-5#1)(2009-6#1)(2010-11#1)
the mechanism of action of this##5##6##(1995-6#1)(1996-7#1)(1997-2#1)(2006-10#1)(2010-12#1)
the mechanism of action of##64##5##(1990-1#1)(1990-11#1)(1990-3#1)(1990-7#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1993-6#1)(1993-9#1)(1994-10#3)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-7#1)(1997-2#2)(2005-7#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-9#2)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#1)(2013-8#1)
the mechanism of action##76##4##(1990-1#1)(1990-11#1)(1990-3#1)(1990-7#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-10#3)(1994-11#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-7#1)(1997-2#2)(2005-3#1)(2005-7#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-4#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#2)(2008-9#2)(2009-12#1)(2009-6#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-1#1)(2013-8#1)
the mechanism of activation of the##2##6##(1993-6#1)(2008-10#1)
the mechanism of activation of##4##5##(1991-1#1)(1993-6#1)(2008-10#2)
the mechanism of androgen##2##4##(1990-9#1)(1996-11#1)
the mechanism of assembly of##2##5##(1995-1#2)
the mechanism of biocontrol of R##2##6##(2008-10#2)
the mechanism of catalysis##2##4##(1990-2#1)(1994-11#1)
the mechanism of cell##4##4##(1991-4#1)(2008-11#1)(2012-11#2)
the mechanism of cellular##2##4##(1991-12#1)(2004-11#1)
the mechanism of drug release##2##5##(2004-12#1)(2012-2#1)
the mechanism of drug##3##4##(2004-12#1)(2011-1#1)(2012-2#1)
the mechanism of enhancement##2##4##(1991-5#2)
the mechanism of formation##2##4##(1991-9#1)(2012-1#1)
the mechanism of image formation##2##5##(2007-11#1)(2008-2#1)
the mechanism of inhibition by the##2##6##(1991-2#1)(1992-8#1)
the mechanism of inhibition by##3##5##(1991-2#2)(1992-8#1)
the mechanism of inhibition of##2##5##(1992-3#1)(2011-2#1)
the mechanism of inhibition##5##4##(1991-2#2)(1992-3#1)(1992-8#1)(2011-2#1)
the mechanism of injury##3##4##(2007-7#1)(2009-3#1)(2013-1#1)
the mechanism of insulin##2##4##(1996-5#1)(2010-12#1)
the mechanism of integration of##2##5##(1990-9#1)(1993-11#1)
the mechanism of interaction##4##4##(1990-2#2)(2005-4#1)(2008-10#1)
the mechanism of ischemic preconditioning##2##5##(1996-9#2)
the mechanism of its##3##4##(1997-4#1)(2006-10#1)(2008-5#1)
the mechanism of lipid##2##4##(1993-9#1)(2008-8#1)
the mechanism of neuronal##4##4##(1996-9#1)(2008-7#1)(2009-4#1)(2010-12#1)
the mechanism of nuclear##2##4##(1993-6#1)(1994-8#1)
the mechanism of protein##2##4##(1992-6#1)(1996-8#1)
the mechanism of proteinase inhibitors##2##5##(1996-12#2)
the mechanism of regulation by##2##5##(1991-8#1)(1994-12#1)
the mechanism of regulation##5##4##(1990-8#1)(1991-8#1)(1993-2#1)(1994-12#1)(2008-11#1)
the mechanism of release##2##4##(2011-2#2)
the mechanism of resistance in##2##5##(1995-12#1)(2008-10#1)
the mechanism of resistance##5##4##(1995-12#1)(2008-10#3)(2012-3#1)
the mechanism of steroid##3##4##(1990-11#1)(1996-2#1)(2008-4#1)
the mechanism of such inhibition##2##5##(1991-9#1)(1996-11#1)
the mechanism of such##4##4##(1991-9#1)(1996-11#1)(2007-11#1)(2010-4#1)
the mechanism of the effect of##2##6##(1995-8#1)(2008-5#1)
the mechanism of the##32##4##(1991-1#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-8#1)(1995-10#1)(1995-4#1)(1995-8#3)(1996-12#1)(1996-7#1)(1997-1#1)(2004-12#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-7#1)
the mechanism of their##4##4##(1991-11#1)(1995-1#1)(1996-8#1)(2006-12#1)
the mechanism of these##2##4##(2012-11#1)(2013-7#1)
the mechanism of this##15##4##(1990-7#1)(1990-9#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-11#1)(2007-10#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#1)(2010-5#2)(2013-8#1)
the mechanism of transcriptional##2##4##(1991-3#1)(2008-9#1)
the mechanism of which might be##2##6##(2007-12#1)(2008-5#1)
the mechanism of which##3##4##(2007-12#1)(2008-5#1)(2008-7#1)
the mechanism of##458##3##(1990-1#1)(1990-10#1)(1990-11#3)(1990-2#3)(1990-3#1)(1990-5#1)(1990-7#3)(1990-8#2)(1990-9#3)(1991-1#5)(1991-10#2)(1991-11#2)(1991-12#4)(1991-2#3)(1991-3#2)(1991-4#5)(1991-5#5)(1991-6#2)(1991-7#4)(1991-8#2)(1991-9#3)(1992-10#2)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#3)(1993-11#7)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#1)(1993-6#5)(1993-8#2)(1993-9#4)(1994-10#4)(1994-11#5)(1994-12#7)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#4)(1994-8#7)(1994-9#5)(1995-1#3)(1995-10#1)(1995-11#3)(1995-12#7)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#7)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#3)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#4)(1996-9#6)(1997-1#2)(1997-2#4)(1997-4#2)(1997-7#2)(1997-8#2)(2004-11#1)(2004-12#2)(2005-11#6)(2005-12#1)(2005-3#1)(2005-4#4)(2005-7#2)(2005-9#1)(2006-10#9)(2006-11#2)(2006-12#5)(2006-4#2)(2006-7#2)(2006-8#3)(2007-1#1)(2007-10#2)(2007-11#8)(2007-12#5)(2007-3#1)(2007-4#6)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#27)(2008-11#9)(2008-12#3)(2008-2#5)(2008-3#6)(2008-4#6)(2008-5#14)(2008-6#6)(2008-7#9)(2008-8#7)(2008-9#8)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#5)(2010-2#2)(2010-4#1)(2010-5#6)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#7)(2012-1#3)(2012-11#3)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#6)
the mechanism remains##2##3##(2008-11#1)(2013-1#1)
the mechanism responsible for the##3##5##(2007-9#1)(2008-4#1)(2009-4#1)
the mechanism responsible for##7##4##(1991-8#1)(1992-1#1)(1997-2#1)(2006-7#1)(2007-9#1)(2008-4#1)(2009-4#1)
the mechanism that is##2##4##(2006-1#1)(2008-3#1)
the mechanism that leads to##2##5##(2011-2#1)(2013-1#1)
the mechanism that##7##3##(2006-1#1)(2008-11#2)(2008-3#1)(2011-2#2)(2013-1#1)
the mechanism through which##5##4##(1993-6#1)(2008-11#2)(2008-8#1)(2009-3#1)
the mechanism to##3##3##(1992-3#1)(2008-3#1)(2012-1#1)
the mechanism underlying cell##2##4##(2006-10#1)(2009-5#1)
the mechanism underlying the##6##4##(1995-1#1)(2007-11#1)(2008-9#1)(2009-4#1)(2009-7#1)(2011-2#1)
the mechanism underlying this##5##4##(1993-4#1)(2008-10#1)(2010-11#1)(2012-11#1)(2012-2#1)
the mechanism underlying##22##3##(1991-8#1)(1993-4#1)(1995-1#1)(1996-12#2)(2006-10#1)(2007-11#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-4#3)(2009-5#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#1)
the mechanism was##2##3##(2007-9#1)(2008-5#1)
the mechanism whereby##2##3##(1991-12#1)(2008-1#1)
the mechanism which##3##3##(1993-2#1)(1993-9#1)(1996-8#1)
the mechanism##684##2##(1990-1#1)(1990-10#1)(1990-11#8)(1990-2#4)(1990-3#1)(1990-5#2)(1990-7#5)(1990-8#3)(1990-9#4)(1991-1#5)(1991-10#2)(1991-11#3)(1991-12#5)(1991-2#3)(1991-3#2)(1991-4#5)(1991-5#5)(1991-6#2)(1991-7#5)(1991-8#5)(1991-9#4)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#2)(1992-2#3)(1992-3#5)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#2)(1992-9#4)(1993-11#7)(1993-12#3)(1993-2#4)(1993-3#5)(1993-4#2)(1993-6#8)(1993-8#2)(1993-9#7)(1994-10#5)(1994-11#6)(1994-12#7)(1994-2#4)(1994-3#4)(1994-5#7)(1994-6#5)(1994-8#7)(1994-9#6)(1995-1#4)(1995-10#1)(1995-11#3)(1995-12#10)(1995-2#3)(1995-3#6)(1995-4#1)(1995-5#4)(1995-6#3)(1995-7#1)(1995-8#9)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#8)(1996-2#3)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#6)(1996-9#6)(1997-1#3)(1997-2#8)(1997-4#3)(1997-5#1)(1997-7#2)(1997-8#3)(2004-11#1)(2004-12#2)(2005-11#8)(2005-12#2)(2005-3#2)(2005-4#6)(2005-7#2)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#13)(2006-11#2)(2006-12#5)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#11)(2007-12#9)(2007-2#1)(2007-3#2)(2007-4#7)(2007-7#4)(2007-8#4)(2007-9#5)(2008-1#8)(2008-10#38)(2008-11#19)(2008-12#3)(2008-2#7)(2008-3#14)(2008-4#8)(2008-5#16)(2008-6#10)(2008-7#11)(2008-8#18)(2008-9#11)(2009-10#1)(2009-12#1)(2009-3#3)(2009-4#6)(2009-5#3)(2009-6#3)(2009-7#3)(2009-8#3)(2009-9#2)(2010-10#2)(2010-11#5)(2010-12#6)(2010-2#3)(2010-4#1)(2010-5#6)(2010-6#1)(2010-8#2)(2011-1#6)(2011-12#1)(2011-2#11)(2012-1#5)(2012-11#4)(2012-12#6)(2012-2#8)(2012-3#8)(2013-1#13)(2013-7#1)(2013-8#9)
the mechanism(s) and##2##3##(1994-9#1)(2004-11#1)
the mechanism(s) by which##4##4##(1997-4#1)(2007-8#1)(2008-5#1)(2008-8#1)
the mechanism(s) of##6##3##(1992-11#1)(1992-6#1)(1993-8#1)(1994-8#1)(2008-10#1)(2010-12#1)
the mechanism(s) underlying the##2##4##(1995-1#1)(2008-5#1)
the mechanism(s) underlying##3##3##(1995-1#1)(2008-10#1)(2008-5#1)
the mechanism(s)##19##2##(1992-11#1)(1992-6#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-1#1)(1997-4#1)(2004-11#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-8#1)(2009-10#1)(2010-12#1)(2010-4#1)(2012-12#1)(2013-1#1)
the mechanism-based##2##2##(1992-6#1)(1992-8#1)
the mechanisms and regulation of##2##5##(2006-10#1)(2008-4#1)
the mechanisms and##19##3##(1990-8#1)(1997-7#1)(2006-10#2)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-4#1)(2009-8#2)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-8#1)
the mechanisms are not##2##4##(2008-4#1)(2008-7#1)
the mechanisms are##6##3##(1990-8#1)(2006-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)
the mechanisms associated with##2##4##(2007-8#2)
the mechanisms behind the##4##4##(2006-10#1)(2009-8#1)(2010-5#1)(2013-8#1)
the mechanisms behind these##3##4##(2006-12#1)(2008-11#1)(2012-2#1)
the mechanisms behind##12##3##(1992-9#1)(2006-10#1)(2006-12#1)(2007-1#1)(2008-11#2)(2008-8#1)(2009-8#1)(2010-3#1)(2010-5#1)(2012-2#1)(2013-8#1)
the mechanisms by which a##2##5##(1993-6#1)(1993-9#1)
the mechanisms by which the antidepressants##2##6##(2010-5#2)
the mechanisms by which the##8##5##(1995-3#1)(1995-8#1)(1996-4#1)(2005-11#1)(2010-5#2)(2012-1#2)
the mechanisms by which these##3##5##(1993-9#1)(1994-3#1)(2008-7#1)
the mechanisms by which##52##4##(1993-6#1)(1993-9#3)(1994-3#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(2005-11#1)(2006-10#2)(2006-2#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-5#2)(2011-3#1)(2012-1#2)(2012-2#2)(2013-1#2)
the mechanisms by##54##3##(1993-6#1)(1993-9#3)(1994-3#1)(1994-8#1)(1995-1#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(2005-11#1)(2006-10#2)(2006-2#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-5#2)(2011-3#1)(2012-1#2)(2012-2#3)(2013-1#2)
the mechanisms causing##3##3##(2006-10#2)(2008-7#1)
the mechanisms controlling##2##3##(1992-11#1)(2007-8#1)
the mechanisms employed by the##2##5##(1997-5#1)(2008-10#1)
the mechanisms for the##3##4##(1990-12#1)(1994-2#1)(2009-12#1)
the mechanisms for##8##3##(1990-12#1)(1994-2#1)(1997-7#1)(2007-11#1)(2008-6#1)(2009-12#1)(2009-8#1)(2012-3#1)
the mechanisms governing##3##3##(2008-7#1)(2009-10#1)(2011-1#1)
the mechanisms in##2##3##(2011-1#1)(2012-3#1)
the mechanisms involved and##3##4##(2006-10#1)(2010-10#1)(2011-2#1)
the mechanisms involved have been##2##5##(1995-2#1)(2010-3#1)
the mechanisms involved in the##7##5##(1993-3#1)(1996-4#1)(1997-3#1)(2006-10#1)(2007-5#1)(2008-2#1)(2010-12#1)
the mechanisms involved in this##3##5##(1993-6#1)(2008-1#1)(2009-2#1)
the mechanisms involved in##24##4##(1991-11#1)(1993-3#1)(1993-6#1)(1994-7#1)(1995-2#1)(1996-11#1)(1996-4#1)(1996-7#1)(1997-3#1)(1997-5#1)(2004-11#1)(2006-10#1)(2006-2#1)(2007-5#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2009-2#1)(2010-12#1)(2013-8#1)
the mechanisms involved##35##3##(1990-1#1)(1991-11#1)(1993-3#1)(1993-6#1)(1994-6#1)(1994-7#1)(1995-2#2)(1996-11#1)(1996-4#1)(1996-7#1)(1997-3#2)(1997-5#1)(2004-11#1)(2004-12#1)(2006-10#2)(2006-2#1)(2007-5#1)(2008-1#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#2)(2009-2#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-11#1)(2013-8#1)
the mechanisms leading to##5##4##(1992-9#1)(1995-12#1)(1996-5#1)(2006-3#1)(2012-1#1)
the mechanisms leading##6##3##(1992-9#1)(1995-12#1)(1996-5#1)(2006-3#1)(2008-6#1)(2012-1#1)
the mechanisms mediating##2##3##(1997-8#1)(2009-8#1)
the mechanisms of PCP abuse##2##5##(1996-10#2)
the mechanisms of action of##7##5##(1995-3#1)(2006-10#2)(2006-11#1)(2006-8#1)(2010-8#1)(2012-1#1)
the mechanisms of action##14##4##(1995-3#1)(2006-10#2)(2006-11#1)(2006-8#2)(2008-10#2)(2008-7#1)(2008-9#1)(2010-8#1)(2012-1#1)(2012-12#2)
the mechanisms of axon degeneration##2##5##(2011-1#2)
the mechanisms of disease##2##4##(2008-7#2)
the mechanisms of evolution##3##4##(2008-7#1)(2008-8#1)(2010-3#1)
the mechanisms of gene##2##4##(1992-7#1)(2011-2#1)
the mechanisms of heat##2##4##(1994-11#1)(2012-2#1)
the mechanisms of induction of##2##5##(2006-10#1)(2008-8#1)
the mechanisms of induction##3##4##(2006-10#1)(2008-8#2)
the mechanisms of injury##3##4##(2006-10#1)(2007-4#2)
the mechanisms of neuronal##2##4##(2008-4#1)(2008-7#1)
the mechanisms of probiotic##2##4##(2011-2#1)(2012-1#1)
the mechanisms of resistance to##2##5##(1995-12#1)(2006-11#1)
the mechanisms of resistance##3##4##(1995-12#1)(2006-11#1)(2008-10#1)
the mechanisms of the interactions##2##5##(2008-4#2)
the mechanisms of the##15##4##(1991-3#1)(1992-3#1)(2004-12#1)(2005-11#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-4#2)(2009-8#2)(2010-12#1)(2010-4#1)(2010-9#1)(2013-1#1)
the mechanisms of thermal##2##4##(2008-10#1)(2013-1#1)
the mechanisms of these interactions##2##5##(1990-6#1)(2007-11#1)
the mechanisms of these##4##4##(1990-11#1)(1990-6#1)(2007-11#1)(2008-10#1)
the mechanisms of this##2##4##(2008-5#1)(2012-1#1)
the mechanisms of tumorigenesis and##2##5##(2007-10#1)(2012-3#1)
the mechanisms of##200##3##(1990-11#1)(1990-4#1)(1990-6#1)(1991-12#2)(1991-3#1)(1991-8#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-10#3)(1996-6#1)(1996-8#2)(1996-9#1)(1997-6#1)(1997-8#2)(2004-12#1)(2005-10#2)(2005-11#3)(2005-7#1)(2006-10#13)(2006-11#2)(2006-12#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-4#5)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#11)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#7)(2008-5#2)(2008-7#7)(2008-8#7)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#6)(2010-1#1)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#6)(2012-1#5)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#3)
the mechanisms regulating the##3##4##(1991-1#1)(1997-4#1)(2010-3#1)
the mechanisms regulating##8##3##(1991-1#1)(1997-4#1)(2008-1#1)(2008-11#1)(2008-8#1)(2010-3#1)(2010-8#1)(2013-1#1)
the mechanisms responsible for the##4##5##(1991-4#1)(1994-11#1)(1997-1#1)(2008-2#1)
the mechanisms responsible for##15##4##(1991-4#1)(1994-11#1)(1996-3#1)(1997-1#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-2#1)
the mechanisms responsible##16##3##(1991-4#1)(1994-11#1)(1996-3#1)(1997-1#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-2#1)
the mechanisms that cause##4##4##(2005-10#1)(2008-10#1)(2009-8#1)(2013-1#1)
the mechanisms that contribute to the##2##6##(2008-11#1)(2010-12#1)
the mechanisms that control their##2##5##(2008-10#1)(2008-9#1)
the mechanisms that control##6##4##(2006-6#1)(2008-10#1)(2008-7#1)(2008-9#2)(2009-4#1)
the mechanisms that explain##2##4##(2010-9#1)(2011-1#1)
the mechanisms that increase##2##4##(1993-3#1)(2012-2#1)
the mechanisms that mediate the##2##5##(1996-2#1)(2011-2#1)
the mechanisms that regulate##4##4##(1995-8#1)(2008-11#1)(2009-8#1)(2010-12#1)
the mechanisms that underlie the##4##5##(1997-3#1)(2005-11#1)(2008-9#1)(2009-8#1)
the mechanisms that##39##3##(1991-5#1)(1993-3#1)(1994-9#1)(1995-7#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-4#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-9#3)(2009-4#1)(2009-5#1)(2009-8#3)(2010-12#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
the mechanisms through which##4##4##(1992-8#1)(2008-4#1)(2010-1#1)(2012-12#1)
the mechanisms underlying the##20##4##(1992-4#1)(1993-8#1)(1994-10#1)(1995-12#1)(2006-10#2)(2006-2#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-10#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
the mechanisms underlying these changes##2##5##(2009-10#1)(2013-8#1)
the mechanisms underlying these##3##4##(2008-10#1)(2009-10#1)(2013-8#1)
the mechanisms underlying this##3##4##(2008-1#1)(2008-9#1)(2012-1#1)
the mechanisms underlying##52##3##(1990-5#1)(1990-6#1)(1992-4#1)(1993-8#1)(1994-10#1)(1994-2#1)(1995-11#1)(1995-12#1)(1997-4#1)(1997-8#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#2)(2009-5#1)(2010-11#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
the mechanisms used##2##3##(2008-1#1)(2009-9#1)
the mechanisms which##3##3##(1997-6#1)(2005-11#1)(2007-8#1)
the mechanisms##503##2##(1990-1#1)(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-4#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#4)(1993-4#2)(1993-6#2)(1993-8#1)(1993-9#4)(1994-10#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#6)(1995-2#4)(1995-3#3)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#3)(1996-1#1)(1996-10#3)(1996-11#3)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#2)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#5)(2004-11#1)(2004-12#2)(2005-10#3)(2005-11#6)(2005-7#1)(2005-8#2)(2006-10#29)(2006-11#2)(2006-12#4)(2006-2#3)(2006-3#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#6)(2007-12#6)(2007-3#1)(2007-4#6)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#10)(2008-1#12)(2008-10#23)(2008-11#19)(2008-12#3)(2008-2#6)(2008-3#6)(2008-4#11)(2008-5#4)(2008-6#4)(2008-7#21)(2008-8#11)(2008-9#13)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#15)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#9)(2010-2#3)(2010-3#5)(2010-4#2)(2010-5#3)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#9)(2011-2#12)(2011-3#1)(2012-1#10)(2012-11#1)(2012-12#13)(2012-2#15)(2012-3#6)(2013-1#10)(2013-7#2)(2013-8#7)
the mechanistic basis of##2##4##(1995-8#1)(2011-2#1)
the mechanistic details##2##3##(2010-2#1)(2012-2#1)
the mechanistic model##2##3##(2008-10#1)(2009-8#1)
the mechanistic underpinnings of##2##4##(1993-4#1)(2006-5#1)
the mechanistic##21##2##(1993-4#1)(1993-6#1)(1994-12#1)(1995-10#1)(1995-8#1)(1996-11#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-2#2)
the mechanoreceptor##2##2##(1993-12#1)(1994-2#1)
the mechanosensitivity of the##2##4##(2008-12#2)
the medaka Oryzias##2##3##(2008-1#1)(2008-5#1)
the medaka fish##6##3##(1997-9#1)(2008-4#2)(2008-5#2)(2008-6#1)
the medaka##10##2##(1997-9#1)(2008-1#1)(2008-4#2)(2008-5#5)(2008-6#1)
the medfly Ceratitis capitata##3##4##(2007-12#3)
the medfly##4##2##(1996-11#1)(2007-12#3)
the media about##2##3##(2006-2#1)(2010-2#1)
the media and the##2##4##(1991-2#1)(2005-7#1)
the media and##9##3##(1991-2#2)(2005-7#1)(2006-5#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#2)
the media as well as##4##5##(1996-12#1)(2008-3#1)(2009-5#1)(2010-8#1)
the media as##5##3##(1996-12#1)(1996-2#1)(2008-3#1)(2009-5#1)(2010-8#1)
the media for##2##3##(2006-5#1)(2012-2#1)
the media from##2##3##(2008-11#1)(2010-12#1)
the media noise##6##3##(2008-2#4)(2008-3#2)
the media of the##3##4##(1993-8#1)(1995-1#1)(2009-5#1)
the media of##7##3##(1990-8#1)(1991-5#1)(1993-8#1)(1995-1#1)(2008-3#1)(2009-5#1)(2010-7#1)
the media on##4##3##(2007-12#3)(2009-7#1)
the media to##2##3##(2006-7#1)(2012-2#1)
the media with##3##3##(2008-2#2)(2008-8#1)
the media##113##2##(1990-8#1)(1991-2#2)(1991-5#1)(1991-9#2)(1992-8#2)(1993-12#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-1#2)(1995-12#1)(1995-3#2)(1996-11#2)(1996-12#1)(1996-2#2)(1997-1#2)(1997-8#2)(2005-7#1)(2006-10#1)(2006-11#3)(2006-12#1)(2006-2#1)(2006-5#3)(2006-7#1)(2007-11#1)(2007-12#10)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#10)(2008-12#2)(2008-2#7)(2008-3#8)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-1#1)(2009-4#2)(2009-5#2)(2009-7#1)(2010-12#1)(2010-2#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#3)(2013-7#1)
the media's##5##2##(1991-1#1)(2006-10#1)(2007-1#1)(2007-12#2)
the medial agranular##3##3##(1993-9#1)(1994-3#2)
the medial amygdala##3##3##(1991-6#1)(1993-9#1)(1997-3#1)
the medial and lateral##4##4##(1996-9#1)(2005-7#2)(2008-1#1)
the medial and ventral##2##4##(1991-1#1)(1994-8#1)
the medial and##8##3##(1991-1#1)(1994-8#1)(1996-9#1)(2005-7#2)(2008-1#1)(2008-8#1)(2009-2#1)
the medial antebrachial cutaneous nerve##2##5##(2008-9#2)
the medial aspect of the##3##5##(1990-5#1)(2006-11#1)(2007-8#1)
the medial aspect##4##3##(1990-5#1)(2006-11#2)(2007-8#1)
the medial border of the##2##5##(1996-9#1)(2007-10#1)
the medial border of##3##4##(1996-9#1)(2007-10#1)(2012-12#1)
the medial branch##3##3##(2006-12#1)(2006-7#1)(2006-8#1)
the medial canthal ligament##2##4##(2010-12#2)
the medial collateral ligament##2##4##(2008-8#1)(2012-2#1)
the medial collateral##3##3##(2008-5#1)(2008-8#1)(2012-2#1)
the medial compartment##3##3##(1990-6#1)(1992-3#1)(2013-1#1)
the medial cortex of the##2##5##(2010-3#1)(2011-2#1)
the medial epicondyle##4##3##(1995-6#2)(2012-3#2)
the medial flagellum and##2##4##(2007-12#2)
the medial forebrain bundle##6##4##(1992-10#1)(1992-12#1)(1993-12#1)(1994-3#1)(1995-12#1)(1996-2#1)
the medial frontal cortex of the rat##3##7##(1990-10#2)(1996-9#1)
the medial frontal cortex##4##4##(1990-10#2)(1994-5#1)(1996-9#1)
the medial frontal##6##3##(1990-10#2)(1992-8#1)(1994-5#1)(1996-9#1)(2008-11#1)
the medial gastrocnemius (MG) muscle##2##5##(1992-9#1)(1996-2#1)
the medial gastrocnemius##3##3##(1992-9#1)(1996-2#1)(2011-1#1)
the medial geniculate nucleus##2##4##(1994-5#1)(1996-6#1)
the medial geniculate##6##3##(1991-3#1)(1994-5#1)(1996-6#3)(2013-8#1)
the medial head of the triceps##2##6##(2006-3#1)(2008-9#1)
the medial head of the##3##5##(2006-3#1)(2007-11#1)(2008-9#1)
the medial longitudinal fasciculus##2##4##(1996-4#1)(1996-5#1)
the medial malleolus##3##3##(2007-1#1)(2010-12#1)(2010-3#1)
the medial one##2##3##(2007-2#1)(2011-2#1)
the medial part of the##5##5##(1995-7#1)(1997-8#2)(2008-7#1)(2009-4#1)
the medial perforant path##4##4##(1992-9#1)(1993-12#3)
the medial perforant##6##3##(1992-1#1)(1992-9#1)(1993-12#3)(1995-12#1)
the medial pontine reticular formation##3##5##(1990-7#3)
the medial prefrontal and##3##4##(1993-12#1)(1994-5#1)(2008-11#1)
the medial prefrontal cortex and##2##5##(2008-11#2)
the medial prefrontal cortex of##3##5##(1996-10#1)(1997-5#1)(2010-2#1)
the medial prefrontal cortex##21##4##(1991-9#2)(1994-8#1)(1996-10#4)(1996-2#2)(1997-2#1)(1997-5#1)(1997-6#1)(2004-11#1)(2008-11#4)(2008-6#2)(2010-2#2)
the medial prefrontal##25##3##(1991-2#1)(1991-9#2)(1993-12#1)(1994-5#1)(1994-8#1)(1996-10#4)(1996-2#2)(1997-2#1)(1997-5#1)(1997-6#1)(2004-11#1)(2008-11#5)(2008-6#2)(2010-2#2)
the medial preoptic area##7##4##(1990-5#1)(1991-4#1)(1992-12#1)(1992-5#1)(1996-1#2)(1997-8#1)
the medial preoptic nucleus##3##4##(1990-4#1)(1990-5#1)(2009-2#1)
the medial preoptic##10##3##(1990-4#1)(1990-5#2)(1991-4#1)(1992-12#1)(1992-5#1)(1996-1#2)(1997-8#1)(2009-2#1)
the medial projection##2##3##(1996-9#2)
the medial septal area##2##4##(1993-12#1)(2013-8#1)
the medial septal##5##3##(1992-7#1)(1993-12#2)(1994-2#1)(2013-8#1)
the medial septum##8##3##(1993-12#5)(1994-3#1)(1994-5#2)
the medial septum/diagonal band##2##4##(1990-7#1)(1991-3#1)
the medial superior olivary nucleus##4##5##(1997-3#4)
the medial superior##5##3##(1996-9#1)(1997-3#4)
the medial surface of the##2##5##(2007-12#1)(2008-5#1)
the medial surface of##3##4##(2007-12#2)(2008-5#1)
the medial surface##4##3##(2007-12#2)(2008-5#1)(2012-2#1)
the medial temporal lobe##6##4##(1991-10#2)(1992-11#1)(1997-8#1)(2010-7#2)
the medial temporal##8##3##(1991-10#2)(1992-11#1)(1997-8#1)(2008-11#1)(2010-7#3)
the medial vestibular nucleus##4##4##(1996-11#4)
the medial wall of the##3##5##(2005-5#1)(2008-9#1)(2013-7#1)
the medial wall of##4##4##(2005-5#1)(2006-12#1)(2008-9#1)(2013-7#1)
the medial wall##5##3##(1997-8#1)(2005-5#1)(2006-12#1)(2008-9#1)(2013-7#1)
the medial##248##2##(1990-10#2)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#6)(1990-9#2)(1991-1#1)(1991-10#2)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#5)(1993-12#14)(1993-5#1)(1993-7#1)(1993-9#2)(1994-2#4)(1994-3#4)(1994-5#6)(1994-8#2)(1995-10#1)(1995-11#1)(1995-12#6)(1995-5#2)(1995-6#2)(1995-7#2)(1995-8#1)(1996-1#2)(1996-10#4)(1996-11#5)(1996-12#1)(1996-2#4)(1996-4#1)(1996-5#1)(1996-6#3)(1996-9#9)(1997-2#1)(1997-3#6)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#5)(2004-11#1)(2005-5#1)(2005-7#2)(2006-11#2)(2006-12#2)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-4#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#4)(2008-7#4)(2008-8#3)(2008-9#4)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#4)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-12#5)(2010-2#2)(2010-3#2)(2010-5#1)(2010-7#3)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#3)(2013-8#2)
the median MoM##2##3##(1996-12#2)
the median P##2##3##(2008-10#2)
the median SP1 (0##2##4##(1995-8#2)
the median UIE level##2##4##(2006-10#2)
the median age of##2##4##(1992-8#1)(2007-2#1)
the median age##5##3##(1992-4#1)(1992-8#1)(2007-2#1)(2007-9#1)(2013-1#1)
the median and##2##3##(1997-8#1)(2012-3#1)
the median diastolic##2##3##(1992-8#2)
the median domain##6##3##(2007-12#6)
the median duration of##2##4##(2008-7#1)(2010-12#1)
the median duration##3##3##(2008-6#1)(2008-7#1)(2010-12#1)
the median eminence##6##3##(1993-7#1)(1994-10#1)(1994-2#1)(1994-9#1)(1995-12#1)(1996-8#1)
the median filter##3##3##(1996-12#3)
the median follow-up of##3##4##(1992-5#1)(2006-6#1)(2012-12#1)
the median follow-up##5##3##(1990-2#1)(1992-5#1)(1993-11#1)(2006-6#1)(2012-12#1)
the median in##3##3##(1991-7#2)(1997-5#1)
the median nerve was##2##4##(2008-9#1)(2011-2#1)
the median nerve with##2##4##(2008-9#2)
the median nerve##15##3##(1992-6#1)(1994-11#1)(2006-3#2)(2008-9#9)(2011-2#2)
the median of the##2##4##(1997-5#1)(2004-3#1)
the median preoptic nucleus##2##4##(1991-8#1)(1997-8#1)
the median raphe nucleus##5##4##(1991-2#1)(1993-12#2)(1994-12#2)
the median raphe##7##3##(1991-2#2)(1993-12#2)(1994-12#2)(1996-4#1)
the median reservoir/accessory gland##3##4##(2004-2#3)
the median survival of##2##4##(1990-10#1)(1992-9#1)
the median survival time##4##4##(1996-1#2)(2007-11#1)(2009-8#1)
the median survival was##3##4##(1990-10#2)(1997-5#1)
the median survival when the KPS was &gt##2##8##(2008-5#2)
the median survival##13##3##(1990-10#3)(1990-4#1)(1992-9#1)(1996-1#2)(1997-5#1)(2007-11#1)(2008-10#1)(2008-5#2)(2009-8#1)
the median time to progression was##2##6##(1993-1#1)(2010-12#1)
the median time to##4##4##(1993-1#1)(2006-12#1)(2008-6#1)(2010-12#1)
the median total##2##3##(1994-3#1)(2008-10#1)
the median value was##2##4##(2011-2#2)
the median value##6##3##(1993-11#1)(2006-5#2)(2007-7#1)(2011-2#2)
the median values for##2##4##(2004-1#1)(2006-5#1)
the median values##4##3##(1995-6#1)(2004-1#1)(2006-5#1)(2013-8#1)
the median waiting time was##2##5##(2006-8#2)
the median##163##2##(1990-1#1)(1990-10#3)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-6#1)(1991-7#2)(1991-8#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#2)(1993-7#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#3)(1996-1#3)(1996-12#6)(1996-4#1)(1996-5#1)(1996-8#1)(1997-5#3)(1997-8#2)(2004-1#1)(2004-2#3)(2004-3#1)(2006-10#4)(2006-12#2)(2006-3#2)(2006-5#3)(2006-6#1)(2006-8#2)(2007-11#1)(2007-12#7)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#3)(2008-10#6)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#9)(2009-8#2)(2010-12#2)(2010-2#2)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
the medians##2##2##(1990-8#1)(2012-1#1)
the mediastinal##7##2##(1991-11#1)(1992-8#1)(2007-8#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-7#1)
the mediastinum and##4##3##(2007-8#1)(2008-6#1)(2008-9#1)(2012-2#1)
the mediastinum was##2##3##(1990-8#1)(1997-3#1)
the mediastinum##30##2##(1990-8#3)(1991-8#2)(1991-9#1)(1997-3#1)(2004-1#2)(2006-11#1)(2007-8#6)(2008-11#1)(2008-6#4)(2008-9#1)(2009-5#1)(2010-12#1)(2011-2#2)(2012-1#2)(2012-2#2)
the mediated##2##2##(1996-11#1)(2010-2#1)
the mediating role of##4##4##(2009-5#1)(2010-2#1)(2012-1#1)(2012-3#1)
the mediating##9##2##(2006-10#1)(2009-5#1)(2009-7#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
the mediation of central nervous system##2##6##(1995-12#1)(1997-4#1)
the mediation of##22##3##(1990-12#1)(1991-1#2)(1991-11#1)(1991-2#1)(1992-4#1)(1992-8#1)(1993-2#1)(1994-10#1)(1995-12#1)(1996-1#1)(1997-1#2)(1997-4#1)(1997-8#2)(2006-10#1)(2008-11#1)(2008-4#2)(2009-3#1)(2011-2#1)
the mediation process##2##3##(2006-1#1)(2010-2#1)
the mediation##27##2##(1990-12#1)(1991-1#2)(1991-11#1)(1991-2#1)(1992-4#1)(1992-8#1)(1993-2#1)(1994-10#1)(1995-12#1)(1995-5#1)(1996-1#1)(1997-1#2)(1997-4#1)(1997-8#2)(2006-1#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-4#2)(2009-3#1)(2010-2#2)(2011-2#1)
the mediator of##2##3##(1990-2#1)(2010-5#1)
the mediator##6##2##(1990-2#1)(2008-10#3)(2010-5#2)
the mediators and##2##3##(2006-6#1)(2008-1#1)
the mediators of##3##3##(1994-3#1)(2009-3#1)(2010-2#1)
the mediators##11##2##(1994-3#1)(1997-4#1)(2006-10#1)(2006-6#1)(2008-1#1)(2008-10#2)(2009-3#1)(2009-7#2)(2010-2#1)
the medical and health##2##4##(2009-10#1)(2013-8#1)
the medical and nursing##3##4##(2007-11#1)(2007-9#1)(2013-8#1)
the medical and public health##2##5##(1997-3#1)(2013-8#1)
the medical and surgical##3##4##(1993-3#1)(2007-7#1)(2013-7#1)
the medical and##23##3##(1991-1#1)(1991-11#1)(1993-3#1)(1997-3#1)(2006-4#1)(2007-11#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-11#2)(2010-4#1)(2013-7#1)(2013-8#4)
the medical care and public health##2##6##(1995-2#1)(2013-8#1)
the medical care system##5##4##(1995-12#3)(1997-3#1)(2005-11#1)
the medical care##12##3##(1991-12#1)(1991-6#1)(1995-12#3)(1995-2#1)(1996-12#1)(1997-3#1)(2005-11#1)(2007-7#1)(2010-3#1)(2013-8#1)
the medical charts of##2##4##(2008-6#1)(2013-8#1)
the medical college##2##3##(2012-2#1)(2012-3#1)
the medical community to##2##4##(2008-3#1)(2008-5#1)
the medical community##22##3##(1990-12#1)(1993-6#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-8#2)(2009-4#1)(2010-6#1)(2010-8#1)(2011-12#1)(2013-1#3)
the medical course##2##3##(1991-2#1)(2007-2#1)
the medical curriculum##6##3##(2007-2#3)(2010-12#2)(2011-12#1)
the medical device industry##2##4##(2005-10#1)(2006-5#1)
the medical devices##2##3##(2008-11#2)
the medical disorder##2##3##(2012-2#2)
the medical doctors##2##3##(1996-12#1)(1997-8#1)
the medical establishment##2##3##(1993-3#1)(2006-2#1)
the medical evaluation##2##3##(2006-9#1)(2011-2#1)
the medical examination##2##3##(1995-11#1)(2008-4#1)
the medical examiner##3##3##(1995-3#1)(2005-8#1)(2011-2#1)
the medical expenditure##2##3##(2010-8#2)
the medical field##7##3##(1991-3#1)(1994-2#1)(2008-2#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
the medical files##2##3##(2008-11#1)(2011-2#1)
the medical group##5##3##(1991-1#1)(1993-12#1)(1993-6#1)(1994-3#2)
the medical health##2##3##(2006-10#1)(2008-7#1)
the medical history##7##3##(1994-6#1)(2006-8#1)(2007-9#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-1#1)
the medical implant and the##2##5##(2010-4#2)
the medical indications##2##3##(1993-11#1)(2007-11#1)
the medical industrial complex##2##4##(2011-1#2)
the medical industry##3##3##(1995-2#1)(2006-6#1)(2007-2#1)
the medical interview##3##3##(1992-12#1)(1996-12#1)(2010-12#1)
the medical journals##2##3##(2006-10#1)(2006-4#1)
the medical literature and##4##4##(1996-9#1)(2006-10#1)(2008-12#1)(2010-2#1)
the medical literature of##2##4##(1991-9#1)(2006-12#1)
the medical literature regarding##3##4##(2007-4#1)(2008-6#1)(2013-1#1)
the medical literature##39##3##(1990-8#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-6#1)(1993-9#2)(1996-9#1)(2006-10#2)(2006-12#1)(2007-12#1)(2007-4#2)(2007-5#4)(2007-7#2)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#1)(2010-2#2)(2010-6#4)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
the medical management of the##2##5##(2007-9#1)(2012-2#1)
the medical management of##7##4##(1991-2#1)(2007-9#1)(2008-4#1)(2009-9#1)(2012-2#2)(2013-8#1)
the medical management##9##3##(1991-2#1)(1992-9#1)(2007-9#1)(2008-4#1)(2008-9#1)(2009-9#1)(2012-2#2)(2013-8#1)
the medical model##2##3##(1996-12#1)(2009-10#1)
the medical officer##2##3##(1993-8#1)(2007-2#1)
the medical or##2##3##(2006-2#1)(2008-12#1)
the medical perspective##2##3##(2011-7#1)(2012-2#1)
the medical practice##2##3##(1996-2#1)(1997-3#1)
the medical profession and the##3##5##(2008-7#1)(2009-10#1)(2010-1#1)
the medical profession has##2##4##(1990-1#1)(1991-3#1)
the medical profession##24##3##(1990-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-10#1)(1995-11#1)(1996-11#1)(2005-11#1)(2005-12#1)(2007-4#1)(2008-12#3)(2008-7#5)(2009-10#1)(2009-5#1)(2010-1#1)(2012-2#2)(2013-1#1)
the medical professions##2##3##(2008-8#1)(2012-3#1)
the medical provider##3##3##(2013-1#3)
the medical record was##2##4##(2004-12#1)(2013-1#1)
the medical record##12##3##(1990-12#1)(1991-6#1)(1992-3#1)(1996-2#1)(2004-12#1)(2007-10#1)(2007-12#2)(2008-7#1)(2013-1#3)
the medical records and##2##4##(1993-1#1)(2010-4#1)
the medical records of patients with##3##6##(2008-6#1)(2012-12#1)(2012-2#1)
the medical records of##12##4##(1990-2#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the medical records##21##3##(1990-2#1)(1991-1#1)(1991-7#1)(1993-1#1)(1994-3#1)(1994-8#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the medical resources##2##3##(1990-6#1)(2007-11#1)
the medical response to##2##4##(2004-7#1)(2006-4#1)
the medical school of the##2##5##(2012-3#1)(2013-1#1)
the medical school##8##3##(1995-4#1)(2008-3#1)(2012-3#5)(2013-1#1)
the medical science of##2##4##(1994-3#1)(2009-7#1)
the medical science##3##3##(1994-3#1)(2009-7#1)(2010-12#1)
the medical service##2##3##(1993-12#1)(1995-12#1)
the medical services for##2##4##(1996-12#1)(2010-8#1)
the medical services##4##3##(1994-2#1)(1996-11#1)(1996-12#1)(2010-8#1)
the medical specialist##2##3##(1992-5#1)(2009-10#1)
the medical staff as##2##4##(1991-3#1)(1994-3#1)
the medical staff in##2##4##(1994-2#1)(2012-2#1)
the medical staff##22##3##(1991-3#2)(1992-2#3)(1993-1#1)(1993-2#2)(1993-3#1)(1994-1#1)(1994-2#3)(1994-3#1)(1997-1#1)(2004-4#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-8#1)(2012-2#2)
the medical students##7##3##(1993-3#1)(2006-10#2)(2008-4#1)(2009-4#1)(2011-1#1)(2012-2#1)
the medical system##2##3##(2007-11#1)(2011-2#1)
the medical team##6##3##(1997-1#1)(2005-7#1)(2008-6#1)(2012-12#1)(2012-2#1)(2013-8#1)
the medical termination of##2##4##(1995-8#2)
the medical treatment of##12##4##(1992-9#1)(1994-2#1)(1994-9#1)(1995-4#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#1)(2009-5#1)(2011-2#2)(2013-8#1)
the medical treatment##15##3##(1992-9#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-4#1)(2006-10#1)(2006-12#1)(2007-11#2)(2008-10#1)(2009-5#1)(2010-3#1)(2011-2#2)(2013-8#1)
the medical##460##2##(1990-1#1)(1990-10#2)(1990-12#4)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#3)(1991-11#2)(1991-12#4)(1991-2#3)(1991-3#5)(1991-4#1)(1991-6#3)(1991-7#1)(1991-9#2)(1992-10#2)(1992-12#2)(1992-2#4)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#3)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#5)(1993-6#5)(1993-7#1)(1993-8#2)(1993-9#2)(1994-1#2)(1994-2#7)(1994-3#6)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#3)(1995-12#4)(1995-2#3)(1995-3#1)(1995-4#2)(1995-5#1)(1995-7#1)(1995-8#3)(1996-11#5)(1996-12#6)(1996-2#2)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#4)(1997-4#2)(1997-8#1)(2004-12#1)(2004-4#1)(2004-5#1)(2004-7#2)(2005-10#1)(2005-11#2)(2005-12#2)(2005-7#1)(2005-8#1)(2006-10#10)(2006-12#2)(2006-2#3)(2006-4#4)(2006-5#1)(2006-6#2)(2006-8#5)(2006-9#3)(2007-10#2)(2007-11#8)(2007-12#7)(2007-2#9)(2007-4#4)(2007-5#9)(2007-7#7)(2007-8#2)(2007-9#3)(2008-1#4)(2008-10#7)(2008-11#9)(2008-12#9)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#5)(2008-7#13)(2008-8#7)(2008-9#4)(2009-10#8)(2009-11#3)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#5)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#7)(2010-2#3)(2010-3#2)(2010-4#4)(2010-6#5)(2010-8#5)(2010-9#1)(2011-1#5)(2011-12#3)(2011-2#21)(2011-7#1)(2012-12#6)(2012-2#17)(2012-3#11)(2013-1#16)(2013-7#1)(2013-8#14)
the medical-legal discourse##2##3##(2009-7#2)
the medical-legal##3##2##(1994-1#1)(2009-7#2)
the medicalization##2##2##(2006-8#1)(2009-10#1)
the medically##5##2##(1992-2#1)(1992-3#1)(2007-11#1)(2008-1#1)(2013-8#1)
the medicare##3##2##(1994-1#1)(2007-4#1)(2007-9#1)
the medication and##2##3##(1994-4#1)(2007-7#1)
the medication group##2##3##(2008-3#2)
the medication in##3##3##(1996-9#1)(2013-1#2)
the medication is##2##3##(1990-5#1)(2006-9#1)
the medication prescribed##2##3##(2010-5#2)
the medication##42##2##(1990-5#1)(1992-12#3)(1994-4#1)(1995-2#1)(1996-9#1)(1997-2#1)(2006-12#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-7#1)(2008-11#3)(2008-12#1)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2010-5#2)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
the medications used##2##3##(2008-10#1)(2010-12#1)
the medications##10##2##(1992-12#1)(2006-10#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-1#1)
the medicinal plant##2##3##(2006-12#1)(2008-10#1)
the medicinal properties of##3##4##(2008-3#1)(2011-2#1)(2012-2#1)
the medicinal##9##2##(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-6#1)(2011-2#2)(2012-2#1)
the medicine##7##2##(1994-3#1)(1996-11#1)(1996-3#1)(2006-10#1)(2008-11#1)(2010-8#1)(2012-3#1)
the medicines##3##2##(2005-10#1)(2008-11#1)(2011-1#1)
the medieval##2##2##(2008-3#1)(2013-8#1)
the mediodorsal thalamic nucleus##2##4##(1996-5#1)(1997-2#1)
the mediodorsal##3##2##(1996-5#1)(1997-2#2)
the mediterranean##2##2##(2010-2#1)(2012-12#1)
the medium (0##2##3##(1992-8#1)(2007-8#1)
the medium SPM##2##3##(2012-2#2)
the medium and distal third of##2##6##(2006-2#2)
the medium and distal third##3##5##(2006-2#3)
the medium and the##5##4##(1994-8#1)(2007-12#1)(2008-10#2)(2011-2#1)
the medium and##29##3##(1991-8#1)(1993-8#1)(1994-8#1)(1994-9#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-7#1)(2006-2#3)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-4#1)(2008-7#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-4#1)(2013-1#1)
the medium as##2##3##(1992-3#1)(2008-3#1)
the medium by##4##3##(1990-3#1)(1991-3#1)(2007-12#2)
the medium can##3##3##(2008-11#1)(2008-3#1)(2012-1#1)
the medium composition##5##3##(1997-6#1)(2008-11#3)(2008-6#1)
the medium conditioned by##2##4##(1994-5#1)(2008-11#1)
the medium containing human serum and basic fibroblast growth factor##2##10##(2008-11#2)
the medium containing only##3##4##(2008-11#3)
the medium containing##19##3##(1996-11#3)(1997-8#1)(2006-12#1)(2007-12#1)(2008-11#9)(2008-5#1)(2008-6#2)(2013-1#1)
the medium during the##2##4##(2008-10#1)(2008-5#1)
the medium during##3##3##(1993-9#1)(2008-10#1)(2008-5#1)
the medium formulation##2##3##(2008-11#2)
the medium from##2##3##(1991-9#1)(2008-3#1)
the medium had##3##3##(1991-1#1)(1993-3#1)(2008-7#1)
the medium in the##3##4##(1991-7#1)(2005-12#1)(2006-3#1)
the medium in##5##3##(1990-12#1)(1991-7#1)(2005-12#1)(2006-3#1)(2008-2#1)
the medium is##8##3##(1991-5#1)(1994-6#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2011-1#1)
the medium of the##2##4##(1992-6#1)(2008-3#1)
the medium of##18##3##(1991-1#1)(1991-11#1)(1991-5#1)(1992-5#1)(1992-6#2)(1993-3#1)(1994-11#1)(1994-12#1)(1995-12#1)(1996-9#1)(2005-12#1)(2005-4#1)(2007-10#1)(2008-10#2)(2008-3#2)
the medium or##3##3##(1995-11#1)(2008-10#1)(2008-5#1)
the medium pH##2##3##(2008-10#2)
the medium perfusion rate##3##4##(2008-11#3)
the medium scattering coefficient##2##4##(2008-2#2)
the medium surface##3##3##(2005-11#1)(2008-2#1)(2008-3#1)
the medium term##6##3##(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2010-5#1)(2013-7#1)
the medium to##5##3##(1996-7#1)(2006-4#1)(2008-11#2)(2008-3#1)
the medium used##2##3##(2008-10#1)(2008-5#1)
the medium was increased##4##4##(2008-11#1)(2008-3#1)(2008-7#1)(2010-2#1)
the medium was##22##3##(1990-2#1)(1991-12#1)(1991-2#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1995-2#1)(1995-5#1)(1995-6#1)(2007-8#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-2#1)
the medium were##2##3##(1996-2#1)(2008-10#1)
the medium with 1##2##4##(2008-8#2)
the medium with##11##3##(1991-1#1)(1992-5#1)(1993-12#1)(2006-11#1)(2008-11#3)(2008-6#1)(2008-7#1)(2008-8#2)
the medium without##3##3##(1991-9#1)(1992-6#1)(2008-11#1)
the medium##376##2##(1990-12#2)(1990-2#2)(1990-3#5)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#4)(1991-11#1)(1991-12#2)(1991-2#5)(1991-3#4)(1991-5#4)(1991-7#2)(1991-8#1)(1991-9#3)(1992-11#2)(1992-12#4)(1992-3#5)(1992-5#2)(1992-6#5)(1992-8#4)(1993-11#3)(1993-12#5)(1993-3#6)(1993-6#2)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#9)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#4)(1994-9#3)(1995-1#1)(1995-10#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#2)(1996-1#1)(1996-10#1)(1996-11#3)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#3)(1996-9#2)(1997-2#7)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#1)(2004-9#2)(2005-11#2)(2005-12#4)(2005-4#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-2#3)(2006-3#3)(2006-4#1)(2006-5#2)(2007-10#2)(2007-11#2)(2007-12#12)(2007-2#1)(2007-3#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#24)(2008-11#46)(2008-12#2)(2008-2#22)(2008-3#24)(2008-4#2)(2008-5#9)(2008-6#11)(2008-7#7)(2008-8#4)(2008-9#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-5#2)(2011-1#3)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-4#1)(2012-7#1)(2013-1#3)(2013-7#4)
the medium- and##3##3##(1995-11#1)(2008-10#1)(2011-2#1)
the medium-term##2##2##(2008-4#1)(2011-2#1)
the medulla and##2##3##(2008-5#2)
the medulla oblongata##9##3##(1991-11#1)(1991-9#3)(1996-1#1)(1996-9#1)(1997-2#1)(2007-9#2)
the medulla showed##2##3##(1993-12#1)(1997-5#1)
the medulla terminalis##2##3##(2007-12#1)(2008-5#1)
the medulla##29##2##(1991-11#3)(1991-8#2)(1991-9#3)(1993-12#1)(1993-7#1)(1995-3#1)(1995-7#1)(1996-1#1)(1996-9#1)(1997-2#1)(1997-5#2)(1997-8#2)(2007-1#1)(2007-12#1)(2007-9#2)(2008-5#4)(2010-9#1)(2012-12#1)
the medullary cavity##6##3##(1995-6#1)(2010-3#1)(2013-1#4)
the medullary nucleus raphe magnus##2##5##(1991-3#2)
the medullary respiratory##2##3##(1990-7#1)(1992-8#1)
the medullary thick ascending limb of Henle's loop##2##8##(1991-1#1)(2007-7#1)
the medullary##29##2##(1990-7#1)(1991-1#1)(1991-11#1)(1991-3#2)(1991-8#1)(1992-8#2)(1993-7#2)(1995-5#2)(1995-6#1)(1995-7#1)(1996-9#3)(1997-5#1)(1997-8#1)(2006-6#1)(2007-1#1)(2007-7#1)(2008-1#1)(2010-3#1)(2013-1#5)
the meeting and##4##3##(2005-9#1)(2008-10#1)(2008-5#1)(2009-5#1)
the meeting of the##3##4##(2005-11#1)(2008-8#1)(2009-5#1)
the meeting was##16##3##(1994-9#1)(2005-6#1)(2005-7#1)(2005-8#7)(2007-11#2)(2008-5#3)(2008-7#1)
the meeting were##3##3##(2005-8#3)
the meeting with##2##3##(1992-8#1)(2012-3#1)
the meeting##73##2##(1992-8#1)(1994-9#1)(1995-6#1)(1997-8#1)(2004-12#2)(2005-11#1)(2005-6#1)(2005-7#4)(2005-8#21)(2005-9#3)(2006-11#7)(2006-7#1)(2007-11#2)(2007-4#1)(2007-7#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#9)(2008-7#2)(2008-8#1)(2009-5#2)(2010-11#4)(2012-3#1)
the meetings##2##2##(1993-11#1)(1993-3#1)
the megahertz range##2##3##(2008-2#1)(2008-3#1)
the meiosis##2##2##(2008-9#1)(2012-2#1)
the meiotic cell cycle##4##4##(1995-6#1)(2006-10#1)(2008-5#1)(2008-9#1)
the meiotic##8##2##(1995-6#1)(2006-10#1)(2007-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2013-7#1)
the melanin content##2##3##(1994-3#1)(2013-1#1)
the melanin##3##2##(1992-8#1)(1994-3#1)(2013-1#1)
the melanin-concentrating hormone##2##3##(1993-5#1)(1994-2#1)
the melanocortin receptor##2##3##(1990-5#2)
the melanocortin##7##2##(1990-5#2)(1995-12#2)(2008-10#1)(2008-5#1)(2008-9#1)
the melanocortin-1 receptor##2##3##(2006-12#1)(2012-11#1)
the melanocyte##3##2##(2006-11#1)(2006-12#1)(2008-5#1)
the melanocytes##4##2##(1994-12#1)(1994-3#1)(1995-2#1)(2008-5#1)
the melanogenesis##2##2##(2008-11#1)(2008-5#1)
the melanogenic##4##2##(1995-2#1)(2008-11#1)(2008-5#2)
the melanoma cell lines##2##4##(1991-9#1)(2010-7#1)
the melanoma##11##2##(1991-9#1)(1995-8#2)(2007-10#1)(2008-3#1)(2008-5#2)(2008-9#1)(2010-7#2)(2011-2#1)
the melanosome transfer##3##3##(2008-8#2)(2012-12#1)
the melanosome##4##2##(2008-8#2)(2012-12#2)
the melanotrope cells##5##3##(1993-2#1)(1993-5#4)
the melanotrope##6##2##(1993-2#2)(1993-5#4)
the melatonin biosynthesis in the mammalian pineal organ##2##8##(1994-5#2)
the melatonin biosynthesis in##3##4##(1994-5#3)
the melatonin biosynthesis##4##3##(1994-5#4)
the melatonin receptor##6##3##(1994-9#3)(1995-3#2)(2009-12#1)
the melatonin##15##2##(1992-3#1)(1994-5#5)(1994-9#3)(1995-3#2)(2008-10#1)(2008-12#1)(2009-12#1)(2013-1#1)
the melittin##2##2##(1991-2#1)(1991-9#1)
the melodies##2##2##(1994-2#1)(2012-1#1)
the melon aphid##2##3##(2008-10#2)
the melt pool##2##3##(2008-3#2)
the melt##7##2##(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#2)
the melting curves of##2##4##(1993-3#1)(2006-10#1)
the melting curves##3##3##(1993-3#1)(1997-7#1)(2006-10#1)
the melting method##2##3##(2007-12#2)
the melting point##5##3##(1993-8#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-5#1)
the melting profiles of the##2##5##(1994-3#1)(2006-10#1)
the melting temperature of##2##4##(2008-4#1)(2009-3#1)
the melting temperature##6##3##(1995-6#2)(2007-11#1)(2008-4#1)(2009-3#1)(2009-5#1)
the melting##24##2##(1992-3#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-6#2)(1997-7#2)(2005-11#2)(2006-10#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2009-3#1)(2009-5#1)(2013-8#1)
the members of a##5##4##(2007-7#2)(2008-9#1)(2010-7#1)(2011-2#1)
the members of the family##2##5##(2007-7#1)(2008-4#1)
the members of the genus##2##5##(2008-10#1)(2011-2#1)
the members of the team##2##5##(2006-8#1)(2007-8#1)
the members of the##21##4##(1990-12#1)(1990-8#1)(1993-12#1)(1994-7#1)(1994-9#1)(1995-4#1)(1996-3#1)(1997-6#1)(1997-8#1)(2005-7#2)(2006-8#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#2)(2010-5#1)(2011-2#1)
the members of this##4##4##(1993-6#1)(1994-8#1)(1996-8#1)(2010-3#1)
the members of##41##3##(1990-12#1)(1990-8#1)(1991-11#1)(1991-2#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-4#1)(1996-3#1)(1996-8#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-7#2)(2006-8#1)(2007-12#1)(2007-7#4)(2007-8#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-9#2)(2009-8#1)(2010-3#1)(2010-5#1)(2010-7#2)(2011-2#2)(2012-2#1)(2013-8#1)
the members##44##2##(1990-12#1)(1990-8#1)(1991-11#1)(1991-2#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-4#2)(1996-3#1)(1996-8#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-7#2)(2006-2#1)(2006-8#1)(2007-12#1)(2007-7#4)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-8#1)(2010-3#1)(2010-5#1)(2010-7#2)(2011-2#2)(2012-2#1)(2013-8#1)
the membership function values##2##4##(2010-8#2)
the membership to##2##3##(2007-4#1)(2011-1#1)
the membership##10##2##(1994-3#2)(2007-4#1)(2008-11#1)(2008-2#1)(2009-4#1)(2010-10#1)(2010-8#2)(2011-1#1)
the membrane anchor##3##3##(1994-8#2)(1997-7#1)
the membrane and consequently##2##4##(2005-7#1)(2013-7#1)
the membrane and the##9##4##(1990-11#1)(1990-4#1)(1992-3#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-5#1)
the membrane and##34##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-11#1)(1992-3#2)(1994-11#1)(1994-2#2)(1994-5#1)(1995-6#1)(1996-11#1)(1996-8#1)(1997-4#1)(2005-7#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-5#1)(2013-7#1)
the membrane are##5##3##(1994-12#1)(1995-6#1)(1997-1#1)(2006-10#1)(2008-10#1)
the membrane as##3##3##(1996-8#1)(1997-7#1)(2006-10#1)
the membrane association##2##3##(1991-8#1)(1992-6#1)
the membrane at##3##3##(1995-11#1)(1997-7#1)(2008-8#1)
the membrane bilayer##6##3##(1991-11#1)(1991-4#1)(1991-9#1)(1994-11#1)(1994-2#1)(1997-4#1)
the membrane binding domain##2##4##(1995-6#1)(2006-12#1)
the membrane binding protein##2##4##(1990-5#2)
the membrane binding##6##3##(1990-5#2)(1992-12#1)(1994-11#1)(1995-6#1)(2006-12#1)
the membrane by the action of##2##6##(1992-5#1)(1993-8#1)
the membrane by the##4##4##(1992-5#1)(1993-8#1)(1994-8#1)(2008-10#1)
the membrane by##9##3##(1992-5#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-8#1)(2007-2#1)(2008-10#1)(2008-4#1)(2010-5#1)
the membrane can be##3##4##(2008-10#2)(2008-2#1)
the membrane can##4##3##(2008-10#3)(2008-2#1)
the membrane conductance##3##3##(1991-5#1)(1995-7#1)(1997-1#1)
the membrane current##2##3##(1990-11#1)(1993-12#1)
the membrane domain##2##3##(1992-11#1)(1997-6#1)
the membrane during##4##3##(1996-5#1)(1997-7#1)(2012-2#1)(2013-7#1)
the membrane electrode##2##3##(2008-10#2)
the membrane environment##4##3##(1990-7#1)(1991-2#1)(1991-5#1)(1993-6#1)
the membrane fluidity of##3##4##(1992-8#2)(2008-9#1)
the membrane fluidity##5##3##(1991-9#2)(1992-8#2)(2008-9#1)
the membrane for##2##3##(1995-10#1)(2008-10#1)
the membrane form of##2##4##(1993-9#1)(1994-12#1)
the membrane fraction of##5##4##(1990-11#1)(1990-3#1)(1991-3#1)(1991-7#1)(1996-5#1)
the membrane fraction was##3##4##(1991-1#1)(1991-2#1)(1995-5#1)
the membrane fraction##29##3##(1990-11#1)(1990-2#1)(1990-3#1)(1991-1#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#2)(1992-3#1)(1992-6#2)(1993-12#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-5#4)(1996-11#1)(1996-5#2)(1997-6#3)(2008-11#1)(2010-3#1)
the membrane fusion##3##3##(1991-5#1)(1993-3#1)(2005-7#1)
the membrane has been##2##4##(2007-8#1)(2008-10#1)
the membrane having##3##3##(2008-10#3)
the membrane in a##5##4##(1991-2#1)(1994-6#1)(2008-4#2)(2012-2#1)
the membrane in the##2##4##(1990-11#1)(1992-12#1)
the membrane in##16##3##(1990-11#1)(1990-3#1)(1991-2#1)(1992-12#1)(1993-11#1)(1994-6#1)(1994-9#1)(1995-1#1)(1996-2#1)(2005-11#1)(2008-4#2)(2009-11#1)(2009-9#1)(2011-1#1)(2012-2#1)
the membrane inhibitor of reactive lysis##2##6##(1991-3#1)(2008-4#1)
the membrane integrity##2##3##(1993-4#1)(2008-10#1)
the membrane interface##3##3##(1991-3#1)(1997-1#1)(2008-10#1)
the membrane into the##2##4##(2007-8#1)(2008-7#1)
the membrane into##3##3##(1994-8#1)(2007-8#1)(2008-7#1)
the membrane is the##2##4##(1990-4#1)(2011-1#1)
the membrane is washed and the antibody-antigen complexes are identified with horseradish peroxidase (HRPO) or alkaline phosphatase enzymes coupled to the secondary anti-IgG antibody (e##2##25##(2008-4#2)
the membrane is##11##3##(1990-4#1)(1992-1#1)(1992-12#1)(1994-6#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-4#2)(2010-5#1)(2011-1#1)
the membrane labyrinth##4##3##(2007-12#4)
the membrane lipid bilayer##3##4##(1990-7#1)(1992-6#1)(1993-3#1)
the membrane lipid##6##3##(1990-7#1)(1991-9#1)(1992-6#1)(1993-3#1)(1994-11#1)(2009-7#1)
the membrane lipids##3##3##(1990-3#1)(1994-11#1)(1997-1#1)
the membrane localization##2##3##(2008-8#1)(2012-2#1)
the membrane matrix##3##3##(1990-4#1)(1996-8#1)(2012-2#1)
the membrane of Escherichia coli##2##5##(1991-10#1)(2008-10#1)
the membrane of a##2##4##(1995-8#1)(2009-2#1)
the membrane of the endoplasmic reticulum (ER)##2##7##(1995-3#1)(1997-1#1)
the membrane of the endoplasmic reticulum##3##6##(1992-6#1)(1995-3#1)(1997-1#1)
the membrane of the##14##4##(1990-12#2)(1990-5#1)(1992-6#1)(1993-6#1)(1993-8#1)(1995-11#1)(1995-3#1)(1996-12#1)(1997-1#1)(2007-11#1)(2007-5#1)(2008-8#1)(2008-9#1)
the membrane of##37##3##(1990-12#2)(1990-5#1)(1991-10#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-2#2)(1994-6#1)(1994-8#2)(1995-11#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#2)(1997-1#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)
the membrane orientation of##2##4##(1996-7#2)
the membrane other than##2##4##(1992-11#1)(1992-6#1)
the membrane permeability to##2##4##(1990-5#1)(2008-8#1)
the membrane permeability##7##3##(1990-5#1)(1991-2#1)(1992-6#1)(1994-10#1)(1997-1#1)(2005-11#1)(2008-8#1)
the membrane phospholipids##2##3##(1994-8#1)(2011-2#1)
the membrane pore##2##3##(1997-6#1)(2008-7#1)
the membrane pores##2##3##(2005-11#1)(2008-4#1)
the membrane potential and Ca2+##2##5##(1990-8#1)(1994-11#1)
the membrane potential and##3##4##(1990-8#1)(1994-11#1)(1994-8#1)
the membrane potential in##4##4##(1990-3#1)(1993-12#2)(2009-2#1)
the membrane potential of##2##4##(1990-5#1)(2008-9#1)
the membrane potential##31##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-9#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#3)(1993-2#1)(1994-10#1)(1994-11#1)(1994-8#1)(1995-3#1)(1997-1#1)(1997-7#1)(2005-11#1)(2008-9#1)(2009-2#2)(2013-8#1)
the membrane potentials##2##3##(1993-12#1)(2009-2#1)
the membrane properties of##2##4##(1991-5#1)(1991-8#1)
the membrane protein##4##3##(1992-4#1)(2006-10#1)(2011-2#2)
the membrane proteins##7##3##(1990-4#1)(1991-2#1)(1993-4#1)(1993-8#1)(1994-8#1)(2008-4#1)(2008-7#1)
the membrane recycling hypothesis##3##4##(1997-1#3)
the membrane resistance##3##3##(1991-2#1)(2008-4#1)(2010-2#1)
the membrane samples##2##3##(2005-11#1)(2008-11#1)
the membrane sensor has been##2##5##(2008-10#2)
the membrane sensor has##3##4##(2008-10#3)
the membrane skeleton##7##3##(1990-3#1)(1991-7#1)(1993-3#1)(1993-4#1)(1994-12#1)(2007-9#1)(2009-7#1)
the membrane spanning region##3##4##(1991-12#2)(1994-9#1)
the membrane structure##3##3##(1991-2#1)(2005-11#1)(2009-7#1)
the membrane surface into##2##4##(1993-3#1)(2010-4#1)
the membrane surface of##3##4##(1990-12#1)(2006-10#1)(2012-2#1)
the membrane surface##24##3##(1990-11#1)(1990-12#1)(1990-2#1)(1991-4#1)(1991-9#1)(1992-1#2)(1992-9#1)(1993-3#1)(1994-11#2)(1994-2#1)(1994-5#1)(1996-9#1)(1997-2#1)(1997-7#1)(2005-11#1)(2006-10#4)(2008-5#1)(2010-4#1)(2012-2#1)
the membrane through a##2##4##(1990-2#1)(1996-3#1)
the membrane time constant##2##4##(1993-2#1)(2011-2#1)
the membrane to##3##3##(1990-7#1)(1997-7#1)(2008-10#1)
the membrane topology of proteins##2##5##(1997-7#2)
the membrane topology of##5##4##(1992-11#1)(1994-2#1)(1994-9#1)(1997-7#2)
the membrane vesicles##3##3##(1990-2#1)(1990-5#1)(1993-6#1)
the membrane was##17##3##(1990-3#1)(1991-3#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-11#1)(1996-5#1)(2005-11#1)(2008-10#5)(2008-4#1)(2008-5#2)(2011-2#1)
the membrane were##3##3##(1990-2#1)(2005-11#1)(2006-10#1)
the membrane where##2##3##(1996-1#1)(1997-6#1)
the membrane with the##2##4##(2005-10#1)(2008-10#1)
the membrane with##5##3##(1992-11#1)(2005-10#1)(2008-10#2)(2008-5#1)
the membrane##678##2##(1990-10#1)(1990-11#11)(1990-12#7)(1990-2#11)(1990-3#13)(1990-4#9)(1990-5#12)(1990-6#2)(1990-7#10)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#3)(1991-11#2)(1991-12#2)(1991-2#11)(1991-3#6)(1991-4#5)(1991-5#12)(1991-7#5)(1991-8#2)(1991-9#9)(1992-1#5)(1992-11#6)(1992-12#9)(1992-2#1)(1992-3#7)(1992-4#2)(1992-5#1)(1992-6#12)(1992-7#3)(1992-8#3)(1992-9#2)(1993-11#5)(1993-12#9)(1993-2#3)(1993-3#14)(1993-4#6)(1993-6#3)(1993-8#11)(1993-9#2)(1994-10#2)(1994-11#10)(1994-12#12)(1994-2#12)(1994-5#6)(1994-6#4)(1994-8#11)(1994-9#5)(1995-1#3)(1995-10#1)(1995-11#4)(1995-2#3)(1995-3#3)(1995-5#6)(1995-6#7)(1995-7#1)(1995-8#3)(1996-1#6)(1996-10#1)(1996-11#4)(1996-12#2)(1996-2#3)(1996-3#3)(1996-5#11)(1996-7#2)(1996-8#5)(1996-9#1)(1997-1#15)(1997-2#2)(1997-4#7)(1997-6#6)(1997-7#16)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#19)(2005-12#2)(2005-7#3)(2006-10#16)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#8)(2007-2#2)(2007-5#1)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#77)(2008-11#7)(2008-2#5)(2008-3#1)(2008-4#17)(2008-5#12)(2008-7#6)(2008-8#8)(2008-9#6)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#5)(2009-3#2)(2009-5#2)(2009-7#3)(2009-8#2)(2009-9#3)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#6)(2010-5#3)(2011-1#4)(2011-2#6)(2012-12#1)(2012-2#7)(2013-1#1)(2013-7#2)(2013-8#2)
the membrane-active peptides melittin and glucagon##2##6##(1991-2#2)
the membrane-active##3##2##(1991-2#2)(1997-6#1)
the membrane-associated##9##2##(1990-2#1)(1990-5#1)(1992-11#2)(1992-3#1)(1992-4#1)(1993-12#1)(1995-8#1)(2007-1#1)
the membrane-bound form of the##2##5##(1991-5#1)(1995-3#1)
the membrane-bound form of##3##4##(1991-5#1)(1992-2#1)(1995-3#1)
the membrane-bound form##4##3##(1991-5#2)(1992-2#1)(1995-3#1)
the membrane-bound##30##2##(1990-10#1)(1990-11#1)(1990-5#4)(1990-7#3)(1991-2#1)(1991-5#3)(1991-7#1)(1992-1#1)(1992-2#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-8#1)(1997-4#2)(1997-6#1)(1997-7#2)(2005-12#1)(2006-10#1)(2009-7#1)(2011-12#1)
the membrane-forming solution##2##3##(1996-7#2)
the membrane-proximal##2##2##(1995-3#1)(1996-9#1)
the membrane-spanning##2##2##(1990-4#1)(1995-6#1)
the membrane-surface##2##2##(2007-9#2)
the membrane-water interface##2##3##(1990-2#1)(1992-3#1)
the membrane/solution##4##2##(1996-1#1)(2005-11#1)(2008-10#2)
the membranes and the##2##4##(1994-12#1)(1995-5#1)
the membranes and##7##3##(1994-12#1)(1995-5#1)(1995-6#1)(1997-1#1)(2005-11#1)(2008-6#1)(2012-8#1)
the membranes as##2##3##(1995-3#1)(2008-10#1)
the membranes of synaptic vesicles##2##5##(1994-9#1)(2008-8#1)
the membranes of the##3##4##(1996-8#1)(1997-1#1)(2008-10#1)
the membranes of##18##3##(1990-2#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-4#1)(1992-11#1)(1992-4#1)(1993-9#2)(1994-9#1)(1995-2#1)(1996-8#1)(1996-9#1)(1997-1#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-2#1)
the membranes was##4##3##(1990-11#1)(1992-6#1)(2008-5#1)(2009-7#1)
the membranes were##8##3##(1992-3#1)(1993-8#1)(1997-1#1)(2005-11#1)(2008-10#1)(2008-5#2)(2011-2#1)
the membranes with##7##3##(1991-4#1)(1992-7#1)(1993-3#1)(1995-11#1)(1995-7#1)(1997-7#1)(2008-10#1)
the membranes##93##2##(1990-11#3)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#2)(1991-1#1)(1991-10#2)(1991-12#1)(1991-4#2)(1991-9#1)(1992-11#1)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-11#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-7#1)(1996-2#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-1#4)(1997-7#1)(2004-10#1)(2005-11#4)(2006-8#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-8#1)
the membranolytic activity of##2##4##(1997-2#1)(2005-11#1)
the membranolytic##4##2##(1991-9#1)(1997-2#2)(2005-11#1)
the membranous enzyme##2##3##(1991-4#2)
the membranous fraction##2##3##(1992-11#1)(1996-1#1)
the membranous##10##2##(1991-4#2)(1992-11#1)(1993-4#1)(1994-6#1)(1996-1#1)(2006-12#1)(2007-8#1)(2008-7#1)(2010-8#1)
the memory deficits##2##3##(1993-11#1)(1995-5#1)
the memory effect of the weapon##2##6##(2013-7#2)
the memory effect##3##3##(2007-11#1)(2013-7#2)
the memory is##2##3##(2008-2#1)(2008-3#1)
the memory of##6##3##(1990-5#1)(1992-5#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
the memory##31##2##(1990-11#1)(1990-5#1)(1992-5#1)(1993-11#2)(1994-6#1)(1994-8#1)(1995-5#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#4)(2008-9#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#2)
the memory-access time##2##3##(2008-3#2)
the memory-enhancing##2##2##(1993-12#1)(1994-6#1)
the men and##5##3##(1990-5#1)(1994-11#1)(2013-1#1)(2013-8#2)
the men in##2##3##(1995-12#1)(2005-10#1)
the men##20##2##(1990-5#1)(1991-12#2)(1994-11#1)(1995-12#1)(2005-10#1)(2006-8#1)(2007-10#1)(2007-7#2)(2008-4#1)(2009-5#3)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#3)
the men's##2##2##(2008-11#1)(2009-5#1)
the meninges##4##2##(1994-10#1)(2004-12#1)(2008-7#1)(2012-3#1)
the meningioma##3##2##(1995-12#1)(1996-2#1)(2007-12#1)
the meningitis##2##2##(2007-11#1)(2007-2#1)
the meningococcal C conjugate vaccine##2##5##(2010-10#2)
the meningococcal##3##2##(2010-10#3)
the menisci##2##2##(2007-4#1)(2008-5#1)
the meniscus##12##2##(1997-8#2)(2006-10#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#4)(2010-4#2)
the menopause and##2##3##(1991-11#1)(2008-2#1)
the menopause in women##2##4##(2008-12#1)(2008-7#1)
the menopause##11##2##(1991-11#1)(1991-4#1)(1991-9#1)(1993-11#1)(1997-3#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-7#2)(2011-2#1)
the menstrual cycle in women##2##5##(1997-8#1)(2006-10#1)
the menstrual cycle##19##3##(1990-4#1)(1992-7#1)(1994-4#3)(1994-7#1)(1994-9#1)(1997-8#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-4#1)(2009-6#1)(2011-2#3)(2012-3#1)(2013-8#1)
the menstrual##22##2##(1990-4#1)(1992-7#1)(1994-4#3)(1994-7#1)(1994-9#1)(1997-8#1)(2004-10#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-4#2)(2008-7#1)(2009-6#1)(2011-2#3)(2012-3#1)(2013-8#1)
the mental and physical##3##4##(1996-9#1)(2006-10#1)(2010-1#1)
the mental and##7##3##(1995-5#1)(1996-9#1)(2006-10#1)(2010-1#1)(2011-1#2)(2012-3#1)
the mental domain##2##3##(2007-10#2)
the mental health care##3##4##(1997-3#1)(2004-12#1)(2008-2#1)
the mental health field##8##4##(1994-1#1)(1995-1#1)(1997-3#2)(2007-8#2)(2008-11#1)(2008-2#1)
the mental health of##6##4##(2007-3#2)(2007-7#2)(2008-12#1)(2012-12#1)
the mental health system##5##4##(2008-2#5)
the mental health user##2##4##(2008-11#2)
the mental health##40##3##(1992-1#1)(1994-1#1)(1995-1#2)(1997-3#3)(2004-12#2)(2006-1#1)(2007-3#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-11#6)(2008-12#2)(2008-2#8)(2008-4#1)(2009-4#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
the mental healthcare##3##3##(1992-2#1)(1993-12#1)(2010-9#1)
the mental illness##2##3##(2012-3#2)
the mental nerve##2##3##(2012-3#2)
the mental##74##2##(1992-1#1)(1992-2#1)(1993-12#1)(1993-5#1)(1994-1#1)(1994-6#1)(1995-1#2)(1995-5#1)(1996-9#1)(1997-3#4)(2004-12#2)(2006-1#1)(2006-10#1)(2007-10#3)(2007-11#1)(2007-3#2)(2007-7#2)(2007-8#3)(2008-1#1)(2008-11#6)(2008-12#2)(2008-2#8)(2008-4#1)(2008-7#1)(2009-4#1)(2009-6#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#4)(2011-2#2)(2011-7#2)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#2)(2013-8#1)
the mentally ill and the##2##5##(2011-7#1)(2012-2#1)
the mentally ill and##4##4##(2008-2#1)(2008-7#1)(2011-7#1)(2012-2#1)
the mentally ill are##2##4##(2006-9#1)(2010-8#1)
the mentally ill in##4##4##(2008-2#1)(2008-4#2)(2008-8#1)
the mentally ill##26##3##(1992-1#1)(1992-3#1)(1994-3#1)(1995-2#1)(1996-1#1)(1997-2#1)(2006-9#4)(2007-5#1)(2008-2#3)(2008-4#3)(2008-7#1)(2008-8#1)(2009-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2011-7#2)(2012-2#1)
the mentally ill]##2##3##(1991-2#1)(2012-1#1)
the mentally retarded in##3##4##(1992-5#1)(1996-1#1)(1997-8#1)
the mentally retarded##9##3##(1991-1#2)(1992-5#3)(1996-1#1)(1997-8#2)(2006-4#1)
the mentally sick##2##3##(1991-3#2)
the mentally##43##2##(1991-1#2)(1991-2#1)(1991-3#2)(1992-1#1)(1992-3#1)(1992-5#3)(1994-1#2)(1994-3#1)(1995-2#1)(1996-1#2)(1996-9#1)(1997-2#2)(1997-8#2)(2006-4#1)(2006-9#4)(2007-5#1)(2008-2#3)(2008-4#3)(2008-7#1)(2008-8#1)(2009-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2011-7#2)(2012-1#1)(2012-2#1)
the mentioned##19##2##(1990-7#1)(1991-11#1)(1991-3#1)(1992-1#1)(1997-8#1)(2006-12#1)(2006-2#1)(2006-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2010-6#1)(2011-2#2)
the mentor##3##2##(2008-11#1)(2008-12#1)(2008-7#1)
the mentoring##2##2##(2008-9#1)(2009-9#1)
the menu##2##2##(1991-12#1)(2008-5#1)
the meq gene##4##3##(2013-8#4)
the meq##5##2##(2013-8#5)
the mercapto ligand##2##3##(2008-10#2)
the mercapto##3##2##(2008-10#3)
the mercury capture##2##3##(2009-3#2)
the mercury concentration in##2##4##(1993-4#2)
the mercury drop##2##3##(2008-10#2)
the mercury electrode and##5##4##(2008-10#5)
the mercury electrode surface##4##4##(2008-10#4)
the mercury electrode##13##3##(1990-5#1)(2005-11#1)(2008-10#11)
the mercury film##3##3##(2008-10#3)
the mercury is##2##3##(2008-10#2)
the mercury surface##2##3##(2008-10#2)
the mercury##40##2##(1990-2#1)(1990-5#1)(1993-4#2)(1993-9#1)(2005-11#2)(2007-12#1)(2008-10#28)(2008-6#1)(2009-3#2)(2010-5#1)
the mere perception of##2##4##(2007-12#1)(2013-8#1)
the mere##7##2##(2007-12#1)(2009-6#1)(2009-7#1)(2010-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
the merged##2##2##(2008-10#1)(2008-2#1)
the merger##3##2##(1992-3#1)(1996-3#1)(1997-1#1)
the merging of##2##3##(1991-3#1)(1995-2#1)
the merging-zone##2##2##(2008-10#2)
the meridian##5##2##(2008-2#2)(2008-9#3)
the meridional##5##2##(1990-8#1)(2008-2#2)(2008-7#2)
the merit function##2##3##(2007-11#1)(2008-2#1)
the merit of##4##3##(2005-11#1)(2005-3#1)(2006-4#1)(2008-10#1)
the merit##7##2##(2005-11#1)(2005-3#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-2#1)(2013-8#1)
the merits and the##2##4##(2007-12#1)(2009-6#1)
the merits and##4##3##(2007-12#1)(2008-10#1)(2008-4#1)(2009-6#1)
the merits of different##2##4##(2008-6#1)(2008-7#1)
the merits of having##2##4##(1992-5#1)(1992-9#1)
the merits of the##4##4##(2007-2#2)(2008-3#1)(2010-12#1)
the merits of this##2##4##(2006-6#1)(2008-3#1)
the merits of##28##3##(1992-5#1)(1992-9#1)(1993-1#1)(1993-2#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-6#1)(2007-12#1)(2007-2#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-12#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-1#1)
the merits##32##2##(1992-5#1)(1992-9#1)(1993-1#1)(1993-2#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-6#1)(2007-12#2)(2007-2#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-12#1)(2009-6#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-1#1)
the merozoite surface protein-1##2##4##(2006-4#1)(2008-4#1)
the merozoite surface##4##3##(2006-4#1)(2008-4#1)(2012-12#1)(2012-2#1)
the merozoite##5##2##(1994-8#1)(2006-4#1)(2008-4#1)(2012-12#1)(2012-2#1)
the mesangial##2##2##(2007-11#1)(2007-9#1)
the mesectodermal##2##2##(2006-7#1)(2007-12#1)
the mesencephalic nucleus cuneiformis##2##4##(1991-3#2)
the mesencephalic nucleus##3##3##(1990-9#1)(1991-3#2)
the mesencephalic trigeminal nucleus##4##4##(1990-4#2)(1995-11#1)(1996-9#1)
the mesencephalic##11##2##(1990-4#2)(1990-9#1)(1991-3#3)(1991-9#1)(1994-2#1)(1995-11#1)(1996-9#1)(1997-2#1)
the mesencephalon##5##2##(1990-8#2)(1992-9#1)(1993-6#1)(2008-7#1)
the mesenchymal##7##2##(1990-5#1)(1993-12#1)(2008-11#1)(2008-5#1)(2008-9#2)(2011-2#1)
the mesenchyme cells##4##3##(2008-5#4)
the mesenchyme##12##2##(1993-3#1)(1995-11#1)(1995-8#1)(2006-7#1)(2007-9#1)(2008-5#4)(2008-6#1)(2009-5#1)(2012-12#1)
the mesenteric artery##2##3##(1992-3#1)(1994-8#1)
the mesenteric lymph node##2##4##(2008-5#1)(2009-2#1)
the mesenteric lymph nodes##2##4##(1996-12#1)(2006-7#1)
the mesenteric lymph##4##3##(1996-12#1)(2006-7#1)(2008-5#1)(2009-2#1)
the mesenteric##20##2##(1990-6#1)(1992-3#2)(1992-5#1)(1993-3#2)(1994-8#1)(1996-12#1)(1996-2#1)(1996-9#1)(2006-4#1)(2006-7#1)(2007-7#1)(2008-12#1)(2008-5#1)(2009-2#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#1)
the mesentery##8##2##(1990-5#1)(1990-8#1)(1991-4#3)(2006-4#1)(2011-2#1)(2012-2#1)
the mesh size##2##3##(2008-5#1)(2009-10#1)
the mesh##8##2##(2007-4#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-7#1)(2011-2#2)
the mesial##3##2##(1995-5#1)(1996-1#1)(2009-10#1)
the meso##6##2##(1994-5#1)(1996-2#1)(2005-11#1)(2008-5#2)(2009-5#1)
the mesoaccumbocingulate dopaminergic##2##3##(2009-2#2)
the mesocarp and##2##3##(2008-10#2)
the mesocarp##3##2##(2008-10#3)
the mesocortex (limbic) and the isocortex##2##6##(1997-6#2)
the mesocortex and##2##3##(1997-6#2)
the mesocortex##4##2##(1997-6#4)
the mesocortical DA system##3##4##(1996-5#3)
the mesocorticolimbic##2##2##(2008-7#1)(2009-2#1)
the mesocosm##3##2##(2004-4#1)(2010-8#1)(2013-1#1)
the mesoderm##3##2##(1993-3#1)(2008-10#1)(2008-9#1)
the mesodermal##4##2##(1996-3#1)(2007-12#1)(2012-12#2)
the mesolimbic DA system##2##4##(1993-6#1)(1994-10#1)
the mesolimbic DA##3##3##(1992-10#1)(1993-6#1)(1994-10#1)
the mesolimbic##6##2##(1992-10#2)(1993-6#1)(1994-10#1)(1996-10#1)(2009-8#1)
the mesopause region##2##3##(1993-2#1)(2008-3#1)
the mesopause##4##2##(1993-2#1)(2008-3#3)
the mesophilic##3##2##(1994-12#1)(2006-8#2)
the mesophyll cells##2##3##(2008-10#1)(2009-8#1)
the mesophyll##7##2##(2007-12#1)(2008-10#5)(2009-8#1)
the mesopore##2##2##(2005-11#2)
the mesopores of##2##3##(2008-10#1)(2010-4#1)
the mesopores##3##2##(2008-10#2)(2010-4#1)
the mesoporosity##2##2##(2005-11#2)
the mesoporous##3##2##(2008-10#2)(2010-4#1)
the mesorectum##3##2##(2009-12#3)
the mesoscale##2##2##(2005-11#2)
the mesoscopic##4##2##(2005-11#1)(2007-8#1)(2008-11#1)(2013-1#1)
the mesosphere##4##2##(1993-2#1)(2008-3#3)
the mesostructure##5##2##(2005-11#2)(2006-12#3)
the mesostructured tin oxide##2##4##(2008-10#2)
the mesostructures##2##2##(2005-11#2)
the mesothelial cells##2##3##(2012-2#2)
the mesothelial##4##2##(2011-2#1)(2012-2#3)
the mesothelium##2##2##(2012-2#1)(2012-3#1)
the mesotrophic##3##2##(2004-4#3)
the message about##2##3##(1997-6#1)(2013-8#1)
the message levels of##3##4##(1991-9#1)(1994-2#1)(1997-1#1)
the message##25##2##(1991-9#1)(1993-3#1)(1994-11#2)(1994-2#2)(1995-12#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-12#3)(2007-2#1)(2008-1#1)(2008-2#1)(2010-8#1)(2012-2#1)(2013-8#1)
the messages##4##2##(1996-4#1)(2007-11#1)(2008-7#1)(2012-3#1)
the messenger RNA encoding##2##4##(1991-5#1)(1996-12#1)
the messenger RNA##6##3##(1991-12#1)(1991-5#1)(1992-8#1)(1996-12#1)(2007-11#2)
the messenger RNAs##2##3##(1990-11#1)(2011-12#1)
the messenger##13##2##(1990-11#1)(1990-3#1)(1991-12#1)(1991-5#1)(1992-8#1)(1993-3#1)(1994-3#1)(1996-12#1)(2007-11#2)(2008-1#1)(2008-11#1)(2011-12#1)
the met##3##2##(1990-5#1)(1992-8#1)(1997-7#1)
the metF##2##2##(1992-1#2)
the meta cleavage pathway##3##4##(2006-3#3)
the meta cleavage##4##3##(2006-3#4)
the meta position##2##3##(1997-1#1)(2013-1#1)
the meta##8##2##(1997-1#1)(1997-7#1)(2006-3#5)(2013-1#1)
the meta-analysis by##2##3##(1995-8#1)(2008-12#1)
the meta-analysis of##4##3##(1991-11#1)(1995-2#1)(2008-4#1)(2008-7#1)
the meta-analysis##17##2##(1991-11#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-6#1)(2006-9#1)(2007-7#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2012-3#1)(2013-1#1)
the meta-position##2##2##(2006-12#1)(2007-11#1)
the meta-substituted##2##2##(1997-7#1)(2006-12#1)
the metabolic aberrations##2##3##(2012-11#2)
the metabolic actions of##2##4##(2005-10#1)(2010-10#1)
the metabolic activation of##6##4##(1991-5#1)(1991-9#1)(1993-9#1)(1994-6#1)(2008-8#1)(2010-2#1)
the metabolic activation##9##3##(1991-5#1)(1991-9#1)(1992-1#2)(1992-2#1)(1993-9#1)(1994-6#1)(2008-8#1)(2010-2#1)
the metabolic activity of##2##4##(1992-7#1)(1997-8#1)
the metabolic activity##5##3##(1992-7#1)(1997-8#1)(2007-12#1)(2007-8#1)(2013-1#1)
the metabolic alterations##2##3##(1992-4#1)(2008-3#1)
the metabolic and##8##3##(1990-5#1)(1994-12#1)(1996-10#1)(1996-3#1)(2005-10#1)(2008-3#1)(2009-5#1)(2011-12#1)
the metabolic basis##2##3##(1995-5#1)(2008-3#1)
the metabolic behavior of denitrifying phosphate-accumulating organisms##2##7##(2007-6#2)
the metabolic changes##3##3##(1994-6#1)(2005-3#1)(2007-9#1)
the metabolic characteristics of##2##4##(2008-11#1)(2011-3#1)
the metabolic consequences of##2##4##(2008-12#1)(2008-3#1)
the metabolic consequences##3##3##(2008-12#1)(2008-3#1)(2008-5#1)
the metabolic defect##3##3##(1990-11#1)(1990-2#1)(1994-12#1)
the metabolic disorder##2##3##(1990-2#2)
the metabolic disorders##2##3##(1992-2#1)(2006-8#1)
the metabolic disturbances##3##3##(1996-1#1)(2007-5#1)(2009-3#1)
the metabolic effect##2##3##(1990-2#1)(2011-1#1)
the metabolic effects of##3##4##(1990-2#1)(2008-4#1)(2010-6#1)
the metabolic fate of##2##4##(1993-12#1)(2008-7#1)
the metabolic flux##3##3##(1997-2#1)(2005-11#2)
the metabolic imbalance##2##3##(1995-1#1)(2008-3#1)
the metabolic network##3##3##(2008-7#2)(2012-2#1)
the metabolic parameters##2##3##(1990-5#1)(2012-12#1)
the metabolic pathway of##3##4##(2006-12#1)(2012-12#1)(2012-5#1)
the metabolic pathway##8##3##(1991-2#1)(1993-2#1)(2006-12#1)(2006-8#1)(2009-10#1)(2012-12#1)(2012-3#1)(2012-5#1)
the metabolic pathways of##3##4##(1995-1#1)(2008-8#1)(2013-1#1)
the metabolic pathways##6##3##(1995-1#1)(2008-8#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-1#1)
the metabolic pattern##2##3##(1996-3#1)(2013-7#1)
the metabolic potential##3##3##(1995-6#1)(2008-11#1)(2009-5#1)
the metabolic products##2##3##(1990-11#1)(2006-10#1)
the metabolic profile##2##3##(2010-4#2)
the metabolic rate##4##3##(1996-11#2)(2007-4#1)(2008-7#1)
the metabolic reactions##2##3##(1993-8#1)(2007-6#1)
the metabolic response of##2##4##(1997-8#1)(2009-10#1)
the metabolic response##3##3##(1997-8#1)(2009-10#1)(2013-1#1)
the metabolic responses##2##3##(1993-7#1)(1996-9#1)
the metabolic role of##2##4##(2008-10#1)(2008-3#1)
the metabolic state of the##2##5##(1991-1#1)(2008-7#1)
the metabolic state of##7##4##(1991-1#1)(1996-12#1)(2007-10#1)(2008-7#1)(2010-12#1)(2012-11#1)(2012-2#1)
the metabolic status##2##3##(1996-9#1)(2012-2#1)
the metabolic syndrome (MS)##5##4##(2008-3#4)(2011-2#1)
the metabolic syndrome according to##3##5##(2008-3#3)
the metabolic syndrome and diabetes##2##5##(2008-1#1)(2008-3#1)
the metabolic syndrome and##13##4##(2008-1#3)(2008-3#5)(2008-5#1)(2008-7#1)(2009-3#1)(2010-4#2)
the metabolic syndrome are##5##4##(2008-11#1)(2008-3#4)
the metabolic syndrome has been##2##5##(2008-3#1)(2008-6#1)
the metabolic syndrome has##3##4##(2008-3#1)(2008-6#1)(2011-2#1)
the metabolic syndrome have##2##4##(2008-3#1)(2010-5#1)
the metabolic syndrome in both##2##5##(2008-3#2)
the metabolic syndrome in later life##2##6##(2008-3#2)
the metabolic syndrome in##14##4##(2008-10#1)(2008-3#10)(2008-5#1)(2011-2#1)(2013-8#1)
the metabolic syndrome is##6##4##(2008-1#2)(2008-3#2)(2008-6#1)(2010-4#1)
the metabolic syndrome may##2##4##(2005-10#1)(2008-1#1)
the metabolic syndrome##182##3##(1990-2#1)(1995-12#1)(2005-10#5)(2006-6#2)(2008-1#20)(2008-10#4)(2008-11#1)(2008-3#93)(2008-5#4)(2008-6#7)(2008-7#10)(2009-10#3)(2009-11#1)(2009-3#1)(2009-6#1)(2010-4#9)(2010-5#3)(2011-1#1)(2011-2#7)(2012-2#4)(2012-5#1)(2013-8#3)
the metabolic syndrome?##2##3##(2008-10#1)(2008-3#1)
the metabolic syndrome]##2##3##(1993-2#1)(2012-3#1)
the metabolic##357##2##(1990-11#2)(1990-2#6)(1990-5#2)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#3)(1992-11#1)(1992-2#2)(1992-4#1)(1992-5#1)(1992-7#1)(1993-12#2)(1993-2#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#3)(1995-12#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#3)(1996-9#3)(1997-2#1)(1997-8#2)(2004-11#2)(2005-10#8)(2005-11#3)(2005-3#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-6#3)(2007-8#1)(2007-9#1)(2008-1#21)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#103)(2008-4#2)(2008-5#5)(2008-6#9)(2008-7#17)(2008-8#4)(2008-9#1)(2009-10#5)(2009-11#1)(2009-3#2)(2009-5#2)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#11)(2010-5#3)(2010-6#2)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#10)(2011-3#1)(2012-1#1)(2012-11#3)(2012-12#2)(2012-2#8)(2012-3#3)(2012-5#2)(2013-1#4)(2013-7#1)(2013-8#6)
the metabolically active##2##3##(2011-1#1)(2011-2#1)
the metabolically##4##2##(1994-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
the metabolism and##10##3##(1993-11#1)(1994-6#1)(1997-8#1)(2006-12#1)(2008-10#1)(2008-7#2)(2013-1#2)(2013-8#1)
the metabolism of NA##2##4##(2008-8#2)
the metabolism of [125I]ET-1##2##4##(1995-11#2)
the metabolism of a##2##4##(1996-1#1)(2008-10#1)
the metabolism of domperidone and##2##5##(2011-2#2)
the metabolism of domperidone##3##4##(2011-2#3)
the metabolism of endogenous##2##4##(2007-11#1)(2010-12#1)
the metabolism of levodopa##2##4##(2008-8#2)
the metabolism of many##3##4##(2006-10#1)(2006-2#1)(2010-2#1)
the metabolism of microorganisms##3##4##(2008-5#2)(2012-3#1)
the metabolism of other##2##4##(2008-3#1)(2008-5#1)
the metabolism of phenytoin##3##4##(1995-7#3)
the metabolism of retinol and beta-carotene##2##6##(2009-6#2)
the metabolism of serotonin##2##4##(1990-5#1)(2007-12#1)
the metabolism of the##10##4##(1991-5#1)(1993-6#1)(1994-10#1)(1995-3#1)(2006-10#2)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
the metabolism of these##3##4##(1991-12#1)(1996-5#1)(1997-3#1)
the metabolism of##126##3##(1990-11#1)(1990-5#1)(1991-12#2)(1991-2#1)(1991-5#3)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-3#1)(1993-12#1)(1993-2#1)(1993-4#2)(1993-6#2)(1993-9#1)(1994-10#1)(1994-12#3)(1994-3#4)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#3)(1995-11#2)(1995-3#2)(1995-4#1)(1995-7#4)(1996-1#1)(1996-10#1)(1996-3#2)(1996-5#2)(1996-7#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-11#1)(2005-7#1)(2006-10#5)(2006-12#2)(2006-2#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-11#4)(2008-3#3)(2008-5#6)(2008-7#2)(2008-8#6)(2008-9#1)(2009-4#1)(2009-6#2)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#2)(2010-7#1)(2011-1#5)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
the metabolism via##2##3##(2008-11#2)
the metabolism##147##2##(1990-11#1)(1990-5#1)(1991-12#2)(1991-2#1)(1991-5#3)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#2)(1993-6#2)(1993-9#1)(1994-10#1)(1994-12#4)(1994-3#4)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#3)(1995-11#2)(1995-3#2)(1995-4#1)(1995-7#4)(1996-1#1)(1996-10#1)(1996-3#2)(1996-5#2)(1996-7#1)(1997-2#2)(1997-3#1)(1997-8#2)(2004-11#1)(2005-10#1)(2005-7#1)(2006-10#5)(2006-12#3)(2006-2#2)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#7)(2008-11#7)(2008-3#4)(2008-5#6)(2008-7#4)(2008-8#6)(2008-9#1)(2009-4#1)(2009-6#2)(2009-8#3)(2009-9#1)(2010-12#1)(2010-2#2)(2010-7#1)(2011-1#5)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
the metabolite##20##2##(1990-2#1)(1990-3#1)(1990-6#1)(1991-6#1)(1991-8#1)(1992-1#1)(1993-2#1)(1993-4#1)(1995-12#1)(1996-8#2)(1997-2#1)(2008-10#3)(2008-8#1)(2009-12#1)(2010-11#1)(2010-4#1)(2012-1#1)
the metabolites isolated from##2##4##(2007-1#2)
the metabolites of##7##3##(1990-5#1)(1995-8#1)(1997-8#1)(2005-12#1)(2006-2#1)(2008-11#1)(2013-1#1)
the metabolites that are##2##4##(2008-10#2)
the metabolites##36##2##(1990-11#1)(1990-5#2)(1990-7#1)(1992-2#1)(1992-7#3)(1993-2#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-8#2)(2005-12#1)(2006-2#1)(2006-5#1)(2007-1#2)(2008-10#4)(2008-11#2)(2008-7#2)(2009-8#1)(2010-11#1)(2011-2#1)(2011-3#2)(2012-3#1)(2013-1#1)(2013-7#1)
the metabolome##6##2##(2008-9#1)(2009-3#1)(2009-8#2)(2010-11#1)(2012-5#1)
the metabotropic glutamate receptor##3##4##(1995-11#1)(1997-5#2)
the metabotropic##7##2##(1993-11#2)(1995-11#1)(1997-5#3)(2008-4#1)
the metacarpal##2##2##(2006-3#1)(2006-4#1)
the metacarpal-phalangeal##2##2##(1997-1#1)(2008-9#1)
the metacarpophalangeal joints##2##3##(2006-10#1)(2007-7#1)
the metacarpophalangeal##11##2##(1990-10#1)(1992-5#1)(2006-10#2)(2006-3#2)(2007-11#1)(2007-7#1)(2008-9#2)(2012-1#1)
the metacestode##4##2##(2005-12#1)(2012-2#3)
the metachromatic##2##2##(2008-9#2)
the metal M##3##3##(2008-10#3)
the metal and ligand##2##4##(2006-6#1)(2008-10#1)
the metal and##6##3##(1991-4#1)(2006-12#1)(2006-6#1)(2008-10#3)
the metal atom##2##3##(1996-2#2)
the metal atoms##2##3##(1996-2#1)(2007-11#1)
the metal beta-diketonate complexes##2##4##(2005-11#2)
the metal binding##3##3##(1992-4#1)(2008-10#2)
the metal by##2##3##(2004-4#1)(2008-5#1)
the metal cations##6##3##(1997-4#1)(2005-11#1)(2008-10#3)(2010-7#1)
the metal center##4##3##(1996-2#2)(2008-5#1)(2010-5#1)
the metal centers##3##3##(1995-11#1)(1997-7#2)
the metal chelate##5##3##(1991-7#1)(1991-8#1)(2008-10#3)
the metal cluster##8##3##(1991-4#2)(1994-5#5)(1996-5#1)
the metal complex##4##3##(2008-10#1)(2008-3#3)
the metal complexes##6##3##(2006-3#1)(2008-10#1)(2008-4#1)(2008-5#2)(2010-5#1)
the metal concentrations##4##3##(1997-4#2)(2006-12#1)(2008-10#1)
the metal content##2##3##(1991-12#1)(1991-7#1)
the metal contents##2##3##(2007-8#1)(2008-10#1)
the metal foil##2##3##(2006-4#2)
the metal in the##2##4##(1996-3#1)(2006-6#1)
the metal in##3##3##(1996-3#1)(2006-6#1)(2008-10#1)
the metal ion and##2##4##(1996-2#1)(2006-2#1)
the metal ion in##3##4##(2008-10#2)(2010-5#1)
the metal ion is##6##4##(2008-10#2)(2008-3#1)(2008-5#1)(2010-5#1)(2010-6#1)
the metal ion##33##3##(1991-4#1)(1991-7#1)(1992-11#1)(1992-3#1)(1992-5#1)(1994-11#1)(1996-2#1)(1997-2#1)(1997-4#1)(2006-2#2)(2008-10#13)(2008-3#1)(2008-5#4)(2010-5#3)(2010-6#1)
the metal ions and##3##4##(2005-11#1)(2008-10#1)(2013-1#1)
the metal ions are##2##4##(2007-8#1)(2008-10#1)
the metal ions have##2##4##(2008-10#1)(2010-6#1)
the metal ions in the##2##5##(2008-10#1)(2008-5#1)
the metal ions in##4##4##(2008-10#3)(2008-5#1)
the metal ions with##2##4##(2008-10#2)
the metal ions##40##3##(1990-4#1)(2005-11#3)(2007-8#1)(2008-10#27)(2008-3#2)(2008-5#2)(2010-11#1)(2010-6#1)(2013-1#1)(2013-8#1)
the metal is not##2##4##(1994-12#1)(2010-4#1)
the metal is##6##3##(1994-12#1)(2007-12#1)(2008-3#1)(2009-3#1)(2010-4#1)(2010-5#1)
the metal may##2##3##(2005-10#1)(2008-10#1)
the metal prosthesis##2##3##(2008-6#2)
the metal ring##2##3##(2008-3#2)
the metal species##3##3##(2008-10#2)(2010-11#1)
the metal stress##2##3##(1994-8#1)(2008-7#1)
the metal surface##6##3##(2004-9#1)(2007-12#2)(2008-5#1)(2008-7#1)(2010-4#1)
the metal surfaces##2##3##(2007-8#1)(2013-1#1)
the metal to##3##3##(1991-8#1)(2008-10#1)(2008-5#1)
the metal vapour pressure##2##4##(2009-11#2)
the metal was##4##3##(1991-4#1)(2008-10#3)
the metal##277##2##(1990-10#1)(1990-4#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-4#5)(1991-7#3)(1991-8#2)(1992-11#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#2)(1993-6#2)(1994-11#1)(1994-12#1)(1994-5#8)(1994-6#3)(1994-8#2)(1995-11#1)(1995-3#1)(1996-2#6)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#4)(1997-3#1)(1997-4#4)(1997-7#3)(2004-4#2)(2004-9#1)(2005-10#1)(2005-11#6)(2006-12#4)(2006-2#2)(2006-3#3)(2006-4#2)(2006-6#5)(2007-11#2)(2007-12#5)(2007-5#1)(2007-8#4)(2008-10#99)(2008-2#3)(2008-3#11)(2008-4#2)(2008-5#17)(2008-6#2)(2008-7#5)(2009-11#3)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-11#4)(2010-12#2)(2010-4#4)(2010-5#10)(2010-6#2)(2010-7#1)(2011-1#2)(2011-12#1)(2012-12#1)(2013-1#2)(2013-8#1)
the metal-binding##2##2##(1995-3#1)(1995-6#1)
the metal-catalyzed##2##2##(1991-8#1)(2008-10#1)
the metal-free form##2##3##(1994-12#2)
the metal-free##4##2##(1994-12#4)
the metal-ligand##3##2##(1996-2#1)(2006-6#1)(2010-5#1)
the metal-metal##2##2##(1996-2#1)(1997-7#1)
the metallic cations##2##3##(1990-7#2)
the metallic ions##2##3##(2004-9#1)(2008-10#1)
the metallic particles##2##3##(2008-10#1)(2012-12#1)
the metallic state##3##3##(1991-6#1)(2008-10#1)(2011-1#1)
the metallic##25##2##(1990-7#2)(1991-6#2)(2004-9#1)(2005-11#1)(2005-4#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-8#1)(2010-4#1)(2010-6#2)(2011-1#2)(2012-12#1)
the metallocenes##3##2##(2007-11#3)
the metalloid##2##2##(2008-3#1)(2010-11#1)
the metalloprotease##2##2##(1992-8#1)(2012-2#1)
the metallothionein##3##2##(1991-12#1)(2008-10#1)(2008-11#1)
the metallurgical##2##2##(1991-3#1)(2008-3#1)
the metals and##3##3##(2008-10#1)(2010-11#1)(2011-12#1)
the metals are##3##3##(1995-10#1)(2008-10#1)(2008-5#1)
the metals can be##2##4##(2008-10#2)
the metals were##3##3##(1993-9#1)(2008-10#2)
the metals##35##2##(1992-6#1)(1993-9#2)(1995-10#1)(1997-7#1)(2006-1#1)(2008-10#18)(2008-12#1)(2008-5#1)(2008-6#1)(2010-11#2)(2010-12#1)(2011-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
the metamorphic##2##2##(1997-6#1)(2008-5#1)
the metaphyseal##2##2##(2010-3#2)
the metaphyses of##2##3##(1993-10#1)(1995-6#1)
the metaphysis##2##2##(2009-1#1)(2009-3#1)
the metapopulation dynamics of##2##4##(2008-8#2)
the metapopulation##12##2##(2008-10#2)(2008-8#4)(2008-9#6)
the metastable##4##2##(1990-3#1)(1995-3#1)(2005-11#2)
the metastases are##2##3##(2007-11#2)
the metastases##10##2##(1993-10#1)(1997-6#1)(2005-10#1)(2007-11#4)(2008-9#1)(2010-11#1)(2013-1#1)
the metastases-free##2##2##(2008-6#2)
the metastasis in##3##3##(1996-6#1)(1997-6#1)(2007-11#1)
the metastasis of##3##3##(1991-9#2)(2005-10#1)
the metastasis##12##2##(1991-3#1)(1991-6#1)(1991-9#2)(1996-6#1)(1997-6#2)(2005-10#1)(2007-11#2)(2009-10#1)(2009-5#1)
the metastatic effect##2##3##(1995-8#2)
the metastatic foci##3##3##(1996-6#1)(2007-11#1)(2012-1#1)
the metastatic focus##2##3##(1991-6#1)(2007-11#1)
the metastatic lesion##2##3##(1993-12#1)(2006-2#1)
the metastatic lesions##3##3##(2011-2#1)(2013-8#2)
the metastatic lymph nodes##2##4##(1994-12#1)(2007-6#1)
the metastatic melanoma##2##3##(1997-7#1)(2010-6#1)
the metastatic phenotype of##2##4##(1994-5#1)(2009-3#1)
the metastatic potential of the##2##5##(2012-2#2)
the metastatic potential of##9##4##(1992-9#2)(1994-6#1)(1995-8#1)(2008-1#1)(2010-3#1)(2011-2#1)(2012-2#2)
the metastatic potential##11##3##(1992-9#2)(1994-6#1)(1995-1#1)(1995-8#1)(2008-1#1)(2010-3#2)(2011-2#1)(2012-2#2)
the metastatic process##6##3##(1990-6#1)(1990-8#1)(1993-9#1)(2008-1#1)(2008-4#1)(2010-3#1)
the metastatic tumor##2##3##(2010-12#1)(2013-8#1)
the metastatic##51##2##(1990-6#1)(1990-8#1)(1991-3#1)(1991-4#2)(1991-6#1)(1992-9#4)(1993-12#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-1#2)(1995-8#3)(1996-6#1)(1997-7#1)(2006-2#2)(2007-11#3)(2007-6#1)(2008-1#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#2)(2010-12#1)(2010-3#3)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-8#3)
the metatarsal##2##2##(2006-8#1)(2010-3#1)
the metathesis##2##2##(2006-4#1)(2010-12#1)
the meteorite##3##2##(1995-3#1)(2007-8#2)
the meteoritic##2##2##(1993-7#1)(1997-5#1)
the meteorological##4##2##(2007-11#1)(2008-2#2)(2008-8#1)
the meter##3##2##(2008-2#2)(2008-3#1)
the metered-dose inhaler (MDI)##2##4##(1996-2#1)(1997-1#1)
the metering valve is##2##4##(1996-1#2)
the methacrylate##2##2##(2007-11#1)(2008-5#1)
the methamphetamine dose##2##3##(1995-3#2)
the methane lines##3##3##(2008-1#3)
the methane production##2##3##(2013-1#2)
the methane##10##2##(1995-2#1)(1997-4#1)(2004-9#1)(2008-1#3)(2008-2#2)(2013-1#2)
the methanogen was##2##3##(2008-7#2)
the methanogenic##2##2##(2006-5#1)(2008-7#1)
the methanol concentration in##2##4##(1996-5#1)(2008-7#1)
the methanol concentration##4##3##(1996-5#2)(2008-7#2)
the methanol extract of the##3##5##(2008-11#1)(2010-12#1)(2012-2#1)
the methanol extract of##5##4##(1996-4#1)(2008-11#1)(2010-12#1)(2012-2#1)(2013-8#1)
the methanol extract##6##3##(1996-4#1)(2008-11#2)(2010-12#1)(2012-2#1)(2013-8#1)
the methanol extracts from##2##4##(2011-12#1)(2011-2#1)
the methanol extracts of##2##4##(2011-1#1)(2011-12#1)
the methanol extracts##4##3##(2011-1#1)(2011-12#2)(2011-2#1)
the methanol##23##2##(1990-5#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-4#1)(1997-7#1)(2006-8#1)(2008-10#3)(2008-11#2)(2008-7#2)(2009-5#1)(2010-12#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-2#1)(2013-8#1)
the methanolic extract of##4##4##(2007-1#1)(2008-12#1)(2009-5#1)(2013-1#1)
the methanolic extract##6##3##(2007-1#1)(2008-12#2)(2008-4#1)(2009-5#1)(2013-1#1)
the methanolic fractions##2##3##(1997-2#2)
the methanolic##11##2##(1997-2#3)(2007-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2009-5#1)(2013-1#1)
the methanotroph##2##2##(2013-7#2)
the methicillin resistant##2##3##(2007-8#1)(2010-2#1)
the methionine##10##2##(1990-8#1)(1994-9#1)(1995-5#1)(1997-2#1)(2004-10#1)(2006-12#2)(2008-10#1)(2008-3#1)(2013-8#1)
the method a##2##3##(2008-10#1)(2008-11#1)
the method accuracy##2##3##(2005-4#1)(2008-10#1)
the method allowed##2##3##(1996-12#1)(2008-10#1)
the method allows for##3##4##(1997-2#1)(2008-11#1)(2008-5#1)
the method allows##5##3##(1992-6#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
the method also##3##3##(2007-9#1)(2008-2#1)(2010-2#1)
the method and its##3##4##(2008-10#2)(2010-9#1)
the method and the results##3##5##(2007-8#1)(2008-2#1)(2013-8#1)
the method and the##6##4##(2007-8#1)(2008-2#2)(2008-7#1)(2008-8#1)(2013-8#1)
the method and to##2##4##(2008-3#1)(2010-3#1)
the method and##23##3##(1990-10#1)(1992-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-3#1)(2010-9#1)(2013-8#1)
the method are also##2##4##(1992-2#1)(2008-3#1)
the method are presented##5##4##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)
the method are##34##3##(1990-10#1)(1990-11#1)(1992-2#2)(1993-2#1)(1994-9#1)(1995-12#1)(1996-7#1)(2007-11#2)(2007-12#2)(2007-8#3)(2008-10#8)(2008-2#6)(2008-3#4)(2008-9#1)
the method at##2##3##(2007-11#1)(2008-3#1)
the method based on reaction with##2##6##(2008-10#2)
the method based on the color reaction of##2##8##(2008-10#2)
the method based on##4##4##(2008-10#4)
the method by measuring##3##4##(2008-10#1)(2008-3#2)
the method by##12##3##(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)
the method can also be##2##5##(1991-5#1)(2008-3#1)
the method can be applied to##3##6##(2005-12#1)(2008-10#1)(2011-1#1)
the method can be applied##4##5##(2005-12#1)(2007-12#1)(2008-10#1)(2011-1#1)
the method can be used for##2##6##(1991-3#1)(1997-8#1)
the method can be used to measure##2##7##(2008-2#2)
the method can be used to##3##6##(1996-5#1)(2008-2#2)
the method can be used##6##5##(1991-3#1)(1996-5#1)(1997-8#1)(2008-10#1)(2008-2#2)
the method can be##18##4##(1991-3#1)(1991-5#1)(1996-5#1)(1997-8#1)(2005-12#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-5#1)(2009-10#1)(2010-12#1)(2011-1#1)(2013-7#1)
the method can easily##2##4##(2006-10#1)(2008-3#1)
the method can##24##3##(1991-3#1)(1991-5#2)(1996-5#1)(1997-8#1)(2005-12#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2009-10#1)(2010-12#1)(2011-1#1)(2013-7#1)
the method could be##2##4##(2008-10#1)(2008-11#1)
the method could effectively separate##3##5##(2008-10#3)
the method could##6##3##(2008-10#4)(2008-11#1)(2013-8#1)
the method described by##2##4##(2008-11#1)(2012-12#1)
the method described here is##2##5##(2008-11#1)(2008-5#1)
the method described here##8##4##(1997-4#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-5#2)(2009-4#2)
the method described##11##3##(1997-4#1)(2007-11#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-9#1)(2009-4#2)(2012-12#1)
the method detection##2##3##(2008-10#2)
the method developed##7##3##(1996-5#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-5#1)
the method development##3##3##(2008-10#1)(2010-11#2)
the method does not suffer##2##5##(2008-10#2)
the method does not##4##4##(2008-10#2)(2008-2#1)(2008-3#1)
the method enables##2##3##(2008-10#1)(2008-3#1)
the method for a##2##4##(2008-2#1)(2008-3#1)
the method for detecting##2##4##(2008-10#1)(2013-8#1)
the method for the determination of##3##6##(2008-10#3)
the method for the##6##4##(2008-10#6)
the method for##40##3##(1991-7#1)(1992-6#1)(1993-2#1)(1997-2#1)(1997-3#1)(2005-4#1)(2007-10#1)(2007-6#1)(2007-8#3)(2008-10#20)(2008-11#1)(2008-2#3)(2008-3#2)(2010-11#1)(2012-2#1)(2013-8#1)
the method gives##2##3##(1993-8#1)(2010-6#1)
the method had##3##3##(1997-8#1)(2006-12#1)(2012-3#1)
the method has a##3##4##(1991-2#1)(2008-10#1)(2008-2#1)
the method has been applied to##3##6##(2008-10#3)
the method has been applied##4##5##(2008-10#4)
the method has been satisfactorily##2##5##(2008-10#2)
the method has been successfully applied to the##3##8##(2008-10#3)
the method has been##18##4##(1992-8#1)(2008-10#16)(2008-3#1)
the method has##24##3##(1991-2#1)(1991-8#1)(1992-8#1)(2005-4#1)(2008-10#18)(2008-2#1)(2008-3#1)
the method here##2##3##(1990-4#1)(2008-10#1)
the method holds##2##3##(2007-8#1)(2008-10#1)
the method in a##4##4##(2007-11#1)(2007-12#1)(2008-10#1)(2013-8#1)
the method in the##3##4##(1991-5#1)(2008-2#1)(2008-8#1)
the method in##22##3##(1991-4#1)(1991-5#1)(1992-11#1)(1994-12#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#1)(2012-1#1)(2012-2#1)(2013-8#1)
the method is also##2##4##(2008-9#1)(2010-2#1)
the method is applicable to##2##5##(2008-7#1)(2010-5#1)
the method is applied to##2##5##(2008-10#2)
the method is applied##3##4##(2008-10#2)(2008-3#1)
the method is based on the##3##6##(1997-4#1)(2008-2#1)(2008-3#1)
the method is based on##4##5##(1997-4#1)(2008-10#1)(2008-2#1)(2008-3#1)
the method is demonstrated##6##4##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)
the method is free##2##4##(2008-10#2)
the method is illustrated##2##4##(1997-2#1)(2009-3#1)
the method is in##3##4##(2008-10#2)(2011-1#1)
the method is linear over##2##5##(2008-10#2)
the method is not##2##4##(2008-3#1)(2010-5#1)
the method is readily applicable to##2##6##(1990-11#1)(2008-10#1)
the method is reproducible##2##4##(1997-8#1)(2008-10#1)
the method is sensitive##2##4##(2008-10#1)(2009-5#1)
the method is suggested##2##4##(1997-2#1)(2008-10#1)
the method is suitable for the##4##6##(1991-5#1)(2008-10#2)(2008-3#1)
the method is suitable for##8##5##(1991-5#1)(1996-12#1)(2008-10#5)(2008-3#1)
the method is the use of##3##6##(1992-4#1)(2007-11#1)(2008-10#1)
the method is the##4##4##(1992-4#1)(1994-11#1)(2007-11#1)(2008-10#1)
the method is very##3##4##(2007-12#1)(2008-6#1)(2008-7#1)
the method is##140##3##(1990-11#2)(1990-8#1)(1990-9#2)(1991-5#1)(1992-2#1)(1992-4#2)(1993-10#1)(1994-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-12#2)(2005-4#2)(2006-6#1)(2007-11#2)(2007-12#7)(2007-8#1)(2008-1#1)(2008-10#51)(2008-11#2)(2008-12#1)(2008-2#11)(2008-3#17)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-10#2)(2009-3#1)(2009-5#1)(2010-2#2)(2010-4#1)(2010-5#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)
the method most##2##3##(1996-6#1)(2011-2#1)
the method needs to be##2##5##(2006-10#1)(2008-5#1)
the method of 'replenishing qi##2##5##(2013-8#2)
the method of choice for the##4##6##(1991-9#1)(2007-6#1)(2008-6#1)(2008-9#1)
the method of choice for##18##5##(1991-9#1)(1992-11#1)(1997-5#1)(2004-2#1)(2006-10#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#2)(2010-12#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-7#1)
the method of choice in the##2##6##(1993-6#1)(2007-11#1)
the method of choice in##7##5##(1993-6#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2010-12#1)(2011-2#1)
the method of choice to##2##5##(2008-4#1)(2013-7#1)
the method of choice##40##4##(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-6#1)(1996-2#1)(1997-5#1)(2004-2#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-6#1)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#2)(2008-6#2)(2008-9#4)(2010-12#2)(2010-6#1)(2011-2#2)(2012-3#1)(2013-7#2)
the method of constant stimuli##4##5##(1990-11#4)
the method of constant##5##4##(1990-11#4)(2013-1#1)
the method of data collection##3##5##(1993-3#1)(2007-12#1)(2008-11#1)
the method of delivery##2##4##(1997-1#1)(2012-2#1)
the method of detection##2##4##(2008-10#2)
the method of encryption##2##4##(2006-10#2)
the method of gene fusion##2##5##(1990-3#2)
the method of gene##3##4##(1990-3#2)(2008-9#1)
the method of polymerase chain##2##5##(2011-2#2)
the method of preparation##3##4##(1990-5#1)(2008-10#1)(2008-11#1)
the method of principal##2##4##(2009-9#1)(2011-1#1)
the method of standard additions##6##5##(2008-10#6)
the method of standard##8##4##(2007-8#1)(2008-10#7)
the method of the##3##4##(2005-4#1)(2006-6#1)(2013-8#1)
the method of##201##3##(1990-11#6)(1990-12#2)(1990-3#3)(1990-5#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-6#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-6#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-5#1)(1995-7#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-11#1)(2004-2#1)(2005-10#1)(2005-11#1)(2005-4#4)(2006-10#5)(2006-2#1)(2006-6#2)(2007-11#3)(2007-12#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#6)(2008-1#5)(2008-10#23)(2008-11#6)(2008-12#3)(2008-2#6)(2008-3#6)(2008-4#4)(2008-5#1)(2008-6#5)(2008-7#1)(2008-9#7)(2009-2#4)(2009-9#1)(2010-12#4)(2010-3#1)(2010-6#2)(2011-1#3)(2011-12#2)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#3)(2013-7#2)(2013-8#6)
the method on##4##3##(1990-12#1)(1995-4#1)(2008-2#1)(2012-3#1)
the method performance##2##3##(2008-10#1)(2011-2#1)
the method performs##2##3##(2008-10#1)(2011-2#1)
the method presented here is##2##5##(2008-10#2)
the method presented in##2##4##(2010-5#1)(2013-8#1)
the method presented##8##3##(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2010-5#1)(2013-8#1)
the method promises to##2##4##(1995-4#1)(2007-9#1)
the method proposed##6##3##(2008-10#3)(2008-2#1)(2008-3#2)
the method provides##6##3##(1996-1#1)(2007-11#1)(2008-10#2)(2008-3#2)
the method should be##3##4##(1991-8#1)(1997-7#1)(2008-10#1)
the method showed##3##3##(1994-11#1)(2008-10#2)
the method shows a##2##4##(2008-10#2)
the method shows##4##3##(2008-10#3)(2008-6#1)
the method that##3##3##(1996-9#1)(2008-3#1)(2008-4#1)
the method to a##6##4##(2008-2#2)(2008-8#1)(2010-2#1)(2013-1#2)
the method to be##4##4##(1990-12#1)(2008-10#2)(2008-3#1)
the method to the##13##4##(1995-12#1)(2006-3#1)(2008-10#7)(2008-2#2)(2008-3#2)
the method to##58##3##(1990-12#1)(1991-4#1)(1993-6#1)(1994-4#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-3#1)(2008-1#1)(2008-10#21)(2008-2#8)(2008-3#7)(2008-8#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-9#1)(2012-3#1)(2013-1#2)
the method used for the##3##5##(2005-11#1)(2008-11#1)(2010-5#1)
the method used for##11##4##(2005-11#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#2)(2010-5#1)(2011-2#1)
the method used to##5##4##(2007-11#1)(2008-10#1)(2010-6#1)(2013-1#1)(2013-8#1)
the method used##21##3##(1996-2#1)(1997-3#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#3)(2008-4#2)(2010-5#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
the method using##3##3##(2008-10#1)(2008-6#1)(2010-7#1)
the method utilized##2##3##(2007-10#1)(2008-10#1)
the method was applicable##2##4##(2008-10#2)
the method was applied to the analysis of##2##8##(1993-2#1)(2008-10#1)
the method was applied to the##3##6##(1993-2#1)(2008-10#2)
the method was applied to##5##5##(1993-2#1)(2007-8#1)(2008-10#2)(2008-3#1)
the method was applied##7##4##(1993-2#1)(2007-8#1)(2008-10#4)(2008-3#1)
the method was highly##2##4##(2005-4#1)(2013-8#1)
the method was successfully applied to the determination of##2##9##(2008-10#2)
the method was successfully applied to the##3##7##(2008-10#3)
the method was successfully applied to##4##6##(2008-10#4)
the method was successfully##5##4##(2008-10#5)
the method was tested##9##4##(2007-3#1)(2007-8#1)(2008-10#6)(2010-4#1)
the method was##116##3##(1990-8#1)(1991-7#1)(1992-3#1)(1993-2#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-6#1)(1996-8#1)(2005-3#1)(2005-4#3)(2007-11#3)(2007-12#1)(2007-3#1)(2007-6#1)(2007-8#5)(2008-10#70)(2008-3#2)(2008-5#2)(2008-8#2)(2009-2#3)(2010-12#2)(2010-2#1)(2010-4#1)(2011-1#1)(2011-12#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-8#1)
the method we##3##3##(2008-2#1)(2008-3#1)(2010-12#1)
the method were##17##3##(1990-8#1)(1996-6#2)(1997-3#1)(2005-4#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-5#2)(2010-4#1)(2011-1#1)(2012-12#1)
the method when applied to##2##5##(2008-10#1)(2008-3#1)
the method which##2##3##(1991-9#1)(2006-6#1)
the method with##9##3##(1994-9#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-10#1)(2009-5#1)(2010-8#1)(2012-1#1)
the method works##2##3##(2008-11#1)(2008-2#1)
the method##1098##2##(1990-10#2)(1990-11#10)(1990-12#4)(1990-3#5)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#3)(1991-1#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#5)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#2)(1992-10#2)(1992-11#2)(1992-12#1)(1992-2#4)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#2)(1992-9#2)(1993-10#1)(1993-12#1)(1993-2#5)(1993-3#2)(1993-6#3)(1993-8#3)(1994-10#1)(1994-11#3)(1994-12#2)(1994-4#1)(1994-5#1)(1994-6#4)(1994-7#1)(1994-8#1)(1994-9#4)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-4#3)(1995-5#1)(1995-6#2)(1995-7#1)(1996-1#5)(1996-11#2)(1996-12#3)(1996-2#4)(1996-3#5)(1996-5#3)(1996-6#6)(1996-7#3)(1996-8#5)(1996-9#2)(1997-1#1)(1997-2#7)(1997-3#8)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#3)(1997-8#4)(2004-11#1)(2004-2#1)(2005-10#1)(2005-11#2)(2005-12#3)(2005-3#1)(2005-4#15)(2006-10#11)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#4)(2007-10#2)(2007-11#22)(2007-12#19)(2007-2#1)(2007-3#2)(2007-4#2)(2007-5#2)(2007-6#3)(2007-7#5)(2007-8#29)(2007-9#2)(2008-1#8)(2008-10#375)(2008-11#21)(2008-12#8)(2008-2#64)(2008-3#83)(2008-4#13)(2008-5#16)(2008-6#10)(2008-7#8)(2008-8#9)(2008-9#12)(2009-10#5)(2009-12#2)(2009-2#8)(2009-3#2)(2009-4#3)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#8)(2010-2#5)(2010-3#3)(2010-4#5)(2010-5#4)(2010-6#4)(2010-7#2)(2010-8#1)(2010-9#4)(2011-1#11)(2011-12#4)(2011-2#15)(2011-3#1)(2012-1#7)(2012-11#1)(2012-12#8)(2012-2#6)(2012-3#8)(2013-1#7)(2013-7#3)(2013-8#14)
the method's##9##2##(1997-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)
the methodological approach##2##3##(1992-3#1)(2008-10#1)
the methodological approaches and##2##4##(2008-1#1)(2009-6#1)
the methodological approaches##3##3##(2008-1#1)(2009-6#1)(2010-4#1)
the methodological issues##2##3##(2008-12#2)
the methodological problems##6##3##(1992-3#1)(1993-2#1)(1993-7#1)(1995-8#1)(2006-4#1)(2012-2#1)
the methodological quality of##2##4##(2008-11#1)(2011-2#1)
the methodological##25##2##(1991-11#1)(1991-12#1)(1992-3#3)(1993-2#1)(1993-3#1)(1993-7#1)(1995-8#1)(2006-4#1)(2007-1#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-8#1)(2009-6#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
the methodologies##6##2##(1996-9#1)(1997-6#1)(2006-12#1)(2008-7#1)(2012-12#1)(2013-7#1)
the methodology and##6##3##(1995-3#1)(2006-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2012-1#1)
the methodology based on##2##4##(2008-10#2)
the methodology can be used to##2##6##(1992-2#1)(2008-3#1)
the methodology developed##3##3##(2008-10#2)(2008-3#1)
the methodology employed to##2##4##(2006-11#1)(2008-11#1)
the methodology employed##4##3##(2006-10#1)(2006-11#1)(2008-10#1)(2008-11#1)
the methodology for##4##3##(1992-3#1)(1995-2#1)(2008-3#1)(2009-6#1)
the methodology in##2##3##(2006-11#1)(2008-10#1)
the methodology of the##3##4##(2007-5#1)(2008-7#1)(2011-1#1)
the methodology of##17##3##(1991-10#1)(1993-12#1)(1993-2#1)(2005-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
the methodology proposed by the##2##5##(2008-5#1)(2011-2#1)
the methodology to the##5##4##(2008-10#1)(2008-2#1)(2009-10#1)(2012-12#2)
the methodology to##7##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-10#1)(2012-12#2)
the methodology used##2##3##(1995-2#1)(2006-11#1)
the methodology was##2##3##(2007-1#1)(2008-7#1)
the methodology##84##2##(1991-10#1)(1991-2#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-6#1)(1995-2#3)(1995-3#1)(1996-12#1)(2005-11#1)(2006-10#3)(2006-11#3)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#15)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
the methods adopted##2##3##(1995-3#1)(2011-12#1)
the methods and materials presented##2##5##(2008-11#2)
the methods and##14##3##(1996-2#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-4#1)(2008-9#2)(2009-2#1)(2010-2#1)(2011-2#1)(2012-12#1)
the methods are applicable to##2##5##(1996-12#1)(2008-3#1)
the methods are##11##3##(1993-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(2008-10#2)(2008-3#2)(2008-4#1)(2011-1#1)(2012-1#1)
the methods available for##3##4##(2008-4#1)(2009-10#1)(2011-2#1)
the methods available to##2##4##(2013-1#2)
the methods available##5##3##(2008-4#1)(2009-10#1)(2011-2#1)(2013-1#2)
the methods based on##3##4##(1994-5#1)(2007-8#1)(2012-12#1)
the methods by which##2##4##(2007-9#1)(2008-9#1)
the methods can##2##3##(1993-1#1)(2008-9#1)
the methods considered##2##3##(2008-10#1)(2012-3#1)
the methods currently##2##3##(2006-2#1)(2008-1#1)
the methods described##7##3##(2006-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-5#1)
the methods developed##4##3##(1992-12#1)(2007-12#1)(2008-10#1)(2008-3#1)
the methods employed for##2##4##(1994-2#1)(2010-7#1)
the methods employed##6##3##(1991-3#1)(1994-2#1)(1997-2#1)(2006-9#1)(2008-11#1)(2010-7#1)
the methods for the##2##4##(2007-8#1)(2013-1#1)
the methods for##18##3##(2007-5#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-9#3)(2009-11#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
the methods have##2##3##(1994-11#1)(2008-12#1)
the methods in all##2##4##(2007-7#1)(2008-10#1)
the methods in##5##3##(1993-4#1)(2007-7#1)(2008-10#2)(2013-1#1)
the methods of choice##2##4##(1994-7#1)(2007-8#1)
the methods of examination##2##4##(1994-4#1)(2011-2#1)
the methods of##41##3##(1990-6#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-11#2)(1994-3#1)(1994-4#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-7#1)(1996-11#1)(2005-9#1)(2006-1#1)(2006-10#1)(2007-11#3)(2007-8#3)(2008-1#1)(2008-11#1)(2008-2#1)(2009-2#4)(2009-7#1)(2010-12#2)(2010-8#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2013-8#2)
the methods on##3##3##(1995-2#1)(1997-6#1)(2008-4#1)
the methods outlined##2##3##(2008-5#1)(2008-9#1)
the methods that have been##2##5##(2007-12#1)(2008-8#1)
the methods that use##2##4##(2008-3#2)
the methods that##8##3##(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2011-1#1)
the methods to evaluate##2##4##(2008-10#1)(2009-5#1)
the methods to##7##3##(2005-4#1)(2008-10#3)(2008-2#1)(2009-10#1)(2009-5#1)
the methods used by##3##4##(1990-1#1)(2005-7#1)(2010-2#1)
the methods used for##5##4##(1992-4#1)(1993-1#1)(2006-5#1)(2007-11#1)(2008-10#1)
the methods used in the##2##5##(2008-10#1)(2008-11#1)
the methods used to detect their activation involve determining phosphorylation state and protein kinase activities##2##15##(2008-1#1)(2008-2#1)
the methods used to generate##2##5##(2010-5#1)(2012-12#1)
the methods used to##16##4##(1997-7#1)(2007-11#3)(2007-7#2)(2008-1#2)(2008-11#1)(2008-2#1)(2008-4#3)(2010-5#1)(2011-1#1)(2012-12#1)
the methods used##32##3##(1990-1#1)(1991-2#1)(1992-4#1)(1993-1#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-11#4)(2007-12#1)(2007-7#4)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#3)(2010-2#2)(2010-5#1)(2011-1#1)(2012-12#1)
the methods using##2##3##(1996-1#1)(2009-10#1)
the methods we##5##3##(1994-6#1)(1996-12#1)(1997-6#1)(2013-1#2)
the methods were##5##3##(2008-10#5)
the methods which##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
the methods with##4##3##(1997-7#1)(2008-1#1)(2008-10#1)(2010-1#1)
the methods##261##2##(1990-1#1)(1990-6#2)(1991-2#1)(1991-3#1)(1991-5#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-1#3)(1993-11#2)(1993-12#1)(1993-4#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-4#2)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-7#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#2)(2005-11#1)(2005-4#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#8)(2007-12#4)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#8)(2007-9#2)(2008-1#6)(2008-10#39)(2008-11#8)(2008-12#1)(2008-2#9)(2008-3#9)(2008-4#12)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#9)(2009-10#4)(2009-11#1)(2009-2#5)(2009-5#1)(2009-7#1)(2009-9#3)(2010-1#1)(2010-12#4)(2010-2#5)(2010-5#3)(2010-7#2)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#2)(2012-12#7)(2012-2#1)(2012-3#4)(2013-1#6)(2013-8#3)
the methods'##3##2##(2007-11#1)(2010-2#1)(2010-3#1)
the methotrexate (MTX)##2##3##(1991-2#1)(1994-9#1)
the methotrexate complex##2##3##(1991-2#2)
the methotrexate##5##2##(1991-2#4)(1994-9#1)
the methoxy group##3##3##(1996-2#1)(1996-9#1)(2008-10#1)
the methoxy##8##2##(1991-4#1)(1993-6#1)(1996-2#1)(1996-5#1)(1996-9#1)(2008-10#1)(2008-5#1)(2010-12#1)
the methoxyl group##2##3##(1993-8#1)(2006-8#1)
the methyl donor##3##3##(1990-1#1)(1990-7#1)(1995-8#1)
the methyl ester##3##3##(1992-10#1)(1994-9#1)(1996-4#1)
the methyl esters of##2##4##(1994-3#1)(2008-10#1)
the methyl esters##4##3##(1994-3#1)(2008-10#1)(2008-5#1)(2010-12#1)
the methyl group of##4##4##(1990-4#1)(1994-7#1)(1997-2#1)(2005-12#1)
the methyl group##14##3##(1990-2#1)(1990-4#1)(1990-7#1)(1991-5#2)(1992-1#1)(1992-6#1)(1994-5#1)(1994-7#1)(1997-2#1)(2005-12#1)(2007-11#1)(2008-10#1)(2008-5#1)
the methyl phenyl derivative##2##4##(2007-11#2)
the methyl##41##2##(1990-1#2)(1990-2#2)(1990-4#1)(1990-7#2)(1991-2#1)(1991-5#3)(1992-1#1)(1992-10#1)(1992-12#1)(1992-6#1)(1992-7#2)(1994-3#1)(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-4#2)(1997-2#1)(2005-12#1)(2007-11#3)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#2)(2010-12#1)(2011-1#1)
the methyl-accepting##3##2##(1992-8#1)(1996-7#2)
the methylase##2##2##(1990-5#1)(1995-8#1)
the methylated##10##2##(1992-7#1)(1995-10#1)(1995-8#1)(1997-2#1)(1997-4#1)(2007-1#1)(2007-8#2)(2008-10#2)
the methylating##2##2##(1993-9#1)(2010-11#1)
the methylation of the##4##4##(1994-2#1)(1995-2#1)(1997-4#1)(2008-9#1)
the methylation of##11##3##(1994-2#1)(1994-8#1)(1995-2#1)(1995-8#1)(1997-4#1)(2007-11#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-2#2)
the methylation patterns of##2##4##(1995-12#1)(2008-7#1)
the methylation status of the##2##5##(1994-3#1)(2007-10#1)
the methylation status of##5##4##(1994-3#1)(2007-10#2)(2008-4#1)(2011-2#1)
the methylation##26##2##(1991-5#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-8#1)(1997-4#1)(2007-10#2)(2007-11#3)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-2#2)(2011-2#1)
the methylation-sensitive restriction enzyme##2##4##(1994-3#1)(1996-4#1)
the methylene blue dye reduction test##2##6##(2007-7#2)
the methylene blue##6##3##(2007-7#3)(2008-10#2)(2008-2#1)
the methylene group##6##3##(1990-2#1)(1997-1#2)(2005-12#1)(2008-5#1)(2011-2#1)
the methylene##15##2##(1990-2#1)(1994-8#1)(1997-1#2)(2005-12#1)(2007-7#3)(2008-10#2)(2008-2#1)(2008-5#2)(2011-2#1)(2013-1#1)
the methylotrophic yeast Pichia pastoris##6##5##(1994-11#1)(1994-3#1)(1996-11#1)(1996-9#1)(1997-4#1)(1997-7#1)
the methylotrophic yeast##11##3##(1994-11#2)(1994-3#1)(1995-8#1)(1996-11#1)(1996-9#1)(1997-4#4)(1997-7#1)
the methylotrophic##12##2##(1992-7#1)(1994-11#2)(1994-3#1)(1995-8#1)(1996-11#1)(1996-9#1)(1997-4#4)(1997-7#1)
the methyltransferase (MTase)##2##3##(1991-9#1)(1993-9#1)
the methyltransferase##4##2##(1991-9#1)(1993-9#1)(1994-12#1)(1995-8#1)
the metric used in##2##4##(2011-2#2)
the metric##7##2##(1997-8#1)(2008-3#1)(2008-6#1)(2009-10#1)(2011-2#3)
the metrics##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
the metrology##2##2##(2008-2#1)(2008-3#1)
the metropolitan area of Monterrey##2##5##(2006-10#1)(2011-1#1)
the metropolitan area of##3##4##(1991-6#1)(2006-10#1)(2011-1#1)
the metropolitan##5##2##(1991-6#1)(2006-10#1)(2007-12#1)(2011-1#1)(2013-8#1)
the mexican##2##2##(2008-10#2)
the mgt gene##2##3##(1993-11#2)
the miR-30 family##2##3##(2010-11#2)
the miRNA##3##2##(2007-12#1)(2008-1#1)(2013-8#1)
the miRNAs##2##2##(2010-1#1)(2011-2#1)
the mice irradiated at 0##2##5##(2008-7#2)
the mice were infected with Klebsiella pneumoniae##2##7##(2006-10#1)(2006-8#1)
the mice were infected##3##4##(2006-10#1)(2006-8#2)
the mice were treated with##3##5##(2008-7#1)(2008-9#1)(2009-3#1)
the mice were##17##3##(1995-10#1)(1995-8#1)(1995-9#1)(1996-5#1)(2005-10#1)(2006-10#1)(2006-8#2)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
the mice##57##2##(1991-8#1)(1992-7#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-6#1)(1995-10#1)(1995-12#2)(1995-8#3)(1995-9#2)(1996-10#1)(1996-11#1)(1996-4#1)(1996-5#2)(1997-2#1)(1997-4#3)(2005-10#2)(2006-10#2)(2006-8#4)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#4)(2008-9#1)(2009-3#1)(2010-1#1)(2010-3#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
the micellar medium##3##3##(2008-10#3)
the micellar phase##3##3##(1990-2#1)(1996-5#1)(2005-11#1)
the micellar state##4##3##(1992-7#1)(2008-10#3)
the micellar system##6##3##(1990-5#5)(1995-2#1)
the micellar##38##2##(1990-2#2)(1990-5#5)(1992-7#1)(1993-11#1)(1994-9#1)(1995-2#1)(1996-5#2)(1997-2#1)(2005-11#10)(2008-10#11)(2008-3#1)(2008-8#1)(2009-2#1)
the micelle##13##2##(1991-8#1)(1992-8#1)(2005-11#5)(2005-4#2)(2008-10#2)(2008-5#1)(2010-7#1)
the micelle-forming##2##2##(1996-5#1)(2008-3#1)
the micelles with##2##3##(2005-11#1)(2008-8#1)
the micelles##10##2##(1990-8#1)(1996-5#1)(2005-11#4)(2008-5#1)(2008-8#1)(2012-11#2)
the micro##6##2##(1997-3#1)(2007-9#1)(2008-10#2)(2011-1#2)
the micro- and nanoscale##2##4##(2010-4#2)
the micro- and##5##3##(1994-3#1)(2009-9#1)(2010-12#1)(2010-4#2)
the micro-channel by##2##3##(2007-8#2)
the micro-channel##4##2##(2007-8#4)
the micro-colorimetric method##2##3##(2008-10#2)
the micro-colorimetric##3##2##(2008-10#3)
the micro-flora in##2##3##(2006-8#2)
the micro-flora##3##2##(2006-8#3)
the micro-hardness of##2##3##(2012-12#2)
the micro-optical##2##2##(2008-2#1)(2008-3#1)
the micro-organism##2##2##(2011-2#2)
the micro-organisms##4##2##(2006-8#2)(2010-4#1)(2013-8#1)
the micro-regional##2##2##(2011-1#2)
the microalga##2##2##(2007-6#1)(2013-1#1)
the microalgae##3##2##(2012-2#1)(2013-1#2)
the microanatomical##2##2##(1994-6#1)(2008-5#1)
the microarray data##3##3##(2008-4#1)(2008-5#1)(2008-7#1)
the microarray##8##2##(2006-12#1)(2006-5#1)(2007-8#1)(2008-4#2)(2008-5#1)(2008-7#2)
the microarrays##2##2##(2008-7#1)(2010-4#1)
the microbe##7##2##(2007-1#1)(2007-11#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-2#1)
the microbial cell##4##3##(2008-11#2)(2008-4#1)(2008-6#1)
the microbial community##5##3##(2004-4#1)(2006-5#1)(2008-10#1)(2008-11#1)(2013-8#1)
the microbial complex that incites apple replant disease##2##8##(2008-10#2)
the microbial complex##3##3##(2008-10#3)
the microbial composition##2##3##(2008-10#1)(2010-5#1)
the microbial ecology of##3##4##(2007-12#1)(2008-10#1)(2008-5#1)
the microbial flora##2##3##(2011-12#2)
the microbial functional diversity##2##4##(2013-8#2)
the microbial load in##2##4##(2007-2#2)
the microbial load##3##3##(1997-5#1)(2007-2#2)
the microbial##61##2##(1992-8#1)(1994-12#1)(1995-9#1)(1997-5#1)(2004-4#1)(2005-11#2)(2006-12#1)(2006-3#2)(2006-5#1)(2006-8#2)(2007-11#1)(2007-12#3)(2007-2#2)(2007-3#2)(2008-1#1)(2008-10#10)(2008-11#4)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#2)(2010-4#1)(2010-5#1)(2011-1#2)(2011-12#2)(2011-2#1)(2012-12#2)(2012-2#2)(2013-8#5)
the microbicidal##3##2##(1992-10#1)(2007-7#1)(2008-4#1)
the microbiological and##2##3##(2007-3#1)(2012-2#1)
the microbiological laboratory##3##3##(1990-8#1)(2010-6#2)
the microbiological##11##2##(1990-8#1)(2005-10#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-5#1)(2010-6#2)(2012-2#1)(2013-7#1)(2013-8#1)
the microbiology laboratory##2##3##(2011-2#1)(2013-1#1)
the microbiology of##3##3##(1997-5#1)(2006-2#1)(2012-2#1)
the microbiology##6##2##(1997-5#1)(2006-2#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
the microbioreactor##2##2##(2008-11#2)
the microbiota of##3##3##(2011-12#1)(2011-2#1)(2012-2#1)
the microbiota##13##2##(2008-5#1)(2010-12#1)(2011-12#1)(2011-2#4)(2012-1#5)(2012-2#1)
the microcalcification foci##2##3##(2005-12#2)
the microcapillary##2##2##(2007-8#2)
the microcapsules was measured by##2##5##(2008-5#2)
the microcarrier##3##2##(2008-11#2)(2008-9#1)
the microcarriers##2##2##(2008-11#2)
the microcatheter##2##2##(2008-7#2)
the microcavity##3##2##(2007-12#2)(2008-3#1)
the microchannel##5##2##(2007-10#1)(2008-10#3)(2009-9#1)
the microchannels##5##2##(2007-5#1)(2008-10#1)(2008-11#3)
the microchip##11##2##(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#7)
the microcirculation in##4##3##(1996-3#1)(2005-10#1)(2009-11#1)(2010-7#1)
the microcirculation##12##2##(1990-8#1)(1991-2#1)(1991-4#1)(1996-3#1)(2005-10#1)(2008-5#1)(2009-11#1)(2009-4#1)(2010-12#1)(2010-7#2)(2010-9#1)
the microcirculatory##6##2##(1992-9#1)(2005-10#1)(2008-5#1)(2010-12#2)(2012-1#1)
the microcolumn##5##2##(2008-10#5)
the microcrystalline cellulose##4##3##(2008-5#1)(2010-12#3)
the microcrystalline##6##2##(2008-10#2)(2008-5#1)(2010-12#3)
the microdialysis probe is##2##4##(2008-10#2)
the microdialysis probe##5##3##(1996-9#1)(1997-2#2)(2008-10#2)
the microdialysis technique##3##3##(1995-12#1)(1996-9#1)(2008-8#1)
the microdialysis##10##2##(1995-12#1)(1996-11#1)(1996-6#1)(1996-9#2)(1997-2#2)(2008-10#2)(2008-8#1)
the microdissected dentate gyrus##2##4##(1996-9#2)
the microelectrode##7##2##(1993-12#1)(1997-1#1)(2008-10#4)(2010-2#1)
the microelectronic##2##2##(2008-2#1)(2008-3#1)
the microemulsion##7##2##(1991-2#1)(1995-2#1)(1996-5#1)(2005-11#1)(2005-4#1)(2007-11#1)(2008-10#1)
the microenvironment of the##4##4##(1996-8#1)(2005-8#1)(2008-10#1)(2011-1#1)
the microenvironment of##10##3##(1990-8#1)(1992-2#1)(1996-8#1)(2005-8#1)(2008-10#3)(2009-3#1)(2009-4#1)(2011-1#1)
the microenvironment##26##2##(1990-8#1)(1992-2#1)(1992-8#1)(1995-12#1)(1996-8#1)(2005-8#1)(2006-10#1)(2008-1#1)(2008-10#4)(2009-10#2)(2009-3#7)(2009-4#1)(2010-10#2)(2011-1#1)(2011-2#1)
the microenvironments##2##2##(2005-11#1)(2009-3#1)
the microfabrication##2##2##(2007-8#1)(2010-10#1)
the microfine oxides##2##3##(2008-5#2)
the microflora in##2##3##(2008-10#1)(2012-3#1)
the microflora of##2##3##(2008-5#2)
the microflora##7##2##(1995-11#1)(2006-10#1)(2008-10#1)(2008-5#2)(2012-1#1)(2012-3#1)
the microfluidic channels##4##3##(2008-11#2)(2008-3#1)(2010-8#1)
the microfluidic device##4##3##(2008-10#1)(2008-11#3)
the microfluidic##16##2##(2006-2#1)(2008-10#3)(2008-11#7)(2008-3#1)(2009-12#1)(2010-6#1)(2010-8#1)(2011-2#1)
the microgels##3##2##(2005-11#1)(2008-10#2)
the microglia##3##2##(1995-12#1)(1995-6#1)(2008-4#1)
the microglial response##2##3##(1997-3#1)(2008-4#1)
the microglial##3##2##(1997-3#1)(2008-4#2)
the microgram##2##2##(2008-10#2)
the micrographs##3##2##(1990-3#1)(2008-5#1)(2009-7#1)
the microgrooves##4##2##(2012-11#4)
the microhabitat##2##2##(2008-10#1)(2008-4#1)
the microheterogeneity of##2##3##(1990-8#1)(1996-3#1)
the microinjected##2##2##(1996-9#1)(1997-2#1)
the microlens##7##2##(2008-10#1)(2008-2#3)(2008-3#3)
the microm##2##2##(1996-11#2)
the micromechanical properties of##3##4##(2010-4#3)
the micromechanics of the##2##4##(1995-5#1)(2012-2#1)
the micrometer##7##2##(1997-2#1)(2005-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2012-2#1)
the micromolar concentration range##3##4##(1990-12#2)(2008-10#1)
the micromolar concentration##4##3##(1990-12#2)(2008-10#2)
the micromolar##15##2##(1990-12#2)(1990-2#1)(1991-10#1)(1992-4#1)(1994-5#1)(1994-8#1)(1995-5#1)(1997-1#1)(1997-7#1)(2006-12#1)(2008-10#3)(2008-4#1)
the microneedle##5##2##(2007-2#1)(2011-1#4)
the micronucleus frequency##2##3##(1993-8#2)
the micronucleus##4##2##(1993-8#2)(1997-2#1)(2008-8#1)
the micronutrient##4##2##(2006-10#2)(2006-4#1)(2009-5#1)
the microorganism##12##2##(1990-10#1)(1993-3#2)(2006-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-12#1)(2011-1#2)(2012-2#1)
the microorganisms studied##2##3##(2005-11#2)
the microorganisms##17##2##(1994-2#1)(1994-9#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-9#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
the microparticle##3##2##(1996-4#1)(2008-2#1)(2008-4#1)
the micropore size distribution##2##4##(2005-11#2)
the micropore##3##2##(2005-11#3)
the micropores##3##2##(2005-11#2)(2008-10#1)
the micropylar##6##2##(2007-12#1)(2008-11#1)(2008-9#1)(2009-12#2)(2010-8#1)
the micropyle##4##2##(1994-5#1)(2007-12#1)(2009-8#1)(2010-8#1)
the microsatellite marker##3##3##(2008-10#3)
the microsatellite markers##2##3##(2008-5#1)(2012-2#1)
the microsatellite##10##2##(2006-2#1)(2008-10#4)(2008-4#1)(2008-5#1)(2010-12#1)(2012-2#2)
the microscale##5##2##(2006-6#1)(2008-11#1)(2009-3#1)(2010-10#1)(2010-4#1)
the microscope and the##2##4##(2007-11#1)(2010-1#1)
the microscope##31##2##(1993-11#1)(1995-7#1)(2005-5#1)(2006-12#2)(2006-5#3)(2007-11#2)(2007-12#3)(2007-2#1)(2008-11#3)(2008-2#1)(2008-3#8)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-1#1)
the microscope's##4##2##(1992-5#1)(2006-6#1)(2007-11#1)(2008-3#1)
the microscopic activity##3##3##(2008-11#3)
the microscopic agglutination test (MAT)##2##5##(2005-7#1)(2006-10#1)
the microscopic level##3##3##(1990-5#1)(2005-11#1)(2013-8#1)
the microscopic rate constants##4##4##(1994-8#1)(1997-3#1)(2008-5#2)
the microscopic##39##2##(1990-5#1)(1991-6#1)(1992-6#1)(1993-6#1)(1994-8#1)(1995-3#2)(1997-3#1)(1997-8#1)(2005-11#2)(2005-12#1)(2005-7#1)(2006-10#3)(2007-11#2)(2007-3#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2009-7#1)(2010-4#1)(2013-1#1)(2013-8#2)
the microsecond time scale##4##4##(1990-8#1)(1995-2#1)(1996-2#1)(2008-2#1)
the microsecond##10##2##(1990-8#1)(1991-5#1)(1995-2#1)(1996-2#1)(1997-3#2)(1997-5#1)(2007-12#1)(2008-2#2)
the microshear bond strength##4##4##(2013-1#4)
the microsomal cytochrome P-450##2##4##(1992-11#1)(1993-9#1)
the microsomal cytochrome##3##3##(1991-12#1)(1992-11#1)(1993-9#1)
the microsomal fraction of##5##4##(1990-11#1)(1992-1#1)(1993-3#1)(1994-11#1)(1997-3#1)
the microsomal fraction##11##3##(1990-11#1)(1992-1#1)(1993-2#1)(1993-3#2)(1994-11#1)(1994-6#1)(1995-7#1)(1996-3#1)(1997-3#1)(1997-4#1)
the microsomal fractions from##2##4##(1990-2#1)(1994-5#1)
the microsomal fractions##5##3##(1990-11#1)(1990-2#1)(1990-6#1)(1994-3#1)(1994-5#1)
the microsomal membrane##3##3##(1991-9#2)(1994-12#1)
the microsomal membranes integrated pma+##2##5##(1990-11#2)
the microsomal membranes##8##3##(1990-11#2)(1991-12#1)(1991-3#2)(1993-11#1)(1993-3#1)(1994-12#1)
the microsomal oxidative demethylation of##2##5##(1993-8#2)
the microsomal oxysterol binding site##2##5##(1990-2#2)
the microsomal preparation##2##3##(1991-1#1)(1992-6#1)
the microsomal##53##2##(1990-11#4)(1990-12#1)(1990-2#5)(1990-6#2)(1991-1#1)(1991-12#2)(1991-3#3)(1991-9#4)(1992-1#1)(1992-11#1)(1992-6#2)(1993-11#1)(1993-2#1)(1993-3#3)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-7#2)(1996-3#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-4#1)(2011-2#2)
the microsomes by##2##3##(1990-6#1)(1997-8#1)
the microsomes##9##2##(1990-6#2)(1991-10#1)(1991-7#1)(1994-11#1)(1994-8#1)(1997-7#1)(1997-8#2)
the microsphere##3##2##(2006-12#1)(2007-1#1)(2010-12#1)
the microspheres##4##2##(2008-2#1)(2008-7#1)(2010-12#1)(2010-5#1)
the microstructure and##3##3##(2006-2#1)(2008-5#1)(2009-7#1)
the microstructure fiber##2##3##(2007-11#2)
the microstructure of the##5##4##(1991-3#2)(2008-5#1)(2009-7#2)
the microstructure of##12##3##(1991-3#3)(1992-5#1)(2008-10#1)(2008-5#4)(2009-7#2)(2010-4#1)
the microstructure##29##2##(1991-3#3)(1992-5#1)(2006-2#1)(2006-7#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-3#5)(2008-5#5)(2009-7#6)(2010-4#2)
the microstructures##2##2##(2007-8#1)(2010-9#1)
the microsurgical##5##2##(2006-5#1)(2006-6#1)(2007-7#1)(2008-9#1)(2012-3#1)
the microsyringe needle##2##3##(2008-10#2)
the microsyringe##3##2##(2008-10#3)
the microtopography of##2##3##(2008-3#1)(2008-5#1)
the microtopography##4##2##(2007-3#1)(2008-3#1)(2008-5#2)
the microtubular cytoskeleton##2##3##(1991-9#1)(2008-11#1)
the microtubular system##4##3##(1990-4#1)(1994-8#3)
the microtubular##6##2##(1990-4#1)(1991-9#1)(1994-8#3)(2008-11#1)
the microtubule length##3##3##(1995-1#1)(2006-10#1)(2008-5#1)
the microtubule network##2##3##(2010-2#1)(2013-1#1)
the microtubule organizing center (MTOC)##2##5##(2008-8#1)(2013-1#1)
the microtubule organizing center##3##4##(2008-8#1)(2008-9#1)(2013-1#1)
the microtubule system##2##3##(2009-10#2)
the microtubule##19##2##(1991-9#1)(1994-2#1)(1994-9#1)(1995-1#3)(1995-3#1)(2006-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-7#1)(2010-2#1)(2012-2#1)(2013-1#2)
the microtubule-associated protein tau##2##4##(1995-11#1)(1995-3#1)
the microtubule-associated protein##4##3##(1994-12#1)(1995-11#1)(1995-3#1)(2007-10#1)
the microtubule-associated##5##2##(1994-12#1)(1995-11#1)(1995-3#1)(1997-6#1)(2007-10#1)
the microtubules##5##2##(1990-3#1)(1992-5#1)(1994-2#1)(2007-8#1)(2008-7#1)
the microvascular response to norepinephrine##2##5##(1994-8#2)
the microvascular response to##3##4##(1994-8#2)(2006-10#1)
the microvascular##9##2##(1990-5#1)(1994-8#2)(1995-10#1)(2006-10#1)(2007-8#1)(2011-1#1)(2013-1#2)
the microvasculature of##2##3##(2008-1#1)(2011-2#1)
the microvasculature##6##2##(1991-9#1)(2005-10#1)(2008-1#1)(2009-10#1)(2009-4#1)(2011-2#1)
the microvesicles##2##2##(1990-12#2)
the microvillar##3##2##(2007-12#2)(2008-7#1)
the microvilli and##2##3##(1995-2#1)(2008-7#1)
the microvilli of the##2##4##(2007-12#1)(2008-7#1)
the microvilli##8##2##(1995-2#1)(2007-12#3)(2008-7#4)
the microvillous border##2##3##(1996-3#2)
the microvillous##3##2##(1991-12#1)(1996-3#2)
the microwave and##3##3##(2008-1#1)(2008-2#1)(2012-12#1)
the microwave assisted##3##3##(2007-11#2)(2007-8#1)
the microwave digestion of##2##4##(2005-4#1)(2008-10#1)
the microwave digestion##3##3##(2005-4#1)(2008-10#2)
the microwave oven##2##3##(2008-10#2)
the microwave##26##2##(1994-10#1)(2005-4#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#9)(2008-2#4)(2008-3#1)(2010-4#1)(2012-12#1)(2013-8#1)
the microwave-assisted##5##2##(2007-8#1)(2008-10#4)
the microwaves##2##2##(2008-10#1)(2008-3#1)
the micturition reflex##6##3##(1990-5#3)(1992-3#2)(2010-8#1)
the micturition##7##2##(1990-5#4)(1992-3#2)(2010-8#1)
the mid 1970s##3##3##(2007-1#1)(2008-12#1)(2008-5#1)
the mid 1980's##2##3##(2007-4#1)(2011-2#1)
the mid 1980s##2##3##(1996-1#1)(2008-7#1)
the mid and##3##3##(2006-11#1)(2007-4#1)(2008-10#1)
the mid point of the humerus##3##6##(2013-8#3)
the mid to##4##3##(2005-8#1)(2011-2#1)(2012-3#1)(2013-7#1)
the mid##40##2##(1991-8#1)(1996-1#1)(2005-12#1)(2005-8#1)(2006-11#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-2#1)(2007-4#3)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-7#1)(2010-3#1)(2011-2#2)(2012-3#2)(2013-7#1)(2013-8#3)
the mid- and##4##3##(2008-10#2)(2009-7#2)
the mid-##6##2##(1993-10#1)(2008-10#3)(2009-7#2)
the mid-1950s##2##2##(2008-7#1)(2010-8#1)
the mid-1960s##3##2##(2004-4#1)(2012-1#1)(2013-8#1)
the mid-1970s##5##2##(1991-9#1)(1995-8#1)(2005-8#1)(2007-7#1)(2009-2#1)
the mid-1980s##9##2##(1990-3#1)(1991-2#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-9#1)(2008-1#1)(2010-3#1)(2010-4#1)
the mid-1990 s##2##3##(2008-4#1)(2009-12#1)
the mid-1990s##9##2##(2005-11#1)(2006-7#2)(2009-10#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
the mid-IR##10##2##(2007-12#4)(2008-10#2)(2008-2#2)(2008-3#2)
the mid-blastula transition##3##3##(1994-12#1)(1994-5#2)
the mid-depth zone##3##3##(1991-10#3)
the mid-exponential phase##2##3##(2008-11#1)(2008-5#1)
the mid-exponential##3##2##(1996-7#1)(2008-11#1)(2008-5#1)
the mid-gut gland of Patnopecten##2##5##(1990-5#2)
the mid-infrared region##8##3##(2006-12#1)(2007-11#1)(2008-2#3)(2008-3#3)
the mid-infrared wavelength##2##3##(2007-11#1)(2008-3#1)
the mid-infrared##23##2##(2006-12#1)(2007-11#6)(2007-12#3)(2008-1#1)(2008-2#4)(2008-3#8)
the mid-point##2##2##(1995-12#1)(2013-8#1)
the mid-region (amino##2##3##(1990-12#1)(1991-9#1)
the mid-region##3##2##(1990-12#1)(1991-9#1)(2008-4#1)
the mid-shaft bending moments at failure##2##6##(2007-1#2)
the mid-shaft##4##2##(2007-1#3)(2011-2#1)
the mid-term##12##2##(2007-8#9)(2008-10#1)(2009-3#1)(2009-4#1)
the mid-visible##2##2##(2008-2#1)(2008-3#1)
the midbrain##25##2##(1991-11#3)(1991-3#1)(1992-7#1)(1993-12#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-5#2)(2007-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-10#1)(2010-10#1)
the midcarpal joint##2##3##(2006-3#1)(2012-2#1)
the midcollicular line and microinjected with IC##3##7##(1992-11#3)
the midcollicular line##4##3##(1992-11#4)
the midcollicular##5##2##(1992-11#4)(2007-1#1)
the middle Miocene##3##3##(1991-11#2)(2011-2#1)
the middle and inner ear##2##5##(1990-8#1)(2006-12#1)
the middle and lower Keys##2##5##(2007-5#2)
the middle and lower##4##4##(2007-5#2)(2013-1#1)(2013-8#1)
the middle and posterior##4##4##(1996-1#1)(2005-5#1)(2006-12#1)(2008-7#1)
the middle and##17##3##(1990-8#1)(1991-9#1)(1994-6#1)(1996-1#1)(2005-11#1)(2005-5#1)(2006-1#1)(2006-12#2)(2007-12#1)(2007-5#2)(2008-7#1)(2008-9#2)(2013-1#1)(2013-8#1)
the middle cerebral artery (MCA)##7##5##(1996-1#1)(1996-5#1)(2006-11#1)(2007-10#2)(2008-12#1)(2008-7#1)
the middle cerebral artery in##2##5##(2006-11#1)(2007-10#1)
the middle cerebral artery occlusion##2##5##(2007-9#1)(2008-10#1)
the middle cerebral artery territory##2##5##(2007-9#2)
the middle cerebral artery##39##4##(1991-6#1)(1994-10#1)(1996-1#1)(1996-5#1)(1997-6#1)(1997-8#1)(2006-11#2)(2006-5#1)(2007-10#10)(2007-8#1)(2007-9#6)(2008-10#1)(2008-12#2)(2008-4#1)(2008-7#6)(2010-11#1)(2010-12#1)(2011-1#1)
the middle cerebral##41##3##(1991-6#1)(1994-10#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-6#1)(1997-8#1)(2006-11#3)(2006-5#1)(2007-10#10)(2007-8#1)(2007-9#6)(2008-10#1)(2008-12#2)(2008-4#1)(2008-7#6)(2010-11#1)(2010-12#1)(2011-1#1)
the middle cranial fossa##2##4##(2006-12#1)(2008-7#1)
the middle deltoid##2##3##(2009-3#2)
the middle dose##2##3##(2008-3#2)
the middle ear##20##3##(1991-1#1)(1991-3#3)(1993-12#1)(1995-4#3)(1995-5#1)(2007-2#4)(2007-9#2)(2008-1#1)(2010-2#1)(2013-1#2)(2013-7#1)
the middle fossa##4##3##(2006-12#2)(2008-7#1)(2011-2#1)
the middle layer##4##3##(1991-9#1)(2008-8#1)(2010-8#2)
the middle layers##2##3##(1993-12#1)(2013-1#1)
the middle meningeal artery##5##4##(1996-9#2)(2007-12#1)(2008-12#2)
the middle of the##46##4##(1990-10#1)(1991-1#1)(1991-11#2)(1991-4#1)(1992-11#1)(1992-2#1)(1992-7#1)(1992-9#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-6#1)(1995-8#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-11#1)(2009-7#3)(2011-2#1)(2012-2#1)(2013-7#1)
the middle of##58##3##(1990-10#1)(1991-1#1)(1991-11#3)(1991-12#1)(1991-4#1)(1992-11#1)(1992-2#1)(1992-7#1)(1992-9#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#3)(2009-10#1)(2009-11#1)(2009-7#3)(2010-1#1)(2010-4#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-7#1)
the middle phase##3##3##(2008-10#3)
the middle portion of the##2##5##(2007-8#1)(2008-7#1)
the middle portion of##4##4##(1992-3#1)(1993-6#1)(2007-8#1)(2008-7#1)
the middle rectum##2##3##(1993-10#1)(2013-8#1)
the middle temporal gyrus##2##4##(1996-2#1)(1996-9#1)
the middle temporal##4##3##(1996-2#1)(1996-9#1)(2008-9#2)
the middle third of the##7##5##(1991-4#1)(1993-2#1)(2006-2#1)(2007-12#2)(2007-2#1)(2009-2#1)
the middle to the##2##4##(2007-1#1)(2007-5#1)
the middle to##6##3##(1990-11#1)(1993-6#1)(2007-1#1)(2007-5#1)(2007-6#1)(2013-8#1)
the middle turbinate##3##3##(2008-5#3)
the middle##253##2##(1990-10#1)(1990-11#1)(1990-8#1)(1991-1#2)(1991-11#5)(1991-12#1)(1991-3#3)(1991-4#2)(1991-6#1)(1991-9#2)(1992-11#1)(1992-2#2)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#3)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-4#1)(1993-6#3)(1993-8#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-4#1)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#1)(1995-12#2)(1995-4#3)(1995-5#2)(1995-6#4)(1995-8#1)(1996-1#2)(1996-2#3)(1996-3#1)(1996-5#1)(1996-9#3)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#3)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-5#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#3)(2006-12#5)(2006-2#1)(2006-3#3)(2006-5#2)(2006-8#1)(2007-1#1)(2007-10#10)(2007-11#1)(2007-12#8)(2007-2#7)(2007-5#3)(2007-6#2)(2007-8#4)(2007-9#8)(2008-1#3)(2008-10#13)(2008-11#2)(2008-12#6)(2008-2#2)(2008-3#8)(2008-4#2)(2008-5#6)(2008-7#10)(2008-8#4)(2008-9#5)(2009-10#1)(2009-11#3)(2009-2#1)(2009-3#2)(2009-7#4)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#6)(2011-3#1)(2012-12#7)(2012-2#1)(2013-1#4)(2013-7#2)(2013-8#4)
the midface and##3##3##(1996-6#1)(2007-12#1)(2010-11#1)
the midface##9##2##(1996-6#1)(2007-12#3)(2010-11#3)(2010-8#1)(2012-12#1)
the midge##2##2##(1991-5#1)(2004-4#1)
the midget##4##2##(2008-5#4)
the midgut and salivary glands##3##5##(2008-10#2)(2008-11#1)
the midgut and##7##3##(2007-12#1)(2008-10#3)(2008-11#1)(2008-6#1)(2013-1#1)
the midgut cells##2##3##(1996-3#1)(2007-12#1)
the midgut epithelial cells of##2##5##(1994-3#1)(1996-3#1)
the midgut epithelial cells##3##4##(1994-3#1)(1996-3#2)
the midgut epithelium in##2##4##(2007-12#2)
the midgut epithelium##5##3##(2007-12#2)(2008-12#2)(2008-7#1)
the midgut lumen##2##3##(2007-12#2)
the midgut of adult##2##4##(2008-10#2)
the midgut of##4##3##(1991-12#1)(1993-12#1)(2008-10#2)
the midgut##46##2##(1991-12#1)(1992-3#2)(1993-12#1)(1994-3#1)(1996-3#4)(1997-3#1)(2007-12#9)(2008-10#12)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#2)(2011-1#4)(2013-1#1)(2013-7#4)
the midline of the##6##4##(1992-9#1)(1995-5#1)(2007-1#1)(2007-12#1)(2010-12#1)(2012-2#1)
the midline##32##2##(1990-8#1)(1991-3#1)(1992-9#1)(1995-5#1)(1996-12#1)(1997-1#1)(1997-5#2)(2005-9#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-12#3)(2008-12#1)(2008-2#4)(2009-1#1)(2009-6#1)(2010-12#1)(2011-1#2)(2012-12#2)(2012-2#1)(2013-1#3)
the midplane of##2##3##(1995-6#1)(2008-3#1)
the midpoint of the##7##4##(1995-1#1)(1995-2#1)(1995-4#1)(1997-2#1)(1997-7#1)(2007-9#1)(2010-12#1)
the midpoint of##8##3##(1995-1#1)(1995-2#1)(1995-4#1)(1997-2#1)(1997-7#1)(2007-9#1)(2008-12#1)(2010-12#1)
the midpoint potential of##2##4##(1997-4#1)(1997-7#1)
the midpoint potentials##5##3##(1995-10#1)(1995-6#1)(1995-8#1)(2008-10#2)
the midpoint##19##2##(1995-1#1)(1995-10#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-4#1)(1997-7#2)(2006-10#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#2)(2010-12#1)
the midportion of the##2##4##(1990-6#1)(1996-6#1)
the midrange market##2##3##(1993-2#2)
the midrange##3##2##(1993-2#2)(2007-12#1)
the midsagittal plane##3##3##(1996-5#2)(1996-7#1)
the midsagittal##6##2##(1995-5#2)(1996-5#2)(1996-7#2)
the midsize adult male##3##4##(2006-11#2)(2007-4#1)
the midst of the##2##4##(2008-12#1)(2011-1#1)
the midst of##12##3##(1993-12#3)(1993-2#1)(1995-12#1)(1996-12#1)(2007-10#1)(2007-4#1)(2007-7#1)(2008-12#1)(2008-3#1)(2011-1#1)
the midwestern##3##2##(2006-11#1)(2008-10#1)(2011-2#1)
the midwife##2##2##(1993-3#1)(2013-1#1)
the midwifery model of care##3##5##(2007-2#2)(2010-9#1)
the midwives##2##2##(2009-10#2)
the migraine attack##3##3##(2008-9#3)
the migraine##5##2##(1994-11#1)(2007-10#1)(2008-9#3)
the migrant##4##2##(2008-12#1)(2008-2#1)(2008-3#1)(2013-8#1)
the migrating##3##2##(2008-2#1)(2008-7#1)(2009-7#1)
the migration and invasion of NSCLC##2##6##(2013-8#2)
the migration and invasion of##3##5##(2012-3#1)(2013-8#2)
the migration and invasion##4##4##(1993-7#1)(2012-3#1)(2013-8#2)
the migration and##6##3##(1993-7#1)(2008-11#1)(2012-3#1)(2013-8#3)
the migration indices##2##3##(1996-5#2)
the migration of cells##2##4##(2012-12#1)(2013-8#1)
the migration of the##6##4##(1994-12#1)(1997-6#1)(2005-11#1)(2008-10#1)(2008-4#1)(2008-9#1)
the migration of these cells##3##5##(1995-11#1)(2008-7#1)(2012-2#1)
the migration of##34##3##(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-8#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-3#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
the migration pool##2##3##(2008-8#2)
the migration route##2##3##(2008-5#1)(2008-6#1)
the migration time and##5##4##(1996-5#1)(2008-10#4)
the migration time of##2##4##(1996-5#1)(2008-10#1)
the migration time##11##3##(1996-5#2)(1997-8#1)(2008-10#8)
the migration times##2##3##(2008-10#2)
the migration##74##2##(1992-2#1)(1993-2#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-5#5)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-3#1)(2007-9#2)(2008-1#2)(2008-10#14)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-8#4)
the migration/invasion abilities of breast stromal fibroblasts##2##7##(2013-1#2)
the migratory behavior##2##3##(2008-6#1)(2008-8#1)
the migratory journey and##2##4##(2008-2#2)
the migratory##16##2##(1997-4#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-6#1)(2008-8#2)(2009-7#1)(2009-9#2)(2011-2#1)(2012-3#2)
the mild strain##2##3##(2008-10#2)
the mild subgroup##2##3##(2009-2#2)
the mild##16##2##(1991-11#1)(1993-12#1)(1996-3#1)(1996-9#1)(2004-11#1)(2006-6#1)(2007-10#2)(2008-10#4)(2008-4#2)(2009-2#2)
the mildly##2##2##(1996-2#1)(2008-1#1)
the milieu##2##2##(2006-6#1)(2013-8#1)
the military hospital##2##3##(2007-8#1)(2009-6#1)
the military to##2##3##(1992-3#1)(1995-6#1)
the military##22##2##(1990-3#1)(1991-3#1)(1992-3#1)(1993-3#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-6#1)(2004-7#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-12#1)
the milk and##5##3##(2007-7#2)(2008-12#1)(2009-8#1)(2013-1#1)
the milk of transgenic##2##4##(1994-5#1)(2008-12#1)
the milk of##9##3##(1994-5#1)(1997-8#2)(2006-10#1)(2008-10#2)(2008-12#2)(2013-1#1)
the milk samples were##2##4##(2008-10#2)
the milk samples##4##3##(2008-10#4)
the milk##39##2##(1990-7#1)(1991-8#1)(1992-10#1)(1994-5#2)(1997-2#1)(1997-8#2)(2006-10#1)(2007-4#1)(2007-7#3)(2008-10#9)(2008-12#3)(2009-8#1)(2010-2#3)(2011-2#1)(2012-1#3)(2012-2#2)(2013-1#3)(2013-8#1)
the millennium##8##2##(1996-12#1)(2004-1#1)(2004-3#1)(2005-8#1)(2006-10#2)(2008-4#2)
the millimeter range##2##3##(2007-11#1)(2008-3#1)
the millimeter##4##2##(2007-11#1)(2008-3#2)(2013-7#1)
the millimolar range##7##3##(1990-11#1)(1992-11#1)(1992-3#1)(1994-5#1)(1995-5#1)(1996-9#2)
the millimolar##8##2##(1990-11#1)(1992-11#1)(1992-3#1)(1994-10#1)(1994-5#1)(1995-5#1)(1996-9#2)
the millions##3##2##(2007-2#1)(2008-10#1)(2010-1#1)
the millisecond timescale##2##3##(1991-4#1)(2006-10#1)
the millisecond##6##2##(1991-4#1)(1997-3#1)(2006-10#1)(2006-5#1)(2008-2#2)
the mimetic##2##2##(2006-2#1)(2010-5#1)
the minced##2##2##(2008-10#1)(2008-4#1)
the mind and##3##3##(2006-3#1)(2009-10#1)(2012-2#1)
the mind##14##2##(2006-3#1)(2006-9#1)(2008-12#1)(2008-4#1)(2008-5#4)(2009-10#3)(2012-2#3)
the mind/body##2##2##(1992-8#1)(2009-9#1)
the mind/brain##2##2##(2008-7#1)(2011-12#1)
the mine##4##2##(2005-11#2)(2008-10#2)
the mineral composition of##2##4##(2008-10#1)(2008-5#1)
the mineral content##2##3##(1990-11#1)(2009-7#1)
the mineral oil content##2##4##(2004-4#2)
the mineral oil##3##3##(2004-4#3)
the mineral soil fraction##2##4##(2008-10#2)
the mineral surfaces##2##3##(2005-11#2)
the mineral water group##3##4##(2008-5#3)
the mineral water##5##3##(1990-10#1)(2008-10#1)(2008-5#3)
the mineral##41##2##(1990-10#1)(1990-11#1)(1991-6#1)(1992-3#1)(1993-11#1)(1994-3#1)(2004-4#3)(2005-10#1)(2005-11#10)(2006-6#3)(2007-5#1)(2008-10#7)(2008-5#6)(2008-8#1)(2009-7#1)(2010-2#1)(2013-8#1)
the mineralization of##2##3##(2005-12#1)(2008-10#1)
the mineralization process##2##3##(1992-12#1)(2009-7#1)
the mineralization##8##2##(1992-12#1)(2005-12#1)(2008-10#2)(2008-4#1)(2009-3#1)(2009-7#2)
the mineralized##4##2##(2008-10#1)(2009-8#1)(2013-8#2)
the mineralocorticoid receptor##3##3##(1994-11#1)(1996-4#1)(1996-5#1)
the mineralocorticoid##5##2##(1991-6#1)(1994-11#1)(1996-4#1)(1996-5#1)(2008-8#1)
the mineralogical##4##2##(2008-10#4)
the miners##2##2##(2008-6#1)(2009-4#1)
the mini##3##2##(2007-10#1)(2010-5#1)(2011-2#1)
the mini-Tn5 delivery system##2##4##(1997-2#2)
the mini-Tn5##3##2##(1993-11#1)(1997-2#2)
the mini-pig##2##2##(2011-12#1)(2013-1#1)
the mini-spider plate##2##3##(2006-3#2)
the miniature##5##2##(1992-12#1)(1994-9#1)(2008-10#2)(2009-10#1)
the miniaturization of the##2##4##(2008-10#2)
the miniaturization of##5##3##(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)
the miniaturization##6##2##(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#1)
the minicolumn##8##2##(2008-10#8)
the minigene##3##2##(1995-1#3)
the minimAl homeodomain##4##3##(1994-8#4)
the minima of##2##3##(2008-10#1)(2008-11#1)
the minima##5##2##(2008-10#1)(2008-11#1)(2008-2#1)(2009-5#2)
the minimal amount of##2##4##(2008-10#2)
the minimal erythema dose (MED)##3##5##(1992-2#1)(2007-7#1)(2011-2#1)
the minimal inhibitory concentration (MIC)##4##5##(2009-6#1)(2011-1#1)(2011-2#2)
the minimal model##3##3##(2010-2#2)(2012-2#1)
the minimal number of##2##4##(1994-3#1)(2011-2#1)
the minimal or##2##3##(1992-3#1)(2006-12#1)
the minimal promoter##3##3##(1990-4#1)(1995-8#1)(1997-6#1)
the minimal sample##2##3##(2008-10#2)
the minimal sequence##2##3##(1995-2#1)(1997-2#1)
the minimal##74##2##(1990-11#1)(1990-4#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#2)(1992-2#2)(1992-3#1)(1992-4#1)(1993-12#2)(1993-2#1)(1994-12#1)(1994-3#1)(1994-9#3)(1995-1#1)(1995-2#3)(1995-3#2)(1995-4#1)(1995-8#1)(1996-5#1)(1996-8#3)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(2005-5#1)(2006-12#2)(2006-5#1)(2006-8#1)(2007-4#1)(2007-7#1)(2008-10#7)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-2#2)(2011-1#1)(2011-2#4)(2012-2#5)(2012-3#1)(2013-1#1)
the minimally invasive pain surgical##2##5##(2011-1#2)
the minimally invasive##7##3##(2006-10#1)(2006-7#1)(2007-5#1)(2011-1#2)(2011-2#1)(2013-1#1)
the minimally##10##2##(2006-10#2)(2006-7#1)(2007-5#1)(2007-8#1)(2008-10#1)(2011-1#2)(2011-2#1)(2013-1#1)
the minimisation of##2##3##(2008-10#1)(2011-2#1)
the minimization of a##2##4##(2008-2#2)
the minimization of the##2##4##(2006-6#1)(2008-3#1)
the minimization of##11##3##(1995-9#1)(2006-6#1)(2007-6#1)(2008-2#4)(2008-3#4)
the minimization##13##2##(1995-9#1)(2006-6#1)(2007-6#1)(2008-10#1)(2008-2#4)(2008-3#5)
the minimum acceptable##2##3##(2007-2#1)(2007-4#1)
the minimum amount which can be injected is##2##8##(1992-2#2)
the minimum amount##3##3##(1992-2#2)(2008-10#1)
the minimum and maximum##3##4##(2008-5#1)(2010-9#1)(2013-8#1)
the minimum and##4##3##(2008-10#1)(2008-5#1)(2010-9#1)(2013-8#1)
the minimum concentration of##2##4##(1993-1#1)(2008-10#1)
the minimum concentration##4##3##(1993-1#1)(2008-10#2)(2008-5#1)
the minimum description length principle##2##5##(2007-11#1)(2008-6#1)
the minimum detectable signal##2##4##(2008-2#2)
the minimum detectable##4##3##(1991-1#1)(1992-2#1)(2008-2#2)
the minimum error in##2##4##(2008-10#1)(2008-3#1)
the minimum error##4##3##(2008-10#2)(2008-3#2)
the minimum expected##2##3##(1992-3#1)(1995-4#1)
the minimum feature##2##3##(2008-10#1)(2008-3#1)
the minimum in##2##3##(2008-2#1)(2013-8#1)
the minimum infective dose##2##4##(2009-6#2)
the minimum inhibitory concentration (MIC)##3##5##(1991-8#1)(1994-12#1)(2006-8#1)
the minimum inhibitory concentration##9##4##(1991-8#1)(1994-12#1)(2006-10#3)(2006-8#2)(2010-5#1)(2012-11#1)
the minimum inhibitory concentrations##2##4##(2008-5#1)(2010-4#1)
the minimum inhibitory##11##3##(1991-8#1)(1994-12#1)(2006-10#3)(2006-8#2)(2008-5#1)(2010-4#1)(2010-5#1)(2012-11#1)
the minimum intrahelical distance##2##4##(2013-8#2)
the minimum necessary##3##3##(1994-3#1)(1996-12#1)(2006-8#1)
the minimum number of patients##2##5##(2012-2#2)
the minimum number of recombinations##2##5##(2006-10#2)
the minimum number of##15##4##(1992-9#1)(2006-10#3)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#1)(2008-8#1)(2012-2#2)
the minimum of##5##3##(1993-1#1)(1996-8#1)(2007-8#1)(2008-10#1)(2008-11#1)
the minimum possible##2##3##(2008-10#1)(2008-3#1)
the minimum recommended##2##3##(1996-12#1)(1997-3#1)
the minimum required number of index subjects##2##7##(1996-3#2)
the minimum required performance##2##4##(2007-8#1)(2008-10#1)
the minimum required training sample size was approximately 125 samples for SVM classifiers with inverted cross-validation##2##16##(2013-1#2)
the minimum required##8##3##(1991-11#1)(1996-3#2)(2007-8#1)(2008-10#2)(2013-1#2)
the minimum sample size required to detect##2##7##(1992-9#1)(1994-6#1)
the minimum sample size##3##4##(1992-9#1)(1994-6#1)(2010-2#1)
the minimum size of##2##4##(1993-4#1)(1995-5#1)
the minimum standard##2##3##(2005-3#1)(2011-2#1)
the minimum temperature##4##3##(1995-6#1)(2008-10#1)(2008-2#1)(2008-8#1)
the minimum toe clearance##2##4##(2010-2#2)
the minimum value##3##3##(2009-9#1)(2013-8#2)
the minimum values##4##3##(2005-11#1)(2008-2#2)(2008-5#1)
the minimum viable metapopulation size##2##5##(2007-9#2)
the minimum##184##2##(1990-11#1)(1990-4#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-8#3)(1992-2#5)(1992-3#1)(1992-9#2)(1993-1#2)(1993-3#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-7#1)(1994-9#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#2)(1996-3#2)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#1)(2004-12#1)(2005-11#2)(2005-3#1)(2006-10#7)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#3)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#2)(2007-5#1)(2007-8#2)(2007-9#2)(2008-10#18)(2008-11#3)(2008-2#21)(2008-3#13)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#2)(2008-8#6)(2008-9#1)(2009-6#4)(2009-7#1)(2009-9#1)(2010-10#1)(2010-2#3)(2010-4#2)(2010-5#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#4)(2013-1#7)(2013-7#1)(2013-8#7)
the mining##3##2##(1993-9#1)(2005-11#1)(2009-4#1)
the minor allele##3##3##(2010-12#2)(2012-3#1)
the minor component##2##3##(1997-7#1)(2007-12#1)
the minor components##2##3##(2008-10#2)
the minor groove in the##2##5##(1990-5#1)(1996-7#1)
the minor groove of DNA##2##5##(1995-7#1)(1996-3#1)
the minor groove of the DNA##3##6##(1990-2#1)(1995-1#1)(1996-2#1)
the minor groove of the##6##5##(1990-2#1)(1993-1#1)(1994-5#1)(1995-1#1)(1995-3#1)(1996-2#1)
the minor groove of##12##4##(1990-2#1)(1991-4#1)(1992-3#1)(1993-1#1)(1994-5#1)(1995-1#1)(1995-3#1)(1995-7#1)(1996-2#1)(1996-3#1)(2006-12#1)(2008-4#1)
the minor groove##28##3##(1990-2#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-4#2)(1992-3#1)(1992-9#1)(1993-1#2)(1993-3#2)(1994-5#2)(1995-1#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-5#1)(2005-11#2)(2006-12#2)(2008-4#1)
the minor papilla##3##3##(1995-4#1)(2007-5#1)(2008-3#1)
the minor salivary glands##2##4##(1991-11#1)(1991-9#1)
the minor salivary##3##3##(1991-11#1)(1991-9#1)(2008-4#1)
the minor##76##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-3#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-12#2)(1993-3#2)(1994-5#3)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-5#1)(1997-7#1)(2005-11#2)(2006-12#2)(2006-8#1)(2007-11#1)(2007-12#4)(2007-5#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-4#4)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#2)(2010-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
the minority of patients##2##4##(2006-9#1)(2010-12#1)
the minority of##5##3##(1993-1#1)(2005-8#1)(2006-9#1)(2010-12#1)(2013-7#1)
the minority##13##2##(1993-1#1)(1994-3#1)(2004-2#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-2#1)(2008-9#1)(2010-12#1)(2010-5#1)(2010-8#1)(2013-7#1)
the minus strand##3##3##(1990-10#2)(1990-11#1)
the minus##5##2##(1990-10#2)(1990-11#1)(1995-3#1)(2008-5#1)
the minute virus of mice##2##5##(1993-5#2)
the minute volume##2##3##(2007-9#2)
the minute##13##2##(1992-9#1)(1993-5#2)(2006-10#1)(2007-11#1)(2007-12#3)(2007-9#2)(2008-10#1)(2008-3#1)(2013-7#1)
the minutes##3##2##(1991-7#1)(1993-3#1)(2013-1#1)
the mipA gene##2##3##(1990-6#2)
the miracle##2##2##(2007-2#1)(2011-2#1)
the mirror is##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
the mirror neuron system##2##4##(2008-11#2)
the mirror##35##2##(1997-7#1)(2007-11#2)(2007-12#7)(2007-4#1)(2007-9#1)(2008-1#2)(2008-11#2)(2008-2#10)(2008-3#7)(2008-4#1)(2008-5#1)
the mirrors##15##2##(2006-5#2)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#8)
the misalignment##5##2##(2008-2#3)(2008-3#2)
the misclassification of##2##3##(2007-12#1)(2009-9#1)
the misclassification probabilities##3##3##(1992-6#1)(1995-6#1)(1996-7#1)
the misclassification##7##2##(1992-2#1)(1992-6#2)(1995-6#1)(1996-7#1)(2007-12#1)(2009-9#1)
the misconceptions##3##2##(2010-3#3)
the misdiagnosis##2##2##(2007-8#1)(2011-12#1)
the misinsertion##2##2##(1993-3#2)
the misinterpretation of##2##3##(1993-3#1)(2008-5#1)
the misleading##3##2##(2007-11#1)(2008-3#1)(2008-7#1)
the mismatch between the##3##4##(1994-7#1)(2007-12#1)(2008-3#1)
the mismatch negativity (MMN)##4##4##(1995-12#1)(1995-5#1)(2008-9#1)(2012-1#1)
the mismatch of##2##3##(2008-2#1)(2012-1#1)
the mismatch repair protein##2##4##(1997-1#1)(2013-1#1)
the mismatch repair##3##3##(1997-1#2)(2013-1#1)
the mismatch response##2##3##(1995-11#1)(2009-2#1)
the mismatch##21##2##(1991-7#2)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1997-1#2)(2007-12#2)(2008-2#2)(2008-3#2)(2008-9#1)(2009-2#1)(2010-8#1)(2012-1#2)(2013-1#1)
the mismatched##3##2##(1991-7#1)(2010-11#1)(2011-2#1)
the misogynist##2##2##(2009-10#2)
the missed##2##2##(2010-1#1)(2010-4#1)
the missense##3##2##(1990-10#1)(1997-5#1)(2011-1#1)
the missing at random assumption##3##5##(1995-6#3)
the missing censoring indicator model##2##5##(2008-10#2)
the missing data##4##3##(1995-12#2)(2005-11#1)(2009-12#1)
the missing element##2##3##(1996-2#1)(1997-1#1)
the missing genetic##2##3##(2010-5#1)(2012-3#1)
the missing heritability of##2##4##(2012-3#2)
the missing link between##2##4##(1994-3#1)(1997-4#1)
the missing link?##2##3##(1992-1#1)(2009-5#1)
the missing person##2##3##(1995-6#2)
the missing precipitation data##2##4##(2013-8#2)
the missing##41##2##(1991-2#1)(1992-1#1)(1992-5#1)(1993-3#1)(1994-3#1)(1995-12#2)(1995-6#5)(1996-2#1)(1997-1#1)(1997-2#2)(1997-4#1)(2004-9#1)(2005-11#2)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-12#2)(2009-5#2)(2009-8#1)(2010-5#1)(2012-2#2)(2012-3#4)(2013-8#2)
the mission and##2##3##(2008-3#1)(2009-11#1)
the mission of the##2##4##(2007-4#1)(2008-7#1)
the mission of##6##3##(1996-12#1)(2006-9#1)(2007-4#1)(2008-7#1)(2012-3#2)
the mission statement##2##3##(2007-4#2)
the mission##17##2##(1993-12#1)(1993-7#1)(1994-1#1)(1996-12#1)(2005-5#1)(2006-9#1)(2007-4#3)(2008-3#2)(2008-7#2)(2009-11#1)(2010-12#1)(2012-3#2)
the mistakes##2##2##(1993-12#1)(1995-8#1)
the mistletoe extract##2##3##(1990-5#2)
the mistletoe##4##2##(1990-5#3)(2008-10#1)
the misuse of##4##3##(2004-10#1)(2006-7#1)(2008-7#1)(2009-4#1)
the mite Varroa destructor Anderson##2##5##(2008-6#2)
the mite##7##2##(1991-2#1)(2006-10#1)(2008-4#2)(2008-6#2)(2013-1#1)
the mites##3##2##(1997-5#1)(2006-10#1)(2008-5#1)
the mitochondria and##6##3##(1994-3#1)(1996-7#1)(2008-11#1)(2008-7#1)(2009-2#1)(2011-2#1)
the mitochondria in##6##3##(1994-11#1)(2006-9#1)(2008-10#2)(2009-11#1)(2012-2#1)
the mitochondria of##6##3##(1992-9#1)(1996-8#1)(1997-2#1)(2005-8#1)(2006-12#1)(2010-12#1)
the mitochondria##47##2##(1990-6#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-7#2)(2005-8#2)(2006-12#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-7#2)(2009-11#2)(2009-2#2)(2009-5#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#2)
the mitochondrial (mt)##2##3##(1991-6#1)(1993-2#1)
the mitochondrial 12S rRNA gene##3##5##(2008-6#1)(2009-5#2)
the mitochondrial ATPase inhibitor##2##4##(1992-11#2)
the mitochondrial ATPase##3##3##(1992-11#3)
the mitochondrial DNA (mtDNA)##2##4##(1997-2#1)(2012-2#1)
the mitochondrial DNA##15##3##(1990-7#1)(1994-11#5)(1995-6#1)(1996-6#1)(1997-2#1)(2005-8#1)(2008-10#1)(2009-2#1)(2009-5#1)(2010-8#1)(2012-2#1)
the mitochondrial RNA##2##3##(1995-3#1)(1997-4#1)
the mitochondrial and nuclear##2##4##(1991-4#1)(2008-10#1)
the mitochondrial and##7##3##(1990-6#1)(1991-11#1)(1991-4#1)(1997-4#1)(2006-12#1)(2008-10#1)(2008-7#1)
the mitochondrial citrate synthase##2##4##(1997-4#1)(1997-8#1)
the mitochondrial citrate##3##3##(1992-2#1)(1997-4#1)(1997-8#1)
the mitochondrial control region##2##4##(1994-6#1)(1995-11#1)
the mitochondrial cristae##2##3##(2005-8#1)(2008-7#1)
the mitochondrial cytochrome b gene##7##5##(1995-11#2)(2008-5#1)(2010-4#1)(2010-8#3)
the mitochondrial cytochrome oxidase I##3##5##(2007-12#1)(2011-2#2)
the mitochondrial cytochrome oxidase##5##4##(2007-12#1)(2008-10#1)(2011-2#3)
the mitochondrial cytochrome##13##3##(1992-11#1)(1995-11#2)(2007-12#1)(2008-10#1)(2008-5#1)(2010-4#1)(2010-8#3)(2011-2#3)
the mitochondrial electron transport chain##4##5##(1990-7#1)(1996-7#1)(2010-12#1)(2011-1#1)
the mitochondrial electron transport##5##4##(1990-7#1)(1996-7#1)(2008-11#1)(2010-12#1)(2011-1#1)
the mitochondrial enzyme##5##3##(1991-4#1)(1994-6#1)(1997-3#1)(2007-11#1)(2012-12#1)
the mitochondrial fraction prepared##2##4##(2005-8#2)
the mitochondrial fraction##5##3##(1990-6#2)(1996-6#1)(2005-8#2)
the mitochondrial gene products##3##4##(1990-8#3)
the mitochondrial gene##6##3##(1990-8#3)(1993-2#1)(2008-2#1)(2008-6#1)
the mitochondrial genes##3##3##(1991-6#1)(2008-6#1)(2010-4#1)
the mitochondrial genetic##2##3##(1997-2#1)(2008-10#1)
the mitochondrial genome and##2##4##(1995-11#1)(1995-6#1)
the mitochondrial genome of the##2##5##(1995-6#1)(1996-10#1)
the mitochondrial genome of##5##4##(1995-6#1)(1996-10#2)(1997-4#2)
the mitochondrial genome##19##3##(1993-4#1)(1995-11#1)(1995-12#1)(1995-6#3)(1996-10#2)(1996-7#1)(1997-4#4)(2005-8#1)(2007-11#1)(2008-2#1)(2009-5#1)(2009-8#1)(2012-2#1)
the mitochondrial genomes of##2##4##(1994-9#1)(1996-7#1)
the mitochondrial genomes##5##3##(1994-9#1)(1996-7#1)(2010-12#3)
the mitochondrial inner membrane and##2##5##(1994-8#1)(1995-6#1)
the mitochondrial inner membrane##6##4##(1994-12#1)(1994-8#2)(1995-2#1)(1995-6#1)(2011-1#1)
the mitochondrial inner##7##3##(1994-12#1)(1994-8#2)(1995-2#1)(1995-6#1)(2008-1#1)(2011-1#1)
the mitochondrial manganese-containing superoxide dismutase##2##5##(1994-6#1)(1996-4#1)
the mitochondrial matrix##10##3##(1990-5#1)(1990-9#1)(1991-10#1)(1991-7#1)(1994-11#1)(1994-8#1)(1994-9#1)(1997-6#1)(2010-12#1)(2010-2#1)
the mitochondrial membrane and##3##4##(1991-5#1)(1995-6#1)(2009-9#1)
the mitochondrial membrane potential##7##4##(1994-3#1)(2008-7#1)(2008-9#2)(2011-1#1)(2012-2#1)(2013-1#1)
the mitochondrial membrane##19##3##(1990-2#1)(1990-8#1)(1991-5#1)(1992-1#1)(1993-11#1)(1994-3#1)(1995-6#1)(1997-4#1)(2005-8#1)(2008-1#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#1)
the mitochondrial membranes##5##3##(1990-2#1)(1993-3#1)(1994-8#1)(1996-3#1)(2012-2#1)
the mitochondrial metabolism##3##3##(1994-8#3)
the mitochondrial outer membrane##5##4##(1992-6#2)(1997-2#2)(2012-2#1)
the mitochondrial permeability transition pore##2##5##(2010-3#1)(2012-2#1)
the mitochondrial permeability transition##6##4##(2006-10#2)(2008-1#2)(2010-3#1)(2012-2#1)
the mitochondrial protein##4##3##(1991-9#1)(1994-6#1)(1996-5#1)(1996-9#1)
the mitochondrial proteome##2##3##(2005-8#1)(2011-2#1)
the mitochondrial respiratory chain##8##4##(1995-1#1)(1996-5#1)(1997-1#1)(1997-6#1)(2005-8#2)(2007-11#1)(2011-2#1)
the mitochondrial respiratory##10##3##(1994-8#1)(1995-1#1)(1996-5#1)(1997-1#1)(1997-6#1)(2004-12#1)(2005-8#2)(2007-11#1)(2011-2#1)
the mitochondrial##263##2##(1990-12#2)(1990-2#2)(1990-5#2)(1990-6#3)(1990-7#4)(1990-8#5)(1990-9#1)(1991-10#2)(1991-11#1)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#2)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#5)(1992-12#2)(1992-2#1)(1992-4#1)(1992-6#2)(1993-11#1)(1993-2#2)(1993-3#1)(1993-4#2)(1994-11#7)(1994-12#3)(1994-3#1)(1994-6#5)(1994-8#11)(1994-9#2)(1995-1#2)(1995-11#5)(1995-12#1)(1995-2#2)(1995-3#4)(1995-6#7)(1995-7#1)(1995-9#1)(1996-10#3)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#6)(1996-9#1)(1997-1#1)(1997-2#6)(1997-3#4)(1997-4#10)(1997-6#5)(1997-7#2)(1997-8#1)(2004-12#1)(2005-8#20)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-5#1)(2008-1#6)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#3)(2008-7#7)(2008-8#1)(2008-9#2)(2009-2#1)(2009-5#4)(2009-8#2)(2009-9#1)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#4)(2010-8#4)(2011-1#4)(2011-2#6)(2012-12#1)(2012-2#8)(2012-3#1)(2013-1#1)(2013-8#3)
the mitochondrially encoded##2##3##(1994-3#1)(2008-10#1)
the mitochondrially##4##2##(1992-3#1)(1994-3#1)(1995-6#1)(2008-10#1)
the mitochondrion and the##3##4##(1993-9#1)(1996-7#1)(2005-8#1)
the mitochondrion in##2##3##(2005-8#2)
the mitochondrion##12##2##(1993-9#1)(1994-9#1)(1996-7#1)(1996-9#1)(2005-8#4)(2007-5#1)(2008-11#1)(2009-10#1)(2010-12#1)
the mitogen##6##2##(1991-2#1)(1993-8#1)(1995-2#1)(2008-4#1)(2012-2#1)(2013-7#1)
the mitogen-activated protein kinase (MAPK) cascade in##2##7##(1995-1#1)(1995-2#1)
the mitogen-activated protein kinase (MAPK) cascade##3##6##(1995-1#1)(1995-2#2)
the mitogen-activated protein kinase (MAPK)##5##5##(1995-1#1)(1995-2#2)(2006-12#1)(2008-4#1)
the mitogen-activated protein kinase##11##4##(1995-1#1)(1995-2#2)(1995-3#2)(1996-5#3)(2006-12#1)(2008-11#1)(2008-4#1)
the mitogen-activated protein kinases (MAPKs)##2##5##(1995-2#1)(2010-10#1)
the mitogen-activated protein kinases##3##4##(1995-2#1)(2006-10#1)(2010-10#1)
the mitogen-activated protein##15##3##(1995-1#1)(1995-2#3)(1995-3#3)(1996-5#3)(2006-10#1)(2006-12#1)(2008-11#1)(2008-4#1)(2010-10#1)
the mitogen-activated##16##2##(1995-1#1)(1995-2#3)(1995-3#3)(1996-5#3)(2006-10#1)(2006-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-10#1)
the mitogen-induced##2##2##(1993-12#1)(1995-5#1)
the mitogenic action of##2##4##(1995-6#1)(1996-12#1)
the mitogenic activity of##3##4##(1990-12#1)(2008-2#1)(2008-4#1)
the mitogenic activity##4##3##(1990-12#1)(1994-11#1)(2008-2#1)(2008-4#1)
the mitogenic agents##2##3##(1991-1#1)(1991-8#1)
the mitogenic effect of##4##4##(1994-12#1)(1994-2#1)(1997-1#1)(2008-6#1)
the mitogenic effect##5##3##(1994-12#1)(1994-2#1)(1997-1#1)(2008-11#1)(2008-6#1)
the mitogenic effects of EGF##2##5##(2008-6#2)
the mitogenic effects of##3##4##(1996-2#1)(2008-6#2)
the mitogenic effects##4##3##(1996-2#1)(2008-11#1)(2008-6#2)
the mitogenic response to##2##4##(1994-2#1)(1996-12#1)
the mitogenic response##5##3##(1992-10#1)(1994-12#1)(1994-2#1)(1996-11#1)(1996-12#1)
the mitogenic signal##3##3##(1990-12#1)(1995-1#1)(2008-4#1)
the mitogenic##29##2##(1990-12#2)(1990-3#1)(1991-1#1)(1991-8#2)(1992-10#1)(1992-9#1)(1994-11#1)(1994-12#3)(1994-2#2)(1995-1#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-2#1)(1997-1#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-6#3)
the mitomycin##2##2##(1995-5#1)(1997-7#1)
the mitosene##4##2##(1992-3#3)(1997-7#1)
the mitotic index was##2##4##(2008-11#1)(2008-6#1)
the mitotic index##4##3##(1994-6#1)(2008-11#2)(2008-6#1)
the mitotic spindle in##2##4##(2007-12#1)(2011-2#1)
the mitotic spindle##7##3##(2007-12#1)(2008-1#1)(2008-8#1)(2008-9#1)(2011-2#3)
the mitotic##28##2##(1990-2#1)(1990-4#1)(1992-4#1)(1994-5#1)(1994-6#1)(1996-4#1)(2006-5#1)(2007-12#1)(2008-1#3)(2008-11#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-2#4)(2013-1#1)
the mitral and tricuspid valve##2##5##(2011-1#2)
the mitral and##3##3##(2011-1#2)(2011-2#1)
the mitral annulus##2##3##(2008-10#2)
the mitral position##2##3##(2007-8#1)(2013-1#1)
the mitral valve and##2##4##(2013-1#2)
the mitral valve by##2##4##(2007-9#1)(2008-4#1)
the mitral valve##27##3##(1990-6#2)(1993-5#1)(1994-3#1)(2006-10#1)(2007-8#3)(2007-9#1)(2008-11#1)(2008-4#1)(2009-10#2)(2009-8#1)(2010-12#2)(2010-8#1)(2012-12#2)(2013-1#7)(2013-8#1)
the mitral valves##3##3##(1997-1#1)(2007-8#1)(2010-12#1)
the mitral##43##2##(1990-3#1)(1990-6#2)(1992-3#1)(1993-5#1)(1994-3#1)(1995-6#2)(1997-1#1)(2006-10#1)(2007-8#5)(2007-9#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-10#2)(2009-8#1)(2010-12#3)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#2)(2013-1#8)(2013-8#1)
the mix of##6##3##(1992-4#1)(1993-1#1)(1996-12#1)(2004-2#1)(2008-10#1)(2008-11#1)
the mix##7##2##(1992-4#1)(1993-1#1)(1996-12#1)(2004-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
the mixed culture##7##3##(1993-12#1)(2006-3#1)(2008-6#3)(2008-7#2)
the mixed cultures##5##3##(2008-6#1)(2013-1#4)
the mixed dentition##3##3##(2005-9#1)(2007-12#1)(2012-2#1)
the mixed disulfide##2##3##(1992-9#1)(2008-5#1)
the mixed films##7##3##(2005-11#7)
the mixed infections##2##3##(2008-10#1)(2012-3#1)
the mixed inoculum##2##3##(2008-10#2)
the mixed liquor##2##3##(2008-12#2)
the mixed micelles##3##3##(1990-11#1)(1990-2#1)(2005-11#1)
the mixed monolayer##3##3##(2005-11#2)(2008-10#1)
the mixed solution##4##3##(2008-10#4)
the mixed strategy##2##3##(2008-8#2)
the mixed system##2##3##(2005-11#2)
the mixed type##4##3##(1990-2#1)(1995-4#1)(1996-6#1)(2011-1#1)
the mixed valence##2##3##(1991-5#1)(2009-5#1)
the mixed##110##2##(1990-11#1)(1990-2#3)(1990-4#1)(1990-7#2)(1991-5#1)(1992-8#1)(1992-9#2)(1993-10#1)(1993-12#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-4#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-8#1)(2005-10#1)(2005-11#16)(2005-4#1)(2005-9#1)(2006-3#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-5#2)(2007-9#1)(2008-10#30)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#4)(2008-7#3)(2008-8#2)(2009-5#1)(2009-6#1)(2010-4#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)
the mixed-farming area##2##3##(2008-5#2)
the mixed-field##2##2##(1992-9#2)
the mixed-ligand##2##2##(2008-10#1)(2008-5#1)
the mixed-solution method##2##3##(2008-10#2)
the mixed-valent##4##2##(1997-7#4)
the mixing efficiency##3##3##(2008-2#3)
the mixing induced by##2##4##(2005-11#1)(2008-6#1)
the mixing layer##2##3##(1992-6#1)(2008-2#1)
the mixing of the##3##4##(2008-10#1)(2010-2#1)(2010-5#1)
the mixing of##6##3##(2008-10#2)(2008-2#1)(2010-2#1)(2010-4#1)(2010-5#1)
the mixing process##2##3##(2008-3#1)(2008-5#1)
the mixing ratio of##2##4##(2005-11#1)(2008-2#1)
the mixing ratio##3##3##(1995-10#1)(2005-11#1)(2008-2#1)
the mixing time constant##3##4##(2008-7#3)
the mixing time##6##3##(1992-3#1)(2004-9#1)(2007-10#1)(2008-7#3)
the mixing##39##2##(1992-3#1)(1992-6#1)(1995-10#1)(1997-3#1)(2004-9#1)(2005-11#2)(2005-4#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-2#9)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#4)(2010-2#1)(2010-4#1)(2010-5#1)(2011-12#2)
the mixture and the##2##4##(1995-8#1)(2010-4#1)
the mixture and##3##3##(1995-8#1)(2006-10#1)(2010-4#1)
the mixture for##2##3##(1990-12#1)(2008-10#1)
the mixture in##3##3##(1997-8#1)(2008-10#1)(2008-2#1)
the mixture into##2##3##(1994-3#1)(2010-4#1)
the mixture is cycled many times (usually 30) through temperatures that permit denaturation##2##13##(2008-2#1)(2008-9#1)
the mixture is##5##3##(1990-12#1)(2008-10#2)(2008-2#1)(2008-9#1)
the mixture of 2-propanol##2##4##(2008-10#2)
the mixture of all##2##4##(1992-6#1)(2008-10#1)
the mixture of both##3##4##(1990-5#1)(2007-11#1)(2008-10#1)
the mixture of the##4##4##(1990-7#1)(2008-10#2)(2010-7#1)
the mixture of##45##3##(1990-3#1)(1990-5#1)(1990-7#1)(1992-6#1)(2005-11#1)(2007-1#2)(2007-11#2)(2007-6#1)(2008-10#18)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#3)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-3#2)(2013-1#1)
the mixture to##2##3##(2008-10#1)(2010-2#1)
the mixture was##4##3##(1997-7#1)(2008-10#1)(2008-5#1)(2013-8#1)
the mixture were##3##3##(1996-4#1)(1996-5#1)(2005-11#1)
the mixture##115##2##(1990-12#2)(1990-3#1)(1990-5#2)(1990-7#1)(1992-6#1)(1994-3#1)(1994-9#1)(1995-8#1)(1996-4#2)(1996-5#1)(1997-7#1)(1997-8#1)(2004-9#2)(2005-11#3)(2006-10#1)(2006-12#1)(2006-5#1)(2007-1#2)(2007-11#2)(2007-5#2)(2007-6#2)(2008-10#46)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#4)(2008-8#1)(2008-9#1)(2010-2#1)(2010-4#3)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#3)
the mixture)##2##2##(2006-12#1)(2007-5#1)
the mixtures of##5##3##(2004-4#1)(2004-9#1)(2008-10#2)(2008-11#1)
the mixtures were##3##3##(1993-8#1)(1996-4#1)(2008-10#1)
the mixtures##26##2##(1992-5#1)(1992-7#1)(1993-8#2)(1996-4#1)(2004-4#1)(2004-9#3)(2008-10#15)(2008-11#1)(2008-8#1)
the mnemonic##2##2##(1991-3#1)(1994-10#1)
the mobil phase##2##3##(2005-12#1)(2008-10#1)
the mobile carrier##2##3##(2008-10#2)
the mobile home park##2##4##(1996-12#1)(1996-6#1)
the mobile phase and##11##4##(1997-8#3)(2005-12#1)(2006-10#1)(2008-10#4)(2011-1#2)
the mobile phase as an##2##5##(2008-10#2)
the mobile phase as##3##4##(2008-10#3)
the mobile phase consisted of##3##5##(2007-8#1)(2011-3#1)(2012-12#1)
the mobile phase containing##3##4##(1992-1#1)(2008-10#2)
the mobile phase for##3##4##(1990-8#3)
the mobile phase in##2##4##(1997-3#1)(2008-10#1)
the mobile phase is##2##4##(2008-10#2)
the mobile phase of##6##4##(1990-12#1)(2005-12#1)(2008-10#2)(2011-1#1)(2013-8#1)
the mobile phase pH##2##4##(2008-10#2)
the mobile phase was##7##4##(1990-12#1)(1997-3#1)(2008-10#5)
the mobile phase water content##2##5##(2008-10#2)
the mobile phase were##3##4##(2008-10#3)
the mobile phase##110##3##(1990-11#1)(1990-12#3)(1990-6#1)(1990-8#5)(1991-3#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-2#5)(1993-11#1)(1993-12#1)(1994-9#1)(1995-6#1)(1996-5#3)(1996-6#1)(1996-8#2)(1997-1#1)(1997-3#3)(1997-8#4)(2004-12#2)(2005-12#2)(2006-10#1)(2007-8#4)(2008-10#49)(2008-6#1)(2011-1#9)(2011-3#1)(2012-12#2)(2012-3#1)(2013-8#1)
the mobile phases##8##3##(1990-3#1)(1996-5#1)(1997-3#1)(2008-10#2)(2011-1#2)(2012-12#1)
the mobile##134##2##(1990-11#1)(1990-12#3)(1990-3#1)(1990-6#1)(1990-8#5)(1991-3#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-2#5)(1993-11#1)(1993-12#1)(1994-3#1)(1994-9#1)(1995-6#1)(1996-12#1)(1996-5#4)(1996-6#2)(1996-8#3)(1997-1#1)(1997-3#4)(1997-8#4)(2004-12#2)(2005-12#3)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-8#5)(2008-10#55)(2008-11#1)(2008-6#1)(2011-1#11)(2011-2#1)(2011-3#1)(2012-12#4)(2012-3#1)(2013-8#1)
the mobilities of the##2##4##(1990-7#1)(2008-4#1)
the mobility of the##9##4##(1993-11#1)(1994-3#1)(1996-4#1)(1996-7#1)(1997-1#1)(2007-10#1)(2007-7#1)(2008-10#1)(2010-2#1)
the mobility of##19##3##(1993-11#1)(1994-3#1)(1994-6#1)(1994-9#1)(1996-4#1)(1996-7#2)(1997-1#1)(1997-8#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-8#2)(2010-2#1)(2010-4#1)(2011-2#1)
the mobility shift##2##3##(1993-11#2)
the mobility##31##2##(1990-10#1)(1993-11#3)(1994-3#2)(1994-6#1)(1994-9#1)(1996-12#1)(1996-4#1)(1996-7#2)(1997-1#1)(1997-8#1)(2005-11#1)(2007-10#1)(2007-7#1)(2008-10#4)(2008-3#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-2#2)(2010-4#1)(2011-2#1)(2012-2#1)
the mobilization of##10##3##(1990-3#3)(1990-9#1)(1992-3#1)(1996-8#1)(1997-8#1)(2007-5#1)(2008-1#1)(2013-1#1)
the mobilization##14##2##(1990-3#3)(1990-9#1)(1992-3#1)(1996-8#1)(1997-4#2)(1997-8#1)(2007-5#1)(2008-1#1)(2011-2#2)(2013-1#1)
the modal behavior##4##3##(2008-2#2)(2008-3#2)
the modal birefringence of single-mode##2##5##(2008-3#2)
the modal birefringence of##3##4##(2008-3#3)
the modal distribution inside a##2##5##(2007-12#2)
the modal weights##2##3##(2008-2#1)(2008-3#1)
the modal##28##2##(1991-4#1)(2007-12#6)(2007-3#1)(2008-12#2)(2008-2#6)(2008-3#12)
the modalities of##3##3##(2006-6#1)(2008-6#1)(2012-2#1)
the modalities##7##2##(2004-9#2)(2006-6#1)(2006-7#1)(2008-6#1)(2012-2#1)(2013-1#1)
the modality has##2##3##(1992-1#1)(2009-9#1)
the modality of choice for##3##5##(2007-4#1)(2010-12#1)(2010-4#1)
the modality of choice##4##4##(2007-4#1)(2010-12#1)(2010-4#1)(2012-2#1)
the modality of##7##3##(2007-4#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#1)(2012-2#1)
the modality##13##2##(1992-1#1)(2004-9#1)(2007-4#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-4#1)(2012-1#1)(2012-2#1)(2013-1#1)
the mode and##3##3##(1996-4#1)(2007-3#1)(2007-5#1)
the mode field##5##3##(2007-11#1)(2008-2#2)(2008-3#2)
the mode of action of the##6##6##(1997-1#1)(1997-2#1)(1997-7#1)(2005-7#1)(2008-10#1)(2008-5#1)
the mode of action of##26##5##(1990-5#2)(1991-11#1)(1992-1#1)(1994-9#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-7#2)(2006-12#1)(2008-10#3)(2008-5#3)(2009-3#1)(2010-12#1)(2010-5#1)(2011-2#2)
the mode of action##29##4##(1990-5#2)(1991-11#1)(1991-3#1)(1992-1#1)(1994-9#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-7#2)(2006-10#1)(2006-12#1)(2008-10#3)(2008-5#3)(2009-3#1)(2009-7#1)(2010-12#1)(2010-5#1)(2011-2#2)
the mode of application##2##4##(1993-8#1)(2004-12#1)
the mode of cell death##2##5##(1996-7#1)(2008-4#1)
the mode of cell##3##4##(1996-7#1)(2008-4#1)(2008-9#1)
the mode of delivery##4##4##(1993-4#1)(2006-10#2)(2012-3#1)
the mode of dissemination##2##4##(2008-10#1)(2013-1#1)
the mode of infection##2##4##(2007-7#1)(2008-10#1)
the mode of transmission##2##4##(2006-10#2)
the mode of##79##3##(1990-5#2)(1991-11#1)(1991-3#1)(1992-1#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#4)(1997-6#3)(1997-7#2)(2004-12#1)(2005-10#1)(2005-11#1)(2005-7#2)(2006-10#5)(2006-12#1)(2007-11#2)(2007-6#2)(2007-7#1)(2008-1#1)(2008-10#11)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#4)(2008-9#3)(2009-3#1)(2009-7#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#3)
the mode spacing##2##3##(2007-12#1)(2008-2#1)
the mode##116##2##(1990-5#2)(1991-11#1)(1991-3#1)(1992-1#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-12#1)(1996-3#1)(1996-4#2)(1996-7#1)(1997-1#1)(1997-2#4)(1997-6#4)(1997-7#2)(2004-12#1)(2005-10#1)(2005-11#1)(2005-7#2)(2006-10#5)(2006-12#1)(2007-11#5)(2007-12#9)(2007-3#2)(2007-5#1)(2007-6#2)(2007-7#1)(2008-1#2)(2008-10#12)(2008-12#1)(2008-2#13)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#2)(2008-9#3)(2009-3#1)(2009-7#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-3#1)(2013-1#4)
the mode-lock frequency##2##3##(2007-12#2)
the mode-locked##3##2##(2007-11#2)(2008-3#1)
the mode-locking##3##2##(2007-11#3)
the model CA3 pyramidal cell##2##5##(2008-11#2)
the model accounted for##2##4##(2008-1#1)(2008-10#1)
the model agree well with the##2##6##(1995-8#1)(2008-3#1)
the model allows##2##3##(2008-2#1)(2013-8#1)
the model also##6##3##(1993-9#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-7#1)(2012-3#1)
the model and experimental##2##4##(2010-2#1)(2011-2#1)
the model and suggests##2##4##(2008-12#1)(2010-5#1)
the model and the##5##4##(1994-2#1)(1995-7#1)(2008-3#2)(2010-4#1)
the model and to##2##4##(1992-6#1)(2007-6#1)
the model and##23##3##(1991-1#1)(1992-12#1)(1992-6#1)(1994-2#1)(1995-7#1)(1996-2#1)(1997-1#1)(2007-12#2)(2007-6#1)(2008-10#2)(2008-12#1)(2008-3#3)(2008-7#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)
the model are found to be in good agreement with##2##10##(2008-2#2)
the model are##16##3##(1992-12#1)(1992-6#1)(1996-1#1)(1997-4#1)(1997-8#1)(2005-7#1)(2008-1#1)(2008-10#3)(2008-2#3)(2008-6#1)(2008-8#1)(2012-1#1)
the model as a##3##4##(1990-8#1)(2008-11#1)(2013-1#1)
the model as##4##3##(1990-8#1)(1996-3#1)(2008-11#1)(2013-1#1)
the model assumptions##2##3##(1995-9#1)(1996-12#1)
the model based on the##3##5##(2007-11#1)(2008-10#1)(2011-1#1)
the model based on##6##4##(1997-7#2)(2007-11#2)(2008-10#1)(2011-1#1)
the model by##6##3##(1995-2#1)(1995-9#1)(1996-8#1)(1997-2#1)(2008-10#1)(2008-3#1)
the model can be used##2##5##(2008-8#1)(2013-8#1)
the model can be##7##4##(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#1)(2011-1#1)(2013-8#1)
the model can##12##3##(1997-7#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-1#1)(2013-8#1)
the model compound##3##3##(1995-5#1)(1996-2#1)(2008-10#1)
the model design##2##3##(2009-9#1)(2012-2#1)
the model developed##5##3##(1992-3#1)(1996-11#1)(2008-10#1)(2008-2#1)(2010-5#1)
the model equations##2##3##(2007-9#1)(2008-9#1)
the model fits##2##3##(1994-5#1)(1995-8#1)
the model for the##10##4##(1993-4#1)(1993-8#1)(1994-5#1)(1995-8#1)(1996-1#1)(2008-2#4)(2013-1#1)
the model for##21##3##(1992-1#1)(1993-4#1)(1993-8#1)(1994-5#2)(1995-12#1)(1995-8#1)(1996-1#1)(2006-3#1)(2006-9#1)(2008-10#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-6#1)(2008-7#1)(2010-4#1)(2013-1#1)
the model formulation##2##3##(2008-10#2)
the model further##2##3##(2008-2#1)(2008-3#1)
the model gave a##2##4##(2008-2#1)(2008-7#1)
the model group##3##3##(1990-12#3)
the model has##5##3##(2006-11#1)(2008-10#2)(2008-3#1)(2013-8#1)
the model in order##2##4##(1991-9#1)(2007-4#1)
the model in terms of##2##5##(1994-3#1)(2008-10#1)
the model in##10##3##(1991-9#1)(1994-3#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2011-1#1)
the model include the##2##4##(1997-4#1)(2008-3#1)
the model indicated exertional chest pain is negatively associated with cardiac disease##2##12##(2013-1#2)
the model input##2##3##(2008-3#2)
the model is a##2##4##(2008-2#1)(2008-6#1)
the model is also discussed##2##5##(2008-2#1)(2010-12#1)
the model is consistent with##2##5##(1991-1#1)(2008-8#1)
the model is that##3##4##(1997-8#1)(2008-2#1)(2008-7#1)
the model is##31##3##(1990-12#1)(1991-1#1)(1995-5#1)(1997-8#2)(2007-4#1)(2007-9#2)(2008-10#3)(2008-11#3)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-12#1)(2010-12#1)(2011-2#1)(2013-1#1)
the model obtained##2##3##(2008-2#1)(2012-1#1)
the model of the##8##4##(1992-9#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2012-1#1)(2012-12#1)(2013-1#1)
the model of##45##3##(1991-4#1)(1991-7#1)(1992-9#1)(1994-2#1)(1996-12#1)(1996-7#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#4)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-2#2)(2011-1#1)(2011-2#2)(2012-1#6)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
the model or##3##3##(1992-6#1)(2008-10#1)(2010-8#1)
the model organism##3##3##(2007-12#1)(2008-8#1)(2011-1#1)
the model organisms##2##3##(2008-4#1)(2009-6#1)
the model outputs##4##3##(2008-10#1)(2013-1#3)
the model parameters##16##3##(1991-12#1)(1993-9#1)(1994-11#1)(1995-8#1)(1996-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#1)(2011-2#1)
the model plant Arabidopsis thaliana##4##5##(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)
the model plant Arabidopsis##5##4##(2008-7#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)
the model plant##8##3##(2008-10#1)(2008-7#3)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)
the model predicted the##2##4##(2006-11#1)(2008-7#1)
the model predicted##5##3##(2006-11#1)(2008-7#3)(2008-9#1)
the model prediction##2##3##(2008-3#1)(2008-7#1)
the model predictions##10##3##(1994-3#1)(1996-3#1)(2005-11#1)(2006-7#1)(2008-10#2)(2008-2#1)(2008-7#2)(2009-7#1)
the model predictive##2##3##(2007-8#1)(2008-7#1)
the model predicts a linear dependence##2##6##(2005-11#1)(2008-10#1)
the model predicts##3##3##(2005-11#1)(2008-10#1)(2008-9#1)
the model proposed##3##3##(1993-5#1)(2008-10#1)(2013-8#1)
the model provides##4##3##(2006-10#1)(2008-12#1)(2008-3#1)(2008-8#1)
the model results with##2##4##(2007-8#1)(2008-3#1)
the model results##8##3##(1996-4#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#1)
the model show##2##3##(1995-1#1)(2008-3#1)
the model showed that the##2##5##(1991-2#1)(2007-2#1)
the model showed that##3##4##(1991-2#1)(2007-2#1)(2008-10#1)
the model showed##5##3##(1991-2#1)(1992-9#1)(2006-8#1)(2007-2#1)(2008-10#1)
the model shows that##2##4##(2008-11#2)
the model shows##3##3##(2008-11#2)(2009-3#1)
the model significantly##2##3##(1991-12#1)(2007-10#1)
the model simulation and##2##4##(2008-7#2)
the model solution##2##3##(2007-8#1)(2008-7#1)
the model species##2##3##(2006-12#1)(2009-10#1)
the model structure of##2##4##(1990-4#1)(1995-6#1)
the model structure##6##3##(1990-4#1)(1992-2#1)(1995-6#3)(1995-8#1)
the model studied##2##3##(2008-9#1)(2011-1#1)
the model suggests that##3##4##(2008-10#1)(2008-2#1)(2008-8#1)
the model system of##3##4##(2008-11#1)(2008-3#1)(2008-8#1)
the model system to##2##4##(2006-10#1)(2008-9#1)
the model system##9##3##(1995-8#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-10#1)
the model systems##2##3##(1994-2#1)(2010-4#1)
the model that##6##3##(1994-1#1)(1995-2#1)(2006-10#1)(2006-11#1)(2008-3#1)(2012-3#1)
the model to a##6##4##(1993-9#1)(1994-8#1)(1996-2#1)(2008-7#1)(2010-8#1)(2013-8#1)
the model to allow for##2##5##(2008-3#1)(2008-8#1)
the model to allow##3##4##(1993-6#1)(2008-3#1)(2008-8#1)
the model to any##2##4##(2008-10#1)(2008-5#1)
the model to include##2##4##(2008-11#1)(2009-7#1)
the model to##36##3##(1993-6#1)(1993-9#1)(1994-8#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-7#1)(2006-11#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-7#1)(2010-6#1)(2010-8#1)(2012-3#1)(2013-8#2)
the model used##4##3##(1991-4#1)(1997-1#1)(2007-9#1)(2010-6#1)
the model using a##4##4##(2008-7#1)(2011-2#1)(2013-1#2)
the model using##10##3##(2007-4#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#4)
the model via##2##3##(2008-3#1)(2008-7#1)
the model was used to##2##5##(1991-2#1)(2006-10#1)
the model was used##4##4##(1991-2#1)(2006-10#1)(2008-10#1)(2008-3#1)
the model was##24##3##(1991-2#1)(1992-3#1)(1995-9#1)(1997-2#1)(2005-11#1)(2006-10#2)(2006-11#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2013-8#1)
the model we##3##3##(2007-12#1)(2007-9#1)(2008-10#1)
the model were##6##3##(1991-9#1)(1993-9#1)(1997-2#1)(2007-4#1)(2008-10#1)(2012-1#1)
the model which##3##3##(1992-12#1)(1996-5#1)(2013-8#1)
the model will##2##3##(2007-12#1)(2013-1#1)
the model with a##2##4##(1997-6#1)(2008-2#1)
the model with##6##3##(1996-7#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-2#1)(2013-8#1)
the model##745##2##(1990-12#8)(1990-4#1)(1990-8#4)(1991-1#3)(1991-12#2)(1991-2#2)(1991-4#3)(1991-7#2)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#4)(1992-4#1)(1992-6#3)(1992-9#4)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-5#2)(1993-6#1)(1993-8#2)(1993-9#7)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#4)(1994-7#1)(1994-8#2)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-5#2)(1995-6#4)(1995-7#1)(1995-8#10)(1995-9#3)(1996-1#3)(1996-11#1)(1996-12#5)(1996-2#7)(1996-3#3)(1996-4#5)(1996-5#3)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#5)(1997-2#5)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#5)(1997-8#5)(2004-12#2)(2005-10#1)(2005-11#10)(2005-7#1)(2005-8#1)(2006-10#12)(2006-11#14)(2006-12#2)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#7)(2007-11#9)(2007-12#17)(2007-2#1)(2007-4#12)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#4)(2007-9#9)(2008-1#2)(2008-10#82)(2008-11#25)(2008-12#6)(2008-2#45)(2008-3#53)(2008-4#5)(2008-5#11)(2008-6#10)(2008-7#47)(2008-8#27)(2008-9#14)(2009-10#2)(2009-12#3)(2009-2#1)(2009-3#5)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#4)(2010-1#1)(2010-10#4)(2010-12#3)(2010-2#9)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#9)(2011-1#10)(2011-2#11)(2012-1#10)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#9)(2013-1#16)(2013-7#1)(2013-8#17)
the model's predictions##2##3##(1995-2#1)(2008-3#1)
the model's response##3##3##(2006-11#1)(2006-7#1)(2007-1#1)
the model's##16##2##(1992-2#1)(1995-2#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-1#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
the model)##3##2##(1996-6#1)(1997-5#1)(2008-10#1)
the model-based##2##2##(2012-1#1)(2012-3#1)
the model-free##2##2##(1996-7#2)
the modeled##7##2##(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#3)(2013-1#1)
the modeless laser##4##3##(2008-2#4)
the modeling and##2##3##(2008-3#2)
the modeling environment##2##3##(2010-9#2)
the modeling of the##3##4##(2008-3#1)(2009-10#1)(2009-2#1)
the modeling of##17##3##(2005-11#1)(2006-5#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#5)(2009-10#1)(2009-2#1)(2009-9#1)(2010-8#1)(2010-9#1)(2011-2#1)
the modeling##30##2##(2005-11#1)(2006-11#1)(2006-2#1)(2006-5#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#9)(2008-7#1)(2009-10#1)(2009-2#1)(2009-9#1)(2010-8#1)(2010-9#3)(2011-2#1)
the modelled##2##2##(1997-8#1)(2006-6#1)
the modelling and##2##3##(2006-11#1)(2007-10#1)
the modelling of the##2##4##(1995-7#1)(2008-10#1)
the modelling of##8##3##(1993-9#1)(1994-10#1)(1995-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-12#1)
the modelling##14##2##(1993-9#1)(1994-10#1)(1995-7#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-10#1)
the models and##3##3##(2008-9#1)(2009-3#1)(2010-11#1)
the models based on the##2##5##(2007-12#1)(2013-8#1)
the models based on##4##4##(2007-12#1)(2008-10#1)(2013-8#2)
the models can be##3##4##(1995-4#1)(1996-12#1)(2008-11#1)
the models can##4##3##(1995-4#1)(1996-12#1)(2008-11#1)(2010-12#1)
the models developed##2##3##(2008-10#1)(2009-4#1)
the models for##2##3##(2007-11#1)(2012-3#1)
the models in##3##3##(1994-8#1)(2008-11#1)(2008-8#1)
the models involving##2##3##(1997-3#1)(2008-4#1)
the models of##8##3##(1993-3#1)(1997-5#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-9#1)
the models predict##2##3##(2008-8#1)(2008-9#1)
the models presented in this##2##5##(2005-11#1)(2009-3#1)
the models to##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-9#1)(2012-8#1)
the models were##4##3##(2008-10#3)(2013-8#1)
the models will##2##3##(2007-9#1)(2013-8#1)
the models with##4##3##(2007-8#1)(2008-10#1)(2008-5#1)(2009-3#1)
the models##108##2##(1992-12#1)(1992-2#1)(1992-9#1)(1993-3#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-12#2)(1996-5#4)(1997-1#1)(1997-3#1)(1997-5#1)(2005-11#2)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#2)(2006-9#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#17)(2008-11#4)(2008-12#1)(2008-2#5)(2008-4#2)(2008-5#2)(2008-8#3)(2008-9#5)(2009-3#4)(2009-4#3)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2012-8#1)(2013-1#4)(2013-7#1)(2013-8#7)
the models'##4##2##(1991-2#1)(1994-12#1)(2006-10#1)(2007-8#1)
the moderate and##2##3##(2007-10#1)(2011-2#1)
the moderate consumption of##2##4##(1991-5#1)(2005-10#1)
the moderate subgroup##2##3##(2009-2#2)
the moderate##21##2##(1990-4#1)(1991-5#1)(1992-3#1)(1993-6#1)(1994-6#1)(1995-7#1)(1996-3#1)(2005-10#1)(2007-10#2)(2008-10#1)(2008-4#1)(2008-7#1)(2009-2#2)(2011-2#3)(2012-3#1)(2013-1#2)
the moderate-resolution imaging spectroradiometer airborne simulator##2##6##(2008-3#2)
the moderate-resolution imaging##3##3##(2008-3#3)
the moderately resistant##2##3##(2008-10#2)
the moderately##6##2##(1996-9#1)(1997-5#1)(2008-1#1)(2008-10#3)
the moderating effects of##4##4##(1996-1#1)(1996-2#1)(2007-12#1)(2011-2#1)
the moderating role of interpersonal distress##2##6##(2011-1#2)
the moderating role of##6##4##(2007-12#1)(2008-12#1)(2009-4#1)(2011-1#2)(2012-11#1)
the moderating##13##2##(1996-1#1)(1996-2#1)(2007-12#4)(2008-12#1)(2009-4#1)(2010-1#1)(2011-1#2)(2011-2#1)(2012-11#1)
the modern U##3##3##(2008-9#3)
the modern and##3##3##(2007-1#1)(2007-6#1)(2008-10#1)
the modern era##4##3##(2006-7#1)(2008-10#1)(2008-5#1)(2010-12#1)
the modern science##2##3##(2006-10#1)(2013-1#1)
the modern world##3##3##(1996-1#1)(2006-12#1)(2013-1#1)
the modern##67##2##(1990-12#2)(1991-2#1)(1991-5#1)(1992-2#1)(1993-2#2)(1994-2#1)(1995-2#1)(1996-1#1)(1997-1#1)(1997-4#1)(2004-10#1)(2006-10#3)(2006-12#1)(2006-4#2)(2006-7#1)(2007-1#1)(2007-4#1)(2007-6#2)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#4)(2009-11#1)(2009-2#1)(2010-12#2)(2010-2#1)(2010-6#1)(2011-2#4)(2011-3#1)(2012-1#2)(2013-1#4)
the modernization##3##2##(2009-2#1)(2009-7#1)(2012-3#1)
the modes in##2##3##(2006-5#1)(2007-12#1)
the modes of a##2##4##(2007-12#1)(2012-11#1)
the modes of action and##2##5##(2006-4#1)(2008-10#1)
the modes of action##3##4##(2006-4#1)(2008-10#1)(2010-5#1)
the modes of##13##3##(1991-2#1)(1992-6#1)(1994-9#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2009-12#1)(2010-5#1)(2011-2#1)(2012-11#1)
the modes##22##2##(1991-2#1)(1992-6#1)(1994-9#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#5)(2007-2#1)(2008-10#2)(2008-2#4)(2009-12#1)(2010-5#1)(2011-2#1)(2012-11#1)
the modest##7##2##(1992-3#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-8#1)
the modifiable factors##2##3##(2007-7#1)(2010-4#1)
the modifiable##3##2##(2007-7#2)(2010-4#1)
the modification and##2##3##(1995-6#1)(2008-10#1)
the modification of the##11##4##(1992-5#1)(1993-9#1)(1996-1#1)(1996-5#1)(2005-11#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-7#1)(2010-2#1)
the modification of##54##3##(1990-2#1)(1990-8#2)(1991-8#1)(1991-9#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#3)(1994-8#1)(1995-5#1)(1996-1#1)(1996-5#1)(1997-2#1)(2005-11#1)(2005-7#1)(2006-10#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-4#1)(2008-7#2)(2009-12#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-11#2)(2012-2#1)(2013-1#1)(2013-8#1)
the modification##69##2##(1990-2#1)(1990-8#2)(1991-2#1)(1991-8#1)(1991-9#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-6#2)(1993-9#3)(1994-8#1)(1995-2#1)(1995-5#2)(1995-6#2)(1996-1#1)(1996-5#1)(1997-2#2)(2005-11#1)(2005-7#1)(2006-10#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-4#3)(2008-5#1)(2008-7#2)(2009-12#1)(2009-3#2)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-2#1)(2013-1#1)(2013-8#1)
the modifications of the##4##4##(1991-4#1)(1992-5#1)(1994-3#1)(2008-2#1)
the modifications of##7##3##(1991-4#1)(1992-5#1)(1994-3#1)(2008-1#1)(2008-2#1)(2009-6#1)(2010-12#1)
the modifications##14##2##(1991-4#1)(1992-3#1)(1992-5#1)(1994-3#1)(1997-1#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2009-6#1)(2010-12#1)(2012-12#1)
the modified Quad procedure##2##4##(2013-1#2)
the modified RDV peptide##2##4##(1991-10#2)
the modified Rankin Scale##3##4##(2012-2#1)(2012-3#2)
the modified Ravitch##2##3##(2007-8#2)
the modified Strehl ratio##2##4##(2008-2#2)
the modified Tessier scheme##2##4##(2008-10#2)
the modified approach##2##3##(2008-3#2)
the modified base##4##3##(1991-1#2)(1991-7#1)(1995-1#1)
the modified electrode is##3##4##(1995-6#2)(2008-10#1)
the modified electrode was##3##4##(2008-10#3)
the modified electrode##22##3##(1995-6#3)(2008-10#19)
the modified electrodes##6##3##(2007-8#1)(2008-10#5)
the modified enzyme##6##3##(1990-7#2)(1992-5#1)(1993-6#1)(2008-10#2)
the modified group##2##3##(2006-11#1)(2008-8#1)
the modified instrument##2##3##(2008-10#1)(2008-3#1)
the modified maze procedure using cryoablation##2##6##(2007-8#2)
the modified maze procedure##3##4##(2007-8#3)
the modified nucleotide##3##3##(1993-11#1)(2006-11#1)(2008-2#1)
the modified nucleotides##3##3##(2008-4#1)(2008-8#2)
the modified peptide##2##3##(2007-8#1)(2010-2#1)
the modified power law##2##4##(2008-10#2)
the modified protein##8##3##(1993-11#1)(1995-11#1)(1995-2#2)(1996-10#1)(2008-4#1)(2009-10#2)
the modified proteins##2##3##(1990-2#1)(1995-2#1)
the modified resin##4##3##(2008-10#4)
the modified screen-printed carbon electrodes##3##5##(2008-10#3)
the modified screen-printed##4##3##(2008-10#4)
the modified silica gel##3##4##(2008-10#3)
the modified silica##4##3##(2008-10#4)
the modified site##2##3##(1992-5#1)(1996-11#1)
the modified surface##4##3##(2005-11#1)(2008-10#3)
the modified synthetic##3##3##(1995-5#1)(2006-5#1)(2008-5#1)
the modified technique##3##3##(2006-7#1)(2007-12#1)(2007-8#1)
the modified transcochlear approach##2##4##(2005-5#2)
the modified triangular interferometer##3##4##(2008-3#3)
the modified##271##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#4)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#1)(1992-5#3)(1992-6#2)(1993-11#3)(1993-2#1)(1993-6#1)(1993-9#1)(1994-3#2)(1994-4#1)(1994-8#1)(1995-1#4)(1995-10#2)(1995-11#1)(1995-2#7)(1995-4#2)(1995-5#2)(1995-6#3)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-7#4)(1997-2#2)(1997-4#1)(2005-1#1)(2005-11#6)(2005-5#2)(2006-10#2)(2006-11#4)(2006-12#1)(2006-5#2)(2006-7#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-7#2)(2007-8#11)(2008-1#1)(2008-10#77)(2008-11#4)(2008-12#1)(2008-2#11)(2008-3#11)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-10#4)(2009-6#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-8#3)(2010-9#1)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#4)
the modifier##9##2##(1997-7#1)(2007-8#1)(2008-10#7)
the modifiers##5##2##(2008-10#5)
the modifying effect of##2##4##(1992-8#1)(2008-10#1)
the modifying##3##2##(1990-6#1)(1992-8#1)(2008-10#1)
the modular##9##2##(1996-2#1)(2008-3#1)(2008-9#1)(2009-5#1)(2011-12#2)(2011-2#3)
the modulated##8##2##(1991-11#1)(1994-8#1)(2004-9#1)(2007-12#1)(2008-2#2)(2008-3#1)(2011-1#1)
the modulating effects of##2##4##(2008-1#1)(2009-5#1)
the modulating##9##2##(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-11#1)(2009-5#1)
the modulation amplitude##3##3##(2005-4#1)(2008-3#2)
the modulation by##3##3##(1994-6#1)(1995-7#1)(1996-10#1)
the modulation depth of moiré signals under incoherent illumination##2##9##(2008-2#2)
the modulation depth of##3##4##(2008-2#3)
the modulation depth##4##3##(2008-2#3)(2008-3#1)
the modulation frequency is##3##4##(2007-11#1)(2007-12#2)
the modulation frequency##7##3##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)(2012-2#1)
the modulation in the##2##4##(2008-3#1)(2009-5#1)
the modulation of a##2##4##(1991-1#1)(2009-8#1)
the modulation of cell cycle##2##5##(1991-9#1)(2008-11#1)
the modulation of cell##3##4##(1991-9#1)(2008-11#1)(2008-7#1)
the modulation of cellular##2##4##(1995-12#1)(2010-7#1)
the modulation of chromatin##2##4##(2010-2#2)
the modulation of cytokine##2##4##(2007-11#1)(2013-8#1)
the modulation of gene expression##2##5##(2006-10#1)(2008-7#1)
the modulation of inflammatory##2##4##(2008-1#2)
the modulation of ion channels##2##5##(2008-3#1)(2008-4#1)
the modulation of its##2##4##(1990-3#1)(1993-12#1)
the modulation of neuronal##2##4##(1996-1#1)(2009-8#1)
the modulation of such##2##4##(1996-4#1)(2008-4#1)
the modulation of the##17##4##(1990-4#1)(1992-11#1)(1992-9#1)(1993-12#1)(1994-8#1)(1994-9#1)(1997-3#1)(2007-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2010-12#2)(2013-1#2)
the modulation of##109##3##(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-7#1)(1991-1#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-12#3)(1993-3#2)(1993-6#2)(1993-9#3)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#5)(1995-3#1)(1996-1#1)(1996-10#1)(1996-4#3)(1996-7#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#4)(2008-11#3)(2008-2#1)(2008-3#5)(2008-4#7)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#1)(2009-3#1)(2009-8#4)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#4)(2013-8#3)
the modulation parameters##3##3##(2008-3#3)
the modulation term##2##3##(2008-3#2)
the modulation transfer function (MTF) of a##3##7##(2008-2#3)
the modulation transfer function (MTF) of##4##6##(2008-2#4)
the modulation transfer function for##2##5##(2008-3#2)
the modulation transfer function of##4##5##(2008-2#2)(2008-3#2)
the modulation transfer function##13##4##(2007-12#1)(2008-2#7)(2008-3#5)
the modulation##165##2##(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-7#1)(1991-1#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-12#3)(1993-3#2)(1993-6#2)(1993-9#3)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#5)(1995-3#1)(1995-7#1)(1996-1#1)(1996-10#2)(1996-12#2)(1996-4#3)(1996-7#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-4#1)(2006-10#2)(2007-11#6)(2007-12#9)(2007-9#1)(2008-1#4)(2008-11#3)(2008-2#13)(2008-3#24)(2008-4#7)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#1)(2009-3#1)(2009-5#1)(2009-8#4)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-12#3)(2012-2#3)(2013-1#4)(2013-8#3)
the modulator##9##2##(1993-8#1)(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#1)
the modulators##3##2##(1996-6#2)(2008-2#1)
the modulatory action of##2##4##(2008-11#1)(2008-7#1)
the modulatory effect of##5##4##(1992-6#1)(1993-3#1)(1995-11#2)(2008-8#1)
the modulatory effects##2##3##(1991-1#1)(2007-11#1)
the modulatory role of##2##4##(1994-8#1)(1996-2#1)
the modulatory##14##2##(1991-1#1)(1991-9#1)(1992-6#1)(1993-3#1)(1994-8#1)(1995-11#2)(1996-2#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-2#1)
the module##7##2##(1996-6#1)(1996-7#1)(2005-10#1)(2008-11#2)(2009-7#1)(2013-1#1)
the modules##3##2##(1992-12#1)(2008-3#1)(2012-3#1)
the modulus between##2##3##(1996-2#2)
the modulus of elasticity##2##4##(2007-9#2)
the modulus of the coherence function##2##6##(2008-3#2)
the modulus of the##5##4##(2007-12#1)(2008-2#1)(2008-3#2)(2009-9#1)
the modulus of##8##3##(2007-12#1)(2007-9#2)(2008-2#1)(2008-3#2)(2009-9#1)(2012-2#1)
the modulus##18##2##(1996-2#2)(2007-12#1)(2007-9#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2009-4#1)(2009-7#3)(2009-9#1)(2010-4#1)(2012-2#1)
the moiré fringes are##2##4##(2008-3#2)
the moiré fringes in Talbot interferometry are##2##7##(2008-3#2)
the moiré fringes in Talbot interferometry##3##6##(2008-3#3)
the moiré fringes in##4##4##(2008-3#4)
the moiré fringes##11##3##(2008-2#1)(2008-3#10)
the moiré pattern##2##3##(2008-3#2)
the moiré profile##3##3##(2008-3#3)
the moiré##22##2##(2008-2#6)(2008-3#16)
the moist samples##2##3##(2008-10#2)
the moist##6##2##(2007-3#2)(2008-10#4)
the moisture content and##2##4##(2008-12#1)(2009-7#1)
the moisture content of the##3##5##(2006-12#1)(2008-5#2)
the moisture content##10##3##(2006-12#1)(2008-10#1)(2008-12#1)(2008-5#3)(2009-7#1)(2010-4#1)(2013-7#2)
the moisture level##2##3##(2008-10#1)(2008-5#1)
the moisture##16##2##(2006-12#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#4)(2009-7#1)(2010-4#1)(2013-7#3)
the moisturizing##2##2##(2008-5#2)
the molar absorption coefficients##2##4##(2005-4#1)(2007-12#1)
the molar absorption##3##3##(2005-4#1)(2007-12#1)(2008-4#1)
the molar absorptivities of the##3##5##(2008-10#3)
the molar absorptivities of##4##4##(2008-10#4)
the molar absorptivities##5##3##(2008-10#5)
the molar absorptivity is##2##4##(2008-10#2)
the molar absorptivity of the##2##5##(2008-10#1)(2010-2#1)
the molar absorptivity of##3##4##(2008-10#2)(2010-2#1)
the molar absorptivity was##2##4##(2008-10#2)
the molar absorptivity##10##3##(2008-10#9)(2010-2#1)
the molar ratio between##2##4##(1991-2#1)(2008-10#1)
the molar ratio of amylin to insulin secreted from##2##9##(1991-10#2)
the molar ratio of myristic acid to pyrene carboxylic acid##3##10##(2008-10#3)
the molar ratio of the##5##5##(1990-10#1)(2008-10#3)(2012-2#1)
the molar ratio of##25##4##(1990-10#1)(1990-5#1)(1991-10#2)(1992-7#1)(1995-3#1)(2005-11#2)(2006-10#1)(2008-10#11)(2008-11#1)(2008-4#1)(2011-2#2)(2012-2#1)
the molar ratio##28##3##(1990-10#1)(1990-5#1)(1991-10#2)(1991-2#1)(1992-7#1)(1995-10#1)(1995-3#1)(2005-11#2)(2006-10#1)(2008-10#12)(2008-11#1)(2008-4#1)(2011-2#2)(2012-2#1)
the molar ratios##3##3##(1991-12#1)(1996-1#1)(2010-12#1)
the molar refractivities of##2##4##(2008-3#2)
the molar volumes##2##3##(2005-11#1)(2008-10#1)
the molar##70##2##(1990-10#1)(1990-5#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-9#1)(1992-5#1)(1992-7#1)(1994-5#2)(1995-10#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-6#1)(2005-11#5)(2005-4#2)(2006-10#1)(2007-12#1)(2008-10#30)(2008-11#2)(2008-3#3)(2008-4#4)(2010-12#1)(2010-2#1)(2011-2#3)(2012-2#1)
the molars##3##2##(1991-11#1)(2013-1#2)
the mold##3##2##(1990-9#1)(1997-4#1)(2006-12#1)
the molding compound##2##3##(2006-12#2)
the molding process##2##3##(2008-3#2)
the molding##5##2##(2006-12#2)(2008-3#2)(2008-5#1)
the molds##3##2##(2008-3#1)(2011-2#2)
the mole fraction of the##2##5##(2008-10#2)
the mole fraction of##5##4##(1992-12#1)(2008-10#4)
the mole fraction##8##3##(1990-8#2)(1992-12#1)(2008-10#5)
the mole fractions of##2##4##(2008-2#1)(2008-7#1)
the mole fractions##3##3##(2008-10#1)(2008-2#1)(2008-7#1)
the mole##14##2##(1990-5#1)(1990-8#2)(1992-12#1)(1992-6#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-7#1)
the molecular analysis of##3##4##(1996-11#1)(2006-4#1)(2012-2#1)
the molecular analysis##5##3##(1996-11#1)(2006-2#1)(2006-4#1)(2009-8#1)(2012-2#1)
the molecular and biochemical##2##4##(1990-5#1)(2006-11#1)
the molecular and cellular biology of##4##6##(2006-10#4)
the molecular and cellular biology##5##5##(2006-10#5)
the molecular and cellular events##2##5##(2008-7#1)(2010-12#1)
the molecular and cellular mechanism of action of##2##8##(1993-6#1)(1996-1#1)
the molecular and cellular##18##4##(1993-6#1)(1996-1#1)(1997-6#1)(2006-10#5)(2008-2#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-12#2)(2013-1#1)
the molecular and functional##2##4##(2008-4#1)(2009-5#1)
the molecular and genetic##2##4##(2007-10#1)(2008-11#1)
the molecular and physiological##2##4##(2008-2#1)(2009-8#1)
the molecular and##35##3##(1990-5#2)(1993-6#1)(1996-1#1)(1997-6#1)(2006-10#5)(2006-11#1)(2006-8#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#1)(2009-7#1)(2009-8#3)(2010-12#2)(2010-5#1)(2013-1#1)
the molecular bases for##2##4##(1993-9#1)(2008-4#1)
the molecular bases of##2##4##(2010-3#1)(2012-11#1)
the molecular bases##4##3##(1993-9#1)(2008-4#1)(2010-3#1)(2012-11#1)
the molecular basis for the##7##5##(1990-5#1)(1991-8#1)(1995-3#1)(1996-2#1)(2007-10#1)(2008-7#1)(2008-9#1)
the molecular basis for##18##4##(1990-10#1)(1990-5#1)(1991-8#1)(1994-3#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-2#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-7#1)(2008-9#2)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
the molecular basis of a##3##5##(1993-6#1)(2006-12#1)(2008-5#1)
the molecular basis of inherited##2##5##(2008-4#1)(2009-5#1)
the molecular basis of the Bohr effect of hemoglobin##2##9##(1990-8#2)
the molecular basis of the Bohr effect##3##7##(1990-8#3)
the molecular basis of the##15##5##(1990-8#3)(1991-2#1)(1993-2#1)(1995-5#1)(1997-2#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-11#1)(2008-1#1)(2008-10#1)(2008-8#1)(2011-1#1)
the molecular basis of their##2##5##(1997-1#1)(2009-8#1)
the molecular basis of these##2##5##(1995-12#1)(2008-10#1)
the molecular basis of this##5##5##(1994-11#1)(1997-2#1)(2008-10#1)(2008-11#1)(2011-1#1)
the molecular basis of##69##4##(1990-12#2)(1990-7#1)(1990-8#3)(1991-2#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-5#1)(1994-7#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#2)(1997-4#1)(2005-10#1)(2005-11#1)(2006-10#6)(2006-11#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-4#1)(2008-5#2)(2008-8#3)(2008-9#1)(2009-5#1)(2009-8#1)(2010-1#1)(2011-1#3)(2011-2#2)(2012-2#1)(2012-3#1)
the molecular basis underlying the##2##5##(2008-11#1)(2009-12#1)
the molecular basis##90##3##(1990-10#1)(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#3)(1991-2#2)(1991-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-7#1)(1994-9#2)(1995-1#2)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#3)(1997-1#1)(1997-2#2)(1997-4#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-10#7)(2006-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#6)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-12#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-4#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)
the molecular biology of the##2##5##(2008-10#1)(2013-1#1)
the molecular biology of##11##4##(1997-7#1)(2005-8#2)(2006-10#1)(2008-10#1)(2008-6#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
the molecular biology##13##3##(1997-7#1)(2005-8#2)(2006-10#1)(2007-5#1)(2008-10#1)(2008-6#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
the molecular changes##5##3##(1994-5#1)(2008-5#2)(2010-1#1)(2012-2#1)
the molecular chaperone##2##3##(1995-11#1)(1996-4#1)
the molecular characteristics of##2##4##(2005-7#1)(2009-2#1)
the molecular characterization of##8##4##(1990-7#1)(1993-3#1)(1994-4#1)(1996-9#1)(2008-10#2)(2008-6#1)(2012-12#1)
the molecular classification of##2##4##(2010-3#1)(2013-7#1)
the molecular clock##2##3##(2008-4#1)(2008-5#1)
the molecular cloning and expression of##2##6##(1991-2#1)(1995-2#1)
the molecular cloning and##3##4##(1991-2#1)(1994-12#1)(1995-2#1)
the molecular cloning of##4##4##(1991-12#1)(1992-8#1)(1993-12#1)(1995-3#1)
the molecular cloning##7##3##(1991-12#1)(1991-2#1)(1992-8#1)(1993-12#1)(1994-12#1)(1995-2#1)(1995-3#1)
the molecular components##2##3##(1996-10#1)(2011-2#1)
the molecular composition##2##3##(1994-11#1)(2008-11#1)
the molecular data##2##3##(1995-8#1)(2009-8#1)
the molecular defect##3##3##(1990-5#1)(1991-10#1)(1991-5#1)
the molecular design of##2##4##(2009-12#1)(2012-2#1)
the molecular design##4##3##(2008-1#1)(2009-12#1)(2011-1#1)(2012-2#1)
the molecular details of steroid hormone##2##6##(1996-4#2)
the molecular details of##3##4##(1994-2#1)(1996-4#2)
the molecular details##4##3##(1994-2#1)(1996-4#2)(2009-6#1)
the molecular determinants of##3##4##(1995-5#1)(1995-8#1)(1997-6#1)
the molecular determinants##6##3##(1993-3#1)(1995-5#1)(1995-8#1)(1997-1#1)(1997-6#1)(2005-7#1)
the molecular diagnosis of##4##4##(1997-4#1)(2009-2#1)(2013-8#2)
the molecular diagnosis##5##3##(1997-4#1)(2009-2#1)(2012-12#1)(2013-8#2)
the molecular dimensions of##3##4##(1990-9#1)(2008-4#1)(2009-7#1)
the molecular distillation process##3##4##(2008-5#1)(2008-6#2)
the molecular dynamics##4##3##(1992-11#1)(1995-2#1)(2010-2#1)(2012-2#1)
the molecular effects##2##3##(1997-3#1)(2010-12#1)
the molecular environment within##2##4##(1990-2#2)
the molecular environment##3##3##(1990-2#2)(2008-2#1)
the molecular epidemiology of##3##4##(2007-7#1)(2008-10#1)(2008-5#1)
the molecular etiology of##3##4##(2008-4#1)(2010-12#1)(2012-12#1)
the molecular events involved in the##2##6##(2005-8#1)(2008-10#1)
the molecular events involved in##3##5##(2005-8#1)(2008-10#1)(2008-7#1)
the molecular events that lead to progressive##2##7##(2008-7#2)
the molecular events that lead to##3##6##(1995-8#1)(2008-7#2)
the molecular events that##6##4##(1991-3#1)(1994-11#1)(1995-8#1)(2008-7#2)(2009-8#1)
the molecular events underlying the##2##5##(1996-10#1)(2009-12#1)
the molecular events underlying##3##4##(1996-10#1)(2006-10#1)(2009-12#1)
the molecular events##17##3##(1991-3#1)(1994-11#1)(1995-8#1)(1996-10#2)(1996-11#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-8#1)(2010-12#1)
the molecular evolution of##3##4##(2008-1#1)(2012-2#1)(2013-8#1)
the molecular evolution##4##3##(1990-8#1)(2008-1#1)(2012-2#1)(2013-8#1)
the molecular form of##4##4##(1990-7#2)(1991-5#1)(1993-4#1)
the molecular genetic basis of##2##5##(1997-1#1)(2008-8#1)
the molecular genetic##7##3##(1994-3#1)(1995-2#1)(1997-1#1)(1997-6#1)(2006-10#1)(2008-8#1)(2009-9#1)
the molecular genetics of##7##4##(1993-10#1)(1997-7#1)(2006-10#2)(2008-4#1)(2008-7#1)(2010-8#1)
the molecular genetics##10##3##(1993-10#1)(1997-7#1)(2006-10#2)(2007-7#1)(2008-4#1)(2008-7#1)(2009-3#1)(2010-8#1)(2012-3#1)
the molecular imaging##3##3##(2008-7#1)(2008-8#1)(2010-1#1)
the molecular interaction between the##2##5##(2008-8#1)(2008-9#1)
the molecular interaction between##3##4##(1992-11#1)(2008-8#1)(2008-9#1)
the molecular interaction##4##3##(1992-11#1)(2008-10#1)(2008-8#1)(2008-9#1)
the molecular interactions between##5##4##(1992-9#1)(1995-10#1)(2006-12#1)(2008-10#1)(2008-8#1)
the molecular interactions##9##3##(1991-2#1)(1992-9#1)(1995-10#1)(1995-8#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-8#1)(2010-7#1)
the molecular ion of##3##4##(1996-3#2)(1996-5#1)
the molecular ion##4##3##(1996-3#2)(1996-5#1)(2009-12#1)
the molecular layer of the dentate gyrus##5##7##(1990-7#1)(1991-9#2)(1995-12#2)
the molecular layer of the##6##5##(1990-7#1)(1991-9#2)(1995-12#2)(2010-12#1)
the molecular layer##17##3##(1990-7#1)(1991-6#2)(1991-9#2)(1993-9#1)(1994-10#1)(1994-11#2)(1994-2#2)(1994-8#1)(1995-12#2)(1996-5#1)(2010-12#1)(2013-8#1)
the molecular level##57##3##(1990-7#1)(1990-8#1)(1991-12#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-2#1)(1995-2#1)(1996-4#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-8#1)(2005-7#2)(2006-10#2)(2006-12#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#6)(2008-2#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-4#2)(2011-1#4)(2011-2#2)(2012-12#3)(2012-2#1)(2013-8#1)
the molecular linkage map##2##4##(2008-5#1)(2008-8#1)
the molecular machinery that##2##4##(1993-12#1)(2008-7#1)
the molecular machinery##3##3##(1993-12#1)(1993-6#1)(2008-7#1)
the molecular markers##2##3##(2008-10#2)
the molecular mass of the##9##5##(1992-6#1)(1994-2#1)(1994-9#1)(1996-5#1)(1997-8#1)(2008-10#2)(2008-4#1)(2008-5#1)
the molecular mass of##11##4##(1992-12#1)(1992-6#1)(1994-2#1)(1994-9#1)(1996-5#1)(1997-8#1)(2005-11#1)(2008-10#2)(2008-4#1)(2008-5#1)
the molecular mass##15##3##(1990-3#1)(1992-12#1)(1992-6#1)(1994-2#1)(1994-9#1)(1995-3#1)(1996-5#1)(1997-8#1)(2005-11#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)
the molecular masses##7##3##(1990-12#1)(1993-8#1)(1993-9#1)(1994-12#1)(1996-5#1)(2008-3#2)
the molecular mechanics##3##3##(2006-4#2)(2008-11#1)
the molecular mechanism by which##3##5##(2008-8#1)(2012-11#1)(2013-8#1)
the molecular mechanism involved##2##4##(1991-10#1)(2012-2#1)
the molecular mechanism of HIV##2##5##(2008-1#1)(2011-3#1)
the molecular mechanism of action of##2##6##(2006-8#1)(2008-10#1)
the molecular mechanism of action##3##5##(2006-8#1)(2008-10#2)
the molecular mechanism of the##6##5##(1993-8#1)(1994-8#1)(1996-4#1)(1997-4#1)(2009-12#1)(2011-1#1)
the molecular mechanism of this##2##5##(1994-11#1)(1994-3#1)
the molecular mechanism of##37##4##(1992-4#1)(1992-8#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-4#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-5#1)(2006-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2011-1#2)(2011-3#1)(2012-1#2)(2012-2#1)(2012-3#1)
the molecular mechanism underlying the##2##5##(1991-9#1)(2010-12#1)
the molecular mechanism underlying##4##4##(1991-9#1)(2008-4#1)(2010-12#1)(2013-1#1)
the molecular mechanism##52##3##(1991-10#1)(1991-9#1)(1992-4#1)(1992-8#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-4#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-5#1)(2006-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-8#2)(2010-12#1)(2011-1#2)(2011-3#1)(2012-1#2)(2012-11#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
the molecular mechanism(s) that##2##4##(1994-11#1)(2012-2#1)
the molecular mechanisms by which##9##5##(1996-3#1)(2008-10#1)(2008-9#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
the molecular mechanisms by##10##4##(1996-3#1)(2008-10#1)(2008-9#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#1)
the molecular mechanisms governing##2##4##(1992-4#1)(2012-2#1)
the molecular mechanisms involved in synaptic##2##6##(2007-10#1)(2008-4#1)
the molecular mechanisms involved in the##5##6##(1993-2#1)(2006-10#1)(2007-5#1)(2008-11#1)(2008-6#1)
the molecular mechanisms involved in##9##5##(1993-2#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-5#1)(2008-11#1)(2008-4#1)(2008-6#1)(2011-1#1)
the molecular mechanisms of these##3##5##(1991-9#1)(2008-1#1)(2008-9#1)
the molecular mechanisms of##38##4##(1991-7#1)(1991-9#1)(1993-11#1)(1993-2#1)(1996-11#1)(1996-2#1)(1997-4#1)(1997-7#1)(2004-9#1)(2005-7#1)(2006-10#2)(2006-5#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-4#2)(2008-6#2)(2008-7#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2011-2#2)(2012-12#1)(2013-1#1)
the molecular mechanisms regulating##3##4##(1997-6#1)(2007-12#2)
the molecular mechanisms responsible for##3##5##(1990-8#1)(2008-1#1)(2013-8#1)
the molecular mechanisms that control the##2##6##(1995-3#1)(2006-12#1)
the molecular mechanisms that control##3##5##(1995-3#1)(2006-12#1)(2008-1#1)
the molecular mechanisms that##12##4##(1994-12#1)(1994-2#1)(1995-3#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-12#1)(2012-2#1)
the molecular mechanisms underlying the cytostatic effects of Smad7 remain unknown##2##11##(2012-12#2)
the molecular mechanisms underlying the##5##5##(2004-11#1)(2008-8#1)(2012-12#3)
the molecular mechanisms underlying##14##4##(1995-8#1)(2004-11#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-9#1)(2012-11#1)(2012-12#4)
the molecular mechanisms which##2##4##(1991-11#1)(1991-6#1)
the molecular mechanisms##104##3##(1990-8#1)(1991-11#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-4#1)(1993-11#1)(1993-2#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-4#1)(1997-6#2)(1997-7#2)(2004-11#1)(2004-9#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-5#1)(2007-10#1)(2007-12#4)(2007-5#1)(2008-1#5)(2008-10#3)(2008-11#5)(2008-4#3)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#4)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-11#1)(2012-12#7)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#2)
the molecular mediators##2##3##(2007-2#1)(2012-3#1)
the molecular modeling##3##3##(1996-8#1)(2008-12#1)(2011-2#1)
the molecular nature of the##4##5##(1995-1#1)(1997-6#1)(2012-12#2)
the molecular nature of##5##4##(1995-1#1)(1996-3#1)(1997-6#1)(2012-12#2)
the molecular nature##6##3##(1995-1#1)(1996-3#1)(1997-6#1)(2007-12#1)(2012-12#2)
the molecular organization of the##2##5##(1990-6#1)(1997-2#1)
the molecular orientation of##2##4##(2005-11#1)(2008-2#1)
the molecular orientation##4##3##(2005-11#1)(2008-10#1)(2008-2#2)
the molecular origin of the##2##5##(2006-10#1)(2010-7#1)
the molecular packing##3##3##(1991-3#1)(1992-6#1)(2005-11#1)
the molecular pathogenesis of##10##4##(1995-2#1)(2006-11#1)(2007-12#1)(2007-6#1)(2007-8#2)(2008-3#2)(2010-2#1)(2010-4#1)
the molecular pathway##2##3##(1995-3#1)(2010-4#1)
the molecular pathways involved##2##4##(1991-11#1)(2008-4#1)
the molecular pathways##8##3##(1991-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2010-9#1)(2012-12#1)
the molecular peak##2##3##(2008-10#2)
the molecular pharmacology and##2##4##(1991-12#1)(2008-4#1)
the molecular pharmacology##3##3##(1991-12#1)(2008-4#1)(2012-12#1)
the molecular phylogenetic##2##3##(1993-6#1)(2008-8#1)
the molecular phylogenies##2##3##(1995-8#1)(2012-3#1)
the molecular processes##2##3##(2010-12#1)(2013-1#1)
the molecular properties of##4##4##(1990-2#1)(1992-11#1)(1992-3#1)(1997-8#1)
the molecular recognition event##2##4##(2009-3#2)
the molecular regulation of##3##4##(1997-2#1)(2006-10#1)(2011-2#1)
the molecular ruler mechanism##2##4##(2012-2#2)
the molecular scattering##2##3##(2008-2#2)
the molecular signaling##2##3##(2008-1#1)(2009-8#1)
the molecular signals##3##3##(2008-4#1)(2008-5#1)(2008-7#1)
the molecular signatures##2##3##(2008-6#1)(2010-1#1)
the molecular size of antigens##2##5##(1990-12#2)
the molecular size of##3##4##(1990-12#2)(2008-10#1)
the molecular size##5##3##(1990-12#2)(2006-4#1)(2007-1#1)(2008-10#1)
the molecular species##2##3##(1992-1#1)(1996-8#1)
the molecular strain##2##3##(2010-12#1)(2011-1#1)
the molecular structure of the##7##5##(1994-5#1)(1997-6#1)(2005-11#1)(2006-12#1)(2006-2#1)(2008-10#1)(2008-7#1)
the molecular structure of##12##4##(1991-3#1)(1994-5#1)(1997-6#1)(2005-11#2)(2006-12#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-7#1)(2012-2#2)
the molecular structure##15##3##(1991-3#1)(1994-5#1)(1995-8#1)(1997-6#1)(2005-11#2)(2006-12#1)(2006-2#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-2#2)
the molecular structures and vibration spectra of##2##7##(2011-2#2)
the molecular structures##5##3##(1996-2#1)(2008-10#2)(2011-2#2)
the molecular substrate##2##3##(2007-10#1)(2009-10#1)
the molecular surface##4##3##(1990-5#1)(1994-8#1)(2008-10#1)(2013-1#1)
the molecular target of##2##4##(2005-8#1)(2012-1#1)
the molecular target##3##3##(2005-8#1)(2008-8#1)(2012-1#1)
the molecular techniques##2##3##(2005-11#1)(2008-5#1)
the molecular understanding of##4##4##(1992-12#1)(2006-12#1)(2009-8#1)(2013-7#1)
the molecular weight and##6##4##(2005-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-4#2)
the molecular weight of each##2##5##(1992-7#1)(2008-8#1)
the molecular weight of the##10##5##(1991-12#3)(1991-2#1)(1992-12#1)(1992-8#1)(1993-11#1)(1995-2#1)(2008-10#1)(2008-5#1)
the molecular weight of##21##4##(1991-12#3)(1991-2#1)(1992-12#1)(1992-7#2)(1992-8#1)(1993-11#2)(1995-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-2#1)
the molecular weight##35##3##(1991-12#3)(1991-2#1)(1992-12#1)(1992-2#1)(1992-7#2)(1992-8#1)(1993-11#2)(1995-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-11#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#1)(2008-8#1)(2010-2#1)(2010-4#2)(2012-3#1)
the molecular weights of##6##4##(1990-7#1)(1992-9#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-8#1)
the molecular weights##8##3##(1990-7#1)(1991-11#1)(1992-9#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-5#1)(2008-8#1)
the molecular##855##2##(1990-10#1)(1990-11#2)(1990-12#6)(1990-2#4)(1990-3#1)(1990-5#5)(1990-6#1)(1990-7#8)(1990-8#6)(1990-9#1)(1991-10#2)(1991-11#4)(1991-12#7)(1991-2#5)(1991-3#4)(1991-5#2)(1991-6#4)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#2)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#2)(1992-6#3)(1992-7#2)(1992-8#4)(1992-9#2)(1993-10#3)(1993-11#4)(1993-12#2)(1993-2#3)(1993-3#4)(1993-4#1)(1993-6#5)(1993-8#3)(1993-9#4)(1994-10#2)(1994-11#13)(1994-12#3)(1994-2#7)(1994-3#5)(1994-4#1)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#5)(1994-9#6)(1995-1#4)(1995-10#1)(1995-11#5)(1995-12#4)(1995-2#9)(1995-3#5)(1995-5#4)(1995-6#1)(1995-8#9)(1996-1#1)(1996-10#3)(1996-11#4)(1996-12#1)(1996-2#8)(1996-3#4)(1996-4#5)(1996-5#7)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#3)(1997-2#7)(1997-3#1)(1997-4#7)(1997-5#2)(1997-6#11)(1997-7#6)(1997-8#5)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#11)(2005-4#1)(2005-7#5)(2005-8#8)(2005-9#1)(2006-10#29)(2006-11#4)(2006-12#9)(2006-2#2)(2006-4#4)(2006-5#2)(2006-6#1)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#9)(2007-12#12)(2007-2#1)(2007-5#3)(2007-6#4)(2007-7#2)(2007-8#4)(2008-1#13)(2008-10#49)(2008-11#27)(2008-12#1)(2008-2#14)(2008-3#8)(2008-4#24)(2008-5#20)(2008-6#9)(2008-7#23)(2008-8#20)(2008-9#16)(2009-10#3)(2009-12#7)(2009-2#2)(2009-3#5)(2009-4#1)(2009-5#4)(2009-6#3)(2009-7#4)(2009-8#14)(2009-9#2)(2010-1#7)(2010-11#3)(2010-12#16)(2010-2#3)(2010-3#3)(2010-4#8)(2010-5#5)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#15)(2011-2#14)(2011-3#2)(2012-1#3)(2012-11#6)(2012-12#19)(2012-2#25)(2012-3#8)(2013-1#10)(2013-7#4)(2013-8#11)
the molecular-level##2##2##(2011-1#1)(2012-1#1)
the molecularly imprinted##2##3##(2007-8#1)(2008-10#1)
the molecule has##3##3##(1990-11#1)(1995-1#1)(2008-11#1)
the molecule in##4##3##(1993-12#1)(1997-2#1)(2008-10#1)(2008-11#1)
the molecule is##9##3##(1990-5#1)(1990-6#1)(1991-11#1)(1992-5#1)(1993-3#1)(1995-1#1)(1997-6#1)(2008-10#1)(2011-1#1)
the molecule may##2##3##(1993-11#1)(1994-8#1)
the molecule of##2##3##(1995-11#1)(2007-9#1)
the molecule on the##2##4##(2007-9#1)(2008-10#1)
the molecule on##3##3##(1996-6#1)(2007-9#1)(2008-10#1)
the molecule to bind##2##4##(1995-3#1)(1996-7#1)
the molecule to##4##3##(1993-12#1)(1995-3#1)(1996-7#1)(2008-11#1)
the molecule##151##2##(1990-11#3)(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-11#2)(1991-12#3)(1991-2#5)(1991-3#1)(1991-4#1)(1991-5#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#3)(1993-12#3)(1993-3#3)(1993-4#2)(1993-8#2)(1994-11#7)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#2)(1994-9#5)(1995-1#3)(1995-11#2)(1995-3#5)(1995-6#1)(1995-8#3)(1996-2#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#3)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(1997-9#1)(2005-11#1)(2006-10#3)(2006-5#1)(2007-11#2)(2007-9#2)(2008-10#7)(2008-11#5)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
the molecules are##6##3##(1991-3#1)(1992-3#1)(1997-7#1)(2008-10#1)(2009-5#1)(2012-2#1)
the molecules from##2##3##(2008-10#1)(2008-7#1)
the molecules in the##3##4##(1991-2#1)(1992-9#1)(2008-11#1)
the molecules in##4##3##(1991-2#1)(1992-9#1)(2008-11#1)(2008-8#1)
the molecules of##4##3##(2006-10#2)(2006-4#1)(2008-10#1)
the molecules tested##2##3##(1995-6#1)(2012-12#1)
the molecules that are##2##4##(2006-1#1)(2013-8#1)
the molecules that##4##3##(1991-3#1)(2006-1#1)(2008-8#1)(2013-8#1)
the molecules which##2##3##(2008-10#1)(2008-5#1)
the molecules##68##2##(1991-2#2)(1991-3#2)(1991-5#1)(1992-3#2)(1992-5#1)(1992-8#1)(1992-9#4)(1993-11#1)(1993-8#1)(1994-8#1)(1995-5#1)(1995-6#1)(1996-8#2)(1997-7#2)(2005-11#3)(2005-4#1)(2006-1#1)(2006-10#5)(2006-4#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-5#2)(2009-9#1)(2010-4#1)(2010-5#1)(2012-12#2)(2012-2#2)(2013-8#2)
the mollusk##2##2##(1994-2#1)(2008-5#1)
the molt cycle of the American crayfish##2##7##(2008-6#2)
the molt cycle##3##3##(2008-6#3)
the molt##6##2##(2007-12#1)(2008-6#4)(2008-7#1)
the molten globule state##3##4##(1993-11#1)(1995-4#1)(1997-6#1)
the molten globule##11##3##(1991-5#1)(1993-11#2)(1994-11#1)(1995-4#6)(1997-6#1)
the molten##14##2##(1991-5#1)(1993-11#2)(1994-11#1)(1995-4#6)(1997-6#1)(2008-3#1)(2010-4#1)(2010-8#1)
the molybdene blue##2##3##(2008-10#2)
the molybdenum blue method##4##4##(2008-10#4)
the molybdenum blue##6##3##(2008-10#6)
the molybdenum cofactor##2##3##(1994-12#1)(1997-2#1)
the molybdenum containing##2##3##(1994-12#2)
the molybdenum##18##2##(1991-3#1)(1994-12#3)(1997-2#1)(1997-7#1)(2007-11#2)(2008-10#10)
the moment of ionization##2##4##(2007-12#2)
the moment of the##3##4##(1990-3#1)(2007-7#1)(2009-4#1)
the moment of##19##3##(1990-3#1)(1990-4#1)(1990-9#1)(1994-2#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2009-4#1)(2010-4#1)(2010-8#1)(2012-3#1)(2013-1#2)(2013-8#1)
the moment when the##3##4##(2008-9#1)(2009-10#1)(2013-1#1)
the moment##53##2##(1990-3#2)(1990-4#1)(1990-9#1)(1991-9#1)(1994-2#1)(1995-11#1)(1996-12#1)(1996-4#1)(2005-8#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-6#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#3)(2009-4#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#2)
the moment)##2##2##(2005-7#1)(2008-4#1)
the momentary##3##2##(2007-12#1)(2008-3#1)(2008-5#1)
the moments of the##2##4##(2008-2#1)(2008-8#1)
the moments of##3##3##(2008-2#1)(2008-3#1)(2008-8#1)
the moments##8##2##(2007-4#1)(2008-2#4)(2008-3#2)(2008-8#1)
the momentum of strength in the flexor and extensor muscle groups##2##11##(2007-8#2)
the momentum of##3##3##(2006-12#1)(2007-8#2)
the momentum##7##2##(1994-2#1)(2006-12#1)(2007-8#4)(2008-3#1)
the money##7##2##(1990-3#1)(1991-1#1)(1992-2#1)(1995-12#1)(1996-12#1)(1996-2#1)(2007-9#1)
the monitor##11##2##(2006-6#1)(2007-4#2)(2008-10#1)(2008-5#2)(2011-1#1)(2011-12#1)(2012-12#2)(2012-3#1)
the monitored##6##2##(1993-8#1)(2006-5#1)(2007-12#1)(2008-10#1)(2009-3#1)(2010-8#1)
the monitoring and evaluation of##2##5##(2008-6#1)(2012-12#1)
the monitoring and##6##3##(1997-4#1)(2006-10#1)(2007-8#1)(2008-6#1)(2011-1#1)(2012-12#1)
the monitoring of the##14##4##(1990-11#1)(1992-1#1)(1992-3#1)(1992-5#1)(1994-3#1)(2006-7#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-6#1)(2008-7#1)(2013-8#1)
the monitoring of##62##3##(1990-10#1)(1990-11#2)(1991-5#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-5#1)(1994-3#2)(1994-6#3)(1996-8#2)(1997-2#1)(1997-6#1)(2004-4#1)(2006-10#2)(2006-7#2)(2007-8#2)(2008-1#1)(2008-10#20)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-5#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
the monitoring period##2##3##(1997-4#1)(2011-2#1)
the monitoring##87##2##(1990-10#1)(1990-11#2)(1990-8#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-5#1)(1994-3#2)(1994-6#3)(1996-7#1)(1996-8#2)(1997-2#2)(1997-4#3)(1997-6#1)(2004-4#1)(2006-10#3)(2006-6#1)(2006-7#2)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#23)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-8#1)
the monitors##6##2##(2004-9#3)(2008-10#2)(2008-5#1)
the monkey brain##2##3##(1997-2#1)(2007-9#1)
the monkey##32##2##(1991-2#1)(1991-3#3)(1991-4#1)(1991-9#2)(1992-11#1)(1993-11#1)(1993-2#3)(1993-6#1)(1993-7#1)(1993-9#1)(1994-12#2)(1994-2#2)(1994-9#1)(1995-12#2)(1996-11#1)(1996-8#1)(1996-9#1)(1997-2#1)(2007-9#2)(2008-8#3)(2009-5#1)
the monkey's##2##2##(1993-2#1)(2009-5#1)
the monkeys##6##2##(1992-11#1)(1993-2#2)(1993-6#1)(2010-2#1)(2011-2#1)
the mono- and##2##3##(2008-10#1)(2008-8#1)
the mono-amphimers of##2##3##(1996-7#2)
the mono-amphimers##3##2##(1996-7#3)
the monoadduct##3##2##(2008-5#3)
the monoadducts##2##2##(1992-11#2)
the monoamine neurotransmitters##3##3##(2008-10#3)
the monoamine oxidase type##2##4##(1995-11#1)(2008-7#1)
the monoamine oxidase##3##3##(1995-11#1)(1996-5#1)(2008-7#1)
the monoamine##13##2##(1992-7#1)(1993-12#1)(1994-8#1)(1995-11#1)(1996-12#1)(1996-5#1)(2008-10#3)(2008-4#1)(2008-7#1)(2010-2#2)
the monochromatic##3##2##(2008-2#3)
the monochromator is##2##3##(2006-4#1)(2006-5#1)
the monochromator##5##2##(2006-4#1)(2006-5#3)(2008-2#1)
the monoclinic space group##14##4##(1991-12#1)(1992-8#1)(1996-2#6)(1997-7#3)(2007-10#2)(2007-11#1)
the monoclinic space##15##3##(1991-12#1)(1992-8#1)(1996-2#6)(1997-7#4)(2007-10#2)(2007-11#1)
the monoclinic##19##2##(1991-12#1)(1992-8#1)(1996-2#6)(1997-7#5)(2007-10#2)(2007-11#2)(2008-10#1)(2013-1#1)
the monoclonal antibodies (MAbs)##2##4##(1991-5#1)(1994-3#1)
the monoclonal antibodies##12##3##(1990-12#1)(1991-10#1)(1991-2#1)(1991-5#1)(1992-7#1)(1994-3#2)(1994-5#1)(1995-2#1)(2008-7#1)(2008-8#1)(2009-2#1)
the monoclonal antibody against##2##4##(2005-10#1)(2005-11#1)
the monoclonal antibody##40##3##(1990-12#1)(1990-5#2)(1990-7#3)(1990-8#1)(1990-9#2)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-5#3)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-4#3)(2010-12#1)(2011-1#2)(2012-12#1)
the monoclonal##63##2##(1990-12#2)(1990-5#2)(1990-7#3)(1990-8#1)(1990-9#2)(1991-10#1)(1991-2#1)(1991-5#3)(1991-9#1)(1992-12#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-3#4)(1994-5#1)(1995-1#1)(1995-12#2)(1995-2#1)(1996-5#3)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2005-1#1)(2005-10#1)(2005-11#1)(2006-2#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-11#3)(2008-4#3)(2008-7#1)(2008-8#1)(2009-2#1)(2010-11#1)(2010-12#1)(2011-1#2)(2012-12#2)
the monocyclic##4##2##(1993-8#1)(1994-9#1)(2007-11#1)(2008-10#1)
the monocyte IgA Fc receptor##2##5##(1994-8#2)
the monocyte##11##2##(1993-11#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-8#2)(1994-9#1)(1995-4#1)(2006-10#1)(2008-10#1)(2013-1#1)
the monocyte/macrophage##2##2##(1990-11#1)(1994-11#1)
the monocytes and##2##3##(1993-12#1)(2008-4#1)
the monocytes##3##2##(1993-12#1)(2008-4#1)(2013-1#1)
the monocytic##3##2##(1993-3#1)(1994-3#1)(1994-5#1)
the monoesters##5##2##(1992-12#4)(2008-4#1)
the monofunctional##4##2##(1992-6#1)(1993-12#1)(2008-10#1)(2008-5#1)
the monolayer and##2##3##(1994-3#1)(2008-10#1)
the monolayer contains##2##3##(1990-5#1)(1996-8#1)
the monolayer culture##3##3##(2008-11#3)
the monolayer in##4##3##(1992-6#1)(1994-5#1)(2008-10#2)
the monolayer is##4##3##(1994-3#1)(1994-6#2)(2008-10#1)
the monolayer of##2##3##(2007-9#1)(2008-11#1)
the monolayer spontaneous curvature properties##3##5##(1996-1#3)
the monolayer spontaneous curvature##5##4##(1996-1#5)
the monolayer##50##2##(1990-4#2)(1990-5#2)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#3)(1992-6#1)(1994-3#4)(1994-5#1)(1994-6#3)(1996-1#5)(1996-6#1)(1996-8#2)(1997-2#2)(2005-11#5)(2007-8#1)(2007-9#2)(2008-10#7)(2008-11#6)
the monolayers##6##2##(1990-4#1)(1994-3#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
the monolith##2##2##(2008-10#2)
the monolithic columns##3##3##(2008-10#3)
the monolithic##11##2##(2005-12#1)(2006-7#1)(2007-12#1)(2008-10#4)(2008-3#2)(2013-8#2)
the monomer and##5##3##(2005-11#1)(2006-10#1)(2008-10#2)(2012-1#1)
the monomer are##2##3##(1992-4#1)(1995-5#1)
the monomer of##2##3##(1991-8#1)(2008-8#1)
the monomer phase##2##3##(1996-6#1)(2008-10#1)
the monomer##42##2##(1990-2#1)(1990-8#2)(1991-8#1)(1992-12#4)(1992-4#2)(1994-8#1)(1995-1#3)(1995-5#2)(1996-6#1)(1997-4#1)(2005-11#5)(2006-10#3)(2006-12#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#3)(2012-1#1)
the monomer--dimer##2##2##(1993-3#2)
the monomeric 190/170-kDa PFn fragment##2##5##(1991-4#2)
the monomeric and the##2##4##(1994-11#1)(1997-6#1)
the monomeric and##4##3##(1994-11#1)(1997-6#2)(2008-10#1)
the monomeric form of##2##4##(1997-2#1)(2008-5#1)
the monomeric form##7##3##(1990-5#1)(1991-3#1)(1994-11#1)(1997-2#1)(1997-7#1)(2005-11#1)(2008-5#1)
the monomeric gp18##2##3##(1990-5#2)
the monomeric state##2##3##(1993-6#1)(2009-12#1)
the monomeric##38##2##(1990-2#1)(1990-5#3)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#1)(1992-2#1)(1993-6#3)(1994-11#3)(1994-5#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#1)(2005-11#1)(2006-12#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-2#1)(2010-5#1)(2011-1#1)
the monomers of##2##3##(1994-5#1)(2010-4#1)
the monomers##12##2##(1994-2#1)(1994-5#1)(1994-8#2)(2008-10#1)(2008-8#1)(2010-12#1)(2010-4#4)(2013-1#1)
the monomolecular film technique##2##4##(1995-8#2)
the monomolecular##3##2##(1995-8#2)(2008-10#1)
the mononuclear cells##2##3##(2008-4#1)(2013-8#1)
the mononuclear phagocyte system##2##4##(1991-9#1)(2006-10#1)
the mononuclear phagocyte##3##3##(1991-9#1)(2006-10#1)(2008-4#1)
the mononuclear phagocytic system##4##4##(1990-12#1)(2007-11#3)
the mononuclear phagocytic##5##3##(1990-12#1)(2007-11#4)
the mononuclear##13##2##(1990-12#1)(1991-9#1)(1995-11#2)(2006-10#1)(2007-11#4)(2008-4#3)(2013-8#1)
the monophyletic##3##2##(2007-12#1)(2013-7#1)(2013-8#1)
the monophyly of##6##3##(2007-12#1)(2008-10#3)(2010-3#2)
the monopolar##3##2##(1992-12#1)(1994-9#1)(2008-9#1)
the monoprotonated##2##2##(1990-4#1)(1991-9#1)
the monosaccharide sequence##2##3##(1994-3#2)
the monosaccharide##5##2##(1990-8#1)(1994-3#2)(1995-4#2)
the monosegment##2##2##(2008-10#2)
the monosynaptic##4##2##(1995-12#1)(1996-1#1)(1996-2#1)(1997-7#1)
the monotonic##2##2##(2007-12#1)(2008-10#1)
the monovalent Fab##2##3##(2008-1#1)(2008-4#1)
the monovalent##7##2##(1990-3#1)(1992-12#2)(2007-11#1)(2008-1#1)(2008-4#2)
the month of January##2##4##(1996-8#1)(2006-8#1)
the month of Ramadan##5##4##(2006-2#1)(2008-4#3)(2013-7#1)
the month of##10##3##(1996-8#1)(2006-2#2)(2006-8#1)(2007-5#1)(2008-4#3)(2011-2#1)(2013-7#1)
the month##30##2##(1994-3#1)(1994-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(2004-12#2)(2006-2#2)(2006-8#2)(2007-2#1)(2007-5#2)(2008-10#1)(2008-3#2)(2008-4#3)(2008-5#1)(2010-5#1)(2011-2#5)(2012-12#1)(2013-1#1)(2013-7#1)
the monthly average##2##3##(2007-12#1)(2013-8#1)
the monthly##13##2##(1991-12#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-3#1)(2013-7#2)(2013-8#2)
the months of November##2##4##(2010-5#1)(2013-8#1)
the months of##13##3##(1996-8#1)(2004-11#1)(2004-4#1)(2006-2#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
the months##21##2##(1991-12#1)(1991-2#1)(1996-8#2)(2004-11#1)(2004-4#1)(2005-12#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-5#3)(2010-5#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
the mood disorders##3##3##(2010-12#3)
the mood##10##2##(1991-1#1)(1991-8#1)(2007-11#1)(2007-6#1)(2008-5#1)(2010-12#3)(2011-2#1)(2013-8#1)
the moon##9##2##(2007-9#4)(2008-2#2)(2008-3#2)(2013-8#1)
the moral legitimacy of##2##4##(2006-4#1)(2012-2#1)
the moral of a story##2##5##(1995-11#2)
the moral of##3##3##(1995-11#3)
the moral##19##2##(1991-12#1)(1995-11#3)(2005-7#2)(2006-4#1)(2006-7#1)(2007-11#1)(2008-11#3)(2008-7#1)(2008-9#1)(2009-2#1)(2009-7#2)(2011-2#1)(2012-2#1)
the morbid##2##2##(2006-5#1)(2008-7#1)
the morbidity and mortality associated with coronary##2##7##(1996-9#1)(2008-1#1)
the morbidity and mortality associated with##8##6##(1996-9#1)(2004-11#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-3#1)(2009-3#1)(2012-12#1)
the morbidity and mortality of patients##3##6##(2007-7#1)(2008-8#1)(2012-3#1)
the morbidity and mortality of the population##8##7##(2013-8#8)
the morbidity and mortality of the##10##6##(2010-9#1)(2012-3#1)(2013-8#8)
the morbidity and mortality of##15##5##(2007-6#1)(2007-7#1)(2008-8#1)(2010-8#1)(2010-9#1)(2012-3#2)(2013-8#8)
the morbidity and mortality rates##2##5##(2006-10#1)(2011-12#1)
the morbidity and mortality##33##4##(1996-9#1)(2004-11#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-8#1)(2010-9#1)(2011-12#1)(2012-12#2)(2012-3#2)(2013-8#8)
the morbidity and the mortality##2##5##(2007-2#1)(2007-7#1)
the morbidity and##40##3##(1996-6#1)(1996-9#1)(1997-8#1)(2004-11#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-2#2)(2007-6#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-8#1)(2010-9#1)(2011-12#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-8#8)
the morbidity associated with##8##4##(2006-10#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#2)(2008-7#1)
the morbidity of the##3##4##(2007-8#1)(2008-8#1)(2011-2#1)
the morbidity of##9##3##(1993-1#1)(2007-3#1)(2007-8#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)
the morbidity related to##2##4##(1991-4#1)(2006-10#1)
the morbidity##67##2##(1991-12#1)(1991-2#1)(1991-4#1)(1993-1#1)(1996-6#1)(1996-9#2)(1997-8#1)(2004-11#1)(2006-10#4)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-11#3)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#4)(2007-8#2)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-3#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-11#1)(2011-12#1)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#3)(2013-8#8)
the more abundant##4##3##(1990-2#1)(1991-7#1)(2008-2#1)(2009-10#1)
the more accessible##2##3##(2005-11#2)
the more accurate identification of##2##5##(1990-11#1)(2008-10#1)
the more accurate##3##3##(1990-11#1)(2008-10#1)(2008-2#1)
the more acidic##3##3##(1991-2#1)(2005-11#1)(2008-10#1)
the more active##4##3##(1991-3#1)(1995-10#1)(1996-10#1)(2006-10#1)
the more advanced##4##3##(1995-11#1)(2005-6#1)(2008-1#1)(2008-11#1)
the more aggressive##4##3##(2006-10#1)(2008-10#1)(2011-1#1)(2012-3#1)
the more basic##2##3##(1990-8#1)(1996-2#1)
the more challenging##2##3##(2006-7#1)(2008-10#1)
the more common serogroups were O8##2##6##(1993-10#2)
the more common serogroups were##4##5##(1993-10#4)
the more common##32##3##(1991-9#1)(1992-12#1)(1992-5#1)(1993-10#4)(1993-4#1)(1996-12#1)(1996-9#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-12#2)(2008-2#2)(2008-4#1)(2008-6#2)(2008-9#2)(2009-5#1)(2009-9#1)(2010-1#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)
the more commonly used##8##4##(1991-12#1)(1997-4#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-4#3)
the more commonly##11##3##(1991-12#1)(1997-4#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-8#1)(2010-4#1)
the more complex##10##3##(1991-2#1)(1992-1#1)(1994-1#1)(2006-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-9#1)(2012-1#2)
the more complicated##2##3##(1997-6#1)(2008-2#1)
the more consistent##3##3##(2004-11#1)(2009-7#1)(2010-1#1)
the more conventional##8##3##(1993-4#1)(1994-5#1)(1997-7#1)(2005-11#1)(2006-10#1)(2008-2#1)(2008-3#1)(2008-4#1)
the more dense##2##3##(1996-8#1)(2008-12#1)
the more difficult##4##3##(2007-10#1)(2008-1#1)(2008-3#1)(2012-2#1)
the more distant##3##3##(1992-7#1)(1996-3#1)(2008-8#1)
the more distantly related##2##4##(2008-10#1)(2010-12#1)
the more effective##4##3##(1991-5#1)(2007-11#1)(2008-3#2)
the more efficient##6##3##(1995-10#1)(1997-6#2)(2008-10#2)(2012-2#1)
the more expensive##3##3##(2004-1#1)(2006-10#1)(2008-3#1)
the more familiar##3##3##(2007-4#1)(2007-8#1)(2011-1#1)
the more flexible##2##3##(1997-3#1)(2012-1#1)
the more frequent##6##3##(1992-11#1)(1996-3#1)(1996-9#1)(2005-11#1)(2006-1#1)(2010-12#1)
the more frequently##3##3##(1994-5#1)(2008-8#1)(2011-12#1)
the more general##5##3##(2008-10#1)(2008-3#1)(2009-10#1)(2010-2#1)(2010-8#1)
the more hindered Z##2##4##(2007-11#2)
the more hydrophilic##2##3##(1996-6#1)(2005-11#1)
the more hydrophobic##3##3##(1995-2#1)(2005-11#2)
the more important##10##3##(1991-1#1)(1992-3#1)(1994-5#1)(1995-9#1)(1996-10#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2012-2#1)
the more intense##3##3##(1997-8#1)(2008-10#2)
the more intensive##2##3##(2005-8#1)(2013-8#1)
the more likely##3##3##(1991-2#1)(1994-5#1)(2007-9#1)
the more number of##2##4##(1991-2#2)
the more or less##2##4##(2008-2#1)(2010-12#1)
the more polar##2##3##(1993-11#1)(2008-10#1)
the more positive##2##3##(1990-5#1)(2007-11#1)
the more potent##7##3##(1992-6#1)(1993-4#1)(1994-9#1)(2008-11#2)(2008-8#1)(2009-8#1)
the more powerful##2##3##(2005-11#1)(2011-2#1)
the more practical##2##3##(1997-7#1)(2006-8#1)
the more precise##2##3##(2006-6#1)(2007-11#1)
the more prevalent##5##3##(1992-12#1)(2005-8#1)(2007-3#1)(2007-6#1)(2008-6#1)
the more pronounced##2##3##(2007-12#1)(2013-8#1)
the more realistic##2##3##(2008-2#1)(2010-2#1)
the more recent##15##3##(1990-4#1)(1994-6#1)(1997-4#1)(1997-8#1)(2005-10#1)(2006-12#1)(2006-4#1)(2006-8#1)(2008-1#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-6#1)(2010-11#1)
the more recently reported##2##4##(1993-2#1)(2013-8#1)
the more recently##4##3##(1993-2#1)(2005-11#1)(2006-10#1)(2013-8#1)
the more resistant C57BL/10 mice##2##5##(1996-12#2)
the more resistant##5##3##(1990-2#1)(1996-12#2)(2008-10#2)
the more robust##2##3##(2008-4#1)(2009-3#1)
the more selective##3##3##(1994-2#1)(1997-5#1)(2005-9#1)
the more sensitive##3##3##(1990-8#1)(2008-10#2)
the more serious##2##3##(1990-5#1)(2010-3#1)
the more severe cases##3##4##(2005-11#1)(2009-2#1)(2010-5#1)
the more severe##10##3##(1994-6#1)(1995-4#1)(1997-3#1)(2005-11#1)(2006-11#1)(2008-4#1)(2009-2#1)(2010-5#1)(2012-2#1)(2013-8#1)
the more severely##2##3##(1996-2#1)(2008-11#1)
the more significant##7##3##(1993-1#1)(1994-10#1)(1995-6#1)(1996-3#1)(2007-12#1)(2009-8#1)(2011-1#1)
the more slowly##2##3##(1995-3#1)(1995-8#1)
the more soluble##3##3##(1995-10#2)(2008-5#1)
the more sophisticated##2##3##(2007-4#1)(2008-2#1)
the more stable##4##3##(1994-2#1)(2006-7#1)(2008-10#1)(2009-3#1)
the more subtle##2##3##(2009-9#1)(2010-12#1)
the more susceptible##3##3##(2008-10#2)(2009-5#1)
the more than 100##2##4##(2007-11#1)(2012-1#1)
the more than##9##3##(1991-12#1)(1993-12#1)(1994-3#1)(1995-12#1)(2004-5#1)(2007-11#1)(2007-12#1)(2007-9#1)(2012-1#1)
the more the##5##3##(1995-11#1)(2008-5#1)(2010-12#1)(2013-8#2)
the more traditional##4##3##(1996-3#1)(2008-3#1)(2008-5#1)(2009-11#1)
the more used##2##3##(2008-10#1)(2012-3#1)
the more useful##3##3##(2008-10#1)(2008-3#1)(2008-6#1)
the more virulent##3##3##(2006-10#1)(2008-10#2)
the more widely##3##3##(1992-2#1)(1994-9#1)(2012-3#1)
the more widespread##2##3##(2005-9#1)(2013-1#1)
the more##445##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#5)(1990-8#2)(1991-1#1)(1991-12#2)(1991-2#5)(1991-3#3)(1991-5#2)(1991-7#3)(1991-9#1)(1992-1#1)(1992-11#4)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-7#1)(1993-1#1)(1993-10#4)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#3)(1994-1#1)(1994-10#1)(1994-12#4)(1994-2#2)(1994-3#2)(1994-5#4)(1994-6#2)(1994-9#3)(1995-10#4)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-1#3)(1996-10#4)(1996-12#3)(1996-2#3)(1996-3#4)(1996-5#2)(1996-6#1)(1996-8#2)(1996-9#3)(1997-2#1)(1997-3#4)(1997-4#2)(1997-5#2)(1997-6#4)(1997-7#3)(1997-8#3)(2004-1#1)(2004-11#1)(2004-2#1)(2004-5#1)(2005-10#2)(2005-11#13)(2005-12#1)(2005-6#1)(2005-8#3)(2005-9#2)(2006-1#1)(2006-10#11)(2006-11#4)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#3)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#6)(2007-2#1)(2007-3#1)(2007-4#4)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#5)(2008-10#38)(2008-11#11)(2008-12#5)(2008-2#14)(2008-3#14)(2008-4#9)(2008-5#10)(2008-6#5)(2008-7#2)(2008-8#9)(2008-9#5)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-5#4)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#4)(2010-1#3)(2010-11#3)(2010-12#6)(2010-2#4)(2010-3#1)(2010-4#5)(2010-5#2)(2010-7#1)(2010-8#5)(2011-1#4)(2011-12#1)(2011-2#3)(2012-1#4)(2012-12#1)(2012-2#8)(2012-3#3)(2012-5#2)(2013-1#3)(2013-7#1)(2013-8#7)
the morning after##2##3##(1996-5#1)(2007-12#1)
the morning and##5##3##(2007-3#1)(2008-10#1)(2008-5#1)(2010-1#1)(2010-5#1)
the morning following##2##3##(2004-11#1)(2008-8#1)
the morning of##4##3##(1996-8#1)(2005-7#1)(2008-5#2)
the morning##40##2##(1990-12#1)(1993-10#1)(1993-5#1)(1995-1#2)(1996-4#1)(1996-5#1)(1996-8#1)(2004-11#1)(2005-7#1)(2006-2#1)(2007-11#3)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#3)(2008-5#7)(2008-8#3)(2009-4#1)(2010-1#3)(2010-5#1)(2010-8#1)(2011-2#1)
the morning-after pill##2##3##(1992-10#1)(1992-7#1)
the mornings##2##2##(2008-1#1)(2009-4#1)
the morphine##8##2##(1991-1#1)(1994-8#1)(1995-12#2)(1995-5#1)(1996-12#1)(2007-11#1)(2008-10#1)
the morpho-functional##2##2##(2007-5#1)(2011-1#1)
the morphogenesis and##2##3##(2008-10#1)(2009-2#1)
the morphogenesis of##7##3##(1991-8#1)(1993-4#1)(2006-11#1)(2007-12#2)(2008-11#1)(2010-12#1)
the morphogenesis##9##2##(1991-8#1)(1993-4#1)(2006-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2009-2#1)(2010-12#1)
the morphogenetic##5##2##(1993-6#1)(2007-12#2)(2008-5#1)(2009-6#1)
the morphologic and##3##3##(1992-9#1)(2007-10#1)(2007-2#1)
the morphologic appearance##2##3##(1992-11#1)(2010-12#1)
the morphologic##14##2##(1991-2#1)(1991-6#1)(1992-11#1)(1992-6#1)(1992-9#1)(2007-10#1)(2007-2#3)(2008-5#1)(2009-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
the morphological and functional changes##2##5##(1992-9#1)(1994-12#1)
the morphological and functional##5##4##(1991-11#1)(1992-9#1)(1994-12#1)(2007-11#1)(2012-12#1)
the morphological and ultrastructural changes##2##5##(2008-10#2)
the morphological and##20##3##(1991-11#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-2#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#1)(2009-2#1)(2011-2#1)(2012-12#1)(2012-9#1)(2013-7#1)
the morphological appearance##2##3##(2006-6#1)(2007-9#1)
the morphological basis##2##3##(1995-9#1)(2007-12#1)
the morphological changes and##2##4##(1990-12#1)(2008-5#1)
the morphological changes##10##3##(1990-12#1)(1991-3#1)(1992-7#1)(1994-8#1)(1996-1#1)(1997-8#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-9#1)
the morphological characteristics of the##2##5##(2008-5#1)(2008-8#1)
the morphological characteristics of##4##4##(2006-8#1)(2008-5#1)(2008-8#1)(2009-5#1)
the morphological characteristics##5##3##(2006-8#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)
the morphological correlation##2##3##(2008-3#2)
the morphological differentiation of##3##4##(1994-8#1)(2005-11#1)(2009-8#1)
the morphological differentiation##4##3##(1994-8#1)(2005-11#1)(2009-8#1)(2011-2#1)
the morphological evolution of##2##4##(2008-3#1)(2009-8#1)
the morphological features##5##3##(2007-9#1)(2008-5#1)(2009-4#1)(2012-3#1)(2013-7#1)
the morphological trait##2##3##(2008-10#1)(2013-7#1)
the morphological##97##2##(1990-12#1)(1990-7#1)(1991-11#1)(1991-3#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-12#2)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#12)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#6)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#3)(2010-2#1)(2010-4#1)(2011-12#2)(2011-2#5)(2012-12#1)(2012-3#2)(2012-9#1)(2013-7#3)(2013-8#1)
the morphologically similar##2##3##(2008-10#2)
the morphology and biochemistry of##2##5##(1996-5#1)(2008-7#1)
the morphology and composition##2##4##(2007-11#1)(2007-5#1)
the morphology and distribution of##3##5##(1991-9#1)(2008-5#1)(2010-6#1)
the morphology and function of the brain##2##7##(2012-1#2)
the morphology and function of the##3##6##(2008-11#1)(2012-1#2)
the morphology and function of##5##5##(2008-10#1)(2008-11#1)(2011-1#1)(2012-1#2)
the morphology and the##2##4##(2005-11#1)(2008-2#1)
the morphology and##32##3##(1991-9#1)(1996-5#1)(1997-1#1)(1997-5#2)(1997-8#1)(2005-11#2)(2005-12#1)(2006-10#1)(2007-11#2)(2007-12#3)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-7#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#2)(2013-8#1)
the morphology of dorsal lips##2##5##(2011-2#2)
the morphology of the substomatal##2##5##(2008-10#2)
the morphology of the##32##4##(1990-12#1)(1991-2#1)(1992-6#1)(1993-6#1)(1994-8#1)(1996-9#2)(2005-11#1)(2006-5#1)(2006-6#1)(2007-12#6)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-4#1)(2013-7#1)
the morphology of their##3##4##(1995-11#1)(2006-5#1)(2009-12#1)
the morphology of##67##3##(1990-12#1)(1991-12#1)(1991-2#1)(1992-6#2)(1992-9#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-6#1)(1996-9#2)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#2)(2006-5#2)(2006-6#1)(2007-12#6)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2010-4#1)(2011-12#1)(2011-2#3)(2013-1#2)(2013-7#1)
the morphology##112##2##(1990-12#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-6#2)(1992-9#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-5#1)(1995-6#1)(1996-5#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-5#2)(1997-8#2)(2004-12#1)(2005-10#1)(2005-11#4)(2005-12#1)(2006-10#2)(2006-5#2)(2006-6#1)(2007-11#2)(2007-12#9)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#5)(2007-9#1)(2008-10#11)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
the morphometric##6##2##(1996-10#2)(1996-8#1)(2008-5#1)(2009-2#1)(2013-8#1)
the morphometry of##2##3##(1996-2#1)(2013-1#1)
the morphometry##4##2##(1995-8#1)(1996-2#1)(2009-12#1)(2013-1#1)
the mortality after##2##3##(1990-12#1)(2007-10#1)
the mortality and morbidity##4##4##(1990-8#1)(2007-10#1)(2007-7#1)(2010-1#1)
the mortality and the##2##4##(1992-12#1)(2013-8#1)
the mortality and##10##3##(1990-8#1)(1992-12#1)(1994-4#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-9#1)(2010-1#1)(2013-8#1)
the mortality associated with##3##4##(2008-10#1)(2010-12#1)(2010-7#1)
the mortality caused by##2##4##(2007-2#1)(2012-12#1)
the mortality event##3##3##(2008-5#3)
the mortality from##3##3##(1993-3#1)(2004-11#1)(2008-2#1)
the mortality in##5##3##(2007-8#1)(2008-1#1)(2009-8#1)(2011-2#1)(2013-8#1)
the mortality induced by##2##4##(2008-5#1)(2012-2#1)
the mortality is##3##3##(1996-9#1)(2008-8#1)(2011-2#1)
the mortality of children##2##4##(2008-8#1)(2013-1#1)
the mortality of dialysis patients##2##5##(2008-1#2)
the mortality of the##2##4##(2007-7#1)(2011-12#1)
the mortality of##19##3##(1990-4#1)(1994-7#1)(1995-4#2)(1997-7#1)(1997-8#1)(2006-6#2)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-3#2)(2008-8#1)(2011-12#1)(2012-2#1)(2013-1#1)
the mortality rate and##2##4##(2007-12#1)(2008-9#1)
the mortality rate due to##2##5##(2008-9#1)(2009-6#1)
the mortality rate for##2##4##(1991-4#1)(2005-7#1)
the mortality rate from##2##4##(2008-9#1)(2012-12#1)
the mortality rate is##5##4##(1992-9#1)(2008-1#1)(2008-4#1)(2009-3#1)(2011-1#1)
the mortality rate of##8##4##(1994-7#1)(2007-12#1)(2007-2#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#2)
the mortality rate was 2##2##5##(1992-9#1)(2006-12#1)
the mortality rate was##5##4##(1991-2#1)(1992-9#1)(2006-12#1)(2008-5#1)(2012-2#1)
the mortality rate##37##3##(1991-2#1)(1991-4#1)(1992-9#2)(1993-10#1)(1994-7#3)(1995-9#1)(2005-7#1)(2005-9#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-3#1)(2009-6#1)(2011-1#1)(2012-12#4)(2012-2#1)(2013-1#2)
the mortality rates##5##3##(2005-10#1)(2007-8#1)(2008-8#1)(2010-12#1)(2012-2#1)
the mortality##118##2##(1990-10#1)(1990-12#3)(1990-4#2)(1990-6#1)(1990-8#1)(1991-2#1)(1991-4#1)(1992-12#1)(1992-9#2)(1993-10#1)(1993-3#1)(1993-8#1)(1994-4#1)(1994-5#1)(1994-7#4)(1995-4#2)(1995-9#1)(1996-7#1)(1996-9#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#2)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#2)(2007-7#2)(2007-8#3)(2008-1#4)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#8)(2008-7#2)(2008-8#4)(2008-9#5)(2009-3#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-12#2)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#6)(2012-2#4)(2013-1#5)(2013-8#4)
the mortar preparation did not correspond to the complex##2##9##(2008-10#2)
the morula-like cell##2##3##(2008-5#2)
the morula-like cells##2##3##(2008-5#2)
the morula-like##4##2##(2008-5#4)
the mosaic##3##2##(2006-5#1)(2008-12#1)(2011-1#1)
the mosquito Aedes aegypti##3##4##(1990-3#1)(1995-1#1)(2008-5#1)
the mosquito Aedes##4##3##(1990-3#1)(1995-1#1)(2008-5#1)(2011-2#1)
the mosquito midgut##2##3##(2006-10#1)(2008-11#1)
the mosquito population##2##3##(2008-2#1)(2011-3#1)
the mosquito vectors##2##3##(2008-1#1)(2010-1#1)
the mosquito##30##2##(1990-3#1)(1990-5#4)(1995-1#1)(2004-11#1)(2005-12#1)(2006-10#5)(2007-2#1)(2008-1#1)(2008-11#4)(2008-2#1)(2008-4#2)(2008-5#1)(2010-1#1)(2010-2#1)(2011-2#3)(2011-3#2)
the mosquitoes##2##2##(2008-5#2)
the moss Physcomitrella patens using##3##5##(2010-2#3)
the moss Physcomitrella patens##8##4##(2006-11#1)(2010-2#7)
the moss##12##2##(2006-11#1)(2008-10#2)(2008-8#2)(2010-2#7)
the mossy fibers##2##3##(1994-6#1)(1995-7#1)
the mossy##4##2##(1993-6#2)(1994-6#1)(1995-7#1)
the most 5'##2##3##(1995-10#1)(1995-5#1)
the most abundant and##8##4##(1992-9#1)(2007-12#1)(2007-3#1)(2010-11#1)(2010-2#1)(2012-2#2)(2013-1#1)
the most abundant chemical##2##4##(2013-7#1)(2013-8#1)
the most abundant component##2##4##(2007-1#1)(2008-11#1)
the most abundant constituents##3##4##(1997-2#1)(2012-12#2)
the most abundant genotypes##2##4##(2008-10#1)(2008-8#1)
the most abundant in the##2##5##(1990-7#1)(2010-8#1)
the most abundant protein in##3##5##(1995-3#1)(2011-2#1)(2013-8#1)
the most abundant protein##5##4##(1995-3#1)(2008-3#1)(2010-10#1)(2011-2#1)(2013-8#1)
the most abundant proteins##3##4##(1995-3#1)(2008-6#1)(2011-1#1)
the most abundant transcript##2##4##(1992-11#1)(2006-12#1)
the most abundant type of##2##5##(2007-12#1)(2012-3#1)
the most abundant##105##3##(1990-3#1)(1990-7#1)(1991-4#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-7#1)(1995-11#1)(1995-3#2)(1996-12#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(2005-7#1)(2005-8#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#4)(2007-5#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-2#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#10)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#5)(2013-8#2)
the most abundantly##2##3##(2008-10#1)(2009-10#1)
the most acceptable##2##3##(2008-7#1)(2013-1#1)
the most accepted##5##3##(2006-2#1)(2008-9#1)(2011-1#1)(2012-2#2)
the most accessible##2##3##(2007-3#1)(2009-9#1)
the most accurate and##3##4##(1991-6#1)(2008-3#1)(2011-2#1)
the most accurate representation of the##2##6##(1993-11#1)(1995-6#1)
the most accurate##31##3##(1991-6#1)(1993-11#2)(1993-5#1)(1995-6#1)(2005-12#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#3)(2008-7#1)(2008-8#1)(2009-4#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-8#1)
the most active against##3##4##(2008-7#2)(2009-3#1)
the most active compound##5##4##(1994-11#1)(1996-4#1)(1997-1#1)(2007-1#1)(2008-4#1)
the most active compounds##5##4##(1995-3#1)(1997-2#2)(2008-5#2)
the most active cytotoxic##2##4##(2007-5#1)(2008-11#1)
the most active fractions##2##4##(1997-8#1)(2010-12#1)
the most active##49##3##(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-3#1)(1996-4#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#2)(2009-12#1)(2009-3#1)(2010-12#2)(2013-1#3)(2013-8#1)
the most adequate##2##3##(2009-9#1)(2013-1#1)
the most advanced##7##3##(1992-5#1)(2008-1#1)(2008-5#1)(2008-8#2)(2010-7#1)(2012-2#1)
the most affected by##2##4##(1995-3#1)(1996-3#1)
the most affected##13##3##(1992-5#1)(1995-3#1)(1996-3#1)(1996-7#1)(2004-4#1)(2008-2#1)(2008-5#1)(2009-2#1)(2009-6#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-7#1)
the most aggressive##8##3##(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-2#1)(2011-3#1)(2013-8#1)
the most and##5##3##(1994-12#1)(2005-11#1)(2006-9#1)(2008-12#2)
the most anterior##3##3##(2006-7#1)(2007-12#2)
the most apical##2##3##(2008-12#1)(2008-7#1)
the most apparent##3##3##(1995-1#1)(2006-11#1)(2008-5#1)
the most appealing##3##3##(1991-3#1)(2008-2#2)
the most appropriate agent##2##4##(2005-10#1)(2008-2#1)
the most appropriate and##2##4##(2007-10#1)(2008-5#1)
the most appropriate approach##2##4##(2009-4#1)(2013-1#1)
the most appropriate diagnostic##2##4##(1990-9#1)(2012-12#1)
the most appropriate form of##2##5##(1993-6#1)(2006-10#1)
the most appropriate method##2##4##(2008-3#1)(2008-4#1)
the most appropriate methods##3##4##(1990-5#1)(2008-10#1)(2008-7#1)
the most appropriate option for##2##5##(2007-12#1)(2009-11#1)
the most appropriate strategy for##2##5##(2008-7#1)(2009-5#1)
the most appropriate treatment strategy##2##5##(1996-6#1)(2009-7#1)
the most appropriate treatment##5##4##(1996-6#1)(2007-9#1)(2009-7#1)(2011-1#1)(2012-2#1)
the most appropriate type of##2##5##(2010-12#1)(2010-8#1)
the most appropriate##80##3##(1990-5#1)(1990-6#1)(1990-9#1)(1992-8#1)(1993-12#1)(1993-6#1)(1996-1#2)(1996-2#2)(1996-6#1)(2004-2#1)(2005-10#2)(2005-5#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-8#3)(2007-9#1)(2008-10#13)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-4#2)(2009-5#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-12#4)(2012-2#3)(2012-9#1)(2013-1#2)(2013-8#1)
the most are##2##3##(2008-4#1)(2013-1#1)
the most attractive##3##3##(1992-3#1)(2008-8#1)(2011-1#1)
the most basal##3##3##(1995-12#1)(2008-10#1)(2011-2#1)
the most basic##7##3##(1997-2#1)(2006-10#1)(2006-7#1)(2007-4#1)(2008-1#1)(2008-5#1)(2008-9#1)
the most beneficial##3##3##(1991-7#1)(2008-10#1)(2008-12#1)
the most benefit from##3##4##(2007-5#1)(2008-10#1)(2008-3#1)
the most benefit##4##3##(2006-10#1)(2007-5#1)(2008-10#1)(2008-3#1)
the most between##2##3##(2008-12#1)(2010-5#1)
the most bothersome##2##3##(2007-11#1)(2008-10#1)
the most broadly##2##3##(1997-1#1)(2009-9#1)
the most caudal##3##3##(1990-2#1)(1992-9#1)(1993-5#1)
the most challenging issues##2##4##(2006-10#1)(2008-7#1)
the most challenging##14##3##(1991-12#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-7#2)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#1)
the most characteristic change was##2##5##(2008-10#1)(2008-6#1)
the most characteristic feature##2##4##(1997-8#1)(2005-8#1)
the most characteristic##6##3##(1992-3#1)(1997-8#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-6#1)
the most clinically relevant##3##4##(2008-4#1)(2008-6#1)(2008-8#1)
the most clinically##7##3##(2006-2#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2013-1#1)
the most closely##2##3##(2009-12#1)(2011-1#1)
the most common acquired##2##4##(2011-2#1)(2013-1#1)
the most common adverse events##2##5##(2007-11#2)
the most common adverse##4##4##(2007-11#2)(2008-3#1)(2011-2#1)
the most common allergic##2##4##(2007-2#1)(2011-2#1)
the most common and##13##4##(1991-12#1)(1996-7#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-5#1)(2010-7#1)(2013-1#2)
the most common anomalies##2##4##(1992-6#1)(2012-3#1)
the most common associated##3##4##(1992-3#1)(2007-10#1)(2007-3#1)
the most common being##3##4##(1992-3#1)(2008-12#1)(2010-8#1)
the most common benign##6##4##(1993-4#1)(1993-9#1)(2007-8#1)(2008-10#1)(2009-9#1)(2012-2#1)
the most common cancer##3##4##(2007-3#1)(2007-8#1)(2010-12#1)
the most common cancers##5##4##(1991-7#1)(2007-11#1)(2008-4#1)(2008-8#1)(2011-2#1)
the most common causative agent##2##5##(2008-1#1)(2012-3#1)
the most common causative##5##4##(2006-6#1)(2008-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
the most common cause for##3##5##(2007-4#1)(2008-11#1)(2012-2#1)
the most common cause of acute##3##6##(2008-10#1)(2008-7#1)(2009-5#1)
the most common cause of death in children##2##8##(2006-10#1)(2006-2#1)
the most common cause of death in##8##7##(1993-1#1)(1993-9#1)(2006-10#1)(2006-2#1)(2008-5#1)(2011-2#2)(2013-1#1)
the most common cause of lower gastrointestinal##2##7##(2006-8#1)(2010-8#1)
the most common cause of the##2##6##(2007-2#1)(2007-7#1)
the most common cause of##53##5##(1992-10#1)(1993-1#1)(1993-9#1)(2004-3#1)(2005-12#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-5#3)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-2#2)(2013-1#3)(2013-8#1)
the most common cause##61##4##(1992-10#1)(1992-5#1)(1993-1#1)(1993-9#1)(2004-3#1)(2005-12#1)(2005-8#1)(2006-10#4)(2006-2#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-5#3)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-2#3)(2013-1#3)(2013-8#1)
the most common causes of death##2##6##(2006-10#1)(2010-4#1)
the most common causes of##19##5##(1990-6#1)(1991-4#1)(1996-3#1)(1997-8#1)(2006-10#4)(2006-7#1)(2007-7#1)(2008-7#2)(2009-3#1)(2009-5#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-8#1)
the most common causes##20##4##(1990-6#1)(1991-4#1)(1996-3#1)(1997-8#1)(2006-10#4)(2006-7#1)(2007-7#1)(2007-8#1)(2008-7#2)(2009-3#1)(2009-5#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-8#1)
the most common childhood##3##4##(2008-9#1)(2011-2#2)
the most common chronic##8##4##(1991-2#1)(2007-9#1)(2008-1#1)(2008-9#1)(2009-4#1)(2010-7#1)(2011-1#1)(2013-7#1)
the most common clinical presentation##2##5##(2008-6#1)(2011-2#1)
the most common clinical sign##2##5##(2008-1#1)(2008-10#1)
the most common clinical##8##4##(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-2#1)(2011-2#1)
the most common coexistent##2##4##(2006-10#2)
the most common combination##2##4##(2007-11#1)(2011-2#1)
the most common complaint##3##4##(1990-6#1)(2012-2#1)(2013-8#1)
the most common complaints in##2##5##(2011-2#1)(2012-2#1)
the most common complaints##4##4##(2011-1#1)(2011-2#1)(2012-2#2)
the most common complication of##4##5##(1991-6#1)(2007-11#1)(2008-1#1)(2008-7#1)
the most common complication##10##4##(1991-6#1)(2006-10#2)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-7#1)(2008-9#1)
the most common complications##3##4##(2008-1#1)(2010-8#1)(2011-11#1)
the most common congenital heart##2##5##(2008-4#1)(2010-9#1)
the most common congenital##9##4##(1993-8#1)(2007-5#1)(2008-4#1)(2010-11#1)(2010-9#1)(2012-12#2)(2012-2#1)(2013-1#1)
the most common dermatological##2##4##(2005-11#1)(2010-8#1)
the most common diagnoses were##3##5##(2008-1#1)(2011-2#1)(2012-3#1)
the most common diagnoses##5##4##(1992-8#1)(1994-6#1)(2008-1#1)(2011-2#1)(2012-3#1)
the most common diagnosis##4##4##(2006-8#1)(2007-2#1)(2009-2#1)(2011-2#1)
the most common disease##3##4##(2010-12#2)(2011-2#1)
the most common disorders##4##4##(2006-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
the most common endocrine##2##4##(2008-1#1)(2009-3#1)
the most common finding##2##4##(2006-10#1)(2007-7#1)
the most common form of primary##4##6##(1991-11#1)(2008-6#1)(2010-9#1)(2013-1#1)
the most common form of##21##5##(1991-11#1)(1992-4#1)(2005-8#1)(2006-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the most common forms of##3##5##(2008-1#1)(2010-12#1)(2012-2#1)
the most common genetic##2##4##(2012-12#1)(2013-8#1)
the most common genotype was 1a##2##6##(2007-2#2)
the most common group##2##4##(2009-5#1)(2013-7#1)
the most common histological##8##4##(2008-1#2)(2008-8#1)(2011-1#1)(2011-11#1)(2011-2#1)(2012-2#2)
the most common histology##2##4##(1992-8#1)(2009-3#1)
the most common histopathological##2##4##(2008-1#1)(2011-2#1)
the most common human##2##4##(2007-6#1)(2009-4#1)
the most common indication for##4##5##(2007-7#1)(2008-1#2)(2010-4#1)
the most common indication##5##4##(2007-7#1)(2008-1#2)(2010-4#1)(2011-12#1)
the most common inflammatory##3##4##(2006-10#1)(2008-4#1)(2008-5#1)
the most common injuries##4##4##(1993-1#1)(2005-12#1)(2007-4#1)(2012-2#1)
the most common injury##3##4##(2006-11#1)(2007-3#1)(2009-6#1)
the most common liver##2##4##(2006-10#1)(2010-12#1)
the most common locations of##2##5##(2007-7#1)(2011-2#1)
the most common lysosomal storage disorder##2##6##(2006-10#1)(2008-10#1)
the most common malignancy in##3##5##(2011-2#2)(2013-1#1)
the most common malignancy##11##4##(2006-10#1)(2007-3#3)(2008-4#1)(2008-9#1)(2009-2#1)(2010-4#1)(2011-2#2)(2013-1#1)
the most common malignant##7##4##(1995-11#1)(2006-8#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-2#2)
the most common manifestation of##2##5##(2007-10#1)(2011-2#1)
the most common manifestation##4##4##(2007-10#1)(2007-7#1)(2008-11#1)(2011-2#1)
the most common materials used##2##5##(2007-7#1)(2008-9#1)
the most common mechanism of##3##5##(2007-7#2)(2010-1#1)
the most common mechanism##7##4##(2007-7#2)(2009-2#1)(2010-1#1)(2010-12#1)(2011-2#1)(2013-8#1)
the most common medical##3##4##(1992-1#1)(2006-10#1)(2008-7#1)
the most common mesenchymal tumors of the##2##7##(2007-9#1)(2012-12#1)
the most common mesenchymal##3##4##(2007-9#1)(2012-12#1)(2012-3#1)
the most common metabolic##3##4##(2004-11#1)(2007-11#1)(2008-1#1)
the most common method##5##4##(2006-10#2)(2008-4#1)(2008-9#1)(2012-2#1)
the most common methods for##2##5##(2008-4#1)(2012-12#1)
the most common methods of##2##5##(2008-9#1)(2012-3#1)
the most common methods##7##4##(2005-8#1)(2006-10#1)(2008-4#1)(2008-9#1)(2009-11#1)(2012-12#1)(2012-3#1)
the most common mode of##2##5##(2006-8#1)(2007-7#1)
the most common molecular##2##4##(2006-8#1)(2011-2#1)
the most common movement##2##4##(1995-3#1)(2008-11#1)
the most common mutation in##2##5##(1994-9#1)(1995-4#1)
the most common neoplasm of##2##5##(2010-6#1)(2013-7#1)
the most common neoplasm##5##4##(2006-2#1)(2010-6#1)(2012-12#1)(2012-3#1)(2013-7#1)
the most common nosocomial infection##2##5##(2005-8#1)(2008-12#1)
the most common nosocomial##3##4##(2005-8#1)(2007-11#1)(2008-12#1)
the most common of the##5##5##(2006-2#1)(2007-6#1)(2008-11#1)(2008-2#1)(2009-2#1)
the most common of##7##4##(2006-2#1)(2007-12#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-2#1)
the most common one##3##4##(2006-10#1)(2006-9#1)(2012-2#1)
the most common ones##2##4##(2006-7#1)(2008-10#1)
the most common organic##2##4##(2006-8#1)(2008-10#1)
the most common organism isolated##2##5##(2007-7#1)(2010-6#1)
the most common organism##3##4##(2007-7#1)(2008-5#1)(2010-6#1)
the most common pediatric##2##4##(2006-5#1)(2013-1#1)
the most common preventable##2##4##(2010-4#1)(2012-2#1)
the most common primary brain tumors##2##6##(2010-12#1)(2013-8#1)
the most common primary liver##2##5##(2008-4#1)(2011-1#1)
the most common primary##8##4##(2006-10#1)(2007-8#1)(2008-4#1)(2010-12#1)(2010-3#1)(2011-1#1)(2013-1#1)(2013-8#1)
the most common problems seen##2##5##(2008-12#1)(2010-12#1)
the most common problems##4##4##(2005-12#1)(2007-2#1)(2008-12#1)(2010-12#1)
the most common procedure for##2##5##(1992-5#1)(2007-5#1)
the most common procedure##3##4##(1992-5#1)(2007-5#1)(2013-7#1)
the most common psychiatric##3##4##(2006-9#1)(2008-6#1)(2013-1#1)
the most common reason for##3##5##(2006-10#1)(2009-5#1)(2009-7#1)
the most common reasons for##7##5##(2007-10#1)(2007-3#1)(2007-7#1)(2009-5#1)(2009-6#1)(2010-8#1)(2011-2#1)
the most common reasons##8##4##(2007-10#1)(2007-3#1)(2007-7#1)(2009-5#1)(2009-6#1)(2010-8#1)(2011-2#2)
the most common reported##2##4##(2007-8#1)(2008-8#1)
the most common resistance##2##4##(2009-2#1)(2011-2#1)
the most common risk factor##2##5##(2007-10#1)(2008-3#1)
the most common risk factors##3##5##(2006-10#2)(2007-10#1)
the most common risk##5##4##(2006-10#2)(2007-10#2)(2008-3#1)
the most common sexually transmitted##4##5##(2007-7#1)(2008-11#1)(2011-2#1)(2013-1#1)
the most common site for##2##5##(2006-10#1)(2008-6#1)
the most common site of##6##5##(2006-6#1)(2007-11#1)(2008-6#1)(2008-7#1)(2010-10#1)(2011-2#1)
the most common site##8##4##(2006-10#1)(2006-6#1)(2007-11#1)(2008-6#2)(2008-7#1)(2010-10#1)(2011-2#1)
the most common sites of##3##5##(2008-12#1)(2013-1#1)(2013-8#1)
the most common sites##5##4##(2008-12#1)(2009-9#1)(2013-1#2)(2013-8#1)
the most common skin##2##4##(1994-8#1)(2010-3#1)
the most common source of##4##5##(1990-4#1)(2005-12#1)(2006-10#1)(2011-1#1)
the most common sources of##3##5##(2008-11#1)(2008-12#1)(2009-5#1)
the most common species##2##4##(2008-10#1)(2010-8#1)
the most common stressors##2##4##(2007-10#1)(2010-10#1)
the most common surgical procedure performed in##2##7##(2006-10#1)(2006-2#1)
the most common symptom##3##4##(2006-7#1)(2006-8#1)(2008-1#1)
the most common symptoms##3##4##(1996-2#1)(2006-10#1)(2012-2#1)
the most common systemic diseases##2##5##(2007-11#1)(2011-1#1)
the most common therapeutic##3##4##(2006-6#1)(2010-12#1)(2011-2#1)
the most common toxicity##3##4##(2008-10#2)(2008-7#1)
the most common type of primary##2##6##(2007-11#1)(2008-1#1)
the most common type of##14##5##(2006-2#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-6#1)(2011-1#2)(2011-2#2)(2013-1#2)(2013-7#1)
the most common type##15##4##(2006-2#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-6#1)(2011-1#2)(2011-2#2)(2013-1#2)(2013-7#1)
the most common types of##4##5##(2008-1#1)(2008-6#1)(2008-7#1)(2011-1#1)
the most common types##5##4##(2008-1#2)(2008-6#1)(2008-7#1)(2011-1#1)
the most common viral##3##4##(2008-11#1)(2008-6#1)(2013-1#1)
the most common were##2##4##(2008-10#1)(2008-5#1)
the most common##791##3##(1990-4#1)(1990-6#4)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-6#3)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#3)(1992-3#4)(1992-4#2)(1992-5#4)(1992-6#1)(1992-8#3)(1993-1#4)(1993-10#1)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#3)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-4#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#3)(2004-11#2)(2004-2#1)(2004-3#3)(2005-10#3)(2005-11#3)(2005-12#6)(2005-8#8)(2005-9#1)(2006-1#1)(2006-10#42)(2006-11#2)(2006-12#4)(2006-2#8)(2006-5#1)(2006-6#3)(2006-7#3)(2006-8#14)(2006-9#4)(2007-1#4)(2007-10#10)(2007-11#21)(2007-12#7)(2007-2#14)(2007-3#10)(2007-4#3)(2007-5#2)(2007-6#3)(2007-7#24)(2007-8#15)(2007-9#7)(2008-1#28)(2008-10#24)(2008-11#14)(2008-12#10)(2008-2#4)(2008-3#14)(2008-4#19)(2008-5#10)(2008-6#9)(2008-7#16)(2008-8#6)(2008-9#18)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#3)(2009-2#7)(2009-3#4)(2009-4#4)(2009-5#8)(2009-6#4)(2009-7#2)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#4)(2010-12#19)(2010-2#7)(2010-3#2)(2010-4#5)(2010-5#3)(2010-6#4)(2010-7#4)(2010-8#11)(2010-9#4)(2011-1#18)(2011-11#2)(2011-12#2)(2011-2#59)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#18)(2012-2#31)(2012-3#9)(2013-1#33)(2013-7#12)(2013-8#13)
the most commonly affected##2##4##(2008-5#1)(2008-6#1)
the most commonly applied##2##4##(2006-12#1)(2008-4#1)
the most commonly diagnosed##3##4##(2010-2#1)(2012-2#1)(2013-1#1)
the most commonly employed##2##4##(2007-8#1)(2008-4#1)
the most commonly encountered##4##4##(2006-6#1)(2007-9#1)(2008-1#1)(2013-1#1)
the most commonly injured##2##4##(2007-4#1)(2009-5#1)
the most commonly isolated##4##4##(1996-3#1)(2006-10#1)(2008-1#1)(2008-10#1)
the most commonly mutated gene in human##2##7##(1994-9#1)(2005-12#1)
the most commonly observed##2##4##(2006-12#1)(2012-2#1)
the most commonly performed procedure##2##5##(2006-8#1)(2007-12#1)
the most commonly performed procedures##2##5##(1990-3#1)(2011-2#1)
the most commonly performed vascular##2##5##(2005-10#1)(2009-7#1)
the most commonly performed##7##4##(1990-3#1)(2005-10#1)(2006-8#1)(2007-12#1)(2009-7#1)(2011-2#2)
the most commonly prescribed##3##4##(2008-8#1)(2010-12#1)(2013-8#1)
the most commonly reported adverse##2##5##(2007-11#1)(2011-2#1)
the most commonly reported##7##4##(1992-4#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2011-2#1)
the most commonly seen##4##4##(2008-6#1)(2010-1#1)(2011-1#2)
the most commonly used animal##3##5##(2008-4#2)(2010-12#1)
the most commonly used drugs for##2##6##(1994-12#1)(2011-1#1)
the most commonly used illicit drug##2##6##(2008-1#1)(2008-4#1)
the most commonly used medications##2##5##(1996-7#1)(2007-8#1)
the most commonly used procedures##2##5##(2008-9#2)
the most commonly used##49##4##(1994-12#2)(1994-6#1)(1996-7#1)(1997-4#1)(1997-6#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#7)(2008-7#2)(2008-8#2)(2008-9#6)(2009-12#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
the most commonly##112##3##(1990-3#1)(1992-4#1)(1994-12#2)(1994-6#1)(1994-9#2)(1996-3#1)(1996-7#1)(1997-4#1)(1997-6#1)(2005-10#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-2#2)(2006-6#1)(2006-8#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#3)(2008-10#4)(2008-11#2)(2008-2#2)(2008-4#10)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#6)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#2)
the most compelling evidence##2##4##(2007-12#1)(2009-4#1)
the most compelling##3##3##(2007-12#1)(2007-8#1)(2009-4#1)
the most competitive##2##3##(1997-1#1)(2011-2#1)
the most complex and##4##4##(1997-6#1)(2005-10#1)(2008-10#1)(2011-2#1)
the most complex##9##3##(1995-3#1)(1997-6#1)(2005-10#1)(2008-10#3)(2008-9#1)(2011-2#1)(2012-12#1)
the most comprehensive##10##3##(1991-8#1)(1997-3#1)(2005-7#1)(2006-10#1)(2007-11#2)(2007-3#1)(2007-6#1)(2007-8#1)(2008-3#1)
the most conservative##3##3##(1992-5#1)(2008-10#1)(2013-1#1)
the most conserved proteins##2##4##(1990-12#1)(1991-9#1)
the most conserved region##2##4##(1994-3#1)(2012-12#1)
the most conserved regions##2##4##(1996-5#1)(2008-9#1)
the most conserved##9##3##(1990-12#1)(1990-9#1)(1991-9#1)(1994-3#1)(1995-11#1)(1996-5#1)(2008-10#1)(2008-9#1)(2012-12#1)
the most consistent##7##3##(2006-12#1)(2007-11#1)(2007-5#1)(2008-10#2)(2012-2#1)(2012-3#1)
the most conspicuous##5##3##(1994-12#1)(2007-2#1)(2008-12#1)(2008-6#1)(2008-7#1)
the most controversial##4##3##(2004-11#1)(2007-11#1)(2007-4#1)(2009-7#1)
the most convenient##3##3##(1993-3#1)(2008-10#1)(2008-4#1)
the most convincing##3##3##(2008-2#1)(2008-8#1)(2011-2#1)
the most cost-effective approach##2##4##(1995-3#1)(2010-6#1)
the most cost-effective strategy##2##4##(2011-1#1)(2012-12#1)
the most cost-effective way to##2##5##(2008-11#1)(2011-2#1)
the most cost-effective##14##3##(1994-3#1)(1995-3#1)(1996-1#1)(1996-12#1)(2006-10#1)(2008-10#1)(2008-11#1)(2010-6#2)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
the most costly##2##3##(2007-4#1)(2013-8#1)
the most critical issue##2##4##(2008-3#1)(2008-7#1)
the most critical part of the##2##6##(2008-10#1)(2013-8#1)
the most critical##18##3##(1991-3#1)(1992-11#1)(1995-2#1)(2005-10#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-7#1)(2008-9#1)(2010-4#1)(2012-2#1)(2012-3#2)(2013-8#1)
the most crucial and##2##4##(1996-2#1)(2010-12#1)
the most crucial##6##3##(1996-2#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-8#1)
the most current##7##3##(1995-3#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-6#1)(2012-1#1)
the most cytotoxic##2##3##(1995-5#1)(1997-2#1)
the most damaging pests##2##4##(2007-6#1)(2012-11#1)
the most damaging##4##3##(2007-6#1)(2008-10#2)(2012-11#1)
the most dangerous##3##3##(2007-11#1)(2011-2#1)(2013-8#1)
the most daunting##2##3##(2007-4#1)(2008-9#1)
the most deadly##2##3##(2005-8#1)(2012-2#1)
the most demanding##2##3##(2008-10#1)(2008-2#1)
the most densely##3##3##(2006-12#1)(2008-2#1)(2013-1#1)
the most destructive##12##3##(2008-10#8)(2009-2#1)(2011-1#1)(2012-11#1)(2013-8#1)
the most detailed##4##3##(1994-8#1)(2006-4#1)(2008-7#1)(2008-9#1)
the most devastating##8##3##(1997-7#1)(2005-7#1)(2007-11#1)(2008-10#3)(2011-2#1)(2012-3#1)
the most developed##4##3##(1994-2#1)(2006-10#1)(2007-2#1)(2008-2#1)
the most diagnostic##2##3##(1996-6#1)(2009-4#1)
the most difficult to##4##4##(2008-8#1)(2010-12#2)(2011-2#1)
the most difficult##24##3##(1995-1#1)(2005-11#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
the most direct##6##3##(1997-2#1)(2006-7#1)(2008-10#1)(2008-7#1)(2009-6#1)(2012-12#1)
the most disabling##3##3##(2006-5#1)(2008-7#1)(2010-11#1)
the most disadvantaged##3##3##(1992-3#1)(2011-2#2)
the most discriminant##3##3##(2008-10#1)(2011-1#1)(2013-1#1)
the most distal##6##3##(1992-11#1)(2009-10#1)(2011-2#4)
the most distant##2##3##(1995-9#1)(2008-10#1)
the most distantly related##3##4##(1995-6#1)(1997-1#1)(2008-8#1)
the most distinctive features##2##4##(2007-12#1)(2008-12#1)
the most distinctive##3##3##(1991-9#1)(2007-12#1)(2008-12#1)
the most distinguished##2##3##(1990-3#1)(2007-4#1)
the most distressing side effects##2##5##(1990-9#1)(1991-6#1)
the most distressing##3##3##(1990-9#1)(1991-6#1)(2006-3#1)
the most disturbing##2##3##(1992-8#1)(2008-10#1)
the most divergent##2##3##(1993-12#1)(2005-10#1)
the most diverse and abundant##2##5##(2007-5#1)(2011-2#1)
the most diverse and##3##4##(2007-11#1)(2007-5#1)(2011-2#1)
the most diverse group##2##4##(2008-10#1)(2008-5#1)
the most diverse##15##3##(1997-1#1)(2007-11#1)(2007-5#3)(2007-7#1)(2008-10#2)(2008-5#4)(2009-5#1)(2011-2#1)(2013-7#1)
the most diversified##2##3##(2010-3#1)(2012-3#1)
the most dominant##4##3##(2008-3#1)(2011-1#1)(2011-2#1)(2013-7#1)
the most dominating##2##3##(1991-4#1)(1996-6#1)
the most dramatic##2##3##(2007-8#1)(2008-10#1)
the most dreaded complications of##2##5##(2008-11#1)(2008-5#1)
the most dreaded##6##3##(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-12#1)(2011-2#1)
the most dynamically##2##3##(2009-5#1)(2012-2#1)
the most economic##2##3##(1994-3#1)(2010-8#1)
the most economical transport option##2##5##(2008-5#2)
the most economical##5##3##(1996-1#1)(2008-3#1)(2008-5#2)(2009-10#1)
the most effective AFEX treatment##2##5##(2008-5#2)
the most effective AFEX##3##4##(2008-5#3)
the most effective activator of##2##5##(1990-5#1)(1996-5#1)
the most effective adjuvant##2##4##(1992-8#1)(1996-10#1)
the most effective agent##4##4##(1990-5#1)(1991-3#1)(2008-5#1)(2008-8#1)
the most effective and efficient##2##5##(2008-11#1)(2009-5#1)
the most effective and##14##4##(1990-8#1)(1993-6#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
the most effective antibiotics##2##4##(2007-7#1)(2009-6#1)
the most effective combination##2##4##(1997-3#1)(2008-5#1)
the most effective control##2##4##(2008-10#1)(2012-11#1)
the most effective dose##2##4##(2008-10#1)(2008-4#1)
the most effective drug##3##4##(1996-1#1)(2005-8#1)(2008-7#1)
the most effective drugs for##2##5##(2008-7#2)
the most effective for##4##4##(1997-5#1)(2008-10#1)(2010-12#1)(2012-2#1)
the most effective form of##2##5##(1991-4#1)(2007-7#1)
the most effective form##3##4##(1991-4#1)(2007-7#1)(2008-11#1)
the most effective in inhibiting##2##5##(2008-4#1)(2010-12#1)
the most effective in reducing the##2##6##(2008-10#1)(2008-3#1)
the most effective in##10##4##(1990-8#1)(1995-12#1)(1995-5#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2010-12#1)
the most effective inhibitor of##3##5##(1990-2#1)(1992-5#2)
the most effective means of##3##5##(1994-3#1)(2008-1#1)(2008-3#1)
the most effective means to control##3##6##(1993-12#1)(2008-10#2)
the most effective means##7##4##(1993-12#1)(1994-3#1)(2008-1#1)(2008-10#3)(2008-3#1)
the most effective measure##2##4##(2007-2#1)(2008-9#1)
the most effective method##5##4##(1996-12#1)(2007-11#1)(2007-7#1)(2008-2#1)(2008-5#1)
the most effective methods of##2##5##(2006-10#1)(2007-8#1)
the most effective methods##4##4##(2006-10#1)(2007-11#1)(2007-8#1)(2011-1#1)
the most effective of the##2##5##(1993-9#1)(1996-6#1)
the most effective prophylactic##2##4##(2006-10#1)(2007-9#1)
the most effective recruitment##3##4##(2007-10#1)(2007-12#2)
the most effective substrates##2##4##(1990-7#1)(1996-5#1)
the most effective therapies##3##4##(2005-7#1)(2006-10#1)(2011-12#1)
the most effective therapy for##2##5##(2007-8#1)(2013-8#1)
the most effective therapy##4##4##(1997-1#1)(2006-10#1)(2007-8#1)(2013-8#1)
the most effective treatment for##3##5##(1993-2#1)(2005-7#1)(2006-10#1)
the most effective treatment##7##4##(1993-2#1)(2005-7#1)(2006-10#1)(2006-2#1)(2008-6#1)(2009-3#1)(2010-12#1)
the most effective treatments##2##4##(2004-2#1)(2008-10#1)
the most effective use of##2##5##(2008-10#2)
the most effective way to##2##5##(1994-3#1)(2006-4#1)
the most effective way##4##4##(1994-3#1)(2006-4#1)(2008-7#1)(2013-1#1)
the most effective##195##3##(1990-11#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#3)(1991-3#1)(1991-4#2)(1992-10#1)(1992-11#1)(1992-5#2)(1992-7#1)(1992-8#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-3#2)(1994-7#1)(1994-9#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-5#1)(2004-2#1)(2005-10#1)(2005-7#2)(2005-8#2)(2006-10#6)(2006-2#1)(2006-4#1)(2006-6#3)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#2)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#32)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#9)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#2)(2009-5#2)(2009-6#2)(2010-10#1)(2010-12#4)(2010-3#1)(2011-1#4)(2011-12#1)(2011-2#1)(2012-11#2)(2012-12#2)(2012-2#2)(2012-4#1)(2013-1#4)(2013-7#1)(2013-8#5)
the most efficacious##8##3##(2008-8#1)(2009-3#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-2#2)
the most efficient and cost-effective##2##5##(1993-2#1)(2011-1#1)
the most efficient and##5##4##(1993-2#1)(1993-6#1)(2008-6#1)(2010-4#1)(2011-1#1)
the most efficient for##2##4##(1990-3#1)(1993-6#1)
the most efficient management##2##4##(1992-2#1)(2008-12#1)
the most efficient means of##2##5##(2008-1#1)(2011-2#1)
the most efficient method##3##4##(2007-11#1)(2008-10#2)
the most efficient##49##3##(1990-10#1)(1990-3#2)(1990-7#1)(1990-9#1)(1991-3#1)(1992-2#1)(1993-11#1)(1993-2#2)(1993-6#2)(1994-6#1)(1996-11#1)(1996-2#1)(2005-11#1)(2006-2#2)(2006-4#2)(2007-11#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
the most empirical support as a measure##2##7##(2008-9#2)
the most empirical support##3##4##(2008-4#1)(2008-9#2)
the most encouraging##2##3##(1996-8#1)(2005-8#1)
the most enduring benefit of a common conceptual definition and measurement for CS is the bridge it provides between research and practice##2##22##(2013-1#2)
the most enduring##3##3##(2012-3#1)(2013-1#2)
the most essential##2##3##(2008-9#1)(2009-12#1)
the most exciting##11##3##(2006-10#3)(2006-6#1)(2007-12#1)(2007-5#1)(2008-9#2)(2009-6#1)(2010-7#1)(2011-2#1)
the most expensive##3##3##(1992-12#1)(1993-3#1)(2006-6#1)
the most extensive##5##3##(1994-1#1)(1997-4#1)(2008-1#1)(2008-5#1)(2009-4#1)
the most extensively studied##5##4##(2005-10#1)(2006-2#1)(2009-3#1)(2012-3#1)(2013-8#1)
the most extensively##7##3##(1995-5#1)(2005-10#1)(2006-2#1)(2009-3#1)(2009-4#1)(2012-3#1)(2013-8#1)
the most extreme##2##3##(2008-8#2)
the most famous##4##3##(2006-4#2)(2007-9#1)(2011-2#1)
the most favorable conditions##2##4##(2008-10#2)
the most favorable for the activity##2##6##(1996-9#2)
the most favorable time##2##4##(1994-6#1)(1997-3#1)
the most favorable##15##3##(1994-6#1)(1995-5#1)(1996-9#2)(1997-3#1)(2005-9#1)(2006-10#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-11#1)
the most favourable##3##3##(2004-9#1)(2007-1#1)(2007-7#1)
the most feasible##2##3##(1992-12#1)(2010-12#1)
the most frequent adverse##2##4##(2008-11#1)(2012-3#1)
the most frequent and abundant##2##5##(2007-3#1)(2011-2#1)
the most frequent and##7##4##(1991-4#1)(2007-3#1)(2007-8#1)(2008-10#1)(2009-7#1)(2011-2#2)
the most frequent are##2##4##(1991-4#1)(2011-3#1)
the most frequent bacteria##2##4##(2010-12#1)(2013-1#1)
the most frequent causative agent of##2##6##(2007-7#1)(2008-5#1)
the most frequent causative agent##3##5##(2007-7#2)(2008-5#1)
the most frequent cause of chronic##2##6##(2011-1#1)(2012-3#1)
the most frequent cause of##10##5##(1991-5#1)(1992-2#1)(2006-8#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)
the most frequent cause##12##4##(1991-5#1)(1992-2#1)(2006-8#1)(2009-5#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#3)(2012-3#1)
the most frequent causes of##9##5##(1990-6#1)(1992-5#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2011-2#1)(2013-1#1)
the most frequent causes##12##4##(1990-6#1)(1992-5#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2011-2#1)(2013-1#1)
the most frequent clinical##3##4##(1990-8#1)(2007-7#1)(2013-1#1)
the most frequent complaints##2##4##(2006-2#1)(2012-12#1)
the most frequent complication##5##4##(2006-10#1)(2007-7#1)(2008-7#1)(2012-2#1)(2013-1#1)
the most frequent complications##4##4##(2007-7#2)(2007-8#1)(2008-1#1)
the most frequent congenital##2##4##(1995-5#1)(2006-10#1)
the most frequent diagnosis##3##4##(1996-9#1)(2010-12#1)(2011-2#1)
the most frequent discriminatory factors identified include diagnosis (&gt##2##9##(2013-1#2)
the most frequent diseases##3##4##(1991-12#1)(2009-2#1)(2010-12#1)
the most frequent disorders##2##4##(2006-6#1)(2007-11#1)
the most frequent form of##4##5##(1991-5#1)(2009-2#1)(2012-2#1)(2013-8#1)
the most frequent genetic##2##4##(1993-5#1)(2008-1#1)
the most frequent in##2##4##(2011-2#1)(2012-2#1)
the most frequent mechanism##2##4##(1990-6#1)(2013-1#1)
the most frequent of which is##2##6##(1993-9#1)(2008-11#1)
the most frequent of which##4##5##(1993-9#1)(2006-9#1)(2008-11#1)(2013-1#1)
the most frequent ones##2##4##(2008-5#1)(2011-1#1)
the most frequent site of##3##5##(1990-6#1)(2006-2#1)(2007-7#1)
the most frequent species##6##4##(2006-10#2)(2007-7#1)(2008-5#1)(2008-6#1)(2012-2#1)
the most frequent symptoms##2##4##(2008-6#1)(2011-2#1)
the most frequent type of##6##5##(2007-11#2)(2007-8#1)(2010-8#1)(2011-2#2)
the most frequent type##7##4##(2007-11#2)(2007-3#1)(2007-8#1)(2010-8#1)(2011-2#2)
the most frequent##211##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#3)(1990-8#1)(1990-9#1)(1991-12#1)(1991-4#2)(1991-5#2)(1991-8#2)(1992-1#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-5#2)(1993-9#3)(1995-11#1)(1995-5#1)(1996-1#1)(1996-9#1)(1997-3#2)(2004-2#1)(2005-10#2)(2005-11#1)(2005-8#1)(2006-10#7)(2006-11#1)(2006-12#1)(2006-2#5)(2006-3#1)(2006-6#5)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#1)(2007-2#3)(2007-3#3)(2007-4#3)(2007-7#15)(2007-8#7)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#1)(2009-2#3)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#8)(2010-2#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#7)(2011-2#15)(2011-3#1)(2012-12#8)(2012-2#5)(2012-3#3)(2013-1#20)(2013-7#1)(2013-8#3)
the most frequently applied##2##4##(2006-2#1)(2008-5#1)
the most frequently described##2##4##(2008-12#1)(2009-5#1)
the most frequently detected##6##4##(1996-12#1)(2008-10#4)(2011-2#1)
the most frequently diagnosed##4##4##(2007-6#1)(2011-1#1)(2011-2#1)(2012-12#1)
the most frequently encountered##6##4##(1997-3#1)(2006-3#1)(2006-8#1)(2007-7#1)(2008-8#1)(2011-3#1)
the most frequently found##2##4##(2006-2#1)(2011-1#1)
the most frequently isolated##7##4##(1991-11#1)(2007-7#1)(2008-10#2)(2008-5#1)(2012-12#2)
the most frequently observed##7##4##(1990-7#1)(1997-4#1)(2006-10#1)(2007-4#1)(2008-6#1)(2010-1#1)(2010-4#1)
the most frequently occurring##2##4##(1995-2#1)(2008-4#1)
the most frequently performed##4##4##(2007-8#1)(2008-8#1)(2010-9#1)(2013-1#1)
the most frequently prescribed##6##4##(2006-10#1)(2007-11#1)(2008-11#2)(2008-8#1)(2010-5#1)
the most frequently reported##6##4##(1992-5#1)(2006-10#1)(2008-3#1)(2008-6#1)(2013-1#2)
the most frequently used drugs in##2##6##(1994-6#1)(2007-10#1)
the most frequently used treatment##2##5##(1994-2#1)(2013-1#1)
the most frequently used##26##4##(1990-7#1)(1992-2#1)(1992-3#1)(1994-2#1)(1994-6#1)(1995-12#1)(2004-12#1)(2006-10#1)(2006-12#1)(2006-6#2)(2006-9#1)(2007-10#1)(2007-11#2)(2008-11#2)(2008-3#2)(2008-4#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
the most frequently##98##3##(1990-7#2)(1991-11#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-5#2)(1994-2#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-3#1)(1997-4#1)(2004-12#1)(2004-5#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-2#2)(2006-3#1)(2006-6#3)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#5)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-10#6)(2008-11#4)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2009-3#1)(2009-4#1)(2009-5#1)(2010-1#2)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#4)(2013-1#4)(2013-7#1)
the most fundamental##7##3##(1990-2#1)(1995-12#1)(2008-2#1)(2009-6#1)(2010-12#1)(2012-12#1)(2012-2#1)
the most general##8##3##(1990-8#2)(1997-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-12#1)(2012-3#1)
the most genetically##3##3##(2008-12#1)(2008-5#1)(2013-1#1)
the most hazardous##3##3##(1994-6#1)(2006-12#1)(2010-7#1)
the most heat##2##3##(2008-10#1)(2011-2#1)
the most highly conserved##2##4##(1991-3#1)(1993-12#1)
the most highly expressed##2##4##(1991-11#1)(2013-8#1)
the most highly##15##3##(1990-11#1)(1990-3#1)(1991-11#1)(1991-3#1)(1993-12#1)(1994-6#1)(1994-8#1)(1995-3#1)(2006-12#1)(2007-1#1)(2007-9#1)(2008-10#1)(2008-5#1)(2013-1#1)(2013-8#1)
the most hydrophobic##2##3##(2005-11#1)(2008-12#1)
the most immature##2##3##(1995-12#1)(2008-10#1)
the most impact##2##3##(1994-2#1)(2006-7#1)
the most important advances in##2##5##(2010-7#1)(2013-1#1)
the most important and frequent##2##5##(2005-8#1)(2010-12#1)
the most important and##12##4##(1990-5#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-10#2)(2010-12#1)(2010-7#1)(2012-2#1)(2013-8#1)
the most important applications of##2##5##(2008-4#1)(2008-8#1)
the most important are##4##4##(2006-12#1)(2008-1#1)(2008-10#1)(2008-5#1)
the most important aspect##4##4##(2010-3#1)(2012-12#1)(2013-7#1)(2013-8#1)
the most important aspects of the##4##6##(2008-4#1)(2010-9#1)(2013-1#2)
the most important aspects of##7##5##(1992-2#1)(2008-4#1)(2008-7#1)(2010-9#1)(2011-7#1)(2013-1#2)
the most important causal##2##4##(2007-8#1)(2008-10#1)
the most important cause of morbidity and mortality in##2##9##(2007-11#1)(2008-3#1)
the most important cause of morbidity and mortality##3##8##(2007-11#1)(2008-3#1)(2010-8#1)
the most important cause of##6##5##(2006-10#1)(2007-11#2)(2008-3#1)(2010-8#1)(2012-12#1)
the most important causes of##5##5##(1993-5#1)(1994-9#1)(2008-11#1)(2011-2#1)(2013-1#1)
the most important component of##2##5##(2008-12#1)(2008-5#1)
the most important component##3##4##(2008-12#1)(2008-5#2)
the most important contributions##2##4##(2008-10#1)(2010-12#1)
the most important determinant of##3##5##(1991-4#1)(2007-7#1)(2008-3#1)
the most important determinant##5##4##(1991-4#1)(2006-10#1)(2007-7#1)(2008-3#1)(2012-2#1)
the most important determinants##2##4##(1990-12#1)(1994-6#1)
the most important disease of##2##5##(2008-10#1)(2011-1#1)
the most important disorder##2##4##(1995-10#1)(2008-1#1)
the most important effects##2##4##(1990-12#1)(2008-10#1)
the most important environmental risk factor##2##6##(2006-2#1)(2010-9#1)
the most important environmental##5##4##(2006-2#1)(2008-12#1)(2008-5#1)(2010-9#1)(2011-2#1)
the most important events##2##4##(2007-8#1)(2008-7#1)
the most important factor for##3##5##(1991-5#1)(1995-9#1)(2005-11#1)
the most important factor in the##2##6##(1992-6#1)(2010-3#1)
the most important factor influencing##2##5##(2007-7#1)(2007-8#1)
the most important factor##14##4##(1990-5#1)(1991-5#1)(1992-6#1)(1993-11#1)(1995-9#1)(2005-11#1)(2006-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2010-3#1)(2010-8#1)
the most important factors affecting##2##5##(1996-2#1)(2008-6#1)
the most important factors for##2##5##(2013-1#1)(2013-8#1)
the most important factors in the##2##6##(2007-2#1)(2007-3#1)
the most important factors in##6##5##(1994-1#2)(2007-2#2)(2007-3#1)(2008-7#1)
the most important factors##17##4##(1990-12#1)(1994-1#2)(1996-2#1)(2007-2#2)(2007-3#1)(2007-7#1)(2008-3#2)(2008-6#1)(2008-7#2)(2012-2#1)(2013-1#2)(2013-8#1)
the most important features##2##4##(2007-5#1)(2008-2#1)
the most important findings of##2##5##(2006-6#1)(2007-3#1)
the most important findings##3##4##(2004-11#1)(2006-6#1)(2007-3#1)
the most important for the##2##5##(1995-6#1)(2006-10#1)
the most important for##5##4##(1991-11#1)(1995-6#1)(2005-11#1)(2006-10#1)(2008-5#1)
the most important independent##3##4##(1995-4#1)(2008-3#1)(2011-1#1)
the most important indicator##2##4##(2008-12#1)(2010-4#1)
the most important is##4##4##(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
the most important issues##5##4##(1995-1#1)(2008-7#2)(2008-9#1)(2011-2#1)
the most important mechanisms##2##4##(1994-5#1)(2007-11#1)
the most important modality##2##4##(2009-4#1)(2010-11#1)
the most important modifiable risk factor##2##6##(2007-10#1)(2008-1#1)
the most important modifiable risk##3##5##(2007-10#1)(2008-1#1)(2012-2#1)
the most important needs##2##4##(2007-12#1)(2007-7#1)
the most important of which is##2##6##(2005-11#1)(2007-8#1)
the most important of##3##4##(1992-4#1)(2005-11#1)(2007-8#1)
the most important one##2##4##(1991-7#1)(2006-11#1)
the most important ones##3##4##(1994-2#1)(2007-8#1)(2010-8#1)
the most important original##2##4##(2008-10#1)(2010-7#1)
the most important parameter in##2##5##(1992-5#1)(2008-7#1)
the most important parameter##5##4##(1992-5#1)(2006-11#1)(2008-10#1)(2008-7#1)(2008-8#1)
the most important parameters##2##4##(2008-10#2)
the most important pathogen##2##4##(2008-10#1)(2011-2#1)
the most important pathogens of##3##5##(1991-7#1)(2008-10#1)(2010-10#1)
the most important pathogens##4##4##(1991-7#1)(2005-11#1)(2008-10#1)(2010-10#1)
the most important pathway for##2##5##(2006-1#1)(2009-10#1)
the most important plant##2##4##(2007-8#1)(2009-8#1)
the most important predator##2##4##(2007-3#2)
the most important predictor for##2##5##(2009-6#2)
the most important predictor##3##4##(1995-2#1)(2009-6#2)
the most important prognostic factors in##2##6##(2008-1#1)(2011-2#1)
the most important prognostic factors##3##5##(2008-1#1)(2008-6#1)(2011-2#1)
the most important prognostic##7##4##(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#2)(2012-2#1)
the most important reason for##3##5##(1992-2#1)(2006-8#1)(2008-8#1)
the most important recent##2##4##(2008-10#1)(2008-2#1)
the most important risk factor for##4##6##(1994-7#1)(2008-5#1)(2008-8#1)(2012-2#1)
the most important risk factor##5##5##(1994-7#1)(2008-1#1)(2008-5#1)(2008-8#1)(2012-2#1)
the most important risk factors for the development of##2##9##(2007-11#1)(2013-7#1)
the most important risk factors##3##5##(2007-11#1)(2008-10#1)(2013-7#1)
the most important risk##8##4##(1994-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-2#1)(2013-7#1)
the most important role in##3##5##(2007-2#1)(2008-10#1)(2008-12#1)
the most important role##5##4##(1996-5#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-12#1)
the most important source of##2##5##(2006-10#1)(2013-7#1)
the most important source##3##4##(2006-10#1)(2006-6#1)(2013-7#1)
the most important symptom##2##4##(1991-2#1)(2007-11#1)
the most important variables##2##4##(2008-10#2)
the most important viral##2##4##(2008-10#1)(2008-8#1)
the most important weather variable##2##5##(2008-10#2)
the most important##454##3##(1990-12#4)(1990-3#1)(1990-5#3)(1990-6#1)(1991-1#2)(1991-11#2)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#1)(1991-7#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#1)(1992-9#2)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#2)(1993-6#1)(1994-1#3)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#2)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#5)(1995-10#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#2)(1996-2#2)(1996-3#1)(1996-5#2)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(2004-11#1)(2005-1#1)(2005-10#1)(2005-11#6)(2005-12#1)(2005-8#5)(2006-1#1)(2006-10#11)(2006-11#3)(2006-12#5)(2006-2#2)(2006-3#1)(2006-4#1)(2006-6#3)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#14)(2007-12#3)(2007-2#7)(2007-3#5)(2007-4#1)(2007-5#1)(2007-7#11)(2007-8#13)(2008-1#12)(2008-10#49)(2008-11#7)(2008-12#7)(2008-2#5)(2008-3#6)(2008-4#9)(2008-5#17)(2008-6#4)(2008-7#13)(2008-8#7)(2008-9#7)(2009-10#1)(2009-11#1)(2009-4#1)(2009-6#4)(2009-7#1)(2009-8#2)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-7#4)(2010-8#6)(2010-9#4)(2011-1#4)(2011-10#1)(2011-12#1)(2011-2#21)(2011-3#2)(2011-4#1)(2011-7#1)(2012-1#1)(2012-11#3)(2012-12#8)(2012-2#9)(2012-3#4)(2013-1#11)(2013-7#5)(2013-8#8)
the most incident##2##3##(2011-2#1)(2012-1#1)
the most influential journal in##2##5##(2007-3#2)
the most influential##9##3##(1993-9#1)(2007-3#4)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
the most informative##6##3##(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-6#1)(2010-8#1)
the most innovative##3##3##(2007-11#1)(2008-7#1)(2009-11#1)
the most intense immunolabeling##2##4##(1997-4#2)
the most intense##9##3##(1996-2#1)(1997-4#2)(2005-11#1)(2008-10#2)(2008-11#1)(2008-8#1)(2012-3#1)
the most intensive##4##3##(2007-10#1)(2008-10#1)(2008-2#1)(2013-1#1)
the most interesting for##2##4##(1996-3#1)(2013-1#1)
the most interesting results##2##4##(2007-11#1)(2008-8#1)
the most interesting##23##3##(1990-5#1)(1991-11#1)(1991-6#1)(1992-12#1)(1994-12#1)(1996-12#1)(1996-3#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-8#2)(2009-8#1)(2011-2#2)(2013-1#1)
the most known##2##3##(2008-8#1)(2012-3#1)
the most lethal##5##3##(2008-6#1)(2009-3#1)(2010-12#1)(2012-12#1)(2013-8#1)
the most likely cause of##3##5##(2007-7#1)(2008-1#1)(2008-7#1)
the most likely explanation for##3##5##(1990-4#1)(1991-1#1)(2008-10#1)
the most likely site of##3##5##(1994-5#1)(2007-4#1)(2008-10#1)
the most likely source of##2##5##(1997-6#1)(2006-10#1)
the most likely time##2##4##(1996-11#1)(2011-2#1)
the most likely to##6##4##(1990-2#1)(1993-12#1)(2007-2#1)(2007-8#1)(2009-5#1)(2012-3#1)
the most likely underlying##2##4##(2006-2#1)(2010-12#1)
the most likely##52##3##(1990-2#1)(1990-4#2)(1990-9#2)(1991-1#1)(1992-7#1)(1992-8#1)(1993-12#2)(1993-8#1)(1994-2#1)(1994-5#2)(1995-1#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-4#2)(1997-6#1)(2004-11#1)(2005-10#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-7#3)(2009-5#1)(2010-12#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
the most limiting##3##3##(2006-10#1)(2008-10#1)(2012-2#1)
the most logical##2##3##(2007-8#1)(2008-10#1)
the most malignant primary brain##2##5##(2006-10#1)(2013-1#1)
the most malignant##6##3##(2006-10#1)(2008-1#1)(2008-5#1)(2009-4#1)(2012-12#1)(2013-1#1)
the most marked##3##3##(1990-4#1)(1996-12#1)(2008-7#1)
the most meaningful##4##3##(1993-3#1)(2005-12#1)(2008-10#1)(2008-8#1)
the most modern##4##3##(1990-9#1)(1992-9#1)(2008-10#1)(2008-9#1)
the most northern##2##3##(1993-6#1)(2008-10#1)
the most notable##2##3##(2007-11#1)(2010-8#1)
the most numerous##5##3##(1991-2#1)(2007-8#1)(2007-9#1)(2011-12#1)(2013-7#1)
the most objective##2##3##(1991-12#1)(2007-5#1)
the most obvious##3##3##(2006-10#1)(2008-5#1)(2009-5#1)
the most of the##5##4##(1992-6#1)(1994-9#1)(2008-7#1)(2009-6#1)(2011-1#1)
the most of##11##3##(1992-6#1)(1994-12#2)(1994-9#1)(1996-3#1)(2008-1#1)(2008-7#1)(2009-6#1)(2011-1#2)(2012-3#1)
the most often found##3##4##(2008-10#3)
the most often used##2##4##(2008-5#1)(2009-8#1)
the most often##11##3##(2006-2#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-7#1)(2009-8#1)
the most out of##2##4##(2007-4#1)(2008-7#1)
the most painful experience##2##4##(2008-11#1)(2012-2#1)
the most painful##5##3##(1996-6#1)(2006-9#1)(2008-11#1)(2012-2#1)(2013-1#1)
the most part##36##3##(1990-6#1)(1991-1#1)(1991-3#2)(1991-5#1)(1992-1#1)(1992-5#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1996-3#1)(1996-4#2)(1996-9#1)(1997-8#1)(2005-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-5#1)(2008-6#1)(2008-9#1)(2009-6#1)(2010-4#2)(2011-2#1)(2012-3#1)(2013-1#2)
the most persistent##2##3##(2007-6#1)(2012-2#1)
the most plausible##3##3##(1990-12#1)(2007-2#1)(2008-3#1)
the most popular method##2##4##(2009-8#1)(2011-2#1)
the most popular of##2##4##(1997-6#1)(2006-9#1)
the most popular technique##2##4##(2006-3#1)(2013-1#1)
the most popular##42##3##(1991-10#1)(1995-3#1)(1996-1#1)(1996-9#2)(1997-2#1)(1997-6#1)(2005-11#1)(2005-9#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2009-6#1)(2009-8#2)(2010-2#1)(2010-8#2)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)
the most populous region##2##4##(2011-2#2)
the most populous##4##3##(1994-9#1)(2011-2#2)(2012-3#1)
the most positive##4##3##(1996-2#1)(1997-5#1)(2008-5#2)
the most potent (MED = 0##2##6##(1993-11#2)
the most potent activity##3##4##(1994-12#1)(2009-3#1)(2011-2#1)
the most potent analog##3##4##(1990-2#1)(1994-5#1)(1994-9#1)
the most potent and selective##2##5##(2006-12#1)(2008-4#1)
the most potent and##4##4##(1994-9#1)(2006-12#1)(2008-4#1)(2011-2#1)
the most potent antigen-presenting cells##2##5##(2006-10#1)(2008-5#1)
the most potent in##3##4##(1992-5#1)(1993-1#1)(2013-8#1)
the most potent inhibitor##6##4##(1992-11#1)(1994-3#1)(1994-9#1)(1996-6#1)(2007-1#1)(2012-11#1)
the most potent inhibitors of##2##5##(1994-11#1)(1994-8#1)
the most potent inhibitors##5##4##(1994-11#1)(1994-8#1)(1995-1#1)(2010-4#1)(2013-1#1)
the most potent of all##3##5##(1994-11#1)(1994-9#1)(2006-11#1)
the most potent of##5##4##(1994-11#1)(1994-9#1)(2006-11#1)(2006-12#1)(2008-8#1)
the most potent with##3##4##(1993-4#1)(2006-12#1)(2013-1#1)
the most potent##89##3##(1990-2#1)(1990-7#2)(1991-3#2)(1991-4#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#3)(1993-4#1)(1993-8#1)(1994-11#3)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#5)(1995-1#2)(1995-11#1)(1995-12#1)(1995-5#2)(1995-7#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-9#1)(2007-1#1)(2007-11#2)(2008-10#2)(2008-4#2)(2008-5#1)(2008-8#4)(2009-11#1)(2009-3#2)(2009-6#1)(2009-7#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#2)(2013-1#2)(2013-8#1)
the most powerful predictor##2##4##(2008-3#1)(2011-2#1)
the most powerful##22##3##(1993-4#1)(1993-7#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-7#2)(2008-9#1)(2011-2#3)
the most practical##2##3##(2006-9#1)(2008-7#1)
the most precise##3##3##(2006-8#1)(2008-10#1)(2012-1#1)
the most precisely##2##3##(2007-9#1)(2008-7#1)
the most predictive##2##3##(1994-3#1)(2009-4#1)
the most predominant##5##3##(2005-8#1)(2009-3#1)(2009-7#1)(2010-12#1)(2013-8#1)
the most preferred##4##3##(1997-6#1)(2007-8#1)(2010-12#1)(2013-8#1)
the most prescribed##3##3##(1996-3#1)(2007-12#1)(2011-2#1)
the most pressing##6##3##(2008-7#1)(2009-12#1)(2009-4#1)(2010-4#1)(2010-8#1)(2012-2#1)
the most prevalent and##3##4##(2008-10#1)(2008-8#1)(2009-5#1)
the most prevalent clinical##2##4##(2007-7#1)(2008-5#1)
the most prevalent complication##2##4##(1991-4#1)(2011-2#1)
the most prevalent form of##2##5##(2008-10#1)(2012-2#1)
the most prevalent forms of##2##5##(1994-12#1)(2004-11#1)
the most prevalent genotype##2##4##(2008-10#2)
the most prevalent in##2##4##(2006-5#1)(2011-1#1)
the most prevalent pathogen##2##4##(2007-2#1)(2013-1#1)
the most prevalent type##2##4##(2007-7#1)(2012-2#1)
the most prevalent##79##3##(1990-2#1)(1990-5#1)(1991-4#1)(1991-9#1)(1992-3#1)(1993-12#1)(1994-12#1)(1995-6#1)(1997-6#1)(1997-7#1)(2004-11#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#4)(2007-8#1)(2008-1#6)(2008-10#11)(2008-12#1)(2008-4#2)(2008-5#5)(2008-7#2)(2008-8#2)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#1)(2010-2#1)(2010-3#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#3)
the most primitive##10##3##(1994-11#1)(1995-11#1)(1996-7#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-12#1)
the most probable precursor of##2##5##(1994-5#1)(2008-5#1)
the most probable##22##3##(1991-12#1)(1992-4#1)(1994-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-10#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-3#2)(2008-5#1)(2010-6#1)(2011-12#1)(2012-1#1)(2012-3#1)(2013-1#2)
the most productive and##2##4##(2007-3#1)(2012-2#1)
the most productive##11##3##(1992-8#1)(2007-3#2)(2007-5#1)(2007-6#1)(2008-9#2)(2009-2#1)(2010-12#1)(2012-2#1)(2013-8#1)
the most profound##5##3##(1996-3#1)(2008-5#2)(2011-2#1)(2012-1#1)
the most prominent of##3##4##(1993-1#1)(1997-1#1)(2009-7#1)
the most prominent##28##3##(1990-5#1)(1991-4#1)(1993-1#1)(1993-8#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-4#1)(1997-1#1)(2005-10#1)(2006-2#1)(2007-7#1)(2008-10#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-7#1)(2010-6#1)(2011-2#2)(2012-2#1)
the most promise##2##3##(2005-7#1)(2008-8#1)
the most promising and##2##4##(2008-10#1)(2009-3#1)
the most promising approach##2##4##(2007-11#1)(2008-5#1)
the most promising candidates##2##4##(2008-10#1)(2013-1#1)
the most promising in##2##4##(2006-2#1)(2011-1#1)
the most promising therapeutic##2##4##(1997-5#1)(2010-6#1)
the most promising##42##3##(1997-5#1)(2004-11#1)(2005-11#1)(2005-7#2)(2006-10#4)(2006-2#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-2#1)(2009-3#2)(2010-12#1)(2010-6#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
the most pronounced##8##3##(1991-5#1)(1996-4#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-4#1)(2011-2#1)
the most proximal##3##3##(1997-7#1)(2008-11#1)(2009-10#1)
the most rapid##2##3##(1995-4#1)(2008-10#1)
the most rapidly increasing##2##4##(1994-12#1)(2008-12#1)
the most rapidly##9##3##(1994-12#1)(1995-2#1)(1996-2#1)(2007-12#1)(2007-7#1)(2008-12#1)(2010-7#1)(2011-10#1)(2013-1#1)
the most readily##2##3##(2008-4#1)(2009-8#1)
the most recent acquisitions concerning##2##5##(1991-2#1)(1991-7#1)
the most recent advances in##5##5##(2005-7#1)(2006-10#2)(2008-5#1)(2010-7#1)
the most recent advances##6##4##(2005-7#1)(2006-10#2)(2008-5#1)(2010-12#1)(2010-7#1)
the most recent clinical##2##4##(2008-5#1)(2010-12#1)
the most recent concepts##2##4##(2006-10#2)
the most recent data##4##4##(2005-8#1)(2006-10#1)(2008-4#1)(2011-3#1)
the most recent development##2##4##(2006-11#1)(2009-7#1)
the most recent developments in##3##5##(2005-8#1)(2007-5#1)(2008-10#1)
the most recent developments regarding##2##5##(2011-2#1)(2013-1#1)
the most recent developments##6##4##(2005-8#1)(2006-10#1)(2007-5#1)(2008-10#1)(2011-2#1)(2013-1#1)
the most recent findings on##2##5##(2006-10#1)(2009-2#1)
the most recent findings##7##4##(2006-10#2)(2006-2#1)(2007-9#1)(2008-5#1)(2009-2#1)(2013-8#1)
the most recent information##2##4##(1997-2#1)(2009-1#1)
the most recent literature on##2##5##(2007-11#1)(2008-4#1)
the most recent literature##9##4##(1991-2#1)(1991-4#1)(1993-5#1)(2006-10#1)(2007-11#1)(2008-4#1)(2008-8#1)(2010-9#1)(2011-2#1)
the most recent research##2##4##(2005-8#1)(2008-11#1)
the most recent studies##4##4##(1995-6#1)(2006-10#1)(2010-5#1)(2012-1#1)
the most recent versions of the##2##6##(1997-8#1)(2011-2#1)
the most recent##107##3##(1991-12#2)(1991-2#2)(1991-4#3)(1991-7#1)(1992-1#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-5#1)(1995-1#1)(1995-6#1)(1996-11#1)(1997-2#2)(1997-8#1)(2005-7#1)(2005-8#3)(2006-10#13)(2006-11#1)(2006-2#1)(2006-5#1)(2006-6#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-8#4)(2008-9#1)(2009-1#1)(2009-2#2)(2009-6#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
the most recently available data##2##5##(1992-3#1)(1993-2#1)
the most recently discovered##2##4##(1993-11#1)(2008-11#1)
the most recently evolved##2##4##(2008-10#2)
the most recently published##2##4##(2006-10#1)(2008-3#1)
the most recently##15##3##(1992-3#1)(1993-11#1)(1993-2#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-8#1)(2009-8#1)(2011-2#1)
the most recurrent##3##3##(2007-2#1)(2008-10#1)(2008-7#1)
the most relevant and##2##4##(2009-10#1)(2013-8#1)
the most relevant##27##3##(1993-2#1)(1997-3#1)(2007-1#1)(2007-5#2)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-7#2)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the most reliable and##2##4##(2006-10#1)(2011-2#1)
the most reliable features##2##4##(2008-12#1)(2012-1#1)
the most reliable method##2##4##(1993-5#1)(2006-5#1)
the most reliable##38##3##(1991-11#1)(1991-4#1)(1993-10#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#3)(1996-12#1)(1996-6#1)(2004-4#1)(2005-10#2)(2006-10#1)(2006-5#1)(2006-7#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-7#1)
the most remarkable##4##3##(1994-3#1)(2008-2#1)(2008-8#1)(2008-9#1)
the most remote##2##3##(2007-12#1)(2013-1#1)
the most representative##5##3##(1995-1#1)(1995-7#1)(2007-5#1)(2008-5#1)(2010-1#1)
the most resistant to##2##4##(2008-10#1)(2012-3#1)
the most resistant##10##3##(2008-10#7)(2008-12#1)(2012-2#1)(2012-3#1)
the most responsive##3##3##(1991-6#1)(1997-3#1)(1997-8#1)
the most restricted##2##3##(1991-4#1)(1995-8#1)
the most richly##2##3##(1995-12#1)(1997-4#1)
the most robust of##2##4##(2009-3#1)(2012-3#1)
the most robust##10##3##(1995-5#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-3#1)(2012-3#1)
the most salient##3##3##(1994-1#1)(2008-10#1)(2010-5#1)
the most selective##4##3##(1991-2#1)(1994-9#1)(1996-2#1)(1997-2#1)
the most sensible##2##3##(2008-10#1)(2008-6#1)
the most sensitive and specific##2##5##(1992-12#1)(2008-1#1)
the most sensitive and##5##4##(1992-12#1)(2008-1#1)(2008-12#1)(2010-6#1)(2012-2#1)
the most sensitive indicator of##2##5##(2006-12#1)(2012-2#1)
the most sensitive methods##2##4##(2007-12#1)(2008-10#1)
the most sensitive of the three##2##6##(1995-1#1)(1995-12#1)
the most sensitive of the##3##5##(1995-1#1)(1995-12#1)(2008-10#1)
the most sensitive of##4##4##(1995-1#1)(1995-12#1)(2008-10#2)
the most sensitive to##8##4##(1992-1#1)(1993-11#1)(1995-1#1)(1996-3#1)(2006-5#1)(2008-3#1)(2008-8#1)(2009-8#1)
the most sensitive##72##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1995-1#2)(1995-12#1)(1995-5#1)(1995-7#2)(1996-1#1)(1996-3#1)(1997-3#1)(2004-4#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#17)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-2#3)(2013-1#2)
the most serious adverse##3##4##(2007-11#2)(2012-2#1)
the most serious and##4##4##(1990-4#1)(2006-10#1)(2007-7#1)(2008-10#1)
the most serious complication of##8##5##(1991-11#1)(1993-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2009-2#1)(2011-2#1)
the most serious complication##9##4##(1991-11#1)(1993-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2007-9#1)(2009-2#1)(2011-2#1)
the most serious##39##3##(1990-4#1)(1991-11#1)(1991-12#1)(1991-3#2)(1992-8#1)(1993-10#1)(2006-10#2)(2007-10#1)(2007-11#4)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)
the most severe cases of##2##5##(1996-3#1)(2013-8#1)
the most severe cases##4##4##(1994-9#1)(1996-3#1)(2007-11#1)(2013-8#1)
the most severe form##3##4##(1995-9#1)(2006-2#1)(2012-12#1)
the most severe forms of##2##5##(2008-5#1)(2009-5#1)
the most severe forms##4##4##(1996-3#1)(2007-10#1)(2008-5#1)(2009-5#1)
the most severe##37##3##(1990-8#1)(1994-9#2)(1995-2#1)(1995-9#1)(1996-3#2)(1997-1#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#2)
the most severely affected##3##4##(1995-9#1)(2008-8#1)(2011-2#1)
the most severely obstructed##2##4##(1990-5#1)(1996-2#1)
the most severely##8##3##(1990-5#1)(1995-9#1)(1996-2#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-8#1)(2011-2#1)
the most significant advances##2##4##(2006-10#1)(2008-1#1)
the most significant and##4##4##(1996-5#1)(2008-1#1)(2013-8#2)
the most significant contributor to##2##5##(2006-10#1)(2008-10#1)
the most significant data##2##4##(2006-2#1)(2012-2#1)
the most significant effect##3##4##(2008-10#1)(2008-11#1)(2011-1#1)
the most significant factor##6##4##(1994-3#1)(1996-7#1)(1997-8#1)(2008-10#2)(2008-8#1)
the most significant increase##2##4##(2008-6#1)(2008-7#1)
the most significant predictor of##2##5##(1990-4#1)(2008-9#1)
the most significant prognostic##2##4##(1995-4#1)(2011-2#1)
the most significant##77##3##(1990-4#1)(1991-2#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-8#1)(2004-10#1)(2006-10#4)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#4)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#2)
the most similar to##2##4##(1993-6#1)(1997-2#1)
the most similar##4##3##(1993-6#1)(1997-2#1)(2008-10#1)(2008-5#1)
the most species-rich##4##3##(1994-3#1)(2010-6#3)
the most specific##4##3##(2008-11#1)(2008-5#1)(2010-3#1)(2012-2#1)
the most stable##12##3##(1995-4#1)(1996-2#1)(1996-4#1)(1996-7#1)(2006-2#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
the most stressful##3##3##(1992-2#1)(1994-12#1)(2012-1#1)
the most striking##6##3##(1991-8#1)(1994-11#1)(1996-11#1)(2006-12#1)(2008-10#1)(2008-5#1)
the most strongly##3##3##(1995-7#1)(2005-11#1)(2013-1#1)
the most structurally##2##3##(2010-12#1)(2011-12#1)
the most studied##15##3##(1996-9#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-8#1)(2008-1#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
the most successful and##2##4##(2008-10#1)(2011-1#1)
the most successful in##2##4##(2008-10#1)(2011-1#1)
the most successful methods##3##4##(1990-12#1)(1995-5#1)(2009-3#1)
the most successful##21##3##(1990-12#1)(1994-3#1)(1995-5#1)(1996-12#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#2)(2009-2#1)(2009-3#2)(2010-3#1)(2011-1#2)(2011-12#1)(2012-2#2)(2013-8#1)
the most suitable approach for##2##5##(2008-10#2)
the most suitable for the##4##5##(1990-8#1)(2008-8#1)(2009-8#1)(2013-1#1)
the most suitable for##8##4##(1990-8#1)(2007-8#1)(2008-10#2)(2008-8#1)(2009-8#1)(2010-7#1)(2013-1#1)
the most suitable of##2##4##(2005-7#1)(2008-10#1)
the most suitable##52##3##(1990-10#2)(1990-8#1)(1991-10#1)(1991-5#1)(1992-10#1)(1992-2#1)(1993-3#1)(1994-2#1)(1995-8#1)(1996-12#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-5#1)(2007-8#3)(2008-10#14)(2008-12#2)(2008-2#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#4)
the most superficial layers of the##2##6##(2008-5#2)
the most superficial layers##3##4##(2008-5#3)
the most susceptible to##4##4##(2005-11#1)(2006-11#1)(2006-8#1)(2013-8#1)
the most susceptible##15##3##(1994-8#1)(2004-4#1)(2005-11#1)(2006-11#1)(2006-8#1)(2007-10#1)(2008-10#7)(2008-12#1)(2013-8#1)
the most thermostable##3##3##(1997-7#1)(2008-5#1)(2011-1#1)
the most thoroughly investigated##2##4##(2006-10#1)(2011-1#1)
the most thoroughly##4##3##(2006-10#1)(2006-8#1)(2011-1#1)(2013-8#1)
the most tightly bound##3##4##(1990-5#1)(1992-5#1)(2005-11#1)
the most to##4##3##(2008-10#1)(2008-2#1)(2008-8#1)(2010-8#1)
the most tolerant##2##3##(2004-4#1)(2011-2#1)
the most toxic##7##3##(1992-1#1)(1992-5#1)(2006-10#1)(2007-11#1)(2008-10#3)
the most typical##3##3##(2006-6#1)(2008-9#1)(2011-1#1)
the most ubiquitous##3##3##(2006-12#1)(2008-10#1)(2010-12#1)
the most unusual##2##3##(2007-12#1)(2007-3#1)
the most up-to-date##2##3##(2005-9#1)(2006-8#1)
the most upstream of which defines a##2##7##(1991-4#2)
the most upstream##3##3##(1991-4#2)(1993-11#1)
the most urgent##2##3##(1990-2#1)(1991-5#1)
the most used##12##3##(1993-11#1)(1997-3#1)(2006-8#2)(2008-10#3)(2009-1#1)(2011-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
the most useful diagnostic##2##4##(2005-12#1)(2011-1#1)
the most useful way##2##4##(2008-9#1)(2011-2#1)
the most useful##29##3##(1990-4#1)(1991-3#1)(1991-6#2)(1992-1#1)(1996-6#1)(2004-10#1)(2005-11#1)(2005-12#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-4#2)(2011-1#1)(2011-2#3)(2012-2#1)(2013-7#1)
the most usual##4##3##(1997-7#1)(2008-10#1)(2008-12#1)(2008-9#1)
the most valuable##6##3##(1992-2#1)(1992-9#1)(1994-5#1)(2008-9#1)(2013-1#2)
the most value##2##3##(1994-3#1)(2012-3#1)
the most variable region in##2##5##(1994-9#1)(2009-5#1)
the most variable##6##3##(1994-9#1)(2008-10#2)(2009-5#1)(2012-12#1)(2013-7#1)
the most versatile##5##3##(1990-12#1)(1997-2#1)(2004-2#1)(2008-2#1)(2008-8#1)
the most violent##2##3##(2006-7#1)(2008-7#1)
the most virulent##4##3##(2008-10#3)(2013-8#1)
the most visible##2##3##(2008-9#1)(2012-1#1)
the most vulnerable##6##3##(1994-5#1)(1995-11#1)(1996-1#1)(2008-10#1)(2008-3#1)(2012-2#1)
the most widely accepted##3##4##(2005-7#1)(2008-4#1)(2009-3#1)
the most widely distributed##5##4##(2008-10#3)(2013-7#1)(2013-8#1)
the most widely employed##2##4##(2005-11#1)(2008-5#1)
the most widely investigated##2##4##(2008-5#1)(2009-8#1)
the most widely prescribed drugs in the##2##7##(2007-11#1)(2008-11#1)
the most widely prescribed##3##4##(2007-11#1)(2008-11#1)(2013-1#1)
the most widely used form of##2##6##(1997-1#1)(2008-1#1)
the most widely used measures##2##5##(2009-12#1)(2010-2#1)
the most widely used method of##2##6##(2005-7#1)(2006-12#1)
the most widely used method##3##5##(2005-7#1)(2006-12#1)(2008-4#1)
the most widely used##52##4##(1991-3#1)(1996-1#1)(1997-1#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-12#3)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#7)(2008-5#1)(2008-6#2)(2008-8#3)(2008-9#1)(2009-12#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
the most widely##82##3##(1991-3#1)(1994-3#1)(1996-1#1)(1997-1#1)(2005-11#2)(2005-7#2)(2006-10#3)(2006-12#3)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#8)(2008-11#3)(2008-2#3)(2008-3#2)(2008-4#9)(2008-5#4)(2008-6#2)(2008-8#5)(2008-9#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-12#3)(2010-2#2)(2010-4#2)(2010-8#1)(2011-1#3)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
the most widespread##14##3##(1991-3#1)(1994-3#1)(1997-2#1)(2005-1#1)(2005-11#1)(2008-10#2)(2008-9#2)(2009-2#1)(2011-1#1)(2011-2#1)(2012-2#2)
the most##4460##2##(1990-10#4)(1990-11#4)(1990-12#10)(1990-2#9)(1990-3#9)(1990-4#8)(1990-5#12)(1990-6#12)(1990-7#8)(1990-8#10)(1990-9#10)(1991-1#4)(1991-10#3)(1991-11#8)(1991-12#11)(1991-2#8)(1991-3#18)(1991-4#19)(1991-5#8)(1991-6#10)(1991-7#7)(1991-8#4)(1991-9#7)(1992-1#8)(1992-10#3)(1992-11#6)(1992-12#8)(1992-2#13)(1992-3#15)(1992-4#8)(1992-5#19)(1992-6#8)(1992-7#2)(1992-8#13)(1992-9#10)(1993-1#9)(1993-10#4)(1993-11#12)(1993-12#16)(1993-2#10)(1993-3#13)(1993-4#3)(1993-5#12)(1993-6#8)(1993-7#2)(1993-8#8)(1993-9#10)(1994-1#7)(1994-11#10)(1994-12#18)(1994-2#9)(1994-3#19)(1994-4#2)(1994-5#10)(1994-6#10)(1994-7#3)(1994-8#10)(1994-9#18)(1995-1#15)(1995-10#2)(1995-11#8)(1995-12#14)(1995-2#10)(1995-3#19)(1995-4#5)(1995-5#14)(1995-6#11)(1995-7#6)(1995-8#5)(1995-9#6)(1996-1#11)(1996-10#1)(1996-11#5)(1996-12#11)(1996-2#21)(1996-3#18)(1996-4#10)(1996-5#7)(1996-6#11)(1996-7#10)(1996-8#4)(1996-9#10)(1997-1#14)(1997-2#22)(1997-3#13)(1997-4#13)(1997-5#8)(1997-6#11)(1997-7#14)(1997-8#12)(2004-10#3)(2004-11#7)(2004-12#1)(2004-2#5)(2004-3#4)(2004-4#6)(2004-5#1)(2004-9#3)(2005-1#2)(2005-10#19)(2005-11#28)(2005-12#11)(2005-5#1)(2005-7#16)(2005-8#30)(2005-9#4)(2006-1#5)(2006-10#139)(2006-11#12)(2006-12#32)(2006-2#39)(2006-3#5)(2006-4#9)(2006-5#8)(2006-6#31)(2006-7#11)(2006-8#32)(2006-9#15)(2007-1#11)(2007-10#30)(2007-11#92)(2007-12#47)(2007-2#41)(2007-3#36)(2007-4#22)(2007-5#24)(2007-6#17)(2007-7#79)(2007-8#76)(2007-9#25)(2008-1#88)(2008-10#393)(2008-11#71)(2008-12#46)(2008-2#53)(2008-3#63)(2008-4#85)(2008-5#127)(2008-6#49)(2008-7#94)(2008-8#85)(2008-9#74)(2009-1#3)(2009-10#10)(2009-11#13)(2009-12#12)(2009-2#21)(2009-3#25)(2009-4#22)(2009-5#27)(2009-6#23)(2009-7#17)(2009-8#25)(2009-9#12)(2010-1#8)(2010-10#11)(2010-11#10)(2010-12#73)(2010-2#20)(2010-3#11)(2010-4#29)(2010-5#20)(2010-6#18)(2010-7#23)(2010-8#41)(2010-9#14)(2011-1#90)(2011-10#2)(2011-11#2)(2011-12#12)(2011-2#224)(2011-3#8)(2011-4#1)(2011-7#1)(2012-1#20)(2012-11#17)(2012-12#79)(2012-2#110)(2012-3#54)(2012-4#1)(2012-9#1)(2013-1#147)(2013-7#46)(2013-8#70)
the most-potent##2##2##(2006-12#2)
the mostly##6##2##(1991-6#1)(2006-6#1)(2007-12#1)(2008-8#2)(2010-2#1)
the motA gene##2##3##(1995-2#2)
the moth Manduca sexta##2##4##(2007-12#1)(2009-8#1)
the moth##9##2##(1992-5#1)(1995-8#1)(2007-12#4)(2007-3#1)(2008-9#1)(2009-8#1)
the mother and daughter##2##4##(1995-6#1)(1996-6#1)
the mother and her##3##4##(2007-2#1)(2008-7#1)(2010-10#1)
the mother and the fetus##2##5##(1997-8#1)(2008-8#1)
the mother and the##6##4##(1997-8#1)(2006-2#1)(2008-2#1)(2008-8#2)(2011-1#1)
the mother and##16##3##(1994-6#1)(1995-6#1)(1996-6#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#2)(2009-9#1)(2010-10#1)(2011-1#1)(2012-3#1)
the mother as##2##3##(1991-9#1)(2013-1#1)
the mother had##2##3##(1991-11#1)(2006-7#1)
the mother has##3##3##(2006-9#1)(2011-2#1)(2012-2#1)
the mother have##2##3##(1990-10#1)(2006-10#1)
the mother is##3##3##(1991-9#1)(2006-7#1)(2008-3#1)
the mother may##2##3##(1994-6#1)(2006-10#1)
the mother must##2##3##(1992-2#1)(1996-8#1)
the mother of the child##2##5##(1990-10#1)(2012-3#1)
the mother of the##4##4##(1990-10#1)(1997-3#1)(2007-10#1)(2012-3#1)
the mother or the##2##4##(1992-12#1)(2008-8#1)
the mother or##3##3##(1992-12#1)(2008-8#1)(2010-9#1)
the mother to##4##3##(2006-8#1)(2007-8#1)(2008-3#1)(2008-8#1)
the mother was##2##3##(1990-5#1)(2011-1#1)
the mother with##2##3##(2008-8#1)(2011-2#1)
the mother##108##2##(1990-10#2)(1990-5#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-9#2)(1992-10#1)(1992-12#2)(1992-2#2)(1993-10#1)(1993-2#2)(1993-6#1)(1994-6#4)(1995-2#1)(1995-6#2)(1996-5#1)(1996-6#2)(1996-8#1)(1997-3#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#4)(2006-2#1)(2006-3#1)(2006-7#3)(2006-8#1)(2006-9#2)(2007-10#1)(2007-12#1)(2007-2#4)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#1)(2008-7#3)(2008-8#8)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#3)(2012-1#2)(2012-2#2)(2012-3#2)(2013-1#3)
the mother's body##2##3##(2006-9#1)(2008-8#1)
the mother's imagination##2##3##(2009-2#2)
the mother's milk##2##3##(1996-9#2)
the mother's##20##2##(1990-1#1)(1990-10#1)(1992-4#2)(1995-4#1)(1996-9#3)(2005-10#1)(2005-12#1)(2006-8#1)(2006-9#2)(2008-11#1)(2008-8#1)(2009-2#2)(2011-1#1)(2011-2#1)(2012-2#1)
the mother-child relationship##3##3##(2004-3#1)(2008-2#1)(2011-1#1)
the mother-child##5##2##(2004-3#1)(2008-2#1)(2009-4#1)(2009-9#1)(2011-1#1)
the mother-infant##3##2##(1990-12#1)(2009-11#1)(2009-9#1)
the mother?##2##2##(1990-10#2)
the mothers had##2##3##(1990-12#1)(1995-1#1)
the mothers of##2##3##(2010-2#1)(2012-1#1)
the mothers were##3##3##(1990-10#1)(2007-12#1)(2008-10#1)
the mothers##43##2##(1990-10#3)(1990-12#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-6#1)(1993-12#1)(1993-6#2)(1995-1#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-9#2)(2008-1#1)(2008-10#5)(2008-2#2)(2008-4#2)(2009-10#1)(2010-2#1)(2010-9#1)(2011-1#5)(2011-2#2)(2012-1#2)(2012-2#2)
the motif##14##2##(1990-7#1)(1991-6#1)(1994-3#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-8#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-7#1)(2010-12#1)(2012-2#1)
the motifs##7##2##(1993-11#1)(1995-6#1)(2008-4#1)(2008-8#1)(2008-9#1)(2013-1#2)
the motile##2##2##(2008-1#1)(2008-5#1)
the motility and##2##3##(1995-8#1)(2013-8#1)
the motility of the##2##4##(1993-7#1)(2007-10#1)
the motility of##11##3##(1993-7#1)(1996-12#2)(1996-5#1)(1997-7#1)(1997-8#1)(2005-7#1)(2006-5#1)(2007-10#2)(2008-11#1)
the motility##19##2##(1993-7#1)(1995-2#1)(1995-8#1)(1996-12#3)(1996-5#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-7#1)(2006-5#1)(2007-10#2)(2007-8#1)(2008-11#1)(2008-7#1)(2013-1#1)(2013-8#1)
the motion in the##2##4##(2008-2#1)(2012-1#1)
the motion model##4##3##(2008-2#1)(2008-3#3)
the motion of a##3##4##(2005-11#1)(2006-6#1)(2007-12#1)
the motion of the##9##4##(1990-2#1)(1991-7#1)(1994-3#1)(2006-11#1)(2007-8#1)(2008-3#2)(2009-11#1)(2011-1#1)
the motion of##23##3##(1990-2#1)(1991-7#1)(1994-3#1)(1996-12#1)(2005-11#1)(2006-11#1)(2006-6#1)(2007-1#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-3#5)(2009-11#2)(2009-4#1)(2011-1#1)(2012-1#1)
the motion##53##2##(1990-2#1)(1991-7#1)(1994-3#1)(1996-12#2)(2005-11#1)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-11#3)(2007-12#2)(2007-2#2)(2007-7#2)(2007-8#1)(2008-11#1)(2008-2#7)(2008-3#9)(2008-4#1)(2008-6#1)(2008-9#1)(2009-11#2)(2009-4#2)(2011-1#2)(2012-1#3)(2012-12#1)(2012-2#1)
the motional##3##2##(1995-8#2)(2008-10#1)
the motions of individual##2##4##(1992-1#1)(2008-11#1)
the motions of the##4##4##(1995-11#1)(1997-7#1)(2009-9#1)(2013-1#1)
the motions of##6##3##(1992-1#1)(1995-11#1)(1997-7#1)(2008-11#1)(2009-9#1)(2013-1#1)
the motions##7##2##(1992-1#1)(1995-10#1)(1995-11#1)(1997-7#1)(2008-11#1)(2009-9#1)(2013-1#1)
the motivation and##4##3##(1993-5#1)(2006-4#1)(2007-4#1)(2011-2#1)
the motivation for the##2##4##(2008-11#1)(2008-3#1)
the motivation for##6##3##(1997-3#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-12#1)(2010-5#1)
the motivation of clients##2##4##(2012-2#2)
the motivation of##3##3##(2010-9#1)(2012-2#2)
the motivation##18##2##(1993-2#1)(1993-5#1)(1995-2#1)(1997-3#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-2#2)
the motivational factors##2##3##(2006-6#1)(2008-12#1)
the motivational##16##2##(1993-2#1)(1994-6#1)(1995-2#1)(1996-5#1)(2005-12#1)(2006-6#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-1#1)(2010-10#1)(2011-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
the motivations of##2##3##(1990-3#1)(1993-12#1)
the motivations##6##2##(1990-3#1)(1993-12#1)(2006-5#1)(2007-12#1)(2007-2#1)(2009-4#1)
the motive##2##2##(1990-8#1)(2006-8#1)
the motoneuron##3##2##(1996-12#2)(2007-11#1)
the motoneurons##3##2##(1996-12#2)(2010-2#1)
the motor activity##3##3##(1991-2#1)(1992-8#1)(1996-10#1)
the motor and sensory##3##4##(1997-8#1)(2006-3#2)
the motor and##9##3##(1995-3#1)(1996-11#1)(1997-8#1)(2006-3#3)(2007-9#1)(2010-7#1)(2012-1#1)
the motor control##3##3##(2006-10#1)(2008-7#1)(2013-7#1)
the motor cortex##15##3##(1990-2#1)(1991-1#1)(1993-9#3)(1995-11#1)(1996-9#1)(2006-10#2)(2006-3#1)(2008-7#2)(2008-9#1)(2010-7#2)
the motor cortical##5##3##(1990-2#1)(1991-9#3)(2010-7#1)
the motor depressant##2##3##(1996-12#2)
the motor effects elicited by##2##5##(1996-12#2)
the motor effects##3##3##(1992-6#1)(1996-12#2)
the motor explant##2##3##(1996-3#2)
the motor imagery##2##3##(2012-1#1)(2013-7#1)
the motor neuron##2##3##(1990-5#1)(2006-10#1)
the motor neurons##2##3##(1997-8#1)(2008-4#1)
the motor nucleus##2##3##(1994-2#1)(1997-2#1)
the motor output##2##3##(1993-6#1)(2012-1#1)
the motor pathways##2##3##(2006-12#2)
the motor pattern##2##3##(1994-10#1)(2006-2#1)
the motor performance of##2##4##(2008-7#1)(2013-8#1)
the motor protein##3##3##(2006-10#2)(2008-11#1)
the motor seizure stage##2##4##(1994-2#2)
the motor status##2##3##(2006-12#2)
the motor system##4##3##(2007-11#2)(2008-12#1)(2012-1#1)
the motor##113##2##(1990-2#2)(1990-5#1)(1991-1#1)(1991-2#1)(1991-9#3)(1992-6#1)(1992-8#4)(1992-9#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#8)(1994-10#2)(1994-2#3)(1994-9#1)(1995-11#1)(1995-12#2)(1995-3#2)(1996-10#2)(1996-11#1)(1996-12#6)(1996-3#2)(1996-5#2)(1996-6#3)(1996-9#1)(1997-2#1)(1997-8#3)(2006-10#8)(2006-12#4)(2006-2#1)(2006-3#4)(2007-11#3)(2007-7#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-4#2)(2008-7#8)(2008-9#2)(2009-2#1)(2010-1#1)(2010-7#4)(2012-1#7)(2013-1#2)(2013-7#2)(2013-8#1)
the mould##6##2##(1991-2#1)(1991-7#2)(2008-5#2)(2009-3#1)
the moulting##2##2##(1991-10#2)
the mountain##3##2##(2008-10#1)(2008-6#1)(2008-8#1)
the mountainous region##2##3##(2008-5#1)(2013-8#1)
the mountainous##4##2##(2008-1#1)(2008-10#1)(2008-5#1)(2013-8#1)
the mounting##3##2##(1997-7#1)(2007-7#1)(2008-2#1)
the mouse 2##2##3##(1990-8#1)(1992-2#1)
the mouse CCK-A receptor gene##2##5##(1997-7#2)
the mouse DBH##3##3##(1992-11#3)
the mouse EndoA gene##2##4##(1993-3#2)
the mouse EndoA##3##3##(1993-3#3)
the mouse Hes-3 gene##2##4##(1994-8#2)
the mouse MHC##2##3##(1997-9#1)(2008-4#1)
the mouse TrkB##2##3##(2008-9#2)
the mouse Y chromosome##2##4##(1990-11#2)
the mouse and human genes##4##5##(1990-3#1)(1992-7#1)(1993-3#1)(1993-6#1)
the mouse and human##19##4##(1990-11#1)(1990-3#3)(1991-6#1)(1992-4#1)(1992-7#1)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#1)(1994-5#1)(1994-9#1)(1995-8#1)(1997-2#1)(1997-7#1)(2008-4#1)
the mouse and rat##4##4##(1990-8#1)(1991-2#1)(1992-7#1)(1996-5#1)
the mouse and the##2##4##(2008-11#1)(2010-11#1)
the mouse and##30##3##(1990-11#1)(1990-3#3)(1990-8#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-4#1)(1992-7#2)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-7#1)(2006-10#1)(2008-11#1)(2008-4#1)(2010-11#1)
the mouse anterior pituitary##2##4##(2008-5#2)
the mouse bone marrow##2##4##(2008-11#1)(2008-4#1)
the mouse brain##14##3##(1990-2#1)(1992-6#1)(1995-11#1)(1995-3#2)(1996-10#1)(1996-2#1)(1997-5#5)(2007-10#1)(2009-4#1)
the mouse cDNA##2##3##(1993-3#1)(1997-7#1)
the mouse central nervous system##2##5##(1993-3#1)(1996-2#1)
the mouse cerebellum by##2##4##(1996-10#1)(1996-4#1)
the mouse cerebellum##4##3##(1993-3#1)(1996-10#2)(1996-4#1)
the mouse ear##3##3##(1991-8#1)(1992-9#1)(2008-9#1)
the mouse embryo##5##3##(1991-12#1)(1995-1#1)(1995-11#1)(1997-4#1)(2008-10#1)
the mouse enzyme##5##3##(1990-11#3)(1990-5#2)
the mouse erythroleukemia##2##3##(1997-1#1)(2008-9#1)
the mouse eye lens##2##4##(1993-2#2)
the mouse for##2##3##(1993-3#1)(1994-6#1)
the mouse gene##3##3##(1992-6#1)(1994-8#1)(1996-2#1)
the mouse genome are##2##4##(1995-2#1)(2007-9#1)
the mouse genome##17##3##(1991-5#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-6#1)(1995-2#1)(1995-6#1)(1996-11#1)(2007-9#1)(2008-2#1)(2008-7#1)(2008-8#5)(2012-2#1)
the mouse genomic sequence##2##4##(2008-4#1)(2009-5#1)
the mouse germline##3##3##(1991-6#1)(1995-11#2)
the mouse heart##2##3##(1993-3#1)(2013-8#1)
the mouse homolog of##2##4##(1994-9#1)(1995-8#1)
the mouse homolog##3##3##(1994-9#1)(1995-8#1)(2010-2#1)
the mouse homologue of DAX1##2##5##(1996-10#2)
the mouse homologue of##4##4##(1991-7#1)(1996-10#2)(1997-1#1)
the mouse homologue##6##3##(1991-12#1)(1991-7#1)(1993-4#1)(1996-10#2)(1997-1#1)
the mouse in##2##3##(1995-11#1)(2008-4#1)
the mouse isolated##4##3##(1991-1#1)(1997-5#1)(2008-4#2)
the mouse liver/bone/kidney-type alkaline phosphatase gene##2##6##(1991-9#2)
the mouse low##2##3##(1993-3#1)(1997-2#1)
the mouse mammary tumor virus##4##5##(1992-12#1)(1992-8#2)(1994-11#1)
the mouse mammary##5##3##(1992-12#1)(1992-8#2)(1994-11#1)(2009-12#1)
the mouse model##7##3##(1995-6#1)(2006-10#1)(2007-6#1)(2008-10#1)(2008-4#1)(2012-12#2)
the mouse myogenic gene Myo-D1##2##5##(1993-2#1)(1994-12#1)
the mouse myogenic gene##3##4##(1993-2#1)(1994-12#2)
the mouse myogenic##4##3##(1993-2#1)(1993-4#1)(1994-12#2)
the mouse neuroblastoma##3##3##(1991-2#1)(1993-6#1)(2008-4#1)
the mouse peroxisome proliferator activated receptor alpha gene##2##8##(1994-2#2)
the mouse pituitary##2##3##(1992-12#1)(2008-5#1)
the mouse retina##2##3##(1994-3#2)
the mouse sequence##3##3##(1990-3#1)(1992-11#1)(1997-9#1)
the mouse skin##5##3##(1992-2#1)(1992-7#3)(1997-4#1)
the mouse third largest##2##4##(1997-1#2)
the mouse thymidine kinase##2##4##(1994-12#2)
the mouse type##3##3##(1996-4#1)(1997-1#2)
the mouse which##2##3##(1996-1#1)(2008-4#1)
the mouse##457##2##(1990-11#8)(1990-12#1)(1990-2#2)(1990-3#6)(1990-4#2)(1990-5#5)(1990-6#2)(1990-7#2)(1990-8#5)(1990-9#1)(1991-1#3)(1991-11#3)(1991-12#3)(1991-2#4)(1991-4#1)(1991-5#4)(1991-6#4)(1991-7#1)(1991-8#1)(1991-9#4)(1992-11#12)(1992-12#7)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#6)(1992-6#4)(1992-7#7)(1992-8#7)(1992-9#2)(1993-11#2)(1993-12#3)(1993-2#4)(1993-3#16)(1993-4#3)(1993-5#3)(1993-6#6)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#10)(1994-2#4)(1994-3#4)(1994-5#7)(1994-6#2)(1994-8#7)(1994-9#5)(1995-1#6)(1995-11#12)(1995-12#3)(1995-2#3)(1995-3#8)(1995-5#3)(1995-6#5)(1995-8#4)(1996-1#3)(1996-10#10)(1996-11#10)(1996-12#4)(1996-2#4)(1996-3#4)(1996-4#4)(1996-5#5)(1996-8#1)(1996-9#1)(1997-1#8)(1997-2#9)(1997-4#7)(1997-5#9)(1997-6#1)(1997-7#9)(1997-8#2)(1997-9#2)(2004-9#1)(2006-1#1)(2006-10#2)(2006-11#2)(2006-12#3)(2006-4#1)(2007-10#2)(2007-6#1)(2007-9#1)(2008-10#6)(2008-11#5)(2008-2#2)(2008-3#2)(2008-4#42)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#14)(2008-9#5)(2009-12#2)(2009-4#2)(2009-5#1)(2010-11#2)(2010-12#2)(2010-2#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#1)(2013-8#3)
the mouth and##8##3##(1996-1#1)(2005-10#1)(2005-9#1)(2007-6#1)(2011-2#2)(2013-1#2)
the mouth corners##2##3##(2008-5#2)
the mouth in##6##3##(2008-11#2)(2008-5#2)(2012-2#1)(2013-1#1)
the mouth is##2##3##(2007-12#1)(2011-2#1)
the mouth may##2##3##(2007-12#1)(2008-8#1)
the mouth of the spermathecal duct##2##6##(2008-5#2)
the mouth of the##8##4##(1997-2#1)(2006-8#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-8#1)
the mouth of##11##3##(1997-2#1)(2006-8#1)(2008-11#1)(2008-5#2)(2008-7#3)(2008-8#1)(2010-8#2)
the mouth region##2##3##(2009-10#1)(2009-4#1)
the mouth was##2##3##(2007-12#1)(2008-11#1)
the mouth with##3##3##(2011-1#1)(2011-2#2)
the mouth##81##2##(1990-12#1)(1990-8#1)(1991-1#1)(1993-12#1)(1995-11#1)(1996-1#1)(1996-5#1)(1997-2#1)(1997-4#2)(2005-10#2)(2005-11#1)(2005-9#1)(2006-8#1)(2007-12#3)(2007-2#2)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#5)(2008-5#10)(2008-7#5)(2008-8#4)(2009-10#1)(2009-4#4)(2010-2#1)(2010-5#2)(2010-8#2)(2011-1#2)(2011-2#12)(2012-2#3)(2013-1#4)
the mouths of##3##3##(2007-5#1)(2008-10#2)
the movable##4##2##(2008-2#1)(2008-3#1)(2008-5#1)(2013-1#1)
the move to##2##3##(2005-12#1)(2008-11#1)
the movement and##2##3##(1995-1#1)(2006-12#1)
the movement of the##13##4##(1995-12#1)(1996-1#1)(1996-12#1)(1997-7#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-8#2)(2008-10#2)(2008-3#2)
the movement of##41##3##(1990-11#1)(1990-12#1)(1991-5#1)(1992-3#1)(1995-12#1)(1996-1#2)(1996-12#1)(1996-5#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-8#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-8#2)(2008-1#2)(2008-10#6)(2008-11#2)(2008-3#2)(2008-8#1)(2009-1#1)(2009-2#1)(2009-4#1)(2009-5#1)(2011-2#3)(2012-1#1)(2012-12#1)
the movement patterns of##2##4##(2008-8#1)(2010-5#1)
the movement to##2##3##(1995-3#1)(1997-3#1)
the movement##73##2##(1990-11#1)(1990-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#3)(1996-12#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#3)(2008-1#2)(2008-10#6)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#4)(2008-8#2)(2009-1#1)(2009-2#3)(2009-4#1)(2009-5#1)(2009-7#1)(2010-5#1)(2011-2#3)(2012-1#3)(2012-12#1)(2013-1#1)
the movements of the##2##4##(2008-8#1)(2012-1#1)
the movements of##9##3##(1991-1#1)(2005-10#1)(2006-10#1)(2007-12#3)(2008-3#1)(2008-8#1)(2012-1#1)
the movements were##2##3##(1994-3#1)(2008-11#1)
the movements##19##2##(1991-1#1)(1992-9#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-5#1)(2005-10#1)(2006-10#1)(2007-12#3)(2008-11#2)(2008-3#1)(2008-8#1)(2010-9#1)(2012-1#1)(2012-3#1)
the movie##5##2##(1996-12#2)(2006-5#1)(2008-8#1)(2012-2#1)
the moving target##3##3##(1996-1#2)(1996-12#1)
the moving##17##2##(1996-1#2)(1996-12#1)(2005-11#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#5)(2009-6#1)(2011-2#1)(2012-1#1)
the mt genome##2##3##(1994-10#1)(2009-5#1)
the mt##4##2##(1991-4#1)(1994-10#1)(1996-7#1)(2009-5#1)
the mtDNA content##2##3##(2005-8#2)
the mtDNA control region##5##4##(2008-12#1)(2008-3#1)(2010-8#3)
the mtDNA of##3##3##(1994-10#1)(1995-1#1)(1996-7#1)
the mtDNA##24##2##(1994-10#1)(1994-11#1)(1994-8#1)(1995-1#2)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-7#1)(2005-8#2)(2008-12#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-12#1)(2010-8#3)
the mtRNA##2##2##(1991-4#2)
the mu (monkey) receptor##2##4##(1994-9#2)
the mu opioid receptor##4##4##(1994-9#1)(2008-11#2)(2012-12#1)
the mu opioid##6##3##(1994-10#1)(1994-9#1)(1995-12#1)(2008-11#2)(2012-12#1)
the mu receptor##4##3##(1992-3#1)(1995-6#2)(2005-8#1)
the mu rhythm##2##3##(2012-1#2)
the mu##25##2##(1991-1#1)(1991-5#2)(1991-9#1)(1992-3#1)(1994-10#1)(1994-9#3)(1995-1#1)(1995-12#1)(1995-6#2)(1996-8#1)(1997-4#1)(1997-7#1)(2005-8#1)(2007-11#3)(2008-11#2)(2012-1#2)(2012-12#1)
the mu- and##2##3##(1990-7#1)(1991-9#1)
the mu-##5##2##(1990-7#1)(1991-9#2)(1995-11#2)
the mu-EFFF##2##2##(2008-6#2)
the mu-opioid receptor##6##3##(1990-7#1)(1991-9#1)(1995-11#1)(1996-2#1)(1996-7#1)(1997-2#1)
the muIMER##2##2##(2008-10#2)
the muM##2##2##(2008-10#2)
the much greater##7##3##(1991-4#1)(1993-4#1)(1994-8#1)(1997-7#1)(2008-10#2)(2011-1#1)
the much larger##7##3##(1991-9#1)(1994-8#1)(2007-9#1)(2008-10#1)(2008-7#2)(2010-12#1)
the much lower##3##3##(1994-1#1)(2006-10#1)(2008-7#1)
the much more##3##3##(1991-11#1)(1992-3#1)(2006-10#1)
the much##30##2##(1991-11#1)(1991-4#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-4#1)(1994-1#1)(1994-11#1)(1994-8#2)(1997-7#1)(2006-1#1)(2006-10#2)(2007-9#1)(2008-10#5)(2008-2#1)(2008-7#3)(2009-8#1)(2010-12#1)(2011-1#1)(2012-10#1)(2013-7#1)(2013-8#1)
the mucin##7##2##(1992-5#1)(1993-2#1)(1996-5#1)(1997-7#1)(2005-12#1)(2007-1#1)(2013-8#1)
the mucociliary##3##2##(1995-8#1)(1997-1#2)
the mucocutaneous junction##2##3##(2009-5#1)(2010-12#1)
the mucosa and submucosa##2##4##(1990-9#1)(2007-12#1)
the mucosa and##5##3##(1990-9#1)(2007-12#1)(2008-5#1)(2012-2#1)(2013-1#1)
the mucosa is##3##3##(1997-1#1)(2006-10#1)(2008-5#1)
the mucosa of the##5##4##(1992-12#1)(2005-11#1)(2008-3#1)(2008-4#1)(2008-5#1)
the mucosa to##2##3##(1997-2#1)(2006-10#1)
the mucosa with##2##3##(2009-2#1)(2010-12#1)
the mucosa##54##2##(1990-1#1)(1990-11#1)(1990-5#1)(1990-9#3)(1991-6#1)(1992-12#1)(1992-5#1)(1993-7#1)(1995-4#1)(1997-1#1)(1997-2#1)(2005-11#2)(2005-7#1)(2006-10#7)(2006-2#1)(2007-12#1)(2008-3#2)(2008-4#1)(2008-5#9)(2009-2#2)(2010-12#4)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#4)(2013-8#3)
the mucosa-associated##2##2##(1992-4#1)(2009-9#1)
the mucosal IgA response##2##4##(2008-11#2)
the mucosal cells##2##3##(1991-12#1)(1994-6#1)
the mucosal epithelium##3##3##(1997-2#2)(2006-10#1)
the mucosal immune response##3##4##(2006-10#1)(2007-11#1)(2010-9#1)
the mucosal immune system##9##4##(2005-11#1)(2006-10#3)(2006-2#1)(2009-2#3)(2011-1#1)
the mucosal immune##13##3##(2005-11#1)(2006-10#5)(2006-2#1)(2007-11#1)(2009-2#3)(2010-9#1)(2011-1#1)
the mucosal layer##4##3##(2006-10#1)(2008-12#1)(2009-2#1)(2009-8#1)
the mucosal side##4##3##(1994-3#2)(2008-1#1)(2008-5#1)
the mucosal surface##3##3##(2008-4#1)(2008-5#1)(2011-1#1)
the mucosal##46##2##(1990-5#1)(1991-12#1)(1994-3#2)(1994-6#1)(1994-9#1)(1996-10#1)(1996-3#1)(1997-2#2)(2005-11#1)(2006-10#12)(2006-2#1)(2007-11#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2009-2#4)(2009-8#1)(2010-9#1)(2011-1#2)
the mucous barrier##2##3##(1997-1#2)
the mucous layer##2##3##(1997-1#1)(1997-2#1)
the mucous membrane##4##3##(2007-8#1)(2009-2#1)(2012-2#2)
the mucous##11##2##(1996-3#1)(1997-1#3)(1997-2#1)(2006-10#1)(2007-8#1)(2009-2#1)(2010-6#1)(2012-2#2)
the mucus gel##2##3##(2006-10#1)(2008-8#1)
the mucus##4##2##(1996-6#2)(2006-10#1)(2008-8#1)
the mullerian##2##2##(2007-7#1)(2010-12#1)
the multi##3##2##(2007-7#1)(2008-9#2)
the multi-bilinear model##2##3##(2008-10#2)
the multi-coil system##2##3##(2013-7#2)
the multi-drug resistance gene##2##4##(1991-8#2)
the multi-drug##3##2##(1991-8#2)(2012-2#1)
the multi-element determination in##2##4##(2008-10#2)
the multi-element determination##3##3##(2008-10#3)
the multi-element##4##2##(2008-10#4)
the multi-frequency laser##2##3##(2008-10#2)
the multi-level##2##2##(2006-10#1)(2012-11#1)
the multi-organ system##2##3##(1990-11#2)
the multi-organ##3##2##(1990-11#2)(2007-11#1)
the multi-resolution##2##2##(2008-10#1)(2010-2#1)
the multi-stage##3##2##(2007-7#1)(2009-3#1)(2013-8#1)
the multi-step##3##2##(2008-11#1)(2008-5#1)(2008-8#1)
the multicatalytic proteinase##3##3##(1990-2#2)(1994-5#1)
the multicategory##2##2##(2011-1#2)
the multicenter##4##2##(1991-7#1)(1997-5#1)(2006-11#1)(2008-11#1)
the multicentre trials##2##3##(1995-9#1)(2008-7#1)
the multicentre##3##2##(1995-9#1)(2008-7#1)(2010-3#1)
the multichannel acousto-optic Bragg cell##3##5##(2008-3#3)
the multichannel##10##2##(1997-6#1)(2005-4#1)(2007-12#1)(2008-2#3)(2008-3#4)
the multicommutation approach and##2##4##(2008-10#2)
the multicommutation approach##4##3##(2008-10#4)
the multicommutation##5##2##(2007-10#1)(2008-10#4)
the multicomponent##7##2##(1990-11#1)(1995-2#1)(1995-6#2)(2005-4#1)(2006-7#1)(2008-10#1)
the multicopy plasmid##4##3##(1990-1#1)(1990-11#1)(1993-11#1)(1995-5#1)
the multicopy suppressor gene##2##4##(1995-6#1)(1997-6#1)
the multicopy vector##2##3##(1990-10#1)(1990-4#1)
the multicopy##9##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-4#1)(1993-11#1)(1995-5#1)(1995-6#1)(1997-6#1)(2008-6#1)
the multicultural##2##2##(2004-12#1)(2008-5#1)
the multicystic dysplastic kidney##2##4##(2008-10#1)(2012-2#1)
the multicystic##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
the multidimensional nature of##2##4##(2007-9#1)(2010-6#1)
the multidimensional##12##2##(1995-3#1)(2006-1#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-1#1)
the multidisciplinary care##5##3##(2006-2#1)(2008-10#1)(2010-11#1)(2013-1#2)
the multidisciplinary team management of##2##5##(2012-2#2)
the multidisciplinary team##13##3##(1996-7#1)(2006-8#2)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#5)(2013-1#1)(2013-8#1)
the multidisciplinary##30##2##(1996-3#2)(1996-7#1)(2006-2#1)(2006-6#2)(2006-8#2)(2007-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-11#1)(2010-3#2)(2011-2#1)(2012-12#1)(2012-2#5)(2013-1#5)(2013-8#2)
the multidomain##2##2##(2008-10#1)(2008-7#1)
the multidrug resistance (MDR)##2##4##(1997-1#1)(2012-1#1)
the multidrug resistance phenotype##2##4##(2008-11#2)
the multidrug resistance##9##3##(1996-5#1)(1997-1#1)(2007-10#1)(2008-11#4)(2012-1#1)(2012-3#1)
the multidrug resistant##4##3##(1993-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
the multidrug transporter##2##3##(2008-11#1)(2008-7#1)
the multidrug##17##2##(1993-7#1)(1996-5#1)(1997-1#1)(2007-10#1)(2008-11#7)(2008-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
the multidrug-resistant phenotype##2##3##(1995-11#1)(2008-11#1)
the multidrug-resistant##5##2##(1992-6#1)(1995-10#1)(1995-11#1)(2004-1#1)(2008-11#1)
the multienzyme complex##2##3##(1991-10#2)
the multienzyme##3##2##(1991-10#3)
the multifaceted nature of##3##4##(2008-11#1)(2009-7#1)(2012-3#1)
the multifaceted##9##2##(2006-10#1)(2008-10#1)(2008-11#2)(2009-10#1)(2009-7#1)(2010-12#1)(2012-3#1)(2013-7#1)
the multifactorial##6##2##(1990-6#1)(2006-10#1)(2007-6#1)(2010-12#1)(2010-5#1)(2013-7#1)
the multifractal##3##2##(1992-1#1)(2008-8#2)
the multifunctional Ca2+/calmodulin-dependent##2##3##(1992-11#1)(1996-8#1)
the multifunctional##9##2##(1992-11#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-8#1)
the multigrasp##2##2##(2012-1#2)
the multilayer coating##5##3##(2008-2#4)(2008-3#1)
the multilayer grating##4##3##(2008-2#1)(2008-3#3)
the multilayer##26##2##(2005-11#1)(2007-12#3)(2008-10#1)(2008-2#8)(2008-3#12)(2013-1#1)
the multilayers##8##2##(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-2#1)
the multimedia##3##2##(2008-11#1)(2008-3#1)(2013-8#1)
the multimeric forms##2##3##(1997-4#1)(2008-4#1)
the multimeric##5##2##(1991-2#1)(1994-12#1)(1997-4#1)(2008-10#1)(2008-4#1)
the multimerization function of NifA central domain##2##7##(2008-9#2)
the multimerization##3##2##(2008-9#3)
the multimodal##2##2##(2008-12#1)(2009-6#1)
the multimodality##2##2##(2004-1#1)(2012-12#1)
the multimode fiber##2##3##(2007-12#2)
the multimode##8##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#3)
the multinational##2##2##(2004-7#1)(2008-7#1)
the multinomial##2##2##(2012-1#1)(2012-12#1)
the multiparametric##2##2##(2008-9#2)
the multiparas##2##2##(2008-4#2)
the multiphoton fluorescence##3##3##(2007-12#2)(2008-9#1)
the multiphoton##7##2##(1992-11#1)(1992-9#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-9#1)
the multiple and##2##3##(1996-3#1)(2011-1#1)
the multiple causes##2##3##(2007-12#1)(2011-2#1)
the multiple cell##2##3##(2006-10#2)
the multiple cloning site##3##4##(1993-11#1)(1995-8#1)(1997-4#1)
the multiple flow rates maneuver##2##5##(2010-6#2)
the multiple functions of##2##4##(1994-3#1)(1997-6#1)
the multiple harvest process##2##4##(2008-11#2)
the multiple needs of##3##4##(2007-8#1)(2012-12#1)(2012-2#1)
the multiple regression##4##3##(2008-10#2)(2009-7#1)(2010-12#1)
the multiple roles##2##3##(1996-3#1)(2013-1#1)
the multiple sites of##2##4##(1993-6#1)(2012-2#1)
the multiple sites##3##3##(1993-6#1)(1994-9#1)(2012-2#1)
the multiple ways##2##3##(2007-3#1)(2009-4#1)
the multiple##145##2##(1990-5#2)(1990-7#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-8#2)(1996-1#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-2#1)(1997-4#4)(1997-5#1)(1997-6#1)(1997-8#3)(2004-9#1)(2005-11#2)(2006-1#1)(2006-10#4)(2006-12#3)(2006-8#2)(2007-1#3)(2007-10#2)(2007-11#2)(2007-12#3)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-2#5)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#5)(2009-1#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#2)(2010-1#2)(2010-12#1)(2010-3#1)(2010-6#2)(2011-1#4)(2011-2#3)(2012-11#1)(2012-12#5)(2012-2#4)(2012-3#4)(2013-1#2)(2013-7#2)
the multiple-choice##2##2##(2012-1#2)
the multiple-reflection interference effect##2##4##(2008-1#2)
the multiple-reflection##3##2##(2008-1#2)(2008-3#1)
the multiple-scattering images##2##3##(2008-2#2)
the multiple-scattering##10##2##(2007-11#1)(2008-2#5)(2008-3#4)
the multiple-schedule-disrupter paradigm##2##3##(2010-10#2)
the multiplex PCR##2##3##(2011-2#2)
the multiplex real-time PCR##2##4##(2008-10#2)
the multiplex real-time##3##3##(2008-10#2)(2013-8#1)
the multiplex##8##2##(2008-10#3)(2010-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
the multiplexed##3##2##(2008-4#1)(2010-12#1)(2010-2#1)
the multiplexing##4##2##(2007-11#1)(2008-2#2)(2010-2#1)
the multiplication partial products##2##4##(2008-2#2)
the multiplication##4##2##(2007-1#1)(2008-2#2)(2010-11#1)
the multiplicative##3##2##(1996-3#1)(2007-12#1)(2008-11#1)
the multiplicity of factors##2##4##(1996-3#1)(2013-1#1)
the multiplicity of infection (MOI)##2##5##(1995-1#1)(2008-11#1)
the multiplicity of infection##3##4##(1995-1#1)(1997-3#1)(2008-11#1)
the multiplicity of the##2##4##(1997-4#1)(2007-8#1)
the multiplicity of##11##3##(1990-8#1)(1993-8#1)(1995-1#1)(1996-3#1)(1997-3#1)(1997-4#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-9#1)(2013-1#1)
the multiplicity##12##2##(1990-8#1)(1993-8#1)(1995-1#1)(1996-3#1)(1997-3#1)(1997-4#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2013-1#1)
the multiply scattered##2##3##(2007-12#1)(2008-2#1)
the multiply##3##2##(2006-10#1)(2007-12#1)(2008-2#1)
the multipolar##2##2##(2008-2#1)(2010-2#1)
the multipotent##2##2##(2008-5#1)(2012-12#1)
the multiprotein complex of DNA polymerase alpha##2##7##(1993-3#2)
the multiprotein##4##2##(1992-6#1)(1993-3#2)(1995-8#1)
the multiresolution histogram##2##3##(2008-6#2)
the multistage process##2##3##(2013-1#2)
the multistage##6##2##(1994-8#1)(1997-1#1)(2008-2#1)(2009-11#1)(2013-1#2)
the multitude of##5##3##(2007-11#1)(2007-12#1)(2008-4#1)(2008-5#1)(2013-8#1)
the multitude##6##2##(2007-11#1)(2007-12#1)(2008-4#1)(2008-5#2)(2013-8#1)
the multivalent##4##2##(1997-4#3)(2010-12#1)
the multivariable##3##2##(2007-11#1)(2007-4#1)(2013-8#1)
the multivariate analysis##12##3##(2006-6#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-2#4)(2012-2#1)
the multivariate calibration##3##3##(2008-10#3)
the multivariate relative##2##3##(1991-7#1)(1993-9#1)
the multivariate statistical##2##3##(2008-10#1)(2012-3#1)
the multivariate##37##2##(1991-7#1)(1992-6#1)(1993-9#2)(1994-11#1)(2006-6#2)(2007-11#1)(2007-8#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-12#1)(2009-4#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#3)
the multivitamin and##2##3##(1994-6#1)(2009-9#1)
the multivitamin##3##2##(1994-6#1)(2009-9#2)
the multiwavelength##4##2##(2007-12#1)(2008-10#1)(2008-3#2)
the municipal health services##2##4##(1993-8#2)
the municipal health##4##3##(1992-11#1)(1993-8#2)(2012-12#1)
the municipal##14##2##(1992-11#1)(1992-3#1)(1993-3#1)(1993-8#2)(2008-10#2)(2008-9#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)
the municipalities of##3##3##(1992-2#1)(2011-2#1)(2012-12#1)
the municipalities##14##2##(1990-10#2)(1991-6#1)(1992-2#1)(1992-3#2)(1993-8#1)(1996-6#1)(2006-12#1)(2008-9#1)(2011-2#1)(2012-12#3)
the municipality of Nordkapp##2##4##(1995-6#2)
the municipality of##15##3##(1990-6#1)(1991-9#1)(1992-10#1)(1993-5#1)(1993-9#2)(1995-6#3)(1997-4#1)(2010-9#1)(2011-2#1)(2012-12#2)(2013-7#1)
the municipality##27##2##(1990-6#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-3#2)(1993-5#1)(1993-8#3)(1993-9#2)(1995-6#3)(1997-4#1)(2007-2#1)(2008-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-3#1)(2013-7#1)
the mural##5##2##(1991-12#1)(2008-12#1)(2008-5#1)(2012-12#2)
the murder of##3##3##(2004-12#1)(2008-12#1)(2009-2#1)
the murine GLUT2 promoter##2##4##(1995-10#2)
the murine GM-CSF##2##3##(1994-12#2)
the murine T cell line##2##5##(1994-5#1)(2008-4#1)
the murine and human##3##4##(1993-2#1)(1994-8#1)(1996-10#1)
the murine and##4##3##(1990-11#1)(1993-2#1)(1994-8#1)(1996-10#1)
the murine cDNA##2##3##(1990-5#1)(1997-7#1)
the murine enzyme##2##3##(1992-4#1)(1994-3#1)
the murine genome##2##3##(1991-2#1)(1992-7#1)
the murine leukemia##3##3##(1991-12#1)(1991-9#1)(1996-4#1)
the murine lysosomal##2##3##(1997-8#2)
the murine major histocompatibility complex##2##5##(1995-1#1)(2008-4#1)
the murine model of##3##4##(2007-5#1)(2008-4#1)(2010-12#1)
the murine promoter##2##3##(1991-6#1)(1993-9#1)
the murine##113##2##(1990-11#2)(1990-5#5)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-2#3)(1993-3#1)(1993-6#1)(1993-9#4)(1994-11#2)(1994-12#4)(1994-3#5)(1994-5#3)(1994-8#2)(1994-9#2)(1995-1#4)(1995-10#2)(1995-11#1)(1995-2#1)(1995-3#4)(1995-5#3)(1995-6#1)(1996-10#6)(1996-4#2)(1996-5#9)(1996-7#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#4)(2006-10#1)(2007-1#1)(2007-11#1)(2007-5#1)(2008-11#4)(2008-4#6)(2008-5#1)(2008-9#2)(2010-12#1)(2012-2#2)(2013-8#1)
the muscarinic agonist##2##3##(1991-9#1)(1993-12#1)
the muscarinic receptor antagonist##3##4##(1996-12#1)(1996-2#1)(1997-1#1)
the muscarinic receptor##7##3##(1990-2#1)(1994-2#2)(1995-11#1)(1996-12#1)(1996-2#1)(1997-1#1)
the muscarinic response##4##3##(1994-2#4)
the muscarinic##23##2##(1990-2#1)(1990-5#2)(1990-9#1)(1991-9#1)(1992-7#1)(1993-12#1)(1994-2#7)(1995-11#1)(1995-3#1)(1995-7#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-4#1)(2009-2#1)(2011-2#1)
the muscle 12##2##3##(2008-5#2)
the muscle activity##3##3##(2008-5#3)
the muscle and##8##3##(1990-5#1)(1992-11#1)(1997-4#1)(2007-1#1)(2008-5#2)(2012-2#1)(2012-3#1)
the muscle cell surface##2##4##(1996-3#2)
the muscle cell##3##3##(1996-3#3)
the muscle cells##3##3##(1993-6#1)(2005-10#2)
the muscle enzyme##2##3##(1990-3#1)(1990-8#1)
the muscle fibers##7##3##(1995-3#1)(2006-4#1)(2008-2#1)(2009-10#1)(2010-12#2)(2013-1#1)
the muscle membrane##3##3##(1997-6#1)(2006-2#1)(2009-10#1)
the muscle potential latency in head magnetic stimulation##2##8##(2008-7#2)
the muscle potential latency##3##4##(2008-7#3)
the muscle potential##4##3##(2008-7#4)
the muscle potentials##2##3##(2008-7#2)
the muscle strength of the##2##5##(2007-7#1)(2008-3#1)
the muscle strength##3##3##(2007-7#2)(2008-3#1)
the muscle tissue##6##3##(1990-5#1)(1992-9#1)(2009-3#1)(2011-1#1)(2012-12#1)(2013-1#1)
the muscle to##2##3##(1995-6#1)(2005-10#1)
the muscle##111##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-3#2)(1992-8#3)(1992-9#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-3#4)(1996-5#2)(1996-9#2)(1997-2#1)(1997-4#1)(1997-6#1)(2004-11#1)(2005-1#1)(2005-10#5)(2006-10#1)(2006-2#1)(2006-4#1)(2007-1#1)(2007-12#3)(2007-6#1)(2007-7#3)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#10)(2008-6#2)(2008-7#7)(2008-8#1)(2009-10#2)(2009-12#1)(2009-3#4)(2009-9#1)(2010-12#4)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#1)
the muscle-specific##2##2##(1993-8#1)(1996-2#1)
the muscles and##4##3##(2007-12#1)(2007-7#1)(2009-3#1)(2012-2#1)
the muscles in the##2##4##(2007-12#1)(2007-8#1)
the muscles in##4##3##(1990-4#1)(2007-12#1)(2007-8#1)(2010-4#1)
the muscles of the neck##2##5##(2006-11#1)(2010-9#1)
the muscles of the##10##4##(1995-5#1)(1996-8#1)(2006-11#1)(2007-12#2)(2008-10#1)(2008-9#2)(2010-9#1)(2013-8#1)
the muscles of##15##3##(1995-5#1)(1996-8#1)(2006-11#1)(2007-12#4)(2008-10#1)(2008-9#2)(2010-12#1)(2010-4#1)(2010-9#1)(2013-1#1)(2013-8#1)
the muscles surrounding the##2##4##(2007-11#1)(2009-1#1)
the muscles were##2##3##(2010-4#2)
the muscles##44##2##(1990-4#1)(1991-1#1)(1994-2#1)(1995-5#1)(1995-9#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-4#1)(2006-11#2)(2007-11#1)(2007-12#6)(2007-4#1)(2007-7#3)(2007-8#3)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#2)(2009-1#1)(2009-3#1)(2010-12#1)(2010-4#5)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
the muscular fascia##2##3##(2009-1#1)(2012-12#1)
the muscular portion##3##3##(2008-9#2)(2013-1#1)
the muscular##32##2##(1991-5#1)(1997-5#1)(2007-1#2)(2007-11#1)(2007-12#4)(2007-4#1)(2008-5#4)(2008-6#2)(2008-8#1)(2008-9#3)(2009-1#2)(2009-10#1)(2009-3#1)(2010-12#1)(2010-6#1)(2012-12#2)(2012-2#2)(2013-1#2)
the muscularis##5##2##(1995-9#1)(2008-5#2)(2012-12#1)(2013-1#1)
the musculature of the pelvic limb##2##6##(2005-7#2)
the musculature of the##3##4##(2005-7#2)(2007-12#1)
the musculature##7##2##(1993-3#1)(2005-7#2)(2006-12#1)(2007-12#1)(2011-2#2)
the musculo-skeletal system##2##3##(2007-8#2)
the musculoskeletal system are##3##4##(2007-11#1)(2012-12#2)
the musculoskeletal system##14##3##(1990-6#1)(1997-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-3#1)(2010-9#1)(2012-12#4)
the musculoskeletal##21##2##(1990-6#1)(1997-6#1)(2006-10#1)(2006-2#3)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-3#2)(2010-9#1)(2012-12#4)
the musculotendinous junction##4##3##(2009-3#1)(2013-1#1)(2013-7#2)
the musculotendinous##5##2##(2007-8#1)(2009-3#1)(2013-1#1)(2013-7#2)
the mushroom bodies of##2##4##(2007-12#2)
the mushroom bodies##7##3##(2007-12#7)
the mushroom body##3##3##(2007-12#3)
the mushroom##16##2##(1994-2#2)(1995-2#1)(2007-12#10)(2008-10#1)(2008-11#1)(2011-2#1)
the mushrooms##3##2##(1994-9#1)(1995-7#1)(2008-5#1)
the music and##2##3##(2007-6#1)(2011-2#1)
the music##10##2##(2007-6#3)(2007-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#2)
the musk##2##2##(2006-12#2)
the mussel##3##2##(1992-6#1)(2008-10#1)(2010-8#1)
the mutagenesis##3##2##(1994-9#1)(2008-4#1)(2012-3#1)
the mutagenic##10##2##(1993-11#1)(1993-3#1)(1993-9#2)(1997-4#1)(2008-10#2)(2008-11#1)(2008-4#2)
the mutagenicity of##2##3##(1992-9#1)(1993-9#1)
the mutagenicity##6##2##(1992-5#1)(1992-9#1)(1993-9#2)(1997-1#1)(2011-2#1)
the mutagenized##3##2##(1994-3#1)(1995-2#1)(1997-8#1)
the mutant allele##8##3##(1990-8#1)(1991-12#1)(1992-1#1)(1994-2#1)(1996-6#1)(2006-10#1)(2008-10#1)(2008-4#1)
the mutant alpha 1-PI cDNA and the##2##7##(1990-8#2)
the mutant and the wild type##2##6##(2008-10#2)
the mutant and the##3##4##(1994-11#1)(2008-10#2)
the mutant and wild-type##2##4##(1995-5#1)(2008-10#1)
the mutant and##8##3##(1991-9#1)(1994-11#1)(1995-5#1)(2008-10#5)
the mutant behaved##2##3##(2006-12#1)(2006-3#1)
the mutant cells showed##2##4##(1991-7#1)(1993-3#1)
the mutant cells##14##3##(1991-5#1)(1991-7#1)(1991-8#1)(1993-3#1)(1994-3#1)(1996-5#1)(2006-8#7)(2013-8#1)
the mutant characteristics and##2##4##(2008-8#1)(2013-8#1)
the mutant characteristics##3##3##(2008-8#2)(2013-8#1)
the mutant enzyme had##2##4##(1990-10#1)(1992-3#1)
the mutant enzyme to##2##4##(1990-9#1)(1995-6#1)
the mutant enzyme was##2##4##(1990-12#1)(1992-3#1)
the mutant enzyme##17##3##(1990-10#2)(1990-12#1)(1990-9#1)(1992-3#3)(1992-6#1)(1992-9#1)(1993-6#1)(1995-2#2)(1995-6#2)(1996-5#1)(1997-4#1)(1997-7#1)
the mutant enzymes were##4##4##(1995-2#1)(1995-5#1)(1997-3#1)(2013-8#1)
the mutant enzymes##11##3##(1992-6#1)(1994-11#1)(1995-11#1)(1995-2#1)(1995-5#1)(1997-3#1)(1997-5#1)(1997-6#2)(2013-8#2)
the mutant failed to##2##4##(2008-10#2)
the mutant hemoglobin##2##3##(1990-7#1)(1994-9#1)
the mutant in##3##3##(1992-9#1)(2007-12#1)(2008-10#1)
the mutant is##4##3##(1994-11#1)(1995-1#2)(2008-8#1)
the mutant mice##8##3##(1993-12#1)(1994-12#3)(1995-12#1)(1997-7#2)(2008-8#1)
the mutant mouse##4##3##(1991-8#1)(1994-10#1)(1995-11#1)(2008-2#1)
the mutant phenotype was##2##4##(1990-8#1)(2008-10#1)
the mutant phenotype##4##3##(1990-8#1)(1996-3#1)(2008-10#1)(2012-3#1)
the mutant protein is##2##4##(1994-9#1)(1995-3#1)
the mutant protein##10##3##(1990-3#1)(1991-12#1)(1994-9#2)(1995-1#1)(1995-3#1)(1995-6#1)(1996-2#1)(2009-8#1)(2011-1#1)
the mutant proteins in##3##4##(1990-9#1)(1994-12#1)(2011-1#1)
the mutant proteins were##5##4##(1990-12#1)(1991-2#1)(1992-2#1)(1994-6#1)(1996-2#1)
the mutant proteins##12##3##(1990-12#1)(1990-9#1)(1991-2#1)(1992-2#1)(1993-11#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-2#1)(2011-1#2)
the mutant receptor##4##3##(1992-12#1)(1995-10#1)(1995-7#1)(1996-2#1)
the mutant receptors##2##3##(1994-12#1)(1995-6#1)
the mutant strain##6##3##(1995-6#1)(2008-10#3)(2011-2#1)(2012-2#1)
the mutant strains##10##3##(1990-5#2)(1991-7#1)(1992-6#1)(1995-6#1)(2006-9#1)(2008-10#2)(2008-7#1)(2011-1#1)
the mutant to##3##3##(1994-11#1)(1995-5#1)(2008-10#1)
the mutant was##4##3##(1990-12#1)(1994-11#1)(1994-9#1)(2007-12#1)
the mutant##262##2##(1990-10#3)(1990-12#6)(1990-3#2)(1990-5#4)(1990-7#1)(1990-8#4)(1990-9#2)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#4)(1991-6#1)(1991-7#4)(1991-8#3)(1991-9#2)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#5)(1992-4#2)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#1)(1992-9#3)(1993-11#3)(1993-12#2)(1993-3#2)(1993-6#4)(1994-10#1)(1994-11#9)(1994-12#9)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#5)(1995-1#6)(1995-10#2)(1995-11#6)(1995-12#1)(1995-2#5)(1995-3#1)(1995-5#6)(1995-6#7)(1995-7#1)(1995-8#4)(1996-11#1)(1996-2#4)(1996-3#1)(1996-5#3)(1996-6#2)(1996-7#1)(1996-9#1)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#2)(2006-10#1)(2006-12#2)(2006-3#2)(2006-8#11)(2006-9#1)(2007-12#3)(2008-10#27)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#9)(2008-9#3)(2009-10#1)(2009-8#1)(2011-1#4)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#6)
the mutant's##4##2##(1991-4#1)(1992-6#1)(1993-8#1)(1995-10#1)
the mutants had##2##3##(1993-7#1)(1995-2#1)
the mutants than in##2##4##(1997-1#1)(2008-7#1)
the mutants than##3##3##(1997-1#1)(2008-10#1)(2008-7#1)
the mutants were##4##3##(1992-12#1)(1996-4#1)(2008-7#1)(2009-12#1)
the mutants with##2##3##(1995-1#1)(2008-10#1)
the mutants##75##2##(1990-12#1)(1990-8#1)(1991-2#3)(1991-4#1)(1992-12#1)(1992-7#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#2)(1995-1#6)(1995-10#1)(1995-11#1)(1995-2#2)(1995-4#1)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(2008-10#7)(2008-12#1)(2008-7#4)(2008-9#4)(2009-12#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#1)
the mutated gene##2##3##(2008-2#1)(2009-10#1)
the mutated protein##4##3##(1991-9#1)(1993-12#1)(1996-5#1)(2008-11#1)
the mutated sites##2##3##(2008-9#1)(2012-11#1)
the mutated##29##2##(1990-4#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-11#1)(1992-4#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-6#1)(1994-9#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2012-11#1)(2013-8#1)
the mutation 173T##2##3##(2006-8#2)
the mutation and##4##3##(1991-6#1)(1991-9#1)(1995-1#1)(2012-11#1)
the mutation at nucleotide##2##4##(1994-11#1)(2007-6#1)
the mutation at##3##3##(1994-11#1)(1996-5#1)(2007-6#1)
the mutation frequency##6##3##(1991-8#1)(1997-3#5)
the mutation in the##7##4##(1990-12#1)(1995-5#1)(1995-6#1)(1996-6#1)(2008-9#1)(2010-3#1)(2012-12#1)
the mutation in##16##3##(1990-12#1)(1990-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1995-5#1)(1995-6#2)(1996-6#1)(1996-7#1)(2008-9#1)(2010-3#1)(2010-9#1)(2012-12#1)(2013-8#1)
the mutation is##3##3##(1991-9#1)(1997-4#1)(2008-12#1)
the mutation may##2##3##(1990-8#1)(1993-8#1)
the mutation of a##2##4##(1994-3#1)(2011-1#1)
the mutation of the##2##4##(1995-8#1)(1997-2#1)
the mutation of##8##3##(1994-3#1)(1994-9#1)(1995-8#1)(1997-2#1)(1997-7#1)(2007-10#1)(2008-8#1)(2011-1#1)
the mutation rate##2##3##(1990-11#1)(2007-4#1)
the mutation rates were##3##4##(1996-4#1)(1997-7#1)(2008-12#1)
the mutation rates##4##3##(1990-8#1)(1996-4#1)(1997-7#1)(2008-12#1)
the mutation responsible for##2##4##(1991-7#1)(1996-4#1)
the mutation site##3##3##(1997-2#1)(2008-10#1)(2013-1#1)
the mutation was##5##3##(1995-12#1)(1996-5#1)(1996-6#1)(2006-10#1)(2006-8#1)
the mutation##113##2##(1990-11#1)(1990-12#3)(1990-2#2)(1990-5#1)(1990-6#2)(1990-8#2)(1991-4#1)(1991-6#2)(1991-7#4)(1991-8#3)(1991-9#2)(1992-1#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-10#1)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#2)(1995-1#4)(1995-11#1)(1995-12#1)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-4#2)(1996-5#5)(1996-6#2)(1996-7#1)(1997-2#2)(1997-3#6)(1997-4#1)(1997-7#4)(2006-10#2)(2006-12#1)(2006-8#5)(2007-10#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-12#5)(2008-8#2)(2008-9#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
the mutation(s)##2##2##(1995-6#1)(1997-2#1)
the mutational effect of##2##4##(2008-7#2)
the mutational##4##2##(1997-4#1)(2008-7#2)(2009-5#1)
the mutationally altered enzymes##2##4##(1990-8#2)
the mutationally altered##3##3##(1990-8#3)
the mutationally##4##2##(1990-8#3)(1996-4#1)
the mutations are##3##3##(1994-9#1)(1997-2#1)(2012-12#1)
the mutations causing##2##3##(1992-1#1)(1992-10#1)
the mutations in the Modulatory##2##5##(2013-1#2)
the mutations in the##4##4##(1995-1#1)(2012-12#1)(2013-1#2)
the mutations in##6##3##(1991-10#1)(1995-1#1)(2007-2#1)(2012-12#1)(2013-1#2)
the mutations of the##3##4##(1991-9#1)(2008-10#1)(2011-1#1)
the mutations of##6##3##(1991-9#1)(1993-3#1)(1995-5#1)(2008-10#1)(2011-1#1)(2013-1#1)
the mutations that##2##3##(1996-9#1)(1997-5#1)
the mutations were##2##3##(1995-2#1)(2008-8#1)
the mutations##55##2##(1990-12#1)(1990-8#2)(1991-10#2)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-2#3)(1995-5#1)(1995-6#5)(1996-4#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-5#1)(2007-2#1)(2008-10#2)(2008-8#2)(2009-3#1)(2011-1#3)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#3)
the mutator##4##2##(1996-4#2)(2008-7#1)(2010-12#1)
the mutual coherence##2##3##(2007-11#1)(2007-12#1)
the mutual coupling##3##3##(2007-11#1)(2007-12#1)(2013-7#1)
the mutual influence##2##3##(2008-1#1)(2008-10#1)
the mutual information between##2##4##(2008-1#1)(2008-7#1)
the mutual information##4##3##(2008-1#1)(2008-2#1)(2008-7#1)(2010-8#1)
the mutual intensity of a##2##5##(2007-12#2)
the mutual intensity##3##3##(2007-12#3)
the mutual interaction of##2##4##(2007-12#1)(2008-9#1)
the mutual interactions between##2##4##(1990-11#1)(2006-10#1)
the mutual interactions##3##3##(1990-11#1)(2006-10#2)
the mutual interference of rare earth elements##2##7##(2005-4#2)
the mutual interference of##3##4##(2005-4#2)(2008-3#1)
the mutual##37##2##(1990-11#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(2005-4#2)(2005-7#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#6)(2008-1#2)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2010-8#1)(2013-7#1)
the mutualism##2##2##(2008-8#1)(2012-12#1)
the mutually##2##2##(2007-12#1)(2008-3#1)
the myc##3##2##(1990-9#1)(1991-7#1)(1996-2#1)
the mycelial growth##3##3##(2008-10#2)(2008-6#1)
the mycelial##6##2##(2008-10#4)(2008-5#1)(2008-6#1)
the mycelium of the##2##4##(2008-10#1)(2008-4#1)
the mycelium of##4##3##(2008-10#3)(2008-4#1)
the mycelium was##2##3##(2008-10#2)
the mycelium##14##2##(1996-2#1)(2007-7#1)(2008-10#10)(2008-4#1)(2008-7#1)
the mycobacteria##2##2##(2007-7#1)(2011-2#1)
the mycobacterial##4##2##(1995-5#2)(2008-9#1)(2012-2#1)
the mycobacterium##2##2##(2006-10#1)(2011-1#1)
the mycobionts##2##2##(2008-1#2)
the mycoherbicide##3##2##(2008-10#3)
the mycoparasite##4##2##(2008-10#4)
the mycorrhizal fungus##2##3##(2011-1#1)(2011-12#1)
the mycorrhizal##4##2##(1997-4#1)(2008-10#1)(2011-1#1)(2011-12#1)
the mycorrhizosphere##3##2##(2008-10#3)
the mycotoxin##4##2##(1990-12#1)(2008-10#3)
the mycotoxins##2##2##(2010-3#1)(2010-7#1)
the myelin oligodendrocyte glycoprotein##2##4##(1996-12#2)
the myelin sheath##4##3##(2006-8#1)(2008-7#3)
the myelin##7##2##(1996-12#2)(2006-8#1)(2008-7#4)
the myelinated axons##2##3##(1991-10#1)(2008-4#1)
the myelinated##4##2##(1991-10#1)(1996-7#1)(2008-4#1)(2008-5#1)
the myelination##5##2##(1996-5#2)(2008-5#1)(2008-7#1)(2008-8#1)
the myeloid##5##2##(1992-3#1)(2007-11#1)(2008-11#2)(2009-3#1)
the myeloma##7##2##(1993-7#2)(1997-7#1)(2008-1#2)(2008-11#1)(2008-3#1)
the myenteric neurons##2##3##(1992-8#1)(1993-11#1)
the myenteric plexus and##2##4##(1995-3#1)(1997-4#1)
the myenteric plexus##9##3##(1992-8#2)(1993-11#1)(1995-3#1)(1995-5#1)(1997-1#1)(1997-4#1)(2006-10#1)(2009-4#1)
the myenteric##14##2##(1992-8#3)(1993-11#2)(1995-3#2)(1995-5#1)(1997-1#1)(1997-4#1)(2006-10#1)(2009-12#1)(2009-4#1)(2013-8#1)
the mylohyoid muscle##3##3##(2012-1#3)
the myocardial beta-adrenergic receptor##2##4##(1997-6#2)
the myocardial calcium##2##3##(1992-9#1)(1996-9#1)
the myocardial cell##2##3##(1991-9#1)(2004-11#1)
the myocardial infarction##4##3##(1991-9#1)(1997-3#1)(2012-1#1)(2012-2#1)
the myocardial microcirculation##2##3##(2006-6#1)(2011-2#1)
the myocardial tissue##2##3##(2007-8#1)(2013-1#1)
the myocardial##29##2##(1991-1#1)(1991-9#3)(1992-4#1)(1992-9#1)(1995-6#1)(1996-9#1)(1997-3#1)(1997-6#2)(2004-11#1)(2006-6#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#2)
the myocardium after##2##3##(2012-1#1)(2012-2#1)
the myocardium and##4##3##(1990-2#1)(2005-1#1)(2008-7#1)(2011-2#1)
the myocardium during##3##3##(1996-9#1)(2010-12#1)(2012-1#1)
the myocardium following##2##3##(2004-11#1)(2010-6#1)
the myocardium in patients##2##4##(2007-8#1)(2011-2#1)
the myocardium in##3##3##(2007-8#1)(2010-12#1)(2011-2#1)
the myocardium is##3##3##(1990-9#1)(2007-8#1)(2012-1#1)
the myocardium of##4##3##(1994-7#1)(1996-6#1)(1996-9#1)(2013-7#1)
the myocardium##65##2##(1990-2#1)(1990-9#2)(1991-9#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-10#2)(1993-7#1)(1994-6#1)(1994-7#2)(1996-6#2)(1996-9#5)(2004-11#1)(2005-1#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-2#1)(2007-3#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#4)(2008-8#1)(2010-1#1)(2010-12#8)(2010-6#1)(2010-8#1)(2011-2#3)(2012-1#4)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
the myoclonus##4##2##(1991-12#1)(2008-11#3)
the myocyte and##2##3##(1995-8#1)(2006-6#1)
the myocyte##3##2##(1995-8#1)(2006-6#1)(2007-9#1)
the myocytes##4##2##(1990-3#1)(1990-9#1)(1993-3#1)(1994-12#1)
the myoelectric##2##2##(2008-9#1)(2012-1#1)
the myofibrillar##4##2##(1993-12#1)(1994-3#1)(1996-11#1)(2008-5#1)
the myofibrils##3##2##(1994-3#1)(2009-7#2)
the myofibroblast##4##2##(1994-6#1)(2009-3#1)(2009-8#1)(2012-12#1)
the myofilaments##2##2##(1991-12#1)(2007-12#1)
the myogenic activity of##2##4##(1993-8#1)(2008-5#1)
the myogenic cells##2##3##(1992-8#2)
the myogenic factors##2##3##(1995-6#2)
the myogenic##13##2##(1990-8#1)(1992-5#1)(1992-8#2)(1993-12#1)(1993-5#1)(1993-8#1)(1995-6#2)(2005-10#1)(2008-11#1)(2008-5#2)
the myoglobin##2##2##(1990-5#1)(1993-6#1)
the myoid##2##2##(2009-10#2)
the myometrium##7##2##(1994-3#1)(2006-5#1)(2008-8#1)(2010-12#3)(2013-7#1)
the myosin head in##2##4##(1994-11#2)
the myosin head##7##3##(1994-11#3)(1995-3#1)(1997-4#3)
the myosin heads##4##3##(1990-4#1)(1997-4#3)
the myosin heavy chain##3##4##(1997-6#1)(2008-5#1)(2008-9#1)
the myosin motor##2##3##(1996-11#1)(1996-4#1)
the myosin##29##2##(1990-4#1)(1990-5#1)(1991-10#1)(1991-2#1)(1992-4#1)(1992-5#2)(1993-12#1)(1993-6#1)(1994-11#4)(1994-8#2)(1995-3#1)(1996-11#2)(1996-4#1)(1997-4#6)(1997-6#2)(2008-5#1)(2008-9#1)
the myostatin gene on##2##4##(2010-4#2)
the myostatin gene##3##3##(2010-4#3)
the myotendinous##2##2##(2012-12#1)(2013-7#1)
the myotonic dystrophy##3##3##(1994-9#2)(2008-8#1)
the myotubes##3##2##(1994-11#2)(2012-12#1)
the myriad of##7##3##(1995-2#1)(2006-10#1)(2006-5#1)(2006-8#1)(2008-9#1)(2010-1#1)(2011-2#1)
the myriad##8##2##(1992-4#1)(1995-2#1)(2006-10#1)(2006-5#1)(2006-8#1)(2008-9#1)(2010-1#1)(2011-2#1)
the myristoylated##4##2##(1990-10#1)(1990-12#1)(1991-7#2)
the myristoylation of##2##3##(1990-10#1)(1990-12#1)
the myristoylation##3##2##(1990-10#1)(1990-12#2)
the mysteries of##2##3##(1997-1#1)(2009-10#1)
the mysteries##3##2##(1995-4#1)(1997-1#1)(2009-10#1)
the mysterious##5##2##(2005-10#1)(2007-8#1)(2007-9#2)(2012-2#1)
the mystery of##5##3##(1990-10#1)(2005-10#1)(2007-11#1)(2010-8#1)(2011-2#1)
the mystery##7##2##(1990-10#1)(1990-11#1)(2005-10#1)(2007-11#1)(2010-8#1)(2011-2#1)(2013-8#1)
the myth of##2##3##(1991-6#1)(2008-11#1)
the myth##4##2##(1991-6#1)(1993-3#1)(2007-5#1)(2008-11#1)
the myths##4##2##(1991-6#1)(1997-1#1)(2006-5#1)(2009-7#1)
the müllerian##2##2##(1995-11#2)
the n##12##2##(1990-4#3)(1991-7#1)(1991-9#1)(1994-5#1)(1995-4#1)(1996-1#1)(1996-2#1)(2007-12#1)(2008-2#1)(2008-3#1)
the n-3 PUFA content##2##4##(2013-1#2)
the n-3##5##2##(1994-2#1)(1997-2#1)(2004-11#1)(2013-1#2)
the n-6/n-3##3##2##(2010-4#2)(2013-1#1)
the n-back task##3##3##(2006-9#2)(2012-2#1)
the n-butanol fraction##2##3##(2008-10#2)
the n10##3##2##(2011-1#3)
the nTP process##2##3##(2009-2#2)
the nadD gene##2##3##(2013-1#2)
the nadir of##3##3##(1990-10#1)(1997-6#1)(2011-1#1)
the nadir##6##2##(1990-10#1)(1997-6#1)(2008-2#1)(2008-3#1)(2011-1#2)
the nafion layer##2##3##(2008-10#2)
the nafion##3##2##(2008-10#3)
the nail matrix##2##3##(2008-5#1)(2010-6#1)
the nail plate##6##3##(2006-12#3)(2007-7#1)(2008-5#2)
the nail##30##2##(2005-11#1)(2006-12#4)(2006-3#1)(2007-7#1)(2007-8#2)(2008-4#1)(2008-5#13)(2008-9#1)(2009-2#2)(2010-5#1)(2010-6#1)(2013-1#1)(2013-8#1)
the nails##4##2##(2007-7#1)(2011-2#3)
the naive##5##2##(1991-12#1)(1993-12#1)(1995-7#1)(2008-6#1)(2009-3#1)
the naked eye##8##3##(1996-12#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#2)(2013-7#1)
the naked siRNA##2##3##(2012-3#2)
the naked##15##2##(1996-12#1)(1997-7#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-8#2)(2011-2#1)(2012-3#2)(2013-7#1)
the name Tomato##2##3##(2008-10#2)
the name and##2##3##(1990-9#1)(2010-4#1)
the name of the##9##4##(1990-11#1)(1992-5#1)(1992-8#1)(1993-12#1)(1995-3#1)(2007-11#1)(2007-12#1)(2011-1#1)(2012-11#1)
the name of##18##3##(1990-11#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#2)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#3)(2009-2#1)(2011-1#1)(2011-2#1)(2012-11#2)(2013-8#1)
the name##60##2##(1990-11#1)(1990-9#2)(1991-7#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#2)(1995-3#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-10#22)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#3)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
the names are##2##3##(2008-7#2)
the names of##5##3##(1996-12#1)(2005-10#1)(2008-10#1)(2008-9#1)(2012-3#1)
the names##9##2##(1996-12#1)(2005-10#1)(2006-10#2)(2008-10#1)(2008-7#2)(2008-9#1)(2012-3#1)
the nano##2##2##(2007-2#1)(2010-9#1)
the nano-bioprinting system##2##3##(2010-9#2)
the nano-scale##2##2##(2008-10#1)(2010-9#1)
the nanoESI-IMS##2##2##(2013-8#2)
the nanocages##2##2##(2008-4#2)
the nanochannels##2##2##(2008-7#2)
the nanocomposites##4##2##(2007-8#2)(2008-10#1)(2008-8#1)
the nanocrystal##2##2##(2009-2#1)(2013-8#1)
the nanocrystalline##3##2##(2008-10#2)(2008-2#1)
the nanocrystals is##2##3##(2007-11#1)(2009-2#1)
the nanocrystals##9##2##(2006-12#1)(2007-11#2)(2008-10#1)(2008-7#1)(2009-2#2)(2012-11#2)
the nanofibers##3##2##(2006-12#1)(2009-12#1)(2009-2#1)
the nanofilter##3##2##(2008-10#3)
the nanogap sensor##2##3##(2013-1#2)
the nanogap##4##2##(2013-1#4)
the nanogram level of reactants##2##5##(2008-10#2)
the nanogram level##5##3##(2008-10#4)(2013-7#1)
the nanogram##7##2##(2008-10#4)(2008-2#1)(2008-4#1)(2013-7#1)
the nanomedicine##2##2##(2011-2#1)(2012-3#1)
the nanometer level##4##3##(2008-2#2)(2008-3#1)(2008-7#1)
the nanometer scale and##2##4##(2007-9#1)(2009-12#1)
the nanometer scale##7##3##(2006-6#1)(2007-12#1)(2007-9#1)(2008-2#1)(2009-11#1)(2009-12#1)(2010-1#1)
the nanometer##15##2##(2006-5#2)(2006-6#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-2#3)(2008-3#1)(2008-7#1)(2009-11#2)(2009-12#1)(2010-1#1)
the nanometer-scale##2##2##(2007-12#1)(2008-5#1)
the nanometre scale##2##3##(2006-2#1)(2008-7#1)
the nanometre##3##2##(2006-2#2)(2008-7#1)
the nanomolar concentration range##2##4##(1990-12#2)
the nanomolar concentration##3##3##(1990-12#2)(2008-10#1)
the nanomolar range##10##3##(1992-12#1)(1993-3#1)(1994-2#1)(1994-5#1)(1995-5#1)(2005-7#1)(2006-12#2)(2008-10#1)(2009-7#1)
the nanomolar##15##2##(1990-12#2)(1992-12#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-5#1)(2005-7#1)(2006-12#2)(2008-10#2)(2008-4#1)(2009-7#1)
the nanoparticle##6##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-12#1)(2011-2#1)
the nanoparticles and##5##3##(2005-11#1)(2007-8#1)(2008-4#1)(2009-11#1)(2009-3#1)
the nanoparticles are##4##3##(2008-10#1)(2008-7#1)(2009-2#1)(2010-7#1)
the nanoparticles##36##2##(2005-11#3)(2007-8#4)(2008-10#6)(2008-4#1)(2008-7#7)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#1)(2010-1#2)(2010-12#1)(2010-2#2)(2010-7#2)(2012-1#1)(2012-11#1)
the nanopillars##2##2##(2009-11#1)(2010-4#1)
the nanopore##6##2##(2008-7#2)(2009-11#1)(2009-7#2)(2010-2#1)
the nanoscale and##2##3##(2008-7#1)(2010-4#1)
the nanoscale level##2##3##(2007-12#1)(2009-4#1)
the nanoscale##26##2##(2006-12#4)(2006-6#1)(2007-12#1)(2007-9#1)(2008-4#1)(2008-7#7)(2009-11#2)(2009-2#1)(2009-4#1)(2009-5#1)(2010-4#2)(2010-7#2)(2012-2#2)
the nanosecond time##3##3##(1990-8#2)(1994-9#1)
the nanosecond##6##2##(1990-8#2)(1992-7#1)(1994-11#1)(1994-9#1)(2008-10#1)
the nanosensor##2##2##(2008-10#2)
the nanosheets##3##2##(2008-10#3)
the nanoshells##3##2##(2010-4#1)(2013-1#2)
the nanospheres##3##2##(2007-8#1)(2010-4#1)(2011-2#1)
the nanospikes##2##2##(2010-4#2)
the nanostructure of the##2##4##(2008-10#1)(2008-3#1)
the nanostructure of##4##3##(2006-2#1)(2008-10#1)(2008-3#1)(2012-2#1)
the nanostructure##9##2##(2006-12#1)(2006-2#1)(2007-8#2)(2008-10#2)(2008-3#1)(2010-4#1)(2012-2#1)
the nanostructures##6##2##(2005-11#1)(2009-12#1)(2010-12#1)(2010-4#3)
the nanotechnology##3##2##(1991-11#1)(2007-8#1)(2013-1#1)
the nanotube wall##2##3##(2008-10#1)(2008-7#1)
the nanotube##11##2##(2005-11#1)(2007-9#1)(2008-10#2)(2008-7#5)(2009-2#1)(2009-9#1)
the nanotubes##12##2##(2006-12#2)(2008-3#1)(2008-7#5)(2009-6#1)(2009-9#2)(2010-7#1)
the nanowire##2##2##(2008-7#2)
the nanowires can be##2##4##(2008-7#2)
the nanowires##3##2##(2008-7#2)(2009-2#1)
the nanoworld##4##2##(2007-9#1)(2008-7#3)
the naphthalene bioavailability##2##3##(2011-12#2)
the naphthalene ring##2##3##(2008-10#2)
the naphthalene##9##2##(1996-11#1)(2004-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2011-12#2)
the naphthalenes##2##2##(1993-4#1)(2007-11#1)
the naphthyl##2##2##(2008-10#1)(2008-11#1)
the narcotic##5##2##(1996-12#1)(2006-10#1)(2008-10#2)(2008-4#1)
the narrative of##4##3##(2008-12#1)(2009-10#1)(2013-1#2)
the narrative##6##2##(2008-12#1)(2009-10#1)(2009-9#1)(2010-3#1)(2013-1#2)
the narratives of##3##3##(2005-10#1)(2006-9#1)(2007-7#1)
the narratives##4##2##(1996-3#1)(2005-10#1)(2006-9#1)(2007-7#1)
the narrow therapeutic##2##3##(1991-2#1)(2008-8#1)
the narrow##17##2##(1991-2#1)(1992-12#1)(1996-2#1)(2004-8#1)(2006-9#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-2#5)(2008-8#1)(2009-2#1)
the narrow-band laser##2##3##(2008-2#2)
the narrow-band##7##2##(2007-12#2)(2008-2#3)(2008-3#1)(2008-6#1)
the narrower##6##2##(1995-5#1)(2005-11#1)(2009-8#1)(2012-11#2)(2012-12#1)
the narrowest##3##2##(2007-11#1)(2008-3#1)(2008-7#1)
the narrowing of the##3##4##(2008-11#1)(2008-2#1)(2013-8#1)
the narrowing of##4##3##(2007-12#1)(2008-11#1)(2008-2#1)(2013-8#1)
the narrowing##5##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-8#1)
the nasal airway##4##3##(2005-11#1)(2008-11#1)(2013-1#2)
the nasal and oral##3##4##(2008-11#2)(2012-12#1)
the nasal and##4##3##(2007-3#1)(2008-11#2)(2012-12#1)
the nasal cavities##3##3##(1993-8#1)(2008-5#1)(2011-1#1)
the nasal cavity or##2##4##(1993-4#1)(2008-10#1)
the nasal cavity##27##3##(1990-6#1)(1992-10#2)(1993-2#1)(1993-4#2)(1993-8#1)(1997-6#1)(2006-8#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#1)(2011-1#1)(2012-2#5)(2013-1#3)(2013-8#5)
the nasal epithelium##2##3##(1997-1#1)(2009-9#1)
the nasal mucosa##9##3##(1993-8#1)(1995-7#1)(1996-3#1)(1996-5#1)(1997-5#1)(1997-6#1)(2005-11#2)(2008-5#1)
the nasal passages##2##3##(1992-4#1)(2008-5#1)
the nasal septum##8##3##(1990-6#1)(2007-5#2)(2009-1#1)(2012-12#4)
the nasal symptom##2##3##(2008-11#1)(2012-3#1)
the nasal##82##2##(1990-6#2)(1990-9#1)(1992-10#2)(1992-4#2)(1993-2#1)(1993-4#3)(1993-8#3)(1993-9#1)(1994-2#1)(1995-7#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-5#1)(1997-6#3)(2005-11#3)(2006-10#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#5)(2008-2#1)(2008-5#4)(2009-1#1)(2009-11#1)(2009-9#2)(2010-8#1)(2011-1#4)(2011-2#1)(2012-12#5)(2012-2#5)(2012-3#1)(2013-1#6)(2013-8#6)
the nasal-temporal (N-T)##2##3##(1992-3#1)(1992-7#1)
the nascent transcript##2##3##(1994-8#1)(1994-9#1)
the nascent##17##2##(1990-12#2)(1993-3#1)(1993-8#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-4#1)(1996-3#1)(1996-8#1)(2005-4#1)(2007-12#1)(2009-5#1)(2011-1#1)(2012-12#1)
the nasolabial fold and chin##3##5##(2008-5#3)
the nasolabial fold##6##3##(2008-5#4)(2008-8#1)(2009-8#1)
the nasolabial groove##2##3##(2008-5#2)
the nasolabial##10##2##(2005-11#1)(2007-12#1)(2008-5#6)(2008-8#1)(2009-8#1)
the nasolacrimal system##2##3##(2006-11#2)
the nasolacrimal##4##2##(2006-11#4)
the nasopharyngeal##5##2##(1995-10#1)(2006-10#1)(2008-1#1)(2008-10#1)(2011-2#1)
the nasopharynx##11##2##(1993-12#1)(1994-10#1)(1995-5#2)(2006-12#2)(2009-5#2)(2010-12#1)(2011-12#1)(2012-12#1)
the natal territory##2##3##(2008-8#2)
the natal##6##2##(1996-5#2)(2006-5#1)(2008-8#2)(2013-8#1)
the nation##32##2##(1990-12#2)(1990-9#1)(1991-11#1)(1991-2#1)(1991-8#1)(1994-3#1)(1995-3#1)(1996-12#1)(1996-6#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-7#1)(2007-2#1)(2007-5#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-9#2)(2010-1#3)(2010-4#1)(2010-8#2)(2011-2#1)(2013-1#1)
the nation's economy##2##3##(1996-11#1)(2007-5#1)
the nation's health care##3##4##(1995-2#1)(1996-2#1)(2007-9#1)
the nation's health##6##3##(1990-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-6#1)(2007-9#1)
the nation's largest##4##3##(1994-12#1)(1995-11#1)(1995-6#1)(2008-12#1)
the nation's most##3##3##(1995-3#1)(2013-1#2)
the nation's##36##2##(1990-12#2)(1991-4#2)(1992-2#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-11#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-6#1)(2004-9#1)(2005-7#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
the nation-wide##2##2##(1990-8#1)(1995-8#1)
the national agenda##2##3##(2008-1#1)(2008-11#1)
the national and international##5##4##(2005-5#1)(2006-5#1)(2008-10#1)(2010-9#1)(2013-8#1)
the national and state##4##4##(1995-1#1)(2008-11#1)(2012-12#1)(2013-8#1)
the national and##14##3##(1995-1#1)(2005-5#1)(2006-5#1)(2008-10#1)(2008-11#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#2)
the national average in the counties of Split-Dalmatia##3##8##(2010-9#3)
the national average##12##3##(1992-12#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-6#1)(2010-9#4)
the national cancer##2##3##(2005-10#1)(2011-2#1)
the national clinical##2##3##(2008-3#1)(2012-1#1)
the national equations##4##3##(2013-1#4)
the national health##5##3##(1992-11#1)(1995-12#1)(1996-12#1)(2009-4#1)(2011-1#1)
the national labs##2##3##(2007-8#1)(2007-9#1)
the national level##14##3##(1995-2#1)(2004-10#1)(2006-10#1)(2007-11#3)(2007-5#1)(2007-7#1)(2008-1#1)(2010-12#1)(2010-8#1)(2011-1#2)(2013-1#1)
the national longitudinal##2##3##(2008-8#1)(2009-8#1)
the national malaria##3##3##(2008-3#1)(2008-4#1)(2012-12#1)
the national population##2##3##(1997-1#1)(2013-8#1)
the national science##2##3##(2007-9#1)(2009-4#1)
the national standards##2##3##(2012-12#1)(2012-3#1)
the national tuberculosis##2##3##(2007-2#1)(2013-7#1)
the national##173##2##(1990-3#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-12#1)(1993-10#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-1#1)(1994-12#3)(1994-2#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-4#2)(1996-11#3)(1996-12#1)(1997-1#3)(1997-4#1)(2004-10#1)(2005-10#1)(2005-4#1)(2005-5#3)(2006-10#3)(2006-12#1)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#4)(2007-12#1)(2007-2#4)(2007-3#3)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#4)(2008-1#2)(2008-10#8)(2008-11#3)(2008-3#6)(2008-4#1)(2008-6#2)(2008-8#3)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#3)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#2)(2010-8#2)(2010-9#6)(2011-1#6)(2011-2#12)(2012-1#2)(2012-12#5)(2012-2#3)(2012-3#4)(2013-1#8)(2013-7#2)(2013-8#3)
the nationwide##5##2##(1990-12#1)(2006-10#1)(2013-1#3)
the native EP##2##3##(1990-11#2)
the native GMH4##2##3##(1994-8#2)
the native and denatured states##2##5##(1995-4#1)(2006-10#1)
the native and mutant##2##4##(1995-1#1)(2010-7#1)
the native and unfolded states##2##5##(1995-4#1)(1997-7#1)
the native and unfolded##4##4##(1994-8#1)(1995-4#1)(1995-5#1)(1997-7#1)
the native and##19##3##(1990-7#1)(1991-4#2)(1992-8#1)(1993-8#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-4#2)(1995-5#1)(1997-7#1)(2006-10#1)(2008-1#1)(2008-4#2)(2010-7#1)(2011-2#1)
the native complex##2##3##(1990-5#1)(2013-1#1)
the native conformation of##2##4##(1990-7#1)(2008-8#1)
the native conformation##7##3##(1990-7#1)(1991-4#1)(1992-6#1)(1994-5#1)(1995-4#1)(1997-2#1)(2008-8#1)
the native enzyme and##3##4##(1990-10#1)(1992-11#1)(1993-11#1)
the native enzyme from##2##4##(1990-5#1)(1994-8#1)
the native enzyme is##2##4##(1990-2#1)(1997-4#1)
the native enzyme##39##3##(1990-10#1)(1990-11#4)(1990-2#1)(1990-5#3)(1990-9#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#1)(1996-6#1)(1996-9#1)(1997-4#3)(1997-5#1)(1997-6#1)(2008-10#1)(2008-5#1)
the native extracellular matrix##2##4##(2008-5#1)(2012-6#1)
the native extracellular##4##3##(2008-5#1)(2012-11#2)(2012-6#1)
the native fluorescence emission##2##4##(2008-10#2)
the native fluorescence of##2##4##(2008-10#2)
the native fluorescence##4##3##(2008-10#4)
the native form of endothelin receptor##2##6##(1990-2#2)
the native form of##3##4##(1990-2#2)(1995-10#1)
the native form##7##3##(1990-2#2)(1992-11#1)(1992-12#1)(1994-8#1)(1995-10#1)(2010-5#1)
the native hand##2##3##(2012-1#2)
the native human##5##3##(1990-12#1)(1992-11#1)(1992-8#1)(1997-6#1)(2006-9#1)
the native kinase##2##3##(1991-10#1)(1993-7#1)
the native ligand##2##3##(1995-11#1)(2012-2#1)
the native molecular##2##3##(2008-4#1)(2011-1#1)
the native molecule##3##3##(1992-2#1)(1997-6#1)(2008-4#1)
the native one##2##3##(1997-2#1)(2008-8#1)
the native or##2##3##(1995-5#1)(1997-6#1)
the native peptide##2##3##(1994-8#1)(2012-2#1)
the native phase##2##3##(2008-4#2)
the native population of##2##4##(1993-6#1)(2009-8#1)
the native population##3##3##(1992-8#1)(1993-6#1)(2009-8#1)
the native protein with##2##4##(1990-4#1)(1993-6#1)
the native protein##29##3##(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#1)(1990-8#2)(1991-2#1)(1992-5#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#3)(1995-1#1)(1995-2#1)(1995-3#2)(1997-4#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2010-7#1)
the native proteins and##2##4##(1993-12#1)(2007-11#1)
the native proteins##3##3##(1993-12#1)(1993-9#1)(2007-11#1)
the native receptor##3##3##(1990-11#1)(1995-10#1)(1996-4#1)
the native sequence##3##3##(1992-6#1)(1995-8#1)(1997-4#1)
the native state and##2##4##(1991-4#1)(1995-1#1)
the native state is##3##4##(1994-12#1)(1994-5#1)(1996-11#1)
the native state of##3##4##(1992-6#1)(1993-11#2)
the native state##22##3##(1990-2#1)(1990-3#1)(1990-9#1)(1991-4#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-11#3)(1994-12#1)(1994-5#1)(1995-1#2)(1995-3#1)(1995-4#1)(1996-11#2)(1997-4#1)(2006-10#3)
the native structure##13##3##(1991-5#1)(1992-6#1)(1993-11#2)(1995-1#3)(1995-4#2)(1996-11#1)(1997-4#1)(2005-11#1)(2008-9#1)
the native##334##2##(1990-10#1)(1990-11#9)(1990-12#2)(1990-2#7)(1990-3#1)(1990-4#1)(1990-5#6)(1990-7#7)(1990-8#3)(1990-9#2)(1991-10#2)(1991-2#3)(1991-4#8)(1991-5#2)(1991-9#2)(1992-1#1)(1992-11#3)(1992-12#3)(1992-2#5)(1992-3#1)(1992-5#2)(1992-6#5)(1992-8#3)(1993-1#1)(1993-11#8)(1993-12#2)(1993-3#2)(1993-4#1)(1993-6#3)(1993-7#1)(1993-8#6)(1993-9#2)(1994-10#1)(1994-11#5)(1994-12#3)(1994-5#7)(1994-8#19)(1994-9#5)(1995-1#10)(1995-10#3)(1995-11#2)(1995-12#1)(1995-2#6)(1995-3#7)(1995-4#6)(1995-5#5)(1995-6#2)(1995-8#3)(1996-10#1)(1996-11#4)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#5)(1997-4#11)(1997-5#1)(1997-6#5)(1997-7#2)(1997-8#1)(2005-11#4)(2006-10#5)(2006-11#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-3#1)(2007-8#2)(2008-1#2)(2008-10#19)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#11)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#2)(2009-2#1)(2009-3#1)(2009-8#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#3)(2012-11#2)(2012-12#1)(2012-2#4)(2012-6#1)(2013-1#1)(2013-8#1)
the natriferic action of##2##4##(2008-8#2)
the natriuretic peptides##2##3##(1992-11#1)(1993-4#1)
the natriuretic##6##2##(1990-11#1)(1991-3#1)(1992-11#2)(1993-4#1)(2008-2#1)
the natural Hoxc11 activity domain##2##5##(2012-12#2)
the natural acceptor##2##3##(1991-7#2)
the natural and the##2##4##(1991-2#1)(2008-11#1)
the natural and##6##3##(1990-3#1)(1991-2#1)(1992-10#1)(1993-6#1)(2008-11#1)(2009-2#1)
the natural assemblage of##2##4##(2007-6#1)(2008-9#1)
the natural background##3##3##(1992-2#1)(1994-9#1)(2008-10#1)
the natural bacterial##2##3##(2004-4#1)(2011-1#1)
the natural barriers##2##3##(2008-11#1)(2011-3#1)
the natural cofactor##6##3##(1993-6#1)(1995-10#5)
the natural course and##3##4##(1997-3#1)(2008-12#1)(2011-2#1)
the natural course of the disease##4##6##(1995-6#1)(2005-7#1)(2006-12#1)(2010-12#1)
the natural course of##10##4##(1992-10#1)(1995-6#1)(1996-12#1)(2004-11#1)(2005-7#1)(2006-11#1)(2006-12#1)(2007-12#1)(2009-12#1)(2010-12#1)
the natural course##16##3##(1990-6#1)(1992-10#1)(1992-9#1)(1995-6#1)(1996-12#1)(1997-3#1)(2004-11#1)(2005-7#1)(2006-11#1)(2006-12#1)(2007-12#1)(2008-12#1)(2008-7#1)(2009-12#1)(2010-12#1)(2011-2#1)
the natural development of the##3##5##(1990-9#1)(1991-6#1)(1993-11#1)
the natural development of##4##4##(1990-9#1)(1991-6#1)(1993-11#1)(2008-10#1)
the natural diversity##2##3##(2007-3#1)(2008-10#1)
the natural environment##11##3##(1994-11#1)(1995-9#1)(2007-5#2)(2008-10#3)(2008-4#1)(2009-6#1)(2010-8#1)(2011-1#1)
the natural evolution of##3##4##(1991-3#1)(1994-12#1)(1997-8#1)
the natural evolution##4##3##(1991-3#1)(1994-12#1)(1997-8#1)(2006-4#1)
the natural extracellular matrix##2##4##(2008-5#1)(2010-8#1)
the natural form##2##3##(1992-11#1)(2007-12#1)
the natural habitat##4##3##(2007-1#2)(2008-5#1)(2013-8#1)
the natural history and##5##4##(2006-10#1)(2009-8#1)(2010-12#1)(2012-2#1)(2013-1#1)
the natural history of 2DM##2##5##(2010-10#2)
the natural history of both##2##5##(2006-2#1)(2007-7#1)
the natural history of chronic##2##5##(2005-10#1)(2009-8#1)
the natural history of familial##2##5##(1995-10#1)(2011-2#1)
the natural history of peptic ulcer##2##6##(1992-10#1)(2006-10#1)
the natural history of the disease##8##6##(1991-6#1)(1991-9#1)(1993-11#1)(2006-10#1)(2006-9#1)(2010-10#1)(2010-12#1)(2010-5#1)
the natural history of the##18##5##(1991-6#1)(1991-9#1)(1993-11#1)(1996-3#1)(1996-6#1)(2004-12#1)(2005-10#1)(2006-10#2)(2006-9#1)(2007-2#1)(2007-3#1)(2007-5#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-5#1)(2012-3#1)
the natural history of these##4##5##(1997-8#1)(2006-12#1)(2008-4#1)(2011-12#1)
the natural history of this disease##2##6##(1990-12#1)(2012-2#1)
the natural history of this##6##5##(1990-12#1)(1991-6#1)(2007-9#1)(2008-7#1)(2009-1#1)(2012-2#1)
the natural history of type##2##5##(2009-5#1)(2010-4#1)
the natural history of##69##4##(1990-12#1)(1991-10#1)(1991-6#2)(1991-9#1)(1992-10#1)(1993-10#1)(1993-11#1)(1994-4#1)(1994-9#1)(1995-1#1)(1995-10#1)(1996-3#1)(1996-6#1)(1997-8#1)(2004-1#1)(2004-12#1)(2005-10#2)(2005-11#1)(2006-10#5)(2006-12#2)(2006-2#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2009-1#1)(2009-5#1)(2009-8#1)(2010-10#3)(2010-12#3)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
the natural history##86##3##(1990-12#1)(1991-10#1)(1991-6#2)(1991-9#1)(1992-10#1)(1993-10#1)(1993-11#1)(1994-4#1)(1994-9#1)(1995-1#1)(1995-10#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-8#1)(2004-1#1)(2004-11#3)(2004-12#1)(2005-10#2)(2005-11#1)(2006-10#6)(2006-12#2)(2006-2#2)(2006-9#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#3)(2009-1#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-10#3)(2010-12#6)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
the natural killer (NK) cell##2##5##(1993-9#1)(2013-1#1)
the natural killer cell##2##4##(2008-10#1)(2008-4#1)
the natural killer##5##3##(1993-9#1)(1994-9#1)(2008-10#1)(2008-4#1)(2013-1#1)
the natural ligand##2##3##(2008-11#1)(2010-1#1)
the natural outcome##2##3##(2006-10#1)(2006-2#1)
the natural population##2##3##(2007-1#1)(2008-10#1)
the natural product##11##3##(1990-7#1)(1996-11#1)(2004-7#1)(2005-8#1)(2007-1#1)(2009-5#2)(2010-2#1)(2010-7#1)(2012-3#2)
the natural products##5##3##(1996-2#1)(2007-12#1)(2009-10#1)(2010-2#2)
the natural progression of##5##4##(2006-10#1)(2007-11#2)(2008-11#1)(2013-7#1)
the natural regeneration##2##3##(2008-5#2)
the natural resistance##4##3##(1990-5#1)(1997-2#1)(2009-6#1)(2010-8#1)
the natural resources##3##3##(2008-1#1)(2009-7#1)(2013-7#1)
the natural route of##2##4##(2006-10#1)(2008-9#1)
the natural sciences and##3##4##(2006-3#1)(2008-4#1)(2009-2#1)
the natural sciences##5##3##(2006-3#1)(2008-4#1)(2009-10#1)(2009-2#1)(2010-5#1)
the natural selection##3##3##(2008-8#1)(2010-2#2)
the natural substrate##5##3##(1990-7#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-2#1)
the natural suppressiveness##2##3##(2008-10#2)
the natural systems##2##3##(2007-12#2)
the natural target##2##3##(1992-6#1)(2013-7#1)
the natural variability##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
the natural water samples##2##4##(2008-10#1)(2008-11#1)
the natural world##2##3##(2008-10#2)
the natural##403##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#3)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#3)(1990-9#2)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#4)(1991-7#3)(1991-9#1)(1992-1#1)(1992-10#3)(1992-11#2)(1992-2#1)(1992-3#2)(1992-5#3)(1992-6#2)(1992-9#2)(1993-1#1)(1993-10#2)(1993-11#2)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#3)(1993-9#1)(1994-11#3)(1994-12#3)(1994-3#1)(1994-4#1)(1994-5#2)(1994-8#1)(1994-9#4)(1995-1#3)(1995-10#7)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#3)(1995-6#2)(1995-8#1)(1995-9#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#4)(2004-1#1)(2004-11#5)(2004-12#1)(2004-4#1)(2004-7#1)(2005-10#2)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#10)(2006-11#1)(2006-12#12)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#4)(2007-11#5)(2007-12#11)(2007-2#1)(2007-3#3)(2007-5#4)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#33)(2008-11#7)(2008-12#7)(2008-2#5)(2008-3#3)(2008-4#8)(2008-5#15)(2008-6#5)(2008-7#7)(2008-8#6)(2008-9#5)(2009-1#2)(2009-10#2)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#3)(2010-12#8)(2010-2#6)(2010-4#4)(2010-5#3)(2010-7#1)(2010-8#5)(2011-1#4)(2011-12#1)(2011-2#7)(2011-3#2)(2012-12#6)(2012-2#6)(2012-3#5)(2013-1#5)(2013-7#4)(2013-8#4)
the naturally occurring##29##3##(1990-4#1)(1991-9#2)(1992-1#1)(1992-3#1)(1992-8#1)(1993-6#1)(1993-9#1)(1994-9#3)(1997-7#2)(1997-8#2)(2005-9#1)(2006-1#1)(2006-4#1)(2006-8#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-5#2)(2008-7#1)(2010-5#1)(2012-2#1)
the naturally##34##2##(1990-4#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-6#1)(1993-9#1)(1994-9#3)(1997-7#3)(1997-8#2)(2005-9#1)(2006-1#1)(2006-4#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-5#2)(2008-7#1)(2010-5#1)(2012-2#1)(2013-8#1)
the naturally-occurring##3##2##(1990-12#1)(1992-1#1)(2008-5#1)
the nature and cause of##2##5##(2007-4#1)(2012-12#1)
the nature and concentration of##2##5##(2004-9#1)(2010-5#1)
the nature and content of##2##5##(2008-10#2)
the nature and degree of##3##5##(1995-1#1)(1997-5#1)(2006-2#1)
the nature and distribution of##2##5##(1994-3#1)(2010-5#1)
the nature and extent of the##3##6##(2006-2#1)(2007-9#1)(2008-4#1)
the nature and extent of##12##5##(1996-12#1)(1997-3#1)(1997-8#1)(2006-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2011-1#1)(2012-2#1)
the nature and level of##2##5##(2007-10#1)(2008-7#1)
the nature and magnitude of##2##5##(2006-10#1)(2007-1#1)
the nature and origin of##2##5##(2007-8#1)(2008-10#1)
the nature and role of##2##5##(1993-1#1)(1996-7#1)
the nature and scope of##2##5##(2010-10#1)(2010-3#1)
the nature and the##9##4##(1991-2#1)(1992-8#1)(2006-3#1)(2006-9#1)(2008-3#1)(2008-5#2)(2010-4#1)(2010-5#1)
the nature and type of damage##2##6##(2008-6#2)
the nature and type of##3##5##(2008-10#1)(2008-6#2)
the nature and##90##3##(1991-2#1)(1992-11#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-3#1)(1994-1#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#2)(2004-9#1)(2006-10#3)(2006-2#2)(2006-3#1)(2006-7#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-4#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#1)(2008-9#1)(2010-10#1)(2010-11#2)(2010-3#2)(2010-4#1)(2010-5#3)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)
the nature as well as##2##5##(2006-8#1)(2013-1#1)
the nature of a##5##4##(2008-10#2)(2008-2#2)(2008-3#1)
the nature of an##2##4##(1996-12#1)(2012-1#1)
the nature of any##2##4##(2008-11#1)(2012-12#1)
the nature of clinical##2##4##(2006-11#1)(2008-11#1)
the nature of complexes##2##4##(2008-10#2)
the nature of each##2##4##(1994-6#1)(2013-1#1)
the nature of inhibitor##2##4##(1994-8#2)
the nature of interactions##2##4##(1991-12#1)(2011-1#1)
the nature of medical##2##4##(1993-10#1)(2012-2#1)
the nature of membrane##2##4##(2008-10#1)(2008-9#1)
the nature of relationships##2##4##(1993-1#1)(2013-7#1)
the nature of that##2##4##(1995-4#1)(2005-8#1)
the nature of the acid##2##5##(2008-10#2)
the nature of the anion##2##5##(1994-5#1)(2008-10#1)
the nature of the bonding##2##5##(2007-9#2)
the nature of the compounds##2##5##(2008-10#1)(2012-12#1)
the nature of the deficit##2##5##(1990-3#1)(1992-9#1)
the nature of the disease##6##5##(1991-3#1)(2004-3#1)(2006-4#1)(2008-4#1)(2008-9#1)(2013-1#1)
the nature of the effect##2##5##(1993-11#1)(2008-1#1)
the nature of the genetic##2##5##(2010-4#1)(2010-9#1)
the nature of the ligand##3##5##(1990-10#1)(1990-8#1)(2008-4#1)
the nature of the mechanisms##2##5##(1995-6#1)(1997-6#1)
the nature of the membrane##4##5##(1990-3#1)(2005-11#1)(2008-10#1)(2008-5#1)
the nature of the promoter##2##5##(2007-12#1)(2011-1#1)
the nature of the relationship between##3##6##(1995-3#1)(2008-2#1)(2008-7#1)
the nature of the relationship##5##5##(1995-3#1)(2006-10#1)(2006-7#1)(2008-2#1)(2008-7#1)
the nature of the right to confidentiality of medical and mental health records##2##13##(1991-12#1)(1992-3#1)
the nature of the solvent and##2##6##(1997-7#1)(2008-10#1)
the nature of the species##2##5##(2008-10#1)(2009-3#1)
the nature of the stationary phase##2##6##(1992-2#1)(2008-10#1)
the nature of the substrate##3##5##(1995-10#1)(2007-10#1)(2013-7#1)
the nature of the supporting electrolyte##2##6##(2008-10#1)(2008-5#1)
the nature of the tumor##2##5##(1994-7#1)(2005-9#1)
the nature of the##229##4##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#5)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#2)(1992-8#1)(1992-9#4)(1993-10#1)(1993-11#3)(1993-2#1)(1993-4#1)(1993-5#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#2)(1995-1#2)(1995-10#1)(1995-12#2)(1995-3#4)(1995-6#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-10#1)(2004-12#1)(2004-3#1)(2005-11#3)(2005-5#1)(2005-7#2)(2005-9#1)(2006-1#1)(2006-10#4)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#2)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#5)(2007-5#1)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#29)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#6)(2008-7#5)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#2)(2010-4#2)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#5)
the nature of their##9##4##(1993-2#1)(1996-2#1)(2004-4#1)(2006-10#1)(2010-12#2)(2010-4#1)(2013-1#2)
the nature of these##9##4##(1995-1#1)(1996-3#1)(2006-7#1)(2006-8#1)(2008-10#1)(2008-11#1)(2009-12#1)(2012-12#1)(2012-2#1)
the nature of this interaction##3##5##(1991-6#1)(1995-7#1)(2008-1#1)
the nature of this relationship##2##5##(1994-5#1)(2006-7#1)
the nature of this##18##4##(1990-5#1)(1991-6#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-3#1)(1995-7#1)(1997-2#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-4#1)(2012-1#1)
the nature of those##2##4##(1997-1#1)(2007-9#1)
the nature of volatile products released by a substance subjected to a controlled temperature program##2##15##(2008-10#2)
the nature of which##2##4##(1996-6#1)(1997-7#1)
the nature of working relationships##2##5##(1996-12#1)(2010-9#1)
the nature of##421##3##(1990-10#1)(1990-11#1)(1990-12#3)(1990-3#5)(1990-4#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#6)(1991-2#2)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#3)(1992-8#1)(1992-9#4)(1993-1#1)(1993-10#2)(1993-11#4)(1993-2#4)(1993-3#1)(1993-4#2)(1993-5#2)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#4)(1995-1#4)(1995-10#2)(1995-12#2)(1995-2#1)(1995-3#6)(1995-4#2)(1995-5#2)(1995-6#1)(1995-7#2)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#4)(1996-3#1)(1996-4#3)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#2)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-10#2)(2004-12#2)(2004-3#1)(2004-4#1)(2005-11#4)(2005-5#1)(2005-7#3)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#8)(2006-11#3)(2006-12#5)(2006-2#1)(2006-3#2)(2006-4#1)(2006-7#4)(2006-8#4)(2006-9#4)(2007-1#2)(2007-10#3)(2007-11#8)(2007-12#5)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#4)(2008-10#48)(2008-11#15)(2008-12#2)(2008-2#8)(2008-3#9)(2008-4#6)(2008-5#9)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#2)(2009-5#1)(2009-8#3)(2009-9#2)(2010-10#1)(2010-12#3)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#7)(2012-1#7)(2012-11#1)(2012-12#4)(2012-2#7)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#7)
the nature or##3##3##(1997-7#1)(2006-10#1)(2006-8#1)
the nature##535##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-3#6)(1990-4#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#6)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#5)(1993-1#2)(1993-10#2)(1993-11#4)(1993-2#4)(1993-3#2)(1993-4#2)(1993-5#2)(1993-8#1)(1993-9#1)(1994-1#2)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#4)(1995-1#5)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#6)(1995-4#2)(1995-5#2)(1995-6#1)(1995-7#2)(1996-10#1)(1996-11#2)(1996-12#6)(1996-2#5)(1996-3#2)(1996-4#3)(1996-5#2)(1996-6#2)(1996-7#3)(1996-8#2)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#4)(2004-10#3)(2004-12#2)(2004-3#1)(2004-4#1)(2004-9#1)(2005-11#4)(2005-5#1)(2005-7#3)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#13)(2006-11#3)(2006-12#5)(2006-2#3)(2006-3#3)(2006-4#1)(2006-7#6)(2006-8#6)(2006-9#5)(2007-1#3)(2007-10#4)(2007-11#8)(2007-12#8)(2007-2#2)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#6)(2008-1#5)(2008-10#61)(2008-11#18)(2008-12#3)(2008-2#8)(2008-3#11)(2008-4#8)(2008-5#14)(2008-6#4)(2008-7#9)(2008-8#4)(2008-9#10)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#2)(2009-5#1)(2009-8#3)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#3)(2010-3#3)(2010-4#4)(2010-5#5)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#8)(2011-12#1)(2011-2#10)(2011-3#1)(2012-1#7)(2012-11#1)(2012-12#7)(2012-2#10)(2012-3#2)(2013-1#12)(2013-7#2)(2013-8#7)
the navel##2##2##(1996-8#1)(2009-7#1)
the navigation controlled shaver##2##4##(2007-5#2)
the navigation##5##2##(2007-12#1)(2007-5#2)(2012-12#1)(2013-1#1)
the naïve##2##2##(2010-2#1)(2012-3#1)
the near IR##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
the near UV##3##3##(1992-7#1)(2007-11#1)(2008-10#1)
the near and far##2##4##(2006-10#1)(2008-2#1)
the near and##3##3##(2006-10#1)(2008-2#1)(2008-3#1)
the near field of a##4##5##(2008-2#1)(2008-3#2)(2013-8#1)
the near field of##6##4##(2007-11#1)(2008-2#1)(2008-3#3)(2013-8#1)
the near field##22##3##(2007-11#2)(2007-12#5)(2008-2#7)(2008-3#7)(2013-8#1)
the near full-length##2##3##(1994-12#1)(1997-4#1)
the near future##85##3##(1990-10#1)(1990-12#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-6#1)(1993-11#1)(1994-11#2)(1994-12#2)(1994-7#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-4#1)(1995-5#1)(1997-4#1)(1997-8#1)(2005-10#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-6#4)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2009-10#1)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-9#1)(2011-2#7)(2012-11#1)(2012-12#1)(2013-1#3)
the near infrared from##2##4##(2007-12#1)(2008-3#1)
the near infrared the##2##4##(2007-11#1)(2008-3#1)
the near infrared##31##3##(1991-7#1)(1993-3#1)(2007-11#4)(2007-12#7)(2008-1#1)(2008-10#1)(2008-2#6)(2008-3#9)(2010-5#1)
the near term##3##3##(1994-3#1)(2009-11#1)(2010-12#1)
the near to##2##3##(2007-12#1)(2008-1#1)
the near##172##2##(1990-10#1)(1990-12#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-7#1)(1993-11#1)(1993-3#1)(1994-11#2)(1994-12#3)(1994-3#1)(1994-7#1)(1995-1#1)(1995-12#2)(1995-3#2)(1995-4#1)(1995-5#1)(1997-4#2)(1997-8#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-10#4)(2006-12#2)(2006-4#1)(2006-6#4)(2007-10#1)(2007-11#12)(2007-12#16)(2007-2#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#19)(2008-3#20)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#2)(2010-9#1)(2011-2#7)(2012-11#1)(2012-12#1)(2013-1#4)(2013-8#2)
the near- and the far-field##2##5##(2008-2#1)(2008-3#1)
the near- and the##3##4##(2008-2#1)(2008-3#2)
the near- and##6##3##(1990-12#1)(1994-11#1)(2008-2#2)(2008-3#2)
the near-IR excitation##2##3##(2008-2#2)
the near-IR##5##2##(2007-11#1)(2008-2#3)(2008-3#1)
the near-UV CD spectrum##2##4##(1997-4#2)
the near-UV##7##2##(1994-11#1)(1997-4#2)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)
the near-field diffraction##2##3##(2007-12#2)
the near-field optical##3##3##(2008-2#1)(2008-3#2)
the near-field##16##2##(2007-12#5)(2008-1#2)(2008-2#4)(2008-3#5)
the near-future##2##2##(2008-3#2)
the near-infrared (NIR)##3##3##(2006-12#1)(2008-10#1)(2008-3#1)
the near-infrared and infrared##2##4##(2007-12#1)(2008-3#1)
the near-infrared bands##2##3##(2008-3#2)
the near-infrared region##5##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-11#1)
the near-infrared spectral##6##3##(2007-12#2)(2008-2#1)(2008-3#3)
the near-infrared##34##2##(1997-6#1)(2006-12#1)(2007-11#2)(2007-12#5)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#14)(2008-5#1)(2009-11#1)
the near-ultraviolet##3##2##(1990-7#1)(1993-8#1)(2008-2#1)
the nearby##15##2##(1990-11#1)(1990-5#1)(1991-4#1)(1991-8#1)(2006-4#1)(2006-7#1)(2007-8#1)(2008-10#4)(2009-6#1)(2011-2#2)(2012-1#1)
the nearest hospital##3##3##(1997-4#2)(2008-3#1)
the nearest neighbor##2##3##(1996-1#1)(2005-11#1)
the nearest##19##2##(1992-12#1)(1995-7#1)(1996-1#1)(1997-4#2)(2005-11#1)(2007-2#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-1#1)
the nearest-neighbor##3##2##(2006-10#1)(2008-3#1)(2010-2#1)
the nearly identical##2##3##(1992-6#1)(2008-2#1)
the nearly##13##2##(1990-11#1)(1992-6#1)(1995-8#1)(1996-1#1)(1996-5#1)(2004-2#1)(2006-1#1)(2007-10#1)(2007-12#1)(2008-2#2)(2008-8#1)(2009-7#1)
the neat##2##2##(2010-4#1)(2012-11#1)
the nebulizer of##2##3##(2008-10#2)
the nebulizer##13##2##(1994-12#4)(1995-12#1)(1995-3#1)(1996-3#1)(2008-10#6)
the nebulizer-burner system of##3##4##(2007-8#1)(2008-10#2)
the nebulizer-burner system##5##3##(2007-8#1)(2008-10#4)
the nebulizers##6##2##(1993-2#2)(1995-3#3)(2013-8#1)
the necessary and##2##3##(1996-3#1)(2006-7#1)
the necessary conditions for##3##4##(2008-2#1)(2008-3#2)
the necessary equipment##2##3##(2004-2#1)(2008-10#1)
the necessary experience##2##3##(2006-7#1)(2008-11#1)
the necessary hardware##2##3##(2008-12#1)(2009-10#1)
the necessary information##2##3##(2008-5#1)(2012-12#1)
the necessary organizational changes##2##4##(1996-1#1)(2006-10#1)
the necessary skills##2##3##(1994-12#1)(2008-8#1)
the necessary steps to##2##4##(2008-10#1)(2008-11#1)
the necessary steps##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
the necessary##110##2##(1990-12#1)(1990-8#1)(1991-12#1)(1992-3#1)(1993-1#1)(1993-3#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#3)(1996-6#1)(1997-6#1)(1997-8#3)(2004-2#1)(2005-5#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-7#2)(2007-10#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-2#7)(2008-3#8)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#6)(2012-12#3)(2012-2#2)(2013-1#4)
the necessity for a##5##4##(1993-11#1)(2008-10#2)(2009-8#1)(2012-12#1)
the necessity for further##2##4##(1993-12#1)(1994-6#1)
the necessity for##22##3##(1992-11#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-6#1)(1995-8#1)(1997-7#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2009-6#1)(2009-8#1)(2011-12#1)(2012-12#2)
the necessity of a##3##4##(1990-10#1)(1993-6#1)(1996-6#1)
the necessity of an##2##4##(1990-6#1)(1997-4#1)
the necessity of external##2##4##(2007-11#1)(2008-2#1)
the necessity of providing##2##4##(1995-1#1)(2008-12#1)
the necessity of the##3##4##(2006-3#1)(2009-5#1)(2011-1#1)
the necessity of using##4##4##(2007-12#1)(2008-3#1)(2011-1#2)
the necessity of##60##3##(1990-10#1)(1990-12#1)(1990-6#2)(1990-8#1)(1992-5#1)(1993-12#1)(1993-6#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(2005-1#1)(2005-8#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#4)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
the necessity to change##2##4##(2007-5#1)(2010-7#1)
the necessity to make##2##4##(2007-2#1)(2007-8#1)
the necessity to take##2##4##(2007-11#1)(2008-10#1)
the necessity to##27##3##(1990-12#1)(1991-5#1)(1995-1#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-11#3)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
the necessity##111##2##(1990-10#1)(1990-12#2)(1990-6#2)(1990-8#1)(1991-5#1)(1992-11#1)(1992-5#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-6#1)(1995-1#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-1#1)(2005-8#3)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2007-11#5)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#1)
the neck and##15##3##(1994-2#1)(2006-3#1)(2006-7#1)(2006-8#2)(2007-2#1)(2007-4#1)(2007-8#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#2)
the neck are##2##3##(2008-9#1)(2010-12#1)
the neck chord##2##3##(2007-1#2)
the neck hair cells##2##4##(1995-8#2)
the neck in##6##3##(2007-12#1)(2007-4#1)(2008-1#1)(2009-6#1)(2010-6#1)(2011-1#1)
the neck injury##2##3##(2006-11#1)(2007-4#1)
the neck loads##3##3##(2007-4#3)
the neck muscles##3##3##(2004-11#1)(2007-1#2)
the neck musculature is##2##4##(2007-1#2)
the neck musculature##3##3##(2006-11#1)(2007-1#2)
the neck of the femur##3##5##(2006-6#1)(2008-4#1)(2013-1#1)
the neck of the##6##4##(1995-8#2)(2006-6#1)(2008-4#1)(2010-5#1)(2013-1#1)
the neck of##8##3##(1991-11#1)(1995-8#2)(2006-6#1)(2008-4#1)(2010-5#1)(2013-1#1)(2013-7#1)
the neck region##6##3##(1992-6#2)(2007-7#1)(2008-12#1)(2010-11#1)(2010-9#1)
the neck seal##5##3##(1994-4#5)
the neck was##2##3##(1991-8#1)(2007-3#1)
the neck were found##2##4##(2007-4#1)(2012-1#1)
the neck were##3##3##(2007-4#1)(2012-1#2)
the neck##145##2##(1990-3#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-6#2)(1993-2#1)(1993-6#1)(1993-7#1)(1994-2#1)(1994-4#5)(1995-4#2)(1995-8#5)(1996-4#3)(1997-3#1)(1997-6#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-11#3)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#5)(2007-1#8)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-4#11)(2007-5#1)(2007-7#7)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#2)(2008-4#2)(2008-7#7)(2008-8#1)(2008-9#3)(2009-6#2)(2009-7#2)(2010-11#6)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#2)(2011-2#7)(2012-1#2)(2012-12#7)(2012-2#2)(2013-1#2)(2013-7#1)
the neck)##2##2##(1993-5#2)
the neck-banded snake Scaphiodontophis annulatus##2##5##(2008-5#2)
the necropsy##2##2##(1996-12#1)(2008-5#1)
the necrosis##7##2##(1992-6#1)(1993-10#1)(1993-2#1)(2008-10#3)(2012-2#1)
the necrosis-inducing##2##2##(2008-10#2)
the necrotic area##2##3##(2008-10#1)(2011-2#1)
the necrotic areas##2##3##(2008-10#1)(2008-5#1)
the necrotic tissue##2##3##(1991-8#1)(2008-10#1)
the necrotic##16##2##(1991-8#1)(2008-10#8)(2008-4#1)(2008-5#1)(2009-1#1)(2010-2#1)(2011-2#2)(2012-2#1)
the necrotrophic##5##2##(2008-10#5)
the need and##7##3##(1992-1#1)(1993-3#1)(2010-11#1)(2011-2#1)(2012-11#3)
the need arises##4##3##(2008-10#1)(2008-11#1)(2008-3#2)
the need for &quot##2##4##(1991-2#1)(1996-11#1)
the need for a better understanding of##3##7##(2008-12#1)(2011-2#2)
the need for a better##5##5##(1991-6#1)(1997-3#1)(2008-12#1)(2011-2#2)
the need for a comprehensive##2##5##(1990-5#1)(1993-3#1)
the need for a definition##2##5##(2010-12#1)(2012-1#1)
the need for a more##5##5##(2006-4#1)(2007-7#1)(2008-11#1)(2008-2#1)(2009-2#1)
the need for a new generation of##2##7##(2007-2#1)(2008-10#1)
the need for a new##6##5##(1996-12#1)(1996-2#1)(2006-10#1)(2007-2#1)(2008-10#1)(2011-2#1)
the need for a specific##3##5##(2007-10#1)(2008-5#1)(2013-7#1)
the need for a support network for##2##7##(2011-2#2)
the need for a##92##4##(1990-5#1)(1990-6#1)(1991-6#2)(1992-1#2)(1992-2#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#1)(1996-7#1)(1997-3#2)(1997-6#1)(2005-8#1)(2006-10#2)(2006-12#3)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#3)(2008-1#1)(2008-10#5)(2008-11#6)(2008-12#3)(2008-2#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
the need for accurate##4##4##(1994-2#1)(2005-12#1)(2007-7#1)(2008-2#1)
the need for active##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
the need for additional research##2##5##(2009-7#1)(2010-10#1)
the need for additional##11##4##(1997-2#1)(2004-12#1)(2007-12#1)(2008-10#2)(2009-10#1)(2009-11#1)(2009-7#1)(2010-10#2)(2012-12#1)
the need for adequate##4##4##(1993-1#1)(1996-1#1)(2004-2#1)(2008-8#1)
the need for allogenic##2##4##(2009-3#2)
the need for alternatives##2##4##(1994-9#1)(2008-11#1)
the need for an appropriate##3##5##(1994-3#1)(2005-8#1)(2010-12#1)
the need for an##22##4##(1990-4#1)(1991-3#1)(1992-8#1)(1994-3#1)(1994-9#1)(1997-7#1)(2005-8#1)(2005-9#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
the need for and##5##4##(1992-12#1)(1993-1#1)(1996-1#1)(1997-3#1)(2008-8#1)
the need for any##6##4##(1994-11#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)
the need for appropriate##3##4##(2007-2#1)(2008-11#1)(2013-8#1)
the need for awareness of##2##5##(2006-10#1)(2011-2#1)
the need for better##5##4##(1995-2#1)(2005-12#1)(2005-8#1)(2007-12#1)(2013-1#1)
the need for blood##3##4##(1995-9#1)(2007-7#1)(2011-1#1)
the need for care##3##4##(1997-1#1)(2011-2#1)(2012-2#1)
the need for careful##5##4##(1990-8#1)(1991-2#1)(1995-1#1)(2009-4#1)(2009-8#1)
the need for caution in##3##5##(2006-7#1)(2008-11#1)(2009-9#1)
the need for caution when using##2##6##(1992-7#1)(2008-10#1)
the need for caution when##3##5##(1992-1#1)(1992-7#1)(2008-10#1)
the need for caution##7##4##(1991-2#1)(1992-1#1)(1992-7#1)(2006-7#1)(2008-10#1)(2008-11#1)(2009-9#1)
the need for clinical##3##4##(2006-7#1)(2008-10#1)(2012-2#1)
the need for close##2##4##(1991-2#1)(2007-8#1)
the need for complementary##2##4##(2006-4#1)(2008-10#1)
the need for considering the##2##5##(2010-5#1)(2011-1#1)
the need for considering##3##4##(1997-6#1)(2010-5#1)(2011-1#1)
the need for continued##4##4##(2008-7#1)(2008-9#1)(2009-11#1)(2010-1#1)
the need for continuous##4##4##(2006-10#1)(2008-1#1)(2010-9#1)(2013-8#1)
the need for conventional##2##4##(2007-6#1)(2012-2#1)
the need for creating##2##4##(2007-7#1)(2013-1#1)
the need for custom design and fabrication of application-specific##2##9##(2008-2#2)
the need for custom##3##4##(2008-2#2)(2008-6#1)
the need for developing##4##4##(2005-7#1)(2007-11#1)(2007-7#1)(2011-2#1)
the need for diagnostic##2##4##(2007-7#1)(2008-7#1)
the need for dialogue between##2##5##(2008-2#1)(2011-1#1)
the need for dialysis services##2##5##(2010-5#2)
the need for drawing##2##4##(2006-10#1)(2007-12#1)
the need for early##6##4##(1992-7#2)(2007-2#1)(2008-1#1)(2009-8#1)(2013-1#1)
the need for education##4##4##(1993-3#1)(1996-7#1)(2010-9#1)(2011-1#1)
the need for effective##5##4##(2005-7#1)(2007-10#1)(2008-12#1)(2009-9#1)(2010-7#1)
the need for emergency##2##4##(2007-11#1)(2008-1#1)
the need for endotracheal intubation and##2##6##(1995-4#1)(2006-9#1)
the need for expanded##2##4##(2007-2#1)(2012-11#1)
the need for exploratory##2##4##(2007-9#1)(2010-11#1)
the need for extensive##3##4##(1991-5#1)(2006-2#1)(2008-10#1)
the need for external##2##4##(1994-9#1)(2007-11#1)
the need for family##2##4##(2011-12#1)(2013-1#1)
the need for formal representations for EHR-driven phenotyping algorithms has been recognized for some time##2##15##(2013-1#2)
the need for frequent##2##4##(2008-10#1)(2008-5#1)
the need for further research in##2##6##(2007-2#1)(2012-12#1)
the need for further research##9##5##(2007-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the need for further studies of##2##6##(1997-2#1)(2013-8#1)
the need for further studies##3##5##(1997-2#1)(2007-12#1)(2013-8#1)
the need for further study##2##5##(2006-7#1)(2007-4#1)
the need for further##25##4##(1992-11#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-2#1)(1996-9#1)(1997-2#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
the need for future##2##4##(2006-10#1)(2008-12#1)
the need for good##2##4##(2004-1#1)(2011-1#1)
the need for greater##3##4##(1996-1#1)(2006-10#1)(2012-2#1)
the need for health care providers to##2##7##(2009-10#1)(2009-5#1)
the need for health care##4##5##(1993-2#1)(2008-11#1)(2009-10#1)(2009-5#1)
the need for health##5##4##(1993-2#1)(2008-11#1)(2008-9#1)(2009-10#1)(2009-5#1)
the need for immediate##5##4##(2007-2#1)(2008-10#1)(2010-10#2)(2012-2#1)
the need for improved##3##4##(2005-8#1)(2006-12#1)(2008-8#1)
the need for increased##7##4##(1997-4#1)(2008-3#2)(2010-10#1)(2011-2#1)(2013-1#2)
the need for information on##2##5##(1990-12#1)(1992-3#1)
the need for information##3##4##(1990-12#1)(1992-3#1)(2005-7#1)
the need for innovative##2##4##(2007-2#1)(2012-3#1)
the need for intensive##2##4##(2007-8#1)(2009-10#1)
the need for large##2##4##(2008-10#1)(2010-8#1)
the need for liver##2##4##(2004-11#1)(2007-11#1)
the need for long term##2##5##(1993-2#1)(2007-10#1)
the need for long-term follow-up##2##5##(1992-2#1)(2011-2#1)
the need for long-term##4##4##(1992-2#1)(2008-1#1)(2011-2#2)
the need for management##2##4##(2008-10#2)
the need for monitoring##2##4##(2006-10#1)(2008-7#1)
the need for more research##2##5##(2010-3#1)(2010-9#1)
the need for more##15##4##(1990-12#1)(1994-3#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-9#2)(2011-2#1)
the need for multiple##2##4##(2007-11#1)(2009-11#1)
the need for new and##2##5##(2008-6#1)(2012-2#1)
the need for new##8##4##(2006-2#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-1#1)(2012-2#1)
the need for novel##3##4##(2005-11#1)(2008-5#1)(2011-2#1)
the need for nursing##2##4##(1996-3#1)(2008-11#1)
the need for ongoing##6##4##(1996-2#1)(2006-4#1)(2007-6#1)(2008-11#1)(2012-11#1)(2013-1#1)
the need for other##2##4##(2008-3#1)(2008-9#1)
the need for patients##2##4##(2007-12#1)(2008-12#1)
the need for periodic##2##4##(1991-2#1)(2008-10#1)
the need for phase##2##4##(2007-11#1)(2007-12#1)
the need for policies##2##4##(1991-5#1)(2010-1#1)
the need for postoperative##2##4##(1993-1#1)(2005-8#1)
the need for prevention##2##4##(2007-11#1)(2007-12#1)
the need for preventive##2##4##(1995-12#1)(2009-10#1)
the need for prior##2##4##(2008-3#1)(2010-6#1)
the need for prompt##3##4##(2008-1#1)(2008-3#1)(2012-12#1)
the need for quality##3##4##(1993-12#1)(1996-12#1)(2005-11#1)
the need for rapid##4##4##(1993-3#1)(1995-8#1)(2008-10#2)
the need for renal##3##4##(2006-4#1)(2007-7#1)(2008-6#1)
the need for repeated##4##4##(2006-12#1)(2007-7#1)(2008-3#1)(2012-2#1)
the need for research into##3##5##(1994-1#1)(2007-10#1)(2012-12#1)
the need for research##7##4##(1994-1#1)(1996-2#1)(1996-3#1)(1997-7#1)(2007-10#2)(2012-12#1)
the need for revascularization procedures##2##5##(2008-5#1)(2009-10#1)
the need for rigorous##2##4##(2005-11#1)(2012-2#1)
the need for role##2##4##(2008-12#1)(2011-2#1)
the need for screening##2##4##(2011-12#1)(2011-2#1)
the need for separation##3##4##(2008-10#1)(2008-4#2)
the need for sophisticated##2##4##(2008-11#1)(2008-4#1)
the need for special##2##4##(1997-8#1)(2007-11#1)
the need for specific##2##4##(2008-1#1)(2013-8#1)
the need for strong##2##4##(1994-11#1)(1994-3#1)
the need for such##5##4##(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-9#1)
the need for suitable##2##4##(1995-11#1)(2009-11#1)
the need for surgery##3##4##(1997-3#1)(2006-4#1)(2012-2#1)
the need for surgical excision##2##5##(2006-11#1)(2011-2#1)
the need for surgical##4##4##(2006-11#1)(2006-2#1)(2008-9#1)(2011-2#1)
the need for systematic evaluation##2##5##(2006-6#1)(2006-8#1)
the need for tedious##3##4##(2008-10#3)
the need for the development of##4##6##(2005-7#1)(2009-5#1)(2011-1#1)(2012-12#1)
the need for the establishment of a##2##7##(2007-3#1)(2011-2#1)
the need for the use of##2##6##(2006-10#1)(2008-6#1)
the need for the##25##4##(1994-3#1)(1995-1#1)(1995-11#1)(1997-7#1)(2005-7#1)(2006-10#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#2)(2013-8#1)
the need for therapy##2##4##(1992-8#1)(2008-6#1)
the need for these##2##4##(1993-12#1)(2008-1#1)
the need for this##2##4##(2007-7#1)(2011-12#1)
the need for thorough##3##4##(1991-12#1)(1991-2#1)(2008-4#1)
the need for timely##2##4##(1993-12#1)(2012-3#1)
the need for transfusion##2##4##(1994-6#1)(2007-7#1)
the need for treatment##2##4##(2004-3#1)(2007-9#1)
the need for using##2##4##(2007-11#1)(2008-2#1)
the need for##821##3##(1990-10#3)(1990-11#1)(1990-12#2)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-2#7)(1991-3#4)(1991-5#3)(1991-6#2)(1992-1#3)(1992-11#2)(1992-12#2)(1992-2#4)(1992-3#2)(1992-4#2)(1992-7#4)(1992-8#3)(1992-9#1)(1993-1#4)(1993-12#5)(1993-2#2)(1993-3#3)(1993-5#1)(1993-6#1)(1994-1#1)(1994-11#4)(1994-2#3)(1994-3#7)(1994-6#3)(1994-8#2)(1994-9#3)(1995-1#7)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#2)(1995-4#2)(1995-5#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#8)(1996-11#2)(1996-12#5)(1996-2#5)(1996-3#4)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#5)(1997-4#4)(1997-6#3)(1997-7#3)(1997-8#2)(2004-1#1)(2004-10#2)(2004-11#1)(2004-12#1)(2004-2#1)(2004-3#1)(2005-11#4)(2005-12#2)(2005-5#1)(2005-7#5)(2005-8#9)(2005-9#1)(2006-10#21)(2006-11#1)(2006-12#6)(2006-2#4)(2006-4#6)(2006-5#6)(2006-6#7)(2006-7#4)(2006-8#4)(2006-9#3)(2007-1#2)(2007-10#10)(2007-11#27)(2007-12#18)(2007-2#12)(2007-3#5)(2007-4#1)(2007-5#5)(2007-6#3)(2007-7#21)(2007-8#10)(2007-9#5)(2008-1#15)(2008-10#60)(2008-11#27)(2008-12#13)(2008-2#17)(2008-3#20)(2008-4#14)(2008-5#11)(2008-6#7)(2008-7#16)(2008-8#10)(2008-9#13)(2009-1#1)(2009-10#6)(2009-11#4)(2009-12#2)(2009-2#2)(2009-3#4)(2009-4#4)(2009-5#5)(2009-6#3)(2009-7#2)(2009-8#3)(2009-9#6)(2010-1#2)(2010-10#7)(2010-11#5)(2010-12#7)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#5)(2010-6#3)(2010-7#3)(2010-8#3)(2010-9#7)(2011-1#12)(2011-12#5)(2011-2#32)(2011-3#1)(2012-1#4)(2012-11#4)(2012-12#13)(2012-2#17)(2012-3#8)(2013-1#22)(2013-7#2)(2013-8#12)
the need of a##9##4##(1996-5#1)(2007-9#1)(2008-10#3)(2008-11#1)(2009-4#1)(2011-1#1)(2013-1#1)
the need of further##2##4##(2008-10#1)(2012-3#1)
the need of taking##2##4##(2006-8#1)(2007-7#1)
the need of the##2##4##(2011-2#1)(2013-1#1)
the need of##49##3##(1990-3#1)(1992-3#1)(1993-2#1)(1995-5#1)(1996-5#1)(2006-1#1)(2006-4#1)(2006-8#1)(2007-11#2)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#1)(2008-8#1)(2009-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
the need to account for##2##5##(2008-10#1)(2008-3#1)
the need to address##2##4##(1991-12#1)(2008-11#1)
the need to balance##2##4##(2010-12#1)(2013-1#1)
the need to be##5##4##(2006-10#1)(2008-12#1)(2011-2#2)(2012-3#1)
the need to better##2##4##(2007-9#1)(2013-1#1)
the need to care for##2##5##(1995-12#1)(2008-4#1)
the need to combine##2##4##(2006-10#1)(2008-8#1)
the need to compensate for##2##5##(2007-11#1)(2010-8#1)
the need to consider the##4##5##(2007-2#1)(2008-7#1)(2010-12#1)(2010-2#1)
the need to consider##13##4##(1994-3#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-1#1)(2010-12#1)(2010-2#2)(2011-2#1)
the need to create##2##4##(2007-10#1)(2008-1#1)
the need to decompress the##2##5##(2007-8#1)(2008-2#1)
the need to define##2##4##(2010-5#1)(2013-1#1)
the need to demystify##2##4##(1993-3#1)(2011-2#1)
the need to determine##5##4##(1990-5#1)(2007-9#1)(2008-10#1)(2010-4#1)(2010-6#1)
the need to develop a##2##5##(1997-2#1)(2008-3#1)
the need to develop##10##4##(1996-3#1)(1997-2#2)(1997-3#1)(1997-4#1)(2005-7#1)(2008-3#1)(2008-5#1)(2012-1#1)(2013-1#1)
the need to establish##2##4##(2005-8#1)(2012-2#1)
the need to examine the##2##5##(2006-8#1)(2008-11#1)
the need to examine##4##4##(1996-12#1)(2006-8#1)(2008-11#1)(2013-7#1)
the need to focus on##2##5##(2005-10#1)(2006-10#1)
the need to focus##3##4##(2005-10#1)(2006-10#1)(2007-7#1)
the need to further##3##4##(1996-8#1)(2010-8#1)(2011-2#1)
the need to have##2##4##(2006-6#1)(2009-8#1)
the need to identify##3##4##(2008-10#1)(2009-7#1)(2011-2#1)
the need to implement##4##4##(1994-7#1)(2007-1#1)(2007-12#1)(2011-2#1)
the need to improve##2##4##(1996-1#1)(2008-2#1)
the need to include the##2##5##(2005-10#1)(2008-11#1)
the need to include##7##4##(2005-10#1)(2006-10#1)(2008-11#2)(2008-2#1)(2008-9#1)(2012-2#1)
the need to integrate##3##4##(1994-12#1)(2008-3#1)(2009-8#1)
the need to keep##2##4##(2008-4#1)(2008-7#1)
the need to make##4##4##(1991-6#1)(2006-9#1)(2008-1#1)(2012-3#1)
the need to modify##2##4##(1991-3#1)(2012-3#1)
the need to obtain##2##4##(1991-2#1)(2005-12#1)
the need to optimize##2##4##(2008-10#1)(2010-12#1)
the need to pay##2##4##(2012-2#1)(2012-3#1)
the need to perform##2##4##(2006-9#1)(2009-4#1)
the need to preserve##2##4##(2008-3#1)(2008-7#1)
the need to provide##5##4##(1995-2#1)(2006-10#1)(2006-4#1)(2007-3#1)(2013-8#1)
the need to put##2##4##(1991-3#1)(2010-5#1)
the need to recognize and##2##5##(2008-11#1)(2010-9#1)
the need to recognize the##2##5##(2005-11#1)(2008-12#1)
the need to recognize##6##4##(1994-2#1)(2005-11#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-9#1)
the need to reduce##2##4##(1996-1#1)(2008-12#1)
the need to search for##2##5##(2008-10#1)(2008-6#1)
the need to search##3##4##(2008-10#1)(2008-6#1)(2008-7#1)
the need to seek##3##4##(2007-2#1)(2008-6#1)(2012-3#1)
the need to strengthen##3##4##(2008-11#1)(2011-1#1)(2012-12#1)
the need to study the##2##5##(2008-5#1)(2012-12#1)
the need to study##3##4##(2008-5#2)(2012-12#1)
the need to take##2##4##(2008-12#1)(2009-4#1)
the need to understand how##2##5##(2008-3#1)(2010-3#1)
the need to understand the##2##5##(2011-1#1)(2013-8#1)
the need to understand##7##4##(2006-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-3#1)(2011-1#1)(2013-8#1)
the need to use##6##4##(1991-8#1)(2007-12#1)(2007-5#1)(2008-5#1)(2009-8#1)(2013-1#1)
the need to work##3##4##(1990-5#1)(2009-4#1)(2013-7#1)
the need to##269##3##(1990-4#1)(1990-5#2)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-6#1)(1991-8#1)(1992-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(2005-10#2)(2005-11#1)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#11)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#1)(2006-6#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#6)(2007-2#3)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#4)(2008-1#2)(2008-10#14)(2008-11#11)(2008-12#4)(2008-2#6)(2008-3#6)(2008-4#5)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#4)(2009-1#1)(2009-2#1)(2009-4#4)(2009-5#1)(2009-7#1)(2009-8#6)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#5)(2010-2#4)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#13)(2012-1#3)(2012-12#5)(2012-2#4)(2012-3#8)(2013-1#15)(2013-7#4)(2013-8#3)
the need##1166##2##(1990-10#3)(1990-11#1)(1990-12#2)(1990-3#3)(1990-4#3)(1990-5#3)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#8)(1991-3#7)(1991-4#1)(1991-5#3)(1991-6#3)(1991-8#1)(1992-1#6)(1992-11#2)(1992-12#2)(1992-2#5)(1992-3#3)(1992-4#2)(1992-7#4)(1992-8#3)(1992-9#2)(1993-1#4)(1993-12#6)(1993-2#5)(1993-3#5)(1993-5#1)(1993-6#2)(1993-9#1)(1994-1#1)(1994-11#4)(1994-12#1)(1994-2#4)(1994-3#8)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#3)(1995-1#8)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#2)(1995-4#2)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#11)(1996-11#3)(1996-12#6)(1996-2#6)(1996-3#7)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#3)(1997-2#5)(1997-3#6)(1997-4#6)(1997-6#3)(1997-7#3)(1997-8#2)(2004-1#1)(2004-10#2)(2004-11#1)(2004-12#1)(2004-2#1)(2004-3#1)(2005-10#2)(2005-11#5)(2005-12#3)(2005-5#2)(2005-7#6)(2005-8#11)(2005-9#1)(2006-1#1)(2006-10#32)(2006-11#1)(2006-12#8)(2006-2#5)(2006-3#2)(2006-4#8)(2006-5#6)(2006-6#8)(2006-7#4)(2006-8#7)(2006-9#6)(2007-1#3)(2007-10#13)(2007-11#34)(2007-12#24)(2007-2#15)(2007-3#6)(2007-4#1)(2007-5#6)(2007-6#3)(2007-7#23)(2007-8#18)(2007-9#11)(2008-1#18)(2008-10#83)(2008-11#43)(2008-12#17)(2008-2#25)(2008-3#29)(2008-4#19)(2008-5#15)(2008-6#9)(2008-7#25)(2008-8#15)(2008-9#17)(2009-1#2)(2009-10#6)(2009-11#4)(2009-12#2)(2009-2#3)(2009-3#4)(2009-4#10)(2009-5#6)(2009-6#3)(2009-7#3)(2009-8#10)(2009-9#7)(2010-1#3)(2010-10#7)(2010-11#7)(2010-12#12)(2010-2#7)(2010-3#4)(2010-4#4)(2010-5#8)(2010-6#4)(2010-7#6)(2010-8#5)(2010-9#8)(2011-1#19)(2011-12#5)(2011-2#51)(2011-3#1)(2012-1#8)(2012-11#7)(2012-12#18)(2012-2#22)(2012-3#18)(2013-1#40)(2013-7#6)(2013-8#17)
the needed long-term##2##3##(2006-2#1)(2008-1#1)
the needed##5##2##(1996-1#1)(2006-2#1)(2008-1#2)(2008-8#1)
the needle and##2##3##(2006-8#1)(2008-10#1)
the needle in the##3##4##(1997-8#1)(2010-6#1)(2012-2#1)
the needle in##4##3##(1997-8#1)(2010-6#1)(2012-2#2)
the needle into the##2##4##(1990-2#1)(2007-8#1)
the needle into##3##3##(1990-2#1)(2007-8#1)(2008-10#1)
the needle is##3##3##(2010-6#1)(2010-8#1)(2012-2#1)
the needle method##2##3##(2008-2#1)(2008-3#1)
the needle tip of a##2##5##(2008-10#1)(2012-2#1)
the needle tip##4##3##(2008-10#2)(2008-4#1)(2012-2#1)
the needle tract and##2##4##(1990-5#1)(2008-9#1)
the needle tract##4##3##(1990-5#1)(1995-11#1)(2008-9#2)
the needle was##4##3##(1996-12#1)(2006-12#1)(2007-8#1)(2008-11#1)
the needle##50##2##(1990-2#1)(1990-5#1)(1991-12#1)(1992-12#2)(1995-11#1)(1996-11#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-8#1)(2006-10#2)(2006-12#1)(2006-8#2)(2007-11#1)(2007-8#3)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-2#1)(2010-6#4)(2010-8#4)(2011-2#1)(2012-2#5)
the needles##6##2##(2007-1#1)(2007-7#2)(2010-6#1)(2011-10#1)(2013-1#1)
the needlestick##2##2##(1996-5#1)(2012-12#1)
the needs and expectations of the##3##6##(1995-1#1)(2010-4#1)(2011-1#1)
the needs and experiences of##2##5##(2006-12#1)(2013-1#1)
the needs and interests of##2##5##(1997-1#1)(1997-3#1)
the needs and##17##3##(1995-1#1)(1997-1#1)(1997-3#1)(2006-12#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-7#3)(2010-10#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#1)
the needs for##7##3##(1991-6#1)(1993-3#1)(2007-8#1)(2008-3#1)(2009-4#1)(2010-12#1)(2013-8#1)
the needs of a##3##4##(1991-3#1)(2008-10#1)(2008-11#1)
the needs of all##2##4##(1994-12#1)(2010-12#1)
the needs of both primary and secondary information users##2##9##(2008-2#2)
the needs of both##5##4##(2006-2#1)(2008-2#2)(2008-6#1)(2010-7#1)
the needs of children and their##2##6##(1994-1#1)(2012-2#1)
the needs of children who are##2##6##(1992-1#1)(2013-1#1)
the needs of children##8##4##(1992-1#1)(1992-3#1)(1994-1#1)(2008-11#1)(2008-8#1)(2010-7#1)(2012-2#1)(2013-1#1)
the needs of chronically ill patients##2##6##(1997-1#2)
the needs of different##2##4##(1994-3#1)(2007-5#1)
the needs of its##3##4##(1994-2#1)(1996-3#1)(2007-8#1)
the needs of our##4##4##(1996-2#1)(1996-3#1)(2008-10#1)(2010-1#1)
the needs of parents of##2##5##(1992-2#1)(1994-3#1)
the needs of patients##5##4##(1992-2#1)(1996-12#1)(1996-2#1)(2007-8#1)(2010-2#1)
the needs of persons##2##4##(1994-2#1)(2007-10#1)
the needs of society##2##4##(1991-3#1)(2008-7#1)
the needs of the community##2##5##(1993-1#1)(1995-3#1)
the needs of the individual##3##5##(1993-12#1)(2008-8#1)(2013-8#1)
the needs of the patient and##3##6##(2007-12#1)(2013-1#2)
the needs of the patient##9##5##(1995-1#1)(1995-3#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-7#1)(2008-1#1)(2013-1#2)
the needs of the##53##4##(1993-1#3)(1993-12#2)(1994-2#1)(1995-1#3)(1995-2#3)(1995-3#2)(1995-9#1)(1996-1#1)(1996-3#1)(1997-1#1)(2005-11#1)(2006-10#2)(2006-3#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-5#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-7#1)(2010-8#1)(2013-1#2)(2013-8#3)
the needs of their##5##4##(1993-1#1)(2007-10#1)(2008-1#1)(2010-3#1)(2013-7#1)
the needs of these##2##4##(2013-1#2)
the needs of this##2##4##(1993-12#1)(2010-2#1)
the needs of those##2##4##(2007-1#1)(2011-2#1)
the needs of##165##3##(1990-12#2)(1991-1#2)(1991-3#2)(1992-1#1)(1992-2#2)(1992-3#1)(1993-1#4)(1993-12#6)(1993-2#1)(1994-1#3)(1994-12#1)(1994-2#4)(1994-3#5)(1994-9#1)(1995-1#5)(1995-2#3)(1995-3#2)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#4)(1996-3#3)(1997-1#3)(1997-2#1)(2005-11#1)(2005-12#1)(2006-10#3)(2006-2#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#6)(2008-12#1)(2008-2#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-3#1)(2010-6#1)(2010-7#3)(2010-8#5)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#6)(2013-7#1)(2013-8#4)
the needs##200##2##(1990-12#2)(1991-1#2)(1991-3#2)(1991-6#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-1#4)(1993-12#6)(1993-2#1)(1993-3#1)(1994-1#3)(1994-12#1)(1994-2#4)(1994-3#5)(1994-9#1)(1995-1#6)(1995-2#3)(1995-3#2)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#4)(1996-3#3)(1997-1#4)(1997-2#1)(1997-3#1)(2005-11#1)(2005-12#1)(2006-10#3)(2006-12#1)(2006-2#3)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#4)(2007-11#1)(2007-12#3)(2007-2#2)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#7)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#7)(2008-8#4)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#3)(2010-8#5)(2010-9#1)(2011-1#4)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#7)(2013-7#1)(2013-8#5)
the negative affective##2##3##(2010-3#1)(2010-8#1)
the negative and positive##2##4##(2007-11#1)(2008-3#1)
the negative and##4##3##(1990-2#1)(2007-11#1)(2008-3#1)(2010-1#1)
the negative association##2##3##(2008-1#1)(2009-5#1)
the negative attitudes##3##3##(2007-2#1)(2008-11#2)
the negative binomial distribution##6##4##(2008-10#4)(2011-12#1)(2013-1#1)
the negative charge of##2##4##(1990-5#1)(2008-11#1)
the negative charge on##2##4##(1996-7#1)(2010-5#1)
the negative charge##5##3##(1990-5#1)(1991-2#1)(1996-7#1)(2008-11#1)(2010-5#1)
the negative charges of##2##4##(1996-11#1)(2008-4#1)
the negative consequences of##5##4##(1990-6#1)(2007-8#1)(2008-11#1)(2010-2#1)(2013-7#1)
the negative consequences##6##3##(1990-6#1)(2007-8#1)(2008-11#1)(2008-6#1)(2010-2#1)(2013-7#1)
the negative control of##2##4##(1997-1#1)(2006-10#1)
the negative control##10##3##(1990-6#1)(1996-11#1)(1997-1#1)(2006-10#1)(2006-12#1)(2008-10#3)(2010-5#1)(2012-2#1)
the negative correlation between##3##4##(1996-12#1)(1997-2#1)(2008-9#1)
the negative effect of the##3##5##(2007-11#1)(2008-12#1)(2008-3#1)
the negative effect of##9##4##(2007-11#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)
the negative effects of socioeconomic change##2##6##(2008-12#2)
the negative effects of##9##4##(1994-2#1)(2005-1#1)(2007-5#1)(2008-12#2)(2008-2#1)(2010-7#1)(2010-8#1)(2013-8#1)
the negative effects##13##3##(1994-2#1)(2005-1#1)(2007-5#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2013-8#1)
the negative electrode##2##3##(2009-12#2)
the negative feedback##4##3##(1994-2#1)(2007-9#1)(2008-11#1)(2012-2#1)
the negative group##2##3##(2008-1#2)
the negative health##2##3##(2006-2#1)(2008-1#1)
the negative impact of##9##4##(1991-3#1)(1993-1#1)(1997-1#1)(2008-9#1)(2010-2#1)(2010-7#1)(2011-2#1)(2013-7#1)(2013-8#1)
the negative impact##10##3##(1991-3#1)(1993-1#1)(1997-1#1)(2007-8#1)(2008-9#1)(2010-2#1)(2010-7#1)(2011-2#1)(2013-7#1)(2013-8#1)
the negative influence of##3##4##(2005-11#1)(2008-1#1)(2008-10#1)
the negative influence##4##3##(2005-11#1)(2008-1#1)(2008-10#1)(2008-3#1)
the negative outcome##2##3##(2005-10#1)(2013-1#1)
the negative phototropism##2##3##(2008-9#2)
the negative predictive##3##3##(1993-1#1)(2006-10#1)(2013-1#1)
the negative psychological##2##3##(1995-9#1)(2007-12#1)
the negative regulation of##2##4##(1994-9#1)(2008-11#1)
the negative regulatory element (NRE)##3##5##(1991-5#2)(1994-8#1)
the negative regulatory element##4##4##(1991-12#1)(1991-5#2)(1994-8#1)
the negative regulatory##8##3##(1991-12#1)(1991-5#2)(1992-5#1)(1994-8#1)(2008-11#2)(2008-8#1)
the negative selection of##2##4##(2008-8#2)
the negative slope##3##3##(1990-7#1)(1995-3#2)
the negative stereotype group##2##4##(2008-11#2)
the negative strand of##3##4##(1994-8#1)(2008-8#2)
the negative strand##5##3##(1994-8#3)(2008-8#2)
the negative strands##2##3##(1994-8#2)
the negative surface charge##2##4##(1994-3#1)(1996-7#1)
the negative symptoms of schizophrenia##2##5##(1995-3#1)(2004-3#1)
the negative symptoms##4##3##(1995-3#1)(1996-2#2)(2004-3#1)
the negative##201##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#2)(1990-7#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#1)(1991-7#1)(1992-3#1)(1992-5#1)(1992-6#3)(1993-1#2)(1993-8#1)(1994-2#3)(1994-3#2)(1994-8#6)(1994-9#1)(1995-12#1)(1995-3#3)(1995-4#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-11#3)(1996-12#2)(1996-2#2)(1996-5#1)(1996-7#2)(1997-1#2)(1997-2#1)(1997-3#2)(1997-7#2)(2004-3#1)(2005-1#1)(2005-10#1)(2005-11#2)(2006-10#2)(2006-12#1)(2006-2#2)(2006-4#1)(2007-11#2)(2007-12#4)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#6)(2008-10#17)(2008-11#14)(2008-12#4)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#11)(2008-9#7)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-5#2)(2010-7#2)(2010-8#2)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-7#2)(2013-8#3)
the negative-sense##2##2##(2008-10#1)(2010-5#1)
the negatively charged side chain of##2##6##(1990-8#1)(1992-9#1)
the negatively charged##19##3##(1990-2#1)(1990-8#2)(1991-8#2)(1991-9#1)(1992-12#1)(1992-9#1)(1994-2#1)(1995-10#1)(1996-8#1)(2005-11#1)(2008-10#4)(2008-7#1)(2010-7#1)(2011-1#1)
the negatively##20##2##(1990-2#1)(1990-8#2)(1991-8#2)(1991-9#1)(1992-12#1)(1992-9#1)(1994-2#1)(1995-10#1)(1996-8#1)(2005-11#1)(2008-10#4)(2008-11#1)(2008-7#1)(2010-7#1)(2011-1#1)
the negatives##3##2##(1995-3#1)(1997-3#1)(2009-12#1)
the neglect##2##2##(2006-3#1)(2008-2#1)
the negligence of##2##3##(1991-7#1)(1993-12#1)
the negligence##4##2##(1991-7#1)(1992-2#1)(1993-12#1)(1996-12#1)
the negligible##5##2##(1991-3#1)(1995-11#1)(2007-11#1)(2007-12#1)(2011-1#1)
the negotiated##2##2##(1996-12#1)(2007-8#1)
the negotiating##2##2##(1997-6#1)(2012-3#1)
the negotiation of##2##3##(2006-11#1)(2013-1#1)
the negotiation##4##2##(1994-1#1)(2006-11#1)(2012-2#1)(2013-1#1)
the neighbor##4##2##(2007-11#1)(2008-10#1)(2008-2#2)
the neighbor-joining method##2##3##(2008-10#2)
the neighbor-joining##4##2##(2008-10#2)(2008-6#1)(2013-8#1)
the neighborhood level##3##3##(1990-2#1)(2008-1#1)(2012-2#1)
the neighborhood##19##2##(1990-2#1)(1995-1#1)(1996-3#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-2#4)(2008-3#2)(2008-5#1)(2008-6#1)(2009-9#1)(2011-2#1)(2012-2#1)
the neighborhoods##2##2##(2012-12#1)(2012-2#1)
the neighboring##15##2##(1991-9#1)(1996-5#1)(1997-8#1)(2007-8#2)(2008-11#1)(2008-2#3)(2008-5#2)(2008-6#1)(2008-8#1)(2009-7#1)(2012-11#1)
the neighbourhood##3##2##(1996-6#1)(1997-1#1)(2012-3#1)
the neighbouring organs##2##3##(2007-12#1)(2008-7#1)
the neighbouring##12##2##(1990-4#1)(1991-10#1)(1993-6#1)(1996-4#1)(1997-4#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-12#1)(2008-7#1)(2010-12#1)
the nematic liquid crystal##2##4##(2007-11#1)(2007-12#1)
the nematic##5##2##(2005-11#1)(2007-11#1)(2007-12#2)(2008-2#1)
the nematicidal##2##2##(2006-10#1)(2011-2#1)
the nematode (10 per gram of soil)##2##7##(2008-10#2)
the nematode C##3##3##(1990-11#1)(2007-12#1)(2010-12#1)
the nematode Caenorhabditis elegans##16##4##(1990-5#1)(1992-9#1)(1995-3#1)(1995-8#2)(1996-6#2)(1997-7#1)(2007-12#2)(2007-8#2)(2008-10#1)(2008-4#1)(2012-12#2)
the nematode cuticle##2##3##(1994-12#1)(2007-12#1)
the nematode population##5##3##(2008-10#3)(2009-3#2)
the nematode to##2##3##(2007-12#1)(2008-10#1)
the nematode##68##2##(1990-11#1)(1990-5#1)(1992-9#4)(1993-12#1)(1994-12#1)(1995-3#1)(1995-6#1)(1995-8#4)(1996-6#2)(1997-2#2)(1997-7#1)(2005-7#1)(2006-11#1)(2007-12#8)(2007-2#1)(2007-8#2)(2008-10#24)(2008-4#1)(2008-8#1)(2009-3#4)(2010-12#2)(2010-8#1)(2012-12#3)
the nematode's##2##2##(1993-12#1)(2008-10#1)
the nematodes##13##2##(2007-11#1)(2007-12#2)(2008-10#7)(2008-12#1)(2008-8#1)(2013-7#1)
the nematophagous fungus##3##3##(2007-1#1)(2008-10#2)
the neo gene##3##3##(1993-5#1)(1996-4#1)(2008-8#1)
the neo##6##2##(1993-5#1)(1994-9#1)(1996-4#1)(1997-8#1)(2008-11#1)(2008-8#1)
the neoR gene##2##3##(1990-10#2)
the neocortex is affected##2##4##(1991-3#1)(2008-11#1)
the neocortex is largely##2##4##(1994-3#1)(2009-5#1)
the neocortex is##4##3##(1991-3#1)(1994-3#1)(2008-11#1)(2009-5#1)
the neocortex##25##2##(1990-5#1)(1990-7#1)(1991-10#1)(1991-3#2)(1992-10#1)(1993-2#1)(1993-7#1)(1994-3#1)(1995-3#2)(1997-2#1)(2008-1#2)(2008-11#5)(2009-5#3)(2010-12#1)(2010-7#2)
the neodymium##3##2##(2008-10#1)(2008-2#2)
the neoformed bone##2##3##(2008-5#2)
the neoglycolipid technology##2##3##(1992-9#2)
the neoglycolipid##3##2##(1992-9#3)
the neointima##4##2##(1997-5#2)(1997-8#1)(2007-8#1)
the neomycin##4##2##(1997-4#1)(2006-8#1)(2008-11#2)
the neomycin-resistance##2##2##(1994-5#1)(1997-8#1)
the neonatal age##3##3##(1996-9#2)(2013-1#1)
the neonatal and##2##3##(1995-7#1)(2013-1#1)
the neonatal intensive care unit##12##5##(1993-3#1)(1993-5#1)(1995-1#1)(1997-3#1)(2006-10#1)(2007-3#1)(2008-5#1)(2009-2#1)(2010-10#1)(2010-2#1)(2010-9#1)(2011-2#1)
the neonatal intensive care##15##4##(1990-6#1)(1993-3#1)(1993-5#1)(1995-1#1)(1996-12#1)(1997-3#1)(2006-10#1)(2007-3#1)(2008-5#1)(2009-2#1)(2010-10#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-2#1)
the neonatal mouse##2##3##(1995-1#1)(2012-2#1)
the neonatal period and##5##4##(1992-7#1)(1997-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
the neonatal period##26##3##(1991-6#1)(1992-2#2)(1992-7#2)(1992-8#1)(1993-5#1)(1995-10#1)(1996-3#1)(1997-3#1)(2006-1#2)(2006-6#2)(2007-11#2)(2007-8#2)(2008-10#1)(2008-4#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-2#1)
the neonatal rat optic nerve##2##5##(1994-2#1)(1995-11#1)
the neonatal rat spinal cord##2##5##(1994-2#2)
the neonatal rat##13##3##(1991-5#1)(1992-7#1)(1994-2#4)(1995-10#1)(1995-11#1)(1995-6#2)(1997-2#2)(2009-12#1)
the neonatal stage##3##3##(1991-6#1)(1993-12#1)(2009-9#1)
the neonatal unit of##2##4##(1992-2#1)(2006-8#1)
the neonatal unit##4##3##(1992-2#1)(1995-5#1)(2006-8#1)(2008-11#1)
the neonatal##93##2##(1990-6#1)(1991-5#1)(1991-6#2)(1992-2#4)(1992-7#6)(1992-8#2)(1993-12#1)(1993-3#1)(1993-5#3)(1994-2#4)(1994-8#1)(1995-1#2)(1995-10#2)(1995-11#2)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#2)(1997-2#2)(1997-3#4)(1997-4#1)(2006-1#3)(2006-10#1)(2006-6#2)(2006-8#2)(2007-11#2)(2007-3#3)(2007-8#2)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#2)(2009-12#1)(2009-2#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-2#3)(2013-1#3)
the neonate and##2##3##(1991-12#1)(1992-6#1)
the neonate##22##2##(1990-6#1)(1991-12#1)(1991-4#1)(1992-5#1)(1992-6#1)(1993-10#2)(1996-12#1)(1996-3#2)(2006-10#3)(2008-4#1)(2008-6#1)(2009-1#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-3#2)
the neonates##6##2##(1992-2#1)(1996-9#1)(2007-8#1)(2011-1#2)(2012-2#1)
the neonatologist##2##2##(1990-6#1)(1993-6#1)
the neoplasia##2##2##(1990-6#1)(2012-3#1)
the neoplasm was##3##3##(1992-9#1)(2008-5#1)(2008-7#1)
the neoplasm##16##2##(1990-10#1)(1990-3#1)(1991-2#1)(1991-8#1)(1992-9#1)(1993-6#1)(1997-8#1)(2006-2#1)(2007-6#1)(2007-7#1)(2008-5#1)(2008-7#1)(2011-12#1)(2011-2#2)(2012-2#1)
the neoplasms##5##2##(1990-5#1)(1991-6#1)(2007-2#1)(2008-4#1)(2008-5#1)
the neoplastic cells##8##3##(1990-12#1)(1992-2#2)(1997-1#1)(2008-6#1)(2009-1#1)(2009-8#1)(2012-1#1)
the neoplastic transformation##2##3##(2006-10#1)(2010-12#1)
the neoplastic##25##2##(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1991-12#1)(1992-2#2)(1994-3#1)(1997-1#1)(1997-5#1)(2006-10#2)(2006-6#2)(2008-10#1)(2008-4#1)(2008-6#1)(2009-1#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-12#1)(2012-1#1)(2013-1#1)
the neostriatum in##3##3##(1991-3#2)(2009-12#1)
the neostriatum on##2##3##(1994-10#2)
the neostriatum##10##2##(1991-3#3)(1993-3#2)(1994-10#3)(1994-8#1)(2009-12#1)
the neotropical##5##2##(2007-3#1)(2007-9#1)(2008-5#2)(2008-7#1)
the nephrectomy##3##2##(2006-7#2)(2011-2#1)
the nephrographic and early excretory phases##2##6##(2008-4#2)
the nephrographic##3##2##(2008-4#3)
the nephrologists##2##2##(2008-1#1)(2008-4#1)
the nephrology department##2##3##(2008-1#1)(2010-7#1)
the nephrology##5##2##(2005-2#3)(2008-1#1)(2010-7#1)
the nephron##3##2##(1991-5#1)(2006-6#1)(2012-11#1)
the nephrotic syndrome##19##3##(1990-8#2)(1996-6#1)(1997-2#1)(2007-7#5)(2008-1#9)(2013-8#1)
the nephrotic##23##2##(1990-8#2)(1996-6#1)(1997-2#1)(2006-7#2)(2007-7#6)(2008-1#10)(2013-8#1)
the nephrotoxic##3##2##(1993-3#1)(2008-4#1)(2012-12#1)
the nephrotoxicity of##4##3##(1990-3#1)(1990-4#1)(2006-10#1)(2008-6#1)
the nephrotoxicity##6##2##(1990-3#2)(1990-4#1)(2006-10#1)(2008-6#1)(2010-11#1)
the nerve branch##2##3##(2008-9#1)(2010-12#1)
the nerve cell##3##3##(1991-9#1)(1995-8#1)(2008-8#1)
the nerve cells##4##3##(1997-8#3)(2008-11#1)
the nerve fiber##2##3##(1991-10#1)(2010-1#1)
the nerve fibres##2##3##(1991-3#1)(1994-2#1)
the nerve findings##2##3##(2008-1#2)
the nerve growth factor (NGF)##2##5##(1994-2#1)(1997-2#1)
the nerve growth factor##3##4##(1992-9#1)(1994-2#1)(1997-2#1)
the nerve growth##4##3##(1992-9#1)(1994-11#1)(1994-2#1)(1997-2#1)
the nerve injury##2##3##(1991-3#1)(1995-12#1)
the nerve of##2##3##(2008-5#1)(2011-1#1)
the nerve root##7##3##(2006-11#1)(2006-8#3)(2007-1#2)(2007-8#1)
the nerve roots##5##3##(2006-12#2)(2007-8#2)(2012-3#1)
the nerve sheath##3##3##(1996-2#1)(2007-11#1)(2013-7#1)
the nerve terminals or dendrites##2##5##(1995-7#2)
the nerve to the##4##4##(1991-10#1)(1992-9#1)(2006-3#1)(2008-9#1)
the nerve to##5##3##(1991-10#1)(1992-9#1)(2006-3#1)(2008-9#1)(2010-1#1)
the nerve trunk##2##3##(1997-3#1)(2011-1#1)
the nerve##86##2##(1990-5#1)(1990-7#2)(1991-10#2)(1991-2#1)(1991-3#2)(1991-9#1)(1992-11#1)(1992-8#1)(1992-9#3)(1993-12#1)(1994-11#1)(1994-2#2)(1995-12#1)(1995-7#2)(1995-8#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-8#3)(2006-11#1)(2006-12#4)(2006-3#1)(2006-8#4)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#3)(2007-8#3)(2008-1#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#5)(2009-5#4)(2009-9#1)(2010-1#2)(2010-12#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)
the nerves of the##3##4##(1992-1#1)(1993-2#1)(2007-7#1)
the nerves##10##2##(1990-10#1)(1990-8#1)(1992-1#1)(1993-2#1)(2006-11#1)(2007-7#2)(2008-1#1)(2008-5#1)(2010-9#1)
the nervous and immune systems##3##5##(2007-11#2)(2013-1#1)
the nervous and immune##4##4##(1995-12#1)(2007-11#2)(2013-1#1)
the nervous and##6##3##(1994-2#1)(1995-12#1)(2007-11#2)(2012-2#1)(2013-1#1)
the nervous mutant mouse##2##4##(1994-10#2)
the nervous mutant##3##3##(1994-10#3)
the nervous system and##6##4##(1995-5#1)(1997-6#1)(2006-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
the nervous system are of##2##5##(2008-5#1)(2008-7#1)
the nervous system are##8##4##(1994-10#1)(2006-12#1)(2008-1#1)(2008-5#2)(2008-7#1)(2010-12#1)(2012-2#1)
the nervous system as##4##4##(1996-3#1)(2008-2#1)(2013-1#2)
the nervous system by disturbing the##2##6##(1991-11#2)
the nervous system by##4##4##(1991-11#2)(1997-2#1)(2007-12#1)
the nervous system can##2##4##(2008-5#1)(2008-7#1)
the nervous system depends##2##4##(1991-3#1)(2008-4#1)
the nervous system during##2##4##(1997-3#1)(2006-11#1)
the nervous system in the##4##5##(1995-5#1)(2007-12#2)(2010-8#1)
the nervous system in##5##4##(1994-11#1)(1995-5#1)(2007-12#2)(2010-8#1)
the nervous system of the##2##5##(1992-9#1)(1997-6#1)
the nervous system of##4##4##(1992-9#1)(1997-6#1)(2008-7#2)
the nervous system or##2##4##(1991-12#1)(2009-10#1)
the nervous system that##3##4##(2006-10#1)(2008-9#1)(2012-2#1)
the nervous system was##3##4##(1991-7#1)(1997-4#1)(2008-5#1)
the nervous system##162##3##(1990-5#2)(1990-7#2)(1990-8#1)(1991-11#2)(1991-12#1)(1991-3#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-6#3)(1993-9#1)(1994-10#1)(1994-11#3)(1994-2#3)(1994-5#2)(1995-12#1)(1995-2#1)(1995-5#2)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#2)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#5)(1997-7#2)(2004-11#1)(2004-12#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-6#1)(2006-8#2)(2007-11#8)(2007-12#9)(2007-8#4)(2008-1#4)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#11)(2008-5#9)(2008-6#1)(2008-7#9)(2008-8#3)(2008-9#1)(2009-10#2)(2009-3#4)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#1)
the nervous tissue##6##3##(1990-3#1)(1996-2#1)(2006-12#1)(2008-4#1)(2010-11#2)
the nervous##188##2##(1990-3#1)(1990-5#2)(1990-7#2)(1990-8#1)(1991-11#2)(1991-12#1)(1991-3#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-6#3)(1993-9#1)(1994-10#5)(1994-11#3)(1994-2#4)(1994-5#2)(1994-6#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#2)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#6)(1997-7#2)(2004-11#1)(2004-12#1)(2006-10#1)(2006-11#2)(2006-12#4)(2006-6#2)(2006-8#2)(2007-11#11)(2007-12#9)(2007-8#4)(2008-1#4)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#13)(2008-5#9)(2008-6#1)(2008-7#9)(2008-8#3)(2008-9#1)(2009-10#2)(2009-3#4)(2009-6#2)(2009-7#1)(2010-11#3)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#3)(2013-8#1)
the nervus##2##2##(1995-5#1)(2010-11#1)
the nest of a##3##4##(2008-8#1)(2008-9#2)
the nest of##5##3##(2007-3#1)(2008-8#2)(2008-9#2)
the nest or carcass##2##4##(2005-7#2)
the nest##15##2##(1992-3#1)(1992-6#1)(2005-7#2)(2007-3#1)(2008-5#1)(2008-8#5)(2008-9#4)
the nested##7##2##(1993-12#2)(1993-9#1)(1996-2#1)(1997-4#1)(2008-10#1)(2008-11#1)
the nesting##6##2##(1990-8#1)(1995-3#1)(2007-3#2)(2007-5#1)(2008-6#1)
the nests##5##2##(2004-4#2)(2007-3#1)(2007-5#1)(2008-8#1)
the net calcium-activated chloride conductance##2##5##(1996-2#2)
the net charge##6##3##(1990-2#1)(1995-1#1)(1996-7#1)(2008-4#1)(2009-4#1)(2010-1#1)
the net effect of this##2##5##(2008-10#1)(2008-8#1)
the net effect of##5##4##(2007-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
the net effects of##2##4##(2009-4#1)(2010-9#1)
the net mucosal-to-serosal##2##3##(2008-6#2)
the net negative charge##2##4##(1996-8#1)(2008-5#1)
the net negative##3##3##(1996-8#1)(2007-11#1)(2008-5#1)
the net of acupuncture points and meridians##2##7##(2011-1#2)
the net of##3##3##(2008-5#1)(2011-1#2)
the net positive charge##2##4##(1991-9#1)(1997-7#1)
the net rates of##2##4##(1996-5#2)
the net result of##4##4##(1995-4#1)(2006-9#1)(2008-5#1)(2008-8#1)
the net result##5##3##(1992-9#1)(1995-4#1)(2006-9#1)(2008-5#1)(2008-8#1)
the net transfer##2##3##(1997-7#1)(2009-9#1)
the net uptake of##2##4##(1994-5#1)(1995-5#1)
the net##97##2##(1990-10#1)(1990-2#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-9#1)(1993-11#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-1#2)(1996-2#3)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1997-7#2)(2005-10#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#3)(2008-8#5)(2008-9#3)(2009-4#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
the network and the##2##4##(1993-12#1)(2008-3#1)
the network and##7##3##(1993-12#1)(2006-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-7#1)
the network are##3##3##(1996-12#1)(2006-10#1)(2009-8#1)
the network as well as##2##5##(1991-6#1)(2007-12#1)
the network can##4##3##(2008-10#1)(2008-2#1)(2013-1#2)
the network is##4##3##(1993-12#1)(1994-8#1)(2008-2#2)
the network mesh size##2##4##(2009-10#2)
the network of##13##3##(1991-10#1)(1994-8#1)(1996-4#1)(2004-9#1)(2005-5#1)(2006-10#1)(2007-10#1)(2008-7#2)(2009-10#1)(2012-1#1)(2012-2#2)
the network provides##2##3##(1994-3#1)(2011-12#1)
the network structure of##2##4##(2006-10#1)(2007-12#1)
the network structure##4##3##(2006-10#1)(2007-12#1)(2008-7#1)(2009-10#1)
the network to##5##3##(1993-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-3#1)
the network was##3##3##(2008-10#2)(2013-1#1)
the network##113##2##(1991-10#1)(1991-6#3)(1993-12#3)(1994-3#1)(1994-8#2)(1995-1#1)(1995-11#1)(1996-12#1)(1996-3#1)(1996-4#2)(1997-3#3)(1997-8#1)(2004-9#3)(2005-10#1)(2005-11#2)(2005-5#1)(2006-10#6)(2006-4#1)(2006-7#3)(2007-10#1)(2007-12#3)(2008-1#3)(2008-10#6)(2008-11#10)(2008-2#12)(2008-3#5)(2008-5#1)(2008-7#4)(2008-9#1)(2009-10#5)(2009-4#3)(2009-8#2)(2010-1#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#6)(2012-3#1)(2013-1#3)(2013-7#2)
the networks of##2##3##(2008-9#1)(2012-2#1)
the networks##18##2##(1995-7#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-4#1)(2012-2#2)
the neural activity##2##3##(2008-11#2)
the neural and genetic##2##4##(1995-1#1)(2007-12#1)
the neural and##3##3##(1995-1#1)(2007-12#1)(2008-8#1)
the neural bases of##4##4##(2008-1#1)(2008-11#1)(2009-2#1)(2010-2#1)
the neural basis of##6##4##(2007-12#1)(2008-11#3)(2009-4#1)(2010-2#1)
the neural basis##7##3##(2007-12#1)(2008-11#3)(2009-4#1)(2010-2#1)(2012-2#1)
the neural cell adhesion molecule (NCAM)##2##6##(2009-7#1)(2009-8#1)
the neural cell adhesion molecule##3##5##(2009-7#2)(2009-8#1)
the neural cell##4##3##(1992-6#1)(2009-7#2)(2009-8#1)
the neural circuitry underlying##2##4##(2008-11#2)
the neural circuitry##5##3##(2008-11#3)(2009-9#1)(2013-8#1)
the neural code##4##3##(1991-6#1)(2007-12#1)(2013-8#2)
the neural coding##2##3##(2008-11#1)(2008-8#1)
the neural control of##5##4##(1992-8#1)(1997-4#1)(2007-7#1)(2007-8#1)(2008-4#1)
the neural control##6##3##(1992-8#1)(1997-4#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-4#1)
the neural correlates of##10##4##(2007-8#2)(2008-11#1)(2009-1#1)(2009-2#1)(2010-2#2)(2011-2#1)(2012-2#1)(2013-1#1)
the neural crest##6##3##(1990-8#2)(1994-12#1)(1994-2#1)(2012-12#1)(2013-8#1)
the neural lobe##3##3##(1992-12#1)(1995-11#1)(1995-5#1)
the neural mechanism##2##3##(2008-6#1)(2008-9#1)
the neural mechanisms involved in the##2##6##(2007-1#1)(2009-2#1)
the neural mechanisms involved in##3##5##(2007-1#1)(2009-2#1)(2012-2#1)
the neural mechanisms that##2##4##(2013-1#1)(2013-8#1)
the neural mechanisms underlying##5##4##(1996-10#1)(2008-11#1)(2008-7#1)(2012-12#1)(2012-2#1)
the neural mechanisms##13##3##(1993-9#1)(1995-12#1)(1996-10#1)(2007-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
the neural model##2##3##(1995-11#1)(2007-12#1)
the neural net##2##3##(2007-8#1)(2008-2#1)
the neural network analysis##2##4##(2008-8#1)(2010-8#1)
the neural network with##2##4##(2008-10#1)(2008-3#1)
the neural network##18##3##(1994-9#1)(1997-7#1)(2008-10#7)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2009-5#1)(2010-4#1)(2010-8#1)
the neural organization##2##3##(1991-2#1)(2012-1#1)
the neural pathway##2##3##(1996-2#1)(2009-5#1)
the neural precursor cells##3##4##(2007-12#1)(2008-11#2)
the neural processing of##2##4##(1996-5#1)(2008-11#1)
the neural representation##2##3##(2008-11#1)(2008-2#1)
the neural responses##2##3##(2008-11#2)
the neural retina and##2##4##(1997-6#1)(2008-4#1)
the neural retina##3##3##(1997-6#2)(2008-4#1)
the neural substrate for##2##4##(1992-2#1)(2007-9#1)
the neural substrate##3##3##(1992-2#1)(1993-5#1)(2007-9#1)
the neural substrates of##3##4##(1995-12#1)(2008-11#1)(2009-9#1)
the neural substrates##5##3##(1991-1#1)(1993-2#1)(1995-12#1)(2008-11#1)(2009-9#1)
the neural systems##2##3##(2008-10#1)(2008-11#1)
the neural tube##5##3##(1996-3#1)(1997-4#1)(2006-7#1)(2008-11#1)(2008-5#1)
the neural##172##2##(1990-11#1)(1990-8#2)(1991-1#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#4)(1995-5#1)(1995-8#1)(1996-1#1)(1996-10#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(2006-10#1)(2006-7#2)(2006-8#1)(2007-1#2)(2007-12#7)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#27)(2008-2#5)(2008-3#4)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-1#1)(2009-2#3)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#2)(2009-9#2)(2010-2#4)(2010-4#1)(2010-8#3)(2011-12#1)(2011-2#4)(2012-1#3)(2012-12#3)(2012-2#6)(2012-7#1)(2013-1#2)(2013-8#5)
the neuraminidase activity##3##3##(1990-11#1)(1990-12#2)
the neuraminidase##4##2##(1990-11#2)(1990-12#2)
the neurite outgrowth##5##3##(1994-11#1)(1995-6#1)(2008-11#3)
the neurite outgrowth-promoting activity##2##4##(1992-4#1)(2008-10#1)
the neurite##13##2##(1990-7#1)(1992-4#2)(1994-11#1)(1995-6#1)(1996-7#1)(1996-9#2)(2008-10#1)(2008-11#3)(2008-5#1)
the neurites##6##2##(1990-3#1)(1996-3#1)(2007-10#1)(2008-11#3)
the neuritic plaque##2##3##(1991-1#1)(1994-2#1)
the neuritic##5##2##(1990-3#1)(1990-5#1)(1991-1#2)(1994-2#1)
the neuritogenic effect of##2##4##(1995-5#1)(2008-4#1)
the neuro-endocrine and circulatory systems##2##5##(2011-1#2)
the neuro-endocrine##3##2##(2006-1#1)(2011-1#2)
the neuro-muscular##2##2##(2008-9#2)
the neuroanatomic##2##2##(1996-5#1)(2006-9#1)
the neuroanatomical basis of this##2##5##(1994-2#1)(1997-8#1)
the neuroanatomical##9##2##(1990-7#1)(1991-1#1)(1993-12#1)(1994-10#1)(1994-2#1)(1997-8#1)(2008-4#2)(2010-2#1)
the neuroanatomy of##2##3##(1994-2#1)(2007-12#1)
the neurobehavioral##2##2##(1992-4#1)(1996-12#1)
the neurobiological and##2##3##(2008-8#2)
the neurobiological model##2##3##(2008-6#1)(2013-8#1)
the neurobiological underpinnings of##3##4##(1995-1#1)(2009-10#1)(2010-2#1)
the neurobiological##13##2##(1993-11#1)(1993-12#1)(1995-1#1)(1996-1#1)(2008-2#1)(2008-6#1)(2008-8#2)(2009-10#1)(2009-4#1)(2010-2#1)(2010-3#1)(2013-8#1)
the neurobiology of pain and##2##5##(2006-12#1)(2008-7#1)
the neurobiology of##11##3##(2006-12#1)(2007-8#1)(2008-11#1)(2008-4#2)(2008-7#2)(2009-10#2)(2012-2#2)
the neurobiology##13##2##(2006-12#1)(2007-8#1)(2008-11#1)(2008-4#3)(2008-7#2)(2009-10#2)(2012-12#1)(2012-2#2)
the neuroblastoma cell line##2##4##(1996-10#1)(2008-7#1)
the neuroblastoma cell##3##3##(1996-10#1)(2008-7#1)(2012-12#1)
the neuroblastoma##6##2##(1991-9#1)(1992-5#1)(1996-10#1)(2003-11#1)(2008-7#1)(2012-12#1)
the neuroblasts##3##2##(1990-5#2)(2007-12#1)
the neurochemical and##2##3##(1993-6#1)(1995-11#1)
the neurochemical basis of##2##4##(1991-5#1)(1996-10#1)
the neurochemical changes in##2##4##(1993-9#1)(1995-11#1)
the neurochemical mechanism##2##3##(1996-10#1)(2008-10#1)
the neurochemical##15##2##(1991-5#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-2#1)(1995-11#2)(1996-10#2)(1997-5#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2013-1#1)
the neurochemistry##2##2##(1996-10#1)(2005-7#1)
the neurocognitive effects##2##3##(2011-1#2)
the neurocognitive##8##2##(1997-8#1)(2006-4#1)(2008-11#1)(2008-2#2)(2009-7#1)(2011-1#2)
the neurodegenerative disorder##2##3##(1995-1#1)(2006-12#1)
the neurodegenerative##7##2##(1995-1#2)(1995-5#1)(1996-11#1)(1997-4#1)(2006-12#1)(2007-12#1)
the neurodevelopment of##3##3##(2008-5#1)(2013-1#2)
the neurodynamics##2##2##(2008-11#2)
the neuroectoderm##4##2##(1990-5#2)(1997-7#1)(2008-4#1)
the neuroendocrine system##2##3##(2006-1#1)(2008-5#1)
the neuroendocrine##17##2##(1990-12#1)(1994-10#2)(1995-9#1)(1996-4#2)(1997-2#1)(2006-1#1)(2007-2#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-2#2)(2012-3#1)(2013-1#2)
the neuroendocrine-immune##3##2##(1994-5#1)(1996-4#2)
the neurofibrillary##2##2##(1991-8#1)(2005-7#1)
the neurofibromatosis 1##4##3##(1992-8#1)(1995-7#2)(1996-1#1)
the neurofibromatosis##6##2##(1991-12#1)(1991-5#1)(1992-8#1)(1995-7#2)(1996-1#1)
the neurogenic##7##2##(1991-9#1)(1993-11#1)(1996-11#1)(2004-12#1)(2007-7#1)(2008-7#1)(2012-7#1)
the neurohumoral##2##2##(2006-10#2)
the neurohypophyseal##5##2##(1990-5#1)(1997-8#3)(2007-12#1)
the neuroimaging##3##2##(2006-9#1)(2011-1#1)(2011-2#1)
the neurokinin##3##2##(1994-2#1)(1994-8#1)(2006-10#1)
the neurokinin-1##3##2##(1994-9#2)(1997-8#1)
the neuroleptic##2##2##(1995-2#1)(1996-5#1)
the neurologic deficit##2##3##(1993-8#1)(2008-7#1)
the neurologic signs##2##3##(2006-10#1)(2008-7#1)
the neurologic##11##2##(1993-4#1)(1993-8#1)(2005-5#1)(2006-10#2)(2008-7#3)(2010-8#1)(2012-3#2)
the neurological and##4##3##(1991-11#1)(1992-10#1)(2008-9#1)(2011-2#1)
the neurological control##2##3##(1993-8#1)(2008-8#1)
the neurological deficit score##2##4##(2008-10#2)
the neurological deficit##7##3##(1997-5#1)(2007-10#1)(2008-10#2)(2011-2#3)
the neurological deficits##2##3##(1992-5#1)(2006-5#1)
the neurological examination##2##3##(2007-3#1)(2007-9#1)
the neurological injury##2##3##(2007-8#2)
the neurological symptoms were##2##4##(2008-7#2)
the neurological symptoms##6##3##(1991-6#1)(1994-3#1)(2007-10#1)(2008-7#2)(2013-8#1)
the neurological##55##2##(1991-11#2)(1991-6#2)(1992-10#1)(1992-5#1)(1993-11#1)(1993-8#1)(1994-3#1)(1996-11#1)(1996-12#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-12#1)(2006-4#2)(2006-5#2)(2007-10#3)(2007-11#2)(2007-3#1)(2007-8#3)(2007-9#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#5)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
the neurology clinic##2##3##(2008-8#2)
the neuromast##3##2##(1995-8#1)(2012-12#2)
the neuromere##3##2##(1994-9#1)(2007-12#2)
the neuromeres of the ventral nerve cord##2##7##(2007-12#2)
the neuromodulatory##6##2##(2007-12#1)(2008-6#1)(2009-10#2)(2010-6#1)(2011-1#1)
the neuromuscular disorders##2##3##(2010-8#1)(2013-1#1)
the neuromuscular junction and##2##4##(1996-8#1)(2008-7#1)
the neuromuscular junction##13##3##(1992-8#2)(1994-5#1)(1996-1#1)(1996-8#1)(2007-12#2)(2007-7#1)(2008-7#2)(2009-11#1)(2009-8#1)(2012-2#1)
the neuromuscular junctions##5##3##(1992-8#1)(1997-8#1)(2007-12#1)(2012-12#2)
the neuromuscular system##4##3##(2006-3#1)(2007-12#1)(2008-12#1)(2009-12#1)
the neuromuscular##30##2##(1992-8#3)(1994-5#1)(1995-12#1)(1996-1#1)(1996-8#1)(1997-8#1)(2006-3#1)(2007-12#4)(2007-7#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-8#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)
the neuron and##3##3##(1992-3#1)(2008-2#1)(2008-3#1)
the neuron in##2##3##(1996-3#1)(2008-5#1)
the neuron is##4##3##(1993-12#2)(1995-8#1)(2008-2#1)
the neuron microfluidic device##3##4##(2008-11#3)
the neuron specific enolase (NSE)##2##5##(1990-10#2)
the neuron under study##2##4##(1997-8#2)
the neuron##30##2##(1990-10#2)(1992-12#1)(1992-3#1)(1993-12#5)(1993-9#1)(1994-11#1)(1995-8#1)(1995-9#1)(1996-3#2)(1997-8#2)(2006-3#1)(2006-9#1)(2007-10#1)(2008-11#3)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)
the neuron's##2##2##(1993-2#1)(2012-2#1)
the neuron-specific splicing##2##3##(1992-5#1)(1993-8#1)
the neuron-specific##4##2##(1991-9#1)(1992-5#1)(1993-8#1)(1994-3#1)
the neuronal and##3##3##(1990-7#2)(2007-12#1)
the neuronal cell line##3##4##(1994-9#2)(2009-12#1)
the neuronal cell##12##3##(1991-12#1)(1992-1#1)(1993-8#2)(1994-9#2)(1996-12#1)(1997-7#1)(2008-11#1)(2009-12#1)(2009-8#1)(2012-12#1)
the neuronal cells of##2##4##(1991-2#1)(1996-2#1)
the neuronal cells##3##3##(1991-12#1)(1991-2#1)(1996-2#1)
the neuronal circuitry##2##3##(1991-3#1)(2008-10#1)
the neuronal cytoplasm##2##3##(1990-5#1)(1992-3#1)
the neuronal cytoskeleton##5##3##(1991-9#1)(1996-5#1)(1997-2#1)(1997-6#1)(2007-8#1)
the neuronal death##2##3##(1990-7#1)(2008-5#1)
the neuronal function##2##3##(1997-2#1)(2010-12#1)
the neuronal isoform##2##3##(1995-12#1)(2005-10#1)
the neuronal marker##4##3##(1993-4#1)(1994-2#1)(1996-3#1)(2009-10#1)
the neuronal network##2##3##(1994-10#1)(2008-7#1)
the neuronal nitric oxide synthase##2##5##(1993-12#2)
the neuronal origin of##2##4##(1996-11#1)(2008-7#1)
the neuronal responses##3##3##(1996-12#2)(1997-7#1)
the neuronal soma##2##3##(1991-12#1)(2010-12#1)
the neuronal voltage-dependent sodium channel##5##5##(1994-9#5)
the neuronal##109##2##(1990-12#1)(1990-5#2)(1990-7#3)(1991-12#4)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-12#4)(1993-4#1)(1993-8#2)(1993-9#3)(1994-10#2)(1994-2#1)(1994-5#1)(1994-9#8)(1995-11#1)(1995-12#2)(1995-5#2)(1995-6#2)(1996-11#2)(1996-12#4)(1996-2#1)(1996-3#3)(1996-5#1)(1996-8#2)(1996-9#1)(1997-2#2)(1997-6#2)(1997-7#2)(2005-10#1)(2005-8#1)(2007-11#1)(2007-12#3)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#7)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#2)(2010-3#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
the neurones##7##2##(1991-2#1)(1993-9#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-5#1)(1997-3#1)
the neurons are##2##3##(2007-9#1)(2008-11#1)
the neurons containing##2##3##(1991-8#1)(2009-2#1)
the neurons in the##5##4##(1990-12#1)(1992-3#1)(1994-10#1)(1996-9#1)(2008-11#1)
the neurons in##8##3##(1990-12#1)(1992-3#1)(1992-7#1)(1994-10#1)(1995-6#1)(1996-9#1)(2008-11#2)
the neurons of the##5##4##(1992-8#1)(1996-8#1)(2009-12#1)(2009-2#2)
the neurons of##8##3##(1992-8#1)(1996-8#1)(1997-2#1)(2008-7#1)(2009-12#1)(2009-2#3)
the neurons that##2##3##(2006-1#1)(2007-9#1)
the neurons were##3##3##(1992-8#1)(1996-9#1)(2008-8#1)
the neurons##63##2##(1990-12#1)(1990-7#2)(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#5)(1992-9#2)(1993-2#1)(1993-4#1)(1993-5#1)(1994-10#3)(1994-2#1)(1994-3#1)(1994-5#2)(1995-6#2)(1996-10#1)(1996-12#1)(1996-5#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-8#2)(2006-1#1)(2006-9#1)(2007-8#1)(2007-9#2)(2008-11#8)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-2#4)(2009-8#1)(2012-12#1)(2013-7#1)(2013-8#1)
the neuropathic##3##2##(1993-4#1)(1993-9#1)(2008-4#1)
the neuropathologic##2##2##(1991-1#1)(2008-7#1)
the neuropathology of##4##3##(1991-8#1)(1996-2#1)(2008-11#1)(2009-10#1)
the neuropeptide Y Y1 receptor##3##5##(1995-12#1)(1996-12#1)(1997-5#1)
the neuropeptide Y##7##3##(1992-9#1)(1995-12#2)(1996-12#1)(1997-2#1)(1997-5#2)
the neuropeptide expression##2##3##(1994-2#2)
the neuropeptide##20##2##(1990-5#2)(1991-9#2)(1992-8#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-2#2)(1995-12#2)(1996-11#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#2)(2013-7#1)
the neuropeptides##10##2##(1990-11#3)(1994-10#1)(1995-5#1)(1996-2#1)(2006-10#1)(2007-12#1)(2008-4#1)(2013-1#1)
the neuropharmacological##3##2##(1993-12#1)(1996-10#1)(2008-4#1)
the neuropharmacology##2##2##(1990-3#1)(2008-1#1)
the neurophysiological##5##2##(1995-8#1)(2004-11#1)(2008-9#1)(2010-1#1)(2012-1#1)
the neurophysiology model##2##3##(2008-10#2)
the neurophysiology##3##2##(1995-12#1)(2008-10#2)
the neuropil and##2##3##(1991-9#1)(1994-2#1)
the neuropil in##2##3##(1994-5#1)(2008-7#1)
the neuropil##11##2##(1991-6#1)(1991-9#1)(1994-2#2)(1994-5#1)(1996-9#1)(2007-10#1)(2007-12#1)(2008-7#2)(2013-8#1)
the neuroprotectant##2##2##(1996-3#1)(2007-9#1)
the neuroprotective actions of##3##4##(1996-10#2)(1996-6#1)
the neuroprotective effect of deprenyl##2##5##(2009-12#2)
the neuroprotective effect of##5##4##(1997-5#1)(2009-12#2)(2012-2#2)
the neuroprotective effect##6##3##(1994-11#1)(1997-5#1)(2009-12#2)(2012-2#2)
the neuroprotective effects of##6##4##(1996-11#1)(1997-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-8#1)
the neuroprotective role of##2##4##(2007-11#1)(2008-2#1)
the neuroprotective##27##2##(1991-9#1)(1994-11#1)(1994-2#1)(1996-10#2)(1996-11#1)(1996-6#1)(1996-9#1)(1997-5#1)(1997-8#1)(2005-7#1)(2006-7#2)(2007-10#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#2)(2010-8#1)(2012-2#2)(2013-1#1)(2013-8#1)
the neuropsychiatric##5##2##(1991-9#1)(1995-2#1)(2007-11#1)(2007-9#2)
the neuropsychological assessment##2##3##(2011-1#1)(2013-8#1)
the neuropsychological sequelae##2##3##(1994-5#1)(2013-1#1)
the neuropsychological##12##2##(1994-5#1)(1997-7#1)(2007-1#2)(2007-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-1#1)(2013-8#2)
the neuroradiological##2##2##(2005-10#1)(2008-7#1)
the neurosciences##3##2##(1992-12#1)(2009-5#1)(2012-3#1)
the neurosecretory##3##2##(1992-2#1)(1996-8#1)(2008-5#1)
the neurosurgeon to##2##3##(2007-1#1)(2008-9#1)
the neurosurgeon##4##2##(2006-10#1)(2006-2#1)(2007-1#1)(2008-9#1)
the neurosurgical aspects of##2##4##(2008-5#1)(2008-7#1)
the neurosurgical##13##2##(1990-9#1)(1993-10#1)(1993-5#1)(2006-12#1)(2006-4#2)(2006-7#2)(2008-5#1)(2008-7#2)(2011-2#1)(2012-3#1)
the neurotoxic effect of##3##4##(1994-2#1)(1995-5#1)(1997-8#1)
the neurotoxic effects of p-chloroamphetamine##2##5##(1991-8#2)
the neurotoxic effects of##9##4##(1991-8#2)(1992-4#1)(1993-4#1)(1994-2#1)(1996-10#1)(1996-12#1)(2006-10#1)(2008-5#1)
the neurotoxic effects##11##3##(1991-8#2)(1992-4#1)(1993-4#1)(1994-2#1)(1996-10#1)(1996-12#1)(2006-10#1)(2008-5#1)(2008-7#2)
the neurotoxic potential of##3##4##(2006-10#1)(2007-12#1)(2008-8#1)
the neurotoxic##23##2##(1990-11#1)(1990-7#1)(1991-8#2)(1992-4#1)(1993-4#1)(1994-2#2)(1994-8#1)(1995-5#2)(1995-7#1)(1996-10#1)(1996-12#1)(1997-8#1)(2006-10#2)(2007-12#2)(2008-5#1)(2008-7#2)(2008-8#1)
the neurotoxicity of##9##3##(1991-3#1)(1993-7#1)(1994-2#1)(1996-10#3)(1996-9#1)(2008-10#1)(2010-8#1)
the neurotoxicity##16##2##(1990-5#2)(1991-3#1)(1993-1#1)(1993-7#1)(1994-11#1)(1994-2#1)(1995-5#1)(1996-10#4)(1996-9#1)(2007-7#1)(2008-10#1)(2010-8#1)
the neurotoxin 1-methyl-4-phenylpyridinium (MPP+)##2##4##(1990-5#1)(1996-12#1)
the neurotoxin and##2##3##(1992-3#1)(1993-12#1)
the neurotoxin##16##2##(1990-2#1)(1990-5#2)(1992-3#2)(1993-12#1)(1994-11#4)(1994-3#1)(1996-12#1)(1996-3#1)(2008-5#1)(2008-7#1)(2012-1#1)
the neurotransmitter dopamine##3##3##(1993-8#1)(2008-10#1)(2010-7#1)
the neurotransmitter gamma-aminobutyric acid (GABA)##2##5##(1990-5#1)(2007-12#1)
the neurotransmitter serotonin##2##3##(1996-1#1)(1997-1#1)
the neurotransmitter##20##2##(1990-5#1)(1993-8#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-5#2)(1996-7#1)(1997-1#1)(1997-5#1)(2005-8#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2010-7#1)(2013-8#1)
the neurotrophic##6##2##(1993-4#1)(1996-2#1)(1996-3#1)(1997-4#1)(2013-1#2)
the neurotrophin receptor##2##3##(1997-6#1)(2006-8#1)
the neurotrophin##12##2##(1991-5#1)(1994-2#1)(1994-8#1)(1996-1#1)(1996-3#4)(1997-6#1)(2006-8#1)(2008-4#1)(2012-12#1)
the neurotrophins##4##2##(1991-5#1)(1996-3#3)
the neurovascular bundle##2##3##(2008-3#1)(2008-9#1)
the neurovascular##7##2##(2006-10#1)(2006-8#1)(2007-11#1)(2008-3#1)(2008-9#1)(2013-1#2)
the neurula stage##4##3##(1991-9#1)(1997-7#1)(2012-12#2)
the neutral and lipid-soluble##2##4##(1994-9#2)
the neutral and##5##3##(1993-11#1)(1994-9#2)(2008-10#1)(2013-1#1)
the neutral axis##2##3##(2007-1#1)(2009-7#1)
the neutral enzyme##2##3##(1991-1#2)
the neutral form of the##2##5##(1990-4#1)(2008-10#1)
the neutral form##6##3##(1990-4#1)(1992-2#1)(2008-10#3)(2011-1#1)
the neutral lipid##2##3##(1996-5#1)(2006-10#1)
the neutral lipids##4##3##(1994-3#1)(1996-4#2)(1996-5#1)
the neutral marker##2##3##(2008-10#1)(2012-3#1)
the neutral posture##5##3##(2006-11#5)
the neutral##67##2##(1990-4#1)(1990-7#1)(1991-1#2)(1991-2#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-9#1)(1994-3#1)(1994-8#1)(1994-9#3)(1995-2#2)(1995-5#1)(1996-2#1)(1996-4#2)(1996-5#2)(1997-2#1)(2006-10#2)(2006-11#5)(2007-1#1)(2007-12#1)(2008-10#15)(2008-3#1)(2008-4#3)(2008-8#1)(2009-11#2)(2009-4#1)(2009-6#1)(2009-7#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the neutralization of##2##3##(2008-10#1)(2012-11#1)
the neutralization##4##2##(1995-5#1)(2006-10#1)(2008-10#1)(2012-11#1)
the neutralizing capacity of the##2##5##(2008-10#1)(2008-5#1)
the neutralizing##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
the neutron##4##2##(1995-7#1)(2008-10#1)(2008-3#2)
the neutropenic##2##2##(2006-10#1)(2007-11#1)
the neutrophil and##2##3##(1993-11#1)(2005-7#1)
the neutrophil count##2##3##(2007-11#1)(2012-3#1)
the neutrophil##30##2##(1990-11#1)(1990-9#3)(1991-5#1)(1992-1#1)(1992-8#2)(1993-11#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-3#1)(1994-5#1)(1994-8#2)(1995-3#1)(1997-8#1)(2004-11#1)(2005-7#1)(2007-11#1)(2008-10#1)(2009-6#1)(2012-1#3)(2012-3#2)
the neutrophils##2##2##(1994-3#1)(1996-2#1)
the new &quot##5##3##(2006-2#1)(2008-10#1)(2009-10#1)(2013-1#2)
the new AFFFF-MALS##2##3##(2011-2#2)
the new Abak(®) bottle in comparison with##2##7##(2011-2#2)
the new Abak(®) bottle in##3##5##(2011-2#3)
the new Abak(®) bottle##5##4##(2011-2#5)
the new Abak(®)##6##3##(2011-2#6)
the new American##3##3##(1995-2#1)(2008-3#1)(2010-3#1)
the new European##3##3##(1996-8#2)(2008-7#1)
the new International##2##3##(2008-1#1)(2013-7#1)
the new Medicare##7##3##(1992-1#2)(1992-12#1)(2007-9#2)(2008-4#1)(2011-2#1)
the new PTH cap##2##4##(2006-7#2)
the new Regulations##2##3##(2008-1#2)
the new abdomen##3##3##(2007-4#3)
the new age##2##3##(2004-3#1)(2008-1#1)
the new algorithm is##5##4##(2008-10#1)(2008-2#1)(2008-3#3)
the new algorithm##11##3##(2008-1#1)(2008-10#2)(2008-2#4)(2008-3#4)
the new alkaloid##2##3##(2007-1#2)
the new and complex##2##4##(2006-8#1)(2008-1#1)
the new and the##2##4##(2007-12#1)(2008-3#1)
the new and##7##3##(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)(2011-2#1)
the new approach and##2##4##(2008-10#2)
the new approach reduces##2##4##(2007-12#1)(2008-10#1)
the new approach##15##3##(1994-6#1)(1995-2#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#1)(2012-3#1)(2013-1#1)
the new architecture##3##3##(2008-10#1)(2008-2#2)
the new assay##3##3##(1992-9#1)(2007-8#2)
the new biology##2##3##(1995-10#1)(2008-11#1)
the new born##2##3##(1997-4#1)(2009-9#1)
the new cases##4##3##(1997-6#1)(2007-7#2)(2012-3#1)
the new cell##4##3##(2005-11#1)(2006-2#1)(2008-11#2)
the new century##5##3##(1995-9#1)(2005-11#1)(2006-9#1)(2008-10#1)(2008-9#1)
the new challenges facing##2##4##(1991-1#1)(1992-3#1)
the new challenges##3##3##(1991-1#1)(1992-3#1)(1994-1#1)
the new chiral##2##3##(2007-10#1)(2010-5#1)
the new classification##2##3##(1991-9#1)(1997-8#1)
the new compound##7##3##(1997-1#1)(2007-1#5)(2008-4#1)
the new compounds were##10##4##(1995-3#1)(2006-12#2)(2007-1#3)(2008-8#1)(2012-11#2)(2013-1#1)
the new compounds##18##3##(1992-3#1)(1995-3#1)(1996-2#1)(2006-12#2)(2007-1#3)(2007-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-1#1)(2012-11#2)(2012-2#1)(2013-1#1)
the new concept of##3##4##(1995-12#1)(2006-5#1)(2007-4#1)
the new concept##5##3##(1995-12#1)(2006-4#1)(2006-5#1)(2007-4#1)(2008-8#1)
the new consensus##2##3##(1996-5#1)(2008-6#1)
the new convexity measure##3##4##(2008-6#3)
the new curriculum##2##3##(2006-2#1)(2008-11#1)
the new data on##2##4##(2008-2#1)(2008-7#1)
the new data##4##3##(1994-8#1)(2007-12#1)(2008-2#1)(2008-7#1)
the new death criterion##2##4##(1991-9#2)
the new dental##2##3##(2006-8#2)
the new derivatives##2##3##(1992-6#1)(2008-4#1)
the new design##4##3##(2008-2#1)(2009-6#1)(2012-1#1)(2012-2#1)
the new designs##2##3##(2008-3#1)(2012-3#1)
the new device##3##3##(2007-7#1)(2008-2#1)(2008-7#1)
the new devices have##2##4##(1991-12#1)(2012-3#1)
the new diagnostic methods##2##4##(1992-9#1)(2009-2#1)
the new dipeptide-containing##2##3##(2006-7#2)
the new discipline##2##3##(2006-3#1)(2008-4#1)
the new dosing system##2##4##(2008-10#2)
the new drug##5##3##(1992-1#1)(1993-11#1)(2005-8#1)(2006-2#1)(2007-11#1)
the new dynamic##3##3##(2008-11#1)(2008-12#1)(2008-6#1)
the new entity##2##3##(2006-9#1)(2013-7#1)
the new environment of##2##4##(2008-6#1)(2009-4#1)
the new environment##4##3##(1995-5#1)(2008-6#1)(2009-4#1)(2012-2#1)
the new era of##3##4##(2008-6#2)(2008-7#1)
the new evidence##2##3##(2007-11#1)(2008-1#1)
the new extractor##2##3##(2008-10#2)
the new federal##2##3##(2007-4#1)(2010-4#1)
the new female##2##3##(2006-11#2)
the new field of##2##4##(2008-9#1)(2011-12#1)
the new filter##3##3##(2008-2#3)
the new formula##2##3##(2008-10#1)(2008-5#1)
the new formulas to##2##4##(2006-8#1)(2008-3#1)
the new formulation##2##3##(2008-10#1)(2008-2#1)
the new framework##2##3##(2007-8#1)(2008-9#1)
the new frontier##2##3##(2008-11#1)(2010-3#1)
the new generation of optical##2##5##(2008-2#1)(2008-3#1)
the new generation of##6##4##(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-1#1)(2012-2#1)
the new generation##8##3##(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
the new genetics##2##3##(1991-11#1)(1997-8#1)
the new genotypes##2##3##(2008-10#2)
the new guidelines##2##3##(2008-11#1)(2008-3#1)
the new handle##2##3##(2006-6#2)
the new health##3##3##(1992-2#2)(1994-12#1)
the new host##6##3##(1991-9#1)(2008-8#4)(2012-2#1)
the new isolates##2##3##(1992-10#1)(2008-10#1)
the new kinetically derived##2##4##(1990-8#2)
the new knowledge##2##3##(1995-12#1)(2006-9#1)
the new laser##2##3##(2008-2#1)(2008-5#1)
the new law##4##3##(1992-1#1)(1992-6#1)(1996-5#2)
the new load size##3##4##(1993-5#3)
the new method are##2##4##(2008-2#1)(2008-6#1)
the new method can##2##4##(2008-2#1)(2008-3#1)
the new method for##3##4##(2005-4#1)(2008-10#1)(2008-3#1)
the new method is##4##4##(2006-10#1)(2008-10#2)(2008-2#1)
the new method of##2##4##(2008-10#1)(2009-2#1)
the new method was##3##4##(1990-9#1)(1992-2#1)(2008-10#1)
the new method will##2##4##(2007-11#1)(2008-2#1)
the new method##37##3##(1990-9#1)(1992-2#1)(1993-4#1)(1997-8#2)(2005-4#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#10)(2008-2#6)(2008-3#4)(2008-6#2)(2009-2#2)(2013-1#2)
the new methods of##2##4##(2007-11#1)(2008-8#1)
the new methods##6##3##(1997-3#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-8#1)
the new millennium##27##3##(1993-2#1)(2004-1#2)(2005-11#1)(2005-12#1)(2006-10#4)(2006-12#1)(2006-8#2)(2007-12#2)(2007-2#2)(2007-3#2)(2007-8#2)(2008-1#4)(2008-11#1)(2008-3#1)(2008-4#1)
the new model of##2##4##(1994-11#1)(2013-1#1)
the new model##6##3##(1994-11#1)(1995-12#1)(1995-4#1)(2007-1#1)(2011-2#1)(2013-1#1)
the new mouthwash##2##3##(2006-2#2)
the new nonlinear##2##3##(2007-12#2)
the new one##4##3##(1990-7#1)(1996-6#2)(2008-10#1)
the new organizational structure##2##4##(1992-5#1)(1995-1#1)
the new paradigm##3##3##(1991-3#1)(2009-11#1)(2012-3#1)
the new payment system##2##4##(1992-12#1)(1992-2#1)
the new policy##2##3##(1992-12#1)(2008-2#1)
the new possibilities of##2##4##(1991-5#1)(1994-8#1)
the new possibilities##4##3##(1991-11#1)(1991-5#1)(1994-8#1)(2006-5#1)
the new prediction##2##3##(2008-6#1)(2012-2#1)
the new pressures##2##3##(2008-5#2)
the new probes##2##3##(2008-10#2)
the new procedure##4##3##(2005-11#1)(2007-9#1)(2008-10#1)(2008-3#1)
the new procedures##2##3##(2007-4#1)(2012-2#1)
the new prognostic##2##3##(2006-6#1)(2011-2#1)
the new proposed##3##3##(2006-8#1)(2007-6#1)(2008-3#1)
the new public health##2##4##(1992-1#2)
the new quality##2##3##(1993-2#1)(2008-1#1)
the new radiology##2##3##(2007-4#2)
the new reagent##3##3##(2005-4#2)(2008-10#1)
the new regulations##2##3##(1991-1#1)(2007-12#1)
the new resistance gene##2##4##(1995-2#1)(2008-10#1)
the new results##2##3##(2008-2#1)(2008-3#1)
the new role of##2##4##(2005-5#1)(2012-2#1)
the new schedule##3##3##(1992-2#3)
the new scheme##4##3##(1993-12#1)(2006-8#1)(2007-8#1)(2008-3#1)
the new science of##3##4##(1996-3#1)(2009-9#1)(2012-2#1)
the new scientific##2##3##(2008-11#1)(2010-3#1)
the new situation##2##3##(1996-2#1)(1997-2#1)
the new software##2##3##(1991-2#1)(2008-2#1)
the new species##8##3##(1993-11#1)(2007-3#3)(2008-10#1)(2008-5#1)(2010-10#1)(2012-11#1)
the new standard of care##3##5##(2006-10#1)(2008-1#1)(2008-5#1)
the new stationary phase##2##4##(2008-10#2)
the new steady state##2##4##(1990-3#1)(2008-11#1)
the new strategies##2##3##(2006-10#1)(2006-6#1)
the new synthesis of LH beta mRNA##2##7##(1997-2#2)
the new system##9##3##(2006-1#1)(2006-6#1)(2007-1#1)(2007-4#1)(2007-9#1)(2008-3#2)(2008-9#1)(2010-8#1)
the new task##2##3##(1994-8#1)(2007-12#1)
the new technique of##2##4##(2006-9#1)(2008-3#1)
the new technique##11##3##(2006-10#1)(2006-9#1)(2007-1#1)(2008-11#1)(2008-2#2)(2008-3#5)
the new techniques##2##3##(1994-2#1)(2009-2#1)
the new technology##9##3##(2006-4#2)(2007-6#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-4#1)(2013-8#1)
the new test##7##3##(1995-4#1)(1996-5#1)(2005-8#1)(2007-7#2)(2012-1#1)(2012-3#1)
the new vectors##2##3##(1991-9#1)(1996-10#1)
the new verb##2##3##(2008-4#2)
the new version of##2##4##(1997-2#1)(2008-10#1)
the new word##2##3##(2008-4#2)
the new##945##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#2)(1991-1#3)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#2)(1991-3#3)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#7)(1992-1#9)(1992-10#2)(1992-11#2)(1992-12#5)(1992-2#7)(1992-3#5)(1992-5#2)(1992-6#4)(1992-8#2)(1992-9#4)(1993-1#1)(1993-10#1)(1993-11#4)(1993-12#3)(1993-2#3)(1993-3#1)(1993-4#1)(1993-5#4)(1993-6#2)(1993-9#1)(1994-1#5)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#4)(1995-1#3)(1995-10#2)(1995-11#2)(1995-12#6)(1995-2#9)(1995-3#2)(1995-4#2)(1995-5#1)(1995-7#2)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#8)(1996-6#3)(1996-7#1)(1996-8#4)(1997-1#4)(1997-2#9)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#6)(2003-11#1)(2004-1#2)(2004-10#1)(2004-2#1)(2004-3#2)(2004-9#2)(2005-10#3)(2005-11#7)(2005-12#1)(2005-4#6)(2005-5#3)(2005-7#3)(2005-8#5)(2005-9#1)(2006-1#1)(2006-10#23)(2006-11#5)(2006-12#10)(2006-2#9)(2006-3#2)(2006-4#4)(2006-5#5)(2006-6#7)(2006-7#5)(2006-8#15)(2006-9#5)(2007-1#15)(2007-10#1)(2007-11#23)(2007-12#22)(2007-2#5)(2007-3#6)(2007-4#14)(2007-5#1)(2007-6#3)(2007-7#10)(2007-8#15)(2007-9#16)(2008-1#17)(2008-10#84)(2008-11#24)(2008-12#4)(2008-2#54)(2008-3#48)(2008-4#17)(2008-5#18)(2008-6#13)(2008-7#14)(2008-8#15)(2008-9#9)(2009-10#3)(2009-11#4)(2009-2#4)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#3)(2009-9#3)(2010-10#3)(2010-12#1)(2010-2#2)(2010-3#3)(2010-4#4)(2010-5#1)(2010-6#3)(2010-7#4)(2010-8#6)(2011-1#9)(2011-12#1)(2011-2#25)(2012-1#6)(2012-11#4)(2012-12#7)(2012-2#17)(2012-3#11)(2013-1#16)(2013-7#3)(2013-8#3)
the new-born##3##2##(1993-9#1)(2007-2#2)
the newborn and the##2##4##(2011-1#1)(2012-12#1)
the newborn and##3##3##(1994-2#1)(2011-1#1)(2012-12#1)
the newborn baby##2##3##(1991-4#1)(2013-1#1)
the newborn has##2##3##(2007-2#1)(2011-1#1)
the newborn hip##2##3##(2007-11#2)
the newborn rat##5##3##(1990-11#1)(1991-5#1)(1992-11#1)(1992-8#1)(2007-9#1)
the newborn screening##2##3##(2010-8#2)
the newborn was##3##3##(2008-4#2)(2012-3#1)
the newborn##68##2##(1990-11#1)(1990-5#1)(1990-9#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-12#2)(1992-8#1)(1993-12#2)(1993-4#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-3#1)(1996-5#1)(1997-6#1)(2005-11#3)(2005-7#1)(2006-8#3)(2007-1#1)(2007-11#3)(2007-2#3)(2007-9#2)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#3)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)
the newborn's##2##2##(2007-11#1)(2009-9#1)
the newborns##7##2##(1996-10#1)(2006-9#1)(2007-11#1)(2007-2#1)(2008-4#1)(2011-1#2)
the newer agents##6##3##(1993-12#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-5#1)(2010-12#1)
the newer antiepileptic##2##3##(2008-11#1)(2008-3#1)
the newer techniques##2##3##(2008-1#1)(2009-5#1)
the newer##48##2##(1993-12#2)(1993-3#1)(1994-1#1)(1996-1#1)(1996-12#1)(1996-9#1)(2004-3#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#7)(2006-2#1)(2007-11#5)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-12#2)(2010-5#1)(2010-6#2)(2010-7#1)(2012-2#2)(2013-1#3)(2013-7#1)
the newest generation of##2##4##(2007-1#1)(2011-2#1)
the newest##13##2##(1991-9#1)(2005-8#1)(2005-9#1)(2006-6#1)(2006-7#1)(2007-1#1)(2008-1#1)(2008-11#1)(2008-4#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#1)
the newly available##2##3##(2007-11#1)(2007-8#1)
the newly described##10##3##(1993-6#1)(1994-3#1)(1996-2#1)(1996-4#1)(1997-3#1)(2007-12#1)(2008-10#3)(2011-1#1)
the newly designed##2##3##(2008-10#1)(2011-2#1)
the newly developed##22##3##(1990-12#1)(1991-11#1)(1992-8#2)(1994-10#1)(1994-3#1)(1996-2#1)(1997-4#1)(2006-4#1)(2007-12#1)(2007-4#1)(2008-10#5)(2008-3#1)(2008-5#2)(2010-11#2)(2011-1#1)
the newly diagnosed##6##3##(2006-9#1)(2009-11#1)(2011-2#1)(2013-1#2)(2013-8#1)
the newly discovered##3##3##(1992-5#1)(2006-12#1)(2013-1#1)
the newly emerging##5##3##(2005-7#1)(2007-4#1)(2008-5#1)(2008-7#1)(2010-11#1)
the newly established##5##3##(2007-11#1)(2008-10#1)(2008-11#1)(2012-12#1)(2013-8#1)
the newly formed##9##3##(1997-8#1)(2005-7#1)(2007-12#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)
the newly found##3##3##(1996-5#1)(1997-5#1)(2008-10#1)
the newly grown bone##3##4##(2004-9#3)
the newly identified ORFs##2##4##(1996-6#1)(1997-4#1)
the newly identified##7##3##(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#1)(2006-10#1)
the newly isolated##3##3##(1990-5#1)(1993-9#1)(1994-12#1)
the newly prepared##2##3##(2008-11#1)(2008-5#1)
the newly proposed##7##3##(2008-10#2)(2008-3#3)(2012-12#1)(2013-1#1)
the newly revised##2##3##(1993-2#1)(2008-6#1)
the newly synthesized##17##3##(1990-2#1)(1992-4#1)(1992-6#2)(1993-11#1)(1994-9#1)(1996-4#1)(1996-7#1)(1997-5#1)(2005-10#1)(2007-11#3)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)
the newly##126##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-11#1)(1991-5#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-3#2)(1994-9#1)(1995-6#1)(1996-2#3)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#1)(1997-8#1)(2004-9#3)(2005-10#1)(2005-5#1)(2005-7#2)(2006-10#3)(2006-12#1)(2006-4#1)(2006-9#1)(2007-11#5)(2007-12#3)(2007-2#1)(2007-4#2)(2007-8#1)(2007-9#1)(2008-10#18)(2008-11#3)(2008-3#6)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-11#3)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#2)(2013-1#4)(2013-8#2)
the newly-formed##2##2##(1997-8#1)(2007-11#1)
the news to the##2##4##(1991-7#1)(1993-12#1)
the news##9##2##(1990-12#1)(1991-7#1)(1993-12#1)(2005-8#1)(2006-10#2)(2007-9#2)(2008-10#1)
the newspapers##3##2##(1992-9#2)(1993-5#1)
the newt##2##2##(2008-4#1)(2008-6#1)
the next 10 years##6##4##(1990-2#1)(1997-3#1)(2006-10#1)(2007-12#1)(2007-8#1)(2010-8#1)
the next 10##10##3##(1990-11#1)(1990-2#1)(1994-11#1)(1997-3#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2010-8#1)
the next 12 months##2##4##(2004-12#1)(2009-4#1)
the next 15##2##3##(1991-12#1)(2013-8#1)
the next 2 years##4##4##(1990-5#1)(1996-9#1)(2006-5#1)(2007-8#1)
the next 2##6##3##(1990-5#1)(1994-12#1)(1996-9#1)(2006-5#1)(2007-8#1)(2012-12#1)
the next 20 hours##2##4##(2007-2#2)
the next 20 years##2##4##(1995-2#1)(2011-2#1)
the next 20##4##3##(1995-2#1)(2007-2#2)(2011-2#1)
the next 24 hours##2##4##(1994-9#2)
the next 24##3##3##(1994-9#2)(2008-7#1)
the next 3 months##2##4##(1994-7#1)(2008-10#1)
the next 3##6##3##(1991-2#1)(1992-5#1)(1994-7#1)(1996-2#1)(2008-10#2)
the next 5 years##4##4##(1993-11#1)(2008-12#1)(2011-2#1)(2012-12#1)
the next 5##6##3##(1993-11#1)(2007-11#1)(2008-12#1)(2011-2#2)(2012-12#1)
the next 6 months##3##4##(2008-5#1)(2009-5#2)
the next 6##5##3##(1997-6#1)(2005-10#1)(2008-5#1)(2009-5#2)
the next G1 phase##2##4##(1992-8#2)
the next century as##2##4##(1995-12#1)(2005-7#1)
the next century##10##3##(1993-1#1)(1995-12#1)(1995-4#1)(2005-7#1)(2006-5#1)(2008-4#3)(2008-7#1)(2008-9#1)
the next day##6##3##(1996-7#1)(2007-12#1)(2007-8#3)(2013-8#1)
the next decade##26##3##(1991-12#2)(1991-2#1)(1994-3#1)(1996-2#1)(1997-1#1)(2005-6#1)(2006-10#4)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2009-4#1)(2009-9#3)(2011-1#1)
the next decades##4##3##(1990-4#1)(2008-7#1)(2008-8#1)(2011-2#1)
the next few decades##3##4##(1996-3#1)(2008-10#1)(2010-9#1)
the next few years##19##4##(1993-11#1)(1993-3#1)(1994-12#1)(1994-3#1)(2006-10#2)(2007-1#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#2)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
the next few##25##3##(1993-11#1)(1993-3#1)(1994-12#1)(1994-3#1)(1996-3#1)(1997-6#1)(2006-10#2)(2007-1#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
the next fifty years##3##4##(2012-3#3)
the next five years##4##4##(1996-11#1)(2005-8#1)(2013-1#2)
the next five##5##3##(1996-11#1)(2005-8#1)(2007-7#1)(2013-1#2)
the next four weeks##2##4##(2008-5#2)
the next four##6##3##(1994-2#1)(2008-5#2)(2008-7#1)(2009-4#1)(2011-2#1)
the next frontier##3##3##(1996-3#1)(2009-9#1)(2011-2#1)
the next generation of researchers##2##5##(2009-4#1)(2012-1#1)
the next generation of the##2##5##(2008-3#1)(2012-12#1)
the next generation of##28##4##(1991-6#1)(1992-3#1)(1996-11#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-4#1)(2010-10#1)(2010-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
the next generation##39##3##(1991-6#1)(1992-3#2)(1996-11#1)(1997-8#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-10#2)(2010-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
the next issue of this##2##5##(1992-3#1)(1996-2#1)
the next issue of##3##4##(1992-3#1)(1993-2#1)(1996-2#1)
the next issue##5##3##(1992-3#1)(1993-2#1)(1996-2#1)(2010-5#1)(2013-8#1)
the next level of##3##4##(1993-6#1)(1995-12#1)(2006-5#1)
the next level##7##3##(1991-2#1)(1993-6#1)(1995-12#1)(2006-5#1)(2009-4#1)(2011-1#1)(2013-8#1)
the next millennium##11##3##(1993-11#1)(2004-1#1)(2006-10#3)(2006-5#1)(2007-6#1)(2008-10#1)(2008-4#3)
the next month##3##3##(1994-12#1)(2008-7#1)(2010-7#1)
the next morning##2##3##(1995-11#1)(2010-8#1)
the next most common##2##4##(2011-2#1)(2013-1#1)
the next most##3##3##(1995-2#1)(2011-2#1)(2013-1#1)
the next part##2##3##(2010-9#1)(2013-1#1)
the next phase of##2##4##(2005-7#1)(2006-4#1)
the next phase##4##3##(2005-7#1)(2006-4#1)(2007-9#1)(2008-7#1)
the next round of##3##4##(1996-3#1)(2006-10#1)(2008-11#1)
the next routine test in##2##5##(2006-10#2)
the next sample##2##3##(1990-8#1)(2008-10#1)
the next season##2##3##(1996-6#1)(2010-4#1)
the next section##3##3##(2005-6#1)(2008-8#1)(2009-4#1)
the next several##7##3##(1995-1#1)(1997-1#1)(2006-10#1)(2006-11#1)(2008-5#1)(2010-2#1)(2012-12#1)
the next stage of the##2##5##(2007-11#1)(2008-10#1)
the next stage of##3##4##(2007-11#1)(2008-10#1)(2013-7#1)
the next stage##9##3##(1997-4#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-2#1)(2012-2#1)(2013-7#1)
the next step for##2##4##(2004-3#1)(2008-4#1)
the next step##11##3##(1994-11#1)(1995-9#1)(2004-3#1)(2005-5#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-4#1)
the next steps##2##3##(2008-7#1)(2009-8#1)
the next ten years##2##4##(1993-12#1)(1993-2#1)
the next three##3##3##(1991-11#1)(2007-7#1)(2012-12#1)
the next time##2##3##(1992-11#1)(2012-12#1)
the next two decades##3##4##(1991-5#1)(2006-10#1)(2009-3#1)
the next two weeks##3##4##(1990-11#1)(2006-4#1)(2007-11#1)
the next two##10##3##(1990-11#1)(1991-5#1)(1995-12#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-1#1)(2008-4#1)(2009-3#1)(2009-4#1)
the next wave##2##3##(1991-12#1)(1994-3#1)
the next year##8##3##(1994-1#1)(1996-12#1)(2006-9#1)(2008-11#1)(2008-3#1)(2009-6#1)(2011-1#2)
the next years##3##3##(1995-5#1)(1997-1#1)(2013-1#1)
the next##409##2##(1990-10#1)(1990-11#3)(1990-2#2)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#4)(1991-2#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#3)(1993-1#2)(1993-11#4)(1993-12#1)(1993-2#3)(1993-3#3)(1993-6#3)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#5)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-9#2)(1996-1#3)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#3)(1996-4#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#3)(1997-3#1)(1997-4#2)(1997-6#3)(1997-7#1)(1997-8#1)(2004-1#1)(2004-10#1)(2004-12#2)(2004-3#1)(2004-5#1)(2004-7#1)(2005-10#1)(2005-5#1)(2005-6#2)(2005-7#2)(2005-8#2)(2006-10#17)(2006-11#1)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#6)(2006-6#2)(2006-9#2)(2007-1#2)(2007-11#6)(2007-12#6)(2007-2#5)(2007-3#1)(2007-4#2)(2007-6#2)(2007-7#11)(2007-8#10)(2007-9#3)(2008-1#5)(2008-10#20)(2008-11#17)(2008-12#4)(2008-2#9)(2008-3#7)(2008-4#12)(2008-5#12)(2008-6#1)(2008-7#13)(2008-8#7)(2008-9#5)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#9)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#4)(2010-10#2)(2010-12#2)(2010-2#5)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#7)(2011-2#11)(2012-1#3)(2012-12#8)(2012-2#6)(2012-3#4)(2013-1#8)(2013-7#4)(2013-8#4)
the next-generation##6##2##(2006-12#1)(2008-10#1)(2008-3#1)(2010-10#1)(2011-1#1)(2013-1#1)
the nexus between##3##3##(1991-12#1)(2009-4#1)(2010-10#1)
the nexus of##2##3##(2008-4#2)
the nexus##5##2##(1991-12#1)(2008-4#2)(2009-4#1)(2010-10#1)
the ng##2##2##(2008-10#2)
the nhaAv gene##2##3##(1995-6#2)
the niche hypothesis##2##3##(2008-9#2)
the niche space##3##3##(2008-1#3)
the niche##14##2##(2005-10#1)(2008-1#4)(2008-9#3)(2009-3#3)(2009-4#1)(2012-12#2)
the niches##3##2##(2008-8#1)(2011-2#1)(2012-12#1)
the nickel complex##2##3##(2008-10#2)
the nickel##10##2##(1997-7#1)(2007-12#1)(2008-10#8)
the nickel(II)##3##2##(1996-2#1)(2008-10#2)
the nicotinamide ring##2##3##(1993-11#1)(1994-11#1)
the nicotinamide##10##2##(1990-5#2)(1991-3#1)(1992-7#1)(1993-11#1)(1994-11#1)(1995-2#1)(1997-4#2)(2011-1#1)
the nicotine-induced##2##2##(1994-2#2)
the nicotinic acetylcholine receptor (AChR)##2##5##(2008-4#1)(2012-2#1)
the nicotinic acetylcholine receptor##7##4##(1991-7#1)(1994-11#1)(1995-1#1)(1997-5#1)(2008-4#1)(2008-7#1)(2012-2#1)
the nicotinic acetylcholine##8##3##(1991-7#1)(1994-11#1)(1995-1#1)(1997-5#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-2#1)
the nicotinic receptor antagonist mecamylamine##2##5##(1990-2#1)(1996-10#1)
the nicotinic receptor##8##3##(1990-2#1)(1995-11#2)(1996-10#1)(1996-12#1)(1997-5#1)(2010-9#2)
the nicotinic##21##2##(1990-2#1)(1991-7#1)(1992-3#1)(1994-11#1)(1995-1#1)(1995-11#5)(1996-10#1)(1996-12#1)(1997-5#2)(2007-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-9#2)(2012-2#1)
the nidus and##4##3##(2008-7#3)(2008-9#1)
the nidus of##3##3##(1997-3#1)(2006-6#1)(2010-9#1)
the nidus size##2##3##(2008-7#2)
the nidus##23##2##(1991-2#1)(1996-3#1)(1997-3#1)(2006-6#1)(2008-3#1)(2008-7#13)(2008-9#3)(2010-9#1)(2012-3#1)
the nifedipine group##5##3##(2011-2#5)
the nifedipine##7##2##(1992-4#1)(1994-3#1)(2011-2#5)
the night and##5##3##(1994-2#1)(1994-6#1)(1997-4#1)(2008-3#1)(2012-2#1)
the night at##2##3##(1990-8#1)(1992-12#1)
the night in##4##3##(1992-3#1)(1995-4#1)(2009-10#1)(2011-1#1)
the night was##2##3##(2004-11#1)(2012-12#1)
the night##39##2##(1990-7#2)(1990-8#1)(1991-5#2)(1992-12#1)(1992-3#1)(1994-2#2)(1994-6#1)(1995-12#2)(1995-4#1)(1997-4#1)(2004-11#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#4)(2009-10#2)(2009-4#1)(2010-8#3)(2011-1#1)(2012-12#1)(2012-2#1)
the nightly##2##2##(2008-7#1)(2009-8#1)
the nighttime##3##2##(1995-3#1)(2008-3#1)(2013-7#1)
the nigra##7##2##(1990-5#5)(1993-4#2)
the nigral##3##2##(1992-11#2)(1995-8#1)
the nigro-striatal##3##2##(1991-12#1)(1993-5#1)(2008-11#1)
the nigrostriatal dopamine system##3##4##(1992-10#1)(1996-4#1)(1997-1#1)
the nigrostriatal dopamine##4##3##(1992-10#1)(1994-10#1)(1996-4#1)(1997-1#1)
the nigrostriatal pathway##4##3##(1991-6#1)(1995-8#1)(1996-12#1)(2008-4#1)
the nigrostriatal system##12##3##(1993-5#1)(1994-10#1)(1994-2#1)(1994-8#1)(1995-11#1)(1996-4#1)(2008-7#2)(2012-1#1)(2012-12#1)(2012-2#2)
the nigrostriatal##24##2##(1990-5#1)(1991-6#1)(1992-10#1)(1992-7#1)(1993-5#1)(1994-10#2)(1994-2#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-12#2)(1996-4#2)(1997-1#1)(2008-4#1)(2008-7#2)(2012-1#2)(2012-12#1)(2012-2#2)
the nine KHQ domains##2##4##(2011-1#2)
the nine cases##3##3##(1996-11#1)(2007-7#2)
the nine cultivars##2##3##(2008-5#2)
the nine patients##2##3##(1993-6#1)(2006-12#1)
the nine##59##2##(1991-2#1)(1991-4#1)(1992-2#2)(1992-7#1)(1993-3#1)(1993-5#1)(1993-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-10#1)(2006-12#1)(2007-11#1)(2007-2#2)(2007-7#2)(2008-1#1)(2008-10#10)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2011-1#4)(2012-3#1)(2013-8#2)
the nine-amino-acid hemagglutinin peptide sequence##2##5##(1992-9#2)
the nine-amino-acid##3##2##(1992-9#3)
the nineteen##2##2##(1990-2#1)(1991-4#1)
the nineteenth and##2##3##(2008-7#1)(2013-8#1)
the nineteenth century the##2##4##(2012-2#1)(2013-1#1)
the nineteenth century##20##3##(1991-12#2)(2005-12#1)(2008-2#1)(2009-10#1)(2009-2#1)(2009-7#1)(2010-1#2)(2010-7#2)(2011-2#3)(2012-2#2)(2013-1#4)
the nineteenth##23##2##(1991-12#2)(2005-12#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-1#2)(2010-7#2)(2011-2#3)(2012-2#2)(2013-1#4)(2013-8#1)
the nineties##2##2##(2010-9#1)(2012-12#1)
the ninth##8##2##(1992-3#1)(1992-8#1)(1997-7#1)(2007-12#2)(2007-8#1)(2008-3#1)(2011-2#1)
the niobic acid precipitate##4##4##(2005-11#4)
the nipple and##3##3##(1996-6#2)(2006-9#1)
the nipple##17##2##(1994-12#2)(1996-6#7)(1997-5#1)(2004-2#1)(2006-9#1)(2010-9#2)(2011-1#1)(2011-2#1)(2013-1#1)
the nirB gene and##2##4##(1990-7#2)
the nirB##3##2##(1990-7#3)
the nit mutant##2##3##(2008-10#2)
the nit##3##2##(2008-10#3)
the nitrate pollution sources##3##4##(2013-8#3)
the nitrate reductase A enzyme##2##5##(1990-3#2)
the nitrate reductase Z##3##4##(1990-3#3)
the nitrate reductase##6##3##(1990-3#5)(1993-6#1)
the nitrate##20##2##(1990-3#5)(1991-9#1)(1993-6#1)(1994-2#1)(2008-10#7)(2008-3#1)(2010-4#1)(2013-8#3)
the nitric oxide donor##3##4##(1995-5#1)(1997-4#1)(2013-7#1)
the nitric oxide pathway##3##4##(1994-2#2)(2009-4#1)
the nitric oxide production##2##4##(2008-11#2)
the nitric oxide synthase inhibitor##4##5##(1993-3#1)(1994-2#1)(1996-12#1)(2004-11#1)
the nitric oxide synthase##6##4##(1993-3#1)(1994-11#1)(1994-2#1)(1995-5#1)(1996-12#1)(2004-11#1)
the nitric oxide synthases##3##4##(2005-7#1)(2008-10#2)
the nitric oxide system##2##4##(2010-8#1)(2012-8#1)
the nitric oxide##33##3##(1991-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-2#4)(1995-12#1)(1995-5#3)(1996-1#1)(1996-11#1)(1996-12#3)(1996-9#1)(1997-4#1)(2004-11#1)(2004-4#1)(2005-7#1)(2008-10#2)(2008-11#3)(2009-4#1)(2010-8#1)(2012-8#1)(2013-1#1)(2013-7#1)
the nitric oxide/cyclic GMP##2##4##(1993-6#1)(1996-9#1)
the nitric##39##2##(1991-3#1)(1992-6#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-11#1)(1994-2#4)(1995-12#1)(1995-5#3)(1996-1#1)(1996-11#1)(1996-12#3)(1996-9#3)(1997-4#1)(2004-11#1)(2004-4#1)(2005-7#1)(2006-10#1)(2008-10#3)(2008-11#3)(2009-4#1)(2010-8#1)(2012-8#1)(2013-1#1)(2013-7#1)
the nitrile##3##2##(1993-4#1)(2007-11#1)(2007-12#1)
the nitrite concentration##2##3##(2008-10#2)
the nitrite##8##2##(1992-8#1)(1992-9#1)(1996-2#1)(2008-10#5)
the nitro group##8##3##(1991-3#1)(1994-11#1)(1995-6#2)(1996-2#1)(2007-11#3)
the nitro##15##2##(1991-3#1)(1994-11#1)(1995-3#1)(1995-6#3)(1995-8#1)(1996-2#1)(1997-2#1)(1997-8#1)(2007-11#3)(2008-10#2)
the nitroaromatic##2##2##(1991-3#1)(2007-11#1)
the nitrogen atom in##2##4##(1995-10#1)(2007-11#1)
the nitrogen atom of the##2##5##(1993-6#1)(2006-12#1)
the nitrogen atom of##3##4##(1991-4#1)(1993-6#1)(2006-12#1)
the nitrogen atom##9##3##(1991-4#1)(1993-4#2)(1993-6#1)(1995-10#1)(2006-12#2)(2007-11#1)(2008-10#1)
the nitrogen atoms of the##3##5##(2007-11#1)(2008-5#2)
the nitrogen atoms##4##3##(2007-11#1)(2008-10#1)(2008-5#2)
the nitrogen contents##2##3##(2008-12#1)(2009-5#1)
the nitrogen donor##2##3##(1996-2#2)
the nitrogen mustard mechlorethamine##2##4##(1995-8#1)(2008-4#1)
the nitrogen of the##2##4##(1992-3#1)(1994-9#1)
the nitrogen##41##2##(1991-4#1)(1992-3#1)(1993-4#2)(1993-6#3)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-8#1)(1996-2#2)(1996-8#1)(2006-12#2)(2007-1#1)(2007-11#3)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-9#3)(2009-5#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-8#3)
the nitrogen-centered radical##4##3##(1993-11#4)
the nitrogen-centered##5##2##(1993-11#4)(1997-7#1)
the nitrogen-fixing soil bacterium Azotobacter chroococcum Az12##2##7##(2008-11#2)
the nitrogenous##2##2##(1995-8#1)(2008-9#1)
the nitroso##2##2##(1996-5#1)(2008-10#1)
the nitrous oxide-acetylene flame##2##4##(2008-10#2)
the nitrous##3##2##(1992-8#1)(2008-10#2)
the nitroxide##3##2##(1991-10#1)(1993-8#1)(2008-10#1)
the nm23 antibody##2##3##(1993-8#2)
the nm23##4##2##(1990-11#1)(1993-8#2)(1993-9#1)
the no MPA##2##3##(1996-3#2)
the no current mood disorder group##2##6##(2010-2#2)
the no music control group##2##5##(2007-6#2)
the no##13##2##(1996-3#2)(2007-6#2)(2008-10#2)(2008-11#1)(2008-12#1)(2009-4#1)(2009-8#1)(2010-2#2)(2011-2#1)
the no-visor group##2##3##(2010-1#2)
the noble gas##2##3##(2006-1#1)(2012-1#1)
the noble##5##2##(2006-1#1)(2008-10#1)(2012-1#1)(2013-8#2)
the nociceptive responses##2##3##(1992-7#1)(1997-2#1)
the nociceptive##14##2##(1990-7#1)(1992-7#3)(1993-9#2)(1995-12#1)(1996-7#1)(1997-2#1)(2007-6#1)(2008-8#1)(2009-12#1)(2009-7#1)(2013-1#1)
the nocturnal peak##2##3##(1992-8#1)(2013-7#1)
the nocturnal##11##2##(1992-8#1)(1994-2#1)(2007-12#2)(2008-3#3)(2008-5#1)(2010-12#1)(2013-7#2)
the nodD3##2##2##(2008-9#2)
the nodal##3##2##(2007-7#1)(2008-7#1)(2010-4#1)
the node of##2##3##(2007-11#1)(2008-7#1)
the node##5##2##(1990-10#1)(2007-11#1)(2008-7#2)(2012-2#1)
the nodes##5##2##(1993-5#1)(2008-1#1)(2008-10#1)(2008-5#1)(2011-12#1)
the nodose ganglion##5##3##(1992-9#2)(1996-5#3)
the nodose##6##2##(1992-9#2)(1996-5#4)
the nodule and##2##3##(2008-7#1)(2012-2#1)
the nodule##11##2##(2006-6#1)(2008-1#2)(2008-7#4)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
the nodules were##2##3##(2008-1#1)(2008-5#1)
the nodules##9##2##(1990-7#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-5#1)(2011-1#2)(2011-12#1)(2012-3#1)
the noise and##2##3##(2008-2#2)
the noise at the detector##2##5##(2008-2#2)
the noise components##2##3##(2007-12#1)(2008-2#1)
the noise in the##2##4##(2008-2#2)
the noise in##4##3##(2008-1#1)(2008-2#2)(2008-3#1)
the noise is##8##3##(2008-1#1)(2008-11#1)(2008-2#3)(2008-3#3)
the noise level is##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
the noise level##8##3##(1996-12#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-3#2)(2009-8#1)(2012-2#1)
the noise of the data##2##5##(1997-2#1)(2008-3#1)
the noise of##4##3##(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#1)
the noise power spectral##2##4##(2007-12#1)(2008-2#1)
the noise power##4##3##(2007-12#1)(2008-2#2)(2010-12#1)
the noise reduction##2##3##(2007-12#1)(2008-2#1)
the noise response##3##3##(2010-12#3)
the noise spectrum##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
the noise that##5##3##(1991-12#1)(1991-9#1)(2007-12#1)(2008-2#2)
the noise##96##2##(1991-12#1)(1991-9#1)(1996-12#1)(1997-2#1)(2007-10#2)(2007-11#5)(2007-12#9)(2007-4#1)(2007-7#1)(2007-9#2)(2008-1#3)(2008-10#3)(2008-11#1)(2008-2#29)(2008-3#24)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#4)(2012-2#1)(2013-7#1)
the noise-equivalent absorption##2##3##(2008-2#1)(2008-3#1)
the noise-equivalent##3##2##(2008-2#1)(2008-3#2)
the noises and##2##3##(2008-10#1)(2008-4#1)
the noises in the ear##2##5##(2008-4#2)
the noises##4##2##(2008-10#1)(2008-4#3)
the noisy image##3##3##(2008-2#2)(2008-3#1)
the noisy##7##2##(2007-12#1)(2008-2#3)(2008-3#1)(2009-8#1)(2013-7#1)
the nomenclature for##3##3##(1990-12#2)(1996-2#1)
the nomenclature of##3##3##(1990-12#1)(2005-5#1)(2008-10#1)
the nomenclature##12##2##(1990-12#3)(1990-6#1)(1992-10#1)(1996-2#1)(2005-5#1)(2006-10#1)(2008-10#1)(2008-4#2)(2009-3#1)
the nominal groove##2##3##(2008-2#1)(2008-3#1)
the nominal level of##3##4##(1993-4#1)(2012-3#2)
the nominal##22##2##(1992-2#1)(1993-3#1)(1993-4#1)(1997-3#1)(2004-8#1)(2006-7#1)(2007-12#1)(2007-5#1)(2008-2#2)(2008-3#3)(2008-8#2)(2009-12#1)(2010-8#2)(2011-2#1)(2012-3#3)
the nomination and##2##3##(1996-10#1)(2008-11#1)
the non invasive##2##3##(2008-10#1)(2013-8#1)
the non irradiated##2##3##(2008-10#2)
the non##24##2##(1991-12#1)(1994-2#1)(1994-6#2)(2006-9#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-7#1)(2009-6#2)(2010-1#1)(2010-9#1)(2011-1#1)(2013-8#3)
the non-##3##2##(1994-2#1)(1997-3#1)(2008-11#1)
the non-A##2##2##(1993-8#1)(1997-2#1)
the non-Bayesian analysis##2##3##(2008-10#2)
the non-Bayesian##3##2##(2008-10#2)(2010-2#1)
the non-MOH##2##2##(2007-7#2)
the non-NMDA##6##2##(1990-11#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-8#1)
the non-PTS strain##2##3##(2008-7#2)
the non-activated##4##2##(1995-12#1)(1997-1#3)
the non-additive effects##2##3##(2008-10#2)
the non-additive##3##2##(2008-10#3)
the non-alcoholics##2##2##(1990-4#2)
the non-aqueous elution/separation buffer##2##4##(2007-8#2)
the non-aqueous##3##2##(1990-4#1)(2007-8#2)
the non-availability of##3##3##(2008-1#1)(2009-4#1)(2012-3#1)
the non-basic##2##2##(1994-9#2)
the non-biological##2##2##(2006-10#1)(2010-12#1)
the non-cisplatin##2##2##(2008-7#2)
the non-coding strand##2##3##(1990-7#1)(2012-2#1)
the non-coding##8##2##(1990-7#1)(1994-12#1)(2005-8#2)(2006-11#1)(2007-12#1)(2008-8#1)(2012-2#1)
the non-collagenous domain of type VII collagen##2##7##(1992-3#2)
the non-competitive NMDA receptor antagonist##2##5##(1992-3#1)(1996-9#1)
the non-competitive NMDA receptor##3##4##(1992-3#1)(1993-7#1)(1996-9#1)
the non-competitive NMDA##5##3##(1990-2#1)(1992-3#1)(1993-7#1)(1994-5#1)(1996-9#1)
the non-competitive##9##2##(1990-2#1)(1991-6#1)(1992-3#1)(1993-2#1)(1993-7#1)(1994-5#2)(1996-9#1)(2006-5#1)
the non-contact##2##2##(2009-7#1)(2010-8#1)
the non-convulsing rats##2##3##(1993-4#2)
the non-covalent##4##2##(1993-6#1)(1996-12#1)(1996-8#1)(2008-9#1)
the non-demented##4##2##(1995-11#1)(1997-1#1)(2008-7#2)
the non-displaced##2##2##(2013-1#2)
the non-dominant##2##2##(2007-7#1)(2011-2#1)
the non-entrapped chlorothiazide##2##3##(2008-10#2)
the non-enzymatic##3##2##(1994-9#1)(1997-2#1)(2007-8#1)
the non-erect state of the penis##2##6##(2006-5#2)
the non-erect##3##2##(2006-5#3)
the non-frozen preservation of mammalian cells##2##6##(2008-5#2)
the non-functional iron is converted to a##2##7##(1992-8#2)
the non-functional##3##2##(1992-8#2)(1995-5#1)
the non-helical##2##2##(1990-6#1)(1995-3#1)
the non-heme##2##2##(1990-8#1)(2012-12#1)
the non-hydrolyzable##2##2##(1994-9#1)(1997-1#1)
the non-invasive measurement of##2##4##(1997-6#1)(2006-10#1)
the non-invasive##7##2##(1990-11#1)(1997-3#1)(1997-6#1)(2006-10#1)(2008-1#1)(2010-8#1)(2012-2#1)
the non-ionic detergent##2##3##(1990-9#1)(1993-12#1)
the non-ionic surfactant Triton X-100##2##5##(1990-3#1)(2008-10#1)
the non-ionic surfactant##5##3##(1990-3#1)(2008-10#4)
the non-ionic##11##2##(1990-11#1)(1990-3#1)(1990-9#1)(1992-4#1)(1993-12#1)(2008-10#6)
the non-irradiated group##3##3##(1995-10#3)
the non-irradiated##5##2##(1995-10#3)(2009-7#1)(2010-4#1)
the non-linear Poisson-Boltzmann equation##2##4##(1997-2#1)(2006-10#1)
the non-linear Poisson-Boltzmann##3##3##(1997-2#2)(2006-10#1)
the non-linear and##2##3##(2010-2#1)(2010-8#1)
the non-linear##20##2##(1993-5#1)(1997-2#3)(2006-10#1)(2008-10#8)(2008-11#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-2#1)(2010-8#2)
the non-linearity of##2##3##(2007-4#1)(2008-7#1)
the non-metastatic LLC-C8##2##3##(1993-7#2)
the non-natural scenes##2##3##(2008-4#2)
the non-neovascular##2##2##(2011-1#2)
the non-neural cholinergic system##2##4##(2010-8#2)
the non-nucleoside reverse transcriptase##2##4##(2009-12#1)(2011-2#1)
the non-parametric##2##2##(1996-1#1)(1997-7#1)
the non-peptide##2##2##(1992-8#1)(1995-5#1)
the non-permissive temperature##3##3##(1994-11#1)(1995-3#1)(1995-6#1)
the non-phagocytic##2##2##(2009-5#1)(2012-2#1)
the non-pharmacological treatment##2##3##(2008-7#1)(2009-9#1)
the non-pharmacological##3##2##(2008-7#2)(2009-9#1)
the non-phosphorylating##2##2##(1991-12#2)
the non-polar##7##2##(1995-3#1)(2006-10#2)(2008-10#2)(2010-2#2)
the non-porous packings##2##3##(1991-8#2)
the non-pregnant##6##2##(1990-11#1)(1993-10#1)(1993-12#1)(1994-8#1)(2007-2#1)(2010-10#1)
the non-protein##3##2##(2008-7#2)(2012-1#1)
the non-reducing end##2##3##(1995-11#2)
the non-reducing##3##2##(1994-5#1)(1995-11#2)
the non-related renal transplantation##2##4##(2007-7#2)
the non-related##3##2##(2007-7#2)(2012-12#1)
the non-selective agonist##2##3##(1994-8#1)(1995-12#1)
the non-selective##12##2##(1990-2#1)(1991-5#2)(1994-8#1)(1995-12#2)(1996-11#1)(2005-9#1)(2007-12#1)(2007-8#1)(2008-8#2)
the non-specific adsorption of##2##4##(2005-12#1)(2008-10#1)
the non-specific adsorption##3##3##(2005-12#1)(2008-10#1)(2013-8#1)
the non-specific binding##3##3##(1992-7#1)(1993-7#1)(2010-2#1)
the non-specific##20##2##(1991-10#1)(1991-11#2)(1992-7#1)(1993-7#1)(1994-12#2)(2005-12#1)(2005-4#1)(2006-8#1)(2007-12#1)(2008-10#3)(2009-1#1)(2010-2#1)(2011-1#3)(2013-8#1)
the non-steroidal##3##2##(1990-11#1)(1995-1#1)(2008-3#1)
the non-stimulated##4##2##(1990-7#3)(1995-11#1)
the non-structural protein##2##3##(2008-10#1)(2009-7#1)
the non-sulfated##2##2##(1991-12#1)(1991-2#1)
the non-supplemented group##2##3##(2008-3#2)
the non-supplemented##4##2##(2006-7#1)(2008-3#3)
the non-surgical treatment of developmental dysplasia of the hip##2##9##(2007-8#2)
the non-surgical treatment of##4##4##(1991-8#1)(2007-8#3)
the non-surgical##6##2##(1991-8#1)(2006-8#1)(2007-8#3)(2012-2#1)
the non-targeted##2##2##(2008-5#1)(2008-7#1)
the non-thermal##2##2##(2011-2#1)(2012-2#1)
the non-toxic##4##2##(1992-9#1)(2006-8#1)(2008-10#1)(2011-1#1)
the non-transformed##4##2##(1991-9#2)(1992-8#1)(2006-12#1)
the non-translated##2##2##(1991-12#1)(1994-12#1)
the non-transport group##3##3##(2013-1#3)
the non-treated##7##2##(2004-4#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-8#1)
the non-uniform##2##2##(2008-3#1)(2012-12#1)
the non-verbal##3##2##(2009-7#1)(2009-9#1)(2012-1#1)
the non-viable##2##2##(1992-8#1)(1996-1#1)
the non-violent##7##2##(1991-9#1)(1997-8#6)
the nonadjuvanted subunit vaccine##3##4##(2007-11#3)
the nonadjuvanted subunit##4##3##(2007-11#4)
the nonalternant##2##2##(2008-10#2)
the nonaqueous##4##2##(1996-7#2)(2008-10#1)(2013-1#1)
the nonautoclaved and the recolonized##2##5##(2008-10#2)
the nonbreeding phase##2##3##(2007-9#2)
the nonbreeding##7##2##(2006-5#4)(2007-9#2)(2008-8#1)
the noncancer##2##2##(1993-11#1)(2008-11#1)
the noncatalytic nucleotide binding site##2##5##(1996-5#2)
the noncatalytic##6##2##(1990-9#1)(1992-12#1)(1992-6#1)(1993-11#1)(1996-5#2)
the nonchoice##3##2##(2007-5#2)(2008-10#1)
the noncleavable##2##2##(1991-10#1)(1994-11#1)
the nonclinical safety assessment##2##4##(2010-11#2)
the nonclinical##3##2##(1993-3#1)(2010-11#2)
the noncoding regions of##3##4##(2008-11#1)(2008-12#1)(2013-8#1)
the noncoding regions##4##3##(1990-4#1)(2008-11#1)(2008-12#1)(2013-8#1)
the noncoding sequences##2##3##(1991-7#1)(2013-8#1)
the noncoding##9##2##(1990-4#1)(1991-7#1)(2007-10#1)(2008-11#1)(2008-12#1)(2009-10#1)(2013-8#3)
the noncompetitive##5##2##(1991-7#2)(1995-11#1)(2007-11#1)(2007-8#1)
the nonconserved##2##2##(1991-11#1)(1993-11#1)
the noncovalent##3##2##(1995-1#1)(1995-11#1)(1996-9#1)
the noncystic##2##2##(2007-12#2)
the nondegenerate##2##2##(2007-12#2)
the nondisabled limb##2##3##(2013-1#2)
the nondisabled##3##2##(2013-1#3)
the nondominant hemisphere##2##3##(1996-3#1)(2006-3#1)
the nondominant##5##2##(1996-3#1)(2006-3#1)(2007-7#1)(2008-7#1)(2009-4#1)
the nonelectrostatic##2##2##(1994-8#1)(2005-11#1)
the nonequilibrium##7##2##(1990-2#1)(1993-7#1)(2006-2#1)(2007-12#1)(2008-3#2)(2010-9#1)
the nonfortified supplement##2##3##(2006-10#2)
the nongenomic response##2##3##(1992-12#1)(1994-5#1)
the nongenomic##4##2##(1992-12#2)(1994-5#2)
the nonglutinous cultivar##3##3##(2008-10#3)
the nonhomologous##3##2##(1990-5#1)(1994-8#1)(2013-1#1)
the nonhost##3##2##(2008-10#3)
the nonhydrolyzable##6##2##(1991-6#1)(1993-6#1)(1994-9#1)(1995-3#2)(1995-8#1)
the nonideal##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
the noninduced##2##2##(1997-4#1)(2008-10#1)
the noninfected##2##2##(2007-4#1)(2008-10#1)
the noninoculated control##4##3##(2008-10#4)
the noninoculated##5##2##(2008-10#5)
the noninvasive determination of##2##4##(1990-5#1)(2008-2#1)
the noninvasive##17##2##(1990-5#1)(1994-9#1)(1997-4#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-4#1)(2008-2#2)(2010-9#1)(2012-1#3)(2012-2#1)
the nonionic detergent##3##3##(1994-11#1)(1994-8#1)(2013-1#1)
the nonionic##10##2##(1994-11#1)(1994-8#1)(2005-11#3)(2005-9#1)(2008-10#1)(2010-4#1)(2011-2#1)(2013-1#1)
the nonlasing##2##2##(2007-12#2)
the nonlinear Faraday effect##2##4##(2007-12#2)
the nonlinear Faraday##3##3##(2007-11#1)(2007-12#2)
the nonlinear Poisson-Boltzmann equation##2##4##(1996-4#1)(2005-11#1)
the nonlinear Schrödinger equation##11##4##(2007-11#3)(2007-12#6)(2008-1#2)
the nonlinear absorption coefficient##2##4##(2008-3#2)
the nonlinear absorption##4##3##(2007-12#1)(2008-3#3)
the nonlinear behavior of##2##4##(2007-1#1)(2008-2#1)
the nonlinear coupling between##2##4##(2007-12#1)(2008-3#1)
the nonlinear coupling##3##3##(2007-12#1)(2008-3#2)
the nonlinear crystal##2##3##(2008-1#1)(2008-2#1)
the nonlinear dynamical##2##3##(2007-12#1)(2009-8#1)
the nonlinear dynamics of##2##4##(2007-12#2)
the nonlinear filtering techniques##2##4##(2008-2#2)
the nonlinear function##2##3##(2008-7#1)(2009-4#1)
the nonlinear index of##2##4##(2007-11#1)(2007-12#1)
the nonlinear interaction##3##3##(2005-4#1)(2007-12#2)
the nonlinear joint transform correlator##4##5##(2008-2#4)
the nonlinear least squares##2##4##(2008-7#1)(2011-1#1)
the nonlinear material##5##3##(2007-12#3)(2008-2#1)(2008-3#1)
the nonlinear medium##2##3##(2007-12#2)
the nonlinear optical properties of##3##5##(2007-11#1)(2008-2#1)(2008-7#1)
the nonlinear optical##10##3##(2007-11#2)(2007-12#4)(2008-2#3)(2008-7#1)
the nonlinear phase noise##2##4##(2007-11#2)
the nonlinear phase shift##4##4##(2007-11#3)(2007-12#1)
the nonlinear phase##7##3##(2007-11#5)(2007-12#2)
the nonlinear process##2##3##(2007-11#1)(2011-1#1)
the nonlinear profile##2##3##(2007-12#2)
the nonlinear propagation##2##3##(2007-12#2)
the nonlinear refractive index of the##2##6##(2007-11#1)(2007-12#1)
the nonlinear refractive index of##6##5##(2007-11#1)(2007-12#4)(2008-3#1)
the nonlinear refractive index##9##4##(2007-11#3)(2007-12#4)(2008-1#1)(2008-3#1)
the nonlinear relationship between##2##4##(2008-10#1)(2009-2#1)
the nonlinear relationship##3##3##(2008-10#1)(2008-7#1)(2009-2#1)
the nonlinear response of the##4##5##(2007-11#1)(2007-12#2)(2008-2#1)
the nonlinear response of##5##4##(2007-11#1)(2007-12#2)(2008-2#2)
the nonlinear response##7##3##(2007-11#1)(2007-12#4)(2008-2#2)
the nonlinear susceptibility of the##2##5##(2007-11#1)(2008-3#1)
the nonlinear susceptibility##4##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)
the nonlinear system##2##3##(2008-2#1)(2012-1#1)
the nonlinear transmission##2##3##(2007-12#1)(2008-2#1)
the nonlinear##180##2##(1991-6#1)(1991-8#1)(1996-4#1)(2005-11#3)(2005-4#1)(2007-1#1)(2007-11#24)(2007-12#70)(2008-1#9)(2008-10#1)(2008-2#30)(2008-3#24)(2008-6#2)(2008-7#4)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2011-1#2)(2012-1#1)(2013-8#1)
the nonlinearity of the##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
the nonlinearity of##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
the nonlinearity was##2##3##(2007-11#1)(2007-12#1)
the nonlinearity##20##2##(2007-11#4)(2007-12#6)(2008-2#7)(2008-3#2)(2008-9#1)
the nonlinearly transformed matched filter for phase-encoded images with##2##9##(2008-2#2)
the nonlinearly transformed matched filter##3##5##(2008-2#3)
the nonlocal equation that##2##4##(2007-11#1)(2007-12#1)
the nonmalignant##2##2##(1990-12#2)
the nonmetastatic##2##2##(1995-8#1)(2008-9#1)
the nonobese patients##3##3##(2011-2#3)
the nonobese##6##2##(2004-11#1)(2011-2#5)
the nonoxidative##3##2##(1990-3#1)(1992-12#2)
the nonpalpable##2##2##(2006-2#1)(2006-9#1)
the nonparametric##8##2##(1997-5#1)(2007-10#1)(2008-10#2)(2009-10#1)(2009-5#1)(2010-2#1)(2010-3#1)
the nonparaxial##2##2##(2007-11#1)(2008-2#1)
the nonpathogenic isolates##3##3##(2008-10#3)
the nonpathogenic mutant##2##3##(2008-10#2)
the nonpathogenic##8##2##(2008-10#8)
the nonpeptide antagonist##2##3##(1994-9#1)(1996-12#1)
the nonpeptide##4##2##(1994-9#2)(1996-12#2)
the nonpharmacologic methods##2##3##(2010-8#2)
the nonphosphorylated form of RNA polymerase II##2##7##(1992-5#2)
the nonpolar fraction##2##3##(2013-8#2)
the nonpolar molecular area##2##4##(1996-11#2)
the nonpolar##8##2##(1995-8#1)(1996-11#2)(2005-11#1)(2008-10#1)(2011-1#1)(2013-8#2)
the nonpregnant##2##2##(1990-11#1)(1990-12#1)
the nonprofit form##2##3##(1995-2#2)
the nonprofit hospital##4##3##(1991-1#1)(1992-3#1)(1993-2#1)(1996-2#1)
the nonprofit sector##2##3##(1994-2#2)
the nonprofit##11##2##(1991-1#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-2#2)(1995-2#2)(1996-2#1)(1997-1#1)(2008-11#1)
the nonradiative##2##2##(2005-4#1)(2008-1#1)
the nonreciprocal phase##2##3##(2008-3#2)
the nonreciprocal##4##2##(2008-1#1)(2008-3#3)
the nonreducing end##2##3##(1994-3#1)(1996-2#1)
the nonreducing terminal##4##3##(1994-5#4)
the nonreducing##8##2##(1992-12#1)(1994-3#1)(1994-5#4)(1996-2#1)(2008-7#1)
the nonrelapsing period##2##3##(2008-11#2)
the nonresonant idler##2##3##(2007-12#2)
the nonresonant##6##2##(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#1)
the nonselected##2##2##(1990-11#1)(2008-4#1)
the nonselective cation##3##3##(1992-7#1)(1995-7#1)(1995-8#1)
the nonselective##5##2##(1992-7#1)(1994-2#1)(1995-7#1)(1995-8#1)(1996-8#1)
the nonsinusoidal profile of the##2##5##(2008-2#1)(2008-3#1)
the nonspecific lipid-transfer protein##2##4##(1990-5#1)(1992-6#1)
the nonspecific##10##2##(1990-5#1)(1991-2#1)(1992-6#1)(1995-12#1)(1995-3#1)(1995-8#1)(1997-4#1)(2008-10#1)(2010-2#1)(2010-8#1)
the nonsphericity##2##2##(2007-12#1)(2008-2#1)
the nonstationary##3##2##(2007-12#2)(2008-2#1)
the nonstructural##6##2##(1994-11#1)(2008-10#4)(2009-7#1)
the nonsubstrate##3##2##(1992-12#1)(1995-10#2)
the nonsurgical management of##2##4##(2005-10#1)(2009-3#1)
the nonsurgical##5##2##(2005-10#1)(2006-11#1)(2006-7#1)(2006-8#1)(2009-3#1)
the nonsutured##2##2##(1992-3#1)(2004-9#1)
the nontranscribed strand##3##3##(1994-8#1)(1996-7#1)(1997-1#1)
the nontransformed##3##2##(1995-2#1)(2008-10#2)
the nontransgenic##2##2##(2008-10#2)
the nontreated##4##2##(1992-4#1)(2007-2#1)(2008-10#2)
the nonuniform##4##2##(2007-12#1)(2007-4#1)(2008-2#2)
the nonuniformity of the##3##4##(2008-3#2)(2010-4#1)
the nonuniformity of##4##3##(2008-3#3)(2010-4#1)
the nonuniformity##5##2##(2008-3#4)(2010-4#1)
the nonunion##2##2##(2013-1#1)(2013-8#1)
the nonvector##2##2##(2008-10#2)
the nonverbal##2##2##(1996-2#1)(2012-12#1)
the nonzero##2##2##(2008-2#1)(2010-1#1)
the nopaline synthase##2##3##(1993-5#1)(1997-2#1)
the noradrenaline response to 8-OH-DPAT##2##5##(1996-10#2)
the noradrenaline##4##2##(1990-7#1)(1996-10#2)(1996-12#1)
the noradrenergic system##3##3##(1995-5#1)(2007-7#1)(2011-1#1)
the noradrenergic systems##2##3##(1994-6#2)
the noradrenergic##16##2##(1991-12#1)(1993-4#1)(1994-6#2)(1995-12#3)(1995-5#1)(1996-5#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-6#1)(2011-1#1)(2012-12#1)
the norepinephrine-stimulated response##2##3##(1990-2#2)
the norepinephrine-stimulated##3##2##(1990-2#2)(1993-3#1)
the norm and##2##3##(1992-7#1)(2008-11#1)
the norm for##2##3##(2006-10#1)(2008-5#1)
the norm in##4##3##(1992-12#1)(2008-11#1)(2010-9#1)(2012-1#1)
the norm##16##2##(1992-12#2)(1992-7#1)(1994-12#1)(1997-6#2)(2006-10#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)(2010-9#1)(2012-1#1)(2012-2#1)
the normal adjacent##2##3##(1991-7#1)(1992-8#1)
the normal aerobic##2##3##(2007-7#1)(2008-5#1)
the normal ageing process##2##4##(2009-12#2)
the normal allele##6##3##(1994-11#3)(1995-1#2)(1997-3#1)
the normal anatomy of the##2##5##(2004-2#1)(2006-3#1)
the normal anatomy##4##3##(2004-2#1)(2006-3#1)(2008-1#1)(2012-2#1)
the normal and abnormal##5##4##(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2012-2#1)
the normal and alkalotic preparations##2##5##(1994-2#2)
the normal and the##4##4##(1995-12#1)(1996-10#1)(1996-11#1)(2009-8#1)
the normal and##29##3##(1992-4#1)(1992-5#1)(1993-12#1)(1994-2#3)(1995-11#1)(1995-12#1)(1996-10#1)(1996-11#1)(1996-6#1)(1997-8#1)(2006-10#2)(2007-10#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2012-1#1)(2012-2#1)(2013-1#1)
the normal approximation##2##3##(1994-5#1)(2010-2#1)
the normal brain##3##3##(1991-9#1)(1995-12#1)(2004-12#1)
the normal catalytic##2##3##(1990-4#1)(1995-2#1)
the normal cell##3##3##(1990-3#1)(2013-1#2)
the normal cells##2##3##(1990-3#1)(2007-12#1)
the normal clinical##3##3##(1992-3#1)(1996-9#1)(2008-10#1)
the normal condition##3##3##(1991-9#1)(2006-5#1)(2006-8#1)
the normal control##4##3##(1990-4#1)(1996-3#1)(2009-4#1)(2011-3#1)
the normal controls##8##3##(1997-2#1)(2006-8#1)(2008-10#3)(2008-11#1)(2008-7#2)
the normal daily##2##3##(2008-5#1)(2010-10#1)
the normal development of the##3##5##(1991-9#1)(2008-8#1)(2011-1#1)
the normal development of##9##4##(1991-9#1)(1992-7#1)(1995-12#1)(2006-4#1)(2008-1#2)(2008-8#1)(2010-1#1)(2011-1#1)
the normal development##11##3##(1991-11#1)(1991-9#1)(1992-7#1)(1995-12#1)(2006-4#1)(2008-1#2)(2008-8#1)(2009-4#1)(2010-1#1)(2011-1#1)
the normal direction##2##3##(1990-8#1)(2007-11#1)
the normal dispersion of the##2##5##(2007-11#2)
the normal dispersion##5##3##(2007-11#2)(2007-12#3)
the normal distribution##2##3##(1993-5#1)(2012-3#1)
the normal embryonic development##2##4##(2009-3#1)(2011-1#1)
the normal function of the##2##5##(1992-6#1)(2007-9#1)
the normal function of##3##4##(1990-8#1)(1992-6#1)(2007-9#1)
the normal function##4##3##(1990-8#1)(1992-6#1)(2007-9#1)(2011-2#1)
the normal group##8##3##(1990-10#1)(1990-12#1)(1991-12#1)(1995-11#2)(1996-7#2)(2007-8#1)
the normal growth and##2##4##(2008-5#1)(2013-8#1)
the normal growth temperature (23 degrees C)##2##7##(1994-8#2)
the normal growth##6##3##(1993-11#1)(1994-8#2)(1996-3#1)(2008-5#1)(2013-8#1)
the normal healthy##2##3##(2012-3#1)(2013-8#1)
the normal host##3##3##(2006-10#1)(2006-12#1)(2013-1#1)
the normal human##11##3##(1990-7#1)(1994-12#1)(1994-5#1)(1995-8#1)(1997-1#1)(2006-10#1)(2007-7#1)(2007-9#1)(2010-10#1)(2010-12#1)(2013-7#1)
the normal individuals##2##3##(1994-12#1)(2007-6#1)
the normal intestinal##3##3##(2005-9#1)(2006-2#2)
the normal labour group##2##4##(1992-5#2)
the normal level in##2##4##(1991-9#1)(2012-1#1)
the normal level of##2##4##(1991-2#1)(1995-1#1)
the normal level##14##3##(1991-2#2)(1991-8#1)(1991-9#1)(1995-1#1)(1996-9#1)(1997-2#1)(2008-11#1)(2008-4#1)(2008-6#1)(2010-12#1)(2012-1#3)
the normal levels##4##3##(1993-9#1)(1994-2#1)(2005-8#1)(2012-12#1)
the normal limits of##2##4##(1994-6#1)(2008-8#1)
the normal limits##3##3##(1994-6#1)(2006-2#1)(2008-8#1)
the normal liver##3##3##(1990-5#2)(1990-7#1)
the normal mature##2##3##(1990-7#1)(2007-9#1)
the normal mode##5##3##(2008-10#4)(2013-1#1)
the normal myeloid##2##3##(1991-2#1)(2008-4#1)
the normal operation of##2##4##(1994-12#1)(2008-9#1)
the normal or##5##3##(1991-11#1)(1992-5#1)(1993-2#2)(1994-2#1)
the normal oral##2##3##(2007-6#1)(2013-7#1)
the normal organ##2##3##(2008-10#1)(2008-11#1)
the normal pathway of##3##4##(1991-5#1)(2013-1#2)
the normal pattern of##2##4##(1993-12#1)(1993-9#1)
the normal physiological##3##3##(2007-1#1)(2008-8#1)(2013-1#1)
the normal physiology of##3##4##(1993-7#1)(2006-10#1)(2008-6#1)
the normal physiology##4##3##(1993-7#1)(2006-10#2)(2008-6#1)
the normal plantaris muscle##2##4##(2012-2#2)
the normal population##13##3##(1990-11#1)(1992-10#1)(1992-6#1)(1994-9#1)(1995-5#1)(1996-6#1)(2004-11#1)(2008-1#1)(2008-12#1)(2008-6#2)(2010-10#1)(2010-3#1)
the normal position##3##3##(1997-7#1)(2007-8#1)(2010-11#1)
the normal post-operative##2##3##(2008-2#1)(2012-2#1)
the normal process of##3##4##(2004-12#1)(2008-5#1)(2012-2#1)
the normal process##4##3##(2004-12#1)(2008-5#1)(2008-6#1)(2012-2#1)
the normal range and##4##4##(1990-12#1)(1995-10#1)(2013-1#2)
the normal range before##2##4##(2006-7#1)(2011-11#1)
the normal range for plasma HCII levels was defined to be between 0##2##13##(1990-11#2)
the normal range for##7##4##(1990-11#2)(1996-3#1)(2006-12#1)(2008-2#1)(2009-4#1)(2010-3#1)
the normal range in##7##4##(1991-10#2)(1993-2#1)(1994-10#1)(1995-10#1)(2006-8#1)(2007-7#1)
the normal range of##4##4##(1996-8#1)(2005-10#1)(2006-7#1)(2009-11#1)
the normal range or##2##4##(1995-10#1)(2007-8#1)
the normal range##69##3##(1990-11#3)(1990-12#1)(1991-10#2)(1991-5#1)(1991-7#1)(1992-2#1)(1992-9#3)(1993-2#2)(1993-7#1)(1993-9#1)(1994-10#1)(1994-3#1)(1995-10#5)(1995-2#1)(1995-7#2)(1996-12#1)(1996-3#3)(1996-8#1)(1997-5#2)(2005-10#1)(2005-12#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#4)(2006-8#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-11#1)(2011-12#2)(2011-2#2)(2013-1#2)(2013-7#1)
the normal rat##9##3##(1996-2#2)(1997-2#1)(2008-7#2)(2008-8#1)(2008-9#2)(2013-7#1)
the normal reference range##3##4##(2006-5#3)
the normal reference##4##3##(2006-10#1)(2006-5#3)
the normal response to##2##4##(1992-6#1)(2008-12#1)
the normal sequence##3##3##(1990-11#1)(1991-7#1)(2007-12#1)
the normal skin##2##3##(2008-5#1)(2008-9#1)
the normal state##4##3##(1992-9#1)(1993-3#1)(2006-10#1)(2012-2#1)
the normal subjects##11##3##(1990-2#1)(1994-12#1)(1996-1#2)(1996-5#2)(2007-7#1)(2009-8#3)(2011-1#1)
the normal tissue##4##3##(1992-7#1)(1994-2#1)(2008-5#1)(2011-2#1)
the normal to the##3##4##(1990-4#1)(1997-4#1)(2008-3#1)
the normal twin##2##3##(2011-12#2)
the normal value##3##3##(1992-9#1)(2006-9#1)(2008-6#1)
the normal values for##2##4##(2010-12#1)(2013-3#1)
the normal values##4##3##(2008-7#1)(2010-12#1)(2011-2#1)(2013-3#1)
the normal##589##2##(1990-10#3)(1990-11#8)(1990-12#3)(1990-2#2)(1990-3#3)(1990-4#4)(1990-5#2)(1990-7#4)(1990-8#4)(1990-9#1)(1991-10#2)(1991-11#2)(1991-12#3)(1991-2#4)(1991-3#3)(1991-5#4)(1991-6#1)(1991-7#5)(1991-8#2)(1991-9#6)(1992-10#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#4)(1992-6#5)(1992-7#3)(1992-8#2)(1992-9#8)(1993-1#1)(1993-11#3)(1993-12#3)(1993-2#6)(1993-3#3)(1993-5#2)(1993-6#1)(1993-7#3)(1993-8#1)(1993-9#5)(1994-10#3)(1994-11#3)(1994-12#7)(1994-2#7)(1994-3#2)(1994-4#1)(1994-5#4)(1994-6#3)(1994-7#1)(1994-8#6)(1994-9#1)(1995-1#5)(1995-10#5)(1995-11#6)(1995-12#5)(1995-2#7)(1995-5#2)(1995-7#2)(1995-8#2)(1996-1#4)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#5)(1996-4#2)(1996-5#2)(1996-6#2)(1996-7#4)(1996-8#3)(1996-9#3)(1997-1#1)(1997-2#8)(1997-3#2)(1997-4#4)(1997-5#2)(1997-7#3)(1997-8#5)(2004-11#2)(2004-12#2)(2004-2#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-4#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#10)(2006-12#4)(2006-2#4)(2006-3#1)(2006-4#2)(2006-5#7)(2006-7#4)(2006-8#5)(2006-9#3)(2007-1#4)(2007-10#2)(2007-11#8)(2007-12#13)(2007-2#4)(2007-5#1)(2007-6#3)(2007-7#8)(2007-8#7)(2007-9#3)(2008-1#8)(2008-10#15)(2008-11#7)(2008-12#3)(2008-2#8)(2008-3#4)(2008-4#8)(2008-5#13)(2008-6#8)(2008-7#10)(2008-8#6)(2008-9#12)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#7)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#5)(2010-2#3)(2010-3#3)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#5)(2011-11#1)(2011-12#5)(2011-2#12)(2011-3#2)(2012-1#8)(2012-11#2)(2012-12#5)(2012-2#11)(2012-3#6)(2013-1#10)(2013-3#1)(2013-7#7)(2013-8#10)
the normal-dispersion region##3##3##(2007-11#1)(2007-12#2)
the normal-dispersion##6##2##(2007-11#2)(2007-12#4)
the normal-incidence##4##2##(2008-2#2)(2008-3#2)
the normalisation of##2##3##(2006-2#1)(2007-11#1)
the normalization of##7##3##(1994-9#1)(1995-3#2)(1997-8#1)(2006-12#1)(2008-4#1)(2011-1#1)
the normalized difference vegetation index##2##5##(2008-8#2)
the normalized intensity of the##2##5##(2007-11#1)(2008-5#1)
the normalized##38##2##(1990-7#1)(1991-9#1)(1993-2#1)(1995-12#1)(1995-7#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#5)(2008-3#7)(2008-5#1)(2008-8#2)(2009-2#2)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
the normally##10##2##(1990-3#1)(1995-6#1)(1996-2#1)(1996-9#1)(1997-4#1)(2007-12#1)(2008-11#1)(2008-9#1)(2010-12#1)(2013-8#1)
the normals and##2##3##(1993-9#1)(2008-6#1)
the normals##6##2##(1993-9#1)(1994-4#1)(2008-6#2)(2013-8#2)
the normative##8##2##(1990-1#1)(2008-1#1)(2008-12#1)(2008-9#1)(2009-10#1)(2012-11#1)(2012-12#1)(2012-3#1)
the normativity of##3##3##(2012-11#1)(2012-2#2)
the normotensive group##2##3##(2008-1#1)(2008-7#1)
the normotensive##8##2##(1990-3#1)(1991-2#1)(1991-6#1)(1997-6#1)(2008-1#1)(2008-7#1)(2013-8#2)
the normothermic##5##2##(1994-2#1)(1995-12#1)(1996-12#2)(2008-7#1)
the norms##4##2##(1993-5#1)(2006-12#1)(2007-10#1)(2009-4#1)
the north and##4##3##(2007-1#1)(2008-10#1)(2008-4#1)(2013-7#1)
the north central United States##2##5##(2008-10#2)
the north central##3##3##(2008-10#2)(2008-7#1)
the north coast of Venezuela##2##5##(2007-5#2)
the north coast of##3##4##(2007-5#2)(2008-5#1)
the north coast##4##3##(2007-5#3)(2008-5#1)
the north of the##2##4##(2008-12#1)(2013-1#1)
the north of##8##3##(2007-9#1)(2008-10#2)(2008-12#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
the north##38##2##(1991-11#1)(1992-8#1)(1994-7#1)(2007-1#1)(2007-5#4)(2007-9#3)(2008-10#7)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2009-10#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
the north-central region of the United States##4##7##(2008-10#4)
the north-central region##5##3##(2008-10#5)
the north-central##9##2##(1991-5#1)(2008-10#8)
the north-west of##2##3##(1996-11#2)
the north-west##6##2##(1996-11#2)(2010-8#4)
the north-western zone of the Bogota Savanna##3##7##(2012-12#3)
the north-western zone of the Bogota##4##6##(2012-12#4)
the north-western##8##2##(2008-10#1)(2008-8#1)(2010-8#2)(2012-12#4)
the northeast of##2##3##(2008-10#1)(2008-12#1)
the northeast##4##2##(1995-6#1)(2008-10#1)(2008-12#1)(2009-2#1)
the northeastern United States and##2##5##(2006-10#1)(2008-10#1)
the northeastern United States##6##4##(1991-2#1)(1996-1#1)(2006-10#1)(2008-10#2)(2011-2#1)
the northeastern and##2##3##(2009-7#1)(2011-2#1)
the northeastern##19##2##(1990-7#1)(1991-2#1)(1993-3#1)(1996-1#1)(1996-4#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-5#2)(2009-7#1)(2011-2#2)(2013-1#1)
the northern Caribbean##2##3##(2008-5#2)
the northern Great Plains##3##4##(2008-10#2)(2011-12#1)
the northern and##3##3##(2007-5#1)(2008-10#1)(2008-5#1)
the northern areas##2##3##(2010-8#1)(2012-2#1)
the northern hemisphere##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
the northern mummichog Fundulus heteroclitus macrolepidotus##2##6##(2010-8#2)
the northern part of##10##4##(1990-6#1)(1996-11#1)(1997-4#1)(1997-6#1)(2006-8#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-5#1)(2011-2#1)
the northern part##11##3##(1990-6#1)(1996-11#1)(1997-4#1)(1997-6#1)(2006-8#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-5#1)(2011-2#1)
the northern region##6##3##(2007-1#1)(2007-3#1)(2011-1#1)(2013-7#1)(2013-8#2)
the northern source##2##3##(2008-10#2)
the northern##68##2##(1990-11#1)(1990-6#1)(1993-4#2)(1996-11#1)(1997-4#1)(1997-6#2)(2004-4#1)(2005-8#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-3#1)(2007-5#3)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#12)(2008-5#10)(2008-8#1)(2008-9#1)(2010-12#1)(2010-8#5)(2011-1#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
the northernmost##4##2##(1991-6#1)(1992-4#1)(2008-10#1)(2009-8#1)
the northwest##4##2##(2006-12#1)(2007-5#1)(2008-10#1)(2008-2#1)
the northwestern coast of##3##4##(2007-5#1)(2008-5#2)
the northwestern##6##2##(1992-1#1)(2007-5#1)(2007-8#1)(2008-5#2)(2011-1#1)
the nose and mouth##2##4##(2006-10#1)(2010-5#1)
the nose and nasal septum were##2##6##(1990-6#2)
the nose and paranasal sinuses with##2##6##(2008-3#1)(2013-8#1)
the nose and paranasal sinuses##6##5##(2007-4#1)(2008-3#2)(2010-7#1)(2013-1#1)(2013-8#1)
the nose and paranasal##7##4##(1991-11#1)(2007-4#1)(2008-3#2)(2010-7#1)(2013-1#1)(2013-8#1)
the nose and##15##3##(1990-6#2)(1991-11#1)(1992-4#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-3#2)(2010-5#1)(2010-7#1)(2011-12#1)(2013-1#1)(2013-8#1)
the nose to##2##3##(2007-11#1)(2009-6#1)
the nose##47##2##(1990-6#3)(1991-11#1)(1992-4#2)(1993-2#1)(1994-2#1)(1995-4#1)(2004-7#2)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#3)(2008-11#2)(2008-3#2)(2008-5#5)(2008-7#1)(2009-2#3)(2009-6#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-12#1)(2011-2#1)(2013-1#3)(2013-8#2)
the nosocomial##4##2##(1995-4#1)(2008-1#1)(2011-2#1)(2013-8#1)
the nosological classification of##2##4##(1990-6#1)(1991-2#1)
the nosological##7##2##(1990-6#1)(1991-2#1)(2006-3#1)(2007-6#1)(2008-1#1)(2009-8#1)(2010-9#1)
the nosology of##3##3##(1993-11#1)(1994-8#1)(2005-7#1)
the nosology##4##2##(1993-11#1)(1994-8#1)(2005-7#1)(2011-1#1)
the not##7##2##(1994-1#1)(2007-11#1)(2007-9#1)(2012-12#4)
the not-for-profit##7##2##(1990-12#1)(1992-3#1)(1994-5#1)(1997-4#1)(2005-11#2)(2008-11#1)
the notable##4##2##(1990-3#1)(1991-5#1)(2009-9#1)(2011-2#1)
the noted##3##2##(2006-8#1)(2007-6#1)(2010-8#1)
the notification process##3##3##(1995-4#1)(2008-11#1)(2011-2#1)
the notification system##3##3##(1995-4#1)(2013-1#2)
the notification##7##2##(1995-4#2)(2007-4#1)(2008-11#1)(2011-2#1)(2013-1#2)
the notified cases##2##3##(1990-2#2)
the notified##3##2##(1990-2#2)(1990-3#1)
the notion of &quot##3##4##(1993-9#1)(2008-10#2)
the notion of a##6##4##(2005-8#1)(2005-9#1)(2006-3#1)(2007-9#1)(2008-2#1)(2011-1#1)
the notion of cultural##2##4##(2008-1#1)(2008-7#1)
the notion of standard##2##4##(2009-7#2)
the notion of##36##3##(1993-9#1)(1994-2#2)(1995-2#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-3#1)(2006-4#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-7#1)(2011-1#2)(2012-1#1)(2012-2#1)(2013-8#1)
the notion that a##5##4##(1992-8#1)(1995-12#1)(2005-10#1)(2005-6#1)(2009-1#1)
the notion that one or more##2##6##(1990-8#1)(1995-3#1)
the notion that the##22##4##(1990-1#1)(1990-8#1)(1991-10#1)(1991-2#1)(1992-3#1)(1993-11#1)(1994-10#1)(1994-9#1)(1995-10#2)(1995-2#1)(1995-3#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-3#1)(2012-12#1)(2012-3#1)
the notion that##93##3##(1990-1#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-10#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-3#1)(1994-10#1)(1994-12#1)(1994-5#2)(1994-9#2)(1995-10#2)(1995-12#1)(1995-2#1)(1995-3#5)(1996-4#1)(1996-8#3)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-10#2)(2005-6#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#1)(2007-2#1)(2007-3#1)(2007-8#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-1#1)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-2#4)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
the notion##132##2##(1990-1#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-10#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-5#2)(1994-9#2)(1995-10#2)(1995-12#1)(1995-2#2)(1995-3#5)(1996-4#1)(1996-5#1)(1996-8#3)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-10#3)(2005-6#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#1)(2006-6#1)(2007-2#1)(2007-3#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#4)(2008-2#3)(2008-3#3)(2008-5#2)(2008-7#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#3)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#4)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#2)
the notions of##3##3##(2007-12#1)(2009-3#1)(2012-2#1)
the notions that##2##3##(2006-7#1)(2008-8#1)
the notions##5##2##(2006-7#1)(2007-12#1)(2008-8#1)(2009-3#1)(2012-2#1)
the notochord and floor plate##3##5##(1994-12#3)
the notochord and##4##3##(1994-12#3)(1997-4#1)
the notochord##10##2##(1993-12#2)(1994-12#3)(1997-4#3)(2008-6#1)(2008-9#1)
the notorious##2##2##(2007-9#1)(2008-7#1)
the novalgin##2##2##(2008-10#2)
the novel acrylates##4##3##(2008-3#4)
the novel and##2##3##(2012-3#1)(2013-7#1)
the novel approach##2##3##(2008-4#1)(2012-12#1)
the novel compounds##2##3##(2008-5#2)
the novel diamond IRE##2##4##(2007-11#2)
the novel eLOX-3##2##3##(2008-3#2)
the novel gene##2##3##(1996-2#1)(2005-11#1)
the novel host##2##3##(2008-8#1)(2013-1#1)
the novel mechanism of action of##3##6##(2007-11#1)(2012-12#2)
the novel mechanism of action##4##5##(2007-11#1)(2008-6#1)(2012-12#2)
the novel use of##2##4##(2005-8#1)(2008-5#1)
the novel##157##2##(1990-2#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-3#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-8#2)(1994-9#1)(1995-12#3)(1995-3#2)(1995-4#1)(1995-5#1)(1996-10#2)(1996-12#1)(1996-2#3)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-5#3)(1997-7#2)(2004-4#2)(2005-11#2)(2005-8#1)(2006-10#2)(2006-12#2)(2006-4#1)(2006-9#1)(2007-11#5)(2007-12#3)(2007-8#1)(2008-1#3)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#10)(2008-4#2)(2008-5#13)(2008-6#2)(2008-7#2)(2008-8#6)(2008-9#4)(2009-12#1)(2009-2#1)(2009-7#1)(2010-10#1)(2010-4#1)(2010-6#1)(2011-1#6)(2011-12#1)(2011-2#4)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#1)
the novelty filter to##2##4##(2008-2#2)
the novelty filter##4##3##(2008-2#3)(2008-3#1)
the novelty of the##2##4##(2008-5#1)(2010-11#1)
the novelty of##4##3##(2008-5#1)(2008-7#1)(2010-11#1)(2010-7#1)
the novelty##11##2##(1993-2#1)(2008-2#4)(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-7#1)(2010-9#1)
the novice##6##2##(1991-1#1)(2005-8#1)(2007-12#1)(2008-11#1)(2008-7#1)(2009-6#1)
the now##7##2##(1990-4#1)(1995-11#1)(1995-12#1)(1996-6#1)(2007-11#1)(2008-11#1)(2010-4#1)
the noxious stimulus##2##3##(1993-9#1)(2008-11#1)
the noxious##5##2##(1991-8#1)(1993-2#1)(1993-9#1)(2006-6#1)(2008-11#1)
the nozzle of a##2##4##(2006-4#1)(2011-1#1)
the nozzle##5##2##(2006-4#1)(2008-3#1)(2010-9#2)(2011-1#1)
the nt 8993##2##3##(1994-8#2)
the nt and aa##2##4##(1996-10#1)(2011-1#1)
the nt and##3##3##(1990-11#1)(1996-10#1)(2011-1#1)
the nt sequence of the##2##5##(1990-4#1)(1994-12#1)
the nt sequence of##3##4##(1990-4#1)(1994-12#1)(1997-1#1)
the nt##13##2##(1990-11#1)(1990-4#1)(1991-6#1)(1991-8#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-8#2)(1995-8#1)(1996-10#1)(1997-1#1)(2011-1#1)
the ntra ntrb mutant##4##4##(2009-10#4)
the ntra ntrb##6##3##(2009-10#6)
the nuances of##2##3##(2007-5#1)(2012-2#1)
the nuc##2##2##(1991-5#2)
the nuchal##3##2##(1995-8#2)(1996-12#1)
the nuclear DNA##2##3##(1995-6#1)(2008-5#1)
the nuclear Overhauser effect##3##4##(1991-2#1)(1994-11#2)
the nuclear and##6##3##(1990-10#1)(1994-11#1)(1994-8#1)(2008-10#1)(2008-12#1)(2009-3#1)
the nuclear antigen##2##3##(1991-9#1)(1995-2#1)
the nuclear chromatin##2##3##(2008-4#1)(2012-1#1)
the nuclear encoded##3##3##(1992-12#1)(1993-3#1)(1997-2#1)
the nuclear envelope and##5##4##(2008-9#1)(2011-2#2)(2012-12#2)
the nuclear envelope##18##3##(1994-8#1)(1995-2#1)(2007-12#1)(2008-9#1)(2011-12#2)(2011-2#9)(2012-12#2)(2012-2#1)
the nuclear exclusion of##2##4##(1993-9#1)(2011-2#1)
the nuclear exosome##2##3##(2006-11#2)
the nuclear export of##3##4##(1996-4#3)
the nuclear export##4##3##(1996-4#4)
the nuclear extract##5##3##(1990-2#1)(1994-9#1)(1995-3#2)(1996-7#1)
the nuclear factor##5##3##(1995-3#2)(1997-6#1)(2006-10#1)(2007-6#1)
the nuclear fraction in the##2##5##(1990-10#1)(1997-7#1)
the nuclear fraction of##2##4##(1995-11#1)(2011-2#1)
the nuclear fraction##8##3##(1990-10#2)(1991-8#1)(1994-11#1)(1994-9#1)(1995-11#1)(1997-7#1)(2011-2#1)
the nuclear fuel cycle##2##4##(2007-8#1)(2010-5#1)
the nuclear gene##2##3##(1991-2#1)(1992-11#1)
the nuclear genes##3##3##(1995-3#1)(1997-6#1)(2008-7#1)
the nuclear genome and##3##4##(1995-1#1)(2005-8#1)(2010-6#1)
the nuclear genome##9##3##(1995-1#3)(1995-11#1)(1995-6#2)(2005-8#1)(2009-10#1)(2010-6#1)
the nuclear genomes of##2##4##(1994-12#1)(1995-11#1)
the nuclear genomes##3##3##(1994-12#1)(1995-11#1)(1997-4#1)
the nuclear hormone##8##3##(1993-6#1)(1994-2#1)(1994-8#1)(1995-2#1)(1996-5#1)(2005-11#1)(2006-8#1)(2010-12#1)
the nuclear lamina##6##3##(1992-12#1)(1997-4#1)(1997-6#1)(2008-8#2)(2011-12#1)
the nuclear level##3##3##(1997-3#1)(2008-4#1)(2008-6#1)
the nuclear localization of##3##4##(1990-6#1)(2009-8#1)(2012-12#1)
the nuclear localization signal##2##4##(1991-12#1)(1994-11#1)
the nuclear localization##5##3##(1990-6#1)(1991-12#1)(1994-11#1)(2009-8#1)(2012-12#1)
the nuclear magnetic resonance##2##4##(2009-6#1)(2010-9#1)
the nuclear matrix##18##3##(1990-8#1)(1991-8#3)(1992-12#5)(1992-4#1)(1994-9#1)(1996-11#3)(1997-4#3)(1997-6#1)
the nuclear membrane##6##3##(1992-6#1)(1994-10#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
the nuclear pore complex and##3##5##(1994-11#2)(2009-8#1)
the nuclear pore complex##8##4##(1993-6#1)(1994-11#3)(1995-2#2)(2007-8#1)(2009-8#1)
the nuclear pore##14##3##(1993-6#1)(1994-11#3)(1995-1#2)(1995-2#2)(2007-8#1)(2008-9#1)(2009-8#2)(2011-2#2)
the nuclear pores##2##3##(1995-1#1)(2008-10#1)
the nuclear protein##4##3##(1992-2#1)(1994-2#2)(1997-2#1)
the nuclear proteins##6##3##(1992-11#2)(1996-5#1)(1997-2#1)(2007-9#1)(2008-9#1)
the nuclear rDNA##2##3##(2008-10#2)
the nuclear receptor superfamily##4##4##(1994-12#1)(1995-11#1)(2008-3#1)(2013-8#1)
the nuclear receptor##13##3##(1990-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-8#1)(2008-1#1)(2008-3#1)(2008-4#2)(2008-7#2)(2013-8#1)
the nuclear ribosomal DNA internal transcribed spacer##2##7##(2008-10#2)
the nuclear ribosomal DNA##5##4##(2008-10#5)
the nuclear ribosomal RNA##4##4##(2006-10#1)(2008-10#3)
the nuclear ribosomal##11##3##(2006-10#1)(2008-10#10)
the nuclear run-on##2##3##(1992-2#1)(2012-3#1)
the nuclear scaffold and##2##4##(1992-12#1)(1995-8#1)
the nuclear scaffold##5##3##(1992-12#1)(1992-4#2)(1993-11#1)(1995-8#1)
the nuclear target##2##3##(2008-11#1)(2010-12#1)
the nuclear translation elongation factor 1alpha##2##6##(2008-10#2)
the nuclear transport##3##3##(1994-11#1)(2009-8#1)(2011-2#1)
the nuclear##263##2##(1990-10#3)(1990-12#2)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#3)(1991-11#1)(1991-12#2)(1991-2#3)(1991-5#1)(1991-8#4)(1991-9#1)(1992-11#6)(1992-12#8)(1992-2#2)(1992-4#3)(1992-6#2)(1993-11#1)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#12)(1994-12#3)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#5)(1994-9#4)(1995-1#10)(1995-11#4)(1995-2#7)(1995-3#6)(1995-6#3)(1995-8#3)(1996-11#3)(1996-4#5)(1996-5#4)(1996-7#1)(1997-2#3)(1997-3#1)(1997-4#7)(1997-6#4)(1997-7#1)(1997-8#1)(2005-11#1)(2005-8#2)(2006-10#2)(2006-11#2)(2006-2#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#4)(2009-10#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#5)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-12#4)(2011-2#20)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-8#1)
the nuclear-encoded##4##2##(1990-5#1)(1991-6#1)(1996-7#1)(2010-4#1)
the nuclease activity of##2##4##(1995-1#1)(2008-3#1)
the nuclease activity##3##3##(1995-1#1)(1995-8#1)(2008-3#1)
the nuclease##4##2##(1995-1#1)(1995-8#1)(2008-3#2)
the nucleated state##2##3##(1997-4#2)
the nucleated##4##2##(1997-4#2)(2007-12#1)(2008-5#1)
the nucleation and growth of##4##5##(1992-2#1)(1996-7#1)(2008-2#1)(2008-5#1)
the nucleation and growth##5##4##(1992-2#1)(1996-7#1)(2006-12#1)(2008-2#1)(2008-5#1)
the nucleation of##4##3##(1995-7#1)(2006-12#1)(2008-10#1)(2008-7#1)
the nucleation process##4##3##(1996-4#4)
the nucleation rate##2##3##(2005-11#2)
the nucleation##22##2##(1991-4#1)(1992-2#1)(1995-7#1)(1996-4#6)(1996-7#1)(1996-8#1)(1997-7#1)(2005-11#2)(2006-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)
the nuclei and##3##3##(1992-2#1)(1994-8#1)(1997-2#1)
the nuclei are##2##3##(1990-3#1)(2008-1#1)
the nuclei of all##2##4##(1996-9#1)(1997-4#1)
the nuclei of mammalian##3##4##(1996-9#2)(2008-1#1)
the nuclei of the##4##4##(1993-6#1)(1995-11#1)(2008-6#1)(2008-7#1)
the nuclei of these##2##4##(1994-3#1)(2013-8#1)
the nuclei of##27##3##(1990-11#2)(1992-3#2)(1993-6#1)(1993-7#1)(1994-3#1)(1994-6#2)(1995-11#1)(1996-5#1)(1996-9#4)(1997-4#1)(2007-2#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-12#1)(2009-2#2)(2013-8#1)
the nuclei were##2##3##(2008-12#1)(2008-9#1)
the nuclei##50##2##(1990-11#2)(1990-12#1)(1990-3#1)(1991-5#1)(1992-2#1)(1992-3#2)(1993-6#1)(1993-7#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#4)(1997-2#1)(1997-4#1)(1997-8#2)(2007-12#1)(2007-2#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#4)(2009-12#1)(2009-2#2)(2013-8#1)
the nucleic acid and##4##4##(1990-12#1)(1991-4#1)(1993-6#1)(1994-6#1)
the nucleic acid binding##2##4##(1991-4#1)(1995-11#1)
the nucleic acid##20##3##(1990-12#1)(1991-4#3)(1991-7#1)(1992-6#3)(1993-6#1)(1994-11#1)(1994-3#1)(1994-6#2)(1994-8#2)(1995-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-4#1)
the nucleic acids##7##3##(1994-3#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)
the nucleic##29##2##(1990-12#1)(1991-4#3)(1991-7#1)(1992-6#3)(1993-6#1)(1994-11#1)(1994-3#2)(1994-6#2)(1994-8#2)(1995-11#1)(2006-10#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-4#1)(2010-5#1)
the nucleobase##5##2##(1996-5#1)(2008-4#3)(2008-5#1)
the nucleobases##3##2##(2006-10#2)(2008-4#1)
the nucleocapsid (N)##4##3##(2008-10#4)
the nucleocapsid protein##7##3##(1994-9#5)(1997-6#1)(2008-10#1)
the nucleocapsid##13##2##(1994-9#5)(1997-6#1)(2008-10#5)(2008-11#1)(2008-5#1)
the nucleoid##2##2##(1992-4#1)(1997-4#1)
the nucleolar targeting##2##3##(1994-9#2)
the nucleolar targetting signal##2##4##(1991-2#2)
the nucleolar##8##2##(1991-2#2)(1994-9#2)(2008-10#1)(2008-12#1)(2008-8#2)
the nucleolar-organizing regions of##2##4##(2013-1#2)
the nucleoli of##2##3##(2008-2#1)(2011-12#1)
the nucleoli##5##2##(1991-12#1)(1992-11#1)(2008-2#1)(2011-12#1)(2013-1#1)
the nucleolus of##3##3##(1991-10#1)(1994-9#2)
the nucleolus##14##2##(1991-10#1)(1991-2#3)(1994-9#4)(2008-12#2)(2008-2#1)(2008-7#1)(2011-12#1)(2013-1#1)
the nucleolytic##2##2##(1991-9#2)
the nucleon##4##2##(1992-8#1)(1992-9#1)(2007-8#2)
the nucleophile in##2##3##(1990-5#1)(2006-12#1)
the nucleophile##8##2##(1990-5#1)(1991-5#4)(2006-12#1)(2008-7#1)(2010-2#1)
the nucleophiles##2##2##(1991-5#1)(2007-11#1)
the nucleophilic attack is##2##4##(2007-11#1)(2010-5#1)
the nucleophilic attack##3##3##(2007-11#1)(2010-5#2)
the nucleophilic substitution of##2##4##(2007-10#1)(2008-10#1)
the nucleophilic substrate##2##3##(1992-4#1)(1993-6#1)
the nucleophilic##12##2##(1992-4#1)(1993-6#1)(1993-9#1)(1994-8#1)(1995-2#2)(1997-8#1)(2007-10#1)(2007-11#1)(2008-10#1)(2010-5#2)
the nucleoplasm##6##2##(1991-2#1)(1996-11#4)(2009-6#1)
the nucleoprotein##5##2##(1990-11#2)(1995-11#1)(1996-5#1)(2008-10#1)
the nucleoside analogues##3##3##(1996-5#1)(2006-10#1)(2007-11#1)
the nucleoside##11##2##(1994-8#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-5#1)(1996-8#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-4#2)
the nucleosides##4##2##(1990-7#1)(1996-5#1)(1997-2#2)
the nucleosome##4##2##(1991-11#1)(1992-9#1)(2006-10#1)(2009-5#1)
the nucleosomes##3##2##(1990-12#1)(2008-2#1)(2008-8#1)
the nucleotide (nt) sequence of the##4##6##(1991-8#1)(1993-12#2)(1997-2#1)
the nucleotide (nt) sequence of##6##5##(1991-8#1)(1993-12#2)(1993-4#1)(1993-6#1)(1997-2#1)
the nucleotide (nt) sequence##9##4##(1991-8#1)(1993-12#4)(1993-4#1)(1993-6#1)(1997-1#1)(1997-2#1)
the nucleotide (nt)##11##3##(1991-8#1)(1993-12#4)(1993-2#1)(1993-4#1)(1993-6#2)(1997-1#1)(1997-2#1)
the nucleotide and amino acid##6##5##(1990-7#1)(1990-8#1)(1995-8#1)(2006-5#1)(2008-10#1)(2011-1#1)
the nucleotide and polypeptide binding domains##3##6##(1996-8#3)
the nucleotide and the##3##4##(1991-9#1)(1993-11#1)(2013-8#1)
the nucleotide and##17##3##(1990-7#1)(1990-8#1)(1991-5#1)(1991-9#1)(1993-11#1)(1993-3#1)(1994-3#1)(1995-8#1)(1996-8#3)(2006-5#1)(2008-10#2)(2011-1#1)(2013-8#2)
the nucleotide binding site##4##4##(1991-11#1)(1991-12#1)(1993-3#1)(1996-7#1)
the nucleotide binding sites##2##4##(1991-4#1)(1996-5#1)
the nucleotide binding##9##3##(1991-11#1)(1991-12#1)(1991-4#1)(1992-12#1)(1993-3#1)(1996-5#1)(1996-7#1)(2008-10#2)
the nucleotide concentration##2##3##(1997-4#1)(2008-10#1)
the nucleotide diversities##2##3##(1994-8#2)
the nucleotide excision repair##3##4##(1996-11#1)(1997-1#1)(2008-11#1)
the nucleotide homology of##2##4##(2005-11#1)(2011-1#1)
the nucleotide level##11##3##(1991-7#1)(1992-5#1)(1993-4#1)(1993-7#1)(1994-12#1)(1994-9#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-6#1)(2007-1#1)
the nucleotide sequence and##6##4##(1990-11#1)(1990-12#1)(1991-12#1)(1993-3#1)(1994-8#1)(1997-5#1)
the nucleotide sequence of a##6##5##(1991-5#1)(1992-7#1)(1993-3#1)(1997-3#2)(2008-10#1)
the nucleotide sequence of the cDNA##3##6##(1991-7#1)(1993-3#1)(1994-8#1)
the nucleotide sequence of the pnbA##2##6##(1994-12#2)
the nucleotide sequence of the##32##5##(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-11#1)(1993-3#1)(1993-8#1)(1994-12#4)(1994-8#1)(1995-8#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#1)(2007-3#1)(2008-10#3)(2009-2#1)(2013-8#1)
the nucleotide sequence of this##3##5##(1990-2#1)(1993-11#1)(1994-9#1)
the nucleotide sequence of##51##4##(1990-11#3)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#3)(1991-7#1)(1991-9#2)(1992-11#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-3#3)(1993-8#1)(1994-12#4)(1994-8#1)(1994-9#2)(1995-12#1)(1995-6#1)(1995-8#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(2006-10#1)(2007-3#1)(2008-10#5)(2009-2#1)(2010-7#1)(2013-8#1)
the nucleotide sequence##90##3##(1990-11#5)(1990-12#3)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#2)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#3)(1991-7#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-3#1)(1992-7#1)(1993-11#2)(1993-2#1)(1993-3#5)(1993-8#1)(1993-9#1)(1994-12#5)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#4)(2006-10#1)(2007-3#1)(2008-10#8)(2008-5#1)(2009-2#1)(2010-7#1)(2012-11#1)(2012-2#1)(2013-8#1)
the nucleotide sequences in##2##4##(1995-2#1)(2008-10#1)
the nucleotide sequences of five##2##5##(1992-11#1)(1993-12#1)
the nucleotide sequences of the##11##5##(1990-3#1)(1991-7#1)(1992-2#1)(1992-7#1)(1994-12#1)(1996-4#1)(1997-6#1)(2005-9#1)(2007-6#1)(2008-10#1)(2008-5#1)
the nucleotide sequences of##23##4##(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-7#1)(1993-12#2)(1994-12#1)(1996-10#2)(1996-4#1)(1997-6#1)(1997-8#1)(2005-9#1)(2007-6#1)(2008-10#2)(2008-5#2)
the nucleotide sequences were##2##4##(2009-5#2)
the nucleotide sequences##32##3##(1990-2#1)(1990-3#1)(1990-5#2)(1990-8#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-7#1)(1993-12#2)(1994-12#1)(1994-9#1)(1995-10#1)(1995-2#1)(1996-10#2)(1996-4#1)(1996-8#1)(1997-6#1)(1997-8#1)(2005-9#1)(2007-6#1)(2008-10#3)(2008-5#2)(2009-5#2)
the nucleotide site##2##3##(1993-3#1)(1994-9#1)
the nucleotide##211##2##(1990-11#5)(1990-12#3)(1990-2#4)(1990-3#3)(1990-4#1)(1990-5#4)(1990-7#1)(1990-8#3)(1990-9#2)(1991-11#2)(1991-12#2)(1991-2#3)(1991-4#4)(1991-5#4)(1991-7#4)(1991-8#2)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#4)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#2)(1993-11#4)(1993-12#6)(1993-2#2)(1993-3#8)(1993-4#2)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#7)(1994-3#2)(1994-5#1)(1994-8#5)(1994-9#5)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#2)(1996-10#3)(1996-11#2)(1996-2#1)(1996-4#2)(1996-5#1)(1996-7#2)(1996-8#5)(1997-1#3)(1997-2#4)(1997-3#2)(1997-4#6)(1997-5#2)(1997-6#6)(1997-8#1)(2004-8#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-5#2)(2007-1#1)(2007-3#1)(2007-6#1)(2008-10#17)(2008-11#3)(2008-4#2)(2008-5#5)(2008-9#1)(2009-2#1)(2009-5#2)(2010-7#1)(2011-1#2)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#6)
the nucleotide-binding##3##2##(1990-12#1)(1995-6#1)(2008-11#1)
the nucleotide-free##2##2##(1994-12#1)(1997-6#1)
the nucleotide-induced##3##2##(1995-8#2)(2008-4#1)
the nucleotides##11##2##(1990-5#1)(1990-8#1)(1991-1#1)(1993-11#1)(1994-11#2)(1995-10#2)(2006-10#1)(2008-11#1)(2008-4#1)
the nucleus 24##2##3##(2008-9#2)
the nucleus accumbens and##10##4##(1993-12#1)(1993-6#4)(1994-2#1)(1996-10#1)(1997-7#1)(2008-7#1)(2009-2#1)
the nucleus accumbens have##2##4##(1997-3#1)(2010-3#1)
the nucleus accumbens in##2##4##(1991-1#1)(1993-6#1)
the nucleus accumbens of freely moving##2##6##(1996-9#1)(1997-3#1)
the nucleus accumbens of##8##4##(1993-6#2)(1993-7#3)(1994-2#1)(1996-9#1)(1997-3#1)
the nucleus accumbens produced##2##4##(1991-2#1)(1994-2#1)
the nucleus accumbens septi##2##4##(1991-5#1)(1993-2#1)
the nucleus accumbens was##2##4##(1991-2#1)(1993-6#1)
the nucleus accumbens##93##3##(1990-2#4)(1991-1#1)(1991-2#5)(1991-3#1)(1991-5#2)(1991-6#1)(1992-10#1)(1993-12#3)(1993-2#1)(1993-5#1)(1993-6#17)(1993-7#4)(1994-2#4)(1994-3#1)(1994-8#2)(1995-10#5)(1995-12#2)(1995-2#2)(1995-5#1)(1996-10#4)(1996-12#5)(1996-5#1)(1996-6#1)(1996-9#3)(1997-2#1)(1997-3#4)(1997-7#4)(1997-8#2)(2008-4#2)(2008-6#2)(2008-7#4)(2009-2#1)(2010-3#1)
the nucleus ambiguus##3##3##(1993-12#1)(1993-7#2)
the nucleus and cytoplasm##5##4##(1995-3#1)(1995-8#1)(2007-3#1)(2008-10#1)(2012-12#1)
the nucleus and the cytosol##2##5##(2008-1#1)(2011-2#1)
the nucleus and the##6##4##(2006-5#1)(2008-1#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
the nucleus and##35##3##(1990-8#1)(1991-7#1)(1994-9#3)(1995-3#2)(1995-8#1)(1996-12#1)(1996-9#1)(1997-1#2)(1997-6#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-5#1)(2008-7#5)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
the nucleus are##2##3##(2008-7#1)(2012-2#1)
the nucleus basalis magnocellularis (NBM)##3##5##(1993-3#1)(1995-12#1)(1996-9#1)
the nucleus basalis magnocellularis##7##4##(1991-9#1)(1993-12#1)(1993-3#2)(1994-12#1)(1995-12#1)(1996-9#1)
the nucleus basalis##12##3##(1991-9#1)(1992-10#1)(1992-8#2)(1993-12#1)(1993-3#2)(1994-12#1)(1995-12#1)(1996-9#1)(2010-8#2)
the nucleus by##3##3##(1994-6#1)(2008-1#1)(2008-10#1)
the nucleus in addition to##2##5##(1997-1#2)
the nucleus in cytoplasmic##2##4##(1997-4#1)(2008-7#1)
the nucleus in the##3##4##(1997-6#1)(2008-11#1)(2008-9#1)
the nucleus in##13##3##(1997-1#2)(1997-4#1)(1997-6#2)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#3)(2012-12#2)
the nucleus is a##2##4##(1995-1#1)(2007-12#1)
the nucleus is##6##3##(1992-11#1)(1993-8#1)(1995-1#1)(2007-12#1)(2008-7#1)(2009-8#1)
the nucleus lentiformis mesencephali##2##4##(1992-3#1)(1995-11#1)
the nucleus of infected cells##2##5##(1991-7#1)(2008-11#1)
the nucleus of the solitary tract##10##6##(1991-11#3)(1992-8#2)(1993-12#2)(1995-5#1)(1996-5#1)(2013-1#1)
the nucleus of the##16##4##(1991-10#1)(1991-11#3)(1991-2#1)(1992-7#1)(1992-8#2)(1993-12#2)(1995-11#1)(1995-5#1)(1996-5#1)(2008-11#1)(2008-9#1)(2013-1#1)
the nucleus of##38##3##(1991-10#2)(1991-11#3)(1991-2#1)(1991-7#2)(1992-1#1)(1992-11#1)(1992-7#1)(1992-8#2)(1993-12#3)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-11#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-5#1)(1997-6#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
the nucleus or##3##3##(2008-4#1)(2011-2#2)
the nucleus pulposus##8##3##(2007-1#1)(2007-11#1)(2007-8#4)(2009-5#1)(2012-3#1)
the nucleus raphe magnus##2##4##(1993-7#1)(1996-9#1)
the nucleus raphe##3##3##(1991-3#1)(1993-7#1)(1996-9#1)
the nucleus through##2##3##(2005-11#1)(2011-2#1)
the nucleus to regulate##2##4##(2007-12#1)(2008-4#1)
the nucleus to the##9##4##(1992-3#1)(1993-9#1)(1995-2#2)(1995-3#1)(2009-10#1)(2009-7#1)(2009-8#1)(2011-2#1)
the nucleus to##14##3##(1992-3#1)(1993-9#1)(1995-2#2)(1995-3#1)(1996-2#1)(1997-7#1)(2007-12#1)(2008-4#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-2#1)
the nucleus tractus solitarii (NTS) by##2##6##(1992-3#1)(1997-5#1)
the nucleus tractus solitarii (NTS)##4##5##(1991-8#1)(1992-3#1)(1993-2#1)(1997-5#1)
the nucleus tractus solitarii##8##4##(1991-8#2)(1992-3#2)(1993-2#2)(1997-5#2)
the nucleus tractus solitarius (NTS) of##3##6##(1990-9#1)(1997-2#2)
the nucleus tractus solitarius##10##4##(1990-9#1)(1993-7#1)(1994-10#1)(1994-2#1)(1997-2#2)(1997-5#4)
the nucleus tractus##18##3##(1990-9#1)(1991-8#2)(1992-3#2)(1993-2#2)(1993-7#1)(1994-10#1)(1994-2#1)(1997-2#2)(1997-5#6)
the nucleus was##3##3##(1996-9#1)(2011-12#1)(2011-2#1)
the nucleus were##2##3##(1992-9#1)(1997-4#1)
the nucleus with##4##3##(1991-1#1)(1991-3#1)(2008-7#2)
the nucleus##403##2##(1990-11#1)(1990-12#2)(1990-2#4)(1990-4#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#3)(1991-10#3)(1991-11#7)(1991-2#6)(1991-3#3)(1991-5#8)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#2)(1992-1#3)(1992-10#4)(1992-11#3)(1992-12#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-7#2)(1992-8#6)(1992-9#1)(1993-12#9)(1993-2#4)(1993-3#2)(1993-5#3)(1993-6#18)(1993-7#8)(1993-8#2)(1993-9#2)(1994-10#4)(1994-11#2)(1994-12#3)(1994-2#7)(1994-3#1)(1994-6#4)(1994-8#5)(1994-9#7)(1995-1#1)(1995-10#5)(1995-11#2)(1995-12#5)(1995-2#6)(1995-3#4)(1995-5#4)(1995-7#3)(1995-8#1)(1996-1#1)(1996-10#6)(1996-12#7)(1996-2#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-9#9)(1997-1#5)(1997-2#3)(1997-3#4)(1997-4#6)(1997-5#7)(1997-6#6)(1997-7#5)(1997-8#3)(2005-11#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-12#5)(2007-3#1)(2007-8#4)(2008-1#2)(2008-10#5)(2008-11#7)(2008-2#5)(2008-3#1)(2008-4#6)(2008-5#5)(2008-6#3)(2008-7#19)(2008-8#3)(2008-9#7)(2009-10#3)(2009-11#1)(2009-2#3)(2009-5#2)(2009-7#1)(2009-8#4)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#21)(2012-1#1)(2012-12#8)(2012-2#4)(2012-3#1)(2013-1#3)
the null hypothesis of##4##4##(1995-5#1)(1996-7#1)(2008-10#2)
the null hypothesis that the##2##5##(1995-9#1)(2008-7#1)
the null hypothesis that##4##4##(1995-9#1)(2008-10#1)(2008-5#1)(2008-7#1)
the null hypothesis##18##3##(1995-2#1)(1995-5#1)(1995-9#1)(1996-7#1)(1997-2#1)(2008-10#4)(2008-3#3)(2008-5#1)(2008-7#1)(2012-3#2)(2013-1#2)
the null model when##2##4##(2008-8#2)
the null model##4##3##(1993-12#1)(2008-8#3)
the null##35##2##(1992-1#1)(1993-12#1)(1993-7#1)(1994-2#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-7#1)(2008-10#4)(2008-12#1)(2008-3#6)(2008-5#1)(2008-7#1)(2008-8#3)(2010-2#1)(2010-3#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#2)
the null-direction##2##2##(2008-8#2)
the nulling##3##2##(2007-11#1)(2008-3#2)
the number and area of##2##5##(1991-6#1)(1995-8#1)
the number and area##3##4##(1991-6#1)(1995-8#2)
the number and distribution of##4##5##(1994-9#1)(1997-7#1)(2007-12#1)(2008-3#1)
the number and doses of psychotropics##2##6##(2013-8#2)
the number and length of##2##5##(1990-6#1)(2008-5#1)
the number and location of##2##5##(1991-11#1)(1996-11#1)
the number and magnitude of##2##5##(1991-3#1)(2008-1#1)
the number and position of##2##5##(2007-1#1)(2008-5#1)
the number and quality of the##2##6##(1991-11#1)(1991-6#1)
the number and quality of##4##5##(1991-11#1)(1991-6#1)(2006-5#1)(2010-3#1)
the number and severity of##3##5##(1990-9#1)(2007-11#1)(2010-12#1)
the number and size of##9##5##(1990-5#1)(1995-3#1)(1995-8#1)(2006-5#1)(2008-10#2)(2008-9#1)(2010-12#1)(2010-4#1)
the number and the position of##2##6##(2008-10#1)(2008-2#1)
the number and the size of##2##6##(2008-3#1)(2013-8#1)
the number and the volume of glomeruli##2##7##(1996-7#2)
the number and the##11##4##(1995-1#1)(1996-7#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-8#1)(2012-1#1)(2013-8#1)
the number and type of##7##5##(1992-4#1)(2008-11#1)(2008-5#1)(2009-2#2)(2010-9#1)(2011-12#1)
the number and types of##2##5##(1992-3#1)(1994-2#1)
the number and volume of gonadotrophic cells of##2##8##(2007-3#2)
the number and volume of gonadotrophic cells##3##7##(2007-3#3)
the number and##91##3##(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#2)(1991-3#1)(1991-6#2)(1992-3#1)(1992-4#1)(1993-3#1)(1994-2#2)(1994-6#2)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-7#3)(1997-2#1)(1997-7#1)(2006-10#1)(2006-5#2)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#5)(2007-3#3)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-9#2)(2009-10#1)(2009-2#2)(2009-6#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-12#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#4)
the number concentration of##2##4##(1995-3#1)(2008-12#1)
the number density of##2##4##(2008-3#1)(2010-12#1)
the number density##4##3##(2006-12#1)(2008-3#2)(2010-12#1)
the number of &quot##2##4##(1992-5#1)(1993-3#1)
the number of C##2##4##(2007-3#2)
the number of CFU-GM##2##4##(1991-10#2)
the number of Fos-LI neurons##2##5##(1995-3#2)
the number of HIV infected##2##5##(1991-6#1)(1993-8#1)
the number of HIV##4##4##(1991-6#1)(1993-8#1)(2007-12#1)(2008-7#1)
the number of HIV-1##2##4##(1990-2#1)(1994-2#1)
the number of ICSS trains##2##5##(1991-2#2)
the number of LH/hCG receptor##2##5##(1990-10#2)
the number of LHRH neurones##2##5##(1993-2#2)
the number of LNs retrieved and/or##2##6##(2010-12#2)
the number of LNs retrieved##4##5##(2010-12#4)
the number of NADPH-diaphorase stained##3##5##(1994-5#3)
the number of T##2##4##(1995-9#1)(2008-4#1)
the number of TURP operations##2##5##(2006-8#2)
the number of abortions##2##4##(1991-3#1)(1991-8#1)
the number of acceptable solutions##2##5##(2008-3#2)
the number of active##5##4##(1992-9#1)(1995-3#1)(2008-10#1)(2008-4#1)(2008-9#1)
the number of actual##2##4##(1996-4#1)(2008-12#1)
the number of actuators##2##4##(2008-2#2)
the number of acute##4##4##(2007-11#1)(2008-1#1)(2008-5#1)(2013-8#1)
the number of additional##2##4##(2007-12#1)(2008-5#1)
the number of adult##3##4##(1994-3#1)(1996-12#1)(2008-8#1)
the number of amino groups##2##5##(1990-4#1)(2008-10#1)
the number of amino##3##4##(1990-4#1)(1992-6#1)(2008-10#1)
the number of amniocenteses##2##4##(2012-3#2)
the number of antibody##2##4##(2008-4#1)(2008-9#1)
the number of antibody-producing##2##4##(2008-4#2)
the number of apothecia##3##4##(2008-10#3)
the number of applicants##2##4##(2007-4#1)(2012-3#1)
the number of applied##2##4##(2004-9#1)(2011-1#1)
the number of ascospores##3##4##(2008-10#3)
the number of astrocytes##3##4##(1993-11#1)(2006-4#1)(2009-3#1)
the number of asymptomatic##2##4##(1990-3#1)(2012-12#1)
the number of available##6##4##(1991-5#1)(2007-4#1)(2008-3#2)(2009-10#1)(2010-11#1)
the number of bacteria in##2##5##(2008-10#1)(2012-3#1)
the number of bacteria##7##4##(1993-7#1)(2008-10#3)(2008-5#1)(2008-9#1)(2012-3#1)
the number of beads and##2##5##(2005-11#2)
the number of bends##2##4##(2009-11#2)
the number of binding sites##10##5##(1990-11#1)(1990-7#1)(1991-1#1)(1992-9#1)(1995-8#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)
the number of binding##11##4##(1990-11#1)(1990-7#1)(1991-1#1)(1992-9#1)(1995-8#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-4#1)
the number of births##3##4##(1990-6#1)(1995-12#1)(2007-11#1)
the number of bits##3##4##(2007-12#1)(2008-2#2)
the number of blood transfusions##2##5##(2007-7#1)(2008-1#1)
the number of blood##3##4##(2006-12#1)(2007-7#1)(2008-1#1)
the number of blossoms##2##4##(2008-10#2)
the number of both##2##4##(2006-10#1)(2010-10#1)
the number of bromodeoxyuridine##2##4##(2007-10#1)(2010-12#1)
the number of calibration##2##4##(2008-10#1)(2008-3#1)
the number of cancer##2##4##(2008-10#1)(2011-2#1)
the number of cardiac##2##4##(2006-10#1)(2007-8#1)
the number of cases in##2##5##(1994-9#1)(2006-6#1)
the number of cases of##9##5##(1991-8#1)(1992-11#1)(1992-8#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-11#1)(2009-2#1)(2012-1#1)
the number of cases reported##2##5##(1990-6#1)(1994-9#1)
the number of cases##25##4##(1990-3#1)(1990-6#1)(1990-9#1)(1991-8#1)(1992-11#1)(1992-8#1)(1992-9#2)(1994-9#2)(1995-2#1)(1996-2#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-6#1)(2009-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
the number of cell##3##4##(1990-8#1)(1994-6#1)(1996-4#1)
the number of cells expressing##2##5##(1995-11#1)(1997-5#1)
the number of cells in the##3##6##(1997-1#1)(2006-12#1)(2009-8#1)
the number of cells in##4##5##(1997-1#1)(2006-12#1)(2009-8#2)
the number of cells per##3##5##(1996-3#1)(2006-5#1)(2008-11#1)
the number of cells present in##2##6##(1994-3#1)(2008-4#1)
the number of cells##20##4##(1990-12#1)(1990-3#1)(1994-3#1)(1995-11#1)(1995-5#1)(1996-3#1)(1997-1#1)(1997-5#1)(2006-12#2)(2006-5#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#3)
the number of channels##5##4##(2008-3#2)(2008-7#1)(2008-9#2)
the number of children with##2##5##(2008-1#1)(2012-12#1)
the number of children##6##4##(1992-10#1)(1992-4#1)(2008-1#1)(2009-12#1)(2012-12#2)
the number of cigarettes smoked daily##2##6##(2005-10#1)(2013-1#1)
the number of cigarettes smoked##3##5##(2005-10#1)(2012-1#1)(2013-1#1)
the number of clinical##2##4##(1994-5#1)(2011-2#1)
the number of clusters##2##4##(2012-3#1)(2013-1#1)
the number of coil elements##2##5##(2013-7#2)
the number of colonies##2##4##(1990-10#1)(1995-7#1)
the number of colorectal polyps##2##5##(2007-4#1)(2008-11#1)
the number of common variants in the##2##7##(2012-3#2)
the number of complications##2##4##(2007-9#1)(2013-8#1)
the number of components##3##4##(2008-10#2)(2008-4#1)
the number of conidia##6##4##(2008-10#6)
the number of contact sites was##2##6##(1994-12#2)
the number of contact sites##3##5##(1994-12#3)
the number of contact##4##4##(1994-12#3)(2007-12#1)
the number of contacts##3##4##(1994-6#1)(1994-9#1)(1995-11#1)
the number of controls##2##4##(1996-12#2)
the number of correct responses##3##5##(1991-1#1)(1991-2#1)(1991-4#1)
the number of correct##4##4##(1991-1#1)(1991-2#1)(1991-4#1)(2011-2#1)
the number of coughs##2##4##(1993-11#1)(1993-3#1)
the number of covariates##2##4##(1994-2#1)(2008-8#1)
the number of cycles##2##4##(2006-8#2)
the number of cytotoxic T cells##2##6##(1997-7#1)(2008-10#1)
the number of data points##3##5##(2006-10#1)(2008-2#1)(2008-3#1)
the number of data##4##4##(2006-10#2)(2008-2#1)(2008-3#1)
the number of days##10##4##(1992-3#1)(1993-1#1)(1996-1#1)(2006-5#1)(2008-10#3)(2008-11#1)(2010-8#1)(2012-2#1)
the number of deaths from##2##5##(1997-7#1)(2006-11#1)
the number of deaths##5##4##(1990-9#1)(1997-7#2)(2006-11#1)(2008-5#1)
the number of desired spatial frequencies##2##6##(2008-3#2)
the number of desired##3##4##(2008-3#3)
the number of detected##2##4##(1996-12#1)(2012-3#1)
the number of diagnoses##3##4##(1993-1#1)(1997-6#1)(2006-8#1)
the number of diseased##3##4##(1995-12#1)(2008-10#2)
the number of diseases##3##4##(2006-6#1)(2008-10#1)(2008-7#1)
the number of dissected lymph nodes on the##2##8##(2011-2#2)
the number of distinct##2##4##(1991-7#1)(2009-10#1)
the number of documented##2##4##(1995-12#1)(2008-5#1)
the number of doses##4##4##(2004-12#2)(2009-6#1)(2012-2#1)
the number of drugs prescribed##2##5##(1990-4#1)(2010-12#1)
the number of drugs##3##4##(1990-4#1)(2010-12#1)(2013-8#1)
the number of edges##2##4##(1991-2#1)(2009-3#1)
the number of eggs laid##2##5##(2008-4#2)
the number of eggs##4##4##(2008-10#1)(2008-4#2)(2008-8#1)
the number of elderly drivers##2##5##(1993-5#1)(2006-8#1)
the number of elderly patients##2##5##(1991-11#1)(2011-2#1)
the number of elderly##6##4##(1991-11#1)(1993-5#1)(2006-8#1)(2008-11#1)(2011-2#1)(2012-3#1)
the number of electrons##2##4##(2007-12#1)(2008-10#1)
the number of elements##3##4##(2007-12#1)(2008-2#1)(2011-2#1)
the number of embryos##3##4##(1992-3#1)(2008-12#2)
the number of entries##2##4##(1993-6#1)(1993-9#1)
the number of errors (attempts to pass through two incorrect panels of the##3##13##(1993-12#1)(1993-3#1)(1996-12#1)
the number of errors##7##4##(1991-1#1)(1991-2#1)(1993-12#2)(1993-3#1)(1996-12#1)(2006-6#1)
the number of events##3##4##(1993-12#1)(2008-3#1)(2012-2#1)
the number of experimental##2##4##(2008-10#2)
the number of experiments##2##4##(2008-4#1)(2008-5#1)
the number of extinctions##2##4##(2008-8#2)
the number of facilities##2##4##(1995-12#1)(2007-2#1)
the number of factors##7##4##(2008-10#7)
the number of failures##2##4##(2011-2#1)(2012-2#1)
the number of falls##2##4##(1994-2#1)(2010-2#1)
the number of false rejections##2##5##(2010-3#1)(2011-1#1)
the number of false##4##4##(1997-2#1)(2008-10#1)(2010-3#1)(2011-1#1)
the number of false-positive##2##4##(2006-10#1)(2012-3#1)
the number of female##2##4##(1993-9#1)(2008-10#1)
the number of females##2##4##(2008-9#1)(2013-1#1)
the number of fermentation cycles##2##5##(2008-7#2)
the number of fixed charges##2##5##(2009-10#2)
the number of fixed##3##4##(2009-10#2)(2012-1#1)
the number of foci##2##4##(2008-10#2)
the number of friends and##2##5##(2009-7#2)
the number of fringes in##2##5##(2008-2#1)(2008-3#1)
the number of frontal cortical##2##5##(1995-12#2)
the number of fruit##2##4##(2008-5#1)(2011-1#1)
the number of functional##3##4##(2008-8#1)(2008-9#1)(2012-2#1)
the number of gene##2##4##(1993-3#1)(2010-6#1)
the number of generations##2##4##(2007-11#1)(2013-1#1)
the number of genes in##2##5##(2008-7#1)(2009-10#1)
the number of genes that##3##5##(1996-9#1)(2008-4#1)(2010-7#1)
the number of genes##10##4##(1996-9#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-5#1)(2010-7#1)
the number of genotypes observed##2##5##(2008-10#2)
the number of genotypes##4##4##(2008-10#3)(2010-10#1)
the number of giant##2##4##(1995-11#1)(2008-10#1)
the number of grains##2##4##(1990-10#1)(2008-12#1)
the number of groups##2##4##(2007-5#1)(2012-2#1)
the number of health##4##4##(1990-11#1)(2007-7#2)(2008-11#1)
the number of healthy##2##4##(2008-10#1)(2012-2#1)
the number of heart##2##4##(1991-4#1)(1996-8#1)
the number of hepatic##3##4##(1990-4#2)(1994-11#1)
the number of holograms that##2##5##(2008-2#1)(2008-3#1)
the number of holograms##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
the number of hospital beds##2##5##(2011-7#1)(2013-8#1)
the number of hospital visits##2##5##(1993-1#1)(2007-11#1)
the number of hospital##4##4##(1993-1#1)(2007-11#1)(2011-7#1)(2013-8#1)
the number of hospitals##2##4##(2008-11#1)(2011-2#1)
the number of hours##4##4##(2007-9#1)(2008-10#3)
the number of hydroxyl##2##4##(2008-10#1)(2009-3#1)
the number of identified##3##4##(2008-11#1)(2009-5#1)(2013-8#1)
the number of image pixels##2##5##(2008-3#2)
the number of immigrants##4##4##(1993-9#1)(1995-5#1)(1996-6#1)(2008-9#1)
the number of immunizations##2##4##(1995-5#2)
the number of immunopositive cells##2##5##(2008-4#1)(2008-6#1)
the number of independent clusters is small##2##7##(1996-8#2)
the number of independent clusters##3##5##(1996-8#3)
the number of independent##4##4##(1996-8#3)(2008-3#1)
the number of individuals living##3##5##(2012-1#1)(2013-1#2)
the number of individuals who##2##5##(2009-5#1)(2012-3#1)
the number of individuals with##3##5##(1995-12#1)(2008-1#1)(2008-10#1)
the number of individuals##13##4##(1995-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
the number of infected##8##4##(1997-4#1)(2008-10#7)
the number of infections##2##4##(2006-10#1)(2008-10#1)
the number of inflammatory##2##4##(2008-10#1)(2010-5#1)
the number of input##3##4##(1997-4#1)(2008-10#1)(2008-2#1)
the number of integrated##2##4##(1990-9#1)(2008-10#1)
the number of intensity petals##2##5##(2007-11#2)
the number of intensity##4##4##(2007-11#2)(2008-3#1)(2009-5#1)
the number of intertrial responses##2##5##(1994-6#2)
the number of interventions##3##4##(2007-2#1)(2007-7#2)
the number of involved nodes##3##5##(1995-10#3)
the number of involved##5##4##(1993-9#1)(1995-10#3)(2004-2#1)
the number of ions per##2##5##(2005-11#1)(2007-12#1)
the number of ions##3##4##(2005-11#1)(2007-12#1)(2008-10#1)
the number of items##2##4##(2011-1#1)(2012-2#1)
the number of iterations##2##4##(2008-2#1)(2008-7#1)
the number of its##2##4##(1990-2#1)(2008-5#1)
the number of known##4##4##(1995-5#1)(2006-5#1)(2008-4#1)(2009-10#1)
the number of labeled##2##4##(1995-3#1)(1996-9#1)
the number of large##3##4##(1995-11#1)(1996-6#1)(2009-2#1)
the number of layers in the##2##6##(2007-11#1)(2008-3#1)
the number of layers##5##4##(2007-11#1)(2008-10#1)(2008-3#3)
the number of legal abortions##2##5##(1996-11#2)
the number of lesions increased##2##5##(2008-10#2)
the number of lesions per##2##5##(2008-10#2)
the number of lesions##12##4##(1997-6#2)(2006-2#1)(2006-6#1)(2007-7#1)(2008-10#7)
the number of letters to the left##2##7##(2009-2#2)
the number of letters##4##4##(2009-2#4)
the number of lines##2##4##(1991-2#1)(2008-2#1)
the number of live##2##4##(1991-3#1)(2008-11#1)
the number of long-term##3##4##(1994-5#1)(2006-10#1)(2010-11#1)
the number of longer##2##4##(1994-8#1)(2010-11#1)
the number of loop##2##4##(2011-2#2)
the number of lymphocytes##3##4##(1996-3#1)(2006-6#1)(2008-7#1)
the number of lysine##2##4##(1990-4#1)(1997-4#1)
the number of mENK-immunoreactive neurons##2##5##(1991-10#2)
the number of major##2##4##(2008-1#1)(2008-10#1)
the number of malaria##2##4##(1992-5#1)(2008-8#1)
the number of males##2##4##(2008-8#1)(2013-1#1)
the number of mappings and the parameters of an IFS##2##10##(2008-2#2)
the number of mappings##3##4##(2008-2#3)
the number of mast cells##3##5##(1997-7#2)(2009-6#1)
the number of maxima##4##4##(2008-2#1)(2008-9#3)
the number of measurements##2##4##(2005-11#1)(2008-10#1)
the number of medical##2##4##(1990-10#1)(1991-12#1)
the number of men presenting with##2##6##(2006-9#2)
the number of metastatic##4##4##(1992-10#1)(1993-7#2)(2010-12#1)
the number of methylene groups in the##2##7##(2005-11#2)
the number of microorganisms##2##4##(2007-12#1)(2008-5#1)
the number of migrants##3##4##(2008-10#1)(2008-8#1)(2013-1#1)
the number of minor alleles##4##5##(2012-3#4)
the number of modes##2##4##(2007-11#1)(2008-3#1)
the number of molecular##3##4##(1990-8#1)(1992-12#1)(2008-11#1)
the number of molecules of##3##5##(1990-12#1)(1995-8#1)(2008-11#1)
the number of molecules##5##4##(1990-12#2)(1995-8#1)(1997-8#1)(2008-11#1)
the number of multiple##2##4##(1997-2#1)(2007-12#1)
the number of neurones##2##4##(1993-2#1)(1995-8#1)
the number of neurons and##2##5##(1997-7#1)(2009-2#1)
the number of neurons in the##2##6##(2012-3#2)
the number of neurons##14##4##(1993-2#1)(1994-5#1)(1996-10#1)(1996-3#4)(1997-5#1)(1997-7#1)(2008-2#2)(2009-2#1)(2012-3#2)
the number of new##9##4##(1990-6#1)(1991-2#1)(1996-12#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-12#1)
the number of nuclei##2##4##(2006-5#1)(2008-10#1)
the number of nursing##2##4##(2007-10#1)(2013-8#1)
the number of ommatidia per eye##2##6##(2007-12#2)
the number of oospores##2##4##(2008-10#2)
the number of osteoclasts in##2##5##(1990-9#1)(2010-10#1)
the number of osteoclasts##3##4##(1990-9#1)(1997-7#1)(2010-10#1)
the number of oxyethylene units##2##5##(1990-3#1)(2008-10#1)
the number of parameters##4##4##(1995-9#1)(2008-10#1)(2008-2#1)(2008-3#1)
the number of participants##2##4##(2010-11#1)(2010-7#1)
the number of patches##3##4##(2008-8#3)
the number of patent##3##4##(2008-1#1)(2010-12#1)(2010-7#1)
the number of patients is##2##5##(2005-5#1)(2007-8#1)
the number of patients per##2##5##(1990-8#1)(2011-1#1)
the number of patients presenting##2##5##(2007-10#1)(2007-8#1)
the number of patients removed from the list##2##8##(1991-11#2)
the number of patients treated on an ineffective therapy##2##9##(2012-2#2)
the number of patients treated##8##5##(1994-5#1)(2007-7#1)(2008-7#2)(2010-5#1)(2011-2#1)(2012-2#2)
the number of patients who##6##5##(1991-5#1)(1992-10#1)(2006-8#1)(2007-8#1)(2009-8#1)(2012-3#1)
the number of patients with a##2##6##(1992-2#1)(2012-2#1)
the number of patients with##12##5##(1990-3#1)(1992-2#1)(1993-1#1)(1994-12#1)(1995-5#2)(2006-10#1)(2006-6#1)(2007-11#1)(2008-7#1)(2010-12#1)(2012-2#1)
the number of patients##52##4##(1990-3#1)(1990-8#1)(1991-11#3)(1991-5#1)(1992-1#1)(1992-10#1)(1992-2#1)(1993-1#1)(1994-12#2)(1994-5#1)(1995-5#2)(1996-9#1)(2004-10#1)(2005-5#1)(2006-10#3)(2006-6#1)(2006-8#3)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-6#1)(2008-7#3)(2009-3#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#5)(2012-3#2)(2013-1#1)(2013-8#1)
the number of peaks##2##4##(1990-2#1)(2008-10#1)
the number of people who##2##5##(1993-2#1)(2012-2#1)
the number of people with dementia##2##6##(2008-6#1)(2013-8#1)
the number of people with##4##5##(1996-2#1)(2008-6#1)(2011-2#1)(2013-8#1)
the number of people##12##4##(1991-6#1)(1992-2#1)(1993-2#1)(1994-2#1)(1995-12#1)(1996-2#1)(2007-11#1)(2008-6#1)(2011-2#2)(2012-2#1)(2013-8#1)
the number of pertussis cases reported##2##6##(2010-12#2)
the number of photons##3##4##(2008-2#1)(2008-3#1)(2008-4#1)
the number of pixels in the image##2##7##(2008-3#2)
the number of pixels##8##4##(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#3)(2008-8#1)
the number of plants visited per time##2##7##(2008-10#2)
the number of points##2##4##(2008-3#2)
the number of positive##3##4##(1990-8#1)(2008-9#1)(2010-4#1)
the number of possible##2##4##(1997-7#1)(2008-1#1)
the number of potential mates##2##5##(2008-8#2)
the number of potential##8##4##(1995-8#1)(2007-5#1)(2008-12#1)(2008-8#3)(2012-12#2)
the number of pregnancies##4##4##(2011-2#4)
the number of previous hospitalizations##2##5##(1991-2#2)
the number of previous##3##4##(1991-2#2)(2008-1#1)
the number of procedures##4##4##(1993-12#1)(2006-10#2)(2011-2#1)
the number of processors##2##4##(2008-2#2)
the number of propagules##3##4##(2008-10#3)
the number of protein##3##4##(1991-8#1)(2007-8#1)(2008-8#1)
the number of publications##3##4##(2007-4#1)(2007-8#1)(2013-1#1)
the number of race-change mutants##2##5##(2008-10#2)
the number of recorded##2##4##(1997-6#1)(2008-3#1)
the number of reflections##2##4##(2008-3#2)
the number of rejections##2##4##(1997-5#1)(2011-1#1)
the number of removed lymph nodes##2##6##(2011-2#2)
the number of repeats##2##4##(1991-12#1)(1995-8#1)
the number of reported##3##4##(1991-3#1)(2007-12#1)(2007-2#1)
the number of reports##2##4##(2007-11#1)(2009-12#1)
the number of residents##2##4##(1991-8#1)(1994-12#1)
the number of response categories##3##5##(2010-1#2)(2012-2#1)
the number of risk factors##2##5##(2011-2#1)(2013-8#1)
the number of saccharide units##2##5##(1995-4#2)
the number of samples that can be##2##7##(2005-8#1)(2008-10#1)
the number of samples##8##4##(2005-8#1)(2006-2#1)(2006-8#1)(2008-10#3)(2009-11#1)(2012-3#1)
the number of scales between the##2##6##(2008-5#1)(2013-7#1)
the number of sclerotia##5##4##(2008-10#5)
the number of screen changes involved in both searching (F (2##2##11##(2013-1#2)
the number of seeds##2##4##(2008-8#2)
the number of sessions correlated positively with the academic performance##2##10##(2013-8#2)
the number of sessions##3##4##(2013-8#3)
the number of severe##2##4##(1990-8#1)(1993-5#1)
the number of sexual partners##3##5##(1996-1#2)(2013-1#1)
the number of sexual##5##4##(1990-6#1)(1996-1#2)(2008-9#1)(2013-1#1)
the number of single cells##3##5##(2008-7#3)
the number of single##4##4##(1993-12#1)(2008-7#3)
the number of sites and##2##5##(1993-6#1)(1997-2#1)
the number of sites##6##4##(1993-6#3)(1997-2#1)(2007-7#1)(2008-10#1)
the number of small##2##4##(2008-10#1)(2009-2#1)
the number of sodium ions##2##5##(1991-8#2)
the number of spatial##2##4##(2007-11#1)(2009-9#1)
the number of species in a community##2##7##(2008-8#2)
the number of species in##3##5##(2008-10#1)(2008-8#2)
the number of species of##2##5##(2008-10#2)
the number of species planted##2##5##(2008-9#2)
the number of species##12##4##(2007-6#1)(2008-10#3)(2008-8#3)(2008-9#2)(2010-3#1)(2011-2#1)(2013-7#1)
the number of specific##3##4##(1995-6#1)(1995-8#1)(1996-2#1)
the number of sperm##2##4##(2008-5#1)(2008-9#1)
the number of spermatophylaces presented to females##2##7##(2008-4#2)
the number of sporangia##2##4##(2008-10#2)
the number of spores##3##4##(1997-4#1)(2008-10#2)
the number of steps##2##4##(1992-8#1)(2010-3#1)
the number of stops##2##4##(1993-2#2)
the number of stroke patients##2##5##(2007-10#2)
the number of subjects##4##4##(1990-3#1)(1995-9#2)(2013-8#1)
the number of such##2##4##(1991-12#1)(2006-2#1)
the number of surgical##2##4##(2007-8#1)(2013-7#1)
the number of surviving##2##4##(1994-5#1)(2008-9#1)
the number of survivors of##2##5##(2008-11#2)
the number of symptoms##3##4##(2009-9#2)(2012-2#1)
the number of synapses##2##4##(1992-12#1)(1995-11#1)
the number of taxa##2##4##(2008-8#1)(2012-12#1)
the number of tendons##3##4##(2008-7#2)(2009-9#1)
the number of tests and##2##5##(1994-3#1)(2008-10#1)
the number of tests##5##4##(1994-3#1)(1996-11#1)(2007-8#1)(2008-10#2)
the number of the##15##4##(1992-6#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-12#1)(2012-3#1)(2013-1#2)
the number of theoretical plates##3##5##(1996-5#1)(2008-10#2)
the number of theoretical##4##4##(1996-5#1)(2007-7#1)(2008-10#2)
the number of these##2##4##(2008-10#1)(2011-2#1)
the number of ticks collected##2##5##(2004-11#2)
the number of times##3##4##(1993-2#1)(1996-3#1)(1997-7#1)
the number of total##4##4##(1990-2#1)(1991-9#1)(2008-7#1)(2008-8#1)
the number of trained##2##4##(1993-11#1)(2010-8#1)
the number of transfused blood units##2##6##(1991-8#2)
the number of traps##2##4##(2013-7#2)
the number of treatment##3##4##(2007-10#1)(2007-2#1)(2010-12#1)
the number of trees to be sampled in the orchard##2##10##(2008-10#2)
the number of trees##3##4##(2008-10#3)
the number of trials required##3##5##(1993-12#1)(2007-9#1)(2008-11#1)
the number of trials##5##4##(1993-12#1)(1993-3#1)(1996-10#1)(2007-9#1)(2008-11#1)
the number of turns##2##4##(2008-9#1)(2012-12#1)
the number of units##2##4##(2005-12#1)(2008-12#1)
the number of unnecessary##2##4##(2008-3#1)(2013-1#1)
the number of variables##5##4##(2007-8#1)(2008-10#1)(2008-7#1)(2013-1#2)
the number of vertebral##3##4##(2008-8#1)(2010-10#2)
the number of viable cells##3##5##(2006-11#1)(2008-2#1)(2008-4#1)
the number of viable##11##4##(1993-3#1)(1995-2#1)(2006-11#1)(2006-5#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2011-2#2)
the number of vines infected at a##2##7##(2008-10#2)
the number of water molecules##2##5##(1995-11#1)(2005-11#1)
the number of wet-dog shakes##2##5##(1995-12#2)
the number of white##2##4##(2009-7#1)(2013-8#1)
the number of whorl##2##4##(2011-2#2)
the number of wire twists##2##5##(2007-8#2)
the number of women who##5##5##(1991-6#1)(2006-10#3)(2007-2#1)
the number of women##11##4##(1991-6#1)(1993-6#1)(1993-8#1)(2006-10#3)(2007-2#1)(2007-4#1)(2008-11#1)(2010-7#1)(2012-3#1)
the number of working hours##2##5##(1990-11#1)(1995-8#1)
the number of working memory errors##3##6##(1993-12#1)(1993-3#1)(1996-12#1)
the number of working##6##4##(1990-11#1)(1993-12#1)(1993-3#1)(1995-8#1)(1996-12#1)(2008-10#1)
the number of writhes##2##4##(2013-7#2)
the number of years of##3##5##(1993-12#2)(2009-6#1)
the number of years##4##4##(1993-12#2)(1995-8#1)(2009-6#1)
the number of young##2##4##(1996-2#1)(2010-7#1)
the number of youth##2##4##(2007-3#1)(2008-11#1)
the number of##1868##3##(1990-10#6)(1990-11#8)(1990-12#8)(1990-2#5)(1990-3#9)(1990-4#7)(1990-5#4)(1990-6#8)(1990-7#5)(1990-8#8)(1990-9#5)(1991-1#4)(1991-10#8)(1991-11#7)(1991-12#5)(1991-2#12)(1991-3#5)(1991-4#3)(1991-5#4)(1991-6#3)(1991-7#3)(1991-8#14)(1991-9#2)(1992-1#4)(1992-10#4)(1992-11#3)(1992-12#5)(1992-2#3)(1992-3#4)(1992-4#4)(1992-5#2)(1992-6#3)(1992-7#2)(1992-8#11)(1992-9#7)(1993-1#6)(1993-11#7)(1993-12#19)(1993-2#9)(1993-3#10)(1993-4#1)(1993-5#2)(1993-6#10)(1993-7#6)(1993-8#4)(1993-9#6)(1994-10#3)(1994-11#6)(1994-12#12)(1994-2#4)(1994-3#10)(1994-4#1)(1994-5#18)(1994-6#8)(1994-7#1)(1994-8#7)(1994-9#7)(1995-1#2)(1995-10#3)(1995-11#8)(1995-12#19)(1995-2#5)(1995-3#7)(1995-4#4)(1995-5#7)(1995-6#8)(1995-7#7)(1995-8#12)(1995-9#7)(1996-1#8)(1996-10#2)(1996-11#5)(1996-12#15)(1996-2#11)(1996-3#11)(1996-4#3)(1996-5#6)(1996-6#3)(1996-7#2)(1996-8#5)(1996-9#3)(1997-1#2)(1997-2#15)(1997-3#4)(1997-4#6)(1997-5#3)(1997-6#11)(1997-7#17)(1997-8#2)(2004-10#1)(2004-11#5)(2004-12#3)(2004-2#1)(2004-3#1)(2004-4#1)(2004-9#1)(2005-10#2)(2005-11#16)(2005-12#3)(2005-5#1)(2005-7#4)(2005-8#3)(2005-9#3)(2006-10#32)(2006-11#3)(2006-12#9)(2006-2#4)(2006-3#2)(2006-4#3)(2006-5#12)(2006-6#9)(2006-7#2)(2006-8#15)(2006-9#3)(2007-1#2)(2007-10#10)(2007-11#29)(2007-12#31)(2007-2#9)(2007-3#7)(2007-4#11)(2007-5#3)(2007-6#2)(2007-7#18)(2007-8#19)(2007-9#7)(2008-1#18)(2008-10#207)(2008-11#40)(2008-12#28)(2008-2#56)(2008-3#59)(2008-4#30)(2008-5#40)(2008-6#12)(2008-7#38)(2008-8#52)(2008-9#39)(2009-10#8)(2009-11#6)(2009-12#5)(2009-2#10)(2009-3#6)(2009-4#4)(2009-5#6)(2009-6#4)(2009-7#5)(2009-8#9)(2009-9#5)(2010-1#2)(2010-10#10)(2010-11#9)(2010-12#20)(2010-2#8)(2010-3#4)(2010-4#10)(2010-5#2)(2010-6#3)(2010-7#8)(2010-8#12)(2010-9#3)(2011-1#11)(2011-12#3)(2011-2#48)(2011-7#1)(2012-1#9)(2012-11#1)(2012-12#19)(2012-2#24)(2012-3#27)(2012-4#1)(2013-1#34)(2013-7#20)(2013-8#30)
the number one cause of##3##5##(1997-6#1)(2011-2#1)(2012-2#1)
the number one killer##2##4##(2007-2#1)(2013-7#1)
the number one##5##3##(1997-6#1)(2007-2#1)(2011-2#1)(2012-2#1)(2013-7#1)
the number or##5##3##(1995-1#1)(1997-5#1)(2007-8#1)(2008-4#1)(2011-2#1)
the number predicted##2##3##(1996-4#1)(2008-2#1)
the number reported for##2##4##(1991-11#1)(2008-5#1)
the number who##2##3##(2008-11#1)(2008-7#1)
the number##2029##2##(1990-10#6)(1990-11#8)(1990-12#8)(1990-2#5)(1990-3#10)(1990-4#7)(1990-5#5)(1990-6#9)(1990-7#5)(1990-8#8)(1990-9#6)(1991-1#4)(1991-10#9)(1991-11#10)(1991-12#5)(1991-2#12)(1991-3#7)(1991-4#3)(1991-5#4)(1991-6#5)(1991-7#3)(1991-8#14)(1991-9#3)(1992-1#4)(1992-10#4)(1992-11#3)(1992-12#5)(1992-2#3)(1992-3#5)(1992-4#5)(1992-5#2)(1992-6#3)(1992-7#2)(1992-8#11)(1992-9#7)(1993-1#6)(1993-11#7)(1993-12#20)(1993-2#9)(1993-3#11)(1993-4#1)(1993-5#3)(1993-6#10)(1993-7#6)(1993-8#4)(1993-9#6)(1994-10#3)(1994-11#6)(1994-12#12)(1994-2#6)(1994-3#10)(1994-4#1)(1994-5#18)(1994-6#10)(1994-7#1)(1994-8#8)(1994-9#8)(1995-1#4)(1995-10#4)(1995-11#8)(1995-12#19)(1995-2#5)(1995-3#9)(1995-4#4)(1995-5#9)(1995-6#10)(1995-7#7)(1995-8#17)(1995-9#8)(1996-1#8)(1996-10#2)(1996-11#6)(1996-12#17)(1996-2#12)(1996-3#11)(1996-4#4)(1996-5#6)(1996-6#3)(1996-7#5)(1996-8#5)(1996-9#3)(1997-1#2)(1997-2#16)(1997-3#4)(1997-4#6)(1997-5#4)(1997-6#12)(1997-7#18)(1997-8#2)(2004-10#1)(2004-11#5)(2004-12#3)(2004-2#1)(2004-3#1)(2004-4#1)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#16)(2005-12#3)(2005-5#1)(2005-7#4)(2005-8#3)(2005-9#3)(2006-10#33)(2006-11#3)(2006-12#10)(2006-2#4)(2006-3#2)(2006-4#3)(2006-5#14)(2006-6#9)(2006-7#2)(2006-8#16)(2006-9#3)(2007-1#3)(2007-10#10)(2007-11#32)(2007-12#37)(2007-2#10)(2007-3#10)(2007-4#11)(2007-5#3)(2007-6#2)(2007-7#18)(2007-8#20)(2007-9#7)(2008-1#19)(2008-10#217)(2008-11#46)(2008-12#29)(2008-2#59)(2008-3#69)(2008-4#33)(2008-5#49)(2008-6#12)(2008-7#39)(2008-8#52)(2008-9#41)(2009-10#9)(2009-11#6)(2009-12#5)(2009-2#12)(2009-3#6)(2009-4#4)(2009-5#9)(2009-6#5)(2009-7#5)(2009-8#9)(2009-9#5)(2010-1#2)(2010-10#10)(2010-11#10)(2010-12#24)(2010-2#10)(2010-3#5)(2010-4#12)(2010-5#2)(2010-6#3)(2010-7#8)(2010-8#13)(2010-9#4)(2011-1#11)(2011-12#4)(2011-2#50)(2011-7#1)(2012-1#10)(2012-11#1)(2012-12#21)(2012-2#27)(2012-3#27)(2012-4#1)(2013-1#38)(2013-7#21)(2013-8#40)
the numbers and##2##3##(2008-5#1)(2008-7#1)
the numbers of cases##2##4##(1992-5#1)(2012-2#1)
the numbers of patients##2##4##(1995-2#1)(2008-10#1)
the numbers of##67##3##(1990-4#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#2)(1993-12#2)(1993-4#1)(1993-7#2)(1994-11#1)(1994-9#1)(1995-12#2)(1995-2#2)(1996-12#2)(1996-6#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2006-8#2)(2007-4#1)(2007-7#1)(2008-10#13)(2008-11#1)(2008-2#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-3#1)(2010-11#1)(2010-2#2)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
the numbers##82##2##(1990-4#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#2)(1993-12#2)(1993-2#1)(1993-4#1)(1993-7#2)(1994-11#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#2)(1996-12#2)(1996-6#2)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-9#1)(2006-8#2)(2007-4#1)(2007-5#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-3#1)(2010-11#1)(2010-2#2)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
the numerator##3##2##(1995-3#1)(1996-2#1)(2008-9#1)
the numeric##2##2##(2006-10#1)(2008-12#1)
the numerical analysis of the##2##5##(2008-10#1)(2008-5#1)
the numerical analysis of##5##4##(1990-8#1)(2007-12#2)(2008-10#1)(2008-5#1)
the numerical analysis##8##3##(1990-8#1)(1995-2#1)(2007-12#2)(2008-10#1)(2008-5#1)(2008-9#2)
the numerical and##2##3##(2007-1#1)(2008-3#1)
the numerical aperture (NA) of the focusing##2##7##(2007-11#1)(2008-3#1)
the numerical aperture for##2##4##(2007-11#1)(2008-3#1)
the numerical aperture is##2##4##(2008-3#1)(2013-8#1)
the numerical aperture of an objective##2##6##(2008-2#1)(2008-3#1)
the numerical aperture of the objective lens and the##2##9##(2007-12#2)
the numerical aperture of the##7##5##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#1)
the numerical aperture of##10##4##(2007-11#2)(2007-12#2)(2008-2#4)(2008-3#2)
the numerical aperture##20##3##(2007-11#4)(2007-12#3)(2008-2#6)(2008-3#6)(2013-8#1)
the numerical data##2##3##(2008-10#1)(2008-3#1)
the numerical estimates##2##3##(2008-3#2)
the numerical implementation##2##3##(2006-11#1)(2008-2#1)
the numerical information##2##3##(2008-11#1)(2010-3#1)
the numerical results##8##3##(2006-10#1)(2007-12#3)(2008-2#2)(2008-3#2)
the numerical simulation##4##3##(2006-6#1)(2008-2#2)(2009-8#1)
the numerical solution##4##3##(2006-2#1)(2008-2#1)(2008-7#1)(2008-9#1)
the numerical value of the##2##5##(2008-2#1)(2008-6#1)
the numerical##94##2##(1990-8#1)(1995-2#1)(1996-4#1)(1996-6#1)(1996-8#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-11#6)(2007-12#8)(2007-5#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#18)(2008-3#20)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#5)(2009-10#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-3#1)(2012-1#1)(2012-11#1)(2012-3#2)(2013-1#2)(2013-8#1)
the numerically##4##2##(1991-4#1)(2007-11#1)(2008-10#1)(2008-2#1)
the numerous advantages of##2##4##(2007-8#1)(2008-10#1)
the numerous other##2##3##(1997-3#1)(2008-10#1)
the numerous studies##2##3##(2011-2#1)(2012-3#1)
the numerous ways##2##3##(2006-2#1)(2008-8#1)
the numerous##52##2##(1990-10#1)(1990-4#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-1#1)(1995-3#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-11#1)(2006-2#2)(2006-8#2)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-5#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
the nurse and the##2##4##(1994-1#1)(2010-7#1)
the nurse and##3##3##(1994-1#1)(2010-7#1)(2011-2#1)
the nurse cell nuclei##2##4##(1994-3#1)(2007-12#1)
the nurse cell##3##3##(1994-3#1)(2007-12#2)
the nurse cells##5##3##(1994-3#1)(2007-12#2)(2008-10#1)(2008-9#1)
the nurse educator in##2##4##(2008-11#2)
the nurse in##6##3##(1991-11#1)(2005-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
the nurse leader's role##2##4##(2008-1#2)
the nurse who develops mental illness##2##6##(2011-1#2)
the nurse who##3##3##(2011-1#3)
the nurse working##2##3##(1991-11#1)(2011-1#1)
the nurse##56##2##(1991-11#3)(1993-2#1)(1994-1#1)(1994-10#1)(1994-3#3)(1995-3#1)(1996-2#1)(1997-1#1)(2005-11#1)(2006-1#1)(2007-12#5)(2008-1#3)(2008-10#2)(2008-11#6)(2008-12#1)(2008-6#2)(2008-9#1)(2010-12#1)(2010-3#2)(2010-7#2)(2011-1#5)(2011-2#8)(2012-12#1)(2012-3#2)(2013-8#1)
the nurse's##8##2##(1990-2#1)(1991-1#1)(1991-11#1)(2008-1#1)(2009-4#1)(2011-2#2)(2012-3#1)
the nurse-physician relationship##4##3##(2006-1#4)
the nursery##3##2##(2008-10#3)
the nurses and the##2##4##(1995-9#1)(2008-9#1)
the nurses and##3##3##(1995-9#1)(2007-2#1)(2008-9#1)
the nurses don't##2##3##(2011-2#2)
the nurses in the##2##4##(2007-9#1)(2008-10#1)
the nurses in##3##3##(2006-6#1)(2007-9#1)(2008-10#1)
the nurses were##2##3##(1991-2#1)(1994-4#1)
the nurses##37##2##(1990-2#5)(1991-2#1)(1991-6#1)(1994-4#1)(1995-9#1)(1996-1#1)(2005-7#1)(2006-1#1)(2006-6#1)(2007-10#1)(2007-2#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#3)
the nurses'##12##2##(1990-12#1)(1993-12#1)(1996-2#2)(2004-10#1)(2007-10#2)(2010-11#2)(2010-2#2)(2012-11#1)
the nursing and##2##3##(2008-11#1)(2010-10#1)
the nursing care of older adults##2##6##(2008-11#2)
the nursing care of##3##4##(2008-11#3)
the nursing care##6##3##(2007-10#1)(2008-1#1)(2008-11#3)(2012-3#1)
the nursing clinicians'##2##3##(2007-10#2)
the nursing curriculum##8##3##(2008-11#4)(2008-12#3)(2010-3#1)
the nursing diagnoses##2##3##(2011-2#2)
the nursing diagnosis##2##3##(1990-2#1)(2011-2#1)
the nursing education##2##3##(2008-11#1)(2008-12#1)
the nursing home##17##3##(1990-12#1)(1991-1#2)(1992-1#1)(1992-2#1)(1992-3#1)(1994-7#1)(1995-3#1)(1996-11#1)(1997-2#1)(2007-12#1)(2008-11#2)(2008-12#1)(2009-3#1)(2010-10#1)(2010-11#1)
the nursing homes##2##3##(2008-11#1)(2012-12#1)
the nursing literature##3##3##(1994-3#1)(2013-1#2)
the nursing process##3##3##(2008-12#1)(2008-4#1)(2010-3#1)
the nursing profession is##2##4##(1996-3#1)(2011-1#1)
the nursing profession##20##3##(1994-2#1)(1995-9#1)(1996-3#1)(1997-3#1)(2005-8#2)(2007-8#2)(2008-11#1)(2008-12#2)(2009-4#1)(2011-1#3)(2012-3#1)(2013-8#4)
the nursing staff##10##3##(1990-2#1)(1991-11#1)(1997-4#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-9#1)(2011-2#2)
the nursing team in##2##4##(2011-2#1)(2012-3#1)
the nursing team##3##3##(2011-2#2)(2012-3#1)
the nursing workforce##6##3##(2008-11#1)(2008-12#1)(2011-1#2)(2012-3#2)
the nursing##130##2##(1990-10#1)(1990-12#1)(1990-2#3)(1990-4#1)(1991-1#3)(1991-11#2)(1992-1#1)(1992-2#2)(1992-3#1)(1993-3#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-7#1)(1995-3#1)(1995-9#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#2)(2005-10#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-2#1)(2007-10#5)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#3)(2008-1#2)(2008-10#1)(2008-11#21)(2008-12#11)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#2)(2010-10#2)(2010-11#1)(2010-3#2)(2011-1#7)(2011-2#8)(2012-12#1)(2012-3#8)(2013-1#5)(2013-8#7)
the nut##3##2##(1995-3#1)(2008-10#1)(2008-5#1)
the nutrient content of##3##4##(1993-9#1)(2008-1#1)(2011-12#1)
the nutrient foramen was##3##4##(2013-8#3)
the nutrient foramen##7##3##(2013-8#7)
the nutrient foramina##2##3##(2013-8#2)
the nutrient solution##2##3##(2007-1#1)(2008-10#1)
the nutrient##35##2##(1991-11#1)(1993-9#1)(1996-10#1)(2006-2#1)(2007-1#1)(2008-1#1)(2008-10#6)(2008-6#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-8#1)(2011-12#1)(2012-12#1)(2013-1#2)(2013-8#12)
the nutrients##3##2##(1991-11#1)(2011-12#1)(2013-8#1)
the nutrition status##2##3##(2006-10#2)
the nutrition support##2##3##(2005-10#2)
the nutrition transition and##2##4##(2012-1#2)
the nutrition transition##5##3##(2012-1#5)
the nutrition##25##2##(1994-3#1)(1995-7#1)(2005-1#1)(2005-10#3)(2005-7#1)(2006-10#2)(2006-4#3)(2007-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-4#1)(2012-1#5)(2012-12#1)(2013-1#1)
the nutritional and##2##3##(2011-1#1)(2012-1#1)
the nutritional composition of (-) diet simulated that of food consumed by Japanese victims of Itai-Itai disease##2##17##(1997-4#2)
the nutritional composition of (-) diet simulated that of food consumed by Japanese##3##13##(1997-4#3)
the nutritional composition##4##3##(1997-4#3)(2010-4#1)
the nutritional management##2##3##(2005-10#1)(2006-2#1)
the nutritional needs of##4##4##(1995-2#1)(2006-4#2)(2012-2#1)
the nutritional profile##2##3##(2008-9#2)
the nutritional quality of##3##4##(2006-12#1)(2008-5#1)(2012-12#1)
the nutritional regulation of##2##4##(2008-7#2)
the nutritional sciences##3##3##(2012-2#3)
the nutritional status improved##2##4##(2006-6#2)
the nutritional status of Palestinian preschool children##2##7##(2013-7#2)
the nutritional status of children##2##5##(2010-6#1)(2013-1#1)
the nutritional status of infants##3##5##(1997-4#1)(2010-5#1)(2013-1#1)
the nutritional status of the##3##5##(2007-7#1)(2008-10#1)(2008-7#1)
the nutritional status of##18##4##(1997-4#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-7#3)(2008-10#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2013-1#2)(2013-7#2)
the nutritional status##28##3##(1991-12#1)(1997-4#1)(2006-2#1)(2006-4#1)(2006-6#4)(2007-12#1)(2007-7#3)(2008-1#1)(2008-10#1)(2008-2#2)(2008-7#1)(2008-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#2)(2013-1#2)(2013-7#2)
the nutritional value of the##2##5##(1994-3#1)(2010-11#1)
the nutritional value of##6##4##(1994-3#1)(2006-4#1)(2008-10#1)(2008-6#1)(2010-11#1)(2010-4#1)
the nutritional##76##2##(1990-2#1)(1991-11#1)(1991-12#1)(1993-3#1)(1994-3#1)(1995-2#1)(1995-7#1)(1997-4#4)(2005-10#2)(2006-10#1)(2006-12#1)(2006-2#2)(2006-4#5)(2006-6#4)(2006-9#1)(2007-12#2)(2007-7#3)(2008-1#2)(2008-10#4)(2008-12#2)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#4)(2010-11#1)(2010-12#1)(2010-4#3)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#5)(2013-1#2)(2013-7#2)
the nutritive##3##2##(2007-12#1)(2008-10#1)(2008-5#1)
the nuts##2##2##(1994-3#1)(2008-10#1)
the nymphs##3##2##(2007-12#3)
the nystagmus##2##2##(2008-4#1)(2012-12#1)
the nystatin perforated##2##3##(1994-2#1)(1997-1#1)
the o-nitrophenol##2##2##(2009-3#2)
the oak##4##2##(2008-10#1)(2008-5#1)(2012-6#1)(2012-9#1)
the oat##2##2##(1990-5#1)(2008-3#1)
the obese Zucker rat##4##4##(1996-12#1)(1997-5#3)
the obese and##2##3##(2008-10#1)(2012-12#1)
the obese individuals##2##3##(2008-4#1)(2013-1#1)
the obese patients##3##3##(2011-1#1)(2011-2#2)
the obese subjects##3##3##(2008-4#1)(2012-2#2)
the obese##33##2##(1991-2#1)(1992-8#1)(1995-6#1)(1996-12#3)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#3)(2004-11#1)(2006-2#1)(2006-8#2)(2008-10#1)(2008-3#1)(2008-4#2)(2009-11#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#2)
the obesity epidemic##7##3##(2006-1#1)(2007-9#1)(2008-12#1)(2009-12#1)(2009-5#1)(2012-2#2)
the obesity prevention movement##2##4##(2012-1#2)
the obesity##13##2##(2006-1#1)(2007-9#1)(2008-12#1)(2008-3#1)(2009-12#1)(2009-5#1)(2009-6#1)(2011-2#1)(2012-1#2)(2012-2#3)
the object and the##3##4##(2008-2#2)(2008-3#1)
the object and##9##3##(1992-9#1)(2007-12#1)(2008-2#4)(2008-3#2)(2008-5#1)
the object are##2##3##(2008-11#1)(2011-1#1)
the object at##3##3##(2007-12#1)(2008-3#2)
the object field##2##3##(2008-2#2)
the object in##6##3##(1995-2#1)(2007-12#2)(2008-11#2)(2008-2#1)
the object is##13##3##(1996-2#1)(2007-12#1)(2008-2#1)(2008-3#7)(2008-4#1)(2009-11#1)(2011-1#1)
the object motion##3##3##(2008-2#3)
the object of investigation##2##4##(1993-3#1)(2006-8#1)
the object of##21##3##(1990-12#1)(1990-4#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-3#2)(1995-6#1)(1996-12#1)(1997-6#1)(2006-8#1)(2008-12#1)(2008-4#2)(2008-5#2)(2009-7#1)(2010-11#1)(2011-2#1)(2012-12#1)
the object plane##2##3##(2007-12#1)(2008-2#1)
the object size##2##3##(1992-9#1)(2008-7#1)
the object spectrum phase##2##4##(2008-3#2)
the object spectrum##4##3##(2008-2#1)(2008-3#3)
the object structure##3##3##(2007-12#1)(2008-2#1)(2012-1#1)
the object surface is##2##4##(2008-2#1)(2008-3#1)
the object surface##5##3##(2008-2#1)(2008-3#4)
the object to be grasped##2##5##(1992-9#1)(1996-3#1)
the object to be##6##4##(1992-9#1)(1996-3#1)(2008-3#2)(2012-12#2)
the object to##7##3##(1992-9#1)(1996-3#1)(2008-11#1)(2008-3#2)(2012-12#2)
the object vibration##2##3##(2008-2#2)
the object was##4##3##(1994-6#1)(2007-12#2)(2008-2#1)
the object##172##2##(1990-12#1)(1990-4#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#3)(1993-3#2)(1993-6#1)(1993-7#2)(1994-6#2)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-3#2)(1997-6#1)(2006-4#1)(2006-8#1)(2007-11#4)(2007-12#18)(2008-1#3)(2008-10#1)(2008-11#6)(2008-12#1)(2008-2#43)(2008-3#38)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#4)(2009-11#1)(2009-7#1)(2010-11#1)(2011-1#2)(2011-2#3)(2012-1#3)(2012-12#3)(2012-2#1)(2013-8#2)
the object's##4##2##(1997-8#1)(2008-3#1)(2009-4#1)(2011-1#1)
the object-based##2##2##(2008-1#1)(2008-2#1)
the objections##2##2##(1990-12#1)(2010-4#1)
the objective SCORAD##2##3##(2012-1#2)
the objective function##2##3##(2010-8#1)(2012-3#1)
the objective is to##2##4##(2008-10#2)
the objective is##4##3##(2007-8#1)(2008-10#3)
the objective lens and the##3##5##(2007-12#2)(2008-3#1)
the objective lens and##5##4##(2007-12#2)(2008-3#3)
the objective lens##13##3##(2007-12#3)(2008-2#3)(2008-3#7)
the objective measures##2##3##(2008-9#1)(2013-7#1)
the objective of the##4##4##(2005-5#1)(2008-4#1)(2008-5#1)(2010-1#1)
the objective of this paper##2##5##(2006-5#1)(2012-12#1)
the objective of this study was to develop a##2##9##(1997-3#1)(2010-2#1)
the objective of this study was to##6##7##(1997-3#1)(2008-10#2)(2009-7#1)(2010-2#1)(2010-9#1)
the objective of this##10##4##(1997-3#1)(2006-5#2)(2008-10#2)(2009-6#1)(2009-7#1)(2010-2#1)(2010-9#1)(2012-12#1)
the objective of##35##3##(1992-2#1)(1994-2#1)(1994-6#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-3#1)(2005-5#1)(2006-5#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-9#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#1)
the objective signal##2##3##(2008-3#2)
the objective structured clinical examination##2##5##(1994-2#1)(2013-8#1)
the objective to##5##3##(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-1#1)
the objective##93##2##(1991-2#1)(1991-6#2)(1991-9#1)(1992-2#1)(1992-3#1)(1994-2#2)(1994-6#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-3#1)(2005-11#1)(2005-5#1)(2006-10#2)(2006-5#2)(2007-11#1)(2007-12#4)(2007-8#2)(2008-1#1)(2008-10#10)(2008-2#6)(2008-3#11)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#5)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
the objectives and##3##3##(2007-10#1)(2007-7#1)(2013-7#1)
the objectives of the workshop##2##5##(1996-4#1)(2011-2#1)
the objectives of the##6##4##(1996-4#1)(2008-7#1)(2009-4#1)(2010-3#1)(2011-2#2)
the objectives of this##3##4##(2007-4#2)(2011-1#1)
the objectives of##16##3##(1994-6#1)(1996-12#1)(1996-4#1)(1997-6#1)(2006-10#1)(2006-2#1)(2007-4#2)(2008-7#2)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#3)
the objectives##31##2##(1992-1#1)(1994-6#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-3#1)(1997-6#1)(2006-10#1)(2006-2#2)(2007-10#1)(2007-11#1)(2007-4#2)(2007-7#1)(2007-9#1)(2008-5#1)(2008-7#2)(2009-1#1)(2009-4#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-3#1)(2013-7#2)
the objects and##3##3##(1995-8#1)(2007-11#1)(2012-12#1)
the objects in the##2##4##(1992-11#1)(2008-3#1)
the objects in##4##3##(1992-11#1)(2008-3#2)(2009-12#1)
the objects of##3##3##(2005-11#1)(2008-3#1)(2010-10#1)
the objects##20##2##(1992-11#1)(1995-8#2)(2005-11#1)(2007-11#1)(2007-8#1)(2008-2#3)(2008-3#8)(2009-12#1)(2010-10#1)(2012-12#1)
the objects-target##2##2##(2007-11#2)
the obligate intracellular##2##3##(1992-5#1)(1994-12#1)
the obligate parasite##2##3##(2008-10#2)
the obligate##8##2##(1992-5#1)(1994-12#1)(2006-10#1)(2008-10#3)(2008-7#1)(2009-10#1)
the obligation of##3##3##(1993-6#1)(2006-11#1)(2007-11#1)
the obligation to##3##3##(2006-7#1)(2006-8#1)(2008-7#1)
the obligation##6##2##(1993-6#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-11#1)(2008-7#1)
the obligations of##3##3##(1991-2#1)(2006-2#1)(2007-3#1)
the obligatory##4##2##(1990-4#1)(1991-11#1)(1997-8#1)(2011-1#1)
the oblique##3##2##(1996-11#1)(2007-12#1)(2008-2#1)
the obliquity cycle##3##3##(1990-8#3)
the obliquity##7##2##(1990-8#4)(1992-1#1)(1993-2#1)(2007-11#1)
the obliteration##3##2##(2008-7#3)
the observable##3##2##(2006-12#1)(2008-10#1)(2010-7#1)
the observation and execution of##2##5##(2008-11#2)
the observation and##3##3##(2008-11#2)(2008-12#1)
the observation height##2##3##(2008-10#2)
the observation of a##12##4##(1991-5#2)(1992-10#1)(1994-2#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-12#2)(2008-3#1)(2010-5#1)(2013-1#1)
the observation of abnormal##2##4##(1994-3#1)(2007-11#1)
the observation of clouds and aerosols with the##2##8##(2008-3#2)
the observation of immune##2##4##(2005-10#1)(2013-1#1)
the observation of the##9##4##(1990-6#1)(1994-2#1)(1996-2#1)(2007-5#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-1#1)(2012-3#1)
the observation of##76##3##(1990-2#1)(1990-6#1)(1991-5#2)(1992-10#1)(1992-9#1)(1994-10#1)(1994-2#2)(1994-3#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-10#1)(2005-11#2)(2005-7#1)(2006-12#1)(2007-11#7)(2007-12#11)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#5)(2008-5#2)(2008-7#2)(2009-7#1)(2010-12#1)(2010-3#2)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#3)(2012-3#1)(2013-1#4)
the observation period of##3##4##(1991-2#1)(2007-8#1)(2008-3#1)
the observation period##30##3##(1990-8#2)(1991-2#1)(1991-9#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-5#1)(1995-9#1)(1997-3#2)(1997-4#1)(2006-10#1)(2007-1#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2009-12#1)(2011-1#1)
the observation that most##2##4##(2008-10#1)(2008-3#1)
the observation that the normal##2##5##(1990-3#1)(1994-8#1)
the observation that the##17##4##(1990-3#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-9#1)(1997-5#1)(1997-7#1)(2007-10#1)(2007-9#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-3#1)
the observation that this##2##4##(1992-2#1)(1993-9#1)
the observation that##66##3##(1990-3#2)(1991-10#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-9#3)(1994-11#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(2004-12#1)(2005-8#1)(2005-9#1)(2006-10#1)(2007-10#2)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-8#1)
the observation time##3##3##(1990-11#1)(1990-12#1)(2006-12#1)
the observation unit##2##3##(2008-3#2)
the observation##208##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#1)(1990-8#3)(1991-10#2)(1991-2#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-9#3)(1994-10#1)(1994-11#2)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#1)(1995-2#1)(1995-8#1)(1995-9#2)(1996-2#1)(1996-4#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2004-12#1)(2005-10#1)(2005-11#3)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#2)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#16)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#14)(2008-11#4)(2008-12#1)(2008-2#7)(2008-3#15)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-3#2)(2010-5#1)(2010-8#1)(2011-1#5)(2011-2#2)(2012-1#3)(2012-3#4)(2013-1#4)(2013-8#2)
the observational##9##2##(1996-4#1)(1997-2#1)(2004-1#1)(2005-12#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-2#1)
the observations and##3##3##(1990-9#1)(2005-11#1)(2007-11#1)
the observations are##3##3##(1991-8#1)(2008-2#1)(2012-2#1)
the observations in##2##3##(1995-6#1)(1995-8#1)
the observations of the##2##4##(1994-1#1)(1995-3#1)
the observations of##7##3##(1990-5#1)(1994-1#1)(1995-3#1)(2007-2#1)(2007-8#1)(2007-9#1)(2009-4#1)
the observations that##2##3##(1990-2#1)(2008-3#1)
the observations to##2##3##(2008-3#1)(2008-8#1)
the observations##40##2##(1990-2#1)(1990-5#1)(1990-9#1)(1991-8#1)(1993-2#1)(1994-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#3)(1996-4#1)(2005-1#1)(2005-11#1)(2005-7#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#4)(2008-3#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
the observed LRET##2##3##(1997-1#2)
the observed abnormalities##2##3##(1994-12#1)(2007-7#1)
the observed activation##2##3##(1990-5#1)(1991-2#1)
the observed and expected##2##4##(1993-9#1)(2012-1#1)
the observed and##6##3##(1993-9#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-9#1)(2012-1#1)
the observed bands##3##3##(1991-5#1)(2008-2#1)(2008-3#1)
the observed behavior of##3##4##(1990-12#1)(2007-12#1)(2008-2#1)
the observed behavior##8##3##(1990-12#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#2)(2010-6#1)
the observed behavioral##2##3##(1994-6#1)(2007-12#1)
the observed beneficial effects of##2##5##(2008-5#1)(2009-5#1)
the observed beneficial effects##3##4##(2007-11#1)(2008-5#1)(2009-5#1)
the observed binding##4##3##(1995-1#1)(1995-11#1)(1997-6#1)(2008-8#1)
the observed biological activity##2##4##(1994-9#1)(2010-12#1)
the observed cell cycle arrest##2##5##(1997-3#1)(1997-7#1)
the observed cell##3##3##(1997-1#1)(1997-3#1)(1997-7#1)
the observed change in##2##4##(1997-7#1)(2006-8#1)
the observed changes in##2##4##(1995-3#1)(2005-11#1)
the observed changes##6##3##(1993-11#1)(1995-12#1)(1995-3#1)(2005-11#1)(2008-1#1)(2008-10#1)
the observed complex##3##3##(1993-2#1)(2006-10#1)(2008-3#1)
the observed correlation between##2##4##(1994-12#1)(1995-4#1)
the observed correlation##3##3##(1994-12#1)(1995-4#2)
the observed data##12##3##(1995-2#1)(1995-8#1)(1996-8#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#3)(2011-2#1)
the observed decline in##2##4##(2008-11#1)(2008-7#1)
the observed decrease##2##3##(2008-11#1)(2008-3#1)
the observed difference in##3##4##(1990-8#1)(1993-3#1)(2006-5#1)
the observed difference##4##3##(1990-8#1)(1993-3#1)(1997-6#1)(2006-5#1)
the observed differences in##7##4##(1991-1#1)(1992-2#1)(1993-11#1)(1994-2#1)(1995-5#1)(2008-5#1)(2008-9#1)
the observed differences##12##3##(1991-1#1)(1992-2#1)(1993-11#1)(1994-2#1)(1995-3#1)(1995-5#1)(1996-5#1)(2007-8#1)(2008-5#1)(2008-9#1)(2012-12#1)(2013-1#1)
the observed dynamics##3##3##(1993-3#1)(1995-5#1)(2008-10#1)
the observed effect of##2##4##(1991-10#1)(1992-2#1)
the observed effect##5##3##(1991-10#1)(1992-2#1)(2008-3#1)(2010-2#1)(2012-2#1)
the observed effects of##2##4##(1995-1#1)(1995-6#1)
the observed effects##8##3##(1990-6#1)(1995-1#1)(1995-6#1)(1996-11#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-8#1)
the observed electron##2##3##(1993-8#1)(2007-5#1)
the observed epidemic##2##3##(1996-1#1)(1997-7#1)
the observed exposure response##3##4##(2008-7#3)
the observed fluorescence##3##3##(1992-6#1)(1996-1#1)(2008-2#1)
the observed folding##2##3##(1992-6#1)(1996-5#1)
the observed gene##2##3##(2010-10#1)(2012-11#1)
the observed heterogeneity of##2##4##(1992-10#1)(1996-11#1)
the observed heterogeneity##4##3##(1990-5#1)(1992-10#1)(1996-11#1)(2007-12#1)
the observed image##3##3##(2008-2#1)(2008-3#2)
the observed incidence##2##3##(2008-10#2)
the observed increase in##6##4##(1991-8#1)(1995-3#1)(2005-11#1)(2006-10#1)(2008-4#1)(2009-8#1)
the observed increased##2##3##(2005-10#1)(2008-5#1)
the observed induced##3##3##(2004-2#1)(2008-10#2)
the observed inhibition##3##3##(1991-9#1)(1992-3#1)(1994-8#1)
the observed interaction##2##3##(2008-3#1)(2012-2#1)
the observed interactions##2##3##(2008-7#1)(2013-8#1)
the observed kinetic##4##3##(1991-7#2)(1995-6#1)(2010-2#1)
the observed mortality##3##3##(2007-8#2)(2008-8#1)
the observed number of##2##4##(2008-10#2)
the observed object##2##3##(2007-11#1)(2008-3#1)
the observed pattern##2##3##(2008-8#1)(2010-8#1)
the observed patterns of##3##4##(2008-8#2)(2009-7#1)
the observed patterns##10##3##(1994-3#1)(2006-9#1)(2008-2#1)(2008-8#4)(2009-7#1)(2009-8#1)(2010-11#1)
the observed period##3##3##(1993-5#1)(2008-1#1)(2010-9#1)
the observed poor##2##3##(2009-4#2)
the observed products##3##3##(1992-11#1)(2008-6#1)(2008-9#1)
the observed rate##5##3##(1992-9#1)(1994-8#2)(1997-4#2)
the observed reduction in##3##4##(1996-7#1)(2008-10#1)(2008-5#1)
the observed relationship##3##3##(2008-10#1)(2012-1#1)(2012-12#1)
the observed response##3##3##(1991-8#1)(1996-9#1)(2008-10#1)
the observed results##2##3##(2007-12#1)(2008-4#1)
the observed seroprevalence##2##3##(2011-2#2)
the observed signal##4##3##(1992-6#1)(1997-2#1)(2008-3#1)(2010-5#1)
the observed similarities##2##3##(1990-5#1)(2008-7#1)
the observed spectra##2##3##(1997-7#1)(2007-12#1)
the observed spectral##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2009-9#1)
the observed spectrum##2##3##(2008-2#1)(2008-3#1)
the observed stimulation of##2##4##(1991-5#1)(2008-11#1)
the observed surface##2##3##(2008-3#2)
the observed times of##3##4##(1995-8#3)
the observed total##2##3##(1995-12#1)(2008-2#1)
the observed toxicity was##2##4##(1990-2#1)(2004-4#1)
the observed trend in obesity prevalence##2##6##(2006-10#2)
the observed trend##3##3##(2006-10#3)
the observed values##3##3##(1997-2#1)(2008-10#1)(2010-3#1)
the observed variation in##2##4##(1992-9#1)(2008-5#1)
the observed variation##5##3##(1992-9#1)(1995-3#1)(2008-10#1)(2008-5#1)(2013-7#1)
the observed variations in##2##4##(2006-10#1)(2008-10#1)
the observed variations##3##3##(2006-10#1)(2008-10#1)(2009-7#1)
the observed weak##2##3##(1996-10#1)(2008-11#1)
the observed##480##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#3)(1991-7#4)(1991-8#3)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-6#4)(1992-7#2)(1992-9#2)(1993-11#4)(1993-12#3)(1993-2#2)(1993-3#3)(1993-5#4)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#4)(1994-8#5)(1994-9#1)(1995-1#3)(1995-10#2)(1995-11#2)(1995-12#5)(1995-2#2)(1995-3#4)(1995-4#3)(1995-5#2)(1995-6#6)(1995-8#8)(1996-1#3)(1996-10#2)(1996-11#3)(1996-12#2)(1996-2#2)(1996-4#1)(1996-5#3)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#4)(1997-2#5)(1997-3#2)(1997-4#4)(1997-6#3)(1997-7#4)(2004-2#1)(2004-4#1)(2004-9#1)(2005-10#3)(2005-11#5)(2005-8#1)(2006-10#8)(2006-2#2)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#11)(2007-12#17)(2007-4#2)(2007-5#2)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#10)(2008-10#43)(2008-11#10)(2008-12#2)(2008-2#18)(2008-3#25)(2008-4#4)(2008-5#14)(2008-6#3)(2008-7#14)(2008-8#18)(2008-9#7)(2009-12#2)(2009-4#4)(2009-5#1)(2009-7#3)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#3)(2012-11#1)(2012-12#6)(2012-2#3)(2013-1#4)(2013-7#2)(2013-8#4)
the observer and##2##3##(2007-11#1)(2008-2#1)
the observer to##2##3##(2007-6#1)(2012-2#1)
the observer##18##2##(2007-11#1)(2007-12#2)(2007-5#1)(2007-6#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2009-11#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#2)
the observer's##2##2##(2008-11#1)(2012-3#1)
the obstacle##2##2##(2005-8#1)(2008-8#1)
the obstacles and##3##3##(2007-8#1)(2009-5#1)(2012-12#1)
the obstacles faced by##2##4##(1993-2#1)(2012-12#1)
the obstacles to##5##3##(1992-5#1)(2007-4#1)(2007-5#1)(2008-5#1)(2009-5#1)
the obstacles##15##2##(1990-9#1)(1992-5#1)(1993-2#1)(1995-3#1)(1996-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-5#2)(2010-11#1)(2012-12#2)
the obstetric and##2##3##(1990-3#1)(1992-1#1)
the obstetric patient##2##3##(1993-10#1)(2006-10#1)
the obstetric##6##2##(1990-3#1)(1991-9#1)(1992-1#1)(1993-10#1)(2006-10#1)(2011-1#1)
the obstetrical##2##2##(2008-4#1)(2011-2#1)
the obstructed##4##2##(1990-4#1)(2005-10#1)(2006-10#1)(2007-10#1)
the obstructing##2##2##(2005-11#1)(2008-10#1)
the obstruction and##2##3##(2007-12#1)(2008-3#1)
the obstruction of the##2##4##(1991-4#1)(2008-10#1)
the obstruction##10##2##(1991-4#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
the obstructive##7##2##(1992-9#1)(2006-6#1)(2006-8#1)(2007-12#1)(2011-2#1)(2013-1#2)
the obtained Kringle 5##2##4##(2012-12#2)
the obtained cDNA##2##3##(1992-8#1)(1997-2#1)
the obtained correlation##2##3##(1990-9#1)(2008-2#1)
the obtained data##7##3##(2008-10#1)(2008-5#2)(2009-4#2)(2011-1#1)(2011-2#1)
the obtained ones##2##3##(2008-10#1)(2011-2#1)
the obtained results were used on##2##6##(2008-10#2)
the obtained results were##4##4##(2008-10#4)
the obtained results##28##3##(1993-4#1)(2006-4#1)(2007-10#1)(2007-8#2)(2008-10#18)(2008-5#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
the obtained##91##2##(1990-9#1)(1992-8#1)(1993-4#1)(1994-10#1)(1994-12#1)(1996-10#2)(1996-8#1)(1997-2#1)(1997-7#1)(2005-11#1)(2006-4#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#2)(2008-10#34)(2008-12#1)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#2)(2010-12#2)(2010-4#2)(2011-1#2)(2011-2#4)(2012-12#2)(2013-8#4)
the obtention of##2##3##(1991-12#1)(2008-10#1)
the obturator##3##2##(1995-6#1)(2006-12#1)(2006-7#1)
the obvious##10##2##(1993-6#1)(1994-3#1)(1995-11#1)(2005-9#2)(2007-8#1)(2008-1#1)(2008-7#1)(2008-9#1)(2013-1#1)
the occasion of his##3##4##(1990-8#1)(1992-5#1)(2008-4#1)
the occasion of##11##3##(1990-8#1)(1992-5#1)(1994-3#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2010-6#1)(2011-1#1)(2013-1#1)
the occasional failure##2##3##(1994-6#1)(1996-11#1)
the occasional##9##2##(1992-11#1)(1994-6#1)(1996-11#1)(1996-5#1)(2007-5#1)(2008-4#1)(2008-7#1)(2010-8#1)(2011-2#1)
the occipital cortex##4##3##(1995-1#1)(1995-12#1)(1997-5#1)(1997-6#1)
the occipital lobe##5##3##(1995-8#1)(2007-9#1)(2008-7#1)(2011-1#1)(2011-2#1)
the occipital lobes##2##3##(1990-8#1)(2011-1#1)
the occipital region##3##3##(1991-12#1)(1992-8#1)(2006-5#1)
the occipital##31##2##(1990-8#1)(1991-12#1)(1992-8#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-9#2)(1997-5#1)(1997-6#1)(2006-5#1)(2006-7#2)(2007-4#1)(2007-9#1)(2008-5#1)(2008-7#7)(2010-6#2)(2011-1#2)(2011-2#2)
the occiput##8##2##(1992-7#1)(2006-12#1)(2006-9#3)(2009-3#1)(2012-3#2)
the occiput-C-2##3##2##(2006-9#3)
the occluded##7##2##(1997-3#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-12#1)(2008-5#1)(2009-4#1)
the occlusal plane and##2##4##(2013-8#2)
the occlusal plane##4##3##(2004-3#1)(2010-2#1)(2013-8#2)
the occlusal##10##2##(2004-3#1)(2004-9#1)(2007-9#1)(2008-7#1)(2010-2#1)(2010-6#1)(2011-12#1)(2011-2#1)(2013-8#2)
the occlusion and the##3##4##(1996-6#1)(2008-11#1)(2010-9#1)
the occlusion in##2##3##(2008-4#1)(2013-8#1)
the occlusion is##2##3##(1991-4#1)(1994-11#1)
the occlusion of the##2##4##(2007-10#1)(2008-12#1)
the occlusion of##5##3##(1993-10#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-12#1)
the occlusion##24##2##(1991-4#1)(1992-8#1)(1993-10#2)(1993-3#1)(1994-11#1)(1995-11#1)(1996-6#1)(1997-6#1)(2007-10#2)(2007-12#1)(2007-9#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2010-9#1)(2011-1#1)(2013-8#1)
the occlusive##3##2##(1991-6#1)(2008-5#1)(2010-12#1)
the occupancy of##3##3##(1993-8#1)(1994-8#1)(2008-2#1)
the occupancy##4##2##(1993-8#1)(1994-8#1)(2008-11#1)(2008-2#1)
the occupation of##3##3##(1996-5#2)(2011-2#1)
the occupation##7##2##(1990-6#4)(1996-5#2)(2011-2#1)
the occupational and social##2##4##(1996-6#1)(2007-3#1)
the occupational and##3##3##(1996-6#1)(2007-3#1)(2008-10#1)
the occupational environment##3##3##(1990-2#1)(1993-5#1)(1996-2#1)
the occupational exposure##3##3##(1994-6#1)(2007-10#1)(2008-6#1)
the occupational health care unit##2##5##(1995-6#2)
the occupational health##11##3##(1995-2#2)(1995-6#2)(2006-2#1)(2007-9#1)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#2)
the occupational therapist##2##3##(1993-3#2)
the occupational##32##2##(1990-2#1)(1993-12#1)(1993-3#2)(1993-5#1)(1994-6#2)(1995-2#2)(1995-6#2)(1996-2#1)(1996-3#1)(1996-6#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2013-7#1)
the occupied##2##2##(1996-7#1)(2008-8#1)
the occurrence and degree of##2##5##(1996-11#1)(2008-10#1)
the occurrence and the##3##4##(2008-4#1)(2008-5#1)(2008-7#1)
the occurrence and##20##3##(1990-11#1)(1993-10#1)(1994-4#1)(1996-11#1)(2006-10#2)(2007-9#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2010-10#1)(2012-12#1)(2013-1#1)
the occurrence in nature of##2##5##(1991-6#1)(2008-10#1)
the occurrence in##4##3##(1991-6#1)(2006-12#1)(2008-10#2)
the occurrence of DNA fragmentation##2##5##(1992-3#1)(1995-3#1)
the occurrence of DNA##3##4##(1992-3#1)(1995-3#1)(1997-4#1)
the occurrence of Parkinson's disease##2##5##(2008-7#2)
the occurrence of a##17##4##(1993-11#1)(1993-2#1)(1993-9#1)(1994-9#1)(2005-11#2)(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-3#1)(2009-8#1)(2012-2#3)
the occurrence of abnormal##2##4##(1991-4#1)(2008-10#1)
the occurrence of acute rejection##2##5##(2007-9#1)(2012-2#1)
the occurrence of acute##4##4##(1992-2#1)(2007-7#1)(2007-9#1)(2012-2#1)
the occurrence of adverse events and##2##6##(1992-1#1)(2009-7#1)
the occurrence of adverse##5##4##(1992-1#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)
the occurrence of an##6##4##(1990-3#1)(1994-6#1)(1994-9#1)(1996-5#1)(2008-10#1)(2008-8#1)
the occurrence of both##2##4##(2008-10#1)(2008-4#1)
the occurrence of bovine##2##4##(2005-5#1)(2010-4#1)
the occurrence of cardiovascular disease##2##5##(2010-9#1)(2011-1#1)
the occurrence of cardiovascular##3##4##(1994-7#1)(2010-9#1)(2011-1#1)
the occurrence of cerebral##3##4##(1996-3#1)(1997-6#1)(2010-8#1)
the occurrence of certain##2##4##(1993-5#1)(2008-5#1)
the occurrence of chromosomal##2##4##(1990-8#1)(1996-12#1)
the occurrence of complications##3##4##(1990-3#1)(2011-1#1)(2013-8#1)
the occurrence of dental caries##3##5##(1992-5#1)(2008-7#1)(2012-12#1)
the occurrence of dental##4##4##(1992-5#1)(2008-7#1)(2011-2#1)(2012-12#1)
the occurrence of diarrhea##2##4##(1992-12#1)(2008-5#1)
the occurrence of different##2##4##(1990-6#1)(2006-10#1)
the occurrence of empty##2##4##(2004-4#1)(2008-10#1)
the occurrence of faba bean fusarium wilt##2##7##(2013-8#2)
the occurrence of flashbacks##2##4##(1996-7#2)
the occurrence of infection##3##4##(2007-11#1)(2008-10#1)(2008-7#1)
the occurrence of lateral##2##4##(1995-7#1)(1997-7#1)
the occurrence of lung cancer##2##5##(1994-7#1)(2008-7#1)
the occurrence of major complications##2##5##(2006-2#1)(2008-9#1)
the occurrence of malignant##4##4##(1996-4#1)(2008-9#1)(2010-1#1)(2010-9#1)
the occurrence of more##2##4##(2008-10#1)(2013-8#1)
the occurrence of oscillations##2##4##(1990-8#2)
the occurrence of osteoporosis##2##4##(2005-1#1)(2007-7#1)
the occurrence of postextubation laryngeal edema##2##6##(2010-7#2)
the occurrence of postoperative##2##4##(2006-10#1)(2007-8#1)
the occurrence of potential##2##4##(2007-6#1)(2010-2#1)
the occurrence of several##2##4##(2008-10#1)(2010-5#1)
the occurrence of severe##3##4##(1995-11#1)(1996-12#1)(2011-1#1)
the occurrence of significant##3##4##(1997-6#1)(2007-7#1)(2007-9#1)
the occurrence of spontaneous hyperplastic foci in the lung##2##9##(2013-1#2)
the occurrence of such##2##4##(2008-7#1)(2008-9#1)
the occurrence of the actin coronas in the embryo sac during fertilization##2##12##(2008-11#2)
the occurrence of the infection##2##5##(1994-5#1)(2005-8#1)
the occurrence of the##23##4##(1991-11#1)(1991-3#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-6#1)(1996-10#1)(1997-4#1)(2004-9#1)(2005-8#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#1)
the occurrence of this##4##4##(1996-4#1)(2007-8#1)(2008-9#1)(2010-5#1)
the occurrence of type##2##4##(2007-8#1)(2009-3#1)
the occurrence of violence##2##4##(2013-8#2)
the occurrence of##390##3##(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#3)(1991-10#2)(1991-11#3)(1991-12#2)(1991-3#1)(1991-4#2)(1991-8#1)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-7#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#4)(1994-7#3)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#1)(1995-3#3)(1995-4#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#2)(1996-10#1)(1996-12#3)(1996-3#4)(1996-4#3)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#1)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#4)(1997-7#1)(2003-11#1)(2004-4#1)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#3)(2005-5#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#6)(2006-11#3)(2006-12#2)(2006-2#2)(2006-3#1)(2006-5#1)(2006-8#1)(2007-1#3)(2007-10#6)(2007-11#5)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#7)(2007-8#9)(2007-9#6)(2008-1#2)(2008-10#34)(2008-11#8)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#21)(2008-8#13)(2008-9#9)(2009-10#1)(2009-11#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#5)(2011-2#13)(2012-1#2)(2012-12#6)(2012-2#6)(2012-3#2)(2013-1#9)(2013-7#5)(2013-8#12)
the occurrence##426##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#3)(1991-10#2)(1991-11#3)(1991-12#2)(1991-3#1)(1991-4#3)(1991-6#1)(1991-8#1)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-5#1)(1993-7#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-4#1)(1994-5#1)(1994-6#4)(1994-7#3)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#1)(1995-3#3)(1995-4#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#2)(1996-10#1)(1996-11#1)(1996-12#3)(1996-3#4)(1996-4#3)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#2)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#4)(1997-7#1)(2003-11#1)(2004-4#1)(2004-9#1)(2005-1#1)(2005-10#3)(2005-11#3)(2005-5#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#8)(2006-11#4)(2006-12#3)(2006-2#2)(2006-3#1)(2006-5#1)(2006-8#1)(2007-1#3)(2007-10#6)(2007-11#5)(2007-12#8)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#7)(2007-8#9)(2007-9#7)(2008-1#2)(2008-10#40)(2008-11#8)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#8)(2008-6#2)(2008-7#24)(2008-8#14)(2008-9#10)(2009-10#1)(2009-11#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#3)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#5)(2011-2#14)(2012-1#2)(2012-12#7)(2012-2#6)(2012-3#3)(2013-1#10)(2013-7#5)(2013-8#12)
the occurrences of##2##3##(2007-10#1)(2009-12#1)
the occurrences##3##2##(2007-10#1)(2008-9#1)(2009-12#1)
the ocean and atmosphere##2##4##(2008-2#1)(2008-3#1)
the ocean and##5##3##(2007-8#1)(2008-2#3)(2008-3#1)
the ocean color and temperature scanner##3##6##(2008-2#1)(2008-3#2)
the ocean color and##4##4##(2008-2#1)(2008-3#3)
the ocean color##5##3##(2008-2#2)(2008-3#3)
the ocean##48##2##(1990-8#1)(1996-4#3)(2007-8#1)(2008-11#5)(2008-2#20)(2008-3#12)(2008-5#2)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)
the ocean's##3##2##(2008-2#2)(2008-3#1)
the ocean-atmosphere system##2##3##(2007-9#1)(2008-2#1)
the oceanic##8##2##(2007-3#1)(2007-9#1)(2008-10#1)(2008-2#3)(2010-8#2)
the oceans##7##2##(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)(2012-2#1)(2013-8#1)
the ocelli of##2##3##(2007-12#2)
the octahedral and##2##3##(2005-11#1)(2005-4#1)
the octahedral geometry around##2##4##(2008-3#1)(2008-5#1)
the octahedral##11##2##(1996-2#1)(1997-7#1)(2005-11#2)(2005-4#2)(2008-10#1)(2008-3#1)(2008-5#2)(2010-5#1)
the octamer motif##2##3##(1994-9#1)(1996-5#1)
the octamer##9##2##(1991-10#1)(1992-12#1)(1992-6#1)(1992-8#1)(1994-9#2)(1996-4#2)(1996-5#1)
the octameric##3##2##(1992-8#2)(1995-6#1)
the octanol phase##2##3##(1991-5#2)
the octanol##3##2##(1991-5#2)(2008-2#1)
the octanol/water partition coefficients##2##4##(1991-5#1)(2007-11#1)
the octanol/water##3##2##(1991-5#1)(1996-2#1)(2007-11#1)
the octapeptide##3##2##(1992-5#1)(1992-6#1)(1996-8#1)
the octopole##2##2##(2008-10#2)
the octopus##2##2##(2008-2#1)(2009-10#1)
the ocular bioavailability##3##3##(2008-3#1)(2011-3#2)
the ocular dominance##2##3##(1994-8#1)(2012-2#1)
the ocular findings##2##3##(2008-4#1)(2011-1#1)
the ocular surface and##2##4##(2006-11#1)(2007-1#1)
the ocular surface##26##3##(2006-11#3)(2007-1#17)(2009-8#2)(2012-11#2)(2012-2#2)
the ocular##54##2##(1990-5#2)(1992-2#3)(1992-4#1)(1992-7#1)(1994-8#1)(1995-7#1)(2006-11#3)(2007-1#17)(2007-2#1)(2007-3#1)(2008-12#1)(2008-3#2)(2008-4#2)(2009-10#2)(2009-2#1)(2009-8#2)(2011-1#3)(2011-3#3)(2012-11#2)(2012-2#3)(2013-1#1)(2013-8#1)
the oculomotor circuit##2##3##(1995-1#2)
the oculomotor nerve##6##3##(2006-12#6)
the oculomotor system##3##3##(1996-1#1)(1997-8#2)
the oculomotor##14##2##(1995-1#2)(1996-1#1)(1997-8#3)(2006-12#7)(2008-6#1)
the oddball situation##2##3##(1996-1#2)
the odds of CCU with##2##5##(2012-3#2)
the odds of a favorable outcome##2##6##(2007-10#2)
the odds of being##3##4##(2010-6#1)(2011-1#2)
the odds of having##2##4##(2006-4#1)(2010-12#1)
the odds of##21##3##(2006-4#1)(2007-10#4)(2008-12#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#3)(2012-3#2)(2013-1#5)
the odds ratio for##3##4##(1995-8#1)(2008-3#1)(2012-3#1)
the odds ratio of##4##4##(1995-9#1)(2008-5#1)(2008-8#1)(2010-12#1)
the odds ratio##17##3##(1991-5#1)(1991-9#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-8#1)(1995-9#1)(1996-7#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#2)(2012-3#1)
the odds ratios##3##3##(2007-10#1)(2008-3#1)(2011-2#1)
the odds that##2##3##(1993-5#1)(2011-2#1)
the odds##48##2##(1991-5#1)(1991-7#1)(1991-9#1)(1993-5#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-8#1)(1995-9#1)(1996-7#1)(2006-4#1)(2007-10#5)(2007-4#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#2)(2009-12#1)(2010-12#3)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#4)(2012-3#3)(2013-1#5)
the odontoblastic layer##3##3##(1994-5#2)(2013-8#1)
the odontogenic keratocyst##6##3##(2007-12#6)
the odontoid process##3##3##(2011-2#3)
the odor of a##2##4##(1994-8#1)(1997-7#1)
the odor of##4##3##(1994-8#1)(1997-7#1)(2006-12#1)(2009-8#1)
the odor##7##2##(1994-8#1)(1997-7#1)(2006-12#1)(2008-10#1)(2008-4#1)(2009-8#2)
the oedema##2##2##(2005-12#1)(2013-7#1)
the oesophageal##5##2##(1993-12#1)(1993-3#1)(1994-2#1)(2005-1#2)
the oesophagus and gastric cardia##2##5##(1990-6#2)
the oesophagus and##7##3##(1990-6#2)(1993-10#1)(1993-12#1)(2005-1#1)(2013-8#2)
the oesophagus##30##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#3)(1990-9#1)(1991-8#2)(1993-10#1)(1993-12#2)(1993-6#1)(2005-1#2)(2006-6#1)(2007-8#3)(2008-1#3)(2008-11#1)(2009-6#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#2)
the oestrogen receptor negative##2##4##(2004-2#1)(2008-2#1)
the oestrogen receptor positive##2##4##(1995-9#1)(2004-2#1)
the oestrogen receptor##6##3##(1990-11#2)(1995-9#1)(2004-2#2)(2008-2#1)
the oestrous cycle##3##3##(1990-8#1)(2007-1#2)
the oestrous##4##2##(1990-8#1)(1994-7#1)(2007-1#2)
the of the##2##3##(2007-8#1)(2012-3#1)
the of##10##2##(2007-11#1)(2007-8#2)(2008-10#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-2#2)(2012-3#1)
the off##4##2##(1990-12#1)(2005-11#1)(2007-8#2)
the off-axis performance##2##3##(2008-2#1)(2008-3#1)
the off-axis##14##2##(1995-11#1)(2007-11#2)(2008-2#3)(2008-3#8)
the off-label 'opened capsule' dosing method##2##6##(2010-7#2)
the off-label opened capsule dosing method##2##6##(2010-7#2)
the off-label opened capsule##3##4##(2010-7#3)
the off-label##5##2##(2010-7#5)
the off-line##6##2##(2007-12#1)(2008-10#3)(2008-7#2)
the off-pump##7##2##(2006-6#1)(2007-8#6)
the off-rate of##2##3##(1992-9#1)(1995-8#1)
the off-rate##4##2##(1992-9#1)(1995-11#1)(1995-8#1)(2005-7#1)
the off-resonance##2##2##(2007-11#1)(2008-3#1)
the off-season is##2##3##(2008-10#2)
the off-state##2##2##(2008-3#1)(2008-7#1)
the offending agent##2##3##(1994-6#1)(1996-8#1)
the offending##10##2##(1993-6#1)(1994-6#1)(1996-8#1)(2006-10#1)(2006-11#1)(2007-8#1)(2008-7#2)(2008-8#1)(2010-5#1)
the offensive type##2##3##(2004-11#2)
the offensive##3##2##(1993-2#1)(2004-11#2)
the offer##2##2##(1996-5#1)(2011-2#1)
the office and the##2##4##(1991-2#1)(2007-12#1)
the office and##3##3##(1991-2#1)(2007-12#1)(2009-8#1)
the office or##2##3##(1992-4#1)(2010-5#1)
the office##24##2##(1990-10#1)(1990-12#1)(1991-2#1)(1992-4#1)(1994-12#1)(1995-12#1)(2006-10#4)(2006-11#1)(2006-6#1)(2006-8#3)(2007-12#2)(2008-4#1)(2009-4#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)
the offices of the##2##4##(1990-4#1)(2009-4#1)
the offices of##3##3##(1990-4#1)(1996-1#1)(2009-4#1)
the official Mexican##3##3##(2008-10#1)(2008-11#1)(2012-12#1)
the official Veterinary Services##2##4##(2005-5#1)(2011-2#1)
the official journal##2##3##(2008-3#1)(2011-1#1)
the official method of the##2##5##(2008-10#2)
the official method##8##3##(2008-10#8)
the official methods for these##2##5##(2008-10#1)(2011-1#1)
the official methods##4##3##(2008-10#2)(2008-11#1)(2011-1#1)
the official##35##2##(1990-10#1)(1991-9#1)(1993-3#1)(1993-5#1)(1995-6#1)(1996-12#1)(1997-6#1)(2005-5#1)(2007-9#1)(2008-10#13)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#2)
the officially##2##2##(2007-11#1)(2008-10#1)
the offline##3##2##(2005-7#2)(2008-6#1)
the offset of##2##3##(1996-12#1)(1996-5#1)
the offset##4##2##(1996-12#1)(1996-5#1)(2008-1#1)(2008-2#1)
the offspring and##2##3##(2008-9#1)(2013-1#1)
the offspring from the isolated females had higher survival and growth rates##2##12##(2012-12#2)
the offspring from##3##3##(2008-5#1)(2012-12#2)
the offspring of DM2##2##4##(2006-9#2)
the offspring of the##6##4##(1996-10#3)(2008-10#1)(2008-7#1)(2008-8#1)
the offspring of##29##3##(1993-7#1)(1996-10#3)(1996-4#1)(1997-2#1)(1997-4#1)(2005-7#1)(2006-5#1)(2006-9#4)(2007-2#4)(2008-10#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-5#2)(2009-8#2)(2013-8#1)
the offspring##53##2##(1990-9#1)(1993-7#1)(1996-10#3)(1996-12#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#2)(2005-7#1)(2006-5#1)(2006-9#4)(2007-12#2)(2007-2#4)(2007-3#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#2)(2009-5#2)(2009-8#2)(2010-8#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#2)
the offsprings##7##2##(2008-4#2)(2013-8#5)
the often##16##2##(1990-11#1)(1993-5#1)(1994-12#1)(1997-8#2)(2006-10#2)(2007-11#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
the ogt protein##2##3##(1992-8#2)
the oh8Gua##7##2##(1997-1#7)
the ohmic resistance##2##3##(2008-10#1)(2008-5#1)
the oil and##2##3##(2008-4#1)(2010-12#1)
the oil extracted from the##2##5##(2008-5#2)
the oil industry##3##3##(1993-2#1)(2011-1#1)(2011-11#1)
the oil of H##2##4##(2008-11#2)
the oil of##5##3##(2006-12#1)(2007-1#1)(2008-11#2)(2008-12#1)
the oil palm biosolid extract for the##2##7##(2011-2#2)
the oil phase##8##3##(2004-12#1)(2008-5#4)(2012-12#3)
the oil was##2##3##(2007-3#1)(2008-11#1)
the oil##57##2##(1992-7#1)(1993-2#1)(2004-12#1)(2005-11#4)(2006-12#3)(2006-9#1)(2007-1#4)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#9)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#12)(2010-12#1)(2011-1#2)(2011-11#1)(2011-2#2)(2012-12#3)
the oil-water interface##4##3##(1992-7#1)(2005-11#1)(2008-5#2)
the oil-water##6##2##(1992-7#1)(2005-11#1)(2008-10#2)(2008-5#2)
the oils were##4##3##(2007-1#2)(2008-11#1)(2012-12#1)
the oils##12##2##(2006-12#1)(2006-9#3)(2007-1#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-12#2)
the oily##2##2##(2008-10#1)(2008-5#1)
the ointment##2##2##(1993-11#1)(2008-12#1)
the okadaic##3##2##(1992-9#1)(1994-2#1)(1994-8#1)
the old age##3##3##(1996-8#1)(2007-7#1)(2010-8#1)
the old and the##2##4##(1990-10#1)(1992-12#1)
the old and##4##3##(1990-10#1)(1992-12#1)(1993-4#1)(1996-1#1)
the old animals##3##3##(1990-3#1)(1990-5#1)(1995-6#1)
the old cells##4##3##(1992-3#4)
the old cuticle##2##3##(2008-7#2)
the old hearts##2##3##(2010-7#2)
the old host##2##3##(2008-8#2)
the old patient##3##3##(1993-1#1)(2008-4#1)(2012-3#1)
the old schedule##2##3##(1992-2#2)
the old##68##2##(1990-10#1)(1990-3#7)(1990-5#2)(1992-12#3)(1992-2#2)(1992-3#4)(1993-1#1)(1993-4#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-8#1)(1996-9#4)(1997-3#2)(2005-12#1)(2005-3#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#3)(2009-2#1)(2009-7#1)(2010-2#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
the older adult population##4##4##(2009-12#2)(2013-1#2)
the older adult##5##3##(2007-1#1)(2009-12#2)(2013-1#2)
the older age group##4##4##(1994-4#1)(1996-11#1)(2007-7#1)(2008-9#1)
the older and more##2##4##(2008-1#1)(2008-10#1)
the older and##3##3##(2008-1#1)(2008-10#1)(2012-3#1)
the older animals##3##3##(1993-12#1)(1994-5#2)
the older children##2##3##(2007-7#1)(2010-10#1)
the older control##3##3##(2008-10#3)
the older generation##2##3##(1995-11#1)(2010-6#1)
the older group##7##3##(2006-10#2)(2006-8#1)(2007-1#1)(2007-9#1)(2008-6#1)(2012-12#1)
the older patients##3##3##(1992-9#1)(1997-1#1)(2010-2#1)
the older person##7##3##(1995-1#1)(2010-10#5)(2011-1#1)
the older population##3##3##(1991-6#1)(2012-1#2)
the older rats##2##3##(1990-3#1)(1993-2#1)
the older subjects##4##3##(2006-9#2)(2008-3#1)(2008-6#1)
the older workers##2##3##(2008-6#2)
the older##90##2##(1990-1#1)(1990-3#1)(1990-6#1)(1991-1#3)(1991-6#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-12#1)(1993-2#3)(1993-9#1)(1994-4#1)(1994-5#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-11#1)(2006-10#3)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#2)(2007-11#1)(2007-7#3)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-6#4)(2008-9#1)(2009-11#1)(2009-12#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#9)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#2)(2012-1#2)(2012-12#2)(2012-3#4)(2013-1#3)
the oldest age group##5##4##(1992-8#1)(2006-8#1)(2011-2#1)(2012-3#2)
the oldest age##6##3##(1992-8#1)(1993-12#1)(2006-8#1)(2011-2#1)(2012-3#2)
the oldest and##5##3##(1992-12#1)(1996-11#1)(2010-12#1)(2011-1#1)(2013-1#1)
the oldest existing##2##3##(2008-1#1)(2011-2#1)
the oldest known##7##3##(1990-3#1)(1997-1#1)(2006-7#1)(2007-7#1)(2007-9#2)(2008-1#1)
the oldest old##8##3##(1994-5#2)(1994-6#2)(2007-10#1)(2010-3#3)
the oldest patients##3##3##(1990-3#1)(2011-2#1)(2012-3#1)
the oldest##79##2##(1990-3#3)(1991-6#1)(1992-12#1)(1992-2#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-4#1)(1994-11#1)(1994-5#2)(1994-6#2)(1995-7#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-1#2)(2006-1#1)(2006-10#4)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#5)(2008-1#2)(2008-10#3)(2008-7#2)(2009-4#3)(2009-7#1)(2010-10#1)(2010-12#1)(2010-3#4)(2010-4#1)(2010-7#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
the oleaginous yeast Yarrowia lipolytica##2##5##(2011-1#2)
the oleaginous yeast##3##3##(1996-6#1)(2011-1#2)
the olecranon fossa##5##3##(2011-2#1)(2013-8#4)
the olecranon##7##2##(2007-2#1)(2009-3#1)(2011-2#1)(2013-8#4)
the oleosin knockdown##3##3##(2009-10#3)
the oleosin##4##2##(2009-10#4)
the olfactive##2##2##(1992-9#1)(2008-5#1)
the olfactory bulb (OB)##4##4##(1990-7#1)(1991-9#1)(1996-7#1)(2009-10#1)
the olfactory bulb and the##4##5##(1990-6#1)(2009-12#1)(2013-1#2)
the olfactory bulb and##8##4##(1990-6#1)(1991-9#1)(1997-4#1)(2008-11#1)(2009-12#2)(2013-1#2)
the olfactory bulb of##6##4##(1995-12#1)(1995-5#1)(2008-7#4)
the olfactory bulb##47##3##(1990-6#2)(1990-7#2)(1991-6#1)(1991-9#2)(1992-8#4)(1993-6#1)(1994-10#1)(1995-11#1)(1995-12#1)(1995-5#4)(1996-4#1)(1996-7#1)(1997-3#4)(1997-4#1)(2006-6#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-6#2)(2008-7#5)(2009-10#1)(2009-12#6)(2012-2#1)(2013-1#2)
the olfactory bulbs##4##3##(1994-2#1)(1995-5#2)(1996-5#1)
the olfactory epithelium##8##3##(1993-6#1)(1997-4#2)(2008-5#3)(2008-6#1)(2012-2#1)
the olfactory groove##3##3##(2006-12#3)
the olfactory information##2##3##(1996-6#2)
the olfactory nerve##12##3##(1992-8#4)(1995-12#4)(1996-3#1)(1996-7#2)(2008-5#1)
the olfactory organ of##3##4##(2007-12#2)(2008-5#1)
the olfactory organ##5##3##(2007-12#4)(2008-5#1)
the olfactory pathway##2##3##(2007-12#1)(2013-8#1)
the olfactory receptor##2##3##(2009-12#2)
the olfactory system of the##3##5##(2007-12#1)(2008-6#1)(2008-7#1)
the olfactory system of##4##4##(1991-11#1)(2007-12#1)(2008-6#1)(2008-7#1)
the olfactory system##13##3##(1991-11#1)(1993-6#1)(1995-5#1)(1997-4#1)(2007-12#3)(2008-11#2)(2008-6#1)(2008-7#2)(2012-2#1)
the olfactory tubercle##4##3##(1991-2#2)(1996-12#2)
the olfactory##132##2##(1990-6#2)(1990-7#2)(1991-11#1)(1991-2#2)(1991-6#1)(1991-9#2)(1992-8#9)(1993-6#4)(1994-10#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-12#6)(1995-5#8)(1996-10#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#3)(1997-2#2)(1997-3#5)(1997-4#4)(1997-8#4)(2006-12#5)(2006-6#1)(2007-11#1)(2007-12#10)(2007-5#1)(2008-1#1)(2008-11#4)(2008-5#7)(2008-6#4)(2008-7#7)(2009-10#1)(2009-12#8)(2009-8#1)(2011-12#1)(2011-2#1)(2012-2#6)(2013-1#2)(2013-8#1)
the oligodendrocytes##2##2##(1996-12#1)(2008-7#1)
the oligodeoxynucleotide##2##2##(1995-10#1)(1996-1#1)
the oligomer##7##2##(1990-11#2)(1993-3#1)(1994-11#1)(1994-5#1)(2006-10#1)(2011-2#1)
the oligomeric state of RXR##2##5##(1995-10#2)
the oligomeric structure of the##2##5##(1992-7#1)(1994-6#1)
the oligomeric structure of##5##4##(1991-5#1)(1992-7#1)(1994-6#1)(1997-3#1)(1997-8#1)
the oligomeric structure##6##3##(1991-5#1)(1992-7#1)(1994-6#1)(1997-3#1)(1997-8#1)(2008-4#1)
the oligomeric##13##2##(1990-4#1)(1991-10#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-7#1)(1994-6#1)(1995-10#2)(1995-2#1)(1997-3#1)(1997-8#1)(2008-4#1)
the oligomerization##5##2##(1990-11#1)(1993-8#1)(1997-5#1)(2008-3#1)(2011-1#1)
the oligonucleotide probe##5##3##(1991-7#1)(1992-9#1)(2008-10#2)(2008-9#1)
the oligonucleotide##28##2##(1990-2#2)(1991-7#1)(1992-9#2)(1993-11#1)(1994-8#1)(1995-1#1)(1996-12#1)(1996-7#1)(1997-1#2)(1997-4#1)(2008-10#5)(2008-4#7)(2008-5#1)(2008-9#1)(2012-3#1)
the oligopeptide##2##2##(1991-9#1)(2008-5#1)
the oligosaccharide backbone##2##3##(1993-11#2)
the oligosaccharide moiety##2##3##(1990-12#1)(1996-5#1)
the oligosaccharide side chains##2##4##(1993-7#1)(1994-11#1)
the oligosaccharide##22##2##(1990-12#1)(1990-9#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-12#1)(1993-11#3)(1993-7#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-5#2)(1996-10#2)(1996-5#1)(2008-7#2)
the oligosaccharides of##3##3##(1990-12#1)(1997-7#1)(2005-7#1)
the oligosaccharides released##2##3##(1991-12#1)(1996-4#1)
the oligosaccharides##17##2##(1990-12#1)(1990-7#1)(1990-9#1)(1991-12#1)(1992-10#1)(1993-11#3)(1996-2#1)(1996-4#1)(1997-4#1)(1997-7#1)(2005-7#2)(2008-10#2)(2008-11#1)
the oligotrophic##3##2##(1991-11#1)(2004-4#1)(2007-3#1)
the olive fruit fly##2##4##(2008-3#1)(2013-8#1)
the olive##6##2##(1994-2#1)(1997-6#1)(2008-3#1)(2013-8#3)
the omega##5##2##(1991-4#3)(1995-2#1)(1997-2#1)
the omega-3 ethyl ester concentrate##2##5##(2008-3#2)
the omental##2##2##(1992-2#1)(2008-6#1)
the omentum and##3##3##(2008-3#2)(2013-7#1)
the omentum##7##2##(2005-12#1)(2006-10#1)(2007-2#1)(2008-3#2)(2012-2#1)(2013-7#1)
the omission of##4##3##(1992-9#1)(2006-3#1)(2008-1#1)(2009-8#1)
the omission or##2##3##(2008-10#1)(2013-8#1)
the omission##8##2##(1992-9#1)(2006-3#1)(2006-5#1)(2008-1#1)(2008-10#1)(2009-8#1)(2013-8#2)
the omitted##3##2##(1992-6#2)(1993-1#1)
the omnibus##2##2##(1996-3#1)(1997-2#1)
the omnidirectional bandwidth##2##3##(2008-3#2)
the omnidirectional##4##2##(2008-3#4)
the omnivorous##2##2##(2007-3#1)(2008-10#1)
the on and off##2##4##(2008-2#1)(2008-3#1)
the on going##2##3##(2008-4#2)
the on##7##2##(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)
the on-axis field##2##3##(2007-11#1)(2008-2#1)
the on-axis##13##2##(2007-11#1)(2008-2#7)(2008-3#5)
the on-capillary##2##2##(2007-8#1)(2008-10#1)
the on-column##2##2##(2008-10#2)
the on-going##3##2##(1997-1#1)(2008-11#1)(2008-3#1)
the on-lattice simulations##4##3##(2005-11#4)
the on-line column##2##3##(2008-10#2)
the on-line monitoring of##2##4##(2007-8#1)(2008-10#1)
the on-line monitoring##3##3##(2007-8#1)(2008-10#2)
the on-line photochemical##2##3##(2008-10#2)
the on-line precipitation of##2##4##(2008-10#2)
the on-line precipitation##3##3##(2008-10#3)
the on-line removal of##2##4##(2008-10#2)
the on-line speciation##2##3##(2008-10#2)
the on-line wavelet transform##4##4##(2008-10#4)
the on-line##63##2##(2007-1#1)(2007-8#2)(2008-10#52)(2008-11#5)(2008-2#2)(2010-4#1)
the on-pump group##2##3##(2007-8#2)
the on-pump##3##2##(2007-8#3)
the on-site environmental##2##3##(2008-10#2)
the on-site##5##2##(2006-8#1)(2008-10#3)(2013-8#1)
the once##2##2##(2006-10#1)(2007-4#1)
the oncogene##5##2##(1990-11#1)(1995-2#1)(2008-11#2)(2012-12#1)
the oncogenes##2##2##(1991-5#1)(2009-12#1)
the oncogenic effects of##4##4##(1991-12#1)(2006-10#2)(2008-4#1)
the oncogenic##16##2##(1991-12#2)(1991-4#1)(1991-7#2)(1994-8#1)(2006-10#4)(2007-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2013-8#1)
the oncologic and functional##2##4##(2008-6#2)
the oncologic##6##2##(1991-12#1)(2008-6#3)(2010-5#1)(2011-2#1)
the oncological##3##2##(2006-6#1)(2008-10#1)(2012-3#1)
the oncologist##8##2##(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#2)(2013-7#1)(2013-8#1)
the oncology##10##2##(2006-10#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#2)(2012-1#1)(2012-3#1)
the oncolytic efficacy of##3##4##(2009-4#3)
the oncoprotein Bcl-2##2##3##(2012-2#2)
the oncoprotein##3##2##(2005-7#1)(2012-2#2)
the one and only##2##4##(1995-5#1)(2008-1#1)
the one being##3##3##(1993-12#1)(1995-8#1)(2006-9#1)
the one between##2##3##(1990-8#1)(2008-7#1)
the one described##3##3##(1995-4#1)(1996-3#1)(2011-2#1)
the one for##2##3##(2007-12#1)(2012-12#1)
the one found##3##3##(1990-2#1)(1996-8#1)(1996-9#1)
the one hand##68##3##(1990-5#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-8#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-7#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-8#1)(2006-3#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#4)(2009-10#1)(2009-2#3)(2009-5#1)(2009-9#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#5)(2013-8#1)
the one in##2##3##(1990-11#1)(1991-2#1)
the one megabase##2##3##(1995-12#2)
the one obtained##2##3##(1995-3#1)(1996-2#1)
the one of##7##3##(2007-2#1)(2008-10#1)(2008-9#1)(2009-11#1)(2011-2#2)(2012-2#1)
the one produced##2##3##(1994-2#1)(1997-6#1)
the one proposed##2##3##(2008-2#2)
the one reported##2##3##(1994-6#1)(2007-7#1)
the one study##2##3##(1991-12#1)(2007-8#1)
the one that##8##3##(1992-11#1)(1995-4#1)(2006-2#1)(2008-1#1)(2008-10#2)(2008-2#2)
the one used##3##3##(1990-8#1)(1992-1#1)(2010-2#1)
the one which##2##3##(1994-10#1)(2011-2#1)
the one who##4##3##(1994-1#1)(2006-11#1)(2007-2#1)(2009-6#1)
the one with a##2##4##(2008-10#1)(2008-4#1)
the one with the highest##2##5##(2008-1#1)(2008-5#1)
the one with the##4##4##(2008-1#1)(2008-2#1)(2008-5#1)(2013-8#1)
the one with##9##3##(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-6#1)(2013-8#1)
the one year##2##3##(1997-2#1)(2006-10#1)
the one##194##2##(1990-11#1)(1990-2#2)(1990-5#1)(1990-8#2)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-8#2)(1993-12#1)(1994-1#2)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#2)(1995-12#2)(1995-3#1)(1995-4#3)(1995-5#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-8#2)(1996-9#2)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#1)(2004-10#1)(2004-12#1)(2004-2#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#3)(2006-8#2)(2006-9#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#16)(2008-11#5)(2008-2#9)(2008-3#5)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#7)(2009-10#2)(2009-11#2)(2009-2#3)(2009-5#1)(2009-6#2)(2009-9#2)(2010-2#1)(2010-5#3)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#8)(2012-12#2)(2012-2#4)(2013-1#5)(2013-8#2)
the one- and##3##3##(1996-11#1)(2008-2#1)(2010-4#1)
the one-beam cross-correlation dynamic light-scattering##2##5##(2008-3#2)
the one-beam##3##2##(2007-12#1)(2008-3#2)
the one-carbon##2##2##(1992-10#1)(2009-12#1)
the one-cell##2##2##(2007-12#1)(2009-7#1)
the one-channel condition##2##3##(2008-9#2)
the one-dimensional Hubbard model##2##4##(1991-12#2)
the one-dimensional sample##2##3##(2007-12#2)
the one-dimensional thermodynamic limit##2##4##(2008-3#2)
the one-dimensional wavelet transform (WT)##2##5##(2008-10#1)(2008-2#1)
the one-dimensional##17##2##(1990-4#1)(1991-12#2)(1993-5#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#4)(2010-12#1)
the one-electron reduction of##2##4##(1994-8#2)
the one-electron reduction product##2##4##(1994-5#1)(1997-8#1)
the one-electron reduction##5##3##(1994-5#1)(1994-8#2)(1995-6#1)(1997-8#1)
the one-electron##7##2##(1990-2#1)(1993-8#1)(1994-5#1)(1994-8#2)(1995-6#1)(1997-8#1)
the one-photon##3##2##(2007-12#1)(2008-2#1)(2011-1#1)
the one-pot##2##2##(2008-11#1)(2010-5#1)
the one-sided##3##2##(1995-6#1)(1995-8#1)(2012-1#1)
the one-step##7##2##(1991-10#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-2#2)(2008-3#1)
the one-year##2##2##(2006-7#1)(2008-10#1)
the oneness of##2##3##(2008-8#1)(2012-2#1)
the onerous##2##2##(1996-5#1)(2007-9#1)
the ones found in##2##4##(2007-1#1)(2008-10#1)
the ones most likely to##2##5##(1993-11#1)(1997-6#1)
the ones obtained by##6##4##(2008-10#4)(2008-2#1)(2008-6#1)
the ones obtained with##2##4##(2008-3#1)(2012-1#1)
the ones obtained##9##3##(2005-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-6#1)(2012-1#1)
the ones that are##3##4##(1990-2#1)(1996-1#1)(2008-11#1)
the ones that##10##3##(1990-2#1)(1996-1#1)(2008-11#2)(2008-2#2)(2008-4#1)(2008-8#1)(2010-4#1)(2011-12#1)
the ones used in##2##4##(2006-11#1)(2010-8#1)
the ones used##3##3##(1997-4#1)(2006-11#1)(2010-8#1)
the ones who##3##3##(1992-3#2)(2011-1#1)
the ones with##3##3##(1995-11#1)(2009-5#1)(2012-3#1)
the ones##53##2##(1990-2#1)(1992-3#2)(1992-4#1)(1992-9#1)(1993-11#1)(1994-6#1)(1995-11#1)(1996-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-11#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-5#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#3)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-11#1)(2010-4#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#2)
the ongoing clinical##2##3##(2008-5#1)(2009-6#1)
the ongoing debate on##2##4##(1991-1#1)(2009-10#1)
the ongoing debate##4##3##(1991-1#1)(2006-10#1)(2007-7#1)(2009-10#1)
the ongoing development of##2##4##(1994-12#1)(2008-11#1)
the ongoing development##3##3##(1994-12#1)(2006-8#1)(2008-11#1)
the ongoing research##3##3##(2006-10#1)(2008-7#1)(2013-7#1)
the ongoing search for##2##4##(2006-10#1)(2008-10#1)
the ongoing##58##2##(1991-1#1)(1991-12#1)(1991-6#1)(1992-2#1)(1993-12#2)(1994-1#1)(1994-12#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#1)(1997-6#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-4#1)(2006-5#1)(2006-8#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#2)(2009-6#2)(2009-7#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#2)(2012-6#1)(2013-1#3)(2013-7#1)(2013-8#1)
the onion##2##2##(2008-10#2)
the online##11##2##(2005-7#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#1)(2011-2#3)(2012-1#1)(2012-12#1)
the only 2##2##3##(1991-6#1)(1995-9#1)
the only adverse event##2##4##(2008-3#1)(2009-11#1)
the only approved therapy##2##4##(2006-12#1)(2012-3#1)
the only available##8##3##(2006-8#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-5#1)(2012-2#1)
the only choice##2##3##(1994-7#1)(2013-8#1)
the only clue##2##3##(2008-4#1)(2010-4#1)
the only complication##4##3##(1990-4#1)(1997-8#1)(2006-12#1)(2007-7#1)
the only compound that##3##4##(2005-8#2)(2009-8#1)
the only consistent##2##3##(1993-5#1)(2012-1#1)
the only curative##4##3##(1992-8#1)(2008-3#1)(2008-6#1)(2010-7#1)
the only currently##2##3##(2007-9#1)(2009-3#1)
the only detectable##2##3##(1991-8#1)(1993-12#1)
the only diagnostic##2##3##(1990-6#1)(2007-10#1)
the only drugs##2##3##(2006-5#1)(2007-11#1)
the only effective therapy##2##4##(1992-6#1)(2006-10#1)
the only effective treatment##7##4##(2004-11#1)(2006-10#4)(2007-11#1)(2007-7#1)
the only effective##18##3##(1992-6#1)(1996-11#1)(2004-11#2)(2006-10#6)(2007-11#1)(2007-7#2)(2007-8#1)(2008-6#1)(2009-11#1)(2009-8#1)(2010-6#1)
the only element##2##3##(2008-10#1)(2013-7#1)
the only endogenous##2##3##(1996-5#1)(2007-6#1)
the only exception##4##3##(1990-2#1)(1996-11#1)(2007-6#1)(2007-8#1)
the only factor associated with##3##5##(2007-10#1)(2011-1#1)(2013-1#1)
the only factor that##5##4##(1990-10#1)(1991-2#1)(2006-9#1)(2007-7#1)(2012-12#1)
the only factor##11##3##(1990-10#1)(1991-2#1)(2005-8#1)(2006-9#1)(2007-10#1)(2007-7#1)(2008-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
the only factors##2##3##(1990-4#1)(2008-10#1)
the only feasible##2##3##(2010-12#1)(2012-11#1)
the only form of##5##4##(1994-12#1)(1995-12#1)(2006-10#2)(2007-11#1)
the only fungus##2##3##(2008-10#2)
the only genotypes##2##3##(2008-10#2)
the only identifiable##2##3##(1991-12#1)(2008-6#1)
the only in vitro model##2##5##(1994-5#1)(1995-1#1)
the only independent##3##3##(1997-1#1)(2012-3#1)(2013-1#1)
the only known case##2##4##(2007-12#1)(2010-12#1)
the only known##17##3##(1991-12#1)(1991-5#1)(1991-7#1)(1995-12#1)(1995-3#1)(1996-11#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-12#2)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
the only major##3##3##(1994-8#1)(2008-7#1)(2011-12#1)
the only manifestation of##3##4##(2007-7#1)(2007-8#1)(2009-10#1)
the only means for##2##4##(2006-10#1)(2006-4#1)
the only means of##4##4##(1991-2#1)(2008-11#1)(2008-8#1)(2009-9#1)
the only means to##3##4##(1990-11#1)(2007-6#1)(2007-8#1)
the only means##10##3##(1990-11#1)(1991-2#1)(2006-10#1)(2006-4#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-8#1)(2009-9#1)(2011-2#1)
the only mechanism##2##3##(1994-11#1)(1995-1#1)
the only medical##3##3##(2007-11#1)(2009-3#1)(2013-8#1)
the only medication##2##3##(1991-3#1)(2010-12#1)
the only method that##2##4##(2007-12#1)(2008-3#1)
the only method##6##3##(1990-6#1)(1992-8#1)(2007-12#1)(2008-10#1)(2008-3#2)
the only model##2##3##(1997-2#1)(2007-4#1)
the only one of##2##4##(1994-2#1)(2009-3#1)
the only one reported##2##4##(1991-7#1)(2007-9#1)
the only one that##3##4##(1990-12#1)(2008-2#1)(2008-4#1)
the only one to##2##4##(1991-5#1)(1995-8#1)
the only one which can##2##5##(1991-11#1)(1997-7#1)
the only one which##3##4##(1991-11#1)(1997-7#1)(2008-7#1)
the only one##23##3##(1990-12#1)(1991-11#1)(1991-4#1)(1991-5#1)(1991-7#1)(1994-2#1)(1994-9#1)(1995-8#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-12#1)(2011-2#1)(2013-7#1)
the only ones with##2##4##(2008-10#2)
the only ones##4##3##(2008-10#2)(2010-12#1)(2013-1#1)
the only option##4##3##(1992-3#1)(2004-11#1)(2008-7#1)(2008-9#1)
the only other##4##3##(1993-6#1)(1995-6#1)(1997-4#1)(2008-10#1)
the only patient##2##3##(1994-12#1)(1996-6#1)
the only pharmacy in##2##4##(1995-11#1)(2004-4#1)
the only phase##2##3##(1994-3#1)(2006-10#1)
the only possible##5##3##(1992-5#1)(1993-10#1)(2007-7#1)(2008-4#1)(2008-6#1)
the only potentially##2##3##(2011-2#1)(2013-1#1)
the only presenting##2##3##(1996-3#1)(2009-8#1)
the only product##3##3##(2004-9#1)(2007-10#1)(2008-5#1)
the only protein##2##3##(1994-8#1)(2007-12#1)
the only public hospital##2##4##(1990-5#1)(2011-2#1)
the only reason for##2##4##(2006-10#1)(2008-9#1)
the only recognized##2##3##(1992-8#1)(1993-3#1)
the only reliable method to##2##5##(1997-8#1)(2007-7#1)
the only reliable method##3##4##(1993-7#1)(1997-8#1)(2007-7#1)
the only reliable##5##3##(1993-7#1)(1994-6#1)(1996-12#1)(1997-8#1)(2007-7#1)
the only reported##2##3##(2007-8#1)(2012-12#1)
the only sign of##2##4##(2011-1#1)(2013-1#1)
the only significant predictor of##3##5##(2007-8#1)(2008-6#1)(2008-9#1)
the only significant predictor##5##4##(1993-1#1)(2007-10#1)(2007-8#1)(2008-6#1)(2008-9#1)
the only significant##15##3##(1990-4#2)(1991-11#1)(1993-1#1)(1994-12#1)(1995-1#1)(2007-10#1)(2007-6#1)(2007-8#1)(2008-6#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
the only source of primary inoculum##2##6##(2008-10#1)(2008-12#1)
the only source of##4##4##(1991-12#1)(2008-10#1)(2008-12#1)(2013-8#1)
the only species of##2##4##(2010-8#1)(2011-2#1)
the only species##5##3##(1990-2#1)(2009-8#1)(2010-8#1)(2011-2#2)
the only statistically significant##2##4##(2010-12#1)(2013-8#1)
the only such##2##3##(2007-7#1)(2008-7#1)
the only symptom##3##3##(1993-5#1)(1993-8#1)(2006-2#1)
the only therapeutic##2##3##(1994-3#1)(2006-2#1)
the only tool##4##3##(1992-1#1)(2007-9#1)(2013-1#2)
the only treatment of##2##4##(2007-8#1)(2012-12#1)
the only treatment option##5##4##(2010-8#1)(2013-8#4)
the only treatment##17##3##(1991-6#1)(1996-11#1)(2006-8#1)(2007-7#1)(2007-8#2)(2008-10#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-8#4)
the only two##3##3##(1990-5#1)(2008-7#1)(2011-2#1)
the only type##2##3##(1992-8#1)(2006-2#1)
the only way to obtain##2##5##(2005-12#1)(2012-2#1)
the only way to##9##4##(1991-11#1)(1994-9#1)(1997-5#1)(1997-6#1)(2005-12#1)(2006-10#1)(2007-11#1)(2008-9#1)(2012-2#1)
the only way##18##3##(1990-3#1)(1991-11#1)(1994-9#2)(1995-1#1)(1996-6#1)(1997-5#1)(1997-6#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-4#2)(2007-8#1)(2008-9#1)(2010-6#1)(2010-7#1)(2012-2#1)
the only well documented curative treatment##2##6##(2006-10#2)
the only well##3##3##(2006-10#2)(2008-5#1)
the only##606##2##(1990-10#3)(1990-11#1)(1990-12#2)(1990-2#4)(1990-3#4)(1990-4#4)(1990-5#3)(1990-6#2)(1990-7#3)(1990-8#2)(1990-9#3)(1991-1#1)(1991-11#3)(1991-12#3)(1991-2#3)(1991-3#6)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#4)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#1)(1992-8#5)(1992-9#2)(1993-1#2)(1993-10#2)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#4)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#6)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#5)(1994-9#7)(1995-1#6)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#3)(1995-4#1)(1995-6#2)(1995-8#1)(1995-9#3)(1996-1#1)(1996-10#1)(1996-11#6)(1996-12#3)(1996-2#2)(1996-3#4)(1996-5#5)(1996-6#4)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#4)(2004-11#3)(2004-12#2)(2004-4#1)(2004-9#2)(2005-12#1)(2005-7#2)(2005-8#3)(2006-10#20)(2006-12#6)(2006-2#5)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#2)(2006-7#2)(2006-8#8)(2006-9#1)(2007-10#4)(2007-11#9)(2007-12#8)(2007-2#1)(2007-4#5)(2007-6#7)(2007-7#15)(2007-8#13)(2007-9#7)(2008-1#5)(2008-10#40)(2008-11#4)(2008-12#6)(2008-2#3)(2008-3#10)(2008-4#10)(2008-5#16)(2008-6#11)(2008-7#9)(2008-8#5)(2008-9#10)(2009-10#2)(2009-11#4)(2009-12#2)(2009-3#4)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#6)(2009-9#1)(2010-10#4)(2010-12#14)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#3)(2010-7#4)(2010-8#4)(2011-1#7)(2011-12#2)(2011-2#19)(2012-1#2)(2012-11#3)(2012-12#6)(2012-2#11)(2012-3#5)(2012-5#1)(2013-1#10)(2013-7#5)(2013-8#12)
the onset and duration of##2##5##(1991-8#1)(2007-8#1)
the onset and progression of cell injury##2##7##(1996-4#2)
the onset and progression of##9##5##(1993-9#1)(1996-4#2)(2007-11#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-8#1)
the onset and the##2##4##(2007-11#1)(2011-2#1)
the onset and##26##3##(1991-8#1)(1993-2#1)(1993-9#1)(1994-9#1)(1996-10#1)(1996-4#2)(2006-10#1)(2006-2#1)(2007-11#3)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-7#1)(2010-12#2)(2011-12#1)(2011-2#3)(2012-12#1)(2013-8#1)
the onset of AF##2##4##(2007-8#2)
the onset of AIDS##2##4##(1994-4#1)(1995-6#1)
the onset of Alzheimer's disease##2##5##(1996-5#1)(2008-7#1)
the onset of DNA synthesis##2##5##(1994-5#2)
the onset of DNA##4##4##(1994-3#1)(1994-5#2)(1995-2#1)
the onset of HIV##2##4##(1991-5#1)(2010-8#1)
the onset of PD##2##4##(2008-7#1)(2011-2#1)
the onset of a##8##4##(1990-9#2)(2006-5#1)(2008-1#2)(2008-4#1)(2010-6#1)(2011-2#1)
the onset of acute##3##4##(1995-3#1)(2007-11#1)(2012-2#1)
the onset of an##3##4##(2007-7#1)(2007-9#1)(2008-8#1)
the onset of apoptosis##2##4##(1994-3#1)(2008-5#1)
the onset of cardiovascular##2##4##(1990-5#1)(2008-7#1)
the onset of cell death##2##5##(1994-12#1)(1996-12#1)
the onset of clinical##4##4##(1990-3#1)(2008-11#1)(2012-1#1)(2012-2#1)
the onset of degradation##2##4##(2008-10#2)
the onset of depression##3##4##(1994-2#1)(2011-2#1)(2012-3#1)
the onset of diabetes##2##4##(1994-12#1)(2010-10#1)
the onset of disease##10##4##(1992-10#1)(1994-11#1)(1994-5#1)(1997-3#1)(2005-7#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-10#2)
the onset of estrus##3##4##(2006-5#1)(2013-1#2)
the onset of fatigue##2##4##(2008-5#1)(2010-8#1)
the onset of fever##2##4##(2007-12#1)(2008-11#1)
the onset of human##2##4##(2007-11#1)(2012-1#1)
the onset of injury##2##4##(1992-7#1)(1995-3#1)
the onset of irreversible##2##4##(1995-7#1)(2007-11#1)
the onset of labor##2##4##(2006-8#1)(2013-1#1)
the onset of mitosis##3##4##(1991-6#1)(1994-3#1)(2008-8#1)
the onset of obsessive-compulsive disorder##2##5##(2007-6#2)
the onset of overt##3##4##(1990-3#1)(1997-8#1)(2009-11#1)
the onset of pseudothecia maturity##3##5##(2008-10#3)
the onset of puberty##5##4##(1991-1#1)(2006-10#1)(2008-4#1)(2009-5#1)(2013-8#1)
the onset of reproductive##3##4##(1996-12#1)(2010-10#1)(2013-1#1)
the onset of skin##2##4##(2011-1#1)(2013-1#1)
the onset of spontaneous##2##4##(1994-3#1)(1996-9#1)
the onset of stroke symptoms##2##5##(2007-10#1)(2010-10#1)
the onset of stroke##9##4##(2007-10#3)(2007-11#1)(2007-9#2)(2008-5#1)(2008-7#1)(2010-10#1)
the onset of symptoms and the##2##6##(2006-10#1)(2012-12#1)
the onset of symptoms and##6##5##(2006-10#1)(2008-7#1)(2012-12#4)
the onset of symptoms##30##4##(1992-8#1)(1993-12#2)(2004-11#1)(2006-10#1)(2006-4#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#6)(2008-5#2)(2008-7#2)(2008-9#1)(2009-8#1)(2010-10#1)(2012-12#5)
the onset of systemic##2##4##(1992-11#1)(2008-10#1)
the onset of the AIDS epidemic##2##6##(1990-3#1)(1996-5#1)
the onset of the disease##10##5##(1995-6#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-6#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
the onset of the induction##2##5##(1991-10#1)(2008-10#1)
the onset of the late##2##5##(1990-4#1)(2008-6#1)
the onset of the stationary phase##2##6##(2008-7#1)(2011-2#1)
the onset of the symptoms##3##5##(2008-7#1)(2010-2#1)(2012-12#1)
the onset of the##52##4##(1990-11#1)(1990-3#1)(1990-4#1)(1991-10#1)(1991-11#1)(1991-12#1)(1992-1#2)(1993-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-1#1)(2006-10#3)(2006-6#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-2#1)(2009-3#2)(2009-8#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
the onset of their##4##4##(1996-8#1)(2006-10#1)(2006-7#1)(2012-1#1)
the onset of therapy##2##4##(1990-12#1)(1997-1#1)
the onset of these##4##4##(1993-10#1)(2008-11#1)(2012-11#2)
the onset of this##3##4##(1990-8#1)(2008-5#1)(2013-1#1)
the onset of type 2 diabetes##3##6##(2008-1#1)(2008-7#1)(2009-12#1)
the onset of type##4##4##(2008-1#1)(2008-7#1)(2009-12#1)(2011-2#1)
the onset of vitellogenesis##2##4##(2007-12#1)(2008-7#1)
the onset of##433##3##(1990-11#1)(1990-12#3)(1990-3#3)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#3)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-7#2)(1992-8#2)(1993-10#3)(1993-11#3)(1993-12#3)(1993-2#1)(1993-7#3)(1994-11#4)(1994-12#3)(1994-2#4)(1994-3#5)(1994-4#1)(1994-5#5)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#3)(1995-7#3)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#5)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#3)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#2)(2004-9#2)(2005-1#1)(2005-10#1)(2005-7#4)(2005-8#2)(2006-10#13)(2006-12#2)(2006-2#1)(2006-4#4)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-10#6)(2007-11#12)(2007-12#8)(2007-2#5)(2007-3#1)(2007-5#1)(2007-6#7)(2007-7#3)(2007-8#5)(2007-9#15)(2008-1#12)(2008-10#24)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#6)(2008-5#13)(2008-6#4)(2008-7#17)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-5#2)(2009-6#1)(2009-8#3)(2010-10#4)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#11)(2011-7#1)(2012-1#3)(2012-11#4)(2012-12#11)(2012-2#15)(2012-3#2)(2012-5#1)(2013-1#15)(2013-7#1)(2013-8#4)
the onset or##3##3##(2008-4#2)(2011-2#1)
the onset time of##2##4##(2008-5#1)(2012-2#1)
the onset time##3##3##(2008-5#1)(2009-6#1)(2012-2#1)
the onset##480##2##(1990-11#1)(1990-12#3)(1990-3#3)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#3)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#2)(1991-9#2)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#1)(1992-5#1)(1992-7#2)(1992-8#2)(1993-10#3)(1993-11#3)(1993-12#3)(1993-2#2)(1993-7#3)(1993-9#1)(1994-11#4)(1994-12#3)(1994-2#4)(1994-3#5)(1994-4#1)(1994-5#5)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#3)(1995-7#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#2)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#3)(1996-5#5)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#3)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#2)(2004-9#2)(2005-1#1)(2005-10#1)(2005-7#4)(2005-8#2)(2006-1#1)(2006-10#14)(2006-11#1)(2006-12#2)(2006-2#2)(2006-4#4)(2006-5#3)(2006-6#1)(2006-7#2)(2006-8#4)(2006-9#1)(2007-10#6)(2007-11#15)(2007-12#8)(2007-2#5)(2007-3#1)(2007-5#1)(2007-6#7)(2007-7#3)(2007-8#6)(2007-9#15)(2008-1#12)(2008-10#26)(2008-11#8)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#8)(2008-5#14)(2008-6#5)(2008-7#18)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#4)(2010-10#4)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#16)(2011-7#1)(2012-1#3)(2012-11#4)(2012-12#12)(2012-2#16)(2012-3#2)(2012-5#1)(2013-1#15)(2013-7#2)(2013-8#5)
the onslaught of##2##3##(1993-2#1)(2012-12#1)
the ontogenesis##2##2##(2007-11#1)(2009-2#1)
the ontogenetic##4##2##(1991-4#1)(1992-3#1)(2007-12#1)(2010-8#1)
the ontogenic development of##2##4##(1995-3#1)(2008-7#1)
the ontogeny and##3##3##(1997-5#1)(2007-11#1)(2008-11#1)
the ontogeny of##11##3##(1991-9#1)(1993-12#1)(1993-7#1)(1994-3#1)(1996-4#1)(2007-12#2)(2008-10#1)(2008-11#1)(2009-12#1)(2011-2#1)
the ontogeny##15##2##(1991-9#1)(1993-12#1)(1993-7#1)(1994-11#1)(1994-3#1)(1996-4#1)(1997-5#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#2)(2009-12#1)(2011-2#1)
the ontological##3##2##(2008-7#1)(2010-5#1)(2012-2#1)
the ontology will##2##3##(2008-7#2)
the ontology##8##2##(2008-7#8)
the onychophoran eyes##2##3##(2007-12#2)
the onychophoran##7##2##(2007-12#7)
the oocyte and the##2##4##(2008-12#1)(2008-7#1)
the oocyte and##4##3##(1993-6#1)(2007-12#1)(2008-12#1)(2008-7#1)
the oocyte cytoplasm##2##3##(2007-12#1)(2008-7#1)
the oocyte for##2##3##(2007-12#1)(2013-1#1)
the oocyte maturation-inducing substance##2##4##(2008-4#2)
the oocyte nucleus and##2##4##(2007-12#2)
the oocyte nucleus##7##3##(2007-12#7)
the oocyte##46##2##(1991-11#1)(1991-12#1)(1991-5#1)(1992-11#1)(1993-6#1)(1994-12#1)(1994-9#3)(1995-8#1)(1997-2#1)(2007-12#14)(2007-8#1)(2008-10#2)(2008-12#3)(2008-4#2)(2008-7#2)(2008-8#1)(2012-12#8)(2013-1#2)
the oocytes were##2##3##(2006-5#1)(2008-8#1)
the oocytes##19##2##(1990-7#1)(1992-11#1)(1995-1#1)(2006-5#3)(2007-12#5)(2008-12#1)(2008-5#1)(2008-8#5)(2008-9#1)
the oolemma##3##2##(1990-12#3)
the oomycete Pythium##2##3##(1997-2#1)(2008-10#1)
the oomycete##5##2##(1997-2#1)(2008-10#4)
the ooplasm##3##2##(2006-5#1)(2007-12#2)
the oospores##2##2##(2008-10#2)
the op mutation##2##3##(1990-5#2)
the op##3##2##(1990-5#2)(1995-8#1)
the opacity##4##2##(1996-5#1)(2008-2#2)(2008-3#1)
the open and closed##4##4##(1996-2#1)(2008-8#1)(2009-9#2)
the open approach##2##3##(2010-12#1)(2011-2#1)
the open arms##2##3##(1995-12#1)(2011-2#1)
the open channel##2##3##(1991-4#1)(2008-7#1)
the open configuration##2##3##(1990-11#1)(1997-1#1)
the open eye##2##3##(1992-9#1)(1994-6#1)
the open field test##2##4##(1995-11#1)(2012-1#1)
the open field##22##3##(1990-10#2)(1992-3#1)(1993-12#3)(1993-2#1)(1993-3#4)(1993-7#1)(1994-2#1)(1995-10#1)(1995-11#2)(2008-10#1)(2008-4#1)(2009-4#1)(2009-5#1)(2012-1#1)(2013-1#1)
the open form##3##3##(1996-11#2)(2008-10#1)
the open group##6##3##(2007-8#5)(2009-6#1)
the open ocean##2##3##(2007-9#1)(2008-3#1)
the open one##2##3##(2011-2#2)
the open pasture##2##3##(2008-5#2)
the open probability of##2##4##(1994-2#1)(1995-5#1)
the open reading frame (ORF) of##2##6##(1995-8#1)(2013-1#1)
the open reading frame and##2##5##(1993-12#1)(1994-12#1)
the open reading frame of the##3##6##(1992-6#1)(1992-8#1)(1995-12#1)
the open reading frame of##8##5##(1992-1#1)(1992-6#2)(1992-8#1)(1994-11#1)(1994-2#1)(1995-12#1)(1996-12#1)
the open reading frame##31##4##(1990-5#1)(1990-9#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#2)(1992-8#2)(1993-12#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#2)(1995-12#1)(1995-8#1)(1996-12#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#1)(2008-10#1)(2013-1#1)
the open reading frames (ORFs)##3##5##(1995-12#1)(1996-3#1)(1997-6#1)
the open reading frames##7##4##(1995-12#1)(1996-3#2)(1997-6#1)(2011-1#2)(2013-8#1)
the open reading##40##3##(1990-5#1)(1990-9#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#2)(1992-8#3)(1993-12#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#2)(1995-12#2)(1995-8#1)(1996-12#1)(1996-3#2)(1996-6#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2008-10#1)(2011-1#3)(2013-1#1)(2013-8#1)
the open sea##2##3##(2007-3#1)(2008-11#1)
the open time##2##3##(1996-12#1)(1996-7#1)
the open wound##2##3##(2008-9#1)(2010-12#1)
the open##151##2##(1990-10#2)(1990-11#1)(1990-5#2)(1990-9#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#3)(1992-9#2)(1993-12#4)(1993-2#1)(1993-3#4)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-6#2)(1994-9#2)(1995-10#1)(1995-11#3)(1995-12#3)(1995-3#1)(1995-5#1)(1995-8#1)(1996-11#4)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#3)(2006-6#2)(2007-10#1)(2007-3#1)(2007-7#2)(2007-8#6)(2007-9#2)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#5)(2008-9#2)(2009-10#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#3)(2010-12#2)(2010-3#1)(2010-7#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#3)(2013-1#2)(2013-8#5)
the open-field##2##2##(1991-11#1)(1994-6#1)
the open-label portion##2##3##(2012-2#2)
the open-label##4##2##(2004-3#1)(2008-6#1)(2012-2#2)
the open-source##2##2##(2008-10#1)(2008-4#1)
the opened-mouth from##2##3##(2010-2#2)
the opening angles and residual strains in##2##7##(2008-9#2)
the opening angles and residual strains##3##6##(2008-9#3)
the opening ceremony##2##3##(2007-8#1)(2008-5#1)
the opening of the##7##4##(1995-4#1)(2007-9#1)(2008-6#1)(2008-7#2)(2010-3#1)(2012-2#1)
the opening of##19##3##(1991-8#1)(1992-2#1)(1993-12#1)(1994-9#1)(1995-2#1)(1995-4#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)(2010-3#1)(2012-2#2)(2013-1#1)
the opening wedge high tibial osteotomy##3##6##(2008-8#3)
the opening wedge##4##3##(2008-8#4)
the opening##43##2##(1991-8#1)(1992-2#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#2)(1995-4#1)(1997-2#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#4)(2010-12#1)(2010-3#1)(2012-2#2)(2013-1#2)(2013-8#1)
the openness##2##2##(2012-12#1)(2013-8#1)
the operant##3##2##(1990-7#1)(1997-6#1)(2008-8#1)
the operated animal##2##3##(2008-5#2)
the operated group is##2##4##(2008-5#2)
the operated group##5##3##(2008-5#4)(2009-9#1)
the operated joint##8##3##(2007-11#2)(2007-7#1)(2007-8#5)
the operated knee##3##3##(2007-11#2)(2007-7#1)
the operated limb##3##3##(2007-7#1)(2007-8#2)
the operated patients##3##3##(2007-7#1)(2011-2#1)(2013-1#1)
the operated side##6##3##(1995-8#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-1#1)
the operated##41##2##(1995-8#1)(2004-1#1)(2006-6#1)(2006-8#1)(2007-11#6)(2007-7#6)(2007-8#8)(2007-9#1)(2008-3#2)(2008-5#7)(2008-6#1)(2009-9#1)(2010-7#1)(2011-1#2)(2011-2#1)(2013-1#1)
the operating characteristics of the##4##5##(1997-2#1)(2007-12#1)(2009-5#1)(2012-3#1)
the operating characteristics of##7##4##(1997-2#1)(2007-12#1)(2008-2#1)(2009-10#1)(2009-5#1)(2011-2#1)(2012-3#1)
the operating conditions of the##2##5##(1997-3#1)(2007-8#1)
the operating conditions of##3##4##(1997-3#1)(2007-8#1)(2008-10#1)
the operating conditions##6##3##(1997-3#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-7#1)
the operating field##2##3##(1990-4#1)(2007-11#1)
the operating microscope##7##3##(2006-5#1)(2006-9#1)(2007-1#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
the operating parameters##3##3##(2005-12#1)(2008-10#2)
the operating principle##2##3##(2007-9#1)(2010-4#1)
the operating range of the##2##5##(2007-11#1)(2008-2#1)
the operating range##4##3##(2007-11#1)(2008-2#1)(2008-5#1)(2009-9#1)
the operating ratio are##2##4##(2008-11#2)
the operating room and##4##4##(2006-10#2)(2010-12#1)(2010-2#1)
the operating room environment##3##4##(1991-1#1)(2007-5#1)(2008-8#1)
the operating room to##2##4##(2008-6#1)(2013-7#1)
the operating room##63##3##(1990-8#1)(1991-1#3)(1991-2#2)(1996-1#1)(1996-3#1)(2006-10#18)(2006-2#1)(2006-6#4)(2006-8#1)(2006-9#2)(2007-10#1)(2007-3#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-4#2)(2008-6#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-6#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-7#1)
the operating surgeon##2##3##(2007-11#1)(2007-7#1)
the operating table##4##3##(2007-12#1)(2007-8#1)(2008-2#1)(2011-2#1)
the operating temperature##4##3##(2008-10#2)(2013-1#1)(2013-8#1)
the operating theatre##9##3##(1991-7#1)(1992-3#1)(1995-4#1)(1996-9#1)(2006-10#1)(2008-10#1)(2010-7#1)(2012-2#1)(2012-3#1)
the operating##144##2##(1990-4#1)(1990-8#1)(1991-1#4)(1991-2#2)(1991-7#1)(1991-8#2)(1992-12#1)(1992-3#1)(1995-4#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(2005-12#1)(2006-10#20)(2006-2#1)(2006-5#3)(2006-6#7)(2006-8#2)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-10#11)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#1)
the operation and##13##3##(1990-2#1)(1991-5#1)(1994-3#2)(1996-2#1)(1996-9#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-8#2)(2008-10#2)
the operation by##2##3##(1993-9#1)(2008-3#1)
the operation field##2##3##(2007-8#2)
the operation for##2##3##(1993-2#1)(2009-2#1)
the operation in both groups##2##5##(2007-8#1)(2013-7#1)
the operation in##3##3##(1991-12#1)(2007-8#1)(2013-7#1)
the operation is performed##2##4##(2007-8#2)
the operation is##9##3##(1990-4#1)(1991-3#1)(1991-5#1)(2006-3#1)(2007-11#1)(2007-8#3)(2008-4#1)
the operation modes##2##3##(2007-12#1)(2012-3#1)
the operation of a diode-pumped##2##5##(2007-12#1)(2008-2#1)
the operation of a##8##4##(2004-8#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2012-12#1)
the operation of an##7##4##(1996-1#1)(1996-12#1)(1997-3#1)(2007-12#2)(2007-8#1)(2008-2#1)
the operation of choice for##2##5##(2006-10#1)(2009-12#1)
the operation of the##17##4##(1990-12#1)(1993-10#1)(1995-12#1)(2005-11#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#3)(2008-3#3)(2008-7#1)(2010-11#1)
the operation of these##2##4##(2006-12#1)(2008-3#1)
the operation of this##2##4##(1991-3#1)(2007-11#1)
the operation of##58##3##(1990-12#1)(1991-3#1)(1993-10#1)(1993-9#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-12#1)(1997-3#3)(2004-8#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-2#8)(2008-3#7)(2008-4#2)(2008-7#1)(2009-12#1)(2010-11#1)(2010-8#1)(2012-1#1)(2012-12#1)
the operation should##2##3##(1996-11#1)(2006-10#1)
the operation the##3##3##(1992-6#1)(2007-10#1)(2008-6#1)
the operation theatre##2##3##(2007-11#1)(2013-8#1)
the operation time##3##3##(2007-11#1)(2007-8#1)(2008-10#1)
the operation was a##2##4##(1992-8#1)(1996-3#1)
the operation was##10##3##(1992-8#1)(1996-2#1)(1996-3#1)(2006-7#1)(2006-8#1)(2007-8#1)(2008-5#1)(2011-2#1)(2012-12#2)
the operation were##3##3##(1993-2#1)(1994-3#1)(2006-8#1)
the operation will be##2##4##(2006-6#2)
the operation with##2##3##(1990-3#1)(2007-8#1)
the operation without##2##3##(1994-9#1)(2010-8#1)
the operation##251##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-9#1)(1991-12#2)(1991-3#2)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-10#1)(1993-2#3)(1993-3#1)(1993-5#1)(1993-9#4)(1994-11#2)(1994-3#5)(1994-9#1)(1995-1#1)(1995-12#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#2)(1996-9#2)(1997-2#1)(1997-3#3)(2004-10#1)(2004-8#1)(2005-11#1)(2005-5#1)(2006-10#5)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#9)(2006-7#1)(2006-8#5)(2007-10#8)(2007-11#9)(2007-12#9)(2007-2#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#9)(2007-8#23)(2007-9#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#11)(2008-3#8)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#1)(2010-10#1)(2010-11#1)(2010-8#2)(2011-1#1)(2011-2#9)(2012-1#2)(2012-12#5)(2012-2#4)(2012-3#2)(2012-8#1)(2013-1#5)(2013-7#3)(2013-8#2)
the operational and storage stability of##2##6##(2008-10#2)
the operational and##3##3##(2007-4#1)(2008-10#2)
the operational availability of doctors##2##5##(2013-1#2)
the operational characteristics##2##3##(2008-10#1)(2008-2#1)
the operational principles##2##3##(2007-12#1)(2013-8#1)
the operational##28##2##(1995-1#1)(1995-6#1)(1996-3#1)(1996-7#1)(1997-3#1)(2006-2#1)(2006-4#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#6)(2008-2#3)(2008-7#1)(2009-5#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
the operations of##2##3##(2007-12#1)(2007-9#1)
the operations were##2##3##(1993-6#1)(2009-3#1)
the operations##13##2##(1992-9#1)(1993-3#1)(1993-6#1)(1996-9#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-2#1)(2009-3#1)(2010-2#1)(2013-1#1)
the operative and##2##3##(2007-8#1)(2011-2#1)
the operative approach##3##3##(1996-1#1)(2008-9#2)
the operative area##2##3##(2006-12#1)(2007-7#1)
the operative corridor##2##3##(2007-1#2)
the operative field##5##3##(1995-1#1)(2006-9#1)(2007-8#1)(2008-5#1)(2010-8#1)
the operative findings##2##3##(1997-8#1)(2008-9#1)
the operative mortality##2##3##(1991-8#1)(2007-8#1)
the operative procedure##3##3##(2007-1#2)(2007-8#1)
the operative report##3##3##(2012-12#1)(2013-1#2)
the operative site##5##3##(2006-6#2)(2008-7#1)(2011-11#2)
the operative technique##8##3##(1990-12#1)(2006-3#1)(2006-7#1)(2007-11#1)(2008-4#1)(2008-7#1)(2013-8#2)
the operative time##4##3##(2006-6#2)(2008-10#1)(2011-2#1)
the operative treatment of##9##4##(1991-6#1)(1992-2#2)(1992-8#1)(2007-11#2)(2007-8#1)(2008-10#1)(2013-1#1)
the operative treatment##11##3##(1991-6#1)(1992-2#2)(1992-8#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#2)(2013-1#1)
the operative##77##2##(1990-12#1)(1990-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-2#3)(1992-8#1)(1995-1#1)(1995-5#1)(1996-1#1)(1996-6#1)(1997-8#1)(2005-5#1)(2006-12#1)(2006-3#2)(2006-4#1)(2006-6#4)(2006-7#1)(2006-9#1)(2007-1#4)(2007-11#3)(2007-7#4)(2007-8#11)(2008-10#8)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#3)(2009-2#1)(2010-8#1)(2011-11#2)(2011-2#3)(2012-12#1)(2013-1#5)(2013-8#2)
the operator and assistants##2##4##(2008-5#2)
the operator and##5##3##(1990-4#1)(1990-5#1)(2007-7#1)(2008-5#2)
the operator in##2##3##(1991-2#1)(2008-9#1)
the operator to##5##3##(2007-7#1)(2007-8#1)(2008-11#2)(2008-2#1)
the operator##29##2##(1990-4#3)(1990-5#1)(1991-2#1)(1991-6#1)(1992-6#2)(2006-6#1)(2007-11#2)(2007-3#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-5#2)(2008-9#1)(2012-10#1)(2013-1#2)
the operator's##3##2##(1991-8#1)(2008-10#1)(2011-2#1)
the operator-proximal CRP binding##2##4##(1997-6#2)
the operators##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
the operculum and##2##3##(1996-5#1)(2007-12#1)
the operculum##3##2##(1996-5#1)(2007-12#2)
the operon##4##2##(1990-3#1)(1990-4#1)(1994-6#1)(2011-2#1)
the ophthalmic artery##6##3##(1996-9#1)(2005-5#1)(2006-12#1)(2008-7#1)(2009-8#1)(2012-3#1)
the ophthalmic division of the##2##5##(1992-8#1)(2009-8#1)
the ophthalmic segment of the ICA##2##6##(2005-5#1)(2012-3#1)
the ophthalmic segment of the##3##5##(2005-5#2)(2012-3#1)
the ophthalmic##18##2##(1991-7#1)(1992-8#1)(1993-12#1)(1996-9#1)(2005-5#3)(2006-12#1)(2007-5#1)(2008-7#1)(2009-8#2)(2011-1#1)(2012-3#3)(2013-7#2)
the ophthalmologic##2##2##(1996-10#1)(2007-3#1)
the ophthalmologist and##3##3##(2009-4#1)(2013-1#1)(2013-7#1)
the ophthalmologist##7##2##(1993-11#1)(2006-12#1)(2007-3#1)(2009-4#1)(2013-1#1)(2013-7#1)(2013-8#1)
the ophthalmologists##2##2##(2011-1#1)(2012-2#1)
the opiate antagonist##3##3##(1990-7#1)(1991-1#1)(1991-2#1)
the opiate##6##2##(1990-7#2)(1991-1#1)(1991-2#1)(1992-8#1)(2010-9#1)
the opiates##2##2##(1991-1#2)
the opinion of the nurses##2##5##(1990-2#2)
the opinion of the##9##4##(1990-2#2)(1991-3#1)(1993-5#1)(1993-8#1)(1995-6#1)(1995-9#1)(1996-12#1)(1997-3#1)
the opinion of##15##3##(1990-2#2)(1991-3#1)(1992-1#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-2#1)(1995-6#1)(1995-9#1)(1996-12#1)(1997-3#1)(2007-12#1)(2011-1#1)(2013-1#1)
the opinion that##9##3##(1990-4#1)(1994-12#1)(1995-5#1)(2004-10#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-7#1)(2011-2#1)
the opinion##30##2##(1990-2#2)(1990-4#1)(1991-3#1)(1992-1#1)(1993-12#2)(1993-5#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#1)(1997-3#1)(2004-10#1)(2007-12#2)(2007-3#1)(2007-9#1)(2008-1#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-11#1)(2013-1#3)
the opinions of##8##3##(1990-11#1)(1997-3#1)(1997-8#1)(2007-9#1)(2008-12#2)(2008-2#1)(2008-6#1)
the opinions##12##2##(1990-11#1)(1994-12#1)(1997-3#1)(1997-8#1)(2007-2#1)(2007-9#1)(2008-12#2)(2008-2#1)(2008-6#1)(2010-12#1)(2011-2#1)
the opioid antagonist##3##3##(1995-6#1)(1996-7#1)(1997-2#1)
the opioid peptide##4##3##(1992-12#1)(1992-3#1)(1993-11#1)(1996-2#1)
the opioid receptor-like##2##3##(1996-2#1)(2008-11#1)
the opioid system##3##3##(1991-1#1)(1996-12#2)
the opioid##24##2##(1991-1#2)(1992-12#1)(1992-3#1)(1993-11#1)(1994-10#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-10#1)(1996-12#3)(1996-2#2)(1996-7#1)(1997-2#1)(2006-10#1)(2006-7#1)(2007-2#2)(2008-11#1)(2008-7#1)(2010-5#1)
the opioid-sparing##2##2##(2007-2#1)(2011-1#1)
the opioids##5##2##(1990-2#1)(1993-5#1)(2005-8#1)(2007-12#1)(2008-3#1)
the opponent's outcomes##2##3##(2008-11#2)
the opportunistic##2##2##(2007-8#1)(2011-2#1)
the opportunities and##5##3##(1993-1#1)(2009-8#1)(2010-11#1)(2013-1#2)
the opportunities for##6##3##(1997-1#1)(2006-10#1)(2008-1#1)(2008-5#1)(2010-7#1)(2012-1#1)
the opportunities to##2##3##(2008-2#1)(2012-1#1)
the opportunities##19##2##(1993-1#1)(1993-3#1)(1997-1#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-2#3)(2008-5#2)(2008-9#1)(2009-8#1)(2010-11#1)(2010-7#1)(2012-1#2)(2013-1#2)
the opportunity cost for men who seek##2##7##(2011-2#2)
the opportunity cost of##2##4##(1991-2#1)(2013-8#1)
the opportunity cost##4##3##(1991-2#1)(2011-2#2)(2013-8#1)
the opportunity for sexual selection##3##5##(2008-8#3)
the opportunity for##17##3##(1994-12#1)(2005-7#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#4)(2008-9#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)
the opportunity of##7##3##(1991-2#1)(1992-9#1)(1994-9#1)(2008-1#1)(2008-3#1)(2008-7#1)(2012-3#1)
the opportunity to assess the##2##5##(2006-10#1)(2012-3#1)
the opportunity to be a##2##5##(2011-2#1)(2012-3#1)
the opportunity to discuss##2##4##(2007-2#1)(2008-1#1)
the opportunity to explore##2##4##(1993-9#1)(2008-12#1)
the opportunity to identify##2##4##(1991-6#1)(2012-11#1)
the opportunity to make##2##4##(1994-1#1)(2008-9#1)
the opportunity to plan##2##4##(1992-4#1)(2013-8#1)
the opportunity to present##3##4##(2008-5#1)(2011-2#1)(2012-2#1)
the opportunity to study##5##4##(1993-11#1)(2007-5#1)(2008-2#2)(2009-8#1)
the opportunity to test##3##4##(1994-8#1)(2008-1#1)(2012-3#1)
the opportunity to use##2##4##(2008-2#1)(2010-5#1)
the opportunity to##88##3##(1991-6#2)(1992-4#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-4#1)(1995-9#1)(1996-12#1)(1997-2#1)(2004-12#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-3#1)(2009-4#2)(2009-8#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#4)
the opportunity##123##2##(1991-2#2)(1991-6#2)(1992-4#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-4#1)(1995-9#1)(1996-12#1)(1997-2#1)(2004-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-7#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#5)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#4)(2008-5#2)(2008-7#3)(2008-8#5)(2008-9#4)(2009-12#1)(2009-3#1)(2009-4#2)(2009-8#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#1)(2013-7#1)(2013-8#5)
the opposing##5##2##(1990-5#1)(1993-3#1)(2008-8#1)(2009-4#1)(2013-1#1)
the opposite direction of##3##4##(2008-2#1)(2009-7#1)(2012-2#1)
the opposite direction##17##3##(1991-5#1)(1993-2#1)(1994-3#1)(1996-8#1)(1997-2#2)(1997-3#1)(2005-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-7#2)(2010-12#1)(2012-2#1)
the opposite effect##9##3##(1995-12#1)(1997-7#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)
the opposite end of the##2##5##(2007-8#1)(2011-2#1)
the opposite end##4##3##(2007-12#1)(2007-8#1)(2008-10#1)(2011-2#1)
the opposite kidney##2##3##(1995-2#1)(2011-1#1)
the opposite limb##2##3##(2007-11#2)
the opposite occurred##3##3##(1991-1#1)(2008-10#1)(2011-2#1)
the opposite of what has been##2##6##(1990-8#1)(2008-9#1)
the opposite of##6##3##(1990-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#1)
the opposite sex##8##3##(1990-8#1)(1995-12#1)(2007-12#2)(2008-5#1)(2008-9#1)(2010-2#2)
the opposite side of the##2##5##(2008-2#1)(2008-3#1)
the opposite side of##3##4##(2008-2#1)(2008-3#1)(2009-9#1)
the opposite side##15##3##(1992-12#1)(1993-4#1)(2007-7#1)(2008-2#3)(2008-3#2)(2008-5#1)(2009-6#2)(2009-9#1)(2010-3#1)(2011-1#1)(2013-7#1)
the opposite sides of##2##4##(2009-12#1)(2012-4#1)
the opposite trend##3##3##(2009-10#1)(2009-2#1)(2012-1#1)
the opposite was##5##3##(1990-7#1)(1993-12#1)(2008-7#1)(2010-8#1)(2012-2#1)
the opposite##142##2##(1990-1#1)(1990-10#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-10#2)(1991-11#1)(1991-5#3)(1991-6#1)(1992-12#2)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-4#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#2)(1997-7#1)(2005-10#1)(2006-10#2)(2007-11#3)(2007-12#5)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#4)(2008-10#7)(2008-11#2)(2008-2#6)(2008-3#8)(2008-4#1)(2008-5#5)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-6#2)(2009-7#3)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#1)(2012-4#1)(2013-1#2)(2013-7#1)(2013-8#1)
the oppositely charged##3##3##(2005-11#1)(2008-10#1)(2010-7#1)
the opsonic effect of serum on the##2##7##(1992-6#2)
the opsonic##3##2##(1991-6#1)(1992-6#2)
the optic axis##6##3##(2008-2#4)(2008-3#2)
the optic chiasm##2##3##(1997-8#1)(2008-7#1)
the optic disc and retinal nerve fiber layer in glaucoma##3##10##(2007-6#3)
the optic disc and retinal nerve fiber layer##6##8##(2007-6#6)
the optic disc##7##3##(2007-1#1)(2007-6#6)
the optic lobe##6##3##(2007-12#3)(2008-3#1)(2008-5#2)
the optic lobes##3##3##(1994-3#1)(1995-5#1)(2007-12#1)
the optic nerve as##2##4##(2005-9#1)(2008-7#1)
the optic nerve head##8##4##(1995-9#1)(2007-11#1)(2007-6#1)(2008-5#5)
the optic nerve##36##3##(1991-3#1)(1992-2#2)(1993-12#4)(1995-9#1)(1996-3#1)(2005-5#1)(2005-9#1)(2006-12#2)(2007-11#1)(2007-6#1)(2008-10#1)(2008-5#6)(2008-7#2)(2009-2#1)(2009-8#3)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-3#1)
the optic nerves##3##3##(2008-5#2)(2013-8#1)
the optic tectum##5##3##(1990-5#1)(1993-12#1)(1995-5#1)(1997-3#1)(2008-6#1)
the optic tract and##2##4##(2007-10#1)(2008-7#1)
the optic tract##4##3##(1992-7#1)(1992-9#1)(2007-10#1)(2008-7#1)
the optic##88##2##(1990-12#1)(1990-5#1)(1991-2#1)(1991-3#1)(1992-2#2)(1992-7#1)(1992-9#1)(1993-12#5)(1994-3#1)(1995-5#2)(1995-9#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-5#1)(2005-9#2)(2006-12#4)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-6#7)(2008-10#1)(2008-2#4)(2008-3#8)(2008-5#10)(2008-6#1)(2008-7#5)(2009-2#1)(2009-4#1)(2009-8#4)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-8#1)
the optical Kerr effect and##2##5##(2007-12#1)(2008-3#1)
the optical Kerr effect##3##4##(2007-12#1)(2008-3#2)
the optical absorption coefficient of a##2##6##(2006-12#1)(2008-3#1)
the optical absorption coefficient of##3##5##(2006-12#1)(2008-3#2)
the optical absorption##10##3##(1990-8#1)(1992-9#1)(2006-12#1)(2008-3#5)(2008-4#1)(2011-1#1)
the optical activity##2##3##(2008-2#1)(2009-5#1)
the optical amplifier##3##3##(2007-12#3)
the optical analyser TURBISCAN MA 2000##2##6##(2008-10#2)
the optical and##7##3##(2005-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-2#1)
the optical arrangement##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
the optical attenuation##2##3##(2008-2#1)(2008-3#1)
the optical axis and##2##4##(2008-2#1)(2008-3#1)
the optical axis in##2##4##(2007-11#1)(2007-12#1)
the optical axis of the system##2##6##(2008-2#1)(2008-3#1)
the optical axis of the##5##5##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
the optical axis of##6##4##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#2)
the optical axis with##3##4##(2008-3#3)
the optical axis##30##3##(2007-11#3)(2007-12#3)(2008-10#1)(2008-2#7)(2008-3#16)
the optical beam##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
the optical beat##2##3##(2008-1#1)(2008-3#1)
the optical bio-sniffer##2##3##(2007-8#2)
the optical biosensor##3##3##(1997-2#2)(2008-10#1)
the optical buffer##2##3##(2008-3#2)
the optical cavity##4##3##(2007-11#1)(2008-3#2)(2009-2#1)
the optical cell##2##3##(2007-8#1)(2008-3#1)
the optical characteristics of the##2##5##(2008-2#1)(2008-3#1)
the optical characteristics of##7##4##(2008-2#5)(2008-3#2)
the optical characteristics##8##3##(2007-12#1)(2008-2#5)(2008-3#2)
the optical characterization of##2##4##(2008-3#2)
the optical coefficients of the two layers and the thickness of the first layer##2##14##(2008-2#2)
the optical coefficients of##3##4##(2008-2#2)(2008-3#1)
the optical coefficients##6##3##(2008-2#5)(2008-3#1)
the optical coherence##2##3##(2008-3#1)(2012-12#1)
the optical component##3##3##(2008-2#2)(2008-3#1)
the optical components##2##3##(2007-11#1)(2008-2#1)
the optical configuration of##3##4##(2008-2#1)(2008-3#2)
the optical configuration##6##3##(2008-2#4)(2008-3#2)
the optical constants and the##3##5##(2008-2#1)(2008-3#2)
the optical constants n##2##4##(2008-2#1)(2008-3#1)
the optical constants of the##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
the optical constants of##12##4##(2007-12#1)(2008-2#8)(2008-3#3)
the optical constants##32##3##(2007-12#1)(2008-2#21)(2008-3#10)
the optical contrast between##2##4##(2007-11#1)(2008-2#1)
the optical cross sections##2##4##(2008-2#1)(2008-3#1)
the optical data##2##3##(2007-12#1)(2008-2#1)
the optical degradation of white paint in a##2##8##(2008-3#2)
the optical density of the##4##5##(2006-11#1)(2008-10#1)(2008-6#1)(2008-7#1)
the optical density of##5##4##(2006-11#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)
the optical density##6##3##(2006-11#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)
the optical depth##7##3##(2008-2#3)(2008-3#4)
the optical design of##2##4##(2008-2#1)(2008-3#1)
the optical design##3##3##(2008-2#2)(2008-3#1)
the optical disk##4##3##(2008-2#2)(2008-3#2)
the optical domain##8##3##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#3)
the optical efficiency##4##3##(2008-2#3)(2008-3#1)
the optical elements##3##3##(2006-5#1)(2008-3#2)
the optical emission##2##3##(2008-3#1)(2013-8#1)
the optical energy##2##3##(2008-3#1)(2012-2#1)
the optical excitation area##2##4##(2007-11#2)
the optical excitation##3##3##(2007-11#2)(2007-12#1)
the optical feedback##4##3##(2008-3#4)
the optical fiber used##2##4##(2007-11#1)(2008-10#1)
the optical fiber##11##3##(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#3)(2013-1#1)
the optical field is##2##4##(2007-12#1)(2008-3#1)
the optical field##12##3##(2007-11#3)(2007-12#4)(2008-2#1)(2008-3#4)
the optical filter##2##3##(2007-12#1)(2008-9#1)
the optical frequency##9##3##(2007-11#1)(2007-12#4)(2008-2#3)(2008-3#1)
the optical functions of##5##4##(2008-1#2)(2008-2#2)(2008-3#1)
the optical functions##7##3##(2007-12#1)(2008-1#2)(2008-2#3)(2008-3#1)
the optical gain##2##3##(2008-2#1)(2008-3#1)
the optical image##2##3##(2008-3#1)(2008-9#1)
the optical implementation of##4##4##(2008-2#2)(2008-3#2)
the optical implementation##5##3##(2008-2#3)(2008-3#2)
the optical interference##2##3##(2013-8#2)
the optical length of the##2##5##(2007-11#1)(2008-1#1)
the optical limiting behavior##3##4##(2007-11#2)(2008-3#1)
the optical loss##2##3##(2007-12#1)(2008-2#1)
the optical method##3##3##(1996-5#1)(1997-6#1)(2008-3#1)
the optical near field##3##4##(2007-11#2)(2008-2#1)
the optical nonlinearity##4##3##(2006-12#1)(2007-12#2)(2008-3#1)
the optical parameters##9##3##(2007-12#1)(2008-2#3)(2008-3#4)(2010-4#1)
the optical path by the##2##5##(2008-10#1)(2008-3#1)
the optical path difference between##2##5##(2008-2#1)(2008-3#1)
the optical path difference##15##4##(2007-12#3)(2008-2#4)(2008-3#6)(2013-8#2)
the optical path length through the##2##6##(2008-2#1)(2008-3#1)
the optical path length##5##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-2#1)
the optical path lengths##2##4##(2007-12#1)(2008-3#1)
the optical path of the##4##5##(2007-12#1)(2008-10#1)(2008-3#1)(2013-8#1)
the optical path of##5##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-8#1)
the optical path##34##3##(2007-11#1)(2007-12#7)(2008-10#3)(2008-2#8)(2008-3#11)(2010-2#1)(2013-8#3)
the optical path-length##2##3##(2007-12#1)(2008-3#1)
the optical pathlength##2##3##(2008-10#1)(2011-1#1)
the optical performance of##3##4##(2007-12#1)(2008-3#2)
the optical performance##5##3##(2007-12#1)(2008-3#4)
the optical phase##8##3##(2007-12#3)(2008-2#3)(2008-3#2)
the optical polarization properties of biological##2##6##(2008-3#2)
the optical power supply to the##2##6##(2008-2#2)
the optical power##10##3##(2007-12#3)(2008-2#5)(2008-3#2)
the optical probing beam##2##4##(2007-11#1)(2008-3#1)
the optical properties and##5##4##(2008-2#1)(2008-3#1)(2009-2#2)(2010-9#1)
the optical properties for##2##4##(2008-3#1)(2011-1#1)
the optical properties from##2##4##(2008-2#1)(2008-3#1)
the optical properties of the tissue##2##6##(2007-12#1)(2008-2#1)
the optical properties of the##17##5##(2006-11#1)(2006-7#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#6)(2009-2#1)
the optical properties of turbid media##2##6##(2007-12#1)(2008-3#1)
the optical properties of two-layer##2##5##(2008-3#2)
the optical properties of##61##4##(1991-12#1)(1997-6#1)(2006-11#1)(2006-7#1)(2007-11#8)(2007-12#6)(2007-9#1)(2008-10#2)(2008-2#16)(2008-3#22)(2009-2#1)(2011-1#1)
the optical properties##77##3##(1991-12#1)(1997-6#1)(2006-11#1)(2006-7#1)(2007-11#8)(2007-12#7)(2007-9#1)(2008-10#2)(2008-2#22)(2008-3#26)(2009-2#3)(2010-4#1)(2010-9#1)(2011-1#2)
the optical pulse##4##3##(2007-12#3)(2012-2#1)
the optical quality of the##2##5##(2008-3#2)
the optical quality of##3##4##(2008-3#3)
the optical quality##5##3##(2007-12#1)(2008-3#4)
the optical region##2##3##(2007-12#1)(2008-2#1)
the optical response of##2##4##(1995-2#1)(2008-2#1)
the optical response##5##3##(1990-8#1)(1995-2#1)(2008-2#1)(2008-3#1)(2008-7#1)
the optical rotation##3##3##(1990-3#1)(2008-2#1)(2008-3#1)
the optical setup##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
the optical signal in##2##4##(2007-12#1)(2011-1#1)
the optical signal##13##3##(2006-12#1)(2007-11#1)(2007-12#5)(2008-1#1)(2008-2#2)(2008-3#1)(2008-9#1)(2011-1#1)
the optical signals are##2##4##(2008-2#1)(2008-3#1)
the optical signals##4##3##(2008-2#1)(2008-3#3)
the optical source##2##3##(2007-12#2)
the optical spectrum##6##3##(1990-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)(2011-2#1)
the optical system itself##2##4##(2008-2#1)(2008-3#1)
the optical system to##2##4##(2007-12#1)(2008-10#1)
the optical system##28##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#8)(2008-3#16)
the optical thickness of the##4##5##(2007-11#1)(2008-3#3)
the optical thickness##8##3##(2007-11#1)(2008-2#3)(2008-3#4)
the optical thicknesses of##2##4##(2008-2#2)
the optical throughput of##2##4##(2008-3#2)
the optical transfer function##2##4##(2008-2#2)
the optical transmission##2##3##(2008-2#1)(2008-3#1)
the optical transpose interconnection system##2##5##(2008-3#2)
the optical trap##3##3##(1997-4#1)(2005-11#2)
the optical trapping of##2##4##(2007-12#2)
the optical trapping##3##3##(2007-12#2)(2008-3#1)
the optical tunneling##2##3##(2008-3#2)
the optical wave front##2##4##(2008-2#2)
the optical wavelength##4##3##(2007-11#2)(2008-2#1)(2008-3#1)
the optical##694##2##(1990-3#2)(1990-8#4)(1991-12#1)(1991-7#1)(1992-3#1)(1992-9#1)(1994-5#1)(1994-6#1)(1995-2#1)(1996-5#1)(1997-2#2)(1997-4#1)(1997-6#3)(2005-11#3)(2006-10#1)(2006-11#2)(2006-12#3)(2006-5#1)(2006-7#1)(2006-9#1)(2007-11#47)(2007-12#102)(2007-8#3)(2007-9#1)(2008-1#10)(2008-10#19)(2008-2#190)(2008-3#242)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-12#1)(2009-2#5)(2009-5#2)(2010-1#1)(2010-2#2)(2010-4#2)(2010-7#2)(2010-9#1)(2011-1#7)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#6)(2013-8#6)
the optical-sectioning##2##2##(2007-12#1)(2008-2#1)
the optically addressed##2##3##(2008-3#2)
the optically induced##2##3##(2007-11#1)(2008-3#1)
the optically pure##4##3##(1992-3#1)(1994-3#1)(1995-3#2)
the optically sensitive##2##3##(2007-12#1)(2008-3#1)
the optically##16##2##(1992-3#1)(1994-3#1)(1995-3#2)(2005-11#1)(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#4)(2008-5#1)(2011-1#1)
the optics of##2##3##(2006-5#1)(2008-3#1)
the optics##13##2##(2006-5#1)(2007-12#1)(2008-1#2)(2008-2#5)(2008-3#3)(2008-4#1)
the optima##2##2##(2008-10#2)
the optimal approach to##2##4##(2007-11#1)(2009-3#1)
the optimal approach##3##3##(2007-11#1)(2009-3#1)(2009-8#1)
the optimal breathing pattern##2##4##(2007-9#2)
the optimal choice##2##3##(2008-10#1)(2012-3#1)
the optimal combination of##5##4##(2006-10#1)(2008-1#1)(2010-2#2)(2011-2#1)
the optimal concentration of##3##4##(1994-11#1)(2008-4#2)
the optimal concentration##4##3##(1994-11#1)(2008-4#2)(2008-8#1)
the optimal concentrations of##2##4##(1990-8#1)(2008-11#1)
the optimal conditions for the##3##5##(2008-10#2)(2013-8#1)
the optimal conditions for##8##4##(1991-5#1)(2007-12#1)(2008-10#4)(2008-7#1)(2013-8#1)
the optimal conditions##33##3##(1991-5#1)(2006-12#2)(2007-12#1)(2008-10#25)(2008-7#1)(2013-1#1)(2013-8#2)
the optimal decision##2##3##(2008-10#1)(2012-3#1)
the optimal design of##5##4##(1995-4#2)(2008-3#1)(2008-5#1)(2013-1#1)
the optimal design##8##3##(1995-4#4)(2008-3#1)(2008-5#1)(2010-2#1)(2013-1#1)
the optimal dosage and##2##4##(1992-9#1)(2013-1#1)
the optimal dosage##6##3##(1992-9#1)(1994-6#1)(2007-11#1)(2008-4#1)(2012-12#1)(2013-1#1)
the optimal dose and##3##4##(2004-10#1)(2006-10#1)(2008-8#1)
the optimal dose of##3##4##(2007-8#2)(2008-7#1)
the optimal dose##10##3##(1994-6#1)(1997-6#1)(2004-10#1)(2006-10#2)(2007-8#2)(2008-7#1)(2008-8#1)(2012-12#1)
the optimal doses##2##3##(1997-3#1)(2007-8#1)
the optimal duration of##3##4##(2007-11#1)(2012-2#2)
the optimal duration##4##3##(2007-11#1)(2012-2#2)(2013-8#1)
the optimal environmental conditions##2##4##(2008-10#1)(2008-3#1)
the optimal experimental conditions##5##4##(2008-10#5)
the optimal experimental##6##3##(2007-8#1)(2008-10#5)
the optimal extraction##3##3##(2008-10#3)
the optimal filters is##3##4##(2008-2#1)(2008-6#2)
the optimal flux##2##3##(2005-11#2)
the optimal harvest time##2##4##(2008-11#1)(2008-7#1)
the optimal level of##4##4##(2007-8#1)(2008-10#1)(2008-8#2)
the optimal level##5##3##(1996-3#1)(2007-8#1)(2008-10#1)(2008-8#2)
the optimal management of these##2##5##(2008-4#1)(2012-11#1)
the optimal management of##7##4##(1996-6#1)(2006-10#1)(2007-11#1)(2008-3#1)(2008-4#1)(2010-10#1)(2012-11#1)
the optimal management##8##3##(1996-6#1)(2006-10#1)(2007-11#1)(2008-3#1)(2008-4#1)(2010-10#1)(2012-11#1)(2012-2#1)
the optimal means of##2##4##(2006-10#1)(2008-3#1)
the optimal medium##4##3##(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
the optimal method for##2##4##(2007-11#1)(2009-5#1)
the optimal method of##2##4##(2008-1#1)(2008-11#1)
the optimal method##5##3##(2006-5#1)(2007-11#1)(2008-1#1)(2008-11#1)(2009-5#1)
the optimal moment##2##3##(2008-10#1)(2008-5#1)
the optimal number of##2##4##(2007-12#1)(2012-3#1)
the optimal operating##3##3##(2006-5#1)(2008-2#1)(2008-5#1)
the optimal pH##4##3##(1994-11#1)(2004-11#1)(2005-11#1)(2008-10#1)
the optimal path##2##3##(2008-2#1)(2008-3#1)
the optimal period##2##3##(2009-2#1)(2011-1#1)
the optimal phase##2##3##(2008-3#2)
the optimal reaction##2##3##(2008-10#1)(2008-5#1)
the optimal region##2##3##(2008-10#1)(2008-5#1)
the optimal selection of##2##4##(2008-10#1)(2008-2#1)
the optimal solution##6##3##(2007-8#1)(2008-2#2)(2008-3#1)(2009-3#1)(2009-7#1)
the optimal strategy for##4##4##(1991-11#1)(2005-8#1)(2006-10#1)(2012-2#1)
the optimal strategy of treatment##2##5##(2008-7#1)(2013-1#1)
the optimal strategy##7##3##(1991-11#1)(2005-8#1)(2006-10#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#1)
the optimal surface##2##3##(2008-2#2)
the optimal surgical approach##2##4##(2006-10#1)(2010-5#1)
the optimal surgical treatment##2##4##(1994-12#1)(2012-12#1)
the optimal surgical##8##3##(1994-12#1)(2006-1#1)(2006-10#1)(2006-6#1)(2007-7#1)(2008-12#1)(2010-5#1)(2012-12#1)
the optimal system##3##3##(2008-2#2)(2011-2#1)
the optimal target for##2##4##(2006-5#1)(2010-3#1)
the optimal therapeutic##3##3##(2009-9#1)(2010-8#1)(2012-2#1)
the optimal therapy for##2##4##(1995-2#1)(2009-8#1)
the optimal time##2##3##(2008-11#1)(2011-2#1)
the optimal timing for##2##4##(2008-1#1)(2010-12#1)
the optimal timing of training remains unclear--whether to engage in extensive pre go-live training vs##2##15##(2013-1#2)
the optimal timing of##9##4##(1996-4#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-9#1)(2013-1#2)
the optimal timing##12##3##(1996-4#1)(2006-10#1)(2006-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-12#1)(2013-1#2)
the optimal treatment for##4##4##(2006-9#1)(2007-8#1)(2008-6#1)(2008-7#1)
the optimal treatment of##2##4##(1995-5#1)(1996-9#1)
the optimal treatment##16##3##(1995-5#1)(1996-9#1)(1997-1#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-3#2)(2013-1#1)
the optimal use of the##2##5##(2005-7#1)(2007-7#1)
the optimal use of##7##4##(1996-12#1)(2005-7#1)(2007-11#3)(2007-7#1)(2008-7#1)
the optimal value of the##2##5##(2008-10#1)(2008-2#1)
the optimal value of##4##4##(1996-8#1)(2008-10#2)(2008-2#1)
the optimal value##5##3##(1996-8#1)(2008-1#1)(2008-10#2)(2008-2#1)
the optimal values##3##3##(2008-3#1)(2008-6#1)(2013-1#1)
the optimal velocity to moving##2##5##(2008-8#2)
the optimal working##2##3##(2006-2#1)(2008-10#1)
the optimal##414##2##(1990-12#1)(1990-8#1)(1991-11#1)(1991-5#2)(1992-12#1)(1992-9#2)(1993-11#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-4#1)(1994-6#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#4)(1995-5#1)(1995-8#4)(1996-12#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-1#1)(2004-10#1)(2004-11#1)(2004-12#1)(2005-1#1)(2005-11#6)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#13)(2006-12#4)(2006-2#2)(2006-5#3)(2006-6#2)(2006-9#1)(2007-11#11)(2007-12#9)(2007-7#5)(2007-8#19)(2007-9#3)(2008-1#7)(2008-10#57)(2008-11#7)(2008-12#1)(2008-2#28)(2008-3#27)(2008-4#8)(2008-5#13)(2008-6#7)(2008-7#14)(2008-8#15)(2008-9#4)(2009-10#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#3)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#3)(2010-7#1)(2010-8#4)(2011-1#5)(2011-2#10)(2011-3#1)(2011-7#1)(2012-1#1)(2012-11#2)(2012-12#6)(2012-2#9)(2012-3#7)(2013-1#15)(2013-8#6)
the optimality model##2##3##(2006-5#2)
the optimality##4##2##(2006-5#2)(2007-9#1)(2008-2#1)
the optimisation and##3##3##(2008-10#3)
the optimisation of the##5##4##(1996-8#1)(2008-10#4)
the optimisation of##9##3##(1996-8#1)(2008-10#5)(2008-11#2)(2010-5#1)
the optimisation process##2##3##(2008-10#1)(2010-5#1)
the optimisation##18##2##(1996-8#1)(2008-10#12)(2008-11#2)(2008-3#1)(2010-5#2)
the optimised BCR##3##3##(2008-10#3)
the optimised conditions the##2##4##(2008-10#2)
the optimised conditions##5##3##(2008-10#5)
the optimised##15##2##(1996-8#1)(2007-8#2)(2008-10#12)
the optimization and##4##3##(2008-10#2)(2008-2#2)
the optimization design of##2##4##(2008-3#2)
the optimization of a##8##4##(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)
the optimization of all##2##4##(2008-10#1)(2008-8#1)
the optimization of experimental##2##4##(2008-10#2)
the optimization of instrumental##2##4##(2008-10#2)
the optimization of metabolic pathways##2##5##(2008-7#2)
the optimization of spatial allocation##2##5##(2013-8#2)
the optimization of the##16##4##(1997-2#2)(2008-10#5)(2008-2#1)(2008-3#3)(2008-9#1)(2009-2#1)(2011-1#1)(2012-11#2)
the optimization of##79##3##(1993-11#1)(1997-1#1)(1997-2#2)(2005-11#1)(2007-12#3)(2007-5#1)(2007-8#1)(2008-10#24)(2008-11#1)(2008-2#12)(2008-3#7)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
the optimization problem##4##3##(2008-2#2)(2008-3#1)(2009-3#1)
the optimization procedure##2##3##(2008-10#1)(2008-2#1)
the optimization process##6##3##(2007-12#2)(2008-10#4)
the optimization##116##2##(1993-11#1)(1997-1#1)(1997-2#2)(2005-11#1)(2006-5#1)(2007-12#6)(2007-5#1)(2007-8#1)(2008-10#41)(2008-11#1)(2008-12#1)(2008-2#19)(2008-3#11)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-2#2)(2009-3#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#3)
the optimized condition the##2##4##(2008-10#2)
the optimized condition##3##3##(2008-10#3)
the optimized conditions of##4##4##(1996-7#1)(2008-10#2)(2011-1#1)
the optimized conditions##36##3##(1996-7#2)(2004-12#1)(2005-12#1)(2007-12#1)(2007-8#3)(2008-10#21)(2008-12#1)(2011-1#4)(2013-1#1)(2013-7#1)
the optimized experimental conditions##4##4##(2007-8#1)(2008-10#2)(2013-8#1)
the optimized formulation##3##3##(2010-12#1)(2012-12#2)
the optimized geometrical##2##3##(1993-8#1)(1997-7#1)
the optimized medium was##2##4##(2008-11#1)(2013-7#1)
the optimized medium##4##3##(2008-11#1)(2008-6#1)(2013-7#2)
the optimized system##4##3##(2007-12#2)(2008-3#2)
the optimized##101##2##(1993-8#2)(1996-5#1)(1996-7#2)(1997-7#1)(2004-12#2)(2005-12#1)(2006-11#1)(2007-12#3)(2007-8#4)(2008-10#48)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#2)(2008-6#1)(2009-2#2)(2010-12#1)(2011-1#5)(2012-12#5)(2013-1#2)(2013-7#4)(2013-8#1)
the optimum SFE##2##3##(2008-10#2)
the optimum absorption coefficient##3##4##(2007-12#3)
the optimum amount of##2##4##(1996-9#1)(2007-12#1)
the optimum amounts##2##3##(2008-12#1)(2010-12#1)
the optimum analytical##2##3##(2008-10#2)
the optimum and##2##3##(2008-10#1)(2008-8#1)
the optimum at##3##3##(2008-10#3)
the optimum beam##2##3##(2008-2#1)(2008-3#1)
the optimum composition of the##2##5##(2007-8#1)(2009-2#1)
the optimum concentration ranges##2##4##(2008-10#2)
the optimum concentration##3##3##(1996-12#1)(2008-10#2)
the optimum condition##8##3##(2007-10#1)(2008-10#7)
the optimum conditions for the##7##5##(1992-2#1)(2005-11#1)(2008-10#4)(2008-3#1)
the optimum conditions for##15##4##(1992-2#1)(1994-3#1)(2005-11#1)(2007-12#2)(2008-10#8)(2008-3#1)(2008-5#1)
the optimum conditions found##2##4##(2008-10#2)
the optimum conditions of##3##4##(2007-8#1)(2008-10#2)
the optimum conditions that##2##4##(2007-12#1)(2008-10#1)
the optimum conditions were##4##4##(2008-10#3)(2012-12#1)
the optimum conditions##74##3##(1992-2#1)(1994-3#1)(2005-11#1)(2007-12#4)(2007-8#1)(2008-10#61)(2008-3#1)(2008-5#1)(2012-12#2)(2012-3#1)
the optimum dose##2##3##(2008-4#1)(2013-8#1)
the optimum experimental conditions for##2##5##(2008-10#2)
the optimum experimental conditions##8##4##(2007-8#1)(2008-10#7)
the optimum filter##2##3##(2008-2#2)
the optimum for##2##3##(1990-3#1)(1997-3#1)
the optimum irrigation water##2##4##(2008-12#2)
the optimum length of the##2##5##(2008-3#1)(2011-2#1)
the optimum management of##2##4##(2006-5#1)(2008-10#1)
the optimum number of##2##4##(2005-5#1)(2008-10#1)
the optimum operating conditions##3##4##(2008-10#1)(2008-3#1)(2011-12#1)
the optimum operating##4##3##(2008-10#1)(2008-3#2)(2011-12#1)
the optimum pH for##4##4##(1990-2#1)(1990-7#1)(1996-5#1)(2004-11#1)
the optimum pH##11##3##(1990-2#1)(1990-7#2)(1996-5#1)(2004-11#1)(2008-10#5)(2008-9#1)
the optimum parameters##2##3##(2012-12#1)(2013-1#1)
the optimum performance of##2##4##(2007-10#1)(2010-2#1)
the optimum performance##3##3##(2007-10#1)(2008-3#1)(2010-2#1)
the optimum polarization##2##3##(2008-3#2)
the optimum reaction conditions##3##4##(2008-10#2)(2013-1#1)
the optimum separation##2##3##(2008-10#2)
the optimum services##2##3##(2007-7#2)
the optimum temperature for##3##4##(2008-10#2)(2008-6#1)
the optimum temperature##6##3##(2008-10#4)(2008-5#1)(2008-6#1)
the optimum treatment##3##3##(2007-10#1)(2009-5#1)(2012-2#1)
the optimum use of##3##4##(2007-11#1)(2009-5#1)(2010-5#1)
the optimum value##2##3##(2007-12#1)(2008-10#1)
the optimum values of the##3##5##(1997-6#1)(2008-10#1)(2008-3#1)
the optimum values of##4##4##(1997-6#1)(2008-10#1)(2008-12#1)(2008-3#1)
the optimum values##5##3##(1997-6#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)
the optimum wavelengths##2##3##(2006-5#1)(2008-2#1)
the optimum working conditions##4##4##(2008-10#4)
the optimum##294##2##(1990-2#1)(1990-3#1)(1990-7#3)(1991-11#1)(1992-12#1)(1992-2#4)(1992-5#1)(1992-8#1)(1993-5#1)(1994-12#1)(1994-3#2)(1996-12#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-3#3)(1997-6#1)(2004-1#1)(2004-11#1)(2004-2#1)(2005-11#1)(2005-4#1)(2005-5#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-7#1)(2007-10#4)(2007-11#6)(2007-12#13)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#123)(2008-11#2)(2008-12#6)(2008-2#16)(2008-3#27)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#4)(2009-5#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-12#1)(2011-2#3)(2012-12#5)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#2)
the optimums##2##2##(2008-10#1)(2010-10#1)
the option of##15##3##(1994-12#1)(1997-3#1)(2004-9#1)(2006-2#1)(2006-7#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)
the option to##2##3##(1994-12#1)(2012-3#1)
the option##20##2##(1994-12#2)(1997-3#1)(2004-9#1)(2006-2#1)(2006-7#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#2)
the optional##2##2##(1996-5#1)(2008-10#1)
the options available to##2##4##(2007-7#1)(2009-5#1)
the options available##5##3##(1992-12#1)(2005-5#1)(2007-7#1)(2008-11#1)(2009-5#1)
the options for##6##3##(2006-10#2)(2007-11#1)(2008-4#2)(2013-8#1)
the options of##2##3##(2009-4#1)(2010-7#1)
the options##20##2##(1992-12#1)(1996-1#1)(2005-5#1)(2006-10#2)(2006-9#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#2)(2009-4#1)(2009-5#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-8#1)
the optode##8##2##(2008-10#8)
the optoelectronic chips##2##3##(2008-2#2)
the optoelectronic imaging##2##3##(2008-3#2)
the optoelectronic##11##2##(2008-2#7)(2008-3#4)
the optogeometrical parameters of##2##4##(2008-3#2)
the optomotor##3##2##(2007-12#2)(2008-8#1)
the oracle property##2##3##(2010-1#2)
the oral administration of##7##4##(1990-6#1)(1990-7#1)(1992-9#1)(1993-9#1)(2008-11#1)(2010-10#1)(2012-2#1)
the oral agents##2##3##(2008-1#1)(2010-10#1)
the oral and maxillofacial surgeon##5##5##(2007-12#4)(2008-7#1)
the oral and maxillofacial surgery##4##5##(2007-12#3)(2008-7#1)
the oral and maxillofacial##12##4##(2007-12#8)(2008-7#3)(2012-12#1)
the oral and##15##3##(2007-12#8)(2008-7#3)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
the oral anticoagulants group##2##4##(1993-7#2)
the oral bacterium##2##3##(1990-12#1)(1991-1#1)
the oral bioavailability of Drug X##2##6##(2009-4#2)
the oral cavity and pharynx##4##5##(1995-5#1)(2009-10#1)(2013-1#2)
the oral cavity and##9##4##(1993-12#1)(1995-5#1)(2008-12#1)(2009-10#1)(2011-1#2)(2012-3#1)(2013-1#2)
the oral cavity is##5##4##(2005-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the oral cavity of##6##4##(1995-9#1)(2007-7#1)(2013-1#4)
the oral cavity or##3##4##(1991-6#1)(1995-8#1)(2007-12#1)
the oral cavity that##2##4##(1991-5#1)(2012-1#1)
the oral cavity##70##3##(1990-1#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-8#1)(1993-12#1)(1994-2#1)(1995-5#1)(1995-8#2)(1995-9#1)(1997-4#1)(2005-11#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-12#3)(2007-7#2)(2007-9#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-10#2)(2010-7#2)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#10)(2013-7#1)(2013-8#1)
the oral cavity]##3##3##(1990-10#1)(1997-4#1)(2007-9#1)
the oral commissure##2##3##(2008-8#1)(2012-12#1)
the oral delivery of LMWH##2##5##(2007-8#2)
the oral delivery of insulin##3##5##(2008-5#1)(2011-1#2)
the oral delivery of##6##4##(2007-8#2)(2008-5#1)(2008-8#1)(2011-1#2)
the oral dose of##3##4##(1993-4#1)(2006-6#1)(2008-6#1)
the oral dyskinesia##3##3##(1991-8#3)
the oral environment##3##3##(2007-12#1)(2008-11#1)(2013-1#1)
the oral form##3##3##(2005-8#1)(2008-11#1)(2009-1#1)
the oral formulation##3##3##(2005-8#1)(2008-3#1)(2008-5#1)
the oral glucose tolerance test##2##5##(1992-8#1)(2009-3#1)
the oral health of##4##4##(2008-9#1)(2009-4#1)(2010-4#1)(2012-3#1)
the oral health##5##3##(2007-2#1)(2008-9#1)(2009-4#1)(2010-4#1)(2012-3#1)
the oral health-related quality of##2##5##(2011-2#1)(2011-7#1)
the oral health-related##3##3##(2011-2#1)(2011-7#1)(2012-12#1)
the oral lesions##2##3##(2006-2#1)(2013-7#1)
the oral management of##2##4##(2005-8#1)(2008-5#1)
the oral manifestations##3##3##(2006-2#1)(2006-8#1)(2007-7#1)
the oral mucosa##9##3##(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#1)(1993-1#1)(2007-7#1)(2010-12#1)(2010-4#1)(2013-8#1)
the oral polio vaccine##2##4##(2007-10#1)(2008-8#1)
the oral positive control##2##4##(2010-5#2)
the oral route##9##3##(1991-10#1)(1991-11#1)(1992-11#1)(2005-1#2)(2007-1#1)(2008-4#1)(2009-4#1)(2012-12#1)
the oral temperature##2##3##(1990-2#2)
the oral vaccine##2##3##(1996-10#1)(2005-11#1)
the oral##220##2##(1990-1#1)(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#3)(1992-11#1)(1992-5#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-12#1)(1993-4#1)(1993-7#2)(1993-9#1)(1994-11#1)(1994-2#1)(1995-5#2)(1995-8#2)(1995-9#1)(1996-10#1)(1996-5#1)(1997-4#2)(2005-1#3)(2005-11#3)(2005-8#3)(2006-2#3)(2006-4#1)(2006-6#2)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#1)(2007-12#15)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#4)(2007-8#3)(2007-9#4)(2008-1#2)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#11)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#3)(2009-1#1)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#5)(2009-9#1)(2010-10#2)(2010-12#1)(2010-4#3)(2010-5#3)(2010-7#2)(2011-1#5)(2011-2#7)(2011-7#1)(2012-1#3)(2012-12#7)(2012-2#6)(2012-3#6)(2013-1#13)(2013-7#3)(2013-8#8)
the orange juice phase##4##4##(2007-8#4)
the orange peel##2##3##(2008-5#2)
the orange##7##2##(2007-8#4)(2008-10#1)(2008-5#2)
the orange-spotted grouper##3##3##(2010-5#3)
the orbit and frontal sinus##3##5##(2011-2#3)
the orbit##21##2##(1996-6#1)(2006-12#2)(2008-10#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-2#2)(2009-9#1)(2010-10#1)(2010-12#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
the orbital angular momentum##2##4##(2007-11#2)
the orbital cavity##2##3##(2008-8#1)(2013-1#1)
the orbital roof##2##3##(2006-12#1)(2009-2#1)
the orbital septum##2##3##(2010-12#2)
the orbital##15##2##(1997-7#1)(2006-12#2)(2007-11#2)(2007-9#1)(2008-4#3)(2008-8#1)(2009-2#1)(2010-12#2)(2011-2#1)(2013-1#1)
the orbitofrontal and##2##3##(2011-2#1)(2012-12#1)
the orbitofrontal cortex and##3##4##(2009-10#2)(2011-1#1)
the orbitofrontal cortex##8##3##(2006-9#1)(2008-11#1)(2009-10#4)(2011-1#1)(2012-12#1)
the orbitofrontal##10##2##(2006-9#1)(2008-11#1)(2009-10#4)(2011-1#1)(2011-2#1)(2012-12#2)
the orbitopterional approach in##2##4##(2011-2#2)
the orbitozygomatic craniotomy##2##3##(2006-12#2)
the orbitozygomatic##3##2##(2006-12#2)(2008-7#1)
the orbits##4##2##(1991-6#1)(2011-2#2)(2013-8#1)
the orchard and##3##3##(2008-10#3)
the orchard experiments##2##3##(2008-10#2)
the orchard floor##6##3##(2008-10#6)
the orchard##29##2##(2008-10#29)
the orchards and##2##3##(2008-10#2)
the orchards##5##2##(2008-10#5)
the orchid##8##2##(1997-4#4)(2007-3#1)(2008-10#1)(2012-2#1)(2013-8#1)
the orchid-bee fauna##2##3##(2008-6#2)
the order Desulfarculales##2##3##(2011-2#2)
the order Spirochaetales##2##3##(2008-9#1)(2013-8#1)
the order in the##4##4##(2008-10#3)(2008-5#1)
the order in which##3##4##(2007-1#1)(2008-4#1)(2008-8#1)
the order in##7##3##(2007-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#1)
the order of 0##12##4##(1990-4#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2010-9#1)(2013-1#1)
the order of 1##16##4##(1996-1#1)(1996-3#1)(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#3)(2008-8#1)(2008-9#1)(2009-7#1)(2010-9#1)
the order of 1%##3##4##(1993-11#1)(2007-12#1)(2008-2#1)
the order of 1&gt##2##4##(2007-12#1)(2008-10#1)
the order of 10##11##4##(1995-11#1)(1995-6#1)(2006-2#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-12#1)(2010-7#1)(2010-9#1)
the order of 10(-4)##2##4##(2008-3#1)(2010-4#1)
the order of 100##12##4##(1996-4#2)(2006-4#1)(2006-5#2)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#2)(2008-7#1)
the order of 5##6##4##(1992-2#1)(2006-4#1)(2007-12#1)(2008-2#1)(2008-3#2)
the order of a few##6##5##(2007-12#1)(2008-2#1)(2008-3#3)(2009-11#1)
the order of a##7##4##(2007-12#1)(2008-2#1)(2008-3#3)(2009-11#1)(2009-5#1)
the order of approximately##2##4##(2008-10#1)(2008-2#1)
the order of decreasing molecular##2##5##(1994-9#1)(2008-4#1)
the order of genes##2##4##(1993-12#1)(1994-3#1)
the order of hours##2##4##(1990-3#1)(2011-2#1)
the order of introduction##2##4##(2008-10#1)(2012-2#1)
the order of less than##3##5##(2008-10#1)(2008-11#1)(2008-3#1)
the order of magnitude of the##5##6##(1997-8#1)(2005-11#1)(2007-12#1)(2008-3#2)
the order of magnitude of##7##5##(1993-3#1)(1997-8#1)(2005-11#1)(2007-12#1)(2008-3#3)
the order of only##2##4##(2007-12#1)(2008-10#1)
the order of oxidations##2##4##(1991-2#2)
the order of several##6##4##(1995-3#1)(1997-6#1)(2008-2#2)(2008-3#2)
the order of substrate preference was collagen##2##7##(1992-11#2)
the order of tens of##5##5##(2007-12#3)(2008-10#1)(2008-3#1)
the order of the GRIN profile##2##6##(2010-4#2)
the order of the##27##4##(1990-4#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-9#2)(1996-10#1)(1996-3#1)(1996-6#1)(1997-1#1)(2006-12#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#1)(2010-1#1)(2010-4#2)(2011-1#1)(2013-8#1)
the order of##289##3##(1990-11#4)(1990-12#2)(1990-3#1)(1990-4#3)(1990-8#2)(1990-9#1)(1991-1#1)(1991-2#3)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#2)(1992-11#3)(1992-2#1)(1992-3#1)(1992-7#1)(1992-9#4)(1993-11#1)(1993-12#1)(1993-3#1)(1993-7#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-6#2)(1994-9#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-3#2)(1996-4#2)(1996-5#2)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#8)(2005-4#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-5#2)(2006-6#1)(2007-11#7)(2007-12#32)(2007-4#1)(2007-5#1)(2007-7#2)(2007-9#1)(2008-1#3)(2008-10#30)(2008-11#1)(2008-12#1)(2008-2#26)(2008-3#41)(2008-4#4)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-4#4)(2010-7#1)(2010-9#3)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#3)
the order parameter##6##3##(1990-12#1)(1990-2#1)(1992-9#1)(1995-8#1)(1997-1#1)(2008-9#1)
the order##399##2##(1990-10#1)(1990-11#4)(1990-12#4)(1990-2#1)(1990-3#2)(1990-4#3)(1990-5#1)(1990-8#2)(1990-9#2)(1991-1#2)(1991-11#1)(1991-2#4)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#2)(1991-8#2)(1992-1#2)(1992-11#3)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#6)(1993-11#1)(1993-12#2)(1993-3#1)(1993-7#2)(1993-8#2)(1993-9#1)(1994-12#4)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#3)(1994-9#2)(1995-11#3)(1995-12#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#3)(1996-6#1)(1996-7#4)(1997-1#4)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2005-11#11)(2005-12#1)(2005-4#2)(2006-1#1)(2006-10#1)(2006-12#4)(2006-2#1)(2006-4#2)(2006-5#2)(2006-6#1)(2007-1#1)(2007-11#7)(2007-12#36)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-9#1)(2008-1#3)(2008-10#49)(2008-11#1)(2008-12#1)(2008-2#28)(2008-3#44)(2008-4#5)(2008-5#9)(2008-6#3)(2008-7#3)(2008-8#8)(2008-9#4)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#3)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-4#6)(2010-5#1)(2010-7#1)(2010-9#3)(2011-1#3)(2011-2#8)(2012-1#1)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#5)
the ordered##10##2##(1990-11#1)(1990-5#1)(1991-5#1)(1992-11#1)(1995-5#1)(1996-12#1)(2005-11#2)(2006-10#1)(2006-5#1)
the ordering of the##2##4##(1993-11#1)(2008-10#1)
the ordering of##5##3##(1993-11#1)(1996-3#1)(2008-10#2)(2013-1#1)
the ordering##6##2##(1993-11#1)(1996-3#1)(2008-10#2)(2008-2#1)(2013-1#1)
the orderly##4##2##(1990-12#1)(1991-3#1)(2008-8#1)(2009-6#1)
the orders of##4##3##(1993-6#2)(2006-5#1)(2006-7#1)
the orders##8##2##(1993-6#2)(2006-5#1)(2006-7#1)(2007-12#1)(2007-3#1)(2008-4#1)(2011-2#1)
the ordinal##4##2##(1993-6#1)(1995-9#1)(1997-4#1)(2012-1#1)
the ordinary and##3##3##(2008-10#1)(2008-2#2)
the ordinary serous##2##3##(2008-7#2)
the ordinary##31##2##(1990-4#1)(1991-6#1)(1992-6#2)(1993-3#1)(1997-2#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-6#1)(2007-12#4)(2008-10#3)(2008-12#1)(2008-2#5)(2008-3#2)(2008-6#1)(2008-7#3)(2008-8#1)(2010-12#1)
the ordinate##2##2##(2008-10#1)(2008-2#1)
the organ distribution of##2##4##(1992-9#1)(2006-10#1)
the organ donation##2##3##(1993-10#1)(2008-12#1)
the organ in##3##3##(1993-10#1)(2008-9#1)(2010-12#1)
the organ of Corti##4##4##(1993-9#2)(1994-6#1)(1996-3#1)
the organ of##5##3##(1993-9#2)(1994-6#1)(1996-3#1)(2009-2#1)
the organ##42##2##(1990-10#2)(1990-11#1)(1990-12#1)(1991-5#1)(1992-9#1)(1993-10#2)(1993-8#1)(1993-9#2)(1994-6#1)(1996-3#1)(1996-9#1)(2006-10#3)(2007-4#1)(2007-7#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#3)(2009-2#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
the organ-specific##2##2##(1990-10#1)(2011-2#1)
the organelle##4##2##(1994-8#1)(1996-5#1)(2008-10#1)(2011-2#1)
the organelles of##2##3##(2005-7#1)(2009-3#1)
the organelles##7##2##(1991-1#1)(1995-6#1)(2005-7#1)(2007-12#1)(2008-7#1)(2009-3#1)(2009-8#1)
the organic acids##2##3##(1992-3#1)(2008-10#1)
the organic and aqueous phases##2##5##(2005-11#1)(2008-10#1)
the organic and##3##3##(2005-11#1)(2008-10#1)(2010-4#1)
the organic components##2##3##(2008-10#1)(2010-7#1)
the organic compound##2##3##(2010-5#1)(2011-1#1)
the organic compounds##4##3##(2008-10#4)
the organic constituents##2##3##(2008-10#1)(2008-7#1)
the organic fraction of the##2##5##(2008-10#1)(2008-5#1)
the organic fraction of##4##4##(2008-10#3)(2008-5#1)
the organic fraction##5##3##(2008-10#4)(2008-5#1)
the organic ionic salt##2##4##(2007-12#2)
the organic layer##4##3##(2008-10#3)(2010-4#1)
the organic liquid##2##3##(2005-11#1)(2008-10#1)
the organic matrix##7##3##(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-7#1)(2013-8#1)
the organic matter content##2##4##(2008-10#1)(2008-5#1)
the organic matter##4##3##(1993-9#1)(2008-10#1)(2008-11#1)(2008-5#1)
the organic modifier##3##3##(1994-9#1)(1996-5#1)(2007-8#1)
the organic phase and##4##4##(1996-8#1)(2007-8#1)(2008-10#2)
the organic phase in the##3##5##(2005-11#2)(2008-10#1)
the organic phase is##2##4##(2008-10#1)(2010-4#1)
the organic phase was##5##4##(1992-10#1)(1993-2#1)(2005-11#1)(2008-10#2)
the organic phase with##3##4##(2008-10#3)
the organic phase##40##3##(1992-10#1)(1993-2#1)(1994-3#1)(1994-8#1)(1996-8#1)(2005-11#4)(2007-8#1)(2008-10#25)(2008-7#1)(2010-4#1)(2010-5#3)
the organic salt##3##3##(2007-12#3)
the organic solvent and##2##4##(1996-5#1)(2008-10#1)
the organic solvent used##2##4##(1997-8#1)(2008-10#1)
the organic solvent##15##3##(1992-3#1)(1994-12#1)(1996-5#1)(1997-1#1)(1997-8#1)(2008-10#10)
the organic species##2##3##(2007-8#1)(2008-10#1)
the organic##165##2##(1990-6#1)(1990-7#1)(1990-9#1)(1991-9#1)(1992-10#1)(1992-3#2)(1993-2#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-6#2)(1996-5#3)(1996-8#1)(1997-1#1)(1997-8#1)(2005-11#7)(2006-10#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#10)(2007-5#1)(2007-7#2)(2007-8#6)(2007-9#2)(2008-10#72)(2008-11#3)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#1)(2009-2#1)(2009-7#1)(2010-12#1)(2010-4#5)(2010-5#4)(2010-7#1)(2011-1#1)(2011-12#1)(2012-8#1)(2013-1#1)(2013-7#1)(2013-8#2)
the organisation and##2##3##(1993-7#1)(2011-1#1)
the organisation of##7##3##(1990-11#1)(1990-5#1)(1995-6#1)(1996-12#1)(2005-5#2)(2006-12#1)
the organisation##18##2##(1990-11#1)(1990-5#1)(1993-7#1)(1995-6#1)(1996-12#1)(2005-5#3)(2006-12#1)(2006-6#1)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#2)(2011-1#1)(2012-2#1)
the organisation's##4##2##(2007-2#1)(2008-12#1)(2008-7#2)
the organisational and##2##3##(2004-7#1)(2008-11#1)
the organisational##5##2##(2004-7#1)(2005-5#1)(2006-2#1)(2008-11#1)(2008-7#1)
the organisations##2##2##(2007-2#1)(2010-3#1)
the organised##2##2##(1995-5#1)(2011-1#1)
the organisers##2##2##(2006-2#1)(2007-10#1)
the organism against##2##3##(1995-5#1)(2008-7#1)
the organism and for##2##4##(2006-7#1)(2008-5#1)
the organism and the##2##4##(1996-9#1)(2009-12#1)
the organism and##10##3##(1994-5#1)(1995-2#1)(1996-9#1)(2005-1#1)(2006-7#1)(2008-4#1)(2008-5#1)(2009-12#1)(2011-2#1)(2013-8#1)
the organism are##2##3##(1991-6#1)(2006-10#1)
the organism as##3##3##(1992-4#1)(2008-11#1)(2008-7#1)
the organism can##2##3##(1995-8#1)(2008-9#1)
the organism in##4##3##(1991-11#1)(1996-11#1)(1997-1#1)(2009-5#1)
the organism is##10##3##(1996-9#1)(2005-7#1)(2005-8#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2011-2#2)
the organism that##3##3##(1995-8#1)(2006-8#1)(2010-12#1)
the organism to##6##3##(1990-8#1)(1996-2#1)(1997-6#1)(2009-10#1)(2010-2#2)
the organism was##4##3##(2006-8#1)(2007-12#1)(2008-5#2)
the organism with##3##3##(2008-10#2)(2012-1#1)
the organism##137##2##(1990-8#1)(1991-11#1)(1991-6#2)(1991-9#1)(1992-4#1)(1993-2#1)(1994-11#1)(1994-5#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-9#4)(1997-1#1)(1997-6#2)(1997-8#1)(2005-1#3)(2005-12#2)(2005-7#2)(2005-8#2)(2006-10#4)(2006-11#1)(2006-12#2)(2006-7#2)(2006-8#2)(2007-11#1)(2007-12#6)(2007-2#1)(2007-7#3)(2008-1#2)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#3)(2008-5#7)(2008-7#7)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#2)(2009-8#2)(2010-11#4)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#4)(2011-1#1)(2011-2#13)(2012-1#2)(2012-3#1)(2013-1#1)(2013-8#2)
the organism's ability to##3##4##(2008-9#1)(2011-2#1)(2012-1#1)
the organism's##9##2##(1994-11#1)(1994-8#1)(2006-11#2)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)
the organismal##3##2##(2009-5#1)(2010-5#1)(2012-12#1)
the organisms in##3##3##(2006-8#1)(2008-7#1)(2013-8#1)
the organisms were##4##3##(2008-10#1)(2008-11#1)(2011-12#1)(2013-1#1)
the organisms##33##2##(1991-10#1)(1992-6#1)(1996-9#1)(2004-4#2)(2006-8#1)(2007-12#1)(2007-3#1)(2007-7#3)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#2)
the organization and##19##3##(1990-2#1)(1993-12#2)(1993-6#1)(1994-11#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#2)(2010-1#1)(2010-9#1)(2012-1#1)(2012-2#2)
the organization as well as##2##5##(1995-2#1)(2009-8#1)
the organization as##3##3##(1995-2#1)(2008-1#1)(2009-8#1)
the organization by##2##3##(1992-2#1)(2008-7#1)
the organization in the##2##4##(1993-12#1)(1994-2#1)
the organization in##3##3##(1993-12#1)(1994-2#1)(2008-10#1)
the organization is##4##3##(1992-2#1)(1992-9#1)(1993-1#1)(2008-7#1)
the organization must##2##3##(1994-2#1)(1995-2#1)
the organization of a##2##4##(1995-11#1)(2006-10#1)
the organization of the central##2##5##(1995-5#1)(2007-12#1)
the organization of the gene##2##5##(1994-11#1)(2010-4#1)
the organization of the##37##4##(1991-3#1)(1991-5#1)(1992-3#2)(1992-9#1)(1993-12#1)(1993-9#2)(1994-11#1)(1994-5#1)(1994-6#1)(1995-5#3)(1996-4#2)(1997-3#1)(2006-10#1)(2006-6#1)(2007-12#6)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-10#2)(2009-4#1)(2009-5#1)(2010-4#1)(2011-2#1)(2013-8#2)
the organization of these##2##4##(2008-2#1)(2008-7#1)
the organization of this complex##2##5##(2006-8#1)(2009-8#1)
the organization of this##3##4##(1993-6#1)(2006-8#1)(2009-8#1)
the organization of##88##3##(1990-10#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#3)(1995-5#6)(1996-4#2)(1996-5#1)(1997-3#1)(1997-8#1)(2006-10#3)(2006-6#1)(2006-8#1)(2007-12#9)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#3)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-6#2)(2011-11#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#3)
the organization on##2##3##(1994-1#1)(2007-4#1)
the organization through the##3##4##(1993-12#1)(1995-12#2)
the organization to##2##3##(1992-3#1)(2008-8#1)
the organization was##2##3##(1991-2#1)(2007-9#1)
the organization##192##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#3)(1992-3#3)(1992-5#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-12#5)(1993-2#3)(1993-3#1)(1993-6#2)(1993-9#2)(1994-1#7)(1994-11#2)(1994-12#1)(1994-2#6)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#3)(1995-11#3)(1995-12#4)(1995-2#3)(1995-3#7)(1995-5#6)(1996-1#3)(1996-12#1)(1996-2#2)(1996-3#3)(1996-4#2)(1996-5#1)(1997-1#3)(1997-2#3)(1997-3#1)(1997-8#1)(2004-12#1)(2006-1#1)(2006-10#4)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#4)(2007-12#9)(2007-2#1)(2007-4#3)(2007-9#2)(2008-1#2)(2008-10#6)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#4)(2009-10#3)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-4#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#3)(2011-11#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#3)
the organization's bottom line##3##4##(2008-9#3)
the organization's image##2##3##(2008-11#1)(2008-12#1)
the organization's##16##2##(1990-12#3)(1993-1#3)(1996-2#1)(2006-5#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#3)(2011-2#1)
the organization)##2##2##(2008-11#2)
the organizational and##4##3##(1992-2#1)(2007-10#1)(2007-12#1)(2008-11#1)
the organizational context##2##3##(2010-8#1)(2012-3#1)
the organizational culture of##2##4##(2009-8#1)(2011-1#1)
the organizational culture##3##3##(2009-8#1)(2011-1#1)(2011-2#1)
the organizational level##3##3##(1994-12#1)(1996-3#1)(2007-10#1)
the organizational structure of##2##4##(1995-3#1)(2007-12#1)
the organizational structure##4##3##(1990-12#1)(1995-3#1)(1995-8#1)(2007-12#1)
the organizational##35##2##(1990-12#1)(1992-12#2)(1992-2#1)(1993-1#1)(1993-12#1)(1994-12#1)(1995-3#2)(1995-8#1)(1996-12#2)(1996-2#2)(1996-3#1)(2005-9#1)(2007-10#2)(2007-12#2)(2007-3#1)(2008-11#2)(2008-12#2)(2008-2#1)(2009-7#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)
the organizations and##2##3##(2011-2#1)(2013-1#1)
the organizations responsible for##2##4##(2008-11#1)(2008-8#1)
the organizations##8##2##(1994-12#1)(1996-12#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
the organized training##2##3##(1993-8#2)
the organized##4##2##(1993-8#2)(2008-10#1)(2010-12#1)
the organochlorine##2##2##(1990-4#1)(2008-10#1)
the organogenesis##2##2##(2008-4#1)(2011-2#1)
the organoleptic##2##2##(2008-5#1)(2013-8#1)
the organolithium##2##2##(1996-5#2)
the organomercury##2##2##(1990-12#1)(2008-10#1)
the organophosphate##2##2##(2012-12#1)(2013-8#1)
the organophosphorus##2##2##(1997-4#1)(2008-11#1)
the organotin##5##2##(2005-4#1)(2008-10#1)(2008-3#1)(2008-5#2)
the organs and##2##3##(2007-11#1)(2009-6#1)
the organs involved##3##3##(1991-5#1)(2008-10#1)(2010-12#1)
the organs of##4##3##(1990-8#1)(2004-2#1)(2007-8#1)(2008-7#1)
the organs##20##2##(1990-1#1)(1990-4#1)(1990-8#1)(1991-5#1)(1997-3#1)(1997-6#1)(2004-11#2)(2004-2#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-5#1)(2013-8#1)
the ori beta region##2##4##(1994-12#2)
the ori##3##2##(1994-12#2)(1996-6#1)
the oriC-deleted##2##2##(1997-4#2)
the oriental fruit fly##2##4##(1997-1#1)(2011-2#1)
the oriental fruit##3##3##(1997-1#1)(2011-12#1)(2011-2#1)
the oriental##4##2##(1997-1#1)(2008-6#1)(2011-12#1)(2011-2#1)
the orientation and##5##3##(1991-6#1)(1997-7#1)(2006-2#1)(2008-10#1)(2008-3#1)
the orientation component of##2##4##(1990-3#2)
the orientation of a##4##4##(1990-10#1)(2006-5#1)(2008-2#2)
the orientation of caldesmon##2##4##(1994-5#2)
the orientation of its##3##4##(1992-7#1)(2008-3#2)
the orientation of partially polarized light##2##6##(2008-3#2)
the orientation of the field of view##2##7##(2008-5#2)
the orientation of the field##3##5##(2008-3#1)(2008-5#2)
the orientation of the lipid##2##5##(1996-1#1)(2010-5#1)
the orientation of the local##2##5##(2007-12#1)(2008-4#1)
the orientation of the polarization ellipse##2##6##(2007-12#2)
the orientation of the polarization##3##5##(2007-12#2)(2008-2#1)
the orientation of the proximal##2##5##(1991-7#1)(2007-5#1)
the orientation of the##46##4##(1991-2#1)(1991-7#1)(1992-6#1)(1993-11#1)(1995-4#1)(1996-1#1)(1996-4#1)(1997-2#1)(1997-7#2)(2005-11#1)(2006-11#1)(2006-4#1)(2007-11#5)(2007-12#5)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#1)(2009-12#1)(2010-5#2)(2013-7#1)(2013-8#1)
the orientation of##81##3##(1990-10#1)(1991-10#1)(1991-2#1)(1991-7#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-11#1)(1994-2#1)(1994-5#4)(1994-9#1)(1995-4#1)(1996-1#2)(1996-4#1)(1996-8#1)(1997-2#1)(1997-7#2)(2005-11#2)(2006-11#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#6)(2007-12#5)(2007-4#1)(2007-5#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#6)(2008-3#12)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-12#1)(2010-5#2)(2011-1#1)(2012-12#2)(2013-7#1)(2013-8#1)
the orientation##102##2##(1990-10#1)(1990-11#1)(1990-3#2)(1991-10#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-5#4)(1994-9#1)(1995-10#1)(1995-3#1)(1995-4#1)(1996-1#2)(1996-4#1)(1996-8#1)(1997-2#1)(1997-7#3)(2005-11#2)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#6)(2007-12#5)(2007-4#1)(2007-5#1)(2008-1#2)(2008-10#3)(2008-11#4)(2008-2#8)(2008-3#14)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-2#2)(2010-5#2)(2011-1#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
the orientational distribution##2##3##(2006-10#1)(2008-3#1)
the orientational order##2##3##(1990-2#2)
the orientational##10##2##(1990-2#2)(1994-11#1)(1995-11#1)(1996-8#1)(2006-10#2)(2006-12#1)(2008-2#1)(2008-3#1)
the orientations of the##3##4##(1997-4#1)(2007-11#1)(2010-5#1)
the orientations of##7##3##(1995-11#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-7#1)(2010-5#1)
the orientations##8##2##(1995-11#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-7#1)(2010-5#1)(2011-2#1)
the oriented##3##2##(1995-10#1)(2007-9#1)(2008-2#1)
the orifice##6##2##(1995-11#1)(2008-5#4)(2013-1#1)
the origin and evolution of the##2##6##(2008-5#1)(2012-2#1)
the origin and evolution of##5##5##(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)
the origin and histology of##2##5##(2006-10#1)(2008-11#1)
the origin and history of##2##5##(2007-8#1)(2008-11#1)
the origin and the##6##4##(1993-12#1)(1993-6#1)(2008-10#1)(2008-2#1)(2011-2#1)(2012-3#1)
the origin and##36##3##(1992-12#1)(1993-12#1)(1993-6#1)(1995-11#1)(1995-8#1)(1997-1#1)(2006-10#1)(2006-5#2)(2006-7#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#3)(2009-2#1)(2011-1#3)(2011-2#2)(2012-2#1)(2012-3#2)
the origin of a##3##4##(1997-6#1)(2009-2#1)(2010-12#1)
the origin of all##2##4##(1996-9#1)(2007-12#1)
the origin of chromosomal instability in##2##6##(2008-8#2)
the origin of life##7##4##(1994-6#1)(1995-11#1)(2006-12#1)(2007-8#1)(2008-10#2)(2010-7#1)
the origin of novel inheritable variations was a major obstacle to acceptance of natural selection (Bowler##2##16##(2012-12#2)
the origin of replication of the##2##6##(1990-11#1)(1995-8#1)
the origin of replication##8##4##(1990-11#1)(1993-11#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-3#2)(1995-8#1)
the origin of the dorsal fin##2##6##(2008-5#2)
the origin of the expression##2##5##(2004-3#2)
the origin of the left##3##5##(2006-6#1)(2007-7#1)(2013-8#1)
the origin of the##69##4##(1990-7#1)(1991-3#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-11#1)(1995-6#1)(1996-3#1)(1996-4#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-3#2)(2005-12#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#3)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-12#1)(2008-2#6)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#2)(2009-3#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-8#1)
the origin of these species##2##5##(1996-6#1)(2010-3#1)
the origin of these##6##4##(1995-1#1)(1996-6#1)(2006-10#1)(2006-9#1)(2008-3#1)(2010-3#1)
the origin of this##8##4##(1994-11#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
the origin of##195##3##(1990-11#1)(1990-3#2)(1990-7#2)(1990-8#2)(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#3)(1994-3#3)(1994-6#2)(1994-8#1)(1995-1#2)(1995-11#4)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#3)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#2)(1997-6#2)(1997-8#2)(2004-3#2)(2005-12#1)(2006-10#3)(2006-11#1)(2006-12#3)(2006-2#1)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#2)(2007-11#3)(2007-12#7)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#5)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#8)(2009-2#1)(2009-3#1)(2009-6#2)(2009-8#1)(2010-1#2)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#9)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#4)
the origin or##2##3##(2008-10#1)(2011-1#1)
the origin##248##2##(1990-11#2)(1990-3#2)(1990-4#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-12#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#3)(1994-3#3)(1994-6#2)(1994-8#1)(1995-1#2)(1995-11#5)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#3)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#3)(1997-3#2)(1997-4#2)(1997-6#2)(1997-8#3)(2004-3#2)(2005-12#1)(2006-10#4)(2006-11#1)(2006-12#3)(2006-2#1)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#1)(2006-9#3)(2007-11#4)(2007-12#7)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#22)(2008-11#6)(2008-12#2)(2008-2#8)(2008-3#6)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#9)(2008-9#4)(2009-2#2)(2009-3#1)(2009-6#2)(2009-8#1)(2010-1#2)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#7)(2011-12#1)(2011-2#6)(2012-1#2)(2012-12#9)(2012-2#4)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#4)
the origin(s) of genotype-environment interaction##2##5##(2009-2#2)
the original 16##2##3##(1994-2#1)(2008-5#1)
the original DNA##2##3##(1995-3#1)(2008-10#1)
the original N##2##3##(2008-10#2)
the original activity##3##3##(2006-10#1)(2008-10#1)(2008-5#1)
the original algorithm##2##3##(2008-10#1)(2008-2#1)
the original american##2##3##(2006-10#2)
the original and reduced datasets##2##5##(2007-8#2)
the original and the##4##4##(2008-10#1)(2008-2#1)(2008-3#2)
the original and##10##3##(1996-12#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2009-4#1)
the original antibody##2##3##(1994-12#1)(2012-2#1)
the original antigen##2##3##(1994-12#1)(2008-4#1)
the original calibration set##2##4##(2007-11#2)
the original cell population##2##4##(2007-6#1)(2008-7#1)
the original cell##3##3##(1990-3#1)(2007-6#1)(2008-7#1)
the original clone##3##3##(2008-11#3)
the original compound##2##3##(2007-11#1)(2008-9#1)
the original concentration of##2##4##(2008-10#2)
the original concentration##4##3##(2008-10#3)(2010-3#1)
the original concept of##2##4##(2010-12#1)(2012-12#1)
the original data##15##3##(1995-5#1)(2006-10#1)(2007-12#1)(2008-10#7)(2008-3#2)(2008-8#2)(2012-1#1)
the original description of##3##4##(2008-10#1)(2008-12#1)(2012-3#1)
the original description##5##3##(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2012-3#1)
the original dissolved organic matter (DOM)##2##6##(2008-10#2)
the original family##2##3##(1995-5#2)
the original field##2##3##(2008-10#1)(2008-5#1)
the original form##2##3##(2007-5#1)(2008-10#1)
the original formulation##2##3##(2007-11#2)
the original host##2##3##(2008-10#1)(2008-8#1)
the original hypothesis##3##3##(2006-5#1)(2008-11#1)(2008-9#1)
the original image##7##3##(2007-11#1)(2008-2#5)(2010-9#1)
the original information##2##3##(2008-3#2)
the original level##5##3##(1990-2#1)(1992-1#1)(1992-9#1)(1994-5#1)(1996-7#1)
the original line##2##3##(2008-10#1)(2008-11#1)
the original method of##2##4##(2008-2#1)(2008-6#1)
the original method##4##3##(1992-4#1)(2007-12#1)(2008-2#1)(2008-6#1)
the original model##3##3##(2006-10#2)(2013-8#1)
the original mutation##2##3##(1991-12#1)(1994-10#1)
the original observations##3##3##(1995-2#1)(2008-11#1)(2012-1#1)
the original one##2##3##(1997-1#1)(2008-11#1)
the original plasmid##2##3##(1990-11#1)(1993-5#1)
the original population##2##3##(2008-10#2)
the original primary##3##3##(2010-6#1)(2010-9#1)(2012-12#1)
the original sample and the sample##2##6##(2008-10#2)
the original sample set##2##4##(2008-2#2)
the original sample##11##3##(1990-10#1)(1993-7#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#2)
the original scene##2##3##(2008-3#2)
the original sequence##2##3##(1994-12#1)(2008-3#1)
the original serum-free##2##3##(2008-11#2)
the original shape of a##2##5##(2006-12#1)(2008-3#1)
the original signal##5##3##(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#1)
the original source##2##3##(2007-12#1)(2008-3#1)
the original strain##6##3##(1990-7#1)(2008-10#2)(2008-5#3)
the original study##8##3##(1994-2#1)(1996-12#1)(2005-11#1)(2006-6#2)(2010-8#1)(2012-3#2)
the original technique##2##3##(2008-3#1)(2009-5#1)
the original tissue##2##3##(1990-4#1)(2009-6#1)
the original variety##3##3##(2012-11#3)
the original version##6##3##(1994-2#1)(2007-8#1)(2008-2#1)(2012-12#2)(2013-1#1)
the original virus##2##3##(1996-4#1)(2013-8#1)
the original##471##2##(1990-10#3)(1990-11#1)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-4#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-5#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#3)(1994-11#1)(1994-12#10)(1994-2#5)(1994-3#2)(1994-4#1)(1994-5#1)(1994-8#3)(1995-2#3)(1995-3#3)(1995-4#2)(1995-5#4)(1995-6#1)(1995-9#1)(1996-12#5)(1996-2#2)(1996-4#2)(1996-7#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-1#1)(2004-2#2)(2004-9#1)(2005-11#4)(2005-7#1)(2006-10#7)(2006-11#1)(2006-12#3)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#5)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#12)(2007-12#10)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#9)(2007-9#1)(2008-1#4)(2008-10#57)(2008-11#16)(2008-12#3)(2008-2#28)(2008-3#33)(2008-4#5)(2008-5#16)(2008-6#9)(2008-7#6)(2008-8#9)(2008-9#8)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#5)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#3)(2011-2#8)(2011-3#1)(2012-1#4)(2012-11#4)(2012-12#5)(2012-2#4)(2012-3#8)(2013-1#17)(2013-7#1)(2013-8#7)
the originality of the##2##4##(1992-6#1)(1997-2#1)
the originality##3##2##(1992-6#1)(1997-2#1)(2010-7#1)
the originally##8##2##(1990-5#1)(1990-8#1)(1992-1#1)(1992-2#1)(1994-12#1)(1994-6#1)(2008-3#1)(2009-11#1)
the origins of life##2##4##(2007-8#1)(2012-2#1)
the origins of modern##2##4##(2009-2#2)
the origins of the##6##4##(1995-1#1)(2005-10#1)(2008-11#1)(2009-10#1)(2009-4#1)(2012-1#1)
the origins of these##3##4##(1994-8#1)(2008-11#1)(2009-11#1)
the origins of this##2##4##(1992-8#1)(2013-7#1)
the origins of##42##3##(1990-7#2)(1991-6#1)(1992-8#1)(1993-2#1)(1994-8#1)(1995-1#1)(2005-10#1)(2005-9#1)(2006-3#1)(2006-7#2)(2007-12#3)(2007-8#1)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-2#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
the origins##49##2##(1990-7#2)(1991-6#1)(1992-8#1)(1993-2#1)(1994-8#1)(1995-1#1)(1996-12#1)(2005-10#1)(2005-9#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-7#2)(2007-12#3)(2007-8#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-2#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
the ornamental##2##2##(2008-10#1)(2008-8#1)
the ornithine decarboxylase activity in##2##5##(1994-6#1)(2010-9#1)
the ornithine decarboxylase activity##3##4##(1994-6#2)(2010-9#1)
the ornithine decarboxylase##4##3##(1991-3#1)(1994-6#2)(2010-9#1)
the ornithine##5##2##(1991-3#1)(1994-6#2)(2008-7#1)(2010-9#1)
the oro-hypopharynx##2##2##(2012-2#2)
the oro-pharynx##3##2##(2008-2#1)(2008-5#2)
the orocecal transit time##2##4##(1997-8#2)
the orofacial region##2##3##(1996-8#1)(2007-12#1)
the orofacial##4##2##(1996-8#1)(2007-12#1)(2009-11#1)(2012-2#1)
the oropharyngeal##6##2##(1995-6#1)(2007-7#1)(2011-1#1)(2012-12#1)(2013-1#2)
the oropharynx and##3##3##(2006-6#1)(2008-8#1)(2011-2#1)
the oropharynx##13##2##(1991-5#2)(2005-11#1)(2006-10#1)(2006-6#2)(2008-7#1)(2008-8#1)(2009-10#2)(2010-7#2)(2011-2#1)
the orotate##2##2##(1995-4#1)(1995-8#1)
the orphan nuclear receptor##2##4##(1995-11#1)(2012-12#1)
the orphan receptor##2##3##(1992-3#1)(1996-5#1)
the orphan##6##2##(1992-3#1)(1995-11#1)(1996-5#2)(2008-7#1)(2012-12#1)
the ortho##4##2##(1996-8#1)(2008-10#1)(2008-11#2)
the orthodontic treatment of##2##4##(2011-1#1)(2012-3#1)
the orthodontic treatment##5##3##(2011-1#1)(2012-12#2)(2012-3#1)(2013-8#1)
the orthodontic##7##2##(1991-5#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-8#2)
the orthodontist##2##2##(2007-12#1)(2013-7#1)
the orthodox##2##2##(2011-2#1)(2013-1#1)
the orthogonal polarization##4##3##(2007-12#1)(2008-2#3)
the orthogonal##15##2##(2006-12#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#3)(2008-2#4)(2011-1#1)
the orthogonality##2##2##(2008-3#2)
the orthogonally##2##2##(2007-11#1)(2007-12#1)
the orthographic-visual##2##2##(2012-1#2)
the ortholog##2##2##(2008-11#1)(2009-10#1)
the orthologous##7##2##(1993-9#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-3#1)(2011-1#1)
the orthopaedic surgeon##2##3##(2007-11#1)(2008-6#1)
the orthopaedic##8##2##(1990-9#1)(1993-8#1)(2004-9#1)(2007-11#1)(2008-6#1)(2010-3#1)(2012-12#1)(2013-8#1)
the orthopedic and psychiatric patients##2##5##(2006-10#2)
the orthopedic surgeon##10##3##(2007-11#1)(2007-7#1)(2008-8#1)(2009-3#2)(2009-4#2)(2009-8#1)(2009-9#1)(2012-12#1)
the orthopedic surgeons##2##3##(2007-11#1)(2009-9#1)
the orthopedic surgery##2##3##(2011-2#2)
the orthopedic##23##2##(2006-10#2)(2007-11#3)(2007-7#1)(2007-8#1)(2008-8#1)(2009-3#3)(2009-4#2)(2009-8#1)(2009-9#2)(2011-2#3)(2012-12#2)(2013-8#2)
the orthophosphate##3##2##(2008-10#2)(2010-2#1)
the orthorhombic space group P2(1)2(1)2(1)##5##5##(1994-9#1)(1996-2#3)(1997-6#1)
the orthorhombic space group##7##4##(1992-8#1)(1994-9#1)(1996-2#4)(1997-6#1)
the orthorhombic##12##2##(1992-12#1)(1992-8#1)(1993-8#1)(1994-9#1)(1996-2#4)(1997-6#1)(1997-7#1)(2008-8#1)(2013-8#1)
the os pubis##3##3##(2006-10#3)
the os##5##2##(2006-10#3)(2008-6#2)
the oscillating tails of##2##4##(2007-12#2)
the oscillating##13##2##(1992-7#1)(2005-11#1)(2007-12#2)(2008-10#5)(2008-3#1)(2008-7#1)(2009-9#1)(2011-2#1)
the oscillation amplitude##6##3##(2005-11#1)(2008-10#5)
the oscillation of##2##3##(2007-12#1)(2008-3#1)
the oscillation period and##2##4##(1996-5#1)(2008-10#1)
the oscillation period is##2##4##(2010-10#2)
the oscillation period##6##3##(1996-5#1)(2007-12#1)(2008-10#1)(2010-10#3)
the oscillation profile##2##3##(2009-12#2)
the oscillation threshold##3##3##(2007-12#2)(2008-3#1)
the oscillation##26##2##(1996-5#1)(1996-7#1)(2005-11#3)(2007-12#5)(2008-1#1)(2008-10#7)(2008-2#1)(2008-3#2)(2009-12#2)(2010-10#3)
the oscillations are##2##3##(2007-11#1)(2007-12#1)
the oscillations of##2##3##(1996-5#1)(2012-2#1)
the oscillations were##2##3##(1995-11#1)(1996-11#1)
the oscillations##18##2##(1994-11#1)(1995-11#1)(1996-11#1)(1996-5#2)(1997-1#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#4)(2012-2#1)
the oscillator and##3##3##(2008-3#3)
the oscillator to##3##3##(2007-12#2)(2008-1#1)
the oscillator##10##2##(1990-8#1)(2007-12#4)(2008-1#1)(2008-3#4)
the oscillatory behavior in continuous fermentation of Zymomonas mobilis##2##9##(2008-7#2)
the oscillatory behavior##4##3##(1992-7#1)(2008-3#1)(2008-7#2)
the oscillatory##17##2##(1991-7#1)(1992-7#1)(1995-11#1)(1995-5#1)(1996-3#1)(1997-1#1)(2006-10#2)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-6#1)(2010-8#1)
the osmium##5##2##(1992-2#1)(1996-2#2)(2008-10#1)(2010-6#1)
the osmolality of##2##3##(1990-3#1)(1992-5#1)
the osmolality##4##2##(1990-3#1)(1992-5#1)(1996-9#1)(2008-11#1)
the osmolarity of the growth medium##4##6##(1991-11#2)(1994-12#2)
the osmolarity of the growth##5##5##(1991-11#2)(1994-12#2)(1995-1#1)
the osmolarity of the##6##4##(1991-11#3)(1994-12#2)(1995-1#1)
the osmolarity##10##2##(1991-1#3)(1991-11#4)(1994-12#2)(1995-1#1)
the osmotic pressure##4##3##(2005-11#1)(2008-11#1)(2008-5#1)(2009-12#1)
the osmotic stress##2##3##(2008-11#1)(2013-1#1)
the osmotic##15##2##(1990-2#1)(1991-7#1)(1994-12#2)(1994-2#1)(2004-4#1)(2005-11#2)(2008-11#2)(2008-5#2)(2009-12#2)(2013-1#1)
the osseous tissue##3##3##(2006-6#2)(2011-2#1)
the osseous##7##2##(2006-6#2)(2007-11#1)(2010-5#1)(2011-2#1)(2013-7#2)
the ossicles##2##2##(2008-9#2)
the ossification##2##2##(1993-12#1)(2006-11#1)
the ossified cochlea##4##3##(2008-9#4)
the osteloclast-like giant cells##2##4##(2012-3#2)
the osteoarthritic##4##2##(2006-5#2)(2010-11#1)(2011-1#1)
the osteoblast##5##2##(1991-11#1)(1991-3#1)(1996-8#1)(2009-8#2)
the osteoblast-like##2##2##(1993-3#1)(1994-3#1)
the osteoblastic##3##2##(1994-2#1)(1994-6#1)(2008-11#1)
the osteoblasts to##2##3##(1993-6#1)(2008-11#1)
the osteoblasts##6##2##(1993-6#2)(2006-5#1)(2008-11#1)(2008-5#1)(2010-10#1)
the osteocalcin gene##2##3##(1993-3#2)
the osteocalcin##4##2##(1992-1#1)(1992-12#1)(1993-3#2)
the osteochondral##3##2##(2007-8#1)(2008-3#1)(2008-6#1)
the osteoclast##5##2##(1990-2#1)(1991-11#1)(1993-11#1)(2008-11#1)(2012-1#1)
the osteoclast-like##2##2##(2007-12#1)(2012-3#1)
the osteogenic process##2##3##(2008-5#2)
the osteogenic##3##2##(1994-2#1)(2008-5#2)
the osteoid##5##2##(2009-8#3)(2013-1#2)
the osteometric##2##2##(1995-6#1)(2013-8#1)
the osteonecrosis##2##2##(1994-7#1)(2012-12#1)
the osteonecrotic##2##2##(1994-7#1)(2007-9#1)
the osteopathic##3##2##(1991-12#2)(2008-3#1)
the osteophyte##2##2##(2011-2#2)
the osteophytic##2##2##(2011-2#2)
the osteoporotic vertebral##2##3##(2006-8#1)(2008-12#1)
the osteoporotic##3##2##(2006-8#1)(2008-12#1)(2008-8#1)
the osteosynthesis##2##2##(2007-11#1)(2011-2#1)
the osteotomy is##3##3##(2006-3#3)
the osteotomy##14##2##(2006-3#6)(2007-12#1)(2007-5#1)(2007-7#3)(2009-10#1)(2011-2#2)
the ostium of##2##3##(2007-8#1)(2008-7#1)
the ostium##3##2##(2007-8#1)(2008-7#2)
the other 1##2##3##(2007-10#1)(2007-7#1)
the other 10##3##3##(1990-2#1)(1992-2#1)(2008-12#1)
the other 12##2##3##(2008-7#1)(2008-9#1)
the other 15##2##3##(1991-5#1)(2008-5#1)
the other 16##2##3##(2008-1#1)(2013-1#1)
the other 2##10##3##(1992-8#1)(1993-8#1)(1994-7#1)(1995-12#1)(1997-5#1)(2004-9#1)(2006-5#2)(2007-8#1)(2013-1#1)
the other 22##2##3##(2007-9#1)(2012-11#1)
the other 25##4##3##(1990-5#1)(1991-6#1)(2006-8#1)(2008-4#1)
the other 27##2##3##(1994-6#1)(2007-9#1)
the other 3##6##3##(1990-7#1)(1993-7#1)(1995-12#1)(1996-5#1)(2006-8#1)(2013-1#1)
the other 4##4##3##(1994-7#1)(2008-10#1)(2008-12#1)(2008-8#1)
the other 5##2##3##(1993-12#1)(2008-5#1)
the other 8##2##3##(1995-11#1)(2007-8#1)
the other 9##2##3##(1992-12#1)(2008-12#1)
the other Ca2+##2##3##(1993-3#1)(1994-6#1)
the other FABPs##2##3##(1994-9#2)
the other X##2##3##(2008-10#2)
the other a##13##3##(1991-3#1)(1991-9#1)(1992-8#1)(1995-8#1)(1996-8#1)(2007-2#1)(2008-10#2)(2008-3#1)(2008-7#2)(2008-9#1)(2011-2#1)
the other amino acid##2##4##(1992-1#1)(1995-11#1)
the other amino acids##2##4##(1991-9#1)(2008-5#1)
the other amino##4##3##(1991-9#1)(1992-1#1)(1995-11#1)(2008-5#1)
the other analytes##2##3##(2008-10#2)
the other and##5##3##(1995-11#1)(1997-3#1)(2008-8#1)(2009-4#1)(2011-12#1)
the other approved##2##3##(2011-1#2)
the other assays##2##3##(1992-12#1)(2008-4#1)
the other at the##3##4##(2008-2#1)(2013-1#2)
the other at##10##3##(1990-7#1)(1991-3#1)(1995-12#1)(1997-6#1)(2006-8#1)(2008-2#2)(2013-1#3)
the other based on##3##4##(1993-11#1)(2007-12#1)(2008-2#1)
the other being##3##3##(1996-7#1)(2006-7#1)(2008-7#1)
the other between##3##3##(1996-2#2)(2006-5#1)
the other by##8##3##(1990-9#1)(1994-11#1)(1995-3#1)(1996-5#1)(1997-1#1)(1997-7#1)(2005-8#1)(2007-8#1)
the other cancer##2##3##(1993-10#1)(1993-9#1)
the other case##2##3##(2006-11#1)(2008-7#1)
the other cases##4##3##(1993-10#1)(2008-10#1)(2008-9#2)
the other cations##5##3##(1993-6#1)(1997-2#1)(2008-10#3)
the other cell lines##4##4##(1990-12#1)(1991-7#1)(2008-11#1)(2011-12#1)
the other cell##5##3##(1990-12#1)(1991-7#1)(1993-7#1)(2008-11#1)(2011-12#1)
the other cells##3##3##(1994-12#1)(1994-2#1)(2008-5#1)
the other clinical##2##3##(2006-10#1)(2008-1#1)
the other complexes##2##3##(1996-5#1)(2008-5#1)
the other complications##2##3##(1990-5#1)(2008-7#1)
the other components in the##2##5##(2008-10#1)(2012-12#1)
the other components of the##4##5##(1991-3#1)(1992-11#1)(2008-3#1)(2012-3#1)
the other components of##7##4##(1991-3#1)(1992-1#1)(1992-11#1)(2007-6#1)(2008-3#1)(2010-7#1)(2012-3#1)
the other components##12##3##(1991-3#1)(1992-1#1)(1992-11#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-4#1)(2010-7#1)(2012-12#2)(2012-3#1)
the other compounds##7##3##(1993-3#1)(1994-2#2)(1994-8#1)(2006-12#1)(2008-10#1)(2013-7#1)
the other conditions##4##3##(1992-9#1)(2008-10#1)(2008-5#1)(2013-1#1)
the other contains##2##3##(1993-11#1)(2008-11#1)
the other countries##3##3##(2007-12#1)(2008-3#1)(2010-6#1)
the other cytokines##2##3##(1993-6#1)(2008-4#1)
the other dimension##2##3##(2007-12#1)(2011-2#1)
the other does not##2##4##(1992-6#1)(2007-12#1)
the other drugs##6##3##(1990-12#1)(1990-9#1)(1995-1#1)(2008-10#2)(2008-8#1)
the other due to##3##4##(1994-10#1)(2006-2#1)(2008-10#1)
the other elements##2##3##(2005-4#1)(2008-10#1)
the other end of the##2##5##(2006-10#1)(2008-10#1)
the other end##7##3##(1990-9#1)(2006-10#1)(2006-11#1)(2007-11#1)(2008-10#1)(2008-6#1)(2012-1#1)
the other enzymes##3##3##(1993-6#1)(1994-6#1)(2011-12#1)
the other extreme##2##3##(1997-1#1)(2007-11#1)
the other facet##2##3##(2008-2#1)(2008-3#1)
the other factors##2##3##(2008-1#1)(2010-8#1)
the other family##2##3##(1993-10#1)(2006-8#1)
the other five species##3##4##(2008-9#3)
the other five##16##3##(1990-2#1)(1990-3#1)(1994-9#1)(1996-5#1)(1997-1#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#3)(2009-4#1)(2012-1#1)(2013-8#1)
the other flow cells##2##4##(2008-10#2)
the other for the##5##4##(1995-4#1)(2007-9#1)(2008-11#1)(2011-1#1)(2011-2#1)
the other for##13##3##(1991-3#1)(1994-8#1)(1995-4#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2011-1#1)(2011-2#1)
the other forms of##5##4##(2007-11#1)(2008-6#1)(2010-7#1)(2010-8#1)(2012-2#1)
the other four cases##3##4##(1994-6#1)(2006-12#1)(2007-8#1)
the other four##18##3##(1990-8#1)(1994-3#1)(1994-6#1)(1995-9#1)(1996-12#1)(1997-6#1)(2006-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-5#2)(2008-9#1)(2012-2#1)
the other from##11##3##(1990-5#1)(1991-9#1)(1992-2#1)(1996-8#1)(2006-6#1)(2007-9#1)(2008-10#3)(2008-3#1)(2010-8#1)
the other fungal##2##3##(1994-12#1)(2007-7#1)
the other gene##2##3##(1997-2#1)(2008-10#1)
the other genes##4##3##(1990-7#1)(1994-3#1)(2009-10#1)(2012-3#1)
the other genotypes##3##3##(2008-10#1)(2008-8#1)(2010-4#1)
the other group of##3##4##(1990-4#1)(2006-4#1)(2008-5#1)
the other group received##2##4##(1996-8#1)(2007-7#1)
the other group##21##3##(1990-4#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-8#1)(1994-6#1)(1996-2#1)(1996-8#1)(2006-12#1)(2006-4#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#2)(2009-11#1)(2010-4#1)(2012-11#1)(2013-8#1)
the other groups of##2##4##(1991-2#1)(2008-8#1)
the other groups##26##3##(1991-2#1)(1993-12#1)(1996-8#1)(1997-2#1)(1997-4#1)(2004-2#1)(2006-5#1)(2006-8#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-4#2)(2008-7#2)(2008-8#2)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-5#1)(2013-7#1)(2013-8#2)
the other had 787##2##4##(2013-1#2)
the other had a##2##4##(1991-3#1)(2007-8#1)
the other had##5##3##(1991-3#1)(1993-8#1)(2007-8#1)(2013-1#2)
the other half had##2##4##(2009-7#1)(2011-2#1)
the other half were##2##4##(1996-1#1)(2005-10#1)
the other half##15##3##(1994-9#1)(1995-3#1)(1996-1#1)(1996-8#1)(2005-10#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-2#3)(2009-7#1)(2010-8#1)(2011-2#1)(2012-1#1)
the other hand a##2##4##(2008-2#1)(2008-5#1)
the other hand there is##3##5##(2005-8#1)(2009-5#1)(2013-8#1)
the other hand there##4##4##(2005-8#1)(2006-2#1)(2009-5#1)(2013-8#1)
the other hand##735##3##(1990-10#4)(1990-11#2)(1990-12#6)(1990-2#5)(1990-3#2)(1990-4#6)(1990-5#3)(1990-6#1)(1990-7#5)(1990-8#3)(1990-9#1)(1991-1#6)(1991-10#2)(1991-11#2)(1991-12#7)(1991-2#4)(1991-3#5)(1991-4#6)(1991-5#4)(1991-6#2)(1991-7#1)(1991-9#3)(1992-1#3)(1992-10#3)(1992-11#4)(1992-12#4)(1992-2#1)(1992-3#3)(1992-4#4)(1992-5#2)(1992-6#3)(1992-7#4)(1992-8#11)(1992-9#7)(1993-10#1)(1993-11#1)(1993-12#6)(1993-2#2)(1993-3#4)(1993-4#6)(1993-5#1)(1993-6#3)(1993-8#5)(1993-9#2)(1994-10#4)(1994-11#2)(1994-12#4)(1994-2#7)(1994-3#9)(1994-5#6)(1994-6#2)(1994-7#1)(1994-8#5)(1994-9#6)(1995-1#4)(1995-10#2)(1995-11#6)(1995-12#4)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#6)(1995-8#3)(1996-1#1)(1996-10#3)(1996-11#5)(1996-12#7)(1996-2#3)(1996-3#4)(1996-4#3)(1996-5#8)(1996-6#7)(1996-7#4)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#9)(1997-3#1)(1997-4#6)(1997-5#1)(1997-6#3)(1997-7#4)(1997-8#7)(2004-4#2)(2004-8#1)(2004-9#1)(2005-11#17)(2005-3#2)(2005-8#3)(2006-10#10)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#6)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#8)(2007-12#3)(2007-2#2)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#6)(2008-10#54)(2008-11#28)(2008-12#9)(2008-2#13)(2008-3#11)(2008-4#8)(2008-5#28)(2008-6#12)(2008-7#13)(2008-8#8)(2008-9#11)(2009-10#4)(2009-12#2)(2009-2#4)(2009-3#2)(2009-4#1)(2009-5#8)(2009-6#2)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#5)(2010-4#2)(2010-5#5)(2010-6#4)(2010-7#1)(2011-1#9)(2011-12#2)(2011-2#11)(2011-3#1)(2011-7#1)(2012-1#7)(2012-11#1)(2012-12#12)(2012-2#8)(2012-3#2)(2013-1#10)(2013-7#5)(2013-8#8)
the other hormones##2##3##(2004-10#1)(2005-3#1)
the other in a##5##4##(1991-12#1)(2008-10#1)(2009-5#1)(2012-12#1)(2013-7#1)
the other in the##6##4##(1992-8#1)(2007-8#1)(2008-3#2)(2008-8#1)(2012-2#1)
the other in##22##3##(1991-12#1)(1992-8#1)(1994-9#1)(1996-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-8#1)(2009-5#1)(2012-12#2)(2012-2#2)(2013-7#1)
the other is in##3##4##(1990-12#1)(1991-1#1)(2006-2#1)
the other is##29##3##(1990-12#1)(1991-1#1)(1992-5#1)(1992-9#1)(1993-3#1)(1994-11#1)(1995-2#1)(1995-3#1)(2005-11#2)(2006-12#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2009-3#1)(2010-8#1)
the other isoforms##4##3##(1994-9#1)(1996-5#1)(1997-4#2)
the other known##3##3##(1995-1#1)(1997-4#1)(2013-7#1)
the other larvae##2##3##(2008-7#2)
the other laser##2##3##(2008-3#2)
the other lobes##2##3##(2008-5#1)(2013-8#1)
the other major##2##3##(2006-4#1)(2010-2#1)
the other markers##3##3##(2004-10#1)(2008-1#1)(2012-3#1)
the other members of the##4##5##(1990-6#1)(1997-7#1)(2006-10#1)(2007-12#1)
the other members of##5##4##(1990-6#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-8#1)
the other membranes##3##3##(2007-7#1)(2008-1#1)(2008-10#1)
the other metal##5##3##(1991-4#1)(1997-2#2)(2008-10#2)
the other metals##5##3##(1990-4#1)(2008-10#3)(2010-11#1)
the other method##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
the other methods##10##3##(1990-12#1)(1994-12#1)(1996-12#1)(2008-2#2)(2012-12#2)(2012-3#2)(2013-7#1)
the other mil/raf genes##2##4##(1993-6#2)
the other milk replacers##2##4##(2010-2#2)
the other minor##2##3##(2008-10#1)(2009-12#1)
the other mirror##2##3##(2008-3#2)
the other models##2##3##(1992-4#1)(2008-10#1)
the other molecular##2##3##(1990-6#1)(2008-8#1)
the other more##2##3##(2007-12#2)
the other mutant##2##3##(1996-2#1)(2006-9#1)
the other mutants##3##3##(1991-2#1)(1993-11#1)(2008-10#1)
the other of##7##3##(1990-2#1)(1992-12#1)(1995-8#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-6#1)
the other on the##4##4##(1993-6#1)(2007-9#1)(2008-2#1)(2010-8#1)
the other on##8##3##(1993-6#1)(1996-3#1)(2007-9#1)(2008-2#2)(2008-5#1)(2008-9#1)(2010-8#1)
the other one by##2##4##(2007-3#1)(2008-10#1)
the other one is##3##4##(2006-2#1)(2008-11#1)(2008-2#1)
the other one was##3##4##(1991-10#1)(1997-4#1)(2006-10#1)
the other one##26##3##(1990-8#1)(1991-10#1)(1992-10#1)(1995-1#1)(1995-3#1)(1997-4#1)(2006-10#1)(2006-2#1)(2007-3#1)(2007-6#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-6#1)(2010-10#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-11#1)(2013-1#1)
the other ones##3##3##(2008-10#1)(2008-5#1)(2012-12#1)
the other orders of##3##4##(1993-12#1)(2007-12#2)
the other organs##2##3##(2007-6#1)(2009-8#1)
the other over##2##3##(1993-1#1)(1993-2#1)
the other parameters were##2##4##(2008-10#1)(2009-8#1)
the other parameters##7##3##(1996-1#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-8#2)
the other part##3##3##(2007-12#1)(2008-9#1)(2013-1#1)
the other parts of the##2##5##(1996-2#1)(2008-10#1)
the other party to##2##4##(1992-2#1)(2008-8#1)
the other pathway##2##3##(2006-10#1)(2007-12#1)
the other patient had##3##4##(1992-3#1)(1995-1#1)(2013-1#1)
the other patient##6##3##(1991-2#1)(1992-3#1)(1994-2#1)(1995-1#1)(2006-4#1)(2013-1#1)
the other patients##6##3##(1990-12#1)(1990-5#1)(1990-8#1)(2008-7#1)(2011-2#1)(2013-1#1)
the other peptides##6##3##(1991-12#1)(1991-5#2)(1991-9#1)(1992-12#1)(1993-5#1)
the other population##2##3##(2008-8#1)(2008-9#1)
the other populations##4##3##(2008-10#1)(2008-12#1)(2008-5#1)(2013-7#1)
the other possible causes##2##4##(2008-8#1)(2009-2#1)
the other procedures##3##3##(1995-1#1)(2008-10#2)
the other products##2##3##(2007-6#1)(2008-10#1)
the other protocols##2##3##(2008-4#2)
the other reactions of##2##4##(1994-9#1)(2008-7#1)
the other reactions##3##3##(1991-3#1)(1994-9#1)(2008-7#1)
the other reagents##2##3##(1990-12#1)(2008-10#1)
the other received##2##3##(2012-2#1)(2013-1#1)
the other regions##4##3##(1991-6#1)(1994-10#1)(2009-11#1)(2011-1#1)
the other set##2##3##(2008-10#1)(2008-4#1)
the other side of the##5##5##(1993-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#1)
the other side of##6##4##(1993-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)
the other side##19##3##(1993-7#1)(2005-11#1)(2006-9#2)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#2)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
the other sites##2##3##(1991-9#1)(2010-5#1)
the other six##4##3##(1996-2#1)(2008-10#2)(2008-5#1)
the other species of##3##4##(2006-8#1)(2008-6#1)(2011-2#1)
the other species##19##3##(1994-3#1)(2006-8#3)(2007-7#1)(2007-8#1)(2008-10#5)(2008-5#1)(2008-6#1)(2008-8#2)(2010-3#1)(2011-12#1)(2011-2#1)(2012-5#1)
the other specific##3##3##(1996-12#1)(2007-1#1)(2008-10#1)
the other strains##3##3##(1995-5#1)(2006-5#1)(2008-10#1)
the other strand##2##3##(1990-5#1)(1997-2#1)
the other structures##3##3##(1993-12#2)(2007-11#1)
the other students##2##3##(2008-11#2)
the other studied##2##3##(2007-7#1)(2008-5#1)
the other subject##2##3##(1993-2#1)(1994-6#1)
the other subjects##4##3##(1995-9#1)(1996-6#1)(2008-5#1)(2011-2#1)
the other substrate##3##3##(1994-5#1)(1995-10#1)(1997-7#1)
the other subunits##2##3##(1991-5#1)(1994-9#1)
the other systems##3##3##(2008-2#1)(2008-5#1)(2010-9#1)
the other techniques##3##3##(1990-6#1)(2008-10#1)(2011-2#1)
the other tested##3##3##(1993-9#1)(2006-8#1)(2008-10#1)
the other the##6##3##(1991-5#1)(1993-7#1)(1993-8#1)(1996-9#1)(2007-12#1)(2008-3#1)
the other three groups##3##4##(2007-2#1)(2008-7#1)(2009-11#1)
the other three methods##2##4##(2008-10#1)(2008-7#1)
the other three species##2##4##(2007-3#1)(2008-10#1)
the other three##47##3##(1990-3#2)(1992-4#1)(1992-7#1)(1993-2#1)(1993-5#1)(1994-12#1)(1994-8#2)(1994-9#1)(1997-1#1)(1997-5#1)(1997-6#2)(2006-5#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2009-10#1)(2009-11#3)(2009-3#1)(2010-2#1)(2011-1#1)(2012-3#1)(2013-8#1)
the other to##13##3##(1990-2#1)(1991-2#1)(1996-4#1)(1997-1#1)(1997-8#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#1)(2010-6#1)(2012-2#1)
the other treatment modalities##2##4##(1991-9#1)(1995-11#1)
the other treatment##3##3##(1991-9#1)(1995-11#1)(1995-3#1)
the other treatments##7##3##(2006-5#1)(2007-5#1)(2008-10#2)(2010-2#1)(2010-4#1)(2011-2#1)
the other two adducts##2##4##(1990-2#2)
the other two are##3##4##(1990-11#1)(1995-3#1)(2011-1#1)
the other two cases##3##4##(1990-12#1)(2008-7#1)(2013-1#1)
the other two components##3##4##(1995-10#1)(1995-3#1)(2008-10#1)
the other two factors##3##4##(1996-4#1)(2007-5#1)(2008-10#1)
the other two groups##14##4##(1991-11#1)(1993-4#1)(1997-5#2)(2006-9#1)(2007-8#1)(2008-10#4)(2008-7#1)(2010-7#1)(2011-2#1)(2013-1#1)
the other two methods##5##4##(1994-9#1)(1995-2#1)(2008-10#2)(2012-3#1)
the other two minority populations##3##5##(2011-1#3)
the other two patients##3##4##(2006-12#1)(2006-6#1)(2013-1#1)
the other two populations are##2##5##(2007-3#1)(2012-1#1)
the other two populations##4##4##(2007-3#1)(2008-10#2)(2012-1#1)
the other two respectively##2##4##(1990-6#1)(2007-2#1)
the other two samples##2##4##(2005-11#1)(2013-8#1)
the other two were##5##4##(1990-7#1)(1994-6#1)(2005-11#1)(2007-4#1)(2008-4#1)
the other two##114##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-4#2)(1993-6#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#2)(1995-3#3)(1995-4#1)(1995-6#1)(1996-12#1)(1996-4#1)(1996-6#1)(1997-4#1)(1997-5#3)(1997-7#1)(2004-11#1)(2005-11#3)(2006-12#2)(2006-6#2)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#22)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#3)(2010-2#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#3)(2013-1#3)(2013-8#1)
the other type##3##3##(1992-8#1)(1993-9#1)(2007-11#1)
the other types of##4##4##(1991-1#1)(2007-11#1)(2008-10#1)(2008-9#1)
the other types##7##3##(1991-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-1#1)
the other underwent##2##3##(2007-8#1)(2008-10#1)
the other variables##10##3##(1991-7#1)(2006-10#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-5#1)(2009-4#1)
the other was##19##3##(1991-4#1)(1992-11#2)(1993-3#1)(1996-11#1)(1997-8#1)(2004-9#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-9#1)(2012-2#1)(2013-1#2)
the other which##5##3##(1990-5#1)(1990-8#2)(1992-1#1)(1995-6#1)
the other with a##5##4##(1997-6#1)(2006-12#1)(2008-3#1)(2008-5#1)(2010-10#1)
the other with##28##3##(1990-3#1)(1991-10#1)(1992-2#1)(1992-8#1)(1993-11#1)(1994-6#1)(1994-9#1)(1997-6#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-10#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
the other##2433##2##(1990-10#6)(1990-11#7)(1990-12#21)(1990-2#14)(1990-3#8)(1990-4#11)(1990-5#15)(1990-6#7)(1990-7#15)(1990-8#12)(1990-9#6)(1991-1#8)(1991-10#4)(1991-11#4)(1991-12#14)(1991-2#14)(1991-3#11)(1991-4#10)(1991-5#10)(1991-6#8)(1991-7#6)(1991-8#1)(1991-9#11)(1992-1#8)(1992-10#6)(1992-11#8)(1992-12#10)(1992-2#12)(1992-3#9)(1992-4#8)(1992-5#5)(1992-6#9)(1992-7#6)(1992-8#22)(1992-9#11)(1993-1#2)(1993-10#6)(1993-11#10)(1993-12#17)(1993-2#9)(1993-3#12)(1993-4#9)(1993-5#4)(1993-6#10)(1993-7#4)(1993-8#10)(1993-9#8)(1994-1#4)(1994-10#7)(1994-11#7)(1994-12#14)(1994-2#15)(1994-3#18)(1994-4#1)(1994-5#9)(1994-6#17)(1994-7#3)(1994-8#16)(1994-9#21)(1995-1#15)(1995-10#4)(1995-11#10)(1995-12#10)(1995-2#13)(1995-3#16)(1995-4#4)(1995-5#4)(1995-6#9)(1995-7#3)(1995-8#6)(1995-9#4)(1996-1#4)(1996-10#6)(1996-11#7)(1996-12#17)(1996-2#10)(1996-3#6)(1996-4#8)(1996-5#19)(1996-6#9)(1996-7#7)(1996-8#14)(1996-9#11)(1997-1#11)(1997-2#20)(1997-3#8)(1997-4#19)(1997-5#8)(1997-6#10)(1997-7#11)(1997-8#10)(2004-1#1)(2004-10#2)(2004-11#1)(2004-2#1)(2004-3#1)(2004-4#3)(2004-8#1)(2004-9#3)(2005-10#5)(2005-11#29)(2005-12#1)(2005-3#3)(2005-4#2)(2005-7#1)(2005-8#8)(2006-10#23)(2006-11#5)(2006-12#19)(2006-2#6)(2006-3#3)(2006-4#5)(2006-5#14)(2006-6#11)(2006-7#7)(2006-8#19)(2006-9#7)(2007-1#10)(2007-10#7)(2007-11#30)(2007-12#35)(2007-2#10)(2007-3#15)(2007-4#8)(2007-5#4)(2007-6#7)(2007-7#25)(2007-8#31)(2007-9#13)(2008-1#25)(2008-10#270)(2008-11#49)(2008-12#29)(2008-2#58)(2008-3#57)(2008-4#32)(2008-5#87)(2008-6#24)(2008-7#46)(2008-8#41)(2008-9#35)(2009-10#12)(2009-11#6)(2009-12#6)(2009-2#9)(2009-3#7)(2009-4#7)(2009-5#13)(2009-6#9)(2009-7#1)(2009-8#11)(2009-9#5)(2010-1#3)(2010-10#4)(2010-11#5)(2010-12#13)(2010-2#12)(2010-3#4)(2010-4#10)(2010-5#7)(2010-6#9)(2010-7#7)(2010-8#8)(2010-9#3)(2011-1#28)(2011-12#7)(2011-2#36)(2011-3#1)(2011-7#1)(2012-1#15)(2012-11#5)(2012-12#30)(2012-2#24)(2012-3#20)(2012-5#2)(2013-1#44)(2013-7#14)(2013-8#23)
the other's##5##2##(2007-4#1)(2008-11#1)(2008-8#1)(2011-2#1)(2013-8#1)
the other)##4##2##(1990-3#1)(2008-8#1)(2012-1#1)(2013-8#1)
the others are##2##3##(1994-12#1)(2008-10#1)
the others by##3##3##(1990-11#1)(2007-3#1)(2008-10#1)
the others for##2##3##(2008-10#1)(2008-5#1)
the others in all##2##4##(2004-4#1)(2008-10#1)
the others in##5##3##(1990-10#1)(1990-12#1)(2004-4#1)(2008-10#2)
the others to##2##3##(1990-10#1)(1990-12#1)
the others were##8##3##(1990-11#1)(1990-5#1)(1994-7#1)(1995-2#1)(2007-10#2)(2007-7#1)(2008-7#1)
the others##92##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-5#1)(1993-3#1)(1993-5#1)(1993-7#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-7#2)(1994-8#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-8#1)(2004-4#2)(2005-11#1)(2005-6#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-10#2)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-2#3)(2008-4#2)(2008-5#7)(2008-7#3)(2008-9#2)(2010-11#1)(2010-4#2)(2010-7#1)(2012-12#1)(2012-3#2)(2013-1#6)(2013-7#2)
the otherwise##13##2##(1990-7#1)(1990-8#1)(1991-11#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-2#1)
the otic capsule##3##3##(1993-12#1)(2006-12#1)(2011-2#1)
the otic##5##2##(1993-12#1)(1996-4#2)(2006-12#1)(2011-2#1)
the otocyst##2##2##(1996-3#2)
the otolith##6##2##(2008-7#3)(2010-8#2)(2012-2#1)
the ouabain##2##2##(1991-1#1)(2008-1#1)
the ouabain-sensitive##5##2##(1992-11#1)(1994-8#1)(1997-5#1)(2008-4#1)(2008-8#1)
the out-of-focus##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
the out-of-hours service##2##3##(2012-11#2)
the out-of-hours##4##2##(1997-8#1)(2012-11#3)
the out-of-phase##2##2##(1995-11#1)(2008-1#1)
the out-of-phase-locked state##3##3##(2008-1#3)
the out-of-plane component##2##3##(2008-2#1)(2008-3#1)
the out-of-plane##9##2##(1997-7#1)(2005-4#1)(2007-11#2)(2008-2#3)(2008-3#1)(2009-7#1)
the out-of-pocket##2##2##(2007-6#1)(2011-1#1)
the out-of-position##2##2##(2007-4#2)
the outbreak clone##3##3##(2008-5#3)
the outbreak in##2##3##(2008-12#2)
the outbreak of##6##3##(1997-5#1)(2007-12#1)(2008-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
the outbreak strain##3##3##(2006-8#1)(2008-7#1)(2012-3#1)
the outbreak was##3##3##(1994-4#1)(2008-6#1)(2013-8#1)
the outbreak##34##2##(1994-4#1)(1996-1#1)(1997-5#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-12#5)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#4)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#4)
the outbreaks of##2##3##(1994-4#1)(2008-12#1)
the outbreaks##6##2##(1992-6#1)(1994-4#1)(1996-3#1)(2008-12#1)(2009-2#1)(2010-12#1)
the outburst of herpes virus##2##5##(2009-2#2)
the outcome and##4##3##(1995-2#1)(2008-7#1)(2012-2#2)
the outcome by##2##3##(2006-3#1)(2008-6#1)
the outcome following##3##3##(2007-7#1)(2007-8#2)
the outcome for patients with##2##5##(2008-9#1)(2010-3#1)
the outcome for##7##3##(1990-10#1)(1994-6#1)(2004-2#1)(2006-10#2)(2008-9#1)(2010-3#1)
the outcome in patients with##2##5##(2008-5#1)(2008-8#1)
the outcome in patients##3##4##(2008-5#1)(2008-8#1)(2013-1#1)
the outcome in##14##3##(1994-11#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#2)(2013-1#1)
the outcome is##6##3##(1990-12#1)(2006-12#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-12#1)
the outcome measures##4##3##(2008-11#1)(2009-11#1)(2012-1#1)(2013-8#1)
the outcome of a##5##4##(1994-1#2)(2006-11#1)(2007-3#1)(2013-8#1)
the outcome of all pregnancies##2##5##(1990-9#2)
the outcome of all##3##4##(1990-9#2)(2010-3#1)
the outcome of an##3##4##(2008-9#1)(2012-11#1)(2012-3#1)
the outcome of clinical trials##2##5##(2005-7#1)(2008-1#1)
the outcome of competition##2##4##(2008-8#1)(2008-9#1)
the outcome of gene##2##4##(2008-7#1)(2012-12#1)
the outcome of infections##2##4##(2009-2#2)
the outcome of interest is##2##5##(1994-8#1)(2008-5#1)
the outcome of interest##5##4##(1994-2#1)(1994-8#1)(2008-5#1)(2008-7#1)(2012-3#1)
the outcome of patients with##9##5##(1994-4#2)(2006-10#1)(2006-2#1)(2007-5#1)(2007-7#1)(2008-6#1)(2010-3#1)(2010-9#1)
the outcome of patients##12##4##(1994-4#2)(2004-1#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-6#1)(2010-3#1)(2010-9#1)
the outcome of pregnancy##6##4##(1991-2#1)(1997-4#1)(2005-10#1)(2008-3#1)(2010-12#1)(2013-8#1)
the outcome of such##4##4##(2008-12#1)(2009-2#1)(2012-12#1)(2012-2#1)
the outcome of surgery##2##4##(2008-3#1)(2009-7#1)
the outcome of the current##2##5##(2006-10#1)(2009-5#1)
the outcome of the disease##3##5##(1994-8#1)(2008-8#1)(2009-2#1)
the outcome of the procedure##3##5##(2008-2#1)(2008-5#1)(2008-7#1)
the outcome of the##38##4##(1992-3#1)(1993-1#1)(1993-5#1)(1994-8#1)(1995-12#1)(2004-7#1)(2006-10#2)(2006-12#1)(2007-11#2)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#2)
the outcome of these patients##3##5##(2006-10#1)(2008-1#1)(2008-6#1)
the outcome of these##5##4##(2006-10#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-7#1)
the outcome of this##3##4##(1990-9#1)(2008-6#1)(2010-12#1)
the outcome of those##2##4##(1995-1#1)(2013-8#1)
the outcome of treatment##3##4##(1993-1#1)(2008-11#1)(2011-1#1)
the outcome of vitiligo##2##4##(2007-7#2)
the outcome of which is##2##5##(2008-9#2)
the outcome of which##3##4##(2008-9#2)(2011-1#1)
the outcome of##197##3##(1990-8#1)(1990-9#5)(1991-11#1)(1991-2#1)(1992-1#1)(1992-10#1)(1992-3#1)(1993-1#2)(1993-11#2)(1993-5#1)(1994-1#3)(1994-12#1)(1994-2#3)(1994-4#2)(1994-8#3)(1995-1#1)(1995-12#1)(1995-9#1)(1997-4#2)(1997-8#1)(2004-1#1)(2004-7#1)(2005-10#1)(2005-11#2)(2005-7#1)(2006-10#10)(2006-11#1)(2006-12#2)(2006-2#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#8)(2007-8#6)(2007-9#2)(2008-1#5)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#8)(2008-8#5)(2008-9#7)(2009-10#2)(2009-12#1)(2009-2#5)(2009-3#1)(2009-4#2)(2009-5#3)(2009-7#1)(2009-9#2)(2010-10#1)(2010-12#6)(2010-2#1)(2010-3#2)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#5)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#5)(2013-8#4)
the outcome variables##2##3##(1993-9#1)(1994-3#1)
the outcome was judged##2##4##(2007-10#1)(2007-7#1)
the outcome was##12##3##(1996-2#1)(1997-3#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-6#1)(2007-7#4)(2012-2#1)
the outcome##314##2##(1990-10#1)(1990-12#2)(1990-8#1)(1990-9#5)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-3#2)(1992-4#1)(1992-8#1)(1993-1#3)(1993-11#2)(1993-5#1)(1993-9#1)(1994-1#3)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-4#2)(1994-6#2)(1994-8#3)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2004-1#1)(2004-2#1)(2004-7#1)(2005-10#3)(2005-11#3)(2005-7#1)(2005-8#1)(2006-10#17)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#4)(2007-11#5)(2007-12#1)(2007-2#3)(2007-3#2)(2007-4#2)(2007-5#3)(2007-6#1)(2007-7#17)(2007-8#13)(2007-9#4)(2008-1#6)(2008-10#6)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#6)(2008-6#6)(2008-7#11)(2008-8#7)(2008-9#11)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#5)(2009-3#1)(2009-4#2)(2009-5#3)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#8)(2010-2#2)(2010-3#7)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#6)(2011-2#11)(2012-1#5)(2012-11#1)(2012-12#7)(2012-2#6)(2012-3#5)(2013-1#9)(2013-8#5)
the outcomes and##3##3##(2008-5#1)(2012-3#1)(2013-1#1)
the outcomes from##2##3##(2005-10#1)(2008-2#1)
the outcomes in##4##3##(2007-1#1)(2007-11#1)(2010-12#1)(2011-2#1)
the outcomes model##4##3##(2008-4#4)
the outcomes movement##4##3##(1991-12#1)(1994-11#1)(1996-1#1)(1997-1#1)
the outcomes of a##2##4##(2007-10#1)(2008-5#1)
the outcomes of care##2##4##(1996-2#1)(2006-1#1)
the outcomes of the##4##4##(2006-1#1)(2007-12#1)(2007-8#1)(2011-2#1)
the outcomes of their##2##4##(2007-3#1)(2012-3#1)
the outcomes of these##3##4##(1996-3#1)(2008-9#1)(2010-5#1)
the outcomes of this##2##4##(1996-3#1)(2006-10#1)
the outcomes of treatment##2##4##(2011-2#1)(2013-8#1)
the outcomes of##46##3##(1990-3#1)(1993-3#1)(1995-3#1)(1996-2#1)(1996-3#3)(2005-10#1)(2005-5#1)(2005-7#1)(2006-1#2)(2006-10#1)(2006-3#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-3#1)(2010-10#1)(2010-3#2)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
the outcomes that##3##3##(1992-12#1)(2006-12#1)(2008-8#1)
the outcomes##91##2##(1990-3#1)(1991-12#1)(1992-12#1)(1993-3#1)(1994-11#2)(1994-3#1)(1994-5#1)(1995-3#2)(1996-1#1)(1996-2#2)(1996-3#3)(1997-1#1)(2005-10#2)(2005-11#1)(2005-5#1)(2005-7#1)(2006-1#2)(2006-10#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#2)(2009-6#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-5#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#7)(2013-8#2)
the outcoupled##2##2##(2008-2#1)(2008-3#1)
the outdoor air##2##3##(2010-5#2)
the outdoor and##2##3##(2005-12#1)(2013-8#1)
the outdoor##6##2##(2005-12#1)(2007-3#1)(2008-3#1)(2010-5#2)(2013-8#1)
the outer 1##2##3##(1996-5#1)(2007-7#1)
the outer and inner mitochondrial membranes##2##6##(1990-10#1)(1995-12#1)
the outer and inner##6##4##(1990-10#1)(1990-11#1)(1994-2#1)(1995-12#1)(2007-7#1)(2012-2#1)
the outer and##7##3##(1990-10#1)(1990-11#1)(1991-5#1)(1994-2#1)(1995-12#1)(2007-7#1)(2012-2#1)
the outer cell##3##3##(1991-1#1)(1992-4#1)(2008-10#1)
the outer cortex##2##3##(2008-10#1)(2008-7#1)
the outer cortical bone##2##4##(1995-6#2)
the outer cortical##3##3##(1995-6#2)(2008-3#1)
the outer covering##2##3##(2008-5#1)(2008-7#1)
the outer dendritic segments##2##4##(2008-7#2)
the outer hair cell##3##4##(1995-3#1)(1997-7#2)
the outer hair cells (OHCs)##2##5##(1993-9#1)(2008-4#1)
the outer hair##5##3##(1993-9#1)(1995-3#1)(1997-7#2)(2008-4#1)
the outer layer of the##3##5##(1992-6#1)(2008-11#1)(2008-7#1)
the outer layer of##4##4##(1992-6#1)(2008-11#1)(2008-12#1)(2008-7#1)
the outer layer##10##3##(1992-6#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2010-4#1)(2011-1#1)
the outer layers of the##2##5##(2008-11#1)(2009-8#1)
the outer layers##3##3##(2008-10#1)(2008-11#1)(2009-8#1)
the outer leaflet of the plasma membrane##2##7##(1990-5#1)(2008-11#1)
the outer leaflet of the##7##5##(1990-11#1)(1990-5#1)(1992-3#1)(1995-2#1)(2008-11#1)(2009-2#1)(2010-7#1)
the outer leaflet##8##3##(1990-11#1)(1990-5#1)(1992-3#1)(1995-2#1)(1995-6#1)(2008-11#1)(2009-2#1)(2010-7#1)
the outer lipid##2##3##(1991-5#1)(1994-11#1)
the outer membrane and##3##4##(1994-8#1)(2005-8#1)(2006-8#1)
the outer membrane of##7##4##(1990-11#1)(1991-9#1)(1992-7#1)(1996-9#2)(2006-8#1)(2009-8#1)
the outer membrane##41##3##(1990-11#1)(1990-3#2)(1991-1#1)(1991-9#1)(1992-12#1)(1992-7#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#5)(1994-8#1)(1995-6#1)(1996-10#1)(1996-5#1)(1996-9#2)(1997-2#3)(1997-4#1)(1997-8#3)(2005-8#4)(2006-8#2)(2007-3#1)(2008-11#1)(2008-5#1)(2009-8#1)(2011-2#1)(2013-8#2)
the outer mitochondrial membrane is##2##5##(2005-8#1)(2012-2#1)
the outer mitochondrial membrane##6##4##(1997-4#1)(2005-8#3)(2012-2#2)
the outer mitochondrial##8##3##(1990-3#1)(1994-8#1)(1997-4#1)(2005-8#3)(2012-2#2)
the outer molecular layer of the dentate gyrus##2##8##(1992-7#2)
the outer monolayer of##2##4##(1992-6#1)(2008-11#1)
the outer monolayer##3##3##(1990-11#1)(1992-6#1)(2008-11#1)
the outer nuclear layer##2##4##(1991-10#1)(2010-1#1)
the outer nuclear membrane##3##4##(1993-6#1)(2008-9#2)
the outer nuclear##6##3##(1991-10#1)(1993-6#1)(2008-9#2)(2010-1#1)(2011-2#1)
the outer part of the##3##5##(1994-5#1)(2007-12#2)
the outer ring##2##3##(2012-2#2)
the outer scale##2##3##(2008-3#2)
the outer shell##2##3##(2006-1#1)(2008-8#1)
the outer surface of a##2##5##(2008-2#1)(2010-10#1)
the outer surface of the##7##5##(1990-2#1)(1991-9#1)(1997-7#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-7#1)
the outer surface of##10##4##(1990-2#1)(1991-9#1)(1997-7#1)(2007-11#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-10#1)
the outer surface##12##3##(1990-2#1)(1991-9#1)(1994-5#1)(1997-7#1)(2007-11#2)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2010-10#1)
the outer surfaces of the##2##5##(2007-12#1)(2008-5#1)
the outer surfaces of##3##4##(2007-12#1)(2008-2#1)(2008-5#1)
the outer vestibule of##2##4##(1995-8#1)(2008-8#1)
the outer vestibule##3##3##(1995-8#1)(2008-8#2)
the outer wall##2##3##(1996-11#1)(2008-9#1)
the outer##209##2##(1990-10#1)(1990-11#6)(1990-2#2)(1990-3#3)(1990-5#2)(1990-6#1)(1991-1#2)(1991-10#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-9#4)(1992-1#1)(1992-12#3)(1992-3#3)(1992-4#1)(1992-6#3)(1992-7#3)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#5)(1994-2#2)(1994-5#2)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#5)(1995-8#1)(1996-10#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-9#2)(1997-2#3)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#5)(2005-1#1)(2005-11#1)(2005-8#7)(2006-1#1)(2006-11#1)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#4)(2007-11#3)(2007-12#6)(2007-3#1)(2007-5#1)(2007-7#3)(2007-9#2)(2008-1#1)(2008-10#10)(2008-11#8)(2008-12#3)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#6)(2008-7#11)(2008-8#3)(2008-9#3)(2009-12#1)(2009-2#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#7)(2013-8#2)
the outermost SC layer##3##4##(2008-5#3)
the outermost layer of##3##4##(2008-5#3)
the outermost surface##2##3##(2005-11#1)(2008-10#1)
the outermost##14##2##(2005-11#1)(2008-10#4)(2008-5#8)(2009-8#1)
the outflow of the##3##4##(2007-8#1)(2007-9#1)(2008-10#1)
the outflow of##5##3##(1991-2#1)(2007-8#1)(2007-9#2)(2008-10#1)
the outflow tract##2##3##(1992-9#1)(2013-1#1)
the outflow##9##2##(1991-2#1)(1992-9#1)(2007-8#3)(2007-9#2)(2008-10#1)(2013-1#1)
the outgoing##8##2##(1996-11#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2012-3#1)
the outgroup A##2##3##(2008-10#2)
the outgroup##6##2##(1992-12#1)(2007-12#3)(2008-10#2)
the outgrowing##4##2##(1995-1#1)(2007-12#1)(2008-5#1)(2011-1#1)
the outgrowth cultures##2##3##(2006-8#2)
the outgrowth of a##2##4##(1991-12#1)(2008-11#1)
the outgrowth of##8##3##(1991-12#1)(2006-10#1)(2007-2#2)(2008-11#2)(2008-5#1)(2013-1#1)
the outgrowth##14##2##(1991-12#1)(1991-3#1)(1995-11#1)(2006-10#1)(2006-8#2)(2007-2#2)(2008-11#4)(2008-5#1)(2013-1#1)
the outlet of the##5##4##(2006-8#1)(2008-10#3)(2008-5#1)
the outlet of##8##3##(2006-8#1)(2007-8#1)(2008-10#5)(2008-5#1)
the outlet septum##2##3##(2007-8#2)
the outlet##17##2##(2006-8#2)(2007-8#4)(2008-10#6)(2008-11#2)(2008-5#1)(2008-7#1)(2013-7#1)
the outlets##2##2##(2008-10#1)(2008-5#1)
the outline of the##3##4##(1994-4#1)(1995-6#1)(2006-6#1)
the outline of##4##3##(1994-4#1)(1995-6#1)(2006-6#1)(2007-7#1)
the outline##6##2##(1994-4#1)(1995-6#3)(2006-6#1)(2007-7#1)
the outlook for##3##3##(1993-12#1)(1995-1#1)(2006-4#1)
the outlook##5##2##(1993-12#1)(1993-3#1)(1995-1#1)(1996-5#1)(2006-4#1)
the outpatient clinic of the##2##5##(2010-7#1)(2012-12#1)
the outpatient clinic of##3##4##(2010-7#1)(2012-12#2)
the outpatient clinic##8##3##(1992-3#1)(1995-11#1)(1996-3#1)(2008-11#1)(2010-7#1)(2011-2#1)(2012-12#2)
the outpatient department of the Mangochi##2##6##(1996-12#2)
the outpatient department of##5##4##(1996-12#2)(1997-3#1)(2007-6#1)(2007-7#1)
the outpatient department##9##3##(1991-9#1)(1996-12#2)(1997-3#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-8#1)
the outpatient setting##9##3##(1993-12#2)(1995-2#1)(2006-10#2)(2008-3#2)(2010-9#1)(2011-1#1)
the outpatient##42##2##(1991-9#1)(1992-12#1)(1992-3#1)(1993-12#3)(1993-2#1)(1994-2#3)(1995-11#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#2)(1996-3#1)(1997-3#1)(1997-4#1)(2006-10#3)(2006-6#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#1)
the outpatients##3##2##(1991-7#1)(2007-7#1)(2010-12#1)
the output PISHG signal##2##4##(2008-3#2)
the output beam was##3##4##(2007-12#1)(2008-3#1)(2011-1#1)
the output beam##8##3##(2007-12#5)(2008-2#1)(2008-3#1)(2011-1#1)
the output characteristics of##2##4##(2008-2#1)(2008-3#1)
the output constraints hypothesis##2##4##(2013-8#2)
the output correlation##2##3##(2008-2#1)(2008-3#1)
the output coupler##2##3##(2008-3#2)
the output coupling rate##2##4##(2008-2#2)
the output coupling##4##3##(2007-12#1)(2008-2#3)
the output energy##2##3##(2007-12#1)(2008-3#1)
the output frequency##2##3##(2007-11#1)(2007-12#1)
the output from a##3##4##(2007-12#2)(2008-2#1)
the output from the##4##4##(1996-12#1)(2007-12#2)(2008-3#1)
the output from##9##3##(1996-12#1)(2006-9#1)(2007-12#5)(2008-2#1)(2008-3#1)
the output impedance##2##3##(2013-7#2)
the output intensity profile##2##4##(2007-12#1)(2008-2#1)
the output intensity##4##3##(2007-12#2)(2008-2#1)(2010-6#1)
the output is##3##3##(2007-12#1)(2008-2#2)
the output layer##7##3##(2008-10#2)(2010-8#5)
the output of a cw##2##5##(2007-12#1)(2008-3#1)
the output of a##22##4##(1993-9#1)(2007-1#1)(2007-11#5)(2007-12#4)(2008-10#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#1)
the output of an##6##4##(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#1)
the output of the laser##2##5##(2007-12#1)(2008-2#1)
the output of the neuron##2##5##(2008-2#1)(2008-3#1)
the output of the##27##4##(1995-12#1)(1996-12#1)(1996-2#1)(1997-7#1)(2005-10#1)(2007-11#2)(2007-12#4)(2008-11#1)(2008-2#8)(2008-3#5)(2008-9#1)(2009-12#1)
the output of this##2##4##(2007-12#1)(2008-3#1)
the output of##69##3##(1990-3#1)(1993-9#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#7)(2007-12#15)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#12)(2008-3#12)(2008-4#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-4#1)
the output optical spectrum##2##4##(2013-8#2)
the output optical##3##3##(2007-11#1)(2013-8#2)
the output plane is##2##4##(2008-2#1)(2008-3#1)
the output plane of##2##4##(2008-2#1)(2008-3#1)
the output plane##8##3##(2008-2#3)(2008-3#5)
the output power at##2##4##(2007-12#1)(2008-2#1)
the output power of##2##4##(2007-12#1)(2008-3#1)
the output power##20##3##(1990-3#1)(2007-11#1)(2007-12#4)(2008-2#6)(2008-3#7)(2013-7#1)
the output pulse##6##3##(2007-12#3)(2008-2#1)(2008-3#2)
the output pulses##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
the output response##2##3##(2007-12#1)(2008-11#1)
the output signal is##2##4##(2007-11#1)(2008-2#1)
the output signal##10##3##(2007-11#3)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)
the output signals##3##3##(2008-2#2)(2008-3#1)
the output spatial beam profile##2##5##(2007-12#1)(2008-3#1)
the output surface##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
the output wavelength##2##3##(2007-11#1)(2008-3#1)
the output##254##2##(1990-3#2)(1991-12#1)(1991-6#2)(1993-6#1)(1993-9#1)(1995-1#1)(1995-12#1)(1996-11#1)(1996-12#2)(1996-2#2)(1997-7#1)(1997-8#1)(2005-10#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#21)(2007-12#56)(2008-1#2)(2008-10#11)(2008-11#3)(2008-2#51)(2008-3#62)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#2)(2009-12#1)(2009-4#1)(2010-6#1)(2010-8#7)(2011-1#1)(2013-1#1)(2013-7#3)(2013-8#4)
the output-stagnation objects##2##3##(2008-3#2)
the outputs of the##2##4##(2008-10#1)(2012-1#1)
the outputs of##7##3##(1992-6#1)(1995-12#1)(2004-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2012-1#1)
the outputs##8##2##(1992-2#1)(1992-6#1)(1995-12#1)(2004-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2012-1#1)
the outreach team was##2##4##(2007-9#2)
the outreach team##3##3##(2007-9#2)(2011-1#1)
the outreach##5##2##(1995-1#1)(2007-9#3)(2011-1#1)
the outset of incubation##3##4##(2005-11#3)
the outset of the##2##4##(1997-4#1)(2013-8#1)
the outset of##7##3##(1995-1#1)(1995-12#1)(1997-4#1)(2005-11#3)(2013-8#1)
the outset##19##2##(1991-9#1)(1993-1#1)(1995-1#1)(1995-12#1)(1996-9#1)(1997-4#1)(2005-11#3)(2005-12#1)(2007-1#1)(2007-7#1)(2008-10#1)(2008-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
the outside of the cell##3##5##(2005-10#1)(2008-8#1)(2011-1#1)
the outside of the##9##4##(1990-4#1)(2005-10#1)(2007-12#1)(2008-10#2)(2008-8#1)(2011-1#1)(2012-2#2)
the outside of##10##3##(1990-4#1)(2005-10#1)(2007-12#1)(2008-10#3)(2008-8#1)(2011-1#1)(2012-2#2)
the outside world##2##3##(1997-8#1)(2008-5#1)
the outside##27##2##(1990-2#1)(1990-4#1)(1996-12#1)(1997-8#1)(2005-10#2)(2007-1#1)(2007-12#3)(2008-10#6)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-3#1)(2010-12#1)(2011-1#1)(2012-2#2)(2013-7#1)
the outskirts of##4##3##(2007-7#1)(2008-10#1)(2008-11#1)(2011-12#1)
the outskirts##5##2##(1992-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2011-12#1)
the outstanding##11##2##(1994-5#1)(1994-6#1)(1995-3#1)(1996-6#1)(1997-8#1)(2005-8#1)(2008-10#1)(2008-2#2)(2008-5#1)(2011-2#1)
the outward rectifying potassium conductance##2##5##(1994-2#2)
the outward rectifying potassium##3##4##(1994-2#3)
the outward##10##2##(1992-11#1)(1994-2#3)(1994-3#1)(1995-2#1)(1997-2#1)(2008-3#1)(2008-7#1)(2008-8#1)
the ova##3##2##(2006-5#1)(2011-1#1)(2012-2#1)
the oval##4##2##(1997-8#1)(2008-9#1)(2009-2#1)(2009-4#1)
the ovalbumin##3##2##(1996-12#1)(2007-8#1)(2008-11#1)
the ovarian cancer##2##3##(1993-9#1)(2012-12#1)
the ovarian cyst cavity##2##4##(1992-3#2)
the ovarian follicle##2##3##(1991-9#1)(2008-9#1)
the ovarian follicles##3##3##(2008-12#3)
the ovarian mass##2##3##(1996-1#1)(2010-9#1)
the ovarian stroma##3##3##(2008-12#3)
the ovarian surface epithelium##3##4##(1995-12#1)(2008-1#1)(2011-2#1)
the ovarian surface##4##3##(1995-12#1)(2008-1#1)(2011-2#2)
the ovarian tumor##3##3##(1991-7#1)(1994-6#1)(2007-12#1)
the ovarian##44##2##(1990-10#1)(1990-11#1)(1990-9#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#5)(1993-9#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-8#2)(1996-1#2)(1996-2#1)(2004-10#1)(2007-12#1)(2008-1#1)(2008-12#7)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2010-9#1)(2011-2#3)(2012-12#2)(2012-3#2)
the ovaries and##2##3##(2007-6#1)(2011-1#1)
the ovaries of##2##3##(2008-5#2)
the ovaries##19##2##(1992-3#2)(1995-3#1)(2004-10#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-4#1)(2010-12#2)(2011-1#1)(2012-1#1)(2012-12#1)(2013-8#1)
the ovary and hepatopancreas##2##4##(2008-6#2)
the ovary and oviduct##2##4##(2008-12#2)
the ovary and the##5##4##(1995-10#1)(2008-10#1)(2008-4#2)(2008-6#1)
the ovary and##15##3##(1990-11#1)(1993-2#1)(1993-3#1)(1995-10#1)(2007-4#1)(2008-10#1)(2008-12#2)(2008-4#2)(2008-6#3)(2012-1#2)
the ovary is##8##3##(1991-5#1)(1996-2#1)(2008-4#1)(2008-9#1)(2012-2#1)(2013-1#2)(2013-8#1)
the ovary of##2##3##(2007-12#1)(2010-5#1)
the ovary##103##2##(1990-10#1)(1990-11#3)(1990-2#1)(1990-3#2)(1990-7#1)(1991-5#3)(1991-9#1)(1992-3#1)(1993-1#2)(1993-10#1)(1993-2#2)(1993-3#1)(1993-9#4)(1994-6#3)(1995-10#1)(1995-11#2)(1995-12#2)(1996-2#5)(1996-4#1)(1996-5#1)(1997-3#1)(1997-8#1)(2004-10#2)(2006-5#1)(2007-12#2)(2007-4#4)(2007-8#2)(2008-1#1)(2008-10#3)(2008-12#4)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#4)(2008-7#1)(2008-9#4)(2009-12#1)(2009-7#1)(2010-12#3)(2010-5#3)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#3)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#6)
the oven##2##2##(2008-10#1)(2011-12#1)
the over##6##2##(1994-5#1)(1995-4#1)(2005-11#1)(2009-3#1)(2010-8#1)(2011-1#1)
the over-expressed##2##2##(1996-11#1)(2007-2#1)
the over-expression of##5##3##(2007-12#1)(2008-11#1)(2010-2#1)(2011-2#2)
the over-expression##7##2##(1994-12#1)(2007-12#1)(2008-11#1)(2008-4#1)(2010-2#1)(2011-2#2)
the overall QOL##3##3##(1994-12#1)(1995-4#2)
the overall Strehl ratio##2##4##(2008-3#2)
the overall accuracy of the##2##5##(2008-2#2)
the overall accuracy##3##3##(2008-2#2)(2010-8#1)
the overall activity of##2##4##(1991-10#1)(2008-5#1)
the overall age-adjusted incidence rate##2##5##(1995-5#2)
the overall agreement##2##3##(2009-8#2)
the overall aim of##2##4##(2008-11#1)(2012-2#1)
the overall and disease-free survival##2##5##(2006-10#1)(2007-11#1)
the overall assessment##2##3##(1991-4#1)(2006-7#1)
the overall average##2##3##(2008-10#1)(2011-2#1)
the overall balance of##2##4##(2008-5#1)(2010-6#1)
the overall behavior of##2##4##(1996-12#1)(2008-10#1)
the overall body##2##3##(2008-5#1)(2012-12#1)
the overall cellular##3##3##(1992-12#1)(1995-1#1)(2011-2#1)
the overall characteristics of the ecosystem##2##6##(2013-8#2)
the overall characteristics of the##3##5##(2012-2#1)(2013-8#2)
the overall charge of##2##4##(1991-2#1)(2011-1#1)
the overall charge##3##3##(1991-2#1)(2008-5#1)(2011-1#1)
the overall clinical##3##3##(1994-6#1)(2005-10#1)(2008-1#1)
the overall conformation of the##2##5##(1990-12#1)(1997-1#1)
the overall cost of##3##4##(2008-5#2)(2009-7#1)
the overall cost##4##3##(1997-3#1)(2008-5#2)(2009-7#1)
the overall data##2##3##(2008-3#1)(2010-1#1)
the overall degree of##3##4##(1990-8#1)(2009-2#1)(2011-10#1)
the overall density of prey##2##5##(2008-8#2)
the overall difference##2##3##(2008-1#2)
the overall economic##2##3##(2007-11#1)(2008-11#1)
the overall economy##5##3##(1992-12#1)(1992-2#1)(1995-3#1)(1997-1#1)(2008-11#1)
the overall effect of##3##4##(1992-4#1)(2006-10#1)(2010-2#1)
the overall effect##5##3##(1992-4#1)(2005-11#1)(2006-10#1)(2009-4#1)(2010-2#1)
the overall effectiveness of##2##4##(2008-10#1)(2012-1#1)
the overall effects##2##3##(2006-9#1)(2008-10#1)
the overall efficacy##2##3##(1991-2#1)(2007-1#1)
the overall efficiency of##3##4##(1990-10#1)(1995-2#1)(1996-9#1)
the overall efficiency##4##3##(1990-10#1)(1995-2#1)(1996-9#1)(2008-6#1)
the overall enzyme##3##3##(2008-6#2)(2009-5#1)
the overall estimated##2##3##(1996-3#1)(1997-1#1)
the overall experience of##2##4##(2007-2#1)(2007-9#1)
the overall experience##3##3##(2005-7#1)(2007-2#1)(2007-9#1)
the overall experiences##2##3##(2007-12#1)(2008-11#1)
the overall extent of##2##4##(1991-3#1)(2008-10#1)
the overall extent##3##3##(1991-3#1)(2008-10#1)(2009-2#1)
the overall extraction##3##3##(2008-10#3)
the overall features##2##3##(1993-6#1)(2008-3#1)
the overall folding of##2##4##(1990-7#1)(1993-2#1)
the overall frequency of##2##4##(1991-6#1)(2012-2#1)
the overall frequency##3##3##(1991-6#1)(2007-11#1)(2012-2#1)
the overall group##6##3##(1991-4#1)(1995-9#1)(1996-4#1)(2006-10#1)(2008-10#1)(2010-6#1)
the overall health##2##3##(2006-9#1)(2013-7#1)
the overall hospital##2##3##(1994-1#1)(2008-4#1)
the overall image##2##3##(2007-11#1)(2008-2#1)
the overall impact of this##2##5##(2008-12#1)(2011-2#1)
the overall impact of##3##4##(2007-8#1)(2008-12#1)(2011-2#1)
the overall impact##5##3##(2006-11#1)(2006-4#1)(2007-8#1)(2008-12#1)(2011-2#1)
the overall improvement of##2##4##(2008-12#1)(2011-2#1)
the overall improvement##3##3##(1992-6#1)(2008-12#1)(2011-2#1)
the overall incidence of##3##4##(2007-11#1)(2009-3#1)(2011-12#1)
the overall intensity of##2##4##(2008-3#1)(2012-2#1)
the overall kidding rate##2##4##(2006-5#2)
the overall length##2##3##(1992-11#1)(2013-8#1)
the overall level of##2##4##(1990-12#1)(1990-4#1)
the overall magnitude of##2##4##(2008-2#1)(2008-8#1)
the overall magnitude##3##3##(2008-10#1)(2008-2#1)(2008-8#1)
the overall management##4##3##(2007-6#1)(2008-7#1)(2008-9#1)(2010-3#1)
the overall mean##10##3##(2004-11#1)(2007-11#1)(2008-10#3)(2008-7#1)(2008-9#2)(2010-3#1)(2013-8#1)
the overall mechanism##2##3##(1995-4#1)(2006-10#1)
the overall mortality rate##3##4##(1990-9#1)(1994-7#1)(2013-8#1)
the overall mortality##5##3##(1990-9#1)(1994-7#1)(2006-10#1)(2007-11#1)(2013-8#1)
the overall number of##2##4##(1992-8#1)(2013-1#1)
the overall optical##4##3##(2008-2#1)(2008-3#2)(2011-1#1)
the overall orientation of##2##4##(1995-3#1)(1996-11#1)
the overall outcome of the##3##5##(2007-5#1)(2013-1#2)
the overall outcome of##7##4##(1997-7#1)(2007-10#1)(2007-5#1)(2007-8#1)(2010-3#1)(2013-1#2)
the overall patient##2##3##(2010-8#1)(2011-2#1)
the overall pattern of##2##4##(1990-9#1)(1997-4#1)
the overall pattern##4##3##(1990-9#1)(1994-12#1)(1996-5#1)(1997-4#1)
the overall performance and##2##4##(2008-12#1)(2009-6#1)
the overall performance of the##3##5##(2008-2#1)(2008-5#1)(2010-12#1)
the overall performance of##6##4##(1992-8#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-12#1)
the overall performance##8##3##(1992-8#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-6#1)(2010-12#1)
the overall population##4##3##(1993-5#1)(1995-9#1)(2008-10#1)(2008-7#1)
the overall power##2##3##(1996-8#1)(2010-4#1)
the overall predictive##2##3##(1993-9#1)(2008-10#1)
the overall prevalence of##5##4##(2007-12#3)(2011-2#1)(2012-12#1)
the overall process of##3##4##(2005-11#1)(2007-10#1)(2009-3#1)
the overall process##6##3##(2005-11#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2009-3#1)
the overall prognosis##3##3##(2008-12#1)(2008-4#1)(2009-10#1)
the overall quality of care##2##5##(1995-12#1)(2013-1#1)
the overall quality of the##4##5##(2008-10#1)(2008-11#1)(2008-6#1)(2010-1#1)
the overall quality of##8##4##(1995-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2010-1#1)(2013-1#2)
the overall rate of##9##4##(1991-11#1)(1991-8#1)(1993-11#1)(1994-8#1)(1995-2#1)(1996-11#1)(2006-10#1)(2006-8#1)(2008-7#1)
the overall rate##12##3##(1991-11#1)(1991-8#1)(1993-11#2)(1994-8#1)(1995-10#1)(1995-2#1)(1996-11#1)(2006-10#1)(2006-8#1)(2007-3#1)(2008-7#1)
the overall reaction rate##2##4##(1994-8#1)(2010-5#1)
the overall reaction##5##3##(1990-7#1)(1994-8#1)(2008-10#2)(2010-5#1)
the overall reliability of the##2##5##(2008-11#1)(2008-2#1)
the overall response rate (ORR)##2##5##(2008-10#2)
the overall response rate##3##4##(2008-10#2)(2010-12#1)
the overall response to##2##4##(1997-1#1)(2007-8#1)
the overall response##7##3##(1997-1#1)(1997-6#1)(2007-1#1)(2007-8#1)(2008-10#2)(2010-12#1)
the overall responsibility for##2##4##(2007-10#1)(2008-12#1)
the overall responsibility##3##3##(1993-3#1)(2007-10#1)(2008-12#1)
the overall result##2##3##(2006-8#2)
the overall results in##2##4##(2007-12#1)(2008-1#1)
the overall results##3##3##(2006-8#1)(2007-12#1)(2008-1#1)
the overall risk##3##3##(1994-2#1)(2008-5#1)(2008-7#1)
the overall secondary structure##3##4##(1994-9#1)(1995-8#1)(2006-10#1)
the overall sensitivity of##3##4##(1997-5#1)(2005-8#1)(2010-12#1)
the overall sensitivity##4##3##(1997-5#1)(2005-8#1)(2006-10#1)(2010-12#1)
the overall shape of the##3##5##(1997-5#1)(2008-3#1)(2012-2#1)
the overall shape of##4##4##(1997-5#1)(2008-3#1)(2009-11#1)(2012-2#1)
the overall shape##5##3##(1994-9#1)(1997-5#1)(2008-3#1)(2009-11#1)(2012-2#1)
the overall size of the##2##5##(2008-8#1)(2012-2#1)
the overall stability of the##3##5##(1992-6#1)(1993-9#1)(2008-8#1)
the overall stability of##6##4##(1992-2#1)(1992-6#1)(1993-6#1)(1993-9#1)(2008-8#1)(2013-1#1)
the overall stability##7##3##(1992-2#1)(1992-6#1)(1993-6#1)(1993-9#1)(2008-10#1)(2008-8#1)(2013-1#1)
the overall structure of the##2##5##(1991-5#1)(2011-12#1)
the overall structure of##3##4##(1991-5#1)(1994-8#1)(2011-12#1)
the overall structure##5##3##(1991-5#1)(1991-7#1)(1994-8#1)(2009-2#1)(2011-12#1)
the overall success of##2##4##(2013-1#2)
the overall survival of patients with##2##6##(2006-10#1)(2008-6#1)
the overall survival of##5##4##(2006-10#1)(2008-1#1)(2008-6#1)(2010-5#1)(2013-8#1)
the overall survival rate##2##4##(1995-10#1)(2008-11#1)
the overall survival was##3##4##(2011-2#1)(2012-12#1)(2013-1#1)
the overall survival##17##3##(1991-4#1)(1995-10#1)(1996-11#1)(2006-10#3)(2008-1#1)(2008-11#1)(2008-6#1)(2010-11#2)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
the overall system is##3##4##(1994-8#1)(2008-2#2)
the overall system##8##3##(1994-12#1)(1994-8#1)(2006-10#1)(2008-2#4)(2008-3#1)
the overall treatment##5##3##(1991-12#1)(1995-4#1)(1996-3#1)(2007-12#1)(2010-10#1)
the overall uncertainty##3##3##(2008-3#2)(2011-2#1)
the overall usefulness of##2##4##(2007-1#1)(2008-11#1)
the overall utilization##2##3##(1993-12#1)(2008-3#1)
the overall well-being##3##3##(2006-2#1)(2007-12#1)(2008-12#1)
the overall yield##3##3##(1996-5#1)(2011-2#1)(2013-8#1)
the overall##591##2##(1990-10#3)(1990-11#2)(1990-12#6)(1990-2#1)(1990-3#3)(1990-4#2)(1990-7#2)(1990-8#2)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#3)(1991-4#3)(1991-5#4)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#3)(1992-2#3)(1992-4#2)(1992-6#4)(1992-8#4)(1992-9#3)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#3)(1993-7#1)(1993-9#5)(1994-1#1)(1994-10#2)(1994-12#6)(1994-2#1)(1994-6#2)(1994-7#1)(1994-8#4)(1994-9#4)(1995-1#2)(1995-10#2)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#3)(1995-4#5)(1995-5#3)(1995-7#1)(1995-8#2)(1995-9#3)(1996-1#1)(1996-11#4)(1996-12#3)(1996-2#2)(1996-3#3)(1996-4#2)(1996-5#3)(1996-6#2)(1996-7#3)(1996-8#2)(1996-9#2)(1997-1#4)(1997-2#4)(1997-3#1)(1997-4#3)(1997-5#4)(1997-6#1)(1997-7#2)(2004-11#1)(2004-12#1)(2004-2#1)(2005-10#1)(2005-11#8)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#17)(2006-11#2)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#5)(2006-9#2)(2007-1#3)(2007-10#3)(2007-11#17)(2007-12#11)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#4)(2007-6#2)(2007-8#6)(2007-9#2)(2008-1#6)(2008-10#52)(2008-11#15)(2008-12#10)(2008-2#20)(2008-3#18)(2008-4#8)(2008-5#17)(2008-6#7)(2008-7#12)(2008-8#10)(2008-9#5)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#4)(2009-3#3)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#5)(2010-3#5)(2010-4#2)(2010-5#5)(2010-6#3)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#5)(2011-10#1)(2011-12#2)(2011-2#16)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#15)(2012-3#5)(2013-1#15)(2013-7#2)(2013-8#7)
the overarching##4##2##(1996-2#1)(1996-3#1)(2007-8#1)(2011-2#1)
the overcoming of##2##3##(1991-9#1)(1996-9#1)
the overdose##3##2##(1990-6#1)(1991-8#1)(2009-6#1)
the overexpressed##9##2##(1994-12#2)(1994-5#2)(1995-1#1)(1995-8#1)(1996-5#1)(1997-6#1)(2009-8#1)
the overexpression and##2##3##(1995-6#1)(2011-2#1)
the overexpression of p53##2##4##(2008-10#1)(2010-10#1)
the overexpression of the##2##4##(1991-2#1)(1992-12#1)
the overexpression of##16##3##(1991-2#1)(1992-12#1)(1994-5#1)(1995-1#1)(1995-6#2)(1996-5#1)(2005-11#1)(2007-10#1)(2008-10#2)(2008-11#3)(2010-10#1)(2011-2#1)
the overexpression##18##2##(1991-2#1)(1992-12#1)(1994-5#1)(1995-1#1)(1995-6#3)(1996-5#1)(2005-11#1)(2007-10#1)(2008-10#2)(2008-11#3)(2010-10#1)(2011-2#2)
the overflow of##2##3##(1990-11#1)(2008-2#1)
the overgrowth of##2##3##(1992-10#1)(2008-9#1)
the overgrowth##3##2##(1991-11#1)(1992-10#1)(2008-9#1)
the overhead##2##2##(2008-2#1)(2008-8#1)
the overlap between the##3##4##(1995-8#1)(2008-2#1)(2009-2#1)
the overlap between##8##3##(1995-8#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-2#1)(2010-3#1)
the overlap of the##3##4##(2008-10#2)(2008-2#1)
the overlap of two##2##4##(2008-10#2)
the overlap of##11##3##(1993-4#1)(2006-2#1)(2007-3#1)(2008-10#4)(2008-2#1)(2008-3#2)(2010-12#1)
the overlap##24##2##(1993-4#1)(1995-8#1)(2006-2#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#2)(2008-7#1)(2009-2#1)(2009-8#2)(2010-12#1)(2010-3#1)
the overlapped##3##2##(2008-10#2)(2008-2#1)
the overlapping spectra##2##3##(2008-10#1)(2011-2#1)
the overlapping##28##2##(1990-3#1)(1992-11#1)(1994-11#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-2#2)(2008-10#13)(2008-2#1)(2008-3#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
the overlay##5##2##(1991-7#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-3#1)
the overload phenomenon##3##3##(2008-7#3)
the overload##6##2##(2006-12#1)(2008-7#5)
the overlooked##2##2##(2008-10#1)(2012-12#1)
the overlying##11##2##(1990-6#1)(1993-6#1)(2005-11#1)(2006-10#1)(2006-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-1#1)
the overnight##3##2##(1997-2#1)(2008-10#1)(2011-2#1)
the overpotential##2##2##(2008-10#2)
the overproduction of##6##3##(1992-11#1)(1995-8#2)(2009-8#1)(2011-1#2)
the overproduction##7##2##(1992-11#1)(1995-8#2)(2007-8#1)(2009-8#1)(2011-1#2)
the overriding##3##2##(2007-12#1)(2008-4#1)(2011-1#1)
the overt##3##2##(2006-7#1)(2010-11#1)(2012-1#1)
the overtone##2##2##(2008-10#1)(2008-3#1)
the overutilization of##2##3##(2007-4#2)
the overview##3##2##(2008-4#1)(2009-9#1)(2012-12#1)
the overweight patients##2##3##(2008-10#2)
the overweight##7##2##(1991-12#1)(2006-2#1)(2007-8#1)(2008-10#4)
the overwhelming majority of##4##4##(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
the overwhelming majority##5##3##(2005-10#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
the overwhelming##12##2##(1992-9#1)(1994-3#1)(2005-10#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-2#1)(2011-11#1)(2011-2#1)(2013-1#3)
the oviduct and##3##3##(1991-5#1)(2008-11#1)(2008-5#1)
the oviduct##12##2##(1990-8#1)(1991-5#1)(1992-9#1)(1994-9#1)(1995-6#1)(2007-1#1)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#1)
the oviductal##3##2##(1997-6#1)(2008-12#2)
the ovine and human PACAP##2##5##(1990-12#2)
the ovine##8##2##(1990-12#2)(1991-12#2)(1994-9#1)(1996-12#1)(1997-3#1)(2008-8#1)
the ovipositor##8##2##(2007-12#8)
the ovoid cells##2##3##(2008-7#2)
the ovulation and conception rates##2##5##(2013-8#2)
the ovulation##3##2##(2007-3#1)(2013-8#2)
the ovulatory##2##2##(1992-4#1)(2008-12#1)
the ovules##2##2##(2009-8#2)
the ovum##2##2##(1994-7#1)(1994-8#1)
the own##9##2##(1991-4#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
the owner of##2##3##(1996-5#1)(2011-4#1)
the owner##7##2##(1994-1#1)(1996-5#1)(2010-8#1)(2011-2#1)(2011-4#1)(2013-1#1)(2013-8#1)
the owners##3##2##(1991-11#1)(2008-5#1)(2013-8#1)
the ownership of##2##3##(2008-10#1)(2011-2#1)
the ox liver##2##3##(1995-7#2)
the ox##3##2##(1993-6#1)(1995-7#2)
the oxalacetate pool##2##3##(1991-3#2)
the oxalacetate##3##2##(1991-3#2)(1993-11#1)
the oxalate level for nucleation##2##5##(1995-7#2)
the oxalate##5##2##(1995-7#3)(2008-10#2)
the oxazine##2##2##(1995-3#1)(2007-12#1)
the oxazolidinones##2##2##(2006-8#2)
the oxidant and##3##3##(1994-3#1)(2008-12#2)
the oxidant of choice##2##4##(2007-11#1)(2008-10#1)
the oxidant##27##2##(1994-3#2)(1995-8#2)(1997-6#1)(2005-8#1)(2007-10#1)(2007-11#6)(2008-10#9)(2008-12#2)(2008-5#1)(2009-9#1)(2012-2#1)
the oxidant-resistant phenotype##2##3##(1994-3#2)
the oxidants##3##2##(2007-11#1)(2008-10#1)(2011-2#1)
the oxidase activity##3##3##(1994-3#1)(1996-2#2)
the oxidase was##2##3##(1991-6#1)(1993-8#1)
the oxidase##15##2##(1990-11#1)(1991-2#1)(1991-6#2)(1993-8#3)(1994-12#1)(1994-3#1)(1994-8#1)(1995-2#2)(1996-2#2)(2008-10#1)
the oxidation and reduction##2##4##(2008-10#2)
the oxidation and##3##3##(1993-9#1)(2008-10#2)
the oxidation current##2##3##(2008-10#2)
the oxidation in##2##3##(1997-8#1)(2007-11#1)
the oxidation is##2##3##(1997-8#1)(2008-5#1)
the oxidation of HSO(3)(-)##2##4##(2008-10#2)
the oxidation of LDL##4##4##(1995-12#1)(1997-2#2)(2005-7#1)
the oxidation of N##4##4##(1991-3#1)(2008-10#2)(2008-3#1)
the oxidation of NADH##5##4##(1995-6#1)(2008-10#3)(2008-6#1)
the oxidation of NADPH##2##4##(1995-6#1)(2008-5#1)
the oxidation of NO##3##4##(2008-10#3)
the oxidation of a##2##4##(2008-10#2)
the oxidation of ammonia##2##4##(2008-10#2)
the oxidation of ascorbic acid##2##5##(2008-10#2)
the oxidation of glucose and##2##5##(1990-7#1)(2008-10#1)
the oxidation of glucose##3##4##(1990-7#1)(2008-10#2)
the oxidation of iodide##2##4##(2008-10#2)
the oxidation of iron##2##4##(1994-9#1)(2004-9#1)
the oxidation of luminol by##2##5##(2008-10#2)
the oxidation of luminol with hydrogen peroxide##3##7##(2008-10#3)
the oxidation of luminol##6##4##(2008-10#6)
the oxidation of the##12##4##(1990-12#1)(1991-1#1)(1992-5#1)(1993-6#1)(1994-8#1)(2007-8#2)(2008-10#5)
the oxidation of these##2##4##(2008-10#2)
the oxidation of this##2##4##(1995-7#1)(2008-10#1)
the oxidation of tryptophan residues##2##5##(1992-8#2)
the oxidation of urea with##2##5##(2008-10#2)
the oxidation of urea##3##4##(2008-10#3)
the oxidation of##174##3##(1990-12#2)(1990-4#1)(1990-5#2)(1990-7#1)(1991-1#2)(1991-12#1)(1991-3#1)(1992-5#2)(1992-8#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#3)(1993-9#3)(1994-2#1)(1994-3#1)(1994-5#4)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#3)(1995-7#2)(1996-3#2)(1996-4#1)(1996-7#1)(1997-2#2)(1997-6#1)(1997-8#2)(2004-9#1)(2005-7#1)(2006-12#1)(2006-3#2)(2007-11#3)(2007-2#1)(2007-8#3)(2008-10#101)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-5#1)(2010-7#1)(2011-1#1)
the oxidation peak potential shifts##2##5##(2008-10#2)
the oxidation peak potential##4##4##(2008-10#4)
the oxidation peak##6##3##(2008-10#6)
the oxidation peaks##2##3##(2008-10#2)
the oxidation potential of##2##4##(2005-11#1)(2008-10#1)
the oxidation potential##4##3##(2005-11#1)(2008-10#2)(2010-5#1)
the oxidation process##7##3##(1996-6#1)(2007-8#2)(2008-10#3)(2008-5#1)
the oxidation processes##3##3##(2007-10#1)(2008-10#1)(2008-5#1)
the oxidation product of##4##4##(1992-6#1)(2005-7#1)(2008-10#2)
the oxidation product##5##3##(1992-6#1)(1993-4#1)(2005-7#1)(2008-10#2)
the oxidation rate of##2##4##(1994-2#1)(2008-10#1)
the oxidation rate##3##3##(1994-2#1)(1997-8#1)(2008-10#1)
the oxidation reaction of##11##4##(2008-10#10)(2008-8#1)
the oxidation reaction##14##3##(2008-10#13)(2008-8#1)
the oxidation state of glutathione and##2##6##(1994-6#1)(1995-1#1)
the oxidation state of the##6##5##(1994-9#1)(1997-7#1)(2008-10#3)(2010-5#1)
the oxidation state of##13##4##(1992-8#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1997-6#1)(1997-7#1)(2008-10#5)(2010-5#1)
the oxidation state##18##3##(1990-10#1)(1992-8#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#7)(2009-6#1)(2010-5#1)
the oxidation step##3##3##(2008-10#2)(2012-3#1)
the oxidation##262##2##(1990-10#1)(1990-12#3)(1990-4#1)(1990-5#2)(1990-7#1)(1991-1#2)(1991-12#1)(1991-3#1)(1992-5#2)(1992-6#1)(1992-8#3)(1993-12#1)(1993-3#1)(1993-4#2)(1993-6#3)(1993-9#4)(1994-2#2)(1994-3#1)(1994-5#4)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#3)(1995-7#2)(1996-11#1)(1996-3#2)(1996-4#1)(1996-6#2)(1996-7#1)(1997-2#2)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#5)(2004-9#1)(2005-11#1)(2005-7#2)(2006-12#1)(2006-3#3)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-8#6)(2008-10#149)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#6)(2008-6#2)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#1)(2010-5#3)(2010-7#1)(2011-1#1)(2012-3#1)
the oxidation-labile##2##2##(1990-12#2)
the oxidation-reduction##4##2##(1991-8#1)(1995-8#1)(1997-4#1)(2007-12#1)
the oxidative burst in neutrophils##2##5##(2008-10#2)
the oxidative burst in##4##4##(1994-3#1)(1995-6#1)(2008-10#2)
the oxidative burst##15##3##(1994-3#1)(1995-6#6)(1997-4#1)(2008-10#6)(2009-6#1)
the oxidative cleavage of##2##4##(1990-5#2)
the oxidative coupling of 3-methyl-2-benzothiazolinone hydrazone with N-ethyl-N-(2-hydroxy-3-sulfopropyl)-3##2##8##(2008-10#2)
the oxidative coupling of 3-methyl-2-benzothiazolinone hydrazone##3##6##(2008-10#3)
the oxidative coupling of##6##4##(2008-10#6)
the oxidative coupling reaction of##3##5##(2008-10#2)(2011-1#1)
the oxidative coupling##9##3##(2008-10#8)(2011-1#1)
the oxidative damage##4##3##(1992-4#1)(1997-8#1)(2011-1#1)(2013-1#1)
the oxidative deamination##2##3##(1992-11#1)(2009-8#1)
the oxidative degradation of##3##4##(2008-10#2)(2010-1#1)
the oxidative folding##2##3##(1992-6#1)(2012-2#1)
the oxidative iodination of##4##4##(2007-11#4)
the oxidative modification of##4##4##(1990-5#1)(1997-2#1)(2005-7#1)(2008-10#1)
the oxidative phosphorylation##6##3##(1990-2#2)(1991-5#1)(1997-7#1)(2005-8#1)(2013-8#1)
the oxidative process##2##3##(2008-10#1)(2010-8#1)
the oxidative reaction of##2##4##(2008-10#2)
the oxidative reaction##3##3##(2008-10#3)
the oxidative reactions##2##3##(2008-10#1)(2008-5#1)
the oxidative stress and##2##4##(2011-2#2)
the oxidative stress in the##2##5##(2008-8#1)(2009-4#1)
the oxidative stress in##4##4##(1993-2#1)(2008-8#1)(2009-4#1)(2013-8#1)
the oxidative stress of##2##4##(1992-6#1)(2008-5#1)
the oxidative stress##23##3##(1992-6#1)(1993-2#1)(1993-6#1)(1997-2#1)(1997-5#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-5#2)(2008-8#1)(2009-11#1)(2009-4#2)(2009-5#1)(2010-4#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
the oxidative system##2##3##(2009-12#1)(2011-1#1)
the oxidative##111##2##(1990-11#1)(1990-2#2)(1990-4#1)(1990-5#3)(1991-10#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-6#2)(1993-2#1)(1993-4#2)(1993-6#1)(1994-3#1)(1994-5#1)(1995-6#6)(1995-7#1)(1995-8#1)(1997-2#2)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-12#2)(2006-2#1)(2006-8#2)(2007-11#5)(2007-3#1)(2007-8#1)(2008-10#26)(2008-11#1)(2008-4#1)(2008-5#3)(2008-8#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-4#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#2)
the oxide##11##2##(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-11#3)
the oxides##5##2##(1996-5#1)(2005-11#1)(2007-8#1)(2008-10#1)(2012-2#1)
the oxidisable fraction##2##3##(2008-10#2)
the oxidised##3##2##(1996-8#2)(1997-5#1)
the oxidizable##3##2##(1991-7#1)(2008-10#1)(2008-6#1)
the oxidized and##4##3##(1997-4#2)(2009-7#2)
the oxidized form of##7##4##(1991-4#1)(1993-6#1)(1995-10#1)(2006-12#2)(2008-10#2)
the oxidized form##11##3##(1991-4#1)(1993-6#1)(1995-10#1)(1995-3#1)(1997-4#1)(2006-12#3)(2008-10#2)(2008-11#1)
the oxidized methionine##2##3##(1995-5#2)
the oxidized product##2##3##(2008-10#1)(2010-2#1)
the oxidized protein##3##3##(1991-7#1)(1997-1#1)(1997-4#1)
the oxidized state##5##3##(1990-12#1)(1990-7#2)(1991-4#1)(1997-6#1)
the oxidized##48##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-7#2)(1991-4#3)(1991-7#2)(1992-12#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-3#1)(1995-5#2)(1996-2#1)(1997-1#1)(1997-4#4)(1997-6#1)(2006-12#3)(2007-12#1)(2008-10#8)(2008-11#3)(2009-5#1)(2009-7#2)(2010-2#1)(2010-3#1)
the oxidizing agent##4##3##(2008-10#3)(2012-3#1)
the oxidizing##8##2##(1992-3#1)(1997-7#1)(2008-10#4)(2011-2#1)(2012-3#1)
the oxidoreductase##2##2##(1991-4#1)(1994-6#1)
the oxo group##2##3##(1994-9#2)
the oxo##3##2##(1994-9#2)(1997-7#1)
the oxocarbenium ion##2##3##(1995-1#2)
the oxy##2##2##(1992-8#1)(1994-8#1)
the oxyanion hole##3##3##(1991-2#1)(1991-3#1)(1996-7#1)
the oxyanion##5##2##(1990-2#1)(1991-2#1)(1991-3#1)(1992-9#1)(1996-7#1)
the oxycomplex of isozyme H1##2##5##(1990-2#2)
the oxycomplex of##3##3##(1990-2#3)
the oxycomplex##5##2##(1990-2#5)
the oxyethylene##2##2##(1990-3#1)(1994-12#1)
the oxygen A band##2##4##(2008-3#2)
the oxygen affinity is##2##4##(1990-8#1)(1991-5#1)
the oxygen affinity of hemoglobin##2##5##(1990-8#1)(1992-9#1)
the oxygen affinity of##4##4##(1990-8#1)(1992-9#1)(1993-6#1)(1996-7#1)
the oxygen affinity##9##3##(1990-8#2)(1991-5#1)(1992-9#1)(1993-6#2)(1994-9#1)(1996-7#1)(2013-8#1)
the oxygen atom of##2##4##(2008-3#1)(2008-8#1)
the oxygen atom##3##3##(2008-3#1)(2008-8#1)(2010-5#1)
the oxygen atoms from##2##4##(2008-7#1)(2011-2#1)
the oxygen atoms of the##3##5##(1995-5#1)(2007-11#1)(2012-2#1)
the oxygen atoms##8##3##(1995-5#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)
the oxygen binding properties##2##4##(1993-9#1)(2012-12#1)
the oxygen binding##8##3##(1991-5#1)(1993-9#1)(1994-9#3)(1997-1#1)(2012-12#1)(2013-8#1)
the oxygen concentration##2##3##(2007-8#1)(2008-3#1)
the oxygen consumption##5##3##(1994-8#1)(1997-8#2)(2005-1#1)(2007-8#1)
the oxygen content##3##3##(2005-11#1)(2006-10#1)(2007-7#1)
the oxygen equilibrium properties of##2##5##(1993-8#2)
the oxygen equilibrium##4##3##(1992-9#1)(1993-8#3)
the oxygen free radicals##2##4##(1990-11#1)(2013-8#1)
the oxygen level##2##3##(2008-10#2)
the oxygen of##2##3##(1996-7#1)(2008-5#1)
the oxygen partial pressure##3##4##(2005-11#1)(2008-2#1)(2013-8#1)
the oxygen production##2##3##(1993-12#1)(1995-8#1)
the oxygen saturation of blood in retinal arteries and veins##2##10##(2008-2#1)(2008-3#1)
the oxygen saturation##3##3##(2008-2#2)(2008-3#1)
the oxygen sensor##2##3##(2007-8#1)(2008-10#1)
the oxygen tension##4##3##(1991-8#1)(1994-5#1)(2008-11#1)(2008-9#1)
the oxygen uptake##2##3##(2013-8#2)
the oxygen##105##2##(1990-11#1)(1990-5#1)(1990-8#2)(1991-5#2)(1991-8#1)(1992-11#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-6#4)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-8#1)(1994-9#4)(1995-5#2)(1995-8#1)(1996-7#2)(1997-1#1)(1997-7#2)(1997-8#2)(2005-1#1)(2005-11#2)(2006-10#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#6)(2008-10#10)(2008-11#2)(2008-2#9)(2008-3#6)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-8#8)
the oxygen-binding data##3##3##(1990-8#3)
the oxygen-binding##5##2##(1990-8#5)
the oxygen-rich##2##2##(2008-10#1)(2008-11#1)
the oxygen-sensitive##3##2##(2007-9#1)(2008-10#1)(2012-12#1)
the oxygenase##2##2##(1994-10#1)(1997-4#1)
the oxygenated##6##2##(1990-2#1)(1992-8#2)(1993-8#1)(1993-9#1)(1994-6#1)
the oxygenation of##2##3##(1995-6#1)(2008-8#1)
the oxygenation##3##2##(1990-8#1)(1995-6#1)(2008-8#1)
the oxyhemoglobin level##4##3##(2007-9#4)
the oyster Crassostrea gigas##2##4##(2008-11#2)
the ozonation##3##2##(1992-5#1)(1994-8#1)(2008-9#1)
the ozone layer##5##3##(1991-6#2)(1996-1#2)(2010-12#1)
the ozone profile##3##3##(2008-2#1)(2008-3#2)
the ozone##24##2##(1991-12#1)(1991-6#2)(1996-1#3)(2006-12#1)(2008-11#1)(2008-2#3)(2008-3#8)(2010-12#1)(2010-5#1)(2011-1#1)(2013-8#2)
the ozonotherapy##2##2##(2007-11#2)
the p and##2##3##(2007-12#1)(2010-3#1)
the p instruments##2##3##(1997-8#2)
the p value##2##3##(1994-9#1)(1997-2#1)
the p##15##2##(1994-9#1)(1997-2#1)(1997-4#1)(1997-8#3)(2007-11#1)(2007-12#2)(2008-3#3)(2008-6#1)(2010-3#1)(2013-1#1)
the p-polarized##3##2##(2008-3#3)
the p10##2##2##(1995-12#1)(1996-5#1)
the p13-agarose##2##2##(1994-9#2)
the p15##3##2##(1997-1#3)
the p150 protein##2##3##(1995-6#2)
the p16INK4a and p16beta transcripts##2##5##(1997-7#2)
the p16INK4a##3##2##(1997-7#3)
the p20/p10##2##2##(1996-5#2)
the p21##2##2##(1997-7#1)(2009-4#1)
the p21ras##2##2##(1992-12#1)(1995-11#1)
the p24##2##2##(1991-10#1)(1997-4#1)
the p27##2##2##(2007-6#1)(2007-8#1)
the p34 subunit of##2##4##(1994-8#2)
the p34cdc2 protein kinase##3##4##(1991-6#1)(1993-9#2)
the p35 and p40##2##4##(1996-10#2)
the p38 mitogen-activated protein kinase##2##5##(2008-7#1)(2009-9#1)
the p38##4##2##(1996-3#1)(2008-3#1)(2008-7#1)(2009-9#1)
the p38α##2##2##(2012-3#2)
the p45##3##2##(1996-4#1)(1996-5#2)
the p50/p65##2##2##(1991-7#1)(1994-8#1)
the p53 C-terminus##3##3##(1995-6#3)
the p53 anti-oncogene##2##3##(1990-8#1)(1997-7#1)
the p53 gene are##2##4##(1991-11#1)(1993-10#1)
the p53 gene in##2##4##(1993-11#2)
the p53 gene on##2##4##(1993-3#1)(2008-7#1)
the p53 gene##17##3##(1991-10#1)(1991-11#2)(1993-10#1)(1993-11#2)(1993-3#1)(1996-4#1)(2005-12#2)(2007-11#1)(2007-9#1)(2008-10#2)(2008-6#2)(2008-7#1)
the p53 haploinsufficient##3##3##(2008-8#1)(2008-9#2)
the p53 level##2##3##(1995-8#1)(1997-7#1)
the p53 molecule##2##3##(2007-11#2)
the p53 mutations##3##3##(1991-10#1)(1992-3#1)(2007-5#1)
the p53 pathway##3##3##(2008-9#1)(2009-9#1)(2012-12#1)
the p53 protein##7##3##(1990-8#3)(1992-3#1)(1994-3#1)(2008-5#1)(2013-7#1)
the p53 tumor suppressor gene##4##5##(1993-9#2)(1994-8#1)(1996-6#1)
the p53 tumor suppressor##6##4##(1993-9#2)(1994-5#1)(1994-8#1)(1995-6#1)(1996-6#1)
the p53 tumour suppressor gene##4##5##(1994-2#2)(2008-6#1)(2008-7#1)
the p53 tumour suppressor##5##4##(1994-2#2)(2003-11#1)(2008-6#1)(2008-7#1)
the p53##68##2##(1990-8#5)(1991-10#2)(1991-11#2)(1992-3#2)(1993-10#1)(1993-11#2)(1993-3#1)(1993-9#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-5#1)(1995-6#4)(1995-8#1)(1995-9#1)(1996-4#1)(1996-6#1)(1997-7#3)(2003-11#1)(2005-12#2)(2006-10#1)(2007-11#5)(2007-4#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#3)(2009-9#1)(2010-10#1)(2010-3#3)(2011-2#1)(2012-12#1)(2013-7#1)
the p53-mediated transactivation##2##3##(1993-8#2)
the p53-mediated##4##2##(1993-8#2)(1994-3#1)(1995-2#1)
the p54##2##2##(1997-7#2)
the p57 Xenopus tyrosine kinase##2##5##(1996-5#2)
the p60 TNF receptor##3##4##(1997-6#3)
the p60##5##2##(1996-5#1)(1997-6#4)
the p65 subunit##2##3##(1994-8#1)(1995-3#1)
the p70##3##2##(1992-5#1)(1995-1#1)(1997-6#1)
the p75##3##2##(1992-8#1)(2005-8#1)(2010-8#1)
the p85 subunit##3##3##(1993-6#1)(1994-3#1)(1995-6#1)
the p85##5##2##(1993-6#1)(1994-3#2)(1994-6#1)(1995-6#1)
the p85alpha and##2##3##(1996-8#1)(1997-4#1)
the p86 Ku##2##3##(1995-1#2)
the pCDNA6##2##2##(2011-2#2)
the pCG##2##2##(2009-4#2)
the pGRM-B11 plasmid##2##3##(1990-3#2)
the pH 6##2##3##(1994-8#1)(2008-10#1)
the pH and ionic strength of the##2##7##(2008-10#2)
the pH and ionic strength##3##5##(1990-12#1)(2008-10#2)
the pH and the ionic##2##5##(2005-11#1)(2008-10#1)
the pH and the##3##4##(2005-10#1)(2005-11#1)(2008-10#1)
the pH and##12##3##(1990-12#1)(2005-10#1)(2005-11#1)(2006-10#1)(2008-10#7)(2008-3#1)
the pH at##4##3##(2005-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
the pH change##2##3##(2008-10#2)
the pH dependence of the##7##5##(1990-5#1)(1991-7#1)(1992-3#1)(1993-3#1)(1996-4#1)(2008-10#2)
the pH dependence of##10##4##(1990-5#1)(1991-7#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-5#1)(1996-4#1)(2008-10#2)
the pH dependence##12##3##(1990-5#1)(1991-7#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-5#1)(1996-4#1)(2005-11#1)(2008-10#2)
the pH effect##3##3##(2008-10#3)
the pH from 7##2##4##(1991-8#1)(1996-7#1)
the pH gradient##4##3##(1991-9#1)(1993-12#1)(2008-4#1)(2012-12#1)
the pH in##3##3##(2008-10#3)
the pH increased to##2##4##(2008-10#2)
the pH increased##3##3##(2008-10#2)(2008-6#1)
the pH is##5##3##(1991-2#1)(1993-9#1)(1996-4#1)(1997-7#1)(2008-5#1)
the pH of the analyte solution##2##6##(2008-10#2)
the pH of the aqueous##2##5##(2008-10#2)
the pH of the bulk##2##5##(2008-10#1)(2008-6#1)
the pH of the culture medium##2##6##(1994-12#1)(1995-6#1)
the pH of the medium##4##5##(1994-6#1)(1994-8#1)(2008-10#1)(2013-1#1)
the pH of the mixed##2##5##(2008-10#1)(2008-6#1)
the pH of the perfusion medium##2##6##(1990-2#2)
the pH of the solution##6##5##(1990-11#1)(1990-5#1)(1990-8#1)(2004-9#1)(2008-10#1)(2008-5#1)
the pH of the test solution##2##6##(2008-10#2)
the pH of the##38##4##(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-8#2)(1991-5#1)(1992-6#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-6#2)(2004-9#1)(2005-11#2)(2007-8#1)(2008-10#13)(2008-5#3)(2008-6#2)(2013-1#1)
the pH of##53##3##(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-5#1)(1992-6#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-6#2)(2004-9#1)(2005-11#2)(2006-10#1)(2007-3#1)(2007-8#3)(2008-10#16)(2008-11#1)(2008-5#5)(2008-6#2)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
the pH optimum of##2##4##(1993-11#1)(1996-5#1)
the pH optimum##5##3##(1992-7#1)(1993-11#1)(1996-5#2)(2006-10#1)
the pH or the ionic strength##2##6##(1990-5#1)(1990-6#1)
the pH or##3##3##(1990-5#1)(1990-6#1)(2013-1#1)
the pH range 1##2##4##(2008-10#2)
the pH range 2##4##4##(2008-10#4)
the pH range 2-10##2##4##(1991-2#1)(2008-10#1)
the pH range 3##6##4##(1990-5#1)(2008-10#5)
the pH range 4##6##4##(2008-10#5)(2010-4#1)
the pH range 5##5##4##(1992-6#1)(1996-11#1)(2008-10#2)(2008-3#1)
the pH range 6##4##4##(2008-10#3)(2008-5#1)
the pH range 7##4##4##(1992-12#1)(1995-5#1)(1997-1#1)(2008-10#1)
the pH range from 1 to##2##6##(2008-10#2)
the pH range from 1##3##5##(2008-10#3)
the pH range from##8##4##(1994-3#1)(2008-10#7)
the pH range of 1##3##5##(2008-10#3)
the pH range of 2##5##5##(2008-10#5)
the pH range of 4-8##2##5##(2008-10#2)
the pH range of 5##2##5##(2008-10#1)(2013-8#1)
the pH range of 6##6##5##(1992-7#1)(1993-3#1)(1997-8#1)(2008-10#3)
the pH range of##32##4##(1990-7#1)(1991-9#1)(1992-7#2)(1993-3#1)(1997-8#1)(2005-11#1)(2007-8#1)(2008-10#21)(2008-4#1)(2010-9#1)(2013-8#1)
the pH range##96##3##(1990-5#1)(1990-7#1)(1991-2#2)(1991-9#1)(1992-12#1)(1992-6#1)(1992-7#2)(1993-3#1)(1994-3#1)(1994-8#1)(1995-5#2)(1996-11#1)(1997-1#1)(1997-3#2)(1997-8#1)(2005-11#1)(2007-8#1)(2008-10#66)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2010-4#1)(2010-8#1)(2010-9#1)(2013-8#1)
the pH response of##2##4##(2008-10#2)
the pH response##3##3##(2008-10#3)
the pH sensitivity of##2##4##(1997-4#1)(2009-11#1)
the pH to##4##3##(1991-8#2)(2008-10#2)
the pH value of the##2##5##(2005-11#1)(2008-10#1)
the pH value of##3##4##(2005-11#1)(2008-10#1)(2012-12#1)
the pH value was##3##4##(2008-10#3)
the pH value##14##3##(1991-8#1)(1997-7#1)(2005-11#1)(2008-10#7)(2009-11#1)(2012-12#2)(2012-2#1)
the pH values were##2##4##(2006-10#1)(2008-10#1)
the pH values##5##3##(1992-12#1)(2006-10#1)(2008-10#3)
the pH was adjusted##3##4##(1991-4#1)(2008-10#2)
the pH was##10##3##(1990-6#1)(1991-4#1)(1995-5#1)(2004-9#1)(2008-10#4)(2008-6#1)(2013-8#1)
the pH without##2##3##(1997-6#1)(2008-5#1)
the pH##330##2##(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#3)(1990-7#1)(1990-8#2)(1991-2#4)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#4)(1991-9#2)(1992-12#2)(1992-3#1)(1992-6#2)(1992-7#4)(1993-11#2)(1993-12#1)(1993-3#3)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#2)(1995-3#1)(1995-5#4)(1995-6#3)(1996-11#1)(1996-4#2)(1996-5#3)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#1)(2004-4#1)(2004-9#2)(2005-10#2)(2005-11#11)(2005-12#1)(2006-10#6)(2006-3#1)(2006-6#1)(2007-3#1)(2007-8#4)(2007-9#1)(2008-10#154)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#13)(2008-6#6)(2009-11#2)(2009-12#2)(2010-4#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#4)(2012-2#1)(2013-1#3)(2013-8#5)
the pH-dependent##6##2##(1990-8#1)(1992-4#1)(1995-2#1)(1997-3#1)(2008-6#1)(2008-9#1)
the pH-induced##2##2##(1992-12#1)(1995-3#1)
the pH-value##2##2##(2013-1#2)
the pH1N1##2##2##(2012-2#2)
the pHg/pSILBAγ##2##2##(2011-1#2)
the pHi##5##2##(1991-5#2)(1992-4#1)(1994-11#1)(2008-9#1)
the pHs were##2##3##(2004-9#2)
the pI of the##2##4##(1992-12#1)(2006-10#1)
the pI##6##2##(1990-5#1)(1992-1#1)(1992-12#1)(2006-10#1)(2008-10#1)(2008-5#1)
the pK of##2##3##(1994-5#1)(1996-5#1)
the pK value##2##3##(1992-7#1)(2005-11#1)
the pK values for##2##4##(1990-8#1)(1991-9#1)
the pK values of##2##4##(1990-11#2)
the pK values##4##3##(1990-11#2)(1990-8#1)(1991-9#1)
the pK##9##2##(1990-11#2)(1990-8#1)(1991-9#1)(1992-7#1)(1994-5#1)(1995-2#1)(1996-5#1)(2005-11#1)
the pK(a) of the##2##4##(2008-10#2)
the pK(a) value##2##3##(2007-12#1)(2008-10#1)
the pK(a) values##4##3##(2008-10#4)
the pK(a)##10##2##(2007-12#1)(2008-10#9)
the pKa and##2##3##(1996-8#1)(1997-2#1)
the pKa of the leaving group##5##6##(1991-7#3)(1993-8#2)
the pKa of the##6##4##(1991-7#3)(1993-8#2)(1995-5#1)
the pKa of##9##3##(1991-7#5)(1993-2#1)(1993-8#2)(1995-5#1)
the pKa value##2##3##(1994-11#1)(2008-6#1)
the pKa values of##2##4##(2008-10#1)(2008-3#1)
the pKa##15##2##(1991-7#5)(1993-2#1)(1993-8#2)(1994-11#1)(1995-5#1)(1996-8#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-6#1)
the pKa1##2##2##(1990-5#1)(2008-10#1)
the pMLZ-4 mRNA##2##3##(1993-2#2)
the pNPPase activity##2##3##(1997-1#2)
the pNZ8149-scd1##2##2##(2013-1#2)
the pO(2) in##2##3##(2006-7#1)(2008-11#1)
the pO(2)##3##2##(2006-7#1)(2008-11#2)
the pOSEX##2##2##(1994-12#2)
the pQE30##2##2##(1997-4#1)(2005-11#1)
the pS2 gene##3##3##(1990-2#3)
the pS2##4##2##(1990-2#4)
the pTC##3##2##(2012-2#3)
the pUC19##3##2##(1990-5#1)(1991-7#1)(1991-9#1)
the pace of##7##3##(1995-2#1)(2006-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
the pace##11##2##(1992-3#1)(1993-2#1)(1995-2#1)(2006-12#1)(2006-9#1)(2009-6#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
the pacemaker##5##2##(1994-11#1)(1994-2#1)(1997-1#1)(2006-9#1)(2008-3#1)
the pacific##5##2##(1994-11#1)(2008-10#2)(2012-2#1)(2013-1#1)
the package insert##3##3##(2006-10#2)(2006-11#1)
the package##17##2##(2005-10#2)(2006-10#4)(2006-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-7#1)(2012-2#1)
the packaged##2##2##(1991-5#1)(1992-8#1)
the packaging of##3##3##(2008-2#1)(2008-4#1)(2009-8#1)
the packaging##9##2##(1990-3#2)(2005-11#1)(2006-11#2)(2007-12#1)(2008-2#1)(2008-4#1)(2009-8#1)
the packed##4##2##(2008-10#2)(2008-6#1)(2013-8#1)
the packed-bedreactor##2##2##(2008-11#2)
the packet loss rate##5##4##(2008-3#5)
the packet##8##2##(2007-12#1)(2008-3#7)
the packing density of##3##4##(2008-3#1)(2008-9#1)(2013-1#1)
the packing density##4##3##(1990-11#1)(2008-3#1)(2008-9#1)(2013-1#1)
the packing of##2##3##(2005-11#1)(2008-10#1)
the packing##15##2##(1990-11#2)(1990-3#1)(1996-8#1)(2005-11#1)(2006-8#1)(2007-11#2)(2008-10#2)(2008-3#2)(2008-9#1)(2013-1#1)(2013-8#1)
the paclitaxel##2##2##(1997-4#1)(2010-11#1)
the padding##2##2##(2007-4#2)
the paediatric age group##6##4##(2006-4#2)(2008-11#1)(2009-10#1)(2013-8#2)
the paediatric age##8##3##(2006-4#2)(2008-11#1)(2008-9#1)(2009-10#1)(2013-1#1)(2013-8#2)
the paediatric and##3##3##(2008-9#2)(2012-1#1)
the paediatric chest##3##3##(2005-11#3)
the paediatric health care##2##4##(2008-11#2)
the paediatric intensive care##2##4##(2010-7#1)(2013-1#1)
the paediatric##54##2##(1996-6#1)(1996-9#1)(2005-11#4)(2006-10#6)(2006-2#1)(2006-4#2)(2006-8#1)(2006-9#1)(2008-10#3)(2008-11#10)(2008-12#1)(2008-7#1)(2008-9#5)(2009-10#1)(2009-5#1)(2010-3#1)(2010-7#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#5)(2013-8#3)
the pages of##4##3##(2008-1#1)(2008-4#1)(2009-10#1)(2011-2#1)
the pages##5##2##(2006-3#1)(2008-1#1)(2008-4#1)(2009-10#1)(2011-2#1)
the paid##2##2##(2011-2#1)(2013-1#1)
the pain and stiffness of osteoarthritis##3##6##(2006-10#3)
the pain and##9##3##(1995-12#1)(2006-10#4)(2008-12#1)(2009-1#1)(2012-2#1)(2013-1#1)
the pain associated with chest drain##2##6##(2007-8#2)
the pain associated with##3##4##(2007-8#3)
the pain by##2##3##(1990-3#1)(2007-7#1)
the pain clinician##2##3##(2006-11#1)(2006-12#1)
the pain generator##2##3##(2006-12#1)(2012-2#1)
the pain in##3##3##(1993-8#1)(2006-10#1)(2008-8#1)
the pain is##8##3##(1990-6#1)(1992-2#1)(2007-7#2)(2008-7#1)(2008-9#1)(2012-2#2)
the pain of##3##3##(2006-10#1)(2010-1#1)(2012-1#1)
the pain patch]##2##3##(1997-6#2)
the pain school##2##3##(1991-5#2)
the pain scores##2##3##(2006-10#2)
the pain status##2##3##(2006-6#1)(2012-2#1)
the pain syndrome##5##3##(2006-6#1)(2007-11#1)(2008-6#1)(2011-2#2)
the pain threshold##3##3##(1991-2#1)(2008-5#1)(2010-12#1)
the pain was##3##3##(1996-3#1)(2006-8#1)(2008-6#1)
the pain##102##2##(1990-3#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-5#2)(1992-2#3)(1993-1#2)(1993-8#1)(1995-12#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-6#2)(2004-10#1)(2004-12#1)(2005-10#1)(2006-10#9)(2006-11#2)(2006-12#2)(2006-3#1)(2006-6#2)(2006-8#2)(2007-10#1)(2007-11#5)(2007-12#1)(2007-7#4)(2007-8#4)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-9#2)(2010-1#1)(2010-12#1)(2010-4#2)(2010-7#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#7)(2012-3#1)(2013-1#3)
the painful ankle/foot##4##3##(2006-12#4)
the painful area##2##3##(2010-7#2)
the painful shoulder##4##3##(2006-12#3)(2007-11#1)
the painful##19##2##(2006-10#1)(2006-12#7)(2007-11#1)(2008-1#1)(2008-3#1)(2008-8#1)(2009-9#1)(2010-11#1)(2010-7#3)(2011-2#1)(2012-12#1)
the paint layer##2##3##(2007-12#1)(2008-3#1)
the paint##8##2##(2007-12#3)(2008-10#1)(2008-3#2)(2013-8#2)
the painted surface##4##3##(2008-10#4)
the painted##5##2##(2008-10#4)(2013-8#1)
the painting##2##2##(2008-10#1)(2008-6#1)
the pair of##4##3##(1995-2#1)(1995-5#1)(2007-12#1)(2008-2#1)
the pair##8##2##(1995-2#1)(1995-5#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2011-2#1)
the paired t test##2##4##(1990-12#1)(2010-10#1)
the paired t-test##8##3##(2007-8#1)(2008-10#6)(2012-2#1)
the paired##22##2##(1990-12#1)(1991-8#1)(1993-6#1)(1994-6#2)(1994-8#1)(1995-5#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-10#6)(2010-10#1)(2011-2#1)(2012-2#3)
the pairs of##2##3##(1994-3#1)(2008-3#1)
the pairs##7##2##(1993-6#1)(1994-3#1)(1994-6#1)(1996-6#1)(1997-1#1)(2008-3#1)(2008-5#1)
the pairwise##4##2##(2006-11#1)(2007-9#1)(2011-2#1)(2012-1#1)
the palatal##5##2##(2007-12#1)(2009-7#1)(2009-8#1)(2012-12#1)(2012-2#1)
the palate##13##2##(1990-1#1)(1991-1#2)(1991-2#1)(1996-8#1)(2006-2#1)(2009-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)
the palea##2##2##(2008-10#2)
the palindromic##2##2##(1994-5#1)(1994-9#1)
the palladium##3##2##(2008-10#3)
the palliation of##3##3##(2007-5#1)(2008-4#1)(2008-7#1)
the palliative care team##2##4##(1996-2#1)(2010-8#1)
the palliative care##5##3##(1996-2#1)(2005-4#1)(2006-4#1)(2007-8#1)(2010-8#1)
the palliative treatment of##4##4##(1990-6#1)(2008-3#1)(2008-5#1)(2008-6#1)
the palliative##17##2##(1990-6#1)(1991-12#1)(1992-4#1)(1996-2#1)(2005-4#1)(2006-4#1)(2007-11#1)(2007-8#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-9#1)(2010-8#1)
the pallidum##4##2##(1991-5#1)(1995-5#1)(2008-7#1)(2009-2#1)
the palm##16##2##(2006-3#1)(2007-12#1)(2008-10#4)(2008-6#4)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)
the palmar arch##2##3##(2008-9#1)(2011-2#1)
the palmar##10##2##(2006-3#2)(2007-7#1)(2008-9#4)(2011-2#2)(2012-2#1)
the palmaris longus##2##3##(2008-9#1)(2009-1#1)
the palmitic acid##3##3##(1991-5#1)(1994-5#1)(2012-11#1)
the palmitic##4##2##(1991-5#2)(1994-5#1)(2012-11#1)
the palmitoylated cysteine 341##2##4##(1996-8#2)
the palms##3##2##(1997-3#1)(2008-10#1)(2012-3#1)
the palpebral and##2##3##(2011-1#1)(2013-1#1)
the palpebral##4##2##(1991-5#1)(2007-3#1)(2011-1#1)(2013-1#1)
the palsy##2##2##(2006-12#1)(2009-7#1)
the pamphlets##7##2##(1990-2#7)
the pan##2##2##(1997-1#1)(2013-8#1)
the panacea##2##2##(2008-2#1)(2008-6#1)
the pancake##2##2##(2005-11#2)
the pancreas and the##5##4##(1990-3#1)(1993-3#1)(1993-5#1)(2008-10#1)(2011-2#1)
the pancreas and##17##3##(1990-3#1)(1990-6#1)(1991-3#1)(1993-3#1)(1993-5#2)(1994-8#1)(2006-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-12#1)(2011-2#1)(2013-1#2)
the pancreas are##5##3##(2006-10#1)(2006-6#1)(2008-1#1)(2013-1#2)
the pancreas have##2##3##(2008-8#1)(2009-5#1)
the pancreas is a rare##2##5##(2008-3#1)(2013-1#1)
the pancreas is a##4##4##(2006-10#1)(2006-8#1)(2008-3#1)(2013-1#1)
the pancreas is##13##3##(1990-3#1)(1991-3#1)(1991-9#1)(1992-6#1)(2006-10#4)(2006-8#1)(2008-3#1)(2012-2#1)(2013-1#2)
the pancreas may##2##3##(2008-7#1)(2013-7#1)
the pancreas of##8##3##(1990-2#1)(1992-12#1)(1994-3#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-3#1)
the pancreas on##2##3##(2006-6#1)(2008-7#1)
the pancreas showed##2##3##(2010-11#1)(2013-1#1)
the pancreas that##3##3##(1992-8#1)(2005-10#2)
the pancreas##181##2##(1990-2#2)(1990-3#7)(1990-6#1)(1990-9#7)(1991-10#1)(1991-3#2)(1991-5#1)(1991-9#3)(1992-12#1)(1992-5#2)(1992-6#3)(1992-8#1)(1992-9#1)(1993-10#1)(1993-3#2)(1993-5#6)(1994-3#5)(1994-8#1)(1995-10#1)(1997-5#1)(1997-8#1)(2005-10#4)(2006-10#13)(2006-2#1)(2006-4#2)(2006-6#9)(2006-8#1)(2007-10#2)(2007-12#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2008-1#5)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#11)(2008-5#1)(2008-7#9)(2008-8#4)(2009-2#2)(2009-5#2)(2010-10#1)(2010-11#4)(2010-12#13)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#4)(2013-1#18)(2013-7#2)
the pancreas]##3##2##(1991-3#1)(1992-2#1)(2006-6#1)
the pancreatic acinar cells##3##4##(2008-7#1)(2009-7#2)
the pancreatic acinar##6##3##(1991-1#1)(1993-3#1)(1997-7#1)(2008-7#1)(2009-7#2)
the pancreatic beta-cells##3##3##(1991-1#1)(1991-12#1)(1992-12#1)
the pancreatic duct and##3##4##(2006-6#2)(2010-12#1)
the pancreatic duct##9##3##(2006-6#3)(2008-10#2)(2009-7#1)(2010-12#2)(2011-2#1)
the pancreatic head##6##3##(1990-9#1)(1993-3#1)(2008-10#2)(2008-6#1)(2013-1#1)
the pancreatic islet##5##3##(1991-7#1)(1996-6#1)(1997-4#1)(2008-11#1)(2010-10#1)
the pancreatic islets of Langerhans##2##5##(1997-4#1)(2010-12#1)
the pancreatic islets of##3##4##(1995-10#1)(1997-4#1)(2010-12#1)
the pancreatic islets##6##3##(1995-10#2)(1997-4#1)(2007-5#1)(2010-10#1)(2010-12#1)
the pancreatic juice##2##3##(2009-7#2)
the pancreatic parenchyma##2##3##(2009-7#1)(2010-12#1)
the pancreatic polypeptide##2##3##(1992-11#1)(1996-12#1)
the pancreatic secretion##3##3##(2004-12#1)(2008-10#1)(2012-1#1)
the pancreatic β-cell##2##3##(2010-10#1)(2013-1#1)
the pancreatic##81##2##(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-3#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-6#2)(1995-10#2)(1995-5#1)(1995-6#1)(1996-12#3)(1996-4#1)(1996-6#1)(1997-4#2)(1997-7#2)(1997-8#1)(2004-12#1)(2005-9#1)(2006-10#2)(2006-6#4)(2006-8#1)(2007-4#1)(2007-5#3)(2008-10#5)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-7#6)(2010-10#3)(2010-11#2)(2010-12#4)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
the pancreaticoduodenal##4##2##(1990-10#1)(1991-6#1)(1995-2#1)(2008-7#1)
the pancreatitis pathway##2##3##(2008-3#2)
the pancreatitis##8##2##(2006-10#1)(2006-4#2)(2008-3#2)(2013-8#3)
the pandemic (H1N1) 2009 virus##2##5##(2011-2#2)
the pandemic##9##2##(2007-2#1)(2008-10#1)(2008-4#1)(2011-2#5)(2012-12#1)
the panel of##6##3##(1992-9#1)(1997-1#1)(2006-12#1)(2008-10#1)(2011-2#1)(2012-12#1)
the panel##28##2##(1991-7#1)(1992-9#1)(1993-12#1)(1995-6#1)(1997-1#1)(1997-6#1)(2005-7#5)(2006-12#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-7#1)(2009-6#1)(2009-9#2)(2010-12#2)(2011-2#2)(2012-12#1)(2012-3#1)
the panelists##4##2##(2006-4#1)(2008-5#3)
the panellists##2##2##(2008-5#1)(2010-4#1)
the panic##3##2##(1995-1#2)(2007-9#1)
the pap smear##3##3##(2006-10#1)(2008-3#1)(2011-2#1)
the pap##6##2##(1997-4#2)(2006-10#2)(2008-3#1)(2011-2#1)
the paper &quot##2##3##(2008-1#1)(2008-10#1)
the paper addresses##2##3##(1997-8#1)(2012-2#1)
the paper affirms##2##3##(1991-4#1)(2006-7#1)
the paper and##2##3##(2006-12#1)(2010-12#1)
the paper are##4##3##(1990-12#1)(2006-6#1)(2007-8#1)(2008-10#1)
the paper argues##2##3##(2008-5#1)(2008-7#1)
the paper by##4##3##(1996-1#1)(1997-2#1)(2008-2#1)(2008-3#1)
the paper considers##2##3##(2008-11#1)(2011-1#1)
the paper deals##2##3##(2008-5#1)(2009-6#1)
the paper describes the##2##4##(1992-5#1)(2008-1#1)
the paper describes##3##3##(1992-5#1)(2008-1#1)(2008-11#1)
the paper focuses on##2##4##(2007-10#1)(2008-12#1)
the paper illustrates##2##3##(1992-9#1)(1996-3#1)
the paper is##15##3##(1996-1#1)(1996-9#1)(2006-5#1)(2006-6#3)(2007-11#1)(2007-6#1)(2008-1#1)(2008-12#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
the paper of##2##3##(2008-10#1)(2012-2#1)
the paper reviews##2##3##(2008-11#1)(2010-1#1)
the paper sheet phantom##3##4##(2008-2#3)
the paper shows how##2##4##(2006-7#1)(2007-12#1)
the paper shows that##2##4##(2010-5#1)(2011-2#1)
the paper shows##4##3##(2006-7#1)(2007-12#1)(2010-5#1)(2011-2#1)
the paper we##4##3##(2007-11#1)(2008-5#1)(2009-8#1)(2013-8#1)
the paper##130##2##(1990-10#1)(1990-12#1)(1990-6#1)(1991-2#1)(1991-4#1)(1992-5#1)(1992-9#2)(1993-10#2)(1994-12#1)(1995-8#1)(1996-1#3)(1996-3#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-7#1)(2005-6#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#5)(2006-7#2)(2007-10#4)(2007-11#3)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#8)(2008-11#4)(2008-12#6)(2008-2#10)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#3)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#7)(2011-3#2)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#1)(2013-8#2)
the paper's##4##2##(2008-12#1)(2008-2#3)
the papers in this##2##4##(2007-8#1)(2008-2#1)
the papers in##3##3##(1992-6#1)(2007-8#1)(2008-2#1)
the papers that##2##3##(1993-12#1)(2013-1#1)
the papers##15##2##(1992-6#1)(1993-12#1)(1994-6#1)(1996-1#1)(2007-8#2)(2008-10#1)(2008-2#2)(2008-7#1)(2008-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
the papilla of Vater##2##4##(2006-6#1)(2011-2#1)
the papilla##6##2##(1990-3#1)(2006-2#1)(2006-6#2)(2008-5#1)(2011-2#1)
the papillae##3##2##(1993-12#1)(2008-5#1)(2011-2#1)
the papillary##7##2##(1990-9#1)(2006-1#1)(2008-5#1)(2010-6#3)(2011-2#1)
the papillomavirus##2##2##(1994-8#1)(1997-2#1)
the para position##4##3##(1994-5#1)(1997-1#1)(2008-10#1)(2013-1#1)
the para##6##2##(1994-3#1)(1994-5#1)(1997-1#1)(2008-10#1)(2010-7#1)(2013-1#1)
the paraaortic splanchnopleura##2##3##(1995-1#2)
the parabolic##8##2##(2007-11#2)(2008-2#3)(2008-3#3)
the parabrachial nucleus##2##3##(1993-12#1)(2009-10#1)
the parabrachial##4##2##(1992-10#1)(1993-12#1)(1996-9#1)(2009-10#1)
the paracetamol group##2##3##(1990-8#2)
the paracetamol##4##2##(1990-8#2)(2008-10#1)(2010-3#1)
the paracrine##5##2##(1991-7#1)(2007-11#1)(2008-6#1)(2009-9#1)(2013-1#1)
the paradigm for##4##3##(1993-1#1)(2008-3#1)(2011-2#1)(2012-3#1)
the paradigm of the##5##4##(2008-2#1)(2008-7#1)(2012-12#1)(2013-1#2)
the paradigm of##10##3##(2006-12#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#2)
the paradigm##24##2##(1991-1#2)(1993-1#1)(1994-12#1)(1995-5#1)(1997-2#1)(2006-12#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#3)
the paradox of enrichment##2##4##(2008-8#1)(2008-9#1)
the paradox of##6##3##(2006-11#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#2)
the paradox##9##2##(2006-11#1)(2007-8#1)(2008-1#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#2)(2013-8#1)
the paradoxical##5##2##(1995-7#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-11#1)
the paraelectric phase##2##3##(2008-2#1)(2008-3#1)
the paraffin##2##2##(2008-5#2)
the paraffin-embedded##2##2##(1996-12#1)(2013-7#1)
the parahippocampal gyrus and medial inferotemporal cortex##2##7##(1990-10#2)
the parahippocampal gyrus##3##3##(1990-10#2)(1997-8#1)
the parahippocampal##6##2##(1990-10#2)(1991-3#1)(1993-5#2)(1997-8#1)
the parallel application of##2##4##(2007-8#1)(2013-7#1)
the parallel wire construct##3##4##(2009-3#3)
the parallel##30##2##(1991-11#1)(1991-12#1)(1991-5#2)(1995-5#1)(1997-7#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-2#3)(2008-5#2)(2008-6#1)(2009-10#1)(2009-3#3)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
the parallel-hole SPECT##2##3##(2009-8#2)
the parallel-slab##3##2##(2008-3#3)
the parallel-stranded d(T-C-G-A) duplex##2##4##(1994-9#2)
the parallels##3##2##(1991-2#1)(2007-12#1)(2009-2#1)
the paralyzed##2##2##(2006-3#1)(2007-11#1)
the paramagnetic##7##2##(1991-7#1)(1993-6#2)(1994-5#1)(1994-8#1)(1997-4#1)(2011-2#1)
the paramedical##4##2##(1995-1#1)(2007-10#1)(2007-7#1)(2011-2#1)
the parameter estimates for drip irrigation##2##6##(2008-10#2)
the parameter estimates##8##3##(1992-6#1)(1992-8#1)(2008-10#5)(2010-2#1)
the parameter of##4##3##(2008-3#1)(2008-9#2)(2009-3#1)
the parameter plane##2##3##(1993-9#1)(2008-10#1)
the parameter range##2##3##(2007-12#2)
the parameter space of##2##4##(1993-9#1)(2005-11#1)
the parameter space##9##3##(1993-9#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-6#1)(2010-10#1)(2010-6#1)
the parameter to be##2##4##(2008-10#2)
the parameter values##4##3##(2008-10#2)(2008-12#1)(2008-2#1)
the parameter weights##2##3##(2008-10#2)
the parameter##55##2##(1992-4#1)(1992-6#2)(1992-8#1)(1993-4#1)(1993-9#2)(2005-11#1)(2006-10#2)(2007-11#4)(2007-12#2)(2007-3#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-3#1)(2009-5#1)(2010-10#1)(2010-2#2)(2010-6#1)(2012-2#1)(2013-8#1)
the parameterized##2##2##(2008-2#1)(2008-3#1)
the parameters affecting the##4##4##(1990-12#1)(2008-10#3)
the parameters and##2##3##(2008-12#1)(2009-5#1)
the parameters are##3##3##(1995-4#1)(1997-2#1)(2005-4#1)
the parameters characterizing the##2##4##(1997-2#1)(2006-9#1)
the parameters considered##3##3##(1990-11#1)(1997-1#1)(2006-11#1)
the parameters for the##2##4##(2008-10#1)(2008-3#1)
the parameters for##5##3##(2006-12#1)(2008-10#1)(2008-3#2)(2013-1#1)
the parameters in the##8##4##(1992-6#1)(1995-8#1)(1995-9#1)(1997-2#1)(2008-2#1)(2008-7#1)(2009-8#1)(2010-8#1)
the parameters in##10##3##(1992-6#1)(1993-6#1)(1995-8#1)(1995-9#1)(1997-2#1)(2007-12#1)(2008-2#1)(2008-7#1)(2009-8#1)(2010-8#1)
the parameters influencing the##2##4##(1996-5#1)(2008-7#1)
the parameters involved##2##3##(1992-7#1)(2010-12#1)
the parameters needed to##2##4##(2008-10#1)(2008-3#1)
the parameters of a##4##4##(2006-4#1)(2007-12#1)(2008-3#2)
the parameters of interest##4##4##(1993-9#1)(1995-6#1)(1996-7#1)(2008-3#1)
the parameters of the deterministic##2##5##(1991-12#2)
the parameters of the model##6##5##(1996-8#1)(1997-2#1)(2008-10#1)(2008-3#1)(2010-6#1)(2011-1#1)
the parameters of the##38##4##(1990-2#1)(1991-12#2)(1992-6#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-4#1)(1996-8#1)(1997-2#1)(2004-2#1)(2005-11#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-2#6)(2008-3#3)(2008-7#1)(2009-10#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#1)
the parameters of this##2##4##(1996-2#1)(2013-1#1)
the parameters of##79##3##(1990-2#1)(1991-12#2)(1991-2#1)(1991-9#1)(1992-6#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-4#1)(1995-6#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-2#1)(2004-2#1)(2005-1#1)(2005-10#1)(2005-11#2)(2006-4#1)(2007-11#4)(2007-12#4)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#10)(2008-3#8)(2008-4#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#4)(2013-1#2)(2013-7#1)(2013-8#1)
the parameters studied##4##3##(1994-6#1)(2006-6#1)(2008-4#1)(2010-4#1)
the parameters such as##2##4##(2012-12#1)(2013-8#1)
the parameters that affect the reaction were evaluated##2##8##(2008-10#2)
the parameters that affect the##5##5##(2008-10#3)(2008-11#1)(2008-4#1)
the parameters that affect##7##4##(1990-12#1)(1992-3#1)(2008-10#3)(2008-11#1)(2008-4#1)
the parameters that characterize the##4##5##(2007-12#1)(2008-2#1)(2008-3#2)
the parameters that characterize##5##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
the parameters that control##2##4##(1995-9#1)(2008-8#1)
the parameters that describe##2##4##(2008-10#1)(2008-3#1)
the parameters that influence the##2##5##(1996-1#1)(2008-10#1)
the parameters that##24##3##(1990-12#1)(1992-3#1)(1995-9#1)(1996-1#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-8#1)(2009-7#1)(2011-2#1)(2013-1#1)
the parameters to##2##3##(2008-10#1)(2011-2#1)
the parameters used##5##3##(1992-9#1)(2006-11#1)(2007-4#1)(2007-6#1)(2010-6#1)
the parameters were##3##3##(1994-8#1)(2007-1#1)(2008-7#1)
the parameters##212##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#1)(1991-12#2)(1991-2#1)(1991-9#1)(1992-2#3)(1992-3#2)(1992-6#2)(1992-7#1)(1992-9#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-4#2)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#6)(1997-7#1)(2004-12#2)(2004-2#1)(2005-1#1)(2005-10#1)(2005-11#4)(2005-4#1)(2006-11#2)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#6)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#32)(2008-11#1)(2008-12#5)(2008-2#14)(2008-3#19)(2008-4#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#2)(2010-8#2)(2011-1#3)(2011-2#5)(2011-3#1)(2012-1#5)(2012-12#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
the parametric and nonparametric components##2##5##(2009-10#1)(2010-7#1)
the parametric and nonparametric##4##4##(2009-10#3)(2010-7#1)
the parametric bootstrap##2##3##(2006-5#2)
the parametric gain##3##3##(2007-11#1)(2007-12#2)
the parametric model##3##3##(2008-10#1)(2010-1#1)(2011-1#1)
the parametric##28##2##(1993-5#1)(1996-1#1)(1997-5#1)(1997-8#1)(2004-9#1)(2006-5#2)(2007-11#1)(2007-12#5)(2008-10#1)(2008-2#2)(2008-3#4)(2009-10#3)(2010-1#2)(2010-5#1)(2010-7#1)(2011-1#1)
the paramount##5##2##(1990-5#1)(1991-10#1)(1995-12#1)(2008-5#1)(2010-7#1)
the paranasal sinuses and##2##4##(2005-5#1)(2006-6#1)
the paranasal sinuses##7##3##(1991-6#1)(2005-5#1)(2006-12#2)(2006-6#1)(2008-11#1)(2011-2#1)
the paranasal##8##2##(1991-6#1)(2005-5#1)(2006-12#2)(2006-6#1)(2008-11#1)(2011-2#1)(2013-1#1)
the paranoid##2##2##(1997-2#1)(2007-7#1)
the paraoesophageal##3##2##(1997-3#1)(2005-1#2)
the paraoxonase##2##2##(1995-9#1)(1996-3#1)
the parapharyngeal space##4##3##(2006-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
the parasagittal##2##2##(2004-11#1)(2006-11#1)
the parasite and##5##3##(1992-9#1)(1996-6#1)(2006-10#2)(2012-2#1)
the parasite is##5##3##(1990-2#1)(2007-2#1)(2007-6#1)(2008-8#1)(2012-12#1)
the parasite life cycle##2##4##(1997-6#1)(2012-3#1)
the parasite may##2##3##(2006-10#1)(2008-8#1)
the parasite population##2##3##(1997-7#1)(2012-12#1)
the parasite species##2##3##(2012-12#2)
the parasite to##3##3##(1996-12#1)(2008-9#1)(2012-12#1)
the parasite were##3##3##(2005-8#1)(2006-10#1)(2008-5#1)
the parasite within##2##3##(2010-12#1)(2011-1#1)
the parasite##99##2##(1990-2#1)(1991-10#1)(1991-2#1)(1992-7#2)(1992-8#2)(1992-9#2)(1993-6#1)(1994-11#1)(1994-5#1)(1995-8#1)(1996-12#1)(1996-6#2)(1996-8#1)(1997-6#2)(1997-7#2)(2005-8#1)(2006-10#12)(2007-10#1)(2007-2#1)(2007-3#3)(2007-5#1)(2007-6#2)(2007-9#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#6)(2008-5#3)(2008-8#6)(2008-9#5)(2009-6#1)(2010-12#2)(2010-2#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-12#6)(2012-2#5)(2012-3#3)(2013-1#2)(2013-8#1)
the parasite's##6##2##(1990-12#1)(1994-8#1)(2005-7#1)(2006-10#1)(2008-9#1)(2009-8#1)
the parasites are##2##3##(1996-8#1)(2008-5#1)
the parasites of##4##3##(2008-4#1)(2012-12#1)(2013-1#2)
the parasites to##2##3##(2007-1#1)(2008-2#1)
the parasites were##2##3##(1997-4#1)(2008-5#1)
the parasites##21##2##(1996-12#1)(1996-8#1)(1997-4#2)(2007-1#1)(2007-7#2)(2007-8#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#2)(2011-2#2)(2012-12#1)(2013-1#2)
the parasitic nematode##2##3##(1990-6#1)(1991-7#1)
the parasitic plants##2##3##(2009-8#2)
the parasitic##21##2##(1990-11#1)(1990-6#1)(1990-7#2)(1991-7#1)(1995-1#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-12#3)(2008-10#2)(2008-8#2)(2008-9#1)(2009-8#2)(2012-2#2)
the parasitism index##2##3##(2008-6#2)
the parasitism##8##2##(2008-5#1)(2008-6#7)
the parasitoid larva##2##3##(2007-12#2)
the parasitoid larvae##2##3##(2007-12#2)
the parasitoid wasp##2##3##(1992-6#1)(2008-8#1)
the parasitoid##13##2##(1992-6#1)(2007-12#10)(2008-8#1)(2008-9#1)
the parasitoids##4##2##(2007-12#1)(2008-6#2)(2009-6#1)
the parasitological##2##2##(2005-8#1)(2008-8#1)
the paraspinal##2##2##(2007-1#1)(2008-12#1)
the parasternal lymph nodes##2##4##(1993-8#2)
the parasternal lymph##3##3##(1993-8#3)
the parathyroid hormone##4##3##(1991-5#1)(1992-9#1)(1996-5#1)(2008-5#1)
the parathyroid##11##2##(1990-6#2)(1990-9#1)(1991-5#1)(1992-9#1)(1996-12#1)(1996-5#1)(2007-3#2)(2008-5#2)
the paraventricular and supraoptic nuclei##3##5##(1995-12#1)(1995-7#1)(1997-8#1)
the paraventricular and##4##3##(1990-11#1)(1995-12#1)(1995-7#1)(1997-8#1)
the paraventricular hypothalamic nucleus##4##4##(1993-9#1)(1994-10#2)(1994-2#1)
the paraventricular nucleus (P &lt##2##5##(1996-12#2)
the paraventricular nucleus (PVN) of the hypothalamus##3##7##(1995-12#2)(1996-12#1)
the paraventricular nucleus (PVN)##6##4##(1993-7#1)(1995-12#3)(1996-12#1)(2005-10#1)
the paraventricular nucleus of the hypothalamus (PVN)##3##7##(1994-2#1)(1996-4#1)(1997-8#1)
the paraventricular nucleus of the hypothalamus##7##6##(1992-8#1)(1994-2#1)(1995-12#3)(1996-4#1)(1997-8#1)
the paraventricular nucleus was##2##4##(1994-10#1)(1995-7#1)
the paraventricular nucleus##27##3##(1992-8#1)(1993-2#3)(1993-7#1)(1994-10#1)(1994-2#1)(1994-9#1)(1995-12#7)(1995-7#1)(1996-12#3)(1996-4#1)(1996-9#4)(1997-8#2)(2005-10#1)
the paraventricular##39##2##(1990-11#1)(1990-2#1)(1992-8#1)(1993-12#1)(1993-2#3)(1993-7#1)(1993-9#1)(1994-10#4)(1994-2#2)(1994-9#1)(1995-12#8)(1995-7#2)(1996-12#4)(1996-4#1)(1996-9#4)(1997-8#3)(2005-10#1)
the paravertebral##4##2##(1991-8#1)(1997-6#1)(2006-10#1)(2010-12#1)
the paraxial approximation the##2##4##(2007-11#1)(2008-2#1)
the paraxial approximation##6##3##(2007-11#2)(2007-12#3)(2008-2#1)
the paraxial##14##2##(2007-11#3)(2007-12#4)(2008-2#4)(2008-3#3)
the parenchyma of the##3##4##(1994-3#1)(2006-7#2)
the parenchyma of##4##3##(1994-3#1)(1997-8#1)(2006-7#2)
the parenchyma##11##2##(1990-3#1)(1994-3#1)(1996-1#1)(1997-8#1)(2006-10#2)(2006-7#2)(2007-9#2)(2008-10#1)
the parenchymal##4##2##(1996-2#1)(2007-5#1)(2008-5#1)(2008-6#1)
the parent and##3##3##(2008-10#2)(2012-2#1)
the parent body of the##2##5##(1992-2#2)
the parent clone##2##3##(2007-1#2)
the parent compound and##2##4##(1990-2#1)(1996-7#1)
the parent compound##24##3##(1990-12#2)(1990-2#1)(1990-3#1)(1991-5#1)(1992-5#1)(1993-2#1)(1993-4#1)(1994-11#1)(1995-6#1)(1996-10#1)(1996-7#1)(1996-9#1)(1997-2#1)(2006-12#1)(2008-11#3)(2008-5#2)(2010-11#1)(2010-12#1)(2010-2#2)
the parent compounds##5##3##(1994-3#1)(1995-7#1)(2008-10#1)(2009-12#1)(2010-4#1)
the parent drug were##2##4##(2008-10#2)
the parent drug##15##3##(1993-2#1)(1994-11#1)(1995-3#1)(2008-10#5)(2008-5#1)(2008-8#2)(2010-12#1)(2011-3#1)(2013-1#2)
the parent ion##3##3##(2008-10#3)
the parent ligase##2##3##(1991-4#2)
the parent molecule##4##3##(1990-6#1)(1992-12#1)(2008-3#1)(2009-7#1)
the parent peptide##3##3##(1992-4#1)(1994-10#2)
the parent protein##2##3##(1995-10#1)(2008-4#1)
the parent strain##6##3##(1997-7#1)(2005-11#1)(2008-10#1)(2008-7#1)(2013-1#2)
the parent substrate##2##3##(1994-12#2)
the parent##135##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-4#2)(1991-5#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-5#1)(1992-9#2)(1993-2#2)(1993-4#1)(1994-10#2)(1994-11#3)(1994-12#5)(1994-3#1)(1994-8#3)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-10#1)(1996-2#2)(1996-4#1)(1996-6#1)(1996-7#2)(1996-9#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-4#1)(2005-11#1)(2006-12#2)(2006-5#2)(2006-8#1)(2007-1#2)(2007-11#2)(2007-6#1)(2007-8#2)(2008-10#19)(2008-11#5)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#7)(2008-7#2)(2008-8#3)(2009-12#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2011-1#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
the parent's##7##2##(1993-2#1)(1995-9#1)(2009-7#3)(2012-12#1)(2013-1#1)
the parent-child relationship##4##3##(1992-2#1)(1995-5#1)(1996-9#1)(2010-9#1)
the parent-child##6##2##(1992-2#1)(1995-5#1)(1996-9#1)(2008-4#1)(2009-12#1)(2010-9#1)
the parental and##2##3##(2008-10#1)(2008-11#1)
the parental care##4##3##(2008-8#1)(2008-9#3)
the parental cell line##2##4##(1995-3#1)(2008-4#1)
the parental cells and##2##4##(1992-5#1)(1995-5#1)
the parental cells##10##3##(1991-1#1)(1992-5#1)(1993-4#1)(1993-7#1)(1993-9#1)(1994-3#2)(1995-5#2)(1996-6#1)
the parental enzyme##3##3##(1992-3#1)(1995-3#2)
the parental generation##2##3##(1997-5#1)(2008-9#1)
the parental isolates##3##3##(2008-10#3)
the parental line##3##3##(1994-11#1)(1995-6#1)(1997-7#1)
the parental lines##6##3##(1994-12#1)(2008-10#2)(2008-11#1)(2008-5#2)
the parental origin of the##2##5##(1993-1#1)(1997-3#1)
the parental origin##3##3##(1993-1#1)(1997-3#1)(2010-12#1)
the parental population##2##3##(1991-4#1)(2011-1#1)
the parental species##6##3##(2008-8#1)(2013-1#5)
the parental strain##10##3##(1993-11#1)(1993-9#1)(1995-8#1)(2008-10#5)(2008-5#1)(2009-6#1)
the parental strains##2##3##(2005-11#1)(2008-12#1)
the parental tumor##2##3##(1990-8#1)(1995-5#1)
the parental virus##3##3##(2008-10#1)(2013-8#2)
the parental##118##2##(1990-12#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-4#2)(1991-6#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#3)(1995-5#6)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-11#2)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#6)(2009-11#1)(2009-2#1)(2009-4#2)(2009-6#1)(2010-12#2)(2010-4#1)(2011-1#2)(2011-2#2)(2012-11#2)(2012-3#1)(2013-1#7)(2013-8#5)
the parenteral##4##2##(1990-2#1)(2005-7#1)(2007-11#1)(2012-12#1)
the parenting stress of mothers##2##5##(2007-10#2)
the parenting##4##2##(2007-10#2)(2007-8#2)
the parents and the##2##4##(1990-12#1)(2008-10#1)
the parents and##10##3##(1990-12#1)(1993-7#1)(2006-8#1)(2008-10#4)(2008-4#1)(2009-4#1)(2011-2#1)
the parents of the##4##4##(1995-5#1)(2008-10#1)(2008-11#1)(2008-4#1)
the parents of##10##3##(1990-2#1)(1995-12#1)(1995-5#1)(2004-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)
the parents or##4##3##(2005-7#1)(2007-7#1)(2010-4#1)(2011-2#1)
the parents to##2##3##(2009-11#1)(2013-1#1)
the parents were##4##3##(1995-12#1)(2008-10#2)(2013-7#1)
the parents##65##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#1)(1992-4#1)(1993-7#1)(1995-12#3)(1995-5#2)(1996-2#2)(2004-12#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-2#2)(2007-7#2)(2008-10#18)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2013-1#4)(2013-7#2)
the parents'##10##2##(1990-12#1)(1993-12#1)(1994-3#1)(1995-5#1)(1996-2#1)(1997-5#1)(2005-12#1)(2008-2#1)(2008-4#1)(2010-9#1)
the parents]##2##2##(1997-2#1)(2008-4#1)
the paretic arm##2##3##(2012-1#2)
the paretic hand##3##3##(2007-11#1)(2012-1#2)
the paretic leg##5##3##(2012-1#5)
the paretic##13##2##(2007-10#1)(2007-11#1)(2012-1#11)
the parhelic circle##4##3##(2008-3#4)
the parietal and##4##3##(1991-10#1)(1995-6#1)(2012-1#1)(2013-8#1)
the parietal cell##13##3##(1995-11#1)(1997-1#3)(2006-10#8)(2012-12#1)
the parietal cells##6##3##(1992-3#1)(1992-6#1)(1993-6#1)(2007-12#1)(2012-1#1)(2013-8#1)
the parietal cortex of##2##4##(1991-2#1)(2007-9#1)
the parietal cortex##11##3##(1991-2#2)(1992-8#2)(1994-12#1)(1997-5#1)(1997-6#3)(2007-9#1)(2010-7#1)
the parietal lobe##4##3##(1997-6#1)(2007-10#1)(2007-9#1)(2008-7#1)
the parietal##49##2##(1991-10#1)(1991-2#2)(1992-3#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-4#1)(1993-6#1)(1994-12#1)(1995-1#2)(1995-11#1)(1995-6#1)(1997-1#3)(1997-5#1)(1997-6#4)(2006-10#8)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-9#2)(2008-10#1)(2008-5#1)(2008-7#2)(2010-10#1)(2010-7#1)(2012-1#2)(2012-12#1)(2013-8#2)
the parieto-occipital##2##2##(1995-12#1)(1997-1#1)
the parish of##2##3##(1992-1#1)(1993-12#1)
the parish##3##2##(1992-1#1)(1993-12#2)
the parity##2##2##(2008-11#1)(2010-4#1)
the park##3##2##(1994-11#1)(2008-5#1)(2008-8#1)
the parkin##3##2##(2005-10#1)(2008-11#1)(2012-12#1)
the parkinsonian striatum##2##3##(1990-10#2)
the parkinsonian##5##2##(1990-10#2)(1991-9#1)(2008-7#1)(2012-2#1)
the parotid gland in##2##4##(1992-5#1)(2010-12#1)
the parotid gland is a##2##5##(2007-5#2)
the parotid gland is##3##4##(1996-5#1)(2007-5#2)
the parotid gland##28##3##(1991-6#2)(1992-5#2)(1996-5#1)(1996-6#1)(1997-5#1)(2007-10#1)(2007-5#5)(2008-4#1)(2009-3#1)(2010-12#4)(2010-2#1)(2012-2#3)(2013-1#1)(2013-8#4)
the parotid glands##3##3##(1992-11#1)(1993-12#1)(2007-10#1)
the parotid##38##2##(1990-11#1)(1991-6#2)(1992-11#1)(1992-5#2)(1993-10#1)(1993-12#1)(1996-5#1)(1996-6#1)(1997-5#1)(2007-10#2)(2007-5#6)(2008-4#1)(2009-10#1)(2009-3#1)(2010-12#4)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#1)(2013-8#4)
the pars esophagus##2##3##(2006-8#2)
the pars reticulata of the substantia nigra##2##7##(1992-9#2)
the pars reticulata of##3##4##(1992-9#3)
the pars##9##2##(1992-7#1)(1992-9#3)(1993-2#1)(2006-8#2)(2007-11#1)(2010-12#1)
the parsimony of##2##3##(2006-10#1)(2010-11#1)
the parsimony##3##2##(2006-10#1)(2008-4#1)(2010-11#1)
the part I and the part II receiving fibers##2##9##(2008-2#2)
the part of the##24##4##(1990-11#1)(1990-12#1)(1991-3#1)(1993-10#1)(1995-2#1)(1995-5#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-5#2)(2008-9#2)(2009-2#1)(2009-4#1)(2010-12#1)(2010-5#1)(2012-12#1)
the part of##51##3##(1990-11#1)(1990-12#1)(1991-3#1)(1992-1#2)(1992-3#1)(1993-10#1)(1994-1#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-9#1)(1997-3#1)(2005-10#1)(2005-4#1)(2006-12#1)(2006-2#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-9#2)(2009-2#1)(2009-4#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
the part played by##2##4##(2007-9#1)(2009-8#1)
the part that##2##3##(1996-12#1)(2010-2#1)
the part they play in the##2##6##(1996-2#1)(2006-6#1)
the part##65##2##(1990-11#1)(1990-12#1)(1991-3#1)(1991-4#1)(1992-1#2)(1992-3#1)(1993-10#1)(1994-1#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-9#1)(1997-3#1)(2005-10#1)(2005-11#1)(2005-4#1)(2006-12#1)(2006-2#2)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-5#3)(2008-9#2)(2009-2#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
the parthenogenetic##2##2##(2008-12#1)(2012-2#1)
the partial amino acid sequence##2##5##(1991-1#1)(1993-9#1)
the partial amino acid##3##4##(1991-1#1)(1993-9#1)(2008-10#1)
the partial and##2##3##(1996-9#1)(2006-6#1)
the partial characterization of a##2##5##(1990-2#1)(2008-10#1)
the partial charges##2##3##(2007-9#2)
the partial least squares (PLS)##2##5##(2008-10#2)
the partial least squares##4##4##(2007-11#1)(2008-10#3)
the partial least##5##3##(2007-11#1)(2008-10#4)
the partial least-squares##3##3##(2008-10#3)
the partial likelihood##2##3##(1994-9#2)
the partial molar volumes of##2##5##(2006-10#2)
the partial molar##4##3##(1997-2#1)(2006-10#2)(2008-10#1)
the partial or complete##2##4##(1991-2#1)(2008-10#1)
the partial phase diagram##2##4##(2004-9#2)
the partial positive##2##3##(1992-3#2)
the partial pressure of oxygen##3##5##(2006-7#1)(2008-10#1)(2009-3#1)
the partial pulpotomy##2##3##(1990-3#1)(2012-2#1)
the partial reactions##2##3##(1995-8#1)(1997-6#1)
the partial recovery##3##3##(1990-5#1)(2008-10#2)
the partial sequences##2##3##(1991-2#1)(2008-5#1)
the partial##88##2##(1990-2#2)(1990-3#2)(1990-5#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-9#1)(1992-3#2)(1992-7#1)(1993-12#3)(1993-2#1)(1993-4#1)(1993-9#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-8#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-5#1)(1997-6#1)(1997-7#1)(2004-9#2)(2005-11#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-9#2)(2008-10#20)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#1)
the partially denervated EDL##2##4##(1995-9#2)
the partially denervated##3##3##(1995-9#3)
the partially purified preparation of##2##5##(1990-2#2)
the partially purified##9##3##(1990-2#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1992-2#1)(1993-3#1)(1996-8#1)
the partially resistant##4##3##(2008-10#4)
the partially unfolded##2##3##(1995-3#2)
the partially##36##2##(1990-2#2)(1990-5#1)(1990-6#1)(1990-8#2)(1991-12#1)(1991-3#2)(1991-9#1)(1992-2#1)(1993-3#1)(1993-8#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-9#3)(1996-3#1)(1996-8#1)(1997-2#2)(2007-7#1)(2008-10#4)(2008-2#1)(2008-5#2)(2010-12#1)(2010-2#1)
the participant in##2##3##(2008-3#1)(2013-1#1)
the participant##16##2##(2006-2#1)(2008-10#1)(2008-12#2)(2008-3#2)(2008-9#1)(2009-12#1)(2009-2#1)(2010-2#2)(2010-5#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
the participant's##6##2##(2008-1#1)(2008-11#1)(2008-9#1)(2010-2#1)(2013-1#1)(2013-8#1)
the participants (n =##2##4##(2007-10#1)(2012-3#1)
the participants from the other nations##2##6##(2006-8#2)
the participants from the##3##4##(1991-10#1)(2006-8#2)
the participants from##4##3##(1991-10#1)(2006-8#2)(2010-7#1)
the participants had##5##3##(1994-12#1)(2007-7#1)(2008-10#1)(2010-10#1)(2012-2#1)
the participants in both seminars##2##5##(2010-1#2)
the participants in##7##3##(2006-8#1)(2007-7#1)(2009-10#1)(2010-1#2)(2011-2#1)(2012-1#1)
the participants of##4##3##(2008-12#1)(2010-11#1)(2011-12#1)(2012-2#1)
the participants to##2##3##(2009-4#1)(2012-2#1)
the participants was##6##3##(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2012-1#1)(2012-12#1)
the participants were tested##3##4##(2006-8#2)(2008-7#1)
the participants were##18##3##(1991-12#1)(2005-9#1)(2006-7#1)(2006-8#3)(2007-2#1)(2007-7#1)(2008-7#1)(2009-6#1)(2009-9#2)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#2)
the participants with##5##3##(2006-3#1)(2007-12#1)(2010-12#1)(2013-1#1)(2013-8#1)
the participants##114##2##(1990-12#1)(1991-10#1)(1991-12#1)(1991-3#1)(1992-12#1)(1993-6#1)(1994-12#1)(1995-1#2)(1995-5#2)(1997-8#1)(2005-9#1)(2006-10#2)(2006-3#1)(2006-7#2)(2006-8#8)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#3)(2007-7#5)(2007-8#1)(2008-1#4)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#3)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#4)(2010-7#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#4)(2013-8#4)
the participants'##15##2##(2004-12#1)(2007-12#1)(2008-11#1)(2008-3#1)(2010-1#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
the participating hospitals##2##3##(1991-2#1)(1994-3#1)
the participating laboratories##2##3##(2008-10#1)(2008-12#1)
the participating students##2##3##(2008-11#1)(2012-12#1)
the participating##22##2##(1991-2#2)(1991-8#1)(1992-5#1)(1994-3#1)(1994-6#1)(1996-9#1)(2005-11#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#1)(2012-12#1)(2012-3#1)(2013-1#1)
the participation of a##2##4##(1990-12#1)(2012-1#1)
the participation of an##4##4##(2007-8#1)(2008-10#1)(2008-5#1)(2010-4#1)
the participation of other##2##4##(1992-11#1)(1994-8#1)
the participation of patients##2##4##(2008-11#1)(2010-4#1)
the participation of the##8##4##(1990-5#1)(1993-10#1)(1994-1#1)(2008-8#1)(2009-11#1)(2009-2#1)(2012-12#1)(2013-1#1)
the participation of this##4##4##(1991-1#1)(1995-6#1)(2004-8#1)(2008-7#1)
the participation of##60##3##(1990-12#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-3#1)(1991-5#1)(1992-11#2)(1992-5#1)(1992-8#1)(1993-10#1)(1993-11#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#3)(1996-4#1)(1996-8#1)(2004-8#1)(2005-11#1)(2005-7#1)(2006-11#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#2)(2009-11#1)(2009-2#2)(2009-7#1)(2010-10#1)(2010-2#1)(2010-4#2)(2011-2#1)(2012-1#2)(2012-12#2)(2013-1#1)
the participation##63##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-3#1)(1991-5#1)(1992-11#2)(1992-5#1)(1992-8#1)(1993-10#1)(1993-11#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#3)(1996-4#1)(1996-8#1)(2004-8#1)(2005-11#1)(2005-7#1)(2006-11#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-5#3)(2008-7#1)(2008-8#2)(2009-11#1)(2009-2#3)(2009-7#1)(2010-10#1)(2010-2#1)(2010-4#2)(2011-2#2)(2012-1#2)(2012-12#2)(2013-1#1)
the particle and the##4##4##(2005-11#1)(2007-12#1)(2008-3#2)
the particle and##6##3##(2005-11#2)(2007-12#1)(2008-3#2)(2008-7#1)
the particle boundaries##2##3##(2008-3#2)
the particle core##4##3##(2005-11#2)(2006-12#2)
the particle density and the##2##5##(2008-1#1)(2008-2#1)
the particle diameter##3##3##(2007-9#1)(2008-2#1)(2008-3#1)
the particle distribution##2##3##(1992-2#1)(1992-3#1)
the particle is##2##3##(2007-12#1)(2008-3#1)
the particle motion##2##3##(2006-2#1)(2008-3#1)
the particle parameters##2##3##(2008-3#2)
the particle several##2##3##(2008-3#2)
the particle shape##3##3##(2007-12#2)(2008-3#1)
the particle shell##2##3##(2005-11#2)
the particle size and##4##4##(2005-11#1)(2007-11#2)(2010-5#1)
the particle size distribution (PSD)##2##5##(2005-11#1)(2008-3#1)
the particle size distribution##7##4##(1992-2#1)(2005-11#1)(2007-11#1)(2008-3#3)(2008-7#1)
the particle size is##2##4##(2008-2#1)(2013-8#1)
the particle size of the##2##5##(1997-2#1)(2008-8#1)
the particle size of##5##4##(1997-2#1)(2007-8#1)(2008-8#1)(2013-8#2)
the particle size##37##3##(1991-7#1)(1992-2#1)(1997-2#2)(2004-9#1)(2005-11#4)(2007-11#4)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#5)(2008-5#2)(2008-7#1)(2008-8#2)(2009-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-8#4)
the particle sizes##2##3##(2008-3#2)
the particle surface##5##3##(2005-11#1)(2007-8#1)(2008-10#1)(2010-1#1)(2013-1#1)
the particle swarm##2##3##(2007-9#2)
the particle volume##2##3##(2008-2#1)(2008-3#1)
the particle was##3##3##(2008-10#1)(2008-2#1)(2010-4#1)
the particle##139##2##(1991-5#1)(1991-6#1)(1991-7#1)(1992-2#2)(1992-3#1)(1992-6#1)(1994-11#1)(1994-3#1)(1997-2#2)(2004-9#2)(2005-10#1)(2005-11#27)(2006-12#2)(2006-2#1)(2007-11#9)(2007-12#4)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#6)(2008-2#11)(2008-3#33)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-2#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-4#4)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#4)
the particle's##2##2##(2007-11#1)(2008-3#1)
the particle-induced error##2##3##(2008-3#2)
the particle-particle##3##2##(2005-11#1)(2010-4#1)(2010-7#1)
the particle-size distribution##2##3##(2008-3#2)
the particle-size distributions##2##3##(2008-2#1)(2008-3#1)
the particle-size##6##2##(2008-2#2)(2008-3#4)
the particle/matrix interfaces##2##3##(2004-9#1)(2009-7#1)
the particles and##6##3##(2005-11#1)(2006-2#1)(2008-11#1)(2008-3#2)(2012-11#1)
the particles are##5##3##(2005-11#2)(2006-5#1)(2008-3#2)
the particles in##6##3##(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)
the particles that are##2##4##(2005-11#1)(2008-3#1)
the particles that##3##3##(1993-8#1)(2005-11#1)(2008-3#1)
the particles to##2##3##(2005-11#1)(2008-6#1)
the particles was##4##3##(2004-9#1)(2005-11#1)(2008-10#2)
the particles were##7##3##(1990-8#1)(1997-1#1)(2008-10#1)(2008-3#2)(2010-2#1)(2010-4#1)
the particles with##3##3##(1992-6#1)(2008-2#1)(2008-3#1)
the particles##96##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-7#1)(1992-6#1)(1992-8#1)(1993-4#1)(1993-8#2)(1995-2#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-2#1)(2004-9#2)(2005-11#15)(2006-12#2)(2006-2#2)(2006-5#2)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#12)(2008-11#1)(2008-2#8)(2008-3#15)(2008-5#2)(2008-6#1)(2008-8#2)(2009-3#1)(2010-2#1)(2010-4#2)(2010-7#1)(2012-11#6)(2012-3#1)(2013-1#2)
the particles' surface##2##3##(2005-11#2)
the particles'##6##2##(2005-11#3)(2007-11#1)(2008-3#1)(2009-9#1)
the particular case of a##4##5##(1997-7#1)(2005-11#1)(2007-12#2)
the particular case of##6##4##(1997-7#1)(2005-11#1)(2007-12#2)(2008-2#1)(2012-12#1)
the particular challenges##2##3##(1992-3#1)(2008-11#1)
the particular characteristics##2##3##(2008-4#1)(2010-2#1)
the particular functional##2##3##(1993-8#1)(2008-7#1)
the particular needs of##2##4##(2006-5#1)(2012-3#1)
the particular patient##2##3##(2008-4#1)(2011-1#1)
the particular problems##2##3##(1991-12#1)(2007-11#1)
the particular risk##2##3##(2006-10#1)(2008-8#1)
the particular##94##2##(1990-3#1)(1991-12#1)(1991-8#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-5#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-6#1)(1997-4#1)(1997-7#1)(2004-4#1)(2005-10#1)(2005-11#2)(2006-10#4)(2006-12#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#5)(2008-4#7)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#2)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
the particularities of##3##3##(2009-4#1)(2012-12#1)(2013-1#1)
the particularities##4##2##(2009-4#2)(2012-12#1)(2013-1#1)
the particularly##2##2##(1996-8#1)(2008-9#1)
the particulate and##3##3##(1996-12#1)(1997-2#1)(2009-11#1)
the particulate attenuation at##2##4##(2008-3#2)
the particulate attenuation##3##3##(2008-3#3)
the particulate fraction of##5##4##(1993-7#1)(1995-12#1)(1996-5#2)(1997-1#1)
the particulate fraction##20##3##(1991-2#1)(1992-11#2)(1992-8#1)(1993-7#1)(1994-12#2)(1994-8#1)(1995-12#1)(1995-3#2)(1995-8#1)(1996-11#3)(1996-5#3)(1997-1#2)
the particulate matter##4##3##(2008-10#3)(2008-3#1)
the particulate nature of##2##4##(2012-3#2)
the particulate phase##3##3##(2009-11#3)
the particulate##44##2##(1991-2#2)(1992-11#2)(1992-3#1)(1992-8#1)(1993-7#1)(1994-12#2)(1994-8#1)(1995-12#1)(1995-3#3)(1995-8#1)(1996-11#3)(1996-12#1)(1996-5#3)(1997-1#2)(1997-2#1)(2007-8#2)(2008-10#3)(2008-2#2)(2008-3#6)(2009-11#4)(2012-3#2)
the parties##4##2##(1990-2#1)(1992-2#1)(2007-4#2)
the parties'##2##2##(2007-4#1)(2009-4#1)
the partition coefficient of the substrate##2##6##(1990-5#2)
the partition coefficient of the##3##5##(1990-5#2)(2008-10#1)
the partition coefficient of##5##4##(1990-5#2)(2008-10#2)(2012-1#1)
the partition coefficient##11##3##(1990-5#2)(1996-2#1)(2004-12#1)(2006-10#1)(2008-10#4)(2008-6#1)(2012-1#1)
the partition coefficients of##2##4##(2006-12#1)(2008-7#1)
the partition coefficients##8##3##(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#3)(2008-7#1)(2013-1#1)
the partition equilibrium##2##3##(1990-11#1)(1991-9#1)
the partition for various diluents##2##5##(2008-10#2)
the partition function##2##3##(2006-10#1)(2009-11#1)
the partition locus##2##3##(1990-3#1)(1995-8#1)
the partition of##3##3##(1990-11#1)(1992-7#1)(2008-11#1)
the partition##37##2##(1990-11#2)(1990-3#1)(1990-4#1)(1990-5#2)(1991-5#1)(1991-9#1)(1992-7#1)(1994-5#1)(1995-8#1)(1996-2#1)(2004-12#1)(2006-10#5)(2006-12#1)(2007-11#1)(2008-10#10)(2008-11#1)(2008-6#1)(2008-7#1)(2009-11#1)(2012-1#1)(2012-3#1)(2013-1#1)
the partitioning of the##4##4##(1992-12#1)(2008-10#1)(2008-2#1)(2008-9#1)
the partitioning of##17##3##(1990-4#1)(1991-7#1)(1992-12#2)(1993-6#1)(1996-8#1)(2005-11#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-8#2)(2008-9#1)(2012-2#1)
the partitioning process##2##3##(1992-12#1)(2008-10#1)
the partitioning##22##2##(1990-4#1)(1991-7#1)(1992-12#3)(1992-6#1)(1993-6#1)(1996-8#1)(2005-11#1)(2006-10#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-6#1)(2008-8#2)(2008-9#1)(2012-2#1)
the partner##12##2##(1990-5#1)(1992-7#1)(1992-9#3)(2006-9#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-9#1)(2009-12#1)(2010-5#1)
the partner's##3##2##(2006-9#2)(2008-8#1)
the partner-affirmation process##2##3##(2009-9#2)
the partners in the##2##4##(1990-2#1)(2008-12#1)
the partners who##2##3##(2008-12#1)(2009-4#1)
the partners##14##2##(1990-2#1)(1990-8#1)(2007-12#4)(2007-4#1)(2008-12#2)(2008-6#1)(2008-7#1)(2009-4#1)(2009-6#1)(2010-10#1)
the partnership between the##2##4##(2007-10#1)(2010-5#1)
the partnership between##3##3##(2007-10#1)(2010-5#1)(2012-3#1)
the partnership##6##2##(1997-2#2)(2007-10#1)(2009-5#1)(2010-5#1)(2012-3#1)
the partnerships##2##2##(1996-9#1)(1997-2#1)
the partogram##3##2##(1992-5#3)
the parts of the##2##4##(2008-3#1)(2012-2#1)
the parts of##3##3##(2008-3#1)(2008-7#1)(2012-2#1)
the parts##16##2##(1997-8#2)(2007-12#1)(2007-3#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-8#1)(2011-12#1)(2012-2#3)(2013-1#1)
the parturient##5##2##(1993-10#2)(1993-7#1)(2006-10#2)
the party##2##2##(2008-7#1)(2008-8#1)
the parvicellular reticular formation##2##4##(1995-7#2)
the parvicellular##4##2##(1995-7#2)(1996-9#1)(2008-4#1)
the parvocellular pathway##2##3##(1996-2#1)(1996-5#1)
the parvocellular##6##2##(1993-12#1)(1995-5#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-2#1)
the pass of##2##3##(2008-10#2)
the passage of a##2##4##(2007-12#1)(2008-10#1)
the passage of cells through##2##5##(1995-2#1)(2004-11#1)
the passage of the##8##4##(1990-12#1)(1996-11#1)(2006-10#1)(2006-2#1)(2007-4#1)(2008-2#1)(2008-4#1)(2012-1#1)
the passage of time##3##4##(2006-10#1)(2008-11#1)(2011-2#1)
the passage of##32##3##(1990-12#1)(1991-12#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(2004-11#1)(2006-10#3)(2006-2#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-12#1)(2011-11#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-2#2)
the passage to a marine##2##5##(2008-9#2)
the passage##40##2##(1990-12#1)(1991-12#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-7#1)(2004-11#1)(2006-10#3)(2006-2#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#3)(2009-12#1)(2009-4#1)(2010-1#1)(2011-11#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)
the passband##5##2##(2007-12#3)(2008-2#2)
the passenger##4##2##(1991-10#1)(1996-10#1)(1996-12#1)(2006-11#1)
the passengers##2##2##(2006-7#2)
the passiflora##2##2##(2008-10#2)
the passing##3##2##(2006-12#1)(2006-8#1)(2012-2#1)
the passions of##2##3##(2008-12#1)(2008-8#1)
the passions##3##2##(1991-3#1)(2008-12#1)(2008-8#1)
the passivation agent##2##3##(2010-4#2)
the passive avoidance test##4##4##(1991-5#2)(1992-8#1)(1994-5#1)
the passive avoidance##8##3##(1991-5#2)(1992-8#1)(1993-12#1)(1993-3#1)(1994-5#2)(1996-12#1)
the passive cutaneous##2##3##(2008-10#1)(2010-12#1)
the passive diffusion##2##3##(2008-9#1)(2011-2#1)
the passive mode##2##3##(2008-2#1)(2012-1#1)
the passive sampler##2##3##(2008-10#2)
the passive##44##2##(1991-2#2)(1991-5#2)(1992-1#2)(1992-6#2)(1992-8#1)(1993-12#1)(1993-3#2)(1993-5#1)(1994-5#2)(1995-8#1)(1996-12#1)(1996-5#1)(1997-2#1)(2006-2#1)(2006-8#1)(2007-11#4)(2007-12#2)(2007-4#1)(2008-10#5)(2008-2#3)(2008-3#2)(2008-9#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-1#2)
the past 10 years##34##4##(1991-4#2)(1992-3#1)(1993-8#1)(1996-5#1)(1997-1#1)(2005-7#2)(2006-1#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#1)(2009-1#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
the past 10##35##3##(1991-4#2)(1992-3#1)(1993-8#1)(1996-5#1)(1997-1#1)(2005-7#2)(2006-1#1)(2006-10#2)(2006-3#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#1)(2009-1#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
the past 10-15 years##2##4##(1991-12#1)(2008-8#1)
the past 100 years##3##4##(1997-7#1)(2008-10#1)(2012-12#1)
the past 100##6##3##(1994-3#1)(1997-7#1)(2008-10#1)(2010-5#1)(2012-12#1)(2013-8#1)
the past 12 months##9##4##(1995-3#2)(2008-10#1)(2009-5#4)(2012-12#1)(2012-3#1)
the past 12 years##2##4##(1993-3#1)(2008-11#1)
the past 12##14##3##(1993-3#1)(1995-3#2)(2006-3#1)(2008-10#1)(2008-11#1)(2009-5#6)(2012-12#1)(2012-3#1)
the past 15 years##15##4##(1997-1#1)(2004-3#1)(2006-10#1)(2008-1#1)(2008-11#3)(2008-3#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#3)
the past 15##16##3##(1997-1#1)(2004-3#1)(2006-10#1)(2008-1#1)(2008-11#3)(2008-3#1)(2008-4#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-2#3)
the past 18 months##2##4##(2006-10#2)
the past 18##3##3##(2006-10#2)(2008-10#1)
the past 2 decades##9##4##(1992-8#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#2)(2007-11#1)(2007-4#1)(2007-9#1)
the past 2 years##7##4##(1997-6#1)(2005-7#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-11#1)
the past 2##18##3##(1992-8#1)(1997-6#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-12#2)(2007-11#2)(2007-4#1)(2007-9#1)(2008-10#1)(2008-7#1)(2009-11#1)(2011-1#1)(2013-8#1)
the past 20 years in##3##5##(1995-12#1)(2008-10#2)
the past 20 years to##2##5##(2007-9#1)(2010-7#1)
the past 20 years##43##4##(1992-2#1)(1992-7#1)(1992-8#2)(1994-3#1)(1995-1#1)(1995-12#1)(2004-1#1)(2005-10#1)(2005-7#1)(2006-10#4)(2006-11#1)(2007-1#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
the past 20##45##3##(1992-2#1)(1992-7#1)(1992-8#2)(1994-3#1)(1995-1#1)(1995-12#1)(2004-1#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-11#1)(2007-1#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
the past 25 years and##2##5##(2005-8#1)(2007-12#1)
the past 25 years##16##4##(1993-3#1)(1997-1#1)(1997-2#1)(2005-8#1)(2006-12#1)(2007-12#2)(2007-9#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-7#1)(2011-1#1)(2012-2#1)
the past 28 years##2##4##(2008-6#1)(2011-1#1)
the past 3 decades##3##4##(2009-2#1)(2010-3#1)(2012-2#1)
the past 3 months##4##4##(2010-7#1)(2011-12#2)(2012-3#1)
the past 3 years##2##4##(1994-11#1)(2008-10#1)
the past 3##11##3##(1994-11#1)(1995-11#1)(1996-3#1)(2008-10#1)(2009-2#1)(2010-3#1)(2010-7#1)(2011-12#2)(2012-2#1)(2012-3#1)
the past 30 years and##2##5##(2006-12#1)(2012-1#1)
the past 30 years##20##4##(1991-9#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
the past 30##27##3##(1991-9#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-1#1)(2010-11#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
the past 35 years##4##4##(1990-2#1)(2010-4#1)(2012-12#1)(2013-8#1)
the past 35##5##3##(1990-2#1)(1993-4#1)(2010-4#1)(2012-12#1)(2013-8#1)
the past 4 years##5##4##(1993-2#1)(2006-6#1)(2007-2#1)(2008-10#1)(2013-8#1)
the past 4##7##3##(1993-2#1)(1993-4#1)(2006-6#1)(2007-2#1)(2008-10#1)(2009-3#1)(2013-8#1)
the past 40 years##8##4##(1993-11#1)(2006-10#1)(2006-7#2)(2006-9#1)(2008-11#1)(2010-3#1)(2011-2#1)
the past 5 years##8##4##(1995-3#1)(2006-4#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#1)(2010-4#1)(2012-3#1)
the past 5##10##3##(1995-3#1)(2005-8#1)(2006-4#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-6#1)(2010-4#1)(2012-3#1)
the past 50 years##10##4##(2006-10#2)(2006-7#1)(2007-9#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-1#1)(2012-12#1)
the past 6##3##3##(1991-3#2)(2007-9#1)
the past 7##2##3##(2004-3#1)(2007-8#1)
the past 8 years##2##4##(1996-6#1)(1997-6#1)
the past achievements##2##3##(2012-12#1)(2012-3#1)
the past and##7##3##(1994-6#1)(2006-8#1)(2007-7#1)(2008-12#1)(2008-4#1)(2009-10#1)(2012-2#1)
the past century##12##3##(1997-7#1)(2006-12#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-3#1)(2009-5#1)(2011-2#1)(2012-1#1)
the past decade a##2##4##(2007-2#1)(2012-12#1)
the past decade has been##2##5##(2008-10#1)(2008-7#1)
the past decade has##6##4##(1993-12#1)(1994-1#1)(2006-1#1)(2007-11#1)(2008-10#1)(2008-7#1)
the past decade have##3##4##(2007-12#1)(2011-1#1)(2012-2#1)
the past decade in##3##4##(2008-10#2)(2012-1#1)
the past decade there has been a##2##7##(2007-11#1)(2007-12#1)
the past decade there has been##5##6##(1991-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-11#1)
the past decade to##3##4##(2005-8#1)(2007-11#1)(2008-3#1)
the past decade with##2##4##(2006-10#1)(2007-8#1)
the past decade##163##3##(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-7#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-1#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-4#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-8#1)(2004-10#1)(2005-10#1)(2005-5#1)(2005-8#3)(2006-1#2)(2006-10#8)(2006-11#1)(2006-2#1)(2006-3#1)(2006-6#2)(2006-8#2)(2006-9#2)(2007-1#1)(2007-11#5)(2007-12#5)(2007-2#1)(2007-5#1)(2007-6#2)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#12)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#7)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-5#4)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#6)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#2)
the past decades have##3##4##(2006-9#1)(2008-5#1)(2011-2#1)
the past decades##16##3##(2006-2#1)(2006-6#1)(2006-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-1#3)
the past eight years##2##4##(1997-2#1)(2008-2#1)
the past few decades with##2##5##(2008-10#1)(2013-1#1)
the past few decades##18##4##(1994-5#1)(2005-7#1)(2006-10#3)(2006-8#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)
the past few years has##3##5##(2006-10#1)(2007-8#1)(2010-9#1)
the past few years have##3##5##(1995-4#1)(1997-8#1)(2008-8#1)
the past few years significant##3##5##(2006-10#2)(2008-8#1)
the past few years##70##4##(1992-9#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-4#1)(1997-8#1)(2006-10#15)(2006-2#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#4)(2009-5#1)(2009-9#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#2)(2013-8#1)
the past few##89##3##(1992-9#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-4#1)(1997-8#1)(2005-7#1)(2006-10#18)(2006-2#1)(2006-8#2)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#4)(2009-5#1)(2009-9#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#4)(2013-7#2)(2013-8#1)
the past five decades##2##4##(1994-12#1)(2010-8#1)
the past five years##12##4##(1992-3#1)(1992-8#1)(1994-2#1)(1995-2#1)(1995-5#1)(1996-6#1)(1996-7#1)(1997-6#1)(2006-10#2)(2007-7#1)(2007-9#1)
the past five##14##3##(1992-3#1)(1992-8#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-5#1)(1996-6#1)(1996-7#1)(1997-6#1)(2006-10#2)(2007-7#1)(2007-9#1)(2010-8#1)
the past for##4##3##(1996-12#1)(1997-8#1)(2008-10#1)(2008-12#1)
the past four decades##4##4##(1994-3#1)(1997-1#1)(2006-10#1)(2011-2#1)
the past four years##2##4##(2005-7#1)(2008-11#1)
the past four##7##3##(1994-3#1)(1997-1#1)(2005-7#1)(2006-10#1)(2006-7#1)(2008-11#1)(2011-2#1)
the past half century##3##4##(1997-1#1)(2009-5#1)(2010-4#1)
the past history##3##3##(1991-12#1)(2008-8#1)(2010-9#1)
the past in##5##3##(2006-3#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-10#1)
the past month##5##3##(2011-2#2)(2012-1#1)(2013-1#1)(2013-7#1)
the past or##2##3##(2007-7#1)(2012-3#1)
the past quarter century##3##4##(2006-7#1)(2007-12#1)(2009-12#1)
the past several decades##10##4##(1992-12#1)(2008-6#1)(2009-10#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)
the past several years##24##4##(1991-1#1)(1991-12#1)(1992-2#1)(1992-3#2)(1995-10#1)(1995-12#1)(1997-5#1)(2006-10#2)(2007-12#1)(2007-4#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#2)(2009-3#1)(2010-7#1)(2010-9#1)
the past several##35##3##(1991-1#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-3#2)(1995-10#1)(1995-12#1)(1997-5#1)(2006-10#2)(2006-8#1)(2007-12#1)(2007-4#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-3#1)(2009-7#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)
the past six years##2##4##(1995-1#1)(1995-5#1)
the past studies of##2##4##(2006-4#1)(2008-7#1)
the past ten years##10##4##(1990-6#1)(1991-12#1)(1996-3#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-8#1)(2009-8#1)
the past three decades##24##4##(1991-12#1)(1992-12#1)(1992-3#1)(1996-2#2)(2006-10#2)(2007-2#1)(2007-4#1)(2008-1#1)(2008-11#3)(2008-7#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#3)(2012-2#1)(2013-8#1)
the past three years##4##4##(1991-9#1)(1993-3#1)(2007-7#1)(2012-3#1)
the past three##28##3##(1991-12#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-3#1)(1996-2#2)(2006-10#2)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-11#3)(2008-7#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#3)(2012-2#1)(2012-3#1)(2013-8#1)
the past to##4##3##(1994-3#1)(2006-10#1)(2008-3#1)(2012-2#1)
the past twenty years##3##4##(1991-3#1)(1992-1#1)(2013-8#1)
the past two decades in##2##5##(2008-5#2)
the past two decades##46##4##(1990-6#1)(1992-11#1)(1992-4#1)(1993-4#1)(1995-1#1)(1995-4#1)(2005-7#2)(2006-1#1)(2006-10#4)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#3)(2009-3#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
the past two years several##2##5##(2005-7#1)(2006-10#1)
the past two years##15##4##(1991-2#1)(1992-12#1)(1994-1#1)(1996-8#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
the past two##62##3##(1990-6#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-4#1)(1993-4#1)(1994-1#1)(1995-1#1)(1995-4#1)(1996-8#1)(2005-7#3)(2006-1#1)(2006-10#5)(2006-11#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#3)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-3#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#3)(2013-8#1)
the past week##2##3##(2005-10#1)(2013-1#1)
the past year a##2##4##(2005-7#1)(2006-10#1)
the past year and##3##4##(1994-3#1)(2006-10#1)(2011-2#1)
the past year are##3##4##(2005-7#1)(2006-10#2)
the past year has##5##4##(2006-10#4)(2010-5#1)
the past year have##5##4##(1996-2#1)(2006-10#4)
the past year in the##4##5##(2006-10#4)
the past year in##6##4##(2006-10#6)
the past year on##2##4##(2006-10#2)
the past year that##3##4##(2006-10#3)
the past year##82##3##(1994-3#1)(1996-12#1)(1996-2#1)(2005-7#2)(2006-10#63)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-4#1)(2009-5#1)(2009-9#2)(2010-4#1)(2010-5#1)(2011-2#1)
the past years in##2##4##(1992-1#1)(2006-10#1)
the past years many##2##4##(1990-9#1)(2008-10#1)
the past years##22##3##(1990-9#1)(1992-1#1)(1993-6#1)(1996-3#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-3#1)(2010-2#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-12#2)
the past##1032##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#3)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#9)(1991-2#2)(1991-3#5)(1991-4#2)(1991-7#1)(1991-9#3)(1992-1#5)(1992-11#1)(1992-12#5)(1992-2#3)(1992-3#7)(1992-4#1)(1992-5#3)(1992-7#2)(1992-8#5)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#6)(1993-4#3)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-1#4)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#8)(1994-5#1)(1994-6#2)(1995-1#3)(1995-10#1)(1995-11#3)(1995-12#4)(1995-2#2)(1995-3#5)(1995-4#3)(1995-5#2)(1996-1#1)(1996-12#2)(1996-2#4)(1996-3#4)(1996-4#2)(1996-5#1)(1996-6#3)(1996-7#1)(1996-8#1)(1997-1#7)(1997-2#4)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#6)(2004-1#1)(2004-10#2)(2004-3#2)(2004-4#1)(2005-10#4)(2005-11#3)(2005-2#1)(2005-5#1)(2005-7#13)(2005-8#9)(2006-1#5)(2006-10#128)(2006-11#4)(2006-12#6)(2006-2#4)(2006-3#4)(2006-4#3)(2006-6#11)(2006-7#6)(2006-8#10)(2006-9#4)(2007-1#2)(2007-10#1)(2007-11#16)(2007-12#18)(2007-2#9)(2007-3#2)(2007-4#11)(2007-5#2)(2007-6#6)(2007-7#9)(2007-8#17)(2007-9#14)(2008-1#18)(2008-10#51)(2008-11#33)(2008-12#9)(2008-2#11)(2008-3#17)(2008-4#17)(2008-5#15)(2008-6#8)(2008-7#23)(2008-8#14)(2008-9#11)(2009-1#1)(2009-10#5)(2009-11#3)(2009-12#1)(2009-2#4)(2009-3#6)(2009-4#6)(2009-5#17)(2009-6#4)(2009-7#3)(2009-8#3)(2009-9#5)(2010-1#2)(2010-10#3)(2010-11#4)(2010-12#9)(2010-2#2)(2010-3#9)(2010-4#7)(2010-5#12)(2010-6#2)(2010-7#6)(2010-8#9)(2010-9#6)(2011-1#15)(2011-12#6)(2011-2#37)(2012-1#15)(2012-11#1)(2012-12#17)(2012-2#22)(2012-3#12)(2012-7#1)(2013-1#22)(2013-7#8)(2013-8#11)
the paste##7##2##(2006-4#1)(2008-10#6)
the pastoral##2##2##(1992-1#1)(2008-2#1)
the pasture trees##4##3##(2008-5#4)
the pasture##8##2##(2008-10#1)(2008-5#5)(2010-2#2)
the patch and##2##3##(2008-8#1)(2010-2#1)
the patch clamp technique##6##4##(1991-1#1)(1991-5#1)(1993-12#1)(1993-3#1)(1994-11#1)(2008-8#1)
the patch occupancy framework##2##4##(2008-8#2)
the patch occupancy##4##3##(2007-9#1)(2008-8#3)
the patch pipette##4##3##(1993-12#1)(1995-12#1)(1996-1#1)(2009-12#1)
the patch was##3##3##(1990-2#1)(2012-12#2)
the patch##36##2##(1990-2#4)(1990-3#1)(1991-1#1)(1991-5#1)(1992-7#1)(1993-12#2)(1993-3#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-1#1)(2007-8#1)(2007-9#1)(2008-5#2)(2008-8#6)(2008-9#5)(2009-12#1)(2010-2#2)(2012-12#2)
the patch-clamp technique##11##3##(1990-10#1)(1990-3#1)(1991-5#1)(1991-6#1)(1992-11#1)(1993-3#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-2#1)(2007-12#1)
the patch-clamp##13##2##(1990-10#1)(1990-3#1)(1991-5#1)(1991-6#1)(1992-11#1)(1993-3#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(2007-12#1)(2008-11#1)
the patches##4##2##(2004-12#1)(2008-5#1)(2008-8#1)(2008-9#1)
the patchy##3##2##(2006-9#1)(2007-9#2)
the patella and##4##3##(2007-1#1)(2007-7#2)(2008-8#1)
the patella##25##2##(2005-7#1)(2006-11#6)(2007-1#1)(2007-11#2)(2007-7#3)(2007-8#6)(2008-8#1)(2009-3#1)(2009-4#1)(2013-1#3)
the patellar tendon##13##3##(2008-1#1)(2008-9#3)(2009-4#2)(2009-9#4)(2013-1#3)
the patellar##17##2##(1995-8#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-9#3)(2009-4#2)(2009-9#4)(2013-1#4)
the patello-femoral joint##4##3##(2006-11#1)(2007-7#2)(2007-8#1)
the patello-femoral##5##2##(2006-11#1)(2007-1#1)(2007-7#2)(2007-8#1)
the patellofemoral joint and##2##4##(2007-7#1)(2008-7#1)
the patellofemoral joint##8##3##(2007-6#1)(2007-7#2)(2007-8#3)(2008-12#1)(2008-7#1)
the patency and##2##3##(2007-10#1)(2007-7#1)
the patency of the##5##4##(1993-10#1)(2006-5#1)(2007-8#1)(2008-6#1)(2011-2#1)
the patency of##7##3##(1993-10#1)(2006-5#1)(2007-8#1)(2007-9#1)(2008-6#2)(2011-2#1)
the patency rate of##3##4##(1994-2#1)(2007-7#2)
the patency rate##4##3##(1994-2#1)(2007-7#3)
the patency##15##2##(1993-10#1)(1994-2#1)(2006-5#1)(2007-10#1)(2007-7#5)(2007-8#1)(2007-9#1)(2008-1#1)(2008-6#2)(2011-2#1)
the patent literature##4##3##(2005-6#1)(2005-7#1)(2008-1#2)
the patent system##4##3##(2008-7#1)(2009-11#1)(2010-7#2)
the patent##16##2##(1997-8#1)(2005-6#1)(2005-7#1)(2008-1#4)(2008-12#1)(2008-7#1)(2009-11#3)(2009-5#1)(2010-7#2)(2013-1#1)
the patented##2##2##(1992-8#1)(2010-7#1)
the patenting of##2##3##(2007-8#1)(2009-2#1)
the paternal allele##2##3##(1992-8#1)(2010-12#1)
the paternal##15##2##(1992-8#2)(1993-2#1)(1994-9#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-12#1)(2011-1#1)(2013-1#1)
the paternity##3##2##(2008-12#1)(2008-6#1)(2010-9#1)
the path difference##4##3##(2007-12#2)(2008-3#2)
the path from##3##3##(2005-7#1)(2009-7#2)
the path length##3##3##(2008-3#3)
the path of a##3##4##(1992-6#1)(2008-3#1)(2008-5#1)
the path of the camera##2##5##(2008-6#2)
the path of the##8##4##(2007-11#1)(2007-3#1)(2008-2#2)(2008-3#1)(2008-6#2)(2010-8#1)
the path of##16##3##(1992-6#1)(1993-6#1)(1996-5#1)(2006-12#1)(2007-11#1)(2007-3#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#2)(2010-7#1)(2010-8#1)
the path to##7##3##(1990-9#1)(1996-3#1)(2006-7#1)(2008-3#1)(2008-6#1)(2010-7#1)(2011-2#1)
the path##48##2##(1990-9#1)(1992-6#1)(1993-6#1)(1996-3#1)(1996-5#1)(2005-7#1)(2006-12#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#14)(2008-5#1)(2008-6#3)(2008-7#1)(2009-7#2)(2009-9#1)(2010-2#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#1)
the path-averaged equation##2##3##(2007-12#2)
the path-averaged##4##2##(2007-12#3)(2008-2#1)
the path-length distribution of##3##4##(2007-12#1)(2008-3#2)
the path-length##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
the pathobiology of##3##3##(2006-2#1)(2008-7#1)(2010-5#1)
the pathobiology##5##2##(2006-2#1)(2008-7#1)(2009-10#1)(2010-5#1)(2011-1#1)
the pathogen Fusarium oxysporum f##2##5##(2008-10#2)
the pathogen and the##8##4##(2007-12#1)(2008-10#7)
the pathogen and##20##3##(2007-12#1)(2008-10#17)(2008-9#1)(2013-1#1)
the pathogen are##2##3##(2007-7#1)(2008-10#1)
the pathogen by##5##3##(2008-10#4)(2009-6#1)
the pathogen can be##3##4##(2008-10#3)
the pathogen can##5##3##(2008-10#5)
the pathogen did not##3##4##(2008-10#3)
the pathogen directly##2##3##(2008-10#2)
the pathogen from##4##3##(2007-12#1)(2008-10#3)
the pathogen had##2##3##(2008-10#2)
the pathogen has##4##3##(2008-10#4)
the pathogen in planta##2##4##(2008-10#2)
the pathogen in##20##3##(2008-10#18)(2008-5#2)
the pathogen is##4##3##(2008-10#3)(2008-8#1)
the pathogen multiplied abundantly through much of the##2##8##(2008-10#2)
the pathogen mycelium##4##3##(2008-10#4)
the pathogen on the##3##4##(2008-10#3)
the pathogen on##7##3##(2008-10#7)
the pathogen population from##2##4##(2008-10#2)
the pathogen population is##2##4##(2008-10#2)
the pathogen population##24##3##(2008-10#22)(2008-2#1)(2008-8#1)
the pathogen to test##2##4##(2008-10#2)
the pathogen to##9##3##(2008-10#6)(2009-2#1)(2009-8#1)(2011-1#1)
the pathogen was found##2##4##(2008-10#2)
the pathogen was isolated from##2##5##(2008-10#1)(2013-1#1)
the pathogen was##18##3##(2008-10#17)(2013-1#1)
the pathogen were##8##3##(2008-10#8)
the pathogen within##2##3##(2008-10#2)
the pathogen##339##2##(1994-12#1)(1995-5#2)(1996-3#1)(1997-3#1)(2006-3#1)(2007-12#3)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#285)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#3)(2008-8#4)(2008-9#5)(2009-2#1)(2009-6#2)(2009-8#2)(2011-1#1)(2011-2#3)(2012-11#1)(2012-2#4)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
the pathogen's life##2##3##(2008-10#2)
the pathogen's population structure##2##4##(2008-10#2)
the pathogen's##6##2##(2008-10#6)
the pathogenesis and management of##3##5##(2006-10#1)(2010-2#1)(2013-1#1)
the pathogenesis and potential##2##4##(2006-10#1)(2010-12#1)
the pathogenesis and progression of##4##5##(1991-11#1)(1993-9#1)(2008-3#1)(2009-9#1)
the pathogenesis and the##2##4##(2007-11#1)(2008-7#1)
the pathogenesis and treatment of##8##5##(1990-11#1)(1995-1#1)(1996-8#1)(2008-1#1)(2008-4#1)(2010-10#1)(2011-1#1)(2013-8#1)
the pathogenesis and##35##3##(1990-11#1)(1991-11#1)(1992-3#1)(1993-9#1)(1995-1#1)(1995-3#1)(1996-12#1)(1996-8#1)(2005-7#1)(2006-10#3)(2006-5#1)(2006-8#1)(2007-11#1)(2008-1#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#2)
the pathogenesis is##3##3##(2006-2#1)(2006-4#1)(2008-5#1)
the pathogenesis of AD##4##4##(1992-12#1)(1995-12#1)(2004-12#1)(2009-5#1)
the pathogenesis of AIDS##4##4##(1993-8#1)(2005-7#1)(2007-8#1)(2008-4#1)
the pathogenesis of Alzheimer's Disease##2##5##(1993-11#1)(2011-3#1)
the pathogenesis of Alzheimer's disease##8##5##(1993-12#1)(1995-10#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-7#1)(2013-7#2)
the pathogenesis of Alzheimer's##10##4##(1993-11#1)(1993-12#1)(1995-10#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-7#1)(2011-3#1)(2013-7#2)
the pathogenesis of C##2##4##(1991-10#1)(2008-9#1)
the pathogenesis of CKD-CVD##2##4##(2013-8#2)
the pathogenesis of COPD##2##4##(2010-5#1)(2013-8#1)
the pathogenesis of H##2##4##(1991-3#1)(2008-9#1)
the pathogenesis of IHD##2##4##(2008-3#1)(2013-1#1)
the pathogenesis of MS##2##4##(2008-7#1)(2012-3#1)
the pathogenesis of Marek's disease##2##5##(2013-8#2)
the pathogenesis of NPSLE##2##4##(2007-9#1)(2013-1#1)
the pathogenesis of PD##3##4##(2008-11#1)(2009-10#1)(2013-8#1)
the pathogenesis of Parkinson's disease##5##5##(1997-7#1)(2007-12#1)(2008-11#1)(2008-7#1)(2012-1#1)
the pathogenesis of RA##4##4##(2006-10#3)(2008-3#1)
the pathogenesis of SLE##2##4##(2008-1#1)(2010-12#1)
the pathogenesis of acne##7##4##(2006-12#1)(2006-8#1)(2010-3#1)(2010-5#4)
the pathogenesis of acute##6##4##(1996-12#1)(2006-10#1)(2007-8#1)(2010-4#1)(2011-12#1)(2012-12#1)
the pathogenesis of asthma##7##4##(1992-2#1)(2005-8#2)(2007-11#1)(2010-5#1)(2012-3#2)
the pathogenesis of atherosclerosis and cardiovascular##2##6##(2008-1#1)(2008-6#1)
the pathogenesis of atherosclerosis and##4##5##(2005-12#1)(2008-1#1)(2008-6#1)(2008-7#1)
the pathogenesis of atherosclerosis##18##4##(1991-7#2)(1994-11#1)(1995-3#1)(1995-6#1)(1997-4#1)(1997-8#1)(2005-12#1)(2006-10#2)(2006-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-12#1)
the pathogenesis of autoimmunity##2##4##(2012-1#1)(2013-1#1)
the pathogenesis of cancer##6##4##(1990-11#1)(1990-2#1)(2007-5#1)(2008-4#1)(2009-9#1)(2011-1#1)
the pathogenesis of cardiovascular disease##3##5##(1996-11#1)(2008-3#1)(2013-3#1)
the pathogenesis of cardiovascular##5##4##(1996-11#1)(2007-9#1)(2008-3#1)(2008-7#1)(2013-3#1)
the pathogenesis of chronic##7##4##(2006-9#1)(2008-8#2)(2009-8#1)(2010-12#2)(2012-2#1)
the pathogenesis of common##3##4##(2006-10#1)(2008-3#1)(2008-7#1)
the pathogenesis of congenital##2##4##(1991-3#1)(2011-1#1)
the pathogenesis of coronary##2##4##(1996-1#1)(2007-1#1)
the pathogenesis of degenerative##3##4##(2007-7#1)(2012-12#1)(2013-8#1)
the pathogenesis of diabetes##2##4##(2005-8#1)(2008-1#1)
the pathogenesis of diabetic nephropathy##4##5##(1994-2#1)(2008-1#3)
the pathogenesis of diabetic##15##4##(1993-11#1)(1994-2#1)(1994-8#1)(2006-1#2)(2007-2#1)(2007-8#1)(2008-1#8)
the pathogenesis of disease##3##4##(2006-8#1)(2007-7#1)(2008-4#1)
the pathogenesis of endothelial dysfunction##2##5##(2008-1#2)
the pathogenesis of gallstone##2##4##(1990-9#1)(2006-10#1)
the pathogenesis of human immunodeficiency##2##5##(2007-11#1)(2008-1#1)
the pathogenesis of human##9##4##(2004-12#1)(2006-10#2)(2007-11#1)(2008-1#1)(2008-4#1)(2009-9#1)(2012-12#2)
the pathogenesis of hypertension##2##4##(1991-6#1)(2009-6#1)
the pathogenesis of infection##2##4##(1993-12#1)(2013-7#1)
the pathogenesis of inflammatory##12##4##(2005-11#1)(2005-8#1)(2006-10#2)(2007-11#1)(2009-9#5)(2010-12#1)(2013-8#1)
the pathogenesis of insulin resistance and##2##6##(2012-2#2)
the pathogenesis of insulin resistance##5##5##(2008-3#3)(2012-2#2)
the pathogenesis of many diseases##2##5##(2010-4#1)(2012-12#1)
the pathogenesis of many##7##4##(2006-10#2)(2007-11#1)(2010-4#1)(2012-12#2)(2012-2#1)
the pathogenesis of multiple sclerosis##5##5##(2007-11#4)(2012-3#1)
the pathogenesis of multiple##6##4##(2006-10#1)(2007-11#4)(2012-3#1)
the pathogenesis of neurodegenerative##2##4##(2006-4#1)(2009-3#1)
the pathogenesis of ocular##2##4##(2005-11#1)(2005-8#1)
the pathogenesis of pancreatitis##2##4##(1996-8#1)(1996-9#1)
the pathogenesis of pruritus##2##4##(2006-10#1)(2007-8#1)
the pathogenesis of respiratory##2##4##(1991-8#1)(2008-5#1)
the pathogenesis of rheumatoid arthritis##4##5##(1991-10#1)(2006-10#3)
the pathogenesis of several##5##4##(1995-12#1)(1997-8#1)(2006-10#1)(2010-5#1)(2013-8#1)
the pathogenesis of some of the##2##6##(2006-10#1)(2006-2#1)
the pathogenesis of some##5##4##(1992-11#1)(1996-10#1)(2006-10#1)(2006-2#2)
the pathogenesis of the disease##11##5##(1992-10#1)(1992-6#1)(1996-3#1)(2005-8#1)(2006-11#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2012-12#1)(2013-8#1)
the pathogenesis of the##33##4##(1990-11#1)(1990-8#1)(1991-4#1)(1991-5#1)(1992-10#1)(1992-6#1)(1995-10#1)(1995-5#1)(1996-12#1)(1996-3#1)(2004-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-1#1)(2010-6#1)(2012-1#1)(2012-12#1)(2013-8#1)
the pathogenesis of these diseases##3##5##(2006-8#1)(2007-7#1)(2008-7#1)
the pathogenesis of these disorders##2##5##(2006-12#1)(2007-7#1)
the pathogenesis of these##10##4##(1996-6#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)
the pathogenesis of this disease##4##5##(2006-10#1)(2010-6#1)(2012-1#1)(2013-7#1)
the pathogenesis of this disorder##3##5##(2006-12#1)(2007-10#1)(2009-3#1)
the pathogenesis of this entity##2##5##(1993-9#1)(1995-11#1)
the pathogenesis of this##16##4##(1992-2#1)(1993-9#1)(1995-11#1)(1996-10#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-1#1)(2009-11#1)(2009-3#2)(2010-6#1)(2012-1#1)(2013-1#1)(2013-7#1)
the pathogenesis of type##3##4##(1991-3#1)(1992-5#1)(2008-1#1)
the pathogenesis of various##3##4##(1991-12#1)(2008-3#1)(2009-4#1)
the pathogenesis of vascular##2##4##(1993-2#1)(2010-4#1)
the pathogenesis of##546##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-10#2)(1991-12#2)(1991-2#1)(1991-3#4)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#3)(1993-12#4)(1993-2#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#2)(1994-3#4)(1994-4#1)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#3)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#4)(1996-11#3)(1996-12#5)(1996-2#1)(1996-3#2)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#6)(2004-11#2)(2004-12#3)(2005-10#2)(2005-11#3)(2005-12#2)(2005-7#2)(2005-8#7)(2006-1#2)(2006-10#37)(2006-11#3)(2006-12#4)(2006-2#4)(2006-4#2)(2006-5#1)(2006-6#2)(2006-8#6)(2006-9#2)(2007-1#3)(2007-10#5)(2007-11#16)(2007-12#3)(2007-2#4)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#10)(2007-9#4)(2008-1#29)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#13)(2008-4#11)(2008-5#6)(2008-6#2)(2008-7#14)(2008-8#5)(2008-9#4)(2009-1#2)(2009-10#2)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#9)(2010-1#1)(2010-10#1)(2010-12#17)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#8)(2010-6#2)(2010-8#1)(2010-9#2)(2011-1#8)(2011-12#1)(2011-2#12)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#13)(2012-2#14)(2012-3#9)(2013-1#18)(2013-3#1)(2013-7#8)(2013-8#18)
the pathogenesis##605##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#4)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#3)(1993-12#5)(1993-2#2)(1993-7#1)(1993-8#2)(1993-9#2)(1994-11#2)(1994-2#2)(1994-3#4)(1994-4#1)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#3)(1995-1#2)(1995-10#2)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#4)(1996-11#3)(1996-12#6)(1996-2#1)(1996-3#2)(1996-6#2)(1996-7#2)(1996-8#3)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#6)(2004-11#2)(2004-12#3)(2005-10#2)(2005-11#4)(2005-12#2)(2005-7#3)(2005-8#7)(2006-1#2)(2006-10#43)(2006-11#3)(2006-12#4)(2006-2#5)(2006-4#3)(2006-5#2)(2006-6#3)(2006-8#8)(2006-9#2)(2007-1#3)(2007-10#5)(2007-11#17)(2007-12#4)(2007-2#4)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#7)(2007-8#10)(2007-9#4)(2008-1#31)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#14)(2008-4#13)(2008-5#9)(2008-6#2)(2008-7#15)(2008-8#5)(2008-9#5)(2009-1#2)(2009-10#2)(2009-11#3)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#7)(2009-9#11)(2010-1#1)(2010-10#2)(2010-12#20)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#9)(2010-6#2)(2010-8#1)(2010-9#2)(2011-1#9)(2011-12#1)(2011-2#12)(2011-3#1)(2012-1#6)(2012-11#1)(2012-12#13)(2012-2#17)(2012-3#9)(2013-1#19)(2013-3#1)(2013-7#8)(2013-8#21)
the pathogenesis-related##4##2##(1997-2#1)(2008-10#3)
the pathogenetic mechanism##3##3##(1990-6#1)(2008-3#1)(2013-1#1)
the pathogenetic mechanisms of the##2##5##(2005-7#1)(2008-8#1)
the pathogenetic mechanisms of##3##4##(2005-7#1)(2008-8#1)(2013-8#1)
the pathogenetic##11##2##(1990-6#1)(1991-12#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-2#1)(2008-3#1)(2008-8#1)(2010-12#1)(2013-1#1)(2013-8#1)
the pathogenic bacteria##3##3##(1993-9#1)(1997-6#1)(2007-7#1)
the pathogenic complex##2##3##(1991-9#2)
the pathogenic fungi##2##3##(2008-1#1)(2008-10#1)
the pathogenic fungus##2##3##(1997-6#1)(2008-10#1)
the pathogenic mechanism of##3##4##(1996-2#1)(2006-2#1)(2012-2#1)
the pathogenic mechanisms of##3##4##(2006-10#1)(2008-4#1)(2010-6#1)
the pathogenic mechanisms##5##3##(2006-10#1)(2007-8#1)(2008-4#1)(2008-5#1)(2010-6#1)
the pathogenic potential of##2##4##(2008-10#1)(2010-7#1)
the pathogenic process##2##3##(1993-12#1)(1996-6#1)
the pathogenic role of##4##4##(1991-7#1)(1997-7#1)(2010-1#1)(2011-1#1)
the pathogenic role##5##3##(1991-7#1)(1997-7#1)(2008-5#1)(2010-1#1)(2011-1#1)
the pathogenic species##2##3##(2006-10#1)(2008-10#1)
the pathogenic specificity on##2##4##(2008-10#2)
the pathogenic##67##2##(1990-7#1)(1991-12#2)(1991-7#1)(1991-9#2)(1993-11#1)(1993-12#1)(1993-9#1)(1994-3#1)(1995-7#1)(1996-2#1)(1996-6#2)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#2)(2006-10#3)(2006-11#1)(2006-2#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#14)(2008-4#3)(2008-5#5)(2009-10#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
the pathogenicity of the##8##4##(2005-11#1)(2006-10#2)(2008-1#1)(2008-10#2)(2008-5#1)(2013-8#1)
the pathogenicity of##23##3##(2005-11#1)(2006-10#2)(2007-2#1)(2008-1#1)(2008-10#12)(2008-5#3)(2008-6#1)(2013-7#1)(2013-8#1)
the pathogenicity##29##2##(2005-11#1)(2006-10#2)(2007-2#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-5#3)(2008-6#1)(2009-2#1)(2013-7#1)(2013-8#1)
the pathogens and the##2##4##(2005-11#1)(2008-10#1)
the pathogens and##3##3##(2005-11#1)(2008-10#2)
the pathogens in##2##3##(2006-8#1)(2008-10#1)
the pathogens##32##2##(1991-11#1)(1993-2#1)(2005-11#1)(2006-8#2)(2007-12#1)(2008-10#16)(2008-12#1)(2008-3#1)(2008-7#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
the pathologic changes##2##3##(2010-8#1)(2012-12#1)
the pathologic effects of##3##4##(1991-12#1)(2006-10#2)
the pathologic process##2##3##(1992-8#1)(2008-9#1)
the pathologic tissue of##2##4##(1992-8#2)
the pathologic##21##2##(1991-12#1)(1991-9#1)(1992-8#4)(1993-12#1)(2005-7#1)(2006-10#3)(2007-10#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#2)(2010-6#1)(2010-8#1)(2012-12#1)(2012-3#1)
the pathological and##4##3##(1994-5#1)(2006-8#1)(2008-7#1)(2011-1#1)
the pathological basis of##3##4##(2005-8#1)(2007-11#1)(2008-7#1)
the pathological cascade##2##3##(1992-3#1)(2005-9#1)
the pathological changes in##3##4##(1990-5#1)(2007-11#1)(2008-7#1)
the pathological changes##11##3##(1990-5#1)(2005-8#1)(2007-11#3)(2008-1#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
the pathological characteristics of##2##4##(2008-9#1)(2013-8#1)
the pathological characteristics##3##3##(1996-9#1)(2008-9#1)(2013-8#1)
the pathological condition of##2##4##(2009-5#1)(2011-2#1)
the pathological condition##4##3##(1996-8#1)(2006-5#1)(2009-5#1)(2011-2#1)
the pathological conditions associated with##2##5##(2013-1#1)(2013-8#1)
the pathological conditions##5##3##(1994-3#1)(2008-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
the pathological diagnosis##2##3##(2007-6#1)(2011-2#1)
the pathological effects of##3##4##(1995-8#1)(2005-10#1)(2008-6#1)
the pathological examination##2##3##(1997-3#1)(2006-9#1)
the pathological features of##3##4##(1995-3#1)(2007-2#1)(2010-2#1)
the pathological findings##4##3##(1996-12#1)(2006-5#1)(2007-12#1)(2013-1#1)
the pathological mechanisms##2##3##(2007-5#1)(2012-12#1)
the pathological phenotype##2##3##(1994-12#1)(2009-8#1)
the pathological process in##2##4##(1997-3#1)(2008-4#1)
the pathological process##8##3##(1997-3#1)(2006-7#1)(2008-4#2)(2012-1#1)(2012-12#1)(2013-1#2)
the pathological processes##6##3##(1992-6#1)(1993-2#1)(1996-11#1)(2008-11#1)(2008-12#1)(2008-8#1)
the pathological size of the primary##2##6##(1995-10#2)
the pathological size of the##3##5##(1995-10#3)
the pathological##98##2##(1990-3#1)(1990-5#1)(1990-6#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-10#3)(1995-3#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-3#2)(1997-5#1)(2005-10#2)(2005-8#2)(2005-9#1)(2006-4#1)(2006-5#2)(2006-7#2)(2006-8#3)(2006-9#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-5#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-7#1)(2011-1#2)(2011-2#4)(2012-1#3)(2012-12#3)(2012-3#2)(2013-1#5)(2013-8#2)
the pathologies associated with##2##4##(2008-6#1)(2011-1#1)
the pathologies##7##2##(1990-5#1)(1991-7#1)(2008-6#1)(2011-1#2)(2011-2#1)(2013-1#1)
the pathologist##13##2##(1991-2#2)(1992-2#1)(1993-1#1)(1997-5#1)(2005-12#1)(2006-10#1)(2006-2#1)(2007-7#1)(2008-8#1)(2009-1#1)(2011-2#1)(2012-2#1)
the pathology and##5##3##(1997-3#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)
the pathology department##2##3##(2011-1#1)(2011-2#1)
the pathology is##2##3##(2008-9#1)(2013-1#1)
the pathology of OA##2##4##(2013-8#2)
the pathology of the##5##4##(2007-8#1)(2007-9#1)(2008-1#1)(2008-4#1)(2010-12#1)
the pathology of##24##3##(1991-3#1)(1995-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-9#1)(2009-4#1)(2009-8#2)(2010-11#2)(2010-12#1)(2010-8#1)(2011-2#2)(2012-1#2)(2013-8#2)
the pathology report##2##3##(2011-2#1)(2012-12#1)
the pathology that##3##3##(2006-12#1)(2007-12#1)(2007-8#1)
the pathology##68##2##(1990-10#1)(1990-3#1)(1990-4#1)(1991-3#1)(1992-10#1)(1992-12#2)(1993-9#1)(1995-11#1)(1997-3#1)(2005-11#2)(2006-12#1)(2006-3#1)(2007-11#2)(2007-12#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#3)(2009-4#1)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-1#3)(2012-12#2)(2013-1#6)(2013-8#3)
the pathomechanism of##5##3##(1991-12#1)(2007-11#3)(2011-2#1)
the pathomechanism##7##2##(1991-12#1)(1995-12#1)(2007-11#4)(2011-2#1)
the pathomechanisms involved in##2##4##(1990-1#1)(2007-5#1)
the pathomechanisms##4##2##(1990-1#1)(2007-5#1)(2007-7#1)(2013-7#1)
the pathophysiologic mechanisms##2##3##(1991-7#1)(2007-10#1)
the pathophysiologic processes##2##3##(1993-8#1)(2011-2#1)
the pathophysiologic##10##2##(1991-7#1)(1993-1#1)(1993-8#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-9#1)(2011-2#1)
the pathophysiological basis of##2##4##(2005-7#1)(2010-12#1)
the pathophysiological basis##3##3##(1997-5#1)(2005-7#1)(2010-12#1)
the pathophysiological effects of##2##4##(2007-2#2)
the pathophysiological mechanisms of##4##4##(2007-11#1)(2008-1#1)(2008-9#1)(2011-2#1)
the pathophysiological mechanisms##7##3##(2006-11#1)(2007-11#1)(2008-1#1)(2008-9#1)(2009-2#1)(2010-3#1)(2011-2#1)
the pathophysiological process##2##3##(2006-10#1)(2010-1#1)
the pathophysiological processes that are##2##5##(2006-10#1)(2007-11#1)
the pathophysiological processes##3##3##(2006-10#1)(2007-11#1)(2008-4#1)
the pathophysiological significance of##2##4##(1992-7#1)(1993-9#1)
the pathophysiological##35##2##(1990-4#1)(1992-3#1)(1992-7#1)(1993-9#1)(1994-2#1)(1996-9#1)(1997-3#1)(1997-5#1)(2005-7#1)(2005-8#2)(2006-10#3)(2006-11#2)(2006-9#1)(2007-11#3)(2007-2#2)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-8#1)
the pathophysiology and clinical##2##4##(1996-9#1)(2006-9#1)
the pathophysiology and management of##4##5##(2006-10#2)(2006-12#1)(2008-3#1)
the pathophysiology and treatment of##7##5##(1992-8#1)(2006-9#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
the pathophysiology and##24##3##(1992-8#1)(1993-5#1)(1994-6#1)(1996-9#1)(2005-10#1)(2006-10#3)(2006-12#1)(2006-9#3)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2012-2#1)
the pathophysiology is##2##3##(2008-11#1)(2011-1#1)
the pathophysiology of Graves'##2##4##(1992-7#1)(2012-3#1)
the pathophysiology of PD##2##4##(1995-3#1)(2008-11#1)
the pathophysiology of a number of##2##6##(2009-12#1)(2013-1#1)
the pathophysiology of a##5##4##(1997-5#1)(2005-7#1)(2009-12#1)(2012-12#1)(2013-1#1)
the pathophysiology of acute##2##4##(2008-10#1)(2009-7#1)
the pathophysiology of asthma##3##4##(2005-11#1)(2008-11#1)(2011-12#1)
the pathophysiology of bone##2##4##(1992-3#1)(1997-6#1)
the pathophysiology of cerebral##2##4##(2009-9#1)(2012-3#1)
the pathophysiology of chronic##2##4##(2008-11#1)(2008-12#1)
the pathophysiology of congenital hypothyroidism##2##5##(2008-1#1)(2010-10#1)
the pathophysiology of depression##3##4##(2008-7#2)(2013-1#1)
the pathophysiology of diabetes##2##4##(2008-1#1)(2008-4#1)
the pathophysiology of fibrotic##2##4##(2012-12#1)(2012-2#1)
the pathophysiology of insulin resistance##2##5##(2009-1#1)(2013-1#1)
the pathophysiology of migraine##2##4##(2004-12#2)
the pathophysiology of neuropsychiatric##2##4##(2008-4#1)(2011-1#1)
the pathophysiology of renal##3##4##(2005-7#2)(2013-1#1)
the pathophysiology of schizophrenia##3##4##(2005-7#1)(2011-1#2)
the pathophysiology of some##2##4##(2008-1#1)(2011-2#1)
the pathophysiology of the disease##4##5##(2006-6#1)(2008-1#1)(2008-3#1)(2012-12#1)
the pathophysiology of the disorder##5##5##(2006-9#2)(2008-6#1)(2008-9#1)(2009-4#1)
the pathophysiology of the##14##4##(1995-2#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-10#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-4#1)(2011-1#1)(2012-11#1)(2012-12#1)
the pathophysiology of these##6##4##(1997-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2011-1#1)(2013-8#1)
the pathophysiology of this rare##2##5##(2005-10#1)(2008-4#1)
the pathophysiology of this##8##4##(1993-11#1)(2005-10#1)(2008-1#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-12#1)(2012-2#1)
the pathophysiology of various##2##4##(2008-11#1)(2008-7#1)
the pathophysiology of##168##3##(1990-3#1)(1992-3#1)(1992-7#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-9#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-5#1)(1997-6#2)(1997-7#1)(2004-11#1)(2004-12#3)(2005-10#3)(2005-11#1)(2005-7#5)(2005-8#1)(2006-10#10)(2006-6#2)(2006-8#1)(2006-9#5)(2007-10#2)(2007-11#5)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#12)(2008-10#6)(2008-11#4)(2008-12#1)(2008-3#4)(2008-4#5)(2008-5#1)(2008-6#3)(2008-7#6)(2008-8#3)(2008-9#1)(2009-1#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-8#2)(2011-1#5)(2011-12#1)(2011-2#6)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#8)(2013-8#3)
the pathophysiology underlying##3##3##(1996-2#1)(2007-10#1)(2010-12#1)
the pathophysiology##221##2##(1990-3#1)(1990-4#1)(1992-3#2)(1992-7#1)(1992-8#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-5#1)(1997-6#2)(1997-7#1)(2004-11#1)(2004-12#3)(2005-10#5)(2005-11#1)(2005-7#5)(2005-8#3)(2006-10#15)(2006-12#1)(2006-5#2)(2006-6#2)(2006-8#1)(2006-9#8)(2007-10#3)(2007-11#5)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#13)(2008-10#7)(2008-11#5)(2008-12#1)(2008-3#5)(2008-4#7)(2008-5#3)(2008-6#4)(2008-7#7)(2008-8#4)(2008-9#3)(2009-1#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#2)(2010-8#2)(2011-1#6)(2011-12#1)(2011-2#7)(2012-11#1)(2012-12#3)(2012-2#7)(2012-3#4)(2013-1#10)(2013-7#2)(2013-8#4)
the pathotype##4##2##(2008-10#4)
the pathovar##3##2##(2008-10#3)
the pathovars##2##2##(2008-10#2)
the paths of##4##3##(2005-11#1)(2008-12#1)(2008-2#1)(2008-3#1)
the paths##6##2##(2005-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2013-8#1)
the pathway and##3##3##(2010-11#1)(2010-12#1)(2011-3#1)
the pathway are##2##3##(1996-10#1)(2010-9#1)
the pathway by which##3##4##(1995-10#1)(1997-4#1)(2008-1#1)
the pathway for the##2##4##(2008-3#1)(2010-10#1)
the pathway for##5##3##(1997-8#1)(2008-3#2)(2010-10#1)(2012-11#1)
the pathway intermediates##2##3##(2008-10#1)(2008-7#1)
the pathway involved in##2##4##(1996-2#1)(2010-10#1)
the pathway of##13##3##(1991-12#1)(1993-6#2)(1995-11#1)(1996-5#1)(1997-2#1)(2005-11#1)(2007-12#1)(2008-11#2)(2011-3#1)(2013-8#2)
the pathway that##4##3##(1995-3#1)(1995-7#1)(2008-11#1)(2009-8#1)
the pathway to##2##3##(1994-2#1)(2010-8#1)
the pathway with##2##3##(2008-5#1)(2011-3#1)
the pathway##74##2##(1990-1#1)(1990-7#1)(1991-1#1)(1991-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-7#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-3#7)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-3#5)(2012-11#1)(2012-2#1)(2013-1#3)(2013-8#3)
the pathway-specific TSF1##2##3##(2010-10#2)
the pathway-specific##3##2##(1994-6#1)(2010-10#2)
the pathways and##3##3##(1993-7#1)(2010-12#1)(2011-12#1)
the pathways between the##2##4##(2004-9#1)(2010-1#1)
the pathways by which##5##4##(1997-4#1)(2008-10#1)(2013-1#2)(2013-8#1)
the pathways by##6##3##(1997-2#1)(1997-4#1)(2008-10#1)(2013-1#2)(2013-8#1)
the pathways in##3##3##(1996-2#1)(2007-8#1)(2008-4#1)
the pathways involved in the##2##5##(1994-3#1)(2011-1#1)
the pathways involved##6##3##(1993-12#1)(1994-3#1)(1996-10#1)(2009-9#1)(2011-1#1)(2011-2#1)
the pathways of the##3##4##(1995-11#1)(2013-1#2)
the pathways of##7##3##(1994-11#1)(1995-11#1)(2006-7#1)(2010-5#1)(2012-12#1)(2013-1#2)
the pathways that##6##3##(1991-3#1)(1996-8#1)(2009-12#1)(2009-9#1)(2010-12#1)(2012-2#1)
the pathways##49##2##(1991-3#2)(1993-12#1)(1993-7#1)(1994-11#1)(1994-3#1)(1995-11#2)(1995-12#1)(1996-10#1)(1996-2#2)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#2)(2004-9#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
the patient a##2##3##(1992-10#1)(2007-8#1)
the patient about##7##3##(1992-1#1)(1992-12#1)(1992-3#1)(1996-12#1)(2005-11#1)(2008-3#1)(2010-11#1)
the patient achieved complete remission##2##5##(2007-6#1)(2008-10#1)
the patient achieved##4##3##(2007-10#1)(2007-6#1)(2008-10#1)(2009-8#1)
the patient after##3##3##(1995-3#1)(2006-8#1)(2007-11#1)
the patient age##2##3##(2008-1#1)(2010-12#1)
the patient also had##2##4##(1994-12#1)(2007-7#1)
the patient also##3##3##(1994-12#1)(2006-12#1)(2007-7#1)
the patient and family##5##4##(1991-7#1)(2008-3#1)(2011-12#1)(2012-2#1)(2013-1#1)
the patient and for##2##4##(2007-11#1)(2012-12#1)
the patient and her##3##4##(1991-7#1)(1994-12#1)(1996-6#1)
the patient and his##7##4##(1991-11#1)(1991-6#1)(1991-7#1)(1996-3#1)(2006-2#1)(2011-1#1)(2012-12#1)
the patient and his/her##2##4##(2010-3#1)(2010-6#1)
the patient and in##2##4##(1993-12#1)(2006-2#1)
the patient and of##3##4##(1990-9#1)(2006-10#1)(2007-5#1)
the patient and surgeon##2##4##(2008-10#1)(2013-1#1)
the patient and the clinician##2##5##(2012-12#1)(2012-3#1)
the patient and the family##3##5##(2009-8#1)(2009-9#1)(2010-3#1)
the patient and the##28##4##(1990-10#1)(1991-12#1)(1994-2#1)(1995-2#1)(1995-9#1)(2004-2#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-8#1)
the patient and##105##3##(1990-10#1)(1990-2#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-7#3)(1992-2#1)(1992-3#3)(1992-8#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-7#1)(1994-8#1)(1995-2#1)(1995-9#1)(1996-3#1)(1996-6#2)(1996-8#1)(1997-2#1)(2004-2#1)(2005-12#1)(2006-10#4)(2006-2#4)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-6#4)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#2)(2009-8#1)(2009-9#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#2)
the patient and/or##2##3##(2008-10#1)(2012-12#1)
the patient are##7##3##(2006-10#1)(2007-10#1)(2007-5#1)(2008-8#1)(2009-3#1)(2011-12#1)(2012-1#1)
the patient as a person##2##5##(2008-3#1)(2013-8#1)
the patient as a##3##4##(2008-3#1)(2012-3#1)(2013-8#1)
the patient as the##3##4##(2007-12#1)(2008-11#1)(2010-12#1)
the patient as##10##3##(1993-12#1)(1996-6#1)(2007-12#1)(2008-11#2)(2008-3#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
the patient at the##3##4##(2008-10#1)(2008-7#1)(2010-5#1)
the patient at##5##3##(1992-2#1)(1992-8#1)(2008-10#1)(2008-7#1)(2010-5#1)
the patient background##2##3##(1995-10#1)(2010-12#1)
the patient base##2##3##(2007-7#1)(2010-8#1)
the patient became##6##3##(1992-12#1)(1996-3#2)(2006-5#1)(2013-1#2)
the patient becomes##2##3##(1993-8#1)(2011-12#1)
the patient before the##2##4##(1997-4#1)(2007-8#1)
the patient before##4##3##(1997-4#1)(2007-8#1)(2011-2#1)(2013-8#1)
the patient being##2##3##(1991-2#1)(1996-9#1)
the patient belongs##3##3##(1997-1#1)(2009-8#1)(2010-12#1)
the patient by##6##3##(1990-10#2)(1990-11#1)(1994-2#1)(1995-12#1)(2006-12#1)
the patient came##2##3##(1992-1#1)(1995-3#1)
the patient can be##2##4##(2006-2#1)(2010-2#1)
the patient can##7##3##(1991-6#1)(1992-4#1)(1995-8#1)(2006-12#1)(2006-2#1)(2007-8#1)(2010-2#1)
the patient care process##3##4##(1995-3#3)
the patient care##6##3##(1995-12#2)(1995-3#3)(2008-10#1)
the patient complained of severe##2##5##(2007-8#1)(2012-3#1)
the patient complained of##5##4##(2007-8#2)(2009-1#1)(2012-3#1)(2013-1#1)
the patient concerning##2##3##(1990-11#1)(2007-12#1)
the patient continued to##2##4##(2006-4#1)(2008-1#1)
the patient continues to##2##4##(1993-3#1)(2005-4#1)
the patient could not##2##4##(1996-2#1)(2007-8#1)
the patient could##4##3##(1996-2#1)(2006-8#1)(2007-8#1)(2012-1#1)
the patient data##2##3##(2007-11#1)(2010-8#1)
the patient demonstrated##2##3##(2008-12#1)(2012-2#1)
the patient described##2##3##(1993-7#1)(1996-12#1)
the patient deteriorated##2##3##(2007-7#1)(2007-8#1)
the patient developed a symptomatic hepatomegaly due to growth of cysts##2##11##(2013-1#2)
the patient developed a##6##4##(2007-11#1)(2007-8#1)(2011-2#1)(2012-1#1)(2013-1#2)
the patient developed acute##2##4##(2006-4#1)(2009-3#1)
the patient developed an##3##4##(2007-7#1)(2009-3#1)(2011-1#1)
the patient developed clinical##2##4##(2009-4#1)(2010-5#1)
the patient developed multiple##2##4##(2007-6#1)(2011-1#1)
the patient developed##35##3##(1992-1#1)(1992-11#1)(1996-12#1)(2005-12#1)(2006-4#4)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-4#1)(2008-7#1)(2009-3#3)(2009-4#1)(2009-6#1)(2010-5#1)(2011-1#3)(2011-2#4)(2012-1#1)(2013-1#2)
the patient did not##8##4##(1997-4#1)(2006-3#1)(2007-11#1)(2008-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
the patient died a few##2##5##(2006-5#1)(2008-1#1)
the patient died after##2##4##(2009-4#1)(2011-1#1)
the patient died from##3##4##(2008-6#1)(2009-8#1)(2011-2#1)
the patient died of disease progression##2##6##(1991-6#1)(2012-2#1)
the patient died of##6##4##(1991-12#1)(1991-6#1)(2006-10#1)(2006-4#1)(2012-2#2)
the patient died##24##3##(1991-12#1)(1991-6#1)(1991-8#1)(1992-6#1)(1995-7#1)(2006-10#1)(2006-4#2)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-6#1)(2009-4#1)(2009-8#2)(2011-1#1)(2011-2#2)(2012-2#2)
the patient does not##2##4##(1996-6#1)(2009-6#1)
the patient does##4##3##(1996-6#1)(2008-7#1)(2009-6#1)(2009-9#1)
the patient during the procedure##2##5##(1992-12#1)(2011-1#1)
the patient during the##5##4##(1992-12#1)(2008-10#1)(2010-9#1)(2011-1#1)(2012-1#1)
the patient during##9##3##(1992-12#1)(2005-9#1)(2006-8#1)(2007-11#1)(2008-10#1)(2009-8#1)(2010-9#1)(2011-1#1)(2012-1#1)
the patient exhibited##2##3##(1994-12#1)(2012-12#1)
the patient experience and##2##4##(2009-8#1)(2010-2#1)
the patient experience##4##3##(2009-8#1)(2010-2#1)(2011-2#1)(2012-3#1)
the patient experienced an##2##4##(1994-6#1)(2008-5#1)
the patient experienced##4##3##(1994-6#1)(2006-4#1)(2006-9#1)(2008-5#1)
the patient failed to##2##4##(1990-2#1)(2008-9#1)
the patient following##2##3##(2011-2#1)(2012-12#1)
the patient for##9##3##(1990-2#1)(1992-3#1)(1992-6#1)(1996-8#1)(2005-12#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-5#1)
the patient from##10##3##(1992-1#1)(1994-11#1)(2006-10#1)(2007-11#2)(2007-7#1)(2011-12#1)(2012-2#2)(2013-8#1)
the patient group and##3##4##(2007-8#2)(2008-11#1)
the patient group##16##3##(1992-4#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-8#2)(2008-11#1)(2008-5#1)(2010-4#1)(2011-1#3)(2011-2#1)(2012-2#1)
the patient groups##3##3##(1992-6#1)(2007-10#1)(2013-8#1)
the patient had a history of##2##6##(2010-12#1)(2010-9#1)
the patient had a satisfactory##2##5##(2010-3#1)(2011-2#1)
the patient had a##13##4##(1992-6#1)(1994-12#1)(1996-6#1)(2006-9#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-11#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-2#2)
the patient had an##6##4##(1991-1#1)(2006-10#1)(2006-12#1)(2010-12#1)(2010-7#1)(2012-2#1)
the patient had been taking##2##5##(1991-3#1)(2006-7#1)
the patient had been##5##4##(1991-3#1)(1994-12#1)(2006-7#1)(2007-8#1)(2010-7#1)
the patient had experienced##2##4##(1993-10#1)(2011-2#1)
the patient had full##2##4##(2012-12#1)(2012-3#1)
the patient had low##2##4##(2007-2#1)(2010-10#1)
the patient had no symptoms##2##5##(2006-9#1)(2010-9#1)
the patient had no##5##4##(2006-10#1)(2006-9#1)(2008-9#1)(2010-9#1)(2013-7#1)
the patient had paroxysmal##2##4##(2008-10#1)(2008-11#1)
the patient had recovered##2##4##(2012-12#1)(2012-3#1)
the patient had##67##3##(1991-1#1)(1991-3#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-10#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#2)(1995-9#1)(1996-6#2)(1997-6#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-4#2)(2006-7#2)(2006-8#1)(2006-9#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-7#2)(2010-9#2)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#3)
the patient has a##2##4##(1993-11#1)(2008-6#1)
the patient has been stabilized##2##5##(1991-2#1)(1992-3#1)
the patient has been##10##4##(1990-5#1)(1991-2#1)(1992-3#1)(1997-5#1)(2007-11#1)(2008-1#1)(2008-5#1)(2008-9#1)(2012-2#1)(2013-8#1)
the patient has experienced no further complications or need for invasive procedures##2##12##(2013-1#2)
the patient has had##3##4##(1993-6#1)(2010-12#1)(2012-12#1)
the patient has no##2##4##(2007-9#1)(2010-12#1)
the patient has the##3##4##(1990-12#1)(2005-10#1)(2008-7#1)
the patient has##42##3##(1990-12#1)(1990-3#1)(1990-5#1)(1991-2#1)(1992-3#2)(1993-11#1)(1993-6#1)(1995-5#1)(1996-5#1)(1997-2#1)(1997-5#1)(2005-10#1)(2006-2#1)(2007-11#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#2)(2010-6#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
the patient himself##4##3##(1993-11#1)(2006-6#2)(2011-1#1)
the patient in the##11##4##(1995-4#1)(1996-8#1)(2006-2#1)(2007-10#1)(2007-2#1)(2009-6#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
the patient in this##2##4##(2008-12#1)(2012-2#1)
the patient in whom##2##4##(2006-7#1)(2006-9#1)
the patient in##31##3##(1990-6#1)(1995-4#1)(1996-8#1)(2006-12#1)(2006-2#2)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-8#2)(2008-11#2)(2008-12#1)(2008-3#1)(2009-6#1)(2010-5#1)(2011-2#3)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#1)
the patient into##3##3##(1994-6#1)(2009-11#1)(2012-1#1)
the patient is a##2##4##(2011-2#1)(2012-3#1)
the patient is alive##2##4##(1991-6#1)(2013-8#1)
the patient is at risk for##2##6##(2010-2#1)(2013-1#1)
the patient is at##3##4##(2007-8#1)(2010-2#1)(2013-1#1)
the patient is doing well##3##5##(2007-8#2)(2013-1#1)
the patient is essential##2##4##(2007-8#1)(2011-1#1)
the patient is in a good clinical condition and has not shown yet signs of a recurrence of the fistula##2##20##(2013-1#2)
the patient is in##3##4##(2013-1#2)(2013-8#1)
the patient is known to##2##5##(1995-5#1)(2007-9#1)
the patient is not##4##4##(1991-11#1)(1993-2#1)(2006-10#1)(2007-2#1)
the patient is referred##2##4##(2008-8#1)(2011-3#1)
the patient is the##3##4##(1992-3#1)(2012-3#1)(2013-1#1)
the patient is without evidence of##2##6##(1993-3#1)(2008-6#1)
the patient is##88##3##(1990-11#1)(1990-3#1)(1991-11#2)(1991-12#1)(1991-4#2)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-3#2)(1994-9#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-9#1)(1997-8#1)(2005-10#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#7)(2007-9#1)(2008-1#1)(2008-6#3)(2008-7#2)(2008-8#1)(2009-2#1)(2009-3#2)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#5)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#8)(2013-8#3)
the patient left##2##3##(1994-5#1)(2013-1#1)
the patient made a full recovery##3##6##(2006-7#1)(2012-12#2)
the patient made a##5##4##(2006-7#1)(2011-12#1)(2012-12#2)(2012-2#1)
the patient made##6##3##(2006-7#1)(2007-10#1)(2011-12#1)(2012-12#2)(2012-2#1)
the patient may##5##3##(1993-11#1)(2006-2#1)(2007-9#1)(2010-8#1)(2011-2#1)
the patient must be##2##4##(2007-7#1)(2013-1#1)
the patient nor the##2##4##(2008-5#1)(2009-10#1)
the patient nor##3##3##(2007-12#1)(2008-5#1)(2009-10#1)
the patient of the##2##4##(2010-9#1)(2013-1#1)
the patient of##4##3##(1992-1#1)(2007-11#1)(2010-9#1)(2013-1#1)
the patient on a##2##4##(2006-10#1)(2008-1#1)
the patient on the##2##4##(2008-4#1)(2011-2#1)
the patient on##7##3##(1996-1#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-4#1)(2011-2#1)
the patient or the patient's family##2##6##(1995-3#1)(1996-2#1)
the patient or the##3##4##(1995-3#1)(1996-2#1)(2007-11#1)
the patient or##8##3##(1991-2#1)(1995-3#1)(1996-2#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2013-8#1)
the patient perspective##5##3##(2007-8#1)(2008-7#1)(2012-3#1)(2013-1#2)
the patient population##12##3##(1992-3#1)(1993-5#1)(1995-1#1)(1995-2#1)(1997-8#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-6#1)(2010-11#1)(2010-12#1)
the patient populations##2##3##(1995-3#1)(2008-11#1)
the patient presented a##3##4##(2007-8#1)(2011-2#1)(2013-1#1)
the patient presented with a##2##5##(1997-5#1)(2010-5#1)
the patient presented with sudden onset chest##2##7##(2013-1#2)
the patient presented with##9##4##(1997-5#1)(2006-10#2)(2007-12#1)(2010-12#1)(2010-5#1)(2012-12#1)(2013-1#2)
the patient presented##17##3##(1990-12#1)(1997-5#1)(2006-10#2)(2006-11#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#3)
the patient presenting with##2##4##(2008-6#1)(2010-9#1)
the patient prior to##2##4##(2005-8#1)(2007-4#1)
the patient reaches##2##3##(2006-2#1)(2008-7#1)
the patient received a##2##4##(2006-10#1)(2006-12#1)
the patient received##6##3##(1991-9#1)(2006-10#1)(2006-12#1)(2007-12#1)(2012-12#1)(2012-2#1)
the patient receives##3##3##(2006-2#1)(2007-1#1)(2011-2#1)
the patient record##2##3##(1992-4#1)(1993-2#1)
the patient recovered well##3##4##(2010-9#1)(2012-12#1)(2012-2#1)
the patient recovered##7##3##(1997-2#1)(2006-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
the patient refused##3##3##(2007-6#1)(2009-6#1)(2011-2#1)
the patient regained the ability to##2##6##(1996-9#1)(2007-7#1)
the patient regained##3##3##(1996-9#1)(2007-7#1)(2010-12#1)
the patient relapsed##3##3##(1990-10#1)(1991-4#1)(2007-4#1)
the patient remained##4##3##(2005-11#1)(2007-3#1)(2007-8#1)(2013-8#1)
the patient remains asymptomatic##5##4##(2007-2#1)(2007-9#1)(2008-7#1)(2012-3#1)(2013-1#1)
the patient remains free of##2##5##(2005-5#1)(2012-2#1)
the patient remains##11##3##(2005-5#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-7#1)(2010-12#1)(2010-2#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
the patient reported##6##3##(1992-11#1)(2005-11#1)(2008-1#1)(2008-12#1)(2008-6#1)(2009-3#1)
the patient required##3##3##(2006-4#1)(2011-2#1)(2013-8#1)
the patient responded##2##3##(2007-7#1)(2009-8#1)
the patient returned for##2##4##(2006-10#1)(2011-2#1)
the patient returned to##4##4##(2008-1#1)(2008-9#1)(2012-12#2)
the patient returned##7##3##(2006-10#1)(2008-1#1)(2008-9#1)(2011-2#1)(2012-12#3)
the patient revealed a##4##4##(1993-3#1)(1993-6#1)(1994-11#1)(2010-11#1)
the patient revealed##6##3##(1993-3#1)(1993-6#1)(1994-11#1)(2007-7#1)(2010-11#1)(2013-8#1)
the patient satisfaction##2##3##(2008-12#1)(2010-8#1)
the patient seeks medical##2##4##(2005-12#1)(2008-1#1)
the patient should be##14##4##(1992-6#1)(1993-6#1)(1994-12#1)(1996-11#1)(2006-9#1)(2007-12#1)(2008-4#1)(2009-9#1)(2010-12#2)(2011-2#2)(2012-12#1)(2012-2#1)
the patient should##18##3##(1992-6#1)(1993-6#2)(1994-12#1)(1996-1#1)(1996-11#1)(2006-4#1)(2006-9#1)(2007-12#1)(2008-4#1)(2009-9#1)(2010-12#2)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)
the patient showed clinical##2##4##(1990-2#1)(1991-6#1)
the patient showed no##2##4##(2012-11#1)(2013-8#1)
the patient showed##9##3##(1990-2#1)(1991-6#1)(1992-5#1)(1993-11#1)(2006-10#1)(2008-7#2)(2012-11#1)(2013-8#1)
the patient successfully##2##3##(2008-5#1)(2009-3#1)
the patient succumbed to##2##4##(2008-6#1)(2012-3#1)
the patient succumbed##3##3##(2007-7#1)(2008-6#1)(2012-3#1)
the patient suffered a##2##4##(2006-4#1)(2006-5#1)
the patient suffered from##6##4##(1993-2#1)(1995-4#1)(2006-2#1)(2008-12#1)(2012-12#1)(2013-8#1)
the patient suffered##11##3##(1993-2#1)(1995-4#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-8#1)(2008-12#2)(2009-6#1)(2012-12#1)(2013-8#1)
the patient suffers##2##3##(1992-10#1)(2012-2#1)
the patient than##4##3##(1994-4#1)(1996-8#1)(1997-4#1)(2007-7#1)
the patient that##3##3##(1994-12#1)(1996-2#1)(2006-12#1)
the patient the##3##3##(1993-11#1)(2009-6#1)(2011-2#1)
the patient to be##3##4##(2006-7#1)(2007-9#1)(2011-1#1)
the patient to return##2##4##(1993-12#1)(2009-6#1)
the patient to the##4##4##(1992-3#1)(1993-9#1)(2007-8#1)(2008-3#1)
the patient to##43##3##(1992-11#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-9#1)(1994-8#1)(1995-4#1)(2004-3#2)(2004-7#1)(2006-10#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-6#5)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the patient together with##2##4##(2009-6#1)(2012-1#1)
the patient underwent a##4##4##(2006-10#1)(2009-3#1)(2010-12#1)(2012-2#1)
the patient underwent repeated##2##4##(2006-12#1)(2011-2#1)
the patient underwent surgical##2##4##(2006-8#1)(2008-4#1)
the patient underwent##27##3##(1991-11#1)(1993-10#1)(2005-12#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-4#1)(2008-7#1)(2009-3#1)(2010-10#1)(2010-12#2)(2011-2#3)(2012-12#2)(2012-2#1)(2013-8#2)
the patient was a##2##4##(1991-9#1)(2013-1#1)
the patient was able to##5##5##(1993-1#1)(1993-2#1)(2008-4#1)(2009-3#1)(2012-1#1)
the patient was admitted for spontaneous bacterial peritonitis (SBP)##2##9##(2013-1#2)
the patient was admitted to hospital##2##6##(1993-9#1)(2008-4#1)
the patient was admitted to the##3##6##(2007-8#1)(2013-1#1)(2013-8#1)
the patient was admitted to##5##5##(1993-9#1)(2007-8#1)(2008-4#1)(2013-1#1)(2013-8#1)
the patient was admitted##13##4##(1993-9#1)(1995-7#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2013-1#5)(2013-8#1)
the patient was asymptomatic##5##4##(1996-3#1)(2006-9#1)(2007-8#1)(2008-5#1)(2013-1#1)
the patient was completely##4##4##(2007-7#1)(2007-8#1)(2011-2#1)(2012-12#1)
the patient was diagnosed with##2##5##(2013-1#1)(2013-8#1)
the patient was diagnosed##4##4##(2008-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
the patient was discharged in good health##2##7##(2006-6#1)(2007-8#1)
the patient was discharged##12##4##(1992-5#1)(1994-9#1)(2006-4#2)(2006-6#1)(2007-8#1)(2009-4#1)(2010-7#1)(2011-2#1)(2012-12#2)(2013-8#1)
the patient was found to have chronic kidney disease stage 3 secondary to hypertension##2##14##(2013-1#2)
the patient was found to have##4##6##(2008-6#1)(2012-2#1)(2013-1#2)
the patient was free of##2##5##(2006-8#1)(2009-1#1)
the patient was free##3##4##(2006-8#1)(2009-1#1)(2013-8#1)
the patient was given##3##4##(1992-2#1)(1992-5#1)(2007-7#1)
the patient was hemodynamically stable##2##5##(2009-4#1)(2011-2#1)
the patient was in##5##4##(1990-5#1)(1994-3#1)(2007-12#1)(2008-4#1)(2013-8#1)
the patient was initially##2##4##(2007-10#1)(2013-8#1)
the patient was mentally##2##4##(1994-12#1)(2011-1#1)
the patient was on##3##4##(2006-10#1)(2008-7#1)(2012-11#1)
the patient was provided##2##4##(2007-9#1)(2009-11#1)
the patient was put on##4##5##(2006-2#1)(2007-4#1)(2010-9#1)(2012-2#1)
the patient was referred to##4##5##(2008-1#1)(2008-6#1)(2008-7#1)(2011-1#1)
the patient was referred##9##4##(1991-11#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#2)(2011-2#1)
the patient was taken to##2##5##(2011-12#1)(2011-2#1)
the patient was transferred to##3##5##(2007-9#1)(2009-6#1)(2013-8#1)
the patient was treated with##4##5##(1994-6#1)(2006-10#1)(2008-11#1)(2013-1#1)
the patient was treated##7##4##(1994-6#1)(2005-10#1)(2006-10#1)(2008-11#1)(2008-12#1)(2009-6#1)(2013-1#1)
the patient was weaned from the##2##6##(2007-9#1)(2012-2#1)
the patient was##161##3##(1990-3#1)(1990-5#2)(1990-9#1)(1991-11#1)(1991-5#2)(1991-9#1)(1992-2#2)(1992-5#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-7#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-6#1)(2005-10#2)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#5)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-4#1)(2007-7#6)(2007-8#6)(2007-9#3)(2008-1#6)(2008-11#1)(2008-12#4)(2008-4#3)(2008-5#2)(2008-6#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-11#2)(2009-3#2)(2009-4#3)(2009-6#3)(2010-10#2)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#8)(2012-3#1)(2013-1#14)(2013-8#7)
the patient were##6##3##(1992-12#1)(1994-11#1)(1996-8#1)(2007-12#1)(2007-7#1)(2012-12#1)
the patient when the##2##4##(2006-3#1)(2006-8#1)
the patient when##4##3##(1997-7#1)(2006-3#1)(2006-8#1)(2010-9#1)
the patient who##8##3##(1991-10#1)(1993-6#1)(1997-8#1)(2006-2#1)(2007-5#1)(2007-7#1)(2008-8#1)(2010-9#1)
the patient whose##2##3##(1994-7#1)(2006-10#1)
the patient will be##2##4##(2011-1#1)(2012-12#1)
the patient will##5##3##(2011-1#2)(2012-12#1)(2013-1#2)
the patient with a##7##4##(1992-2#1)(1992-3#1)(2006-10#4)(2008-5#1)
the patient with acute coronary syndrome##3##6##(2008-10#3)
the patient with cancer##2##4##(2006-10#1)(2011-2#1)
the patient with diabetes##3##4##(2007-11#1)(2008-1#1)(2008-4#1)
the patient with liver##2##4##(1990-8#1)(2007-12#1)
the patient with primary##2##4##(2006-12#1)(2008-1#1)
the patient with symptomatic##2##4##(1993-2#1)(1997-4#1)
the patient with the##3##4##(1991-10#1)(1991-12#1)(2006-12#1)
the patient with##75##3##(1990-12#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-2#1)(1994-10#1)(1994-4#1)(1994-5#1)(1996-2#1)(1996-8#1)(1997-4#1)(2005-1#1)(2005-10#1)(2006-10#8)(2006-12#3)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#2)(2008-1#2)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-2#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
the patient's RBCs##2##3##(1994-12#1)(1994-9#1)
the patient's ability to##4##4##(1991-9#1)(2006-10#1)(2008-10#1)(2011-2#1)
the patient's advocate##2##3##(2005-7#1)(2008-11#1)
the patient's age at##2##4##(2007-8#1)(2013-1#1)
the patient's age##14##3##(1991-4#1)(1996-1#1)(1996-6#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-8#2)(2008-6#1)(2010-12#1)(2011-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
the patient's and##2##3##(2006-6#1)(2006-7#1)
the patient's arm##2##3##(2007-6#1)(2008-5#1)
the patient's behavior##2##3##(1997-1#1)(2011-1#1)
the patient's blood##3##3##(1992-4#1)(2008-11#1)(2013-1#1)
the patient's body##2##3##(1991-6#1)(2007-12#1)
the patient's cardiac##2##3##(2007-8#1)(2008-7#1)
the patient's care##3##3##(1997-3#1)(2006-12#1)(2010-10#1)
the patient's cervical##2##3##(2006-10#1)(2013-7#1)
the patient's charter##2##3##(1992-2#1)(1992-5#1)
the patient's clinical condition##4##4##(2006-1#1)(2007-10#1)(2011-2#1)(2012-3#1)
the patient's clinical##10##3##(1996-9#1)(2006-1#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#2)(2011-2#1)(2012-3#1)(2013-1#1)
the patient's condition##9##3##(1990-8#1)(1991-12#1)(1991-6#1)(2006-10#1)(2007-11#1)(2008-5#1)(2012-12#1)(2013-8#2)
the patient's culture##2##3##(2011-2#1)(2013-1#1)
the patient's death##4##3##(1993-10#1)(2008-11#2)(2013-7#1)
the patient's demographic##2##3##(2007-10#1)(2008-10#1)
the patient's family##3##3##(1995-3#1)(1996-2#1)(2007-7#1)
the patient's functional##3##3##(2006-5#1)(2007-12#1)(2010-10#1)
the patient's gender##2##3##(2005-10#1)(2012-2#1)
the patient's general##4##3##(1994-4#1)(1996-6#1)(2007-11#1)(2012-2#1)
the patient's health status##4##4##(1994-3#1)(2007-12#1)(2007-8#1)(2008-11#1)
the patient's health##7##3##(1994-3#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-7#1)(2013-1#1)
the patient's history and##2##4##(1990-6#1)(2005-11#1)
the patient's history##9##3##(1990-4#1)(1990-6#1)(1997-2#1)(2005-11#1)(2006-2#1)(2007-12#1)(2008-11#1)(2008-8#1)(2013-7#1)
the patient's illness##3##3##(1990-10#1)(1991-1#1)(1996-12#1)
the patient's immune system##3##4##(2008-5#1)(2010-11#1)(2013-8#1)
the patient's individual##2##3##(1994-5#1)(2007-11#1)
the patient's left foot remained spared from gangrenous changes possibly due to a chronic external iliac artery occlusion and thus the lower concentration of vasopressors in that extremity##2##28##(2013-1#2)
the patient's left##3##3##(2007-7#1)(2013-1#2)
the patient's life##12##3##(1990-5#1)(1992-12#2)(1993-8#1)(2007-11#1)(2007-12#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
the patient's medical record##3##4##(2006-8#2)(2010-8#1)
the patient's medical##9##3##(2006-10#1)(2006-12#1)(2006-8#2)(2007-9#1)(2010-3#1)(2010-8#1)(2012-12#1)(2013-1#1)
the patient's mother##7##3##(1990-1#6)(1990-11#1)
the patient's motivation##2##3##(2006-2#1)(2010-8#1)
the patient's mouth##5##3##(1995-3#1)(2006-2#1)(2007-6#1)(2010-5#1)(2012-2#1)
the patient's neurological##3##3##(1996-9#1)(2007-10#1)(2008-7#1)
the patient's nutritional status##2##4##(2007-12#1)(2007-7#1)
the patient's nutritional##3##3##(2007-12#1)(2007-7#1)(2012-12#1)
the patient's outcome##3##3##(1995-6#1)(1995-8#1)(2012-11#1)
the patient's own bone##2##4##(2006-8#1)(2007-11#1)
the patient's own##6##3##(1992-4#2)(1994-5#1)(2006-10#1)(2006-8#1)(2007-11#1)
the patient's pain##2##3##(2006-8#1)(2007-6#1)
the patient's perspective##4##3##(2007-8#1)(2008-11#1)(2008-12#1)(2012-3#1)
the patient's physical and mental##2##5##(2007-11#1)(2007-8#1)
the patient's physical##5##3##(1992-12#1)(2007-11#2)(2007-8#2)
the patient's position##2##3##(2006-12#1)(2007-6#1)
the patient's preoperative##4##3##(1994-3#1)(2006-6#1)(2011-2#1)(2013-1#1)
the patient's presentation##2##3##(2010-8#1)(2010-9#1)
the patient's previous##2##3##(2006-10#1)(2012-2#1)
the patient's prior##2##3##(1991-6#1)(2007-12#1)
the patient's problems##3##3##(2007-11#1)(2013-1#2)
the patient's prognosis##3##3##(1990-3#1)(2008-7#1)(2010-12#1)
the patient's prolidase were##2##4##(1990-1#2)
the patient's prolidase##3##3##(1990-1#3)
the patient's quality of attention##2##5##(2008-10#2)
the patient's quality of life and##2##6##(2008-3#1)(2013-1#1)
the patient's quality of life##12##5##(1991-8#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#1)(2009-9#1)(2011-12#1)(2013-1#1)
the patient's quality of##14##4##(1991-8#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-9#1)(2011-12#1)(2013-1#1)
the patient's right to##4##4##(1991-2#1)(1992-12#1)(1996-2#1)(2005-7#1)
the patient's rights##3##3##(1997-8#1)(2008-2#2)
the patient's risk of##2##4##(1995-9#1)(2008-4#1)
the patient's risk##3##3##(1995-9#1)(2008-3#1)(2008-4#1)
the patient's serum and##2##4##(1993-6#1)(1994-6#1)
the patient's serum##6##3##(1992-6#1)(1992-9#1)(1993-6#1)(1994-6#2)(2006-9#1)
the patient's shoulder##3##3##(2006-8#1)(2012-1#2)
the patient's situation##2##3##(2004-3#1)(2010-11#1)
the patient's sleep##2##3##(2007-6#1)(2008-7#1)
the patient's social##2##3##(2008-10#1)(2008-5#1)
the patient's specific##2##3##(2011-1#1)(2011-2#1)
the patient's state of##2##4##(1993-8#1)(2006-10#1)
the patient's status##3##3##(1994-7#1)(2007-11#1)(2012-2#1)
the patient's stay##2##3##(2008-3#1)(2008-5#1)
the patient's story##2##3##(1996-3#1)(2007-8#1)
the patient's symptoms and the##3##5##(1991-6#1)(2007-12#1)(2008-3#1)
the patient's symptoms and##4##4##(1991-6#1)(2007-12#1)(2008-3#1)(2012-3#1)
the patient's symptoms on##2##4##(2008-9#1)(2012-2#1)
the patient's symptoms##11##3##(1991-6#1)(1991-9#1)(2007-12#1)(2008-3#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-1#1)(2012-2#1)(2012-3#1)
the patient's tracheostomy tube##2##4##(2006-4#1)(2009-6#1)
the patient's treatment##2##3##(2009-11#2)
the patient's voice##2##3##(2008-12#1)(2013-7#1)
the patient's wishes##3##3##(1992-12#1)(2006-10#2)
the patient's##468##2##(1990-1#11)(1990-10#4)(1990-11#5)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-6#5)(1991-8#1)(1991-9#2)(1992-12#7)(1992-2#1)(1992-3#3)(1992-4#3)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#2)(1993-10#2)(1993-11#3)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-4#3)(1994-5#2)(1994-6#3)(1994-7#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#2)(1996-4#1)(1996-6#3)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#2)(1997-8#4)(2004-10#1)(2004-3#3)(2005-10#2)(2005-11#2)(2005-12#2)(2005-7#3)(2005-9#1)(2006-1#3)(2006-10#16)(2006-12#8)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#4)(2006-7#3)(2006-8#6)(2006-9#5)(2007-1#2)(2007-10#5)(2007-11#21)(2007-12#10)(2007-2#2)(2007-5#2)(2007-6#5)(2007-7#9)(2007-8#11)(2007-9#3)(2008-1#2)(2008-10#9)(2008-11#7)(2008-12#5)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#8)(2008-6#3)(2008-7#9)(2008-8#1)(2008-9#7)(2009-1#1)(2009-11#2)(2009-3#4)(2009-4#2)(2009-5#2)(2009-6#5)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#5)(2010-11#2)(2010-12#4)(2010-2#2)(2010-3#2)(2010-5#4)(2010-7#2)(2010-8#5)(2010-9#2)(2011-1#6)(2011-11#1)(2011-12#3)(2011-2#13)(2012-1#5)(2012-11#1)(2012-12#8)(2012-2#14)(2012-3#4)(2012-8#1)(2013-1#22)(2013-7#6)(2013-8#4)
the patient)##2##2##(2007-7#1)(2010-6#1)
the patient-doctor relationship##2##3##(2008-3#1)(2011-2#1)
the patient-doctor##3##2##(1993-9#1)(2008-3#1)(2011-2#1)
the patient-focused##2##2##(1992-12#1)(1994-1#1)
the patient-physician relationship##4##3##(1990-12#1)(1993-3#1)(1995-12#1)(2007-12#1)
the patient-provider##2##2##(2013-1#2)
the patient?##2##2##(2009-7#1)(2012-3#1)
the patient]##5##2##(1991-4#1)(1993-10#2)(1994-3#1)(1997-6#1)
the patients (p##2##3##(1991-5#1)(2010-4#1)
the patients about the##2##4##(1990-4#1)(1997-8#1)
the patients achieved##4##3##(1992-3#1)(2006-12#1)(2008-8#1)(2011-2#1)
the patients admitted##2##3##(2012-3#1)(2013-1#1)
the patients after##6##3##(2006-10#1)(2006-8#1)(2007-11#2)(2007-9#1)(2010-8#1)
the patients and control subjects##2##5##(1996-7#1)(2009-6#1)
the patients and the##5##4##(1991-9#1)(2007-7#1)(2007-9#1)(2010-7#1)(2013-1#1)
the patients and their families##3##5##(1997-4#1)(2008-11#1)(2009-7#1)
the patients and their##9##4##(1997-4#1)(2006-12#1)(2006-6#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)
the patients and to##2##4##(2006-2#1)(2012-2#1)
the patients and##43##3##(1990-2#1)(1990-4#1)(1990-8#1)(1991-3#1)(1991-9#1)(1992-2#1)(1993-2#1)(1993-9#1)(1994-11#1)(1996-7#1)(1997-4#1)(1997-6#1)(2005-1#1)(2006-12#1)(2006-2#2)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
the patients are asymptomatic##2##4##(1993-1#1)(2008-7#1)
the patients are##19##3##(1990-12#1)(1991-12#1)(1991-9#1)(1993-1#1)(1997-4#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-7#1)(2009-10#1)(2010-3#1)(2011-2#1)(2012-1#1)
the patients at##5##3##(1993-7#1)(2006-8#1)(2007-7#2)(2007-8#1)
the patients before##4##3##(1990-4#1)(1993-12#1)(1994-12#1)(2007-8#1)
the patients being##5##3##(1990-10#1)(2007-7#1)(2008-5#1)(2008-7#1)(2012-2#1)
the patients but also##2##4##(2010-8#1)(2011-2#1)
the patients but##4##3##(1992-8#1)(2008-9#1)(2010-8#1)(2011-2#1)
the patients by##5##3##(2007-9#1)(2008-11#1)(2008-9#1)(2012-3#1)(2013-8#1)
the patients came##2##3##(1994-3#1)(2008-7#1)
the patients can easily##2##4##(2006-1#1)(2008-4#1)
the patients can##3##3##(2006-1#1)(2008-4#1)(2010-8#1)
the patients completed##2##3##(1991-3#1)(1992-11#1)
the patients continued to##2##4##(2007-7#1)(2013-7#1)
the patients could##4##3##(1990-9#1)(2007-2#1)(2007-7#1)(2009-10#1)
the patients developed##4##3##(2006-6#1)(2007-7#1)(2008-1#2)
the patients diagnosed in the##2##5##(2008-1#2)
the patients diagnosed##3##3##(2007-7#1)(2008-1#2)
the patients did not##3##4##(1990-12#1)(2007-7#1)(2011-1#1)
the patients do##4##3##(1996-9#1)(2006-10#1)(2008-7#1)(2008-8#1)
the patients during##4##3##(1995-9#1)(2004-12#1)(2009-8#1)(2011-2#1)
the patients either##2##3##(2007-7#1)(2011-2#1)
the patients enrolled##2##3##(2007-1#1)(2008-11#1)
the patients evaluated##3##3##(1990-8#1)(1991-3#1)(2011-2#1)
the patients except one##2##4##(2007-3#1)(2008-1#1)
the patients experienced##6##3##(1990-8#1)(2006-8#2)(2007-11#1)(2010-4#1)(2012-2#1)
the patients for##7##3##(1993-6#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-7#1)(2013-8#1)
the patients from##6##3##(1993-10#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2012-2#1)
the patients general##3##3##(2006-10#1)(2008-12#1)(2008-8#1)
the patients had a##16##4##(1991-1#1)(1991-6#1)(1992-1#1)(1993-2#2)(1993-5#1)(1995-5#1)(2004-4#1)(2006-12#2)(2006-8#1)(2007-8#1)(2008-1#1)(2009-10#1)(2010-6#1)(2013-1#1)
the patients had an##3##4##(1990-11#1)(2007-8#1)(2011-11#1)
the patients had been##7##4##(1990-4#1)(1994-5#1)(1995-4#1)(2007-11#1)(2007-7#1)(2008-6#1)(2011-1#1)
the patients had conventional##2##4##(2007-11#1)(2007-12#1)
the patients had diabetes##3##4##(2012-12#1)(2013-1#2)
the patients had no##4##4##(1991-6#1)(2005-10#1)(2008-11#1)(2013-1#1)
the patients had normal##2##4##(2006-8#1)(2007-7#1)
the patients had##93##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-2#2)(1991-6#3)(1992-1#1)(1992-5#1)(1992-9#2)(1993-12#1)(1993-2#2)(1993-5#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-5#1)(1996-6#1)(1997-8#1)(2004-4#1)(2005-10#1)(2006-10#2)(2006-12#2)(2006-7#1)(2006-8#5)(2006-9#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#3)(2007-7#5)(2007-8#6)(2008-1#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2010-6#1)(2011-1#4)(2011-11#1)(2012-12#2)(2013-1#8)(2013-8#1)
the patients has been##4##4##(2006-8#1)(2007-11#1)(2007-2#1)(2010-8#1)
the patients has##6##3##(2005-11#1)(2006-8#2)(2007-11#1)(2007-2#1)(2010-8#1)
the patients have to be##2##5##(2011-1#1)(2011-2#1)
the patients have to##4##4##(2011-1#1)(2011-2#1)(2013-8#2)
the patients have##12##3##(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#3)
the patients having##4##3##(1996-2#1)(2007-7#1)(2007-9#1)(2008-1#1)
the patients in both groups##2##5##(2007-11#1)(2009-12#1)
the patients in group II##2##5##(2007-7#2)
the patients in group##5##4##(2007-11#1)(2007-2#1)(2007-7#2)(2007-9#1)
the patients in the study##2##5##(1994-3#1)(2006-8#1)
the patients in the##16##4##(1990-5#1)(1990-8#1)(1993-11#1)(1993-12#1)(1994-3#1)(1995-9#1)(1997-5#2)(2006-10#1)(2006-8#3)(2007-11#2)(2007-8#1)(2012-2#1)
the patients in these##2##4##(1992-8#1)(2009-6#1)
the patients in this##3##4##(1995-11#1)(2006-8#1)(2011-2#1)
the patients in whom##2##4##(1991-5#1)(2010-7#1)
the patients in##41##3##(1990-5#1)(1990-8#1)(1991-5#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-7#1)(1994-3#1)(1995-11#1)(1995-9#1)(1997-5#2)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#4)(2007-11#4)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-10#1)(2008-6#1)(2009-12#1)(2009-6#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#1)
the patients included in##2##4##(2007-7#1)(2013-8#1)
the patients into##4##3##(1997-2#1)(2006-6#1)(2008-1#1)(2011-2#1)
the patients is##6##3##(1990-10#1)(1992-2#1)(1992-6#1)(1993-10#1)(1997-7#1)(2011-2#1)
the patients may##2##3##(1996-9#1)(2008-5#1)
the patients not##2##3##(2006-6#1)(2007-8#1)
the patients of acute##2##4##(2010-8#1)(2011-1#1)
the patients of the##4##4##(1992-6#1)(2008-1#1)(2012-12#1)(2013-1#1)
the patients of this##3##4##(2008-10#1)(2009-2#1)(2011-1#1)
the patients of##12##3##(1992-6#1)(2008-1#1)(2008-10#1)(2009-2#1)(2010-11#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
the patients often##2##3##(1991-8#1)(2010-12#1)
the patients on a##2##4##(2006-1#1)(2007-7#1)
the patients on##6##3##(1997-1#2)(2006-1#1)(2006-6#1)(2007-7#1)(2011-12#1)
the patients operated on##2##4##(2006-6#1)(2007-11#1)
the patients operated##3##3##(1992-5#1)(2006-6#1)(2007-11#1)
the patients perceived##2##3##(2008-9#1)(2011-2#1)
the patients presented with##5##4##(1991-8#1)(1997-3#1)(2007-10#1)(2007-3#1)(2013-8#1)
the patients presented##6##3##(1991-8#1)(1997-3#1)(2007-10#1)(2007-3#1)(2011-11#1)(2013-8#1)
the patients presenting##4##3##(2007-10#1)(2012-2#1)(2013-8#2)
the patients receive##2##3##(1990-8#1)(2010-8#1)
the patients received##10##3##(1990-12#1)(1992-6#1)(2004-1#1)(2006-10#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-5#1)(2008-7#1)
the patients receiving##6##3##(1995-4#1)(2007-11#1)(2008-1#1)(2008-5#1)(2010-7#1)(2013-1#1)
the patients recovered without##2##4##(1997-6#1)(2007-10#1)
the patients recovered##3##3##(1997-6#1)(2007-10#1)(2007-8#1)
the patients referred##3##3##(1992-5#1)(2007-8#1)(2008-1#1)
the patients registered##2##3##(2006-4#1)(2013-1#1)
the patients remained##2##3##(1993-7#1)(2008-7#1)
the patients reported##9##3##(1991-3#1)(1992-5#2)(1993-2#1)(1995-12#1)(1997-2#1)(2006-10#1)(2006-11#1)(2012-2#1)
the patients responded##4##3##(2006-8#1)(2007-7#1)(2007-8#1)(2011-2#1)
the patients served##2##3##(2007-11#1)(2007-7#1)
the patients should be##2##4##(1995-8#1)(1996-1#1)
the patients should##3##3##(1995-8#1)(1996-1#1)(2007-11#1)
the patients suffered##7##3##(1993-3#1)(1993-9#1)(1997-8#1)(2005-5#1)(2007-7#1)(2011-1#1)(2013-1#1)
the patients suffering from##7##4##(2007-9#1)(2008-7#4)(2012-12#1)(2013-7#1)
the patients suffering##8##3##(2006-8#1)(2007-9#1)(2008-7#4)(2012-12#1)(2013-7#1)
the patients surveyed##3##3##(1992-5#1)(2006-10#2)
the patients survived##2##3##(1990-12#1)(2011-2#1)
the patients taking##2##3##(2007-6#1)(2011-2#1)
the patients than in controls##2##5##(1994-11#1)(1997-2#1)
the patients than in##5##4##(1994-11#1)(1997-2#1)(2008-7#2)(2011-2#1)
the patients that##5##3##(1995-11#1)(1997-2#1)(2004-10#1)(2008-8#1)(2011-2#1)
the patients the##4##3##(1990-6#1)(1990-9#1)(1992-5#1)(2005-3#1)
the patients themselves##7##3##(1993-2#1)(1995-2#1)(1995-4#1)(2005-7#1)(2007-11#1)(2007-12#1)(2007-8#1)
the patients they##3##3##(1991-1#1)(1991-2#1)(2012-3#1)
the patients to##10##3##(1995-11#2)(1995-6#1)(1996-12#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2009-7#1)
the patients took##2##3##(2011-2#1)(2012-2#1)
the patients treated by##2##4##(1992-8#1)(2008-7#1)
the patients treated in the geriatric assessment unit##2##8##(1990-5#2)
the patients treated with##7##4##(1990-6#1)(1991-4#1)(2006-10#1)(2006-6#1)(2007-6#1)(2008-11#2)
the patients treated##15##3##(1990-5#2)(1990-6#1)(1991-4#1)(1992-8#1)(1996-8#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-6#1)(2008-11#2)(2008-7#2)(2011-1#1)
the patients treatment##2##3##(2011-1#1)(2011-2#1)
the patients undergoing##2##3##(2007-9#1)(2011-2#1)
the patients understand##2##3##(2008-7#2)
the patients underwent##7##3##(1990-9#1)(1991-8#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-4#1)(2013-1#1)
the patients was##48##3##(1990-12#1)(1990-4#1)(1990-7#1)(1991-4#1)(1991-8#1)(1992-8#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-4#1)(1995-4#1)(1996-1#1)(1996-7#1)(1997-8#1)(2007-3#2)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-10#2)(2009-8#1)(2010-6#1)(2011-1#2)(2011-11#1)(2011-2#1)(2011-3#1)(2012-2#3)(2012-3#1)(2013-7#1)
the patients were assessed##2##4##(2008-4#1)(2011-12#1)
the patients were considered##2##4##(1993-5#1)(1996-12#1)
the patients were discharged##3##4##(1990-8#1)(2007-8#2)
the patients were divided into two groups##2##7##(2008-4#1)(2011-1#1)
the patients were divided into two##3##6##(2007-9#1)(2008-4#1)(2011-1#1)
the patients were divided into##6##5##(2007-9#1)(2008-4#1)(2008-7#1)(2011-1#1)(2011-12#1)(2012-12#1)
the patients were evaluated##6##4##(2007-7#1)(2007-8#3)(2012-2#1)(2013-8#1)
the patients were followed up for##3##6##(1995-5#1)(2007-7#1)(2013-8#1)
the patients were followed up##4##5##(1995-5#1)(2007-7#1)(2013-8#2)
the patients were found##2##4##(1993-1#1)(1995-4#1)
the patients were given##2##4##(2007-3#1)(2007-7#1)
the patients were in##6##4##(1993-3#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-7#1)
the patients were male##3##4##(1990-9#1)(2007-8#1)(2013-1#1)
the patients were not##2##4##(1990-10#1)(2008-11#1)
the patients were on##3##4##(2008-1#1)(2008-4#1)(2012-5#1)
the patients were randomized##2##4##(1992-4#1)(2005-1#1)
the patients were referred##2##4##(2007-11#1)(2007-3#1)
the patients were studied##2##4##(1996-1#1)(2006-8#1)
the patients were subjected to##2##5##(1990-11#1)(1997-2#1)
the patients were treated with##3##5##(1991-9#1)(1997-6#1)(2008-4#1)
the patients were treated##6##4##(1990-10#1)(1991-9#1)(1994-8#1)(1997-6#1)(2007-8#1)(2008-4#1)
the patients were younger than##2##5##(1990-4#1)(1990-6#1)
the patients were##140##3##(1990-10#3)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#3)(1990-6#2)(1990-8#4)(1990-9#3)(1991-2#1)(1991-9#1)(1992-10#1)(1992-4#2)(1992-6#1)(1993-1#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-6#2)(2004-10#1)(2004-12#1)(2005-1#1)(2005-10#2)(2005-6#1)(2006-10#1)(2006-12#1)(2006-6#3)(2006-7#1)(2006-8#3)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#3)(2007-6#1)(2007-7#6)(2007-8#12)(2007-9#3)(2008-1#4)(2008-10#1)(2008-11#1)(2008-3#4)(2008-4#5)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#1)(2010-7#1)(2011-1#4)(2011-12#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#5)(2013-7#1)(2013-8#4)
the patients who are##2##4##(2008-10#1)(2008-7#1)
the patients who died##3##4##(1997-4#1)(2008-2#1)(2012-3#1)
the patients who had##5##4##(1995-9#2)(1997-3#1)(2007-10#1)(2007-8#1)
the patients who received##5##4##(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2012-2#1)
the patients who underwent surgery##2##5##(2008-3#1)(2008-7#1)
the patients who underwent##3##4##(2008-3#1)(2008-7#1)(2011-2#1)
the patients who were##4##4##(1992-6#1)(1996-11#1)(2007-10#1)(2012-3#1)
the patients who##43##3##(1990-12#1)(1992-11#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-12#1)(1995-3#1)(1995-9#2)(1996-11#1)(1996-12#1)(1997-3#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
the patients whose age were 35 and##2##7##(2010-12#2)
the patients whose##3##3##(2006-5#1)(2010-12#2)
the patients will##3##3##(1996-12#1)(2009-5#1)(2011-2#1)
the patients with Crohn's##2##4##(1994-2#1)(2012-11#1)
the patients with ICC##2##4##(2010-12#2)
the patients with a##6##4##(1990-10#1)(2006-8#2)(2008-11#1)(2010-3#1)(2011-3#1)
the patients with acute coronary##2##5##(2008-10#2)
the patients with acute##4##4##(1997-8#1)(2008-10#2)(2012-2#1)
the patients with an##3##4##(1992-5#1)(1993-2#1)(2009-6#1)
the patients with benign##2##4##(1990-9#1)(2011-1#1)
the patients with breast cancer##2##5##(2007-1#1)(2007-6#1)
the patients with cancer of the pancreas##4##7##(2008-7#4)
the patients with cancer of the stomach##4##7##(2008-7#4)
the patients with cancer of the##8##6##(2008-7#8)
the patients with cancer##10##4##(2008-7#8)(2010-8#1)(2011-2#1)
the patients with chronic low back pain##3##7##(2006-7#1)(2006-8#2)
the patients with chronic##7##4##(2006-10#1)(2006-7#1)(2006-8#3)(2008-4#1)(2009-8#1)
the patients with colorectal##2##4##(2008-10#1)(2012-1#1)
the patients with end-stage##3##4##(2008-7#1)(2011-2#1)(2012-2#1)
the patients with habits##2##4##(2013-8#2)
the patients with low##2##4##(2006-7#1)(2013-8#1)
the patients with multiple##2##4##(2006-7#1)(2011-2#1)
the patients with no##2##4##(1990-11#1)(2007-8#1)
the patients with osteoarthritis of##2##5##(2008-5#2)
the patients with rheumatic##2##4##(1990-6#1)(2007-12#1)
the patients with suspected##2##4##(2008-12#1)(2009-7#1)
the patients with the##4##4##(2006-3#1)(2007-7#1)(2008-1#1)(2008-12#1)
the patients with this##2##4##(1997-6#1)(2009-11#1)
the patients with vascular##2##4##(1993-2#1)(2013-1#1)
the patients with##208##3##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#5)(1990-6#3)(1990-9#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-4#2)(1992-5#1)(1992-7#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(2004-1#1)(2004-8#1)(2005-1#1)(2005-10#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#3)(2006-7#3)(2006-8#9)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#2)(2007-2#2)(2007-3#1)(2007-6#2)(2007-7#6)(2007-8#8)(2007-9#1)(2008-1#3)(2008-10#7)(2008-11#3)(2008-12#4)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#17)(2008-8#1)(2008-9#2)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#6)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#6)(2011-3#1)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#7)(2013-8#10)
the patients within##3##3##(2008-5#1)(2010-7#2)
the patients without##8##3##(1991-6#1)(1992-7#1)(1994-7#1)(2007-10#1)(2007-8#2)(2008-7#2)
the patients would##4##3##(1997-6#1)(2008-5#1)(2010-3#1)(2012-2#1)
the patients##1458##2##(1990-10#13)(1990-11#5)(1990-12#14)(1990-2#9)(1990-3#3)(1990-4#16)(1990-5#5)(1990-6#10)(1990-7#2)(1990-8#12)(1990-9#12)(1991-1#3)(1991-10#1)(1991-12#4)(1991-2#7)(1991-3#10)(1991-4#4)(1991-5#4)(1991-6#6)(1991-7#1)(1991-8#7)(1991-9#5)(1992-1#2)(1992-10#2)(1992-11#4)(1992-12#3)(1992-2#3)(1992-3#6)(1992-4#6)(1992-5#10)(1992-6#7)(1992-7#2)(1992-8#6)(1992-9#2)(1993-1#5)(1993-10#4)(1993-11#3)(1993-12#8)(1993-2#9)(1993-3#7)(1993-4#1)(1993-5#6)(1993-6#3)(1993-7#4)(1993-8#1)(1993-9#4)(1994-11#4)(1994-12#2)(1994-2#3)(1994-3#5)(1994-4#1)(1994-5#4)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#4)(1995-1#2)(1995-10#2)(1995-11#6)(1995-12#2)(1995-2#6)(1995-3#1)(1995-4#6)(1995-5#6)(1995-6#3)(1995-7#1)(1995-8#2)(1995-9#12)(1996-1#8)(1996-11#2)(1996-12#9)(1996-2#7)(1996-3#2)(1996-4#3)(1996-5#2)(1996-6#3)(1996-7#6)(1996-8#4)(1996-9#7)(1997-1#2)(1997-2#7)(1997-3#3)(1997-4#6)(1997-5#3)(1997-6#6)(1997-7#2)(1997-8#13)(2004-1#4)(2004-10#5)(2004-12#4)(2004-4#1)(2004-8#1)(2005-1#3)(2005-10#10)(2005-11#1)(2005-12#3)(2005-3#1)(2005-5#1)(2005-6#1)(2005-7#2)(2005-8#3)(2006-1#2)(2006-10#31)(2006-11#2)(2006-12#13)(2006-2#6)(2006-3#1)(2006-4#4)(2006-5#1)(2006-6#19)(2006-7#8)(2006-8#49)(2006-9#1)(2007-1#4)(2007-10#19)(2007-11#42)(2007-12#13)(2007-2#12)(2007-3#17)(2007-4#1)(2007-5#2)(2007-6#7)(2007-7#77)(2007-8#64)(2007-9#23)(2008-1#41)(2008-10#27)(2008-11#15)(2008-12#7)(2008-2#1)(2008-3#12)(2008-4#19)(2008-5#16)(2008-6#8)(2008-7#60)(2008-8#19)(2008-9#12)(2009-1#1)(2009-10#7)(2009-11#1)(2009-12#2)(2009-2#6)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#3)(2009-8#5)(2009-9#1)(2010-10#2)(2010-11#4)(2010-12#13)(2010-2#1)(2010-3#7)(2010-4#6)(2010-6#3)(2010-7#9)(2010-8#14)(2011-1#27)(2011-11#3)(2011-12#8)(2011-2#60)(2011-3#4)(2012-1#7)(2012-11#3)(2012-12#13)(2012-2#22)(2012-3#14)(2012-5#1)(2013-1#38)(2013-7#6)(2013-8#32)
the patients' QOL##2##3##(1995-10#1)(1995-4#1)
the patients' age##2##3##(1990-8#1)(1993-2#1)
the patients' cultural##2##3##(2008-5#1)(2013-1#1)
the patients' perspective##2##3##(2008-12#1)(2011-2#1)
the patients' quality of life##6##5##(1992-5#1)(2005-3#1)(2011-2#2)(2012-2#2)
the patients' rights##2##3##(1997-8#1)(2013-8#1)
the patients' sera##2##3##(1991-9#1)(2005-12#1)
the patients' waiting##2##3##(2006-2#2)
the patients'##92##2##(1990-10#1)(1990-12#1)(1990-2#3)(1990-4#1)(1990-7#1)(1990-8#1)(1991-2#4)(1991-4#1)(1991-9#2)(1992-2#1)(1992-5#1)(1993-2#2)(1993-5#1)(1994-2#2)(1994-8#1)(1995-10#1)(1995-4#1)(1995-9#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-12#1)(2005-3#3)(2005-7#1)(2006-1#1)(2006-10#4)(2006-2#2)(2006-7#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-11#1)(2008-12#2)(2008-5#5)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#2)(2009-11#1)(2009-2#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#6)(2012-11#1)(2012-2#3)(2013-1#3)(2013-8#1)
the patients)##6##2##(1991-4#1)(1994-2#1)(2005-10#1)(2006-10#1)(2007-7#2)
the patriarchal##2##2##(2006-12#1)(2007-12#1)
the pattern and##14##3##(1991-8#2)(1995-2#1)(1996-4#1)(1997-2#1)(2005-9#1)(2007-6#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-1#1)(2011-12#1)
the pattern code##2##3##(2008-2#2)
the pattern found in##2##4##(1993-11#1)(2007-5#1)
the pattern in the##2##4##(1994-10#1)(1996-4#1)
the pattern in##3##3##(1994-10#1)(1996-4#1)(2007-12#1)
the pattern is##2##3##(2006-10#1)(2010-2#1)
the pattern of accumulation of##2##5##(1995-8#1)(2008-7#1)
the pattern of cerebral##3##4##(1990-7#1)(1992-2#1)(2007-9#1)
the pattern of changes in##2##5##(2007-2#1)(2010-8#1)
the pattern of distribution of##3##5##(2008-10#1)(2013-1#2)
the pattern of distribution##5##4##(1996-3#1)(2008-10#2)(2013-1#2)
the pattern of expression of the##3##6##(1994-11#1)(1995-2#1)(1997-4#1)
the pattern of expression of##4##5##(1994-11#1)(1995-12#1)(1995-2#1)(1997-4#1)
the pattern of expression##5##4##(1994-11#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-4#1)
the pattern of gene expression##2##5##(2008-10#1)(2008-6#1)
the pattern of impairments to specific components of the face-processing system##2##11##(2009-4#2)
the pattern of induction of##2##5##(1993-4#1)(1996-5#1)
the pattern of induction##3##4##(1990-5#1)(1993-4#1)(1996-5#1)
the pattern of metabolic##2##4##(1996-9#1)(2008-3#1)
the pattern of proton##2##4##(1997-6#2)
the pattern of rabies spread##2##5##(1991-12#2)
the pattern of selection##2##4##(2008-8#2)
the pattern of skin##2##4##(2006-4#1)(2007-7#1)
the pattern of spread##2##4##(1991-12#1)(2005-12#1)
the pattern of the##9##4##(1990-12#1)(1991-2#1)(1994-10#1)(1994-5#1)(1995-7#1)(1997-7#1)(2008-8#1)(2012-1#1)(2013-8#1)
the pattern of these##2##4##(1992-11#1)(2007-7#1)
the pattern of use of##3##5##(2010-8#2)(2012-2#1)
the pattern of use##5##4##(1996-9#1)(2010-8#2)(2011-1#1)(2012-2#1)
the pattern of##190##3##(1990-11#1)(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#2)(1991-11#2)(1991-12#4)(1991-2#1)(1991-3#2)(1991-6#1)(1991-8#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#2)(1993-12#2)(1993-2#1)(1993-4#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-2#1)(1994-5#2)(1995-1#2)(1995-10#1)(1995-11#4)(1995-12#6)(1995-2#2)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#2)(1997-4#3)(1997-6#4)(1997-7#3)(1997-8#1)(2003-11#1)(2004-11#2)(2005-10#2)(2005-12#1)(2005-8#1)(2005-9#1)(2006-12#3)(2006-4#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-3#4)(2007-7#5)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#4)(2008-3#4)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#9)(2008-9#1)(2009-10#2)(2009-4#3)(2009-7#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#3)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
the pattern##250##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#2)(1991-11#3)(1991-12#4)(1991-2#2)(1991-3#2)(1991-6#1)(1991-8#3)(1992-11#2)(1992-12#2)(1992-2#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-9#2)(1994-10#2)(1994-11#1)(1994-2#1)(1994-5#2)(1995-1#2)(1995-10#1)(1995-11#4)(1995-12#7)(1995-2#3)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#3)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-2#1)(1997-4#3)(1997-6#4)(1997-7#3)(1997-8#1)(2003-11#1)(2004-11#2)(2005-10#2)(2005-12#1)(2005-8#1)(2005-9#2)(2006-10#3)(2006-12#4)(2006-4#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#7)(2007-2#2)(2007-3#4)(2007-5#1)(2007-6#1)(2007-7#5)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#5)(2008-2#3)(2008-3#8)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#12)(2008-9#3)(2009-10#2)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#1)(2010-2#2)(2010-7#1)(2010-8#3)(2011-1#2)(2011-12#2)(2011-2#6)(2012-1#3)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
the patterned##2##2##(2009-7#1)(2010-7#1)
the patterning of a##2##4##(1996-2#1)(2007-11#1)
the patterning of##6##3##(1996-2#1)(2007-11#1)(2007-12#2)(2008-11#1)(2010-4#1)
the patterning##7##2##(1996-2#1)(2007-11#1)(2007-12#3)(2008-11#1)(2010-4#1)
the patterns and##2##3##(2007-12#1)(2009-12#1)
the patterns are##2##3##(2007-3#1)(2007-8#1)
the patterns in##2##3##(2007-7#1)(2008-2#1)
the patterns of disfluency##3##4##(2008-2#3)
the patterns of renal histology##2##5##(2008-1#1)(2010-4#1)
the patterns of use##2##4##(2007-4#1)(2008-11#1)
the patterns of variation##2##4##(2004-11#1)(2009-8#1)
the patterns of##62##3##(1991-12#1)(1993-12#1)(1993-9#1)(1994-3#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-8#1)(1996-9#2)(1997-5#1)(2004-11#1)(2006-10#1)(2007-4#1)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-2#6)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
the patterns to be##2##4##(2006-12#1)(2008-2#1)
the patterns were##2##3##(1996-5#1)(2008-11#1)
the patterns##85##2##(1991-12#1)(1991-5#1)(1993-12#1)(1993-9#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#3)(1997-5#1)(2004-11#1)(2006-10#2)(2006-12#2)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#4)(2007-8#3)(2008-1#4)(2008-10#5)(2008-11#2)(2008-2#9)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
the paucity of data on the##2##6##(2007-11#1)(2008-10#1)
the paucity of##21##3##(1990-7#1)(1991-8#1)(1995-1#1)(1997-2#1)(1997-9#1)(2004-11#1)(2007-10#2)(2007-11#1)(2007-5#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-12#2)(2011-2#1)
the paucivalent selectin##2##3##(1997-4#2)
the paucivalent##3##2##(1997-4#3)
the pavine##2##2##(2007-1#1)(2008-5#1)
the paw##7##2##(1991-1#2)(1994-3#1)(1994-6#1)(1995-12#2)(2010-2#1)
the paws##2##2##(1996-1#1)(1997-2#1)
the payback##2##2##(1992-2#1)(2008-2#1)
the payer##3##2##(1996-1#1)(2008-12#1)(2013-8#1)
the payment for##2##3##(1994-1#1)(2008-11#1)
the payment methodology##2##3##(1996-3#1)(2007-2#1)
the payment##9##2##(1990-12#1)(1992-1#1)(1992-2#1)(1994-1#1)(1994-12#2)(1996-3#1)(2007-2#1)(2008-11#1)
the payoff##3##2##(1992-2#1)(2008-2#1)(2008-8#1)
the payor##2##2##(1990-12#1)(1992-1#1)
the pea lectin##3##3##(1993-8#3)
the pea##13##2##(1993-6#1)(1993-8#4)(2008-10#7)(2009-8#1)
the peace##2##2##(1990-2#1)(2004-7#1)
the peak BMD##2##3##(2010-3#2)
the peak absorption##3##3##(2008-3#3)
the peak age##2##3##(2007-10#1)(2007-7#1)
the peak amplitude of the EPSP##2##6##(1992-8#2)
the peak amplitude of##3##4##(1992-8#2)(1995-11#1)
the peak amplitude##4##3##(1992-8#2)(1995-11#1)(1996-9#1)
the peak and##3##3##(1996-2#1)(1997-2#1)(2010-8#1)
the peak angular speeds##2##4##(2007-1#1)(2007-4#1)
the peak ankle moment##2##4##(2006-11#1)(2007-1#1)
the peak area of##3##4##(2008-10#2)(2011-1#1)
the peak area ratios##2##4##(2008-10#2)
the peak area##13##3##(1990-8#1)(2008-10#10)(2011-1#2)
the peak areas##4##3##(2006-12#1)(2008-4#1)(2011-1#1)(2013-1#1)
the peak at##4##3##(2005-11#1)(2008-10#1)(2008-11#1)(2010-12#1)
the peak bone##2##3##(2005-3#1)(2010-3#1)
the peak concentration##3##3##(1992-9#1)(2008-11#1)(2012-12#1)
the peak current and##5##4##(2008-10#5)
the peak current is proportional to##3##6##(2007-8#1)(2008-10#2)
the peak current is proportional##4##5##(2007-8#2)(2008-10#2)
the peak current of the##2##5##(2008-10#2)
the peak current of##4##4##(2008-10#4)
the peak current##23##3##(2007-8#2)(2008-10#21)
the peak currents are linearly proportional to the concentration of##3##10##(2008-10#3)
the peak currents are##4##4##(2008-10#4)
the peak currents were##2##4##(2007-8#1)(2008-10#1)
the peak currents##10##3##(2007-8#2)(2008-10#8)
the peak experiences of psilocybin users##2##6##(2013-8#2)
the peak expiratory flow##2##4##(1990-6#1)(2013-8#1)
the peak frequency##2##3##(2008-11#1)(2008-2#1)
the peak grating##2##3##(2008-2#1)(2008-3#1)
the peak height and peak##2##5##(1996-5#1)(2008-10#1)
the peak height and##4##4##(1996-5#1)(2008-10#2)(2008-2#1)
the peak height of the##2##5##(2005-4#1)(2006-12#1)
the peak height of##3##4##(2005-4#1)(2006-12#1)(2008-10#1)
the peak height##15##3##(1993-8#1)(1996-5#1)(2005-11#1)(2005-4#1)(2006-12#1)(2008-10#9)(2008-2#1)
the peak heights obtained##4##4##(2008-10#4)
the peak heights##7##3##(2008-10#6)(2008-2#1)
the peak in the##2##4##(1997-1#1)(1997-7#1)
the peak in##5##3##(1997-1#1)(1997-7#1)(2008-9#2)(2010-2#1)
the peak intensities##4##3##(1992-9#1)(2007-12#1)(2008-10#1)(2008-2#1)
the peak intensity of a##2##5##(2008-2#2)
the peak intensity of the##3##5##(2008-2#2)(2008-3#1)
the peak intensity of##5##4##(2008-2#4)(2008-3#1)
the peak intensity##10##3##(2007-11#1)(2007-12#1)(2008-2#5)(2008-3#3)
the peak latency of the visual evoked potential##2##8##(1995-12#2)
the peak latency of##3##4##(1995-12#2)(2008-7#1)
the peak level##2##3##(1996-12#1)(2006-10#1)
the peak of T wave##2##5##(2007-9#2)
the peak of spine##2##4##(2007-8#2)
the peak of the dry season##2##6##(2007-2#1)(2007-3#1)
the peak of the##18##4##(1990-11#1)(1990-3#1)(1995-11#1)(2004-9#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-2#5)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)
the peak of##35##3##(1990-11#1)(1990-3#1)(1991-5#1)(1991-9#1)(1993-8#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-3#1)(1996-8#1)(2004-9#1)(2005-4#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#3)(2007-9#3)(2008-10#1)(2008-2#6)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2011-1#1)(2013-1#1)
the peak period of fruit susceptibility##2##6##(2008-10#2)
the peak period of##3##4##(2008-10#2)(2008-7#1)
the peak position at maximum height##2##6##(2008-10#2)
the peak position of the##2##5##(2007-11#1)(2008-3#1)
the peak position##7##3##(2005-11#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)
the peak potential##3##3##(2008-10#3)
the peak potentials##4##3##(2008-10#4)
the peak power##7##3##(2007-11#2)(2007-12#3)(2012-1#2)
the peak reflectivity and the##2##5##(2007-11#1)(2008-2#1)
the peak shape##3##3##(1996-8#1)(2005-12#1)(2008-10#1)
the peak shift##2##3##(2006-10#2)
the peak systolic##3##3##(1990-8#1)(1994-4#1)(2007-10#1)
the peak time and##2##4##(2007-5#1)(2011-2#1)
the peak time##3##3##(2007-5#1)(2008-10#1)(2011-2#1)
the peak value of the##3##5##(2008-3#1)(2008-7#1)(2013-8#1)
the peak values of the##2##5##(2008-3#2)
the peak values of##4##4##(2008-3#2)(2008-8#1)(2013-8#1)
the peak values##5##3##(2005-10#1)(2008-3#2)(2008-8#1)(2013-8#1)
the peak velocity of motion in the ischaemic area in##2##10##(2005-1#2)
the peak wavelength##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
the peak##289##2##(1990-11#1)(1990-3#1)(1990-6#1)(1990-8#2)(1991-12#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-6#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-8#2)(1994-4#1)(1994-5#1)(1994-6#1)(1995-11#2)(1995-12#3)(1995-3#2)(1995-8#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#2)(2004-9#1)(2005-1#2)(2005-10#1)(2005-11#3)(2005-12#2)(2005-3#1)(2005-4#2)(2005-9#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-8#1)(2007-1#5)(2007-10#4)(2007-11#7)(2007-12#8)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#1)(2007-8#8)(2007-9#3)(2008-10#88)(2008-11#3)(2008-2#24)(2008-3#17)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#5)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-8#1)(2011-1#4)(2011-2#4)(2012-1#3)(2012-12#3)(2012-2#2)(2013-1#2)(2013-8#5)
the peak-power frequency##2##3##(2008-3#2)
the peak-to-output-energy ratio##2##3##(2008-2#2)
the peak-to-peak amplitude##2##3##(2008-7#2)
the peak-to-peak##4##2##(2008-10#1)(2008-3#1)(2008-7#2)
the peaks corresponding to##2##4##(2008-10#2)
the peaks due to##2##4##(2008-10#1)(2010-12#1)
the peaks of the##5##4##(2007-11#2)(2008-10#3)
the peaks of##11##3##(1995-7#1)(2007-11#2)(2007-12#1)(2008-10#6)(2011-2#1)
the peaks were##2##3##(2008-10#2)
the peaks##35##2##(1991-5#1)(1995-7#1)(1996-7#1)(1996-8#1)(1997-4#1)(2005-11#1)(2007-11#2)(2007-12#3)(2008-10#19)(2008-12#1)(2008-3#1)(2010-12#1)(2011-2#1)(2013-7#1)
the peanut##2##2##(2007-3#2)
the pear##2##2##(2008-10#1)(2009-6#1)
the peasants##2##2##(1993-3#1)(1993-6#1)
the peat##5##2##(2008-10#5)
the pecking behavior##2##3##(2008-6#2)
the pecking##3##2##(2008-6#2)(2009-9#1)
the pecten##3##2##(2008-5#3)
the pectin##4##2##(1990-4#1)(1995-4#1)(2008-10#2)
the pectoral##8##2##(1994-7#1)(1997-6#1)(2004-2#1)(2008-5#4)(2009-7#1)
the pectoralis major##4##3##(2009-1#1)(2012-2#3)
the pectoralis minor##3##3##(2010-9#2)(2013-1#1)
the pectoralis##7##2##(2009-1#1)(2010-9#2)(2012-2#3)(2013-1#1)
the peculiar##10##2##(1990-10#1)(1995-4#1)(2006-10#1)(2007-3#1)(2008-3#1)(2008-5#2)(2010-7#1)(2012-2#1)(2013-1#1)
the peculiarities of the##3##4##(1991-6#1)(2009-2#1)(2012-3#1)
the peculiarities of##10##3##(1991-6#1)(2005-11#1)(2006-5#1)(2008-10#1)(2008-3#1)(2009-2#3)(2010-12#1)(2012-3#1)
the peculiarities##11##2##(1991-6#1)(2005-11#1)(2006-5#1)(2008-10#1)(2008-3#1)(2009-2#3)(2009-6#1)(2010-12#1)(2012-3#1)
the peculiarity of##3##3##(1990-12#1)(2010-1#1)(2013-7#1)
the pedagogic##2##2##(2011-2#1)(2012-12#1)
the pedestal components##2##3##(2007-12#2)
the pedestrian model##2##3##(2006-11#1)(2007-4#1)
the pedestrian##4##2##(2006-11#2)(2007-4#2)
the pediatric age group##10##4##(2006-9#1)(2007-12#1)(2007-3#1)(2008-4#2)(2009-3#1)(2012-12#2)(2013-1#2)
the pediatric age##12##3##(2006-11#1)(2006-9#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-4#2)(2009-3#1)(2012-12#2)(2013-1#2)
the pediatric and##3##3##(1990-6#1)(2008-4#1)(2009-11#1)
the pediatric emergency##4##3##(1992-3#1)(2007-7#1)(2009-6#1)(2010-3#1)
the pediatric head##2##3##(2007-1#2)
the pediatric immunization##2##3##(2012-12#2)
the pediatric nurse practitioner##3##4##(2009-9#1)(2010-10#1)(2010-7#1)
the pediatric paradox##5##3##(2009-4#5)
the pediatric patient##5##3##(2004-8#1)(2005-10#1)(2008-10#1)(2008-7#1)(2011-2#1)
the pediatric population##20##3##(2005-2#1)(2006-10#5)(2006-11#1)(2007-12#1)(2008-10#1)(2008-4#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-8#2)
the pediatric unit##2##3##(2007-7#1)(2011-2#1)
the pediatric##101##2##(1990-6#1)(1992-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(2004-8#1)(2005-10#2)(2005-2#1)(2005-6#2)(2006-10#8)(2006-11#3)(2006-8#1)(2006-9#1)(2007-1#4)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#2)(2008-4#8)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#5)(2009-6#1)(2009-9#2)(2010-10#2)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#5)(2012-12#11)(2012-2#7)(2013-1#2)(2013-8#2)
the pediatrician##4##2##(1996-2#1)(2008-7#1)(2010-3#1)(2013-1#1)
the pediatricians##3##2##(1995-12#1)(2007-12#1)(2011-1#1)
the pedicle##13##2##(2007-1#2)(2007-11#2)(2007-5#4)(2008-4#1)(2008-7#1)(2011-2#1)(2012-12#2)
the pedicled dorsalis pedis flap from the##2##7##(2011-2#2)
the pedigree##4##2##(2005-7#1)(2008-10#2)(2012-1#1)
the peduncle##2##2##(2008-10#2)
the pedunculopontine tegmental nucleus (PPTg)##3##5##(1994-10#1)(1994-2#1)(1995-12#1)
the pedunculopontine tegmental nucleus##9##4##(1991-11#1)(1994-10#2)(1994-2#2)(1994-3#1)(1995-12#1)(1995-5#1)(2008-7#1)
the pedunculopontine##13##2##(1991-11#1)(1992-1#2)(1994-10#2)(1994-2#2)(1994-3#2)(1995-12#1)(1995-5#1)(2008-7#1)(2012-2#1)
the peel##6##2##(2008-10#3)(2008-5#2)(2011-12#1)
the peeled grated cocoyam and plantain porridge##3##7##(2008-4#3)
the peeled grated cocoyam and plantain##4##6##(2008-4#4)
the peeling of##2##3##(2006-7#1)(2011-2#1)
the peeling##4##2##(2004-12#2)(2006-7#1)(2011-2#1)
the peer group##2##3##(2009-8#1)(2010-4#1)
the peer review process##6##4##(1992-12#1)(1993-1#1)(2005-7#1)(2006-1#2)(2008-11#1)
the peer review##7##3##(1992-12#1)(1993-1#1)(2005-7#1)(2006-1#2)(2008-11#1)(2009-2#1)
the peer tutoring##2##3##(2005-10#2)
the peer##16##2##(1992-12#1)(1993-1#1)(2005-10#2)(2005-7#2)(2006-1#2)(2007-12#2)(2008-11#1)(2008-8#1)(2009-2#1)(2009-8#1)(2010-2#1)(2010-4#1)
the peer-review and editorial processes##2##5##(2005-7#2)
the peer-review process and##2##4##(2005-7#2)
the peer-review##6##2##(2005-7#4)(2007-4#1)(2012-12#1)
the peer-reviewed literature##4##3##(2007-1#1)(2010-8#1)(2012-12#1)(2013-7#1)
the peer-reviewed##6##2##(2007-1#1)(2010-8#2)(2012-12#1)(2013-7#1)(2013-8#1)
the pellet##7##2##(1991-2#1)(1991-4#2)(2007-9#1)(2008-6#1)(2008-7#1)(2010-9#1)
the pellets##2##2##(2008-10#2)
the pelvic and##2##3##(2006-11#1)(2006-8#1)
the pelvic area##3##3##(2007-4#1)(2007-6#1)(2012-2#1)
the pelvic cavity##3##3##(1992-3#1)(2008-12#1)(2008-7#1)
the pelvic fins##3##3##(2008-5#3)
the pelvic floor##10##3##(1990-4#2)(1992-3#2)(2007-4#2)(2010-12#1)(2011-2#2)(2012-1#1)
the pelvic joint syndrome##2##4##(1990-6#1)(1991-2#1)
the pelvic limb##3##3##(2005-7#2)(2010-4#1)
the pelvic nerve##3##3##(1992-3#2)(1993-12#1)
the pelvic organs##3##3##(1994-3#1)(2007-4#1)(2013-8#1)
the pelvic region##5##3##(1993-8#1)(2007-4#1)(2007-6#1)(2008-10#1)(2012-1#1)
the pelvic##61##2##(1990-4#2)(1990-5#2)(1990-6#2)(1991-2#1)(1992-10#1)(1992-12#1)(1992-3#5)(1993-12#1)(1993-8#1)(1994-3#1)(1994-4#2)(2005-10#1)(2005-7#2)(2006-11#2)(2006-8#1)(2006-9#1)(2007-4#5)(2007-5#1)(2007-6#5)(2007-7#2)(2008-10#1)(2008-12#1)(2008-5#3)(2008-6#3)(2008-7#2)(2009-4#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-1#3)(2012-2#1)(2013-8#1)
the pelvis and##5##3##(1991-11#1)(2007-10#1)(2007-4#1)(2010-3#1)(2013-1#1)
the pelvis during##2##3##(2012-1#2)
the pelvis in##2##3##(2008-6#1)(2012-1#1)
the pelvis of##2##3##(1992-9#1)(2006-11#1)
the pelvis was##3##3##(2006-11#2)(2009-2#1)
the pelvis##65##2##(1991-11#1)(1991-12#1)(1991-2#1)(1992-12#2)(1992-9#1)(2006-10#1)(2006-11#7)(2006-6#1)(2007-10#1)(2007-11#3)(2007-4#4)(2007-7#4)(2008-12#1)(2008-6#5)(2008-8#4)(2009-12#1)(2009-2#1)(2010-3#4)(2010-9#1)(2011-2#12)(2012-1#6)(2012-12#1)(2013-1#2)
the penalized##4##2##(2008-4#2)(2008-6#1)(2010-5#1)
the penalties##2##2##(1992-2#1)(2013-1#1)
the pencil##2##2##(2007-8#1)(2010-9#1)
the pendant##5##2##(2005-11#1)(2006-12#1)(2007-12#1)(2009-10#1)(2010-5#1)
the pendulum##3##2##(1995-6#1)(2007-4#2)
the penetrance of the##2##4##(2006-10#1)(2008-4#1)
the penetrating##4##2##(2005-11#1)(2006-5#2)(2011-3#1)
the penetration and##4##3##(2006-10#1)(2008-10#1)(2008-8#1)(2012-3#1)
the penetration depth of the##2##5##(2008-2#1)(2008-3#1)
the penetration depth of##4##4##(2008-2#1)(2008-3#2)(2011-1#1)
the penetration depth##6##3##(2008-2#3)(2008-3#2)(2011-1#1)
the penetration of the##3##4##(2005-11#1)(2006-11#1)(2007-12#1)
the penetration of##16##3##(1991-9#1)(1994-3#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-12#2)(2008-2#1)(2008-5#2)(2009-4#1)(2010-7#1)(2011-1#1)(2011-2#1)
the penetration pore##3##3##(2008-10#3)
the penetration##37##2##(1991-12#1)(1991-9#1)(1994-3#1)(1997-1#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#1)(2007-12#2)(2008-10#8)(2008-2#4)(2008-3#2)(2008-5#4)(2008-8#1)(2009-4#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-3#1)
the penicillin##6##2##(1995-3#1)(1996-2#1)(2008-10#2)(2011-1#2)
the penicillins##3##2##(1995-3#1)(2013-8#2)
the penile shaft##3##3##(2006-9#1)(2007-7#1)(2008-10#1)
the penile##7##2##(1992-8#1)(2006-9#1)(2007-7#1)(2008-10#2)(2011-1#1)(2013-8#1)
the penis and##5##3##(2005-7#2)(2006-10#1)(2007-7#1)(2008-10#1)
the penis is##6##3##(1990-12#1)(1992-8#1)(2008-10#1)(2009-5#1)(2011-1#2)
the penis##41##2##(1990-12#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-8#2)(1995-5#1)(2005-7#2)(2006-10#1)(2006-5#6)(2007-3#1)(2007-7#3)(2008-10#5)(2008-6#1)(2009-5#7)(2011-1#2)(2012-12#1)(2013-1#2)(2013-8#1)
the pension fund##2##3##(2006-8#2)
the pension##3##2##(1995-11#1)(2006-8#2)
the pentaammine ruthenium(II)##2##3##(2008-10#2)
the pentabromo diphenyl ether##2##4##(1990-4#2)
the pentahydrated##2##2##(2006-1#2)
the pentamer##2##2##(1990-7#1)(2008-10#1)
the pentapeptide##4##2##(1990-7#1)(1991-3#2)(2008-7#1)
the pentasaccharide##3##2##(1992-1#1)(1992-12#1)(1996-4#1)
the penton##2##2##(1994-9#2)
the pentose cycle##2##3##(2012-1#2)
the pentose phosphate pathway (PPP)##2##5##(2008-7#2)
the pentose phosphate pathway##11##4##(1991-5#1)(1991-6#1)(1994-3#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-5#1)(2010-12#1)
the pentose##15##2##(1991-5#1)(1991-6#1)(1994-3#1)(1994-6#1)(1996-6#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-5#1)(2010-12#1)(2012-1#2)
the pentose-phosphate pathway##4##3##(1990-3#2)(1992-3#1)(2007-6#1)
the pentose-phosphate##5##2##(1990-3#2)(1992-3#1)(2007-6#1)(2008-11#1)
the people are##3##3##(2007-6#1)(2010-12#1)(2011-2#1)
the people in the##2##4##(2010-8#1)(2013-8#1)
the people in##4##3##(1995-2#1)(2010-8#1)(2012-2#1)(2013-8#1)
the people living in##2##4##(2008-3#1)(2012-11#1)
the people of##7##3##(1995-1#1)(1997-4#1)(2008-1#1)(2008-3#1)(2010-8#1)(2012-12#1)(2013-8#1)
the people they serve##2##4##(1994-2#1)(2012-3#1)
the people who##5##3##(1994-4#1)(1996-3#1)(2008-1#1)(2011-2#1)(2013-8#1)
the people##58##2##(1990-12#1)(1991-1#1)(1991-2#1)(1992-12#1)(1994-11#1)(1994-2#1)(1994-4#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-4#1)(2007-1#1)(2007-10#1)(2007-3#1)(2007-5#2)(2007-6#1)(2008-1#4)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#2)(2009-12#1)(2010-12#2)(2010-8#2)(2011-2#5)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#5)
the people's##2##2##(2010-10#1)(2012-3#1)
the peopling of##2##3##(1991-9#1)(2008-8#1)
the pepper##5##2##(2007-12#1)(2008-1#1)(2008-10#3)
the pepsinogen##2##2##(1995-3#1)(1995-8#1)
the peptic##2##2##(2007-8#1)(2013-8#1)
the peptidase activity##2##3##(1990-11#1)(1990-3#1)
the peptidase##3##2##(1990-11#1)(1990-3#1)(2008-4#1)
the peptidases##2##2##(1991-2#1)(1996-2#1)
the peptide LHRH##2##3##(1993-2#2)
the peptide adopts##2##3##(1992-3#1)(2006-12#1)
the peptide and its##2##4##(1996-12#1)(2006-12#1)
the peptide and the##4##4##(1990-10#1)(1990-12#1)(1993-3#1)(2008-10#1)
the peptide and##17##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#2)(1991-1#1)(1991-10#1)(1991-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1996-12#1)(2006-12#1)(2008-10#1)(2008-5#1)(2010-10#1)(2011-1#1)
the peptide backbone##10##3##(1990-8#1)(1992-6#1)(1993-11#1)(1994-11#3)(1994-3#1)(1995-10#1)(1997-7#1)(2008-4#1)
the peptide binding site##2##4##(1993-11#1)(1996-8#1)
the peptide binding##3##3##(1992-11#1)(1993-11#1)(1996-8#1)
the peptide bond##5##3##(1992-6#1)(1993-11#1)(1995-6#1)(2008-10#1)(2012-3#1)
the peptide by##2##3##(1991-7#1)(1992-3#1)
the peptide chain##2##3##(1994-9#1)(1996-12#1)
the peptide chains##3##3##(1995-3#1)(2006-12#2)
the peptide conformation##2##3##(1991-7#1)(1992-6#1)
the peptide corresponding to residues##2##5##(1994-5#1)(1994-9#1)
the peptide deformylase inhibitors##2##4##(2008-5#2)
the peptide exists##2##3##(1992-10#1)(1996-12#1)
the peptide fragment##2##3##(1993-3#1)(1993-5#1)
the peptide fragments##2##3##(1990-12#1)(1996-8#1)
the peptide has been##2##4##(1990-8#1)(1991-7#1)
the peptide has##3##3##(1990-8#1)(1991-1#1)(1991-7#1)
the peptide hormone##2##3##(1995-12#1)(2011-1#1)
the peptide in both##2##4##(1993-11#1)(2010-4#1)
the peptide in##11##3##(1990-7#1)(1991-10#1)(1992-6#2)(1992-9#1)(1993-11#1)(1994-11#1)(1997-4#1)(2008-6#1)(2010-4#1)(2012-3#1)
the peptide inhibited##2##3##(1995-6#1)(2013-7#1)
the peptide is##10##3##(1990-11#1)(1990-2#1)(1994-11#1)(1994-5#1)(1995-1#1)(1996-5#1)(1996-7#1)(1997-4#1)(2005-11#1)(2008-8#1)
the peptide mapping##2##3##(1992-11#1)(1996-5#1)
the peptide may be##3##4##(1993-3#1)(1995-12#1)(2006-10#1)
the peptide mixtures##3##3##(1995-3#1)(2004-12#1)(2012-12#1)
the peptide or##2##3##(1997-4#1)(2010-5#1)
the peptide part##3##3##(1990-12#3)
the peptide products##2##3##(2006-12#1)(2009-12#1)
the peptide ring##2##3##(1996-8#1)(2006-10#1)
the peptide sequence##11##3##(1991-9#1)(1993-6#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-5#1)(2008-10#1)(2008-4#3)(2012-12#1)
the peptide sequences##3##3##(1991-6#1)(2008-10#1)(2008-4#1)
the peptide substrate##8##3##(1990-12#1)(1992-11#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-8#1)(2012-3#1)
the peptide synthesis of##2##4##(1993-12#1)(2008-10#1)
the peptide synthesis##3##3##(1993-12#1)(2008-1#1)(2008-10#1)
the peptide to##4##3##(1990-3#1)(1991-7#1)(1991-9#1)(1995-11#1)
the peptide was##14##3##(1990-11#1)(1990-7#1)(1991-5#1)(1991-7#1)(1993-8#1)(1994-12#1)(1995-5#1)(1996-4#1)(1996-9#1)(2005-11#1)(2008-10#2)(2012-11#2)
the peptide with an excess##2##5##(2008-8#2)
the peptide with##5##3##(1992-4#1)(1992-7#1)(1993-3#1)(2008-8#2)
the peptide##323##2##(1990-10#2)(1990-11#2)(1990-12#8)(1990-2#5)(1990-3#4)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#2)(1991-1#4)(1991-10#3)(1991-12#3)(1991-2#5)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#7)(1991-8#1)(1991-9#6)(1992-1#1)(1992-10#2)(1992-11#8)(1992-12#1)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#3)(1992-6#8)(1992-7#3)(1992-8#3)(1992-9#5)(1993-11#6)(1993-12#2)(1993-2#3)(1993-3#9)(1993-5#1)(1993-6#4)(1993-8#2)(1993-9#1)(1994-11#7)(1994-12#9)(1994-2#3)(1994-3#4)(1994-5#4)(1994-6#2)(1994-8#2)(1994-9#4)(1995-1#3)(1995-10#2)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#3)(1995-5#4)(1995-6#6)(1995-8#5)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#8)(1996-4#1)(1996-5#4)(1996-7#7)(1996-8#5)(1996-9#3)(1997-4#13)(1997-7#1)(2004-12#1)(2005-11#4)(2006-10#2)(2006-12#9)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#10)(2008-3#1)(2008-4#15)(2008-5#8)(2008-6#1)(2008-8#4)(2009-12#3)(2009-5#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-1#2)(2012-11#4)(2012-12#2)(2012-3#4)(2013-7#1)
the peptide-binding groove##3##3##(1995-8#2)(2006-10#1)
the peptide-lipid##4##2##(1992-10#1)(1993-9#2)(2008-11#1)
the peptides and##3##3##(1993-9#2)(2008-10#1)
the peptides are##6##3##(1993-3#1)(1993-9#1)(1994-8#1)(1994-9#1)(1996-5#1)(2008-5#1)
the peptides as##2##3##(1997-2#1)(1997-8#1)
the peptides containing the##2##4##(1990-7#1)(1991-2#1)
the peptides derived from the##2##5##(1990-4#1)(1992-4#1)
the peptides in##2##3##(1992-4#1)(2008-9#1)
the peptides were##5##3##(1992-9#1)(1993-9#1)(1995-11#1)(2008-5#1)(2012-1#1)
the peptides with##3##3##(1991-7#1)(1993-3#1)(2011-2#1)
the peptides##88##2##(1990-10#1)(1990-11#3)(1990-2#1)(1990-4#3)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-7#1)(1992-11#2)(1992-3#1)(1992-4#3)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-3#4)(1993-4#1)(1993-9#6)(1994-11#1)(1994-12#1)(1994-8#4)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-11#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-2#2)(1997-4#2)(1997-7#1)(1997-8#1)(2005-11#1)(2005-12#1)(2006-10#4)(2008-10#2)(2008-4#4)(2008-5#2)(2008-6#1)(2008-9#2)(2009-10#1)(2011-2#2)(2012-1#1)
the peptidoglycan##4##2##(1990-7#1)(1995-2#1)(1997-4#1)(2012-2#1)
the peptidolytic reaction##2##3##(1991-9#2)
the peptidyl-transferase activity##2##3##(1992-8#1)(2005-10#1)
the peptone##5##2##(2008-5#1)(2008-7#4)
the per capita growth##2##4##(2008-8#1)(2013-8#1)
the per capita##8##3##(2006-8#1)(2008-8#3)(2011-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
the per cent##5##3##(1991-2#2)(2012-12#2)(2012-2#1)
the per##18##2##(1991-2#2)(1992-4#1)(1997-8#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-8#3)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-8#1)
the per-cell MPI yield##2##4##(1995-6#2)
the perceived benefits##3##3##(2007-12#2)(2008-11#1)
the perceived effectiveness##2##3##(1994-2#1)(2008-8#1)
the perceived level of##2##4##(2007-11#1)(2012-2#1)
the perceived need for##3##4##(1991-2#1)(1995-12#1)(2005-7#1)
the perceived need##4##3##(1991-2#1)(1995-12#1)(2005-12#1)(2005-7#1)
the perceived prevalence of##2##4##(2013-1#2)
the perceived quality of##4##4##(2007-8#1)(2008-11#1)(2009-4#1)(2013-1#1)
the perceived risk of##2##4##(1990-5#1)(1994-3#1)
the perceived social support##2##4##(1992-2#1)(2009-7#1)
the perceived value of##2##4##(1994-1#1)(2012-2#1)
the perceived##69##2##(1990-5#1)(1990-8#2)(1991-1#1)(1991-2#1)(1992-1#1)(1992-2#1)(1993-12#1)(1994-1#1)(1994-2#2)(1994-3#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(2004-11#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-7#1)(2007-11#1)(2007-12#5)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#3)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#1)
the percent change##3##3##(1995-9#1)(1996-3#1)(2006-5#1)
the percent identity##2##3##(2006-5#1)(2008-4#1)
the percent of##14##3##(1991-8#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-4#1)(2007-2#1)(2008-11#1)(2008-12#1)(2009-2#1)(2009-8#2)(2011-2#1)(2012-2#1)(2013-7#1)
the percent recoveries were increased##2##5##(2008-10#2)
the percent recovery##3##3##(2008-10#3)
the percent##37##2##(1991-2#1)(1991-8#1)(1992-7#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-5#1)(1995-7#1)(1995-9#1)(1996-12#1)(1996-3#2)(1997-4#1)(2005-11#1)(2006-5#2)(2007-2#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2009-2#1)(2009-8#2)(2011-2#1)(2012-2#1)(2013-7#1)
the percentage and##3##3##(1991-4#1)(2008-8#1)(2010-1#1)
the percentage change in##2##4##(2012-2#2)
the percentage change##3##3##(1991-2#1)(2012-2#2)
the percentage content of##2##4##(2008-10#2)
the percentage extraction##2##3##(2008-10#2)
the percentage increment of##2##4##(2011-2#2)
the percentage inhibition of##2##4##(1996-3#1)(2008-10#1)
the percentage inhibition##3##3##(1996-3#1)(2008-10#1)(2009-5#1)
the percentage loss of##2##4##(1996-9#2)
the percentage of Purkinje cells##2##5##(1993-11#2)
the percentage of all##2##4##(1995-3#1)(2011-2#1)
the percentage of budded cells##2##5##(1996-3#2)
the percentage of cells with##2##5##(1997-6#1)(2011-12#1)
the percentage of cells##7##4##(1997-6#1)(2008-10#3)(2008-4#2)(2011-12#1)
the percentage of damage##2##4##(2007-9#2)
the percentage of deaths due to##2##6##(1992-6#1)(2012-2#1)
the percentage of discolored kernels##2##5##(2011-2#2)
the percentage of diseased spikelets##2##5##(2008-10#2)
the percentage of diseased##4##4##(2008-10#4)
the percentage of ear##2##4##(2008-10#1)(2008-9#1)
the percentage of infected##3##4##(1997-4#1)(2008-10#2)
the percentage of leaf##2##4##(2008-10#2)
the percentage of lymphocytes##2##4##(1995-12#1)(2008-1#1)
the percentage of m5Cyt##2##4##(1991-5#2)
the percentage of mice with tumors##2##6##(1992-7#2)
the percentage of necrotic##2##4##(2011-1#1)(2011-2#1)
the percentage of neutrophils##2##4##(2009-6#1)(2011-1#1)
the percentage of nitrogen in the##2##6##(2006-12#1)(2011-12#1)
the percentage of parents who##2##5##(1994-2#1)(1994-3#1)
the percentage of patients who##5##5##(1991-7#1)(1995-1#1)(1995-5#1)(2008-7#1)(2009-9#1)
the percentage of patients with##3##5##(2008-3#1)(2011-11#1)(2013-7#1)
the percentage of patients##11##4##(1991-7#1)(1995-1#1)(1995-2#1)(1995-5#1)(2006-5#1)(2008-3#1)(2008-7#1)(2009-9#1)(2011-11#1)(2013-7#1)(2013-8#1)
the percentage of positive##2##4##(2007-7#1)(2010-4#1)
the percentage of reproductive##2##4##(2011-2#2)
the percentage of smokers##3##4##(1991-4#1)(1991-8#1)(2013-1#1)
the percentage of soil##3##4##(2013-8#3)
the percentage of the##13##4##(1993-3#1)(2004-9#1)(2006-6#1)(2007-1#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#1)(2010-9#1)
the percentage of total##2##4##(1990-8#1)(1992-8#1)
the percentage of water##2##4##(2008-10#1)(2008-5#1)
the percentage of##240##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#2)(1990-8#1)(1991-11#3)(1991-4#1)(1991-5#4)(1991-6#1)(1991-7#1)(1991-8#4)(1991-9#1)(1992-1#1)(1992-10#1)(1992-6#3)(1992-7#2)(1992-8#3)(1993-11#4)(1993-12#2)(1993-3#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#2)(1996-12#1)(1996-3#4)(1996-5#2)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-5#6)(2006-6#3)(2006-8#2)(2007-1#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#4)(2007-8#5)(2007-9#3)(2008-1#3)(2008-10#42)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#7)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-4#1)(2009-6#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#4)(2010-8#1)(2010-9#1)(2011-1#5)(2011-11#1)(2011-12#3)(2011-2#13)(2012-12#2)(2012-2#1)(2012-3#3)(2012-4#1)(2013-1#10)(2013-7#1)(2013-8#6)
the percentage reduction##2##3##(1994-8#1)(2008-9#1)
the percentage##281##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#3)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#3)(1991-2#2)(1991-4#2)(1991-5#4)(1991-6#1)(1991-7#1)(1991-8#5)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-6#3)(1992-7#2)(1992-8#3)(1993-11#4)(1993-12#2)(1993-3#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#2)(1996-12#1)(1996-3#5)(1996-5#2)(1996-9#2)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-5#6)(2006-6#3)(2006-8#2)(2007-1#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#6)(2007-8#5)(2007-9#3)(2008-1#4)(2008-10#52)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#5)(2008-5#8)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#4)(2010-8#2)(2010-9#1)(2011-1#5)(2011-11#1)(2011-12#3)(2011-2#16)(2012-12#2)(2012-2#3)(2012-3#3)(2012-4#1)(2013-1#10)(2013-7#1)(2013-8#6)
the percentages of the##4##4##(1993-8#1)(2008-11#1)(2009-7#1)(2013-8#1)
the percentages of##28##3##(1992-8#1)(1993-8#1)(1994-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(2005-10#1)(2005-11#1)(2006-7#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-1#1)(2013-8#3)
the percentages##30##2##(1990-12#1)(1992-8#1)(1993-8#1)(1994-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(2005-10#1)(2005-11#1)(2006-7#1)(2007-10#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-1#1)(2013-8#3)
the percentile##2##2##(2008-1#1)(2013-8#1)
the percentual##2##2##(1991-4#1)(2008-11#1)
the percept##3##2##(2008-4#1)(2012-11#1)(2012-2#1)
the perception and interpretation of##2##5##(2008-11#1)(2008-6#1)
the perception and##7##3##(2006-8#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#1)(2011-2#1)
the perception of depth##2##4##(1997-8#1)(2009-3#1)
the perception of pain##2##4##(1996-7#1)(2006-10#1)
the perception of stress##2##4##(2007-10#1)(2011-2#1)
the perception of the##7##4##(1996-12#1)(2005-9#1)(2007-12#1)(2007-5#1)(2008-2#1)(2011-2#1)(2012-2#1)
the perception of##58##3##(1990-9#1)(1992-3#1)(1994-12#1)(1995-1#1)(1995-10#1)(1995-5#1)(1996-12#1)(1996-7#1)(1997-8#2)(2005-9#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#3)(2008-11#3)(2008-2#1)(2008-5#1)(2009-12#2)(2009-3#1)(2009-4#4)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#6)
the perception that##5##3##(1994-7#1)(1996-1#1)(2005-8#1)(2006-9#1)(2012-3#1)
the perception##78##2##(1990-9#1)(1991-2#1)(1991-4#1)(1992-3#1)(1994-12#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-10#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-7#1)(1997-8#2)(2005-8#1)(2005-9#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#3)(2008-11#5)(2008-2#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#2)(2009-3#1)(2009-4#4)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#6)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#6)
the perception-assist##2##2##(2012-1#2)
the perceptions and##3##3##(2009-5#1)(2010-11#1)(2011-2#1)
the perceptions of hematuria##2##4##(2007-2#2)
the perceptions of neighborhood##2##4##(2009-9#2)
the perceptions of staff##2##4##(2007-11#2)
the perceptions of##21##3##(2007-11#2)(2007-12#1)(2007-2#3)(2007-3#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-9#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
the perceptions were##2##3##(2006-7#1)(2013-1#1)
the perceptions##28##2##(2006-7#2)(2007-11#2)(2007-12#1)(2007-2#3)(2007-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-9#2)(2010-11#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
the perceptual abilities of##2##4##(2008-8#1)(2012-11#1)
the perceptual encoding##2##3##(2007-8#2)
the perceptual loop##2##3##(2007-10#2)
the perceptual system##2##3##(1997-8#1)(2010-5#1)
the perceptual##21##2##(1993-2#1)(1997-8#2)(2007-10#2)(2007-12#1)(2007-5#1)(2007-8#3)(2008-11#1)(2008-3#1)(2008-8#1)(2009-9#1)(2010-5#2)(2010-8#1)(2012-11#1)(2012-2#1)(2013-8#2)
the perchlorate ion##2##3##(2008-10#2)
the perchlorate##10##2##(2005-4#1)(2007-8#1)(2008-10#7)(2010-2#1)
the percolation threshold##2##3##(1995-2#1)(2005-11#1)
the percolation##4##2##(1995-2#1)(2005-11#2)(2008-2#1)
the percutaneous absorption of##3##4##(2008-5#1)(2011-3#2)
the percutaneous absorption##4##3##(2008-5#2)(2011-3#2)
the percutaneous approach##4##3##(1991-3#1)(1996-9#1)(2006-6#2)
the percutaneous treatment##2##3##(2006-6#1)(2011-2#1)
the percutaneous##22##2##(1990-4#1)(1991-3#2)(1996-9#1)(2006-6#3)(2007-7#1)(2007-8#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-5#1)(2011-2#1)(2011-3#2)(2012-12#1)(2013-1#1)(2013-8#1)
the perennial##5##2##(2008-10#1)(2008-8#1)(2008-9#2)(2011-2#1)
the perfect##15##2##(1994-5#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
the perfectly##2##2##(2006-10#1)(2013-1#1)
the perflubron emulsion and carbogen breathing##2##6##(1995-5#2)
the perflubron emulsion and carbogen##3##5##(1995-5#3)
the perfluoroalkyl group content##2##4##(2005-11#2)
the perfluorocarbons##2##2##(2007-11#2)
the perforant path##7##3##(1990-5#1)(1990-7#1)(1992-7#1)(1992-9#2)(1996-7#1)(1997-5#1)
the perforant##11##2##(1990-5#2)(1990-7#1)(1992-1#2)(1992-7#1)(1992-9#2)(1993-2#1)(1996-7#1)(1997-5#1)
the perforated##2##2##(1994-9#1)(2012-3#1)
the perforation##3##2##(2007-8#1)(2008-2#1)(2013-8#1)
the perforin##2##2##(1992-4#1)(1994-5#1)
the performance and##11##3##(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-4#1)(2013-1#3)
the performance between##2##3##(2008-2#1)(2008-9#1)
the performance can##2##3##(2007-11#1)(2008-3#1)
the performance characteristics of##3##4##(2008-2#1)(2008-3#1)(2008-5#1)
the performance characteristics##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
the performance is##2##3##(2008-10#1)(2008-2#1)
the performance of MAPB##2##4##(2012-3#2)
the performance of SMBG in T2DM##2##6##(2009-11#2)
the performance of SMBG in##3##5##(2009-11#3)
the performance of a diagnostic test##2##6##(1996-8#1)(1997-6#1)
the performance of a diagnostic##3##5##(1996-8#1)(1997-6#1)(2008-7#1)
the performance of a laser##2##5##(2008-2#1)(2008-3#1)
the performance of a number of##2##6##(1995-5#1)(2008-3#1)
the performance of a##54##4##(1990-10#1)(1993-12#1)(1995-5#1)(1996-8#1)(1997-2#1)(1997-6#1)(2006-1#1)(2006-4#1)(2006-8#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#8)(2008-3#15)(2008-4#3)(2008-7#2)(2008-9#1)(2009-11#1)(2009-6#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#1)(2013-1#2)
the performance of all##2##4##(1994-9#1)(2012-3#1)
the performance of an##10##4##(1993-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-5#1)(2013-1#2)(2013-8#1)
the performance of any##2##4##(2007-10#1)(2008-6#1)
the performance of both##6##4##(2006-11#1)(2008-10#2)(2008-2#1)(2008-3#2)
the performance of cardiac##2##4##(2007-4#1)(2007-8#1)
the performance of cylindrical##2##4##(2008-2#1)(2008-3#1)
the performance of daily##2##4##(2007-11#2)
the performance of different##4##4##(2008-2#1)(2010-2#1)(2012-2#1)(2012-3#1)
the performance of distal##2##4##(1993-7#1)(1996-9#1)
the performance of electronic##3##4##(2006-12#1)(2008-7#1)(2011-2#1)
the performance of five##3##4##(2008-6#1)(2012-1#1)(2012-2#1)
the performance of four##4##4##(1993-1#1)(1995-2#1)(2008-3#1)(2011-1#1)
the performance of health care##3##5##(1995-12#1)(1996-2#1)(2007-4#1)
the performance of health##4##4##(1995-12#1)(1996-12#1)(1996-2#1)(2007-4#1)
the performance of its##2##4##(1990-11#1)(1993-12#1)
the performance of many##2##4##(2008-7#1)(2011-2#1)
the performance of multiple##2##4##(2007-10#1)(2008-9#1)
the performance of new##2##4##(1994-3#1)(2011-2#1)
the performance of our##5##4##(1997-2#1)(2008-2#1)(2008-3#1)(2008-6#1)(2012-3#1)
the performance of patients##2##4##(1997-8#1)(2008-9#1)
the performance of physicians##2##4##(1996-3#2)
the performance of rats##2##4##(1992-11#1)(1992-9#1)
the performance of subjects##2##4##(1992-11#1)(1993-7#1)
the performance of such##4##4##(2007-12#1)(2007-8#1)(2008-2#1)(2008-6#1)
the performance of surgical##2##4##(2006-6#1)(2009-4#1)
the performance of the algorithm##4##5##(1997-3#1)(2008-2#2)(2008-3#1)
the performance of the algorithms##2##5##(2007-11#1)(2008-2#1)
the performance of the device as##2##6##(2007-12#1)(2008-2#1)
the performance of the device##4##5##(2007-12#1)(2008-2#1)(2008-3#2)
the performance of the etalon##2##5##(2008-3#2)
the performance of the joint transform correlator##2##7##(2008-2#2)
the performance of the method##6##5##(2008-10#1)(2008-2#3)(2010-4#1)(2012-1#1)
the performance of the native##2##5##(2008-3#1)(2012-1#1)
the performance of the new##4##5##(2006-2#1)(2006-3#1)(2008-2#1)(2012-3#1)
the performance of the nonlinear joint transform correlator##2##8##(2008-2#2)
the performance of the optical system##2##6##(2008-2#1)(2008-3#1)
the performance of the pointing system##2##6##(2008-3#2)
the performance of the proposed method##5##6##(2008-10#1)(2008-3#1)(2008-6#1)(2012-3#2)
the performance of the proposed##12##5##(2007-9#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-6#1)(2009-9#1)(2010-8#1)(2012-3#2)
the performance of the system were##2##6##(2008-10#2)
the performance of the system with##2##6##(2008-10#1)(2008-3#1)
the performance of the system##6##5##(2008-10#4)(2008-3#2)
the performance of the test##2##5##(2004-9#1)(2008-11#1)
the performance of the two##3##5##(1991-2#1)(2008-12#1)(2008-5#1)
the performance of the whole##2##5##(2008-10#1)(2008-2#1)
the performance of the##156##4##(1990-10#1)(1991-1#1)(1991-2#1)(1992-12#1)(1992-2#2)(1993-3#1)(1993-4#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#2)(1996-7#1)(1996-9#1)(1997-3#1)(1997-6#1)(2004-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#2)(2007-11#5)(2007-12#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#35)(2008-3#26)(2008-5#4)(2008-6#3)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#4)(2011-1#3)(2011-2#2)(2012-1#5)(2012-2#1)(2012-3#7)(2013-1#5)(2013-8#2)
the performance of their##4##4##(1994-2#1)(1996-12#1)(2008-5#2)
the performance of these systems##2##5##(2008-3#2)
the performance of these three##2##5##(2012-3#1)(2013-8#1)
the performance of these##9##4##(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#2)(2012-3#1)(2013-8#1)
the performance of this approach##3##5##(2008-3#2)(2012-3#1)
the performance of this system##5##5##(2006-12#1)(2007-12#1)(2008-10#2)(2008-11#1)
the performance of this##19##4##(1996-7#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#3)(2011-1#1)(2012-3#1)
the performance of three##3##4##(2004-8#1)(2008-10#2)
the performance of two##3##4##(1991-2#1)(2008-5#1)(2012-3#1)
the performance of various##4##4##(2008-10#1)(2008-3#1)(2012-3#2)
the performance of##498##3##(1990-10#3)(1990-11#1)(1990-12#1)(1990-3#1)(1991-1#1)(1991-12#1)(1991-2#2)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#3)(1992-9#3)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#3)(1993-8#2)(1993-9#1)(1994-1#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-9#1)(1995-1#3)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#3)(1997-8#2)(2004-8#1)(2004-9#2)(2005-10#1)(2005-12#1)(2006-1#1)(2006-10#3)(2006-11#2)(2006-12#4)(2006-2#1)(2006-3#3)(2006-4#5)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#13)(2007-12#13)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#8)(2007-9#1)(2008-1#3)(2008-10#50)(2008-11#7)(2008-12#4)(2008-2#61)(2008-3#71)(2008-4#5)(2008-5#13)(2008-6#9)(2008-7#7)(2008-9#5)(2009-11#4)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#3)(2010-2#5)(2010-4#4)(2010-5#1)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#8)(2011-2#8)(2011-3#1)(2012-1#7)(2012-12#1)(2012-2#4)(2012-3#19)(2013-1#18)(2013-7#1)(2013-8#5)
the performance on the##2##4##(2008-10#2)
the performance on##4##3##(2008-10#2)(2008-2#1)(2010-3#1)
the performance requirements##4##3##(2006-11#1)(2008-3#1)(2011-2#1)(2012-1#1)
the performance status##2##3##(1994-12#1)(1995-10#1)
the performance that##2##3##(2008-2#2)
the performance was##2##3##(2008-10#1)(2013-1#1)
the performance##572##2##(1990-10#3)(1990-11#1)(1990-12#1)(1990-3#1)(1991-1#1)(1991-12#1)(1991-2#2)(1992-1#1)(1992-10#1)(1992-11#4)(1992-12#1)(1992-2#4)(1992-3#1)(1992-9#3)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#3)(1993-8#2)(1993-9#1)(1994-1#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#2)(1994-9#1)(1995-1#3)(1995-10#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#1)(1996-1#1)(1996-12#4)(1996-2#2)(1996-3#2)(1996-5#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#3)(1997-8#2)(2004-11#1)(2004-8#1)(2004-9#2)(2005-10#2)(2005-12#1)(2006-1#1)(2006-10#3)(2006-11#3)(2006-12#4)(2006-2#1)(2006-3#3)(2006-4#5)(2006-5#2)(2006-6#2)(2006-7#3)(2006-8#2)(2007-1#1)(2007-10#4)(2007-11#15)(2007-12#14)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#10)(2007-9#1)(2008-1#3)(2008-10#60)(2008-11#9)(2008-12#4)(2008-2#77)(2008-3#76)(2008-4#6)(2008-5#18)(2008-6#10)(2008-7#7)(2008-9#6)(2009-11#4)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#3)(2010-2#5)(2010-3#1)(2010-4#4)(2010-5#1)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#9)(2011-2#9)(2011-3#1)(2012-1#9)(2012-12#1)(2012-2#4)(2012-3#19)(2013-1#22)(2013-7#1)(2013-8#5)
the performance-based ranking within a group of##2##7##(2011-2#2)
the performance-based##3##2##(1996-2#1)(2011-2#2)
the performances of different##2##4##(1993-1#1)(2005-11#1)
the performances of the sensor##2##5##(2008-10#2)
the performances of the##9##4##(2007-8#1)(2008-10#6)(2008-2#1)(2011-2#1)
the performances of two different##2##5##(1996-11#1)(2008-10#1)
the performances of##22##3##(1990-10#1)(1991-3#1)(1993-1#1)(1996-11#1)(2005-11#1)(2005-4#1)(2007-8#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-6#1)(2009-12#1)(2011-2#1)(2013-7#1)
the performances##24##2##(1990-10#1)(1991-3#1)(1993-1#1)(1996-11#1)(2005-11#1)(2005-4#1)(2007-8#1)(2008-10#10)(2008-2#2)(2008-3#1)(2008-6#1)(2009-12#1)(2011-2#1)(2013-7#1)
the performed##8##2##(2006-6#1)(2007-11#1)(2008-10#2)(2008-8#1)(2009-6#1)(2011-12#1)(2013-8#1)
the perfusate and##2##3##(1996-12#1)(2005-12#1)
the perfusate was##3##3##(1991-6#1)(1991-9#1)(1995-1#1)
the perfusate##16##2##(1990-2#1)(1990-7#1)(1991-6#2)(1991-9#3)(1992-3#1)(1993-3#1)(1995-1#1)(1996-12#3)(1997-8#1)(2005-12#1)(2008-7#1)
the perfused livers##2##3##(1991-3#1)(1991-8#1)
the perfused##12##2##(1990-10#1)(1990-11#2)(1990-6#1)(1991-10#1)(1991-3#1)(1991-5#1)(1991-8#1)(1993-11#1)(1995-3#1)(1997-8#1)(2008-6#1)
the perfusing##2##2##(1991-5#1)(2008-4#1)
the perfusion buffer##2##3##(1990-7#1)(1991-10#1)
the perfusion chamber##5##3##(2008-11#5)
the perfusion fluid##2##3##(1991-9#1)(1994-10#1)
the perfusion of the liver##2##5##(1993-1#1)(2009-11#1)
the perfusion of the##5##4##(1990-4#1)(1993-1#1)(1996-3#1)(2008-10#1)(2009-11#1)
the perfusion of##12##3##(1990-4#1)(1992-3#1)(1993-1#1)(1996-3#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-8#1)
the perfusion pressure##2##3##(1991-6#1)(1993-11#1)
the perfusion rate##3##3##(2008-11#3)
the perfusion system##4##3##(1997-8#1)(2008-11#2)(2012-2#1)
the perfusion##47##2##(1990-2#3)(1990-4#1)(1990-7#1)(1991-10#1)(1991-6#1)(1991-9#1)(1992-3#1)(1993-1#1)(1993-11#1)(1994-10#1)(1995-12#1)(1996-3#1)(1997-8#1)(2005-11#1)(2006-6#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#15)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#3)(2009-4#1)(2010-12#1)(2010-8#1)(2012-2#1)
the peri-implant soft tissue unit##3##5##(2012-11#2)(2012-12#1)
the peri-implant soft tissue##4##4##(2012-11#3)(2012-12#1)
the peri-implant soft##5##3##(2012-11#3)(2012-12#1)(2013-1#1)
the peri-implant soft-tissue unit##2##4##(2012-11#2)
the peri-implant##10##2##(2012-11#5)(2012-12#1)(2013-1#3)(2013-8#1)
the peri-implantation##2##2##(1994-8#1)(1994-9#1)
the peri-infarct##4##2##(2007-10#2)(2012-12#2)
the peri-operative##2##2##(2007-11#1)(2007-8#1)
the periambigual reticular formation##2##4##(1994-6#2)
the periamygdaloid cortex##6##3##(1995-5#1)(1996-6#5)
the periapical##5##2##(1991-9#1)(2005-10#1)(2009-8#1)(2013-1#2)
the periaqueductal gray area##2##4##(1993-11#1)(1993-12#1)
the periaqueductal gray##5##3##(1993-11#1)(1993-12#1)(1994-5#1)(1995-6#1)(2008-7#1)
the periaqueductal grey (PAG)##3##4##(1991-3#2)(1994-6#1)
the periaqueductal grey##4##3##(1991-3#2)(1994-6#2)
the periaqueductal##10##2##(1991-3#2)(1991-5#1)(1993-11#1)(1993-12#1)(1994-5#1)(1994-6#2)(1995-6#1)(2008-7#1)
the periaxonal##2##2##(1994-2#1)(1994-6#1)
the pericardial##6##2##(2006-7#1)(2007-8#4)(2012-2#1)
the pericardium and##5##3##(1992-2#1)(2007-8#2)(2008-9#1)(2010-8#1)
the pericardium##14##2##(1992-2#1)(2004-9#1)(2007-4#2)(2007-8#5)(2008-11#1)(2008-7#1)(2008-9#2)(2010-8#1)
the pericarp##3##2##(2008-10#2)(2011-2#1)
the pericellular##5##2##(1993-12#1)(1993-4#1)(1994-12#1)(2008-4#1)(2011-2#1)
the perifornical##3##2##(1993-2#1)(1994-10#1)(2008-9#1)
the perihypoglossal##2##2##(1997-6#2)
the perikarya of##3##3##(1992-3#1)(1994-12#1)(2008-6#1)
the perikarya##5##2##(1990-4#2)(1992-3#1)(1994-12#1)(2008-6#1)
the perikaryal cytoplasm##2##3##(1990-4#1)(1994-2#1)
the perikaryal##3##2##(1990-4#1)(1991-8#1)(1994-2#1)
the perikaryon##5##2##(1994-2#1)(2008-7#4)
the perils of##2##3##(2007-11#1)(2007-2#1)
the perils##3##2##(2006-9#1)(2007-11#1)(2007-2#1)
the perilymphatic##2##2##(1996-3#2)
the perimeter##4##2##(1995-11#1)(1996-3#1)(2007-6#1)(2008-2#1)
the perinatal mortality rate##3##4##(1990-3#1)(1995-6#1)(2004-10#1)
the perinatal mortality##5##3##(1990-3#1)(1994-3#1)(1995-6#1)(2004-10#1)(2010-6#1)
the perinatal period##11##3##(1993-6#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-12#1)(2006-8#1)(2007-2#1)(2009-2#1)(2009-9#1)(2011-2#1)
the perinatal##29##2##(1990-3#1)(1991-6#1)(1991-9#1)(1993-6#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-6#2)(1996-11#1)(1996-12#1)(1997-7#1)(2004-10#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-2#5)(2007-7#1)(2009-2#1)(2009-9#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
the perine##2##2##(2012-2#2)
the perineal##3##2##(1995-5#1)(2008-10#1)(2010-12#1)
the perineum##6##2##(1992-9#1)(2008-10#2)(2008-7#2)(2010-2#1)
the perineurium##2##2##(1991-9#1)(2007-12#1)
the perinuclear region##2##3##(1992-11#1)(2012-3#1)
the perinuclear space##3##3##(2007-5#1)(2008-9#1)(2011-2#1)
the perinuclear##11##2##(1992-11#1)(1993-11#1)(1994-8#1)(2007-12#1)(2007-5#1)(2008-7#3)(2008-9#1)(2011-2#1)(2012-3#1)
the period 1##3##3##(1990-4#2)(1991-9#1)
the period 1970 to##2##4##(1991-5#1)(1997-4#1)
the period 1970-1995##2##3##(2006-8#1)(2008-5#1)
the period 1974-1992##2##3##(1995-12#1)(1995-5#1)
the period 1975-1994##2##3##(2006-10#2)
the period 1976-87##2##3##(1990-4#1)(1992-10#1)
the period 1979-1987##2##3##(1990-4#1)(1993-3#1)
the period 1980##2##3##(1993-6#1)(1997-8#1)
the period 1985 to##2##4##(1993-1#1)(1993-3#1)
the period 1986-1989##3##3##(1990-12#1)(1991-8#2)
the period 1996-2000##4##3##(2006-8#2)(2008-1#1)(2008-5#1)
the period 1997-1999##2##3##(2007-11#1)(2007-6#1)
the period 1997-2000##2##3##(2006-6#1)(2007-8#1)
the period 1998-2002##2##3##(2007-11#1)(2007-7#1)
the period 2000-2005##2##3##(2008-10#1)(2010-4#1)
the period 2001-2005##2##3##(2010-9#2)
the period 2008-2010##2##3##(2012-12#2)
the period January##9##3##(1990-6#1)(1992-6#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
the period July##2##3##(1992-2#1)(2008-1#1)
the period May##2##3##(1992-10#1)(2007-3#1)
the period September##3##3##(1995-11#1)(2008-4#1)(2011-2#1)
the period after##2##3##(1995-12#1)(1995-3#1)
the period and cohort##2##4##(1996-3#2)
the period and the##2##4##(2008-2#1)(2008-3#1)
the period and##8##3##(1996-3#2)(1996-5#1)(2006-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)
the period before##6##3##(2006-3#1)(2007-10#1)(2007-2#1)(2007-9#1)(2009-10#1)(2009-3#1)
the period between##19##3##(1993-7#1)(1994-2#1)(1996-5#1)(1997-6#1)(1997-7#1)(2005-9#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2011-1#2)(2011-2#1)(2013-1#1)
the period covered by##2##4##(1993-1#1)(2006-10#1)
the period covered##3##3##(1993-1#1)(2006-10#1)(2008-7#1)
the period during which the##2##5##(2008-7#1)(2012-12#1)
the period following the##2##4##(1993-3#1)(1993-6#1)
the period from 1966##2##4##(2006-12#1)(2006-2#1)
the period from 1970##2##4##(1992-1#1)(2008-2#1)
the period from 1990##2##4##(1997-3#1)(2008-8#1)
the period from 1996 to 2000##2##6##(2005-10#2)
the period from December##2##4##(2012-12#2)
the period from January##6##4##(2006-7#2)(2007-8#2)(2008-5#1)(2013-1#1)
the period from July##2##4##(1992-6#1)(2007-2#1)
the period from May##3##4##(2013-1#2)(2013-8#1)
the period from November##4##4##(1993-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
the period from October##2##4##(1995-5#1)(2011-3#1)
the period from September##2##4##(2008-2#1)(2008-3#1)
the period from one##2##4##(2006-4#1)(2008-8#1)
the period from the initiation of##2##6##(2008-5#2)
the period from the##4##4##(2008-4#1)(2008-5#3)
the period from##63##3##(1990-12#1)(1990-3#1)(1990-8#1)(1991-12#1)(1992-1#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-5#1)(1997-3#1)(2005-10#4)(2006-12#2)(2006-2#1)(2006-4#1)(2006-7#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#1)(2010-12#2)(2011-1#1)(2011-3#1)(2012-12#3)(2012-2#2)(2013-1#3)(2013-8#1)
the period in question##4##4##(1990-8#1)(2007-8#2)(2011-2#1)
the period in which##5##4##(1990-11#1)(1995-11#1)(2008-10#1)(2008-5#1)(2011-2#1)
the period in##10##3##(1990-11#1)(1990-8#1)(1995-11#1)(2007-8#2)(2008-10#1)(2008-5#2)(2011-2#2)
the period of 1998-2002##2##4##(2007-11#2)
the period of 1999 - 2001##2##6##(2006-6#2)
the period of 3##2##4##(2007-8#1)(2010-12#1)
the period of 6 weeks##3##5##(2005-11#1)(2008-11#1)(2013-1#1)
the period of 6##4##4##(2005-11#1)(2007-8#1)(2008-11#1)(2013-1#1)
the period of exposure##2##4##(1993-7#1)(2006-8#1)
the period of highest##2##4##(2008-10#1)(2013-8#1)
the period of investigation##2##4##(1991-11#1)(1992-6#1)
the period of maximum##2##4##(1990-5#1)(2008-10#1)
the period of observation##2##4##(1997-7#1)(2009-6#1)
the period of one year##3##5##(2007-8#1)(2012-3#1)(2013-8#1)
the period of review##3##4##(2006-10#3)
the period of stimulation##2##4##(2007-8#1)(2010-7#1)
the period of study##5##4##(2008-12#1)(2008-6#1)(2009-6#1)(2011-1#1)(2012-12#1)
the period of the##16##4##(1993-6#1)(1994-8#1)(1996-12#1)(2005-1#1)(2006-4#1)(2007-11#2)(2007-4#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-9#1)(2011-2#1)
the period of this##2##4##(1996-9#1)(2005-5#1)
the period of time##4##4##(1993-2#1)(2008-5#1)(2013-1#2)
the period of treatment##2##4##(1992-3#1)(2006-6#1)
the period of##129##3##(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#2)(1991-5#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#3)(1996-12#2)(1996-3#2)(1996-6#2)(1996-9#3)(1997-4#1)(1997-6#1)(1997-7#1)(2005-1#1)(2005-10#2)(2005-11#1)(2005-5#1)(2005-6#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-4#1)(2006-6#4)(2006-7#1)(2006-8#1)(2007-11#5)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#5)(2008-1#2)(2008-10#11)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-11#1)(2009-2#1)(2009-6#2)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#4)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#6)(2013-8#2)
the period studied##8##3##(1993-3#1)(1995-5#1)(1995-8#1)(1996-11#2)(1997-6#1)(2008-10#1)(2011-1#1)
the period that##2##3##(2007-8#1)(2008-10#1)
the period under##4##3##(2006-10#2)(2006-8#1)(2007-5#1)
the period was##4##3##(1997-8#1)(2007-12#1)(2007-2#1)(2008-5#1)
the period when##8##3##(1994-12#1)(1994-7#1)(1996-5#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#1)(2012-12#1)
the period with##2##3##(1991-2#1)(2012-11#1)
the period##513##2##(1990-10#3)(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#3)(1990-4#5)(1990-5#1)(1990-6#4)(1990-7#1)(1990-8#4)(1990-9#2)(1991-1#1)(1991-11#3)(1991-12#2)(1991-2#2)(1991-5#2)(1991-6#4)(1991-8#3)(1991-9#4)(1992-1#2)(1992-10#3)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#6)(1992-8#2)(1992-9#2)(1993-1#4)(1993-10#3)(1993-2#2)(1993-3#5)(1993-5#1)(1993-6#5)(1993-7#3)(1993-8#2)(1993-9#1)(1994-12#3)(1994-2#2)(1994-5#2)(1994-6#2)(1994-7#3)(1994-8#1)(1994-9#2)(1995-1#3)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#5)(1995-6#1)(1995-7#1)(1995-8#3)(1995-9#2)(1996-1#1)(1996-11#3)(1996-12#2)(1996-2#1)(1996-3#5)(1996-5#3)(1996-6#3)(1996-8#1)(1996-9#5)(1997-3#2)(1997-4#3)(1997-6#5)(1997-7#2)(1997-8#3)(2005-1#1)(2005-10#6)(2005-11#1)(2005-5#1)(2005-6#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#14)(2006-12#4)(2006-2#2)(2006-3#1)(2006-4#2)(2006-6#6)(2006-7#3)(2006-8#14)(2007-10#1)(2007-11#19)(2007-12#3)(2007-2#3)(2007-3#4)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#9)(2007-8#17)(2007-9#3)(2008-1#7)(2008-10#26)(2008-11#6)(2008-12#3)(2008-2#12)(2008-3#7)(2008-4#3)(2008-5#15)(2008-6#3)(2008-7#12)(2008-8#9)(2008-9#8)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#2)(2009-9#1)(2010-11#1)(2010-12#5)(2010-3#2)(2010-4#2)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#14)(2011-12#2)(2011-2#19)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#12)(2012-2#7)(2012-3#5)(2012-4#1)(2012-7#1)(2013-1#12)(2013-7#1)(2013-8#4)
the periodate oxidation of##3##4##(2008-10#3)
the periodic distribution of##2##4##(1990-5#1)(2007-9#1)
the periodic##31##2##(1990-5#2)(1991-12#1)(1992-4#1)(1993-2#1)(1993-6#2)(1994-3#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-12#6)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
the periodical##4##2##(2007-11#1)(2008-3#1)(2009-4#1)(2011-2#1)
the periodically poled##5##3##(2007-11#2)(2007-12#2)(2008-3#1)
the periodically##6##2##(2007-11#2)(2007-12#2)(2008-10#1)(2008-3#1)
the periodicity of the##3##4##(2007-12#1)(2008-2#1)(2010-4#1)
the periodicity of##6##3##(1993-5#1)(2007-12#3)(2008-2#1)(2010-4#1)
the periodicity##9##2##(1993-5#1)(2007-12#4)(2008-2#1)(2009-6#1)(2010-4#1)(2013-8#1)
the periodontal attachment##3##3##(2012-2#1)(2012-3#2)
the periodontal health status##2##4##(2008-8#1)(2012-3#1)
the periodontal status of the##2##5##(2006-8#1)(2013-1#1)
the periodontal status##3##3##(2006-8#1)(2013-1#2)
the periodontal tissue##2##3##(2005-3#1)(2012-12#1)
the periodontal tissues##3##3##(1991-9#1)(2006-2#1)(2008-1#1)
the periodontal##34##2##(1990-11#1)(1990-3#1)(1991-9#2)(1995-11#2)(1996-2#1)(2004-3#1)(2005-3#1)(2006-2#3)(2006-5#2)(2006-8#2)(2007-12#1)(2008-1#1)(2008-11#1)(2008-8#1)(2011-1#1)(2012-12#3)(2012-2#1)(2012-3#5)(2013-1#3)(2013-7#1)
the periodontium##2##2##(2012-12#1)(2013-7#1)
the periods of##7##3##(1992-1#1)(1995-8#1)(1997-8#1)(2006-12#1)(2008-10#1)(2008-2#1)(2012-1#1)
the periods##21##2##(1990-3#1)(1992-1#1)(1995-12#1)(1995-6#1)(1995-8#1)(1997-8#1)(2004-11#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#2)(2012-1#1)(2012-2#1)(2013-1#1)
the perioperative care##3##3##(2010-2#1)(2012-2#2)
the perioperative course##2##3##(2006-10#1)(2007-9#1)
the perioperative management of patients##4##5##(2006-10#1)(2007-12#2)(2012-3#1)
the perioperative management of##9##4##(2006-10#2)(2007-12#3)(2007-8#1)(2012-3#1)(2013-1#2)
the perioperative period##33##3##(1992-3#1)(2004-2#1)(2005-12#1)(2006-1#1)(2006-10#10)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#4)(2008-8#2)(2010-2#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
the perioperative period]##2##3##(2008-10#1)(2009-5#1)
the perioperative##62##2##(1992-3#1)(1992-5#1)(2004-2#1)(2005-12#1)(2006-1#1)(2006-10#17)(2006-11#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#7)(2007-8#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#1)(2010-2#2)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#3)
the perioral##3##2##(1991-11#1)(2007-12#1)(2008-5#1)
the periorbital area##2##3##(2008-5#2)
the periosteal##4##2##(1993-9#1)(2011-1#1)(2012-12#1)(2013-7#1)
the periosteum and##2##3##(2011-2#1)(2012-12#1)
the periosteum of the##4##4##(2006-10#1)(2007-12#1)(2008-9#1)(2010-12#1)
the periosteum##11##2##(1994-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-9#2)(2009-2#1)(2010-12#1)(2011-2#1)(2012-12#2)
the peripancreatic##3##2##(1990-3#1)(1993-3#1)(1997-4#1)
the peripartum period##3##3##(2006-12#1)(2007-2#2)
the peripheral and central nervous systems##2##6##(1991-11#1)(2010-1#1)
the peripheral and##6##3##(1990-4#1)(1991-11#1)(1994-11#1)(1994-8#1)(1997-7#1)(2010-1#1)
the peripheral areas of##2##4##(2008-11#1)(2009-10#1)
the peripheral benzodiazepine receptor##3##4##(1995-12#1)(2008-8#1)(2012-2#1)
the peripheral blood and##3##4##(1990-5#1)(2008-4#2)
the peripheral blood by##2##4##(1990-4#1)(1996-10#1)
the peripheral blood of##14##4##(1990-12#1)(1991-4#1)(1996-12#2)(1996-3#1)(2005-8#1)(2007-1#1)(2007-10#1)(2008-10#1)(2009-4#1)(2010-4#2)(2011-1#1)(2012-1#1)
the peripheral blood##55##3##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-2#1)(1991-4#1)(1992-1#1)(1994-11#1)(1994-3#1)(1995-1#1)(1996-10#1)(1996-12#2)(1996-3#1)(1997-6#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#7)(2008-5#1)(2008-7#2)(2009-4#1)(2010-11#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#5)(2012-2#1)(2012-3#3)(2013-7#1)(2013-8#2)
the peripheral circulation##5##3##(1993-4#1)(2008-5#1)(2008-9#1)(2012-1#1)(2013-8#1)
the peripheral dose##3##3##(2009-10#3)
the peripheral glial##2##3##(2007-12#1)(2008-7#1)
the peripheral immune system##2##4##(1992-5#1)(2007-11#1)
the peripheral nerve##7##3##(1991-9#2)(1993-4#1)(1993-6#1)(2008-7#1)(2009-10#1)(2013-8#1)
the peripheral nerves##2##3##(2006-10#1)(2011-1#1)
the peripheral nervous system##23##4##(1990-7#1)(1990-8#1)(1991-10#1)(1993-6#2)(1994-10#1)(1994-11#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#2)(2005-7#1)(2007-10#1)(2007-7#2)(2008-7#1)(2009-10#1)(2012-1#1)(2012-12#1)(2013-1#1)
the peripheral nicotinic##2##3##(1996-12#1)(1996-2#1)
the peripheral or central nervous##2##5##(1993-9#1)(2008-9#1)
the peripheral or##3##3##(1990-8#1)(1993-9#1)(2008-9#1)
the peripheral production of##2##4##(1990-8#1)(2007-11#1)
the peripheral resistance##2##3##(1990-1#1)(2006-2#1)
the peripheral site##2##3##(2008-7#1)(2009-1#1)
the peripheral terminals of##2##4##(1991-9#1)(1996-3#1)
the peripheral tissues##9##3##(1991-7#2)(1995-12#3)(1995-5#4)
the peripheral vascular##2##3##(1990-8#1)(1993-3#1)
the peripheral venous##3##3##(1992-8#1)(2007-7#1)(2013-1#1)
the peripheral zone of##2##4##(1994-3#1)(1996-11#1)
the peripheral zone##3##3##(1994-3#1)(1996-11#1)(2011-2#1)
the peripheral##199##2##(1990-1#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#4)(1991-10#1)(1991-11#3)(1991-2#1)(1991-4#1)(1991-7#2)(1991-9#3)(1992-1#1)(1992-10#1)(1992-3#1)(1992-5#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-4#3)(1993-6#3)(1993-7#2)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#3)(1994-3#3)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#5)(1995-2#1)(1995-5#5)(1995-6#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#5)(1996-6#2)(1997-1#1)(1997-6#1)(1997-7#2)(2005-10#2)(2005-7#1)(2005-8#1)(2006-10#3)(2006-2#2)(2006-5#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#2)(2007-7#4)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#7)(2008-5#3)(2008-7#8)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#6)(2009-12#2)(2009-4#1)(2010-1#1)(2010-11#1)(2010-4#2)(2010-5#2)(2011-1#5)(2011-2#5)(2012-1#7)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#8)
the peripherally##2##2##(1996-12#1)(2008-10#1)
the periphery and##4##3##(1995-12#1)(1996-3#1)(2008-4#1)(2010-2#1)
the periphery is##3##3##(1995-12#2)(1996-4#1)
the periphery of a##2##4##(1991-4#1)(2008-4#1)
the periphery of the##17##4##(1990-10#1)(1991-11#1)(1991-2#1)(1994-3#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-2#1)(2011-2#1)(2013-1#1)
the periphery of##30##3##(1990-10#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-4#1)(1994-3#1)(1995-10#1)(1997-8#1)(2006-10#1)(2007-12#3)(2007-7#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-2#1)(2011-2#2)(2013-1#1)
the periphery or##2##3##(2008-7#1)(2009-10#1)
the periphery to##3##3##(1990-2#1)(2005-11#1)(2008-7#1)
the periphery##83##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-8#2)(1991-11#1)(1991-2#1)(1991-4#1)(1992-12#2)(1992-3#1)(1993-12#1)(1994-2#1)(1994-3#2)(1995-10#1)(1995-12#5)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#1)(1997-6#1)(1997-8#2)(2005-11#1)(2005-12#1)(2006-10#3)(2006-11#1)(2006-12#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#5)(2008-8#4)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
the periplasm and##2##3##(1993-9#1)(1994-2#1)
the periplasm of##3##3##(1995-5#1)(2008-7#1)(2009-6#1)
the periplasm##13##2##(1990-10#1)(1991-10#1)(1993-9#1)(1994-2#3)(1995-5#1)(1996-10#1)(1997-6#2)(2008-7#1)(2008-8#1)(2009-6#1)
the periplasmic [NiFe]hydrogenase##2##3##(1990-9#2)
the periplasmic cyclophilin type##2##4##(1993-6#2)
the periplasmic space##9##3##(1990-8#1)(1991-8#1)(1992-11#1)(1993-6#1)(1994-8#1)(1997-2#1)(1997-3#1)(2008-4#2)
the periplasmic##20##2##(1990-8#1)(1990-9#2)(1991-8#1)(1992-11#1)(1993-3#1)(1993-6#3)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1996-11#1)(1997-2#1)(1997-3#1)(2008-4#2)(2009-2#1)(2011-2#1)
the periprosthetic##2##2##(2008-8#1)(2013-1#1)
the perirenal adipose tissue##2##4##(2007-8#2)
the perirenal fat##3##3##(2010-4#2)(2013-1#1)
the perirenal##5##2##(2007-8#2)(2010-4#2)(2013-1#1)
the perirhinal##3##2##(1997-7#3)
the peristaltic##3##2##(1996-3#1)(2007-8#1)(2008-10#1)
the peritoneal catheter##3##3##(2007-12#1)(2008-1#1)(2011-2#1)
the peritoneal cavity and##5##4##(1990-5#1)(2005-7#1)(2007-12#1)(2008-10#1)(2012-1#1)
the peritoneal cavity by##2##4##(2007-12#1)(2011-11#1)
the peritoneal cavity in##3##4##(1990-5#1)(2008-10#1)(2012-12#1)
the peritoneal cavity of##3##4##(1992-1#1)(1992-2#1)(2008-4#1)
the peritoneal cavity##37##3##(1990-2#1)(1990-4#3)(1990-5#4)(1992-1#1)(1992-2#1)(1994-2#1)(2005-12#1)(2005-7#1)(2006-5#1)(2006-6#2)(2007-12#2)(2007-2#1)(2008-1#3)(2008-10#2)(2008-12#2)(2008-4#2)(2008-5#1)(2008-6#1)(2010-12#1)(2011-11#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)
the peritoneal fluid##5##3##(1994-9#1)(1995-12#1)(2006-5#2)(2012-12#1)
the peritoneal membrane##4##3##(2007-8#1)(2008-10#3)
the peritoneal##62##2##(1990-2#1)(1990-4#4)(1990-5#4)(1992-1#1)(1992-2#1)(1994-2#1)(1994-9#2)(1995-12#2)(1995-3#1)(2005-12#1)(2005-7#1)(2006-4#1)(2006-5#3)(2006-6#2)(2007-12#4)(2007-2#2)(2007-8#2)(2008-1#5)(2008-10#5)(2008-12#2)(2008-4#2)(2008-5#2)(2008-6#1)(2010-12#1)(2011-1#1)(2011-11#1)(2011-2#4)(2012-1#1)(2012-12#3)(2013-1#1)
the peritoneum and##2##3##(2008-1#1)(2008-11#1)
the peritoneum##14##2##(1990-10#2)(1990-2#1)(1990-4#1)(1991-12#1)(2006-6#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-11#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-2#1)
the peritonitis##3##2##(2007-7#2)(2012-2#1)
the peritrophic membrane##4##3##(1996-5#1)(2007-12#1)(2008-7#2)
the peritumoral##6##2##(1990-2#1)(1995-12#1)(2007-12#3)(2011-1#1)
the perivascular##3##2##(1996-1#1)(2010-6#1)(2012-1#1)
the perivenous##4##2##(1990-11#3)(1991-12#1)
the perivitelline##2##2##(1991-5#1)(2008-9#1)
the periwinkle Tympanotonus fuscatus##2##4##(2008-5#2)
the permanence of##3##3##(2008-5#1)(2012-2#2)
the permanent calves##3##3##(1996-12#3)
the permanent dentition##3##3##(2008-12#1)(2008-5#1)(2012-2#1)
the permanent flocks##2##3##(2008-5#2)
the permanent maxillary left central incisor##2##6##(2008-5#2)
the permanent maxillary left##3##4##(2008-5#3)
the permanent teeth##3##3##(2005-9#1)(2007-12#1)(2012-2#1)
the permanent##34##2##(1992-2#1)(1992-9#1)(1993-11#1)(1995-2#1)(1996-12#3)(1997-3#1)(2005-9#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#10)(2008-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2012-2#2)(2013-1#1)
the permanently##2##2##(1991-12#1)(2012-12#1)
the permeability of the##10##4##(1991-3#1)(1991-7#1)(1997-1#1)(2006-10#1)(2006-5#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-1#1)
the permeability of these##2##4##(1991-5#1)(1996-5#1)
the permeability of##26##3##(1990-5#2)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-6#1)(1996-5#1)(1997-1#2)(2005-11#3)(2006-10#1)(2006-5#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2011-1#1)(2012-2#1)
the permeability properties of##2##4##(1994-6#2)
the permeability transition pore (PTP)##2##5##(2005-8#1)(2008-7#1)
the permeability transition##3##3##(1992-11#1)(2005-8#1)(2008-7#1)
the permeability##43##2##(1990-11#1)(1990-2#1)(1990-5#2)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-7#3)(1994-6#2)(1996-5#1)(1997-1#3)(2005-11#3)(2005-8#1)(2006-10#1)(2006-5#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-2#1)
the permeabilized cells##2##3##(1992-12#1)(1992-7#1)
the permeabilized##4##2##(1992-12#1)(1992-7#2)(2009-10#1)
the permeable##2##2##(1994-8#2)
the permeant diffusion coefficient##2##4##(2008-5#2)
the permeant##6##2##(1990-11#2)(1991-5#1)(1996-5#1)(2008-5#2)
the permeate##3##2##(2004-8#1)(2007-8#1)(2008-6#1)
the permeation of##3##3##(1997-1#1)(2008-10#1)(2011-3#1)
the permeation pathway##2##3##(2007-3#1)(2008-8#1)
the permeation rate of##2##4##(2007-2#1)(2008-5#1)
the permeation rate##5##3##(2007-2#4)(2008-5#1)
the permeation##12##2##(1997-1#1)(2007-2#4)(2007-3#1)(2008-10#1)(2008-5#3)(2008-8#1)(2011-3#1)
the permissible increment of oxalate##2##5##(1995-7#2)
the permissible increment of##4##4##(1995-7#4)
the permissible limit##2##3##(2005-11#1)(2008-7#1)
the permissible limits##6##3##(1992-6#1)(2007-10#1)(2008-1#2)(2008-5#2)
the permissible##17##2##(1992-6#1)(1995-7#4)(2005-11#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-5#3)(2008-7#1)(2011-1#1)
the permissive##5##2##(1990-9#1)(1993-4#1)(1993-9#1)(2009-8#2)
the permittivity of the##2##4##(2005-11#1)(2008-3#1)
the permittivity##5##2##(2005-11#2)(2008-11#1)(2008-3#2)
the peroperative##2##2##(2007-8#1)(2008-5#1)
the peroral##3##2##(1992-7#1)(1996-11#1)(2008-5#1)
the perovskite-structure framework##2##3##(2010-12#1)(2012-2#1)
the peroxidase activity##2##3##(2008-10#2)
the peroxidase cycle##2##3##(1991-9#1)(2006-10#1)
the peroxidase##10##2##(1991-9#1)(1995-10#1)(2005-12#1)(2006-10#1)(2006-8#1)(2008-10#5)
the peroxidases##2##2##(1991-9#1)(2008-10#1)
the peroxidation of##3##3##(1991-2#1)(1994-2#1)(2006-12#1)
the peroxidation##8##2##(1990-11#1)(1990-8#1)(1991-2#1)(1994-2#1)(1994-5#1)(2006-12#1)(2008-5#1)(2013-1#1)
the peroxidative reaction of SOD##2##5##(1997-8#2)
the peroxidative##3##2##(1997-2#1)(1997-8#2)
the peroxide and the other##2##5##(2008-5#2)
the peroxide and the##3##4##(2008-5#2)(2008-8#1)
the peroxide##6##2##(1995-8#1)(1996-3#1)(2008-10#1)(2008-5#2)(2008-8#1)
the peroxisomal beta-oxidation of##2##4##(1991-10#2)
the peroxisomal beta-oxidation##4##3##(1990-2#1)(1991-10#2)(1997-7#1)
the peroxisomal matrix##2##3##(1992-6#1)(1995-9#1)
the peroxisomal membrane##2##3##(1995-2#1)(1995-3#1)
the peroxisomal##21##2##(1990-2#1)(1991-10#2)(1991-8#3)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-9#1)(1994-12#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-9#1)(1997-4#1)(1997-7#2)
the peroxisome proliferator activated receptor##3##5##(1992-8#2)(1997-7#1)
the peroxisome proliferator activated##4##4##(1992-8#2)(1997-7#2)
the peroxisome proliferator##6##3##(1992-8#2)(1994-8#1)(1995-3#1)(1997-7#2)
the peroxisome proliferator-activated receptor (PPAR)##3##5##(1995-2#1)(2008-1#1)(2008-5#1)
the peroxisome proliferator-activated receptor##7##4##(1994-8#1)(1995-2#1)(1997-4#1)(2008-1#1)(2008-4#1)(2008-5#2)
the peroxisome proliferator-activated receptors##2##4##(2005-11#1)(2010-3#1)
the peroxisome proliferator-activated##9##3##(1994-8#1)(1995-2#1)(1997-4#1)(2005-11#1)(2008-1#1)(2008-4#1)(2008-5#2)(2010-3#1)
the peroxisome##19##2##(1990-10#1)(1991-3#1)(1992-8#2)(1994-8#2)(1995-2#1)(1995-3#1)(1997-4#1)(1997-7#2)(2005-11#1)(2008-1#1)(2008-4#1)(2008-5#2)(2009-8#2)(2010-3#1)
the peroxo##3##2##(2005-11#2)(2010-5#1)
the peroxynitrite##3##2##(1994-9#1)(1997-7#1)(2004-12#1)
the perpendicular##4##2##(2008-2#1)(2008-3#1)(2010-4#1)(2010-7#1)
the perpetrator##7##2##(2005-9#1)(2007-3#1)(2008-11#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)
the perpetrators##4##2##(2007-3#1)(2008-11#1)(2012-2#1)(2013-8#1)
the perpetuation of##5##3##(2006-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2013-1#1)
the persimmon tannin gel##2##4##(2008-10#2)
the persimmon##4##2##(2008-10#4)
the persistence function##2##3##(1995-12#1)(2008-8#1)
the persistence length##3##3##(2006-10#1)(2009-10#2)
the persistence of Z-DNA in##2##5##(1997-5#2)
the persistence of Z-DNA##4##4##(1997-5#4)
the persistence of the##6##4##(1991-8#1)(1996-10#1)(2008-5#1)(2008-8#1)(2010-6#1)(2013-8#1)
the persistence of##37##3##(1991-8#2)(1995-11#1)(1996-10#1)(1997-4#1)(1997-5#4)(2006-4#1)(2006-6#1)(2006-9#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#4)(2008-8#6)(2009-4#1)(2009-8#1)(2010-6#2)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#2)
the persistence##47##2##(1990-2#1)(1991-8#2)(1994-12#1)(1995-11#1)(1995-12#1)(1996-10#1)(1997-4#1)(1997-5#4)(2006-10#1)(2006-4#1)(2006-6#2)(2006-9#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#4)(2008-8#7)(2009-10#2)(2009-4#1)(2009-8#1)(2010-6#2)(2011-2#2)(2011-3#1)(2012-2#2)(2013-1#1)(2013-8#2)
the persistent current##3##3##(2010-7#3)
the persistent presence of##2##4##(1990-10#1)(2009-3#1)
the persistent##26##2##(1990-10#1)(1990-9#1)(1991-10#1)(1994-10#1)(1997-5#1)(1997-6#1)(2005-7#1)(2005-8#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-11#3)(2008-8#1)(2009-3#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#3)(2011-2#1)(2012-12#2)(2012-3#1)
the persisting##3##2##(2004-4#1)(2008-1#1)(2010-12#1)
the person and##4##3##(1994-1#1)(2006-6#1)(2008-1#1)(2008-2#1)
the person in##2##3##(1991-9#1)(2006-10#1)
the person is##2##3##(1996-5#1)(2009-4#1)
the person of##3##3##(1991-8#1)(2007-2#1)(2008-5#1)
the person responsible for##3##4##(1994-2#1)(2006-6#1)(2009-2#1)
the person to##2##3##(1995-6#1)(2008-3#1)
the person who##2##3##(1997-2#1)(2009-6#1)
the person with##2##3##(2009-4#1)(2010-2#1)
the person##45##2##(1991-12#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-2#2)(1994-1#1)(1994-2#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-3#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-3#1)(2006-6#2)(2007-1#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-4#6)(2009-6#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
the person's##8##2##(1990-3#1)(2006-11#1)(2007-7#1)(2009-4#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-2#1)
the personal and##4##3##(2008-12#1)(2009-1#1)(2012-1#1)(2012-12#1)
the personal care##2##3##(2008-5#1)(2011-1#1)
the personal characteristics##2##3##(2009-7#1)(2010-9#1)
the personal computer##2##3##(1992-10#1)(2007-4#1)
the personal experience##3##3##(1990-12#1)(2006-6#1)(2008-8#1)
the personal experiences of##2##4##(2004-12#1)(2008-11#1)
the personal tutor##2##3##(2008-11#2)
the personal##43##2##(1990-12#1)(1991-12#1)(1992-10#2)(1994-3#1)(1995-12#1)(2004-12#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-2#2)(2007-4#2)(2007-7#2)(2008-11#5)(2008-12#1)(2008-2#2)(2008-5#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-7#2)(2010-12#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
the personality and##2##3##(2009-8#1)(2011-1#1)
the personality characteristics##2##3##(2009-5#2)
the personality construct##2##3##(2008-11#1)(2013-7#1)
the personality of the##3##4##(1994-3#1)(2006-3#1)(2008-8#1)
the personality of##5##3##(1994-3#1)(2006-3#1)(2008-8#1)(2011-1#1)(2012-3#1)
the personality trait of##2##4##(2010-6#1)(2011-2#1)
the personality trait##3##3##(2008-5#1)(2010-6#1)(2011-2#1)
the personality##18##2##(1993-11#1)(1994-3#1)(1996-7#1)(2006-3#1)(2007-1#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-5#2)(2009-8#1)(2010-6#1)(2011-1#3)(2011-2#1)(2012-3#1)(2013-7#1)
the personally##2##2##(1990-4#1)(2012-12#1)
the personnel and##3##3##(1994-3#2)(2009-2#1)
the personnel in the##2##4##(1995-2#1)(2006-8#1)
the personnel of the##2##4##(1994-3#1)(1996-3#1)
the personnel of##3##3##(1994-3#1)(1996-3#1)(2008-10#1)
the personnel shortage##2##3##(1990-12#2)
the personnel##21##2##(1990-12#2)(1992-11#1)(1993-5#1)(1994-11#2)(1994-3#3)(1995-2#1)(1996-3#1)(2006-8#1)(2007-6#2)(2008-10#1)(2008-4#1)(2009-2#3)(2010-9#2)
the persons##13##2##(1991-11#1)(1991-9#1)(1992-2#1)(1993-5#1)(1994-11#1)(1995-8#1)(1996-1#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-7#1)(2011-1#1)(2013-1#1)
the perspective from which##2##4##(2008-3#1)(2009-4#1)
the perspective of a##10##4##(1994-1#1)(1994-12#1)(1994-6#1)(2006-12#1)(2006-5#1)(2007-4#1)(2008-1#2)(2008-4#1)(2009-10#1)
the perspective of an##2##4##(1993-1#1)(2012-2#1)
the perspective of perioperative nurse leaders##3##6##(2012-3#3)
the perspective of the author##2##5##(1990-12#1)(2008-12#1)
the perspective of the##25##4##(1990-12#1)(1991-12#1)(1992-3#1)(1993-12#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-11#2)(2008-12#1)(2008-2#3)(2008-7#1)(2009-4#1)(2010-10#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#1)
the perspective of##89##3##(1990-12#1)(1991-12#1)(1991-6#1)(1992-3#2)(1993-1#1)(1993-12#1)(1994-1#1)(1994-12#2)(1994-6#1)(1996-3#1)(2004-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#4)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-4#1)(2007-5#2)(2007-8#1)(2008-1#6)(2008-10#1)(2008-11#4)(2008-12#2)(2008-2#7)(2008-4#1)(2008-6#2)(2008-7#1)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#1)(2010-10#5)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#5)(2013-1#1)
the perspective##99##2##(1990-12#1)(1991-12#1)(1991-6#1)(1992-3#2)(1993-1#1)(1993-12#1)(1994-1#1)(1994-12#2)(1994-6#1)(1996-3#1)(2004-11#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-5#4)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-4#1)(2007-5#2)(2007-8#1)(2008-1#6)(2008-10#1)(2008-11#4)(2008-12#2)(2008-2#7)(2008-3#1)(2008-4#1)(2008-6#3)(2008-7#2)(2008-9#3)(2009-10#1)(2009-3#2)(2009-4#2)(2010-10#5)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#6)(2013-1#1)(2013-8#1)
the perspectives of##18##3##(1993-1#1)(1993-5#1)(1997-3#1)(2007-10#1)(2007-8#1)(2008-12#2)(2008-3#1)(2008-7#1)(2009-7#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
the perspectives##21##2##(1993-1#1)(1993-5#1)(1996-3#1)(1997-3#1)(2007-10#1)(2007-8#1)(2008-12#2)(2008-3#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-7#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
the pertinence of##2##3##(1994-3#1)(2006-4#1)
the pertinent anatomy##3##3##(1993-7#1)(2006-3#1)(2007-12#1)
the pertinent literature##6##3##(2006-2#1)(2007-12#1)(2007-7#1)(2010-12#1)(2012-12#1)(2012-2#1)
the pertinent##19##2##(1990-2#1)(1993-7#1)(1996-6#1)(2006-10#1)(2006-2#1)(2006-3#1)(2007-12#2)(2007-7#1)(2008-3#1)(2010-10#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
the perturbants##2##2##(1994-3#2)
the perturbation of UA on the##2##6##(2008-10#2)
the perturbation of the##3##4##(1997-4#1)(2007-12#1)(2008-7#1)
the perturbation of##13##3##(1994-12#1)(1994-6#1)(1995-10#1)(1997-4#1)(1997-6#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-7#3)
the perturbation technique##2##3##(2008-2#2)
the perturbation theory##2##3##(2008-2#1)(2008-3#1)
the perturbation##27##2##(1992-9#2)(1994-12#1)(1994-6#1)(1995-10#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-6#1)(2007-12#2)(2008-10#4)(2008-2#3)(2008-3#6)(2008-7#3)
the perturbations in##3##3##(2006-10#1)(2008-5#1)(2012-12#1)
the perturbations##6##2##(1995-5#1)(2006-10#1)(2007-12#1)(2008-5#1)(2011-1#1)(2012-12#1)
the perturbed##2##2##(2008-3#1)(2009-8#1)
the pertussis##2##2##(1997-7#1)(2013-1#1)
the pervasive##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
the pervasiveness of this##2##4##(1995-3#1)(2009-10#1)
the pervasiveness of##3##3##(1994-2#1)(1995-3#1)(2009-10#1)
the pest##12##2##(2004-11#2)(2006-10#1)(2007-12#1)(2008-10#2)(2008-6#1)(2008-8#1)(2009-3#1)(2011-2#1)(2013-8#2)
the pesticide and##2##3##(2008-10#1)(2011-2#1)
the pesticide##28##2##(1991-3#1)(1997-3#1)(2005-7#1)(2007-8#4)(2008-10#13)(2008-7#3)(2011-1#1)(2011-2#2)(2011-3#1)(2013-1#1)
the pesticides at##2##3##(2008-10#2)
the pesticides studied##2##3##(2007-8#1)(2008-10#1)
the pesticides were##2##3##(2007-5#1)(2008-11#1)
the pesticides##18##2##(1990-9#1)(1994-3#1)(2007-5#3)(2007-8#1)(2008-10#7)(2008-11#3)(2012-12#1)(2013-8#1)
the pests##2##2##(2013-8#2)
the petals of##2##3##(2006-12#2)
the petals##5##2##(2006-12#5)
the petition of##2##3##(1990-11#1)(1993-9#1)
the petition##3##2##(1990-11#1)(1993-9#1)(1995-6#1)
the petri##2##2##(2008-10#2)
the petroclival area##2##3##(2006-12#1)(2008-7#1)
the petroclival region##3##3##(2006-12#3)
the petroclival##7##2##(2006-12#5)(2008-7#2)
the petrol##3##2##(2008-10#2)(2009-6#1)
the petroleum##4##2##(2007-1#1)(2007-10#1)(2007-7#1)(2011-1#1)
the petrous apex and##2##4##(2006-12#1)(2011-2#1)
the petrous apex cholesteatoma##2##4##(2011-2#2)
the petrous apex##8##3##(2006-12#4)(2011-2#4)
the petrous bone and##2##4##(2008-7#1)(2008-8#1)
the petrous bone##3##3##(2008-7#1)(2008-8#1)(2011-2#1)
the petrous ridge##2##3##(2006-12#1)(2008-7#1)
the petrous##20##2##(2005-9#2)(2006-12#7)(2008-7#2)(2008-8#1)(2009-10#1)(2011-2#6)(2012-12#1)
the petunia##2##2##(1993-6#2)
the pgsA3 mutation##2##3##(1993-8#2)
the pha genes of P##2##5##(2008-6#2)
the pha genes##3##3##(2008-6#3)
the phage display method##2##4##(2008-11#2)
the phage display##4##3##(1994-9#1)(2008-10#1)(2008-11#2)
the phage genome##3##3##(1990-8#1)(1995-2#1)(2007-12#1)
the phage lambda##5##3##(1990-3#1)(1991-6#2)(1995-3#1)(1995-8#1)
the phage particles##2##3##(1993-4#1)(1994-12#1)
the phage##50##2##(1990-1#3)(1990-11#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-6#2)(1993-4#1)(1994-12#3)(1994-9#2)(1995-2#3)(1995-3#1)(1995-8#2)(1997-1#3)(2007-12#2)(2008-10#6)(2008-11#2)(2008-4#1)(2008-8#1)(2009-2#1)(2009-5#1)(2011-12#4)(2012-1#1)(2012-2#1)(2013-1#1)
the phage-derived##2##2##(2009-2#2)
the phage-display##2##2##(1994-3#1)(2010-1#1)
the phages##4##2##(2012-2#2)(2013-1#2)
the phagocytic ability of##2##4##(1993-4#1)(2009-9#1)
the phagocytic activity##2##3##(1994-3#1)(2008-1#1)
the phagocytic capacity##2##3##(1994-6#1)(1995-5#1)
the phagocytic vacuole##3##3##(1990-12#2)(2008-1#1)
the phagocytic##11##2##(1990-12#2)(1993-4#1)(1994-3#1)(1994-6#2)(1995-5#1)(2008-1#2)(2009-6#1)(2009-9#1)
the phagocytosis of##10##3##(1991-3#1)(1991-5#1)(1992-12#1)(1992-5#1)(1992-6#1)(1994-3#1)(2008-4#1)(2008-6#3)
the phagocytosis##15##2##(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-6#1)(1994-3#2)(2008-4#1)(2008-6#4)
the phagolysosome##2##2##(1994-12#1)(2008-3#1)
the phagosome##2##2##(1990-6#2)
the phalanges##3##2##(1994-6#1)(1997-3#1)(2009-5#1)
the phallus##2##2##(2006-7#1)(2008-1#1)
the phantom is##2##3##(2008-5#1)(2011-1#1)
the phantom tissue##2##3##(2009-11#2)
the phantom##22##2##(2007-11#1)(2008-3#8)(2008-5#3)(2009-11#2)(2009-5#2)(2010-2#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
the phantoms##2##2##(2008-3#1)(2012-1#1)
the pharmaceutical and biotechnology industries##4##5##(2005-7#1)(2008-10#1)(2008-5#1)(2011-1#1)
the pharmaceutical and##6##3##(2005-7#2)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)
the pharmaceutical industry and##6##4##(2006-10#1)(2006-2#1)(2008-5#1)(2009-12#1)(2010-11#1)(2011-2#1)
the pharmaceutical industry has##3##4##(1995-5#1)(2007-11#1)(2012-2#1)
the pharmaceutical industry in##2##4##(1991-3#1)(2008-10#1)
the pharmaceutical industry is##4##4##(1997-4#1)(2006-2#1)(2008-10#1)(2009-11#1)
the pharmaceutical industry to##2##4##(1996-2#1)(2009-11#1)
the pharmaceutical industry##55##3##(1991-2#1)(1991-3#1)(1993-2#1)(1995-5#1)(1996-12#2)(1996-2#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#2)(2005-7#1)(2005-8#5)(2005-9#2)(2006-10#2)(2006-2#3)(2007-11#1)(2008-10#3)(2008-11#5)(2008-4#1)(2008-5#5)(2008-7#1)(2008-9#1)(2009-11#4)(2009-12#1)(2010-11#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#3)
the pharmaceutical market##2##3##(2007-1#1)(2008-5#1)
the pharmaceutical preparations##3##3##(2008-10#3)
the pharmaceutical sector##2##3##(2012-1#1)(2012-2#1)
the pharmaceutical##97##2##(1991-2#2)(1991-3#2)(1993-2#1)(1995-5#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#2)(2005-7#3)(2005-8#5)(2005-9#2)(2006-10#3)(2006-2#3)(2007-1#1)(2007-11#2)(2007-8#3)(2008-10#18)(2008-11#7)(2008-4#1)(2008-5#7)(2008-7#1)(2008-9#1)(2009-11#4)(2009-12#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-11#1)(2012-2#5)(2013-8#1)
the pharmacies##2##2##(1990-2#1)(2011-1#1)
the pharmacist##3##2##(1991-6#1)(2005-1#1)(2008-4#1)
the pharmacist's##2##2##(1993-2#1)(2010-3#1)
the pharmacists to##2##3##(2010-5#2)
the pharmacists##4##2##(2010-5#2)(2011-1#2)
the pharmacodynamic and pharmacokinetic##2##4##(2008-3#1)(2008-8#1)
the pharmacodynamic response of##2##4##(2007-9#1)(2008-5#1)
the pharmacodynamic##6##2##(1996-6#1)(2005-8#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-8#1)
the pharmacodynamics of##2##3##(2009-3#1)(2011-3#1)
the pharmacokinetic parameters were##3##4##(2008-11#1)(2008-5#1)(2010-12#1)
the pharmacokinetic parameters##6##3##(1995-2#1)(2008-11#1)(2008-5#1)(2010-12#1)(2012-2#2)
the pharmacokinetic profile of##4##4##(1996-8#1)(1997-5#1)(2008-10#1)(2013-8#1)
the pharmacokinetic properties of##2##4##(1996-8#1)(2007-2#1)
the pharmacokinetic properties##4##3##(1996-8#1)(2007-2#1)(2008-7#1)(2009-3#1)
the pharmacokinetic study of 6-MP in##2##6##(2008-10#2)
the pharmacokinetic study of##6##4##(1996-8#1)(1997-3#1)(2008-10#3)(2012-12#1)
the pharmacokinetic study##7##3##(1996-8#1)(1997-3#1)(2008-10#3)(2008-5#1)(2012-12#1)
the pharmacokinetic##32##2##(1991-12#1)(1991-2#1)(1995-2#1)(1996-8#3)(1997-3#1)(1997-5#1)(1997-8#1)(2005-7#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-3#1)(2010-12#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
the pharmacokinetics and pharmacodynamics of##5##5##(1991-2#1)(1996-6#1)(2008-8#2)(2009-2#1)
the pharmacokinetics and##11##3##(1991-2#1)(1991-8#1)(1995-3#1)(1996-6#1)(2008-3#1)(2008-5#2)(2008-8#3)(2009-2#1)
the pharmacokinetics of heroin##2##4##(2008-8#2)
the pharmacokinetics of##29##3##(1990-3#1)(1991-12#2)(1991-9#1)(1992-11#1)(1994-3#1)(1995-2#1)(1996-6#1)(1997-8#1)(2006-10#3)(2006-11#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-6#1)(2008-8#3)(2009-4#1)(2010-12#2)(2010-2#1)(2011-2#1)(2012-12#1)
the pharmacokinetics##53##2##(1990-1#1)(1990-3#3)(1991-12#2)(1991-2#1)(1991-8#1)(1991-9#1)(1992-11#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-6#2)(1997-3#1)(1997-8#1)(2005-7#1)(2006-10#3)(2006-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#7)(2009-2#1)(2009-4#1)(2010-12#2)(2010-2#1)(2011-2#3)(2012-12#1)(2012-3#1)
the pharmacologic treatment of obesity##2##5##(2006-10#1)(2011-2#1)
the pharmacologic treatment of##4##4##(1996-9#1)(2006-10#1)(2010-8#1)(2011-2#1)
the pharmacologic treatment##5##3##(1996-9#1)(2006-10#1)(2008-10#1)(2010-8#1)(2011-2#1)
the pharmacologic##18##2##(1991-1#1)(1991-12#1)(1996-7#1)(1996-9#1)(1997-6#1)(2004-1#1)(2006-10#2)(2007-10#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-8#1)(2009-4#1)(2010-8#1)(2011-2#1)
the pharmacological action##2##3##(2005-3#1)(2008-10#1)
the pharmacological actions of##4##4##(1991-1#1)(1995-12#1)(1996-10#1)(1996-12#1)
the pharmacological activities##2##3##(1990-5#1)(2011-3#1)
the pharmacological activity##3##3##(1991-8#1)(2006-12#1)(2008-5#1)
the pharmacological and##3##3##(2008-4#1)(2008-8#1)(2010-9#1)
the pharmacological aspects of##2##4##(2010-5#1)(2012-12#1)
the pharmacological characteristics of##4##4##(1992-3#1)(1993-2#1)(1993-9#1)(2009-7#1)
the pharmacological characteristics##5##3##(1992-3#1)(1993-2#1)(1993-9#1)(2005-3#1)(2009-7#1)
the pharmacological characterization##2##3##(1997-5#1)(2005-8#1)
the pharmacological effects of##2##4##(1994-3#1)(1994-5#1)
the pharmacological effects##3##3##(1994-3#1)(1994-5#1)(2013-1#1)
the pharmacological management of##5##4##(2008-3#2)(2008-7#1)(2008-8#1)(2010-8#1)
the pharmacological profile of##2##4##(2008-1#1)(2012-12#1)
the pharmacological profile##5##3##(1990-3#1)(1992-9#1)(1995-1#1)(2008-1#1)(2012-12#1)
the pharmacological properties of the##2##5##(1995-12#1)(2008-1#1)
the pharmacological properties of##7##4##(1992-5#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1995-12#1)(2008-1#1)
the pharmacological properties##9##3##(1990-3#1)(1992-5#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1995-12#1)(2006-12#1)(2008-1#1)
the pharmacological treatment of##3##4##(1994-6#1)(2007-11#1)(2008-7#1)
the pharmacological treatment##4##3##(1994-6#1)(2007-11#1)(2008-7#1)(2009-7#1)
the pharmacological##74##2##(1990-2#1)(1990-3#2)(1990-5#2)(1991-1#1)(1991-2#1)(1991-8#1)(1992-3#1)(1992-5#1)(1992-9#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-7#2)(1993-9#2)(1994-3#2)(1994-5#1)(1994-6#1)(1995-1#2)(1995-12#2)(1996-10#1)(1996-12#1)(1997-5#1)(2005-3#2)(2005-8#1)(2006-12#2)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#3)(2008-1#3)(2008-10#5)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2009-7#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
the pharmacology and physiology of##2##5##(2005-8#1)(2006-10#1)
the pharmacology and##6##3##(1991-2#1)(1995-3#1)(2005-8#2)(2006-10#1)(2007-12#1)
the pharmacology of the##3##4##(1995-2#1)(2006-8#1)(2008-3#1)
the pharmacology of##14##3##(1994-8#1)(1995-2#1)(1996-7#1)(2005-7#2)(2006-10#3)(2006-12#1)(2006-8#1)(2008-3#1)(2008-7#1)(2009-8#1)(2012-2#1)
the pharmacology##27##2##(1991-2#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-7#1)(2005-7#2)(2005-8#3)(2006-10#4)(2006-12#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-5#1)(2012-2#1)
the pharmacophore##3##2##(1996-9#1)(2012-3#2)
the pharmacopoeial##2##2##(2007-8#1)(2008-10#1)
the pharmacopoeias##2##2##(2008-10#1)(2012-12#1)
the pharmacotherapeutic##2##2##(1997-8#1)(2007-6#1)
the pharmacotherapy of##4##3##(1996-12#1)(2008-3#1)(2008-6#1)(2008-8#1)
the pharmacy and##2##3##(2010-3#1)(2011-1#1)
the pharmacy department##2##3##(2008-1#2)
the pharmacy profession##2##3##(1993-2#2)
the pharmacy##22##2##(1992-3#1)(1993-2#2)(2005-7#1)(2008-1#2)(2008-9#1)(2010-3#8)(2010-9#1)(2011-1#6)
the pharyngeal##3##2##(2010-2#1)(2010-8#1)(2013-8#1)
the pharynx and the##2##4##(1997-7#1)(2008-9#1)
the pharynx##9##2##(1997-7#1)(2007-12#2)(2007-6#1)(2008-5#1)(2008-9#1)(2009-1#1)(2009-10#1)(2011-2#1)
the phase I##5##3##(1995-12#1)(2008-5#2)(2011-2#2)
the phase II and##2##4##(2007-7#1)(2012-2#1)
the phase II##9##3##(1995-12#1)(2005-8#1)(2007-11#1)(2007-7#2)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)
the phase III##4##3##(2005-7#1)(2007-11#1)(2007-7#1)(2010-12#1)
the phase and amplitude##4##4##(2006-5#2)(2008-2#1)(2008-3#1)
the phase and the amplitude of a##2##7##(2007-12#1)(2008-2#1)
the phase and the amplitude of the##2##7##(2007-11#1)(2008-2#1)
the phase and the amplitude of##4##6##(2007-11#1)(2007-12#1)(2008-2#2)
the phase and the##7##4##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#2)
the phase and##17##3##(2006-5#2)(2007-11#1)(2007-12#5)(2008-2#4)(2008-3#5)
the phase behavior and structure##2##5##(2005-11#2)
the phase behavior of##5##4##(1990-2#1)(1990-4#1)(2005-11#1)(2008-12#1)(2010-4#1)
the phase behavior##8##3##(1990-2#1)(1990-4#1)(2005-11#3)(2008-12#2)(2010-4#1)
the phase boundary##2##3##(2008-1#1)(2008-7#1)
the phase change at##2##4##(1991-6#1)(2008-2#1)
the phase change on reflection##5##5##(2007-11#1)(2008-2#4)
the phase change##11##3##(1991-6#1)(2007-11#2)(2008-10#1)(2008-2#5)(2008-3#2)
the phase changes in the##2##5##(2007-11#1)(2008-5#1)
the phase changes##3##3##(2007-11#1)(2008-3#1)(2008-5#1)
the phase coding##2##3##(2008-11#2)
the phase conjugate of##2##4##(2007-12#2)
the phase conjugation##2##3##(2008-2#2)
the phase conjugator##2##3##(2007-12#1)(2008-2#1)
the phase correction##3##3##(2007-12#1)(2008-2#1)(2013-8#1)
the phase delay##2##3##(2007-12#1)(2008-3#1)
the phase diagram##4##3##(2005-11#1)(2008-5#2)(2012-2#1)
the phase difference between the##5##5##(2007-12#2)(2008-3#3)
the phase difference between two##3##5##(2007-12#1)(2008-3#2)
the phase difference between##11##4##(2007-12#5)(2008-3#6)
the phase difference is##2##4##(2007-11#2)
the phase difference of two##2##5##(2007-12#1)(2008-3#1)
the phase difference of##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
the phase difference##21##3##(2007-11#3)(2007-12#8)(2008-2#2)(2008-3#8)
the phase dispersion##2##3##(2008-2#1)(2008-3#1)
the phase distribution in the##2##5##(2008-2#1)(2008-3#1)
the phase distribution in##3##4##(2008-2#1)(2008-3#2)
the phase distribution of##2##4##(2007-11#1)(2008-3#1)
the phase distribution##10##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#5)
the phase distributions of##3##4##(2008-2#1)(2008-3#1)(2011-1#1)
the phase distributions##4##3##(2008-2#2)(2008-3#1)(2011-1#1)
the phase error##3##3##(2008-2#3)
the phase estimator is##2##4##(2008-3#2)
the phase from##2##3##(2007-12#1)(2008-2#1)
the phase function##16##3##(2006-4#1)(2007-12#4)(2008-2#6)(2008-3#5)
the phase gradient##3##3##(2008-2#1)(2008-3#2)
the phase grating##2##3##(2008-3#2)
the phase in the##3##4##(1990-6#1)(2007-12#1)(2008-2#1)
the phase in##5##3##(1990-6#1)(2007-12#1)(2008-2#3)
the phase information##3##3##(2006-5#1)(2007-12#1)(2008-3#1)
the phase is##6##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)
the phase jitter##2##3##(2007-11#1)(2007-12#1)
the phase map##4##3##(2008-2#2)(2008-3#2)
the phase matching##2##3##(2007-11#1)(2007-12#1)
the phase mismatch##6##3##(2007-12#1)(2008-2#2)(2008-3#3)
the phase model##2##3##(1992-1#1)(1995-2#1)
the phase modulation##5##3##(2007-11#1)(2008-2#2)(2008-3#1)(2012-2#1)
the phase modulator##3##3##(2007-12#2)(2008-3#1)
the phase noise##2##3##(2007-12#2)
the phase of a##6##4##(2007-11#1)(2007-12#3)(2008-3#2)
the phase of an##2##4##(2007-12#1)(2008-2#1)
the phase of each##2##4##(2008-10#1)(2012-3#1)
the phase of one##2##4##(2007-12#1)(2008-2#1)
the phase of the input##3##5##(2007-12#2)(2008-3#1)
the phase of the object##2##5##(2008-2#1)(2008-3#1)
the phase of the optical##2##5##(2007-12#2)
the phase of the reference##2##5##(2008-3#2)
the phase of the transmitted light##2##6##(2007-12#1)(2008-3#1)
the phase of the##36##4##(1994-2#1)(1997-1#1)(2006-10#1)(2007-11#5)(2007-12#9)(2008-10#1)(2008-2#9)(2008-3#8)(2010-12#1)
the phase of##72##3##(1994-2#1)(1994-6#1)(1997-1#1)(1997-3#2)(2006-10#1)(2006-12#1)(2007-11#6)(2007-12#22)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#12)(2008-3#13)(2009-10#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
the phase plate##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
the phase profile##2##3##(2007-12#1)(2008-3#1)
the phase properties##2##3##(1990-5#1)(2007-11#1)
the phase relation##2##3##(2007-12#1)(2011-1#1)
the phase relations##2##3##(2008-2#1)(2008-3#1)
the phase response of the error##2##6##(2008-2#2)
the phase response of##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
the phase response##5##3##(2007-12#2)(2008-2#2)(2008-3#1)
the phase screen##5##3##(2008-2#2)(2008-3#3)
the phase separation and##2##4##(2008-10#1)(2008-7#1)
the phase separation of##2##4##(1997-6#1)(2008-7#1)
the phase separation##6##3##(1997-6#1)(2006-12#1)(2008-10#2)(2008-7#2)
the phase shift between##2##4##(2008-2#1)(2008-3#1)
the phase shift of##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
the phase shift on reflection##2##5##(2008-2#2)
the phase shift on##3##4##(2008-2#3)
the phase shift##17##3##(2007-11#4)(2007-12#1)(2008-2#7)(2008-3#4)(2008-5#1)
the phase shifting##3##3##(1997-5#1)(2007-11#1)(2008-3#1)
the phase shifts##5##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
the phase singularities##2##3##(2007-11#1)(2008-3#1)
the phase state##2##3##(2007-11#1)(2008-5#1)
the phase transfer of##2##4##(2005-11#1)(2007-8#1)
the phase transformation##2##3##(2005-11#1)(2007-11#1)
the phase transition in##2##4##(1991-4#1)(1991-9#1)
the phase transition of##2##4##(1992-6#1)(2008-8#1)
the phase transition##22##3##(1990-4#4)(1991-2#1)(1991-4#1)(1991-9#1)(1992-6#1)(1994-11#1)(1996-4#1)(2005-11#3)(2006-12#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-8#2)
the phase unwrapping##2##3##(2008-2#1)(2008-3#1)
the phase variation##3##3##(2008-3#3)
the phase##438##2##(1990-2#1)(1990-4#5)(1990-5#1)(1990-6#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-1#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-4#1)(1994-6#1)(1995-12#2)(1995-2#1)(1996-4#1)(1997-1#1)(1997-3#2)(1997-5#1)(1997-6#1)(2005-11#10)(2005-7#2)(2005-8#1)(2006-10#1)(2006-12#3)(2006-4#2)(2006-5#3)(2007-10#1)(2007-11#40)(2007-12#78)(2007-7#3)(2007-8#1)(2008-1#5)(2008-10#13)(2008-11#5)(2008-12#3)(2008-2#86)(2008-3#106)(2008-5#11)(2008-7#3)(2008-8#3)(2009-10#1)(2009-11#1)(2009-5#1)(2010-12#3)(2010-4#2)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#6)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
the phase-boundary##2##2##(2008-10#2)
the phase-change##3##2##(2008-2#1)(2008-3#2)
the phase-conjugate##6##2##(2007-12#1)(2008-2#3)(2008-3#2)
the phase-conjugating##2##2##(2008-2#2)
the phase-dependent##3##2##(1991-5#2)(2008-2#1)
the phase-iterative algorithm##2##3##(2008-2#1)(2008-3#1)
the phase-iterative##3##2##(2008-2#2)(2008-3#1)
the phase-locked##2##2##(2007-11#1)(2008-3#1)
the phase-matched##2##2##(2007-12#2)
the phase-matching angles##2##3##(2007-12#1)(2008-3#1)
the phase-matching condition for##2##4##(2007-12#2)
the phase-matching condition##10##3##(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#3)
the phase-matching conditions##5##3##(2007-11#1)(2007-12#2)(2008-3#2)
the phase-matching properties of##3##4##(2008-2#1)(2008-3#2)
the phase-matching wavelength##2##3##(2007-12#1)(2008-3#1)
the phase-matching##25##2##(2006-4#1)(2007-11#2)(2007-12#8)(2008-2#4)(2008-3#10)
the phase-noise power spectral density##2##5##(2007-12#2)
the phase-noise##3##2##(2007-12#2)(2013-1#1)
the phase-only filter##2##3##(2008-2#1)(2008-3#1)
the phase-only##3##2##(2008-2#1)(2008-3#2)
the phase-resolved##2##2##(2007-11#1)(2011-1#1)
the phase-retrieval##3##2##(2008-2#3)
the phase-separated PNIPAM particles##2##4##(2008-10#2)
the phase-shift plane##2##3##(2008-3#2)
the phase-shift##6##2##(2008-2#1)(2008-3#5)
the phase-shifting effects of##2##4##(1996-6#1)(1997-5#1)
the phase-shifting shearing interferometer##2##4##(2007-11#2)
the phase-shifting##7##2##(1994-2#1)(1996-6#1)(1997-5#1)(2007-11#2)(2008-3#2)
the phase-stepping##2##2##(2008-2#1)(2008-3#1)
the phase-structure function and##2##4##(2008-2#2)
the phase-structure function##3##3##(2008-2#3)
the phase-unwrapping##4##2##(2008-2#2)(2008-3#2)
the phases of##10##3##(2006-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-9#1)(2012-2#1)(2013-8#1)
the phases##15##2##(1990-12#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-9#1)(2012-2#1)(2013-8#1)
the phasic response to noradrenaline##2##5##(2009-5#2)
the phasic##6##2##(1995-8#1)(1997-4#1)(2004-12#2)(2009-5#2)
the phasing##2##2##(1994-1#1)(2012-3#1)
the phenol group##3##3##(1992-9#1)(1994-5#2)
the phenol##16##2##(1992-9#1)(1994-12#1)(1994-5#3)(2005-11#1)(2006-8#2)(2007-8#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-8#1)(2010-8#1)
the phenolate ligands##2##3##(1996-2#2)
the phenolate##3##2##(1990-5#1)(1996-2#2)
the phenolic OH##3##3##(2006-12#2)(2008-10#1)
the phenolic group##3##3##(1990-5#2)(2006-12#1)
the phenolic hydroxyl group##2##4##(1991-7#1)(1992-9#1)
the phenolic substance##2##3##(2007-10#1)(2008-5#1)
the phenolic##28##2##(1990-5#2)(1991-7#1)(1992-9#1)(1993-2#1)(1995-11#1)(1995-3#2)(2005-11#1)(2005-8#1)(2006-12#3)(2007-10#1)(2007-11#1)(2008-10#7)(2008-5#2)(2009-3#1)(2009-6#1)(2010-6#1)(2011-2#1)
the phenology of##5##3##(2007-3#1)(2008-10#3)(2012-2#1)
the phenols##5##2##(1996-6#1)(2008-10#4)
the phenomena in the##2##4##(2006-10#1)(2008-10#1)
the phenomena of##11##3##(1990-11#1)(1993-11#1)(2007-10#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2010-10#1)(2010-11#1)
the phenomena##24##2##(1990-11#1)(1993-11#1)(1997-8#2)(2006-10#1)(2007-10#1)(2007-2#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-12#1)(2010-10#1)(2010-11#1)(2011-1#1)
the phenomenological approach##2##3##(2006-9#1)(2007-11#1)
the phenomenological##3##2##(2006-9#1)(2007-11#1)(2010-2#1)
the phenomenological-hermeneutic method##2##3##(2006-2#1)(2013-1#1)
the phenomenology of the##2##4##(2008-7#1)(2010-6#1)
the phenomenology of##5##3##(2005-7#1)(2008-11#1)(2008-7#1)(2009-3#1)(2010-6#1)
the phenomenology##9##2##(1995-12#1)(2005-7#1)(2006-8#1)(2007-12#1)(2008-11#1)(2008-7#1)(2009-3#1)(2010-6#1)(2010-8#1)
the phenomenon in##5##3##(2004-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2009-10#1)
the phenomenon is##2##3##(2007-12#1)(2008-10#1)
the phenomenon known as &quot##2##5##(2012-12#1)(2012-2#1)
the phenomenon may##2##3##(2007-11#1)(2008-10#1)
the phenomenon of suicide##2##4##(2008-2#2)
the phenomenon of the##2##4##(2005-11#1)(2009-9#1)
the phenomenon of##55##3##(1990-8#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-4#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-2#2)(2004-11#2)(2005-11#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-7#1)(2007-11#4)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-10#1)(2011-1#2)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
the phenomenon was##2##3##(2008-10#1)(2010-3#1)
the phenomenon##89##2##(1990-8#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-4#1)(1993-6#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-8#1)(1996-2#2)(2004-11#2)(2004-4#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-11#6)(2007-12#3)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-2#4)(2008-3#3)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
the phenothiazine##2##2##(1992-6#1)(2009-7#1)
the phenotype and##2##3##(2008-6#1)(2012-12#1)
the phenotype is##3##3##(1996-12#1)(1997-6#1)(2006-8#1)
the phenotype may##2##3##(2006-8#1)(2012-2#1)
the phenotype of a##2##4##(2008-7#1)(2009-8#1)
the phenotype of cells##2##4##(1996-5#1)(2008-4#1)
the phenotype of interest##2##4##(2012-3#2)
the phenotype of proliferating##2##4##(1995-2#2)
the phenotype of the##7##4##(1990-11#1)(1990-6#1)(1993-9#1)(1994-3#1)(1995-11#1)(1996-2#1)(2006-8#1)
the phenotype of##32##3##(1990-11#1)(1990-6#1)(1993-9#2)(1994-11#1)(1994-3#2)(1995-11#1)(1995-2#2)(1995-8#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-8#1)(2005-10#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-4#3)(2008-7#1)(2008-8#3)(2009-8#2)(2010-12#1)(2012-2#1)(2012-3#2)
the phenotype##70##2##(1990-11#1)(1990-6#1)(1991-4#1)(1993-2#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-11#1)(1995-2#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-10#1)(2006-8#4)(2007-11#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-2#1)(2009-8#2)(2010-12#1)(2011-1#2)(2011-12#1)(2012-12#3)(2012-2#4)(2012-3#8)(2013-1#2)
the phenotypes and##2##3##(1994-6#1)(2012-12#1)
the phenotypes of susceptibility or resistance to##2##7##(2011-2#2)
the phenotypes of the sl/sl rats##2##6##(1996-4#2)
the phenotypes of the##4##4##(1991-7#1)(1996-4#2)(2010-2#1)
the phenotypes of##15##3##(1991-7#1)(1991-9#1)(1996-2#1)(1996-4#2)(2007-12#1)(2008-11#1)(2008-4#1)(2009-3#1)(2009-8#2)(2010-2#1)(2011-2#2)(2013-8#1)
the phenotypes seen##2##3##(1997-6#1)(2008-7#1)
the phenotypes were##2##3##(1997-8#1)(2008-5#1)
the phenotypes##32##2##(1991-7#1)(1991-9#1)(1994-6#1)(1996-2#1)(1996-4#2)(1997-6#2)(1997-8#2)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#2)(2010-2#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
the phenotypic and##6##3##(1995-1#1)(1997-6#1)(2006-8#1)(2008-10#1)(2008-8#1)(2009-8#1)
the phenotypic characterization of##3##4##(2005-8#1)(2008-4#2)
the phenotypic consequences of##2##4##(2008-4#1)(2010-7#1)
the phenotypic effects of the##2##5##(1993-8#1)(1995-5#1)
the phenotypic effects of##3##4##(1993-8#1)(1995-5#1)(2013-1#1)
the phenotypic effects##4##3##(1993-8#1)(1995-5#1)(2007-12#1)(2013-1#1)
the phenotypic variance##11##3##(2008-10#8)(2012-3#3)
the phenotypic variation in the##2##5##(2008-10#1)(2013-7#1)
the phenotypic variation in##3##4##(2008-10#2)(2013-7#1)
the phenotypic variation##16##3##(2008-10#14)(2009-2#1)(2013-7#1)
the phenotypic##68##2##(1990-8#1)(1991-2#1)(1991-5#1)(1992-2#1)(1993-8#1)(1995-1#1)(1995-4#1)(1995-5#1)(1996-3#2)(1997-6#1)(2005-8#1)(2006-8#1)(2007-12#1)(2008-10#27)(2008-11#1)(2008-4#3)(2008-7#2)(2008-8#2)(2009-2#1)(2009-8#2)(2010-2#2)(2010-7#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#2)(2013-7#1)
the phenotypical##4##2##(1994-12#1)(1995-8#1)(2007-6#1)(2008-11#1)
the phenotypically##2##2##(1992-6#1)(2010-8#1)
the phenoxyl radicals##2##3##(2006-10#1)(2008-10#1)
the phenoxyl##5##2##(2006-10#1)(2007-11#2)(2008-10#1)(2008-8#1)
the phenyl group##4##3##(1994-9#1)(1995-8#1)(2006-12#1)(2008-5#1)
the phenyl ring of##3##4##(1995-5#1)(2006-12#1)(2008-6#1)
the phenyl ring##10##3##(1993-4#1)(1994-12#1)(1995-11#1)(1995-5#1)(2006-12#1)(2007-10#1)(2008-10#1)(2008-6#1)(2010-5#1)(2013-1#1)
the phenyl rings##3##3##(1994-9#1)(1997-7#2)
the phenyl##22##2##(1993-4#2)(1994-12#1)(1994-9#2)(1995-11#1)(1995-3#1)(1995-5#1)(1995-8#1)(1997-7#2)(2006-11#1)(2006-12#2)(2007-10#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2010-5#1)(2013-1#1)
the phenylephrine-induced##4##2##(1990-12#1)(1995-12#1)(1997-5#1)(1997-7#1)
the phenylpropanoid pathway and##2##4##(2008-8#2)
the pheromone##19##2##(1991-12#2)(1992-11#1)(1995-1#1)(1996-2#1)(1997-4#2)(2006-4#3)(2007-12#1)(2008-10#2)(2008-3#1)(2008-6#4)(2013-8#1)
the phi 29 DNA polymerase##2##5##(1990-3#1)(1990-9#1)
the phi 29##3##3##(1990-3#2)(1990-9#1)
the phi##10##2##(1990-3#2)(1990-9#1)(1991-5#1)(1992-9#1)(2008-11#1)(2008-3#3)(2010-1#1)
the philosophical and##4##3##(2006-5#1)(2008-7#3)
the philosophical##17##2##(2005-11#1)(2005-7#2)(2006-11#1)(2006-5#1)(2006-9#1)(2008-12#1)(2008-4#1)(2008-7#3)(2010-11#1)(2012-12#1)(2012-2#4)
the philosophy of##9##3##(1990-12#1)(1991-1#1)(1991-12#1)(1994-12#1)(2006-3#1)(2012-2#4)
the philosophy##13##2##(1990-12#1)(1991-1#1)(1991-12#1)(1994-12#1)(2006-3#2)(2007-11#1)(2008-11#1)(2008-6#1)(2012-2#4)
the phlD##3##2##(2008-10#3)
the phloem and##2##3##(2008-10#2)
the phloem cells and##2##4##(2008-10#2)
the phloem cells##3##3##(2008-10#3)
the phloem of##3##3##(2006-12#1)(2008-10#1)(2008-11#1)
the phloem##20##2##(2006-12#1)(2008-10#11)(2008-11#4)(2009-8#3)(2012-2#1)
the phoAIV##3##2##(1990-11#3)
the phoB##3##2##(1993-12#1)(2007-12#2)
the phone##2##2##(2011-1#1)(2012-3#1)
the phonetic##3##2##(2010-2#1)(2012-1#1)(2013-8#1)
the phonological loop##3##3##(1992-1#1)(2008-4#2)
the phonological##11##2##(1991-2#2)(1992-1#1)(2008-2#1)(2008-4#5)(2008-5#1)(2010-2#1)
the phonon and##2##3##(2005-4#1)(2008-3#1)
the phonon##5##2##(2005-4#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-3#1)
the phorbol ester 12-O-tetradecanoyl##2##4##(1992-3#1)(1993-12#1)
the phorbol ester##10##3##(1992-3#1)(1992-9#2)(1993-12#2)(1993-7#1)(1993-9#1)(1994-12#1)(1995-3#1)(1997-1#1)
the phorbol ester-stimulated##2##3##(1996-12#1)(1996-5#1)
the phorbol##15##2##(1990-11#2)(1992-11#1)(1992-3#1)(1992-9#2)(1993-12#2)(1993-7#1)(1993-9#1)(1994-12#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-1#1)
the phosphatase activities##4##3##(2008-10#3)(2008-9#1)
the phosphatase activity of##4##4##(1995-1#1)(2008-10#1)(2008-9#2)
the phosphatase activity##7##3##(1995-1#1)(1995-2#2)(1997-2#1)(2008-10#1)(2008-9#2)
the phosphatase inhibitor okadaic acid##2##5##(1991-3#1)(1993-8#1)
the phosphatase inhibitor##3##3##(1991-3#1)(1993-8#1)(1994-9#1)
the phosphatase##25##2##(1990-3#1)(1991-3#1)(1992-12#3)(1992-9#3)(1993-8#1)(1994-9#1)(1995-1#1)(1995-2#4)(1997-2#1)(2008-1#1)(2008-10#4)(2008-9#3)(2009-8#1)
the phosphatases##2##2##(1996-4#1)(1997-6#1)
the phosphate buffer##7##3##(1990-8#1)(2008-10#4)(2009-10#1)(2010-4#1)
the phosphate carrier##8##3##(1990-8#2)(1991-9#1)(1992-1#4)(2005-8#1)
the phosphate chain##2##3##(1996-7#1)(2008-4#1)
the phosphate group##6##3##(1992-12#1)(1994-8#1)(2006-10#1)(2008-5#3)
the phosphate groups##2##3##(1990-11#1)(1997-5#1)
the phosphate solubilizing property##2##4##(2008-5#2)
the phosphate transfer##3##3##(2008-4#2)(2012-3#1)
the phosphate##47##2##(1990-11#1)(1990-4#1)(1990-8#4)(1991-9#1)(1992-1#4)(1992-12#1)(1994-11#2)(1994-5#1)(1994-8#1)(1995-11#1)(1996-7#2)(1997-5#1)(2004-9#1)(2005-8#1)(2006-10#1)(2008-10#8)(2008-3#1)(2008-4#5)(2008-5#5)(2009-10#1)(2010-10#1)(2010-4#1)(2011-12#1)(2012-3#1)
the phosphates##3##2##(1990-2#1)(1992-9#1)(1993-6#1)
the phosphatidylcholine##6##2##(1990-2#1)(1990-5#1)(1992-6#1)(1993-11#1)(1995-5#1)(1996-5#1)
the phosphatidylinositol 3-kinase##3##3##(1992-12#1)(2008-1#1)(2012-12#1)
the phosphatidylinositol pathway in##2##4##(1994-6#1)(1995-2#1)
the phosphatidylinositol##12##2##(1992-10#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-7#1)(1994-11#1)(1994-6#1)(1995-2#1)(1997-7#1)(2008-1#1)(2008-5#1)(2012-12#1)
the phosphatidylserine requirement of##2##4##(1990-5#2)
the phosphatidylserine##4##2##(1990-5#2)(1991-7#1)(1992-6#1)
the phosphine ligands##2##3##(1996-2#2)
the phosphine##6##2##(1996-2#2)(2008-11#1)(2008-8#1)(2010-5#2)
the phosphite##2##2##(1996-2#1)(2008-10#1)
the phosphocholine##2##2##(1994-9#1)(1995-2#1)
the phosphodiester backbone##4##3##(1991-7#2)(1995-1#1)(2008-4#1)
the phosphodiester##11##2##(1991-7#2)(1991-9#1)(1992-4#2)(1992-8#1)(1993-8#1)(1995-1#1)(1996-4#1)(1997-5#1)(2008-4#1)
the phosphodiesterase inhibitor##4##3##(1991-10#1)(1993-6#1)(1994-6#1)(1995-12#1)
the phosphodiesterase##9##2##(1991-10#1)(1991-8#1)(1992-12#2)(1993-6#1)(1994-6#1)(1995-12#1)(2008-3#1)(2012-2#1)
the phosphoenzyme##6##2##(1990-5#1)(1994-8#1)(1996-9#4)
the phosphofructokinase##2##2##(1994-3#1)(1995-5#1)
the phosphoinositide pathway in##2##4##(1993-7#1)(2008-8#1)
the phosphoinositide response to##2##4##(1990-2#1)(1994-6#1)
the phosphoinositide turnover system##2##4##(1992-6#2)
the phosphoinositide turnover##3##3##(1992-6#2)(1995-6#1)
the phosphoinositide##12##2##(1990-2#1)(1990-3#1)(1991-6#1)(1992-6#2)(1993-7#1)(1994-6#1)(1995-6#1)(2006-9#1)(2008-4#1)(2008-8#1)(2013-1#1)
the phospholipase A2 reaction##2##4##(1991-2#2)
the phospholipase A2##3##3##(1991-2#2)(1994-3#1)
the phospholipase C inhibitor neomycin##2##5##(1992-7#1)(1994-12#1)
the phospholipase C inhibitor##3##4##(1992-7#1)(1994-11#1)(1994-12#1)
the phospholipase C##7##3##(1990-11#1)(1990-7#1)(1990-9#1)(1992-7#1)(1994-11#1)(1994-12#1)(2006-8#1)
the phospholipase##17##2##(1990-11#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-2#2)(1992-7#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-2#1)(2006-8#1)
the phospholipid bilayer##4##3##(1991-5#1)(1992-3#1)(1993-9#1)(1995-8#1)
the phospholipid composition of the##3##5##(1990-2#1)(1994-12#1)(1995-8#1)
the phospholipid composition of##4##4##(1990-2#1)(1994-12#1)(1995-8#1)(2012-2#1)
the phospholipid composition##7##3##(1990-2#1)(1992-1#2)(1992-3#1)(1994-12#1)(1995-8#1)(2012-2#1)
the phospholipid content##2##3##(1991-9#1)(1995-5#1)
the phospholipid fatty##3##3##(1991-5#1)(1992-12#1)(1992-3#1)
the phospholipid membrane##2##3##(1994-2#1)(2008-10#1)
the phospholipid to##2##3##(1990-2#1)(2008-4#1)
the phospholipid##59##2##(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#2)(1990-5#5)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-5#3)(1991-7#1)(1991-9#1)(1992-1#2)(1992-10#2)(1992-12#1)(1992-3#3)(1992-6#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#1)(1995-5#1)(1995-8#2)(1997-3#1)(2006-10#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-11#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
the phospholipid-binding##2##2##(1991-2#1)(1992-9#1)
the phospholipid-independent interaction between##2##4##(1994-5#2)
the phospholipidic##2##2##(2007-8#1)(2008-10#1)
the phospholipids##11##2##(1990-11#1)(1990-3#1)(1991-9#1)(1992-10#1)(1993-8#1)(1994-3#1)(1994-9#2)(1997-1#1)(2008-10#1)(2008-5#1)
the phosphomolybdenum blue##3##3##(2008-10#3)
the phosphomonoester##3##2##(1992-10#1)(1992-4#2)
the phosphonate group##5##3##(2008-10#1)(2008-3#2)(2008-5#2)
the phosphonate##13##2##(1991-2#4)(1994-5#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#2)
the phosphopeptide is##3##3##(1990-11#3)
the phosphopeptide##8##2##(1990-11#4)(1992-10#1)(1993-11#1)(2007-8#1)(2012-12#1)
the phosphoprotein##2##2##(1991-7#1)(1996-5#1)
the phosphoproteins involved##2##3##(2008-2#1)(2008-4#1)
the phosphoproteins##5##2##(1990-12#1)(1992-10#1)(1995-11#1)(2008-2#1)(2008-4#1)
the phosphor##3##2##(2008-10#2)(2008-3#1)
the phosphoramidite##5##2##(2007-10#1)(2008-4#4)
the phosphorescence intensity##2##3##(2008-10#2)
the phosphorescence##13##2##(1992-12#1)(1993-11#1)(1995-1#1)(2007-8#1)(2008-10#7)(2008-3#1)(2010-4#1)
the phosphorus and##2##3##(1991-7#1)(2008-4#1)
the phosphorus##10##2##(1991-7#1)(1993-8#1)(1997-7#2)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2013-8#1)
the phosphoryl##2##2##(1990-8#1)(1991-7#1)
the phosphorylase##3##2##(1991-11#1)(1994-6#1)(1995-3#1)
the phosphorylated and dephosphorylated forms of##4##6##(1990-8#1)(1996-5#1)(1997-2#2)
the phosphorylated and dephosphorylated##5##4##(1990-8#2)(1996-5#1)(1997-2#2)
the phosphorylated and##6##3##(1990-8#2)(1996-5#1)(1997-2#2)(1997-7#1)
the phosphorylated form of##6##4##(1991-3#2)(1993-8#1)(1996-12#1)(1997-1#1)(2010-2#1)
the phosphorylated form##9##3##(1991-3#2)(1991-6#1)(1993-8#1)(1996-12#1)(1997-1#1)(2007-8#1)(2008-5#1)(2010-2#1)
the phosphorylated myosin##2##3##(1990-7#2)
the phosphorylated residue was##2##4##(1994-5#2)
the phosphorylated state of a##2##5##(1994-9#1)(2008-1#1)
the phosphorylated state of##3##4##(1994-9#1)(1996-6#1)(2008-1#1)
the phosphorylated##38##2##(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#3)(1991-3#3)(1991-6#1)(1992-12#2)(1992-6#1)(1993-11#1)(1993-8#1)(1994-11#2)(1994-5#2)(1994-8#1)(1994-9#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#2)(1997-7#1)(2007-8#2)(2008-1#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-2#1)(2012-2#1)
the phosphorylating##3##2##(1991-12#3)
the phosphorylation and activation of##2##5##(1994-12#1)(1995-8#1)
the phosphorylation and##6##3##(1992-2#1)(1994-12#1)(1994-5#1)(1995-8#1)(1996-9#1)(2006-10#1)
the phosphorylation by##3##3##(1990-9#1)(1995-3#1)(1995-6#1)
the phosphorylation degree of##2##4##(1995-1#2)
the phosphorylation efficiency by CK-2##2##5##(1992-6#2)
the phosphorylation of GST-Shc##2##4##(1997-6#2)
the phosphorylation of MAP2##2##4##(1991-1#2)
the phosphorylation of a##3##4##(1990-7#1)(1991-5#1)(1996-5#1)
the phosphorylation of calmodulin##2##4##(1990-8#1)(1997-6#1)
the phosphorylation of eIF-2##2##4##(1991-7#1)(1994-6#1)
the phosphorylation of phosphorylase b##2##5##(1994-12#2)
the phosphorylation of protein kinase C substrates##2##7##(1992-9#1)(1993-9#1)
the phosphorylation of serine##2##4##(1991-12#1)(1994-11#1)
the phosphorylation of the##19##4##(1990-10#1)(1990-11#1)(1990-12#1)(1991-11#1)(1991-9#2)(1992-11#1)(1994-9#1)(1996-2#4)(1996-5#2)(1996-9#1)(1997-2#1)(2005-8#1)(2008-9#1)(2011-2#1)
the phosphorylation of these proteins by cyclic##2##7##(1994-9#1)(1995-3#1)
the phosphorylation of these##5##4##(1992-11#1)(1994-9#1)(1995-3#2)(1997-2#1)
the phosphorylation of two##2##4##(1990-11#1)(1990-4#1)
the phosphorylation of##91##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-3#2)(1990-4#1)(1990-7#2)(1990-8#3)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-7#1)(1991-9#3)(1992-11#2)(1992-5#1)(1992-9#2)(1993-11#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#4)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#2)(1995-8#2)(1996-2#6)(1996-5#3)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-6#6)(1997-7#2)(2005-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#3)(2008-9#1)(2009-3#2)(2011-2#1)(2012-3#2)(2013-1#2)
the phosphorylation reaction##4##3##(1990-11#1)(1994-3#2)(1996-11#1)
the phosphorylation site##4##3##(1990-12#1)(1992-5#1)(1996-8#1)(2008-8#1)
the phosphorylation sites##3##3##(1990-6#1)(1993-8#1)(1994-9#1)
the phosphorylation state of the##4##5##(1992-4#1)(1996-4#1)(1996-8#1)(1997-2#1)
the phosphorylation state of##15##4##(1991-6#1)(1992-4#1)(1994-6#1)(1994-9#2)(1996-4#1)(1996-8#1)(1997-2#2)(1997-6#2)(2003-11#1)(2008-4#1)(2010-11#2)
the phosphorylation status of##2##4##(1996-5#1)(2009-2#1)
the phosphorylation##150##2##(1990-10#1)(1990-11#5)(1990-12#4)(1990-2#1)(1990-3#2)(1990-4#1)(1990-6#1)(1990-7#2)(1990-8#4)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#3)(1992-11#2)(1992-2#2)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#1)(1992-9#2)(1993-11#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#3)(1994-6#2)(1994-8#3)(1994-9#7)(1995-1#3)(1995-12#1)(1995-2#1)(1995-3#4)(1995-6#4)(1995-8#3)(1996-11#1)(1996-2#6)(1996-4#1)(1996-5#4)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#4)(1997-6#8)(1997-7#2)(2003-11#1)(2005-8#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#4)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#2)(2010-11#2)(2011-2#1)(2012-3#3)(2013-1#2)
the phosphothreonine##3##2##(1994-9#1)(1995-2#2)
the phosphotriesterase##3##2##(1991-7#2)(1997-6#1)
the phosphotyrosine binding domain##2##4##(1996-5#2)
the phosphotyrosine binding##3##3##(1996-5#3)
the phosphotyrosine content of##3##4##(1991-5#1)(1994-9#2)
the phosphotyrosine##10##2##(1991-5#1)(1994-2#2)(1994-9#2)(1996-5#4)(1996-9#1)
the photic##2##2##(1993-2#1)(1994-2#1)
the photo standard##3##3##(2008-5#3)
the photo##4##2##(1990-3#1)(2008-5#3)
the photo-induced##3##2##(1994-5#1)(2004-4#1)(2008-1#1)
the photo-oxidation of##2##3##(2008-10#2)
the photo-oxidation##3##2##(2008-10#3)
the photoacoustic##10##2##(2005-4#1)(2007-12#1)(2008-2#2)(2008-3#4)(2011-1#1)(2011-7#1)
the photoactivated##2##2##(1995-6#1)(1996-5#1)
the photoactivation##2##2##(1990-12#1)(2008-1#1)
the photoactive##7##2##(1991-12#1)(1992-8#3)(1994-11#1)(2007-12#1)(2008-10#1)
the photoadduct##2##2##(1994-5#1)(2007-8#1)
the photoaffinity##3##2##(1991-4#1)(1996-8#2)
the photoassembly##2##2##(2009-2#2)
the photobleached##3##2##(2008-1#2)(2008-2#1)
the photobleaching##4##2##(2008-2#2)(2008-9#2)
the photocatalytic performance##2##3##(2009-8#2)
the photocatalytic##7##2##(1994-3#1)(2008-10#2)(2009-8#3)(2013-1#1)
the photochemical process##2##3##(2008-10#2)
the photochemical reaction##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
the photochemical##22##2##(1990-7#1)(1991-4#1)(1992-2#1)(1992-8#1)(1997-2#1)(2006-12#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-4#1)(2010-5#2)
the photochromic reaction##2##3##(2009-8#2)
the photoconductive##4##2##(2007-12#1)(2008-2#3)
the photoconductor##3##2##(2008-2#2)(2008-3#1)
the photocurrent generated by##2##4##(2008-10#1)(2010-5#1)
the photocurrent##9##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2010-4#1)(2010-5#1)
the photocycle of the##3##4##(1992-11#1)(1994-5#1)(1997-4#1)
the photocycle of##5##3##(1992-11#1)(1994-5#2)(1997-4#1)(2006-10#1)
the photocycle##11##2##(1990-2#1)(1992-11#1)(1994-11#2)(1994-5#2)(1995-5#1)(1997-3#1)(1997-4#2)(2006-10#1)
the photodamage##4##2##(1997-1#2)(2008-1#1)(2008-8#1)
the photodegradation of##3##3##(2004-12#1)(2007-12#1)(2011-1#1)
the photodegradation process##2##3##(2008-10#1)(2011-1#1)
the photodegradation##11##2##(1994-3#1)(2004-12#2)(2007-12#1)(2008-10#3)(2008-5#1)(2011-1#3)
the photodestruction##2##2##(1990-11#1)(2008-10#1)
the photodetector and##3##3##(2008-2#3)
the photodetector##9##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#2)
the photodiode##8##2##(2008-10#1)(2008-2#2)(2008-3#5)
the photodiodes##3##2##(2007-12#2)(2008-2#1)
the photodissociation of##3##3##(1990-8#1)(1992-12#1)(2008-2#1)
the photodynamic action##3##3##(1992-2#1)(1997-1#1)(2008-5#1)
the photodynamic oxidation of uric acid##2##6##(2008-5#2)
the photodynamic oxidation##3##3##(2008-5#3)
the photodynamic therapy (PDT)##2##4##(1990-11#1)(2012-3#1)
the photodynamic therapy##5##3##(1990-11#1)(2005-7#1)(2011-2#1)(2012-3#2)
the photodynamic##19##2##(1990-11#1)(1992-2#1)(1997-1#1)(2005-7#3)(2008-2#1)(2008-5#8)(2009-4#1)(2011-2#1)(2012-3#2)
the photoelastic effect##3##3##(2008-3#3)
the photoelastic modulators are##2##4##(2008-2#2)
the photoelastic##6##2##(2008-2#2)(2008-3#4)
the photoexcitation of##2##3##(2007-11#1)(2010-5#1)
the photoexcited##3##2##(1992-12#1)(2005-11#1)(2008-10#1)
the photographic##2##2##(2008-10#1)(2008-3#1)
the photographs##5##2##(1991-11#1)(2007-5#1)(2007-7#1)(2008-2#1)(2008-5#1)
the photoinactivation##3##2##(1992-6#1)(1996-7#2)
the photoinduced refractive-index change##2##4##(2007-12#2)
the photoinduced##14##2##(1995-11#1)(2007-11#2)(2007-12#6)(2008-1#1)(2008-2#1)(2008-3#1)(2010-4#1)(2010-5#1)
the photoionization##3##2##(2006-5#2)(2007-12#1)
the photolabeled binding##2##3##(1990-11#1)(1996-8#1)
the photolabeled##4##2##(1990-11#1)(1993-8#1)(1996-8#2)
the photolysis of##2##3##(2008-11#1)(2013-8#1)
the photolysis was##3##3##(1992-1#1)(2010-5#2)
the photolysis##10##2##(1990-11#1)(1992-1#1)(1995-2#1)(2008-11#1)(2008-3#3)(2010-5#2)(2013-8#1)
the photometric##4##2##(2008-10#3)(2008-3#1)
the photomultiplier tube##4##3##(2008-3#4)
the photomultiplier##7##2##(2007-12#1)(2008-3#6)
the photon and##2##3##(2008-3#1)(2012-2#1)
the photon density##2##3##(2008-2#1)(2008-3#1)
the photon diffusion coefficient##2##4##(2007-11#2)
the photon energy##2##3##(2007-11#1)(2008-2#1)
the photon flux##2##3##(2006-5#1)(2008-3#1)
the photon##31##2##(1992-11#1)(1993-8#1)(2006-4#1)(2006-5#1)(2007-11#7)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#8)(2008-6#1)(2009-10#1)(2010-4#1)(2012-2#1)
the photon-diffusion##2##2##(2007-12#1)(2008-2#1)
the photon-echo novelty filter##2##4##(2008-2#2)
the photon-echo output##2##3##(2007-12#2)
the photon-echo##5##2##(2007-12#3)(2008-2#2)
the photon-number##4##2##(2007-11#1)(2007-12#3)
the photonic band##3##3##(2007-12#3)
the photonic bandgap##5##3##(2007-11#2)(2007-12#2)(2008-2#1)
the photonic crystal waveguide##2##4##(2007-12#2)
the photonic crystal##4##3##(2007-12#3)(2008-7#1)
the photonic stop band##2##4##(2008-3#2)
the photonic##22##2##(2007-11#4)(2007-12#8)(2008-2#1)(2008-3#7)(2008-7#1)(2010-6#1)
the photons##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
the photooxidation of##2##3##(1990-5#1)(2006-12#1)
the photooxidation##4##2##(1990-5#1)(1994-8#1)(1996-2#1)(2006-12#1)
the photooxidative##2##2##(1991-7#1)(2008-10#1)
the photopeak##2##2##(2006-5#2)
the photoperiod sensitivity gene##2##4##(1995-6#2)
the photoperiod was##2##3##(2008-7#1)(2010-8#1)
the photoperiod##7##2##(1995-6#2)(2008-7#1)(2009-5#1)(2009-6#1)(2010-8#2)
the photoperiodic##2##2##(1997-5#1)(2009-6#1)
the photophysical properties of##4##4##(2006-10#1)(2006-12#1)(2008-4#1)(2010-2#1)
the photophysical properties##5##3##(2006-10#1)(2006-12#1)(2008-4#1)(2008-5#1)(2010-2#1)
the photophysical##9##2##(1995-1#1)(2006-10#1)(2006-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-2#1)(2013-8#1)
the photophysics##4##2##(2008-2#1)(2009-6#1)(2010-2#2)
the photoproducts##3##2##(1992-8#1)(2008-10#2)
the photoreceptive##3##2##(2008-5#2)(2012-3#1)
the photoreceptor layer##2##3##(1990-11#1)(1992-7#1)
the photoreceptor outer segments##3##4##(1995-9#1)(2008-3#2)
the photoreceptor##9##2##(1990-11#1)(1992-7#1)(1993-3#1)(1995-1#1)(1995-8#1)(1995-9#1)(2008-3#2)(2009-10#1)
the photoreceptors and the retinal pigment##3##6##(1990-6#1)(2008-4#1)(2011-2#1)
the photoreceptors and the##4##4##(1990-6#2)(2008-4#1)(2011-2#1)
the photoreceptors and##5##3##(1990-6#3)(2008-4#1)(2011-2#1)
the photoreceptors##10##2##(1990-6#3)(1992-7#2)(1994-2#1)(2007-12#1)(2007-5#1)(2008-4#1)(2011-2#1)
the photoreduction of##2##3##(1992-12#1)(2008-8#1)
the photoreduction##3##2##(1992-12#1)(1996-2#1)(2008-8#1)
the photorefractive crystal##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
the photorefractive effect in##3##4##(2007-12#2)(2008-3#1)
the photorefractive effect##7##3##(2007-12#5)(2008-3#2)
the photorefractive fanning effect##6##4##(2007-12#2)(2008-1#2)(2008-2#2)
the photorefractive properties of##3##4##(2007-11#2)(2007-12#1)
the photorefractive response##2##3##(2007-11#1)(2007-12#1)
the photorefractive##30##2##(2007-11#4)(2007-12#14)(2008-1#3)(2008-2#5)(2008-3#4)
the photoresist##6##2##(2008-2#2)(2008-3#2)(2008-7#1)(2010-4#1)
the photoresponse##4##2##(1992-2#1)(2005-4#1)(2007-12#2)
the photos##2##2##(2010-2#2)
the photosensitiser##2##2##(2007-11#2)
the photosensitive##2##2##(2007-12#1)(2008-2#1)
the photosensitivity in##2##3##(1990-1#1)(2007-12#1)
the photosensitivity is due to uroporphyrin##2##6##(1990-1#1)(1991-10#1)
the photosensitivity is due to##3##5##(1990-1#2)(1991-10#1)
the photosensitivity is##4##3##(1990-1#2)(1991-10#1)(2007-12#1)
the photosensitivity of Ge-doped silica##2##5##(2007-12#2)
the photosensitivity of##3##3##(2007-12#3)
the photosensitivity##14##2##(1990-1#3)(1991-10#2)(1993-12#1)(2007-12#7)(2008-5#1)
the photosensitization##4##2##(1991-10#2)(2008-8#1)(2010-5#1)
the photosensitized solution##2##3##(2008-2#2)
the photosensitized##3##2##(1993-8#1)(2008-2#2)
the photosensitizer##13##2##(1992-1#1)(1996-7#1)(2005-7#1)(2008-2#5)(2008-3#1)(2008-5#1)(2009-4#2)(2012-12#1)
the photosensitizers##6##2##(1992-6#1)(1993-11#2)(1994-3#1)(2008-11#1)(2008-5#1)
the photostability of the##2##4##(2008-10#1)(2012-12#1)
the photostability of these##2##4##(2009-2#1)(2011-1#1)
the photostability of##7##3##(2008-10#1)(2008-5#3)(2009-2#1)(2011-1#1)(2012-12#1)
the photosynthesis##2##2##(2004-11#1)(2008-10#1)
the photosynthetic apparatus##5##3##(1991-3#1)(2008-10#3)(2012-6#1)
the photosynthetic bacterium##2##3##(1991-3#1)(1995-1#1)
the photosynthetic capacity of##2##4##(1995-8#1)(2008-11#1)
the photosynthetic reaction center of##2##5##(1993-8#1)(1997-7#1)
the photosynthetic##25##2##(1990-7#1)(1991-3#2)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-8#1)(1997-6#1)(1997-7#1)(2008-10#5)(2008-11#1)(2009-10#1)(2009-2#1)(2009-6#1)(2011-12#1)(2012-1#1)(2012-5#1)(2012-6#1)(2013-8#1)
the photosystem II reaction center##2##5##(1995-8#2)
the photosystem II##3##3##(1991-12#1)(1995-8#2)
the photosystem-II##2##2##(1990-5#2)
the photothermal##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
the photovoltaic##3##2##(2007-12#1)(2008-1#1)(2008-2#1)
the phrase &quot##2##3##(1996-2#1)(2007-2#1)
the phrase##4##2##(1996-2#1)(2005-8#1)(2007-2#1)(2012-1#1)
the phrenic nerve activity##2##4##(1994-10#2)
the phrenic nerve responses to##2##5##(1994-10#2)
the phrenic nerve to##2##4##(2008-9#2)
the phrenic nerve##8##3##(1994-10#5)(2008-9#3)
the phrenic##13##2##(1990-7#3)(1994-10#6)(1997-4#1)(2008-9#3)
the phthalate##2##2##(2008-5#1)(2011-2#1)
the phthaloyl##2##2##(1996-4#1)(1997-1#1)
the phycobilisomes##3##2##(1992-3#3)
the phycoerythrin##3##2##(1997-2#1)(2008-3#1)(2008-8#1)
the phyletic##2##2##(2009-6#1)(2010-3#1)
the phyllosilicate##3##2##(2008-6#3)
the phyllosphere##2##2##(2007-12#1)(2008-10#1)
the phylogenetic analyses##2##3##(2008-10#1)(2010-3#1)
the phylogenetic history##2##3##(2012-2#1)(2012-3#1)
the phylogenetic relationship among##2##4##(2008-10#1)(2013-1#1)
the phylogenetic relationship##3##3##(2007-12#1)(2008-10#1)(2013-1#1)
the phylogenetic relationships among##2##4##(2008-10#1)(2008-5#1)
the phylogenetic relationships of##2##4##(2008-10#1)(2010-6#1)
the phylogenetic relationships##7##3##(2007-12#1)(2008-10#3)(2008-5#2)(2010-6#1)
the phylogenetic tree##7##3##(1996-5#1)(2005-11#1)(2007-1#1)(2008-4#1)(2008-8#1)(2013-8#2)
the phylogenetic trees produced##2##4##(1993-6#1)(2008-9#1)
the phylogenetic trees##5##3##(1993-6#1)(1994-6#1)(2008-1#1)(2008-10#1)(2008-9#1)
the phylogenetic##53##2##(1991-6#1)(1993-6#2)(1994-5#1)(1994-6#1)(1995-11#1)(1996-5#1)(2005-11#1)(2007-1#1)(2007-12#4)(2008-1#3)(2008-10#9)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2010-3#1)(2010-6#4)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
the phylogenetically##3##2##(1995-8#1)(1996-8#1)(2008-10#1)
the phylogeny inferred from##2##4##(1994-12#1)(2008-10#1)
the phylogeny of the##2##4##(1993-6#1)(2008-7#1)
the phylogeny of##5##3##(1993-6#1)(1995-2#1)(2007-12#1)(2008-7#1)(2008-8#1)
the phylogeny##8##2##(1993-6#1)(1994-12#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-3#1)
the phylum Chloroflexi##2##3##(2011-2#2)
the phylum##18##2##(1992-6#1)(1994-12#1)(1996-5#2)(2006-10#1)(2007-12#1)(2008-7#1)(2011-1#1)(2011-2#7)(2013-8#3)
the physical activity##3##3##(2007-7#1)(2013-1#2)
the physical and chemical mechanisms of##2##6##(2009-11#2)
the physical and chemical mechanisms##3##5##(2009-11#2)(2009-8#1)
the physical and chemical properties of##7##6##(1991-2#1)(1992-8#1)(1993-12#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-8#1)
the physical and chemical properties##8##5##(1991-2#1)(1992-8#1)(1993-12#1)(2008-3#1)(2008-5#1)(2011-2#1)(2011-3#1)(2013-8#1)
the physical and chemical##21##4##(1990-1#1)(1991-2#1)(1992-8#1)(1993-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-8#1)(2011-1#1)(2011-11#1)(2011-2#1)(2011-3#1)(2013-8#1)
the physical and emotional##2##4##(1997-2#1)(2008-6#1)
the physical and mental health##2##5##(2010-10#1)(2011-2#1)
the physical and mental##3##4##(1994-3#1)(2010-10#1)(2011-2#1)
the physical and psychological health##2##5##(2008-1#1)(2008-2#1)
the physical and psychological##7##4##(2006-7#1)(2008-1#1)(2008-2#1)(2008-4#1)(2011-12#1)(2012-12#1)(2013-8#1)
the physical and the##2##4##(2008-2#1)(2008-3#1)
the physical and##47##3##(1990-1#1)(1990-12#1)(1991-2#1)(1992-8#1)(1993-12#1)(1994-3#1)(1997-1#1)(1997-2#1)(2005-11#1)(2005-7#1)(2006-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#2)(2009-12#2)(2009-7#2)(2009-8#1)(2010-10#1)(2011-1#2)(2011-11#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-8#2)
the physical aspects were##2##4##(1990-10#1)(2011-1#1)
the physical characteristics of the##5##5##(1990-9#1)(1992-2#1)(1996-3#1)(2008-2#1)(2010-12#1)
the physical characteristics of##9##4##(1990-9#1)(1992-2#1)(1996-3#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)
the physical characteristics##11##3##(1990-7#1)(1990-9#2)(1992-2#1)(1996-3#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)
the physical component of##2##4##(2008-5#1)(2008-7#1)
the physical condition##2##3##(2012-1#2)
the physical depth##2##3##(2008-3#2)
the physical dimensions of the##2##5##(1993-2#2)
the physical dimensions##3##3##(1993-2#2)(2008-11#1)
the physical distance##2##3##(2008-9#2)
the physical effects of##2##4##(1994-9#1)(2006-6#1)
the physical environment were##2##4##(1992-4#1)(2012-3#1)
the physical environment##6##3##(1992-4#2)(2007-3#1)(2007-9#1)(2011-2#1)(2012-3#1)
the physical examination##4##3##(2006-10#1)(2006-8#1)(2008-12#1)(2010-8#1)
the physical findings##4##3##(1991-4#1)(2006-10#1)(2006-2#1)(2007-12#1)
the physical fitness##2##3##(1996-2#1)(2010-4#1)
the physical growth and health of##2##6##(2008-11#2)
the physical growth##3##3##(2008-11#2)(2008-8#1)
the physical health needs of##3##5##(2011-2#3)
the physical health##6##3##(1995-2#1)(2009-6#1)(2010-12#1)(2011-2#3)
the physical interactions between##2##4##(2007-12#1)(2008-12#1)
the physical map of##5##4##(1995-6#2)(1997-6#1)(1997-8#1)(2006-12#1)
the physical map was##2##4##(2007-12#1)(2012-3#1)
the physical map##10##3##(1995-6#2)(1997-2#1)(1997-6#1)(1997-8#1)(1997-9#1)(2006-12#1)(2007-12#1)(2008-8#1)(2012-3#1)
the physical mapping of##3##4##(1997-4#2)(2008-5#1)
the physical mechanism##3##3##(2008-1#3)
the physical mechanisms of##2##4##(2006-10#1)(2008-7#1)
the physical mechanisms##3##3##(2006-10#1)(2008-7#1)(2009-4#1)
the physical optics##3##3##(2008-2#3)
the physical parameters##5##3##(2005-11#1)(2006-11#1)(2007-11#1)(2007-4#1)(2008-2#1)
the physical principles##3##3##(1996-4#1)(2008-2#1)(2012-2#1)
the physical process of##2##4##(2008-10#1)(2008-2#1)
the physical processes##3##3##(1996-4#1)(2007-12#1)(2008-3#1)
the physical properties and the##2##5##(1991-5#1)(2008-8#1)
the physical properties and##3##4##(1991-5#1)(2007-8#1)(2008-8#1)
the physical properties of skin##2##5##(2008-5#2)
the physical properties of the skin##2##6##(2008-5#2)
the physical properties of the##13##5##(1990-9#1)(1991-2#1)(1992-5#1)(1996-8#1)(2007-6#1)(2008-2#1)(2008-5#4)(2008-7#1)(2012-2#1)(2013-1#1)
the physical properties of##27##4##(1990-8#1)(1990-9#1)(1991-1#2)(1991-2#1)(1992-2#1)(1992-5#2)(1993-11#1)(1996-8#1)(1997-2#1)(2007-6#1)(2007-9#1)(2008-2#1)(2008-5#7)(2008-7#1)(2009-3#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
the physical properties##32##3##(1990-8#1)(1990-9#1)(1991-1#2)(1991-2#1)(1991-5#1)(1992-2#1)(1992-5#2)(1993-11#1)(1996-8#1)(1997-2#1)(2005-11#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-5#7)(2008-7#1)(2008-8#1)(2009-3#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
the physical serviceability##2##3##(2008-5#2)
the physical size##2##3##(2008-3#1)(2008-4#1)
the physical space##2##3##(2008-11#1)(2013-1#1)
the physical state of the##3##5##(1991-3#1)(1991-5#1)(1991-7#1)
the physical state of##6##4##(1990-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-9#1)(2008-4#1)
the physical state##7##3##(1990-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-9#1)(2008-4#1)(2008-5#1)
the physical structure of##2##4##(2008-2#2)
the physical system##2##3##(2007-9#1)(2009-10#1)
the physical tests##2##3##(2006-11#1)(2012-2#1)
the physical therapist##2##3##(2006-1#1)(2008-12#1)
the physical therapy##5##3##(2007-7#1)(2008-12#2)(2012-1#1)(2013-7#1)
the physical##294##2##(1990-1#1)(1990-10#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#3)(1990-9#3)(1991-1#2)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#2)(1991-7#1)(1992-1#1)(1992-2#3)(1992-3#1)(1992-4#2)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-5#1)(1994-3#1)(1994-9#2)(1995-1#2)(1995-2#1)(1995-4#1)(1995-6#2)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#2)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#4)(1997-4#2)(1997-6#1)(1997-8#1)(1997-9#1)(2005-11#4)(2005-7#1)(2006-1#1)(2006-10#6)(2006-11#2)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#9)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#4)(2008-1#5)(2008-10#10)(2008-11#6)(2008-12#5)(2008-2#15)(2008-3#16)(2008-4#5)(2008-5#18)(2008-6#3)(2008-7#6)(2008-8#9)(2008-9#3)(2009-10#2)(2009-11#2)(2009-12#5)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-10#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#6)(2011-11#1)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#8)(2013-7#3)(2013-8#2)
the physical-chemical parameters##2##3##(2008-1#1)(2008-5#1)
the physical-chemical##3##2##(1992-3#1)(2008-1#1)(2008-5#1)
the physically##4##2##(2008-2#1)(2008-3#1)(2013-1#2)
the physician and the patient##2##5##(1991-4#1)(1996-6#1)
the physician and the##5##4##(1990-9#1)(1991-4#1)(1993-1#1)(1996-6#1)(2013-1#1)
the physician and##9##3##(1990-9#1)(1991-4#1)(1992-4#1)(1993-1#1)(1994-2#1)(1996-6#1)(2008-3#1)(2010-7#1)(2013-1#1)
the physician for##2##3##(1991-9#1)(1997-2#1)
the physician has##4##3##(1996-7#1)(2006-8#1)(2006-9#1)(2008-11#1)
the physician in the##2##4##(1995-2#1)(1996-4#1)
the physician in##9##3##(1991-11#1)(1991-6#1)(1993-2#1)(1995-2#1)(1996-1#1)(1996-4#1)(2006-8#1)(2007-4#1)(2010-12#1)
the physician is##5##3##(1990-6#1)(1993-5#1)(1993-8#1)(1996-2#1)(2012-12#1)
the physician may##4##3##(1990-10#1)(1992-1#1)(1993-11#1)(1996-2#1)
the physician of##2##3##(1990-3#1)(2010-12#1)
the physician or##2##3##(1995-12#1)(2008-12#1)
the physician payment##2##3##(2007-4#1)(2008-4#1)
the physician to##11##3##(1992-9#1)(1996-7#1)(2006-3#1)(2007-7#3)(2008-11#1)(2008-8#1)(2010-5#1)(2010-8#1)(2013-8#1)
the physician was##2##3##(1992-4#1)(2007-8#1)
the physician who##2##3##(1992-12#1)(2006-9#1)
the physician workforce##2##3##(2010-11#1)(2010-9#1)
the physician##130##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-6#3)(1991-9#1)(1992-1#2)(1992-12#2)(1992-4#3)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-8#2)(1994-1#1)(1994-2#1)(1994-3#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-2#3)(1996-4#2)(1996-6#1)(1996-7#2)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-1#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-3#2)(2006-8#5)(2006-9#2)(2007-12#1)(2007-2#2)(2007-4#6)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
the physician's office##3##3##(1995-12#1)(1996-12#1)(1996-3#1)
the physician's privacy##2##3##(1991-7#2)
the physician's##25##2##(1990-12#2)(1991-2#1)(1991-3#2)(1991-7#2)(1994-1#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-7#1)(2005-12#1)(2006-8#1)(2008-11#1)(2008-4#2)(2008-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2013-1#1)
the physician-hospital##4##2##(1994-1#1)(1994-3#2)(1996-2#1)
the physician-patient relationship and##3##4##(2007-9#1)(2009-7#1)(2011-2#1)
the physician-patient relationship##7##3##(1996-12#1)(2005-12#1)(2006-10#1)(2007-9#1)(2008-4#1)(2009-7#1)(2011-2#1)
the physician-patient##10##2##(1991-5#1)(1994-5#1)(1996-12#1)(2005-12#1)(2006-10#1)(2007-9#1)(2008-4#1)(2009-7#1)(2011-2#1)(2012-3#1)
the physicians in disadvantageous position##2##5##(1993-5#2)
the physicians in##7##3##(1993-5#3)(2007-7#2)(2008-1#1)(2008-7#1)
the physicians will##2##3##(1992-1#1)(1994-2#1)
the physicians##46##2##(1991-5#1)(1991-7#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#5)(1994-2#1)(1995-5#1)(1995-8#1)(1996-3#1)(1997-3#4)(1997-6#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-3#2)(2007-4#1)(2007-7#3)(2007-8#1)(2008-1#3)(2008-7#1)(2008-8#1)(2009-5#1)(2010-5#1)(2011-1#1)(2013-1#2)(2013-8#1)
the physicians'##8##2##(1990-6#1)(1993-3#1)(1995-2#2)(1996-1#2)(1997-6#1)(2007-10#1)
the physico-chemical conditions##2##3##(1991-7#1)(2008-10#1)
the physico-chemical properties of a calcium phosphate cement##2##8##(2004-9#2)
the physico-chemical properties of##8##4##(1990-7#1)(1992-6#1)(2004-9#2)(2006-10#1)(2006-12#1)(2008-5#2)
the physico-chemical##14##2##(1990-7#1)(1991-7#1)(1992-5#1)(1992-6#1)(1994-12#1)(2004-9#2)(2006-10#1)(2006-12#1)(2008-10#3)(2008-5#2)
the physicochemical and##2##3##(2005-8#1)(2012-11#1)
the physicochemical characteristics of##4##4##(2006-12#1)(2008-5#2)(2010-4#1)
the physicochemical properties of the##3##5##(2008-5#2)(2008-8#1)
the physicochemical properties of##6##4##(1994-11#1)(2008-5#2)(2008-8#1)(2010-12#1)(2012-11#1)
the physicochemical properties##8##3##(1992-5#1)(1992-9#1)(1994-11#1)(2008-5#2)(2008-8#1)(2010-12#1)(2012-11#1)
the physicochemical stability of##2##4##(2010-12#2)
the physicochemical##27##2##(1992-2#1)(1992-5#1)(1992-9#1)(1994-11#1)(1995-11#1)(1997-4#1)(2005-8#1)(2006-12#1)(2008-10#1)(2008-11#2)(2008-5#4)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#3)(2010-4#2)(2010-8#1)(2012-11#2)(2012-2#1)
the physics of##5##3##(1996-2#1)(2006-10#1)(2008-2#2)(2013-1#1)
the physics underlying##2##3##(2008-3#1)(2009-9#1)
the physics##10##2##(1996-2#1)(1996-5#1)(2006-10#1)(2007-12#1)(2008-2#2)(2008-3#2)(2009-9#1)(2013-1#1)
the physiochemical##2##2##(2008-5#1)(2012-2#1)
the physiologic and##2##3##(1992-7#1)(2010-6#1)
the physiologic mechanisms##2##3##(1996-4#1)(2006-10#1)
the physiologic role of##3##4##(1994-12#1)(1995-12#1)(1997-4#1)
the physiologic roles##2##3##(1995-7#1)(2008-5#1)
the physiologic##22##2##(1990-5#1)(1991-10#1)(1991-3#1)(1992-7#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-7#1)(1996-4#1)(1997-4#1)(2006-10#5)(2008-5#1)(2008-6#1)(2010-12#1)(2010-6#2)(2013-1#2)
the physiological activity##2##3##(1992-1#2)
the physiological and molecular effects##2##5##(2009-10#1)(2009-8#1)
the physiological and molecular##3##4##(2009-10#1)(2009-8#2)
the physiological and pathological roles of##2##6##(2008-8#1)(2012-2#1)
the physiological and pathophysiological roles of##2##6##(2007-11#1)(2009-12#1)
the physiological and pathophysiological##6##4##(2006-12#1)(2007-11#1)(2008-4#1)(2009-12#1)(2010-7#1)(2012-12#1)
the physiological and pharmacological##2##4##(2008-1#1)(2008-7#1)
the physiological and psychological##2##4##(2007-11#1)(2007-2#1)
the physiological and##25##3##(1992-11#1)(1993-6#1)(1994-3#1)(1997-3#1)(2006-12#1)(2006-2#1)(2007-11#2)(2007-2#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-12#1)(2009-8#2)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#1)
the physiological attractant##2##3##(1993-11#2)
the physiological benefits of laughter##2##5##(2010-7#2)
the physiological changes##3##3##(1993-7#1)(2007-2#1)(2011-2#1)
the physiological concentration##2##3##(1990-11#1)(1993-8#1)
the physiological constraints##2##3##(2008-7#2)
the physiological control of##2##4##(1990-2#1)(2008-5#1)
the physiological costs of##2##4##(2008-9#1)(2013-1#1)
the physiological effect of##3##4##(1994-11#1)(2005-7#1)(2008-10#1)
the physiological effects of##4##4##(1995-3#1)(2005-12#1)(2008-4#1)(2012-3#1)
the physiological effects##5##3##(1995-3#1)(2005-12#1)(2008-4#1)(2012-3#1)(2013-1#1)
the physiological electron##3##3##(1992-6#1)(1994-9#1)(1995-2#1)
the physiological function of the##2##5##(1992-12#1)(2012-2#1)
the physiological function of##7##4##(1992-12#1)(1994-12#1)(1997-2#1)(2008-4#1)(2010-10#1)(2012-2#1)(2013-8#1)
the physiological function##8##3##(1992-12#1)(1994-12#1)(1997-2#2)(2008-4#1)(2010-10#1)(2012-2#1)(2013-8#1)
the physiological functions and##2##4##(1992-7#1)(1994-12#1)
the physiological functions of the##2##5##(1991-7#1)(2006-6#1)
the physiological functions of##3##4##(1990-3#1)(1991-7#1)(2006-6#1)
the physiological functions##5##3##(1990-3#1)(1991-7#1)(1992-7#1)(1994-12#1)(2006-6#1)
the physiological fusion##2##3##(2012-2#2)
the physiological mechanisms involved##2##4##(1990-5#1)(2008-1#1)
the physiological mechanisms that underlie this phenotypic plasticity remain uncertain##2##10##(2012-12#2)
the physiological mechanisms that underlie##3##5##(2012-12#3)
the physiological mechanisms that##5##4##(2007-9#1)(2012-12#3)(2013-1#1)
the physiological mechanisms##11##3##(1990-11#1)(1990-5#1)(2006-7#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-5#1)(2012-12#3)(2013-1#1)
the physiological pH##2##3##(1996-12#1)(2010-5#1)
the physiological parameters##3##3##(1994-12#1)(2007-10#1)(2012-2#1)
the physiological pattern##2##3##(1991-11#1)(1994-3#1)
the physiological processes##5##3##(1996-2#1)(2005-9#1)(2006-10#1)(2008-8#1)(2011-2#1)
the physiological properties of##4##4##(1991-8#1)(2008-5#1)(2008-6#1)(2012-1#1)
the physiological range of##2##4##(1993-6#1)(2008-10#1)
the physiological range##8##3##(1990-11#1)(1990-3#1)(1993-6#1)(1995-5#1)(2007-11#1)(2007-9#1)(2008-10#2)
the physiological relevance of the##2##5##(1995-11#1)(2009-12#1)
the physiological relevance of##4##4##(1995-11#1)(2006-11#1)(2007-12#1)(2009-12#1)
the physiological response of the tissues under##2##7##(2013-1#2)
the physiological response of##3##4##(2008-9#1)(2013-1#2)
the physiological response to##2##4##(2006-10#1)(2010-8#1)
the physiological response##7##3##(1992-1#1)(1993-7#1)(2006-10#1)(2008-9#1)(2010-8#1)(2013-1#2)
the physiological responses of##3##4##(1994-6#1)(1997-8#1)(2013-7#1)
the physiological responses##4##3##(1993-3#1)(1994-6#1)(1997-8#1)(2013-7#1)
the physiological role of the##6##5##(1992-3#1)(1994-6#1)(1995-12#2)(1997-4#1)(2008-4#1)
the physiological role of##20##4##(1992-3#1)(1993-11#2)(1993-4#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-12#2)(1996-2#1)(1996-9#1)(1997-2#1)(1997-4#2)(2008-10#1)(2008-4#2)(2009-8#1)(2010-2#1)(2011-2#1)
the physiological role##22##3##(1992-3#1)(1993-11#2)(1993-4#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-12#2)(1996-2#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#2)(2005-8#1)(2008-10#1)(2008-4#2)(2009-8#1)(2010-2#1)(2011-2#1)
the physiological roles of##2##4##(1993-11#1)(2010-12#1)
the physiological roles##4##3##(1993-11#1)(2007-8#1)(2008-8#1)(2010-12#1)
the physiological significance of the##5##5##(1991-3#1)(1994-5#1)(1994-6#1)(2005-8#1)(2010-3#1)
the physiological significance of##6##4##(1991-3#1)(1994-12#1)(1994-5#1)(1994-6#1)(2005-8#1)(2010-3#1)
the physiological state of##2##4##(1995-9#1)(1996-5#1)
the physiological state##3##3##(1995-9#1)(1996-5#1)(2010-10#1)
the physiological status##2##3##(1997-3#1)(2012-12#1)
the physiological stress##2##3##(2006-10#1)(2008-8#1)
the physiological##251##2##(1990-11#4)(1990-12#3)(1990-2#2)(1990-3#3)(1990-5#1)(1990-7#1)(1991-11#1)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#3)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#2)(1993-11#5)(1993-3#1)(1993-4#1)(1993-6#2)(1993-7#2)(1993-8#1)(1994-11#2)(1994-12#7)(1994-3#2)(1994-5#3)(1994-6#4)(1994-9#1)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#2)(1996-2#3)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-8#2)(2005-12#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#2)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#13)(2008-11#8)(2008-2#2)(2008-4#8)(2008-5#6)(2008-6#3)(2008-7#8)(2008-8#4)(2008-9#2)(2009-10#3)(2009-12#2)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#4)(2010-10#3)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#12)(2012-1#3)(2012-12#5)(2012-2#6)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#1)
the physiologically relevant##3##3##(1997-1#1)(2008-6#1)(2011-1#1)
the physiologically##9##2##(1990-12#1)(1997-1#1)(2006-2#1)(2008-10#2)(2008-5#2)(2008-6#1)(2011-1#1)
the physiology and pathophysiology of the##2##6##(2006-10#1)(2007-1#1)
the physiology and pathophysiology of##4##5##(1992-9#1)(2006-10#1)(2007-1#1)(2007-11#1)
the physiology and##13##3##(1992-9#1)(2006-10#1)(2007-1#2)(2007-11#1)(2007-2#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2013-1#1)
the physiology of the##17##4##(1990-5#1)(1993-2#1)(1995-12#1)(1996-2#1)(1997-7#1)(2006-10#1)(2006-11#1)(2007-11#1)(2008-7#1)(2009-10#1)(2009-3#2)(2009-5#1)(2011-1#1)(2011-2#2)(2012-12#1)
the physiology of##45##3##(1990-5#1)(1990-7#1)(1991-10#1)(1993-2#1)(1995-12#1)(1996-11#1)(1996-2#2)(1997-2#1)(1997-7#2)(2005-11#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-8#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#4)(2009-4#1)(2009-5#1)(2010-2#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)
the physiology##61##2##(1990-5#1)(1990-7#1)(1991-10#1)(1992-9#1)(1993-2#1)(1995-12#1)(1996-11#1)(1996-2#2)(1997-2#1)(1997-7#2)(2005-11#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-8#1)(2007-1#2)(2007-11#4)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#5)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#1)(2013-1#1)
the physiopathological##10##2##(1992-10#1)(1992-5#1)(1993-6#1)(1997-3#1)(2004-12#1)(2006-2#1)(2007-8#2)(2008-1#1)(2010-6#1)
the physiopathology of##9##3##(1990-2#1)(1990-9#1)(1994-9#1)(1997-7#1)(2007-2#1)(2008-10#3)(2008-7#1)
the physiopathology##12##2##(1990-2#1)(1990-9#1)(1992-5#1)(1994-9#1)(1997-7#1)(2007-2#1)(2008-10#4)(2008-7#2)
the physiotherapist in the Family Health Program##2##7##(2008-9#2)
the physiotherapist is##2##3##(1991-2#1)(1992-2#1)
the physiotherapist##6##2##(1991-2#1)(1992-12#1)(1992-2#1)(2008-9#2)(2010-3#1)
the phytase group##2##3##(2010-2#2)
the phytase##5##2##(2008-4#2)(2010-2#3)
the phytoalexin##2##2##(1990-6#1)(2008-10#1)
the phytochemical##2##2##(2007-1#1)(2008-12#1)
the phytochrome##2##2##(1995-2#1)(2009-8#1)
the phytoextraction duration of a specific HM-polluted soil##2##8##(2008-2#2)
the phytoextraction##3##2##(2008-2#3)
the phytohormone##3##2##(1991-11#1)(2008-10#1)(2011-1#1)
the phytopathogenic bacterium Xanthomonas campestris pv##2##6##(1990-4#1)(2008-10#1)
the phytopathogenic bacterium##5##3##(1990-4#1)(1992-3#1)(2008-10#3)
the phytopathogenic fungus Botryotinia fuckeliana##3##5##(1997-2#2)(1997-4#1)
the phytopathogenic fungus##4##3##(1997-2#2)(1997-4#1)(2009-8#1)
the phytopathogenic##9##2##(1990-4#1)(1992-3#1)(1997-2#2)(1997-4#1)(2008-10#3)(2009-8#1)
the phytophagous##3##2##(1992-1#1)(2008-10#1)(2008-7#1)
the phytoplankton absorption coefficient##2##4##(2008-2#2)
the phytoplankton##11##2##(2008-10#1)(2008-2#5)(2008-5#2)(2013-8#3)
the phytoplasma strain##2##3##(2005-11#1)(2008-10#1)
the phytoplasma##4##2##(2005-11#1)(2008-10#3)
the phytoplasmas##3##2##(2008-10#3)
the phytoremediation of##2##3##(2008-10#1)(2011-1#1)
the phytoremediation##3##2##(2008-10#1)(2008-11#1)(2011-1#1)
the phytotoxic##3##2##(2004-2#1)(2008-10#1)(2008-12#1)
the pi##5##2##(1995-5#1)(1997-2#1)(1997-7#1)(2008-10#1)(2011-2#1)
the pi-A isotherm of DDP##2##5##(2005-11#2)
the pi-A isotherms of##2##4##(1992-6#1)(2005-11#1)
the pi-A##4##2##(1992-6#1)(2005-11#3)
the pi-electron##5##2##(2005-11#1)(2007-11#4)
the pi-pi electron interactions##2##4##(2008-10#2)
the pial##5##2##(1992-8#4)(1997-5#1)
the picomolar##2##2##(1990-7#1)(2008-7#1)
the picosecond time##4##3##(1995-1#2)(2006-3#1)(2008-2#1)
the picosecond##7##2##(1990-8#1)(1995-1#2)(2006-3#1)(2007-11#1)(2007-12#1)(2008-2#1)
the picrate##6##2##(2008-10#6)
the picture archiving and communication system##2##6##(2004-9#1)(2007-4#1)
the picture of a##2##4##(2006-12#1)(2012-3#1)
the picture of##6##3##(1991-5#1)(1994-3#1)(2006-12#1)(2008-4#1)(2008-7#1)(2012-3#1)
the picture##20##2##(1991-5#1)(1993-12#1)(1993-3#1)(1994-3#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-4#3)(2008-7#2)(2009-2#1)(2010-9#1)(2012-3#1)
the piece##2##2##(1997-3#1)(2008-10#1)
the pieces of the##2##4##(2008-11#1)(2011-1#1)
the piecewise##3##2##(1996-1#1)(2008-10#1)(2008-6#1)
the piecewise-linear function##2##3##(2008-2#2)
the pier abutment##2##3##(2012-2#2)
the piezoelectric quartz crystal##3##4##(2008-10#3)
the piezoelectric##11##2##(1992-5#1)(2007-10#1)(2008-10#5)(2008-2#1)(2008-3#1)(2009-5#1)(2012-12#1)
the pig and##2##3##(1995-10#1)(1996-2#1)
the pig genome##5##3##(2008-7#3)(2008-8#2)
the pig industry##2##3##(2008-7#1)(2011-2#1)
the pig louse##2##3##(2007-12#2)
the pig##31##2##(1990-11#3)(1990-2#1)(1990-4#1)(1990-9#1)(1991-12#1)(1992-3#1)(1994-9#1)(1995-10#1)(1996-12#4)(1996-2#1)(1996-4#1)(2005-7#1)(2006-5#1)(2007-12#2)(2007-8#1)(2008-7#4)(2008-8#2)(2011-1#1)(2011-2#2)(2012-3#1)
the pigeon##10##2##(1992-12#1)(1993-8#1)(1995-11#1)(1995-12#1)(2006-5#1)(2007-12#1)(2008-5#1)(2008-8#2)(2009-11#1)
the pigeons##6##2##(1990-10#3)(1994-2#1)(2009-11#1)(2011-2#1)
the piglets##2##2##(2005-11#2)
the pigment epithelium##2##3##(2008-1#1)(2008-4#1)
the pigment##16##2##(1990-12#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-8#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-4#2)
the pigmentation##4##2##(1991-6#1)(2007-7#2)(2008-6#1)
the pigmented##7##2##(1990-4#1)(2007-3#1)(2008-10#1)(2008-5#2)(2012-12#2)
the pigments and##2##3##(1991-3#1)(2008-10#1)
the pigments##12##2##(1991-3#1)(1996-7#1)(1997-6#1)(2008-10#8)(2008-2#1)
the pigs##6##2##(2010-2#1)(2010-4#3)(2011-1#1)(2013-1#1)
the pike MT gene##2##4##(1997-2#2)
the pike##4##2##(1992-4#1)(1997-2#3)
the pill##8##2##(1991-3#1)(1991-6#1)(1993-2#2)(2007-7#4)
the pillar##2##2##(2008-5#1)(2008-7#1)
the pilocarpine group##2##3##(2006-10#2)
the pilosebaceous unit##5##3##(2008-5#1)(2010-3#3)(2010-7#1)
the pilosebaceous##6##2##(2008-5#2)(2010-3#3)(2010-7#1)
the pilot phase of##2##4##(2010-9#1)(2012-3#1)
the pilot program##3##3##(2007-2#2)(2007-5#1)
the pilot project##2##3##(2012-3#2)
the pilot study were##2##4##(1990-12#1)(2010-7#1)
the pilot study##15##3##(1990-12#1)(1996-1#1)(2006-1#1)(2007-10#1)(2007-8#1)(2008-7#1)(2009-2#1)(2010-3#4)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
the pilot##35##2##(1990-12#1)(1993-1#1)(1994-5#1)(1996-1#1)(2006-1#1)(2006-4#2)(2007-10#1)(2007-2#2)(2007-5#1)(2007-8#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2009-2#1)(2010-3#4)(2010-7#3)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#1)
the pilot3##2##2##(2012-3#2)
the pin##4##2##(2006-12#1)(2007-8#1)(2009-4#2)
the pine bark##2##3##(1995-8#1)(2008-10#1)
the pine weevil##2##3##(2011-10#2)
the pine##5##2##(1995-8#1)(2007-8#1)(2008-10#1)(2011-10#2)
the pineal experiments##4##3##(1994-9#4)
the pineal gland of##4##4##(1994-5#1)(1995-11#1)(1995-9#2)
the pineal gland was##2##4##(1993-4#1)(2008-12#1)
the pineal gland##25##3##(1993-4#2)(1994-2#2)(1994-5#6)(1994-9#1)(1995-11#1)(1995-3#3)(1995-9#2)(1997-5#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-4#2)(2013-7#1)
the pineal hormone melatonin (MLT)##2##5##(1992-12#1)(1995-9#1)
the pineal hormone melatonin as a##2##6##(1990-2#1)(1992-12#1)
the pineal hormone melatonin##7##4##(1990-2#2)(1991-6#1)(1992-12#2)(1994-8#1)(1995-9#1)
the pineal hormone##11##3##(1990-2#3)(1991-6#1)(1992-12#2)(1994-8#2)(1995-1#1)(1995-9#1)(2008-5#1)
the pineal organ##5##3##(1994-5#5)
the pineal region##3##3##(1996-4#1)(2008-5#2)
the pineal##62##2##(1990-2#3)(1990-5#3)(1991-6#1)(1992-12#2)(1993-4#2)(1994-2#2)(1994-5#16)(1994-8#2)(1994-9#5)(1995-1#2)(1995-11#1)(1995-12#1)(1995-3#3)(1995-9#3)(1996-4#1)(1997-5#2)(2006-1#1)(2008-12#1)(2008-5#4)(2008-7#1)(2010-4#3)(2012-2#1)(2013-7#2)
the pinhole##7##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#2)
the pink shrimp##2##3##(2008-5#2)
the pink##5##2##(2008-10#2)(2008-5#2)(2010-10#1)
the pioneer##3##2##(1997-6#1)(2007-1#1)(2007-3#1)
the pioneering##5##2##(2007-8#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-5#1)
the pioneers of##2##3##(2007-12#1)(2012-2#1)
the pioneers##7##2##(1993-6#1)(2007-12#3)(2008-5#1)(2012-2#2)
the pip##2##2##(2008-4#2)
the pipeline##4##2##(2005-8#1)(2008-1#1)(2008-3#1)(2012-3#1)
the piper##2##2##(1992-1#1)(2007-7#1)
the piperazine##7##2##(1993-4#1)(1997-1#1)(2006-12#1)(2007-11#1)(2008-5#1)(2012-11#1)(2013-7#1)
the piperidine##3##2##(1995-3#2)(1995-6#1)
the pipette solution##2##3##(1994-5#2)
the pipette was##3##3##(1992-7#1)(1994-5#1)(2013-1#1)
the pipette##8##2##(1992-7#1)(1994-5#3)(1995-11#1)(1995-8#1)(2008-11#1)(2013-1#1)
the piriform cortex##8##3##(1990-5#1)(1993-2#1)(1993-4#2)(1994-3#1)(2012-1#1)(2013-1#2)
the piriform##10##2##(1990-5#1)(1993-2#1)(1993-4#2)(1993-7#1)(1994-3#1)(1997-3#1)(2012-1#1)(2013-1#2)
the piriformis muscle##3##3##(2006-7#3)
the piriformis##4##2##(1990-2#1)(2006-7#3)
the pistachio isolates##2##3##(2008-10#2)
the piston##5##2##(2008-10#1)(2008-2#1)(2008-3#2)(2012-1#1)
the pit cell lineage##2##4##(1995-2#1)(1995-6#1)
the pit patterns of the colorectal mucosa##2##7##(2008-5#2)
the pit##8##2##(1995-2#1)(1995-6#1)(2008-10#3)(2008-2#1)(2008-5#2)
the pitch of the##4##4##(1997-7#1)(2008-2#2)(2008-3#1)
the pitch of##6##3##(1995-11#1)(1997-7#1)(2008-2#3)(2008-3#1)
the pitch##14##2##(1995-11#1)(1997-7#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-2#6)(2008-3#1)(2013-8#2)
the pitfalls and##2##3##(2006-5#1)(2008-9#1)
the pitfalls in the##2##4##(2007-10#1)(2010-11#1)
the pitfalls in##3##3##(2007-10#1)(2008-9#1)(2010-11#1)
the pitfalls of##5##3##(2008-11#2)(2008-8#1)(2010-7#1)(2012-2#1)
the pitfalls##13##2##(1993-1#1)(1993-2#1)(1996-12#1)(2006-5#1)(2007-10#1)(2008-11#2)(2008-8#1)(2008-9#2)(2010-11#1)(2010-7#1)(2012-2#1)
the pith##2##2##(2008-10#2)
the pits##2##2##(1997-1#1)(2007-12#1)
the pituitaries##3##2##(1990-3#1)(1995-11#1)(2006-1#1)
the pituitary adenylate cyclase##2##4##(1990-7#2)
the pituitary and##6##3##(1990-2#1)(1990-3#1)(1993-5#2)(1995-8#1)(2008-5#1)
the pituitary gland and##2##4##(1994-11#1)(1995-7#1)
the pituitary gland##27##3##(1990-10#2)(1991-5#1)(1992-3#1)(1993-9#1)(1994-11#1)(1995-10#1)(1995-12#2)(1995-7#2)(1996-11#1)(1996-2#1)(2006-6#1)(2006-9#2)(2008-5#2)(2009-2#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#1)
the pituitary gonadal hormonal##2##4##(2007-7#2)
the pituitary gonadotropes##2##3##(1997-2#2)
the pituitary##93##2##(1990-10#2)(1990-11#1)(1990-2#2)(1990-3#1)(1990-7#3)(1990-9#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-3#1)(1993-5#5)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#4)(1995-12#7)(1995-3#1)(1995-5#3)(1995-7#2)(1995-8#1)(1995-9#2)(1996-11#1)(1996-2#2)(1997-2#2)(1997-3#1)(1997-5#2)(2005-8#1)(2006-1#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-7#2)(2008-4#4)(2008-5#5)(2008-7#1)(2009-2#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-1#3)(2012-3#2)(2013-1#2)
the pituitary-adrenocortical##2##2##(1995-12#1)(1995-5#1)
the pivot##4##2##(2008-2#1)(2008-3#2)(2009-7#1)
the pivotal clinical trials##2##4##(2008-8#1)(2010-12#1)
the pivotal phase III##2##4##(2005-8#1)(2008-5#1)
the pivotal role of##6##4##(1991-1#1)(2007-11#1)(2008-1#1)(2008-7#1)(2010-12#1)(2013-1#1)
the pivotal role##8##3##(1991-1#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-7#1)(2010-12#1)(2013-1#1)
the pivotal roles of##2##4##(2008-3#1)(2009-10#1)
the pivotal##21##2##(1991-1#1)(1995-3#1)(1997-3#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#2)(2010-12#2)(2010-3#1)(2013-1#1)
the pixel intensities##2##3##(2006-5#1)(2011-2#1)
the pixel##12##2##(2006-5#1)(2007-11#2)(2008-1#1)(2008-2#2)(2008-3#3)(2010-12#1)(2011-2#1)(2013-1#1)
the pixelated lens##2##3##(2008-3#2)
the pixelated structure of##2##4##(2008-2#2)
the pixelated##5##2##(2008-2#2)(2008-3#3)
the pixels##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
the place and##2##3##(2008-2#2)
the place for##3##3##(2008-9#1)(2011-1#1)(2012-2#1)
the place of origin of##2##5##(2010-12#1)(2012-12#1)
the place of origin##6##4##(2010-12#1)(2012-12#1)(2012-3#4)
the place of the##6##4##(1990-6#1)(1994-3#1)(2007-10#1)(2007-11#1)(2007-8#1)(2011-12#1)
the place of##40##3##(1990-5#1)(1990-6#2)(1992-12#1)(1992-5#1)(1994-3#1)(1994-6#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2010-10#1)(2010-12#2)(2010-4#1)(2011-12#2)(2011-2#1)(2012-12#1)(2012-3#5)
the place where he##2##4##(1994-3#1)(2008-10#1)
the place where##5##3##(1994-3#1)(2006-9#1)(2008-10#1)(2010-12#1)(2013-1#1)
the place##58##2##(1990-2#1)(1990-5#1)(1990-6#2)(1992-12#1)(1992-5#1)(1992-9#1)(1994-3#3)(1994-6#1)(1995-12#1)(1996-10#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#3)(2008-12#3)(2008-2#4)(2008-3#1)(2008-6#1)(2008-9#1)(2010-10#1)(2010-12#3)(2010-4#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#1)
the placebo and##2##3##(2009-10#1)(2010-12#1)
the placebo group (P = 0##2##6##(1992-1#1)(2007-8#1)
the placebo group (p = 0##2##6##(2008-3#2)
the placebo group and##4##4##(1990-8#1)(1991-7#2)(2008-7#1)
the placebo group were##4##4##(1990-6#1)(1990-8#1)(2006-10#1)(2013-1#1)
the placebo group##68##3##(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#4)(1991-11#1)(1991-6#1)(1991-7#2)(1992-1#2)(1992-10#2)(1992-5#1)(1993-11#1)(1995-12#1)(1996-2#1)(1997-5#1)(1997-6#1)(1997-7#2)(2004-1#1)(2005-7#1)(2006-10#2)(2007-10#1)(2007-5#2)(2007-8#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#11)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#2)(2009-8#1)(2010-5#1)(2011-1#2)(2012-12#1)(2012-2#3)(2013-1#3)
the placebo##91##2##(1990-10#1)(1990-12#1)(1990-3#2)(1990-6#1)(1990-8#4)(1991-11#1)(1991-6#1)(1991-7#2)(1992-1#2)(1992-10#2)(1992-4#1)(1992-5#1)(1993-11#1)(1995-12#1)(1996-2#2)(1997-5#1)(1997-6#1)(1997-7#2)(2004-1#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-7#1)(2007-10#1)(2007-5#2)(2007-8#3)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#16)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#2)(2009-11#1)(2009-7#2)(2009-8#1)(2010-12#2)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#1)
the placebo-treated##4##2##(1997-7#1)(2008-5#1)(2011-2#2)
the placement of a CVC##3##5##(2007-7#3)
the placement of a central venous catheter##2##7##(2007-7#2)
the placement of a##9##4##(2007-7#5)(2007-8#1)(2008-2#1)(2011-2#1)(2012-11#1)
the placement of an##5##4##(1990-2#1)(2006-6#1)(2007-8#3)
the placement of dental implants##3##5##(1993-2#1)(2007-12#1)(2012-12#1)
the placement of the##9##4##(1994-5#1)(1996-7#1)(2006-3#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-5#1)(2009-10#1)
the placement of##50##3##(1990-2#1)(1991-12#1)(1991-5#1)(1993-2#1)(1994-5#1)(1996-3#1)(1996-7#1)(2006-2#2)(2006-3#1)(2006-6#1)(2006-8#1)(2007-12#2)(2007-4#1)(2007-7#11)(2007-8#8)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-10#2)(2009-2#2)(2010-2#1)(2010-4#1)(2011-2#1)(2012-11#1)(2012-12#1)
the placement##55##2##(1990-2#1)(1991-12#1)(1991-5#1)(1993-2#1)(1994-5#1)(1996-3#1)(1996-7#1)(2006-2#2)(2006-3#1)(2006-6#1)(2006-8#1)(2007-12#2)(2007-4#1)(2007-7#11)(2007-8#8)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#4)(2008-2#1)(2008-5#1)(2008-6#1)(2009-10#2)(2009-2#2)(2010-2#1)(2010-4#1)(2011-2#1)(2012-11#1)(2012-12#1)
the placenta and##5##3##(2006-10#1)(2007-3#1)(2008-10#1)(2012-12#1)(2013-1#1)
the placenta in##2##3##(1994-6#1)(2013-7#1)
the placenta##31##2##(1990-2#3)(1990-5#2)(1990-9#1)(1992-1#1)(1992-10#1)(1992-4#1)(1992-8#1)(1994-6#3)(1995-12#1)(1996-4#1)(1996-7#1)(2006-10#1)(2007-3#1)(2008-10#2)(2008-9#2)(2009-2#1)(2009-9#2)(2010-5#1)(2012-12#1)(2013-1#3)(2013-7#1)
the placental barrier##3##3##(2010-2#1)(2010-5#2)
the placental##16##2##(1990-9#1)(1991-4#1)(1992-3#1)(1992-8#1)(1995-8#1)(1996-7#1)(2006-10#1)(2006-5#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-2#1)(2010-2#1)(2010-5#3)
the places where##3##3##(2008-10#1)(2012-1#2)
the places##6##2##(2008-10#1)(2009-6#1)(2009-7#1)(2011-12#1)(2012-1#2)
the placing of##4##3##(1990-1#1)(2007-12#1)(2008-11#1)(2008-8#1)
the plague##6##2##(1990-6#1)(2007-2#2)(2007-5#2)(2008-8#1)
the plain film and##2##4##(2006-8#1)(2007-11#1)
the plain film##3##3##(2006-8#1)(2007-11#2)
the plain##7##2##(1992-1#1)(2006-5#1)(2006-8#1)(2007-11#2)(2008-6#1)(2008-7#1)
the plaintiff had##3##3##(1991-7#3)
the plaintiff##8##2##(1991-6#1)(1991-7#4)(1996-11#2)(1997-5#1)
the plaintiff's##2##2##(1991-7#1)(1996-11#1)
the plaintiffs##4##2##(1995-6#1)(1996-11#1)(1996-5#1)(1996-6#1)
the plan was##2##3##(1990-12#1)(1992-12#1)
the plan##19##2##(1990-12#1)(1992-1#1)(1992-12#1)(1992-3#1)(1994-2#1)(1994-3#1)(1995-6#3)(1996-3#1)(1997-2#1)(2006-8#1)(2007-5#1)(2007-9#2)(2008-2#2)(2011-1#1)(2012-3#1)
the planar integration of##2##4##(2008-2#1)(2008-3#1)
the planar waveguide##3##3##(2006-2#1)(2008-1#1)(2008-2#1)
the planar##16##2##(1992-9#1)(1993-3#1)(1995-2#1)(1996-7#1)(1997-7#1)(2006-2#2)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2013-8#1)
the plane of incidence##12##4##(2007-12#2)(2008-1#1)(2008-2#3)(2008-3#6)
the plane of the bilayer##3##5##(1990-4#1)(1991-5#1)(1994-12#1)
the plane of the grating##2##5##(2008-3#2)
the plane of the interference fringes##2##6##(2008-3#2)
the plane of the##28##4##(1990-4#1)(1991-5#1)(1991-9#1)(1994-12#1)(1994-3#1)(1995-10#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-8#1)(1997-5#1)(2004-7#1)(2005-4#1)(2006-11#1)(2006-12#1)(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#5)(2010-6#1)(2013-1#1)
the plane of##51##3##(1990-4#1)(1991-5#1)(1991-9#1)(1993-4#1)(1994-12#1)(1994-3#1)(1995-10#2)(1995-2#1)(1995-5#1)(1996-2#1)(1996-8#1)(1997-5#1)(1997-6#1)(2004-7#1)(2005-4#1)(2006-11#1)(2006-12#1)(2006-4#1)(2007-11#2)(2007-12#6)(2008-1#1)(2008-2#6)(2008-3#13)(2009-8#1)(2010-6#1)(2013-1#1)(2013-8#1)
the plane##63##2##(1990-4#1)(1991-5#1)(1991-9#1)(1993-4#1)(1994-12#1)(1994-3#1)(1995-10#2)(1995-2#1)(1995-5#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-6#1)(2004-7#1)(2005-11#2)(2005-4#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2007-11#3)(2007-12#7)(2008-1#1)(2008-10#1)(2008-2#7)(2008-3#14)(2009-8#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
the plane-parallel resonator##2##3##(2008-3#2)
the plane-parallel##3##2##(2008-3#3)
the plane-wave##4##2##(1990-3#1)(2007-12#1)(2008-3#2)
the planet future energy needs##2##5##(2009-3#2)
the planet##12##2##(1991-8#1)(1992-10#2)(1995-9#1)(2006-10#1)(2006-7#1)(2007-9#2)(2009-3#2)(2010-5#1)(2012-12#1)
the planet's##3##2##(2006-7#1)(2007-9#1)(2010-4#1)
the planetary boundary layer##7##4##(2008-2#4)(2008-3#3)
the planetary##10##2##(1992-1#1)(1992-2#1)(2007-9#1)(2008-2#4)(2008-3#3)
the plankton##3##2##(2008-3#1)(2012-2#1)(2013-8#1)
the planktonic##7##2##(2007-5#2)(2008-3#3)(2009-6#1)(2012-2#1)
the planned isocenter position during treatment##2##6##(2009-2#2)
the planned surgical##3##3##(2006-6#1)(2007-8#1)(2012-3#1)
the planned##21##2##(1992-1#1)(1992-9#2)(1996-7#1)(2004-1#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#3)(2009-2#2)(2009-9#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
the planning and execution of##2##5##(1994-6#1)(2009-8#1)
the planning and implementation of##4##5##(1993-3#1)(2005-10#1)(2008-10#1)(2009-4#1)
the planning and##14##3##(1991-2#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-6#1)(1996-2#1)(2005-10#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-4#1)(2009-8#1)(2013-1#1)
the planning of health services##2##5##(1993-11#1)(1993-6#1)
the planning of##14##3##(1992-2#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-6#1)(1995-8#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-5#1)(2008-6#1)(2010-2#1)(2011-2#1)(2013-7#1)
the planning period##2##3##(2011-2#2)
the planning process and##3##4##(1992-2#1)(1994-2#1)(1996-1#1)
the planning process##6##3##(1992-2#1)(1994-2#1)(1996-1#2)(2008-1#1)(2008-2#1)
the planning target volume (PTV) and##2##6##(2008-3#1)(2008-6#1)
the planning target volume (PTV)##5##5##(2008-2#2)(2008-3#1)(2008-6#1)(2009-5#1)
the planning##56##2##(1991-2#1)(1992-12#1)(1992-2#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1995-8#1)(1996-1#2)(1996-2#1)(2005-10#1)(2006-12#1)(2006-2#3)(2006-5#1)(2006-6#1)(2007-1#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-6#3)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-2#3)(2013-1#1)(2013-7#1)
the planovalgus##2##2##(2009-3#2)
the plans##5##2##(1996-3#1)(1997-3#1)(2008-1#1)(2008-3#1)(2013-1#1)
the plant PKC##2##3##(1994-8#2)
the plant against##3##3##(2008-4#1)(2008-8#1)(2009-8#1)
the plant and animal kingdoms##2##5##(2008-10#1)(2009-6#1)
the plant and animal##3##4##(2008-10#1)(2008-7#1)(2009-6#1)
the plant and the##2##4##(2008-10#2)
the plant and##11##3##(2007-1#1)(2008-10#6)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)
the plant availability of##2##4##(1992-3#2)
the plant canopy##2##3##(2008-10#2)
the plant cell##4##3##(2009-8#2)(2012-1#1)(2013-8#1)
the plant community##2##3##(2008-8#1)(2013-8#1)
the plant complex##2##3##(2008-5#2)
the plant cuticle##2##3##(2007-12#2)
the plant defense##2##3##(2008-10#2)
the plant expression vectors##2##4##(2008-8#1)(2008-9#1)
the plant extract##2##3##(1994-6#1)(2013-7#1)
the plant extracts##2##3##(2008-5#1)(2011-1#1)
the plant from##2##3##(2008-10#1)(2008-6#1)
the plant genome##2##3##(2008-10#1)(2008-7#1)
the plant genus##2##3##(2008-8#1)(2012-3#1)
the plant growth hormone##2##4##(2008-10#1)(2008-11#1)
the plant growth##3##3##(1997-1#1)(2008-10#1)(2008-11#1)
the plant hormone##4##3##(1992-1#1)(2009-6#2)(2011-10#1)
the plant host##4##3##(2005-8#1)(2008-8#1)(2008-9#1)(2013-1#1)
the plant in##5##3##(2008-10#2)(2009-8#1)(2010-5#1)(2012-2#1)
the plant is##4##3##(2008-10#1)(2008-12#1)(2009-8#1)(2011-2#1)
the plant kingdom##9##3##(1991-8#1)(2008-10#1)(2009-12#1)(2009-5#1)(2009-8#2)(2011-2#1)(2013-8#2)
the plant leaf N##4##4##(2013-8#4)
the plant leaf##6##3##(2013-8#6)
the plant pathogen##3##3##(2008-10#1)(2010-10#1)(2011-1#1)
the plant pathogenic##2##3##(2008-11#1)(2009-6#1)
the plant physiologist##2##3##(2008-7#2)
the plant population##2##3##(2008-10#2)
the plant protein##2##3##(1997-2#1)(2009-8#1)
the plant revealed##2##3##(2008-10#2)
the plant roots##4##3##(1992-3#1)(2008-12#1)(2008-4#2)
the plant species tested##2##4##(2004-4#1)(2008-6#1)
the plant species##7##3##(2004-4#1)(2008-10#2)(2008-2#1)(2008-6#2)(2008-8#1)
the plant surface##8##3##(1992-6#1)(2007-12#2)(2008-10#3)(2008-8#1)(2009-8#1)
the plant system##2##3##(2009-8#2)
the plant tissue##5##3##(2007-12#2)(2008-10#2)(2013-1#1)
the plant to##5##3##(2005-8#1)(2008-10#2)(2008-8#1)(2009-8#1)
the plant was##4##3##(2005-11#1)(2008-10#1)(2008-4#1)(2013-7#1)
the plant##267##2##(1990-4#1)(1990-5#1)(1991-11#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-3#4)(1992-6#1)(1993-3#1)(1994-11#1)(1994-3#3)(1994-6#2)(1994-8#2)(1995-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-6#1)(2004-11#1)(2004-2#2)(2004-4#2)(2005-11#2)(2005-8#2)(2006-10#1)(2006-11#2)(2006-12#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#7)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#68)(2008-11#7)(2008-12#3)(2008-2#5)(2008-4#7)(2008-5#10)(2008-6#4)(2008-7#7)(2008-8#10)(2008-9#5)(2009-10#4)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#7)(2009-8#20)(2010-10#3)(2010-11#1)(2010-4#1)(2010-5#2)(2011-1#7)(2011-10#2)(2011-12#1)(2011-2#6)(2012-1#4)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#12)
the plant's##3##2##(2008-10#1)(2009-10#1)(2009-8#1)
the plant-parasitic nematode Meloidogyne incognita##2##5##(1994-12#2)
the plant-pathogenic fungus##3##3##(2008-10#3)
the plant-pathogenic##7##2##(2005-12#1)(2008-10#6)
the plantar surface of the hindpaw##2##6##(1990-4#1)(2009-12#1)
the plantar surface of##3##4##(1990-4#1)(2008-1#1)(2009-12#1)
the plantar##8##2##(1990-4#1)(2006-10#2)(2008-1#1)(2009-12#1)(2009-9#1)(2010-11#1)(2011-12#1)
the plantation##2##2##(2012-2#1)(2013-8#1)
the plants and##2##3##(2008-6#1)(2012-2#1)
the plants expressing OC-I##2##4##(2006-12#2)
the plants of##3##3##(2004-2#1)(2007-1#1)(2008-10#1)
the plants to##5##3##(2008-10#4)(2009-8#1)
the plants were evaluated for##2##5##(2008-10#2)
the plants were##11##3##(1997-6#1)(2004-4#1)(2006-12#1)(2007-1#1)(2008-10#5)(2008-12#1)(2008-2#1)
the plants with##3##3##(2006-12#1)(2007-1#1)(2008-10#1)
the plants##75##2##(1990-7#2)(1994-6#1)(1995-2#1)(1995-8#1)(1997-6#1)(2004-11#1)(2004-2#1)(2004-4#1)(2006-10#2)(2006-12#5)(2006-3#1)(2007-1#4)(2008-10#33)(2008-12#2)(2008-2#3)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#1)(2009-8#3)(2011-2#2)(2012-2#2)
the planum##2##2##(2005-9#1)(2012-2#1)
the plaque assay##4##3##(2006-3#3)(2013-1#1)
the plaque instability##2##3##(2007-1#1)(2008-4#1)
the plaque##12##2##(1993-6#1)(2006-2#1)(2006-3#3)(2007-1#1)(2007-10#3)(2008-4#1)(2008-5#1)(2013-1#1)
the plaques##4##2##(1994-11#1)(2007-8#1)(2008-5#2)
the plasma ACh content##2##4##(1997-3#2)
the plasma ACh##3##3##(1997-3#3)
the plasma B7-H3##2##3##(2011-12#2)
the plasma adrenocorticotropic hormone##2##4##(1990-2#1)(2011-2#1)
the plasma and urine##2##4##(1990-3#1)(2005-12#1)
the plasma and##13##3##(1990-2#1)(1990-3#1)(1991-3#1)(1992-6#1)(1993-9#1)(1995-1#1)(2005-12#1)(2006-5#1)(2008-10#2)(2008-7#1)(2008-9#1)(2012-12#1)
the plasma at##2##3##(1990-12#1)(2005-4#1)
the plasma by the##2##4##(1993-9#1)(2008-1#1)
the plasma by##5##3##(1991-2#1)(1993-9#1)(2008-1#1)(2008-9#1)(2012-2#1)
the plasma cholesterol level##3##4##(1997-1#3)
the plasma cholesterol##4##3##(1993-9#1)(1997-1#3)
the plasma concentration of alpha-tocopherol##3##5##(2007-8#3)
the plasma concentration of##14##4##(1990-4#1)(1995-9#1)(1996-5#1)(2005-10#1)(2006-7#1)(2007-8#4)(2008-1#2)(2008-12#1)(2013-8#2)
the plasma concentration##22##3##(1990-4#1)(1990-6#1)(1991-12#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-8#1)(2004-12#1)(2005-10#1)(2006-7#1)(2007-8#4)(2008-1#2)(2008-12#1)(2008-5#1)(2013-8#2)
the plasma concentration-time##5##3##(1996-5#1)(2008-5#2)(2008-8#2)
the plasma concentrations of##3##4##(1993-9#1)(2007-8#1)(2009-4#1)
the plasma concentrations##4##3##(1993-9#1)(2007-8#1)(2009-4#2)
the plasma enzyme##3##3##(1992-9#1)(1993-1#1)(1995-6#1)
the plasma exchange efficiency##2##4##(2011-2#2)
the plasma for##5##3##(2008-10#4)(2008-11#1)
the plasma glucose concentration##2##4##(2007-8#1)(2008-1#1)
the plasma glucose##6##3##(1991-8#1)(2007-8#2)(2008-1#1)(2009-6#2)
the plasma kinetics##2##3##(1996-12#1)(2012-1#1)
the plasma level of##4##4##(1991-9#1)(1995-1#1)(1996-3#1)(1997-4#1)
the plasma level##5##3##(1991-9#1)(1993-2#1)(1995-1#1)(1996-3#1)(1997-4#1)
the plasma levels of##13##4##(1990-11#2)(1991-3#1)(1992-3#1)(1996-6#1)(1997-5#1)(1997-8#1)(2004-4#1)(2008-4#1)(2008-5#2)(2010-4#1)(2011-2#1)
the plasma levels##15##3##(1990-11#2)(1991-3#1)(1992-3#1)(1995-12#1)(1996-6#1)(1997-5#2)(1997-8#1)(2004-4#1)(2008-4#1)(2008-5#2)(2010-4#1)(2011-2#1)
the plasma lipoproteins##2##3##(1993-6#1)(2008-5#1)
the plasma membrane (PM) of##2##5##(2009-10#1)(2009-8#1)
the plasma membrane H(+)-ATPase##4##4##(1992-11#1)(1995-2#1)(1995-4#1)(1997-3#1)
the plasma membrane and cell wall##3##6##(1997-6#2)(2009-8#1)
the plasma membrane and cell##4##5##(1997-6#2)(2009-8#1)(2010-3#1)
the plasma membrane and its##2##5##(1991-2#1)(1994-11#1)
the plasma membrane and the cytoplasm##2##6##(1995-8#1)(2009-2#1)
the plasma membrane and the##13##5##(1990-12#1)(1991-5#1)(1991-9#1)(1993-2#1)(1994-9#1)(1995-8#1)(1997-4#2)(2008-1#2)(2008-11#1)(2009-2#1)(2009-8#1)
the plasma membrane and##35##4##(1990-12#1)(1990-8#1)(1991-10#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-6#1)(1995-8#1)(1997-1#1)(1997-4#2)(1997-6#3)(2005-8#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2009-2#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-3#1)
the plasma membrane as##2##4##(1994-8#1)(2007-10#1)
the plasma membrane by##10##4##(1992-3#1)(1992-4#1)(1992-9#1)(1994-3#2)(1995-6#1)(2008-4#1)(2009-8#1)(2010-11#2)
the plasma membrane calcium pump##4##5##(1992-11#1)(1992-12#1)(1992-3#1)(2008-4#1)
the plasma membrane during the##2##5##(1992-1#1)(2008-11#1)
the plasma membrane fraction##4##4##(1990-2#1)(1993-8#1)(1994-11#2)
the plasma membrane from##2##4##(1996-8#1)(2008-10#1)
the plasma membrane has##2##4##(1997-1#1)(2008-11#1)
the plasma membrane in the##3##5##(1992-4#1)(1994-3#1)(2008-7#1)
the plasma membrane in##11##4##(1990-11#1)(1992-12#1)(1992-4#1)(1994-3#3)(1997-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-6#1)
the plasma membrane is##2##4##(1994-3#1)(2007-8#1)
the plasma membrane of T##2##5##(1992-4#1)(1994-3#1)
the plasma membrane of eggs##2##5##(2008-8#2)
the plasma membrane of human placental syncytiotrophoblast##2##7##(1990-12#1)(1990-9#1)
the plasma membrane of human##4##5##(1990-12#1)(1990-5#1)(1990-9#1)(1997-1#1)
the plasma membrane of the##8##5##(1990-2#1)(1992-4#1)(1994-10#1)(1994-11#1)(1994-8#1)(1997-7#1)(2008-8#2)
the plasma membrane of##45##4##(1990-12#3)(1990-2#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-2#1)(1992-3#1)(1992-4#2)(1993-11#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#1)(1997-1#2)(1997-4#1)(1997-7#1)(2006-10#2)(2007-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#4)(2009-8#2)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#2)(2012-12#1)
the plasma membrane permeability##2##4##(1994-2#1)(2008-9#1)
the plasma membrane proteins##3##4##(1995-12#1)(1997-1#1)(2008-11#1)
the plasma membrane surface##2##4##(2007-12#2)
the plasma membrane that##4##4##(1996-8#1)(2007-10#1)(2009-10#1)(2010-5#1)
the plasma membrane to##7##4##(1990-11#1)(1993-6#1)(1994-12#1)(1996-10#1)(2006-10#1)(2009-2#1)(2012-12#1)
the plasma membrane were##4##4##(1990-10#1)(1991-1#1)(1997-6#1)(2012-3#1)
the plasma membrane##276##3##(1990-10#2)(1990-11#5)(1990-12#5)(1990-2#6)(1990-5#3)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#1)(1991-2#4)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-11#3)(1992-12#5)(1992-3#5)(1992-4#4)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#2)(1993-11#3)(1993-2#1)(1993-3#3)(1993-4#3)(1993-6#2)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#6)(1994-12#9)(1994-2#2)(1994-3#14)(1994-5#3)(1994-6#2)(1994-8#4)(1994-9#4)(1995-11#1)(1995-12#1)(1995-2#4)(1995-4#1)(1995-6#5)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-8#4)(1997-1#8)(1997-3#4)(1997-4#4)(1997-6#11)(1997-7#1)(2005-8#2)(2006-10#5)(2007-10#5)(2007-12#3)(2007-8#1)(2008-1#4)(2008-10#3)(2008-11#9)(2008-4#10)(2008-7#2)(2008-8#7)(2008-9#3)(2009-10#4)(2009-12#1)(2009-2#2)(2009-6#1)(2009-7#1)(2009-8#9)(2009-9#3)(2010-11#3)(2010-12#4)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2012-12#4)(2012-3#1)(2013-1#2)
the plasma membranes in##3##4##(1994-5#1)(2008-4#1)(2013-1#1)
the plasma membranes of the##2##5##(1991-9#1)(1997-1#1)
the plasma membranes of##8##4##(1991-10#1)(1991-12#1)(1991-9#1)(1993-6#1)(1997-1#1)(1997-6#1)(2008-5#1)(2010-10#1)
the plasma membranes##15##3##(1991-10#1)(1991-12#1)(1991-9#1)(1992-1#1)(1993-6#1)(1994-5#1)(1994-6#1)(1996-9#1)(1997-1#1)(1997-6#2)(2008-4#1)(2008-5#1)(2010-10#1)(2013-1#1)
the plasma of a##3##4##(1993-11#1)(1994-9#2)
the plasma of the##2##4##(1994-8#1)(1995-5#1)
the plasma of##30##3##(1990-7#1)(1991-2#4)(1991-3#1)(1991-5#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-11#1)(1994-8#2)(1994-9#3)(1995-5#1)(2007-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-2#1)
the plasma potassium concentration##2##4##(1993-1#1)(1995-9#1)
the plasma proteome##4##3##(2010-12#4)
the plasma triglyceride##2##3##(2008-3#1)(2009-8#1)
the plasma was##4##3##(1991-2#2)(1995-2#1)(2008-10#1)
the plasma were determined by##2##5##(2007-8#1)(2008-1#1)
the plasma were##5##3##(1990-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)
the plasma with##4##3##(1994-8#1)(1996-4#1)(1997-8#1)(2008-10#1)
the plasma##553##2##(1990-10#2)(1990-11#10)(1990-12#6)(1990-2#8)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#3)(1990-7#5)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#15)(1991-3#3)(1991-4#1)(1991-5#2)(1991-8#3)(1991-9#4)(1992-1#3)(1992-11#4)(1992-12#6)(1992-2#2)(1992-3#6)(1992-4#4)(1992-5#1)(1992-6#6)(1992-7#2)(1992-8#3)(1992-9#6)(1993-1#2)(1993-11#4)(1993-2#2)(1993-3#3)(1993-4#3)(1993-6#5)(1993-7#1)(1993-8#1)(1993-9#13)(1994-10#1)(1994-11#6)(1994-12#9)(1994-2#2)(1994-3#14)(1994-5#4)(1994-6#3)(1994-8#8)(1994-9#7)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#5)(1995-4#1)(1995-5#2)(1995-6#8)(1995-7#1)(1995-8#3)(1995-9#3)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#3)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#2)(1996-8#6)(1996-9#1)(1997-1#13)(1997-2#2)(1997-3#9)(1997-4#5)(1997-5#2)(1997-6#13)(1997-7#4)(1997-8#3)(2004-12#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-4#1)(2005-8#2)(2006-10#5)(2006-4#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-1#2)(2007-10#5)(2007-11#3)(2007-12#6)(2007-8#13)(2008-1#11)(2008-10#27)(2008-11#12)(2008-12#3)(2008-2#4)(2008-3#6)(2008-4#13)(2008-5#7)(2008-7#5)(2008-8#10)(2008-9#8)(2009-10#5)(2009-12#2)(2009-2#2)(2009-4#2)(2009-6#3)(2009-7#1)(2009-8#12)(2009-9#3)(2010-10#1)(2010-11#3)(2010-12#13)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#3)(2011-2#6)(2012-1#1)(2012-12#6)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#7)
the plasma-derived vaccine##4##3##(1992-8#1)(2007-11#3)
the plasma-membrane##3##2##(1990-11#1)(1991-2#1)(1992-6#1)
the plasmalemma of the##2##4##(2008-10#2)
the plasmalemma of##4##3##(1995-9#1)(2008-10#3)
the plasmalemma to##2##3##(1997-4#2)
the plasmalemma##18##2##(1991-11#1)(1993-3#1)(1995-9#2)(1996-9#1)(1997-4#3)(1997-7#1)(2007-12#1)(2008-10#6)(2008-5#1)(2008-7#1)
the plasmalemmal##2##2##(1995-2#1)(1997-4#1)
the plasmas##2##2##(2008-3#2)
the plasmatic##4##2##(1990-9#1)(2008-8#1)(2010-12#1)(2012-2#1)
the plasmic membrane##2##3##(1993-6#2)
the plasmid DNA##5##3##(1990-11#1)(1995-2#1)(1996-7#1)(2008-8#1)(2010-4#1)
the plasmid that carried##2##4##(1993-3#2)
the plasmid to##2##3##(1996-7#1)(2008-5#1)
the plasmid vector pGEM-T##2##4##(2008-10#1)(2008-9#1)
the plasmid vector##7##3##(1990-12#1)(1990-5#1)(1991-3#1)(1991-7#1)(1992-3#1)(2008-10#1)(2008-9#1)
the plasmid was##2##3##(1997-4#1)(2011-2#1)
the plasmid were##2##3##(1995-8#1)(2011-2#1)
the plasmid with the##2##4##(1992-8#1)(2007-6#1)
the plasmid##81##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-3#1)(1991-7#2)(1991-8#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-3#2)(1994-12#1)(1994-2#1)(1994-9#1)(1995-2#2)(1995-6#1)(1995-8#3)(1996-10#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2005-11#1)(2007-11#3)(2007-6#1)(2008-10#4)(2008-11#5)(2008-12#3)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#2)(2010-4#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
the plasmid-based##2##2##(1994-12#1)(1996-8#1)
the plasmids##12##2##(1990-3#1)(1990-5#1)(1991-7#2)(1991-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1997-3#1)(2008-10#1)(2008-5#1)(2008-8#1)
the plasmin receptor from##2##4##(1990-7#2)
the plasminogen activator system##3##4##(1994-5#1)(1995-5#1)(2005-7#1)
the plasminogen activator##9##3##(1994-5#1)(1994-6#1)(1995-5#1)(1996-5#1)(1997-2#1)(2005-7#1)(2007-9#2)(2008-7#1)
the plasminogen##13##2##(1990-5#1)(1992-7#1)(1994-5#1)(1994-6#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-2#1)(2005-7#1)(2007-9#2)(2008-5#1)(2008-7#1)
the plasmon resonances##2##3##(2008-3#1)(2010-2#1)
the plasmon##3##2##(2007-12#1)(2008-3#1)(2010-2#1)
the plaster##2##2##(2007-12#2)
the plastic surface of##2##4##(1990-12#1)(1994-9#1)
the plastic surgeon##2##3##(2011-2#1)(2012-2#1)
the plastic surgery population##2##4##(2013-1#2)
the plastic surgery##4##3##(1993-9#1)(2010-8#1)(2013-1#2)
the plastic type##2##3##(2008-8#2)
the plastic##26##2##(1990-12#1)(1991-3#1)(1993-9#1)(1994-9#1)(1996-7#1)(2005-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#2)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#3)
the plasticity in##2##3##(2008-9#1)(2010-12#1)
the plasticity of the##5##4##(1993-9#1)(2008-11#1)(2010-12#1)(2011-1#1)(2012-2#1)
the plasticity of##9##3##(1993-9#1)(1995-12#1)(1996-12#1)(2008-11#3)(2010-12#1)(2011-1#1)(2012-2#1)
the plasticity##14##2##(1991-8#1)(1993-9#1)(1995-12#1)(1996-12#1)(2008-11#3)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#2)(2011-1#1)(2012-2#1)
the plasticized PVC membrane##2##4##(2008-10#2)
the plasticizer and##2##3##(2008-10#2)
the plasticizer##7##2##(2004-12#1)(2008-10#6)
the plastid##8##2##(1995-10#1)(1997-6#4)(2009-10#1)(2011-2#1)(2013-1#1)
the plastidic##2##2##(1995-8#2)
the plate and the##2##4##(2008-10#2)
the plate by##2##3##(2008-2#1)(2008-3#1)
the plate counts##2##3##(2007-7#1)(2008-10#1)
the plate diagram sheet##2##4##(2013-1#2)
the plate diagram##3##3##(2013-1#3)
the plate is##2##3##(2006-3#1)(2008-3#1)
the plate painters##2##3##(1994-6#2)
the plate surface##2##3##(2008-8#2)
the plate##45##2##(1990-4#1)(1991-8#1)(1993-8#1)(1994-6#3)(2005-10#1)(2006-12#1)(2006-3#6)(2007-12#1)(2007-7#2)(2007-8#2)(2008-10#7)(2008-11#3)(2008-2#3)(2008-3#3)(2008-7#1)(2008-8#4)(2012-2#1)(2012-3#1)(2013-1#3)
the plate's##2##2##(2007-11#2)
the plateau contraction induced by##2##5##(1996-3#2)
the plateau contraction##4##3##(1996-3#4)
the plateau phase##3##3##(1990-11#2)(1990-7#1)
the plateau region of the##3##5##(1992-1#1)(2008-5#1)(2011-1#1)
the plateau##26##2##(1990-11#2)(1990-7#2)(1992-1#1)(1994-6#3)(1996-3#4)(2005-11#5)(2007-1#1)(2008-10#3)(2008-5#1)(2008-9#1)(2009-7#1)(2011-1#1)(2013-1#1)
the platelet 5HT2 receptor complex##2##5##(1996-7#2)
the platelet aggregation induced##2##4##(1992-8#1)(1997-7#1)
the platelet aggregation##5##3##(1992-5#1)(1992-8#2)(1993-3#1)(1997-7#1)
the platelet count##5##3##(1992-2#1)(2006-6#2)(2007-6#1)(2013-8#1)
the platelet glycoprotein##3##3##(1991-10#1)(2007-11#1)(2008-11#1)
the platelet level##2##3##(2008-8#2)
the platelet lysate##2##3##(2008-11#2)
the platelet membranes##4##3##(1992-6#3)(1993-6#1)
the platelet##51##2##(1990-12#2)(1990-2#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-6#3)(1992-8#2)(1993-3#1)(1993-6#1)(1994-12#3)(1995-11#1)(1995-2#1)(1996-7#3)(1997-7#4)(2004-9#1)(2006-12#1)(2006-6#6)(2006-9#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-8#2)(2009-5#1)(2013-8#1)
the platelet-activating factor##3##3##(1993-12#2)(2007-11#1)
the platelet-aggregating##2##2##(1995-5#1)(2006-12#1)
the platelet-derived growth factor (PDGF)##2##5##(1995-3#1)(1996-8#1)
the platelet-derived growth factor##8##4##(1990-3#1)(1994-3#1)(1995-3#1)(1996-5#1)(1996-8#2)(1997-7#1)(2006-6#1)
the platelet-derived growth##10##3##(1990-3#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-5#1)(1996-8#2)(1997-7#1)(2006-6#1)(2007-7#1)
the platelet-derived##11##2##(1990-3#1)(1991-6#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-5#1)(1996-8#2)(1997-7#1)(2006-6#1)(2007-7#1)
the platelets and##2##3##(1994-2#1)(2008-7#1)
the platelets##4##2##(1990-11#1)(1994-2#1)(1997-6#1)(2008-7#1)
the plates showed##2##3##(2008-11#1)(2009-2#1)
the plates##11##2##(1990-12#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-7#1)(2009-2#1)(2011-2#1)
the platform can be used##2##5##(2008-2#1)(2013-1#1)
the platform for##2##3##(2005-10#1)(2011-1#1)
the platform was##2##3##(2008-10#1)(2008-7#1)
the platform##18##2##(1993-9#2)(2005-10#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-5#3)(2008-7#1)(2009-9#1)(2011-1#1)(2013-1#1)
the plating##2##2##(2008-10#1)(2008-9#1)
the platinum group elements##5##4##(2008-10#4)(2008-11#1)
the platinum##16##2##(1991-10#1)(1992-1#1)(1994-6#1)(1997-6#1)(2008-10#8)(2008-11#1)(2008-5#3)
the platinum-based##2##2##(2010-8#1)(2012-12#1)
the platypus##2##2##(1997-8#1)(2008-8#1)
the platysma##3##2##(2007-12#1)(2010-11#1)(2013-8#1)
the plausibility of the##2##4##(2008-6#1)(2008-9#1)
the plausibility of##5##3##(2008-6#1)(2008-9#1)(2011-12#1)(2012-2#1)(2013-7#1)
the plausible##5##2##(2008-5#2)(2008-7#1)(2013-1#1)(2013-8#1)
the play lady legacy##2##4##(1992-12#2)
the play of##2##3##(1993-12#1)(2008-2#1)
the play##9##2##(1992-12#2)(1993-12#1)(2008-12#1)(2008-2#2)(2008-9#1)(2010-2#1)(2012-2#1)
the player##2##2##(2006-3#1)(2007-10#1)
the players##3##2##(1991-12#1)(2008-9#1)(2009-10#1)
the pleasurable##2##2##(2009-6#1)(2011-2#1)
the pleckstrin homology domain##6##4##(1994-11#2)(1994-12#4)
the pleckstrin homology##8##3##(1994-11#2)(1994-12#5)(1996-10#1)
the plectin gene##3##3##(1996-4#3)
the pleiotropic effects of##2##4##(1992-8#1)(1992-9#1)
the pleiotropic effects##3##3##(1992-8#1)(1992-9#1)(1995-10#1)
the pleiotropic##5##2##(1992-8#1)(1992-9#1)(1995-10#1)(2010-10#1)(2011-2#1)
the plenary##6##2##(2005-7#1)(2005-8#2)(2008-5#2)(2013-7#1)
the pleopod##2##2##(2008-5#2)
the plesiomorphic##2##2##(2007-12#2)
the plethora of potential applications##2##5##(2012-12#2)
the plethora of##10##3##(1991-1#1)(1996-12#1)(2008-1#1)(2008-5#2)(2008-8#1)(2009-6#1)(2012-12#2)(2012-2#1)
the pleura and##2##3##(1991-12#1)(2010-12#1)
the pleura##27##2##(1990-12#1)(1991-12#2)(2007-5#2)(2007-8#6)(2008-6#2)(2010-12#3)(2010-3#1)(2010-8#1)(2011-1#2)(2012-2#5)(2012-3#2)
the pleural cavity##11##3##(1990-10#1)(1991-8#1)(1995-6#1)(2007-1#1)(2007-12#2)(2007-8#1)(2010-10#1)(2011-2#1)(2012-1#2)
the pleural effusion##4##3##(1990-10#1)(1996-12#1)(2007-7#1)(2013-8#1)
the pleural fluid##3##3##(1996-12#1)(2007-7#1)(2010-10#1)
the pleural space##4##3##(2006-10#1)(2007-7#2)(2012-2#1)
the pleural##34##2##(1990-10#2)(1991-8#1)(1995-6#1)(1996-12#3)(2006-10#1)(2007-1#1)(2007-12#5)(2007-7#7)(2007-8#1)(2008-7#1)(2009-6#1)(2010-10#3)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-8#2)
the plexus choroideus##2##3##(1996-3#2)
the plexus##3##2##(1996-3#2)(2008-8#1)
the ploidy##3##2##(1991-6#1)(2008-5#2)
the plot of the##2##4##(1997-8#1)(2011-1#1)
the plot of##7##3##(1997-1#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-12#1)(2011-1#1)
the plot##15##2##(1993-12#1)(1997-1#1)(1997-8#1)(2008-10#8)(2008-3#1)(2008-8#1)(2009-12#1)(2011-1#1)
the plot)##3##2##(2008-10#3)
the plots##12##2##(1995-9#1)(2006-12#1)(2007-3#1)(2008-10#7)(2008-12#1)(2008-3#1)
the plug and##2##3##(2008-10#1)(2009-6#1)
the plug test##3##3##(2013-1#3)
the plug##20##2##(1994-3#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-9#1)(2008-10#1)(2009-6#11)(2013-1#3)
the plume##6##2##(1991-6#1)(2008-2#1)(2008-3#4)
the pluripotent##4##2##(1990-5#1)(2008-9#1)(2010-12#1)(2013-1#1)
the plus##2##2##(2008-5#1)(2011-2#1)
the plus-maze##6##2##(1991-2#1)(1992-7#2)(1993-3#1)(1994-2#1)(2008-11#1)
the pnbA##3##2##(1994-12#3)
the pneumococcal##7##2##(1990-1#1)(1994-9#1)(2007-11#1)(2007-6#1)(2008-10#1)(2010-9#1)(2011-2#1)
the pneumology##2##2##(2010-12#1)(2013-7#1)
the pneumonia##7##2##(1992-3#1)(2006-10#1)(2008-5#1)(2012-12#1)(2013-1#3)
the poetic##2##2##(1993-2#1)(1995-1#1)
the point at nullity##2##4##(1997-8#2)
the point at which##5##4##(1994-11#1)(2005-11#2)(2008-3#1)(2012-2#1)
the point at##7##3##(1994-11#1)(1997-8#2)(2005-11#2)(2008-3#1)(2012-2#1)
the point mutation##4##3##(1990-12#1)(1996-6#1)(1997-5#1)(2009-4#1)
the point mutations##2##3##(2008-10#1)(2008-12#1)
the point of care##6##4##(1997-3#1)(2007-2#1)(2008-11#1)(2010-8#1)(2013-1#2)
the point of departure for##2##5##(2007-7#1)(2012-2#1)
the point of discharge##2##4##(2008-3#1)(2010-12#1)
the point of entry##2##4##(2007-7#1)(2008-11#1)
the point of inflection##3##4##(2008-10#2)(2008-2#1)
the point of the##3##4##(2005-7#1)(2007-11#1)(2008-10#1)
the point of##89##3##(1990-3#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#2)(1993-1#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-2#2)(1994-3#2)(1995-11#1)(1995-2#1)(1996-1#1)(1997-3#2)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#4)(2007-2#1)(2007-7#4)(2007-8#1)(2008-1#3)(2008-10#10)(2008-11#5)(2008-2#4)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#4)(2009-12#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#4)
the point on##2##3##(2008-7#1)(2010-4#1)
the point source##3##3##(2008-10#1)(2008-3#2)
the point spread function##3##4##(2006-4#1)(2007-12#1)(2009-4#1)
the point that##6##3##(2008-5#1)(2008-8#1)(2009-3#1)(2009-7#1)(2009-8#1)(2013-1#1)
the point where the##3##4##(1990-12#1)(1992-7#1)(2008-8#1)
the point where##10##3##(1990-12#1)(1991-2#1)(1992-3#1)(1992-7#1)(1995-8#1)(2007-12#1)(2008-5#1)(2008-8#1)(2009-12#2)
the point##149##2##(1990-12#2)(1990-3#1)(1990-9#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-7#1)(1993-1#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#3)(1994-3#2)(1995-11#1)(1995-2#1)(1995-8#1)(1996-1#2)(1996-2#1)(1996-6#1)(1997-3#2)(1997-5#1)(1997-8#2)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-4#4)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-7#4)(2007-8#2)(2008-1#3)(2008-10#14)(2008-11#5)(2008-12#1)(2008-2#6)(2008-3#11)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#2)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#6)
the point-of-care##2##2##(1996-1#1)(2010-2#1)
the point-spread function (PSF)##3##4##(2008-2#1)(2008-3#2)
the point-spread function is##3##4##(2008-2#1)(2008-3#2)
the point-spread function of the##6##5##(2007-12#3)(2008-2#2)(2008-3#1)
the point-spread function##18##3##(2007-12#5)(2008-2#6)(2008-3#7)
the point-spread functions##2##3##(2008-3#2)
the point-spread##20##2##(2007-12#5)(2008-2#6)(2008-3#9)
the point-symmetrical solution##2##3##(2008-2#2)
the pointing##8##2##(1992-10#2)(1995-12#1)(2008-2#2)(2008-3#3)
the points of##3##3##(2008-10#1)(2008-3#2)
the points that##2##3##(2010-2#1)(2012-1#1)
the points##18##2##(1997-8#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2009-2#1)(2010-2#1)(2012-1#1)(2013-1#3)
the poison##2##2##(2007-12#1)(2008-5#1)
the poisoning of##2##3##(2008-9#1)(2009-2#1)
the poisoning##3##2##(2008-9#1)(2009-2#1)(2012-12#1)
the pol I family##2##4##(1997-8#2)
the pol delta holoenzyme##2##4##(1994-8#2)
the pol##8##2##(1990-9#1)(1993-3#1)(1994-8#2)(1995-2#1)(1997-8#2)(2006-12#1)
the polI family##2##3##(1997-6#2)
the polar coordinates of##2##4##(2008-2#2)
the polar environment##2##3##(1992-3#1)(1994-11#1)
the polar fraction##2##3##(2013-8#2)
the polar head group of##3##5##(1990-5#1)(1991-2#1)(1997-7#1)
the polar head group##5##4##(1990-5#1)(1991-2#1)(1996-7#1)(1997-7#1)(2005-11#1)
the polar head##9##3##(1990-2#1)(1990-5#1)(1991-2#1)(1996-6#1)(1996-7#1)(1997-7#1)(2005-11#2)(2008-11#1)
the polar headgroup##5##3##(1990-11#1)(1991-7#1)(1991-9#1)(1994-8#1)(2008-10#1)
the polar heads##2##3##(1991-5#2)
the polar lipids##3##3##(1996-11#1)(2008-11#1)(2011-2#1)
the polar localization of##2##4##(2009-10#1)(2009-8#1)
the polar##61##2##(1990-11#1)(1990-2#2)(1990-5#1)(1991-2#1)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-3#1)(1992-6#2)(1992-9#1)(1994-10#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-3#1)(1996-11#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-7#1)(2005-11#6)(2005-12#1)(2006-12#1)(2007-11#1)(2007-5#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-8#1)(2011-2#2)(2012-12#1)(2013-8#2)
the polarimeter##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
the polarimetric##2##2##(2008-10#1)(2008-3#1)
the polarity of the##6##4##(1991-5#1)(1995-1#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-5#1)
the polarity of##9##3##(1991-5#1)(1995-1#1)(2005-11#1)(2006-12#1)(2008-10#2)(2008-5#1)(2008-9#1)(2012-12#1)
the polarity##12##2##(1991-5#1)(1995-1#1)(2005-11#1)(2006-12#1)(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#1)
the polarizability of##2##3##(1997-6#1)(2007-12#1)
the polarizability##5##2##(1994-7#1)(1997-6#2)(2007-12#2)
the polarization and##6##3##(1995-8#1)(2006-10#1)(2006-12#1)(2008-2#2)(2013-8#1)
the polarization angle##2##3##(2007-11#1)(2007-12#1)
the polarization characteristics of##2##4##(2008-2#2)
the polarization dependence of Raman gain##2##6##(2007-11#2)
the polarization dependence of##4##4##(2007-11#2)(2008-1#1)(2008-3#1)
the polarization direction of the##2##5##(2008-1#1)(2008-3#1)
the polarization direction of##4##4##(2008-1#1)(2008-2#1)(2008-3#2)
the polarization effects##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
the polarization is##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
the polarization of light scattered by##2##6##(2007-12#1)(2008-2#1)
the polarization of light##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
the polarization of the incident##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
the polarization of the laser##2##5##(2008-2#2)
the polarization of the##14##4##(1995-6#1)(2005-11#1)(2007-11#2)(2008-2#5)(2008-3#4)(2008-8#1)
the polarization of##29##3##(1990-2#1)(1990-3#1)(1991-5#1)(1995-6#1)(2005-11#1)(2007-11#4)(2007-12#1)(2008-2#7)(2008-3#8)(2008-8#1)(2008-9#2)(2012-2#1)
the polarization optics of the##2##5##(2008-2#2)
the polarization properties of fiber lasers##2##6##(2008-2#2)
the polarization properties of##5##4##(2008-1#1)(2008-2#3)(2011-1#1)
the polarization properties##7##3##(2007-11#1)(2008-1#1)(2008-2#3)(2008-3#1)(2011-1#1)
the polarization response of##2##4##(2007-12#1)(2008-2#1)
the polarization rotation##3##3##(2008-2#2)(2008-3#1)
the polarization sensitivity of the##2##5##(2008-2#1)(2008-3#1)
the polarization sensitivity of##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
the polarization sensitivity##5##3##(2007-12#3)(2008-2#1)(2008-3#1)
the polarization state and##2##4##(2007-12#2)
the polarization state of an##2##5##(2007-12#1)(2008-3#1)
the polarization state of light##4##5##(2007-12#2)(2008-3#2)
the polarization state of the incident##3##6##(2007-12#1)(2008-2#1)(2008-3#1)
the polarization state of the##6##5##(2007-12#1)(2008-2#1)(2008-3#4)
the polarization state of##19##4##(2007-11#3)(2007-12#7)(2008-2#1)(2008-3#8)
the polarization state##26##3##(2007-11#3)(2007-12#12)(2008-2#3)(2008-3#8)
the polarization states of the##2##5##(2007-12#2)
the polarization states of##3##4##(2007-12#2)(2013-7#1)
the polarization states##4##3##(2007-12#3)(2013-7#1)
the polarization##155##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-5#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-7#1)(2005-11#2)(2006-10#1)(2006-12#2)(2007-11#16)(2007-12#38)(2007-8#1)(2008-1#4)(2008-2#33)(2008-3#41)(2008-8#1)(2008-9#2)(2009-4#1)(2011-1#1)(2012-2#1)(2013-7#1)(2013-8#2)
the polarization-dependent##4##2##(2007-12#1)(2008-3#3)
the polarization-mode dispersion##3##3##(2007-12#2)(2008-2#1)
the polarization-mode##4##2##(2007-12#3)(2008-2#1)
the polarization-modulated##2##2##(2007-12#1)(2008-3#1)
the polarization-resolved##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
the polarization-state evolution##2##3##(2007-11#2)
the polarization-state##4##2##(2007-11#2)(2008-3#2)
the polarized##19##2##(1992-3#1)(1996-5#2)(1997-6#1)(2006-10#1)(2007-12#2)(2008-2#5)(2008-3#4)(2010-8#1)(2012-12#2)
the polarizer and the##2##4##(2008-2#2)
the polarizer##8##2##(2007-12#1)(2008-2#2)(2008-3#5)
the polarizing activity##2##3##(1991-5#1)(1993-12#1)
the polarizing direction##3##3##(2008-2#3)
the polarizing##10##2##(1991-5#1)(1993-12#1)(2007-11#1)(2008-2#4)(2008-3#3)
the polarographic determination of benzaldehyde##2##5##(2008-10#2)
the polarographic determination of##3##4##(2008-10#3)
the polarographic method##2##3##(2008-10#2)
the polarographic##7##2##(2008-10#7)
the pole##5##2##(1992-9#1)(2007-8#1)(2011-2#3)
the poles of##2##3##(2008-8#1)(2008-9#1)
the poles##5##2##(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-6#1)
the polh##4##2##(1997-4#4)
the police in##2##3##(1996-6#1)(1997-8#1)
the police##16##2##(1991-8#1)(1993-3#1)(1993-5#1)(1994-4#1)(1996-6#1)(1997-8#4)(2005-8#2)(2005-9#1)(2006-8#1)(2007-3#1)(2009-2#1)(2009-7#1)
the policies that##2##3##(2007-2#1)(2012-1#1)
the policies##8##2##(1993-3#1)(2006-12#1)(2007-2#1)(2008-7#1)(2010-2#1)(2010-6#1)(2012-1#1)(2012-3#1)
the policy implications of##4##4##(2007-6#1)(2008-7#1)(2010-12#1)(2011-1#1)
the policy implications##5##3##(1993-12#1)(2007-6#1)(2008-7#1)(2010-12#1)(2011-1#1)
the policy of##2##3##(1993-8#1)(2008-7#1)
the policy process##3##3##(1995-1#1)(1995-2#1)(1996-12#1)
the policy##32##2##(1991-12#1)(1992-12#2)(1993-12#1)(1993-3#1)(1993-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-7#2)(2007-6#1)(2008-2#1)(2008-6#1)(2008-7#2)(2009-3#3)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)
the poling temperature##2##3##(2007-12#2)
the poling##8##2##(2007-12#8)
the polio##4##2##(2007-10#1)(2008-4#1)(2012-12#2)
the polishing##2##2##(1994-6#1)(2008-3#1)
the political and economic##3##4##(1995-2#1)(2008-5#1)(2009-4#1)
the political and##7##3##(1993-3#1)(1994-3#1)(1995-2#1)(2008-2#1)(2008-5#1)(2009-4#1)(2012-2#1)
the political process##2##3##(1991-2#1)(1997-1#1)
the political##37##2##(1991-2#1)(1992-1#1)(1992-6#1)(1993-3#2)(1994-3#2)(1995-12#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-12#1)(1997-1#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#3)(2009-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
the politicization of##2##3##(2006-7#2)
the politics of##8##3##(1992-1#1)(1994-2#1)(2006-7#1)(2008-10#2)(2008-8#1)(2009-5#1)(2013-7#1)
the politics##9##2##(1992-1#1)(1994-2#1)(2006-7#1)(2008-10#2)(2008-8#1)(2009-5#1)(2010-8#1)(2013-7#1)
the pollen season##2##3##(2007-9#1)(2012-7#1)
the pollen tube##7##3##(2008-11#3)(2009-10#1)(2009-8#3)
the pollen##19##2##(1996-5#1)(2005-10#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-6#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-8#3)(2012-7#2)(2013-1#1)
the pollinator##2##2##(2008-8#1)(2012-2#1)
the pollutant##5##2##(2007-8#1)(2008-10#2)(2010-2#1)(2010-9#1)
the pollutants##10##2##(2004-4#1)(2007-10#3)(2008-10#3)(2008-11#1)(2008-3#1)(2011-2#1)
the polluted rivers##2##3##(2008-7#2)
the polluted##10##2##(1996-3#1)(2004-4#2)(2006-10#1)(2006-12#2)(2008-5#2)(2008-7#2)
the pollution of##2##3##(2006-10#1)(2012-12#1)
the pollution##7##2##(2004-4#2)(2006-10#1)(2007-10#1)(2008-11#1)(2012-12#2)
the poly##2##2##(2008-10#1)(2013-8#1)
the poly(A) tail##6##3##(1990-3#1)(1990-4#1)(1991-9#1)(1997-2#1)(2008-10#1)(2008-4#1)
the poly(A)##8##2##(1990-3#1)(1990-4#1)(1991-9#1)(1994-11#1)(1997-2#1)(2008-10#1)(2008-4#1)(2011-1#1)
the poly(ADP-ribose) polymerase##2##3##(1992-6#1)(2008-1#1)
the poly(ADP-ribose)##3##2##(1992-6#1)(1993-12#1)(2008-1#1)
the poly(P)-dependent reaction##2##3##(1996-7#2)
the poly-alanine##2##2##(2012-2#2)
the polyacrylamide##2##2##(1991-10#1)(2008-10#1)
the polyacrylate##2##2##(2005-11#1)(2008-11#1)
the polyadenylation##4##2##(1992-12#1)(1994-11#1)(1996-11#1)(2010-4#1)
the polyalcohol##3##2##(1991-12#3)
the polyamine site of the NMDA receptor##2##7##(1996-2#2)
the polyamine site of##3##4##(1996-2#3)
the polyamine site##6##3##(1990-2#1)(1992-3#1)(1996-2#3)(2007-9#1)
the polyamine##10##2##(1990-2#1)(1990-7#1)(1991-4#1)(1992-3#1)(1996-2#3)(1997-7#1)(2007-9#1)(2010-4#1)
the polyamines##3##2##(1991-8#1)(1993-12#1)(1996-10#1)
the polyanion##3##2##(1996-4#1)(1997-1#1)(2006-10#1)
the polyanions##4##2##(1997-1#3)(2008-10#1)
the polycation##4##2##(1994-2#1)(1996-4#1)(2005-11#1)(2006-10#1)
the polycationic##5##2##(1994-9#4)(2008-11#1)
the polychaete annelid Nereis diversicolor##2##5##(1994-10#2)
the polychaete annelid##3##3##(1990-5#1)(1994-10#2)
the polyclonal antibodies##3##3##(1990-12#1)(1990-5#1)(2006-8#1)
the polyclonal antibody##2##3##(1997-7#1)(2008-10#1)
the polyclonal##14##2##(1990-12#1)(1990-5#1)(1990-8#1)(1994-3#1)(1997-7#1)(2006-8#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)
the polycrystalline##5##2##(1996-2#1)(2007-12#2)(2008-2#1)(2010-7#1)
the polycyclic aromatic##2##3##(1991-8#1)(2009-4#1)
the polycystic ovary syndrome##9##4##(1993-1#1)(2008-3#3)(2008-4#4)(2010-4#1)
the polyelectrolyte##5##2##(2005-11#2)(2008-10#1)(2008-7#1)(2010-9#1)
the polyester##4##2##(2005-11#1)(2010-4#1)(2010-8#2)
the polyethylene glycol##3##3##(2006-3#1)(2008-3#1)(2011-2#1)
the polyethylene##6##2##(2006-3#1)(2008-3#1)(2008-8#2)(2011-2#1)(2012-1#1)
the polygenic##3##2##(1993-9#1)(2008-10#2)
the polygon##2##2##(2007-11#1)(2008-2#1)
the polyhedrin gene locus##2##4##(2008-11#1)(2008-8#1)
the polyhedrin gene##3##3##(1995-12#1)(2008-11#1)(2008-8#1)
the polyhedrin promoter##6##3##(1994-11#1)(1997-4#2)(2005-11#1)(2008-11#2)
the polyhedrin##9##2##(1994-11#1)(1995-12#1)(1997-4#2)(2005-11#1)(2008-11#3)(2008-8#1)
the polyion##4##2##(1996-4#2)(2006-10#2)
the polymer aggregates##2##3##(2010-4#2)
the polymer and the##5##4##(1995-6#1)(2005-11#1)(2008-10#1)(2010-12#1)(2010-8#1)
the polymer and##8##3##(1995-11#1)(1995-6#1)(2005-11#2)(2008-10#2)(2010-12#1)(2010-8#1)
the polymer backbone##5##3##(2005-11#2)(2007-12#1)(2008-10#1)(2009-10#1)
the polymer brushes with##2##4##(2005-11#2)
the polymer brushes##7##3##(2005-11#5)(2009-10#1)(2010-4#1)
the polymer chain##2##3##(2005-11#1)(2008-10#1)
the polymer chains##3##3##(1994-2#1)(2005-11#1)(2008-7#1)
the polymer coating##4##3##(2008-10#3)(2010-2#1)
the polymer did##2##3##(2008-11#1)(2010-4#1)
the polymer film##4##3##(2006-12#1)(2008-10#3)
the polymer films##6##3##(2007-12#1)(2008-10#2)(2008-2#1)(2010-4#1)(2013-1#1)
the polymer gel##2##3##(2007-8#1)(2009-10#1)
the polymer heteronuclei##2##3##(2011-3#2)
the polymer host##2##3##(2007-12#1)(2010-4#1)
the polymer in##2##3##(1991-7#1)(2009-2#1)
the polymer is##4##3##(2005-11#2)(2008-10#1)(2008-5#1)
the polymer matrix and##4##4##(2007-12#1)(2009-11#1)(2009-12#1)(2010-4#1)
the polymer matrix during the##2##5##(2008-10#2)
the polymer matrix##14##3##(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#2)(2008-7#2)(2009-11#1)(2009-12#2)(2010-4#1)
the polymer molecule##2##3##(2008-3#1)(2008-7#1)
the polymer network##2##3##(1991-10#1)(2008-5#1)
the polymer phase##4##3##(1996-6#3)(2008-10#1)
the polymer residue##2##3##(2008-5#2)
the polymer surface##5##3##(2005-11#1)(2008-10#1)(2008-5#1)(2013-1#2)
the polymer that##2##3##(2007-11#1)(2009-10#1)
the polymer to##6##3##(2006-12#1)(2008-10#2)(2008-11#1)(2009-3#1)(2011-2#1)
the polymer was##5##3##(2007-11#1)(2009-3#1)(2010-12#1)(2012-11#2)
the polymer were##2##3##(1996-6#1)(2008-10#1)
the polymer with##3##3##(2008-8#1)(2009-3#1)(2010-1#1)
the polymer##187##2##(1991-10#1)(1991-3#1)(1991-7#2)(1991-8#1)(1994-2#1)(1994-9#5)(1995-11#2)(1995-2#1)(1995-6#2)(1996-2#1)(1996-6#5)(2004-9#2)(2005-11#28)(2005-7#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-9#1)(2007-11#3)(2007-12#7)(2007-8#2)(2008-10#35)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#4)(2008-5#7)(2008-7#5)(2008-8#2)(2009-10#6)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#3)(2009-5#1)(2010-1#1)(2010-12#4)(2010-2#3)(2010-4#11)(2010-5#3)(2010-7#2)(2010-8#2)(2011-2#1)(2011-3#2)(2012-11#2)(2012-12#2)(2013-1#5)
the polymer's##3##2##(2007-11#1)(2008-5#1)(2009-8#1)
the polymerase chain reaction (PCR) and the##2##7##(2008-10#1)(2008-4#1)
the polymerase chain reaction (PCR) and##4##6##(1994-7#1)(2008-10#1)(2008-4#2)
the polymerase chain reaction (PCR) technique##2##6##(1990-3#1)(1992-9#1)
the polymerase chain reaction (PCR) to amplify##2##7##(1993-4#1)(2008-2#1)
the polymerase chain reaction (PCR) to detect##2##7##(1991-6#1)(1993-5#1)
the polymerase chain reaction (PCR) to##9##6##(1991-6#1)(1992-1#1)(1993-4#1)(1993-5#1)(2008-2#2)(2008-4#3)
the polymerase chain reaction (PCR)##43##5##(1990-11#1)(1990-2#1)(1990-3#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-4#1)(1993-5#2)(1993-7#1)(1994-12#2)(1994-7#1)(1994-8#1)(1995-8#2)(1996-11#1)(1996-7#1)(1997-4#1)(1997-7#1)(2006-8#1)(2007-8#1)(2008-10#4)(2008-2#3)(2008-4#7)(2008-9#1)
the polymerase chain reaction and##11##5##(1990-8#2)(1991-12#1)(1991-5#2)(1993-11#1)(1994-11#1)(1994-12#1)(2006-10#1)(2007-10#1)(2008-11#1)
the polymerase chain reaction is a##2##6##(1996-2#1)(2006-10#1)
the polymerase chain reaction is##4##5##(1996-2#2)(2006-10#2)
the polymerase chain reaction products##2##5##(1991-9#1)(1996-10#1)
the polymerase chain reaction technique##4##5##(1990-12#1)(1990-2#1)(1991-9#1)(1993-2#1)
the polymerase chain reaction to##9##5##(1991-6#1)(1991-7#1)(1991-9#2)(1992-12#1)(1993-11#1)(2008-11#1)(2011-2#2)
the polymerase chain reaction using primers##2##6##(1992-6#1)(1993-2#1)
the polymerase chain reaction using##4##5##(1992-6#1)(1993-2#1)(1996-7#1)(1997-6#1)
the polymerase chain reaction with a##2##6##(1992-2#1)(1994-9#1)
the polymerase chain reaction with##4##5##(1992-2#1)(1994-11#1)(1994-9#1)(1997-5#1)
the polymerase chain reaction##142##4##(1990-11#3)(1990-12#2)(1990-2#3)(1990-3#3)(1990-7#2)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#6)(1991-7#1)(1991-9#7)(1992-1#3)(1992-10#2)(1992-11#1)(1992-12#4)(1992-2#3)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#3)(1993-12#2)(1993-2#6)(1993-4#1)(1993-5#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#6)(1994-2#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#2)(1996-2#2)(1996-7#2)(1996-9#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#1)(2006-10#3)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-8#2)(2008-10#6)(2008-11#2)(2008-2#4)(2008-4#7)(2008-5#3)(2008-9#1)(2009-10#1)(2011-2#2)(2013-8#1)
the polymerase chain reaction]##2##4##(1990-8#1)(1996-8#1)
the polymerase chain##145##3##(1990-11#3)(1990-12#2)(1990-2#3)(1990-3#3)(1990-7#2)(1990-8#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#6)(1991-7#1)(1991-9#7)(1992-1#3)(1992-10#2)(1992-11#1)(1992-12#4)(1992-2#3)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#3)(1993-12#2)(1993-2#6)(1993-4#1)(1993-5#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#6)(1994-2#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#2)(1996-2#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#1)(2006-10#3)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-8#2)(2008-10#6)(2008-11#2)(2008-2#4)(2008-4#7)(2008-5#3)(2008-9#1)(2009-10#1)(2011-2#2)(2013-8#1)
the polymerase##165##2##(1990-11#3)(1990-12#2)(1990-2#3)(1990-3#3)(1990-7#2)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#6)(1991-7#1)(1991-9#7)(1992-1#3)(1992-10#2)(1992-11#1)(1992-12#4)(1992-2#3)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#3)(1993-12#3)(1993-2#6)(1993-4#1)(1993-5#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#7)(1994-2#1)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#2)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#2)(1996-2#2)(1996-7#3)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#3)(1997-5#4)(1997-6#3)(1997-7#1)(1997-8#1)(2006-10#3)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-8#2)(2008-10#6)(2008-11#2)(2008-2#4)(2008-4#7)(2008-5#4)(2008-9#1)(2009-10#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-8#1)
the polymeric matrix##9##3##(1996-2#1)(2008-10#6)(2008-2#1)(2010-4#1)
the polymeric##42##2##(1990-2#1)(1990-8#2)(1991-3#2)(1991-7#1)(1996-2#1)(1996-8#4)(1997-6#1)(2004-9#1)(2006-12#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#12)(2008-11#1)(2008-2#2)(2008-5#3)(2008-6#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
the polymerizable lecithin##2##3##(1991-2#2)
the polymerizable##3##2##(1991-2#3)
the polymerization and##2##3##(1997-4#1)(2011-2#1)
the polymerization mode##2##3##(2008-5#2)
the polymerization of##10##3##(1990-10#1)(1990-7#1)(1993-5#1)(1993-6#1)(1997-8#1)(2005-8#1)(2007-9#1)(2008-10#1)(2008-7#1)(2012-2#1)
the polymerization process##4##3##(2005-11#1)(2008-3#2)(2010-10#1)
the polymerization rate##2##3##(1990-9#1)(2008-3#1)
the polymerization reaction is##2##4##(2008-2#1)(2010-7#1)
the polymerization reaction##3##3##(2005-11#1)(2008-2#1)(2010-7#1)
the polymerization step##2##3##(1997-1#2)
the polymerization##36##2##(1990-10#1)(1990-7#2)(1990-9#1)(1992-9#1)(1993-5#1)(1993-6#1)(1994-8#1)(1997-1#2)(1997-4#1)(1997-8#1)(2005-11#3)(2005-8#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2009-10#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
the polymerized##6##2##(1990-6#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-5#2)
the polymers and##4##3##(1996-11#1)(2008-10#1)(2008-11#2)
the polymers that##2##3##(2007-12#1)(2008-10#1)
the polymers were##2##3##(2008-5#1)(2010-9#1)
the polymers##28##2##(1990-8#1)(1994-11#1)(1994-9#1)(1996-11#2)(2005-11#1)(2006-5#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-12#1)(2010-4#2)(2010-5#2)(2010-9#1)(2013-1#2)
the polymethylene##3##2##(1990-2#2)(1992-11#1)
the polymorphic markers##2##3##(2007-2#1)(2008-10#1)
the polymorphic site##4##3##(1996-5#1)(2007-2#1)(2008-4#2)
the polymorphic##20##2##(1990-3#1)(1992-6#2)(1994-9#1)(1995-6#1)(1996-5#1)(1997-5#1)(2006-6#1)(2007-2#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#3)(2010-12#1)(2012-12#2)
the polymorphism of the##3##4##(1990-3#1)(2009-5#1)(2013-1#1)
the polymorphism of##7##3##(1990-3#1)(2008-10#2)(2009-5#1)(2012-1#1)(2012-12#1)(2013-1#1)
the polymorphism##13##2##(1990-3#1)(1995-11#1)(1995-3#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-9#1)(2009-5#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-1#1)
the polymorphisms of##5##3##(1997-8#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-12#1)
the polymorphisms##11##2##(1997-8#1)(2006-10#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the polymorphonuclear##2##2##(1990-4#1)(1992-5#1)
the polynomial##4##2##(2008-10#1)(2008-3#1)(2008-6#2)
the polynucleotides##3##2##(1995-5#1)(2006-10#2)
the polyol pathway##2##3##(1992-3#1)(2008-1#1)
the polyol##3##2##(1992-3#1)(2008-1#1)(2008-10#1)
the polyoma origin of replication##2##5##(1995-2#2)
the polyoma##4##2##(1992-8#1)(1995-2#3)
the polyoxyethylene##2##2##(2005-11#1)(2010-1#1)
the polyp##6##2##(1993-9#1)(2006-1#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
the polypeptide backbone##2##3##(1994-9#2)
the polypeptide backbones##2##3##(1994-3#1)(2009-2#1)
the polypeptide chain folds##2##4##(1994-8#1)(1997-4#1)
the polypeptide chain of##3##4##(1991-4#1)(1994-3#1)(1997-7#1)
the polypeptide chain##20##3##(1990-5#1)(1991-4#3)(1991-8#1)(1992-4#1)(1992-8#1)(1992-9#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1997-4#1)(1997-6#2)(1997-7#1)(2006-10#1)(2008-8#1)(2012-1#1)
the polypeptide to##3##3##(1990-5#1)(1993-8#1)(2006-10#1)
the polypeptide##44##2##(1990-2#1)(1990-4#1)(1990-5#2)(1991-1#2)(1991-3#1)(1991-4#3)(1991-8#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-8#2)(1994-9#3)(1995-3#1)(1996-8#1)(1997-4#1)(1997-6#2)(1997-7#1)(2005-11#1)(2006-10#3)(2008-8#1)(2009-2#1)(2010-2#1)(2010-7#1)(2012-1#1)
the polypeptides##4##2##(1994-12#1)(2008-4#1)(2008-7#1)(2010-7#1)
the polyphagous##2##2##(2004-2#1)(2008-8#1)
the polyphenol##2##2##(2008-10#1)(2013-7#1)
the polyphosphate##3##2##(1993-12#1)(2009-2#2)
the polyploidization##2##2##(1994-11#2)
the polypoid##2##2##(2009-7#1)(2013-1#1)
the polypropylene##5##2##(2005-11#1)(2008-7#1)(2012-3#3)
the polyps##4##2##(2008-11#1)(2008-5#1)(2009-12#1)(2010-12#1)
the polypurine tract##3##3##(1990-6#1)(1996-4#2)
the polypurine##4##2##(1990-6#1)(1996-4#3)
the polypyrrole film##2##3##(2008-10#2)
the polypyrrole##5##2##(2008-10#5)
the polyradical##2##2##(2008-10#2)
the polysaccharide concentration##2##3##(2005-8#2)
the polysaccharide to##2##3##(1991-12#1)(2011-2#1)
the polysaccharide##16##2##(1990-3#1)(1991-12#2)(1991-7#3)(1992-8#1)(1993-6#1)(1994-9#1)(1995-11#1)(2005-8#2)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
the polysaccharides##3##2##(2012-12#2)(2012-6#1)
the polysomnography##2##2##(2007-6#2)
the polystyrene##2##2##(2005-11#1)(2008-11#1)
the polysynaptic##2##2##(1996-2#2)
the polyunsaturated##5##2##(1991-4#1)(1995-11#1)(1996-10#1)(1996-11#1)(2008-7#1)
the polyurethane coating##2##3##(2013-8#2)
the polyurethane foam##5##3##(2008-10#5)
the polyurethane##10##2##(2007-7#1)(2008-10#6)(2009-7#1)(2013-8#2)
the pomegranate##2##2##(2013-8#2)
the pond snail##2##3##(1990-7#1)(1991-11#1)
the pond##7##2##(1990-7#1)(1991-11#1)(2005-10#1)(2006-8#3)(2013-7#1)
the pons##6##2##(1992-1#1)(1992-2#1)(1995-2#1)(1995-5#1)(1996-5#1)(2007-10#1)
the pontine nuclei##6##3##(1996-9#1)(2008-11#5)
the pontine reticular formation##3##4##(1990-7#3)
the pontine##15##2##(1990-7#3)(1991-3#1)(1993-5#1)(1995-5#1)(1995-7#1)(1996-9#2)(2008-11#5)(2010-8#1)
the pontomedullary##2##2##(1990-9#1)(1994-2#1)
the pontomesencephalic reticular formation##2##4##(1997-3#2)
the pontomesencephalic##3##2##(1995-12#1)(1997-3#2)
the pooid-infecting##2##2##(2008-10#2)
the pool of##17##3##(1994-2#1)(1995-1#1)(1997-2#2)(2005-12#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-6#1)(2012-3#2)(2013-7#1)
the pool##26##2##(1990-3#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-2#1)(1995-1#3)(1997-2#2)(1997-8#1)(2005-12#1)(2007-10#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-6#1)(2012-3#2)(2013-7#1)
the pooled MD##3##3##(2013-1#3)
the pooled comparators##2##3##(2012-3#2)
the pooled data##5##3##(1990-11#2)(2008-10#2)(2008-12#1)
the pooled##22##2##(1990-11#2)(1993-12#1)(1995-2#2)(1995-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#2)(2008-8#1)(2011-1#1)(2012-1#1)(2012-3#2)(2013-1#4)
the poor and##3##3##(1993-3#1)(1994-2#1)(1994-7#1)
the poor clinical##2##3##(2008-1#1)(2009-7#1)
the poor functional##2##3##(2008-5#1)(2009-3#1)
the poor in##2##3##(2006-7#1)(2009-5#1)
the poor oral##2##3##(2008-1#1)(2009-4#1)
the poor outcome##2##3##(1994-12#1)(2010-12#1)
the poor outcomes of##2##4##(2008-8#1)(2011-2#1)
the poor prognosis of##5##4##(1991-2#1)(1992-2#1)(1992-6#1)(1996-4#1)(2008-8#1)
the poor prognosis##11##3##(1991-2#1)(1991-5#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-5#1)(1996-4#1)(2008-3#1)(2008-6#1)(2008-8#2)
the poor prognostic##2##3##(2007-7#1)(2008-1#1)
the poor response##2##3##(2008-10#1)(2013-1#1)
the poor sensitivity of##2##4##(2004-1#1)(2008-10#1)
the poor solubility of##2##4##(2006-10#1)(2010-2#1)
the poor survival##2##3##(1991-4#1)(2009-10#1)
the poor with##2##3##(2007-5#1)(2010-5#1)
the poor##89##2##(1990-12#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-2#2)(1992-4#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-7#1)(1995-12#1)(1995-9#1)(1996-1#3)(1996-2#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-6#1)(2004-1#1)(2006-10#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-4#1)(2007-5#2)(2007-7#3)(2008-1#3)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-2#2)(2011-3#1)(2013-1#1)
the poorer##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2009-2#1)
the poorest and most##2##4##(2012-12#1)(2012-3#1)
the poorest countries##2##3##(1992-5#1)(2008-7#1)
the poorest survival##2##3##(2008-10#1)(2010-3#1)
the poorest##21##2##(1990-2#1)(1992-2#1)(1992-5#1)(1993-6#1)(2006-10#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-7#1)(2008-9#2)(2009-6#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)
the poorly##8##2##(1990-2#1)(1991-8#1)(1993-9#1)(1995-8#1)(1996-4#1)(2010-7#1)(2012-12#1)(2013-7#1)
the popliteal artery##7##3##(1990-10#3)(1991-3#2)(2007-11#1)(2007-8#1)
the popliteal fossa##2##3##(1993-7#1)(2010-12#1)
the popliteal lymph node##2##4##(2008-10#2)
the popliteal##14##2##(1990-10#4)(1991-3#3)(1993-7#1)(2005-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2010-12#1)
the popliteus##3##2##(2010-12#3)
the popular##22##2##(1992-8#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-4#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-8#1)(2009-2#1)(2009-7#1)(2010-9#1)(2013-8#2)
the popularity of##9##3##(1993-2#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-7#1)(2009-6#1)(2010-9#1)
the population aged##2##3##(1995-9#1)(2007-10#1)
the population ages##3##3##(2008-3#1)(2008-7#1)(2009-5#1)
the population and the##4##4##(2007-11#1)(2008-9#1)(2009-7#1)(2013-1#1)
the population and##28##3##(1990-10#1)(1990-7#1)(1992-1#1)(1992-5#1)(1993-1#1)(1993-2#2)(1996-3#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-12#1)(2011-2#2)(2012-11#1)(2013-1#1)
the population as a whole##6##5##(1992-4#1)(1993-11#2)(2008-4#1)(2008-8#1)(2012-12#1)
the population as##8##3##(1992-4#1)(1993-11#2)(1997-6#1)(2006-10#1)(2008-4#1)(2008-8#1)(2012-12#1)
the population at large##6##4##(1992-2#2)(2006-10#1)(2007-9#1)(2008-4#1)(2011-2#1)
the population at##10##3##(1992-2#2)(1993-11#1)(1994-4#1)(1997-6#1)(2006-10#1)(2007-9#1)(2008-4#1)(2009-6#1)(2011-2#1)
the population being##5##3##(1997-2#1)(2008-7#1)(2008-9#1)(2010-5#1)(2012-12#1)
the population between##5##3##(1994-6#1)(2013-8#4)
the population biology of##4##4##(2008-10#3)(2008-8#1)
the population by##7##3##(1991-3#1)(1997-7#1)(2008-1#1)(2008-11#1)(2010-8#1)(2012-2#1)(2013-8#1)
the population data are going to be available in the EMPOP database (www##3##13##(2008-12#3)
the population densities of##7##4##(2005-8#1)(2007-5#1)(2008-10#4)(2008-7#1)
the population densities##8##3##(2005-8#1)(2007-5#1)(2008-10#5)(2008-7#1)
the population density and metabolic activity of the##2##8##(2008-10#2)
the population density of the pathogen##2##6##(2008-10#2)
the population density of the##3##5##(2008-10#3)
the population density of##8##4##(2008-10#7)(2009-3#1)
the population density##12##3##(2007-2#1)(2008-10#9)(2009-3#1)(2012-2#1)
the population distribution##2##3##(2008-1#1)(2010-2#1)
the population distributions##2##3##(2008-9#1)(2010-2#1)
the population during##2##3##(2008-10#2)
the population dynamics of the##2##5##(2007-12#1)(2008-10#1)
the population dynamics of##13##4##(1994-8#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-8#2)(2008-9#1)(2010-12#1)(2012-3#1)(2013-8#1)
the population dynamics##16##3##(1994-8#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-8#3)(2008-9#1)(2010-12#1)(2012-3#1)(2013-8#2)
the population from##5##3##(1991-12#1)(2008-10#2)(2008-5#1)(2010-3#1)
the population genetic structure of##3##5##(2008-10#2)(2011-2#1)
the population genetic##4##3##(2008-10#2)(2008-12#1)(2011-2#1)
the population genetics##2##3##(2008-10#1)(2013-1#1)
the population groups##2##3##(1993-1#1)(2007-6#1)
the population growth rate##2##4##(2008-8#1)(2008-9#1)
the population growth##4##3##(2008-10#1)(2008-8#1)(2008-9#1)(2012-2#1)
the population has##7##3##(1992-3#1)(1997-5#1)(1997-8#1)(2006-10#2)(2006-2#1)(2008-7#1)
the population have##2##3##(1997-1#1)(2008-8#1)
the population in the##9##4##(1993-8#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#2)(2011-2#1)(2012-12#1)
the population in##16##3##(1991-12#1)(1993-8#1)(2006-10#1)(2006-4#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#2)(2011-1#1)(2011-2#1)(2012-12#1)
the population is##23##3##(1991-12#1)(1991-9#1)(1993-4#1)(1994-6#1)(1994-9#1)(1997-8#1)(2006-2#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#1)
the population level##20##3##(1991-2#1)(1994-12#1)(2006-10#1)(2006-5#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-8#2)(2009-4#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
the population living in the##2##5##(1993-6#1)(2010-9#1)
the population may##2##3##(2006-4#1)(2012-2#1)
the population mean##3##3##(1991-3#1)(1992-9#1)(2009-12#1)
the population might##2##3##(2008-10#1)(2008-3#1)
the population of D##4##4##(2008-10#1)(2012-2#1)(2013-8#2)
the population of Phytophthora infestans##2##5##(2008-10#2)
the population of TRH-responding cells was##2##6##(1994-3#2)
the population of a##4##4##(1995-9#1)(2007-2#1)(2011-2#1)(2013-8#1)
the population of interest##2##4##(1994-1#1)(2008-6#1)
the population of the##17##4##(1990-12#1)(1991-11#1)(1995-1#1)(1995-4#1)(1996-5#1)(1997-5#1)(2007-1#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
the population of these##2##4##(1990-6#1)(2012-1#1)
the population of##93##3##(1990-12#1)(1990-6#1)(1991-10#1)(1991-11#1)(1992-10#1)(1992-5#1)(1992-7#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-3#3)(1995-1#2)(1995-12#1)(1995-4#1)(1995-9#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-5#1)(1997-8#1)(2004-4#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-12#2)(2007-2#3)(2007-8#2)(2008-1#3)(2008-10#12)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-8#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#4)
the population or##2##3##(1992-11#1)(2013-8#1)
the population over##4##3##(1990-6#1)(1995-10#1)(2008-10#1)(2011-1#1)
the population parameter##2##3##(2008-8#1)(2012-2#1)
the population risk##2##3##(1996-8#2)
the population size of the##3##5##(2008-10#2)(2011-2#1)
the population size of##7##4##(2006-10#1)(2008-10#5)(2011-2#1)
the population size##10##3##(2006-10#1)(2008-10#5)(2008-5#1)(2008-8#1)(2010-2#1)(2011-2#1)
the population spike##6##3##(1990-7#1)(1991-12#3)(1995-12#1)(1996-5#1)
the population structure and the##3##5##(2008-10#2)(2013-7#1)
the population structure and##6##4##(2008-10#3)(2008-3#1)(2008-5#1)(2013-7#1)
the population structure of X##2##5##(2008-10#2)
the population structure of##9##4##(2006-3#1)(2008-10#5)(2011-2#1)(2012-3#1)(2013-8#1)
the population structure##17##3##(2006-3#1)(2008-10#8)(2008-3#1)(2008-5#1)(2011-2#2)(2012-3#2)(2013-7#1)(2013-8#1)
the population studied##4##3##(1995-11#1)(2007-10#1)(2009-5#1)(2013-1#1)
the population they##2##3##(2007-4#1)(2013-1#1)
the population to be##2##4##(1997-2#1)(2008-10#1)
the population to##10##3##(1997-2#1)(2006-2#2)(2008-10#1)(2008-8#1)(2008-9#2)(2011-2#2)(2013-1#1)
the population under study##2##4##(1997-7#1)(2008-1#1)
the population was##7##3##(2006-8#1)(2007-12#1)(2008-10#2)(2008-5#2)(2011-1#1)
the population will##2##3##(1990-9#1)(2008-8#1)
the population with##5##3##(1990-9#1)(1996-1#1)(2007-2#1)(2008-5#1)(2010-12#1)
the population##672##2##(1990-10#1)(1990-12#5)(1990-3#2)(1990-5#1)(1990-6#3)(1990-7#2)(1990-9#3)(1991-10#1)(1991-11#1)(1991-12#9)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#1)(1992-2#4)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#1)(1993-1#3)(1993-11#4)(1993-12#1)(1993-2#4)(1993-4#1)(1993-5#1)(1993-6#4)(1993-8#2)(1993-9#2)(1994-1#1)(1994-10#1)(1994-12#4)(1994-2#5)(1994-3#8)(1994-4#2)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#3)(1995-4#2)(1995-5#2)(1995-8#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#4)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#3)(1997-1#4)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#6)(1997-7#2)(1997-8#4)(2004-3#1)(2004-4#2)(2005-10#2)(2005-11#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#12)(2006-11#1)(2006-2#5)(2006-3#1)(2006-4#4)(2006-5#1)(2006-7#1)(2006-8#10)(2006-9#1)(2007-1#2)(2007-10#6)(2007-11#4)(2007-12#7)(2007-2#7)(2007-3#3)(2007-4#3)(2007-5#4)(2007-6#1)(2007-7#4)(2007-8#3)(2007-9#2)(2008-1#10)(2008-10#90)(2008-11#9)(2008-12#11)(2008-2#10)(2008-3#12)(2008-4#5)(2008-5#11)(2008-6#5)(2008-7#11)(2008-8#29)(2008-9#18)(2009-12#2)(2009-2#1)(2009-3#4)(2009-4#6)(2009-5#5)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#8)(2010-2#10)(2010-3#2)(2010-5#2)(2010-7#1)(2010-8#5)(2010-9#3)(2011-1#12)(2011-12#1)(2011-2#30)(2012-1#4)(2012-11#2)(2012-12#15)(2012-2#15)(2012-3#9)(2012-4#1)(2013-1#16)(2013-7#2)(2013-8#31)
the population's##6##2##(1994-3#1)(1994-6#1)(2008-1#1)(2010-2#1)(2010-8#1)(2011-2#1)
the population-aging effect##2##3##(2007-1#2)
the population-based Cancer Registry of the Swiss Canton of Vaud##2##10##(1990-4#1)(1993-9#1)
the population-based model##2##3##(2009-8#2)
the population-based studies##3##3##(2007-10#1)(2007-12#1)(2008-6#1)
the population-based##12##2##(1990-4#1)(1993-9#2)(1997-6#1)(2007-10#1)(2007-12#1)(2008-6#1)(2009-8#2)(2010-8#1)(2013-1#2)
the population-level model##2##3##(2008-9#2)
the population-level##6##2##(2008-11#1)(2008-9#3)(2012-11#1)(2013-8#1)
the population-wide##2##2##(2008-8#2)
the populations from##6##3##(2008-10#5)(2008-8#1)
the populations in##4##3##(2008-10#4)
the populations of the##3##4##(1990-8#1)(2008-10#1)(2008-8#1)
the populations of##21##3##(1990-8#1)(1991-1#1)(1993-6#1)(1993-7#1)(1997-2#1)(2005-11#1)(2007-2#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-8#3)(2010-12#1)(2012-11#1)(2012-2#1)
the populations revealed##2##3##(2008-10#2)
the populations studied##3##3##(1992-12#1)(2008-1#1)(2008-10#1)
the populations was##2##3##(2006-9#1)(2012-1#1)
the populations were##4##3##(1997-7#1)(2008-10#2)(2008-5#1)
the populations##82##2##(1990-8#1)(1991-1#1)(1992-12#1)(1992-2#1)(1993-6#1)(1993-7#1)(1994-3#1)(1994-7#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-7#1)(2004-4#1)(2005-11#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-5#2)(2007-6#1)(2008-1#1)(2008-10#30)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#3)(2009-9#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the porcine Tex11##3##3##(2012-2#3)
the porcine and##3##3##(1992-11#1)(1996-2#1)(2007-1#1)
the porcine aortic##2##3##(1990-2#1)(2010-8#1)
the porcine lacrimal##2##3##(1997-5#2)
the porcine model##5##3##(2005-8#1)(2006-6#1)(2007-12#1)(2009-2#1)(2011-2#1)
the porcine pancreas##2##3##(1990-12#1)(2010-11#1)
the porcine##42##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-10#1)(1991-12#3)(1991-4#1)(1991-6#1)(1992-11#1)(1992-8#1)(1993-3#1)(1994-9#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-5#2)(1997-8#1)(2004-11#2)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-1#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-7#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#4)
the pore and##2##3##(2010-11#1)(2011-2#1)
the pore gates##2##3##(2009-3#2)
the pore helix##2##3##(2008-8#2)
the pore of##3##3##(1991-9#1)(1995-8#1)(2006-10#1)
the pore size distribution##3##4##(2005-11#2)(2008-10#1)
the pore size of the##3##5##(1994-8#1)(2005-11#1)(2008-5#1)
the pore size##10##3##(1994-8#1)(2005-11#5)(2008-10#1)(2008-5#1)(2009-2#1)(2009-7#1)
the pore water##3##3##(2008-10#2)(2013-8#1)
the pore width##2##3##(2005-11#1)(2008-10#1)
the pore##52##2##(1991-9#1)(1994-12#1)(1994-8#1)(1995-8#2)(1997-2#1)(1997-4#1)(1997-6#2)(2005-11#15)(2006-10#3)(2008-10#4)(2008-4#2)(2008-5#1)(2008-8#6)(2008-9#1)(2009-2#3)(2009-3#3)(2009-7#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
the pore-forming##4##2##(1991-3#1)(1994-3#1)(2006-10#1)(2012-12#1)
the pore-lining##2##2##(2006-2#1)(2008-8#1)
the pores and##2##3##(2008-4#1)(2010-12#1)
the pores in##2##3##(2007-12#1)(2008-2#1)
the pores of a##2##4##(2008-10#1)(2008-11#1)
the pores of the##5##4##(2008-10#4)(2010-2#1)
the pores of##9##3##(2007-8#1)(2008-10#5)(2008-11#1)(2010-12#1)(2010-2#1)
the pores with##2##3##(2005-11#1)(2008-10#1)
the pores##29##2##(1991-3#1)(2004-8#1)(2004-9#2)(2005-11#2)(2007-12#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2010-12#2)(2010-2#1)(2010-4#2)(2013-8#1)
the porin##4##2##(1990-8#1)(1996-5#1)(2006-8#1)(2008-8#1)
the pork tapeworm Taenia##2##4##(1995-12#1)(2008-7#1)
the pork##6##2##(1995-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-4#2)
the porogenic##2##2##(2008-10#1)(2013-8#1)
the porosity of the films##2##5##(2008-10#1)(2008-2#1)
the porosity of the##5##4##(2005-11#2)(2008-10#1)(2008-2#1)(2010-5#1)
the porosity of##7##3##(2005-11#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-5#1)
the porosity##15##2##(2005-11#3)(2008-10#1)(2008-2#6)(2008-5#1)(2008-7#1)(2009-7#1)(2010-5#2)
the porous layer##7##3##(2005-11#7)
the porous material##3##3##(2008-3#3)
the porous packings##2##3##(1991-8#2)
the porous silica##4##3##(1990-8#1)(2008-7#1)(2012-12#2)
the porous structure of##3##4##(2005-11#2)(2010-12#1)
the porous structure##4##3##(2005-11#2)(2010-12#1)(2013-8#1)
the porous substrate##5##3##(2005-11#5)
the porous##40##2##(1990-8#1)(1991-8#2)(2005-11#16)(2006-6#1)(2008-10#1)(2008-3#3)(2008-5#4)(2008-7#2)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-8#1)
the porphyrin macrocycle##2##3##(1997-6#1)(2010-6#1)
the porphyrin system##2##3##(2008-10#2)
the porphyrin to##2##3##(2008-10#1)(2010-6#1)
the porphyrin##29##2##(1990-1#1)(1991-5#1)(1991-7#1)(1992-8#1)(1994-5#1)(1996-2#3)(1997-6#3)(2005-4#1)(2007-9#1)(2008-10#10)(2010-5#1)(2010-6#3)(2010-7#2)
the porphyrins##5##2##(1992-9#2)(2006-12#1)(2008-10#1)(2008-6#1)
the port access##2##3##(2007-8#1)(2008-11#1)
the port of##2##3##(2007-5#1)(2008-4#1)
the port##11##2##(2006-6#2)(2007-5#1)(2007-7#2)(2007-8#2)(2008-11#1)(2008-4#2)(2011-2#1)
the portable##4##2##(2006-6#1)(2008-10#1)(2013-1#1)(2013-8#1)
the portal of entry of##2##5##(2006-10#1)(2008-5#1)
the portal vein of##2##4##(1993-12#1)(1995-2#1)
the portal vein##13##3##(1990-4#1)(1993-12#1)(1995-2#1)(1997-4#1)(1997-8#1)(2005-12#2)(2008-12#1)(2009-11#2)(2009-9#1)(2012-2#2)
the portal##25##2##(1990-4#1)(1993-12#1)(1993-3#1)(1994-7#1)(1995-2#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-12#2)(2006-10#1)(2006-2#1)(2007-5#1)(2008-12#1)(2008-5#1)(2009-11#2)(2009-2#1)(2009-9#2)(2010-12#1)(2011-12#1)(2012-2#2)
the portfolio##3##2##(2006-5#1)(2012-12#2)
the portion of the##4##4##(1992-2#1)(1997-6#1)(1997-9#1)(2009-1#1)
the portion of##9##3##(1992-2#1)(1997-6#1)(1997-7#1)(1997-9#2)(2008-10#1)(2008-11#1)(2008-7#1)(2009-1#1)
the portions##3##2##(1993-3#1)(1994-8#1)(2009-6#1)
the portrayal of African Americans##2##5##(2005-12#2)
the portrayal of##3##3##(2005-12#2)(2012-2#1)
the portuguese##2##2##(2011-1#1)(2013-1#1)
the position and orientation##2##4##(2008-3#1)(2010-4#1)
the position and the orientation of a##2##7##(2008-2#2)
the position and the orientation of##3##6##(2008-2#3)
the position and the##4##4##(1991-2#1)(2008-2#3)
the position and##10##3##(1991-2#1)(1992-12#1)(2008-10#1)(2008-2#4)(2008-3#1)(2009-8#1)(2010-4#1)
the position corresponding to##5##4##(1990-2#1)(1991-11#1)(1991-12#1)(1991-9#1)(1996-5#1)
the position described##2##3##(2008-7#1)(2009-6#1)
the position is##2##3##(1996-5#1)(2008-7#1)
the position of a##7##4##(1994-8#1)(1995-5#1)(1997-7#1)(2006-6#1)(2007-7#1)(2008-2#2)
the position of each##2##4##(2007-11#1)(2007-12#1)
the position of individual##2##4##(1997-4#1)(2008-2#1)
the position of the catheter tip##3##6##(2007-7#3)
the position of the desired image##3##6##(2008-3#3)
the position of the focal point##2##6##(2006-5#1)(2007-12#1)
the position of the fringe under##2##6##(2008-2#2)
the position of the mouth##2##5##(2008-5#2)
the position of the reference beam##2##6##(2008-3#2)
the position of the sample##2##5##(2006-5#1)(2007-11#1)
the position of the tip##2##5##(2007-12#1)(2007-7#1)
the position of the##97##4##(1991-10#1)(1991-7#1)(1992-10#1)(1993-6#1)(1994-11#1)(1994-3#2)(1994-9#1)(1995-11#2)(1995-12#1)(1995-8#1)(1996-11#1)(1996-5#2)(1996-6#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-11#1)(2004-9#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-12#2)(2006-3#1)(2006-5#4)(2007-11#2)(2007-12#4)(2007-4#2)(2007-7#5)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#10)(2008-3#13)(2008-4#2)(2008-5#4)(2008-8#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)
the position of##149##3##(1990-12#1)(1990-5#1)(1991-10#1)(1991-6#1)(1991-7#2)(1992-10#1)(1992-9#1)(1993-6#2)(1994-11#1)(1994-3#2)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#3)(2004-11#1)(2004-9#1)(2005-11#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-3#1)(2006-5#4)(2006-6#1)(2007-11#4)(2007-12#6)(2007-4#2)(2007-7#6)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#16)(2008-3#17)(2008-4#3)(2008-5#4)(2008-7#1)(2008-8#4)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#2)
the position papers##2##3##(2007-2#2)
the position sense##2##3##(2012-1#2)
the position that##3##3##(2006-7#1)(2008-12#1)(2008-2#1)
the position##196##2##(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-5#5)(1996-6#3)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#3)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-3#1)(2006-5#4)(2006-6#1)(2006-7#1)(2007-11#4)(2007-12#6)(2007-2#2)(2007-4#2)(2007-7#6)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#21)(2008-3#20)(2008-4#4)(2008-5#4)(2008-7#3)(2008-8#4)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#4)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#2)
the position-specific regulatory element of murine Hoxa-7##2##7##(1997-4#2)
the position-specific##3##2##(1997-4#3)
the positional##11##2##(1991-4#1)(1993-3#1)(1995-6#1)(1996-6#1)(1996-8#1)(2008-3#1)(2008-9#1)(2012-1#1)(2012-2#2)(2013-8#1)
the positioning and##3##3##(1995-10#1)(1996-7#1)(2006-2#1)
the positioning of the##10##4##(1991-4#1)(1992-6#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#2)(2009-10#1)
the positioning of##15##3##(1991-3#1)(1991-4#1)(1992-6#1)(1995-1#1)(2006-5#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#2)(2009-10#1)(2010-1#1)(2010-3#1)
the positioning##19##2##(1991-3#1)(1991-4#1)(1992-6#1)(1995-1#1)(1995-10#1)(1995-8#1)(1996-7#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#2)(2009-10#1)(2010-1#1)(2010-3#1)
the positions and##4##3##(1994-1#1)(1997-2#1)(2008-3#2)
the positions for##2##3##(1994-8#1)(2008-6#1)
the positions in##3##3##(1997-2#2)(2007-10#1)
the positions of the##8##4##(1993-3#2)(1995-8#1)(1996-8#1)(2007-11#1)(2007-12#1)(2008-2#1)(2012-1#1)
the positions of##23##3##(1990-2#1)(1990-5#1)(1991-8#1)(1993-3#2)(1994-12#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-2#2)(1996-3#1)(1996-8#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-4#1)(2012-1#1)
the positions##39##2##(1990-2#1)(1990-5#1)(1991-8#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-8#1)(1996-2#3)(1996-3#1)(1996-8#1)(1997-2#3)(1997-3#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-6#2)(2008-9#1)(2009-4#1)(2012-1#1)
the positive action of##2##4##(1994-3#1)(2007-3#1)
the positive and negative aspects of##3##6##(1990-5#1)(2008-11#1)(2009-12#1)
the positive and negative effects of##2##6##(2007-12#1)(2007-8#1)
the positive and negative symptoms of schizophrenia##2##7##(2004-3#1)(2010-6#1)
the positive and negative##13##4##(1990-5#1)(1991-4#1)(1994-3#1)(1997-2#1)(2004-3#1)(2007-12#1)(2007-8#2)(2008-11#2)(2009-12#2)(2010-6#1)
the positive and##18##3##(1990-10#1)(1990-5#1)(1990-6#1)(1991-4#1)(1994-3#1)(1997-2#1)(2004-3#1)(2007-12#1)(2007-8#2)(2008-11#2)(2009-12#2)(2010-5#1)(2010-6#1)(2011-1#1)(2013-1#1)
the positive aspects of##2##4##(1990-9#1)(2011-2#1)
the positive association between##2##4##(2008-11#1)(2010-1#1)
the positive association##3##3##(2008-1#1)(2008-11#1)(2010-1#1)
the positive associations##2##3##(2009-5#1)(2010-8#1)
the positive cases##5##3##(2006-1#1)(2007-7#2)(2008-10#1)(2013-8#1)
the positive characteristics of the##2##5##(1990-9#1)(2008-11#1)
the positive characteristics##3##3##(1990-9#1)(1996-2#1)(2008-11#1)
the positive charge of the##2##5##(1994-10#1)(2008-4#1)
the positive charge of##5##4##(1994-10#1)(1994-3#1)(2005-11#1)(2008-4#1)(2011-2#1)
the positive charge##6##3##(1994-10#1)(1994-3#1)(1996-7#1)(2005-11#1)(2008-4#1)(2011-2#1)
the positive clones##2##3##(1993-4#1)(2008-8#1)
the positive control group##3##4##(1992-2#1)(1993-4#1)(2013-1#1)
the positive control##6##3##(1992-2#1)(1993-4#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
the positive correlation between##2##4##(2008-12#1)(2012-12#1)
the positive correlation##4##3##(1995-4#1)(2007-11#1)(2008-12#1)(2012-12#1)
the positive effect of##6##4##(1995-4#1)(2004-9#1)(2006-3#1)(2008-3#1)(2008-9#1)(2011-1#1)
the positive effect##7##3##(1995-4#1)(2004-9#1)(2006-3#1)(2007-11#1)(2008-3#1)(2008-9#1)(2011-1#1)
the positive effects of##9##4##(2005-6#1)(2006-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-12#1)(2012-12#1)(2013-1#1)
the positive effects##12##3##(2005-11#1)(2005-6#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-12#1)(2012-12#1)(2013-1#1)
the positive electrode##2##3##(2009-12#1)(2013-8#1)
the positive feedback##2##3##(2009-10#1)(2009-8#1)
the positive impact of##3##4##(2008-11#1)(2009-4#1)(2013-7#1)
the positive impact##4##3##(2007-2#1)(2008-11#1)(2009-4#1)(2013-7#1)
the positive influence of##4##4##(1990-1#1)(2008-10#1)(2008-5#1)(2011-1#1)
the positive inotropic action of forskolin##2##6##(1997-7#2)
the positive inotropic action of##3##5##(1997-7#3)
the positive inotropic effect of##2##5##(1991-2#1)(1995-12#1)
the positive inotropic effect##4##4##(1991-2#1)(1993-11#1)(1995-12#1)(2008-5#1)
the positive inotropic effects of##3##5##(1997-7#3)
the positive inotropic##10##3##(1991-2#1)(1993-11#1)(1995-12#1)(1997-7#6)(2008-5#1)
the positive ion##4##3##(1997-3#1)(2008-10#1)(2011-3#2)
the positive or negative##2##4##(1996-10#1)(2009-11#1)
the positive or##3##3##(1993-11#1)(1996-10#1)(2009-11#1)
the positive outcomes of##3##4##(1995-1#1)(2005-12#1)(2008-9#1)
the positive outcomes##5##3##(1995-1#1)(2005-12#1)(2008-12#1)(2008-9#1)(2010-12#1)
the positive predictive value for##2##5##(2006-10#1)(2012-2#1)
the positive predictive value##8##4##(1990-4#1)(1992-10#1)(1992-5#1)(1993-1#1)(1997-2#1)(2006-10#2)(2012-2#1)
the positive predictive##9##3##(1990-4#1)(1992-10#1)(1992-5#1)(1993-1#1)(1997-2#1)(2006-10#2)(2012-2#1)(2013-1#1)
the positive rate was##2##4##(2011-3#1)(2013-8#1)
the positive rate##3##3##(2011-3#1)(2012-3#1)(2013-8#1)
the positive rates of##2##4##(1997-2#1)(2010-12#1)
the positive rates##4##3##(1997-2#2)(2010-12#1)(2012-2#1)
the positive regulatory##2##3##(1997-1#1)(1997-7#1)
the positive relationship between##3##4##(2010-12#1)(2012-12#1)(2013-7#1)
the positive results observed in##2##5##(1992-12#1)(2007-7#1)
the positive results##6##3##(1992-12#1)(2007-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2011-3#1)
the positive role of##2##4##(2008-12#1)(2013-1#1)
the positive samples##4##3##(1993-8#1)(2010-6#1)(2012-12#2)
the positive stereotype group was##2##5##(2008-11#2)
the positive strand##3##3##(1994-8#2)(2008-10#1)
the positive##224##2##(1990-1#1)(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#3)(1990-9#2)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#2)(1992-6#2)(1993-1#2)(1993-11#2)(1993-4#2)(1993-8#1)(1994-10#1)(1994-2#1)(1994-3#3)(1994-8#4)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-4#3)(1996-10#1)(1996-12#3)(1996-2#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-7#9)(1997-8#1)(2004-3#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-6#1)(2006-1#1)(2006-10#3)(2006-2#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-3#2)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#10)(2008-11#12)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#1)(2008-8#6)(2008-9#5)(2009-10#3)(2009-11#1)(2009-12#3)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#3)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#4)(2011-3#5)(2012-12#9)(2012-2#5)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#5)
the positively charged##17##3##(1990-1#1)(1990-5#1)(1991-8#1)(1992-9#1)(1994-3#1)(1995-11#1)(1996-5#2)(1997-3#1)(1997-8#1)(2008-10#2)(2008-8#1)(2009-12#2)(2010-4#1)(2011-1#1)
the positively##18##2##(1990-1#1)(1990-5#1)(1991-8#1)(1992-9#1)(1994-3#1)(1995-11#1)(1996-5#2)(1997-3#1)(1997-8#1)(2008-10#2)(2008-6#1)(2008-8#1)(2009-12#2)(2010-4#1)(2011-1#1)
the positivity constraint on##2##4##(2008-2#1)(2013-1#1)
the positivity constraint##3##3##(2008-2#1)(2013-1#2)
the positivity of##4##3##(1990-4#1)(1991-9#1)(2008-5#1)(2013-1#1)
the positivity rate was##2##4##(2006-8#1)(2007-7#1)
the positivity##11##2##(1990-4#1)(1990-8#1)(1991-9#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-2#1)(2008-5#1)(2013-1#3)
the positron annihilation##2##3##(2005-11#2)
the positron##5##2##(1992-5#1)(1994-9#1)(2005-11#2)(2013-1#1)
the possession of##3##3##(2006-10#1)(2008-6#1)(2010-12#1)
the possibilities and limitations of##3##5##(2006-10#1)(2008-3#1)(2013-7#1)
the possibilities and##8##3##(1997-2#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2012-2#2)(2013-7#1)
the possibilities for the##3##4##(2006-5#1)(2007-11#1)(2008-5#1)
the possibilities for##14##3##(1993-12#1)(1995-6#1)(1995-8#1)(2005-5#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-5#1)(2009-8#1)(2011-2#1)
the possibilities of its##3##4##(1991-2#1)(2006-6#1)(2012-3#1)
the possibilities of the##3##4##(1995-11#1)(2007-11#1)(2008-1#1)
the possibilities of using##4##4##(2007-11#1)(2008-10#1)(2008-5#1)(2013-1#1)
the possibilities of##36##3##(1991-11#1)(1991-2#1)(1991-8#1)(1993-5#1)(1994-4#1)(1994-9#1)(1995-11#1)(1996-9#1)(2006-6#1)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-2#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
the possibilities offered by##2##4##(2007-11#1)(2008-11#1)
the possibilities offered##3##3##(2007-11#1)(2008-11#1)(2008-2#1)
the possibilities that##4##3##(1993-11#1)(2008-10#1)(2008-5#1)(2012-12#1)
the possibilities to##3##3##(1990-12#1)(2007-6#1)(2009-1#1)
the possibilities##70##2##(1990-12#1)(1991-11#1)(1991-2#1)(1991-8#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-4#1)(1994-9#2)(1995-11#1)(1995-6#1)(1995-8#1)(1996-9#1)(1997-2#1)(2005-5#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-11#5)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#3)(2008-6#1)(2008-8#2)(2009-1#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
the possibility exists that##6##4##(1994-11#1)(1994-8#1)(1995-8#1)(1996-4#1)(1996-5#1)(2011-2#1)
the possibility for a##2##4##(2006-12#1)(2012-3#1)
the possibility for improvement of##2##5##(2008-10#1)(2011-2#1)
the possibility for the##2##4##(2008-10#1)(2008-7#1)
the possibility for##18##3##(1994-9#1)(1996-6#1)(2004-11#1)(2006-10#1)(2006-12#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-4#1)(2008-7#1)(2009-3#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#1)
the possibility of a new##2##5##(2007-11#1)(2012-3#1)
the possibility of a novel##3##5##(1992-12#1)(1994-12#1)(2008-4#1)
the possibility of a##42##4##(1990-3#1)(1990-4#1)(1990-6#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-2#1)(1993-12#2)(1994-12#1)(1994-8#1)(1995-11#1)(1995-5#1)(1995-6#1)(1997-8#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#2)(2008-1#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-3#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
the possibility of achieving##3##4##(2007-11#1)(2008-11#1)(2008-3#1)
the possibility of an alternative##2##5##(2007-8#1)(2008-6#1)
the possibility of an##15##4##(1990-12#1)(1990-5#1)(1990-7#1)(1996-3#1)(1997-8#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2013-1#1)(2013-8#1)
the possibility of applying##2##4##(2013-1#1)(2013-7#1)
the possibility of complications##2##4##(2008-6#1)(2008-7#1)
the possibility of contamination##4##4##(1995-7#1)(1997-2#1)(2007-11#1)(2008-4#1)
the possibility of controlling##3##4##(1992-2#1)(2007-12#1)(2008-1#1)
the possibility of creating##2##4##(1997-4#1)(2006-12#1)
the possibility of designing##2##4##(1990-5#1)(2010-9#1)
the possibility of determining the##2##5##(2008-2#2)
the possibility of developing a##2##5##(2008-10#1)(2008-5#1)
the possibility of developing new##2##5##(2007-11#1)(2008-7#1)
the possibility of developing##8##4##(1991-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
the possibility of different##3##4##(1994-6#1)(2009-2#1)(2013-7#1)
the possibility of direct##2##4##(1992-12#1)(2008-10#1)
the possibility of disease##2##4##(2006-9#1)(2011-2#1)
the possibility of early##2##4##(2006-10#1)(2010-12#1)
the possibility of extending##2##4##(2007-11#1)(2008-2#1)
the possibility of formation of##2##5##(1994-2#1)(2008-5#1)
the possibility of further##2##4##(1997-3#1)(2006-9#1)
the possibility of generating##2##4##(2007-11#1)(2008-11#1)
the possibility of genetic##4##4##(1993-10#1)(2006-10#1)(2010-8#1)(2012-1#1)
the possibility of growing##2##4##(2008-2#1)(2009-11#1)
the possibility of having##2##4##(2006-10#1)(2012-2#1)
the possibility of home##2##4##(2007-7#2)
the possibility of identifying##2##4##(1997-8#1)(2010-6#1)
the possibility of imaging the##2##5##(2007-11#1)(2012-2#1)
the possibility of improving the##3##5##(1990-2#1)(1996-6#1)(2006-10#1)
the possibility of improving##4##4##(1990-2#1)(1996-6#1)(2006-10#1)(2012-1#1)
the possibility of increased##2##4##(2008-11#1)(2012-3#1)
the possibility of infection##3##4##(2006-10#1)(2008-12#1)(2012-3#1)
the possibility of investigating##2##4##(2007-11#1)(2008-7#1)
the possibility of its##4##4##(1993-8#1)(2008-2#1)(2009-12#1)(2010-7#1)
the possibility of making##3##4##(2007-11#1)(2008-7#1)(2008-9#1)
the possibility of malignancy##2##4##(2008-5#1)(2012-12#1)
the possibility of measuring##3##4##(1990-8#1)(2008-2#1)(2008-7#1)
the possibility of memory recovery##2##5##(2013-7#2)
the possibility of multiple##2##4##(2007-12#1)(2007-8#1)
the possibility of new therapeutic##2##5##(2006-10#1)(2012-2#1)
the possibility of obtaining##5##4##(1991-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
the possibility of other##2##4##(2007-2#1)(2008-4#1)
the possibility of performing##4##4##(2007-11#1)(2007-8#1)(2008-2#1)(2008-7#1)
the possibility of predicting##2##4##(1994-6#1)(2008-4#1)
the possibility of rapid and##2##5##(2007-11#1)(2013-1#1)
the possibility of reducing##2##4##(2008-5#1)(2013-1#1)
the possibility of restoring##2##4##(1994-7#1)(2012-1#1)
the possibility of simplifying##2##4##(2011-2#1)(2012-1#1)
the possibility of studying##2##4##(2006-11#1)(2007-6#1)
the possibility of superior##2##4##(2005-10#1)(2005-7#1)
the possibility of the##10##4##(1990-9#2)(1991-4#1)(2008-10#1)(2008-2#1)(2009-2#1)(2009-5#1)(2010-12#1)(2011-2#2)
the possibility of their##4##4##(1994-11#1)(2008-10#1)(2008-4#1)(2012-1#1)
the possibility of therapeutic##2##4##(1994-8#1)(2008-1#1)
the possibility of these##2##4##(1995-12#1)(2007-3#1)
the possibility of this##4##4##(1990-9#1)(2006-10#1)(2007-12#1)(2008-5#1)
the possibility of thrombosis##2##4##(1992-3#1)(2007-2#1)
the possibility of two##2##4##(1990-9#1)(2012-2#1)
the possibility of using a##5##5##(2007-12#2)(2008-10#1)(2008-2#2)
the possibility of using the##5##5##(2007-11#1)(2008-10#2)(2008-5#1)(2008-8#1)
the possibility of using this##2##5##(2008-10#1)(2008-5#1)
the possibility of using##35##4##(1991-8#1)(1993-3#1)(1995-7#1)(1997-1#1)(2005-11#1)(2007-11#3)(2007-12#2)(2007-7#1)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#3)(2010-9#1)(2012-1#1)(2012-2#1)(2013-1#1)
the possibility of utilizing##3##4##(1990-8#1)(2008-10#1)(2011-1#1)
the possibility of##504##3##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#3)(1990-6#2)(1990-7#2)(1990-8#2)(1990-9#4)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#5)(1992-2#4)(1992-3#3)(1992-5#1)(1992-7#2)(1993-10#2)(1993-11#2)(1993-12#3)(1993-3#3)(1993-5#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-7#3)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#3)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-7#2)(2006-10#19)(2006-11#1)(2006-12#2)(2006-2#3)(2006-4#4)(2006-6#2)(2006-7#1)(2006-8#4)(2006-9#2)(2007-10#3)(2007-11#30)(2007-12#17)(2007-2#4)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#6)(2007-8#8)(2007-9#4)(2008-1#9)(2008-10#34)(2008-11#11)(2008-12#4)(2008-2#14)(2008-3#17)(2008-4#10)(2008-5#13)(2008-6#3)(2008-7#14)(2008-8#10)(2008-9#5)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#8)(2011-12#2)(2011-2#17)(2011-3#1)(2012-1#10)(2012-12#4)(2012-2#14)(2012-3#9)(2013-1#16)(2013-7#4)(2013-8#6)
the possibility that a##5##4##(1992-1#1)(1992-12#1)(1992-2#1)(1996-6#1)(2008-10#1)
the possibility that an##2##4##(2008-10#1)(2008-11#1)
the possibility that certain##2##4##(1996-8#1)(2008-1#1)
the possibility that changes in##2##5##(1993-2#1)(2008-9#1)
the possibility that different##2##4##(1995-11#1)(2008-9#1)
the possibility that it may##4##5##(1991-8#1)(2006-2#1)(2007-11#1)(2008-10#1)
the possibility that it##8##4##(1990-10#1)(1991-8#1)(1995-11#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-9#1)
the possibility that local##2##4##(1994-3#1)(2004-10#1)
the possibility that models##2##4##(1995-4#1)(2009-12#1)
the possibility that one##2##4##(1991-7#1)(2007-12#1)
the possibility that some##3##4##(1990-7#1)(1996-5#1)(2008-3#1)
the possibility that specific##2##4##(1994-5#1)(1995-1#1)
the possibility that such##2##4##(1991-4#1)(2008-11#1)
the possibility that the two##2##5##(1990-8#1)(2009-10#1)
the possibility that the##43##4##(1990-12#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-7#1)(1993-3#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-6#1)(1995-9#1)(1996-10#2)(1996-3#1)(1996-4#1)(1997-8#1)(2006-4#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-5#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
the possibility that these two##2##5##(1996-12#1)(1997-8#1)
the possibility that these##10##4##(1993-5#1)(1995-11#1)(1996-12#1)(1996-7#1)(1997-8#2)(2006-9#1)(2008-11#1)(2008-5#1)(2011-2#1)
the possibility that they##2##4##(1995-8#1)(2008-10#1)
the possibility that this##5##4##(1991-4#1)(1994-8#1)(1995-1#1)(1997-4#1)(2008-11#1)
the possibility that##206##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#2)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#5)(1991-3#2)(1991-4#3)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-3#4)(1994-5#3)(1994-6#1)(1994-8#4)(1994-9#4)(1995-1#5)(1995-11#3)(1995-12#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-10#3)(1996-12#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#3)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#4)(2004-10#1)(2005-12#1)(2006-1#1)(2006-10#3)(2006-2#3)(2006-4#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#3)(2007-8#2)(2008-1#2)(2008-10#11)(2008-11#5)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#3)(2008-9#8)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-8#5)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#3)(2013-8#4)
the possibility to apply##2##4##(2008-11#1)(2009-8#1)
the possibility to improve##2##4##(2008-10#1)(2008-8#1)
the possibility to study##2##4##(2006-8#1)(2008-5#1)
the possibility to use##4##4##(2007-9#1)(2008-5#1)(2009-5#1)(2010-12#1)
the possibility to##54##3##(1990-10#1)(1990-2#2)(1992-6#1)(1996-11#1)(1996-6#1)(2005-11#3)(2006-10#1)(2006-8#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#11)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#2)(2008-8#2)(2009-12#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-12#2)(2010-3#1)(2011-1#3)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
the possibility##797##2##(1990-10#3)(1990-11#1)(1990-12#3)(1990-2#3)(1990-3#3)(1990-4#2)(1990-5#3)(1990-6#2)(1990-7#3)(1990-8#3)(1990-9#4)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#6)(1991-3#2)(1991-4#4)(1991-5#3)(1991-6#3)(1991-7#1)(1991-8#4)(1991-9#3)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#6)(1992-2#6)(1992-3#4)(1992-5#2)(1992-6#1)(1992-7#3)(1992-8#1)(1993-1#1)(1993-10#3)(1993-11#2)(1993-12#5)(1993-2#1)(1993-3#4)(1993-5#2)(1993-8#2)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#4)(1994-5#6)(1994-6#3)(1994-7#1)(1994-8#8)(1994-9#6)(1995-1#7)(1995-11#6)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#2)(1995-7#4)(1995-8#3)(1995-9#1)(1996-1#1)(1996-10#3)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#6)(1996-4#2)(1996-5#3)(1996-6#4)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#7)(2004-10#1)(2004-11#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#7)(2005-12#1)(2005-7#3)(2006-1#1)(2006-10#25)(2006-11#1)(2006-12#3)(2006-2#6)(2006-4#5)(2006-6#2)(2006-7#2)(2006-8#6)(2006-9#3)(2007-10#4)(2007-11#32)(2007-12#19)(2007-2#7)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#9)(2007-8#12)(2007-9#6)(2008-1#12)(2008-10#59)(2008-11#18)(2008-12#4)(2008-2#17)(2008-3#24)(2008-4#13)(2008-5#21)(2008-6#3)(2008-7#17)(2008-8#15)(2008-9#13)(2009-1#2)(2009-10#1)(2009-11#2)(2009-12#4)(2009-2#3)(2009-3#3)(2009-4#3)(2009-5#4)(2009-6#3)(2009-7#2)(2009-8#7)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#6)(2010-2#4)(2010-3#2)(2010-4#5)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#15)(2011-12#2)(2011-2#28)(2011-3#1)(2012-1#12)(2012-12#7)(2012-2#16)(2012-3#10)(2013-1#20)(2013-7#4)(2013-8#12)
the possible action of##3##4##(1992-3#1)(1997-7#1)(2013-1#1)
the possible adverse effects of##2##5##(2008-8#1)(2012-2#1)
the possible adverse effects##3##4##(2008-8#1)(2012-2#1)(2013-1#1)
the possible alterations##2##3##(2008-5#1)(2009-4#1)
the possible application of##2##4##(1991-2#1)(2006-10#1)
the possible application##3##3##(1991-2#1)(2006-10#1)(2008-10#1)
the possible association between the##2##5##(1997-8#1)(2013-8#1)
the possible association between##6##4##(1997-8#1)(2005-10#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-8#1)
the possible association of##3##4##(1992-12#1)(2010-10#1)(2011-2#1)
the possible association##9##3##(1992-12#1)(1997-8#1)(2005-10#1)(2008-11#1)(2010-10#1)(2011-1#1)(2011-2#2)(2013-8#1)
the possible benefits of##5##4##(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#1)(2012-1#1)
the possible benefits##9##3##(2005-11#1)(2006-10#1)(2007-11#3)(2007-2#1)(2008-10#1)(2008-5#1)(2012-1#1)
the possible binding##4##3##(1992-8#1)(2005-10#1)(2008-5#1)(2008-8#1)
the possible causative##2##3##(1997-7#1)(2012-2#1)
the possible cause##2##3##(1994-11#1)(2013-8#1)
the possible causes of this##2##5##(2005-9#1)(2008-9#1)
the possible causes of##4##4##(2005-9#1)(2006-5#1)(2008-7#1)(2008-9#1)
the possible causes##6##3##(1997-8#1)(2005-9#1)(2006-5#1)(2008-7#1)(2008-9#1)(2010-8#1)
the possible cellular##2##3##(2004-11#1)(2009-8#1)
the possible combination of##2##4##(2007-6#1)(2012-2#1)
the possible complications of##4##4##(1993-10#1)(1993-9#1)(2006-3#1)(2010-10#1)
the possible complications that##2##4##(1994-3#1)(2012-12#1)
the possible complications##11##3##(1993-10#1)(1993-9#1)(1994-3#1)(2005-10#1)(2006-12#1)(2006-3#1)(2007-7#1)(2008-7#1)(2010-10#1)(2012-12#2)
the possible consequences of##4##4##(2004-12#1)(2006-10#1)(2008-3#1)(2011-2#1)
the possible contribution of##2##4##(1997-5#1)(2009-6#1)
the possible contribution##3##3##(1995-7#1)(1997-5#1)(2009-6#1)
the possible differences in##2##4##(2008-4#1)(2012-12#1)
the possible differences##3##3##(2007-8#1)(2008-4#1)(2012-12#1)
the possible differential##2##3##(2008-5#1)(2012-8#1)
the possible distribution of##2##4##(2008-5#1)(2010-12#1)
the possible effect of the##2##5##(1994-8#1)(2008-10#1)
the possible effect of##6##4##(1992-2#1)(1994-8#1)(2006-10#1)(2008-10#1)(2012-2#1)(2013-1#1)
the possible effect##9##3##(1992-2#1)(1993-1#1)(1994-8#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-10#1)(2012-2#1)(2013-1#1)
the possible effects of##8##4##(1990-6#1)(1995-12#1)(1996-2#1)(2005-7#2)(2006-12#1)(2006-8#1)(2007-12#1)
the possible effects##10##3##(1990-6#1)(1995-12#1)(1996-2#2)(2005-7#2)(2006-11#1)(2006-12#1)(2006-8#1)(2007-12#1)
the possible etiology of the##2##5##(1990-2#1)(2010-9#1)
the possible etiology of##4##4##(1990-2#1)(2010-9#1)(2013-1#2)
the possible existence of multiple##3##5##(1990-2#1)(1995-2#1)(2007-8#1)
the possible existence of##11##4##(1990-2#1)(1990-8#1)(1992-3#1)(1992-9#1)(1995-2#1)(1997-7#1)(2007-10#1)(2007-8#1)(2008-6#1)(2010-11#1)(2012-2#1)
the possible extension##2##3##(1994-12#1)(2008-3#1)
the possible extent of##2##4##(1997-8#1)(2007-10#1)
the possible factors which##2##4##(2009-1#1)(2013-1#1)
the possible formation of##3##4##(1994-5#1)(1996-8#1)(2011-2#1)
the possible function of##2##4##(1997-2#1)(2007-2#1)
the possible functional role of##2##5##(2009-10#1)(2013-1#1)
the possible functional##3##3##(2008-1#1)(2009-10#1)(2013-1#1)
the possible functions of##3##4##(1996-7#1)(2012-12#2)
the possible future##2##3##(2006-6#1)(2008-1#1)
the possible harmful##2##3##(1994-4#1)(2011-2#1)
the possible hazards##2##3##(1992-8#1)(2013-1#1)
the possible health##2##3##(2006-10#1)(2011-2#1)
the possible impact of##3##4##(1995-12#1)(2008-11#1)(2008-8#1)
the possible impact##4##3##(1995-12#1)(2008-11#1)(2008-8#2)
the possible implications of##2##4##(2006-7#1)(2008-6#1)
the possible importance of##3##4##(2005-8#1)(2008-9#1)(2010-8#1)
the possible in vivo##2##4##(1993-9#1)(1997-6#1)
the possible influence of##7##4##(1993-9#1)(2006-6#2)(2008-10#1)(2008-7#1)(2012-3#1)(2013-8#1)
the possible influence##8##3##(1993-9#1)(2006-6#2)(2008-10#1)(2008-7#1)(2012-3#1)(2013-8#2)
the possible inhibition##2##3##(1994-9#1)(1995-11#1)
the possible interaction between##2##4##(1993-12#1)(2008-4#1)
the possible interaction of##3##4##(1993-5#1)(1994-11#1)(2012-8#1)
the possible interaction##5##3##(1993-12#1)(1993-5#1)(1994-11#1)(2008-4#1)(2012-8#1)
the possible interactions##3##3##(1993-9#1)(2006-10#1)(2011-1#1)
the possible involvement of a##2##5##(1992-7#1)(1994-8#1)
the possible involvement of##22##4##(1990-3#1)(1990-6#1)(1991-8#1)(1991-9#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#1)(1994-2#2)(1994-6#1)(1994-8#1)(1996-7#1)(1997-7#1)(2008-11#1)(2009-8#2)(2013-1#1)(2013-7#1)(2013-8#1)
the possible involvement##23##3##(1990-3#1)(1990-6#1)(1991-8#1)(1991-9#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#1)(1994-2#2)(1994-6#1)(1994-8#1)(1996-7#1)(1997-7#1)(2008-11#2)(2009-8#2)(2013-1#1)(2013-7#1)(2013-8#1)
the possible link between##2##4##(2006-10#1)(2013-7#1)
the possible link##3##3##(2006-10#1)(2008-10#1)(2013-7#1)
the possible loss of##2##4##(1990-5#1)(2008-4#1)
the possible loss##3##3##(1990-5#1)(1994-3#1)(2008-4#1)
the possible mechanism for##2##4##(2008-10#2)
the possible mechanism of the##2##5##(2008-10#1)(2011-3#1)
the possible mechanism of##13##4##(1990-4#1)(1993-7#1)(1996-5#1)(2008-10#5)(2008-5#1)(2008-6#1)(2009-12#1)(2010-7#1)(2011-3#1)
the possible mechanism##19##3##(1990-4#1)(1991-5#1)(1993-12#1)(1993-7#1)(1996-5#1)(2008-10#7)(2008-5#1)(2008-6#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-3#1)
the possible mechanism(s)##2##3##(2006-10#1)(2009-5#1)
the possible mechanisms for##4##4##(2006-10#1)(2007-10#1)(2007-12#1)(2010-3#1)
the possible mechanisms of##5##4##(1996-1#1)(2006-10#1)(2006-2#2)(2007-9#1)
the possible mechanisms underlying##2##4##(2008-8#1)(2012-12#1)
the possible mechanisms##18##3##(1993-9#1)(1996-1#1)(1996-9#1)(2006-10#3)(2006-2#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-3#1)(2012-12#1)(2013-7#1)
the possible mode##2##3##(1995-5#1)(2013-1#1)
the possible negative effects##2##4##(2005-12#1)(2013-8#1)
the possible negative##3##3##(2004-3#1)(2005-12#1)(2013-8#1)
the possible occurrence of##3##4##(1994-6#1)(2006-12#1)(2011-2#1)
the possible origin##2##3##(2008-5#1)(2009-7#1)
the possible pathogenetic##4##3##(1992-2#1)(2006-2#2)(2007-4#1)
the possible pathogenic##3##3##(1996-8#1)(2008-2#1)(2008-7#1)
the possible pathogens##2##3##(1997-4#1)(2008-9#1)
the possible pathological##3##3##(2005-7#1)(2008-7#1)(2010-12#1)
the possible physiological##2##3##(1994-11#1)(2009-8#1)
the possible position of##2##4##(2008-5#1)(2009-8#1)
the possible presence of a##2##5##(1994-11#1)(1997-5#1)
the possible presence of##5##4##(1992-3#1)(1994-11#1)(1995-1#1)(1997-5#1)(2008-10#1)
the possible protective##3##3##(2007-2#1)(2011-2#1)(2012-4#1)
the possible reaction mechanism##2##4##(1990-5#1)(2008-10#1)
the possible reasons for the##3##5##(1996-5#1)(2005-8#1)(2011-2#1)
the possible reasons for##4##4##(1996-5#1)(2005-8#1)(2009-5#1)(2011-2#1)
the possible reasons##5##3##(1996-5#1)(2005-8#1)(2006-10#1)(2009-5#1)(2011-2#1)
the possible recurrence##2##3##(1992-6#1)(2012-1#1)
the possible relation between the##2##5##(1995-9#1)(2013-1#1)
the possible relationship between##2##4##(1993-2#1)(2013-1#1)
the possible relationship with##2##4##(2008-10#1)(2013-1#1)
the possible relationship##5##3##(1993-2#1)(1993-4#1)(2008-10#1)(2013-1#2)
the possible relevance of this##3##5##(1990-12#1)(1992-12#1)(2008-9#1)
the possible relevance of##6##4##(1990-12#1)(1992-12#1)(1992-9#1)(1997-5#1)(2008-10#1)(2008-9#1)
the possible risk factors##2##4##(2008-1#1)(2012-2#1)
the possible risk of##2##4##(2006-4#1)(2012-2#1)
the possible risk##4##3##(2006-4#1)(2008-1#1)(2012-2#2)
the possible risks##2##3##(1994-1#1)(2011-2#1)
the possible role of betaAPP as##2##6##(2005-9#2)
the possible role of the##6##5##(1995-11#1)(1995-6#1)(2007-12#1)(2008-1#1)(2011-2#1)(2013-8#1)
the possible role of these##2##5##(1995-2#1)(2012-12#1)
the possible role of##52##4##(1990-1#1)(1990-10#1)(1991-3#2)(1991-9#1)(1992-2#1)(1992-4#2)(1992-5#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-8#1)(2005-9#2)(2007-10#1)(2007-12#1)(2007-7#2)(2007-9#1)(2008-1#3)(2008-10#1)(2008-4#2)(2008-7#2)(2009-12#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-7#1)(2013-8#1)
the possible role##54##3##(1990-1#1)(1990-10#1)(1991-3#2)(1991-9#1)(1992-2#1)(1992-4#2)(1992-5#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-8#1)(2005-9#2)(2006-10#1)(2007-10#1)(2007-12#1)(2007-7#2)(2007-9#1)(2008-1#3)(2008-10#1)(2008-4#2)(2008-7#2)(2009-12#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-7#1)(2013-8#1)
the possible role(s)##2##3##(1991-5#1)(1997-4#1)
the possible roles of##9##4##(1990-7#1)(1994-8#1)(1996-9#1)(2007-8#1)(2008-7#2)(2009-8#1)(2011-2#1)(2012-3#1)
the possible roles##10##3##(1990-7#1)(1994-8#1)(1996-9#1)(2006-10#1)(2007-8#1)(2008-7#2)(2009-8#1)(2011-2#1)(2012-3#1)
the possible side effects of##2##5##(2007-11#1)(2008-8#1)
the possible solutions##2##3##(2008-6#1)(2012-3#1)
the possible source of##2##4##(2006-6#1)(2012-2#1)
the possible subunit##2##3##(1995-11#1)(2006-12#1)
the possible therapeutic approaches to##2##5##(1996-2#1)(1997-1#1)
the possible therapeutic approaches##3##4##(1990-5#1)(1996-2#1)(1997-1#1)
the possible therapeutic##5##3##(1990-5#1)(1996-2#1)(1997-1#1)(2008-7#1)(2012-2#1)
the possible underlying##3##3##(1995-11#1)(1997-1#1)(2011-12#1)
the possible use of this##2##5##(2007-12#1)(2008-5#1)
the possible use of##18##4##(1994-8#1)(1995-12#1)(1997-6#1)(2005-7#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-5#3)(2009-8#2)(2010-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
the possible usefulness of##2##4##(1992-6#1)(2004-10#1)
the possible utility of##2##4##(2008-7#1)(2010-2#1)
the possible ways to##2##4##(2007-2#1)(2009-9#1)
the possible ways##3##3##(2007-2#1)(2009-9#1)(2013-1#1)
the possible##600##2##(1990-1#1)(1990-10#2)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#4)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#3)(1991-7#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#4)(1992-2#3)(1992-3#3)(1992-4#3)(1992-5#2)(1992-6#4)(1992-7#4)(1992-8#5)(1992-9#3)(1993-1#1)(1993-10#2)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#2)(1993-7#1)(1993-9#6)(1994-1#1)(1994-11#5)(1994-12#1)(1994-2#3)(1994-3#3)(1994-4#1)(1994-5#2)(1994-6#4)(1994-7#1)(1994-8#5)(1994-9#1)(1995-1#2)(1995-11#5)(1995-12#4)(1995-2#2)(1995-5#3)(1995-6#1)(1995-7#2)(1995-8#1)(1995-9#3)(1996-1#2)(1996-12#1)(1996-2#7)(1996-3#2)(1996-5#4)(1996-7#2)(1996-8#2)(1996-9#5)(1997-1#2)(1997-2#2)(1997-4#4)(1997-5#3)(1997-6#2)(1997-7#4)(1997-8#6)(2004-10#1)(2004-11#1)(2004-12#2)(2004-3#1)(2004-9#1)(2005-1#1)(2005-10#5)(2005-11#1)(2005-12#1)(2005-7#7)(2005-8#2)(2005-9#3)(2006-10#23)(2006-11#1)(2006-12#6)(2006-2#5)(2006-3#3)(2006-4#3)(2006-5#1)(2006-6#5)(2006-7#1)(2006-8#1)(2007-10#4)(2007-11#8)(2007-12#10)(2007-2#6)(2007-3#1)(2007-4#2)(2007-6#2)(2007-7#4)(2007-8#5)(2007-9#5)(2008-1#9)(2008-10#39)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#9)(2008-5#14)(2008-6#6)(2008-7#17)(2008-8#12)(2008-9#8)(2009-1#1)(2009-10#1)(2009-12#3)(2009-4#3)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#8)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#8)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#22)(2011-3#2)(2012-1#4)(2012-12#9)(2012-2#12)(2012-3#8)(2012-4#1)(2012-5#1)(2012-8#2)(2013-1#19)(2013-7#6)(2013-8#15)
the possibly##3##2##(1994-12#1)(2008-3#1)(2010-5#1)
the post mortem##2##3##(1996-8#1)(1996-9#1)
the post operative##2##3##(2009-5#1)(2009-6#1)
the post##15##2##(1993-7#1)(1996-8#2)(1996-9#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2010-7#1)(2012-12#1)(2013-8#1)
the post-anaesthesia care unit##3##4##(2006-10#2)(2012-2#1)
the post-apartheid##3##2##(2006-7#2)(2007-7#1)
the post-cataract surgery##2##3##(2010-8#2)
the post-column##3##2##(1997-3#2)(2006-11#1)
the post-genome era of##2##4##(2008-7#2)
the post-genomic era##7##3##(2008-7#4)(2011-2#1)(2012-3#2)
the post-infusion##2##2##(2008-7#2)
the post-mortem##2##2##(2008-6#1)(2010-4#1)
the post-natal##5##2##(1990-5#1)(1996-8#1)(2006-8#1)(2008-10#1)(2009-3#1)
the post-operative period##9##3##(2006-10#1)(2006-9#1)(2007-8#1)(2007-9#1)(2008-11#1)(2009-10#1)(2011-2#1)(2013-1#2)
the post-operative##17##2##(1990-9#1)(1993-2#1)(1993-5#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-5#1)(2009-10#1)(2011-2#1)(2012-1#1)(2013-1#3)
the post-partum period##2##3##(1994-3#1)(2007-8#1)
the post-reproductive period##5##3##(1997-4#5)
the post-reproductive##6##2##(1997-4#5)(2008-1#1)
the post-stimulus##2##2##(1990-5#1)(1997-6#1)
the post-surgical##2##2##(1993-2#1)(2011-1#1)
the post-synaptic apparatus at##2##4##(1991-3#2)
the post-synaptic membrane##2##3##(1997-5#1)(2008-11#1)
the post-synaptic##4##2##(1991-3#2)(1997-5#1)(2008-11#1)
the post-test##4##2##(2004-10#1)(2007-6#2)(2007-7#1)
the post-transcriptional regulation of##2##4##(1995-5#1)(1996-12#1)
the post-transcriptional##5##2##(1993-6#1)(1994-10#1)(1995-5#1)(1996-12#1)(2011-2#1)
the post-translational modification of##2##4##(1993-6#1)(1997-6#1)
the post-translational modification##3##3##(1993-6#1)(1997-6#1)(2008-12#1)
the post-translational modifications of##3##4##(1997-2#1)(1997-6#1)(2008-12#1)
the post-translational modifications##4##3##(1992-6#1)(1997-2#1)(1997-6#1)(2008-12#1)
the post-translational##14##2##(1992-6#1)(1993-6#1)(1997-2#1)(1997-6#2)(2008-12#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-7#1)(2011-3#1)(2013-1#1)
the post-translationally modified##2##3##(1997-2#1)(1997-6#1)
the post-transplant##7##2##(1996-3#1)(2007-11#3)(2008-4#1)(2010-6#1)(2011-3#1)
the post-treatment##4##2##(2006-10#1)(2008-2#1)(2012-12#1)(2013-1#1)
the postal survey##2##3##(1993-8#2)
the postanaesthesia care unit##2##4##(2009-3#1)(2011-12#1)
the postanesthetic care unit##2##4##(2006-10#2)
the postembryonic development of##2##4##(2007-12#1)(2009-8#1)
the poster sessions##2##3##(2005-8#1)(2008-5#1)
the poster##4##2##(2005-8#1)(2006-7#1)(2008-5#1)(2009-5#1)
the posterior and anterior##3##4##(1994-8#1)(2009-7#1)(2011-7#1)
the posterior and lateral##3##4##(2006-11#1)(2013-7#2)
the posterior and##7##3##(1994-8#1)(2006-11#1)(2007-12#1)(2009-7#1)(2011-7#1)(2013-7#2)
the posterior approach using metal##2##5##(2007-8#2)
the posterior approach##14##3##(2006-8#2)(2007-11#2)(2007-7#3)(2007-8#3)(2009-8#1)(2011-2#3)
the posterior aspect of the##3##5##(1995-8#1)(2007-10#1)(2007-7#1)
the posterior cerebral artery##4##4##(2007-9#3)(2011-1#1)
the posterior cerebral##5##3##(2007-9#3)(2011-1#1)(2012-12#1)
the posterior cervical##2##3##(1997-6#1)(2012-3#1)
the posterior chamber##2##3##(2011-2#1)(2013-7#1)
the posterior chest wall##2##4##(2007-8#2)
the posterior cingulate##2##3##(1995-7#1)(2009-4#1)
the posterior circulation##5##3##(1993-3#1)(2006-12#1)(2008-7#1)(2012-12#1)(2012-3#1)
the posterior communicating artery##5##4##(2008-7#1)(2011-1#4)
the posterior communicating##6##3##(2008-7#2)(2011-1#4)
the posterior compartment##2##3##(1993-2#1)(2013-1#1)
the posterior cruciate ligament (PCL)##2##5##(2007-1#2)
the posterior cruciate ligament in##2##5##(2007-7#1)(2013-1#1)
the posterior cruciate ligament##6##4##(2007-1#2)(2007-7#2)(2009-9#1)(2013-1#1)
the posterior dislocation##2##3##(2008-12#1)(2010-12#1)
the posterior distribution##5##3##(1995-6#1)(1996-8#1)(1997-2#1)(2010-5#1)(2012-1#1)
the posterior drawer##2##3##(2007-1#1)(2008-8#1)
the posterior end##2##3##(2008-4#1)(2009-10#1)
the posterior fossa and##4##4##(1996-6#1)(2005-5#1)(2006-5#2)
the posterior fossa approach##2##4##(2006-5#2)
the posterior fossa to##2##4##(2006-5#2)
the posterior fossa##27##3##(1996-6#2)(1996-9#1)(2005-5#1)(2006-12#1)(2006-5#8)(2006-9#1)(2008-5#4)(2008-7#5)(2011-2#4)
the posterior hypothalamic area##6##4##(1995-12#1)(1996-11#4)(1996-3#1)
the posterior hypothalamus and histaminergic neurons##2##6##(2007-1#2)
the posterior hypothalamus and##3##4##(1995-12#1)(2007-1#2)
the posterior hypothalamus##9##3##(1991-8#1)(1995-12#2)(1996-3#1)(2007-1#4)(2010-12#1)
the posterior iliac##3##3##(1991-6#1)(2007-10#1)(2009-8#1)
the posterior inferior cerebellar artery (PICA)##3##6##(2007-10#1)(2007-9#1)(2008-7#1)
the posterior inferior cerebellar artery##5##5##(2006-11#1)(2007-10#1)(2007-9#1)(2008-7#2)
the posterior lobe##5##3##(1991-5#1)(1992-9#2)(1997-8#1)(2012-3#1)
the posterior longitudinal ligament##3##4##(2006-8#1)(2007-8#1)(2008-12#1)
the posterior mediastinum##6##3##(2007-8#2)(2010-12#2)(2011-2#2)
the posterior parietal cortex##3##4##(1994-3#2)(1997-2#1)
the posterior parietal##6##3##(1992-9#2)(1994-3#2)(1996-2#1)(1997-2#1)
the posterior part of the disc##2##6##(2009-4#2)
the posterior part of the##8##5##(1992-10#1)(2006-11#1)(2007-12#1)(2008-2#1)(2009-4#3)(2010-12#1)
the posterior pituitary##6##3##(1994-10#2)(1997-8#1)(2007-10#1)(2008-4#1)(2013-1#1)
the posterior pole##6##3##(2007-12#1)(2007-3#2)(2008-2#1)(2009-2#1)(2009-8#1)
the posterior portion of##3##4##(1996-7#1)(1997-3#1)(2008-4#1)
the posterior probability##3##3##(1994-11#1)(2008-2#1)(2008-3#1)
the posterior quadrants##2##3##(1996-7#1)(2009-8#1)
the posterior right##2##3##(2007-8#1)(2008-11#1)
the posterior segment##3##3##(1997-2#1)(2009-3#1)(2009-4#1)
the posterior side##2##3##(1997-8#1)(2008-9#1)
the posterior superior iliac spine##2##5##(2006-8#2)
the posterior superior temporal##2##4##(2008-11#2)
the posterior superior##4##3##(2006-8#2)(2008-11#2)
the posterior surface##2##3##(2012-1#1)(2013-8#1)
the posterior third##2##3##(2006-8#2)
the posterior tibial##4##3##(1990-9#2)(1991-4#1)(2008-8#1)
the posterior tibialis muscle##2##4##(2009-3#2)
the posterior to##2##3##(1997-8#1)(2008-5#1)
the posterior tongue##2##3##(1993-12#2)
the posterior vaginal##2##3##(2006-6#1)(2009-11#1)
the posterior wall of the##5##5##(1997-8#1)(2008-5#1)(2008-7#1)(2011-12#1)(2013-8#1)
the posterior walls##2##3##(1991-6#2)
the posterior##304##2##(1990-10#1)(1990-12#1)(1990-4#1)(1990-9#2)(1991-11#3)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#3)(1991-8#1)(1992-10#1)(1992-9#4)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#4)(1993-3#1)(1994-10#2)(1994-11#1)(1994-3#2)(1994-7#1)(1994-8#1)(1995-12#3)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#5)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#6)(1997-2#5)(1997-3#4)(1997-6#1)(1997-7#2)(1997-8#6)(2005-5#1)(2006-10#1)(2006-11#3)(2006-12#4)(2006-4#2)(2006-5#9)(2006-6#2)(2006-8#8)(2006-9#1)(2007-1#9)(2007-10#4)(2007-11#5)(2007-12#17)(2007-3#2)(2007-5#1)(2007-7#8)(2007-8#12)(2007-9#4)(2008-10#1)(2008-11#3)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#5)(2008-5#7)(2008-7#14)(2008-8#4)(2008-9#3)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#3)(2009-4#7)(2009-5#1)(2009-7#2)(2009-8#6)(2009-9#1)(2010-10#1)(2010-12#6)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#6)(2011-12#1)(2011-2#15)(2011-7#2)(2012-1#3)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#5)(2013-7#4)(2013-8#2)
the postero lateral bundle group##2##5##(2009-9#2)
the postero-lateral##3##2##(2007-11#3)
the postero-medial##4##2##(1993-6#3)(2008-2#1)
the posterobasal##3##2##(1991-3#1)(2013-1#2)
the posterolateral approach##3##3##(2007-1#2)(2007-11#1)
the posterolateral##14##2##(1995-5#1)(1997-3#1)(2006-8#1)(2007-1#2)(2007-11#1)(2007-6#1)(2008-10#1)(2009-10#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
the posteromedial##3##2##(1993-2#1)(1997-3#1)(2013-1#1)
the posterosuperior##6##2##(2007-10#4)(2007-9#2)
the posters##4##2##(2006-7#4)
the postgraduate##3##2##(1992-1#1)(2008-7#1)(2013-1#1)
the postharvest pathogens##2##3##(2008-10#2)
the postharvest##5##2##(2008-10#5)
the posthypoxic period##2##3##(2012-1#2)
the postimplementation##4##2##(2013-1#4)
the postinjury##2##2##(2005-2#1)(2008-7#1)
the postmarketing##2##2##(2008-11#1)(2010-12#1)
the postmenopausal women is##2##4##(2005-3#2)
the postmenopausal women##3##3##(2005-3#2)(2012-2#1)
the postmenopausal##10##2##(1990-6#1)(2005-3#2)(2006-10#1)(2007-1#2)(2008-3#1)(2012-2#1)(2013-8#2)
the postmortem##5##2##(1996-1#1)(1996-6#1)(2011-1#3)
the postnatal development of##8##4##(1992-6#1)(1993-12#2)(1996-3#1)(1996-5#1)(2009-8#1)(2011-2#2)
the postnatal development##9##3##(1992-6#1)(1993-12#2)(1996-3#1)(1996-5#2)(2009-8#1)(2011-2#2)
the postnatal growth and##2##4##(2009-3#1)(2009-5#1)
the postnatal period##4##3##(1992-7#1)(1996-8#1)(2008-10#1)(2009-9#1)
the postnatal##32##2##(1990-5#2)(1991-4#1)(1992-11#1)(1992-6#1)(1992-7#1)(1993-12#2)(1994-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-8#1)(1997-5#1)(2008-10#1)(2008-4#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#3)(2009-9#1)(2011-2#2)(2012-2#3)(2012-3#1)
the postocclusion##2##2##(1990-11#2)
the postoperative blood##2##3##(2008-7#1)(2009-6#1)
the postoperative care##3##3##(2006-10#2)(2012-2#1)
the postoperative complications and the##2##5##(2008-10#1)(2008-9#1)
the postoperative course was##3##4##(1996-8#1)(2007-8#2)
the postoperative course##7##3##(1992-6#1)(1996-8#1)(2006-10#1)(2007-8#3)(2008-6#1)
the postoperative day##2##3##(2007-8#2)
the postoperative evaluation of##2##4##(1994-3#1)(2006-6#1)
the postoperative follow-up##2##3##(1992-6#1)(2010-12#1)
the postoperative outcome##3##3##(1992-8#1)(2005-5#1)(2011-2#1)
the postoperative pain##3##3##(2004-12#1)(2009-5#1)(2010-6#1)
the postoperative period##30##3##(1990-12#2)(1990-2#1)(1991-5#1)(1993-6#1)(1993-8#1)(1995-5#1)(2006-8#1)(2007-11#1)(2007-7#2)(2007-8#5)(2007-9#3)(2008-2#1)(2009-2#1)(2010-10#2)(2011-1#2)(2012-12#1)(2013-1#3)(2013-8#1)
the postoperative rehabilitation##2##3##(2008-6#1)(2013-1#1)
the postoperative time##2##3##(2007-8#1)(2008-5#1)
the postoperative treatment##3##3##(1992-6#1)(1993-4#1)(2009-2#1)
the postoperative##109##2##(1990-12#2)(1990-2#1)(1991-2#1)(1991-5#1)(1992-6#4)(1992-8#1)(1993-10#1)(1993-4#2)(1993-6#1)(1993-8#1)(1994-3#1)(1995-10#1)(1995-5#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-4#1)(2004-10#1)(2004-12#1)(2005-5#1)(2006-10#4)(2006-12#2)(2006-6#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#2)(2007-8#16)(2007-9#4)(2008-10#1)(2008-2#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#2)(2009-5#1)(2009-6#1)(2010-10#2)(2010-12#3)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#8)(2013-8#2)
the postpartum period and##2##4##(2004-3#1)(2007-2#1)
the postpartum period##19##3##(1992-7#1)(1992-9#1)(1995-8#1)(1996-3#1)(2004-3#2)(2006-4#1)(2007-2#4)(2008-3#1)(2010-8#2)(2011-2#1)(2012-2#2)(2013-8#2)
the postpartum##25##2##(1992-7#1)(1992-9#1)(1993-6#1)(1995-8#1)(1996-3#1)(2004-3#2)(2006-4#1)(2006-5#1)(2007-2#5)(2008-3#1)(2008-6#1)(2010-6#1)(2010-8#2)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#2)
the postponement of##3##3##(2008-11#1)(2011-1#1)(2012-12#1)
the postponement##4##2##(2008-11#1)(2011-1#2)(2012-12#1)
the postprandial state##3##3##(2004-11#1)(2008-1#1)(2008-3#1)
the postprandial##7##2##(1996-9#2)(2004-11#1)(2007-5#1)(2008-1#1)(2008-3#1)(2010-8#1)
the postpubertal##2##2##(2008-10#1)(2008-5#1)
the poststroke##5##2##(2007-10#2)(2007-9#1)(2012-12#2)
the postsurgical##2##2##(2005-12#1)(2006-10#1)
the postsynaptic actions of GABA##2##5##(1990-3#2)
the postsynaptic cell##2##3##(1990-11#1)(1991-6#1)
the postsynaptic density (PSD)##5##4##(1996-12#2)(2008-11#1)(2008-4#1)(2010-3#1)
the postsynaptic density##7##3##(1996-12#2)(2008-11#1)(2008-4#1)(2008-5#1)(2010-3#1)(2012-3#1)
the postsynaptic membrane of##3##4##(1996-8#1)(1997-5#1)(2012-2#1)
the postsynaptic membrane##7##3##(1996-12#2)(1996-4#1)(1996-8#1)(1997-5#1)(2008-11#1)(2012-2#1)
the postsynaptic neuron##4##3##(1995-1#1)(1997-7#2)(2009-8#1)
the postsynaptic##38##2##(1990-11#1)(1990-3#2)(1990-4#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-8#2)(1993-11#1)(1994-10#1)(1995-1#1)(1996-12#5)(1996-4#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-5#2)(1997-7#2)(1997-8#1)(2007-10#1)(2007-12#1)(2008-11#2)(2008-4#1)(2008-5#1)(2009-8#1)(2010-3#1)(2012-2#1)(2012-3#1)
the posttranslational modification##2##3##(1992-11#1)(1997-7#1)
the posttranslational##5##2##(1992-11#1)(1994-11#1)(1994-12#1)(1996-8#1)(1997-7#1)
the posttransplant##3##2##(2007-2#1)(2009-2#1)(2011-1#1)
the posttreatment##6##2##(1994-11#1)(1996-5#3)(2006-11#1)(2008-10#1)
the postulated##15##2##(1990-7#2)(1991-2#1)(1991-9#1)(1992-4#1)(1995-5#1)(1997-3#1)(2007-12#1)(2007-5#1)(2008-11#2)(2008-3#1)(2008-5#1)(2010-10#1)(2012-12#1)
the postural##2##2##(2006-8#1)(2008-7#1)
the posture and##2##3##(1995-5#1)(2007-9#1)
the posture of##2##3##(1995-5#1)(2007-8#1)
the posture##6##2##(1995-5#2)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)
the potassium channel##6##3##(1992-8#1)(1994-11#1)(1997-2#1)(1997-7#1)(2007-12#1)(2007-7#1)
the potassium equilibrium potential##2##4##(1995-7#1)(1997-2#1)
the potassium##25##2##(1990-11#1)(1991-10#1)(1991-3#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-11#1)(1994-11#1)(1995-7#1)(1995-8#1)(1996-2#1)(1997-2#3)(1997-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-3#1)(2008-5#1)(2010-5#1)
the potato carboxypeptidase A##4##4##(1991-4#4)
the potato genome##2##3##(2006-12#2)
the potato##19##2##(1991-4#4)(1994-12#1)(2006-12#2)(2008-10#12)
the potencies of a##2##4##(1994-3#1)(1995-11#1)
the potencies of the##2##4##(1995-11#1)(2010-6#1)
the potencies of##5##3##(1994-3#1)(1995-11#2)(1995-3#1)(2010-6#1)
the potency (IC50 =##2##4##(1995-1#2)
the potency and##5##3##(1992-3#1)(1996-10#1)(1996-12#1)(1996-8#1)(2011-12#1)
the potency of iloprost##2##4##(2008-7#2)
the potency of the effect##2##5##(1991-9#1)(1995-5#1)
the potency of the##7##4##(1990-4#1)(1991-9#1)(1995-12#1)(1995-5#2)(1996-6#1)(2013-1#1)
the potency of these##2##4##(1997-8#1)(2008-11#1)
the potency of##40##3##(1990-10#1)(1990-11#2)(1990-4#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-3#1)(1993-9#1)(1994-3#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#2)(1996-11#1)(1996-4#1)(1996-6#1)(1996-7#2)(1997-1#1)(1997-8#2)(2006-5#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#2)(2009-9#1)(2013-1#2)
the potency##56##2##(1990-10#1)(1990-11#2)(1990-4#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-3#2)(1992-9#1)(1993-12#2)(1993-8#1)(1993-9#1)(1994-3#1)(1994-8#2)(1995-1#3)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#2)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-8#2)(2006-5#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-3#1)(2009-9#1)(2011-12#1)(2013-1#2)
the potent agonist##2##3##(1995-6#1)(1997-7#1)
the potent angiogenesis inhibitor##2##4##(1996-6#1)(2009-7#1)
the potent antinociceptive##2##3##(1995-7#1)(1996-12#1)
the potent##49##2##(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-11#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-3#2)(1995-6#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-7#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-2#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
the potential ability of##2##4##(2007-8#1)(2008-10#1)
the potential ability##3##3##(2006-12#1)(2007-8#1)(2008-10#1)
the potential advantage of##2##4##(2007-5#1)(2013-7#1)
the potential advantages of##10##4##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-12#2)(2010-2#1)(2012-12#1)
the potential advantages##12##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2008-9#2)(2010-12#2)(2010-2#2)(2012-12#1)
the potential adverse##4##3##(2006-10#1)(2007-11#1)(2011-3#1)(2012-11#1)
the potential and the depredating capacity of##2##7##(2007-10#2)
the potential and##6##3##(2006-10#1)(2007-10#2)(2008-5#1)(2008-8#1)(2010-8#1)
the potential applicability of##3##4##(2008-3#1)(2008-8#1)(2010-6#1)
the potential application of the##2##5##(1996-5#1)(2005-11#1)
the potential application of this##4##5##(2008-10#3)(2012-3#1)
the potential application of##10##4##(1996-5#1)(2005-11#1)(2008-10#3)(2008-3#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-3#1)
the potential application##11##3##(1996-5#1)(2005-11#1)(2008-10#4)(2008-3#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-3#1)
the potential applications of##4##4##(2008-12#1)(2008-7#1)(2010-11#1)(2010-9#1)
the potential applications##7##3##(1994-11#1)(1996-5#1)(2007-12#1)(2008-12#1)(2008-7#1)(2010-11#1)(2010-9#1)
the potential at##4##3##(2005-11#2)(2008-10#2)
the potential barriers and##2##4##(2006-2#1)(2012-11#1)
the potential beneficial effects of##2##5##(2008-10#1)(2008-5#1)
the potential beneficial##3##3##(2006-10#1)(2008-10#1)(2008-5#1)
the potential benefit of##5##4##(2006-10#1)(2007-4#1)(2007-8#1)(2008-9#1)(2009-11#1)
the potential benefit##6##3##(2006-10#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-9#1)(2009-11#1)
the potential benefits and risks##2##5##(1997-8#1)(2008-10#1)
the potential benefits and##6##4##(1997-8#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#1)
the potential benefits of##17##4##(1994-3#1)(2005-8#1)(2006-11#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-1#1)(2010-12#1)(2012-1#1)(2013-7#2)
the potential benefits##25##3##(1994-3#1)(1997-8#1)(2005-8#1)(2006-11#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-7#1)(2009-11#1)(2009-5#1)(2010-1#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-7#2)
the potential bioavailability of##2##4##(2007-11#1)(2008-11#1)
the potential biological##3##3##(2008-10#1)(2010-10#1)(2012-3#1)
the potential buffer##4##3##(2008-10#4)
the potential but##2##3##(1990-5#1)(1995-11#1)
the potential challenges##2##3##(1996-1#1)(2009-9#1)
the potential change##5##3##(2008-10#5)
the potential clinical applications of##3##5##(2008-1#1)(2008-7#1)(2011-1#1)
the potential clinical##9##3##(2004-12#1)(2006-10#2)(2008-1#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-2#1)
the potential complications associated with##2##5##(2007-3#1)(2012-12#1)
the potential complications##3##3##(2007-3#1)(2008-8#1)(2012-12#1)
the potential consequences of##5##4##(2005-11#1)(2009-8#1)(2010-8#1)(2012-12#1)(2012-2#1)
the potential contribution of##5##4##(2005-8#1)(2008-1#1)(2008-10#2)(2008-12#1)
the potential contributions##2##3##(2009-11#1)(2012-2#1)
the potential control##2##3##(2007-8#1)(2012-12#1)
the potential dangers##2##3##(2008-9#1)(2012-3#1)
the potential detrimental##2##3##(1995-5#1)(2011-2#1)
the potential diagnostic##2##3##(1992-11#1)(2008-10#1)
the potential difference##2##3##(1997-1#1)(2008-10#1)
the potential difficulties that##2##4##(2008-8#1)(2010-12#1)
the potential difficulties##4##3##(2006-4#1)(2008-8#1)(2010-12#1)(2013-1#1)
the potential distribution of##2##4##(2008-10#1)(2008-8#1)
the potential distribution##4##3##(2006-2#2)(2008-10#1)(2008-8#1)
the potential effect of##4##4##(1996-1#1)(2008-10#1)(2010-12#1)(2013-1#1)
the potential effect##6##3##(1996-1#1)(2006-10#1)(2007-7#1)(2008-10#1)(2010-12#1)(2013-1#1)
the potential effectiveness of##4##4##(2008-11#1)(2010-12#1)(2010-8#1)(2012-1#1)
the potential effects of##8##4##(2006-10#1)(2007-2#1)(2008-1#1)(2008-11#1)(2010-12#1)(2010-8#2)(2013-8#1)
the potential efficacy of##5##4##(2007-4#1)(2010-5#1)(2012-3#1)(2013-7#1)(2013-8#1)
the potential efficacy##7##3##(2007-4#1)(2008-7#1)(2010-5#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
the potential energy surface##3##4##(2006-3#2)(2011-1#1)
the potential energy well##2##4##(1991-9#2)
the potential energy##9##3##(1991-9#2)(1993-4#1)(1995-10#1)(2006-10#1)(2006-3#2)(2007-11#1)(2011-1#1)
the potential exists##2##3##(1991-9#1)(1995-5#1)
the potential factors##2##3##(2008-10#1)(2012-12#1)
the potential for BDNF##2##4##(2013-1#1)(2013-8#1)
the potential for DnHP to adversely affect human development or reproduction##2##11##(2005-7#2)
the potential for a##10##4##(1991-6#1)(2006-7#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-8#1)(2010-2#1)(2012-1#1)(2013-1#2)
the potential for adverse##2##4##(1996-1#1)(2007-9#1)
the potential for an##2##4##(1996-12#1)(2007-7#1)
the potential for contamination of##2##5##(2005-8#1)(2008-4#1)
the potential for contamination##3##4##(2005-8#1)(2008-11#1)(2008-4#1)
the potential for early##2##4##(2009-3#1)(2012-2#1)
the potential for enhancing##2##4##(2009-1#1)(2013-1#1)
the potential for establishing a complete series of tomato chromosome##2##10##(2008-5#2)
the potential for establishing##3##4##(2008-5#3)
the potential for exposure to##2##5##(1994-6#1)(2008-9#1)
the potential for further##2##4##(2006-12#1)(2009-8#1)
the potential for future lesion growth##2##6##(1992-9#2)
the potential for future##4##4##(1992-9#2)(2008-8#1)(2011-2#1)
the potential for greater##2##4##(2008-2#1)(2008-3#1)
the potential for improved outcomes##2##5##(2008-3#1)(2008-9#1)
the potential for improved##5##4##(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)
the potential for injury##2##4##(1993-10#1)(2007-4#1)
the potential for more##2##4##(2008-3#1)(2008-6#1)
the potential for new##2##4##(2008-4#1)(2011-2#1)
the potential for other##2##4##(2008-11#1)(2008-7#1)
the potential for outcrossing##2##4##(2008-10#2)
the potential for serious##4##4##(2005-8#1)(2006-7#1)(2007-7#1)(2011-2#1)
the potential for simultaneous##2##4##(2008-10#1)(2009-11#1)
the potential for the development of##2##6##(2008-11#1)(2008-8#1)
the potential for the##16##4##(1991-1#1)(1991-4#1)(1992-1#1)(1997-4#1)(1997-6#1)(2005-11#1)(2005-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-8#2)(2010-4#1)
the potential for this##2##4##(2008-10#1)(2008-2#1)
the potential for use##3##4##(2006-5#1)(2008-4#1)(2010-2#1)
the potential for using##3##4##(2008-11#2)(2009-12#1)
the potential for violence##2##4##(1995-2#1)(1996-12#1)
the potential for##261##3##(1990-12#1)(1990-2#1)(1990-8#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-9#2)(1993-10#2)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-2#1)(1994-6#1)(1995-1#2)(1995-10#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-6#2)(2004-11#1)(2004-9#1)(2005-11#1)(2005-6#1)(2005-7#6)(2005-8#4)(2006-10#7)(2006-11#3)(2006-12#3)(2006-4#1)(2006-5#2)(2006-7#2)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#2)(2007-2#2)(2007-4#2)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#17)(2008-11#10)(2008-12#2)(2008-2#5)(2008-3#9)(2008-4#6)(2008-5#12)(2008-6#4)(2008-7#6)(2008-8#9)(2008-9#6)(2009-1#1)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#10)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#5)(2013-1#10)(2013-7#1)(2013-8#3)
the potential functions of##2##4##(2006-12#1)(2009-8#1)
the potential gains##2##3##(2010-8#1)(2013-1#1)
the potential genetic##2##3##(1997-5#1)(2011-2#1)
the potential harm of##2##4##(2007-4#1)(2008-1#1)
the potential hazards of##3##4##(1993-2#1)(2008-10#1)(2013-1#1)
the potential hazards##7##3##(1993-2#1)(2005-8#1)(2008-10#1)(2008-11#1)(2010-7#1)(2012-1#1)(2013-1#1)
the potential health effects of##2##5##(2007-8#1)(2008-9#1)
the potential health risks##2##4##(2008-10#1)(2011-1#1)
the potential health##5##3##(2007-11#1)(2007-8#1)(2008-10#1)(2008-9#1)(2011-1#1)
the potential immunogenicity##2##3##(2008-10#1)(2012-3#1)
the potential impact of the##6##5##(2006-9#1)(2007-12#2)(2007-2#1)(2009-12#1)(2012-12#1)
the potential impact of##19##4##(1994-6#1)(1997-2#1)(2006-9#1)(2007-12#2)(2007-2#1)(2007-4#2)(2008-10#1)(2008-3#1)(2008-8#2)(2009-12#1)(2009-3#1)(2012-12#1)(2013-7#1)(2013-8#3)
the potential impact on##4##4##(2008-7#2)(2009-5#1)(2012-3#1)
the potential impact##26##3##(1992-3#1)(1994-6#1)(1997-2#1)(2006-9#1)(2007-12#2)(2007-2#1)(2007-4#2)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-3#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-7#1)(2013-8#3)
the potential impacts##2##3##(2007-4#2)
the potential implications of##3##4##(2009-5#1)(2010-12#1)(2012-12#1)
the potential importance of the##2##5##(1990-2#1)(1995-11#1)
the potential importance of##12##4##(1990-2#1)(1991-5#1)(1995-11#1)(1995-3#1)(2006-10#1)(2006-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-10#1)(2010-1#1)(2010-2#1)
the potential in##4##3##(1990-12#1)(2008-1#1)(2008-10#2)
the potential increase##2##3##(2008-3#1)(2008-5#1)
the potential influence of the##2##5##(2009-9#1)(2012-12#1)
the potential influence of##6##4##(2005-11#1)(2007-12#1)(2009-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
the potential inhibitory##2##3##(1992-12#1)(2008-10#1)
the potential interaction##3##3##(1995-11#1)(1995-6#1)(2009-9#1)
the potential interference of##2##4##(2008-10#2)
the potential involvement of##3##4##(1995-12#1)(2008-10#1)(2010-3#1)
the potential is##3##3##(1991-4#1)(2006-10#1)(2008-10#1)
the potential liability of##2##4##(1991-12#1)(1992-1#1)
the potential market##2##3##(2005-9#1)(2008-5#1)
the potential mechanism of##4##4##(2008-10#2)(2011-2#2)
the potential mechanism##5##3##(2008-10#2)(2011-2#2)(2012-3#1)
the potential mechanisms##9##3##(2005-8#1)(2006-10#2)(2006-11#1)(2008-1#1)(2008-11#1)(2008-4#1)(2011-12#1)(2013-8#1)
the potential molecular mechanisms##2##4##(2008-11#1)(2009-10#1)
the potential molecular##3##3##(2008-11#1)(2009-10#1)(2012-3#1)
the potential morbidity##3##3##(2008-6#1)(2009-12#1)(2010-8#1)
the potential need for early##2##5##(1992-1#1)(2007-12#1)
the potential need for##4##4##(1992-1#1)(2006-2#1)(2007-12#1)(2008-6#1)
the potential need##5##3##(1992-1#1)(2006-2#1)(2006-3#1)(2007-12#1)(2008-6#1)
the potential negative effects##2##4##(2013-8#2)
the potential negative##6##3##(1995-12#1)(1996-4#1)(2006-10#1)(2012-2#1)(2013-8#2)
the potential of +0##2##4##(1990-11#1)(2008-10#1)
the potential of Uf##3##4##(1991-8#3)
the potential of a new##2##5##(2006-11#1)(2008-10#1)
the potential of a##10##4##(2006-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2010-5#1)(2011-1#2)
the potential of advanced##2##4##(2011-1#1)(2011-12#1)
the potential of being a##5##5##(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)
the potential of being##6##4##(2008-1#1)(2008-10#3)(2008-7#1)(2008-8#1)
the potential of developing##2##4##(2006-4#1)(2008-10#1)
the potential of human##2##4##(1994-9#1)(2009-3#1)
the potential of improving##2##4##(2008-3#1)(2010-4#1)
the potential of integrating##2##4##(1997-2#1)(2008-12#1)
the potential of mean force (PMF)##2##6##(2005-11#1)(2007-3#1)
the potential of mean force##5##5##(2005-11#3)(2007-3#1)(2008-10#1)
the potential of oral##2##4##(2007-11#1)(2009-9#1)
the potential of polymer##2##4##(2009-5#1)(2010-7#1)
the potential of such##4##4##(1994-5#1)(2006-10#1)(2006-7#1)(2011-2#1)
the potential of terahertz##2##4##(2010-5#1)(2012-12#1)
the potential of the proposed##2##5##(2006-10#1)(2008-2#1)
the potential of the technique##3##5##(2006-4#1)(2007-12#2)
the potential of the##33##4##(1992-3#1)(1994-5#1)(1996-8#1)(2005-11#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-10#7)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-3#1)(2011-1#2)
the potential of these##8##4##(1995-7#1)(2004-9#1)(2007-5#1)(2008-10#1)(2009-10#1)(2010-1#1)(2011-2#2)
the potential of this method##3##5##(1995-8#1)(1996-4#1)(2008-3#1)
the potential of this technique to##2##6##(1991-8#1)(2007-12#1)
the potential of this technique##6##5##(1991-8#1)(1994-5#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-3#1)
the potential of this##21##4##(1991-5#1)(1991-8#1)(1994-5#1)(1995-12#1)(1995-8#1)(1996-4#1)(2005-9#1)(2006-2#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#3)(2010-10#1)(2010-7#1)(2011-1#1)(2012-1#2)(2013-1#1)
the potential of tissue##2##4##(2008-11#1)(2012-3#1)
the potential of two##2##4##(2008-10#2)
the potential of using##4##4##(2006-12#1)(2008-10#2)(2012-1#1)
the potential of working electrode##2##5##(2008-10#2)
the potential of##263##3##(1990-11#1)(1991-11#1)(1991-5#1)(1991-8#4)(1991-9#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-5#3)(1994-6#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-6#1)(2004-9#1)(2005-10#1)(2005-11#5)(2005-8#3)(2005-9#1)(2006-10#8)(2006-11#1)(2006-12#2)(2006-2#3)(2006-4#2)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#5)(2007-12#6)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#6)(2008-10#38)(2008-11#7)(2008-12#2)(2008-2#7)(2008-3#10)(2008-4#4)(2008-5#7)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#5)(2010-5#4)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#10)(2011-12#1)(2011-2#4)(2012-1#6)(2012-12#3)(2012-2#7)(2012-3#1)(2012-7#1)(2013-1#9)(2013-8#1)
the potential participants##2##3##(1994-1#1)(2009-6#1)
the potential pitfalls##2##3##(1994-3#1)(2009-5#1)
the potential power##2##3##(1997-3#1)(2006-11#1)
the potential practical##2##3##(2006-10#1)(2013-1#1)
the potential prevention of##2##4##(2008-10#1)(2008-5#1)
the potential problem of##2##4##(1992-4#1)(2008-4#1)
the potential problems##4##3##(1991-3#1)(1993-2#1)(1995-9#1)(2007-12#1)
the potential public health##3##4##(1991-3#1)(2011-1#1)(2012-12#1)
the potential public##4##3##(1991-3#1)(1992-3#1)(2011-1#1)(2012-12#1)
the potential range of##2##4##(2008-10#2)
the potential range##5##3##(2008-10#5)
the potential reasons##2##3##(2008-10#1)(2010-9#1)
the potential reduction of##2##4##(2008-2#1)(2008-3#1)
the potential relationships among##2##4##(2013-8#2)
the potential relationships##3##3##(2008-3#1)(2013-8#2)
the potential reproductive rate##3##4##(2008-8#1)(2012-12#2)
the potential risk factors##3##4##(2007-8#1)(2011-1#1)(2013-1#1)
the potential risk for##2##4##(2008-10#1)(2011-2#1)
the potential risk of##9##4##(1992-6#1)(1994-7#1)(2008-10#1)(2008-7#1)(2009-5#1)(2011-2#2)(2012-2#1)(2013-8#1)
the potential risk##16##3##(1992-6#1)(1994-7#1)(1995-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
the potential risks and benefits of##3##6##(1993-9#1)(2006-9#1)(2008-10#1)
the potential risks and##4##4##(1993-9#1)(2006-9#1)(2007-2#1)(2008-10#1)
the potential risks of##6##4##(2008-10#2)(2008-9#1)(2009-4#1)(2013-1#2)
the potential risks##18##3##(1993-9#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-7#1)(2012-12#1)(2013-1#2)
the potential role of IGFs in regulating##2##7##(1992-3#2)
the potential role of the##3##5##(1990-7#1)(1994-11#1)(2012-12#1)
the potential role of these##3##5##(1992-12#1)(1993-6#1)(1994-6#1)
the potential role of##47##4##(1990-7#1)(1992-12#1)(1992-3#2)(1992-9#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-6#1)(1996-5#1)(1997-1#1)(2005-9#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-11#2)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-8#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
the potential role##48##3##(1990-7#1)(1992-12#1)(1992-3#2)(1992-9#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-6#1)(1996-5#1)(1997-1#1)(2005-9#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-11#2)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-8#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
the potential roles of##6##4##(2005-7#1)(2009-9#1)(2010-3#1)(2012-1#2)(2013-1#1)
the potential shift##2##3##(1995-5#2)
the potential side-effects##2##3##(2010-12#2)
the potential significance of##3##4##(2006-9#1)(2008-9#2)
the potential that such##2##4##(1995-6#1)(2005-7#1)
the potential that##4##3##(1992-12#1)(1995-6#1)(2005-7#1)(2007-8#1)
the potential therapeutic role##2##4##(2006-10#2)
the potential therapeutic##10##3##(1992-9#1)(1996-1#1)(2005-10#1)(2005-8#1)(2006-10#2)(2007-11#1)(2008-11#1)(2008-7#1)(2012-12#1)
the potential to act as##2##5##(2007-12#1)(2010-8#1)
the potential to affect the##3##5##(2009-4#1)(2010-12#1)(2010-2#1)
the potential to affect##5##4##(2008-8#1)(2009-4#1)(2010-12#1)(2010-2#1)(2013-1#1)
the potential to aid in the development of##2##8##(2008-10#1)(2009-2#1)
the potential to allow##2##4##(2008-10#1)(2008-3#1)
the potential to assess##3##4##(1997-8#1)(2011-2#1)(2012-1#1)
the potential to be an##2##5##(2008-10#2)
the potential to be applied##2##5##(2008-3#1)(2010-12#1)
the potential to be used as##3##6##(1991-9#1)(2009-7#1)(2012-12#1)
the potential to be used##8##5##(1991-9#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-7#1)(2012-12#1)
the potential to be##28##4##(1991-9#1)(1997-7#1)(2007-11#2)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2009-7#1)(2010-12#1)(2011-12#2)(2012-12#1)(2012-2#3)
the potential to become##10##4##(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2010-12#2)(2011-7#1)(2012-3#1)(2013-8#1)
the potential to bind##2##4##(1993-7#1)(2005-12#1)
the potential to cause##4##4##(2009-10#1)(2010-10#1)(2011-1#1)(2012-1#1)
the potential to change##3##4##(1995-12#1)(2006-10#1)(2010-10#1)
the potential to control##2##4##(1994-6#1)(2009-6#1)
the potential to decrease##2##4##(2008-7#1)(2011-7#1)
the potential to detect##4##4##(1996-4#1)(2008-1#1)(2008-2#1)(2008-7#1)
the potential to develop##3##4##(2009-2#1)(2013-1#2)
the potential to differentiate into##4##5##(1995-1#1)(2008-11#2)(2008-8#1)
the potential to differentiate##5##4##(1995-1#1)(2008-11#2)(2008-5#1)(2008-8#1)
the potential to enhance##8##4##(2007-10#1)(2008-1#1)(2008-10#1)(2010-12#1)(2011-1#1)(2011-12#2)(2012-2#1)
the potential to establish##2##4##(2008-8#1)(2009-12#1)
the potential to generate##3##4##(2008-6#1)(2010-10#1)(2012-12#1)
the potential to give rise to##2##6##(2007-8#1)(2009-3#1)
the potential to help##4##4##(1997-2#1)(2009-10#1)(2010-12#1)(2012-2#1)
the potential to identify novel##2##5##(2005-8#1)(2013-1#1)
the potential to identify##5##4##(2005-8#1)(2008-7#1)(2009-8#1)(2010-9#1)(2013-1#1)
the potential to impact##2##4##(2007-12#1)(2010-12#1)
the potential to improve quality##3##5##(1994-2#1)(2013-1#2)
the potential to improve the##6##5##(1993-6#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-8#1)(2013-1#1)
the potential to improve##16##4##(1993-6#1)(1994-12#1)(1994-2#1)(2005-10#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2009-9#1)(2012-2#1)(2013-1#5)
the potential to increase the##3##5##(2006-4#1)(2008-3#1)(2011-1#1)
the potential to increase##6##4##(1996-11#1)(2006-4#1)(2006-5#1)(2007-9#1)(2008-3#1)(2011-1#1)
the potential to lead to##2##5##(2006-10#1)(2010-9#1)
the potential to make##2##4##(1996-11#1)(2011-1#1)
the potential to meet##2##4##(2005-11#1)(2012-1#1)
the potential to metastasize##2##4##(2004-1#1)(2012-3#1)
the potential to offer a##2##5##(2008-12#1)(2010-12#1)
the potential to overcome##2##4##(2007-7#1)(2008-1#1)
the potential to permit##2##4##(2008-2#1)(2008-3#1)
the potential to predict##2##4##(2007-4#1)(2008-10#1)
the potential to prevent##2##4##(2007-11#1)(2008-11#1)
the potential to produce##6##4##(1994-11#1)(1996-11#1)(2007-1#1)(2007-12#1)(2008-7#1)(2009-5#1)
the potential to protect##4##4##(1993-11#2)(2008-10#1)(2012-12#1)
the potential to provide a##5##5##(2007-4#1)(2008-10#2)(2011-7#1)(2012-2#1)
the potential to provide##17##4##(1991-3#1)(1996-1#1)(2005-11#1)(2006-5#1)(2007-4#1)(2008-10#2)(2008-2#1)(2008-9#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
the potential to reduce the##5##5##(2006-5#1)(2007-4#1)(2008-3#1)(2009-10#1)(2010-1#1)
the potential to reduce##14##4##(2006-10#1)(2006-5#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-10#1)(2010-1#1)(2010-12#1)(2010-5#1)(2013-1#2)
the potential to regulate##3##4##(1994-11#1)(1994-9#1)(2007-2#1)
the potential to revolutionize the##2##5##(2006-10#1)(2013-1#1)
the potential to revolutionize##4##4##(2006-10#1)(2012-12#1)(2012-3#1)(2013-1#1)
the potential to significantly reduce##3##5##(2008-10#1)(2008-2#1)(2012-12#1)
the potential to significantly##6##4##(2008-10#1)(2008-11#1)(2008-2#1)(2012-12#1)(2013-1#2)
the potential to slow##2##4##(2007-10#1)(2007-11#1)
the potential to substantially##2##4##(2006-6#1)(2007-11#1)
the potential to support##2##4##(2008-1#1)(2008-7#1)
the potential to transform##2##4##(2008-11#1)(2008-7#1)
the potential to use##3##4##(1994-8#1)(2007-11#1)(2008-3#1)
the potential to utilize##2##4##(2008-10#1)(2008-12#1)
the potential to##326##3##(1990-7#1)(1991-10#1)(1991-3#2)(1991-7#1)(1991-9#1)(1993-11#2)(1993-6#1)(1993-7#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-11#3)(1996-2#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-7#2)(1997-8#1)(2004-1#2)(2004-2#1)(2004-3#1)(2004-8#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#5)(2006-11#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#11)(2007-12#6)(2007-2#1)(2007-4#4)(2007-5#4)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#8)(2008-10#25)(2008-11#11)(2008-12#4)(2008-2#11)(2008-3#13)(2008-5#8)(2008-6#1)(2008-7#10)(2008-8#7)(2008-9#4)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#5)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#13)(2010-2#6)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#3)(2011-1#7)(2011-12#4)(2011-2#5)(2011-7#4)(2012-1#4)(2012-12#7)(2012-2#8)(2012-3#7)(2013-1#19)(2013-7#1)(2013-8#2)
the potential toxicity of##4##4##(2008-10#1)(2008-8#1)(2010-3#1)(2013-1#1)
the potential toxicological##2##3##(2008-11#1)(2008-12#1)
the potential treatment##36##3##(2005-6#2)(2005-7#9)(2005-8#9)(2005-9#4)(2008-5#9)(2008-8#1)(2009-4#1)(2011-2#1)
the potential use of poly(ethylene oxide)##2##6##(2008-5#2)
the potential use of the##3##5##(2006-10#1)(2008-5#1)(2008-8#1)
the potential use of this##5##5##(2008-1#1)(2008-7#1)(2008-9#1)(2010-1#1)(2012-2#1)
the potential use of##34##4##(1994-11#1)(1995-8#1)(2004-9#1)(2005-7#3)(2005-8#1)(2006-10#1)(2006-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-5#1)(2010-1#1)(2010-5#1)(2011-1#1)(2012-2#1)
the potential use##37##3##(1994-11#1)(1995-8#1)(2004-9#1)(2005-7#3)(2005-8#1)(2006-10#1)(2006-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#6)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-5#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#1)
the potential usefulness of##6##4##(1995-7#1)(2008-10#2)(2008-7#1)(2009-7#1)(2013-7#1)
the potential uses of##3##4##(1991-12#1)(2007-12#1)(2008-10#1)
the potential utility of the##6##5##(1995-1#1)(1996-2#1)(2007-12#1)(2013-1#3)
the potential utility of##15##4##(1995-1#1)(1995-5#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-3#1)(2006-12#1)(2007-11#1)(2007-12#1)(2010-3#1)(2012-12#1)(2012-3#1)(2013-1#3)
the potential utility##17##3##(1995-1#1)(1995-5#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-3#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2010-12#1)(2010-3#1)(2012-12#1)(2012-3#1)(2013-1#3)
the potential value of telethermography in the early diagnosis of Sudeck's disease##2##12##(1991-7#2)
the potential value of##10##4##(1991-7#2)(1995-11#1)(1995-12#1)(2006-12#1)(2006-3#1)(2007-11#1)(2007-12#1)(2008-7#1)(2011-2#1)
the potential was##2##3##(2008-10#2)
the potential##1641##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-3#6)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#4)(1991-8#4)(1991-9#6)(1992-1#3)(1992-11#3)(1992-12#6)(1992-2#2)(1992-3#6)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#6)(1993-10#2)(1993-11#3)(1993-12#3)(1993-2#3)(1993-3#3)(1993-4#1)(1993-6#4)(1993-7#2)(1993-8#2)(1993-9#2)(1994-1#4)(1994-11#9)(1994-12#2)(1994-2#3)(1994-3#5)(1994-4#1)(1994-5#6)(1994-6#9)(1994-7#1)(1994-8#3)(1994-9#5)(1995-1#8)(1995-10#3)(1995-11#5)(1995-12#7)(1995-2#5)(1995-3#1)(1995-5#9)(1995-6#3)(1995-7#3)(1995-8#4)(1995-9#1)(1996-1#6)(1996-10#1)(1996-11#3)(1996-12#7)(1996-2#4)(1996-3#5)(1996-4#4)(1996-5#5)(1996-6#2)(1996-7#2)(1996-8#5)(1996-9#2)(1997-1#5)(1997-2#5)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#4)(1997-8#3)(2004-1#2)(2004-11#1)(2004-12#1)(2004-2#1)(2004-3#1)(2004-4#1)(2004-8#1)(2004-9#5)(2005-10#4)(2005-11#13)(2005-12#1)(2005-6#3)(2005-7#21)(2005-8#25)(2005-9#7)(2006-1#1)(2006-10#51)(2006-11#12)(2006-12#10)(2006-2#8)(2006-3#5)(2006-4#6)(2006-5#7)(2006-6#2)(2006-7#4)(2006-8#2)(2006-9#6)(2007-1#4)(2007-10#8)(2007-11#33)(2007-12#26)(2007-2#8)(2007-3#4)(2007-4#17)(2007-5#9)(2007-6#1)(2007-7#10)(2007-8#19)(2007-9#8)(2008-1#33)(2008-10#177)(2008-11#48)(2008-12#12)(2008-2#29)(2008-3#42)(2008-4#16)(2008-5#56)(2008-6#12)(2008-7#42)(2008-8#39)(2008-9#25)(2009-1#1)(2009-10#9)(2009-11#6)(2009-12#10)(2009-2#9)(2009-3#5)(2009-4#11)(2009-5#15)(2009-6#4)(2009-7#7)(2009-8#9)(2009-9#7)(2010-1#5)(2010-10#7)(2010-11#4)(2010-12#32)(2010-2#19)(2010-3#6)(2010-4#8)(2010-5#8)(2010-6#3)(2010-7#5)(2010-8#12)(2010-9#7)(2011-1#31)(2011-12#6)(2011-2#36)(2011-3#2)(2011-7#4)(2012-1#20)(2012-11#3)(2012-12#35)(2012-2#28)(2012-3#29)(2012-7#1)(2013-1#59)(2013-7#9)(2013-8#23)
the potential-dependent##3##2##(2007-12#3)
the potentialities of the##2##4##(2008-10#1)(2008-7#1)
the potentialities of##4##3##(2008-10#2)(2008-7#2)
the potentialities##7##2##(1990-6#1)(2008-10#2)(2008-7#2)(2009-10#1)(2009-6#1)
the potentiality of##4##3##(1997-4#1)(1997-5#1)(2008-10#1)(2010-3#1)
the potentiality##5##2##(1990-10#1)(1997-4#1)(1997-5#1)(2008-10#1)(2010-3#1)
the potentially deleterious effects of##3##5##(2006-10#2)(2006-3#1)
the potentially lethal##2##3##(1993-10#1)(2006-11#1)
the potentially##27##2##(1990-10#1)(1990-5#1)(1992-3#1)(1992-5#1)(1993-10#1)(1995-11#1)(1997-2#1)(1997-8#1)(2006-10#3)(2006-11#1)(2006-3#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
the potentials of##5##3##(1995-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)
the potentials##15##2##(1995-7#1)(1996-6#1)(1997-7#1)(2005-11#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2009-12#1)(2010-2#1)(2012-2#1)(2013-1#1)
the potentiating effect of CGRP##2##5##(1997-4#2)
the potentiating effect of##7##4##(1994-5#1)(1996-12#1)(1997-4#3)(2008-4#2)
the potentiating##8##2##(1994-5#1)(1995-11#1)(1996-12#1)(1997-4#3)(2008-4#2)
the potentiation in##3##3##(1991-6#1)(1994-5#1)(2008-5#1)
the potentiation of carbon tetrachloride hepatotoxicity by methamphetamine##2##8##(1995-3#2)
the potentiation of carbon##3##4##(1995-3#3)
the potentiation of phagocytosis##3##4##(1993-6#3)
the potentiation of the##4##4##(1994-5#1)(1995-12#1)(1995-8#1)(1997-7#1)
the potentiation of##19##3##(1992-8#1)(1993-6#4)(1994-2#1)(1994-5#1)(1995-12#1)(1995-3#3)(1995-8#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#1)
the potentiation##23##2##(1991-6#1)(1992-8#1)(1993-6#4)(1994-2#1)(1994-5#2)(1995-12#1)(1995-3#3)(1995-8#2)(1996-2#1)(1997-7#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)
the potentiometric detection of##2##4##(2008-10#1)(2010-5#1)
the potentiometric determination of##4##4##(2008-10#4)
the potentiometric response characteristics##3##4##(2007-8#1)(2008-10#2)
the potentiometric response##5##3##(2007-8#1)(2008-10#4)
the potentiometric selectivity of##5##4##(2008-10#5)
the potentiometric selectivity##8##3##(2008-10#8)
the potentiometric sensor##2##3##(2008-10#2)
the potentiometric titration of VO(2+)##2##5##(2008-10#2)
the potentiometric titration of##14##4##(2008-10#14)
the potentiometric titration##18##3##(2005-11#1)(2008-10#17)
the potentiometric titrations##3##3##(2008-10#2)(2008-3#1)
the potentiometric##49##2##(2005-11#1)(2007-8#2)(2008-10#43)(2008-3#1)(2008-5#1)(2010-5#1)
the potting mix##4##3##(2008-10#4)
the potting##7##2##(2004-9#1)(2008-10#6)
the potyvirus##2##2##(2008-10#2)
the pouch lumen##2##3##(2007-12#2)
the pouch##9##2##(1994-9#1)(2007-12#5)(2008-10#1)(2008-8#1)(2009-12#1)
the poultry industry##3##3##(2012-2#1)(2013-8#2)
the poultry isolate##2##3##(2006-8#2)
the poultry##9##2##(2006-8#3)(2007-6#1)(2010-4#1)(2011-12#1)(2012-2#1)(2013-8#2)
the pounded yam with plain soup##4##6##(2008-4#4)
the powder and##2##3##(2009-9#1)(2011-2#1)
the powder bed##3##3##(2005-11#3)
the powder properties##2##3##(2004-9#2)
the powder to##2##3##(2010-5#1)(2012-2#1)
the powder##20##2##(2004-9#4)(2005-11#3)(2006-4#1)(2008-10#4)(2008-5#2)(2009-9#1)(2010-5#1)(2011-2#3)(2012-2#1)
the powder-to-liquid##2##2##(2004-9#2)
the powdered##3##2##(2005-11#1)(2007-12#1)(2009-8#1)
the powders##6##2##(2004-9#4)(2007-6#1)(2010-4#1)
the powdery mildew##3##3##(2006-9#1)(2008-10#2)
the power amplifier##3##3##(2007-12#2)(2008-3#1)
the power and##7##3##(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-7#1)(2012-1#1)(2012-3#1)
the power consumption##3##3##(2008-2#3)
the power density##2##3##(2007-12#1)(2008-4#1)
the power distribution##2##3##(2008-3#1)(2011-1#1)
the power in the##2##4##(2008-3#2)
the power increases##2##3##(1995-12#1)(2008-3#1)
the power law exponent##2##4##(2006-7#1)(2009-12#1)
the power law##8##3##(1994-3#1)(2005-11#1)(2006-12#1)(2006-7#1)(2008-10#2)(2009-12#1)(2010-5#1)
the power level##2##3##(2007-12#2)
the power of a##5##4##(1997-4#1)(2008-2#1)(2008-4#1)(2008-8#1)(2012-2#1)
the power of an##2##4##(2007-12#1)(2012-3#1)
the power of both##2##4##(1993-3#1)(2008-2#1)
the power of combining##2##4##(2007-11#1)(2009-5#1)
the power of the test##2##5##(1996-3#1)(2012-3#1)
the power of the##19##4##(1992-2#1)(1996-3#3)(1997-6#1)(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2009-10#1)(2009-5#1)(2010-4#1)(2012-3#2)
the power of##69##3##(1992-2#1)(1993-3#1)(1996-2#2)(1996-3#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-7#1)(2007-11#3)(2007-12#3)(2007-4#1)(2007-9#1)(2008-11#2)(2008-2#6)(2008-3#2)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-4#1)(2009-5#4)(2009-6#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#4)(2012-3#8)(2013-1#1)
the power penalty##2##3##(2007-12#1)(2008-2#1)
the power performance of##2##4##(2007-12#1)(2008-2#1)
the power plant##4##3##(2004-4#4)
the power ratio##2##3##(2007-12#1)(2008-2#1)
the power series method##2##4##(2008-3#2)
the power series##3##3##(2008-2#1)(2008-3#2)
the power spectra of##2##4##(2007-12#1)(2008-3#1)
the power spectra##4##3##(2007-12#1)(2008-3#2)(2008-9#1)
the power spectral density (PSD)##2##5##(2010-8#1)(2012-1#1)
the power spectral density##5##4##(2008-3#2)(2010-8#1)(2012-1#1)(2012-2#1)
the power spectral##6##3##(2008-3#3)(2010-8#1)(2012-1#1)(2012-2#1)
the power spectrum is##2##4##(2007-11#1)(2007-12#1)
the power spectrum of the spontaneous##2##6##(2008-3#2)
the power spectrum of the##6##5##(2007-12#1)(2008-2#2)(2008-3#3)
the power spectrum of##7##4##(2007-12#1)(2008-2#2)(2008-3#4)
the power spectrum##14##3##(1997-1#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#6)
the power stroke##3##3##(1996-11#1)(1997-4#1)(2009-3#1)
the power to detect##5##4##(2008-4#1)(2008-9#1)(2012-3#3)
the power to the##2##4##(2007-11#1)(2008-3#1)
the power to##16##3##(1991-6#1)(1992-1#1)(1993-10#1)(1993-3#1)(1994-9#1)(1997-1#1)(2006-8#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#2)(2012-3#3)
the power transfer efficiency##3##4##(2010-10#3)
the power transmission##2##3##(2008-10#1)(2008-3#1)
the power was##2##3##(2008-7#1)(2012-3#1)
the power##207##2##(1991-6#1)(1992-1#1)(1992-2#1)(1992-6#1)(1993-10#1)(1993-3#2)(1993-6#1)(1994-3#1)(1994-9#1)(1995-12#2)(1995-3#2)(1995-4#1)(1996-11#1)(1996-2#2)(1996-3#3)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(2004-4#4)(2005-11#1)(2006-10#1)(2006-12#1)(2006-7#2)(2006-8#1)(2007-11#7)(2007-12#25)(2007-2#1)(2007-4#1)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#2)(2008-2#22)(2008-3#26)(2008-4#7)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#3)(2012-2#6)(2012-3#17)(2013-1#2)
the power-law exponent of##3##4##(2007-12#2)(2008-3#1)
the power-law form of the species-area relationship##2##7##(2008-8#2)
the power-law##7##2##(2007-12#2)(2008-2#1)(2008-3#1)(2008-8#2)(2012-11#1)
the power-limiting##2##2##(2007-11#1)(2007-12#1)
the powered##4##2##(2006-2#1)(2012-1#3)
the powerful actions of neuropeptides##2##5##(1994-10#2)
the powerful and##2##3##(1994-2#1)(2008-3#1)
the powerful##22##2##(1990-5#1)(1994-10#2)(1994-2#1)(1994-4#1)(1996-12#1)(1996-8#1)(1997-2#1)(2006-7#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)
the powers of##2##3##(2006-5#1)(2008-8#1)
the powers##4##2##(2006-5#1)(2008-2#2)(2008-8#1)
the ppb##3##2##(1997-8#1)(2008-10#1)(2008-3#1)
the ppk promoter##2##3##(1993-12#2)
the practicability of##2##3##(2008-10#1)(2012-12#1)
the practical and the##2##4##(1996-3#1)(2008-2#1)
the practical and##6##3##(1996-3#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-6#1)(2013-1#1)
the practical applicability of the##2##5##(1996-11#1)(2008-10#1)
the practical applicability of##4##4##(1996-11#1)(2007-8#1)(2008-10#2)
the practical application of##2##4##(1992-3#1)(1996-8#1)
the practical application##3##3##(1992-3#1)(1996-8#1)(2010-9#1)
the practical aspects of the##2##5##(2007-7#1)(2008-11#1)
the practical aspects of##6##4##(1993-12#1)(1994-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2010-3#1)
the practical aspects##8##3##(1993-12#1)(1994-12#1)(1997-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2010-3#1)(2012-2#1)
the practical case of##2##4##(2008-2#2)
the practical clinical##2##3##(2007-11#1)(2008-4#1)
the practical constraints##2##3##(1993-5#1)(1995-3#1)
the practical cutoff frequency##2##4##(2008-3#2)
the practical difficulties##2##3##(1992-3#1)(2008-11#1)
the practical experiences of##2##4##(1995-12#1)(1995-6#1)
the practical implementation of##2##4##(2007-12#1)(2007-4#1)
the practical implementation##3##3##(2007-12#1)(2007-4#1)(2008-3#1)
the practical implications of##4##4##(1990-9#1)(2008-11#1)(2008-4#1)(2013-7#1)
the practical implications##6##3##(1990-9#1)(1993-5#1)(2008-11#1)(2008-4#1)(2009-7#1)(2013-7#1)
the practical management of##2##4##(2007-11#1)(2013-1#1)
the practical realities of##2##4##(2007-4#1)(2009-2#1)
the practical requirements##3##3##(2007-9#1)(2008-10#1)(2011-1#1)
the practical significance of##2##4##(2005-11#1)(2007-11#1)
the practical use of the##3##5##(2006-11#1)(2008-10#1)(2008-2#1)
the practical use of##5##4##(2006-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
the practical use##6##3##(1992-5#1)(2006-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
the practical##90##2##(1990-9#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-5#2)(1994-12#1)(1994-2#1)(1995-12#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-5#1)(2005-11#1)(2006-11#1)(2006-7#1)(2007-11#3)(2007-12#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#9)(2008-12#1)(2008-2#4)(2008-3#10)(2008-4#2)(2008-6#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
the practicality and##2##3##(2007-11#1)(2008-7#1)
the practicality of the##4##4##(1990-2#1)(2007-11#1)(2007-12#1)(2008-3#1)
the practicality of##8##3##(1990-2#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2011-12#1)
the practicality##10##2##(1990-2#1)(2006-10#1)(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2011-12#1)
the practice and the##2##4##(2006-2#1)(2013-1#1)
the practice and##5##3##(2006-1#1)(2006-2#1)(2011-1#1)(2013-1#2)
the practice are##2##3##(2007-4#2)
the practice can##2##3##(1996-2#1)(2006-7#1)
the practice is##2##3##(2008-3#1)(2012-2#1)
the practice of a##2##4##(2008-11#1)(2008-9#1)
the practice of anesthesia##2##4##(2006-10#1)(2008-8#1)
the practice of community##3##4##(1994-3#1)(2008-2#1)(2010-3#1)
the practice of dentistry and##2##5##(1995-6#1)(2012-3#1)
the practice of health##2##4##(1993-2#1)(2012-3#1)
the practice of interventional pain management in##2##7##(2006-8#2)
the practice of law##2##4##(2006-8#1)(2011-2#1)
the practice of medical##3##4##(1992-9#1)(2007-12#1)(2009-12#1)
the practice of medicine##10##4##(1991-2#1)(1992-1#1)(1992-2#1)(1993-12#1)(2004-11#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-4#2)
the practice of physical activity##4##5##(2010-11#4)
the practice of public health##3##5##(1996-2#1)(1997-3#1)(2010-8#1)
the practice of radiology##5##4##(2007-4#4)(2009-9#1)
the practice of##130##3##(1990-5#1)(1990-6#1)(1991-2#1)(1991-6#2)(1992-1#1)(1992-2#2)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-1#2)(1994-3#2)(1995-3#1)(1995-6#1)(1996-2#2)(1997-3#1)(2004-11#1)(2004-12#1)(2005-12#2)(2005-2#1)(2006-10#5)(2006-12#2)(2006-2#1)(2006-7#1)(2006-8#4)(2006-9#2)(2007-12#5)(2007-2#4)(2007-3#2)(2007-4#7)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#5)(2010-12#1)(2010-3#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#3)(2011-7#1)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#4)(2013-8#1)
the practice setting##4##3##(1993-2#1)(2008-11#2)(2008-4#1)
the practice to##3##3##(2006-8#1)(2007-3#1)(2009-10#1)
the practice##186##2##(1990-3#3)(1990-5#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-6#2)(1992-1#1)(1992-2#2)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-7#1)(1994-1#2)(1994-12#1)(1994-3#3)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#3)(1997-3#1)(2004-11#1)(2004-12#1)(2005-12#2)(2005-2#1)(2006-1#1)(2006-10#5)(2006-12#2)(2006-2#2)(2006-7#3)(2006-8#5)(2006-9#2)(2007-12#5)(2007-2#4)(2007-3#3)(2007-4#12)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#9)(2008-11#14)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#3)(2008-7#3)(2008-8#4)(2008-9#4)(2009-10#3)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-11#6)(2010-12#1)(2010-3#2)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#5)(2011-7#1)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#5)(2013-1#2)(2013-8#1)
the practice's##2##2##(1995-1#1)(2010-11#1)
the practices of##3##3##(1995-4#1)(2008-11#1)(2009-2#1)
the practices##6##2##(1993-3#2)(1995-4#1)(2008-11#1)(2009-2#1)(2013-1#1)
the practicing clinician##4##3##(2007-10#1)(2008-7#1)(2009-9#1)(2011-2#1)
the practicing physician##2##3##(1996-3#1)(2006-6#1)
the practicing##28##2##(1996-3#1)(2006-10#10)(2006-6#1)(2007-10#2)(2007-3#1)(2007-5#1)(2008-1#1)(2008-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
the practise of##2##3##(1994-12#1)(2007-11#1)
the practising##2##2##(2006-8#1)(2013-1#1)
the practitioner and##2##3##(2006-10#1)(2006-8#1)
the practitioner in the##3##4##(1997-7#1)(2007-11#1)(2008-3#1)
the practitioner in##5##3##(1997-7#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)
the practitioner##19##2##(1990-10#1)(1990-6#1)(1991-12#1)(1994-1#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-10#1)(2012-2#1)
the practitioner's##2##2##(1993-8#1)(2008-1#1)
the practitioners##7##2##(2008-1#2)(2008-10#1)(2008-3#1)(2008-9#2)(2011-2#1)
the practitioners'##2##2##(2008-12#1)(2008-7#1)
the pragmatic##3##2##(2008-12#3)
the pram##2##2##(2005-8#2)
the prawn##2##2##(2011-12#1)(2012-3#1)
the pre and post##3##4##(2008-10#1)(2010-12#1)(2011-3#1)
the pre##4##2##(2008-10#1)(2010-12#1)(2011-1#1)(2011-3#1)
the pre- and post-treatment##2##4##(1996-6#1)(2013-7#1)
the pre- and postsynaptic##2##4##(1995-8#1)(2008-2#1)
the pre- and##22##3##(1990-5#1)(1991-1#1)(1992-10#1)(1994-11#1)(1995-8#1)(1996-5#1)(1996-6#1)(2006-10#2)(2006-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-7#1)
the pre-##23##2##(1990-5#1)(1991-1#1)(1992-10#1)(1994-11#1)(1994-9#1)(1995-8#1)(1996-5#1)(1996-6#1)(2006-10#2)(2006-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-7#1)
the pre-B##2##2##(1992-5#1)(1993-7#1)
the pre-antibiotic era##2##3##(2007-11#1)(2010-2#1)
the pre-antibiotic##3##2##(1996-6#1)(2007-11#1)(2010-2#1)
the pre-averaging method##2##3##(2013-1#2)
the pre-clinical##4##2##(2008-10#1)(2008-8#1)(2009-7#1)(2013-1#1)
the pre-column##5##2##(1993-2#1)(1997-3#2)(2008-10#2)
the pre-concentration of##3##3##(2008-10#3)
the pre-concentration##8##2##(2007-8#1)(2008-10#7)
the pre-existing##10##2##(1992-4#2)(2007-3#1)(2007-8#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-8#1)(2012-2#1)(2013-8#1)
the pre-hospital##5##2##(1990-12#1)(1991-9#1)(2006-10#2)(2008-1#1)
the pre-implantation##2##2##(2006-6#1)(2008-8#1)
the pre-monsoon season in##2##4##(2008-7#1)(2009-6#1)
the pre-monsoon season##5##3##(2007-10#1)(2008-7#2)(2009-6#1)(2013-7#1)
the pre-operative and##2##3##(2006-9#1)(2010-12#1)
the pre-operative diagnosis##2##3##(2007-6#1)(2013-8#1)
the pre-operative##11##2##(1990-10#1)(1993-4#1)(2006-9#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2009-9#1)(2010-12#2)(2013-8#1)
the pre-ovulatory ovarian follicle##2##4##(1991-9#2)
the pre-ovulatory##3##2##(1991-9#2)(1994-3#1)
the pre-polymerisation##2##2##(2008-10#1)(2010-5#1)
the pre-reduction##2##2##(2008-10#1)(2009-6#1)
the pre-reflective self##2##3##(2008-11#2)
the pre-registration curricula##2##3##(2008-11#2)
the pre-registration##3##2##(2008-11#3)
the pre-test##2##2##(1993-2#1)(2012-12#1)
the pre-travel##2##2##(2007-2#2)
the pre-treatment##10##2##(1995-5#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-9#1)(2011-1#1)(2011-2#2)
the preS1##3##2##(1993-8#2)(1994-8#1)
the preS2 region##4##3##(1993-8#1)(1997-6#3)
the preS2##5##2##(1993-8#2)(1997-6#3)
the preadipose state##2##3##(1992-9#2)
the preadministration value along with##3##5##(1996-10#3)
the prebiotic##3##2##(1995-11#1)(2006-8#2)
the precancerous##2##2##(1993-5#1)(2011-3#1)
the precarious##3##2##(1991-12#1)(2006-9#1)(2007-9#1)
the precautional strategy##2##3##(2011-1#2)
the precautionary measures##2##3##(2012-3#1)(2013-1#1)
the precautionary principle##2##3##(2013-8#2)
the precautionary##4##2##(2012-3#1)(2013-1#1)(2013-8#2)
the precautions used by##2##4##(1991-5#1)(2010-3#1)
the precautions##8##2##(1991-5#1)(1994-7#1)(1995-7#1)(2007-2#1)(2008-12#1)(2008-7#1)(2010-3#1)(2010-8#1)
the preceding 12 months##2##4##(2008-10#1)(2012-12#1)
the preceding 3 weeks##2##4##(1992-5#1)(2013-8#1)
the preceding 3##3##3##(1992-5#1)(2013-7#1)(2013-8#1)
the preceding 5 years##2##4##(2008-10#2)
the preceding 6 months##2##4##(2013-1#2)
the preceding article##3##3##(1991-4#1)(1992-1#1)(1992-3#1)
the preceding discourse##2##3##(2008-5#2)
the preceding paper##7##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1991-7#1)(1993-12#1)(1995-11#1)
the preceding sinus##2##3##(1996-6#2)
the preceding tone##2##3##(1992-9#1)(1996-5#1)
the preceding year##3##3##(2005-10#1)(2009-5#1)(2012-12#1)
the preceding##52##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#2)(1991-4#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-9#1)(1995-11#1)(1996-12#1)(1996-5#2)(1996-6#3)(1997-6#1)(2005-10#1)(2006-5#2)(2006-7#1)(2007-3#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-5#2)(2008-7#1)(2009-5#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
the precessional##2##2##(1992-1#1)(2007-9#1)
the precious metals##2##3##(2008-10#2)
the precious##3##2##(2007-8#1)(2008-10#2)
the precipitant##2##2##(1996-9#1)(2008-3#1)
the precipitate is##5##3##(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#2)
the precipitate##22##2##(1990-10#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#2)(2008-4#4)(2008-5#1)(2013-8#1)
the precipitated##9##2##(1990-2#1)(2005-11#1)(2008-10#1)(2008-4#1)(2008-7#2)(2013-1#3)
the precipitates were##3##3##(2005-11#1)(2008-10#2)
the precipitates##12##2##(1990-11#1)(2005-11#2)(2007-11#1)(2008-10#6)(2008-5#2)
the precipitating factors##2##3##(1990-11#1)(2006-12#1)
the precipitating##3##2##(1990-11#1)(1991-7#1)(2006-12#1)
the precipitation of##16##3##(1991-7#1)(1995-5#1)(1996-10#1)(2005-11#2)(2008-10#7)(2009-5#1)(2009-7#1)(2010-5#2)
the precipitation reaction##3##3##(2008-10#3)
the precipitation##30##2##(1991-7#1)(1992-4#1)(1995-5#1)(1996-10#1)(2005-11#4)(2006-7#1)(2008-10#11)(2008-7#3)(2009-5#1)(2009-7#1)(2010-5#2)(2012-2#1)(2013-8#2)
the precipitous##2##2##(1995-2#1)(1996-6#1)
the precise chromosomal##2##3##(1992-12#1)(1994-12#1)
the precise delivery##2##3##(2008-10#1)(2009-5#1)
the precise etiology##2##3##(2008-7#1)(2012-3#1)
the precise form of##2##4##(2008-10#1)(2008-9#1)
the precise impact##2##3##(1997-7#1)(2012-12#1)
the precise localization of##2##4##(2008-3#1)(2008-4#1)
the precise location##2##3##(1993-12#1)(2008-7#1)
the precise measurement of##2##4##(1991-8#1)(2007-7#1)
the precise measurement##3##3##(1991-8#1)(2007-7#1)(2008-10#1)
the precise mechanism of action##2##5##(2006-8#1)(2008-10#1)
the precise mechanism of##5##4##(2006-8#1)(2008-10#1)(2010-8#1)(2011-1#2)
the precise mechanism##8##3##(1996-4#1)(2006-8#1)(2008-10#1)(2008-9#1)(2009-12#1)(2010-8#1)(2011-1#2)
the precise mechanisms of##2##4##(2010-7#1)(2012-12#1)
the precise mechanisms##7##3##(1994-10#1)(1995-12#1)(2006-10#1)(2008-1#1)(2008-9#1)(2010-7#1)(2012-12#1)
the precise mode of action##2##5##(1997-3#1)(2008-7#1)
the precise molecular mechanisms##2##4##(2008-11#1)(2008-7#1)
the precise molecular##4##3##(1996-7#1)(2008-1#1)(2008-11#1)(2008-7#1)
the precise nature of the##4##5##(1994-1#1)(2008-11#1)(2008-2#1)(2008-4#1)
the precise nature of##5##4##(1994-1#1)(1995-12#1)(2008-11#1)(2008-2#1)(2008-4#1)
the precise nature##6##3##(1994-1#1)(1995-12#1)(2006-12#1)(2008-11#1)(2008-2#1)(2008-4#1)
the precise role of##8##4##(1990-5#1)(1993-6#1)(1994-8#1)(2005-7#1)(2007-11#2)(2010-5#1)(2012-12#1)
the precise site of##2##4##(2012-2#2)
the precise time##2##3##(2012-2#1)(2013-8#1)
the precise timing of##2##4##(2008-10#1)(2012-12#1)
the precise##130##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#2)(1991-2#1)(1991-5#2)(1991-6#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-9#2)(1993-12#2)(1993-2#1)(1993-6#1)(1994-1#1)(1994-10#2)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#3)(1995-10#1)(1995-12#3)(1996-4#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-7#1)(2004-11#1)(2005-7#2)(2006-10#3)(2006-12#4)(2006-3#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-1#3)(2008-10#8)(2008-11#3)(2008-2#3)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#8)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#2)(2012-12#6)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
the precision (R##3##3##(2007-8#2)(2008-10#1)
the precision and accuracy of the##4##6##(2008-10#4)
the precision and accuracy of##6##5##(2008-10#5)(2010-11#1)
the precision and##9##3##(2008-10#5)(2008-3#2)(2010-11#1)(2010-4#1)
the precision grip##2##3##(1993-7#2)
the precision of measurement is##2##5##(2008-10#1)(2008-3#1)
the precision of registration##2##4##(2006-12#2)
the precision of the method##3##5##(2008-10#3)
the precision of the results##2##5##(2005-4#1)(2008-10#1)
the precision of the##20##4##(1992-11#1)(1994-2#1)(1996-12#1)(2005-4#1)(2007-12#1)(2008-10#9)(2008-3#2)(2010-9#1)(2012-11#1)(2013-1#1)(2013-7#1)
the precision of this##3##4##(2008-10#1)(2008-2#2)
the precision of##49##3##(1991-9#1)(1992-11#1)(1994-2#1)(1996-12#1)(2005-4#1)(2006-10#1)(2006-12#2)(2006-6#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#19)(2008-2#2)(2008-3#6)(2008-5#1)(2008-7#1)(2008-8#1)(2010-9#2)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
the precision with##2##3##(1996-7#1)(2008-10#1)
the precision##95##2##(1990-6#1)(1991-3#1)(1991-9#1)(1992-11#1)(1993-7#2)(1994-2#1)(1996-12#1)(1996-7#1)(1997-3#2)(2005-12#1)(2005-4#2)(2006-10#1)(2006-12#2)(2006-6#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#3)(2008-10#44)(2008-2#5)(2008-3#10)(2008-5#1)(2008-7#2)(2008-8#1)(2010-11#1)(2010-4#1)(2010-9#2)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
the precisions##4##2##(1990-8#1)(2008-10#3)
the preclinical and clinical##5##4##(1991-10#1)(1995-5#1)(2006-10#1)(2009-9#1)(2012-1#1)
the preclinical and early clinical##3##5##(2008-5#1)(2008-8#1)(2011-2#1)
the preclinical and##9##3##(1991-10#1)(1995-5#1)(2006-10#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-1#1)
the preclinical development of##2##4##(2005-7#1)(2008-4#1)
the preclinical development##4##3##(2005-7#1)(2008-4#1)(2012-12#2)
the preclinical evaluation of##3##4##(1991-9#1)(2006-10#1)(2008-10#1)
the preclinical evidence##2##3##(2008-1#1)(2008-6#1)
the preclinical findings##3##3##(2005-7#1)(2007-5#1)(2008-1#1)
the preclinical stage of##3##4##(1994-3#1)(2007-5#1)(2012-1#1)
the preclinical stage##5##3##(1991-9#1)(1994-3#1)(2007-5#1)(2010-10#1)(2012-1#1)
the preclinical##36##2##(1991-10#1)(1991-9#2)(1994-3#1)(1995-5#1)(1996-9#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#2)(2007-11#2)(2007-5#2)(2008-1#3)(2008-10#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-1#2)(2012-12#2)
the precolumn##6##2##(1990-8#2)(2008-10#4)
the preconcentrated##2##2##(2007-8#1)(2008-10#1)
the preconcentration and determination of##5##5##(2007-8#1)(2008-10#4)
the preconcentration and##15##3##(2007-8#1)(2008-10#14)
the preconcentration factor##2##3##(2008-10#2)
the preconcentration of Cu##2##4##(2008-10#2)
the preconcentration of the##3##4##(1997-1#1)(2008-10#2)
the preconcentration of trace metals##3##5##(2008-10#3)
the preconcentration of trace##7##4##(2008-10#7)
the preconcentration of##30##3##(1997-1#2)(2007-8#1)(2008-10#27)
the preconcentration step##3##3##(1996-11#1)(2008-10#2)
the preconcentration system##6##3##(2008-10#6)
the preconcentration time of##2##4##(2008-10#2)
the preconcentration time##3##3##(2008-10#3)
the preconcentration##75##2##(1996-11#1)(1997-1#2)(2007-8#3)(2008-10#69)
the preconditioned##2##2##(1996-9#1)(2013-7#1)
the preconditioning response##2##3##(1996-9#2)
the preconditioning##3##2##(1996-9#2)(2010-2#1)
the precursor and##3##3##(1990-12#1)(1994-11#1)(2008-6#1)
the precursor film##3##3##(2009-6#3)
the precursor for the##3##4##(1993-3#1)(1994-12#1)(2005-11#1)
the precursor for##6##3##(1991-2#1)(1993-3#1)(1994-12#1)(2005-11#1)(2012-1#2)
the precursor ion##2##3##(2008-10#1)(2009-10#1)
the precursor of adenoregulin##2##4##(1993-3#2)
the precursor of protamine P2##2##5##(1991-2#2)
the precursor of the##6##4##(1990-11#1)(1992-12#1)(1992-3#1)(1994-11#1)(1997-1#1)(2008-3#1)
the precursor of##30##3##(1990-1#1)(1990-11#1)(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-7#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-10#1)(1994-11#3)(1994-3#1)(1994-6#1)(1995-12#1)(1996-10#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2013-8#1)
the precursor protein of##2##4##(1997-2#1)(2008-5#1)
the precursor protein##8##3##(1991-5#1)(1992-2#1)(1994-8#1)(1995-2#2)(1996-2#1)(1997-2#1)(2008-5#1)
the precursor to the##4##4##(1990-9#1)(1994-11#1)(1994-3#1)(1996-5#1)
the precursor to##6##3##(1990-9#1)(1994-11#1)(1994-3#2)(1996-5#1)(1997-1#1)
the precursor was##2##3##(1990-12#2)
the precursor##94##2##(1990-1#1)(1990-11#1)(1990-12#4)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#5)(1991-5#1)(1991-7#3)(1991-8#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#2)(1992-7#2)(1993-11#2)(1993-12#2)(1993-3#5)(1994-10#1)(1994-11#6)(1994-12#1)(1994-2#1)(1994-3#3)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#2)(1996-4#1)(1996-5#2)(1997-1#2)(1997-2#1)(1997-4#2)(2005-11#2)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-6#3)(2010-4#2)(2012-1#2)(2013-1#1)(2013-7#1)(2013-8#1)
the precursors of##9##3##(1992-12#1)(1992-5#1)(1996-8#1)(2006-10#1)(2007-12#1)(2007-9#1)(2010-5#1)(2011-2#1)(2012-2#1)
the precursors##16##2##(1992-12#1)(1992-5#1)(1992-9#1)(1995-2#1)(1996-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-8#1)(2010-5#2)(2011-2#1)(2012-2#2)
the predator has a##2##4##(2008-9#2)
the predator##14##2##(2007-3#1)(2007-9#1)(2008-12#1)(2008-6#2)(2008-8#4)(2008-9#3)(2010-8#2)
the predatory mite##3##3##(2007-6#2)(2011-2#1)
the predatory stinkbug Podisus nigrispinus (Dallas)##2##6##(2008-6#2)
the predatory stinkbug##3##3##(2008-6#3)
the predatory##10##2##(2007-6#3)(2008-6#4)(2011-12#2)(2011-2#1)
the predefined##6##2##(2007-5#1)(2008-10#1)(2010-4#1)(2011-2#2)(2013-7#1)
the predetermination of exponential growth##2##5##(2008-7#2)
the predetermined lung lobe##2##4##(2013-1#2)
the predetermined##3##2##(2009-1#1)(2013-1#2)
the prediabetic##3##2##(2007-5#2)(2010-11#1)
the predictability of##4##3##(2008-10#1)(2008-9#1)(2011-7#1)(2013-7#1)
the predictable##2##2##(2008-1#1)(2010-3#1)
the predicted aa##2##3##(1991-9#1)(1993-2#1)
the predicted amino acid (aa) sequence##2##6##(1990-9#1)(1993-5#1)
the predicted amino acid (aa)##3##5##(1990-9#1)(1991-9#1)(1993-5#1)
the predicted amino acid sequence of##3##6##(1991-2#1)(1993-7#1)(1994-8#1)
the predicted amino acid sequence##7##5##(1991-2#1)(1993-7#1)(1994-8#2)(1995-3#1)(1995-8#1)(2008-10#1)
the predicted amino acid##12##4##(1990-9#1)(1991-2#1)(1991-9#1)(1992-12#1)(1993-5#1)(1993-7#1)(1994-8#2)(1995-3#1)(1995-8#1)(2008-10#2)
the predicted and the measured##3##5##(2007-12#1)(2008-3#1)(2013-1#1)
the predicted and the##4##4##(2007-12#1)(2008-10#1)(2008-3#1)(2013-1#1)
the predicted and##8##3##(1993-9#1)(1996-5#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-3#1)(2013-1#1)
the predicted benefits##2##3##(2007-10#1)(2010-11#1)
the predicted concentrations##2##3##(2008-10#2)
the predicted increase##2##3##(1991-2#1)(1992-3#1)
the predicted model##2##3##(1993-8#1)(2008-6#1)
the predicted number of##2##4##(2008-8#1)(2010-5#1)
the predicted primary##2##3##(1994-11#1)(1994-9#1)
the predicted product of##2##4##(2008-10#1)(2008-9#1)
the predicted protein##6##3##(1991-4#1)(1993-12#1)(1993-6#1)(1997-4#1)(1997-6#1)(2008-10#1)
the predicted proteins##2##3##(1991-4#1)(1992-12#1)
the predicted risk##2##3##(2006-11#1)(2010-12#1)
the predicted secondary structure of##2##5##(1992-1#1)(1994-8#1)
the predicted secondary structure##4##4##(1992-1#1)(1994-8#1)(1996-8#1)(2010-7#1)
the predicted sequence##2##3##(1990-4#1)(1993-12#1)
the predicted snail##2##3##(2008-8#2)
the predicted structure##2##3##(1991-12#1)(2011-1#1)
the predicted transmembrane##3##3##(1992-12#1)(1994-11#1)(1995-2#1)
the predicted values##3##3##(2004-12#1)(2008-10#1)(2013-8#1)
the predicted##150##2##(1990-1#1)(1990-4#1)(1990-5#2)(1990-9#1)(1991-12#1)(1991-2#4)(1991-4#3)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#2)(1992-11#1)(1992-12#3)(1992-3#2)(1992-4#1)(1993-12#2)(1993-2#1)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-8#3)(1994-9#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#2)(1995-8#2)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#3)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#2)(1997-8#2)(2004-12#1)(2005-11#1)(2006-11#3)(2006-12#2)(2006-5#1)(2007-10#1)(2007-12#3)(2007-4#1)(2008-10#17)(2008-2#2)(2008-3#4)(2008-4#1)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#3)(2009-12#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#4)
the prediction ability of##4##4##(2008-10#4)
the prediction accuracy##3##3##(2008-2#1)(2010-7#1)(2012-3#1)
the prediction and##3##3##(1995-3#1)(2008-4#1)(2008-6#1)
the prediction error##2##3##(2008-11#1)(2012-2#1)
the prediction model##2##3##(2005-12#1)(2010-8#1)
the prediction of a new##2##5##(2008-2#1)(2009-8#1)
the prediction of a##4##4##(1997-6#1)(2007-11#1)(2008-2#1)(2009-8#1)
the prediction of outcome##2##4##(2006-10#1)(2009-4#1)
the prediction of the##12##4##(1990-5#1)(2006-5#1)(2006-8#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)(2010-4#2)(2010-8#1)
the prediction of their##2##4##(2008-6#1)(2012-3#1)
the prediction of these##3##4##(2008-5#1)(2008-7#1)(2011-2#1)
the prediction of##91##3##(1990-5#2)(1991-11#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-5#1)(1995-4#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-7#1)(1997-6#2)(2005-7#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#5)(2007-12#2)(2007-6#2)(2007-8#3)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-3#1)(2009-4#4)(2009-7#3)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#2)(2010-8#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#5)(2012-3#1)(2013-1#1)
the prediction performance##2##3##(2008-10#1)(2013-1#1)
the prediction results##2##3##(2008-10#1)(2012-2#1)
the prediction that##5##3##(1990-7#1)(2008-5#1)(2008-8#2)(2013-1#1)
the prediction##141##2##(1990-5#2)(1990-7#1)(1991-11#1)(1992-9#1)(1993-12#3)(1993-4#1)(1993-5#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-7#1)(1997-6#2)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-11#6)(2007-12#3)(2007-6#3)(2007-8#3)(2007-9#1)(2008-10#22)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-3#1)(2009-4#4)(2009-7#4)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#3)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#8)(2012-3#3)(2013-1#3)
the predictions are##2##3##(1996-1#1)(2007-11#1)
the predictions from##2##3##(2008-3#1)(2008-9#1)
the predictions of a##5##4##(1995-3#1)(2007-11#1)(2007-12#2)(2008-3#1)
the predictions of the model##2##5##(1990-8#1)(1995-8#1)
the predictions of the theory##2##5##(2007-11#1)(2008-8#1)
the predictions of the##9##4##(1990-8#1)(1992-3#1)(1995-8#1)(2004-2#1)(2007-11#2)(2008-8#1)(2008-9#1)(2012-1#1)
the predictions of##28##3##(1990-8#1)(1992-3#1)(1993-7#1)(1995-3#1)(1995-8#1)(2004-2#2)(2006-10#2)(2007-11#4)(2007-12#2)(2007-9#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-8#3)(2008-9#1)(2010-4#1)(2012-1#1)
the predictions were##3##3##(2008-10#1)(2008-7#1)(2009-5#1)
the predictions##47##2##(1990-8#2)(1992-3#1)(1993-2#1)(1993-7#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-1#1)(2004-2#2)(2006-10#2)(2006-12#1)(2007-11#5)(2007-12#2)(2007-5#1)(2007-9#1)(2008-10#2)(2008-2#5)(2008-3#4)(2008-7#2)(2008-8#3)(2008-9#3)(2009-3#1)(2009-5#1)(2010-4#1)(2010-8#1)(2012-1#1)
the predictive ability of the model##2##6##(2008-10#2)
the predictive ability of the##7##5##(2008-10#5)(2008-8#1)(2012-3#1)
the predictive ability of##11##4##(2005-11#1)(2008-10#7)(2008-8#1)(2012-12#1)(2012-3#1)
the predictive ability##12##3##(1996-8#1)(2005-11#1)(2008-10#7)(2008-8#1)(2012-12#1)(2012-3#1)
the predictive accuracy of##2##4##(1993-3#1)(2012-12#1)
the predictive factors##2##3##(2007-11#1)(2007-8#1)
the predictive performance of##2##4##(2008-10#1)(2012-3#1)
the predictive power of the##4##5##(1990-12#1)(2008-5#1)(2008-7#1)(2010-2#1)
the predictive power of##11##4##(1990-12#1)(1992-12#1)(1992-2#1)(1995-6#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-2#1)(2012-2#1)(2013-1#1)
the predictive validity of nursing home pre-admission screens##2##8##(1994-2#2)
the predictive validity of##6##4##(1992-2#1)(1994-2#2)(1994-3#1)(2008-4#1)(2008-8#1)
the predictive validity##7##3##(1992-2#1)(1994-2#2)(1994-3#1)(2008-4#1)(2008-8#1)(2013-1#1)
the predictive value for##2##4##(1993-12#1)(2011-1#1)
the predictive value of a positive##3##6##(1990-3#1)(1992-5#1)(1997-1#1)
the predictive value of a##5##5##(1990-3#1)(1992-5#2)(1997-1#1)(2011-2#1)
the predictive value of the##2##5##(1992-10#1)(2009-7#1)
the predictive value of this##2##5##(1990-7#1)(1991-12#1)
the predictive value of##26##4##(1990-3#1)(1990-7#1)(1991-12#1)(1992-10#1)(1992-5#3)(1993-2#1)(1995-3#1)(1996-1#1)(1997-1#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-3#1)(2008-10#1)(2009-6#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
the predictive value##29##3##(1990-3#1)(1990-7#1)(1991-12#1)(1992-10#1)(1992-5#3)(1993-12#1)(1993-2#1)(1995-3#1)(1996-1#1)(1997-1#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-3#2)(2008-10#1)(2009-6#1)(2009-7#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
the predictive##80##2##(1990-12#1)(1990-3#1)(1990-7#1)(1991-12#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-5#3)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#2)(1994-3#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-8#2)(1997-1#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-3#2)(2007-8#2)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-2#1)(2011-1#3)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#7)(2013-8#1)
the predictor factors##2##3##(2008-9#1)(2010-6#1)
the predictor variable##2##3##(1991-12#1)(2010-12#1)
the predictor##12##2##(1991-12#1)(1993-6#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-6#2)(2008-9#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)
the predictors for##2##3##(2010-5#1)(2012-2#1)
the predictors of the##2##4##(2008-11#1)(2012-12#1)
the predictors of##15##3##(1993-1#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-11#2)(2009-11#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
the predictors##26##2##(1990-12#1)(1993-1#1)(1993-6#1)(1994-6#2)(1995-12#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-11#3)(2009-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#1)
the predisposing factors##4##3##(1997-9#1)(2007-7#1)(2008-1#1)(2008-5#1)
the predisposing##8##2##(1993-1#1)(1993-10#1)(1997-9#1)(2007-7#2)(2008-1#1)(2008-4#1)(2008-5#1)
the predisposition of##2##3##(1991-12#1)(2008-4#1)
the predisposition to##3##3##(1991-12#1)(1993-6#1)(2009-5#1)
the predisposition##6##2##(1991-12#2)(1993-6#1)(2008-4#1)(2009-10#1)(2009-5#1)
the prednisolone##2##2##(2006-4#1)(2007-8#1)
the prednisone dose##2##3##(1990-11#2)
the prednisone##5##2##(1990-11#2)(1992-5#1)(2006-10#1)(2007-8#1)
the predominance of the##3##4##(2005-11#1)(2008-1#1)(2012-3#1)
the predominance of##21##3##(1990-12#1)(1990-8#1)(1991-10#1)(1992-6#1)(1994-9#1)(1995-2#1)(1996-11#1)(1997-2#1)(2005-11#1)(2007-10#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-3#3)
the predominant cause of##3##4##(1992-2#1)(1994-10#1)(2010-4#1)
the predominant cell##2##3##(1995-6#1)(2008-1#1)
the predominant clinical##3##3##(2007-8#1)(2009-6#1)(2011-2#1)
the predominant conformation##2##3##(1995-1#1)(2005-7#1)
the predominant expression##2##3##(1991-1#1)(1996-12#1)
the predominant factor##2##3##(2010-8#1)(2013-1#1)
the predominant fatty##2##3##(2008-11#1)(2012-12#1)
the predominant form of##4##4##(1990-11#1)(1992-6#1)(1994-6#1)(2008-11#1)
the predominant form##6##3##(1990-11#1)(1991-7#1)(1992-6#1)(1994-6#1)(2008-10#1)(2008-11#1)
the predominant genotype in##2##4##(2010-12#1)(2013-8#1)
the predominant genotype##3##3##(2008-10#1)(2010-12#1)(2013-8#1)
the predominant intermediate is the##2##5##(1997-4#2)
the predominant isoform of##2##4##(1992-12#1)(1994-8#1)
the predominant isoform##3##3##(1992-12#1)(1992-3#1)(1994-8#1)
the predominant mechanism for the##2##5##(2007-5#1)(2008-10#1)
the predominant mechanism of##3##4##(2006-1#1)(2007-10#1)(2008-3#1)
the predominant mechanism##6##3##(2006-1#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-3#1)
the predominant mode of inheritance##2##5##(2008-10#1)(2011-2#1)
the predominant mode##4##3##(2008-10#3)(2011-2#1)
the predominant mutation##3##3##(1995-4#3)
the predominant organisms##3##3##(2007-12#1)(2007-3#1)(2007-8#1)
the predominant population##2##3##(1992-11#1)(2006-10#1)
the predominant protein##3##3##(1991-8#1)(1995-3#1)(1996-8#1)
the predominant source##2##3##(2008-10#1)(2010-5#1)
the predominant species##9##3##(1990-3#1)(1994-11#1)(1996-12#1)(2007-8#1)(2008-10#4)(2013-8#1)
the predominant strain##2##3##(2010-12#2)
the predominant symptom##2##3##(2006-10#1)(2011-2#1)
the predominant##182##2##(1990-11#2)(1990-3#4)(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-7#2)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#3)(1995-1#1)(1995-3#3)(1995-4#3)(1995-6#1)(1996-12#3)(1996-8#3)(1997-4#4)(2004-2#1)(2004-9#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-3#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#4)(2008-1#6)(2008-10#25)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#9)
the predominantly expressed##2##3##(1991-12#1)(2011-1#1)
the predominantly##7##2##(1990-10#1)(1991-12#1)(1994-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2011-1#1)
the predominate##4##2##(1994-9#1)(1996-5#1)(2008-12#1)(2010-1#1)
the preeminent##2##2##(1994-9#1)(2008-10#1)
the preemptive##2##2##(2006-10#1)(2007-11#1)
the preexisting##4##2##(1990-11#1)(2007-10#1)(2007-9#1)(2008-1#1)
the preferable##2##2##(1995-6#1)(2008-5#1)
the preference for##7##3##(1991-1#1)(1991-11#1)(1992-6#1)(2008-5#1)(2009-3#1)(2013-7#1)(2013-8#1)
the preference of the##3##4##(1991-6#1)(1992-11#1)(2008-4#1)
the preference of##9##3##(1991-3#1)(1991-6#1)(1992-11#1)(1992-9#1)(1996-5#1)(2008-10#1)(2008-4#1)(2012-11#1)(2013-1#1)
the preference##19##2##(1991-1#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-6#1)(1996-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-8#1)(2012-11#1)(2013-1#1)(2013-7#1)(2013-8#1)
the preferential accumulation of##2##4##(1996-5#1)(2008-11#1)
the preferential repair of##2##4##(1993-12#1)(1994-5#1)
the preferential##33##2##(1990-11#1)(1990-4#1)(1991-12#1)(1991-2#2)(1991-4#2)(1991-8#1)(1992-3#1)(1993-12#3)(1993-7#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#3)(2009-12#1)(2009-7#1)(2011-2#1)
the preferred binding site##2##4##(1997-4#1)(2008-5#1)
the preferred binding##4##3##(1997-4#1)(2008-5#1)(2010-6#1)(2013-8#1)
the preferred cell##2##3##(2008-11#1)(2008-9#1)
the preferred food##2##3##(2008-1#1)(2008-8#1)
the preferred method for treating##2##5##(2007-12#1)(2007-8#1)
the preferred method for##6##4##(2005-10#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-4#1)(2009-12#1)
the preferred method of treatment for##2##6##(2007-7#1)(2010-7#1)
the preferred method of##4##4##(1994-1#1)(2005-10#1)(2007-7#1)(2010-7#1)
the preferred method##10##3##(1994-1#1)(2005-10#2)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-4#1)(2009-12#1)(2010-7#1)
the preferred option##2##3##(2011-1#1)(2013-8#1)
the preferred orientation of the##2##5##(1995-3#1)(1995-6#1)
the preferred orientation##4##3##(1995-3#1)(1995-6#1)(2008-11#1)(2008-8#1)
the preferred route of##2##4##(2006-2#1)(2008-5#1)
the preferred strategy##4##3##(2008-5#1)(2012-3#3)
the preferred technique for##2##4##(2004-2#1)(2007-8#1)
the preferred technique##5##3##(1996-6#1)(2004-2#1)(2007-8#1)(2008-1#1)(2011-2#1)
the preferred therapy for##2##4##(2006-10#1)(2008-3#1)
the preferred treatment modality##2##4##(2005-12#1)(2006-10#1)
the preferred treatment##9##3##(1996-3#1)(2005-12#2)(2006-10#1)(2006-5#1)(2007-12#1)(2007-5#1)(2007-7#1)(2010-3#1)
the preferred##98##2##(1990-12#2)(1990-7#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-1#1)(1995-10#1)(1995-3#1)(1995-6#2)(1996-1#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#1)(1996-8#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-11#2)(2004-2#1)(2005-10#3)(2005-12#2)(2006-10#5)(2006-2#1)(2006-5#1)(2007-12#3)(2007-5#1)(2007-7#4)(2007-8#3)(2008-1#3)(2008-10#2)(2008-11#4)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-7#1)(2013-8#6)
the prefix &quot##2##3##(2007-10#1)(2012-12#1)
the preflexion stage##2##3##(2008-5#2)
the preformed##2##2##(1995-6#1)(2008-10#1)
the prefrontal and##2##3##(1997-6#1)(2010-2#1)
the prefrontal area##3##3##(1994-8#1)(1996-2#1)(2011-2#1)
the prefrontal cortex (PFC)##3##4##(2008-11#1)(2008-7#1)(2013-8#1)
the prefrontal cortex and the##2##5##(1997-6#1)(2008-7#1)
the prefrontal cortex and##4##4##(1991-6#1)(1997-6#1)(2008-7#1)(2013-8#1)
the prefrontal cortex in schizophrenia##2##5##(1995-11#1)(2006-9#1)
the prefrontal cortex in##5##4##(1993-5#1)(1995-11#1)(1996-10#1)(1997-2#1)(2006-9#1)
the prefrontal cortex of##4##4##(1995-12#1)(1997-5#1)(2008-10#1)(2009-12#1)
the prefrontal cortex were##2##4##(1996-10#1)(2011-1#1)
the prefrontal cortex##35##3##(1991-6#1)(1993-5#2)(1994-2#1)(1994-6#1)(1995-11#3)(1995-12#2)(1996-10#2)(1996-2#1)(1996-4#1)(1997-2#1)(1997-5#1)(1997-6#1)(2006-9#1)(2008-10#1)(2008-11#2)(2008-7#3)(2009-10#2)(2009-12#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#2)(2013-8#3)
the prefrontal lobe##2##3##(2008-11#1)(2012-1#1)
the prefrontal##48##2##(1991-6#1)(1993-3#2)(1993-5#2)(1994-2#1)(1994-6#1)(1994-8#2)(1995-11#3)(1995-12#2)(1996-10#2)(1996-2#2)(1996-4#1)(1997-2#1)(1997-5#2)(1997-6#2)(2006-9#1)(2008-10#1)(2008-11#4)(2008-7#3)(2009-10#2)(2009-12#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#3)(2013-8#4)
the preganglionic##2##2##(1992-1#2)
the pregnancies##6##2##(1992-12#1)(1992-6#1)(1993-1#1)(1995-6#1)(2008-11#1)(2008-8#1)
the pregnancy and birth##2##4##(1994-9#1)(2009-10#1)
the pregnancy and##5##3##(1994-9#1)(2004-10#1)(2008-12#1)(2008-2#1)(2009-10#1)
the pregnancy rate in##2##4##(2006-5#1)(2007-10#1)
the pregnancy rate##8##3##(1992-12#1)(2006-5#5)(2007-10#1)(2009-5#1)
the pregnancy was##5##3##(1993-3#1)(2006-8#1)(2008-4#1)(2012-11#1)(2013-8#1)
the pregnancy##50##2##(1990-5#1)(1990-6#1)(1990-8#2)(1991-12#2)(1991-8#1)(1992-12#2)(1993-3#1)(1994-2#2)(1994-7#1)(1994-9#1)(1995-2#1)(1996-9#1)(2004-10#2)(2005-10#1)(2006-10#1)(2006-5#5)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-3#1)(2008-12#1)(2008-2#4)(2008-4#1)(2009-10#2)(2009-5#1)(2010-3#3)(2011-1#1)(2011-2#2)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
the pregnane##2##2##(1991-11#1)(2007-1#1)
the pregnant and##2##3##(2006-10#1)(2007-2#1)
the pregnant mothers##3##3##(2008-5#2)(2012-2#1)
the pregnant patients##2##3##(1993-10#2)
the pregnant state##3##3##(1994-6#1)(2008-4#2)
the pregnant uterus]##2##3##(1992-3#1)(2007-8#1)
the pregnant woman and##2##4##(1992-9#1)(2009-10#1)
the pregnant woman##5##3##(1992-9#1)(2007-2#1)(2009-10#1)(2009-5#1)(2011-2#1)
the pregnant woman's##2##3##(1991-4#1)(2008-2#1)
the pregnant women in these##2##5##(1990-2#1)(2007-2#1)
the pregnant women were##2##4##(2007-2#1)(2011-1#1)
the pregnant women##12##3##(1990-2#1)(1997-3#1)(1997-4#1)(2007-2#3)(2008-12#1)(2009-5#1)(2011-1#3)(2012-12#1)
the pregnant##48##2##(1990-2#1)(1991-4#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-10#2)(1993-12#1)(1994-6#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-7#1)(2006-10#4)(2007-2#8)(2007-4#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#4)(2009-10#1)(2009-5#3)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)
the prehospital phase of##2##4##(2007-9#1)(2008-3#1)
the prehospital##6##2##(2006-10#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-3#2)
the prehydrolysates##3##2##(2008-5#3)
the preimplantation development of##2##4##(1994-3#1)(2012-2#1)
the preimplantation##5##2##(1994-3#1)(1995-11#2)(2008-5#1)(2012-2#1)
the preincubation##3##2##(1991-9#2)(1996-12#1)
the prejunctional##3##2##(2008-2#1)(2013-1#2)
the prelimbic##3##2##(1993-6#1)(1995-12#1)(1996-10#1)
the preliminary analysis##2##3##(1991-2#1)(1996-6#1)
the preliminary data##3##3##(2008-11#1)(2008-7#1)(2012-2#1)
the preliminary findings of##3##4##(1990-3#1)(1996-6#1)(1997-1#1)
the preliminary findings##6##3##(1990-3#1)(1992-3#1)(1996-6#1)(1997-1#1)(2013-1#2)
the preliminary model##2##3##(2007-6#1)(2010-8#1)
the preliminary results of##7##4##(2006-2#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-3#1)(2011-1#1)(2013-8#1)
the preliminary results showed##2##4##(2007-2#1)(2008-4#1)
the preliminary results##11##3##(1990-12#1)(2006-2#1)(2006-6#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-6#1)(2011-1#1)(2013-8#1)
the preliminary stage of##2##4##(2008-10#1)(2012-3#1)
the preliminary study##2##3##(2006-4#1)(2008-5#1)
the preliminary success of the program##2##6##(1990-12#1)(2013-1#1)
the preliminary ultrasound diagnosis##2##4##(2006-6#2)
the preliminary ultrasound##3##3##(2006-6#3)
the preliminary##54##2##(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#1)(1991-2#1)(1991-8#1)(1992-3#1)(1992-5#1)(1993-4#1)(1996-6#2)(1997-1#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-6#4)(2007-2#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-2#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
the premalignant##2##2##(2006-10#1)(2013-1#1)
the premature aging##2##3##(2007-7#1)(2010-2#1)
the premature newborn##2##3##(2009-9#1)(2013-1#1)
the premature termination of##2##4##(1992-2#1)(2007-11#1)
the premature##21##2##(1992-2#1)(1993-6#1)(1993-9#1)(1994-8#1)(1994-9#1)(2007-10#3)(2007-11#1)(2007-7#1)(2007-9#1)(2009-5#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#2)
the premenstrual##2##2##(1994-9#1)(2009-10#1)
the premier##3##2##(2008-4#2)(2011-2#1)
the premise of##2##3##(1996-8#1)(2008-7#1)
the premise that the##4##4##(1990-8#1)(1994-3#1)(2006-8#1)(2008-9#1)
the premise that##20##3##(1990-8#1)(1992-3#1)(1992-6#1)(1994-3#1)(1996-11#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-8#1)(2013-1#1)
the premise##25##2##(1990-8#1)(1992-3#1)(1992-6#1)(1994-3#1)(1996-11#1)(1996-2#1)(1996-8#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2010-8#1)(2013-1#1)(2013-8#1)
the premises##5##2##(2006-10#1)(2007-8#1)(2008-10#1)(2010-9#1)(2012-12#1)
the premium##3##2##(1997-2#1)(1997-8#1)(2010-2#1)
the prenatal and postpartum periods##2##5##(2007-2#1)(2010-9#1)
the prenatal diagnosis of##2##4##(2006-8#1)(2012-2#1)
the prenatal period##7##3##(1995-5#1)(1996-5#1)(2005-11#2)(2007-2#1)(2010-5#1)(2012-2#1)
the prenatal##22##2##(1993-10#1)(1993-3#1)(1995-5#1)(1996-10#1)(1996-5#1)(2005-11#2)(2006-7#1)(2006-8#2)(2007-11#1)(2007-2#2)(2008-4#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)
the prenylation of##2##3##(1996-4#2)
the preoperative and postoperative##3##4##(1993-7#1)(1994-3#1)(2007-8#1)
the preoperative and##6##3##(1993-7#1)(1994-3#1)(2007-8#2)(2012-3#1)(2013-7#1)
the preoperative assessment of##2##4##(1990-10#1)(2012-3#1)
the preoperative assessment##5##3##(1990-10#1)(2006-10#1)(2007-12#1)(2010-11#1)(2012-3#1)
the preoperative clinical##2##3##(1997-2#1)(2011-2#1)
the preoperative diagnosis##3##3##(1997-8#1)(2006-6#1)(2007-8#1)
the preoperative evaluation##4##3##(1990-9#1)(2006-10#1)(2006-2#1)(2012-12#1)
the preoperative examinations##3##3##(2006-7#1)(2012-12#2)
the preoperative period##6##3##(2007-9#1)(2008-2#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
the preoperative preparation##2##3##(1992-9#1)(2008-10#1)
the preoperative risk##2##3##(2007-8#1)(2010-7#1)
the preoperative staging##3##3##(2006-10#2)(2008-5#1)
the preoperative values##2##3##(2007-8#1)(2009-10#1)
the preoperative##81##2##(1990-10#1)(1990-11#1)(1990-4#1)(1990-9#2)(1992-9#2)(1993-5#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-1#1)(1997-1#4)(1997-2#1)(1997-6#1)(1997-8#1)(2004-10#1)(2006-10#5)(2006-2#2)(2006-3#1)(2006-6#1)(2006-7#2)(2007-12#1)(2007-5#2)(2007-7#1)(2007-8#5)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#3)(2008-8#1)(2009-10#1)(2009-2#1)(2009-3#2)(2009-6#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-7#1)(2010-9#3)(2011-1#1)(2011-2#5)(2012-12#3)(2012-2#1)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#2)
the preoptic area (POA) and##2##5##(1991-5#1)(1997-3#1)
the preoptic area (POA)##4##4##(1991-5#1)(1995-10#1)(1997-3#1)(2008-8#1)
the preoptic area and##3##4##(1990-4#2)(1997-5#1)
the preoptic area##14##3##(1990-4#2)(1991-5#1)(1992-1#1)(1992-3#1)(1995-10#1)(1996-9#2)(1997-3#2)(1997-5#2)(2008-8#1)(2008-9#1)
the preoptic##17##2##(1990-4#3)(1991-5#1)(1992-1#1)(1992-3#1)(1993-12#1)(1995-10#1)(1995-5#1)(1996-9#2)(1997-3#2)(1997-5#2)(2008-8#1)(2008-9#1)
the preovulatory##3##2##(2006-5#2)(2008-12#1)
the prepairing and interdimer mechanisms##2##5##(2008-10#2)
the prepairing##4##2##(2008-10#4)
the preparation and use of##3##5##(2008-11#1)(2008-2#1)(2008-4#1)
the preparation and##9##3##(1991-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2013-8#1)
the preparation for##4##3##(1993-2#1)(1995-5#1)(2009-4#1)(2012-2#1)
the preparation of a##17##4##(1990-12#1)(1991-7#1)(1992-2#1)(1996-2#1)(1996-7#1)(1997-3#1)(2005-8#1)(2006-11#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-1#1)
the preparation of an##2##4##(2008-10#1)(2008-11#1)
the preparation of both##2##4##(2008-4#1)(2008-7#1)
the preparation of highly##3##4##(1990-3#1)(2010-12#1)(2010-4#1)
the preparation of large##2##4##(1996-5#1)(2008-4#1)
the preparation of media##2##4##(2008-4#1)(2008-9#1)
the preparation of metal##2##4##(2008-5#1)(2010-5#1)
the preparation of novel##2##4##(1991-8#1)(2008-1#1)
the preparation of nuclear##2##4##(2008-2#1)(2008-8#1)
the preparation of the##18##4##(1990-2#1)(1992-3#1)(2007-1#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-5#1)(2012-12#1)(2013-8#1)
the preparation of these##4##4##(1992-5#1)(2005-11#1)(2007-11#1)(2010-12#1)
the preparation of tissue##2##4##(2008-2#1)(2010-10#1)
the preparation of##218##3##(1990-12#2)(1990-2#2)(1990-3#2)(1990-9#1)(1991-2#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-9#2)(1994-11#1)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#1)(1995-11#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#4)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#2)(2005-10#1)(2005-11#3)(2005-12#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-3#1)(2006-9#1)(2007-1#1)(2007-11#11)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#24)(2008-11#11)(2008-12#3)(2008-2#9)(2008-3#2)(2008-4#32)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#6)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#4)(2010-2#3)(2010-4#5)(2010-5#2)(2010-7#2)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#3)(2013-7#1)(2013-8#2)
the preparation procedure of##2##4##(2007-9#1)(2010-4#1)
the preparation procedure##5##3##(1990-2#1)(2007-9#1)(2008-10#2)(2010-4#1)
the preparation was##3##3##(1990-2#1)(1991-11#1)(1993-6#1)
the preparation##268##2##(1990-11#2)(1990-12#2)(1990-2#4)(1990-3#2)(1990-9#1)(1991-11#1)(1991-2#2)(1991-4#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#2)(1992-2#3)(1992-3#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-11#2)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#1)(1995-11#2)(1995-5#1)(1995-6#2)(1995-7#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#4)(1996-7#2)(1997-1#1)(1997-2#2)(1997-3#2)(2005-10#1)(2005-11#3)(2005-12#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-3#1)(2006-9#1)(2007-1#1)(2007-11#11)(2007-12#1)(2007-5#1)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#34)(2008-11#15)(2008-12#3)(2008-2#11)(2008-3#2)(2008-4#35)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#6)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#4)(2010-2#3)(2010-4#6)(2010-5#2)(2010-7#2)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#3)(2013-7#1)(2013-8#3)
the preparations##18##2##(1990-4#2)(1991-11#1)(1996-5#1)(1996-7#1)(2004-12#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-5#3)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-12#1)
the preparative##3##2##(1996-12#1)(1997-7#1)(2008-9#1)
the preparatory phase##2##3##(1996-2#1)(2010-6#1)
the preparatory##6##2##(1996-2#1)(2010-2#1)(2010-6#1)(2012-3#1)(2013-8#2)
the prepared Au-NP/SAM-modified electrodes##2##4##(2008-10#2)
the prepared ISFETs##2##3##(2008-10#2)
the prepared complexes##3##3##(2007-11#1)(2008-5#2)
the prepared matrix##2##3##(2005-12#2)
the prepared stationary phase##2##4##(2012-12#2)
the prepared##35##2##(2005-12#2)(2007-11#2)(2008-10#10)(2008-11#1)(2008-5#7)(2009-11#1)(2010-12#1)(2010-5#3)(2012-12#3)(2012-2#3)(2013-8#2)
the preparedness of##2##3##(1996-1#1)(2008-10#1)
the preponderance of##6##3##(1990-2#1)(1994-12#1)(2007-11#1)(2007-8#1)(2009-5#1)(2011-12#1)
the prepontine##3##2##(2005-5#1)(2006-12#1)(2012-3#1)
the preprocessing##2##2##(2008-2#2)
the prepropeptides##2##2##(1992-11#1)(1994-11#1)
the preprophase band##3##3##(2009-10#2)(2009-8#1)
the prepubertal period##4##3##(2008-4#1)(2011-1#2)(2012-2#1)
the prepubertal##5##2##(2008-4#1)(2011-1#2)(2012-2#2)
the prepulseless period##2##3##(2006-10#2)
the preregistration internship##2##3##(1995-6#2)
the preregistration##3##2##(1995-6#3)
the prerequisite and##2##3##(2011-2#1)(2013-8#1)
the prerequisite for##3##3##(1995-8#1)(2007-5#1)(2013-1#1)
the prerequisite of##3##3##(2005-11#1)(2013-7#1)(2013-8#1)
the prerequisite##9##2##(1995-8#1)(2005-10#1)(2005-11#1)(2007-5#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
the prerequisites for the##2##4##(1991-3#1)(2008-4#1)
the prerequisites for##4##3##(1991-3#1)(1995-4#2)(2008-4#1)
the preruminant calf##2##3##(1992-2#1)(1993-12#1)
the preschool children##2##3##(2006-4#1)(2012-2#1)
the preschool##9##2##(2006-3#1)(2006-4#1)(2006-8#1)(2008-2#1)(2010-7#1)(2011-12#1)(2012-12#2)(2012-2#1)
the prescribed##18##2##(1990-6#1)(1993-11#2)(1994-4#1)(1995-2#1)(1996-3#1)(2006-7#1)(2007-4#1)(2008-10#1)(2008-3#2)(2009-11#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
the prescriber##2##2##(2008-11#1)(2010-9#1)
the prescribers##3##2##(2008-3#1)(2013-8#2)
the prescribing of##3##3##(1993-12#1)(2006-6#1)(2009-3#1)
the prescribing rates##2##3##(2008-11#2)
the prescribing##9##2##(1993-12#1)(2006-10#1)(2006-6#1)(2007-2#1)(2008-11#3)(2008-4#1)(2009-3#1)
the prescription and##3##3##(2008-3#1)(2008-7#1)(2011-12#1)
the prescription of antidepressants##2##4##(2008-8#1)(2012-3#1)
the prescription of new anticoagulation and##2##6##(2007-10#2)
the prescription of such##2##4##(1991-11#1)(1997-5#1)
the prescription of##22##3##(1991-11#1)(1993-8#1)(1995-4#1)(1996-1#1)(1996-4#2)(1997-5#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
the prescription##36##2##(1991-11#1)(1993-8#1)(1995-11#1)(1995-4#1)(1996-1#1)(1996-4#2)(1996-6#1)(1997-5#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-5#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)
the prescriptions of##2##3##(2012-12#1)(2013-8#1)
the prescriptions##13##2##(1990-4#1)(1995-11#2)(2007-2#2)(2008-10#1)(2010-12#4)(2012-12#2)(2013-8#1)
the preselected##2##2##(1990-6#1)(2008-10#1)
the presence (or absence) of##2##5##(2006-10#1)(2008-10#1)
the presence and absence of the##7##6##(1990-5#1)(1992-3#1)(1994-10#1)(1994-11#1)(2008-10#2)(2011-1#1)
the presence and absence of##81##5##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#3)(1990-5#2)(1990-6#1)(1990-7#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-6#2)(1992-3#2)(1992-4#2)(1992-6#2)(1992-8#2)(1993-3#2)(1993-6#1)(1993-7#2)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-7#2)(2007-11#1)(2007-8#1)(2008-10#12)(2008-11#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2010-11#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)
the presence and distribution of##3##5##(1994-2#2)(2012-2#1)
the presence and extent of##3##5##(1991-12#1)(2007-6#1)(2010-2#1)
the presence and location of##3##5##(1991-7#1)(1992-12#1)(2013-7#1)
the presence and magnitude of##2##5##(1997-6#1)(2008-1#1)
the presence and severity of the##2##6##(1993-12#1)(2004-1#1)
the presence and severity of##7##5##(1991-8#1)(1993-12#1)(1997-1#1)(1997-8#1)(2004-1#1)(2006-2#1)(2009-3#1)
the presence and the absence of##3##6##(2005-11#1)(2008-10#2)
the presence and the##5##4##(2005-11#1)(2007-5#1)(2008-10#2)(2012-12#1)
the presence and##137##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#3)(1990-5#2)(1990-6#1)(1990-7#1)(1991-1#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#2)(1992-6#2)(1992-8#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-7#2)(1994-10#1)(1994-11#5)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-1#1)(2004-11#1)(2005-11#1)(2006-2#1)(2007-11#1)(2007-5#1)(2007-6#2)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-2#1)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
the presence and/or##2##3##(1997-2#1)(2006-2#1)
the presence in the##4##4##(1991-5#1)(1993-8#1)(1994-12#1)(1994-9#1)
the presence in this area of##2##6##(2006-4#1)(2008-10#1)
the presence in this##3##4##(1990-5#1)(2006-4#1)(2008-10#1)
the presence in##16##3##(1990-3#1)(1990-5#1)(1991-5#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-9#1)(1996-7#1)(1997-3#1)(2006-10#1)(2006-4#1)(2008-10#2)(2008-5#1)(2008-7#1)
the presence of &quot##3##4##(1990-3#1)(2008-5#1)(2009-7#1)
the presence of 0##40##4##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-3#1)(1991-7#2)(1992-3#1)(1992-6#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-8#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-6#1)(1997-5#1)(2005-11#3)(2006-5#1)(2006-9#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-8#1)(2010-5#1)(2011-2#1)
the presence of 1 mM##7##5##(1991-4#1)(1993-6#1)(1995-12#1)(1996-1#1)(1997-4#1)(2005-11#1)(2008-5#1)
the presence of 1 microM##7##5##(1990-12#1)(1991-12#1)(1992-8#1)(1995-11#1)(1997-6#1)(1997-7#1)(2009-12#1)
the presence of 1##34##4##(1990-10#1)(1990-12#1)(1990-3#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-8#1)(1993-6#1)(1994-10#1)(1994-11#2)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(2005-11#1)(2006-8#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-5#1)(2009-12#1)(2009-2#1)
the presence of 10 mM##8##5##(1990-10#1)(1990-2#1)(1990-4#1)(1990-8#1)(1991-11#1)(1995-11#1)(2005-11#1)(2008-5#1)
the presence of 10##20##4##(1990-10#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-4#1)(1992-2#1)(1995-11#1)(1996-10#1)(1997-3#1)(2005-11#1)(2006-5#2)(2008-5#2)(2010-11#1)(2012-12#1)(2012-2#1)
the presence of 10(-9) M##2##5##(1990-11#1)(1994-3#1)
the presence of 100##6##4##(1991-6#1)(1992-7#1)(1994-12#1)(1995-11#1)(2008-10#1)(2008-8#1)
the presence of 11##2##4##(2007-6#1)(2008-10#1)
the presence of 12##2##4##(1993-3#1)(1995-7#1)
the presence of 16##3##4##(1992-8#1)(2006-10#1)(2008-8#1)
the presence of 2##15##4##(1990-10#1)(1990-8#3)(1992-6#1)(1992-9#1)(1993-8#1)(1995-8#1)(1996-2#1)(2008-10#4)(2008-8#1)(2013-1#1)
the presence of 20 mM K+##2##6##(1990-2#2)
the presence of 20 mM##3##5##(1990-2#2)(2007-9#1)
the presence of 20##5##4##(1990-2#2)(1995-5#1)(2007-5#1)(2007-9#1)
the presence of 200##6##4##(1990-2#1)(1990-5#1)(1996-5#2)(2008-10#2)
the presence of 4 mM CaCl2##2##6##(1992-5#2)
the presence of 4 mM##3##5##(1992-5#2)(1994-9#1)
the presence of 4##4##4##(1992-1#1)(1992-5#2)(1994-9#1)
the presence of 5 mM##5##5##(1991-6#1)(1992-11#1)(1996-1#1)(1997-2#1)(2005-11#1)
the presence of 5##13##4##(1991-2#1)(1991-6#1)(1992-11#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-2#1)(2005-11#1)(2008-10#1)(2008-7#1)(2008-8#1)
the presence of 50##11##4##(1990-7#2)(1990-8#1)(1997-4#2)(2006-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-7#1)
the presence of 6##3##4##(1990-11#1)(1995-12#1)(1995-2#1)
the presence of 8##4##4##(1992-11#1)(1995-1#1)(2008-10#2)
the presence of ADP or##2##5##(1996-5#1)(1997-4#1)
the presence of ADP##7##4##(1991-4#1)(1991-9#1)(1994-11#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-4#1)
the presence of ANP##2##4##(1993-11#1)(1995-5#1)
the presence of ATA##2##4##(1992-6#1)(1995-1#1)
the presence of ATP and##6##5##(1992-1#1)(1993-6#2)(1994-12#1)(1994-9#1)(1995-3#1)
the presence of ATP or##2##5##(1994-8#1)(1995-3#1)
the presence of ATP##24##4##(1990-5#1)(1990-7#3)(1991-12#1)(1992-1#1)(1992-8#1)(1993-11#1)(1993-6#5)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-3#2)(1995-8#1)(2008-4#1)(2008-7#1)
the presence of Aspergillus##2##4##(2008-7#1)(2010-4#1)
the presence of B##3##4##(1992-3#1)(2008-10#2)
the presence of C##3##4##(1996-2#1)(2007-3#1)(2007-7#1)
the presence of CH(3)CN##2##4##(2008-10#1)(2010-5#1)
the presence of Ca(2+)##4##4##(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)
the presence of Ca2+ and##6##5##(1990-12#1)(1994-11#3)(1995-5#1)(1995-6#1)
the presence of Ca2+##20##4##(1990-12#1)(1990-8#1)(1991-3#1)(1992-1#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#2)(1995-1#1)(1995-5#2)(1995-6#3)(1995-8#1)(1997-6#1)
the presence of Cd##4##4##(1996-3#1)(2008-10#2)(2008-11#1)
the presence of Cl-##3##4##(1990-3#1)(1994-9#1)(1995-7#1)
the presence of Cl-dAdo##2##4##(1994-9#2)
the presence of Co2+ or Mn2+##2##6##(1993-4#2)
the presence of Co2+##3##4##(1993-4#2)(1997-4#1)
the presence of CpG##2##4##(1992-11#1)(1996-10#1)
the presence of Cu##2##4##(2005-4#1)(2008-10#1)
the presence of Cu2+##4##4##(1994-3#1)(1997-7#2)(2007-11#1)
the presence of DNA##14##4##(1990-11#1)(1994-2#1)(1994-3#1)(1995-2#1)(1997-4#1)(1997-7#2)(2008-10#6)(2008-9#1)
the presence of EBV in HRS cells and##2##8##(1997-7#2)
the presence of EBV in##3##5##(1997-7#3)
the presence of EDTA##7##4##(1990-2#1)(1992-8#1)(1995-6#1)(1996-1#1)(1996-7#1)(2008-10#2)
the presence of Fe(III)##2##4##(1997-7#1)(2008-10#1)
the presence of Fusarium##3##4##(2008-10#2)(2010-10#1)
the presence of G418##2##4##(1995-2#1)(2008-11#1)
the presence of GSH##3##4##(1993-8#1)(2008-3#1)(2013-1#1)
the presence of GTP gamma S##3##6##(1991-10#1)(1991-2#1)(1995-8#1)
the presence of GTP##10##4##(1990-10#1)(1990-5#1)(1991-10#2)(1991-12#2)(1991-2#1)(1995-8#2)(2008-6#1)
the presence of H##4##4##(1997-1#1)(2008-5#2)(2011-12#1)
the presence of HA##2##4##(2004-9#1)(2008-10#1)
the presence of HCV##2##4##(2007-2#1)(2013-1#1)
the presence of HP##3##4##(1991-12#1)(2007-3#2)
the presence of HSA##3##4##(1994-8#1)(1997-8#2)
the presence of IGF-I##2##4##(2008-11#2)
the presence of IR##2##4##(1993-5#1)(1994-2#1)
the presence of IgM##2##4##(2007-7#2)
the presence of K+##3##4##(1991-7#1)(1992-11#1)(1992-6#1)
the presence of L##2##4##(2007-3#1)(2008-7#1)
the presence of Lewy bodies##2##5##(2008-7#2)
the presence of M##2##4##(2008-10#2)
the presence of Mg2+ ion##2##5##(1991-5#1)(1997-4#1)
the presence of Mg2+##23##4##(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#2)(1991-5#2)(1991-6#1)(1992-3#1)(1992-8#1)(1993-4#1)(1995-1#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-7#2)(1997-4#3)(2008-8#1)
the presence of Mn(II)##4##4##(1995-8#2)(2005-11#1)(2008-10#1)
the presence of Mycobacterium tuberculosis##3##5##(1990-9#1)(2012-12#1)(2013-8#1)
the presence of NADH##4##4##(1990-5#1)(1991-1#1)(1994-6#1)(1995-1#1)
the presence of NADPH##11##4##(1990-12#2)(1991-5#2)(1991-6#1)(1994-3#1)(1994-9#1)(1996-4#1)(1996-6#1)(2008-5#1)(2009-9#1)
the presence of NGF##3##4##(1990-7#1)(1992-7#1)(1993-4#1)
the presence of NO##4##4##(1995-11#1)(1996-2#1)(2008-10#2)
the presence of Na(+)##2##4##(2008-6#1)(2013-1#1)
the presence of Na+ and##2##5##(1991-3#1)(1992-6#1)
the presence of Na+##5##4##(1990-11#1)(1990-2#1)(1990-8#1)(1991-3#1)(1992-6#1)
the presence of NaCl##5##4##(1991-12#1)(1992-9#1)(2008-11#1)(2008-4#1)(2012-2#1)
the presence of O2##3##4##(1990-10#1)(1995-6#1)(2006-12#1)
the presence of P##3##4##(2008-10#3)
the presence of PCR inhibitors##3##5##(2008-11#1)(2008-12#2)
the presence of PSPC##3##4##(1995-1#3)
the presence of Pb##2##4##(1993-7#1)(2008-10#1)
the presence of RGD##2##4##(1990-5#1)(1992-12#1)
the presence of RU486##2##4##(1994-12#1)(1995-10#1)
the presence of Raman scattering##2##5##(2008-3#2)
the presence of S##2##4##(1992-7#1)(2008-10#1)
the presence of SDS##5##4##(1990-10#2)(1992-12#1)(1996-7#1)(2008-10#1)
the presence of T##2##4##(2006-10#1)(2008-10#1)
the presence of T-CD4 T cells##2##6##(2012-12#2)
the presence of T1##2##4##(2008-10#1)(2012-12#1)
the presence of T2DM##2##4##(2012-2#2)
the presence of TH##2##4##(1992-12#1)(1997-3#1)
the presence of TPA##3##4##(1990-9#1)(1991-6#1)(1992-9#1)
the presence of Triton X-100 and##3##6##(1990-5#1)(1995-10#1)(2008-10#1)
the presence of Triton X-100##5##5##(1990-5#1)(1992-6#1)(1993-9#1)(1995-10#1)(2008-10#1)
the presence of Tu-GDP##2##4##(1995-1#2)
the presence of X##3##4##(2008-10#3)
the presence of Z-D-Phe-L-PheGly##3##4##(1992-3#3)
the presence of a &quot##4##5##(1993-9#1)(1994-5#1)(1996-8#1)(2008-5#1)
the presence of a cocaine use disorder##2##7##(2010-6#2)
the presence of a consensus sequence##2##6##(1991-2#1)(2008-10#1)
the presence of a consensus##3##5##(1991-2#1)(1993-2#1)(2008-10#1)
the presence of a conserved##2##5##(1993-11#1)(1994-2#1)
the presence of a conspecific##2##5##(1994-8#1)(2009-6#1)
the presence of a different##2##5##(1990-3#1)(1992-7#1)
the presence of a distinct##3##5##(1990-12#1)(1992-8#1)(2007-12#1)
the presence of a dominant##2##5##(2005-11#1)(2007-12#1)
the presence of a dynamic##2##5##(2005-11#1)(2006-10#1)
the presence of a few##2##5##(2010-11#1)(2011-1#1)
the presence of a foreign body was discovered on imaging study when she presented with orbital swelling and purulent discharges##2##20##(2013-1#2)
the presence of a gene in##2##6##(2010-2#1)(2012-1#1)
the presence of a high##7##5##(1991-8#1)(1992-3#1)(2006-6#1)(2007-7#1)(2008-10#2)(2012-12#1)
the presence of a hydrophobic##2##5##(2006-12#1)(2008-10#1)
the presence of a large amount of##3##7##(1992-7#1)(2008-10#1)(2008-6#1)
the presence of a large number of##5##7##(2007-12#1)(2008-10#2)(2011-1#1)(2012-11#1)
the presence of a large##14##5##(1992-7#1)(1996-7#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2011-1#1)(2012-11#1)
the presence of a long##2##5##(1995-12#1)(1996-12#1)
the presence of a low level of##2##7##(1991-10#1)(2008-11#1)
the presence of a low##4##5##(1991-10#1)(1991-2#1)(1995-5#1)(2008-11#1)
the presence of a negatively charged##2##6##(1992-6#1)(1996-8#1)
the presence of a normal##2##5##(1994-8#1)(1995-2#1)
the presence of a novel##6##5##(1992-2#1)(1992-8#1)(1995-6#1)(1996-6#1)(1997-2#1)(1997-6#1)
the presence of a number##2##5##(1990-2#1)(2010-2#1)
the presence of a polyp##2##5##(2011-2#1)(2012-12#1)
the presence of a positive##3##5##(1991-4#1)(1996-5#1)(2010-11#1)
the presence of a previously##2##5##(1995-11#1)(1995-3#1)
the presence of a protein##3##5##(1991-5#1)(2007-9#1)(2008-8#1)
the presence of a reaction##2##5##(1997-7#1)(2006-10#1)
the presence of a reducing agent##3##6##(1992-11#1)(2008-10#2)
the presence of a regular##2##5##(1991-3#1)(2008-3#1)
the presence of a saturating##2##5##(1990-10#1)(2007-11#1)
the presence of a second charge##2##6##(1996-7#2)
the presence of a second##9##5##(1990-3#1)(1995-2#1)(1995-3#1)(1996-7#2)(2005-10#1)(2007-6#1)(2008-2#1)(2008-4#1)
the presence of a signal##2##5##(1995-2#1)(2006-8#1)
the presence of a single class of##3##7##(1991-4#1)(1991-5#1)(1993-12#1)
the presence of a single class##4##6##(1990-2#1)(1991-4#1)(1991-5#1)(1993-12#1)
the presence of a single##22##5##(1990-10#1)(1990-11#1)(1990-2#1)(1991-4#2)(1991-5#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-11#1)(1997-2#1)(1997-5#1)(2008-10#2)(2009-5#1)(2010-2#1)(2010-3#1)(2012-3#1)
the presence of a small amount of##2##7##(2008-10#1)(2011-2#1)
the presence of a small amount##3##6##(1993-8#1)(2008-10#1)(2011-2#1)
the presence of a small##7##5##(1992-12#1)(1993-3#1)(1993-8#1)(1994-8#1)(2007-12#1)(2008-10#1)(2011-2#1)
the presence of a spatial##2##5##(2008-3#1)(2008-8#1)
the presence of a specific##4##5##(1990-4#1)(2008-7#1)(2012-11#1)(2013-1#1)
the presence of a strong##3##5##(2007-2#1)(2008-10#1)(2008-5#1)
the presence of a structural##2##5##(1992-3#1)(1996-8#1)
the presence of a substrate##3##5##(1991-9#2)(1994-11#1)
the presence of a surfactant##2##5##(2005-11#1)(2008-10#1)
the presence of a thin##2##5##(2008-2#1)(2008-5#1)
the presence of a tumor##2##5##(1996-11#2)
the presence of a tumour##2##5##(1992-1#1)(1995-12#1)
the presence of a unique##4##5##(1990-4#1)(1993-8#1)(1995-1#1)(2008-10#1)
the presence of a vascular##2##5##(2008-7#1)(2012-12#1)
the presence of a very##2##5##(1997-7#1)(2005-11#1)
the presence of a water##2##5##(2008-10#2)
the presence of a##441##4##(1990-1#1)(1990-10#2)(1990-11#3)(1990-12#4)(1990-2#4)(1990-3#3)(1990-4#3)(1990-5#4)(1991-1#1)(1991-10#3)(1991-11#2)(1991-12#2)(1991-2#6)(1991-3#1)(1991-4#6)(1991-5#5)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#5)(1992-3#3)(1992-4#2)(1992-6#3)(1992-7#2)(1992-8#3)(1992-9#1)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#4)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#3)(1994-11#5)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#3)(1994-6#3)(1994-8#5)(1994-9#4)(1995-1#5)(1995-11#5)(1995-12#4)(1995-2#7)(1995-3#4)(1995-5#3)(1995-6#4)(1995-8#3)(1996-10#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#4)(1996-6#3)(1996-7#3)(1996-8#4)(1996-9#2)(1997-1#6)(1997-2#6)(1997-4#2)(1997-5#4)(1997-6#3)(1997-7#6)(1997-8#4)(2004-9#1)(2005-10#3)(2005-11#7)(2005-8#2)(2006-1#1)(2006-10#5)(2006-12#3)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#17)(2007-2#5)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#45)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#9)(2008-5#8)(2008-6#3)(2008-7#3)(2008-8#5)(2008-9#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#3)(2009-7#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#3)(2010-8#1)(2011-1#6)(2011-2#5)(2012-1#1)(2012-11#2)(2012-12#5)(2012-2#4)(2012-3#3)(2013-1#3)(2013-7#1)
the presence of aberrations##4##4##(2007-12#1)(2008-3#3)
the presence of abnormal##4##4##(1990-12#1)(1995-10#1)(2008-10#1)(2011-2#1)
the presence of abundant##4##4##(1990-3#1)(2007-8#1)(2008-7#1)(2009-10#1)
the presence of acetone##3##4##(2008-10#2)(2008-9#1)
the presence of acidic phospholipids##2##5##(1994-12#1)(1994-2#1)
the presence of acidic##3##4##(1994-12#1)(1994-2#1)(1997-7#1)
the presence of activated##2##4##(1994-5#1)(1995-3#1)
the presence of active##9##4##(1990-12#1)(1990-2#1)(1993-12#1)(1994-5#1)(1995-10#1)(1996-12#1)(1997-6#1)(2008-11#2)
the presence of additional##10##4##(1993-7#1)(1994-12#1)(1994-8#1)(1997-3#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-5#2)(2009-3#1)
the presence of advanced##2##4##(2007-3#1)(2012-3#1)
the presence of aggregates##2##4##(1994-2#1)(2005-11#1)
the presence of air##6##4##(1991-3#1)(1997-4#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-6#1)
the presence of airborne##2##4##(2007-5#1)(2008-3#1)
the presence of alanine##2##4##(1990-2#1)(1992-8#1)
the presence of albumin##2##4##(1994-12#1)(1996-5#1)
the presence of alcohol##5##4##(1993-12#1)(1996-12#1)(2005-11#1)(2007-6#1)(2010-5#1)
the presence of alkyl##2##4##(2008-10#1)(2008-5#1)
the presence of all four##3##5##(1991-9#1)(1994-3#1)(2012-3#1)
the presence of all##7##4##(1991-9#1)(1994-3#1)(1995-2#1)(2007-2#1)(2007-9#1)(2008-10#1)(2012-3#1)
the presence of alpha##2##4##(1990-8#1)(2008-5#1)
the presence of altered##2##4##(1997-1#1)(2008-6#1)
the presence of amino groups##2##5##(2011-2#2)
the presence of amino##3##4##(2008-10#1)(2011-2#2)
the presence of an NADPH##2##5##(1993-8#1)(1995-6#1)
the presence of an acidic##2##5##(2006-8#1)(2010-10#1)
the presence of an active##3##5##(1991-5#1)(1995-12#1)(1996-4#1)
the presence of an acute##2##5##(1991-8#1)(2007-9#1)
the presence of an additional##4##5##(1997-3#1)(1997-7#1)(1997-8#1)(2007-12#1)
the presence of an anaesthesiologist##2##5##(2006-10#2)
the presence of an androgen binding component##2##7##(1990-11#2)
the presence of an applied##3##5##(2007-12#1)(2008-5#1)(2008-7#1)
the presence of an appropriate##3##5##(1991-4#1)(1997-1#1)(1997-2#1)
the presence of an excess of##9##6##(1991-7#1)(1992-9#1)(2008-10#4)(2008-12#1)(2008-5#1)(2010-5#1)
the presence of an exogenous##4##5##(1994-3#1)(1994-9#1)(2008-10#1)(2008-2#1)
the presence of an extra##6##5##(1990-12#1)(1996-10#1)(1996-6#1)(1997-2#1)(2006-10#1)(2010-4#1)
the presence of an old##2##5##(2008-10#1)(2008-9#1)
the presence of an oxidizing##2##5##(1996-5#1)(2005-11#1)
the presence of an unstable##2##5##(2011-2#1)(2013-1#1)
the presence of an##140##4##(1990-11#2)(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#3)(1992-10#1)(1992-12#3)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-12#1)(2005-11#3)(2006-10#4)(2006-12#1)(2006-2#1)(2006-3#1)(2006-8#2)(2007-11#1)(2007-12#5)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#18)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
the presence of anions##3##4##(1990-8#2)(2008-10#1)
the presence of another character in the##2##7##(2008-5#2)
the presence of another##8##4##(1992-6#1)(1993-9#1)(1995-1#1)(1996-10#1)(2008-5#2)(2008-7#1)(2008-8#1)
the presence of anti-HCV##2##4##(1991-9#1)(2008-1#1)
the presence of anti-SM##2##4##(1991-9#2)
the presence of anti-insulin receptor antibodies##2##6##(2006-10#2)
the presence of antibodies to##3##5##(2008-4#1)(2008-5#1)(2010-12#1)
the presence of antibodies##5##4##(1990-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-12#1)
the presence of antioxidant##2##4##(1997-8#1)(2008-10#1)
the presence of any##10##4##(2008-10#3)(2008-11#1)(2008-5#3)(2008-8#1)(2010-6#1)(2012-12#1)
the presence of arginine##2##4##(1990-11#1)(1992-9#1)
the presence of arterial hypertension##2##5##(2012-3#1)(2013-1#1)
the presence of asbestos fibres##2##5##(2013-8#2)
the presence of asci##2##4##(2008-10#2)
the presence of ascorbate##3##4##(1993-8#1)(1995-2#1)(2013-1#1)
the presence of ascorbic acid##11##5##(1995-10#1)(1996-6#1)(2008-10#8)(2011-1#1)
the presence of associated##3##4##(1991-9#1)(1997-8#1)(2008-9#1)
the presence of at least the##2##6##(1990-11#1)(1993-2#1)
the presence of at least two distinct##2##7##(1990-8#1)(1991-3#1)
the presence of at least two##5##6##(1990-3#1)(1990-4#1)(1990-8#1)(1991-3#1)(1994-8#1)
the presence of at least##9##5##(1990-11#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-3#1)(1993-2#1)(1994-8#1)(1995-6#1)(2012-3#1)
the presence of atherosclerotic##2##4##(1991-9#1)(2006-6#1)
the presence of atopy is not significantly associated with severe alopecia or onset at younger age##2##16##(2007-7#1)(2007-8#1)
the presence of atopy##5##4##(2007-7#2)(2007-8#2)(2012-3#1)
the presence of atropine##5##4##(1990-11#1)(1996-12#1)(1997-4#2)(2011-2#1)
the presence of autoantibodies##4##4##(1990-5#1)(2006-10#1)(2007-11#1)(2011-2#1)
the presence of auxin##2##4##(2009-8#2)
the presence of bFGF and its##2##6##(1994-11#1)(1995-12#1)
the presence of bFGF and##3##5##(1994-11#2)(1995-12#1)
the presence of bFGF##4##4##(1994-11#2)(1995-12#1)(2006-11#1)
the presence of background noise##2##5##(2008-2#1)(2008-3#1)
the presence of background##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
the presence of bacteria##3##4##(2008-10#1)(2008-12#1)(2008-4#1)
the presence of bacterial##2##4##(1991-12#1)(2006-10#1)
the presence of base##2##4##(2007-11#1)(2008-8#1)
the presence of basic fibroblast growth factor (bFGF)##2##8##(1992-3#1)(1992-7#1)
the presence of basic fibroblast growth factor##3##7##(1991-3#1)(1992-3#1)(1992-7#1)
the presence of basic##4##4##(1991-3#1)(1992-2#1)(1992-3#1)(1992-7#1)
the presence of beta##3##4##(1994-9#2)(2008-10#1)
the presence of beta-CD in the##2##6##(1994-3#2)
the presence of beta-CD##6##4##(1994-3#2)(2008-10#4)
the presence of beta-cyclodextrin and##3##5##(2008-10#2)(2008-5#1)
the presence of beta-cyclodextrin##4##4##(2007-8#1)(2008-10#2)(2008-5#1)
the presence of bias##2##4##(2011-1#1)(2012-3#1)
the presence of bicuculline##2##4##(1996-3#1)(2008-7#1)
the presence of bilateral##3##4##(2006-12#1)(2012-12#1)(2013-1#1)
the presence of biological##2##4##(2008-3#1)(2008-5#1)
the presence of bizarre##2##4##(2005-8#1)(2007-2#1)
the presence of blood##2##4##(1995-3#1)(2012-2#1)
the presence of bone##3##4##(1991-8#1)(2011-1#2)
the presence of both high##2##5##(1994-11#1)(2007-3#1)
the presence of both pathogens##2##5##(2007-7#1)(2008-10#1)
the presence of both the##4##5##(1993-2#1)(1997-6#1)(1997-7#1)(2007-6#1)
the presence of both##46##4##(1990-5#2)(1991-12#1)(1991-2#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-7#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-8#1)(1997-1#1)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-7#1)(2012-12#1)
the presence of bound##4##4##(1991-5#1)(1992-8#1)(1994-5#1)(1995-8#1)
the presence of bovine serum albumin in the##2##8##(1993-4#1)(1995-12#1)
the presence of bovine serum albumin##7##6##(1993-4#1)(1993-8#1)(1995-12#3)(2008-10#2)
the presence of caffeine##2##4##(1990-2#1)(2008-10#1)
the presence of calcification##2##4##(1993-4#1)(2012-2#1)
the presence of calcium and SP-A##2##6##(1996-1#2)
the presence of calcium and##7##5##(1990-8#1)(1991-3#1)(1992-12#1)(1993-12#1)(1993-6#1)(1996-1#2)
the presence of calcium ions##6##5##(1991-11#1)(1992-8#1)(1994-5#1)(1995-8#1)(1997-4#1)(2008-10#1)
the presence of calcium##30##4##(1990-3#5)(1990-8#1)(1991-11#1)(1991-3#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-6#2)(1994-3#1)(1994-5#1)(1995-3#1)(1995-8#1)(1996-1#2)(1996-11#1)(1997-4#1)(1997-6#1)(2008-10#2)(2010-8#1)(2011-2#1)(2013-1#1)
the presence of cancer##2##4##(2007-3#1)(2013-1#1)
the presence of cardiovascular risk factors##2##6##(2010-11#1)(2013-8#1)
the presence of catalase##3##4##(1991-9#1)(2006-10#1)(2008-10#1)
the presence of catalytic##2##4##(1990-7#1)(1996-12#1)
the presence of cell##5##4##(2008-10#3)(2008-4#1)(2009-8#1)
the presence of cellular##2##4##(2007-8#1)(2013-1#1)
the presence of certain##14##4##(1992-11#1)(1992-6#1)(2005-7#1)(2006-8#2)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2011-2#2)
the presence of chemotactic##2##4##(1993-12#1)(2008-10#1)
the presence of chloride ions##3##5##(1990-4#1)(1991-9#1)(2008-10#1)
the presence of chloride##4##4##(1990-4#1)(1991-9#1)(2008-10#2)
the presence of cholesterol##3##4##(1993-3#1)(1994-5#1)(2006-2#1)
the presence of chronic##3##4##(2008-1#1)(2008-4#1)(2008-7#1)
the presence of circulating##4##4##(1992-3#1)(2007-11#1)(2007-9#1)(2008-10#1)
the presence of clinical##2##4##(1992-3#1)(2011-2#1)
the presence of clouds##3##4##(2008-3#3)
the presence of co-existing##2##4##(2006-10#1)(2008-10#1)
the presence of coma##2##4##(1991-9#1)(2006-4#1)
the presence of comorbidity##2##4##(2008-5#1)(2008-6#1)
the presence of competing##3##4##(1991-5#1)(2007-12#1)(2012-3#1)
the presence of complex##2##4##(2008-4#1)(2008-5#1)
the presence of congenital##3##4##(1993-10#1)(2010-7#1)(2011-1#1)
the presence of conserved##2##4##(1997-4#1)(2013-1#1)
the presence of copper##10##4##(1992-4#1)(1995-6#1)(2008-10#8)
the presence of coronary##2##4##(1991-3#1)(2008-4#1)
the presence of crystalline##2##4##(2007-11#1)(2008-5#1)
the presence of cubic##2##4##(2005-11#1)(2006-10#1)
the presence of cupric ion##2##5##(1995-6#1)(1997-8#1)
the presence of cytochrome##2##4##(1995-10#1)(2008-7#1)
the presence of cytoplasmic##2##4##(2007-6#1)(2008-1#1)
the presence of damage##2##4##(1997-4#1)(2007-8#1)
the presence of defects##2##4##(2008-10#1)(2010-4#1)
the presence of depressive symptoms##3##5##(2010-12#2)(2013-1#1)
the presence of detergents##3##4##(1991-12#1)(1992-7#2)
the presence of developmental##2##4##(1994-1#1)(2012-12#1)
the presence of diabetes mellitus##2##5##(2006-10#1)(2006-6#1)
the presence of diabetes##4##4##(2006-10#1)(2006-6#1)(2008-1#1)(2008-3#1)
the presence of dibenzo-18-crown-6##2##4##(2008-10#2)
the presence of different##18##4##(1990-10#1)(1990-5#1)(1991-5#1)(1992-5#1)(1993-3#1)(1994-10#1)(1994-11#1)(2005-11#1)(2008-10#4)(2008-2#1)(2008-5#2)(2008-7#1)(2010-10#1)(2010-4#1)
the presence of dipyridamole##2##4##(1991-3#2)
the presence of disease##6##4##(1994-11#1)(2007-11#1)(2008-10#2)(2012-2#1)(2013-8#1)
the presence of distant##2##4##(1994-6#1)(2006-2#1)
the presence of divalent cations##2##5##(1991-5#1)(1995-2#1)
the presence of divalent##3##4##(1991-5#1)(1995-2#1)(1997-4#1)
the presence of each of the##2##6##(1996-5#1)(2011-2#1)
the presence of each##7##4##(1996-5#2)(1997-4#1)(2007-2#1)(2008-10#1)(2008-5#1)(2011-2#1)
the presence of eggs##4##4##(2007-10#1)(2012-12#2)(2013-1#1)
the presence of eight##2##4##(1997-3#2)
the presence of either##15##4##(1991-2#1)(1991-8#2)(1992-4#1)(1994-6#1)(1995-11#1)(1995-9#1)(1996-1#1)(1996-5#1)(1997-3#1)(1997-6#1)(2006-8#1)(2007-11#1)(2008-11#2)
the presence of endogenous##3##4##(1996-12#1)(2008-10#1)(2010-11#1)
the presence of endometrial##2##4##(2004-10#1)(2009-8#1)
the presence of epithelial##2##4##(1992-2#1)(1993-3#1)
the presence of equivalent##2##4##(2009-10#1)(2013-1#1)
the presence of estrogen receptor##2##5##(1994-3#1)(2010-5#1)
the presence of estrogen##4##4##(1994-3#1)(1996-8#1)(1996-9#1)(2010-5#1)
the presence of ethylene glycol##4##5##(1990-2#1)(2005-8#2)(2009-8#1)
the presence of excess unlabeled##3##5##(1991-6#1)(1995-11#2)
the presence of excess##18##4##(1990-2#1)(1990-5#1)(1991-4#1)(1991-6#1)(1991-9#1)(1994-12#1)(1995-1#1)(1995-11#2)(1996-8#1)(2008-10#5)(2008-5#2)(2010-5#1)
the presence of exogenous##9##4##(1992-1#2)(1992-9#1)(1994-12#1)(1994-9#1)(1995-1#1)(1996-2#1)(1996-5#1)(1996-7#1)
the presence of extensive##3##4##(1994-12#1)(2010-8#1)(2011-2#1)
the presence of external Ca2+##5##5##(1992-11#1)(1992-12#2)(1994-10#1)(1997-5#1)
the presence of external##7##4##(1992-11#1)(1992-12#2)(1994-10#1)(1995-2#1)(1997-5#1)(2007-11#1)
the presence of extracellular Ca2+##6##5##(1990-4#1)(1990-7#1)(1991-5#1)(1993-6#1)(1994-6#1)(1997-5#1)
the presence of extracellular##14##4##(1990-3#1)(1990-4#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-5#2)(1992-3#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-6#2)(1997-5#1)
the presence of factor##4##4##(1990-11#1)(1993-11#1)(1994-3#1)(2005-10#1)
the presence of fatty##3##4##(1990-11#2)(1993-6#1)
the presence of feeder cells##2##5##(1993-9#2)
the presence of fetal##3##4##(1990-11#1)(2011-2#2)
the presence of fibrin##2##4##(1992-2#1)(2010-8#1)
the presence of fibroblasts##3##4##(1991-11#1)(1991-5#1)(1995-5#1)
the presence of fixed##3##4##(1991-11#1)(1994-12#1)(2008-9#1)
the presence of flavonoids and##2##5##(2010-12#1)(2011-2#1)
the presence of flavonoids##3##4##(2008-5#1)(2010-12#1)(2011-2#1)
the presence of fluoride##2##4##(1992-1#1)(2008-10#1)
the presence of four##7##4##(1991-2#1)(1997-7#1)(2008-10#2)(2008-4#1)(2010-3#1)(2012-12#1)
the presence of free##5##4##(1997-4#1)(1997-8#1)(2008-10#2)(2011-2#1)
the presence of functional receptors for##2##6##(1993-9#2)
the presence of functional##5##4##(1990-7#1)(1993-9#2)(1994-2#1)(1996-4#1)
the presence of functionally##2##4##(2007-10#1)(2009-8#1)
the presence of galactose##2##4##(1990-3#1)(2008-5#1)
the presence of gallium##2##4##(2004-9#1)(2006-12#1)
the presence of glucose##9##4##(1991-9#1)(1994-11#1)(1995-1#2)(1995-8#2)(2008-10#2)(2009-10#1)
the presence of glutamate##2##4##(1990-2#1)(1994-12#1)
the presence of healthy##3##4##(2008-10#2)(2011-2#1)
the presence of hemocyanin##2##4##(2011-12#2)
the presence of hemoglobin##2##4##(1994-2#1)(1995-5#1)
the presence of hemorrhage##3##4##(1996-9#1)(2007-10#1)(2007-9#1)
the presence of heparin##7##4##(1990-12#1)(1992-5#1)(1994-10#1)(1994-3#1)(1995-10#1)(2009-4#1)(2010-8#1)
the presence of hepatic##3##4##(1991-10#1)(2006-10#1)(2008-1#1)
the presence of hepatitis##2##4##(1991-4#1)(2008-7#1)
the presence of herpes simplex##2##5##(2006-10#1)(2009-4#1)
the presence of high concentrations of##6##6##(1990-12#1)(1994-3#1)(1994-9#1)(2008-10#2)(2008-4#1)
the presence of high glucose##2##5##(1991-4#1)(1994-3#1)
the presence of high levels of##5##6##(1990-10#2)(1990-8#1)(1992-9#1)(2008-10#1)
the presence of high##31##4##(1990-10#2)(1990-12#2)(1990-2#2)(1990-8#1)(1991-2#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-9#1)(1994-11#1)(1994-3#2)(1994-9#1)(1997-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-6#1)
the presence of higher concentrations##2##5##(2008-10#1)(2009-9#1)
the presence of higher##5##4##(1996-6#1)(2008-10#1)(2009-9#1)(2010-8#1)(2011-1#1)
the presence of higher-order##2##4##(1994-8#1)(2007-12#1)
the presence of highly##3##4##(1990-9#1)(2007-11#1)(2008-10#1)
the presence of host##4##4##(1997-2#1)(2007-11#1)(2008-10#2)
the presence of human papillomavirus (HPV)##2##6##(1992-9#1)(2011-2#1)
the presence of human##10##4##(1990-12#1)(1991-2#1)(1991-8#1)(1992-7#1)(1992-9#1)(2005-10#1)(2008-10#1)(2009-4#1)(2011-2#2)
the presence of humic##3##4##(2008-10#3)
the presence of hydrogen##10##4##(1994-2#1)(2007-12#2)(2008-10#7)
the presence of hypercholesterolemia##2##4##(1993-9#1)(2006-7#1)
the presence of hypochlorite##2##4##(2008-10#2)
the presence of increased##3##4##(1993-5#1)(2008-6#1)(2011-1#1)
the presence of increasing concentrations of##4##6##(1991-7#1)(1992-12#1)(1993-4#1)(1995-3#1)
the presence of increasing##5##4##(1991-7#1)(1992-12#1)(1993-4#1)(1995-3#1)(1995-6#1)
the presence of individual##2##4##(2010-7#1)(2013-1#1)
the presence of infection##2##4##(2007-3#1)(2008-12#1)
the presence of inflammation##2##4##(2008-7#1)(2013-1#1)
the presence of inflammatory##2##4##(2007-2#1)(2008-5#1)
the presence of inhibitors##3##4##(1992-3#1)(1993-8#1)(2013-8#1)
the presence of insulin resistance##2##5##(2008-1#1)(2008-3#1)
the presence of insulin##6##4##(1994-11#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-8#1)(2010-12#1)
the presence of intact##2##4##(1997-4#1)(2008-11#1)
the presence of interfering##3##4##(2008-10#2)(2013-1#1)
the presence of interferon##2##4##(1994-8#1)(2008-5#1)
the presence of intravascular##3##4##(1991-8#1)(2008-6#1)(2010-12#1)
the presence of ions##2##4##(2005-11#1)(2008-10#1)
the presence of iron in the##2##6##(2006-2#1)(2013-8#1)
the presence of iron##9##4##(1991-5#1)(1992-4#1)(1995-3#1)(2006-2#1)(2008-10#2)(2009-2#1)(2013-1#1)(2013-8#1)
the presence of iron(III)##2##4##(2007-11#1)(2008-10#1)
the presence of isosbestic points##2##5##(2006-12#2)
the presence of its##10##4##(1990-11#1)(1993-8#1)(1995-5#1)(2008-10#3)(2008-4#1)(2010-4#1)(2013-7#2)
the presence of key##2##4##(2011-2#1)(2012-12#1)
the presence of known##3##4##(2007-2#1)(2008-10#1)(2013-7#1)
the presence of large amounts of##3##6##(2008-10#3)
the presence of large##21##4##(1996-5#1)(2004-11#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#2)(2008-10#8)(2008-2#1)(2012-12#1)(2012-3#1)
the presence of laser##2##4##(2008-1#1)(2012-3#1)
the presence of lateral##2##4##(1995-8#1)(2013-8#1)
the presence of left##3##4##(1997-1#1)(2009-1#1)(2010-12#1)
the presence of ligand##3##4##(1992-12#1)(1994-11#1)(2008-10#1)
the presence of ligands##4##4##(1992-5#1)(1994-12#1)(1995-11#1)(1996-11#1)
the presence of light##5##4##(1990-2#1)(1991-2#2)(2007-12#1)(2008-8#1)
the presence of lipid##3##4##(1990-3#1)(2007-9#1)(2008-10#1)
the presence of local##3##4##(1991-9#1)(2008-10#1)(2008-12#1)
the presence of low##16##4##(1991-2#1)(1991-7#1)(1994-11#2)(1994-2#1)(1994-5#1)(1994-9#1)(1995-3#1)(1996-5#2)(2005-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)(2013-1#1)
the presence of lymph node metastasis##3##6##(1990-10#1)(2011-2#2)
the presence of mRNA##2##4##(1991-9#1)(1996-2#1)
the presence of magnesium##4##4##(1992-7#1)(1996-8#1)(1997-3#1)(2008-4#1)
the presence of malignancy##2##4##(1990-10#1)(2013-1#1)
the presence of maltose##2##4##(1994-12#2)
the presence of many##3##4##(2008-10#1)(2009-6#1)(2012-3#1)
the presence of matrix##2##4##(1995-5#1)(2008-10#1)
the presence of metastases##3##4##(1990-6#1)(1996-3#1)(2007-8#1)
the presence of metastatic##3##4##(1991-10#1)(2005-11#1)(2008-1#1)
the presence of methyl##2##4##(1995-11#1)(2012-2#1)
the presence of misalignment##2##4##(2008-3#2)
the presence of molecular##4##4##(1994-11#1)(1995-4#1)(2009-3#1)(2010-6#1)
the presence of mood disorders##2##5##(1996-7#1)(2010-2#1)
the presence of more than one##5##6##(1990-11#1)(1991-9#1)(2008-10#1)(2008-5#2)
the presence of more##7##4##(1990-11#1)(1991-3#1)(1991-9#1)(2006-6#1)(2008-10#1)(2008-5#2)
the presence of motion##2##4##(2008-2#1)(2008-6#1)
the presence of multiple copies##2##5##(1993-5#1)(1994-3#1)
the presence of multiple diseases within one person##2##8##(2013-1#2)
the presence of multiple nodules##2##5##(2006-6#2)
the presence of multiple scattering##2##5##(2008-2#2)
the presence of multiple##27##4##(1990-8#1)(1991-10#1)(1991-5#1)(1991-6#1)(1992-6#1)(1993-5#1)(1994-3#1)(1995-8#1)(1996-1#1)(1996-9#1)(1997-5#1)(2005-12#1)(2006-10#1)(2006-6#2)(2008-10#1)(2008-2#2)(2009-4#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
the presence of mutant##2##4##(1993-3#1)(2008-10#1)
the presence of mutations##4##4##(1996-6#1)(2006-11#1)(2008-4#1)(2010-12#1)
the presence of natural##2##4##(1994-11#1)(2008-5#1)
the presence of necrosis##2##4##(2006-10#1)(2007-11#1)
the presence of negatively charged##2##5##(1992-12#1)(2008-1#1)
the presence of nerve##5##4##(1991-11#1)(1994-9#2)(2006-8#1)(2008-4#1)
the presence of nitrate##4##4##(1992-6#1)(2008-10#2)(2008-11#1)
the presence of nitric oxide synthase (NOS)##2##7##(1992-8#2)
the presence of nitrites##3##4##(2007-10#2)(2008-11#1)
the presence of noise##17##4##(2007-12#2)(2008-2#5)(2008-3#3)(2008-5#1)(2008-6#2)(2008-9#2)(2010-10#1)(2011-1#1)
the presence of noradrenergic##2##4##(1990-7#1)(1996-5#1)
the presence of normal##6##4##(1991-3#1)(2006-10#1)(2006-5#1)(2008-1#1)(2011-12#1)(2011-2#1)
the presence of obesity##2##4##(2008-3#1)(2010-12#1)
the presence of obstructive##4##4##(2006-6#1)(2010-12#1)(2010-6#2)
the presence of oedema##3##4##(2008-7#2)(2013-7#1)
the presence of one or more##2##6##(1993-3#1)(1994-6#1)
the presence of one##9##4##(1991-9#2)(1993-3#1)(1994-6#1)(2008-10#3)(2008-8#1)(2012-12#1)
the presence of only##6##4##(1990-5#1)(1991-5#1)(1993-12#1)(1994-5#1)(1997-2#1)(2007-12#1)
the presence of oocysts##3##4##(1996-12#1)(2004-11#1)(2008-5#1)
the presence of optical##2##4##(2008-2#1)(2008-3#1)
the presence of organic##3##4##(2005-11#1)(2007-6#1)(2008-3#1)
the presence of other##31##4##(1990-9#1)(1991-5#1)(1991-8#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-4#1)(1997-4#1)(1997-8#1)(2007-11#1)(2008-10#10)(2008-4#2)(2008-7#1)(2009-12#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-8#2)
the presence of oxaloacetate##2##4##(1991-4#2)
the presence of oxidized##3##4##(1990-8#1)(1992-6#1)(2010-12#1)
the presence of oxygen##14##4##(1990-12#1)(1991-10#1)(1991-2#1)(1993-6#1)(1994-10#1)(1995-2#1)(1997-1#1)(1997-4#1)(2008-10#4)(2008-9#1)(2009-3#1)
the presence of ozone##2##4##(2008-10#2)
the presence of p53##2##4##(1995-8#1)(2008-7#1)
the presence of parallel##3##4##(1991-3#1)(2005-11#1)(2010-8#1)
the presence of particular##2##4##(1995-8#1)(2010-12#1)
the presence of peritumoral edema##2##5##(2007-12#2)
the presence of perturbations##2##4##(2008-3#2)
the presence of pheochromocytoma##2##4##(1991-10#1)(2006-9#1)
the presence of phosphatidylserine and##4##5##(1990-12#1)(1991-4#1)(1992-9#1)(1993-8#1)
the presence of phospholipid##3##4##(1991-8#1)(1992-2#1)(1993-8#1)
the presence of phospholipids##2##4##(1990-5#1)(1997-4#1)
the presence of phosphorylated##2##4##(1990-7#1)(2008-10#1)
the presence of picrotoxin##2##4##(1995-12#1)(2008-8#1)
the presence of polyethylene glycol##3##5##(1992-11#1)(2005-12#1)(2008-10#1)
the presence of polyethylene##4##4##(1992-11#1)(2004-12#1)(2005-12#1)(2008-10#1)
the presence of potassium##5##4##(2005-4#1)(2007-11#2)(2008-10#2)
the presence of potential##5##4##(1990-3#1)(2006-12#1)(2008-10#2)(2011-1#1)
the presence of predators##2##4##(2008-8#2)
the presence of preexisting##2##4##(2007-1#1)(2008-7#1)
the presence of protein kinase##2##5##(1990-7#1)(1994-11#1)
the presence of protein##3##4##(1990-7#1)(1994-11#1)(2010-4#1)
the presence of proteins##5##4##(1990-12#1)(2006-10#1)(2008-10#1)(2008-6#1)(2008-7#1)
the presence of pulmonary artery sling##2##6##(1993-12#2)
the presence of pulmonary##3##4##(1992-2#1)(1993-12#2)
the presence of pulp calcification##2##5##(2013-8#2)
the presence of rDNA sites##2##5##(2010-8#2)
the presence of rare alleles##3##5##(2012-3#3)
the presence of rare##5##4##(2012-3#5)
the presence of rat##3##4##(1992-7#1)(1993-11#1)(2008-9#1)
the presence of reactive oxygen##2##5##(1994-10#1)(2008-4#1)
the presence of reactive##4##4##(1994-10#1)(2008-10#1)(2008-4#1)(2009-8#1)
the presence of regional##2##4##(2008-7#1)(2010-2#1)
the presence of relatively##3##4##(1990-12#1)(1991-9#1)(2008-10#1)
the presence of renal##2##4##(2008-3#1)(2008-4#1)
the presence of residual##5##4##(2007-2#1)(2008-10#1)(2009-11#1)(2009-3#1)(2013-8#1)
the presence of risk factors##2##5##(1991-9#1)(2011-2#1)
the presence of saponins##2##4##(2008-10#1)(2013-7#1)
the presence of saturating##6##4##(1990-10#1)(1995-11#1)(1995-8#1)(1996-9#1)(1997-2#1)(2008-8#1)
the presence of secondary##5##4##(2006-10#1)(2008-10#1)(2010-11#1)(2011-2#1)(2013-1#1)
the presence of serum and##4##5##(1992-11#1)(1993-12#1)(1995-1#1)(1997-7#1)
the presence of serum in the##2##6##(1991-5#1)(2008-11#1)
the presence of serum##13##4##(1991-3#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-12#1)(1995-1#1)(1997-7#1)(2008-10#1)(2008-11#3)
the presence of seven##2##4##(1993-6#1)(2008-10#1)
the presence of several##22##4##(1991-6#1)(1991-9#1)(1994-9#1)(1995-4#1)(1996-5#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-12#1)(2008-3#1)(2008-8#1)
the presence of severe##5##4##(2006-10#1)(2007-11#3)(2010-7#1)
the presence of shock##2##4##(2006-10#1)(2007-5#1)
the presence of significant##6##4##(1990-5#1)(2006-9#1)(2008-10#1)(2010-1#1)(2010-2#1)(2012-12#1)
the presence of single##3##4##(1990-5#1)(2004-11#1)(2008-2#1)
the presence of small##10##4##(1992-9#1)(1993-11#1)(1994-11#1)(1997-6#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-12#1)
the presence of sodium##34##4##(1990-11#1)(1991-2#1)(1991-9#1)(1992-5#2)(1994-12#1)(1994-8#1)(1995-11#1)(1996-12#1)(2005-11#1)(2007-11#3)(2008-10#16)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)
the presence of soluble##2##4##(1990-3#1)(2008-11#1)
the presence of some##9##4##(1990-4#1)(1997-2#1)(2005-11#2)(2008-10#2)(2010-4#1)(2010-7#1)(2011-2#1)
the presence of sound##2##4##(1992-11#1)(2013-8#1)
the presence of specific binding sites for##2##7##(1990-5#1)(1992-7#1)
the presence of specific binding sites##3##6##(1990-5#1)(1992-12#1)(1992-7#1)
the presence of specific##10##4##(1990-3#1)(1990-5#1)(1992-12#1)(1992-7#1)(1997-2#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-9#1)(2012-12#1)
the presence of static##2##4##(1994-8#1)(1994-9#1)
the presence of strong##5##4##(1990-5#1)(1995-10#1)(2008-10#1)(2008-3#2)
the presence of strongly##3##4##(1995-10#1)(2008-10#2)
the presence of structural##2##4##(2005-11#1)(2006-4#1)
the presence of such a##2##5##(2007-6#1)(2008-1#1)
the presence of such##12##4##(1991-12#1)(1991-6#1)(1995-7#1)(1997-4#1)(2005-8#1)(2006-5#1)(2007-6#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-2#1)
the presence of sugar##2##4##(2008-12#1)(2008-9#1)
the presence of sulfate##3##4##(2008-3#1)(2008-6#1)(2012-2#1)
the presence of superoxide dismutase##3##5##(1995-3#1)(1997-5#2)
the presence of surface charges##3##5##(2005-11#2)(2007-9#1)
the presence of surface##4##4##(1996-5#1)(2005-11#2)(2007-9#1)
the presence of surfactants##9##4##(2005-11#1)(2008-10#5)(2008-5#2)(2013-1#1)
the presence of symptoms##4##4##(1993-12#1)(2008-10#1)(2013-1#2)
the presence of systematic##2##4##(2007-12#1)(2008-10#1)
the presence of testosterone in the##2##6##(1995-2#1)(2012-2#1)
the presence of tetrodotoxin##2##4##(1995-12#1)(1996-12#1)
the presence of thapsigargin##2##4##(1997-5#1)(2008-4#1)
the presence of that##2##4##(1993-8#1)(1995-4#1)
the presence of the Ca2+##2##5##(1990-10#1)(1991-5#1)
the presence of the agonist##2##5##(1994-2#1)(1996-9#1)
the presence of the alternate##2##5##(1995-6#1)(2008-10#1)
the presence of the c-myc##2##5##(1992-12#1)(2008-11#1)
the presence of the cross-link##2##5##(2011-1#1)(2013-8#1)
the presence of the cytidine component is##2##7##(1997-5#2)
the presence of the different##3##5##(2008-10#1)(2008-7#1)(2010-3#1)
the presence of the disease##3##5##(2005-12#1)(2011-2#2)
the presence of the enzyme##2##5##(2008-10#2)
the presence of the jelly coat##2##6##(2008-8#2)
the presence of the mutation##3##5##(1991-9#1)(2006-8#1)(2010-9#1)
the presence of the offending##2##5##(1993-6#1)(1994-6#1)
the presence of the other##7##5##(1990-2#1)(1994-2#2)(1996-4#1)(2008-10#2)(2008-12#1)
the presence of the pathogen##2##5##(2008-10#2)
the presence of the polymer##2##5##(2008-10#1)(2008-12#1)
the presence of the previously##2##5##(1996-6#1)(2008-7#1)
the presence of the substrate##2##5##(2008-3#1)(2008-4#1)
the presence of the traT gene##2##6##(1991-8#2)
the presence of the transgene##3##5##(1995-11#1)(2006-12#1)(2008-10#1)
the presence of the two##4##5##(1990-7#1)(1994-11#1)(2007-7#1)(2008-11#1)
the presence of the viral##2##5##(1994-8#1)(2007-11#1)
the presence of the virus##4##5##(2008-10#3)(2008-5#1)
the presence of the wild-type##2##5##(1991-12#1)(1991-2#1)
the presence of the##323##4##(1990-1#1)(1990-10#2)(1990-11#4)(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#4)(1990-7#1)(1990-8#1)(1991-10#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#3)(1991-8#2)(1991-9#3)(1992-11#1)(1992-12#3)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#2)(1992-9#2)(1993-11#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#5)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#5)(1994-2#7)(1994-3#4)(1994-5#2)(1994-6#6)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#4)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#3)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#2)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#2)(1997-5#6)(1997-7#3)(1997-8#1)(2005-11#4)(2005-12#1)(2006-10#2)(2006-12#5)(2006-3#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-6#2)(2007-7#3)(2007-8#2)(2008-10#51)(2008-11#3)(2008-12#5)(2008-2#4)(2008-3#9)(2008-4#7)(2008-5#9)(2008-6#1)(2008-7#4)(2008-8#9)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#5)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#3)
the presence of their##4##4##(2006-10#1)(2008-10#2)(2008-9#1)
the presence of thermal##2##4##(1994-11#1)(2008-3#1)
the presence of these##18##4##(1990-10#1)(1991-1#1)(1991-5#1)(1991-8#1)(1993-11#1)(1995-2#1)(1997-5#1)(2006-5#1)(2006-9#1)(2008-10#2)(2008-4#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#2)(2013-1#1)
the presence of this organism in##2##6##(1996-8#1)(2011-2#1)
the presence of this##22##4##(1991-8#1)(1993-8#1)(1994-12#1)(1995-11#1)(1996-8#1)(1997-2#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-9#1)(2009-9#1)(2011-2#2)(2012-2#2)(2013-7#1)
the presence of three##20##4##(1992-11#1)(1993-11#1)(1994-5#1)(1995-11#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-3#1)(2005-11#2)(2006-10#1)(2006-12#1)(2007-1#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
the presence of thrombocytopenia##2##4##(1990-6#1)(2013-1#1)
the presence of thyroid##2##4##(1990-5#1)(1997-7#1)
the presence of tissue##2##4##(2008-10#1)(2009-6#1)
the presence of total coliforms and##2##6##(2011-1#1)(2011-2#1)
the presence of toxic substances##2##5##(1992-6#1)(2008-10#1)
the presence of toxic##4##4##(1992-6#1)(2008-10#1)(2011-1#1)(2012-1#1)
the presence of trace##2##4##(1992-7#1)(2008-10#1)
the presence of transcripts for##2##5##(1992-9#1)(2008-4#1)
the presence of transcripts##3##4##(1992-9#1)(1995-4#1)(2008-4#1)
the presence of troponin##3##4##(1990-12#2)(2005-9#1)
the presence of tumor##2##4##(1994-11#1)(2007-7#1)
the presence of two classes of##3##6##(1993-1#1)(1994-3#1)(1994-8#1)
the presence of two different##6##5##(1990-7#1)(1992-7#1)(1996-2#1)(2008-10#2)(2008-4#1)
the presence of two distinct##3##5##(1992-3#1)(1995-5#1)(2009-4#1)
the presence of two forms of##2##6##(1992-6#1)(1994-11#1)
the presence of two isoforms##2##5##(1992-1#1)(1994-8#1)
the presence of two isomers##2##5##(2006-1#1)(2008-10#1)
the presence of two major##2##5##(1991-2#1)(1994-8#1)
the presence of two or##2##5##(1997-2#1)(2006-10#1)
the presence of two potential##2##5##(1991-9#1)(1994-11#1)
the presence of two types of##2##6##(1991-4#1)(2012-2#1)
the presence of two##71##4##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#2)(1991-12#1)(1991-2#2)(1991-4#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-1#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-8#3)(1995-11#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-2#2)(1997-2#2)(1997-3#1)(2006-1#1)(2006-10#1)(2006-12#2)(2007-11#1)(2007-3#1)(2008-10#10)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-10#1)(2009-4#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
the presence of type I##2##5##(1991-1#1)(1991-10#1)
the presence of type##4##4##(1990-8#1)(1991-1#1)(1991-10#1)(2008-1#1)
the presence of typical##3##4##(2008-5#1)(2008-7#1)(2012-3#1)
the presence of urea##2##4##(1995-5#1)(2008-10#1)
the presence of various##21##4##(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-6#1)(1992-9#1)(1994-3#1)(1996-5#2)(1997-2#1)(1997-4#1)(1997-7#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#2)(2012-3#1)(2013-8#1)
the presence of varying##4##4##(1994-11#1)(2008-10#2)(2008-5#1)
the presence of vascular##2##4##(1990-6#1)(1993-10#1)
the presence of ventricular##2##4##(1996-4#1)(1997-8#1)
the presence of viral##3##4##(1993-8#1)(2008-11#1)(2012-3#1)
the presence of virus##3##4##(1992-8#1)(1996-2#1)(2008-10#1)
the presence of vitamin##5##4##(1992-12#1)(1993-6#1)(1995-1#1)(1997-2#1)(2010-10#1)
the presence of water##6##4##(1990-2#1)(1990-7#1)(1995-6#1)(2004-9#1)(2005-11#1)(2008-5#1)
the presence of which##2##4##(2005-12#1)(2007-12#1)
the presence of zinc##4##4##(1994-6#1)(2008-10#1)(2010-10#1)(2010-11#1)
the presence of##5090##3##(1990-1#5)(1990-10#26)(1990-11#37)(1990-12#38)(1990-2#44)(1990-3#27)(1990-4#11)(1990-5#50)(1990-6#11)(1990-7#37)(1990-8#27)(1990-9#13)(1991-1#15)(1991-10#17)(1991-11#15)(1991-12#27)(1991-2#46)(1991-3#23)(1991-4#31)(1991-5#41)(1991-6#15)(1991-7#14)(1991-8#26)(1991-9#43)(1992-1#18)(1992-10#3)(1992-11#31)(1992-12#31)(1992-2#18)(1992-3#34)(1992-4#14)(1992-5#19)(1992-6#31)(1992-7#24)(1992-8#30)(1992-9#32)(1993-1#1)(1993-10#4)(1993-11#26)(1993-12#22)(1993-2#11)(1993-3#25)(1993-4#16)(1993-5#6)(1993-6#33)(1993-7#11)(1993-8#34)(1993-9#25)(1994-1#1)(1994-10#9)(1994-11#44)(1994-12#55)(1994-2#30)(1994-3#44)(1994-5#31)(1994-6#30)(1994-7#6)(1994-8#48)(1994-9#37)(1995-1#38)(1995-10#22)(1995-11#30)(1995-12#24)(1995-2#41)(1995-3#35)(1995-4#9)(1995-5#30)(1995-6#30)(1995-7#7)(1995-8#44)(1995-9#5)(1996-1#21)(1996-10#14)(1996-11#9)(1996-12#22)(1996-2#27)(1996-3#14)(1996-4#15)(1996-5#49)(1996-6#17)(1996-7#19)(1996-8#19)(1996-9#15)(1997-1#23)(1997-2#35)(1997-3#16)(1997-4#50)(1997-5#27)(1997-6#19)(1997-7#43)(1997-8#23)(2004-1#1)(2004-10#1)(2004-11#7)(2004-12#5)(2004-2#2)(2004-4#3)(2004-9#5)(2005-1#1)(2005-10#11)(2005-11#75)(2005-12#14)(2005-4#8)(2005-7#1)(2005-8#10)(2005-9#2)(2006-1#3)(2006-10#61)(2006-11#7)(2006-12#34)(2006-2#10)(2006-3#6)(2006-4#8)(2006-5#13)(2006-6#12)(2006-7#2)(2006-8#25)(2006-9#10)(2007-1#9)(2007-10#23)(2007-11#80)(2007-12#70)(2007-2#25)(2007-3#18)(2007-4#5)(2007-5#10)(2007-6#18)(2007-7#29)(2007-8#40)(2007-9#18)(2008-1#30)(2008-10#774)(2008-11#93)(2008-12#28)(2008-2#59)(2008-3#96)(2008-4#73)(2008-5#118)(2008-6#35)(2008-7#58)(2008-8#52)(2008-9#32)(2009-1#2)(2009-10#8)(2009-11#6)(2009-12#4)(2009-2#7)(2009-3#10)(2009-4#9)(2009-5#7)(2009-6#12)(2009-7#8)(2009-8#16)(2009-9#16)(2010-1#3)(2010-10#8)(2010-11#9)(2010-12#28)(2010-2#19)(2010-3#10)(2010-4#22)(2010-5#21)(2010-6#18)(2010-7#8)(2010-8#16)(2010-9#6)(2011-1#41)(2011-12#11)(2011-2#86)(2011-3#1)(2011-7#1)(2012-1#9)(2012-11#5)(2012-12#50)(2012-2#44)(2012-3#40)(2013-1#70)(2013-4#1)(2013-7#16)(2013-8#47)
the presence on##2##3##(2008-5#1)(2013-1#1)
the presence or absence of a##13##6##(1990-7#1)(1991-8#1)(1994-3#1)(1996-12#1)(1996-4#1)(2005-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#2)(2012-12#1)
the presence or absence of an##7##6##(1991-4#1)(1992-7#1)(1997-7#1)(2007-12#2)(2008-10#1)(2008-12#1)
the presence or absence of each##2##6##(2007-9#1)(2008-10#1)
the presence or absence of other##2##6##(2008-8#1)(2012-2#1)
the presence or absence of specific##2##6##(1994-11#1)(1997-4#1)
the presence or absence of the##18##6##(1991-5#2)(1994-6#1)(1995-11#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-7#1)(1996-9#1)(2006-12#1)(2008-10#4)(2008-5#1)(2008-7#1)(2010-9#1)(2013-8#1)
the presence or absence of various##2##6##(2006-7#1)(2011-2#1)
the presence or absence of##132##5##(1990-11#1)(1990-3#2)(1990-5#1)(1990-7#2)(1990-9#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#3)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#3)(1993-8#1)(1994-11#1)(1994-3#1)(1994-6#2)(1995-11#2)(1995-3#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-4#2)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#1)(2005-11#1)(2005-12#2)(2005-8#3)(2006-12#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-9#2)(2008-10#23)(2008-11#1)(2008-12#4)(2008-2#3)(2008-4#5)(2008-5#2)(2008-7#2)(2008-8#4)(2009-11#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#3)(2013-8#1)
the presence or absence##136##4##(1990-11#1)(1990-3#2)(1990-5#1)(1990-7#2)(1990-9#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#3)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#2)(1992-3#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#3)(1993-8#1)(1994-11#1)(1994-3#1)(1994-6#2)(1995-11#2)(1995-3#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-4#2)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#1)(2005-11#1)(2005-12#2)(2005-4#2)(2005-8#3)(2006-12#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-9#2)(2008-10#23)(2008-11#2)(2008-12#4)(2008-2#3)(2008-4#5)(2008-5#2)(2008-7#2)(2008-8#4)(2009-11#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#3)(2013-8#1)
the presence or not of##3##5##(2006-10#1)(2008-2#1)(2011-1#1)
the presence or the absence of##2##6##(1994-12#1)(2008-7#1)
the presence or the absence##3##5##(1991-9#1)(1994-12#1)(2008-7#1)
the presence or the##4##4##(1991-9#1)(1994-12#1)(2008-7#1)(2011-2#1)
the presence or##147##3##(1990-11#1)(1990-3#2)(1990-5#1)(1990-7#2)(1990-9#1)(1991-11#1)(1991-2#1)(1991-4#2)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-12#2)(1992-3#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#3)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#2)(1995-11#2)(1995-3#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-4#2)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#1)(2005-11#1)(2005-12#2)(2005-4#2)(2005-8#3)(2006-10#1)(2006-12#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#23)(2008-11#2)(2008-12#4)(2008-2#4)(2008-4#6)(2008-5#2)(2008-7#3)(2008-8#4)(2009-11#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#3)(2013-8#1)
the presence##5428##2##(1990-1#5)(1990-10#26)(1990-11#39)(1990-12#39)(1990-2#45)(1990-3#33)(1990-4#11)(1990-5#55)(1990-6#12)(1990-7#42)(1990-8#27)(1990-9#14)(1991-1#17)(1991-10#17)(1991-11#16)(1991-12#28)(1991-2#47)(1991-3#25)(1991-4#34)(1991-5#45)(1991-6#17)(1991-7#16)(1991-8#29)(1991-9#45)(1992-1#20)(1992-10#3)(1992-11#32)(1992-12#34)(1992-2#18)(1992-3#37)(1992-4#16)(1992-5#19)(1992-6#33)(1992-7#25)(1992-8#33)(1992-9#33)(1993-1#2)(1993-10#4)(1993-11#28)(1993-12#25)(1993-2#13)(1993-3#30)(1993-4#17)(1993-5#6)(1993-6#36)(1993-7#14)(1993-8#36)(1993-9#25)(1994-1#1)(1994-10#10)(1994-11#50)(1994-12#59)(1994-2#33)(1994-3#46)(1994-5#33)(1994-6#33)(1994-7#6)(1994-8#50)(1994-9#39)(1995-1#39)(1995-10#22)(1995-11#33)(1995-12#24)(1995-2#42)(1995-3#37)(1995-4#9)(1995-5#31)(1995-6#32)(1995-7#7)(1995-8#46)(1995-9#6)(1996-1#21)(1996-10#16)(1996-11#11)(1996-12#23)(1996-2#27)(1996-3#14)(1996-4#17)(1996-5#51)(1996-6#18)(1996-7#22)(1996-8#21)(1996-9#16)(1997-1#28)(1997-2#37)(1997-3#17)(1997-4#52)(1997-5#29)(1997-6#21)(1997-7#46)(1997-8#25)(2004-1#2)(2004-10#1)(2004-11#8)(2004-12#5)(2004-2#2)(2004-4#3)(2004-9#5)(2005-1#1)(2005-10#11)(2005-11#77)(2005-12#16)(2005-4#10)(2005-7#1)(2005-8#13)(2005-9#2)(2006-1#3)(2006-10#64)(2006-11#7)(2006-12#36)(2006-2#12)(2006-3#6)(2006-4#9)(2006-5#15)(2006-6#12)(2006-7#3)(2006-8#25)(2006-9#10)(2007-1#9)(2007-10#24)(2007-11#82)(2007-12#72)(2007-2#25)(2007-3#19)(2007-4#5)(2007-5#12)(2007-6#20)(2007-7#30)(2007-8#41)(2007-9#20)(2008-1#32)(2008-10#820)(2008-11#103)(2008-12#32)(2008-2#64)(2008-3#101)(2008-4#79)(2008-5#127)(2008-6#36)(2008-7#67)(2008-8#59)(2008-9#32)(2009-1#2)(2009-10#9)(2009-11#7)(2009-12#4)(2009-2#7)(2009-3#11)(2009-4#9)(2009-5#8)(2009-6#13)(2009-7#8)(2009-8#16)(2009-9#16)(2010-1#3)(2010-10#9)(2010-11#10)(2010-12#29)(2010-2#20)(2010-3#12)(2010-4#22)(2010-5#21)(2010-6#18)(2010-7#9)(2010-8#17)(2010-9#7)(2011-1#44)(2011-12#11)(2011-2#90)(2011-3#1)(2011-7#1)(2012-1#9)(2012-11#5)(2012-12#55)(2012-2#50)(2012-3#41)(2013-1#74)(2013-4#1)(2013-7#17)(2013-8#49)
the presence/absence of##5##3##(2009-6#1)(2010-10#1)(2010-4#1)(2012-3#1)(2013-1#1)
the presenceof##2##2##(2008-11#1)(2009-8#1)
the present FDTD program##2##4##(2008-3#2)
the present FDTD##3##3##(2008-3#3)
the present admission##2##3##(1995-3#1)(2007-8#1)
the present analysis##5##3##(2007-7#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-3#1)
the present and future##3##4##(1997-1#1)(2005-9#1)(2011-1#1)
the present and##7##3##(1997-1#1)(2005-9#1)(2006-6#1)(2007-4#1)(2008-9#1)(2011-1#1)(2011-2#1)
the present approach##4##3##(1993-11#1)(2007-11#1)(2008-10#2)
the present article is##3##4##(2008-11#1)(2012-2#2)
the present article##30##3##(1990-6#1)(1991-9#1)(1994-10#1)(1995-8#2)(2007-10#1)(2007-12#2)(2007-4#1)(2008-10#2)(2008-11#6)(2008-4#1)(2008-5#1)(2009-12#1)(2009-3#1)(2010-1#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-2#4)(2013-8#1)
the present assay##2##3##(1991-10#1)(2008-10#1)
the present case the##3##4##(1990-5#1)(2008-12#1)(2011-2#1)
the present case was##2##4##(1997-7#1)(2007-7#1)
the present case##33##3##(1990-10#1)(1990-5#1)(1993-1#1)(1994-7#1)(1995-4#1)(1996-2#1)(1997-7#1)(2005-10#1)(2006-4#2)(2007-12#2)(2007-7#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#3)(2010-3#1)(2010-6#1)(2011-2#2)(2012-1#2)(2012-12#3)(2013-1#1)(2013-7#1)
the present communication##2##3##(2008-8#1)(2012-3#1)
the present conditions##2##3##(2008-4#1)(2010-8#1)
the present contribution##2##3##(2008-5#1)(2008-6#1)
the present data are##2##4##(1995-5#1)(1995-7#1)
the present data demonstrate that##2##5##(1996-6#1)(1997-5#1)
the present data indicate that##2##5##(1993-8#1)(1995-7#1)
the present data##20##3##(1990-2#1)(1991-1#1)(1991-6#1)(1992-7#1)(1993-8#1)(1995-5#1)(1995-7#2)(1996-3#1)(1996-6#2)(1997-2#2)(1997-5#1)(2007-3#1)(2007-7#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
the present day##9##3##(1990-4#1)(1992-3#1)(2006-8#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-6#1)(2012-3#1)
the present epidemiological situation##2##4##(1990-6#1)(1992-5#1)
the present example##2##3##(1996-2#1)(2008-3#1)
the present experiment##9##3##(1992-10#1)(1992-7#2)(1993-11#1)(1994-3#1)(1995-5#1)(1997-2#1)(2008-12#1)(2008-8#1)
the present experimental##5##3##(1990-8#1)(2008-10#1)(2008-5#1)(2009-6#1)(2010-4#1)
the present experiments##11##3##(1992-11#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-10#1)(1996-12#1)(1997-4#1)(2008-10#1)(2008-5#1)(2009-4#1)
the present findings suggest that##3##5##(1994-5#1)(1995-8#1)(1996-12#1)
the present findings##6##3##(1992-9#1)(1994-5#1)(1995-8#1)(1996-12#1)(1997-8#1)(2008-5#1)
the present investigation##42##3##(1990-11#1)(1990-12#1)(1991-12#1)(1992-3#1)(1994-10#1)(1994-6#1)(1995-11#2)(1995-3#1)(1996-12#1)(1996-4#1)(1997-7#1)(1997-8#1)(2006-12#1)(2007-2#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#2)(2009-4#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-11#1)(2013-1#4)(2013-7#1)(2013-8#1)
the present investigations##3##3##(2008-6#1)(2008-7#1)(2011-2#1)
the present is##2##3##(1997-8#1)(2010-8#1)
the present knowledge of##2##4##(2008-10#1)(2008-11#1)
the present knowledge##5##3##(1995-2#1)(2008-10#2)(2008-11#1)(2008-7#1)
the present literature##3##3##(2008-1#1)(2010-9#1)(2012-12#1)
the present method a##2##4##(2008-10#1)(2008-4#1)
the present method and##3##4##(1990-2#1)(2008-10#1)(2012-2#1)
the present method have##2##4##(1994-8#1)(2008-10#1)
the present method is##2##4##(2008-10#2)
the present method provided##2##4##(2008-10#2)
the present method were##3##4##(2008-10#3)
the present method with##2##4##(1993-8#1)(2008-10#1)
the present method##41##3##(1990-2#1)(1991-9#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-11#1)(1996-5#2)(2008-10#28)(2008-4#1)(2011-2#1)(2012-2#1)
the present model##3##3##(2006-10#2)(2009-8#1)
the present observations##3##3##(1991-3#1)(2008-3#1)(2013-8#1)
the present of##4##3##(2007-8#1)(2008-10#1)(2008-9#1)(2011-1#1)
the present on-going##2##3##(1997-7#1)(2011-1#1)
the present paper develops##2##4##(2008-10#1)(2013-8#1)
the present paper the##8##4##(1990-12#1)(1990-2#1)(1990-6#1)(1991-5#1)(2007-12#1)(2008-10#1)(2011-1#1)(2012-3#1)
the present paper we##12##4##(1991-9#1)(2006-10#2)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-2#1)(2012-2#1)
the present paper##100##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-5#2)(1991-9#2)(1992-12#1)(1992-9#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-4#1)(1996-8#1)(2005-11#2)(2005-8#1)(2006-10#3)(2006-12#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-6#2)(2008-10#21)(2008-11#4)(2008-12#2)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#5)
the present patient##3##3##(1997-1#1)(2006-10#1)(2012-12#1)
the present procedure##4##3##(2008-10#4)
the present report##22##3##(1992-7#1)(1992-8#1)(1993-11#1)(1994-9#2)(1995-10#1)(1996-2#1)(1996-5#1)(1997-3#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#3)(2013-7#1)
the present research##10##3##(2008-12#2)(2008-2#3)(2009-11#1)(2010-8#1)(2012-1#1)(2013-7#1)(2013-8#1)
the present results and##3##4##(1990-2#1)(1994-11#1)(2008-7#1)
the present results demonstrate that##2##5##(1995-11#1)(1995-7#1)
the present results provide##3##4##(1991-6#1)(1993-6#2)
the present results strongly##2##4##(2006-12#1)(2009-2#1)
the present results suggest that a##2##6##(1992-1#1)(1993-6#1)
the present results suggest that##5##5##(1992-1#1)(1993-11#1)(1993-6#1)(2008-10#1)(2011-2#1)
the present results suggest##7##4##(1992-1#1)(1993-11#1)(1993-6#1)(1997-5#1)(2006-5#1)(2008-10#1)(2011-2#1)
the present results##37##3##(1990-2#1)(1990-9#2)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#1)(1993-11#2)(1993-6#3)(1994-11#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-7#2)(1996-12#1)(1996-8#1)(1997-5#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#1)
the present review##44##3##(1993-11#1)(1994-6#1)(1994-8#1)(1995-4#1)(1995-8#1)(2005-7#1)(2006-10#5)(2007-1#1)(2007-9#1)(2008-1#5)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
the present role of##3##4##(1992-12#1)(1997-7#1)(2008-5#1)
the present sample##4##3##(1992-9#1)(1996-5#1)(2008-10#1)(2008-8#1)
the present series##5##3##(1990-12#1)(1991-4#1)(1996-2#1)(2007-8#1)(2008-7#1)
the present situation and##2##4##(1991-3#1)(2008-1#1)
the present situation in##2##4##(1991-6#1)(2008-10#1)
the present situation##5##3##(1991-3#1)(1991-6#1)(2006-6#1)(2008-1#1)(2008-10#1)
the present stage of##2##4##(2007-12#1)(2007-5#1)
the present stage##3##3##(2007-11#1)(2007-12#1)(2007-5#1)
the present standard##2##3##(1992-3#1)(1992-5#1)
the present state of knowledge##2##5##(1991-3#1)(2006-10#1)
the present state of the art##2##6##(1994-6#1)(2009-12#1)
the present state of the##3##5##(1994-6#1)(2009-12#1)(2011-3#1)
the present state of##12##4##(1991-3#1)(1994-6#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-6#1)(2008-11#1)(2009-12#1)(2009-2#1)(2011-1#1)(2011-3#1)(2013-8#1)
the present state##14##3##(1991-3#1)(1994-6#1)(2005-7#2)(2006-10#1)(2006-4#1)(2006-6#1)(2007-6#1)(2008-11#1)(2009-12#1)(2009-2#1)(2011-1#1)(2011-3#1)(2013-8#1)
the present status of the##2##5##(1993-3#1)(1997-4#1)
the present status of##4##4##(1993-3#1)(1997-4#1)(2008-7#1)(2012-11#1)
the present studies##15##3##(1990-11#1)(1990-3#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-4#1)(1993-12#1)(1994-9#1)(1996-10#1)(1996-5#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-8#1)(2013-1#1)
the present study and##2##4##(1995-9#1)(1996-2#1)
the present study are##4##4##(1992-8#1)(1997-4#1)(1997-5#1)(2012-2#1)
the present study demonstrated that##3##5##(1994-3#1)(2009-4#1)(2010-5#1)
the present study evaluated##2##4##(2008-6#1)(2012-12#1)
the present study examined##3##4##(1994-3#1)(2010-2#1)(2013-1#1)
the present study had##2##4##(2008-2#1)(2013-1#1)
the present study has##2##4##(2007-2#1)(2008-10#1)
the present study in##2##4##(2011-12#1)(2011-2#1)
the present study indicate that##7##5##(2006-5#1)(2008-10#2)(2008-12#1)(2010-2#1)(2011-12#1)(2012-12#1)
the present study indicated that##2##5##(2008-10#1)(2008-5#1)
the present study indicates that##2##5##(1996-9#1)(2008-7#1)
the present study indicates##3##4##(1996-9#1)(2008-7#1)(2009-8#1)
the present study investigated the##2##5##(2007-12#1)(2013-8#1)
the present study investigated##3##4##(1996-12#1)(2007-12#1)(2013-8#1)
the present study is the##3##5##(2007-7#1)(2009-12#1)(2012-5#1)
the present study is##37##4##(1993-9#1)(1996-3#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#3)(2007-9#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2011-2#2)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#3)(2013-7#1)(2013-8#2)
the present study it is##2##5##(1990-12#1)(2008-6#1)
the present study it##5##4##(1990-12#1)(1997-1#1)(2008-6#1)(2012-2#2)
the present study may be##2##5##(2008-10#1)(2010-9#1)
the present study may##5##4##(1994-2#1)(1994-5#1)(2008-10#1)(2010-9#1)(2013-1#1)
the present study on##3##4##(1994-11#1)(1995-7#1)(2008-12#1)
the present study provides##3##4##(2010-12#1)(2011-2#1)(2012-1#1)
the present study show that##2##5##(1994-3#1)(1995-1#1)
the present study showed##6##4##(2007-8#1)(2008-1#2)(2008-5#1)(2009-5#1)(2012-12#1)
the present study shows##2##4##(1997-2#1)(2011-1#1)
the present study suggest that##13##5##(1991-4#1)(1995-10#1)(1996-7#1)(2006-8#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-5#1)
the present study suggest the##2##5##(1992-8#1)(1996-1#1)
the present study suggest##15##4##(1991-4#1)(1992-8#1)(1995-10#1)(1996-1#1)(1996-7#1)(2006-8#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-5#1)
the present study suggests that##2##5##(2011-2#1)(2013-8#1)
the present study that##5##4##(1994-8#1)(1995-12#1)(1996-7#1)(2008-12#1)(2008-8#1)
the present study to determine##2##5##(2006-8#1)(2007-10#1)
the present study to screen##2##5##(2008-8#1)(2008-9#1)
the present study to##7##4##(2006-8#1)(2007-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-9#1)(2013-7#1)
the present study using##2##4##(1994-2#1)(2013-8#1)
the present study was aimed##2##5##(2012-12#1)(2012-3#1)
the present study was carried out to##2##7##(2007-8#1)(2012-11#1)
the present study was carried out##3##6##(2007-8#1)(2007-9#1)(2012-11#1)
the present study was designed to evaluate the##2##8##(2008-6#1)(2011-12#1)
the present study was designed to##6##6##(1993-11#1)(2007-10#1)(2008-6#1)(2010-4#1)(2011-12#1)(2012-2#1)
the present study was to evaluate the##18##7##(2006-5#1)(2006-6#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-5#2)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2013-1#4)(2013-7#1)(2013-8#1)
the present study was to evaluate##24##6##(1992-2#1)(1993-6#1)(1996-3#1)(2004-12#1)(2006-5#1)(2006-6#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-5#2)(2008-7#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2013-1#4)(2013-7#1)(2013-8#1)
the present study was to##192##5##(1990-10#1)(1990-8#1)(1990-9#1)(1991-10#1)(1992-12#1)(1992-2#2)(1993-1#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-7#2)(1994-10#1)(1994-12#1)(1994-2#2)(1994-5#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-2#1)(2004-9#1)(2005-12#1)(2006-10#1)(2006-4#3)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#5)(2007-11#3)(2007-2#1)(2007-7#2)(2007-8#6)(2007-9#5)(2008-10#9)(2008-11#2)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#5)(2008-8#1)(2009-1#2)(2009-10#1)(2009-2#3)(2009-4#1)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-12#2)(2010-2#3)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#14)(2012-1#2)(2012-12#4)(2012-2#8)(2012-3#1)(2013-1#10)(2013-7#4)(2013-8#9)
the present study was undertaken to##2##6##(2007-8#1)(2013-7#1)
the present study was##221##4##(1990-10#1)(1990-8#1)(1990-9#1)(1991-10#1)(1992-12#1)(1992-2#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-7#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-2#1)(2004-9#1)(2005-12#1)(2006-10#2)(2006-4#3)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#3)(2006-9#1)(2007-10#6)(2007-11#3)(2007-12#1)(2007-2#2)(2007-7#2)(2007-8#8)(2007-9#6)(2008-10#10)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#10)(2008-6#2)(2008-7#5)(2008-8#1)(2009-1#2)(2009-10#1)(2009-2#3)(2009-4#1)(2009-6#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#15)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#11)(2012-3#2)(2013-1#10)(2013-7#5)(2013-8#9)
the present study we compared the##3##6##(1994-12#1)(1995-11#1)(2006-10#1)
the present study we compared##4##5##(1994-12#1)(1995-11#1)(1995-12#1)(2006-10#1)
the present study we examined the##5##6##(1994-8#1)(1995-10#1)(1996-12#1)(1996-5#1)(1997-8#1)
the present study we examined##10##5##(1990-7#1)(1994-8#1)(1995-10#2)(1996-12#1)(1996-5#1)(1997-8#1)(2006-8#1)(2010-12#1)(2012-1#1)
the present study we have examined##2##6##(1997-2#1)(2007-10#1)
the present study we have investigated the##2##7##(1995-12#1)(2012-2#1)
the present study we have investigated##5##6##(1994-2#1)(1994-9#1)(1995-12#1)(1997-7#1)(2012-2#1)
the present study we have##27##5##(1991-11#1)(1991-2#1)(1991-7#1)(1992-12#1)(1993-12#2)(1993-9#1)(1994-2#1)(1994-8#1)(1994-9#2)(1995-12#2)(1995-3#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-7#1)(2009-7#1)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
the present study we investigated##15##5##(1995-7#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-10#1)(2007-10#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
the present study we##105##4##(1990-7#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-7#2)(1992-12#2)(1992-5#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#5)(1993-9#2)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#4)(1994-9#4)(1995-10#2)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#2)(1995-7#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-6#2)(1997-7#2)(1997-8#3)(2006-10#2)(2006-8#2)(2007-10#2)(2007-12#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#4)
the present study were##19##4##(1990-10#1)(1993-3#1)(1996-3#1)(1996-4#1)(1997-2#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-2#1)(2010-8#1)(2012-1#1)(2012-2#1)
the present study##1036##3##(1990-1#1)(1990-10#5)(1990-11#2)(1990-12#3)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#4)(1990-6#3)(1990-7#4)(1990-8#1)(1990-9#2)(1991-1#3)(1991-10#3)(1991-11#2)(1991-12#2)(1991-2#4)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#4)(1991-8#3)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#6)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#3)(1992-8#5)(1992-9#4)(1993-1#1)(1993-11#5)(1993-12#10)(1993-2#1)(1993-3#3)(1993-4#3)(1993-5#1)(1993-6#6)(1993-7#4)(1993-8#2)(1993-9#7)(1994-10#4)(1994-11#5)(1994-12#5)(1994-2#13)(1994-3#8)(1994-5#7)(1994-6#6)(1994-8#13)(1994-9#6)(1995-1#3)(1995-10#5)(1995-11#5)(1995-12#16)(1995-2#7)(1995-3#10)(1995-4#1)(1995-5#1)(1995-7#3)(1995-8#7)(1995-9#1)(1996-1#7)(1996-10#2)(1996-11#2)(1996-12#8)(1996-2#8)(1996-3#5)(1996-4#3)(1996-5#9)(1996-6#5)(1996-7#6)(1996-8#4)(1996-9#5)(1997-1#4)(1997-2#14)(1997-3#7)(1997-4#10)(1997-5#5)(1997-6#7)(1997-7#8)(1997-8#7)(2003-11#1)(2004-11#3)(2004-12#2)(2004-2#1)(2004-4#1)(2004-9#2)(2005-12#2)(2006-10#12)(2006-11#1)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#4)(2006-5#3)(2006-6#4)(2006-7#2)(2006-8#13)(2006-9#1)(2007-1#1)(2007-10#14)(2007-11#5)(2007-12#11)(2007-2#7)(2007-4#1)(2007-5#1)(2007-7#11)(2007-8#16)(2007-9#9)(2008-1#3)(2008-10#52)(2008-11#27)(2008-12#14)(2008-2#7)(2008-3#7)(2008-4#10)(2008-5#35)(2008-6#13)(2008-7#14)(2008-8#12)(2008-9#8)(2009-1#3)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#5)(2009-3#3)(2009-4#4)(2009-5#2)(2009-6#9)(2009-7#5)(2009-8#5)(2009-9#3)(2010-1#1)(2010-10#4)(2010-11#3)(2010-12#15)(2010-2#9)(2010-3#5)(2010-4#4)(2010-5#6)(2010-6#1)(2010-7#2)(2010-8#9)(2010-9#4)(2011-1#8)(2011-12#8)(2011-2#38)(2011-7#1)(2012-1#10)(2012-11#1)(2012-12#21)(2012-2#32)(2012-3#12)(2012-5#3)(2013-1#33)(2013-7#12)(2013-8#29)
the present system of##2##4##(1992-9#1)(2007-7#1)
the present system##11##3##(1992-9#1)(1994-1#1)(1996-10#1)(2006-6#2)(2007-7#1)(2008-10#3)(2008-2#1)(2008-8#1)
the present technique##3##3##(1996-6#1)(2008-10#1)(2008-2#1)
the present time of##2##4##(1996-3#1)(2006-1#1)
the present time that##2##4##(1992-12#1)(2008-6#1)
the present time we##2##4##(2007-8#1)(2008-5#1)
the present time##40##3##(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-3#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-9#1)(1996-12#1)(1996-3#2)(1997-3#1)(1997-4#1)(1997-8#1)(2006-1#1)(2006-10#3)(2006-5#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-7#1)(2012-3#1)
the present trend##2##3##(1991-6#1)(2008-4#1)
the present use of##2##4##(2007-11#1)(2013-1#1)
the present work is to##9##5##(1995-2#1)(1995-6#1)(1997-2#1)(2005-1#1)(2008-1#1)(2008-6#1)(2008-8#1)(2009-12#1)(2011-2#1)
the present work is##11##4##(1995-2#1)(1995-6#1)(1997-2#1)(2005-1#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-8#1)(2009-12#1)(2011-2#1)
the present work was##16##4##(1990-12#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-9#1)(1996-5#1)(2008-10#2)(2008-5#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#2)
the present work we##16##4##(1990-12#1)(1991-1#1)(1992-11#1)(1992-8#1)(1994-12#1)(1996-3#1)(1997-4#1)(2007-7#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)(2013-1#1)
the present work##137##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-7#1)(1991-1#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#2)(1992-5#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-4#2)(1997-5#1)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#3)(2006-10#4)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#39)(2008-11#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#3)(2009-11#1)(2009-12#2)(2009-5#1)(2009-7#2)(2010-11#1)(2010-2#1)(2010-3#3)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#2)
the present##1970##2##(1990-1#1)(1990-10#10)(1990-11#5)(1990-12#13)(1990-2#8)(1990-3#3)(1990-4#3)(1990-5#8)(1990-6#8)(1990-7#8)(1990-8#4)(1990-9#5)(1991-1#6)(1991-10#4)(1991-11#3)(1991-12#5)(1991-2#7)(1991-3#3)(1991-4#2)(1991-5#4)(1991-6#9)(1991-7#4)(1991-8#5)(1991-9#8)(1992-1#3)(1992-10#3)(1992-11#3)(1992-12#11)(1992-2#3)(1992-3#10)(1992-4#4)(1992-5#8)(1992-6#2)(1992-7#8)(1992-8#8)(1992-9#9)(1993-1#2)(1993-11#12)(1993-12#12)(1993-2#3)(1993-3#6)(1993-4#4)(1993-5#1)(1993-6#12)(1993-7#4)(1993-8#4)(1993-9#7)(1994-1#1)(1994-10#7)(1994-11#7)(1994-12#8)(1994-2#17)(1994-3#11)(1994-5#9)(1994-6#11)(1994-7#1)(1994-8#18)(1994-9#11)(1995-1#3)(1995-10#6)(1995-11#10)(1995-12#18)(1995-2#11)(1995-3#13)(1995-4#3)(1995-5#4)(1995-6#2)(1995-7#7)(1995-8#11)(1995-9#3)(1996-1#9)(1996-10#4)(1996-11#3)(1996-12#17)(1996-2#14)(1996-3#10)(1996-4#5)(1996-5#15)(1996-6#12)(1996-7#6)(1996-8#9)(1996-9#6)(1997-1#6)(1997-2#20)(1997-3#11)(1997-4#16)(1997-5#8)(1997-6#7)(1997-7#13)(1997-8#13)(2003-11#1)(2004-11#3)(2004-12#2)(2004-2#1)(2004-4#1)(2004-9#3)(2005-1#1)(2005-10#2)(2005-11#7)(2005-12#2)(2005-7#3)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#35)(2006-11#1)(2006-12#5)(2006-2#4)(2006-3#1)(2006-4#8)(2006-5#7)(2006-6#11)(2006-7#2)(2006-8#17)(2006-9#3)(2007-1#2)(2007-10#18)(2007-11#11)(2007-12#23)(2007-2#8)(2007-3#1)(2007-4#3)(2007-5#4)(2007-6#5)(2007-7#21)(2007-8#26)(2007-9#11)(2008-1#15)(2008-10#191)(2008-11#55)(2008-12#26)(2008-2#21)(2008-3#21)(2008-4#23)(2008-5#60)(2008-6#21)(2008-7#32)(2008-8#29)(2008-9#14)(2009-1#3)(2009-10#11)(2009-11#3)(2009-12#9)(2009-2#9)(2009-3#5)(2009-4#7)(2009-5#5)(2009-6#12)(2009-7#8)(2009-8#8)(2009-9#3)(2010-1#6)(2010-10#7)(2010-11#7)(2010-12#22)(2010-2#11)(2010-3#9)(2010-4#9)(2010-5#10)(2010-6#4)(2010-7#5)(2010-8#14)(2010-9#8)(2011-1#22)(2011-12#9)(2011-2#62)(2011-3#1)(2011-7#1)(2012-1#15)(2012-11#4)(2012-12#30)(2012-2#44)(2012-3#24)(2012-5#3)(2012-7#1)(2013-1#54)(2013-7#22)(2013-8#48)
the present-day##5##2##(1990-11#1)(1997-4#1)(2008-10#1)(2008-3#2)
the presentation and##6##3##(1995-11#1)(2008-4#1)(2008-5#1)(2009-6#1)(2011-2#1)(2012-2#1)
the presentation of a simultaneous sound##2##6##(2012-2#2)
the presentation of a##3##4##(1997-3#1)(2012-2#2)
the presentation of results from a##2##6##(2008-2#1)(2008-5#1)
the presentation of the##3##4##(1993-2#1)(2008-11#1)(2012-1#1)
the presentation of this##4##4##(2007-4#1)(2008-11#1)(2008-6#1)(2012-3#1)
the presentation of two##4##4##(1992-6#1)(1997-7#1)(2005-9#1)(2008-4#1)
the presentation of##45##3##(1991-11#2)(1991-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1995-2#1)(1996-2#1)(1997-3#1)(1997-7#1)(2004-7#1)(2005-8#1)(2005-9#2)(2006-10#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)
the presentation##59##2##(1991-11#2)(1991-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1995-11#1)(1995-2#1)(1996-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-7#1)(2005-8#1)(2005-9#2)(2006-10#1)(2006-2#2)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#2)
the presentations##14##2##(2005-7#1)(2005-8#3)(2006-10#1)(2006-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-5#3)(2010-11#1)
the presented approach##3##3##(2008-6#1)(2013-1#2)
the presented case##6##3##(1990-9#1)(2006-6#1)(2007-2#1)(2007-9#1)(2008-10#1)(2009-4#1)
the presented data##2##3##(1991-12#1)(1995-10#1)
the presented method are##2##4##(2008-10#1)(2008-3#1)
the presented method##5##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
the presented procedure##3##3##(1991-5#1)(2007-5#1)(2008-10#1)
the presented work##2##3##(2005-1#1)(2008-3#1)
the presented##42##2##(1990-9#1)(1991-12#1)(1991-5#1)(1995-10#1)(1995-12#1)(1996-7#1)(2005-1#1)(2006-2#1)(2006-6#1)(2007-12#2)(2007-2#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
the presenters will##2##3##(2013-1#2)
the presenters##3##2##(2013-1#3)
the presenting complaint##2##3##(2010-12#1)(2010-3#1)
the presenting complaints##2##3##(2009-11#1)(2012-2#1)
the presenting feature of##2##4##(2007-7#1)(2010-6#1)
the presenting feature##4##3##(2007-7#1)(2008-1#1)(2010-6#1)(2012-11#1)
the presenting features of##2##4##(2007-11#1)(2007-2#1)
the presenting features##3##3##(2007-11#1)(2007-2#1)(2011-2#1)
the presenting manifestation of##3##4##(2006-10#2)(2007-11#1)
the presenting sign of##5##4##(2007-2#1)(2008-1#1)(2010-10#1)(2011-2#1)(2012-12#1)
the presenting symptom##5##3##(1993-6#1)(2006-12#1)(2006-8#1)(2007-7#1)(2007-8#1)
the presenting symptoms##5##3##(1990-6#1)(1991-11#1)(2006-11#1)(2007-7#1)(2008-12#1)
the presenting##38##2##(1990-3#1)(1990-6#1)(1991-11#1)(1992-10#1)(1993-6#1)(1995-11#1)(1997-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-8#2)(2007-11#2)(2007-2#3)(2007-7#5)(2007-8#1)(2008-1#2)(2008-12#1)(2009-11#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)
the presently available##2##3##(2007-8#1)(2013-8#1)
the presently##6##2##(1991-2#1)(1995-12#1)(2007-8#1)(2008-3#2)(2013-8#1)
the presequence of the##3##4##(1991-12#1)(1991-9#1)(1994-11#1)
the presequence##11##2##(1991-12#2)(1991-9#2)(1992-6#4)(1993-3#1)(1994-11#2)
the preservation of a##4##4##(2007-11#1)(2008-5#1)(2011-2#2)
the preservation of residual##2##4##(2007-5#1)(2008-9#1)
the preservation of the##6##4##(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-9#1)(2013-8#1)
the preservation of this##2##4##(2008-10#1)(2008-11#1)
the preservation of##26##3##(1992-8#1)(1995-12#1)(1996-9#1)(1997-7#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-8#1)(2010-9#1)(2011-2#3)(2013-8#1)
the preservation##31##2##(1992-8#1)(1995-12#1)(1995-7#1)(1996-9#1)(1997-7#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#2)(2007-5#2)(2007-8#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2010-8#1)(2010-9#1)(2011-2#3)(2013-8#1)
the preservative##3##2##(1990-11#1)(2008-5#2)
the preservatives##2##2##(1990-10#2)
the preserved##4##2##(1996-12#1)(2008-9#1)(2012-1#1)(2013-7#1)
the presidency##3##2##(1995-1#1)(2006-7#1)(2012-2#1)
the president of##3##3##(1994-9#1)(2005-12#1)(2010-12#1)
the president##8##2##(1994-9#1)(2005-12#1)(2006-7#2)(2007-9#1)(2008-7#1)(2010-12#1)(2011-2#1)
the president's##3##2##(2006-7#2)(2007-1#1)
the prespawning phase##2##3##(2010-8#2)
the press in##4##3##(1990-12#1)(1991-3#1)(2006-10#1)(2009-10#1)
the press releases##2##3##(1996-2#1)(2008-7#1)
the press##17##2##(1990-12#2)(1991-3#1)(1992-3#1)(1996-2#1)(1996-9#1)(1997-6#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-5#2)(2008-7#1)(2009-10#3)(2009-4#1)
the pressing##3##2##(1996-3#1)(2007-8#1)(2008-10#1)
the pressor and tachycardiac effects of##2##6##(1993-11#2)
the pressor and tachycardiac##3##4##(1993-11#2)(1996-12#1)
the pressor and##5##3##(1990-10#1)(1993-11#2)(1996-12#1)(1997-2#1)
the pressor effect of##3##4##(1993-11#1)(1993-4#1)(1995-1#1)
the pressor effects of##2##4##(1993-11#1)(1995-11#1)
the pressor response induced by##2##5##(1992-8#2)
the pressor response to big ET-1##2##6##(1995-1#2)
the pressor response to big endothelin-1##2##6##(1991-6#1)(1992-7#1)
the pressor response to big##4##5##(1991-6#1)(1992-7#1)(1995-1#2)
the pressor response to intravenous (i##2##6##(1992-8#1)(1995-12#1)
the pressor response to##12##4##(1991-5#2)(1991-6#1)(1992-7#1)(1992-8#2)(1995-1#2)(1995-12#1)(1997-2#2)(2012-1#1)
the pressor response##18##3##(1991-5#2)(1991-6#1)(1992-7#2)(1992-8#4)(1993-4#1)(1995-1#2)(1995-12#1)(1997-2#4)(2012-1#1)
the pressor responses##3##3##(1991-5#2)(1992-8#1)
the pressor##32##2##(1990-10#1)(1991-5#5)(1991-6#1)(1992-7#2)(1992-8#5)(1993-11#4)(1993-4#2)(1995-1#3)(1995-11#1)(1995-12#1)(1996-12#1)(1997-2#5)(2012-1#1)
the pressure and##3##3##(2008-10#1)(2008-7#1)(2009-6#1)
the pressure dependence of##4##4##(1991-2#1)(1992-1#2)(2008-3#1)
the pressure distribution##3##3##(2007-6#1)(2009-9#1)(2012-1#1)
the pressure drop##3##3##(2008-10#1)(2008-7#1)(2009-6#1)
the pressure for##3##3##(2005-11#1)(2006-8#1)(2007-7#1)
the pressure gradient##3##3##(2006-5#1)(2009-6#2)
the pressure in##2##3##(2007-2#1)(2008-12#1)
the pressure is##2##3##(2006-12#1)(2009-6#1)
the pressure of the##2##4##(1992-10#1)(2007-12#1)
the pressure of##8##3##(1991-12#1)(1992-10#1)(1994-12#1)(2005-11#1)(2006-8#1)(2007-12#1)(2008-10#1)(2013-8#1)
the pressure on the##2##4##(1997-8#1)(2010-4#1)
the pressure on##5##3##(1995-3#1)(1997-8#1)(2008-2#1)(2010-4#1)(2011-2#1)
the pressure phosphene tonometer##5##4##(2010-8#5)
the pressure range##3##3##(2007-1#1)(2008-10#1)(2008-3#1)
the pressure sensitivity of##2##4##(1991-10#1)(2010-9#1)
the pressure to##4##3##(2006-4#1)(2008-3#1)(2009-11#1)(2012-2#1)
the pressure within##2##3##(2008-10#1)(2009-3#1)
the pressure##88##2##(1990-12#1)(1990-2#1)(1990-3#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#2)(1992-1#2)(1992-10#1)(1992-7#1)(1994-12#1)(1995-1#1)(1995-3#1)(1997-8#1)(2005-11#4)(2006-11#1)(2006-12#3)(2006-4#2)(2006-5#1)(2006-8#3)(2007-1#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#5)(2009-9#1)(2010-2#1)(2010-4#1)(2010-8#5)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-8#2)
the pressure-distance##2##2##(1994-8#2)
the pressures that##2##3##(2008-7#1)(2008-8#1)
the pressures##6##2##(1993-2#1)(1995-12#1)(1996-2#1)(2008-11#1)(2008-7#1)(2008-8#1)
the presumably##3##2##(1992-3#1)(1993-11#1)(2011-2#1)
the presumed protective##2##3##(1995-3#1)(2006-10#1)
the presumed##21##2##(1991-12#1)(1991-9#1)(1993-6#1)(1994-12#1)(1994-8#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-6#1)(2006-10#3)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2010-4#1)(2011-2#1)
the presumption of##2##3##(1990-12#1)(2013-8#1)
the presumption that##3##3##(1997-6#1)(2007-6#1)(2012-12#1)
the presumption##6##2##(1990-12#1)(1995-1#1)(1997-6#1)(2007-6#1)(2012-12#1)(2013-8#1)
the presumptive VU##2##3##(1994-12#2)
the presumptive##16##2##(1991-5#1)(1991-9#1)(1992-7#1)(1993-2#1)(1994-12#3)(1994-8#1)(1995-11#1)(1995-8#1)(1997-3#1)(2006-5#1)(2008-5#1)(2012-12#2)(2013-8#1)
the presurgical evaluation of patients with##2##6##(1990-3#1)(2009-9#1)
the presurgical evaluation of##3##4##(1990-3#1)(1994-2#1)(2009-9#1)
the presurgical##4##2##(1990-10#1)(1990-3#1)(1994-2#1)(2009-9#1)
the presynaptic membrane##3##3##(1990-11#1)(1995-8#1)(2012-2#1)
the presynaptic nerve terminal##3##4##(1991-11#1)(1993-3#1)(1996-12#1)
the presynaptic nerve##4##3##(1991-11#1)(1991-5#1)(1993-3#1)(1996-12#1)
the presynaptic neuron and##2##4##(1997-7#1)(2007-12#1)
the presynaptic neuron##3##3##(1997-7#2)(2007-12#1)
the presynaptic terminal##3##3##(1994-8#1)(2008-11#1)(2008-5#1)
the presynaptic terminals##2##3##(1992-12#1)(2007-12#1)
the presynaptic##35##2##(1990-11#1)(1991-11#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-8#2)(1993-3#1)(1994-8#2)(1995-12#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-9#1)(1997-2#1)(1997-7#2)(1997-8#1)(2007-10#2)(2007-12#2)(2008-11#3)(2008-3#1)(2008-5#1)(2012-2#1)
the pretectum##4##2##(1992-7#1)(1992-8#2)(1997-3#1)
the pretension##2##2##(2006-11#2)
the preterm##4##2##(1992-7#2)(1993-12#1)(2011-12#1)
the pretherapeutic##2##2##(1990-9#1)(2008-7#1)
the pretibial area##2##3##(2012-3#2)
the pretransplant##2##2##(2009-2#1)(2011-2#1)
the pretreated##10##2##(1990-10#1)(1991-12#1)(2004-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2012-12#1)(2013-1#3)
the pretreatment of a##2##4##(2008-8#1)(2013-1#1)
the pretreatment of the##4##4##(2005-11#1)(2008-10#2)(2013-8#1)
the pretreatment of##18##3##(1990-2#1)(1992-12#1)(1993-11#1)(1996-2#1)(2004-8#1)(2005-11#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-8#1)(2013-1#1)(2013-8#1)
the pretreatment value##2##3##(1995-3#1)(2007-11#1)
the pretreatment##29##2##(1990-2#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-11#1)(1995-3#1)(1996-2#1)(1996-6#1)(2004-8#1)(2005-11#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-5#3)(2008-8#1)(2012-3#1)(2013-1#2)(2013-8#1)
the prevacuolar compartment##2##3##(1997-6#2)
the prevacuolar##3##2##(1997-6#3)
the prevailing environment##2##3##(1992-3#1)(2010-2#1)
the prevailing wind##3##3##(2007-12#1)(2008-10#2)
the prevailing##29##2##(1992-3#2)(1993-6#1)(1994-3#1)(1996-7#1)(1996-9#1)(2006-4#1)(2006-6#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-9#1)(2012-2#1)(2013-8#1)
the prevalence and characteristics of##2##5##(2006-10#1)(2012-2#1)
the prevalence and clinical##6##4##(2007-2#1)(2007-7#1)(2008-5#1)(2008-9#1)(2009-10#1)(2013-8#1)
the prevalence and distribution of##2##5##(2012-12#1)(2013-8#1)
the prevalence and factors associated with##3##6##(2007-7#1)(2011-2#1)(2013-8#1)
the prevalence and frequency##2##4##(2009-11#1)(2013-1#1)
the prevalence and incidence##2##4##(2007-7#1)(2009-5#1)
the prevalence and intensity of##2##5##(2006-10#1)(2011-1#1)
the prevalence and pattern of##3##5##(2008-1#1)(2011-2#1)(2013-7#1)
the prevalence and population densities of H##2##7##(2008-10#2)
the prevalence and predictors of##2##5##(2011-1#2)
the prevalence and severity of##6##5##(2006-10#1)(2006-4#1)(2007-7#1)(2008-1#1)(2010-6#1)(2011-1#1)
the prevalence and the number of##2##6##(1992-2#1)(2011-2#1)
the prevalence and the##6##4##(1992-2#2)(2006-10#1)(2007-7#1)(2011-2#1)(2011-7#1)
the prevalence and##70##3##(1992-2#2)(1994-11#1)(2006-10#6)(2006-2#1)(2006-4#1)(2006-8#1)(2007-1#2)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#5)(2008-1#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#2)(2010-10#1)(2010-4#2)(2010-6#1)(2010-9#1)(2011-1#6)(2011-2#4)(2011-7#1)(2012-1#2)(2012-12#1)(2012-2#4)(2013-1#2)(2013-4#1)(2013-7#2)(2013-8#4)
the prevalence in##7##3##(1994-6#1)(1996-3#1)(2006-7#1)(2007-6#1)(2007-8#1)(2010-8#1)(2012-2#1)
the prevalence is##2##3##(2010-12#1)(2011-2#1)
the prevalence of CSDS varied between 11 and 65%##2##9##(2013-8#2)
the prevalence of H##4##4##(2006-8#1)(2007-8#1)(2008-1#1)(2011-1#1)
the prevalence of HBeAg##2##4##(2013-1#2)
the prevalence of HIV and##2##5##(2012-3#2)
the prevalence of HIV infection among##3##6##(2007-7#1)(2010-12#1)(2011-2#1)
the prevalence of HIV##8##4##(1996-1#1)(2007-7#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-3#3)
the prevalence of HIV-1##2##4##(1995-9#1)(2008-2#1)
the prevalence of HIV-associated##2##4##(2006-8#1)(2010-12#1)
the prevalence of HP among##2##5##(2007-3#2)
the prevalence of IBS in##2##5##(1997-2#2)
the prevalence of IBS##4##4##(1997-2#3)(2013-1#1)
the prevalence of Japanese cedar pollinosis##2##6##(2012-12#2)
the prevalence of MS##2##4##(2008-3#2)
the prevalence of OSAS##2##4##(2007-1#2)
the prevalence of a##3##4##(2006-10#1)(2010-5#1)(2012-2#1)
the prevalence of active##2##4##(1995-3#1)(2009-12#1)
the prevalence of anaemia##2##4##(2006-2#1)(2012-12#1)
the prevalence of and##2##4##(2008-6#1)(2011-2#1)
the prevalence of anemia and iron deficiency##2##7##(2006-4#2)
the prevalence of anemia##6##4##(2006-4#3)(2007-11#1)(2011-2#1)(2012-2#1)
the prevalence of anxiety and depressive disorders##2##7##(2009-10#2)
the prevalence of anxiety##3##4##(2009-10#2)(2010-2#1)
the prevalence of asthma and##3##5##(2007-2#1)(2009-1#1)(2012-3#1)
the prevalence of asthma##7##4##(2005-8#1)(2006-10#2)(2006-8#1)(2007-2#1)(2009-1#1)(2012-3#1)
the prevalence of asymptomatic bacteriuria among##2##6##(2010-12#2)
the prevalence of asymptomatic##3##4##(2007-9#1)(2010-12#2)
the prevalence of bacterial##2##4##(2005-7#1)(2010-4#1)
the prevalence of body dissatisfaction among##2##6##(2007-12#2)
the prevalence of body dissatisfaction##3##5##(2007-12#3)
the prevalence of breast##2##4##(1996-9#1)(2008-5#1)
the prevalence of bronchial asthma##2##5##(1996-7#1)(2011-1#1)
the prevalence of burnout##2##4##(2010-2#1)(2013-7#1)
the prevalence of cardiovascular##2##4##(2009-11#2)
the prevalence of caries##2##4##(1990-3#1)(1992-5#1)
the prevalence of chronic##3##4##(1990-12#1)(2012-3#1)(2013-8#1)
the prevalence of colorectal##2##4##(2011-2#2)
the prevalence of complications##2##4##(1996-9#1)(2008-7#1)
the prevalence of congenital##2##4##(2011-1#1)(2013-8#1)
the prevalence of dementia##2##4##(1991-11#1)(2008-7#1)
the prevalence of dental caries##2##5##(1992-5#2)
the prevalence of depression and##2##5##(2010-11#1)(2013-8#1)
the prevalence of depression##4##4##(2007-10#2)(2010-11#1)(2013-8#1)
the prevalence of depressive symptoms in##2##6##(2013-8#2)
the prevalence of depressive symptoms##4##5##(2011-2#1)(2013-1#1)(2013-8#2)
the prevalence of depressive##7##4##(2009-10#1)(2011-2#1)(2013-1#1)(2013-8#4)
the prevalence of diabetes##5##4##(2006-8#1)(2008-1#1)(2008-7#1)(2013-8#2)
the prevalence of different##4##4##(2006-10#2)(2006-5#1)(2010-12#1)
the prevalence of disability##3##4##(2006-8#2)(2008-7#1)
the prevalence of each##2##4##(2011-2#1)(2012-3#1)
the prevalence of elevated blood##2##5##(1997-4#1)(2008-5#1)
the prevalence of elevated##3##4##(1997-4#1)(2007-7#1)(2008-5#1)
the prevalence of facet joint mediated pain in##3##8##(2006-8#3)
the prevalence of facet joint pain##2##6##(2006-8#2)
the prevalence of facet joint##6##5##(2006-8#6)
the prevalence of facet##7##4##(2006-7#1)(2006-8#6)
the prevalence of headache##2##4##(2007-3#2)
the prevalence of hepatitis##2##4##(2008-1#1)(2013-1#1)
the prevalence of high##2##4##(2008-4#1)(2011-2#1)
the prevalence of hypertension##5##4##(2008-1#3)(2010-9#1)(2013-1#1)
the prevalence of infection##3##4##(1990-9#1)(1991-6#1)(2011-1#1)
the prevalence of intestinal##2##4##(2009-10#1)(2012-12#1)
the prevalence of iron deficiency##2##5##(2006-4#2)
the prevalence of low##3##4##(1997-5#1)(2009-4#2)
the prevalence of lumbar facet joint pain##2##7##(2006-8#2)
the prevalence of lumbar facet joint##3##6##(2006-8#3)
the prevalence of malaria and##2##5##(2006-2#1)(2007-2#1)
the prevalence of malaria##4##4##(2006-2#1)(2007-2#3)
the prevalence of metabolic syndrome and##2##6##(2008-3#2)
the prevalence of metabolic syndrome in Japanese##2##7##(2008-3#2)
the prevalence of metabolic syndrome in##5##6##(2008-3#4)(2009-6#1)
the prevalence of metabolic syndrome##9##5##(2008-3#8)(2009-6#1)
the prevalence of migraine was##2##5##(2010-2#2)
the prevalence of migraine##5##4##(2008-9#1)(2010-2#4)
the prevalence of musculoskeletal symptoms among##2##6##(2006-10#2)
the prevalence of musculoskeletal##3##4##(2006-10#2)(2008-12#1)
the prevalence of myocardial infarction and stroke##2##7##(2009-9#2)
the prevalence of neurogenic##2##4##(2007-8#2)
the prevalence of obesity and##3##5##(2008-3#1)(2008-6#1)(2012-2#1)
the prevalence of obesity##15##4##(2006-10#1)(2006-2#2)(2007-11#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-2#4)(2013-1#1)
the prevalence of one##2##4##(2006-2#1)(2013-7#1)
the prevalence of oral##2##4##(2008-5#1)(2012-2#1)
the prevalence of osteoporosis in##2##5##(2010-3#2)
the prevalence of osteoporosis is##2##5##(2005-3#1)(2010-3#1)
the prevalence of osteoporosis##5##4##(2005-3#2)(2010-3#3)
the prevalence of other##2##4##(2008-3#1)(2011-1#1)
the prevalence of overweight and obesity among children##2##8##(2006-1#2)
the prevalence of overweight and obesity in##3##7##(2006-10#1)(2008-3#1)(2012-12#1)
the prevalence of overweight and obesity##8##6##(2006-1#3)(2006-10#2)(2008-3#1)(2012-12#2)
the prevalence of overweight and##10##5##(2006-1#3)(2006-10#2)(2008-3#2)(2012-12#2)(2013-8#1)
the prevalence of pain##2##4##(2010-12#1)(2012-12#1)
the prevalence of respiratory##2##4##(1995-8#1)(2012-3#1)
the prevalence of risk factors for coronary##2##7##(2006-9#1)(2008-12#1)
the prevalence of risk factors##4##5##(1993-2#1)(2006-9#1)(2008-12#1)(2013-8#1)
the prevalence of self-reported##2##4##(1990-9#1)(2013-1#1)
the prevalence of seropositivity##2##4##(1991-11#2)
the prevalence of sexual##2##4##(2009-7#1)(2009-9#1)
the prevalence of skin##3##4##(2007-12#1)(2007-2#1)(2011-2#1)
the prevalence of smoking among##3##5##(1991-4#1)(2007-3#1)(2009-7#1)
the prevalence of smoking##4##4##(1991-4#1)(1994-6#1)(2007-3#1)(2009-7#1)
the prevalence of stress##2##4##(2012-2#2)
the prevalence of stroke in the young##2##7##(2007-9#2)
the prevalence of stroke##3##4##(2007-10#1)(2007-9#2)
the prevalence of such##3##4##(1995-8#1)(2008-8#1)(2012-2#1)
the prevalence of the MS##2##5##(2008-3#2)
the prevalence of the disease##3##5##(2008-10#2)(2008-9#1)
the prevalence of the metabolic syndrome was##2##7##(2008-3#1)(2010-4#1)
the prevalence of the metabolic syndrome##3##6##(2008-3#2)(2010-4#1)
the prevalence of the##21##4##(1993-10#1)(1996-11#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#4)(2008-9#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#4)
the prevalence of these##6##4##(1990-9#1)(2006-6#1)(2007-7#1)(2008-2#1)(2008-5#1)(2013-1#1)
the prevalence of this##4##4##(1996-12#1)(2004-11#1)(2006-9#1)(2010-5#1)
the prevalence of thyroid autoimmunity##2##5##(2008-7#2)
the prevalence of tooth##2##4##(2005-11#1)(2008-12#1)
the prevalence of tuberculosis##4##4##(1995-10#1)(2007-4#1)(2011-1#2)
the prevalence of type##2##4##(2007-2#1)(2008-5#1)
the prevalence of urinary incontinence##2##5##(2006-7#1)(2011-1#1)
the prevalence of urinary##3##4##(2006-7#1)(2007-10#1)(2011-1#1)
the prevalence of use##2##4##(1991-12#1)(2006-8#1)
the prevalence of viral hepatitis##2##5##(2006-10#1)(2006-6#1)
the prevalence of viral##3##4##(2006-10#1)(2006-6#1)(2008-1#1)
the prevalence of##538##3##(1990-11#2)(1990-12#4)(1990-3#1)(1990-6#3)(1990-9#3)(1991-11#3)(1991-12#2)(1991-4#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-4#1)(1992-5#3)(1992-9#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-6#5)(1994-7#1)(1994-9#2)(1995-1#1)(1995-10#2)(1995-3#1)(1995-8#3)(1995-9#1)(1996-1#3)(1996-11#2)(1996-12#4)(1996-7#2)(1996-9#2)(1997-2#3)(1997-3#4)(1997-4#1)(1997-5#1)(1997-8#1)(2004-10#1)(2004-11#2)(2005-11#1)(2005-3#2)(2005-7#2)(2005-8#2)(2005-9#1)(2006-1#3)(2006-10#19)(2006-12#3)(2006-2#7)(2006-4#6)(2006-5#1)(2006-6#2)(2006-7#5)(2006-8#24)(2006-9#3)(2007-1#2)(2007-10#5)(2007-11#2)(2007-12#5)(2007-2#11)(2007-3#6)(2007-4#2)(2007-6#4)(2007-7#14)(2007-8#12)(2007-9#3)(2008-1#16)(2008-10#10)(2008-11#2)(2008-12#12)(2008-2#3)(2008-3#20)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#9)(2008-8#10)(2008-9#5)(2009-1#1)(2009-10#5)(2009-11#4)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#6)(2009-6#1)(2009-7#4)(2009-8#1)(2009-9#4)(2010-1#1)(2010-11#1)(2010-12#12)(2010-2#7)(2010-3#3)(2010-4#4)(2010-5#2)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#17)(2011-12#2)(2011-2#22)(2012-1#3)(2012-11#2)(2012-12#15)(2012-2#22)(2012-3#14)(2013-1#24)(2013-7#4)(2013-8#19)
the prevalence rate of GB##2##5##(2013-8#2)
the prevalence rate of malaria##2##5##(2007-2#1)(2007-8#1)
the prevalence rate of reflux esophagitis##2##6##(2007-3#2)
the prevalence rate of##10##4##(1993-3#1)(2006-8#1)(2007-2#1)(2007-3#2)(2007-8#2)(2013-7#1)(2013-8#2)
the prevalence rate##13##3##(1991-12#1)(1993-3#1)(2006-8#1)(2007-2#1)(2007-3#2)(2007-8#2)(2008-7#1)(2013-7#1)(2013-8#3)
the prevalence rates of##5##4##(1991-2#1)(1997-3#1)(2006-10#1)(2008-3#1)(2012-1#1)
the prevalence rates##6##3##(1991-2#1)(1997-3#1)(2006-10#1)(2007-2#1)(2008-3#1)(2012-1#1)
the prevalence ratios##3##3##(2010-12#3)
the prevalence was##4##3##(2006-8#1)(2007-8#1)(2010-4#1)(2012-3#1)
the prevalence##686##2##(1990-11#2)(1990-12#4)(1990-3#1)(1990-6#4)(1990-9#3)(1991-11#3)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-2#2)(1992-4#1)(1992-5#3)(1992-9#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#6)(1994-7#1)(1994-9#2)(1995-1#1)(1995-10#2)(1995-12#1)(1995-3#1)(1995-8#3)(1995-9#1)(1996-1#3)(1996-11#2)(1996-12#6)(1996-3#1)(1996-7#3)(1996-9#2)(1997-2#4)(1997-3#5)(1997-4#1)(1997-5#1)(1997-8#1)(2004-10#1)(2004-11#2)(2004-3#1)(2005-11#1)(2005-3#2)(2005-7#2)(2005-8#2)(2005-9#1)(2006-1#3)(2006-10#26)(2006-12#3)(2006-2#9)(2006-4#7)(2006-5#1)(2006-6#2)(2006-7#7)(2006-8#29)(2006-9#4)(2007-1#4)(2007-10#5)(2007-11#2)(2007-12#6)(2007-2#16)(2007-3#10)(2007-4#2)(2007-6#6)(2007-7#20)(2007-8#16)(2007-9#4)(2008-1#23)(2008-10#12)(2008-11#3)(2008-12#14)(2008-2#4)(2008-3#22)(2008-4#3)(2008-5#10)(2008-6#3)(2008-7#10)(2008-8#11)(2008-9#6)(2009-1#1)(2009-10#6)(2009-11#5)(2009-12#4)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#8)(2009-6#1)(2009-7#4)(2009-8#1)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#17)(2010-2#7)(2010-3#3)(2010-4#7)(2010-5#3)(2010-6#2)(2010-8#4)(2010-9#3)(2011-1#26)(2011-12#2)(2011-2#31)(2011-7#1)(2012-1#6)(2012-11#2)(2012-12#17)(2012-2#27)(2012-3#15)(2013-1#29)(2013-4#1)(2013-7#7)(2013-8#27)
the prevalences of##5##3##(1990-12#1)(1995-9#1)(2005-8#1)(2007-2#1)(2008-10#1)
the prevalences##6##2##(1990-12#1)(1995-9#1)(2005-8#1)(2006-1#1)(2007-2#1)(2008-10#1)
the prevalent cause of##2##4##(2008-5#1)(2008-7#1)
the prevalent trend##2##3##(1994-2#1)(2010-8#1)
the prevalent use of##2##4##(1997-2#1)(1997-6#1)
the prevalent wind##2##3##(2008-5#2)
the prevalent##26##2##(1992-1#1)(1993-4#1)(1994-2#1)(1997-2#1)(1997-6#1)(2005-8#1)(2007-11#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#4)(2008-7#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)
the prevent-and-detect##2##2##(2010-7#2)
the preventative##3##2##(2007-12#2)(2011-1#1)
the prevention and control of NCDs##2##6##(2013-8#2)
the prevention and control of##12##5##(1991-5#1)(2004-10#2)(2006-2#1)(2007-6#1)(2008-9#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-8#2)
the prevention and control##13##4##(1991-5#1)(2004-10#2)(2006-2#1)(2007-6#1)(2008-9#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-8#2)
the prevention and early##2##4##(2007-8#1)(2007-9#1)
the prevention and management of##8##5##(1990-2#1)(1996-1#1)(2005-7#1)(2008-7#2)(2009-4#1)(2012-2#1)(2013-1#1)
the prevention and the##2##4##(1993-11#1)(2007-8#1)
the prevention and treatment of osteoporosis##7##6##(1993-11#2)(1997-6#2)(2005-1#1)(2007-11#1)(2008-3#1)
the prevention and treatment of##43##5##(1992-7#1)(1993-11#2)(1993-12#1)(1994-4#1)(1997-6#2)(2004-12#1)(2005-1#1)(2005-10#1)(2005-7#1)(2005-8#2)(2006-10#3)(2007-11#5)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#3)(2008-8#1)(2010-12#1)(2010-3#1)(2012-12#1)(2013-1#2)(2013-8#1)
the prevention and treatment##44##4##(1992-7#1)(1993-11#2)(1993-12#1)(1994-4#1)(1997-6#2)(2004-12#1)(2005-1#1)(2005-10#1)(2005-7#1)(2005-8#2)(2006-10#3)(2007-11#5)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#3)(2008-8#1)(2010-12#1)(2010-3#1)(2012-12#1)(2013-1#2)(2013-8#2)
the prevention and##78##3##(1990-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-7#1)(1993-11#3)(1993-12#1)(1994-4#1)(1995-6#1)(1996-1#1)(1996-12#1)(1997-6#2)(2004-10#2)(2004-12#1)(2005-1#1)(2005-10#1)(2005-7#3)(2005-8#2)(2006-10#3)(2006-2#1)(2007-11#6)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#4)
the prevention and/or treatment of##2##5##(1991-12#1)(1997-4#1)
the prevention of TB##2##4##(2007-2#1)(2009-4#1)
the prevention of a##3##4##(2007-10#1)(2009-3#1)(2012-12#1)
the prevention of acute##6##4##(1990-5#1)(2007-11#2)(2007-2#1)(2007-8#1)(2008-5#1)
the prevention of atherosclerosis##2##4##(2005-7#1)(2008-3#1)
the prevention of cancer##2##4##(2010-12#1)(2011-2#1)
the prevention of cardiac##2##4##(2008-8#1)(2013-8#1)
the prevention of cardiovascular disease##3##5##(1993-12#1)(2005-10#1)(2008-1#1)
the prevention of cardiovascular##6##4##(1990-4#1)(1993-12#1)(2005-10#1)(2008-1#1)(2008-10#1)(2008-7#1)
the prevention of chemotherapy-induced##2##4##(2008-7#1)(2010-12#1)
the prevention of chronic##3##4##(1997-2#1)(2006-2#1)(2008-3#1)
the prevention of coronary##3##4##(1993-9#2)(2006-12#1)
the prevention of disease in##2##5##(2005-7#1)(2008-9#1)
the prevention of disease##4##4##(1996-10#1)(2005-7#1)(2008-1#1)(2008-9#1)
the prevention of disordered eating##2##5##(2006-6#2)
the prevention of future##2##4##(2007-4#1)(2010-12#1)
the prevention of hepatitis A##2##5##(1994-8#1)(2007-11#1)
the prevention of human##2##4##(2008-5#1)(2011-2#1)
the prevention of illness##2##4##(2007-10#1)(2012-2#1)
the prevention of left ventricle failure##2##6##(2006-6#2)
the prevention of nausea and vomiting##3##6##(2008-7#3)
the prevention of new##2##4##(2008-10#1)(2009-4#1)
the prevention of obesity##6##4##(2008-10#3)(2011-2#2)(2012-12#1)
the prevention of occupational##2##4##(2007-3#1)(2007-4#1)
the prevention of oral##2##4##(1992-9#1)(2012-2#1)
the prevention of osteoporosis##4##4##(1995-4#1)(2005-3#1)(2006-10#1)(2007-11#1)
the prevention of postoperative##7##4##(1994-6#1)(2006-10#1)(2007-12#2)(2008-5#1)(2010-7#1)(2011-12#1)
the prevention of primary##2##4##(2007-11#1)(2010-4#1)
the prevention of progression##2##4##(2007-10#1)(2007-8#1)
the prevention of recurrences of##2##5##(1996-12#1)(2008-1#1)
the prevention of recurrences##3##4##(1996-12#1)(2007-7#1)(2008-1#1)
the prevention of recurrent stroke##2##5##(2007-10#1)(2007-9#1)
the prevention of recurrent##4##4##(2007-10#1)(2007-9#1)(2008-3#2)
the prevention of restenosis##3##4##(2005-7#1)(2007-11#1)(2008-12#1)
the prevention of skin##3##4##(1997-4#1)(2007-11#1)(2008-5#1)
the prevention of sudden cardiac death##2##6##(2006-7#1)(2006-9#1)
the prevention of sudden##3##4##(2006-7#1)(2006-9#1)(2007-12#1)
the prevention of the spread of##2##6##(1996-3#1)(2011-2#1)
the prevention of the##8##4##(1991-9#1)(1992-6#1)(1996-3#1)(2008-5#1)(2009-10#1)(2009-3#1)(2011-2#1)(2012-12#1)
the prevention of these##3##4##(1995-8#1)(2008-7#1)(2010-4#1)
the prevention of this disease##2##5##(1994-3#1)(2009-5#1)
the prevention of this##7##4##(1990-3#1)(1991-3#1)(1994-3#1)(2007-2#1)(2007-4#1)(2008-3#1)(2009-5#1)
the prevention of transmission of##2##5##(1993-3#1)(2010-5#1)
the prevention of venous thromboembolism in##2##6##(2006-2#1)(2010-11#1)
the prevention of venous thromboembolism##3##5##(2006-2#1)(2007-10#1)(2010-11#1)
the prevention of##277##3##(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#4)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#3)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-10#2)(1996-11#1)(1996-12#2)(1996-3#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-10#1)(2004-2#1)(2004-9#1)(2005-10#2)(2005-12#1)(2005-3#1)(2005-7#4)(2005-8#2)(2006-10#13)(2006-11#1)(2006-12#4)(2006-2#6)(2006-6#4)(2006-7#3)(2006-8#3)(2006-9#2)(2007-1#4)(2007-10#8)(2007-11#19)(2007-12#4)(2007-2#5)(2007-3#2)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#6)(2007-9#2)(2008-1#7)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#7)(2008-7#13)(2008-8#3)(2008-9#1)(2009-10#5)(2009-3#2)(2009-4#3)(2009-5#3)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#5)(2010-4#2)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#4)(2011-12#3)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#9)(2012-2#7)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
the prevention or treatment of##4##5##(2006-10#1)(2007-11#1)(2008-7#1)(2010-2#1)
the prevention or##6##3##(1991-9#1)(2006-10#1)(2007-11#1)(2007-5#1)(2008-7#1)(2010-2#1)
the prevention program##2##3##(1990-12#1)(2006-7#1)
the prevention##370##2##(1990-12#3)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#3)(1992-11#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#7)(1993-12#2)(1993-2#1)(1993-3#1)(1993-9#3)(1994-12#1)(1994-3#1)(1994-4#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#3)(1996-3#1)(1997-2#1)(1997-4#2)(1997-6#2)(1997-8#1)(2004-10#3)(2004-12#1)(2004-2#1)(2004-9#1)(2005-1#1)(2005-10#3)(2005-12#1)(2005-3#1)(2005-7#7)(2005-8#4)(2006-10#17)(2006-11#1)(2006-12#4)(2006-2#7)(2006-6#4)(2006-7#4)(2006-8#3)(2006-9#2)(2007-1#4)(2007-10#8)(2007-11#26)(2007-12#5)(2007-2#6)(2007-3#2)(2007-4#3)(2007-5#4)(2007-6#2)(2007-7#4)(2007-8#8)(2007-9#3)(2008-1#9)(2008-10#9)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#10)(2008-7#20)(2008-8#4)(2008-9#2)(2009-10#5)(2009-3#2)(2009-4#4)(2009-5#3)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#4)(2011-2#8)(2012-1#2)(2012-11#2)(2012-12#10)(2012-2#9)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#5)
the preventive action of##2##4##(1993-7#1)(2010-12#1)
the preventive effect of##6##4##(1992-10#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-12#1)(2013-8#1)
the preventive effect##7##3##(1992-10#1)(1993-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-12#1)(2013-8#1)
the preventive effects of##2##4##(2008-6#1)(2011-2#1)
the preventive value of folic acid##2##6##(2006-8#2)
the preventive##23##2##(1990-10#1)(1990-3#1)(1990-9#1)(1992-10#1)(1993-3#1)(1993-7#1)(1993-9#1)(1996-2#1)(2006-10#1)(2006-8#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#2)(2013-8#1)
the previous 12 months was##2##5##(2006-10#1)(2010-10#1)
the previous 12 months##8##4##(1994-12#1)(1997-3#1)(2006-10#2)(2009-5#1)(2010-10#1)(2010-8#1)(2013-1#1)
the previous 24##2##3##(2005-8#1)(2010-2#1)
the previous 3##2##3##(1993-5#1)(2005-7#1)
the previous 30##2##3##(2008-4#1)(2010-5#1)
the previous 6 months was##2##5##(2012-12#2)
the previous 6 months##4##4##(2005-10#1)(2012-12#2)(2013-1#1)
the previous R-R intervals and##2##5##(2009-9#1)(2010-5#1)
the previous and##3##3##(1994-6#1)(2006-8#1)(2010-7#1)
the previous article##2##3##(2005-8#1)(2007-4#1)
the previous day##2##3##(2011-1#1)(2011-2#1)
the previous decade##4##3##(2008-5#1)(2013-1#3)
the previous description of##2##4##(2008-10#1)(2012-2#1)
the previous dissection##2##3##(2008-11#2)
the previous dose##2##3##(1991-12#1)(2005-8#1)
the previous extraction##2##3##(2007-12#1)(2008-10#1)
the previous finding##2##3##(1993-8#1)(1997-5#1)
the previous findings##2##3##(2007-4#1)(2009-7#1)
the previous history##2##3##(2006-10#1)(2012-2#1)
the previous level##3##3##(1990-2#1)(1992-2#1)(2008-5#1)
the previous method##7##3##(1990-9#1)(1995-2#1)(1996-5#1)(2007-8#1)(2008-11#1)(2008-2#2)
the previous model##3##3##(1992-3#1)(2008-10#1)(2008-5#1)
the previous models##2##3##(2009-2#1)(2013-1#1)
the previous month##3##3##(2012-3#3)
the previous night##3##3##(1990-2#1)(1992-5#1)(2010-8#1)
the previous observation that##3##4##(1991-9#1)(1994-9#1)(2008-5#1)
the previous observations that##2##4##(1990-2#1)(1991-12#1)
the previous observations##6##3##(1990-2#1)(1990-7#1)(1991-12#1)(1993-3#1)(2008-11#1)(2008-5#1)
the previous one##9##3##(2006-12#1)(2006-6#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#3)
the previous operation##2##3##(2008-6#1)(2010-12#1)
the previous paper##4##3##(1990-9#1)(1994-5#1)(2008-10#1)(2008-2#1)
the previous passage##2##3##(2011-3#2)
the previous procedures##2##3##(1990-11#1)(1997-6#1)
the previous report##2##3##(1990-1#1)(2008-11#1)
the previous reports on the##2##5##(1991-9#1)(2007-8#1)
the previous reports on##4##4##(1991-9#1)(1992-2#1)(2007-8#1)(2008-5#1)
the previous reports##9##3##(1991-9#1)(1992-2#1)(1994-3#1)(2006-1#1)(2007-8#1)(2008-2#1)(2008-5#2)(2012-12#1)
the previous research##3##3##(2007-12#1)(2008-2#1)(2011-1#1)
the previous results##3##3##(1990-4#1)(1992-12#1)(1997-6#1)
the previous six months##4##4##(2004-3#1)(2011-1#3)
the previous six years##3##4##(2008-5#1)(2013-1#2)
the previous six##7##3##(2004-3#1)(2008-5#1)(2011-1#3)(2013-1#2)
the previous step##2##3##(1992-3#1)(1995-3#1)
the previous studies##6##3##(1996-7#1)(2006-10#1)(2008-10#1)(2010-9#1)(2011-1#2)
the previous study of##2##4##(1991-4#1)(1992-6#1)
the previous study##15##3##(1990-2#1)(1991-4#1)(1991-8#1)(1992-6#1)(1993-12#2)(1994-2#1)(1994-3#1)(1994-9#1)(1996-5#1)(2004-9#1)(2006-8#1)(2008-9#1)(2011-12#1)(2012-1#1)
the previous system##2##3##(2008-10#1)(2012-1#1)
the previous two years##3##4##(1995-4#1)(2008-5#1)(2011-2#1)
the previous two##4##3##(1991-5#1)(1995-4#1)(2008-5#1)(2011-2#1)
the previous version##2##3##(1993-12#1)(2008-2#1)
the previous week##2##3##(1990-3#1)(2013-7#1)
the previous work##5##3##(2005-4#1)(2008-10#1)(2009-7#1)(2010-5#1)(2012-2#1)
the previous year and##2##4##(2007-3#1)(2008-10#1)
the previous year had##2##4##(2008-10#2)
the previous year were##2##4##(2008-10#2)
the previous year##21##3##(1991-3#1)(1992-2#1)(1993-5#1)(1994-12#1)(1996-12#1)(2006-10#1)(2007-3#1)(2007-5#1)(2008-10#8)(2008-12#2)(2008-5#1)(2008-7#1)(2011-2#1)
the previous year's##3##3##(2008-10#2)(2011-2#1)
the previous years##2##3##(1997-7#1)(2011-1#1)
the previous##316##2##(1990-1#1)(1990-11#2)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#2)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-12#1)(1992-2#3)(1992-3#3)(1992-5#1)(1992-6#2)(1992-7#1)(1993-12#4)(1993-3#1)(1993-5#2)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#3)(1994-6#1)(1994-9#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-5#3)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#2)(2004-3#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-4#1)(2005-7#2)(2005-8#3)(2006-1#1)(2006-10#8)(2006-11#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-10#3)(2007-11#3)(2007-12#5)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#2)(2007-8#5)(2008-10#33)(2008-11#7)(2008-12#3)(2008-2#12)(2008-3#7)(2008-4#2)(2008-5#17)(2008-6#4)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-9#3)(2010-10#3)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-5#3)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#11)(2011-12#1)(2011-2#14)(2011-3#2)(2012-1#4)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#5)(2012-7#1)(2013-1#11)(2013-7#1)(2013-8#4)
the previously characterized##8##3##(1990-5#1)(1991-9#1)(1994-12#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-7#1)(2012-12#1)
the previously cloned rat##3##4##(1991-3#1)(1991-7#1)(1994-8#1)
the previously cloned##7##3##(1991-3#1)(1991-7#1)(1991-9#2)(1992-5#1)(1994-3#1)(1994-8#1)
the previously defined##3##3##(1994-6#1)(1995-2#1)(2008-10#1)
the previously described EC-2##2##4##(2008-10#2)
the previously described##47##3##(1990-4#1)(1990-5#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-9#1)(1993-2#1)(1993-4#1)(1994-12#1)(1994-3#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-6#2)(1996-7#1)(1996-9#1)(2004-12#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2010-11#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
the previously determined##5##3##(1992-12#1)(1993-8#1)(1995-4#1)(1997-4#1)(2008-3#1)
the previously developed##2##3##(1996-2#1)(2008-10#1)
the previously dominant##2##3##(2008-10#2)
the previously estimated##2##3##(1996-8#1)(2006-10#1)
the previously existing##2##3##(2011-2#1)(2013-8#1)
the previously identified gene##2##4##(1991-6#1)(1993-6#1)
the previously identified##12##3##(1991-6#1)(1993-6#1)(1994-9#1)(1996-12#1)(1996-3#1)(1996-8#2)(1997-4#1)(2008-10#1)(2009-4#1)(2010-9#1)(2012-3#1)
the previously isolated##5##3##(1990-12#1)(1990-2#1)(1992-12#1)(1993-9#1)(1996-9#1)
the previously known##4##3##(1990-9#1)(1992-3#1)(1996-6#1)(2005-11#1)
the previously learned##2##3##(1990-10#1)(1996-10#1)
the previously mapped##2##3##(1994-12#1)(2008-10#1)
the previously observed##4##3##(1993-12#1)(1994-12#1)(1996-6#1)(2011-1#1)
the previously proposed##8##3##(1991-5#1)(1992-4#1)(1994-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-7#1)
the previously published##11##3##(1990-4#1)(1993-8#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-11#1)(2006-10#1)(2008-2#1)(2008-5#1)(2010-2#1)(2013-1#1)
the previously reported cases##3##4##(1993-8#1)(2006-10#1)(2006-8#1)
the previously reported compounds##2##4##(1992-9#1)(1997-7#1)
the previously reported sequence##2##4##(1991-6#1)(1996-6#1)
the previously reported##54##3##(1990-1#1)(1990-5#1)(1991-1#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#3)(1996-12#1)(1996-2#2)(1996-6#1)(1996-7#1)(1997-2#4)(1997-7#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#3)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-12#2)(2013-8#1)
the previously sequenced##5##3##(1991-2#1)(1991-6#1)(1993-12#1)(1994-12#1)(1997-8#1)
the previously studied##8##3##(1993-4#2)(1994-2#1)(2005-10#1)(2007-11#2)(2010-3#1)(2010-4#1)
the previously synthesized##2##3##(1995-11#2)
the previously unexplained##3##3##(1990-2#1)(1995-7#1)(2007-12#1)
the previously unknown##2##3##(1997-7#1)(2007-3#1)
the previously used##5##3##(1990-4#1)(1991-5#1)(1993-4#1)(2011-2#1)(2012-3#1)
the previously##254##2##(1990-1#2)(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#3)(1990-5#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#3)(1991-3#3)(1991-5#4)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#7)(1992-1#1)(1992-10#1)(1992-12#2)(1992-3#2)(1992-4#2)(1992-5#2)(1992-7#1)(1992-9#2)(1993-12#5)(1993-2#1)(1993-4#4)(1993-6#2)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#8)(1994-2#1)(1994-3#4)(1994-6#1)(1994-8#1)(1994-9#4)(1995-11#4)(1995-12#2)(1995-2#3)(1995-3#2)(1995-4#1)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#2)(1996-6#5)(1996-7#2)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#4)(1997-4#3)(1997-7#3)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#1)(2006-10#4)(2006-8#1)(2007-1#2)(2007-11#5)(2007-12#6)(2007-3#1)(2007-7#2)(2007-8#3)(2008-10#30)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#5)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#3)
the previtellogenic##2##2##(2008-8#1)(2010-5#1)
the prewar and##2##3##(1990-6#1)(2008-11#1)
the prey species##3##3##(2008-8#2)(2009-4#1)
the prey##24##2##(2006-12#2)(2007-12#3)(2007-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-8#5)(2008-9#5)(2009-4#1)(2010-8#1)(2012-2#2)(2012-3#1)
the prey's##3##2##(2008-8#2)(2008-9#1)
the prey-to-predator conversion efficiency##2##4##(2008-8#2)
the prg isolates##3##3##(2008-10#3)
the prg pathogens##3##3##(2008-10#3)
the prg##6##2##(2008-10#6)
the price of health##2##4##(1991-4#2)
the price of the##3##4##(1990-9#1)(1996-2#1)(2008-2#1)
the price of tobacco##2##4##(2006-8#1)(2012-1#1)
the price of##24##3##(1990-9#1)(1991-1#1)(1991-4#2)(1993-1#1)(1994-1#1)(1994-2#1)(1994-7#1)(1996-12#1)(1996-2#1)(2006-11#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
the price to##2##3##(2008-12#1)(2013-8#1)
the price##34##2##(1990-9#1)(1991-1#1)(1991-4#2)(1993-1#1)(1994-1#1)(1994-2#2)(1994-3#1)(1994-7#1)(1996-12#1)(1996-2#1)(2006-11#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2009-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
the prices of##2##3##(1997-6#1)(2013-8#1)
the pricing and##2##3##(1995-12#1)(2008-7#1)
the primacy of the##2##4##(2006-9#1)(2007-4#1)
the primacy of##8##3##(2005-8#1)(2006-9#1)(2007-4#1)(2009-4#1)(2009-8#1)(2012-1#1)(2013-1#1)(2013-8#1)
the primary EPR##2##3##(1997-7#2)
the primary afferent neurons##2##4##(1990-4#1)(1995-12#1)
the primary afferent##9##3##(1990-4#1)(1994-8#1)(1995-12#2)(1995-5#2)(1996-7#1)(1997-3#1)(2006-12#1)
the primary aim of therapy is to##2##7##(2008-7#1)(2013-8#1)
the primary aim of##3##4##(2007-1#1)(2008-7#1)(2013-8#1)
the primary amine of##2##4##(2007-8#1)(2011-1#1)
the primary amine##4##3##(2007-8#1)(2008-10#2)(2011-1#1)
the primary amino acid sequence##2##5##(1990-11#1)(1996-12#1)
the primary amino acid##4##4##(1990-11#1)(1991-7#1)(1996-12#1)(2009-4#1)
the primary amino group of the##2##6##(1993-5#1)(2008-10#1)
the primary amino group##4##4##(1993-5#1)(1996-8#2)(2008-10#1)
the primary amino##8##3##(1990-11#1)(1991-7#1)(1993-5#1)(1996-12#1)(1996-8#2)(2008-10#1)(2009-4#1)
the primary analysis##2##3##(1995-4#1)(1997-4#1)
the primary and metastatic tumor##2##5##(1992-6#2)
the primary and metastatic##4##4##(1992-6#3)(2013-8#1)
the primary and permanent dentition##2##5##(2008-5#1)(2012-2#1)
the primary and permanent dentitions##2##5##(2008-12#1)(2008-5#1)
the primary and permanent##4##4##(2008-12#1)(2008-5#2)(2012-2#1)
the primary and secondary prevention of##4##6##(2006-5#2)(2008-1#1)(2008-11#1)
the primary and secondary spongiosa##3##5##(2009-3#3)
the primary and secondary##22##4##(1991-4#1)(1991-7#1)(1992-6#2)(1993-9#1)(2006-5#2)(2006-7#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-3#3)(2010-11#1)(2011-2#1)(2011-3#1)
the primary and the secondary principal##2##6##(2008-2#2)
the primary and the##4##4##(1991-8#1)(1992-6#1)(2008-2#2)
the primary and##47##3##(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-3#1)(1992-6#6)(1992-9#1)(1993-3#1)(1993-9#1)(2006-5#2)(2006-7#1)(2006-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#2)(2009-11#1)(2009-3#3)(2010-11#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
the primary anion##2##3##(1990-5#2)
the primary antibody was##2##4##(2004-1#1)(2008-10#1)
the primary antibody##9##3##(2004-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)
the primary approach##2##3##(2008-10#1)(2008-4#1)
the primary auditory cortex##3##4##(1991-3#1)(2008-11#1)(2013-8#1)
the primary auditory##4##3##(1991-3#1)(1995-5#1)(2008-11#1)(2013-8#1)
the primary beam##4##3##(2007-2#1)(2008-2#1)(2010-2#2)
the primary binding site##2##4##(1997-3#1)(2008-3#1)
the primary binding##3##3##(1994-12#1)(1997-3#1)(2008-3#1)
the primary breast##4##3##(1995-10#1)(2007-6#1)(2011-12#1)(2011-3#1)
the primary cancer##3##3##(1995-4#1)(2006-2#1)(2013-8#1)
the primary carbon##2##3##(1994-5#1)(2008-3#1)
the primary care management##5##4##(1996-3#1)(2006-5#4)
the primary care physician##7##4##(1994-10#1)(1995-2#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-12#1)(2008-8#1)
the primary care setting is##3##5##(2006-5#1)(2007-5#1)(2009-9#1)
the primary care setting##19##4##(1996-12#5)(2006-5#1)(2006-7#1)(2007-5#1)(2008-11#2)(2008-12#2)(2008-8#1)(2009-5#1)(2009-9#1)(2010-1#2)(2013-1#2)
the primary care##50##3##(1990-9#1)(1992-7#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-8#1)(1995-11#2)(1995-2#1)(1996-12#6)(1996-3#2)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-5#5)(2006-7#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-11#2)(2008-12#3)(2008-2#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-9#1)(2010-1#2)(2011-1#1)(2012-12#1)(2013-1#2)
the primary caregiver##2##3##(2009-4#1)(2009-5#1)
the primary causative agent of##2##5##(2007-11#1)(2013-8#1)
the primary causative##3##3##(2007-11#1)(2008-2#1)(2013-8#1)
the primary cause of the##3##5##(1994-9#1)(2009-3#1)(2012-2#1)
the primary cause of##13##4##(1994-9#1)(1996-12#1)(2005-7#1)(2005-8#1)(2006-4#1)(2008-11#1)(2008-7#1)(2009-12#1)(2009-3#1)(2012-2#2)(2013-1#1)(2013-8#1)
the primary cause##16##3##(1994-9#1)(1996-12#1)(2005-7#1)(2005-8#1)(2006-4#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-3#1)(2012-11#1)(2012-2#2)(2013-1#1)(2013-8#1)
the primary cells##2##3##(2008-11#2)
the primary coating##3##3##(2007-11#3)
the primary component of##2##4##(2006-9#1)(2007-12#1)
the primary component##3##3##(2006-9#1)(2007-12#1)(2008-10#1)
the primary concern##3##3##(1992-8#1)(1997-2#1)(2012-1#1)
the primary contact##3##3##(1991-4#1)(1993-8#1)(2007-11#1)
the primary culture of##3##4##(1990-10#1)(2008-11#1)(2012-1#1)
the primary cultured##2##3##(1991-4#1)(2010-3#1)
the primary data##2##3##(1995-8#1)(2008-1#1)
the primary defect##2##3##(1994-5#1)(2006-5#1)
the primary degradation product##2##4##(1990-4#1)(2008-10#1)
the primary degradation##3##3##(1990-4#1)(2007-8#1)(2008-10#1)
the primary dentition##4##3##(2008-5#2)(2011-2#1)(2012-12#1)
the primary determinant for the##2##5##(2008-10#1)(2011-1#1)
the primary determinant##6##3##(1996-5#1)(2007-12#2)(2008-1#1)(2008-10#1)(2011-1#1)
the primary diagnosis##4##3##(1991-9#1)(1992-1#2)(1996-12#1)
the primary diagnostic##3##3##(2005-9#1)(2006-8#1)(2008-6#1)
the primary disease##2##3##(1997-4#1)(2007-12#1)
the primary donor##3##3##(1993-11#1)(1997-4#1)(1997-7#1)
the primary effect of##4##4##(1990-7#1)(1994-2#1)(1994-8#1)(2007-8#1)
the primary efficacy##2##3##(2008-7#2)
the primary electron donor##7##4##(1992-6#2)(1993-11#2)(2008-8#3)
the primary electron##9##3##(1992-6#2)(1993-11#2)(1995-11#2)(2008-8#3)
the primary emulsifier##2##3##(2008-5#2)
the primary end point##4##4##(2007-8#1)(2009-11#2)(2012-2#1)
the primary end##5##3##(2007-8#1)(2009-11#2)(2010-9#1)(2012-2#1)
the primary endosperm##3##3##(2008-9#3)
the primary endpoint of##3##4##(2008-5#1)(2009-8#1)(2010-4#1)
the primary endpoint##6##3##(1997-2#1)(2005-8#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-4#1)
the primary event in the##2##5##(1995-1#1)(2008-3#1)
the primary factor##4##3##(2008-10#1)(2008-3#1)(2008-9#1)(2009-5#1)
the primary focus of##4##4##(2006-6#1)(2007-8#1)(2008-1#1)(2008-7#1)
the primary focus##6##3##(1994-2#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-5#1)
the primary function of##5##4##(2007-12#1)(2008-2#2)(2008-5#2)
the primary gene##2##3##(1990-5#1)(2009-10#1)
the primary generation##2##3##(1995-3#1)(2008-10#1)
the primary goal of##4##4##(2006-10#1)(2006-5#1)(2007-1#1)(2007-11#1)
the primary goal##8##3##(2006-10#1)(2006-5#1)(2007-1#1)(2007-11#1)(2008-3#1)(2008-9#2)(2013-1#1)
the primary goals of##3##4##(2006-10#2)(2006-7#1)
the primary health care system and##2##6##(1995-9#2)
the primary health care##12##4##(1990-5#1)(1991-6#1)(1994-5#1)(1995-8#1)(1995-9#3)(1996-3#1)(2008-1#2)(2011-2#1)(2013-7#1)
the primary health service##3##4##(1991-5#2)(1995-9#1)
the primary health services##5##4##(1991-6#1)(1992-11#2)(1994-6#1)(1995-6#1)
the primary health##23##3##(1990-10#1)(1990-5#1)(1991-5#2)(1991-6#2)(1992-11#2)(1994-5#1)(1994-6#1)(1995-6#1)(1995-8#1)(1995-9#4)(1996-3#1)(2008-1#2)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
the primary healthcare##3##3##(2008-9#1)(2011-1#1)(2012-2#1)
the primary hematopoietic##2##3##(1997-3#1)(2010-11#1)
the primary hydroxyl##2##3##(1991-12#1)(1996-5#1)
the primary imaging##2##3##(2008-7#1)(2012-2#1)
the primary immune response##2##4##(2008-10#1)(2008-11#1)
the primary infection##9##3##(2006-10#2)(2007-10#1)(2008-10#5)(2010-1#1)
the primary inoculum##4##3##(2008-10#4)
the primary isolation of##2##4##(2008-12#1)(2008-5#1)
the primary lesion##7##3##(1991-5#1)(1992-2#1)(2004-1#1)(2007-12#1)(2007-7#1)(2008-10#1)(2013-8#1)
the primary means of##3##4##(2008-10#2)(2008-5#1)
the primary means##5##3##(2007-4#1)(2008-10#3)(2008-5#1)
the primary mechanism of##3##4##(2007-7#1)(2008-10#1)(2009-11#1)
the primary mechanism##4##3##(1997-3#1)(2007-7#1)(2008-10#1)(2009-11#1)
the primary method##2##3##(2008-4#1)(2011-2#1)
the primary mirror##3##3##(2008-2#2)(2008-3#1)
the primary modality##3##3##(2007-4#1)(2011-2#1)(2012-12#1)
the primary motor cortex##2##4##(1997-8#1)(2011-2#1)
the primary motor##5##3##(1993-2#1)(1995-11#1)(1997-8#1)(2008-9#1)(2011-2#1)
the primary mycelium##3##3##(2008-10#3)
the primary neurotransmitter##2##3##(1997-3#1)(1997-5#1)
the primary nutrients##2##3##(2006-10#1)(2008-10#1)
the primary objective##3##3##(1992-1#1)(2008-9#1)(2012-12#1)
the primary olfactory center##2##4##(2007-12#2)
the primary olfactory##4##3##(2007-12#4)
the primary open angle glaucoma patients##2##6##(2013-8#2)
the primary open angle##3##4##(2013-8#3)
the primary operation##4##3##(1993-5#2)(2007-8#1)(2008-6#1)
the primary or secondary##2##4##(1996-12#1)(2008-5#1)
the primary or##3##3##(1990-12#1)(1996-12#1)(2008-5#1)
the primary outcome measure##2##4##(2006-12#1)(2013-1#1)
the primary outcome##5##3##(1996-7#1)(2006-12#1)(2007-9#1)(2013-1#2)
the primary outcomes##4##3##(2008-7#1)(2010-1#1)(2011-2#1)(2013-8#1)
the primary particles##2##3##(2008-3#1)(2008-5#1)
the primary pathogenic##2##3##(1992-3#1)(2008-2#1)
the primary photochemical##2##3##(2008-8#1)(2011-1#1)
the primary photoproduct##3##3##(1991-7#3)
the primary predictor##2##3##(2007-12#1)(2008-6#1)
the primary prevention of coronary##4##5##(1993-9#1)(1995-4#1)(2006-12#1)(2010-6#1)
the primary prevention of##6##4##(1993-9#1)(1995-4#1)(2006-12#1)(2009-4#1)(2010-6#1)(2010-8#1)
the primary prevention##9##3##(1993-9#1)(1995-4#1)(2006-12#1)(2006-7#1)(2008-3#1)(2009-4#1)(2010-12#1)(2010-6#1)(2010-8#1)
the primary procedure in the##2##5##(1990-11#1)(1990-2#1)
the primary procedure in##3##4##(1990-11#1)(1990-2#1)(2006-5#1)
the primary procedure##4##3##(1990-11#1)(1990-2#1)(2006-5#1)(2007-7#1)
the primary pulmonary##2##3##(2005-11#1)(2005-8#1)
the primary radiation##2##3##(2006-4#1)(2007-11#1)
the primary reason for##2##4##(1997-4#1)(1997-7#1)
the primary reasons for##2##4##(2007-11#1)(2007-12#1)
the primary reasons##3##3##(1994-5#1)(2007-11#1)(2007-12#1)
the primary response gene##2##4##(1992-12#1)(1995-2#1)
the primary role of##2##4##(1990-11#1)(2007-3#1)
the primary role##3##3##(1990-11#1)(2006-2#1)(2007-3#1)
the primary root##2##3##(2008-5#2)
the primary school##4##3##(2006-8#1)(2007-5#1)(2008-12#1)(2012-12#1)
the primary schools##2##3##(2008-10#1)(2008-3#1)
the primary sensory system##3##4##(2011-2#3)
the primary sequence of##2##4##(1991-8#1)(1992-2#1)
the primary sequence##7##3##(1991-2#1)(1991-8#1)(1992-2#1)(1993-2#2)(1993-6#1)(1995-1#1)
the primary sequences##3##3##(1992-12#1)(1995-5#1)(2006-8#1)
the primary site and##2##4##(1993-4#1)(1995-8#1)
the primary site of the##2##5##(2012-12#1)(2012-3#1)
the primary site of##7##4##(1991-2#1)(1997-6#1)(2008-10#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
the primary site##18##3##(1990-7#2)(1991-2#1)(1992-12#1)(1993-4#1)(1995-8#1)(1997-6#1)(2006-12#1)(2008-10#1)(2008-6#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
the primary somatosensory (SI)##2##4##(1992-2#1)(1995-12#1)
the primary somatosensory##3##3##(1992-2#1)(1995-12#1)(1996-1#1)
the primary source of##7##4##(1994-9#2)(1997-8#1)(2007-7#1)(2008-1#1)(2008-4#1)(2013-1#1)
the primary source##9##3##(1994-9#2)(1997-8#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2013-1#1)
the primary sources of##2##4##(2008-3#1)(2010-5#1)
the primary sources##3##3##(1992-6#1)(2008-3#1)(2010-5#1)
the primary specificity##2##3##(1992-12#1)(1994-11#1)
the primary stage##2##3##(1997-3#1)(2007-11#1)
the primary structure of Orpotrin##2##5##(2011-2#2)
the primary structure of goat Mb##2##6##(2010-4#2)
the primary structure of the enzyme##2##6##(1992-1#2)
the primary structure of the peptide##2##6##(1992-1#1)(1994-2#1)
the primary structure of the protein##2##6##(1991-9#1)(2008-10#1)
the primary structure of the##15##5##(1990-12#1)(1990-7#1)(1991-9#1)(1992-1#3)(1992-3#3)(1994-2#1)(1994-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)
the primary structure of##30##4##(1990-11#1)(1990-12#2)(1990-4#1)(1990-7#1)(1991-5#1)(1991-9#1)(1992-1#3)(1992-3#3)(1992-8#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-4#1)(1997-8#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-4#2)(2011-2#2)
the primary structure##37##3##(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-7#1)(1991-5#1)(1991-9#1)(1992-1#3)(1992-2#2)(1992-3#3)(1992-8#1)(1993-3#1)(1993-4#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-4#1)(1997-8#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-4#2)(2011-1#1)(2011-2#2)
the primary structures of##3##4##(1991-6#1)(1992-1#1)(1993-12#1)
the primary structures##4##3##(1991-6#1)(1992-1#1)(1993-12#1)(1993-3#1)
the primary success rate##3##4##(1991-3#1)(2008-12#2)
the primary success##4##3##(1991-3#1)(2006-7#1)(2008-12#2)
the primary supernumerary tooth##2##4##(2008-5#2)
the primary target of##4##4##(1996-5#1)(2008-1#1)(2008-10#1)(2011-1#1)
the primary target##8##3##(1991-12#1)(1996-5#1)(2005-7#1)(2007-1#1)(2008-1#1)(2008-10#1)(2011-1#1)(2012-2#1)
the primary targets##2##3##(1992-12#1)(2013-8#1)
the primary therapy for##2##4##(2006-10#1)(2006-9#1)
the primary tissue##2##3##(1994-3#2)
the primary treatment for this condition##2##6##(2006-5#2)
the primary treatment of##2##4##(2007-8#1)(2013-1#1)
the primary treatment##8##3##(1991-6#1)(1993-8#1)(2006-5#2)(2006-8#1)(2007-8#1)(2010-11#1)(2013-1#1)
the primary tumor and##8##4##(1992-6#1)(1993-1#1)(2008-10#1)(2010-12#2)(2010-3#2)(2011-12#1)
the primary tumor as well as##2##6##(2007-8#1)(2008-1#1)
the primary tumor in the##2##5##(2008-4#1)(2011-2#1)
the primary tumor in##3##4##(1995-10#1)(2008-4#1)(2011-2#1)
the primary tumor is##3##4##(1992-6#1)(2008-4#1)(2011-12#1)
the primary tumor to the##2##5##(1990-6#1)(2012-12#1)
the primary tumor to##3##4##(1990-6#1)(2012-12#1)(2012-2#1)
the primary tumor was##7##4##(1992-6#2)(1992-8#1)(1995-10#1)(2007-6#1)(2008-6#2)
the primary tumor##64##3##(1990-12#1)(1990-6#1)(1991-3#1)(1991-4#1)(1992-6#4)(1992-8#3)(1993-1#1)(1994-12#1)(1995-10#3)(2006-10#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#3)(2008-1#2)(2008-10#2)(2008-4#5)(2008-6#3)(2009-3#2)(2009-5#2)(2010-12#3)(2010-3#6)(2010-6#1)(2011-1#1)(2011-12#3)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
the primary tumors##3##3##(1991-9#1)(1994-12#1)(2008-8#1)
the primary tumour and##2##4##(1997-3#1)(2008-1#1)
the primary tumour was##3##4##(1995-8#1)(2006-10#2)
the primary tumour##18##3##(1990-1#1)(1991-6#1)(1995-8#2)(1997-3#1)(2004-2#1)(2006-10#4)(2008-1#1)(2008-6#1)(2009-2#1)(2009-3#1)(2011-2#1)(2011-3#1)(2013-7#1)(2013-8#1)
the primary type##2##3##(2008-11#1)(2010-6#1)
the primary visual cortex (V1)##5##5##(1995-11#1)(1995-12#1)(1997-8#1)(2008-11#1)(2012-2#1)
the primary visual cortex of adult##2##6##(1992-10#1)(1993-12#1)
the primary visual cortex of##3##5##(1992-10#1)(1993-12#1)(2008-8#1)
the primary visual cortex##11##4##(1992-10#1)(1993-12#1)(1995-11#2)(1995-12#1)(1997-7#1)(1997-8#1)(2007-9#1)(2008-11#1)(2008-8#1)(2012-2#1)
the primary visual##14##3##(1992-10#1)(1993-12#1)(1995-11#2)(1995-12#1)(1996-1#1)(1997-7#1)(1997-8#1)(2006-3#1)(2007-9#1)(2008-11#1)(2008-8#2)(2012-2#1)
the primary wear zone##3##4##(2009-7#3)
the primary##1023##2##(1990-1#1)(1990-10#2)(1990-11#4)(1990-12#4)(1990-2#2)(1990-3#2)(1990-4#3)(1990-5#6)(1990-6#1)(1990-7#4)(1990-8#2)(1990-9#1)(1991-1#3)(1991-11#2)(1991-12#3)(1991-2#3)(1991-3#5)(1991-4#4)(1991-5#5)(1991-6#9)(1991-7#9)(1991-8#4)(1991-9#3)(1992-1#7)(1992-10#1)(1992-11#2)(1992-12#6)(1992-2#7)(1992-3#7)(1992-6#17)(1992-7#2)(1992-8#5)(1992-9#2)(1993-1#2)(1993-11#5)(1993-12#3)(1993-2#7)(1993-3#5)(1993-4#2)(1993-5#3)(1993-6#4)(1993-8#3)(1993-9#5)(1994-10#2)(1994-11#4)(1994-12#8)(1994-2#4)(1994-3#4)(1994-5#5)(1994-6#2)(1994-8#3)(1994-9#6)(1995-1#4)(1995-10#5)(1995-11#7)(1995-12#7)(1995-2#3)(1995-3#4)(1995-4#4)(1995-5#4)(1995-6#3)(1995-8#7)(1995-9#4)(1996-1#4)(1996-11#1)(1996-12#10)(1996-2#1)(1996-3#4)(1996-4#2)(1996-5#9)(1996-7#4)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#11)(1997-4#6)(1997-5#2)(1997-6#3)(1997-7#8)(1997-8#4)(2004-1#2)(2004-10#1)(2004-11#1)(2004-2#1)(2004-7#1)(2005-10#2)(2005-11#1)(2005-5#1)(2005-7#4)(2005-8#6)(2005-9#1)(2006-10#20)(2006-12#5)(2006-2#6)(2006-3#3)(2006-4#2)(2006-5#16)(2006-6#1)(2006-7#5)(2006-8#4)(2006-9#4)(2007-1#7)(2007-10#3)(2007-11#18)(2007-12#16)(2007-2#3)(2007-3#2)(2007-4#4)(2007-5#5)(2007-6#4)(2007-7#10)(2007-8#19)(2007-9#5)(2008-1#17)(2008-10#61)(2008-11#21)(2008-12#11)(2008-2#18)(2008-3#24)(2008-4#18)(2008-5#27)(2008-6#12)(2008-7#18)(2008-8#19)(2008-9#14)(2009-10#5)(2009-11#5)(2009-12#2)(2009-2#1)(2009-3#11)(2009-4#3)(2009-5#10)(2009-7#3)(2009-8#4)(2009-9#1)(2010-1#4)(2010-10#2)(2010-11#5)(2010-12#10)(2010-2#2)(2010-3#7)(2010-4#4)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#10)(2011-12#7)(2011-2#30)(2011-3#3)(2012-1#3)(2012-11#2)(2012-12#12)(2012-2#17)(2012-3#8)(2013-1#26)(2013-7#4)(2013-8#19)
the primase##5##2##(1992-3#1)(1994-12#1)(1995-6#1)(2011-1#2)
the primate cortical visual system##2##5##(1995-5#2)
the primate endometrium##2##3##(1995-11#2)
the primate lineage leading to modern humans##2##7##(1997-4#2)
the primate visual system##2##4##(1995-5#2)
the primate##23##2##(1991-3#1)(1992-2#1)(1992-9#1)(1993-2#1)(1994-2#1)(1995-11#2)(1995-5#5)(1995-8#1)(1996-1#1)(1997-2#2)(1997-4#2)(2007-2#1)(2008-1#1)(2010-3#1)(2011-2#1)(2012-2#1)
the primates##2##2##(2008-8#1)(2012-2#1)
the primatised##2##2##(2007-11#2)
the prime##23##2##(1991-3#1)(1991-9#1)(1995-3#1)(1996-1#1)(1996-6#1)(2006-1#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)
the primed##3##2##(1990-3#1)(1995-2#1)(2008-11#1)
the primer layer##2##3##(2010-4#2)
the primer##18##2##(1990-5#5)(1993-3#2)(1994-12#1)(1995-5#1)(1996-4#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-4#2)(2009-7#1)(2010-4#2)
the primers used##2##3##(1997-7#1)(2008-5#1)
the primers##20##2##(1993-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-11#1)(1997-4#1)(1997-7#2)(2006-5#1)(2008-10#7)(2008-4#1)(2008-5#3)
the priming effect##3##3##(2008-2#1)(2008-4#2)
the priming##9##2##(1990-3#2)(1992-8#2)(2007-12#2)(2008-2#1)(2008-4#2)
the primitive##13##2##(1995-1#1)(1997-4#1)(2006-11#1)(2006-8#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-9#1)(2010-11#2)(2010-3#1)(2012-12#1)(2013-1#1)
the primordial germ##2##3##(2006-6#1)(2007-12#1)
the primordial##9##2##(2006-6#1)(2007-12#6)(2012-12#1)(2013-1#1)
the principal axis of##2##4##(2007-12#1)(2012-1#1)
the principal axis##4##3##(1997-4#1)(2007-12#1)(2008-3#1)(2012-1#1)
the principal basis for##2##4##(1995-4#1)(2008-3#1)
the principal cause of##3##4##(2006-10#1)(2008-2#1)(2009-2#1)
the principal cause##5##3##(2006-10#1)(2008-2#1)(2008-7#1)(2009-2#1)(2013-8#1)
the principal causes of##3##4##(1994-4#1)(2007-9#1)(2012-2#1)
the principal component analysis##2##4##(2011-2#1)(2013-8#1)
the principal component of##3##4##(1993-11#2)(2008-10#1)
the principal component##7##3##(1993-11#2)(2008-10#2)(2011-2#1)(2012-3#1)(2013-8#1)
the principal components of##2##4##(1993-11#1)(2008-6#1)
the principal components##6##3##(1993-11#1)(2008-10#1)(2008-6#1)(2010-8#1)(2012-3#2)
the principal constituent of##2##4##(2008-4#1)(2013-1#1)
the principal indices##2##3##(2007-11#1)(2008-3#1)
the principal investigators##2##3##(2010-11#1)(2012-12#1)
the principal mechanism##2##3##(1994-9#1)(2008-10#1)
the principal methods##2##3##(2008-1#1)(2012-1#1)
the principal olive##2##3##(1993-12#2)
the principal plane##4##3##(2008-2#1)(2008-3#3)
the principal preganglionic cell column##2##5##(1992-1#2)
the principal refractive indices and##3##5##(2008-2#3)
the principal refractive indices##5##4##(2008-2#4)(2008-3#1)
the principal sensory##2##3##(1996-9#2)
the principal source of##3##4##(1991-8#1)(2007-12#1)(2008-10#1)
the principal targets for##2##4##(1992-8#1)(2011-2#1)
the principal treatment##2##3##(1991-12#1)(1997-6#1)
the principal##194##2##(1990-2#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-8#2)(1991-9#1)(1992-1#3)(1992-3#2)(1992-4#1)(1992-8#1)(1993-10#1)(1993-11#4)(1993-12#2)(1993-2#1)(1993-9#1)(1994-12#2)(1994-4#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-4#2)(1995-5#1)(1995-8#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-3#2)(1997-4#2)(1997-6#3)(1997-7#1)(2004-11#2)(2005-11#1)(2005-12#1)(2005-7#3)(2005-8#2)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#1)(2006-5#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#9)(2007-2#1)(2007-7#1)(2007-9#3)(2008-1#3)(2008-10#11)(2008-11#4)(2008-12#2)(2008-2#12)(2008-3#12)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#3)(2009-10#2)(2009-2#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#4)
the principal-component##2##2##(2007-12#1)(2008-10#1)
the principle features of##2##4##(2007-11#1)(2008-10#1)
the principle for##2##3##(2008-1#1)(2013-7#1)
the principle of operation##2##4##(2007-12#1)(2007-8#1)
the principle of the##6##4##(1997-6#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)
the principle of##64##3##(1992-1#1)(1992-3#1)(1992-4#1)(1995-8#1)(1996-1#2)(1996-3#1)(1997-6#2)(1997-8#2)(2005-4#1)(2005-6#1)(2006-6#1)(2007-12#4)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#2)(2011-1#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#2)
the principle that the##3##4##(1992-2#1)(1994-9#1)(2011-2#1)
the principle that##8##3##(1992-2#1)(1994-2#1)(1994-9#1)(2008-4#2)(2008-7#1)(2011-2#1)(2012-10#1)
the principle##99##2##(1992-1#1)(1992-2#1)(1992-3#1)(1992-4#1)(1994-2#1)(1994-9#1)(1995-8#1)(1996-1#2)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-6#2)(1997-8#2)(2005-4#1)(2005-5#1)(2005-6#1)(2006-6#1)(2007-11#1)(2007-12#5)(2007-4#1)(2007-5#1)(2007-8#3)(2008-1#3)(2008-10#13)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#10)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#2)(2011-1#3)(2011-2#1)(2012-1#1)(2012-10#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#3)
the principles and practice of##2##5##(1993-12#1)(1997-3#1)
the principles and strategies##2##4##(2005-8#1)(2013-1#1)
the principles and techniques of##2##5##(1995-1#1)(2007-12#1)
the principles and##15##3##(1992-3#1)(1993-11#1)(1993-12#2)(1995-1#1)(1995-3#1)(1997-3#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-9#1)(2009-2#1)(2009-3#1)(2013-1#1)
the principles discussed##2##3##(2008-4#1)(2010-8#1)
the principles for the##2##4##(1991-9#1)(2005-7#1)
the principles for##6##3##(1991-9#1)(1993-6#1)(2005-7#1)(2007-11#1)(2007-8#1)(2013-8#1)
the principles governing##2##3##(2007-11#1)(2011-1#1)
the principles guiding##2##3##(2008-10#1)(2010-12#1)
the principles involved in##2##4##(2006-9#1)(2008-4#1)
the principles of CQI##2##4##(1993-3#1)(1994-1#1)
the principles of induction##2##4##(2011-2#2)
the principles of management of##2##5##(2012-2#2)
the principles of management##3##4##(2009-4#1)(2012-2#2)
the principles of molecular##2##4##(1997-6#1)(2010-9#1)
the principles of the##6##4##(2008-1#1)(2008-10#1)(2008-3#2)(2009-6#1)(2010-9#1)
the principles of##87##3##(1991-2#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-1#2)(1994-2#1)(1995-6#1)(1996-12#1)(1997-3#1)(1997-5#1)(1997-6#2)(2005-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#2)(2007-11#2)(2007-12#5)(2007-2#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#4)(2008-2#4)(2008-3#4)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#4)(2009-1#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-7#1)(2010-9#2)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)
the principles that##4##3##(2008-2#2)(2011-2#1)(2012-12#1)
the principles underlying the##2##4##(2006-11#1)(2007-4#1)
the principles underlying##4##3##(1995-1#1)(2006-11#1)(2007-4#1)(2008-11#1)
the principles##138##2##(1991-2#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#2)(1994-1#3)(1994-2#1)(1995-1#2)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-3#2)(1997-5#1)(1997-6#2)(1997-7#1)(2005-10#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#2)(2006-9#1)(2007-11#6)(2007-12#6)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#6)(2008-2#6)(2008-3#5)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#7)(2009-1#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#7)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#1)
the print##5##2##(1991-3#1)(2008-6#1)(2009-9#1)(2010-8#1)(2013-7#1)
the printed##3##2##(1991-5#1)(2005-11#1)(2007-12#1)
the prion protein##7##3##(1993-2#1)(1996-5#1)(2006-10#4)(2010-11#1)
the prion##13##2##(1992-7#2)(1993-2#1)(1996-3#2)(1996-5#1)(2006-10#4)(2008-11#1)(2010-11#1)(2010-12#1)
the prior PDF##2##3##(2008-2#2)
the prior##35##2##(1991-12#1)(1992-12#1)(1992-3#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#1)(1995-2#2)(1995-6#3)(1995-8#1)(1997-2#1)(2006-10#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2013-1#2)
the priorities of##3##3##(1993-3#1)(2008-7#1)(2011-2#1)
the priorities##7##2##(1991-2#1)(1993-3#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
the priority of##2##3##(2008-12#1)(2011-1#1)
the priority##13##2##(1992-5#1)(1996-1#1)(1996-12#1)(2006-4#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-4#1)(2011-1#1)(2012-12#1)(2013-1#2)
the prism##12##2##(1994-11#1)(2007-12#1)(2007-5#2)(2008-2#5)(2008-3#3)
the prismatic##4##2##(2007-12#1)(2008-2#2)(2013-1#1)
the prisms##4##2##(2008-3#4)
the prison##5##2##(2009-11#1)(2012-11#3)(2012-2#1)
the pristine##7##2##(2007-5#1)(2008-10#1)(2008-5#1)(2009-11#1)(2010-12#1)(2010-8#1)(2012-2#1)
the privacy of##5##3##(1996-5#1)(1997-5#1)(2007-11#1)(2013-1#2)
the privacy rule requirements##2##4##(2007-12#2)
the privacy rule##6##3##(2006-7#1)(2007-12#5)
the privacy##16##2##(1991-7#1)(1995-6#1)(1996-5#1)(1997-5#1)(2006-7#1)(2007-11#2)(2007-12#6)(2012-12#1)(2013-1#2)
the private and public##2##4##(1994-1#1)(1995-12#1)
the private health##5##3##(1990-12#1)(1991-2#1)(1992-2#1)(2013-8#2)
the private market##2##3##(1994-1#1)(2010-1#1)
the private practice##2##3##(2008-10#1)(2012-3#1)
the private sector and##3##4##(1997-3#1)(2013-1#2)
the private sector##37##3##(1990-12#1)(1991-1#1)(1992-3#1)(1993-2#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-3#1)(1997-3#1)(1997-5#5)(2005-5#3)(2006-10#4)(2007-2#1)(2007-7#1)(2008-1#2)(2008-6#1)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#2)
the private##67##2##(1990-12#3)(1990-6#1)(1991-1#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-5#5)(2005-5#3)(2006-10#4)(2006-2#3)(2006-5#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#2)
the privileged##2##2##(2008-1#1)(2009-10#1)
the privileges against disclosure##2##4##(1991-12#1)(1992-3#1)
the prize##2##2##(2007-9#1)(2010-8#1)
the pro##3##2##(1995-3#1)(1995-6#2)
the pro- and##2##3##(2006-10#1)(2008-4#1)
the pro-R oxygen##3##3##(1996-7#3)
the pro-R##4##2##(1994-11#1)(1996-7#3)
the pro-S hydrogen##2##3##(1992-1#1)(1996-7#1)
the pro-S oxygen##3##3##(1996-7#3)
the pro-S##5##2##(1992-1#1)(1996-7#4)
the pro-apoptotic protein##2##3##(2009-12#1)(2010-12#1)
the pro-apoptotic##6##2##(2007-8#1)(2009-12#2)(2010-12#1)(2012-12#2)
the pro-domain##2##2##(2008-4#2)
the pro-inflammatory cytokine##2##3##(1995-12#1)(2008-10#1)
the pro-inflammatory cytokines##2##3##(2008-10#1)(2010-1#1)
the pro-inflammatory##9##2##(1995-12#1)(2008-10#3)(2008-11#2)(2010-1#1)(2010-5#1)(2013-1#1)
the pro-oocyte##2##2##(1991-11#2)
the pro-opiomelanocortin##3##2##(1991-5#1)(1991-9#1)(2006-12#1)
the pro-oxidant properties of##2##4##(1992-4#1)(1997-8#1)
the pro-oxidant##4##2##(1992-4#1)(1997-8#2)(2008-1#1)
the pro-peptide##5##2##(1990-5#4)(1993-3#1)
the proU##4##2##(1994-12#4)
the proacrosin##6##2##(1990-5#1)(1992-4#5)
the proapoptotic##3##2##(2008-11#1)(2010-1#1)(2010-12#1)
the probabilistic##4##2##(2005-10#1)(2007-7#1)(2010-6#1)(2012-2#1)
the probabilities of##10##3##(1990-3#1)(1991-4#2)(1994-6#1)(2004-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-12#1)
the probabilities##15##2##(1990-3#1)(1991-4#2)(1994-11#1)(1994-6#1)(2004-11#1)(2005-4#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-12#2)(2012-3#1)
the probability and##2##3##(1994-7#1)(2010-4#1)
the probability density function of the##3##6##(2008-2#1)(2008-3#2)
the probability density function##5##4##(2008-2#2)(2008-3#2)(2013-1#1)
the probability density functions of the residence time##3##8##(2007-9#3)
the probability density##9##3##(2007-9#3)(2008-2#3)(2008-3#2)(2013-1#1)
the probability distribution##4##3##(2007-12#2)(2009-4#2)
the probability distributions##2##3##(2008-10#1)(2008-2#1)
the probability for##3##3##(2007-11#1)(2008-11#2)
the probability of a##9##4##(1993-8#1)(1996-3#1)(2004-12#1)(2007-9#1)(2008-10#2)(2008-9#1)(2009-4#1)(2012-3#1)
the probability of an##2##4##(1995-12#1)(2007-10#1)
the probability of applying##2##4##(2007-5#2)
the probability of being##5##4##(1995-8#1)(1996-7#1)(2008-8#1)(2010-2#1)(2010-8#1)
the probability of detecting##3##4##(1994-2#1)(1996-5#1)(2012-12#1)
the probability of developing##5##4##(1992-9#2)(1993-5#1)(2008-4#1)(2012-3#1)
the probability of discordant classification##2##5##(1997-3#2)
the probability of each##2##4##(2008-7#1)(2010-11#1)
the probability of having##3##4##(1990-5#1)(2005-7#1)(2009-6#1)
the probability of head injury##2##5##(2007-4#2)
the probability of hospitalization##2##4##(1995-2#1)(2008-7#1)
the probability of mortality##3##4##(1997-4#1)(2008-10#2)
the probability of occurrence##3##4##(1997-4#1)(2009-10#1)(2009-8#1)
the probability of offspring survival##2##5##(2008-8#1)(2008-9#1)
the probability of photon##2##4##(2008-2#1)(2008-3#1)
the probability of reaching the##2##5##(2008-11#1)(2011-2#1)
the probability of reinforcers for##2##5##(2011-2#2)
the probability of success##2##4##(1991-9#1)(2010-8#1)
the probability of surgery##2##4##(2012-3#2)
the probability of survival##3##4##(2006-10#1)(2006-4#1)(2008-7#1)
the probability of##143##3##(1990-10#1)(1990-11#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-9#2)(1992-2#1)(1992-5#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-5#2)(1993-7#1)(1993-8#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-12#4)(1995-2#2)(1995-8#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-3#2)(1997-4#3)(2004-12#1)(2005-7#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#2)(2007-9#1)(2008-1#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-7#7)(2008-8#8)(2008-9#6)(2009-10#2)(2009-12#2)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#2)(2012-3#6)(2013-1#1)(2013-8#1)
the probability that a tick infects the##2##7##(2013-8#2)
the probability that a##10##4##(1993-9#1)(1994-3#1)(1997-4#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2013-7#1)(2013-8#2)
the probability that an##2##4##(2008-10#1)(2012-3#1)
the probability that caregivers##2##4##(1991-12#2)
the probability that the##6##4##(1995-12#1)(1997-2#1)(2006-10#3)(2008-9#1)
the probability that this##2##4##(2008-2#1)(2008-7#1)
the probability that##36##3##(1991-12#2)(1993-9#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-6#4)(1995-8#1)(1997-2#1)(1997-4#1)(1997-9#1)(2006-10#3)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#2)(2008-9#2)(2012-3#2)(2013-7#1)(2013-8#2)
the probability##209##2##(1990-10#1)(1990-11#1)(1990-5#1)(1990-8#1)(1991-12#3)(1991-4#1)(1991-9#2)(1992-2#1)(1992-5#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-5#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-12#6)(1995-2#2)(1995-6#4)(1995-8#2)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#2)(1997-4#4)(1997-9#1)(2004-12#1)(2005-7#1)(2006-10#4)(2006-4#1)(2006-5#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#3)(2007-9#4)(2008-1#1)(2008-10#22)(2008-11#6)(2008-12#1)(2008-2#9)(2008-3#6)(2008-4#2)(2008-7#11)(2008-8#10)(2008-9#8)(2009-10#2)(2009-12#2)(2009-4#4)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#2)(2012-3#8)(2013-1#2)(2013-7#1)(2013-8#3)
the probability-density function##2##3##(2007-12#1)(2008-6#1)
the probability-density##3##2##(2007-12#1)(2008-2#1)(2008-6#1)
the probable cause of##2##4##(1991-5#1)(2006-10#1)
the probable##27##2##(1990-5#1)(1991-11#1)(1991-4#1)(1991-5#1)(1992-9#1)(1993-10#1)(1995-12#1)(1995-3#1)(1995-8#1)(2004-11#1)(2006-1#1)(2006-10#1)(2006-2#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-6#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-2#3)(2013-8#1)
the probably##5##2##(1992-3#1)(2007-12#1)(2007-7#1)(2008-11#1)(2012-3#1)
the proband and##2##3##(2006-7#1)(2009-4#1)
the proband##10##2##(1991-12#2)(1993-3#1)(2006-7#1)(2008-11#1)(2009-4#1)(2010-2#1)(2010-3#1)(2012-12#1)(2012-3#1)
the proband's father##2##3##(2007-12#2)
the proband's##6##2##(1994-2#1)(1995-11#1)(2007-12#3)(2012-12#1)
the probands##5##2##(1990-9#1)(1991-11#2)(1994-2#1)(1995-11#1)
the probands'##2##2##(1996-5#1)(1997-2#1)
the probe DNA##2##3##(2008-10#1)(2008-5#1)
the probe and the##4##4##(2007-11#1)(2008-1#1)(2008-3#1)(2008-7#1)
the probe and##11##3##(1996-5#1)(1996-7#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2012-1#1)
the probe beam##11##3##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#6)
the probe cross-sectional area##2##4##(2008-3#2)
the probe for##2##3##(1992-7#1)(1996-3#1)
the probe is##9##3##(1992-11#1)(2006-10#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-2#2)(2010-2#1)(2010-5#1)
the probe laser##2##3##(2007-12#2)
the probe of##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
the probe particle##2##3##(2005-11#1)(2008-1#1)
the probe pulse##5##3##(2007-11#1)(2007-12#4)
the probe tip##4##3##(1996-5#1)(2007-12#1)(2008-2#1)(2011-1#1)
the probe to produce##2##4##(2007-11#1)(2012-3#1)
the probe to the##4##4##(1992-6#2)(2008-1#1)(2008-4#1)
the probe to##11##3##(1992-6#3)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-3#1)(2008-4#1)(2011-1#1)(2012-3#1)
the probe volume##3##3##(2008-3#3)
the probe##146##2##(1990-10#1)(1990-11#2)(1990-5#2)(1990-9#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-11#2)(1992-3#1)(1992-6#6)(1992-7#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-3#1)(1996-5#2)(1996-7#1)(1997-1#1)(1997-3#3)(1997-7#1)(2005-11#2)(2006-10#3)(2006-12#2)(2006-6#1)(2007-11#5)(2007-12#16)(2007-5#2)(2007-9#1)(2008-1#4)(2008-10#19)(2008-12#1)(2008-2#10)(2008-3#24)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#3)(2009-2#1)(2010-2#2)(2010-5#2)(2011-1#2)(2012-1#1)(2012-3#1)
the probed##3##2##(1997-6#1)(2011-1#2)
the probes were##2##3##(1992-8#1)(2008-5#1)
the probes##22##2##(1990-4#1)(1990-5#1)(1992-11#1)(1992-8#1)(1994-1#1)(1994-2#1)(1994-3#1)(2008-10#4)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-5#2)
the probing of##6##3##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2011-1#1)
the probing##10##2##(2007-11#2)(2008-10#1)(2008-2#3)(2008-3#1)(2011-1#1)(2012-12#1)(2013-8#1)
the probiotic##14##2##(2007-3#5)(2009-11#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#3)
the problem and its##2##4##(2007-8#1)(2009-6#1)
the problem and the##3##4##(1995-1#2)(2008-8#1)
the problem and##16##3##(1994-1#1)(1995-1#2)(2005-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-6#1)(2012-1#1)(2012-12#1)
the problem are##2##3##(2005-11#1)(2010-11#1)
the problem as##2##3##(1990-5#1)(1995-5#1)
the problem based##2##3##(2008-11#1)(2008-2#1)
the problem by using##2##4##(2008-2#1)(2008-3#1)
the problem by##8##3##(1995-2#1)(2008-10#1)(2008-2#2)(2008-3#2)(2009-4#1)(2012-3#1)
the problem can be##2##4##(1992-9#1)(2011-2#1)
the problem concerning the##2##4##(1990-2#1)(2011-2#1)
the problem for##3##3##(2007-12#1)(2008-3#1)(2009-4#1)
the problem has##4##3##(1997-4#1)(2007-11#1)(2008-3#1)(2013-1#1)
the problem in a##2##4##(1997-6#1)(2012-2#1)
the problem in terms of##2##5##(2008-1#1)(2009-4#1)
the problem in##14##3##(1993-11#1)(1995-1#1)(1997-6#1)(2004-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2008-1#1)(2008-10#1)(2009-4#1)(2009-6#1)(2011-2#1)(2012-2#1)
the problem is a##2##4##(2010-9#1)(2012-12#1)
the problem is compounded##2##4##(2008-9#1)(2010-3#1)
the problem is not##2##4##(2008-7#1)(2009-9#1)
the problem is the##2##4##(2005-1#1)(2008-5#1)
the problem is##26##3##(1991-12#1)(1992-1#1)(1992-8#1)(2005-1#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-6#1)(2009-9#1)(2010-3#1)(2010-9#1)(2011-2#3)(2012-12#1)(2013-1#1)
the problem list is a centralized place where healthcare providers can summarize key clinical information about patients##2##17##(2013-1#2)
the problem of computing##2##4##(2008-2#1)(2008-3#1)
the problem of delay in seeking##2##6##(2007-6#2)
the problem of designing##2##4##(2008-2#1)(2010-8#1)
the problem of detecting##2##4##(1997-7#1)(2009-2#1)
the problem of determining##3##4##(1993-1#1)(1994-11#1)(2008-10#1)
the problem of efficient##2##4##(2008-5#1)(2010-4#1)
the problem of estimating##2##4##(2008-2#1)(2013-7#1)
the problem of finding a##2##5##(1992-6#1)(2013-8#1)
the problem of finding the##2##5##(1994-8#1)(2006-10#1)
the problem of finding##7##4##(1992-6#1)(1994-8#1)(2006-10#2)(2008-10#1)(2008-11#1)(2013-8#1)
the problem of global##2##4##(2008-2#1)(2008-7#1)
the problem of how to##3##5##(1994-2#1)(2008-2#1)(2009-2#1)
the problem of how##4##4##(1993-6#1)(1994-2#1)(2008-2#1)(2009-2#1)
the problem of identifying##3##4##(2004-12#1)(2006-6#1)(2008-7#1)
the problem of low##3##4##(2006-6#2)(2008-10#1)
the problem of protein##2##4##(1991-6#1)(2008-7#1)
the problem of reconstructing a##2##5##(2008-2#1)(2011-3#1)
the problem of reconstructing##4##4##(2008-2#1)(2008-3#2)(2011-3#1)
the problem of representing a##2##5##(2007-5#1)(2008-7#1)
the problem of representing##3##4##(2007-11#1)(2007-5#1)(2008-7#1)
the problem of synthesizing a##2##5##(2007-12#1)(2008-6#1)
the problem of testing the##2##5##(1995-8#1)(2009-9#1)
the problem of the##14##4##(1991-4#1)(1993-2#1)(1994-6#1)(1995-5#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-8#1)(2011-1#1)(2013-1#2)
the problem of their##2##4##(1996-3#1)(2007-11#1)
the problem of tobacco use##2##5##(1997-1#1)(2010-9#1)
the problem of##233##3##(1990-10#1)(1990-12#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-4#2)(1991-6#3)(1991-9#2)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#4)(1994-8#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-2#1)(1996-3#3)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#3)(1997-5#1)(1997-7#2)(2004-10#2)(2004-12#1)(2004-7#1)(2005-11#3)(2005-8#1)(2005-9#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-6#5)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#8)(2007-12#8)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#4)(2007-6#4)(2007-7#4)(2007-8#2)(2008-1#4)(2008-10#10)(2008-11#4)(2008-12#3)(2008-2#16)(2008-3#12)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#8)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#2)(2010-3#1)(2010-4#2)(2010-8#2)(2010-9#2)(2011-1#3)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#8)(2013-7#2)(2013-8#3)
the problem that##6##3##(1993-12#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-3#2)
the problem to##2##3##(1992-6#1)(1997-5#1)
the problem under##3##3##(2007-9#1)(2008-3#1)(2013-8#1)
the problem was##4##3##(1993-7#1)(2006-7#1)(2008-10#1)(2011-2#1)
the problem with##4##3##(2006-3#1)(2007-3#1)(2008-10#1)(2012-2#1)
the problem would##2##3##(2007-10#1)(2008-11#1)
the problem-solving##2##2##(2008-10#1)(2010-11#1)
the problem]##3##2##(1991-6#1)(2011-2#1)(2013-1#1)
the problematic##9##2##(1994-5#1)(1995-1#1)(2008-12#1)(2008-2#1)(2008-9#1)(2011-1#1)(2011-12#2)(2011-2#1)
the problems and issues##3##4##(1995-3#1)(1997-2#1)(2013-8#1)
the problems and solutions##2##4##(1996-2#1)(2012-1#1)
the problems and the##2##4##(1993-8#1)(1996-2#1)
the problems and##12##3##(1993-8#1)(1995-3#1)(1995-8#1)(1996-2#2)(1997-2#1)(2008-11#1)(2008-8#1)(2010-11#1)(2012-1#1)(2013-1#1)(2013-8#1)
the problems associated with the##4##5##(1992-3#1)(1993-1#1)(2008-2#1)(2010-6#1)
the problems associated with this##2##5##(2007-9#1)(2008-4#1)
the problems associated with using##2##5##(2007-8#1)(2009-5#1)
the problems associated with##18##4##(1992-3#1)(1993-1#1)(2005-11#1)(2005-5#1)(2006-5#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)
the problems due to##2##4##(1990-3#1)(2010-4#1)
the problems encountered in##5##4##(1993-9#1)(2007-11#1)(2007-7#1)(2008-7#1)(2008-9#1)
the problems encountered##9##3##(1990-9#1)(1993-9#1)(2005-7#1)(2007-11#1)(2007-7#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)
the problems faced by##3##4##(2007-11#1)(2008-11#1)(2008-6#1)
the problems faced##4##3##(2007-11#1)(2008-1#1)(2008-11#1)(2008-6#1)
the problems facing the##2##4##(2005-8#2)
the problems facing##3##3##(2005-8#2)(2007-4#1)
the problems in##7##3##(1990-6#1)(1994-2#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-10#1)(2011-2#1)
the problems inherent in##3##4##(1993-3#1)(2008-6#1)(2011-2#1)
the problems involved in##2##4##(2005-8#1)(2008-12#1)
the problems listed##2##3##(1994-3#1)(2008-9#1)
the problems of diagnosis and##2##5##(1993-9#1)(2008-1#1)
the problems of drug##2##4##(1990-11#1)(2007-6#1)
the problems of the##4##4##(1990-5#1)(1991-3#1)(1993-12#1)(1994-2#1)
the problems of##49##3##(1990-11#1)(1990-5#1)(1991-3#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-1#1)(1994-2#2)(1994-6#1)(1994-8#1)(1996-1#1)(1996-3#1)(1997-5#1)(2005-4#1)(2005-7#1)(2006-10#4)(2006-6#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-2#1)(2013-1#2)(2013-8#2)
the problems or##2##3##(2010-4#1)(2012-2#1)
the problems related to##4##4##(1993-5#1)(2007-7#1)(2008-3#1)(2008-8#1)
the problems related##5##3##(1993-5#1)(2007-7#1)(2008-3#1)(2008-8#1)(2010-7#1)
the problems relating to the##2##5##(1992-5#1)(2011-2#1)
the problems that would##2##4##(1990-2#1)(1991-12#1)
the problems that##10##3##(1990-12#1)(1990-2#1)(1991-12#1)(1993-3#1)(1995-11#1)(2008-1#1)(2008-2#1)(2008-7#1)(2010-6#1)(2011-2#1)
the problems they cause##2##4##(2006-10#2)
the problems which##2##3##(1992-10#1)(2007-10#1)
the problems with##4##3##(1997-5#1)(2007-11#1)(2010-12#1)(2010-8#1)
the problems##171##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#2)(1990-9#1)(1991-12#2)(1991-3#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#2)(1993-8#1)(1993-9#2)(1994-1#1)(1994-2#3)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-2#3)(1996-3#2)(1996-6#1)(1997-2#1)(1997-5#2)(2005-10#1)(2005-11#1)(2005-4#1)(2005-5#1)(2005-7#2)(2005-8#3)(2006-10#6)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#6)(2007-4#1)(2007-6#1)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#9)(2008-12#3)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#4)(2008-7#5)(2008-8#2)(2008-9#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#3)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#9)(2012-1#1)(2012-2#2)(2013-1#3)(2013-8#3)
the proboscis##4##2##(1994-8#1)(2007-12#2)(2008-4#1)
the procapsid##2##2##(1995-1#2)
the procathepsin L recognition##2##4##(1995-6#2)
the procathepsin L##3##3##(1995-6#3)
the procedural##6##2##(1991-6#1)(2005-8#1)(2007-8#1)(2008-2#1)(2008-7#1)(2012-1#1)
the procedure and its##4##4##(2006-5#1)(2006-8#1)(2008-1#1)(2008-4#1)
the procedure and the##5##4##(2006-8#1)(2007-6#1)(2007-7#1)(2012-2#1)(2013-8#1)
the procedure and there##2##4##(2007-12#1)(2008-7#1)
the procedure and##31##3##(1992-12#1)(1993-5#1)(1994-11#1)(1995-12#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-8#4)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#1)
the procedure applied##2##3##(1991-10#1)(2008-10#1)
the procedure are##4##3##(2006-12#1)(2006-8#2)(2008-3#1)
the procedure as##6##3##(1996-12#2)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#1)
the procedure being##3##3##(2006-7#1)(2013-1#2)
the procedure by##4##3##(1996-8#1)(2006-10#2)(2008-10#1)
the procedure can be##2##4##(2008-2#1)(2010-5#1)
the procedure can##4##3##(2008-10#2)(2008-2#1)(2010-5#1)
the procedure could be##3##4##(1996-9#1)(2008-5#1)(2009-8#1)
the procedure could##4##3##(1996-9#1)(2008-10#1)(2008-5#1)(2009-8#1)
the procedure developed##4##3##(1994-12#1)(2007-10#1)(2008-10#1)(2008-9#1)
the procedure for conducting##2##4##(1996-6#1)(2010-11#1)
the procedure for issuance of a DNR order##2##8##(1992-12#1)(1992-3#1)
the procedure for its##2##4##(2008-10#1)(2008-3#1)
the procedure for the##2##4##(2005-4#1)(2007-8#1)
the procedure for##28##3##(1992-12#1)(1992-3#1)(1994-11#1)(1996-6#1)(2005-4#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#4)(2008-6#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-12#1)(2012-1#1)(2012-12#1)
the procedure has##4##3##(1991-12#1)(2006-9#1)(2007-5#1)(2007-7#1)
the procedure in the##3##4##(2006-11#1)(2008-3#1)(2008-6#1)
the procedure in##13##3##(1990-8#1)(1997-3#2)(2006-10#1)(2006-11#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2013-1#1)
the procedure involving##3##3##(1991-3#1)(2008-10#2)
the procedure is carried out##2##5##(2006-8#1)(2008-7#1)
the procedure is not##2##4##(2008-10#2)
the procedure is performed##2##4##(1996-3#1)(2006-10#1)
the procedure is##34##3##(1996-12#1)(1996-3#1)(2006-10#1)(2006-6#2)(2006-8#1)(2007-3#1)(2007-9#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-7#1)(2008-9#2)(2010-12#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#1)
the procedure may##2##3##(2006-5#1)(2011-1#1)
the procedure more##2##3##(2006-6#1)(2010-7#1)
the procedure of choice for##3##5##(1996-11#1)(2008-5#1)(2010-10#1)
the procedure of choice in##3##5##(2008-11#1)(2009-5#1)(2011-2#1)
the procedure of choice##12##4##(1996-11#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
the procedure of##22##3##(1996-11#1)(1996-8#1)(2006-9#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
the procedure or the##2##4##(2006-12#1)(2006-8#1)
the procedure or##6##3##(1995-3#1)(2006-12#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-9#1)
the procedure proposed##2##3##(2008-10#1)(2011-1#1)
the procedure the##3##3##(1990-8#1)(2007-5#1)(2013-1#1)
the procedure to be##3##4##(1992-12#1)(1992-8#1)(2005-12#1)
the procedure to##11##3##(1992-12#1)(1992-8#1)(1993-3#1)(1996-11#1)(2005-11#1)(2005-12#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-5#1)
the procedure used##3##3##(1995-8#1)(1996-1#1)(2007-11#1)
the procedure using##2##3##(2007-12#1)(2012-12#1)
the procedure was carried out##2##5##(1991-8#1)(2008-10#1)
the procedure was performed##4##4##(1991-11#1)(1995-12#1)(2006-5#1)(2008-10#1)
the procedure was##32##3##(1990-4#1)(1990-7#1)(1991-11#1)(1991-8#1)(1993-12#1)(1995-12#2)(1997-8#1)(2004-10#1)(2006-10#1)(2006-5#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#10)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
the procedure were##4##3##(2008-10#3)(2011-2#1)
the procedure with##2##3##(1997-3#1)(2008-10#1)
the procedure##440##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#2)(1992-12#4)(1992-2#1)(1992-3#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#1)(1994-11#2)(1994-12#3)(1994-6#1)(1994-9#1)(1995-12#5)(1995-3#1)(1995-8#2)(1996-1#1)(1996-11#2)(1996-12#8)(1996-3#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-3#4)(1997-8#3)(2004-10#5)(2004-11#1)(2004-2#2)(2005-11#3)(2005-12#2)(2005-4#1)(2006-1#1)(2006-10#15)(2006-11#3)(2006-12#2)(2006-3#2)(2006-4#2)(2006-5#5)(2006-6#10)(2006-7#3)(2006-8#12)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#2)(2007-3#2)(2007-5#4)(2007-6#3)(2007-7#11)(2007-8#20)(2007-9#5)(2008-1#4)(2008-10#59)(2008-11#10)(2008-12#1)(2008-2#9)(2008-3#12)(2008-4#12)(2008-5#9)(2008-6#3)(2008-7#14)(2008-8#3)(2008-9#6)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#2)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#5)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#4)(2010-8#1)(2011-1#7)(2011-2#19)(2011-3#1)(2012-1#2)(2012-12#12)(2012-2#11)(2012-3#2)(2013-1#13)(2013-7#1)(2013-8#4)
the procedures and##5##3##(1993-10#1)(2008-6#1)(2010-9#1)(2011-2#1)(2012-1#1)
the procedures are##5##3##(1994-7#1)(2006-1#1)(2006-6#1)(2008-4#1)(2010-6#1)
the procedures described##2##3##(1992-12#1)(2008-4#1)
the procedures for##6##3##(1991-1#1)(1991-2#1)(2007-10#1)(2008-1#1)(2008-10#1)(2012-3#1)
the procedures in##4##3##(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#1)
the procedures of##2##3##(1992-9#1)(2008-7#1)
the procedures required to##2##4##(2008-4#1)(2010-2#1)
the procedures that##5##3##(1995-3#1)(2007-11#1)(2007-2#1)(2008-4#1)(2010-6#1)
the procedures to be##2##4##(1990-4#1)(1996-6#1)
the procedures used by##2##4##(1991-12#1)(2007-1#1)
the procedures used in##3##4##(2008-1#1)(2008-3#1)(2008-7#1)
the procedures used##9##3##(1991-12#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-7#2)(2010-6#1)
the procedures were##5##3##(1996-11#1)(1996-3#1)(2006-5#1)(2008-4#1)(2011-3#1)
the procedures with##2##3##(1995-4#1)(2012-3#1)
the procedures##94##2##(1990-2#1)(1990-4#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-9#1)(1993-10#1)(1993-2#1)(1994-1#1)(1994-7#1)(1995-3#1)(1995-4#1)(1996-11#2)(1996-3#1)(1996-6#1)(1997-2#2)(1997-7#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#3)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-2#1)(2008-3#2)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#2)(2009-3#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-6#3)(2010-8#2)(2010-9#1)(2011-2#2)(2011-3#2)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#2)
the proceedings of the##4##4##(1993-11#1)(2005-7#1)(2008-5#1)(2011-2#1)
the proceedings of##5##3##(1993-11#1)(2005-7#1)(2008-12#1)(2008-5#1)(2011-2#1)
the proceedings##9##2##(1993-11#1)(1995-6#1)(2005-7#1)(2007-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)
the process and outcome##2##4##(2008-12#1)(2008-9#1)
the process and outcomes of##2##5##(1994-2#1)(2012-12#1)
the process and##28##3##(1991-1#1)(1992-6#1)(1994-1#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-5#1)(2005-11#1)(2005-4#1)(2005-7#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-12#2)(2012-2#1)
the process are##4##3##(2007-3#1)(2008-11#1)(2008-9#1)(2012-12#1)
the process as##2##3##(1992-3#1)(2008-10#1)
the process at the##2##4##(2006-9#1)(2008-10#1)
the process by which a##2##5##(2008-11#1)(2010-10#1)
the process by which the##3##5##(2007-12#1)(2008-4#1)(2010-4#1)
the process by which##21##4##(1991-12#1)(1991-4#1)(1992-1#1)(1993-3#1)(1993-9#1)(1995-2#1)(2006-10#2)(2006-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2010-10#1)(2010-4#1)(2011-2#1)
the process by##27##3##(1991-12#1)(1991-4#1)(1992-1#1)(1993-3#1)(1993-9#1)(1995-2#1)(1996-6#1)(2006-10#2)(2006-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-4#2)(2008-5#2)(2010-10#1)(2010-4#1)(2011-2#1)
the process can be##2##4##(2007-8#1)(2008-10#1)
the process can##3##3##(2007-8#1)(2008-10#1)(2008-7#1)
the process does not##3##4##(2007-2#1)(2011-1#1)(2011-2#1)
the process even##2##3##(1993-12#1)(2006-12#1)
the process for the##2##4##(1994-12#1)(2008-11#1)
the process for##8##3##(1994-12#2)(1996-2#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-11#2)
the process has been developed##2##5##(2008-6#1)(2010-8#1)
the process has been##3##4##(1995-1#1)(2008-6#1)(2010-8#1)
the process has##5##3##(1993-3#1)(1995-1#1)(2008-5#1)(2008-6#1)(2010-8#1)
the process in##4##3##(2005-11#1)(2007-12#1)(2008-10#2)
the process involves##2##3##(1994-11#1)(2009-3#1)
the process is independent of##2##5##(1990-2#1)(1994-9#1)
the process is##12##3##(1990-2#1)(1992-2#1)(1994-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#2)(2013-1#1)
the process itself##2##3##(2008-3#1)(2011-2#1)
the process leading to##4##4##(1990-11#1)(1990-5#1)(1996-8#1)(2011-2#1)
the process may be##4##4##(2005-7#1)(2007-3#1)(2008-2#1)(2008-8#1)
the process of adaptation to##3##5##(2009-6#1)(2012-1#1)(2012-3#1)
the process of adaptation##4##4##(2008-1#1)(2009-6#1)(2012-1#1)(2012-3#1)
the process of aging##3##4##(1992-9#1)(1993-12#1)(2008-7#1)
the process of an##2##4##(2008-10#1)(2012-1#1)
the process of assembly##3##4##(1995-2#2)(2009-11#1)
the process of bone##5##4##(2005-2#1)(2007-11#3)(2007-8#1)
the process of building##2##4##(2009-7#1)(2011-1#1)
the process of care and##2##5##(1996-3#2)
the process of care related to acute coronary##3##8##(2008-3#3)
the process of care##7##4##(1996-3#2)(1997-1#1)(2008-3#4)
the process of change##3##4##(1990-5#1)(2008-11#1)(2008-12#1)
the process of chronic##2##4##(1995-2#1)(2012-2#1)
the process of clinical data annotation is both time consuming and costly##2##12##(2013-1#2)
the process of clinical##3##4##(1996-7#1)(2013-1#2)
the process of conscious##2##4##(1994-2#1)(2012-3#1)
the process of consent##2##4##(2006-3#2)
the process of conversion##2##4##(2006-3#1)(2007-12#1)
the process of data##2##4##(1993-12#1)(2008-7#1)
the process of designing##2##4##(2012-12#1)(2012-3#1)
the process of determining##4##4##(2007-4#1)(2008-11#1)(2008-4#1)(2008-9#1)
the process of developing a##4##5##(2006-5#1)(2006-7#1)(2007-10#1)(2007-4#1)
the process of developing##7##4##(1995-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-4#1)(2007-7#1)
the process of development##2##4##(2005-7#1)(2009-12#1)
the process of diagnosing##2##4##(2006-7#1)(2010-7#1)
the process of drug##2##4##(1997-4#1)(2008-4#1)
the process of establishing##2##4##(2007-2#1)(2008-10#1)
the process of fertilization##2##4##(1996-4#1)(2008-8#1)
the process of finding##3##4##(2008-3#1)(2008-7#1)(2009-4#1)
the process of health care##2##5##(1996-3#1)(2013-1#1)
the process of hepatocarcinogenesis##2##4##(2006-10#1)(2010-12#1)
the process of hologram formation##3##5##(2008-2#3)
the process of improving##2##4##(1996-2#1)(1997-4#1)
the process of innovation##2##4##(2007-4#1)(2009-7#1)
the process of internalization##2##4##(2006-7#2)
the process of light##2##4##(2006-8#1)(2008-3#1)
the process of map##2##4##(1991-3#1)(1997-8#1)
the process of medical staff credentialing##2##6##(1993-12#2)
the process of medical##4##4##(1993-12#2)(2012-3#1)(2013-7#1)
the process of medication##3##4##(2007-12#1)(2013-1#2)
the process of metastasis##2##4##(1991-7#1)(2009-3#1)
the process of myocardial##2##4##(1994-11#1)(2013-8#1)
the process of neuronal##2##4##(1994-2#1)(2006-3#1)
the process of obtaining##2##4##(2006-6#1)(2010-6#1)
the process of planning##2##4##(2008-11#1)(2008-2#1)
the process of preparing##2##4##(2008-11#1)(2011-1#1)
the process of production of##2##5##(2008-10#1)(2012-2#1)
the process of protein##2##4##(1995-4#1)(2012-1#1)
the process of reflection##2##4##(2008-11#1)(2008-12#1)
the process of spermatogenesis##3##4##(2007-12#1)(2008-4#1)(2011-1#1)
the process of the##8##4##(1994-7#1)(1994-8#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-8#1)(2011-2#1)(2012-3#1)
the process of tissue##2##4##(2006-6#1)(2007-12#1)
the process of transformation##2##4##(2006-11#1)(2012-2#1)
the process of using##2##4##(1995-2#1)(2012-3#1)
the process of water##2##4##(1991-5#1)(2008-10#1)
the process of writing##2##4##(2009-4#1)(2012-1#1)
the process of##444##3##(1990-11#1)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#1)(1992-7#1)(1992-9#3)(1993-11#1)(1993-12#5)(1993-3#2)(1993-6#3)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#3)(1995-7#1)(1996-1#2)(1996-10#1)(1996-12#2)(1996-2#3)(1996-3#4)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#2)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#2)(2004-3#1)(2005-10#2)(2005-11#5)(2005-2#1)(2005-7#1)(2006-10#4)(2006-11#2)(2006-12#1)(2006-2#2)(2006-3#5)(2006-5#3)(2006-6#4)(2006-7#4)(2006-8#4)(2006-9#2)(2007-10#6)(2007-11#12)(2007-12#13)(2007-2#4)(2007-4#6)(2007-7#4)(2007-8#8)(2007-9#2)(2008-1#9)(2008-10#18)(2008-11#23)(2008-12#12)(2008-2#10)(2008-3#12)(2008-4#6)(2008-5#11)(2008-6#2)(2008-7#7)(2008-8#12)(2008-9#10)(2009-11#2)(2009-12#5)(2009-2#1)(2009-3#4)(2009-4#5)(2009-6#1)(2009-7#3)(2009-8#3)(2010-10#1)(2010-12#1)(2010-2#4)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#9)(2011-12#2)(2011-2#8)(2012-1#4)(2012-11#1)(2012-12#8)(2012-2#12)(2012-3#14)(2013-1#13)(2013-7#4)(2013-8#7)
the process that##9##3##(1995-1#1)(1995-3#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-5#2)(2009-8#1)(2012-2#1)
the process the##4##3##(1996-7#1)(2007-12#1)(2008-11#1)(2008-3#1)
the process through which##3##4##(1993-12#1)(1996-12#1)(2011-2#1)
the process through##4##3##(1993-12#1)(1996-12#1)(2005-11#1)(2011-2#1)
the process to##6##3##(2007-2#1)(2007-4#1)(2008-5#1)(2012-2#1)(2013-1#2)
the process under##2##3##(1997-2#1)(2008-3#1)
the process used in##2##4##(1996-2#1)(2006-8#1)
the process used to develop##3##5##(1994-1#1)(1996-2#2)
the process used to##5##4##(1994-1#1)(1995-1#1)(1996-2#2)(2009-9#1)
the process used##9##3##(1992-2#1)(1994-1#1)(1995-1#1)(1996-12#1)(1996-2#3)(2006-8#1)(2009-9#1)
the process was##9##3##(2005-11#1)(2007-1#1)(2008-10#2)(2008-5#3)(2008-6#1)(2013-7#1)
the process with##2##3##(2008-12#1)(2008-5#1)
the process##771##2##(1990-11#3)(1990-2#2)(1990-3#2)(1990-5#3)(1990-6#2)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-1#3)(1992-11#1)(1992-12#1)(1992-2#5)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#3)(1992-7#1)(1992-9#3)(1993-11#1)(1993-12#9)(1993-3#4)(1993-6#3)(1993-9#1)(1994-1#3)(1994-10#1)(1994-11#2)(1994-12#6)(1994-2#7)(1994-3#6)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#4)(1995-11#1)(1995-12#2)(1995-2#8)(1995-3#6)(1995-4#1)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#1)(1996-1#4)(1996-10#2)(1996-12#5)(1996-2#7)(1996-3#4)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#5)(1997-2#3)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#3)(1997-8#2)(2004-12#1)(2004-3#2)(2004-4#1)(2005-10#5)(2005-11#14)(2005-12#2)(2005-2#1)(2005-4#1)(2005-5#2)(2005-7#4)(2006-10#8)(2006-11#3)(2006-12#4)(2006-2#4)(2006-3#5)(2006-5#4)(2006-6#4)(2006-7#4)(2006-8#7)(2006-9#3)(2007-1#1)(2007-10#8)(2007-11#15)(2007-12#19)(2007-2#8)(2007-3#2)(2007-4#11)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#11)(2007-9#3)(2008-1#14)(2008-10#44)(2008-11#38)(2008-12#16)(2008-2#19)(2008-3#23)(2008-4#12)(2008-5#31)(2008-6#12)(2008-7#17)(2008-8#14)(2008-9#14)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#6)(2009-2#1)(2009-3#5)(2009-4#7)(2009-6#4)(2009-7#3)(2009-8#4)(2009-9#2)(2010-10#4)(2010-12#3)(2010-2#5)(2010-3#1)(2010-4#4)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#13)(2011-12#2)(2011-2#14)(2012-1#5)(2012-11#3)(2012-12#16)(2012-2#18)(2012-3#14)(2013-1#18)(2013-7#6)(2013-8#9)
the processed##10##2##(1994-12#1)(1994-9#1)(1995-6#1)(1996-8#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-6#1)(2012-1#1)(2013-1#1)
the processes and outcomes of##2##5##(1993-3#1)(2008-8#1)
the processes and##10##3##(1992-6#1)(1993-3#1)(1993-7#1)(1994-1#1)(1995-2#1)(2007-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2012-1#1)
the processes associated with##3##4##(1992-12#1)(1992-8#1)(1993-2#1)
the processes by which##2##4##(2007-12#1)(2009-5#1)
the processes involved in influencing##2##5##(2012-3#2)
the processes involved in##10##4##(1994-9#1)(1995-2#1)(1996-12#1)(2008-10#2)(2008-11#2)(2009-2#1)(2012-3#2)
the processes involved##14##3##(1990-3#1)(1994-9#1)(1995-2#1)(1996-12#1)(1997-5#1)(2006-11#1)(2008-10#2)(2008-11#2)(2008-9#1)(2009-2#1)(2012-3#2)
the processes leading to##2##4##(1991-2#1)(1994-10#1)
the processes occurring##2##3##(1997-3#1)(2008-10#1)
the processes of cell##2##4##(2007-8#1)(2008-5#1)
the processes of disease##2##4##(2008-10#1)(2010-3#1)
the processes of ion##2##4##(2008-10#2)
the processes of##56##3##(1991-3#1)(1991-4#1)(1991-9#1)(1992-5#1)(1993-4#1)(1993-8#1)(1994-3#1)(1996-4#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-3#1)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
the processes responsible for these##2##5##(1996-4#1)(2008-11#1)
the processes responsible for##4##4##(1991-5#1)(1996-4#1)(2007-12#1)(2008-11#1)
the processes taking place in the##2##6##(2007-11#1)(2008-12#1)
the processes taking place on the##2##6##(2007-11#1)(2008-10#1)
the processes taking place##5##4##(2007-11#2)(2008-10#1)(2008-12#1)(2013-1#1)
the processes that underlie the##2##5##(2006-10#1)(2012-11#1)
the processes that underlie##4##4##(2006-10#1)(2007-7#1)(2008-11#1)(2012-11#1)
the processes that##18##3##(1992-2#1)(1996-6#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-8#1)(2009-5#1)(2010-9#1)(2012-11#2)(2013-8#1)
the processes underlying##3##3##(1995-4#1)(2006-10#1)(2008-8#1)
the processes##151##2##(1990-3#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-1#1)(1994-10#1)(1994-3#1)(1994-9#1)(1995-2#2)(1995-4#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-4#2)(1996-6#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#1)(2005-11#1)(2005-5#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-3#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#7)(2007-12#3)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#11)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-5#3)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#4)(2010-7#1)(2010-9#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#5)(2012-2#2)(2012-3#5)(2013-1#4)(2013-8#3)
the processing and presentation of##2##5##(1994-11#2)
the processing and##6##3##(1993-11#1)(1994-11#2)(2006-12#1)(2008-7#1)(2013-8#1)
the processing of ET-1(1-39)##3##4##(1991-6#3)
the processing of a##4##4##(1992-8#1)(1995-11#1)(1995-2#1)(1996-5#1)
the processing of an##2##4##(2008-1#1)(2010-5#1)
the processing of emotional##2##4##(2008-1#1)(2008-4#1)
the processing of that##2##4##(2008-7#1)(2010-11#1)
the processing of the##10##4##(1990-8#1)(1992-12#1)(1995-3#1)(2005-11#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2013-8#1)
the processing of##81##3##(1990-12#2)(1990-5#2)(1990-8#3)(1991-10#1)(1991-6#3)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-5#1)(1993-6#2)(1994-2#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-5#1)(1996-6#3)(1997-3#1)(1997-7#1)(2005-11#1)(2006-6#1)(2006-8#1)(2007-3#1)(2007-8#2)(2008-1#5)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#2)(2009-4#1)(2009-8#2)(2010-11#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2013-8#2)
the processing site##2##3##(1990-2#1)(1991-10#1)
the processing##118##2##(1990-12#2)(1990-2#1)(1990-5#2)(1990-8#3)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#3)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-5#2)(1993-6#2)(1993-9#1)(1994-11#2)(1994-2#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-5#1)(1996-6#3)(1997-3#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-3#1)(2007-8#2)(2008-1#5)(2008-10#6)(2008-11#2)(2008-2#6)(2008-3#7)(2008-4#3)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-8#2)(2010-11#1)(2010-4#2)(2010-5#2)(2010-8#2)(2011-1#1)(2011-2#2)(2012-11#1)(2013-1#1)(2013-8#3)
the processive##3##2##(1994-8#1)(1995-2#1)(1997-2#1)
the processivity##2##2##(1994-12#1)(1994-8#1)
the processor##5##2##(2008-2#2)(2008-3#2)(2008-9#1)
the procollagen##2##2##(1990-11#2)
the procurement of vascular stents in interventional radiology##3##8##(2012-2#3)
the procurement of##4##3##(2005-8#1)(2012-2#3)
the procurement##6##2##(1997-6#1)(2005-8#1)(2012-2#4)
the prodomain##7##2##(1995-11#7)
the prodrome##3##2##(2010-5#1)(2012-1#2)
the prodrug was##2##3##(1994-11#2)
the prodrug##4##2##(1994-11#2)(1994-5#1)(2008-5#1)
the prodrugs##3##2##(1994-11#1)(1995-3#1)(2009-4#1)
the produced water##5##3##(2008-10#1)(2008-7#2)(2013-1#2)
the produced##26##2##(1990-5#1)(1995-8#1)(1996-7#1)(1997-4#1)(2006-12#1)(2008-10#7)(2008-11#3)(2008-4#2)(2008-7#2)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
the producer cell line##2##4##(1990-5#1)(2008-11#1)
the producer##7##2##(1990-5#1)(1992-2#1)(1993-3#1)(2008-10#1)(2008-11#3)
the producers of##2##3##(2012-12#1)(2012-2#1)
the producers##5##2##(1994-6#1)(2008-10#1)(2008-12#1)(2012-12#1)(2012-2#1)
the producing cells##3##3##(1992-9#2)(2010-11#1)
the producing##5##2##(1992-9#3)(1994-2#1)(2010-11#1)
the product and##3##3##(1995-5#1)(2008-5#2)
the product at##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
the product can##3##3##(2008-1#1)(2008-10#1)(2012-2#1)
the product formation##3##3##(1991-5#1)(1997-8#1)(2008-7#1)
the product has been##3##4##(2006-6#1)(2008-10#1)(2008-11#1)
the product in##4##3##(1991-7#1)(2005-7#1)(2008-7#1)(2013-1#1)
the product is##6##3##(1994-3#1)(2005-8#1)(2008-11#1)(2008-4#1)(2009-12#1)(2013-1#1)
the product limit##2##3##(1997-3#1)(2007-8#1)
the product obtained##3##3##(1990-7#1)(2008-10#1)(2008-3#1)
the product of ORF7##2##4##(2008-10#2)
the product of a##4##4##(1990-4#1)(1996-5#1)(2008-3#1)(2011-2#1)
the product of an##2##4##(1995-5#1)(1995-8#1)
the product of enzymatic hydrolysis##2##5##(1993-9#1)(2013-1#1)
the product of gene##5##4##(1990-12#1)(1990-9#1)(1991-6#1)(1995-2#2)
the product of reaction##2##4##(2008-10#2)
the product of the effective##2##5##(2007-12#1)(2008-3#1)
the product of the enzymatic reaction##2##6##(1990-8#1)(2008-10#1)
the product of the refractive index##2##6##(2008-3#2)
the product of the##53##4##(1990-11#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#1)(1991-11#3)(1991-5#2)(1992-1#1)(1992-6#2)(1993-12#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-7#2)(1996-7#1)(1997-1#1)(1997-3#2)(1997-6#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-10#7)(2008-2#3)(2008-3#7)(2008-4#1)(2010-10#1)(2012-12#1)
the product of this gene##2##5##(1993-8#1)(2008-6#1)
the product of this##3##4##(1993-8#1)(1995-8#1)(2008-6#1)
the product of two##4##4##(2007-12#1)(2008-2#1)(2008-3#1)(2011-2#1)
the product of which is##2##5##(1990-8#1)(1993-4#1)
the product of which produces a sensitive##2##7##(2008-10#2)
the product of which##4##4##(1990-8#1)(1993-4#1)(2008-10#2)
the product of##108##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#3)(1991-5#2)(1991-6#1)(1992-1#1)(1992-11#1)(1992-4#1)(1992-6#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-7#2)(1995-8#2)(1996-5#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-6#1)(2006-10#1)(2006-3#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-2#2)(2007-4#1)(2007-8#1)(2008-10#15)(2008-2#5)(2008-3#10)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2010-10#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
the product on##2##3##(2006-6#1)(2008-5#1)
the product specificities of prenyltransferases##2##5##(1993-4#1)(2011-2#1)
the product terms of the##2##5##(2008-3#1)(2011-2#1)
the product was##7##3##(1990-5#1)(1990-9#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2012-2#1)
the product which##2##3##(1990-7#1)(2008-11#1)
the product yield##2##3##(2008-7#1)(2010-4#1)
the product##253##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#3)(1990-6#2)(1990-7#3)(1990-8#3)(1990-9#2)(1991-11#3)(1991-2#1)(1991-5#3)(1991-6#1)(1991-7#1)(1992-1#1)(1992-11#2)(1992-4#1)(1992-6#2)(1993-12#1)(1993-3#1)(1993-4#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-8#5)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-7#2)(1995-8#3)(1996-2#2)(1996-5#4)(1996-7#1)(1996-8#3)(1997-1#1)(1997-2#1)(1997-3#3)(1997-6#1)(1997-8#1)(2004-12#1)(2004-8#1)(2005-7#1)(2005-8#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-3#1)(2006-6#2)(2006-7#1)(2007-1#1)(2007-11#4)(2007-12#4)(2007-2#2)(2007-3#2)(2007-4#1)(2007-6#2)(2007-8#3)(2008-1#1)(2008-10#33)(2008-11#7)(2008-12#1)(2008-2#7)(2008-3#12)(2008-4#3)(2008-5#17)(2008-6#4)(2008-7#5)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-9#1)(2010-10#2)(2010-4#3)(2010-8#2)(2011-2#10)(2012-1#2)(2012-12#4)(2012-2#8)(2013-1#5)(2013-8#1)
the product(s)##2##2##(1990-5#1)(2008-7#1)
the production and characterization of##2##5##(1996-5#1)(2008-5#1)
the production and the##2##4##(2010-12#1)(2010-4#1)
the production and##32##3##(1991-1#1)(1991-9#1)(1994-9#1)(1996-4#1)(1996-5#1)(2006-10#3)(2006-5#1)(2006-6#1)(2007-4#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2010-12#2)(2010-4#3)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
the production capacity##2##3##(2006-12#1)(2008-6#1)
the production costs##2##3##(1994-5#1)(2008-12#1)
the production cycle##2##3##(2008-11#1)(2011-2#1)
the production medium##3##3##(2006-9#1)(2008-10#1)(2008-4#1)
the production of Anticarsia gemmatalis##2##5##(2008-11#2)
the production of EPO in##2##5##(2008-11#2)
the production of HA-2-91##3##4##(2006-9#3)
the production of IFN-gamma by##2##5##(1993-4#1)(2009-9#1)
the production of IFN-gamma##4##4##(1993-4#1)(2008-11#1)(2009-9#2)
the production of IL-10 by##3##5##(1994-12#1)(2006-10#1)(2011-2#1)
the production of IL-10##6##4##(1994-12#2)(1996-12#1)(2006-10#1)(2007-9#1)(2011-2#1)
the production of IL-12 by##3##5##(1996-10#3)
the production of IL-12##4##4##(1996-10#3)(2011-2#1)
the production of IL-2##2##4##(1992-8#2)
the production of IL-6##2##4##(1992-4#1)(2008-10#1)
the production of MDA##2##4##(1996-2#2)
the production of NO##2##4##(2006-8#2)
the production of PAF##2##4##(2007-9#2)
the production of RNA##2##4##(2006-10#1)(2008-4#1)
the production of ROS##4##4##(1994-5#3)(2008-11#1)
the production of TBARS##2##4##(2012-2#2)
the production of TNF##4##4##(1995-9#3)(2006-8#1)
the production of a recombinant##3##5##(1994-12#1)(1994-2#1)(2008-11#1)
the production of a specific##2##5##(2008-10#1)(2012-2#1)
the production of a truncated##2##5##(1997-7#2)
the production of a##37##4##(1990-11#1)(1990-12#1)(1990-7#2)(1991-7#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#3)(1997-3#1)(1997-7#2)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
the production of an##10##4##(1991-6#1)(1996-1#1)(1996-5#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-10#1)(2009-9#1)(2010-6#1)(2012-3#1)
the production of anti-inflammatory##2##4##(2007-11#1)(2008-10#1)
the production of antibodies in##3##5##(1990-12#1)(1993-3#1)(2007-11#1)
the production of antibodies##8##4##(1990-12#1)(1993-3#1)(1995-5#1)(2007-11#1)(2008-11#2)(2008-5#1)(2011-2#1)
the production of antibody##2##4##(2007-8#1)(2011-2#1)
the production of biodiesel##3##4##(2008-5#2)(2008-6#1)
the production of biologically active##4##5##(1993-6#1)(1994-8#1)(1997-4#1)(2007-11#1)
the production of both##4##4##(1990-12#1)(1990-7#1)(1994-2#1)(2008-11#1)
the production of butanol##3##4##(2013-1#3)
the production of certain##2##4##(1994-12#1)(1997-4#1)
the production of cobalt##2##4##(1994-6#2)
the production of complex##3##4##(2007-11#1)(2007-12#1)(2008-7#1)
the production of cytokines##4##4##(1991-10#1)(2008-11#2)(2013-1#1)
the production of different##5##4##(2008-10#2)(2008-11#1)(2008-2#1)(2011-2#1)
the production of ethanol##3##4##(2008-6#1)(2008-7#1)(2008-8#1)
the production of extracellular##2##4##(2007-3#1)(2008-10#1)
the production of foreign proteins##2##5##(1997-4#1)(2011-12#1)
the production of foreign##3##4##(1997-4#2)(2011-12#1)
the production of free radicals##4##5##(1991-12#1)(2005-8#1)(2006-10#1)(2008-10#1)
the production of gas##2##4##(2009-6#2)
the production of glucose##2##4##(1997-7#1)(2008-10#1)
the production of heat##2##4##(2006-12#1)(2013-1#1)
the production of high##2##4##(1994-11#1)(2008-10#1)
the production of highly##3##4##(1990-2#1)(1996-7#1)(2008-1#1)
the production of human##3##4##(2006-10#1)(2008-11#2)
the production of hybridomas##2##4##(1992-7#1)(1992-8#1)
the production of inflammatory mediators##3##5##(2004-11#1)(2007-11#1)(2008-4#1)
the production of inflammatory##4##4##(1996-3#1)(2004-11#1)(2007-11#1)(2008-4#1)
the production of inhibitory mediators##2##5##(2006-10#2)
the production of inositol trisphosphate##2##5##(1990-8#1)(1994-10#1)
the production of inositol##4##4##(1990-8#1)(1994-10#1)(1996-8#1)(1997-1#1)
the production of interferon##2##4##(2008-11#1)(2008-5#1)
the production of interleukin-6 (IL-6)##2##5##(1992-12#1)(1992-4#1)
the production of its##2##4##(2005-6#1)(2008-10#1)
the production of knowledge##2##4##(1991-9#1)(2007-5#1)
the production of labelled##2##4##(1990-12#1)(1991-6#1)
the production of large##2##4##(1994-8#1)(2008-7#1)
the production of monoclonal antibodies##6##5##(1992-8#2)(2008-11#1)(2008-4#2)(2008-9#1)
the production of monoclonal antibody##3##5##(2008-11#2)(2008-4#1)
the production of monoclonal##10##4##(1992-8#2)(1996-2#1)(2008-11#3)(2008-4#3)(2008-9#1)
the production of nitric oxide from##2##6##(1993-12#1)(2009-9#1)
the production of nitric oxide##6##5##(1991-10#1)(1992-5#1)(1993-12#2)(2008-11#1)(2009-9#1)
the production of organic acids##3##5##(2008-10#2)(2012-11#1)
the production of osteocalcin##3##4##(1990-2#2)(1991-3#1)
the production of polyclonal##2##4##(2008-4#2)
the production of pro-inflammatory cytokines##3##5##(2005-10#1)(2010-12#1)(2011-1#1)
the production of pro-inflammatory mediators##3##5##(2006-2#1)(2007-11#1)(2008-10#1)
the production of pro-inflammatory##6##4##(2005-10#1)(2006-2#1)(2007-11#1)(2008-10#1)(2010-12#1)(2011-1#1)
the production of proinflammatory cytokines##4##5##(2008-1#1)(2008-4#1)(2010-7#1)(2011-2#1)
the production of prostaglandin E2##2##5##(1992-4#2)
the production of proteins##4##4##(1995-7#2)(1995-8#1)(2011-1#1)
the production of quantities##2##4##(1997-7#1)(2007-11#1)
the production of reactive oxygen species (ROS)##3##7##(1994-5#1)(1997-4#1)(2008-3#1)
the production of reactive oxygen species and##2##7##(2008-4#1)(2013-8#1)
the production of reactive oxygen species##9##6##(1994-5#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-12#1)(2011-1#1)(2013-8#2)
the production of reactive oxygen##10##5##(1994-5#2)(1997-4#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-12#1)(2011-1#1)(2013-8#2)
the production of reactive##11##4##(1994-5#2)(1997-4#1)(2005-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-12#1)(2011-1#1)(2013-8#2)
the production of recombinant protein##2##5##(2008-11#1)(2012-3#1)
the production of recombinant proteins##8##5##(1997-3#1)(2008-11#7)
the production of recombinant##17##4##(1997-3#1)(1997-7#1)(2007-11#1)(2008-11#13)(2012-3#1)
the production of secondary##3##4##(2008-10#3)
the production of secreted##2##4##(1992-9#1)(1997-4#1)
the production of singlet oxygen##3##5##(2008-10#1)(2008-5#2)
the production of soluble##3##4##(1997-7#1)(2007-11#1)(2009-6#1)
the production of some##2##4##(1995-10#1)(2009-12#1)
the production of specific##2##4##(1992-8#1)(1997-6#1)
the production of succinic acid##2##5##(2008-6#1)(2013-1#1)
the production of such##3##4##(2008-1#1)(2010-2#1)(2010-5#1)
the production of superoxide##2##4##(1995-6#1)(1997-5#1)
the production of synthetic##3##4##(1992-11#1)(1992-12#1)(2011-12#1)
the production of tannase##2##4##(2008-5#2)
the production of the cell##2##5##(1992-9#1)(2008-10#1)
the production of the knowledge on the long-lived elderly##2##9##(2012-3#2)
the production of the##26##4##(1990-9#1)(1991-5#1)(1992-9#1)(1993-8#1)(1994-2#1)(1994-6#1)(1997-2#1)(2006-5#1)(2007-11#1)(2007-6#1)(2008-10#6)(2008-3#1)(2008-4#1)(2009-2#1)(2009-8#1)(2010-4#1)(2012-3#2)(2013-1#2)(2013-8#1)
the production of these##2##4##(1994-11#1)(2010-2#1)
the production of this metabolite##2##5##(2006-10#2)
the production of this##4##4##(1994-3#1)(2006-10#2)(2008-10#1)
the production of toxic##2##4##(1995-2#1)(2008-10#1)
the production of transforming growth factor-beta##2##6##(1995-12#1)(2006-10#1)
the production of transgenic##4##4##(1995-2#1)(2006-12#1)(2008-2#1)(2011-2#1)
the production of tumor necrosis factor##2##6##(1994-8#1)(2006-12#1)
the production of two##3##4##(1993-12#1)(2009-2#1)(2010-5#1)
the production of various##5##4##(2007-12#1)(2008-11#2)(2008-4#2)
the production of viral##3##4##(1994-11#1)(2007-11#1)(2008-11#1)
the production of##688##3##(1990-10#1)(1990-11#5)(1990-12#4)(1990-2#3)(1990-3#2)(1990-7#7)(1990-8#2)(1990-9#2)(1991-10#3)(1991-12#4)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#4)(1992-4#5)(1992-5#3)(1992-6#2)(1992-7#2)(1992-8#7)(1992-9#3)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#1)(1993-4#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#2)(1994-11#7)(1994-12#6)(1994-2#9)(1994-3#6)(1994-4#1)(1994-5#6)(1994-6#5)(1994-7#1)(1994-8#9)(1994-9#2)(1995-1#2)(1995-10#2)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#1)(1995-9#3)(1996-1#1)(1996-10#4)(1996-12#1)(1996-2#5)(1996-3#2)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#12)(1997-5#1)(1997-6#2)(1997-7#8)(1997-8#4)(2004-11#1)(2004-9#2)(2005-10#1)(2005-11#7)(2005-12#1)(2005-5#1)(2005-6#1)(2005-7#2)(2005-8#1)(2005-9#2)(2006-1#2)(2006-10#16)(2006-11#2)(2006-12#6)(2006-2#3)(2006-3#1)(2006-5#4)(2006-6#2)(2006-7#1)(2006-8#4)(2006-9#3)(2007-1#1)(2007-11#15)(2007-12#12)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#4)(2008-1#7)(2008-10#58)(2008-11#59)(2008-12#7)(2008-2#7)(2008-3#6)(2008-4#22)(2008-5#26)(2008-6#15)(2008-7#16)(2008-8#8)(2008-9#7)(2009-10#3)(2009-12#2)(2009-2#3)(2009-3#2)(2009-6#4)(2009-7#1)(2009-8#2)(2009-9#4)(2010-10#3)(2010-12#2)(2010-2#5)(2010-3#2)(2010-4#5)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#7)(2011-12#2)(2011-2#11)(2011-3#1)(2012-1#3)(2012-11#5)(2012-12#4)(2012-2#12)(2012-3#7)(2013-1#13)(2013-7#2)(2013-8#9)
the production or##2##3##(2008-11#1)(2013-7#1)
the production phase##3##3##(2008-11#3)
the production plant##3##3##(2007-4#1)(2008-10#1)(2012-2#1)
the production process##8##3##(1993-6#1)(2008-11#2)(2008-7#2)(2012-2#2)(2013-8#1)
the production rate##2##3##(2008-11#1)(2008-5#1)
the production system##2##3##(2008-4#1)(2010-2#1)
the production team##2##3##(2008-11#1)(2008-12#1)
the production##786##2##(1990-10#1)(1990-11#5)(1990-12#4)(1990-2#3)(1990-3#2)(1990-7#7)(1990-8#2)(1990-9#2)(1991-1#1)(1991-10#3)(1991-12#4)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#4)(1992-4#5)(1992-5#4)(1992-6#2)(1992-7#2)(1992-8#7)(1992-9#3)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#1)(1993-4#2)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#2)(1994-11#7)(1994-12#6)(1994-2#9)(1994-3#6)(1994-4#1)(1994-5#7)(1994-6#7)(1994-7#1)(1994-8#10)(1994-9#3)(1995-1#2)(1995-10#2)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#1)(1995-9#3)(1996-1#1)(1996-10#4)(1996-12#1)(1996-2#5)(1996-3#2)(1996-4#1)(1996-5#6)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#12)(1997-5#1)(1997-6#2)(1997-7#8)(1997-8#4)(2004-11#1)(2004-9#2)(2005-10#1)(2005-11#7)(2005-12#1)(2005-5#1)(2005-6#1)(2005-7#2)(2005-8#1)(2005-9#2)(2006-1#2)(2006-10#20)(2006-11#2)(2006-12#7)(2006-2#3)(2006-3#1)(2006-5#5)(2006-6#3)(2006-7#1)(2006-8#4)(2006-9#5)(2007-1#1)(2007-11#15)(2007-12#12)(2007-2#1)(2007-3#2)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#4)(2008-1#7)(2008-10#65)(2008-11#73)(2008-12#9)(2008-2#8)(2008-3#8)(2008-4#28)(2008-5#31)(2008-6#17)(2008-7#19)(2008-8#8)(2008-9#7)(2009-10#3)(2009-12#2)(2009-2#3)(2009-3#2)(2009-6#4)(2009-7#1)(2009-8#2)(2009-9#4)(2010-10#4)(2010-12#4)(2010-2#6)(2010-3#2)(2010-4#8)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#7)(2011-12#2)(2011-2#16)(2011-3#1)(2012-1#3)(2012-11#5)(2012-12#4)(2012-2#16)(2012-3#10)(2013-1#16)(2013-7#3)(2013-8#15)
the productions of##2##3##(1991-7#1)(2008-11#1)
the productions##4##2##(1991-7#1)(2008-11#1)(2012-3#2)
the productive binding##3##3##(1990-7#2)(1992-6#1)
the productive##11##2##(1990-7#2)(1991-6#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-11#1)(1995-2#1)(1995-3#1)(2008-1#1)(2013-1#1)
the productivity and##3##3##(1993-6#1)(1994-12#1)(2012-3#1)
the productivity of HA-2-91##2##4##(2006-9#2)
the productivity of##18##3##(1991-1#1)(1995-3#1)(2006-9#2)(2007-3#1)(2008-10#2)(2008-11#5)(2008-6#2)(2008-7#2)(2010-9#1)(2012-1#1)
the productivity per##2##3##(2008-11#2)
the productivity##27##2##(1990-11#1)(1991-1#1)(1993-6#1)(1994-12#1)(1995-3#1)(2006-9#2)(2007-3#1)(2008-10#2)(2008-11#10)(2008-6#2)(2008-7#2)(2010-9#1)(2012-1#1)(2012-3#1)
the products are##6##3##(1990-2#1)(1993-12#1)(2005-11#1)(2006-3#1)(2008-4#1)(2011-2#1)
the products formed##5##3##(1992-2#1)(1993-4#1)(2004-4#1)(2008-10#2)
the products in##3##3##(2007-10#1)(2010-6#1)(2013-8#1)
the products obtained##4##3##(2007-1#1)(2007-8#1)(2008-10#1)(2010-12#1)
the products of an##2##4##(1997-8#1)(2008-4#1)
the products of the##15##4##(1990-11#1)(1991-12#1)(1991-9#1)(1992-12#1)(1994-12#1)(1994-8#1)(2006-3#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#1)(2010-4#1)(2013-7#1)
the products of##50##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-12#2)(1991-9#1)(1992-12#1)(1993-2#1)(1994-12#1)(1994-8#3)(1994-9#2)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#2)(1996-8#1)(1997-8#1)(2005-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-4#3)(2008-5#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2013-7#1)
the products to##2##3##(2010-12#1)(2011-2#1)
the products were detected##2##4##(1992-4#1)(2008-4#1)
the products were##10##3##(1990-4#1)(1990-8#1)(1991-2#1)(1992-4#1)(1995-6#1)(1996-8#1)(2005-11#1)(2007-11#2)(2008-4#1)
the products##137##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#4)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-12#1)(1994-8#6)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#3)(1996-12#2)(1996-5#1)(1996-8#3)(1997-4#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-11#3)(2005-12#2)(2006-10#2)(2006-2#1)(2006-3#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#2)(2007-8#4)(2008-10#10)(2008-12#3)(2008-3#4)(2008-4#9)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-12#3)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
the prodynorphin gene##2##3##(1995-12#2)
the proenkephalin mRNA level##2##4##(1994-2#2)
the proenzyme##3##2##(1992-11#1)(1995-3#1)(1995-8#1)
the profession and the##3##4##(2011-2#1)(2012-3#1)(2013-8#1)
the profession and##7##3##(1993-1#1)(1994-12#1)(2006-2#1)(2008-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
the profession as##4##3##(1991-2#2)(2007-11#1)(2008-11#1)
the profession has##2##3##(2006-2#2)
the profession of medicine##2##4##(2007-4#2)
the profession of##6##3##(1996-1#1)(2005-9#1)(2007-4#3)(2008-12#1)
the profession to##4##3##(2007-4#1)(2007-8#1)(2012-3#2)
the profession##70##2##(1991-2#3)(1992-12#1)(1993-1#3)(1993-2#1)(1994-12#3)(1995-1#2)(1996-1#2)(2005-9#1)(2006-2#7)(2007-11#1)(2007-12#1)(2007-4#8)(2007-8#2)(2008-1#1)(2008-11#2)(2008-12#4)(2008-7#1)(2008-8#1)(2009-4#3)(2010-12#1)(2010-5#2)(2010-6#1)(2011-1#2)(2011-2#3)(2012-11#2)(2012-12#3)(2012-3#7)(2013-1#1)(2013-8#1)
the profession's##8##2##(1992-12#2)(2007-4#1)(2007-9#2)(2008-12#1)(2012-11#1)(2012-2#1)
the professional and##4##3##(1990-10#1)(2006-2#1)(2008-9#1)(2010-3#1)
the professional development of##3##4##(2007-10#1)(2010-9#1)(2013-1#1)
the professional development##4##3##(2007-10#1)(2008-11#1)(2010-9#1)(2013-1#1)
the professional liability insurance##2##4##(1993-3#1)(2007-4#1)
the professional liability##3##3##(1993-3#1)(2007-4#2)
the professional model##2##3##(1992-5#2)
the professional practice##3##3##(2007-12#1)(2008-8#1)(2009-8#1)
the professional status of##2##4##(1990-12#1)(2010-12#1)
the professional training##3##3##(1990-12#1)(1992-3#1)(2008-7#1)
the professional##63##2##(1990-10#1)(1990-12#2)(1990-2#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-3#2)(1992-5#2)(1993-1#1)(1993-3#4)(1994-1#1)(1995-4#1)(1995-5#1)(1996-3#1)(2006-2#2)(2006-3#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#3)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-12#1)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#3)
the professional's##3##2##(1991-6#1)(2011-2#1)(2012-3#1)
the professionalization of##2##3##(1990-12#1)(2007-12#1)
the professionalization##3##2##(1990-12#1)(2007-12#1)(2011-2#1)
the professionals to##2##3##(1994-1#1)(2012-12#1)
the professionals who##3##3##(2008-12#1)(2010-1#2)
the professionals##10##2##(1993-3#2)(1994-1#1)(1997-8#1)(2008-12#1)(2010-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
the professionals' approach towards them##2##5##(2011-2#2)
the professionals' approach##4##3##(2011-2#4)
the professionals'##6##2##(2008-5#1)(2011-2#4)(2013-1#1)
the professions##11##2##(1990-12#2)(1995-1#1)(1996-12#1)(1996-3#2)(2007-11#1)(2008-10#1)(2009-10#1)(2012-2#2)
the professor##2##2##(1993-2#1)(2011-1#1)
the profile and##6##3##(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-12#2)
the profile obtained##2##3##(1992-1#1)(2011-2#1)
the profile of a##4##4##(1990-2#1)(2007-12#1)(2008-3#1)(2013-7#1)
the profile of the##10##4##(1996-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-6#1)(2010-3#1)(2011-2#1)(2012-3#1)
the profile of##39##3##(1990-2#1)(1991-2#2)(1992-2#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-7#1)(1996-10#1)(2006-10#1)(2006-2#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-2#3)(2008-3#4)(2008-7#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
the profile##67##2##(1990-2#1)(1991-2#2)(1992-1#1)(1992-2#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-7#1)(1996-1#2)(1996-10#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#9)(2008-7#2)(2008-8#2)(2009-4#1)(2009-6#1)(2010-2#1)(2010-3#3)(2010-5#1)(2010-7#1)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
the profile-based method##4##3##(2013-1#4)
the profiles from##2##3##(2006-10#1)(2010-11#1)
the profiles is##2##3##(2006-5#1)(2008-3#1)
the profiles obtained##2##3##(2008-12#1)(2008-5#1)
the profiles of the##4##4##(2008-2#1)(2008-3#2)(2008-7#1)
the profiles of##12##3##(2006-10#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-7#1)(2012-1#1)(2012-2#1)(2013-1#2)
the profiles##26##2##(1997-3#1)(2006-10#3)(2006-5#1)(2007-12#2)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#1)(2009-7#1)(2010-11#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)
the profiling##4##2##(2007-1#1)(2008-10#1)(2010-5#1)(2013-7#1)
the profitability of##2##3##(1994-3#1)(2007-4#1)
the profound impact of##2##4##(1993-4#1)(2011-1#1)
the profound##7##2##(1992-1#1)(1993-4#1)(1995-7#1)(2008-11#1)(2011-1#1)(2013-1#1)(2013-8#1)
the progenies##2##2##(2008-10#1)(2008-9#1)
the progenitor of the##2##4##(1991-5#1)(2008-10#1)
the progenitor##8##2##(1991-5#1)(1994-5#1)(1997-5#1)(2008-10#1)(2008-8#1)(2009-10#1)(2009-12#1)(2012-12#1)
the progenitors of##3##3##(1995-2#1)(1996-11#1)(2008-5#1)
the progenitors##5##2##(1995-2#1)(1996-11#1)(2008-11#2)(2008-5#1)
the progeny of the##4##4##(2008-10#3)(2012-2#1)
the progeny of transplanted##2##4##(2008-4#2)
the progeny of two##2##4##(2008-10#1)(2012-2#1)
the progeny of##17##3##(2007-12#1)(2008-10#7)(2008-4#2)(2008-8#3)(2008-9#1)(2010-8#1)(2012-2#2)
the progeny##26##2##(2007-12#1)(2008-10#10)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-6#1)(2010-4#1)(2010-8#1)(2012-2#2)
the progesterone antagonist RU 486##2##5##(1994-9#1)(2008-4#1)
the progesterone receptor (PgR)##2##4##(1993-4#1)(1993-7#1)
the progesterone receptor##7##3##(1993-4#1)(1993-7#1)(1994-12#1)(2007-12#1)(2008-4#1)(2009-12#1)(2010-3#1)
the progesterone##13##2##(1991-11#1)(1993-4#1)(1993-7#1)(1994-12#1)(1994-9#1)(1996-3#1)(2007-1#1)(2007-12#1)(2008-4#3)(2009-12#1)(2010-3#1)
the progestin antagonist RU 486##2##5##(1993-9#2)
the progestin##3##2##(1993-9#2)(2004-1#1)
the prognoses of##3##3##(1995-10#1)(2011-2#1)(2012-3#1)
the prognosis and survival of##2##5##(2008-10#1)(2011-2#1)
the prognosis and##9##3##(1991-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#1)(2013-1#1)
the prognosis as##2##3##(1990-1#1)(1990-5#1)
the prognosis for patients##3##4##(2007-6#1)(2010-3#1)(2011-2#1)
the prognosis for these patients is poor##2##7##(2008-5#1)(2009-2#1)
the prognosis for these patients##3##5##(1995-8#1)(2008-5#1)(2009-2#1)
the prognosis for##16##3##(1995-8#1)(2004-1#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-2#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-2#1)
the prognosis in##4##3##(1992-2#1)(1996-11#1)(2006-10#1)(2013-1#1)
the prognosis is good if##2##5##(1996-8#1)(1996-9#1)
the prognosis is good##3##4##(1996-8#1)(1996-9#1)(2007-11#1)
the prognosis is not##2##4##(2005-10#1)(2007-8#1)
the prognosis is##14##3##(1990-8#1)(1992-6#1)(1993-3#1)(1996-8#1)(1996-9#1)(1997-3#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#2)(2011-2#1)
the prognosis of patients with breast cancer##2##7##(1996-6#1)(2013-1#1)
the prognosis of patients with##8##5##(1996-6#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-5#1)(2010-5#1)(2012-1#1)(2013-1#1)
the prognosis of patients##10##4##(1996-6#1)(2005-6#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
the prognosis of the disease##3##5##(1993-8#1)(1995-1#1)(2007-11#1)
the prognosis of the##7##4##(1990-2#1)(1993-12#1)(1993-2#1)(1993-8#1)(1995-1#1)(2007-11#1)(2010-6#1)
the prognosis of these patients##2##5##(2007-11#1)(2010-8#1)
the prognosis of these##4##4##(1993-5#1)(1994-6#1)(2007-11#1)(2010-8#1)
the prognosis of this disease##2##5##(1994-6#1)(2006-10#1)
the prognosis of this##4##4##(1994-6#1)(2006-10#1)(2006-2#1)(2008-6#1)
the prognosis of##60##3##(1990-2#1)(1990-9#1)(1992-1#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-6#2)(1995-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(2005-1#1)(2005-10#1)(2005-6#1)(2006-10#4)(2006-2#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-12#4)(2010-5#1)(2010-6#2)(2010-8#2)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#2)
the prognosis remains poor##2##4##(2010-5#1)(2013-1#1)
the prognosis remains##5##3##(1991-9#1)(2008-6#1)(2010-5#1)(2011-2#1)(2013-1#1)
the prognosis was poor##2##4##(2007-4#1)(2008-6#1)
the prognosis was##8##3##(1990-5#1)(1991-8#1)(1994-12#1)(1995-8#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-6#1)
the prognosis##148##2##(1990-1#1)(1990-2#2)(1990-5#4)(1990-8#2)(1990-9#2)(1991-3#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-6#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-6#2)(1995-1#1)(1995-4#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-3#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#2)(2004-1#1)(2005-1#1)(2005-10#2)(2005-11#1)(2005-6#1)(2006-10#6)(2006-2#2)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#4)(2007-12#4)(2007-2#2)(2007-4#2)(2007-6#2)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#3)(2008-8#3)(2008-9#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-12#4)(2010-3#3)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-2#9)(2011-3#1)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#1)
the prognostic assessment##2##3##(1990-10#1)(2011-2#1)
the prognostic impact##2##3##(2006-6#1)(2011-2#1)
the prognostic power of##2##4##(2005-9#1)(2012-3#1)
the prognostic significance of##7##4##(1992-2#1)(1993-9#1)(2006-6#1)(2007-8#1)(2008-11#1)(2009-2#1)(2012-3#1)
the prognostic value of late potentials after myocardial infarction##2##9##(1996-4#2)
the prognostic value of##12##4##(1994-6#1)(1996-4#2)(1997-8#1)(2008-11#1)(2008-6#2)(2009-1#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-11#1)
the prognostic value##15##3##(1990-4#1)(1994-6#1)(1996-4#2)(1997-8#1)(2007-8#1)(2008-11#1)(2008-6#2)(2009-1#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)
the prognostic##41##2##(1990-10#1)(1990-4#1)(1990-6#1)(1990-9#1)(1992-2#1)(1993-9#1)(1994-6#1)(1995-9#1)(1996-4#2)(1997-8#1)(2005-9#1)(2006-6#2)(2007-10#1)(2007-8#2)(2008-1#1)(2008-11#2)(2008-6#3)(2009-1#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-3#3)
the prognostication##3##2##(2010-12#1)(2011-2#2)
the program CHARMM##2##3##(1992-12#1)(1995-5#1)
the program CHARMm##2##3##(1993-11#1)(1994-11#1)
the program and##6##3##(1993-1#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)
the program at##4##3##(1991-1#1)(1995-2#1)(2006-8#1)(2007-1#1)
the program director##2##3##(1994-3#1)(2007-7#1)
the program during##2##3##(1993-3#1)(1997-2#1)
the program for##2##3##(1993-2#1)(1996-2#1)
the program has##5##3##(1991-1#1)(1992-2#1)(1995-12#1)(1996-3#1)(2008-11#1)
the program in the past##2##5##(1992-3#1)(1995-1#1)
the program in the##4##4##(1992-3#1)(1995-1#2)(2007-4#1)
the program in##6##3##(1992-3#1)(1995-1#3)(2007-12#1)(2007-4#1)
the program include##2##3##(1996-12#1)(2005-8#1)
the program is##8##3##(1993-12#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-4#1)(2012-3#1)(2013-1#1)
the program may##2##3##(1996-1#1)(2008-4#1)
the program of##6##3##(2005-10#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-9#1)
the program should be##2##4##(1995-12#1)(2008-3#1)
the program to##4##3##(1991-2#1)(1995-12#1)(2008-3#1)(2008-7#1)
the program was##6##3##(1992-1#1)(1993-12#1)(1994-12#1)(1997-2#1)(2008-6#1)(2008-9#1)
the program with##2##3##(2008-11#1)(2008-9#1)
the program##179##2##(1990-11#1)(1990-12#2)(1990-3#1)(1991-1#3)(1991-12#4)(1991-2#2)(1992-1#2)(1992-12#3)(1992-2#2)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-4#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#6)(1995-12#6)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#2)(1996-12#2)(1996-2#6)(1996-3#3)(1997-1#1)(1997-2#6)(1997-3#1)(1997-5#1)(2005-10#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-3#3)(2006-8#1)(2007-1#3)(2007-11#1)(2007-12#3)(2007-2#2)(2007-4#3)(2007-6#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#8)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#6)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#4)(2009-11#1)(2009-4#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#3)(2010-7#2)(2010-9#3)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#6)
the program's financial##2##3##(1996-1#1)(2007-1#1)
the program's##11##2##(1995-6#1)(1996-1#1)(2006-3#1)(2007-1#1)(2007-12#1)(2007-9#1)(2008-6#3)(2010-2#1)(2010-3#1)
the programmable##4##2##(2006-8#2)(2007-12#1)(2008-6#1)
the programme and##3##3##(2006-2#1)(2008-11#1)(2008-12#1)
the programme has##3##3##(2006-2#1)(2008-8#1)(2012-12#1)
the programme in##2##3##(1991-9#1)(2012-3#1)
the programme is##6##3##(1991-11#1)(1992-3#1)(2008-11#1)(2008-12#2)(2010-9#1)
the programme was##6##3##(2007-2#1)(2007-7#1)(2008-2#1)(2008-7#2)(2012-12#1)
the programme##56##2##(1990-11#1)(1991-11#1)(1991-4#1)(1991-9#2)(1992-3#1)(1993-6#2)(1996-4#1)(2004-2#2)(2006-2#4)(2006-4#2)(2007-2#1)(2007-7#3)(2008-1#2)(2008-10#1)(2008-11#6)(2008-12#6)(2008-2#1)(2008-7#2)(2008-8#1)(2010-1#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#4)(2013-8#1)
the programme's##2##2##(2008-11#1)(2008-7#1)
the programmed##5##2##(1991-11#1)(1994-5#1)(2008-2#1)(2010-9#1)(2012-2#1)
the programmes##2##2##(2008-9#1)(2012-11#1)
the programming of the##2##4##(1996-12#1)(2009-9#1)
the programming of##3##3##(1996-12#1)(1996-5#1)(2009-9#1)
the programming rate for the##2##5##(2008-10#2)
the programming##8##2##(1996-12#1)(1996-5#1)(2007-12#2)(2008-10#2)(2008-9#1)(2009-9#1)
the programs are##2##3##(2008-6#1)(2008-9#1)
the programs must be##2##4##(1997-2#1)(2013-1#1)
the programs of the##2##4##(1997-2#1)(2013-1#1)
the programs##32##2##(1990-10#2)(1990-12#4)(1991-1#1)(1992-1#1)(1992-12#1)(1993-2#1)(1994-3#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-6#1)(1997-2#3)(2008-6#2)(2008-7#1)(2008-9#4)(2009-4#1)(2011-2#1)(2013-1#4)
the programs'##2##2##(1997-3#1)(2007-11#1)
the progress achieved##2##3##(2006-10#1)(2008-1#1)
the progress and##4##3##(1993-6#1)(2006-4#1)(2008-7#1)(2010-12#1)
the progress being made in the##2##6##(2005-9#1)(2006-10#1)
the progress being made##3##4##(2005-9#1)(2006-10#1)(2008-5#1)
the progress curves##2##3##(1991-5#1)(1992-8#1)
the progress has been##2##4##(2006-9#1)(2008-8#1)
the progress in the##2##4##(2008-5#1)(2008-8#1)
the progress in##7##3##(2005-7#1)(2007-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)
the progress made by##4##4##(2008-11#1)(2008-9#1)(2012-3#2)
the progress made in the past##2##6##(2010-5#1)(2011-2#1)
the progress made in the##3##5##(2008-5#1)(2010-5#1)(2011-2#1)
the progress made in understanding the##2##6##(2009-2#1)(2011-1#1)
the progress made in##5##4##(2008-5#1)(2009-2#1)(2010-5#1)(2011-1#1)(2011-2#1)
the progress made##12##3##(2006-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
the progress of infection with##2##5##(2008-11#2)
the progress of research##2##4##(2010-10#1)(2013-8#1)
the progress of the disease##4##5##(1993-11#1)(1993-5#1)(2007-7#2)
the progress of the##10##4##(1991-9#1)(1993-11#1)(1993-5#1)(1996-4#1)(2005-11#1)(2006-10#1)(2007-7#2)(2008-12#1)(2008-5#1)
the progress of this##2##4##(2008-10#1)(2008-9#1)
the progress of##52##3##(1991-9#2)(1993-11#1)(1993-5#1)(1995-1#1)(1995-6#1)(1996-11#1)(1996-4#1)(1996-5#2)(1997-2#1)(1997-5#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-12#1)(2007-11#2)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-4#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-8#2)
the progress that has been made in understanding the##2##9##(2009-7#1)(2011-1#1)
the progress that has been made in##4##7##(2006-12#1)(2008-8#1)(2009-7#1)(2011-1#1)
the progress that has been made##6##6##(2006-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-1#1)
the progress that has been##7##5##(2006-12#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-1#1)
the progress to date in##2##5##(2008-1#1)(2011-1#1)
the progress##104##2##(1991-12#2)(1991-5#1)(1991-9#2)(1992-8#1)(1993-11#1)(1993-5#1)(1993-6#1)(1995-1#1)(1995-6#1)(1996-11#2)(1996-4#1)(1996-5#2)(1997-2#1)(1997-5#1)(1997-8#1)(2005-11#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#8)(2006-12#2)(2006-4#1)(2006-5#1)(2006-9#1)(2007-11#3)(2007-2#1)(2007-7#3)(2007-8#1)(2008-1#4)(2008-10#7)(2008-11#4)(2008-12#1)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#4)(2009-2#1)(2009-4#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#2)(2010-8#2)(2011-1#4)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
the progresses##2##2##(2008-10#1)(2012-3#1)
the progression and the##2##4##(1995-12#1)(2013-1#1)
the progression and##7##3##(1991-10#1)(1995-12#1)(2005-11#1)(2007-12#1)(2008-10#1)(2013-1#1)(2013-7#1)
the progression from##5##3##(2006-10#1)(2007-11#1)(2007-6#1)(2008-1#1)(2012-2#1)
the progression model##2##3##(2010-7#2)
the progression of DR##2##4##(2008-1#2)
the progression of Parkinson's disease##2##5##(1997-2#1)(2013-8#1)
the progression of a##2##4##(1991-7#1)(2011-1#1)
the progression of atherosclerosis##6##4##(1993-12#1)(1995-1#1)(2008-1#3)(2010-12#1)
the progression of breast cancer##2##5##(1996-3#1)(2008-4#1)
the progression of cardiac dysfunction##2##5##(2011-2#2)
the progression of cell cycle##2##5##(1997-1#1)(2008-8#1)
the progression of cells from##2##5##(1994-12#1)(1996-4#1)
the progression of chronic renal##5##5##(1994-3#1)(2006-8#2)(2006-9#1)(2008-1#1)
the progression of chronic##7##4##(1994-3#1)(1997-7#1)(2005-7#1)(2006-8#2)(2006-9#1)(2008-1#1)
the progression of colorectal cancer##3##5##(1994-6#1)(2008-4#1)(2009-4#1)
the progression of coronary artery disease##2##6##(1996-1#1)(2009-11#1)
the progression of coronary atherosclerosis##2##5##(1991-7#1)(2005-12#1)
the progression of coronary##5##4##(1991-7#1)(1996-1#1)(1996-5#1)(2005-12#1)(2009-11#1)
the progression of diabetic nephropathy##4##5##(2007-11#2)(2009-11#2)
the progression of diabetic##5##4##(2007-11#2)(2009-11#2)(2011-2#1)
the progression of disability##2##4##(2007-11#1)(2008-7#1)
the progression of disease##2##4##(2008-10#1)(2008-11#1)
the progression of human immunodeficiency##2##5##(2007-11#2)
the progression of human##3##4##(2007-11#2)(2008-7#1)
the progression of insulin##2##4##(2008-1#2)
the progression of liver##4##4##(2006-6#1)(2011-12#1)(2012-12#1)(2013-8#1)
the progression of myopia##5##4##(2012-12#5)
the progression of numerous##2##4##(2007-3#1)(2008-9#1)
the progression of prostate cancer##2##5##(1997-7#1)(2006-10#1)
the progression of renal failure##2##5##(1990-4#1)(2007-11#1)
the progression of renal insufficiency##3##5##(1990-5#1)(1990-9#1)(2005-7#1)
the progression of renal##12##4##(1990-4#1)(1990-5#1)(1990-9#1)(2004-11#1)(2005-10#2)(2005-7#2)(2007-11#1)(2007-7#1)(2012-12#2)
the progression of the disease##9##5##(1993-12#1)(1994-5#1)(1994-6#1)(1996-6#1)(2005-11#1)(2007-11#1)(2008-1#1)(2010-12#1)(2011-1#1)
the progression of the##21##4##(1990-10#1)(1993-11#1)(1993-12#2)(1994-5#2)(1994-6#1)(1996-6#1)(2005-11#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
the progression of this disease##2##5##(1997-7#1)(2008-1#1)
the progression of tumors##2##4##(1995-1#1)(2012-1#1)
the progression of vascular##2##4##(2007-10#1)(2012-12#1)
the progression of##172##3##(1990-10#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-7#3)(1993-11#1)(1993-12#4)(1993-9#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-6#4)(1995-1#2)(1995-11#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-7#4)(2004-11#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-7#3)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#2)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#10)(2007-3#1)(2007-7#5)(2007-8#4)(2007-9#1)(2008-1#11)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#7)(2008-8#3)(2008-9#2)(2009-11#4)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#11)(2012-2#1)(2013-1#4)(2013-8#9)
the progression to##5##3##(2006-2#1)(2008-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
the progression##195##2##(1990-10#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-7#3)(1993-11#1)(1993-12#4)(1993-9#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-6#4)(1995-1#2)(1995-11#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-7#4)(2004-11#1)(2004-3#1)(2005-10#2)(2005-11#3)(2005-12#1)(2005-7#3)(2006-10#3)(2006-12#1)(2006-2#2)(2006-6#1)(2006-8#2)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#11)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#5)(2007-8#4)(2007-9#1)(2008-1#12)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#7)(2008-8#3)(2008-9#2)(2009-11#4)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-7#2)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#8)(2011-3#1)(2012-1#2)(2012-12#11)(2012-2#3)(2013-1#6)(2013-7#1)(2013-8#10)
the progressive destruction of##2##4##(1990-8#1)(2011-2#1)
the progressive development of##2##4##(2006-10#1)(2008-4#1)
the progressive disease##2##3##(1991-8#1)(2011-1#1)
the progressive hearing loss##2##4##(2012-2#2)
the progressive increase in##3##4##(1994-2#1)(2008-10#1)(2009-2#1)
the progressive increase##4##3##(1994-2#1)(2008-10#1)(2009-2#1)(2011-2#1)
the progressive loss of##3##4##(1990-3#1)(2008-5#2)
the progressive thickening of the arterial intima##2##7##(1992-12#2)
the progressive##56##2##(1990-3#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-8#1)(1992-12#2)(1993-6#1)(1994-2#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-5#1)(1997-8#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-12#2)(2007-3#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#2)(2009-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2013-8#2)
the prohibited list##2##3##(2010-4#2)
the prohibition on##3##3##(1995-6#1)(1996-6#1)(2006-3#1)
the prohormone##3##2##(1992-12#1)(1993-5#1)(2008-4#1)
the proinflammatory cytokine##4##3##(1995-3#1)(2007-12#1)(2008-4#1)(2010-12#1)
the proinflammatory cytokines##3##3##(1995-12#1)(2009-9#1)(2013-7#1)
the proinflammatory##11##2##(1995-12#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-12#1)(2013-7#1)
the proinsulin##3##2##(1995-5#1)(1996-7#1)(2008-11#1)
the project &quot##2##3##(2011-2#2)
the project and##5##3##(1992-1#1)(1992-2#1)(2008-1#1)(2008-8#1)(2009-9#1)
the project are##6##3##(1993-3#1)(1996-1#1)(2006-1#1)(2007-9#1)(2008-11#1)(2008-6#1)
the project as well as##2##5##(2007-11#1)(2008-11#1)
the project contributed to##2##4##(2005-12#1)(2008-1#1)
the project is##5##3##(1993-3#1)(1996-2#1)(2005-10#1)(2008-1#1)(2011-9#1)
the project of##3##3##(2009-7#1)(2012-2#2)
the project team##3##3##(1995-3#3)
the project to##2##3##(1995-2#1)(2008-4#1)
the project was to##3##4##(1996-7#1)(1997-4#1)(2012-1#1)
the project was##7##3##(1995-3#1)(1996-7#1)(1997-4#1)(2010-5#1)(2011-9#2)(2012-1#1)
the project were##3##3##(1995-3#1)(2006-5#1)(2008-11#1)
the project will##2##3##(2009-10#1)(2012-12#1)
the project##108##2##(1990-4#3)(1991-3#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#4)(1995-11#1)(1995-2#2)(1995-3#6)(1995-5#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-3#4)(1997-4#1)(2005-10#3)(2005-12#2)(2006-1#2)(2006-10#1)(2006-5#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-9#4)(2008-1#4)(2008-10#2)(2008-11#9)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#2)(2009-7#3)(2009-9#1)(2010-2#1)(2010-5#2)(2010-8#3)(2010-9#1)(2011-2#4)(2011-9#4)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)
the project's##2##2##(2005-12#1)(2006-10#1)
the projected grating##3##3##(2008-2#1)(2008-3#2)
the projected##18##2##(1990-12#1)(1996-1#1)(2005-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-6#2)(2008-8#1)(2010-11#1)(2010-2#1)(2011-1#1)
the projection from the##2##4##(1996-6#1)(1997-6#1)
the projection lens##3##3##(2008-2#1)(2008-3#2)
the projection neurons of the##4##5##(1995-12#1)(1996-12#2)(2009-12#1)
the projection of the##4##4##(1991-8#1)(2008-2#1)(2008-4#1)(2011-2#1)
the projection of##7##3##(1991-8#1)(2008-2#1)(2008-3#2)(2008-4#1)(2010-6#1)(2011-2#1)
the projection##32##2##(1991-8#1)(1991-9#1)(1992-10#2)(1993-2#1)(1995-12#1)(1996-12#2)(1996-6#1)(1997-6#1)(2007-1#1)(2007-12#1)(2008-11#1)(2008-2#5)(2008-3#8)(2008-4#1)(2008-5#1)(2009-12#1)(2010-6#1)(2011-2#1)(2013-7#1)
the projections from the##2##4##(1997-7#1)(2008-11#1)
the projections of the##2##4##(2007-12#1)(2009-2#1)
the projections##13##2##(1991-1#1)(1991-9#1)(1996-9#1)(1997-7#1)(2006-10#1)(2007-12#2)(2008-11#1)(2008-2#2)(2009-2#1)(2009-5#1)(2012-11#1)
the projector##3##2##(2008-3#3)
the projects##11##2##(1994-1#1)(1997-2#1)(2007-1#1)(2008-1#1)(2008-2#1)(2009-4#2)(2012-12#1)(2012-3#2)(2013-1#1)
the prokaryote Acaryochloris marina##2##4##(1997-6#2)
the prokaryote##4##2##(1997-6#2)(2008-10#1)(2008-9#1)
the prokaryotic expression##2##3##(1995-11#1)(2005-11#1)
the prokaryotic##12##2##(1990-11#1)(1993-11#1)(1994-12#1)(1995-11#1)(2005-11#1)(2008-10#1)(2008-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#1)
the prolactin gene##3##3##(1995-3#3)
the prolactin receptor##2##3##(1990-11#1)(2008-4#1)
the prolactin requirement##2##3##(1994-11#2)
the prolactin##10##2##(1990-11#2)(1992-7#1)(1994-11#2)(1995-3#3)(2004-1#1)(2008-4#1)
the proliferating cell##2##3##(1995-2#1)(1997-7#1)
the proliferating cells##2##3##(1995-12#1)(2008-5#1)
the proliferating##9##2##(1992-9#1)(1993-8#2)(1994-9#1)(1995-12#1)(1995-2#1)(1997-7#1)(2008-5#1)(2009-9#1)
the proliferation and differentiation of mesenchymal stem cells##2##8##(2008-5#2)
the proliferation and differentiation of##10##5##(1990-4#1)(1995-10#1)(1996-10#1)(1997-1#1)(2008-5#4)(2012-12#1)(2013-7#1)
the proliferation and differentiation##12##4##(1990-4#1)(1995-10#1)(1995-2#1)(1996-10#1)(1997-1#1)(2008-5#5)(2012-12#1)(2013-7#1)
the proliferation and invasion of##7##5##(2008-11#5)(2013-1#2)
the proliferation and migration of endothelial cells##2##7##(1991-12#1)(1993-9#1)
the proliferation and survival of##3##5##(2005-11#1)(2013-1#2)
the proliferation and##33##3##(1990-4#1)(1991-12#1)(1993-3#1)(1993-9#1)(1994-6#2)(1995-10#1)(1995-2#2)(1996-10#1)(1997-1#1)(2005-11#1)(2007-4#1)(2008-11#5)(2008-5#6)(2011-2#2)(2012-12#2)(2013-1#4)(2013-7#1)
the proliferation kinetics of##2##4##(1993-11#1)(2013-8#1)
the proliferation of B##2##4##(2007-11#1)(2008-10#1)
the proliferation of MCF-7##2##4##(1996-3#1)(2008-11#1)
the proliferation of T##2##4##(1993-3#1)(2012-2#1)
the proliferation of all##2##4##(1991-5#1)(2010-4#1)
the proliferation of allogeneic##2##4##(2008-4#1)(2009-9#1)
the proliferation of another##2##4##(2007-4#1)(2008-11#1)
the proliferation of cell##2##4##(1996-2#1)(2008-5#1)
the proliferation of human##6##4##(1991-9#1)(1994-3#1)(2004-9#1)(2008-11#1)(2008-5#1)(2008-8#1)
the proliferation of malignant cells##2##5##(2010-1#2)
the proliferation of mouse##2##4##(1992-5#1)(2008-11#1)
the proliferation of neural##2##4##(1994-11#1)(1995-11#1)
the proliferation of normal##2##4##(1991-3#1)(1996-3#1)
the proliferation of peroxisomes##3##4##(2009-8#3)
the proliferation of the human##2##5##(1994-6#1)(2008-4#1)
the proliferation of the##16##4##(1991-9#1)(1993-9#1)(1994-6#1)(2006-9#1)(2008-11#5)(2008-3#1)(2008-4#3)(2008-8#1)(2010-11#1)(2011-1#1)
the proliferation of this##2##4##(1997-7#1)(2005-8#1)
the proliferation of uterine epithelial cells##3##6##(2008-6#3)
the proliferation of vascular##2##4##(1990-12#1)(1997-1#1)
the proliferation of##118##3##(1990-12#2)(1990-5#2)(1990-7#2)(1991-12#2)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-2#1)(1992-5#1)(1993-12#1)(1993-3#2)(1993-4#2)(1993-9#2)(1994-11#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#3)(1997-7#2)(2004-9#1)(2005-8#2)(2005-9#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-11#18)(2008-3#2)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#5)(2008-9#2)(2009-4#1)(2009-8#3)(2009-9#2)(2010-1#2)(2010-11#2)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#3)(2012-3#2)(2013-8#1)
the proliferation rate and##2##4##(2008-11#1)(2008-7#1)
the proliferation rate##4##3##(1995-4#1)(2008-11#1)(2008-5#1)(2008-7#1)
the proliferation##173##2##(1990-12#2)(1990-4#1)(1990-5#2)(1990-7#2)(1991-12#3)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#2)(1992-2#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-4#2)(1993-6#1)(1993-9#4)(1994-11#1)(1994-3#2)(1994-5#1)(1994-6#3)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-4#1)(1995-5#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1997-1#4)(1997-7#2)(2004-9#2)(2005-11#1)(2005-8#2)(2005-9#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-4#2)(2008-10#1)(2008-11#26)(2008-3#2)(2008-4#7)(2008-5#10)(2008-6#3)(2008-7#3)(2008-8#6)(2008-9#2)(2009-4#1)(2009-8#3)(2009-9#2)(2010-1#2)(2010-11#2)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
the proliferative activity of##2##4##(1997-7#1)(2008-11#1)
the proliferative activity##3##3##(1990-8#1)(1997-7#1)(2008-11#1)
the proliferative lymphocytes were##2##4##(2008-9#2)
the proliferative lymphocytes##3##3##(2008-9#3)
the proliferative phase of##2##4##(1994-9#1)(2006-9#1)
the proliferative phase##3##3##(1994-9#1)(2006-9#1)(2011-2#1)
the proliferative potential in##2##4##(2007-12#1)(2008-11#1)
the proliferative potential##3##3##(2007-12#2)(2008-11#1)
the proliferative response of human##2##5##(1994-8#1)(1995-12#1)
the proliferative response of##7##4##(1992-7#1)(1994-8#2)(1995-10#1)(1995-12#1)(1995-2#2)
the proliferative response##8##3##(1992-7#1)(1994-8#2)(1995-10#1)(1995-12#1)(1995-2#2)(2008-7#1)
the proliferative responses##2##3##(1997-4#2)
the proliferative##49##2##(1990-8#2)(1990-9#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1994-12#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-6#1)(1997-3#1)(1997-4#2)(1997-7#2)(2006-9#1)(2007-1#1)(2007-12#2)(2008-10#1)(2008-11#5)(2008-5#1)(2008-7#1)(2008-9#4)(2009-2#1)(2011-2#4)(2012-2#1)(2013-1#1)
the proline residues##2##3##(1990-5#1)(1995-6#1)
the proline##7##2##(1990-5#1)(1991-5#1)(1994-12#2)(1995-6#1)(1996-2#1)(2008-5#1)
the proline-rich domain##2##3##(1990-5#1)(2013-8#1)
the proline-rich##5##2##(1990-5#1)(1991-6#1)(1994-9#1)(1995-3#1)(2013-8#1)
the prolines##2##2##(1994-12#1)(1995-7#1)
the prolongation of the##6##4##(1991-2#1)(1991-3#1)(1997-7#1)(2005-1#1)(2006-10#1)(2008-8#1)
the prolongation of##10##3##(1991-2#1)(1991-3#1)(1991-4#1)(1993-3#1)(1997-7#1)(2005-1#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-8#1)
the prolongation##11##2##(1991-2#1)(1991-3#1)(1991-4#1)(1993-3#2)(1997-7#1)(2005-1#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-8#1)
the prolonged and##2##3##(2008-9#1)(2010-12#1)
the prolonged expiratory##2##3##(1997-5#2)
the prolonged exposure##2##3##(1991-8#1)(1995-12#1)
the prolonged use of##2##4##(2005-10#1)(2012-3#1)
the prolonged##30##2##(1990-11#2)(1991-8#1)(1991-9#1)(1992-11#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-5#3)(2005-10#1)(2005-12#1)(2006-10#2)(2007-2#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
the prominence of##3##3##(1991-11#1)(2008-11#1)(2009-5#1)
the prominent role of the##2##5##(1990-8#1)(1994-8#1)
the prominent role of##4##4##(1990-8#1)(1994-8#1)(2008-10#1)(2008-6#1)
the prominent##19##2##(1990-5#1)(1990-8#1)(1991-8#1)(1991-9#1)(1994-8#1)(1995-12#1)(2006-8#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
the promiscuous##2##2##(1996-8#1)(2005-10#1)
the promise and the##2##4##(1994-12#1)(1996-12#1)
the promise and##4##3##(1994-12#1)(1996-12#1)(2006-10#1)(2010-2#1)
the promise of more##2##4##(2009-12#2)
the promise of the##2##4##(2007-9#1)(2009-7#1)
the promise of##29##3##(1995-8#1)(1996-3#2)(2006-7#1)(2007-1#1)(2007-9#3)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#2)(2009-12#3)(2009-7#2)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the promise to##4##3##(2007-12#1)(2007-8#1)(2008-1#1)(2009-4#1)
the promise##42##2##(1994-12#1)(1995-8#1)(1996-12#1)(1996-3#2)(2005-8#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#2)(2008-11#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#2)(2009-12#3)(2009-4#1)(2009-7#2)(2010-2#2)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
the promised##2##2##(2007-2#1)(2008-5#1)
the promises and##2##3##(2007-4#1)(2010-7#1)
the promises of##3##3##(2008-11#1)(2008-7#1)(2010-9#1)
the promises##7##2##(2006-9#1)(2007-4#1)(2008-11#1)(2008-7#1)(2009-3#1)(2010-7#1)(2010-9#1)
the promising results##2##3##(2005-12#1)(2008-1#1)
the promising##11##2##(2005-12#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#1)(2009-10#1)(2011-1#1)(2012-12#1)(2013-8#1)
the promontory stimulation test##2##4##(2008-9#2)
the promontory##4##2##(2008-9#4)
the promoted##2##2##(2005-11#1)(2009-3#1)
the promoter II##2##3##(1992-9#2)
the promoter activity in##2##4##(1995-3#1)(1995-6#1)
the promoter activity of##2##4##(1995-2#1)(1996-7#1)
the promoter activity##12##3##(1992-9#1)(1994-8#1)(1995-2#2)(1995-3#2)(1995-6#1)(1996-7#1)(1997-2#3)(1997-7#1)
the promoter alone##2##3##(1993-3#2)
the promoter and 5' flanking##2##5##(1991-5#1)(1994-11#1)
the promoter and the first##2##5##(1990-11#1)(1991-2#1)
the promoter and the##5##4##(1990-11#1)(1991-12#1)(1991-2#1)(1993-3#1)(1997-4#1)
the promoter and##17##3##(1990-11#3)(1991-12#1)(1991-2#1)(1991-5#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#1)(1997-4#1)(2006-10#1)(2008-3#1)(2011-2#1)
the promoter elements##2##3##(1994-11#1)(1995-3#1)
the promoter for the##3##4##(1990-4#1)(1992-8#1)(1995-2#1)
the promoter for##6##3##(1990-4#1)(1991-4#1)(1992-8#1)(1993-5#1)(1995-2#1)(1995-6#1)
the promoter in##4##3##(1995-6#1)(1997-2#1)(1997-4#2)
the promoter is##4##3##(1997-4#2)(1997-7#1)(2008-2#1)
the promoter of the CYP19a gene##2##6##(2009-7#2)
the promoter of the gene##2##5##(1996-12#1)(1997-2#1)
the promoter of the##16##4##(1990-9#1)(1992-11#1)(1994-12#1)(1995-2#1)(1996-12#1)(1997-2#3)(1997-4#1)(2006-6#1)(2008-11#2)(2009-7#2)(2011-2#1)(2012-12#1)
the promoter of##24##3##(1990-11#1)(1990-9#1)(1992-11#1)(1993-12#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-2#3)(1997-4#1)(2006-6#1)(2007-10#1)(2008-11#2)(2008-9#2)(2009-7#2)(2009-8#1)(2011-2#1)(2012-12#2)
the promoter or##3##3##(1993-3#1)(2008-5#1)(2012-3#1)
the promoter region of K##2##5##(1993-12#2)
the promoter region of the human##3##6##(1993-3#1)(1994-6#1)(1997-2#1)
the promoter region of the##15##5##(1990-5#1)(1990-9#2)(1992-11#1)(1992-3#1)(1993-3#1)(1994-3#1)(1994-6#2)(1995-11#1)(1995-3#1)(1997-2#1)(1997-7#1)(2007-9#2)
the promoter region of##29##4##(1990-5#1)(1990-9#2)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-3#1)(1994-6#2)(1995-11#1)(1995-3#1)(1997-2#1)(1997-6#1)(1997-7#2)(2007-10#1)(2007-8#1)(2007-9#2)(2009-4#1)(2009-8#2)(2011-2#1)(2012-2#1)
the promoter region##50##3##(1990-5#1)(1990-9#2)(1991-12#1)(1991-6#3)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#3)(1994-12#2)(1994-3#1)(1994-6#2)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#2)(1997-6#2)(1997-7#2)(2007-10#1)(2007-2#1)(2007-8#1)(2007-9#2)(2009-4#1)(2009-8#2)(2011-1#1)(2011-2#2)(2012-2#1)
the promoter regions of the##2##5##(1993-3#1)(2009-8#1)
the promoter regions of##7##4##(1993-3#1)(1995-3#1)(1997-2#3)(2009-8#2)
the promoter regions##8##3##(1993-3#1)(1995-3#1)(1997-2#3)(2009-8#2)(2012-3#1)
the promoter sequence of##2##4##(1995-8#1)(1996-5#1)
the promoter sequence##4##3##(1995-8#1)(1996-5#1)(2011-1#2)
the promoter sequences##3##3##(1994-9#1)(1996-4#1)(1997-4#1)
the promoter was##3##3##(1990-3#1)(1992-5#1)(1994-5#1)
the promoter with##2##3##(1993-12#1)(1996-7#1)
the promoter##206##2##(1990-11#4)(1990-3#2)(1990-4#2)(1990-5#5)(1990-9#4)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-9#2)(1992-11#3)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#4)(1993-12#7)(1993-2#1)(1993-3#13)(1993-5#1)(1993-6#3)(1993-9#1)(1994-11#3)(1994-12#4)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#3)(1995-11#1)(1995-2#6)(1995-3#11)(1995-6#4)(1995-8#2)(1996-10#1)(1996-12#1)(1996-4#3)(1996-5#2)(1996-7#4)(1997-2#13)(1997-4#11)(1997-5#3)(1997-6#2)(1997-7#4)(2006-10#2)(2006-12#1)(2006-6#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#2)(2008-11#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-4#1)(2009-7#2)(2009-8#5)(2010-3#1)(2011-1#5)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#2)
the promoter-proximal##4##2##(1995-8#2)(1997-6#2)
the promoterless##6##2##(1990-10#1)(1990-5#1)(1993-12#1)(1994-12#1)(1997-2#2)
the promoters for the##3##4##(1990-5#1)(1994-11#1)(1995-8#1)
the promoters of the##2##4##(1993-3#1)(2008-2#1)
the promoters of these##2##4##(2008-7#2)
the promoters of##13##3##(1993-3#1)(1994-6#1)(1997-2#1)(2006-12#1)(2007-10#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-8#1)(2012-2#1)
the promoters##20##2##(1990-5#1)(1992-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-8#1)(1997-2#1)(2006-12#1)(2007-10#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-8#1)(2012-2#1)
the promoting effects of##2##4##(1992-9#2)
the promoting##5##2##(1992-1#1)(1992-9#2)(1993-9#1)(2008-9#1)
the promotion of health##3##4##(2008-1#1)(2008-10#1)(2012-2#1)
the promotion of healthy##2##4##(2010-10#1)(2011-1#1)
the promotion of non-smoking##3##4##(2007-3#3)
the promotion of the##2##4##(2008-3#1)(2013-8#1)
the promotion of##48##3##(1990-7#1)(1991-12#1)(1991-3#1)(1993-3#1)(1993-6#2)(1996-10#1)(1996-11#1)(1996-3#1)(2005-8#1)(2007-11#1)(2007-2#1)(2007-3#6)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-9#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#3)
the promotion##51##2##(1990-7#1)(1991-12#1)(1991-3#1)(1993-3#1)(1993-6#2)(1993-7#2)(1996-10#1)(1996-11#1)(1996-3#1)(2005-8#1)(2007-11#1)(2007-2#1)(2007-3#6)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-9#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#3)
the promotor##2##2##(1997-8#1)(2008-8#1)
the prompt##4##2##(1994-5#1)(1996-5#1)(2010-10#1)(2013-1#1)
the prone position##15##3##(1992-11#7)(1992-4#3)(2008-7#1)(2010-10#3)(2013-7#1)
the prone sleeping position##5##4##(1991-2#1)(1992-11#2)(1992-4#1)(2007-1#1)
the prone##22##2##(1991-2#1)(1992-11#9)(1992-4#4)(2006-8#1)(2007-1#1)(2008-7#1)(2010-10#3)(2013-7#2)
the pronephros##3##2##(1997-9#1)(2012-12#2)
the proneural##2##2##(2009-5#1)(2011-12#1)
the prongs##3##2##(1992-11#1)(2008-7#2)
the pronounced##7##2##(1990-7#1)(1995-8#1)(1996-8#1)(2007-11#1)(2008-10#1)(2009-4#1)(2010-4#1)
the proof of##3##3##(1997-4#1)(2008-1#1)(2011-9#1)
the proof##5##2##(1996-6#1)(1997-4#1)(2008-1#1)(2008-5#1)(2011-9#1)
the proofreading##2##2##(1990-5#1)(1991-9#1)
the proopiomelanocortin##3##2##(1993-5#1)(2008-4#2)
the prooxidant##2##2##(2006-12#1)(2008-8#1)
the prooxidant/antioxidant##2##2##(1994-6#1)(2008-4#1)
the propagating##14##2##(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#6)(2009-2#1)
the propagation axis##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
the propagation characteristics of##2##4##(2007-11#1)(2008-2#1)
the propagation constants##2##3##(2008-3#2)
the propagation direction by##2##4##(2007-11#1)(2008-3#1)
the propagation direction##5##3##(2007-11#2)(2007-12#1)(2008-3#2)
the propagation distance##4##3##(2007-12#3)(2008-1#1)
the propagation dynamics of##2##4##(2007-12#2)
the propagation losses##3##3##(2007-12#1)(2008-2#2)
the propagation of a##7##4##(1991-6#1)(2007-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-6#1)
the propagation of femtosecond pulses##2##5##(2007-11#2)
the propagation of intense##4##4##(2007-12#4)
the propagation of light in##2##5##(2007-12#1)(2008-2#1)
the propagation of light through##2##5##(2007-12#1)(2008-3#1)
the propagation of light##5##4##(2007-12#3)(2008-2#1)(2008-3#1)
the propagation of seizure activity##2##5##(1990-5#1)(1991-3#1)
the propagation of the##7##4##(1991-11#1)(1994-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)
the propagation of##52##3##(1990-5#1)(1991-11#2)(1991-3#1)(1991-6#1)(1994-3#1)(1994-9#1)(1997-4#1)(2004-12#1)(2005-11#2)(2007-11#4)(2007-12#13)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#8)(2008-4#1)(2008-9#3)(2009-12#1)(2009-6#1)(2011-2#1)
the propagation properties of the##4##5##(2007-12#3)(2008-3#1)
the propagation properties of##5##4##(2007-12#3)(2008-3#2)
the propagation properties##6##3##(2007-12#3)(2008-3#3)
the propagation vector##2##3##(2007-12#1)(2008-2#1)
the propagation##115##2##(1990-5#1)(1991-11#2)(1991-12#3)(1991-3#1)(1991-6#1)(1993-11#1)(1994-3#1)(1994-9#1)(1997-4#1)(1997-8#3)(2004-12#1)(2005-11#2)(2007-11#11)(2007-12#29)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#17)(2008-3#26)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#4)(2009-12#1)(2009-6#1)(2011-2#1)
the propagator##2##2##(2007-11#2)
the propanol vapor##2##3##(2008-3#2)
the propellant##3##2##(1996-1#1)(1996-2#1)(2008-10#1)
the propensity for##4##3##(1993-6#1)(2008-8#1)(2012-12#1)(2013-1#1)
the propensity of##13##3##(1991-9#1)(1996-12#1)(1997-2#1)(1997-4#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-12#1)(2011-1#1)(2012-2#2)
the propensity score##7##3##(2007-8#2)(2010-3#1)(2011-1#2)(2012-3#2)
the propensity to develop##2##4##(2005-10#1)(2006-1#1)
the propensity to##8##3##(1993-6#1)(2005-10#1)(2006-1#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-7#1)(2011-2#1)
the propensity##32##2##(1991-9#1)(1993-6#2)(1996-12#1)(1997-2#1)(1997-4#1)(2005-10#1)(2006-1#1)(2007-8#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-7#2)(2010-12#1)(2010-3#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
the propeptide##10##2##(1991-9#2)(1994-11#4)(1994-9#1)(1995-3#3)
the proper application of the##2##5##(2007-11#1)(2013-7#1)
the proper application of##3##4##(2007-11#1)(2008-3#1)(2013-7#1)
the proper assessment##2##3##(1991-3#1)(2008-11#1)
the proper balance of##2##4##(1991-12#1)(2007-11#1)
the proper balance##3##3##(1991-12#1)(1997-2#1)(2007-11#1)
the proper care##2##3##(1994-1#1)(1995-2#1)
the proper choice of##4##4##(2007-12#1)(2007-7#1)(2008-2#1)(2008-9#1)
the proper choice##5##3##(2007-12#1)(2007-7#1)(2008-2#1)(2008-9#2)
the proper combination of##3##4##(1994-9#1)(2005-7#1)(2012-2#1)
the proper conditions for##2##4##(1993-11#1)(2008-3#1)
the proper course of treatment##2##5##(2007-11#2)
the proper diagnosis##2##3##(2007-11#1)(2011-12#1)
the proper function of##2##4##(2011-1#1)(2012-12#1)
the proper functioning of##3##4##(2005-10#1)(2007-11#1)(2012-2#1)
the proper indications##2##3##(2007-11#1)(2008-8#1)
the proper management of##2##4##(2005-11#1)(2010-8#1)
the proper management##3##3##(2005-11#1)(2010-8#2)
the proper muscular layer##2##4##(1993-8#1)(2008-5#1)
the proper name##2##3##(2013-1#2)
the proper optimum##2##3##(2008-10#2)
the proper physiological##2##3##(2007-11#1)(2008-7#1)
the proper role of##2##4##(1996-12#1)(2013-8#1)
the proper selection of the##2##5##(2007-12#1)(2008-11#1)
the proper selection of##7##4##(1990-5#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-11#1)(2010-5#1)
the proper structure##2##3##(1992-3#1)(1996-3#1)
the proper timing##2##3##(1997-4#1)(2009-8#1)
the proper use of these##2##5##(2007-11#1)(2010-9#1)
the proper use of##5##4##(1993-12#1)(2007-1#1)(2007-11#1)(2007-4#1)(2010-9#1)
the proper way to##2##4##(2007-5#1)(2011-1#1)
the proper##151##2##(1990-5#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#4)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-3#1)(2005-7#2)(2006-10#3)(2006-11#1)(2006-6#1)(2007-1#1)(2007-11#18)(2007-12#6)(2007-4#2)(2007-5#1)(2007-7#3)(2007-8#4)(2008-10#7)(2008-11#4)(2008-2#5)(2008-3#7)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-8#3)(2010-4#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#3)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#2)
the properly##3##2##(1994-11#1)(2011-2#1)(2012-3#1)
the properties and##9##3##(1995-5#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-7#1)
the properties of 1##2##4##(1993-7#1)(1994-11#1)
the properties of a##7##4##(1991-11#2)(1993-11#1)(2008-11#1)(2008-2#1)(2008-5#1)(2013-8#1)
the properties of an##2##4##(1994-11#1)(2008-3#1)
the properties of both##2##4##(1995-5#1)(2007-11#1)
the properties of highly##3##4##(1992-3#1)(1993-12#1)(2008-2#1)
the properties of interest##2##4##(2008-11#1)(2008-9#1)
the properties of known##2##4##(1994-12#1)(2008-7#1)
the properties of the cell##2##5##(2008-11#1)(2008-5#1)
the properties of the membrane##3##5##(1993-8#1)(2008-10#1)(2009-5#1)
the properties of the protein##2##5##(1991-2#1)(1996-1#1)
the properties of the two##2##5##(1996-1#1)(1996-11#1)
the properties of the##65##4##(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-5#1)(1993-8#2)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1996-1#2)(1996-11#2)(1996-7#1)(1997-3#1)(2004-9#1)(2005-11#2)(2006-11#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#4)(2008-10#3)(2008-11#2)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#2)(2010-4#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
the properties of these##6##4##(1991-11#1)(1991-2#1)(1994-9#1)(2004-2#1)(2008-11#1)(2008-3#1)
the properties of this##2##4##(1995-8#1)(2008-7#1)
the properties of two##2##4##(2007-12#1)(2008-5#1)
the properties of waveguides##2##4##(2007-11#1)(2008-2#1)
the properties of##187##3##(1990-12#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-11#3)(1991-12#1)(1991-2#2)(1991-4#2)(1991-5#1)(1992-1#1)(1992-10#1)(1992-3#3)(1992-9#1)(1993-11#1)(1993-12#2)(1993-5#1)(1993-7#2)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-2#2)(1995-5#4)(1995-6#1)(1995-8#1)(1996-1#3)(1996-11#2)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-8#1)(2004-2#1)(2004-9#2)(2005-11#4)(2006-11#1)(2006-4#1)(2006-5#2)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#12)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#11)(2008-11#7)(2008-12#1)(2008-2#10)(2008-3#10)(2008-4#2)(2008-5#9)(2008-7#4)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#2)(2009-9#1)(2010-10#1)(2010-4#3)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#3)(2013-8#3)
the properties related to##2##4##(2007-9#1)(2008-10#1)
the properties that##2##3##(2007-12#1)(2012-2#1)
the properties##213##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-1#1)(1991-11#3)(1991-12#1)(1991-2#2)(1991-4#2)(1991-5#1)(1992-1#1)(1992-10#1)(1992-3#3)(1992-9#1)(1993-11#1)(1993-12#2)(1993-5#1)(1993-7#2)(1993-8#3)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-2#2)(1995-5#5)(1995-6#1)(1995-8#1)(1996-1#3)(1996-11#2)(1996-2#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-8#1)(2004-2#1)(2004-9#2)(2005-11#5)(2006-10#1)(2006-11#1)(2006-4#1)(2006-5#2)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#14)(2007-7#1)(2007-9#3)(2008-1#3)(2008-10#13)(2008-11#9)(2008-12#1)(2008-2#11)(2008-3#11)(2008-4#2)(2008-5#11)(2008-7#4)(2008-8#4)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#3)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#3)(2010-7#2)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#3)(2013-8#3)
the property of a##2##4##(1991-11#1)(2007-12#1)
the property of the AstraZeneca group of companies)##2##8##(2007-9#2)
the property of the##3##4##(2007-9#2)(2009-2#1)
the property of##15##3##(1991-11#1)(1992-12#1)(1996-11#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-9#2)(2008-10#1)(2008-2#1)(2009-2#1)(2010-12#2)(2012-3#1)(2013-8#1)
the property that##3##3##(1990-8#1)(2007-11#1)(2008-2#1)
the property##22##2##(1990-8#1)(1991-11#1)(1992-12#1)(1994-9#1)(1996-11#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-9#2)(2008-10#2)(2008-2#4)(2009-2#1)(2010-12#2)(2012-3#1)(2013-8#1)
the prophase##2##2##(2009-10#2)
the prophylactic effects of##2##4##(1993-12#1)(2010-12#1)
the prophylactic efficacy of##2##4##(2006-12#1)(2010-4#1)
the prophylactic efficacy##3##3##(2006-12#1)(2010-4#1)(2013-1#1)
the prophylactic use of##3##4##(1990-5#1)(1992-11#1)(2006-10#1)
the prophylactic##16##2##(1990-2#1)(1990-5#1)(1990-7#1)(1992-11#1)(1993-12#1)(2006-10#1)(2006-12#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
the prophylaxis and therapy of candidiasis##2##6##(2008-5#2)
the prophylaxis and treatment of##6##5##(1990-6#1)(2006-10#1)(2007-12#1)(2008-11#1)(2010-12#1)(2013-1#1)
the prophylaxis and##10##3##(1990-6#1)(2005-7#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-5#2)(2010-12#1)(2010-8#1)(2013-1#1)
the prophylaxis of##18##3##(1990-7#2)(1991-3#1)(1991-5#1)(2006-2#1)(2006-8#1)(2007-11#3)(2007-8#2)(2008-1#1)(2008-5#2)(2008-7#1)(2009-5#1)(2009-8#1)(2010-11#1)
the prophylaxis##30##2##(1990-6#1)(1990-7#2)(1991-3#1)(1991-5#1)(1996-4#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-8#1)(2013-1#1)
the propionic acid##2##3##(2004-8#1)(2006-8#1)
the propofol##2##2##(1993-1#1)(2009-8#1)
the proportion of HIV-infected##2##4##(1990-11#1)(2007-7#1)
the proportion of P##2##4##(2008-10#2)
the proportion of Ras in the##2##6##(1992-7#2)
the proportion of affected relatives of index##2##7##(1992-9#2)
the proportion of ascospores##2##4##(2008-10#2)
the proportion of cases##2##4##(1990-2#1)(1995-6#1)
the proportion of cells in S phase##2##7##(1993-9#1)(1996-6#1)
the proportion of cells in##3##5##(1993-11#1)(1993-9#1)(1996-6#1)
the proportion of cells##7##4##(1992-7#1)(1993-11#2)(1993-9#1)(1996-6#1)(1997-4#1)(2008-4#1)
the proportion of children with##2##5##(1996-11#1)(2005-7#1)
the proportion of children##5##4##(1993-1#1)(1996-11#1)(2005-7#1)(2006-8#1)(2011-2#1)
the proportion of deleted mtDNA to normal mtDNA##2##8##(1990-10#2)
the proportion of disease##2##4##(2008-10#2)
the proportion of diseased roots##3##5##(2008-10#3)
the proportion of diseased##4##4##(2008-10#4)
the proportion of each##4##4##(1996-3#1)(2008-10#2)(2008-4#1)
the proportion of elderly##2##4##(2008-7#2)
the proportion of embryos##2##4##(2006-5#2)
the proportion of flies##2##4##(2004-11#2)
the proportion of infested##2##4##(2008-10#2)
the proportion of leaflets##3##4##(2008-10#3)
the proportion of low birth weight##2##6##(1993-3#1)(1993-6#1)
the proportion of mothers##2##4##(1993-3#1)(2007-7#1)
the proportion of n-3 PUFA in RBC##2##7##(2007-8#2)
the proportion of osteoclasts##2##4##(1993-9#2)
the proportion of overwintering adult corn flea beetles infested with P##2##11##(2008-10#2)
the proportion of patients achieving##3##5##(2010-8#2)(2013-1#1)
the proportion of patients who can##2##6##(2007-10#1)(2009-8#1)
the proportion of patients who##5##5##(1995-4#1)(2007-10#1)(2007-8#1)(2008-7#1)(2009-8#1)
the proportion of patients with a##2##6##(1997-7#1)(2007-10#1)
the proportion of patients with##12##5##(1992-5#1)(1994-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2008-7#1)(2012-12#1)(2013-8#3)
the proportion of patients##25##4##(1992-5#1)(1994-4#1)(1995-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-8#1)(2007-9#1)(2008-7#3)(2009-8#1)(2010-8#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
the proportion of people##2##4##(1994-2#1)(1996-1#1)
the proportion of persons dying of##2##6##(1990-12#2)
the proportion of philopatric (and thereby altruistic) individuals##2##8##(2008-8#2)
the proportion of pollen tubes reaching the bottom of the style##2##11##(2009-12#2)
the proportion of responders##3##4##(2006-10#1)(2013-1#2)
the proportion of subjects with no peristalsis##2##7##(2012-2#2)
the proportion of the total##2##5##(2008-10#1)(2013-8#1)
the proportion of the##15##4##(1991-6#1)(1991-7#2)(1992-6#1)(1995-2#1)(2004-11#1)(2006-7#1)(2008-10#4)(2008-12#1)(2008-8#1)(2013-8#2)
the proportion of their##2##4##(1992-12#1)(2008-3#1)
the proportion of time spent in##2##6##(2008-8#1)(2011-2#1)
the proportion of time spent##3##5##(2008-8#1)(2011-2#1)(2012-2#1)
the proportion of time##4##4##(1991-11#1)(2008-8#1)(2011-2#1)(2012-2#1)
the proportion of total tuberculosis cases that are##2##8##(2005-10#2)
the proportion of total##13##4##(1990-5#1)(1995-3#2)(2005-10#2)(2007-8#2)(2008-10#1)(2008-8#2)(2010-11#1)(2010-12#1)(2012-2#1)
the proportion of tumor cells##2##5##(1990-4#2)
the proportion of women##3##4##(1991-8#1)(2009-7#1)(2012-3#1)
the proportion of##299##3##(1990-10#5)(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#2)(1990-5#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-3#2)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#2)(1992-12#2)(1992-2#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#4)(1992-8#1)(1992-9#4)(1993-1#1)(1993-11#2)(1993-3#2)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#4)(1994-12#3)(1994-2#2)(1994-4#1)(1994-5#1)(1994-6#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#2)(1995-4#1)(1995-6#4)(1996-1#2)(1996-11#1)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#1)(1997-1#6)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#2)(2004-11#4)(2004-12#1)(2004-2#1)(2005-10#3)(2005-7#1)(2006-10#5)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#3)(2006-7#2)(2006-8#2)(2007-10#2)(2007-11#1)(2007-12#3)(2007-7#5)(2007-8#9)(2007-9#1)(2008-10#39)(2008-11#6)(2008-12#3)(2008-3#2)(2008-4#5)(2008-5#2)(2008-6#3)(2008-7#8)(2008-8#12)(2008-9#1)(2009-12#2)(2009-2#1)(2009-5#2)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#8)(2013-1#8)(2013-8#8)
the proportion##318##2##(1990-10#5)(1990-11#1)(1990-12#3)(1990-2#1)(1990-4#3)(1990-5#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-3#2)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#2)(1992-12#2)(1992-2#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#4)(1992-8#1)(1992-9#4)(1993-1#1)(1993-11#2)(1993-3#2)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#4)(1994-12#4)(1994-2#2)(1994-4#1)(1994-5#1)(1994-6#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#2)(1995-4#1)(1995-6#4)(1996-1#2)(1996-11#1)(1996-12#3)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#2)(1997-1#6)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#2)(2004-11#4)(2004-12#1)(2004-2#1)(2005-10#3)(2005-7#1)(2006-10#5)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#3)(2006-7#4)(2006-8#2)(2007-10#2)(2007-11#1)(2007-12#3)(2007-7#5)(2007-8#9)(2007-9#1)(2008-10#40)(2008-11#6)(2008-12#3)(2008-3#2)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#8)(2008-8#12)(2008-9#2)(2009-12#2)(2009-2#1)(2009-5#2)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#11)(2013-1#12)(2013-8#9)
the proportional hazard assumption of##2##5##(1997-3#2)
the proportional hazard assumption##3##4##(1997-3#3)
the proportional hazard##4##3##(1996-12#1)(1997-3#3)
the proportional hazards assumption##2##4##(1994-5#1)(1997-3#1)
the proportional hazards model##4##4##(1997-8#2)(2008-10#1)(2010-8#1)
the proportional hazards##6##3##(1994-5#1)(1997-3#1)(1997-8#2)(2008-10#1)(2010-8#1)
the proportional odds##2##3##(1997-2#1)(2010-8#1)
the proportional##23##2##(1991-10#1)(1991-4#1)(1992-6#1)(1993-9#1)(1994-5#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-3#4)(1997-8#2)(2005-10#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-9#1)(2010-8#2)(2011-2#1)
the proportions of oocytes##2##4##(2006-5#2)
the proportions of subjects who##2##5##(2006-2#2)
the proportions of the elderly population##2##6##(2008-7#2)
the proportions of the##8##4##(1992-6#1)(1994-10#1)(2008-10#3)(2008-7#2)(2010-4#1)
the proportions of##35##3##(1990-12#2)(1990-2#1)(1991-9#1)(1992-11#1)(1992-6#2)(1992-9#1)(1993-4#1)(1994-10#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-4#1)(1996-2#1)(1996-4#1)(1997-6#1)(2005-12#1)(2006-2#2)(2006-5#3)(2007-10#1)(2007-11#1)(2007-2#1)(2008-10#4)(2008-7#2)(2009-7#1)(2010-4#1)(2013-8#1)
the proportions##44##2##(1990-12#2)(1990-2#1)(1991-9#2)(1992-11#1)(1992-6#2)(1992-9#1)(1993-4#1)(1994-10#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-4#1)(1995-9#1)(1996-2#1)(1996-4#1)(1997-3#1)(1997-6#3)(2005-10#1)(2005-12#1)(2006-2#2)(2006-5#4)(2007-10#1)(2007-11#1)(2007-2#1)(2008-10#5)(2008-7#2)(2009-7#1)(2010-4#1)(2013-8#2)
the proposal of##5##3##(1995-2#1)(2005-10#1)(2009-8#1)(2010-2#1)(2010-4#1)
the proposal that the##7##4##(1990-10#1)(1990-8#1)(1991-1#1)(1991-2#1)(1993-3#1)(1995-8#1)(1997-2#1)
the proposal that##22##3##(1990-10#1)(1990-11#2)(1990-5#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-7#1)(1993-3#1)(1994-11#1)(1994-6#1)(1994-8#2)(1995-8#1)(1996-5#1)(1997-2#2)(2007-2#1)(2008-4#1)(2009-4#1)(2009-5#1)(2013-8#1)
the proposal to##2##3##(1993-5#1)(2008-10#1)
the proposal##39##2##(1990-10#1)(1990-11#2)(1990-5#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-7#1)(1992-2#5)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-6#1)(1994-8#2)(1995-2#1)(1995-8#1)(1996-5#1)(1997-2#2)(1997-7#1)(2005-10#1)(2006-7#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-4#1)(2013-8#1)
the proposals##3##2##(1992-1#1)(1997-3#1)(2006-3#1)
the proposed &quot##2##3##(1990-9#1)(2008-10#1)
the proposed FI##2##3##(2008-10#2)
the proposed active site##2##4##(1994-5#1)(1995-1#1)
the proposed algorithm can##2##4##(2008-2#1)(2012-2#1)
the proposed algorithm is##6##4##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)
the proposed algorithm##22##3##(2007-12#3)(2008-10#2)(2008-2#8)(2008-3#2)(2009-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
the proposed algorithms##5##3##(2008-2#4)(2012-1#1)
the proposed analysis##2##3##(2008-3#1)(2008-5#1)
the proposed and##4##3##(2005-11#1)(2008-10#3)
the proposed approach and##3##4##(2007-11#1)(2008-10#1)(2013-1#1)
the proposed approach is##6##4##(2008-10#1)(2008-2#3)(2012-2#1)(2013-7#1)
the proposed approach##33##3##(2007-11#2)(2008-10#7)(2008-2#9)(2008-3#2)(2008-5#1)(2009-12#1)(2009-8#1)(2011-1#2)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
the proposed approaches##5##3##(2008-2#2)(2010-2#1)(2013-1#2)
the proposed architecture##7##3##(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#1)(2009-11#1)(2010-8#1)
the proposed bills##2##3##(1994-8#1)(2009-12#1)
the proposed biosensor##3##3##(2008-10#3)
the proposed concept##2##3##(2006-2#1)(2008-3#1)
the proposed conditions##2##3##(2008-10#2)
the proposed criteria##2##3##(2006-10#1)(2012-3#1)
the proposed design##2##3##(2010-8#1)(2011-2#1)
the proposed device##2##3##(2007-12#1)(2008-2#1)
the proposed diagnostic criteria##2##4##(2009-7#1)(2011-1#1)
the proposed diet##3##3##(2008-3#3)
the proposed digestion method##2##4##(2007-8#1)(2008-10#1)
the proposed electrode##3##3##(2008-10#3)
the proposed electrodes##4##3##(2008-10#4)
the proposed flow##4##3##(2008-10#4)
the proposed flow-injection##2##3##(2008-10#2)
the proposed framework##8##3##(2005-10#1)(2006-10#1)(2008-2#2)(2008-7#1)(2008-9#1)(2012-2#2)
the proposed genus##2##3##(2008-10#1)(2011-2#1)
the proposed idea##2##3##(2007-12#1)(2008-2#1)
the proposed joint##2##3##(2008-2#2)
the proposed mechanism of##2##4##(1994-3#1)(2009-10#1)
the proposed mechanism##5##3##(1994-3#1)(2008-10#2)(2009-10#1)(2010-5#1)
the proposed mechanisms of action##2##5##(2006-9#1)(2008-1#1)
the proposed method a##2##4##(2008-10#2)
the proposed method agreed##2##4##(2008-10#2)
the proposed method and the reference procedure##2##7##(2008-10#2)
the proposed method and the##10##5##(2007-8#1)(2008-10#8)(2008-6#1)
the proposed method and##19##4##(2007-8#1)(2008-10#16)(2008-6#2)
the proposed method are##10##4##(2006-10#1)(2008-10#6)(2008-2#1)(2008-3#2)
the proposed method can##5##4##(2007-12#1)(2007-8#1)(2008-10#1)(2013-1#1)(2013-8#1)
the proposed method could be used for##2##7##(2008-10#1)(2008-5#1)
the proposed method could##5##4##(2008-10#3)(2008-5#1)(2012-3#1)
the proposed method has been applied to##2##7##(2008-10#2)
the proposed method has been##4##5##(2008-10#3)(2012-1#1)
the proposed method has##5##4##(2007-12#1)(2008-10#3)(2012-1#1)
the proposed method in##7##4##(2006-12#1)(2008-10#4)(2010-4#1)(2010-8#1)
the proposed method is cleaner than the reference method as 75-80% of the extractant is recycled##2##16##(2008-10#2)
the proposed method is compared with##2##6##(2008-10#1)(2008-3#1)
the proposed method is robust##4##5##(1995-4#1)(2012-3#1)(2013-1#2)
the proposed method is##41##4##(1995-4#1)(2005-11#1)(2008-10#24)(2008-2#5)(2008-3#5)(2010-2#1)(2010-7#1)(2012-3#1)(2013-1#2)
the proposed method to the##2##5##(2008-10#1)(2012-3#1)
the proposed method to##6##4##(2005-4#1)(2008-10#2)(2012-3#1)(2013-1#2)
the proposed method was successfully applied to the##2##8##(2008-10#1)(2012-1#1)
the proposed method was##30##4##(2005-4#1)(2007-8#2)(2008-10#23)(2008-3#1)(2012-1#3)
the proposed method were##6##4##(2007-8#1)(2008-10#5)
the proposed method with those##2##5##(2008-10#2)
the proposed method with##4##4##(2008-10#2)(2009-5#1)(2012-3#1)
the proposed method yielded results##2##5##(2008-10#2)
the proposed method##244##3##(1995-4#1)(2005-11#1)(2005-4#2)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#6)(2007-8#8)(2008-10#155)(2008-2#13)(2008-3#16)(2008-5#2)(2008-6#2)(2008-9#1)(2009-5#3)(2009-6#1)(2010-2#4)(2010-4#1)(2010-7#1)(2010-8#1)(2012-1#4)(2012-12#3)(2012-3#6)(2013-1#6)(2013-7#1)(2013-8#2)
the proposed methodology for##3##4##(2007-8#1)(2008-10#1)(2012-1#1)
the proposed methodology is##2##4##(2005-5#1)(2010-3#1)
the proposed methodology was##3##4##(2008-10#3)
the proposed methodology##18##3##(2005-5#1)(2007-8#1)(2008-10#12)(2008-2#1)(2010-3#1)(2012-1#2)
the proposed methods to##2##4##(2006-10#1)(2008-10#1)
the proposed methods##16##3##(2006-10#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)(2010-11#1)(2010-4#1)(2012-3#1)
the proposed model and##3##4##(2008-10#1)(2008-9#1)(2009-8#1)
the proposed model for##2##4##(1991-10#1)(2013-1#1)
the proposed model is##3##4##(2008-2#1)(2008-7#1)(2012-1#1)
the proposed model with##2##4##(1996-7#1)(2009-9#1)
the proposed model##25##3##(1991-10#1)(1994-2#1)(1995-6#2)(1996-7#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-3#1)(2011-1#1)(2012-1#1)(2013-1#2)
the proposed modeling##2##3##(2007-12#1)(2010-11#1)
the proposed models and##3##4##(2009-5#1)(2009-8#1)(2010-2#1)
the proposed models##8##3##(1996-3#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-2#1)
the proposed modified##2##3##(2005-11#1)(2008-10#1)
the proposed multivariate##2##3##(1993-6#2)
the proposed network##4##3##(2008-2#4)
the proposed neuron##2##3##(2008-2#2)
the proposed new##3##3##(1995-6#1)(2007-9#1)(2008-3#1)
the proposed nutrition##2##3##(1996-1#2)
the proposed on-line##2##3##(2008-10#2)
the proposed optical system##2##4##(2008-2#2)
the proposed optical##4##3##(2008-2#3)(2008-3#1)
the proposed procedure and##3##4##(2008-10#3)
the proposed procedure can##2##4##(2008-10#2)
the proposed procedure had##2##4##(2008-10#2)
the proposed procedure is##3##4##(2008-10#3)
the proposed procedure were##4##4##(2008-10#4)
the proposed procedure##33##3##(2007-10#2)(2007-8#2)(2008-10#25)(2008-3#1)(2008-6#1)(2009-9#1)(2012-1#1)
the proposed procedures##3##3##(2007-11#1)(2009-10#1)(2013-1#1)
the proposed protocol##3##3##(2008-10#1)(2008-2#2)
the proposed recoded##2##3##(2008-2#2)
the proposed regulation##2##3##(1993-3#1)(2007-1#1)
the proposed regulations##2##3##(1991-2#1)(1993-3#1)
the proposed representation##2##3##(2012-2#1)(2013-8#1)
the proposed role of##2##4##(1994-12#1)(1996-9#1)
the proposed sample##2##3##(1995-8#1)(2008-10#1)
the proposed scheme is##3##4##(1995-2#1)(2008-2#2)
the proposed scheme##11##3##(1995-2#1)(2007-12#2)(2008-1#2)(2008-2#3)(2008-3#2)(2010-6#1)
the proposed sensor##7##3##(2008-10#6)(2008-3#1)
the proposed sensors##2##3##(2008-10#2)
the proposed spectrophotometric##2##3##(2008-10#2)
the proposed standard for HMW/u-PA##2##5##(1990-11#2)
the proposed strategy##3##3##(2007-8#1)(2011-2#1)(2012-3#1)
the proposed structure##4##3##(2008-10#1)(2008-3#2)(2012-1#1)
the proposed system can##2##4##(2008-3#1)(2010-8#1)
the proposed system is##7##4##(2008-10#2)(2008-2#2)(2008-3#3)
the proposed system##31##3##(1994-2#2)(2007-11#2)(2008-10#12)(2008-2#5)(2008-3#9)(2010-8#1)
the proposed technique and##3##4##(2008-2#1)(2008-3#2)
the proposed technique is also##2##5##(2008-3#1)(2008-6#1)
the proposed technique is##4##4##(1997-3#1)(2008-2#1)(2008-3#1)(2008-6#1)
the proposed technique of##2##4##(2006-8#1)(2007-11#1)
the proposed technique##26##3##(1997-3#1)(2006-8#1)(2007-11#2)(2008-10#7)(2008-2#6)(2008-3#7)(2008-6#1)(2010-2#1)
the proposed techniques are##2##4##(2008-2#1)(2008-3#1)
the proposed techniques##3##3##(2008-2#1)(2008-3#1)(2008-6#1)
the proposed test##2##3##(1997-7#1)(2013-1#1)
the proposed treatment##7##3##(1997-8#4)(2007-11#1)(2007-3#1)(2007-6#1)
the proposed trial##2##3##(2013-8#2)
the proposed##879##2##(1990-11#2)(1990-6#1)(1990-8#1)(1990-9#4)(1991-1#1)(1991-10#1)(1991-2#2)(1991-3#1)(1991-7#1)(1991-9#2)(1992-2#1)(1992-3#3)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#3)(1993-6#4)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#5)(1994-3#2)(1994-5#2)(1994-8#1)(1995-1#2)(1995-11#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#4)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#5)(2005-10#1)(2005-11#7)(2005-4#3)(2005-5#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#14)(2007-12#22)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#16)(2007-9#3)(2008-1#3)(2008-10#329)(2008-11#5)(2008-2#104)(2008-3#68)(2008-4#1)(2008-5#8)(2008-6#9)(2008-7#5)(2008-8#5)(2008-9#4)(2009-10#4)(2009-11#1)(2009-12#4)(2009-3#2)(2009-5#5)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#3)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#16)(2010-3#3)(2010-4#3)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#11)(2010-9#1)(2011-1#8)(2011-2#5)(2012-1#18)(2012-11#1)(2012-12#9)(2012-2#10)(2012-3#13)(2013-1#22)(2013-7#6)(2013-8#7)
the proposita##10##2##(1992-12#5)(1993-3#2)(1994-12#2)(1997-3#1)
the proposition that the##4##4##(1991-11#1)(1991-5#1)(2008-11#1)(2012-2#1)
the proposition that##10##3##(1991-11#1)(1991-5#1)(1993-3#1)(2008-10#1)(2008-11#1)(2009-11#3)(2009-8#1)(2012-2#1)
the proposition##12##2##(1991-11#1)(1991-5#1)(1993-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-11#3)(2009-8#1)(2012-2#1)(2013-8#1)
the propositions##3##2##(1993-11#1)(2010-4#2)
the propositus##2##2##(1993-5#1)(2006-7#1)
the propranolol##3##2##(2009-8#2)(2011-2#1)
the propriety of##4##3##(1994-3#1)(1995-5#1)(1997-5#1)(2007-9#1)
the proprioceptive##5##2##(1993-12#1)(2009-8#1)(2011-1#3)
the proprioceptors##2##2##(1997-3#1)(2009-1#1)
the propulsion##2##2##(2007-10#1)(2007-5#1)
the propulsive##2##2##(2007-10#1)(2009-2#1)
the propyl##2##2##(1992-3#1)(1996-8#1)
the propylene oxide production##2##4##(2008-6#2)
the propylene oxide##3##3##(2008-6#3)
the propylene##5##2##(2007-11#1)(2008-5#1)(2008-6#3)
the proregion of##2##3##(1992-2#1)(1995-6#1)
the proregion##5##2##(1992-2#3)(1995-6#2)
the pros and cons of each##2##6##(2008-4#1)(2011-2#1)
the pros and cons of the##6##6##(2006-6#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-2#1)(2013-8#1)
the pros and cons of these##3##6##(2011-1#1)(2011-2#1)(2013-1#1)
the pros and cons of##20##5##(1990-12#1)(1992-1#1)(1996-6#1)(2006-6#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-4#2)(2009-5#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
the pros and cons##22##4##(1990-12#1)(1992-1#1)(1996-6#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-7#1)(2009-5#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
the pros##23##2##(1990-12#1)(1992-1#1)(1996-6#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#2)(2008-7#1)(2009-5#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
the prosecution of##2##3##(2007-5#1)(2012-1#1)
the prosecution##3##2##(2007-5#1)(2008-12#1)(2012-1#1)
the prosegment##2##2##(1990-7#1)(1995-3#1)
the prosencephalon##2##2##(1992-9#2)
the prosopagnosic patient##2##3##(2009-4#2)
the prosopagnosic##3##2##(2009-4#3)
the prospect for##2##3##(2006-12#1)(2010-12#1)
the prospect of a##2##4##(2006-10#1)(2012-12#1)
the prospect of greater##2##4##(2008-10#1)(2008-7#1)
the prospect of##17##3##(1991-12#1)(1992-5#1)(1993-12#1)(1995-5#1)(2005-11#1)(2006-10#1)(2007-9#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#3)(2012-1#1)(2012-12#1)(2012-3#1)
the prospect that##2##3##(1997-4#1)(2005-7#1)
the prospect##22##2##(1991-12#1)(1992-5#1)(1993-12#1)(1994-5#1)(1995-5#1)(1997-4#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-9#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#3)(2010-12#1)(2012-1#1)(2012-12#1)(2012-3#1)
the prospective part)##2##3##(2006-10#2)
the prospective payment system (PPS)##3##5##(1991-2#1)(1992-12#2)
the prospective payment system and##2##5##(1990-12#1)(1991-3#1)
the prospective payment system##15##4##(1990-12#2)(1991-1#1)(1991-2#3)(1991-3#2)(1992-12#3)(1992-2#1)(1993-1#2)(2008-11#1)
the prospective payment##16##3##(1990-12#2)(1991-1#2)(1991-2#3)(1991-3#2)(1992-12#3)(1992-2#1)(1993-1#2)(2008-11#1)
the prospective##33##2##(1990-10#1)(1990-12#2)(1991-1#2)(1991-2#3)(1991-3#2)(1991-9#1)(1992-12#3)(1992-2#1)(1993-1#2)(1995-12#1)(2006-10#4)(2006-9#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-3#1)(2012-12#1)(2013-1#2)
the prospects are##2##3##(2008-1#1)(2008-3#1)
the prospects for further##2##4##(1990-11#1)(1990-12#1)
the prospects for the##2##4##(2006-5#1)(2010-11#1)
the prospects for##21##3##(1990-11#1)(1990-12#1)(1991-9#1)(1994-12#1)(1996-12#1)(2005-7#1)(2005-9#1)(2006-12#2)(2006-5#1)(2006-7#1)(2007-11#3)(2008-10#1)(2008-2#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-5#1)(2012-12#1)
the prospects of##5##3##(1997-7#1)(2007-6#1)(2008-4#1)(2011-7#1)(2013-1#1)
the prospects##29##2##(1990-11#1)(1990-12#1)(1991-9#1)(1994-12#1)(1995-2#1)(1996-12#1)(1997-7#1)(2005-7#1)(2005-9#1)(2006-12#2)(2006-5#1)(2006-7#1)(2007-11#3)(2007-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-7#1)(2012-12#1)(2013-1#1)
the prostaglandin##4##2##(1990-4#1)(1992-3#1)(1995-4#1)(1996-2#1)
the prostaglandins##2##2##(1991-4#1)(2008-4#1)
the prostate and##6##3##(1995-11#1)(1997-6#1)(1997-8#1)(2006-9#1)(2008-6#1)(2013-1#1)
the prostate gland##4##3##(2007-2#1)(2008-12#1)(2008-7#1)(2012-3#1)
the prostate in##3##3##(1995-4#1)(2007-7#1)(2012-3#1)
the prostate is##3##3##(2007-11#1)(2007-5#1)(2008-11#1)
the prostate of##2##3##(2007-9#2)
the prostate specific antigen##2##4##(1994-12#2)
the prostate specific##3##3##(1994-12#2)(2007-11#1)
the prostate were##3##3##(1992-9#1)(1995-3#1)(2009-8#1)
the prostate##74##2##(1990-9#2)(1991-8#2)(1991-9#3)(1992-10#1)(1992-9#1)(1993-8#2)(1994-11#1)(1994-12#2)(1995-11#1)(1995-3#1)(1995-4#3)(1995-8#3)(1996-4#1)(1997-6#1)(1997-8#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#5)(2007-11#2)(2007-2#1)(2007-3#4)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
the prostate-specific antigen##3##3##(2007-4#1)(2009-5#1)(2010-10#1)
the prostatic urethra##7##3##(2006-1#1)(2007-7#2)(2011-12#1)(2012-3#1)(2013-8#2)
the prostatic##15##2##(1994-7#1)(1997-7#1)(2006-1#1)(2006-7#1)(2006-9#2)(2007-7#2)(2007-9#1)(2008-6#1)(2010-2#1)(2011-12#1)(2012-3#1)(2013-8#2)
the prostheses##5##2##(1990-4#1)(1991-3#1)(2007-5#1)(2009-1#1)(2012-2#1)
the prosthesis must be##2##4##(1990-2#1)(1991-2#1)
the prosthesis was##5##3##(1990-2#1)(2007-11#1)(2009-3#2)(2009-4#1)
the prosthesis##31##2##(1990-10#1)(1990-2#3)(1991-2#2)(1997-6#1)(2007-11#1)(2007-3#1)(2007-7#5)(2007-8#3)(2008-11#1)(2008-6#2)(2008-9#1)(2009-1#1)(2009-3#3)(2009-4#1)(2011-12#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-1#1)
the prosthetic group##6##3##(1992-10#1)(1995-3#1)(1995-8#2)(2008-12#1)(2013-1#1)
the prosthetic rehabilitation of a##2##5##(2009-11#1)(2013-8#1)
the prosthetic##16##2##(1992-10#1)(1993-2#1)(1995-3#1)(1995-8#2)(1995-9#1)(2006-12#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-11#1)(2010-6#1)(2012-1#1)(2013-1#1)(2013-8#1)
the prosthodontic##2##2##(2011-12#1)(2013-1#1)
the protease activity##7##3##(1991-1#1)(1991-4#1)(1996-9#4)(2011-2#1)
the protease domain##3##3##(1994-12#1)(1995-3#1)(1995-6#1)
the protease gene##4##3##(1994-12#4)
the protease inhibitor domain##4##4##(1990-8#2)(1992-12#1)(1994-11#1)
the protease inhibitor##8##3##(1990-8#2)(1992-12#1)(1994-11#1)(1994-8#2)(1995-9#1)(2009-12#1)
the protease is##2##3##(1991-9#1)(2008-10#1)
the protease treatments##2##3##(1993-12#2)
the protease was##2##3##(2008-10#2)
the protease##62##2##(1990-10#2)(1990-8#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#3)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-8#1)(1994-11#1)(1994-12#6)(1994-8#3)(1995-1#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-9#4)(2008-1#1)(2008-10#5)(2008-2#1)(2008-4#2)(2008-5#1)(2009-12#1)(2010-4#1)(2011-2#1)(2013-1#1)
the protease-binding##3##2##(1991-11#2)(1997-5#1)
the proteases##8##2##(1991-2#1)(1991-7#1)(1994-3#1)(1996-3#1)(1997-4#1)(2006-10#2)(2008-6#1)
the proteasomal##3##2##(2008-7#1)(2008-8#2)
the proteasome and##2##3##(2007-8#1)(2009-7#1)
the proteasome##22##2##(1994-10#3)(1996-2#4)(1997-7#3)(2007-8#3)(2008-1#1)(2008-4#1)(2008-8#4)(2009-7#1)(2013-1#2)
the protectant##2##2##(2008-10#2)
the protected##10##2##(1990-11#1)(1992-12#1)(1994-9#1)(1995-3#1)(2005-8#1)(2008-10#2)(2008-3#1)(2013-7#2)
the protecting groups##4##3##(1994-9#1)(1996-4#1)(1997-2#1)(2010-2#1)
the protecting##6##2##(1994-9#1)(1996-4#1)(1996-9#1)(1997-2#1)(2010-2#1)(2010-4#1)
the protection afforded##5##3##(1991-5#1)(1994-3#1)(2004-12#1)(2006-11#1)(2008-5#1)
the protection against W-CI##2##4##(2008-10#2)
the protection against##12##3##(1990-2#1)(2008-10#3)(2008-11#3)(2008-5#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-8#1)
the protection and##7##3##(1997-1#1)(2007-8#1)(2010-9#2)(2012-12#1)(2013-1#1)(2013-8#1)
the protection from##2##3##(1994-10#1)(1995-12#1)
the protection of hydrogen##2##4##(2009-3#1)(2010-4#1)
the protection of patients##2##4##(1992-3#1)(2006-10#1)
the protection of people living in long-term contaminated areas##2##9##(2010-5#2)
the protection of people##3##4##(2007-10#1)(2010-5#2)
the protection of the##8##4##(1995-5#1)(2006-6#1)(2007-10#1)(2008-10#1)(2009-5#1)(2009-6#1)(2010-4#1)(2013-7#1)
the protection of women and children##2##6##(1990-2#2)
the protection of##40##3##(1990-2#2)(1991-10#1)(1992-3#1)(1995-5#2)(1996-10#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-4#2)(2010-5#2)(2010-9#2)(2011-3#1)(2013-7#1)(2013-8#1)
the protection potential of##2##4##(2006-11#2)
the protection was##3##3##(2008-10#2)(2013-1#1)
the protection##86##2##(1990-2#3)(1991-10#1)(1991-5#1)(1992-3#1)(1994-10#1)(1994-3#2)(1995-12#1)(1995-5#3)(1996-10#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(2004-12#1)(2005-11#1)(2006-10#1)(2006-11#4)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#11)(2008-11#5)(2008-5#4)(2008-7#2)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2010-2#1)(2010-4#2)(2010-5#2)(2010-9#4)(2011-1#1)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#4)
the protective action of##4##4##(1990-12#1)(1993-11#1)(1996-2#1)(2008-11#1)
the protective actions of##2##4##(1993-12#1)(2008-8#1)
the protective activity of carbamazepine##2##5##(1997-5#2)
the protective effect of adaptation##2##5##(2008-4#2)
the protective effect of cystathionine on acute gastric mucosal injury induced by ischemia-reperfusion##2##13##(1995-12#2)
the protective effect of male circumcision from HIV infection and##2##10##(2011-1#2)
the protective effect of the##3##5##(1995-12#1)(2008-10#1)(2013-8#1)
the protective effect of##35##4##(1991-1#1)(1993-11#1)(1993-2#1)(1994-3#1)(1995-12#3)(1996-12#1)(1996-4#2)(1996-9#2)(2005-10#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-6#1)(2010-11#1)(2011-1#2)(2012-2#1)(2013-1#2)(2013-8#1)
the protective effect##41##3##(1990-5#1)(1991-1#1)(1993-11#2)(1993-2#1)(1993-6#1)(1994-3#1)(1995-12#4)(1996-12#1)(1996-4#2)(1996-9#2)(2005-10#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-6#1)(2010-11#1)(2011-1#2)(2012-2#1)(2013-1#3)(2013-8#1)
the protective effects of family##2##5##(2010-7#1)(2013-1#1)
the protective effects of##18##4##(1993-9#1)(1994-2#1)(1994-6#1)(1995-1#1)(1996-10#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
the protective effects##21##3##(1993-9#1)(1994-2#1)(1994-6#1)(1995-1#1)(1996-10#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
the protective efficacy of##3##4##(1991-2#1)(1992-10#1)(1995-5#1)
the protective efficacy##5##3##(1991-2#1)(1992-10#1)(1995-5#1)(2008-5#2)
the protective function##2##3##(2007-11#1)(2013-1#1)
the protective immune response to##2##5##(1991-12#1)(1992-8#1)
the protective immune response##3##4##(1991-12#1)(1992-8#1)(1997-7#1)
the protective mechanism##2##3##(1991-7#1)(1994-8#1)
the protective mechanisms##2##3##(2008-5#1)(2013-7#1)
the protective role of##7##4##(1992-6#1)(2009-6#1)(2010-8#1)(2012-12#1)(2013-1#3)
the protective time##3##3##(2008-10#3)
the protective##117##2##(1990-12#1)(1990-5#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-7#1)(1992-10#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#4)(1995-5#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#2)(1996-9#3)(1997-2#1)(1997-5#2)(1997-7#1)(2005-10#1)(2006-10#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#3)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#5)(2009-6#2)(2009-7#2)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#4)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#1)
the protein A1##3##3##(1992-7#3)
the protein adsorption##2##3##(2010-4#1)(2012-11#1)
the protein affected##3##3##(1996-2#1)(2011-1#1)(2011-12#1)
the protein and lipid##6##4##(1993-11#2)(1995-1#1)(2008-5#1)(2008-9#1)(2010-5#1)
the protein and mRNA##2##4##(1992-3#1)(2010-1#1)
the protein and the##9##4##(1992-6#1)(1994-3#1)(1997-2#2)(2005-11#1)(2006-10#1)(2006-8#1)(2008-4#1)(2009-3#1)
the protein and##45##3##(1990-7#2)(1990-8#2)(1991-6#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-8#2)(1995-1#2)(1995-8#1)(1996-3#1)(1997-2#3)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-1#1)(2010-4#1)(2010-5#1)(2011-2#1)
the protein as a##2##4##(1994-12#1)(1995-10#1)
the protein as well as##2##5##(1990-8#1)(2011-2#1)
the protein as##12##3##(1990-5#1)(1990-8#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-10#1)(2008-12#1)(2008-8#1)(2011-2#1)
the protein at##4##3##(1992-9#2)(1995-2#1)(1995-8#1)
the protein backbone##3##3##(1997-1#2)(2008-7#1)
the protein band##3##3##(2008-4#1)(2010-3#2)
the protein binding##4##3##(1992-11#1)(2010-2#2)(2010-8#1)
the protein by##10##3##(1990-12#1)(1990-5#1)(1990-7#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-12#1)(1996-3#1)(1997-2#1)(2008-1#1)
the protein can be##2##4##(2008-1#1)(2008-4#1)
the protein can##4##3##(1997-4#1)(2008-1#1)(2008-4#1)(2012-12#1)
the protein coding##3##3##(1993-6#1)(1995-10#1)(1997-4#1)
the protein complexes##2##3##(2008-10#1)(2008-7#1)
the protein components of##2##4##(2008-2#1)(2010-11#1)
the protein components##4##3##(2008-2#1)(2008-7#1)(2010-11#1)(2013-8#1)
the protein composition of the##3##5##(1991-2#1)(1991-8#2)
the protein composition of##5##4##(1991-2#1)(1991-8#2)(1992-4#1)(2008-9#1)
the protein composition##8##3##(1991-2#1)(1991-8#2)(1992-4#1)(1995-7#1)(2008-1#1)(2008-9#1)(2010-11#1)
the protein concentration and##3##4##(1990-7#1)(2009-7#1)(2010-12#1)
the protein concentration in the##2##5##(1991-11#1)(2008-4#1)
the protein concentration was##2##4##(1994-8#1)(1996-5#1)
the protein concentration##14##3##(1990-10#1)(1990-7#1)(1991-11#2)(1994-8#1)(1996-5#1)(2004-12#2)(2006-10#1)(2008-1#1)(2008-2#1)(2008-4#1)(2009-7#1)(2010-12#1)
the protein content of##3##4##(1993-4#1)(2006-12#1)(2008-4#1)
the protein content##8##3##(1990-7#1)(1991-2#1)(1993-4#1)(2006-12#2)(2008-4#1)(2010-11#1)(2013-1#1)
the protein core##6##3##(1993-2#1)(1995-1#1)(1995-5#1)(1997-8#2)(2009-8#1)
the protein could be precipitated using 10% wt/vol PEG##2##9##(2008-5#2)
the protein could be##5##4##(1990-11#1)(1991-8#1)(1993-3#1)(2008-5#2)
the protein could##6##3##(1990-11#1)(1991-8#1)(1993-3#1)(1996-5#1)(2008-5#2)
the protein data##2##3##(2008-4#1)(2011-2#1)
the protein due to##2##4##(1991-5#1)(1992-2#1)
the protein dynamics##2##3##(2006-10#1)(2010-10#1)
the protein encoded by the##7##5##(1990-10#1)(1990-12#1)(1991-6#1)(1992-8#1)(1993-12#1)(1994-3#1)(1994-6#1)
the protein encoded by##12##4##(1990-10#1)(1990-12#1)(1990-9#1)(1991-6#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-6#1)
the protein encoded##13##3##(1990-10#1)(1990-12#1)(1990-9#1)(1991-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-6#1)
the protein environment##5##3##(1991-7#1)(1992-12#1)(1995-1#1)(2006-12#1)(2010-2#1)
the protein expression##5##3##(1993-6#1)(2008-1#1)(2008-12#1)(2010-12#1)(2013-8#1)
the protein extract of##2##4##(1997-8#1)(2012-2#1)
the protein extract##3##3##(1996-2#1)(1997-8#1)(2012-2#1)
the protein families##2##3##(2008-7#1)(2010-7#1)
the protein fluorescence##3##3##(1991-2#1)(1992-12#1)(1994-9#1)
the protein folding problem##2##4##(1991-2#2)
the protein folding##3##3##(1991-2#2)(1994-12#1)
the protein folds into a##2##5##(2006-10#1)(2013-1#1)
the protein for##5##3##(1991-4#1)(1997-2#1)(1997-4#1)(2006-12#1)(2008-11#1)
the protein fraction##5##3##(1994-11#2)(2008-10#2)(2011-2#1)
the protein from the##4##4##(1992-3#1)(1993-9#1)(1995-1#1)(2009-12#1)
the protein from##10##3##(1992-3#1)(1993-9#1)(1994-9#2)(1995-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-12#1)(2010-7#1)
the protein has been##4##4##(1991-2#2)(1995-6#1)(1997-7#1)
the protein has##9##3##(1991-2#2)(1991-7#2)(1994-12#1)(1994-9#1)(1995-6#1)(1997-7#1)(2009-3#1)
the protein in a##3##4##(1995-8#1)(1996-8#1)(1997-1#1)
the protein in the##14##4##(1991-2#1)(1991-3#1)(1992-12#1)(1995-10#1)(1995-3#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-11#1)(2009-10#1)(2010-2#1)(2011-2#1)
the protein in##30##3##(1990-5#1)(1991-2#2)(1991-3#1)(1991-7#1)(1992-12#1)(1992-3#1)(1993-6#1)(1995-10#2)(1995-3#4)(1995-5#1)(1995-8#1)(1996-10#1)(1996-8#1)(1997-1#2)(1997-3#1)(1997-4#2)(1997-7#1)(2005-11#1)(2008-10#1)(2009-10#1)(2009-12#1)(2010-2#1)(2011-2#1)
the protein interaction##2##3##(2008-9#1)(2009-8#1)
the protein into the mitochondrial matrix##3##6##(1990-5#1)(1990-9#1)(1991-7#1)
the protein into the##5##4##(1990-5#1)(1990-9#1)(1991-7#1)(2006-10#1)(2009-3#1)
the protein into##9##3##(1990-4#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-7#1)(2006-10#1)(2007-11#1)(2009-12#1)(2009-3#1)
the protein is expressed##2##4##(2008-5#1)(2011-12#1)
the protein is highly conserved##3##5##(1991-2#1)(1992-5#1)(1993-12#1)
the protein is highly##4##4##(1991-2#1)(1992-5#1)(1993-12#1)(1996-7#1)
the protein is in##2##4##(1994-8#1)(1996-8#1)
the protein is not##5##4##(1990-4#1)(1990-6#1)(1991-4#1)(1992-6#1)(1993-8#1)
the protein is then##2##4##(1994-9#1)(2008-4#1)
the protein is very##2##4##(1990-4#1)(1992-6#1)
the protein is##73##3##(1990-12#1)(1990-4#2)(1990-5#2)(1990-6#2)(1990-7#3)(1990-9#1)(1991-2#4)(1991-3#1)(1991-4#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#3)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#2)(1994-8#2)(1994-9#3)(1995-1#1)(1995-10#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#1)(1996-8#2)(1997-2#2)(1997-6#1)(2006-8#1)(2008-4#3)(2008-5#1)(2009-2#1)(2009-5#1)(2011-12#1)(2012-12#3)
the protein isoelectric point##2##4##(2005-11#1)(2008-4#1)
the protein kinase A inhibitor##2##5##(1992-5#1)(1992-6#1)
the protein kinase A##5##4##(1992-5#1)(1992-6#1)(1995-12#1)(1996-9#1)(2007-12#1)
the protein kinase C (PKC) activator##2##6##(1992-3#1)(1996-11#1)
the protein kinase C (PKC) inhibitor##2##6##(1996-5#1)(2013-1#1)
the protein kinase C (PKC) pathway##2##6##(1993-6#1)(1996-5#1)
the protein kinase C (PKC)##13##5##(1990-5#1)(1992-3#1)(1992-9#1)(1993-6#1)(1994-2#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-5#2)(2011-12#1)(2013-1#1)
the protein kinase C activator##3##5##(1990-10#1)(1992-12#1)(1992-8#1)
the protein kinase C inhibitor H-7##2##6##(1990-7#1)(1994-11#1)
the protein kinase C inhibitor##5##5##(1990-11#1)(1990-7#1)(1991-7#1)(1994-11#1)(1995-6#1)
the protein kinase C inhibitors##2##5##(1990-10#1)(1991-5#1)
the protein kinase C pathway##3##5##(1990-10#1)(1995-12#1)(2008-1#1)
the protein kinase C##32##4##(1990-10#3)(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-5#2)(1996-8#1)(1997-2#1)(2008-1#1)(2011-12#1)(2013-1#1)
the protein kinase activities associated with##2##6##(1996-5#1)(1997-2#1)
the protein kinase activity##3##4##(1991-1#2)(1997-6#1)
the protein kinase domain##3##4##(1990-7#2)(1997-6#1)
the protein kinase inhibitor##7##4##(1991-3#1)(1992-3#1)(1994-3#2)(1995-3#1)(1997-2#1)(2008-10#1)
the protein kinase was##2##4##(1990-9#1)(1996-8#1)
the protein kinase##64##3##(1990-10#3)(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#3)(1990-9#1)(1991-1#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-12#3)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-5#3)(1996-8#2)(1996-9#2)(1997-2#3)(1997-6#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2011-12#1)(2013-1#1)(2013-8#1)
the protein kinases##4##3##(1994-2#1)(2007-6#1)(2008-4#1)(2013-7#1)
the protein lability##2##3##(1995-1#2)
the protein level of the##2##5##(1992-10#1)(1997-4#1)
the protein level of##4##4##(1992-10#1)(1997-1#1)(1997-4#1)(2008-9#1)
the protein level##21##3##(1990-5#1)(1992-10#1)(1994-11#1)(1995-5#2)(1995-6#1)(1996-5#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-10#1)(2012-12#1)(2013-1#1)
the protein levels of##5##4##(1994-6#1)(1994-9#1)(1997-8#1)(2008-11#1)(2011-2#1)
the protein levels##9##3##(1992-5#1)(1994-6#1)(1994-9#1)(1995-5#1)(1997-8#1)(2008-11#2)(2008-8#1)(2011-2#1)
the protein matrix##6##3##(1990-8#1)(1994-5#1)(1995-11#1)(1996-8#1)(2009-6#2)
the protein may be involved in##2##6##(1993-6#1)(1993-8#1)
the protein may be##3##4##(1991-2#1)(1993-6#1)(1993-8#1)
the protein may##5##3##(1991-2#1)(1993-6#1)(1993-8#1)(2008-8#1)(2008-9#1)
the protein moiety##2##3##(1990-2#1)(1994-11#1)
the protein molecule##2##3##(1990-5#1)(1997-6#1)
the protein molecules##2##3##(1990-12#1)(1996-5#1)
the protein most##2##3##(1994-11#1)(2005-11#1)
the protein near the##2##4##(1992-3#1)(1997-4#1)
the protein of interest is##3##5##(2008-4#3)
the protein of interest##12##4##(1992-5#1)(1993-12#1)(2008-1#2)(2008-4#7)(2008-9#1)
the protein of##15##3##(1992-5#1)(1992-9#1)(1993-12#1)(2005-11#1)(2008-1#2)(2008-12#1)(2008-4#7)(2008-9#1)
the protein part##2##3##(2009-8#2)
the protein phosphorylation##2##3##(1990-12#2)
the protein product of the##3##5##(1993-12#1)(1993-4#1)(2010-2#1)
the protein product##7##3##(1993-12#1)(1993-4#1)(1994-12#1)(1996-4#1)(1997-4#1)(2008-9#1)(2010-2#1)
the protein products of##2##4##(1991-12#1)(2008-11#1)
the protein products##3##3##(1991-12#1)(1996-4#1)(2008-11#1)
the protein reacted with##2##4##(1990-2#1)(1993-11#1)
the protein recognition##2##3##(1994-12#1)(2013-1#1)
the protein responsible for##2##4##(1990-2#1)(1990-3#1)
the protein sequence##12##3##(1992-1#1)(1992-12#1)(1992-8#1)(1992-9#1)(1994-9#1)(2008-2#1)(2008-4#3)(2008-7#1)(2010-11#1)(2011-2#1)
the protein sequences of the##2##5##(1990-6#1)(1994-12#1)
the protein species##2##3##(2008-7#1)(2013-8#1)
the protein structural##2##3##(1990-8#1)(1997-4#1)
the protein structure##15##3##(1990-2#1)(1991-7#1)(1993-3#1)(1995-2#1)(1995-6#1)(1996-8#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-6#1)(2009-9#1)(2010-7#1)(2012-3#1)
the protein substrate##6##3##(1992-11#2)(1994-9#1)(1995-2#2)(2006-10#1)
the protein subunits of##2##4##(1990-5#1)(1994-9#1)
the protein surface##9##3##(1990-5#1)(1991-4#1)(1991-7#1)(1993-3#1)(1995-2#1)(1997-4#1)(1997-7#1)(2006-10#1)(2008-8#1)
the protein synthesis inhibitor##5##4##(1993-9#1)(1994-12#1)(1994-5#1)(1995-3#1)(1996-9#1)
the protein synthesis inhibitors##2##4##(1991-5#1)(1994-9#1)
the protein synthesis##13##3##(1991-5#1)(1993-9#1)(1994-12#2)(1994-5#1)(1994-9#1)(1995-3#1)(1996-4#1)(1996-9#1)(1997-2#2)(2007-2#1)(2008-11#1)
the protein than##2##3##(1994-9#1)(1997-5#1)
the protein that##7##3##(1993-12#1)(1993-3#1)(1994-8#1)(1996-7#1)(2008-11#1)(2008-4#1)(2012-2#1)
the protein to the##4##4##(1990-5#2)(1992-3#1)(2006-12#1)
the protein to##21##3##(1990-5#2)(1991-7#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-5#1)(1996-5#1)(1997-7#1)(2006-12#1)(2008-4#2)(2008-5#1)(2008-9#1)(2012-1#1)
the protein truncation test##2##4##(2004-2#1)(2008-4#1)
the protein tyrosine kinase (PTK)##2##5##(1994-8#1)(1994-9#1)
the protein tyrosine##5##3##(1991-7#1)(1992-8#1)(1994-3#1)(1994-8#1)(1994-9#1)
the protein upon##2##3##(1997-7#1)(2006-10#1)
the protein was not##5##4##(1990-2#1)(1993-3#2)(1994-8#1)(2009-10#1)
the protein was##40##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#1)(1991-1#2)(1991-2#1)(1991-3#1)(1991-9#3)(1992-11#1)(1992-7#1)(1992-9#1)(1993-3#3)(1993-9#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-2#1)(1996-7#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-8#1)(2009-10#1)(2010-1#1)(2011-2#1)(2013-7#1)
the protein were##5##3##(1991-7#1)(1993-2#1)(1994-9#1)(2008-9#1)(2009-11#1)
the protein which##4##3##(1990-4#1)(1991-2#1)(1991-7#1)(2008-4#1)
the protein with a##2##4##(1993-12#1)(2012-2#1)
the protein with##9##3##(1991-5#1)(1991-7#1)(1993-12#1)(1994-8#1)(1995-10#1)(1995-11#1)(2008-8#1)(2011-12#1)(2012-2#1)
the protein##1125##2##(1990-10#8)(1990-11#6)(1990-12#17)(1990-2#10)(1990-3#4)(1990-4#7)(1990-5#18)(1990-6#5)(1990-7#14)(1990-8#10)(1990-9#6)(1991-1#4)(1991-10#2)(1991-11#4)(1991-12#2)(1991-2#24)(1991-3#6)(1991-4#6)(1991-5#8)(1991-6#6)(1991-7#22)(1991-8#9)(1991-9#8)(1992-1#1)(1992-10#1)(1992-11#5)(1992-12#16)(1992-2#3)(1992-3#13)(1992-4#3)(1992-5#5)(1992-6#8)(1992-7#8)(1992-8#11)(1992-9#13)(1993-11#11)(1993-12#12)(1993-2#5)(1993-3#9)(1993-4#5)(1993-6#12)(1993-7#1)(1993-8#5)(1993-9#7)(1994-11#17)(1994-12#18)(1994-2#6)(1994-3#14)(1994-5#19)(1994-6#5)(1994-8#23)(1994-9#25)(1995-1#17)(1995-10#9)(1995-11#4)(1995-12#5)(1995-2#13)(1995-3#13)(1995-5#7)(1995-6#12)(1995-7#1)(1995-8#10)(1995-9#1)(1996-1#1)(1996-10#7)(1996-11#4)(1996-12#1)(1996-2#6)(1996-3#6)(1996-4#4)(1996-5#14)(1996-6#1)(1996-7#8)(1996-8#12)(1996-9#5)(1997-1#11)(1997-2#22)(1997-3#5)(1997-4#14)(1997-5#3)(1997-6#10)(1997-7#17)(1997-8#5)(2004-12#2)(2004-2#2)(2005-10#5)(2005-11#10)(2005-12#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#13)(2006-12#11)(2006-5#1)(2006-8#3)(2007-11#2)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#10)(2008-10#35)(2008-11#15)(2008-12#4)(2008-2#12)(2008-3#3)(2008-4#58)(2008-5#8)(2008-6#2)(2008-7#20)(2008-8#9)(2008-9#16)(2009-10#4)(2009-11#1)(2009-12#7)(2009-2#2)(2009-3#7)(2009-5#2)(2009-6#4)(2009-7#4)(2009-8#6)(2009-9#3)(2010-1#3)(2010-10#6)(2010-11#6)(2010-12#4)(2010-2#7)(2010-3#3)(2010-4#2)(2010-5#1)(2010-7#7)(2010-8#2)(2011-1#7)(2011-10#1)(2011-12#5)(2011-2#12)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#7)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#6)
the protein's binding##2##3##(1995-11#1)(2006-12#1)
the protein's native##2##3##(1997-2#1)(2011-2#1)
the protein's##18##2##(1990-10#1)(1991-2#1)(1991-5#1)(1994-11#1)(1994-8#1)(1995-11#2)(1995-2#2)(1996-5#1)(1997-2#1)(2006-12#1)(2008-2#1)(2008-8#2)(2008-9#1)(2010-10#1)(2011-2#1)
the protein(s)##5##2##(1992-12#1)(1992-3#1)(1994-12#1)(1995-8#1)(1997-4#1)
the protein-DNA interface##2##3##(1995-8#2)
the protein-DNA##5##2##(1991-11#1)(1995-5#1)(1995-8#2)(1996-7#1)
the protein-bound##8##2##(1990-3#2)(1991-12#1)(1991-7#1)(1991-9#1)(1994-11#1)(1995-1#1)(2010-6#1)
the protein-coding genes##2##3##(2008-7#1)(2011-2#1)
the protein-coding##5##2##(1990-4#1)(1997-2#1)(2008-4#1)(2008-7#1)(2011-2#1)
the protein-ligand##2##2##(1997-2#1)(2011-3#1)
the protein-protein interaction function##2##4##(1996-8#2)
the protein-protein interaction##3##3##(1996-8#2)(1997-6#1)
the protein-solvent##4##2##(1990-10#1)(2006-10#3)
the protein-tyrosine phosphorylation##2##3##(1992-8#1)(1993-11#1)
the protein-tyrosine##3##2##(1992-8#1)(1993-11#1)(1995-10#1)
the proteinaceous##4##2##(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)
the proteinase##16##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-3#1)(1991-8#1)(1992-3#1)(1992-6#2)(1992-7#1)(1992-9#1)(1994-9#2)(1996-2#2)(1997-8#1)(2008-11#1)
the proteinases##6##2##(1990-5#2)(1991-3#1)(1993-11#2)(1994-6#1)
the proteins and##6##3##(1991-9#1)(1992-12#1)(1996-2#1)(2008-4#1)(2008-8#1)(2009-5#1)
the proteins are##7##3##(1990-7#1)(1991-1#2)(1993-11#1)(1995-10#1)(1997-2#1)(2008-10#1)
the proteins could##2##3##(1990-4#1)(1994-9#1)
the proteins encoded by the##3##5##(1990-10#1)(1990-5#1)(1994-8#1)
the proteins encoded by##4##4##(1990-10#1)(1990-5#1)(1994-8#1)(2008-10#1)
the proteins in the##10##4##(1990-11#1)(1990-12#1)(1990-9#1)(1995-6#1)(1997-1#1)(1997-7#1)(2005-11#1)(2007-9#1)(2008-10#1)(2008-6#1)
the proteins in##14##3##(1990-11#1)(1990-12#1)(1990-9#1)(1995-6#2)(1997-1#1)(1997-6#1)(1997-7#1)(2005-11#1)(2007-9#1)(2008-10#1)(2008-6#2)(2013-8#1)
the proteins involved in##2##4##(1993-6#1)(2008-4#1)
the proteins involved##4##3##(1993-6#1)(2006-10#1)(2008-4#1)(2008-7#1)
the proteins of interest##6##4##(1994-5#1)(2005-11#1)(2008-2#1)(2008-4#2)(2008-7#1)
the proteins of the##4##4##(2006-10#1)(2008-10#1)(2008-5#1)(2011-2#1)
the proteins of##15##3##(1993-5#1)(1994-5#1)(1996-5#1)(1997-6#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#1)(2011-2#1)
the proteins on##2##3##(1994-5#1)(1995-12#1)
the proteins that are##2##4##(2008-4#1)(2010-2#1)
the proteins that##9##3##(1991-11#1)(1997-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-2#1)(2011-1#1)(2012-2#1)
the proteins they##2##3##(1995-2#1)(2006-10#1)
the proteins were##6##3##(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-4#1)(2008-5#1)
the proteins with an alanine substituted at position##2##8##(1992-6#2)
the proteins with an alanine substituted##3##6##(1992-6#3)
the proteins with##4##3##(1992-6#3)(1994-9#1)
the proteins##155##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-9#3)(1991-1#2)(1991-11#1)(1991-2#2)(1991-4#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#4)(1992-7#1)(1993-11#1)(1993-5#1)(1993-6#5)(1993-8#1)(1994-12#1)(1994-5#3)(1994-8#1)(1994-9#5)(1995-10#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#5)(1995-7#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-5#2)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#3)(1997-6#3)(1997-7#3)(2005-11#3)(2006-1#4)(2006-10#4)(2007-9#1)(2008-1#2)(2008-10#14)(2008-2#2)(2008-3#1)(2008-4#9)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#2)(2013-8#2)
the proteins'##2##2##(1995-5#1)(2008-9#1)
the proteinuria##2##2##(2006-10#1)(2008-1#1)
the proteoglycan##7##2##(1990-10#1)(1992-6#3)(1997-2#1)(2005-3#1)(2007-11#1)
the proteolipid protein##2##3##(1993-6#1)(2008-7#1)
the proteolipid##4##2##(1992-11#1)(1993-6#1)(1994-9#1)(2008-7#1)
the proteoliposomes##3##2##(1990-11#1)(1990-2#1)(1994-8#1)
the proteolysis of##3##3##(1991-10#1)(1991-8#1)(1993-11#1)
the proteolysis was##3##3##(1992-11#1)(1997-1#1)(1997-4#1)
the proteolysis##10##2##(1991-10#1)(1991-5#1)(1991-8#1)(1992-11#2)(1992-3#1)(1993-11#1)(1997-1#1)(1997-4#1)(2011-1#1)
the proteolytic activation of##3##4##(1990-12#1)(1994-12#1)(2008-5#1)
the proteolytic activation##4##3##(1990-12#1)(1994-12#1)(2008-5#2)
the proteolytic activity by##2##4##(1991-3#1)(1994-3#1)
the proteolytic activity of##5##4##(1992-11#1)(1995-7#1)(1995-8#1)(2006-12#1)(2010-12#1)
the proteolytic activity##11##3##(1991-3#1)(1992-11#1)(1992-9#2)(1993-3#1)(1994-3#1)(1995-7#1)(1995-8#1)(2006-12#1)(2008-6#1)(2010-12#1)
the proteolytic cleavage of##2##4##(1991-10#1)(1991-8#1)
the proteolytic cleavage##3##3##(1991-10#1)(1991-8#1)(1996-5#1)
the proteolytic enzyme##3##3##(1990-5#1)(2008-10#1)(2008-9#1)
the proteolytic processing##3##3##(1990-8#1)(1991-9#1)(2007-12#1)
the proteolytic##35##2##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-3#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-9#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-7#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-4#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-5#3)(2008-6#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
the proteome of##7##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-6#1)(2011-3#1)
the proteome profiles of##2##4##(2009-6#2)
the proteome##18##2##(2005-10#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#2)(2008-9#1)(2009-6#2)(2009-8#1)(2010-12#2)(2010-6#1)(2011-3#1)
the proteome)##2##2##(2006-12#1)(2008-7#1)
the proteomic##3##2##(2008-11#1)(2010-12#2)
the proteosomes##2##2##(1990-12#2)
the protestors##3##2##(1997-1#3)
the protexin##2##2##(2010-4#2)
the prothoracic glands##2##3##(1995-11#1)(2008-6#1)
the prothoracic##3##2##(1995-11#2)(2008-6#1)
the prothrombin time##3##3##(1990-12#2)(1991-11#1)
the prothrombin##4##2##(1990-11#1)(1990-12#2)(1991-11#1)
the prothrombinase complex##6##3##(1994-5#1)(1994-8#5)
the prothrombotic state##2##3##(1997-7#1)(2005-10#1)
the prothrombotic##3##2##(1997-7#1)(2005-10#1)(2005-11#1)
the proto-oncogene Wnt-1##2##3##(1991-11#2)
the proto-oncogene##12##2##(1991-11#2)(1992-5#1)(1992-9#1)(1993-6#1)(1994-12#1)(1994-6#1)(1997-7#1)(2008-4#2)(2010-7#1)(2011-2#1)
the protocerebral commissure##3##3##(2007-12#3)
the protocerebral##6##2##(2007-12#6)
the protocerebrum and##2##3##(2007-12#2)
the protocerebrum##9##2##(2007-12#8)(2008-9#1)
the protocol and##2##3##(1992-8#1)(2010-3#1)
the protocol can be##2##4##(2008-2#1)(2008-8#1)
the protocol for##4##3##(1997-2#1)(2008-4#2)(2010-2#1)
the protocol is##6##3##(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#1)
the protocol to other##2##4##(2008-9#1)(2013-8#1)
the protocol to##4##3##(2008-7#1)(2008-9#1)(2012-3#1)(2013-8#1)
the protocol was##2##3##(1991-6#1)(2008-10#1)
the protocol were##2##3##(2006-10#1)(2011-2#1)
the protocol will##4##3##(2008-10#1)(2008-8#1)(2008-9#2)
the protocol with##2##3##(2009-2#1)(2011-2#1)
the protocol##57##2##(1991-6#2)(1992-3#1)(1992-8#1)(1994-7#1)(1995-4#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-5#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-7#3)(2007-8#2)(2008-10#3)(2008-11#2)(2008-2#2)(2008-4#10)(2008-7#1)(2008-8#3)(2008-9#5)(2009-2#2)(2010-2#1)(2010-3#1)(2011-2#5)(2012-3#2)(2013-8#1)
the protocols by##3##3##(2008-10#2)(2008-4#1)
the protocols described##3##3##(2008-1#1)(2008-4#1)(2008-9#1)
the protocols for##5##3##(1995-5#1)(2007-9#1)(2008-4#1)(2008-9#2)
the protocols used##3##3##(2008-4#2)(2008-8#1)
the protocols##33##2##(1995-5#1)(2007-7#1)(2007-9#1)(2008-1#4)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#10)(2008-7#1)(2008-8#1)(2008-9#6)(2010-2#1)(2011-2#1)(2013-1#1)
the protoderm##2##2##(2008-5#1)(2012-1#1)
the protolytic constants##3##3##(2008-10#3)
the protolytic##4##2##(2008-10#4)
the proton and##2##3##(1993-3#1)(2010-5#1)
the proton electrochemical gradient##2##4##(1996-5#2)
the proton gradient was##2##4##(1996-8#2)
the proton gradient##4##3##(1990-2#1)(1996-8#2)(2008-11#1)
the proton is##2##3##(2006-3#1)(2008-5#1)
the proton pump##7##3##(1994-12#2)(2006-10#3)(2008-11#1)(2008-8#1)
the proton pumping##3##3##(1991-12#1)(1995-2#1)(2006-8#1)
the proton pumps##2##3##(1990-7#1)(1994-8#1)
the proton translocation activity of F(0) vesicles##2##7##(2008-8#2)
the proton translocation activity of##3##5##(1991-3#1)(2008-8#2)
the proton translocation##4##3##(1991-3#1)(2008-8#3)
the proton uptake##2##3##(1994-9#1)(1995-5#1)
the proton##51##2##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-3#1)(1991-4#1)(1992-6#1)(1993-3#1)(1994-11#1)(1994-12#2)(1994-8#4)(1994-9#1)(1995-11#2)(1995-2#1)(1995-5#2)(1996-5#2)(1996-7#1)(1996-8#2)(1997-4#1)(2005-10#1)(2006-10#3)(2006-3#1)(2006-8#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-8#4)(2008-9#1)(2010-4#1)(2010-5#1)(2012-12#2)
the proton-transfer reaction##2##3##(2006-3#2)
the proton-transfer##3##2##(1994-8#1)(2006-3#2)
the proton-translocating##3##2##(1990-2#1)(1991-2#1)(1997-7#1)
the protonated amino##2##3##(1995-6#1)(2008-10#1)
the protonated form of##2##4##(2006-10#1)(2008-10#1)
the protonated form##4##3##(1991-5#1)(2006-10#1)(2008-10#2)
the protonated forms##3##3##(1990-12#1)(2006-4#1)(2008-10#1)
the protonated##20##2##(1990-12#1)(1991-5#1)(1992-6#2)(1995-5#2)(1995-6#1)(2006-10#1)(2006-2#1)(2006-3#2)(2006-4#1)(2008-10#7)(2009-11#1)
the protonation constants##2##3##(2008-10#2)
the protonation equilibria##2##3##(2008-10#1)(2010-5#1)
the protonation of the##4##4##(1990-10#1)(1992-6#1)(1993-3#1)(2005-11#1)
the protonation of##11##3##(1990-10#1)(1991-8#1)(1992-6#1)(1993-3#1)(1997-1#1)(1997-4#1)(2005-11#1)(2006-10#1)(2008-10#3)
the protonation##18##2##(1990-10#1)(1991-8#1)(1992-6#1)(1993-3#1)(1997-1#2)(1997-4#1)(2005-11#1)(2006-10#1)(2008-10#7)(2009-9#1)(2010-5#1)
the protonmotive force##5##3##(1994-8#3)(1996-8#1)(1996-9#1)
the protonophore carbonyl cyanide##2##4##(1994-9#1)(1996-9#1)
the protons##4##2##(1993-6#1)(2006-10#1)(2008-3#1)(2009-3#1)
the protoplasts##2##2##(2008-8#1)(2008-9#1)
the protoporphyrine IX##3##3##(2008-11#3)
the prototype BEF-1 sequence##2##4##(1995-6#2)
the prototype for##2##3##(1994-8#1)(1997-3#1)
the prototype of a##6##4##(1992-4#1)(1994-9#1)(1996-7#1)(2008-3#1)(2008-9#1)(2012-1#1)
the prototype of##13##3##(1992-4#1)(1994-9#1)(1996-5#1)(1996-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-9#1)(2010-4#1)(2011-2#1)(2012-1#1)
the prototype##40##2##(1992-4#1)(1992-7#1)(1993-11#2)(1994-8#1)(1994-9#2)(1995-2#1)(1995-6#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-3#1)(2006-6#1)(2007-11#3)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#3)(2008-2#2)(2008-3#3)(2008-5#4)(2008-9#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#2)
the prototypes of##2##3##(2010-12#1)(2012-3#1)
the prototypes##3##2##(2008-5#1)(2010-12#1)(2012-3#1)
the prototypic##7##2##(1990-7#1)(1994-12#1)(1995-8#1)(1997-1#1)(2005-2#1)(2008-10#1)(2011-2#1)
the prototypical##7##2##(1996-3#2)(1997-8#1)(2008-7#1)(2010-12#1)(2012-12#1)(2012-2#1)
the protozoa##4##2##(2008-5#2)(2013-1#2)
the protozoan Trypanosoma##2##3##(1993-9#1)(2006-10#1)
the protozoan parasite Entamoeba histolytica##2##5##(2009-7#1)(2009-8#1)
the protozoan parasite Trypanosoma brucei##2##5##(1995-8#1)(1996-4#1)
the protozoan parasite Trypanosoma##3##4##(1995-3#1)(1995-8#1)(1996-4#1)
the protozoan parasite##11##3##(1993-5#2)(1995-3#1)(1995-8#1)(1996-4#1)(2005-8#1)(2006-10#1)(2009-6#1)(2009-7#1)(2009-8#1)(2012-12#1)
the protozoan##19##2##(1992-2#1)(1992-8#1)(1993-5#2)(1993-9#2)(1995-3#1)(1995-8#1)(1996-4#1)(2005-8#1)(2006-10#2)(2007-12#2)(2007-9#1)(2009-6#1)(2009-7#1)(2009-8#1)(2012-12#1)
the proven##6##2##(2004-9#1)(2005-8#1)(2007-1#1)(2007-11#1)(2008-10#1)(2009-6#1)
the provenance of the cell line##2##6##(2008-11#2)
the provenance of the##3##4##(2008-10#1)(2008-11#2)
the provenance of##4##3##(2006-12#1)(2008-10#1)(2008-11#2)
the provenance##5##2##(2006-12#1)(2008-10#2)(2008-11#2)
the provided##5##2##(2006-2#1)(2008-10#2)(2010-7#1)(2012-2#1)
the provider and##2##3##(1995-1#1)(1997-2#1)
the provider community##3##3##(1994-2#1)(1996-2#1)(2007-4#1)
the provider##27##2##(1990-12#2)(1993-12#4)(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-2#1)(2004-3#1)(2006-10#2)(2007-12#3)(2007-4#1)(2008-1#1)(2008-3#1)(2010-10#1)(2010-3#1)(2012-2#1)(2013-8#1)
the provider's##6##2##(1994-3#1)(2006-8#1)(2008-11#2)(2011-2#1)(2013-8#1)
the providers and##2##3##(1996-1#1)(2008-1#1)
the providers of##4##3##(1994-3#1)(1996-2#1)(2006-8#1)(2008-11#1)
the providers##8##2##(1994-3#1)(1996-1#1)(1996-2#1)(2006-8#1)(2008-1#1)(2008-11#1)(2011-2#1)(2013-8#1)
the providers'##5##2##(1994-1#1)(1994-2#1)(1996-2#1)(2012-12#1)(2013-8#1)
the province of Antioquia##2##4##(2012-12#2)
the province of Misiones##2##4##(2008-5#2)
the province of##34##3##(1992-8#1)(1994-9#2)(1996-3#1)(1996-6#1)(1997-5#1)(2005-5#1)(2007-12#3)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#4)(2008-8#2)(2009-10#2)(2009-7#3)(2010-5#1)(2012-12#4)(2013-1#2)(2013-7#1)
the province who##2##3##(1994-1#1)(2010-11#1)
the province with##2##3##(1990-9#1)(1993-9#1)
the province##58##2##(1990-9#1)(1992-10#4)(1992-8#1)(1993-1#1)(1993-9#2)(1994-1#1)(1994-9#2)(1995-2#1)(1995-3#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-5#1)(2005-5#1)(2006-2#1)(2007-12#3)(2007-2#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#4)(2008-8#2)(2009-10#2)(2009-4#1)(2009-7#3)(2010-11#1)(2010-12#1)(2010-5#1)(2012-12#6)(2013-1#4)(2013-7#1)
the provinces##12##2##(1992-6#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-4#2)(2011-12#1)(2011-2#1)(2012-12#1)
the provincial##12##2##(1991-1#1)(1992-2#1)(1994-12#1)(1995-2#1)(1997-5#1)(2007-11#1)(2008-8#1)(2009-4#2)(2011-12#1)(2012-12#2)
the proviral##4##2##(1991-12#1)(1994-12#1)(1994-3#2)
the provirus##3##2##(1991-12#1)(1994-3#1)(2008-5#1)
the provision of a##5##4##(1994-2#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-8#1)
the provision of adequate##4##4##(2005-12#1)(2006-10#1)(2008-1#1)(2008-11#1)
the provision of appropriate care##2##5##(2007-3#1)(2008-11#1)
the provision of appropriate##3##4##(1995-9#1)(2007-3#1)(2008-11#1)
the provision of care##3##4##(1995-3#1)(1997-8#1)(2007-9#1)
the provision of effective##2##4##(2006-10#1)(2008-8#1)
the provision of good quality##2##5##(2007-6#1)(2008-11#1)
the provision of good##3##4##(2007-6#1)(2008-11#1)(2012-12#1)
the provision of health care services##2##6##(1992-3#1)(1995-2#1)
the provision of health care to the##2##7##(2006-8#1)(2008-4#1)
the provision of health care##7##5##(1992-3#1)(1995-2#1)(1996-3#1)(2006-8#1)(2007-6#1)(2008-4#1)(2012-12#1)
the provision of health##8##4##(1992-3#1)(1995-2#1)(1996-3#1)(2006-8#1)(2007-6#1)(2008-4#1)(2012-12#1)(2012-3#1)
the provision of integrated##2##4##(1994-3#1)(2011-1#1)
the provision of mental health##2##5##(1994-1#1)(2008-12#1)
the provision of outpatient##2##4##(1993-12#1)(2012-2#1)
the provision of primary##2##4##(1996-2#1)(2006-5#1)
the provision of quality##2##4##(1992-2#1)(1994-2#1)
the provision of safe and##2##5##(2010-10#1)(2013-8#1)
the provision of services##5##4##(1990-2#1)(1993-2#1)(1996-3#1)(2005-5#1)(2007-12#1)
the provision of specialized##2##4##(1993-2#1)(2008-11#1)
the provision of support and##2##5##(2007-8#1)(2013-1#1)
the provision of support##3##4##(1997-2#1)(2007-8#1)(2013-1#1)
the provision of the best possible care##2##7##(1995-1#1)(2006-10#1)
the provision of the##5##4##(1990-12#1)(1995-1#1)(2006-10#1)(2012-3#1)(2013-1#1)
the provision of workplace accommodations##2##5##(2010-2#2)
the provision of##118##3##(1990-12#2)(1990-2#1)(1991-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#2)(1994-1#2)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-9#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#3)(1997-5#2)(1997-8#1)(2004-11#1)(2004-7#1)(2004-8#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-5#1)(2006-10#8)(2006-5#2)(2006-8#1)(2007-10#1)(2007-12#2)(2007-2#3)(2007-3#1)(2007-4#1)(2007-6#2)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#3)(2008-11#7)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2010-10#1)(2010-2#3)(2010-5#1)(2010-8#2)(2011-1#5)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#4)(2013-8#1)
the provision##121##2##(1990-12#2)(1990-2#1)(1991-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#2)(1994-1#2)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-5#1)(1995-9#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#3)(1997-5#2)(1997-8#1)(2004-11#1)(2004-7#1)(2004-8#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-5#1)(2006-10#8)(2006-5#2)(2006-8#1)(2007-10#1)(2007-12#2)(2007-2#3)(2007-3#1)(2007-4#1)(2007-6#2)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#3)(2008-11#7)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2010-10#1)(2010-11#1)(2010-2#3)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#4)(2013-8#1)
the provisional##7##2##(1992-12#1)(2006-11#1)(2007-6#1)(2008-4#1)(2012-2#2)(2013-1#1)
the provisioning of##3##3##(2006-7#1)(2009-4#1)(2012-12#1)
the provisions of the##6##4##(1991-1#1)(1992-1#1)(1993-2#1)(1994-3#1)(2005-5#2)
the provisions##9##2##(1991-1#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-3#1)(2005-5#2)
the provocation##4##2##(1990-6#1)(2004-12#1)(2010-6#1)(2012-3#1)
the provocative tests##3##3##(2006-1#1)(2006-8#2)
the provocative##5##2##(2006-1#1)(2006-8#2)(2008-4#1)(2008-7#1)
the proximal 1##2##3##(2010-2#1)(2012-12#1)
the proximal anastomosis##3##3##(2007-8#3)
the proximal and distal##9##4##(1991-11#1)(1997-8#1)(2006-10#1)(2008-11#1)(2008-6#1)(2009-7#1)(2010-4#1)(2012-1#1)(2012-12#1)
the proximal and mid left anterior descending artery##2##8##(2008-11#2)
the proximal and middle##2##4##(1992-5#1)(2013-8#1)
the proximal and##14##3##(1991-11#1)(1992-5#1)(1997-2#1)(1997-8#1)(2006-10#1)(2008-11#3)(2008-6#1)(2009-7#1)(2010-4#1)(2012-1#1)(2012-12#1)(2013-8#1)
the proximal apex##4##3##(2008-11#4)
the proximal component##2##3##(1992-9#1)(2008-9#1)
the proximal composition##2##3##(2012-2#2)
the proximal end of the##6##5##(1995-6#1)(2005-9#1)(2007-11#1)(2007-8#1)(2008-6#1)(2013-7#1)
the proximal end of##8##4##(1995-6#1)(1997-7#1)(2005-9#1)(2007-11#1)(2007-8#1)(2008-6#1)(2013-7#1)(2013-8#1)
the proximal end##9##3##(1995-6#1)(1997-7#1)(2005-9#1)(2007-11#1)(2007-8#1)(2008-6#1)(2011-2#1)(2013-7#1)(2013-8#1)
the proximal ends of##2##4##(2007-11#1)(2008-5#1)
the proximal epiphysis of the femur##5##6##(2007-11#3)(2007-8#2)
the proximal epiphysis of the##6##5##(2007-11#4)(2007-8#2)
the proximal epiphysis##7##3##(2007-11#5)(2007-8#2)
the proximal femur##37##3##(2005-12#1)(2007-11#8)(2007-5#2)(2007-7#17)(2007-8#1)(2008-6#2)(2009-3#3)(2011-2#1)(2013-1#2)
the proximal fragment##3##3##(1991-6#1)(2006-3#2)
the proximal histidine##5##3##(1991-7#1)(1994-5#1)(1995-2#2)(2009-3#1)
the proximal humerus of##2##4##(1996-11#1)(2012-3#1)
the proximal humerus##11##3##(1996-11#1)(2007-2#1)(2007-8#2)(2008-6#3)(2009-3#2)(2010-7#1)(2012-3#1)
the proximal interphalangeal joint##4##4##(2006-3#2)(2006-4#1)(2007-7#1)
the proximal interphalangeal##8##3##(2006-10#1)(2006-3#2)(2006-4#1)(2007-7#1)(2008-9#2)(2011-2#1)
the proximal left##2##3##(2007-8#1)(2008-4#1)
the proximal ligand##3##3##(1994-5#2)(1995-5#1)
the proximal limb of the plate##2##6##(2006-3#2)
the proximal nail fold##4##4##(2008-5#4)
the proximal part of the##4##5##(1991-5#1)(1993-12#1)(2007-5#1)(2013-8#1)
the proximal part of##6##4##(1991-5#1)(1993-12#1)(2007-11#1)(2007-5#1)(2012-2#1)(2013-8#1)
the proximal part##7##3##(1991-5#1)(1993-12#1)(2007-11#1)(2007-5#1)(2009-3#1)(2012-2#1)(2013-8#1)
the proximal portion and a##2##5##(1997-4#1)(2012-12#1)
the proximal portion of the##6##5##(1991-2#1)(1993-8#1)(1996-3#1)(2007-12#1)(2008-7#1)(2011-2#1)
the proximal portion of##8##4##(1991-2#1)(1993-8#1)(1995-12#1)(1996-3#1)(1996-8#1)(2007-12#1)(2008-7#1)(2011-2#1)
the proximal portion##10##3##(1991-2#1)(1993-8#1)(1995-12#1)(1996-3#1)(1996-8#1)(1997-4#1)(2007-12#1)(2008-7#1)(2011-2#1)(2012-12#1)
the proximal promoter##5##3##(1992-5#1)(1993-4#1)(1995-10#1)(1996-11#1)(2009-4#1)
the proximal region of the##5##5##(1990-5#1)(1992-9#1)(1993-5#1)(2008-10#1)(2009-12#1)
the proximal region of##6##4##(1990-5#1)(1992-9#1)(1993-2#1)(1993-5#1)(2008-10#1)(2009-12#1)
the proximal region##8##3##(1990-5#1)(1990-8#1)(1992-9#1)(1993-2#1)(1993-5#1)(2008-10#1)(2009-12#1)(2013-8#1)
the proximal regions I and II##2##6##(1994-9#2)
the proximal regions##3##3##(1994-12#1)(1994-9#2)
the proximal segment of the##2##5##(1991-9#1)(2008-7#1)
the proximal sequence element##2##4##(1995-8#1)(1996-4#1)
the proximal sequence##3##3##(1995-8#1)(1996-4#1)(1997-7#1)
the proximal short arm of the X-chromosome##2##7##(1997-5#2)
the proximal small bowel##2##4##(2008-8#1)(2010-12#1)
the proximal small intestine of##2##5##(1996-4#1)(1997-2#1)
the proximal small intestine##6##4##(1992-11#1)(1994-3#1)(1996-2#2)(1996-4#1)(1997-2#1)
the proximal small##8##3##(1992-11#1)(1994-3#1)(1996-2#2)(1996-4#1)(1997-2#1)(2008-8#1)(2010-12#1)
the proximal stump of##2##4##(1994-2#1)(2008-12#1)
the proximal surfaces##2##3##(2008-12#2)
the proximal tibia##8##3##(2008-6#1)(2008-8#1)(2009-3#3)(2009-9#1)(2012-1#2)
the proximal tibial##3##3##(2008-8#1)(2012-12#2)
the proximal transcription##2##3##(1991-12#2)
the proximal tsp##2##3##(1991-12#2)
the proximal tubular##4##3##(1991-2#1)(1994-5#1)(2007-12#1)(2011-2#1)
the proximal tubule##6##3##(1990-11#1)(1990-9#1)(1993-3#1)(1994-5#1)(2007-9#1)(2008-11#1)
the proximal##279##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#3)(1990-9#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-11#3)(1992-12#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-9#4)(1993-12#3)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-8#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#7)(1994-9#3)(1995-10#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-11#3)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#1)(1996-8#1)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#2)(1997-7#4)(1997-8#2)(2005-12#1)(2005-7#2)(2005-9#1)(2006-10#4)(2006-11#1)(2006-3#10)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#16)(2007-12#6)(2007-2#1)(2007-3#1)(2007-5#3)(2007-7#18)(2007-8#15)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#8)(2008-12#4)(2008-4#1)(2008-5#5)(2008-6#8)(2008-7#6)(2008-8#3)(2008-9#3)(2009-1#1)(2009-12#1)(2009-3#10)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-12#3)(2010-2#1)(2010-3#4)(2010-4#2)(2010-7#1)(2011-2#6)(2012-1#4)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#5)
the proximate biochemical composition and fatty acid##2##7##(2010-11#2)
the proximate cause of##3##4##(2012-2#1)(2013-1#2)
the proximate##11##2##(1991-5#1)(1992-11#1)(1992-4#1)(1996-1#1)(2008-8#1)(2010-11#2)(2010-2#1)(2012-2#1)(2013-1#2)
the proximity of the##7##4##(1990-12#1)(2006-12#1)(2007-4#1)(2008-11#1)(2009-3#1)(2011-2#1)(2013-1#1)
the proximity of##22##3##(1990-11#1)(1990-12#1)(1993-12#1)(1994-8#1)(1995-7#1)(1995-8#1)(1996-3#1)(1997-8#1)(2006-12#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-8#1)(2011-2#2)(2013-1#1)
the proximity##26##2##(1990-11#1)(1990-12#1)(1993-12#1)(1993-6#1)(1994-8#1)(1995-2#1)(1995-7#1)(1995-8#1)(1996-3#1)(1997-8#1)(2006-12#1)(2007-12#2)(2007-4#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
the proxy##3##2##(2011-1#3)
the pruritus of cholestasis##2##4##(2004-11#2)
the psbA-trnH##2##2##(2011-2#2)
the psbP gene##2##3##(1996-10#2)
the pseudo##2##2##(2008-9#1)(2012-1#1)
the pseudo-first-order rate constant##3##4##(1991-9#1)(1993-3#1)(1993-8#1)
the pseudo-first-order rate##4##3##(1991-9#1)(1993-3#1)(1993-8#1)(1994-8#1)
the pseudo-first-order##5##2##(1991-9#1)(1992-5#1)(1993-3#1)(1993-8#1)(1994-8#1)
the pseudoaneurysm##6##2##(2007-8#3)(2010-12#1)(2012-12#1)(2012-2#1)
the pseudoarthrosis##2##2##(2007-8#1)(2009-2#1)
the pseudoautosomal boundary##2##3##(1990-11#2)
the pseudoautosomal region##4##3##(1990-11#2)(1995-11#2)
the pseudoautosomal##6##2##(1990-11#4)(1995-11#2)
the pseudocysts##3##2##(1991-8#2)(2013-1#1)
the pseudogene contained##2##3##(1990-8#1)(1997-4#1)
the pseudogene##6##2##(1990-8#2)(1995-11#1)(1997-2#1)(1997-4#2)
the pseudogenes##4##2##(1990-8#2)(1991-6#2)
the pseudoknot and##2##3##(1990-7#1)(1996-8#1)
the pseudoknot##6##2##(1990-7#2)(1996-8#2)(1996-9#1)(2008-10#1)
the pseudophase##2##2##(1990-5#1)(2005-11#1)
the pseudorevertants##2##2##(1997-1#2)
the pseudosubstrate##4##2##(1992-8#1)(1992-9#3)
the psoas muscle##3##3##(2006-8#1)(2008-10#1)(2009-2#1)
the psoas##7##2##(1991-3#1)(1996-6#1)(2006-8#1)(2008-10#2)(2009-2#1)(2009-4#1)
the psoralen##2##2##(1992-6#1)(2007-8#1)
the psoriasis##2##2##(2006-5#1)(2008-5#1)
the psoriatic lesions##2##3##(2007-7#1)(2008-5#1)
the psoriatic##3##2##(2007-11#1)(2007-7#1)(2008-5#1)
the psychiatric assessment and management of physically ill children and adolescents##2##11##(2009-12#2)
the psychiatric assessment##3##3##(2009-12#2)(2010-12#1)
the psychiatric department##2##3##(1996-1#1)(1996-11#1)
the psychiatric departments##2##3##(1992-3#1)(1993-8#1)
the psychiatric hospital##3##3##(1991-12#1)(1991-9#1)(1993-2#1)
the psychiatric inpatient##2##3##(2009-7#1)(2009-9#1)
the psychiatric morbidity##2##3##(2006-9#1)(2010-9#1)
the psychiatric outpatient department##2##4##(1991-9#2)
the psychiatric outpatient##4##3##(1991-11#1)(1991-9#2)(1994-8#1)
the psychiatric##53##2##(1991-11#1)(1991-12#1)(1991-9#3)(1992-2#3)(1992-3#1)(1993-10#1)(1993-2#2)(1993-5#1)(1993-6#1)(1993-8#1)(1994-8#1)(1996-1#1)(1996-11#2)(2004-3#3)(2005-7#1)(2006-2#1)(2006-3#1)(2006-9#2)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#2)(2009-12#2)(2009-7#3)(2009-9#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
the psychiatrist is##2##3##(1995-4#2)
the psychiatrist##7##2##(1995-4#3)(2008-7#1)(2009-2#1)(2012-12#2)
the psychiatry##2##2##(2009-7#1)(2013-8#1)
the psycho-geriatric##2##2##(1992-3#2)
the psychoactive##2##2##(2008-7#2)
the psychoanalytic##2##2##(2008-4#2)
the psychobiological##3##2##(2008-1#1)(2008-4#1)(2009-9#1)
the psychodynamic##2##2##(2004-12#1)(2006-3#1)
the psychogeriatric##2##2##(1992-3#1)(1994-6#1)
the psychological and social##2##4##(1994-9#1)(2006-9#1)
the psychological and##7##3##(1993-12#1)(1994-9#1)(2006-9#1)(2007-9#1)(2008-2#1)(2009-11#1)(2011-2#1)
the psychological aspects of##3##4##(2006-3#1)(2009-10#1)(2010-11#1)
the psychological aspects##5##3##(2006-3#1)(2008-12#1)(2009-10#1)(2010-11#1)(2013-1#1)
the psychological impact of##4##4##(2007-3#1)(2008-12#1)(2008-4#1)(2010-8#1)
the psychological impact##6##3##(2006-10#1)(2007-3#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-8#1)
the psychological process##3##3##(1990-10#3)
the psychological symptoms##2##3##(2008-10#1)(2008-2#1)
the psychological well-being of the##2##5##(2008-11#1)(2013-1#1)
the psychological##56##2##(1990-10#3)(1990-8#1)(1991-4#1)(1993-12#1)(1994-12#1)(1994-9#1)(1996-1#1)(1996-9#1)(1997-7#1)(2004-2#1)(2006-10#2)(2006-3#1)(2006-8#1)(2006-9#1)(2007-3#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-2#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-7#1)(2010-11#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#3)
the psychology of##6##3##(2006-7#1)(2007-11#1)(2008-12#1)(2008-7#1)(2009-12#1)(2013-8#1)
the psychology##7##2##(2006-7#1)(2007-11#1)(2008-12#1)(2008-7#1)(2009-12#1)(2013-1#1)(2013-8#1)
the psychometric characteristics of the##2##5##(2007-12#1)(2011-2#1)
the psychometric evaluation##2##3##(2006-9#1)(2012-1#1)
the psychometric function##2##3##(1994-2#1)(2012-2#1)
the psychometric properties of the##9##5##(2007-9#1)(2008-11#1)(2008-9#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#2)(2013-1#1)
the psychometric properties of##15##4##(1996-3#1)(1997-8#1)(2007-9#1)(2008-11#2)(2008-9#1)(2009-9#1)(2010-11#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)
the psychometric properties##17##3##(1996-3#1)(1997-8#1)(2007-9#1)(2008-11#2)(2008-9#1)(2009-9#1)(2010-11#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2013-1#2)
the psychometric##26##2##(1990-3#1)(1994-2#1)(1996-3#1)(1997-8#1)(2006-9#1)(2007-12#1)(2007-9#1)(2008-11#2)(2008-9#1)(2009-9#1)(2010-11#2)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-11#1)(2012-2#1)(2013-1#3)
the psychomotor##4##2##(1991-2#1)(1993-6#1)(1994-6#1)(2006-3#1)
the psychopathological correlates of##2##4##(1996-2#2)
the psychopathological##4##2##(1991-3#1)(1996-2#2)(1996-8#1)
the psychopathology of##2##3##(2008-1#1)(2009-9#1)
the psychopathology##3##2##(2008-1#1)(2009-7#1)(2009-9#1)
the psychopharmacological##2##2##(2011-2#1)(2012-2#1)
the psychophysical curve##3##3##(2011-2#3)
the psychophysical##8##2##(1991-2#1)(2008-7#1)(2008-9#2)(2011-2#3)(2012-12#1)
the psychophysiological responses to##3##4##(1992-12#3)
the psychosocial and##4##3##(1997-4#1)(2006-2#1)(2010-7#1)(2012-2#1)
the psychosocial care of hospitalized children##2##6##(1991-1#2)
the psychosocial consequences of the##2##5##(2008-2#1)(2008-6#1)
the psychosocial development of children##2##5##(1993-1#2)
the psychosocial impact of##2##4##(1997-5#1)(2008-11#1)
the psychosocial needs of##3##4##(1990-12#1)(1991-2#1)(2008-9#1)
the psychosocial rehabilitation##2##3##(2008-2#1)(2012-12#1)
the psychosocial##31##2##(1990-12#1)(1991-1#2)(1991-2#2)(1992-3#1)(1993-1#3)(1994-8#1)(1995-5#1)(1996-12#1)(1997-4#1)(1997-5#1)(2006-2#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-2#3)(2008-4#1)(2008-6#1)(2008-9#1)(2010-3#1)(2010-7#2)(2012-12#1)(2012-2#2)
the psychotherapy of##2##3##(1991-9#1)(2013-8#1)
the psychotherapy##4##2##(1991-9#1)(1996-1#1)(2006-9#1)(2013-8#1)
the psychotic##2##2##(2011-2#1)(2012-2#1)
the psychotropic##4##2##(2008-10#1)(2008-4#1)(2010-2#1)(2012-12#1)
the pteridine ring##2##3##(1991-2#1)(1995-2#1)
the pteridine##3##2##(1991-2#1)(1995-2#2)
the pterin molybdenum cofactor##2##4##(1991-3#1)(1992-3#1)
the pterin##4##2##(1991-3#1)(1991-5#1)(1992-3#1)(1995-2#1)
the pterygote##2##2##(2008-5#1)(2008-7#1)
the pubertal##3##2##(2010-3#1)(2011-1#2)
the puberty##2##2##(1991-12#1)(1991-9#1)
the pubic symphysis##6##3##(1997-7#3)(2006-10#1)(2007-2#1)(2012-12#1)
the pubic##8##2##(1997-7#3)(2006-10#1)(2007-2#1)(2007-4#1)(2008-1#1)(2012-12#1)
the public Healthcare Units##2##4##(2008-9#2)
the public about##4##3##(1992-1#1)(1995-1#1)(1996-2#1)(2012-2#1)
the public and government##2##4##(2004-9#1)(2011-2#1)
the public and medical##2##4##(2006-10#1)(2011-2#1)
the public and private sectors to##2##6##(1996-2#1)(1997-3#1)
the public and private sectors##7##5##(1992-12#1)(1996-2#1)(1997-3#1)(2004-4#1)(2005-5#2)(2007-7#1)
the public and private##12##4##(1992-12#1)(1996-12#1)(1996-2#1)(1997-3#1)(2004-4#1)(2005-5#2)(2007-7#1)(2008-9#1)(2011-2#2)(2013-7#1)
the public and the##2##4##(2006-2#1)(2012-2#1)
the public and##35##3##(1992-12#1)(1993-1#1)(1995-1#1)(1995-5#1)(1996-12#2)(1996-2#2)(1997-3#1)(2004-4#1)(2004-9#1)(2005-5#2)(2005-7#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-5#2)(2008-9#1)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-7#2)
the public as##3##3##(1997-3#2)(2007-2#1)
the public at large##4##4##(1997-2#1)(2009-12#1)(2009-4#1)(2010-12#1)
the public at##5##3##(1997-2#1)(2006-9#1)(2009-12#1)(2009-4#1)(2010-12#1)
the public clinic##2##3##(2006-4#2)
the public databases##4##3##(1996-10#1)(1997-3#1)(2005-7#1)(2006-10#1)
the public debate on##2##4##(2010-11#1)(2013-7#1)
the public debate##3##3##(2008-11#1)(2010-11#1)(2013-7#1)
the public dental##2##3##(1996-9#1)(2006-8#1)
the public domain and##4##4##(2007-9#1)(2008-4#1)(2008-7#1)(2009-12#1)
the public domain##12##3##(1994-12#1)(1996-1#1)(1996-2#1)(2007-9#1)(2008-10#1)(2008-4#3)(2008-7#1)(2009-12#1)(2012-3#1)(2013-1#1)
the public group##2##3##(2006-10#2)
the public health and##3##4##(2008-2#1)(2010-12#1)(2012-12#1)
the public health community##4##4##(1995-12#1)(1996-3#1)(1997-1#1)(2008-7#1)
the public health impact of##4##5##(1991-3#1)(1997-3#1)(2006-10#2)
the public health implications of##2##5##(2008-4#1)(2013-1#1)
the public health importance of##3##5##(2006-10#1)(2010-8#1)(2013-1#1)
the public health message##2##4##(1996-3#1)(2008-4#1)
the public health needs of##2##5##(1994-3#1)(1996-3#1)
the public health of##2##4##(1996-2#1)(2013-7#1)
the public health practice##2##4##(1997-2#1)(2010-12#1)
the public health sector##3##4##(2006-10#1)(2007-7#1)(2008-8#1)
the public health system in##2##5##(1995-12#1)(1996-2#1)
the public health system##8##4##(1995-12#1)(1996-2#2)(1997-2#1)(2006-5#1)(2007-11#1)(2008-9#1)(2012-1#1)
the public health##74##3##(1991-2#1)(1991-3#2)(1991-4#1)(1992-4#1)(1994-3#1)(1995-12#3)(1996-2#4)(1996-3#3)(1997-1#1)(1997-2#2)(1997-3#3)(2006-10#5)(2006-2#1)(2006-5#1)(2007-11#2)(2007-12#2)(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#3)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#3)(2013-1#5)(2013-7#1)
the public hospital##2##3##(2008-9#1)(2013-8#1)
the public in##4##3##(1994-3#1)(1996-12#1)(2011-2#1)(2013-1#1)
the public interest##5##3##(1993-1#1)(1996-12#1)(2005-10#1)(2005-11#1)(2007-4#1)
the public is##7##3##(1996-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-5#1)(2013-1#2)
the public of##3##3##(2007-2#1)(2008-2#1)(2008-3#1)
the public on##3##3##(1994-5#1)(2007-4#1)(2009-4#1)
the public press##2##3##(1996-11#1)(2007-11#1)
the public sector##12##3##(1995-3#1)(1996-12#1)(1997-2#1)(1997-3#1)(2005-5#1)(2006-10#1)(2006-2#1)(2010-3#1)(2011-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
the public service##2##3##(2010-8#1)(2012-12#1)
the public should be##3##4##(1993-9#1)(2007-10#1)(2008-10#1)
the public sphere##4##3##(2009-7#1)(2013-1#2)(2013-7#1)
the public the##2##3##(1995-6#1)(1997-5#1)
the public through##2##3##(2008-9#1)(2013-1#1)
the public to the##3##4##(1991-3#1)(1991-8#1)(1992-2#1)
the public to##13##3##(1991-3#2)(1991-8#1)(1992-2#1)(1993-8#1)(1994-1#1)(1996-4#1)(2007-9#1)(2008-4#1)(2008-5#3)(2008-7#1)
the public##315##2##(1990-4#1)(1991-11#1)(1991-2#1)(1991-3#6)(1991-4#1)(1991-8#1)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#4)(1994-5#1)(1995-1#2)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-10#1)(1996-11#5)(1996-12#7)(1996-2#10)(1996-3#4)(1996-4#3)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#8)(1997-4#1)(1997-5#1)(1997-8#3)(2004-1#1)(2004-4#1)(2004-9#2)(2005-10#1)(2005-11#1)(2005-5#3)(2005-7#3)(2006-10#13)(2006-11#1)(2006-12#1)(2006-2#5)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-2#4)(2007-3#1)(2007-4#4)(2007-5#1)(2007-7#4)(2007-9#4)(2008-1#2)(2008-10#4)(2008-11#5)(2008-12#4)(2008-2#4)(2008-3#5)(2008-4#6)(2008-5#11)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#7)(2009-12#3)(2009-4#5)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#4)(2011-1#7)(2011-12#1)(2011-2#10)(2011-7#1)(2012-1#1)(2012-12#6)(2012-2#5)(2012-3#6)(2013-1#17)(2013-7#7)(2013-8#2)
the public's health and##2##4##(1996-3#1)(2010-7#1)
the public's health##5##3##(1996-3#1)(2007-4#1)(2008-7#1)(2010-7#1)(2011-2#1)
the public's need for##2##4##(2006-2#1)(2008-5#1)
the public's oral##2##3##(1995-12#1)(2006-2#1)
the public's role##2##3##(1995-3#1)(2013-7#1)
the public's##26##2##(1991-3#1)(1992-12#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-3#2)(1997-8#1)(2005-11#1)(2006-2#2)(2006-5#1)(2007-11#1)(2007-4#1)(2008-5#1)(2008-7#1)(2009-4#2)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
the publication and##2##3##(2008-12#1)(2012-2#1)
the publication of the first##2##5##(2006-10#1)(2011-1#1)
the publication of the##9##4##(1996-2#1)(2004-1#1)(2006-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-9#1)(2011-1#1)(2011-2#1)
the publication of this##3##4##(2010-8#2)(2013-1#1)
the publication of##26##3##(1994-10#1)(1994-3#1)(1996-2#1)(2004-1#2)(2005-7#1)(2006-10#3)(2006-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-4#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
the publication##33##2##(1994-10#1)(1994-3#1)(1996-2#1)(2004-1#2)(2005-7#2)(2006-10#3)(2006-5#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-4#2)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
the publications##7##2##(1995-7#1)(2008-1#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#1)
the publicly available##3##3##(2011-2#1)(2012-11#1)(2012-12#1)
the published X-ray crystal##2##4##(1996-11#1)(2011-2#1)
the published articles##2##3##(2007-4#1)(2012-12#1)
the published clone##2##3##(1994-12#2)
the published data##2##3##(1991-2#1)(1993-5#1)
the published evidence##2##3##(2007-7#1)(2009-7#1)
the published experience##2##3##(2009-2#1)(2011-7#1)
the published experimental##3##3##(2007-4#1)(2008-11#1)(2008-2#1)
the published literature and##4##4##(2006-3#1)(2010-10#1)(2010-12#2)
the published literature for##2##4##(2007-3#1)(2008-8#1)
the published literature on##3##4##(2006-10#1)(2008-3#1)(2009-9#1)
the published literature was##3##4##(2008-6#2)(2013-1#1)
the published literature##18##3##(1991-3#1)(1996-2#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-3#1)(2008-3#1)(2008-4#1)(2008-6#3)(2008-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2012-12#1)(2013-1#1)
the published relevant##2##3##(2008-3#1)(2008-5#1)
the published research##2##3##(2007-10#1)(2012-3#1)
the published results of##2##4##(1992-11#1)(2006-8#1)
the published results##3##3##(1992-11#1)(2005-1#1)(2006-8#1)
the published sequence of##3##4##(1990-7#1)(1992-12#1)(1993-6#1)
the published sequence##7##3##(1990-7#2)(1992-12#1)(1993-6#1)(1994-12#1)(1995-1#1)(1996-6#1)
the published sequences of##2##4##(1990-9#1)(2008-10#1)
the published sequences##3##3##(1990-9#1)(2008-10#1)(2008-5#1)
the published trials##2##3##(2008-12#1)(2012-2#1)
the published##86##2##(1990-7#2)(1990-9#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-12#3)(1994-3#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-6#1)(2005-1#1)(2005-5#1)(2006-10#2)(2006-3#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-4#2)(2007-7#3)(2008-10#2)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-2#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#2)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#3)
the publisher##23##2##(2007-4#1)(2013-8#22)
the publishing##3##2##(2007-4#1)(2008-10#1)(2011-1#1)
the pudendal nerve##2##3##(1992-6#1)(1992-7#1)
the puerperium##5##2##(1991-5#1)(1992-5#1)(1993-10#1)(2006-10#1)(2008-8#1)
the pull-off##3##2##(2005-11#2)(2006-7#1)
the pullets##3##2##(2008-5#3)
the pulling##5##2##(1990-5#1)(2007-12#1)(2009-12#2)(2009-7#1)
the pulmonary and##3##3##(1994-6#1)(1997-5#1)(2008-11#1)
the pulmonary arterial##2##3##(2007-11#1)(2008-4#1)
the pulmonary arteries and##3##4##(2005-11#1)(2010-5#1)(2010-6#1)
the pulmonary arteries##14##3##(1997-8#1)(2005-11#1)(2008-10#1)(2008-4#2)(2008-7#4)(2010-5#1)(2010-6#2)(2013-1#2)
the pulmonary artery and##4##4##(1991-3#1)(2013-7#3)
the pulmonary artery in##4##4##(2008-4#1)(2010-10#1)(2013-7#2)
the pulmonary artery is##3##4##(1997-8#1)(2007-8#2)
the pulmonary artery pressure##5##4##(2006-10#1)(2007-9#3)(2010-8#1)
the pulmonary artery using##2##4##(2007-8#1)(2013-7#1)
the pulmonary artery##42##3##(1991-3#1)(1991-9#1)(1994-3#1)(1996-3#1)(1997-8#1)(2006-10#2)(2007-8#8)(2007-9#3)(2008-11#2)(2008-12#1)(2008-4#3)(2010-10#3)(2010-12#1)(2010-5#1)(2010-8#2)(2012-2#1)(2013-1#1)(2013-7#9)
the pulmonary aspergillosis##2##3##(2012-12#2)
the pulmonary autograft##2##3##(2007-8#2)
the pulmonary blood##2##3##(2007-8#1)(2007-9#1)
the pulmonary circulation##7##3##(1992-3#1)(1994-8#1)(2005-11#1)(2006-10#2)(2008-4#1)(2010-10#1)
the pulmonary complications##2##3##(2007-2#1)(2007-8#1)
the pulmonary function##2##3##(1994-3#1)(2007-3#1)
the pulmonary lesions##2##3##(2008-5#1)(2013-8#1)
the pulmonary parenchyma##2##3##(1991-3#1)(2007-8#1)
the pulmonary surfactant##3##3##(2006-6#3)
the pulmonary valve##5##3##(2007-8#3)(2008-4#1)(2009-9#1)
the pulmonary vascular bed##4##4##(1991-2#2)(1991-8#1)(2008-10#1)
the pulmonary vascular##10##3##(1991-2#3)(1991-8#1)(1993-3#1)(2006-10#1)(2008-10#1)(2008-11#1)(2010-6#1)(2012-1#1)
the pulmonary vasculature and the##2##5##(1993-10#1)(2010-10#1)
the pulmonary vasculature and##3##4##(1993-10#1)(2010-10#1)(2013-1#1)
the pulmonary vasculature##9##3##(1993-10#1)(1997-1#1)(2005-8#1)(2007-8#1)(2010-10#1)(2010-5#1)(2013-1#3)
the pulmonary vein##5##3##(2007-8#2)(2009-10#1)(2011-2#1)(2013-7#1)
the pulmonary veins##4##3##(2006-8#1)(2007-8#1)(2008-11#1)(2013-1#1)
the pulmonary##155##2##(1990-5#1)(1991-2#3)(1991-3#2)(1991-8#2)(1991-9#3)(1992-2#1)(1992-3#2)(1993-10#1)(1993-3#1)(1994-12#1)(1994-3#2)(1994-6#2)(1994-8#1)(1995-3#1)(1995-6#1)(1996-3#1)(1997-1#2)(1997-3#1)(1997-5#1)(1997-8#2)(2005-11#3)(2005-8#1)(2005-9#1)(2006-10#5)(2006-6#3)(2006-8#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-8#21)(2007-9#6)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#2)(2008-4#9)(2008-5#1)(2008-7#4)(2009-10#1)(2009-9#1)(2010-1#1)(2010-10#5)(2010-12#3)(2010-5#3)(2010-6#4)(2010-8#4)(2011-2#3)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#7)(2013-7#10)(2013-8#3)
the pulmonologist##2##2##(2011-3#1)(2012-3#1)
the pulp cavity##2##3##(2008-7#1)(2013-8#1)
the pulp chamber##7##3##(1991-2#2)(1994-5#3)(2013-8#2)
the pulp of##2##3##(2008-10#1)(2013-8#1)
the pulp##26##2##(1991-2#3)(1994-5#3)(2005-10#1)(2006-8#1)(2007-2#1)(2008-10#2)(2008-5#3)(2008-7#1)(2011-2#3)(2012-2#1)(2013-8#7)
the pulpotomy##2##2##(2011-2#2)
the pulsatile nature of##2##4##(2008-3#2)
the pulsatile##5##2##(1993-2#1)(2007-12#1)(2008-3#2)(2008-7#1)
the pulsatility of##2##3##(1990-9#1)(2007-7#1)
the pulse chirp##2##3##(2007-11#1)(2007-12#1)
the pulse duration and##2##4##(2007-11#1)(2007-12#1)
the pulse duration is##3##4##(1991-2#1)(2007-12#1)(2008-3#1)
the pulse duration##20##3##(1991-2#3)(2007-11#2)(2007-12#7)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)
the pulse energy and##2##4##(2007-11#2)
the pulse energy to##2##4##(2007-12#1)(2008-3#1)
the pulse energy##10##3##(2007-11#3)(2007-12#5)(2008-1#1)(2008-3#1)
the pulse envelope##3##3##(2007-12#3)
the pulse evolution##2##3##(2007-12#2)
the pulse frequency##2##3##(1992-11#1)(2013-1#1)
the pulse intensity##2##3##(2007-12#1)(2008-3#1)
the pulse is##5##3##(2007-11#1)(2007-12#3)(2008-2#1)
the pulse leading-trailing time##2##4##(2008-3#2)
the pulse leading-trailing##3##3##(2008-3#3)
the pulse length##3##3##(1990-5#1)(2007-12#1)(2008-2#1)
the pulse phase##2##3##(2007-12#2)
the pulse pressure##2##3##(1990-8#1)(2011-1#1)
the pulse propagation##2##3##(2008-3#2)
the pulse rate##2##3##(1993-2#1)(2008-4#1)
the pulse repetition rate##3##4##(2007-12#2)(2008-3#1)
the pulse shape##3##3##(2007-12#2)(2008-2#1)
the pulse spectrum##4##3##(2007-12#1)(2008-3#3)
the pulse train##8##3##(2006-5#1)(2007-11#3)(2007-12#3)(2008-1#1)
the pulse trains##3##3##(2007-11#2)(2007-12#1)
the pulse were##2##3##(2007-11#1)(2007-7#1)
the pulse width is##2##4##(2007-12#1)(2008-3#1)
the pulse width of the##2##5##(2007-12#1)(2012-12#1)
the pulse width of##4##4##(2007-12#1)(2008-3#2)(2012-12#1)
the pulse width when it is##2##6##(2008-3#2)
the pulse width when##3##4##(2008-3#3)
the pulse width##23##3##(2007-11#2)(2007-12#4)(2008-1#1)(2008-2#1)(2008-3#14)(2012-12#1)
the pulse##167##2##(1990-5#1)(1990-8#1)(1991-2#3)(1992-11#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-2#1)(2006-5#2)(2007-11#26)(2007-12#62)(2007-7#3)(2008-1#7)(2008-10#4)(2008-11#1)(2008-2#9)(2008-3#30)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)
the pulse-front tilt##2##3##(2007-11#2)
the pulse-to-pulse amplitude##2##3##(2007-12#2)
the pulsed##11##2##(1991-3#1)(1997-1#1)(2005-11#1)(2007-12#3)(2008-10#1)(2008-3#3)(2009-4#1)
the pulses and##2##3##(2007-12#2)
the pulses at the##2##4##(2007-12#2)
the pulses is##2##3##(2007-12#2)
the pulses to a##2##4##(2007-12#2)
the pulses to##3##3##(2007-12#2)(2010-11#1)
the pulses##24##2##(1991-5#1)(2006-5#1)(2007-11#3)(2007-12#14)(2008-2#1)(2008-3#1)(2008-5#1)(2010-11#1)(2011-1#1)
the pump and signal##2##4##(2007-12#2)
the pump and the idler##2##5##(2007-12#1)(2008-1#1)
the pump and the laser##2##5##(2007-12#1)(2008-3#1)
the pump and the signal##2##5##(2007-12#2)
the pump and the##9##4##(2007-12#4)(2008-1#1)(2008-2#2)(2008-3#2)
the pump and##16##3##(2007-11#1)(2007-12#6)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#3)
the pump beam to##2##4##(2007-12#1)(2008-3#1)
the pump beam##14##3##(2007-11#1)(2007-12#4)(2008-2#3)(2008-3#6)
the pump flow##2##3##(2007-8#1)(2008-10#1)
the pump is##2##3##(2007-12#2)
the pump laser##6##3##(2007-11#3)(2007-12#2)(2008-2#1)
the pump power##10##3##(2007-11#4)(2007-12#5)(2008-3#1)
the pump pulse##8##3##(2007-11#3)(2007-12#3)(2008-1#1)(2008-2#1)
the pump pulses##3##3##(2007-12#3)
the pump source##8##3##(2007-12#2)(2008-2#2)(2008-3#4)
the pump spectrum##2##3##(2007-11#1)(2007-12#1)
the pump to##2##3##(2007-11#1)(2007-12#1)
the pump wave##4##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)
the pump wavelength##3##3##(2007-12#3)
the pump##128##2##(1992-1#1)(1992-5#1)(1994-9#1)(2006-7#1)(2006-8#1)(2007-11#25)(2007-12#44)(2007-8#1)(2008-1#7)(2008-10#9)(2008-2#16)(2008-3#20)(2008-5#1)
the pump's##5##2##(2007-12#1)(2008-10#3)(2008-3#1)
the pump-power##5##2##(2007-12#4)(2008-3#1)
the pump-to-mode##2##2##(2008-3#2)
the pumped##4##2##(1996-1#1)(2008-2#1)(2008-3#2)
the pumping of##2##3##(1997-8#1)(2008-3#1)
the pumping rate##2##3##(1996-1#1)(2008-2#1)
the pumping source##2##3##(2008-3#2)
the pumping wavelength##2##3##(2008-2#2)
the pumping##17##2##(1990-3#1)(1996-1#1)(1997-8#1)(2007-11#1)(2007-12#3)(2008-2#6)(2008-3#4)
the pumps##4##2##(1995-12#1)(2008-1#1)(2008-10#1)(2010-9#1)
the puncture site##2##3##(1992-2#1)(2011-2#1)
the puncture##7##2##(1992-2#1)(2005-1#1)(2007-7#1)(2008-11#2)(2011-2#2)
the pungency of the##2##4##(1992-4#1)(2008-10#1)
the pungent##4##2##(1990-7#1)(1997-5#1)(2004-11#1)(2006-12#1)
the pupae##2##2##(1990-7#1)(2008-6#1)
the pupal ecdysteroid peak##2##4##(2007-12#2)
the pupal stage##8##3##(1991-11#1)(2007-12#4)(2008-8#1)(2011-12#2)
the pupal##12##2##(1991-11#1)(2007-12#8)(2008-8#1)(2011-12#2)
the pupil function##4##3##(2008-2#4)
the pupil of##4##3##(2008-2#3)(2008-7#1)
the pupil##14##2##(2007-12#1)(2008-2#9)(2008-3#2)(2008-7#2)
the pupillary response to##2##4##(2008-7#2)
the pupillary##4##2##(1992-7#1)(2008-7#2)(2011-1#1)
the pupils in##2##3##(1992-8#1)(2006-8#1)
the pupils##5##2##(1992-8#1)(2006-8#1)(2007-9#1)(2008-2#1)(2012-12#1)
the pupils'##2##2##(1993-6#2)
the pups from##2##3##(1992-3#1)(2013-8#1)
the pups were##2##3##(1996-5#1)(2009-5#1)
the pups##7##2##(1992-3#1)(1993-2#1)(1996-4#1)(1996-5#1)(2005-7#1)(2009-5#1)(2013-8#1)
the purchase of##3##3##(1994-4#1)(1996-12#1)(2010-9#1)
the purchase##6##2##(1994-4#1)(1995-2#1)(1996-12#1)(1996-2#1)(2008-11#1)(2010-9#1)
the pure components##2##3##(2005-11#1)(2008-10#1)
the pure compound##3##3##(1996-4#1)(2007-6#1)(2008-10#1)
the pure diffusion##3##3##(2008-3#3)
the pure drug##4##3##(2008-10#3)(2010-2#1)
the pure proband method##4##4##(1997-5#4)
the pure stands##2##3##(2008-10#2)
the pure wild##2##3##(2010-10#2)
the pure xanthophylls##2##3##(2008-12#2)
the pure##74##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-4#2)(1991-6#1)(1992-5#1)(1994-12#1)(1995-1#1)(1995-4#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-5#4)(1997-7#1)(2005-11#6)(2006-10#4)(2006-5#1)(2007-12#4)(2007-6#2)(2008-10#16)(2008-12#3)(2008-2#1)(2008-3#3)(2008-5#1)(2009-3#1)(2010-1#1)(2010-10#3)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)
the purely##3##2##(1991-2#1)(1992-5#1)(2008-2#1)
the purest##2##2##(2008-11#1)(2008-2#1)
the purge##2##2##(2008-10#1)(2008-5#1)
the purification and characterization of a##3##6##(1994-5#1)(1995-3#1)(1997-6#1)
the purification and characterization of the##2##6##(1990-7#1)(1997-7#1)
the purification and characterization of##7##5##(1990-7#1)(1994-5#1)(1995-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-4#1)
the purification and##13##3##(1990-7#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-3#1)(1996-4#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)
the purification of TSP-1##2##4##(2008-1#2)
the purification of a##4##4##(1990-11#1)(1991-11#1)(1996-4#1)(2008-10#1)
the purification of acidic and basic##2##6##(1990-12#1)(1990-7#1)
the purification of crude##2##4##(1996-5#1)(2008-4#1)
the purification of human##4##4##(1990-7#1)(1992-11#1)(2008-4#2)
the purification of large##2##4##(1997-5#1)(2010-10#1)
the purification of multisubunit protein complexes from mammalian cells##2##9##(2008-2#2)
the purification of recombinant##3##4##(1997-1#1)(2008-1#1)(2008-4#1)
the purification of the##11##4##(1991-2#1)(1992-11#1)(1997-2#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#1)
the purification of these enzymes##2##5##(1991-5#1)(1992-5#1)
the purification of this##3##4##(1991-11#1)(1992-11#1)(1996-8#1)
the purification of##84##3##(1990-11#1)(1990-12#2)(1990-4#1)(1990-5#1)(1990-7#4)(1990-8#2)(1991-11#3)(1991-2#1)(1991-5#1)(1992-11#4)(1992-5#1)(1994-11#1)(1994-8#1)(1995-3#2)(1995-6#2)(1995-8#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#2)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-7#1)(2008-1#6)(2008-10#3)(2008-11#3)(2008-2#3)(2008-4#20)(2008-5#1)(2009-12#1)(2010-10#2)(2012-2#1)
the purification procedure##5##3##(1990-12#1)(1992-6#1)(1996-8#1)(2008-10#2)
the purification process##3##3##(2005-4#1)(2007-8#1)(2008-11#1)
the purification steps##2##3##(1996-3#1)(2008-10#1)
the purification##120##2##(1990-11#2)(1990-12#4)(1990-4#1)(1990-5#1)(1990-7#5)(1990-8#2)(1990-9#1)(1991-11#3)(1991-2#1)(1991-5#1)(1992-11#4)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-2#1)(1995-3#3)(1995-6#2)(1995-8#1)(1996-2#1)(1996-3#4)(1996-4#2)(1996-5#3)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(2005-4#1)(2007-7#1)(2007-8#1)(2008-1#8)(2008-10#7)(2008-11#4)(2008-2#4)(2008-4#21)(2008-5#1)(2008-7#1)(2009-12#1)(2010-10#2)(2012-12#1)(2012-2#1)(2013-1#1)
the purified RNA##2##3##(1995-5#1)(2008-9#1)
the purified alpha##3##3##(1990-7#1)(1992-9#1)(1997-8#1)
the purified compound##2##3##(2008-11#1)(2010-11#1)
the purified enzyme was##6##4##(1990-11#1)(1990-2#1)(1991-8#1)(1993-5#1)(1997-6#1)(2008-5#1)
the purified enzyme##30##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-5#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-5#1)(1996-7#2)(1997-2#1)(1997-4#1)(1997-6#1)(2006-3#1)(2008-10#1)(2008-5#1)(2009-8#1)
the purified fraction##3##3##(1991-10#1)(1992-8#1)(1996-7#1)
the purified material##3##3##(1990-12#1)(1994-2#1)(1996-9#1)
the purified mutant##2##3##(1990-10#1)(1994-5#1)
the purified paraplantaricin C7##2##4##(2007-12#2)
the purified peptide##2##3##(1996-4#2)
the purified phosphatase##2##3##(1997-7#2)
the purified preparation##2##3##(1990-7#1)(2013-1#1)
the purified protein was found##2##5##(1990-12#1)(1994-6#1)
the purified protein was##4##4##(1990-12#1)(1990-5#1)(1994-6#1)(2008-10#1)
the purified protein##21##3##(1990-12#1)(1990-2#1)(1990-5#1)(1991-7#1)(1992-12#1)(1992-3#2)(1992-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-2#2)(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#2)
the purified proteins##2##3##(1994-8#1)(1995-8#1)
the purified rat 3-DG-reducing enzyme##2##5##(1993-5#2)
the purified rat##5##3##(1990-7#1)(1992-7#1)(1993-5#2)(1995-11#1)
the purified receptors##2##3##(1995-3#1)(2012-2#1)
the purified recombinant##7##3##(1990-12#1)(1990-6#1)(1995-2#2)(1997-4#1)(2006-12#1)(2008-8#1)
the purified##189##2##(1990-10#1)(1990-11#6)(1990-12#3)(1990-2#2)(1990-3#5)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#11)(1990-8#2)(1991-1#1)(1991-10#1)(1991-2#2)(1991-3#2)(1991-4#3)(1991-5#1)(1991-7#3)(1991-8#2)(1991-9#1)(1992-11#2)(1992-12#3)(1992-3#3)(1992-6#1)(1992-7#3)(1992-8#5)(1992-9#3)(1993-11#1)(1993-12#1)(1993-5#4)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-5#3)(1994-6#1)(1994-8#2)(1994-9#4)(1995-1#1)(1995-11#1)(1995-2#7)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#3)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#3)(1996-7#4)(1996-8#2)(1996-9#1)(1997-2#4)(1997-4#2)(1997-6#4)(1997-7#2)(1997-8#2)(2005-11#3)(2006-12#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#2)(2008-4#5)(2008-5#2)(2008-6#1)(2008-8#5)(2008-9#2)(2009-8#1)(2010-11#1)(2012-2#2)(2013-1#1)
the purified/reconstituted##2##2##(1991-3#2)
the purine nucleoside##2##3##(1997-7#1)(2006-12#1)
the purine ring##3##3##(2006-12#1)(2010-2#2)
the purine strand of the duplex##2##6##(1995-3#2)
the purine strand##4##3##(1992-9#1)(1993-8#1)(1995-3#2)
the purine##28##2##(1992-8#1)(1992-9#1)(1993-8#1)(1994-9#2)(1995-3#4)(1995-8#1)(1996-8#1)(1997-7#1)(2006-10#1)(2006-12#4)(2008-10#5)(2008-5#1)(2008-7#1)(2010-2#4)
the purinergic##4##2##(1990-5#1)(2008-4#2)(2008-6#1)
the purines##5##2##(1990-8#1)(1991-10#2)(2008-3#1)(2008-4#1)
the purity and##7##3##(1994-12#1)(1996-5#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#1)
the purity of Hb solutions##2##5##(1992-11#2)
the purity of isolated##2##4##(2007-2#1)(2008-4#1)
the purity of the##11##4##(1991-9#1)(1995-7#1)(2004-9#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#1)(2012-11#1)(2012-12#1)(2013-1#1)
the purity of##28##3##(1991-9#1)(1992-11#2)(1995-7#1)(2004-9#1)(2005-12#1)(2007-2#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-5#3)(2008-8#2)(2011-1#4)(2012-11#1)(2012-12#1)(2013-1#2)
the purity##38##2##(1990-11#1)(1991-9#1)(1992-11#2)(1994-12#1)(1995-7#1)(1996-5#1)(1997-3#1)(2004-9#1)(2005-12#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#2)(2011-1#4)(2012-11#1)(2012-12#1)(2013-1#2)
the puromycin##2##2##(1990-2#1)(1992-8#1)
the purple acid phosphatase from##2##5##(1991-8#1)(1992-3#1)
the purple asFP595 and yellow zFP538##2##6##(2009-9#2)
the purple bacterium##4##3##(1993-8#2)(1995-6#2)
the purple membrane of Halobacterium salinarium##2##6##(1994-11#1)(1995-11#1)
the purple membrane##4##3##(1994-11#1)(1995-11#1)(1995-6#2)
the purple##20##2##(1991-8#1)(1992-3#1)(1993-8#3)(1994-11#1)(1995-11#1)(1995-6#4)(1997-8#1)(2007-3#1)(2008-10#3)(2009-9#2)(2010-2#1)(2011-2#1)
the purported benefits of##2##4##(1992-2#1)(2012-3#1)
the purported benefits##3##3##(1992-2#1)(2006-9#1)(2012-3#1)
the purported##6##2##(1992-2#1)(2005-9#1)(2006-12#1)(2006-9#1)(2008-5#1)(2012-3#1)
the purpose and the##3##4##(1995-12#1)(1996-9#1)(2008-9#1)
the purpose and##9##3##(1995-1#1)(1995-12#1)(1995-5#1)(1996-9#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2013-1#1)
the purpose for which##3##4##(2006-8#1)(2008-1#1)(2008-9#1)
the purpose for##5##3##(1992-1#1)(2006-8#1)(2008-1#1)(2008-9#1)(2010-1#1)
the purpose of a##2##4##(2008-11#1)(2008-2#1)
the purpose of assessing##3##4##(1990-8#1)(1992-10#1)(2012-2#1)
the purpose of characterizing the##2##5##(1996-12#1)(2008-10#1)
the purpose of characterizing##3##4##(1996-12#1)(2008-10#1)(2008-3#1)
the purpose of finding##3##4##(1994-12#1)(2006-10#1)(2013-1#1)
the purpose of our##2##4##(2008-1#1)(2008-10#1)
the purpose of providing##6##4##(2008-1#1)(2008-7#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
the purpose of studying the##2##5##(1993-6#1)(2008-10#1)
the purpose of studying##3##4##(1993-4#1)(1993-6#1)(2008-10#1)
the purpose of the present study was to##2##8##(1992-12#1)(1993-12#1)
the purpose of the present study##3##6##(1992-12#1)(1993-12#1)(2006-8#1)
the purpose of the present##4##5##(1992-12#1)(1993-12#1)(2006-8#1)(2008-7#1)
the purpose of the study was to##3##7##(1996-9#1)(2011-2#2)
the purpose of the study##5##5##(1996-9#1)(2007-7#1)(2011-2#3)
the purpose of the##19##4##(1991-6#1)(1992-12#1)(1993-12#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-9#1)(2006-8#1)(2007-7#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-3#1)(2011-2#3)(2012-2#1)(2013-1#1)
the purpose of therapy##2##4##(1994-9#1)(2010-2#1)
the purpose of this review is to##2##7##(2008-5#1)(2010-12#1)
the purpose of this review##5##5##(2005-10#1)(2007-7#1)(2008-5#1)(2010-12#1)(2010-5#1)
the purpose of this study is to##3##7##(2007-4#1)(2012-1#1)(2013-1#1)
the purpose of this study was to##4##7##(2008-12#2)(2010-2#1)(2010-3#1)
the purpose of this study##14##5##(1995-12#1)(1997-8#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#2)(2010-12#1)(2010-2#1)(2010-3#1)(2011-12#1)(2012-1#1)(2013-1#2)
the purpose of this##24##4##(1995-12#1)(1997-8#1)(2005-10#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-5#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2011-12#1)(2012-1#1)(2012-11#1)(2013-1#2)
the purpose of##180##3##(1990-6#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-5#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-9#2)(1997-4#1)(1997-8#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#2)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#5)(2007-8#2)(2008-1#2)(2008-10#15)(2008-11#8)(2008-12#3)(2008-2#7)(2008-3#7)(2008-4#2)(2008-5#7)(2008-7#7)(2008-8#1)(2008-9#3)(2009-1#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#7)(2010-2#3)(2010-3#3)(2010-5#2)(2011-12#1)(2011-2#4)(2011-3#1)(2012-1#5)(2012-11#1)(2012-2#6)(2012-3#1)(2013-1#9)(2013-8#3)
the purpose to##4##3##(2008-10#1)(2008-11#1)(2010-4#1)(2011-2#1)
the purpose was##2##3##(2011-1#1)(2012-2#1)
the purpose##214##2##(1990-6#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#5)(1995-5#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-9#3)(1997-4#1)(1997-8#1)(2004-10#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-1#2)(2007-11#1)(2007-2#1)(2007-3#2)(2007-4#2)(2007-7#6)(2007-8#2)(2008-1#3)(2008-10#18)(2008-11#10)(2008-12#4)(2008-2#7)(2008-3#7)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#5)(2009-1#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#7)(2010-2#3)(2010-3#3)(2010-4#1)(2010-5#2)(2011-1#1)(2011-12#1)(2011-2#6)(2011-3#1)(2012-1#5)(2012-11#1)(2012-2#7)(2012-3#1)(2013-1#10)(2013-8#3)
the purposes of the##6##4##(1994-3#1)(1996-9#1)(2007-8#1)(2010-9#1)(2013-1#2)
the purposes of##22##3##(1990-3#1)(1991-12#1)(1993-12#1)(1993-3#1)(1994-3#1)(1996-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-8#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-9#1)(2010-6#1)(2010-9#1)(2013-1#3)
the purposes##24##2##(1990-3#1)(1991-12#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-3#1)(1996-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-9#1)(2010-6#1)(2010-9#1)(2013-1#3)
the pursuit of##10##3##(1993-2#1)(1997-3#1)(2005-7#1)(2008-12#2)(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
the pursuit##14##2##(1993-2#3)(1996-1#1)(1997-3#1)(2005-7#1)(2008-12#2)(2008-2#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
the purview of##5##3##(2008-2#2)(2010-7#1)(2012-1#1)(2013-1#1)
the pus##4##2##(1991-5#1)(1993-3#2)(2007-7#1)
the push-pull TES##2##3##(2008-3#2)
the push-pull##8##2##(2004-11#1)(2008-2#3)(2008-3#4)
the putA and related genes##4##5##(1996-2#4)
the putA gene##2##3##(1996-2#2)
the putA##6##2##(1996-2#6)
the putamen and##2##3##(1995-5#1)(2012-3#1)
the putamen##9##2##(1995-1#1)(1995-5#1)(1995-7#1)(1995-8#1)(2008-7#2)(2012-3#3)
the putative ATP binding##2##4##(1994-9#1)(1997-7#1)
the putative DNA##3##3##(1990-11#1)(1996-10#1)(1997-4#1)
the putative LDL receptor-binding domains##2##5##(1996-10#2)
the putative active site of##4##5##(1992-3#1)(1997-3#1)(2010-10#2)
the putative active site##11##4##(1991-12#1)(1991-9#1)(1992-12#1)(1992-3#1)(1997-3#2)(1997-7#2)(2010-10#3)
the putative amino##2##3##(2006-5#1)(2013-1#1)
the putative coding region##2##4##(1992-7#1)(1993-3#1)
the putative endogenous##2##3##(1993-11#1)(2012-2#1)
the putative first##3##3##(1990-8#1)(1997-2#2)
the putative gene##2##3##(1996-6#1)(2008-5#1)
the putative glycoprotein##3##3##(1991-2#2)(1993-12#1)
the putative inhibitory##2##3##(1995-11#1)(1995-3#1)
the putative mechanisms##2##3##(2008-8#1)(2013-8#1)
the putative movement protein##2##4##(2008-10#2)
the putative peptide##2##3##(1994-10#1)(1995-10#1)
the putative precursor of##2##4##(1991-5#1)(1992-12#1)
the putative product of##3##4##(1993-2#1)(1995-4#1)(1996-4#1)
the putative product##4##3##(1993-2#1)(1995-4#1)(1996-4#1)(1997-7#1)
the putative promoter region##3##4##(1993-11#1)(1996-10#1)(2008-9#1)
the putative promoter##7##3##(1992-10#1)(1992-6#1)(1993-11#1)(1996-10#1)(2008-7#1)(2008-9#1)(2009-10#1)
the putative proteins encoded by##2##5##(1996-4#1)(2008-10#1)
the putative role of the serotoninergic system##2##7##(2008-6#2)
the putative role of the##3##5##(2008-10#1)(2008-6#2)
the putative role of##11##4##(1993-3#1)(2006-10#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#2)(2009-8#2)(2010-4#1)
the putative roles of CRMP2 in a panoply of neurodegenerative##2##10##(2013-1#2)
the putative second##4##3##(1990-11#1)(1990-7#1)(1997-2#2)
the putative signal peptide##2##4##(1991-8#1)(1993-2#1)
the putative stem cell##3##4##(2009-12#1)(2012-12#2)
the putative transmembrane##3##3##(1991-3#1)(1995-10#1)(1997-2#1)
the putative transposable element##2##4##(2008-10#2)
the putative vesicular transporter for acetylcholine##2##6##(1996-12#2)
the putative##247##2##(1990-1#1)(1990-10#1)(1990-11#3)(1990-2#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#3)(1991-12#1)(1991-2#4)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#5)(1992-10#1)(1992-11#2)(1992-12#5)(1992-3#4)(1992-5#1)(1992-6#7)(1992-7#2)(1992-8#1)(1992-9#2)(1993-11#4)(1993-12#8)(1993-2#4)(1993-3#3)(1993-4#2)(1993-6#2)(1993-8#1)(1994-10#2)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#3)(1995-11#3)(1995-12#2)(1995-2#4)(1995-3#3)(1995-4#1)(1995-5#3)(1995-6#2)(1995-8#3)(1996-10#5)(1996-12#4)(1996-4#4)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#9)(1997-3#3)(1997-4#5)(1997-6#3)(1997-7#5)(1997-8#1)(1997-9#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-9#2)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#15)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#3)(2009-12#1)(2009-3#1)(2009-8#2)(2009-9#1)(2010-10#3)(2010-2#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#1)
the putatively##4##2##(1990-7#1)(1995-2#1)(2008-10#1)(2008-8#1)
the puzzle##3##2##(2006-7#1)(2009-3#1)(2012-12#1)
the puzzling##3##2##(1992-10#1)(1994-11#1)(2008-11#1)
the pycnidiospores ofBotryodiplodia theobromae##2##4##(2008-5#2)
the pyelonephritic##2##2##(2011-2#2)
the pygmy##2##2##(1995-8#1)(2011-2#1)
the pyloric##7##2##(1991-12#1)(1993-12#1)(2005-12#1)(2008-6#2)(2009-4#1)(2010-12#1)
the pylorus##3##2##(1993-12#1)(2010-12#1)(2013-8#1)
the pyralid##3##2##(2008-10#3)
the pyramid##8##2##(2007-11#1)(2007-9#1)(2008-10#1)(2008-6#2)(2013-1#3)
the pyramidal cell layer##2##4##(1992-8#1)(1996-3#1)
the pyramidal cell##3##3##(1990-4#1)(1992-8#1)(1996-3#1)
the pyramidal cells of the##2##5##(1997-8#1)(2010-12#1)
the pyramidal cells##3##3##(1996-6#1)(1997-8#1)(2010-12#1)
the pyramidal layer##3##3##(1997-1#1)(2010-12#2)
the pyramidal tract##2##3##(1996-10#1)(1996-5#1)
the pyramidal##17##2##(1990-2#1)(1990-4#1)(1992-1#1)(1992-8#1)(1995-12#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-8#1)(2006-7#1)(2010-12#4)
the pyrazine core##3##3##(2010-4#3)
the pyrazine##6##2##(1991-6#1)(1992-10#1)(2008-5#1)(2010-4#3)
the pyrazole##3##2##(1996-12#1)(2005-7#1)(2008-10#1)
the pyrene probe on GM1##2##5##(1997-7#2)
the pyrethroid##2##2##(2008-9#1)(2011-1#1)
the pyridine derivative##2##3##(1995-11#2)
the pyridine nucleotide##4##3##(1992-1#2)(1993-6#1)(2009-9#1)
the pyridine ring##5##3##(1993-4#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-11#1)
the pyridine##19##2##(1992-1#2)(1992-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-11#2)(2006-4#1)(2007-11#2)(2008-10#2)(2008-3#1)(2008-5#1)(2009-11#1)(2009-9#1)
the pyridinic ring##4##3##(1991-2#3)(1994-8#1)
the pyridinium##2##2##(2005-11#2)
the pyridone##2##2##(1994-9#2)
the pyridyl##3##2##(1997-7#1)(2008-10#1)(2008-5#1)
the pyrimidine ring of##2##4##(1996-5#1)(1996-6#1)
the pyrimidine ring##8##3##(1991-4#2)(1993-9#1)(1994-7#1)(1996-5#1)(1996-6#3)
the pyrimidine##15##2##(1990-7#1)(1991-4#2)(1992-8#1)(1993-9#1)(1994-7#1)(1995-3#1)(1995-8#1)(1996-5#1)(1996-6#4)(2007-11#1)(2008-9#1)
the pyrogenic##2##2##(2008-11#1)(2009-9#1)
the pyrolysis and atomization##2##4##(2008-10#2)
the pyrolysis and##3##3##(2005-11#1)(2008-10#2)
the pyrolysis of##2##3##(2008-10#2)
the pyrolysis##10##2##(2005-11#1)(2008-10#8)(2008-3#1)
the pyrophosphate moiety of##2##4##(1990-12#1)(1995-8#1)
the pyrophosphate##3##2##(1990-12#1)(1991-2#1)(1995-8#1)
the pyrrole ring of##2##4##(1992-3#1)(1995-3#1)
the pyrrole##8##2##(1991-7#1)(1992-3#1)(1994-5#1)(1995-3#1)(1996-2#2)(1996-5#1)(2008-10#1)
the pyrrole-strapped##2##2##(2011-1#2)
the pyrrolizidine alkaloid senecionine##2##4##(1991-7#2)
the pyruvate decarboxylase##2##3##(1990-3#1)(1993-8#1)
the pyruvate dehydrogenase complex##3##4##(1994-5#1)(2010-2#2)
the pyruvate dehydrogenase##7##3##(1990-7#3)(1994-5#1)(2005-8#1)(2010-2#2)
the pyruvate kinase L gene##2##5##(1990-8#2)
the pyruvate kinase##3##3##(1990-8#2)(2008-7#1)
the pyruvate prosthetic group##2##4##(1992-8#2)
the pyruvate##21##2##(1990-3#1)(1990-7#3)(1990-8#2)(1992-8#4)(1993-11#1)(1993-8#2)(1994-5#1)(1996-5#1)(2005-8#1)(2006-12#1)(2008-10#1)(2008-7#1)(2010-2#2)
the pyruvate-dehydrogenase complex is##3##4##(1991-3#3)
the pyruvate-dehydrogenase complex##4##3##(1991-3#4)
the q##3##2##(1991-6#1)(2007-12#1)(2008-2#1)
the qPTH assay##4##3##(2005-12#4)
the qkI##2##2##(2012-2#2)
the quadrat and##2##3##(2008-10#2)
the quadrat##10##2##(2008-10#10)
the quadratic and##2##3##(2007-12#2)
the quadratic equation##3##3##(2008-10#2)(2008-2#1)
the quadratic nonlinear##2##3##(2007-12#2)
the quadratic term##2##3##(2008-10#2)
the quadratic##20##2##(2007-11#1)(2007-12#6)(2007-9#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-6#1)(2009-4#1)
the quadrature components of##2##4##(2008-2#1)(2011-1#1)
the quadrature signals##2##3##(2008-2#1)(2008-3#1)
the quadrature##9##2##(2006-12#1)(2007-3#1)(2008-2#3)(2008-3#3)(2011-1#1)
the quadriceps was##2##3##(2009-3#1)(2013-1#1)
the quadriceps##14##2##(2007-11#2)(2007-7#1)(2007-8#3)(2008-3#1)(2008-4#1)(2009-3#1)(2009-9#1)(2012-1#2)(2012-3#1)(2013-1#1)
the quadrivalent vaccine##4##3##(2011-2#4)
the quadrivalent##6##2##(2011-2#5)(2013-1#1)
the quadruple##3##2##(2007-9#1)(2008-3#1)(2010-12#1)
the quadruplex##5##2##(1994-11#1)(2006-10#1)(2007-9#2)(2008-12#1)
the quail##4##2##(1990-4#1)(1990-7#1)(1993-6#1)(1996-4#1)
the qualification of##2##3##(2007-11#1)(2007-8#1)
the qualification##4##2##(2007-11#1)(2007-7#2)(2007-8#1)
the qualifications of##2##3##(1992-1#1)(2008-9#1)
the qualifications##3##2##(1992-1#1)(2008-3#1)(2008-9#1)
the qualified##2##2##(1992-3#1)(2012-3#1)
the qualitative analysis of##8##4##(1993-3#1)(2008-10#3)(2008-6#1)(2008-8#1)(2012-2#1)(2013-1#1)
the qualitative and quantitative analysis of##5##6##(1997-2#1)(2007-8#2)(2008-10#2)
the qualitative and quantitative assessment of##3##6##(2008-2#1)(2008-4#2)
the qualitative and quantitative##11##4##(1994-12#1)(1997-2#1)(2005-5#1)(2007-8#3)(2008-10#2)(2008-2#1)(2008-4#2)
the qualitative and##12##3##(1994-12#1)(1997-2#1)(1997-3#1)(2005-5#1)(2007-8#3)(2008-10#2)(2008-2#1)(2008-4#2)
the qualitative data##3##3##(2007-9#1)(2013-1#2)
the qualitative features of##2##4##(1990-8#1)(2008-8#1)
the qualitative research##3##3##(1997-3#1)(2010-10#1)(2012-11#1)
the qualitative##55##2##(1990-8#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-8#1)(1997-2#1)(1997-3#3)(1997-7#1)(2005-11#1)(2005-5#1)(2007-11#1)(2007-8#3)(2007-9#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#3)(2008-6#1)(2008-8#2)(2008-9#1)(2010-10#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-11#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#1)
the qualitatively different##2##3##(1996-5#1)(2008-12#1)
the qualitatively##3##2##(1996-5#1)(2008-12#1)(2008-2#1)
the qualities of the##3##4##(2006-12#1)(2007-12#1)(2008-10#1)
the qualities of##8##3##(1991-2#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-6#1)(2009-2#1)(2010-11#1)(2012-12#1)
the qualities##9##2##(1991-2#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-2#1)(2010-11#1)(2012-12#1)
the quality and appropriateness of##2##5##(2012-2#1)(2013-1#1)
the quality and effectiveness of the##2##6##(1994-2#1)(2005-10#1)
the quality and effectiveness of##3##5##(1993-12#1)(1994-2#1)(2005-10#1)
the quality and efficiency of##2##5##(1992-2#1)(2006-12#1)
the quality and quantity of##4##5##(2006-5#1)(2008-11#1)(2008-7#1)(2011-10#1)
the quality and safety of the##2##6##(2009-4#1)(2011-2#1)
the quality and safety of##3##5##(2009-4#1)(2011-2#1)(2013-1#1)
the quality and stability of##2##5##(2007-2#1)(2012-2#1)
the quality and##45##3##(1991-1#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1996-12#1)(1997-1#1)(2005-10#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-2#2)(2007-4#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#2)(2008-7#2)(2008-9#1)(2009-4#1)(2009-7#1)(2011-10#1)(2011-2#2)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
the quality assurance##10##3##(2005-5#1)(2006-2#1)(2007-8#2)(2008-10#3)(2008-11#1)(2012-12#2)
the quality control of the##3##5##(1994-1#1)(2005-4#1)(2012-3#1)
the quality control of##19##4##(1994-1#1)(2005-4#1)(2007-8#1)(2008-10#9)(2008-3#1)(2010-2#1)(2010-4#1)(2011-1#3)(2012-3#1)
the quality control##29##3##(1992-10#1)(1994-1#1)(1996-8#1)(2005-4#1)(2005-7#1)(2007-4#1)(2007-8#1)(2008-10#12)(2008-3#1)(2008-9#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#4)(2012-3#1)
the quality evaluation of##2##4##(2011-2#1)(2013-8#1)
the quality factor##5##3##(2007-12#3)(2010-4#1)(2013-8#1)
the quality improvement process##3##4##(1993-2#1)(1995-2#2)
the quality improvement##6##3##(1993-2#1)(1994-2#1)(1995-2#2)(1996-2#1)(2007-5#1)
the quality indicators##2##3##(2008-11#1)(2013-8#1)
the quality management##4##3##(1994-1#1)(1996-1#1)(2013-1#2)
the quality of a##6##4##(2005-5#1)(2008-10#1)(2008-3#2)(2008-7#1)(2011-1#1)
the quality of an##4##4##(2008-2#2)(2008-6#1)(2011-2#1)
the quality of analytical##2##4##(1994-6#1)(2008-10#1)
the quality of bone##4##4##(1991-11#1)(2007-12#1)(2008-11#1)(2008-6#1)
the quality of cancellous bone##2##5##(2008-6#2)
the quality of care and##4##5##(1995-12#1)(1996-2#1)(1996-3#1)(2008-7#1)
the quality of care delivered##2##5##(1997-1#1)(2008-7#1)
the quality of care in##9##5##(1994-12#1)(1995-9#1)(1996-2#1)(1997-1#1)(2007-4#1)(2007-5#1)(2012-2#1)(2012-3#2)
the quality of care is##2##5##(2012-2#2)
the quality of care of##3##5##(1991-6#1)(2007-10#1)(2008-3#1)
the quality of care provided to##2##6##(1996-2#1)(2008-3#1)
the quality of care provided##4##5##(1996-2#1)(2008-11#1)(2008-12#1)(2008-3#1)
the quality of care that##2##5##(2006-6#1)(2013-8#1)
the quality of care they provide##2##6##(1996-2#1)(2008-11#1)
the quality of care they##3##5##(1995-2#1)(1996-2#1)(2008-11#1)
the quality of care##52##4##(1991-12#1)(1991-6#1)(1993-3#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#5)(1996-3#2)(1996-9#1)(1997-1#2)(1997-2#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-3#1)(2007-4#2)(2007-5#1)(2008-11#3)(2008-12#1)(2008-3#5)(2008-7#2)(2009-4#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#1)
the quality of children's##2##4##(2011-1#1)(2013-1#1)
the quality of clinical documents has been debated##2##8##(2013-1#2)
the quality of clinical##6##4##(1992-2#1)(1997-6#1)(2007-10#1)(2010-4#1)(2013-1#2)
the quality of communication between##2##5##(2007-3#1)(2013-1#1)
the quality of communication##3##4##(2007-3#1)(2011-2#1)(2013-1#1)
the quality of data##6##4##(1990-10#1)(2009-11#1)(2009-4#1)(2010-2#1)(2012-12#2)
the quality of erythropoietin##2##4##(2007-8#2)
the quality of food##2##4##(2008-11#1)(2008-7#1)
the quality of health care##9##5##(1990-12#1)(1991-12#1)(1993-2#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-4#1)(2006-8#1)(2010-1#1)
the quality of health services##2##5##(1993-6#1)(1997-1#1)
the quality of health##14##4##(1990-12#1)(1991-12#1)(1993-12#1)(1993-2#1)(1993-6#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(2006-8#1)(2008-7#1)(2010-1#1)(2013-8#1)
the quality of hospital care##3##5##(1992-3#1)(1994-3#1)(2006-2#1)
the quality of hospital##4##4##(1991-3#1)(1992-3#1)(1994-3#1)(2006-2#1)
the quality of information##2##4##(1991-11#1)(2008-11#1)
the quality of life (QOL) of##2##6##(2007-8#1)(2011-2#1)
the quality of life (QOL)##3##5##(1994-12#1)(2007-8#1)(2011-2#1)
the quality of life and the##2##6##(2007-11#1)(2013-8#1)
the quality of life and##14##5##(1991-12#1)(1992-1#1)(2006-6#1)(2007-11#1)(2007-7#2)(2008-3#1)(2008-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-5#1)(2011-2#1)(2013-8#1)
the quality of life during childhood and##2##7##(2008-9#2)
the quality of life for many##3##6##(1990-4#1)(2010-8#1)(2012-1#1)
the quality of life for##14##5##(1990-4#1)(1994-5#1)(1995-1#1)(1995-12#1)(2006-2#1)(2006-7#1)(2007-12#1)(2008-5#1)(2009-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-1#2)
the quality of life in patients with##2##7##(2009-9#1)(2011-1#1)
the quality of life in the patients##2##7##(1993-6#1)(2011-2#1)
the quality of life in##14##5##(1990-2#1)(1992-6#1)(1993-11#1)(1993-6#1)(1997-4#1)(2006-7#1)(2008-12#1)(2009-11#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
the quality of life is##2##5##(2007-7#1)(2007-8#1)
the quality of life of African American women during the breast cancer treatment phase##2##14##(2008-4#2)
the quality of life of African American##3##7##(2008-4#3)
the quality of life of patients with##2##7##(2008-7#1)(2009-1#1)
the quality of life of patients##6##6##(2006-10#1)(2007-11#1)(2008-11#1)(2008-7#1)(2009-1#1)(2010-12#1)
the quality of life of the patient##3##7##(1993-11#1)(2008-5#1)(2012-3#1)
the quality of life of the patients##4##7##(1990-9#1)(2007-11#1)(2010-7#1)(2013-1#1)
the quality of life of the##9##6##(1990-9#1)(1993-11#1)(1994-4#1)(2007-11#1)(2008-5#1)(2010-11#1)(2010-7#1)(2012-3#1)(2013-1#1)
the quality of life of##34##5##(1990-10#1)(1990-9#1)(1991-6#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-3#1)(1994-4#1)(1995-10#1)(2005-3#1)(2006-10#1)(2006-9#1)(2007-11#3)(2007-8#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#3)(2012-3#1)(2013-1#1)
the quality of life through##2##5##(2009-4#1)(2012-3#1)
the quality of life##126##4##(1990-1#1)(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-9#1)(1991-12#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-11#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-4#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-5#1)(2005-1#1)(2005-3#1)(2006-10#2)(2006-2#1)(2006-6#2)(2006-7#2)(2006-9#1)(2007-11#8)(2007-12#1)(2007-7#5)(2007-8#3)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#5)(2008-7#3)(2008-8#2)(2008-9#2)(2009-1#1)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#8)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#3)
the quality of malaria diagnosis in##2##6##(2005-8#1)(2007-2#1)
the quality of medical care##8##5##(1991-2#1)(1991-4#1)(1992-2#2)(1993-3#1)(1996-12#1)(2006-6#1)(2013-8#1)
the quality of medical##9##4##(1991-2#1)(1991-4#1)(1992-2#2)(1993-3#1)(1996-12#1)(1996-3#1)(2006-6#1)(2013-8#1)
the quality of nursing care##4##5##(2008-12#1)(2009-8#1)(2012-12#1)(2012-3#1)
the quality of nursing##5##4##(1996-2#1)(2008-12#1)(2009-8#1)(2012-12#1)(2012-3#1)
the quality of pain management##2##5##(2009-12#1)(2012-2#1)
the quality of patient care##8##5##(1993-3#1)(1994-1#1)(1997-1#1)(2005-11#1)(2006-10#1)(2008-11#1)(2009-8#1)(2012-3#1)
the quality of patient##13##4##(1993-3#1)(1994-1#1)(1997-1#1)(2005-11#1)(2006-10#1)(2008-11#1)(2009-8#1)(2012-11#2)(2012-3#1)(2013-1#3)
the quality of plasma##2##4##(2007-8#2)
the quality of prenatal care at a##2##7##(1993-3#1)(1995-12#1)
the quality of prenatal care##3##5##(1993-3#1)(1994-3#1)(1995-12#1)
the quality of prenatal##4##4##(1993-3#1)(1994-3#1)(1995-12#1)(1996-6#1)
the quality of radiology##2##4##(2007-4#1)(2012-2#1)
the quality of service provided##2##5##(1994-2#1)(1996-2#1)
the quality of service##3##4##(1994-2#1)(1996-2#1)(2010-8#1)
the quality of services##3##4##(1997-3#1)(2007-4#1)(2013-1#1)
the quality of skin##2##4##(2008-5#2)
the quality of survival##2##4##(1995-4#1)(2008-3#1)
the quality of the bone##2##5##(2007-11#1)(2010-12#1)
the quality of the caretaking environment##2##6##(1992-4#2)
the quality of the data##4##5##(1992-3#1)(1995-8#1)(2008-3#1)(2013-1#1)
the quality of the images##3##5##(1995-11#1)(2007-11#1)(2008-3#1)
the quality of the individual##2##5##(2006-4#1)(2008-10#1)
the quality of the local##2##5##(1996-9#1)(2008-8#1)
the quality of the matrix##3##5##(2008-8#3)
the quality of the phase##2##5##(2008-3#1)(2008-8#1)
the quality of the product##2##5##(2008-11#1)(2012-2#1)
the quality of the reconstructed##2##5##(2006-5#1)(2007-11#1)
the quality of the results##2##5##(2008-2#1)(2010-11#1)
the quality of the service##2##5##(1993-1#1)(1996-7#1)
the quality of the##118##4##(1990-3#2)(1990-4#1)(1991-6#2)(1992-3#2)(1992-4#2)(1993-1#1)(1994-3#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-2#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-8#1)(2005-7#1)(2006-4#1)(2006-5#1)(2006-6#2)(2007-1#3)(2007-11#7)(2007-12#5)(2007-2#1)(2007-7#1)(2007-8#4)(2008-1#3)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#13)(2008-7#1)(2008-8#5)(2008-9#1)(2009-2#1)(2009-7#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-2#5)(2012-3#4)(2013-1#3)(2013-8#2)
the quality of their lives##2##5##(2008-1#1)(2008-11#1)
the quality of their##9##4##(1992-2#1)(1993-3#1)(2008-1#1)(2008-11#2)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#1)
the quality of these##2##4##(2007-12#1)(2008-1#1)
the quality of this##3##4##(2007-5#1)(2008-10#1)(2008-11#1)
the quality of thrombocyte concentrates##2##5##(1996-1#2)
the quality of water##3##4##(2008-11#1)(2008-5#1)(2009-6#1)
the quality of work##2##4##(1993-3#1)(2008-2#1)
the quality of working life##2##5##(1992-3#1)(2008-11#1)
the quality of working##3##4##(1992-3#1)(2008-11#1)(2012-3#1)
the quality of##581##3##(1990-1#1)(1990-10#2)(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#2)(1990-9#1)(1991-11#2)(1991-12#4)(1991-2#1)(1991-3#2)(1991-4#1)(1991-6#4)(1991-7#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#4)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#1)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#7)(1993-4#1)(1993-5#2)(1993-6#2)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#4)(1994-4#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#5)(1996-11#1)(1996-12#5)(1996-2#13)(1996-3#5)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#4)(1997-1#4)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-12#1)(2005-1#1)(2005-11#1)(2005-12#1)(2005-3#1)(2005-5#4)(2005-7#1)(2005-8#1)(2006-10#9)(2006-12#1)(2006-2#5)(2006-4#1)(2006-5#1)(2006-6#8)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#18)(2007-12#12)(2007-2#2)(2007-3#2)(2007-4#5)(2007-5#2)(2007-7#8)(2007-8#15)(2007-9#1)(2008-1#8)(2008-10#25)(2008-11#18)(2008-12#7)(2008-2#10)(2008-3#26)(2008-4#4)(2008-5#11)(2008-6#5)(2008-7#14)(2008-8#10)(2008-9#8)(2009-1#1)(2009-11#4)(2009-12#3)(2009-2#1)(2009-4#4)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#5)(2009-9#4)(2010-1#3)(2010-10#2)(2010-11#4)(2010-12#9)(2010-2#4)(2010-3#1)(2010-4#9)(2010-5#3)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#12)(2011-12#1)(2011-2#21)(2012-1#5)(2012-11#4)(2012-12#7)(2012-2#14)(2012-3#12)(2013-1#24)(2013-7#1)(2013-8#14)
the quality process##2##3##(1993-3#1)(1995-1#1)
the quality system##2##3##(2008-6#1)(2011-2#1)
the quality to##2##3##(1994-8#1)(2007-8#1)
the quality##724##2##(1990-1#1)(1990-10#2)(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#2)(1990-6#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#2)(1991-4#1)(1991-6#4)(1991-7#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#5)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#1)(1993-1#2)(1993-11#2)(1993-12#2)(1993-2#4)(1993-3#9)(1993-4#1)(1993-5#2)(1993-6#2)(1993-8#1)(1994-1#3)(1994-11#1)(1994-12#4)(1994-2#4)(1994-3#4)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#3)(1995-4#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#6)(1996-11#1)(1996-12#6)(1996-2#14)(1996-3#5)(1996-5#1)(1996-6#1)(1996-7#3)(1996-8#2)(1996-9#5)(1997-1#5)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-12#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-3#1)(2005-4#1)(2005-5#5)(2005-7#3)(2005-8#1)(2006-10#10)(2006-12#2)(2006-2#6)(2006-4#1)(2006-5#3)(2006-6#8)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#4)(2007-11#18)(2007-12#16)(2007-2#4)(2007-3#2)(2007-4#7)(2007-5#3)(2007-7#8)(2007-8#19)(2007-9#1)(2008-1#9)(2008-10#45)(2008-11#24)(2008-12#8)(2008-2#10)(2008-3#30)(2008-4#4)(2008-5#11)(2008-6#6)(2008-7#16)(2008-8#10)(2008-9#10)(2009-1#1)(2009-11#5)(2009-12#3)(2009-2#1)(2009-4#5)(2009-5#1)(2009-6#3)(2009-7#3)(2009-8#5)(2009-9#4)(2010-1#3)(2010-10#2)(2010-11#5)(2010-12#9)(2010-2#5)(2010-3#1)(2010-4#11)(2010-5#3)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#19)(2011-10#1)(2011-12#2)(2011-2#26)(2011-7#1)(2012-1#5)(2012-11#4)(2012-12#14)(2012-2#19)(2012-3#17)(2013-1#28)(2013-7#1)(2013-8#18)
the quality-of-life##2##2##(2005-4#1)(2011-2#1)
the quantal##5##2##(1991-5#3)(1995-8#1)(1996-2#1)
the quantification and##4##3##(1993-11#1)(2007-8#1)(2012-2#1)(2013-8#1)
the quantification limit was##2##4##(2008-10#2)
the quantification limit##6##3##(2008-10#5)(2012-12#1)
the quantification of all the##2##5##(1990-6#1)(2008-10#1)
the quantification of antibodies against##3##5##(2007-11#3)
the quantification of the##12##4##(1995-6#1)(2005-11#1)(2008-10#4)(2008-2#1)(2008-4#1)(2009-12#1)(2009-9#1)(2011-1#1)(2012-1#1)
the quantification of##85##3##(1990-12#2)(1990-6#1)(1992-12#1)(1992-7#2)(1993-2#1)(1994-12#2)(1995-6#1)(1996-8#1)(1997-8#2)(2004-9#1)(2005-11#1)(2007-11#3)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#31)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#4)(2008-6#1)(2009-12#1)(2009-8#1)(2009-9#2)(2010-1#1)(2011-1#2)(2011-2#1)(2012-1#4)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#1)
the quantification##101##2##(1990-12#2)(1990-6#1)(1992-12#1)(1992-7#2)(1993-1#1)(1993-11#1)(1993-2#1)(1994-12#2)(1995-6#1)(1996-8#1)(1997-8#2)(2004-9#1)(2005-11#1)(2007-11#3)(2007-4#1)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#37)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#4)(2008-6#1)(2009-12#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#4)(2012-12#4)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
the quantitation limit was##2##4##(2008-10#2)
the quantitation of the##6##4##(1992-1#1)(1992-7#1)(1996-8#1)(1997-2#1)(2008-10#2)
the quantitation of##37##3##(1990-11#1)(1990-4#2)(1991-8#1)(1992-1#1)(1992-6#1)(1992-7#1)(1995-10#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#2)(2008-10#13)(2008-4#7)(2009-4#1)
the quantitation##43##2##(1990-11#1)(1990-4#2)(1991-8#1)(1992-1#1)(1992-6#1)(1992-7#1)(1995-10#1)(1996-6#2)(1996-8#2)(1996-9#1)(1997-2#2)(1997-3#2)(2007-8#1)(2008-10#15)(2008-4#8)(2008-5#1)(2009-4#1)
the quantitative ELISA##2##3##(2007-8#1)(2008-10#1)
the quantitative accuracy##2##3##(1997-6#1)(2011-1#1)
the quantitative analysis of the##3##5##(1996-12#1)(1997-6#1)(2012-3#1)
the quantitative analysis of##20##4##(1994-3#1)(1996-12#3)(1996-8#1)(1997-6#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-12#1)(2010-1#1)(2010-8#1)(2012-3#1)
the quantitative analysis##24##3##(1994-3#1)(1996-12#3)(1996-8#2)(1997-6#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-12#1)(2010-1#1)(2010-8#2)(2012-3#1)(2013-8#1)
the quantitative and qualitative##7##4##(2006-4#1)(2007-8#1)(2008-5#2)(2008-8#1)(2011-1#1)(2011-2#1)
the quantitative and##8##3##(2006-4#1)(2007-8#2)(2008-5#2)(2008-8#1)(2011-1#1)(2011-2#1)
the quantitative aspects of the##3##5##(1992-3#1)(1993-12#1)(2008-10#1)
the quantitative aspects of##4##4##(1992-3#1)(1993-12#1)(2008-10#1)(2008-11#1)
the quantitative assay of##2##4##(2007-8#1)(2008-10#1)
the quantitative assessment of##3##4##(1996-12#1)(2008-3#1)(2009-10#1)
the quantitative capabilities of##2##4##(1991-8#1)(2008-10#1)
the quantitative characteristics of##2##4##(1995-5#1)(2006-10#1)
the quantitative characterization of##2##4##(2006-10#1)(2012-2#1)
the quantitative contribution of##2##4##(2008-7#1)(2009-10#1)
the quantitative detection of##3##4##(2008-1#1)(2012-12#1)(2013-8#1)
the quantitative detection##5##3##(2007-8#1)(2008-1#1)(2008-10#1)(2012-12#1)(2013-8#1)
the quantitative determination of the##3##5##(1990-11#1)(1992-2#1)(2008-10#1)
the quantitative determination of##47##4##(1990-11#1)(1991-2#1)(1992-2#1)(1995-4#1)(1996-8#1)(1997-2#2)(1997-8#1)(2005-12#1)(2006-10#1)(2007-1#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#25)(2008-12#1)(2008-5#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-12#3)
the quantitative determination##49##3##(1990-11#1)(1991-2#1)(1992-2#1)(1995-4#1)(1996-8#1)(1997-2#2)(1997-8#1)(2005-12#1)(2006-10#1)(2007-1#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#26)(2008-12#1)(2008-5#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-12#3)
the quantitative elemental analysis##2##4##(2007-9#1)(2008-10#1)
the quantitative estimation of##3##4##(1991-8#1)(1997-3#1)(2010-2#1)
the quantitative evaluation of##8##4##(1991-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-8#1)(2013-1#2)
the quantitative extraction of metal ions##3##6##(2008-10#3)
the quantitative extraction of##5##4##(2008-10#5)
the quantitative indices##2##3##(2012-1#1)(2013-8#1)
the quantitative information##2##3##(2005-11#1)(2012-2#1)
the quantitative level##2##3##(2008-9#1)(2009-3#1)
the quantitative measurement of##5##4##(1991-8#1)(2008-10#1)(2008-8#1)(2009-12#1)(2010-11#1)
the quantitative methods##2##3##(2007-7#1)(2010-10#1)
the quantitative prediction of the##2##5##(2008-5#1)(2009-6#1)
the quantitative resistance##2##3##(2008-10#2)
the quantitative results##5##3##(1993-11#1)(1996-7#1)(2007-6#1)(2008-10#1)(2012-2#1)
the quantitative retention##2##3##(1997-1#1)(2008-10#1)
the quantitative sorption of##2##4##(2008-10#2)
the quantitative sorption##3##3##(2008-10#3)
the quantitative trait Q1##6##4##(2012-3#6)
the quantitative trait loci##3##4##(2008-10#1)(2008-8#1)(2012-3#1)
the quantitative trait##9##3##(2008-10#1)(2008-8#1)(2012-3#7)
the quantitative##232##2##(1990-11#1)(1990-5#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#4)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-12#4)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-6#2)(1997-8#2)(2005-11#1)(2005-12#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-6#2)(2007-7#1)(2007-8#7)(2007-9#3)(2008-1#4)(2008-10#68)(2008-11#2)(2008-12#3)(2008-2#6)(2008-3#4)(2008-4#1)(2008-5#6)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#2)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-2#2)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#14)(2013-1#3)(2013-7#2)(2013-8#3)
the quantities of##11##3##(2004-4#1)(2005-10#1)(2005-12#1)(2008-10#3)(2010-11#1)(2012-12#2)(2013-8#2)
the quantities##17##2##(1990-8#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-12#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-7#1)(2010-11#1)(2012-12#2)(2013-8#2)
the quantity and quality of##3##5##(2006-4#1)(2008-5#1)(2010-2#1)
the quantity and##8##3##(2006-4#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)(2013-7#1)
the quantity of drug##2##4##(1992-3#2)
the quantity of pathogen DNA detected##2##6##(2008-10#2)
the quantity of pathogen DNA##4##5##(2008-10#4)
the quantity of signalling##2##4##(2009-9#2)
the quantity of the##3##4##(1996-12#1)(1997-8#1)(2010-2#1)
the quantity of water##2##4##(2008-10#2)
the quantity of##49##3##(1990-3#1)(1990-4#1)(1992-1#1)(1992-12#1)(1992-3#2)(1993-12#1)(1993-2#1)(1994-8#1)(1995-1#1)(1995-4#1)(1995-5#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-8#1)(2004-4#2)(2004-9#1)(2006-1#1)(2007-11#1)(2007-2#1)(2008-10#10)(2008-4#1)(2008-5#4)(2008-8#1)(2008-9#2)(2009-4#1)(2009-6#2)(2009-9#2)(2010-2#1)(2011-1#1)(2013-7#1)(2013-8#1)
the quantity##64##2##(1990-3#1)(1990-4#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-12#1)(1993-2#1)(1994-8#1)(1995-1#1)(1995-4#1)(1995-5#1)(1996-12#1)(1996-8#1)(1997-2#2)(1997-8#1)(2004-4#2)(2004-9#1)(2006-1#1)(2006-4#1)(2007-11#1)(2007-2#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#6)(2008-7#1)(2008-8#1)(2008-9#3)(2009-4#1)(2009-6#2)(2009-9#2)(2010-2#2)(2010-9#1)(2011-1#1)(2012-12#1)(2013-7#2)(2013-8#1)
the quantization error##2##3##(2008-2#1)(2008-3#1)
the quantization noise##2##3##(2007-12#1)(2008-2#1)
the quantization of the##2##4##(2008-3#1)(2013-1#1)
the quantization of##4##3##(2007-12#1)(2007-9#1)(2008-3#1)(2013-1#1)
the quantization##11##2##(2007-12#3)(2007-9#1)(2008-2#4)(2008-3#2)(2013-1#1)
the quantized##3##2##(2007-12#1)(2008-10#1)(2013-1#1)
the quantum Hall effect##3##4##(1993-6#1)(1993-8#1)(1995-7#1)
the quantum Hall##5##3##(1993-6#1)(1993-8#2)(1995-5#1)(1995-7#1)
the quantum dot##2##3##(2007-11#1)(2010-2#1)
the quantum dots and##2##4##(2008-7#1)(2009-12#1)
the quantum dots##9##3##(1995-3#1)(2007-11#2)(2008-3#1)(2008-7#3)(2009-12#1)(2009-6#1)
the quantum efficiency of##2##4##(2007-12#2)
the quantum efficiency##3##3##(2007-11#1)(2007-12#2)
the quantum limit##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
the quantum mechanical##2##3##(2008-10#1)(2011-2#1)
the quantum theory of##2##4##(2007-9#1)(2008-3#1)
the quantum yield##3##3##(2005-11#1)(2008-11#1)(2008-2#1)
the quantum##46##2##(1993-6#1)(1993-8#2)(1995-3#1)(1995-5#1)(1995-7#1)(2005-11#2)(2006-4#1)(2007-11#5)(2007-12#9)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2008-7#4)(2009-12#1)(2009-6#1)(2009-9#2)(2010-12#1)(2010-2#1)(2011-2#1)
the quantum-noise##2##2##(2007-11#1)(2007-12#1)
the quark-gluon plasma##2##3##(1993-5#1)(1994-10#1)
the quarterly number of clients HIV tested increased from##2##9##(2009-3#2)
the quartz fiber##2##3##(2008-10#1)(2008-3#1)
the quartz in near ore body rock##2##7##(2013-8#2)
the quartz in the mineralized rock##2##6##(2013-8#2)
the quartz in##5##3##(2013-8#5)
the quartz##21##2##(2005-11#2)(2007-11#1)(2008-10#6)(2008-3#2)(2008-5#1)(2013-8#9)
the quasi-firm##2##2##(1992-12#2)
the quasi-phase-matching##2##2##(2007-12#1)(2008-3#1)
the quasi-static and the physical optics approximations##2##7##(2008-2#2)
the quasi-static##6##2##(2007-1#1)(2008-2#3)(2008-3#1)(2010-8#1)
the quasispecies##3##2##(1997-3#1)(2009-9#1)(2013-1#1)
the quaternary T##2##3##(1994-8#2)
the quaternary ammonium positive charge##2##5##(1994-9#2)
the quaternary ammonium##8##3##(1994-9#2)(2005-11#3)(2007-8#1)(2009-10#1)(2013-1#1)
the quaternary complex##2##3##(1994-9#1)(1995-8#1)
the quaternary enhancement effect##2##4##(1990-8#1)(1997-2#1)
the quaternary structure of the##3##5##(1990-8#1)(1994-8#1)(1995-5#1)
the quaternary structure of##6##4##(1990-8#1)(1992-2#1)(1994-8#1)(1995-5#1)(1996-7#1)(2008-4#1)
the quaternary structure##10##3##(1990-4#1)(1990-8#1)(1990-9#1)(1992-2#1)(1994-8#1)(1995-5#1)(1996-7#1)(2008-4#3)
the quaternary##29##2##(1990-4#1)(1990-7#1)(1990-8#2)(1990-9#1)(1992-2#1)(1994-8#6)(1994-9#3)(1995-11#1)(1995-5#1)(1995-8#1)(1996-7#1)(1997-2#1)(2005-11#3)(2007-8#1)(2008-4#3)(2009-10#1)(2013-1#1)
the queen##4##2##(1991-2#1)(2007-7#1)(2008-5#1)(2008-8#1)
the queen's##2##2##(2008-8#2)
the quenched fluorescence##2##3##(2008-10#1)(2008-7#1)
the quencher##6##2##(1990-8#1)(1991-7#1)(1992-12#1)(1996-9#1)(2006-10#1)(2010-5#1)
the quenching and VET rates##2##5##(2008-2#2)
the quenching effect of the##2##5##(2008-10#1)(2013-8#1)
the quenching effect of##3##4##(2008-10#2)(2013-8#1)
the quenching effect##7##3##(2007-12#1)(2008-10#4)(2008-4#1)(2013-8#1)
the quenching of the fluorescence##3##5##(2008-10#2)(2008-3#1)
the quenching of##7##3##(1991-5#1)(1994-12#1)(1995-8#1)(2008-10#3)(2008-3#1)
the quenching rate constants##2##4##(1997-7#1)(2006-10#1)
the quenching rate##3##3##(1997-7#1)(2006-10#1)(2007-12#1)
the quenching##33##2##(1991-5#2)(1994-12#1)(1995-8#1)(1996-1#1)(1997-7#1)(2005-11#2)(2006-10#1)(2007-12#3)(2008-10#13)(2008-2#2)(2008-3#2)(2008-4#1)(2010-4#1)(2013-8#2)
the query##5##2##(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)
the quest for##12##3##(2004-10#1)(2006-10#1)(2006-12#1)(2007-5#1)(2007-6#1)(2008-8#3)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
the quest##15##2##(2004-10#1)(2006-10#1)(2006-12#1)(2007-5#1)(2007-6#1)(2008-8#3)(2008-9#1)(2010-4#1)(2010-5#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
the question &quot##3##3##(1994-3#1)(2007-2#1)(2013-1#1)
the question about##2##3##(1994-6#1)(2008-5#1)
the question and##2##3##(2008-12#1)(2008-8#1)
the question arises##2##3##(2006-6#1)(2007-10#1)
the question arose##2##3##(1994-2#1)(1994-3#1)
the question as to whether##7##5##(1991-3#1)(1993-5#1)(1996-8#1)(2006-10#1)(2006-7#1)(2008-10#1)(2012-3#1)
the question as to which##2##5##(1995-5#1)(2010-12#1)
the question as to##11##4##(1991-3#1)(1993-5#1)(1995-12#1)(1995-5#1)(1996-8#1)(2006-10#1)(2006-4#1)(2006-7#1)(2008-10#1)(2010-12#1)(2012-3#1)
the question as##12##3##(1991-3#1)(1993-5#1)(1995-12#1)(1995-5#1)(1996-8#1)(2006-10#1)(2006-4#1)(2006-7#1)(2008-10#1)(2010-12#1)(2012-2#1)(2012-3#1)
the question if##3##3##(2011-2#2)(2013-8#1)
the question of a##3##4##(1995-12#1)(1997-3#1)(2005-11#1)
the question of how and why##2##6##(2006-7#1)(2007-12#1)
the question of how the##2##5##(2008-2#1)(2012-3#1)
the question of how to##2##5##(1996-12#1)(2012-2#1)
the question of how##19##4##(1990-11#1)(1996-12#1)(2005-7#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#3)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
the question of the effect of##2##6##(1990-5#1)(1997-8#1)
the question of the##28##4##(1990-3#1)(1990-5#2)(1991-12#1)(1992-9#1)(1993-10#2)(1993-4#1)(1995-1#1)(1995-12#1)(1995-7#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-7#1)(2007-10#1)(2007-11#1)(2008-11#2)(2008-9#2)(2009-12#1)(2009-8#1)(2010-7#1)(2011-2#1)
the question of what##2##4##(2008-7#1)(2008-9#1)
the question of where##2##4##(1994-8#1)(2008-5#1)
the question of whether or not##3##6##(2006-12#1)(2007-7#1)(2008-12#1)
the question of whether the##10##5##(1996-4#1)(2004-9#1)(2006-11#1)(2006-12#1)(2007-12#1)(2008-11#1)(2008-3#1)(2009-7#1)(2011-12#1)(2012-2#1)
the question of whether there##2##5##(2007-2#1)(2012-2#1)
the question of whether these##2##5##(1995-2#1)(2008-12#1)
the question of whether this##2##5##(2010-12#1)(2011-2#1)
the question of whether to##2##5##(1996-2#1)(1997-1#1)
the question of whether##38##4##(1990-12#2)(1991-3#1)(1992-10#1)(1994-5#1)(1995-2#1)(1996-1#1)(1996-2#2)(1996-4#1)(1996-8#1)(1997-1#1)(1997-6#1)(2004-9#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-8#1)(2009-11#1)(2009-7#2)(2010-12#1)(2011-12#1)(2011-2#2)(2012-2#3)
the question of why##3##4##(2008-8#1)(2009-3#1)(2013-7#1)
the question of##128##3##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#2)(1990-8#1)(1991-12#2)(1991-3#2)(1992-10#1)(1992-12#1)(1992-2#2)(1992-9#1)(1993-10#2)(1993-2#3)(1993-4#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-6#2)(1997-8#1)(2004-11#1)(2004-9#1)(2005-11#1)(2005-7#2)(2006-10#3)(2006-11#1)(2006-12#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#3)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#6)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#2)(2010-12#1)(2010-4#1)(2010-7#1)(2011-12#1)(2011-2#4)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
the question was raised##2##4##(1995-8#1)(2007-11#1)
the question was##4##3##(1995-8#2)(1997-5#1)(2007-11#1)
the question whether the##5##4##(1990-9#1)(1992-12#1)(1994-4#1)(2006-10#1)(2008-7#1)
the question whether##20##3##(1990-9#1)(1991-12#1)(1991-9#1)(1992-12#1)(1993-2#1)(1994-12#1)(1994-4#1)(1994-8#1)(1996-10#1)(1996-9#1)(1997-2#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-7#2)(2009-10#1)(2009-4#1)(2011-12#2)
the question?##2##2##(2005-12#1)(2006-9#1)
the questionable##3##2##(1993-1#1)(2008-12#1)(2010-3#1)
the questionnaire and##2##3##(2006-8#1)(2010-8#1)
the questionnaire had##3##3##(1993-2#1)(2004-10#1)(2008-2#1)
the questionnaire survey##2##3##(1996-3#1)(2007-7#1)
the questionnaire to##2##3##(2008-10#1)(2008-11#1)
the questionnaire was##5##3##(2006-10#1)(2006-8#1)(2007-2#1)(2007-3#1)(2008-7#1)
the questionnaire##64##2##(1992-1#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-11#2)(1993-2#2)(1993-3#1)(1993-5#2)(1996-3#1)(1997-2#1)(2004-10#5)(2006-10#1)(2006-2#1)(2006-8#3)(2007-10#1)(2007-2#2)(2007-3#2)(2007-7#2)(2008-1#2)(2008-10#2)(2008-11#6)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-2#6)(2013-1#3)(2013-7#1)
the questionnaires and##3##3##(1993-2#1)(1997-3#1)(2006-10#1)
the questionnaires##15##2##(1990-2#1)(1993-2#1)(1994-2#1)(1995-9#1)(1996-12#1)(1997-3#1)(2006-10#1)(2007-2#2)(2008-10#1)(2008-11#1)(2008-7#1)(2009-12#1)(2013-1#1)(2013-8#1)
the questions addressed##2##3##(1996-2#1)(2006-5#1)
the questions and##2##3##(2008-7#1)(2013-8#1)
the questions from##2##3##(2008-7#1)(2013-1#1)
the questions of##6##3##(1995-2#1)(2006-10#1)(2008-11#1)(2008-7#1)(2009-3#1)(2012-3#1)
the questions posed##3##3##(2004-12#1)(2008-3#1)(2008-7#1)
the questions regarding##2##3##(2011-2#1)(2013-1#1)
the questions that##5##3##(2007-7#1)(2008-1#1)(2008-2#1)(2008-7#1)(2009-4#1)
the questions they##2##3##(2005-10#1)(2007-8#1)
the questions##58##2##(1990-2#1)(1991-12#1)(1993-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-8#2)(2004-12#1)(2005-10#1)(2006-10#10)(2006-5#1)(2006-7#1)(2006-8#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-7#5)(2009-3#1)(2009-4#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#1)
the quick B&amp##2##3##(2012-2#2)
the quick Favor method##2##4##(2012-2#2)
the quick hit method##2##4##(1994-12#2)
the quick##14##2##(1994-12#2)(2005-12#1)(2006-12#1)(2006-7#1)(2007-1#1)(2008-10#1)(2008-5#1)(2009-11#1)(2012-2#5)
the quickest##2##2##(2006-8#1)(2008-4#1)
the quiescent##2##2##(1996-3#1)(2008-8#1)
the quinazoline ring##2##3##(1990-7#1)(2007-11#1)
the quinol##2##2##(1990-11#1)(2008-10#1)
the quinoline##4##2##(1993-9#2)(2008-5#1)(2008-7#1)
the quinolines##2##2##(1993-6#1)(1993-9#1)
the quinolones##5##2##(1991-12#1)(2005-8#1)(2008-5#2)(2012-3#1)
the quinone##10##2##(1990-7#2)(1991-5#1)(1994-3#1)(1995-5#1)(1996-5#1)(1997-1#1)(1997-3#1)(2006-8#1)(2008-10#1)
the quinones##2##2##(1991-5#1)(1997-1#1)
the quinoxaline-type##2##2##(1993-9#2)
the quorum##2##2##(2008-10#1)(2009-8#1)
the quorum-quenching##2##2##(2008-9#2)
the quotient between##2##3##(2008-10#2)
the quotient of the##2##4##(2008-3#1)(2012-3#1)
the quotient of##4##3##(2008-3#1)(2012-3#2)(2012-6#1)
the quotient##7##2##(1990-8#1)(2008-10#2)(2008-3#1)(2012-3#2)(2012-6#1)
the r of##2##3##(2012-2#2)
the r(2)##2##2##(2008-10#1)(2008-7#1)
the r-HuEPO##2##2##(2007-7#1)(2008-1#1)
the rCCSP promoter##2##3##(1997-2#2)
the rCCSP##3##2##(1997-2#3)
the rCRBPI-RARE##2##2##(1992-9#2)
the rDNA locus##2##3##(1991-8#2)
the rDNA repeat##2##3##(1997-2#1)(2008-10#1)
the rDNA##17##2##(1991-12#2)(1991-8#2)(1996-5#1)(1997-2#1)(2006-10#1)(2008-10#9)(2008-5#1)
the rGO##3##2##(2013-1#3)
the rH##3##2##(2013-8#3)
the rRNA##7##2##(1991-4#1)(1996-8#1)(2008-10#2)(2008-5#1)(2010-4#2)
the rRNA-encoding##2##2##(1993-12#1)(1993-5#1)
the rVLM##3##2##(1997-6#3)
the rab class##2##3##(1992-8#2)
the rab##6##2##(1992-8#3)(1993-8#1)(1996-10#2)
the rabbit VLDL receptor cDNA##2##5##(1995-6#2)
the rabbit and##2##3##(1990-12#1)(1993-12#1)
the rabbit aorta##2##3##(1993-6#1)(1996-10#1)
the rabbit cava and jugular veins##2##6##(1991-4#2)
the rabbit corpus luteum##2##4##(1990-7#1)(1992-9#1)
the rabbit enzyme##2##3##(1994-8#1)(1995-5#1)
the rabbit is##3##3##(2008-4#2)(2008-9#1)
the rabbit muscle enzyme##2##4##(1992-11#1)(1992-12#1)
the rabbit muscle##3##3##(1990-8#1)(1992-11#1)(1992-12#1)
the rabbit or##2##3##(1995-6#1)(2006-9#1)
the rabbit pulmonary artery##2##4##(1991-4#1)(1993-3#1)
the rabbit retina##3##3##(1997-3#1)(2008-4#2)
the rabbit serum##3##3##(1990-12#1)(1994-3#1)(1995-3#1)
the rabbit small intestine##2##4##(1991-12#1)(1992-11#1)
the rabbit##88##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#3)(1991-8#1)(1991-9#1)(1992-11#3)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#2)(1993-3#1)(1993-6#1)(1993-7#3)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#3)(1996-10#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#3)(2006-9#1)(2007-9#3)(2008-10#2)(2008-4#5)(2008-5#1)(2008-8#3)(2008-9#6)(2010-12#1)(2013-1#1)
the rabbit's##3##2##(1990-10#1)(2007-11#1)(2008-5#1)
the rabbits were mated##2##4##(1992-3#2)
the rabbits were##3##3##(1992-3#2)(2010-4#1)
the rabbits##8##2##(1992-10#1)(1992-3#2)(1993-12#2)(2007-8#1)(2008-8#1)(2010-4#1)
the rabies##3##2##(1991-12#2)(2011-2#1)
the race model inequality##2##4##(2008-8#2)
the race model##3##3##(2008-8#3)
the race structure##3##3##(2008-10#3)
the race##19##2##(1991-12#1)(1993-12#1)(1996-11#1)(2004-3#1)(2006-2#1)(2007-3#1)(2008-10#8)(2008-8#3)(2009-7#1)(2012-1#1)
the race-specific##2##2##(2008-10#2)
the racemate##3##2##(1994-3#1)(1997-2#1)(2006-10#1)
the racemic mixture##3##3##(2006-12#1)(2008-10#1)(2008-5#1)
the racemic##7##2##(1990-3#1)(1995-3#1)(1996-3#1)(2006-12#1)(2008-10#1)(2008-5#2)
the races##3##2##(1997-6#1)(2008-10#2)
the rachis##5##2##(2008-10#4)(2012-12#1)
the racial##5##2##(1997-4#1)(2008-1#1)(2008-5#1)(2009-9#1)(2011-2#1)
the radar##6##2##(2006-6#1)(2007-12#1)(2008-3#4)
the radial access##2##3##(2011-2#2)
the radial and##4##3##(2007-12#1)(2008-9#1)(2009-7#1)(2011-2#1)
the radial approach##2##3##(2011-2#2)
the radial arm maze##5##4##(1992-12#1)(1993-2#1)(2008-4#3)
the radial arm##6##3##(1992-12#1)(1993-2#1)(2008-4#3)(2008-7#1)
the radial artery is an##2##5##(1990-8#1)(2008-11#1)
the radial artery is##4##4##(1990-8#1)(2006-3#1)(2008-11#1)(2011-2#1)
the radial artery to##4##4##(2005-12#1)(2007-8#2)(2011-2#1)
the radial artery##32##3##(1990-4#2)(1990-8#3)(2005-12#2)(2006-3#1)(2006-9#2)(2007-7#2)(2007-8#8)(2008-11#1)(2008-7#1)(2008-9#3)(2011-2#4)(2013-1#2)(2013-8#1)
the radial basis##2##3##(2008-2#2)
the radial direction##6##3##(2007-1#1)(2007-11#1)(2008-2#2)(2008-7#1)(2010-12#1)
the radial distance##5##3##(1995-6#1)(2008-10#1)(2008-2#1)(2008-3#2)
the radial distribution##2##3##(2006-5#1)(2008-10#1)
the radial forearm flap##2##4##(2007-12#1)(2011-2#1)
the radial forearm##3##3##(2007-12#1)(2011-2#2)
the radial growth of##2##4##(2008-10#1)(2011-12#1)
the radial nerve##7##3##(2006-3#2)(2006-4#1)(2007-8#1)(2008-7#2)(2012-2#1)
the radial or posterior##2##4##(1990-11#1)(2006-3#1)
the radial position of the##2##5##(2006-10#1)(2006-12#1)
the radial##111##2##(1990-11#1)(1990-4#2)(1990-8#3)(1991-12#1)(1992-12#1)(1993-2#1)(1993-3#1)(1995-5#1)(1995-6#1)(2005-11#1)(2005-12#2)(2006-10#1)(2006-12#1)(2006-3#5)(2006-4#1)(2006-5#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-3#1)(2007-7#2)(2007-8#12)(2008-10#8)(2008-11#1)(2008-2#5)(2008-3#5)(2008-4#4)(2008-7#5)(2008-9#6)(2009-11#1)(2009-6#1)(2009-7#1)(2010-12#2)(2011-12#1)(2011-2#14)(2012-11#1)(2012-2#2)(2013-1#2)(2013-8#1)
the radiance received##2##3##(2008-2#1)(2008-3#1)
the radiance##13##2##(2008-2#9)(2008-3#3)(2008-6#1)
the radiant reflectance of##2##4##(2008-3#2)
the radiant##3##2##(2008-3#2)(2011-2#1)
the radiated##5##2##(1997-6#1)(1997-7#1)(2007-12#1)(2008-2#1)(2008-3#1)
the radiation and##2##3##(2008-2#1)(2012-2#1)
the radiation at##2##3##(2007-11#1)(2008-10#1)
the radiation burden##2##3##(2012-2#2)
the radiation dose to the##3##5##(1994-7#1)(2006-2#1)(2008-2#1)
the radiation dose to##4##4##(1994-7#1)(2006-2#1)(2008-2#1)(2013-1#1)
the radiation dose##8##3##(1994-7#1)(2006-2#1)(2007-4#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-7#1)(2013-1#1)
the radiation emitted##2##3##(2007-12#1)(2008-10#1)
the radiation exposure##2##3##(2010-4#1)(2010-9#1)
the radiation field##4##3##(2007-12#1)(2010-6#1)(2010-7#2)
the radiation force exerted upon a gold particle##2##8##(2007-12#2)
the radiation from##3##3##(2007-12#1)(2008-3#1)(2012-2#1)
the radiation hormesis##2##3##(2008-7#2)
the radiation induced haematological damage in rats##2##7##(2013-8#2)
the radiation induced haematological##3##4##(2013-8#3)
the radiation induced##5##3##(2008-7#1)(2013-8#4)
the radiation is##2##3##(2008-2#1)(2008-7#1)
the radiation of the##3##4##(1997-4#1)(2008-10#1)(2013-8#1)
the radiation of##7##3##(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2013-8#1)
the radiation on the##3##4##(2008-3#2)(2013-7#1)
the radiation on##4##3##(2008-3#2)(2013-7#2)
the radiation oncologist##3##3##(2009-11#2)(2011-2#1)
the radiation pressure##3##3##(2007-12#2)(2008-2#1)
the radiation sensitivity of##3##4##(2008-9#3)
the radiation source##2##3##(2006-8#1)(2008-3#1)
the radiation treatment##2##3##(2008-7#2)
the radiation used##2##3##(2006-12#1)(2008-3#1)
the radiation was##2##3##(1992-9#1)(2008-2#1)
the radiation##102##2##(1992-9#1)(1994-7#1)(1996-6#1)(1997-4#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#13)(2007-4#2)(2008-1#3)(2008-10#6)(2008-12#1)(2008-2#11)(2008-3#12)(2008-4#1)(2008-5#2)(2008-7#10)(2008-9#3)(2009-10#1)(2009-11#3)(2010-4#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#4)(2013-1#2)(2013-7#3)(2013-8#5)
the radiation-resistant##2##2##(2005-11#1)(2006-12#1)
the radiative forcing##3##3##(2008-2#3)
the radiative properties of##3##4##(2008-2#3)
the radiative transfer equation and##2##5##(2007-12#1)(2008-2#1)
the radiative transfer equation for##3##5##(2008-2#1)(2008-3#1)(2010-4#1)
the radiative transfer equation##13##4##(2007-12#1)(2008-2#7)(2008-3#4)(2010-4#1)
the radiative transfer in a##2##5##(2008-10#1)(2008-2#1)
the radiative transfer model##2##4##(2008-3#2)
the radiative transfer theory##3##4##(2008-2#1)(2008-3#2)
the radiative transfer##24##3##(2007-12#3)(2008-10#1)(2008-2#9)(2008-3#10)(2010-4#1)
the radiative##39##2##(2007-11#1)(2007-12#5)(2008-10#2)(2008-2#17)(2008-3#13)(2010-4#1)
the radiative-transfer##2##2##(2008-2#2)
the radical anion of##2##4##(2008-10#1)(2010-5#1)
the radical anion##3##3##(2006-10#1)(2008-10#1)(2010-5#1)
the radical pair##3##3##(1991-7#2)(2006-10#1)
the radical rearrangement##2##3##(1996-2#1)(1996-5#1)
the radical scavenger##2##3##(2008-11#1)(2010-2#1)
the radical scavenging##2##3##(2008-11#2)
the radical##40##2##(1990-12#1)(1991-7#2)(1992-9#2)(1995-10#2)(1995-2#3)(1996-2#5)(1996-5#2)(2006-10#3)(2007-11#2)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#2)(2008-8#1)(2009-2#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#1)
the radicality of surgery##2##4##(1991-4#1)(2010-12#1)
the radicality##3##2##(1991-4#1)(1995-9#1)(2010-12#1)
the radicals##10##2##(1993-3#1)(1994-8#1)(1997-8#3)(2007-11#1)(2007-3#1)(2008-10#2)(2008-2#1)
the radii##6##2##(1996-12#1)(2005-11#2)(2008-2#1)(2011-2#2)
the radio##3##2##(2007-7#1)(2008-3#1)(2010-7#1)
the radioactive ligand##2##3##(1990-2#2)
the radioactive tracer##3##3##(1990-12#1)(1990-2#1)(1993-8#1)
the radioactive##18##2##(1990-11#1)(1990-12#2)(1990-2#4)(1991-3#2)(1992-3#2)(1992-9#1)(1993-8#1)(1994-5#1)(1997-3#1)(2007-10#1)(2008-4#2)
the radioactivity in the##4##4##(1990-7#1)(1991-4#1)(1997-3#1)(2008-4#1)
the radioactivity in##7##3##(1990-7#1)(1991-1#1)(1991-4#1)(1997-3#1)(1997-8#1)(2008-4#1)(2008-5#1)
the radioactivity of the##2##4##(1993-11#1)(2008-11#1)
the radioactivity of##4##3##(1991-1#1)(1992-6#1)(1993-11#1)(2008-11#1)
the radioactivity was##3##3##(1990-10#1)(1991-7#1)(1994-3#1)
the radioactivity##18##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-7#1)(1991-1#2)(1991-3#1)(1991-4#1)(1991-7#1)(1992-6#1)(1993-11#2)(1994-3#1)(1997-3#1)(1997-8#1)(2008-11#1)(2008-4#1)(2008-5#1)
the radioantigen binding assay##2##4##(1990-12#2)
the radiobiological##2##2##(1995-9#1)(2007-11#1)
the radiocarpal joint and##2##4##(2008-10#1)(2012-2#1)
the radiochemical assay##2##3##(1991-12#2)
the radiofrequency##2##2##(2006-7#1)(2008-10#1)
the radiograph##2##2##(2008-12#1)(2010-8#1)
the radiographic features##2##3##(2005-8#2)
the radiographic##12##2##(1991-12#1)(1993-1#2)(2005-11#1)(2005-8#2)(2006-10#1)(2007-1#1)(2008-1#1)(2008-12#1)(2008-7#1)(2008-8#1)
the radiographs##5##2##(2007-7#1)(2008-1#1)(2011-2#1)(2013-1#2)
the radioimmunoassay##4##2##(1991-7#1)(1991-8#2)(2007-9#1)
the radioiodinated##2##2##(1992-10#1)(1994-12#1)
the radioisotope and##2##3##(1992-2#2)
the radioisotope##4##2##(1990-11#1)(1990-12#1)(1992-2#2)
the radiolabel was##2##3##(1993-4#1)(1993-7#1)
the radiolabel##4##2##(1992-2#1)(1993-4#1)(1993-7#1)(1995-9#1)
the radiolabeled##12##2##(1990-8#2)(1990-9#1)(1991-2#1)(1992-12#1)(1993-7#1)(1994-11#1)(1994-5#2)(1994-8#1)(1995-8#1)(1996-8#1)
the radiolabeling##3##2##(1992-2#1)(2007-10#1)(2008-4#1)
the radiolabelled##12##2##(1990-1#1)(1990-12#1)(1990-2#1)(1991-4#1)(1992-6#1)(1994-12#2)(1994-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-8#1)
the radiolar crown##2##3##(2011-2#2)
the radioligand was##3##3##(1990-5#1)(1991-11#1)(1996-3#1)
the radioligand##5##2##(1990-5#1)(1991-11#1)(1991-12#1)(1996-3#1)(2008-4#1)
the radiologic features of##2##4##(2011-2#1)(2013-7#1)
the radiologic literature##2##3##(1992-1#1)(1997-8#1)
the radiologic##9##2##(1992-1#1)(1996-1#1)(1997-8#1)(2006-6#1)(2007-4#2)(2011-2#1)(2012-12#1)(2013-7#1)
the radiological and clinical##2##4##(2007-11#1)(2007-7#1)
the radiological appearance of##3##4##(1993-8#1)(2005-8#1)(2012-3#1)
the radiological diagnosis##2##3##(2007-11#1)(2011-2#1)
the radiological evaluation of##2##4##(2007-8#2)
the radiological features of##3##4##(1992-12#1)(2011-2#1)(2012-2#1)
the radiological features##6##3##(1992-12#1)(2008-3#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-2#1)
the radiological findings##3##3##(1993-8#1)(2012-2#2)
the radiological interpretation##2##3##(1993-3#1)(2010-12#1)
the radiological##33##2##(1991-12#1)(1992-12#1)(1993-3#1)(1993-8#2)(1997-8#1)(2005-8#2)(2007-11#3)(2007-7#2)(2007-8#3)(2007-9#2)(2008-3#1)(2009-9#1)(2010-12#2)(2011-2#4)(2012-2#4)(2012-3#1)(2013-1#2)
the radiologically##2##2##(2006-12#1)(2008-6#1)
the radiologist and##2##3##(1991-3#1)(2012-1#1)
the radiologist to the##2##4##(2007-4#1)(2012-2#1)
the radiologist to##5##3##(2007-4#1)(2010-4#1)(2012-2#3)
the radiologist##19##2##(1991-3#1)(1993-3#1)(2007-4#9)(2009-9#1)(2010-4#1)(2012-1#1)(2012-2#5)
the radiologist's##2##2##(2008-8#1)(2010-9#1)
the radiologists##4##2##(1990-12#1)(2007-4#1)(2007-8#1)(2008-1#1)
the radiology administrator##3##3##(1992-12#1)(1994-12#1)(1996-3#1)
the radiology department##13##3##(1991-12#1)(1995-1#1)(1995-2#2)(1996-1#1)(1996-2#1)(1996-3#1)(1997-8#1)(2006-10#1)(2009-6#1)(2009-9#1)(2012-2#2)
the radiology manager##4##3##(1991-1#1)(1991-12#1)(1993-2#1)(1994-12#1)
the radiology practice##2##3##(1996-1#1)(2007-4#1)
the radiology##38##2##(1991-1#1)(1991-12#2)(1992-12#2)(1993-2#1)(1994-12#2)(1995-1#1)(1995-2#2)(1995-3#3)(1996-1#2)(1996-2#1)(1996-3#2)(1997-8#1)(2006-10#1)(2007-4#12)(2009-6#1)(2009-9#1)(2012-2#3)
the radiometer##2##2##(2007-11#1)(2008-2#1)
the radiometric calibration of the##2##5##(2008-3#2)
the radiometric calibration##3##3##(2008-2#1)(2008-3#2)
the radiometric sensitivities of the SeaWiFS##2##6##(2008-3#2)
the radiometric##13##2##(2008-10#1)(2008-2#5)(2008-3#7)
the radionuclide##9##2##(1994-6#1)(1996-4#1)(2007-5#1)(2007-8#1)(2008-7#3)(2011-1#1)(2013-7#1)
the radioprotective activity##2##3##(2008-5#2)
the radioprotective agent 2-aminoethyl-isothiouronium bromide hydrobromide (AET)##2##7##(1994-5#2)
the radioprotective##4##2##(1994-5#2)(2008-5#2)
the radioreceptor assay##2##3##(1991-7#1)(2008-4#1)
the radiosensitive##3##2##(1995-3#1)(1997-1#1)(1997-3#1)
the radiosensitivity of head and neck cancer patients##2##8##(2008-5#2)
the radiosensitizing effects of the##2##5##(2007-11#2)
the radiosurgery##4##2##(2008-7#3)(2009-5#1)
the radiotherapeutic##3##2##(1991-2#1)(1993-9#2)
the radiotherapy##9##2##(1991-8#1)(1992-12#1)(2007-4#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#1)
the radiotracer##2##2##(1996-5#1)(2006-9#1)
the radius and the##4##4##(1995-6#2)(2008-3#2)
the radius and##6##3##(1995-6#2)(2007-11#1)(2008-2#1)(2008-3#2)
the radius in the##2##4##(1991-11#1)(2008-2#1)
the radius of curvature of the##2##6##(2008-3#2)
the radius of curvature of##3##5##(2008-3#2)(2013-8#1)
the radius of curvature##5##4##(1990-12#1)(2008-3#2)(2012-2#1)(2013-8#1)
the radius of gyration of##2##5##(2006-5#1)(2008-3#1)
the radius of gyration##4##4##(2006-12#1)(2006-5#1)(2008-2#1)(2008-3#1)
the radius of the drop##2##5##(2005-11#2)
the radius of the##12##4##(1990-7#1)(1994-3#1)(1997-7#1)(2005-11#3)(2006-11#1)(2008-10#1)(2008-2#3)(2008-3#1)
the radius of##23##3##(1990-12#1)(1990-7#1)(1994-3#1)(1997-7#1)(2005-11#3)(2006-11#1)(2006-12#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-2#4)(2008-3#4)(2008-5#1)(2012-2#1)(2013-8#1)
the radius##43##2##(1990-12#1)(1990-7#1)(1991-11#1)(1991-4#1)(1994-3#1)(1995-6#3)(1997-7#1)(2005-11#4)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#3)(2006-5#1)(2007-11#3)(2008-10#1)(2008-2#6)(2008-3#7)(2008-5#1)(2009-3#1)(2012-2#3)(2013-8#1)
the radon concentration##2##3##(2008-1#2)
the rails##2##2##(1997-4#2)
the rain##6##2##(1991-3#1)(2008-10#3)(2008-5#1)(2013-8#1)
the rainbow hologram##2##3##(2007-12#1)(2008-3#1)
the rainbow trout (Oncorhynchus mykiss)##2##5##(2008-5#1)(2008-6#1)
the rainbow trout##13##3##(1991-9#1)(1992-12#1)(1994-5#2)(1995-7#1)(1997-2#3)(2008-10#1)(2008-5#2)(2008-6#2)
the rainbow##24##2##(1991-9#1)(1992-12#1)(1994-5#2)(1995-7#1)(1997-2#3)(2007-12#2)(2008-10#1)(2008-2#5)(2008-3#4)(2008-5#2)(2008-6#2)
the rainfall##2##2##(2007-2#1)(2008-10#1)
the rainforest canopy##2##3##(2007-12#2)
the rainforest##3##2##(2007-12#2)(2010-10#1)
the rainwater##3##2##(2007-8#1)(2008-10#2)
the rainy and##2##3##(2008-3#1)(2013-7#1)
the rainy season (May##2##4##(2012-2#1)(2013-7#1)
the rainy season and##3##4##(2007-3#1)(2007-7#1)(2008-8#1)
the rainy season##39##3##(1994-9#1)(2006-2#1)(2007-2#1)(2007-3#4)(2007-5#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#14)(2008-6#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-7#4)(2013-8#1)
the rainy seasons##2##3##(2007-2#1)(2012-2#1)
the rainy##44##2##(1994-9#1)(2006-2#1)(2007-2#2)(2007-3#4)(2007-5#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#14)(2008-6#1)(2008-8#2)(2012-12#1)(2012-2#2)(2013-7#5)(2013-8#1)
the raised serum##2##3##(1996-12#1)(2013-1#1)
the raised##5##2##(1996-12#1)(2006-2#1)(2013-1#3)
the raisin trial##3##3##(1993-2#3)
the raising##2##2##(2005-10#1)(2011-2#1)
the raloxifene response element##2##4##(1996-8#2)
the ramp direction of V(c)##2##5##(2008-10#2)
the ramp##5##2##(2007-9#1)(2008-10#2)(2008-3#1)(2012-2#1)
the random amplified polymorphic DNA (RAPD) technique##2##7##(2008-10#2)
the random amplified polymorphic DNA (RAPD)##5##6##(1993-12#1)(2005-11#1)(2008-10#3)
the random amplified polymorphic DNA##6##5##(1993-12#1)(2005-11#1)(2008-10#4)
the random dimer model##2##4##(1991-6#2)
the random effects##2##3##(1996-3#1)(2008-8#1)
the random phase##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
the random projection algorithm##3##4##(2006-10#3)
the random sample##2##3##(2006-10#2)
the random##64##2##(1990-7#1)(1991-6#2)(1991-9#1)(1992-10#1)(1993-12#2)(1993-7#1)(1994-2#1)(1994-6#1)(1995-2#2)(1995-7#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-6#1)(2005-11#2)(2006-10#6)(2006-12#2)(2007-11#2)(2007-12#3)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#6)(2008-7#3)(2008-8#2)(2008-9#1)(2009-4#2)(2009-5#1)(2010-6#1)(2010-8#2)(2012-3#2)(2013-8#1)
the randomised clinical##2##3##(2007-5#1)(2007-8#1)
the randomised##7##2##(2007-11#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-3#1)(2010-5#1)
the randomization##3##2##(1996-12#1)(2008-6#1)(2012-2#1)
the randomized controlled##2##3##(2008-8#1)(2009-5#1)
the randomized##14##2##(1991-5#1)(1992-6#1)(1995-11#1)(1995-2#1)(2005-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-7#1)(2012-2#1)
the randomly##4##2##(1990-5#1)(2008-10#1)(2008-3#1)(2011-2#1)
the randomness##2##2##(2008-10#1)(2010-10#1)
the range 0 degrees##2##4##(2007-12#1)(2008-2#1)
the range 0##126##3##(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-5#1)(1991-8#1)(1993-1#1)(1993-2#1)(1993-4#2)(1993-8#1)(1994-11#1)(1996-6#2)(1996-8#1)(1997-3#1)(1997-7#1)(2004-9#1)(2005-11#1)(2005-7#2)(2007-12#2)(2007-8#1)(2008-10#85)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#3)(2012-1#1)(2012-12#2)(2013-7#2)(2013-8#1)
the range 0-0##3##3##(2008-10#2)(2008-6#1)
the range 1##31##3##(1992-8#1)(1994-2#1)(1996-6#1)(1997-1#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#19)(2008-2#1)(2008-5#1)(2010-5#1)
the range 1-10##6##3##(1990-3#1)(1993-4#1)(2008-10#3)(2010-5#1)
the range 1-30##3##3##(1996-5#1)(2008-10#1)(2008-2#1)
the range 1-5%##2##3##(1992-3#1)(2008-10#1)
the range 10-40##2##3##(1995-2#1)(2008-7#1)
the range 2##12##3##(1992-11#1)(1992-2#1)(1996-6#1)(2008-10#9)
the range 3##7##3##(2008-10#7)
the range 5##7##3##(1991-10#1)(1991-9#1)(2008-10#5)
the range 5-1000ngmL(-1)##2##3##(2008-10#2)
the range 6##8##3##(1991-5#1)(1997-4#1)(2008-10#5)(2008-7#1)
the range and the##2##4##(2008-2#1)(2013-8#1)
the range and##7##3##(1996-2#1)(2008-10#2)(2008-2#2)(2013-1#1)(2013-8#1)
the range between##15##3##(1997-1#1)(2006-2#1)(2006-5#1)(2008-10#8)(2008-2#3)(2008-3#1)
the range examined##2##3##(2008-10#2)
the range expected for##3##4##(1992-3#2)(2008-7#1)
the range for##4##3##(1991-10#1)(2004-11#1)(2007-1#1)(2008-11#1)
the range from 0 to 1##2##6##(2008-10#2)
the range from 0 to##5##5##(2007-12#1)(2007-8#1)(2008-10#3)
the range from 0##20##4##(1990-12#1)(1992-11#1)(2005-11#1)(2007-12#2)(2007-8#2)(2008-10#8)(2008-3#3)(2010-4#2)
the range from 10 to##3##5##(1990-8#1)(2008-10#1)(2008-8#1)
the range from 10##4##4##(1990-8#1)(2008-10#1)(2008-2#1)(2008-8#1)
the range from 2 to##2##5##(2007-7#1)(2008-10#1)
the range from 2##3##4##(2007-7#1)(2008-10#2)
the range from 5##2##4##(1996-7#1)(2008-3#1)
the range from##65##3##(1990-12#1)(1990-2#1)(1990-8#3)(1991-2#1)(1991-9#1)(1992-11#1)(1996-7#1)(2005-11#3)(2006-4#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#2)(2008-10#23)(2008-2#6)(2008-3#7)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-4#2)(2011-2#1)(2013-1#1)
the range in which##2##4##(2005-7#1)(2008-2#1)
the range in##3##3##(2005-7#1)(2007-7#1)(2008-2#1)
the range investigated##2##3##(1991-12#1)(2004-9#1)
the range is##2##3##(2007-12#1)(2008-3#1)
the range of 0##109##4##(1990-7#3)(1991-10#1)(1992-8#1)(1997-8#2)(2005-12#1)(2005-4#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#82)(2008-2#1)(2008-5#2)(2009-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2013-1#1)(2013-8#1)
the range of 1##31##4##(1990-5#1)(1992-1#1)(1994-5#1)(1996-12#1)(1996-5#1)(1996-6#1)(2006-7#1)(2007-1#1)(2008-10#19)(2008-11#1)(2008-3#1)(2010-4#1)(2011-1#1)
the range of 10##7##4##(1994-8#1)(1996-1#1)(2005-12#2)(2008-10#1)(2008-11#1)(2012-11#1)
the range of 100##3##4##(2008-11#1)(2009-11#1)(2010-11#1)
the range of 19##2##4##(1990-9#1)(2010-12#1)
the range of 2##18##4##(1991-8#1)(1996-8#1)(2005-4#1)(2006-10#1)(2007-8#1)(2008-10#13)
the range of 200-400##2##4##(2008-5#2)
the range of 24##2##4##(2006-6#1)(2010-5#1)
the range of 3##11##4##(1994-8#1)(2006-12#1)(2007-8#1)(2008-10#6)(2010-12#1)(2010-3#1)
the range of 4##10##4##(2006-8#1)(2008-10#6)(2008-11#1)(2008-3#1)(2013-1#1)
the range of 5##12##4##(1996-8#1)(2007-10#1)(2008-10#10)
the range of 7##6##4##(1996-5#1)(2008-10#4)(2010-5#1)
the range of 82##2##4##(2008-10#2)
the range of 99##6##4##(2005-4#1)(2008-10#3)(2010-2#1)(2011-2#1)
the range of a##2##4##(2007-12#1)(2008-3#1)
the range of applications##2##4##(2008-11#1)(2012-2#1)
the range of concentrations##6##4##(1994-11#1)(1997-8#1)(2008-10#4)
the range of conditions in##2##5##(2008-10#1)(2008-8#1)
the range of conditions##4##4##(2006-11#1)(2008-10#1)(2008-8#2)
the range of decision thresholds##3##5##(1997-3#3)
the range of differences##2##4##(2004-11#1)(2008-10#1)
the range of doses##2##4##(1996-3#1)(2004-12#1)
the range of factors##3##4##(1995-3#1)(2008-11#1)(2012-2#1)
the range of flexion and extension##2##6##(2007-8#2)
the range of forces##2##4##(2007-12#2)
the range of indications##2##4##(2006-10#2)
the range of issues##2##4##(1994-12#1)(2009-4#1)
the range of its##2##4##(2008-8#1)(2009-12#1)
the range of linearity##2##4##(2009-8#1)(2013-1#1)
the range of low##2##4##(1990-5#1)(2008-10#1)
the range of motion (ROM)##2##5##(2008-12#1)(2009-1#1)
the range of motion in##3##5##(2007-7#2)(2008-8#1)
the range of motion of the##3##6##(2007-11#1)(2007-8#2)
the range of motion of##4##5##(2007-11#1)(2007-8#3)
the range of motion##14##4##(2007-11#1)(2007-7#3)(2007-8#3)(2008-12#1)(2008-8#1)(2009-1#1)(2010-12#1)(2012-1#2)(2012-3#1)
the range of movement in the hip##2##7##(2007-8#2)
the range of movement##12##4##(2007-11#3)(2007-7#3)(2007-8#5)(2012-12#1)
the range of operation of##2##5##(2007-11#1)(2007-9#1)
the range of pH##8##4##(1995-2#1)(1996-12#1)(2005-4#1)(2008-10#5)
the range of parameters##4##4##(2008-2#1)(2008-3#2)(2008-8#1)
the range of potential##2##4##(1990-3#1)(2008-4#1)
the range of pulses presented##2##5##(2012-2#2)
the range of temperatures##3##4##(2007-6#1)(2008-3#1)(2008-8#1)
the range of the optical##2##5##(2008-3#1)(2013-8#1)
the range of the values##2##5##(1995-8#1)(2008-2#1)
the range of the##20##4##(1990-11#1)(1992-12#1)(1994-2#1)(1995-8#1)(2005-11#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2013-8#1)
the range of those##3##4##(2007-11#1)(2007-12#1)(2008-5#1)
the range of validity of the##4##6##(2008-2#2)(2008-3#2)
the range of validity of##7##5##(2008-2#3)(2008-3#4)
the range of values##4##4##(2007-12#1)(2008-10#1)(2008-6#1)(2013-1#1)
the range of##706##3##(1990-11#2)(1990-3#2)(1990-5#2)(1990-7#4)(1990-8#1)(1990-9#1)(1991-10#1)(1991-4#1)(1991-8#1)(1992-1#3)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-1#3)(1993-12#1)(1993-2#1)(1993-7#1)(1993-9#4)(1994-11#3)(1994-12#4)(1994-2#3)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#2)(1995-10#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-7#1)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#4)(1996-9#2)(1997-3#5)(1997-6#1)(1997-8#6)(2004-11#1)(2004-12#1)(2004-4#2)(2004-9#1)(2005-11#5)(2005-12#4)(2005-2#1)(2005-4#14)(2005-7#3)(2006-10#6)(2006-11#4)(2006-12#3)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#6)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#13)(2007-12#13)(2007-2#1)(2007-6#1)(2007-7#9)(2007-8#29)(2007-9#3)(2008-10#275)(2008-11#11)(2008-12#3)(2008-2#17)(2008-3#22)(2008-4#5)(2008-5#10)(2008-6#7)(2008-7#5)(2008-8#18)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#5)(2010-3#1)(2010-4#5)(2010-5#4)(2010-9#1)(2011-1#4)(2011-12#3)(2011-2#11)(2011-7#1)(2012-1#6)(2012-11#2)(2012-12#7)(2012-2#7)(2012-3#4)(2013-1#14)(2013-8#4)
the range pH##3##3##(2008-10#3)
the range predicted by##2##4##(1995-8#1)(2011-2#1)
the range tested##2##3##(2008-10#1)(2008-11#1)
the range to##3##3##(2006-11#2)(2008-3#1)
the range was 0##2##4##(2006-10#1)(2007-5#1)
the range was##5##3##(1995-2#1)(2006-10#1)(2007-5#1)(2008-10#2)
the range where##2##3##(1993-9#1)(2013-1#1)
the range##1264##2##(1990-11#2)(1990-12#4)(1990-2#2)(1990-3#4)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#4)(1990-8#4)(1990-9#1)(1991-10#3)(1991-12#2)(1991-2#2)(1991-4#2)(1991-5#3)(1991-8#3)(1991-9#2)(1992-1#3)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#6)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#2)(1993-1#4)(1993-12#1)(1993-2#3)(1993-3#1)(1993-4#3)(1993-7#2)(1993-8#1)(1993-9#5)(1994-11#6)(1994-12#5)(1994-2#4)(1994-3#2)(1994-5#3)(1994-6#3)(1994-8#3)(1994-9#3)(1995-1#2)(1995-10#2)(1995-11#2)(1995-12#2)(1995-2#8)(1995-3#1)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#5)(1996-1#2)(1996-11#2)(1996-12#5)(1996-2#4)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#7)(1996-7#2)(1996-8#5)(1996-9#2)(1997-1#3)(1997-2#3)(1997-3#6)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#6)(2004-11#3)(2004-12#1)(2004-4#2)(2004-9#3)(2005-10#1)(2005-11#10)(2005-12#4)(2005-2#1)(2005-4#14)(2005-7#6)(2005-9#1)(2006-10#7)(2006-11#6)(2006-12#3)(2006-2#3)(2006-4#3)(2006-5#3)(2006-6#1)(2006-7#2)(2006-8#6)(2006-9#2)(2007-1#2)(2007-10#4)(2007-11#22)(2007-12#33)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#12)(2007-8#37)(2007-9#3)(2008-1#3)(2008-10#560)(2008-11#15)(2008-12#4)(2008-2#44)(2008-3#40)(2008-4#6)(2008-5#19)(2008-6#8)(2008-7#12)(2008-8#22)(2008-9#5)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-4#3)(2009-5#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#5)(2010-3#3)(2010-4#8)(2010-5#6)(2010-9#2)(2011-1#6)(2011-12#3)(2011-2#13)(2011-7#1)(2012-1#7)(2012-11#2)(2012-12#9)(2012-2#7)(2012-3#4)(2013-1#20)(2013-7#2)(2013-8#9)
the range-corrected##2##2##(2008-2#2)
the range-of-motion##2##2##(2012-1#2)
the range-resolved##2##2##(2008-3#2)
the ranges 0##5##3##(1990-3#1)(2007-8#1)(2008-10#3)
the ranges of##24##3##(1991-3#1)(1995-6#1)(2005-4#1)(2007-12#1)(2008-10#12)(2008-2#2)(2008-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#1)
the ranges studied##2##3##(1991-10#1)(2008-11#1)
the ranges##50##2##(1990-12#1)(1990-3#1)(1991-10#1)(1991-3#1)(1995-6#1)(1996-6#1)(1997-3#1)(2005-12#1)(2005-4#1)(2007-12#3)(2007-8#1)(2008-10#26)(2008-11#1)(2008-2#3)(2008-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#2)
the rank and replace##2##4##(2010-3#2)
the rank and##3##3##(1993-2#1)(2010-3#2)
the rank of##9##3##(1995-11#1)(2007-8#1)(2008-10#4)(2010-12#2)(2012-3#1)
the rank order of potency##4##5##(1990-2#1)(1993-3#1)(1995-12#1)(1996-10#1)
the rank order of##10##4##(1990-2#1)(1991-11#1)(1993-3#1)(1994-11#1)(1995-11#2)(1995-12#3)(1996-10#1)
the rank order##13##3##(1990-2#1)(1991-11#1)(1993-3#1)(1994-11#1)(1995-11#2)(1995-12#3)(1995-8#1)(1996-10#1)(2005-11#1)(2009-4#1)
the rank##31##2##(1990-2#1)(1991-11#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-11#1)(1995-11#3)(1995-12#3)(1995-2#1)(1995-8#1)(1996-10#1)(2005-11#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-9#1)(2009-4#1)(2010-12#2)(2010-3#2)(2012-3#1)
the rank-citation profile##2##3##(2012-2#2)
the ranking##7##2##(1993-1#1)(1993-12#1)(1997-3#1)(2007-2#1)(2008-5#1)(2012-3#1)(2013-8#1)
the ranks of the##3##4##(1994-12#1)(1995-2#1)(1997-2#1)
the ranks##6##2##(1994-12#1)(1995-2#1)(1997-2#1)(2006-11#1)(2010-3#1)(2012-3#1)
the rap1A##2##2##(1992-11#2)
the rap2 protein##2##3##(1991-9#1)(1992-11#1)
the rap2A protein##2##3##(1992-11#2)
the rapeseed##4##2##(1992-2#2)(2008-6#2)
the raphe nuclei##6##3##(1996-12#1)(2008-7#5)
the raphe##9##2##(1991-12#1)(1996-12#1)(1997-3#1)(2008-7#5)(2012-3#1)
the rapid acceptance of##2##4##(1990-4#1)(2007-5#1)
the rapid adherence of##2##4##(2008-10#2)
the rapid advances in##2##4##(1992-1#1)(2007-1#1)
the rapid amplification of cDNA ends##2##6##(1997-6#1)(2009-5#1)
the rapid analysis of##4##4##(1994-6#1)(2008-10#2)(2010-9#1)
the rapid and##23##3##(1990-12#1)(1993-4#1)(1993-6#1)(1994-8#1)(1995-6#1)(1996-6#1)(1997-3#1)(2005-11#1)(2007-6#1)(2008-10#8)(2008-7#2)(2008-9#1)(2009-11#1)(2012-1#1)(2012-3#1)
the rapid appearance of##2##4##(1991-2#1)(1994-10#1)
the rapid appearance##3##3##(1991-2#1)(1991-7#1)(1994-10#1)
the rapid assembly of##2##4##(1994-12#1)(2008-8#1)
the rapid clearance of##2##4##(1991-2#1)(2008-10#1)
the rapid clinical##4##3##(2007-5#1)(2008-3#2)(2011-2#1)
the rapid cold hardening##2##4##(2011-12#2)
the rapid collection of##2##4##(2006-5#1)(2007-11#1)
the rapid construction of##2##4##(1993-2#2)
the rapid decline##2##3##(1997-6#1)(2012-12#1)
the rapid detection and##2##4##(1993-12#1)(2008-10#1)
the rapid detection of##7##4##(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2009-6#1)(2012-3#1)
the rapid detection##9##3##(1993-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2009-6#1)(2012-3#1)
the rapid determination of the##3##5##(2006-12#1)(2006-3#1)(2008-10#1)
the rapid determination of##14##4##(1991-9#1)(2006-12#1)(2006-3#1)(2007-12#1)(2008-10#10)
the rapid determination##15##3##(1991-9#1)(2006-12#1)(2006-3#1)(2007-12#1)(2008-10#11)
the rapid development of a##2##5##(2006-10#1)(2007-12#1)
the rapid development of new##2##5##(2005-7#1)(2006-10#1)
the rapid development of##17##4##(1997-4#1)(2005-7#1)(2006-10#2)(2007-11#1)(2007-12#2)(2008-10#4)(2009-11#1)(2009-5#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
the rapid development##18##3##(1997-4#1)(2005-7#1)(2006-10#2)(2007-11#1)(2007-12#2)(2008-10#4)(2009-11#1)(2009-5#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
the rapid diagnosis of##2##4##(2007-7#2)
the rapid diagnosis##3##3##(2007-7#2)(2012-3#1)
the rapid differentiation of##2##4##(1995-8#1)(2012-12#1)
the rapid effects##2##3##(1994-10#1)(2008-7#1)
the rapid energy exchange limit##2##5##(2006-4#2)
the rapid energy exchange##3##4##(2006-4#3)
the rapid evaluation of##2##4##(1994-3#1)(2008-3#1)
the rapid evaluation##3##3##(1994-3#1)(2008-3#2)
the rapid expansion of##7##4##(2007-11#1)(2008-10#1)(2011-2#1)(2012-1#1)(2013-1#3)
the rapid exploration of##2##4##(2007-3#1)(2009-8#1)
the rapid formation##2##3##(1991-7#1)(2009-4#1)
the rapid growth in##3##4##(1994-3#1)(2007-11#1)(2009-3#1)
the rapid growth of the##4##5##(2006-6#1)(2008-5#1)(2008-7#1)(2009-5#1)
the rapid growth of##8##4##(2006-6#1)(2007-11#1)(2007-4#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-7#1)
the rapid growth##12##3##(1992-2#1)(1994-3#1)(2006-6#1)(2007-11#2)(2007-4#2)(2008-5#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-7#1)
the rapid identification of##10##4##(1991-12#1)(1994-9#1)(2006-8#1)(2007-6#2)(2008-9#1)(2010-12#1)(2012-12#2)(2013-1#1)
the rapid identification##12##3##(1991-12#1)(1994-9#1)(2006-8#1)(2007-6#2)(2007-7#1)(2008-10#1)(2008-9#1)(2010-12#1)(2012-12#2)(2013-1#1)
the rapid increase in the##2##5##(1996-9#1)(2008-2#1)
the rapid increase in##9##4##(1996-9#1)(1997-7#1)(2008-10#3)(2008-2#1)(2008-3#1)(2012-2#2)
the rapid increase of##3##4##(1994-2#1)(2011-1#1)(2011-2#1)
the rapid increase##13##3##(1994-2#1)(1996-9#1)(1997-7#1)(2008-10#3)(2008-2#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#3)
the rapid induction of##2##4##(1992-12#1)(2010-12#1)
the rapid onset of##2##4##(1995-12#1)(2006-10#1)
the rapid onset##4##3##(1995-12#1)(2006-10#1)(2013-1#2)
the rapid pace of##2##4##(2007-4#1)(2011-1#1)
the rapid pace##3##3##(2006-8#1)(2007-4#1)(2011-1#1)
the rapid phase of##2##4##(1993-11#1)(1994-8#1)
the rapid phase##4##3##(1993-11#1)(1994-8#1)(2007-12#1)(2008-5#1)
the rapid phosphorylation of##2##4##(1991-5#1)(1993-6#1)
the rapid production of##2##4##(1990-9#1)(2012-11#1)
the rapid progress in##2##4##(2005-8#1)(2008-10#1)
the rapid progress of##2##4##(1993-3#1)(2006-4#1)
the rapid progress##5##3##(1993-3#1)(2005-8#1)(2006-4#1)(2008-10#1)(2008-11#1)
the rapid prototyping##2##3##(2008-8#1)(2010-8#1)
the rapid reaction of##3##4##(1990-8#1)(2008-10#2)
the rapid recovery of##2##4##(1993-8#1)(1995-7#1)
the rapid screening of##5##4##(1991-10#1)(2008-10#2)(2008-11#1)(2011-1#1)
the rapid separation##5##3##(1997-2#1)(2005-11#1)(2008-10#3)
the rapid synthesis of##3##4##(1991-7#1)(1992-8#1)(2008-10#1)
the rapid test##4##3##(2007-11#2)(2007-12#1)(2012-2#1)
the rapid turnover of##2##4##(1990-7#1)(1993-9#1)
the rapid tyrosine phosphorylation of##2##5##(1995-3#1)(1995-6#1)
the rapid tyrosine phosphorylation##3##4##(1995-3#1)(1995-6#2)
the rapid urease test##2##4##(2008-5#1)(2010-5#1)
the rapid##332##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-10#2)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-7#5)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-8#2)(1993-11#3)(1993-12#1)(1993-2#3)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#2)(1993-9#3)(1994-10#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#4)(1995-7#2)(1995-8#3)(1996-2#4)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#1)(2005-11#3)(2005-7#1)(2005-8#1)(2006-10#6)(2006-12#2)(2006-3#1)(2006-4#4)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-11#9)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#3)(2007-6#6)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#61)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#7)(2008-7#6)(2008-8#6)(2008-9#5)(2009-11#2)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#6)(2011-12#2)(2011-2#5)(2012-1#3)(2012-11#1)(2012-12#6)(2012-2#7)(2012-3#4)(2013-1#11)(2013-8#2)
the rapidity of##4##3##(2007-7#1)(2011-1#2)(2011-2#1)
the rapidity##5##2##(1997-4#1)(2007-7#1)(2011-1#2)(2011-2#1)
the rapidly advancing##2##3##(2005-7#2)
the rapidly aging population##2##4##(1990-12#1)(2011-2#1)
the rapidly changing##2##3##(2007-4#1)(2013-1#1)
the rapidly developing##2##3##(2007-8#1)(2008-12#1)
the rapidly expanding##3##3##(2006-10#1)(2013-1#2)
the rapidly growing##8##3##(1990-5#1)(1991-6#1)(1992-3#1)(1994-11#1)(2007-7#1)(2011-2#1)(2013-1#2)
the rapidly reversible increase##2##4##(1992-3#2)
the rapidly##36##2##(1990-12#1)(1990-5#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-3#3)(1993-4#1)(1994-11#1)(1995-6#2)(1996-10#1)(1996-4#1)(2005-3#1)(2005-7#2)(2006-10#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#6)
the rare allele##4##3##(1997-2#2)(1997-4#2)
the rare case of##2##4##(2012-2#1)(2013-7#1)
the rare earth elements##3##4##(2008-10#3)
the rare earth##8##3##(2005-4#2)(2006-4#1)(2008-10#5)
the rare earths and##2##4##(2008-10#2)
the rare earths##6##3##(1992-11#1)(2008-10#5)
the rare occurrence of the sexual stage of##2##8##(2008-10#2)
the rare variant##2##3##(2012-3#2)
the rare##67##2##(1992-11#1)(1992-2#1)(1992-6#1)(1992-8#1)(1994-11#1)(1994-3#1)(1996-7#2)(1997-2#2)(1997-4#2)(1997-5#1)(2005-10#1)(2005-4#2)(2006-1#1)(2006-4#1)(2007-2#1)(2007-5#1)(2007-8#3)(2008-10#16)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-10#2)(2010-4#1)(2010-5#1)(2012-12#2)(2012-2#3)(2012-3#7)(2013-1#2)(2013-7#1)(2013-8#2)
the rarefaction##2##2##(2008-10#1)(2008-3#1)
the rarely##3##2##(1992-5#1)(2008-11#1)(2013-1#1)
the rareness of##2##3##(2006-2#1)(2012-11#1)
the rarest##6##2##(1997-7#1)(2008-4#1)(2010-12#1)(2010-3#1)(2010-8#1)(2013-1#1)
the rarity of its##2##4##(1991-11#1)(2011-2#1)
the rarity of the disease##3##5##(2007-12#1)(2008-8#1)(2010-12#1)
the rarity of the##6##4##(1990-5#1)(2007-12#1)(2008-8#1)(2010-12#1)(2010-5#1)(2013-1#1)
the rarity of these##5##4##(2007-2#1)(2008-6#1)(2010-7#2)(2012-12#1)
the rarity of this condition and its##2##7##(2010-12#1)(2011-2#1)
the rarity of this condition##3##5##(2010-12#1)(2011-2#1)(2012-12#1)
the rarity of this##11##4##(1990-10#1)(1991-10#1)(1992-5#1)(2007-10#1)(2007-9#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#2)
the rarity of##31##3##(1990-10#1)(1990-5#1)(1991-10#1)(1991-11#1)(1992-5#1)(1992-8#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#2)(2010-5#3)(2010-7#2)(2011-2#3)(2012-12#4)(2012-3#1)(2013-1#1)
the ras genes##2##3##(1992-12#1)(1995-2#1)
the ras##11##2##(1991-11#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-8#2)(1993-6#1)(1994-6#1)(1995-2#1)(1995-3#1)(1997-4#1)
the rash##5##2##(1997-4#1)(2006-10#1)(2006-8#1)(2008-11#1)(2008-8#1)
the rat ALR cDNA##2##4##(1993-5#2)
the rat AT1 receptor##3##4##(1992-3#2)(1992-5#1)
the rat AT1##4##3##(1992-3#3)(1992-5#1)
the rat Gadd45##2##3##(1994-12#2)
the rat PACAP##4##3##(1990-12#3)(1994-12#1)
the rat SCN##3##3##(1993-12#3)
the rat adrenal cortex##2##4##(1995-10#1)(1996-5#1)
the rat adrenal gland##2##4##(1990-5#1)(1996-12#1)
the rat adrenal##7##3##(1990-5#1)(1993-4#1)(1995-10#3)(1996-12#1)(1996-5#1)
the rat after##2##3##(1994-10#1)(1995-12#1)
the rat alveolar##2##3##(1990-4#1)(1997-5#1)
the rat amygdala##5##3##(1993-2#2)(1997-6#3)
the rat and chick##2##4##(1996-12#2)
the rat and human##10##4##(1991-10#1)(1991-9#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-8#2)(1995-2#1)(2011-12#1)
the rat and mouse AT2R##2##5##(1994-11#1)(1994-9#1)
the rat and mouse##7##4##(1992-7#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-7#1)(2008-4#2)
the rat and other species##2##5##(1991-1#1)(1995-1#1)
the rat and quail##2##4##(1997-5#2)
the rat and##40##3##(1990-3#1)(1990-6#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-7#2)(1996-12#2)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-5#3)(2007-10#1)(2008-11#2)(2008-4#2)(2008-5#1)(2011-12#1)
the rat anterior pituitary##3##4##(1992-3#1)(1992-7#1)(1996-5#1)
the rat anterior##4##3##(1992-3#1)(1992-7#1)(1996-5#1)(2009-2#1)
the rat aorta##6##3##(1991-9#3)(1994-11#2)(2008-8#1)
the rat are##3##3##(1992-3#1)(1992-9#1)(1997-2#1)
the rat aryl sulfotransferase cDNA##2##5##(1993-4#2)
the rat as a model##2##5##(1995-2#1)(2008-7#1)
the rat as a##3##4##(1995-2#1)(2005-10#1)(2008-7#1)
the rat at different ages##2##5##(1990-5#1)(1994-2#1)
the rat at##5##3##(1990-5#1)(1993-12#1)(1994-2#1)(1996-4#1)(2008-8#1)
the rat brain and##3##4##(1994-11#1)(1997-8#1)(2008-4#1)
the rat brain by##6##4##(1995-3#1)(1995-5#1)(1996-12#1)(2007-1#1)(2008-10#1)(2010-2#1)
the rat brain in##2##4##(1991-4#1)(1993-3#1)
the rat brain is##2##4##(1993-8#1)(2008-10#1)
the rat brain using the##2##5##(1995-7#1)(2010-12#1)
the rat brain using##5##4##(1993-8#1)(1995-5#1)(1995-7#1)(2010-12#1)(2011-1#1)
the rat brain##73##3##(1990-7#1)(1991-2#1)(1991-3#2)(1991-4#3)(1992-10#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#3)(1993-8#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-3#3)(1995-5#4)(1995-6#1)(1995-7#2)(1995-9#1)(1996-10#3)(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#2)(1997-5#3)(1997-8#5)(2005-8#1)(2006-11#1)(2007-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-1#1)(2013-1#1)
the rat but##3##3##(1992-12#1)(2008-8#1)(2011-2#1)
the rat by##7##3##(1992-6#1)(1992-9#1)(1993-12#1)(1993-7#1)(1996-9#1)(2008-4#1)(2010-2#1)
the rat cDNA##3##3##(1992-10#1)(1995-10#1)(1995-2#1)
the rat central nervous system##5##5##(1992-6#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-12#1)
the rat cerebellar cortex##3##4##(1994-2#2)(1995-8#1)
the rat cerebral cortex##8##4##(1990-2#1)(1990-7#1)(1995-6#1)(1996-5#2)(1997-2#2)(1997-8#1)
the rat colon##3##3##(1996-5#1)(1997-4#2)
the rat dopamine##2##3##(1991-10#1)(1996-10#1)
the rat dorsal##4##3##(1990-7#1)(1994-10#1)(1995-11#1)(1997-7#1)
the rat enzyme##2##3##(1991-8#1)(1993-12#1)
the rat epididymis##4##3##(1992-3#3)(1992-8#1)
the rat erythrocyte##3##3##(1990-2#2)(1991-5#1)
the rat esophagus##2##3##(1993-4#1)(1995-3#1)
the rat eye##6##3##(1992-6#1)(1997-2#2)(2008-11#2)(2008-4#1)
the rat following##4##3##(1992-9#1)(1995-12#1)(1996-1#2)
the rat forebrain##4##3##(1992-3#1)(1994-11#1)(1995-12#2)
the rat gene encoding##4##4##(1991-5#1)(1993-3#1)(1993-6#1)(1993-8#1)
the rat gene##8##3##(1991-2#1)(1991-5#1)(1991-7#1)(1992-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)
the rat genome##5##3##(1991-6#1)(1992-3#1)(1993-8#1)(2007-9#1)(2008-4#1)
the rat heart##9##3##(1991-9#1)(1993-3#1)(1993-9#1)(1997-5#2)(2008-12#1)(2008-7#1)(2013-1#1)(2013-7#1)
the rat high affinity neurotensin receptor##2##6##(1997-2#2)
the rat hind##2##3##(1996-3#1)(2008-5#1)
the rat hippocampal slice##5##4##(1990-4#1)(1991-9#2)(1992-1#1)(1994-2#1)
the rat hippocampal##6##3##(1990-4#1)(1991-9#2)(1992-1#1)(1992-7#1)(1994-2#1)
the rat hippocampus was##2##4##(1990-5#1)(1995-5#1)
the rat hippocampus##21##3##(1990-2#2)(1990-5#2)(1990-7#1)(1991-5#2)(1994-11#2)(1994-2#2)(1995-12#2)(1995-5#1)(1995-7#1)(1996-12#1)(1997-2#1)(1997-5#1)(1997-7#2)(1997-8#1)
the rat hypothalamus##11##3##(1991-4#2)(1991-8#1)(1992-12#2)(1993-12#1)(1994-8#1)(1995-12#1)(1996-11#1)(1996-9#2)
the rat in order to##4##5##(1990-2#1)(1992-8#1)(1993-3#1)(2008-7#1)
the rat in##8##3##(1990-2#1)(1991-3#1)(1991-8#1)(1992-8#1)(1993-3#1)(1995-12#1)(1996-3#1)(2008-7#1)
the rat is##8##3##(1991-12#1)(1992-3#1)(1994-3#1)(1994-8#2)(1996-1#1)(2007-9#1)(2008-4#1)
the rat kidney##20##3##(1992-6#1)(1993-3#1)(1993-4#7)(1994-5#2)(1994-6#1)(1995-1#1)(1995-12#2)(1996-7#1)(1997-2#1)(2009-2#2)(2012-2#1)
the rat lateral##2##3##(1992-1#1)(1994-2#1)
the rat left##2##3##(2008-12#1)(2013-1#1)
the rat liver enzyme##2##4##(1991-1#1)(1991-4#1)
the rat liver vitamin K-dependent##2##5##(1990-5#1)(1991-5#1)
the rat liver was##2##4##(1991-5#1)(2009-8#1)
the rat liver##20##3##(1990-5#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1992-12#2)(1992-2#1)(1992-7#2)(1993-7#1)(1994-11#1)(1994-3#1)(1994-6#1)(1996-5#1)(2008-10#2)(2009-8#1)
the rat mammary gland##2##4##(1990-5#1)(1995-11#1)
the rat mammary##4##3##(1990-5#1)(1993-2#1)(1995-11#2)
the rat medial##2##3##(1997-2#1)(2013-8#1)
the rat mesentery##2##3##(1990-10#1)(1993-11#1)
the rat model##4##3##(1995-12#1)(1996-5#1)(2008-4#1)(2008-7#1)
the rat neocortex##2##3##(1991-3#1)(2008-11#1)
the rat neuronal cell adhesion molecule-encoding gene##2##7##(1993-6#2)
the rat neuronal cell##5##4##(1993-6#2)(2008-11#3)
the rat neuronal##6##3##(1993-6#2)(2008-11#3)(2010-12#1)
the rat neuropeptide Y##2##4##(1992-12#2)
the rat olfactory bulb##9##4##(1990-2#2)(1990-7#1)(1992-3#2)(1993-7#2)(1995-5#1)(1996-3#1)
the rat olfactory##13##3##(1990-2#2)(1990-7#1)(1991-11#1)(1992-3#2)(1993-7#2)(1995-5#1)(1996-10#1)(1996-3#1)(1997-3#2)
the rat ovary##3##3##(1990-4#1)(1996-8#1)(2008-5#1)
the rat pancreas##2##3##(1992-2#1)(1993-6#1)
the rat pituitary##12##3##(1990-10#1)(1991-9#2)(1992-12#3)(1992-2#1)(1992-6#1)(1992-7#1)(1993-11#1)(1995-11#2)
the rat placenta##2##3##(1995-12#1)(2008-10#1)
the rat rDNA##3##3##(1993-3#3)
the rat renal##3##3##(1990-2#1)(1991-2#1)(1994-3#1)
the rat sequence##2##3##(1991-9#1)(1997-5#1)
the rat skin##2##3##(2005-10#1)(2007-2#1)
the rat spinal cord##16##4##(1990-7#1)(1991-5#2)(1991-9#1)(1992-9#1)(1993-12#1)(1994-10#1)(1994-2#3)(1994-3#1)(1995-12#1)(1995-3#2)(1995-7#2)
the rat spinal trigeminal##2##4##(1994-2#2)
the rat spinal##18##3##(1990-7#1)(1991-5#2)(1991-9#1)(1992-9#1)(1993-12#1)(1994-10#1)(1994-2#5)(1994-3#1)(1995-12#1)(1995-3#2)(1995-7#2)
the rat stomach##4##3##(1995-5#1)(1997-4#2)(2012-12#1)
the rat striatum##13##3##(1991-5#1)(1994-2#2)(1995-11#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-5#4)(1996-6#1)(2009-10#1)
the rat subfornical organ##2##4##(1995-6#2)
the rat superior##2##3##(1996-5#1)(2008-4#1)
the rat suprachiasmatic nucleus (SCN)##2##5##(1996-1#1)(1997-8#1)
the rat suprachiasmatic nucleus##4##4##(1993-12#1)(1994-2#1)(1996-1#1)(1997-8#1)
the rat testis##8##3##(1990-5#1)(1991-2#2)(1991-7#1)(1992-3#1)(2008-9#1)(2012-2#1)(2013-1#1)
the rat thyroid lobes##3##4##(1991-12#1)(1991-7#2)
the rat thyrotropin##2##3##(1992-2#1)(1993-8#1)
the rat to##2##3##(1990-7#1)(1992-11#1)
the rat trachea##3##3##(2008-9#3)
the rat type##3##3##(1992-7#1)(1997-8#1)(2005-8#1)
the rat tyrosine hydroxylase (TH)##2##5##(1997-6#1)(2010-12#1)
the rat tyrosine##3##3##(1991-11#1)(1997-6#1)(2010-12#1)
the rat urinary bladder##3##4##(1992-12#1)(1992-3#1)(1992-8#1)
the rat using a##3##4##(1990-5#1)(1994-5#1)(2008-4#1)
the rat using the##2##4##(1990-5#1)(2008-4#1)
the rat using##9##3##(1990-5#2)(1993-2#1)(1994-5#2)(1996-9#1)(2008-10#1)(2008-4#2)
the rat uterine##2##3##(1992-12#1)(2012-1#1)
the rat uterus##5##3##(1990-9#1)(1991-5#1)(1991-6#1)(1995-10#2)
the rat was##5##3##(1992-10#1)(1993-6#1)(1995-5#1)(2011-1#1)(2011-2#1)
the rat were investigated##5##4##(1992-8#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-12#1)
the rat were##11##3##(1990-10#1)(1990-4#1)(1990-9#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-5#1)(1996-8#1)
the rat which##2##3##(1991-11#1)(1992-3#1)
the rat with##4##3##(1991-2#1)(1993-4#1)(2008-12#1)(2008-4#1)
the rat##1195##2##(1990-10#7)(1990-11#5)(1990-12#6)(1990-2#18)(1990-3#5)(1990-4#5)(1990-5#27)(1990-6#4)(1990-7#18)(1990-8#3)(1990-9#4)(1991-1#7)(1991-10#5)(1991-11#8)(1991-12#6)(1991-2#18)(1991-3#10)(1991-4#17)(1991-5#21)(1991-6#8)(1991-7#5)(1991-8#7)(1991-9#16)(1992-1#5)(1992-10#7)(1992-11#6)(1992-12#20)(1992-2#7)(1992-3#26)(1992-5#5)(1992-6#14)(1992-7#13)(1992-8#13)(1992-9#16)(1993-1#2)(1993-11#10)(1993-12#35)(1993-2#12)(1993-3#27)(1993-4#23)(1993-5#8)(1993-6#10)(1993-7#7)(1993-8#12)(1993-9#3)(1994-10#8)(1994-11#19)(1994-12#16)(1994-2#35)(1994-3#18)(1994-4#1)(1994-5#12)(1994-6#7)(1994-8#16)(1994-9#11)(1995-1#6)(1995-10#10)(1995-11#15)(1995-12#45)(1995-2#6)(1995-3#17)(1995-5#16)(1995-6#7)(1995-7#11)(1995-8#3)(1995-9#2)(1996-1#12)(1996-10#10)(1996-11#7)(1996-12#21)(1996-2#12)(1996-3#6)(1996-4#4)(1996-5#23)(1996-6#6)(1996-7#1)(1996-8#6)(1996-9#11)(1997-1#3)(1997-2#23)(1997-3#8)(1997-4#6)(1997-5#15)(1997-6#10)(1997-7#14)(1997-8#17)(2004-9#1)(2005-10#3)(2005-8#3)(2006-10#2)(2006-11#1)(2006-6#1)(2006-9#1)(2007-1#3)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#4)(2007-8#1)(2007-9#11)(2008-10#10)(2008-11#14)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#34)(2008-5#7)(2008-6#1)(2008-7#9)(2008-8#9)(2008-9#8)(2009-10#3)(2009-11#2)(2009-2#4)(2009-5#2)(2009-8#2)(2009-9#1)(2010-12#4)(2010-2#2)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#12)(2013-7#2)(2013-8#2)
the rat's##11##2##(1991-2#1)(1992-7#1)(1993-2#1)(1993-3#1)(1993-9#4)(1994-2#1)(2008-12#1)(2008-3#1)
the rate and extent of dense tubular Ca2+ uptake##2##9##(1992-6#2)
the rate and extent of##14##5##(1992-6#3)(1992-8#1)(1994-12#1)(1996-4#1)(1996-5#1)(1997-3#2)(2006-1#1)(2006-10#1)(2007-11#1)(2008-10#2)
the rate and pattern of##2##5##(1997-6#1)(2008-5#1)
the rate and the extent of##3##6##(1990-7#1)(1992-8#1)(1993-6#1)
the rate and the##4##4##(1990-7#1)(1992-8#1)(1993-6#1)(1994-12#1)
the rate and##31##3##(1990-7#1)(1990-9#1)(1992-6#3)(1992-8#2)(1993-6#1)(1994-12#2)(1995-1#1)(1996-4#1)(1996-5#1)(1997-3#2)(1997-4#1)(1997-6#1)(2006-1#1)(2006-10#1)(2007-11#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-2#1)(2011-12#1)(2011-2#1)
the rate at which cells##2##5##(2007-9#1)(2008-4#1)
the rate at which foragers##2##5##(2008-8#2)
the rate at which new##3##5##(1990-12#1)(2005-7#1)(2008-10#1)
the rate at which the##7##5##(1991-2#1)(2008-5#1)(2008-7#3)(2008-8#1)(2010-8#1)
the rate at which this##2##5##(2013-1#1)(2013-8#1)
the rate at which##28##4##(1990-12#1)(1991-2#1)(1992-1#1)(1992-6#1)(1994-12#1)(1995-6#1)(2005-7#1)(2006-9#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#6)(2010-12#1)(2010-8#1)(2013-1#1)(2013-8#1)
the rate constant for the##3##5##(1990-7#1)(2008-7#1)(2008-8#1)
the rate constant for thrombin inhibition by##3##7##(1994-12#3)
the rate constant for##8##4##(1990-7#1)(1994-11#1)(1994-12#3)(1995-2#1)(2008-7#1)(2008-8#1)
the rate constant of the##3##5##(1995-2#1)(1996-7#1)(1997-4#1)
the rate constant of##6##4##(1995-2#1)(1995-6#1)(1996-1#1)(1996-7#1)(1997-4#1)(2006-10#1)
the rate constant was##2##4##(1992-6#2)
the rate constant##25##3##(1990-2#1)(1990-7#1)(1991-1#1)(1992-6#2)(1994-11#1)(1994-12#3)(1995-1#1)(1995-2#3)(1995-6#1)(1996-1#1)(1996-12#1)(1996-7#1)(1997-4#1)(2005-11#1)(2006-10#1)(2008-10#3)(2008-7#1)(2008-8#1)
the rate constants for##6##4##(1994-9#1)(1995-10#1)(1997-2#1)(1997-4#2)(1997-8#1)
the rate constants of##2##4##(1992-9#1)(1996-9#1)
the rate constants##12##3##(1992-11#1)(1992-9#1)(1994-9#1)(1995-10#1)(1995-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2008-10#1)
the rate equations##2##3##(2008-2#2)
the rate for the##2##4##(1995-5#1)(1995-6#1)
the rate for##9##3##(1991-2#1)(1991-8#1)(1994-2#1)(1995-5#1)(1995-6#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-9#1)
the rate in##7##3##(1991-5#1)(1993-11#1)(1994-12#1)(1997-7#1)(2008-10#2)(2008-11#1)
the rate is##4##3##(1997-6#2)(2006-11#1)(2008-10#1)
the rate limiting enzyme in the##2##6##(1994-6#1)(2008-4#1)
the rate limiting enzyme of##2##5##(1993-3#1)(1995-12#1)
the rate limiting enzyme##4##4##(1993-3#1)(1994-6#1)(1995-12#1)(2008-4#1)
the rate limiting step in##2##5##(1997-4#1)(2008-5#1)
the rate limiting step##3##4##(1994-9#1)(1997-4#1)(2008-5#1)
the rate limiting##10##3##(1993-12#1)(1993-3#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-12#1)(1997-4#1)(2008-4#1)(2008-5#1)(2013-1#1)
the rate monotonic algorithm##2##4##(2008-2#2)
the rate of ATP synthesis##3##5##(1991-2#1)(1996-7#1)(1996-9#1)
the rate of ATP##6##4##(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#1)(1996-7#1)(1996-9#1)
the rate of DNA synthesis##2##5##(1994-6#1)(1995-5#1)
the rate of DNA##8##4##(1990-2#2)(1992-11#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-5#1)(1996-7#1)
the rate of Fe(II) uptake##3##5##(1992-4#1)(1996-2#2)
the rate of accumulation##2##4##(2006-9#2)
the rate of acute##3##4##(2006-10#1)(2007-11#1)(2013-1#1)
the rate of adverse events##2##5##(1992-4#1)(2008-8#1)
the rate of aging##2##4##(2008-9#1)(2009-5#1)
the rate of apoptosis##2##4##(1991-12#1)(1995-12#1)
the rate of aspartate##2##4##(1990-7#1)(1991-3#1)
the rate of catecholamine##2##4##(1990-2#1)(1990-6#1)
the rate of cell##4##4##(1995-5#1)(1995-7#1)(1996-12#1)(1996-5#1)
the rate of cellular##3##4##(1996-11#1)(1997-8#1)(2011-2#1)
the rate of change of kinetic energy##2##7##(2007-4#2)
the rate of change of##6##5##(2006-3#1)(2007-4#2)(2008-8#1)(2009-6#1)(2012-12#1)
the rate of change##8##4##(2006-3#1)(2007-4#2)(2007-8#1)(2008-8#2)(2009-6#1)(2012-12#1)
the rate of cholesterol synthesis##2##5##(1992-2#1)(1994-8#1)
the rate of complex formation##2##5##(1995-5#1)(2008-10#1)
the rate of complications##5##4##(1990-12#1)(1990-9#1)(2010-7#1)(2013-1#1)(2013-7#1)
the rate of convergence of the##2##6##(1996-8#1)(2008-2#1)
the rate of convergence##4##4##(1996-8#1)(2008-2#2)(2008-7#1)
the rate of conversion of##2##5##(1995-10#1)(2008-5#1)
the rate of conversion##3##4##(1995-10#1)(2008-10#1)(2008-5#1)
the rate of decay##2##4##(1991-2#1)(1993-12#1)
the rate of decline##3##4##(1994-6#1)(2008-7#1)(2010-8#1)
the rate of degradation of##5##5##(1990-11#1)(1990-5#1)(1992-12#1)(1992-5#1)(2008-10#1)
the rate of degradation##6##4##(1990-11#1)(1990-5#1)(1991-7#1)(1992-12#1)(1992-5#1)(2008-10#1)
the rate of depressive##2##4##(2008-6#1)(2013-1#1)
the rate of detection of##3##5##(2006-9#1)(2007-12#1)(2008-1#1)
the rate of development##2##4##(2008-8#1)(2008-9#1)
the rate of disease progression##3##5##(2004-11#1)(2008-10#1)(2012-2#1)
the rate of disease##6##4##(2004-11#1)(2007-11#1)(2008-10#3)(2012-2#1)
the rate of dissociation of the##2##6##(1994-12#1)(1994-9#1)
the rate of dissociation of##4##5##(1990-7#1)(1994-12#1)(1994-9#1)(1995-10#1)
the rate of dissociation##6##4##(1990-7#1)(1994-12#1)(1994-9#1)(1995-10#2)(1995-11#1)
the rate of early##2##4##(1991-9#1)(2006-7#1)
the rate of efflux of##2##5##(1991-1#1)(1992-5#1)
the rate of electron transfer##2##5##(1991-2#1)(1995-8#1)
the rate of enzymatic hydrolysis##2##5##(2008-7#1)(2013-1#1)
the rate of ethanol##2##4##(2005-9#1)(2008-7#1)
the rate of failure##2##4##(1991-8#1)(2004-9#1)
the rate of formation of the##4##6##(1991-2#2)(1991-7#1)(2008-5#1)
the rate of formation of##9##5##(1991-2#2)(1991-6#1)(1991-7#1)(1992-12#2)(1993-11#1)(1994-3#1)(2008-5#1)
the rate of formation##10##4##(1991-2#2)(1991-6#1)(1991-7#1)(1992-12#2)(1993-11#1)(1994-3#1)(2007-11#1)(2008-5#1)
the rate of full thickness##2##5##(2009-9#2)
the rate of germination##2##4##(2004-2#1)(2008-10#1)
the rate of gluconeogenesis##2##4##(1991-3#1)(1994-8#1)
the rate of glucose##2##4##(2008-11#1)(2008-6#1)
the rate of growth and##2##5##(2009-6#1)(2011-1#1)
the rate of growth in##3##5##(1990-12#1)(1992-2#1)(2013-7#1)
the rate of growth of##3##5##(1990-7#1)(2005-10#1)(2012-2#1)
the rate of growth##11##4##(1990-12#1)(1990-7#1)(1992-2#1)(2005-10#1)(2007-12#2)(2009-6#1)(2011-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
the rate of hydrolysis of the##2##6##(1992-5#1)(2009-4#1)
the rate of hydrolysis of##6##5##(1990-5#1)(1992-5#1)(1993-6#1)(1994-11#1)(2009-4#1)(2010-8#1)
the rate of hydrolysis##10##4##(1990-11#1)(1990-5#1)(1992-12#1)(1992-5#1)(1993-6#2)(1994-11#1)(2009-4#1)(2010-8#1)(2013-1#1)
the rate of inactivation##5##4##(1992-12#1)(1993-11#2)(1994-9#1)(1995-1#1)
the rate of incorporation of##3##5##(1991-12#1)(1997-1#1)(2008-1#1)
the rate of incorporation##4##4##(1991-12#1)(1996-7#1)(1997-1#1)(2008-1#1)
the rate of increase in##4##5##(1990-7#1)(1993-12#1)(2007-8#1)(2008-9#1)
the rate of increase of the DNR fluorescence intensity in the##2##11##(1996-1#2)
the rate of increase of##3##5##(1996-1#2)(2008-10#1)
the rate of increase##9##4##(1990-7#1)(1993-12#1)(1993-3#1)(1996-1#2)(2006-10#1)(2007-8#1)(2008-10#1)(2008-9#1)
the rate of induced abortion among##2##6##(1991-8#2)
the rate of induced abortion for unmarried women##2##8##(1991-8#2)
the rate of induced abortion##5##5##(1991-8#5)
the rate of infection##4##4##(2007-10#1)(2008-10#2)(2009-9#1)
the rate of infusion##2##4##(1990-4#1)(2008-7#1)
the rate of insulin##2##4##(1994-11#1)(2011-1#1)
the rate of interconversion##2##4##(1995-11#2)
the rate of late##2##4##(2006-10#1)(2007-11#1)
the rate of local##2##4##(2007-8#1)(2008-6#1)
the rate of lysis of fibrin thrombi and##2##8##(1990-12#2)
the rate of lysis of##3##5##(1990-12#3)
the rate of minors' abortions per 1000##2##7##(1994-2#2)
the rate of neonatal cord blood HBV-DNA##2##7##(2011-1#2)
the rate of new##4##4##(2007-11#1)(2007-5#1)(2010-5#1)(2013-1#1)
the rate of occurrence of##2##5##(1991-9#1)(1996-4#1)
the rate of oxygen consumption##3##5##(2008-10#1)(2009-6#1)(2010-11#1)
the rate of oxygen##4##4##(2008-10#1)(2008-5#1)(2009-6#1)(2010-11#1)
the rate of phosphodiester bond formation##2##6##(1996-7#2)
the rate of phosphorylation of the glycine receptor by##2##9##(1992-11#2)
the rate of photoinhibition is##2##5##(1995-8#2)
the rate of platelet aggregation was##2##6##(1995-12#2)
the rate of population##3##4##(1994-7#1)(2008-10#1)(2012-2#1)
the rate of primary##3##4##(2008-10#2)(2008-7#1)
the rate of production of##2##5##(1993-9#1)(1996-5#1)
the rate of progression##3##4##(1991-8#1)(2005-7#1)(2011-3#1)
the rate of proliferation##2##4##(1995-5#1)(1995-6#1)
the rate of protein synthesis##3##5##(1990-3#1)(1994-6#1)(1995-6#1)
the rate of protein##9##4##(1990-11#1)(1990-3#1)(1990-5#1)(1991-7#1)(1994-6#1)(1995-1#1)(1995-6#2)(2008-4#1)
the rate of pustule appearance##2##5##(2008-10#2)
the rate of reaction between the##2##6##(1997-4#1)(1997-7#1)
the rate of reaction##5##4##(1995-10#1)(1995-5#1)(1997-4#1)(1997-7#1)(2008-10#1)
the rate of recovery of##2##5##(2008-11#1)(2008-5#1)
the rate of recovery##4##4##(1992-9#1)(2008-11#1)(2008-12#1)(2008-5#1)
the rate of recurrence##3##4##(2006-6#1)(2008-10#1)(2013-8#1)
the rate of reduction of##3##5##(1991-10#1)(1991-12#1)(2008-10#1)
the rate of reduction##5##4##(1991-10#1)(1991-12#1)(1993-4#1)(2006-3#1)(2008-10#1)
the rate of release of 11-KT##3##6##(2010-8#3)
the rate of release of##7##5##(1991-2#1)(1991-7#1)(1992-3#1)(2010-8#4)
the rate of release##9##4##(1991-2#1)(1991-7#1)(1992-3#1)(2008-10#1)(2010-8#4)(2011-2#1)
the rate of replication##2##4##(2008-8#2)
the rate of reported##2##4##(2006-10#1)(2013-8#1)
the rate of resolution in##2##5##(2006-10#2)
the rate of responding##3##4##(1993-6#1)(1996-10#1)(1997-7#1)
the rate of restenosis##5##4##(1994-11#2)(2007-11#1)(2008-11#1)(2010-5#1)
the rate of rotation of##2##5##(1997-1#1)(2008-3#1)
the rate of secondary##2##4##(2007-10#1)(2008-10#1)
the rate of secretion##3##4##(1990-8#1)(1991-6#1)(1993-9#1)
the rate of signal##2##4##(1995-3#1)(2008-3#1)
the rate of splicing##3##4##(1991-2#1)(1997-4#2)
the rate of spontaneous##3##4##(1991-2#1)(1993-3#1)(1994-3#1)
the rate of state 3 respiration##2##6##(1994-12#2)
the rate of stillbirth and death##2##6##(1993-1#2)
the rate of substrate##2##4##(1990-3#1)(1995-10#1)
the rate of surface##3##4##(2007-7#1)(2008-4#1)(2009-12#1)
the rate of the increase##2##5##(1994-8#1)(2008-10#1)
the rate of the propagation period##2##6##(1991-12#2)
the rate of the release of##2##6##(1990-12#1)(2008-12#1)
the rate of the##27##4##(1990-12#1)(1990-7#1)(1991-12#2)(1992-1#2)(1992-12#1)(1994-6#1)(1994-8#1)(1996-5#1)(1997-4#1)(2005-11#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2011-1#2)(2013-1#1)
the rate of their##2##4##(2007-11#1)(2007-7#1)
the rate of transcription of the two genes##2##8##(1991-2#2)
the rate of transcription of the##5##6##(1991-2#2)(1991-7#1)(1992-1#1)(1992-12#1)
the rate of transcription of##6##5##(1991-2#2)(1991-7#1)(1992-1#1)(1992-12#1)(1996-8#1)
the rate of transcription##9##4##(1990-7#1)(1991-2#2)(1991-7#1)(1992-1#1)(1992-12#1)(1994-9#1)(1996-8#2)
the rate of transfer##2##4##(1993-3#1)(2010-5#1)
the rate of transport##4##4##(1995-11#1)(1997-8#1)(2008-10#2)
the rate of tumor##3##4##(1990-7#1)(1993-7#1)(2013-1#1)
the rate of turnover of##2##5##(1995-3#1)(2008-4#1)
the rate of unfolding##3##4##(1992-6#1)(1993-6#1)(2008-4#1)
the rate of uptake and##2##5##(1995-11#1)(2008-10#1)
the rate of uptake##3##4##(1995-11#1)(2008-10#1)(2008-7#1)
the rate of water##3##4##(2007-7#2)(2009-5#1)
the rate of wound##2##4##(2008-10#1)(2008-11#1)
the rate of xylose##2##4##(2008-5#1)(2008-6#1)
the rate of##705##3##(1990-11#7)(1990-12#10)(1990-2#5)(1990-3#8)(1990-4#1)(1990-5#4)(1990-6#4)(1990-7#10)(1990-8#3)(1990-9#2)(1991-1#3)(1991-10#4)(1991-11#1)(1991-12#10)(1991-2#11)(1991-3#2)(1991-4#2)(1991-5#3)(1991-6#2)(1991-7#7)(1991-8#8)(1991-9#4)(1992-1#4)(1992-10#1)(1992-11#7)(1992-12#8)(1992-2#3)(1992-3#1)(1992-4#3)(1992-5#5)(1992-6#4)(1992-7#1)(1992-8#1)(1992-9#3)(1993-1#2)(1993-10#1)(1993-11#9)(1993-12#2)(1993-3#5)(1993-4#1)(1993-5#1)(1993-6#4)(1993-7#1)(1993-8#2)(1993-9#3)(1994-11#9)(1994-12#6)(1994-2#2)(1994-3#5)(1994-5#2)(1994-6#6)(1994-7#2)(1994-8#11)(1994-9#6)(1995-1#4)(1995-10#5)(1995-11#7)(1995-12#5)(1995-2#2)(1995-3#6)(1995-4#1)(1995-5#5)(1995-6#7)(1995-7#1)(1995-8#4)(1995-9#1)(1996-1#2)(1996-10#2)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#6)(1996-6#1)(1996-7#5)(1996-8#5)(1996-9#4)(1997-1#5)(1997-2#2)(1997-4#9)(1997-6#1)(1997-7#3)(1997-8#4)(2003-11#1)(2004-11#2)(2004-2#1)(2004-9#2)(2005-10#1)(2005-11#5)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#12)(2006-3#2)(2006-4#2)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#3)(2007-1#3)(2007-10#10)(2007-11#14)(2007-12#9)(2007-2#3)(2007-3#3)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#7)(2008-1#7)(2008-10#57)(2008-11#10)(2008-12#6)(2008-2#4)(2008-3#4)(2008-4#8)(2008-5#14)(2008-6#7)(2008-7#15)(2008-8#13)(2008-9#4)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#4)(2009-6#3)(2009-8#2)(2009-9#3)(2010-10#1)(2010-11#4)(2010-12#3)(2010-2#3)(2010-4#2)(2010-5#4)(2010-7#1)(2010-8#8)(2011-1#12)(2011-12#1)(2011-2#13)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#12)(2012-3#8)(2013-1#10)(2013-7#3)(2013-8#8)
the rate ratio##2##3##(1991-9#1)(1994-7#1)
the rate was##2##3##(2006-3#1)(2007-5#1)
the rate##882##2##(1990-11#7)(1990-12#11)(1990-2#6)(1990-3#9)(1990-4#1)(1990-5#4)(1990-6#5)(1990-7#14)(1990-8#4)(1990-9#3)(1991-1#4)(1991-10#4)(1991-11#1)(1991-12#11)(1991-2#14)(1991-3#2)(1991-4#2)(1991-5#4)(1991-6#2)(1991-7#7)(1991-8#10)(1991-9#5)(1992-1#5)(1992-10#1)(1992-11#8)(1992-12#8)(1992-2#3)(1992-3#1)(1992-4#3)(1992-5#6)(1992-6#10)(1992-7#1)(1992-8#3)(1992-9#4)(1993-1#2)(1993-10#1)(1993-11#10)(1993-12#4)(1993-3#6)(1993-4#1)(1993-5#1)(1993-6#5)(1993-7#2)(1993-8#3)(1993-9#3)(1994-11#10)(1994-12#14)(1994-2#3)(1994-3#5)(1994-5#2)(1994-6#7)(1994-7#4)(1994-8#12)(1994-9#8)(1995-1#6)(1995-10#6)(1995-11#7)(1995-12#6)(1995-2#5)(1995-3#6)(1995-4#1)(1995-5#6)(1995-6#10)(1995-7#1)(1995-8#5)(1995-9#2)(1996-1#3)(1996-10#2)(1996-11#2)(1996-12#3)(1996-2#3)(1996-3#1)(1996-4#3)(1996-5#7)(1996-6#1)(1996-7#6)(1996-8#5)(1996-9#5)(1997-1#6)(1997-2#3)(1997-3#3)(1997-4#14)(1997-6#4)(1997-7#5)(1997-8#6)(2003-11#1)(2004-11#2)(2004-2#1)(2004-9#2)(2005-10#1)(2005-11#8)(2005-12#1)(2005-7#3)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#14)(2006-11#3)(2006-3#3)(2006-4#3)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#5)(2007-1#3)(2007-10#12)(2007-11#15)(2007-12#10)(2007-2#3)(2007-3#3)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#7)(2007-8#8)(2007-9#1)(2008-1#8)(2008-10#77)(2008-11#12)(2008-12#6)(2008-2#8)(2008-3#5)(2008-4#11)(2008-5#19)(2008-6#8)(2008-7#19)(2008-8#21)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#4)(2009-6#3)(2009-8#2)(2009-9#3)(2010-10#1)(2010-11#4)(2010-12#5)(2010-2#4)(2010-4#2)(2010-5#4)(2010-7#1)(2010-8#9)(2010-9#1)(2011-1#12)(2011-12#2)(2011-2#16)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#12)(2012-3#9)(2013-1#13)(2013-7#3)(2013-8#9)
the rate-determining step##3##3##(1994-8#1)(1995-4#1)(2008-10#1)
the rate-determining steps##2##3##(1995-4#1)(1997-7#1)
the rate-determining##5##2##(1994-8#1)(1995-4#2)(1997-7#1)(2008-10#1)
the rate-distortion##2##2##(2008-2#2)
the rate-limiting enzyme in de novo##2##6##(1994-11#1)(2007-11#1)
the rate-limiting enzyme in the##6##5##(1991-9#1)(1994-8#1)(1997-5#1)(2005-9#1)(2010-2#1)(2012-2#1)
the rate-limiting enzyme in##10##4##(1990-4#1)(1991-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1997-5#1)(2005-9#1)(2007-11#1)(2010-2#1)(2012-2#1)
the rate-limiting enzyme##11##3##(1990-4#1)(1991-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1997-5#1)(2005-9#1)(2007-11#1)(2010-2#1)(2012-2#2)
the rate-limiting step in hepatic gluconeogenesis##2##6##(1995-6#1)(1996-2#1)
the rate-limiting step in the##4##5##(1992-6#2)(1994-12#1)(2013-1#1)
the rate-limiting step in##10##4##(1990-2#1)(1991-5#1)(1992-6#2)(1994-12#1)(1995-1#1)(1995-10#1)(1995-6#1)(1996-2#1)(2013-1#1)
the rate-limiting step of##6##4##(1992-12#2)(1997-4#1)(2012-2#3)
the rate-limiting step##27##3##(1990-2#2)(1990-5#1)(1991-5#1)(1991-7#1)(1992-12#2)(1992-6#2)(1994-12#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-12#1)(2008-1#1)(2008-5#1)(2008-6#1)(2012-2#3)(2013-1#1)
the rate-limiting##47##2##(1990-2#4)(1990-4#1)(1990-5#1)(1991-5#2)(1991-7#2)(1991-9#2)(1992-12#2)(1992-3#1)(1992-6#4)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-4#1)(1997-5#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-12#1)(2007-11#1)(2008-1#1)(2008-5#1)(2008-6#1)(2010-2#1)(2012-2#5)(2013-1#1)
the rated##2##2##(2007-5#1)(2007-6#1)
the ratemeter##3##2##(1996-2#3)
the ratemeter's##2##2##(1996-2#2)
the rater##2##2##(2006-10#2)
the rates and the##2##4##(1990-5#1)(1990-8#1)
the rates and##6##3##(1990-5#1)(1990-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
the rates are##4##3##(1995-5#1)(2008-11#1)(2008-4#1)(2010-9#1)
the rates at which##3##4##(1992-12#1)(2007-8#1)(2013-8#1)
the rates in##2##3##(1997-7#1)(2005-8#1)
the rates of Fe(II)##2##4##(1992-4#1)(1996-2#1)
the rates of Si increased in the soil##2##8##(2008-10#2)
the rates of formation##3##4##(1991-7#1)(2008-10#1)(2008-5#1)
the rates of growth##2##4##(1995-1#1)(2008-11#1)
the rates of incorporation of [(sup3)H]TdR##2##6##(2006-3#2)
the rates of incorporation of##3##5##(1996-7#1)(2006-3#2)
the rates of lactate production and pyruvate decarboxylation##2##8##(1991-5#2)
the rates of lactate production##3##5##(1991-5#3)
the rates of oxygen##2##4##(2008-11#1)(2010-5#1)
the rates of primary and secondary##3##6##(1996-12#1)(2008-10#2)
the rates of primary##4##4##(1996-12#1)(2008-10#2)(2011-2#1)
the rates of##93##3##(1990-11#1)(1990-2#1)(1990-5#2)(1991-5#3)(1991-7#3)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-4#2)(1992-7#2)(1993-11#1)(1993-4#1)(1994-11#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#4)(1996-12#2)(1996-2#3)(1996-4#1)(1996-7#1)(1996-9#1)(1997-8#1)(2005-11#2)(2005-4#1)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-5#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#2)
the rates were##3##3##(1990-2#1)(1991-2#1)(2004-1#1)
the rates##124##2##(1990-11#1)(1990-2#3)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#3)(1991-7#3)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#4)(1992-4#2)(1992-5#1)(1992-7#2)(1993-11#1)(1993-4#1)(1994-11#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#4)(1996-12#2)(1996-2#3)(1996-4#2)(1996-7#1)(1996-9#2)(1997-7#1)(1997-8#1)(2004-1#1)(2005-11#2)(2005-4#1)(2005-8#1)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#5)(2008-4#1)(2008-5#5)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-9#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#3)
the rather##9##2##(1991-5#1)(1993-8#1)(1996-5#1)(1997-8#1)(2005-4#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)
the rating##6##2##(1996-5#1)(1997-3#1)(2007-6#2)(2012-2#1)(2013-7#1)
the ratings of the##2##4##(1991-6#1)(1992-4#1)
the ratings of##4##3##(1991-6#1)(1992-4#1)(1997-8#1)(2004-11#1)
the ratio 1##9##3##(1990-2#1)(1994-3#1)(2008-10#6)(2008-3#1)
the ratio before average##2##4##(2008-2#2)
the ratio between the fluorescence##2##5##(2007-11#1)(2008-10#1)
the ratio between the##18##4##(1991-2#1)(1991-5#1)(2004-9#1)(2007-11#1)(2007-12#3)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2013-1#1)
the ratio between##33##3##(1991-2#1)(1991-5#1)(1993-2#1)(1994-6#1)(1995-11#1)(2004-9#1)(2005-11#2)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#3)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2012-3#1)(2013-1#2)(2013-8#1)
the ratio derivative##2##3##(2008-10#2)
the ratio in the##3##4##(1991-1#1)(1997-2#2)
the ratio in##4##3##(1991-1#1)(1992-3#1)(1997-2#2)
the ratio index##3##3##(1994-5#2)(1996-5#1)
the ratio of CD11b(+)Gr1(+) cells##2##5##(2013-8#2)
the ratio of IC50##2##4##(1993-4#1)(1996-5#1)
the ratio of activity##3##4##(1991-2#1)(1992-11#1)(1996-1#1)
the ratio of apoptotic cells##2##5##(2008-11#1)(2012-1#1)
the ratio of cholesterol to##2##5##(1991-9#1)(1997-1#1)
the ratio of each##2##4##(2008-10#1)(2008-5#1)
the ratio of fast to slow##2##6##(1993-2#1)(2008-3#1)
the ratio of fasting glucose##2##5##(1992-6#1)(2005-8#1)
the ratio of fos immunoreactive cells to Nissl-stained neurons##2##9##(2006-8#2)
the ratio of male to female##2##6##(1993-9#1)(2008-3#1)
the ratio of polyunsaturated##3##4##(1997-7#1)(2010-4#2)
the ratio of rms roughness##2##5##(2008-2#2)
the ratio of sample##2##4##(1995-1#1)(2008-10#1)
the ratio of serum##2##4##(2007-8#1)(2012-12#1)
the ratio of the area of##2##6##(1995-8#1)(2008-4#1)
the ratio of the number of##4##6##(1993-9#1)(2008-11#1)(2010-8#1)(2013-8#1)
the ratio of the particle radius##2##6##(2005-11#2)
the ratio of the total##3##5##(2007-9#1)(2010-8#1)(2012-1#1)
the ratio of the##81##4##(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-6#1)(1992-7#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-8#1)(1995-5#2)(1995-8#1)(1996-5#1)(1996-9#1)(2004-12#3)(2005-11#4)(2006-10#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#10)(2007-9#1)(2008-10#11)(2008-11#1)(2008-2#7)(2008-3#9)(2008-4#2)(2008-5#3)(2008-8#1)(2010-10#1)(2010-8#2)(2012-1#2)(2012-11#1)(2012-2#1)(2013-8#1)
the ratio of their##2##4##(2008-3#1)(2008-5#1)
the ratio of total##2##4##(1990-5#1)(2008-3#1)
the ratio of##279##3##(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-6#3)(1992-7#1)(1993-12#3)(1993-2#1)(1993-4#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-12#8)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#3)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#2)(2004-12#3)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#6)(2005-12#1)(2005-4#1)(2005-8#1)(2006-10#2)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#5)(2006-9#2)(2007-11#4)(2007-12#14)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#34)(2008-11#9)(2008-12#1)(2008-2#12)(2008-3#20)(2008-4#3)(2008-5#11)(2008-6#2)(2008-8#2)(2008-9#2)(2009-2#1)(2010-10#1)(2010-4#4)(2010-6#1)(2010-8#4)(2011-1#5)(2011-12#2)(2011-2#2)(2011-3#2)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#1)(2012-7#1)(2013-1#3)(2013-8#4)
the ratio was##2##3##(2008-8#1)(2012-11#1)
the ratio##388##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#1)(1990-8#1)(1990-9#2)(1991-1#3)(1991-10#2)(1991-11#1)(1991-12#6)(1991-2#4)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#3)(1992-7#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-4#2)(1993-6#2)(1993-8#2)(1993-9#2)(1994-10#1)(1994-12#8)(1994-2#2)(1994-3#3)(1994-5#3)(1994-6#2)(1994-8#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#3)(1996-5#3)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#3)(1997-6#1)(1997-7#2)(1997-8#2)(2004-12#3)(2004-4#1)(2004-9#2)(2005-1#1)(2005-10#1)(2005-11#8)(2005-12#1)(2005-4#1)(2005-8#2)(2006-10#3)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#5)(2006-9#2)(2007-10#1)(2007-11#6)(2007-12#17)(2007-3#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#67)(2008-11#12)(2008-12#1)(2008-2#21)(2008-3#24)(2008-4#3)(2008-5#14)(2008-6#3)(2008-8#3)(2008-9#3)(2009-1#1)(2009-2#1)(2010-10#1)(2010-2#1)(2010-4#4)(2010-6#1)(2010-8#4)(2011-1#5)(2011-12#2)(2011-2#4)(2011-3#2)(2012-1#3)(2012-11#2)(2012-12#3)(2012-2#5)(2012-3#2)(2012-7#1)(2013-1#5)(2013-8#6)
the rational design of##9##4##(1992-10#1)(1995-1#1)(2006-10#1)(2007-6#1)(2008-10#1)(2008-11#1)(2009-9#1)(2011-1#1)(2013-7#1)
the rational design##10##3##(1992-10#1)(1995-1#1)(2006-10#2)(2007-6#1)(2008-10#1)(2008-11#1)(2009-9#1)(2011-1#1)(2013-7#1)
the rational use of medicines##2##5##(2006-2#2)
the rational use of##8##4##(1995-2#1)(1995-9#1)(1996-1#1)(2006-10#1)(2006-2#3)(2010-1#1)
the rational##30##2##(1992-1#1)(1992-10#1)(1992-5#1)(1995-1#2)(1995-2#1)(1995-9#1)(1996-1#1)(1996-3#1)(2006-10#3)(2006-2#3)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-1#2)(2013-7#1)
the rationale and##6##3##(2005-10#1)(2005-8#1)(2008-7#1)(2010-11#1)(2011-1#1)(2012-2#1)
the rationale behind the##2##4##(1995-2#1)(2007-10#1)
the rationale behind##7##3##(1995-2#1)(2007-10#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#2)
the rationale for a##4##4##(1991-6#1)(1996-10#1)(2010-11#1)(2010-5#1)
the rationale for and##3##4##(2006-9#1)(2008-3#1)(2009-6#1)
the rationale for choosing##2##4##(2005-7#1)(2008-4#1)
the rationale for its use##2##5##(1996-9#1)(2005-11#1)
the rationale for its##3##4##(1996-9#1)(2005-11#1)(2006-12#1)
the rationale for such##2##4##(2008-7#1)(2009-4#1)
the rationale for targeting##2##4##(2005-11#1)(2008-6#1)
the rationale for the development of##2##6##(2006-10#1)(2006-6#1)
the rationale for the##9##4##(2005-8#1)(2006-10#1)(2006-6#1)(2007-4#1)(2007-5#1)(2008-8#1)(2008-9#2)(2010-11#1)
the rationale for use##3##4##(1996-9#1)(1997-2#1)(2007-10#1)
the rationale for using##2##4##(2009-5#1)(2011-2#1)
the rationale for##48##3##(1991-6#1)(1992-2#1)(1993-1#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-9#2)(1997-2#1)(1997-3#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-4#1)(2007-5#2)(2008-1#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#2)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#1)
the rationale of##3##3##(2007-11#1)(2007-12#1)(2009-9#1)
the rationale##73##2##(1991-6#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-7#1)(1995-12#1)(1995-2#2)(1996-10#1)(1996-9#2)(1997-2#1)(1997-3#1)(2005-10#2)(2005-11#2)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#2)(2008-1#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#3)(2010-3#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)
the rationales##2##2##(2007-4#1)(2008-8#1)
the rationality of##2##3##(2009-2#1)(2010-7#1)
the rationalization##2##2##(2008-6#1)(2008-7#1)
the ratios in the##2##4##(1995-3#2)
the ratios in##3##3##(1992-3#1)(1995-3#2)
the ratios of##15##3##(1992-11#1)(1993-6#1)(1994-9#1)(1995-10#1)(1996-8#2)(2007-8#1)(2008-3#2)(2010-9#1)(2011-1#1)(2011-2#1)(2013-8#3)
the ratios were##2##3##(1992-9#1)(1996-2#1)
the ratios##31##2##(1991-12#1)(1991-7#2)(1992-11#1)(1992-3#1)(1992-9#1)(1993-6#1)(1994-9#1)(1995-10#1)(1995-3#2)(1996-2#1)(1996-8#2)(2005-11#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-8#3)
the rats and##4##3##(1996-10#1)(1997-2#3)
the rats in group##2##4##(1997-2#1)(2008-8#1)
the rats in the##3##4##(1990-10#1)(2011-2#2)
the rats in##6##3##(1990-10#1)(1993-4#1)(1997-2#1)(2008-8#1)(2011-2#2)
the rats increased##2##3##(1993-4#1)(2008-8#1)
the rats of##2##3##(1991-10#1)(2013-8#1)
the rats to##2##3##(1993-4#1)(2010-5#1)
the rats treated with##9##4##(1990-2#1)(1990-9#1)(2008-6#1)(2010-12#2)(2011-1#2)(2011-2#1)(2013-1#1)
the rats were decapitated and the##2##6##(1995-6#1)(1996-10#1)
the rats were given##2##4##(1993-2#1)(2008-4#1)
the rats were killed##2##4##(2007-9#1)(2008-10#1)
the rats were subjected to##2##5##(1997-1#1)(2013-1#1)
the rats were##19##3##(1991-6#1)(1993-2#1)(1995-6#1)(1996-10#1)(1997-1#1)(1997-2#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#3)(2013-1#3)(2013-8#1)
the rats which had##2##4##(1996-10#1)(1996-9#1)
the rats which##4##3##(1996-10#1)(1996-9#1)(1997-1#1)(1997-3#1)
the rats with##3##3##(1995-12#1)(1997-2#1)(2008-10#1)
the rats##99##2##(1990-10#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-7#2)(1992-9#1)(1993-12#1)(1993-2#2)(1993-4#3)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-2#2)(1994-5#1)(1995-12#2)(1995-3#2)(1995-6#1)(1996-10#4)(1996-11#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#2)(1997-2#12)(1997-3#1)(1997-8#2)(2004-11#1)(2007-9#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#2)(2010-12#3)(2010-5#1)(2011-1#2)(2011-2#6)(2012-2#2)(2013-1#6)(2013-8#2)
the rats'##4##2##(1991-1#1)(1992-7#1)(1994-6#1)(2011-3#1)
the rattlesnake##3##2##(1991-9#1)(1992-8#1)(1994-6#1)
the raw data##5##3##(1996-12#1)(1996-7#1)(2008-3#1)(2013-1#2)
the raw material##4##3##(2008-10#1)(2008-4#1)(2008-5#1)(2013-1#1)
the raw materials##7##3##(1994-3#2)(2008-10#4)(2012-3#1)
the raw##46##2##(1992-5#1)(1994-3#2)(1996-12#1)(1996-7#1)(2005-8#1)(2007-2#1)(2008-10#7)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#2)(2010-10#1)(2010-2#2)(2010-4#3)(2010-8#2)(2011-1#1)(2011-2#3)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#1)
the ray optics model##4##4##(2008-3#4)
the ray optics##7##3##(2008-2#1)(2008-3#6)
the ray trace##2##3##(2008-3#2)
the ray##15##2##(2008-2#3)(2008-3#11)(2013-8#1)
the ray-optics##4##2##(2008-1#1)(2008-3#3)
the ray-tracing##4##2##(2008-3#4)
the rays that are##2##4##(2007-11#1)(2007-12#1)
the rays##7##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)
the rbcS genes##2##3##(1993-12#2)
the rbcS##4##2##(1993-12#3)(1994-8#1)
the rbs##2##2##(2011-1#2)
the rcsB gene##2##3##(1991-7#2)
the rdo phenotype##2##3##(2008-9#2)
the rdo##3##2##(2008-9#3)
the re-emergence of cutaneous##2##4##(2011-2#1)(2012-12#1)
the re-emergence of##4##3##(2008-1#1)(2008-8#1)(2011-2#1)(2012-12#1)
the re-emerging##2##2##(2007-2#1)(2009-8#1)
the re-establishment of##4##3##(2008-5#1)(2008-6#1)(2012-12#1)(2013-1#1)
the re-establishment##5##2##(2008-5#1)(2008-6#1)(2012-12#2)(2013-1#1)
the re-estimation##2##2##(2008-5#1)(2008-6#1)
the re-proteins##2##2##(1997-4#2)
the reach of the##5##4##(2007-12#1)(2007-7#1)(2008-1#1)(2008-3#1)(2011-11#1)
the reach of##12##3##(1996-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-2#1)(2011-11#1)(2013-1#1)
the reach##17##2##(1994-3#1)(1996-1#1)(1996-3#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-2#1)(2011-11#1)(2011-2#1)(2013-1#1)
the reachability##2##2##(2006-10#1)(2006-6#1)
the reaching##5##2##(1992-9#1)(1996-2#1)(2008-4#2)(2008-6#1)
the reactant addition rate##2##4##(2004-9#2)
the reactant and the##2##4##(2006-3#1)(2008-5#1)
the reactant##14##2##(1993-6#1)(1997-8#1)(2004-12#1)(2004-9#2)(2005-11#1)(2006-3#1)(2008-3#1)(2008-5#2)(2013-8#4)
the reactants and##2##3##(1990-7#1)(2008-10#1)
the reactants are##2##3##(1990-7#1)(2008-10#1)
the reactants##14##2##(1990-7#3)(1994-9#1)(1996-2#1)(1997-1#1)(2005-11#1)(2007-11#1)(2008-10#3)(2009-11#1)(2010-12#1)(2013-8#1)
the reacted##3##2##(1992-9#1)(2008-10#2)
the reaction and the##3##4##(1990-2#1)(2007-5#1)(2008-10#1)
the reaction and##11##3##(1990-2#1)(1991-7#1)(1996-5#1)(2006-8#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-5#1)(2009-2#1)(2010-7#1)
the reaction are##3##3##(1993-4#1)(2006-10#1)(2008-10#1)
the reaction at the##2##4##(1994-6#1)(2008-10#1)
the reaction at##4##3##(1990-2#1)(1994-6#1)(2006-12#1)(2008-10#1)
the reaction between the analytes and##3##6##(2008-10#3)
the reaction between the##6##4##(2007-11#1)(2008-10#5)
the reaction between##47##3##(1990-12#1)(1990-5#1)(1994-5#1)(1997-3#1)(2004-9#1)(2005-11#1)(2006-12#1)(2007-11#3)(2008-10#34)(2008-5#1)(2010-4#1)(2011-2#1)
the reaction by##7##3##(1993-6#1)(1995-1#1)(1995-11#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-9#1)
the reaction catalysed by##3##4##(1991-5#1)(1993-2#1)(1995-6#1)
the reaction catalyzed by##4##4##(1992-3#1)(1994-8#2)(2008-10#1)
the reaction catalyzed##5##3##(1992-3#1)(1994-8#3)(2008-10#1)
the reaction cell##2##3##(2007-8#1)(2008-10#1)
the reaction center complex##2##4##(1991-7#1)(1997-7#1)
the reaction center##11##3##(1991-7#1)(1991-8#1)(1992-3#2)(1993-11#1)(1993-8#1)(1994-8#1)(1995-8#1)(1997-4#1)(1997-7#1)(2008-8#1)
the reaction centre##2##3##(2008-10#2)
the reaction coil##3##3##(2008-10#3)
the reaction conditions##18##3##(1992-12#1)(1995-10#1)(1996-2#2)(1997-2#1)(2005-11#1)(2005-7#1)(2007-11#1)(2008-10#7)(2008-7#1)(2009-3#1)(2013-8#1)
the reaction coordinate##2##3##(1991-8#1)(2012-2#1)
the reaction cycle##2##3##(1995-6#1)(1997-4#1)
the reaction field method##2##4##(2013-1#2)
the reaction field##5##3##(2007-11#1)(2008-10#1)(2010-12#1)(2013-1#2)
the reaction from##2##3##(2012-1#1)(2013-1#1)
the reaction has##2##3##(2008-10#1)(2008-4#1)
the reaction in##3##3##(2006-10#1)(2007-11#1)(2008-10#1)
the reaction intermediates##2##3##(2006-10#1)(2009-9#1)
the reaction involving##2##3##(2005-11#1)(2008-10#1)
the reaction is##21##3##(1990-2#1)(1991-7#2)(1992-3#1)(1994-12#1)(1995-3#1)(1996-5#1)(1996-6#1)(2007-10#1)(2008-10#10)(2009-10#1)(2011-1#1)
the reaction loads##3##3##(2007-1#2)(2007-4#1)
the reaction mechanism of##2##4##(1990-5#1)(1995-6#1)
the reaction mechanism##6##3##(1990-5#1)(1994-2#1)(1995-6#1)(2007-11#1)(2008-10#2)
the reaction mechanisms##5##3##(1992-8#1)(2006-5#1)(2007-11#1)(2008-10#2)
the reaction media##2##3##(2008-10#2)
the reaction medium and##3##4##(2007-6#1)(2008-10#2)
the reaction medium##16##3##(1991-7#1)(1995-1#1)(1996-5#1)(2007-6#1)(2008-10#9)(2008-7#2)(2010-5#1)
the reaction mixture was##3##4##(1994-2#1)(2008-10#1)(2010-4#1)
the reaction mixture##30##3##(1991-12#1)(1991-2#1)(1991-3#2)(1992-1#1)(1992-9#1)(1993-2#1)(1994-12#1)(1994-2#2)(1994-5#2)(1994-9#1)(1996-8#1)(2005-12#1)(2006-12#1)(2007-8#1)(2008-10#6)(2008-4#2)(2008-5#1)(2008-8#1)(2010-4#1)(2013-8#2)
the reaction mixtures##5##3##(1990-12#1)(1991-10#1)(2007-10#1)(2008-10#2)
the reaction model##2##3##(1990-10#2)
the reaction norm##2##3##(2008-10#1)(2008-8#1)
the reaction of 1##2##4##(2008-10#1)(2008-5#1)
the reaction of 3##2##4##(2007-11#2)
the reaction of 4 with##2##5##(1996-5#1)(2005-7#1)
the reaction of DNA##2##4##(2005-4#1)(2008-7#1)
the reaction of an##3##4##(2006-9#1)(2007-11#1)(2012-11#1)
the reaction of cobalt##2##4##(2008-10#2)
the reaction of compound 1 with##2##6##(2007-11#2)
the reaction of enzyme with##2##5##(1990-2#1)(1990-7#1)
the reaction of free##2##4##(1997-2#1)(1997-8#1)
the reaction of luminol with##4##5##(2008-10#4)
the reaction of luminol##5##4##(2008-10#5)
the reaction of mercury##2##4##(2008-10#2)
the reaction of pyruvate to form acetaldehyde##2##7##(1995-10#2)
the reaction of the##17##4##(1991-11#1)(1991-7#1)(1991-9#1)(1994-4#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#1)(2010-4#1)(2011-1#1)(2013-8#1)
the reaction of##165##3##(1990-11#1)(1990-2#2)(1990-5#2)(1990-7#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-7#2)(1991-9#3)(1992-7#1)(1992-9#1)(1993-11#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-4#1)(1994-5#3)(1994-6#3)(1994-8#1)(1995-1#2)(1995-10#2)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#2)(1996-5#4)(1996-8#1)(1997-2#2)(1997-8#3)(2004-9#1)(2005-10#1)(2005-11#2)(2005-4#2)(2005-7#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-11#12)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#65)(2008-3#1)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-3#1)(2010-4#1)(2011-1#3)(2012-11#2)(2013-1#1)(2013-8#2)
the reaction on##3##3##(1995-9#1)(2007-7#1)(2008-10#1)
the reaction pH##3##3##(1997-3#1)(2005-11#1)(2008-10#1)
the reaction pathway##7##3##(1991-9#1)(1995-2#1)(2005-11#1)(2008-1#1)(2008-7#1)(2010-6#2)
the reaction pathways##2##3##(1997-6#1)(2008-10#1)
the reaction proceeds##3##3##(1992-9#1)(1995-4#1)(2008-10#1)
the reaction process##2##3##(2006-12#1)(2008-10#1)
the reaction product##8##3##(1990-7#1)(1990-8#1)(1993-11#1)(1995-5#1)(1997-8#2)(2008-10#1)(2008-6#1)
the reaction products and by##2##5##(1991-1#1)(2010-12#1)
the reaction products by##2##4##(1991-8#1)(2008-4#1)
the reaction products was##2##4##(2008-10#1)(2008-4#1)
the reaction products were##2##4##(1994-6#1)(2007-10#1)
the reaction products##16##3##(1990-1#1)(1990-7#2)(1991-1#1)(1991-8#1)(1994-6#1)(1996-12#1)(2007-10#1)(2008-10#4)(2008-4#2)(2009-8#1)(2010-12#1)
the reaction rate is##4##4##(2006-11#2)(2008-10#1)(2008-7#1)
the reaction rate of##2##4##(1991-12#1)(2008-10#1)
the reaction rate was##3##4##(2008-10#2)(2008-7#1)
the reaction rate##18##3##(1990-7#1)(1991-12#1)(2006-11#2)(2006-12#1)(2007-11#1)(2008-10#6)(2008-7#3)(2010-6#1)(2010-7#1)(2011-2#1)
the reaction rates of##2##4##(2008-10#1)(2008-9#1)
the reaction rates##5##3##(2008-10#2)(2008-5#2)(2008-9#1)
the reaction sequence##2##3##(1990-3#2)
the reaction system##9##3##(1990-3#1)(2005-12#1)(2008-10#5)(2009-8#1)(2011-1#1)
the reaction temperature and##2##4##(2004-9#1)(2011-2#1)
the reaction temperature##6##3##(2004-9#1)(2008-10#2)(2010-4#2)(2011-2#1)
the reaction time of##2##4##(1996-2#1)(2008-10#1)
the reaction time##17##3##(1990-10#1)(1990-5#1)(1996-2#1)(1996-5#1)(2004-9#1)(2007-8#2)(2008-10#7)(2008-5#2)(2010-12#1)
the reaction times were always notably shortened##2##7##(2007-11#2)
the reaction to an##2##4##(2007-12#1)(2007-9#1)
the reaction to proceed##2##4##(2008-10#1)(2010-12#1)
the reaction to##8##3##(1990-11#1)(1993-5#1)(2007-12#1)(2007-9#1)(2008-10#3)(2010-12#1)
the reaction vessel##2##3##(2008-10#1)(2008-7#1)
the reaction was also##2##4##(2008-10#2)
the reaction was investigated##2##4##(2008-10#2)
the reaction was##20##3##(1990-1#1)(1990-2#1)(1990-6#1)(1992-12#1)(1994-11#1)(1994-12#1)(1995-10#1)(1995-8#1)(1996-2#1)(2005-12#1)(2007-11#1)(2008-10#6)(2008-5#1)(2008-8#1)(2013-8#1)
the reaction were##9##3##(1994-11#1)(1995-11#1)(1997-2#1)(2008-10#5)(2008-11#1)
the reaction with##19##3##(1992-3#1)(1994-9#1)(1996-9#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-10#10)(2008-11#2)(2008-5#1)
the reaction##707##2##(1990-1#3)(1990-10#3)(1990-11#2)(1990-12#2)(1990-2#7)(1990-3#3)(1990-5#6)(1990-6#1)(1990-7#7)(1990-8#1)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#4)(1991-2#3)(1991-3#2)(1991-5#3)(1991-7#8)(1991-8#3)(1991-9#4)(1992-1#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#6)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#4)(1993-11#3)(1993-2#3)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#4)(1993-8#3)(1993-9#1)(1994-11#4)(1994-12#5)(1994-2#6)(1994-3#1)(1994-4#1)(1994-5#8)(1994-6#6)(1994-8#6)(1994-9#2)(1995-1#7)(1995-10#5)(1995-11#2)(1995-2#4)(1995-3#2)(1995-4#2)(1995-5#2)(1995-6#5)(1995-8#2)(1995-9#1)(1996-12#1)(1996-2#6)(1996-3#2)(1996-5#9)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#2)(1997-6#4)(1997-7#3)(1997-8#5)(2004-9#5)(2005-10#2)(2005-11#8)(2005-12#3)(2005-4#2)(2005-7#2)(2005-8#1)(2006-10#11)(2006-11#2)(2006-12#5)(2006-4#1)(2006-5#2)(2006-8#1)(2006-9#1)(2007-1#3)(2007-10#5)(2007-11#29)(2007-12#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#7)(2007-9#1)(2008-1#2)(2008-10#247)(2008-11#4)(2008-2#3)(2008-3#1)(2008-4#11)(2008-5#25)(2008-6#4)(2008-7#12)(2008-8#7)(2008-9#4)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#3)(2009-8#2)(2009-9#1)(2010-12#5)(2010-4#6)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#2)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#11)
the reactions are##4##3##(1997-5#1)(2007-8#1)(2008-10#1)(2008-3#1)
the reactions between##2##3##(1991-4#1)(1996-2#1)
the reactions catalyzed by##2##4##(1990-5#1)(2006-12#1)
the reactions of CO##2##4##(1990-10#2)
the reactions of the##6##4##(1990-10#1)(1992-12#1)(1992-6#1)(2008-10#2)(2012-2#1)
the reactions of##35##3##(1990-10#4)(1991-4#1)(1991-7#1)(1992-12#1)(1992-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1996-2#1)(1997-2#1)(2005-4#1)(2006-12#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-8#1)(2010-5#1)(2012-2#1)(2012-3#1)
the reactions were##3##3##(2008-10#3)
the reactions which##2##3##(1992-6#1)(2010-2#1)
the reactions with##4##3##(1994-5#1)(1995-2#1)(1996-2#1)(2008-10#1)
the reactions##71##2##(1990-10#4)(1990-12#1)(1990-5#1)(1991-4#2)(1991-7#1)(1992-12#1)(1992-3#1)(1992-6#2)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-2#1)(1996-1#1)(1996-2#3)(1997-2#1)(1997-5#1)(2004-4#1)(2005-4#1)(2006-12#2)(2006-8#1)(2007-10#1)(2007-11#3)(2007-6#1)(2007-8#2)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-2#2)(2010-4#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-8#2)
the reactivated enzyme##2##3##(1997-4#2)
the reactivated##3##2##(1997-4#2)(2008-9#1)
the reactivation of##5##3##(2007-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)
the reactivation##8##2##(1995-6#1)(1995-8#1)(2007-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-12#1)
the reactive center##3##3##(1994-11#1)(1996-9#1)(2012-2#1)
the reactive intermediate##3##3##(1995-6#3)
the reactive oxygen species (ROS)##3##5##(2008-10#2)(2013-1#1)
the reactive oxygen species##5##4##(2008-10#2)(2011-2#1)(2013-1#2)
the reactive oxygen##7##3##(1993-6#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#2)
the reactive site##5##3##(1991-8#3)(1995-1#1)(1995-6#1)
the reactive species##4##3##(1992-12#1)(2008-10#1)(2008-3#1)(2013-1#1)
the reactive##51##2##(1990-12#1)(1991-8#3)(1992-12#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-6#4)(1995-7#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#1)(2006-3#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#5)(2013-8#1)
the reactivities##2##2##(1997-4#1)(2012-3#1)
the reactivity of the##13##4##(1991-8#1)(1992-9#1)(1995-12#1)(1996-2#1)(1996-5#1)(1997-7#1)(1997-8#2)(2008-10#2)(2010-5#1)(2012-2#1)(2013-1#1)
the reactivity of two##2##4##(1990-12#1)(1992-8#1)
the reactivity of##37##3##(1990-10#1)(1990-12#1)(1990-5#1)(1991-8#1)(1992-7#1)(1992-8#1)(1992-9#1)(1994-3#2)(1994-9#1)(1995-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-7#1)(1997-8#2)(2006-12#1)(2006-9#1)(2007-11#3)(2007-12#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#1)(2012-2#1)(2013-1#2)
the reactivity ratios were determined to be r(AGE) = 1##2##10##(2012-12#2)
the reactivity ratios were r(EGVGE) = 3##2##7##(2012-12#2)
the reactivity ratios were##4##4##(2012-12#4)
the reactivity with##2##3##(1991-7#1)(1994-5#1)
the reactivity##50##2##(1990-10#1)(1990-12#2)(1990-5#1)(1991-7#1)(1991-8#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-3#2)(1994-5#1)(1994-9#2)(1995-12#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-7#1)(1997-8#2)(2006-12#1)(2006-9#1)(2007-11#3)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#1)(2010-5#1)(2012-12#4)(2012-2#1)(2013-1#2)
the reactor and##3##3##(2008-11#1)(2008-5#1)(2008-7#1)
the reactor at a##2##4##(2004-8#1)(2008-11#1)
the reactor at##3##3##(2004-8#1)(2008-11#1)(2009-6#1)
the reactor##25##2##(1991-5#2)(2004-8#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#4)(2008-5#2)(2008-6#1)(2008-7#2)(2009-2#1)(2009-6#1)(2013-1#1)
the reactors##4##2##(2008-10#2)(2008-5#1)(2008-7#1)
the reacylation##2##2##(1990-2#1)(1991-7#1)
the read##2##2##(2008-3#1)(2012-3#1)
the readability and comprehensiveness of##2##5##(2011-1#2)
the readability of##2##3##(2013-7#2)
the readability##4##2##(2011-1#2)(2013-7#2)
the reader in##3##3##(1996-2#1)(2006-1#1)(2008-1#1)
the reader is referred to##2##5##(2008-5#1)(2009-3#1)
the reader is##3##3##(2008-4#1)(2008-5#1)(2009-3#1)
the reader should##4##3##(1992-2#1)(2008-7#3)
the reader through##2##3##(2008-12#1)(2009-4#1)
the reader to the##3##4##(2007-2#1)(2008-9#1)(2010-11#1)
the reader to##9##3##(2005-7#1)(2006-10#1)(2007-2#1)(2008-4#2)(2008-9#2)(2010-11#1)(2011-12#1)
the reader up-to-date on##2##4##(1992-2#1)(2012-3#1)
the reader will be able to##2##6##(2012-12#1)(2012-3#1)
the reader will##3##3##(2008-4#1)(2012-12#1)(2012-3#1)
the reader with a##2##4##(2009-5#1)(2011-2#1)
the reader with the##2##4##(2010-12#1)(2010-9#1)
the reader with##11##3##(1997-3#1)(2006-9#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-8#1)
the reader##49##2##(1992-2#2)(1994-8#1)(1996-2#1)(1997-1#1)(1997-3#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-9#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#4)(2008-5#2)(2008-7#4)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#2)
the reader's##2##2##(1997-3#1)(2012-11#1)
the readers of##2##3##(1991-3#1)(2008-10#1)
the readers##8##2##(1991-3#1)(1992-7#1)(2008-1#2)(2008-10#1)(2009-12#1)(2011-2#1)(2012-12#1)
the readership of##4##3##(2006-7#1)(2008-4#2)(2012-2#1)
the readily available##3##3##(2008-10#1)(2008-2#1)(2008-7#1)
the readily##6##2##(1992-9#1)(1993-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)
the readiness for##2##3##(2008-11#1)(2011-2#1)
the readiness##4##2##(1992-12#1)(2008-11#1)(2011-2#1)(2012-3#1)
the reading and##2##3##(2008-4#1)(2008-9#1)
the reading frame of the##2##5##(1994-12#1)(2005-11#1)
the reading frame of##3##4##(1991-1#1)(1994-12#1)(2005-11#1)
the reading frame##8##3##(1990-7#1)(1991-1#1)(1991-10#1)(1992-9#1)(1994-12#2)(1997-4#1)(2005-11#1)
the reading light##2##3##(2008-3#2)
the reading of##7##3##(1995-11#1)(2004-10#2)(2007-5#1)(2007-9#1)(2008-1#1)(2008-2#1)
the reading skills##2##3##(2007-9#1)(2011-2#1)
the reading##30##2##(1990-7#1)(1991-1#1)(1991-10#1)(1992-9#1)(1994-12#2)(1995-11#1)(1997-4#1)(2004-10#2)(2005-11#1)(2007-5#1)(2007-9#2)(2008-1#2)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-9#2)(2011-2#2)
the readings##2##2##(1993-1#1)(2010-7#1)
the readmission##5##2##(1996-1#1)(1997-1#1)(2008-3#1)(2013-1#2)
the readout characteristics##2##3##(2008-2#2)
the readout of##3##3##(1995-10#1)(2008-2#1)(2008-3#1)
the readout signal##6##3##(2008-2#1)(2008-3#5)
the readout##21##2##(1995-10#1)(2008-2#9)(2008-3#10)(2013-8#1)
the readthrough##2##2##(1996-7#1)(2008-10#1)
the ready##4##2##(1994-5#1)(2009-8#1)(2012-12#1)(2013-7#1)
the reagent and sample##2##4##(2008-10#2)
the reagent and##6##3##(2007-8#1)(2008-10#5)
the reagent blank##5##3##(2008-10#5)
the reagent concentration##2##3##(2008-10#2)
the reagent in##3##3##(1991-7#1)(2008-10#2)
the reagent reacts with##2##4##(2008-10#2)
the reagent solution##3##3##(2008-10#3)
the reagent stream##4##3##(1992-1#1)(2008-10#3)
the reagent to##2##3##(2008-10#1)(2008-4#1)
the reagent was##2##3##(2008-10#2)
the reagent##64##2##(1990-7#1)(1990-9#1)(1991-4#1)(1991-7#2)(1992-1#1)(1993-11#1)(1994-11#1)(2007-10#1)(2007-8#3)(2008-10#49)(2008-4#1)(2008-5#1)(2008-8#1)
the reagent-injection##2##2##(2008-10#2)
the reagents and##2##3##(2007-11#1)(2008-10#1)
the reagents was##2##3##(1995-10#1)(2008-10#1)
the reagents were##3##3##(2007-8#1)(2008-10#1)(2013-1#1)
the reagents##29##2##(1994-11#1)(1995-10#1)(2007-11#1)(2007-8#1)(2008-10#19)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-3#1)(2013-1#1)
the real and the imaginary parts of the complex##2##9##(2007-11#1)(2008-2#1)
the real and the imaginary parts of the refractive index##3##10##(2007-11#1)(2007-12#2)
the real and the imaginary parts of the##12##8##(2007-11#2)(2007-12#4)(2008-2#2)(2008-3#4)
the real and the imaginary parts of##14##7##(2007-11#3)(2007-12#5)(2008-2#2)(2008-3#4)
the real and the imaginary##17##5##(2007-11#3)(2007-12#6)(2008-1#1)(2008-2#2)(2008-3#5)
the real and the##18##4##(2007-11#3)(2007-12#6)(2008-1#1)(2008-2#2)(2008-3#6)
the real and##22##3##(1997-7#1)(2007-11#3)(2007-12#6)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#7)
the real data##2##3##(2007-12#1)(2012-1#1)
the real need##2##3##(1991-2#1)(1993-12#1)
the real needs of##2##4##(2007-6#1)(2012-1#1)
the real number##3##3##(1992-10#2)(1994-3#1)
the real part of the aerosol refractive index##2##8##(2008-3#2)
the real part of the complex refractive index to +/-0##2##10##(2008-3#2)
the real part of the complex refractive index##3##8##(2008-3#3)
the real part of the index of refraction##2##8##(2008-2#1)(2008-3#1)
the real part of the index##3##6##(2008-2#1)(2008-3#2)
the real part of the refractive index##3##7##(2008-2#1)(2008-3#2)
the real part of the##12##5##(2005-11#1)(2008-2#2)(2008-3#9)
the real part of##13##4##(2005-11#1)(2007-11#1)(2008-2#2)(2008-3#9)
the real part##16##3##(2005-11#2)(2007-11#1)(2008-2#2)(2008-3#11)
the real prevalence##2##3##(2006-10#2)
the real problem##5##3##(1994-1#1)(2005-9#1)(2007-4#1)(2007-8#1)(2009-4#1)
the real refractive index##2##4##(2008-3#2)
the real sample##4##3##(2008-10#4)
the real samples##7##3##(2008-10#6)(2008-5#1)
the real time PCR##2##4##(2008-11#1)(2013-1#1)
the real time##4##3##(1994-2#1)(2008-10#1)(2008-11#1)(2013-1#1)
the real value##2##3##(2007-3#1)(2010-12#1)
the real world in##2##4##(2006-5#1)(2013-8#1)
the real world##17##3##(1994-12#2)(1995-6#1)(1996-4#1)(1997-1#1)(2006-2#1)(2006-5#2)(2006-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-12#1)(2009-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
the real##165##2##(1991-2#1)(1991-4#1)(1992-1#1)(1992-10#2)(1992-12#1)(1993-12#2)(1993-8#1)(1993-9#2)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#2)(1995-6#1)(1995-9#1)(1996-11#1)(1996-4#1)(1997-1#1)(1997-7#1)(2005-11#2)(2005-9#2)(2006-10#3)(2006-2#2)(2006-5#3)(2006-6#2)(2006-7#1)(2007-11#5)(2007-12#10)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#21)(2008-11#3)(2008-2#13)(2008-3#25)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-12#2)(2009-4#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#4)
the real-time PCR##5##3##(2008-10#3)(2008-4#1)(2013-8#1)
the real-time detection##2##3##(2008-10#1)(2009-12#1)
the real-time measurement of##2##4##(2008-2#2)
the real-time ultrasound##2##3##(1994-4#1)(2007-7#1)
the real-time##35##2##(1994-4#1)(1995-1#1)(2005-11#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-11#2)(2008-2#10)(2008-3#1)(2008-4#2)(2008-9#1)(2009-12#1)(2011-1#1)(2012-2#2)(2013-8#4)
the realism of role plays##2##5##(2009-11#2)
the realism of##4##3##(2009-11#3)(2012-2#1)
the realism##5##2##(2009-11#3)(2010-2#1)(2012-2#1)
the realistic##5##2##(1991-12#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-5#1)
the realities of##5##3##(1993-7#1)(2008-11#2)(2010-4#1)(2013-8#1)
the reality has##2##3##(1995-12#1)(1996-3#1)
the reality in##2##3##(2011-2#1)(2012-3#1)
the reality of the##5##4##(2006-4#1)(2007-10#1)(2008-11#2)(2012-12#1)
the reality of##15##3##(1994-12#2)(2005-2#1)(2006-4#1)(2007-10#1)(2008-11#2)(2008-2#1)(2009-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
the reality##23##2##(1994-1#1)(1994-12#2)(1995-12#1)(1996-3#1)(2005-2#1)(2006-10#1)(2006-4#1)(2007-10#1)(2008-11#2)(2008-2#1)(2009-10#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#3)
the realization of a novel##2##5##(2008-3#2)
the realization of a##10##4##(2007-11#1)(2007-12#1)(2008-3#5)(2008-7#1)(2009-12#1)(2011-2#1)
the realization of an##4##4##(2007-12#3)(2013-1#1)
the realization of the##3##4##(1992-3#1)(1992-5#1)(2008-10#1)
the realization of these##2##4##(2008-10#1)(2008-7#1)
the realization of this##2##4##(2008-11#1)(2008-2#1)
the realization of##36##3##(1992-3#1)(1992-5#1)(2006-4#1)(2006-5#1)(2007-11#3)(2007-12#5)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#5)(2008-7#2)(2009-11#1)(2009-12#1)(2009-8#1)(2011-2#2)(2012-3#2)(2013-1#3)
the realization that the##2##4##(1991-12#1)(2007-8#1)
the realization that##9##3##(1991-12#1)(1993-11#1)(1994-12#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)
the realization##45##2##(1991-12#1)(1992-3#1)(1992-5#1)(1993-11#1)(1994-12#1)(2005-10#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-11#3)(2007-12#6)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#5)(2008-7#2)(2009-11#1)(2009-12#1)(2009-8#1)(2011-2#2)(2012-3#2)(2013-1#3)
the realized##7##2##(2008-1#1)(2008-10#1)(2008-8#3)(2009-10#1)(2009-8#1)
the realm of##16##3##(1996-9#1)(1997-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-2#1)(2010-7#2)(2010-8#1)
the realm##17##2##(1996-9#1)(1997-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-2#1)(2010-7#2)(2010-8#1)
the reappearance of##6##3##(1992-6#1)(1993-10#2)(1993-2#1)(2006-10#1)(2008-8#1)
the rear bridges of rigor##2##5##(1996-11#2)
the rear bridges##3##3##(1996-11#3)
the rear surface of the##2##5##(2007-12#2)
the rear surface##3##3##(2007-12#3)
the rear##16##2##(1996-11#3)(1996-12#1)(2005-11#1)(2006-10#1)(2007-12#5)(2008-10#2)(2008-3#1)(2012-3#1)(2013-1#1)
the rearing conditions and##2##4##(1991-2#1)(2012-1#1)
the rearing conditions##4##3##(1991-2#2)(2012-1#2)
the rearing##11##2##(1990-3#2)(1991-2#2)(2005-9#1)(2007-12#1)(2008-5#1)(2010-4#2)(2012-1#2)
the rearranged##2##2##(1996-5#1)(2012-12#1)
the rearrangement of##5##3##(1990-4#1)(1994-6#1)(2009-11#1)(2009-12#1)(2012-2#1)
the rearrangement##11##2##(1990-4#1)(1993-11#1)(1994-6#1)(1995-3#1)(1996-5#2)(2005-11#1)(2009-11#1)(2009-12#1)(2012-2#2)
the rearrangements##2##2##(2008-8#1)(2009-12#1)
the reason for the presence of stereoisomers in these systems is not well understood##2##14##(2010-2#2)
the reason for the##13##4##(1992-12#1)(1992-9#1)(2006-10#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-2#2)
the reason for this##4##4##(1995-8#1)(2007-11#1)(2008-2#1)(2009-8#1)
the reason for##38##3##(1990-10#1)(1992-12#1)(1992-9#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-12#1)(1997-6#1)(2005-9#1)(2006-10#2)(2007-11#1)(2007-2#2)(2007-3#2)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#3)(2010-12#1)(2010-2#3)(2011-1#2)(2012-3#1)
the reason of the##2##4##(2007-11#1)(2007-2#1)
the reason of##3##3##(2007-11#1)(2007-2#1)(2013-8#1)
the reason that the##2##4##(2005-12#1)(2008-10#1)
the reason that##6##3##(2005-12#1)(2008-10#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
the reason the##2##3##(1992-1#1)(1995-9#1)
the reason to##2##3##(2006-7#1)(2011-2#1)
the reason why the##4##4##(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#1)
the reason why##6##3##(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2010-6#1)(2012-1#1)
the reason##62##2##(1990-10#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-9#1)(1995-5#1)(1995-8#1)(1995-9#2)(1996-12#1)(1997-6#1)(2005-12#1)(2005-9#1)(2006-10#2)(2006-6#1)(2006-7#1)(2007-11#2)(2007-2#3)(2007-3#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-8#3)(2009-9#1)(2010-12#1)(2010-2#3)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#2)
the reasonable##3##2##(1993-3#1)(1994-6#1)(2008-3#1)
the reasons and##3##3##(2007-2#1)(2009-4#1)(2012-1#1)
the reasons are##2##3##(2005-8#1)(2008-12#1)
the reasons behind this##2##4##(2008-12#1)(2012-11#1)
the reasons behind##8##3##(2007-12#1)(2008-12#1)(2009-4#1)(2010-11#1)(2010-12#1)(2012-11#1)(2012-2#2)
the reasons for choosing##2##4##(2008-3#1)(2010-11#1)
the reasons for its##2##4##(2008-7#2)
the reasons for non-attendance##2##4##(1991-6#2)
the reasons for the##17##4##(1994-2#1)(1994-5#1)(1996-2#1)(2004-12#1)(2004-3#1)(2005-7#1)(2006-10#2)(2006-7#1)(2007-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2013-1#2)
the reasons for their##2##4##(2008-10#1)(2008-11#1)
the reasons for these##2##4##(2006-12#1)(2008-1#1)
the reasons for this##8##4##(1997-7#1)(2006-7#1)(2007-11#1)(2007-7#2)(2008-10#2)(2011-2#1)
the reasons for##58##3##(1991-6#3)(1992-1#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-5#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-7#1)(2004-10#1)(2004-12#1)(2004-3#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-7#2)(2007-11#3)(2007-12#1)(2007-7#4)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#2)(2013-1#4)
the reasons of##5##3##(1996-12#1)(2005-4#1)(2006-6#1)(2007-11#1)(2007-7#1)
the reasons why faculty choose not to participate in these courses##2##11##(2013-1#2)
the reasons why people##2##4##(2009-6#1)(2012-12#1)
the reasons why the##3##4##(2008-4#1)(2010-4#1)(2011-12#1)
the reasons why##22##3##(1990-12#1)(1991-2#1)(1993-11#1)(1995-12#1)(2004-10#1)(2005-10#1)(2005-5#1)(2007-4#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-6#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#2)
the reasons##106##2##(1990-12#1)(1991-2#1)(1991-6#3)(1991-9#1)(1992-1#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-12#2)(1996-12#2)(1996-2#1)(1996-9#1)(1997-3#1)(1997-7#1)(2004-10#2)(2004-12#1)(2004-3#1)(2005-10#1)(2005-4#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-6#1)(2006-7#2)(2007-11#5)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#5)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#2)(2009-4#2)(2009-6#2)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#5)(2013-1#6)
the recA gene of Pseudomonas cepacia##2##6##(1990-9#2)
the recA gene##4##3##(1990-9#4)
the recA##5##2##(1990-9#4)(1995-8#1)
the recA-Mf gene##2##3##(1990-9#2)
the recalcification time##2##3##(2004-11#2)
the recall##4##2##(1996-3#1)(2008-2#1)(2010-11#1)(2011-2#1)
the receding##2##2##(2005-11#1)(2008-10#1)
the receipt of scratch lottery tickets as gifts##2##8##(2013-1#2)
the receipt of scratch lottery tickets##3##6##(2013-1#3)
the receipt of##6##3##(1990-11#1)(1996-1#1)(2012-12#1)(2013-1#3)
the receipt##7##2##(1990-11#1)(1996-1#1)(2008-11#1)(2012-12#1)(2013-1#3)
the receive aperture##2##3##(2008-2#2)
the receive mode of##2##4##(2008-3#2)
the receive##5##2##(2008-2#2)(2008-3#2)(2011-2#1)
the received data##2##3##(2007-11#1)(2008-2#1)
the received optical##2##3##(2008-2#1)(2008-3#1)
the received power##2##3##(2008-2#1)(2010-12#1)
the received##17##2##(2007-11#1)(2007-3#1)(2008-2#7)(2008-3#5)(2009-7#1)(2010-12#2)
the receiver is calculated##2##4##(2007-11#1)(2008-2#1)
the receiver is##4##3##(2007-11#1)(2008-2#3)
the receiver operating characteristic curve##5##5##(2006-6#1)(2010-2#2)(2011-1#1)(2012-2#1)
the receiver operating##9##3##(2006-6#1)(2007-8#1)(2008-3#1)(2010-2#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
the receiver output##2##3##(2007-11#1)(2008-2#1)
the receiver##57##2##(1995-1#1)(2006-6#1)(2007-11#7)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#19)(2008-3#16)(2010-2#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
the receiver's##3##2##(2008-2#1)(2008-3#2)
the receiver-stimulator##4##2##(2008-9#2)(2012-2#2)
the receiver/stimulator package##2##3##(2012-2#2)
the receiving end##2##3##(2007-7#1)(2008-2#1)
the receiving phase##3##3##(2008-10#3)
the receiving##11##2##(1990-5#1)(2007-7#1)(2008-10#4)(2008-2#3)(2008-3#1)(2009-10#1)
the recent 10 years##2##4##(2009-2#2)
the recent achievements in the##2##5##(2006-10#1)(2008-10#1)
the recent acquisition of##2##4##(2008-7#1)(2008-8#1)
the recent advancement##2##3##(1991-8#1)(2008-7#1)
the recent advances and##2##4##(2008-1#1)(2012-3#1)
the recent advances in our##2##5##(2006-10#1)(2012-1#1)
the recent advances in the##9##5##(2005-2#1)(2006-10#1)(2007-6#1)(2008-5#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-1#2)
the recent advances in understanding the##3##6##(2006-8#1)(2008-5#1)(2012-2#1)
the recent advances in understanding##4##5##(2005-8#1)(2006-8#1)(2008-5#1)(2012-2#1)
the recent advances in##20##4##(2005-2#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-8#1)(2007-6#1)(2008-1#1)(2008-5#2)(2011-1#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
the recent advances##24##3##(2005-2#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-8#1)(2007-6#1)(2008-1#2)(2008-5#2)(2008-7#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)
the recent availability of##4##4##(2005-7#1)(2005-9#1)(2008-10#1)(2008-4#1)
the recent case of##2##4##(1991-12#1)(2006-1#1)
the recent clinical##2##3##(1993-11#1)(2008-1#1)
the recent data##2##3##(2008-3#1)(2013-1#1)
the recent development in##3##4##(2006-6#1)(2010-12#1)(2010-8#1)
the recent development of new experimental models##2##7##(2006-10#2)
the recent development of new##3##5##(2006-10#3)
the recent development of##13##4##(2004-2#1)(2006-10#4)(2007-11#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-5#1)(2010-12#2)(2010-7#1)
the recent development##16##3##(2004-2#1)(2006-10#4)(2006-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-5#1)(2010-12#3)(2010-7#1)(2010-8#1)
the recent developments and##2##4##(2005-8#1)(2010-5#1)
the recent developments in the##3##5##(2005-8#1)(2008-10#1)(2008-4#1)
the recent developments in##7##4##(1993-6#1)(2005-8#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-4#1)(2011-1#1)
the recent developments of##3##4##(2006-12#1)(2007-11#1)(2008-3#1)
the recent developments##12##3##(1993-6#1)(2005-8#2)(2006-10#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-5#1)(2011-1#1)
the recent discoveries##3##3##(1996-12#1)(2010-4#1)(2012-2#1)
the recent discovery of##2##4##(1990-6#1)(2008-4#1)
the recent emergence of##3##4##(2008-10#1)(2008-12#1)(2009-12#1)
the recent epidemiological##2##3##(1994-6#1)(2007-1#1)
the recent finding##4##3##(1990-8#1)(1996-3#1)(2006-9#1)(2010-11#1)
the recent findings on##2##4##(2006-10#1)(2010-3#1)
the recent findings##6##3##(2006-10#2)(2008-11#1)(2008-4#1)(2009-8#1)(2010-3#1)
the recent history of##2##4##(2007-8#1)(2008-2#1)
the recent history##5##3##(1991-1#1)(1996-5#1)(2006-8#1)(2007-8#1)(2008-2#1)
the recent identification of multiple##2##5##(2008-10#1)(2010-12#1)
the recent identification of##5##4##(2007-12#1)(2008-10#1)(2008-8#1)(2010-12#1)(2012-12#1)
the recent improvements##3##3##(2007-11#1)(2008-2#1)(2012-8#1)
the recent increase in##2##4##(2008-10#1)(2010-1#1)
the recent increase##3##3##(2008-10#2)(2010-1#1)
the recent interest in##2##4##(2005-8#1)(2007-1#1)
the recent literature and##2##4##(2006-10#1)(2008-8#1)
the recent literature concerning this##2##5##(1997-7#1)(2006-10#1)
the recent literature concerning##5##4##(1997-7#1)(2006-10#2)(2008-8#1)(2011-2#1)
the recent literature in##2##4##(2006-10#1)(2013-1#1)
the recent literature on the##3##5##(1991-12#1)(2006-2#1)(2008-8#1)
the recent literature on##5##4##(1991-12#1)(1994-6#1)(2006-2#1)(2008-8#1)(2011-1#1)
the recent literature##39##3##(1990-6#1)(1991-12#1)(1993-10#1)(1994-6#1)(1997-7#1)(2006-10#12)(2006-2#1)(2006-3#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#3)(2009-3#1)(2009-9#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#4)
the recent outbreak##2##3##(2008-10#1)(2008-3#1)
the recent past and##3##4##(1991-3#2)(2012-5#1)
the recent past##15##3##(1991-3#2)(1994-12#1)(2006-10#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-9#1)(2012-12#1)(2012-2#1)(2012-5#1)
the recent patents##3##3##(2008-1#3)
the recent progress in the##4##5##(2005-7#1)(2008-2#1)(2010-11#1)(2013-1#1)
the recent progress in##7##4##(1993-3#1)(2005-7#1)(2008-2#1)(2008-3#1)(2010-11#1)(2011-1#1)(2013-1#1)
the recent progress on##3##4##(2010-2#1)(2011-1#2)
the recent progress##13##3##(1993-3#1)(2005-7#1)(2006-10#1)(2008-2#1)(2008-3#2)(2010-11#1)(2010-2#1)(2011-1#4)(2013-1#1)
the recent proposition that##2##4##(1995-6#1)(2008-10#1)
the recent publications##2##3##(2008-10#1)(2008-4#1)
the recent recognition of a##2##5##(2007-3#1)(2010-5#1)
the recent research##4##3##(2006-10#1)(2008-10#1)(2011-1#1)(2012-12#1)
the recent results of##3##4##(2008-4#1)(2008-5#1)(2010-3#1)
the recent results##7##3##(1995-9#1)(2005-7#1)(2008-4#1)(2008-5#2)(2010-3#1)(2011-2#1)
the recent studies##4##3##(2006-10#1)(2007-5#1)(2009-1#1)(2010-5#1)
the recent success##2##3##(2005-7#1)(2006-2#1)
the recent surge##2##3##(2008-10#1)(2012-11#1)
the recent trends in##2##4##(2007-7#1)(2008-1#1)
the recent years##12##3##(1994-11#1)(1995-4#1)(1995-5#1)(1997-4#1)(2007-7#1)(2008-12#1)(2008-3#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
the recent##356##2##(1990-12#1)(1990-5#2)(1990-6#2)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#2)(1991-6#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#3)(1996-4#2)(1996-5#1)(1997-4#2)(1997-7#1)(1997-8#1)(2004-2#1)(2005-2#1)(2005-7#6)(2005-8#8)(2005-9#1)(2006-1#1)(2006-10#31)(2006-11#1)(2006-12#2)(2006-2#2)(2006-3#1)(2006-6#1)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#4)(2007-12#6)(2007-2#3)(2007-3#2)(2007-4#4)(2007-5#3)(2007-6#3)(2007-7#3)(2007-8#6)(2007-9#2)(2008-1#15)(2008-10#21)(2008-11#6)(2008-12#4)(2008-2#5)(2008-3#8)(2008-4#6)(2008-5#8)(2008-7#10)(2008-8#10)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#3)(2009-5#2)(2009-8#1)(2009-9#4)(2010-1#1)(2010-11#3)(2010-12#6)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#5)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#10)(2011-12#1)(2011-2#8)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#8)(2012-3#6)(2012-5#1)(2012-8#1)(2013-1#12)(2013-7#3)(2013-8#2)
the recently cloned##5##3##(1992-8#1)(1993-6#1)(1996-1#1)(1997-5#1)(2008-4#1)
the recently created##2##3##(1994-12#1)(2011-2#1)
the recently described##13##3##(1992-8#1)(1992-9#1)(1995-5#1)(1996-1#1)(1997-6#1)(2005-3#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-6#1)(2012-2#1)(2013-7#1)
the recently developed technique of##2##5##(2007-12#2)
the recently developed##21##3##(1990-5#1)(1992-10#1)(1997-3#1)(2006-4#1)(2007-12#2)(2007-8#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-8#1)(2009-9#1)(2010-9#1)(2011-1#1)(2013-1#2)(2013-8#1)
the recently discovered##4##3##(1995-10#1)(2008-10#1)(2012-12#1)(2013-1#1)
the recently identified##7##3##(1990-12#1)(1995-6#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-12#1)(2013-7#1)
the recently introduced##10##3##(1992-4#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#2)
the recently isolated##2##3##(1991-2#1)(2013-8#1)
the recently proposed##8##3##(1990-12#1)(1992-12#1)(2007-12#2)(2008-10#2)(2008-5#1)(2008-7#1)
the recently published##8##3##(1992-4#1)(1996-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#2)
the recently reported rat##2##4##(1995-6#1)(1997-4#1)
the recently reported##14##3##(1991-7#1)(1991-9#1)(1993-12#1)(1994-3#1)(1995-11#1)(1995-6#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-6#1)(2006-6#1)(2007-12#1)(2008-10#1)(2010-7#1)
the recently revised##3##3##(1994-5#1)(2009-4#1)(2012-2#1)
the recently solved##3##3##(1993-6#1)(1997-7#1)(1997-9#1)
the recently##127##2##(1990-12#2)(1990-5#2)(1991-2#2)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-4#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-1#2)(1996-2#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-9#1)(2005-11#1)(2005-3#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#7)(2007-5#1)(2007-8#2)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-12#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#4)(2013-7#2)(2013-8#2)
the receptacle area##5##3##(2008-10#5)
the receptacle##6##2##(2008-10#6)
the reception of##2##3##(2008-11#1)(2012-2#1)
the reception##5##2##(1996-1#1)(2008-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
the receptive field##3##3##(1992-9#1)(1995-11#1)(2008-8#1)
the receptive fields##2##3##(2008-11#1)(2008-8#1)
the receptive stage of the##2##5##(1994-9#2)
the receptive stage##3##3##(1994-9#3)
the receptive##10##2##(1992-9#1)(1994-9#3)(1995-11#1)(2008-11#2)(2008-8#2)(2011-1#1)
the receptor activator of nuclear factor##3##6##(2007-8#1)(2010-10#2)
the receptor activator of nuclear##4##5##(2007-8#1)(2010-10#3)
the receptor activator of##5##4##(2007-8#1)(2008-11#1)(2010-10#3)
the receptor activity##2##3##(1997-4#1)(2008-1#1)
the receptor affinity##4##3##(1991-7#1)(1992-12#1)(1996-5#2)
the receptor and ligand##2##4##(2007-11#1)(2013-8#1)
the receptor and##20##3##(1991-3#1)(1991-9#1)(1993-6#1)(1994-12#1)(1994-9#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-4#2)(2011-2#1)(2013-8#1)
the receptor as a##3##4##(1992-9#1)(1996-8#1)(2009-6#1)
the receptor as##5##3##(1992-9#1)(1995-3#1)(1996-8#1)(1997-1#1)(2009-6#1)
the receptor binding domain of##2##5##(1991-2#1)(1996-5#1)
the receptor binding domain##3##4##(1991-10#1)(1991-2#1)(1996-5#1)
the receptor binding of##2##4##(1995-5#1)(2008-4#1)
the receptor binding##14##3##(1990-11#1)(1990-2#1)(1991-10#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-8#1)(1994-12#1)(1995-5#1)(1996-5#1)(1997-4#1)(2008-4#1)(2008-8#1)(2009-2#1)
the receptor complex##2##3##(1994-12#1)(1996-2#1)
the receptor could##2##3##(1993-9#1)(2007-9#1)
the receptor domain##2##3##(1997-1#2)
the receptor encoded by##2##4##(1991-9#1)(2008-4#1)
the receptor expression##3##3##(1993-7#1)(2008-4#1)(2010-11#1)
the receptor for HIV##2##4##(1990-11#1)(1990-2#1)
the receptor for Stx2##2##4##(2013-1#2)
the receptor for the##4##4##(1990-5#1)(1994-3#1)(1995-3#1)(2009-8#1)
the receptor for##23##3##(1990-11#2)(1990-2#1)(1990-5#1)(1991-3#1)(1991-4#1)(1992-12#1)(1992-6#1)(1993-5#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#2)(2008-7#1)(2009-3#1)(2009-8#1)(2010-11#1)(2013-1#3)
the receptor in the##3##4##(1990-11#1)(1994-11#1)(1997-6#1)
the receptor in##5##3##(1990-11#1)(1991-7#1)(1994-11#1)(1996-5#1)(1997-6#1)
the receptor is necessary for##2##5##(1990-11#1)(1995-1#1)
the receptor is##10##3##(1990-11#2)(1993-3#1)(1994-11#1)(1994-8#2)(1995-1#1)(1995-2#1)(1995-6#1)(2010-8#1)
the receptor itself##2##3##(1995-3#1)(2009-12#1)
the receptor ligand##2##3##(1997-7#1)(2008-7#1)
the receptor molecule##3##3##(1991-4#1)(2006-12#2)
the receptor numbers##2##3##(1992-4#1)(1997-8#1)
the receptor of##3##3##(1991-12#1)(2008-8#2)
the receptor on##2##3##(1992-10#1)(2008-11#1)
the receptor organ of the lateral line##2##7##(2012-12#2)
the receptor profile of##2##4##(1990-2#1)(2005-8#1)
the receptor protein##8##3##(1991-4#1)(1992-12#1)(1993-3#1)(1993-6#1)(1995-10#1)(2006-12#1)(2008-4#1)(2012-12#1)
the receptor site##4##3##(1991-3#1)(1995-3#1)(1997-2#1)(2007-11#1)
the receptor subtype##2##3##(1994-3#1)(1996-12#1)
the receptor that##2##3##(1990-6#1)(1994-8#1)
the receptor to be##2##4##(1990-9#1)(2008-4#1)
the receptor to the##6##4##(1993-4#1)(1993-6#1)(1994-11#1)(1995-3#1)(1996-5#1)(2006-10#1)
the receptor to##17##3##(1990-9#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-3#2)(1996-11#1)(1996-5#2)(1996-8#1)(2006-10#1)(2008-10#1)(2008-4#4)
the receptor tyrosine kinase##5##4##(1996-11#1)(1996-6#2)(2008-6#1)(2013-1#1)
the receptor variant##2##3##(1994-12#2)
the receptor was##6##3##(1990-2#1)(1990-4#1)(1992-8#1)(1994-3#1)(1995-10#1)(2008-11#1)
the receptor with##5##3##(1991-4#1)(1995-10#2)(1995-11#1)(1996-8#1)
the receptor##326##2##(1990-11#7)(1990-12#1)(1990-2#7)(1990-3#2)(1990-4#2)(1990-5#5)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#4)(1991-4#8)(1991-5#4)(1991-7#4)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#6)(1992-2#1)(1992-3#2)(1992-4#3)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#5)(1993-11#1)(1993-12#2)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#7)(1993-7#1)(1993-9#4)(1994-11#4)(1994-12#10)(1994-2#2)(1994-3#5)(1994-5#6)(1994-8#5)(1994-9#6)(1995-1#2)(1995-10#9)(1995-11#4)(1995-12#2)(1995-2#4)(1995-3#12)(1995-4#1)(1995-5#2)(1995-6#4)(1995-8#3)(1996-10#2)(1996-11#4)(1996-12#3)(1996-2#3)(1996-4#3)(1996-5#16)(1996-6#2)(1996-8#8)(1997-1#3)(1997-2#5)(1997-3#1)(1997-4#3)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#2)(2005-11#2)(2005-8#1)(2006-10#3)(2006-12#3)(2006-6#2)(2007-11#3)(2007-12#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-3#2)(2008-4#12)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#6)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#3)(2010-11#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#6)(2013-8#2)
the receptor-associated kinase##2##3##(1997-6#2)
the receptor-associated##3##2##(1994-2#1)(1997-6#2)
the receptor-binding region of##2##4##(1992-11#1)(1993-3#1)
the receptor-binding region##4##3##(1992-11#2)(1993-3#2)
the receptor-binding site##2##3##(1992-9#1)(1996-7#1)
the receptor-binding##10##2##(1991-7#2)(1992-11#3)(1992-9#1)(1993-3#2)(1996-7#1)(1997-8#1)
the receptor-bound##4##2##(1991-7#1)(1993-8#2)(1995-11#1)
the receptor-mediated##9##2##(1990-10#1)(1990-6#1)(1994-10#1)(1994-12#1)(1996-2#1)(1997-1#1)(1997-8#1)(2006-10#1)(2007-11#1)
the receptors and##2##3##(1996-5#1)(2007-12#1)
the receptors for##11##3##(1992-12#2)(1992-4#1)(1993-8#1)(1993-9#1)(1995-12#1)(1995-8#1)(1996-11#1)(1996-2#1)(2008-10#1)(2009-3#1)
the receptors in##5##3##(1991-7#1)(1993-8#1)(1994-3#1)(1995-1#1)(1995-10#1)
the receptors involved##3##3##(1993-4#1)(1995-12#1)(2008-7#1)
the receptors mediating these##2##4##(1997-5#2)
the receptors mediating##3##3##(1997-4#1)(1997-5#2)
the receptors of##3##3##(1993-2#2)(2009-8#1)
the receptors present##2##3##(1995-5#1)(2010-4#1)
the receptors that##2##3##(2008-1#1)(2008-4#1)
the receptors to##2##3##(2009-8#1)(2010-10#1)
the receptors were##3##3##(1995-10#1)(2008-4#2)
the receptors##56##2##(1990-2#1)(1991-2#1)(1991-7#1)(1992-12#2)(1992-4#2)(1993-2#2)(1993-4#1)(1993-8#2)(1993-9#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#3)(1995-3#2)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#2)(1996-5#1)(1997-4#1)(1997-5#2)(2006-10#1)(2007-1#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-4#7)(2008-7#1)(2009-3#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-4#1)(2011-2#1)(2012-2#1)
the recessive allele##2##3##(1990-5#1)(2006-10#1)
the recessive##12##2##(1990-5#2)(1991-11#1)(1993-6#1)(1994-3#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-4#1)(2012-3#1)
the recipes##2##2##(1995-7#2)
the recipient and the##3##4##(1991-11#1)(2011-2#2)
the recipient and##5##3##(1991-11#1)(1995-12#1)(2008-10#1)(2011-2#2)
the recipient enterprises##2##3##(1995-6#2)
the recipient genome##2##3##(2006-12#1)(2008-5#1)
the recipient of##3##3##(1994-12#1)(1997-4#1)(2007-12#1)
the recipient s##3##3##(2008-1#1)(2008-11#2)
the recipient site##2##3##(2004-9#1)(2010-6#1)
the recipient##43##2##(1991-11#2)(1991-7#1)(1993-11#1)(1993-12#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-6#2)(1997-2#1)(1997-4#1)(2004-9#1)(2005-12#1)(2006-12#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#2)(2010-10#1)(2010-6#1)(2011-2#5)(2011-3#2)(2012-3#1)(2013-8#1)
the recipient's##8##2##(1990-3#1)(1992-12#2)(1997-5#2)(2005-12#1)(2006-10#1)(2007-10#1)
the recipients are##2##3##(2008-1#1)(2011-2#1)
the recipients were##3##3##(1995-2#1)(2008-6#1)(2008-9#1)
the recipients##10##2##(1995-2#1)(2007-11#1)(2007-12#1)(2008-1#4)(2008-6#1)(2008-9#1)(2011-2#1)
the reciprocal crosses##2##3##(2009-12#1)(2012-3#1)
the reciprocal of the##6##4##(1990-11#2)(2008-2#1)(2008-3#2)(2008-5#1)
the reciprocal of##7##3##(1990-11#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)
the reciprocal translocation##2##3##(2007-11#1)(2012-12#1)
the reciprocal##33##2##(1990-11#3)(1991-10#1)(1992-3#1)(1995-12#2)(1996-3#1)(1997-7#2)(2004-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#5)(2008-5#2)(2008-9#1)(2009-12#1)(2009-3#1)(2010-1#1)(2011-2#1)(2012-12#2)(2012-3#1)
the reciprocity theorem##5##3##(2008-2#1)(2008-3#4)
the reciprocity##6##2##(2008-2#2)(2008-3#4)
the recognised##3##2##(2007-2#1)(2008-10#1)(2008-8#1)
the recognition and treatment of##3##5##(2007-7#1)(2008-1#1)(2012-3#1)
the recognition and##10##3##(1991-8#1)(1997-7#1)(2005-7#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-1#1)(2012-3#1)
the recognition domain##3##3##(1997-2#3)
the recognition of a##4##4##(1992-9#1)(1997-8#1)(2007-12#1)(2008-3#1)
the recognition of briefly presented visual stimuli##2##7##(2006-5#2)
the recognition of different##2##4##(1996-2#1)(2011-12#1)
the recognition of facial##2##4##(2008-11#1)(2008-5#1)
the recognition of low##2##4##(1994-9#1)(2010-7#1)
the recognition of specific##3##4##(1991-4#1)(2007-2#1)(2008-1#1)
the recognition of the##16##4##(1991-7#1)(1992-2#1)(1993-11#1)(1995-11#1)(1995-9#1)(1996-2#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-1#1)(2012-3#1)
the recognition of##87##3##(1990-12#1)(1990-2#1)(1990-3#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-1#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-2#2)(1996-4#1)(1996-5#1)(1997-6#1)(1997-8#2)(2005-7#1)(2005-8#1)(2006-10#2)(2006-3#1)(2006-5#2)(2006-7#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-3#1)(2009-8#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#2)(2012-3#3)(2013-8#1)
the recognition pattern of##2##4##(2012-3#2)
the recognition process##5##3##(1994-3#1)(1995-8#1)(2008-10#1)(2010-5#1)(2013-1#1)
the recognition sequence##5##3##(1992-10#1)(1994-12#1)(1994-8#1)(1995-3#1)(1995-8#1)
the recognition site for##2##4##(1995-6#2)
the recognition site##3##3##(1995-6#3)
the recognition that##8##3##(1991-12#1)(1992-9#1)(2006-10#1)(2006-9#1)(2007-12#1)(2008-11#1)(2008-4#1)(2009-12#1)
the recognition##139##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#2)(1992-1#1)(1992-10#1)(1992-2#1)(1992-4#2)(1992-9#2)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#3)(1995-8#3)(1995-9#1)(1996-11#1)(1996-2#2)(1996-4#1)(1996-5#1)(1997-2#3)(1997-6#1)(1997-7#1)(1997-8#2)(2005-7#2)(2005-8#1)(2006-10#3)(2006-3#1)(2006-5#2)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-7#3)(2007-8#3)(2008-1#2)(2008-10#8)(2008-11#3)(2008-2#5)(2008-3#4)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#2)(2012-3#7)(2013-1#1)(2013-8#1)
the recognized antigens##2##3##(1990-12#1)(1997-7#1)
the recognized##6##2##(1990-12#1)(1991-12#1)(1997-5#1)(1997-7#1)(2008-10#1)(2010-8#1)
the recombinant DNA##3##3##(1994-5#1)(2008-8#1)(2008-9#1)
the recombinant Escherichia coli##2##4##(1994-12#2)
the recombinant adenovirus##2##3##(2008-8#1)(2011-2#1)
the recombinant antigens##2##3##(1995-5#1)(2005-8#1)
the recombinant enzyme##3##3##(1992-12#1)(1994-3#1)(1994-6#1)
the recombinant expression##2##3##(2005-11#1)(2006-11#1)
the recombinant glycoprotein##2##3##(2008-11#1)(2008-7#1)
the recombinant human proteins##2##4##(1994-5#1)(2005-8#1)
the recombinant human##13##3##(1990-2#2)(1990-5#2)(1990-8#1)(1993-1#1)(1994-5#3)(1994-9#1)(1995-11#1)(2005-8#1)(2008-10#1)
the recombinant membrane##2##3##(1991-4#1)(2008-11#1)
the recombinant mouse##2##3##(1993-6#1)(2008-10#1)
the recombinant plasmid##9##3##(1990-9#1)(1991-4#1)(1994-3#1)(1997-6#1)(2005-11#2)(2008-6#1)(2008-8#1)(2011-1#1)
the recombinant plasmids containing the##2##5##(1993-3#1)(2008-8#1)
the recombinant plasmids##5##3##(1990-1#1)(1993-3#1)(2005-11#2)(2008-8#1)
the recombinant protein showed##2##4##(1995-2#1)(1995-8#1)
the recombinant protein to##2##4##(2008-10#1)(2008-7#1)
the recombinant protein was##4##4##(1993-9#1)(1994-12#1)(2008-11#1)(2008-8#1)
the recombinant protein##30##3##(1990-11#2)(1990-5#1)(1990-7#1)(1993-9#2)(1994-12#2)(1995-2#1)(1995-8#1)(1996-11#1)(1996-5#2)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-11#6)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)
the recombinant proteins expressed##2##4##(1991-10#1)(1994-11#1)
the recombinant proteins##6##3##(1991-10#1)(1991-2#1)(1994-11#1)(1994-12#1)(1994-5#1)(2011-2#1)
the recombinant rat##3##3##(1992-8#1)(1997-8#1)(2008-4#1)
the recombinant receptor##2##3##(1992-7#1)(1995-11#1)
the recombinant strain##5##3##(1994-2#2)(2008-8#1)(2013-1#2)
the recombinant thrombolytic##2##3##(2007-11#2)
the recombinant vaccinia virus##3##4##(2008-8#3)
the recombinant vaccinia##4##3##(2007-2#1)(2008-8#3)
the recombinant vector##3##3##(1992-12#1)(1994-5#1)(2010-4#1)
the recombinant virus##3##3##(1996-4#1)(2005-11#1)(2008-11#1)
the recombinant wild-type##2##3##(1994-8#1)(1995-8#1)
the recombinant##190##2##(1990-1#1)(1990-11#5)(1990-2#2)(1990-5#3)(1990-7#2)(1990-8#2)(1990-9#3)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#3)(1991-9#1)(1992-12#2)(1992-3#2)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#6)(1994-2#3)(1994-3#3)(1994-5#6)(1994-6#2)(1994-8#2)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#3)(1995-2#3)(1995-3#2)(1995-5#1)(1995-8#3)(1996-11#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2005-11#7)(2005-6#1)(2005-8#3)(2006-11#1)(2007-11#8)(2007-2#1)(2008-10#8)(2008-11#14)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#11)(2008-9#2)(2009-3#1)(2010-4#1)(2010-6#1)(2011-1#3)(2011-2#4)(2011-3#1)(2012-3#1)(2013-1#4)(2013-8#1)
the recombinants##5##2##(1990-6#1)(1994-8#1)(1995-2#1)(1997-4#1)(2008-10#1)
the recombinase activating gene 1##3##5##(1994-11#2)(1997-4#1)
the recombination events##2##3##(2008-10#1)(2013-8#1)
the recombination nodules##2##3##(2006-5#2)
the recombination of##6##3##(1991-3#1)(1994-12#1)(1995-8#1)(1996-7#1)(2011-1#1)(2013-8#1)
the recombination parameter of a finite population model without##2##9##(2008-11#2)
the recombination parameter##3##3##(2008-11#3)
the recombination process##3##3##(1990-5#1)(2008-4#1)(2013-1#1)
the recombination products##2##3##(2008-4#2)
the recombination##34##2##(1990-10#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-3#1)(1993-3#1)(1994-12#1)(1995-12#1)(1995-8#2)(1996-10#1)(1996-7#1)(1997-2#1)(2006-5#2)(2007-11#1)(2008-10#3)(2008-11#3)(2008-4#3)(2008-7#1)(2010-2#1)(2011-1#1)(2013-1#1)(2013-8#5)
the recombined##5##2##(1996-5#1)(2007-12#1)(2008-5#3)
the recommendation of the##2##4##(1996-6#1)(2008-8#1)
the recommendation of##8##3##(1993-2#1)(1996-6#1)(1997-6#1)(2007-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2013-1#1)
the recommendation that##3##3##(1991-8#1)(1993-5#1)(2011-12#1)
the recommendation##13##2##(1991-8#1)(1992-10#1)(1993-2#1)(1993-5#1)(1996-6#1)(1997-6#1)(2007-2#2)(2008-3#1)(2008-8#1)(2008-9#1)(2011-12#1)(2013-1#1)
the recommendations by the##2##4##(2007-12#1)(2007-4#1)
the recommendations for##5##3##(1994-6#1)(2005-3#1)(2010-12#1)(2013-8#2)
the recommendations in##2##3##(1990-6#1)(2007-11#1)
the recommendations made##2##3##(1996-3#1)(2013-1#1)
the recommendations of the##15##4##(1990-3#1)(1996-9#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-11#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#4)
the recommendations of##22##3##(1990-3#1)(1995-2#1)(1996-9#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-11#1)(2010-2#1)(2011-2#1)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#4)
the recommendations##50##2##(1990-3#1)(1990-6#1)(1994-6#1)(1995-2#1)(1996-3#1)(1996-9#1)(2005-3#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-4#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#2)(2010-1#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-12#1)(2011-2#3)(2011-3#1)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#6)(2013-8#2)
the recommended daily dietary allowances##2##5##(1997-4#2)
the recommended daily##8##3##(1997-4#2)(2010-4#1)(2010-6#1)(2012-2#1)(2013-1#3)
the recommended dietary allowances##3##4##(1992-2#1)(2005-3#2)
the recommended dosage##2##3##(1995-7#1)(2007-11#1)
the recommended dose of##2##4##(2007-11#1)(2012-2#1)
the recommended dose##4##3##(2005-8#1)(2007-11#1)(2007-2#1)(2012-2#1)
the recommended guidelines##3##3##(2005-10#1)(2006-2#1)(2010-5#1)
the recommended level of##3##4##(2008-1#1)(2011-2#1)(2013-1#1)
the recommended levels for##2##4##(2008-5#1)(2011-2#1)
the recommended levels of HbA1c##3##5##(2011-2#3)
the recommended levels##6##3##(1997-3#1)(2008-5#1)(2011-2#4)
the recommended method##2##3##(2008-10#2)
the recommended procedure##7##3##(2006-6#1)(2008-10#5)(2008-3#1)
the recommended values##2##3##(2008-10#2)
the recommended##89##2##(1991-11#1)(1991-9#1)(1992-2#1)(1993-2#1)(1995-7#1)(1997-3#1)(1997-4#2)(2005-10#1)(2005-3#2)(2005-8#1)(2005-9#3)(2006-2#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-2#2)(2008-1#3)(2008-10#12)(2008-11#2)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#2)(2010-1#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#3)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#7)(2012-1#1)(2012-2#7)(2012-3#1)(2013-1#7)(2013-8#4)
the reconciliation##2##2##(2008-1#1)(2010-6#1)
the reconfigurable array of processors with wider bus networks##3##9##(2008-2#3)
the reconfigurable##4##2##(2008-2#4)
the reconnection of interdisciplinary knowledge##2##5##(2012-12#2)
the reconstituted basement membrane##2##4##(1992-9#1)(2008-11#1)
the reconstituted complexes have##2##4##(1990-5#1)(1993-8#1)
the reconstituted system##5##3##(1993-9#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-6#1)
the reconstituted##38##2##(1990-11#1)(1990-12#2)(1990-5#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-7#1)(2008-11#3)(2008-4#1)(2008-8#3)(2008-9#2)
the reconstitution of##10##3##(1990-8#1)(1992-11#1)(1992-3#1)(1994-8#1)(1996-9#1)(1997-7#1)(2008-12#1)(2008-4#2)(2010-11#1)
the reconstitution##20##2##(1990-7#1)(1990-8#3)(1991-7#1)(1992-11#1)(1992-3#1)(1992-9#1)(1994-3#1)(1994-8#1)(1995-8#3)(1996-9#2)(1997-7#1)(2008-12#1)(2008-4#2)(2010-11#1)
the reconstructed epidermis##2##3##(2008-5#2)
the reconstructed field##2##3##(2008-2#1)(2012-12#1)
the reconstructed image is##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
the reconstructed image##12##3##(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#6)
the reconstructed images##9##3##(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)(2009-10#1)
the reconstructed optical##2##3##(2008-3#1)(2011-1#1)
the reconstructed results##2##3##(2008-3#1)(2011-1#1)
the reconstructed wave##3##3##(2008-2#1)(2008-3#2)
the reconstructed##58##2##(1993-5#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-11#4)(2007-12#7)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#7)(2008-3#15)(2008-5#2)(2008-7#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-4#1)(2009-8#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
the reconstruction error##3##3##(2008-3#3)
the reconstruction of a##7##4##(2007-11#1)(2007-5#1)(2008-3#3)(2012-12#2)
the reconstruction of an##2##4##(1990-3#1)(2008-3#1)
the reconstruction of bone##3##4##(2007-11#2)(2011-2#1)
the reconstruction of images##2##4##(2008-2#2)
the reconstruction of the##15##4##(1991-5#1)(2005-11#1)(2007-12#2)(2007-8#1)(2008-2#3)(2008-3#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the reconstruction of##54##3##(1990-3#1)(1990-5#1)(1991-5#2)(1993-6#2)(1993-9#1)(1994-3#1)(1996-8#1)(2005-11#1)(2005-5#2)(2006-3#1)(2007-11#3)(2007-12#4)(2007-5#1)(2007-8#1)(2008-2#8)(2008-3#6)(2008-7#1)(2009-11#1)(2009-3#1)(2010-7#1)(2010-8#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
the reconstruction##97##2##(1990-3#2)(1990-5#1)(1991-5#2)(1993-6#2)(1993-9#1)(1994-3#1)(1996-11#2)(1996-3#1)(1996-8#1)(2005-11#3)(2005-5#2)(2006-11#1)(2006-3#1)(2007-11#7)(2007-12#9)(2007-5#1)(2007-8#1)(2008-11#1)(2008-2#17)(2008-3#17)(2008-7#3)(2008-8#1)(2009-11#1)(2009-3#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
the reconstructions##2##2##(2008-2#1)(2008-3#1)
the reconstructive ladder##2##3##(2007-12#1)(2011-2#1)
the reconstructive surgeon##6##3##(2007-12#2)(2008-9#1)(2011-2#2)(2012-2#1)
the reconstructive##18##2##(2006-8#1)(2007-12#8)(2008-10#1)(2008-9#1)(2011-2#5)(2012-2#2)
the record of##8##3##(1990-8#1)(1995-3#1)(1997-3#1)(1997-5#1)(2006-7#1)(2007-11#1)(2008-10#1)(2009-3#1)
the record##14##2##(1990-8#1)(1995-3#1)(1997-3#1)(1997-5#3)(2006-7#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-4#1)(2009-3#1)(2011-1#1)(2013-7#1)
the recorded and##2##3##(2007-12#1)(2010-3#1)
the recorded cases of##2##4##(1990-3#1)(1994-9#1)
the recorded images##2##3##(2007-11#1)(2008-9#1)
the recorded stress##2##3##(2005-11#2)
the recorded##50##2##(1990-3#1)(1990-8#1)(1992-1#1)(1993-12#2)(1994-9#1)(1996-1#2)(1996-12#1)(1996-5#1)(1997-5#1)(2005-11#2)(2007-1#1)(2007-11#2)(2007-12#4)(2008-1#2)(2008-10#4)(2008-12#1)(2008-2#4)(2008-3#7)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-3#1)(2012-12#1)(2013-1#6)
the recording and reconstruction##2##4##(2008-2#1)(2008-3#1)
the recording and the##3##4##(2007-12#3)
the recording and##9##3##(1993-12#1)(2007-12#3)(2008-2#2)(2008-3#2)(2010-8#1)
the recording chamber##2##3##(2008-11#1)(2013-1#1)
the recording electrodes##2##3##(2008-4#1)(2010-8#1)
the recording laser sources##2##4##(2008-3#2)
the recording layers##2##3##(2008-3#2)
the recording material##3##3##(2007-12#1)(2008-2#2)
the recording material's##2##3##(2008-3#2)
the recording medium##7##3##(2007-11#1)(2007-12#3)(2008-3#3)
the recording of the##2##4##(2008-3#1)(2008-5#1)
the recording of two##2##4##(1997-4#1)(2008-3#1)
the recording of two-color##2##4##(2007-11#1)(2008-3#1)
the recording of volume##2##4##(2008-2#1)(2008-3#1)
the recording of##27##3##(1990-6#1)(1994-12#1)(1995-12#2)(1996-4#1)(1996-6#1)(1997-4#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#1)(2010-11#1)(2010-7#1)(2011-2#1)
the recording parameters##3##3##(2008-2#1)(2008-3#2)
the recording pipette##2##3##(1992-7#1)(1995-11#1)
the recording process##6##3##(2007-12#1)(2008-1#2)(2008-3#3)
the recording session##2##3##(1995-7#2)
the recording site##3##3##(1991-3#1)(1995-7#2)
the recording speed##2##3##(2008-2#1)(2008-3#1)
the recording step##2##3##(2007-12#1)(2008-3#1)
the recording wavelength##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
the recording##95##2##(1990-11#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-3#1)(1992-7#1)(1993-12#1)(1994-12#1)(1995-11#1)(1995-12#3)(1995-7#4)(1996-4#1)(1996-6#1)(1997-4#1)(2007-11#3)(2007-12#17)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#10)(2008-3#32)(2008-4#2)(2008-5#1)(2010-11#1)(2010-7#1)(2010-8#2)(2011-2#1)(2013-1#1)
the recordings##6##2##(1993-12#1)(1994-10#1)(2008-11#1)(2008-3#2)(2008-5#1)
the records from##3##3##(1990-6#1)(1994-3#2)
the records of one##2##4##(1990-9#1)(2012-2#1)
the records of the##4##4##(1995-6#1)(2008-1#3)
the records of##27##3##(1990-9#1)(1993-5#1)(1995-6#1)(1995-9#1)(2005-6#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#3)(2007-7#1)(2007-8#1)(2008-1#4)(2008-5#1)(2008-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#2)
the records##40##2##(1990-6#1)(1990-9#1)(1992-11#1)(1992-8#1)(1993-5#1)(1994-3#4)(1995-6#1)(1995-9#1)(1997-2#1)(2005-10#1)(2005-6#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#3)(2007-7#2)(2007-8#1)(2008-1#5)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#2)
the recovered##19##2##(1993-8#1)(1995-11#1)(1995-6#1)(1996-2#1)(1996-7#1)(2007-11#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-5#1)(2010-4#1)(2011-1#2)(2013-8#1)
the recoveries are##5##3##(2008-10#5)
the recoveries in##2##3##(2008-10#2)
the recoveries obtained##4##3##(1997-6#1)(2008-10#3)
the recoveries of the##2##4##(2008-10#1)(2012-12#1)
the recoveries of these ions are still over 92%##2##9##(2008-10#2)
the recoveries of##14##3##(2008-10#12)(2012-12#1)(2013-8#1)
the recoveries ranged from##4##4##(2008-10#2)(2009-3#1)(2012-12#1)
the recoveries ranged##5##3##(2008-10#3)(2009-3#1)(2012-12#1)
the recoveries were##10##3##(1993-2#1)(2005-4#2)(2007-8#1)(2008-10#3)(2011-1#2)(2013-8#1)
the recoveries##44##2##(1993-2#1)(1997-6#1)(2005-12#1)(2005-4#2)(2007-8#1)(2008-10#31)(2009-3#1)(2011-1#2)(2012-12#2)(2013-8#2)
the recoverin##4##2##(1992-11#2)(1995-6#2)
the recovery and identification of the##2##6##(1996-8#1)(2008-10#1)
the recovery and##10##3##(1991-6#1)(1996-8#1)(2007-11#1)(2007-8#1)(2008-10#4)(2013-1#1)(2013-7#1)
the recovery from##4##3##(1992-3#1)(1994-6#1)(2008-8#1)(2010-7#1)
the recovery is##4##3##(1993-9#1)(2005-4#2)(2008-10#1)
the recovery of a##3##4##(2006-11#1)(2008-10#1)(2011-2#1)
the recovery of activity##4##4##(1991-2#1)(1992-3#1)(1995-1#1)(2011-2#1)
the recovery of arterial pressure induced by hypertonic saline in rats submitted to hemorrhagic shock##2##15##(1992-7#2)
the recovery of copper##2##4##(2008-10#2)
the recovery of each##2##4##(2008-10#2)
the recovery of eyestalk posture##2##5##(2008-5#2)
the recovery of lead in##2##5##(2008-10#2)
the recovery of relatives with eating disorders##2##7##(2011-2#2)
the recovery of the##32##4##(1990-7#1)(1991-5#1)(1992-11#1)(1992-8#1)(1993-9#1)(1995-1#1)(1995-10#1)(1996-12#1)(2005-4#1)(2007-10#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2010-4#1)(2012-2#1)
the recovery of trace##2##4##(2008-10#2)
the recovery of##140##3##(1990-7#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-7#3)(1992-8#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-11#1)(1995-1#2)(1995-10#1)(1995-6#1)(1995-8#1)(1996-12#2)(1997-4#1)(2005-11#1)(2005-12#1)(2005-4#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-12#4)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#48)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#3)(2008-9#3)(2009-11#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-7#1)(2011-1#2)(2011-2#4)(2012-1#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
the recovery percentages##2##3##(2008-10#2)
the recovery period##10##3##(1992-3#1)(1995-7#2)(2007-9#1)(2008-4#1)(2008-5#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
the recovery process##13##3##(1991-2#1)(2006-10#1)(2008-9#1)(2011-2#2)(2012-2#4)(2013-1#4)
the recovery profile##2##3##(2005-11#1)(2008-10#1)
the recovery rate of##2##4##(1993-9#1)(2008-10#1)
the recovery rate was##4##4##(2005-4#1)(2008-10#1)(2013-8#2)
the recovery rate##7##3##(1993-9#1)(2005-4#1)(2008-10#3)(2013-8#2)
the recovery rates were##3##4##(2008-10#3)
the recovery rates##6##3##(2008-10#6)
the recovery time##6##3##(2006-10#1)(2007-11#1)(2008-1#3)(2012-2#1)
the recovery trajectory##2##3##(2007-11#2)
the recovery values##2##3##(2008-10#2)
the recovery was##15##3##(1990-8#2)(1994-9#1)(1995-11#1)(2005-4#3)(2008-10#4)(2008-5#2)(2009-9#1)(2013-8#1)
the recovery were##2##3##(2008-10#2)
the recovery##264##2##(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-3#3)(1992-7#3)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-9#3)(1994-11#1)(1994-4#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-7#2)(1995-8#1)(1996-12#2)(1996-2#2)(1996-8#2)(1997-4#1)(2005-11#2)(2005-12#1)(2005-4#8)(2006-10#3)(2006-11#1)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#5)(2007-12#4)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#86)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#8)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#4)(2009-11#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-7#4)(2011-1#3)(2011-2#6)(2012-1#4)(2012-12#2)(2012-2#10)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#6)
the recruiting of##3##3##(1995-8#1)(2008-5#1)(2010-2#1)
the recruiting##5##2##(1993-12#1)(1995-8#1)(2006-5#1)(2008-5#1)(2010-2#1)
the recruitment and activation of##2##5##(1995-2#1)(2006-10#1)
the recruitment and##10##3##(1994-3#1)(1995-2#1)(2006-10#1)(2007-12#1)(2007-4#2)(2008-1#1)(2008-3#1)(2008-5#1)(2009-5#1)
the recruitment of cells##2##4##(1992-9#1)(2008-1#1)
the recruitment of motor units##2##5##(1996-5#1)(2013-1#1)
the recruitment of##23##3##(1992-6#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-2#1)(1996-2#1)(1996-5#1)(1997-6#1)(2006-6#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-3#1)(2008-4#1)(2009-6#2)(2009-8#1)(2010-3#1)(2011-1#1)(2012-12#1)(2013-1#2)
the recruitment patterns##2##3##(2007-3#1)(2011-2#1)
the recruitment##53##2##(1992-6#1)(1992-9#1)(1993-2#2)(1993-3#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-6#1)(2006-10#1)(2006-6#1)(2007-10#2)(2007-12#2)(2007-3#2)(2007-4#3)(2008-1#3)(2008-3#2)(2008-4#2)(2008-5#3)(2009-5#1)(2009-6#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
the rectal mucosa##3##3##(2010-12#3)
the rectal stump after Hartmann's operation for##2##7##(2008-8#2)
the rectal stump##3##3##(1990-4#1)(2008-8#2)
the rectal temperature##4##3##(1990-2#1)(1991-2#1)(1993-4#1)(1995-6#1)
the rectal tumor##2##3##(2010-12#2)
the rectal wall##4##3##(1990-9#1)(1993-5#1)(2006-6#1)(2008-10#1)
the rectal##30##2##(1990-2#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-9#1)(1992-6#1)(1993-4#1)(1993-5#1)(1995-6#1)(2006-6#2)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#5)(2010-12#7)(2011-2#1)(2013-1#1)(2013-8#1)
the rectangle##2##2##(1996-2#1)(2012-2#1)
the rectangular hyperbolic yield loss model based on weed density##2##10##(2008-12#2)
the rectangular##4##2##(1995-3#1)(2008-12#2)(2008-3#1)
the recto vaginal septum is##2##5##(2006-6#2)
the recto vaginal septum##4##4##(2006-6#4)
the rectum and in the##2##5##(1991-8#1)(2011-2#1)
the rectum and##12##3##(1991-8#1)(1992-3#1)(1992-5#1)(2007-8#1)(2007-9#1)(2008-7#1)(2009-12#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#2)
the rectum for##3##3##(1992-3#1)(2008-8#1)(2013-1#1)
the rectum is##2##3##(2008-7#1)(2012-1#1)
the rectum wall##2##3##(2007-12#1)(2012-1#1)
the rectum with##2##3##(2006-6#1)(2007-2#1)
the rectum##65##2##(1990-10#1)(1990-4#3)(1991-12#1)(1991-8#2)(1992-3#2)(1992-4#2)(1992-5#2)(1993-8#3)(1993-9#2)(1994-4#1)(1996-2#1)(2006-2#1)(2006-5#1)(2006-6#2)(2006-8#2)(2007-12#2)(2007-2#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-12#1)(2009-5#2)(2010-12#2)(2010-5#1)(2011-11#1)(2011-2#3)(2012-1#4)(2012-12#5)(2012-3#1)(2013-1#1)(2013-7#3)(2013-8#2)
the rectus abdominis##4##3##(1990-9#1)(2009-6#1)(2011-1#1)(2012-12#1)
the rectus femoris and##2##4##(2008-6#1)(2012-1#1)
the rectus femoris muscle##3##4##(2008-12#2)(2011-2#1)
the rectus femoris##7##3##(2008-12#2)(2008-6#1)(2011-2#2)(2012-1#2)
the rectus muscle##3##3##(1990-4#1)(1991-12#1)(1993-12#1)
the rectus##17##2##(1990-4#1)(1990-9#1)(1991-12#1)(1993-10#2)(1993-12#1)(2008-12#2)(2008-6#2)(2009-6#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)
the recurrence of IBS symptoms after##2##6##(2010-6#2)
the recurrence of the disease##3##5##(1995-4#1)(2007-3#1)(2010-9#1)
the recurrence of the##4##4##(1995-4#1)(2007-3#1)(2008-3#1)(2010-9#1)
the recurrence of##18##3##(1991-10#1)(1995-2#1)(1995-4#1)(1997-8#1)(2006-10#1)(2006-3#1)(2007-3#1)(2008-11#1)(2008-3#1)(2009-6#1)(2010-6#2)(2010-9#1)(2011-2#3)(2012-2#1)(2013-8#1)
the recurrence rate of##3##4##(1995-3#1)(2006-3#1)(2006-9#1)
the recurrence rate was##2##4##(2009-10#1)(2013-1#1)
the recurrence rate##8##3##(1995-3#1)(2006-3#1)(2006-9#1)(2007-11#2)(2007-2#1)(2009-10#1)(2013-1#1)
the recurrence rates##2##3##(1997-6#1)(2011-2#1)
the recurrence risk##2##3##(1996-6#2)
the recurrence##33##2##(1991-10#1)(1994-7#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-6#2)(1997-6#1)(1997-8#1)(2006-10#2)(2006-3#2)(2006-9#1)(2007-11#2)(2007-2#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-10#1)(2009-6#1)(2010-6#2)(2010-9#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#1)
the recurrences##3##2##(1991-6#1)(1996-9#1)(2013-1#1)
the recurrent laryngeal##2##3##(2006-10#1)(2008-2#1)
the recurrent nature of complications##2##5##(1995-12#2)
the recurrent nature of##3##4##(1995-12#2)(2012-12#1)
the recurrent nerve and##2##4##(1990-4#1)(1991-11#1)
the recurrent nerve##3##3##(1990-4#2)(1991-11#1)
the recurrent##24##2##(1990-4#2)(1991-11#1)(1991-6#2)(1992-8#1)(1995-12#2)(1997-4#3)(2006-10#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-9#3)(2010-4#1)(2010-6#1)(2010-9#1)(2012-12#2)
the recurring##5##2##(1997-4#1)(2007-4#1)(2007-8#1)(2008-5#1)(2010-7#1)
the recursive##5##2##(2007-12#1)(2007-6#1)(2008-2#1)(2008-3#1)(2013-1#1)
the recycled HDPE##2##3##(2009-3#2)
the recycling of##7##3##(1991-12#1)(1993-3#1)(1994-11#1)(1994-8#1)(2008-10#2)(2008-9#1)
the recycling pathway##2##3##(1993-11#1)(1994-9#1)
the recycling##11##2##(1991-12#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-8#1)(1994-9#1)(2008-1#1)(2008-10#3)(2008-9#1)
the red alga Asparagopsis armata##2##5##(2008-10#2)
the red alga##4##3##(2006-12#1)(2008-10#2)(2008-11#1)
the red and the##3##4##(2008-3#3)
the red and##8##3##(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-8#1)
the red blood cell membrane##4##5##(1994-12#1)(1994-6#1)(1997-1#2)
the red blood cell##10##4##(1992-1#1)(1994-12#1)(1994-6#1)(1997-1#2)(1997-6#2)(2007-2#1)(2008-5#1)(2011-2#1)
the red blood cells of##2##5##(1994-12#1)(2012-2#1)
the red blood cells##9##4##(1990-12#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-3#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#1)
the red blood##20##3##(1990-12#1)(1992-1#1)(1993-3#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-3#1)(1997-1#2)(1997-6#2)(2006-6#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#2)(2012-2#1)
the red cell life##2##4##(1995-1#2)
the red cell##13##3##(1990-5#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-1#2)(1996-1#1)(1996-2#1)(1997-6#1)(2006-2#1)(2006-6#1)(2008-11#2)
the red cells##4##3##(1993-3#1)(1994-3#1)(2008-3#2)
the red edge of the##2##5##(1997-1#1)(1997-4#1)
the red edge of##3##4##(1994-5#1)(1997-1#1)(1997-4#1)
the red field##3##3##(1995-11#3)
the red light##5##3##(2007-12#1)(2008-2#2)(2008-4#1)(2012-2#1)
the red mangrove##2##3##(2008-5#1)(2011-2#1)
the red nucleus##12##3##(1990-2#2)(1991-9#1)(1992-11#8)(1996-6#1)
the red poultry mite##2##4##(1997-5#2)
the red side##2##3##(1995-5#1)(2008-3#1)
the red swamp crawfish##2##4##(2006-5#2)
the red to blue##2##4##(2008-10#2)
the red wine##2##3##(2008-10#1)(2010-2#1)
the red##111##2##(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#1)(1991-9#1)(1992-1#1)(1992-11#8)(1992-8#1)(1993-3#2)(1994-12#3)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#2)(1995-1#2)(1995-11#3)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-1#3)(1997-4#2)(1997-5#2)(1997-6#3)(2005-6#1)(2006-12#3)(2006-2#1)(2006-5#2)(2006-6#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#3)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#11)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#4)(2009-4#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-8#1)
the red-shifted intermediates##2##3##(1997-4#2)
the red-shifted##4##2##(1997-4#3)(2008-10#1)
the reddish##3##2##(2004-2#2)(2008-10#1)
the redesign of the##2##4##(1997-3#1)(2008-7#1)
the redesign process##2##3##(1996-3#2)
the redesign##6##2##(1996-3#3)(1997-3#1)(2007-12#1)(2008-7#1)
the redesigned##2##2##(2007-1#1)(2008-11#1)
the redesigning##2##2##(1992-3#1)(2008-11#1)
the redifferentiation of##3##3##(2008-8#1)(2009-3#1)(2009-8#1)
the rediscovery of##2##3##(2006-2#1)(2008-8#1)
the redistribution of##9##3##(1994-12#2)(1994-9#1)(1995-11#1)(1997-6#1)(2006-9#1)(2007-12#1)(2011-2#1)(2012-1#1)
the redox chemistry##2##3##(2008-10#1)(2009-2#1)
the redox component is##3##4##(1995-8#3)
the redox cycle##3##3##(1992-8#2)(1996-2#1)
the redox cycling##3##3##(1992-11#1)(1992-8#1)(2008-11#1)
the redox electrochemistry of ferrocene monocarboxylic acid encapsulated within##2##9##(2007-11#2)
the redox electrochemistry of ferrocene##3##5##(2007-11#3)
the redox electrochemistry of##4##4##(2007-11#4)
the redox potential in the##2##5##(1995-8#1)(2008-4#1)
the redox potential##6##3##(1995-2#1)(1995-5#1)(1995-8#1)(1997-4#1)(2008-10#1)(2008-4#1)
the redox properties of the##2##5##(1995-10#2)
the redox properties of##5##4##(1995-10#2)(1995-5#1)(2008-9#1)(2010-6#1)
the redox properties##6##3##(1994-5#1)(1995-10#2)(1995-5#1)(2008-9#1)(2010-6#1)
the redox reaction between naphthol green B and potassium bromate##2##10##(2008-10#2)
the redox reaction between##5##4##(2008-10#5)
the redox reaction of##3##4##(2005-4#1)(2008-10#2)
the redox reaction##11##3##(2005-4#1)(2008-10#10)
the redox site##2##3##(1994-2#1)(2006-10#1)
the redox state of the##2##5##(1991-2#1)(1994-12#1)
the redox state of##11##4##(1990-8#1)(1991-2#1)(1994-12#2)(1994-3#1)(1994-8#2)(2007-12#1)(2008-10#1)(2008-5#1)(2009-10#1)
the redox state##13##3##(1990-8#1)(1991-2#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-8#2)(2007-12#1)(2008-10#1)(2008-5#1)(2009-10#1)
the redox status of##2##4##(2008-7#1)(2009-10#1)
the redox status##3##3##(1993-4#1)(2008-7#1)(2009-10#1)
the redox##90##2##(1990-8#3)(1991-2#2)(1992-11#1)(1992-8#3)(1993-4#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#4)(1995-10#2)(1995-2#2)(1995-5#2)(1995-8#4)(1996-2#2)(1996-6#1)(1997-3#1)(1997-4#2)(1997-6#2)(2005-4#1)(2006-10#1)(2006-2#1)(2007-11#4)(2007-12#1)(2008-10#26)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#3)(2009-2#1)(2009-8#1)(2010-10#1)(2010-6#1)(2010-7#1)
the redox-active##4##2##(1991-7#1)(1994-8#1)(2008-10#2)
the redox-reductive screen mode##2##4##(1990-8#2)
the redox-sensitive##2##2##(2008-4#1)(2008-5#1)
the reduced ability of##2##4##(1995-1#1)(1997-4#1)
the reduced amount of##2##4##(1992-1#1)(2012-11#1)
the reduced and oxidized forms of Bacillus subtilis##2##8##(2009-7#2)
the reduced and oxidized forms##3##5##(2006-12#1)(2009-7#2)
the reduced and oxidized##5##4##(1993-3#1)(1996-2#1)(2006-12#1)(2009-7#2)
the reduced and##7##3##(1993-3#1)(1995-5#1)(1996-2#1)(2006-12#1)(2009-7#2)(2011-2#1)
the reduced availability of##2##4##(1994-5#1)(2006-2#1)
the reduced cost##2##3##(1990-10#1)(2005-9#1)
the reduced expression of##4##4##(2008-2#1)(2008-5#1)(2011-12#1)(2012-2#1)
the reduced form of##6##4##(1994-5#1)(1996-7#1)(1997-2#1)(2008-10#3)
the reduced form##11##3##(1992-1#1)(1992-6#1)(1994-5#1)(1996-7#1)(1997-2#1)(2006-12#2)(2008-10#4)
the reduced glutathione##2##3##(1990-2#1)(1994-9#1)
the reduced incidence##2##3##(1990-2#1)(1997-3#1)
the reduced number of##3##4##(1991-11#1)(2007-1#1)(2008-2#1)
the reduced oxygen##2##3##(2007-2#1)(2012-2#1)
the reduced protein##2##3##(1997-4#1)(2008-3#1)
the reduced pyridine##2##3##(1995-2#1)(1996-2#1)
the reduced renal blood flow##2##5##(2012-2#2)
the reduced renal##3##3##(2006-2#1)(2012-2#2)
the reduced risk of##2##4##(2008-9#1)(2009-4#1)
the reduced risk##3##3##(2008-9#1)(2009-4#1)(2012-1#1)
the reduced scattering and absorption coefficients##3##6##(2008-2#2)(2008-3#1)
the reduced scattering and##4##4##(2008-2#3)(2008-3#1)
the reduced scattering coefficient##6##4##(2007-12#1)(2008-2#2)(2008-3#3)
the reduced scattering##17##3##(2007-12#2)(2008-2#7)(2008-3#8)
the reduced sensitivity to##2##4##(2008-1#2)
the reduced serum selenium concentration in patients with##2##8##(1991-1#2)
the reduced stability##2##3##(1994-11#1)(1994-6#1)
the reduced state##6##3##(1990-2#1)(1990-7#1)(1991-4#1)(1994-8#1)(1996-5#1)(2008-10#1)
the reduced use of##2##4##(2007-8#1)(2008-10#1)
the reduced##191##2##(1990-10#1)(1990-12#2)(1990-2#5)(1990-3#1)(1990-4#1)(1990-7#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-4#1)(1991-7#2)(1991-8#1)(1992-1#2)(1992-10#1)(1992-12#1)(1992-3#2)(1992-6#3)(1992-8#1)(1993-10#1)(1993-11#3)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#3)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#4)(1995-5#2)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#4)(1996-3#1)(1996-5#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#2)(1997-8#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-12#5)(2006-2#2)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-8#5)(2008-1#4)(2008-10#18)(2008-11#3)(2008-2#13)(2008-3#12)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-7#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#6)(2013-1#1)(2013-7#1)(2013-8#1)
the reducing agent dithiothreitol##2##4##(1990-2#1)(1995-11#1)
the reducing agent##6##3##(1990-2#1)(1994-9#1)(1995-11#1)(2008-10#2)(2011-2#1)
the reducing agents##3##3##(1992-6#2)(2008-5#1)
the reducing end of##4##4##(1992-10#1)(1995-11#1)(2007-8#1)(2011-1#1)
the reducing end##10##3##(1992-10#2)(1992-12#1)(1995-11#3)(1996-2#1)(2005-11#1)(2007-8#1)(2011-1#1)
the reducing of##2##3##(1992-5#1)(2013-8#1)
the reducing sugars##2##3##(2008-10#2)
the reducing terminal##4##3##(1990-5#2)(1994-5#1)(1996-2#1)
the reducing##38##2##(1990-2#1)(1990-5#3)(1992-10#2)(1992-12#2)(1992-5#1)(1992-6#2)(1994-11#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#4)(1996-10#1)(1996-2#2)(1997-4#2)(2005-11#1)(2007-8#1)(2008-10#5)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
the reductant##3##2##(1997-6#1)(2005-11#1)(2009-3#1)
the reductase and##3##3##(1991-2#1)(1993-6#1)(1995-2#1)
the reductase##21##2##(1990-10#1)(1991-2#6)(1993-6#3)(1994-11#1)(1994-8#3)(1995-1#1)(1995-2#2)(1996-3#2)(2008-11#2)
the reduction and##6##3##(2007-11#1)(2008-10#2)(2008-3#1)(2009-12#1)(2011-2#1)
the reduction by##2##3##(1997-7#1)(2008-10#1)
the reduction current##2##3##(2007-8#1)(2008-10#1)
the reduction from##2##3##(1997-3#1)(2012-3#1)
the reduction in coronary##2##4##(1996-9#2)
the reduction in pupil size##2##5##(1993-11#1)(2007-11#1)
the reduction in the##16##4##(1991-1#1)(1991-2#1)(1991-4#1)(1992-3#1)(1992-9#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2010-12#1)(2012-3#1)(2013-7#1)
the reduction in total##3##4##(1992-2#1)(1996-10#1)(2008-8#1)
the reduction in water-accessible nonpolar surface area##2##7##(1991-4#2)
the reduction in water-accessible##3##4##(1991-4#2)(1992-5#1)
the reduction in##85##3##(1990-11#1)(1991-1#2)(1991-10#1)(1991-2#1)(1991-4#3)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#2)(1994-4#1)(1994-5#1)(1995-3#2)(1995-6#1)(1996-10#1)(1996-6#2)(1996-9#3)(2004-9#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-7#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-7#4)(2013-8#1)
the reduction is##2##3##(1991-1#1)(2008-10#1)
the reduction mechanism##2##3##(2008-10#2)
the reduction of Cr(VI)##2##4##(2008-10#1)(2011-2#1)
the reduction of DTNB##2##4##(1992-4#2)
the reduction of Fe(III) to Fe(II)##2##6##(1996-2#1)(2008-10#1)
the reduction of Fe(III)##3##4##(1996-2#1)(2006-8#1)(2008-10#1)
the reduction of a##3##4##(2008-10#1)(2008-4#1)(2011-1#1)
the reduction of an##2##4##(2008-10#1)(2010-7#1)
the reduction of colon cancer##2##5##(2006-10#1)(2008-10#1)
the reduction of complications##2##4##(2007-8#1)(2008-3#1)
the reduction of dopamine biosynthesis##2##5##(2008-10#1)(2008-11#1)
the reduction of elevated##2##4##(1991-7#1)(2005-10#1)
the reduction of ferric##2##4##(1995-6#1)(2009-8#1)
the reduction of glutathione disulfide##2##5##(1995-3#2)
the reduction of glutathione##3##4##(1993-3#1)(1995-3#2)
the reduction of hydrogen##2##4##(2008-10#2)
the reduction of insulin##2##4##(1990-12#1)(2008-3#1)
the reduction of intraocular pressure##2##5##(1996-8#1)(2013-1#1)
the reduction of mortality##2##4##(2010-12#1)(2011-2#1)
the reduction of nitrate to nitrite##2##6##(2008-10#2)
the reduction of nitrate to##3##5##(2008-10#3)
the reduction of number of##2##5##(2008-10#1)(2013-7#1)
the reduction of oxygen##3##4##(1995-2#1)(2008-10#1)(2013-8#1)
the reduction of protein##2##4##(1997-2#1)(2008-11#1)
the reduction of risk##2##4##(2009-4#1)(2012-12#1)
the reduction of serum##2##4##(1995-3#1)(2008-5#1)
the reduction of stroke##2##4##(2007-10#1)(2010-12#1)
the reduction of the##39##4##(1991-3#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-5#2)(1997-8#1)(2007-1#1)(2007-12#2)(2008-10#12)(2008-11#3)(2008-2#2)(2009-2#1)(2009-5#1)(2009-7#1)(2011-1#2)(2012-12#1)(2012-2#1)
the reduction of total##2##4##(1992-8#1)(2010-5#1)
the reduction of trichloroacetic acid##2##5##(1997-1#1)(2008-10#1)
the reduction of##260##3##(1990-10#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#3)(1990-7#1)(1991-1#2)(1991-3#3)(1991-5#1)(1991-7#2)(1991-8#1)(1992-1#1)(1992-4#2)(1992-7#1)(1992-8#3)(1992-9#2)(1993-11#3)(1993-12#1)(1993-3#3)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-12#2)(1996-2#2)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-4#2)(1997-5#2)(1997-7#2)(1997-8#3)(2004-11#1)(2005-10#1)(2005-11#3)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-6#2)(2006-8#2)(2007-1#2)(2007-10#4)(2007-11#4)(2007-12#3)(2007-2#2)(2007-3#3)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#56)(2008-11#7)(2008-12#2)(2008-2#6)(2008-3#11)(2008-4#2)(2008-5#5)(2008-7#2)(2008-8#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-12#3)(2010-2#1)(2010-4#4)(2010-5#2)(2010-7#2)(2011-1#4)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#5)
the reduction or##3##3##(2006-4#1)(2008-11#1)(2013-1#1)
the reduction peak current of##2##5##(2008-10#2)
the reduction peak current##3##4##(2008-10#3)
the reduction peak##4##3##(2008-10#4)
the reduction potential of the##2##5##(2005-11#1)(2008-10#1)
the reduction potential of##3##4##(1991-8#1)(2005-11#1)(2008-10#1)
the reduction potential##7##3##(1991-8#1)(1992-7#1)(1994-8#2)(2005-11#1)(2007-11#1)(2008-10#1)
the reduction potentials of##2##4##(1991-8#1)(1992-7#1)
the reduction potentials##3##3##(1991-8#1)(1992-7#1)(2007-11#1)
the reduction process##3##3##(2006-8#1)(2008-10#1)(2010-12#1)
the reduction product##3##3##(2008-10#3)
the reduction reaction##2##3##(2008-10#1)(2008-8#1)
the reduction site of dopamine beta-monooxygenase##2##6##(1994-9#2)
the reduction site of##3##4##(1994-9#3)
the reduction site##4##3##(1991-3#1)(1994-9#3)
the reduction was##11##3##(1991-7#1)(1991-9#1)(1993-4#1)(1996-10#1)(1997-6#1)(2007-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)
the reduction##427##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#3)(1990-7#1)(1990-8#1)(1991-1#5)(1991-10#1)(1991-2#1)(1991-3#4)(1991-4#3)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#3)(1991-9#2)(1992-1#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#3)(1992-9#3)(1993-11#4)(1993-12#3)(1993-3#3)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-4#1)(1994-5#1)(1994-8#4)(1994-9#4)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#7)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#1)(1996-10#2)(1996-12#2)(1996-2#2)(1996-6#3)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#3)(2004-11#1)(2004-9#1)(2005-10#2)(2005-11#4)(2005-8#1)(2006-10#5)(2006-12#2)(2006-2#2)(2006-3#2)(2006-4#3)(2006-5#1)(2006-6#2)(2006-8#3)(2007-1#4)(2007-10#5)(2007-11#9)(2007-12#3)(2007-2#2)(2007-3#3)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#92)(2008-11#12)(2008-12#3)(2008-2#12)(2008-3#15)(2008-4#4)(2008-5#9)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-12#6)(2010-2#1)(2010-4#6)(2010-5#2)(2010-7#3)(2011-1#6)(2011-12#1)(2011-2#8)(2012-1#1)(2012-12#6)(2012-2#6)(2012-3#4)(2013-1#4)(2013-7#5)(2013-8#6)
the reductions in##3##3##(1994-2#1)(1996-1#1)(2008-10#1)
the reductions##5##2##(1994-2#1)(1996-1#1)(2005-8#1)(2008-10#1)(2008-11#1)
the reductive amination of##2##4##(1996-5#2)
the reductive cleavage##2##3##(1992-3#1)(2008-4#1)
the reductive dehalogenation of##2##4##(2006-3#2)
the reductive desorption##2##3##(2008-10#2)
the reductive pentosephosphate pathway##3##4##(2008-1#3)
the reductive##29##2##(1990-5#1)(1991-1#1)(1991-10#1)(1992-3#1)(1994-8#4)(1995-2#1)(1996-5#2)(1997-3#3)(2006-3#2)(2006-8#1)(2006-9#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-4#1)(2009-10#1)(2010-5#1)(2012-2#1)
the redundancy in##3##3##(1997-8#1)(2008-2#1)(2009-4#1)
the redundancy of##2##3##(2007-5#1)(2008-2#1)
the redundancy##6##2##(1997-8#1)(2007-5#1)(2008-2#3)(2009-4#1)
the redundant information##2##3##(2008-3#1)(2010-4#1)
the redundant signals##3##3##(2008-10#2)(2008-8#1)
the redundant##5##2##(2008-10#2)(2008-3#1)(2008-8#1)(2010-4#1)
the reef##8##2##(2007-3#3)(2007-5#2)(2010-8#1)(2011-2#1)(2012-12#1)
the reefs##3##2##(2007-5#1)(2008-5#1)(2011-2#1)
the reeler mouse##5##3##(1994-10#5)
the reeler##7##2##(1994-10#7)
the reemergence of##2##3##(1992-3#1)(2013-8#1)
the reference and##6##3##(2007-12#1)(2008-2#3)(2008-3#2)
the reference area##4##3##(2008-12#1)(2011-2#3)
the reference arm of the interferometer##2##6##(2008-1#1)(2008-2#1)
the reference arm of##4##4##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
the reference arm##8##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#3)(2008-3#2)
the reference beam is##5##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
the reference beam to##2##4##(2008-2#1)(2008-3#1)
the reference beam##19##3##(2007-11#2)(2007-12#2)(2008-2#4)(2008-3#11)
the reference beams##2##3##(2008-3#2)
the reference compound##2##3##(1995-3#1)(2007-11#1)
the reference digits##2##3##(2008-3#2)
the reference electrode##2##3##(2008-10#2)
the reference field##3##3##(2007-11#1)(2008-3#2)
the reference formulation##4##3##(1993-6#2)(1995-4#2)
the reference group (p&lt##3##4##(2006-7#3)
the reference group##9##3##(1991-5#1)(2006-7#7)(2007-7#1)
the reference image##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
the reference in##2##3##(2008-3#1)(2012-2#1)
the reference interval##2##3##(1990-8#1)(1994-6#1)
the reference light##3##3##(2007-11#2)(2008-11#1)
the reference liquid's##2##3##(2008-2#2)
the reference materials##4##3##(2008-10#4)
the reference medium##2##3##(2008-3#2)
the reference method##18##3##(1995-4#1)(2008-10#15)(2011-1#1)(2012-3#1)
the reference methods##5##3##(2008-10#4)(2010-4#1)
the reference mirror##2##3##(2008-2#1)(2008-3#1)
the reference object##3##3##(2008-2#2)(2008-3#1)
the reference or##3##3##(2008-10#1)(2011-2#2)
the reference points##2##3##(2008-2#1)(2013-8#1)
the reference population##6##3##(1990-11#1)(1994-6#2)(2006-10#1)(2008-11#1)(2012-1#1)
the reference procedure##5##3##(2008-10#5)
the reference range in##2##4##(2006-6#1)(2013-1#1)
the reference range##8##3##(1991-2#1)(1993-2#1)(2006-6#3)(2008-9#1)(2011-11#1)(2013-1#1)
the reference sample##2##3##(2007-8#1)(2012-1#1)
the reference samples##2##3##(2007-12#1)(2007-8#1)
the reference sequence##2##3##(2008-10#1)(2008-12#1)
the reference signal##5##3##(2007-8#1)(2008-2#3)(2012-1#1)
the reference solutions##2##3##(2008-10#1)(2008-5#1)
the reference spectrophotometer##3##3##(2008-3#3)
the reference standard##8##3##(1991-5#1)(1996-9#1)(2007-10#1)(2008-10#3)(2010-11#1)(2010-4#1)
the reference strain of##2##4##(2008-10#2)
the reference strain##11##3##(1995-4#1)(2006-8#1)(2008-10#4)(2008-5#2)(2011-2#2)(2013-8#1)
the reference strains##5##3##(2006-8#1)(2008-10#1)(2008-5#1)(2009-6#1)(2011-1#1)
the reference substrate##2##3##(1993-4#2)
the reference surface##3##3##(2008-3#3)
the reference treatment##2##3##(1993-5#1)(2012-3#1)
the reference values##8##3##(1995-2#1)(1996-12#1)(2005-4#1)(2008-10#3)(2008-3#1)(2010-3#1)
the reference wave##4##3##(2008-3#4)
the reference wavelength##2##3##(2008-2#2)
the reference##290##2##(1990-11#1)(1990-4#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#3)(1991-9#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#2)(1993-5#1)(1993-6#2)(1994-6#3)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#6)(1995-6#1)(1996-12#1)(1996-9#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-4#1)(2006-10#2)(2006-12#1)(2006-4#2)(2006-6#3)(2006-7#7)(2006-8#3)(2007-10#1)(2007-11#9)(2007-12#11)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#60)(2008-11#3)(2008-12#2)(2008-2#33)(2008-3#53)(2008-5#6)(2008-9#1)(2009-10#2)(2009-6#1)(2010-11#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-9#1)(2011-1#4)(2011-11#1)(2011-2#11)(2011-3#1)(2012-1#4)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#4)
the reference-cavity length##2##3##(2008-2#2)
the references##5##2##(1994-1#1)(1994-10#1)(2010-3#1)(2010-9#2)
the referent group##4##3##(1996-6#3)(2008-11#1)
the referent##8##2##(1994-6#1)(1996-6#3)(2008-11#1)(2008-5#1)(2010-3#1)(2013-1#1)
the referral pattern##2##3##(2006-11#1)(2011-2#1)
the referral patterns##2##3##(1996-3#1)(2007-2#1)
the referral##22##2##(1992-9#1)(1995-10#1)(1996-12#1)(1996-3#1)(1997-3#1)(2006-11#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-3#4)(2007-7#2)(2007-8#1)(2011-1#2)(2011-2#2)
the referred pain area##3##4##(2010-9#3)
the referred pain sensation##2##4##(2008-12#2)
the referred pain##8##3##(2008-12#2)(2008-9#1)(2010-9#5)
the referred##15##2##(1992-3#1)(1995-1#3)(2008-12#2)(2008-9#2)(2010-8#1)(2010-9#5)(2013-1#1)
the referring physician##3##3##(1992-3#1)(1993-2#1)(2006-3#1)
the referring physician's##2##3##(1993-12#1)(1996-1#1)
the referring##8##2##(1992-3#1)(1993-12#1)(1993-2#1)(1996-1#1)(1996-3#1)(2006-3#1)(2007-7#1)(2008-12#1)
the refilling state of internal Ca2+##2##6##(1995-3#2)
the refined structures##3##3##(1995-10#1)(1995-11#1)(2009-3#1)
the refined##6##2##(1995-10#2)(1995-11#1)(2008-2#1)(2008-3#1)(2009-3#1)
the refinement of the##2##4##(1994-2#1)(2008-10#1)
the refinement of##6##3##(1994-2#1)(1997-7#1)(2004-8#1)(2008-10#2)(2008-3#1)
the refinement##7##2##(1993-3#1)(1994-2#1)(1997-7#1)(2004-8#1)(2008-10#2)(2008-3#1)
the reflaxicon##2##2##(2008-2#2)
the reflectance and the##2##4##(2008-2#1)(2008-3#1)
the reflectance at##2##3##(2008-10#1)(2008-3#1)
the reflectance curves##2##3##(2008-2#1)(2008-3#1)
the reflectance data##2##3##(2008-2#2)
the reflectance of the##5##4##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)
the reflectance of these##2##4##(2007-11#1)(2008-3#1)
the reflectance of##8##3##(2007-11#3)(2008-10#1)(2008-2#1)(2008-3#3)
the reflectance spectra##2##3##(2008-10#1)(2008-3#1)
the reflectance##34##2##(2006-12#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#11)(2008-3#12)
the reflectances of the##3##4##(2008-2#2)(2008-3#1)
the reflectances##4##2##(2008-2#2)(2008-3#2)
the reflected and the refracted##2##5##(2007-11#1)(2008-2#1)
the reflected and the##3##4##(2007-11#1)(2008-2#2)
the reflected beam is##2##4##(2008-2#1)(2008-3#1)
the reflected beam##6##3##(2007-12#1)(2008-2#3)(2008-3#2)
the reflected beams##2##3##(2008-3#2)
the reflected light wave##2##4##(2008-3#2)
the reflected light##9##3##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#3)
the reflected rays##2##3##(2008-2#2)
the reflected signal##3##3##(2007-12#1)(2008-3#2)
the reflected waves##2##3##(2007-12#2)
the reflected##48##2##(2007-11#2)(2007-12#7)(2008-1#1)(2008-10#1)(2008-2#14)(2008-3#20)(2009-1#1)(2010-12#1)(2012-1#1)
the reflecting##7##2##(2007-11#1)(2007-12#1)(2008-3#4)(2009-8#1)
the reflection and transmission##2##4##(2007-12#2)
the reflection and##3##3##(2007-12#2)(2008-3#1)
the reflection band##3##3##(2007-11#3)
the reflection coefficient##5##3##(2008-2#4)(2008-3#1)
the reflection function of##2##4##(2008-3#2)
the reflection function##3##3##(2008-2#1)(2008-3#2)
the reflection is##2##3##(2007-12#1)(2013-1#1)
the reflection mode##3##3##(2008-2#3)
the reflection of a##5##4##(2007-11#1)(2008-3#3)(2008-9#1)
the reflection of atmospheric-emitted##2##4##(2008-3#2)
the reflection of the##2##4##(2007-12#1)(2008-3#1)
the reflection of##17##3##(2007-11#2)(2007-12#2)(2008-2#4)(2008-3#8)(2008-9#1)
the reflection on##2##3##(2008-11#1)(2013-1#1)
the reflection spectra##2##3##(2007-11#1)(2008-3#1)
the reflection##65##2##(2006-10#1)(2006-5#1)(2007-11#7)(2007-12#12)(2008-11#1)(2008-2#21)(2008-3#17)(2008-9#1)(2009-4#1)(2009-8#1)(2013-1#2)
the reflective grating##2##3##(2008-2#1)(2008-3#1)
the reflective surface##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
the reflective##12##2##(2007-11#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-2#2)(2008-3#4)(2009-9#1)(2012-12#1)
the reflectivities of the##2##4##(2008-2#1)(2008-3#1)
the reflectivity at##2##3##(2007-11#1)(2008-2#1)
the reflectivity curve##2##3##(2008-2#2)
the reflectivity of a##3##4##(2008-2#1)(2008-3#2)
the reflectivity of the##5##4##(2007-12#2)(2008-2#3)
the reflectivity of##15##3##(2007-11#1)(2007-12#3)(2008-2#6)(2008-3#5)
the reflectivity##33##2##(2007-11#4)(2007-12#5)(2008-2#13)(2008-3#11)
the reflector##3##2##(2007-12#2)(2008-2#1)
the reflectors##4##2##(2008-2#1)(2008-3#2)(2008-7#1)
the reflex pressor response to static##2##6##(1991-5#2)
the reflex pressor response to##3##5##(1991-5#3)
the reflex vagal inhibition of the heart##2##7##(1996-6#2)
the reflex##11##2##(1991-5#3)(1991-8#1)(1992-3#1)(1992-8#1)(1993-12#1)(1996-6#2)(2012-1#1)(2013-1#1)
the reflexes##4##2##(1992-12#1)(2010-11#2)(2013-1#1)
the reflexive##3##2##(2006-4#1)(2007-10#1)(2008-11#1)
the refluxate##2##2##(1994-2#1)(2006-10#1)
the refolded##2##2##(1995-2#1)(2009-3#1)
the refolding of##6##3##(1994-5#1)(1995-2#1)(1995-8#1)(1997-4#2)(2011-2#1)
the refolding##11##2##(1994-5#1)(1995-1#1)(1995-2#1)(1995-8#1)(1997-4#3)(1997-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
the reform of health##2##4##(1997-2#1)(2012-12#1)
the reform of the##2##4##(1992-12#1)(1996-1#1)
the reform of##9##3##(1992-12#1)(1993-10#1)(1996-1#1)(1997-2#1)(2006-8#1)(2008-2#2)(2008-8#1)(2012-12#1)
the reform##17##2##(1992-12#1)(1992-5#1)(1993-10#1)(1994-12#1)(1996-1#1)(1997-2#2)(2006-8#1)(2007-5#1)(2008-2#5)(2008-8#1)(2011-7#1)(2012-12#1)
the reforms##8##2##(1993-2#1)(1995-3#1)(1996-3#1)(1997-5#1)(2007-12#1)(2007-3#1)(2012-1#1)(2012-3#1)
the refracted and the reflected##2##5##(2008-2#1)(2008-3#1)
the refracted##7##2##(2007-11#1)(2008-2#3)(2008-3#3)
the refraction of##2##3##(2008-3#1)(2008-4#1)
the refraction##7##2##(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-6#1)
the refractive index and absorption##2##5##(2008-2#1)(2008-3#1)
the refractive index and the extinction coefficient of a##2##9##(2008-2#2)
the refractive index and the extinction coefficient of##3##8##(2008-2#2)(2008-3#1)
the refractive index and the##11##5##(2008-2#4)(2008-3#6)(2011-1#1)
the refractive index and##15##4##(2007-11#1)(2008-2#5)(2008-3#8)(2011-1#1)
the refractive index between##2##4##(2008-1#1)(2008-3#1)
the refractive index for##3##4##(2008-1#1)(2008-2#1)(2008-3#1)
the refractive index is a##2##5##(2008-2#1)(2008-3#1)
the refractive index is##14##4##(2007-11#3)(2007-12#4)(2008-1#1)(2008-2#2)(2008-3#4)
the refractive index n and the##3##6##(2008-10#1)(2008-2#1)(2008-3#1)
the refractive index n and##4##5##(2008-10#1)(2008-2#1)(2008-3#2)
the refractive index n##5##4##(2008-10#1)(2008-2#1)(2008-3#3)
the refractive index of a##7##5##(2007-12#1)(2008-2#2)(2008-3#4)
the refractive index of the medium##4##6##(2007-11#1)(2008-3#3)
the refractive index of the outer##2##6##(2008-2#1)(2008-3#1)
the refractive index of the surrounding##2##6##(2007-11#1)(2010-2#1)
the refractive index of the##28##5##(2005-11#1)(2007-11#5)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#1)(2008-2#5)(2008-3#8)(2009-6#1)(2010-2#1)
the refractive index of thin liquid films with a spectrometer##2##10##(2008-3#2)
the refractive index of water##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
the refractive index of##55##4##(2005-11#2)(2007-11#6)(2007-12#3)(2007-8#1)(2008-1#3)(2008-10#3)(2008-2#13)(2008-3#21)(2009-6#1)(2010-2#1)(2011-12#1)
the refractive index was##2##4##(2008-2#1)(2008-3#1)
the refractive index##141##3##(2005-11#2)(2007-11#12)(2007-12#17)(2007-8#1)(2008-1#6)(2008-10#6)(2008-2#39)(2008-3#52)(2009-6#1)(2010-2#1)(2011-1#2)(2011-12#1)(2013-1#1)
the refractive indices and##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
the refractive indices of a##3##5##(2007-12#1)(2008-3#2)
the refractive indices of the sample##2##6##(2007-12#1)(2008-3#1)
the refractive indices of the##5##5##(2007-12#2)(2008-2#1)(2008-3#2)
the refractive indices of##14##4##(2007-12#3)(2008-2#2)(2008-3#9)
the refractive indices##22##3##(2007-12#4)(2008-2#6)(2008-3#12)
the refractive power##2##3##(2008-2#2)
the refractive##167##2##(2005-11#2)(2007-11#12)(2007-12#21)(2007-8#1)(2008-1#6)(2008-10#6)(2008-2#47)(2008-3#64)(2009-6#1)(2010-2#1)(2011-1#3)(2011-12#1)(2012-12#1)(2013-1#1)
the refractive-index change in##2##4##(2008-3#2)
the refractive-index change##7##3##(2007-11#1)(2007-12#1)(2008-3#5)
the refractive-index difference between the##3##5##(2008-2#3)
the refractive-index difference##4##3##(2008-2#4)
the refractive-index distribution induced##2##4##(2008-3#2)
the refractive-index distribution##4##3##(2008-2#1)(2008-3#3)
the refractive-index grating##2##3##(2007-12#2)
the refractive-index modulation##5##3##(2007-11#1)(2007-12#1)(2008-3#3)
the refractive-index profile of a##2##5##(2008-2#2)
the refractive-index profile of##5##4##(2008-2#5)
the refractive-index profile##11##3##(2008-2#11)
the refractive-index profiles of##2##4##(2008-1#1)(2008-3#1)
the refractive-index variation##2##3##(2008-3#2)
the refractive-index##49##2##(2007-11#4)(2007-12#6)(2008-1#1)(2008-2#20)(2008-3#18)
the refractometer##2##2##(2008-2#2)
the refractory period##2##3##(2004-11#1)(2008-11#1)
the refractory periods of##3##4##(1991-2#1)(1994-2#1)(1994-3#1)
the refractory periods##4##3##(1991-2#1)(1994-2#1)(1994-3#2)
the refractory##10##2##(1991-2#1)(1994-2#1)(1994-3#2)(2004-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#2)
the refugees##3##2##(1991-4#1)(2008-7#1)(2011-12#1)
the regenerated A##5##3##(2008-5#5)
the regenerated gratings##4##3##(2013-8#4)
the regenerated##18##2##(1997-2#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#5)(2008-8#1)(2012-12#2)(2013-8#4)
the regenerating liver##3##3##(1992-11#1)(1994-8#1)(2008-8#1)
the regenerating rat liver##4##4##(1991-7#3)(1992-4#1)
the regenerating##16##2##(1990-2#1)(1991-6#1)(1991-7#3)(1992-11#1)(1992-4#1)(1993-12#1)(1994-8#1)(1996-2#1)(1997-6#2)(2008-1#1)(2008-4#1)(2008-8#1)(2008-9#1)
the regeneration capacity of##2##4##(2007-3#1)(2008-9#1)
the regeneration capacity##3##3##(2007-3#1)(2008-9#2)
the regeneration of the##6##4##(1991-3#1)(2008-10#2)(2008-5#3)
the regeneration of##18##3##(1991-3#1)(1992-6#1)(1992-7#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#5)(2009-10#1)(2009-9#1)(2010-7#1)(2012-12#2)
the regeneration process##4##3##(1991-3#1)(1994-2#1)(2008-11#1)(2012-2#1)
the regeneration##28##2##(1990-11#1)(1991-3#2)(1992-6#1)(1992-7#1)(1994-2#1)(1994-8#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-5#5)(2008-9#2)(2009-10#1)(2009-9#1)(2010-7#1)(2012-12#2)(2012-2#1)
the regenerative amplifier##2##3##(2007-11#1)(2007-12#1)
the regenerative##9##2##(1993-3#1)(2007-11#2)(2007-12#2)(2009-10#1)(2011-1#1)(2012-12#1)(2013-8#1)
the regime in which##2##4##(2007-11#1)(2007-12#1)
the regime of##3##3##(2007-11#1)(2007-12#1)(2007-9#1)
the regime##6##2##(2007-11#2)(2007-12#2)(2007-9#1)(2008-2#1)
the regimen##15##2##(1992-1#1)(1994-11#1)(1994-2#1)(2005-12#1)(2006-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-9#1)(2010-12#1)(2012-1#1)(2012-3#1)(2013-8#2)
the region and the##2##4##(2007-3#1)(2013-7#1)
the region and##8##3##(1996-6#1)(2007-2#1)(2007-3#1)(2008-10#2)(2008-5#1)(2012-12#1)(2013-7#1)
the region are##2##3##(2008-10#1)(2012-12#1)
the region around the##3##4##(1995-7#1)(2006-2#1)(2007-7#1)
the region around##4##3##(1992-9#1)(1995-7#1)(2006-2#1)(2007-7#1)
the region between the##9##4##(1992-11#1)(1993-11#1)(1993-5#1)(1993-6#1)(1995-1#1)(1995-12#1)(1997-2#1)(1997-4#1)(2008-7#1)
the region between##20##3##(1990-3#1)(1991-12#1)(1991-7#1)(1992-11#1)(1993-11#1)(1993-5#1)(1993-6#1)(1994-11#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-6#1)(1996-7#1)(1997-2#2)(1997-4#1)(2005-8#1)(2008-1#1)(2008-7#1)(2008-9#1)
the region close to##2##4##(1995-10#1)(2007-12#1)
the region coding for the##2##5##(1991-6#1)(1994-2#1)
the region coding for##5##4##(1991-12#2)(1991-6#1)(1994-2#1)(2013-1#1)
the region containing the##3##4##(1990-2#1)(1996-12#1)(1997-4#1)
the region containing##6##3##(1990-2#1)(1990-7#1)(1991-7#1)(1995-3#1)(1996-12#1)(1997-4#1)
the region corresponding to##3##4##(1991-2#1)(1996-2#1)(1996-7#1)
the region downstream of the##2##5##(1996-12#1)(1996-7#1)
the region downstream of##3##4##(1991-7#1)(1996-12#1)(1996-7#1)
the region downstream##5##3##(1990-5#1)(1991-7#1)(1993-12#1)(1996-12#1)(1996-7#1)
the region encoding the##3##4##(1996-10#1)(1997-2#2)
the region for##3##3##(1991-12#1)(2011-1#1)(2013-1#1)
the region from the##2##4##(1991-3#1)(1994-3#1)
the region from##11##3##(1991-3#1)(1992-9#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-10#2)(1996-6#1)(1997-7#1)(2008-1#1)(2008-11#1)
the region in the##2##4##(1995-8#1)(1996-2#1)
the region in##4##3##(1995-8#1)(1996-2#1)(2008-1#1)(2013-8#1)
the region including the##2##4##(1990-3#1)(1996-12#1)
the region including##3##3##(1990-3#1)(1992-11#1)(1996-12#1)
the region involved##2##3##(1994-12#1)(1997-7#1)
the region is##3##3##(2007-7#1)(2008-3#1)(2012-2#1)
the region might##2##3##(2007-3#1)(2008-10#1)
the region near##3##3##(2007-11#1)(2007-12#1)(2007-8#1)
the region of chromosome##3##4##(1997-5#1)(2008-10#1)(2012-12#1)
the region of interest##6##4##(1994-3#1)(2008-3#2)(2010-6#1)(2011-1#1)(2012-2#1)
the region of the entorhinal and piriform##2##7##(1991-1#2)
the region of the##56##4##(1990-7#1)(1991-1#2)(1991-11#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-10#1)(1992-12#1)(1992-4#2)(1992-9#1)(1993-1#2)(1993-11#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#2)(1995-3#1)(1995-6#1)(1996-1#2)(1996-12#2)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#1)(2004-9#1)(2006-12#1)(2007-12#4)(2007-2#1)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2009-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
the region of##125##3##(1990-10#1)(1990-12#1)(1990-6#1)(1990-7#2)(1991-1#2)(1991-11#1)(1991-3#2)(1991-4#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#2)(1992-4#2)(1992-9#1)(1993-1#2)(1993-11#2)(1994-11#1)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-3#3)(1995-6#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-4#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#1)(2004-9#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#6)(2007-2#1)(2007-3#2)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#2)(2009-9#1)(2010-6#1)(2011-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)
the region showed##2##3##(2008-10#2)
the region stained with Evans blue##2##6##(2012-2#2)
the region that is##2##4##(1995-6#1)(2008-10#1)
the region that##6##3##(1991-9#1)(1995-6#1)(2006-6#1)(2008-10#3)
the region to##5##3##(1990-11#1)(2008-11#1)(2008-4#1)(2008-8#1)(2013-1#1)
the region upstream from the##2##5##(1993-9#1)(1995-8#1)
the region was##5##3##(1991-9#1)(1995-11#1)(2008-10#1)(2008-3#1)(2008-8#1)
the region were##6##3##(1996-5#1)(2007-10#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-5#1)
the region where##2##3##(1993-11#1)(2008-10#1)
the region##384##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#2)(1990-7#3)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#6)(1991-2#1)(1991-3#3)(1991-4#2)(1991-5#1)(1991-6#3)(1991-7#5)(1991-9#4)(1992-10#1)(1992-11#2)(1992-12#3)(1992-4#3)(1992-9#3)(1993-1#2)(1993-11#4)(1993-12#2)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#3)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#3)(1995-1#3)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#6)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#3)(1996-1#3)(1996-10#3)(1996-11#2)(1996-12#5)(1996-2#2)(1996-4#2)(1996-5#5)(1996-6#2)(1996-7#4)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#4)(1997-5#2)(1997-7#3)(1997-8#5)(1997-9#1)(2004-9#1)(2005-5#2)(2005-8#2)(2005-9#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#3)(2006-7#1)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#9)(2007-2#4)(2007-3#8)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#5)(2008-1#9)(2008-10#35)(2008-11#6)(2008-12#3)(2008-2#9)(2008-3#11)(2008-4#6)(2008-5#12)(2008-6#3)(2008-7#3)(2008-8#9)(2008-9#3)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#4)(2011-2#9)(2012-12#6)(2012-2#9)(2012-3#2)(2013-1#7)(2013-7#3)(2013-8#2)
the region's##8##2##(2007-2#2)(2008-2#1)(2008-3#1)(2008-7#1)(2012-11#1)(2013-1#2)
the regional albedo##2##3##(2008-3#2)
the regional anatomical and##2##4##(2006-3#1)(2008-4#1)
the regional and cellular##2##4##(1996-2#1)(2008-4#1)
the regional and##4##3##(1992-5#1)(1996-2#1)(2008-1#1)(2008-4#1)
the regional differences##2##3##(1994-2#1)(2011-12#1)
the regional distribution of##3##4##(1990-7#1)(2008-3#1)(2013-7#1)
the regional distribution##4##3##(1990-7#1)(1995-5#1)(2008-3#1)(2013-7#1)
the regional hospital##2##3##(1995-5#1)(2008-5#1)
the regional lymph nodes##5##4##(1997-4#1)(2006-6#1)(2008-6#2)(2009-1#1)
the regional lymph##6##3##(1997-4#1)(2006-6#1)(2008-6#2)(2009-1#1)(2013-8#1)
the regional polysterism##2##3##(1997-7#2)
the regional spread of##2##4##(2008-10#2)
the regional vascular##3##3##(1993-3#1)(1996-12#1)(1997-6#1)
the regional##85##2##(1990-11#1)(1990-7#1)(1991-12#1)(1992-5#1)(1992-8#1)(1993-3#2)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-5#4)(1995-7#2)(1996-12#2)(1996-2#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-4#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#3)(2008-8#1)(2008-9#1)(2009-1#1)(2009-7#2)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-12#1)(2011-2#4)(2012-12#2)(2013-7#2)(2013-8#3)
the regions and##2##3##(2007-1#1)(2008-2#1)
the regions examined##2##3##(1994-2#1)(1995-2#1)
the regions in the##2##4##(1995-3#1)(2006-10#1)
the regions in which the##2##5##(1997-6#1)(2006-8#1)
the regions in##4##3##(1995-3#1)(1997-6#1)(2006-10#1)(2006-8#1)
the regions involved in##3##4##(1991-2#1)(1996-8#1)(1997-7#1)
the regions of interest##4##4##(2007-4#1)(2011-1#1)(2013-1#2)
the regions of the##9##4##(1990-12#1)(1991-12#1)(1993-12#2)(1994-12#1)(1995-8#1)(2008-2#1)(2008-8#1)(2008-9#1)
the regions of##26##3##(1990-11#1)(1990-12#1)(1991-12#1)(1991-6#1)(1993-12#2)(1993-8#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-8#1)(1997-8#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2010-2#1)(2011-1#1)(2013-1#2)
the regions where##2##3##(2008-11#1)(2008-4#1)
the regions with##2##3##(2006-4#1)(2008-10#1)
the regions##76##2##(1990-11#1)(1990-12#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-11#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-9#1)(2006-10#4)(2006-3#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-2#1)(2010-8#1)(2011-1#1)(2012-2#2)(2013-1#2)(2013-8#2)
the regioselective##7##2##(1994-11#1)(1996-2#1)(2005-7#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)
the regioselectivity of##2##3##(1994-5#1)(2012-3#1)
the regioselectivity##5##2##(1994-5#1)(1994-8#1)(1996-5#1)(2008-8#1)(2012-3#1)
the regiospecificity of##2##3##(1994-9#2)
the register##9##2##(1995-8#4)(2006-8#1)(2007-2#2)(2008-11#1)(2008-12#1)
the registered##3##2##(1997-2#1)(2006-7#1)(2011-2#1)
the registers##2##2##(1995-2#1)(2013-1#1)
the registrants##2##2##(2007-4#2)
the registration and##2##3##(2007-11#1)(2010-12#1)
the registration authorities##2##3##(2005-10#1)(2007-8#1)
the registration of##7##3##(1991-10#1)(1994-2#1)(2008-3#2)(2008-5#1)(2009-2#1)(2010-3#1)
the registration##23##2##(1990-9#1)(1991-10#1)(1994-2#1)(2005-10#1)(2006-9#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2009-2#1)(2010-12#2)(2010-3#1)(2011-2#1)
the registry##6##2##(1993-5#1)(1997-2#1)(2006-12#1)(2008-8#1)(2011-2#2)
the regolith##2##2##(1990-8#2)
the regression analysis##3##3##(2008-10#3)
the regression between##2##3##(2009-4#1)(2010-2#1)
the regression coefficients are##2##4##(1994-5#1)(2010-11#1)
the regression coefficients##10##3##(1994-5#1)(1995-9#1)(1997-6#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-6#1)(2010-11#1)
the regression equation was##2##4##(2005-12#1)(2008-10#1)
the regression equation##10##3##(1993-9#1)(2005-12#1)(2005-4#1)(2008-10#5)(2009-11#1)(2012-12#1)
the regression equations##2##3##(2007-12#1)(2011-2#1)
the regression lines of##2##4##(1990-12#1)(1992-1#1)
the regression lines##4##3##(1990-12#1)(1992-1#1)(2008-10#2)
the regression model##8##3##(2008-10#3)(2008-11#2)(2008-3#1)(2010-4#1)(2013-8#1)
the regression models##4##3##(1990-12#1)(1990-2#1)(2009-10#1)(2010-11#1)
the regression of the##4##4##(1995-11#1)(2008-12#1)(2008-8#1)(2010-1#1)
the regression of##11##3##(1994-3#1)(1995-11#1)(1996-2#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)
the regression parameters##4##3##(1992-9#1)(1995-6#1)(2008-3#1)(2008-7#1)
the regression slope##2##3##(2008-10#1)(2013-1#1)
the regression triplet##2##3##(2008-10#2)
the regression##84##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-7#1)(1992-1#1)(1992-9#1)(1993-7#1)(1993-9#1)(1994-3#1)(1994-4#1)(1994-5#1)(1995-11#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-2#1)(1997-2#1)(1997-6#2)(2005-12#1)(2005-4#1)(2006-10#1)(2006-7#1)(2007-11#2)(2007-12#1)(2008-10#25)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#4)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2010-1#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-7#1)(2013-1#1)(2013-8#1)
the regrowth##2##2##(1992-9#1)(1995-11#1)
the regular consumption of##2##4##(2008-1#1)(2008-5#1)
the regular solution theory##4##4##(2008-10#4)
the regular solution##5##3##(1994-12#1)(2008-10#4)
the regular use of##2##4##(2008-11#1)(2008-5#1)
the regular##39##2##(1992-10#1)(1993-1#1)(1993-10#1)(1993-3#1)(1994-12#2)(1996-11#1)(1996-4#1)(1997-6#2)(2005-7#1)(2005-9#1)(2007-12#3)(2007-4#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#3)(2008-7#1)(2010-12#1)(2011-2#1)(2013-7#1)(2013-8#1)
the regularities of##2##3##(2007-11#1)(2010-9#1)
the regularity of##2##3##(2006-10#1)(2008-2#1)
the regularity##3##2##(2006-10#1)(2007-12#1)(2008-2#1)
the regularization parameter##3##3##(2008-10#1)(2008-3#1)(2010-2#1)
the regularization##5##2##(2008-10#1)(2008-3#2)(2008-6#1)(2010-2#1)
the regularized image u(x##2##4##(2008-6#2)
the regularized phase-tracking##2##3##(2008-3#2)
the regularized##7##2##(2008-2#3)(2008-3#2)(2008-6#2)
the regularly scheduled use of##2##5##(2005-8#2)
the regularly##4##2##(2005-8#2)(2008-2#1)(2008-5#1)
the regulated and constitutive secretory pathways##2##6##(1992-12#2)
the regulated and##3##3##(1992-12#2)(2008-5#1)
the regulated pathway##2##3##(1990-3#1)(1990-5#1)
the regulated secretory pathway##5##4##(1990-5#2)(1994-11#2)(1996-4#1)
the regulated secretory##6##3##(1990-5#2)(1994-11#2)(1996-4#1)(2010-11#1)
the regulated##27##2##(1990-3#1)(1990-5#3)(1992-12#2)(1992-3#2)(1994-11#2)(1994-12#1)(1994-2#1)(1995-2#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-12#1)(2008-4#3)(2008-5#1)(2010-11#2)(2011-1#1)(2013-8#1)
the regulating##4##2##(1992-9#1)(1994-6#1)(2008-4#1)(2008-7#1)
the regulation and##7##3##(1990-4#1)(2006-12#1)(2008-5#1)(2010-10#2)(2011-1#1)(2011-12#1)
the regulation by##3##3##(1992-11#1)(1995-12#1)(1996-2#1)
the regulation mechanism of the##2##5##(1997-8#1)(2008-9#1)
the regulation mechanism of##3##4##(1997-8#1)(2008-11#1)(2008-9#1)
the regulation of APP gene expression##2##6##(1990-8#1)(1994-9#1)
the regulation of Ca2+##4##4##(1992-9#1)(1994-2#1)(1995-11#1)(1995-6#1)
the regulation of DNA synthesis##2##5##(1990-10#1)(1994-8#1)
the regulation of DNA##3##4##(1990-10#1)(1994-8#2)
the regulation of PEPCK gene expression by insulin##4##8##(1995-6#2)(1996-2#2)
the regulation of PEPCK gene expression##5##6##(1995-6#3)(1996-2#2)
the regulation of PEPCK gene##6##5##(1995-6#3)(1996-2#3)
the regulation of T cell##2##5##(1994-8#1)(2012-1#1)
the regulation of a##3##4##(2007-11#1)(2008-10#1)(2010-12#1)
the regulation of alkaline phosphatase activity##2##6##(1993-11#1)(1994-2#1)
the regulation of alkaline phosphatase##3##5##(1993-11#1)(1994-2#2)
the regulation of apoptosis##3##4##(1994-10#1)(2007-1#1)(2008-8#1)
the regulation of atypical##4##4##(2012-12#4)
the regulation of basal##3##4##(1994-12#1)(1996-5#1)(2013-1#1)
the regulation of both##3##4##(1990-3#1)(2006-1#1)(2006-4#1)
the regulation of brain##4##4##(1991-4#1)(1994-12#1)(1996-12#1)(2008-1#1)
the regulation of calcium##2##4##(1990-7#1)(1995-3#1)
the regulation of cancer##2##4##(2008-11#1)(2012-12#1)
the regulation of cell cycle##2##5##(1993-6#1)(2012-12#1)
the regulation of cell growth and differentiation##2##7##(1991-10#1)(1994-10#1)
the regulation of cell growth and##4##6##(1991-10#1)(1994-10#1)(2005-8#1)(2008-4#1)
the regulation of cell growth##6##5##(1991-10#1)(1994-10#1)(1994-12#1)(2005-8#1)(2007-10#1)(2008-4#1)
the regulation of cell proliferation##3##5##(2008-4#2)(2008-5#1)
the regulation of cell##20##4##(1991-10#1)(1992-7#1)(1993-6#1)(1994-10#2)(1994-12#1)(1995-6#1)(1996-3#1)(2005-8#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-4#5)(2008-5#1)(2008-8#1)(2012-12#1)
the regulation of cellular differentiation##2##5##(2008-7#1)(2008-9#1)
the regulation of cellular functions##3##5##(2007-1#3)
the regulation of cellular##11##4##(1991-4#1)(1991-5#1)(2007-1#3)(2007-10#1)(2007-6#1)(2008-1#1)(2008-7#2)(2008-9#1)
the regulation of cholesterol metabolism##2##5##(2010-12#1)(2013-1#1)
the regulation of delta-opioid receptor##2##5##(1997-8#2)
the regulation of endothelial cell##2##5##(2010-9#1)(2012-3#1)
the regulation of energy homeostasis##3##5##(2008-1#1)(2008-10#1)(2008-4#1)
the regulation of energy##5##4##(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-8#1)
the regulation of estrogen receptor##2##5##(1997-4#1)(2006-5#1)
the regulation of expression of the##3##6##(1991-8#1)(1996-5#1)(2009-9#1)
the regulation of expression of##5##5##(1991-10#1)(1991-8#1)(1996-5#1)(2007-11#1)(2009-9#1)
the regulation of food intake##9##5##(1991-5#1)(1993-7#2)(1994-12#1)(2006-1#1)(2006-10#2)(2006-6#1)(2012-1#1)
the regulation of gastric##4##4##(1990-5#1)(1991-9#1)(1992-6#1)(2006-10#1)
the regulation of gene expression##15##5##(1991-6#1)(1992-5#1)(1996-4#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
the regulation of genes involved in##2##6##(2007-8#1)(2008-1#1)
the regulation of genes##3##4##(2007-8#1)(2008-1#2)
the regulation of glucagon##4##4##(1995-6#1)(2010-11#3)
the regulation of glucose homeostasis##2##5##(1990-3#1)(2008-4#1)
the regulation of glucose##5##4##(1990-3#1)(1991-3#1)(1991-5#1)(1992-11#1)(2008-4#1)
the regulation of growth hormone##2##5##(1991-1#1)(2006-6#1)
the regulation of growth##5##4##(1990-12#1)(1991-1#1)(1994-8#1)(1996-11#1)(2006-6#1)
the regulation of human##4##4##(1994-12#1)(1995-2#1)(1996-10#1)(2008-1#1)
the regulation of insulin##6##4##(1991-1#1)(1994-3#1)(2008-1#1)(2011-1#1)(2013-1#2)
the regulation of intestinal##2##4##(1994-8#1)(2008-4#1)
the regulation of intracellular##5##4##(1990-7#1)(1990-8#1)(1995-11#1)(2007-11#1)(2010-2#1)
the regulation of its##3##4##(1995-11#1)(1996-2#1)(1997-4#1)
the regulation of liver##2##4##(2011-12#1)(2011-2#1)
the regulation of local##2##4##(2008-4#1)(2012-12#1)
the regulation of mitochondrial##3##4##(2005-8#1)(2008-7#2)
the regulation of myocardial##2##4##(1990-2#1)(2005-7#1)
the regulation of neural##2##4##(1996-4#1)(2006-11#1)
the regulation of ocular dominance plasticity##2##6##(1991-8#2)
the regulation of osteoblast##2##4##(1991-12#1)(1991-5#1)
the regulation of pancreatic##5##4##(1991-5#1)(2006-10#4)
the regulation of photoreceptor##2##4##(1996-2#1)(2008-7#1)
the regulation of proliferation of##2##5##(1992-8#1)(2013-8#1)
the regulation of proliferation##4##4##(1992-8#1)(2008-4#1)(2013-1#1)(2013-8#1)
the regulation of protein##4##4##(1990-5#1)(1990-8#1)(1992-8#1)(2008-11#1)
the regulation of renal##2##4##(2012-12#2)
the regulation of ribonucleotide##2##4##(1990-2#1)(1993-11#1)
the regulation of several##2##4##(1994-6#1)(1996-3#1)
the regulation of specific##3##4##(1996-11#1)(1996-8#1)(2007-10#1)
the regulation of spermatogenesis##2##4##(2012-2#2)
the regulation of surrogacy##2##4##(2006-10#2)
the regulation of the actin cytoskeleton##2##6##(1991-5#1)(2008-5#1)
the regulation of the immune system##3##6##(2007-11#1)(2007-5#1)(2008-4#1)
the regulation of the immune##5##5##(1991-2#1)(2007-11#1)(2007-5#1)(2008-4#2)
the regulation of the##74##4##(1990-10#1)(1990-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-9#1)(1992-11#2)(1992-12#2)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#3)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-6#1)(1994-8#1)(1995-12#4)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#3)(1996-12#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-11#4)(2007-12#1)(2007-5#1)(2007-9#1)(2008-11#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
the regulation of their expression##4##5##(1994-11#1)(2006-10#1)(2008-4#1)(2008-8#1)
the regulation of their##5##4##(1994-11#1)(1997-7#1)(2006-10#1)(2008-4#1)(2008-8#1)
the regulation of these##10##4##(1990-5#1)(1991-2#1)(1993-3#1)(1994-12#1)(2008-1#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)
the regulation of this##6##4##(1992-4#2)(1996-5#1)(1996-7#1)(2006-10#1)(2011-2#1)
the regulation of tissue##2##4##(2007-12#1)(2010-3#1)
the regulation of transcription##3##4##(1997-3#1)(1997-4#1)(2011-2#1)
the regulation of vascular tone##2##5##(2008-5#1)(2009-4#1)
the regulation of vascular##4##4##(1994-12#1)(2006-6#1)(2008-5#1)(2009-4#1)
the regulation of##606##3##(1990-10#3)(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#4)(1990-5#5)(1990-6#1)(1990-7#3)(1990-8#7)(1990-9#1)(1991-1#2)(1991-10#4)(1991-11#3)(1991-12#3)(1991-2#4)(1991-3#1)(1991-4#4)(1991-5#9)(1991-6#3)(1991-7#2)(1991-8#5)(1991-9#4)(1992-1#2)(1992-11#5)(1992-12#3)(1992-2#1)(1992-4#4)(1992-5#2)(1992-6#7)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#3)(1993-12#8)(1993-2#1)(1993-3#2)(1993-5#5)(1993-6#5)(1993-7#2)(1993-8#3)(1993-9#1)(1994-10#3)(1994-11#7)(1994-12#13)(1994-2#7)(1994-3#7)(1994-5#3)(1994-6#2)(1994-8#8)(1994-9#5)(1995-10#3)(1995-11#5)(1995-12#10)(1995-2#8)(1995-3#10)(1995-5#4)(1995-6#8)(1995-8#5)(1996-1#1)(1996-10#1)(1996-11#4)(1996-12#4)(1996-2#13)(1996-3#5)(1996-4#4)(1996-5#9)(1996-7#1)(1996-8#2)(1997-1#3)(1997-2#4)(1997-3#3)(1997-4#8)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#4)(2005-10#1)(2005-7#1)(2005-8#2)(2006-1#3)(2006-10#26)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-8#1)(2007-1#5)(2007-10#4)(2007-11#9)(2007-12#7)(2007-5#1)(2007-6#1)(2007-8#3)(2007-9#3)(2008-1#13)(2008-10#4)(2008-11#10)(2008-3#1)(2008-4#26)(2008-5#9)(2008-6#4)(2008-7#14)(2008-8#13)(2008-9#5)(2009-10#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#9)(2009-9#3)(2010-10#3)(2010-11#4)(2010-12#12)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-12#4)(2011-2#12)(2011-3#1)(2012-1#6)(2012-12#14)(2012-2#8)(2012-3#2)(2012-7#1)(2013-1#12)(2013-7#4)(2013-8#3)
the regulation##634##2##(1990-10#3)(1990-11#3)(1990-12#2)(1990-2#3)(1990-3#4)(1990-4#1)(1990-5#6)(1990-6#1)(1990-7#3)(1990-8#7)(1990-9#1)(1991-1#2)(1991-10#4)(1991-11#3)(1991-12#3)(1991-2#4)(1991-3#1)(1991-4#4)(1991-5#9)(1991-6#3)(1991-7#2)(1991-8#5)(1991-9#4)(1992-1#2)(1992-11#6)(1992-12#3)(1992-2#1)(1992-4#4)(1992-5#2)(1992-6#7)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#3)(1993-12#8)(1993-2#1)(1993-3#2)(1993-5#5)(1993-6#5)(1993-7#2)(1993-8#3)(1993-9#1)(1994-10#3)(1994-11#8)(1994-12#13)(1994-2#7)(1994-3#7)(1994-5#3)(1994-6#2)(1994-8#8)(1994-9#5)(1995-10#3)(1995-11#5)(1995-12#11)(1995-2#8)(1995-3#10)(1995-5#4)(1995-6#8)(1995-8#5)(1996-1#1)(1996-10#1)(1996-11#4)(1996-12#4)(1996-2#14)(1996-3#5)(1996-4#4)(1996-5#9)(1996-7#1)(1996-8#2)(1997-1#3)(1997-2#4)(1997-3#3)(1997-4#8)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#5)(2005-10#1)(2005-7#1)(2005-8#2)(2006-1#3)(2006-10#26)(2006-11#1)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#3)(2006-8#1)(2007-1#5)(2007-10#4)(2007-11#9)(2007-12#8)(2007-5#1)(2007-6#1)(2007-8#3)(2007-9#3)(2008-1#13)(2008-10#6)(2008-11#13)(2008-3#1)(2008-4#27)(2008-5#10)(2008-6#4)(2008-7#14)(2008-8#14)(2008-9#7)(2009-10#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#9)(2009-9#3)(2010-10#5)(2010-11#5)(2010-12#12)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#6)(2011-12#5)(2011-2#14)(2011-3#1)(2012-1#6)(2012-12#14)(2012-2#8)(2012-3#3)(2012-7#1)(2013-1#12)(2013-7#4)(2013-8#3)
the regulations and##2##3##(1991-1#1)(1993-12#1)
the regulations for##2##3##(1991-8#1)(1993-3#1)
the regulations of##2##3##(1995-6#1)(2013-8#1)
the regulations##18##2##(1991-1#1)(1991-8#1)(1993-12#1)(1993-3#2)(1995-6#1)(2005-5#1)(2006-8#7)(2007-12#1)(2007-4#1)(2008-11#1)(2013-8#1)
the regulator##11##2##(1990-7#6)(1995-2#2)(1995-6#1)(2008-7#1)(2012-2#1)
the regulators of##3##3##(1994-12#1)(2005-12#1)(2010-2#1)
the regulators##6##2##(1994-12#1)(1995-5#1)(2005-12#1)(2008-9#1)(2010-2#1)(2012-2#1)
the regulatory T##2##3##(2011-2#2)
the regulatory agencies##3##3##(1997-2#1)(2008-12#1)(2012-2#1)
the regulatory and catalytic##2##4##(1992-6#1)(1993-6#1)
the regulatory and##5##3##(1992-6#1)(1993-6#1)(1996-8#1)(2010-11#1)(2012-1#1)
the regulatory authority##2##3##(2008-11#2)
the regulatory complex##3##3##(1997-7#3)
the regulatory domain of PKC##2##5##(1990-12#1)(1993-8#1)
the regulatory domain of PKC-delta##2##5##(1994-2#2)
the regulatory domain of protein kinase C zeta##2##8##(1994-12#2)
the regulatory domain of protein kinase C##3##7##(1994-12#2)(1994-8#1)
the regulatory domain of the##2##5##(1990-12#1)(1990-7#1)
the regulatory domain of##13##4##(1990-12#2)(1990-7#1)(1993-8#1)(1994-12#2)(1994-2#2)(1994-8#1)(1995-3#1)(1995-6#1)(1996-11#2)
the regulatory domain##19##3##(1990-12#4)(1990-7#1)(1993-8#1)(1994-12#2)(1994-2#2)(1994-8#1)(1995-3#1)(1995-6#1)(1996-11#4)(1996-5#1)(1997-6#1)
the regulatory domains##3##3##(1995-11#1)(1996-11#1)(1996-5#1)
the regulatory effects##2##3##(1993-6#1)(2013-1#1)
the regulatory elements##5##3##(1993-5#1)(1994-5#1)(1997-2#1)(1997-7#2)
the regulatory factors of##2##4##(1993-9#1)(2013-8#1)
the regulatory function of##4##4##(1990-3#1)(1991-12#1)(1991-2#1)(2008-9#1)
the regulatory functions of the##2##5##(1990-11#1)(2012-1#1)
the regulatory functions of##3##4##(1990-11#1)(2010-11#1)(2012-1#1)
the regulatory gene##3##3##(2008-1#1)(2008-10#1)(2011-1#1)
the regulatory light##2##3##(1995-1#1)(1996-4#1)
the regulatory mechanism for the##3##5##(1995-2#1)(1997-4#1)(2010-11#1)
the regulatory mechanism for##4##4##(1995-2#1)(1997-4#1)(2010-11#1)(2011-10#1)
the regulatory mechanism of##5##4##(1992-11#1)(1996-7#1)(1997-2#1)(2008-1#1)(2009-8#1)
the regulatory mechanism##12##3##(1991-1#1)(1992-11#1)(1995-2#1)(1996-7#1)(1997-2#1)(1997-4#1)(2006-12#1)(2008-1#1)(2008-8#1)(2009-8#1)(2010-11#1)(2011-10#1)
the regulatory mechanisms of##5##4##(1993-9#1)(1997-4#1)(2010-12#1)(2011-2#2)
the regulatory mechanisms that##2##4##(1994-8#1)(2011-1#1)
the regulatory mechanisms##9##3##(1993-9#1)(1994-8#1)(1997-4#1)(2008-7#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)
the regulatory network##3##3##(2008-7#1)(2009-12#1)(2010-10#1)
the regulatory networks##3##3##(2008-11#1)(2008-7#1)(2010-7#1)
the regulatory processes##2##3##(2009-3#1)(2013-7#1)
the regulatory properties of##3##4##(1994-8#1)(1997-6#1)(2006-10#1)
the regulatory properties##4##3##(1994-2#1)(1994-8#1)(1997-6#1)(2006-10#1)
the regulatory protein##8##3##(1990-7#6)(1997-2#1)(2009-10#1)
the regulatory proteins of##3##4##(1993-8#1)(1995-8#1)(1995-9#1)
the regulatory region R &amp##2##5##(1996-2#2)
the regulatory region of the##3##5##(1992-2#1)(1995-6#1)(2008-4#1)
the regulatory region of##4##4##(1990-7#1)(1992-2#1)(1995-6#1)(2008-4#1)
the regulatory region##9##3##(1990-11#1)(1990-7#1)(1992-2#1)(1995-6#1)(1996-2#4)(2008-4#1)
the regulatory regions of the human##2##6##(1995-12#1)(2008-11#1)
the regulatory regions of the##3##5##(1995-12#1)(2008-11#1)(2012-2#1)
the regulatory regions of##4##4##(1994-5#1)(1995-12#1)(2008-11#1)(2012-2#1)
the regulatory regions##5##3##(1994-5#1)(1995-12#1)(2008-11#1)(2012-2#2)
the regulatory role of##4##4##(1991-12#1)(1993-3#1)(2009-12#1)(2009-8#1)
the regulatory sequences that##2##4##(1994-9#1)(1995-2#1)
the regulatory site##3##3##(1990-4#1)(1991-12#1)(1992-12#1)
the regulatory subunit of PKA##3##5##(1997-1#2)(1997-5#1)
the regulatory subunit of##5##4##(1995-2#1)(1997-1#2)(1997-5#2)
the regulatory subunit##13##3##(1990-10#1)(1990-8#1)(1994-9#1)(1995-11#1)(1995-2#2)(1997-1#3)(1997-5#2)(1997-6#1)(2008-8#1)
the regulatory subunits##3##3##(1990-10#1)(1992-8#1)(1993-6#1)
the regulatory##193##2##(1990-10#2)(1990-11#2)(1990-12#4)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#8)(1990-8#2)(1991-1#1)(1991-12#3)(1991-2#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-8#1)(1993-3#2)(1993-5#1)(1993-6#3)(1993-8#3)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#5)(1996-12#2)(1996-2#5)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-1#4)(1997-2#5)(1997-4#2)(1997-5#3)(1997-6#4)(1997-7#6)(2005-8#1)(2006-10#3)(2006-12#1)(2006-8#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#4)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#2)(2009-3#1)(2009-6#2)(2009-8#2)(2010-10#1)(2010-11#4)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-10#1)(2011-12#2)(2011-2#5)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
the regurgitation##3##2##(1995-3#1)(1997-7#1)(2010-11#1)
the rehabilitation department##2##3##(1995-9#1)(2007-7#1)
the rehabilitation manager##2##3##(1993-12#2)
the rehabilitation of patients with##7##5##(2007-11#5)(2008-10#1)(2012-1#1)
the rehabilitation of patients##10##4##(2007-11#5)(2007-8#2)(2008-10#1)(2012-1#1)(2013-1#1)
the rehabilitation of spinal cord##2##5##(1996-9#2)
the rehabilitation of the##3##4##(1992-12#1)(2008-8#1)(2010-3#1)
the rehabilitation of##30##3##(1992-12#1)(1996-9#2)(2006-12#1)(2007-11#6)(2007-8#4)(2008-10#1)(2008-7#2)(2008-8#1)(2010-3#2)(2011-12#1)(2011-2#1)(2011-7#1)(2012-1#3)(2012-3#1)(2013-1#3)
the rehabilitation outcome##2##3##(1990-8#1)(2007-7#1)
the rehabilitation period##4##3##(1995-5#1)(1995-9#1)(2008-6#2)
the rehabilitation process after##2##4##(2007-11#1)(2010-10#1)
the rehabilitation process is##3##4##(2007-8#1)(2010-10#1)(2013-1#1)
the rehabilitation process##13##3##(1996-3#1)(2006-2#1)(2007-11#4)(2007-7#1)(2007-8#1)(2010-10#2)(2011-2#1)(2012-12#1)(2013-1#1)
the rehabilitation program##8##3##(2006-12#1)(2006-3#1)(2007-12#1)(2007-7#1)(2007-8#3)(2012-1#1)
the rehabilitation programme##6##3##(1990-4#1)(2005-1#1)(2006-8#2)(2008-11#1)(2013-1#1)
the rehabilitation protocol##2##3##(2006-3#1)(2009-9#1)
the rehabilitation team##3##3##(1991-4#1)(2007-11#1)(2007-8#1)
the rehabilitation##96##2##(1990-4#1)(1990-8#1)(1991-4#1)(1991-6#1)(1992-12#1)(1993-12#3)(1995-5#3)(1995-9#2)(1996-3#1)(1996-9#3)(2005-1#1)(2006-12#2)(2006-2#1)(2006-3#2)(2006-5#1)(2006-8#3)(2007-10#1)(2007-11#12)(2007-12#1)(2007-7#5)(2007-8#9)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-9#2)(2010-10#2)(2010-3#2)(2011-1#1)(2011-12#1)(2011-2#2)(2011-7#1)(2012-1#7)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)
the rehabilitative outcomes are still poor##2##6##(2013-1#2)
the rehabilitative##5##2##(2007-10#1)(2008-10#2)(2013-1#2)
the reimbursement rate decrease##2##4##(2007-10#2)
the reimbursement##7##2##(1992-11#1)(1993-12#1)(2007-10#2)(2007-4#1)(2013-1#2)
the reindeer##2##2##(1992-4#1)(2009-2#1)
the reinforcement rate and##2##4##(1990-2#2)
the reinforcement signal##2##3##(1997-7#1)(2009-8#1)
the reinforcement well##2##3##(1997-6#2)
the reinforcement##13##2##(1990-2#3)(1996-10#1)(1997-6#2)(1997-7#1)(2008-2#1)(2008-8#1)(2009-10#1)(2009-7#2)(2009-8#1)
the reinforcer##2##2##(1997-7#2)
the reinforcing effects of##2##4##(1994-2#1)(2008-4#1)
the reinforcing efficacy of##2##4##(1991-1#1)(2008-1#1)
the reinforcing properties of ethanol##2##5##(1996-10#2)
the reinforcing##7##2##(1991-1#1)(1993-6#1)(1994-2#1)(1996-10#2)(2008-1#1)(2008-4#1)
the reinnervation of##2##3##(2013-8#2)
the reinnervation##3##2##(1991-11#1)(2013-8#2)
the reintroduction##3##2##(2007-2#2)(2010-3#1)
the reinvasion of##2##3##(1990-6#2)
the reiterated##2##2##(1991-7#1)(2012-12#1)
the reiterative##2##2##(1991-2#1)(2008-11#1)
the rejection of the##2##4##(2008-10#2)
the rejection of##7##3##(1996-1#1)(2006-10#1)(2006-12#1)(2008-10#3)(2008-8#1)
the rejection##9##2##(1995-2#1)(1996-1#1)(2006-10#1)(2006-12#1)(2008-10#3)(2008-8#1)(2013-7#1)
the rejections or transfers due to lack of capacity and the random length of stays##2##15##(2010-8#2)
the rejections##3##2##(2008-3#1)(2010-8#2)
the relapse rate was##2##4##(2004-1#2)
the relapse rate##8##3##(2004-1#2)(2005-7#1)(2007-1#1)(2007-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
the relapse##16##2##(1990-10#1)(1996-11#1)(2004-1#2)(2005-7#1)(2006-2#1)(2006-7#1)(2007-1#1)(2007-11#1)(2008-1#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#2)
the relapsed##3##2##(2008-3#2)(2008-6#1)
the relapses##2##2##(2007-7#1)(2008-11#1)
the related cardiovascular##2##3##(2008-1#1)(2010-9#1)
the related factors##3##3##(2011-2#1)(2012-3#1)(2013-7#1)
the related literature##5##3##(2006-11#1)(2008-10#1)(2008-9#1)(2012-12#2)
the related strain##2##3##(2006-8#1)(2008-10#1)
the related wild##2##3##(1994-6#1)(2011-12#1)
the related##96##2##(1990-10#1)(1990-11#1)(1990-4#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#2)(1996-1#1)(1996-11#2)(1996-12#1)(1996-5#1)(2005-11#3)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#2)(2007-12#3)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#4)(2009-12#3)(2009-8#2)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#1)(2011-3#1)(2012-12#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
the relatedness of##3##3##(1997-4#1)(2008-10#1)(2010-2#1)
the relatedness##4##2##(1997-4#1)(2008-10#1)(2009-5#1)(2010-2#1)
the relation between RC teacher practices and##2##7##(2008-12#2)
the relation between RC##3##4##(2008-12#3)
the relation between dietary##2##4##(1994-2#1)(2007-12#1)
the relation between personality and depression##2##6##(2010-12#2)
the relation between personality and##3##5##(2008-3#1)(2010-12#2)
the relation between the two##2##5##(1991-8#1)(2005-7#1)
the relation between the##29##4##(1991-6#1)(1991-8#1)(1992-3#1)(1993-5#1)(1993-6#1)(1994-2#1)(1995-5#1)(1997-5#1)(2005-4#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-8#3)(2009-2#2)(2009-6#1)(2010-10#1)(2011-1#2)(2013-1#1)
the relation between these##3##4##(1991-11#1)(2008-10#1)(2008-3#1)
the relation between virologic and immunologic responses in AIDS clinical trials##2##11##(2009-5#1)(2010-2#1)
the relation between##105##3##(1990-8#1)(1991-1#1)(1991-11#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-11#2)(1993-5#1)(1993-6#1)(1994-1#1)(1994-2#3)(1995-1#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-5#2)(2004-12#1)(2004-4#1)(2005-10#1)(2005-4#1)(2005-7#1)(2006-10#2)(2006-3#1)(2006-7#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#3)(2008-2#4)(2008-3#7)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#5)(2008-9#1)(2009-2#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#3)(2010-2#2)(2010-4#3)(2010-7#1)(2011-1#3)(2012-1#1)(2012-2#3)(2013-1#2)(2013-8#2)
the relation of##23##3##(1990-5#1)(1990-7#2)(1993-7#1)(1994-3#1)(1996-2#1)(1996-6#1)(1997-6#1)(2006-10#2)(2006-8#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-3#2)(2009-12#1)(2009-5#1)(2009-7#1)(2012-1#1)(2012-12#2)(2013-7#1)
the relation to##3##3##(1991-10#1)(1996-2#1)(1997-2#1)
the relation##139##2##(1990-5#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-11#2)(1993-5#1)(1993-6#1)(1993-7#1)(1994-1#1)(1994-2#3)(1994-3#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-2#3)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#3)(1997-6#1)(2004-12#1)(2004-4#1)(2005-10#1)(2005-4#1)(2005-7#1)(2006-10#4)(2006-3#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#3)(2008-2#5)(2008-3#11)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#5)(2008-9#1)(2009-12#1)(2009-2#3)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#3)(2010-2#2)(2010-4#3)(2010-7#1)(2011-1#3)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#2)
the relational model##2##3##(1996-2#2)
the relational##8##2##(1990-3#1)(1996-2#2)(2008-12#1)(2008-7#2)(2010-8#1)(2011-2#1)
the relations among the##2##4##(1997-8#1)(2008-3#1)
the relations among##7##3##(1992-9#1)(1997-8#1)(2008-3#3)(2008-7#1)(2012-12#1)
the relations between art and##2##5##(2010-7#2)
the relations between the##3##4##(1996-1#1)(1996-2#1)(2010-8#1)
the relations between##18##3##(1995-5#1)(1996-1#1)(1996-2#1)(2006-5#2)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-10#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
the relations of##2##3##(1990-3#1)(2008-5#1)
the relations##37##2##(1990-3#1)(1992-9#1)(1995-5#1)(1996-1#1)(1996-2#1)(1997-8#1)(2006-5#2)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-2#3)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
the relationship among nurses##2##4##(2011-2#2)
the relationship among##15##3##(1997-2#1)(2006-7#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-8#1)(2009-7#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
the relationship and the##3##4##(1993-5#1)(2008-6#1)(2013-8#1)
the relationship and##6##3##(1993-5#1)(2008-11#1)(2008-6#1)(2009-7#1)(2010-5#1)(2013-8#1)
the relationship between AN and##2##5##(2006-5#2)
the relationship between DON and IND##2##6##(2008-10#2)
the relationship between HBV infection and##2##6##(2011-1#2)
the relationship between HBV##3##4##(2010-12#1)(2011-1#2)
the relationship between WICE and##2##5##(1994-7#2)
the relationship between a##10##4##(1991-3#1)(1993-4#1)(1994-1#1)(2006-9#1)(2008-10#1)(2008-12#2)(2008-7#1)(2012-3#1)(2013-8#1)
the relationship between alcohol##2##4##(2012-12#2)
the relationship between analytical precision and concentration##2##7##(2008-10#2)
the relationship between body dissatisfaction and disordered eating##2##8##(2012-2#2)
the relationship between body image and##3##6##(2006-7#2)(2009-5#1)
the relationship between body image##5##5##(2006-7#2)(2007-12#1)(2009-5#1)(2012-2#1)
the relationship between body##10##4##(2006-7#2)(2007-12#2)(2009-5#1)(2010-7#1)(2011-1#1)(2012-2#3)
the relationship between brain##3##4##(2008-7#1)(2011-1#1)(2012-2#1)
the relationship between burnout and health care utilization of 238 employed adults##2##12##(1996-2#1)(1997-1#1)
the relationship between burnout##3##4##(1996-2#1)(1997-1#1)(2008-11#1)
the relationship between cell##3##4##(1990-7#1)(1993-4#1)(2012-1#1)
the relationship between cerebral##2##4##(2006-7#1)(2007-2#1)
the relationship between clinical##2##4##(2006-10#1)(2008-6#1)
the relationship between developmental##2##4##(2008-10#1)(2008-9#1)
the relationship between different##3##4##(1993-2#1)(1997-6#1)(2012-1#1)
the relationship between disease severity and##2##6##(2008-10#2)
the relationship between disease##3##4##(2008-10#2)(2012-1#1)
the relationship between eating##2##4##(2011-1#1)(2012-2#1)
the relationship between educational level and##2##6##(2006-10#1)(2006-8#1)
the relationship between educational##3##4##(2006-10#1)(2006-8#1)(2008-12#1)
the relationship between executive function and social outcome in##2##9##(2009-10#2)
the relationship between executive function and social outcome##4##8##(2009-10#4)
the relationship between exposure##2##4##(1994-6#1)(2012-2#1)
the relationship between external##2##4##(2008-4#1)(2011-2#1)
the relationship between family functioning##2##5##(2013-1#2)
the relationship between family##3##4##(2011-1#1)(2013-1#2)
the relationship between group size and##3##6##(1994-3#2)(2008-8#1)
the relationship between health belief and sick role behavior##2##9##(1990-8#2)
the relationship between health##4##4##(1990-8#2)(2008-11#1)(2010-12#1)
the relationship between healthcare professional##2##5##(2005-7#2)
the relationship between home range##2##5##(2008-8#2)
the relationship between home##3##4##(1992-2#1)(2008-8#2)
the relationship between host and##2##5##(2007-2#1)(2010-12#1)
the relationship between host##4##4##(2007-2#1)(2008-10#2)(2010-12#1)
the relationship between in##2##4##(1994-2#1)(2009-12#1)
the relationship between incidence##2##4##(2008-10#2)
the relationship between individual##2##4##(2008-3#1)(2010-12#1)
the relationship between information##2##4##(1997-3#1)(2009-9#1)
the relationship between insulin resistance##2##5##(1997-7#1)(2011-2#1)
the relationship between job satisfaction##2##5##(2007-4#1)(2010-10#1)
the relationship between job##4##4##(1996-2#1)(2007-4#1)(2010-10#2)
the relationship between lipid##2##4##(1994-5#1)(2010-4#1)
the relationship between local##2##4##(1994-2#1)(1996-10#1)
the relationship between maternal depressed mood and##3##7##(2010-2#3)
the relationship between maternal##4##4##(2010-2#3)(2011-2#1)
the relationship between mental##2##4##(2010-7#1)(2012-2#1)
the relationship between metallothionein##2##4##(1997-3#1)(2008-10#1)
the relationship between molecular##2##4##(2008-10#2)
the relationship between oral lichen planus##2##6##(2008-4#2)
the relationship between oral##3##4##(2008-11#1)(2008-4#2)
the relationship between outcomes##2##4##(2005-10#1)(2006-7#1)
the relationship between oxygen free radicals and##2##7##(1990-4#1)(1995-8#1)
the relationship between parental##6##4##(1990-5#1)(2007-12#1)(2009-12#2)(2009-7#1)(2012-1#1)
the relationship between perceived##5##4##(2006-9#2)(2007-12#1)(2009-7#1)(2010-7#1)
the relationship between physical##4##4##(2008-10#1)(2013-1#3)
the relationship between physician##2##4##(1995-2#1)(2010-8#1)
the relationship between plasma##2##4##(1992-9#1)(2007-8#1)
the relationship between polymorphism##2##4##(1997-4#1)(2011-1#1)
the relationship between positive/negative cooperativity and enzyme activation/inhibition##2##8##(2010-7#2)
the relationship between potential##2##4##(2007-12#1)(2008-8#1)
the relationship between protein kinase C and##2##7##(1993-6#1)(2008-11#1)
the relationship between psychological##2##4##(2008-2#1)(2012-2#1)
the relationship between risk##2##4##(1995-5#1)(2012-3#1)
the relationship between serum##4##4##(1993-12#1)(1995-4#1)(2008-7#1)(2013-1#1)
the relationship between sleep loss and RTB##2##7##(2013-1#2)
the relationship between sleep##4##4##(1995-6#1)(2006-10#1)(2013-1#2)
the relationship between smoking##3##4##(1996-3#1)(2006-12#1)(2013-1#1)
the relationship between social##5##4##(2006-2#1)(2009-7#1)(2009-8#1)(2010-2#1)(2013-8#1)
the relationship between socioeconomic status and##2##6##(2006-10#1)(2011-1#1)
the relationship between socioeconomic##3##4##(2006-10#1)(2010-2#1)(2011-1#1)
the relationship between spatial##2##4##(2008-11#1)(2008-7#1)
the relationship between species##2##4##(2008-10#1)(2008-8#1)
the relationship between stress and##2##5##(2009-7#1)(2012-1#1)
the relationship between structure and##5##5##(2005-11#1)(2009-5#2)(2010-4#1)(2012-2#1)
the relationship between subjective burn scar severity and body-esteem##2##9##(2007-12#2)
the relationship between surface##2##4##(2005-11#1)(2008-5#1)
the relationship between symptom burden and##2##6##(2008-7#2)
the relationship between symptom##3##4##(2007-11#1)(2008-7#2)
the relationship between symptoms and##2##5##(2008-6#1)(2008-7#1)
the relationship between the Bolton overall##2##6##(2010-2#2)
the relationship between the degree of##2##6##(1991-8#1)(2008-2#1)
the relationship between the distribution of##5##6##(1992-6#1)(1994-2#1)(2007-3#1)(2008-10#1)(2011-1#1)
the relationship between the input##2##5##(2010-2#2)
the relationship between the number of##3##6##(2008-12#1)(2013-1#1)(2013-8#1)
the relationship between the presence of##4##6##(1997-7#1)(2010-12#1)(2010-2#1)(2013-8#1)
the relationship between the structure and function of##2##8##(1997-2#1)(2011-1#1)
the relationship between the two##4##5##(1996-2#1)(2008-11#1)(2009-8#1)(2012-2#1)
the relationship between the use of##2##6##(2005-8#1)(2008-9#1)
the relationship between the variables##3##5##(1995-10#1)(2008-10#2)
the relationship between the volume occupied by dispersal and establishment structures##2##11##(2007-3#2)
the relationship between the##157##4##(1991-1#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#2)(1995-10#1)(1995-11#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-12#1)(2004-7#1)(2005-11#2)(2005-4#2)(2005-8#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-3#3)(2007-7#1)(2007-9#3)(2008-1#3)(2008-10#18)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#6)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#5)(2008-9#5)(2009-2#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-12#3)(2010-2#5)(2010-4#1)(2010-6#1)(2011-1#6)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#4)(2013-8#11)
the relationship between theory##2##4##(1996-3#1)(2008-11#1)
the relationship between these two##2##5##(1996-3#1)(2007-12#1)
the relationship between these##4##4##(1996-3#1)(2006-10#1)(2007-12#1)(2008-2#1)
the relationship between this##3##4##(2006-2#1)(2007-2#1)(2013-7#1)
the relationship between trauma and##2##5##(2008-9#1)(2009-8#1)
the relationship between types of##2##5##(1995-2#1)(1996-2#1)
the relationship between##755##3##(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#4)(1991-3#3)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#3)(1992-8#1)(1992-9#3)(1993-10#1)(1993-12#5)(1993-2#3)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#7)(1994-3#5)(1994-5#5)(1994-6#3)(1994-7#2)(1994-8#3)(1994-9#1)(1995-1#5)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#6)(1995-3#2)(1995-4#2)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#4)(1996-3#4)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#4)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#5)(2004-11#1)(2004-12#3)(2004-7#1)(2005-10#4)(2005-11#6)(2005-4#3)(2005-7#3)(2005-8#1)(2006-1#1)(2006-10#13)(2006-11#1)(2006-12#1)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#7)(2006-6#2)(2006-7#8)(2006-8#7)(2006-9#4)(2007-1#2)(2007-10#4)(2007-11#4)(2007-12#20)(2007-2#4)(2007-3#6)(2007-4#2)(2007-7#2)(2007-8#3)(2007-9#5)(2008-1#3)(2008-10#53)(2008-11#17)(2008-12#12)(2008-2#9)(2008-3#13)(2008-4#5)(2008-5#12)(2008-6#6)(2008-7#16)(2008-8#23)(2008-9#16)(2009-10#7)(2009-11#6)(2009-12#4)(2009-2#1)(2009-3#2)(2009-4#5)(2009-5#6)(2009-6#1)(2009-7#12)(2009-8#5)(2009-9#3)(2010-1#2)(2010-10#4)(2010-11#4)(2010-12#13)(2010-2#20)(2010-3#2)(2010-4#4)(2010-5#1)(2010-6#3)(2010-7#7)(2010-8#7)(2010-9#3)(2011-1#21)(2011-10#1)(2011-12#1)(2011-2#25)(2012-1#13)(2012-11#6)(2012-12#10)(2012-2#22)(2012-3#7)(2012-5#1)(2013-1#31)(2013-7#4)(2013-8#21)
the relationship in##2##3##(2008-11#1)(2012-1#1)
the relationship is##5##3##(1991-4#1)(1994-2#1)(2005-10#1)(2008-5#1)(2012-12#1)
the relationship of Pax6 with##2##5##(2007-12#2)
the relationship of obesity##2##4##(2006-10#1)(2012-2#1)
the relationship of serum##2##4##(2011-11#1)(2011-2#1)
the relationship of the##18##4##(1990-8#1)(1991-10#1)(1991-2#1)(1991-3#1)(1995-9#1)(1997-4#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#3)(2009-11#1)(2010-7#1)(2011-3#1)(2012-1#1)(2012-2#1)
the relationship of these##8##4##(1991-10#1)(1994-2#1)(1996-12#1)(1996-2#1)(2004-3#1)(2011-1#1)(2012-1#2)
the relationship of##101##3##(1990-5#1)(1990-8#2)(1991-1#1)(1991-10#2)(1991-11#1)(1991-2#1)(1991-3#1)(1993-11#2)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-2#2)(1995-4#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-3#1)(2005-1#1)(2005-11#1)(2006-10#2)(2006-4#1)(2006-7#2)(2006-8#1)(2007-10#2)(2007-12#3)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#9)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#5)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-1#5)(2011-11#1)(2011-12#3)(2011-2#4)(2011-3#1)(2012-1#5)(2012-2#3)(2013-1#1)(2013-7#1)
the relationship that##2##3##(1991-6#1)(2006-4#1)
the relationship to##5##3##(1994-6#1)(1997-8#1)(2008-6#1)(2009-12#1)(2013-1#1)
the relationship was##3##3##(2008-10#2)(2012-2#1)
the relationship with the##4##4##(1990-12#1)(1991-1#1)(1992-8#1)(2004-3#1)
the relationship with their##2##4##(2008-10#2)
the relationship with##19##3##(1990-12#1)(1991-1#1)(1992-8#1)(1995-5#1)(2004-3#1)(2006-2#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-7#1)
the relationship##946##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#1)(1990-8#4)(1991-1#3)(1991-10#4)(1991-11#2)(1991-12#3)(1991-2#5)(1991-3#4)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#3)(1992-8#3)(1992-9#3)(1993-10#1)(1993-11#3)(1993-12#7)(1993-2#4)(1993-3#3)(1993-4#2)(1993-5#3)(1993-6#3)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#11)(1994-3#5)(1994-5#6)(1994-6#4)(1994-7#2)(1994-8#3)(1994-9#1)(1995-1#5)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#6)(1995-3#2)(1995-4#3)(1995-5#2)(1995-6#4)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#6)(1996-2#5)(1996-3#5)(1996-4#1)(1996-6#2)(1996-8#2)(1996-9#2)(1997-1#4)(1997-2#5)(1997-3#3)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#4)(1997-8#7)(2004-11#1)(2004-12#3)(2004-3#2)(2004-7#1)(2005-1#1)(2005-10#5)(2005-11#8)(2005-4#3)(2005-7#3)(2005-8#1)(2006-1#1)(2006-10#17)(2006-11#1)(2006-12#1)(2006-2#4)(2006-3#1)(2006-4#4)(2006-5#7)(2006-6#2)(2006-7#11)(2006-8#8)(2006-9#4)(2007-1#4)(2007-10#7)(2007-11#4)(2007-12#23)(2007-2#5)(2007-3#6)(2007-4#3)(2007-7#2)(2007-8#4)(2007-9#5)(2008-1#3)(2008-10#71)(2008-11#20)(2008-12#15)(2008-2#11)(2008-3#16)(2008-4#6)(2008-5#15)(2008-6#8)(2008-7#19)(2008-8#27)(2008-9#22)(2009-10#8)(2009-11#7)(2009-12#5)(2009-2#1)(2009-3#2)(2009-4#6)(2009-5#9)(2009-6#1)(2009-7#14)(2009-8#5)(2009-9#4)(2010-1#3)(2010-10#6)(2010-11#4)(2010-12#14)(2010-2#21)(2010-3#3)(2010-4#4)(2010-5#2)(2010-6#4)(2010-7#8)(2010-8#8)(2010-9#3)(2011-1#28)(2011-10#1)(2011-11#1)(2011-12#4)(2011-2#32)(2011-3#1)(2012-1#21)(2012-11#6)(2012-12#12)(2012-2#27)(2012-3#9)(2012-5#1)(2013-1#34)(2013-7#6)(2013-8#24)
the relationship-constrained partial area subtaxonomy and the root-constrained partial area subtaxonomy are defined and their benefits are demonstrated##2##18##(2013-1#2)
the relationships among body##2##4##(2006-10#1)(2007-12#1)
the relationships among the##5##4##(1995-4#1)(2008-10#2)(2008-8#1)(2010-5#1)
the relationships among##18##3##(1993-2#1)(1995-4#1)(2006-10#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)
the relationships and##4##3##(1992-12#1)(1995-3#1)(2007-12#1)(2013-1#1)
the relationships between physical##2##4##(2008-9#1)(2010-2#1)
the relationships between social##2##4##(1992-3#1)(2013-8#1)
the relationships between the##13##4##(1997-8#1)(2005-8#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)(2010-2#1)(2012-3#2)(2013-8#2)
the relationships between these##4##4##(2007-10#1)(2008-9#1)(2009-12#1)(2011-2#1)
the relationships between various##2##4##(2006-7#1)(2008-10#1)
the relationships between##104##3##(1991-12#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#2)(1993-1#1)(1994-2#1)(1995-11#1)(1995-2#2)(1995-6#1)(1995-7#1)(1996-12#2)(1996-2#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#5)(2009-12#2)(2009-5#1)(2009-7#2)(2010-1#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#1)(2010-6#1)(2010-8#3)(2011-1#3)(2011-2#5)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#4)(2012-5#1)(2013-1#3)(2013-7#1)(2013-8#4)
the relationships of the##2##4##(1993-8#1)(2013-8#1)
the relationships of these##2##4##(2006-3#1)(2007-7#1)
the relationships of##12##3##(1993-8#1)(1995-6#1)(1996-2#1)(2006-3#1)(2007-10#1)(2007-7#2)(2007-9#1)(2008-9#1)(2009-3#1)(2010-6#1)(2013-8#1)
the relationships##148##2##(1991-12#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-3#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-2#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#2)(1995-7#1)(1996-12#2)(1996-2#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-8#1)(2005-8#1)(2006-10#2)(2006-3#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#6)(2009-12#2)(2009-3#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#4)(2011-2#8)(2012-1#2)(2012-11#1)(2012-2#2)(2012-3#4)(2012-5#1)(2013-1#5)(2013-7#1)(2013-8#5)
the relative S##2##3##(2008-10#2)
the relative abundance and##2##4##(2008-10#1)(2012-6#1)
the relative abundance of different##2##5##(2008-10#1)(2008-8#1)
the relative abundance of the##3##5##(1993-5#1)(1995-1#1)(2012-2#1)
the relative abundance of##14##4##(1993-5#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(2005-12#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#1)(2012-2#2)
the relative abundance##17##3##(1993-5#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(1997-6#1)(2005-12#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-8#1)(2012-2#2)(2012-6#1)
the relative abundances of##2##4##(2008-8#1)(2008-9#1)
the relative activity of##2##4##(2008-11#1)(2010-12#1)
the relative affinities of##2##4##(1990-7#1)(1991-7#1)
the relative affinity for##2##4##(1996-2#1)(2008-10#1)
the relative affinity of##2##4##(1990-4#1)(1990-7#1)
the relative affinity##4##3##(1990-4#1)(1990-7#1)(1996-2#1)(2008-10#1)
the relative amount of the##4##5##(1990-3#1)(1994-12#1)(1997-1#1)(2008-11#1)
the relative amount of##13##4##(1990-3#1)(1991-12#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-2#1)(1997-1#1)(1997-7#1)(2008-11#1)(2009-10#1)(2009-2#1)
the relative amounts of the##4##5##(1992-11#1)(2008-2#1)(2008-7#1)(2011-3#1)
the relative amounts of##14##4##(1991-5#1)(1992-11#1)(1992-6#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-2#1)(2011-3#1)
the relative amounts##15##3##(1991-5#1)(1992-11#1)(1992-6#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-9#1)(1996-4#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-2#1)(2011-3#1)
the relative and##3##3##(1995-6#1)(2008-8#2)
the relative area under the##3##5##(2008-10#3)
the relative area##4##3##(2005-11#1)(2008-10#3)
the relative benefits of##2##4##(2005-10#1)(2007-10#1)
the relative benefits##3##3##(2005-10#1)(2007-10#1)(2007-8#1)
the relative binding affinities of##2##5##(1990-5#1)(2006-12#1)
the relative binding##6##3##(1990-5#1)(1994-11#1)(1997-2#1)(2006-12#1)(2008-4#1)(2008-9#1)
the relative bioavailability of##2##4##(1996-6#2)
the relative bioavailability##3##3##(1996-6#2)(2011-2#1)
the relative change in##2##4##(2005-10#1)(2007-7#1)
the relative changes##2##3##(1992-2#1)(1995-1#1)
the relative charge##2##3##(2005-11#1)(2008-10#1)
the relative composition of##2##4##(1996-7#1)(2004-2#1)
the relative concentration of##4##4##(1991-12#1)(1992-9#1)(1994-10#1)(2013-1#1)
the relative concentration##5##3##(1991-12#1)(1992-9#1)(1994-10#1)(2007-11#1)(2013-1#1)
the relative concentrations of##3##4##(1992-12#1)(1992-9#1)(2008-12#1)
the relative content of##3##4##(2008-11#1)(2008-2#1)(2010-4#1)
the relative content##4##3##(1995-5#1)(2008-11#1)(2008-2#1)(2010-4#1)
the relative contribution of both##2##5##(2007-12#1)(2008-10#1)
the relative contribution of each##3##5##(2006-5#1)(2007-12#1)(2011-2#1)
the relative contribution of leucine residues at the nonequivalent##2##9##(1992-6#2)
the relative contribution of the##3##5##(1992-12#1)(2008-10#1)(2009-7#1)
the relative contribution of##22##4##(1991-2#1)(1992-12#1)(1992-6#2)(1994-2#1)(1996-12#1)(1996-7#1)(2006-5#1)(2007-12#2)(2008-10#5)(2008-8#1)(2009-1#1)(2009-2#1)(2009-7#1)(2011-2#1)(2013-1#2)
the relative contribution##23##3##(1991-2#1)(1992-12#1)(1992-6#2)(1994-2#1)(1996-12#1)(1996-7#1)(2006-5#1)(2007-12#2)(2008-10#5)(2008-2#1)(2008-8#1)(2009-1#1)(2009-2#1)(2009-7#1)(2011-2#1)(2013-1#2)
the relative contributions of these##3##5##(1990-11#1)(1992-2#1)(2008-12#1)
the relative contributions of##15##4##(1990-11#1)(1990-5#1)(1992-2#1)(1996-1#1)(2006-6#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-9#1)(2009-2#1)
the relative contributions##16##3##(1990-11#1)(1990-5#1)(1992-2#1)(1996-1#1)(1996-11#1)(2006-6#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-9#1)(2009-2#1)
the relative cost of##2##4##(2008-5#1)(2008-8#1)
the relative cost##3##3##(2005-11#1)(2008-5#1)(2008-8#1)
the relative costs of##2##4##(1993-2#1)(2010-2#1)
the relative difference in##3##4##(2004-9#1)(2008-3#1)(2009-2#1)
the relative difference##4##3##(2004-9#1)(2008-3#1)(2009-2#1)(2011-1#1)
the relative differences##2##3##(2008-3#2)
the relative displacement##2##3##(2007-4#1)(2008-3#1)
the relative distribution of##5##4##(1992-4#1)(1992-9#1)(1995-1#1)(2008-2#1)(2010-12#1)
the relative ease##2##3##(1993-9#1)(2010-7#1)
the relative effect of##2##4##(1992-11#1)(1992-8#1)
the relative effect##3##3##(1992-11#1)(1992-8#1)(2008-2#1)
the relative effectiveness of##3##4##(2008-10#1)(2010-11#1)(2011-2#1)
the relative effects of##6##4##(1992-5#1)(1994-8#1)(1995-12#1)(1997-5#1)(2008-10#1)(2009-4#1)
the relative efficacy and##2##4##(1995-12#1)(2008-7#1)
the relative efficacy of##7##4##(1994-12#1)(2007-11#3)(2008-10#1)(2008-6#1)(2011-2#1)
the relative efficacy##9##3##(1994-12#1)(1995-12#1)(2007-11#3)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)
the relative efficiencies##2##3##(1994-12#1)(1994-8#1)
the relative electrophoretic##2##3##(1991-7#1)(2008-10#1)
the relative entropy between##2##4##(2008-12#1)(2008-2#1)
the relative entropy##4##3##(2008-12#2)(2008-2#2)
the relative error of##2##4##(2008-10#2)
the relative error##6##3##(1997-3#1)(2008-10#3)(2008-2#1)(2013-8#1)
the relative errors##2##3##(2008-10#2)
the relative expression levels##2##4##(2010-12#1)(2011-2#1)
the relative expression of##5##4##(1993-9#1)(1994-2#1)(2008-3#1)(2008-7#1)(2009-11#1)
the relative expression##7##3##(1993-9#1)(1994-2#1)(2008-3#1)(2008-7#1)(2009-11#1)(2010-12#1)(2011-2#1)
the relative fluorescence intensity of the##2##6##(2005-4#1)(2008-10#1)
the relative fluorescence intensity##4##4##(2005-4#2)(2008-10#2)
the relative fluorescence##7##3##(2005-4#2)(2008-10#3)(2008-3#1)(2010-7#1)
the relative formation##2##3##(2008-10#2)
the relative frequencies of##2##4##(2008-8#2)
the relative frequencies##3##3##(2006-6#1)(2008-8#2)
the relative frequency of##5##4##(1995-1#1)(2008-10#1)(2008-7#1)(2009-5#1)(2011-2#1)
the relative growth##2##3##(1996-10#1)(2008-10#1)
the relative humidity (RH)##2##4##(2008-10#2)
the relative humidity##5##3##(2007-12#1)(2008-10#2)(2008-2#1)(2010-4#1)
the relative impact of##3##4##(2006-10#1)(2008-10#1)(2009-8#1)
the relative impedance##2##3##(2011-2#2)
the relative importance and##2##4##(2007-2#1)(2010-4#1)
the relative importance of a##2##5##(1990-7#1)(2008-8#1)
the relative importance of each of the##2##7##(2007-12#1)(2008-4#1)
the relative importance of each##3##5##(2007-11#1)(2007-12#1)(2008-4#1)
the relative importance of habitat amount and arrangement##2##8##(2008-8#2)
the relative importance of prey for##2##6##(2008-5#2)
the relative importance of the two##3##6##(1996-5#1)(2008-10#1)(2008-9#1)
the relative importance of the##11##5##(1992-2#2)(1995-9#1)(1996-5#1)(2006-12#1)(2007-3#1)(2008-10#2)(2008-2#1)(2008-9#1)(2011-1#1)
the relative importance of these##4##5##(1990-9#1)(1993-7#1)(1996-8#1)(2007-1#1)
the relative importance of various##2##5##(2008-4#1)(2009-4#1)
the relative importance of##48##4##(1990-7#1)(1990-9#1)(1991-4#1)(1992-2#2)(1993-7#1)(1994-2#1)(1995-9#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-8#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#5)(2008-9#2)(2009-4#1)(2009-6#1)(2010-1#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-7#1)
the relative importance##52##3##(1990-7#1)(1990-9#1)(1991-4#1)(1992-2#2)(1993-7#1)(1994-2#1)(1994-3#1)(1995-9#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-8#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#5)(2008-9#2)(2009-4#1)(2009-6#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-7#1)
the relative incidence of##2##4##(2009-5#1)(2011-2#1)
the relative increase in##2##4##(2006-10#2)
the relative increase##3##3##(1994-9#1)(2006-10#2)
the relative influence of##3##4##(1996-1#1)(1996-3#1)(2008-10#1)
the relative insensitivity##2##3##(2007-12#1)(2008-3#1)
the relative intensity of##7##4##(2005-4#1)(2008-10#2)(2008-3#1)(2008-8#2)(2011-12#1)
the relative intensity##8##3##(2005-4#1)(2008-10#2)(2008-3#1)(2008-8#2)(2011-12#1)(2013-8#1)
the relative lack of##3##4##(1991-3#1)(1997-8#1)(2005-8#1)
the relative lengths of##2##4##(2008-2#1)(2010-6#1)
the relative level of expression of##2##6##(1996-7#1)(2008-4#1)
the relative level of the##2##5##(1990-3#1)(1996-12#1)
the relative level of##7##4##(1990-3#1)(1994-8#1)(1996-12#1)(1996-7#1)(1997-5#1)(2008-10#1)(2008-4#1)
the relative level##8##3##(1990-3#1)(1994-8#1)(1996-12#1)(1996-7#1)(1997-5#1)(2008-10#1)(2008-4#1)(2008-5#1)
the relative levels of mRNA##2##5##(2008-7#2)
the relative levels of##7##4##(1991-7#3)(1992-8#1)(1994-3#1)(2008-7#2)
the relative location of##2##4##(1994-12#1)(2008-4#1)
the relative magnitude of##5##4##(1994-10#1)(2005-11#1)(2007-10#1)(2007-5#1)(2013-8#1)
the relative magnitudes of##3##4##(1990-3#1)(1993-6#1)(2007-12#1)
the relative merits of the##3##5##(2008-2#1)(2008-3#2)
the relative merits of##6##4##(2006-2#1)(2008-2#1)(2008-3#2)(2008-4#2)
the relative merits##7##3##(2006-2#1)(2008-2#2)(2008-3#2)(2008-4#2)
the relative molecular##2##3##(1993-4#1)(2008-10#1)
the relative motion##3##3##(2008-1#1)(2012-1#2)
the relative orientation of##3##4##(1991-7#1)(2008-10#1)(2008-2#1)
the relative percentages of##2##4##(2008-10#1)(2010-4#1)
the relative performance of the##2##5##(1994-9#1)(2008-10#1)
the relative performance of##5##4##(1994-1#1)(1994-9#1)(2008-10#1)(2011-2#1)(2012-3#1)
the relative performance##6##3##(1994-1#1)(1994-9#1)(2008-10#1)(2010-12#1)(2011-2#1)(2012-3#1)
the relative phase between the##2##5##(2008-3#2)
the relative phase between##3##4##(2008-1#1)(2008-3#2)
the relative phase##8##3##(2007-11#1)(2008-1#2)(2008-2#1)(2008-3#4)
the relative phases of the##2##5##(2007-12#2)
the relative phases of##3##4##(2007-12#2)(2008-3#1)
the relative phases##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
the relative position of the##3##5##(2008-2#2)(2008-3#1)
the relative position of##5##4##(1993-6#1)(1997-7#1)(2008-2#2)(2008-3#1)
the relative position##7##3##(1993-6#1)(1997-7#1)(2008-10#1)(2008-2#2)(2008-3#2)
the relative positioning of##2##4##(1995-5#1)(1996-2#1)
the relative positions of the##3##5##(1991-4#1)(2008-3#2)
the relative positions##4##3##(1991-4#1)(2008-3#2)(2012-3#1)
the relative potencies of##2##4##(1992-9#1)(2008-5#1)
the relative potency of##2##4##(1992-9#1)(1996-9#1)
the relative potency##3##3##(1992-9#1)(1996-9#1)(2008-10#1)
the relative power of##2##4##(2007-11#1)(2008-7#1)
the relative power##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#1)
the relative prediction errors##2##4##(2008-10#2)
the relative prevalence##2##3##(2008-8#1)(2010-8#1)
the relative promoter##2##3##(1991-9#1)(1992-9#1)
the relative proportion of##6##4##(1991-2#1)(1994-2#1)(1996-4#1)(1997-7#1)(2007-12#1)(2008-10#1)
the relative proportions of##6##4##(1991-10#1)(1991-9#1)(1994-12#1)(1995-2#1)(2009-10#1)(2010-5#1)
the relative quality of##2##4##(2008-8#1)(2009-6#1)
the relative quantitative##2##3##(2008-10#1)(2008-4#1)
the relative quantity of##2##4##(1991-12#1)(2007-8#1)
the relative rarity of##2##4##(2006-10#1)(2007-7#1)
the relative rate of##3##4##(1991-10#1)(1996-7#1)(2007-6#1)
the relative rate##5##3##(1991-10#1)(1996-7#1)(2005-8#1)(2007-6#1)(2008-10#1)
the relative rates of##5##4##(1991-12#1)(1991-4#1)(2007-12#1)(2008-10#1)(2008-2#1)
the relative rates##7##3##(1991-12#1)(1991-4#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-1#1)
the relative reactivity of the##2##5##(2007-11#1)(2008-3#1)
the relative recoveries##2##3##(1997-3#1)(2008-10#1)
the relative resistance##2##3##(1992-11#1)(2008-10#1)
the relative risk of developing##2##5##(2006-10#1)(2007-1#1)
the relative risk of stroke##2##5##(2008-1#1)(2008-8#1)
the relative risk of##12##4##(1991-7#1)(1994-2#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-8#1)(2011-1#1)(2013-7#1)
the relative risk was 1##2##5##(1991-7#1)(2006-10#1)
the relative risk was##3##4##(1991-2#1)(1991-7#1)(2006-10#1)
the relative risk##27##3##(1991-2#1)(1991-3#1)(1991-7#3)(1994-2#1)(1994-5#1)(1995-2#1)(1996-1#1)(1996-7#2)(1997-8#2)(2006-10#2)(2006-11#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-4#1)(2011-1#2)(2013-7#1)
the relative risks##6##3##(1991-3#1)(1992-12#1)(2005-10#1)(2007-4#1)(2008-7#1)(2013-7#1)
the relative role of##3##4##(2006-10#1)(2007-12#1)(2012-3#1)
the relative roles of##7##4##(1991-8#1)(1996-8#1)(2008-10#1)(2008-8#2)(2010-12#1)(2012-3#1)
the relative sensitivities of the##2##5##(2008-10#1)(2008-3#1)
the relative sensitivity of##3##4##(1990-11#1)(1997-2#1)(2008-10#1)
the relative significance of##3##4##(2006-5#1)(2008-10#1)(2008-2#1)
the relative size of##2##4##(1996-5#1)(2005-11#1)
the relative skin sensitizing potency of chemicals##2##7##(2008-5#2)
the relative skin sensitizing potency of##3##6##(2008-5#3)
the relative square error of prediction##2##6##(2008-10#2)
the relative stability of the T structure##2##7##(1990-7#2)
the relative stability of##6##4##(1990-7#2)(1991-8#1)(1992-12#1)(1995-6#1)(2008-8#1)
the relative stability##7##3##(1990-7#2)(1991-8#1)(1992-12#1)(1995-6#1)(2006-10#1)(2008-8#1)
the relative standard deviation (R##18##5##(2008-10#17)(2008-3#1)
the relative standard deviation (RSD) is##2##6##(2008-10#2)
the relative standard deviation (RSD) was less than 4##2##9##(2013-8#2)
the relative standard deviation (RSD)##7##5##(2005-4#1)(2008-10#4)(2013-8#2)
the relative standard deviation for eight replicate measurements##2##8##(2008-10#2)
the relative standard deviation for eight##3##6##(2008-10#3)
the relative standard deviation for the determination of##2##8##(2008-10#2)
the relative standard deviation for##10##5##(2008-10#10)
the relative standard deviation in the ringdown time##2##8##(2008-3#2)
the relative standard deviation in the##3##6##(2008-10#1)(2008-3#2)
the relative standard deviation in##5##5##(2008-10#3)(2008-3#2)
the relative standard deviation is 4##3##6##(2005-4#1)(2008-10#2)
the relative standard deviation is##9##5##(2005-4#1)(2008-10#8)
the relative standard deviation of peak##2##6##(2008-10#2)
the relative standard deviation of##8##5##(2008-10#7)(2011-1#1)
the relative standard deviation was 2##2##6##(2008-10#2)
the relative standard deviation was##12##5##(1990-8#1)(1992-2#1)(2008-10#10)
the relative standard deviation##80##4##(1990-8#1)(1992-2#1)(1993-2#1)(2005-4#2)(2008-10#69)(2008-3#3)(2011-1#1)(2013-8#2)
the relative standard deviations (RSDs)##9##5##(2005-12#1)(2011-1#2)(2012-12#4)(2013-8#2)
the relative standard deviations for##2##5##(2008-10#2)
the relative standard deviations##30##4##(2005-12#1)(2005-4#1)(2008-10#14)(2011-1#4)(2012-12#8)(2013-8#2)
the relative standard##114##3##(1990-8#1)(1992-2#1)(1993-2#1)(2005-12#1)(2005-4#3)(2008-10#87)(2008-3#3)(2011-1#5)(2012-12#8)(2013-8#4)
the relative strength of the##3##5##(2005-10#1)(2008-3#1)(2008-7#1)
the relative strength of##7##4##(2005-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
the relative strengths of##3##4##(2007-12#1)(2008-1#1)(2012-3#1)
the relative success of##2##4##(2007-3#1)(2008-8#1)
the relative surface area of the##2##6##(2008-10#1)(2008-2#1)
the relative time of##3##4##(2008-12#2)(2009-10#1)
the relative time##4##3##(2007-11#1)(2008-12#2)(2009-10#1)
the relative usefulness of##2##4##(1992-11#1)(1995-2#1)
the relative value##3##3##(1991-12#1)(1993-2#1)(2008-4#1)
the relative values of##2##4##(1997-6#1)(2008-8#1)
the relative values##3##3##(1997-6#1)(2007-4#1)(2008-8#1)
the relative variation##2##3##(2008-8#1)(2009-10#1)
the relative volume of the##2##5##(1993-2#1)(2009-2#1)
the relative volume of##3##4##(1993-2#1)(2007-3#1)(2009-2#1)
the relative volume##4##3##(1992-8#1)(1993-2#1)(2007-3#1)(2009-2#1)
the relative weight##2##3##(1994-12#1)(2007-12#1)
the relative##856##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#4)(1990-4#1)(1990-5#3)(1990-7#6)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#5)(1991-2#4)(1991-3#4)(1991-4#4)(1991-5#2)(1991-7#9)(1991-8#2)(1991-9#4)(1992-11#4)(1992-12#6)(1992-2#9)(1992-3#1)(1992-4#2)(1992-5#2)(1992-6#4)(1992-8#4)(1992-9#9)(1993-12#1)(1993-2#6)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-10#2)(1994-11#4)(1994-12#7)(1994-2#6)(1994-3#4)(1994-5#1)(1994-8#5)(1994-9#4)(1995-1#5)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#3)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#3)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#3)(1996-4#2)(1996-5#3)(1996-6#3)(1996-7#6)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-5#2)(1997-6#2)(1997-7#5)(1997-8#6)(2004-2#1)(2004-4#2)(2004-9#1)(2005-10#6)(2005-11#10)(2005-12#2)(2005-4#6)(2005-7#3)(2005-8#3)(2006-10#14)(2006-11#1)(2006-12#3)(2006-2#1)(2006-5#3)(2006-6#3)(2006-9#1)(2007-1#4)(2007-10#2)(2007-11#18)(2007-12#22)(2007-2#2)(2007-3#5)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#8)(2008-10#182)(2008-11#9)(2008-12#10)(2008-2#36)(2008-3#35)(2008-4#18)(2008-5#15)(2008-6#2)(2008-7#12)(2008-8#28)(2008-9#9)(2009-1#1)(2009-10#5)(2009-11#1)(2009-12#2)(2009-2#6)(2009-4#2)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#5)(2010-11#2)(2010-12#6)(2010-2#3)(2010-4#8)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#2)(2011-1#10)(2011-12#2)(2011-2#16)(2011-3#1)(2012-1#3)(2012-12#11)(2012-2#6)(2012-3#7)(2012-6#1)(2013-1#4)(2013-7#5)(2013-8#10)
the relatively easy##2##3##(2006-8#1)(2009-8#1)
the relatively few##4##3##(1991-2#1)(1995-12#1)(2008-10#1)(2009-10#1)
the relatively high levels of##2##5##(2005-7#1)(2008-10#1)
the relatively high proportion of##3##5##(1990-12#1)(2008-8#1)(2008-9#1)
the relatively high##23##3##(1990-12#1)(1990-4#1)(1991-9#1)(1994-1#1)(1994-12#1)(1996-11#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-12#1)(2006-6#1)(2008-1#3)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#2)(2011-2#1)(2013-8#2)
the relatively large##7##3##(1992-6#1)(1993-12#1)(1994-11#1)(2007-1#1)(2008-10#1)(2008-11#1)(2012-2#1)
the relatively long##4##3##(1992-6#1)(2007-12#1)(2007-3#1)(2008-11#1)
the relatively low resolution of##2##5##(2008-10#1)(2008-8#1)
the relatively low##23##3##(1991-2#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-9#1)(1995-2#1)(1995-3#1)(2005-11#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-9#1)(2013-1#1)
the relatively lower##2##3##(1993-8#1)(1996-8#1)
the relatively poor##2##3##(2005-11#1)(2008-6#1)
the relatively rapid##2##3##(1994-8#1)(2006-12#1)
the relatively short##3##3##(2007-8#1)(2008-1#1)(2008-2#1)
the relatively simple##3##3##(2007-12#1)(2007-7#1)(2008-2#1)
the relatively slow##3##3##(2008-10#1)(2008-2#1)(2009-6#1)
the relatively small##8##3##(1991-12#1)(1997-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2010-12#1)(2010-9#1)
the relatively young##2##3##(2007-10#1)(2008-8#1)
the relatively##121##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-9#1)(1992-11#1)(1992-3#2)(1992-6#4)(1992-8#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#2)(1996-8#2)(1997-4#1)(1997-5#2)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#3)(2005-7#1)(2006-11#1)(2006-12#3)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#10)(2008-11#6)(2008-2#4)(2008-3#5)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#1)(2009-3#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#3)
the relatives of the##2##4##(1994-2#1)(2007-7#1)
the relatives##8##2##(1990-5#1)(1994-2#1)(2005-7#1)(2006-8#1)(2007-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
the relaxant effect of##2##4##(1992-9#1)(2008-12#1)
the relaxant response##2##3##(1996-10#1)(1996-12#1)
the relaxant##4##2##(1992-9#1)(1996-10#1)(1996-12#1)(2008-12#1)
the relaxation dynamics##2##3##(1993-3#1)(2006-5#1)
the relaxation effect##2##3##(2008-10#1)(2008-12#1)
the relaxation of the##4##4##(1996-10#1)(1996-7#1)(2008-10#1)(2011-1#1)
the relaxation of##10##3##(1990-11#1)(1992-11#1)(1994-5#1)(1995-12#1)(1996-10#1)(1996-7#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
the relaxation oscillation frequency##3##4##(2007-11#2)(2007-12#1)
the relaxation oscillation period##2##4##(2007-11#1)(2007-12#1)
the relaxation oscillation##6##3##(2007-11#3)(2007-12#3)
the relaxation process##2##3##(2007-12#1)(2008-5#1)
the relaxation response to##2##4##(1996-12#1)(2009-5#1)
the relaxation time for the##2##5##(1997-7#1)(2005-11#1)
the relaxation time of the##4##5##(2008-2#1)(2008-3#2)(2009-11#1)
the relaxation time of##5##4##(2007-12#1)(2008-2#1)(2008-3#2)(2009-11#1)
the relaxation time spectrum##3##4##(2008-3#3)
the relaxation time##12##3##(1994-11#1)(1997-7#1)(2005-11#1)(2007-12#1)(2008-2#1)(2008-3#6)(2009-11#1)
the relaxation times for##2##4##(1990-2#1)(1995-11#1)
the relaxation times##5##3##(1990-2#1)(1991-7#1)(1995-11#1)(1997-7#1)(2012-7#1)
the relaxation was not##2##4##(1996-10#1)(2011-2#1)
the relaxation##55##2##(1990-11#1)(1990-2#1)(1991-7#1)(1992-11#1)(1993-3#1)(1994-11#2)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#2)(1996-10#3)(1996-12#1)(1996-7#2)(1997-7#2)(2005-11#1)(2006-5#1)(2007-11#3)(2007-12#6)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#2)(2009-11#1)(2009-5#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-7#1)
the relaxation-oscillation##2##2##(2007-12#2)
the relaxed and##2##3##(2006-11#1)(2010-4#1)
the relaxed##5##2##(1995-6#2)(2006-11#2)(2010-4#1)
the relaxin-like factor##2##3##(1996-7#1)(2009-9#1)
the release and permeation of##2##5##(2008-5#2)
the release and##10##3##(1990-12#1)(1994-8#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#3)(2012-3#1)
the release from##4##3##(1990-2#1)(1995-12#1)(2008-4#1)(2008-5#1)
the release into##2##3##(1990-4#1)(2008-7#1)
the release mechanism##4##3##(1990-7#1)(1995-3#1)(2008-5#1)(2010-1#1)
the release of ATP##4##4##(2008-4#2)(2008-5#1)(2009-3#1)
the release of CGRP from##2##5##(1992-6#2)
the release of Ca2+##3##4##(1990-4#1)(1991-3#1)(1996-8#1)
the release of DNA into##2##5##(2008-11#1)(2009-12#1)
the release of DNA##3##4##(1997-4#1)(2008-11#1)(2009-12#1)
the release of FN##2##4##(1992-6#2)
the release of IL-1##2##4##(1992-5#1)(1992-9#1)
the release of NE and the formation of##2##8##(1996-6#2)
the release of NO and##2##5##(1993-3#1)(2008-8#1)
the release of NO##3##4##(1993-3#1)(2008-10#1)(2008-8#1)
the release of SPS##2##4##(2008-12#2)
the release of a##4##4##(1992-7#1)(2008-10#1)(2008-11#1)(2010-12#1)
the release of acetylcholine##4##4##(1991-6#1)(1993-12#1)(1997-5#1)(2008-8#1)
the release of adenosine##3##4##(1993-4#1)(1996-2#2)
the release of ammonia##2##4##(2006-12#1)(2013-8#1)
the release of anionic polymers##2##5##(2008-12#2)
the release of any##3##4##(1990-2#1)(2008-10#1)(2008-2#1)
the release of arachidonic acid from##3##6##(1992-2#1)(2008-1#1)(2011-2#1)
the release of arachidonic acid##4##5##(1992-2#1)(1996-2#1)(2008-1#1)(2011-2#1)
the release of aspartate##2##4##(1990-2#1)(1997-8#1)
the release of both##6##4##(1990-5#2)(1991-8#1)(1994-10#1)(1994-2#1)(1997-2#1)
the release of calcein##2##4##(1994-11#2)
the release of calcium##3##4##(2008-4#1)(2008-5#1)(2012-3#1)
the release of cyt c##2##5##(2011-2#2)
the release of cytokines and##3##5##(2006-10#1)(2011-2#1)(2013-1#1)
the release of cytokines##7##4##(1997-6#1)(2006-10#3)(2007-11#1)(2011-2#1)(2013-1#1)
the release of cytosolic enzymes##2##5##(1991-2#1)(1995-6#1)
the release of dopamine (DA)##2##5##(1992-7#1)(1997-2#1)
the release of dopamine from##2##5##(1997-7#1)(2008-4#1)
the release of dopamine in the striatum##3##7##(1991-6#1)(1991-9#2)
the release of dopamine##11##4##(1991-6#1)(1991-9#3)(1992-7#1)(1994-10#1)(1997-2#2)(1997-7#1)(2008-4#1)(2009-6#1)
the release of endogenous##3##4##(1990-2#2)(1995-12#1)
the release of endothelium-derived relaxing factor##2##6##(1990-12#1)(1993-3#1)
the release of excitatory##2##4##(1993-7#1)(2007-11#1)
the release of free##2##4##(1997-8#1)(2008-6#1)
the release of glutamate in##3##5##(1991-11#1)(1997-4#1)(2008-4#1)
the release of glutamate##8##4##(1990-11#1)(1990-2#1)(1991-11#1)(1994-8#1)(1997-4#1)(2007-9#1)(2008-4#2)
the release of glycolipids##2##4##(1990-2#2)
the release of growth factors##2##5##(2008-4#1)(2013-8#1)
the release of immunoreactive##2##4##(1995-11#1)(1996-11#1)
the release of insulin##2##4##(1992-6#1)(2011-1#1)
the release of intracellular##3##4##(2007-10#1)(2008-11#2)
the release of lactate dehydrogenase (LDH)##2##6##(1992-8#1)(1995-3#1)
the release of lactate dehydrogenase##3##5##(1990-5#1)(1992-8#1)(1995-3#1)
the release of leuprolide##2##4##(2004-1#2)
the release of many##2##4##(2011-2#1)(2012-12#1)
the release of mediators##2##4##(1991-10#1)(2011-2#1)
the release of newly##2##4##(1995-11#1)(1997-2#1)
the release of nitric oxide##3##5##(1990-5#1)(1992-11#1)(1997-4#1)
the release of noradrenaline##2##4##(1991-2#1)(1996-10#1)
the release of oleic##2##4##(1990-2#2)
the release of physician-specific health care data##2##7##(1994-2#2)
the release of pro-inflammatory cytokines##2##5##(2008-5#1)(2010-7#1)
the release of pro-inflammatory mediators##2##5##(2008-11#1)(2008-5#1)
the release of pro-inflammatory##4##4##(2008-11#1)(2008-5#2)(2010-7#1)
the release of proinflammatory cytokines##2##5##(2007-11#1)(2007-12#1)
the release of prosaposin##2##4##(1991-4#2)
the release of prostacyclin##3##4##(1991-12#1)(1991-5#1)(1994-3#1)
the release of pyrophosphate##2##4##(1990-12#1)(2011-1#1)
the release of secondary cytokines##2##5##(2007-11#1)(2008-5#1)
the release of serotonin##4##4##(1993-7#1)(1995-12#3)
the release of several##2##4##(2008-10#1)(2010-12#1)
the release of t-PA##2##4##(1997-2#2)
the release of the drug##2##5##(2010-12#1)(2010-5#1)
the release of the##25##4##(1990-11#1)(1990-2#1)(1990-7#1)(1995-11#1)(1997-4#1)(2006-12#2)(2006-3#1)(2007-1#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-6#2)(2008-8#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-5#1)(2013-1#1)(2013-8#1)
the release of toxic##2##4##(2006-10#1)(2011-2#1)
the release of toxins##2##4##(2006-10#1)(2008-8#1)
the release of##345##3##(1990-11#2)(1990-12#8)(1990-2#14)(1990-3#3)(1990-4#2)(1990-5#5)(1990-7#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#3)(1991-4#3)(1991-5#2)(1991-6#3)(1991-7#2)(1991-8#2)(1991-9#3)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#6)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#3)(1993-8#1)(1994-10#4)(1994-11#4)(1994-12#1)(1994-2#5)(1994-3#2)(1994-5#2)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#8)(1995-12#6)(1995-3#4)(1995-6#1)(1995-8#1)(1996-10#2)(1996-11#1)(1996-2#3)(1996-3#2)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#10)(1997-4#7)(1997-5#2)(1997-6#4)(1997-7#3)(1997-8#3)(2004-1#2)(2004-9#1)(2005-7#1)(2006-10#6)(2006-12#4)(2006-2#1)(2006-3#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#3)(2007-8#4)(2007-9#1)(2008-1#6)(2008-10#19)(2008-11#9)(2008-12#6)(2008-2#1)(2008-3#2)(2008-4#10)(2008-5#12)(2008-6#3)(2008-7#3)(2008-8#5)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#3)(2009-4#1)(2009-6#1)(2009-8#4)(2010-1#1)(2010-10#1)(2010-12#4)(2010-3#1)(2010-5#1)(2010-7#2)(2011-1#3)(2011-2#11)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#6)
the release profile of##3##4##(2006-1#2)(2012-3#1)
the release profile##4##3##(2006-1#2)(2007-8#1)(2012-3#1)
the release rate and##2##4##(2008-10#1)(2008-5#1)
the release rate of the##2##5##(1995-12#1)(2009-12#1)
the release rate of##3##4##(1995-12#1)(2009-12#1)(2010-2#1)
the release rate##6##3##(1995-12#1)(2008-10#1)(2008-5#1)(2009-12#1)(2010-2#1)(2012-3#1)
the release##407##2##(1990-11#2)(1990-12#9)(1990-2#17)(1990-3#3)(1990-4#3)(1990-5#7)(1990-7#3)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#5)(1991-4#3)(1991-5#2)(1991-6#3)(1991-7#2)(1991-8#3)(1991-9#3)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#6)(1992-7#4)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#3)(1993-8#1)(1994-10#5)(1994-11#4)(1994-12#2)(1994-2#6)(1994-3#2)(1994-5#2)(1994-8#3)(1994-9#1)(1995-1#2)(1995-11#8)(1995-12#8)(1995-3#5)(1995-6#1)(1995-8#1)(1996-10#2)(1996-11#1)(1996-2#3)(1996-3#2)(1996-5#2)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#11)(1997-4#7)(1997-5#2)(1997-6#4)(1997-7#4)(1997-8#3)(2004-1#2)(2004-12#2)(2004-9#1)(2005-7#1)(2006-1#2)(2006-10#8)(2006-12#4)(2006-2#1)(2006-3#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#3)(2007-8#7)(2007-9#1)(2008-1#6)(2008-10#25)(2008-11#11)(2008-12#7)(2008-2#1)(2008-3#3)(2008-4#11)(2008-5#20)(2008-6#3)(2008-7#4)(2008-8#5)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#3)(2009-4#2)(2009-6#1)(2009-8#4)(2010-1#2)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#2)(2011-1#3)(2011-2#11)(2012-12#4)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#6)
the released##19##2##(1991-3#1)(1992-7#3)(1992-8#1)(1993-6#1)(1994-8#1)(1996-3#1)(1996-8#1)(2004-1#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-7#2)(2009-4#1)
the relevance and##6##3##(1997-3#1)(2006-1#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#1)
the relevance for##2##3##(1997-1#1)(2011-2#1)
the relevance of a##2##4##(2006-10#1)(2008-10#1)
the relevance of an##2##4##(1991-9#1)(2008-2#1)
the relevance of documentation##2##4##(2007-9#2)
the relevance of multicultural##3##4##(2004-12#3)
the relevance of such##2##4##(1992-12#1)(2008-8#1)
the relevance of the##15##4##(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2013-1#1)
the relevance of these##11##4##(1994-6#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2011-2#1)(2013-1#1)
the relevance of this##8##4##(1992-5#1)(1993-12#1)(1994-6#1)(2008-12#1)(2008-9#1)(2010-12#1)(2010-2#1)(2011-1#1)
the relevance of##83##3##(1990-12#1)(1990-3#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-6#2)(1995-2#1)(1996-2#1)(1996-3#1)(1997-7#1)(2003-11#1)(2004-12#4)(2005-7#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#6)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-2#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
the relevance##95##2##(1990-12#1)(1990-3#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-6#2)(1995-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-7#1)(2003-11#1)(2004-12#4)(2005-7#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#6)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-2#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-5#2)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
the relevant anatomy and##2##4##(2009-5#1)(2013-8#1)
the relevant anatomy##3##3##(2006-8#1)(2009-5#1)(2013-8#1)
the relevant chemical##2##3##(2008-10#1)(2009-5#1)
the relevant energy##2##3##(2008-3#1)(2008-7#1)
the relevant features##2##3##(2008-10#1)(2012-1#1)
the relevant information##2##3##(2006-9#1)(2008-4#1)
the relevant issues##2##3##(1997-2#1)(2012-3#1)
the relevant laws and##2##4##(2007-2#1)(2012-3#1)
the relevant literature is##2##4##(2005-8#1)(2007-4#1)
the relevant literature on this##2##5##(2007-7#1)(2007-8#1)
the relevant literature on##4##4##(2007-5#1)(2007-7#1)(2007-8#1)(2012-12#1)
the relevant literature##22##3##(1992-3#1)(1994-12#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
the relevant regulatory##2##3##(1996-4#1)(2008-4#1)
the relevant studies##2##3##(2010-12#1)(2011-2#1)
the relevant target##2##3##(2011-2#1)(2012-3#1)
the relevant##154##2##(1990-5#1)(1990-8#2)(1991-12#3)(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-10#2)(1995-12#3)(1995-5#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#2)(2004-1#2)(2004-9#2)(2005-11#1)(2005-5#1)(2005-8#1)(2006-10#4)(2006-2#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#5)(2008-3#4)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#9)(2008-8#3)(2008-9#2)(2009-2#2)(2009-4#1)(2009-5#2)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-6#2)(2010-8#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#2)
the reliability and the##2##4##(1991-2#1)(2006-10#1)
the reliability and validity of the##8##6##(1993-3#1)(2006-12#1)(2007-10#1)(2008-12#1)(2008-6#1)(2011-1#1)(2012-1#1)(2012-12#1)
the reliability and validity of##15##5##(1992-3#1)(1993-11#1)(1993-3#1)(2006-12#2)(2007-10#1)(2008-12#1)(2008-6#1)(2009-9#1)(2010-10#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)
the reliability and##24##3##(1991-2#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-3#1)(2006-10#1)(2006-12#2)(2006-3#1)(2007-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
the reliability of a##6##4##(1991-12#1)(1992-12#1)(1994-3#1)(2008-10#3)
the reliability of test results##2##5##(2005-10#1)(2007-2#1)
the reliability of the method##3##5##(1992-2#1)(2008-10#1)(2008-7#1)
the reliability of the##27##4##(1990-5#1)(1990-9#1)(1992-10#1)(1992-2#1)(1992-7#1)(2006-10#1)(2006-12#1)(2006-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
the reliability of their##2##4##(1997-8#1)(2004-10#1)
the reliability of these##3##4##(2008-10#2)(2008-3#1)
the reliability of##75##3##(1990-3#1)(1990-5#1)(1990-9#1)(1991-12#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-1#1)(1994-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-7#1)(1997-8#1)(2004-10#1)(2004-11#2)(2005-10#1)(2005-5#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-12#3)(2007-2#1)(2008-10#17)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#4)(2008-7#2)(2009-1#1)(2009-11#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
the reliability##109##2##(1990-3#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-7#1)(1997-8#1)(2004-10#1)(2004-11#2)(2005-10#1)(2005-5#1)(2006-10#2)(2006-12#3)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#17)(2008-11#3)(2008-12#6)(2008-2#1)(2008-3#5)(2008-6#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-9#2)(2010-10#3)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#4)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
the reliable detection of##3##4##(2008-10#1)(2008-2#2)
the reliable##16##2##(1990-8#1)(1991-11#1)(1997-2#1)(2006-10#1)(2006-5#1)(2006-6#1)(2008-10#2)(2008-2#2)(2008-3#2)(2009-9#1)(2010-2#1)(2011-2#1)(2013-7#1)
the reliance of##2##3##(2008-1#1)(2008-5#1)
the reliance on##2##3##(2006-7#1)(2012-3#1)
the reliance##4##2##(2006-7#1)(2008-1#1)(2008-5#1)(2012-3#1)
the relief of pain##3##4##(2006-7#1)(2007-10#1)(2013-8#1)
the relief of the##2##4##(2008-3#1)(2009-1#1)
the relief of##11##3##(1993-12#1)(1996-5#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-3#1)(2008-7#1)(2009-1#1)(2012-1#1)(2013-8#1)
the relief##17##2##(1993-12#1)(1996-5#1)(2006-2#1)(2006-7#2)(2007-10#1)(2007-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-1#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-8#1)
the religious##3##2##(1994-3#1)(1996-12#1)(2009-10#1)
the relocation##6##2##(1990-2#1)(1996-8#1)(2007-5#2)(2013-7#2)
the reluctance to##2##3##(2008-5#1)(2008-7#1)
the remainder being##2##3##(1993-8#1)(2008-10#1)
the remainder had##3##3##(2008-6#1)(2008-7#1)(2008-9#1)
the remainder of the controls##2##5##(2007-9#2)
the remainder of the##23##4##(1990-6#1)(1990-9#1)(1991-12#1)(1992-4#1)(1993-1#1)(1994-9#1)(1996-1#1)(1996-9#1)(1997-1#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-9#2)(2008-10#3)(2008-11#1)(2008-2#1)(2011-1#1)(2011-12#2)
the remainder of##29##3##(1990-6#1)(1990-9#1)(1991-12#1)(1992-4#1)(1993-1#1)(1994-9#1)(1996-1#1)(1996-9#1)(1997-1#1)(1997-2#1)(2005-8#1)(2006-2#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-9#2)(2008-10#3)(2008-11#1)(2008-2#1)(2010-3#1)(2011-1#1)(2011-12#2)(2012-2#1)(2013-8#1)
the remainder were maintained as virgin##3##6##(1997-4#3)
the remainder were##6##3##(1993-7#1)(1997-3#1)(1997-4#3)(2006-3#1)
the remainder##70##2##(1990-6#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-3#1)(1992-4#2)(1993-1#1)(1993-11#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#2)(1996-1#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#4)(2004-2#1)(2005-8#1)(2006-2#1)(2006-3#3)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#2)(2010-12#2)(2010-3#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-2#2)(2013-8#1)
the remaining 10##3##3##(1990-1#1)(1991-3#1)(1993-3#1)
the remaining 10%##3##3##(1991-3#1)(2008-1#1)(2008-12#1)
the remaining 11##2##3##(2006-12#1)(2013-1#1)
the remaining 112 patients##2##4##(1996-9#1)(2011-2#1)
the remaining 12 patients##2##4##(2007-8#1)(2008-10#1)
the remaining 14##2##3##(1992-8#1)(2012-3#1)
the remaining 15##2##3##(1995-6#1)(2012-3#1)
the remaining 17##2##3##(1996-3#1)(2004-10#1)
the remaining 2##5##3##(1994-12#1)(1996-3#1)(2008-4#1)(2011-1#1)(2011-2#1)
the remaining 20##2##3##(1996-2#1)(2008-4#1)
the remaining 20%##2##3##(1995-6#1)(2013-1#1)
the remaining 22##2##3##(1997-3#1)(2012-2#1)
the remaining 23 patients##2##4##(1991-3#1)(1994-9#1)
the remaining 27##2##3##(1995-8#1)(2007-10#1)
the remaining 3 patients##2##4##(1993-12#1)(2007-10#1)
the remaining 3##6##3##(1993-12#1)(2005-8#1)(2007-10#1)(2007-8#1)(2008-4#1)(2008-8#1)
the remaining 30##3##3##(1996-1#1)(2007-6#1)(2013-1#1)
the remaining 4##6##3##(1993-9#1)(1996-11#1)(1997-6#2)(2007-10#1)(2008-7#1)
the remaining 5##3##3##(1994-12#1)(1995-4#1)(2007-10#1)
the remaining 6##2##3##(1992-10#1)(2013-1#1)
the remaining 7##3##3##(1993-6#1)(2007-8#1)(2011-2#1)
the remaining cases##5##3##(1995-11#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-4#1)
the remaining cells##2##3##(1990-5#1)(2008-10#1)
the remaining eight##4##3##(2004-9#1)(2008-4#1)(2008-6#2)
the remaining five##2##3##(2008-10#1)(2008-5#1)
the remaining four patients##2##4##(1991-8#1)(2008-7#1)
the remaining four##7##3##(1991-12#1)(1991-8#1)(1993-12#1)(1993-6#1)(2008-10#2)(2008-7#1)
the remaining lesions##2##3##(2007-8#1)(2008-6#1)
the remaining neurons##2##3##(1995-10#1)(1997-2#1)
the remaining nine##2##3##(2007-7#1)(2008-11#1)
the remaining one##4##3##(1993-12#1)(2005-11#1)(2010-3#1)(2011-1#1)
the remaining ones##2##3##(1993-2#1)(2007-11#1)
the remaining part of the##3##5##(2008-7#1)(2011-2#2)
the remaining part of##4##4##(2008-7#1)(2011-2#2)(2012-1#1)
the remaining part##5##3##(2008-10#1)(2008-7#1)(2011-2#2)(2012-1#1)
the remaining patient##2##3##(2006-5#1)(2008-4#1)
the remaining patients with##2##4##(1995-1#1)(2010-6#1)
the remaining patients##12##3##(1990-12#1)(1992-11#1)(1995-1#1)(2006-5#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-4#1)(2010-6#1)(2013-1#2)
the remaining primary##2##3##(2006-11#1)(2008-1#1)
the remaining radioactivity##2##3##(1990-11#1)(1993-11#1)
the remaining seven##2##3##(1995-6#1)(2008-10#1)
the remaining six were##2##4##(2007-3#1)(2007-8#1)
the remaining six##5##3##(1991-6#1)(1995-2#1)(1997-2#1)(2007-3#1)(2007-8#1)
the remaining three patients##2##4##(1991-12#1)(2008-3#1)
the remaining three##5##3##(1991-12#1)(1997-3#1)(2006-6#1)(2008-3#1)(2009-2#1)
the remaining two patients##3##4##(1993-5#1)(2006-11#1)(2007-8#1)
the remaining two##11##3##(1992-5#1)(1993-2#1)(1993-5#1)(1997-3#1)(1997-7#1)(2004-7#1)(2006-11#1)(2007-8#1)(2008-10#1)(2009-2#1)(2012-2#1)
the remaining were##2##3##(1996-2#1)(2008-4#1)
the remaining##348##2##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#2)(1991-8#3)(1991-9#1)(1992-10#3)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#4)(1993-2#3)(1993-3#2)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#3)(1995-2#2)(1995-3#5)(1995-4#1)(1995-6#5)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#3)(1996-6#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#2)(1997-6#2)(1997-7#3)(2004-10#1)(2004-12#2)(2004-7#1)(2004-9#2)(2005-11#2)(2005-8#1)(2006-10#1)(2006-11#3)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#3)(2007-10#7)(2007-11#2)(2007-12#6)(2007-2#2)(2007-3#2)(2007-5#3)(2007-6#2)(2007-7#5)(2007-8#8)(2007-9#4)(2008-1#5)(2008-10#40)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#5)(2008-4#10)(2008-5#7)(2008-6#5)(2008-7#8)(2008-8#6)(2008-9#1)(2009-11#1)(2009-2#3)(2009-3#3)(2009-4#2)(2009-6#1)(2009-8#2)(2009-9#4)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-6#1)(2011-1#3)(2011-10#1)(2011-2#9)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#3)(2012-4#1)(2013-1#11)(2013-7#1)(2013-8#6)
the remains of##4##3##(2008-10#1)(2008-7#1)(2008-8#1)(2011-1#1)
the remains##6##2##(2008-10#1)(2008-7#1)(2008-8#1)(2011-1#2)(2013-1#1)
the remarkable stability##2##3##(2008-5#1)(2012-2#1)
the remarkable##25##2##(1990-12#1)(1990-3#1)(1991-7#1)(1992-1#1)(1992-9#1)(1993-4#1)(1993-9#1)(1997-4#1)(2006-11#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-10#1)(2012-1#1)(2012-2#1)(2013-8#1)
the remarkably##3##2##(2008-6#1)(2009-10#1)(2012-2#1)
the remediation of##2##3##(2004-10#1)(2013-1#1)
the remedy##3##2##(1997-6#1)(2005-3#1)(2007-5#1)
the remethylation##2##2##(2004-11#1)(2012-2#1)
the remineralization of##3##3##(2010-3#1)(2011-2#1)(2013-8#1)
the remission of##3##3##(1992-5#1)(2006-10#1)(2007-7#1)
the remission phase##2##3##(1991-5#1)(2008-5#1)
the remission##13##2##(1991-2#1)(1991-5#1)(1992-2#1)(1992-5#1)(1993-2#1)(1993-8#1)(1996-9#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2011-2#1)
the remittance##2##2##(2012-12#2)
the remnant neck##3##3##(2013-1#3)
the remnant##16##2##(1991-1#2)(1991-10#1)(1991-5#4)(1992-12#1)(1992-7#2)(1995-8#1)(2006-12#1)(2010-12#1)(2013-1#3)
the remnants##2##2##(1995-6#1)(1997-6#1)
the remodeling of the pulmonary##4##5##(2013-1#4)
the remodeling of the##6##4##(2007-11#1)(2008-1#1)(2013-1#4)
the remodeling of##7##3##(2007-11#1)(2008-1#1)(2010-2#1)(2013-1#4)
the remodeling process##3##3##(1993-10#1)(2010-11#1)(2011-2#1)
the remodeling processes in the##2##5##(1993-12#1)(2012-12#1)
the remodeling##17##2##(1993-10#1)(1993-12#1)(2007-11#1)(2008-1#1)(2009-3#4)(2009-4#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#4)
the remodelling of##3##3##(1991-7#1)(1996-2#1)(2008-6#1)
the remodelling##7##2##(1991-7#1)(1996-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)
the remote heavy atom##2##4##(1993-3#2)
the remote##11##2##(1990-5#1)(1993-3#2)(1995-2#1)(1997-4#2)(2006-1#1)(2006-6#1)(2008-2#1)(2011-2#1)(2013-8#1)
the remote-sensing reflectance##4##3##(2008-2#2)(2008-3#2)
the remotely sensed##3##3##(2007-5#1)(2008-2#1)(2008-3#1)
the removal of a##8##4##(1990-12#1)(1993-10#1)(2006-10#1)(2006-2#1)(2006-9#1)(2008-7#1)(2012-3#1)(2013-1#1)
the removal of accumulated##2##4##(1991-12#1)(2008-5#1)
the removal of all##2##4##(2006-9#1)(2008-11#1)
the removal of large##2##4##(1991-10#1)(2008-10#1)
the removal of lead from water##2##6##(2011-2#2)
the removal of nonpolar##3##4##(1992-5#3)
the removal of plaque##2##4##(2006-2#1)(2012-3#1)
the removal of some of##2##5##(2008-5#1)(2009-12#1)
the removal of some##3##4##(2008-5#1)(2009-12#1)(2009-9#1)
the removal of the type-2 copper##2##6##(1992-12#2)
the removal of the##39##4##(1990-12#1)(1990-6#1)(1991-12#2)(1992-12#3)(1992-2#1)(1992-3#1)(1993-6#1)(1993-9#1)(1994-6#1)(1995-10#1)(1997-5#1)(2006-10#2)(2006-12#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-7#3)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#2)(2013-1#2)(2013-7#1)
the removal of##157##3##(1990-12#2)(1990-2#3)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#3)(1991-2#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-4#2)(1993-6#2)(1993-8#1)(1993-9#2)(1994-6#2)(1994-8#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-7#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#6)(2005-5#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-2#2)(2006-9#2)(2007-10#2)(2007-12#4)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#16)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#6)(2008-9#1)(2009-12#1)(2009-4#1)(2009-9#3)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#4)(2011-2#6)(2012-12#4)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
the removal or##2##3##(2006-10#1)(2007-12#1)
the removal##162##2##(1990-12#2)(1990-2#3)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#3)(1991-2#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-4#2)(1993-6#2)(1993-8#1)(1993-9#2)(1994-6#2)(1994-8#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-7#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#6)(2005-5#1)(2005-8#1)(2006-10#4)(2006-12#2)(2006-2#2)(2006-9#2)(2007-10#2)(2007-12#5)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#16)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#6)(2008-9#1)(2009-12#1)(2009-4#1)(2009-9#3)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#4)(2011-2#6)(2012-12#4)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
the renal 25-hydroxycholecalciferol-1##2##3##(1992-5#2)
the renal HSP73##2##3##(1997-2#2)
the renal allograft##2##3##(1991-3#1)(1995-2#1)
the renal apical membranes##2##4##(1990-11#2)
the renal arteries##6##3##(1990-9#1)(1993-10#1)(1996-2#1)(2008-11#1)(2008-7#1)(2012-2#1)
the renal artery##7##3##(1992-5#1)(1993-3#2)(2010-12#1)(2010-4#3)
the renal biopsy##2##3##(2007-9#1)(2012-11#1)
the renal blood flow rate##2##5##(2007-8#2)
the renal blood flow##3##4##(1996-6#1)(2007-8#2)
the renal capsule##2##3##(1992-8#2)
the renal cell carcinoma##2##4##(1992-3#1)(2010-12#1)
the renal cell##3##3##(1992-3#1)(1992-8#1)(2010-12#1)
the renal cortex and##2##4##(2010-7#1)(2012-12#1)
the renal cortex of##2##4##(1994-5#1)(2010-7#1)
the renal cortex##8##3##(1992-2#1)(1994-5#1)(1997-7#1)(2007-8#1)(2010-7#3)(2012-12#1)
the renal disease##2##3##(2007-7#1)(2008-1#1)
the renal epithelial##2##3##(1991-9#1)(1992-1#1)
the renal excretion##2##3##(2012-2#2)
the renal failure##2##3##(2008-4#1)(2008-7#1)
the renal function##2##3##(2006-10#1)(2012-12#1)
the renal injury##2##3##(1994-5#1)(2008-1#1)
the renal medulla##4##3##(1995-2#1)(2008-1#2)(2008-7#1)
the renal microcirculation##2##3##(1992-8#1)(2013-8#1)
the renal parenchyma##4##3##(1993-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
the renal pathology##2##3##(2007-8#2)
the renal pelvis and##3##4##(1994-4#1)(2008-10#1)(2011-2#1)
the renal pelvis##7##3##(1994-4#2)(1995-2#1)(2008-1#2)(2008-10#1)(2011-2#1)
the renal proximal##4##3##(1992-7#1)(1994-3#2)(1997-1#1)
the renal setting##2##3##(2007-10#2)
the renal sodium channel##3##4##(1997-3#3)
the renal toxicity##3##3##(1994-5#3)
the renal transplant##5##3##(2007-7#1)(2008-1#2)(2008-10#1)(2008-4#1)
the renal unit##2##3##(2008-1#1)(2013-8#1)
the renal vascular##3##3##(1995-12#1)(2008-1#2)
the renal vein##2##3##(2008-7#1)(2011-2#1)
the renal##174##2##(1990-11#4)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#1)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#4)(1992-6#1)(1992-7#1)(1992-8#6)(1993-10#1)(1993-2#1)(1993-3#2)(1994-3#2)(1994-4#2)(1994-5#5)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-9#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#4)(1997-3#4)(1997-6#1)(1997-7#1)(2006-10#2)(2006-4#1)(2007-10#3)(2007-12#1)(2007-2#2)(2007-7#9)(2007-8#8)(2007-9#1)(2008-1#17)(2008-10#4)(2008-11#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#4)(2009-2#1)(2009-5#1)(2010-10#1)(2010-12#3)(2010-4#4)(2010-7#3)(2010-9#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-11#2)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#2)
the renewal of##2##3##(2006-10#1)(2012-2#1)
the renewal##4##2##(2006-10#1)(2008-5#1)(2008-8#1)(2012-2#1)
the renewed##3##2##(2008-10#1)(2009-7#1)(2009-8#1)
the renin angiotensin system in##2##5##(2005-7#1)(2008-11#1)
the renin angiotensin system##5##4##(1990-3#1)(2005-7#1)(2006-10#1)(2008-11#1)(2012-3#1)
the renin gene##2##3##(1995-9#2)
the renin##11##2##(1990-3#1)(1990-8#1)(1991-5#1)(1991-8#1)(1995-9#3)(2005-7#1)(2006-10#1)(2008-11#1)(2012-3#1)
the renin-angiotensin system (RAS)##5##4##(1993-12#1)(1995-10#1)(2005-7#2)(2009-10#1)
the renin-angiotensin system in##3##4##(1991-5#1)(1993-11#1)(1993-12#1)
the renin-angiotensin system##23##3##(1990-2#1)(1991-5#1)(1993-11#2)(1993-12#3)(1994-9#1)(1995-10#1)(1995-9#1)(2005-10#1)(2005-7#3)(2006-8#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#2)(2010-12#1)(2011-1#1)
the renin-angiotensin##26##2##(1990-2#1)(1991-5#1)(1993-11#2)(1993-12#3)(1994-9#1)(1995-10#1)(1995-9#1)(2005-10#2)(2005-7#3)(2006-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#2)(2010-12#1)(2011-1#1)
the renin-angiotensin-aldosterone system (RAAS)##5##4##(2005-7#1)(2007-1#3)(2013-1#1)
the renin-angiotensin-aldosterone system##15##3##(1992-8#1)(1996-6#1)(2005-10#1)(2005-7#1)(2006-11#1)(2007-1#4)(2007-8#2)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
the renin-angiotensin-aldosterone##17##2##(1992-8#1)(1994-7#1)(1996-6#1)(2005-10#1)(2005-7#1)(2006-11#1)(2007-1#4)(2007-8#2)(2010-4#1)(2011-2#1)(2013-1#2)(2013-8#1)
the reorganisation##3##2##(1990-5#1)(1996-8#1)(2011-2#1)
the reorganization of health services##2##5##(1993-6#2)
the reorganization of the##4##4##(1994-3#1)(2008-7#1)(2008-9#2)
the reorganization of##12##3##(1993-6#2)(1994-3#1)(1995-12#1)(1997-1#1)(2004-2#1)(2008-7#1)(2008-9#2)(2009-2#1)(2011-1#1)(2012-1#1)
the reorganization##16##2##(1990-2#1)(1992-5#1)(1993-6#2)(1994-3#1)(1995-12#1)(1997-1#1)(2004-2#1)(2008-2#1)(2008-7#1)(2008-9#3)(2009-2#1)(2011-1#1)(2012-1#1)
the reorientation of the##3##4##(2008-1#1)(2008-10#1)(2011-2#1)
the reorientation of##6##3##(1995-5#1)(2007-12#1)(2008-1#1)(2008-10#2)(2011-2#1)
the reorientation##8##2##(1995-5#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2011-2#1)
the reoxidation of the##2##4##(1992-12#1)(2008-10#1)
the reoxidation##4##2##(1991-2#1)(1992-12#1)(2008-10#2)
the reoxygenation##2##2##(2008-11#1)(2011-12#1)
the rep##3##2##(2006-10#1)(2008-10#2)
the rep-PCR fingerprints##2##3##(2008-10#2)
the rep-PCR##3##2##(2008-10#3)
the repK##2##2##(1997-6#2)
the repair and##3##3##(1992-6#1)(2008-1#1)(2008-9#1)
the repair of CPDs##3##4##(1997-1#3)
the repair of DNA##2##4##(1997-1#1)(2007-9#1)
the repair of EIIISS##2##4##(1997-1#2)
the repair of UV induced##2##5##(1997-1#2)
the repair of damaged##2##4##(2007-9#1)(2008-5#1)
the repair of persistent##2##4##(2009-8#1)(2011-2#1)
the repair of the##2##4##(2006-10#1)(2012-2#1)
the repair of##48##3##(1992-5#2)(1992-6#3)(1994-5#1)(1994-8#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-1#11)(1997-2#2)(1997-6#1)(2004-9#1)(2006-10#2)(2007-8#2)(2007-9#2)(2008-11#2)(2008-5#6)(2009-3#1)(2009-8#1)(2010-8#1)(2011-2#4)(2012-2#1)(2013-8#1)
the repair process##4##3##(1997-2#1)(2007-11#1)(2011-2#2)
the repair site##2##3##(1994-2#1)(2006-3#1)
the repair tissue##3##3##(2012-12#3)
the repair##81##2##(1992-5#2)(1992-6#4)(1994-2#1)(1994-5#1)(1994-8#2)(1995-3#2)(1995-5#1)(1995-6#1)(1997-1#13)(1997-2#5)(1997-6#1)(2004-9#1)(2006-10#2)(2006-12#1)(2006-3#2)(2007-11#2)(2007-12#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-11#2)(2008-5#6)(2008-7#1)(2008-8#2)(2008-9#3)(2009-3#1)(2009-8#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-2#7)(2012-12#5)(2012-2#1)(2013-8#1)
the reparative##2##2##(1992-6#1)(2010-12#1)
the repeat domain##3##3##(1995-3#2)(1995-8#1)
the repeat sequence##2##3##(1997-4#2)
the repeat units##2##3##(2006-10#1)(2009-3#1)
the repeat##21##2##(1991-8#1)(1995-3#2)(1995-8#1)(1996-5#1)(1997-4#2)(1997-8#1)(2006-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-8#1)(2012-2#3)
the repeatability and##2##3##(2007-11#1)(2008-10#1)
the repeatability is##2##3##(2008-10#2)
the repeatability of measurements##4##4##(1996-3#1)(2008-10#3)
the repeatability of the##10##4##(2006-11#1)(2008-10#6)(2008-2#1)(2008-3#1)(2010-12#1)
the repeatability of##19##3##(1996-3#1)(2005-12#1)(2006-11#1)(2008-10#11)(2008-2#1)(2008-3#2)(2010-12#1)(2010-8#1)
the repeatability##32##2##(1994-9#1)(1996-3#1)(1996-6#1)(2005-12#1)(2006-11#2)(2007-11#1)(2008-10#19)(2008-2#1)(2008-3#2)(2010-12#2)(2010-8#1)
the repeated administration##2##3##(1993-2#1)(1995-12#1)
the repeated injection##2##3##(2008-11#1)(2008-8#1)
the repeated measures##2##3##(1993-5#1)(1994-8#1)
the repeated##26##2##(1990-3#1)(1993-2#1)(1993-5#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#2)(1997-2#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#1)(2012-2#1)(2013-8#1)
the repeating unit of the##2##5##(1995-11#1)(1996-2#1)
the repeating unit of##3##4##(1990-3#1)(1995-11#1)(1996-2#1)
the repeating##8##2##(1990-12#1)(1990-3#1)(1992-9#1)(1995-11#1)(1996-11#1)(1996-2#1)(2011-2#1)(2012-11#1)
the repeats##4##2##(1993-9#1)(1996-10#1)(1997-6#1)(2008-3#1)
the reperfused##2##2##(2011-1#1)(2013-7#1)
the reperfusion period##2##3##(1994-5#1)(2010-12#1)
the reperfusion##9##2##(1994-5#1)(1995-12#1)(1996-8#1)(2006-10#1)(2007-8#2)(2007-9#1)(2010-12#2)
the repertoire of##9##3##(1991-2#1)(1995-2#1)(1995-3#1)(2005-7#1)(2007-3#1)(2008-11#1)(2008-3#1)(2009-12#1)(2011-1#1)
the repertoire##11##2##(1991-2#1)(1995-2#1)(1995-3#1)(1997-6#1)(2005-7#1)(2007-3#1)(2008-11#2)(2008-3#1)(2009-12#1)(2011-1#1)
the repertory grid technique##2##4##(2010-9#1)(2012-2#1)
the repetition frequency##2##3##(2007-12#2)
the repetition of##4##3##(2008-10#1)(2011-2#2)(2013-1#1)
the repetition rate of a##3##5##(2007-11#1)(2007-12#1)(2008-3#1)
the repetition rate of##6##4##(2007-11#2)(2007-12#1)(2008-3#3)
the repetition rate##9##3##(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#3)
the repetition##16##2##(2007-11#3)(2007-12#4)(2008-10#1)(2008-2#2)(2008-3#3)(2011-2#2)(2013-1#1)
the repetitive structure##2##3##(1990-11#2)
the repetitive##18##2##(1990-11#2)(1991-12#1)(1991-3#1)(1992-12#1)(1993-11#1)(1994-3#1)(2006-10#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#2)(2011-2#1)(2012-1#1)
the replaced##2##2##(1990-4#1)(2013-1#1)
the replacement of BSA with FCS in mSOF##2##8##(2006-5#2)
the replacement of the##7##4##(1994-5#1)(1997-7#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-3#1)(2012-12#1)
the replacement of##35##3##(1990-5#2)(1991-2#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-3#2)(1994-5#1)(1994-9#1)(1997-7#1)(1997-8#1)(2006-11#1)(2006-12#1)(2006-5#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#2)(2009-3#1)(2010-3#1)(2010-6#1)(2012-12#2)(2013-8#1)
the replacement##44##2##(1990-5#2)(1991-2#2)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-3#2)(1994-5#1)(1994-9#2)(1997-5#1)(1997-7#1)(1997-8#1)(2006-11#1)(2006-12#1)(2006-5#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-3#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-6#1)(2012-12#2)(2013-8#1)
the replicability of##2##3##(1997-7#1)(2008-11#1)
the replicase##4##2##(2008-10#1)(2008-9#3)
the replicate analysis##2##3##(2008-10#2)
the replicate##3##2##(2008-10#3)
the replicated##3##2##(2008-10#1)(2008-2#1)(2012-2#1)
the replication and##3##3##(1997-2#1)(2013-1#2)
the replication efficiency##2##3##(2013-1#2)
the replication fork##8##3##(1990-12#1)(1991-12#2)(1992-3#2)(1994-9#2)(1996-8#1)
the replication initiator##2##3##(1997-4#1)(2008-10#1)
the replication of HIV-1##4##4##(1991-10#1)(1996-4#1)(2011-3#2)
the replication of human immunodeficiency virus (HIV)##2##7##(1991-7#1)(2010-2#1)
the replication of the##2##4##(1990-7#1)(2013-1#1)
the replication of##33##3##(1990-3#1)(1990-7#1)(1991-1#2)(1991-10#1)(1991-6#1)(1991-7#1)(1994-12#1)(1994-6#2)(1994-8#1)(1995-2#1)(1996-4#1)(2005-12#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#2)(2008-9#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-3#2)(2012-12#1)(2013-1#2)
the replication origin of##2##4##(1991-5#1)(1991-9#1)
the replication origin##7##3##(1991-5#1)(1991-8#1)(1991-9#1)(1994-11#1)(1994-12#2)(1995-8#1)
the replication terminator protein##2##4##(1993-9#2)
the replication terminator##3##3##(1993-9#3)
the replication terminus region##2##4##(1996-12#1)(1997-2#1)
the replication##82##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-3#2)(1993-11#1)(1993-9#3)(1994-11#2)(1994-12#3)(1994-2#1)(1994-6#2)(1994-8#1)(1994-9#5)(1995-1#1)(1995-2#1)(1995-8#1)(1996-12#2)(1996-4#1)(1996-8#1)(1997-2#2)(1997-4#2)(2005-12#1)(2006-10#1)(2006-2#1)(2008-10#4)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-9#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-3#2)(2012-12#1)(2012-3#1)(2013-1#7)
the replication-unlinked H2A##2##3##(1994-9#2)
the replication-unlinked##3##2##(1994-9#3)
the replicative##4##2##(1990-9#1)(1993-3#1)(1994-8#1)(2008-10#1)
the report &quot##3##3##(1990-11#1)(1992-2#1)(2006-8#1)
the report and##3##3##(2007-9#1)(2009-2#1)(2011-12#1)
the report by##3##3##(2007-9#2)(2010-11#1)
the report is##3##3##(1990-11#1)(2008-1#1)(2011-2#1)
the report of a##3##4##(1994-2#1)(2006-2#1)(2008-10#1)
the report of the##2##4##(2010-3#1)(2013-8#1)
the report of##9##3##(1991-11#1)(1994-11#1)(1994-2#1)(2006-2#1)(2008-10#1)(2010-3#1)(2012-11#1)(2012-2#1)(2013-8#1)
the report on##2##3##(2008-5#1)(2009-5#1)
the report will##2##3##(2007-8#1)(2008-11#1)
the report##39##2##(1990-11#2)(1991-11#1)(1992-2#1)(1994-11#1)(1994-2#1)(1994-5#1)(2006-12#1)(2006-2#2)(2006-8#1)(2007-8#1)(2007-9#4)(2008-1#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-5#2)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#3)(2013-8#1)
the reported amino acid sequence##2##5##(1991-2#1)(1997-2#1)
the reported case##2##3##(2011-2#1)(2012-3#1)
the reported cases of##5##4##(1994-9#1)(1995-3#1)(2007-7#1)(2009-3#1)(2011-2#1)
the reported cases##12##3##(1994-6#1)(1994-9#1)(1995-3#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-5#1)(2009-3#2)(2011-1#1)(2011-2#1)
the reported changes##2##3##(1991-2#1)(2011-2#1)
the reported clinical##3##3##(2008-5#1)(2009-8#1)(2010-6#1)
the reported effects of##2##4##(2005-7#1)(2006-10#1)
the reported effects##3##3##(1993-12#1)(2005-7#1)(2006-10#1)
the reported incidence of##3##4##(2007-3#1)(2007-7#1)(2013-8#1)
the reported incidence##4##3##(2007-3#1)(2007-7#1)(2010-7#1)(2013-8#1)
the reported increase in##2##4##(1990-4#1)(1996-6#1)
the reported lack of##2##4##(1991-3#1)(2009-4#1)
the reported number of##2##4##(2008-7#1)(2013-1#1)
the reported prevalence##2##3##(2006-8#1)(2008-1#1)
the reported search##50##3##(2007-8#50)
the reported therapeutic##3##3##(2007-1#1)(2008-6#1)(2011-2#1)
the reported values##2##3##(1990-7#1)(2008-10#1)
the reported##190##2##(1990-10#3)(1990-11#1)(1990-2#1)(1990-4#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-2#2)(1991-3#2)(1991-7#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-12#2)(1993-9#1)(1994-12#3)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-12#2)(1995-3#2)(1995-6#4)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#2)(2005-7#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-1#2)(2007-12#3)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#5)(2007-8#50)(2007-9#1)(2008-1#4)(2008-10#17)(2008-11#1)(2008-12#3)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-3#2)(2009-4#1)(2009-8#2)(2010-1#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#11)(2012-12#4)(2012-3#3)(2013-1#3)(2013-8#3)
the reporter and##2##3##(1997-4#1)(2008-9#1)
the reporter constructs##3##3##(1994-2#3)
the reporter gene was##6##4##(1991-8#1)(1994-2#1)(1995-5#1)(1997-4#1)(2006-12#1)(2008-11#1)
the reporter gene##26##3##(1991-8#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-10#1)(1995-5#1)(1995-8#1)(1997-1#1)(1997-4#2)(1997-7#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-9#3)(2011-1#1)
the reporter genes##2##3##(1991-7#2)
the reporter protein##4##3##(1997-2#1)(2008-11#2)(2009-5#1)
the reporter##48##2##(1990-12#1)(1991-7#2)(1991-8#1)(1992-12#2)(1992-8#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#2)(1995-10#2)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#3)(1997-7#1)(2005-9#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-11#6)(2008-7#1)(2008-9#4)(2009-5#1)(2011-1#2)(2011-12#1)
the reporters##3##2##(1996-5#1)(1997-8#1)(2007-8#1)
the reporting of adverse events##2##5##(2007-11#1)(2008-7#1)
the reporting of##12##3##(1996-3#1)(1997-3#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-7#1)(2010-6#1)(2011-2#1)(2013-7#1)(2013-8#1)
the reporting quality##2##3##(2011-2#2)
the reporting requirements##2##3##(1992-3#2)
the reporting system##2##3##(1996-1#1)(2007-2#1)
the reporting##28##2##(1991-8#1)(1992-3#2)(1994-2#1)(1996-1#1)(1996-3#1)(1997-3#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-4#2)(2007-7#1)(2008-1#2)(2008-10#1)(2008-7#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#3)(2013-7#1)(2013-8#1)
the reports by##2##3##(1990-10#1)(2007-9#1)
the reports of##10##3##(1990-3#1)(1995-12#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-9#1)(2011-1#1)(2011-12#1)
the reports##27##2##(1990-10#1)(1990-3#2)(1991-2#1)(1992-1#1)(1995-12#1)(1996-5#1)(2006-10#2)(2007-11#1)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#3)(2008-9#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-7#1)
the repositioning of the##2##4##(2006-12#1)(2007-7#1)
the repositioning##4##2##(2006-12#1)(2007-7#1)(2008-7#1)(2010-7#1)
the representation of space##2##4##(2009-10#2)
the representation of the##8##4##(1992-2#1)(1992-6#1)(1995-11#4)(2008-11#1)(2008-2#1)
the representation of##22##3##(1992-2#1)(1992-6#1)(1994-3#1)(1995-11#4)(1995-12#1)(1997-8#1)(2007-10#1)(2007-3#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-6#1)(2008-9#1)(2009-10#2)(2011-1#1)
the representation##27##2##(1992-2#1)(1992-6#1)(1994-3#1)(1995-11#4)(1995-12#1)(1997-8#1)(2007-10#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-6#1)(2008-9#1)(2009-10#3)(2011-1#1)(2012-3#1)(2013-1#2)
the representational##3##2##(1997-8#1)(2008-4#1)(2012-3#1)
the representations##4##2##(2005-10#1)(2009-10#2)(2009-8#1)
the representative##11##2##(1991-5#1)(2007-8#2)(2008-10#4)(2008-2#2)(2012-12#1)(2013-8#1)
the representatives from##2##3##(1997-6#1)(2011-1#1)
the representatives of##2##3##(2008-8#1)(2011-12#1)
the representatives##4##2##(1997-6#1)(2008-8#1)(2011-1#1)(2011-12#1)
the repression of##14##3##(1992-1#1)(1992-8#1)(1993-12#1)(1994-12#2)(1995-12#1)(1996-4#1)(1997-8#1)(2006-3#1)(2008-1#2)(2008-10#2)(2008-11#1)
the repression##23##2##(1992-1#2)(1992-8#1)(1993-11#1)(1993-12#1)(1994-12#2)(1994-5#1)(1994-6#1)(1995-12#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-1#2)(1997-7#1)(1997-8#1)(2006-3#1)(2008-1#2)(2008-10#2)(2008-11#1)
the repressor protein##2##3##(1994-3#1)(1994-9#1)
the repressor##10##2##(1990-5#1)(1992-4#1)(1992-6#2)(1994-3#1)(1994-9#1)(1995-8#1)(1996-11#1)(1997-1#1)(2008-11#1)
the reproducibility and accuracy of##2##5##(1991-3#1)(2008-10#1)
the reproducibility and##12##3##(1991-3#1)(2008-10#7)(2009-11#1)(2012-1#2)(2013-8#1)
the reproducibility is##5##3##(2008-1#1)(2008-10#4)
the reproducibility of analytical##2##4##(1991-11#1)(2008-10#1)
the reproducibility of anorectal manometry##2##5##(1994-4#2)
the reproducibility of anorectal##3##4##(1994-4#3)
the reproducibility of the method##5##5##(1991-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-7#1)
the reproducibility of the technique##2##5##(2007-8#1)(2008-10#1)
the reproducibility of the##18##4##(1991-5#1)(1995-3#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-7#1)(2012-12#1)
the reproducibility of this##2##4##(1994-3#1)(2008-11#1)
the reproducibility of##36##3##(1991-11#1)(1991-5#1)(1994-3#1)(1994-4#3)(1995-3#1)(2004-11#1)(2005-10#1)(2007-10#1)(2007-8#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-5#1)(2010-7#1)(2012-12#1)(2012-2#1)
the reproducibility was##4##3##(2008-10#4)
the reproducibility##66##2##(1991-11#1)(1991-3#1)(1991-5#1)(1994-3#1)(1994-4#3)(1995-3#1)(2004-11#1)(2005-10#1)(2007-10#1)(2007-8#2)(2008-1#1)(2008-10#33)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-8#1)(2010-5#1)(2010-7#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-8#1)
the reproducible##4##2##(1992-10#1)(2008-10#2)(2008-3#1)
the reproducing##2##2##(2004-12#1)(2008-8#1)
the reproduction and##2##3##(2008-5#1)(2012-2#1)
the reproduction cycle of##2##4##(2008-7#2)
the reproduction of##3##3##(2008-10#1)(2008-5#1)(2009-4#1)
the reproduction rate##2##3##(2008-10#1)(2009-9#1)
the reproduction##16##2##(2008-10#3)(2008-5#3)(2008-7#3)(2008-9#1)(2009-4#1)(2009-9#3)(2010-5#1)(2012-2#1)
the reproductive age##3##3##(1993-6#1)(2008-3#1)(2013-8#1)
the reproductive and##4##3##(1997-4#1)(2008-10#1)(2008-5#1)(2013-8#1)
the reproductive axis##2##3##(1995-11#1)(2008-4#1)
the reproductive cycle##7##3##(1990-12#2)(2007-9#3)(2012-12#2)
the reproductive endocrinology of##2##4##(2009-7#1)(2010-8#1)
the reproductive function of##2##4##(2006-1#1)(2006-5#1)
the reproductive function##4##3##(2006-1#1)(2006-2#1)(2006-5#1)(2012-3#1)
the reproductive health##3##3##(2007-3#1)(2008-11#1)(2011-1#1)
the reproductive organs##3##3##(2008-12#2)(2008-8#1)
the reproductive outcome after##2##4##(2004-10#1)(2011-1#1)
the reproductive performance of##5##4##(2005-7#1)(2006-5#1)(2008-10#1)(2008-12#1)(2009-5#1)
the reproductive performance##6##3##(2005-7#1)(2006-5#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-5#1)
the reproductive period and##4##4##(1995-10#1)(1997-4#2)(2013-1#1)
the reproductive period##11##3##(1995-10#1)(1997-4#5)(2012-11#4)(2013-1#1)
the reproductive physiology of##4##4##(2008-7#3)(2010-8#1)
the reproductive physiology##5##3##(1996-9#1)(2008-7#3)(2010-8#1)
the reproductive potential of##2##4##(2008-10#1)(2008-5#1)
the reproductive potential##5##3##(2008-10#1)(2008-5#1)(2009-12#2)(2013-8#1)
the reproductive state of the animal##2##6##(1994-10#2)
the reproductive success of##8##4##(1996-6#1)(2008-6#1)(2008-9#3)(2010-8#1)(2012-2#1)(2012-3#1)
the reproductive success##9##3##(1996-6#1)(2008-6#1)(2008-9#3)(2009-12#1)(2010-8#1)(2012-2#1)(2012-3#1)
the reproductive system##7##3##(2006-10#3)(2008-4#1)(2008-6#1)(2011-2#1)(2012-2#1)
the reproductive tract weight##2##4##(2006-5#2)
the reproductive tract##9##3##(1991-12#1)(1993-2#1)(1994-9#1)(2006-5#4)(2007-12#1)(2013-1#1)
the reproductive##120##2##(1990-12#2)(1991-1#1)(1991-12#2)(1991-6#1)(1993-2#1)(1993-6#1)(1994-10#2)(1994-9#1)(1995-10#1)(1995-11#1)(1996-6#1)(1996-9#1)(1997-4#6)(1997-5#1)(2004-10#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-2#1)(2006-5#6)(2007-1#1)(2007-12#4)(2007-3#5)(2007-9#3)(2008-10#4)(2008-11#1)(2008-12#6)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#4)(2009-12#4)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-8#5)(2011-1#2)(2011-2#6)(2012-11#4)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#3)
the reprogramming of##2##3##(2009-3#1)(2010-7#1)
the reprogramming##4##2##(2006-8#1)(2007-10#1)(2009-3#1)(2010-7#1)
the reprotonation##3##2##(1993-3#1)(1995-11#1)(2008-10#1)
the repulsion##3##2##(2007-12#2)(2008-10#1)
the repulsive##4##2##(1994-8#1)(2005-11#1)(2007-11#1)(2008-2#1)
the reputation of##3##3##(2006-4#1)(2006-6#1)(2013-8#1)
the reputation##4##2##(2006-4#1)(2006-6#1)(2009-2#1)(2013-8#1)
the request for treatment is##2##5##(2009-6#2)
the request for treatment##3##4##(2009-6#3)
the request for##7##3##(2006-4#1)(2007-3#1)(2008-11#1)(2009-6#3)(2011-7#1)
the request of the##11##4##(1990-11#1)(1997-4#1)(1997-6#1)(2007-8#1)(2008-10#4)(2012-11#3)
the request of##15##3##(1990-11#1)(1991-12#1)(1997-4#1)(1997-6#1)(2006-5#1)(2007-8#1)(2008-10#4)(2012-1#1)(2012-11#3)(2013-8#1)
the request##24##2##(1990-11#1)(1991-12#1)(1995-6#1)(1997-4#1)(1997-6#1)(2006-4#1)(2006-5#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-11#1)(2009-6#3)(2011-11#1)(2011-7#1)(2012-1#1)(2012-11#3)(2013-8#1)
the required 1##2##3##(2007-11#2)
the required accuracy##3##3##(1994-11#1)(2008-2#1)(2008-3#1)
the required amount of##2##4##(2008-11#1)(2011-1#1)
the required incubation##2##3##(2006-1#1)(2012-11#1)
the required information##2##3##(2008-3#1)(2008-9#1)
the required laser##2##3##(2007-11#1)(2007-12#1)
the required level of accuracy##2##5##(2008-10#2)
the required level of confidence##2##5##(2008-10#2)
the required level of##5##4##(2008-10#4)(2008-5#1)
the required measurement##2##3##(2008-2#1)(2008-3#1)
the required number of##5##4##(1993-1#1)(2006-11#1)(2007-12#1)(2008-11#1)(2012-3#1)
the required plastic deformation##3##4##(2008-7#3)
the required precision##2##3##(2008-3#2)
the required properties##2##3##(1996-1#1)(2010-4#1)
the required sample sizes##3##4##(2012-3#3)
the required sample##5##3##(2008-3#1)(2012-3#4)
the required sensitivity and reproducibility##2##5##(2008-10#1)(2008-8#1)
the required sensitivity and##3##4##(2008-10#1)(2008-5#1)(2008-8#1)
the required sensitivity##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)
the required time##2##3##(1990-8#1)(2007-8#1)
the required##142##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-9#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#2)(1995-6#1)(1996-1#1)(1996-12#2)(1996-8#1)(2004-10#1)(2004-12#1)(2005-5#3)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-11#5)(2007-12#10)(2007-4#1)(2007-8#1)(2008-1#4)(2008-10#12)(2008-11#4)(2008-2#12)(2008-3#25)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#6)(2013-1#1)
the requirement for Mg2+##2##4##(1990-8#1)(1991-7#1)
the requirement for a##2##4##(1993-12#1)(2007-12#1)
the requirement for an##2##4##(1992-8#1)(1993-7#1)
the requirement for the##2##4##(1995-3#1)(1996-7#1)
the requirement for##45##3##(1990-3#1)(1990-8#2)(1991-7#1)(1991-8#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-7#1)(1994-12#1)(1994-8#1)(1995-3#2)(1995-4#1)(1996-1#1)(1996-7#1)(1997-5#1)(1997-8#1)(2004-11#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-7#2)(2008-8#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-7#2)(2012-12#2)(2013-8#1)
the requirement of a##3##4##(2008-10#1)(2008-6#1)(2013-8#1)
the requirement of##26##3##(1992-10#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-11#1)(1997-2#1)(2006-8#1)(2007-12#1)(2007-9#2)(2008-10#3)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
the requirement that the##4##4##(1992-6#1)(1993-4#1)(2006-10#1)(2012-3#1)
the requirement that##8##3##(1992-6#1)(1992-9#1)(1993-4#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-1#1)(2012-3#1)
the requirement to##3##3##(2008-2#1)(2008-3#1)(2009-10#1)
the requirement was##2##3##(1990-4#1)(2011-2#1)
the requirement##87##2##(1990-3#1)(1990-4#1)(1990-8#2)(1991-7#1)(1991-8#1)(1992-10#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#2)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#3)(1995-4#1)(1996-1#1)(1996-7#1)(1997-2#1)(1997-5#1)(1997-8#2)(2004-11#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-12#3)(2007-5#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#4)(2008-11#3)(2008-2#5)(2008-3#6)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-7#2)(2011-1#2)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#2)
the requirements and##4##3##(1992-3#1)(1996-12#1)(2008-6#1)(2012-1#1)
the requirements for a##4##4##(1991-2#1)(1994-6#1)(2004-9#1)(2007-4#1)
the requirements for the##4##4##(1990-8#1)(2007-4#1)(2008-10#1)(2013-1#1)
the requirements for##26##3##(1990-8#1)(1991-2#1)(1994-6#2)(1997-4#2)(2004-9#1)(2007-11#2)(2007-4#2)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#1)(2008-8#1)(2010-12#1)(2012-3#1)(2013-1#2)
the requirements of a##2##4##(1990-9#1)(2008-1#1)
the requirements of the##23##4##(1991-4#1)(1993-10#1)(1993-3#1)(1994-2#1)(1996-12#1)(2006-8#2)(2007-8#2)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
the requirements of##51##3##(1990-9#1)(1991-3#1)(1991-4#1)(1992-3#1)(1993-10#1)(1993-3#2)(1994-2#1)(1996-1#1)(1996-12#1)(1996-9#1)(2005-5#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#4)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
the requirements to##2##3##(2013-1#1)(2013-8#1)
the requirements under the##2##4##(1991-1#1)(1993-1#1)
the requirements##97##2##(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-11#1)(1992-3#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-3#2)(1994-2#2)(1994-6#2)(1996-1#1)(1996-12#2)(1996-9#1)(1997-4#2)(2004-9#1)(2005-5#2)(2006-5#1)(2006-7#1)(2006-8#2)(2007-11#2)(2007-4#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-2#9)(2008-3#4)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-12#1)(2009-6#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#2)
the requisite##12##2##(1991-3#1)(1991-7#1)(1994-2#1)(1997-8#1)(2006-9#1)(2007-4#1)(2008-3#1)(2008-4#2)(2009-10#1)(2010-2#1)(2012-2#1)
the rescue effect##2##3##(2008-8#2)
the rescue##10##2##(1990-9#1)(1992-3#1)(1995-2#1)(2007-7#1)(2008-4#1)(2008-8#2)(2009-4#1)(2010-7#1)(2010-8#1)
the research and development of##4##5##(2007-11#1)(2008-10#1)(2013-1#1)(2013-8#1)
the research and development process##2##5##(2005-7#1)(2008-11#1)
the research and development##7##4##(2005-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)(2013-8#1)
the research and##17##3##(1992-8#1)(1996-2#1)(2005-10#1)(2005-7#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-4#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
the research base##2##3##(1990-6#1)(2009-5#1)
the research carried out##2##4##(2008-1#1)(2012-12#1)
the research community is##3##4##(2008-6#1)(2013-1#2)
the research community##9##3##(2006-11#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#2)(2013-1#2)
the research conducted##2##3##(2008-2#1)(2013-1#1)
the research contributions of##2##4##(2008-11#1)(2008-8#1)
the research evidence##2##3##(2006-2#1)(2008-11#1)
the research experience##2##3##(2009-4#2)
the research findings##4##3##(2006-2#1)(2010-8#1)(2010-9#1)(2013-1#1)
the research for##3##3##(2006-12#1)(2007-9#1)(2013-8#1)
the research found##2##3##(1996-3#1)(2012-12#1)
the research has##3##3##(2008-10#1)(2008-5#1)(2009-9#1)
the research in this##2##4##(2010-5#1)(2010-9#1)
the research in##3##3##(2008-11#1)(2010-5#1)(2010-9#1)
the research into the##2##4##(2008-9#1)(2009-8#1)
the research into##3##3##(1997-7#1)(2008-9#1)(2009-8#1)
the research involves##2##3##(2009-2#1)(2011-12#1)
the research is##2##3##(1996-3#1)(2013-1#1)
the research literature on##3##4##(2010-2#1)(2012-12#1)(2013-1#1)
the research literature##6##3##(1994-3#1)(2008-4#1)(2009-2#1)(2010-2#1)(2012-12#1)(2013-1#1)
the research methods##2##3##(2008-8#1)(2013-8#1)
the research of##12##3##(2005-4#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-9#1)(2009-5#1)(2010-12#2)(2010-2#1)
the research on the##4##4##(2004-9#1)(2008-10#1)(2011-2#1)(2013-8#1)
the research on##12##3##(1990-10#1)(1995-3#1)(2004-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
the research participant's##2##3##(2010-2#2)
the research participants##3##3##(1995-1#2)(2012-2#1)
the research presented##2##3##(2005-7#1)(2008-3#1)
the research process##11##3##(1992-5#1)(2007-12#1)(2008-12#1)(2009-4#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
the research program##3##3##(2007-12#1)(2007-4#1)(2010-7#1)
the research progress in##2##4##(2013-8#2)
the research project##4##3##(2006-8#1)(2007-11#1)(2008-11#1)(2013-8#1)
the research question##3##3##(1996-8#1)(2007-8#1)(2010-4#1)
the research questions##2##3##(2007-1#1)(2011-2#1)
the research reported##3##3##(1991-2#1)(2008-2#1)(2012-1#1)
the research results##4##3##(1992-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
the research setting##2##3##(2010-7#1)(2012-12#1)
the research subjects##3##3##(1996-3#2)(2009-4#1)
the research team to##2##4##(2007-11#1)(2010-3#1)
the research team##3##3##(2007-11#1)(2010-11#1)(2010-3#1)
the research that##4##3##(2008-5#1)(2008-6#1)(2009-1#1)(2010-3#1)
the research to##2##3##(2006-11#1)(2010-12#1)
the research was##11##3##(1992-1#1)(1992-12#1)(1997-6#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2011-2#1)
the research were##4##3##(2005-10#1)(2008-10#3)
the research##267##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-3#1)(1994-12#2)(1994-3#1)(1994-7#2)(1995-1#3)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#5)(1996-8#1)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-9#1)(2005-10#2)(2005-3#1)(2005-4#2)(2005-7#2)(2006-10#2)(2006-11#2)(2006-12#1)(2006-2#2)(2006-5#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-11#8)(2007-12#4)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#6)(2008-1#3)(2008-10#16)(2008-11#18)(2008-12#3)(2008-2#5)(2008-3#3)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#3)(2009-1#1)(2009-2#2)(2009-4#10)(2009-5#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#5)(2010-2#6)(2010-3#3)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#4)(2010-9#3)(2011-1#3)(2011-12#1)(2011-2#10)(2012-1#2)(2012-12#6)(2012-2#6)(2012-3#3)(2013-1#14)(2013-7#1)(2013-8#13)
the researched##2##2##(2008-10#1)(2008-7#1)
the researcher and the##4##4##(1992-2#1)(2005-8#1)(2008-7#1)(2012-2#1)
the researcher to##6##3##(1992-11#1)(2008-1#1)(2008-9#1)(2009-5#1)(2009-6#1)(2013-1#1)
the researcher##30##2##(1990-12#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-3#2)(1994-3#1)(2004-11#1)(2005-8#1)(2006-2#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#2)
the researcher's##4##2##(1997-1#1)(1997-6#1)(2008-4#1)(2011-1#1)
the researchers conducted two structured interviews per ward##2##8##(2013-1#2)
the researchers conducted##3##3##(2006-7#1)(2013-1#2)
the researchers##23##2##(1996-4#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-5#2)(2007-9#2)(2008-11#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-3#2)(2010-9#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#4)
the researches of##4##3##(2005-4#2)(2013-8#2)
the researches##5##2##(2005-4#2)(2012-3#1)(2013-8#2)
the resectability of##2##3##(2006-6#1)(2008-7#1)
the resectability##3##2##(2006-6#1)(2008-7#1)(2013-8#1)
the resected lung##2##3##(2006-10#2)
the resected lymph nodes##2##4##(2006-9#1)(2007-6#1)
the resected specimen was##2##4##(1992-6#1)(2013-1#1)
the resected specimen##7##3##(1992-6#1)(1996-6#1)(2007-4#1)(2008-10#1)(2011-2#1)(2013-1#1)(2013-7#1)
the resected tumor##4##3##(2007-12#1)(2011-12#1)(2012-2#2)
the resected##25##2##(1992-6#2)(1996-3#1)(1996-6#1)(1997-3#1)(2006-10#2)(2006-6#1)(2006-9#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-6#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-2#4)(2013-1#1)(2013-7#1)(2013-8#1)
the resection and##3##3##(2006-10#1)(2009-10#1)(2012-2#1)
the resection of the##5##4##(1992-9#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
the resection of##15##3##(1992-9#1)(1995-9#1)(2006-12#2)(2006-6#1)(2007-1#1)(2007-3#1)(2007-8#2)(2007-9#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
the resection rate##2##3##(1992-9#1)(2010-3#1)
the resection specimen##2##3##(2006-4#1)(2008-5#1)
the resection was##3##3##(2006-12#1)(2008-10#1)(2009-10#1)
the resection##34##2##(1990-11#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-9#2)(1995-9#1)(2006-10#1)(2006-12#3)(2006-4#1)(2006-6#4)(2007-1#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-5#1)(2009-10#3)(2009-7#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#2)(2013-8#1)
the resemblance to##2##3##(1995-8#1)(2007-12#1)
the reserpine treatment##2##3##(1991-8#2)
the reserpine##4##2##(1990-2#1)(1991-8#2)(2008-10#1)
the reserve pool of##2##4##(2007-10#2)
the reserve pool##3##3##(2007-10#3)
the reserve##8##2##(1992-12#1)(2007-10#3)(2008-10#1)(2008-5#1)(2012-3#1)(2013-7#1)
the reserves of##2##3##(2011-2#1)(2012-1#1)
the reservoir and##2##3##(2008-12#1)(2008-5#1)
the reservoir lumen##2##3##(2007-12#2)
the reservoir of##2##3##(2007-12#1)(2008-10#1)
the reservoir powder inhaler##3##4##(1996-2#3)
the reservoir##26##2##(1995-4#1)(1996-2#3)(2005-11#1)(2007-12#4)(2008-10#8)(2008-12#2)(2008-3#2)(2008-5#2)(2008-7#1)(2010-12#1)(2012-2#1)
the reservoirs of##2##3##(2011-1#1)(2013-7#1)
the reservoirs##7##2##(2008-11#1)(2008-5#2)(2011-1#1)(2011-2#2)(2013-7#1)
the residence of the##2##4##(1991-3#1)(2012-12#1)
the residence of##3##3##(1991-3#1)(2008-8#1)(2012-12#1)
the residence time of the gas in the##2##8##(2008-10#1)(2008-2#1)
the residence time of##4##4##(2007-9#1)(2008-10#1)(2008-2#1)(2013-7#1)
the residence time##9##3##(1996-1#1)(2007-9#5)(2008-10#1)(2008-2#1)(2013-7#1)
the residence times of##2##4##(1996-12#1)(2011-2#1)
the residence times##4##3##(1996-12#1)(2007-8#2)(2011-2#1)
the residence##17##2##(1991-3#1)(1996-1#1)(1996-12#1)(2007-8#2)(2007-9#5)(2008-10#1)(2008-2#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
the residency##2##2##(1996-9#1)(2006-10#1)
the resident and the##3##4##(1996-1#1)(2007-7#1)(2011-2#1)
the resident freshwater populations##2##4##(2010-8#2)
the resident freshwater##3##3##(2010-8#3)
the resident microbiota##2##3##(2009-5#1)(2013-1#1)
the resident microflora##3##3##(2008-10#2)(2008-5#1)
the resident population##2##3##(1996-3#1)(2007-9#1)
the resident##27##2##(1990-9#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-3#1)(2006-6#1)(2007-4#1)(2007-7#1)(2007-9#3)(2008-10#4)(2008-4#1)(2008-5#3)(2008-6#1)(2009-5#1)(2010-8#3)(2011-2#2)(2013-1#1)
the resident's##3##2##(1996-1#1)(2007-4#1)(2011-1#1)
the residential##9##2##(1991-12#2)(1996-3#1)(2007-10#1)(2008-6#1)(2010-12#1)(2010-8#1)(2011-2#2)
the residents of##5##3##(1996-2#1)(1996-3#1)(2007-8#1)(2008-12#1)(2013-8#1)
the residents##11##2##(1995-3#1)(1996-2#1)(1996-3#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-12#1)(2011-2#2)(2013-8#1)
the residual N in##2##4##(2013-8#2)
the residual effects of##2##4##(1990-3#1)(2009-3#1)
the residual effects##3##3##(1990-3#1)(2008-3#1)(2009-3#1)
the residual error##2##3##(2008-2#1)(2010-8#1)
the residual naphthalene concentrations##2##4##(2011-12#2)
the residual part##2##3##(2008-2#2)
the residual risk of hepatitis C virus##2##7##(2012-2#2)
the residual risk of##4##4##(2012-2#4)
the residual risk##5##3##(1990-6#1)(2012-2#4)
the residual signal##2##3##(2008-2#2)
the residual spherical##2##3##(2008-2#2)
the residual stress##2##3##(2008-2#2)
the residual subtype##2##3##(1997-2#2)
the residual tumor##2##3##(2010-12#1)(2012-12#1)
the residual wave##2##3##(2008-3#2)
the residual##114##2##(1990-11#1)(1990-3#1)(1990-6#1)(1990-9#2)(1991-1#1)(1991-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-8#2)(1997-2#3)(1997-3#1)(2004-9#1)(2007-11#3)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#14)(2008-12#6)(2008-2#14)(2008-3#10)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#2)(2009-7#2)(2009-9#1)(2010-12#3)(2010-7#1)(2010-8#1)(2011-12#2)(2012-1#3)(2012-12#2)(2012-2#6)(2013-1#1)(2013-8#2)
the residuals##7##2##(1995-9#1)(2008-10#3)(2008-2#1)(2011-2#2)
the residue and##2##3##(2008-10#1)(2008-5#1)
the residue at position##3##4##(1994-8#1)(1996-5#1)(2006-12#1)
the residue at##5##3##(1994-8#1)(1995-11#2)(1996-5#1)(2006-12#1)
the residue corresponding to##2##4##(1991-7#1)(2006-5#1)
the residue from##2##3##(2008-10#2)
the residue was##3##3##(1995-2#1)(1997-3#1)(2008-10#1)
the residue##40##2##(1990-12#1)(1990-4#1)(1990-5#1)(1991-4#1)(1991-7#1)(1992-7#1)(1993-2#2)(1994-8#2)(1995-11#2)(1995-2#1)(1995-3#2)(1995-5#1)(1996-5#1)(1997-3#2)(2004-2#2)(2005-11#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-5#3)(2008-7#1)(2009-5#1)(2010-4#1)(2012-12#1)(2013-8#1)
the residue(s) involved in##2##4##(1991-9#1)(1995-10#1)
the residues at##2##3##(1994-5#1)(1994-8#1)
the residues from##2##3##(1997-6#1)(2008-8#1)
the residues in the##3##4##(1994-5#1)(1996-11#1)(1997-4#1)
the residues in##5##3##(1994-5#1)(1996-11#1)(1997-4#1)(2010-7#2)
the residues involved in##2##4##(2006-10#1)(2011-1#1)
the residues##40##2##(1990-2#1)(1991-10#1)(1991-4#1)(1991-5#1)(1992-11#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#3)(1995-1#1)(1995-5#1)(1996-11#1)(1996-7#2)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(2004-2#2)(2006-10#1)(2008-10#2)(2008-8#1)(2009-7#1)(2010-7#2)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
the resilience##4##2##(2006-6#1)(2007-3#1)(2009-7#2)
the resin and the##4##4##(2008-10#3)(2010-4#1)
the resin and##5##3##(2008-10#4)(2010-4#1)
the resin cement##2##3##(2008-8#1)(2013-1#1)
the resin for the##3##4##(2008-10#3)
the resin for##6##3##(2008-10#6)
the resin phase##6##3##(2008-10#6)
the resin was found##2##4##(2008-10#2)
the resin was##9##3##(2008-10#9)
the resin##69##2##(1990-12#1)(1996-11#1)(2005-11#3)(2008-10#55)(2008-12#1)(2008-4#2)(2008-8#1)(2010-4#1)(2011-2#2)(2013-1#1)(2013-8#1)
the resin-phase##4##2##(2008-10#4)
the resins are##2##3##(2008-10#1)(2008-4#1)
the resins##8##2##(2008-10#5)(2008-2#1)(2008-4#1)(2008-5#1)
the resist##7##2##(2007-12#6)(2010-2#1)
the resistance allele##3##3##(2008-10#3)
the resistance and##3##3##(2008-10#3)
the resistance conferred by the##2##5##(2008-10#1)(2008-5#1)
the resistance gene with##2##4##(2008-10#2)
the resistance gene##20##3##(2007-6#1)(2008-10#14)(2008-5#3)(2012-11#1)(2012-3#1)
the resistance genes in##2##4##(2008-10#2)
the resistance genes##8##3##(2008-10#8)
the resistance in##2##3##(2008-10#2)
the resistance index##2##3##(1992-6#1)(2012-3#1)
the resistance is##8##3##(1995-1#1)(2008-10#4)(2008-2#1)(2011-2#1)(2013-1#1)
the resistance level of##2##4##(2011-2#2)
the resistance locus##2##3##(2008-10#2)
the resistance mechanism##3##3##(2008-10#3)
the resistance mechanisms##2##3##(1996-10#1)(2012-2#1)
the resistance of LDL to##3##5##(1995-12#1)(1996-3#1)(1997-7#1)
the resistance of S##2##4##(2008-10#1)(2008-5#1)
the resistance of a##2##4##(2008-10#2)
the resistance of horse spermatozoa##2##5##(2006-5#2)
the resistance of the##15##4##(1990-5#1)(1991-5#1)(1991-9#1)(1992-6#1)(1994-11#1)(1994-9#1)(2005-11#2)(2006-10#1)(2008-10#1)(2008-11#2)(2010-12#1)(2010-2#1)(2012-12#1)
the resistance of##61##3##(1990-5#1)(1991-2#1)(1991-5#1)(1991-9#2)(1992-6#1)(1994-11#1)(1994-6#1)(1994-9#2)(1995-12#1)(1995-9#1)(1996-3#1)(1996-4#1)(1997-5#1)(1997-7#1)(2005-11#3)(2005-12#1)(2006-10#1)(2006-12#1)(2006-5#2)(2007-2#1)(2008-10#16)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#1)
the resistance pattern of the##2##5##(2007-7#1)(2013-8#1)
the resistance pattern of##3##4##(2006-8#1)(2007-7#1)(2013-8#1)
the resistance phenotype was##2##4##(2008-10#2)
the resistance profile##2##3##(2009-1#1)(2009-6#1)
the resistance rate##3##3##(1996-12#1)(2008-12#2)
the resistance response and##2##4##(2008-10#2)
the resistance to both##2##4##(2008-10#2)
the resistance to infection##2##4##(1990-6#1)(2007-8#1)
the resistance to stripe rust was##2##6##(2008-10#2)
the resistance to the intracellular killing in the Polymorphonuclear Leucocytes (PMNLs) and the##2##13##(2013-8#2)
the resistance to the##5##4##(2005-11#1)(2008-10#1)(2009-6#1)(2013-8#2)
the resistance to##36##3##(1990-5#1)(1990-6#1)(1990-8#1)(1992-9#1)(1993-3#1)(1993-8#1)(1995-4#1)(1997-7#1)(2005-11#2)(2006-5#2)(2006-6#1)(2007-10#1)(2007-8#1)(2008-10#10)(2008-5#2)(2008-7#1)(2009-6#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#2)
the resistance was##4##3##(2008-10#4)
the resistance##203##2##(1990-5#2)(1990-6#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-9#3)(1992-6#2)(1992-9#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-9#3)(1995-1#1)(1995-12#1)(1995-4#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-5#1)(1997-7#2)(2005-11#6)(2005-12#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-5#4)(2006-6#1)(2006-8#3)(2007-10#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#88)(2008-11#2)(2008-12#4)(2008-2#1)(2008-4#1)(2008-5#8)(2008-7#1)(2008-8#2)(2008-9#3)(2009-1#1)(2009-6#2)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#8)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#3)(2013-8#3)
the resistant accession##3##3##(2008-10#1)(2009-3#2)
the resistant accessions CIho##2##4##(2008-10#2)
the resistant and susceptible##5##4##(2008-10#4)(2009-3#1)
the resistant and##6##3##(2008-10#5)(2009-3#1)
the resistant cell##3##3##(1990-12#1)(1995-8#1)(2008-11#1)
the resistant cells##2##3##(1992-2#1)(2008-11#1)
the resistant cultivar##11##3##(2008-10#8)(2011-10#1)(2012-11#2)
the resistant cultivars##8##3##(2008-10#8)
the resistant cv##3##3##(2008-10#2)(2008-6#1)
the resistant cvs##2##3##(2008-10#2)
the resistant genotype##5##3##(2008-10#5)
the resistant genotypes##3##3##(2008-10#3)
the resistant isolates##2##3##(2008-10#2)
the resistant line Hor2596 (CIho 1243)##2##6##(2008-10#2)
the resistant line##5##3##(1992-2#1)(1994-11#1)(2008-10#3)
the resistant lines were##2##4##(2008-10#2)
the resistant lines##4##3##(2008-10#4)
the resistant parent##6##3##(2008-10#6)
the resistant strain##2##3##(2008-10#1)(2010-12#1)
the resistant strains##3##3##(1990-5#1)(2007-7#1)(2008-5#1)
the resistant winter##2##3##(2008-10#2)
the resistant##120##2##(1990-12#1)(1990-5#1)(1992-2#2)(1994-11#1)(1995-6#2)(1995-8#1)(1996-12#2)(1996-2#1)(1997-8#1)(2004-11#1)(2007-7#1)(2008-10#87)(2008-11#3)(2008-5#1)(2008-6#1)(2008-9#2)(2009-3#3)(2010-12#1)(2011-10#1)(2011-2#2)(2012-11#3)(2012-3#1)(2013-8#1)
the resistive##2##2##(2008-2#1)(2013-7#1)
the resistivity##2##2##(2010-8#1)(2013-8#1)
the resolution and the##2##4##(2008-2#1)(2008-3#1)
the resolution and##9##3##(2006-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-11#1)(2010-2#1)(2010-9#1)
the resolution for##2##3##(2007-12#1)(2012-12#1)
the resolution in the##2##4##(2008-3#2)
the resolution in##5##3##(2006-5#1)(2008-3#4)
the resolution is##4##3##(2008-2#2)(2008-3#2)
the resolution limit##2##3##(2005-4#1)(2007-12#1)
the resolution limits##2##3##(2007-12#1)(2008-3#1)
the resolution of early##2##4##(1995-6#1)(2006-7#1)
the resolution of inflammation##2##4##(2008-5#1)(2010-1#1)
the resolution of optical##2##4##(2007-12#1)(2008-3#1)
the resolution of overlapping peaks##2##5##(2008-10#2)
the resolution of the measurement of the angle##2##8##(2008-3#2)
the resolution of the##27##4##(1990-6#1)(1995-9#1)(1997-2#3)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#1)(2010-9#1)(2011-1#1)
the resolution of these##2##4##(2005-11#1)(2005-8#1)
the resolution of this##2##4##(1991-1#1)(2008-10#1)
the resolution of##93##3##(1990-10#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-8#1)(1993-2#1)(1994-9#1)(1995-6#2)(1995-9#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#3)(1997-7#1)(1997-8#3)(2005-11#1)(2005-7#1)(2005-8#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-2#4)(2008-3#9)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#2)(2013-1#1)
the resolution range##3##3##(1994-9#1)(2006-4#1)(2008-8#1)
the resolution reaches##2##3##(2008-2#1)(2008-3#1)
the resolution to##2##3##(2008-3#1)(2012-2#1)
the resolution##152##2##(1990-10#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-8#1)(1993-2#1)(1994-9#2)(1995-6#2)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#3)(1997-7#1)(1997-8#3)(2005-11#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#3)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#11)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#25)(2008-11#2)(2008-2#12)(2008-3#22)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-11#2)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-9#2)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)
the resolutions##3##2##(2008-10#2)(2008-3#1)
the resolvable##2##2##(2007-12#1)(2008-12#1)
the resolved##5##2##(1990-3#1)(1992-12#1)(1995-3#1)(2007-12#1)(2008-2#1)
the resolving power of the##3##5##(2008-10#2)(2008-3#1)
the resolving power of##5##4##(2007-12#1)(2007-5#1)(2008-10#2)(2008-3#1)
the resolving power##9##3##(2006-4#1)(2007-12#2)(2007-5#1)(2008-10#3)(2008-2#1)(2008-3#1)
the resolving##12##2##(2006-4#1)(2007-12#2)(2007-5#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#1)
the resonance Raman##3##3##(1990-8#1)(1991-7#1)(1995-5#1)
the resonance condition##2##3##(2007-11#1)(2008-2#1)
the resonance energy##2##3##(1995-10#1)(2009-9#1)
the resonance frequency##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2010-4#1)
the resonance light scattering##2##4##(2008-10#2)
the resonance line##2##3##(1993-6#1)(2007-11#1)
the resonance of the##3##4##(2008-2#1)(2008-3#2)
the resonance of##4##3##(1990-8#1)(2008-2#1)(2008-3#2)
the resonance peak##3##3##(2007-12#2)(2008-3#1)
the resonance region##2##3##(2008-2#1)(2008-3#1)
the resonance scattering##3##3##(2006-4#1)(2008-10#2)
the resonance wavelength##6##3##(2007-11#1)(2007-12#3)(2008-10#1)(2008-3#1)
the resonance##63##2##(1990-8#3)(1991-7#1)(1993-6#2)(1993-8#1)(1995-10#1)(1995-5#1)(2006-4#1)(2007-11#6)(2007-12#8)(2008-1#2)(2008-10#6)(2008-2#10)(2008-3#10)(2008-4#1)(2009-7#3)(2009-9#1)(2010-1#1)(2010-4#1)(2011-1#1)(2012-2#3)
the resonances are blueshifted##2##4##(2007-12#2)
the resonances in the##2##4##(1991-2#1)(2008-2#1)
the resonances in##4##3##(1991-2#2)(1992-4#1)(2008-2#1)
the resonances of##2##3##(1996-2#1)(2008-2#1)
the resonances##11##2##(1991-2#2)(1992-4#1)(1996-2#1)(2007-12#3)(2008-2#3)(2008-3#1)
the resonant frequency of the##2##5##(2007-11#1)(2008-10#1)
the resonant frequency##3##3##(2007-11#1)(2008-10#1)(2009-5#1)
the resonant mirror##4##3##(1997-2#1)(2008-10#1)(2008-4#1)(2010-1#1)
the resonant mode##2##3##(2007-12#1)(2008-3#1)
the resonant scattering of light##2##5##(2008-2#2)
the resonant sensitivity of a short-cavity laser to frequency-shifted optical feedback##2##11##(2007-12#1)(2008-3#1)
the resonant wavelength##3##3##(2007-12#1)(2008-3#2)
the resonant##38##2##(1995-11#1)(1997-2#1)(2007-11#5)(2007-12#8)(2008-1#1)(2008-10#3)(2008-2#4)(2008-3#12)(2008-4#1)(2009-5#1)(2010-1#1)
the resonantly enhanced##2##3##(2007-12#1)(2008-2#1)
the resonator and##2##3##(2008-2#1)(2008-7#1)
the resonator design##2##3##(2007-12#1)(2008-3#1)
the resonator of##2##3##(2007-12#1)(2008-1#1)
the resonator was##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
the resonator##43##2##(2007-11#6)(2007-12#12)(2008-1#2)(2008-2#10)(2008-3#8)(2008-7#2)(2009-5#2)(2010-4#1)
the resonators##2##2##(2007-11#1)(2008-3#1)
the resorption of the alveolar bone##2##6##(2005-3#2)
the resorption of##3##3##(2005-3#2)(2008-7#1)
the resorption##7##2##(2005-3#2)(2007-11#2)(2007-2#1)(2008-12#1)(2008-7#1)
the resorptive##5##2##(1991-12#3)(1994-3#1)(2007-2#1)
the resource##12##2##(1991-1#1)(1992-2#1)(1995-3#1)(2008-10#1)(2008-8#4)(2010-4#1)(2012-2#1)(2013-1#2)
the resource-based relative value scale (RBRVS)##2##6##(1994-12#2)
the resource-based relative value scale##3##5##(1992-1#1)(1994-12#2)
the resource-based##4##2##(1992-1#1)(1994-12#2)(2008-8#1)
the resources and##3##3##(1994-3#1)(2007-5#1)(2011-1#1)
the resources available##4##3##(2008-2#1)(2008-4#2)(2012-11#1)
the resources in##2##3##(1997-3#1)(2008-7#1)
the resources necessary to##2##4##(1995-2#1)(2005-5#1)
the resources needed##3##3##(2007-7#1)(2008-2#1)(2008-4#1)
the resources of the##2##4##(1990-12#1)(2012-2#1)
the resources of##7##3##(1990-12#1)(1996-2#1)(2005-5#1)(2005-9#1)(2009-11#1)(2012-2#2)
the resources required to##2##4##(2006-12#1)(2010-5#1)
the resources they##2##3##(2008-11#1)(2008-12#1)
the resources to##5##3##(1994-9#1)(2011-10#1)(2011-12#1)(2013-1#2)
the resources##42##2##(1990-12#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-3#1)(2005-5#2)(2005-9#1)(2006-11#1)(2006-12#1)(2006-7#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#3)(2013-1#2)
the respect##3##2##(1997-8#1)(2008-10#2)
the respective complexes##2##3##(1995-10#1)(2006-12#1)
the respective control##2##3##(1993-1#1)(2012-2#1)
the respective enzymes##3##3##(1991-12#1)(2010-7#1)(2011-2#1)
the respective gene##4##3##(1994-8#1)(2008-8#1)(2010-12#1)(2013-8#1)
the respective groups##2##3##(1991-7#1)(1997-4#1)
the respective results##2##3##(2007-7#1)(2008-10#1)
the respective roles of##3##4##(2009-7#1)(2009-8#1)(2010-3#1)
the respective roles##4##3##(1995-2#1)(2009-7#1)(2009-8#1)(2010-3#1)
the respective specific##2##3##(1990-12#1)(1990-5#1)
the respective specificity was##2##4##(1996-12#1)(2006-10#1)
the respective strains##2##3##(1995-6#1)(2010-4#1)
the respective value of##2##4##(2007-8#1)(2008-10#1)
the respective values were##3##4##(1996-5#1)(2008-5#1)(2011-2#1)
the respective values##4##3##(1996-5#1)(1997-7#1)(2008-5#1)(2011-2#1)
the respective##167##2##(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#3)(1991-11#1)(1991-12#2)(1991-2#1)(1991-7#1)(1992-10#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#3)(1995-1#1)(1995-10#1)(1995-11#4)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#5)(1996-5#3)(1996-6#2)(1996-9#1)(1997-1#2)(1997-2#4)(1997-4#2)(1997-7#1)(2004-2#1)(2004-9#1)(2005-11#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-3#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#17)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#2)(2009-6#2)(2009-7#1)(2009-8#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
the respiration rate and##3##4##(1994-11#1)(2011-2#2)
the respiration rate##6##3##(1994-11#1)(1995-6#1)(2006-3#1)(2008-6#1)(2011-2#2)
the respiration##11##2##(1990-5#1)(1994-11#1)(1995-6#1)(2006-3#1)(2007-8#1)(2008-6#1)(2011-1#1)(2011-2#2)(2012-3#2)
the respiratory activity of##3##4##(2008-10#1)(2008-5#2)
the respiratory and gastrointestinal##2##4##(1996-2#1)(2005-11#1)
the respiratory and##4##3##(1992-8#1)(1996-2#1)(2005-11#1)(2010-12#1)
the respiratory burst of##2##4##(1992-1#1)(2008-5#1)
the respiratory burst##12##3##(1990-2#2)(1991-2#2)(1992-1#2)(1993-6#2)(1993-7#1)(1994-3#1)(1994-6#1)(2008-5#1)
the respiratory chain complexes##2##4##(1994-11#1)(2008-7#1)
the respiratory chain enzyme activities##2##5##(1994-11#2)
the respiratory chain in##2##4##(1996-3#1)(1997-8#1)
the respiratory chain##26##3##(1990-11#1)(1994-11#4)(1994-8#1)(1995-11#2)(1995-2#1)(1995-6#2)(1996-3#4)(1996-5#1)(1997-7#1)(1997-8#2)(2005-8#3)(2006-8#1)(2008-7#2)(2011-2#1)
the respiratory control ratio##2##4##(1994-11#1)(1994-12#1)
the respiratory control##3##3##(1994-11#1)(1994-12#1)(1997-8#1)
the respiratory cycle##2##3##(2007-8#1)(2011-1#1)
the respiratory disease##2##3##(2008-12#1)(2010-12#1)
the respiratory distress##2##3##(1991-9#1)(2011-2#1)
the respiratory epithelium##2##3##(1990-6#1)(2008-2#1)
the respiratory failure##2##3##(1995-3#1)(2006-4#1)
the respiratory gases##3##3##(1997-1#2)(1997-4#1)
the respiratory mucosa##2##3##(1993-8#1)(1997-5#1)
the respiratory muscles##2##3##(1997-4#1)(2012-2#1)
the respiratory organs##2##3##(1992-11#1)(1994-6#1)
the respiratory parameters##3##3##(2008-9#1)(2012-2#1)(2013-1#1)
the respiratory rate##5##3##(1994-11#1)(1996-3#1)(1997-7#2)(2009-6#1)
the respiratory system of##2##4##(1994-4#1)(2007-12#1)
the respiratory system##24##3##(1990-9#3)(1992-2#1)(1994-4#1)(1995-6#1)(1996-3#2)(2006-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2008-5#3)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-1#2)(2013-7#2)
the respiratory tract are##3##4##(1992-3#1)(1994-12#1)(2007-8#1)
the respiratory tract in##3##4##(1994-12#1)(2007-2#1)(2008-10#1)
the respiratory tract is##2##4##(1996-1#1)(2006-10#1)
the respiratory tract of chickens##2##5##(1997-6#1)(2008-5#1)
the respiratory tract of##5##4##(1994-10#1)(1997-6#1)(2007-2#1)(2008-5#2)
the respiratory tract##37##3##(1991-12#1)(1992-3#3)(1992-9#1)(1994-10#1)(1994-12#3)(1994-6#2)(1995-7#1)(1996-1#3)(1996-3#1)(1997-1#1)(1997-6#1)(2005-11#3)(2006-10#1)(2007-10#1)(2007-2#3)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#2)(2011-1#1)(2012-2#2)(2013-1#1)
the respiratory##193##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-5#1)(1990-6#2)(1990-7#1)(1990-9#3)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-2#2)(1992-3#3)(1992-6#1)(1992-8#4)(1992-9#1)(1993-6#2)(1993-7#1)(1993-8#1)(1994-10#1)(1994-11#6)(1994-12#4)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#4)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#3)(1995-7#1)(1995-8#1)(1996-1#3)(1996-10#1)(1996-2#1)(1996-3#9)(1996-5#2)(1997-1#3)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#5)(1997-8#4)(2005-1#1)(2005-11#4)(2005-12#1)(2005-8#5)(2005-9#1)(2006-10#2)(2006-11#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#4)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#12)(2008-7#3)(2008-9#1)(2009-6#1)(2010-12#5)(2010-2#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-1#3)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#2)
the respondent##5##2##(2006-8#1)(2008-1#1)(2012-2#1)(2013-1#2)
the respondents and##3##3##(2006-10#1)(2008-12#1)(2008-3#1)
the respondents in the##2##4##(2008-4#1)(2010-8#1)
the respondents indicated##3##3##(1996-3#1)(2006-8#1)(2011-2#1)
the respondents of##2##3##(2008-9#1)(2009-7#1)
the respondents were##10##3##(2004-10#2)(2006-12#1)(2007-3#1)(2007-6#1)(2008-2#1)(2008-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
the respondents would##2##3##(1993-1#1)(2007-7#1)
the respondents##86##2##(1991-6#3)(1992-5#1)(1993-1#1)(1994-1#1)(1995-12#2)(1996-1#2)(1996-2#1)(1996-3#1)(1996-9#1)(2004-10#4)(2006-10#1)(2006-12#2)(2006-8#4)(2007-10#1)(2007-12#3)(2007-3#3)(2007-6#1)(2007-7#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#12)(2008-3#1)(2008-4#3)(2008-9#4)(2009-7#2)(2010-5#1)(2010-8#4)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#3)(2013-1#3)(2013-8#4)
the respondents'##2##2##(2011-2#1)(2012-3#1)
the responder##4##2##(1992-5#2)(1995-2#1)(2008-3#1)
the responders##9##2##(1990-2#1)(1997-8#2)(2006-2#1)(2006-4#1)(2007-7#1)(2008-6#1)(2011-2#1)(2012-12#1)
the responding tissue##2##3##(1991-5#1)(1993-5#1)
the responding##7##2##(1991-5#1)(1993-5#1)(1996-9#2)(1997-8#1)(2008-11#1)(2008-2#1)
the response and##7##3##(1990-5#1)(2006-10#1)(2007-1#1)(2008-2#1)(2008-6#1)(2010-2#1)(2012-2#1)
the response at##5##3##(1992-12#1)(1992-6#1)(1995-11#1)(1996-12#1)(2008-10#1)
the response behavior##2##3##(2007-8#1)(2008-10#1)
the response characteristics of##2##4##(2008-10#1)(2008-3#1)
the response curve is##2##4##(2008-10#1)(2012-12#1)
the response curve##3##3##(1997-2#1)(2008-10#1)(2012-12#1)
the response elicited by the##2##5##(1994-10#1)(2009-8#1)
the response elicited by##3##4##(1994-10#1)(2009-8#1)(2012-2#1)
the response for##3##3##(1991-5#1)(2008-10#2)
the response function##2##3##(2008-10#2)
the response in the##3##4##(1990-5#1)(1994-8#1)(2008-7#1)
the response in##10##3##(1990-5#1)(1992-8#1)(1994-2#1)(1994-8#1)(1995-6#1)(1997-3#1)(2005-7#1)(2008-11#1)(2008-3#1)(2008-7#1)
the response induced by##3##4##(1992-7#1)(1996-2#1)(2008-4#1)
the response induced##4##3##(1992-7#1)(1995-12#1)(1996-2#1)(2008-4#1)
the response is linear##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
the response is mediated by##2##5##(1996-10#1)(2008-10#1)
the response is not##3##4##(2008-10#1)(2008-8#1)(2010-9#1)
the response is##14##3##(1993-3#1)(1996-10#1)(2007-12#2)(2008-10#4)(2008-3#1)(2008-6#1)(2008-8#1)(2010-9#1)(2011-1#1)(2012-2#1)
the response latency for##2##4##(2008-11#2)
the response measured##2##3##(1993-7#1)(2013-1#1)
the response mechanism##2##3##(2008-10#2)
the response obtained##2##3##(1995-12#1)(2008-10#1)
the response of T cells to mitogenic##2##7##(1990-9#1)(1992-6#1)
the response of a##13##4##(1992-3#1)(1994-5#1)(1996-2#1)(2006-11#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2009-5#1)(2010-2#1)
the response of an##3##4##(2006-5#1)(2007-12#1)(2008-10#1)
the response of beetles to##2##5##(2004-2#2)
the response of cells to##2##5##(2008-9#1)(2011-2#1)
the response of cells##3##4##(1994-10#1)(2008-9#1)(2011-2#1)
the response of endothelial cells to##2##6##(2008-11#1)(2010-1#1)
the response of plants to##2##5##(2008-10#1)(2009-10#1)
the response of the electrode##2##5##(2007-8#1)(2008-10#1)
the response of the enzyme to IPR##2##7##(1995-6#2)
the response of the enzyme to##3##6##(1995-6#3)
the response of the isolated##2##5##(2007-4#2)
the response of the sensor to##2##6##(2008-10#2)
the response of the sensor##3##5##(2008-10#3)
the response of the##56##4##(1991-10#1)(1991-2#1)(1992-12#2)(1992-3#1)(1992-6#1)(1994-11#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-6#3)(1997-2#1)(1997-5#1)(2004-2#1)(2005-10#1)(2006-10#1)(2006-11#2)(2006-8#1)(2007-1#3)(2007-11#1)(2007-4#3)(2007-8#2)(2008-1#2)(2008-10#13)(2008-2#2)(2008-3#2)(2008-7#1)(2008-9#1)(2009-10#1)(2012-3#2)(2013-1#1)
the response of these##2##4##(2008-10#1)(2012-7#1)
the response of this##2##4##(1993-9#1)(2008-2#1)
the response of##189##3##(1990-10#1)(1990-7#1)(1990-9#1)(1991-10#4)(1991-2#1)(1991-3#1)(1992-12#2)(1992-3#3)(1992-6#2)(1992-9#1)(1993-12#1)(1993-3#3)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#2)(1995-1#1)(1995-5#1)(1995-6#3)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-2#3)(2005-10#1)(2006-10#2)(2006-11#3)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#3)(2007-11#2)(2007-12#3)(2007-4#4)(2007-7#4)(2007-8#4)(2008-1#3)(2008-10#37)(2008-11#7)(2008-2#9)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-10#4)(2009-5#1)(2010-1#1)(2010-2#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#3)(2013-7#4)(2013-8#1)
the response on##3##3##(1994-11#1)(2008-6#1)(2012-3#1)
the response patterns##2##3##(1990-4#1)(2012-12#1)
the response properties of the##3##5##(1990-4#1)(2008-10#2)
the response properties of##5##4##(1990-4#1)(2008-10#2)(2008-11#1)(2008-9#1)
the response rate and##3##4##(2006-12#1)(2007-11#1)(2007-6#1)
the response rate of##3##4##(1997-8#1)(2008-6#1)(2013-8#1)
the response rate was##3##4##(1991-6#1)(1994-2#1)(2008-6#1)
the response rate##20##3##(1990-2#2)(1990-6#1)(1991-6#1)(1992-8#1)(1994-2#1)(1996-10#2)(1996-9#1)(1997-8#2)(2006-12#2)(2006-6#1)(2007-11#2)(2007-6#1)(2008-6#2)(2013-8#1)
the response rates##7##3##(2006-10#2)(2006-6#1)(2007-7#1)(2008-5#1)(2011-2#1)(2012-12#1)
the response surface##5##3##(2008-10#4)(2008-5#1)
the response time and##2##4##(2008-10#2)
the response time of##2##4##(2007-12#1)(2008-2#1)
the response time was##2##4##(2008-10#1)(2008-2#1)
the response time##12##3##(1993-6#1)(2007-12#2)(2008-10#7)(2008-2#2)
the response to GH##2##4##(2006-9#1)(2008-3#1)
the response to a variety of##2##6##(2008-11#1)(2008-5#1)
the response to a##10##4##(1990-2#1)(1993-11#1)(1993-12#1)(1993-9#1)(2006-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-3#1)(2009-8#1)
the response to an##2##4##(1993-3#1)(1993-7#1)
the response to each##2##4##(1995-5#1)(2007-12#1)
the response to endothelin-1##2##4##(1995-12#2)
the response to hypoxia##2##4##(1994-3#1)(2008-1#1)
the response to infection##2##4##(1990-8#1)(2008-10#1)
the response to interferon##2##4##(2007-11#2)
the response to repeated##2##4##(2007-10#2)
the response to selection##2##4##(2008-8#1)(2009-2#1)
the response to stress##3##4##(1997-5#1)(2009-8#2)
the response to the##14##4##(1990-11#1)(1991-10#1)(1992-7#1)(1996-10#1)(1996-2#1)(1997-2#1)(2006-10#1)(2006-5#1)(2007-2#1)(2008-1#1)(2008-10#1)(2010-5#1)(2012-12#2)
the response to therapy##2##4##(1992-8#1)(2012-3#1)
the response to treatment is##2##5##(1997-2#1)(2008-1#1)
the response to treatment##8##4##(1997-2#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-6#1)(2010-12#1)(2012-2#1)(2013-8#1)
the response to##156##3##(1990-11#3)(1990-2#1)(1990-5#3)(1990-8#1)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-3#1)(1992-7#2)(1992-8#2)(1993-11#2)(1993-12#3)(1993-3#2)(1993-7#2)(1993-9#1)(1994-12#1)(1994-2#3)(1994-3#2)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#3)(1995-9#1)(1996-10#3)(1996-12#2)(1996-2#2)(1996-4#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#3)(2006-1#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-5#2)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#4)(2008-10#9)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#7)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#5)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#1)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
the response variable##8##3##(1993-7#1)(1994-6#1)(2008-10#3)(2008-6#1)(2012-12#2)
the response was linear##3##4##(1993-2#1)(1996-12#1)(2008-10#1)
the response was not##2##4##(1990-7#1)(1991-10#1)
the response was##19##3##(1990-7#2)(1991-10#1)(1991-8#1)(1992-10#1)(1993-12#1)(1993-2#1)(1995-8#1)(1996-12#1)(2006-2#1)(2007-2#2)(2007-9#1)(2008-10#2)(2008-11#1)(2009-10#1)(2011-2#1)(2013-1#1)
the response when##2##3##(2007-11#1)(2008-10#1)
the response##595##2##(1990-10#1)(1990-11#3)(1990-2#3)(1990-4#3)(1990-5#6)(1990-6#1)(1990-7#6)(1990-8#1)(1990-9#2)(1991-1#2)(1991-10#8)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#2)(1992-10#1)(1992-12#5)(1992-3#5)(1992-4#1)(1992-6#4)(1992-7#4)(1992-8#4)(1992-9#1)(1993-11#3)(1993-12#6)(1993-2#2)(1993-3#6)(1993-4#1)(1993-6#2)(1993-7#6)(1993-8#2)(1993-9#4)(1994-10#5)(1994-11#3)(1994-12#1)(1994-2#5)(1994-3#4)(1994-5#1)(1994-6#3)(1994-8#5)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#5)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#4)(1995-6#4)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#6)(1996-11#1)(1996-12#10)(1996-2#4)(1996-3#1)(1996-4#2)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#2)(1997-2#5)(1997-3#3)(1997-4#3)(1997-5#4)(1997-6#3)(1997-7#1)(1997-8#3)(2004-2#3)(2005-10#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#9)(2006-11#4)(2006-12#4)(2006-2#3)(2006-5#3)(2006-6#3)(2006-7#3)(2006-8#3)(2006-9#2)(2007-1#5)(2007-10#2)(2007-11#9)(2007-12#8)(2007-2#3)(2007-4#5)(2007-6#1)(2007-7#6)(2007-8#5)(2007-9#2)(2008-1#7)(2008-10#99)(2008-11#18)(2008-2#14)(2008-3#11)(2008-4#10)(2008-5#6)(2008-6#9)(2008-7#11)(2008-8#13)(2008-9#5)(2009-10#7)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#7)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#3)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#8)(2012-2#10)(2012-3#6)(2012-7#1)(2013-1#8)(2013-7#6)(2013-8#3)
the response-related##2##2##(1990-10#2)
the responses and##4##3##(1993-12#1)(2008-10#3)
the responses are##2##3##(2008-10#1)(2009-8#1)
the responses in##4##3##(1995-12#1)(1997-5#1)(2006-10#1)(2008-9#1)
the responses induced by##2##4##(1991-6#1)(1991-9#1)
the responses observed##2##3##(1997-4#1)(2008-10#1)
the responses of a##2##4##(1991-2#1)(2008-11#1)
the responses of both##3##4##(1990-10#1)(2006-11#1)(2007-4#1)
the responses of plants to##2##5##(2008-10#1)(2008-8#1)
the responses of rat##2##4##(1990-11#1)(1995-6#1)
the responses of the##15##4##(1990-12#1)(1994-12#1)(1994-2#1)(1997-2#3)(2004-4#1)(2006-11#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-12#1)
the responses of these##2##4##(1991-3#1)(1991-6#1)
the responses of##61##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-4#1)(1995-12#1)(1995-6#1)(1997-2#3)(2004-4#1)(2006-11#2)(2007-11#1)(2007-2#1)(2007-4#3)(2007-7#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#7)(2009-10#2)(2009-7#1)(2009-8#4)(2011-1#1)(2011-12#1)(2012-12#2)(2012-3#1)(2012-5#1)(2012-9#1)
the responses to PBG##2##4##(1993-7#2)
the responses to the stimulation of cardio-pulmonary vagal afferent C fiber endings##2##12##(1993-7#2)
the responses to the stimulation of##3##6##(1993-7#3)
the responses to the##5##4##(1993-7#3)(1996-1#1)(1997-8#1)
the responses to##28##3##(1990-10#1)(1990-12#1)(1990-5#1)(1990-7#2)(1991-12#1)(1991-5#1)(1992-2#1)(1993-7#6)(1994-5#1)(1994-8#1)(1995-10#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-6#1)(2008-11#2)(2009-8#1)(2013-1#1)
the responses were##2##3##(1993-2#1)(1994-9#1)
the responses##135##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-5#1)(1990-7#3)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-7#6)(1994-10#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#4)(1995-6#1)(1996-1#3)(1996-12#1)(1996-9#2)(1997-2#4)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#1)(2004-4#1)(2005-7#1)(2006-10#1)(2006-11#2)(2006-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#3)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#11)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#9)(2008-9#2)(2009-10#2)(2009-7#1)(2009-8#6)(2010-11#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#3)(2012-3#1)(2012-5#1)(2012-9#1)(2013-1#2)
the responsibilities of the##2##4##(1995-6#1)(2012-12#1)
the responsibilities of##5##3##(1995-6#1)(2007-12#1)(2007-8#1)(2010-3#1)(2012-12#1)
the responsibilities##7##2##(1993-5#1)(1995-6#1)(2007-12#1)(2007-8#1)(2010-2#1)(2010-3#1)(2012-12#1)
the responsibility for##9##3##(1992-1#1)(1992-5#1)(1993-11#1)(1994-12#1)(1995-3#1)(2006-10#1)(2006-8#1)(2007-8#1)(2009-4#1)
the responsibility of the##5##4##(1991-3#1)(1995-9#1)(2008-4#1)(2011-1#1)(2012-12#1)
the responsibility of##21##3##(1991-3#1)(1993-1#1)(1993-12#1)(1994-3#1)(1995-9#1)(1996-3#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-5#1)(2010-8#1)(2011-1#2)(2012-12#1)(2012-2#1)
the responsibility to##3##3##(1992-11#1)(2012-2#1)(2012-3#1)
the responsibility##36##2##(1991-3#1)(1992-1#1)(1992-11#1)(1992-5#1)(1993-1#2)(1993-11#2)(1993-12#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-3#1)(1995-9#1)(1996-3#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-5#1)(2010-8#1)(2011-1#2)(2012-12#1)(2012-2#2)(2012-3#1)
the responsible agent##2##3##(2006-12#1)(2008-12#1)
the responsible##24##2##(1990-3#1)(1990-6#1)(1990-7#1)(1992-11#2)(1992-6#1)(1995-11#1)(1995-5#1)(1996-7#1)(1997-2#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-2#1)
the responsive##3##2##(1993-11#1)(1995-11#1)(2009-8#1)
the responsiveness of the##6##4##(1992-7#1)(1993-3#1)(1995-3#1)(1996-8#1)(1997-3#1)(2008-4#1)
the responsiveness of##17##3##(1990-7#2)(1991-2#1)(1991-3#1)(1992-10#1)(1992-7#1)(1993-3#1)(1993-7#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-8#1)(1997-3#1)(1997-7#1)(2008-4#1)(2008-7#1)
the responsiveness to##4##3##(1991-10#1)(1993-12#1)(2006-12#1)(2008-6#1)
the responsiveness##22##2##(1990-7#2)(1991-10#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-10#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-8#1)(1997-3#1)(1997-7#1)(2006-12#1)(2008-4#1)(2008-6#1)(2008-7#1)
the responsivity of##2##3##(1993-6#1)(2008-2#1)
the responsivity##5##2##(1993-6#1)(2008-2#2)(2008-3#2)
the rest are##2##3##(2007-7#1)(2008-4#1)
the rest had##2##3##(1991-7#1)(1995-2#1)
the rest in##3##3##(1991-11#1)(1997-4#1)(2008-1#1)
the rest of Europe##2##4##(1994-2#1)(1997-6#1)
the rest of the area##2##5##(1994-6#1)(2008-10#1)
the rest of the body##6##5##(1992-3#1)(2008-1#1)(2008-3#1)(2011-2#1)(2013-1#2)
the rest of the community##2##5##(1991-1#1)(2012-1#1)
the rest of the health##2##5##(1992-11#1)(2011-2#1)
the rest of the molecule##2##5##(1991-5#1)(1997-2#1)
the rest of the patients##6##5##(1993-5#1)(1995-5#1)(2007-7#1)(2007-8#1)(2009-2#1)(2011-2#1)
the rest of the population##9##5##(1992-4#1)(1995-2#1)(2008-10#2)(2008-2#3)(2008-5#1)(2011-2#1)
the rest of the protein##5##5##(1991-4#1)(1995-1#2)(1997-7#1)(2010-10#1)
the rest of the province##2##5##(1992-10#2)
the rest of the sample##5##5##(1991-8#2)(2006-2#1)(2007-2#1)(2008-10#1)
the rest of the species##2##5##(2008-6#1)(2012-2#1)
the rest of the story##4##5##(1993-12#1)(1997-3#1)(2007-4#1)(2013-8#1)
the rest of the telencephalon##3##5##(1993-2#2)(1994-3#1)
the rest of the world##3##5##(2004-11#1)(2006-10#1)(2011-2#1)
the rest of the##105##4##(1990-3#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#4)(1992-10#3)(1992-11#2)(1992-3#1)(1992-4#1)(1993-12#1)(1993-2#2)(1993-5#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-11#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-7#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#6)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2009-2#1)(2010-10#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#8)(2012-1#1)(2012-2#1)(2012-9#1)(2013-1#3)(2013-7#2)(2013-8#1)
the rest of them##2##4##(2007-3#1)(2012-2#1)
the rest of##130##3##(1990-12#1)(1990-3#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#4)(1992-10#4)(1992-11#2)(1992-3#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-5#1)(1994-2#1)(1994-3#3)(1994-4#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-5#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-7#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#7)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#2)(2009-2#1)(2010-10#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#11)(2012-1#1)(2012-2#3)(2012-9#1)(2013-1#5)(2013-7#2)(2013-8#2)
the rest were##5##3##(2005-12#1)(2006-3#1)(2007-2#1)(2008-10#1)(2012-12#1)
the rest with##2##3##(1996-2#1)(2010-9#1)
the rest##178##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-7#1)(1991-1#2)(1991-11#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#4)(1992-10#4)(1992-11#2)(1992-3#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-5#1)(1994-2#1)(1994-3#3)(1994-4#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-11#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#2)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#3)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#3)(2007-7#4)(2007-8#2)(2008-1#2)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2010-10#1)(2010-4#3)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#13)(2012-1#1)(2012-12#2)(2012-2#3)(2012-9#1)(2013-1#5)(2013-7#2)(2013-8#3)
the restart rate##2##3##(2008-7#2)
the restart##4##2##(2008-7#2)(2013-1#2)
the restenosis rate##6##3##(1991-3#2)(1992-9#1)(2008-12#2)(2008-5#1)
the restenosis##7##2##(1991-3#2)(1992-9#1)(1996-8#1)(2008-12#2)(2008-5#1)
the resting and##3##3##(1991-7#1)(1992-9#1)(2005-10#1)
the resting discharge##2##3##(1995-3#1)(1997-7#1)
the resting level##2##3##(1993-12#1)(2008-4#1)
the resting limb##2##3##(2013-8#2)
the resting membrane potential##2##4##(1990-2#1)(1997-8#1)
the resting membrane##3##3##(1990-2#1)(1993-2#1)(1997-8#1)
the resting motor threshold##2##4##(2011-2#2)
the resting state##5##3##(1996-10#1)(2006-4#1)(2011-1#2)(2012-12#1)
the resting##45##2##(1990-10#2)(1990-2#1)(1990-6#2)(1991-3#1)(1991-6#1)(1991-7#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#1)(1994-3#2)(1994-6#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-4#1)(1996-7#1)(1997-7#2)(1997-8#1)(2005-10#1)(2006-4#1)(2007-12#1)(2008-4#1)(2008-5#2)(2009-2#1)(2010-12#1)(2011-1#2)(2011-2#4)(2012-12#1)(2013-8#4)
the restoration of a##3##4##(1991-5#1)(2008-2#1)(2010-7#1)
the restoration of an##2##4##(2008-7#1)(2011-2#1)
the restoration of function##3##4##(2007-8#1)(2008-9#2)
the restoration of the##12##4##(1997-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-6#1)(2011-11#1)(2011-2#1)(2012-2#1)(2013-1#2)
the restoration of##45##3##(1990-12#1)(1990-5#1)(1991-12#1)(1991-5#1)(1994-10#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-8#1)(2010-11#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
the restoration##55##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-5#1)(1994-10#1)(1994-8#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-2#5)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-8#1)(2010-11#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-11#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
the restorative role of##3##4##(2008-12#3)
the restorative treatment##2##3##(2008-7#1)(2013-1#1)
the restorative##10##2##(2008-12#4)(2008-7#1)(2010-8#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-7#1)
the restored area##3##3##(2011-2#3)
the restored image is##2##4##(2008-2#1)(2008-3#1)
the restored images##2##3##(2007-12#1)(2008-2#1)
the restored##16##2##(1990-11#1)(1991-5#1)(2007-12#2)(2008-11#1)(2008-2#2)(2008-3#2)(2010-10#1)(2011-2#5)(2013-8#1)
the restoring##2##2##(2007-4#1)(2012-12#1)
the restraint##6##2##(2006-11#2)(2007-4#4)
the restricted##13##2##(1990-7#1)(1992-9#1)(1993-12#1)(2006-9#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-5#1)(2012-12#2)(2013-1#1)
the restriction endonuclease EcoRI##2##4##(1994-8#2)
the restriction endonuclease##7##3##(1991-7#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-8#2)(2005-11#1)
the restriction enzyme##3##3##(1990-9#1)(2006-8#1)(2008-10#1)
the restriction enzymes##3##3##(2008-10#1)(2008-5#1)(2009-10#1)
the restriction fragment length polymorphism##3##5##(2006-8#1)(2008-10#1)(2008-4#1)
the restriction fragment length polymorphisms analysis of DNA fragments of the open reading##2##13##(2011-1#2)
the restriction fragment length polymorphisms##3##5##(2008-10#1)(2011-1#2)
the restriction fragment length##6##4##(2006-8#1)(2008-10#2)(2008-4#1)(2011-1#2)
the restriction map##2##3##(1991-12#1)(1994-9#1)
the restriction of##4##3##(1990-8#1)(1991-7#1)(1994-2#1)(2008-11#1)
the restriction on the##2##4##(2008-3#2)
the restriction##40##2##(1990-4#1)(1990-8#1)(1990-9#2)(1991-12#2)(1991-7#2)(1991-9#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#2)(1994-9#1)(1996-5#1)(1996-7#1)(1997-4#1)(2005-11#1)(2006-8#4)(2007-2#1)(2007-6#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-10#1)(2011-1#2)
the restrictions##4##2##(1990-12#1)(1991-6#1)(2008-3#1)(2009-10#1)
the restrictive temperature##2##3##(1995-9#1)(1997-6#1)
the restrictive##6##2##(1991-6#1)(1995-9#1)(1996-9#1)(1997-6#1)(2011-1#1)(2012-3#1)
the restructuring##2##2##(1994-12#1)(1996-1#1)
the result for##3##3##(1992-10#1)(2008-3#1)(2013-1#1)
the result from the##4##4##(1997-7#1)(2008-10#1)(2013-1#2)
the result from##5##3##(1997-7#1)(2006-4#1)(2008-10#1)(2013-1#2)
the result in##2##3##(1995-12#1)(2009-4#1)
the result is##7##3##(1990-12#1)(1994-12#1)(2007-12#2)(2008-3#1)(2008-8#1)(2008-9#1)
the result obtained##2##3##(2007-8#2)
the result of a complex##4##5##(2007-11#1)(2008-1#1)(2010-12#1)(2011-1#1)
the result of a previous##2##5##(2008-2#1)(2008-6#1)
the result of a single##3##5##(1996-7#1)(2007-10#1)(2008-4#1)
the result of a##52##4##(1990-11#1)(1990-12#2)(1990-7#1)(1991-2#1)(1993-7#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-7#1)(2006-1#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#2)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-12#2)(2009-4#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
the result of an evolutionary##2##5##(1997-6#1)(2006-1#1)
the result of an increase in##2##6##(1997-1#2)
the result of an interplay between##2##6##(2006-2#1)(2010-3#1)
the result of an##19##4##(1993-4#1)(1993-8#1)(1995-8#1)(1996-11#1)(1996-5#1)(1997-1#2)(1997-6#1)(2006-1#1)(2006-10#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#2)(2010-3#1)(2010-8#1)(2012-1#1)
the result of both##5##4##(1991-5#1)(2006-11#1)(2008-1#1)(2008-10#1)(2008-8#1)
the result of changes##2##4##(1992-8#1)(2008-5#1)
the result of decreased##4##4##(1993-3#1)(2007-2#1)(2008-1#1)(2013-7#1)
the result of differences in##2##5##(2008-10#1)(2012-3#1)
the result of different##3##4##(1990-8#1)(1991-6#1)(2007-11#1)
the result of good##2##4##(2012-3#2)
the result of increased##5##4##(1991-3#1)(1997-7#1)(2006-10#1)(2008-12#1)(2010-4#1)
the result of its##2##4##(1991-4#1)(1996-12#1)
the result of mutations##2##4##(1996-3#1)(2008-9#1)
the result of recent##2##4##(2008-3#1)(2008-5#1)
the result of reduced##2##4##(1994-3#1)(1995-2#1)
the result of several factors##3##5##(2006-2#1)(2008-2#1)(2008-4#1)
the result of some##3##4##(1996-8#1)(2008-5#1)(2008-6#1)
the result of specific modulation of##2##6##(1992-5#1)(2004-11#1)
the result of successful##2##4##(2008-8#1)(2011-2#1)
the result of the present study##2##6##(2009-12#1)(2012-3#1)
the result of the##41##4##(1990-10#1)(1990-2#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-11#1)(1993-11#2)(1994-5#1)(1997-1#1)(1997-5#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-8#2)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-8#1)
the result of their##2##4##(2008-1#1)(2012-1#1)
the result of three##3##4##(1996-1#1)(2009-2#1)(2010-2#1)
the result of two##3##4##(1991-8#1)(1996-4#1)(2006-10#1)
the result of using##2##4##(2006-2#1)(2007-12#1)
the result of##320##3##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#3)(1992-11#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#3)(1993-12#2)(1993-3#4)(1993-4#1)(1993-7#1)(1993-8#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#1)(1994-8#1)(1995-1#2)(1995-11#3)(1995-12#1)(1995-2#2)(1995-8#3)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#1)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#2)(2004-1#1)(2004-11#1)(2004-3#1)(2005-8#1)(2006-1#2)(2006-10#9)(2006-11#2)(2006-12#1)(2006-2#3)(2006-4#2)(2006-5#2)(2006-6#2)(2006-8#4)(2006-9#1)(2007-10#1)(2007-11#11)(2007-12#10)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#5)(2008-1#9)(2008-10#19)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#10)(2008-4#6)(2008-5#10)(2008-6#3)(2008-7#7)(2008-8#5)(2008-9#6)(2009-1#2)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#5)(2011-1#3)(2011-2#3)(2012-1#2)(2012-12#5)(2012-2#5)(2012-3#6)(2013-1#3)(2013-7#7)(2013-8#6)
the result that the##3##4##(1997-8#1)(2006-1#1)(2007-12#1)
the result that##8##3##(1991-12#1)(1992-2#1)(1997-7#1)(1997-8#1)(2006-1#1)(2007-12#1)(2008-10#1)(2011-2#1)
the result to be##2##4##(1996-12#1)(2009-3#1)
the result to##4##3##(1996-12#1)(2005-9#1)(2006-10#1)(2009-3#1)
the result was##7##3##(1990-6#1)(1991-12#1)(1995-4#1)(2008-10#2)(2009-12#1)(2013-1#1)
the result##392##2##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#4)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#3)(1993-12#2)(1993-3#4)(1993-4#1)(1993-7#1)(1993-8#1)(1994-1#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#4)(1994-5#1)(1994-8#2)(1995-1#2)(1995-11#3)(1995-12#2)(1995-2#3)(1995-4#2)(1995-8#4)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#2)(1997-5#2)(1997-6#3)(1997-7#3)(1997-8#3)(2004-1#1)(2004-11#1)(2004-3#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-1#3)(2006-10#11)(2006-11#2)(2006-12#1)(2006-2#3)(2006-4#3)(2006-5#2)(2006-6#2)(2006-8#4)(2006-9#1)(2007-10#1)(2007-11#12)(2007-12#13)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#7)(2008-1#9)(2008-10#25)(2008-11#4)(2008-12#2)(2008-2#8)(2008-3#13)(2008-4#7)(2008-5#10)(2008-6#3)(2008-7#8)(2008-8#7)(2008-9#7)(2009-1#2)(2009-10#2)(2009-11#1)(2009-12#4)(2009-2#4)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#5)(2011-1#3)(2011-2#5)(2012-1#2)(2012-12#6)(2012-2#6)(2012-3#6)(2013-1#7)(2013-7#7)(2013-8#7)
the resultant fluorescence##2##3##(1997-1#1)(2008-2#1)
the resultant##88##2##(1990-11#1)(1990-12#1)(1991-10#1)(1991-12#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-4#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-4#1)(2004-9#1)(2005-11#3)(2005-2#1)(2006-10#2)(2006-11#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#8)(2008-4#2)(2008-5#4)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
the resulted##3##2##(2008-10#3)
the resulting &quot##2##3##(1991-2#1)(2009-10#1)
the resulting 2D##2##3##(2010-5#1)(2010-6#1)
the resulting astigmatic##2##3##(2008-3#2)
the resulting beam##2##3##(2008-3#2)
the resulting chimeric##3##3##(1996-7#1)(2008-6#2)
the resulting colonies##3##3##(2006-4#1)(2008-10#2)
the resulting complex##3##3##(1994-3#1)(2007-11#1)(2008-10#1)
the resulting complexes##4##3##(1994-6#1)(1997-7#1)(2008-10#1)(2008-5#1)
the resulting data##7##3##(1990-2#1)(1995-2#1)(1997-2#1)(2004-9#1)(2006-12#1)(2008-10#1)(2009-12#1)
the resulting decrease in##3##4##(1994-8#1)(2006-9#1)(2008-8#1)
the resulting disease##2##3##(2008-10#1)(2008-9#1)
the resulting effects on##2##4##(1995-1#1)(1995-3#1)
the resulting images##3##3##(1991-2#1)(2008-2#1)(2009-4#1)
the resulting increase in the##2##5##(1992-8#1)(1997-1#1)
the resulting increase in##5##4##(1992-8#1)(1993-3#1)(1997-1#1)(2009-9#1)(2013-8#1)
the resulting interference patterns##2##4##(2008-2#1)(2008-3#1)
the resulting likelihood##2##3##(1994-8#1)(2011-2#1)
the resulting material##2##3##(2007-8#1)(2008-10#1)
the resulting model##3##3##(1991-1#1)(2008-7#1)(2010-12#1)
the resulting molecular##2##3##(2008-10#1)(2012-2#1)
the resulting need to##2##4##(2008-7#1)(2009-10#1)
the resulting noise level##2##4##(2007-9#1)(2012-1#1)
the resulting number of##3##4##(2008-2#1)(2012-12#2)
the resulting optical##2##3##(2007-11#1)(2007-12#1)
the resulting output files##2##4##(2008-4#2)
the resulting particles##2##3##(2010-4#1)(2010-7#1)
the resulting peptide##4##3##(1994-11#1)(1994-12#1)(1996-6#1)(2008-4#1)
the resulting peptides##3##3##(1993-8#1)(1995-1#1)(2008-4#1)
the resulting phenotype##2##3##(2008-2#1)(2009-5#1)
the resulting phenotypes##3##3##(1996-8#1)(2008-10#1)(2008-4#1)
the resulting product##2##3##(1993-12#1)(2008-10#1)
the resulting sequences##3##3##(2011-12#1)(2011-2#1)(2013-8#1)
the resulting signal##2##3##(2008-2#2)
the resulting solution is##4##4##(2008-10#4)
the resulting solution##5##3##(2008-10#5)
the resulting transgenic##2##3##(2006-12#1)(2008-10#1)
the resulting vesicles##2##3##(1992-6#1)(2008-10#1)
the resulting##382##2##(1990-12#1)(1990-2#1)(1990-3#2)(1990-9#1)(1991-1#1)(1991-2#3)(1991-4#2)(1991-6#2)(1991-7#4)(1991-8#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#7)(1992-7#2)(1992-8#2)(1992-9#2)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#2)(1994-11#5)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#2)(1995-11#1)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#2)(1996-1#1)(1996-2#3)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-7#1)(1997-8#2)(2004-9#1)(2005-11#3)(2006-10#3)(2006-11#2)(2006-12#4)(2006-2#1)(2006-3#2)(2006-4#2)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#10)(2007-12#7)(2007-2#2)(2007-7#1)(2007-8#3)(2007-9#3)(2008-1#4)(2008-10#55)(2008-11#8)(2008-12#2)(2008-2#21)(2008-3#22)(2008-4#16)(2008-5#11)(2008-6#3)(2008-7#7)(2008-8#7)(2008-9#4)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#4)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#7)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#4)(2011-1#2)(2011-12#2)(2011-2#4)(2012-1#2)(2012-11#2)(2012-12#6)(2012-2#5)(2012-3#2)(2013-1#6)(2013-8#4)
the results above##2##3##(2004-9#1)(2005-4#1)
the results achieved##6##3##(1991-3#1)(1995-2#1)(1997-6#1)(2008-1#1)(2009-10#1)(2010-2#1)
the results after##3##3##(1994-6#1)(2009-5#1)(2011-2#1)
the results already##2##3##(2007-6#1)(2013-1#1)
the results also indicate##2##4##(2006-8#1)(2008-10#1)
the results also show that##2##5##(2008-10#1)(2008-5#1)
the results also suggest that##2##5##(1992-6#1)(2006-4#1)
the results also##10##3##(1992-11#1)(1992-6#1)(2006-4#1)(2006-8#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)
the results analyzed##2##3##(2013-1#1)(2013-8#1)
the results and##21##3##(1991-6#1)(1993-8#1)(1994-3#1)(1995-3#1)(1996-5#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#2)(2011-3#1)
the results are better##2##4##(1992-12#1)(2007-8#1)
the results are comparable or superior to##2##7##(2009-10#1)(2011-1#1)
the results are comparable##3##4##(2009-10#1)(2011-1#1)(2012-1#1)
the results are compared with the##7##6##(2008-10#3)(2008-2#3)(2008-3#1)
the results are compared with##12##5##(2008-10#5)(2008-2#3)(2008-3#4)
the results are compared##16##4##(1996-11#1)(2008-10#7)(2008-2#4)(2008-3#4)
the results are consistent with a##2##6##(1996-3#1)(2005-11#1)
the results are consistent with##6##5##(1996-2#1)(1996-3#1)(2005-11#1)(2009-10#1)(2011-1#1)(2012-2#1)
the results are discussed in##3##5##(2007-12#1)(2008-2#1)(2008-5#1)
the results are discussed##8##4##(1996-12#1)(2006-12#1)(2007-12#1)(2008-2#1)(2008-5#2)(2008-9#1)(2012-2#1)
the results are in##3##4##(1996-7#1)(2007-12#1)(2008-4#1)
the results are more##2##4##(2008-10#1)(2008-2#1)
the results are not##2##4##(2008-10#1)(2008-4#1)
the results are poor##2##4##(1995-7#1)(2007-11#1)
the results are##94##3##(1991-10#1)(1991-4#1)(1992-12#1)(1993-12#2)(1995-5#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(2005-11#1)(2005-5#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#4)(2007-2#2)(2007-8#2)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#13)(2008-3#6)(2008-4#2)(2008-5#4)(2008-7#3)(2008-9#1)(2009-10#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
the results as##2##3##(1991-3#1)(2008-2#1)
the results at the##2##4##(2008-2#1)(2013-1#1)
the results at##4##3##(2008-1#1)(2008-2#1)(2008-8#1)(2013-1#1)
the results based on the##3##5##(2006-10#1)(2008-2#1)(2008-3#1)
the results being##2##3##(1994-3#1)(2008-11#1)
the results between##3##3##(1990-12#1)(2010-6#1)(2013-1#1)
the results by molecular replacement##2##5##(2008-8#2)
the results by##6##3##(1996-5#1)(2007-3#1)(2008-1#1)(2008-2#1)(2008-8#2)
the results can be interpreted##2##5##(1996-5#1)(2007-12#1)
the results cannot be##2##4##(1996-2#1)(2008-11#1)
the results confirm##2##3##(1996-8#1)(1997-6#1)
the results correlated##3##3##(2007-8#1)(2008-10#1)(2012-11#1)
the results could##2##3##(2008-9#1)(2012-12#1)
the results demonstrate that the##2##5##(2005-4#1)(2008-7#1)
the results demonstrate that##4##4##(1997-6#1)(2005-11#1)(2005-4#1)(2008-7#1)
the results demonstrated that##6##4##(1992-6#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-8#1)
the results demonstrated##8##3##(1992-6#1)(2005-11#1)(2006-5#1)(2007-8#1)(2008-10#3)(2008-8#1)
the results demonstrating that##2##4##(1995-6#1)(1997-7#1)
the results derived##4##3##(1990-12#1)(2007-10#1)(2008-2#1)(2008-3#1)
the results described##2##3##(2006-12#1)(2010-3#1)
the results did not##2##4##(2006-8#1)(2007-7#1)
the results expected##2##3##(1990-7#1)(2013-1#1)
the results for a##2##4##(2007-11#1)(2008-10#1)
the results for each##2##4##(2008-10#1)(2008-5#1)
the results for the##11##4##(1995-1#1)(1996-2#1)(2006-10#1)(2007-11#1)(2007-6#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
the results for##31##3##(1992-2#1)(1993-12#1)(1995-1#2)(1996-2#1)(2006-10#1)(2007-11#4)(2007-12#1)(2007-6#1)(2007-8#2)(2008-10#7)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-7#1)(2010-8#1)(2011-2#1)
the results found by##2##4##(1994-8#1)(2008-10#1)
the results found##4##3##(1994-8#1)(2007-2#1)(2008-10#2)
the results from a series of##2##6##(2008-10#1)(2008-11#1)
the results from a##4##4##(2008-10#1)(2008-11#1)(2008-2#1)(2010-11#1)
the results from our##2##4##(2007-9#1)(2013-1#1)
the results from the alternative##2##5##(2008-10#1)(2008-5#1)
the results from the three##2##5##(2008-2#1)(2008-7#1)
the results from the##21##4##(1996-3#1)(1996-9#1)(2006-10#1)(2006-8#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-2#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-11#1)(2013-1#2)
the results from these##3##4##(1994-10#1)(2006-1#1)(2008-7#1)
the results from this study##2##5##(2008-9#1)(2009-9#1)
the results from this##4##4##(2008-9#1)(2009-9#1)(2012-3#2)
the results from##66##3##(1990-7#1)(1992-12#1)(1993-3#1)(1994-10#1)(1994-2#1)(1994-3#1)(1995-8#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-2#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#7)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-9#3)(2009-9#1)(2010-11#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#3)(2013-1#3)
the results generated by##2##4##(1994-3#1)(2008-5#1)
the results have been##5##4##(1996-7#1)(2006-10#1)(2007-7#1)(2008-10#1)(2010-8#1)
the results have##9##3##(1996-7#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-7#1)(2008-10#1)(2010-8#2)(2013-7#1)
the results here##2##3##(2008-3#1)(2008-8#1)
the results highlight the##2##4##(1990-8#1)(2013-1#1)
the results illustrate that the##2##5##(2008-6#1)(2010-8#1)
the results in a##2##4##(2004-9#1)(2008-2#1)
the results in relation to##3##5##(1993-10#1)(1994-7#1)(2007-11#1)
the results in terms of##3##5##(1994-2#1)(2007-12#1)(2008-7#1)
the results in the##3##4##(2008-1#1)(2008-10#1)(2008-4#1)
the results in##29##3##(1993-10#1)(1994-12#1)(1994-2#1)(1994-7#1)(1995-3#1)(1995-7#1)(1997-1#1)(2004-9#2)(2005-10#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-9#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
the results indicate a##4##4##(1991-6#1)(1995-5#1)(1997-1#1)(2011-2#1)
the results indicate that the##8##5##(1990-8#1)(1991-4#1)(1997-7#1)(2005-9#1)(2007-12#1)(2010-3#1)(2012-2#1)(2013-8#1)
the results indicate that##21##4##(1990-6#1)(1990-8#1)(1991-4#2)(1992-6#1)(1992-8#1)(1993-2#1)(1994-8#1)(1995-11#1)(1995-2#1)(1997-2#1)(1997-7#1)(2005-9#1)(2007-12#1)(2007-8#1)(2008-1#1)(2010-3#1)(2012-2#1)(2013-1#1)(2013-8#2)
the results indicate the##2##4##(2008-1#1)(2008-12#1)
the results indicate##32##3##(1990-6#1)(1990-8#1)(1991-12#1)(1991-4#2)(1991-6#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-11#1)(2005-9#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-12#1)(2008-3#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
the results indicated a##3##4##(2006-8#1)(2007-12#1)(2008-10#1)
the results indicated that the##3##5##(2005-12#1)(2008-8#1)(2011-3#1)
the results indicated that##9##4##(1995-5#1)(2005-12#1)(2005-4#1)(2008-8#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-8#1)
the results indicated##13##3##(1995-5#1)(1997-1#1)(2005-12#1)(2005-4#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-8#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-8#1)
the results is##7##3##(1991-12#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-7#1)
the results it##4##3##(1990-10#1)(1990-12#1)(1991-2#1)(2008-12#1)
the results may vary##2##4##(1997-1#1)(2007-4#1)
the results may##5##3##(1997-1#1)(2007-4#1)(2008-7#1)(2012-2#2)
the results more##2##3##(1993-9#1)(2012-2#1)
the results obtained a##2##4##(1990-7#1)(1991-5#1)
the results obtained after##2##4##(2008-10#2)
the results obtained are##3##4##(1996-9#1)(2008-10#2)
the results obtained by manual##2##5##(2008-10#1)(2008-2#1)
the results obtained by means of##2##6##(2008-10#2)
the results obtained by the developed##2##6##(2008-10#2)
the results obtained by the two methods##2##7##(2007-7#1)(2008-10#1)
the results obtained by the two##4##6##(1992-4#1)(2007-7#1)(2008-10#2)
the results obtained by the##17##5##(1992-4#1)(2005-11#1)(2006-4#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#11)
the results obtained by this##3##5##(2008-10#2)(2008-3#1)
the results obtained by##42##4##(1990-5#1)(1992-4#1)(1992-8#1)(1993-11#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#27)(2008-2#1)(2008-3#1)(2009-4#1)(2013-8#1)
the results obtained during##2##4##(2007-11#1)(2011-2#1)
the results obtained for the##4##5##(2005-11#1)(2008-10#2)(2009-4#1)
the results obtained for##11##4##(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#1)(2009-4#1)(2010-8#1)
the results obtained from in vivo##2##6##(2008-10#1)(2008-11#1)
the results obtained from##15##4##(1990-10#1)(1992-12#1)(1992-2#1)(1995-11#1)(2005-11#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-2#4)
the results obtained have##2##4##(1993-8#1)(1996-11#1)
the results obtained in 20 patients##3##6##(1990-6#1)(2008-9#2)
the results obtained in the analysis of##2##7##(2008-10#2)
the results obtained in the##6##5##(2008-10#4)(2008-5#1)(2010-5#1)
the results obtained in this study##2##6##(1993-3#1)(2008-10#1)
the results obtained in this##6##5##(1992-2#1)(1993-3#1)(1993-8#1)(2007-10#1)(2008-10#1)(2011-2#1)
the results obtained in##22##4##(1990-10#1)(1990-6#1)(1992-2#1)(1993-3#1)(1993-8#1)(2007-10#1)(2008-10#7)(2008-11#1)(2008-5#2)(2008-9#2)(2009-5#1)(2010-5#1)(2011-2#1)(2013-8#1)
the results obtained it##2##4##(1991-3#1)(2010-2#1)
the results obtained showed##2##4##(2008-10#2)
the results obtained using the##5##5##(1997-4#1)(2008-10#3)(2012-2#1)
the results obtained using##8##4##(1995-2#1)(1997-4#1)(2008-10#5)(2012-2#1)
the results obtained were in agreement with those of##2##9##(2005-4#2)
the results obtained were##5##4##(2005-4#2)(2008-10#3)
the results obtained when##2##4##(2008-10#1)(2008-6#1)
the results obtained with a##2##5##(2007-8#1)(2011-12#1)
the results obtained with the proposed method##2##7##(2008-10#2)
the results obtained with the##14##5##(1994-9#1)(2005-9#1)(2008-10#9)(2008-3#1)(2008-9#1)(2013-1#1)
the results obtained with##33##4##(1990-12#1)(1990-3#1)(1991-6#1)(1992-6#1)(1993-8#1)(1994-9#1)(2005-9#1)(2006-6#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#13)(2008-3#1)(2008-5#1)(2008-9#2)(2011-12#1)(2013-1#1)(2013-8#1)
the results obtained##189##3##(1990-10#2)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-8#3)(1993-9#2)(1994-9#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-4#1)(2005-11#3)(2005-4#2)(2005-9#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-6#3)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#3)(2007-7#1)(2007-8#3)(2008-10#80)(2008-11#2)(2008-2#9)(2008-3#5)(2008-5#7)(2008-6#1)(2008-9#4)(2009-4#2)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
the results of ELISA##2##4##(2008-10#1)(2013-1#1)
the results of Gram staining##2##5##(2010-6#2)
the results of RT-PCR##2##4##(2008-10#1)(2013-1#1)
the results of Western blotting##3##5##(2008-8#1)(2008-9#2)
the results of a case study##2##6##(1996-1#1)(2012-1#1)
the results of a case##3##5##(1996-1#1)(2010-8#1)(2012-1#1)
the results of a clinical study##2##6##(1990-5#2)
the results of a clinical trial##2##6##(1991-9#1)(1997-6#1)
the results of a clinical##5##5##(1990-5#2)(1991-9#1)(1996-2#1)(1997-6#1)
the results of a comprehensive##2##5##(2008-3#1)(2010-9#1)
the results of a detailed##2##5##(1995-10#1)(2004-9#1)
the results of a first##2##5##(2006-10#1)(2008-10#1)
the results of a laboratory##2##5##(1993-5#1)(2008-2#1)
the results of a meta-analysis of##3##6##(1997-7#1)(2007-9#1)(2008-9#1)
the results of a number of##3##6##(1996-1#1)(2006-10#2)
the results of a numerical##2##5##(2007-12#1)(2008-3#1)
the results of a pilot##3##5##(1993-1#1)(2010-12#1)(2013-1#1)
the results of a previous study##2##6##(2007-1#1)(2008-9#1)
the results of a previous##3##5##(1991-7#1)(2007-1#1)(2008-9#1)
the results of a previously##2##5##(1992-11#1)(2007-12#1)
the results of a recent survey##3##6##(1992-3#1)(1995-1#1)(1995-2#1)
the results of a recent##4##5##(1992-3#1)(1995-1#1)(1995-2#1)(1996-8#1)
the results of a seroepidemiological##2##5##(1991-7#1)(2011-2#1)
the results of a study carried out to##2##8##(2007-11#1)(2008-5#1)
the results of a study carried out##3##7##(1993-3#1)(2007-11#1)(2008-5#1)
the results of a study of the##2##7##(1992-5#1)(2009-8#1)
the results of a study of##6##6##(1992-1#1)(1992-5#1)(1996-12#1)(2006-7#1)(2007-12#1)(2009-8#1)
the results of a study on##2##6##(1991-9#1)(2009-4#1)
the results of a study##17##5##(1991-9#1)(1992-1#1)(1992-5#1)(1993-3#1)(1996-1#1)(1996-12#2)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-5#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-9#1)(2012-1#1)
the results of a survey conducted among##2##7##(1996-12#1)(1997-3#1)
the results of a survey conducted##3##6##(1996-12#1)(1997-3#1)(2008-11#1)
the results of a survey of##6##6##(1994-12#1)(1994-3#1)(2006-4#1)(2008-1#1)(2009-4#1)(2009-6#1)
the results of a survey##11##5##(1993-12#1)(1994-12#1)(1994-3#1)(1996-12#2)(1997-3#1)(2006-4#1)(2008-1#1)(2008-11#1)(2009-4#1)(2009-6#1)
the results of a systematic study of##2##7##(1994-10#1)(1997-2#1)
the results of a systematic##3##5##(1994-10#1)(1997-2#1)(2013-1#1)
the results of a##139##4##(1990-10#1)(1990-5#2)(1991-12#2)(1991-5#2)(1991-6#1)(1991-7#2)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-2#3)(1995-4#1)(1995-6#1)(1995-9#1)(1996-1#5)(1996-11#1)(1996-12#4)(1996-2#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#1)(2004-10#2)(2004-9#1)(2005-10#1)(2005-8#1)(2006-10#5)(2006-2#2)(2006-4#2)(2006-7#2)(2007-1#1)(2007-11#2)(2007-12#6)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#4)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#2)(2009-4#2)(2009-6#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-1#3)(2013-1#3)(2013-8#1)
the results of an analysis##2##5##(1990-3#1)(1997-5#1)
the results of an experiment##4##5##(2007-11#1)(2008-2#1)(2008-3#2)
the results of an experimental##2##5##(2007-11#1)(2008-8#1)
the results of an##23##4##(1990-11#1)(1990-3#1)(1990-5#1)(1991-7#1)(1993-2#1)(1997-4#1)(1997-5#1)(2006-7#1)(2007-11#3)(2007-2#1)(2007-9#1)(2008-2#1)(2008-3#4)(2008-6#2)(2008-8#1)(2009-8#1)(2012-2#1)
the results of analysis##3##4##(2005-4#1)(2008-3#1)(2008-7#1)
the results of analytical##2##4##(1991-7#1)(2012-3#1)
the results of any##3##4##(1991-1#1)(2008-7#2)
the results of both methods##2##5##(2007-8#1)(2008-2#1)
the results of circular##2##4##(1991-2#1)(2008-6#1)
the results of clinical and instrumental studies##2##7##(2008-6#1)(2008-7#1)
the results of clinical studies are conflicting and the role of mTOR inhibitors is still uncertain##2##16##(2013-1#2)
the results of clinical trials##5##5##(1994-11#1)(1995-1#1)(1996-8#1)(2005-7#1)(2007-10#1)
the results of clinical##11##4##(1994-11#1)(1995-1#1)(1996-8#1)(2005-7#1)(2007-10#2)(2008-6#1)(2008-7#1)(2012-12#1)(2013-1#2)
the results of controlled##3##4##(2005-10#1)(2006-12#1)(2008-10#1)
the results of coronary##2##4##(1994-2#1)(2007-8#1)
the results of current##3##4##(1997-8#1)(2007-1#1)(2008-8#1)
the results of densitometric tests##2##5##(2007-11#1)(2007-8#1)
the results of determination##2##4##(2005-4#1)(2008-12#1)
the results of different##7##4##(1990-6#1)(1997-4#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-11#1)(2008-9#1)
the results of earlier studies##2##5##(1995-11#1)(2008-5#1)
the results of early##3##4##(2007-8#1)(2008-7#1)(2008-8#1)
the results of empirical##2##4##(2008-8#1)(2008-9#1)
the results of epidemiological studies##2##5##(2007-8#1)(2008-10#1)
the results of experimental##3##4##(1994-7#1)(2008-2#1)(2008-3#1)
the results of experiments##3##4##(1994-2#1)(2008-5#1)(2008-8#1)
the results of his##2##4##(1995-5#1)(2011-2#1)
the results of immunohistochemical##2##4##(1997-8#1)(2008-5#1)
the results of in vivo##2##5##(1993-9#1)(1995-12#1)
the results of in##4##4##(1991-3#1)(1993-9#1)(1995-12#1)(2008-3#1)
the results of interviews conducted with##2##6##(1991-12#1)(1996-12#1)
the results of kinetic studies of##2##6##(1992-4#1)(1992-6#1)
the results of kinetic##4##4##(1992-4#1)(1992-6#1)(1994-3#1)(2008-8#1)
the results of large##3##4##(2006-10#1)(2006-11#1)(2007-11#1)
the results of measurements##3##4##(2008-2#2)(2008-3#1)
the results of modified##2##4##(2009-5#1)(2011-2#1)
the results of molecular dynamics simulations##2##6##(1990-8#1)(1995-3#1)
the results of molecular##3##4##(1990-8#1)(1995-3#1)(1997-8#1)
the results of more than##2##5##(1990-2#1)(2007-2#1)
the results of multiple##3##4##(1995-10#1)(2006-8#1)(2008-7#1)
the results of ongoing##6##4##(2005-10#1)(2008-3#2)(2008-8#1)(2010-12#1)(2011-1#1)
the results of operative treatment##2##5##(2007-11#1)(2008-3#1)
the results of other studies##2##5##(1991-8#1)(1994-2#1)
the results of other##5##4##(1991-8#1)(1994-2#1)(1997-4#1)(2005-9#1)(2013-8#1)
the results of our own research##2##6##(2007-9#1)(2013-1#1)
the results of our own##3##5##(1991-2#1)(2007-9#1)(2013-1#1)
the results of our study##5##5##(2006-11#1)(2008-8#1)(2009-4#1)(2011-1#1)(2011-2#1)
the results of our##24##4##(1990-9#1)(1991-2#1)(1994-11#1)(1995-5#1)(1997-5#1)(2006-11#1)(2007-12#2)(2007-8#2)(2007-9#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#2)(2009-4#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
the results of preliminary##2##4##(1992-3#1)(2006-8#1)
the results of previous studies##4##5##(1991-10#1)(2008-10#1)(2008-11#1)(2010-12#1)
the results of previous##7##4##(1991-10#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-12#1)(2011-1#1)
the results of prior##2##4##(1997-8#1)(2006-2#1)
the results of published##2##4##(2005-7#1)(2008-5#1)
the results of recent clinical##2##5##(1996-11#1)(2008-8#1)
the results of recent studies##2##5##(2008-10#1)(2010-12#1)
the results of recent##7##4##(1996-11#1)(2006-10#1)(2006-9#1)(2008-10#1)(2008-8#1)(2010-12#2)
the results of recently##2##4##(2006-10#1)(2008-11#1)
the results of research on##2##5##(2007-11#2)
the results of research##5##4##(2005-9#1)(2007-11#2)(2008-2#1)(2009-2#1)
the results of screening##3##4##(2006-10#1)(2008-2#1)(2008-5#1)
the results of several##8##4##(2006-10#1)(2006-7#1)(2007-11#1)(2009-4#1)(2009-5#1)(2010-7#1)(2012-1#1)(2012-3#1)
the results of simulation studies##2##5##(2008-2#2)
the results of six##2##4##(1991-3#1)(1993-3#1)
the results of some##4##4##(1993-7#1)(1994-6#1)(2008-4#1)(2013-8#1)
the results of studies on##3##5##(2004-9#1)(2008-10#1)(2008-12#1)
the results of studies with##2##5##(1993-9#1)(2007-11#1)
the results of studies##13##4##(1993-9#1)(1994-5#1)(1997-4#1)(2004-9#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-12#1)(2009-2#1)(2011-2#1)
the results of study of##2##5##(2013-1#2)
the results of studying the##2##5##(2008-7#1)(2013-1#1)
the results of such##3##4##(1993-7#1)(2013-1#1)(2013-7#1)
the results of surgical treatment for##2##6##(2007-7#1)(2008-8#1)
the results of surgical treatment of##2##6##(2007-7#1)(2013-1#1)
the results of surgical treatment##6##5##(2007-7#2)(2007-8#1)(2008-7#1)(2008-8#1)(2013-1#1)
the results of surgical##7##4##(2007-7#2)(2007-8#2)(2008-7#1)(2008-8#1)(2013-1#1)
the results of ten##3##4##(2006-4#1)(2013-1#2)
the results of that##4##4##(1994-1#1)(2008-12#1)(2013-1#2)
the results of the annual IAHSS surveys on crime in hospitals for##2##12##(1992-2#1)(1994-2#1)
the results of the current study##2##6##(2007-1#1)(2007-11#1)
the results of the different##3##5##(2006-10#2)(2008-8#1)
the results of the experiments##2##5##(2007-11#1)(2008-2#1)
the results of the first##9##5##(1990-2#1)(1995-3#1)(1996-6#1)(2007-3#1)(2008-5#1)(2011-2#1)(2012-12#2)(2013-8#1)
the results of the in vitro##2##6##(2008-11#2)
the results of the most##3##5##(1995-6#1)(2006-6#1)(2008-1#1)
the results of the new##3##5##(1995-4#1)(1997-8#1)(2005-11#1)
the results of the pilot##2##5##(1993-1#1)(2010-9#1)
the results of the present study suggest that##2##8##(1995-10#1)(1996-7#1)
the results of the present study suggest##3##7##(1995-10#1)(1996-1#1)(1996-7#1)
the results of the present study##6##6##(1995-10#1)(1996-1#1)(1996-7#1)(1997-3#1)(2008-6#1)(2011-12#1)
the results of the previous##2##5##(1994-2#1)(1994-3#1)
the results of the proposed##3##5##(1997-8#1)(2008-10#1)(2012-1#1)
the results of the simulations show##2##6##(2008-2#1)(2008-3#1)
the results of the study showed##2##6##(2008-10#1)(2008-6#1)
the results of the study##6##5##(1992-10#1)(2007-10#1)(2007-3#1)(2008-10#1)(2008-6#1)(2010-8#1)
the results of the survey##2##5##(1994-4#1)(2012-2#1)
the results of the test##4##5##(1991-12#1)(2008-7#1)(2012-12#2)
the results of the treatment##4##5##(1991-9#1)(1993-9#1)(2008-1#1)(2011-2#1)
the results of the two##5##5##(2007-8#1)(2008-10#2)(2008-4#1)(2013-8#1)
the results of the##167##4##(1990-2#1)(1990-4#1)(1990-5#1)(1990-9#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-1#2)(1993-9#1)(1994-11#2)(1994-2#3)(1994-3#1)(1994-4#1)(1995-1#1)(1995-10#2)(1995-12#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-6#3)(1996-7#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-8#2)(2005-11#6)(2005-12#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-4#2)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-3#4)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#3)(2008-10#12)(2008-11#3)(2008-12#2)(2008-2#9)(2008-3#12)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#5)(2009-3#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2011-7#1)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#3)
the results of their research##2##5##(1990-9#1)(1996-1#1)
the results of their##8##4##(1990-5#1)(1990-9#1)(1991-1#1)(1992-9#1)(1996-1#1)(2006-11#1)(2008-10#1)(2009-2#1)
the results of theoretical##3##4##(2008-2#1)(2011-1#1)(2013-7#1)
the results of these analyses##2##5##(1995-5#1)(1996-1#1)
the results of these experiments##2##5##(2008-10#2)
the results of these studies##3##5##(2008-7#1)(2011-2#1)(2012-1#1)
the results of these tests##4##5##(1993-1#1)(1997-2#1)(2006-10#1)(2008-4#1)
the results of these trials##2##5##(1996-11#1)(2007-4#1)
the results of these##15##4##(1993-1#1)(1995-5#1)(1996-1#1)(1996-11#2)(1997-2#1)(2006-10#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-7#1)(2011-2#1)(2012-1#1)
the results of this analysis##2##5##(2008-6#1)(2011-2#1)
the results of this study also##2##6##(1991-12#1)(1996-5#1)
the results of this study are##3##6##(1996-12#1)(1996-2#1)(2008-4#1)
the results of this study show that##3##7##(1990-12#1)(2006-12#1)(2007-10#1)
the results of this study suggest that##2##7##(2009-4#1)(2009-7#1)
the results of this study suggest##3##6##(1996-11#1)(2009-4#1)(2009-7#1)
the results of this study support the##2##7##(2008-10#1)(2012-1#1)
the results of this study support##3##6##(1991-9#1)(2008-10#1)(2012-1#1)
the results of this study##33##5##(1990-12#1)(1990-6#1)(1991-12#1)(1991-9#1)(1993-1#1)(1995-1#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-10#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2009-4#1)(2009-7#1)(2011-3#1)(2012-1#1)(2013-8#1)
the results of this##54##4##(1990-12#1)(1990-6#1)(1991-12#1)(1991-9#1)(1993-1#1)(1995-1#1)(1995-5#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(2005-11#1)(2006-11#2)(2006-12#1)(2006-6#1)(2007-1#1)(2007-10#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-4#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
the results of three##3##4##(2006-4#1)(2008-2#1)(2009-4#1)
the results of total##2##4##(2008-10#1)(2008-3#1)
the results of treating##2##4##(1996-11#1)(2013-1#1)
the results of treatment with##2##5##(2008-12#1)(2008-6#1)
the results of treatment##6##4##(1990-4#1)(1992-5#1)(1993-1#1)(2008-12#1)(2008-6#1)(2010-3#1)
the results of two##11##4##(1991-2#1)(1994-3#1)(1995-4#1)(1997-4#1)(2006-8#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)
the results of various##2##4##(1994-3#1)(2007-4#1)
the results of which##6##4##(1990-9#1)(1992-5#1)(2005-10#1)(2006-9#1)(2010-2#1)(2011-12#1)
the results of##928##3##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#3)(1990-5#5)(1990-6#7)(1990-8#3)(1990-9#6)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#5)(1991-8#1)(1991-9#5)(1992-1#3)(1992-10#2)(1992-11#3)(1992-12#3)(1992-2#3)(1992-3#3)(1992-4#2)(1992-5#4)(1992-6#2)(1992-7#2)(1992-9#2)(1993-1#6)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#4)(1993-3#3)(1993-5#1)(1993-7#2)(1993-8#3)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#4)(1994-12#1)(1994-2#7)(1994-3#6)(1994-4#1)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#1)(1995-1#4)(1995-10#4)(1995-11#1)(1995-12#3)(1995-2#7)(1995-3#3)(1995-4#3)(1995-5#4)(1995-6#2)(1995-8#2)(1995-9#2)(1996-1#10)(1996-11#6)(1996-12#9)(1996-2#6)(1996-4#2)(1996-5#1)(1996-6#6)(1996-7#1)(1996-8#2)(1996-9#3)(1997-2#3)(1997-3#6)(1997-4#6)(1997-5#3)(1997-6#2)(1997-7#1)(1997-8#8)(2004-10#2)(2004-2#1)(2004-9#2)(2005-10#5)(2005-11#9)(2005-12#1)(2005-4#4)(2005-7#2)(2005-8#1)(2005-9#2)(2006-10#25)(2006-11#9)(2006-12#5)(2006-2#8)(2006-4#7)(2006-5#2)(2006-6#2)(2006-7#5)(2006-8#5)(2006-9#3)(2007-1#4)(2007-10#9)(2007-11#27)(2007-12#20)(2007-2#3)(2007-3#5)(2007-4#4)(2007-5#2)(2007-6#5)(2007-7#13)(2007-8#23)(2007-9#4)(2008-1#7)(2008-10#60)(2008-11#15)(2008-12#9)(2008-2#32)(2008-3#41)(2008-4#14)(2008-5#19)(2008-6#12)(2008-7#21)(2008-8#23)(2008-9#12)(2009-10#2)(2009-12#1)(2009-2#5)(2009-3#4)(2009-4#8)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#1)(2010-11#2)(2010-12#9)(2010-2#5)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#5)(2010-7#1)(2010-8#3)(2010-9#5)(2011-1#9)(2011-12#2)(2011-2#25)(2011-3#2)(2011-7#1)(2012-1#11)(2012-12#9)(2012-2#13)(2012-3#12)(2013-1#25)(2013-7#5)(2013-8#11)
the results on the##5##4##(2007-10#1)(2008-10#1)(2008-11#1)(2008-4#2)
the results on##6##3##(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)
the results point to##3##4##(2007-1#1)(2008-10#1)(2011-2#1)
the results presented here are##2##5##(1993-6#1)(2008-3#1)
the results presented here##5##4##(1991-9#1)(1993-6#1)(2008-3#1)(2008-9#1)(2012-1#1)
the results presented in this work##2##6##(1995-1#1)(2009-5#1)
the results presented##10##3##(1991-9#1)(1993-6#1)(1995-1#1)(2007-11#1)(2008-3#2)(2008-9#1)(2009-5#1)(2012-1#1)(2012-12#1)
the results provide evidence##2##4##(1993-6#1)(2006-10#1)
the results provide##4##3##(1993-6#1)(1995-2#1)(2006-10#1)(2011-1#1)
the results provided by the##2##5##(2008-10#1)(2008-2#1)
the results provided##3##3##(1994-7#1)(2008-10#1)(2008-2#1)
the results published by##3##4##(1990-9#1)(1996-7#1)(2013-1#1)
the results relating to##2##4##(2011-2#1)(2013-8#1)
the results reported by##3##4##(1992-7#1)(2008-10#1)(2008-6#1)
the results reported here##3##4##(1994-3#1)(1997-6#1)(2008-5#1)
the results reported in the literature##2##6##(1994-6#1)(2013-1#1)
the results reported in the##3##5##(1990-3#1)(1994-6#1)(2013-1#1)
the results reported in##5##4##(1990-3#1)(1991-2#1)(1994-6#1)(2008-10#1)(2013-1#1)
the results reported##14##3##(1990-11#1)(1990-3#1)(1991-2#1)(1992-7#1)(1994-3#1)(1994-6#1)(1997-6#1)(2005-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2013-1#1)
the results revealed that the##3##5##(2008-10#1)(2013-7#1)(2013-8#1)
the results revealed that##8##4##(1994-11#1)(2007-4#1)(2008-10#2)(2010-1#1)(2010-3#1)(2013-7#1)(2013-8#1)
the results revealed##9##3##(1994-11#1)(2007-4#1)(2008-10#2)(2010-1#1)(2010-3#1)(2010-5#1)(2013-7#1)(2013-8#1)
the results should be##3##4##(1990-3#1)(1991-12#1)(2008-3#1)
the results should##4##3##(1990-3#1)(1991-12#1)(2008-3#2)
the results show that the##10##5##(1994-1#1)(1997-7#1)(2006-11#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-8#2)(2010-7#1)(2012-1#1)
the results show that##18##4##(1992-3#1)(1994-1#1)(1996-10#1)(1996-5#1)(1997-7#1)(2005-11#1)(2006-11#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#2)(2010-7#1)(2012-1#1)(2013-7#1)
the results show the##2##4##(1990-8#1)(2008-7#1)
the results show##24##3##(1990-8#1)(1992-3#1)(1994-1#1)(1996-10#1)(1996-5#2)(1997-7#1)(2005-11#1)(2006-11#1)(2007-11#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2010-7#1)(2012-1#1)(2013-7#1)
the results showed good agreement##3##5##(2008-10#2)(2011-1#1)
the results showed that all##2##5##(2008-10#1)(2010-3#1)
the results showed that the Pb isotopic composition##2##8##(2013-8#2)
the results showed that the##10##5##(2008-10#2)(2008-12#1)(2008-8#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-8#2)
the results showed that##22##4##(2005-11#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-8#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#2)
the results showed the##2##4##(2010-12#1)(2011-2#1)
the results showed##34##3##(1992-4#1)(1996-12#1)(2005-11#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#11)(2008-12#1)(2008-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#2)
the results strongly##4##3##(1997-7#1)(2008-10#1)(2008-8#1)(2013-1#1)
the results suggest a##2##4##(1992-10#1)(2010-4#1)
the results suggest that the##9##5##(1993-12#1)(1993-6#1)(1994-2#1)(1996-10#1)(2007-11#1)(2008-11#1)(2008-9#1)(2010-1#1)(2010-3#1)
the results suggest that##21##4##(1990-4#1)(1991-1#1)(1991-10#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-7#1)(1996-10#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-1#1)(2010-3#1)(2013-1#1)
the results suggest##25##3##(1990-4#1)(1991-1#1)(1991-10#1)(1992-10#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-7#1)(1996-10#1)(1996-5#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-4#1)(2013-1#1)
the results suggested that the##3##5##(1991-4#1)(1995-5#1)(2008-10#1)
the results suggested that##4##4##(1991-4#1)(1995-5#1)(2007-7#1)(2008-10#1)
the results suggested##5##3##(1991-4#1)(1995-5#1)(2007-7#1)(2008-10#1)(2009-1#1)
the results support the##7##4##(1994-12#1)(1994-2#1)(2007-12#1)(2009-3#1)(2010-8#1)(2013-1#2)
the results support##9##3##(1994-12#1)(1994-2#1)(1994-8#1)(2007-12#1)(2008-11#1)(2009-3#1)(2010-8#1)(2013-1#2)
the results that are##2##4##(2008-10#1)(2008-3#1)
the results that##10##3##(1994-11#1)(2004-10#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-3#2)(2009-8#1)(2011-2#1)
the results the##4##3##(1991-9#1)(1993-10#1)(2011-2#1)(2013-8#1)
the results to a##2##4##(2008-12#1)(2009-7#1)
the results to the##3##4##(2008-11#1)(2008-3#1)(2011-2#1)
the results to those##3##4##(1991-3#1)(1994-2#1)(2012-12#1)
the results to##20##3##(1991-3#1)(1994-2#1)(1995-3#1)(1996-3#1)(1997-2#1)(2005-11#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-7#2)(2009-7#1)(2011-2#1)(2012-12#1)(2012-3#2)
the results using the##2##4##(2007-8#1)(2008-8#1)
the results using##5##3##(1990-1#1)(2007-8#1)(2008-10#2)(2008-8#1)
the results varied##2##3##(2008-10#1)(2009-12#1)
the results was##11##3##(1990-12#2)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#1)(2009-8#1)(2013-8#1)
the results were also##3##4##(1996-12#1)(2008-10#1)(2008-5#1)
the results were as follows##2##5##(1990-12#1)(2007-11#1)
the results were compared with the##5##6##(1996-3#1)(2007-10#1)(2008-10#2)(2010-4#1)
the results were compared with those obtained by##4##8##(2008-10#2)(2008-2#1)(2008-3#1)
the results were compared with those obtained##8##7##(1995-2#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-6#1)
the results were compared with those##12##6##(1995-2#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2012-1#1)
the results were compared with##29##5##(1993-3#1)(1995-2#1)(1996-3#1)(1996-8#1)(2006-10#1)(2007-10#1)(2007-8#3)(2008-10#10)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-3#1)
the results were compared##39##4##(1993-3#1)(1994-3#1)(1995-2#1)(1996-3#1)(1996-8#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-7#1)(2007-8#4)(2008-10#14)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)
the results were consistent with##2##5##(2008-10#1)(2008-8#1)
the results were consistent##4##4##(1993-9#1)(2008-10#1)(2008-8#1)(2013-1#1)
the results were in good agreement with those##4##8##(2008-10#4)
the results were in good agreement with##6##7##(2008-10#6)
the results were in##12##4##(1993-2#1)(2008-10#11)
the results were satisfactory##3##4##(1990-9#1)(2008-10#2)
the results were similar to##2##5##(2008-10#2)
the results were similar##3##4##(2008-10#2)(2008-5#1)
the results were statistically##3##4##(2008-10#2)(2012-12#1)
the results were##122##3##(1990-12#3)(1990-7#1)(1990-9#2)(1991-7#1)(1992-4#1)(1993-10#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-12#1)(2005-11#2)(2006-10#1)(2006-2#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-5#1)(2007-7#2)(2007-8#5)(2008-1#1)(2008-10#41)(2008-2#3)(2008-3#1)(2008-5#5)(2008-6#1)(2008-8#3)(2008-9#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
the results when##4##3##(2007-11#1)(2008-9#1)(2009-9#1)(2012-12#1)
the results will be##2##4##(1997-1#1)(2006-10#1)
the results with a##2##4##(2008-2#1)(2012-12#1)
the results with reference##2##4##(2008-9#1)(2010-9#1)
the results with the##6##4##(1993-11#1)(1993-8#1)(1997-8#1)(2006-7#1)(2008-10#1)(2008-3#1)
the results with those obtained by the##2##7##(2008-10#2)
the results with those obtained by##4##6##(2005-4#1)(2008-10#2)(2008-2#1)
the results with those obtained with##2##6##(2007-10#1)(2008-2#1)
the results with those obtained##7##5##(2005-4#1)(2007-10#1)(2008-10#2)(2008-2#2)(2009-3#1)
the results with those of##4##5##(2006-12#1)(2008-10#2)(2010-11#1)
the results with those##17##4##(1992-7#1)(2005-4#1)(2006-12#1)(2007-10#2)(2007-11#1)(2008-10#5)(2008-2#2)(2008-5#1)(2009-3#1)(2010-11#1)(2012-3#1)
the results with##43##3##(1992-7#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-8#1)(1997-8#1)(2005-4#1)(2006-12#3)(2006-7#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#8)(2008-2#4)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
the results within##2##3##(2008-3#1)(2010-6#1)
the results##2131##2##(1990-1#1)(1990-10#5)(1990-11#2)(1990-12#12)(1990-2#2)(1990-3#4)(1990-4#4)(1990-5#7)(1990-6#11)(1990-7#4)(1990-8#6)(1990-9#10)(1991-1#3)(1991-10#4)(1991-11#1)(1991-12#11)(1991-2#7)(1991-3#7)(1991-4#6)(1991-5#3)(1991-6#6)(1991-7#6)(1991-8#1)(1991-9#10)(1992-1#4)(1992-10#3)(1992-11#4)(1992-12#6)(1992-2#6)(1992-3#4)(1992-4#6)(1992-5#4)(1992-6#7)(1992-7#4)(1992-8#3)(1992-9#3)(1993-1#6)(1993-10#4)(1993-11#4)(1993-12#7)(1993-2#8)(1993-3#6)(1993-5#1)(1993-6#3)(1993-7#2)(1993-8#9)(1993-9#8)(1994-1#2)(1994-10#2)(1994-11#8)(1994-12#4)(1994-2#14)(1994-3#12)(1994-4#1)(1994-5#3)(1994-6#6)(1994-7#4)(1994-8#4)(1994-9#1)(1995-1#7)(1995-10#4)(1995-11#4)(1995-12#4)(1995-2#14)(1995-3#7)(1995-4#4)(1995-5#9)(1995-6#3)(1995-7#3)(1995-8#3)(1995-9#2)(1996-1#12)(1996-10#2)(1996-11#10)(1996-12#16)(1996-2#9)(1996-3#6)(1996-4#3)(1996-5#9)(1996-6#7)(1996-7#5)(1996-8#6)(1996-9#8)(1997-1#9)(1997-2#8)(1997-3#9)(1997-4#10)(1997-5#4)(1997-6#6)(1997-7#6)(1997-8#10)(2004-10#3)(2004-12#2)(2004-2#2)(2004-4#1)(2004-9#5)(2005-10#7)(2005-11#26)(2005-12#2)(2005-4#12)(2005-5#2)(2005-7#3)(2005-8#4)(2005-9#4)(2006-1#2)(2006-10#41)(2006-11#12)(2006-12#12)(2006-2#10)(2006-4#10)(2006-5#5)(2006-6#8)(2006-7#8)(2006-8#15)(2006-9#3)(2007-1#6)(2007-10#20)(2007-11#48)(2007-12#39)(2007-2#11)(2007-3#8)(2007-4#6)(2007-5#6)(2007-6#8)(2007-7#21)(2007-8#45)(2007-9#8)(2008-1#20)(2008-10#302)(2008-11#29)(2008-12#15)(2008-2#82)(2008-3#86)(2008-4#27)(2008-5#52)(2008-6#22)(2008-7#42)(2008-8#40)(2008-9#32)(2009-1#1)(2009-10#7)(2009-12#2)(2009-2#5)(2009-3#7)(2009-4#11)(2009-5#9)(2009-6#3)(2009-7#3)(2009-8#10)(2009-9#6)(2010-1#3)(2010-10#1)(2010-11#7)(2010-12#14)(2010-2#9)(2010-3#7)(2010-4#6)(2010-5#7)(2010-6#9)(2010-7#3)(2010-8#15)(2010-9#10)(2011-1#21)(2011-12#4)(2011-2#56)(2011-3#4)(2011-7#2)(2012-1#17)(2012-11#1)(2012-12#23)(2012-2#27)(2012-3#22)(2012-5#1)(2013-1#54)(2013-7#11)(2013-8#34)
the results]##2##2##(1995-11#1)(2011-2#1)
the resumption of##4##3##(2005-9#1)(2006-10#1)(2007-7#1)(2008-5#1)
the resumption##5##2##(1996-3#1)(2005-9#1)(2006-10#1)(2007-7#1)(2008-5#1)
the resuscitation of##3##3##(1994-6#2)(2006-10#1)
the resuscitation##5##2##(1994-6#2)(2006-10#1)(2006-2#1)(2008-3#1)
the ret proto-oncogene##4##3##(1991-9#1)(1994-12#2)(2008-1#1)
the retail##2##2##(1993-3#1)(1997-1#1)
the retailing of##2##3##(1994-12#1)(2009-2#1)
the retailing##3##2##(1994-12#2)(2009-2#1)
the retained##16##2##(1991-3#1)(1997-3#1)(2004-10#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2009-12#1)(2012-1#2)
the retardance##8##2##(2007-12#1)(2008-2#2)(2008-3#5)
the retardation of##2##3##(1995-5#1)(2008-2#1)
the retardation##5##2##(1995-5#1)(2008-2#1)(2008-3#1)(2009-4#1)(2013-1#1)
the retarded##2##2##(1995-9#1)(2007-3#1)
the retarder##5##2##(2008-2#4)(2008-3#1)
the retching and vomiting##2##4##(1991-11#1)(1993-11#1)
the retention and separation of##2##5##(2008-10#2)
the retention and##7##3##(2008-10#6)(2010-6#1)
the retention behavior of##3##4##(1996-5#1)(2008-10#2)
the retention behavior##7##3##(1996-5#1)(2008-10#6)
the retention behaviour##3##3##(1996-5#1)(2008-10#2)
the retention delay##2##3##(1992-10#2)
the retention indices##3##3##(2007-3#1)(2008-10#2)
the retention mechanism of##2##4##(2013-8#2)
the retention mechanism##6##3##(2005-12#1)(2008-10#3)(2013-8#2)
the retention of basic##2##4##(2005-12#1)(2010-3#1)
the retention of some##2##4##(1996-5#1)(2008-10#1)
the retention of the##7##4##(1995-6#1)(1996-1#1)(1997-3#1)(1997-8#1)(2008-10#2)(2013-8#1)
the retention of##44##3##(1990-4#1)(1990-8#2)(1992-11#1)(1992-7#1)(1994-1#1)(1994-12#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-5#2)(1997-3#1)(1997-4#1)(1997-8#2)(2005-12#3)(2006-5#1)(2007-11#1)(2007-4#2)(2007-5#1)(2008-10#11)(2008-11#1)(2008-5#1)(2009-4#1)(2009-6#1)(2010-3#1)(2011-2#1)(2012-1#1)(2013-8#2)
the retention or##2##3##(1993-7#1)(2008-3#1)
the retention performance of##2##4##(1990-10#1)(2008-11#1)
the retention performance##3##3##(1990-10#1)(1994-8#1)(2008-11#1)
the retention process##2##3##(2008-10#2)
the retention test##2##3##(1991-2#1)(1994-8#1)
the retention time of the##4##5##(2005-12#1)(2008-10#2)(2008-11#1)
the retention time##8##3##(2005-12#1)(2008-10#4)(2008-11#1)(2011-1#1)(2012-12#1)
the retention times of synthetic##2##5##(1991-2#1)(1992-6#1)
the retention times of the##3##5##(1991-5#1)(2008-10#1)(2012-12#1)
the retention times of##7##4##(1991-2#1)(1991-5#1)(1992-6#1)(1992-7#1)(1996-8#1)(2008-10#1)(2012-12#1)
the retention times##12##3##(1991-2#1)(1991-5#1)(1992-6#3)(1992-7#1)(1996-8#1)(2005-12#2)(2008-10#2)(2012-12#1)
the retention##123##2##(1990-10#1)(1990-4#1)(1990-6#2)(1990-8#2)(1991-2#2)(1991-5#1)(1991-8#1)(1992-10#2)(1992-11#1)(1992-6#3)(1992-7#2)(1993-11#1)(1993-7#1)(1994-1#1)(1994-12#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-11#3)(1996-5#6)(1996-8#1)(1997-3#1)(1997-4#1)(1997-8#2)(2005-12#8)(2006-5#1)(2007-11#2)(2007-3#1)(2007-4#2)(2007-5#1)(2008-10#44)(2008-11#4)(2008-3#1)(2008-5#1)(2009-4#1)(2009-6#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-8#5)
the reticular formation##5##3##(1991-3#1)(1994-3#1)(1996-9#1)(1997-2#1)(1997-6#1)
the reticular lamina##4##3##(1995-5#4)
the reticular thalamic nucleus##2##4##(1991-5#1)(1997-2#1)
the reticular##16##2##(1991-3#1)(1991-5#1)(1994-3#1)(1995-5#4)(1996-12#1)(1996-9#2)(1997-2#2)(1997-6#1)(1997-7#1)(2008-9#1)(2013-1#1)
the reticulocyte##2##2##(1992-4#1)(1994-5#1)
the reticuloendothelial system##8##3##(1991-12#1)(1991-9#1)(1992-6#1)(1995-6#1)(2006-10#1)(2008-3#1)(2010-2#1)(2012-11#1)
the reticuloendothelial##9##2##(1991-12#1)(1991-9#1)(1992-6#1)(1995-6#1)(1997-7#1)(2006-10#1)(2008-3#1)(2010-2#1)(2012-11#1)
the reticulum##6##2##(1993-1#5)(2011-2#1)
the retina and the##3##4##(1994-5#1)(2008-3#1)(2013-1#1)
the retina and##19##3##(1992-8#1)(1994-5#1)(1995-11#1)(1997-3#1)(2006-1#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#2)(2010-9#1)(2011-2#1)(2013-1#2)(2013-8#2)
the retina are##5##3##(1995-1#1)(2009-2#2)(2012-12#2)
the retina images##2##3##(2011-1#2)
the retina in the##2##4##(2007-3#1)(2008-3#1)
the retina in##5##3##(1994-2#1)(2007-3#1)(2008-3#1)(2009-2#1)(2010-1#1)
the retina is##2##3##(1996-1#1)(1996-2#1)
the retina of a##2##4##(1994-2#1)(2008-2#1)
the retina of the##4##4##(1991-10#1)(2008-5#1)(2009-2#1)(2010-1#1)
the retina of##12##3##(1991-10#2)(1992-3#1)(1994-2#1)(1996-10#1)(1996-2#1)(1996-6#1)(2008-2#1)(2008-5#1)(2009-2#1)(2010-1#2)
the retina##126##2##(1990-5#1)(1990-7#1)(1991-10#3)(1991-2#1)(1992-2#2)(1992-3#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-2#3)(1994-5#2)(1995-1#4)(1995-11#3)(1995-9#1)(1996-1#1)(1996-10#2)(1996-2#3)(1996-6#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-8#2)(2006-1#2)(2006-10#1)(2006-6#1)(2006-8#2)(2007-11#4)(2007-12#3)(2007-3#2)(2007-6#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#7)(2008-7#2)(2008-8#5)(2009-12#2)(2009-2#7)(2009-4#1)(2010-1#5)(2010-6#1)(2010-9#2)(2011-1#3)(2011-2#3)(2011-7#2)(2012-1#2)(2012-12#8)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#3)
the retina-specific##2##2##(1994-9#2)
the retinal chromophore##6##3##(1990-3#1)(1995-1#2)(1997-3#1)(2007-12#1)(2008-7#1)
the retinal cyclic-GMP phosphodiesterase##2##4##(1991-7#2)
the retinal nerve fiber layer##2##5##(2008-3#1)(2010-12#1)
the retinal parenchyma##2##3##(2008-4#1)(2009-2#1)
the retinal pigment epithelium (RPE)##6##5##(1990-6#1)(1992-2#1)(1995-9#1)(2008-4#1)(2012-12#1)(2013-1#1)
the retinal pigment epithelium and##2##5##(2008-7#1)(2009-4#1)
the retinal pigment epithelium##13##4##(1990-6#1)(1992-2#1)(1995-9#2)(1997-6#1)(2006-4#1)(2008-4#1)(2008-7#1)(2009-4#1)(2011-7#2)(2012-12#1)(2013-1#1)
the retinal pigment##14##3##(1990-6#1)(1992-2#1)(1995-9#2)(1997-6#1)(2006-4#1)(2008-4#1)(2008-7#1)(2009-4#1)(2011-2#1)(2011-7#2)(2012-12#1)(2013-1#1)
the retinal surface##5##3##(2008-2#1)(2008-5#3)(2011-2#1)
the retinal##71##2##(1990-11#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-7#3)(1992-11#1)(1992-2#1)(1992-7#1)(1993-12#1)(1995-1#5)(1995-10#1)(1995-5#1)(1995-9#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-4#1)(2006-9#2)(2007-12#2)(2007-3#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#2)(2009-10#1)(2009-12#3)(2009-2#4)(2009-4#1)(2009-8#2)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#3)(2011-7#3)(2012-12#3)(2013-1#2)
the retinas##3##2##(1990-11#1)(2007-5#2)
the retinitis pigmentosa GTPase##2##4##(2012-12#2)
the retinoblastoma gene product##4##4##(1992-8#1)(1994-5#1)(1995-2#1)(1997-7#1)
the retinoblastoma gene##7##3##(1992-8#1)(1993-6#1)(1994-5#1)(1995-2#1)(1997-7#1)(2008-6#1)(2010-3#1)
the retinoblastoma protein##4##3##(1993-6#1)(1993-9#1)(1996-4#1)(1997-1#1)
the retinoblastoma susceptibility gene product##3##5##(1991-8#1)(1996-2#2)
the retinoblastoma susceptibility gene##4##4##(1991-8#1)(1996-11#1)(1996-2#2)
the retinoblastoma##17##2##(1991-8#1)(1992-8#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-5#1)(1995-2#1)(1996-11#1)(1996-2#2)(1996-4#1)(1997-1#1)(1997-7#1)(2008-6#1)(2010-2#1)(2010-3#1)
the retinoic acid receptor (RAR)##2##5##(1996-8#1)(2005-11#1)
the retinoic acid receptor alpha (RARA) gene##2##7##(1991-11#1)(2012-2#1)
the retinoic acid receptor alpha##4##5##(1990-9#1)(1991-11#1)(1991-9#1)(2012-2#1)
the retinoic acid receptor##7##4##(1990-9#1)(1991-11#1)(1991-9#1)(1992-8#1)(1996-8#1)(2005-11#1)(2012-2#1)
the retinoic acid##11##3##(1990-11#1)(1990-9#1)(1991-11#1)(1991-9#1)(1992-8#1)(1995-11#1)(1996-8#1)(2005-11#1)(2010-3#1)(2012-2#1)(2013-1#1)
the retinoic##12##2##(1990-11#1)(1990-9#1)(1991-11#1)(1991-9#1)(1992-8#1)(1995-11#1)(1996-4#1)(1996-8#1)(2005-11#1)(2010-3#1)(2012-2#1)(2013-1#1)
the retinoid X receptor (RXR)##3##5##(1995-10#1)(1995-3#1)(1996-8#1)
the retinoid X receptor##5##4##(1995-10#2)(1995-3#1)(1995-8#1)(1996-8#1)
the retinoid X##7##3##(1994-8#1)(1994-9#1)(1995-10#2)(1995-3#1)(1995-8#1)(1996-8#1)
the retinoid##11##2##(1994-12#1)(1994-8#1)(1994-9#1)(1995-10#2)(1995-3#2)(1995-8#1)(1996-8#1)(2008-5#1)(2012-2#1)
the retinol deficient group##4##4##(1994-8#4)
the retinol deficient##5##3##(1994-8#5)
the retirement##3##2##(1994-1#1)(2007-4#1)(2009-12#1)
the retraction of##2##3##(1995-12#1)(2013-7#1)
the retraction##4##2##(1995-12#1)(2007-1#1)(2008-8#1)(2013-7#1)
the retractor##2##2##(1991-3#1)(2007-4#1)
the retrieval algorithm##5##3##(2007-12#1)(2008-2#3)(2008-3#1)
the retrieval error##2##3##(2008-3#2)
the retrieval of aerosol##2##4##(2008-2#1)(2008-3#1)
the retrieval of marine constituents in##2##6##(2008-2#2)
the retrieval of such##2##4##(2008-11#1)(2008-3#1)
the retrieval of the##4##4##(2007-12#1)(2008-2#3)
the retrieval of##38##3##(1991-8#1)(1995-3#1)(2007-12#5)(2007-7#1)(2008-11#1)(2008-2#13)(2008-3#9)(2008-4#2)(2008-9#1)(2009-2#1)(2010-8#1)(2013-1#2)
the retrieval procedure##2##3##(2008-2#1)(2008-3#1)
the retrieval##62##2##(1991-8#1)(1995-3#1)(2007-12#7)(2007-7#1)(2008-11#1)(2008-2#21)(2008-3#22)(2008-4#2)(2008-9#1)(2009-2#1)(2010-8#1)(2013-1#2)(2013-8#1)
the retrieved aerosol##3##3##(2008-2#1)(2008-3#2)
the retrieved phase##2##3##(2008-2#1)(2008-3#1)
the retrieved pulse##2##3##(2007-12#2)
the retrieved##33##2##(2005-11#1)(2007-12#4)(2008-2#8)(2008-3#17)(2008-8#2)(2010-9#1)
the retrocerebral complex##3##3##(1997-8#3)
the retrofacial nucleus##3##3##(1990-7#1)(1993-12#1)(1997-7#1)
the retrograde cannula##3##3##(2007-8#3)
the retrograde tracer Fluoro-Gold##2##4##(1990-11#1)(1994-2#1)
the retrograde tracer##5##3##(1990-11#1)(1992-12#1)(1994-2#1)(1995-6#1)(2010-10#1)
the retrograde transport of horseradish peroxidase##2##6##(1990-7#1)(1997-2#1)
the retrograde##18##2##(1990-11#1)(1990-7#1)(1992-12#1)(1993-7#1)(1994-12#1)(1994-2#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#1)(1997-2#1)(2007-8#4)(2009-2#1)(2009-8#1)(2010-10#1)
the retromer##3##2##(2012-12#3)
the retropatellar##2##2##(2008-9#2)
the retroperitoneal approach##4##3##(1992-8#3)(2008-10#1)
the retroperitoneal cavity##2##3##(2012-12#1)(2012-3#1)
the retroperitoneal space is##3##4##(2006-6#1)(2008-10#1)(2008-8#1)
the retroperitoneal space##4##3##(2006-6#1)(2008-10#1)(2008-8#1)(2013-1#1)
the retroperitoneal##13##2##(1992-8#3)(2006-6#2)(2008-10#2)(2008-6#1)(2008-8#1)(2012-12#1)(2012-3#2)(2013-1#1)
the retroperitoneum##15##2##(1992-12#1)(2007-2#1)(2008-6#3)(2009-1#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-12#2)(2012-3#3)(2013-1#1)
the retropubic##2##2##(1996-12#2)
the retrosigmoid##2##2##(2006-11#1)(2006-12#1)
the retrospective part and##2##4##(2006-10#2)
the retrospective part##3##3##(2006-10#3)
the retrospective##15##2##(1995-2#1)(1996-11#1)(1997-7#1)(2006-10#3)(2006-2#1)(2007-1#1)(2008-11#1)(2012-2#3)(2012-3#2)(2013-8#1)
the retrosplenial##2##2##(1992-3#1)(2009-4#1)
the retroviral Rev/RRE##2##3##(2006-12#2)
the retroviral vector##2##3##(1996-10#1)(2008-9#1)
the retroviral##13##2##(1990-2#1)(1990-5#1)(1991-12#1)(1994-6#1)(1995-2#1)(1996-10#1)(2006-12#2)(2007-7#1)(2008-11#3)(2008-9#1)
the retrovirus##4##2##(2008-11#2)(2008-5#1)(2009-6#1)
the return of the##5##4##(1997-3#1)(2007-12#1)(2008-8#1)(2013-1#2)
the return of##11##3##(1991-10#1)(1991-12#1)(1995-1#2)(1997-3#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-8#1)(2013-1#2)
the return on##3##3##(1995-12#1)(2007-4#1)(2008-7#1)
the return to##2##3##(1990-9#1)(2012-1#1)
the return##28##2##(1990-9#1)(1991-10#1)(1991-12#1)(1992-1#1)(1995-1#2)(1995-12#1)(1995-2#1)(1997-3#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-2#4)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-5#1)(2012-1#1)(2013-1#2)
the returned traveller##2##3##(1994-7#1)(2007-2#1)
the returned##3##2##(1994-7#1)(2007-2#1)(2010-5#1)
the returning traveler##2##3##(2010-12#2)
the returning##4##2##(2007-2#2)(2010-12#2)
the returns##2##2##(1994-2#1)(2010-12#1)
the reuptake of##2##3##(1994-3#1)(2012-3#1)
the reusability of the##2##4##(2008-10#1)(2010-4#1)
the reusability##3##2##(2008-1#1)(2008-10#1)(2010-4#1)
the reuse of##6##3##(2006-10#1)(2008-1#2)(2010-5#1)(2012-2#2)
the revealing##2##2##(1997-6#1)(2008-4#1)
the revenue##4##2##(1992-1#1)(1992-12#1)(2007-5#1)(2007-9#1)
the reverberation##2##2##(2008-11#2)
the reversal of arrest##2##4##(2006-5#2)
the reversal of the##2##4##(1994-9#1)(2007-11#1)
the reversal of tolerance##2##4##(1996-2#2)
the reversal of##19##3##(1991-4#1)(1992-6#1)(1993-9#1)(1994-9#1)(1996-10#1)(1996-2#2)(1996-7#1)(1996-8#1)(2006-5#2)(2006-8#1)(2007-11#1)(2009-10#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#2)
the reversal potential and##2##4##(1991-9#1)(1994-2#1)
the reversal potential of##2##4##(1995-6#2)
the reversal potential##10##3##(1991-3#1)(1991-8#1)(1991-9#1)(1992-7#1)(1994-2#2)(1995-6#2)(1996-1#1)(1996-9#1)
the reversal##34##2##(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-6#1)(1992-7#1)(1993-9#1)(1994-2#3)(1994-9#1)(1995-6#2)(1996-1#1)(1996-10#1)(1996-2#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-5#1)(2004-11#1)(2005-11#1)(2006-5#2)(2006-8#1)(2007-11#1)(2008-3#1)(2009-10#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#2)
the reverse effect##2##3##(1990-9#1)(2011-2#1)
the reverse flow##3##3##(1992-5#1)(2006-4#1)(2008-10#1)
the reverse is true##3##4##(1991-5#1)(1991-9#1)(1996-5#1)
the reverse of the##4##4##(1990-2#1)(1992-6#1)(2007-11#1)(2010-7#1)
the reverse of##5##3##(1990-2#1)(1992-6#1)(2007-11#1)(2010-7#1)(2011-2#1)
the reverse reaction##4##3##(1991-5#1)(1995-6#1)(2006-10#1)(2008-3#1)
the reverse transcriptase (RT)##2##4##(1997-1#1)(2013-1#1)
the reverse transcriptase inhibitor lamivudine##2##5##(1996-4#1)(2007-11#1)
the reverse transcriptase polymerase chain reaction##2##6##(1993-9#1)(1995-5#1)
the reverse transcriptase##12##3##(1991-12#1)(1993-9#3)(1994-12#1)(1995-5#1)(1996-4#1)(1997-1#1)(2007-11#1)(2008-1#1)(2009-11#1)(2013-1#1)
the reverse transcriptase-polymerase chain reaction##2##5##(1994-2#1)(1994-9#1)
the reverse transcription and##2##4##(1993-7#1)(2008-4#1)
the reverse transcription polymerase chain reaction (RT-PCR)##3##7##(2007-10#1)(2008-5#1)(2008-7#1)
the reverse transcription polymerase chain reaction##4##6##(1997-7#1)(2007-10#1)(2008-5#1)(2008-7#1)
the reverse transcription reaction##3##4##(1994-12#2)(1997-2#1)
the reverse transcription##10##3##(1993-7#1)(1994-12#2)(1996-4#1)(1997-2#1)(1997-7#1)(2007-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
the reverse transcription-polymerase chain reaction##2##5##(1994-12#1)(1996-1#1)
the reverse transport##2##3##(1991-7#1)(2012-12#1)
the reverse was##2##3##(1996-6#1)(2009-7#1)
the reverse##93##2##(1990-11#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1993-2#1)(1993-7#1)(1993-9#3)(1994-12#4)(1994-2#1)(1994-9#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-4#3)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(1997-9#1)(2005-11#1)(2006-10#1)(2006-4#2)(2007-10#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
the reverse-transcription polymerase chain reaction##3##5##(1994-8#1)(2005-9#1)(2008-5#1)
the reversed##5##2##(2005-11#1)(2006-12#1)(2008-10#1)(2008-8#2)
the reversed-phase##8##2##(1990-2#1)(2008-10#6)(2013-8#1)
the reversibility of the sensor##2##5##(2008-10#2)
the reversibility of the##5##4##(2006-12#1)(2008-10#4)
the reversibility of##8##3##(1990-5#1)(1993-6#1)(2006-12#1)(2007-2#1)(2008-10#4)
the reversibility##9##2##(1990-5#1)(1993-6#1)(2005-11#1)(2006-12#1)(2007-2#1)(2008-10#4)
the reversible conversion of##3##4##(1990-11#1)(1995-2#1)(2008-6#1)
the reversible formation of##2##4##(2009-10#1)(2010-12#1)
the reversible inhibition of##3##4##(1990-3#1)(1993-6#1)(2008-10#1)
the reversible monoamine oxidase-B##2##4##(1995-6#2)
the reversible##28##2##(1990-11#1)(1990-3#1)(1991-10#1)(1991-2#1)(1992-12#1)(1992-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-10#1)(1995-2#1)(1995-5#1)(1995-6#3)(1997-2#1)(1997-4#1)(2006-10#1)(2008-10#4)(2008-6#1)(2009-10#1)(2009-5#1)(2010-12#1)(2013-8#1)
the reversibly cross-linking##2##3##(2010-4#2)
the reversibly##4##2##(1997-1#1)(2008-10#1)(2010-4#2)
the review and##4##3##(1992-1#1)(2012-1#1)(2012-2#1)(2012-3#1)
the review deals with##2##4##(2007-2#1)(2008-11#1)
the review is##6##3##(1992-1#1)(2007-12#1)(2008-11#1)(2009-2#1)(2010-12#1)(2013-8#1)
the review of the literature##4##5##(2007-11#1)(2007-6#1)(2010-12#1)(2013-1#1)
the review of the recent literature##2##6##(1990-6#1)(2007-7#1)
the review of the##9##4##(1990-6#1)(2007-11#2)(2007-6#1)(2007-7#1)(2008-7#1)(2010-12#1)(2010-2#1)(2013-1#1)
the review of these##2##4##(2008-12#1)(2012-1#1)
the review of##28##3##(1990-6#1)(1991-2#1)(1991-6#1)(2006-2#1)(2007-11#3)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-4#1)(2009-5#2)(2010-12#1)(2010-2#1)(2010-7#1)(2012-1#1)(2013-1#1)
the review period##4##3##(2006-10#4)
the review presents##2##3##(2009-4#1)(2011-1#1)
the review process##3##3##(1992-1#1)(2006-1#1)(2012-3#1)
the review shows##2##3##(2006-9#1)(2010-4#1)
the review were##2##3##(1991-2#1)(2013-1#1)
the review will##3##3##(2008-1#1)(2008-11#1)(2012-3#1)
the review##94##2##(1990-6#1)(1991-10#1)(1991-2#2)(1991-6#1)(1992-1#3)(1994-3#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-7#1)(1997-7#1)(2005-7#1)(2006-1#1)(2006-10#4)(2006-2#1)(2006-8#1)(2006-9#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#3)(2008-11#10)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-11#1)(2009-2#2)(2009-4#2)(2009-5#3)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#2)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#2)(2013-8#4)
the reviewed data##2##3##(2006-9#1)(2010-4#1)
the reviewed##5##2##(2006-9#1)(2008-4#1)(2008-7#1)(2010-4#1)(2011-1#1)
the reviewer##3##2##(1993-12#1)(2007-6#1)(2013-7#1)
the reviews and##2##3##(2006-10#1)(2006-8#1)
the reviews##4##2##(2005-3#1)(2006-10#1)(2006-8#1)(2011-2#1)
the revised European##2##3##(2010-11#1)(2011-2#1)
the revised scale##2##3##(2011-1#1)(2012-2#1)
the revised##31##2##(1992-1#2)(1992-2#2)(1993-6#2)(1994-2#1)(1995-12#1)(1997-1#1)(2006-2#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-3#2)(2008-9#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#2)(2010-5#2)(2011-1#2)(2011-2#1)(2012-2#2)(2013-8#1)
the revision of the##7##4##(1992-9#1)(1993-6#1)(2008-10#1)(2008-6#1)(2011-2#1)(2011-3#1)(2012-12#1)
the revision of##10##3##(1992-9#1)(1993-6#1)(2008-10#1)(2008-6#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
the revision##16##2##(1990-6#1)(1992-9#1)(1993-6#1)(2008-10#1)(2008-6#2)(2008-8#1)(2009-3#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#3)
the revisions##2##2##(1992-3#1)(2008-11#1)
the revolution##4##2##(1990-12#1)(2006-6#1)(2008-8#2)
the revolutionary##2##2##(2007-11#1)(2010-8#1)
the reward presentation##2##3##(2009-8#2)
the reward system##3##3##(2008-1#1)(2013-8#2)
the reward##11##2##(1993-2#1)(1993-6#1)(1997-6#2)(2008-1#1)(2009-5#1)(2009-8#2)(2010-10#1)(2013-8#2)
the rewarding effects of##2##4##(1991-1#1)(1992-9#1)
the rewarding properties of a##2##5##(1996-5#1)(2008-4#1)
the rewarding properties of##3##4##(1993-6#1)(1996-5#1)(2008-4#1)
the rewarding properties##4##3##(1993-6#1)(1996-5#1)(2008-4#2)
the rewarding##7##2##(1991-1#1)(1992-9#1)(1993-6#1)(1995-11#1)(1996-5#1)(2008-4#2)
the rewards of##2##3##(1995-12#1)(2013-1#1)
the rf##7##2##(2007-11#1)(2007-12#4)(2008-3#2)
the rhBMP-2##2##2##(2012-12#1)(2013-7#1)
the rhabdom##5##2##(2007-12#3)(2009-10#2)
the rhabdoms##3##2##(2007-12#3)
the rhamnose moiety of phosphoramidon##2##5##(1992-7#1)(1995-1#1)
the rhamnose##4##2##(1992-7#2)(1995-1#2)
the rheological behavior##2##3##(2008-5#2)
the rheological properties of##4##4##(1994-9#1)(2006-11#1)(2008-5#1)(2011-2#1)
the rheological properties##6##3##(1994-9#1)(2006-11#1)(2008-5#3)(2011-2#1)
the rheological##11##2##(1994-8#1)(1994-9#1)(2006-11#1)(2008-5#6)(2011-2#2)
the rheology of##3##3##(2008-5#3)
the rheology##4##2##(2008-5#4)
the rhesus monkey##5##3##(1991-1#1)(1993-5#1)(1994-9#1)(1996-10#1)(1996-5#1)
the rhesus##9##2##(1991-1#1)(1993-5#1)(1994-9#1)(1995-11#1)(1996-10#1)(1996-5#1)(2007-11#1)(2008-4#1)(2013-8#1)
the rhetoric##3##2##(1995-12#1)(2008-11#1)(2013-1#1)
the rheumatic diseases##4##3##(2008-8#3)(2012-1#1)
the rheumatic##8##2##(1990-12#1)(2006-10#1)(2008-1#1)(2008-8#4)(2012-1#1)
the rheumatoid arthritis##3##3##(1990-6#1)(1991-5#1)(2006-10#1)
the rheumatoid process##3##3##(2007-11#1)(2007-7#2)
the rheumatoid##14##2##(1990-6#1)(1991-5#1)(2006-10#1)(2006-4#2)(2007-11#3)(2007-6#1)(2007-7#2)(2007-8#1)(2010-3#1)(2010-7#1)
the rheumatologist##4##2##(1993-3#1)(1997-4#1)(1997-6#1)(2007-11#1)
the rheumatology##2##2##(2007-2#1)(2010-4#1)
the rhinal sulcus##2##3##(1990-10#1)(1994-8#1)
the rhinal##3##2##(1990-10#1)(1994-8#1)(1997-7#1)
the rhizomes of##4##3##(2007-1#2)(2008-11#1)(2013-1#1)
the rhizosphere abundance of##2##4##(2008-10#2)
the rhizosphere and non-rhizosphere soils##2##5##(2013-8#2)
the rhizosphere and##5##3##(2008-10#3)(2013-8#2)
the rhizosphere of apple##2##4##(2008-10#2)
the rhizosphere of crop plants##2##5##(2008-10#2)
the rhizosphere of wheat##4##4##(2008-10#4)
the rhizosphere of##16##3##(2008-10#15)(2008-2#1)
the rhizosphere populations of##2##4##(2008-10#2)
the rhizosphere soil and##2##4##(2008-10#2)
the rhizosphere soil##8##3##(2008-10#3)(2013-8#5)
the rhizosphere##46##2##(2007-3#1)(2008-10#33)(2008-12#2)(2008-2#2)(2009-8#1)(2013-8#7)
the rhizospheres of##4##3##(2008-10#4)
the rhizospheric microbial##2##3##(2013-8#2)
the rhizospheric##4##2##(2013-8#4)
the rhizotomy##4##2##(1995-7#4)
the rhizoxin site##3##3##(1991-7#3)
the rhizoxin##4##2##(1991-7#4)
the rho A component##2##4##(1994-11#2)
the rho A-rho GDI complex##2##5##(1994-11#2)
the rho proteins##5##3##(1991-2#4)(1992-12#1)
the rho##18##2##(1991-2#4)(1991-4#1)(1992-11#1)(1992-12#1)(1992-5#3)(1993-6#1)(1994-11#4)(1995-11#1)(1995-7#2)
the rho2##3##2##(2008-4#3)
the rhodopsin##5##2##(1994-11#1)(1995-1#2)(1995-10#1)(2012-3#1)
the rhynchobdellid leech Theromyzon tessulatum##2##5##(1996-5#2)
the rhythm of##4##3##(1992-3#1)(1994-5#1)(2012-2#2)
the rhythm reversal##2##3##(2008-6#2)
the rhythm##10##2##(1992-3#1)(1994-2#1)(1994-5#1)(2008-5#2)(2008-6#3)(2012-2#2)
the rhythmic bladder contractions##2##4##(1992-3#2)
the rhythmic##7##2##(1992-3#2)(1996-3#2)(1997-4#1)(2004-11#1)(2012-2#1)
the rib cage##2##3##(1996-2#1)(2007-4#1)
the rib hump##2##3##(2007-11#1)(2009-3#1)
the rib##10##2##(1996-2#1)(2007-11#1)(2007-4#1)(2007-8#2)(2009-3#1)(2010-2#2)(2013-1#2)
the ribbon-like structures##3##3##(1992-6#3)
the ribbon-like##6##2##(1992-6#5)(2008-10#1)
the ribo##3##2##(1995-3#2)(1996-6#1)
the riboflavin##3##2##(2008-9#2)(2012-3#1)
the ribonuclease H domain##2##4##(1992-9#1)(2008-10#1)
the ribonuclease H##4##3##(1990-2#2)(1992-9#1)(2008-10#1)
the ribonuclease##7##2##(1990-2#2)(1991-4#1)(1992-12#1)(1992-9#1)(1996-5#1)(2008-10#1)
the ribonucleoprotein##5##2##(1995-2#2)(1995-3#1)(2012-12#2)
the ribonucleoside##2##2##(1990-2#1)(2010-11#1)
the ribose moiety##5##3##(1992-11#1)(1992-9#1)(1994-9#1)(1995-3#1)(1995-8#1)
the ribose##14##2##(1990-5#1)(1992-11#1)(1992-9#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-8#3)(1996-5#1)(1996-7#1)(2008-4#2)
the ribosomal A-site##4##3##(1992-8#1)(2009-4#3)
the ribosomal DNA (rDNA)##3##4##(1991-8#1)(2008-10#2)
the ribosomal DNA##12##3##(1991-8#2)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#6)(2012-2#1)
the ribosomal RNA genes##2##4##(2008-10#1)(2008-5#1)
the ribosomal RNA##5##3##(2006-12#1)(2008-10#2)(2008-5#2)
the ribosomal gene promoter##2##4##(1991-11#1)(1997-6#1)
the ribosomal protein##5##3##(1996-11#1)(1997-2#1)(2008-11#1)(2008-8#1)(2012-12#1)
the ribosomal proteins##4##3##(1995-2#1)(1997-4#1)(2005-10#1)(2006-12#1)
the ribosomal##43##2##(1990-5#2)(1991-11#1)(1991-8#2)(1992-8#1)(1994-12#1)(1995-2#2)(1996-11#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-10#1)(2006-12#3)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#12)(2008-11#1)(2008-5#2)(2008-8#1)(2009-4#3)(2010-8#1)(2012-12#1)(2012-2#1)
the ribosome as a##2##4##(2006-10#1)(2006-12#1)
the ribosome as##3##3##(1990-2#1)(2006-10#1)(2006-12#1)
the ribosome binding##2##3##(1992-12#1)(2010-6#1)
the ribosome##34##2##(1990-2#3)(1992-12#1)(1992-2#1)(1992-6#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-4#1)(1997-2#1)(1997-7#1)(2005-10#2)(2005-7#2)(2006-10#1)(2006-11#2)(2006-12#5)(2007-12#3)(2008-11#1)(2008-7#1)(2009-9#1)(2010-12#1)(2010-6#1)(2012-1#1)
the ribosome-activated ATPase activity of EF-3##2##6##(1996-2#2)
the ribosome-binding site sequence##2##4##(1990-3#1)(1990-9#1)
the ribosome-binding site##3##3##(1990-3#1)(1990-9#1)(1993-9#1)
the ribosome-inactivating protein##2##3##(1991-2#2)
the ribosome-inactivating proteins##2##3##(1990-12#2)
the ribosome-inactivating##5##2##(1990-12#2)(1991-2#3)
the ribosomes##4##2##(1990-2#1)(1995-4#3)
the ribozyme activity##2##3##(1994-11#2)
the ribozyme gene##2##3##(1995-1#2)
the ribozyme##22##2##(1992-7#1)(1993-9#3)(1994-11#6)(1994-9#2)(1995-1#2)(1995-6#2)(1997-6#1)(2004-1#1)(2006-11#1)(2008-3#1)(2008-9#2)
the ribs and##2##3##(2006-11#1)(2007-11#1)
the ribs##8##2##(1991-11#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-11#1)(2010-12#1)(2013-1#2)
the rice blast fungus##4##4##(2008-10#4)
the rice blast##5##3##(2008-10#5)
the rice cultivar##2##3##(2008-10#2)
the rice genome##15##3##(1996-8#2)(1997-2#1)(2006-11#1)(2006-12#1)(2008-10#1)(2008-8#1)(2008-9#4)(2009-10#3)(2012-2#1)
the rice##41##2##(1996-8#2)(1997-2#1)(2005-8#1)(2006-11#1)(2006-12#2)(2007-6#1)(2008-10#12)(2008-8#3)(2008-9#11)(2009-10#5)(2012-1#1)(2012-2#1)
the rich##16##2##(1991-8#1)(1992-12#1)(2004-8#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-11#1)(2010-5#1)(2011-2#2)(2012-12#1)
the richest##5##2##(2007-1#1)(2008-10#1)(2008-12#1)(2010-5#1)(2011-3#1)
the richness and complexity of##2##5##(2006-1#1)(2008-12#1)
the richness of human activities##2##5##(2008-5#2)
the richness of##3##3##(2008-5#2)(2009-10#1)
the richness##5##2##(2006-1#1)(2008-12#1)(2008-5#2)(2009-10#1)
the ricin##3##2##(1991-3#1)(1992-3#1)(2006-7#1)
the riders##2##2##(2012-12#2)
the ridge extraction##2##3##(2008-3#2)
the ridge##3##2##(2008-3#2)(2013-7#1)
the ridges and##2##3##(2008-2#1)(2008-5#1)
the ridges##5##2##(2008-2#4)(2008-5#1)
the right Fallopian tube##2##4##(2011-1#2)
the right IFG##2##3##(2009-1#1)(2013-1#1)
the right IJV##5##3##(2007-7#5)
the right MCA territory##2##4##(2007-10#1)(2008-12#1)
the right MCA##4##3##(2007-10#1)(2008-12#3)
the right adrenal gland##4##4##(2008-5#3)(2012-12#1)
the right adrenal##5##3##(2007-10#1)(2008-5#3)(2012-12#1)
the right and left eyes##2##5##(1997-2#1)(2006-9#1)
the right and left ventricles##3##5##(2007-8#1)(2012-1#2)
the right and left ventricular##3##5##(2007-8#2)(2012-1#1)
the right and left##26##4##(1996-2#1)(1996-5#1)(1997-2#1)(2005-10#3)(2006-9#1)(2007-8#3)(2008-10#1)(2008-4#1)(2008-5#1)(2009-4#2)(2010-6#1)(2012-1#6)(2012-12#1)(2012-2#1)(2013-1#2)
the right and the left##3##5##(1990-11#1)(2008-7#1)(2012-12#1)
the right and##35##3##(1990-11#1)(1993-11#1)(1995-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(2005-10#3)(2005-12#1)(2006-9#1)(2007-8#3)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#2)(2010-6#1)(2011-2#2)(2012-1#6)(2012-12#2)(2012-2#1)(2013-1#2)
the right anterior insula##3##4##(2008-11#3)
the right anterior temporal lobe##2##5##(2009-4#2)
the right anterior##6##3##(2008-11#3)(2008-8#1)(2009-4#2)
the right appendage##2##3##(2007-8#2)
the right approach##2##3##(1996-3#1)(2005-11#1)
the right arm of Saccharomyces cerevisiae chromosome VII##4##8##(1996-3#1)(1997-3#3)
the right arm of Saccharomyces cerevisiae chromosome##5##7##(1996-3#1)(1997-3#4)
the right arm of chromosome IX##2##6##(1995-6#2)
the right arm of chromosome VII##5##6##(1995-6#3)(1996-3#1)(1996-9#1)
the right arm of chromosome##14##5##(1990-12#1)(1995-4#1)(1995-6#6)(1995-9#1)(1996-3#1)(1996-6#3)(1996-9#1)
the right arm of##22##4##(1990-12#1)(1993-11#1)(1993-5#1)(1995-4#1)(1995-6#6)(1995-9#1)(1996-3#2)(1996-6#3)(1996-9#1)(1997-3#5)
the right arm##24##3##(1990-12#1)(1993-11#1)(1993-5#1)(1995-4#1)(1995-6#6)(1995-9#1)(1996-3#2)(1996-6#4)(1996-9#1)(1997-3#5)(2010-9#1)
the right atrial##7##3##(1990-12#2)(1997-1#2)(2007-8#2)(2007-9#1)
the right atrium and ventricle##3##5##(2008-11#1)(2010-8#1)(2012-3#1)
the right atrium and##9##4##(2007-8#4)(2008-11#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-1#1)
the right atrium##33##3##(1992-8#1)(1993-2#1)(1997-6#1)(2006-10#1)(2006-9#1)(2007-7#1)(2007-8#14)(2008-11#1)(2008-4#2)(2010-12#1)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-2#2)
the right axillary vein##2##4##(2012-12#2)
the right axillary##3##3##(2012-12#2)(2012-2#1)
the right balance##4##3##(1990-9#2)(2006-10#1)(2006-8#1)
the right bank of the##2##5##(2013-7#2)
the right breast##8##3##(1994-12#1)(1994-7#1)(1995-4#2)(1996-6#1)(2008-10#2)(2008-2#1)
the right carotid artery##3##4##(2006-2#1)(2006-4#1)(2011-1#1)
the right carotid sinus massage##2##5##(1993-12#2)
the right carotid##7##3##(1993-12#2)(1994-5#1)(2006-2#1)(2006-4#1)(2008-7#1)(2011-1#1)
the right cerebral hemisphere##5##4##(1997-1#1)(2011-1#2)(2013-8#2)
the right cheek##4##3##(2007-8#1)(2008-5#2)(2012-12#1)
the right choice of##4##4##(2007-11#1)(2007-8#1)(2009-5#1)(2013-1#1)
the right choice##6##3##(1993-1#1)(2007-11#1)(2007-8#1)(2007-9#1)(2009-5#1)(2013-1#1)
the right colon##7##3##(1990-4#2)(1991-6#1)(2006-7#1)(2006-8#2)(2012-2#1)
the right common carotid artery##2##5##(1997-7#1)(2010-12#1)
the right common iliac artery##2##5##(2006-6#1)(2007-7#1)
the right common##5##3##(1991-11#1)(1997-7#1)(2006-6#1)(2007-7#1)(2010-12#1)
the right coronary artery and the##2##6##(1990-3#1)(2008-4#1)
the right coronary artery##16##4##(1990-3#2)(1994-11#1)(1996-9#1)(2007-8#7)(2008-4#1)(2009-8#1)(2010-12#1)(2010-7#1)(2013-2#1)
the right coronary system##2##4##(2007-8#2)
the right coronary##21##3##(1990-3#2)(1991-3#1)(1994-11#1)(1996-9#1)(2005-12#1)(2007-8#10)(2008-4#1)(2009-8#1)(2010-12#1)(2010-7#1)(2013-2#1)
the right diagnosis##2##3##(2007-10#1)(2008-10#1)
the right diaphragm##2##3##(2009-8#1)(2010-5#1)
the right direction##5##3##(2006-2#1)(2006-6#1)(2010-3#1)(2010-8#1)(2012-12#1)
the right end of##5##4##(1995-4#1)(1995-6#1)(1995-8#1)(1997-5#2)
the right end##6##3##(1994-12#1)(1995-4#1)(1995-6#1)(1995-8#1)(1997-5#2)
the right external##2##3##(1996-9#1)(2013-7#1)
the right eye and##4##4##(2007-3#2)(2011-2#1)(2013-1#1)
the right eye seeing##2##4##(1994-2#2)
the right eye##22##3##(1994-2#5)(1994-8#1)(1996-2#1)(1997-2#1)(2007-3#3)(2009-8#1)(2011-1#3)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#2)
the right facet##2##3##(2007-4#2)
the right femoral##3##3##(1993-12#1)(2006-10#1)(2012-1#1)
the right femur##2##3##(2008-12#1)(2008-6#1)
the right flank##3##3##(2006-10#1)(2008-11#1)(2009-3#1)
the right foot that had##2##5##(2007-11#1)(2012-3#1)
the right foot##7##3##(2005-11#1)(2006-8#1)(2007-11#1)(2008-12#1)(2008-5#1)(2009-10#1)(2012-3#1)
the right frontal lobe##4##4##(1996-2#1)(2007-10#3)
the right frontal##5##3##(1996-2#1)(2007-10#3)(2008-7#1)
the right fusiform gyrus##3##4##(2009-4#3)
the right gastroepiploic artery##10##4##(1990-4#1)(1995-11#1)(2007-8#8)
the right half of##2##4##(2009-2#1)(2012-2#1)
the right half##3##3##(2008-4#1)(2009-2#1)(2012-2#1)
the right hand##7##3##(1990-11#1)(1995-12#1)(1997-3#1)(2007-7#1)(2008-11#1)(2008-7#1)(2013-7#1)
the right heart##2##3##(1993-5#1)(1997-1#1)
the right hemi-brain##2##3##(2008-7#2)
the right hemidiaphragm##4##3##(2009-2#2)(2012-1#1)(2012-12#1)
the right hemifield##2##3##(1996-1#1)(1996-5#1)
the right hemisphere in the##2##5##(1996-2#1)(2008-1#1)
the right hemisphere operates##2##4##(1993-9#2)
the right hemisphere##23##3##(1990-3#4)(1991-6#1)(1993-9#2)(1995-11#1)(1996-2#3)(1996-5#1)(1997-7#1)(1997-8#2)(2005-10#1)(2007-7#2)(2008-1#2)(2008-11#1)(2009-2#2)
the right hemithorax##2##3##(2007-12#1)(2009-2#1)
the right hepatic lobe##3##4##(2008-5#1)(2009-2#1)(2012-12#1)
the right hepatic##7##3##(1991-6#1)(1996-9#1)(2008-5#1)(2009-2#1)(2012-12#1)(2013-1#2)
the right horn##2##3##(2008-3#1)(2012-1#1)
the right in##9##3##(1994-2#1)(1995-12#1)(1995-3#1)(1996-10#1)(1997-5#1)(2004-12#1)(2005-12#1)(2008-4#1)(2009-5#1)
the right inferior##5##3##(1992-4#2)(2008-11#1)(2010-2#1)(2013-1#1)
the right insula##2##3##(2008-11#2)
the right internal carotid##5##4##(1996-9#1)(2006-2#1)(2006-4#2)(2009-2#1)
the right internal thoracic artery##2##5##(2007-8#2)
the right internal##9##3##(1996-9#1)(2006-2#1)(2006-4#2)(2006-6#1)(2007-8#2)(2009-2#1)(2012-3#1)
the right kidney##9##3##(1990-9#1)(1994-5#1)(2007-10#1)(2007-2#1)(2007-7#1)(2011-1#1)(2012-1#2)(2012-2#1)
the right knee##4##3##(2006-10#1)(2007-11#1)(2008-6#1)(2012-12#1)
the right lateral##2##3##(2011-2#1)(2012-3#1)
the right leg##2##3##(2006-6#1)(2007-12#1)
the right lobe and##3##4##(1990-4#1)(2008-5#1)(2009-9#1)
the right lobe of the liver##5##6##(1993-6#1)(2005-12#1)(2009-8#1)(2010-11#1)(2012-2#1)
the right lobe of the##6##5##(1993-6#1)(2005-12#1)(2009-8#1)(2010-11#1)(2010-12#1)(2012-2#1)
the right lobe of##8##4##(1993-6#1)(2005-12#1)(2006-2#1)(2008-12#1)(2009-8#1)(2010-11#1)(2010-12#1)(2012-2#1)
the right lobe##13##3##(1990-4#1)(1993-6#1)(2005-12#1)(2006-2#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2012-2#1)
the right lower limb##2##4##(1992-11#1)(2010-3#1)
the right lower lung##4##4##(2008-1#2)(2008-6#1)(2010-12#1)
the right lower##15##3##(1991-10#1)(1992-11#1)(1992-2#1)(2007-8#2)(2008-1#2)(2008-4#1)(2008-6#1)(2010-12#1)(2010-3#1)(2010-6#2)(2012-1#1)(2013-1#1)
the right lung##8##3##(1993-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2010-7#1)(2010-9#1)(2013-1#1)
the right main bronchus##3##4##(1990-12#1)(2007-8#2)
the right main##4##3##(1990-12#1)(2007-8#2)(2012-12#1)
the right masseter muscle##3##4##(2012-12#3)
the right medial malleolus##2##4##(2010-6#2)
the right medial##4##3##(1995-12#1)(2006-10#1)(2010-6#2)
the right middle cerebral artery##6##5##(1996-3#1)(2008-12#1)(2008-7#3)(2013-8#1)
the right middle lobe##3##4##(2008-1#2)(2013-8#1)
the right middle##15##3##(1996-2#1)(1996-3#2)(2008-1#3)(2008-12#2)(2008-7#3)(2013-1#2)(2013-8#2)
the right nasal cavity##2##4##(2007-7#1)(2012-2#1)
the right nasal##3##3##(2007-7#1)(2009-9#1)(2012-2#1)
the right occipital lobe##2##4##(2006-11#1)(2009-10#1)
the right of##6##3##(1990-12#1)(1994-12#1)(1995-12#1)(2006-3#1)(2008-4#1)(2009-5#1)
the right one##2##3##(2008-2#1)(2010-2#1)
the right or left insular cortex##2##6##(1995-11#2)
the right or left##4##4##(1995-11#2)(1996-6#1)(2013-8#1)
the right ovary##3##3##(1991-9#1)(2008-3#1)(2011-1#1)
the right patient##3##3##(1993-12#1)(2010-5#1)(2012-2#1)
the right place at the right##2##6##(1994-2#1)(2008-11#1)
the right place##3##3##(1994-2#1)(2008-11#1)(2008-2#1)
the right pleural##2##3##(2008-1#1)(2012-2#1)
the right posterior##4##3##(2006-10#1)(2007-12#1)(2008-12#1)(2008-5#1)
the right pulmonary##5##3##(1997-5#1)(2007-8#2)(2008-11#1)(2010-10#1)
the right question##2##3##(1994-12#1)(2009-4#1)
the right radial##2##3##(2008-11#1)(2011-2#1)
the right renal artery##3##4##(1991-6#1)(2007-7#2)
the right renal##4##3##(1991-6#1)(2007-7#2)(2008-1#1)
the right shoulder##4##3##(2006-10#1)(2007-1#1)(2013-1#2)
the right side and##5##4##(2007-7#1)(2007-8#1)(2008-7#2)(2012-2#1)
the right side of the neck and##2##7##(2007-8#1)(2011-2#1)
the right side of the##11##5##(1996-3#1)(2007-8#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#5)(2013-7#1)
the right side of##15##4##(1996-3#1)(2007-10#1)(2007-8#1)(2008-4#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-12#2)(2013-7#1)
the right side##45##3##(1991-6#1)(1992-10#1)(1995-12#1)(1996-3#1)(2006-7#1)(2007-10#2)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-2#1)(2009-6#2)(2009-9#1)(2010-4#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#2)(2013-7#2)(2013-8#2)
the right size##4##3##(1996-2#1)(2008-11#2)(2008-5#1)
the right sphenoparietal sinus##3##4##(1996-9#3)
the right subclavian artery##3##4##(2007-8#2)(2008-11#1)
the right subclavian##4##3##(2007-8#2)(2008-11#2)
the right superior bronchial trunk##2##5##(2007-8#2)
the right superior##7##3##(1996-7#1)(1996-9#1)(2007-8#3)(2009-1#1)(2013-8#1)
the right temporal lobe##4##4##(2007-12#1)(2007-9#1)(2008-5#1)(2008-9#1)
the right temporal##8##3##(2006-10#1)(2007-12#2)(2007-9#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-8#1)
the right thigh##5##3##(2006-1#1)(2007-6#1)(2007-7#2)(2012-3#1)
the right to be##2##4##(1990-5#1)(1991-6#1)
the right to decide##2##4##(1992-4#1)(2007-7#1)
the right to die##4##4##(1990-12#1)(1994-2#1)(1997-6#1)(2006-9#1)
the right to health##2##4##(2012-12#1)(2013-8#1)
the right to healthcare##2##4##(2008-9#2)
the right to refuse##2##4##(1990-11#1)(2006-5#1)
the right to##40##3##(1990-11#1)(1990-12#1)(1990-5#2)(1991-12#1)(1991-6#1)(1992-10#2)(1992-2#1)(1992-3#1)(1992-4#2)(1993-9#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-9#1)(1996-5#1)(1997-6#1)(2005-12#1)(2005-9#1)(2006-1#1)(2006-2#1)(2006-3#2)(2006-5#1)(2006-9#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-7#1)(2008-9#2)(2009-6#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
the right treatment##2##3##(2008-10#1)(2012-2#1)
the right type of##2##4##(1994-2#1)(1997-7#1)
the right types of##2##4##(1994-2#1)(2013-8#1)
the right upper extremity##2##4##(2005-1#1)(2010-9#1)
the right upper lobe##8##4##(1991-11#1)(2007-11#1)(2007-8#2)(2011-2#1)(2012-1#1)(2013-1#2)
the right upper lung##2##4##(2012-2#1)(2013-1#1)
the right upper##20##3##(1990-9#1)(1991-11#1)(2005-1#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-6#1)(2008-7#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#3)
the right ureteric##2##3##(2008-10#2)
the right uterine##2##3##(2007-12#1)(2008-3#1)
the right ventricle and##2##4##(2008-7#1)(2012-2#1)
the right ventricle in##4##4##(1997-1#1)(2008-10#1)(2008-11#1)(2009-10#1)
the right ventricle##21##3##(1995-12#1)(1997-1#2)(2005-1#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-7#2)(2009-10#1)(2009-12#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-7#1)
the right ventricular apex##2##4##(2006-9#2)
the right ventricular outflow tract##4##5##(1997-1#1)(2007-8#2)(2013-2#1)
the right ventricular##9##3##(1991-10#1)(1997-1#1)(2006-9#2)(2007-8#2)(2008-3#1)(2012-1#1)(2013-2#1)
the right##947##2##(1990-11#7)(1990-12#6)(1990-2#2)(1990-3#7)(1990-4#4)(1990-5#6)(1990-6#1)(1990-9#5)(1991-10#3)(1991-11#5)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#6)(1991-9#1)(1992-1#1)(1992-10#3)(1992-11#3)(1992-2#5)(1992-3#2)(1992-4#4)(1992-8#1)(1993-1#2)(1993-10#3)(1993-11#2)(1993-12#9)(1993-2#4)(1993-3#1)(1993-5#3)(1993-6#1)(1993-8#1)(1993-9#4)(1994-11#2)(1994-12#5)(1994-2#12)(1994-5#2)(1994-7#1)(1994-8#4)(1995-1#3)(1995-11#5)(1995-12#12)(1995-2#1)(1995-3#2)(1995-4#5)(1995-6#10)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#2)(1996-12#1)(1996-2#11)(1996-3#11)(1996-5#5)(1996-6#6)(1996-7#1)(1996-9#9)(1997-1#10)(1997-2#3)(1997-3#8)(1997-5#4)(1997-6#2)(1997-7#3)(1997-8#3)(2004-11#1)(2004-12#1)(2005-1#2)(2005-10#5)(2005-11#3)(2005-12#6)(2005-7#1)(2005-9#2)(2006-1#3)(2006-10#16)(2006-11#1)(2006-12#2)(2006-2#8)(2006-3#3)(2006-4#6)(2006-5#1)(2006-6#8)(2006-7#3)(2006-8#6)(2006-9#7)(2007-1#2)(2007-10#14)(2007-11#4)(2007-12#14)(2007-2#4)(2007-3#3)(2007-4#6)(2007-5#1)(2007-6#1)(2007-7#25)(2007-8#81)(2007-9#7)(2008-1#15)(2008-10#16)(2008-11#30)(2008-12#15)(2008-2#4)(2008-3#9)(2008-4#19)(2008-5#24)(2008-6#7)(2008-7#22)(2008-8#2)(2008-9#6)(2009-1#4)(2009-10#5)(2009-11#1)(2009-12#2)(2009-2#17)(2009-3#2)(2009-4#10)(2009-5#6)(2009-6#4)(2009-7#2)(2009-8#5)(2009-9#6)(2010-10#3)(2010-11#1)(2010-12#8)(2010-2#6)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#8)(2010-7#4)(2010-8#2)(2010-9#5)(2011-1#17)(2011-12#1)(2011-2#27)(2012-1#16)(2012-12#23)(2012-2#21)(2012-3#10)(2013-1#26)(2013-2#4)(2013-7#10)(2013-8#15)
the right-hand##2##2##(1992-2#1)(2007-12#1)
the right-handed##2##2##(1991-5#1)(2006-10#1)
the right-sided cyst##2##3##(2011-2#2)
the right-sided##3##2##(2006-10#1)(2011-2#2)
the righting##2##2##(1995-12#1)(2007-2#1)
the rightmost##2##2##(1992-2#1)(2008-3#1)
the rights and##6##3##(1994-3#1)(2005-11#1)(2005-5#1)(2007-11#1)(2008-12#1)(2010-8#1)
the rights of##10##3##(1990-12#1)(2005-7#1)(2005-8#1)(2006-3#1)(2008-11#1)(2008-7#3)(2009-11#1)(2012-3#1)
the rights to##4##3##(2005-7#1)(2005-8#1)(2005-9#1)(2007-11#1)
the rights##23##2##(1990-12#1)(1991-2#1)(1992-3#1)(1993-9#1)(1994-3#1)(2005-11#1)(2005-5#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-3#1)(2007-11#2)(2008-11#1)(2008-12#1)(2008-7#3)(2009-11#1)(2010-8#1)(2012-3#1)
the rightward##3##2##(1990-10#1)(1995-12#1)(2009-10#1)
the rigid probe##4##3##(2007-10#4)
the rigid##9##2##(1990-2#1)(2006-11#1)(2007-10#4)(2007-4#1)(2009-7#1)(2012-12#1)
the rigidity of the membrane##2##5##(2005-11#2)
the rigidity of the##7##4##(1995-1#1)(2005-11#2)(2007-11#1)(2008-10#1)(2008-11#1)(2009-4#1)
the rigidity of##10##3##(1995-1#1)(2005-11#2)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#2)(2009-4#1)
the rigidity##11##2##(1995-1#1)(2005-11#2)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#3)(2009-4#1)
the rigor lead##2##3##(1996-11#2)
the rigor##9##2##(1994-11#1)(1994-5#1)(1995-6#3)(1996-11#3)(1996-5#1)
the rigorous coupled-wave analysis##4##4##(2008-2#4)
the rigorous##16##2##(1991-8#1)(1993-3#1)(1996-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-2#5)(2008-3#1)(2008-4#1)(2009-6#1)
the rigors of##2##3##(2005-9#1)(2008-1#1)
the rigors##3##2##(1995-12#1)(2005-9#1)(2008-1#1)
the rim of the##5##4##(1990-3#1)(1994-11#1)(1996-9#1)(1997-1#1)(2006-11#1)
the rim##8##2##(1990-3#1)(1994-11#1)(1996-9#1)(1997-1#1)(1997-5#1)(2006-11#1)(2008-11#1)(2008-2#1)
the ring contraction of##2##4##(2007-10#2)
the ring finger##2##3##(2006-8#1)(2010-9#1)
the ring patterns##2##3##(2008-2#2)
the ring portion of##2##4##(1992-3#1)(1995-11#1)
the ring portion##4##3##(1991-5#1)(1992-3#2)(1995-11#1)
the ring resonator##3##3##(2007-11#2)(2011-1#1)
the ring sinus##2##3##(2011-2#2)
the ring system##2##3##(1993-12#2)
the ring##55##2##(1991-10#1)(1991-5#1)(1991-8#2)(1992-3#2)(1992-5#1)(1993-12#2)(1994-12#1)(1994-9#1)(1995-10#1)(1995-11#1)(1996-2#1)(1997-3#1)(2005-11#1)(2006-12#3)(2006-4#1)(2006-8#1)(2007-10#2)(2007-11#7)(2008-1#1)(2008-10#1)(2008-2#7)(2008-3#1)(2008-5#1)(2009-10#1)(2010-12#3)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-2#2)(2012-2#1)
the ring-contracted##2##2##(1992-3#2)
the ring-disk##2##2##(2008-10#2)
the ring-hydroxylase##2##2##(1993-6#2)
the ring-opening##2##2##(1990-9#1)(2010-4#1)
the rings##2##2##(2007-11#1)(2008-4#1)
the rinse##2##2##(1997-6#1)(2012-12#1)
the ripening##7##2##(1990-4#2)(2005-11#1)(2008-10#1)(2008-12#3)
the rise and fall of##3##5##(2006-8#1)(2008-10#1)(2010-7#1)
the rise and##7##3##(2006-1#1)(2006-8#1)(2008-10#1)(2008-7#1)(2010-7#1)(2013-1#2)
the rise in [Ca2+] induced by##2##6##(1991-6#2)
the rise in cytosolic calcium##2##5##(1990-9#1)(1992-4#1)
the rise in cytosolic##3##4##(1990-9#1)(1992-4#1)(1995-12#1)
the rise in incidence##2##4##(1991-12#1)(1995-2#1)
the rise in intracellular Ca2+##2##5##(1994-2#2)
the rise in intracellular calcium##2##5##(1990-9#1)(2007-9#1)
the rise in intracellular##6##4##(1990-3#1)(1990-9#1)(1991-1#1)(1994-2#2)(2007-9#1)
the rise in plasma##2##4##(1991-2#1)(2011-2#1)
the rise in serum##2##4##(1995-12#1)(1996-10#1)
the rise in temperature##2##4##(2008-2#1)(2008-3#1)
the rise in the##5##4##(1997-8#1)(2010-9#1)(2011-1#1)(2012-1#1)(2013-8#1)
the rise in##41##3##(1990-12#1)(1990-3#1)(1990-7#2)(1990-9#2)(1991-1#1)(1991-12#2)(1991-2#2)(1991-6#3)(1992-1#1)(1992-2#1)(1992-4#1)(1993-3#1)(1994-2#2)(1995-10#1)(1995-12#3)(1995-2#1)(1996-10#1)(1997-8#1)(2007-10#1)(2007-9#1)(2008-11#2)(2008-2#1)(2008-3#1)(2009-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2013-8#1)
the rise is##2##3##(1996-7#1)(2005-11#1)
the rise of the##5##4##(1997-4#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
the rise of##23##3##(1990-5#1)(1991-11#1)(1993-9#1)(1994-2#2)(1995-10#1)(1997-4#1)(2005-11#2)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-1#2)(2012-2#1)
the rise was##3##3##(1992-4#1)(1993-2#1)(2008-5#1)
the rise##97##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-6#3)(1992-1#1)(1992-2#1)(1992-4#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-1#1)(1994-2#5)(1995-10#2)(1995-12#4)(1995-2#1)(1996-10#1)(1996-7#1)(1997-4#1)(1997-8#1)(2005-11#3)(2005-8#1)(2006-1#1)(2006-10#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#5)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-4#2)(2010-11#1)(2010-12#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
the rises in##2##3##(1990-3#1)(1990-4#1)
the rising costs of health##2##5##(2007-12#1)(2007-2#1)
the rising costs of##3##4##(2007-12#1)(2007-2#1)(2012-3#1)
the rising incidence of##5##4##(1992-2#1)(2006-10#2)(2009-3#1)(2012-12#1)
the rising##17##2##(1992-2#1)(2005-11#1)(2006-10#3)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2009-3#1)(2009-5#2)(2010-9#1)(2011-12#1)(2012-12#1)(2012-3#1)
the risk analysis##6##3##(2005-5#1)(2007-4#1)(2008-10#1)(2008-3#1)(2012-2#2)
the risk and##9##3##(2004-2#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-7#1)(2009-6#1)(2012-12#1)(2013-1#1)
the risk assessment##6##3##(1997-4#1)(2005-3#1)(2008-10#1)(2008-11#2)(2008-5#1)
the risk associated with##2##4##(2008-10#1)(2008-3#1)
the risk behaviours##2##3##(2010-12#2)
the risk benefit##2##3##(2008-4#1)(2009-12#1)
the risk by##2##3##(1991-5#1)(1992-2#1)
the risk difference##2##3##(1996-7#1)(2008-11#1)
the risk factor of##2##4##(1994-12#1)(2011-1#1)
the risk factor##8##3##(1991-6#1)(1992-11#1)(1994-12#1)(2008-5#1)(2008-7#1)(2011-1#2)(2011-2#1)
the risk factors and##9##4##(1993-2#1)(2006-10#2)(2007-9#1)(2008-1#1)(2008-8#1)(2009-7#1)(2010-6#1)(2012-3#1)
the risk factors associated with##11##5##(1994-8#1)(1996-2#1)(2007-8#1)(2008-1#1)(2008-3#2)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
the risk factors for cardiovascular disease##2##6##(1991-12#1)(2012-2#1)
the risk factors for cardiovascular##3##5##(1991-12#1)(2004-11#1)(2012-2#1)
the risk factors for stroke in##2##6##(2007-10#1)(2007-9#1)
the risk factors for##24##4##(1991-12#1)(1993-12#1)(1996-2#1)(1997-4#1)(2004-11#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-10#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)
the risk factors in##2##4##(1996-2#1)(2011-2#1)
the risk factors of##11##4##(2007-11#1)(2011-1#1)(2012-2#1)(2013-8#8)
the risk factors related to##2##5##(2005-12#1)(2011-1#1)
the risk factors that##2##4##(2005-11#1)(2013-1#1)
the risk factors to##2##4##(2006-2#1)(2013-1#1)
the risk factors##100##3##(1990-6#1)(1990-9#1)(1991-12#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-8#1)(1995-12#1)(1996-2#3)(1997-3#1)(1997-4#1)(2004-11#1)(2005-11#1)(2005-12#1)(2006-10#3)(2006-2#1)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#1)(2008-11#3)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-7#2)(2010-10#1)(2010-6#1)(2010-9#2)(2011-1#9)(2011-2#7)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#13)
the risk for VAPP##2##4##(2004-12#2)
the risk for a##2##4##(1997-8#1)(2008-10#1)
the risk for developing##3##4##(2009-8#1)(2010-8#1)(2013-1#1)
the risk for development of##2##5##(2005-11#1)(2006-6#1)
the risk for patients##2##4##(2007-7#1)(2008-12#1)
the risk for relapse##2##4##(2007-5#2)
the risk for such##2##4##(2006-6#1)(2009-3#1)
the risk for##65##3##(1992-4#1)(1993-8#1)(1994-6#1)(1995-10#1)(1995-9#1)(1996-12#1)(1996-4#1)(1997-1#2)(1997-5#1)(1997-8#2)(2004-11#1)(2004-12#3)(2005-10#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-6#2)(2007-11#1)(2007-12#1)(2007-5#2)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-3#2)(2009-8#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#1)(2012-2#5)(2013-1#4)(2013-7#1)
the risk group and##2##4##(2011-2#1)(2012-12#1)
the risk group##7##3##(1992-9#1)(1997-6#1)(2008-5#1)(2011-2#2)(2012-12#2)
the risk groups##5##3##(1990-9#1)(2007-11#2)(2008-7#1)(2011-2#1)
the risk in the##2##4##(2008-8#1)(2011-2#1)
the risk in##7##3##(1990-6#1)(1992-3#1)(1995-12#1)(2005-10#1)(2008-8#1)(2010-12#1)(2011-2#1)
the risk increasing##2##3##(1995-8#1)(2013-8#1)
the risk is##14##3##(1990-11#1)(1996-11#1)(2007-11#1)(2007-12#3)(2007-4#1)(2008-2#1)(2008-9#1)(2010-12#1)(2010-7#1)(2011-1#1)(2013-1#2)
the risk levels##2##3##(1997-8#1)(2011-2#1)
the risk management##3##3##(2011-2#1)(2012-11#2)
the risk manager should##2##4##(1992-2#1)(1994-1#1)
the risk manager##6##3##(1992-2#2)(1993-2#2)(1994-1#2)
the risk manager's role##3##4##(1992-12#1)(1995-1#1)(1996-1#1)
the risk manager's##5##3##(1990-12#2)(1992-12#1)(1995-1#1)(1996-1#1)
the risk may be##2##4##(1993-12#1)(2007-2#1)
the risk model##2##3##(2007-8#1)(2010-6#1)
the risk of AIS &gt##2##5##(2007-4#2)
the risk of CVD##3##4##(2008-3#1)(2008-6#1)(2011-2#1)
the risk of HBV##2##4##(2009-12#1)(2013-8#1)
the risk of HCC in patients##2##6##(2006-10#1)(2008-11#1)
the risk of HCC in##3##5##(2006-10#1)(2008-11#2)
the risk of HCC##4##4##(2006-10#1)(2008-11#2)(2010-12#1)
the risk of HIV infection##4##5##(1991-2#1)(1995-6#1)(2004-9#1)(2012-12#1)
the risk of HIV transmission##5##5##(1995-6#2)(2007-11#1)(2009-7#1)(2012-12#1)
the risk of HIV##10##4##(1991-2#1)(1995-6#3)(2004-9#1)(2007-11#1)(2009-7#1)(2010-8#1)(2012-12#2)
the risk of NSAID-related gastrointestinal bleeding##2##6##(2006-10#2)
the risk of PD##2##4##(2008-12#1)(2010-10#1)
the risk of PIH##2##4##(1994-3#2)
the risk of Parkinson's disease##3##5##(2008-7#1)(2008-8#1)(2010-10#1)
the risk of a##14##4##(1992-2#1)(1992-3#1)(1993-11#1)(1993-2#1)(1996-12#1)(2008-10#1)(2008-4#2)(2008-5#1)(2010-2#2)(2010-9#1)(2012-2#1)(2013-1#1)
the risk of acquiring##4##4##(2006-10#1)(2007-2#1)(2007-6#1)(2012-11#1)
the risk of acute##2##4##(2007-8#1)(2013-1#1)
the risk of adverse effects##3##5##(2007-11#1)(2009-6#2)
the risk of adverse pregnancy##2##5##(2011-2#2)
the risk of adverse reactions##4##5##(1991-9#1)(1996-3#1)(1997-5#1)(2008-8#1)
the risk of adverse##14##4##(1991-11#1)(1991-9#1)(1996-3#1)(1997-5#1)(2005-8#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-8#1)(2009-6#2)(2010-6#1)(2011-2#2)
the risk of an##4##4##(1994-3#1)(2008-4#1)(2010-8#1)(2013-1#1)
the risk of arterial##2##4##(2007-12#2)
the risk of atherosclerosis##3##4##(2008-1#1)(2008-6#2)
the risk of bacterial##3##4##(2006-2#1)(2006-8#1)(2007-5#1)
the risk of being##4##4##(1993-8#1)(2008-2#1)(2012-12#1)(2013-7#1)
the risk of bias##3##4##(2008-5#1)(2012-2#1)(2013-1#1)
the risk of bleeding##6##4##(2006-10#1)(2006-6#1)(2008-1#1)(2010-12#1)(2010-8#1)(2013-1#1)
the risk of blood group##2##5##(1992-12#2)
the risk of both##2##4##(2009-9#1)(2010-9#1)
the risk of bovine spongiform encephalopathy (BSE)##2##7##(2011-2#2)
the risk of breast cancer in##2##6##(1991-4#1)(2008-3#1)
the risk of breast cancer##10##5##(1991-4#1)(1991-5#1)(1991-7#3)(1994-2#1)(2008-10#1)(2008-3#1)(2009-12#1)(2009-4#1)
the risk of breast##12##4##(1991-4#1)(1991-5#1)(1991-7#3)(1994-2#1)(2008-10#1)(2008-3#1)(2009-12#1)(2009-4#1)(2013-1#2)
the risk of cancer induction##2##5##(2008-7#1)(2012-2#1)
the risk of cancer##14##4##(1990-8#1)(1993-10#1)(1994-2#1)(1997-2#1)(2008-11#1)(2008-7#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-6#1)(2013-1#2)
the risk of cardiac##2##4##(2008-1#1)(2009-5#1)
the risk of cardiovascular disease##9##5##(1991-12#1)(1993-11#1)(1993-6#1)(2005-10#1)(2006-12#1)(2006-6#1)(2008-1#1)(2008-4#1)(2012-2#1)
the risk of cardiovascular events##3##5##(2006-10#1)(2008-3#1)(2011-11#1)
the risk of cardiovascular##15##4##(1991-12#1)(1993-11#1)(1993-6#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-6#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-11#1)(2012-2#1)(2013-8#2)
the risk of cerebral##4##4##(1991-11#1)(2007-8#1)(2008-7#1)(2013-1#1)
the risk of chronic disease##2##5##(2006-10#1)(2008-5#1)
the risk of chronic diseases##4##5##(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)
the risk of chronic##9##4##(1991-4#1)(2006-10#1)(2007-11#1)(2008-5#1)(2009-11#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)
the risk of colorectal cancer##5##5##(1993-9#2)(2006-10#1)(2009-8#1)(2013-1#1)
the risk of complications and##2##5##(2007-8#1)(2011-2#1)
the risk of complications in##2##5##(1990-11#1)(2008-5#1)
the risk of complications##12##4##(1990-11#1)(1994-9#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
the risk of congenital##2##4##(2008-4#1)(2013-1#1)
the risk of contact##2##4##(1992-9#1)(2007-2#1)
the risk of contamination##4##4##(2008-10#2)(2008-11#1)(2009-9#1)
the risk of coronary artery disease##2##6##(1991-8#1)(1996-3#1)
the risk of coronary artery##3##5##(1991-8#1)(1996-3#1)(2013-8#1)
the risk of coronary heart disease (CHD)##2##7##(1995-3#1)(2005-10#1)
the risk of coronary heart disease##6##6##(1993-5#1)(1995-3#1)(1996-3#1)(2005-10#1)(2008-10#1)(2008-12#1)
the risk of coronary##10##4##(1991-8#1)(1993-5#1)(1995-3#1)(1996-3#2)(1996-8#1)(2005-10#1)(2008-10#1)(2008-12#1)(2013-8#1)
the risk of damaging##2##4##(2006-6#1)(2007-8#1)
the risk of death from cardiovascular disease##2##7##(2005-10#1)(2011-1#1)
the risk of death from##4##5##(2005-10#1)(2006-6#1)(2008-7#1)(2011-1#1)
the risk of death##10##4##(1997-3#1)(2005-10#1)(2006-6#1)(2007-10#1)(2008-7#1)(2011-1#2)(2011-3#2)(2013-7#1)
the risk of deep vein thrombosis##2##6##(1990-12#1)(1993-7#1)
the risk of developing breast cancer##4##6##(1994-4#3)(1995-9#1)
the risk of developing cardiovascular disease##2##6##(1995-8#1)(2005-10#1)
the risk of developing cardiovascular##3##5##(1993-11#1)(1995-8#1)(2005-10#1)
the risk of developing this##2##5##(2006-2#1)(2012-12#1)
the risk of developing##32##4##(1991-9#1)(1993-11#1)(1994-4#3)(1995-8#1)(1995-9#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#3)(2009-12#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-12#2)(2012-2#2)
the risk of development of kernicterus##2##6##(1990-1#2)
the risk of development of##8##5##(1990-1#2)(2005-1#2)(2006-6#1)(2007-10#1)(2007-4#1)(2013-1#1)
the risk of development##9##4##(1990-1#2)(2005-1#2)(2006-6#1)(2007-10#1)(2007-4#1)(2013-1#2)
the risk of digestive##2##4##(2008-3#2)
the risk of disease##7##4##(1992-12#1)(1995-6#1)(1997-8#1)(2007-2#1)(2010-12#1)(2012-1#2)
the risk of early and##2##5##(1990-8#1)(2011-2#1)
the risk of early##6##4##(1990-8#1)(2007-2#1)(2010-12#1)(2011-2#2)(2012-3#1)
the risk of epidemics##2##4##(2006-2#1)(2006-4#1)
the risk of exposure##5##4##(1990-2#1)(2010-12#1)(2012-11#2)(2012-2#1)
the risk of extinction of##2##5##(2008-9#1)(2012-12#1)
the risk of extinction##3##4##(2008-9#1)(2010-8#1)(2012-12#1)
the risk of failure##2##4##(1991-11#1)(2012-12#1)
the risk of falling##3##4##(2011-1#3)
the risk of falls##3##4##(2013-8#3)
the risk of false##2##4##(1993-10#1)(2013-1#1)
the risk of fracture##5##4##(2004-9#1)(2007-8#2)(2008-11#2)
the risk of fractures##3##4##(2007-11#1)(2007-8#1)(2008-4#1)
the risk of future##3##4##(2008-3#1)(2009-6#1)(2013-8#1)
the risk of gastric cancer in patients with##2##8##(2008-12#2)
the risk of gastric cancer##3##5##(1997-1#1)(2008-12#2)
the risk of gastric##4##4##(1997-1#1)(2008-1#1)(2008-12#2)
the risk of graft##2##4##(2008-8#1)(2011-2#1)
the risk of haemorrhage##2##4##(1992-6#1)(1996-6#1)
the risk of having##4##4##(2006-4#1)(2007-12#1)(2007-7#1)(2008-11#1)
the risk of hepatitis##3##4##(1996-3#1)(2009-9#1)(2010-12#1)
the risk of hepatocellular carcinoma in##2##6##(1992-9#1)(2010-12#1)
the risk of hepatocellular carcinoma##3##5##(1992-9#1)(2008-11#1)(2010-12#1)
the risk of homicidal behavior##2##5##(1996-5#2)
the risk of human##3##4##(2008-8#2)(2010-11#1)
the risk of hypertension##3##4##(2008-5#1)(2013-1#1)(2013-8#1)
the risk of inducing##2##4##(1994-9#1)(2007-8#1)
the risk of infection and##3##5##(2008-1#1)(2008-10#1)(2010-12#1)
the risk of infection through##2##5##(2008-10#1)(2011-2#1)
the risk of infection##16##4##(1994-6#1)(2005-11#1)(2006-10#1)(2007-2#4)(2008-1#1)(2008-10#2)(2008-11#1)(2009-5#1)(2010-12#1)(2011-2#2)(2012-2#1)
the risk of infections##3##4##(2006-10#1)(2008-11#1)(2011-2#1)
the risk of infectious##2##4##(2006-10#1)(2007-12#1)
the risk of intracranial##2##4##(2011-2#1)(2012-2#1)
the risk of invasive##3##4##(1993-9#1)(2007-12#1)(2008-4#1)
the risk of ischemic stroke among all the samples (OR = 1##2##12##(2011-1#2)
the risk of ischemic stroke among##3##6##(2011-1#3)
the risk of ischemic stroke in Han population from the Northern parts of China##2##14##(2011-1#2)
the risk of ischemic stroke in##3##6##(2011-1#3)
the risk of ischemic stroke##6##5##(2011-1#6)
the risk of ischemic##9##4##(1994-10#1)(2005-10#1)(2008-3#1)(2011-1#6)
the risk of its##2##4##(2008-12#1)(2011-2#1)
the risk of late##4##4##(1992-10#1)(2010-12#1)(2011-2#2)
the risk of liability##3##4##(1992-2#1)(1993-1#1)(1996-3#1)
the risk of losing##3##4##(1991-8#1)(2008-10#1)(2008-8#1)
the risk of major##3##4##(2007-10#1)(2008-10#1)(2010-1#1)
the risk of malignancies##2##4##(2007-11#1)(2007-3#1)
the risk of malignant transformation##3##5##(2007-8#1)(2008-4#1)(2013-1#1)
the risk of malignant##6##4##(1993-10#1)(2007-3#1)(2007-8#1)(2008-4#1)(2012-2#1)(2013-1#1)
the risk of microbial##2##4##(1997-4#1)(2011-2#1)
the risk of morbidity and mortality##4##6##(1990-8#1)(1995-12#1)(2007-2#1)(2007-8#1)
the risk of morbidity##5##4##(1990-8#1)(1995-12#1)(2006-10#1)(2007-2#1)(2007-8#1)
the risk of mortality##4##4##(1994-11#1)(2007-10#1)(2007-8#1)(2011-2#1)
the risk of nicotine dependence##2##5##(2010-9#1)(2011-2#1)
the risk of non-compliance##2##4##(2008-10#1)(2012-2#1)
the risk of nosocomial##3##4##(1992-10#1)(2007-12#1)(2010-4#1)
the risk of obesity and##2##5##(2008-3#1)(2010-3#1)
the risk of obtaining##2##4##(2008-10#1)(2012-12#1)
the risk of occurrence##2##4##(2007-7#1)(2008-12#1)
the risk of osteoporosis and##2##5##(1993-11#1)(1994-9#1)
the risk of osteoporosis##4##4##(1993-11#1)(1994-9#1)(2006-10#1)(2008-4#1)
the risk of ovarian cancer##2##5##(1990-5#2)
the risk of ovarian malignancy##2##5##(1990-5#1)(2012-12#1)
the risk of ovarian##4##4##(1990-5#3)(2012-12#1)
the risk of pancreatic cancer##2##5##(1994-3#1)(2008-3#1)
the risk of patient burns##2##5##(2010-9#1)(2011-2#1)
the risk of patient##3##4##(2010-9#2)(2011-2#1)
the risk of perioperative##2##4##(2009-5#2)
the risk of postoperative infection##2##5##(2007-8#1)(2008-8#1)
the risk of postoperative##6##4##(1996-9#1)(2006-10#1)(2007-8#2)(2008-7#1)(2008-8#1)
the risk of primary##3##4##(1991-11#1)(1992-9#1)(1994-6#1)
the risk of progression and##2##5##(2008-3#1)(2013-8#1)
the risk of progression##3##4##(2008-3#1)(2008-9#1)(2013-8#1)
the risk of prostate cancer##3##5##(2006-9#1)(2009-5#1)(2012-12#1)
the risk of raised ICP##2##5##(2010-5#2)
the risk of recurrence and##2##5##(2007-3#1)(2010-12#1)
the risk of recurrence of choledocholithiasis##2##6##(2008-5#2)
the risk of recurrence of##3##5##(2008-4#1)(2008-5#2)
the risk of recurrence##9##4##(1992-1#1)(1993-9#1)(1996-11#1)(2007-3#1)(2008-4#1)(2008-5#2)(2010-12#1)(2011-2#1)
the risk of recurrent##4##4##(2008-3#1)(2008-8#1)(2009-12#1)(2010-12#1)
the risk of relapse and##2##5##(2007-3#1)(2009-11#1)
the risk of relapse##3##4##(2007-3#1)(2009-11#1)(2011-2#1)
the risk of rupture##2##4##(2006-10#1)(2011-2#1)
the risk of serious complications##2##5##(2007-12#1)(2008-11#1)
the risk of serious##4##4##(2006-10#1)(2007-12#1)(2008-11#2)
the risk of several##2##4##(1992-9#1)(2008-7#1)
the risk of severe##4##4##(2006-6#1)(2007-10#1)(2011-1#1)(2011-2#1)
the risk of skeletal##2##4##(2007-11#1)(2008-8#1)
the risk of skin##2##4##(2007-11#1)(2008-5#1)
the risk of specific##2##4##(2011-3#1)(2013-1#1)
the risk of spinal cord##2##5##(2007-11#2)
the risk of stent thrombosis##2##5##(2010-12#1)(2010-5#1)
the risk of stroke and##3##5##(2006-10#1)(2007-10#1)(2007-4#1)
the risk of stroke in patients with##2##7##(2008-5#1)(2008-8#1)
the risk of stroke##16##4##(1991-11#1)(2006-10#1)(2007-10#5)(2007-4#1)(2008-5#1)(2008-8#3)(2008-9#1)(2010-11#2)(2011-1#1)
the risk of subsequent stroke##2##5##(1995-9#1)(2007-10#1)
the risk of subsequent##6##4##(1994-2#1)(1995-9#2)(1997-1#1)(2007-10#1)(2010-12#1)
the risk of such complications and##2##6##(1995-9#1)(2009-4#1)
the risk of sudden cardiac##2##5##(2006-9#1)(2013-7#1)
the risk of sudden death##3##5##(2006-9#2)(2013-8#1)
the risk of sudden##6##4##(1992-4#1)(2006-9#3)(2013-7#1)(2013-8#1)
the risk of suicide##5##4##(1993-7#2)(2008-8#2)(2012-2#1)
the risk of surgical##2##4##(2006-6#1)(2008-9#1)
the risk of systemic##2##4##(2008-8#1)(2012-3#1)
the risk of the development of##2##6##(1995-6#1)(2009-2#1)
the risk of the##12##4##(1990-9#1)(1995-6#1)(2007-11#1)(2008-12#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-2#1)(2010-4#1)(2010-8#1)(2012-2#1)(2012-3#1)
the risk of these##2##4##(2007-4#1)(2009-9#1)
the risk of this##2##4##(2007-11#1)(2008-5#1)
the risk of thromboembolic##2##4##(1997-5#1)(2005-12#1)
the risk of thrombotic CV accident##2##6##(2007-12#2)
the risk of transmission of##2##5##(2012-1#1)(2013-1#1)
the risk of transmission##8##4##(1992-6#2)(1994-12#1)(2006-10#2)(2006-8#1)(2012-1#1)(2013-1#1)
the risk of treatment##2##4##(1993-9#1)(2008-7#1)
the risk of vascular##2##4##(2005-10#1)(2011-2#1)
the risk of venous##6##4##(1996-3#1)(2006-2#1)(2007-8#1)(2007-9#1)(2010-12#2)
the risk of##896##3##(1990-1#2)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#4)(1990-9#1)(1991-11#6)(1991-12#1)(1991-2#4)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#3)(1991-8#4)(1991-9#4)(1992-1#1)(1992-10#3)(1992-12#4)(1992-2#5)(1992-3#3)(1992-4#1)(1992-6#3)(1992-8#1)(1992-9#6)(1993-1#2)(1993-10#3)(1993-11#4)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#3)(1993-7#4)(1993-8#4)(1993-9#6)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#5)(1994-3#4)(1994-4#3)(1994-6#2)(1994-7#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-6#7)(1995-8#3)(1995-9#4)(1996-1#2)(1996-11#2)(1996-12#2)(1996-2#4)(1996-3#9)(1996-4#2)(1996-5#2)(1996-6#2)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#3)(1997-7#3)(1997-8#1)(2004-4#1)(2004-9#2)(2005-1#3)(2005-10#10)(2005-11#6)(2005-12#2)(2005-6#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#34)(2006-11#3)(2006-12#3)(2006-2#7)(2006-4#2)(2006-5#4)(2006-6#8)(2006-7#1)(2006-8#6)(2006-9#6)(2007-1#1)(2007-10#15)(2007-11#21)(2007-12#15)(2007-2#13)(2007-3#6)(2007-4#10)(2007-5#1)(2007-6#3)(2007-7#6)(2007-8#33)(2007-9#2)(2008-1#10)(2008-10#23)(2008-11#18)(2008-12#12)(2008-2#3)(2008-3#21)(2008-4#17)(2008-5#12)(2008-6#6)(2008-7#16)(2008-8#26)(2008-9#6)(2009-1#1)(2009-10#2)(2009-11#9)(2009-12#7)(2009-2#3)(2009-4#3)(2009-5#6)(2009-6#7)(2009-7#1)(2009-8#2)(2009-9#5)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#21)(2010-2#5)(2010-3#3)(2010-4#4)(2010-5#5)(2010-6#4)(2010-7#4)(2010-8#8)(2010-9#6)(2011-1#18)(2011-11#1)(2011-12#6)(2011-2#45)(2011-3#3)(2012-1#8)(2012-11#5)(2012-12#17)(2012-2#25)(2012-3#4)(2012-6#1)(2013-1#35)(2013-7#8)(2013-8#20)
the risk or##2##3##(1995-8#1)(2013-8#1)
the risk ratio##4##3##(1993-9#1)(2012-2#2)(2012-3#1)
the risk reduction##2##3##(1994-2#1)(2012-1#1)
the risk that##2##3##(2008-6#1)(2011-2#1)
the risk to develop##2##4##(2010-12#1)(2010-9#1)
the risk to the##2##4##(2007-7#2)
the risk to##10##3##(1991-12#1)(2006-11#1)(2007-2#2)(2007-7#2)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#1)
the risk was##2##3##(1994-2#1)(1994-6#1)
the risk##1248##2##(1990-1#2)(1990-11#2)(1990-12#4)(1990-2#5)(1990-3#1)(1990-5#5)(1990-6#5)(1990-7#2)(1990-8#4)(1990-9#3)(1991-11#7)(1991-12#3)(1991-2#4)(1991-4#3)(1991-5#5)(1991-6#3)(1991-7#3)(1991-8#4)(1991-9#4)(1992-1#2)(1992-10#3)(1992-11#1)(1992-12#5)(1992-2#8)(1992-3#4)(1992-4#2)(1992-6#4)(1992-8#1)(1992-9#8)(1993-1#2)(1993-10#3)(1993-11#4)(1993-12#3)(1993-2#5)(1993-3#1)(1993-5#1)(1993-6#3)(1993-7#4)(1993-8#5)(1993-9#7)(1994-1#2)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#8)(1994-3#5)(1994-4#3)(1994-6#4)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#4)(1995-3#1)(1995-4#1)(1995-6#8)(1995-8#7)(1995-9#5)(1996-1#3)(1996-11#3)(1996-12#4)(1996-2#7)(1996-3#9)(1996-4#4)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#4)(1997-2#2)(1997-3#4)(1997-4#3)(1997-5#4)(1997-6#1)(1997-7#3)(1997-8#6)(2004-11#2)(2004-12#3)(2004-2#1)(2004-4#1)(2004-9#2)(2005-1#3)(2005-10#13)(2005-11#8)(2005-12#3)(2005-3#1)(2005-5#1)(2005-6#1)(2005-7#1)(2005-8#3)(2006-1#2)(2006-10#42)(2006-11#5)(2006-12#3)(2006-2#9)(2006-4#2)(2006-5#4)(2006-6#10)(2006-7#1)(2006-8#8)(2006-9#6)(2007-1#1)(2007-10#17)(2007-11#28)(2007-12#24)(2007-2#18)(2007-3#7)(2007-4#12)(2007-5#3)(2007-6#5)(2007-7#13)(2007-8#40)(2007-9#4)(2008-1#15)(2008-10#33)(2008-11#25)(2008-12#15)(2008-2#4)(2008-3#30)(2008-4#23)(2008-5#16)(2008-6#8)(2008-7#24)(2008-8#30)(2008-9#9)(2009-1#1)(2009-10#6)(2009-11#9)(2009-12#8)(2009-2#3)(2009-3#2)(2009-4#3)(2009-5#6)(2009-6#9)(2009-7#3)(2009-8#3)(2009-9#5)(2010-1#2)(2010-10#3)(2010-11#3)(2010-12#28)(2010-2#5)(2010-3#3)(2010-4#5)(2010-5#5)(2010-6#7)(2010-7#7)(2010-8#9)(2010-9#10)(2011-1#32)(2011-11#1)(2011-12#6)(2011-2#65)(2011-3#3)(2012-1#9)(2012-11#7)(2012-12#23)(2012-2#39)(2012-3#9)(2012-6#1)(2013-1#50)(2013-7#10)(2013-8#35)
the risk-benefit ratio of##2##4##(2006-8#1)(2008-3#1)
the risk-benefit ratio##3##3##(2006-8#1)(2007-12#1)(2008-3#1)
the risk-benefit##4##2##(2006-8#1)(2007-12#1)(2008-3#1)(2009-6#1)
the risk/benefit ratio of##2##4##(2007-9#1)(2008-3#1)
the risk/benefit ratio##4##3##(2007-11#1)(2007-8#1)(2007-9#1)(2008-3#1)
the risk/benefit##7##2##(1993-11#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-3#1)(2011-1#1)(2013-1#1)
the risk/return dynamics##2##3##(2008-11#2)
the risk?##5##2##(1994-8#1)(1996-2#1)(2006-10#1)(2008-9#1)(2010-9#1)
the risks and benefits associated with##2##6##(2005-6#1)(2006-10#1)
the risks and benefits of the##2##6##(2007-8#1)(2013-1#1)
the risks and benefits of this##3##6##(2007-9#1)(2011-2#1)(2012-12#1)
the risks and benefits of##19##5##(1990-9#1)(1996-12#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-7#1)(2008-8#2)(2009-12#1)(2009-4#1)(2010-12#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
the risks and benefits##22##4##(1990-9#1)(1996-12#1)(2005-6#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-4#1)(2010-12#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
the risks and the##2##4##(2007-2#1)(2009-6#1)
the risks and##27##3##(1990-9#1)(1996-12#1)(1997-5#1)(2005-6#1)(2006-10#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-4#1)(2009-6#1)(2010-12#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
the risks associated with the##3##5##(2008-10#1)(2008-11#1)(2008-8#1)
the risks associated with##14##4##(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
the risks associated##15##3##(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
the risks for##4##3##(1992-2#1)(2008-3#1)(2013-1#1)(2013-8#1)
the risks involved with##2##4##(2006-6#1)(2012-2#1)
the risks involved##5##3##(1992-3#1)(2005-12#1)(2006-6#1)(2009-6#1)(2012-2#1)
the risks of a##4##4##(1993-11#1)(1996-2#1)(2005-12#1)(2012-11#1)
the risks of knee and thigh injuries in frontal crashes##2##10##(2006-11#2)
the risks of managed care##2##5##(1994-3#1)(1995-3#1)
the risks of serious##2##4##(2006-10#1)(2008-7#1)
the risks of the##2##4##(1994-6#1)(2008-4#1)
the risks of##68##3##(1990-5#1)(1991-11#1)(1991-2#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-3#1)(1995-4#2)(1996-2#1)(1996-6#1)(1997-5#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-2#5)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-2#5)(2012-11#1)(2013-1#1)
the risks posed by##2##4##(2005-8#1)(2010-10#1)
the risks posed##3##3##(2005-8#1)(2008-11#1)(2010-10#1)
the risks related to##3##4##(2010-9#2)(2011-2#1)
the risks to##3##3##(2007-7#1)(2008-8#2)
the risks##159##2##(1990-5#1)(1990-9#1)(1991-11#1)(1991-2#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#2)(1994-3#1)(1994-6#2)(1994-9#1)(1995-3#1)(1995-4#2)(1996-12#1)(1996-2#2)(1996-6#1)(1996-7#1)(1997-3#1)(1997-5#2)(2005-10#3)(2005-11#1)(2005-12#2)(2005-6#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#5)(2006-11#3)(2006-12#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#8)(2007-4#4)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#7)(2008-12#1)(2008-3#3)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#2)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#7)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#12)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#5)(2013-8#2)
the ritual##3##2##(2008-2#1)(2009-10#1)(2013-1#1)
the rival##2##2##(2009-6#1)(2010-12#1)
the river basin##2##3##(2008-12#1)(2008-5#1)
the river or##2##3##(2005-8#1)(2008-10#1)
the river water##7##3##(2008-10#5)(2012-12#2)
the river##37##2##(1997-4#1)(2005-8#1)(2007-3#3)(2007-7#1)(2007-8#1)(2008-10#9)(2008-12#1)(2008-4#1)(2008-5#7)(2009-6#2)(2009-7#1)(2010-8#3)(2012-1#1)(2012-12#3)(2013-1#2)
the rivers##2##2##(2008-8#1)(2013-8#1)
the rms error##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
the rms of the##3##4##(2008-3#3)
the rms##20##2##(1992-4#1)(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#11)(2008-8#1)(2012-1#1)
the rna gene##3##3##(1990-10#3)
the rnpA49 mutation##3##3##(1997-4#3)
the road ahead##3##3##(1994-6#2)(2010-12#1)
the road for##2##3##(2007-11#1)(2008-7#1)
the road to##7##3##(1995-1#1)(1995-3#1)(2005-8#1)(2009-12#1)(2009-6#1)(2012-12#1)(2013-8#1)
the road traffic##4##3##(2008-3#1)(2010-11#2)(2012-2#1)
the road##28##2##(1994-6#2)(1995-1#1)(1995-3#1)(1996-11#1)(1996-3#1)(1997-4#1)(2005-8#1)(2006-11#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-6#1)(2010-11#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-8#1)
the robot design##2##3##(2012-1#2)
the robot##34##2##(2007-5#4)(2007-8#1)(2008-1#1)(2008-2#1)(2011-1#2)(2011-2#1)(2012-1#23)(2012-2#1)
the robot's##4##2##(2006-6#1)(2011-1#2)(2012-1#1)
the robotic system##3##3##(2006-6#2)(2012-1#1)
the robotic##6##2##(2006-6#2)(2007-8#1)(2011-1#1)(2012-1#2)
the robots##3##2##(2007-5#2)(2012-1#1)
the robust literature##2##3##(2007-11#1)(2010-3#1)
the robust##14##2##(2007-11#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-6#1)(2009-8#1)(2010-3#1)(2012-2#1)(2013-7#1)
the robustness of a##2##4##(2006-12#1)(2007-12#1)
the robustness of the method##3##5##(2008-10#2)(2011-1#1)
the robustness of the##18##4##(1995-6#1)(1997-5#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
the robustness of these##2##4##(1994-9#1)(2008-9#1)
the robustness of this##4##4##(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
the robustness of##42##3##(1994-9#1)(1995-6#1)(1997-3#1)(1997-5#1)(2006-10#1)(2006-12#1)(2007-1#2)(2007-12#2)(2008-1#1)(2008-10#9)(2008-11#6)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
the robustness to##3##3##(1994-9#1)(2008-3#2)
the robustness##50##2##(1994-9#2)(1995-11#1)(1995-6#1)(1997-3#1)(1997-5#1)(2006-10#1)(2006-12#1)(2007-1#2)(2007-12#2)(2008-1#1)(2008-10#10)(2008-11#6)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
the rock certified materials##2##4##(2008-10#2)
the rock##5##2##(1996-4#1)(2007-5#1)(2008-10#3)
the rocks and##2##3##(2008-10#2)
the rocks##3##2##(2007-5#1)(2008-10#2)
the rockwool##2##2##(2008-10#2)
the rocky##3##2##(2007-3#2)(2007-5#1)
the rod outer##2##3##(1990-7#1)(1991-10#1)
the rod##22##2##(1990-11#1)(1990-7#5)(1991-10#1)(1995-3#1)(1997-2#3)(1997-4#2)(2007-11#1)(2007-7#1)(2007-9#1)(2008-12#1)(2008-2#3)(2008-7#1)(2008-8#1)
the rod's##4##2##(2008-2#3)(2008-3#1)
the rod-shaped##2##2##(2007-8#1)(2012-2#1)
the rodent micronucleus assay was##2##5##(1997-2#2)
the rodent micronucleus assay##4##4##(1997-2#4)
the rodent##27##2##(1992-9#1)(1993-2#1)(1994-12#1)(1995-12#1)(1995-5#1)(1995-9#2)(1997-2#5)(1997-6#1)(2007-11#1)(2007-9#1)(2008-11#3)(2008-4#3)(2010-11#2)(2010-2#2)(2011-1#1)(2013-8#1)
the rods##4##2##(2008-2#2)(2008-8#1)(2009-7#1)
the roe##2##2##(1996-3#1)(2007-5#1)
the role and function of##4##5##(1990-12#1)(1993-1#1)(2006-1#1)(2012-2#1)
the role and mechanism of##2##5##(2009-6#1)(2011-2#1)
the role and molecular mechanisms of##2##6##(2013-1#2)
the role and##35##3##(1990-12#1)(1992-12#2)(1992-3#1)(1993-1#1)(1995-1#1)(1995-12#1)(1996-2#2)(1996-7#1)(1997-2#1)(1997-8#1)(2004-10#1)(2006-1#1)(2006-10#1)(2007-10#1)(2008-10#2)(2008-12#2)(2008-6#1)(2009-10#1)(2009-6#2)(2009-9#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#2)
the role by##2##3##(1995-2#1)(2012-3#1)
the role for##6##3##(1993-12#1)(1997-3#1)(2006-10#1)(2006-8#1)(2008-11#1)(2010-8#1)
the role in the##2##4##(1993-7#1)(2008-4#1)
the role in##4##3##(1993-7#1)(1993-9#1)(2008-4#1)(2013-1#1)
the role it plays in the##4##6##(2005-12#1)(2013-1#2)(2013-7#1)
the role it##5##3##(2005-12#1)(2008-5#1)(2013-1#2)(2013-7#1)
the role of &quot##4##4##(2006-5#1)(2007-4#1)(2007-8#1)(2012-2#1)
the role of 5-HT in##2##5##(2012-12#2)
the role of 5-HT##3##4##(2008-8#1)(2012-12#2)
the role of B cells in##2##6##(2006-10#1)(2008-3#1)
the role of B##3##4##(2006-10#1)(2008-3#1)(2009-8#1)
the role of B27##2##4##(1990-11#2)
the role of CT##3##4##(1992-9#1)(2007-6#1)(2009-9#1)
the role of Ca2+##2##4##(1994-2#1)(1995-11#1)
the role of DCs in##2##5##(2005-11#1)(2010-5#1)
the role of DNA methylation in##2##6##(1997-4#1)(2007-8#1)
the role of EBV##2##4##(1991-9#1)(1993-8#1)
the role of EGFR##2##4##(2008-1#1)(2012-1#1)
the role of FcgammaR##2##4##(2008-10#2)
the role of GH##3##4##(1997-8#1)(2006-9#1)(2012-1#1)
the role of GR##2##4##(1994-11#1)(2010-10#1)
the role of H##4##4##(2006-10#3)(2006-2#1)
the role of HPV##3##4##(1997-7#1)(2012-12#1)(2013-1#1)
the role of HSPs in##2##5##(2005-10#1)(2013-1#1)
the role of Helicobacter pylori in##4##6##(2006-10#4)
the role of Helicobacter pylori##6##5##(1992-5#2)(2006-10#4)
the role of Hsp90##2##4##(1995-3#2)
the role of IL-12 in the##2##6##(1996-10#2)
the role of IL-12 in##4##5##(1996-10#4)
the role of Institutional Review Boards##2##6##(2006-10#1)(2009-4#1)
the role of MMPs in##2##5##(2007-2#1)(2008-11#1)
the role of MTs in##2##5##(2008-11#1)(2013-7#1)
the role of Myc##2##4##(2006-10#1)(2008-11#1)
the role of NMDA receptors##2##5##(1993-7#1)(1997-2#1)
the role of Nrf2 in the##2##6##(2013-8#2)
the role of P2 receptors##3##5##(2008-3#1)(2008-4#2)
the role of P2##4##4##(2008-3#1)(2008-4#2)(2008-5#1)
the role of PAF##2##4##(2007-11#1)(2007-9#1)
the role of PET/CT##2##4##(2007-4#1)(2009-9#1)
the role of Prosopis pollen as##2##6##(2007-2#2)
the role of RNA##2##4##(2010-5#1)(2012-2#1)
the role of ROS##2##4##(2009-5#1)(2010-4#1)
the role of TSPO in##2##5##(2012-2#2)
the role of Thr246##2##4##(1993-11#2)
the role of a local RAS in the hypertrophic differentiation##2##10##(2013-8#2)
the role of a##20##4##(1990-5#1)(1992-2#1)(1993-11#1)(1995-12#1)(1995-8#2)(1996-9#1)(1997-4#1)(2006-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#2)(2009-3#1)(2009-4#1)(2012-12#1)(2013-8#2)
the role of acute##2##4##(2006-6#1)(2007-11#1)
the role of adjuvant##4##4##(2006-2#1)(2007-11#1)(2008-6#1)(2012-3#1)
the role of affective##2##4##(2008-1#1)(2008-2#1)
the role of an##6##4##(1990-9#1)(1992-3#1)(2008-4#1)(2008-7#1)(2010-4#1)(2011-2#1)
the role of angiotensin##3##4##(1993-6#1)(2005-8#1)(2013-1#1)
the role of antioxidant nutrients##2##5##(1993-12#1)(2005-10#1)
the role of antiplatelet therapy##2##5##(2008-3#1)(2011-2#1)
the role of attention##2##4##(1996-2#1)(2013-8#1)
the role of atypical antipsychotics in##2##6##(2008-8#2)
the role of biopsy##2##4##(2013-7#2)
the role of blood##3##4##(2007-11#1)(2011-2#1)(2013-1#1)
the role of both##2##4##(1997-6#1)(2011-1#1)
the role of c-fos in##2##5##(1994-12#1)(1996-11#1)
the role of calcium##5##4##(1994-2#1)(1995-8#1)(2008-5#1)(2009-5#1)(2010-5#1)
the role of cell##2##4##(2007-8#2)
the role of cellular##3##4##(1993-6#1)(2006-10#1)(2007-10#1)
the role of certain##3##4##(1996-5#1)(2007-9#1)(2012-1#1)
the role of chemotherapy##2##4##(2010-11#1)(2012-12#1)
the role of circulating##4##4##(1993-5#1)(1996-10#1)(1997-8#1)(2007-11#1)
the role of cognitive##2##4##(2008-2#1)(2010-9#1)
the role of commonly used##2##5##(2006-12#1)(2007-7#1)
the role of community##2##4##(2012-12#1)(2012-2#1)
the role of complex##3##4##(1995-2#1)(2008-10#1)(2009-8#1)
the role of corticosterone##2##4##(2007-11#2)
the role of cultural##2##4##(2007-12#1)(2009-7#1)
the role of culture##2##4##(2007-12#1)(2011-2#1)
the role of cytokines and##2##5##(2006-10#2)
the role of cytokines##3##4##(2006-10#2)(2006-11#1)
the role of cytoreductive nephrectomy for##2##6##(2008-6#2)
the role of cytoreductive nephrectomy##3##5##(2008-6#3)
the role of diet##2##4##(1990-8#1)(2008-4#1)
the role of different##6##4##(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#1)(2009-8#1)(2011-2#1)
the role of distributed##2##4##(2008-9#1)(2010-8#1)
the role of drug##3##4##(2008-2#1)(2009-4#1)(2013-8#1)
the role of each of these##4##6##(1990-5#1)(2006-10#1)(2013-1#2)
the role of each##5##4##(1990-5#1)(1992-4#1)(2006-10#1)(2013-1#2)
the role of early##4##4##(2007-12#1)(2008-1#1)(2012-2#1)(2013-1#1)
the role of echocardiography##2##4##(1997-3#1)(2009-10#1)
the role of emotional##2##4##(2008-11#1)(2012-12#1)
the role of endogenous cytokines##2##5##(1996-12#2)
the role of endogenous##3##4##(1996-12#2)(2007-11#1)
the role of endogenously produced##2##5##(1992-3#1)(2013-8#1)
the role of endoscopic ultrasound-guided fine-needle##2##6##(2006-10#2)
the role of endoscopic##6##4##(2006-10#3)(2007-3#1)(2009-5#1)(2013-1#1)
the role of environmental##4##4##(2005-8#1)(2007-8#1)(2008-1#1)(2009-12#1)
the role of epigenetic factors##2##5##(2008-11#1)(2011-9#1)
the role of epigenetic##7##4##(2007-8#1)(2008-1#1)(2008-11#1)(2011-9#1)(2012-2#2)(2013-8#1)
the role of estrogen##2##4##(2007-10#1)(2008-3#1)
the role of exercise as an##2##6##(2008-1#1)(2011-1#1)
the role of exercise##3##4##(2005-10#1)(2008-1#1)(2011-1#1)
the role of extracellular##3##4##(1996-1#1)(1997-6#1)(2013-8#1)
the role of facet##2##4##(1993-11#1)(2006-8#1)
the role of family##4##4##(1991-6#1)(1993-11#1)(2006-4#1)(2008-1#1)
the role of fine needle aspiration##2##6##(2012-2#1)(2013-8#1)
the role of fine-needle aspiration##2##5##(2006-10#1)(2011-1#1)
the role of free##3##4##(1992-12#1)(1993-12#1)(2008-12#1)
the role of gastrin##2##4##(1993-11#1)(2006-2#1)
the role of gene##3##4##(2008-8#1)(2010-12#1)(2012-2#1)
the role of general cognitive style##2##6##(2010-1#2)
the role of general##4##4##(1990-12#1)(1997-6#1)(2010-1#2)
the role of genes in##3##5##(2008-1#1)(2008-2#1)(2012-3#1)
the role of genes##4##4##(2008-1#1)(2008-2#1)(2009-5#1)(2012-3#1)
the role of genetic##5##4##(1997-8#1)(2007-2#1)(2008-8#1)(2009-11#1)(2012-2#1)
the role of genetics in##2##5##(2006-10#1)(2008-7#1)
the role of glutamate##2##4##(1991-3#1)(2008-7#1)
the role of gut##2##4##(2006-10#1)(2011-1#1)
the role of health care professionals in##2##7##(2005-7#1)(2010-4#1)
the role of health##5##4##(1993-12#1)(2005-7#1)(2008-11#1)(2010-4#1)(2012-2#1)
the role of high##5##4##(1997-5#1)(2007-4#1)(2008-5#1)(2009-3#1)(2009-4#1)
the role of higher education##2##5##(2008-12#1)(2011-2#1)
the role of human##2##4##(2009-5#1)(2012-1#1)
the role of hydrogen##3##4##(1990-3#1)(1991-1#1)(1992-5#1)
the role of hypocalcemia##2##4##(2011-2#2)
the role of imaging##2##4##(2007-5#1)(2008-11#1)
the role of immune##2##4##(2012-3#1)(2013-7#1)
the role of individual##5##4##(1991-1#1)(1991-12#1)(1991-6#1)(1997-4#1)(2012-1#1)
the role of inflammatory##2##4##(2007-11#1)(2009-4#1)
the role of information##3##4##(1993-4#1)(1997-3#1)(2011-1#1)
the role of insulin and##2##5##(2008-3#1)(2010-11#1)
the role of insulin##3##4##(2005-10#1)(2008-3#1)(2010-11#1)
the role of intensive##2##4##(2007-1#2)
the role of interleukin-1 (IL-1) in the##2##7##(1992-9#1)(2009-9#1)
the role of international agencies##2##5##(2006-10#2)
the role of intracellular##5##4##(1995-8#2)(2008-10#1)(2009-5#1)(2009-6#1)
the role of ionic##2##4##(1990-7#1)(2006-5#1)
the role of iron##3##4##(1993-11#1)(1996-5#1)(2012-12#1)
the role of leptin##2##4##(2006-10#1)(2006-2#1)
the role of lipid rafts in##2##6##(2005-7#1)(2010-5#1)
the role of local##2##4##(1997-2#1)(2013-1#1)
the role of long term##2##5##(1994-12#1)(2007-11#1)
the role of mTOR##3##4##(2011-2#1)(2013-1#2)
the role of macrophage##2##4##(2008-11#1)(2012-12#1)
the role of magnetic resonance imaging##3##6##(2008-4#1)(2008-8#1)(2013-1#1)
the role of magnetic resonance##4##5##(2008-4#1)(2008-8#1)(2011-2#1)(2013-1#1)
the role of maternal##2##4##(2008-9#1)(2010-7#1)
the role of mechanical stimulation##2##5##(2009-8#1)(2012-2#1)
the role of mechanical##3##4##(2007-10#1)(2009-8#1)(2012-2#1)
the role of medical##3##4##(2008-12#1)(2008-7#1)(2013-8#1)
the role of menin in##3##5##(2010-2#3)
the role of mitochondria##3##4##(2008-1#2)(2013-8#1)
the role of molecular chaperones##3##5##(2008-1#1)(2008-4#1)(2008-7#1)
the role of mucosal##2##4##(1992-8#1)(2012-2#1)
the role of multiple##3##4##(2008-10#1)(2008-11#1)(2008-2#1)
the role of mutations in the##3##6##(1993-11#1)(2008-6#1)(2008-7#1)
the role of natural selection in##3##6##(2008-11#2)(2010-4#1)
the role of natural selection##4##5##(2008-11#2)(2010-4#1)(2010-5#1)
the role of nerve growth factor in##2##7##(1993-11#1)(1996-3#1)
the role of neuronal##2##4##(1996-7#1)(2007-10#1)
the role of neurotrophins in##2##5##(1994-8#1)(2008-7#1)
the role of neutrophils##2##4##(2010-9#1)(2012-3#1)
the role of new##3##4##(2006-10#1)(2008-6#1)(2009-5#1)
the role of nurse##3##4##(2006-1#1)(2008-11#1)(2010-9#1)
the role of obesity in##2##5##(2006-10#1)(2008-1#1)
the role of omega-3 polyunsaturated fatty acids in##2##8##(2006-7#2)
the role of omega-3##3##4##(2006-7#2)(2007-11#1)
the role of oncogenes in drug resistance##2##7##(2008-11#2)
the role of oral##3##4##(1990-6#1)(2007-12#1)(2007-2#1)
the role of other##5##4##(1996-8#1)(2006-9#1)(2008-1#1)(2008-3#1)(2013-7#1)
the role of oxidative stress in##4##6##(1990-4#1)(1996-5#1)(2008-1#1)(2009-6#1)
the role of oxidative stress##5##5##(1990-4#1)(1996-5#1)(2008-1#1)(2009-5#1)(2009-6#1)
the role of oxygen free radicals in##4##7##(1991-9#1)(1992-12#1)(1994-10#1)(1994-2#1)
the role of oxygen##6##4##(1991-9#1)(1992-12#1)(1994-10#1)(1994-2#1)(1994-3#1)(2008-8#1)
the role of p53##3##4##(1995-8#1)(2008-3#1)(2008-8#1)
the role of phosphorylation in##3##5##(1994-11#1)(1995-10#1)(1996-4#1)
the role of phosphorylation##5##4##(1990-4#1)(1994-11#1)(1995-10#1)(1996-4#1)(1997-2#1)
the role of plant##3##4##(2009-4#1)(2009-8#1)(2011-10#1)
the role of polymorphisms##2##4##(2005-11#1)(2013-1#1)
the role of preoperative##2##4##(2006-10#2)
the role of primary##3##4##(1993-6#1)(1997-4#1)(2007-5#1)
the role of protein kinase C##2##6##(1990-4#1)(2013-8#1)
the role of protein##7##4##(1990-4#1)(1991-7#1)(2008-6#1)(2010-12#1)(2013-8#3)
the role of public health##2##5##(1996-2#1)(1997-3#1)
the role of public##3##4##(1996-2#1)(1997-3#1)(2008-12#1)
the role of quality##3##4##(1994-12#1)(2005-5#1)(2008-10#1)
the role of radiation therapy in the##2##7##(1992-4#1)(1994-6#1)
the role of radiofrequency ablation##2##5##(2006-9#2)
the role of radiotherapy in##2##5##(2006-6#1)(2012-2#1)
the role of radiotherapy##5##4##(1993-9#1)(1994-4#1)(2006-6#1)(2007-11#1)(2012-2#1)
the role of reactive oxygen species in photoaging##2##8##(1992-6#2)
the role of reactive oxygen species##3##6##(1992-6#2)(2008-8#1)
the role of reactive oxygen##4##5##(1992-6#2)(1993-7#1)(2008-8#1)
the role of reactive##5##4##(1992-6#2)(1992-7#1)(1993-7#1)(2008-8#1)
the role of regional anaesthesia in##2##6##(2006-10#1)(2013-1#1)
the role of regional##3##4##(2006-10#1)(2008-1#1)(2013-1#1)
the role of regulatory T cells in##2##7##(2006-10#1)(2008-4#1)
the role of relatedness##2##4##(2008-8#1)(2010-4#1)
the role of religion in##2##5##(2009-7#2)
the role of reoperation in the management of malignant glioma##2##10##(2006-12#2)
the role of reoperation in##3##5##(2006-12#3)
the role of reoperation##4##4##(2006-12#4)
the role of serine##2##4##(1994-11#1)(1995-8#1)
the role of serotonin##2##4##(2008-6#1)(2008-8#1)
the role of social support##2##5##(1991-1#1)(2006-3#1)
the role of social##9##4##(1991-1#1)(1994-3#1)(2006-3#1)(2007-7#1)(2008-2#1)(2010-2#1)(2011-2#1)(2012-12#2)
the role of some of the##2##6##(2008-10#1)(2009-10#1)
the role of some of##3##5##(1994-12#1)(2008-10#1)(2009-10#1)
the role of some##7##4##(1994-12#1)(1994-9#1)(2006-10#1)(2007-1#1)(2008-10#1)(2009-10#1)(2009-11#1)
the role of specific##8##4##(1993-11#1)(1994-9#1)(2006-10#2)(2007-12#1)(2008-7#1)(2011-2#1)(2012-1#1)
the role of speech##2##4##(2008-11#1)(2012-2#1)
the role of spirituality##2##4##(2008-12#1)(2012-12#1)
the role of standby emergency##2##5##(2007-2#2)
the role of stem cells##2##5##(2010-12#1)(2013-7#1)
the role of stem##3##4##(2010-12#1)(2012-2#1)(2013-7#1)
the role of structural##3##4##(2005-8#1)(2008-7#1)(2011-3#1)
the role of such##2##4##(1992-8#1)(2007-11#1)
the role of surgical##3##4##(1990-9#1)(2006-7#1)(2007-9#1)
the role of technology in##3##5##(1990-12#1)(2006-6#1)(2012-12#1)
the role of telomeres##2##4##(2008-8#1)(2010-2#1)
the role of the VLO in##2##6##(1994-3#2)
the role of the amino acid##2##6##(1995-7#1)(1997-6#1)
the role of the brain##2##5##(1991-5#1)(2007-9#1)
the role of the central##2##5##(1993-3#1)(2005-10#1)
the role of the clinician##2##5##(2007-4#1)(2012-1#1)
the role of the community##2##5##(1996-2#1)(2013-1#1)
the role of the courts##2##5##(1992-12#1)(1992-3#1)
the role of the dietitian in##2##6##(1993-12#1)(1993-3#1)
the role of the different##2##5##(1995-12#1)(2011-2#1)
the role of the gut microbiome##2##6##(2010-5#1)(2011-1#1)
the role of the hospitalist##2##5##(2008-3#2)
the role of the host in##3##6##(2006-2#1)(2008-10#1)(2011-2#1)
the role of the immune system in##2##7##(2010-12#1)(2012-3#1)
the role of the low##2##5##(1992-12#1)(2007-8#1)
the role of the many##2##5##(2008-11#1)(2011-2#1)
the role of the maternal##2##5##(1994-6#2)
the role of the media##3##5##(1993-12#1)(1995-1#1)(2008-11#1)
the role of the medical provider##2##6##(2013-1#2)
the role of the medical staff##2##6##(1994-2#2)
the role of the medical##6##5##(1990-12#1)(1994-2#2)(2007-2#1)(2013-1#2)
the role of the nurse in##2##6##(2011-1#1)(2011-2#1)
the role of the nurse##4##5##(2008-6#1)(2011-1#2)(2011-2#1)
the role of the paraventricular nucleus##2##6##(1997-8#1)(2005-10#1)
the role of the physician##2##5##(1995-2#1)(1996-2#1)
the role of the substrate in##2##6##(2008-10#1)(2008-7#1)
the role of the##254##4##(1990-12#4)(1990-2#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#2)(1991-1#2)(1991-10#1)(1991-11#1)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-6#1)(1992-9#2)(1993-12#4)(1993-2#1)(1993-3#3)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#4)(1994-3#7)(1994-5#3)(1994-6#3)(1994-8#3)(1995-1#3)(1995-12#3)(1995-2#5)(1995-3#2)(1995-6#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-8#3)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2004-2#1)(2005-1#2)(2005-10#2)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-2#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#2)(2007-11#5)(2007-12#5)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#4)(2008-10#13)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#1)(2009-10#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-3#1)(2010-5#1)(2011-1#9)(2011-2#6)(2011-3#1)(2012-1#3)(2012-12#5)(2012-2#6)(2012-3#5)(2013-1#4)(2013-8#2)
the role of these cells in the pathogenesis of##2##9##(2009-5#1)(2012-12#1)
the role of these cells##3##5##(1991-8#1)(2009-5#1)(2012-12#1)
the role of these factors in##2##6##(2008-2#1)(2013-8#1)
the role of these molecules in##2##6##(1991-2#1)(2007-10#1)
the role of these proteins in##4##6##(1995-2#2)(2007-7#1)(2013-1#1)
the role of these##41##4##(1991-2#1)(1991-8#1)(1992-3#1)(1992-7#1)(1994-10#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#2)(1995-6#1)(2004-11#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
the role of this factor##2##5##(1990-2#1)(2009-3#1)
the role of this modification##2##5##(1994-8#1)(2008-11#1)
the role of this residue##3##5##(1995-2#2)(1996-2#1)
the role of this##26##4##(1990-2#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-5#1)(1993-2#1)(1994-10#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#2)(1996-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-12#1)(2009-3#1)(2009-8#1)(2011-1#1)(2012-2#1)
the role of tumor##4##4##(1990-10#2)(1990-12#1)(2009-12#1)
the role of two##3##4##(1996-5#1)(2008-10#1)(2011-2#1)
the role of tyrosine phosphorylation in the##2##7##(1994-6#1)(1995-5#1)
the role of tyrosine phosphorylation in##3##6##(1994-6#1)(1995-5#1)(2008-4#1)
the role of various##4##4##(1996-3#1)(2006-10#1)(2007-5#1)(2011-1#1)
the role of vascular endothelial growth factor (VEGF)##2##8##(2010-12#1)(2012-12#1)
the role of vascular endothelial growth##3##6##(1995-1#1)(2010-12#1)(2012-12#1)
the role of violent media##2##5##(2009-7#2)
the role of vitamin D in##2##6##(2012-12#2)
the role of vitamin D##3##5##(2012-12#2)(2012-2#1)
the role of vitamin##4##4##(2010-12#1)(2012-12#2)(2012-2#1)
the role of water in##2##5##(1993-4#1)(2006-8#1)
the role of women##2##4##(1992-12#1)(1993-6#1)
the role of zinc##2##4##(1994-5#1)(2013-7#1)
the role of##1749##3##(1990-10#3)(1990-11#5)(1990-12#10)(1990-2#5)(1990-3#2)(1990-4#8)(1990-5#5)(1990-6#2)(1990-7#4)(1990-8#6)(1990-9#3)(1991-1#7)(1991-10#2)(1991-11#3)(1991-12#5)(1991-2#6)(1991-3#4)(1991-4#2)(1991-5#5)(1991-6#6)(1991-7#4)(1991-8#6)(1991-9#3)(1992-1#5)(1992-11#5)(1992-12#8)(1992-2#6)(1992-3#6)(1992-4#4)(1992-5#6)(1992-6#6)(1992-7#5)(1992-8#5)(1992-9#8)(1993-10#1)(1993-11#16)(1993-12#13)(1993-2#4)(1993-3#10)(1993-4#4)(1993-5#1)(1993-6#8)(1993-7#2)(1993-8#3)(1993-9#3)(1994-1#1)(1994-10#5)(1994-11#10)(1994-12#8)(1994-2#12)(1994-3#12)(1994-4#2)(1994-5#8)(1994-6#10)(1994-8#9)(1994-9#9)(1995-1#7)(1995-10#3)(1995-11#4)(1995-12#12)(1995-2#15)(1995-3#6)(1995-4#1)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#12)(1996-1#3)(1996-10#8)(1996-11#6)(1996-12#4)(1996-2#6)(1996-3#5)(1996-4#5)(1996-5#9)(1996-6#2)(1996-7#4)(1996-8#8)(1996-9#2)(1997-2#12)(1997-3#3)(1997-4#8)(1997-5#3)(1997-6#8)(1997-7#8)(1997-8#9)(2004-10#1)(2004-11#4)(2004-12#1)(2004-2#2)(2004-3#1)(2005-1#2)(2005-10#11)(2005-11#4)(2005-12#2)(2005-5#1)(2005-6#1)(2005-7#7)(2005-8#8)(2006-1#3)(2006-10#57)(2006-11#6)(2006-12#10)(2006-2#11)(2006-3#4)(2006-4#1)(2006-5#7)(2006-6#7)(2006-7#9)(2006-8#7)(2006-9#7)(2007-1#4)(2007-10#14)(2007-11#39)(2007-12#25)(2007-2#13)(2007-3#6)(2007-4#16)(2007-5#9)(2007-6#3)(2007-7#15)(2007-8#22)(2007-9#12)(2008-1#36)(2008-10#57)(2008-11#52)(2008-12#23)(2008-2#15)(2008-3#26)(2008-4#26)(2008-5#25)(2008-6#18)(2008-7#35)(2008-8#31)(2008-9#15)(2009-1#4)(2009-10#13)(2009-11#5)(2009-12#7)(2009-2#4)(2009-3#10)(2009-4#13)(2009-5#15)(2009-6#12)(2009-7#10)(2009-8#17)(2009-9#9)(2010-1#5)(2010-10#7)(2010-11#9)(2010-12#24)(2010-2#8)(2010-3#3)(2010-4#10)(2010-5#7)(2010-6#2)(2010-7#4)(2010-8#8)(2010-9#7)(2011-1#38)(2011-10#1)(2011-12#5)(2011-2#48)(2011-3#3)(2011-9#2)(2012-1#21)(2012-11#3)(2012-12#37)(2012-2#47)(2012-3#21)(2012-6#1)(2013-1#48)(2013-2#1)(2013-7#10)(2013-8#39)
the role played by the solvent##2##6##(1997-1#1)(2007-1#1)
the role played by the##8##5##(1997-1#1)(2007-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-10#1)
the role played by##32##4##(1990-11#1)(1990-9#1)(1992-12#1)(1993-12#2)(1996-5#1)(1997-1#1)(2006-10#4)(2007-1#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-10#2)(2012-2#1)(2013-1#1)(2013-8#1)
the role played in##4##4##(2005-9#1)(2007-11#1)(2008-6#1)(2010-7#1)
the role played##36##3##(1990-11#1)(1990-9#1)(1992-12#1)(1993-12#2)(1996-5#1)(1997-1#1)(2005-9#1)(2006-10#4)(2007-1#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-10#2)(2010-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
the role that the##2##4##(2004-9#1)(2008-12#1)
the role that##27##3##(1993-1#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-8#1)(1996-3#1)(1997-2#1)(2004-9#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-2#2)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the role the##2##3##(2007-7#1)(2009-8#1)
the role these##2##3##(1990-5#1)(2007-11#1)
the role they play in##3##5##(1990-12#1)(1995-2#1)(2005-11#1)
the role they play##4##4##(1990-12#1)(1995-2#1)(2005-11#1)(2006-10#1)
the role they##5##3##(1990-12#1)(1995-2#1)(2005-11#1)(2006-10#1)(2008-12#1)
the role this##2##3##(1992-6#1)(2008-9#1)
the role transition##2##3##(2008-11#2)
the role##1914##2##(1990-10#3)(1990-11#6)(1990-12#13)(1990-2#6)(1990-3#2)(1990-4#8)(1990-5#6)(1990-6#2)(1990-7#4)(1990-8#6)(1990-9#4)(1991-1#7)(1991-10#2)(1991-11#3)(1991-12#5)(1991-2#8)(1991-3#4)(1991-4#2)(1991-5#5)(1991-6#6)(1991-7#4)(1991-8#6)(1991-9#3)(1992-1#5)(1992-10#1)(1992-11#5)(1992-12#11)(1992-2#6)(1992-3#7)(1992-4#4)(1992-5#6)(1992-6#7)(1992-7#5)(1992-8#5)(1992-9#8)(1993-1#2)(1993-10#1)(1993-11#16)(1993-12#18)(1993-2#4)(1993-3#10)(1993-4#4)(1993-5#1)(1993-6#9)(1993-7#3)(1993-8#3)(1993-9#4)(1994-1#1)(1994-10#6)(1994-11#10)(1994-12#9)(1994-2#12)(1994-3#12)(1994-4#2)(1994-5#8)(1994-6#10)(1994-8#10)(1994-9#9)(1995-1#8)(1995-10#3)(1995-11#4)(1995-12#13)(1995-2#17)(1995-3#6)(1995-4#1)(1995-5#2)(1995-6#4)(1995-7#1)(1995-8#12)(1996-1#3)(1996-10#8)(1996-11#6)(1996-12#5)(1996-2#8)(1996-3#6)(1996-4#5)(1996-5#10)(1996-6#3)(1996-7#5)(1996-8#8)(1996-9#2)(1997-1#1)(1997-2#14)(1997-3#4)(1997-4#8)(1997-5#3)(1997-6#8)(1997-7#8)(1997-8#10)(2004-10#2)(2004-11#4)(2004-12#1)(2004-2#2)(2004-3#1)(2004-9#1)(2005-1#2)(2005-10#11)(2005-11#6)(2005-12#3)(2005-5#1)(2005-6#1)(2005-7#7)(2005-8#8)(2005-9#1)(2006-1#4)(2006-10#65)(2006-11#6)(2006-12#10)(2006-2#11)(2006-3#4)(2006-4#1)(2006-5#7)(2006-6#7)(2006-7#9)(2006-8#8)(2006-9#7)(2007-1#5)(2007-10#15)(2007-11#42)(2007-12#27)(2007-2#13)(2007-3#6)(2007-4#16)(2007-5#10)(2007-6#3)(2007-7#17)(2007-8#22)(2007-9#12)(2008-1#41)(2008-10#63)(2008-11#60)(2008-12#30)(2008-2#16)(2008-3#27)(2008-4#28)(2008-5#26)(2008-6#20)(2008-7#38)(2008-8#32)(2008-9#18)(2009-1#4)(2009-10#15)(2009-11#7)(2009-12#7)(2009-2#6)(2009-3#10)(2009-4#13)(2009-5#15)(2009-6#14)(2009-7#11)(2009-8#19)(2009-9#10)(2010-1#5)(2010-10#9)(2010-11#10)(2010-12#26)(2010-2#10)(2010-3#5)(2010-4#10)(2010-5#7)(2010-6#2)(2010-7#6)(2010-8#11)(2010-9#7)(2011-1#39)(2011-10#1)(2011-12#6)(2011-2#53)(2011-3#3)(2011-9#2)(2012-1#21)(2012-11#3)(2012-12#40)(2012-2#51)(2012-3#24)(2012-6#1)(2013-1#56)(2013-2#1)(2013-7#11)(2013-8#41)
the roles and responsibilities of##4##5##(1994-1#1)(2007-2#1)(2007-4#2)
the roles and##7##3##(1994-1#1)(1994-2#1)(2004-3#1)(2007-2#1)(2007-4#2)(2010-3#1)
the roles of community##2##4##(2009-4#1)(2011-1#1)
the roles of competition##2##4##(2008-8#1)(2008-9#1)
the roles of cytokines##2##4##(1997-2#1)(2007-11#1)
the roles of histamine and mast cells in##2##8##(1992-7#2)
the roles of lipid##2##4##(1995-12#1)(2011-2#1)
the roles of parents##2##4##(1990-2#1)(2010-10#1)
the roles of several##2##4##(1995-8#1)(2008-7#1)
the roles of the##21##4##(1992-2#1)(1992-3#1)(1993-12#1)(1994-8#1)(1996-10#1)(1996-4#1)(1997-6#1)(2005-11#1)(2005-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
the roles of these##5##4##(1990-5#1)(1995-3#1)(2010-12#1)(2012-12#1)(2012-2#1)
the roles of##128##3##(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1992-2#1)(1992-3#3)(1992-6#1)(1992-7#2)(1993-12#3)(1993-7#1)(1994-1#1)(1994-5#1)(1994-8#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-4#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-6#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-6#1)(2006-10#2)(2006-5#2)(2007-11#3)(2007-12#3)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#3)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#6)(2011-2#3)(2012-11#1)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#2)
the roles played by##3##4##(1990-10#1)(2008-12#1)(2008-2#1)
the roles played##4##3##(1990-10#1)(2007-11#1)(2008-12#1)(2008-2#1)
the roles that##4##3##(1994-3#1)(2008-7#1)(2008-8#1)(2010-3#1)
the roles##152##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-8#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#2)(1992-7#2)(1993-12#3)(1993-7#1)(1994-1#2)(1994-10#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#3)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-4#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-6#1)(1997-8#1)(2004-12#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-6#1)(2006-10#2)(2006-5#2)(2007-11#4)(2007-12#3)(2007-2#1)(2007-4#3)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#5)(2008-11#1)(2008-12#3)(2008-2#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#4)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#6)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#3)(2010-5#1)(2010-8#2)(2011-1#6)(2011-2#3)(2012-11#1)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#2)
the roll##2##2##(1990-10#1)(2012-2#1)
the roll-out##2##2##(2012-12#1)(2012-3#1)
the ronchigram##2##2##(2008-3#2)
the roof of the anterior##2##5##(2006-12#1)(2006-5#1)
the roof of the pulp chamber and pulp horn##3##9##(1994-5#3)
the roof of the##9##4##(1994-5#3)(1997-5#1)(2006-12#1)(2006-5#1)(2007-9#1)(2009-3#1)(2010-5#1)
the roof of##10##3##(1994-5#3)(1997-5#1)(2006-12#1)(2006-5#1)(2007-9#1)(2008-5#1)(2009-3#1)(2010-5#1)
the roof##13##2##(1994-5#3)(1997-5#1)(2006-12#1)(2006-5#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-3#1)(2010-5#1)(2013-8#2)
the room temperature##6##3##(1991-7#1)(2008-10#3)(2013-1#2)
the room##11##2##(1991-3#1)(1991-7#1)(2008-10#4)(2008-9#1)(2011-12#1)(2012-2#1)(2013-1#2)
the room-temperature phosphorescence##2##3##(2008-10#2)
the room-temperature##4##2##(2007-12#1)(2008-10#2)(2008-2#1)
the root and##8##3##(2008-10#5)(2010-2#1)(2013-1#2)
the root apex##2##3##(2009-6#1)(2013-8#1)
the root apical meristem##3##4##(2009-8#3)
the root bark of##6##4##(1994-3#1)(2007-1#1)(2008-10#2)(2008-11#1)(2008-12#1)
the root bark##8##3##(1994-3#1)(2007-1#3)(2008-10#2)(2008-11#1)(2008-12#1)
the root canal and##3##4##(2007-2#2)(2008-7#1)
the root canal filling##3##4##(2013-1#3)
the root canal system##6##4##(2008-7#1)(2013-1#5)
the root canal treatment##2##4##(2013-1#2)
the root canal##22##3##(2005-10#1)(2007-2#2)(2008-7#2)(2011-2#1)(2012-2#1)(2013-1#15)
the root canals##2##3##(2012-3#1)(2013-1#1)
the root cap##3##3##(2008-10#1)(2009-8#2)
the root causes of##4##4##(1995-12#1)(2009-10#1)(2010-8#1)(2013-8#1)
the root cortex##3##3##(2008-10#3)
the root epidermis and##2##4##(2008-10#2)
the root epidermis##3##3##(2008-10#2)(2009-8#1)
the root fraction and##2##4##(2008-10#2)
the root fraction##3##3##(2008-10#3)
the root hair##3##3##(2008-10#1)(2009-8#2)
the root is##2##3##(2008-10#2)
the root mean square deviations##2##5##(2006-10#2)
the root mean square error of calibration and##2##8##(2008-10#1)(2012-12#1)
the root mean square error of##3##6##(2008-10#2)(2012-12#1)
the root mean square##10##4##(2005-11#1)(2006-10#2)(2008-10#2)(2008-2#1)(2008-3#2)(2012-12#2)
the root of Caragana sinica##2##5##(2008-10#2)
the root of the##4##4##(1990-6#1)(2008-1#1)(2008-8#1)(2010-3#1)
the root of##20##3##(1990-11#1)(1990-6#1)(1993-9#1)(2006-4#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-8#1)(2009-5#1)(2009-6#1)(2010-12#4)(2010-3#1)(2012-3#1)(2013-8#1)
the root rot pathogen##2##4##(2008-10#1)(2012-2#1)
the root surface and##2##4##(2008-10#2)
the root surface##6##3##(2008-10#4)(2013-8#2)
the root system##5##3##(2008-10#5)
the root systems of##2##4##(2004-4#1)(2008-10#1)
the root systems##3##3##(2004-4#1)(2008-10#2)
the root tip##2##3##(2008-5#1)(2009-6#1)
the root tissues##3##3##(2008-10#3)
the root was##2##3##(1992-11#1)(2008-9#1)
the root zone##3##3##(2008-7#1)(2011-1#1)(2011-2#1)
the root##165##2##(1990-11#1)(1990-6#1)(1992-11#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-12#1)(2004-4#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-4#2)(2007-1#7)(2007-12#1)(2007-2#3)(2008-1#1)(2008-10#53)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#7)(2008-7#5)(2008-8#1)(2008-9#4)(2009-10#2)(2009-5#1)(2009-6#3)(2009-8#9)(2009-9#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#18)(2013-8#6)
the root-knot nematode (Meloidogyne##2##4##(2008-10#2)
the root-knot nematode Meloidogyne javanica##4##5##(2008-10#4)
the root-knot nematode Meloidogyne##6##4##(2008-10#6)
the root-knot nematode##10##3##(2008-10#9)(2009-3#1)
the root-knot##11##2##(2008-10#9)(2009-3#2)
the root-lesion nematode##3##3##(2008-10#3)
the root-mean-square##9##2##(1995-6#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#2)(2012-2#1)
the root-mean-squared error##2##3##(2008-3#1)(2009-10#1)
the root-mean-squared##3##2##(2008-3#2)(2009-10#1)
the root-soil interface##2##3##(2006-12#2)
the roots and the##3##4##(2007-1#1)(2008-10#2)
the roots and##8##3##(2007-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2009-8#1)
the roots of Derris##3##4##(2011-1#3)
the roots of Goniothalamus##2##4##(2007-1#2)
the roots of Gordonia chrysandra##2##5##(2010-6#2)
the roots of Ligularia dentata##2##5##(2007-1#2)
the roots of Ligularia##4##4##(2007-1#4)
the roots of Panax##2##4##(1994-12#1)(2006-12#1)
the roots of Pueraria lobata##2##5##(2007-1#2)
the roots of the##6##4##(1993-12#1)(2007-1#1)(2007-12#1)(2007-9#1)(2011-2#1)(2012-6#1)
the roots of##67##3##(1990-11#2)(1991-1#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-3#1)(1996-11#1)(2006-12#4)(2007-1#23)(2007-11#3)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#8)(2008-12#2)(2009-3#2)(2010-4#1)(2010-6#2)(2011-1#3)(2011-2#4)(2012-12#1)(2012-6#1)(2013-1#1)
the roots was##2##3##(2008-10#1)(2009-10#1)
the roots##108##2##(1990-11#2)(1991-1#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-9#1)(1996-11#1)(2004-4#1)(2006-12#4)(2007-1#25)(2007-11#3)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#27)(2008-11#2)(2008-12#4)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-3#4)(2009-8#3)(2010-3#1)(2010-4#1)(2010-6#2)(2011-1#3)(2011-2#6)(2012-12#1)(2012-5#1)(2012-6#1)(2013-1#1)
the rosette##3##2##(1997-2#1)(2007-12#1)(2008-10#1)
the rostral part of area 24c and##2##7##(1996-5#2)
the rostral part of area##3##5##(1996-5#3)
the rostral part of the Edinger-Westphal nucleus##3##7##(1993-12#3)
the rostral part of the##5##5##(1991-9#1)(1993-12#4)
the rostral part of##8##4##(1991-9#1)(1993-12#4)(1996-5#3)
the rostral pole of##2##4##(1990-9#1)(1991-5#1)
the rostral ventrolateral medulla (RVLM)##3##5##(1991-5#1)(1997-2#1)(1997-8#1)
the rostral ventrolateral medulla##6##4##(1991-5#1)(1997-2#1)(1997-6#2)(1997-8#2)
the rostral ventromedial medulla##2##4##(1993-2#2)
the rostral##44##2##(1990-9#1)(1991-11#1)(1991-5#2)(1991-9#1)(1992-8#1)(1993-12#7)(1993-2#2)(1993-3#1)(1993-7#1)(1993-9#2)(1994-12#1)(1995-7#2)(1996-12#1)(1996-3#1)(1996-4#2)(1996-5#3)(1997-2#1)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#2)(2007-2#1)(2008-1#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)
the rostral-caudal##2##2##(1997-3#2)
the rostrocaudal##2##2##(1990-4#1)(1995-5#1)
the rotamer##3##2##(1990-5#1)(2012-3#2)
the rotarod##2##2##(1997-2#1)(2009-4#1)
the rotary##7##2##(2007-12#1)(2008-10#1)(2008-2#1)(2010-7#2)(2012-12#2)
the rotated##3##2##(2008-3#3)
the rotating flow##2##3##(2005-11#2)
the rotating##8##2##(1992-3#1)(1992-9#1)(2005-11#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)
the rotation angle##2##3##(2008-2#1)(2008-3#1)
the rotation axis is##2##4##(2008-3#1)(2011-1#1)
the rotation axis##4##3##(1993-4#1)(2008-3#2)(2011-1#1)
the rotation between##2##3##(1993-1#2)
the rotation of the##6##4##(1991-11#1)(1991-5#1)(1996-2#1)(2005-11#1)(2008-3#1)(2009-8#1)
the rotation of##12##3##(1991-11#1)(1991-5#1)(1993-2#1)(1993-3#1)(1996-2#1)(2005-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-8#1)
the rotation rate of##2##4##(1997-4#1)(2008-11#1)
the rotation##37##2##(1991-11#1)(1991-5#1)(1992-9#1)(1993-1#2)(1993-2#1)(1993-3#1)(1993-4#1)(1996-2#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-5#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#10)(2008-7#1)(2008-8#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#1)
the rotational Raman##3##3##(2007-11#1)(2008-3#2)
the rotational correlation time of##2##5##(1992-3#1)(1994-9#1)
the rotational correlation time##5##4##(1992-3#1)(1994-9#1)(1996-5#1)(2008-10#1)(2010-9#1)
the rotational diffusion##3##3##(1990-5#1)(1990-7#1)(2010-9#1)
the rotational response##2##3##(1993-12#1)(1994-10#1)
the rotational##35##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#1)(1992-3#1)(1993-12#3)(1994-10#1)(1994-3#1)(1994-9#1)(1996-5#1)(1997-1#2)(2007-11#2)(2007-12#3)(2008-10#5)(2008-2#2)(2008-3#4)(2010-10#1)(2010-2#1)(2010-9#2)
the rotationally sheared##2##3##(2008-3#2)
the rotator cuff##10##3##(1994-2#2)(2007-11#3)(2007-7#1)(2009-4#1)(2012-12#2)(2012-2#1)
the rotator##11##2##(1990-3#1)(1994-2#2)(2007-11#3)(2007-7#1)(2009-4#1)(2012-12#2)(2012-2#1)
the rotavirus##2##2##(2006-12#1)(2013-8#1)
the rotenone##3##2##(1994-8#1)(1996-9#1)(2011-1#1)
the rotenone-sensitive##4##2##(1990-11#2)(1990-8#2)
the rotifer##4##2##(2010-12#1)(2012-2#3)
the rotor##2##2##(2008-10#1)(2008-8#1)
the rotor-impeller##2##2##(2008-8#2)
the rough endoplasmic reticulum and##3##5##(1992-6#1)(1996-5#1)(2013-1#1)
the rough endoplasmic reticulum##10##4##(1992-12#1)(1992-3#1)(1992-6#1)(1996-5#1)(1996-8#2)(2008-7#2)(2009-2#1)(2013-1#1)
the rough endoplasmic##12##3##(1992-12#1)(1992-3#1)(1992-6#1)(1996-5#1)(1996-8#3)(2008-7#2)(2009-2#2)(2013-1#1)
the rough surface##3##3##(2007-12#1)(2008-3#2)
the rough##26##2##(1991-12#1)(1992-12#1)(1992-3#1)(1992-6#1)(1994-3#1)(1996-5#1)(1996-8#3)(1997-1#1)(2005-11#1)(2006-1#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#2)(2009-2#2)(2013-1#1)
the roughening##2##2##(1995-11#1)(2006-4#1)
the roughly##4##2##(1990-8#1)(2007-12#1)(2007-9#1)(2008-2#1)
the roughness and##3##3##(2008-3#1)(2011-2#1)(2013-1#1)
the roughness feature set##2##4##(2008-2#2)
the roughness heights##2##3##(2007-12#2)
the roughness of the surfaces##2##5##(2005-11#1)(2008-3#1)
the roughness of the##8##4##(2005-11#1)(2008-2#2)(2008-3#5)
the roughness of##12##3##(2005-11#1)(2008-2#3)(2008-3#8)
the roughness##21##2##(2005-11#1)(2007-12#4)(2008-2#5)(2008-3#9)(2011-2#1)(2013-1#1)
the round cells##3##3##(1993-4#2)(1996-5#1)
the round##5##2##(1993-4#2)(1996-5#1)(2008-10#1)(2009-2#1)
the route by which the##3##5##(2006-10#1)(2008-10#1)(2009-5#1)
the route by which##4##4##(2006-10#1)(2008-10#2)(2009-5#1)
the route of administration##4##4##(1992-11#3)(1996-8#1)
the route of delivery##3##4##(1993-6#1)(2006-10#2)
the route of hysterectomy##2##4##(1994-2#1)(1996-2#1)
the route of##15##3##(1992-11#3)(1993-6#1)(1994-2#1)(1996-2#1)(1996-8#1)(2006-10#3)(2007-2#1)(2008-1#1)(2008-5#1)(2008-9#1)(2009-6#1)
the route to and from the breeding##2##7##(2008-5#1)(2008-6#1)
the route to##5##3##(2007-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-12#1)
the route##29##2##(1992-11#3)(1993-6#1)(1994-10#1)(1994-2#1)(1996-2#1)(1996-8#1)(2005-11#1)(2006-10#4)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-6#1)(2012-12#2)(2013-1#1)
the routes of##4##3##(1994-5#1)(2006-10#1)(2011-12#1)(2013-8#1)
the routes##10##2##(1994-5#1)(1997-7#1)(2006-10#1)(2009-9#1)(2011-12#1)(2011-2#3)(2012-12#1)(2013-8#1)
the routine analysis of##8##4##(2008-10#5)(2008-11#1)(2010-2#1)(2010-4#1)
the routine analysis##11##3##(2005-12#1)(2008-10#6)(2008-11#1)(2010-2#1)(2010-4#1)(2011-1#1)
the routine clinical##2##3##(2007-7#1)(2013-1#1)
the routine collection##2##3##(1992-2#1)(2009-3#1)
the routine detection##2##3##(2005-8#1)(2008-10#1)
the routine examination of##2##4##(2008-12#1)(2012-2#1)
the routine examinations##2##3##(1992-11#1)(2006-10#1)
the routine of everyday practice##3##5##(2008-3#3)
the routine physical##2##3##(2006-10#1)(2006-9#1)
the routine screening of##2##4##(1991-10#1)(1997-8#1)
the routine surgical##2##3##(1993-2#1)(2007-8#1)
the routine treatment##2##3##(2007-8#1)(2011-2#1)
the routine use of##24##4##(1993-5#1)(1995-2#1)(2005-12#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-7#1)(2006-9#1)(2007-7#2)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#1)(2010-11#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-3#1)
the routine##118##2##(1990-2#1)(1990-6#1)(1991-10#1)(1991-4#1)(1992-11#1)(1992-2#2)(1992-5#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-5#1)(1994-3#2)(1994-6#1)(1995-2#1)(1996-9#2)(1997-3#1)(1997-8#1)(2005-12#2)(2005-7#1)(2005-8#1)(2006-10#4)(2006-2#2)(2006-6#2)(2006-7#1)(2006-9#3)(2007-10#2)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#16)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#4)(2008-6#4)(2008-7#4)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#3)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
the routinely used##2##3##(1993-7#1)(2008-9#1)
the routinely##3##2##(1993-7#1)(2006-6#1)(2008-9#1)
the routines for##3##3##(1990-4#1)(1990-6#1)(1993-5#1)
the routines##4##2##(1990-4#1)(1990-6#1)(1993-5#1)(2005-11#1)
the routing##3##2##(2006-4#1)(2012-2#1)(2013-8#1)
the rows of##3##3##(2007-12#2)(2011-2#1)
the rows##6##2##(2007-12#2)(2008-10#2)(2008-3#1)(2011-2#1)
the royal##6##2##(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
the rps1##2##2##(2008-10#2)
the rtN236T##2##2##(2013-1#2)
the rubella##2##2##(2007-12#1)(2007-8#1)
the rubrerythrin##2##2##(1991-12#2)
the rubric of the##3##4##(2008-5#1)(2008-6#1)(2010-1#1)
the rubric of##5##3##(2008-11#1)(2008-5#1)(2008-6#1)(2010-1#1)(2012-12#1)
the rudimentary##2##2##(2007-8#1)(2011-1#1)
the ruggedness##2##2##(2008-10#2)
the rule and##2##3##(2008-10#1)(2008-4#1)
the rule for##2##3##(1996-12#1)(2006-7#1)
the rule in##4##3##(1997-2#1)(1997-3#1)(2008-6#1)(2008-8#1)
the rule##32##2##(1990-11#1)(1995-9#1)(1996-12#2)(1997-2#1)(1997-3#1)(2004-4#1)(2006-10#1)(2006-12#1)(2006-7#4)(2006-8#5)(2007-11#2)(2007-7#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-2#1)(2010-7#1)(2011-3#1)
the ruled##2##2##(2008-2#1)(2008-3#1)
the rules and##4##3##(1995-6#1)(2008-9#1)(2009-5#1)(2009-9#1)
the rules are##2##3##(1995-6#1)(2008-2#1)
the rules for##4##3##(1995-10#1)(1997-3#1)(2008-8#1)(2009-10#1)
the rules governing##3##3##(1995-3#1)(1995-5#1)(2008-9#1)
the rules of the##2##4##(2007-11#2)
the rules of##10##3##(1995-6#1)(2007-10#1)(2007-11#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2011-2#2)
the rules##35##2##(1990-5#1)(1991-2#1)(1995-10#1)(1995-3#1)(1995-5#1)(1995-6#6)(1997-3#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-11#1)(2008-2#3)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-9#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-7#1)
the rules?##2##2##(1994-3#1)(1997-3#1)
the ruling##4##2##(1995-12#1)(1996-11#1)(1997-5#1)(2007-8#1)
the rumen fluid of##2##4##(2006-8#2)
the rumen##12##2##(2006-8#6)(2008-12#1)(2009-4#2)(2011-2#2)(2013-1#1)
the ruminal##2##2##(2006-8#1)(2008-5#1)
the run buffer##2##3##(2008-10#2)
the run time##3##3##(1996-8#1)(2010-12#1)(2012-12#1)
the run##9##2##(1991-8#1)(1994-4#1)(1996-8#1)(1997-2#1)(2008-10#2)(2008-7#1)(2010-12#1)(2012-12#1)
the run-in##5##2##(1993-1#4)(1995-12#1)
the running buffer##3##3##(1992-2#1)(2007-8#1)(2008-10#1)
the running##13##2##(1992-2#1)(1993-8#1)(1996-5#1)(2007-6#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-3#2)(2010-7#1)
the rupture force##2##3##(2005-11#1)(2009-9#1)
the rupture of a##4##4##(2007-12#1)(2007-6#1)(2008-6#1)(2013-8#1)
the rupture of foam##2##4##(1992-5#2)
the rupture of the right##2##5##(2009-2#2)
the rupture of the##7##4##(2007-7#1)(2008-10#1)(2008-11#1)(2009-2#2)(2009-5#1)(2012-2#1)
the rupture of##19##3##(1991-5#2)(1992-5#2)(1995-9#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-6#1)(2009-2#3)(2009-5#1)(2012-2#1)(2013-8#2)
the rupture site##2##3##(2007-7#2)
the rupture##35##2##(1991-4#1)(1991-5#2)(1992-5#3)(1993-1#1)(1993-12#1)(1995-5#1)(1995-9#1)(2005-11#1)(2007-12#1)(2007-6#1)(2007-7#5)(2008-10#1)(2008-11#2)(2008-6#2)(2008-7#1)(2009-2#3)(2009-5#1)(2009-9#3)(2011-3#1)(2012-2#1)(2013-8#2)
the ruptured aneurysm##2##3##(2007-10#1)(2008-7#1)
the ruptured##8##2##(1997-3#1)(2006-4#1)(2007-10#1)(2007-5#1)(2008-5#2)(2008-7#1)(2009-5#1)
the rural and urban##2##4##(2009-10#1)(2011-11#1)
the rural area of the##2##5##(2008-6#1)(2012-12#1)
the rural area##3##3##(2008-6#1)(2011-11#1)(2012-12#1)
the rural areas and##3##4##(2007-7#2)(2011-2#1)
the rural areas of##2##4##(2008-5#2)
the rural areas##9##3##(2007-7#3)(2008-3#1)(2008-5#2)(2011-1#2)(2011-2#1)
the rural community##2##3##(2011-1#1)(2011-11#1)
the rural participants##2##3##(2008-11#2)
the rural population of##2##4##(1994-6#1)(2011-1#1)
the rural population##5##3##(1994-6#1)(2007-9#1)(2008-6#1)(2011-1#1)(2012-12#1)
the rural setting##2##3##(2007-12#1)(2010-5#1)
the rural##46##2##(1991-1#1)(1993-12#1)(1994-1#1)(1994-2#1)(1994-6#1)(1995-11#1)(1996-3#1)(1997-6#1)(2007-10#1)(2007-12#1)(2007-7#3)(2007-9#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#3)(2009-10#2)(2009-7#1)(2009-9#1)(2010-4#1)(2010-5#1)(2011-1#6)(2011-11#4)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
the rust fungus##5##3##(2008-10#5)
the rust##12##2##(2008-10#12)
the rusts##2##2##(2008-10#2)
the rut##3##2##(1996-8#3)
the ruthenium center##2##3##(2010-5#2)
the ruthenium complex##3##3##(2005-11#2)(2010-12#1)
the ruthenium##12##2##(2005-11#2)(2008-10#1)(2008-3#3)(2010-12#1)(2010-5#5)
the rvs167##2##2##(1997-6#2)
the ryanodine receptor calcium release channel##2##6##(1995-2#1)(2006-10#1)
the ryanodine receptor in##2##4##(1993-9#1)(1994-8#1)
the ryanodine receptor##8##3##(1991-7#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-2#1)(1997-3#1)(2006-10#2)
the ryanodine##11##2##(1991-7#2)(1993-9#1)(1994-8#3)(1994-9#1)(1995-2#1)(1997-3#1)(2006-10#2)
the rye##4##2##(1997-3#2)(2008-5#2)
the s##6##2##(1992-9#1)(1993-2#1)(1995-11#1)(1995-5#1)(1996-6#1)(2007-11#1)
the s- and##3##3##(2007-8#1)(2008-3#2)
the sAP complex##2##3##(1994-9#2)
the sAP##3##2##(1994-9#3)
the sac##7##2##(1995-11#2)(2007-12#2)(2008-6#1)(2009-6#1)(2012-3#1)
the saca cena##2##3##(2006-7#2)
the saccadic##3##2##(1991-5#1)(1992-10#1)(1993-12#1)
the saccharin##2##2##(2008-2#1)(2008-5#1)
the sacral IML##2##3##(1993-12#2)
the sacral bone and##2##4##(2007-11#1)(2013-8#1)
the sacral bone##3##3##(2007-11#2)(2013-8#1)
the sacral parasympathetic##2##3##(1991-5#1)(1993-12#1)
the sacral spinal cord##2##4##(1993-12#1)(2008-3#1)
the sacral##18##2##(1991-5#1)(1991-8#1)(1993-12#6)(2006-8#2)(2007-11#2)(2007-7#1)(2008-3#1)(2008-6#1)(2008-7#2)(2013-8#1)
the sacrococcygeal region##2##3##(2007-5#1)(2011-12#1)
the sacroiliac joint injection is##2##5##(2006-8#2)
the sacroiliac joint##12##3##(2006-12#2)(2006-8#6)(2007-11#3)(2011-2#1)
the sacroiliac joints##5##3##(1990-6#2)(2006-10#1)(2006-12#1)(2011-2#1)
the sacroiliac##18##2##(1990-6#2)(2006-10#1)(2006-12#3)(2006-8#6)(2007-11#3)(2007-7#1)(2011-2#2)
the sacrum and pelvis##2##4##(1991-11#1)(2006-10#1)
the sacrum and##3##3##(1991-11#1)(2006-10#1)(2011-2#1)
the sacrum##12##2##(1991-11#1)(1991-8#1)(1995-9#1)(2006-10#2)(2007-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2011-2#2)(2013-8#1)
the safe and effective treatment of##2##6##(2006-12#1)(2008-9#1)
the safe and effective##5##4##(2006-12#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)
the safe harbors##2##3##(1991-1#1)(1993-1#1)
the safe range##2##3##(2007-8#1)(2010-12#1)
the safe use of##7##4##(1993-4#1)(1994-12#1)(2007-11#1)(2008-2#2)(2008-8#1)(2010-9#1)
the safe##38##2##(1991-1#1)(1991-3#2)(1993-1#2)(1993-12#1)(1993-4#1)(1994-12#1)(1994-6#1)(1996-10#2)(1996-2#1)(1996-9#1)(2006-12#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-2#1)(2013-1#1)
the safest and most effective##2##5##(1990-12#1)(2007-11#1)
the safest and most##3##4##(1990-12#1)(2007-11#1)(2008-7#1)
the safest and##4##3##(1990-12#1)(2007-11#1)(2008-7#1)(2010-9#1)
the safest treatment for acute psychosis in the critically ill##2##10##(2007-8#2)
the safest##11##2##(1990-12#1)(1991-3#1)(2006-12#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-9#1)
the safety and clinical##2##4##(2007-11#1)(2008-7#1)
the safety and effectiveness of inhalation sedation##2##7##(2011-12#2)
the safety and effectiveness of##8##5##(2006-10#1)(2008-10#1)(2008-8#1)(2010-6#1)(2011-12#2)(2011-2#1)(2012-2#1)
the safety and effectiveness##9##4##(2006-10#1)(2008-10#1)(2008-8#1)(2010-6#1)(2011-12#2)(2011-2#1)(2012-12#1)(2012-2#1)
the safety and efficacy of Intaxel##2##6##(2013-8#2)
the safety and efficacy of a##2##6##(2007-7#1)(2007-8#1)
the safety and efficacy of oral pilocarpine##2##7##(2006-10#2)
the safety and efficacy of percutaneous##2##6##(2006-8#1)(2007-11#1)
the safety and efficacy of the##4##6##(2006-10#1)(2006-8#1)(2008-11#2)
the safety and efficacy of these drugs##2##7##(2008-10#1)(2008-11#1)
the safety and efficacy of these##3##6##(2006-5#1)(2008-10#1)(2008-11#1)
the safety and efficacy of##56##5##(1991-11#1)(1994-5#2)(1996-3#1)(1997-3#1)(2004-1#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-10#3)(2007-11#1)(2007-2#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#5)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#2)
the safety and immunogenicity##2##4##(2008-4#1)(2010-1#1)
the safety and##89##3##(1991-11#1)(1992-2#1)(1994-5#2)(1995-7#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-4#1)(2004-1#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#2)(2007-2#2)(2007-3#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#4)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#2)(2010-4#2)(2010-6#1)(2010-9#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
the safety aspects of##2##4##(1994-6#1)(2011-12#1)
the safety aspects##3##3##(1994-6#2)(2011-12#1)
the safety assessment of##2##4##(2006-12#1)(2013-7#1)
the safety critical##2##3##(2007-2#1)(2012-12#1)
the safety of a##4##4##(1990-11#1)(2006-10#1)(2007-2#1)(2012-3#1)
the safety of acupuncture##2##4##(2008-10#2)
the safety of animal products##2##5##(2005-5#2)
the safety of desmopressin##2##4##(2008-8#2)
the safety of food##2##4##(2008-2#1)(2012-1#1)
the safety of long-term##2##4##(2006-10#1)(2008-10#1)
the safety of oral##2##4##(2005-7#1)(2013-8#1)
the safety of patients##2##4##(1993-12#1)(2010-9#1)
the safety of the drug##2##5##(2006-11#1)(2008-7#1)
the safety of the##29##4##(1990-6#1)(1991-3#1)(1997-3#1)(2006-10#2)(2006-11#1)(2006-4#1)(2006-6#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
the safety of these##2##4##(2006-10#1)(2008-10#1)
the safety of this drug##2##5##(2008-11#1)(2010-12#1)
the safety of this##4##4##(2006-8#1)(2008-11#1)(2008-5#1)(2010-12#1)
the safety of##120##3##(1990-11#1)(1990-6#2)(1991-1#1)(1991-3#1)(1991-5#1)(1992-5#1)(1993-12#1)(1993-3#1)(1995-4#1)(1995-5#1)(1996-3#2)(1996-9#1)(1997-3#1)(2005-11#1)(2005-5#3)(2005-7#1)(2006-10#10)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-11#3)(2007-2#2)(2007-7#2)(2007-8#2)(2007-9#2)(2008-10#5)(2008-11#5)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#5)(2008-9#2)(2009-10#4)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#5)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#3)
the safety profile of##6##4##(2008-10#1)(2008-6#1)(2008-8#2)(2010-12#2)
the safety profile##7##3##(2008-10#1)(2008-6#1)(2008-8#3)(2010-12#2)
the safety requirements##2##3##(2012-1#2)
the safety##256##2##(1990-11#1)(1990-6#2)(1991-1#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-5#1)(1993-12#2)(1993-3#1)(1994-11#1)(1994-5#2)(1994-6#2)(1995-4#1)(1995-5#1)(1995-7#1)(1996-12#1)(1996-3#3)(1996-5#1)(1996-9#1)(1997-3#2)(1997-4#1)(2004-1#1)(2005-11#1)(2005-5#3)(2005-7#2)(2005-8#1)(2006-10#17)(2006-11#2)(2006-12#2)(2006-2#2)(2006-4#2)(2006-5#2)(2006-6#2)(2006-8#4)(2006-9#1)(2007-1#3)(2007-10#4)(2007-11#5)(2007-2#5)(2007-3#3)(2007-7#5)(2007-8#6)(2007-9#2)(2008-1#2)(2008-10#9)(2008-11#10)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#5)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#12)(2008-9#3)(2009-10#4)(2009-12#2)(2009-2#2)(2009-4#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#8)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#4)(2011-12#3)(2011-2#9)(2011-3#1)(2012-1#7)(2012-12#8)(2012-2#5)(2012-3#3)(2013-1#10)(2013-7#2)(2013-8#5)
the sag parameter was##2##4##(2008-5#2)
the sag parameter##4##3##(2008-5#4)
the sag treatment lotion##2##4##(2008-5#2)
the sag##7##2##(2008-5#7)
the sagittal and##2##3##(1995-5#1)(2008-3#1)
the sagittal plane##19##3##(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#2)(2010-9#1)(2012-1#3)(2013-1#1)
the sagittal##34##2##(1995-11#1)(1995-5#1)(2004-3#1)(2005-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#4)(2007-8#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#2)(2010-9#1)(2012-1#4)(2013-1#2)(2013-8#2)
the said##6##2##(2005-11#1)(2008-10#2)(2008-3#1)(2009-6#1)(2010-4#1)
the sake of illustration##2##4##(2008-10#2)
the sake of##10##3##(1994-12#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-9#1)(2009-6#1)(2013-8#1)
the salary and##2##3##(2007-4#1)(2012-12#1)
the sale of##12##3##(1990-5#1)(1991-10#1)(1992-11#1)(1992-8#1)(1993-10#1)(1996-11#1)(1996-12#1)(2005-7#1)(2008-9#1)(2010-8#1)(2013-1#1)(2013-8#1)
the salicylate hydroxylase##2##3##(1996-7#2)
the salicylate##5##2##(1996-7#2)(2008-10#3)
the salicylic acid##2##3##(2009-6#1)(2009-8#1)
the salience of##2##3##(1997-3#1)(2008-3#1)
the salient features of##2##4##(2007-4#1)(2008-2#1)
the salient features##3##3##(2007-4#1)(2008-2#1)(2010-5#1)
the salient##8##2##(2005-8#1)(2007-4#1)(2007-8#2)(2008-10#1)(2008-2#1)(2010-5#1)(2010-8#1)
the saline and##3##3##(2007-12#1)(2007-5#1)(2008-7#1)
the saline control##2##3##(1995-12#1)(2008-7#1)
the saline matrix##3##3##(2008-10#3)
the saline##21##2##(1990-11#1)(1991-6#1)(1993-7#1)(1995-12#1)(2004-10#1)(2006-9#1)(2007-12#1)(2007-5#1)(2008-10#5)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#2)
the saline- and##2##3##(1996-10#1)(2008-10#1)
the saline- or Meth-paired chamber##2##5##(2012-2#2)
the saline-##4##2##(1996-10#1)(2008-10#1)(2012-2#2)
the saline-treated animals##2##3##(1994-10#1)(1996-10#1)
the saline-treated control mice##2##4##(1993-3#2)
the saline-treated control##3##3##(1993-3#2)(1996-10#1)
the saline-treated controls##2##3##(1996-10#2)
the saline-treated##9##2##(1993-3#2)(1994-10#1)(1996-10#5)(2009-10#1)
the salinity and temperature##2##4##(2008-5#1)(2011-2#1)
the salinity##7##2##(1997-6#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)(2013-1#1)
the saliva of##6##3##(2009-3#1)(2011-12#5)
the saliva##16##2##(1991-8#1)(2004-9#1)(2007-9#3)(2008-10#3)(2009-3#1)(2010-12#1)(2011-12#5)(2012-3#1)
the salivary and the serum nitric oxide levels##2##8##(2013-8#2)
the salivary and the serum##4##5##(2013-8#4)
the salivary duct##3##3##(1992-5#2)(2008-10#1)
the salivary gland is##2##4##(1994-7#1)(2009-3#1)
the salivary gland##10##3##(1994-7#1)(1995-8#1)(2007-12#1)(2008-11#2)(2009-1#1)(2009-3#2)(2013-1#1)(2013-8#1)
the salivary glands is##2##4##(2008-10#1)(2008-4#1)
the salivary glands of##7##4##(2008-10#3)(2008-4#2)(2008-8#1)(2013-1#1)
the salivary glands##20##3##(2004-11#2)(2008-10#9)(2008-4#5)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
the salivary proteins##2##3##(2010-2#1)(2011-12#1)
the salivary##50##2##(1992-5#2)(1993-12#1)(1994-7#1)(1995-8#1)(1996-12#1)(2004-11#2)(2007-12#1)(2007-9#3)(2008-10#12)(2008-11#2)(2008-4#5)(2008-7#1)(2008-8#1)(2009-1#1)(2009-3#2)(2010-2#2)(2011-12#1)(2011-2#2)(2013-1#2)(2013-8#7)
the salivation##4##2##(1996-12#2)(2008-10#1)(2010-12#1)
the salmon##4##2##(1992-6#1)(1993-3#1)(1995-11#1)(2008-5#1)
the salpinx##2##2##(1992-8#1)(2011-1#1)
the salt bridge##6##3##(1993-3#3)(1995-1#2)(2008-10#1)
the salt concentration and##3##4##(1990-5#1)(2005-11#1)(2012-12#1)
the salt concentration##6##3##(1990-5#1)(1997-2#1)(1997-6#1)(2005-11#1)(2012-12#1)(2013-8#1)
the salt##33##2##(1990-2#1)(1990-5#1)(1992-11#1)(1992-9#1)(1993-3#3)(1994-10#1)(1995-1#2)(1997-2#3)(1997-6#1)(2005-11#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#4)(2008-12#1)(2008-4#2)(2008-5#1)(2008-9#2)(2009-6#1)(2012-12#1)(2013-8#1)
the salt-bridge form of bradykinin##2##5##(2006-4#2)
the salt-bridge form of##3##4##(2006-2#1)(2006-4#2)
the salt-bridge structure##2##3##(2006-2#2)
the salt-bridge##8##2##(2006-2#5)(2006-4#3)
the salt-free##2##2##(2008-5#2)
the salt-induced##2##2##(1995-5#1)(2008-7#1)
the salt/sodium content of##2##4##(2013-1#2)
the salting-out##3##2##(1990-5#1)(2008-10#2)
the salts##4##2##(1996-2#1)(1996-5#1)(2005-11#1)(2010-4#1)
the saltwater crocodile (Crocodylus porosus)##2##5##(2010-3#2)
the salutary##2##2##(1994-3#1)(2013-1#1)
the salvage of##3##3##(2007-11#1)(2007-2#1)(2008-4#1)
the salvage pathway##3##3##(1995-8#1)(1996-10#2)
the salvage##9##2##(1992-10#1)(1995-8#1)(1996-10#2)(2007-11#2)(2007-2#1)(2008-4#1)(2010-11#1)
the same 2##2##3##(1994-11#1)(2007-6#1)
the same 3##2##3##(2005-10#1)(2011-2#1)
the same AFLP##3##3##(2008-10#3)
the same AG##3##3##(2008-10#3)
the same C##2##3##(1991-12#1)(2008-10#1)
the same C-terminal##2##3##(1992-6#1)(2007-6#1)
the same CT-rich motif##2##4##(1997-1#2)
the same DNA element##2##4##(1992-11#1)(1994-12#1)
the same DNA sequence##2##4##(1991-10#1)(1994-8#1)
the same DNA##10##3##(1990-3#1)(1991-10#1)(1992-11#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-1#1)(2008-10#1)(2009-10#1)
the same ELISA##2##3##(1996-11#1)(2008-10#1)
the same ER##2##3##(1996-9#1)(2009-8#1)
the same N-terminal##3##3##(1993-9#1)(1994-6#1)(1996-3#1)
the same RNA##2##3##(1994-8#1)(2008-7#1)
the same T##2##3##(1991-3#1)(2005-10#1)
the same VCG##2##3##(2008-10#2)
the same VM neurons##2##4##(1997-7#2)
the same accuracy##6##3##(1995-11#1)(1997-6#1)(2008-2#1)(2008-3#1)(2010-12#2)
the same across##2##3##(2008-4#1)(2010-11#1)
the same action##2##3##(1995-5#1)(2008-5#1)
the same active##3##3##(1994-2#1)(2008-10#1)(2008-4#1)
the same activities##2##3##(1991-3#1)(1997-6#1)
the same activity##3##3##(1991-2#1)(1995-5#1)(1997-7#1)
the same acyl##2##3##(1991-7#2)
the same affinity as wild type Ffh##2##7##(1996-5#2)
the same affinity as##4##4##(1990-2#1)(1994-9#1)(1996-5#2)
the same affinity##6##3##(1990-11#1)(1990-2#1)(1991-7#1)(1994-9#1)(1996-5#2)
the same age and##5##4##(1990-11#1)(1991-11#1)(2006-4#1)(2012-2#1)(2013-1#1)
the same age group##9##4##(1990-2#1)(1990-6#1)(1992-4#1)(2004-2#1)(2008-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
the same age groups##2##4##(1991-12#1)(2008-1#1)
the same age in##2##4##(1991-11#1)(2008-1#1)
the same age##36##3##(1990-11#2)(1990-2#1)(1990-6#1)(1991-11#2)(1991-12#2)(1991-9#2)(1992-10#1)(1992-4#1)(1994-12#1)(1995-9#1)(1996-6#1)(1997-5#1)(2004-11#1)(2004-2#1)(2006-10#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-12#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
the same agent##3##3##(1994-5#1)(1997-8#1)(2008-3#1)
the same amino acid sequence as##2##6##(1990-10#1)(1992-5#1)
the same amino acid sequence##7##5##(1990-10#1)(1991-6#1)(1992-5#1)(1995-3#1)(2013-8#3)
the same amino acid##10##4##(1990-10#1)(1991-6#1)(1992-5#1)(1992-7#1)(1993-11#1)(1994-12#1)(1995-3#1)(2013-8#3)
the same amino acids##2##4##(1994-12#1)(2008-8#1)
the same amino##12##3##(1990-10#1)(1991-6#1)(1992-5#1)(1992-7#1)(1993-11#1)(1994-12#2)(1995-3#1)(2008-8#1)(2013-8#3)
the same amount and##2##4##(1992-9#1)(1995-6#1)
the same amount of##13##4##(1990-2#1)(1993-7#1)(1996-1#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-12#1)
the same amount##20##3##(1990-2#1)(1992-1#1)(1992-9#1)(1993-7#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-2#1)(2006-7#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-12#1)
the same analysis##3##3##(1997-2#1)(2008-10#1)(2008-7#1)
the same analyte##3##3##(2008-10#3)
the same analytical##3##3##(1997-8#1)(2008-10#1)(2013-1#1)
the same and different##2##4##(1995-12#1)(2008-3#1)
the same and##7##3##(1990-4#1)(1993-8#1)(1995-12#1)(2007-3#1)(2007-7#1)(2008-3#1)(2012-1#1)
the same animals were##2##4##(1991-5#1)(1993-6#1)
the same animals##6##3##(1990-4#1)(1991-5#1)(1993-12#1)(1993-6#1)(1993-9#1)(1996-3#1)
the same antibody##5##3##(1993-11#1)(1996-7#1)(1997-2#1)(2007-8#1)(2008-7#1)
the same antigen##4##3##(1990-12#1)(2008-10#2)(2008-11#1)
the same aphid##2##3##(2008-10#2)
the same approach##9##3##(1992-5#1)(1996-11#1)(2008-10#1)(2008-4#3)(2008-8#1)(2010-12#1)(2011-1#1)
the same area of##2##4##(2006-6#1)(2008-5#1)
the same area was##2##4##(2008-3#1)(2008-5#1)
the same area##15##3##(1992-6#1)(1993-6#1)(1995-1#2)(1996-7#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-3#1)(2008-2#1)(2008-3#1)(2008-5#3)(2011-1#1)
the same areas##6##3##(2004-2#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-5#1)(2010-5#1)
the same as for##7##4##(1990-5#1)(1991-11#1)(1993-4#1)(1996-8#1)(1997-7#1)(2004-11#1)(2011-2#1)
the same as in the##4##5##(1990-5#1)(1992-2#1)(1994-12#1)(2006-11#1)
the same as in##12##4##(1990-5#1)(1991-8#1)(1992-2#1)(1992-8#1)(1994-12#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-8#1)(2006-11#1)(2007-8#1)(2012-12#1)
the same as or##2##4##(1994-3#1)(2008-2#1)
the same as that in##3##5##(2007-11#1)(2008-8#1)(2008-9#1)
the same as that observed for##3##6##(1992-7#1)(1995-3#1)(2008-10#1)
the same as that obtained with the##2##7##(2004-8#1)(2008-2#1)
the same as that obtained##4##5##(1993-8#1)(2004-8#1)(2008-10#1)(2008-2#1)
the same as that of the wild type##2##8##(1995-8#1)(2008-5#1)
the same as that of the##10##6##(1990-12#1)(1991-7#1)(1993-9#1)(1995-8#1)(1996-11#1)(2007-1#1)(2008-2#2)(2008-5#2)
the same as that of##29##5##(1990-10#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-7#1)(1991-9#1)(1992-3#1)(1993-9#1)(1994-8#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(2005-11#1)(2007-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#2)(2008-8#2)(2011-1#1)(2013-8#1)
the same as that##50##4##(1990-10#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-7#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-6#1)(2004-12#1)(2004-8#1)(2005-11#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#4)(2008-8#3)(2008-9#1)(2010-1#1)(2011-1#1)(2013-8#1)
the same as the##31##4##(1990-4#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-7#1)(1993-2#1)(1994-10#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#1)(1996-11#1)(1997-6#1)(2005-11#1)(2006-9#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-3#1)
the same as those for##2##5##(2006-6#1)(2010-4#1)
the same as those in##6##5##(1990-2#1)(1996-3#2)(1996-6#1)(2006-4#1)(2008-10#1)
the same as those obtained##4##5##(1990-7#1)(1994-11#1)(2005-11#1)(2008-3#1)
the same as those of the##2##6##(1995-8#1)(1997-8#1)
the same as those of##9##5##(1992-8#1)(1993-6#1)(1994-12#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-8#1)(2006-10#1)(2007-5#1)
the same as those##30##4##(1990-2#1)(1990-7#1)(1991-8#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-5#1)(1995-8#2)(1996-12#1)(1996-3#2)(1996-6#1)(1997-5#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-6#1)(2010-4#1)(2011-2#1)
the same as##167##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#3)(1990-5#3)(1990-6#1)(1990-7#3)(1990-8#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-2#2)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#3)(1995-10#1)(1995-12#1)(1995-2#4)(1995-3#4)(1995-5#2)(1995-6#2)(1995-8#5)(1996-11#3)(1996-12#1)(1996-3#2)(1996-6#2)(1996-8#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-12#1)(2004-8#1)(2005-11#3)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#15)(2008-11#1)(2008-2#7)(2008-3#5)(2008-4#3)(2008-5#4)(2008-7#2)(2008-8#5)(2008-9#3)(2009-12#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
the same assay##7##3##(1996-3#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2013-1#1)
the same at the##3##4##(1993-7#1)(2008-3#1)(2009-4#1)
the same at##7##3##(1992-6#1)(1993-7#1)(2008-10#1)(2008-3#2)(2009-4#1)(2012-2#1)
the same bacterium##2##3##(2006-8#1)(2008-4#1)
the same band##2##3##(1993-8#1)(2008-2#1)
the same basic##9##3##(1990-7#1)(1994-12#1)(1996-3#1)(1997-2#1)(2007-12#1)(2008-2#3)(2008-5#1)
the same batch##3##3##(1996-8#2)(2008-4#1)
the same batches##2##3##(1996-8#1)(2008-10#1)
the same behavior##3##3##(2008-10#1)(2008-7#1)(2012-1#1)
the same binding site##5##4##(1990-2#1)(1994-5#1)(1994-9#1)(2008-9#1)(2012-3#1)
the same binding##6##3##(1990-2#1)(1994-2#1)(1994-5#1)(1994-9#1)(2008-9#1)(2012-3#1)
the same biological##3##3##(1991-5#1)(1992-9#1)(2008-10#1)
the same brain regions##2##4##(1995-12#1)(2010-5#1)
the same brain##5##3##(1994-5#1)(1995-12#1)(1996-2#1)(2008-6#1)(2010-5#1)
the same breast##4##3##(1991-2#1)(1994-5#2)(1994-7#1)
the same broad##3##3##(1995-1#1)(1995-12#1)(2008-10#1)
the same buffer##4##3##(1990-9#1)(2008-10#1)(2008-2#1)(2008-4#1)
the same but##4##3##(1992-5#1)(2008-10#2)(2008-5#1)
the same can##2##3##(1991-6#1)(2007-6#1)
the same catalytic##3##3##(1994-5#1)(2004-8#1)(2008-10#1)
the same category as##2##4##(1992-4#1)(2008-4#1)
the same category of##2##4##(2006-6#1)(2010-11#1)
the same category##4##3##(1992-4#1)(2006-6#1)(2008-4#1)(2010-11#1)
the same cell line##4##4##(1992-9#1)(2007-8#1)(2008-8#1)(2013-1#1)
the same cell population##2##4##(1992-8#1)(2008-9#1)
the same cell##25##3##(1990-12#1)(1990-5#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-9#1)(1995-3#2)(1995-8#2)(1996-10#1)(1997-1#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-4#3)(2008-8#2)(2008-9#2)(2009-12#1)(2013-1#1)(2013-8#1)
the same cells##12##3##(1990-11#1)(1990-7#1)(1990-8#1)(1991-8#1)(1992-12#1)(1992-6#1)(1994-12#1)(1994-3#1)(1996-5#1)(2008-11#1)(2008-4#1)(2013-1#1)
the same center##3##3##(2008-6#2)(2012-2#1)
the same chain##2##3##(1993-8#1)(1994-9#1)
the same characteristic##3##3##(1994-12#1)(1997-8#1)(2009-10#1)
the same characteristics as##2##4##(2008-4#1)(2008-5#1)
the same characteristics in the##2##5##(2005-11#1)(2013-1#1)
the same characteristics##4##3##(2005-11#1)(2008-4#1)(2008-5#1)(2013-1#1)
the same chemical##2##3##(2008-10#2)
the same chromatographic##3##3##(1992-12#1)(2008-10#2)
the same chromosomal##3##3##(1993-12#1)(2008-10#2)
the same chromosome##3##3##(1993-11#1)(2008-10#1)(2008-8#1)
the same clade##4##3##(2008-10#2)(2008-6#1)(2013-8#1)
the same class##5##3##(1991-4#1)(1997-5#1)(2008-2#1)(2008-8#1)(2011-1#1)
the same clinical##3##3##(1993-11#1)(2009-8#1)(2011-2#1)
the same cluster##6##3##(1990-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-1#1)(2012-1#1)
the same coding##2##3##(2009-10#1)(2012-12#1)
the same cognitive##2##3##(2007-5#1)(2008-4#1)
the same cohort##3##3##(1992-8#1)(1995-12#1)(2011-1#1)
the same commercial##2##3##(2008-1#1)(2008-10#1)
the same company##2##3##(1992-12#1)(2007-11#1)
the same compounds##5##3##(1993-3#1)(1996-4#1)(2008-10#2)(2008-4#1)
the same concentration of##7##4##(1991-5#1)(1994-8#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-8#1)
the same concentration range##3##4##(1993-12#1)(1994-8#1)(2008-10#1)
the same concentration used for##2##5##(1991-8#1)(2008-11#1)
the same concentration used##3##4##(1991-8#1)(1996-4#1)(2008-11#1)
the same concentration##27##3##(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-6#2)(1993-12#1)(1994-8#2)(1996-4#1)(1997-6#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-12#1)
the same concentrations of##6##4##(1990-2#1)(1990-8#1)(1992-7#1)(2008-10#1)(2008-7#1)(2013-8#1)
the same concentrations##14##3##(1990-2#1)(1990-8#1)(1991-9#1)(1992-7#1)(1994-5#1)(1994-8#1)(1995-6#1)(2006-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2013-8#1)
the same condition##7##3##(1991-5#1)(1994-9#1)(1996-11#1)(2005-10#1)(2006-10#2)(2010-2#1)
the same conditions as those##2##5##(1990-5#1)(1992-7#1)
the same conditions as##6##4##(1990-5#1)(1992-7#1)(1992-8#1)(1996-2#1)(2008-3#1)(2008-5#1)
the same conditions for##2##4##(2008-10#1)(2008-12#1)
the same conditions##62##3##(1990-2#2)(1990-4#1)(1990-5#1)(1991-3#2)(1991-4#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-6#1)(1993-8#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-7#1)(1996-9#2)(1997-8#1)(2004-9#1)(2005-4#1)(2006-5#1)(2006-8#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2009-4#1)(2009-5#1)(2010-4#1)(2011-2#2)(2013-8#2)
the same configuration##2##3##(1991-10#1)(2007-11#1)
the same consensus sequence##2##4##(1993-2#1)(1994-9#1)
the same constant##2##3##(1995-5#1)(2008-3#1)
the same construct##3##3##(2007-3#1)(2008-4#1)(2009-11#1)
the same correct##2##3##(1994-3#1)(2011-2#1)
the same county##2##3##(1992-3#1)(2010-4#1)
the same criteria##2##3##(1995-2#1)(1997-2#1)
the same crystal##2##3##(2007-12#1)(2013-8#1)
the same cultivar##3##3##(2008-10#3)
the same culture conditions##2##4##(1993-12#1)(1993-9#1)
the same culture##5##3##(1993-12#1)(1993-9#1)(1995-7#1)(2006-5#1)(2009-12#1)
the same cultured##2##3##(1997-4#1)(2008-5#1)
the same cytokine##2##3##(1996-5#1)(2008-4#1)
the same data##11##3##(1990-12#1)(1996-12#1)(2004-9#1)(2007-11#2)(2008-10#1)(2008-7#1)(2010-4#1)(2012-2#1)(2013-1#2)
the same day of##2##4##(1995-5#1)(2013-1#1)
the same day to##3##4##(1994-10#1)(2008-5#1)(2013-8#1)
the same day##17##3##(1994-10#1)(1995-5#1)(1995-7#1)(1997-3#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
the same decade##2##3##(1991-8#1)(2012-2#1)
the same degree of##7##4##(1993-11#1)(1994-2#1)(1995-6#1)(1997-8#1)(2006-6#1)(2008-1#1)(2008-2#1)
the same degree##15##3##(1990-2#1)(1993-11#1)(1993-6#1)(1994-2#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-9#2)(1997-8#1)(2006-6#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-2#1)
the same density##6##3##(1994-11#1)(1994-8#1)(1997-3#1)(2005-10#1)(2009-4#1)(2011-12#1)
the same deposition##2##3##(2008-3#2)
the same depth of##2##4##(2008-11#1)(2008-2#1)
the same depth##4##3##(2006-6#1)(2008-11#1)(2008-2#1)(2008-7#1)
the same design##2##3##(2008-2#1)(2010-1#1)
the same detector##3##3##(2007-12#1)(2008-2#2)
the same developmental defects##2##4##(1994-12#1)(1994-3#1)
the same developmental##5##3##(1994-12#1)(1994-3#1)(1995-2#1)(2007-12#2)
the same diagnosis##2##3##(2008-11#1)(2010-8#1)
the same diagnostic##2##3##(1996-8#1)(2009-8#1)
the same diameter##3##3##(2008-2#1)(2008-3#1)(2010-8#1)
the same diet##2##3##(2005-3#1)(2009-12#1)
the same differences in##2##4##(1993-9#1)(2012-1#1)
the same dimensions##3##3##(2004-9#1)(2007-11#1)(2013-1#1)
the same diploid##2##3##(2008-12#1)(2011-12#1)
the same direction as the##4##5##(1994-12#1)(2007-12#1)(2008-2#1)(2008-4#1)
the same direction as##5##4##(1992-4#1)(1994-12#1)(2007-12#1)(2008-2#1)(2008-4#1)
the same direction##23##3##(1990-7#1)(1990-9#1)(1991-5#1)(1991-7#1)(1992-4#2)(1994-12#2)(1994-2#1)(1994-6#1)(1996-7#1)(2006-10#2)(2006-8#1)(2007-12#2)(2008-2#1)(2008-4#1)(2008-8#2)(2008-9#1)(2012-2#1)(2013-8#1)
the same disease##8##3##(1991-9#1)(1992-8#1)(1997-6#1)(2005-8#1)(2006-1#1)(2007-3#1)(2008-10#1)(2009-9#1)
the same distribution##3##3##(1990-12#1)(1994-2#1)(2008-3#1)
the same domain##2##3##(1993-8#1)(2009-10#1)
the same donor##5##3##(1995-12#1)(2008-9#1)(2009-8#1)(2010-3#1)(2012-12#1)
the same dosage##3##3##(2008-7#1)(2009-5#1)(2012-12#1)
the same dose of the##2##5##(1996-10#1)(2007-1#1)
the same dose of##8##4##(1994-8#1)(1995-3#1)(1996-1#1)(1996-10#1)(1997-4#1)(2007-1#1)(2008-5#1)(2009-6#1)
the same dose##17##3##(1992-5#1)(1992-6#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-3#1)(1996-1#1)(1996-10#2)(1996-6#1)(1997-4#1)(1997-7#1)(2007-1#1)(2008-5#1)(2008-6#1)(2009-6#1)(2010-11#1)
the same doses of##4##4##(1995-12#1)(1996-6#1)(2008-10#1)(2009-6#1)
the same doses##10##3##(1993-4#1)(1995-12#1)(1996-6#1)(2005-3#1)(2008-10#1)(2008-8#1)(2008-9#3)(2009-6#1)
the same drugs##3##3##(1992-6#1)(1995-8#1)(2007-7#1)
the same duplex##3##3##(1995-3#1)(1996-7#1)(2007-11#1)
the same duration##5##3##(2006-4#1)(2008-7#2)(2012-2#1)(2012-3#1)
the same during##2##3##(1990-7#1)(2008-10#1)
the same effect as##2##4##(1990-10#1)(1992-3#1)
the same effect on the##2##5##(2006-6#1)(2009-3#1)
the same effect on##6##4##(1991-8#1)(1995-1#1)(1995-12#1)(2006-6#1)(2008-10#1)(2009-3#1)
the same effect##14##3##(1990-10#1)(1991-8#1)(1992-3#1)(1992-6#1)(1995-1#1)(1995-12#2)(1997-4#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-3#1)
the same effects##3##3##(1990-1#1)(1990-2#1)(2008-10#1)
the same electrophoretic mobility as##2##5##(1992-6#1)(1992-7#1)
the same electrophoretic mobility##3##4##(1992-6#2)(1992-7#1)
the same environmental##4##3##(1993-7#1)(1994-6#1)(2008-1#1)(2008-10#1)
the same enzyme##5##3##(1992-1#1)(1993-1#1)(1994-8#1)(1995-6#1)(2008-11#1)
the same enzymes##4##3##(1990-2#1)(1992-4#1)(2008-5#1)(2011-12#1)
the same epithet##2##3##(2013-7#2)
the same essential##2##3##(2008-9#1)(2012-12#1)
the same ethnic group##3##4##(1997-8#1)(2007-11#1)(2008-9#1)
the same ethnic##4##3##(1997-8#1)(2007-11#1)(2008-9#1)(2010-10#1)
the same exercise##2##3##(2008-10#1)(2013-8#1)
the same experience##2##3##(2007-5#1)(2007-7#1)
the same experiment##4##3##(1992-6#1)(1994-9#1)(2007-11#1)(2010-8#1)
the same experimental condition##2##4##(2007-11#1)(2010-2#1)
the same experimental conditions##15##4##(1990-10#1)(1990-8#2)(1995-12#2)(1997-2#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-5#1)(2010-12#1)
the same experimental##25##3##(1990-10#1)(1990-8#2)(1993-4#1)(1995-12#2)(1996-10#1)(1997-2#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-2#1)(2012-1#1)(2013-8#1)
the same experiments##3##3##(1996-2#1)(2007-8#1)(2008-3#1)
the same expression##3##3##(1991-9#1)(2010-1#1)(2012-2#1)
the same extent as##13##4##(1990-10#1)(1990-11#1)(1991-2#1)(1992-11#2)(1993-6#1)(2008-10#3)(2008-3#1)(2008-4#1)(2012-12#1)(2013-8#1)
the same extent##37##3##(1990-10#1)(1990-11#1)(1990-12#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#2)(1992-11#2)(1993-2#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-2#1)(1996-5#1)(2006-8#1)(2007-9#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-8#1)
the same facility##2##3##(1996-2#1)(2008-6#1)
the same factors as##2##4##(2007-12#1)(2009-11#1)
the same factors that##2##4##(2008-11#1)(2011-12#1)
the same factors##4##3##(2007-12#1)(2008-11#1)(2009-11#1)(2011-12#1)
the same family as##2##4##(1995-9#1)(2007-12#1)
the same family##21##3##(1994-11#1)(1994-8#1)(1995-5#1)(1995-9#1)(1996-12#1)(1997-4#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#2)(2009-4#2)(2010-3#1)(2011-2#1)(2012-12#2)
the same fast##2##3##(1990-3#1)(2007-9#1)
the same features##2##3##(1996-2#1)(2013-8#1)
the same fee##2##3##(1993-3#1)(1994-1#1)
the same fiber##5##3##(2007-11#3)(2007-12#1)(2008-3#1)
the same field site##2##4##(2004-11#1)(2006-3#1)
the same field##8##3##(1996-12#1)(2004-11#1)(2006-3#1)(2007-9#2)(2008-10#2)(2013-8#1)
the same final##4##3##(1990-2#1)(1997-7#1)(2008-3#1)(2010-7#1)
the same first##2##3##(1993-9#1)(2013-8#1)
the same five##3##3##(1990-12#1)(2008-11#1)(2012-3#1)
the same flock##2##3##(2005-7#1)(2008-5#1)
the same flow##4##3##(2007-12#1)(2008-10#1)(2008-9#1)(2012-12#1)
the same fold##2##3##(1994-8#1)(2008-4#1)
the same food##2##3##(2008-12#1)(2012-2#1)
the same for all##8##4##(1994-2#1)(1994-5#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-9#1)
the same for both##8##4##(1990-2#1)(1995-11#1)(1996-2#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-6#1)
the same for different##2##4##(2010-10#1)(2013-8#1)
the same for the##3##4##(1994-12#1)(1996-9#1)(1997-8#1)
the same for##36##3##(1990-2#1)(1990-8#1)(1992-1#1)(1992-3#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-6#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-8#1)(2004-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2012-3#1)(2013-8#1)
the same form of##4##4##(1990-5#1)(1991-6#1)(1996-5#1)(2008-10#1)
the same form##7##3##(1990-5#1)(1991-6#1)(1996-5#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)
the same four##7##3##(1990-4#1)(1992-11#1)(1997-5#1)(2007-12#1)(2007-9#1)(2008-10#1)(2011-2#1)
the same framework##2##3##(2008-2#1)(2008-8#1)
the same frequency as the##2##5##(1995-12#1)(2008-3#1)
the same frequency modulation##2##4##(2007-12#2)
the same frequency##12##3##(1995-12#1)(1995-5#1)(2007-12#2)(2008-10#2)(2008-3#3)(2008-6#1)(2008-7#1)(2010-6#1)
the same function in##2##4##(1990-5#1)(1995-6#1)
the same function##7##3##(1990-5#1)(1992-5#2)(1995-6#1)(2007-12#1)(2008-1#1)(2011-1#1)
the same functional##3##3##(1991-2#1)(1995-11#1)(2008-2#1)
the same fungal species##2##4##(2008-10#1)(2013-7#1)
the same fungal##4##3##(2008-10#2)(2011-12#1)(2013-7#1)
the same gene as##2##4##(1994-9#1)(2007-11#1)
the same gene family##2##4##(1991-4#1)(1996-4#1)
the same gene##31##3##(1990-2#1)(1991-11#1)(1991-4#1)(1992-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-9#2)(1995-3#2)(1995-8#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#5)(2010-7#1)(2011-1#1)(2012-3#3)
the same general##4##3##(1997-5#1)(2006-9#1)(2008-10#1)(2010-12#1)
the same genes##2##3##(2008-8#1)(2010-12#1)
the same genetic##11##3##(1994-12#1)(2006-2#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
the same genomic##3##3##(1994-3#1)(2008-10#1)(2012-3#1)
the same genotype##9##3##(2008-10#8)(2012-3#1)
the same geographic##2##3##(1996-7#1)(2008-10#1)
the same geographical area and##2##5##(2006-10#1)(2008-10#1)
the same geographical area##3##4##(2006-10#1)(2007-9#1)(2008-10#1)
the same germ##2##3##(2009-1#1)(2012-2#1)
the same group of##5##4##(1993-8#1)(1995-7#1)(2010-2#1)(2011-2#1)(2013-1#1)
the same group##14##3##(1993-8#1)(1995-4#1)(1995-7#2)(1997-6#2)(2007-11#1)(2008-10#3)(2010-11#1)(2010-2#1)(2011-2#1)(2013-1#1)
the same groups of##3##4##(1991-11#1)(2008-10#2)
the same groups##6##3##(1991-11#1)(2006-5#1)(2008-10#2)(2010-2#1)(2012-2#1)
the same guidelines##2##3##(1995-9#1)(2012-1#1)
the same habitat##2##3##(2007-2#1)(2007-3#1)
the same half-time##2##3##(1990-2#1)(1992-3#1)
the same haplotype##2##3##(2007-7#1)(2008-10#1)
the same health##3##3##(2008-7#1)(2010-10#1)(2012-1#1)
the same height as##2##4##(2008-12#1)(2008-3#1)
the same height##3##3##(2008-12#1)(2008-3#1)(2008-8#1)
the same high degree of##2##5##(1994-3#1)(1995-1#1)
the same high##6##3##(1994-3#1)(1995-1#1)(1995-10#1)(2008-10#1)(2008-3#1)(2009-6#1)
the same hospital##9##3##(1991-2#1)(1991-3#1)(1996-1#2)(1997-8#1)(2004-10#1)(2007-12#2)(2011-12#1)
the same host species##2##4##(2006-10#1)(2008-10#1)
the same host##9##3##(1997-3#1)(2006-10#1)(2008-10#5)(2008-9#1)(2010-12#1)
the same houses##2##3##(2007-6#1)(2008-5#1)
the same human##2##3##(1994-11#1)(2008-8#1)
the same in all of##2##5##(1990-2#1)(2008-10#1)
the same in all##6##4##(1990-2#1)(1996-1#1)(1997-2#1)(2008-10#1)(2008-4#2)
the same in both##9##4##(1991-2#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-1#1)(1996-7#1)(2004-11#1)(2008-11#1)
the same in the two##5##5##(1992-11#1)(2007-11#1)(2007-7#1)(2008-5#1)(2009-9#1)
the same in the##12##4##(1992-11#1)(1993-11#1)(1996-9#1)(1997-1#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-5#2)(2009-9#1)
the same in##53##3##(1990-2#1)(1990-5#1)(1991-11#1)(1991-2#4)(1991-4#1)(1991-7#1)(1992-11#1)(1992-4#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-6#1)(1995-1#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#1)(2004-11#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-11#2)(2008-2#1)(2008-4#3)(2008-5#2)(2008-9#1)(2009-10#1)(2009-9#1)(2011-2#1)(2013-8#1)
the same increase in##2##4##(2007-12#1)(2010-10#1)
the same increase##3##3##(1995-12#1)(2007-12#1)(2010-10#1)
the same index##2##3##(2007-11#1)(2008-3#1)
the same indication##6##3##(1996-11#1)(2007-11#1)(2008-5#2)(2009-3#1)(2012-2#1)
the same individual##13##3##(1990-4#1)(1996-3#1)(2006-10#2)(2006-7#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-6#1)(2012-3#2)
the same individuals##7##3##(1993-12#1)(1996-2#1)(2005-11#1)(2007-2#2)(2009-4#1)(2012-12#1)
the same information##3##3##(1992-12#1)(2007-10#1)(2010-4#1)
the same inhibitory##2##3##(1994-3#1)(2009-12#1)
the same insertion##2##3##(1991-12#1)(1995-8#1)
the same instrument##6##3##(2008-10#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
the same intensity##2##3##(1990-5#1)(2013-1#1)
the same interferogram##3##3##(2008-3#3)
the same internal##2##3##(1997-7#1)(2007-12#1)
the same interval##2##3##(2008-10#1)(2009-11#1)
the same intracellular##2##3##(1993-6#1)(1994-6#1)
the same is true for the##2##6##(2008-3#1)(2012-2#1)
the same is##5##3##(2006-2#1)(2008-10#2)(2008-3#1)(2012-2#1)
the same isolate##5##3##(2008-10#4)(2012-12#1)
the same items##2##3##(2012-2#1)(2013-8#1)
the same kind of##4##4##(1991-12#1)(1997-3#1)(2008-10#2)
the same kinetics##2##3##(1994-11#1)(1997-8#1)
the same laser##3##3##(2007-12#1)(2008-2#2)
the same last name##2##4##(1993-9#1)(1997-5#1)
the same leaf##3##3##(2008-10#3)
the same leaves##2##3##(2008-10#1)(2010-3#1)
the same length##8##3##(1993-3#1)(1994-9#1)(1996-11#1)(2006-8#1)(2007-11#1)(2008-4#1)(2008-9#1)(2011-2#1)
the same lens##2##3##(2008-2#1)(2008-3#1)
the same lesion##3##3##(2008-10#2)(2008-6#1)
the same lesions##3##3##(2006-6#1)(2007-10#1)(2008-10#1)
the same level as in##2##5##(2013-1#2)
the same level as the##3##5##(1991-11#1)(2008-10#1)(2008-5#1)
the same level as##10##4##(1991-11#1)(1996-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#2)(2013-1#2)
the same level in##3##4##(1990-10#1)(2008-6#1)(2008-7#1)
the same level of##15##4##(1990-7#1)(1993-12#1)(1993-5#1)(1995-2#1)(1995-3#2)(2005-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-6#1)(2010-8#1)(2012-12#1)
the same level##45##3##(1990-10#1)(1990-12#1)(1990-7#1)(1991-11#1)(1991-5#1)(1992-10#3)(1992-5#1)(1993-12#1)(1993-5#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-10#1)(1996-5#1)(1996-9#1)(2005-9#1)(2006-4#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-4#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-12#3)(2013-1#2)
the same levels as##4##4##(1993-3#1)(1997-6#1)(2006-12#1)(2006-8#1)
the same life##2##3##(1995-1#1)(2008-8#1)
the same line of##2##4##(1997-7#1)(2006-12#1)
the same line##4##3##(1997-5#1)(1997-7#1)(2006-12#1)(2007-12#1)
the same linkage##4##3##(1990-12#1)(1990-2#1)(2008-10#2)
the same liquid##2##3##(2005-11#1)(2008-10#1)
the same locality##3##3##(2006-10#1)(2007-3#1)(2008-5#1)
the same location as##3##4##(1997-7#1)(2008-2#1)(2008-3#1)
the same location or##2##4##(2007-12#1)(2010-11#1)
the same location##18##3##(1996-11#1)(1996-3#1)(1997-7#1)(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#4)(2010-11#1)(2011-1#1)(2013-1#1)
the same locations##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2012-3#1)
the same locus##8##3##(1997-8#1)(2007-12#1)(2008-10#4)(2008-7#1)(2012-11#1)
the same low##2##3##(1990-2#1)(1997-2#1)
the same lung##2##3##(1993-12#1)(2011-2#1)
the same mRNA##4##3##(1991-6#1)(1992-3#1)(1994-6#1)(2011-2#1)
the same magnitude##8##3##(1993-2#1)(1994-5#1)(1997-4#1)(1997-5#1)(2006-12#1)(2008-1#1)(2008-10#1)(2012-2#1)
the same major##3##3##(2008-4#1)(2010-6#1)(2012-3#1)
the same manifold##2##3##(2008-10#2)
the same manner##22##3##(1991-5#1)(1991-8#2)(1992-8#1)(1994-2#1)(1997-6#1)(2005-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-5#1)(2009-3#1)(2009-6#1)(2010-2#1)(2010-5#2)(2012-2#1)
the same material##9##3##(1990-12#1)(2005-11#1)(2006-5#1)(2006-7#1)(2007-11#1)(2008-3#1)(2008-7#1)(2010-4#1)(2013-8#1)
the same materials##2##3##(2007-12#1)(2008-7#1)
the same mating allele##2##4##(2008-10#2)
the same mating##3##3##(2008-10#3)
the same maximum##2##3##(2008-3#2)
the same mechanism is##3##4##(1990-8#1)(2008-11#1)(2008-7#1)
the same mechanism of action##2##5##(1996-10#1)(2011-2#1)
the same mechanism of##5##4##(1990-8#1)(1996-10#1)(1997-2#1)(2006-10#1)(2011-2#1)
the same mechanism##18##3##(1990-8#2)(1991-9#1)(1993-12#1)(1993-9#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-10#1)(1997-2#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
the same mechanisms##4##3##(2006-10#1)(2007-12#1)(2010-10#1)(2012-11#1)
the same medium without##2##4##(2005-11#1)(2008-11#1)
the same medium##8##3##(1991-3#1)(1992-6#1)(1994-5#1)(2005-11#1)(2007-1#1)(2008-10#2)(2008-11#1)
the same membrane in the##2##5##(1994-10#1)(1997-3#1)
the same membrane##7##3##(1992-1#1)(1993-3#1)(1994-10#1)(1994-11#1)(1997-3#1)(2008-10#1)(2012-4#1)
the same metabolic##2##3##(2005-3#1)(2008-9#1)
the same metal##5##3##(1991-5#1)(2008-5#4)
the same method##5##3##(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-8#1)
the same methodology##4##3##(1993-6#1)(1995-2#1)(2007-12#1)(2013-1#1)
the same methods##2##3##(1993-9#1)(2008-3#1)
the same minerals##2##3##(2005-11#2)
the same mitochondrial DNA##4##4##(1991-5#2)(1992-9#1)(1997-4#1)
the same mobility as##2##4##(1997-8#2)
the same mode of##2##4##(1992-5#1)(2008-9#1)
the same model##5##3##(1990-4#1)(2006-6#1)(2008-2#1)(2008-5#1)(2010-8#1)
the same moisturizer product containing##2##5##(2008-5#2)
the same molecular mass##3##4##(1990-11#1)(1996-9#1)(2010-4#1)
the same molecular weight and##2##5##(1994-11#1)(2007-11#1)
the same molecular weight##5##4##(1992-3#1)(1994-11#1)(1994-2#1)(1994-9#1)(2007-11#1)
the same molecular##14##3##(1990-11#1)(1990-5#1)(1990-8#1)(1992-3#1)(1992-8#1)(1994-11#1)(1994-2#1)(1994-9#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2009-8#1)(2010-4#1)
the same molecule##4##3##(1993-9#1)(2006-10#1)(2007-12#1)(2008-10#1)
the same multiplexed##2##3##(2007-12#1)(2008-9#1)
the same muscle##2##3##(2006-3#1)(2008-7#1)
the same mutants##2##3##(1994-8#1)(2011-1#1)
the same mutation##3##3##(1993-6#1)(2007-10#1)(2010-10#1)
the same mutations##2##3##(1993-11#1)(1994-8#1)
the same nerve##3##3##(1992-3#1)(2008-5#1)(2008-7#1)
the same nerves##2##3##(1994-2#1)(1997-3#1)
the same neural##3##3##(1993-2#1)(2007-9#1)(2008-8#1)
the same number of##10##4##(1990-11#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-5#1)
the same nutrients##2##3##(1995-5#1)(2006-4#1)
the same object##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
the same old##3##3##(1994-1#1)(1995-3#1)(2010-12#1)
the same on##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
the same one##2##3##(1990-3#1)(2007-7#1)
the same operating##3##3##(2008-7#1)(2008-8#2)
the same operation##3##3##(1993-5#1)(2006-2#1)(2010-8#1)
the same operator##2##3##(1996-11#1)(2011-2#1)
the same optical path##3##4##(2008-10#1)(2008-2#2)
the same optical##4##3##(2007-11#1)(2008-10#1)(2008-2#2)
the same or a different##2##5##(2008-3#1)(2008-4#1)
the same or a##3##4##(2007-6#1)(2008-3#1)(2008-4#1)
the same or better##2##4##(2006-6#1)(2008-10#1)
the same or different##5##4##(1996-10#1)(2005-12#1)(2008-3#1)(2008-6#1)(2012-12#1)
the same or lower##2##4##(2011-2#1)(2012-11#1)
the same or mirror images##2##5##(1996-2#2)
the same or similar##5##4##(1991-2#1)(1993-11#1)(2005-11#1)(2008-8#1)(2012-3#1)
the same or##30##3##(1991-2#1)(1993-1#1)(1993-11#1)(1994-3#1)(1996-10#1)(1996-2#2)(1996-6#2)(1996-9#1)(2005-11#1)(2005-12#1)(2006-6#1)(2007-6#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-8#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
the same order and##3##4##(1997-2#1)(2007-12#1)(2008-7#1)
the same order as##7##4##(1991-11#1)(1993-2#1)(1994-6#1)(1995-10#1)(2006-4#1)(2007-12#1)(2008-8#1)
the same order of magnitude as that of##2##8##(1990-3#1)(1994-11#1)
the same order of magnitude as that##3##7##(1990-3#1)(1991-2#1)(1994-11#1)
the same order of magnitude as##9##6##(1990-3#1)(1991-2#1)(1992-6#1)(1993-3#1)(1994-11#1)(2005-11#1)(2007-11#2)(2008-11#1)
the same order of magnitude##12##5##(1990-3#1)(1991-2#1)(1991-5#1)(1992-6#1)(1993-3#1)(1994-11#1)(2004-11#1)(2005-11#1)(2007-11#2)(2008-11#2)
the same order of##15##4##(1990-3#1)(1991-2#1)(1991-5#1)(1992-6#1)(1993-3#1)(1994-11#2)(1995-6#1)(2004-11#1)(2005-11#1)(2007-11#2)(2008-11#2)(2008-9#1)
the same order##31##3##(1990-3#1)(1991-11#2)(1991-2#1)(1991-5#2)(1992-11#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-11#2)(1994-6#1)(1995-10#1)(1995-6#1)(1997-2#1)(2004-11#1)(2005-11#1)(2005-8#1)(2006-4#1)(2007-11#2)(2007-12#2)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
the same organism##9##3##(1990-2#1)(1990-3#1)(1990-9#1)(1993-6#1)(1995-2#1)(1997-6#1)(2008-10#1)(2009-3#1)(2013-1#1)
the same orientation##7##3##(1991-9#1)(1994-12#1)(1995-8#2)(1997-1#2)(1997-6#1)
the same origin##3##3##(1994-8#1)(2007-1#1)(2008-10#1)
the same outcome##2##3##(1990-10#1)(2012-1#1)
the same output##2##3##(2008-11#1)(2012-1#1)
the same oxidative##2##3##(1991-12#1)(2009-3#1)
the same pH range##2##4##(1991-7#1)(2008-10#1)
the same pH##4##3##(1991-7#1)(1994-8#1)(2008-10#2)
the same paradigm##2##3##(1993-2#1)(2012-12#1)
the same parameter##4##3##(2008-12#1)(2008-2#1)(2012-2#1)(2013-1#1)
the same parameters##6##3##(1990-5#1)(2004-11#1)(2007-7#1)(2008-2#1)(2008-5#1)(2010-8#1)
the same participants##3##3##(2008-4#1)(2009-4#1)(2010-3#1)
the same particle##2##3##(1997-2#1)(2008-6#1)
the same path##2##3##(2008-2#1)(2009-10#1)
the same pathophysiologic##2##3##(1994-11#1)(2012-3#1)
the same pathotype##3##3##(2008-10#3)
the same pathway##5##3##(1990-10#1)(1995-8#1)(1997-2#1)(2008-10#1)(2008-11#1)
the same pathways##2##3##(2008-10#1)(2008-7#1)
the same patients were##2##4##(1991-4#1)(2008-1#1)
the same patients##12##3##(1990-5#1)(1990-6#1)(1991-4#1)(1993-4#1)(1996-8#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-7#1)(2012-2#1)(2013-1#1)
the same pattern as the##2##5##(2007-12#1)(2008-10#1)
the same pattern as##9##4##(1990-9#1)(1991-12#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-3#1)(2009-4#1)(2010-8#1)
the same pattern of##7##4##(1991-2#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#1)(2008-10#1)(2008-11#1)
the same pattern##24##3##(1990-12#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-12#2)(1997-6#1)(1997-7#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-4#1)(2009-5#1)(2010-8#1)
the same patterns##2##3##(1996-12#1)(2008-7#1)
the same peptide##5##3##(1991-3#1)(1993-9#1)(1995-2#1)(1997-4#1)(2006-6#1)
the same percentage of##3##4##(1993-10#2)(2006-12#1)
the same percentage##5##3##(1993-10#2)(1994-1#1)(2006-12#1)(2009-11#1)
the same performance as##2##4##(2008-10#1)(2008-3#1)
the same performance##3##3##(2008-10#2)(2008-3#1)
the same period in##5##4##(1991-6#1)(1995-11#1)(1996-11#1)(1996-3#1)(2008-7#1)
the same period of time##12##5##(1990-11#1)(1991-8#1)(1992-8#1)(1995-1#1)(2006-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)(2012-12#1)(2012-2#1)
the same period of##13##4##(1990-11#1)(1991-8#1)(1992-6#1)(1992-8#1)(1995-1#1)(2006-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)(2012-12#1)(2012-2#1)
the same period##70##3##(1990-11#1)(1990-6#1)(1990-7#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-2#2)(1992-6#3)(1992-8#2)(1993-1#1)(1993-8#1)(1994-6#1)(1995-1#2)(1995-11#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-3#1)(2004-10#1)(2004-2#1)(2006-10#2)(2006-11#1)(2006-4#1)(2006-7#1)(2007-12#3)(2007-3#2)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#4)(2008-5#2)(2008-6#2)(2008-7#3)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#2)(2013-1#1)(2013-8#1)
the same periods##3##3##(1995-11#1)(2008-10#1)(2013-8#1)
the same pharmacological profile as##2##5##(1990-10#1)(1995-8#1)
the same phase##3##3##(1996-5#1)(2008-7#1)(2009-10#1)
the same phenomenon##3##3##(2004-11#1)(2008-11#1)(2008-7#1)
the same phenotype as##2##4##(1992-3#1)(2009-10#1)
the same phenotype##9##3##(1992-3#1)(1994-3#1)(1997-6#1)(2007-11#1)(2008-10#3)(2009-10#1)(2012-12#1)
the same physician##2##3##(2007-8#1)(2008-8#1)
the same pigment##2##3##(2008-11#2)
the same pixel##2##3##(2007-12#2)
the same place##4##3##(1993-5#1)(1993-6#1)(1997-8#1)(2012-2#1)
the same plane in##2##4##(2008-3#1)(2010-8#1)
the same plane##5##3##(2008-10#1)(2008-3#1)(2009-8#1)(2010-12#1)(2010-8#1)
the same plant sample##2##4##(2008-10#2)
the same plant species##3##4##(2007-1#1)(2008-10#1)(2013-8#1)
the same plant##9##3##(1994-3#1)(2007-1#1)(2008-10#6)(2013-8#1)
the same plasmid##8##3##(1990-10#1)(1991-9#1)(1994-12#1)(1994-9#1)(1997-6#1)(2005-10#1)(2005-8#1)(2007-2#1)
the same plasmids##2##3##(1994-8#1)(2008-11#1)
the same platform##3##3##(2005-7#1)(2008-10#1)(2009-4#1)
the same plot##2##3##(2008-10#2)
the same point in##2##4##(1992-2#1)(2008-5#1)
the same point##8##3##(1992-2#1)(1993-12#1)(1994-11#1)(1995-11#1)(2007-11#1)(2008-10#1)(2008-5#1)(2010-12#1)
the same polarization state##2##4##(2007-11#1)(2007-12#1)
the same polarization##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
the same polymer##4##3##(1996-11#1)(2008-10#1)(2008-11#2)
the same pool of##2##4##(1997-6#1)(2008-5#1)
the same pool##3##3##(1997-6#1)(2008-10#1)(2008-5#1)
the same population of##5##4##(1990-7#1)(1991-2#1)(1995-12#1)(2008-10#1)(2011-2#1)
the same population##18##3##(1990-12#1)(1990-7#1)(1991-2#1)(1992-2#1)(1994-5#1)(1995-12#1)(1997-3#1)(1997-4#2)(2008-10#6)(2011-2#1)(2012-12#2)
the same populations##2##3##(1991-9#1)(2011-2#1)
the same porosity##2##3##(2004-9#1)(2005-11#1)
the same position as the##2##5##(1996-6#1)(2010-3#1)
the same position as##6##4##(1990-2#1)(1990-7#1)(1993-2#1)(1994-9#1)(1996-6#1)(2010-3#1)
the same position in##2##4##(2007-5#1)(2008-8#1)
the same position##19##3##(1990-2#1)(1990-5#1)(1990-7#2)(1993-2#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-6#1)(1997-1#1)(2006-11#1)(2007-5#2)(2008-11#1)(2008-8#1)(2010-3#1)
the same positions##4##3##(1990-5#1)(1990-7#1)(1992-2#1)(1997-5#1)
the same power##2##3##(2005-11#1)(2008-3#1)
the same precision##2##3##(2008-10#2)
the same precursor##3##3##(1992-8#1)(2007-11#1)(2008-9#1)
the same preoperative##2##3##(1992-6#1)(2006-6#1)
the same preparations##2##3##(1990-2#1)(1994-9#1)
the same primers##3##3##(1997-7#1)(2008-10#2)
the same principle##4##3##(2008-10#3)(2008-2#1)
the same principles##4##3##(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)
the same problem##2##3##(2008-6#1)(2010-11#1)
the same procedure##9##3##(1992-8#1)(1995-2#1)(1995-6#1)(1996-3#1)(2006-8#1)(2008-10#1)(2008-8#1)(2009-6#1)(2012-12#1)
the same procedures##4##3##(1996-12#1)(2006-4#1)(2007-1#1)(2008-9#1)
the same process##3##3##(1996-2#1)(1997-3#1)(2008-5#1)
the same processes##2##3##(1994-12#1)(2007-12#1)
the same processing##2##3##(2008-1#1)(2010-2#1)
the same product##5##3##(2005-8#1)(2008-3#1)(2009-10#1)(2009-6#1)(2012-2#1)
the same products##2##3##(1994-9#1)(2008-11#1)
the same profile##3##3##(1995-12#1)(2008-10#1)(2008-11#1)
the same program##3##3##(2007-11#1)(2007-2#1)(2007-8#1)
the same promoter##2##3##(1994-8#1)(1994-9#1)
the same properties as##3##4##(1992-10#1)(1995-5#1)(2005-11#1)
the same properties##4##3##(1992-10#1)(1995-5#1)(2005-11#1)(2008-1#1)
the same proportion of the##2##5##(1990-10#1)(1994-1#1)
the same proportion##3##3##(1990-10#1)(1991-2#1)(1994-1#1)
the same protein##15##3##(1990-11#2)(1991-10#1)(1991-11#1)(1991-2#1)(1992-7#1)(1993-6#1)(1995-6#1)(1996-7#1)(1997-4#1)(1997-6#1)(2006-10#1)(2008-2#1)(2011-1#1)(2012-2#1)
the same protocol for##2##4##(1993-9#1)(2012-2#1)
the same protocol##7##3##(1992-11#1)(1992-4#1)(1993-9#1)(2008-7#1)(2009-1#1)(2012-2#1)(2013-1#1)
the same pulse##2##3##(2007-12#2)
the same qualitative##4##3##(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)
the same quality of##3##4##(2006-10#1)(2008-11#1)(2008-7#1)
the same quality##4##3##(2006-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
the same question##3##3##(1990-2#1)(2009-12#1)(2012-1#1)
the same questionnaire##3##3##(1995-5#1)(2010-1#1)(2011-1#1)
the same questions##2##3##(1993-2#1)(2012-3#1)
the same race##3##3##(2008-10#3)
the same range as##11##4##(1990-11#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-8#1)(2006-9#1)(2007-4#1)(2008-2#1)(2013-1#1)(2013-8#1)
the same range of##5##4##(1990-2#1)(1990-8#1)(1995-6#1)(2008-3#1)(2010-5#1)
the same range##19##3##(1990-11#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-8#1)(1995-6#1)(2006-9#1)(2007-10#1)(2007-4#1)(2008-2#1)(2008-3#1)(2010-5#1)(2010-8#1)(2013-1#1)(2013-8#1)
the same rank order##2##4##(1994-9#1)(2008-10#1)
the same rapid##2##3##(1990-2#1)(2008-8#1)
the same rate##11##3##(1991-2#1)(1992-4#1)(1993-6#1)(1995-6#1)(1995-8#1)(2004-9#1)(2005-4#1)(2007-1#1)(2007-6#1)(2008-10#1)(2008-11#1)
the same rates as##2##4##(1991-3#1)(2007-4#1)
the same ratio##4##3##(1993-9#1)(1995-7#1)(2008-1#1)(2008-5#1)
the same rats##2##3##(1993-12#1)(1993-3#1)
the same reaction conditions##3##4##(2005-8#1)(2007-11#1)(2010-7#1)
the same reaction##11##3##(1994-9#1)(1995-11#1)(1996-8#1)(2004-7#1)(2005-8#1)(2007-11#1)(2008-10#3)(2009-3#1)(2010-7#1)
the same reactivity##2##3##(1990-12#1)(1993-6#1)
the same reading frame##2##4##(1991-12#1)(2008-9#1)
the same receptor##7##3##(1990-10#1)(1991-5#1)(1993-8#1)(1993-9#1)(1996-5#1)(2007-9#1)(2011-1#1)
the same recognition##3##3##(1992-1#1)(2007-12#1)(2008-10#1)
the same reference##2##3##(2007-12#1)(2008-10#1)
the same regardless of##2##4##(2007-12#1)(2012-3#1)
the same region of##4##4##(1990-12#1)(1992-11#1)(1994-8#1)(2008-1#1)
the same region##19##3##(1990-10#1)(1990-12#1)(1991-3#1)(1992-11#1)(1993-10#1)(1993-8#2)(1994-11#1)(1994-8#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#2)(2011-1#2)
the same regions##7##3##(1993-7#1)(1994-10#1)(1995-2#1)(1995-5#1)(2009-4#1)(2009-5#1)(2012-1#1)
the same regression##2##3##(2007-9#1)(2012-3#1)
the same regulatory##4##3##(1990-5#1)(1991-3#1)(2009-7#2)
the same reproductive##4##3##(1997-4#3)(2009-6#1)
the same resistant##2##3##(2008-10#2)
the same response##3##3##(1997-2#1)(2004-2#1)(2009-8#1)
the same responses##2##3##(1990-7#1)(1994-11#1)
the same restriction pattern##2##4##(1996-7#1)(2008-10#1)
the same result##6##3##(1990-11#1)(1994-11#1)(1994-6#1)(1996-2#1)(1997-4#1)(2008-3#1)
the same results as##3##4##(1997-2#1)(2008-11#1)(2008-2#1)
the same results##13##3##(1990-12#1)(1997-2#1)(2005-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-12#1)(2012-1#1)(2012-2#2)(2013-7#1)(2013-8#1)
the same retention time as the##2##6##(1991-3#1)(2008-11#1)
the same retention time as##3##5##(1990-2#1)(1991-3#1)(2008-11#1)
the same retention time on##2##5##(1990-7#1)(1992-7#1)
the same retention time##5##4##(1990-2#1)(1990-7#1)(1991-3#1)(1992-7#1)(2008-11#1)
the same risk##2##3##(2008-1#2)
the same route##2##3##(1990-3#1)(2010-4#1)
the same rules##2##3##(1997-2#1)(2006-10#1)
the same sample for##2##4##(2008-10#1)(2008-3#1)
the same sample of##3##4##(2008-10#3)
the same sample using##2##4##(2008-10#1)(2009-10#1)
the same sample##17##3##(1990-12#1)(2006-10#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#1)
the same samples##12##3##(1991-12#1)(1993-6#1)(1996-8#1)(2008-10#7)(2008-3#1)(2013-8#1)
the same scale##3##3##(2008-1#1)(2008-5#1)(2008-9#1)
the same scene##5##3##(2008-2#2)(2008-3#2)(2008-6#1)
the same selective pressures##2##4##(2008-8#1)(2010-3#1)
the same selective##3##3##(2008-8#2)(2010-3#1)
the same sensitivity##2##3##(2010-12#1)(2011-2#1)
the same sensitizing##2##3##(2008-10#1)(2012-12#1)
the same sensor##2##3##(2008-10#2)
the same sensory##2##3##(2007-12#1)(2008-11#1)
the same sequence as##2##4##(1991-10#1)(2013-1#1)
the same sequence in##2##4##(2008-5#1)(2008-9#1)
the same sequence of##2##4##(2007-12#1)(2008-8#1)
the same sequence##12##3##(1991-10#1)(1993-6#1)(1996-8#1)(1997-4#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2013-1#1)
the same series of##3##4##(1991-7#1)(1995-2#1)(2013-8#1)
the same serotype##2##3##(1992-10#1)(2008-5#1)
the same serum##4##3##(1992-11#1)(1996-12#1)(2008-5#1)(2011-11#1)
the same session##3##3##(1994-6#1)(2007-6#1)(2007-8#1)
the same set of##18##4##(1990-11#1)(1991-7#1)(1992-5#1)(1994-2#1)(1996-5#1)(1996-7#1)(2004-2#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)(2009-10#1)(2009-11#1)
the same shape as##2##4##(2008-2#2)
the same shape##5##3##(2007-9#1)(2008-2#3)(2011-1#1)
the same side of the helix##2##6##(1990-5#1)(1991-1#1)
the same side of the##6##5##(1990-5#1)(1991-1#1)(1991-9#1)(1996-8#1)(2007-12#1)(2008-10#1)
the same side of##7##4##(1990-5#1)(1991-1#1)(1991-9#1)(1995-11#1)(1996-8#1)(2007-12#1)(2008-10#1)
the same side##11##3##(1990-5#1)(1991-1#1)(1991-9#1)(1995-11#1)(1996-8#1)(2006-9#1)(2007-12#1)(2008-10#1)(2011-2#2)(2013-1#1)
the same single##6##3##(1991-4#1)(1996-5#1)(2008-10#1)(2008-5#1)(2012-12#1)(2012-3#1)
the same site and##3##4##(2008-10#1)(2008-8#1)(2011-1#1)
the same site showed##2##4##(1995-5#1)(2008-7#1)
the same site##26##3##(1990-5#3)(1990-9#1)(1992-5#1)(1993-11#1)(1995-12#1)(1995-5#3)(1996-5#1)(2003-11#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)
the same sites##5##3##(1995-12#1)(2004-4#1)(2006-5#1)(2008-10#1)(2008-11#1)
the same sitting##3##3##(2008-8#1)(2009-6#1)(2009-7#1)
the same size range##2##4##(1994-11#1)(2008-10#1)
the same size##16##3##(1992-9#1)(1994-11#1)(1997-2#1)(1997-3#1)(2005-10#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-1#1)
the same skin surface##2##4##(2008-5#2)
the same slope##2##3##(1995-3#1)(2008-8#1)
the same small##2##3##(2008-4#1)(2010-9#1)
the same social##2##3##(2008-3#1)(2012-2#1)
the same soil##3##3##(2008-10#3)
the same solid##3##3##(2007-9#1)(2008-10#1)(2008-7#1)
the same solution##4##3##(2008-10#3)(2013-1#1)
the same solvent##2##3##(2008-10#1)(2008-5#1)
the same source##7##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-9#1)(2011-2#1)(2013-8#1)
the same spacer##2##3##(2005-11#1)(2008-10#1)
the same spatial##2##3##(1991-1#1)(2006-5#1)
the same species and##3##4##(2008-7#1)(2012-12#1)(2012-2#1)
the same species as##2##4##(2008-4#2)
the same species##25##3##(1995-2#1)(1996-12#2)(2007-3#1)(2007-6#1)(2008-10#4)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2011-12#1)(2012-12#1)(2012-2#2)(2013-7#2)
the same specific##3##3##(1995-8#1)(1995-9#1)(1996-2#1)
the same specificity##4##3##(1991-2#1)(1994-12#1)(2004-1#1)(2008-10#1)
the same specimen##3##3##(2008-5#1)(2010-2#2)
the same spectral##3##3##(2007-11#1)(2008-2#1)(2008-9#1)
the same spectrometer##3##3##(2008-10#1)(2008-3#2)
the same spectrum of##2##4##(1990-4#1)(2008-10#1)
the same spectrum##3##3##(1990-4#1)(2006-12#1)(2008-10#1)
the same stage of##4##4##(1997-6#1)(2006-5#2)(2008-11#1)
the same standard##2##3##(2010-12#1)(2012-3#1)
the same standards##2##3##(1997-8#1)(2008-7#1)
the same step##2##3##(1997-1#1)(2008-10#1)
the same stimuli##2##3##(1993-2#1)(1996-10#1)
the same stimulus##7##3##(1990-5#1)(1994-3#1)(1995-5#1)(1997-1#1)(1997-2#1)(2007-8#1)(2012-1#1)
the same strain of##2##4##(2008-5#2)
the same strain##6##3##(1992-10#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-5#2)
the same strains##4##3##(1990-7#1)(1996-12#1)(2008-10#2)
the same striatal##2##3##(1995-12#1)(1996-1#1)
the same structure and##2##4##(1995-5#1)(2008-10#1)
the same structure##7##3##(1995-5#1)(2007-6#1)(2008-10#1)(2008-2#3)(2009-7#1)
the same students##2##3##(2008-12#1)(2013-1#1)
the same study##3##3##(2008-6#1)(2009-4#1)(2010-2#1)
the same subclass##2##3##(1995-3#1)(2008-8#1)
the same subgroup##3##3##(1994-12#1)(1996-10#1)(2010-5#1)
the same subject##4##3##(1996-3#1)(2007-7#1)(2008-5#1)(2013-1#1)
the same subjects##4##3##(1996-3#1)(2007-1#1)(2008-8#1)(2012-3#1)
the same substance##2##3##(2008-10#1)(2012-2#1)
the same substrate##3##3##(1995-2#1)(1996-4#1)(2007-12#1)
the same surface##4##3##(1990-12#1)(1996-2#1)(2005-11#1)(2010-8#1)
the same surgeon##6##3##(1991-4#1)(2007-8#2)(2008-4#1)(2008-8#1)(2008-9#1)
the same surgical##2##3##(2008-11#1)(2008-7#1)
the same symptom##2##3##(2006-10#1)(2008-10#1)
the same symptoms and signs##2##5##(1990-6#1)(2006-10#1)
the same symptoms##4##3##(1990-6#1)(2006-10#1)(2008-10#1)(2013-1#1)
the same system##8##3##(1991-2#1)(1994-2#1)(2008-10#3)(2008-2#1)(2010-5#1)(2012-2#1)
the same target##2##3##(2008-4#1)(2008-6#1)
the same task##5##3##(1994-8#1)(2008-9#1)(2009-5#1)(2010-2#1)(2012-1#1)
the same tasks##3##3##(1993-9#1)(1997-8#1)(2008-11#1)
the same technique##8##3##(1992-8#1)(2006-10#1)(2006-6#1)(2008-11#1)(2008-5#2)(2009-3#1)(2009-5#1)
the same temperature##9##3##(1991-2#1)(1994-5#1)(1996-1#1)(2004-9#1)(2005-12#1)(2008-8#1)(2008-9#2)(2012-2#1)
the same tendency##4##3##(1996-7#1)(2006-11#1)(2008-4#1)(2008-5#1)
the same test##4##3##(1994-6#1)(2008-9#1)(2013-1#2)
the same therapeutic##2##3##(1996-12#1)(2012-12#1)
the same thickness of##2##4##(2006-6#1)(2007-12#1)
the same thickness##3##3##(2006-6#1)(2007-11#1)(2007-12#1)
the same three##5##3##(1994-2#1)(1994-9#1)(2008-10#2)(2009-12#1)
the same time a##3##4##(1997-6#1)(2006-3#1)(2008-8#1)
the same time as the##7##5##(1993-12#1)(1997-8#1)(2006-12#1)(2008-10#1)(2008-3#2)(2012-3#1)
the same time as##15##4##(1991-8#1)(1993-12#1)(1995-11#1)(1997-8#1)(2004-2#1)(2006-12#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-8#1)(2012-3#1)
the same time course##2##4##(1990-6#1)(1993-2#1)
the same time it##2##4##(1990-5#1)(1997-2#1)
the same time of the##2##5##(1994-6#1)(2012-2#1)
the same time of##4##4##(1994-6#1)(1995-1#1)(1996-3#1)(2012-2#1)
the same time period##7##4##(1991-2#1)(1993-4#1)(2004-3#1)(2007-8#1)(2008-10#1)(2012-11#1)(2013-1#1)
the same time that##8##4##(1990-4#1)(1991-3#1)(1991-7#1)(1994-6#1)(1995-3#1)(2006-7#1)(2009-10#1)(2010-3#1)
the same time the##14##4##(1991-11#1)(1991-5#1)(2005-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-3#1)
the same time their##2##4##(1990-10#1)(2007-12#1)
the same time there##2##4##(2006-8#1)(2012-12#1)
the same time was##2##4##(1990-11#1)(2007-11#1)
the same time##351##3##(1990-10#3)(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#2)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-10#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-6#3)(1994-7#1)(1994-8#1)(1995-1#4)(1995-11#4)(1995-12#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#4)(1997-6#3)(1997-8#2)(2004-11#1)(2004-12#1)(2004-2#1)(2004-3#1)(2005-1#2)(2005-10#1)(2005-11#2)(2005-12#1)(2005-3#1)(2005-5#1)(2006-1#2)(2006-10#1)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#3)(2007-10#4)(2007-11#9)(2007-12#10)(2007-2#1)(2007-3#1)(2007-4#4)(2007-5#2)(2007-7#4)(2007-8#3)(2007-9#4)(2008-1#7)(2008-10#25)(2008-11#5)(2008-12#3)(2008-2#10)(2008-3#8)(2008-4#2)(2008-5#12)(2008-6#4)(2008-7#5)(2008-8#14)(2008-9#3)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#3)(2009-8#2)(2009-9#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#3)(2010-7#5)(2010-8#2)(2010-9#1)(2011-1#9)(2011-2#3)(2011-3#1)(2011-7#1)(2012-11#1)(2012-12#5)(2012-2#8)(2012-3#6)(2013-1#9)(2013-8#4)
the same tissue##8##3##(1990-2#1)(1992-1#1)(1992-3#1)(1994-10#2)(1995-11#1)(2008-7#1)(2009-4#1)
the same tissues in##2##4##(2008-4#1)(2008-5#1)
the same tissues##8##3##(1994-11#1)(1995-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)
the same topics##2##3##(2007-7#1)(2008-11#1)
the same total number of##2##5##(1993-8#1)(2007-11#1)
the same total##7##3##(1993-8#1)(2004-11#1)(2005-11#1)(2007-11#1)(2008-3#1)(2008-4#1)(2011-1#1)
the same training##2##3##(2008-5#1)(2009-1#1)
the same transcriptional orientation as##2##5##(1991-9#1)(1994-3#1)
the same transcriptional orientation##4##4##(1991-9#1)(1994-3#1)(1996-3#1)(1997-6#1)
the same transformation##2##3##(1996-12#1)(2008-10#1)
the same transition##2##3##(1994-2#1)(2007-12#1)
the same transmitter##2##3##(1991-3#1)(1995-11#1)
the same treatment##14##3##(1990-6#1)(1993-6#1)(1994-6#1)(1994-8#1)(1996-7#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-6#1)(2008-8#1)(2012-3#1)(2013-8#1)
the same trend##2##3##(2005-11#1)(2007-1#1)
the same tumor##5##3##(1991-6#1)(1991-9#1)(1992-9#1)(2010-11#1)(2011-2#1)
the same two##8##3##(1993-11#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-3#1)(2011-2#1)
the same type of information##2##5##(2004-2#1)(2007-11#1)
the same type of##15##4##(1990-9#1)(1992-6#1)(1992-9#1)(1995-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#2)(2009-5#1)
the same type##22##3##(1990-9#1)(1992-6#2)(1992-9#1)(1995-12#1)(1995-6#1)(1997-2#1)(1997-4#2)(1997-6#2)(1997-7#1)(2004-2#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-9#1)(2009-5#1)(2012-2#1)
the same types of##5##4##(1991-12#1)(1994-10#1)(1997-3#1)(2008-10#1)(2010-2#1)
the same tyrosine##2##3##(1991-12#2)
the same ultrasonic##2##3##(2008-10#1)(2008-2#1)
the same under##2##3##(1994-6#1)(2005-12#1)
the same underlying##4##3##(1992-8#1)(2006-2#1)(2010-1#1)(2011-1#1)
the same value of##2##4##(1990-3#1)(2006-4#1)
the same value##4##3##(1990-3#1)(2006-4#1)(2008-2#1)(2008-3#1)
the same variable##3##3##(1997-2#2)(2007-3#1)
the same variables##2##3##(2008-10#1)(2008-11#1)
the same variety##3##3##(2008-10#2)(2011-2#1)
the same vector##3##3##(1995-1#1)(1997-2#1)(2008-10#1)
the same villages##5##3##(1994-9#1)(2006-4#2)(2007-2#1)(2013-1#1)
the same viroids##2##3##(2008-10#2)
the same virus##6##3##(1991-3#1)(2008-10#2)(2008-8#2)(2010-4#1)
the same volume of##2##4##(1990-7#1)(2012-3#1)
the same volume##6##3##(1990-7#1)(1996-11#1)(2007-12#1)(2008-3#1)(2011-1#1)(2012-3#1)
the same was##3##3##(2008-7#1)(2011-2#1)(2012-2#1)
the same water##4##3##(1994-8#1)(2008-10#2)(2008-3#1)
the same wavelength##5##3##(2008-10#1)(2008-2#1)(2008-3#3)
the same way as##18##4##(1990-9#1)(1991-9#2)(1993-3#2)(1995-2#1)(1995-9#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2009-4#1)
the same way##47##3##(1990-8#1)(1990-9#1)(1991-9#2)(1992-7#1)(1992-9#1)(1993-3#2)(1994-1#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-7#2)(2005-4#1)(2006-2#1)(2006-8#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#2)(2008-5#2)(2009-10#1)(2009-4#1)(2010-4#1)(2011-12#1)(2013-7#1)
the same when##2##3##(2007-3#1)(2010-11#1)
the same whether##2##3##(1992-6#2)
the same while##2##3##(2008-10#1)(2008-7#1)
the same with##4##3##(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#1)
the same within##2##3##(1995-5#1)(2008-10#1)
the same year and##3##4##(1990-10#1)(2004-11#1)(2008-10#1)
the same year##7##3##(1990-10#1)(2004-11#1)(2008-1#1)(2008-10#2)(2012-1#1)(2013-1#1)
the same##4528##2##(1990-1#2)(1990-10#23)(1990-11#21)(1990-12#27)(1990-2#34)(1990-3#11)(1990-4#14)(1990-5#33)(1990-6#11)(1990-7#20)(1990-8#17)(1990-9#12)(1991-1#5)(1991-10#7)(1991-11#15)(1991-12#22)(1991-2#29)(1991-3#21)(1991-4#12)(1991-5#22)(1991-6#11)(1991-7#12)(1991-8#18)(1991-9#26)(1992-1#11)(1992-10#11)(1992-11#15)(1992-12#18)(1992-2#13)(1992-3#17)(1992-4#13)(1992-5#13)(1992-6#31)(1992-7#13)(1992-8#16)(1992-9#11)(1993-1#5)(1993-10#3)(1993-11#18)(1993-12#19)(1993-2#15)(1993-3#17)(1993-4#10)(1993-5#5)(1993-6#26)(1993-7#8)(1993-8#22)(1993-9#25)(1994-1#6)(1994-10#12)(1994-11#19)(1994-12#36)(1994-2#23)(1994-3#24)(1994-5#23)(1994-6#22)(1994-7#2)(1994-8#32)(1994-9#31)(1995-1#30)(1995-10#6)(1995-11#24)(1995-12#28)(1995-2#34)(1995-3#28)(1995-4#7)(1995-5#34)(1995-6#25)(1995-7#6)(1995-8#26)(1995-9#6)(1996-1#17)(1996-10#12)(1996-11#22)(1996-12#22)(1996-2#21)(1996-3#22)(1996-4#6)(1996-5#18)(1996-6#15)(1996-7#19)(1996-8#18)(1996-9#13)(1997-1#17)(1997-2#29)(1997-3#15)(1997-4#27)(1997-5#13)(1997-6#33)(1997-7#19)(1997-8#28)(2003-11#1)(2004-1#1)(2004-10#2)(2004-11#12)(2004-12#2)(2004-2#8)(2004-3#2)(2004-4#2)(2004-7#1)(2004-8#3)(2004-9#10)(2005-1#2)(2005-10#12)(2005-11#36)(2005-12#10)(2005-3#4)(2005-4#6)(2005-5#1)(2005-7#5)(2005-8#6)(2005-9#2)(2006-1#4)(2006-10#45)(2006-11#8)(2006-12#19)(2006-2#12)(2006-3#10)(2006-4#19)(2006-5#14)(2006-6#17)(2006-7#5)(2006-8#28)(2006-9#9)(2007-1#18)(2007-10#17)(2007-11#74)(2007-12#103)(2007-2#12)(2007-3#18)(2007-4#11)(2007-5#15)(2007-6#12)(2007-7#36)(2007-8#38)(2007-9#28)(2008-1#50)(2008-10#538)(2008-11#100)(2008-12#27)(2008-2#122)(2008-3#143)(2008-4#55)(2008-5#121)(2008-6#34)(2008-7#84)(2008-8#88)(2008-9#63)(2009-1#4)(2009-10#23)(2009-11#10)(2009-12#13)(2009-2#3)(2009-3#10)(2009-4#21)(2009-5#13)(2009-6#17)(2009-7#6)(2009-8#14)(2009-9#10)(2010-1#6)(2010-10#9)(2010-11#9)(2010-12#31)(2010-2#18)(2010-3#12)(2010-4#20)(2010-5#15)(2010-6#4)(2010-7#13)(2010-8#20)(2010-9#3)(2011-1#45)(2011-11#1)(2011-12#11)(2011-2#62)(2011-3#2)(2011-7#1)(2012-1#31)(2012-11#7)(2012-12#50)(2012-2#63)(2012-3#40)(2012-4#2)(2013-1#64)(2013-7#11)(2013-8#59)
the sample and IRE##2##4##(2007-12#2)
the sample and the reference##3##5##(2008-10#1)(2008-2#2)
the sample and the##12##4##(2007-12#1)(2008-10#8)(2008-2#2)(2008-3#1)
the sample and##41##3##(1993-11#1)(1997-2#1)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#23)(2008-2#3)(2008-3#3)(2008-4#1)(2008-7#1)(2009-8#1)(2011-1#1)
the sample and/or##2##3##(2008-10#2)
the sample are##4##3##(2007-12#1)(2008-10#1)(2008-2#2)
the sample area##2##3##(2010-2#1)(2011-2#1)
the sample arm##2##3##(2007-11#2)
the sample at##2##3##(2007-12#1)(2008-10#1)
the sample before analysis##2##4##(1991-5#1)(2008-10#1)
the sample buffer##2##3##(2006-8#1)(2008-10#1)
the sample by##4##3##(2008-10#4)
the sample can be##4##4##(2008-10#3)(2008-2#1)
the sample can##5##3##(2007-5#1)(2008-10#3)(2008-2#1)
the sample cell##2##3##(2008-2#1)(2008-3#1)
the sample chamber##5##3##(2008-10#1)(2008-11#3)(2008-9#1)
the sample characteristics##3##3##(2007-8#1)(2013-1#2)
the sample completed##2##3##(2007-4#1)(2008-8#1)
the sample composition##2##3##(1992-1#1)(2008-10#1)
the sample contained##2##3##(2008-10#1)(2008-8#1)
the sample containing##2##3##(2007-8#1)(2008-10#1)
the sample during##3##3##(1990-5#1)(2007-12#1)(2008-10#1)
the sample for##4##3##(1997-5#1)(2006-7#1)(2008-10#2)
the sample free##2##3##(1996-12#1)(2008-10#1)
the sample frequency was##3##4##(2007-8#1)(2008-10#2)
the sample from the##2##4##(2008-10#1)(2008-2#1)
the sample from##3##3##(1995-6#1)(2008-10#1)(2008-2#1)
the sample group##2##3##(1993-2#1)(2008-1#1)
the sample had##4##3##(1997-8#1)(2008-4#1)(2008-6#1)(2010-3#1)
the sample has been##2##4##(2008-10#1)(2011-12#1)
the sample has##4##3##(1992-2#1)(2008-10#2)(2011-12#1)
the sample in Study##2##4##(1991-2#2)
the sample in the##5##4##(2005-4#1)(2006-5#1)(2008-10#2)(2012-12#1)
the sample in##16##3##(1991-2#2)(2005-4#1)(2006-5#1)(2008-10#9)(2008-5#1)(2008-9#1)(2012-12#1)
the sample injected##2##3##(2008-10#2)
the sample injection##4##3##(2008-10#3)(2012-3#1)
the sample into the##3##4##(1990-12#1)(1992-1#1)(2008-10#1)
the sample into##4##3##(1990-12#1)(1992-1#1)(2008-10#2)
the sample introduction system##2##4##(2008-10#2)
the sample introduction##4##3##(2008-10#4)
the sample is##29##3##(1995-12#1)(2006-5#1)(2007-11#2)(2007-12#3)(2008-10#11)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#1)(2011-2#1)
the sample loop##2##3##(2008-10#2)
the sample material##2##3##(1996-2#1)(2008-1#1)
the sample matrix was##2##4##(2008-10#2)
the sample matrix##10##3##(1992-1#1)(2008-10#8)(2008-5#1)
the sample may be##2##4##(2008-10#1)(2013-1#1)
the sample may##3##3##(2006-6#1)(2008-10#1)(2013-1#1)
the sample mean##2##3##(2008-7#1)(2010-4#1)
the sample of interest##2##4##(1991-8#1)(2008-3#1)
the sample of##7##3##(1991-8#1)(2007-10#1)(2007-8#1)(2008-12#1)(2008-3#1)(2011-1#1)(2013-1#1)
the sample or##2##3##(2008-10#1)(2008-3#1)
the sample pH and sample flow rate##2##7##(2008-10#2)
the sample pH##3##3##(2008-10#3)
the sample plug##4##3##(2008-10#4)
the sample population##3##3##(2007-2#1)(2007-7#2)
the sample preparation and##2##4##(2008-10#2)
the sample preparation##8##3##(2007-8#1)(2008-10#6)(2012-12#1)
the sample processing##2##3##(1990-12#1)(2008-10#1)
the sample profile##2##3##(2007-12#1)(2008-3#1)
the sample set##3##3##(2013-8#3)
the sample size for a##2##5##(1995-9#1)(2006-10#1)
the sample size for##4##4##(1995-8#1)(1995-9#1)(2006-10#1)(2012-12#1)
the sample size is small##3##5##(2008-7#1)(2012-1#1)(2012-2#1)
the sample size is too##2##5##(2007-7#2)
the sample size is##9##4##(2007-7#2)(2008-7#1)(2009-11#1)(2012-1#1)(2012-2#2)(2012-3#2)
the sample size of##3##4##(1996-12#1)(2008-8#1)(2012-2#1)
the sample size required for##3##5##(1992-2#1)(1993-1#1)(1994-6#1)
the sample size required##4##4##(1992-2#1)(1993-1#1)(1994-6#1)(1995-9#1)
the sample size##44##3##(1992-2#1)(1993-1#1)(1994-6#1)(1994-9#1)(1995-8#1)(1995-9#2)(1996-12#1)(1996-7#1)(2006-10#1)(2007-11#1)(2007-7#2)(2008-10#3)(2008-7#1)(2008-8#2)(2009-11#1)(2009-12#2)(2009-9#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#9)(2012-3#4)(2013-8#1)
the sample sizes##6##3##(1996-8#3)(2008-10#1)(2012-12#1)(2012-2#1)
the sample solution can be##2##5##(2007-8#1)(2008-10#1)
the sample solution containing##3##4##(2005-4#1)(2008-10#2)
the sample solution in##2##4##(2008-10#2)
the sample solution is##2##4##(2008-10#2)
the sample solution through the##3##5##(2007-8#1)(2008-10#2)
the sample solution to##2##4##(2008-10#2)
the sample solution was injected##2##5##(2008-10#2)
the sample solution was##7##4##(2008-10#7)
the sample solution were##2##4##(2008-10#1)(2010-5#1)
the sample solution##47##3##(2005-4#1)(2007-8#5)(2008-10#40)(2010-5#1)
the sample solutions##3##3##(2008-10#3)
the sample stream##2##3##(2008-10#2)
the sample structure##2##3##(2008-3#2)
the sample surface as##2##4##(2006-12#1)(2012-2#1)
the sample surface to##2##4##(2007-11#1)(2008-3#1)
the sample surface##17##3##(1994-9#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#4)(2008-7#1)(2012-2#1)
the sample that##2##3##(2006-5#1)(2007-11#1)
the sample thickness##3##3##(2008-2#3)
the sample through the##2##4##(2008-10#1)(2008-3#1)
the sample through##4##3##(2008-10#3)(2008-3#1)
the sample throughput##9##3##(2008-10#8)(2011-1#1)
the sample to the##2##4##(2008-10#2)
the sample to##15##3##(2006-2#1)(2007-12#2)(2008-10#7)(2008-3#1)(2011-1#1)(2011-2#1)(2012-12#2)
the sample treated by##2##4##(2008-10#1)(2008-9#1)
the sample treated##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
the sample under investigation##2##4##(2006-12#1)(2008-3#1)
the sample under##3##3##(2006-12#1)(2008-3#2)
the sample using##6##3##(2008-10#5)(2011-1#1)
the sample volume was##2##4##(2008-10#2)
the sample volume##9##3##(1990-12#1)(2008-10#7)(2008-3#1)
the sample was divided##2##4##(2008-12#1)(2008-6#1)
the sample was##29##3##(1996-4#1)(1997-3#1)(2005-4#3)(2006-10#1)(2006-12#1)(2006-8#2)(2006-9#1)(2007-2#2)(2008-10#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-7#1)(2013-8#1)
the sample were##9##3##(1992-5#1)(1995-5#1)(2007-2#1)(2008-10#2)(2008-12#1)(2011-2#1)(2012-12#1)(2013-7#1)
the sample with the highest##2##5##(2008-10#1)(2008-5#1)
the sample with##14##3##(1990-3#1)(1996-5#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#6)(2008-2#1)(2008-5#1)
the sample without##2##3##(2007-12#1)(2008-10#1)
the sample would##2##3##(1991-8#1)(1992-12#1)
the sample zone is##4##4##(2008-10#4)
the sample zone##10##3##(2008-10#10)
the sample##770##2##(1990-12#4)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-2#4)(1991-5#1)(1991-8#6)(1991-9#1)(1992-1#3)(1992-11#1)(1992-12#2)(1992-2#3)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#3)(1993-11#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#3)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#4)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#2)(2004-9#1)(2005-11#5)(2005-4#6)(2006-10#5)(2006-12#6)(2006-2#2)(2006-4#4)(2006-5#5)(2006-6#2)(2006-7#2)(2006-8#3)(2006-9#1)(2007-10#3)(2007-11#17)(2007-12#36)(2007-2#5)(2007-4#1)(2007-5#2)(2007-7#5)(2007-8#15)(2007-9#3)(2008-1#11)(2008-10#324)(2008-11#5)(2008-12#4)(2008-2#28)(2008-3#56)(2008-4#14)(2008-5#8)(2008-6#4)(2008-7#5)(2008-8#5)(2008-9#4)(2009-11#2)(2009-12#3)(2009-3#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#9)(2011-12#2)(2011-2#10)(2012-1#2)(2012-12#10)(2012-2#13)(2012-3#7)(2013-1#11)(2013-7#1)(2013-8#12)
the sample's##8##2##(2007-11#2)(2008-2#1)(2008-3#3)(2012-11#2)
the sample)##9##2##(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-8#1)(2009-4#1)(2012-3#1)
the sampled populations##2##3##(2008-10#1)(2008-5#1)
the sampled##22##2##(2008-10#10)(2008-11#1)(2008-2#3)(2008-5#5)(2011-12#1)(2013-7#2)
the samples analyzed##4##3##(2008-10#4)
the samples and the##3##4##(2008-10#3)
the samples and##14##3##(1990-11#1)(2005-11#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-5#1)
the samples are##8##3##(2008-10#6)(2008-3#2)
the samples by##3##3##(2008-10#3)
the samples collected##8##3##(1992-3#1)(2007-3#2)(2008-10#2)(2008-5#2)(2010-8#1)
the samples containing##3##3##(2007-9#1)(2008-8#1)(2010-4#1)
the samples could##2##3##(2008-10#2)
the samples for##4##3##(2008-10#4)
the samples from the##2##4##(1995-11#1)(2010-4#1)
the samples from##9##3##(1990-12#1)(1995-11#1)(2006-8#1)(2007-1#1)(2008-12#3)(2010-4#2)
the samples in a##2##4##(1994-11#1)(2008-10#1)
the samples in##12##3##(1990-8#1)(1994-11#1)(2007-8#1)(2008-10#6)(2008-3#1)(2010-4#1)(2012-2#1)
the samples is##3##3##(2008-10#2)(2008-3#1)
the samples may have##2##4##(1990-11#1)(2012-11#1)
the samples may##3##3##(1990-11#1)(2010-11#1)(2012-11#1)
the samples of interest##3##4##(1996-8#1)(2008-10#1)(2008-2#1)
the samples of the##3##4##(1991-1#1)(2008-10#1)(2012-3#1)
the samples of##14##3##(1991-1#1)(1996-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-12#1)(2012-12#1)(2012-3#2)
the samples on the##2##4##(2008-10#2)
the samples on##3##3##(2008-10#2)(2008-8#1)
the samples prepared##3##3##(1990-7#1)(2008-5#2)
the samples studied##5##3##(1992-6#1)(1996-12#1)(1997-3#1)(2008-10#1)(2011-2#1)
the samples that##5##3##(2004-11#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-6#1)
the samples to##6##3##(2008-10#1)(2008-2#1)(2008-3#2)(2009-11#1)(2010-5#1)
the samples treated##2##3##(2005-11#1)(2008-10#1)
the samples under investigation##2##4##(2006-5#1)(2007-8#1)
the samples under study##4##4##(2005-11#2)(2009-3#1)(2009-8#1)
the samples under##7##3##(2004-9#1)(2005-11#2)(2006-5#1)(2007-8#1)(2009-3#1)(2009-8#1)
the samples using##2##3##(2008-10#2)
the samples was determined##2##4##(2008-10#2)
the samples was measured##2##4##(2008-10#1)(2011-12#1)
the samples was##12##3##(2005-4#1)(2007-3#1)(2007-5#1)(2008-10#6)(2011-12#1)(2012-12#1)(2013-1#1)
the samples were determined by##3##5##(2008-10#2)(2011-1#1)
the samples were digested##2##4##(2008-10#2)
the samples were inserted into the system on the day##2##10##(2010-6#2)
the samples were obtained##2##4##(1996-3#1)(2007-3#1)
the samples were##46##3##(1990-1#1)(1992-2#1)(1995-6#1)(1996-3#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-3#1)(2007-7#2)(2008-10#14)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2010-4#1)(2010-6#2)(2011-1#2)(2011-12#1)(2011-3#1)(2012-11#1)(2012-2#1)(2012-3#3)(2013-1#1)
the samples while##2##3##(2008-10#1)(2011-1#1)
the samples with##9##3##(1995-1#1)(1995-6#1)(1996-12#1)(1996-6#1)(2008-10#4)(2008-8#1)
the samples##345##2##(1990-1#1)(1990-11#2)(1990-12#3)(1990-7#2)(1990-8#1)(1991-1#1)(1992-2#1)(1992-3#1)(1992-6#2)(1993-9#1)(1994-11#1)(1994-6#3)(1995-1#2)(1995-11#1)(1995-2#1)(1995-6#3)(1995-7#1)(1996-12#2)(1996-3#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-3#1)(2004-11#1)(2004-4#1)(2004-9#1)(2005-11#7)(2005-4#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#3)(2006-2#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#5)(2007-5#2)(2007-7#4)(2007-8#3)(2007-9#3)(2008-10#132)(2008-11#5)(2008-12#6)(2008-2#7)(2008-3#13)(2008-4#2)(2008-5#14)(2008-6#4)(2008-7#4)(2008-8#5)(2008-9#1)(2009-11#1)(2009-3#2)(2009-4#6)(2009-5#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#6)(2010-5#1)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#8)(2011-12#3)(2011-2#4)(2011-3#2)(2012-1#2)(2012-11#2)(2012-12#6)(2012-2#6)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#2)
the samples' scores##2##3##(2013-7#2)
the samples'##3##2##(2008-10#1)(2013-7#2)
the sampling and##2##3##(2008-10#1)(2008-12#1)
the sampling arm##2##3##(2008-10#2)
the sampling date##2##3##(1996-12#1)(2008-10#1)
the sampling density##2##3##(2008-6#1)(2008-9#1)
the sampling distribution##2##3##(2008-10#2)
the sampling error##2##3##(2008-10#1)(2008-8#1)
the sampling field##2##3##(2008-10#1)(2008-3#1)
the sampling frequency is##2##4##(1995-3#1)(2008-10#1)
the sampling frequency of##2##4##(2008-10#2)
the sampling frequency was##2##4##(2008-10#2)
the sampling frequency##10##3##(1995-3#1)(2008-10#8)(2008-2#1)
the sampling in##2##3##(2008-3#1)(2011-3#1)
the sampling loss##2##3##(2008-10#2)
the sampling period##11##3##(2006-5#1)(2007-5#2)(2008-10#1)(2008-2#1)(2008-5#4)(2012-2#1)(2013-7#1)
the sampling points##5##3##(2008-3#5)
the sampling procedure##2##3##(2008-10#1)(2010-8#1)
the sampling rate of##2##4##(2008-10#2)
the sampling rate was##4##4##(2008-10#4)
the sampling rate##6##3##(2008-10#6)
the sampling rates##3##3##(1997-6#1)(2008-10#2)
the sampling sites##4##3##(2007-5#2)(2008-10#1)(2012-12#1)
the sampling throughput##2##3##(2008-10#2)
the sampling time##3##3##(2008-10#2)(2012-3#1)
the sampling unit##3##3##(2008-10#3)
the sampling variance of##2##4##(2008-10#1)(2008-8#1)
the sampling volume##6##3##(1997-8#1)(2008-2#1)(2008-3#4)
the sampling##118##2##(1993-8#1)(1995-3#1)(1996-12#1)(1997-6#2)(1997-8#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-5#4)(2008-10#52)(2008-11#1)(2008-12#1)(2008-2#10)(2008-3#15)(2008-5#4)(2008-6#1)(2008-8#3)(2008-9#1)(2009-5#1)(2010-2#2)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#3)
the sanatoriums##3##2##(2009-7#3)
the sanctity of life##3##4##(2006-4#1)(2006-7#2)
the sanctuary area##2##3##(2013-7#2)
the sanctuary##3##2##(2013-7#3)
the sand fly##5##3##(2004-11#1)(2007-12#1)(2008-7#1)(2010-1#1)(2012-12#1)
the sand##10##2##(1991-12#1)(2004-11#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-7#1)(2010-1#1)(2012-12#1)
the sandwich estimator##2##3##(2008-2#2)
the sandwich hybridization assay##2##4##(2008-10#1)(2010-5#1)
the sandwich##8##2##(1991-10#1)(2008-10#2)(2008-2#4)(2010-5#1)
the sanitary control##2##3##(2008-10#1)(2012-12#1)
the sanitary##6##2##(2006-8#1)(2008-10#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)
the sanitation of##2##3##(2009-12#1)(2010-1#1)
the sanitation##5##2##(1993-3#1)(1997-3#1)(2009-12#1)(2010-1#1)(2010-4#1)
the sapheno-femoral##2##2##(1991-10#2)
the saphenous nerve##3##3##(1992-3#1)(1997-3#2)
the saphenous vein##7##3##(2007-7#1)(2007-8#4)(2008-11#2)
the saphenous##15##2##(1992-3#1)(1995-11#1)(1996-12#1)(1997-3#2)(2007-7#1)(2007-8#6)(2008-11#3)
the saponin##2##2##(1995-8#1)(2007-1#1)
the sapphire##2##2##(2008-10#1)(2008-3#1)
the saprophyte##3##2##(1993-9#1)(2008-10#1)(2008-9#1)
the saprophytic stage##2##3##(2008-10#2)
the saprophytic##4##2##(2008-10#3)(2008-2#1)
the sapwood##3##2##(2008-10#3)
the sarcolemma and the##2##4##(1994-8#1)(2009-7#1)
the sarcolemma and##3##3##(1991-11#1)(1994-8#1)(2009-7#1)
the sarcolemma##13##2##(1990-8#1)(1991-11#2)(1993-2#1)(1994-5#1)(1994-8#1)(1996-9#1)(2007-9#4)(2008-1#1)(2009-7#1)
the sarcolemmal##2##2##(1991-11#1)(2008-1#1)
the sarcomatous component##2##3##(2007-12#1)(2011-2#1)
the sarcomatous##4##2##(1990-12#1)(1994-5#1)(2007-12#1)(2011-2#1)
the sarcoplasmic reticulum (SR) of##2##5##(1990-11#1)(1994-5#1)
the sarcoplasmic reticulum (SR)##4##4##(1990-11#1)(1994-5#1)(1994-8#1)(2006-10#1)
the sarcoplasmic reticulum Ca2+##2##4##(1992-11#1)(1996-12#1)
the sarcoplasmic reticulum and##3##4##(1994-2#1)(2008-5#1)(2010-2#1)
the sarcoplasmic reticulum in##2##4##(1994-2#1)(2010-12#1)
the sarcoplasmic reticulum##33##3##(1990-11#2)(1990-2#1)(1991-12#2)(1991-2#1)(1991-9#1)(1992-11#2)(1992-3#1)(1992-6#1)(1994-10#1)(1994-12#1)(1994-2#3)(1994-5#1)(1994-8#1)(1994-9#3)(1996-12#1)(1996-9#2)(2006-10#1)(2007-9#2)(2008-5#1)(2009-7#1)(2010-12#2)(2010-2#1)(2013-8#1)
the satellite cell##2##3##(2008-7#1)(2009-3#1)
the satellite##18##2##(1990-7#1)(1996-4#1)(1996-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#5)(2008-7#1)(2009-3#1)(2011-1#1)
the satisfaction of the##5##4##(2008-2#1)(2008-8#1)(2010-9#1)(2011-12#1)(2013-1#1)
the satisfaction of##9##3##(1992-5#1)(2007-10#1)(2007-4#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-9#1)(2011-12#1)(2013-1#1)
the satisfaction##13##2##(1992-3#1)(1992-5#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-2#1)(2008-8#2)(2008-9#1)(2010-9#1)(2011-12#1)(2013-1#1)
the satisfactory##8##2##(2006-12#1)(2008-10#3)(2008-5#1)(2010-6#1)(2011-2#1)(2013-1#1)
the saturable absorber##4##3##(2008-2#1)(2008-3#3)
the saturable##8##2##(1990-12#3)(1996-12#1)(2008-2#1)(2008-3#3)
the saturated alpha-isoprene unit##2##4##(1994-8#2)
the saturated fat diet were##2##5##(1994-2#2)
the saturated fat diet##3##4##(1994-2#3)
the saturated fat##4##3##(1994-2#4)
the saturated fatty acids##3##4##(1991-12#1)(1994-9#1)(2008-11#1)
the saturated fatty##4##3##(1991-12#1)(1994-9#1)(2008-11#1)(2010-4#1)
the saturated##33##2##(1990-11#1)(1990-2#2)(1991-12#2)(1991-2#1)(1991-4#2)(1992-9#1)(1994-2#4)(1994-8#2)(1994-9#2)(2004-4#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#4)(2008-5#1)(2010-4#1)(2012-11#1)
the saturation effects##2##3##(2008-3#1)(2008-7#1)
the saturation intensity##7##3##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#2)
the saturation of the##2##4##(2011-2#1)(2012-11#1)
the saturation of##5##3##(1993-4#1)(2007-11#1)(2008-10#1)(2011-2#1)(2012-11#1)
the saturation##32##2##(1991-3#1)(1991-6#1)(1991-9#1)(1993-4#1)(1994-12#1)(2005-11#1)(2007-11#3)(2007-12#4)(2008-10#1)(2008-2#4)(2008-3#8)(2008-7#1)(2010-7#1)(2011-2#1)(2012-11#2)(2013-8#1)
the saudi##2##2##(2008-1#2)
the sauna##2##2##(1990-10#1)(2008-7#1)
the savings##8##2##(1990-12#1)(1990-4#1)(1992-2#1)(1993-3#1)(1995-2#2)(2007-4#1)(2011-2#1)
the sawdust of##2##3##(2008-12#2)
the sawdust##3##2##(2008-12#3)
the scFv##2##2##(2008-10#1)(2009-2#1)
the scaffold for##2##3##(2007-12#1)(2009-7#1)
the scaffold must##2##3##(2009-7#2)
the scaffold##19##2##(2007-12#1)(2008-1#1)(2008-5#3)(2008-7#2)(2009-4#1)(2009-7#4)(2009-8#1)(2010-4#1)(2012-1#3)(2012-11#1)(2013-8#1)
the scaffolding for##2##3##(2007-7#1)(2012-2#1)
the scaffolding##7##2##(1996-8#1)(2007-7#1)(2008-11#2)(2008-4#1)(2009-7#1)(2012-2#1)
the scaffolds##16##2##(2008-5#8)(2009-4#2)(2009-7#3)(2010-12#1)(2010-9#1)(2012-2#1)
the scalability##4##2##(2013-1#4)
the scalar diffraction theory is##2##5##(2008-2#1)(2008-3#1)
the scalar diffraction##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
the scalar##13##2##(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#5)(2012-11#1)
the scale and scope of##3##5##(2008-9#1)(2013-1#2)
the scale and##8##3##(2007-12#1)(2007-7#1)(2008-2#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
the scale factor##2##3##(2008-2#1)(2008-3#1)
the scale is##2##3##(2008-3#1)(2012-2#1)
the scale of 1-5##2##4##(1990-2#2)
the scale of a##2##4##(2007-12#1)(2012-1#1)
the scale of the data##2##5##(2008-10#1)(2011-1#1)
the scale of the##11##4##(2008-10#3)(2008-2#1)(2008-3#3)(2008-7#2)(2008-8#1)(2011-1#1)
the scale of##33##3##(1990-2#2)(1990-3#1)(1990-7#1)(1992-1#1)(1994-2#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#3)(2008-7#3)(2008-8#2)(2008-9#1)(2011-1#2)(2012-1#2)(2012-2#1)(2013-1#1)
the scale up##4##3##(2008-11#2)(2008-5#1)(2009-7#1)
the scale##87##2##(1990-2#2)(1990-3#1)(1990-7#1)(1992-1#2)(1993-1#1)(1994-2#1)(1996-3#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#10)(2008-11#5)(2008-2#7)(2008-3#7)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#9)(2009-10#1)(2009-7#1)(2010-4#2)(2011-1#3)(2011-2#2)(2012-1#2)(2012-11#2)(2012-2#3)(2012-3#2)(2013-1#3)
the scale's##2##2##(2009-11#1)(2012-11#1)
the scale-up and##2##3##(2006-12#1)(2008-7#1)
the scale-up of##2##3##(2008-11#1)(2011-12#1)
the scale-up##5##2##(2006-12#1)(2008-11#2)(2008-7#1)(2011-12#1)
the scaled##3##2##(2005-11#2)(2009-12#1)
the scales of##2##3##(2006-7#1)(2008-2#1)
the scales were##2##3##(2008-6#1)(2012-2#1)
the scales##14##2##(1990-12#1)(1990-5#1)(2006-10#1)(2006-7#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-6#2)(2011-2#1)(2012-2#1)(2013-8#1)
the scaling and##3##3##(2006-10#1)(2008-10#1)(2013-8#1)
the scaling argument##2##3##(2007-10#2)
the scaling error has##2##4##(2007-12#2)
the scaling exponents##2##3##(1996-12#1)(2008-8#1)
the scaling factor of the##4##5##(2005-11#2)(2007-12#1)(2008-3#1)
the scaling laws##2##3##(2006-2#1)(2012-2#1)
the scaling of the##2##4##(1993-5#1)(2005-11#1)
the scaling of##5##3##(1993-5#1)(2005-11#1)(2007-10#1)(2008-3#1)(2011-1#1)
the scaling properties of##2##4##(2007-11#1)(2008-12#1)
the scaling##29##2##(1993-5#1)(1996-12#1)(2005-11#4)(2006-10#1)(2006-2#1)(2006-4#1)(2007-10#3)(2007-11#1)(2007-12#3)(2007-4#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#1)(2011-1#1)(2012-2#1)(2013-8#2)
the scalp and##5##3##(2005-11#1)(2008-5#2)(2008-7#1)(2013-8#1)
the scalp is##3##3##(2007-11#1)(2010-5#1)(2010-6#1)
the scalp of##2##3##(2007-7#1)(2012-12#1)
the scalp or##2##3##(1995-6#1)(2011-1#1)
the scalp was##2##3##(1990-7#1)(2012-3#1)
the scalp##54##2##(1990-7#1)(1992-8#1)(1995-12#1)(1995-6#2)(1996-7#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-11#2)(2006-12#2)(2007-11#2)(2007-7#5)(2007-8#2)(2008-5#6)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2010-5#5)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-11#3)(2012-12#2)(2012-3#1)(2013-8#2)
the scan rate of##2##4##(2008-10#1)(2008-3#1)
the scan rate##5##3##(2008-10#4)(2008-3#1)
the scan##19##2##(1990-5#1)(1995-11#2)(1996-5#1)(2004-10#1)(2007-11#1)(2008-10#6)(2008-3#2)(2008-7#1)(2009-2#1)(2012-1#2)(2013-1#1)
the scanned##3##2##(2007-1#1)(2007-12#2)
the scanner##7##2##(1992-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2011-1#2)
the scanning and##2##3##(2008-2#1)(2008-5#1)
the scanning direction##2##3##(2008-1#1)(2008-2#1)
the scanning electron microscope##5##4##(1991-2#2)(2006-8#1)(2008-5#2)
the scanning probe##2##3##(2007-9#1)(2008-7#1)
the scanning rate##2##3##(1991-2#1)(2008-2#1)
the scanning tunneling microscope##2##4##(1990-4#1)(1991-11#1)
the scanning tunneling##3##3##(1990-4#1)(1991-11#1)(2008-2#1)
the scanning##37##2##(1990-4#1)(1991-11#1)(1991-2#3)(2004-11#1)(2005-12#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-1#2)(2008-11#1)(2008-2#8)(2008-3#6)(2008-5#4)(2008-7#2)(2011-2#1)
the scant##2##2##(2009-10#1)(2012-11#1)
the scaphoid and lunate##2##4##(2006-3#1)(2012-1#1)
the scaphoid and##3##3##(2006-3#1)(2008-9#1)(2012-1#1)
the scaphoid fracture was detected on MRI##2##7##(2006-3#2)
the scaphoid fracture##4##3##(2006-3#3)(2008-9#1)
the scaphoid with the##2##4##(2006-3#1)(2013-1#1)
the scaphoid##20##2##(2006-3#9)(2008-9#5)(2009-2#3)(2012-1#1)(2012-2#1)(2013-1#1)
the scapholunate##3##2##(2006-3#1)(2006-4#1)(2012-1#1)
the scapula##5##2##(2005-10#1)(2006-11#2)(2007-2#1)(2013-7#1)
the scapular##3##2##(2010-9#1)(2011-2#1)(2012-3#1)
the scar tissue##2##3##(1997-3#1)(2006-11#1)
the scar##9##2##(1996-4#1)(1997-3#1)(2006-11#1)(2006-12#1)(2009-6#1)(2012-1#2)(2013-8#2)
the scarce##5##2##(2007-5#2)(2008-11#1)(2008-7#1)(2012-12#1)
the scarcity of##11##3##(1995-8#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-4#1)(2011-2#1)(2011-3#2)(2012-12#1)
the scarcity##12##2##(1995-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-4#1)(2011-2#1)(2011-3#2)(2012-12#1)
the scarred##3##2##(1991-12#1)(1997-6#1)(2007-10#1)
the scars##2##2##(2008-9#1)(2010-9#1)
the scatter in the##2##4##(1991-9#1)(1996-12#1)
the scatter of contact angle values##2##6##(2005-11#2)
the scatter of##3##3##(2005-11#2)(2005-4#1)
the scatter##13##2##(1991-10#1)(1991-9#1)(1996-12#1)(2005-11#2)(2005-4#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-1#3)
the scattered and##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
the scattered field as a##2##5##(2008-2#1)(2009-10#1)
the scattered field to##3##4##(2007-12#1)(2008-3#2)
the scattered field##12##3##(2007-11#2)(2007-12#1)(2008-2#4)(2008-3#4)(2009-10#1)
the scattered intensity##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
the scattered light and the##2##5##(2007-12#1)(2008-3#1)
the scattered light and##5##4##(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
the scattered light is##2##4##(2008-2#1)(2008-3#1)
the scattered light to##2##4##(2006-2#1)(2007-11#1)
the scattered light##27##3##(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#8)(2008-3#12)(2011-2#1)
the scattered radiation##2##3##(2008-2#1)(2008-3#1)
the scattered wave##7##3##(2008-2#1)(2008-3#6)
the scattered##68##2##(2006-12#1)(2006-2#1)(2007-11#3)(2007-12#5)(2008-10#1)(2008-2#20)(2008-3#33)(2009-10#1)(2009-11#1)(2011-2#1)(2012-2#1)
the scattered-light##3##2##(2008-2#3)
the scatterer##5##2##(2007-11#2)(2007-12#2)(2008-3#1)
the scattering and absorption coefficients##2##5##(2008-2#2)
the scattering and absorption##3##4##(2008-2#2)(2008-3#1)
the scattering and microphysical properties of##2##6##(2008-3#2)
the scattering and the absorption coefficients##2##6##(2008-2#1)(2008-3#1)
the scattering and the absorption##4##5##(2007-11#1)(2008-2#2)(2008-3#1)
the scattering and##10##3##(2007-11#1)(2008-2#5)(2008-3#4)
the scattering angle of##2##4##(2007-12#1)(2008-3#1)
the scattering angle##8##3##(2007-12#1)(2008-2#3)(2008-3#4)
the scattering by sunlit##2##4##(2008-2#2)
the scattering by##3##3##(2007-11#1)(2008-2#2)
the scattering coefficient and##2##4##(2008-3#1)(2011-1#1)
the scattering coefficient##15##3##(1997-6#2)(2007-12#1)(2008-2#3)(2008-3#8)(2011-1#1)
the scattering contribution##2##3##(1997-6#1)(2010-5#1)
the scattering depth##3##3##(2008-2#1)(2008-3#2)
the scattering from##4##3##(2008-3#4)
the scattering intensity from##2##4##(2007-11#1)(2008-2#1)
the scattering intensity##4##3##(2007-11#1)(2008-2#3)
the scattering layer##4##3##(2008-2#4)
the scattering loss##2##3##(2008-2#1)(2008-3#1)
the scattering losses##2##3##(2007-12#1)(2008-3#1)
the scattering matrix elements##2##4##(2008-2#1)(2008-3#1)
the scattering matrix of##2##4##(1993-6#1)(2008-3#1)
the scattering matrix##6##3##(1993-6#1)(2008-2#1)(2008-3#4)
the scattering mean free path##2##5##(2005-11#1)(2007-12#1)
the scattering measurements##2##3##(2008-3#2)
the scattering medium##9##3##(2008-2#5)(2008-3#4)
the scattering object##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
the scattering of a##2##4##(2008-2#2)
the scattering of an##2##4##(2008-2#1)(2009-10#1)
the scattering of diffuse photon density waves##2##7##(2008-2#2)
the scattering of light by##4##5##(2008-3#4)
the scattering of light from the##2##6##(2007-12#1)(2008-2#1)
the scattering of light from##4##5##(2007-12#2)(2008-2#1)(2008-9#1)
the scattering of light##10##4##(2007-12#3)(2008-2#1)(2008-3#5)(2008-9#1)
the scattering of##20##3##(2007-12#4)(2008-2#9)(2008-3#5)(2008-9#1)(2009-10#1)
the scattering particles##2##3##(2008-3#2)
the scattering pattern##4##3##(2008-2#1)(2008-3#3)
the scattering patterns##2##3##(2007-12#1)(2008-2#1)
the scattering phase function are##2##5##(2008-2#1)(2008-3#1)
the scattering phase function##11##4##(2008-2#4)(2008-3#6)(2008-6#1)
the scattering phase##13##3##(2008-2#5)(2008-3#7)(2008-6#1)
the scattering problem##2##3##(2008-2#1)(2008-3#1)
the scattering process##3##3##(2008-2#1)(2008-3#2)
the scattering properties are##2##4##(2008-2#1)(2008-3#1)
the scattering properties of particles##2##5##(2008-3#2)
the scattering properties of the##4##5##(2008-2#1)(2008-3#3)
the scattering properties of##12##4##(2007-11#1)(2008-2#3)(2008-3#8)
the scattering properties##16##3##(2007-11#2)(2008-2#5)(2008-3#9)
the scattering quantities##2##3##(2008-3#2)
the scattering strength##2##3##(2008-3#2)
the scattering##206##2##(1993-6#1)(1994-9#1)(1997-6#3)(2005-11#1)(2006-5#1)(2007-1#1)(2007-11#6)(2007-12#18)(2008-10#3)(2008-2#77)(2008-3#88)(2008-6#2)(2008-9#1)(2009-10#1)(2010-5#1)(2011-1#1)
the scattering-angle##3##2##(2006-4#1)(2008-3#2)
the scavenger##2##2##(1990-2#1)(2008-5#1)
the scavenging of##2##3##(2011-2#1)(2012-2#1)
the scavenging##7##2##(1991-11#1)(1995-12#1)(2008-10#1)(2009-6#1)(2011-2#1)(2012-11#1)(2012-2#1)
the scenario of##2##3##(2005-4#1)(2011-2#1)
the scenario##8##2##(1993-9#1)(1996-2#1)(2005-4#1)(2007-1#1)(2008-11#2)(2011-2#1)(2012-2#1)
the scenarios##6##2##(2008-1#1)(2008-6#1)(2009-10#1)(2012-1#1)(2012-3#1)(2013-8#1)
the scene of##6##3##(1991-8#1)(1995-11#1)(2005-10#1)(2008-10#1)(2011-2#1)(2012-12#1)
the scene##24##2##(1991-8#1)(1995-11#1)(1995-3#1)(2004-7#1)(2005-10#1)(2006-10#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#5)(2008-6#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
the scenes##2##2##(2008-3#1)(2008-8#1)
the scent mark of a male that was not food deprived##2##11##(2009-6#2)
the scent mark of a##4##5##(2009-6#4)
the scent of##3##3##(2008-4#1)(2008-5#2)
the scent##9##2##(2008-4#1)(2008-5#3)(2009-6#5)
the schedule of##2##3##(2008-7#1)(2008-8#1)
the schedule##6##2##(1991-6#1)(2007-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2013-1#1)
the scheduling##2##2##(1996-1#1)(2009-3#1)
the scheme are##2##3##(1991-12#1)(2008-7#1)
the scheme by##2##3##(2008-10#1)(2008-3#1)
the scheme can be##2##4##(2007-11#1)(2008-5#1)
the scheme is##7##3##(2006-8#1)(2007-12#1)(2008-2#3)(2008-3#1)(2012-2#1)
the scheme##26##2##(1991-12#1)(1991-7#1)(1997-7#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#3)(2008-2#4)(2008-3#2)(2008-5#2)(2008-7#3)(2012-2#1)(2013-8#1)
the schemes##4##2##(1993-12#2)(1997-3#1)(2008-3#1)
the schistosomiasis##3##2##(2012-3#3)
the schizo-obsessive subtype##3##3##(2008-3#3)
the schizophrenia group##5##3##(1997-8#2)(2004-11#2)(2013-1#1)
the schizophrenia##11##2##(1993-9#1)(1995-11#1)(1997-2#2)(1997-8#2)(2004-11#2)(2006-9#1)(2012-2#1)(2013-1#1)
the schizophrenic groups##2##3##(1996-8#2)
the schizophrenic##16##2##(1990-11#2)(1995-11#2)(1996-1#1)(1996-10#1)(1996-3#4)(1996-7#2)(1996-8#2)(2006-9#1)(2013-1#1)
the schizophrenics##2##2##(1997-2#1)(1997-8#1)
the schizotypal personality questionnaire##2##4##(1997-8#2)
the scholastic##2##2##(2007-1#1)(2013-1#1)
the school and##3##3##(1994-4#1)(2007-6#1)(2012-12#1)
the school children##4##3##(2007-2#3)(2011-2#1)
the school curriculum##3##3##(1996-4#1)(2007-7#1)(2008-1#1)
the school environment##2##3##(2006-7#1)(2007-10#1)
the school health##2##3##(2009-8#2)
the school setting##5##3##(1990-5#1)(1992-3#1)(1997-2#1)(2008-10#1)(2008-11#1)
the school system##2##3##(1991-12#1)(1993-11#1)
the school to##2##3##(1994-6#1)(2008-7#1)
the school year##7##3##(2008-12#4)(2008-9#1)(2010-3#1)(2010-8#1)
the school years##3##3##(2006-8#1)(2008-11#1)(2009-2#1)
the school##54##2##(1990-5#1)(1990-6#1)(1991-12#2)(1991-2#1)(1992-3#1)(1993-1#2)(1993-11#1)(1994-4#1)(1994-6#1)(1996-4#1)(1997-2#1)(2006-1#1)(2006-10#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-2#3)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#5)(2008-7#3)(2008-9#1)(2009-2#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
the school-age##4##2##(1991-2#1)(2006-10#1)(2006-2#1)(2011-2#1)
the schools of medicine##3##4##(1991-1#1)(1991-6#1)(2007-4#1)
the schools of##4##3##(1991-1#1)(1991-6#1)(2007-4#1)(2012-12#1)
the schools##13##2##(1991-1#1)(1991-12#2)(1991-6#1)(1992-8#1)(1993-8#1)(1994-4#1)(1997-8#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-12#1)(2012-12#1)
the sciatic nerve in the rat##3##6##(1993-12#1)(1995-12#2)
the sciatic nerve in##4##4##(1993-12#1)(1995-12#2)(1996-8#1)
the sciatic nerve of##4##4##(1991-3#1)(1991-6#1)(1992-3#1)(1993-12#1)
the sciatic nerve was##2##4##(1990-7#1)(1996-2#1)
the sciatic nerve##31##3##(1990-2#2)(1990-5#1)(1990-7#3)(1991-2#1)(1991-3#2)(1991-6#3)(1992-3#2)(1993-10#1)(1993-11#1)(1993-12#3)(1994-2#1)(1995-12#3)(1996-2#1)(1996-5#1)(1996-8#1)(2006-12#1)(2006-6#1)(2006-8#1)(2008-1#1)(2008-7#1)
the sciatic or##2##3##(1991-2#1)(2007-8#1)
the sciatic##37##2##(1990-2#2)(1990-5#1)(1990-7#3)(1991-2#2)(1991-3#2)(1991-6#3)(1992-3#2)(1992-5#1)(1993-10#1)(1993-11#1)(1993-12#3)(1994-2#1)(1995-12#3)(1996-2#1)(1996-5#1)(1996-8#1)(1997-3#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-7#1)(2009-5#1)
the sciatica##2##2##(1990-2#1)(1992-11#1)
the science and the##2##4##(1993-11#1)(2009-7#1)
the science and##6##3##(1990-12#1)(1991-3#1)(1993-11#1)(1995-1#1)(2008-4#1)(2009-7#1)
the science base##2##3##(1997-1#1)(2008-8#1)
the science behind##3##3##(2008-3#1)(2008-5#1)(2011-2#1)
the science of early child development##2##6##(2010-12#2)
the science of##19##3##(1990-3#1)(1991-2#1)(1992-6#1)(2006-11#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-5#1)(2010-12#2)(2012-2#1)(2013-1#4)(2013-8#1)
the science##45##2##(1990-12#1)(1990-3#1)(1991-2#1)(1991-3#1)(1992-3#1)(1992-6#1)(1993-11#1)(1995-1#1)(1997-1#1)(1997-5#1)(2005-10#1)(2005-7#1)(2006-11#1)(2006-5#1)(2007-4#1)(2007-7#1)(2007-9#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#2)(2009-7#1)(2010-1#1)(2010-12#3)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
the sciences##8##2##(2006-3#1)(2008-11#1)(2009-2#1)(2009-4#4)(2012-2#1)
the scientific and the##2##4##(1993-2#1)(2010-7#1)
the scientific and##13##3##(1990-7#1)(1993-2#1)(1996-12#1)(1997-8#1)(2006-5#1)(2007-3#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
the scientific basis for##2##4##(1994-2#1)(2013-1#1)
the scientific basis of##3##4##(2008-10#1)(2008-5#1)(2012-2#1)
the scientific basis##5##3##(1994-2#1)(2008-10#1)(2008-5#1)(2012-2#1)(2013-1#1)
the scientific challenge##2##3##(1996-4#1)(2011-1#1)
the scientific community has##4##4##(2006-2#1)(2007-9#1)(2010-12#1)(2012-2#1)
the scientific community to##3##4##(2004-9#1)(2008-10#1)(2009-5#1)
the scientific community##28##3##(1997-3#1)(2004-12#1)(2004-9#1)(2005-7#1)(2006-2#1)(2006-5#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
the scientific evidence##9##3##(2006-10#1)(2006-7#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2012-12#1)(2012-2#1)
the scientific knowledge and##2##4##(2006-10#1)(2012-12#1)
the scientific knowledge##7##3##(2006-10#1)(2007-8#1)(2009-10#2)(2011-2#1)(2012-12#1)(2013-8#1)
the scientific literature on the##2##5##(2008-7#1)(2008-9#1)
the scientific literature on##3##4##(2008-7#2)(2008-9#1)
the scientific literature shows##2##4##(1993-6#1)(2011-1#1)
the scientific literature##27##3##(1993-12#1)(1993-6#1)(1997-2#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#1)(2010-2#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
the scientific negation of##2##4##(2013-1#2)
the scientific production in##2##4##(2011-2#1)(2012-3#1)
the scientific production##4##3##(2009-4#1)(2011-2#1)(2012-3#2)
the scientific rationale for the##2##5##(2006-10#1)(2008-10#1)
the scientific rationale##3##3##(2006-10#1)(2008-10#1)(2010-12#1)
the scientific validity of##2##4##(2007-8#1)(2008-3#1)
the scientific validity##3##3##(2007-8#1)(2008-3#1)(2011-2#1)
the scientific value of##3##4##(1994-6#1)(2007-8#1)(2010-2#1)
the scientific##164##2##(1990-7#1)(1991-11#1)(1991-12#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#2)(1997-2#1)(1997-3#1)(1997-8#2)(2004-12#1)(2004-9#1)(2005-7#1)(2005-8#3)(2006-10#5)(2006-2#1)(2006-5#3)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#2)(2007-7#2)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#9)(2008-8#3)(2008-9#2)(2009-10#2)(2009-2#1)(2009-4#4)(2009-5#1)(2009-9#1)(2010-12#3)(2010-2#3)(2010-4#1)(2010-6#1)(2010-7#2)(2011-1#7)(2011-2#7)(2012-12#6)(2012-2#8)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#6)
the scientist##6##2##(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-5#1)
the scientists##10##2##(2007-8#1)(2007-9#1)(2008-10#2)(2009-2#2)(2010-10#1)(2010-9#1)(2011-2#1)(2013-1#1)
the scintigraphic##2##2##(2008-6#1)(2008-7#1)
the scintillation index##2##3##(2007-12#2)
the scintillation##5##2##(2007-12#2)(2008-2#1)(2012-11#2)
the scissile bond##8##3##(1990-5#1)(1991-2#4)(1991-6#1)(1994-5#1)(1995-5#1)
the scissile##9##2##(1990-5#1)(1991-2#4)(1991-6#1)(1992-3#1)(1994-5#1)(1995-5#1)
the scission##2##2##(1990-2#1)(2008-9#1)
the sclera##2##2##(2006-11#1)(2013-1#1)
the sclerites##2##2##(2007-12#1)(2008-7#1)
the scoliosis angle##3##3##(2007-7#2)(2007-8#1)
the scoliosis##8##2##(2007-11#1)(2007-7#4)(2007-8#3)
the scolopale##2##2##(2008-7#2)
the scope and limitations of##2##5##(2006-12#1)(2013-1#1)
the scope and quality of##2##5##(2008-1#1)(2013-1#1)
the scope and##12##3##(2006-12#1)(2008-1#2)(2008-10#1)(2008-5#1)(2009-4#1)(2012-12#1)(2013-1#5)
the scope for##5##3##(1997-8#1)(2006-12#2)(2006-2#1)(2009-12#1)
the scope of health services##2##5##(1996-12#1)(1997-2#1)
the scope of our##2##4##(2007-4#1)(2009-9#1)
the scope of practice of##3##5##(1997-3#1)(2007-10#1)(2011-1#1)
the scope of the assay##2##5##(1991-5#1)(1997-4#1)
the scope of the problem in##2##6##(2004-7#1)(2006-12#1)
the scope of the problem##4##5##(2004-7#1)(2006-12#1)(2008-4#1)(2012-12#1)
the scope of the##16##4##(1991-5#1)(1997-4#1)(1997-5#1)(2004-7#1)(2005-7#1)(2006-12#1)(2006-2#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-7#1)(2012-12#1)(2012-3#1)
the scope of their##4##4##(1995-3#1)(1997-7#1)(2006-12#1)(2007-2#1)
the scope of this paper##2##5##(2010-6#1)(2013-7#1)
the scope of this review##3##5##(2006-9#1)(2008-5#1)(2012-12#1)
the scope of this##8##4##(2006-9#1)(2007-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-6#1)(2012-12#1)(2013-7#1)
the scope of##72##3##(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-10#1)(1993-1#1)(1993-9#1)(1994-3#1)(1995-3#1)(1996-12#4)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#1)(2004-7#1)(2005-7#1)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-12#2)(2012-3#2)(2013-7#2)
the scope##92##2##(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-10#1)(1993-1#1)(1993-9#1)(1994-3#1)(1995-3#1)(1996-12#4)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#1)(2004-7#1)(2005-7#1)(2006-12#6)(2006-2#2)(2006-4#2)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#4)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#2)(2009-6#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#2)(2012-12#3)(2012-3#2)(2013-1#5)(2013-7#2)
the score criteria of severe hand##2##6##(2010-12#2)
the score criteria##3##3##(2010-12#3)
the score of##2##3##(2007-11#1)(2010-1#1)
the score was##3##3##(2010-7#1)(2013-1#2)
the score##27##2##(1990-7#1)(1991-6#1)(1993-9#2)(1994-6#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-1#2)(2010-12#3)(2010-7#1)(2011-1#1)(2012-3#2)(2013-1#4)
the scores and the##3##4##(2007-8#1)(2010-3#1)(2012-1#1)
the scores obtained for##2##4##(2010-3#1)(2011-1#1)
the scores obtained##3##3##(2010-3#1)(2011-1#2)
the scores of##7##3##(1992-1#1)(2005-8#1)(2007-7#1)(2008-1#2)(2009-10#1)(2010-12#1)
the scores on##2##3##(1997-5#1)(2009-4#1)
the scores##22##2##(1990-3#1)(1992-1#1)(1997-5#1)(2005-8#2)(2005-9#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-11#2)(2009-10#1)(2009-4#2)(2010-12#1)(2010-3#2)(2011-1#2)(2012-1#1)(2013-8#1)
the scoring function##3##3##(2008-7#2)(2011-3#1)
the scoring system##3##3##(2008-7#1)(2012-12#1)(2013-1#1)
the scoring##7##2##(2008-10#1)(2008-7#3)(2011-3#1)(2012-12#1)(2013-1#1)
the scorpion##10##2##(1990-8#1)(1993-3#2)(1993-6#1)(2007-12#4)(2008-7#1)(2008-8#1)
the screen is##3##3##(2008-2#1)(2008-3#1)(2013-7#1)
the screen##16##2##(1992-10#1)(1992-12#1)(1994-5#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#2)(2012-2#1)(2013-7#1)
the screened population##3##3##(1996-12#1)(2006-2#1)(2008-10#1)
the screened##4##2##(1996-12#1)(2006-2#1)(2008-10#2)
the screening and##3##3##(2007-8#1)(2008-10#1)(2010-12#1)
the screening conditions##2##3##(2008-4#1)(2009-8#1)
the screening effect##3##3##(1993-3#2)(2008-10#1)
the screening for##4##3##(1990-11#2)(2010-12#1)(2013-7#1)
the screening method##2##3##(2008-10#1)(2012-3#1)
the screening methods##2##3##(2009-9#1)(2013-1#1)
the screening of a##4##4##(1990-12#1)(1996-10#1)(2008-10#1)(2009-10#1)
the screening of patients##2##4##(1993-9#1)(1997-3#1)
the screening of the##3##4##(1990-3#1)(2007-10#1)(2009-8#1)
the screening of##38##3##(1990-12#1)(1990-3#1)(1991-7#1)(1993-5#1)(1993-9#1)(1996-10#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-3#2)(2007-1#1)(2007-10#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-3#2)(2008-5#2)(2008-7#1)(2009-10#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-11#2)(2012-2#2)(2013-8#1)
the screening process##6##3##(2007-11#1)(2007-6#1)(2007-8#1)(2008-11#2)(2010-11#1)
the screening program##3##3##(1992-2#1)(2012-2#1)(2012-3#1)
the screening programme##5##3##(1996-12#1)(2004-2#4)
the screening test##4##3##(1990-6#1)(1997-2#1)(2011-1#1)(2012-3#1)
the screening tests##3##3##(2007-7#2)(2012-2#1)
the screening was##2##3##(1990-2#1)(1992-10#1)
the screening##112##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#1)(1990-9#1)(1991-6#1)(1991-7#1)(1992-10#1)(1992-2#1)(1993-1#1)(1993-3#2)(1993-5#1)(1993-9#1)(1995-12#1)(1996-10#1)(1996-12#4)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(2004-2#4)(2006-12#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-10#16)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-6#2)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#3)
the screw fixation group##2##4##(2009-3#2)
the screw##7##2##(2007-11#2)(2007-5#1)(2008-8#1)(2009-3#2)(2011-12#1)
the screwless fixation group##2##4##(2009-3#2)
the screws##5##2##(1991-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2011-2#1)
the script##5##2##(1994-3#3)(1996-2#2)
the scrotal##6##2##(1994-8#1)(2008-10#3)(2010-12#1)(2010-3#1)
the scrotum and##3##3##(1995-11#1)(2013-1#2)
the scrotum of a##2##4##(1993-10#1)(2005-11#1)
the scrotum##12##2##(1990-9#1)(1993-10#2)(1994-2#1)(1995-11#1)(2005-11#1)(2006-2#1)(2007-11#1)(2008-10#1)(2012-3#1)(2013-1#2)
the scs region##2##3##(1995-2#2)
the scs##3##2##(1995-2#3)
the scull##2##2##(2007-5#1)(2007-6#1)
the scutellum##3##2##(1990-12#1)(2006-12#1)(2009-12#1)
the sd-t(t)##2##2##(2008-9#2)
the sea and##2##3##(2008-10#1)(2011-1#1)
the sea anemone##4##3##(1991-9#1)(1993-12#1)(1996-2#1)(2012-12#1)
the sea surface temperature##3##4##(2006-7#1)(2007-3#1)(2008-2#1)
the sea surface##14##3##(2006-7#1)(2007-3#1)(2008-2#5)(2008-3#7)
the sea urchin Diadema##2##4##(2007-5#2)
the sea urchin##16##3##(1990-10#1)(1995-6#1)(1995-8#1)(2007-3#2)(2007-5#4)(2008-11#1)(2008-5#4)(2008-8#2)
the sea urchins##2##3##(2007-5#1)(2008-5#1)
the sea##65##2##(1990-10#1)(1991-11#1)(1991-5#3)(1991-9#1)(1992-5#1)(1993-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(2006-7#1)(2007-12#1)(2007-3#3)(2007-4#1)(2007-5#7)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#9)(2008-3#8)(2008-5#5)(2008-7#2)(2008-8#4)(2009-3#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-7#1)
the seafarers'##2##2##(2011-2#2)
the seagrass beds##2##3##(2008-5#1)(2011-2#1)
the seagrass mounds##2##3##(2007-5#2)
the seagrass##7##2##(2007-5#2)(2008-5#1)(2011-2#4)
the sealing of##4##3##(1993-6#1)(1997-4#3)
the sealing##6##2##(1993-6#1)(1997-4#3)(2010-6#1)(2012-12#1)
the search and##2##3##(1990-12#1)(2009-7#1)
the search criteria##3##3##(2006-2#2)(2007-10#1)
the search for a##8##4##(1993-8#1)(1994-2#1)(1994-6#1)(1996-2#1)(2005-8#1)(2006-10#1)(2008-4#1)(2012-12#1)
the search for alternative##2##4##(2006-10#1)(2012-12#1)
the search for an##3##4##(1994-5#1)(2004-12#1)(2006-5#1)
the search for better##2##4##(1991-5#1)(2007-11#1)
the search for genetic##2##4##(2007-10#1)(2012-3#1)
the search for new and more effective##2##7##(1996-4#1)(2008-10#1)
the search for new drugs##2##5##(1994-6#1)(2010-11#1)
the search for new effective##2##5##(2008-6#1)(2009-7#1)
the search for new##20##4##(1993-11#1)(1993-9#1)(1994-6#1)(1996-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-8#1)(2009-7#2)(2010-11#1)(2010-7#1)(2013-1#1)(2013-7#1)
the search for novel##3##4##(1993-4#1)(2008-11#1)(2008-5#1)
the search for other##3##4##(2005-8#1)(2009-3#1)(2013-1#1)
the search for solutions##2##4##(1997-7#1)(2012-2#1)
the search for specific##2##4##(2005-8#1)(2011-2#1)
the search for the best##2##5##(2008-10#1)(2009-4#1)
the search for the ideal##4##5##(1994-3#1)(1996-3#1)(2008-5#1)(2008-6#1)
the search for the##12##4##(1993-6#1)(1994-3#1)(1996-3#1)(2005-8#1)(2006-3#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#1)(2012-3#1)
the search for therapeutic##2##4##(2008-1#1)(2010-2#1)
the search for this##2##4##(2008-5#1)(2011-2#1)
the search for##105##3##(1990-12#1)(1990-2#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-12#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1995-6#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-5#1)(1997-6#1)(1997-7#2)(2004-12#1)(2005-8#4)(2006-10#5)(2006-12#2)(2006-3#1)(2006-5#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-5#1)(2008-1#4)(2008-10#5)(2008-11#3)(2008-2#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-8#3)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#2)(2010-1#1)(2010-11#1)(2010-2#2)(2010-7#1)(2010-9#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
the search is##2##3##(1992-10#1)(2008-6#1)
the search of##9##3##(1994-3#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-7#1)
the search process##3##3##(1991-2#1)(1996-2#1)(2008-2#1)
the search space##4##3##(2010-7#1)(2013-1#3)
the search to##2##3##(2008-10#1)(2008-7#1)
the search##161##2##(1990-12#2)(1990-2#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-12#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#2)(1994-9#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-5#1)(1997-6#1)(1997-7#2)(2004-12#1)(2005-8#5)(2006-10#6)(2006-12#2)(2006-2#3)(2006-3#1)(2006-5#1)(2007-10#3)(2007-11#4)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#6)(2008-7#2)(2008-8#4)(2008-9#1)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#3)(2010-1#1)(2010-11#1)(2010-2#4)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#5)(2013-1#7)(2013-7#2)(2013-8#2)
the searching##2##2##(2008-2#1)(2008-7#1)
the seas##2##2##(2008-11#1)(2009-7#1)
the season and##2##3##(2008-10#1)(2011-2#1)
the season in##3##3##(2007-5#1)(2008-10#1)(2008-8#1)
the season of ascospore##2##4##(2008-10#2)
the season of the##2##4##(2008-3#1)(2013-8#1)
the season of##4##3##(2008-10#2)(2008-3#1)(2013-8#1)
the season progressed##2##3##(2007-5#1)(2010-7#1)
the season##41##2##(1990-8#1)(1993-5#2)(2006-4#1)(2007-12#1)(2007-5#3)(2007-8#1)(2008-10#19)(2008-3#1)(2008-8#7)(2010-7#1)(2010-8#1)(2011-2#1)(2012-6#1)(2013-8#1)
the seasonal and##4##3##(2007-1#1)(2008-10#2)(2011-1#1)
the seasonal breeding##2##3##(2010-8#1)(2013-8#1)
the seasonal changes##2##3##(2007-8#1)(2008-9#1)
the seasonal variation of##3##4##(2008-10#2)(2012-2#1)
the seasonal variation##4##3##(2008-10#2)(2010-5#1)(2012-2#1)
the seasonal##26##2##(1992-12#1)(1996-3#1)(2007-1#1)(2007-8#1)(2008-10#9)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-2#1)(2010-5#1)(2010-8#2)(2011-1#1)(2012-2#2)(2013-8#1)
the seasonality##2##2##(2008-10#1)(2008-3#1)
the seasons of##2##3##(2008-10#1)(2008-5#1)
the seasons##3##2##(2008-10#1)(2008-5#2)
the seat belt##3##3##(2006-11#1)(2007-4#2)
the seat##9##2##(1990-5#1)(2006-11#3)(2007-4#2)(2008-6#3)
the seawater##7##2##(2007-10#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#2)
the seaweed fly##2##3##(2013-1#2)
the seaweed##5##2##(2007-8#2)(2010-4#1)(2013-1#2)
the sebaceous gland##8##3##(2008-5#1)(2010-3#5)(2010-5#1)(2010-7#1)
the sebaceous##10##2##(2008-5#1)(2010-3#6)(2010-5#1)(2010-6#1)(2010-7#1)
the sebum##4##2##(2008-5#3)(2010-5#1)
the second (external-focus) intervention##2##4##(2013-1#2)
the second AUG codon##2##4##(1994-2#2)
the second European##2##3##(2008-2#1)(2010-12#1)
the second Surgeon-in-Chief##3##3##(2008-8#3)
the second T-antigen exon##2##4##(1996-9#2)
the second a##4##3##(2008-10#1)(2008-3#1)(2010-4#1)(2012-12#1)
the second amino acid##3##4##(1997-2#2)(2008-10#1)
the second amino##4##3##(1997-2#2)(1997-3#1)(2008-10#1)
the second ammunition##4##3##(2013-7#4)
the second and fifth##2##4##(1997-1#2)
the second and the third##5##5##(1990-3#1)(1991-12#1)(1991-8#1)(2008-5#1)(2010-2#1)
the second and third decades##2##5##(2007-2#1)(2013-8#1)
the second and third runs##2##5##(2008-5#2)
the second and third trimesters##4##5##(1993-12#2)(2011-1#2)
the second and third##31##4##(1990-3#1)(1991-3#2)(1992-10#1)(1993-12#2)(1994-12#1)(1995-8#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2011-1#2)(2011-2#2)(2013-1#2)(2013-8#1)
the second and##49##3##(1990-12#1)(1990-3#3)(1991-12#1)(1991-3#2)(1991-8#1)(1992-10#1)(1992-2#1)(1992-5#1)(1993-12#2)(1994-12#1)(1995-8#1)(1996-1#1)(1997-1#2)(1997-3#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2009-3#1)(2010-2#1)(2011-1#2)(2011-2#2)(2013-1#4)(2013-8#2)
the second angle##2##3##(2008-3#2)
the second approach##4##3##(1995-2#1)(2008-3#2)(2012-3#1)
the second arch were##2##4##(1993-12#2)
the second arch##3##3##(1993-12#3)
the second assay##2##3##(2008-10#1)(2008-5#1)
the second base of codon##2##5##(1991-12#1)(1994-11#1)
the second base##3##3##(1991-12#1)(1992-8#1)(1994-11#1)
the second being##2##3##(1994-6#1)(2008-2#1)
the second by##3##3##(2008-4#1)(2011-1#1)(2013-1#1)
the second case in the literature##2##6##(1992-4#1)(2005-12#1)
the second case in##3##4##(1992-4#1)(2005-12#1)(2012-2#1)
the second case of##7##4##(2007-8#1)(2008-6#2)(2010-3#1)(2013-1#2)(2013-7#1)
the second case##27##3##(1990-11#1)(1992-4#1)(1995-9#1)(2005-12#2)(2005-8#1)(2006-12#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-6#2)(2009-3#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-7#1)
the second cause of##2##4##(1991-11#1)(2011-3#1)
the second cell##2##3##(1990-11#1)(2007-12#1)
the second cistron##2##3##(1997-8#1)(2008-7#1)
the second cohort##3##3##(1996-3#1)(2012-11#1)(2013-7#1)
the second column##3##3##(1990-8#1)(2008-10#2)
the second commonest##2##3##(2006-10#1)(2009-4#1)
the second complete genome sequence##3##5##(2011-2#3)
the second completed genome sequence of the family##2##8##(2011-2#2)
the second completed genome sequence of##6##6##(2011-2#6)
the second comprised##2##3##(1996-4#1)(2008-10#1)
the second condition##3##3##(2008-11#1)(2008-5#1)(2010-2#1)
the second coordination sphere##2##4##(1993-6#1)(1996-2#1)
the second crystal##2##3##(2006-5#2)
the second cycle of##2##4##(1991-12#1)(2013-1#1)
the second cycle##4##3##(1991-12#1)(2007-7#1)(2008-10#1)(2013-1#1)
the second cysteine-rich motif##2##4##(1990-12#2)
the second day after##2##4##(1993-12#1)(1996-11#1)
the second day of the##2##5##(2005-8#2)
the second day of##9##4##(1993-12#2)(1996-4#1)(2005-8#2)(2008-4#2)(2011-1#1)(2012-3#1)
the second day##20##3##(1991-9#1)(1993-1#1)(1993-12#3)(1995-5#1)(1996-11#1)(1996-4#1)(1997-3#1)(2005-8#2)(2007-12#1)(2008-12#1)(2008-4#2)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
the second decade of life##3##5##(2009-12#1)(2010-2#1)(2013-8#1)
the second decade of##4##4##(2009-12#1)(2010-2#1)(2013-1#1)(2013-8#1)
the second decade##7##3##(1992-5#1)(1993-5#1)(2007-2#1)(2009-12#1)(2010-2#1)(2013-1#1)(2013-8#1)
the second derivative of the##3##5##(2008-10#1)(2008-3#1)(2009-8#1)
the second derivative spectra##2##4##(1995-1#1)(2008-10#1)
the second derivative##7##3##(1995-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-8#1)
the second diffraction order##5##4##(2007-11#1)(2008-2#1)(2008-3#3)
the second dimension##3##3##(2008-10#2)(2008-7#1)
the second dose##3##3##(1992-3#2)(2011-2#1)
the second electron transfer##2##4##(1995-2#1)(1997-4#1)
the second enzyme in the##2##5##(1993-9#1)(2009-3#1)
the second examination##2##3##(2007-8#2)
the second example of##2##4##(2008-10#1)(2008-4#1)
the second example##4##3##(1997-7#1)(2008-10#1)(2008-4#1)(2008-8#1)
the second exon##2##3##(1990-4#1)(1993-6#1)
the second experiment##21##3##(1990-10#1)(1993-12#1)(1994-2#1)(1996-12#1)(1997-3#1)(1997-6#1)(2007-3#1)(2007-6#1)(2008-10#4)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#1)(2010-8#1)(2013-8#1)
the second exposure to##2##4##(1990-7#1)(2008-11#1)
the second family##2##3##(1992-9#1)(1997-6#1)
the second focus##2##3##(2007-12#1)(2008-2#1)
the second for##2##3##(2008-10#1)(2008-4#1)
the second gene##3##3##(1990-3#1)(1996-3#1)(2009-8#1)
the second generation of##3##4##(2005-8#1)(2008-10#1)(2008-3#1)
the second generation##8##3##(1991-6#2)(2005-8#1)(2006-11#1)(2008-10#2)(2008-3#1)(2013-8#1)
the second genome##3##3##(2011-1#1)(2011-2#2)
the second globular##2##3##(1994-3#1)(1995-6#1)
the second grade year##2##4##(2010-3#2)
the second grade##4##3##(2007-9#1)(2010-3#3)
the second grating##2##3##(2008-2#1)(2008-3#1)
the second group included##2##4##(2005-10#1)(2011-2#1)
the second group of##2##4##(2011-2#1)(2012-2#1)
the second group the##2##4##(2007-8#1)(2010-12#1)
the second group were##6##4##(1990-10#1)(1992-8#1)(1994-6#1)(2007-11#1)(2007-8#2)
the second group##29##3##(1990-1#1)(1990-10#2)(1990-2#1)(1991-5#1)(1992-8#1)(1994-6#2)(1996-2#1)(2005-10#1)(2007-11#1)(2007-8#6)(2008-10#2)(2008-3#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)
the second half of the first##2##6##(1991-6#1)(2012-1#1)
the second half of the##20##5##(1991-6#1)(2004-11#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-2#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#2)
the second half of##28##4##(1991-6#1)(1994-3#1)(1995-11#1)(1996-8#1)(2004-11#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-2#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#2)
the second half##30##3##(1991-6#1)(1994-3#1)(1995-11#1)(1996-8#1)(2004-11#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-2#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#2)
the second harmonic (532 nm)##2##5##(2008-10#1)(2008-3#1)
the second harmonic of a Nd##2##6##(2007-12#1)(2008-3#1)
the second harmonic of a##5##5##(2007-12#3)(2008-1#1)(2008-3#1)
the second harmonic of the##5##5##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#2)
the second harmonic of##10##4##(2007-11#1)(2007-12#4)(2008-1#2)(2008-2#2)(2008-3#1)
the second harmonic was##2##4##(2007-12#2)
the second harmonic##26##3##(2007-11#4)(2007-12#11)(2008-1#3)(2008-10#1)(2008-2#3)(2008-3#3)(2013-1#1)
the second harmonics of##3##4##(2007-12#2)(2008-2#1)
the second has##2##3##(2008-3#1)(2008-5#1)
the second helix##2##3##(1991-1#1)(1995-5#1)
the second highest##2##3##(1996-4#1)(2008-7#1)
the second hour##3##3##(2010-5#1)(2011-1#1)(2012-2#1)
the second hyperpolarizability##2##3##(1994-7#1)(2007-11#1)
the second hypothesis##3##3##(2005-10#1)(2008-8#1)(2011-2#1)
the second in a series of##3##6##(1996-12#1)(2007-11#1)(2007-6#1)
the second in a series##4##5##(1993-3#1)(1996-12#1)(2007-11#1)(2007-6#1)
the second in a##8##4##(1993-3#1)(1995-1#1)(1996-12#1)(2005-8#1)(2007-11#1)(2007-6#1)(2008-10#1)(2011-1#1)
the second in##15##3##(1991-4#1)(1992-10#1)(1993-3#1)(1995-1#1)(1996-12#1)(2005-8#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-5#1)(2011-1#1)(2013-1#1)
the second instance##2##3##(2008-3#1)(2012-2#1)
the second intron of the##2##5##(1992-8#1)(2012-3#1)
the second intron##3##3##(1992-8#1)(1994-12#1)(2012-3#1)
the second is a##2##4##(1996-4#1)(2008-2#1)
the second is based on##2##5##(2008-2#1)(2008-3#1)
the second is the##3##4##(1992-9#1)(2008-2#1)(2008-8#1)
the second is to##2##4##(1996-2#1)(2008-8#1)
the second is##25##3##(1990-7#1)(1992-12#1)(1992-9#1)(1995-1#1)(1996-2#1)(1996-4#1)(2006-10#1)(2006-4#1)(2006-5#1)(2008-10#1)(2008-2#5)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#3)(2010-6#1)(2012-3#1)
the second ischemia##2##3##(1996-12#2)
the second largest##8##3##(1992-3#1)(1992-8#1)(1996-2#1)(2006-4#1)(2008-10#1)(2010-11#1)(2010-3#1)(2010-6#1)
the second layer##4##3##(1994-5#1)(1996-12#1)(2008-10#1)(2008-2#1)
the second leading cause of death##3##6##(2007-6#1)(2009-3#1)(2013-1#1)
the second leading cause of##9##5##(2007-6#2)(2008-1#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#2)
the second leading##11##3##(2007-6#2)(2008-1#1)(2009-3#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-11#2)(2013-1#2)
the second ligand##3##3##(1991-5#1)(1995-8#1)(2010-5#1)
the second measure##2##3##(1996-5#1)(2008-2#1)
the second measurement##4##3##(1994-6#1)(2008-3#1)(2010-6#1)(2011-1#1)
the second messenger##11##3##(1991-10#2)(1993-6#2)(1994-12#1)(1994-8#1)(1995-6#1)(1996-2#2)(2010-11#1)(2013-7#1)
the second messengers##4##3##(1991-12#1)(2006-10#1)(2007-11#1)(2010-2#1)
the second method is##3##4##(2008-2#1)(2008-3#1)(2008-8#1)
the second method##10##3##(1992-2#1)(1992-8#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-8#1)
the second model##4##3##(1992-6#2)(1996-4#1)(2008-8#1)
the second molar##4##3##(2007-12#1)(2010-2#1)(2013-8#2)
the second month of##3##4##(2007-5#1)(2008-5#1)(2011-1#1)
the second most abundant##2##4##(1990-8#1)(1996-2#1)
the second most common cancer in men##2##7##(2008-11#1)(2013-1#1)
the second most common cancer in##4##6##(2008-11#1)(2008-5#1)(2012-2#1)(2013-1#1)
the second most common cancer##6##5##(2007-10#1)(2007-6#1)(2008-11#1)(2008-5#1)(2012-2#1)(2013-1#1)
the second most common cause of##5##6##(1996-11#1)(2007-3#1)(2008-11#1)(2008-4#1)(2011-2#1)
the second most common cause##6##5##(1996-11#1)(2006-7#1)(2007-3#1)(2008-11#1)(2008-4#1)(2011-2#1)
the second most common##37##4##(1996-11#1)(1997-5#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#2)(2013-7#1)
the second most frequent cause of death in##2##8##(2010-12#1)(2011-2#1)
the second most frequent cause of##3##6##(2008-5#1)(2010-12#1)(2011-2#1)
the second most frequent##5##4##(1991-6#1)(2007-10#1)(2008-5#1)(2010-12#1)(2011-2#1)
the second most important##3##4##(1995-9#1)(2008-12#1)(2010-10#1)
the second most##50##3##(1990-8#1)(1991-6#1)(1995-9#1)(1996-11#1)(1996-2#1)(1997-5#1)(2006-7#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#4)(2013-7#1)
the second motif##2##3##(1994-12#1)(1995-8#1)
the second nucleotide of the##4##5##(1993-3#2)(1997-2#2)
the second nucleotide##5##3##(1993-12#1)(1993-3#2)(1997-2#2)
the second objective##2##3##(1992-11#1)(2008-10#1)
the second of four##2##4##(1993-5#1)(1997-1#1)
the second of##9##3##(1993-5#1)(1995-1#1)(1995-3#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-4#1)(2007-2#1)(2012-3#1)
the second on##3##3##(2008-11#1)(2010-4#1)(2012-11#1)
the second one is##2##4##(2008-8#1)(2009-9#1)
the second one was##3##4##(2007-3#1)(2008-10#1)(2008-5#1)
the second one##26##3##(1991-3#1)(1994-11#1)(1995-6#1)(1997-4#1)(1997-5#1)(2006-12#1)(2007-3#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-11#2)
the second operation##6##3##(1996-6#2)(2008-6#1)(2008-7#3)
the second or third##4##4##(1991-2#1)(2008-10#3)
the second order of##2##4##(2008-3#2)
the second order##10##3##(1996-7#1)(1996-9#1)(2006-4#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2009-7#1)
the second outbreak##2##3##(2008-5#1)(2011-2#1)
the second overtone##2##3##(2008-2#2)
the second parity##2##3##(2008-7#1)(2011-2#1)
the second part of the study##2##6##(1992-5#1)(2008-1#1)
the second part of the##8##5##(1990-3#2)(1992-5#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2012-12#1)
the second part of this article##3##6##(1997-6#1)(2006-10#1)(2007-6#1)
the second part of this##5##5##(1997-4#1)(1997-6#1)(2006-10#1)(2007-6#1)(2008-1#1)
the second part of##16##4##(1990-3#2)(1992-12#1)(1992-5#1)(1993-2#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-5#1)(2009-2#1)(2012-12#1)
the second part##27##3##(1990-3#2)(1992-12#1)(1992-5#1)(1993-2#1)(1994-6#2)(1997-4#1)(1997-6#1)(2006-10#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
the second patient was##2##4##(2010-12#2)
the second patient##7##3##(1991-8#1)(1993-8#1)(2006-12#1)(2007-7#1)(2010-12#2)(2010-7#1)
the second peak of##2##4##(1992-11#1)(1992-9#1)
the second peak was##3##4##(1991-10#1)(1992-9#1)(2009-6#1)
the second peak##9##3##(1991-10#1)(1992-11#1)(1992-9#2)(2008-10#2)(2009-6#2)(2010-3#1)
the second period##5##3##(1994-5#1)(2011-2#3)(2013-1#1)
the second phase of the formalin test and the cold allodynia in##2##12##(2006-12#2)
the second phase of the formalin test##6##7##(2006-12#6)
the second phase of the##8##5##(1997-1#1)(2006-12#6)(2008-6#1)
the second phase of##12##4##(1991-3#1)(1995-12#1)(1997-1#1)(2006-12#6)(2008-6#1)(2012-11#1)(2012-2#1)
the second phase##24##3##(1990-12#1)(1990-2#1)(1990-3#1)(1991-3#1)(1991-7#1)(1993-9#1)(1994-11#1)(1995-12#1)(1996-11#1)(1997-1#1)(2006-12#6)(2007-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-11#1)(2012-2#1)(2013-1#1)
the second place of##2##4##(2005-10#2)
the second portion of the duodenum##2##6##(1990-10#1)(2008-5#1)
the second posterior##2##3##(2008-12#2)
the second postoperative hour##2##4##(2006-12#2)
the second postoperative##6##3##(2006-12#2)(2007-3#1)(2007-6#1)(2009-3#1)(2013-7#1)
the second primary##2##3##(2011-2#1)(2012-12#1)
the second promoter is##2##4##(1991-9#2)
the second quarter of##2##4##(2008-5#1)(2009-3#1)
the second quartile##2##3##(2007-10#1)(2011-2#1)
the second region of the##2##5##(2009-5#2)
the second region##4##3##(1992-7#1)(2007-12#1)(2009-5#2)
the second repeat##2##3##(2008-10#2)
the second report of##4##4##(1996-10#1)(2006-10#1)(2008-12#1)(2012-3#1)
the second report##5##3##(1996-10#1)(2006-10#1)(2007-2#1)(2008-12#1)(2012-3#1)
the second reported case of##7##5##(1993-12#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-2#1)(2013-1#1)
the second reported case##8##4##(1993-12#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-2#1)(2013-1#1)
the second residue of##2##4##(1993-8#1)(2008-5#1)
the second response##2##3##(1993-2#1)(1996-1#1)
the second round of##2##4##(2007-11#1)(2008-3#1)
the second round##5##3##(1991-6#1)(2007-11#2)(2008-3#1)(2012-3#1)
the second sample##2##3##(2008-10#1)(2008-12#1)
the second sampling bout##2##4##(2008-8#2)
the second sampling##3##3##(2008-10#1)(2008-8#2)
the second scan##2##3##(1996-5#1)(2007-10#1)
the second secretion period##2##4##(1990-3#2)
the second section##7##3##(1991-1#1)(1992-6#1)(2006-10#1)(2008-4#1)(2010-11#1)(2012-2#2)
the second series##4##3##(1996-1#1)(1997-7#1)(2006-11#1)(2008-5#1)
the second set##5##3##(1997-2#1)(2004-9#1)(2008-10#1)(2008-3#1)(2009-4#1)
the second shell##2##3##(1996-2#1)(2006-1#1)
the second simulation##2##3##(1995-5#1)(2008-3#1)
the second situation##2##3##(1992-2#1)(2008-8#1)
the second soaking period##2##4##(2006-7#2)
the second solvation shell##2##4##(2006-3#2)
the second stage and##2##4##(2008-12#1)(2009-5#1)
the second stage of labour##2##5##(1993-4#1)(2013-8#1)
the second stage of##5##4##(1993-4#1)(1994-2#2)(2008-8#1)(2013-8#1)
the second stage was##2##4##(2008-10#1)(2012-2#1)
the second stage##23##3##(1990-12#1)(1993-4#2)(1994-2#2)(2004-10#1)(2005-11#1)(2006-12#2)(2006-3#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-5#3)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
the second step in##3##4##(1994-12#1)(1994-3#1)(2012-2#1)
the second step of the reaction##2##6##(1993-3#1)(2008-10#1)
the second step of the##3##5##(1993-3#1)(2006-10#1)(2008-10#1)
the second step of##4##4##(1993-3#1)(2006-10#1)(2008-10#1)(2008-6#1)
the second step##21##3##(1990-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1996-7#1)(1997-8#1)(2004-9#1)(2006-10#1)(2007-10#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-8#2)(2011-1#1)(2012-2#1)
the second stimulus##3##3##(1992-7#1)(1993-2#1)(1997-5#1)
the second structure##2##3##(2009-6#1)(2010-6#1)
the second study##15##3##(1992-8#1)(1997-5#1)(2005-7#1)(2008-3#1)(2008-5#1)(2008-6#3)(2008-8#3)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
the second substrate##3##3##(1992-3#1)(1995-2#1)(2008-11#1)
the second subunit##2##3##(1992-11#1)(1992-3#1)
the second such##2##3##(2006-12#1)(2010-3#1)
the second surgery##4##3##(2006-12#1)(2007-5#1)(2010-3#1)(2013-7#1)
the second test##4##3##(1991-10#1)(1994-6#1)(2011-1#1)(2012-3#1)
the second theory##2##3##(2005-10#2)
the second time in##3##4##(2007-1#1)(2008-8#1)(2011-2#1)
the second time##5##3##(1991-8#1)(2007-1#1)(2008-3#1)(2008-8#1)(2011-2#1)
the second to the##2##4##(1992-6#1)(1995-3#1)
the second to##4##3##(1992-6#1)(1995-3#1)(2008-3#1)(2011-1#1)
the second trimester of pregnancy##3##5##(2007-2#1)(2008-2#1)(2012-2#1)
the second trimester of##4##4##(2007-2#1)(2008-1#1)(2008-2#1)(2012-2#1)
the second trimester##12##3##(1990-2#1)(1991-6#1)(1993-3#1)(1994-3#1)(1997-8#1)(2007-2#1)(2008-1#1)(2008-2#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)
the second two##3##3##(1992-8#1)(2006-10#1)(2008-8#1)
the second type of##2##4##(1993-3#1)(2009-3#1)
the second type##6##3##(1993-3#1)(1995-3#1)(1997-3#1)(1997-4#1)(2008-2#1)(2009-3#1)
the second underwent##2##3##(2008-1#1)(2012-12#1)
the second visit##3##3##(2009-4#3)
the second was a##2##4##(2006-6#1)(2008-10#1)
the second was##7##3##(1993-1#1)(2004-11#1)(2006-2#1)(2006-6#1)(2008-10#1)(2009-8#1)(2011-1#1)
the second wave##3##3##(2006-8#1)(2007-3#1)(2012-3#1)
the second week of##8##4##(1992-3#1)(1995-9#1)(2005-12#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-8#1)(2009-3#1)
the second week##16##3##(1990-2#2)(1992-3#2)(1995-5#1)(1995-9#1)(1997-2#2)(2005-12#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)
the second with a clinical nurse##2##6##(2013-1#2)
the second with##4##3##(2009-7#1)(2011-12#1)(2013-1#2)
the second world war##3##4##(1997-6#2)(2008-4#1)
the second year of life##6##5##(1993-1#1)(1996-11#1)(2007-8#1)(2008-9#1)(2009-4#1)(2012-1#1)
the second year of the##3##5##(2008-10#1)(2010-3#1)(2011-2#1)
the second year of##10##4##(1993-1#1)(1996-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-4#1)(2010-3#1)(2011-2#1)(2012-1#1)
the second year##24##3##(1990-5#1)(1991-8#1)(1993-1#1)(1995-2#1)(1996-11#1)(1996-12#3)(2006-3#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-6#2)(2008-9#1)(2009-4#1)(2010-1#2)(2010-3#1)(2011-2#2)(2012-1#1)
the second zinc finger domain##3##5##(1994-9#3)
the second zinc finger##4##4##(1994-9#4)
the second##1355##2##(1990-1#1)(1990-10#5)(1990-11#4)(1990-12#7)(1990-2#8)(1990-3#10)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#6)(1990-8#4)(1991-1#4)(1991-10#4)(1991-11#2)(1991-12#6)(1991-2#3)(1991-3#6)(1991-4#4)(1991-5#3)(1991-6#7)(1991-7#1)(1991-8#7)(1991-9#4)(1992-10#2)(1992-11#3)(1992-12#2)(1992-2#5)(1992-3#10)(1992-4#4)(1992-5#4)(1992-6#4)(1992-7#2)(1992-8#9)(1992-9#6)(1993-1#3)(1993-12#16)(1993-2#6)(1993-3#7)(1993-4#3)(1993-5#2)(1993-6#6)(1993-7#1)(1993-8#4)(1993-9#2)(1994-11#4)(1994-12#10)(1994-2#6)(1994-3#8)(1994-5#3)(1994-6#8)(1994-7#2)(1994-8#5)(1994-9#6)(1995-1#9)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#7)(1995-3#3)(1995-4#3)(1995-5#4)(1995-6#8)(1995-7#1)(1995-8#4)(1995-9#6)(1996-1#4)(1996-10#3)(1996-11#4)(1996-12#17)(1996-2#10)(1996-3#7)(1996-4#7)(1996-5#6)(1996-6#2)(1996-7#3)(1996-8#2)(1996-9#4)(1997-1#4)(1997-2#12)(1997-3#9)(1997-4#4)(1997-5#5)(1997-6#7)(1997-7#4)(1997-8#3)(2004-10#2)(2004-11#2)(2004-12#1)(2004-9#2)(2005-10#6)(2005-11#5)(2005-12#4)(2005-7#2)(2005-8#7)(2006-1#1)(2006-10#15)(2006-11#2)(2006-12#20)(2006-2#2)(2006-3#7)(2006-4#4)(2006-5#4)(2006-6#1)(2006-7#4)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#8)(2007-11#18)(2007-12#42)(2007-2#14)(2007-3#5)(2007-4#1)(2007-5#3)(2007-6#8)(2007-7#9)(2007-8#18)(2007-9#3)(2008-1#15)(2008-10#113)(2008-11#21)(2008-12#13)(2008-2#34)(2008-3#55)(2008-4#25)(2008-5#34)(2008-6#18)(2008-7#20)(2008-8#35)(2008-9#4)(2009-10#2)(2009-12#1)(2009-2#3)(2009-3#13)(2009-4#10)(2009-5#7)(2009-6#5)(2009-7#11)(2009-8#10)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#8)(2010-12#15)(2010-2#5)(2010-3#10)(2010-4#5)(2010-5#3)(2010-6#7)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#24)(2011-12#1)(2011-2#48)(2011-3#1)(2012-1#5)(2012-11#7)(2012-12#13)(2012-2#21)(2012-3#12)(2013-1#41)(2013-7#10)(2013-8#11)
the second- and third-order##2##4##(2008-2#1)(2008-3#1)
the second-derivative##2##2##(2008-10#2)
the second-generation##4##2##(2007-8#1)(2008-11#1)(2009-3#1)(2009-8#1)
the second-harmonic generation##4##3##(2007-12#1)(2008-2#3)
the second-harmonic signal##5##3##(2007-11#2)(2007-12#2)(2008-3#1)
the second-harmonic signals##2##3##(2007-12#2)
the second-harmonic wave##3##3##(2007-12#3)
the second-harmonic##26##2##(1995-7#1)(2007-11#3)(2007-12#12)(2008-1#2)(2008-2#4)(2008-3#4)
the second-harmonic-generation##2##2##(2007-12#2)
the second-line##3##2##(2008-2#1)(2010-12#1)(2012-1#1)
the second-order advantage##3##3##(2008-10#2)(2010-5#1)
the second-order dispersion##2##3##(2008-2#1)(2008-3#1)
the second-order nonlinear##5##3##(2007-11#1)(2007-12#4)
the second-order nonlinearity of poled polymer##2##6##(2008-1#1)(2008-3#1)
the second-order nonlinearity of##3##4##(2007-11#1)(2008-1#1)(2008-3#1)
the second-order nonlinearity##4##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)
the second-order polynomial##2##3##(2008-10#1)(2011-1#1)
the second-order rate constant##4##4##(1990-5#1)(1991-2#1)(1993-8#1)(2008-4#1)
the second-order rate constants for##3##5##(1990-2#1)(1990-5#1)(1996-7#1)
the second-order rate##7##3##(1990-2#1)(1990-5#2)(1991-2#1)(1993-8#1)(1996-7#1)(2008-4#1)
the second-order risk factor##2##4##(2009-7#2)
the second-order##48##2##(1990-2#1)(1990-5#2)(1991-2#2)(1991-4#1)(1993-8#1)(1994-5#1)(1996-7#1)(1997-8#1)(2007-11#2)(2007-12#8)(2008-1#3)(2008-10#4)(2008-2#7)(2008-3#9)(2008-4#1)(2009-7#2)(2010-5#1)(2011-1#1)
the second-phase##2##2##(1990-2#1)(1991-5#1)
the secondary amino##2##3##(1990-6#1)(2008-10#1)
the secondary and tertiary structure of the##3##7##(1991-2#1)(1991-5#1)(2008-9#1)
the secondary and tertiary##5##4##(1991-2#1)(1991-5#1)(1992-1#1)(1995-5#1)(2008-9#1)
the secondary antibody##4##3##(1991-3#1)(2008-4#3)
the secondary branch##2##3##(2005-11#1)(2007-12#1)
the secondary complications##2##3##(2008-1#2)
the secondary end##2##3##(2007-8#1)(2009-11#1)
the secondary endpoint##2##3##(2008-10#1)(2008-5#1)
the secondary headspot cells##3##4##(2007-12#3)
the secondary hydroxyl groups of##2##5##(1996-2#1)(2008-11#1)
the secondary infection phase##2##4##(2008-10#2)
the secondary infection##3##3##(2008-10#2)(2008-12#1)
the secondary mirror##4##3##(2008-2#4)
the secondary nucleus##2##3##(2008-9#2)
the secondary olfactory##2##3##(1997-3#1)(2012-2#1)
the secondary phloem##2##3##(2008-10#2)
the secondary prevention of ischemic##2##5##(2007-10#2)
the secondary prevention of##3##4##(2007-10#3)
the secondary response##2##3##(2007-11#1)(2008-5#1)
the secondary spectrum##4##3##(2008-3#4)
the secondary structural##3##3##(1992-4#1)(1995-5#1)(2006-12#1)
the secondary structure is##2##4##(1991-5#1)(2005-11#1)
the secondary structure of DNA##2##5##(1990-2#1)(1992-11#1)
the secondary structure of protein L7/L12##2##6##(1996-11#2)
the secondary structure of the##6##5##(1990-10#1)(1991-5#1)(1992-2#1)(1992-9#1)(2008-10#1)(2012-2#1)
the secondary structure of##23##4##(1990-10#1)(1990-2#1)(1990-7#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-9#1)(1996-11#2)(1997-2#1)(2008-10#3)(2008-7#1)(2012-2#1)
the secondary structure##39##3##(1990-10#2)(1990-2#1)(1990-7#1)(1991-5#2)(1992-11#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-3#2)(1993-8#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-11#2)(1997-1#1)(1997-2#1)(2005-11#1)(2007-9#1)(2008-10#3)(2008-4#2)(2008-7#2)(2012-2#2)
the secondary structures##2##3##(1993-11#1)(2008-10#1)
the secondary##175##2##(1990-10#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-2#2)(1991-3#1)(1991-5#3)(1992-1#1)(1992-11#2)(1992-2#2)(1992-4#2)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-12#2)(1994-3#3)(1994-8#2)(1994-9#1)(1995-11#1)(1995-5#3)(1995-7#1)(1996-11#2)(1996-2#3)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-11#3)(2006-10#6)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-10#4)(2007-11#5)(2007-12#6)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#16)(2008-11#1)(2008-12#2)(2008-2#8)(2008-3#8)(2008-4#10)(2008-5#6)(2008-7#2)(2008-8#1)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2010-12#1)(2010-2#2)(2010-3#1)(2011-1#2)(2011-11#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#3)
the secrecy##2##2##(2008-2#1)(2010-12#1)
the secret to##2##3##(1996-2#1)(2008-11#1)
the secret##3##2##(1996-2#1)(2008-11#1)(2012-12#1)
the secreted form of the##3##5##(1991-1#1)(1991-2#1)(2008-11#1)
the secreted form of##5##4##(1991-1#1)(1991-2#1)(1992-12#1)(1994-12#1)(2008-11#1)
the secreted form##6##3##(1991-1#2)(1991-2#1)(1992-12#1)(1994-12#1)(2008-11#1)
the secreted protein##6##3##(1991-2#1)(1992-5#1)(1997-4#1)(1997-6#1)(1997-7#1)(2009-3#1)
the secreted##31##2##(1990-11#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-2#2)(1991-9#1)(1992-12#1)(1992-5#1)(1992-7#1)(1994-12#1)(1995-1#1)(1996-11#1)(1997-1#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2009-3#1)(2011-2#1)(2012-12#4)
the secretion and##5##3##(1991-5#1)(1993-5#1)(1995-1#1)(1997-6#1)(2008-7#1)
the secretion by##2##3##(1990-9#1)(1995-8#1)
the secretion of ACTH and##2##5##(1993-7#1)(1996-12#1)
the secretion of ANP##2##4##(1991-4#1)(2006-11#1)
the secretion of IL-7##2##4##(2008-11#2)
the secretion of a quantum at a##2##7##(1995-8#2)
the secretion of alpha Gal##2##5##(1993-3#2)
the secretion of beta-endorphin##2##4##(1990-12#1)(1994-9#1)
the secretion of endogenous##2##4##(2006-8#1)(2008-5#1)
the secretion of interleukin 7##2##5##(2008-11#2)
the secretion of mutant##2##4##(1990-12#1)(1995-6#1)
the secretion of prolactin##2##4##(1991-2#2)
the secretion of the##3##4##(2007-12#1)(2008-11#1)(2011-1#1)
the secretion of this##2##4##(1992-3#1)(1993-3#1)
the secretion of transforming growth factor beta##2##7##(1996-4#1)(2008-11#1)
the secretion of##82##3##(1990-11#1)(1990-12#2)(1990-5#1)(1990-9#1)(1991-2#2)(1991-4#1)(1991-6#2)(1992-11#1)(1992-3#3)(1992-6#3)(1992-8#1)(1993-12#2)(1993-3#4)(1993-7#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-9#2)(1995-1#3)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#2)(1996-12#1)(1996-4#2)(1996-9#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#2)(2008-11#9)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
the secretion or##2##3##(2008-7#1)(2012-1#1)
the secretion##108##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-5#1)(1990-9#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#5)(1992-11#1)(1992-2#1)(1992-3#3)(1992-6#3)(1992-8#1)(1993-12#2)(1993-3#5)(1993-5#1)(1993-7#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#4)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#3)(1996-12#1)(1996-4#2)(1996-9#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#5)(2008-11#10)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
the secretions of##2##3##(1991-5#1)(2008-5#1)
the secretions##3##2##(1991-11#1)(1991-5#1)(2008-5#1)
the secretory activity of the##2##5##(1993-5#1)(2006-9#1)
the secretory activity##3##3##(1993-5#1)(2006-9#1)(2008-7#1)
the secretory and##2##3##(1997-4#1)(2012-12#1)
the secretory cycle##2##3##(2008-7#2)
the secretory epithelium##2##3##(1995-6#1)(2008-7#1)
the secretory function of##3##4##(1992-12#1)(1992-6#1)(1997-7#1)
the secretory granules of##2##4##(1996-5#1)(1997-4#1)
the secretory granules##3##3##(1995-8#1)(1996-5#1)(1997-4#1)
the secretory pathway and##3##4##(1990-6#1)(2012-2#2)
the secretory pathway of##2##4##(1997-6#1)(2008-4#1)
the secretory pathway##16##3##(1990-3#1)(1990-6#3)(1992-9#1)(1993-3#1)(1997-1#2)(1997-6#2)(2008-1#1)(2008-11#2)(2008-4#1)(2012-2#2)
the secretory response##4##3##(1993-3#1)(1994-12#2)(1996-5#1)
the secretory responses##2##3##(1993-3#1)(1997-5#1)
the secretory##61##2##(1990-12#1)(1990-3#1)(1990-6#3)(1991-11#1)(1991-5#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#3)(1993-5#2)(1994-12#2)(1994-6#1)(1995-6#1)(1995-8#1)(1996-5#2)(1997-1#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#1)(2004-12#1)(2006-6#1)(2006-9#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#2)(2008-5#1)(2008-7#5)(2009-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#3)
the section of the##3##4##(1996-4#1)(1997-2#1)(2007-8#1)
the section of##5##3##(1990-2#1)(1996-4#1)(1997-2#1)(2007-2#1)(2007-8#1)
the section on##3##3##(1995-2#1)(2006-10#1)(2007-11#1)
the section##12##2##(1990-2#1)(1990-5#2)(1995-2#1)(1996-4#1)(1997-2#1)(2006-10#1)(2007-11#2)(2007-2#1)(2007-8#1)(2008-10#1)
the sectional##2##2##(2007-12#1)(2008-3#1)
the sections of##3##3##(2006-11#1)(2011-1#1)(2012-12#1)
the sections##10##2##(1994-2#1)(2006-11#1)(2008-1#1)(2008-2#1)(2008-4#3)(2009-1#1)(2011-1#1)(2012-12#1)
the sector##6##2##(1995-3#1)(2007-7#1)(2008-10#1)(2008-2#1)(2009-10#1)(2013-7#1)
the secular##4##2##(2009-10#1)(2011-2#1)(2013-1#2)
the secured##2##2##(1991-2#2)
the security and##3##3##(1993-2#1)(2008-7#1)(2010-9#1)
the security department##3##3##(1993-2#2)(1995-2#1)
the security of the##3##4##(1993-3#1)(1994-3#1)(2011-2#1)
the security of##8##3##(1993-3#1)(1994-3#2)(2007-11#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-3#1)
the security requirements##2##3##(1994-6#1)(2007-12#1)
the security rule##5##3##(2006-7#1)(2006-8#2)(2007-12#1)(2008-4#1)
the security##40##2##(1991-1#2)(1992-2#1)(1993-12#1)(1993-2#4)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-2#2)(1996-2#1)(1997-2#2)(2005-8#1)(2006-7#1)(2006-8#4)(2007-11#2)(2007-12#2)(2007-4#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-3#1)
the sedation##3##2##(1992-8#1)(2006-4#1)(2007-11#1)
the sedative##3##2##(2006-10#1)(2008-6#1)(2010-3#1)
the sedentary group##4##3##(1992-3#1)(2012-12#2)(2013-1#1)
the sedentary##5##2##(1992-3#1)(2008-10#1)(2012-12#2)(2013-1#1)
the sediment column##2##3##(2006-6#1)(2008-5#1)
the sediment##18##2##(1992-3#1)(1996-12#1)(2006-6#1)(2007-10#1)(2007-5#2)(2008-10#4)(2008-5#5)(2009-8#1)(2013-1#1)(2013-7#1)
the sedimentation of##2##3##(1990-7#1)(2009-8#1)
the sedimentation rate##3##3##(1993-8#1)(2008-10#2)
the sedimentation##10##2##(1990-11#1)(1990-7#2)(1991-4#1)(1993-8#1)(1997-2#1)(2008-10#2)(2009-2#1)(2009-8#1)
the sedimented phase##2##3##(2008-10#2)
the sediments##15##2##(1992-8#1)(2004-4#1)(2007-5#3)(2007-7#1)(2007-8#2)(2008-10#4)(2008-5#2)(2011-2#1)
the seed and##2##3##(2008-10#2)
the seed beam##2##3##(2008-2#2)
the seed coat##7##3##(2008-10#4)(2012-11#3)
the seed diffusate##2##3##(2008-5#2)
the seed oil##3##3##(2006-12#1)(2008-11#1)(2009-10#1)
the seed shadow##2##3##(2008-9#2)
the seed treatment##2##3##(2008-10#2)
the seed##72##2##(2006-12#7)(2006-9#1)(2007-11#1)(2007-12#2)(2007-5#2)(2008-1#1)(2008-10#28)(2008-11#3)(2008-12#2)(2008-2#3)(2008-5#7)(2008-8#1)(2008-9#2)(2009-10#2)(2009-2#1)(2009-5#1)(2009-6#1)(2011-12#2)(2012-11#3)(2013-8#2)
the seedborne##2##2##(2008-10#2)
the seeded##6##2##(1994-8#1)(1995-1#1)(2006-12#1)(2007-12#1)(2007-4#1)(2012-2#1)
the seeder##2##2##(2007-11#1)(2008-2#1)
the seeding##4##2##(2007-11#1)(2008-1#1)(2008-12#1)(2011-2#1)
the seedling and adult##2##4##(2008-10#2)
the seedling and reproductive stages##2##5##(2008-12#2)
the seedling and##6##3##(2008-10#4)(2008-12#2)
the seedling growth##2##3##(2008-5#2)
the seedling stage##9##3##(2008-10#8)(2008-12#1)
the seedling##20##2##(2008-10#13)(2008-12#3)(2008-5#2)(2009-10#1)(2011-12#1)
the seedlings were##3##3##(2008-10#2)(2011-10#1)
the seedlings##16##2##(2004-4#1)(2008-10#6)(2008-5#2)(2009-8#1)(2011-10#1)(2011-12#3)(2013-8#2)
the seeds in##2##3##(2007-5#1)(2008-5#1)
the seeds of Euphorbia lathyris L##5##6##(2011-1#5)
the seeds of##24##3##(1990-11#1)(1990-2#1)(1994-2#2)(2006-12#3)(2007-1#4)(2007-11#1)(2008-4#1)(2008-8#2)(2010-1#1)(2010-12#1)(2011-1#6)(2012-2#1)
the seeds##35##2##(1990-11#1)(1990-2#1)(1994-2#2)(2006-12#4)(2007-1#4)(2007-11#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-1#6)(2012-2#2)(2013-7#1)
the seeming##2##2##(2007-9#1)(2008-4#1)
the seemingly##7##2##(1995-2#1)(1997-2#1)(2007-1#1)(2009-3#2)(2010-2#1)(2012-2#1)
the segment containing##2##3##(1991-12#1)(2006-6#1)
the segment of the##2##4##(2008-10#1)(2013-7#1)
the segment of##3##3##(2008-10#1)(2008-11#1)(2013-7#1)
the segment##26##2##(1990-5#1)(1991-11#1)(1991-12#1)(1995-10#1)(1996-11#1)(1997-4#1)(2006-6#1)(2007-11#1)(2007-12#4)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#2)(2009-10#1)(2009-8#1)(2013-7#1)
the segmental identity##2##3##(1990-11#1)(1994-8#1)
the segmental organization of the##2##5##(2007-12#2)
the segmental##16##2##(1990-11#1)(1990-7#1)(1993-12#1)(1994-8#1)(2007-11#1)(2007-12#6)(2008-10#1)(2008-6#1)(2008-7#1)(2009-10#1)(2012-3#1)
the segmentation and##2##3##(1995-12#1)(2009-10#1)
the segmentation of##8##3##(2007-12#3)(2008-2#4)(2012-1#1)
the segmentation task##2##3##(2009-10#2)
the segmentation##22##2##(1994-3#1)(1995-12#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-2#5)(2008-3#1)(2008-9#2)(2009-10#4)(2010-12#1)(2012-1#1)
the segmented##8##2##(1991-3#1)(2005-11#1)(2007-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-7#1)
the segments of##2##3##(2008-3#1)(2008-7#1)
the segments##13##2##(1991-3#1)(1995-12#1)(1995-8#1)(2006-8#1)(2007-8#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-1#1)
the segregated##2##2##(1994-9#1)(2008-4#1)
the segregating populations##2##3##(2008-10#1)(2008-8#1)
the segregating##4##2##(1991-4#1)(2008-10#2)(2008-8#1)
the segregation of the##4##4##(2005-11#1)(2008-10#1)(2008-5#1)(2012-11#1)
the segregation of##16##3##(1992-2#1)(1997-7#1)(2005-11#2)(2008-10#7)(2008-5#1)(2008-8#1)(2010-7#1)(2011-1#1)(2012-11#1)
the segregation##19##2##(1992-2#1)(1997-7#1)(2005-11#2)(2008-10#7)(2008-2#1)(2008-5#1)(2008-8#1)(2010-7#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-3#1)
the seismic##2##2##(1995-3#1)(2009-6#1)
the seismicity##4##2##(1996-4#4)
the seizure##12##2##(1992-12#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-7#2)(2009-9#1)(2010-12#1)(2010-5#1)
the seizures##5##2##(1991-11#1)(1994-2#1)(1997-3#1)(2008-7#1)(2009-9#1)
the select##2##2##(2011-2#1)(2013-7#1)
the selectable marker gene hph##2##5##(2006-12#1)(2008-10#1)
the selectable marker gene##3##4##(2006-12#2)(2008-10#1)
the selectable marker##6##3##(1991-9#1)(1997-4#1)(2006-12#2)(2008-10#1)(2008-2#1)
the selected antibodies##2##3##(1995-7#1)(2008-10#1)
the selected cells##2##3##(2007-6#1)(2008-11#1)
the selected conditions##10##3##(2008-10#10)
the selected experimental conditions##2##4##(2008-10#1)(2011-2#1)
the selected flow##2##3##(2008-10#2)
the selected frequencies and powers##2##5##(2011-2#2)
the selected genes##4##3##(2006-10#1)(2008-5#1)(2008-7#1)(2010-11#1)
the selected ion monitoring (SIM) mode##3##6##(2008-10#3)
the selected ion monitoring##6##4##(2008-10#5)(2013-1#1)
the selected patients##2##3##(2010-4#1)(2013-8#1)
the selected sites##2##3##(2005-8#1)(2010-3#1)
the selected species##2##3##(2011-12#2)
the selected strain##2##3##(2008-8#1)(2010-8#1)
the selected strains##2##3##(2008-6#1)(2009-6#1)
the selected treatment##2##3##(2006-2#1)(2010-7#1)
the selected treatment(s)##2##3##(2012-2#2)
the selected variables##2##3##(2008-10#1)(2013-8#1)
the selected worms##2##3##(2004-4#2)
the selected##130##2##(1990-11#1)(1990-7#1)(1991-12#1)(1993-3#1)(1993-9#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-7#1)(1996-8#1)(1997-7#1)(2004-4#2)(2005-12#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-2#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#36)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-6#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#3)(2010-8#3)(2011-1#1)(2011-12#2)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#4)(2013-1#6)(2013-8#4)
the selectin##2##2##(1991-12#1)(1997-4#1)
the selection and##7##3##(1992-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#1)
the selection by##2##3##(1990-8#1)(1995-1#1)
the selection criteria used##2##4##(1993-9#1)(2006-9#1)
the selection criteria##6##3##(1993-9#1)(2006-9#1)(2007-10#1)(2008-2#1)(2008-8#1)(2012-2#1)
the selection differential##2##3##(1991-8#1)(2008-8#1)
the selection marker##2##3##(1991-8#1)(2008-11#1)
the selection medium##2##3##(2012-2#2)
the selection of a suitable##2##5##(2008-4#1)(2008-5#1)
the selection of a##8##4##(1992-9#1)(1993-1#1)(1993-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)
the selection of an##2##4##(2008-2#1)(2011-2#1)
the selection of appropriate##2##4##(2008-9#1)(2012-2#1)
the selection of cells##2##4##(1994-5#1)(2008-11#1)
the selection of certain##2##4##(2008-10#1)(2011-2#1)
the selection of clinical##2##4##(1997-1#1)(2008-1#1)
the selection of drug##2##4##(2005-8#1)(2011-2#1)
the selection of landmarks##2##4##(2012-12#2)
the selection of patients for##3##5##(1994-2#1)(2008-4#1)(2010-11#1)
the selection of patients with##2##5##(1997-2#1)(2007-11#1)
the selection of patients##7##4##(1994-2#1)(1997-2#1)(2007-11#1)(2008-4#1)(2008-7#1)(2009-2#1)(2010-11#1)
the selection of resistant##3##4##(2008-10#1)(2009-6#1)(2012-1#1)
the selection of suitable##3##4##(2007-11#1)(2008-3#2)
the selection of surfactants##2##4##(2008-10#1)(2008-5#1)
the selection of the most##2##5##(2007-9#1)(2009-9#1)
the selection of the##13##4##(1997-1#1)(1997-4#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-2#2)(2008-5#1)(2009-9#1)(2011-2#1)
the selection of treatment##2##4##(2008-12#1)(2010-1#1)
the selection of variables for the##2##6##(2008-10#2)
the selection of variables##4##4##(1995-9#1)(2008-10#3)
the selection of##134##3##(1990-10#2)(1990-12#1)(1990-5#2)(1991-11#2)(1991-12#1)(1991-7#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-7#1)(1995-9#1)(1996-8#2)(1997-1#2)(1997-2#2)(1997-4#1)(1997-5#1)(1997-9#1)(2004-9#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#18)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#7)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#3)(2009-2#1)(2009-6#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-7#1)
the selection pressure##4##3##(1997-6#1)(2008-10#2)(2008-11#1)
the selection process and##2##4##(1997-1#1)(1997-4#1)
the selection process of##2##4##(2006-10#1)(2008-10#1)
the selection process##9##3##(1994-2#1)(1997-1#2)(1997-4#1)(2006-10#1)(2008-10#2)(2008-6#2)
the selection valve##2##3##(2008-10#2)
the selection##188##2##(1990-10#2)(1990-12#1)(1990-5#2)(1990-8#1)(1991-11#2)(1991-12#1)(1991-7#1)(1991-8#2)(1992-12#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-2#2)(1994-5#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-7#1)(1995-9#1)(1996-8#2)(1997-1#5)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-9#1)(2004-9#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#27)(2008-11#8)(2008-12#2)(2008-2#5)(2008-3#8)(2008-4#6)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#5)(2008-9#3)(2009-10#2)(2009-11#3)(2009-12#1)(2009-2#1)(2009-6#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#1)(2013-1#3)(2013-7#1)
the selective 5-HT1A receptor##3##4##(1993-3#1)(1995-12#2)
the selective 5-HT1A##4##3##(1993-3#1)(1995-12#2)(1996-12#1)
the selective 5-HT3 receptor antagonist##2##5##(1993-3#1)(1994-2#1)
the selective 5-HT3 receptor##3##4##(1993-3#2)(1994-2#1)
the selective A2A##2##3##(1993-11#1)(2009-4#1)
the selective COX-1 inhibitor SC-560##2##5##(2008-4#2)
the selective COX-2 inhibitor CAY10404##2##5##(2008-4#2)
the selective COX-2 inhibitor##3##4##(2008-12#1)(2008-4#2)
the selective COX-2##4##3##(2007-7#1)(2008-12#1)(2008-4#2)
the selective V1 antagonist##2##4##(1992-9#1)(1993-4#1)
the selective V1##3##3##(1992-9#1)(1993-4#2)
the selective V2##2##3##(1993-4#2)
the selective adenosine##2##3##(1995-12#2)
the selective advantage of##2##4##(2008-8#1)(2012-3#1)
the selective alpha##4##3##(1991-3#1)(1993-11#1)(1994-10#1)(1994-12#1)
the selective and sensitive determination of##3##6##(2008-10#3)
the selective and##5##3##(2008-10#5)
the selective binding of##2##4##(1990-12#1)(1995-3#1)
the selective binding##4##3##(1990-12#1)(1995-3#1)(2008-10#2)
the selective detection of##4##4##(1990-8#1)(1992-3#1)(2008-10#1)(2010-5#1)
the selective determination of##11##4##(2007-8#2)(2008-10#8)(2013-8#1)
the selective elimination##2##3##(2007-7#1)(2008-7#1)
the selective extraction of##7##4##(1992-3#1)(1996-5#1)(2008-10#5)
the selective extraction##10##3##(1992-3#1)(1996-5#1)(2008-10#8)
the selective forces##3##3##(1992-9#1)(2008-8#1)(2012-12#1)
the selective inhibitor of##2##4##(1994-12#1)(2008-4#1)
the selective inhibitor##3##3##(1994-12#1)(1997-7#1)(2008-4#1)
the selective ion##2##3##(2008-10#2)
the selective loss of##2##4##(1994-10#1)(2008-1#1)
the selective mGlu group III##2##5##(1995-12#2)
the selective mGlu group##3##4##(1995-12#3)
the selective pressure##3##3##(2005-11#1)(2008-1#1)(2008-10#1)
the selective pressures##2##3##(2007-3#1)(2009-8#1)
the selective serotonin reuptake inhibitors##5##5##(1996-12#3)(2004-3#1)(2005-6#1)
the selective serotonin reuptake##6##4##(1996-12#3)(2004-3#1)(2005-6#1)(2012-3#1)
the selective serotonin##7##3##(1996-12#3)(1996-8#1)(2004-3#1)(2005-6#1)(2012-3#1)
the selective targeting of##2##4##(2007-11#1)(2009-1#1)
the selective uptake of##2##4##(1996-5#1)(1996-8#1)
the selective uptake##4##3##(1996-5#2)(1996-8#1)(2008-10#1)
the selective vulnerability of##2##4##(1995-3#1)(1997-1#1)
the selective##220##2##(1990-12#2)(1990-2#2)(1990-5#1)(1990-7#2)(1990-8#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#2)(1991-9#4)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-5#1)(1992-7#1)(1992-9#2)(1993-11#2)(1993-12#2)(1993-3#3)(1993-4#6)(1993-6#1)(1993-9#1)(1994-10#2)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#4)(1994-6#2)(1994-8#1)(1995-1#1)(1995-10#2)(1995-12#9)(1995-3#2)(1995-5#1)(1995-6#1)(1996-10#1)(1996-12#6)(1996-2#2)(1996-5#7)(1996-6#1)(1996-8#2)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2004-3#1)(2005-11#2)(2005-6#1)(2005-7#1)(2005-9#1)(2006-10#3)(2007-11#3)(2007-3#1)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#44)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#7)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#1)(2009-12#1)(2009-4#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#4)
the selectivities##4##2##(2008-10#4)
the selectivity and sensitivity of##4##5##(1997-5#1)(2007-8#1)(2008-10#2)
the selectivity and the sensitivity of##2##6##(2008-10#2)
the selectivity and##10##3##(1997-5#1)(2005-12#1)(2007-8#1)(2008-10#5)(2010-5#1)(2012-12#1)
the selectivity coefficient##3##3##(2005-11#1)(2008-10#2)
the selectivity coefficients##4##3##(2008-10#4)
the selectivity filter##6##3##(2008-8#6)
the selectivity for##4##3##(1995-3#1)(1996-8#2)(2008-10#1)
the selectivity in the##2##4##(2006-12#1)(2008-10#1)
the selectivity is##2##3##(2008-10#2)
the selectivity of separation##2##4##(1996-5#1)(2008-10#1)
the selectivity of the method##2##5##(2008-10#2)
the selectivity of the##17##4##(1990-9#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-2#1)(2006-12#1)(2008-10#10)
the selectivity of this##2##4##(2008-10#1)(2010-5#1)
the selectivity of##35##3##(1990-9#1)(1993-4#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#1)(2006-12#1)(2007-8#1)(2008-10#20)(2008-6#1)(2010-5#1)
the selectivity ratio of acetone/acetic acid response##2##7##(2008-10#2)
the selectivity was##2##3##(2008-10#2)
the selectivity##96##2##(1990-9#1)(1993-4#1)(1994-9#1)(1995-3#3)(1995-6#2)(1995-8#1)(1996-2#2)(1996-5#2)(1996-8#3)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(2005-11#1)(2005-12#1)(2006-12#2)(2007-8#3)(2008-10#54)(2008-2#1)(2008-6#1)(2008-8#6)(2010-4#1)(2010-5#2)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
the selenium present##2##3##(2008-10#2)
the selenium species##2##3##(2008-10#2)
the selenium##14##2##(1995-1#1)(1996-7#1)(2008-10#9)(2008-6#1)(2008-7#2)
the selenocompounds##2##2##(1992-12#1)(2008-10#1)
the selenocysteine tRNA[Ser]Sec##2##3##(1997-2#2)
the self and##2##3##(2008-2#1)(2008-5#1)
the self as##3##3##(2006-3#1)(2006-9#1)(2008-6#1)
the self expandable valved stent##2##5##(2007-8#2)
the self in##4##3##(2006-3#1)(2008-12#1)(2008-5#2)
the self is##3##3##(2008-5#1)(2008-6#1)(2011-1#1)
the self##40##2##(1990-3#1)(1994-12#1)(1996-11#1)(2005-7#1)(2006-3#3)(2006-6#2)(2006-9#1)(2007-7#1)(2007-8#2)(2008-11#7)(2008-12#1)(2008-2#1)(2008-5#9)(2008-6#2)(2010-12#1)(2011-1#2)(2012-12#2)(2012-2#1)(2013-7#1)
the self-##2##2##(2007-12#1)(2008-6#1)
the self-adaptive##2##2##(2007-12#1)(2008-1#1)
the self-administration of medication within OPMH##2##6##(2011-2#2)
the self-administration of##4##3##(1992-2#1)(1993-6#1)(2011-2#2)
the self-assembled monolayers (SAMs) of##2##5##(2007-9#1)(2008-10#1)
the self-assembled##13##2##(1997-4#1)(2007-8#3)(2007-9#1)(2008-10#6)(2008-5#1)(2010-4#1)
the self-assembling##3##2##(2005-11#2)(2007-8#1)
the self-assembly of##8##3##(1996-2#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-12#1)(2009-12#1)(2010-4#2)
the self-assembly##10##2##(1996-2#1)(2005-11#2)(2007-10#1)(2007-9#1)(2008-10#1)(2008-12#1)(2009-12#1)(2010-4#2)
the self-association of##2##3##(1991-4#1)(1997-2#1)
the self-association##3##2##(1991-4#2)(1997-2#1)
the self-broadening half-width##2##3##(2008-2#2)
the self-broadening##3##2##(2008-2#2)(2008-3#1)
the self-concept##4##2##(2007-2#1)(2008-5#2)(2009-7#1)
the self-consistent method##2##3##(1994-9#1)(2008-2#1)
the self-consistent##4##2##(1994-9#1)(2006-4#1)(2008-10#1)(2008-2#1)
the self-convergent-width##2##2##(2008-3#2)
the self-directed##2##2##(2008-11#1)(2010-2#1)
the self-efficacy of##2##3##(2007-2#1)(2010-9#1)
the self-esteem of##2##3##(2007-12#1)(2008-11#1)
the self-esteem##3##2##(2007-12#1)(2008-11#2)
the self-examination group##2##3##(1990-12#2)
the self-focusing dynamics of##2##4##(2007-11#1)(2007-12#1)
the self-focusing of##2##3##(2007-12#2)
the self-focusing##5##2##(2007-11#1)(2007-12#4)
the self-harm measures##2##3##(2006-7#2)
the self-harming behaviors##2##3##(2006-7#2)
the self-help community and##2##4##(1994-1#1)(1996-3#1)
the self-help##4##2##(1994-1#2)(1996-3#2)
the self-image##2##2##(2006-2#1)(2009-2#1)
the self-imaging property of a##2##5##(2008-2#2)
the self-imaging##3##2##(2007-12#1)(2008-2#2)
the self-incompatibility##3##2##(1992-8#1)(1996-8#1)(2009-10#1)
the self-management##2##2##(2006-5#1)(2007-10#1)
the self-mixing effect##2##3##(2008-2#1)(2008-3#1)
the self-mixing##3##2##(2008-2#1)(2008-3#2)
the self-organization##2##2##(2007-9#2)
the self-organized##3##2##(2008-1#1)(2008-7#1)(2011-2#1)
the self-organizing##6##2##(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#1)
the self-perceived competence##2##3##(1993-2#1)(2010-3#1)
the self-perceived##4##2##(1993-2#1)(2010-3#2)(2013-1#1)
the self-phase modulation of##2##4##(2007-11#1)(2007-12#1)
the self-phase modulation##3##3##(2007-11#1)(2007-12#2)
the self-rating of##2##3##(2006-6#1)(2012-3#1)
the self-reference condition##2##3##(2008-9#2)
the self-reference##4##2##(2008-10#1)(2008-9#3)
the self-regulation of##2##3##(2007-4#1)(2012-3#1)
the self-renewal capacity of##2##4##(2008-6#1)(2012-12#1)
the self-renewal##3##2##(1997-4#1)(2008-6#1)(2012-12#1)
the self-report##3##2##(1996-1#1)(2010-2#1)(2013-1#1)
the self-reported##3##2##(1993-6#1)(2012-3#1)(2013-1#1)
the self-similar##2##2##(1996-4#1)(2007-12#1)
the self-stacking##2##2##(2006-10#2)
the self-stimulation##2##2##(1990-10#1)(1993-6#1)
the self-trapped##3##2##(1992-8#1)(2008-1#2)
the selfing##2##2##(2008-9#1)(2013-1#1)
the sella turcica##2##3##(1991-6#1)(2013-1#1)
the sella##6##2##(1991-6#1)(2006-12#1)(2011-2#2)(2013-1#2)
the sellar##8##2##(2007-1#1)(2012-3#5)(2013-1#2)
the sellar-parasellar##2##2##(2005-9#2)
the semantic content of##3##4##(2008-4#1)(2010-12#2)
the semantic network##2##3##(1996-7#2)
the semantic##17##2##(1991-2#2)(1996-7#2)(2008-2#1)(2008-4#2)(2008-7#1)(2009-11#1)(2009-9#1)(2010-12#2)(2010-5#1)(2012-2#1)(2013-1#2)(2013-8#1)
the semantically##2##2##(2010-2#1)(2010-5#1)
the semantics##6##2##(2008-6#1)(2010-4#1)(2013-1#4)
the semen##9##2##(1991-7#1)(1994-8#1)(1995-8#2)(2006-5#1)(2007-12#1)(2008-3#1)(2010-7#1)(2013-1#1)
the semi-arid##3##2##(2007-3#2)(2010-10#1)
the semi-deep##3##2##(2008-12#3)
the semi-quantitative##2##2##(2008-10#1)(2011-2#1)
the semi-solid W/O/W##2##3##(2008-5#2)
the semi-static and PGA-alginate methods##2##5##(2011-2#2)
the semicircular##4##2##(1992-9#1)(2006-12#2)(2012-2#1)
the semiclassical##3##2##(1992-8#1)(1995-5#1)(2010-7#1)
the semiconductor industry##3##3##(1997-3#1)(2006-12#1)(2008-10#1)
the semiconductor laser##3##3##(2007-12#1)(2008-3#2)
the semiconductor##15##2##(1997-3#2)(2006-12#1)(2007-12#5)(2008-10#3)(2008-3#4)
the semicontinuous fermentation process##2##4##(2008-5#1)(2008-6#1)
the semicontinuous fermentation##4##3##(2008-5#3)(2008-6#1)
the semicontinuous##5##2##(2005-11#1)(2008-5#3)(2008-6#1)
the semilunar##2##2##(2008-4#1)(2011-1#1)
the seminal fluid##3##3##(2006-8#1)(2011-1#2)
the seminal paper##2##3##(2008-9#1)(2011-1#1)
the seminal plasma##4##3##(2010-8#3)(2013-8#1)
the seminal receptacle##3##3##(2008-7#3)
the seminal vesicle is##2##4##(2011-2#2)
the seminal vesicle##5##3##(2008-11#2)(2011-2#3)
the seminal vesicles##4##3##(1997-8#1)(2008-7#2)(2012-12#1)
the seminal##27##2##(1991-6#1)(1997-8#2)(2006-8#2)(2008-11#2)(2008-7#5)(2008-9#3)(2010-8#3)(2011-1#3)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
the seminar in the first year##2##6##(2010-1#2)
the seminar in the##3##4##(2010-1#3)
the seminar##6##2##(1994-1#2)(2008-1#1)(2010-1#3)
the seminiferous epithelial cycle##5##4##(2009-10#2)(2012-2#3)
the seminiferous epithelium in##2##4##(2009-10#1)(2012-2#1)
the seminiferous epithelium into the##2##5##(2009-10#1)(2012-2#1)
the seminiferous epithelium via##3##4##(2009-10#2)(2012-2#1)
the seminiferous epithelium##29##3##(2006-5#1)(2009-10#15)(2012-2#12)(2013-8#1)
the seminiferous tubule##4##3##(2009-10#1)(2012-2#2)(2013-1#1)
the seminiferous tubules##7##3##(1991-4#1)(1993-7#1)(1995-6#1)(2008-7#1)(2009-10#3)
the seminiferous##45##2##(1991-4#1)(1993-7#1)(1995-6#1)(2006-5#1)(2008-7#1)(2009-10#21)(2012-2#17)(2013-1#1)(2013-8#1)
the semiparametric model##2##3##(2010-11#1)(2011-1#1)
the semiparametric##4##2##(2010-11#1)(2010-2#1)(2010-7#1)(2011-1#1)
the semiperiodic zones##2##3##(2007-11#1)(2007-12#1)
the semirigid##3##2##(2012-12#3)
the sender's##2##2##(2012-3#2)
the senescence##3##2##(1991-12#1)(2006-12#1)(2008-10#1)
the senescence-associated##2##2##(2008-1#2)
the senescent phenotype##2##3##(1990-9#1)(2008-1#1)
the senescent rats##2##3##(1995-9#1)(2013-7#1)
the senescent##12##2##(1990-9#1)(1991-4#1)(1993-2#2)(1994-6#1)(1995-9#2)(1996-9#1)(2008-1#1)(2013-7#3)
the senile heart##2##3##(1990-3#1)(1991-4#1)
the senile type##2##3##(1992-1#1)(2011-2#1)
the senile##6##2##(1990-3#1)(1991-4#1)(1992-1#1)(1995-10#1)(2008-12#1)(2011-2#1)
the senior author##8##3##(1993-12#1)(2005-5#1)(2006-11#1)(2008-2#1)(2008-9#1)(2010-11#1)(2012-3#1)(2013-1#1)
the senior author's##3##3##(1993-12#1)(2010-8#1)(2011-2#1)
the senior##18##2##(1993-12#2)(1997-2#1)(2005-5#1)(2005-8#1)(2006-11#1)(2006-8#2)(2007-7#1)(2007-8#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
the sennoside##2##2##(2007-1#2)
the sensation of##4##3##(1996-6#1)(2007-5#1)(2011-2#1)(2012-2#1)
the sensations of##2##3##(1994-6#1)(2009-12#1)
the sense of balance##2##4##(1993-5#1)(2008-7#1)
the sense of self##2##4##(2008-11#1)(2010-6#1)
the sense of smell##3##4##(2007-9#2)(2012-2#1)
the sense of touch##2##4##(2007-5#2)
the sense of##30##3##(1990-5#1)(1992-5#1)(1993-5#1)(1994-11#1)(1996-2#2)(1996-9#1)(1997-8#1)(2007-12#3)(2007-5#2)(2007-9#3)(2008-11#2)(2008-3#2)(2008-6#1)(2008-7#3)(2009-9#2)(2010-4#1)(2010-6#1)(2012-1#1)(2012-2#1)
the sense or##2##3##(1995-2#1)(2008-10#1)
the sense##70##2##(1990-11#1)(1990-5#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-5#1)(1994-10#1)(1994-11#3)(1995-10#1)(1995-12#1)(1995-2#2)(1996-2#2)(1996-4#1)(1996-6#1)(1996-9#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#1)(2006-12#2)(2007-12#3)(2007-5#2)(2007-9#4)(2008-1#3)(2008-10#1)(2008-11#3)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#1)(2009-9#2)(2010-3#2)(2010-4#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
the sensibility##4##2##(1993-10#1)(1995-1#1)(2008-10#2)
the sensilla##6##2##(2007-12#6)
the sensillum##6##2##(2005-10#1)(2007-12#3)(2008-7#1)(2010-11#1)
the sensillum-lymph##2##2##(2007-12#1)(2008-7#1)
the sensing channel##2##3##(2009-5#2)
the sensing element##4##3##(2007-9#2)(2008-1#1)(2008-3#1)
the sensing elements##2##3##(2008-10#2)
the sensing head##2##3##(2008-2#2)
the sensing layer##2##3##(2008-10#1)(2010-5#1)
the sensing material and##2##4##(2008-10#2)
the sensing material##4##3##(2007-8#1)(2008-10#3)
the sensing mechanism of##2##4##(2007-8#1)(2009-3#1)
the sensing mechanism##3##3##(2007-8#1)(2008-10#1)(2009-3#1)
the sensing membrane##2##3##(2008-10#1)(2010-2#1)
the sensing molecules##2##3##(2013-8#2)
the sensing of##3##3##(2008-10#2)(2008-3#1)
the sensing phase##3##3##(2008-10#3)
the sensing surface##5##3##(2007-8#1)(2008-10#1)(2008-4#3)
the sensing system##6##3##(2008-10#1)(2008-2#3)(2008-3#2)
the sensing##66##2##(2007-11#2)(2007-8#5)(2007-9#3)(2008-1#1)(2008-10#31)(2008-2#5)(2008-3#6)(2008-4#3)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#2)(2010-2#1)(2010-5#1)(2011-1#1)(2013-8#2)
the sensitiser##2##2##(2007-11#1)(2008-10#1)
the sensitive and resistant##2##4##(1991-12#2)
the sensitive and##10##3##(1990-8#1)(1991-12#2)(1993-2#1)(1995-6#1)(2008-10#3)(2010-5#1)(2012-2#1)
the sensitive cell line##2##4##(1997-1#1)(2008-11#1)
the sensitive cells##2##3##(1992-2#2)
the sensitive detection of##6##4##(1993-2#1)(2007-12#1)(2008-10#2)(2008-3#1)(2010-12#1)
the sensitive detection##7##3##(1993-2#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2010-12#1)
the sensitive determination of##11##4##(1992-3#1)(1993-2#1)(2007-8#1)(2008-10#7)(2008-2#1)
the sensitive membrane##2##3##(2008-10#2)
the sensitive period##3##3##(1992-9#1)(1996-6#1)(2007-5#1)
the sensitive##69##2##(1990-8#1)(1991-10#1)(1991-12#2)(1992-12#1)(1992-2#3)(1992-3#1)(1992-9#2)(1993-2#3)(1994-3#1)(1995-1#1)(1995-6#2)(1996-12#1)(1996-6#1)(1997-1#1)(1997-7#1)(2007-12#1)(2007-5#1)(2007-8#3)(2008-10#22)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#4)(2009-2#1)(2009-3#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#3)
the sensitivities for##3##3##(1990-8#2)(2008-10#1)
the sensitivities of reflectance and path length to scattering variations in a diffusive medium##2##14##(2008-3#2)
the sensitivities of the##5##4##(1995-7#1)(2004-4#1)(2007-2#1)(2008-10#2)
the sensitivities of##18##3##(1990-7#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-7#2)(1995-8#1)(2004-4#1)(2007-2#1)(2008-10#4)(2008-3#4)(2008-7#1)
the sensitivities to##2##3##(1991-10#1)(2007-11#1)
the sensitivities were##2##3##(2008-3#1)(2011-1#1)
the sensitivities##30##2##(1990-7#1)(1990-8#2)(1991-10#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-7#2)(1995-8#1)(2004-4#1)(2007-11#1)(2007-2#1)(2008-10#6)(2008-3#7)(2008-7#1)(2011-1#3)
the sensitivity analysis##2##3##(1991-2#1)(2012-3#1)
the sensitivity and limits of detection##2##6##(2008-10#2)
the sensitivity and selectivity of##2##5##(2007-8#1)(2008-10#1)
the sensitivity and selectivity##4##4##(2007-8#1)(2008-10#3)
the sensitivity and specificity estimates obtained by##2##7##(1996-8#1)(1997-6#1)
the sensitivity and specificity of the##11##6##(1994-11#1)(1997-3#1)(1997-4#1)(2006-10#2)(2007-12#1)(2008-10#1)(2011-1#2)(2012-12#1)(2012-2#1)
the sensitivity and specificity of this##2##6##(1990-9#1)(2007-2#1)
the sensitivity and specificity of##22##5##(1990-9#1)(1992-8#1)(1994-11#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-10#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
the sensitivity and specificity##29##4##(1990-10#1)(1990-9#1)(1992-8#1)(1994-11#1)(1996-8#2)(1997-3#1)(1997-4#1)(1997-6#2)(2006-10#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-4#2)(2010-12#1)(2011-1#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
the sensitivity and the specificity##3##5##(1992-8#1)(2010-6#1)(2013-1#1)
the sensitivity and the##5##4##(1992-8#1)(2007-12#1)(2008-10#1)(2010-6#1)(2013-1#1)
the sensitivity and##57##3##(1990-10#1)(1990-9#1)(1992-8#2)(1993-3#1)(1994-11#1)(1995-12#1)(1996-8#2)(1997-3#1)(1997-4#1)(1997-6#2)(2006-10#2)(2006-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#13)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#2)(2009-8#1)(2010-12#2)(2010-2#1)(2010-6#1)(2011-1#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
the sensitivity by a factor of##2##6##(2008-10#2)
the sensitivity by##6##3##(1994-6#1)(2008-10#5)
the sensitivity can##2##3##(2008-10#1)(2008-3#1)
the sensitivity enhancement##2##3##(2008-10#2)
the sensitivity for##9##3##(1991-12#1)(1993-2#1)(1996-5#1)(2005-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-1#1)
the sensitivity from##2##3##(2008-10#2)
the sensitivity in##4##3##(1997-3#1)(2008-1#1)(2008-10#2)
the sensitivity is##6##3##(1990-4#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)
the sensitivity of Escherichia coli to##2##6##(1990-5#1)(1997-3#1)
the sensitivity of FNAB##2##4##(2004-2#2)
the sensitivity of UV##2##4##(1991-8#1)(2007-8#1)
the sensitivity of a##10##4##(1994-2#1)(1995-12#1)(1995-4#1)(1995-6#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#1)
the sensitivity of an##3##4##(2008-1#2)(2011-2#1)
the sensitivity of both##3##4##(1997-7#1)(2008-4#1)(2008-8#1)
the sensitivity of cancer cells to##2##6##(1994-2#1)(2008-11#1)
the sensitivity of detection##3##4##(2005-12#1)(2006-10#1)(2008-10#1)
the sensitivity of determination##2##4##(2005-4#1)(2011-1#1)
the sensitivity of human##2##4##(1997-7#1)(2008-5#1)
the sensitivity of measurement##2##4##(2008-3#1)(2008-4#1)
the sensitivity of melanoma cells to##2##6##(2009-4#2)
the sensitivity of neural responses##2##5##(2008-11#2)
the sensitivity of results to the##2##6##(2008-3#1)(2008-8#1)
the sensitivity of the ELISA##2##5##(1990-12#1)(2005-9#1)
the sensitivity of the SPR##2##5##(2008-10#2)
the sensitivity of the assay##2##5##(1990-12#1)(1993-11#1)
the sensitivity of the detection##2##5##(1997-4#1)(2008-10#1)
the sensitivity of the electrode##2##5##(2008-10#2)
the sensitivity of the method to##2##6##(1990-12#1)(2008-3#1)
the sensitivity of the method##17##5##(1990-12#2)(1996-12#1)(1997-8#1)(2008-10#11)(2008-3#1)(2008-5#1)
the sensitivity of the methods##2##5##(1990-6#1)(2008-10#1)
the sensitivity of the retrieval##2##5##(2007-12#1)(2008-3#1)
the sensitivity of the sensor##4##5##(2008-10#2)(2008-2#2)
the sensitivity of the system##3##5##(2008-11#1)(2008-2#1)(2012-2#1)
the sensitivity of the tumor##2##5##(2011-1#1)(2012-3#1)
the sensitivity of the two##3##5##(1991-6#1)(1996-9#1)(2007-12#1)
the sensitivity of the##116##4##(1990-12#6)(1990-6#1)(1990-8#1)(1991-6#1)(1992-4#1)(1993-1#1)(1993-11#1)(1993-8#2)(1993-9#1)(1994-4#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-7#1)(1996-12#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-9#1)(2006-5#1)(2007-11#1)(2007-12#5)(2007-7#1)(2007-8#2)(2008-10#33)(2008-11#2)(2008-12#1)(2008-2#10)(2008-3#7)(2008-4#7)(2008-5#3)(2008-8#1)(2008-9#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
the sensitivity of these##5##4##(1990-11#1)(2004-2#1)(2008-10#2)(2010-4#1)
the sensitivity of this##7##4##(1990-4#1)(1991-6#1)(2006-10#1)(2008-10#1)(2008-3#1)(2009-8#1)(2013-1#1)
the sensitivity of##280##3##(1990-11#1)(1990-12#6)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#2)(1991-4#1)(1991-6#2)(1991-8#2)(1992-1#1)(1992-4#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-1#2)(1994-11#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-6#1)(1995-10#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-4#2)(1995-6#2)(1995-7#1)(1996-11#2)(1996-12#3)(1996-3#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#4)(1997-4#4)(1997-5#3)(1997-7#4)(1997-8#1)(2004-2#3)(2005-10#1)(2005-11#2)(2005-12#1)(2005-4#1)(2005-9#1)(2006-10#6)(2006-11#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-12#11)(2007-3#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#4)(2008-10#55)(2008-11#9)(2008-12#1)(2008-2#14)(2008-3#19)(2008-4#10)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#3)(2009-4#2)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-2#2)(2012-3#2)(2012-6#1)(2013-1#1)(2013-7#3)(2013-8#2)
the sensitivity on##3##3##(1990-12#1)(2007-9#1)(2008-5#1)
the sensitivity or the##2##4##(1991-3#1)(2008-3#1)
the sensitivity or##3##3##(1991-3#1)(1993-8#1)(2008-3#1)
the sensitivity required for##3##4##(2008-10#1)(2008-3#1)(2008-8#1)
the sensitivity required##4##3##(2008-10#2)(2008-3#1)(2008-8#1)
the sensitivity to temperature##2##4##(2008-2#1)(2008-7#1)
the sensitivity to the##5##4##(1993-3#1)(1996-5#1)(2008-10#2)(2008-3#1)
the sensitivity to##31##3##(1990-3#1)(1990-5#1)(1992-5#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-3#1)(1997-7#1)(2006-7#1)(2008-10#7)(2008-2#3)(2008-3#5)(2008-7#2)(2012-12#1)
the sensitivity was##8##3##(1990-6#1)(1992-5#1)(1992-7#1)(1996-12#1)(1996-7#1)(2005-8#1)(2008-10#2)
the sensitivity##493##2##(1990-10#1)(1990-11#1)(1990-12#8)(1990-3#1)(1990-4#2)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#2)(1992-1#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#3)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#3)(1993-9#1)(1994-1#2)(1994-11#2)(1994-2#2)(1994-3#2)(1994-4#1)(1994-6#2)(1995-10#2)(1995-11#2)(1995-12#5)(1995-2#2)(1995-3#2)(1995-4#2)(1995-6#3)(1995-7#1)(1996-11#2)(1996-12#4)(1996-3#2)(1996-5#2)(1996-7#2)(1996-8#4)(1996-9#2)(1997-2#1)(1997-3#8)(1997-4#5)(1997-5#3)(1997-6#2)(1997-7#6)(1997-8#1)(2004-2#3)(2005-1#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-3#1)(2005-4#1)(2005-8#1)(2005-9#1)(2006-10#8)(2006-11#2)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-12#18)(2007-2#2)(2007-3#2)(2007-4#1)(2007-7#3)(2007-8#9)(2007-9#3)(2008-1#6)(2008-10#118)(2008-11#9)(2008-12#1)(2008-2#27)(2008-3#34)(2008-4#12)(2008-5#8)(2008-6#1)(2008-7#11)(2008-8#5)(2008-9#4)(2009-1#1)(2009-11#1)(2009-2#1)(2009-4#4)(2009-8#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#3)(2010-9#1)(2011-1#8)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#4)(2012-6#1)(2013-1#3)(2013-7#3)(2013-8#6)
the sensitization phase##2##3##(2005-11#1)(2008-4#1)
the sensitization##12##2##(1991-1#1)(1991-6#2)(1993-3#1)(1996-10#1)(2005-11#1)(2007-10#1)(2007-3#2)(2008-10#1)(2008-4#1)(2010-4#1)
the sensitized and##2##3##(2008-10#2)
the sensitized##11##2##(1990-2#1)(1991-6#2)(1996-10#1)(1997-7#1)(2008-10#6)
the sensitizer##4##2##(1992-1#1)(1992-2#2)(1992-6#1)
the sensitizing agent##2##3##(1990-4#1)(1994-6#1)
the sensitizing effect of##4##4##(2008-10#4)
the sensitizing##10##2##(1990-4#1)(1994-6#1)(1995-11#1)(2007-2#1)(2008-10#5)(2008-3#1)
the sensor and##4##3##(2007-8#1)(2008-2#1)(2008-3#2)
the sensor array##2##3##(2013-1#2)
the sensor by##2##3##(2007-12#1)(2007-8#1)
the sensor can##7##3##(2007-11#1)(2007-8#2)(2008-10#3)(2008-3#1)
the sensor characteristics##3##3##(2007-12#1)(2007-8#1)(2007-9#1)
the sensor chip##9##3##(2007-8#4)(2008-10#5)
the sensor could be##2##4##(2008-10#2)
the sensor could##3##3##(2008-10#3)
the sensor described##2##3##(2008-10#1)(2010-5#1)
the sensor exhibits a##4##4##(2008-10#3)(2008-3#1)
the sensor for##6##3##(2008-10#4)(2008-2#1)(2010-8#1)
the sensor function##2##3##(2008-3#2)
the sensor has##4##3##(2007-11#1)(2007-8#1)(2008-10#2)
the sensor in##2##3##(2008-10#2)
the sensor is##19##3##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-2#1)(2008-3#4)(2009-3#1)(2013-1#2)
the sensor of##2##3##(1990-2#1)(2008-3#1)
the sensor performance##3##3##(2008-2#1)(2008-3#2)
the sensor platform##2##3##(2010-2#2)
the sensor responds##2##3##(2008-10#2)
the sensor response of##2##4##(2007-8#1)(2008-10#1)
the sensor response to##2##4##(2008-10#2)
the sensor response##14##3##(1996-7#1)(2007-8#2)(2008-10#9)(2008-3#1)(2010-5#1)
the sensor sensitivity##2##3##(2008-10#2)
the sensor showed##2##3##(2008-10#2)
the sensor signal##2##3##(2008-10#2)
the sensor signals##2##3##(2007-11#1)(2008-10#1)
the sensor surface and##2##4##(1997-2#1)(2008-5#1)
the sensor surface##9##3##(1997-2#1)(2008-10#7)(2008-5#1)
the sensor system was##3##4##(2008-10#2)(2008-7#1)
the sensor system##7##3##(2007-8#1)(2008-10#5)(2008-7#1)
the sensor tip##2##3##(2008-10#2)
the sensor was found to be##2##6##(2008-10#2)
the sensor was##18##3##(1996-7#1)(2007-11#1)(2008-10#15)(2008-7#1)
the sensor when##2##3##(2007-11#1)(2008-10#1)
the sensor while##2##3##(2008-10#1)(2008-2#1)
the sensor##225##2##(1990-2#1)(1993-12#1)(1996-7#2)(1997-2#1)(1997-4#1)(2004-9#1)(2007-11#12)(2007-12#4)(2007-5#1)(2007-8#15)(2007-9#1)(2008-10#124)(2008-2#10)(2008-3#26)(2008-5#1)(2008-7#2)(2009-11#1)(2009-3#2)(2009-9#2)(2010-12#1)(2010-2#5)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#6)
the sensor's##3##2##(2008-10#1)(2008-2#2)
the sensor-measured radiances##2##3##(2008-2#2)
the sensorial##4##2##(2006-8#1)(2010-4#1)(2011-1#1)(2011-2#1)
the sensorimotor and##2##3##(2007-10#1)(2012-12#1)
the sensorimotor cortex##5##3##(1991-9#1)(1992-10#1)(1995-11#1)(1995-12#1)(1996-2#1)
the sensorimotor##12##2##(1991-9#1)(1992-10#1)(1992-11#1)(1993-11#1)(1993-12#1)(1995-11#1)(1995-12#1)(1996-2#1)(2007-10#1)(2007-8#1)(2012-1#1)(2012-12#1)
the sensorineural hearing loss##2##4##(2008-9#1)(2012-2#1)
the sensors coated with##2##4##(2008-10#2)
the sensors were##2##3##(2008-10#2)
the sensors##18##2##(1994-11#1)(2008-10#13)(2008-2#1)(2008-3#1)(2008-5#1)(2010-9#1)
the sensory and motor##2##4##(2006-3#1)(2008-7#1)
the sensory and##4##3##(1990-7#1)(2006-3#1)(2008-7#1)(2012-2#1)
the sensory discharge##2##3##(1993-12#2)
the sensory ecology of##2##4##(2007-12#2)
the sensory nervous system of the antenna##2##7##(2007-12#2)
the sensory neurons##2##3##(1996-9#1)(2008-11#1)
the sensory organ##3##3##(1993-12#2)(2008-5#1)
the sensory properties of##2##4##(2008-10#1)(2011-2#1)
the sensory quality##3##3##(2010-4#3)
the sensory structures##2##3##(1994-8#1)(1996-3#1)
the sensory system##6##3##(1990-11#1)(2008-10#2)(2009-2#1)(2013-8#2)
the sensory traits##2##3##(2013-1#2)
the sensory##86##2##(1990-10#1)(1990-11#1)(1990-5#1)(1990-7#1)(1992-4#1)(1993-11#1)(1993-12#8)(1993-2#1)(1994-8#1)(1996-1#1)(1996-3#4)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#4)(2006-10#4)(2006-11#1)(2006-3#2)(2007-1#1)(2007-12#11)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-4#6)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#3)
the sentence##6##2##(2007-4#1)(2008-2#1)(2008-4#1)(2010-7#1)(2013-1#2)
the sentinel lymph node##3##4##(2006-6#1)(2008-8#1)(2011-1#1)
the sentinel sheep##3##3##(1997-6#3)
the sentinel##12##2##(1997-6#4)(2005-12#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-8#2)(2010-9#1)(2011-1#1)
the separability of##2##3##(2007-12#1)(2008-3#1)
the separate and combined##2##4##(2008-6#1)(2008-9#1)
the separate columns##2##3##(1990-11#2)
the separate components##2##3##(1995-5#2)
the separate determination of##2##4##(1992-1#1)(1995-4#1)
the separate##31##2##(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#1)(1992-1#1)(1992-8#1)(1994-9#1)(1995-4#1)(1995-5#2)(1997-8#2)(2006-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#2)(2009-2#1)(2009-6#1)(2011-7#1)(2013-7#2)
the separate-monitor method##3##3##(2010-9#3)
the separate-monitor##4##2##(2010-9#4)
the separated fractions##4##3##(1992-9#1)(2008-10#3)
the separated##14##2##(1992-9#1)(1996-2#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-8#1)(2010-5#1)(2010-7#1)
the separately##4##2##(1995-5#2)(2007-12#1)(2011-3#1)
the separation and detection of##5##5##(1997-1#1)(2008-10#4)
the separation and detection##11##4##(1997-1#1)(2008-10#9)(2008-12#1)
the separation and determination of##19##5##(1990-8#1)(1990-9#1)(2008-10#15)(2012-12#1)(2013-8#1)
the separation and determination##20##4##(1990-8#1)(1990-9#1)(2008-10#16)(2012-12#1)(2013-8#1)
the separation and enrichment of##2##5##(2008-10#1)(2013-8#1)
the separation and identification of##2##5##(1991-8#1)(1996-6#1)
the separation and identification##3##4##(1991-8#1)(1996-6#1)(2008-12#1)
the separation and preconcentration of copper(II)##2##6##(2008-10#2)
the separation and preconcentration of the##2##6##(2008-10#2)
the separation and preconcentration of##14##5##(2008-10#14)
the separation and preconcentration##15##4##(2008-10#15)
the separation and quantitation of##2##5##(1997-2#1)(2008-10#1)
the separation and the##3##4##(2008-10#2)(2008-5#1)
the separation and##71##3##(1990-8#1)(1990-9#1)(1991-5#1)(1991-8#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-8#3)(2008-10#51)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2012-12#1)(2013-8#3)
the separation between the##10##4##(1996-5#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#2)(2008-6#1)(2009-2#1)
the separation between##16##3##(1992-2#1)(1996-5#1)(2005-12#2)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#3)(2008-6#1)(2009-2#1)
the separation capillary##2##3##(2008-10#2)
the separation channel##4##3##(2007-8#1)(2008-10#3)
the separation column##2##3##(2008-10#2)
the separation conditions and##2##4##(1990-8#1)(2008-10#1)
the separation conditions##3##3##(1990-8#1)(2008-10#2)
the separation distance between the##2##5##(2005-11#1)(2008-2#1)
the separation distance between##3##4##(2005-11#1)(2008-2#2)
the separation distance was##2##4##(2005-11#1)(2013-1#1)
the separation distance##7##3##(2005-11#3)(2008-2#3)(2013-1#1)
the separation efficiency##4##3##(1991-3#1)(1996-5#1)(2008-10#1)(2011-1#1)
the separation factor##4##3##(2005-11#1)(2005-12#1)(2008-10#2)
the separation factors##2##3##(2005-12#1)(2008-10#1)
the separation mechanism##3##3##(1996-5#1)(1996-8#1)(2011-2#1)
the separation of DNA fragments##3##5##(2008-10#1)(2008-2#1)(2008-4#1)
the separation of a##3##4##(1996-8#1)(2008-10#2)
the separation of anions##2##4##(2005-12#1)(2008-10#1)
the separation of basic compounds##2##5##(2008-10#2)
the separation of basic##3##4##(1990-8#1)(2008-10#2)
the separation of catalytic trimers##2##5##(1990-9#2)
the separation of electrically neutral##2##5##(1996-5#1)(2010-7#1)
the separation of eprosartan##2##4##(2008-10#2)
the separation of neutral##2##4##(2008-10#2)
the separation of seven##3##4##(1990-8#1)(1996-5#1)(2008-10#1)
the separation of six##2##4##(2008-10#2)
the separation of some##2##4##(1996-5#1)(2008-10#1)
the separation of the solutes##2##5##(2012-12#2)
the separation of the three##2##5##(2008-10#2)
the separation of the##25##4##(1991-9#1)(1996-5#1)(1997-6#1)(1997-8#1)(2005-12#2)(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#12)(2008-3#2)(2012-12#2)
the separation of these##3##4##(1991-11#1)(2008-10#1)(2008-7#1)
the separation of two##3##4##(1991-11#1)(1997-7#1)(2007-11#1)
the separation of##197##3##(1990-11#2)(1990-6#1)(1990-8#4)(1990-9#3)(1991-11#4)(1991-12#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-8#1)(1994-9#6)(1995-6#1)(1995-7#2)(1996-5#10)(1996-8#2)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#3)(2005-11#1)(2005-12#5)(2005-4#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#2)(2007-1#1)(2007-11#3)(2007-12#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#89)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#5)(2008-5#1)(2008-7#2)(2008-9#2)(2010-7#2)(2011-1#1)(2012-12#4)(2013-8#4)
the separation performance##2##3##(2006-2#1)(2007-8#1)
the separation procedure##2##3##(1994-9#1)(2008-10#1)
the separation process##4##3##(1992-1#1)(2005-12#1)(2008-10#2)
the separation surgery of##2##4##(2013-1#2)
the separation system##2##3##(2008-7#1)(2012-1#1)
the separation was##4##3##(1991-3#1)(1996-5#1)(2008-10#2)
the separation##368##2##(1990-11#2)(1990-6#1)(1990-8#6)(1990-9#4)(1991-11#4)(1991-12#1)(1991-3#3)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#2)(1993-12#1)(1993-2#2)(1993-4#1)(1993-8#1)(1994-9#7)(1995-3#1)(1995-6#1)(1995-7#2)(1996-5#19)(1996-6#1)(1996-8#3)(1997-1#2)(1997-2#2)(1997-6#1)(1997-7#1)(1997-8#7)(2005-11#5)(2005-12#10)(2005-4#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#2)(2006-6#1)(2007-1#1)(2007-11#4)(2007-12#3)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#176)(2008-11#3)(2008-12#3)(2008-2#10)(2008-3#9)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#4)(2008-9#3)(2009-2#1)(2010-5#1)(2010-7#3)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#5)(2013-1#4)(2013-7#1)(2013-8#7)
the separation-of-variables method##2##3##(2008-3#2)
the separations##5##2##(1990-9#1)(1991-3#1)(2008-10#2)(2008-4#1)
the septa were##3##3##(2008-7#3)
the septal##7##2##(1991-6#1)(1994-12#1)(1994-2#1)(2006-9#1)(2007-8#1)(2010-11#1)(2012-2#1)
the septal-preoptic area##2##3##(1993-2#1)(1995-12#1)
the septic##2##2##(1996-3#1)(2009-4#1)
the septohippocampal##5##2##(1993-11#1)(1993-12#3)(1997-6#1)
the septum and amygdala##2##4##(1991-3#2)
the septum and##6##3##(1991-3#2)(1991-5#2)(1994-12#1)(2008-10#1)
the septum##26##2##(1991-3#3)(1991-5#5)(1991-8#1)(1992-8#1)(1994-12#1)(1994-2#3)(1994-8#1)(1996-12#2)(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#2)(2008-9#1)(2013-1#1)
the sequelae of##11##3##(1990-3#1)(1996-3#1)(2004-3#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-3#1)(2008-9#1)(2012-3#1)(2013-1#2)
the sequelae##14##2##(1990-10#1)(1990-3#1)(1996-3#1)(1997-2#1)(2004-3#1)(2006-10#1)(2006-9#1)(2007-11#2)(2008-3#1)(2008-9#1)(2012-3#1)(2013-1#2)
the sequence alignment##4##3##(1992-12#1)(1992-8#1)(2008-4#1)(2008-7#1)
the sequence analysis of the##3##5##(1992-12#1)(1995-1#1)(2008-10#1)
the sequence analysis of##8##4##(1992-12#1)(1994-6#1)(1995-1#1)(1997-3#1)(2008-10#2)(2008-4#1)(2008-8#1)
the sequence analysis##11##3##(1991-12#1)(1992-11#1)(1992-12#1)(1994-6#1)(1995-1#1)(1997-3#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)
the sequence and expression##2##4##(1992-9#1)(2012-2#1)
the sequence and primer##4##4##(2008-2#1)(2008-4#2)(2008-9#1)
the sequence and structural##2##4##(1996-8#1)(2012-3#1)
the sequence and##10##3##(1992-9#1)(1996-8#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-9#1)(2010-2#1)(2012-2#1)(2012-3#1)
the sequence are##2##3##(1991-6#1)(1992-12#1)
the sequence at##2##3##(1991-11#1)(2008-5#1)
the sequence between##2##3##(1991-3#1)(1992-5#1)
the sequence by which##2##4##(1991-11#1)(2008-10#1)
the sequence context of##2##4##(1995-1#1)(2008-4#1)
the sequence context##4##3##(1995-1#1)(1996-7#1)(2008-4#1)(2010-1#1)
the sequence data##5##3##(1990-3#1)(2005-8#1)(2008-10#2)(2008-7#1)
the sequence database##2##3##(1994-2#1)(2008-4#1)
the sequence differences##2##3##(1994-6#1)(2011-12#1)
the sequence encoding a##2##4##(1991-12#1)(1995-8#1)
the sequence encoding the##4##4##(1990-11#1)(1995-8#1)(1997-7#2)
the sequence encoding##8##3##(1990-11#1)(1991-12#1)(1995-8#2)(1997-7#2)(2008-11#1)(2008-8#1)
the sequence features##2##3##(1995-5#1)(1996-8#1)
the sequence for##2##3##(1992-12#1)(2008-4#1)
the sequence from the##3##4##(1990-7#1)(2008-10#1)(2008-8#1)
the sequence from##8##3##(1990-7#1)(1990-8#1)(1992-9#1)(1995-1#1)(1997-7#1)(2008-10#1)(2008-8#1)(2011-2#1)
the sequence had##2##3##(1994-12#1)(1996-5#1)
the sequence homologous##3##3##(1991-3#1)(2008-10#1)(2011-1#1)
the sequence homology##4##3##(1992-2#1)(1993-11#1)(1995-2#1)(2008-9#1)
the sequence in the##2##4##(1996-8#1)(1997-6#1)
the sequence in##3##3##(1996-8#1)(1997-3#1)(1997-6#1)
the sequence motif##2##3##(1991-2#1)(2012-2#1)
the sequence of a##15##4##(1990-10#1)(1990-11#1)(1990-2#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-6#2)(1994-6#1)(1995-6#1)(1997-1#1)(1997-3#2)(2008-10#2)
the sequence of all##2##4##(1990-2#1)(2008-4#1)
the sequence of events leading##2##5##(1990-9#1)(1993-8#1)
the sequence of events that##2##5##(1991-3#1)(2008-10#1)
the sequence of events##7##4##(1990-9#1)(1991-3#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-3#1)
the sequence of nucleotides##8##4##(1992-5#1)(1992-8#1)(1993-4#3)(1994-5#2)(1995-2#1)
the sequence of one##3##4##(1990-11#1)(1990-12#1)(1990-5#1)
the sequence of operations##2##4##(2007-11#2)
the sequence of reactions##2##4##(1991-6#1)(1994-8#1)
the sequence of the 16S rRNA gene##2##7##(2008-10#2)
the sequence of the mature##2##5##(1994-12#2)
the sequence of the##46##4##(1990-4#1)(1990-5#2)(1990-7#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-12#3)(1994-8#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(2007-12#1)(2008-10#10)(2008-4#3)(2008-5#1)(2008-8#1)(2012-12#2)(2013-1#1)
the sequence of which##4##4##(1990-11#1)(1990-7#1)(1993-2#1)(1994-8#1)
the sequence of##150##3##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#3)(1990-5#3)(1990-6#1)(1990-7#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#3)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#2)(1993-2#2)(1993-4#3)(1993-6#4)(1993-8#2)(1994-11#2)(1994-12#5)(1994-5#2)(1994-6#1)(1994-8#4)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-11#2)(2005-7#1)(2007-11#3)(2007-12#3)(2007-9#1)(2008-10#18)(2008-11#2)(2008-3#1)(2008-4#7)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2010-4#1)(2010-6#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#1)
the sequence predicts##2##3##(1994-9#1)(1995-8#1)
the sequence recognized by##2##4##(1990-11#1)(1994-6#1)
the sequence reported##2##3##(1995-5#1)(2008-9#1)
the sequence shows##2##3##(1991-3#1)(1995-2#1)
the sequence similarity##3##3##(1994-6#1)(2008-10#1)(2012-2#1)
the sequence specificity of##2##4##(1993-6#1)(1997-2#1)
the sequence specificity requirements for##2##5##(1994-8#2)
the sequence specificity##6##3##(1992-11#1)(1993-6#1)(1994-8#2)(1997-2#1)(2008-11#1)
the sequence surrounding##2##3##(1990-3#1)(1997-2#1)
the sequence tagged site##2##4##(1994-12#1)(2008-10#1)
the sequence variation##2##3##(1996-6#1)(2009-8#1)
the sequence was##6##3##(1991-9#2)(1992-11#2)(1996-6#1)(2008-8#1)
the sequence##382##2##(1990-10#2)(1990-11#6)(1990-12#4)(1990-2#4)(1990-3#3)(1990-4#3)(1990-5#3)(1990-6#2)(1990-7#5)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#3)(1991-12#4)(1991-2#4)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#3)(1991-7#4)(1991-9#6)(1992-10#2)(1992-11#7)(1992-12#6)(1992-2#4)(1992-3#2)(1992-4#3)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#6)(1992-9#7)(1993-11#4)(1993-2#2)(1993-4#4)(1993-5#1)(1993-6#8)(1993-8#4)(1993-9#3)(1994-11#2)(1994-12#11)(1994-2#1)(1994-5#3)(1994-6#6)(1994-8#6)(1994-9#3)(1995-1#5)(1995-10#1)(1995-12#1)(1995-2#4)(1995-3#4)(1995-4#2)(1995-5#2)(1995-6#3)(1995-8#7)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#2)(1996-6#3)(1996-7#1)(1996-8#5)(1996-9#1)(1997-1#2)(1997-2#7)(1997-3#5)(1997-4#3)(1997-5#2)(1997-6#4)(1997-7#6)(1997-8#2)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-11#3)(2007-12#4)(2007-6#2)(2007-9#1)(2008-1#1)(2008-10#31)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#16)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#8)(2008-9#6)(2009-10#1)(2009-11#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#2)(2013-8#3)
the sequence-specific##4##2##(1992-3#1)(2008-10#1)(2008-4#1)(2008-7#1)
the sequenced clones##2##3##(1996-10#1)(1997-4#1)
the sequenced##14##2##(1991-1#1)(1993-11#2)(1995-8#1)(1996-10#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#3)(2008-7#1)(2008-8#1)(2012-2#1)
the sequences are##3##3##(1992-3#1)(1992-6#1)(2008-8#1)
the sequences around##2##3##(1992-11#1)(1997-2#1)
the sequences coding for##2##4##(1990-5#1)(1996-6#1)
the sequences encoding the##2##4##(1996-10#1)(2008-9#1)
the sequences in##3##3##(1996-2#1)(1997-6#1)(1997-8#1)
the sequences obtained##2##3##(1990-9#1)(2012-12#1)
the sequences of 40##2##4##(1995-8#1)(1996-2#1)
the sequences of the rat##3##5##(1994-9#1)(1995-3#1)(2008-9#1)
the sequences of the two##2##5##(1990-7#1)(1993-3#1)
the sequences of the##20##4##(1990-4#1)(1990-7#1)(1991-2#1)(1991-7#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-6#1)(1997-4#1)(1997-5#1)(2005-9#1)(2008-4#1)(2008-9#1)(2010-5#1)
the sequences of##43##3##(1990-4#1)(1990-7#1)(1991-2#1)(1991-6#1)(1991-7#2)(1992-2#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-3#1)(1995-8#2)(1996-10#2)(1996-2#2)(1996-6#2)(1996-7#1)(1997-4#1)(1997-5#2)(1997-8#2)(2005-9#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-4#1)(2010-5#1)
the sequences were##6##3##(1991-8#1)(1993-11#1)(1995-8#1)(2006-8#1)(2008-10#1)(2008-8#1)
the sequences which##3##3##(1991-6#1)(1992-7#1)(1993-5#1)
the sequences with##3##3##(1997-4#1)(2008-10#1)(2011-3#1)
the sequences within##2##3##(1995-6#1)(1997-3#1)
the sequences##116##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-7#4)(1990-8#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#2)(1992-9#1)(1993-11#3)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#3)(1994-3#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#4)(1996-10#3)(1996-2#3)(1996-6#3)(1996-7#3)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#3)(2005-9#1)(2006-10#1)(2006-12#1)(2006-8#1)(2008-10#5)(2008-4#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#1)
the sequencing and identification on##2##5##(1994-5#1)(1994-9#1)
the sequencing and##5##3##(1994-5#1)(1994-9#1)(2009-10#1)(2012-2#1)(2012-3#1)
the sequencing of the human genome##3##6##(2005-7#1)(2008-4#2)
the sequencing of the##8##4##(1992-8#1)(1995-12#1)(2005-7#1)(2008-1#1)(2008-4#2)(2008-7#1)(2010-8#1)
the sequencing of this##2##4##(1990-12#1)(2008-8#1)
the sequencing of##16##3##(1990-1#2)(1990-12#1)(1992-8#1)(1995-12#1)(2005-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-7#2)(2008-8#1)(2010-8#1)
the sequencing##30##2##(1990-1#2)(1990-12#1)(1990-9#1)(1992-8#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-7#1)(1996-4#2)(2005-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#4)(2008-7#3)(2008-8#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)
the sequential activation of##2##4##(1995-2#1)(2007-9#1)
the sequential analysis of##2##4##(1996-4#1)(2008-10#1)
the sequential and##2##3##(1993-3#1)(2008-10#1)
the sequential determination of ammonium and nitrate##2##7##(2008-10#2)
the sequential determination of##6##4##(2008-10#6)
the sequential expression of##2##4##(1995-8#1)(2012-2#1)
the sequential injection analysis##3##4##(2007-8#1)(2008-10#1)(2008-5#1)
the sequential injection system##2##4##(2008-10#2)
the sequential injection##14##3##(2007-8#1)(2008-10#12)(2008-5#1)
the sequential methylation of##2##4##(1994-8#2)
the sequential probability ratio test##2##5##(2008-10#2)
the sequential separation of##2##4##(2008-10#2)
the sequential simplex##2##3##(2008-10#2)
the sequential structure of##2##4##(2008-11#2)
the sequential use of##2##4##(2008-12#1)(2010-12#1)
the sequential##83##2##(1990-2#1)(1991-7#1)(1992-1#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-8#3)(1995-2#2)(1995-4#2)(1995-8#1)(1996-4#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#2)(2004-12#1)(2007-11#2)(2007-12#2)(2007-8#2)(2007-9#2)(2008-10#33)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#4)(2008-5#2)(2010-12#2)(2010-5#1)(2011-2#2)(2012-2#2)
the sequestered##2##2##(2007-8#1)(2013-1#1)
the sequestering##4##2##(2008-10#1)(2008-3#1)(2008-5#1)(2009-7#1)
the sequestration of##4##3##(1995-11#1)(1996-4#1)(2010-1#1)(2012-12#1)
the sera from##9##3##(1991-5#1)(1992-3#1)(1993-10#1)(1994-3#3)(1997-3#1)(2008-8#1)(2013-8#1)
the sera of 11##2##4##(1991-8#1)(1996-4#1)
the sera of the##4##4##(1991-9#1)(1994-3#1)(1997-4#1)(2008-8#1)
the sera of##27##3##(1990-1#1)(1990-11#1)(1990-12#2)(1991-8#1)(1991-9#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#1)(1994-2#1)(1994-3#4)(1995-4#1)(1996-10#1)(1996-4#1)(1997-4#1)(2005-8#1)(2006-9#1)(2007-7#1)(2008-7#1)(2008-8#1)(2011-12#1)(2013-8#1)
the sera tested by##2##4##(1997-3#1)(2005-9#1)
the sera using##2##3##(2007-8#1)(2008-10#1)
the sera##46##2##(1990-1#1)(1990-11#1)(1990-12#3)(1991-5#2)(1991-8#1)(1991-9#1)(1992-3#2)(1992-8#1)(1993-1#1)(1993-10#2)(1993-11#1)(1993-2#1)(1994-2#1)(1994-3#7)(1995-4#1)(1996-10#1)(1996-4#2)(1997-3#2)(1997-4#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#3)(2011-12#1)(2013-8#2)
the serendipitous##3##2##(1994-11#1)(2006-10#1)(2008-7#1)
the serial##16##2##(1990-11#1)(1991-12#1)(1991-6#1)(1992-2#1)(1992-6#1)(1993-8#1)(1995-12#1)(2005-12#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-6#1)(2010-1#1)(2012-1#1)
the serial-transfer##3##2##(1997-6#3)
the seric##2##2##(1991-7#1)(2008-10#1)
the series are##3##3##(1992-2#1)(2005-8#1)(2008-3#1)
the series of complexes##2##4##(1996-2#1)(2008-3#1)
the series of experiments##2##4##(2008-7#1)(2011-2#1)
the series of##17##3##(1992-1#1)(1992-11#1)(1993-4#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-7#1)(2004-9#1)(2005-11#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-3#1)(2011-2#1)
the series on##2##3##(1992-12#1)(2008-1#1)
the series was##2##3##(1990-2#1)(2011-2#1)
the series with##2##3##(1993-3#1)(1995-5#1)
the series##71##2##(1990-12#2)(1990-2#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-4#1)(1992-9#2)(1993-3#1)(1993-4#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-7#2)(2004-10#2)(2004-9#1)(2005-11#1)(2005-8#1)(2007-11#4)(2007-2#1)(2008-1#1)(2008-10#4)(2008-3#4)(2008-4#5)(2008-5#1)(2008-7#5)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-11#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-1#2)
the series-expansion method##2##3##(2008-2#2)
the series-expansion##3##2##(2008-2#3)
the serine and##2##3##(1992-12#1)(2009-10#1)
the serine phosphorylation of##2##4##(1996-5#1)(2008-4#1)
the serine protease domain##2##4##(1995-6#2)
the serine protease thrombin##2##4##(1994-12#1)(1996-8#1)
the serine protease##11##3##(1991-4#1)(1993-3#1)(1994-12#2)(1995-6#2)(1995-8#1)(1996-8#1)(1997-4#1)(2006-10#1)(2008-11#1)
the serine proteases##2##3##(1991-6#1)(1993-11#1)
the serine proteinase##5##3##(1990-5#1)(1992-7#1)(1993-3#1)(1995-6#1)(1996-5#1)
the serine receptor##2##3##(1994-5#2)
the serine residues in##2##4##(1992-11#1)(1994-9#1)
the serine residues##3##3##(1992-11#1)(1994-11#1)(1994-9#1)
the serine##40##2##(1990-5#2)(1990-7#2)(1991-4#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-7#1)(1993-11#1)(1993-3#2)(1993-5#1)(1994-11#1)(1994-12#2)(1994-5#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#3)(1995-8#1)(1996-5#3)(1996-8#1)(1997-1#1)(1997-4#1)(2006-1#1)(2006-10#2)(2008-11#1)(2008-4#1)(2009-10#1)(2009-8#1)
the serine-threonine kinase Pak1##2##4##(1996-8#2)
the serine/threonine kinase##5##3##(1994-12#1)(1994-9#1)(1996-2#1)(1997-7#1)(2009-3#1)
the serine/threonine protein##2##3##(1991-2#1)(1994-11#1)
the serine/threonine##9##2##(1991-2#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-9#1)(1996-2#1)(1997-7#1)(2006-5#1)(2009-3#1)
the serious##18##2##(1990-6#1)(1994-2#1)(1995-8#1)(2005-11#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-11#1)(2008-3#1)(2009-6#2)(2010-7#1)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
the seriously##2##2##(1990-12#1)(2011-2#1)
the seriousness of the##4##4##(1990-3#1)(2008-2#1)(2011-2#1)(2013-1#1)
the seriousness of##9##3##(1990-3#1)(1995-6#1)(1997-5#1)(2006-8#1)(2008-2#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
the seroconversion##2##2##(1991-3#1)(2008-8#1)
the serodiagnosis of##3##3##(1996-12#1)(2007-7#1)(2008-5#1)
the serogroup Y##3##3##(2007-12#3)
the serogroup##5##2##(2007-12#3)(2008-5#1)(2012-2#1)
the serologic##2##2##(1997-8#1)(2006-10#1)
the serological diagnosis of##2##4##(1991-5#1)(1996-11#1)
the serological methods##2##3##(1995-12#1)(2008-4#1)
the serological##15##2##(1991-5#1)(1991-9#1)(1993-6#1)(1993-8#1)(1995-12#1)(1995-2#1)(1996-11#1)(1997-8#1)(2006-10#1)(2007-2#1)(2008-10#3)(2008-4#1)(2010-4#1)
the seronegative##5##2##(1994-6#1)(1995-9#1)(2006-4#1)(2012-2#2)
the seropositive##3##2##(1994-6#1)(2008-3#1)(2011-2#1)
the seroprevalence of brucellosis##2##4##(2007-2#2)
the seroprevalence of##7##3##(2006-1#1)(2007-2#3)(2007-8#1)(2011-1#1)(2011-2#1)
the seroprevalence##10##2##(1991-2#1)(2006-1#1)(2007-2#3)(2007-8#1)(2011-1#2)(2011-2#2)
the serosa membrane##2##3##(2007-12#2)
the serosa##6##2##(1990-10#2)(2007-12#2)(2008-3#1)(2008-6#1)
the serotonergic and##2##3##(1994-6#1)(1997-5#1)
the serotonergic system##2##3##(1996-4#1)(2012-3#1)
the serotonergic##12##2##(1990-5#2)(1993-7#1)(1994-10#1)(1994-6#1)(1995-12#1)(1996-4#1)(1997-5#1)(2007-12#1)(2008-7#1)(2009-10#1)(2012-3#1)
the serotonin (5-HT)##3##3##(1994-2#1)(2006-9#1)(2008-5#1)
the serotonin metabolite##2##3##(1995-11#1)(1996-1#1)
the serotonin receptor##2##3##(2005-11#1)(2008-5#1)
the serotonin release rate was##2##5##(1995-12#2)
the serotonin release rate##3##4##(1995-12#3)
the serotonin reuptake transporter##2##4##(2006-10#1)(2008-6#1)
the serotonin reuptake##4##3##(1991-1#1)(2005-7#1)(2006-10#1)(2008-6#1)
the serotonin transporter##7##3##(1995-11#2)(1996-5#1)(1996-7#1)(2010-12#1)(2012-3#2)
the serotonin##36##2##(1991-1#1)(1991-8#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-11#3)(1995-12#3)(1996-1#2)(1996-10#1)(1996-5#2)(1996-7#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-9#3)(2007-11#1)(2007-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#2)(2010-12#1)(2012-3#2)
the serotoninergic system##3##3##(2008-6#2)(2010-12#1)
the serotype A##2##3##(2007-10#1)(2008-5#1)
the serotype of##3##3##(1997-3#1)(2008-10#1)(2008-5#1)
the serotype##10##2##(1991-3#1)(1992-2#1)(1997-3#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-5#4)
the serotypes##3##2##(1993-2#1)(2007-8#1)(2011-2#1)
the serovars##2##2##(2007-7#1)(2007-8#1)
the serpin superfamily##2##3##(1995-5#1)(1995-8#1)
the serpin##6##2##(1991-6#1)(1993-11#1)(1995-5#1)(1995-8#1)(2006-9#1)(2009-4#1)
the serrated##2##2##(2009-12#1)(2009-3#1)
the serratus##3##2##(1992-6#1)(1993-9#1)(2010-9#1)
the serum PSA to##2##4##(2006-9#2)
the serum and liver##2##4##(2004-11#1)(2005-7#1)
the serum and saliva##2##4##(2008-3#1)(2011-12#1)
the serum and the##2##4##(1992-6#1)(2013-8#1)
the serum and urine of the##2##6##(1995-3#2)
the serum and urine of##3##5##(1995-1#1)(1995-3#2)
the serum and urine##7##4##(1995-1#1)(1995-3#2)(2006-10#1)(2008-10#1)(2008-7#1)(2009-3#1)
the serum and##28##3##(1991-10#1)(1991-7#1)(1992-6#1)(1993-2#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#5)(1997-8#2)(2004-11#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-3#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-12#1)(2013-8#1)
the serum by##2##3##(1990-4#1)(1990-8#1)
the serum c-erbB-2 protein level##2##5##(1993-1#2)
the serum calcium concentration##2##4##(2005-3#1)(2007-8#1)
the serum calcium##3##3##(2005-3#1)(2007-8#1)(2010-7#1)
the serum cholesterol level##2##4##(1991-6#1)(2007-8#1)
the serum cholesterol##3##3##(1991-6#1)(2007-8#1)(2013-8#1)
the serum concentration of the##3##5##(1995-3#1)(1996-4#1)(2012-2#1)
the serum concentration of##7##4##(1991-12#1)(1995-2#1)(1995-3#1)(1996-4#1)(2007-7#1)(2008-5#1)(2012-2#1)
the serum concentration##9##3##(1991-12#1)(1995-2#2)(1995-3#1)(1996-4#1)(2005-7#1)(2007-7#1)(2008-5#1)(2012-2#1)
the serum concentrations of##7##4##(1990-3#1)(1991-6#1)(1995-2#1)(1997-5#1)(2007-8#1)(2008-10#1)(2008-4#1)
the serum creatinine##4##3##(1992-1#1)(2007-2#1)(2010-12#1)(2011-2#1)
the serum ferritin levels##3##4##(2013-8#3)
the serum ferritin##4##3##(2012-12#1)(2013-8#3)
the serum free##2##3##(1995-12#1)(2008-11#1)
the serum homocysteine##3##3##(2007-9#1)(2008-11#2)
the serum insulin##2##3##(2008-5#1)(2009-6#1)
the serum iodine concentration##2##4##(2007-8#2)
the serum iron##2##3##(1996-8#1)(2006-9#1)
the serum level of 1##2##5##(1992-5#1)(2006-10#1)
the serum level of##4##4##(1992-5#1)(1996-4#1)(1996-7#1)(2006-10#1)
the serum level##6##3##(1990-4#1)(1992-5#1)(1996-4#1)(1996-7#1)(1997-5#1)(2006-10#1)
the serum levels of the##2##5##(2007-1#1)(2008-5#1)
the serum levels of##20##4##(1991-10#1)(1992-3#1)(1995-10#1)(2007-1#2)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
the serum lipid profile of##2##5##(2007-1#1)(2011-11#1)
the serum lipid profile##3##4##(2006-10#1)(2007-1#1)(2011-11#1)
the serum lipid##5##3##(1994-12#1)(2006-10#1)(2007-1#1)(2011-11#1)(2013-1#1)
the serum neutralisation##2##3##(1991-3#2)
the serum neutralizing activity##2##4##(1992-6#2)
the serum of a##3##4##(1992-4#1)(1992-6#1)(1994-3#1)
the serum of patients with##7##5##(1991-9#1)(1992-9#1)(1994-8#1)(2008-4#1)(2008-8#2)(2012-1#1)
the serum of the##5##4##(1993-1#1)(1994-12#1)(1995-3#1)(1997-4#1)(2007-11#1)
the serum of##34##3##(1990-2#1)(1990-4#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-9#1)(1996-3#1)(1996-4#1)(1997-4#1)(2007-11#1)(2007-2#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)
the serum potassium##2##3##(2007-9#1)(2012-12#1)
the serum protein##2##3##(1994-12#1)(2005-11#1)
the serum proteins##2##3##(2010-12#2)
the serum resistin or RELM concentration##2##6##(2008-1#2)
the serum response element (SRE)##2##5##(1993-6#1)(1994-11#1)
the serum response element##3##4##(1993-6#1)(1994-11#1)(1996-5#1)
the serum samples##3##3##(1996-3#1)(2013-1#1)(2013-8#1)
the serum starvation##2##3##(2008-4#1)(2012-2#1)
the serum total##4##3##(2008-6#1)(2010-4#1)(2012-2#1)(2013-8#1)
the serum triglyceride##3##3##(1991-12#3)
the serum was##3##3##(1990-7#1)(1991-8#1)(2008-7#1)
the serum##280##2##(1990-2#1)(1990-3#1)(1990-4#3)(1990-7#1)(1990-8#1)(1991-10#3)(1991-12#5)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-3#4)(1992-4#3)(1992-5#2)(1992-6#4)(1992-9#1)(1993-1#3)(1993-12#1)(1993-2#3)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-10#1)(1995-12#2)(1995-2#6)(1995-3#7)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#3)(1996-5#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-8#2)(2004-11#2)(2005-11#2)(2005-3#1)(2005-7#2)(2005-8#1)(2005-9#2)(2006-10#4)(2006-4#2)(2006-7#1)(2006-9#3)(2007-1#3)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#4)(2007-7#3)(2007-8#6)(2007-9#4)(2008-1#3)(2008-10#13)(2008-11#4)(2008-12#3)(2008-3#1)(2008-4#5)(2008-5#11)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#2)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#3)(2010-10#1)(2010-12#8)(2010-2#1)(2010-4#3)(2010-6#3)(2010-7#1)(2011-1#5)(2011-11#1)(2011-12#1)(2011-2#5)(2012-1#3)(2012-12#4)(2012-2#9)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#20)
the serum-free medium##5##3##(1990-7#1)(1992-9#2)(1996-2#1)(2008-11#1)
the serum-free##7##2##(1990-7#1)(1992-9#2)(1996-2#1)(2008-11#2)(2008-4#1)
the serum-independent cells##2##3##(2008-11#2)
the serum-supplemented##5##2##(2008-11#5)
the server##6##2##(2007-12#1)(2008-4#1)(2012-3#4)
the service area##2##3##(1992-2#1)(2006-8#1)
the service being provided##2##4##(2011-2#2)
the service encounter##2##3##(1992-3#1)(1993-12#1)
the service is##6##3##(1992-11#1)(2005-5#1)(2007-4#1)(2008-1#1)(2011-1#1)(2012-2#1)
the service of##9##3##(1996-2#1)(2008-11#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
the service provided##3##3##(1994-8#1)(1995-9#1)(2009-3#1)
the service quality##2##3##(1995-2#1)(2006-4#1)
the service rendered##2##3##(1995-9#2)
the service that##2##3##(1995-9#1)(2005-11#1)
the service to##2##3##(2007-9#1)(2008-2#1)
the service##72##2##(1991-1#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-2#3)(1995-9#4)(1996-1#1)(1996-2#2)(1996-3#1)(1996-7#2)(1997-2#1)(2004-9#1)(2005-11#1)(2005-5#1)(2006-4#1)(2006-8#1)(2007-4#2)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#7)(2013-1#4)
the service-class approach##2##3##(1996-1#2)
the services of a##2##4##(1995-3#1)(2008-1#1)
the services of the##2##4##(1994-1#1)(1994-3#1)
the services of##6##3##(1994-1#1)(1994-3#1)(1995-3#1)(2006-8#1)(2008-1#1)(2009-4#1)
the services offered##3##3##(1994-12#1)(1995-1#1)(2007-7#1)
the services provided by##2##4##(1992-1#1)(1995-1#1)
the services provided##4##3##(1992-1#1)(1995-1#2)(2007-4#1)
the services that##2##3##(1993-12#2)
the services##46##2##(1991-3#1)(1992-1#1)(1992-11#3)(1993-12#2)(1993-3#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-1#3)(1995-3#1)(1996-1#1)(1996-9#1)(2005-5#3)(2006-8#2)(2007-12#2)(2007-4#1)(2007-7#5)(2008-1#1)(2008-12#1)(2008-4#1)(2009-4#1)(2010-2#1)(2011-1#1)(2011-7#1)(2012-12#1)(2012-3#5)(2013-1#3)
the servo system##2##3##(2008-2#1)(2008-3#1)
the servo##3##2##(2008-2#2)(2008-3#1)
the sesquiterpene##2##2##(1995-2#1)(2008-10#1)
the sessile##3##2##(2005-11#1)(2007-3#1)(2009-12#1)
the session##11##2##(1990-7#1)(1991-1#1)(1991-12#2)(2007-12#1)(2007-8#1)(2008-4#1)(2008-6#1)(2009-9#1)(2010-1#1)(2012-3#1)
the sessions##15##2##(2005-8#3)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-11#1)(2011-12#3)(2011-2#2)(2013-8#1)
the set of data##2##4##(1996-2#1)(2008-11#1)
the set of resources##2##4##(2008-8#2)
the set of##40##3##(1991-4#1)(1992-12#1)(1994-9#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-7#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-3#5)(2008-5#1)(2008-8#3)(2009-4#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-2#1)(2011-1#1)(2012-3#5)(2013-1#4)
the set point##2##3##(1992-4#1)(2006-8#1)
the set up##2##3##(2008-10#2)
the set##63##2##(1990-11#2)(1991-4#1)(1992-12#2)(1992-4#1)(1994-2#1)(1994-9#1)(1996-1#1)(1996-2#2)(1996-5#1)(1996-7#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#1)(2008-8#3)(2009-4#1)(2009-5#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#6)(2013-1#5)
the set-up##2##2##(2008-11#1)(2010-12#1)
the sets of##5##3##(1990-8#1)(1993-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
the sets technique##3##3##(1997-6#3)
the sets##15##2##(1990-8#1)(1993-8#1)(1997-6#5)(1997-8#1)(2007-3#1)(2008-9#1)(2009-5#2)(2010-2#1)(2011-1#1)(2011-2#1)
the setting of a##11##4##(2005-10#1)(2006-10#1)(2007-5#1)(2007-6#1)(2008-4#2)(2008-9#1)(2010-10#1)(2010-2#1)(2010-6#1)(2013-8#1)
the setting of an##2##4##(1990-12#1)(2006-10#1)
the setting of chronic##2##4##(2007-8#1)(2010-5#1)
the setting of complex##2##4##(2006-9#1)(2008-1#1)
the setting of the encounters##2##5##(1991-6#2)
the setting of the##7##4##(1991-6#2)(2006-9#1)(2008-3#2)(2008-7#1)(2010-4#1)
the setting of##109##3##(1990-12#1)(1991-2#1)(1991-6#2)(1996-12#2)(1996-2#1)(1997-2#1)(1997-8#1)(2004-1#1)(2005-10#5)(2005-7#2)(2006-10#8)(2006-11#1)(2006-4#1)(2006-8#2)(2006-9#3)(2007-10#2)(2007-11#3)(2007-5#6)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-11#4)(2008-3#4)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#4)(2010-5#1)(2010-6#2)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#6)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#5)(2013-8#1)
the setting reaction##3##3##(2004-9#3)
the setting time was##2##4##(2004-9#2)
the setting time##6##3##(2004-9#4)(2008-5#2)
the setting up and##2##4##(1996-11#2)
the setting up of##2##4##(2005-8#1)(2008-7#1)
the setting up##4##3##(1996-11#2)(2005-8#1)(2008-7#1)
the setting##129##2##(1990-12#1)(1991-2#1)(1991-6#2)(1994-12#1)(1996-11#2)(1996-12#2)(1996-2#1)(1997-2#1)(1997-8#1)(2004-1#1)(2004-9#7)(2005-10#5)(2005-7#2)(2005-8#2)(2006-10#8)(2006-11#1)(2006-4#1)(2006-8#2)(2006-9#3)(2007-10#2)(2007-11#3)(2007-12#1)(2007-5#6)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-11#4)(2008-3#5)(2008-4#4)(2008-5#4)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#4)(2010-5#1)(2010-6#2)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#7)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#1)
the settings in which##2##4##(2009-6#1)(2013-8#1)
the settings##5##2##(2009-6#1)(2012-2#2)(2012-3#1)(2013-8#1)
the settled##2##2##(2007-8#1)(2008-4#1)
the settlement of##2##3##(1990-12#1)(1993-9#1)
the settlement period##2##3##(2008-9#2)
the settlement##8##2##(1990-12#1)(1993-9#1)(1995-12#1)(1996-5#1)(1997-5#1)(2008-9#2)(2010-5#1)
the settling column##2##3##(2005-11#2)
the settling##7##2##(1990-3#1)(2005-11#6)
the setup is##3##3##(2007-11#1)(2007-12#2)
the setup of a##2##4##(2008-3#1)(2011-2#1)
the setup of##3##3##(2008-3#1)(2011-2#1)(2013-8#1)
the setup##21##2##(1994-2#1)(2006-11#1)(2007-10#1)(2007-11#3)(2007-12#3)(2008-2#1)(2008-3#6)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
the seven apparent equilibrium constants##3##5##(1997-1#3)
the seven children##2##3##(2006-10#1)(2007-7#1)
the seven compounds##2##3##(2008-10#1)(2012-3#1)
the seven metal ions##4##4##(2008-10#4)
the seven metals##2##3##(2008-10#2)
the seven oldest mice of the##2##6##(1996-11#2)
the seven patients who##3##4##(1996-6#1)(2007-7#1)(2008-1#1)
the seven patients##6##3##(1996-1#1)(1996-6#1)(2007-7#1)(2008-1#1)(2008-6#1)(2011-1#1)
the seven strains##2##3##(2008-10#1)(2011-2#1)
the seven transmembrane##2##3##(1993-3#1)(1997-2#1)
the seven##75##2##(1990-11#1)(1990-5#2)(1991-2#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-7#1)(1995-3#1)(1996-1#1)(1996-11#3)(1996-6#1)(1996-7#1)(1997-1#3)(1997-2#1)(1997-3#1)(2006-10#2)(2006-8#1)(2007-12#2)(2007-7#2)(2008-1#1)(2008-10#18)(2008-12#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-8#2)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#3)
the sevenless##4##2##(1991-12#1)(1992-1#1)(1993-6#2)
the seventeenth century##8##3##(2008-10#1)(2008-8#1)(2008-9#1)(2009-7#2)(2010-1#1)(2012-2#1)(2013-8#1)
the seventeenth##10##2##(2008-10#1)(2008-8#2)(2008-9#1)(2009-7#2)(2010-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
the seventeenth-century##2##2##(2008-10#1)(2008-9#1)
the seventh and eighth##2##4##(2008-10#1)(2011-2#1)
the seventh and##4##3##(1993-8#1)(2008-10#1)(2008-2#1)(2011-2#1)
the seventh day of the##2##5##(2004-4#1)(2008-5#1)
the seventh day of##4##4##(2004-4#1)(2007-8#1)(2008-5#1)(2010-8#1)
the seventh transmembrane##2##3##(1991-9#1)(1994-6#1)
the seventh##31##2##(1991-7#1)(1991-9#1)(1993-8#1)(1994-11#1)(1994-6#1)(1996-7#1)(1997-5#2)(2004-4#1)(2006-12#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
the seventies##3##2##(1993-3#1)(2007-5#2)
the several##24##2##(1991-1#1)(1991-5#1)(1992-1#1)(1994-6#1)(1994-8#1)(1995-1#1)(1997-3#1)(2005-1#1)(2005-10#1)(2005-7#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-12#1)(2012-3#1)(2013-8#2)
the severe acute respiratory syndrome##3##5##(2007-12#1)(2008-5#1)(2008-7#1)
the severe anaemia##2##3##(2006-10#1)(2006-2#1)
the severe form of##3##4##(2008-7#2)(2012-3#1)
the severe form##4##3##(2006-6#1)(2008-7#2)(2012-3#1)
the severe metabolic##2##3##(1992-11#1)(2007-5#1)
the severe vascular abnormalities resulting from the induced dysregulated expression of a Hox gene with regional vascular patterning functions suggest that proper Hox function and regulation is critical for maintaining vascular functional integrity##2##33##(2012-12#2)
the severe##46##2##(1992-11#1)(1992-6#1)(1994-6#1)(1996-10#1)(1996-3#2)(1997-3#1)(2005-12#1)(2006-10#1)(2006-2#2)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2009-12#1)(2010-2#1)(2012-12#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
the severely injured patients##2##4##(2007-11#1)(2012-1#1)
the severely##8##2##(1993-8#1)(1996-2#1)(2005-9#1)(2006-10#1)(2007-11#1)(2008-3#1)(2012-1#1)(2012-3#1)
the severing of##2##3##(1991-3#1)(1994-12#1)
the severing##3##2##(1991-3#1)(1994-12#2)
the severity and duration of##2##5##(2009-5#1)(2010-3#1)
the severity and the##2##4##(2013-1#1)(2013-8#1)
the severity and##22##3##(1990-12#1)(1995-11#1)(2006-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
the severity of Fusarium wilt##3##5##(2008-10#3)
the severity of a##3##4##(2008-7#2)(2012-12#1)
the severity of acute pancreatitis##2##5##(2006-10#2)
the severity of acute##5##4##(1992-10#1)(1995-9#1)(2006-10#2)(2012-2#1)
the severity of asthma##2##4##(2007-11#1)(2010-8#1)
the severity of atherosclerosis##2##4##(1991-9#1)(2007-8#1)
the severity of bacterial leaf spot of radish##2##8##(2008-10#2)
the severity of bacterial##3##4##(2008-10#3)
the severity of cardiac##2##4##(2010-4#1)(2010-8#1)
the severity of clinical##4##4##(1997-8#2)(2010-11#1)(2010-12#1)
the severity of coronary artery disease and##2##7##(1993-12#1)(2013-8#1)
the severity of coronary artery lesions and##2##7##(1993-12#2)
the severity of coronary artery##4##5##(1993-12#3)(2013-8#1)
the severity of disability##3##4##(2007-10#1)(2011-2#2)
the severity of disease##4##4##(1994-9#1)(2008-10#2)(2012-3#1)
the severity of leaf##3##4##(2004-4#1)(2008-10#2)
the severity of lesions##2##4##(1991-8#1)(2008-5#1)
the severity of liver##2##4##(1996-8#1)(2013-1#1)
the severity of malnutrition##2##4##(2006-10#1)(2012-2#1)
the severity of neurological##3##4##(2008-3#1)(2008-4#2)
the severity of non-randomness##2##4##(1995-12#2)
the severity of pain##3##4##(2008-5#1)(2012-2#2)
the severity of schizophrenia##2##4##(2011-1#2)
the severity of skin lesions##2##5##(2008-9#2)
the severity of skin##3##4##(2008-5#1)(2008-9#2)
the severity of symptoms at discharge##2##6##(2011-2#2)
the severity of symptoms##9##4##(1990-9#1)(1993-9#1)(2007-3#1)(2008-10#2)(2008-7#1)(2011-2#2)(2012-2#1)
the severity of the clinical picture##3##6##(1997-6#2)(2007-11#1)
the severity of the clinical##4##5##(1997-6#2)(2007-11#1)(2010-12#1)
the severity of the disease and##2##6##(2005-11#1)(2008-5#1)
the severity of the disease but##2##6##(2008-10#1)(2013-1#1)
the severity of the disease##18##5##(1990-9#1)(1991-2#1)(1993-11#1)(1997-3#1)(2005-1#1)(2005-11#2)(2006-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
the severity of the effects is##2##6##(1991-12#1)(1996-6#1)
the severity of the effects##3##5##(1991-12#1)(1996-6#1)(2009-7#1)
the severity of the lesions##2##5##(2006-10#1)(2008-5#1)
the severity of the##60##4##(1990-9#1)(1991-12#1)(1991-2#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-9#1)(1995-2#1)(1995-7#1)(1996-6#1)(1997-2#2)(1997-3#2)(1997-6#2)(2005-1#1)(2005-11#2)(2006-10#1)(2006-2#1)(2007-11#2)(2007-2#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#1)(2009-7#2)(2010-12#2)(2010-3#1)(2011-12#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
the severity of their##8##4##(1995-11#1)(2005-11#1)(2007-6#1)(2007-8#1)(2008-11#1)(2011-1#1)(2012-1#1)(2012-2#1)
the severity of this condition##2##5##(2010-1#1)(2011-2#1)
the severity of this disease##3##5##(1993-2#1)(2008-10#2)
the severity of this##6##4##(1993-2#1)(2008-10#2)(2009-5#1)(2010-1#1)(2011-2#1)
the severity of##268##3##(1990-3#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#2)(1992-10#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-7#1)(1995-9#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#2)(1997-8#3)(2004-10#1)(2004-11#1)(2004-12#1)(2004-4#1)(2005-1#1)(2005-11#6)(2005-8#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-6#1)(2007-10#1)(2007-11#5)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#30)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#10)(2008-5#12)(2008-6#6)(2008-7#9)(2008-8#4)(2008-9#2)(2009-2#1)(2009-5#3)(2009-7#2)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#5)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#5)(2011-12#1)(2011-2#18)(2012-1#2)(2012-12#5)(2012-2#8)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#5)
the severity or##2##3##(2008-5#1)(2012-3#1)
the severity##304##2##(1990-12#1)(1990-3#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#3)(1992-10#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-6#1)(1994-9#1)(1995-11#3)(1995-12#3)(1995-2#2)(1995-7#1)(1995-9#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#2)(1997-8#3)(2004-10#1)(2004-11#1)(2004-12#1)(2004-4#1)(2005-1#1)(2005-10#1)(2005-11#6)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-6#1)(2006-7#2)(2007-10#1)(2007-11#5)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#32)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#10)(2008-5#14)(2008-6#6)(2008-7#9)(2008-8#4)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#4)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#4)(2010-11#1)(2010-12#6)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#5)(2011-12#1)(2011-2#21)(2012-1#2)(2012-12#5)(2012-2#8)(2012-3#4)(2013-1#10)(2013-7#3)(2013-8#7)
the sewage treatment plant##2##4##(1992-6#1)(2007-12#1)
the sewage##3##2##(1992-6#1)(2007-12#1)(2008-2#1)
the sex and age of the##2##6##(2007-6#1)(2008-6#1)
the sex and age of##3##5##(1994-6#1)(2007-6#1)(2008-6#1)
the sex and##4##3##(1994-6#1)(2007-6#1)(2008-6#1)(2008-7#1)
the sex chromosomes##7##3##(1990-11#3)(2005-10#1)(2008-8#1)(2010-3#1)(2010-5#1)
the sex determination##3##3##(2007-12#2)(2010-3#1)
the sex difference in##4##4##(1993-4#1)(1994-2#1)(2008-3#1)(2008-4#1)
the sex difference##5##3##(1993-2#1)(1993-4#1)(1994-2#1)(2008-3#1)(2008-4#1)
the sex differences##3##3##(1991-3#1)(2008-4#1)(2012-3#1)
the sex of the##4##4##(1994-7#1)(2008-5#2)(2009-2#1)
the sex of##7##3##(1994-7#1)(2008-5#2)(2008-8#1)(2009-2#1)(2011-12#1)(2013-1#1)
the sex pheromone##4##3##(2007-12#1)(2008-10#2)(2013-8#1)
the sex ratio##5##3##(1991-11#1)(2006-10#1)(2008-9#1)(2012-3#2)
the sex steroid hormone##2##4##(1996-4#1)(2008-3#1)
the sex##54##2##(1990-11#3)(1990-2#1)(1991-11#1)(1991-3#1)(1993-2#1)(1993-4#1)(1994-2#1)(1994-6#1)(1994-7#2)(1995-3#1)(1995-5#1)(1996-4#1)(1997-6#1)(2005-10#1)(2006-10#1)(2007-1#1)(2007-12#3)(2007-6#1)(2008-10#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-2#1)(2010-3#2)(2010-5#1)(2011-1#1)(2011-12#1)(2012-3#5)(2013-1#3)(2013-8#1)
the sex-determining region##2##3##(1990-11#2)
the sex-determining##3##2##(1990-11#2)(2008-4#1)
the sex-related differences in liver ID1##2##6##(1995-12#2)
the sex-related differences##3##3##(1995-12#3)
the sex-specific##4##2##(1990-11#1)(2010-5#1)(2012-3#1)(2013-8#1)
the sexes and##3##3##(1991-7#1)(2006-10#1)(2013-7#1)
the sexes as##2##3##(1991-6#1)(2009-10#1)
the sexes in##4##3##(1997-8#1)(2008-8#1)(2008-9#1)(2013-8#1)
the sexes of##2##3##(2006-1#1)(2013-8#1)
the sexes##44##2##(1990-12#1)(1991-10#1)(1991-6#1)(1991-7#1)(1992-4#1)(1995-2#1)(1996-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2006-1#1)(2006-10#1)(2006-4#1)(2006-8#4)(2007-12#3)(2007-6#1)(2007-9#1)(2008-10#2)(2008-7#2)(2008-8#3)(2008-9#8)(2009-10#1)(2012-3#2)(2013-7#1)(2013-8#2)
the sexual abuse of##3##4##(1996-11#2)(2009-9#1)
the sexual behavior##4##3##(1991-2#2)(2005-10#1)(2011-2#1)
the sexual behaviour of##6##4##(1990-9#1)(1996-1#1)(1996-11#1)(2006-7#1)(2008-11#1)(2011-2#1)
the sexual differentiation of##3##4##(1994-2#1)(1994-6#1)(2009-3#1)
the sexual division of labor##2##5##(1991-6#2)
the sexual division of##3##4##(1991-6#2)(1996-3#1)
the sexual health##2##3##(2010-9#1)(2012-12#1)
the sexual morph##6##3##(2013-7#6)
the sexual risk##3##3##(2007-7#1)(2008-12#2)
the sexual stage##4##3##(2008-10#4)
the sexual state##3##3##(2008-10#3)
the sexual##64##2##(1990-9#1)(1991-2#2)(1991-6#2)(1992-9#1)(1993-3#1)(1994-2#1)(1994-6#2)(1996-1#1)(1996-11#3)(1996-2#1)(1996-3#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-3#1)(2007-7#3)(2008-10#9)(2008-11#2)(2008-12#3)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-12#4)(2012-2#1)(2013-7#6)
the sexually abused##2##3##(1995-5#1)(2006-2#1)
the sexually active students##2##4##(2012-12#2)
the sexually active##5##3##(2007-12#2)(2012-12#2)(2013-8#1)
the sexually dimorphic##6##3##(1990-4#2)(1992-3#1)(1994-3#1)(1996-9#2)
the sexually##15##2##(1990-4#2)(1992-3#1)(1994-3#1)(1995-5#1)(1996-9#2)(2006-2#1)(2007-12#3)(2007-7#1)(2012-12#2)(2013-8#1)
the shade##2##2##(2006-12#1)(2009-8#1)
the shaded##2##2##(2008-9#2)
the shadow image##2##3##(2008-3#2)
the shadow of the##2##4##(2008-2#1)(2008-6#1)
the shadow of##9##3##(1990-5#1)(2007-8#1)(2007-9#1)(2008-2#3)(2008-6#2)(2012-1#1)
the shadow##15##2##(1990-5#1)(2007-8#1)(2007-9#1)(2008-2#5)(2008-3#3)(2008-6#3)(2012-1#1)
the shadowing##2##2##(2008-3#2)
the shadows##2##2##(1992-1#1)(2008-2#1)
the shaft of a##2##4##(2007-12#1)(2007-5#1)
the shaft of##3##3##(2007-11#1)(2007-12#1)(2007-5#1)
the shaft##7##2##(2006-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-2#1)(2011-2#1)
the shaking##3##2##(2008-10#2)(2013-1#1)
the shallow##4##2##(2007-5#2)(2008-5#1)(2011-2#1)
the sham and##4##3##(1993-12#1)(1994-5#1)(1995-11#1)(1995-12#1)
the sham group##3##3##(2012-12#1)(2012-2#1)(2012-7#1)
the sham##13##2##(1993-12#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-5#1)(1997-3#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-7#1)(2013-1#1)
the sham-operated control##2##3##(1990-7#1)(1996-12#1)
the sham-operated##7##2##(1990-7#2)(1993-3#1)(1995-12#1)(1996-12#1)(1997-6#1)(1997-8#1)
the sham-treated##2##2##(2006-10#2)
the shampoo##8##2##(2008-10#1)(2008-5#7)
the shape and size of##2##5##(2008-5#1)(2010-3#1)
the shape and size##3##4##(2008-5#1)(2010-3#1)(2013-8#1)
the shape and the##3##4##(2006-5#1)(2008-12#1)(2008-3#1)
the shape and##18##3##(2006-11#1)(2006-5#1)(2007-11#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-8#1)(2010-3#1)(2010-4#1)(2013-1#2)(2013-8#1)
the shape change of the##2##5##(2010-5#1)(2012-12#1)
the shape change##3##3##(2006-10#1)(2010-5#1)(2012-12#1)
the shape memory effect##2##4##(2006-6#2)
the shape of a##14##4##(1994-5#1)(1997-7#1)(2007-12#2)(2007-9#1)(2008-2#2)(2008-3#3)(2009-4#1)(2012-11#2)(2012-2#1)
the shape of astrocytic networks##2##5##(2008-7#2)
the shape of the cavity##2##5##(1996-5#1)(2008-2#1)
the shape of the object##4##5##(2008-2#1)(2008-3#3)
the shape of the particle size distribution##2##7##(2008-3#2)
the shape of the particle##3##5##(2007-11#1)(2008-3#2)
the shape of the phase##2##5##(2008-10#1)(2008-2#1)
the shape of the surface##2##5##(2008-2#1)(2008-4#1)
the shape of the survivorship curve##2##6##(2008-9#1)(2011-2#1)
the shape of the##82##4##(1990-8#1)(1991-5#1)(1992-3#1)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-5#2)(1997-3#1)(2005-11#3)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#5)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#13)(2008-3#14)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
the shape of this##2##4##(2008-2#1)(2008-8#1)
the shape of##136##3##(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-5#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-4#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-3#1)(1997-7#1)(2005-11#4)(2006-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#8)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#3)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#19)(2008-3#23)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
the shape or##2##3##(1997-3#1)(2007-11#1)
the shape parameter##2##3##(2008-10#1)(2012-2#1)
the shape##185##2##(1990-3#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-5#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-4#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-3#2)(1997-7#1)(2005-11#4)(2006-10#2)(2006-11#2)(2006-12#1)(2006-5#1)(2006-6#2)(2007-10#1)(2007-11#5)(2007-12#8)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#3)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#24)(2008-3#26)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#10)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#4)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
the shapes of the##9##4##(1997-7#1)(2004-9#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-2#2)(2008-9#1)(2010-5#1)
the shapes of these##2##4##(2008-7#1)(2008-9#1)
the shapes of##22##3##(1996-6#1)(1997-7#1)(2004-9#1)(2005-11#2)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-5#1)
the shaping of##3##3##(2006-11#1)(2007-10#1)(2008-11#1)
the shaping##7##2##(2005-11#1)(2006-11#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
the share of health##2##4##(1995-3#1)(1997-3#1)
the share of the##3##4##(1992-12#1)(2009-4#1)(2010-8#1)
the share of##9##3##(1991-2#1)(1992-12#1)(1992-2#1)(1995-3#1)(1997-3#1)(2008-7#1)(2009-4#1)(2010-8#1)(2013-1#1)
the shared##14##2##(1990-7#1)(1994-11#1)(1995-12#1)(2005-10#1)(2005-7#1)(2006-9#1)(2008-10#1)(2008-11#3)(2008-5#1)(2010-11#1)(2012-12#2)
the sharing of##10##3##(1995-3#1)(1997-8#1)(2008-11#2)(2008-9#1)(2009-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2013-8#1)
the shark##4##2##(1990-4#1)(1994-11#1)(2007-5#2)
the sharp##13##2##(1990-5#1)(1991-3#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-8#1)
the sharply##2##2##(1990-10#1)(2007-8#1)
the sharpness of the##2##4##(2007-12#1)(2008-2#1)
the sharpness of##4##3##(1994-8#1)(2007-12#1)(2008-2#1)(2008-3#1)
the shaver##5##2##(2007-5#5)
the shear bond strength##2##4##(2006-8#1)(2011-1#1)
the shear bond##3##3##(2006-8#1)(2009-8#1)(2011-1#1)
the shear force##2##3##(2005-11#1)(2008-11#1)
the shear modulus of##2##4##(2007-4#1)(2008-2#1)
the shear modulus##4##3##(2005-11#1)(2007-4#1)(2008-2#1)(2009-7#1)
the shear rate##2##3##(2009-10#1)(2013-1#1)
the shear strain##3##3##(2006-11#2)(2012-2#1)
the shear stress##3##3##(2006-6#1)(2007-1#1)(2008-5#1)
the shear##29##2##(1994-11#1)(1996-4#1)(2005-11#4)(2006-11#4)(2006-6#1)(2006-8#1)(2007-1#2)(2007-4#1)(2008-11#3)(2008-2#2)(2008-3#2)(2008-5#1)(2009-10#1)(2009-7#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
the shear-force value##2##3##(2010-2#2)
the sheared##3##2##(1996-7#2)(2008-3#1)
the shearing##5##2##(1993-7#2)(2007-4#1)(2008-3#1)(2008-4#1)
the shearographic##2##2##(2008-2#1)(2008-3#1)
the sheath##13##2##(1990-5#2)(2006-10#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-5#1)(2010-5#1)
the sheaths in##2##3##(2009-6#1)(2011-12#1)
the shedding##4##2##(1992-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
the sheep heart##2##3##(2007-8#2)
the sheep model of##2##4##(2005-8#1)(2012-1#1)
the sheep##21##2##(1991-5#2)(1993-6#1)(1993-8#1)(1996-10#1)(1996-12#3)(1997-7#1)(2005-8#1)(2006-8#1)(2007-8#2)(2008-10#3)(2008-12#1)(2008-8#1)(2009-4#1)(2011-1#1)(2012-1#1)
the sheet##4##2##(2007-8#2)(2007-9#1)(2008-3#1)
the shelf life of food products##2##6##(2010-7#1)(2013-1#1)
the shelf life of##6##4##(2007-3#2)(2010-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
the shelf life##7##3##(2007-3#2)(2008-10#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
the shelf##12##2##(2007-3#2)(2007-5#1)(2008-10#1)(2010-7#1)(2010-8#3)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
the shelf-life of the product##2##5##(2007-3#1)(2008-5#1)
the shelf-life of##5##3##(2007-3#1)(2008-5#2)(2013-1#2)
the shell and##3##3##(2005-11#1)(2008-10#1)(2008-7#1)
the shell contributions##2##3##(2006-5#2)
the shell of##2##3##(1992-2#1)(1995-2#1)
the shell##24##2##(1992-12#1)(1992-2#1)(1995-2#1)(2005-11#4)(2006-5#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-4#1)(2010-5#1)(2012-2#1)
the shells##2##2##(2005-11#1)(2008-12#1)
the shelter##4##2##(2012-2#4)
the shield##4##2##(2008-10#1)(2008-2#1)(2008-9#1)(2009-2#1)
the shielding##2##2##(1990-5#1)(2009-10#1)
the shift from a##2##4##(1995-11#1)(2008-7#1)
the shift from##7##3##(1991-11#1)(1992-2#1)(1994-11#1)(1995-11#1)(2008-7#1)(2009-10#1)(2009-7#1)
the shift in care from##2##5##(1996-2#1)(2008-3#1)
the shift in the##5##4##(1990-5#1)(2007-11#1)(2008-6#1)(2009-2#1)(2011-2#1)
the shift in##17##3##(1990-5#1)(1990-8#1)(1992-11#1)(1992-9#1)(1993-12#1)(1996-2#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2009-11#1)(2009-2#1)(2010-8#1)(2011-2#1)
the shift is##2##3##(2007-11#1)(2008-2#1)
the shift of one##2##4##(1990-2#1)(2005-11#1)
the shift of the##6##4##(1990-3#1)(1990-7#1)(1993-3#1)(2006-12#1)(2008-2#1)(2008-3#1)
the shift of##16##3##(1990-2#2)(1990-3#1)(1990-7#1)(1993-3#1)(1995-2#1)(2005-11#1)(2006-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2013-1#1)(2013-8#1)
the shift to##3##3##(1997-2#1)(2008-11#2)
the shift tolerance of the##2##5##(2008-3#2)
the shift towards##2##3##(2007-5#1)(2008-9#1)
the shift##64##2##(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-3#1)(1992-11#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-6#2)(1995-11#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-5#1)(2008-10#3)(2008-11#4)(2008-2#6)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
the shift-invariant##2##2##(2008-2#1)(2008-3#1)
the shifted context##2##3##(2009-2#2)
the shifted##7##2##(1993-12#1)(1995-4#1)(2007-11#1)(2008-2#1)(2008-3#1)(2009-2#2)
the shifting##9##2##(1993-12#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-8#1)(2009-5#1)
the shifts in##3##3##(2008-2#2)(2012-3#1)
the shifts of##2##3##(2007-12#1)(2008-5#1)
the shifts##9##2##(1992-2#1)(2007-12#1)(2008-2#4)(2008-3#1)(2008-5#1)(2012-3#1)
the ship##3##2##(1990-6#1)(1992-6#1)(2011-2#1)
the shoaling##2##2##(2008-11#1)(2010-12#1)
the shock and##3##3##(1992-1#1)(1994-9#1)(1997-5#1)
the shock##11##2##(1992-1#1)(1994-9#1)(1996-2#1)(1997-5#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-12#1)
the shock-probe burying##4##3##(1993-3#4)
the shock-probe##5##2##(1993-3#4)(1994-2#1)
the shockwave##2##2##(2008-11#2)
the shoe-surface interface##3##3##(2013-1#3)
the shoot and root##2##4##(2009-8#2)
the shoot and##3##3##(2008-5#1)(2009-8#2)
the shoot apical meristem##3##4##(2009-8#1)(2012-12#1)(2012-2#1)
the shoot from##2##3##(2008-10#2)
the shoot pole##2##3##(2012-1#2)
the shoot##19##2##(2007-8#1)(2008-10#4)(2008-5#1)(2008-8#1)(2009-6#1)(2009-8#4)(2012-1#2)(2012-12#1)(2012-2#1)(2013-8#3)
the shooting##6##2##(1991-3#1)(1995-11#2)(2007-4#1)(2013-7#2)
the shoots##4##2##(1997-6#1)(2004-4#1)(2008-10#1)(2008-11#1)
the shore##5##2##(1992-12#1)(1994-11#1)(2007-3#1)(2008-5#2)
the shoreline##3##2##(2007-3#1)(2008-10#1)(2008-5#1)
the short C-terminal##2##3##(2008-8#1)(2009-10#1)
the short and long term##5##5##(2006-12#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-8#1)
the short and long##6##4##(2006-12#1)(2006-6#1)(2007-12#2)(2008-1#1)(2008-8#1)
the short and the long##3##5##(2007-9#1)(2008-3#2)
the short and the##4##4##(2007-9#1)(2008-3#3)
the short and##11##3##(2006-12#1)(2006-6#2)(2007-12#2)(2007-9#1)(2008-1#1)(2008-3#3)(2008-8#1)
the short arm of chromosome 11##2##6##(1990-12#1)(1996-3#1)
the short arm of chromosome 1B##2##6##(2008-10#2)
the short arm of chromosome 3##2##6##(1997-2#1)(2006-12#1)
the short arm of chromosome 5(1H)##2##6##(2008-10#2)
the short arm of chromosome##21##5##(1990-12#1)(1990-8#1)(1996-12#2)(1996-3#1)(1997-2#1)(2006-12#1)(2007-12#2)(2008-10#9)(2008-4#1)(2012-3#2)
the short arm of human chromosome##2##6##(1990-4#1)(1996-2#1)
the short arm of the##3##5##(1990-11#1)(1995-11#1)(2008-10#1)
the short arm of##32##4##(1990-11#1)(1990-12#1)(1990-4#1)(1990-8#1)(1995-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-2#1)(2006-12#1)(2006-8#1)(2007-12#2)(2008-10#15)(2008-4#1)(2012-3#2)
the short arm##35##3##(1990-11#1)(1990-12#1)(1990-4#1)(1990-8#1)(1990-9#1)(1995-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-2#1)(2006-12#1)(2006-8#1)(2007-12#2)(2008-10#16)(2008-4#1)(2008-5#1)(2012-3#2)
the short chain##2##3##(2005-11#1)(2009-6#1)
the short duration of the##2##5##(1993-5#1)(2007-12#1)
the short duration of##3##4##(1993-5#1)(2007-12#1)(2009-2#1)
the short form##3##3##(1994-8#1)(1997-2#1)(2007-8#1)
the short isoform##2##3##(1996-5#1)(2007-11#1)
the short latency##2##3##(1994-2#1)(1996-2#1)
the short period##3##3##(1990-9#1)(2006-8#1)(2008-10#1)
the short stature##2##3##(2008-4#1)(2013-1#1)
the short term effects of air pollution##2##7##(2010-9#2)
the short term##24##3##(1991-12#1)(1993-11#2)(1993-6#1)(1994-8#1)(1994-9#1)(1996-4#1)(2006-5#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-8#1)(2010-9#2)(2011-12#2)(2012-12#1)(2013-1#1)
the short time##6##3##(1990-9#1)(2006-6#1)(2007-11#1)(2008-10#1)(2009-4#1)(2012-12#1)
the short##168##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-4#2)(1990-8#2)(1990-9#3)(1991-12#2)(1991-4#4)(1991-6#1)(1992-12#1)(1992-5#1)(1993-11#3)(1993-12#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-2#3)(1997-3#2)(2005-11#1)(2006-10#2)(2006-12#3)(2006-2#2)(2006-5#1)(2006-6#5)(2006-8#2)(2007-10#1)(2007-11#6)(2007-12#8)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#22)(2008-11#3)(2008-12#1)(2008-3#6)(2008-4#2)(2008-5#4)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#2)(2009-2#1)(2009-4#1)(2009-6#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-3#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)
the short- and long-term##13##4##(1994-2#1)(1996-7#1)(2006-9#1)(2007-4#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
the short- and long-wavelength##2##4##(2008-2#1)(2008-3#1)
the short- and##16##3##(1994-2#1)(1996-7#1)(2006-9#1)(2007-4#1)(2008-2#1)(2008-3#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
the short-##17##2##(1994-2#1)(1996-7#1)(2006-9#1)(2007-4#1)(2008-2#1)(2008-3#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
the short-acting##2##2##(1991-3#1)(1993-9#1)
the short-chain##5##2##(1994-3#1)(1996-5#1)(2005-11#1)(2006-5#1)(2008-5#1)
the short-circuit current##2##3##(2008-3#1)(2010-4#1)
the short-lived radon##3##3##(1996-3#3)
the short-range electrostatic##2##3##(2006-10#2)
the short-range term is##2##4##(2006-10#2)
the short-range##5##2##(2006-10#4)(2013-8#1)
the short-term and##3##3##(1994-2#1)(2004-11#1)(2008-3#1)
the short-term deficit is##2##4##(1993-12#2)
the short-term dynamics of##2##4##(2008-6#2)
the short-term effects of##2##4##(1994-6#1)(1997-1#1)
the short-term##45##2##(1990-4#1)(1990-9#1)(1991-7#1)(1992-12#1)(1992-4#1)(1993-12#2)(1994-2#1)(1994-6#1)(1995-11#2)(1995-5#1)(1996-4#1)(1996-8#1)(1997-1#1)(2004-11#1)(2005-8#1)(2006-11#1)(2006-12#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-7#1)(2010-8#1)(2011-2#3)(2012-12#1)
the short-time##2##2##(2006-6#1)(2007-12#1)
the short-wave##3##2##(1994-3#2)(2008-2#1)
the short-wavelength edge of##2##4##(2007-12#1)(2008-3#1)
the short-wavelength##8##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#4)
the shortage of donor organs##2##5##(1993-11#1)(2008-1#1)
the shortage of organs##2##4##(2006-10#1)(2008-1#1)
the shortage of personnel##2##4##(1994-1#1)(2005-5#1)
the shortage of##17##3##(1991-7#1)(1992-1#1)(1993-11#1)(1994-1#1)(2005-5#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-7#1)(2010-11#1)(2011-2#2)(2013-1#1)(2013-7#1)
the shortage##22##2##(1990-12#1)(1991-7#1)(1992-1#1)(1993-11#1)(1994-1#1)(2005-5#1)(2006-10#1)(2007-10#1)(2007-4#4)(2007-8#1)(2008-1#2)(2008-11#1)(2008-7#1)(2010-11#1)(2011-2#2)(2013-1#1)(2013-7#1)
the shortcomings of##6##3##(1992-6#1)(1997-3#1)(2005-11#1)(2005-9#1)(2006-6#1)(2011-2#1)
the shortcomings##8##2##(1992-6#1)(1997-3#1)(2005-11#1)(2005-9#1)(2006-6#1)(2008-3#1)(2011-1#1)(2011-2#1)
the shortened##6##2##(1991-2#1)(1995-1#1)(1997-5#1)(2007-11#1)(2012-11#1)(2012-2#1)
the shortening of the##3##4##(1992-1#1)(1992-3#1)(1994-9#1)
the shortening of##6##3##(1992-1#1)(1992-3#1)(1993-3#1)(1994-9#1)(2008-11#1)(2012-12#1)
the shortening##9##2##(1992-1#1)(1992-3#1)(1993-3#1)(1993-7#1)(1994-9#1)(2007-11#2)(2008-11#1)(2012-12#1)
the shorter form##4##3##(1990-3#1)(1991-1#3)
the shorter##30##2##(1990-2#1)(1990-3#1)(1990-7#1)(1991-1#3)(1991-6#1)(1992-5#1)(1994-10#1)(1994-2#1)(1995-12#1)(1995-8#2)(1997-6#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-11#3)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#1)
the shorter-lived##2##2##(2008-3#1)(2013-8#1)
the shortest C-terminal biologically active fragment##2##6##(1990-12#2)
the shortest duration##2##3##(2007-11#1)(2008-3#1)
the shortest possible duration##2##4##(2007-11#1)(2007-12#1)
the shortest possible##5##3##(2007-11#1)(2007-12#2)(2007-8#1)(2008-2#1)
the shortest pulse duration##3##4##(2007-12#1)(2008-3#2)
the shortest pulse##4##3##(2007-12#2)(2008-3#2)
the shortest time##2##3##(2013-7#1)(2013-8#1)
the shortest##42##2##(1990-12#2)(1991-2#2)(1992-11#1)(1992-12#2)(1995-2#1)(1996-5#1)(1997-8#1)(2005-10#1)(2006-8#1)(2007-11#3)(2007-12#8)(2007-6#1)(2007-8#2)(2008-10#3)(2008-2#2)(2008-3#4)(2008-5#2)(2008-6#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
the shortness##2##2##(2009-5#1)(2010-2#1)
the shot noise##2##3##(2008-3#2)
the shot##4##2##(1997-8#1)(2007-12#1)(2008-3#2)
the shot-noise limit##10##3##(2007-11#3)(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#2)
the shot-noise##14##2##(2007-11#3)(2007-12#6)(2008-1#2)(2008-2#1)(2008-3#2)
the shot-noise-limited##3##2##(2008-2#2)(2008-3#1)
the shots##3##2##(2007-10#1)(2013-7#2)
the shoulder and elbow##5##4##(2007-10#1)(2008-9#1)(2012-1#3)
the shoulder and the##2##4##(1997-5#1)(2006-11#1)
the shoulder and##9##3##(1990-12#1)(1997-5#1)(2006-11#1)(2007-10#1)(2008-7#1)(2008-9#1)(2012-1#3)
the shoulder belt##3##3##(2006-11#2)(2013-1#1)
the shoulder due to##2##4##(2007-4#1)(2009-1#1)
the shoulder during##2##3##(2007-10#1)(2009-1#1)
the shoulder girdle##7##3##(1994-7#1)(2006-9#2)(2007-4#1)(2009-3#1)(2012-1#1)(2012-2#1)
the shoulder is##4##3##(2007-11#1)(2007-4#1)(2008-8#1)(2012-1#1)
the shoulder joint##6##3##(1991-4#1)(2007-1#1)(2007-11#2)(2008-7#1)(2008-8#1)
the shoulder of##4##3##(1997-5#1)(2006-11#1)(2008-12#2)
the shoulder region##3##3##(2006-12#1)(2007-4#1)(2007-8#1)
the shoulder rotators##3##3##(2007-7#3)
the shoulder to##2##3##(2006-11#1)(2006-12#1)
the shoulder was##5##3##(2007-10#1)(2007-4#2)(2007-7#2)
the shoulder with##2##3##(2007-11#2)
the shoulder##125##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-4#1)(1992-11#3)(1994-7#1)(1996-9#2)(1997-5#4)(1997-6#1)(2006-11#11)(2006-12#4)(2006-3#1)(2006-9#2)(2007-1#2)(2007-10#4)(2007-11#20)(2007-4#15)(2007-7#8)(2007-8#5)(2008-1#1)(2008-12#2)(2008-7#5)(2008-8#4)(2008-9#1)(2009-1#2)(2009-3#1)(2010-12#3)(2011-12#3)(2011-2#1)(2012-1#8)(2012-2#3)(2013-1#4)
the shoulder)##2##2##(2007-4#1)(2009-3#1)
the shoulders and pelvis##2##4##(1993-9#1)(2007-10#1)
the shoulders and##4##3##(1993-9#1)(2007-10#1)(2011-2#2)
the shoulders##9##2##(1993-9#1)(2006-1#1)(2007-10#2)(2009-6#1)(2011-1#1)(2011-2#2)(2012-2#1)
the shrimp##8##2##(2008-12#1)(2008-5#3)(2011-12#2)(2013-7#2)
the shrinkage##5##2##(2005-11#1)(2010-10#1)(2010-4#1)(2012-2#2)
the shrunken##2##2##(2007-9#1)(2013-7#1)
the shunt vessel was##2##4##(1996-9#2)
the shunt vessel##3##3##(1996-9#3)
the shunt##11##2##(1991-1#2)(1991-12#1)(1996-6#1)(1996-9#4)(2005-10#1)(2006-8#1)(2007-8#1)
the shunts##2##2##(1996-9#1)(2006-5#1)
the shut times##2##3##(1992-9#2)
the shutter##2##2##(2006-5#1)(2008-3#1)
the shuttle vector##2##3##(2005-11#1)(2008-8#1)
the shuttle##6##2##(1993-3#1)(2005-11#1)(2008-2#1)(2008-8#3)
the siRNA##5##2##(2008-11#1)(2008-4#1)(2009-3#1)(2012-2#1)(2013-8#1)
the sialic acid content of##3##5##(1994-9#1)(2008-11#1)(2008-6#1)
the sialic acid residue##2##4##(1997-3#2)
the sialic acid##8##3##(1994-9#1)(1995-1#2)(1996-3#1)(1997-3#2)(2008-11#1)(2008-6#1)
the sialic##9##2##(1993-11#1)(1994-9#1)(1995-1#2)(1996-3#1)(1997-3#2)(2008-11#1)(2008-6#1)
the sialidase##2##2##(1994-3#1)(2008-11#1)
the sialyl and galactosyl molar ratio##2##6##(1993-11#2)
the sialyl and##3##3##(1993-11#2)(1993-8#1)
the sialyl##4##2##(1993-11#2)(1993-8#1)(1997-4#1)
the sialylated##2##2##(1993-11#1)(2006-12#1)
the sialylation of##2##3##(1990-8#1)(2008-11#1)
the sialylation##3##2##(1990-8#1)(1995-3#1)(2008-11#1)
the sibling##6##2##(1995-11#1)(2008-10#1)(2010-9#1)(2013-1#3)
the siblings##6##2##(1995-12#4)(2006-7#1)(2011-1#1)
the siblings'##2##2##(1995-12#1)(2011-2#1)
the sick building syndrome##5##4##(1992-4#5)
the sick##11##2##(1991-8#1)(1992-4#5)(1993-9#1)(2007-11#1)(2007-5#1)(2007-9#1)(2012-3#1)
the sickest##3##2##(1991-3#1)(2008-12#1)(2008-7#1)
the sickness funds##2##3##(2008-7#2)
the sickness##4##2##(1990-4#1)(1991-9#1)(2008-7#2)
the side and##2##3##(2006-6#1)(2013-1#1)
the side branch##3##3##(2007-8#1)(2008-11#2)
the side chain at##3##4##(1995-5#1)(2007-11#1)(2008-8#1)
the side chain in the protein##2##6##(2008-9#2)
the side chain of the##4##5##(1994-8#1)(1996-6#1)(2008-10#1)(2013-8#1)
the side chain of##22##4##(1991-8#1)(1992-1#1)(1992-9#3)(1993-6#4)(1994-10#1)(1994-11#3)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1996-6#1)(2007-11#1)(2008-10#1)(2009-3#1)(2013-8#1)
the side chain##44##3##(1991-2#1)(1991-8#1)(1992-1#1)(1992-9#3)(1993-6#5)(1994-10#1)(1994-11#3)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#1)(2005-3#1)(2006-10#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-8#1)(2008-9#2)(2009-3#1)(2013-8#1)
the side chains of the##3##5##(1991-10#1)(1992-6#1)(2006-8#1)
the side chains of##17##4##(1990-5#1)(1991-10#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-9#2)(1995-1#1)(1995-8#2)(1997-1#1)(1997-4#1)(2006-12#1)(2006-8#2)(2013-8#1)
the side chains##27##3##(1990-5#1)(1991-10#1)(1991-2#1)(1991-7#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-8#1)(1994-9#2)(1995-1#1)(1995-6#1)(1995-8#2)(1996-8#1)(1997-1#1)(1997-4#1)(2006-12#1)(2006-8#2)(2008-10#2)(2013-8#1)
the side effect profile##2##4##(2008-3#1)(2008-7#1)
the side effect##4##3##(1990-10#1)(2008-3#1)(2008-7#1)(2012-2#1)
the side effects and##4##4##(1996-9#1)(1997-4#1)(2008-1#1)(2008-3#1)
the side effects associated with##2##5##(1997-3#1)(2008-7#1)
the side effects of##9##4##(1994-6#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-4#1)
the side effects were##2##4##(1991-8#1)(1996-11#1)
the side effects##30##3##(1991-2#1)(1991-8#1)(1992-12#1)(1993-1#1)(1994-6#1)(1996-11#1)(1996-9#1)(1997-3#2)(1997-4#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2010-10#1)(2010-11#1)(2010-4#1)(2011-1#1)(2013-8#1)
the side impact##3##3##(2006-11#3)
the side ipsilateral to the##7##5##(1991-6#2)(1992-10#1)(1993-7#1)(1995-7#2)(1996-5#1)
the side ipsilateral to##8##4##(1991-6#2)(1992-10#1)(1993-7#1)(1995-11#1)(1995-7#2)(1996-5#1)
the side of a##2##4##(2007-12#2)
the side of the eye##2##5##(2007-12#2)
the side of the lesion##2##5##(1995-12#1)(2007-1#1)
the side of the##18##4##(1993-5#1)(1995-11#1)(1995-12#1)(1995-7#1)(2007-1#1)(2007-12#3)(2007-5#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-6#2)
the side of##27##3##(1990-7#1)(1993-5#1)(1995-11#1)(1995-12#1)(1995-7#1)(2007-1#1)(2007-10#1)(2007-12#5)(2007-5#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#2)(2009-3#1)(2009-6#2)(2012-1#1)
the side position##3##3##(1992-4#2)(2007-1#1)
the side reaction##4##3##(2006-6#2)(2008-10#2)
the side##177##2##(1990-10#1)(1990-5#1)(1990-7#2)(1991-10#1)(1991-2#3)(1991-6#2)(1991-7#1)(1991-8#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-4#3)(1992-5#1)(1992-6#1)(1992-9#4)(1993-1#1)(1993-11#2)(1993-12#2)(1993-5#1)(1993-6#5)(1993-7#2)(1993-8#1)(1994-10#1)(1994-11#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#2)(1995-11#4)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#4)(1995-8#3)(1996-11#1)(1996-5#2)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#2)(2005-3#1)(2006-10#2)(2006-11#3)(2006-12#2)(2006-6#4)(2006-8#2)(2007-1#3)(2007-10#1)(2007-11#3)(2007-12#7)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#3)(2008-1#2)(2008-10#9)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#2)(2009-12#1)(2009-3#2)(2009-6#2)(2010-10#1)(2010-11#1)(2010-4#1)(2010-6#1)(2011-1#3)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#3)
the side-chain cleavage##2##3##(1991-10#1)(1994-2#1)
the side-chain of##2##3##(1996-11#1)(2008-8#1)
the side-chain prediction##3##3##(2012-3#3)
the side-chain##14##2##(1991-10#1)(1992-12#1)(1992-6#1)(1994-2#1)(1994-5#1)(1995-1#1)(1996-11#1)(1997-4#1)(1997-8#1)(2008-8#2)(2012-3#3)
the side-chains of##2##3##(1996-6#1)(2006-10#1)
the side-effect##2##2##(1996-9#1)(2006-2#1)
the side-effects of##4##3##(1993-11#1)(1997-6#1)(2006-10#1)(2007-8#1)
the side-effects##12##2##(1990-2#1)(1993-11#2)(1997-6#1)(2006-10#2)(2007-7#1)(2007-8#2)(2008-5#1)(2008-7#1)(2012-2#1)
the sideband##3##2##(2007-11#2)(2008-3#1)
the sidedness of##2##3##(1990-11#2)
the sidelobes##3##2##(2007-11#2)(2008-2#1)
the siderophore##4##2##(1995-10#1)(1996-10#2)(2011-2#1)
the sides of the##2##4##(1992-9#1)(2007-12#1)
the sides of##6##3##(1992-9#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#1)
the sides##8##2##(1992-9#1)(2007-10#2)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-2#1)
the sidewall##3##2##(2006-6#1)(2008-3#2)
the sidewalls of##3##3##(2007-11#1)(2008-10#1)(2008-4#1)
the sidewalls##4##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)
the sight and ingestion of food##3##6##(1991-5#3)
the sight and ingestion of##4##5##(1991-5#4)
the sight and##5##3##(1991-5#4)(2011-2#1)
the sight of##3##3##(1993-6#3)
the sight##10##2##(1991-5#6)(1993-6#3)(2011-2#1)
the sigma 70 subunit##2##4##(1995-2#2)
the sigma 70##3##3##(1994-12#1)(1995-2#2)
the sigma binding##2##3##(1994-3#1)(1996-8#1)
the sigma ligands##3##3##(1994-5#2)(1997-5#1)
the sigma receptor##3##3##(1994-9#1)(1997-5#1)(2008-3#1)
the sigma##24##2##(1990-2#1)(1991-5#1)(1991-6#1)(1992-5#1)(1993-12#1)(1994-12#2)(1994-3#1)(1994-5#3)(1994-9#2)(1995-2#4)(1995-6#1)(1996-3#1)(1996-8#1)(1997-5#2)(2008-3#1)(2012-2#1)
the sigma-1 receptor##2##3##(2008-3#2)
the sigma1##2##2##(1995-12#2)
the sigma2##2##2##(1995-12#2)
the sigmoid colon##19##3##(1991-4#2)(1991-6#1)(1993-10#1)(2004-10#1)(2006-2#1)(2006-4#1)(2006-8#1)(2008-4#1)(2010-12#2)(2010-5#2)(2011-11#3)(2011-2#2)(2012-1#1)
the sigmoid notch is##2##4##(2008-9#1)(2012-2#1)
the sigmoid notch##5##3##(2008-9#1)(2012-2#4)
the sigmoid sinus##2##3##(1996-9#1)(2008-7#1)
the sigmoid##32##2##(1991-4#2)(1991-6#1)(1993-10#1)(1993-5#1)(1996-9#1)(2004-10#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#2)(2010-5#2)(2011-11#3)(2011-2#3)(2012-1#1)(2012-2#4)
the sign and magnitude of the##3##6##(1997-7#1)(2008-10#1)(2008-8#1)
the sign and##6##3##(1995-4#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-8#1)
the sign of a##3##4##(2006-9#1)(2007-8#1)(2008-9#1)
the sign of the phase##2##5##(2008-3#2)
the sign of the##13##4##(1997-1#1)(2007-11#2)(2007-12#1)(2008-3#5)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)
the sign of##19##3##(1997-1#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)
the sign score regression method##2##5##(1995-2#2)
the sign test##2##3##(1996-1#2)
the sign##33##2##(1995-2#2)(1995-4#1)(1996-1#2)(1996-11#1)(1997-1#1)(1997-7#1)(2006-9#1)(2007-11#5)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2009-8#1)
the signal and from##2##4##(2007-12#1)(2008-1#1)
the signal and the idler##7##5##(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#1)
the signal and the reference##3##5##(2008-3#3)
the signal and the##15##4##(2007-11#3)(2007-12#4)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#4)
the signal and##29##3##(1991-11#1)(1997-7#1)(2007-11#4)(2007-12#8)(2008-1#4)(2008-10#1)(2008-2#3)(2008-3#7)
the signal at##2##3##(2007-12#1)(2008-2#1)
the signal averaged##2##3##(1995-6#2)
the signal bandwidth##2##3##(2008-2#2)
the signal beam##7##3##(2007-12#2)(2008-1#1)(2008-3#4)
the signal becomes##2##3##(2008-3#2)
the signal can be##2##4##(1991-12#1)(2008-10#1)
the signal detected by##2##4##(2007-11#1)(2008-10#1)
the signal field##3##3##(2007-12#2)(2008-3#1)
the signal for##5##3##(1993-12#1)(1995-8#1)(1996-3#1)(2005-8#1)(2006-10#1)
the signal frequency##2##3##(2007-12#2)
the signal from a##3##4##(2005-11#1)(2007-12#1)(2008-2#1)
the signal from the##3##4##(1993-6#1)(2007-11#1)(2008-2#1)
the signal from##9##3##(1993-6#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#2)(2008-4#1)(2012-2#1)
the signal gain##2##3##(2007-12#2)
the signal height##3##3##(1993-8#1)(2007-8#1)(2008-10#1)
the signal in the##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
the signal intensities of##2##4##(2006-8#1)(2012-3#1)
the signal intensities##3##3##(2006-8#1)(2008-10#1)(2012-3#1)
the signal intensity##14##3##(1996-2#1)(2007-8#1)(2008-10#2)(2008-3#5)(2008-7#2)(2010-2#1)(2010-8#1)(2012-3#1)
the signal is##13##3##(1990-5#1)(1991-12#1)(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#3)(2010-8#1)
the signal light##5##3##(2007-12#3)(2008-2#1)(2008-3#1)
the signal may##2##3##(2008-10#1)(2008-3#1)
the signal molecules##2##3##(2007-12#1)(2008-8#1)
the signal noise##2##3##(2008-10#1)(2008-2#1)
the signal obtained##2##3##(1996-2#1)(2008-2#1)
the signal of the##2##4##(2008-10#2)
the signal of##10##3##(1997-5#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-5#1)(2013-7#1)
the signal on##2##3##(1993-3#1)(2009-3#1)
the signal peptide and##4##4##(1990-6#1)(1991-9#1)(1993-12#1)(1997-2#1)
the signal peptide in##3##4##(1992-11#3)
the signal peptide of the##2##5##(1990-12#1)(1992-7#1)
the signal peptide of##4##4##(1990-12#1)(1992-7#1)(2008-5#1)(2013-8#1)
the signal peptide##23##3##(1990-11#1)(1990-12#1)(1990-6#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#3)(1992-12#1)(1992-7#1)(1993-12#3)(1994-2#1)(1997-2#1)(1997-4#2)(1997-7#1)(2008-5#1)(2008-6#1)(2010-6#1)(2013-8#1)
the signal power##3##3##(2008-3#3)
the signal processing##4##3##(1991-12#1)(2008-3#1)(2009-9#2)
the signal pulses##3##3##(2007-12#2)(2008-2#1)
the signal quality##2##3##(2008-10#1)(2010-8#1)
the signal range##2##3##(2007-12#1)(2008-10#1)
the signal recognition particle (SRP)##2##5##(1992-6#1)(1993-8#1)
the signal recognition particle##4##4##(1992-6#2)(1993-8#1)(1995-6#1)
the signal recognition##5##3##(1992-6#2)(1993-8#1)(1995-6#2)
the signal response of##2##4##(2008-10#2)
the signal response##3##3##(1996-2#1)(2008-10#2)
the signal sequence and##6##4##(1991-6#1)(1992-3#1)(1993-9#1)(1997-6#1)(2008-11#2)
the signal sequence from##2##4##(1996-7#1)(2008-11#1)
the signal sequence of##3##4##(1990-1#1)(1993-9#2)
the signal sequence was##2##4##(1991-10#2)
the signal sequence##21##3##(1990-1#1)(1991-10#3)(1991-6#3)(1992-2#1)(1992-3#1)(1993-9#4)(1995-1#1)(1996-4#1)(1996-7#1)(1997-6#1)(2008-11#4)
the signal started to##2##4##(2008-10#1)(2012-3#1)
the signal subspace##2##3##(2008-2#2)
the signal that##6##3##(1994-8#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
the signal to be##2##4##(2007-11#1)(2008-2#1)
the signal to noise ratio##2##5##(2008-10#2)
the signal to the##2##4##(2007-12#1)(2008-10#1)
the signal to##13##3##(1991-12#1)(1991-3#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#2)(2009-6#1)
the signal transducer and activator of##2##6##(2008-8#1)(2012-1#1)
the signal transducer and##3##4##(2008-7#1)(2008-8#1)(2012-1#1)
the signal transducer##5##3##(1996-2#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-1#1)
the signal transducing##4##3##(1993-6#1)(1994-11#1)(1996-11#1)(2009-4#1)
the signal transduction and##2##4##(2012-1#2)
the signal transduction by##2##4##(1993-8#1)(2008-7#1)
the signal transduction cascade##2##4##(1993-12#1)(1995-12#1)
the signal transduction of##6##4##(1993-3#1)(1995-12#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-5#1)
the signal transduction pathway leading to##2##6##(1994-11#1)(1996-10#1)
the signal transduction pathway##10##4##(1991-12#1)(1991-5#1)(1994-11#1)(1994-3#1)(1996-10#1)(1996-11#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#1)
the signal transduction pathways activated by##2##6##(2008-4#2)
the signal transduction pathways of##2##5##(1996-5#1)(2008-10#1)
the signal transduction pathways that##2##5##(1997-1#1)(2009-10#1)
the signal transduction pathways##12##4##(1991-3#1)(1994-11#1)(1996-5#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#3)(2009-10#1)
the signal transduction##46##3##(1990-12#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-6#1)(1993-12#1)(1993-3#2)(1993-8#2)(1994-11#2)(1994-3#1)(1994-9#1)(1995-12#2)(1995-3#1)(1996-10#1)(1996-11#1)(1996-5#3)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2011-2#1)(2012-1#2)
the signal was##4##3##(1997-2#1)(2008-10#1)(2008-3#1)(2013-8#1)
the signal wave##2##3##(2007-11#1)(2008-3#1)
the signal windowed by##2##4##(2007-11#2)
the signal##398##2##(1990-1#1)(1990-11#1)(1990-12#2)(1990-5#2)(1990-6#1)(1990-8#1)(1991-10#3)(1991-11#2)(1991-12#9)(1991-3#2)(1991-5#1)(1991-6#4)(1991-8#2)(1991-9#1)(1992-11#4)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#3)(1992-7#2)(1993-12#5)(1993-3#3)(1993-6#2)(1993-8#4)(1993-9#4)(1994-11#3)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-6#5)(1995-8#1)(1996-10#1)(1996-11#2)(1996-2#5)(1996-3#1)(1996-4#2)(1996-5#4)(1996-7#2)(1997-1#1)(1997-2#3)(1997-4#3)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#2)(2005-11#1)(2005-8#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-11#16)(2007-12#50)(2007-8#3)(2007-9#1)(2008-1#12)(2008-10#42)(2008-11#7)(2008-12#2)(2008-2#37)(2008-3#49)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-8#1)(2009-9#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#3)(2012-1#4)(2012-2#1)(2012-3#4)(2013-7#1)(2013-8#3)
the signal-carrying##2##2##(2008-1#2)
the signal-sequence cleavage site##3##4##(1991-6#3)
the signal-to-background ratio##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
the signal-to-background##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
the signal-to-noise (S/N)##2##3##(2007-8#2)
the signal-to-noise ratio (SNR) of##2##5##(2008-10#1)(2010-8#1)
the signal-to-noise ratio (SNR)##7##4##(2008-10#2)(2008-2#2)(2008-3#1)(2009-5#1)(2010-8#1)
the signal-to-noise ratio and##2##4##(2007-11#1)(2008-3#1)
the signal-to-noise ratio in the reconstruction##2##6##(2007-11#1)(2008-3#1)
the signal-to-noise ratio in the##3##5##(2007-11#1)(2007-12#1)(2008-3#1)
the signal-to-noise ratio in##4##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
the signal-to-noise ratio is##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
the signal-to-noise ratio of the##5##5##(2007-12#1)(2008-10#1)(2008-3#3)
the signal-to-noise ratio of##10##4##(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#4)
the signal-to-noise ratio was##2##4##(1993-7#1)(2008-2#1)
the signal-to-noise ratio with##3##4##(2008-2#1)(2008-3#2)
the signal-to-noise ratio##57##3##(1993-7#1)(2007-11#2)(2007-12#9)(2007-8#1)(2008-10#6)(2008-2#15)(2008-3#20)(2009-5#1)(2010-8#1)(2012-3#1)
the signal-to-noise ratios of##2##4##(2007-8#1)(2008-3#1)
the signal-to-noise##66##2##(1993-7#1)(2007-11#3)(2007-12#9)(2007-8#4)(2008-10#8)(2008-2#16)(2008-3#22)(2009-5#1)(2010-8#1)(2012-3#1)
the signaler##2##2##(2008-9#2)
the signaling cascade leading##2##4##(1995-6#1)(2009-8#1)
the signaling cascade##3##3##(1995-6#1)(1997-6#1)(2009-8#1)
the signaling molecule##2##3##(2009-6#1)(2010-4#1)
the signaling of##3##3##(1995-3#2)(2009-8#1)
the signaling pathway of p21ras##2##5##(1992-12#2)
the signaling pathway of##5##4##(1992-12#2)(1992-6#1)(1994-11#1)(2008-11#1)
the signaling pathway##11##3##(1992-12#2)(1992-6#1)(1994-11#2)(1994-12#1)(1996-5#1)(2008-11#1)(2009-8#1)(2010-12#1)(2011-1#1)
the signaling pathways activated by##2##5##(1997-7#1)(2008-4#1)
the signaling pathways activated##3##4##(1997-7#2)(2008-4#1)
the signaling pathways and##2##4##(2010-12#1)(2012-12#1)
the signaling pathways involved##2##4##(2008-10#1)(2012-1#1)
the signaling pathways leading##2##4##(1997-6#1)(2007-11#1)
the signaling pathways that##3##4##(1996-5#1)(2009-8#2)
the signaling pathways##17##3##(1991-7#1)(1992-5#1)(1995-8#1)(1996-5#1)(1997-6#1)(1997-7#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-8#2)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
the signaling properties of##2##4##(2008-4#1)(2012-1#1)
the signaling##52##2##(1991-2#1)(1991-7#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-6#1)(1994-11#2)(1994-12#2)(1994-9#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-5#2)(1997-6#2)(1997-7#2)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-4#4)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2009-8#6)(2010-1#2)(2010-12#2)(2010-4#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#1)
the signalling pathways##4##3##(2006-12#1)(2008-10#1)(2008-4#1)(2008-7#1)
the signalling##10##2##(1992-3#1)(1992-7#1)(1996-3#1)(1996-8#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-8#1)
the signals for##3##3##(1990-2#1)(2007-1#1)(2007-11#1)
the signals from##4##3##(1990-3#1)(2008-10#3)
the signals in the##3##4##(2008-3#3)
the signals in##4##3##(2008-3#4)
the signals of the##2##4##(2008-10#1)(2013-8#1)
the signals of##9##3##(1994-8#1)(1996-10#1)(2007-12#1)(2008-10#1)(2008-8#1)(2012-1#2)(2013-8#2)
the signals that##3##3##(1994-12#1)(1996-4#1)(2007-9#1)
the signals##57##2##(1990-11#1)(1990-2#1)(1990-3#2)(1991-12#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-4#2)(1997-5#1)(1997-6#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-2#3)(2008-3#8)(2008-8#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-7#1)(2012-1#2)(2013-1#2)(2013-7#1)(2013-8#2)
the signature of##2##3##(1996-4#1)(2012-12#1)
the signature##8##2##(1994-12#1)(1996-4#1)(2007-8#1)(2008-2#1)(2008-8#2)(2009-6#1)(2012-12#1)
the signatures##4##2##(1995-3#2)(2008-3#1)(2009-3#1)
the significance and##3##3##(2012-1#1)(2012-2#1)(2013-8#1)
the significance level##3##3##(1996-12#1)(2008-10#1)(2008-12#1)
the significance of a##2##4##(1991-6#1)(2012-12#1)
the significance of any##4##4##(2006-12#1)(2007-11#1)(2009-6#1)(2010-7#1)
the significance of differences in##2##5##(2006-9#1)(2008-7#1)
the significance of differences##3##4##(2006-9#1)(2007-10#1)(2008-7#1)
the significance of environmental factors##2##5##(2005-8#1)(2008-8#1)
the significance of insulin##2##4##(1990-2#1)(2010-11#1)
the significance of medical##2##4##(1993-10#1)(2009-2#1)
the significance of national##2##4##(1995-6#1)(1995-9#1)
the significance of positive##2##4##(1992-11#1)(2011-2#1)
the significance of such##2##4##(1991-5#1)(2011-2#1)
the significance of the above##2##5##(1993-12#1)(2013-1#1)
the significance of the presence of##2##6##(2007-7#1)(2008-5#1)
the significance of the reported##2##5##(1994-12#1)(2009-8#1)
the significance of the role of##2##6##(2008-10#1)(2013-8#1)
the significance of the##54##4##(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-12#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-9#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-9#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-7#2)(2008-1#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#2)
the significance of these##6##4##(1992-2#1)(1994-9#1)(2006-8#1)(2008-3#1)(2008-8#1)(2009-10#1)
the significance of this##12##4##(1992-9#1)(1993-1#1)(1993-12#1)(1995-5#1)(1995-8#1)(2005-7#1)(2007-6#1)(2008-9#1)(2009-3#1)(2009-4#1)(2011-2#1)(2012-3#1)
the significance of which##2##4##(2006-8#1)(2011-2#1)
the significance of##180##3##(1990-11#1)(1990-2#1)(1990-5#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-12#2)(1993-4#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-9#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-7#1)(1997-8#1)(2004-1#1)(2005-10#1)(2005-11#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#5)(2006-12#2)(2006-4#1)(2006-6#1)(2006-8#2)(2006-9#2)(2007-10#4)(2007-11#4)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#3)(2009-7#2)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#9)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#5)(2013-1#6)(2013-8#3)
the significance##193##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-12#2)(1993-4#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-9#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-9#3)(1997-1#1)(1997-7#1)(1997-8#1)(2004-1#1)(2005-10#1)(2005-11#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#5)(2006-12#2)(2006-4#1)(2006-6#1)(2006-8#2)(2006-9#2)(2007-10#4)(2007-11#4)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#3)(2009-1#1)(2009-10#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#3)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#9)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#5)(2013-1#6)(2013-8#5)
the significant advances in##3##4##(2007-11#1)(2008-8#1)(2010-12#1)
the significant advances##4##3##(2007-11#1)(2008-10#1)(2008-8#1)(2010-12#1)
the significant advantages##2##3##(2008-10#1)(2009-6#1)
the significant difference in##3##4##(1996-1#1)(2008-3#1)(2010-8#1)
the significant difference##5##3##(1996-1#1)(2007-12#1)(2008-3#1)(2010-8#1)(2012-12#1)
the significant differences in##2##4##(1990-11#1)(2007-4#1)
the significant differences##5##3##(1990-11#1)(1996-12#1)(2007-10#1)(2007-4#1)(2012-12#1)
the significant effect of##2##4##(2006-10#1)(2008-10#1)
the significant effects of##2##4##(2005-11#1)(2012-2#1)
the significant factors##3##3##(2008-10#3)
the significant impact##2##3##(2009-6#1)(2011-12#1)
the significant improvements##2##3##(2008-2#1)(2011-2#1)
the significant increase in the level of##2##7##(2009-8#1)(2013-8#1)
the significant increase in the##4##5##(1994-5#1)(1997-4#1)(2009-8#1)(2013-8#1)
the significant increase in##7##4##(1994-5#1)(1997-4#1)(2008-5#1)(2009-8#2)(2012-11#1)(2013-8#1)
the significant increase##8##3##(1994-5#1)(1997-4#1)(2008-5#1)(2009-8#3)(2012-11#1)(2013-8#1)
the significant influence of##2##4##(2007-4#1)(2008-3#1)
the significant loss of##2##4##(2007-4#1)(2008-7#1)
the significant progress in##2##4##(2008-5#1)(2009-8#1)
the significant reduction##2##3##(2010-12#1)(2013-8#1)
the significant role of##4##4##(1992-12#1)(2008-10#1)(2009-4#1)(2013-8#1)
the significant role that##4##4##(2008-2#1)(2008-7#1)(2012-12#1)(2012-3#1)
the significant role##11##3##(1992-12#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2009-4#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
the significant toxicity##2##3##(2008-3#1)(2008-6#1)
the significant variables were##2##4##(2008-10#2)
the significant variables##5##3##(2008-10#4)(2008-2#1)
the significant variation##2##3##(2008-10#1)(2012-12#1)
the significant variations in##2##4##(2007-7#1)(2008-10#1)
the significant##137##2##(1990-11#1)(1991-7#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-5#2)(2005-1#3)(2005-11#2)(2005-7#1)(2005-9#1)(2006-10#3)(2006-4#1)(2006-5#2)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#4)(2007-7#1)(2008-1#1)(2008-10#20)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-8#5)(2010-1#1)(2010-12#3)(2010-3#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#1)(2012-3#4)(2013-1#4)(2013-8#6)
the significantly higher##4##3##(2006-6#1)(2008-4#1)(2008-6#1)(2009-9#1)
the significantly##12##2##(1990-8#1)(1991-2#1)(1995-6#1)(2006-6#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
the signs and symptoms and##2##5##(2006-5#1)(2010-9#1)
the signs and symptoms of the##3##6##(1997-7#1)(2007-7#2)
the signs and symptoms of##13##5##(1997-7#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-2#1)(2007-7#3)(2008-1#1)(2008-3#2)(2008-5#1)(2009-3#1)
the signs and symptoms##20##4##(1997-7#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-2#1)(2007-7#3)(2008-1#1)(2008-3#2)(2008-5#1)(2009-3#1)(2010-12#1)(2010-9#1)(2011-1#1)
the signs of##14##3##(1994-6#1)(2005-1#1)(2006-1#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-5#3)(2009-7#1)(2011-2#1)(2012-2#2)(2013-8#1)
the signs##40##2##(1992-4#1)(1994-6#1)(1996-9#1)(1997-7#1)(2005-1#1)(2005-11#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-7#3)(2008-1#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#4)(2009-3#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
the silage##4##2##(1990-6#1)(2005-7#1)(2012-2#1)(2013-1#1)
the silane coupling##2##3##(2004-9#1)(2005-11#1)
the silane layer##5##3##(2005-11#5)
the silane##9##2##(2004-9#1)(2005-11#8)
the silenced transgenic rice##2##4##(2008-9#2)
the silenced##4##2##(2006-12#2)(2008-9#2)
the silencing of##2##3##(2006-12#1)(2011-2#1)
the silencing##6##2##(2006-12#1)(2008-10#1)(2008-9#1)(2009-8#1)(2010-6#1)(2011-2#1)
the silent mating locus HMR##2##5##(1995-1#2)
the silent mating##3##3##(1995-1#2)(2008-8#1)
the silent##14##2##(1993-11#1)(1994-10#2)(1995-1#2)(1995-2#1)(1995-3#1)(2006-12#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-5#1)(2013-1#1)
the silica content##2##3##(2008-10#2)
the silica gel##6##3##(2005-12#1)(2008-10#5)
the silica surface##11##3##(1996-8#1)(1997-3#1)(2005-11#4)(2007-11#1)(2008-10#4)
the silica##43##2##(1995-3#1)(1996-8#1)(1997-3#2)(2004-9#1)(2005-11#6)(2005-12#1)(2007-11#1)(2007-12#1)(2008-10#20)(2008-2#1)(2008-3#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-7#1)(2013-8#1)
the silica-based##2##2##(1997-2#2)
the silicate##7##2##(1995-6#1)(2005-11#5)(2008-10#1)
the silicon##25##2##(2005-11#1)(2006-12#2)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#3)(2010-4#1)(2013-8#1)
the silicon-based##2##2##(2007-11#1)(2008-10#1)
the silicone adaptor tubing##2##4##(2008-11#2)
the silicone##9##2##(1992-2#1)(1996-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#2)
the silk press##2##3##(2007-12#2)
the silk##7##2##(1996-7#1)(2007-12#6)
the silkworm Bombyx mori##3##4##(1991-10#1)(2008-5#1)(2008-9#1)
the silkworm##20##2##(1990-12#2)(1991-10#4)(1992-11#1)(1993-12#1)(1995-11#5)(1997-4#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-9#1)
the sill##2##2##(1991-11#1)(2008-10#1)
the siloxy bilayers##3##3##(2008-10#3)
the siloxy##5##2##(2008-10#5)
the silver colloid##2##3##(2007-8#2)
the silver nanoparticle##2##3##(2005-11#1)(2008-3#1)
the silver surface##3##3##(2005-4#2)(2008-10#1)
the silver##31##2##(1996-2#1)(2005-11#6)(2005-4#2)(2006-7#1)(2007-12#2)(2007-8#2)(2008-10#8)(2008-3#6)(2008-5#1)(2010-1#1)(2013-8#1)
the simian gastroepiploic artery##2##4##(1993-3#2)
the simian virus 40##2##4##(1990-12#1)(1993-4#1)
the simian##8##2##(1990-12#1)(1992-6#1)(1993-3#2)(1993-4#1)(1995-8#1)(1997-3#1)(2008-9#1)
the similar##28##2##(1990-3#1)(1990-9#1)(1991-5#1)(1991-7#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(1997-6#1)(2005-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-2#1)(2010-4#2)(2012-3#1)(2013-8#3)
the similarities and differences between##6##5##(1997-3#1)(2008-11#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-12#1)
the similarities and differences in##2##5##(2005-4#1)(2009-3#1)
the similarities and differences##11##4##(1997-3#1)(2005-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-3#1)(2009-9#1)(2010-2#1)(2011-2#2)(2012-12#1)
the similarities between the##4##4##(1990-2#1)(1992-9#1)(2008-11#1)(2011-12#1)
the similarities between these##2##4##(1993-3#1)(2008-7#1)
the similarities between##11##3##(1990-2#1)(1992-9#1)(1993-3#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-5#1)(2011-12#1)
the similarities of the##2##4##(2007-11#1)(2008-5#1)
the similarities of##4##3##(1993-3#1)(2007-11#1)(2008-5#1)(2011-2#1)
the similarities##28##2##(1990-2#1)(1991-2#1)(1992-9#1)(1993-3#2)(1997-3#1)(2005-4#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-2#1)(2011-12#1)(2011-2#3)(2012-12#1)
the similarity between adjacent##2##4##(2008-2#1)(2013-8#1)
the similarity between the##5##4##(1992-8#1)(1994-8#1)(1995-3#1)(2008-2#1)(2009-3#1)
the similarity between##11##3##(1992-8#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-10#1)(2007-12#1)(2008-2#3)(2009-3#1)(2013-8#1)
the similarity in the##2##4##(1991-3#1)(1997-1#1)
the similarity in##6##3##(1991-3#1)(1993-3#1)(1997-1#1)(2008-10#2)(2011-2#1)
the similarity of the##8##4##(1990-2#1)(1991-7#1)(1997-3#1)(2008-10#3)(2009-8#1)(2012-12#1)
the similarity of##13##3##(1990-2#1)(1991-7#1)(1994-9#1)(1997-3#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-8#1)(2012-12#1)
the similarity or##2##3##(1994-2#1)(1995-1#1)
the similarity to##3##3##(1993-8#1)(1994-12#1)(2008-5#1)
the similarity##43##2##(1990-2#1)(1991-3#1)(1991-7#2)(1992-8#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-10#1)(1997-1#1)(1997-3#1)(2005-11#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#4)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#3)
the similarly##2##2##(2008-5#1)(2013-1#1)
the similitude##2##2##(2013-7#2)
the simple addition of##2##4##(2007-12#1)(2013-1#1)
the simple determination of##2##4##(2008-10#2)
the simple method of##2##4##(2008-10#1)(2008-3#1)
the simple model##3##3##(2005-10#1)(2005-11#1)(2009-8#1)
the simple reduction##2##3##(1992-3#1)(2010-12#1)
the simple##83##2##(1990-11#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-3#1)(1995-6#1)(1996-3#1)(1996-8#1)(1997-7#1)(2005-10#1)(2005-11#2)(2006-4#2)(2007-11#3)(2007-12#4)(2007-2#1)(2007-5#1)(2007-8#5)(2008-1#2)(2008-10#15)(2008-11#1)(2008-2#9)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#2)(2010-12#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-1#2)(2013-1#1)(2013-8#1)
the simpler##6##2##(1990-7#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-12#1)(2011-2#1)
the simplest and most##6##4##(1990-5#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-4#1)
the simplest and##7##3##(1990-5#1)(2006-2#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-4#1)
the simplest##32##2##(1990-10#1)(1990-5#1)(1995-2#1)(1995-3#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-8#1)(2011-12#1)
the simplex method##3##3##(2008-10#3)
the simplex##4##2##(2008-10#4)
the simplicity and##3##3##(2006-5#1)(2008-1#1)(2008-4#1)
the simplicity of the basic##2##5##(2008-11#1)(2008-3#1)
the simplicity of the##9##4##(2005-11#2)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-10#1)
the simplicity of this##2##4##(2008-10#2)
the simplicity of##13##3##(2005-11#2)(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-10#1)
the simplicity##20##2##(2005-11#2)(2006-5#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-10#1)(2010-5#1)
the simplified icELISA##2##3##(2007-8#2)
the simplified##14##2##(1991-2#1)(1994-2#2)(2005-11#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#1)(2008-2#3)(2008-4#1)
the simulant##4##2##(2005-4#2)(2012-12#2)
the simulated and experimental##2##4##(2007-12#1)(2008-10#1)
the simulated and##4##3##(2005-11#1)(2007-12#1)(2007-5#1)(2008-10#1)
the simulated annealing method##3##4##(2008-3#2)(2011-1#1)
the simulated annealing##5##3##(1992-12#1)(2008-3#3)(2011-1#1)
the simulated data##2##3##(2012-3#2)
the simulated##50##2##(1992-12#1)(1994-3#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-11#2)(2007-12#2)(2007-5#1)(2007-9#2)(2008-10#8)(2008-11#2)(2008-2#3)(2008-3#5)(2008-5#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#10)
the simulated-annealing##2##2##(2008-2#1)(2008-3#1)
the simulation and the experimental results##2##6##(2008-2#1)(2008-3#1)
the simulation and the##3##4##(2008-2#2)(2008-3#1)
the simulation data##2##3##(2008-3#1)(2012-3#1)
the simulation experiments##2##3##(2008-10#2)
the simulation is##3##3##(2007-5#1)(2008-2#2)
the simulation model##6##3##(2008-10#1)(2012-3#5)
the simulation of a##2##4##(2007-5#1)(2008-10#1)
the simulation of the##3##4##(1996-7#1)(2007-9#1)(2008-2#1)
the simulation of##17##3##(1993-11#1)(1996-7#1)(2005-11#1)(2006-5#1)(2007-12#1)(2007-5#2)(2007-9#1)(2008-10#2)(2008-2#3)(2008-3#1)(2010-12#1)(2010-3#1)(2011-2#1)
the simulation results for##2##4##(2008-3#1)(2008-8#1)
the simulation results##5##3##(2008-2#1)(2008-3#3)(2008-8#1)
the simulation study##2##3##(2008-9#1)(2010-8#1)
the simulation system##2##3##(2006-10#1)(2008-10#1)
the simulation temperature##2##3##(1995-2#1)(2006-10#1)
the simulation##82##2##(1993-11#1)(1993-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-7#1)(2005-11#1)(2006-10#4)(2006-12#1)(2006-5#2)(2007-12#1)(2007-5#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-2#15)(2008-3#13)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-8#2)(2011-2#2)(2012-3#10)
the simulations and the experiments##2##5##(2008-3#1)(2010-2#1)
the simulations are##2##3##(1992-3#1)(2008-3#1)
the simulations by##2##3##(1997-3#1)(2007-10#1)
the simulations show##4##3##(2008-2#1)(2008-3#3)
the simulations##40##2##(1990-10#2)(1992-3#1)(1995-6#1)(1995-8#3)(1996-6#1)(1997-3#1)(2007-10#1)(2007-12#1)(2007-9#3)(2008-10#3)(2008-2#5)(2008-3#10)(2008-8#1)(2008-9#2)(2010-12#1)(2010-2#1)(2010-9#2)(2012-1#1)
the simultaneous activity of##2##4##(1995-3#1)(2009-3#1)
the simultaneous addition of the##3##5##(1996-3#1)(2008-10#1)(2009-2#1)
the simultaneous addition of##5##4##(1993-7#1)(1996-3#1)(2008-10#1)(2009-2#1)(2009-8#1)
the simultaneous administration of##4##4##(1990-10#1)(1991-3#1)(1992-6#1)(1994-5#1)
the simultaneous analysis of 11##2##5##(2008-12#1)(2012-3#1)
the simultaneous analysis of##15##4##(1990-8#1)(1996-6#1)(2007-8#2)(2008-10#7)(2008-12#1)(2008-3#1)(2008-4#1)(2012-3#1)
the simultaneous and##4##3##(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#1)
the simultaneous assay of##4##4##(1997-8#1)(2007-12#1)(2008-10#2)
the simultaneous assessment of surface##2##5##(2008-9#2)
the simultaneous assessment of##3##4##(2008-12#1)(2008-9#2)
the simultaneous binding of##2##4##(1990-12#1)(1994-5#1)
the simultaneous comparison of##2##4##(2008-2#1)(2008-4#1)
the simultaneous detection of numerous##2##5##(1994-6#1)(2008-3#1)
the simultaneous detection of##16##4##(1994-6#1)(1996-8#1)(2006-8#1)(2008-10#7)(2008-2#1)(2008-3#2)(2008-9#1)(2010-11#1)(2013-8#1)
the simultaneous detection##21##3##(1994-6#1)(1996-8#1)(2006-8#1)(2008-10#9)(2008-2#1)(2008-3#2)(2008-9#1)(2010-11#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
the simultaneous determination of As##3##5##(2008-10#3)
the simultaneous determination of NA and OH-NA in urine##2##9##(2008-10#2)
the simultaneous determination of Vitamin D(3) and##2##7##(2008-10#2)
the simultaneous determination of both##3##5##(2008-10#3)
the simultaneous determination of copper and##2##6##(2008-10#2)
the simultaneous determination of lead##3##5##(2008-10#3)
the simultaneous determination of nitrite and nitrate in water samples##2##10##(2008-10#2)
the simultaneous determination of nitrite and nitrate in##5##8##(2008-10#5)
the simultaneous determination of nitrite and nitrate##7##7##(2008-10#7)
the simultaneous determination of seven##2##5##(2008-10#2)
the simultaneous determination of the##16##5##(1996-5#1)(1997-8#1)(2008-10#11)(2008-2#1)(2008-3#1)(2012-12#1)
the simultaneous determination of three##3##5##(2008-10#3)
the simultaneous determination of trace amounts of##2##7##(2008-10#2)
the simultaneous determination of trace##5##5##(2008-10#5)
the simultaneous determination of urinary##3##5##(1990-8#1)(1996-6#1)(1997-3#1)
the simultaneous determination of##178##4##(1990-11#2)(1990-6#4)(1990-8#3)(1991-8#1)(1993-2#1)(1993-9#1)(1995-3#2)(1996-11#1)(1996-3#1)(1996-5#1)(1996-6#4)(1996-8#1)(1997-3#1)(1997-8#2)(2004-11#1)(2007-8#1)(2008-10#134)(2008-2#2)(2008-3#1)(2009-6#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-12#6)(2013-7#2)
the simultaneous determination##179##3##(1990-11#2)(1990-6#4)(1990-8#3)(1991-8#1)(1993-2#1)(1993-9#1)(1995-3#2)(1996-11#1)(1996-3#1)(1996-5#1)(1996-6#4)(1996-8#1)(1997-3#1)(1997-8#2)(2004-11#1)(2007-8#1)(2008-10#135)(2008-2#2)(2008-3#1)(2009-6#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-12#6)(2013-7#2)
the simultaneous evaluation of##2##4##(2008-2#1)(2008-5#1)
the simultaneous expression of##2##4##(1996-10#1)(2006-5#1)
the simultaneous identification and quantitative determination of##2##7##(2008-5#2)
the simultaneous identification and##3##4##(2008-5#2)(2008-9#1)
the simultaneous in##2##3##(2008-10#1)(2008-2#1)
the simultaneous inclusion of##2##4##(2008-9#1)(2010-4#1)
the simultaneous influence of##3##4##(1995-12#1)(2009-1#1)(2009-7#1)
the simultaneous maximization of the peak current and minimization of##2##10##(2008-10#2)
the simultaneous maximization of the##3##5##(2008-10#2)(2008-2#1)
the simultaneous measurement of strain and temperature##2##7##(2008-3#2)
the simultaneous measurement of the##2##5##(1992-12#1)(2008-2#1)
the simultaneous measurement of##11##4##(1992-12#1)(1994-12#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#2)(2008-3#4)
the simultaneous multielement determination##2##4##(2008-10#2)
the simultaneous occurrence of##3##4##(2011-1#1)(2013-1#2)
the simultaneous phase##2##3##(2007-11#1)(2007-12#1)
the simultaneous presence of the##3##5##(1994-5#1)(1996-5#1)(1997-8#1)
the simultaneous presence of##11##4##(1992-4#1)(1994-5#1)(1995-1#2)(1996-5#1)(1997-2#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-5#1)
the simultaneous quantification of##5##4##(1993-11#2)(1996-8#1)(2008-10#1)(2012-12#1)
the simultaneous saccharification##2##3##(2008-6#2)
the simultaneous separation and##3##4##(2008-10#3)
the simultaneous separation of the lactone and carboxylate forms of##2##10##(1997-3#2)
the simultaneous separation of##3##4##(1997-3#2)(2008-10#1)
the simultaneous separation##6##3##(1997-3#2)(2008-10#4)
the simultaneous spectrophotometric determination of##10##5##(2008-10#10)
the simultaneous use of##4##4##(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#1)
the simultaneous##403##2##(1990-10#1)(1990-11#3)(1990-12#2)(1990-6#4)(1990-8#4)(1990-9#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-11#2)(1993-2#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#3)(1994-6#1)(1995-1#2)(1995-12#3)(1995-3#3)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#5)(1996-8#3)(1997-2#1)(1997-3#4)(1997-8#4)(2004-11#1)(2006-10#3)(2006-4#1)(2006-5#2)(2006-8#1)(2007-11#3)(2007-12#9)(2007-8#6)(2008-1#4)(2008-10#200)(2008-11#3)(2008-12#3)(2008-2#15)(2008-3#12)(2008-4#4)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#6)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#9)(2012-3#2)(2013-1#5)(2013-7#3)(2013-8#1)
the simultaneously determined##2##3##(1996-8#1)(2008-2#1)
the simultaneously##4##2##(1990-10#1)(1996-8#1)(2007-12#1)(2008-2#1)
the sine##3##2##(2007-12#1)(2007-4#1)(2011-2#1)
the single DNA##2##3##(1993-11#1)(2008-10#1)
the single amino acid##2##4##(1992-12#1)(2012-12#1)
the single and multiple##2##4##(1996-8#1)(2006-11#1)
the single and##4##3##(1995-6#1)(1996-8#1)(2006-11#1)(2007-12#1)
the single application##2##3##(2008-10#2)
the single base##2##3##(1990-5#1)(1992-4#1)
the single case##3##3##(2007-7#2)(2008-4#1)
the single cell gel electrophoresis assay##2##6##(1996-2#1)(1997-4#1)
the single cell gel##3##4##(1996-2#1)(1997-4#1)(2013-1#1)
the single cell level##9##4##(1990-12#1)(1991-10#1)(1997-4#2)(2007-12#1)(2008-9#1)(2011-1#2)(2011-2#1)
the single cell##15##3##(1990-12#1)(1991-10#1)(1994-8#1)(1996-2#1)(1997-4#4)(2007-12#1)(2008-11#1)(2008-9#1)(2011-1#2)(2011-2#1)(2013-1#1)
the single chain of##2##4##(1991-8#1)(2006-12#1)
the single chain##6##3##(1991-8#3)(1994-9#1)(2006-12#1)(2008-8#1)
the single channel conductance##2##4##(1991-2#1)(1996-2#1)
the single cultures##3##3##(2013-1#3)
the single daily##2##3##(1990-7#1)(1991-11#1)
the single dominant gene##4##4##(2008-10#4)
the single dose##3##3##(1993-3#1)(2008-7#1)(2011-2#1)
the single greatest##3##3##(2005-12#1)(2007-12#1)(2007-7#1)
the single histidine residue##2##4##(1994-11#2)
the single largest##2##3##(1997-2#1)(2006-4#1)
the single low##2##3##(1994-3#1)(1995-3#1)
the single molecule##3##3##(2009-2#1)(2009-5#2)
the single most effective##2##4##(1996-12#1)(2008-12#1)
the single most frequent cause of##2##6##(1991-12#1)(2008-1#1)
the single most important cause of##2##6##(1994-7#1)(2010-7#1)
the single most important##8##4##(1994-7#1)(2007-10#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-1#2)(2013-1#1)
the single most##17##3##(1991-12#1)(1993-12#1)(1994-7#1)(1995-10#1)(1996-12#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-7#1)(2011-1#2)(2013-1#1)
the single mutants##5##3##(1990-3#1)(1995-11#1)(1995-6#1)(1997-4#1)(2013-8#1)
the single nucleotide polymorphism##3##4##(2007-12#2)(2011-1#1)
the single photon##2##3##(2008-2#1)(2012-2#1)
the single primer##2##3##(1993-12#1)(2008-8#1)
the single strand##2##3##(1995-3#1)(2008-5#1)
the single tryptophan residue##4##4##(1991-2#2)(1996-7#1)(2005-11#1)
the single tryptophan##8##3##(1991-2#2)(1991-5#1)(1995-1#1)(1995-5#1)(1996-7#1)(1997-7#1)(2005-11#1)
the single zoospore isolates##3##4##(2008-10#3)
the single##241##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#3)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#3)(1992-12#2)(1992-2#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-6#1)(1994-11#3)(1994-2#1)(1994-3#2)(1994-7#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#5)(1995-4#1)(1995-5#1)(1995-6#3)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#5)(1996-2#2)(1996-4#2)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-2#2)(1997-4#5)(1997-5#1)(1997-7#2)(1997-8#2)(2004-11#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#10)(2007-2#1)(2007-3#1)(2007-4#3)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#27)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#3)(2009-6#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#9)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#2)(2012-6#1)(2013-1#5)(2013-8#4)
the single- and##3##3##(2007-11#1)(2008-3#1)(2008-4#1)
the single-##4##2##(1995-2#1)(2007-11#1)(2008-3#1)(2008-4#1)
the single-beam##2##2##(2007-12#1)(2008-2#1)
the single-cell##11##2##(1990-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#2)(2009-12#1)(2009-4#1)(2011-2#1)
the single-chain##4##2##(1990-12#1)(1991-2#1)(1991-7#1)(1991-8#1)
the single-channel conductance##2##3##(1994-2#1)(1997-4#1)
the single-channel##5##2##(1994-2#1)(1996-1#1)(1997-4#1)(1997-6#2)
the single-charged##3##2##(2008-10#3)
the single-copy##3##2##(1993-12#1)(1993-2#1)(1996-7#1)
the single-crystal##3##2##(2007-12#3)
the single-cycle regime##2##3##(2007-12#2)
the single-edge technique##2##3##(2008-2#2)
the single-frequency##5##2##(2007-12#3)(2008-2#2)
the single-gene##2##2##(1992-12#1)(2008-10#1)
the single-ion##2##2##(2008-10#1)(2010-7#1)
the single-locus##2##2##(2012-3#2)
the single-mode fiber##2##3##(2007-12#2)
the single-mode##12##2##(2007-11#3)(2007-12#6)(2007-8#1)(2008-3#2)
the single-molecule level##3##3##(1997-6#1)(2010-7#1)(2013-8#1)
the single-molecule##4##2##(1997-6#1)(2008-7#1)(2010-7#1)(2013-8#1)
the single-monitor##2##2##(2010-9#2)
the single-nucleotide polymorphism (SNP)##3##4##(2012-3#3)
the single-nucleotide##4##2##(2012-3#4)
the single-pass##4##2##(1997-2#1)(2007-12#2)(2008-3#1)
the single-phase##2##2##(2005-11#1)(2008-10#1)
the single-photon##2##2##(2008-2#1)(2008-3#1)
the single-pulse##3##2##(2007-11#1)(2008-3#2)
the single-scatter##3##2##(2008-3#3)
the single-scattering albedo and the##2##5##(2008-2#2)
the single-scattering albedo##8##3##(2008-2#2)(2008-3#6)
the single-scattering properties of##2##4##(2008-3#2)
the single-scattering##13##2##(2007-12#1)(2008-2#3)(2008-3#9)
the single-shot measurement of the##2##5##(2007-11#1)(2008-2#1)
the single-shot##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2011-1#1)
the single-strand##2##2##(1990-11#1)(1994-7#1)
the single-stranded DNA##3##3##(1992-3#1)(1997-7#1)(2008-10#1)
the single-stranded and##2##3##(2008-10#1)(2008-9#1)
the single-stranded##12##2##(1990-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-9#1)
the single-turnover##2##2##(1995-1#1)(1995-10#1)
the singlet oxygen##2##3##(1992-7#1)(2007-8#1)
the singlet##4##2##(1992-7#1)(2007-8#1)(2008-1#1)(2009-10#1)
the singly and doubly##2##4##(1996-7#1)(2013-8#1)
the singly and##3##3##(1996-7#1)(2013-8#2)
the singly protonated ions##2##4##(1996-7#2)
the singly resonant##2##3##(2007-11#1)(2007-12#1)
the singly scattered##2##3##(2008-2#2)
the singly##15##2##(1990-8#1)(1991-4#1)(1991-7#1)(1996-2#1)(1996-7#3)(2007-11#1)(2007-12#1)(2008-2#3)(2013-8#3)
the singular values of##2##4##(2008-2#1)(2008-3#1)
the singular values##3##3##(2008-2#2)(2008-3#1)
the singular##11##2##(2004-8#1)(2007-12#1)(2008-2#6)(2008-3#2)(2008-7#1)
the singularity##2##2##(2007-11#1)(2008-6#1)
the sink##5##2##(2008-10#2)(2008-8#2)(2008-9#1)
the sino-atrial##2##2##(1990-7#2)
the sinonasal region##2##3##(1990-6#1)(2008-8#1)
the sinonasal tract##3##3##(1993-6#1)(2010-7#2)
the sinonasal##7##2##(1990-6#1)(1993-6#1)(2006-12#1)(2008-8#1)(2010-7#2)(2011-2#1)
the sinterability of the two##2##5##(2004-9#2)
the sinterability of##3##3##(2004-9#3)
the sintered density of##3##4##(2004-9#3)
the sintered density##4##3##(2004-9#4)
the sintered##6##2##(2004-9#5)(2009-7#1)
the sintering##3##2##(2004-9#1)(2008-11#1)(2008-5#1)
the sinus gland##5##3##(2008-5#2)(2008-6#3)
the sinus node artery in##2##5##(2007-8#2)
the sinus node artery##4##4##(2007-8#4)
the sinus##27##2##(1992-6#1)(1996-9#1)(1997-2#1)(1997-5#3)(2006-12#1)(2007-12#1)(2007-8#5)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-8#1)(2013-1#1)(2013-8#1)
the sinuses and##2##3##(2008-7#1)(2011-2#1)
the sinuses##6##2##(1990-8#1)(2008-3#1)(2008-7#2)(2011-2#2)
the sinusoidal GSH transporter##2##4##(1995-2#2)
the sinusoidal##12##2##(1990-12#1)(1990-3#1)(1991-12#2)(1995-2#2)(2008-11#1)(2008-2#2)(2008-3#3)
the siphon##3##2##(2006-8#1)(2008-5#2)
the sipunculid##2##2##(1992-8#2)
the siren's##2##2##(2008-11#1)(2013-1#1)
the sister group##3##3##(2007-12#1)(2008-5#1)(2012-12#1)
the sister##7##2##(2004-4#1)(2007-12#2)(2008-5#1)(2008-6#1)(2008-8#1)(2012-12#1)
the site II##2##3##(2008-10#2)
the site and severity of##2##5##(2005-7#1)(2007-11#1)
the site and##9##3##(1990-8#1)(1996-8#1)(1997-5#1)(2005-7#1)(2007-11#1)(2008-6#1)(2010-5#1)(2010-7#1)(2012-2#1)
the site at which##2##4##(1992-3#1)(1992-9#1)
the site at##3##3##(1992-3#1)(1992-9#1)(1997-4#1)
the site corresponding to##2##4##(1994-8#1)(1996-5#1)
the site for the##2##4##(1994-9#1)(2008-10#1)
the site for##9##3##(1994-9#1)(1995-10#1)(1995-8#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-5#3)
the site had##2##3##(2008-10#1)(2012-12#1)
the site most##3##3##(2008-10#2)(2008-6#1)
the site of PNA##2##4##(1996-5#2)
the site of a##10##4##(1991-9#1)(2006-1#1)(2007-3#2)(2008-1#1)(2008-6#1)(2010-6#2)(2011-2#1)(2012-12#1)
the site of action of##2##5##(1990-10#1)(2011-2#1)
the site of action##3##4##(1990-10#1)(1991-2#1)(2011-2#1)
the site of an##5##4##(1996-1#1)(1996-7#1)(2006-4#1)(2008-7#1)(2012-2#1)
the site of application##42##4##(2007-7#1)(2008-9#41)
the site of biological##2##4##(2008-11#1)(2008-5#1)
the site of care##2##4##(2006-10#1)(2007-12#1)
the site of cleavage##2##4##(1992-11#2)
the site of differentiation##2##4##(2007-12#1)(2008-5#1)
the site of disease##2##4##(1990-9#1)(2006-10#1)
the site of infection##11##4##(1996-8#1)(1997-1#1)(2006-8#1)(2008-10#1)(2008-4#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#2)
the site of inflammation##3##4##(1993-2#1)(2006-10#1)(2008-4#1)
the site of initiation of##2##5##(1997-7#1)(2006-10#1)
the site of injection and##3##5##(2007-2#1)(2008-1#1)(2008-11#1)
the site of injection##10##4##(1992-6#1)(1996-5#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-7#1)(2009-10#1)(2011-1#2)
the site of injury##10##4##(1990-4#1)(1991-10#1)(1996-5#1)(2005-10#1)(2006-9#1)(2007-11#1)(2007-4#1)(2008-2#1)(2008-9#1)(2012-12#1)
the site of inoculation##2##4##(2008-10#2)
the site of metastases##2##4##(1991-10#1)(2007-11#1)
the site of pathology##2##4##(2006-8#2)
the site of stimulation##3##4##(1991-11#1)(1992-12#1)(1994-2#1)
the site of substitution##3##4##(1992-3#2)(2008-4#1)
the site of the anastomosis##2##5##(1991-3#1)(2005-9#1)
the site of the lesion##2##5##(1991-1#1)(2007-9#1)
the site of the primary tumor##2##6##(2009-3#1)(2013-1#1)
the site of the primary##4##5##(1991-6#1)(2008-6#1)(2009-3#1)(2013-1#1)
the site of the reaction##2##5##(1994-11#1)(2008-4#1)
the site of the second##2##5##(1991-2#1)(2008-11#1)
the site of the##40##4##(1990-12#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-6#1)(1997-5#1)(1997-6#2)(2005-9#1)(2006-6#1)(2007-10#1)(2007-12#2)(2007-8#2)(2007-9#2)(2008-11#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-4#1)(2011-1#1)(2013-1#2)
the site of their##2##4##(1994-9#1)(2008-9#1)
the site of vaccination##2##4##(1997-4#1)(2008-7#1)
the site of vascular##2##4##(2007-8#1)(2008-6#1)
the site of##277##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#5)(1990-4#3)(1990-5#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-6#3)(1991-7#2)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#4)(1994-8#1)(1994-9#3)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#3)(1996-1#1)(1996-10#2)(1996-5#7)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#5)(1997-5#1)(1997-6#3)(1997-7#2)(2004-12#1)(2005-10#1)(2005-4#1)(2005-9#4)(2006-1#2)(2006-10#7)(2006-4#1)(2006-6#1)(2006-8#3)(2006-9#2)(2007-10#2)(2007-11#3)(2007-12#5)(2007-2#2)(2007-3#2)(2007-4#1)(2007-7#4)(2007-8#6)(2007-9#2)(2008-1#5)(2008-10#8)(2008-11#6)(2008-2#1)(2008-4#8)(2008-5#9)(2008-6#4)(2008-7#5)(2008-8#1)(2008-9#47)(2009-10#1)(2009-11#1)(2009-3#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-4#2)(2010-6#3)(2011-1#4)(2011-2#5)(2012-1#2)(2012-12#5)(2012-2#5)(2012-9#1)(2013-1#2)(2013-7#1)
the site on##2##3##(1995-6#1)(2013-1#1)
the site to##2##3##(2007-12#1)(2012-2#1)
the site where##8##3##(1992-3#1)(1994-2#1)(1996-8#1)(2007-12#1)(2007-7#2)(2013-1#1)(2013-8#1)
the site with##3##3##(2007-1#1)(2007-3#1)(2008-10#1)
the site##374##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#5)(1990-4#3)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#3)(1991-11#3)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#3)(1991-5#1)(1991-6#4)(1991-7#2)(1991-9#3)(1992-1#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#5)(1992-6#2)(1992-8#1)(1992-9#2)(1993-11#2)(1993-2#1)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#4)(1994-6#2)(1994-8#4)(1994-9#4)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#5)(1995-8#1)(1996-1#1)(1996-10#2)(1996-4#1)(1996-5#8)(1996-7#1)(1996-8#3)(1997-1#2)(1997-2#2)(1997-4#7)(1997-5#2)(1997-6#3)(1997-7#4)(2004-11#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-4#1)(2005-6#1)(2005-7#1)(2005-9#4)(2006-1#2)(2006-10#7)(2006-4#1)(2006-6#1)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#7)(2007-2#2)(2007-3#3)(2007-4#1)(2007-7#6)(2007-8#7)(2007-9#3)(2008-1#5)(2008-10#17)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#8)(2008-5#14)(2008-6#7)(2008-7#8)(2008-8#3)(2008-9#48)(2009-10#1)(2009-11#1)(2009-3#1)(2009-8#2)(2010-10#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#1)(2011-1#4)(2011-2#6)(2012-1#2)(2012-12#6)(2012-2#10)(2012-3#1)(2012-9#1)(2013-1#5)(2013-7#1)(2013-8#2)
the site(s)##4##2##(1991-7#1)(1991-9#1)(1995-5#1)(1997-8#1)
the site-directed##4##2##(1995-10#1)(2008-8#2)(2008-9#1)
the site-specific##12##2##(1992-6#1)(1995-1#1)(1995-12#2)(1996-4#1)(1996-8#1)(1997-4#1)(2006-12#1)(2006-5#1)(2007-12#1)(2008-8#1)(2012-2#1)
the sites and##5##3##(1991-9#1)(1992-1#1)(1996-2#1)(1996-5#1)(2007-11#1)
the sites are##4##3##(1991-3#1)(1992-2#1)(1994-5#2)
the sites at which##3##4##(1994-6#1)(1996-8#1)(2008-5#1)
the sites for##6##3##(1990-6#1)(1990-7#2)(1993-3#1)(2012-12#2)
the sites in the##2##4##(1994-6#1)(1997-8#1)
the sites in##3##3##(1994-6#1)(1997-5#1)(1997-8#1)
the sites of glycosylation##2##4##(1991-1#1)(1994-8#1)
the sites of interaction of##2##5##(1992-6#1)(1994-8#1)
the sites of interaction##3##4##(1992-6#1)(1994-8#1)(1996-5#1)
the sites of methylation##2##4##(1994-5#1)(1997-4#1)
the sites of phosphorylation##2##4##(1997-7#1)(2008-4#1)
the sites of##36##3##(1990-12#1)(1990-5#1)(1991-1#1)(1991-2#1)(1991-7#2)(1991-9#1)(1992-10#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-5#1)(1994-7#1)(1994-8#2)(1995-10#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#2)(1997-4#4)(1997-7#1)(1997-8#1)(1997-9#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-4#1)(2013-7#1)
the sites on##2##3##(1991-3#1)(2008-5#1)
the sites studied##2##3##(2004-4#1)(2007-3#1)
the sites that##3##3##(2007-2#1)(2008-5#1)(2012-12#1)
the sites where##6##3##(1991-7#1)(2007-9#2)(2008-4#1)(2008-5#1)(2011-1#1)
the sites##102##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-7#3)(1991-9#2)(1992-1#1)(1992-10#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#1)(1995-10#2)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#4)(1996-7#1)(1996-8#2)(1997-4#5)(1997-5#1)(1997-7#1)(1997-8#2)(1997-9#1)(2004-4#2)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-9#2)(2008-10#6)(2008-4#2)(2008-5#8)(2008-6#1)(2008-8#2)(2010-4#1)(2010-8#1)(2011-1#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
the sitting position##9##3##(1992-11#2)(1993-10#2)(1993-7#1)(2007-2#1)(2010-9#1)(2011-1#1)(2013-8#1)
the sitting##13##2##(1991-7#1)(1991-8#1)(1992-11#2)(1993-10#2)(1993-7#1)(2007-2#1)(2007-7#2)(2010-9#1)(2011-1#1)(2013-8#1)
the situation and##4##3##(1993-1#1)(1996-3#1)(2008-5#1)(2013-7#1)
the situation for##6##3##(1991-5#1)(1993-3#1)(1995-6#1)(2008-12#1)(2008-2#1)(2011-7#1)
the situation in Quebec##2##4##(2008-2#1)(2011-2#1)
the situation in the##6##4##(1990-6#1)(1991-6#1)(1995-7#1)(2005-5#1)(2008-1#1)(2008-5#1)
the situation in##21##3##(1990-6#1)(1991-6#1)(1995-7#1)(1996-4#1)(1997-4#1)(2005-5#1)(2005-7#1)(2006-8#1)(2007-12#2)(2008-1#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
the situation is##6##3##(1993-8#1)(1996-12#1)(1996-2#1)(2005-10#1)(2006-12#1)(2007-9#1)
the situation of the##2##4##(1990-8#1)(2011-1#1)
the situation of##16##3##(1990-8#2)(1992-2#1)(2005-4#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-11#1)(2008-2#2)(2009-5#1)(2010-12#1)(2011-1#1)(2013-1#2)(2013-8#1)
the situation regarding##2##3##(2008-1#2)
the situation where the##4##4##(1993-6#1)(1997-6#1)(2005-11#1)(2010-2#1)
the situation where##6##3##(1993-6#1)(1997-6#1)(2005-11#1)(2008-8#1)(2010-2#1)(2012-3#1)
the situation with##4##3##(1990-4#1)(2005-11#1)(2012-2#1)(2013-7#1)
the situation##119##2##(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-5#1)(1991-6#2)(1992-2#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-3#2)(1993-6#2)(1993-8#1)(1994-2#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-4#1)(1997-6#1)(2005-10#1)(2005-11#2)(2005-4#1)(2005-5#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#4)(2007-12#3)(2007-3#1)(2007-6#1)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#7)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-7#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#1)
the situational##2##2##(1994-2#1)(2008-12#1)
the situations in which##3##4##(2007-9#1)(2013-1#2)
the situations that##3##3##(2008-9#1)(2011-2#2)
the situations where##2##3##(1996-7#1)(2010-7#1)
the situations##10##2##(1996-7#1)(2007-9#1)(2008-9#1)(2009-8#1)(2010-2#1)(2010-7#1)(2011-2#2)(2013-1#2)
the six BC1##2##3##(2008-5#2)
the six care practices##2##4##(2007-2#1)(2008-6#1)
the six common apo-E genotypes##2##5##(2008-10#2)
the six cysteines##2##3##(1990-9#1)(1993-3#1)
the six kinds of phthalate esters##2##6##(2008-5#2)
the six media##2##3##(2005-6#1)(2008-12#1)
the six month follow up##2##5##(2007-11#2)
the six month##5##3##(1992-5#1)(2005-12#1)(2007-11#2)(2007-6#1)
the six most##2##3##(2008-5#1)(2013-8#1)
the six patients##5##3##(1992-2#1)(1995-1#1)(2008-1#1)(2008-9#1)(2013-8#1)
the six##126##2##(1990-10#1)(1990-12#1)(1990-5#2)(1990-9#1)(1991-2#2)(1991-6#1)(1992-1#2)(1992-2#2)(1992-5#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-3#2)(1993-6#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-2#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-7#1)(1997-1#1)(1997-2#2)(1997-5#1)(1997-6#1)(2004-10#1)(2004-9#1)(2005-12#1)(2005-6#1)(2006-1#1)(2006-10#1)(2006-9#1)(2007-11#3)(2007-2#1)(2007-3#2)(2007-5#2)(2007-6#1)(2007-9#2)(2008-1#5)(2008-10#16)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#11)(2008-6#3)(2008-7#1)(2008-8#5)(2008-9#1)(2009-2#1)(2009-5#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#2)(2011-2#1)(2011-3#1)(2012-12#3)(2013-1#4)(2013-7#2)(2013-8#2)
the six-electron reductive cleavage##2##4##(2010-12#2)
the six-electron##3##2##(1993-8#1)(2010-12#2)
the six-hour##2##2##(1992-11#1)(2007-10#1)
the six-membered##2##2##(1996-2#1)(1997-7#1)
the six-month##3##2##(1995-9#1)(2008-1#1)(2008-6#1)
the six-year period##4##3##(1992-3#1)(1995-5#1)(2011-2#2)
the sixteenth##2##2##(2008-8#1)(2013-8#1)
the sixth and seventh in a series##2##7##(1991-1#1)(1992-1#1)
the sixth and seventh##6##4##(1991-1#1)(1992-1#1)(1995-4#1)(1995-8#1)(2007-12#1)(2008-7#1)
the sixth case of##2##4##(1993-10#1)(2006-5#1)
the sixth coordination##2##3##(1993-3#1)(1993-6#1)
the sixth day of##2##4##(1994-3#1)(2013-1#1)
the sixth day##3##3##(1991-12#1)(1994-3#1)(2013-1#1)
the sixth decade##2##3##(1997-7#1)(2005-10#1)
the sixth exon##2##3##(1991-7#1)(1991-9#1)
the sixth strand##2##3##(1997-5#2)
the sixth##48##2##(1990-12#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-1#1)(1993-10#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-4#1)(1995-8#2)(1996-11#1)(1996-6#1)(1997-2#1)(1997-5#3)(1997-7#2)(2005-10#1)(2005-12#1)(2005-8#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)(2010-9#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#4)
the sixties##8##2##(1990-9#1)(1992-8#1)(1997-8#1)(2007-6#1)(2007-8#1)(2008-6#1)(2012-2#2)
the size and frequency of##2##5##(2004-1#1)(2008-8#1)
the size and location of the##2##6##(1995-2#1)(1995-3#1)
the size and number of##2##5##(2008-10#1)(2008-2#1)
the size and shape of the##7##6##(1993-10#1)(2005-11#2)(2006-10#1)(2008-2#1)(2010-12#1)(2013-8#1)
the size and shape of##13##5##(1993-10#1)(1995-5#1)(2005-11#2)(2006-10#1)(2006-11#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-5#1)(2010-12#2)(2013-8#1)
the size and the optical properties of##2##7##(2007-11#1)(2007-12#1)
the size and the power##2##5##(1996-3#1)(2008-2#1)
the size and the shape##2##5##(2008-3#2)
the size and the##14##4##(1995-11#1)(1996-3#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#5)
the size and##67##3##(1991-11#1)(1992-8#1)(1993-10#1)(1993-2#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-3#2)(1996-6#1)(1997-3#1)(1997-7#2)(2004-1#1)(2005-11#3)(2006-10#1)(2006-11#1)(2006-12#1)(2007-11#2)(2007-12#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#6)(2008-2#5)(2008-3#6)(2008-5#1)(2008-8#2)(2009-10#1)(2009-2#1)(2010-12#4)(2010-2#2)(2010-4#1)(2011-2#2)(2012-11#1)(2012-2#2)(2013-1#2)(2013-8#1)
the size at##2##3##(2008-3#1)(2008-5#1)
the size distribution and##2##4##(2008-2#2)
the size distribution is##2##4##(2008-2#1)(2008-9#1)
the size distribution of##11##4##(1991-12#1)(1995-2#1)(1997-8#1)(2005-11#2)(2006-10#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-5#1)
the size distribution##27##3##(1991-12#1)(1995-2#1)(1997-8#1)(2005-11#4)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#11)(2008-3#1)(2008-9#2)(2009-5#1)
the size fractionation of##2##4##(2008-10#2)
the size fractionation##3##3##(2008-10#3)
the size of a single##2##5##(2008-4#1)(2013-7#1)
the size of a##17##4##(1992-5#1)(1992-6#1)(1994-11#1)(1994-3#2)(2005-11#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-9#1)(2010-3#1)(2013-1#1)(2013-7#1)
the size of both the##2##5##(2008-3#1)(2011-2#1)
the size of conventional##2##4##(2008-3#1)(2008-6#1)
the size of neuronal##2##4##(1990-7#1)(1996-6#1)
the size of one of the##2##6##(2007-12#2)
the size of one##3##4##(2007-12#2)(2008-5#1)
the size of particles##3##4##(2006-2#1)(2007-12#1)(2008-2#1)
the size of progeny groups##2##5##(2013-8#2)
the size of such##2##4##(2008-3#1)(2010-5#1)
the size of the control zone##2##6##(1991-12#2)
the size of the defect##2##5##(2007-12#1)(2010-12#1)
the size of the doughnut-like chromatin domain increases##2##8##(2012-12#2)
the size of the fixed-price region depends upon expectations about hospitals' costs##2##12##(1995-2#2)
the size of the hospital##4##5##(2007-12#4)
the size of the interconnections##2##5##(2004-9#2)
the size of the molecule##2##5##(1993-11#1)(1993-4#1)
the size of the mossy fiber##2##6##(1993-6#2)
the size of the nutrient foramen##2##6##(2013-8#2)
the size of the object##2##5##(1992-9#1)(2008-2#1)
the size of the phase screen##2##6##(2008-2#2)
the size of the primary##2##5##(1995-6#1)(2007-5#1)
the size of the protein##3##5##(1994-9#1)(1997-8#1)(2008-7#1)
the size of the segment##2##5##(2008-5#2)
the size of the test##3##5##(2008-10#1)(2010-2#1)(2012-2#1)
the size of the tumor##3##5##(1991-10#1)(2009-2#1)(2010-9#1)
the size of the tumour##2##5##(1990-4#1)(2012-12#1)
the size of the visual span and##2##7##(2008-1#2)
the size of the visual span##3##6##(2008-1#3)
the size of the visual##4##5##(2008-1#4)
the size of the wax matrix was##2##7##(2008-5#2)
the size of the wax matrix##4##6##(2008-5#4)
the size of the##209##4##(1990-10#1)(1990-2#3)(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#2)(1994-11#1)(1994-12#1)(1994-9#3)(1995-10#1)(1995-11#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-6#1)(1996-12#2)(1996-3#5)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-8#2)(2004-11#1)(2004-9#2)(2005-10#1)(2005-11#3)(2006-1#1)(2006-10#2)(2006-2#1)(2007-1#1)(2007-10#4)(2007-11#1)(2007-12#7)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#7)(2008-10#15)(2008-11#2)(2008-2#11)(2008-3#10)(2008-4#4)(2008-5#12)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#4)(2009-10#2)(2009-2#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#3)(2013-1#2)(2013-8#4)
the size of these##5##4##(1994-12#1)(1996-1#1)(2008-3#1)(2009-3#1)(2010-5#1)
the size of this##3##4##(1991-2#1)(1993-4#1)(2010-2#1)
the size of##336##3##(1990-10#2)(1990-2#3)(1990-4#1)(1990-5#1)(1990-7#2)(1991-1#3)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#3)(1993-10#1)(1993-11#2)(1993-2#2)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#3)(1994-11#4)(1994-12#2)(1994-3#2)(1994-8#1)(1994-9#3)(1995-10#1)(1995-11#1)(1995-2#4)(1995-3#1)(1995-4#1)(1995-6#1)(1996-1#2)(1996-12#3)(1996-3#5)(1996-6#2)(1996-7#4)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-6#2)(1997-8#4)(1997-9#1)(2004-11#1)(2004-9#2)(2005-10#2)(2005-11#4)(2006-1#1)(2006-10#7)(2006-12#2)(2006-2#2)(2006-5#1)(2007-1#2)(2007-10#4)(2007-11#2)(2007-12#14)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#4)(2008-1#7)(2008-10#24)(2008-11#2)(2008-2#18)(2008-3#19)(2008-4#6)(2008-5#16)(2008-6#4)(2008-7#9)(2008-8#6)(2008-9#5)(2009-10#2)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#6)(2010-3#1)(2010-5#4)(2010-8#3)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#2)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#7)
the size parameter##4##3##(2008-2#2)(2008-3#2)
the size polydispersity of caseins##2##5##(2013-8#2)
the size polydispersity of##3##4##(2007-12#1)(2013-8#2)
the size polymorphism of##2##4##(1991-10#1)(1993-2#1)
the size range of##6##4##(1991-10#1)(1993-3#1)(1995-3#1)(2008-3#1)(2008-5#1)(2008-7#1)
the size range##10##3##(1991-10#1)(1993-3#1)(1995-3#1)(2007-5#1)(2008-3#1)(2008-5#1)(2008-7#4)
the size##498##2##(1990-10#2)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#2)(1990-9#1)(1991-1#3)(1991-10#4)(1991-11#3)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#3)(1993-10#2)(1993-11#2)(1993-2#4)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#3)(1994-11#4)(1994-12#2)(1994-3#2)(1994-8#1)(1994-9#3)(1995-10#1)(1995-11#2)(1995-2#6)(1995-3#3)(1995-4#2)(1995-5#3)(1995-6#2)(1996-1#2)(1996-12#3)(1996-3#7)(1996-6#4)(1996-7#4)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-6#2)(1997-7#2)(1997-8#5)(1997-9#1)(2004-1#1)(2004-11#1)(2004-9#2)(2005-10#3)(2005-11#13)(2006-1#1)(2006-10#10)(2006-11#1)(2006-12#3)(2006-2#2)(2006-4#1)(2006-5#3)(2007-1#2)(2007-10#4)(2007-11#4)(2007-12#19)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#3)(2007-9#6)(2008-1#8)(2008-10#38)(2008-11#4)(2008-2#42)(2008-3#32)(2008-4#7)(2008-5#21)(2008-6#5)(2008-7#13)(2008-8#10)(2008-9#7)(2009-10#3)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#8)(2010-2#8)(2010-3#1)(2010-4#2)(2010-5#5)(2010-8#3)(2010-9#2)(2011-1#2)(2011-12#2)(2011-2#9)(2012-1#1)(2012-11#4)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#10)
the size-fractionated##2##2##(1997-4#1)(2008-10#1)
the sizeable##2##2##(1993-7#1)(2006-10#1)
the sizes and##4##3##(1997-6#1)(2004-9#1)(2007-12#1)(2008-7#1)
the sizes of the##4##4##(2006-12#1)(2007-8#1)(2010-7#2)
the sizes of their##2##4##(1990-7#1)(2007-12#1)
the sizes of##15##3##(1990-4#1)(1990-7#1)(1991-10#1)(1991-3#1)(1996-4#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-7#2)
the sizes##21##2##(1990-4#1)(1990-7#1)(1991-10#1)(1991-3#1)(1991-9#1)(1996-4#1)(1997-6#1)(2004-9#1)(2005-10#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-7#2)(2008-8#1)(2010-4#1)(2010-7#2)
the sizzled morphant phenotype could be rescued by co-injection of RNAs encoding Noggin and either SFRP2 or Dickkopf (a mechanistically distinct Wnt inhibitor)##2##23##(2012-12#2)
the skeletal and##3##3##(2007-4#1)(2012-3#2)
the skeletal muscle 6-phosphofructo-2-kinase reaction##2##5##(1993-8#2)
the skeletal muscle of##4##4##(1991-4#1)(1992-1#1)(1992-7#1)(1994-4#1)
the skeletal muscle sodium channel gene##2##6##(1992-3#2)
the skeletal muscle tissue##2##4##(2008-2#2)
the skeletal muscle##22##3##(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#2)(1992-5#1)(1992-7#1)(1993-12#1)(1993-8#2)(1994-2#1)(1994-4#1)(1997-1#1)(2004-4#1)(2006-10#1)(2008-2#2)(2008-7#1)(2008-8#1)(2012-1#1)(2013-1#1)
the skeletal muscles##2##3##(2008-7#1)(2012-1#1)
the skeletal system##4##3##(2007-11#2)(2007-8#1)(2008-5#1)
the skeletal##44##2##(1991-11#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#2)(1992-5#1)(1992-7#1)(1993-12#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-4#1)(1995-11#1)(1997-1#1)(2004-4#1)(2006-10#1)(2007-11#3)(2007-12#2)(2007-4#1)(2007-8#1)(2008-1#2)(2008-2#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-7#1)(2010-8#1)(2012-1#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
the skeleton and##2##3##(1993-11#1)(2008-1#1)
the skeleton of##2##3##(2007-5#1)(2013-1#1)
the skeleton##26##2##(1991-5#1)(1993-11#5)(1996-5#1)(1996-9#1)(2006-5#1)(2006-6#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#5)(2008-3#1)(2008-5#2)(2012-12#1)(2012-3#1)(2013-1#3)
the skeletons##2##2##(2010-6#2)
the skew##4##2##(1995-4#1)(2008-2#1)(2008-8#2)
the skewing of##2##3##(2005-10#1)(2008-11#1)
the skill of the##2##4##(2006-10#1)(2007-11#1)
the skill of##5##3##(2006-10#1)(2007-11#1)(2008-11#3)
the skill set##3##3##(2007-12#3)
the skill##14##2##(1991-3#1)(2006-10#1)(2006-5#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-9#1)(2008-11#3)(2013-8#1)
the skills and knowledge of##2##5##(2008-3#1)(2011-2#1)
the skills and processes##2##4##(2008-11#1)(2012-2#1)
the skills and##8##3##(1995-1#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
the skills necessary##2##3##(2007-4#1)(2008-5#1)
the skills needed##2##3##(1995-2#1)(2010-5#1)
the skills of a##2##4##(2007-11#1)(2008-6#1)
the skills of##10##3##(2006-12#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#2)(2008-11#1)(2008-6#1)(2009-4#1)
the skills required to##2##4##(1996-2#1)(2007-12#1)
the skills required##3##3##(1996-2#1)(2004-3#1)(2007-12#1)
the skills to##4##3##(1996-1#1)(2008-11#2)(2012-3#1)
the skills##40##2##(1993-12#1)(1994-2#1)(1995-1#2)(1995-2#1)(1995-4#1)(1996-1#1)(1996-2#1)(2004-3#1)(2005-5#1)(2006-12#1)(2006-3#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-4#2)(2007-5#3)(2007-6#1)(2008-11#4)(2008-12#3)(2008-3#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
the skin above##2##3##(1991-5#1)(2012-2#1)
the skin after##3##3##(2008-5#2)(2012-3#1)
the skin against##3##3##(2008-5#2)(2009-6#1)
the skin aging##2##3##(2008-5#2)
the skin and in##2##4##(1995-1#1)(2008-5#1)
the skin and its##2##4##(2006-4#1)(2009-3#1)
the skin and the##8##4##(1991-8#1)(1994-6#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-9#1)
the skin and##54##3##(1991-11#1)(1991-7#1)(1991-8#1)(1992-6#2)(1994-6#1)(1995-1#1)(1995-12#2)(1996-11#1)(1997-6#1)(2005-7#1)(2006-10#3)(2006-12#2)(2006-4#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#12)(2008-8#2)(2009-3#1)(2009-4#1)(2009-9#1)(2010-3#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
the skin are##3##3##(2008-11#1)(2008-5#2)
the skin around the##2##4##(2007-8#1)(2008-5#1)
the skin as##3##3##(2008-10#1)(2009-6#1)(2012-2#1)
the skin barrier##7##3##(1994-8#1)(2008-5#3)(2010-3#1)(2010-7#1)(2012-2#1)
the skin becomes##2##3##(1992-4#1)(2008-5#1)
the skin biopsy##2##3##(2006-10#1)(2010-6#1)
the skin but##4##3##(1991-6#1)(2010-3#1)(2012-2#1)(2012-3#1)
the skin by##5##3##(2008-3#1)(2008-5#2)(2009-6#1)(2013-1#1)
the skin can##4##3##(1993-5#1)(1994-6#1)(2008-5#1)(2010-9#1)
the skin compatibility of surfactant-based products##2##6##(2008-5#2)
the skin could be##2##4##(2008-5#2)
the skin during##2##3##(1997-8#1)(2007-11#1)
the skin for##2##3##(2006-5#1)(2008-5#1)
the skin from the##2##4##(2006-12#1)(2008-10#1)
the skin from##4##3##(2006-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
the skin graft##3##3##(1991-12#1)(1995-2#1)(2012-3#1)
the skin grafts##2##3##(2012-3#2)
the skin has##2##3##(2008-5#2)
the skin hydration##2##3##(2008-5#1)(2009-4#1)
the skin in##7##3##(1991-5#1)(2007-8#1)(2008-10#1)(2008-5#2)(2011-3#1)(2013-8#1)
the skin infection##2##3##(2008-12#2)
the skin irritation##2##3##(2008-5#1)(2012-12#1)
the skin is a##2##4##(1990-4#1)(2008-9#1)
the skin is##11##3##(1990-4#1)(2006-7#1)(2008-3#1)(2008-5#3)(2008-9#2)(2009-6#1)(2011-2#1)(2013-8#1)
the skin lesions occurred##2##4##(1991-4#1)(2007-11#1)
the skin lesions##10##3##(1990-3#2)(1991-4#2)(1997-6#2)(2007-11#1)(2007-8#1)(2011-2#1)(2013-8#1)
the skin membrane##4##3##(2012-12#4)
the skin model##2##3##(2008-5#1)(2008-6#1)
the skin of a##3##4##(1994-11#2)(2012-3#1)
the skin of patients with##4##5##(1992-8#1)(2011-12#1)(2012-1#1)(2012-2#1)
the skin of patients##6##4##(1992-3#1)(1992-8#1)(2010-5#1)(2011-12#1)(2012-1#1)(2012-2#1)
the skin of the forearm##2##5##(1996-1#1)(2006-8#1)
the skin of the##12##4##(1990-6#1)(1992-11#2)(1992-3#1)(1994-4#1)(1994-5#1)(1996-1#1)(2006-8#1)(2008-5#3)(2008-7#1)
the skin of##45##3##(1990-6#1)(1990-7#1)(1992-11#2)(1992-2#1)(1992-3#2)(1992-8#2)(1993-3#1)(1994-11#2)(1994-3#1)(1994-4#1)(1994-5#1)(1994-8#1)(1996-1#1)(2005-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-5#7)(2008-7#2)(2008-8#4)(2010-5#2)(2011-12#1)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
the skin or the##2##4##(2008-10#1)(2008-5#1)
the skin or##8##3##(1996-1#1)(2007-11#1)(2007-7#2)(2008-10#2)(2008-5#1)(2011-2#1)
the skin paddle##3##3##(2006-3#2)(2008-1#1)
the skin prick##2##3##(2007-2#1)(2008-10#1)
the skin prior to##3##4##(2009-5#3)
the skin surface by##2##4##(2008-5#2)
the skin surface##29##3##(2005-11#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-5#24)(2013-7#1)
the skin that##3##3##(2008-5#1)(2012-12#2)
the skin tissue##3##3##(1992-9#1)(1995-11#1)(2008-3#1)
the skin to##6##3##(2006-7#1)(2008-3#1)(2008-5#4)
the skin transplant##2##3##(2008-11#1)(2010-5#1)
the skin type##2##3##(2008-5#1)(2011-2#1)
the skin using##2##3##(2008-6#1)(2009-4#1)
the skin was##8##3##(1990-9#1)(1994-4#1)(1996-5#1)(2007-12#1)(2008-11#1)(2008-5#3)
the skin were##4##3##(2007-7#1)(2008-5#1)(2008-6#2)
the skin with a##2##4##(2008-6#1)(2009-9#1)
the skin with##6##3##(2008-5#2)(2008-6#1)(2009-9#1)(2010-12#1)(2010-3#1)
the skin##584##2##(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#2)(1990-7#1)(1990-9#2)(1991-10#1)(1991-11#3)(1991-12#1)(1991-2#1)(1991-4#3)(1991-5#2)(1991-6#4)(1991-7#1)(1991-8#5)(1991-9#1)(1992-10#1)(1992-11#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#2)(1992-8#6)(1992-9#1)(1993-3#2)(1993-5#2)(1993-9#1)(1994-10#1)(1994-11#3)(1994-2#1)(1994-3#3)(1994-4#2)(1994-5#1)(1994-6#3)(1994-8#2)(1995-1#1)(1995-11#3)(1995-12#3)(1995-2#1)(1995-8#1)(1996-1#2)(1996-11#2)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#3)(1997-1#1)(1997-3#1)(1997-6#5)(1997-8#2)(2005-10#1)(2005-11#5)(2005-7#1)(2006-10#5)(2006-12#7)(2006-3#2)(2006-4#2)(2006-5#3)(2006-6#1)(2006-7#2)(2006-8#5)(2007-10#1)(2007-11#9)(2007-12#1)(2007-2#5)(2007-4#1)(2007-7#11)(2007-8#7)(2007-9#1)(2008-1#2)(2008-10#20)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#12)(2008-4#5)(2008-5#190)(2008-6#7)(2008-7#3)(2008-8#11)(2008-9#14)(2009-11#1)(2009-3#3)(2009-4#3)(2009-5#4)(2009-6#8)(2009-8#1)(2009-9#3)(2010-12#6)(2010-3#10)(2010-4#1)(2010-5#4)(2010-6#4)(2010-7#4)(2010-8#1)(2010-9#7)(2011-1#4)(2011-12#2)(2011-2#19)(2011-3#2)(2012-1#2)(2012-12#13)(2012-2#14)(2012-3#9)(2013-1#4)(2013-7#6)(2013-8#6)
the skin's##4##2##(2008-5#4)
the skin)##2##2##(1990-9#1)(1993-3#1)
the skin-color##3##2##(2008-6#3)
the skin]##3##2##(2005-11#2)(2011-1#1)
the skins##2##2##(1997-4#1)(2008-8#1)
the skipped##2##2##(1993-8#1)(2008-2#1)
the skipping of##3##3##(1993-8#1)(1996-7#1)(1997-7#1)
the skull and##7##3##(2006-11#2)(2007-11#1)(2007-4#1)(2009-6#1)(2010-12#2)
the skull base and##6##4##(2006-12#2)(2007-1#1)(2007-12#1)(2011-2#1)(2012-2#1)
the skull base in##2##4##(2008-1#1)(2011-2#1)
the skull base was##2##4##(2011-2#2)
the skull base##24##3##(2006-12#5)(2006-6#3)(2007-1#1)(2007-12#1)(2008-1#2)(2008-7#3)(2011-2#7)(2012-2#1)(2013-1#1)
the skull in##2##3##(1995-6#1)(2012-12#1)
the skull or##2##3##(2010-3#1)(2012-2#1)
the skull vault##2##3##(2006-11#1)(2013-8#1)
the skull##87##2##(1991-3#1)(1993-10#3)(1993-2#1)(1994-2#1)(1995-6#4)(1996-3#1)(1996-9#1)(1997-3#1)(2006-11#5)(2006-12#7)(2006-5#1)(2006-6#3)(2007-1#4)(2007-11#4)(2007-12#2)(2007-4#8)(2007-6#2)(2008-1#2)(2008-6#1)(2008-7#4)(2008-9#1)(2009-3#2)(2009-6#3)(2010-12#3)(2010-3#1)(2011-2#9)(2012-12#4)(2012-2#2)(2013-1#4)(2013-8#2)
the skulls##2##2##(1995-9#1)(2007-12#1)
the skunk clownfish Amphiprion akallopisos##2##5##(2010-8#2)
the sky at##2##3##(2007-8#2)
the sky is##2##3##(2006-10#1)(2008-3#1)
the sky polarization pattern##2##4##(2007-12#2)
the sky radiance##4##3##(2008-2#3)(2008-3#1)
the sky radiometer##3##3##(2008-2#3)
the sky##24##2##(2006-10#1)(2007-12#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-2#11)(2008-3#4)(2012-2#1)
the skylight polarization##2##3##(2008-2#2)
the skylight##4##2##(2008-2#4)
the slab##10##2##(1995-6#3)(2007-11#1)(2007-12#1)(2008-3#4)(2013-8#1)
the slabs##2##2##(2008-2#2)
the slag##2##2##(2008-10#2)
the slant##2##2##(2004-3#1)(2007-11#1)
the slave laser##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
the slave##9##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)
the sleep EEG in##2##4##(1994-11#1)(2004-11#1)
the sleep EEG##4##3##(1994-11#2)(2004-11#1)(2009-8#1)
the sleep latency##2##3##(2004-11#1)(2008-4#1)
the sleep##19##2##(1994-11#2)(1995-12#1)(1996-1#1)(1996-7#1)(2004-11#2)(2006-10#1)(2007-1#1)(2007-6#1)(2008-4#1)(2009-8#3)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
the sleep-wake cycle##4##3##(1994-2#3)(2007-1#1)
the sleep-wake##5##2##(1992-3#1)(1994-2#3)(2007-1#1)
the sleeping time induced by##2##5##(1995-12#1)(1996-4#1)
the sleeping time##3##3##(1995-12#2)(1996-4#1)
the sleeping##6##2##(1992-11#1)(1992-4#1)(1995-12#2)(1996-4#1)(2010-1#1)
the sleeve##3##2##(2008-11#2)(2009-2#1)
the slice##6##2##(1995-11#1)(1997-8#1)(2008-11#2)(2008-4#1)(2009-4#1)
the sliced##2##2##(2008-3#1)(2013-8#1)
the slices##6##2##(1992-3#1)(1992-8#1)(1994-3#2)(2008-11#1)(2011-1#1)
the slide##4##2##(1991-5#1)(2006-10#1)(2008-11#1)(2008-8#1)
the slider##6##2##(2007-3#1)(2008-2#2)(2008-3#3)
the slides of##2##3##(2004-1#1)(2008-5#1)
the slides were stained with##2##5##(2008-12#1)(2013-8#1)
the slides##13##2##(2004-1#1)(2006-10#1)(2006-7#1)(2007-5#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2013-8#1)
the sliding of##2##3##(1990-9#1)(2007-11#1)
the sliding velocity##6##3##(1996-4#1)(2005-11#3)(2006-10#2)
the sliding##16##2##(1990-9#1)(1991-2#1)(1996-4#3)(2005-11#3)(2006-10#3)(2006-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-5#1)
the slight##10##2##(1991-2#1)(1996-3#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#3)(2013-1#2)
the slightest##2##2##(1990-9#1)(2008-11#1)
the slightly##3##2##(2007-9#1)(2008-5#1)(2008-9#1)
the slip##3##2##(1996-4#1)(2005-11#1)(2012-2#1)
the slit##11##2##(2006-4#2)(2007-12#3)(2007-7#1)(2008-2#2)(2008-3#2)(2013-8#1)
the slope and intercept##3##4##(2008-10#2)(2013-8#1)
the slope and the##2##4##(1996-12#1)(2008-10#1)
the slope and##7##3##(1993-12#1)(1996-12#1)(2008-10#3)(2010-8#1)(2013-8#1)
the slope changes##2##3##(2008-10#1)(2008-2#1)
the slope distribution of the rough##2##6##(2008-3#2)
the slope efficiency is##2##4##(2007-12#1)(2008-2#1)
the slope efficiency##7##3##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#1)
the slope in the##2##4##(2008-3#2)
the slope method and##2##4##(2005-11#1)(2008-2#1)
the slope method##5##3##(2005-11#2)(2008-2#1)(2008-3#2)
the slope of a##2##4##(2008-2#1)(2009-8#1)
the slope of the anomalous dispersion##2##6##(2008-2#2)
the slope of the calibration curve##5##6##(2008-10#5)
the slope of the calibration##7##5##(2008-10#7)
the slope of the linear##2##5##(1990-11#1)(2008-10#1)
the slope of the relationship##2##5##(1992-8#1)(2008-8#1)
the slope of the straight##2##5##(2008-10#1)(2008-3#1)
the slope of the##44##4##(1990-11#1)(1992-8#1)(1993-12#1)(1993-7#1)(1995-3#2)(1997-2#2)(2005-11#2)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#13)(2008-2#4)(2008-3#6)(2008-8#4)(2009-12#2)(2009-5#1)
the slope of this##2##4##(1991-5#1)(2007-11#1)
the slope of##52##3##(1990-11#1)(1991-5#1)(1992-8#1)(1993-12#1)(1993-7#1)(1995-3#2)(1997-2#2)(2005-11#2)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#14)(2008-2#5)(2008-3#7)(2008-4#1)(2008-8#4)(2009-12#2)(2009-5#1)(2009-8#1)
the slope was##3##3##(1995-8#1)(2008-10#2)
the slope##106##2##(1990-11#3)(1991-5#1)(1992-8#1)(1993-12#2)(1993-7#1)(1995-3#2)(1995-8#1)(1996-12#1)(1997-2#3)(2005-11#4)(2007-11#2)(2007-12#8)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#28)(2008-2#9)(2008-3#17)(2008-4#1)(2008-8#4)(2009-12#2)(2009-4#1)(2009-5#1)(2009-8#2)(2010-8#2)(2011-2#1)(2013-1#1)(2013-8#3)
the slopes of the##9##4##(1991-7#1)(1996-5#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-8#1)(2012-3#1)
the slopes of##13##3##(1991-7#1)(1993-12#1)(1996-5#1)(2007-11#1)(2007-8#2)(2008-10#4)(2008-2#1)(2008-8#1)(2012-3#1)
the slopes##16##2##(1991-7#2)(1993-12#1)(1996-5#1)(2007-11#1)(2007-8#2)(2008-10#5)(2008-2#1)(2008-8#1)(2012-3#1)(2013-7#1)
the slot##3##2##(1995-7#1)(1996-2#1)(2007-8#1)
the slow and the fast##2##5##(1995-1#1)(2007-12#1)
the slow and##5##3##(1991-9#1)(1995-1#1)(1997-2#1)(2007-12#1)(2007-8#1)
the slow component##2##3##(1992-3#1)(2008-3#1)
the slow cooling##2##3##(1997-1#1)(2007-11#1)
the slow dissociation of##2##4##(1993-11#1)(2008-4#1)
the slow dynamics##2##3##(1994-10#1)(2007-12#1)
the slow form##2##3##(1997-1#1)(1997-2#1)
the slow growth##2##3##(1994-11#1)(2006-11#1)
the slow phase##4##3##(1990-5#1)(1991-12#1)(2008-4#1)(2008-5#1)
the slow rate##4##3##(1993-8#1)(2008-5#1)(2008-9#2)
the slow reaction##3##3##(1991-2#2)(2008-10#1)
the slow release of##2##4##(1994-11#1)(1994-12#1)
the slow segmental relaxation##2##4##(2008-10#2)
the slow variant##2##3##(1991-12#2)
the slow##89##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#5)(1991-2#3)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#2)(1993-8#2)(1994-10#1)(1994-11#2)(1994-12#2)(1994-8#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#1)(1996-5#2)(1996-7#1)(1997-1#3)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#2)(2005-11#1)(2006-1#2)(2006-11#1)(2007-11#5)(2007-12#3)(2007-7#1)(2007-8#2)(2008-10#9)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#1)(2010-12#1)(2011-1#1)
the slower the##2##3##(2007-2#1)(2011-2#1)
the slower##12##2##(1990-3#1)(1991-8#1)(1993-3#1)(1993-9#1)(1997-7#1)(1997-8#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)
the slowest growth##2##3##(1997-1#1)(2008-11#1)
the slowest##16##2##(1990-7#1)(1992-4#1)(1993-11#1)(1994-9#1)(1995-4#1)(1997-1#1)(1997-3#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-1#1)(2013-8#1)
the slowing down of the##2##5##(1994-3#1)(2008-10#1)
the slowing of##2##3##(1990-11#1)(1991-12#1)
the slowing##8##2##(1990-11#1)(1991-12#1)(1993-2#1)(1994-3#1)(2004-12#1)(2008-10#1)(2008-8#1)(2012-12#1)
the slowly varying##4##3##(2007-11#2)(2007-12#1)(2008-8#1)
the slowly##9##2##(1994-11#1)(1995-11#1)(1995-6#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-8#1)
the slpA##2##2##(1997-2#2)
the sludge##7##2##(2004-4#1)(2005-11#1)(2007-10#2)(2008-3#1)(2008-6#1)(2012-12#1)
the slug##2##2##(1993-6#1)(2008-6#1)
the slurries##3##2##(2004-9#2)(2008-10#1)
the slurry and the##2##4##(2008-10#2)
the slurry sampling technique were##2##5##(2008-10#2)
the slurry sampling##3##3##(2008-10#3)
the slurry##11##2##(2008-10#11)
the small GTP-binding##2##3##(1994-11#1)(1994-12#1)
the small GTPase##2##3##(2006-10#2)
the small GTPases Rac and##2##5##(1995-6#1)(1996-2#1)
the small GTPases##3##3##(1995-6#1)(1996-2#1)(2008-7#1)
the small airways##3##3##(2005-8#2)(2012-12#1)
the small amount of##3##4##(1996-9#1)(2005-10#1)(2008-10#1)
the small and large intestine##2##5##(1997-5#1)(2008-4#1)
the small and large##5##4##(1990-11#1)(1994-11#1)(1997-5#1)(2008-4#1)(2008-7#1)
the small and the large##2##5##(1991-9#1)(2012-3#1)
the small and##13##3##(1990-11#1)(1991-9#1)(1994-11#1)(1997-5#1)(1997-8#1)(2006-12#2)(2008-10#3)(2008-4#1)(2008-7#1)(2012-3#1)
the small angle##2##3##(2008-3#2)
the small bowel in##6##4##(1990-8#1)(1991-6#1)(2006-8#1)(2009-7#1)(2011-2#2)
the small bowel##36##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-8#1)(1991-6#1)(1991-9#1)(1992-5#2)(1992-9#1)(1993-10#2)(1997-8#2)(2006-10#3)(2006-2#1)(2006-8#1)(2007-5#1)(2008-6#1)(2009-1#1)(2009-4#1)(2009-7#2)(2010-12#3)(2011-2#5)(2012-2#1)(2013-1#1)(2013-8#1)
the small deformation##2##3##(2005-11#1)(2008-8#1)
the small dense LDL phenotype##2##5##(2008-3#2)
the small dense##4##3##(2008-3#4)
the small difference in##2##4##(2007-12#1)(2013-8#1)
the small difference##3##3##(2007-1#1)(2007-12#1)(2013-8#1)
the small heat-shock protein##2##4##(1993-6#1)(1996-10#1)
the small hole##2##3##(1997-3#1)(2007-8#1)
the small inclination angle##2##4##(2008-3#2)
the small inclination##3##3##(2008-3#3)
the small intestinal mucosa is##2##5##(2006-10#2)
the small intestinal mucosa##4##4##(1990-2#1)(2006-10#3)
the small intestinal##6##3##(1990-2#1)(2006-10#4)(2009-5#1)
the small intestine after##2##4##(2005-10#1)(2013-1#1)
the small intestine and##7##4##(1995-3#1)(2008-3#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#2)
the small intestine are##3##4##(1992-11#1)(2006-10#1)(2009-2#1)
the small intestine by##2##4##(2009-2#1)(2009-8#1)
the small intestine in##5##4##(1990-11#1)(1991-9#1)(1992-11#1)(1996-11#1)(2012-2#1)
the small intestine of the##3##5##(1994-11#1)(2008-4#1)(2008-5#1)
the small intestine of##11##4##(1991-12#1)(1992-11#1)(1993-8#1)(1994-11#1)(2006-10#1)(2008-4#1)(2008-5#1)(2012-2#3)(2013-1#1)
the small intestine##97##3##(1990-11#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-5#2)(1991-9#1)(1992-11#5)(1992-5#1)(1992-6#3)(1993-1#1)(1993-10#1)(1993-8#2)(1994-11#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-3#2)(1996-11#3)(1996-2#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-10#1)(2006-10#17)(2006-2#3)(2006-8#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-8#1)(2009-2#5)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#4)(2013-1#5)(2013-7#1)
the small intestine]##8##3##(1990-11#1)(1990-5#1)(1992-5#2)(1993-8#1)(1996-9#1)(2009-2#1)(2012-11#1)
the small intestines##3##3##(1993-9#1)(1997-3#1)(2013-1#1)
the small molecular##2##3##(1990-7#1)(2011-3#1)
the small molecule macroarray##2##4##(2012-12#2)
the small molecule##6##3##(1994-9#1)(2005-12#1)(2008-11#1)(2012-12#2)(2013-8#1)
the small molecules##2##3##(2008-4#1)(2013-1#1)
the small number of patients##7##5##(1994-6#1)(2006-6#1)(2007-6#1)(2008-1#1)(2010-5#2)(2013-8#1)
the small number of##22##4##(1991-5#1)(1993-5#2)(1994-6#1)(1995-3#1)(1995-5#1)(1997-8#1)(2006-6#1)(2007-12#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-6#1)(2009-2#1)(2010-5#2)(2012-2#1)(2013-8#1)
the small numbers##2##3##(1991-12#1)(2008-7#1)
the small population##4##3##(1997-5#1)(2008-1#1)(2008-10#1)(2008-8#1)
the small proteoglycan##2##3##(1995-3#1)(2008-9#1)
the small range of##2##4##(2008-10#1)(2009-5#1)
the small sample size and##4##5##(2008-11#1)(2009-8#1)(2011-2#1)(2013-1#1)
the small sample size##11##4##(2005-10#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-8#1)(2011-2#2)(2013-1#1)
the small sample sizes##2##4##(2013-1#1)(2013-8#1)
the small sample##14##3##(1993-9#1)(2005-10#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-8#1)(2011-2#2)(2013-1#2)(2013-8#1)
the small scale##2##3##(1991-11#1)(2005-11#1)
the small signal gain and saturation irradiance of the gain medium##2##11##(2008-2#1)(2008-3#1)
the small signal##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
the small size of the##4##5##(1991-5#1)(2008-12#1)(2009-3#1)(2010-2#1)
the small size of##10##4##(1991-5#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-10#1)(2009-3#1)(2010-2#1)(2011-2#1)(2012-12#1)
the small size##13##3##(1991-5#1)(1993-8#2)(2006-10#1)(2008-10#2)(2008-12#1)(2008-6#1)(2009-10#1)(2009-3#1)(2010-2#1)(2011-2#1)(2012-12#1)
the small subunit and##2##4##(2005-7#1)(2013-8#1)
the small subunit of ribulose-1##2##5##(1992-3#1)(1994-8#1)
the small subunit of##5##4##(1992-3#1)(1994-12#1)(1994-5#1)(1994-8#1)(2009-10#1)
the small subunit##12##3##(1990-6#1)(1990-9#1)(1991-5#1)(1992-3#1)(1993-12#1)(1994-12#1)(1994-5#1)(1994-8#1)(2005-7#1)(2006-8#1)(2009-10#1)(2013-8#1)
the small t-antigen##2##3##(1996-9#2)
the small##423##2##(1990-10#1)(1990-11#5)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-10#1)(1991-11#2)(1991-12#2)(1991-3#1)(1991-5#7)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#3)(1992-11#6)(1992-3#2)(1992-4#1)(1992-5#6)(1992-6#3)(1992-9#3)(1993-1#1)(1993-10#3)(1993-12#1)(1993-5#2)(1993-6#3)(1993-8#5)(1993-9#2)(1994-11#5)(1994-12#3)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#5)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-3#4)(1995-5#2)(1995-6#3)(1995-7#1)(1996-1#1)(1996-10#1)(1996-11#4)(1996-12#2)(1996-2#3)(1996-4#2)(1996-6#1)(1996-8#2)(1996-9#4)(1997-2#1)(1997-3#6)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#6)(2005-10#3)(2005-11#5)(2005-12#1)(2005-3#1)(2005-7#2)(2005-8#2)(2006-10#29)(2006-11#2)(2006-12#5)(2006-2#4)(2006-4#2)(2006-6#1)(2006-8#6)(2007-1#2)(2007-11#4)(2007-12#7)(2007-3#1)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#6)(2007-9#5)(2008-1#2)(2008-10#20)(2008-11#3)(2008-12#3)(2008-2#3)(2008-3#17)(2008-4#6)(2008-5#6)(2008-6#5)(2008-7#7)(2008-8#6)(2008-9#5)(2009-1#2)(2009-10#2)(2009-11#1)(2009-2#8)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#3)(2009-8#2)(2010-1#1)(2010-11#2)(2010-12#4)(2010-2#2)(2010-5#2)(2010-6#2)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#14)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#8)(2012-2#7)(2012-3#3)(2013-1#10)(2013-7#1)(2013-8#7)
the small-angle X-ray scattering (SAXS) technique##2##6##(2005-11#1)(2006-10#1)
the small-angle X-ray##3##3##(2005-11#1)(2006-10#1)(2008-5#1)
the small-angle approximation##6##3##(2008-2#2)(2008-3#4)
the small-angle##12##2##(2005-11#1)(2006-10#1)(2006-5#1)(2008-2#2)(2008-3#5)(2008-5#1)(2009-12#1)
the small-conductance##2##2##(1997-5#1)(2008-6#1)
the small-scale##4##2##(1994-8#1)(2008-10#2)(2011-1#1)
the small-signal gain##2##3##(2008-2#2)
the small-signal##6##2##(2008-2#5)(2008-3#1)
the smaller hospitals##3##3##(1990-11#1)(1992-6#1)(2006-10#1)
the smaller protein##2##3##(1991-10#1)(1993-12#1)
the smaller size of the##3##5##(1993-2#1)(1994-12#1)(2008-7#1)
the smaller the##5##3##(1993-3#1)(2007-4#1)(2008-3#1)(2008-5#1)(2011-2#1)
the smaller##63##2##(1990-11#3)(1990-3#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-2#2)(1997-7#1)(2004-1#1)(2005-11#1)(2006-10#3)(2007-4#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)
the smallest and##3##3##(1992-7#1)(2008-9#1)(2011-2#1)
the smallest chromosome##2##3##(1996-9#1)(2008-10#1)
the smallest in##2##3##(1993-5#1)(2010-4#1)
the smallest known##3##3##(1992-12#1)(2008-8#1)(2011-12#1)
the smallest possible##4##3##(1994-9#1)(1996-12#1)(2007-12#1)(2012-2#1)
the smallest reported##2##3##(2007-12#1)(2008-5#1)
the smallest spatial##2##3##(2008-10#2)
the smallest stable##2##3##(2006-10#2)
the smallest width of 7##2##5##(2012-11#2)
the smallest##92##2##(1990-7#1)(1991-7#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#2)(1993-3#2)(1993-5#1)(1994-9#1)(1995-8#2)(1996-12#1)(1996-2#2)(1996-9#3)(1997-2#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-5#1)(2007-12#9)(2007-3#1)(2007-4#1)(2007-6#1)(2007-9#2)(2008-10#10)(2008-11#3)(2008-2#3)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-6#1)(2009-7#2)(2010-11#1)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-11#2)(2012-2#2)(2013-1#1)
the smallpox eradication program##2##4##(1993-3#2)
the smallpox##3##2##(1993-3#2)(2008-5#1)
the smart cannula##2##3##(2007-8#2)
the smart##7##2##(2007-8#2)(2008-2#1)(2009-3#1)(2012-11#2)(2013-7#1)
the smcR mutant##2##3##(2007-12#2)
the smco7 mutant##4##3##(1997-4#4)
the smear##4##2##(1992-3#1)(2004-10#1)(2007-8#1)(2008-1#1)
the smearing##2##2##(2005-11#1)(2008-3#1)
the smectic-A##2##2##(1993-7#2)
the smectite##4##2##(2005-11#3)(2008-10#1)
the smell##2##2##(2006-2#1)(2009-6#1)
the smile is##2##3##(2008-7#1)(2012-3#1)
the smoke##3##2##(1996-12#2)(2008-5#1)
the smokers##4##2##(1990-6#1)(1993-10#1)(1993-2#1)(2008-10#1)
the smoking habit##3##3##(1993-6#1)(1994-4#1)(2009-5#1)
the smoking habits of##2##4##(2009-5#2)
the smoking habits##4##3##(1994-5#1)(2009-5#2)(2013-1#1)
the smoking prevalence##3##3##(1996-3#1)(2005-10#1)(2006-8#1)
the smoking status of##4##4##(2005-9#1)(2009-5#3)
the smoking status##6##3##(2005-9#1)(2009-5#3)(2013-1#2)
the smoking##26##2##(1991-1#1)(1991-11#1)(1993-6#1)(1994-4#1)(1994-5#2)(1994-6#1)(1996-3#2)(1997-7#1)(2005-10#1)(2005-9#1)(2006-8#1)(2008-2#1)(2009-5#6)(2012-12#1)(2013-1#5)
the smooth and##2##3##(2004-9#1)(2007-12#1)
the smooth muscle cell##3##4##(1992-4#2)(2007-11#1)
the smooth muscle cells in the##2##6##(1993-2#1)(1995-12#1)
the smooth muscle cells##6##4##(1993-11#1)(1993-2#1)(1995-12#1)(1996-12#1)(1997-5#1)(2008-8#1)
the smooth muscle of##2##4##(1994-9#1)(2012-3#1)
the smooth muscle##21##3##(1990-3#1)(1992-4#3)(1993-11#1)(1993-2#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-5#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)
the smooth muscles##2##3##(1996-3#1)(2006-6#1)
the smooth##40##2##(1990-3#1)(1990-7#1)(1992-4#3)(1993-11#1)(1993-2#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-5#1)(2004-9#1)(2005-11#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-2#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
the smoothed##2##2##(2006-10#1)(2008-2#1)
the smoothing##6##2##(2007-12#1)(2008-2#2)(2008-8#1)(2009-10#1)(2009-12#1)
the smoothness and##2##3##(2006-12#1)(2008-6#1)
the smoothness of the##2##4##(2006-12#1)(2007-11#1)
the smoothness##4##2##(2006-12#2)(2007-11#1)(2008-6#1)
the sn-1 acyl chain##2##4##(1990-7#2)
the sn-1 position##2##3##(1993-3#1)(1995-8#1)
the sn-1##5##2##(1990-7#2)(1993-3#1)(1995-8#1)(2012-1#1)
the sn-2##2##2##(1990-7#1)(2012-1#1)
the snail##9##2##(1993-6#2)(2008-12#1)(2008-4#1)(2008-5#2)(2009-8#1)(2010-11#1)(2012-3#1)
the snails##4##2##(2008-11#1)(2008-12#1)(2008-4#2)
the snake venom##2##3##(1993-3#1)(1997-2#1)
the snake##9##2##(1993-3#1)(1994-5#1)(1995-5#1)(1997-2#1)(2006-2#1)(2007-12#1)(2010-3#1)(2012-2#2)
the snoRNAs##2##2##(1997-7#1)(2008-1#1)
the snout##7##2##(1992-9#2)(2008-5#3)(2010-8#1)(2013-7#1)
the snow cover##3##3##(2013-8#3)
the snow##4##2##(2008-3#1)(2013-8#3)
the so called &quot##6##4##(1990-3#1)(2006-10#1)(2007-3#1)(2008-6#1)(2009-4#1)(2013-1#1)
the so called##18##3##(1990-3#1)(1990-5#1)(1991-5#1)(1992-5#1)(1993-3#1)(1993-8#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-3#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
the so far##3##3##(1997-2#1)(2011-1#2)
the so##21##2##(1990-3#1)(1990-5#1)(1991-5#1)(1992-5#1)(1993-3#1)(1993-8#1)(1997-2#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-3#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-7#1)(2011-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
the so-called &quot##17##3##(1990-1#1)(1990-8#1)(1993-3#1)(1993-6#1)(1994-8#2)(1995-3#1)(2005-11#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2011-2#2)(2012-1#1)
the so-called sandwich membrane method##2##5##(2008-10#2)
the so-called##140##2##(1990-1#1)(1990-11#1)(1990-12#2)(1990-5#1)(1990-6#1)(1990-8#2)(1992-1#1)(1993-3#3)(1993-5#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#3)(1994-8#2)(1995-12#1)(1995-3#2)(1995-8#1)(1996-1#1)(1996-6#1)(1996-7#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#2)(2006-1#1)(2006-10#1)(2006-12#5)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#4)(2007-12#6)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#3)(2009-2#1)(2009-7#2)(2009-8#4)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#2)
the soap##2##2##(1996-6#1)(2008-5#1)
the soccer group##2##3##(1996-6#2)
the social and cultural aspects of##2##6##(1993-11#1)(2011-2#1)
the social and cultural context##2##5##(2005-7#1)(2008-9#1)
the social and cultural##5##4##(1993-11#1)(2005-7#1)(2006-10#1)(2008-9#1)(2011-2#1)
the social and economic##4##4##(1995-4#1)(2008-1#1)(2008-11#1)(2010-2#1)
the social and political##4##4##(1991-6#1)(1993-11#1)(2005-11#1)(2009-4#1)
the social and professional##2##4##(2007-11#1)(2009-10#1)
the social and##29##3##(1991-6#1)(1992-12#1)(1992-4#1)(1992-5#1)(1993-11#2)(1995-4#1)(1995-5#1)(1996-2#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-2#2)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-4#2)(2010-2#1)(2010-7#1)(2011-2#1)(2012-2#2)
the social condition##2##3##(2012-1#2)
the social construction of gender##2##5##(1993-8#1)(2009-4#1)
the social construction of##4##4##(1991-6#1)(1993-8#1)(2008-7#1)(2009-4#1)
the social context of##5##4##(2006-2#1)(2007-3#2)(2008-11#1)(2011-1#1)
the social context##8##3##(2006-2#1)(2007-3#2)(2008-11#2)(2011-1#1)(2012-2#1)(2013-1#1)
the social determinants of health##3##5##(2011-1#1)(2011-2#1)(2013-1#1)
the social determinants of##6##4##(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
the social determinants##7##3##(2008-2#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
the social dynamics of##2##4##(1993-3#1)(1995-8#1)
the social elite##2##3##(2008-12#2)
the social environment of the##2##5##(1995-12#1)(2009-6#1)
the social environment of##5##4##(1995-12#1)(2006-8#1)(2008-11#2)(2009-6#1)
the social environment##8##3##(1995-12#1)(2006-4#1)(2006-8#1)(2008-11#2)(2009-6#2)(2010-2#1)
the social functioning of##2##4##(1996-1#1)(1997-8#1)
the social insurance system##2##4##(1995-5#1)(1996-8#1)
the social insurance##3##3##(1995-5#1)(1996-12#1)(1996-8#1)
the social isolation##2##3##(1994-12#1)(2012-12#1)
the social learning##2##3##(2006-12#1)(2009-7#1)
the social life##3##3##(1991-6#1)(1992-1#1)(2012-1#1)
the social milieu##2##3##(2006-8#1)(2008-8#1)
the social network##3##3##(2006-10#1)(2010-10#1)(2012-3#1)
the social norm##2##3##(2012-12#2)
the social norms##2##3##(2007-2#1)(2013-1#1)
the social organization of##3##4##(1992-12#1)(2008-9#1)(2010-1#1)
the social policy##2##3##(2008-1#1)(2008-9#1)
the social relations##2##3##(2005-2#1)(2009-9#1)
the social representation of##3##4##(1994-3#1)(2008-9#1)(2011-2#1)
the social representations of##2##4##(2007-7#1)(2012-12#1)
the social representations##3##3##(2007-7#1)(2012-12#1)(2012-3#1)
the social role of##2##4##(1991-6#1)(2007-1#1)
the social science##2##3##(2008-2#1)(2009-7#1)
the social sciences in Rio de Janeiro##2##7##(2009-4#2)
the social sciences##10##3##(1996-6#1)(2006-7#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#2)(2009-4#2)(2012-2#1)
the social security##2##3##(1995-5#2)
the social service##2##3##(1996-3#1)(1997-6#1)
the social spider Anelosimus eximius##2##5##(2008-9#2)
the social status##2##3##(1991-12#2)
the social structure##2##3##(2008-5#1)(2008-9#1)
the social support##4##3##(1992-3#1)(2009-7#1)(2011-2#2)
the social ties of hospitalised elderly##2##6##(2011-2#2)
the social validity of##2##4##(1993-1#1)(2009-11#1)
the social welfare##4##3##(1995-3#1)(2008-11#1)(2008-9#1)(2013-8#1)
the social work profession##2##4##(2007-9#1)(2010-2#1)
the social work##3##3##(2007-9#2)(2010-2#1)
the social worker##2##3##(1995-11#1)(1996-1#1)
the social world##3##3##(2008-11#1)(2008-5#1)(2008-6#1)
the social##242##2##(1990-5#1)(1991-12#2)(1991-3#1)(1991-6#4)(1991-9#1)(1992-1#1)(1992-12#3)(1992-3#2)(1992-4#1)(1992-5#1)(1993-1#2)(1993-11#2)(1993-3#2)(1993-8#1)(1993-9#1)(1994-12#2)(1994-3#2)(1995-11#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-5#4)(1995-8#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#1)(2005-11#1)(2005-2#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-2#3)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#1)(2007-12#5)(2007-2#2)(2007-3#3)(2007-5#1)(2007-7#6)(2007-9#3)(2008-1#3)(2008-10#3)(2008-11#11)(2008-12#6)(2008-2#7)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#1)(2008-8#4)(2008-9#11)(2009-10#3)(2009-11#2)(2009-12#1)(2009-4#9)(2009-6#3)(2009-7#5)(2009-8#1)(2009-9#3)(2010-1#3)(2010-10#1)(2010-12#2)(2010-2#3)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#4)(2010-8#1)(2011-1#2)(2011-2#12)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#9)(2013-8#3)
the social-sexual crossover point##2##4##(2008-9#2)
the social/health maintenance organization##2##4##(1995-2#1)(1997-1#1)
the socialization of##2##3##(1992-6#1)(2011-1#1)
the socialization##3##2##(1992-6#1)(2011-1#1)(2011-2#1)
the socially weakened##4##3##(2007-7#4)
the socially##6##2##(2007-7#4)(2008-9#1)(2012-11#1)
the societal##4##2##(1997-1#1)(2006-12#2)(2009-4#1)
the society and the##3##4##(1995-10#1)(2008-12#1)(2012-2#1)
the society and##4##3##(1995-10#1)(2008-12#1)(2012-2#2)
the society as a##2##4##(2010-1#1)(2012-1#1)
the society of##2##3##(2007-2#1)(2007-8#1)
the society##31##2##(1990-5#1)(1993-9#1)(1995-10#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-1#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)
the society's##3##2##(2005-7#1)(2012-2#2)
the socio-demographic correlates##2##3##(2009-4#2)
the socio-demographic##8##2##(2008-8#1)(2008-9#1)(2009-4#2)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
the socio-economic and##2##3##(2007-7#1)(2008-10#1)
the socio-economic function of##2##4##(1991-11#2)
the socio-economic##14##2##(1991-11#2)(2007-6#1)(2007-7#3)(2008-1#1)(2008-10#1)(2008-3#2)(2008-7#2)(2011-12#1)(2012-2#1)
the sociocultural##2##2##(2006-10#1)(2007-3#1)
the sociodemographic##4##2##(1994-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
the socioeconomic and##2##3##(1992-12#1)(1996-3#1)
the socioeconomic impact of##2##4##(1996-2#1)(2008-6#1)
the socioeconomic##8##2##(1992-12#1)(1996-2#1)(1996-3#1)(1997-5#1)(2008-12#1)(2008-6#1)(2010-2#1)(2010-8#1)
the sociological and##2##3##(1993-3#1)(1994-7#1)
the sociological##5##2##(1993-3#1)(1994-7#1)(2007-6#1)(2009-7#1)(2013-8#1)
the sociologists##2##2##(2008-12#2)
the socket##6##2##(2005-10#1)(2008-10#1)(2008-5#1)(2010-11#1)(2013-1#2)
the sodium and##2##3##(1990-6#1)(2013-7#1)
the sodium channel in##2##4##(1994-9#1)(1995-9#1)
the sodium channel##10##3##(1991-9#1)(1992-3#1)(1992-9#1)(1994-3#1)(1994-9#2)(1995-9#2)(2008-8#1)(2009-3#1)
the sodium chloride##2##3##(1991-12#1)(2008-10#1)
the sodium content of##2##4##(2010-4#1)(2013-1#1)
the sodium pump rate constant##2##5##(1991-1#2)
the sodium pump##7##3##(1990-11#1)(1991-1#2)(1992-11#1)(1996-1#1)(2008-7#1)(2010-1#1)
the sodium salt of##6##4##(1993-4#1)(1995-3#1)(2007-10#2)(2007-8#1)(2012-11#1)
the sodium salt##11##3##(1993-4#1)(1993-8#1)(1995-3#1)(1997-2#2)(2007-10#2)(2007-8#1)(2008-5#2)(2012-11#1)
the sodium##59##2##(1990-11#1)(1990-6#1)(1991-1#2)(1991-12#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-9#3)(1993-12#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-3#3)(1994-5#1)(1994-9#2)(1995-3#1)(1995-9#2)(1996-1#1)(1996-2#3)(1997-2#2)(2007-10#2)(2007-12#1)(2007-8#2)(2008-10#4)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-3#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-8#1)(2012-11#1)(2013-1#1)(2013-7#1)
the sodium-proton-antiport have been##2##4##(1991-12#1)(1992-12#1)
the sodium-proton-antiport##3##2##(1991-12#2)(1992-12#1)
the soft and hard##2##4##(2006-5#1)(2007-12#1)
the soft independent##2##3##(2008-10#1)(2013-8#1)
the soft palate and##2##4##(1990-6#1)(2006-6#1)
the soft palate##9##3##(1990-6#1)(1991-3#1)(2006-6#1)(2008-3#1)(2009-8#1)(2010-5#1)(2012-12#3)
the soft tissue and##2##4##(2012-2#1)(2013-1#1)
the soft tissue around the##2##5##(2006-10#1)(2013-1#1)
the soft tissue of the##2##5##(2006-9#1)(2012-12#1)
the soft tissue of##3##4##(1997-4#1)(2006-9#1)(2012-12#1)
the soft tissue##21##3##(1994-6#1)(1997-4#1)(2006-10#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#1)
the soft tissues of the##4##5##(2007-11#1)(2008-12#1)(2009-5#1)(2012-12#1)
the soft tissues of##5##4##(2006-10#1)(2007-11#1)(2008-12#1)(2009-5#1)(2012-12#1)
the soft tissues##19##3##(1994-10#1)(1995-3#1)(2006-10#1)(2007-1#1)(2007-11#2)(2007-4#1)(2008-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-3#2)(2012-12#1)(2012-2#1)(2013-1#2)
the soft##62##2##(1990-5#1)(1990-6#1)(1991-3#1)(1994-10#1)(1994-6#1)(1995-3#1)(1997-4#1)(2006-10#2)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-8#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#5)(2012-2#4)(2013-1#4)(2013-7#1)(2013-8#1)
the soft-tissue envelope##2##3##(2006-3#1)(2007-12#1)
the soft-tissue##3##2##(2006-3#1)(2007-12#1)(2010-3#1)
the soft-x-ray range##2##3##(2008-2#1)(2008-3#1)
the soft-x-ray##8##2##(2007-12#1)(2008-2#5)(2008-3#2)
the softening##2##2##(2008-2#1)(2010-2#1)
the software and##4##3##(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)
the software helps##2##3##(1993-12#2)
the software is##2##3##(2008-4#1)(2011-2#1)
the software program##2##3##(1995-6#1)(2010-12#1)
the software##41##2##(1993-12#3)(1995-6#1)(1996-12#1)(2006-5#1)(2007-4#2)(2008-10#4)(2008-11#2)(2008-2#4)(2008-4#3)(2008-5#3)(2008-7#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
the software's##3##2##(2008-2#1)(2009-2#1)(2011-1#1)
the soil and##9##3##(2008-10#5)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)
the soil available phosphorus##3##4##(2013-8#3)
the soil bacterium##2##3##(2011-1#1)(2011-2#1)
the soil bulk density and##2##5##(2008-12#1)(2013-8#1)
the soil by##2##3##(2011-2#1)(2012-12#1)
the soil can##2##3##(2008-11#1)(2010-5#1)
the soil in##3##3##(2008-10#2)(2008-4#1)
the soil is##4##3##(1992-12#1)(2004-4#2)(2006-10#1)
the soil microbial community##5##4##(2008-10#5)
the soil microbial##7##3##(1990-9#1)(2006-12#1)(2008-10#5)
the soil microflora##3##3##(2008-10#3)
the soil mixtures##2##3##(2008-10#1)(2008-2#1)
the soil moisture content##2##4##(2012-7#1)(2013-8#1)
the soil moisture##4##3##(2008-10#1)(2011-1#1)(2012-7#1)(2013-8#1)
the soil of##3##3##(1996-7#1)(2008-5#1)(2012-2#1)
the soil organic carbon and##3##5##(2008-12#1)(2013-8#2)
the soil pH and##2##4##(2013-8#2)
the soil physical and chemical properties##2##6##(2013-8#2)
the soil profile##3##3##(2008-10#3)
the soil quality##2##3##(2006-12#1)(2008-12#1)
the soil sample##3##3##(2008-10#3)
the soil samples##5##3##(2008-10#4)(2013-7#1)
the soil surface was##3##4##(2008-10#2)(2010-5#1)
the soil surface##17##3##(2008-10#10)(2008-11#1)(2008-6#2)(2010-5#2)(2011-1#1)(2011-12#1)
the soil to##2##3##(2008-10#1)(2012-12#1)
the soil total##2##3##(2013-8#2)
the soil was##5##3##(2008-10#2)(2009-3#1)(2010-3#1)(2012-12#1)
the soil water storage and conservation##2##6##(2013-8#2)
the soil water storage##3##4##(2008-8#1)(2013-8#2)
the soil were##2##3##(2008-10#1)(2008-5#1)
the soil with##4##3##(2008-10#3)(2010-5#1)
the soil##208##2##(1990-9#3)(1992-12#1)(1992-3#3)(1995-3#1)(1996-7#1)(2004-2#1)(2004-4#4)(2005-11#1)(2005-12#1)(2006-10#1)(2006-12#3)(2006-5#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-10#87)(2008-11#9)(2008-12#5)(2008-2#4)(2008-3#1)(2008-4#3)(2008-5#8)(2008-6#7)(2008-7#5)(2008-8#1)(2008-9#1)(2009-3#1)(2010-10#2)(2010-12#1)(2010-3#2)(2010-5#7)(2010-7#1)(2011-1#3)(2011-12#4)(2011-2#2)(2012-12#3)(2012-2#2)(2012-7#1)(2013-7#1)(2013-8#23)
the soil-ingestion equation for wildlife##3##5##(2008-7#3)
the soilborne pathogen##2##3##(2008-10#2)
the soilborne##10##2##(2008-10#10)
the soils amended with##2##4##(2008-10#2)
the soils##17##2##(2004-2#1)(2006-12#2)(2008-10#12)(2008-11#1)(2013-8#1)
the sol##4##2##(2005-11#1)(2008-10#3)
the sol-gel method##2##3##(2008-10#1)(2010-1#1)
the sol-gel technique##2##3##(2004-9#1)(2008-10#1)
the sol-gel transition##6##3##(2005-11#4)(2008-2#2)
the sol-gel##21##2##(2004-9#2)(2005-11#4)(2007-8#1)(2008-10#7)(2008-2#2)(2010-1#2)(2010-12#1)(2010-4#1)(2012-2#1)
the solar background##2##3##(2008-3#2)
the solar irradiance##2##3##(1990-8#1)(2008-7#1)
the solar photosphere##2##3##(1996-5#1)(2008-3#1)
the solar spectrum##5##3##(2008-11#1)(2008-2#2)(2008-3#2)
the solar system##3##3##(2007-9#3)
the solar zenith angle##2##4##(2008-2#2)
the solar##36##2##(1990-8#1)(1992-9#1)(1996-5#5)(1997-5#1)(2006-3#1)(2007-12#1)(2007-9#3)(2008-11#1)(2008-2#7)(2008-3#13)(2008-7#1)(2013-8#1)
the solar-reflected spectrum##3##3##(2008-2#3)
the solder##3##2##(2008-3#3)
the sole determinant of##3##4##(1990-4#1)(1993-3#1)(1996-5#1)
the sole factor in##2##4##(1994-11#1)(2008-10#1)
the sole factor##3##3##(1994-11#1)(2007-11#1)(2008-10#1)
the sole of##2##3##(1994-12#1)(2008-4#1)
the sole or##2##3##(1994-8#1)(2011-2#1)
the sole presence of##2##4##(1994-12#1)(2008-10#1)
the sole products##2##3##(1992-3#1)(1996-5#1)
the sole receptor##2##3##(2008-5#1)(2012-2#1)
the sole source of##7##4##(1991-12#1)(1994-12#1)(1995-6#1)(2008-10#2)(2008-6#1)(2008-7#1)
the sole##97##2##(1990-12#1)(1990-4#2)(1990-5#1)(1990-9#1)(1991-12#2)(1991-5#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#2)(1995-1#1)(1995-2#1)(1995-6#3)(1995-8#1)(1996-10#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-11#1)(2006-10#3)(2006-12#1)(2007-11#1)(2007-2#1)(2007-7#3)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#3)(2009-10#1)(2010-2#1)(2010-5#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-11#1)(2012-2#2)(2013-8#1)
the soleus H-reflex##2##3##(1993-12#2)
the soleus and##3##3##(1993-7#1)(2008-6#1)(2013-8#1)
the soleus##11##2##(1990-4#1)(1991-5#1)(1993-12#2)(1993-7#2)(1996-8#3)(2008-6#1)(2013-8#1)
the solgel##4##2##(2008-1#1)(2008-2#2)(2008-3#1)
the solid and the##4##4##(2005-11#3)(2008-10#1)
the solid and##5##3##(2005-11#3)(2008-10#2)
the solid immersion lens##2##4##(2008-3#2)
the solid mass consisting of the##3##6##(2008-10#3)
the solid mass is shaken with##2##6##(2008-10#2)
the solid mass##5##3##(2008-10#5)
the solid matrix##2##3##(2006-6#1)(2008-10#1)
the solid part of the##2##5##(2007-1#1)(2008-10#1)
the solid phase and the##2##5##(1990-12#1)(1997-3#1)
the solid phase extraction (SPE)##4##5##(2007-8#1)(2008-10#3)
the solid phase extraction of##4##5##(2008-10#4)
the solid phase extraction##10##4##(2007-8#1)(2008-10#9)
the solid phase with##2##4##(2008-10#2)
the solid phase##39##3##(1990-12#1)(1990-6#1)(1991-2#1)(1991-5#1)(1993-2#1)(1993-9#1)(1994-8#1)(1994-9#1)(1997-3#1)(2005-11#1)(2006-12#1)(2006-3#1)(2007-8#1)(2008-10#22)(2008-3#1)(2008-4#1)(2009-11#1)(2013-1#1)
the solid sample##5##3##(2007-8#1)(2008-10#3)(2008-3#1)
the solid samples was##2##4##(2008-1#1)(2008-10#1)
the solid solution##3##3##(2005-11#1)(2007-11#1)(2008-10#1)
the solid state##24##3##(1992-2#1)(1993-3#1)(1996-2#2)(1997-4#1)(1997-7#2)(2004-12#2)(2007-10#3)(2007-11#1)(2008-10#3)(2008-3#2)(2010-5#4)(2011-2#2)
the solid substrate##4##3##(2008-10#4)
the solid support surface##2##4##(1993-3#1)(2006-5#1)
the solid support##15##3##(1993-3#1)(2006-5#1)(2008-10#9)(2008-4#2)(2012-11#2)
the solid surface##2##3##(2008-10#1)(2008-11#1)
the solid tumors##2##3##(2006-6#2)
the solid viewing angle of the sky radiometer##2##8##(2008-2#2)
the solid waste##2##3##(2008-12#1)(2012-12#1)
the solid##157##2##(1990-12#2)(1990-4#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-7#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-10#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-2#2)(1997-3#1)(1997-4#1)(1997-7#2)(2004-12#3)(2005-11#10)(2005-4#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#3)(2007-1#1)(2007-10#3)(2007-11#2)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#63)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#8)(2008-4#3)(2008-5#3)(2009-11#2)(2010-12#1)(2010-5#4)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#1)(2013-1#1)
the solid-liquid##7##2##(2005-11#4)(2008-10#2)(2008-7#1)
the solid-phase extraction##3##3##(1992-11#1)(2008-10#2)
the solid-phase synthesis of##6##4##(1991-10#1)(1997-4#1)(2006-12#1)(2007-11#1)(2008-4#2)
the solid-phase##25##2##(1991-10#1)(1992-11#1)(1994-9#1)(1996-8#1)(1997-3#1)(1997-4#1)(2006-12#1)(2007-11#2)(2008-1#1)(2008-10#9)(2008-4#5)(2012-12#1)
the solid-state##3##2##(1991-11#1)(2008-10#1)(2008-2#1)
the solid-support assisted##2##3##(2008-10#2)
the solids##8##2##(2005-11#2)(2008-10#3)(2008-5#2)(2013-1#1)
the solitary complex##2##3##(1992-9#2)
the solitary kidney##2##3##(2012-2#2)
the solitary tract##16##3##(1991-11#4)(1992-8#2)(1992-9#1)(1993-12#2)(1993-2#1)(1994-10#1)(1995-5#1)(1996-5#1)(1996-8#1)(1997-8#1)(2013-1#1)
the solitary##27##2##(1991-11#4)(1992-8#2)(1992-9#4)(1993-12#2)(1993-2#1)(1994-10#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-5#1)(1996-8#1)(1997-8#1)(2006-7#1)(2007-12#1)(2008-7#1)(2012-2#2)(2013-1#1)(2013-7#1)
the soliton pulse##3##3##(2007-11#3)
the soliton##17##2##(2007-11#6)(2007-12#11)
the soliton's##2##2##(2007-12#2)
the solitons##6##2##(2007-11#1)(2007-12#4)(2008-1#1)
the solubility and dissolution rate of##2##6##(2008-10#1)(2008-5#1)
the solubility and the##2##4##(2006-10#1)(2012-12#1)
the solubility and##8##3##(1996-7#1)(2004-12#1)(2006-10#1)(2008-10#3)(2008-5#1)(2012-12#1)
the solubility limit##5##3##(2005-11#5)
the solubility minimum##2##3##(2006-10#2)
the solubility of UV filters##2##5##(2008-5#2)
the solubility of the##5##4##(2007-11#1)(2008-10#2)(2008-5#1)(2013-1#1)
the solubility of these compounds##2##5##(2008-5#1)(2011-1#1)
the solubility of##29##3##(2005-11#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#11)(2008-4#1)(2008-5#5)(2009-7#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
the solubility parameter##2##3##(2008-10#2)
the solubility product of##2##4##(2007-8#1)(2008-10#1)
the solubility product##3##3##(2007-8#1)(2008-10#1)(2010-4#1)
the solubility##58##2##(1995-1#1)(1996-7#1)(2004-12#1)(2005-11#6)(2006-10#4)(2007-11#1)(2007-8#2)(2008-10#21)(2008-4#2)(2008-5#6)(2009-7#1)(2010-4#2)(2010-5#3)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
the solubilization of##3##3##(1994-12#1)(2005-11#1)(2013-1#1)
the solubilization##7##2##(1990-2#1)(1994-12#1)(1997-1#1)(2005-11#3)(2013-1#1)
the solubilized membrane preparation##2##4##(1991-5#2)
the solubilized membrane##3##3##(1990-2#1)(1991-5#2)
the solubilized membranes##2##3##(1990-2#1)(1994-11#1)
the solubilized##15##2##(1990-2#2)(1990-5#2)(1991-5#2)(1993-11#1)(1994-11#1)(1994-3#1)(1996-5#1)(2008-4#2)(2008-5#1)(2010-4#2)
the soluble aminopeptidases##2##3##(1992-4#2)
the soluble and insoluble##2##4##(1997-4#1)(2008-10#1)
the soluble and membrane-bound##3##4##(1991-7#1)(1994-2#1)(2008-4#1)
the soluble and microsomal##3##4##(1992-6#3)
the soluble and##11##3##(1991-7#1)(1992-3#1)(1992-6#3)(1994-11#1)(1994-2#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-4#1)
the soluble b5##2##3##(1992-6#2)
the soluble components of the##2##5##(2008-10#1)(2008-9#1)
the soluble components##3##3##(2008-10#2)(2008-9#1)
the soluble enzyme##2##3##(1997-2#1)(2008-5#1)
the soluble extracts##2##3##(1990-7#2)
the soluble form can##2##4##(1992-5#2)
the soluble form##6##3##(1992-12#1)(1992-5#2)(1993-6#1)(1995-2#1)(1996-7#1)
the soluble forms##2##3##(1994-11#1)(2008-10#1)
the soluble fraction of the##3##5##(1992-6#1)(1995-10#1)(1997-8#1)
the soluble fraction of##11##4##(1990-6#2)(1991-7#1)(1991-9#1)(1992-6#1)(1992-9#1)(1995-10#1)(1996-12#1)(1996-5#1)(1997-5#1)(1997-8#1)
the soluble fraction##20##3##(1990-2#1)(1990-6#2)(1990-7#2)(1991-7#1)(1991-9#1)(1992-6#1)(1992-9#1)(1994-12#3)(1994-5#2)(1995-10#1)(1996-12#1)(1996-5#1)(1997-5#1)(1997-8#1)(2009-10#1)
the soluble fumarate reductase##2##4##(1996-8#2)
the soluble protein##7##3##(1990-5#2)(1994-6#1)(1994-8#1)(1995-2#2)(2008-11#1)
the soluble starch##2##3##(2008-5#1)(2008-9#1)
the soluble##114##2##(1990-2#4)(1990-5#2)(1990-6#3)(1990-7#4)(1991-1#1)(1991-12#2)(1991-2#1)(1991-7#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#5)(1992-3#2)(1992-4#3)(1992-5#2)(1992-6#7)(1992-7#1)(1992-9#2)(1993-2#1)(1993-6#1)(1994-11#3)(1994-12#4)(1994-2#2)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#1)(1995-10#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#3)(1997-8#2)(2004-4#1)(2005-11#2)(2006-10#1)(2007-11#1)(2008-10#6)(2008-11#3)(2008-4#3)(2008-5#4)(2008-9#3)(2009-10#1)(2009-6#1)(2013-1#1)
the solute and the##4##4##(1990-8#1)(2008-10#2)(2008-7#1)
the solute and##6##3##(1990-8#1)(2006-10#2)(2008-10#2)(2008-7#1)
the solute is##4##3##(2005-11#1)(2006-10#1)(2008-10#1)(2013-1#1)
the solute molecular##2##3##(1992-1#1)(2010-2#1)
the solute##45##2##(1990-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1994-9#1)(2005-11#3)(2006-10#15)(2008-10#13)(2008-3#1)(2008-4#1)(2008-7#2)(2009-5#1)(2010-2#3)(2013-1#1)
the solute-solvent##5##2##(2006-10#2)(2008-10#2)(2010-2#1)
the solutes##18##2##(1992-1#1)(1996-5#3)(1997-8#2)(2005-11#1)(2005-12#1)(2008-10#6)(2012-12#4)
the solution and the##3##4##(2005-11#1)(2008-10#2)
the solution and##10##3##(2005-11#1)(2006-1#1)(2007-8#2)(2008-10#6)
the solution are##2##3##(1992-5#1)(2007-12#1)
the solution as well as##2##5##(2008-5#2)
the solution at##2##3##(2007-8#1)(2008-5#1)
the solution can be##2##4##(1991-3#1)(2008-2#1)
the solution can##3##3##(1991-3#1)(2008-2#1)(2010-5#1)
the solution conformation of##6##4##(1991-12#1)(1991-2#1)(1991-7#1)(1992-1#1)(1996-11#1)(2005-7#1)
the solution conformation##7##3##(1991-12#1)(1991-2#1)(1991-7#1)(1992-1#1)(1995-3#1)(1996-11#1)(2005-7#1)
the solution containing the##2##4##(2008-10#2)
the solution containing##4##3##(2005-11#1)(2008-10#3)
the solution for##4##3##(2007-12#1)(2008-10#2)(2008-7#1)
the solution from##3##3##(2008-10#2)(2008-2#1)
the solution in##4##3##(1995-3#1)(2007-8#1)(2008-10#2)
the solution is##10##3##(2005-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#4)(2008-2#1)
the solution of a quadratic equation##2##6##(1997-6#1)(2008-2#1)
the solution of a##7##4##(1997-6#1)(2008-2#3)(2008-3#1)(2008-7#1)(2009-10#1)
the solution of the above mentioned##2##6##(2008-1#1)(2011-2#1)
the solution of the diffusion equation##2##6##(2008-2#2)
the solution of the##13##4##(2007-12#2)(2008-1#1)(2008-2#7)(2008-3#1)(2009-2#1)(2011-2#1)
the solution of##39##3##(1997-6#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#2)(2008-2#12)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-2#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#2)
the solution pH is##2##4##(1995-3#1)(2006-12#1)
the solution pH was##4##4##(2005-11#1)(2008-10#3)
the solution pH##10##3##(1995-3#1)(2005-11#2)(2006-12#1)(2008-1#1)(2008-10#4)(2008-4#1)
the solution phase##6##3##(1996-6#1)(2005-11#1)(2007-8#1)(2008-10#3)
the solution properties of##2##4##(2005-11#2)
the solution showed##2##3##(2009-3#1)(2010-3#1)
the solution structure of a##2##5##(1995-8#1)(1996-6#1)
the solution structure of the##9##5##(1994-11#1)(1995-1#3)(1995-2#1)(1996-7#3)(2010-5#1)
the solution structure of##16##4##(1991-11#1)(1994-11#1)(1994-5#3)(1995-1#3)(1995-2#2)(1995-8#1)(1996-6#1)(1996-7#3)(2010-5#1)
the solution structure##19##3##(1991-11#1)(1994-11#1)(1994-5#5)(1995-1#3)(1995-2#2)(1995-8#1)(1996-6#1)(1996-7#3)(2009-7#1)(2010-5#1)
the solution structures of##2##4##(1996-7#1)(2010-6#1)
the solution structures##3##3##(1996-11#1)(1996-7#1)(2010-6#1)
the solution that##4##3##(1992-12#1)(1995-1#1)(2009-6#1)(2010-8#1)
the solution to the##2##4##(2009-4#1)(2010-8#1)
the solution to##10##3##(1993-11#1)(1995-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2009-4#1)(2010-8#1)
the solution was then##2##4##(2005-4#1)(2008-10#1)
the solution was##16##3##(1990-8#1)(1996-2#1)(2004-9#1)(2005-4#1)(2007-8#1)(2008-10#8)(2008-2#1)(2010-7#1)(2013-1#1)
the solution were##2##3##(2008-10#2)
the solution will##2##3##(2008-10#1)(2008-2#1)
the solution with##2##3##(2008-10#1)(2008-5#1)
the solution##298##2##(1990-11#1)(1990-2#2)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-7#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-6#3)(1992-8#1)(1993-11#1)(1993-7#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#5)(1994-9#1)(1995-1#6)(1995-10#1)(1995-2#2)(1995-3#3)(1995-8#1)(1996-11#4)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#2)(1996-7#4)(1997-2#1)(1997-6#2)(1997-7#1)(2004-9#2)(2005-11#19)(2005-12#1)(2005-4#6)(2005-7#1)(2006-1#2)(2006-10#3)(2006-12#2)(2007-11#3)(2007-12#7)(2007-3#1)(2007-6#1)(2007-8#9)(2007-9#1)(2008-1#2)(2008-10#83)(2008-12#1)(2008-2#29)(2008-3#7)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-3#2)(2012-7#1)(2013-1#1)(2013-8#2)
the solution?##3##2##(1995-1#2)(1995-2#1)
the solutions in##2##3##(1991-1#1)(2005-11#1)
the solutions is##3##3##(2008-10#2)(2008-3#1)
the solutions of the##2##4##(2008-10#1)(2009-5#1)
the solutions of##9##3##(2008-10#4)(2008-3#1)(2008-5#2)(2009-5#1)(2013-8#1)
the solutions to##5##3##(1994-6#1)(1996-3#1)(2007-10#1)(2011-2#1)(2013-8#1)
the solutions was##2##3##(2005-11#1)(2008-10#1)
the solutions##44##2##(1991-1#1)(1991-9#1)(1994-6#1)(1996-3#1)(1997-4#1)(2005-11#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#19)(2008-3#3)(2008-5#3)(2009-4#1)(2009-5#1)(2011-2#1)(2012-12#2)(2013-8#2)
the solvated##2##2##(1995-5#1)(2005-11#1)
the solvation free energy##4##4##(1994-11#1)(2006-10#2)(2010-2#1)
the solvation of biological macromolecules##2##5##(2006-10#2)
the solvation of##5##3##(1990-2#1)(1996-2#1)(2006-10#2)(2010-2#1)
the solvation pockets##2##3##(2005-11#2)
the solvation shell##2##3##(1995-8#1)(1997-7#1)
the solvation structure and##2##4##(2010-7#2)
the solvation##21##2##(1990-2#1)(1994-11#1)(1995-8#1)(1996-2#1)(1997-7#1)(2005-11#3)(2006-10#5)(2008-5#1)(2010-2#2)(2010-7#3)(2011-3#1)(2013-1#1)
the solvent and the##5##4##(1996-2#1)(1996-5#1)(1997-1#1)(2008-10#2)
the solvent and##9##3##(1996-2#1)(1996-5#1)(1997-1#1)(1997-7#1)(1997-8#1)(2005-11#1)(2008-10#3)
the solvent by##2##3##(1997-1#1)(2005-11#1)
the solvent composition##2##3##(1997-1#1)(2007-10#1)
the solvent concentration##2##3##(2007-1#1)(2008-7#1)
the solvent effect on##2##4##(2007-11#1)(2008-10#1)
the solvent effect##3##3##(2005-4#1)(2007-11#1)(2008-10#1)
the solvent evaporation##2##3##(2011-1#1)(2013-7#1)
the solvent extraction##7##3##(1995-2#1)(2008-10#5)(2010-8#1)
the solvent in##2##3##(1996-2#1)(2008-10#1)
the solvent increased##2##3##(2008-10#1)(2013-7#1)
the solvent is##3##3##(1991-4#1)(2006-10#1)(2007-12#1)
the solvent mixture##2##3##(2008-10#2)
the solvent molecules##5##3##(1997-7#1)(2006-10#2)(2008-10#2)
the solvent of##3##3##(2005-4#1)(2007-11#1)(2008-2#1)
the solvent on the##3##4##(2005-11#1)(2006-1#1)(2008-10#1)
the solvent polarity##4##3##(2008-10#2)(2010-2#1)(2010-5#1)
the solvent properties of##2##4##(1996-2#1)(2012-2#1)
the solvent system##5##3##(1990-10#1)(1997-5#1)(2004-12#1)(2007-1#1)(2008-10#1)
the solvent systems##3##3##(2008-10#3)
the solvent used to##2##4##(2008-10#1)(2010-4#1)
the solvent used##3##3##(1996-7#1)(2008-10#1)(2010-4#1)
the solvent was##3##3##(1992-1#1)(2008-10#1)(2009-9#1)
the solvent##144##2##(1990-10#1)(1990-7#1)(1990-9#1)(1991-4#2)(1992-1#2)(1992-12#1)(1994-11#2)(1995-10#4)(1995-2#4)(1995-4#1)(1996-2#6)(1996-4#1)(1996-5#2)(1996-7#3)(1997-1#5)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2004-12#1)(2005-11#8)(2005-4#2)(2006-1#1)(2006-10#12)(2006-12#1)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#2)(2008-10#38)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#4)(2009-5#1)(2009-9#1)(2010-2#3)(2010-4#2)(2010-5#1)(2010-8#2)(2011-1#1)(2012-2#2)(2013-1#3)(2013-7#2)(2013-8#2)
the solvent-detergent procedure##2##3##(1991-6#2)
the solvent-exposed##4##2##(1990-10#1)(1990-2#1)(2006-10#1)(2008-7#1)
the solvent/detergent##2##2##(1991-6#1)(1992-2#1)
the solvents were##3##3##(1991-1#1)(2008-10#2)
the solvents##10##2##(1991-1#1)(2008-10#6)(2008-5#1)(2008-7#1)(2011-1#1)
the solvolyses of##3##3##(2011-1#3)
the solvolysis of##2##3##(2009-3#1)(2011-1#1)
the solvolysis##4##2##(2008-5#1)(2009-3#2)(2011-1#1)
the solvophobic theory##2##3##(1996-11#2)
the solvothermal##2##2##(2009-11#1)(2010-7#1)
the soma of##2##3##(1990-7#1)(1995-12#1)
the soma##16##2##(1990-7#1)(1992-8#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-3#1)(1996-6#1)(1996-9#3)(1997-5#1)(1997-7#1)(2007-12#2)(2008-11#2)
the somata of##2##3##(1993-12#1)(2009-8#1)
the somata##3##2##(1993-12#1)(1994-12#1)(2009-8#1)
the somatic and##4##3##(1994-10#1)(2012-12#1)(2012-2#1)(2013-8#1)
the somatic cell##3##3##(1991-8#1)(2005-6#1)(2008-9#1)
the somatic gonad##5##3##(2007-12#1)(2012-12#4)
the somatic motor pathway##2##4##(2008-4#2)
the somatic motor##3##3##(1996-12#1)(2008-4#2)
the somatic symptoms##2##3##(2007-4#1)(2011-2#1)
the somatic##41##2##(1990-12#1)(1990-6#1)(1991-12#1)(1991-5#1)(1991-8#2)(1994-10#1)(1994-12#1)(1994-3#1)(1995-3#3)(1996-12#1)(1997-7#2)(2005-6#1)(2006-7#1)(2007-12#3)(2007-4#2)(2008-4#2)(2008-7#1)(2008-9#3)(2010-12#1)(2011-2#1)(2012-12#7)(2012-2#2)(2013-1#1)(2013-8#1)
the somatodendritic##3##2##(1992-3#1)(1997-4#1)(2008-4#1)
the somatogenic##2##2##(1991-12#1)(1992-6#1)
the somatomedin B##2##3##(1996-5#2)
the somatosensory cortex were##2##4##(2008-5#1)(2011-2#1)
the somatosensory cortex##5##3##(1993-12#1)(1995-11#1)(1996-7#1)(2008-5#1)(2011-2#1)
the somatosensory problems##2##3##(2008-5#2)
the somatosensory##13##2##(1993-12#1)(1994-3#1)(1995-11#2)(1996-7#1)(1996-8#1)(2007-9#2)(2008-5#4)(2011-2#1)
the somatostatin analogue octreotide##2##4##(1994-8#1)(1995-5#1)
the somatostatin analogue##4##3##(1994-8#1)(1995-2#1)(1995-5#1)(2006-12#1)
the somatostatin receptor##2##3##(2006-12#1)(2012-3#1)
the somatostatin##15##2##(1990-3#1)(1991-7#2)(1994-8#1)(1995-2#1)(1995-5#1)(1995-8#2)(2006-12#2)(2007-7#1)(2008-7#1)(2010-11#2)(2012-3#1)
the somatotopic##2##2##(1993-9#1)(1997-3#1)
the somatotropic axis##2##3##(2010-5#2)
the some renal##2##3##(2008-8#1)(2011-2#1)
the some##5##2##(1991-10#1)(2005-3#1)(2007-7#1)(2008-8#1)(2011-2#1)
the sometimes subtle##2##3##(1991-12#1)(2011-1#1)
the sometimes##6##2##(1991-12#1)(1996-12#1)(2005-8#1)(2009-5#1)(2011-1#1)(2012-3#1)
the son of##2##3##(2006-12#1)(2007-10#1)
the son##3##2##(2006-12#1)(2007-10#1)(2008-12#1)
the song system of##2##4##(1990-4#1)(1996-7#1)
the song system##3##3##(1990-4#1)(1996-7#1)(2009-2#1)
the song##4##2##(1990-4#1)(1996-7#1)(1997-2#1)(2009-2#1)
the sonic hedgehog protein##2##4##(1996-12#2)
the sonicate##2##2##(1990-9#1)(1991-5#1)
the sonication##3##2##(2005-12#1)(2008-10#1)(2008-5#1)
the sonographic appearance of##2##4##(2008-8#1)(2012-2#1)
the sonographic##3##2##(2008-8#1)(2012-2#1)(2013-1#1)
the soot distribution##3##3##(2008-2#1)(2008-3#2)
the soot##9##2##(2006-12#1)(2007-12#1)(2008-2#2)(2008-3#5)
the sophisticated##3##2##(2007-8#1)(2008-5#1)(2011-2#1)
the sophistication of##2##3##(2004-10#1)(2008-11#1)
the sorbed##4##2##(2005-11#1)(2008-10#3)
the sorbent were##3##3##(2008-10#3)
the sorbent##18##2##(1993-2#1)(1996-8#1)(2008-10#16)
the sorghum ergot pathogen##2##4##(2008-10#2)
the sorghum pathogen##2##3##(2008-10#2)
the sorghum##7##2##(2008-10#5)(2008-7#2)
the sorption and##2##3##(2008-10#2)
the sorption capacities of##2##4##(2005-11#1)(2008-10#1)
the sorption capacity of the##2##5##(2008-10#2)
the sorption capacity##3##3##(2008-10#3)
the sorption equilibria##2##3##(2008-10#2)
the sorption of Cu(II)##2##4##(2008-10#2)
the sorption of metal ions##2##5##(2005-11#1)(2008-10#1)
the sorption of the##3##4##(2008-10#3)
the sorption of##28##3##(2005-11#3)(2007-8#1)(2008-10#24)
the sorption process##3##3##(2008-10#3)
the sorption significantly##2##3##(2008-10#2)
the sorption##58##2##(2005-11#7)(2007-8#1)(2008-10#50)
the sorptive##3##2##(2005-11#2)(2008-10#1)
the sort##3##2##(2006-7#1)(2008-4#1)(2008-9#1)
the sorting from the##2##4##(1996-4#1)(2012-12#1)
the sorting of##7##3##(1996-4#1)(2006-5#1)(2008-7#1)(2008-9#2)(2011-2#1)(2012-12#1)
the sorting##17##2##(1990-5#1)(1994-2#1)(1996-4#2)(2006-5#1)(2008-11#2)(2008-2#1)(2008-7#1)(2008-9#3)(2011-2#2)(2012-1#1)(2012-12#2)
the soul##4##2##(2006-12#1)(2008-11#1)(2008-7#2)
the sound intensity##2##3##(1994-8#1)(2008-8#1)
the sound pressure##2##3##(2008-3#1)(2010-2#1)
the sound speed##3##3##(2007-12#2)(2008-2#1)
the sound velocity##3##3##(2008-2#3)
the sound wave##3##3##(2008-10#1)(2008-2#2)
the sound##28##2##(1992-3#1)(1994-8#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#9)(2008-3#2)(2008-4#2)(2008-8#1)(2009-5#1)(2010-2#2)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#1)
the sound-speed##2##2##(1996-5#2)
the soundness of the##2##4##(1993-3#1)(1996-12#1)
the sounds in##2##3##(1997-1#1)(2012-12#1)
the sounds of##2##3##(2008-11#1)(2008-4#1)
the sounds##6##2##(1997-1#1)(1997-2#1)(2008-11#1)(2008-4#1)(2012-12#1)(2013-8#1)
the sour##2##2##(2008-9#1)(2013-1#1)
the source (0##2##3##(2008-3#2)
the source and load resistances##2##5##(2013-7#2)
the source and the##3##4##(2008-10#1)(2008-3#1)(2008-8#1)
the source and##13##3##(1996-3#1)(2007-10#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-8#1)(2012-3#1)(2013-1#1)(2013-7#2)
the source are##3##3##(2008-3#3)
the source coherence length##2##4##(2007-11#1)(2008-3#1)
the source for##2##3##(2007-11#1)(2007-3#1)
the source in a##2##4##(2007-11#1)(2008-2#1)
the source in##3##3##(2007-11#2)(2008-2#1)
the source is##10##3##(2005-10#1)(2006-10#1)(2008-2#2)(2008-3#5)(2011-12#1)
the source laser##2##3##(2007-12#1)(2008-3#1)
the source of a##2##4##(2008-5#1)(2010-9#1)
the source of chronic pain##3##5##(2006-7#1)(2006-8#1)(2007-6#1)
the source of infection##7##4##(1994-4#1)(1996-3#1)(1997-1#1)(1997-3#1)(2006-8#1)(2008-6#1)(2008-9#1)
the source of light##2##4##(1993-3#2)
the source of progestin##2##4##(2008-12#2)
the source of the##20##4##(1992-1#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-8#1)(1995-9#1)(1996-5#1)(1997-5#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-1#1)
the source of these##2##4##(2007-7#1)(2008-10#1)
the source of this##6##4##(1991-11#1)(1991-9#1)(1993-9#1)(2008-12#1)(2008-7#1)(2008-8#1)
the source of##117##3##(1990-1#1)(1990-2#2)(1991-11#2)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-2#1)(1994-4#1)(1994-5#1)(1994-7#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-3#1)(1997-5#1)(2005-11#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#6)(2008-2#2)(2008-4#5)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#4)(2009-10#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-1#4)(2012-2#2)(2013-1#3)(2013-7#2)(2013-8#1)
the source phase##2##3##(2008-10#2)
the source population##3##3##(1996-7#1)(2008-10#2)
the source than the##2##4##(2008-10#2)
the source than##3##3##(2008-10#3)
the source were##2##3##(2008-10#1)(2008-2#1)
the source##246##2##(1990-1#1)(1990-11#1)(1990-2#2)(1991-11#2)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-2#1)(1994-4#2)(1994-5#1)(1994-7#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-7#1)(1997-1#2)(1997-3#1)(1997-5#2)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#12)(2007-12#9)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#3)(2008-1#2)(2008-10#35)(2008-11#4)(2008-12#6)(2008-2#13)(2008-3#30)(2008-4#5)(2008-5#6)(2008-6#4)(2008-7#3)(2008-8#6)(2008-9#4)(2009-10#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#4)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#4)(2013-8#1)
the source-detector##2##2##(2008-3#1)(2011-1#1)
the source-receiver##2##2##(1991-3#1)(2008-3#1)
the sources and##4##3##(1992-9#1)(1995-1#1)(2007-2#1)(2008-10#1)
the sources are##2##3##(2011-1#1)(2012-1#1)
the sources for##2##3##(1995-2#1)(2008-4#1)
the sources of health##3##4##(2012-3#1)(2013-1#2)
the sources of##21##3##(1991-2#1)(1992-5#1)(1993-9#1)(1994-3#1)(1996-9#2)(2006-10#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-3#2)(2009-9#1)(2012-12#1)(2012-3#1)(2013-1#4)
the sources##33##2##(1990-11#1)(1991-2#1)(1992-5#1)(1992-9#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-9#2)(2006-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2009-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#4)
the south end##2##3##(2007-10#1)(2007-7#1)
the south of##10##3##(1992-9#1)(2007-5#1)(2008-10#4)(2008-2#1)(2012-12#2)(2013-8#1)
the south##27##2##(1992-8#1)(1992-9#1)(1996-8#1)(2007-1#1)(2007-10#1)(2007-5#3)(2007-7#2)(2008-10#7)(2008-11#1)(2008-2#1)(2008-6#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-7#2)(2013-8#1)
the south-western##5##2##(1997-4#1)(2008-4#1)(2010-3#1)(2010-8#2)
the southeast coast of##2##4##(1991-11#1)(2012-2#1)
the southeast of##2##3##(2006-12#1)(2008-12#1)
the southeast##8##2##(1991-11#1)(1991-3#1)(2006-12#1)(2008-12#1)(2008-4#1)(2008-5#1)(2012-2#1)(2012-3#1)
the southeastern USA##3##3##(2007-7#2)(2012-11#1)
the southeastern United States##20##4##(1992-8#1)(1993-1#1)(1994-1#1)(2007-12#1)(2008-10#9)(2008-5#1)(2011-2#5)(2012-1#1)
the southeastern##33##2##(1992-8#1)(1993-1#1)(1994-1#1)(1996-12#1)(2007-12#1)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#10)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#1)(2011-2#5)(2012-1#1)(2012-11#1)(2013-8#1)
the southern African##3##3##(1994-6#3)
the southern Gulf of Mexico##4##5##(2008-5#3)(2012-2#1)
the southern Ryukyus##3##3##(2008-5#1)(2010-3#2)
the southern San##2##3##(1996-4#1)(2011-2#1)
the southern South Island##2##4##(1995-8#2)
the southern and##2##3##(2008-10#1)(2011-12#1)
the southern part of the California Current##2##7##(2010-8#2)
the southern part of the##3##5##(2008-10#1)(2010-8#2)
the southern part of##6##4##(1996-12#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-8#2)
the southern##66##2##(1990-6#1)(1991-3#1)(1993-6#1)(1994-6#3)(1995-6#1)(1995-8#2)(1996-12#1)(1996-4#2)(1996-8#2)(1997-3#1)(1997-4#1)(2006-4#2)(2007-3#2)(2007-5#2)(2007-6#1)(2008-1#2)(2008-10#7)(2008-3#2)(2008-5#4)(2008-8#3)(2009-2#1)(2009-4#1)(2010-1#2)(2010-3#2)(2010-8#6)(2010-9#1)(2011-12#1)(2011-2#4)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#3)
the southernmost##4##2##(1992-4#1)(2007-5#1)(2008-2#1)(2008-5#1)
the southwest##6##2##(2004-4#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-9#1)
the southwestern U##2##3##(2011-12#2)
the southwestern United States##7##4##(1990-8#2)(1993-7#1)(2007-9#1)(2008-10#3)
the southwestern region of##2##4##(2007-3#1)(2008-10#1)
the southwestern##17##2##(1990-8#2)(1991-10#1)(1992-7#1)(1993-5#1)(1993-7#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-10#4)(2011-12#2)(2012-3#1)
the sow##2##2##(2006-8#1)(2013-8#1)
the sowing date from early spring to##2##7##(2008-10#2)
the sowing##3##2##(2008-10#2)(2013-8#1)
the soybean and##2##3##(2008-10#2)
the soybean genome##7##3##(1995-3#1)(2006-12#1)(2012-11#5)
the soybean hull flour##2##4##(2012-2#2)
the soybean lipoxygenase##2##3##(1990-7#1)(1993-6#1)
the soybean##33##2##(1990-11#1)(1990-12#1)(1990-7#1)(1993-6#1)(1995-10#2)(1995-3#1)(1996-12#1)(2006-12#1)(2008-10#9)(2008-12#1)(2009-3#1)(2011-2#3)(2012-11#7)(2012-2#3)
the spa therapy##2##3##(2008-4#2)
the spa##5##2##(1991-11#1)(1992-11#1)(1994-3#1)(2008-4#2)
the space and##3##3##(2007-11#1)(2007-9#1)(2013-8#1)
the space available##2##3##(1991-1#1)(2008-9#1)
the space between the##2##4##(1997-7#1)(2008-10#1)
the space between##3##3##(1997-7#1)(2008-10#1)(2008-9#1)
the space domain##3##3##(2004-3#1)(2008-2#2)
the space group P2(1)2(1)2(1) with##2##5##(1991-4#1)(1996-2#1)
the space group P2(1)2(1)2(1)##3##4##(1991-4#1)(1996-2#1)(2009-3#1)
the space group of##2##4##(2008-8#1)(2011-1#1)
the space group##10##3##(1991-4#1)(1992-12#1)(1993-8#1)(1996-2#1)(1996-6#1)(1997-7#1)(2007-11#1)(2008-8#1)(2009-3#1)(2011-1#1)
the space left##2##3##(1992-3#1)(2008-8#1)
the space of##9##3##(1996-8#1)(2006-10#2)(2006-8#1)(2007-12#1)(2008-3#1)(2009-10#1)(2010-2#1)(2012-2#1)
the space where##2##3##(1991-2#1)(2011-2#1)
the space##57##2##(1991-1#1)(1991-2#2)(1991-4#1)(1992-12#1)(1992-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-6#2)(1997-7#2)(2004-3#2)(2005-11#1)(2005-8#1)(2006-10#2)(2006-8#1)(2007-11#3)(2007-12#2)(2007-9#2)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#2)(2008-6#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-3#1)(2010-2#1)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the space-bandwidth product of the##2##5##(2008-2#2)
the space-charge field##4##3##(2007-11#3)(2007-12#1)
the space-charge region##2##3##(2007-12#1)(2012-2#1)
the space-charge##8##2##(2007-11#3)(2007-12#3)(2008-1#1)(2012-2#1)
the space-charge-field grating##2##3##(2007-11#2)
the space-time##3##2##(2007-12#1)(2007-9#1)(2008-8#1)
the spacer between the##2##4##(1997-1#1)(1997-3#1)
the spacer boxA##4##3##(1997-1#4)
the spacer in##2##3##(2008-10#2)
the spacer length##2##3##(2005-11#1)(2013-1#1)
the spacer regions##2##3##(1993-9#1)(1994-12#1)
the spacer##29##2##(1993-9#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-6#1)(1995-8#1)(1997-1#5)(1997-3#1)(1997-4#1)(2005-11#4)(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#1)(2010-5#2)(2013-1#1)
the spaces between the##2##4##(2008-5#1)(2010-3#1)
the spaces between##3##3##(2008-5#2)(2010-3#1)
the spaces##4##2##(2008-5#2)(2009-6#1)(2010-3#1)
the spacing and##2##3##(2006-10#1)(2011-2#1)
the spacing between the two##2##5##(1994-11#1)(2007-11#1)
the spacing between the##5##4##(1994-11#1)(2007-11#1)(2007-12#1)(2008-3#2)
the spacing between##10##3##(1990-9#1)(1993-12#1)(1994-11#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)
the spacing of the##3##4##(1990-4#1)(2008-2#1)(2008-3#1)
the spacing of##6##3##(1990-4#1)(1995-1#1)(1995-8#1)(2008-2#2)(2008-3#1)
the spacing##23##2##(1990-4#1)(1990-9#1)(1993-12#1)(1994-11#2)(1995-1#1)(1995-8#1)(1996-2#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#7)(2011-2#1)
the span of the##2##4##(2006-10#1)(2007-12#1)
the span of##4##3##(2006-10#1)(2007-12#1)(2008-3#2)
the spanning-bus##2##2##(2008-2#2)
the spared##3##2##(1996-9#1)(2008-4#2)
the sparing of##2##3##(2008-5#1)(2009-5#1)
the spark##6##2##(2006-12#2)(2007-9#1)(2008-1#2)(2008-10#1)
the sparks##2##2##(2008-1#2)
the sparse##6##2##(1993-12#1)(2008-3#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-1#1)
the spastic##4##2##(2006-3#1)(2006-9#1)(2012-1#2)
the spatial VG##4##3##(2010-11#4)
the spatial analysis##2##3##(2008-10#2)
the spatial and temporal characteristics##2##5##(2007-12#1)(2008-8#1)
the spatial and temporal distribution of##3##6##(2007-5#1)(2007-6#1)(2008-5#1)
the spatial and temporal expression of##3##6##(1991-12#1)(1996-6#1)(2008-4#1)
the spatial and temporal expression pattern##3##6##(2006-12#1)(2012-12#2)
the spatial and temporal expression##6##5##(1991-12#1)(1996-6#1)(2006-12#1)(2008-4#1)(2012-12#2)
the spatial and temporal patterns of##3##6##(2008-10#1)(2008-11#1)(2008-7#1)
the spatial and temporal##27##4##(1991-12#1)(1992-9#1)(1994-6#1)(1996-6#1)(2006-12#1)(2007-12#3)(2007-5#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#2)(2009-8#1)(2012-12#2)(2013-7#1)(2013-8#1)
the spatial and the temporal##6##5##(2007-11#1)(2007-12#2)(2008-2#3)
the spatial and the##7##4##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#1)
the spatial and##40##3##(1991-12#1)(1992-9#1)(1994-6#1)(1996-6#1)(2006-12#1)(2007-11#1)(2007-12#6)(2007-5#2)(2007-6#1)(2008-10#2)(2008-11#3)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#2)(2009-8#1)(2011-2#1)(2012-12#2)(2013-7#1)(2013-8#2)
the spatial arrangement of##8##4##(1994-9#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-5#1)(2010-10#1)(2013-1#1)(2013-7#1)
the spatial arrangement##9##3##(1994-9#1)(1996-8#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-5#1)(2010-10#1)(2013-1#1)(2013-7#1)
the spatial autocorrelation depends##2##4##(2008-10#2)
the spatial autocorrelation##5##3##(1994-5#1)(2008-10#2)(2008-2#1)(2008-7#1)
the spatial beam profile##2##4##(2008-3#2)
the spatial beam##3##3##(2007-12#1)(2008-3#2)
the spatial coherence of a##3##5##(2007-12#1)(2008-2#2)
the spatial coherence of light##2##5##(2008-3#2)
the spatial coherence of##6##4##(2007-12#1)(2008-2#2)(2008-3#3)
the spatial coherence##14##3##(2007-11#2)(2007-12#3)(2008-2#5)(2008-3#4)
the spatial configuration of##2##4##(2007-7#1)(2008-2#1)
the spatial conformation of##3##4##(1990-4#1)(1997-3#1)(2008-8#1)
the spatial delayed alternation task##2##5##(1991-1#2)
the spatial dependence of the##3##5##(2007-11#1)(2007-12#1)(2008-3#1)
the spatial dependence##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2009-7#1)
the spatial dimensions##2##3##(1996-8#1)(2008-3#1)
the spatial distribution and the##2##5##(2007-12#1)(2008-8#1)
the spatial distribution of a##3##5##(2007-12#1)(2008-2#2)
the spatial distribution of human##3##5##(2008-11#1)(2008-8#2)
the spatial distribution of the optical##2##6##(2008-2#2)
the spatial distribution of the##12##5##(1995-3#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#2)(2009-4#1)(2010-8#1)(2011-1#1)
the spatial distribution of##48##4##(1990-7#1)(1994-9#1)(1995-3#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#8)(2008-3#4)(2008-5#1)(2008-8#3)(2009-10#2)(2009-4#1)(2009-5#1)(2010-4#1)(2010-8#2)(2011-1#2)(2012-11#1)(2012-2#1)(2013-7#3)(2013-8#1)
the spatial distribution##54##3##(1990-7#1)(1994-9#1)(1995-3#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#9)(2008-3#5)(2008-5#1)(2008-8#4)(2009-10#2)(2009-4#1)(2009-5#1)(2010-4#1)(2010-8#2)(2011-1#2)(2012-11#1)(2012-2#1)(2013-7#3)(2013-8#2)
the spatial domain by##2##4##(2008-2#1)(2008-3#1)
the spatial domain##8##3##(2007-12#2)(2008-2#4)(2008-3#2)
the spatial dynamics of##3##4##(2008-10#3)
the spatial dynamics##4##3##(2007-9#1)(2008-10#3)
the spatial expression##2##3##(1993-2#1)(2008-10#1)
the spatial extent of##2##4##(1996-5#1)(2008-2#1)
the spatial extent##3##3##(1996-5#1)(2007-5#1)(2008-2#1)
the spatial frequencies##2##3##(2007-11#1)(2008-3#1)
the spatial frequency and##2##4##(2007-12#1)(2008-3#1)
the spatial frequency of the##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
the spatial frequency##11##3##(1994-2#2)(1994-8#1)(2007-12#3)(2008-2#2)(2008-3#3)
the spatial heterogeneity##2##3##(2008-10#1)(2008-3#1)
the spatial information##2##3##(2008-3#2)
the spatial learning deficit produced by intraseptal##2##7##(1993-12#2)
the spatial learning deficit produced by##4##6##(1993-12#4)
the spatial learning in##2##4##(2008-9#2)
the spatial learning##8##3##(1993-12#4)(1993-2#1)(1994-3#1)(2008-9#2)
the spatial light modulator##5##4##(2008-1#1)(2008-2#2)(2008-3#2)
the spatial light##7##3##(2008-1#1)(2008-2#4)(2008-3#2)
the spatial localization of##3##4##(1995-2#1)(1996-11#1)(2007-9#1)
the spatial location of##2##4##(2008-3#1)(2010-4#1)
the spatial location##3##3##(2008-11#1)(2008-3#1)(2010-4#1)
the spatial memory##4##3##(1993-2#1)(1993-5#1)(1997-2#1)(2011-2#1)
the spatial mismatch hypothesis##3##4##(2009-9#3)
the spatial mismatch##4##3##(2009-9#3)(2012-12#1)
the spatial organization of##4##4##(2008-1#1)(2008-7#1)(2009-5#2)
the spatial organization##6##3##(2008-1#1)(2008-7#1)(2008-9#1)(2009-5#2)(2010-9#1)
the spatial pattern of##13##4##(1994-5#1)(2007-12#1)(2008-10#8)(2008-8#3)
the spatial patterns of the disease and##2##7##(2008-10#2)
the spatial patterns of##9##4##(2007-8#1)(2007-9#1)(2008-10#6)(2008-2#1)
the spatial patterns##10##3##(2007-8#1)(2007-9#1)(2008-10#6)(2008-2#1)(2008-9#1)
the spatial position of the##3##5##(1997-2#1)(2007-12#1)(2008-3#1)
the spatial position##4##3##(1997-2#1)(2006-6#1)(2007-12#1)(2008-3#1)
the spatial properties of the##3##5##(2008-10#1)(2008-2#1)(2009-6#1)
the spatial relationship##2##3##(2007-8#1)(2008-4#1)
the spatial relationships##5##3##(1997-8#1)(2007-5#1)(2008-10#1)(2008-9#1)(2012-2#1)
the spatial resolution is##2##4##(2007-12#1)(2008-7#1)
the spatial resolution of the##5##5##(1991-2#1)(2008-10#1)(2008-3#3)
the spatial resolution of##8##4##(1991-2#1)(2006-12#1)(2008-10#1)(2008-3#4)(2009-7#1)
the spatial resolution##16##3##(1991-2#1)(2006-12#1)(2006-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#6)(2008-7#1)(2009-7#1)(2011-1#1)
the spatial response##3##3##(2008-2#3)
the spatial scale at which##2##5##(2008-10#1)(2012-12#1)
the spatial scale of##2##4##(2008-8#2)
the spatial scale##4##3##(2008-10#1)(2008-8#2)(2012-12#1)
the spatial scaling exponent##2##4##(1993-2#2)
the spatial statistics of##3##4##(2008-3#3)
the spatial structure of a##2##5##(2008-8#1)(2009-2#1)
the spatial structure of the##3##5##(2008-11#1)(2008-8#1)(2013-1#1)
the spatial structure of##9##4##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#3)(2009-2#1)(2013-1#1)
the spatial structure##11##3##(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#4)(2009-2#1)(2013-1#1)
the spatial uniformity##2##3##(2008-3#2)
the spatial variability of the##2##5##(2007-11#1)(2009-11#1)
the spatial variability of##3##4##(2007-11#1)(2008-2#1)(2009-11#1)
the spatial variability##4##3##(2007-11#1)(2008-2#1)(2009-11#1)(2010-2#1)
the spatial variation of the##2##5##(2007-12#1)(2008-3#1)
the spatial variation of##3##4##(2006-7#1)(2007-12#1)(2008-3#1)
the spatial working memory task##2##5##(1994-8#1)(1997-8#1)
the spatial##392##2##(1990-3#1)(1990-4#1)(1990-7#1)(1991-1#2)(1991-12#1)(1991-2#1)(1992-10#1)(1992-9#1)(1993-12#4)(1993-2#5)(1993-5#2)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#2)(1995-2#1)(1995-3#1)(1996-11#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#2)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#5)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-11#12)(2007-12#36)(2007-3#1)(2007-5#4)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#4)(2008-1#6)(2008-10#38)(2008-11#7)(2008-2#49)(2008-3#62)(2008-4#3)(2008-5#3)(2008-7#4)(2008-8#18)(2008-9#6)(2009-10#5)(2009-11#1)(2009-2#1)(2009-4#2)(2009-5#6)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#4)(2010-10#2)(2010-11#5)(2010-2#1)(2010-4#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#5)(2013-1#2)(2013-7#5)(2013-8#7)
the spatial-frequency plane##2##3##(2008-3#2)
the spatial-frequency##5##2##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)
the spatially encrypted signal##2##4##(2008-3#2)
the spatially resolved##5##3##(2006-10#1)(2007-11#1)(2008-2#2)(2008-3#1)
the spatially varying##3##3##(2008-3#1)(2011-1#1)(2013-1#1)
the spatially##23##2##(2006-10#2)(2006-5#1)(2007-11#1)(2008-2#3)(2008-3#6)(2008-4#1)(2008-8#4)(2009-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
the spatio-temporal##7##2##(1995-6#1)(2008-10#2)(2008-11#1)(2009-5#1)(2011-1#1)(2013-7#1)
the spatiotemporal dynamics of word processing##2##6##(2008-11#2)
the spatiotemporal dynamics of##3##4##(2008-10#1)(2008-11#2)
the spatiotemporal evolution of##3##4##(1995-12#1)(2007-12#1)(2008-11#1)
the spatiotemporal resolution##2##3##(1991-2#1)(2009-7#1)
the spatiotemporal##25##2##(1990-5#1)(1991-2#1)(1995-12#1)(2007-11#1)(2007-12#5)(2008-10#1)(2008-11#3)(2008-3#1)(2008-8#2)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
the spatula##2##2##(2006-6#1)(2009-6#1)
the spawning of##2##3##(1991-8#1)(2008-11#1)
the spawning##7##2##(1991-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-8#3)
the speC gene##2##3##(1994-12#2)
the speaker##5##2##(2008-11#1)(2009-10#2)(2013-8#2)
the speaker's##4##2##(1995-12#1)(2008-11#1)(2008-5#2)
the speakers##3##2##(2005-8#1)(2009-9#1)(2013-8#1)
the special care##2##3##(1993-3#1)(1994-3#1)
the special case model##3##4##(2008-8#3)
the special case of##6##4##(1994-6#1)(2008-10#3)(2008-2#1)(2008-8#1)
the special case where##2##4##(1992-6#1)(2006-4#1)
the special case##12##3##(1992-6#1)(1994-6#1)(2006-10#1)(2006-4#1)(2008-10#3)(2008-2#1)(2008-8#4)
the special characteristics of##2##4##(2010-12#1)(2012-12#1)
the special characteristics##3##3##(2008-6#1)(2010-12#1)(2012-12#1)
the special considerations##2##3##(2008-4#1)(2010-6#1)
the special importance of##2##4##(1990-7#1)(2006-10#1)
the special issue##3##3##(2008-4#1)(2009-4#1)(2013-1#1)
the special issues##2##3##(2009-9#1)(2010-5#1)
the special needs of##6##4##(1991-2#1)(1997-2#1)(1997-8#1)(2007-8#1)(2012-12#1)(2013-1#1)
the special needs##7##3##(1991-2#1)(1996-3#1)(1997-2#1)(1997-8#1)(2007-8#1)(2012-12#1)(2013-1#1)
the special population of##2##4##(2008-2#1)(2008-8#1)
the special properties of the##2##5##(2008-2#2)
the special properties of##3##4##(2007-12#1)(2008-2#2)
the special series##2##3##(2008-6#1)(2012-2#1)
the special##82##2##(1990-2#1)(1990-5#2)(1990-7#1)(1991-2#1)(1991-8#1)(1992-6#1)(1993-10#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1996-11#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-8#1)(2005-3#1)(2005-5#1)(2006-10#2)(2006-4#1)(2007-12#2)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#2)(2008-10#3)(2008-2#5)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#6)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)
the specialised##3##2##(2006-2#2)(2013-1#1)
the specialist doctors##2##3##(2006-10#2)
the specialist in##3##3##(1993-5#1)(1996-9#1)(2013-1#1)
the specialist##23##2##(1990-12#1)(1991-2#1)(1993-12#1)(1993-5#1)(1993-6#1)(1995-3#1)(1995-9#1)(1996-9#1)(2004-2#2)(2006-10#2)(2008-3#1)(2008-6#3)(2008-7#2)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
the specialists##4##2##(2008-9#1)(2012-12#1)(2013-1#2)
the speciality##3##2##(2008-12#1)(2009-10#1)(2013-1#1)
the specialization of function?##2##4##(2011-12#2)
the specialization of##3##3##(2008-10#1)(2011-12#2)
the specialized units##2##3##(1994-8#2)
the specialized##14##2##(1992-11#1)(1992-6#1)(1993-1#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-6#1)(1996-11#1)(2007-11#1)(2008-1#1)(2008-4#1)(2012-1#1)(2013-1#1)
the specially##2##2##(1997-6#1)(2008-10#1)
the specialties##2##2##(1991-6#1)(1996-12#1)
the specialty care##2##3##(2007-6#1)(2008-9#1)
the specialty in##3##3##(1997-8#1)(2007-4#1)(2008-9#1)
the specialty of diagnostic##2##4##(2007-4#2)
the specialty of radiology##2##4##(2007-4#2)
the specialty of##8##3##(1995-9#1)(2006-10#1)(2007-12#1)(2007-4#4)(2012-2#1)
the specialty##27##2##(1992-11#1)(1993-1#1)(1995-9#1)(1997-8#1)(2005-9#1)(2006-10#2)(2007-12#2)(2007-4#10)(2007-6#1)(2007-8#1)(2008-10#1)(2008-9#3)(2012-12#1)(2012-2#1)
the speciation analysis of##3##4##(2005-4#1)(2008-10#2)
the speciation analysis##5##3##(2005-4#1)(2008-10#4)
the speciation and determination of##2##5##(2008-10#2)
the speciation and##4##3##(2008-10#3)(2008-9#1)
the speciation continuum in##2##4##(2010-8#1)(2013-1#1)
the speciation of As(III) and As(V) in##2##7##(2008-10#2)
the speciation of antimony in##3##5##(2008-10#3)
the speciation of antimony##4##4##(2008-10#4)
the speciation of arsenic in##3##5##(2008-10#3)
the speciation of arsenic##5##4##(2008-10#5)
the speciation of chromium in##4##5##(2008-10#4)
the speciation of chromium##6##4##(2008-10#6)
the speciation of##34##3##(1996-8#1)(2008-10#32)(2008-9#1)
the speciation process##3##3##(2008-8#1)(2009-2#1)(2013-1#1)
the speciation##57##2##(1996-8#2)(2005-4#1)(2006-3#1)(2008-10#44)(2008-8#1)(2008-9#3)(2009-2#1)(2010-6#1)(2010-8#1)(2013-1#2)
the specie##2##2##(2007-10#1)(2008-10#1)
the species P##3##3##(2006-8#2)(2008-7#1)
the species and##15##3##(1994-9#1)(1996-11#1)(2007-3#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-2#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
the species are##7##3##(2007-12#1)(2007-3#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-8#1)
the species as##2##3##(2007-3#1)(2010-7#1)
the species barrier##2##3##(1993-1#1)(2006-10#1)
the species composition of##3##4##(2008-9#1)(2009-2#1)(2011-1#1)
the species composition##6##3##(2008-5#1)(2008-9#1)(2009-2#1)(2011-1#1)(2013-7#2)
the species examined##4##3##(1993-2#1)(1996-5#2)(2008-7#1)
the species formed##3##3##(2008-10#2)(2008-5#1)
the species found in##2##4##(2008-5#1)(2010-12#1)
the species found##5##3##(2008-10#1)(2008-5#1)(2010-12#1)(2012-12#1)(2013-7#1)
the species from##2##3##(2008-10#1)(2013-8#1)
the species has been##3##4##(2008-4#1)(2008-5#1)(2010-8#1)
the species have a##3##4##(2007-12#1)(2008-12#1)(2008-5#1)
the species have##4##3##(2007-12#1)(2008-12#1)(2008-5#1)(2013-8#1)
the species in the##7##4##(1995-2#2)(1996-6#1)(2007-9#1)(2008-10#2)(2008-5#1)
the species in##13##3##(1995-2#2)(1996-6#1)(2007-9#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#3)(2012-5#1)
the species is##5##3##(2007-3#1)(2008-10#1)(2008-5#1)(2013-7#2)
the species isolated##2##3##(2008-5#1)(2011-2#1)
the species level##10##3##(2008-10#1)(2008-5#3)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#2)(2012-6#1)
the species most frequently##3##4##(2006-10#1)(2008-4#2)
the species most##4##3##(2006-10#1)(2007-9#1)(2008-4#2)
the species number##2##3##(2008-10#1)(2008-8#1)
the species of the##2##4##(1992-2#1)(2007-9#1)
the species of##21##3##(1992-2#1)(1994-3#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-2#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-8#1)(2009-5#1)(2010-4#1)(2011-12#1)(2013-7#1)
the species present on the##2##5##(2005-11#2)
the species reported in the##2##5##(2007-5#1)(2008-5#1)
the species specificity##2##3##(2008-10#2)
the species studied##6##3##(1990-2#1)(1994-8#1)(2007-11#2)(2008-8#1)(2010-5#1)
the species tested##2##3##(2006-8#1)(2008-5#1)
the species that##3##3##(2008-10#1)(2008-8#1)(2013-7#1)
the species to be##2##4##(2008-3#1)(2010-5#1)
the species trees##2##3##(2010-6#2)
the species used##2##3##(2008-10#1)(2010-5#1)
the species was##9##3##(2006-10#1)(2008-10#1)(2008-5#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-5#1)(2013-1#1)
the species we studied##2##4##(2008-4#1)(2009-8#1)
the species were##5##3##(2005-12#1)(2008-10#2)(2008-5#1)(2012-2#1)
the species with a##2##4##(2007-3#2)
the species with##6##3##(2007-3#2)(2008-10#3)(2013-8#1)
the species##271##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-7#1)(1992-2#1)(1993-1#1)(1993-2#1)(1993-9#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-5#2)(1996-6#1)(1997-4#5)(1997-6#1)(2004-4#1)(2005-10#1)(2005-11#2)(2005-12#1)(2006-10#4)(2006-4#1)(2006-8#4)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-3#12)(2007-5#4)(2007-8#1)(2007-9#4)(2008-1#2)(2008-10#54)(2008-11#1)(2008-12#4)(2008-3#2)(2008-4#5)(2008-5#26)(2008-6#1)(2008-7#2)(2008-8#18)(2008-9#3)(2009-10#1)(2009-2#4)(2009-3#1)(2009-5#1)(2009-8#3)(2010-12#1)(2010-4#4)(2010-5#3)(2010-6#5)(2010-7#2)(2010-8#4)(2011-1#1)(2011-12#1)(2011-2#9)(2012-1#2)(2012-12#1)(2012-2#10)(2012-3#5)(2012-5#2)(2012-6#1)(2013-1#1)(2013-7#9)(2013-8#7)
the species'##4##2##(1996-8#1)(2008-10#1)(2008-12#1)(2008-5#1)
the species-area relationship and##2##4##(2008-8#2)
the species-area relationship##3##3##(2008-8#3)
the species-area##4##2##(2008-8#4)
the species-specific parasitism of##2##4##(2008-10#2)
the species-specific##4##2##(2008-10#3)(2008-9#1)
the specific DNA binding activity##2##5##(1994-3#1)(1994-9#1)
the specific DNA binding##3##4##(1994-3#1)(1994-9#1)(1995-11#1)
the specific DNA##4##3##(1994-3#1)(1994-9#1)(1995-11#1)(1997-1#1)
the specific IgA production rate##3##5##(2008-11#3)
the specific PCR primers##2##4##(2008-10#2)
the specific PCR##4##3##(1996-8#1)(2006-8#1)(2008-10#2)
the specific actions##2##3##(1994-1#1)(2007-1#1)
the specific activities of##5##4##(1991-12#1)(1994-11#1)(2005-11#1)(2005-8#2)
the specific activities##6##3##(1991-12#1)(1994-11#1)(1994-2#1)(2005-11#1)(2005-8#2)
the specific activity of the enzyme##3##6##(1990-4#1)(1993-11#1)(1996-8#1)
the specific activity of the##7##5##(1990-4#1)(1991-8#1)(1993-11#1)(1996-8#1)(2006-10#1)(2008-10#1)(2008-4#1)
the specific activity of##15##4##(1990-4#1)(1990-7#1)(1991-12#1)(1991-8#1)(1992-11#1)(1993-11#2)(1994-11#1)(1994-12#1)(1995-3#1)(1996-8#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-4#1)
the specific activity##19##3##(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#1)(1991-12#1)(1991-8#1)(1992-11#1)(1993-11#2)(1994-11#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-8#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-4#1)
the specific adsorption of##2##4##(2005-11#1)(2008-10#1)
the specific adsorption##4##3##(2005-11#3)(2008-10#1)
the specific alterations##2##3##(1995-8#1)(2010-1#1)
the specific amino acid##2##4##(1991-10#1)(1993-6#1)
the specific amino##3##3##(1991-10#1)(1993-6#1)(1995-5#1)
the specific amplification of##4##4##(1990-3#1)(1993-5#1)(2008-10#2)
the specific amplification##5##3##(1990-3#1)(1993-5#1)(2008-10#3)
the specific and##6##3##(1992-1#1)(1996-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2013-1#1)
the specific antibody##2##3##(2007-12#1)(2008-10#1)
the specific application##2##3##(2008-4#1)(2010-8#1)
the specific approach##2##3##(2008-10#1)(2010-3#1)
the specific behaviors that##2##4##(2006-4#1)(2010-11#1)
the specific binding of##12##4##(1990-12#1)(1990-2#1)(1991-9#1)(1993-12#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-2#1)(2008-11#1)(2008-7#1)(2010-7#1)
the specific binding sites##2##4##(1993-5#1)(1993-8#1)
the specific binding to##2##4##(1995-7#1)(2009-7#1)
the specific binding##19##3##(1990-11#1)(1990-12#1)(1990-2#1)(1991-9#1)(1993-12#1)(1993-5#1)(1993-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-2#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-7#1)(2010-7#1)
the specific brain##2##3##(2006-10#1)(2008-4#1)
the specific case of##6##4##(2008-10#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
the specific case##7##3##(2008-10#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-2#1)
the specific cause of##2##4##(2004-10#1)(2009-3#1)
the specific cause##3##3##(2004-10#1)(2008-2#1)(2009-3#1)
the specific cell##3##3##(1994-3#1)(2008-11#1)(2008-7#1)
the specific cellular##3##3##(1996-2#1)(2009-8#1)(2013-8#1)
the specific challenges##2##3##(2008-11#1)(2012-3#1)
the specific character of##2##4##(2006-3#1)(2012-3#1)
the specific characteristics of the##2##5##(2006-10#1)(2013-8#1)
the specific characteristics of this##2##5##(2008-5#1)(2011-2#1)
the specific characteristics of##6##4##(2006-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-8#1)
the specific characteristics##7##3##(1991-3#1)(2006-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-8#1)
the specific cleavage of##2##4##(2006-12#1)(2008-9#1)
the specific cleavage##3##3##(1995-2#1)(2006-12#1)(2008-9#1)
the specific clinical##2##3##(2008-10#1)(2012-12#1)
the specific conditions##3##3##(2007-11#1)(2008-10#1)(2012-2#1)
the specific contribution of##2##4##(1996-3#1)(2008-11#1)
the specific detection of the##2##5##(2008-10#1)(2010-10#1)
the specific detection of##8##4##(2007-8#2)(2008-10#4)(2010-10#1)(2013-8#1)
the specific detection##9##3##(2007-8#3)(2008-10#4)(2010-10#1)(2013-8#1)
the specific disease##2##3##(2006-8#1)(2008-7#1)
the specific effect of##2##4##(2008-4#1)(2012-2#1)
the specific effects of##4##4##(1990-12#1)(2005-11#1)(2006-9#1)(2008-1#1)
the specific elements##2##3##(2007-5#1)(2012-2#1)
the specific energy dissipation rate and##2##6##(2008-7#2)
the specific energy dissipation rate##7##5##(2008-7#7)
the specific energy dissipation##9##4##(2008-7#9)
the specific energy##10##3##(1990-11#1)(2008-7#9)
the specific enzyme production##2##4##(1994-3#1)(2008-7#1)
the specific enzyme##3##3##(1994-3#1)(2004-11#1)(2008-7#1)
the specific expression of##2##4##(1994-6#1)(1997-6#1)
the specific expression##3##3##(1994-6#1)(1997-6#1)(2008-11#1)
the specific features of different##2##5##(2008-4#1)(2012-3#1)
the specific features of##6##4##(1991-10#1)(1993-10#1)(2008-10#1)(2008-4#1)(2010-12#1)(2012-3#1)
the specific features##7##3##(1991-10#1)(1993-10#1)(2008-10#1)(2008-4#1)(2010-12#1)(2010-8#1)(2012-3#1)
the specific genes##2##3##(2006-10#1)(2007-12#1)
the specific genetic background of##2##5##(2007-10#1)(2008-7#1)
the specific genetic##7##3##(1997-4#1)(2006-10#1)(2007-10#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-11#1)
the specific glucose consumption rate##2##5##(2008-11#2)
the specific glucose uptake rate##3##5##(1994-5#3)
the specific glucose##6##3##(1994-5#3)(2008-11#2)(2008-7#1)
the specific growth rate and the##2##6##(1994-2#1)(1996-2#1)
the specific growth rate of the##2##6##(1995-9#1)(2008-11#1)
the specific growth rate of##6##5##(1995-9#1)(2006-8#1)(2008-11#1)(2008-7#2)(2010-11#1)
the specific growth rate##16##4##(1994-2#1)(1994-5#1)(1995-9#1)(1996-2#3)(2006-8#1)(2007-3#1)(2008-11#3)(2008-7#3)(2008-9#1)(2010-11#1)
the specific growth rates##2##4##(2008-11#1)(2008-7#1)
the specific growth##18##3##(1994-2#1)(1994-5#1)(1995-9#1)(1996-2#3)(2006-8#1)(2007-3#1)(2008-11#4)(2008-7#4)(2008-9#1)(2010-11#1)
the specific immune##2##3##(1992-1#1)(2008-11#1)
the specific incorporation of##2##4##(2007-8#1)(2008-4#1)
the specific inhibition##2##3##(1992-11#1)(2013-1#1)
the specific inhibitor##2##3##(1995-8#1)(2003-11#1)
the specific input##2##3##(2007-7#1)(2008-11#1)
the specific interaction between##2##4##(1995-10#1)(1996-8#1)
the specific interaction of the##2##5##(1991-6#1)(2008-10#1)
the specific interaction of##4##4##(1991-6#1)(1993-3#1)(1996-5#1)(2008-10#1)
the specific interaction with##2##4##(1996-4#1)(1997-4#1)
the specific interaction##10##3##(1991-6#1)(1993-3#1)(1995-10#1)(1996-4#1)(1996-5#1)(1996-8#2)(1997-4#1)(2008-10#1)(2008-2#1)
the specific life##2##3##(2007-6#1)(2013-8#1)
the specific ligand##2##3##(2008-6#1)(2008-9#1)
the specific mechanism of##2##4##(1992-9#1)(2008-10#1)
the specific mechanisms underlying##2##4##(2006-10#1)(2009-4#1)
the specific mechanisms##4##3##(2006-10#1)(2007-11#1)(2009-4#1)(2010-8#1)
the specific monoclonal antibody production rate##2##6##(2008-11#2)
the specific nature of the##3##5##(1990-5#1)(2007-12#1)(2008-2#1)
the specific nature of##5##4##(1990-5#1)(2007-12#1)(2007-7#1)(2008-2#1)(2010-2#1)
the specific needs of##6##4##(1996-3#1)(2006-2#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
the specific needs##7##3##(1996-3#1)(2006-2#1)(2008-7#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
the specific nuclear##2##3##(1992-5#1)(2008-8#1)
the specific physical##2##3##(2012-2#1)(2013-8#1)
the specific population##2##3##(2008-7#1)(2011-2#1)
the specific problems##2##3##(2007-12#1)(2007-9#1)
the specific process and presentation of##2##6##(2008-8#2)
the specific productivity of##2##4##(2008-11#2)
the specific productivity##3##3##(2008-11#2)(2008-7#1)
the specific protein##2##3##(1993-6#1)(2008-8#1)
the specific radioactivity of##2##4##(1991-3#1)(1995-6#1)
the specific radioactivity##3##3##(1990-12#1)(1991-3#1)(1995-6#1)
the specific rate of catabolic activity##2##6##(2006-12#2)
the specific rate of##3##4##(2006-12#2)(2008-11#1)
the specific rates of##2##4##(2008-11#2)
the specific receptor##2##3##(1995-10#1)(2009-8#1)
the specific receptors##2##3##(2008-3#1)(2008-4#1)
the specific recognition of##6##4##(1990-2#1)(1991-9#1)(1995-3#1)(1996-5#2)(2008-10#1)
the specific release of##2##4##(2008-4#1)(2009-3#1)
the specific requirements##3##3##(1995-5#1)(2008-4#1)(2013-8#1)
the specific risk##3##3##(1996-12#1)(1997-8#1)(2008-9#1)
the specific role of##8##4##(1990-11#1)(1991-9#1)(1993-6#1)(1996-2#1)(2006-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
the specific role##11##3##(1990-11#1)(1991-9#1)(1993-6#1)(1996-2#1)(2006-10#1)(2008-11#1)(2008-7#1)(2010-2#1)(2010-7#1)(2012-12#1)(2012-2#1)
the specific roles of##4##4##(1993-8#1)(2006-2#1)(2008-4#1)(2009-9#1)
the specific roles##5##3##(1993-8#1)(2006-2#1)(2007-10#1)(2008-4#1)(2009-9#1)
the specific signal##2##3##(1994-9#1)(2008-9#1)
the specific skills##2##3##(1993-10#1)(2004-10#1)
the specific status of##2##4##(2004-11#2)
the specific structure of##2##4##(1995-5#1)(2012-2#1)
the specific sugar inhibitor##2##4##(1994-6#2)
the specific surface area of the Al adsorbent##2##8##(2005-11#2)
the specific surface area##6##4##(1993-12#1)(2005-11#3)(2010-4#2)
the specific surface##8##3##(1993-12#1)(2005-11#3)(2007-9#1)(2008-10#1)(2010-4#2)
the specific transfer##2##3##(1993-11#1)(2008-9#1)
the specific treatment##8##3##(2006-8#1)(2007-10#1)(2007-7#1)(2008-8#1)(2009-4#1)(2010-12#1)(2011-1#1)(2012-12#1)
the specific type of##2##4##(2006-10#1)(2008-4#1)
the specific type##3##3##(2006-10#1)(2008-4#1)(2011-1#1)
the specific types of##2##4##(2006-1#1)(2008-12#1)
the specific ways##2##3##(1996-1#1)(2008-10#1)
the specific##652##2##(1990-11#4)(1990-12#6)(1990-2#5)(1990-3#4)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#3)(1990-9#1)(1991-10#2)(1991-12#5)(1991-2#3)(1991-3#2)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#4)(1992-1#4)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#5)(1992-6#2)(1992-9#3)(1993-1#1)(1993-10#2)(1993-11#5)(1993-12#5)(1993-2#1)(1993-3#2)(1993-5#4)(1993-6#4)(1993-7#2)(1993-8#3)(1993-9#1)(1994-1#3)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#4)(1994-3#7)(1994-5#5)(1994-6#5)(1994-8#4)(1994-9#4)(1995-1#4)(1995-10#4)(1995-11#3)(1995-12#4)(1995-2#2)(1995-3#4)(1995-5#6)(1995-6#2)(1995-7#1)(1995-8#5)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#6)(1996-2#11)(1996-3#3)(1996-4#2)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#5)(1996-9#3)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#6)(1997-6#5)(1997-7#3)(1997-8#1)(2003-11#1)(2004-10#2)(2004-11#4)(2004-9#1)(2005-11#15)(2005-8#4)(2006-1#1)(2006-10#14)(2006-12#5)(2006-2#4)(2006-3#3)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#6)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#9)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#9)(2007-9#2)(2008-1#3)(2008-10#39)(2008-11#37)(2008-12#4)(2008-2#10)(2008-3#8)(2008-4#17)(2008-5#8)(2008-6#2)(2008-7#34)(2008-8#12)(2008-9#16)(2009-10#3)(2009-3#3)(2009-4#3)(2009-5#2)(2009-7#3)(2009-8#5)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#4)(2010-2#3)(2010-3#2)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#4)(2011-1#7)(2011-2#13)(2012-1#4)(2012-11#2)(2012-12#7)(2012-2#11)(2012-3#6)(2013-1#10)(2013-7#1)(2013-8#10)
the specification of the##2##4##(1995-6#1)(2008-2#1)
the specification of##10##3##(1990-11#1)(1991-1#1)(1994-3#1)(1995-6#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-2#1)(2009-10#1)(2013-1#1)
the specification##12##2##(1990-11#1)(1991-1#1)(1994-3#1)(1995-4#1)(1995-6#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-5#1)(2009-10#1)(2013-1#1)
the specifications of##2##3##(2008-1#1)(2008-10#1)
the specifications##8##2##(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2010-4#1)(2013-1#2)
the specificities##2##2##(2008-9#1)(2010-4#1)
the specificity and sensitivity of##2##5##(2008-10#1)(2013-7#1)
the specificity and sensitivity##3##4##(1996-9#1)(2008-10#1)(2013-7#1)
the specificity and the##3##4##(1993-6#1)(2008-10#1)(2013-1#1)
the specificity and##15##3##(1991-3#1)(1991-6#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-5#1)(1996-9#1)(1997-7#1)(2008-10#2)(2009-4#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-7#1)
the specificity for##5##3##(1990-11#1)(1991-12#1)(1995-3#1)(1995-8#1)(2012-3#1)
the specificity in##3##3##(1993-3#1)(2006-2#1)(2011-2#1)
the specificity is##2##3##(1997-2#1)(2008-5#1)
the specificity of a##4##4##(1994-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
the specificity of diagnosis##2##4##(1993-1#1)(1995-1#1)
the specificity of monoclonal antibodies##2##5##(1992-7#1)(1992-8#1)
the specificity of the interaction##2##5##(1994-3#1)(2006-12#1)
the specificity of the primers##2##5##(2008-10#2)
the specificity of the reduction site of##2##7##(1994-9#2)
the specificity of the##44##4##(1990-6#2)(1990-7#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-9#1)(1992-6#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-9#2)(1995-3#2)(1996-12#1)(1996-9#1)(1997-2#1)(1997-7#2)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#7)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-4#1)(2013-8#1)
the specificity of this##5##4##(1990-10#1)(1993-4#1)(1996-5#1)(1997-2#1)(2008-10#1)
the specificity of##109##3##(1990-10#2)(1990-11#1)(1990-3#1)(1990-6#2)(1990-7#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-4#1)(1991-7#1)(1991-9#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#3)(1993-1#1)(1993-11#1)(1993-4#2)(1993-8#1)(1993-9#2)(1994-12#1)(1994-3#1)(1994-9#4)(1995-1#1)(1995-3#4)(1995-4#1)(1995-6#1)(1996-12#1)(1996-5#4)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-7#2)(2005-10#3)(2005-12#1)(2006-10#2)(2006-12#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#3)(2009-9#2)(2010-1#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
the specificity region##2##3##(1991-4#2)
the specificity to##2##3##(1991-9#1)(1995-10#1)
the specificity was##5##3##(1993-1#1)(1996-12#3)(1997-3#1)
the specificity##168##2##(1990-10#3)(1990-11#2)(1990-2#2)(1990-3#1)(1990-6#2)(1990-7#2)(1990-9#1)(1991-11#1)(1991-12#3)(1991-3#1)(1991-4#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-3#3)(1992-6#1)(1992-7#1)(1992-8#4)(1993-1#2)(1993-11#1)(1993-3#1)(1993-4#2)(1993-6#1)(1993-8#1)(1993-9#3)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#4)(1995-1#1)(1995-10#1)(1995-3#6)(1995-4#1)(1995-6#1)(1995-8#1)(1996-12#4)(1996-5#4)(1996-7#2)(1996-8#1)(1996-9#2)(1997-2#5)(1997-3#3)(1997-7#3)(2005-10#3)(2005-12#2)(2006-10#2)(2006-12#2)(2006-2#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#16)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#3)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#2)(2009-8#3)(2009-9#2)(2010-1#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
the specifics of##9##3##(1996-2#1)(2005-10#1)(2006-7#1)(2007-12#1)(2007-9#1)(2008-4#1)(2010-12#1)(2010-4#1)(2011-1#1)
the specified##16##2##(1996-12#1)(1996-7#1)(1997-6#1)(2005-5#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2011-1#1)(2013-8#1)
the specimen and##2##3##(2008-11#1)(2008-4#1)
the specimen is##3##3##(2008-1#1)(2008-3#1)(2008-7#1)
the specimen was##5##3##(2007-12#1)(2009-3#1)(2011-2#1)(2012-12#2)
the specimen##47##2##(1991-6#1)(1991-9#1)(1994-9#1)(1995-3#1)(1995-4#1)(2004-2#1)(2004-9#1)(2005-12#3)(2006-4#2)(2007-1#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-6#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-7#3)(2010-2#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
the specimens was##4##3##(1990-7#1)(2004-9#1)(2008-12#1)(2013-8#1)
the specimens were loaded##2##4##(2008-12#1)(2013-8#1)
the specimens were##15##3##(1990-7#1)(2004-9#1)(2007-3#1)(2007-8#1)(2008-12#2)(2009-3#2)(2010-2#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#2)
the specimens##44##2##(1990-7#2)(1991-9#2)(1993-3#1)(1994-6#1)(1995-5#1)(2004-9#2)(2006-8#2)(2007-12#1)(2007-3#2)(2007-5#1)(2007-8#3)(2008-10#1)(2008-12#5)(2008-5#2)(2008-9#1)(2009-3#2)(2010-2#3)(2010-8#1)(2012-2#3)(2013-1#1)(2013-7#3)(2013-8#4)
the speckle pattern##4##3##(2007-12#1)(2008-3#2)(2013-1#1)
the speckle size##2##3##(2008-3#2)
the speckle##20##2##(2007-11#1)(2007-12#5)(2008-2#1)(2008-3#12)(2013-1#1)
the spectra and##2##3##(2007-11#1)(2008-10#1)
the spectra evaluation error##2##4##(2008-2#2)
the spectra for##2##3##(1995-2#1)(2007-11#1)
the spectra is##4##3##(2007-8#1)(2008-3#2)(2010-2#1)
the spectra obtained##6##3##(1990-3#1)(2007-8#1)(2008-10#2)(2008-2#1)(2013-7#1)
the spectra of 3-O-acetyl##2##4##(1996-9#2)
the spectra of the##9##4##(1994-11#2)(2007-12#1)(2007-8#2)(2008-10#2)(2008-3#1)(2008-8#1)
the spectra of their##2##4##(2007-8#1)(2008-10#1)
the spectra of##33##3##(1990-12#1)(1992-8#1)(1993-5#1)(1993-6#1)(1994-11#2)(1996-9#2)(2007-12#2)(2007-8#4)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#4)(2008-8#1)(2008-9#1)(2010-5#1)(2010-6#1)(2012-2#1)(2013-8#1)
the spectra were observed##2##4##(1997-7#1)(2007-12#1)
the spectra##86##2##(1990-12#1)(1990-3#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#2)(1995-2#1)(1996-7#1)(1996-9#2)(1997-7#2)(2005-11#1)(2006-5#1)(2007-11#3)(2007-12#4)(2007-8#6)(2008-1#2)(2008-10#19)(2008-12#1)(2008-2#8)(2008-3#10)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-7#2)(2013-8#1)
the spectral EEG##2##3##(1996-12#1)(2008-7#1)
the spectral amplitude and the##2##5##(2007-12#2)
the spectral analysis##2##3##(1997-3#1)(2011-3#1)
the spectral and spatial##2##4##(2007-12#1)(2008-3#1)
the spectral and temporal##2##4##(2007-12#1)(2008-3#1)
the spectral and the##2##4##(2008-10#1)(2008-3#1)
the spectral and##9##3##(1992-2#1)(2007-12#2)(2008-10#1)(2008-3#4)(2008-4#1)
the spectral band##2##3##(2008-3#1)(2012-2#1)
the spectral bandwidth of a##2##5##(2007-11#1)(2008-3#1)
the spectral bandwidth of##4##4##(2007-11#1)(2008-2#1)(2008-3#2)
the spectral bandwidth standard##2##4##(2008-3#2)
the spectral bandwidth##14##3##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#8)
the spectral bandwidths##2##3##(2007-12#1)(2008-3#1)
the spectral basis##2##3##(2008-4#2)
the spectral behavior of##3##4##(2007-12#2)(2008-3#1)
the spectral changes##4##3##(1995-8#1)(2008-10#2)(2010-12#1)
the spectral characteristics of the##2##5##(2008-2#2)
the spectral characteristics of##7##4##(1990-2#1)(2007-11#1)(2008-2#3)(2008-3#2)
the spectral characteristics##9##3##(1990-2#1)(2007-11#1)(2008-2#4)(2008-3#2)(2008-6#1)
the spectral classification##2##3##(2013-8#2)
the spectral data##7##3##(2008-10#4)(2012-12#2)(2013-8#1)
the spectral density of##2##4##(2007-12#2)
the spectral dispersion plane##2##4##(2008-3#2)
the spectral distribution of the##5##5##(2007-11#1)(2008-2#4)
the spectral distribution##7##3##(2007-11#1)(2008-2#4)(2008-3#2)
the spectral domain##9##3##(2007-11#1)(2007-12#3)(2008-2#4)(2011-1#1)
the spectral features of the##2##5##(2007-12#1)(2008-2#1)
the spectral features of##3##4##(1995-10#1)(2007-12#1)(2008-2#1)
the spectral features##7##3##(1991-4#1)(1993-3#1)(1995-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
the spectral frequency##3##3##(2007-11#1)(2008-2#2)
the spectral function##2##3##(2008-2#2)
the spectral information from the##2##5##(2008-2#1)(2008-3#1)
the spectral information in near-field data##2##6##(2008-3#2)
the spectral information##4##3##(2008-2#1)(2008-3#3)
the spectral interference##2##3##(2007-11#1)(2008-10#1)
the spectral irradiance##2##3##(2008-2#2)
the spectral line intensity##2##4##(2013-8#2)
the spectral line##5##3##(2008-3#1)(2013-8#4)
the spectral lines##2##3##(2008-3#1)(2013-8#1)
the spectral linewidth##4##3##(2007-12#2)(2008-3#2)
the spectral overlap is##2##4##(2007-12#1)(2008-10#1)
the spectral overlap##3##3##(2007-12#1)(2008-10#2)
the spectral parameters##2##3##(2008-10#1)(2008-2#1)
the spectral phase of##2##4##(2007-12#1)(2008-3#1)
the spectral phase##7##3##(2007-12#6)(2008-3#1)
the spectral profiles##2##3##(1992-12#1)(2008-3#1)
the spectral properties of the##2##5##(2008-2#1)(2013-1#1)
the spectral properties of##7##4##(1994-11#1)(2006-12#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#1)
the spectral properties##10##3##(1992-1#1)(1994-11#1)(2006-12#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
the spectral purity##2##3##(2007-11#1)(2008-2#1)
the spectral range from##7##4##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2013-7#1)
the spectral range of the##3##5##(2007-12#2)(2008-10#1)
the spectral range of##7##4##(2007-12#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)
the spectral range##28##3##(2007-11#2)(2007-12#6)(2008-1#2)(2008-10#3)(2008-2#5)(2008-3#8)(2008-5#1)(2013-7#1)
the spectral reflectance of##5##4##(2008-10#1)(2008-2#2)(2008-3#2)
the spectral reflectance rho(lambda)##2##4##(2008-12#2)
the spectral reflectance##10##3##(2008-10#1)(2008-12#2)(2008-2#4)(2008-3#3)
the spectral reflectivity##2##3##(2007-12#1)(2008-2#1)
the spectral region near##4##4##(2007-11#1)(2007-12#1)(2008-3#2)
the spectral region##12##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#6)
the spectral regions##2##3##(2008-10#2)
the spectral resolution and##2##4##(2007-12#2)
the spectral resolution of##2##4##(2007-12#2)
the spectral resolution##11##3##(1997-5#1)(2007-12#7)(2008-2#1)(2008-3#2)
the spectral response of a##2##5##(2007-12#1)(2008-2#1)
the spectral response of the##3##5##(2008-2#1)(2008-3#2)
the spectral response of##8##4##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#3)
the spectral response##10##3##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#4)
the spectral scattering##2##3##(2008-3#2)
the spectral sensitivity##2##3##(2007-12#1)(2008-8#1)
the spectral shape of##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
the spectral shape##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
the spectral shapes of##2##4##(2008-2#1)(2008-3#1)
the spectral shift##2##3##(1992-12#1)(2008-2#1)
the spectral signals##2##3##(1994-9#1)(2008-10#1)
the spectral transmission##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
the spectral transmittance and reflectance##2##5##(2008-2#2)
the spectral transmittance##3##3##(2008-2#2)(2008-5#1)
the spectral variation of the##2##5##(2008-2#1)(2008-3#1)
the spectral variation of##4##4##(2008-2#3)(2008-3#1)
the spectral width and##2##4##(2007-11#1)(2007-12#1)
the spectral width of the##4##5##(2007-12#2)(2008-2#1)(2008-3#1)
the spectral width##6##3##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)
the spectral window##2##3##(2008-2#1)(2008-3#1)
the spectral##342##2##(1990-2#1)(1990-3#1)(1991-4#1)(1992-1#1)(1992-12#2)(1992-2#1)(1993-3#1)(1994-11#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-7#2)(2004-4#1)(2005-4#2)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#22)(2007-12#56)(2007-5#1)(2008-1#3)(2008-10#28)(2008-12#2)(2008-2#77)(2008-3#84)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-3#1)(2012-12#3)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#12)
the spectrally resolved##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
the spectrally##8##2##(2007-12#3)(2008-2#2)(2008-3#3)
the spectrin dimer-to-tetramer ratio##2##4##(1990-3#2)
the spectrin tryptophan fluorescence##2##4##(1990-3#2)
the spectrin##7##2##(1990-3#4)(1993-11#1)(1993-4#2)
the spectrin-actin extractability under low ionic conditions##2##7##(1990-3#2)
the spectrochemical##2##2##(1996-3#1)(1997-7#1)
the spectroelectrochemical##2##2##(2008-10#2)
the spectrofluorimetric determination of##5##4##(2008-10#5)
the spectrofluorimetric##7##2##(2008-10#7)
the spectrofluorometric##2##2##(2005-4#1)(2008-10#1)
the spectrogram##4##2##(2007-12#1)(2008-2#1)(2009-3#2)
the spectrograph##3##2##(2006-12#1)(2008-3#2)
the spectrometer that##2##3##(2008-1#1)(2008-3#1)
the spectrometer##28##2##(2006-4#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#11)(2008-2#3)(2008-3#5)
the spectrometer's##2##2##(2008-10#2)
the spectrometric##3##2##(2008-10#2)(2008-3#1)
the spectrophotometer##5##2##(2007-3#1)(2008-10#3)(2008-3#1)
the spectrophotometric and extractive behaviour of##2##6##(2008-10#2)
the spectrophotometric and##4##3##(2008-10#4)
the spectrophotometric data##2##3##(2006-10#1)(2008-10#1)
the spectrophotometric determination of gabapentin##2##5##(2007-10#2)
the spectrophotometric determination of lead with##2##6##(2008-10#2)
the spectrophotometric determination of lead##5##5##(2008-10#5)
the spectrophotometric determination of nickel##4##5##(2008-10#4)
the spectrophotometric determination of zinc##2##5##(2008-10#2)
the spectrophotometric determination of##52##4##(2007-10#2)(2008-10#49)(2010-5#1)
the spectrophotometric method##9##3##(2008-10#5)(2008-5#1)(2011-2#1)(2013-8#2)
the spectrophotometric methods##2##3##(2008-10#1)(2010-2#1)
the spectrophotometric##80##2##(1993-9#1)(1995-2#1)(2006-10#1)(2007-10#2)(2007-8#1)(2008-10#68)(2008-5#1)(2010-2#1)(2010-5#1)(2011-2#1)(2013-8#2)
the spectroscopic and##2##3##(2008-3#1)(2012-12#1)
the spectroscopic data##2##3##(2008-10#2)
the spectroscopic differences##3##3##(1997-8#1)(2010-2#2)
the spectroscopic properties of the##4##5##(1997-2#1)(2008-10#2)(2009-10#1)
the spectroscopic properties of##5##4##(1994-12#1)(1997-2#1)(2008-10#2)(2009-10#1)
the spectroscopic##29##2##(1990-10#1)(1991-8#1)(1993-3#1)(1994-12#1)(1997-2#1)(1997-8#1)(2006-12#1)(2007-12#2)(2008-1#1)(2008-10#10)(2008-2#4)(2008-3#1)(2009-10#1)(2010-2#2)(2012-12#1)
the spectroscopically##2##2##(2008-5#1)(2012-2#1)
the spectroscopy and##3##3##(2008-7#1)(2010-2#2)
the spectroscopy of##3##3##(1993-6#1)(2008-3#1)(2011-1#1)
the spectroscopy##7##2##(1993-6#1)(2007-11#1)(2008-3#1)(2008-7#1)(2010-2#2)(2011-1#1)
the spectrum and the##2##4##(2008-1#1)(2008-3#1)
the spectrum and##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
the spectrum are##3##3##(2007-11#1)(2008-3#2)
the spectrum as a##2##4##(2007-11#1)(2008-2#1)
the spectrum by##3##3##(2008-10#1)(2008-3#2)
the spectrum from##4##3##(2007-12#3)(2008-3#1)
the spectrum is##7##3##(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#2)
the spectrum obtained##2##3##(1990-5#1)(2005-11#1)
the spectrum of HPV types##2##5##(2013-1#2)
the spectrum of a##2##4##(1994-5#1)(2008-3#1)
the spectrum of action of##2##5##(1990-5#1)(2008-8#1)
the spectrum of clinical##2##4##(2006-10#1)(2011-2#1)
the spectrum of disease##3##4##(1991-12#1)(2006-10#1)(2012-2#1)
the spectrum of free molecule##2##5##(2008-10#2)
the spectrum of reduced##2##4##(1991-2#1)(1991-7#1)
the spectrum of the##17##4##(1990-2#1)(1991-7#1)(1996-2#1)(1996-7#1)(2005-4#1)(2006-10#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-3#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-7#1)
the spectrum of##77##3##(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-7#2)(1994-12#1)(1994-5#2)(1994-6#1)(1996-2#2)(1996-7#2)(1997-3#2)(1997-7#1)(1997-8#2)(2005-1#1)(2005-11#1)(2005-4#1)(2006-10#3)(2006-12#2)(2006-6#1)(2006-7#1)(2007-11#2)(2007-12#7)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)
the spectrum that##2##3##(2007-12#1)(2008-2#1)
the spectrum to##3##3##(2007-12#1)(2011-2#1)(2012-12#1)
the spectrum was##3##3##(1995-11#1)(2008-10#1)(2013-8#1)
the spectrum##159##2##(1990-2#1)(1990-3#3)(1990-5#3)(1991-12#1)(1991-2#1)(1991-7#2)(1992-7#1)(1994-10#1)(1994-12#1)(1994-5#2)(1994-6#1)(1995-11#1)(1995-5#1)(1996-2#2)(1996-7#2)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#2)(2005-1#1)(2005-11#2)(2005-4#1)(2006-10#3)(2006-12#2)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#9)(2007-12#20)(2007-9#1)(2008-1#3)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#12)(2008-3#21)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#2)(2009-6#1)(2010-5#1)(2011-1#2)(2011-2#7)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#4)
the specular reflection of##2##4##(2005-11#1)(2008-3#1)
the specular reflection##3##3##(2005-11#1)(2006-7#1)(2008-3#1)
the specular##12##2##(2005-11#1)(2006-7#1)(2007-11#2)(2008-2#2)(2008-3#5)(2011-2#1)
the speech and language skills of##2##6##(2008-9#2)
the speech and language##3##4##(2007-8#1)(2008-9#2)
the speech of##5##3##(2008-2#1)(2008-9#1)(2009-10#2)(2013-8#1)
the speech processor##3##3##(2008-9#3)
the speech##22##2##(1991-11#1)(2006-3#2)(2007-3#1)(2007-8#1)(2008-2#3)(2008-9#10)(2009-10#2)(2010-2#1)(2013-8#1)
the speed adaptation controller##2##4##(2012-1#2)
the speed and##12##3##(1996-12#1)(2008-10#1)(2008-3#4)(2008-7#1)(2009-9#2)(2010-12#1)(2011-2#1)(2012-2#1)
the speed of ascent##2##4##(1992-2#2)
the speed of eating##2##4##(1993-12#2)
the speed of propagation of ultrasound shear waves##2##8##(2008-5#2)
the speed of sound and the thermal diffusivity##2##8##(2008-3#2)
the speed of sound and##3##5##(2008-3#3)
the speed of sound##6##4##(2008-2#3)(2008-3#3)
the speed of the##8##4##(2007-11#1)(2008-2#3)(2008-6#1)(2011-2#2)(2012-2#1)
the speed of##42##3##(1990-3#1)(1992-2#2)(1993-12#2)(1994-8#1)(2004-2#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-9#2)(2008-10#3)(2008-2#8)(2008-3#4)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#2)(2009-7#1)(2011-2#3)(2012-2#1)(2013-1#1)
the speed with which a##2##5##(2008-5#1)(2010-12#1)
the speed with which the##3##5##(1991-10#1)(1993-2#1)(2007-9#1)
the speed with which##8##4##(1991-10#1)(1993-2#1)(2007-12#1)(2007-9#1)(2008-3#1)(2008-5#1)(2010-12#1)(2012-12#1)
the speed##72##2##(1990-3#1)(1991-10#1)(1992-2#2)(1993-12#2)(1993-2#1)(1994-8#1)(1996-12#1)(2004-2#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-8#1)(2007-9#5)(2008-10#4)(2008-2#9)(2008-3#10)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2009-9#2)(2010-12#2)(2011-2#4)(2012-1#3)(2012-12#1)(2012-2#2)(2013-1#3)
the speeds##2##2##(2009-2#1)(2012-1#1)
the spending##4##2##(1995-12#2)(1997-2#1)(1997-3#1)
the spent beads are##2##4##(2008-10#2)
the spent culture medium##2##4##(1995-6#1)(2008-11#1)
the spent culture##3##3##(1995-6#1)(1996-2#1)(2008-11#1)
the spent##7##2##(1995-10#1)(1995-6#1)(1996-2#1)(2008-10#2)(2008-11#2)
the sperm acrosome reaction and##2##5##(1992-8#1)(2008-8#1)
the sperm acrosome reaction##3##4##(1992-8#1)(2008-8#2)
the sperm acrosome##5##3##(1992-8#1)(2008-8#4)
the sperm cell##4##3##(1993-6#1)(2006-5#2)(2007-12#1)
the sperm cells##3##3##(1994-5#1)(2008-12#1)(2009-8#1)
the sperm concentration##2##3##(2008-7#1)(2013-8#1)
the sperm enzyme is##2##4##(1991-8#2)
the sperm enzyme##3##3##(1991-8#3)
the sperm head##4##3##(1992-5#1)(1994-8#1)(2009-5#1)(2012-2#1)
the sperm nuclear matrix##3##4##(1990-11#3)
the sperm of##2##3##(2007-12#1)(2008-4#1)
the sperm stored in the##2##5##(2008-8#2)
the sperm##56##2##(1990-11#5)(1990-5#1)(1991-11#1)(1991-8#3)(1992-12#1)(1992-5#1)(1992-8#1)(1993-6#2)(1994-5#1)(1994-8#5)(1995-5#1)(2006-5#4)(2007-12#3)(2008-12#1)(2008-4#2)(2008-7#4)(2008-8#8)(2009-5#1)(2009-8#1)(2010-8#2)(2011-1#1)(2012-12#3)(2012-2#3)(2013-8#1)
the sperm-specific##2##2##(1997-4#1)(2012-2#1)
the spermatheca##16##2##(2007-12#1)(2008-5#1)(2008-6#5)(2008-8#1)(2012-12#8)
the spermathecae##5##2##(2007-12#2)(2008-7#1)(2008-8#2)
the spermathecal duct##3##3##(2008-5#3)
the spermathecal ducts##2##3##(2008-8#2)
the spermathecal##6##2##(2007-12#1)(2008-5#3)(2008-8#2)
the spermatic cord and##2##4##(2008-6#2)
the spermatic cord##5##3##(2007-7#1)(2008-10#1)(2008-6#3)
the spermatic##7##2##(2007-5#1)(2007-7#1)(2008-10#1)(2008-6#3)(2009-5#1)
the spermatid##2##2##(2008-7#1)(2012-2#1)
the spermatocyte##2##2##(2008-7#1)(2012-12#1)
the spermatogenic##4##2##(2008-10#1)(2008-5#1)(2009-10#1)(2012-2#1)
the spermatophylax##2##2##(2008-4#2)
the spermatozoa during##2##3##(2007-12#1)(2011-1#1)
the spermatozoa of##2##3##(2007-12#1)(2013-8#1)
the spermatozoa##18##2##(2006-5#1)(2007-12#4)(2008-7#3)(2008-8#2)(2010-7#1)(2011-1#4)(2013-8#3)
the spermatozoal##2##2##(2008-7#1)(2011-1#1)
the spermatozoon##4##2##(1990-10#1)(2006-5#1)(2008-7#1)(2008-8#1)
the spermine##2##2##(1991-7#1)(1994-7#1)
the spermogonial##2##2##(2008-10#2)
the spermosphere##3##2##(2008-10#3)
the sph-SiON##2##2##(2013-8#2)
the sphenoid sinus##8##3##(2005-9#1)(2008-7#3)(2011-2#2)(2012-3#2)
the sphenoid##13##2##(2005-9#1)(2007-6#1)(2008-10#3)(2008-7#4)(2011-2#2)(2012-3#2)
the sphere of##2##3##(1991-6#1)(2009-4#1)
the sphere##15##2##(1991-6#1)(2007-11#2)(2007-12#3)(2008-2#5)(2008-3#3)(2009-4#1)
the spheres##7##2##(1995-5#1)(2007-12#2)(2007-8#1)(2008-3#1)(2008-5#1)(2012-11#1)
the spherical LCAL##3##3##(2008-2#3)
the spherical aberration of##2##4##(2008-3#2)
the spherical aberration##6##3##(2008-2#2)(2008-3#3)(2009-5#1)
the spherical shape##2##3##(2008-2#1)(2011-2#1)
the spherical##34##2##(1991-11#1)(1996-5#1)(2005-11#3)(2006-12#1)(2006-8#1)(2007-12#2)(2008-10#1)(2008-2#8)(2008-3#7)(2008-7#1)(2009-5#1)(2011-2#3)(2012-11#2)(2012-2#1)(2013-7#1)
the spheroid##3##2##(1995-1#3)
the spheroids##2##2##(2008-11#1)(2012-12#1)
the sphincter##4##2##(2006-6#2)(2008-8#1)(2010-12#1)
the sphingolipid##3##2##(1993-9#1)(1995-8#1)(2008-5#1)
the sphingomyelin pathway##2##3##(1995-12#2)
the sphingomyelin##3##2##(1995-12#2)(1997-7#1)
the sphingosine##4##2##(1991-9#1)(1993-8#1)(1994-3#1)(1997-5#1)
the spice##3##2##(2008-11#1)(2012-3#2)
the spicules and##2##3##(2007-12#2)
the spider Agelenopsis aperta##2##4##(1990-5#1)(1993-11#1)
the spider##23##2##(1990-5#1)(1993-11#1)(1996-11#2)(2006-12#6)(2007-12#5)(2007-6#4)(2008-5#2)(2008-9#1)(2010-8#1)
the spike train##5##3##(1991-6#1)(2008-11#1)(2009-8#3)
the spike trains##3##3##(1995-12#1)(2008-11#1)(2009-8#1)
the spike##27##2##(1991-6#1)(1992-3#3)(1993-2#1)(1993-9#1)(1995-12#1)(1995-7#1)(1996-10#1)(1996-12#1)(1997-3#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#5)(2012-2#1)(2013-8#1)
the spiked levels##4##3##(2011-1#2)(2012-12#1)(2013-8#1)
the spiked samples##5##3##(2008-10#5)
the spiked water##2##3##(2008-10#2)
the spiked##27##2##(1992-8#1)(2007-1#1)(2008-10#21)(2011-1#2)(2012-12#1)(2013-8#1)
the spiking procedure##2##3##(2008-10#2)
the spiking##5##2##(2008-10#3)(2011-1#1)(2013-8#1)
the spin column##2##3##(2008-4#2)
the spin label##2##3##(1993-8#1)(1995-10#1)
the spin labels##3##3##(1993-8#2)(2010-9#1)
the spin vector##2##3##(2008-2#2)
the spin##26##2##(1992-3#1)(1993-3#1)(1993-8#3)(1994-2#1)(1994-9#1)(1995-10#1)(1995-11#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#2)(2008-7#4)(2009-5#2)(2010-5#1)(2010-9#1)
the spin-dependent effect##2##3##(2006-4#2)
the spin-dependent##3##2##(2006-4#3)
the spin-labeled##2##2##(1990-2#1)(1990-5#1)
the spin-trap##2##2##(1990-12#1)(1991-2#1)
the spina##2##2##(1996-12#1)(2007-7#1)
the spinach##9##2##(1992-3#1)(1992-4#1)(1993-6#1)(2008-10#5)(2011-1#1)
the spinal axis##2##3##(2006-10#1)(2007-8#1)
the spinal canal and##4##4##(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#1)
the spinal canal##25##3##(1991-8#2)(1992-11#1)(2006-10#1)(2006-12#1)(2006-5#2)(2006-8#1)(2007-11#2)(2007-7#1)(2007-8#7)(2008-1#1)(2008-12#1)(2009-3#1)(2009-4#3)(2011-2#1)
the spinal column##4##3##(1995-5#1)(2007-11#1)(2007-8#1)(2008-7#1)
the spinal cord and in##2##5##(1990-7#1)(1995-5#1)
the spinal cord and the##5##5##(1992-12#1)(1996-12#1)(2006-8#1)(2007-11#1)(2008-7#1)
the spinal cord and##19##4##(1990-7#1)(1992-12#1)(1994-8#2)(1995-5#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(2006-12#1)(2006-8#1)(2007-11#2)(2008-7#1)(2009-3#1)(2012-2#1)
the spinal cord at##2##4##(1994-9#1)(2008-5#1)
the spinal cord by##3##4##(1994-8#1)(1995-12#1)(2012-1#1)
the spinal cord dorsal horn##3##5##(1993-12#1)(1994-8#1)(2008-4#1)
the spinal cord for##2##4##(2007-11#1)(2008-5#1)
the spinal cord from##2##4##(1993-4#1)(2006-8#1)
the spinal cord in##7##4##(1995-12#1)(1996-5#1)(1996-9#1)(2007-11#1)(2008-1#1)(2008-7#1)(2013-8#1)
the spinal cord is##4##4##(2007-12#1)(2008-4#1)(2008-5#1)(2011-1#1)
the spinal cord may##2##4##(2006-10#1)(2006-5#1)
the spinal cord of the##4##5##(1991-6#1)(1995-5#1)(1996-11#1)(2006-11#1)
the spinal cord of##11##4##(1990-5#1)(1991-6#2)(1992-9#1)(1995-5#1)(1996-11#2)(1996-6#1)(2006-11#1)(2006-8#1)(2012-1#1)
the spinal cord to##2##4##(1996-9#1)(2006-8#1)
the spinal cord was also##2##5##(1992-8#1)(2008-5#1)
the spinal cord was##5##4##(1992-8#2)(2007-2#2)(2008-5#1)
the spinal cord with##3##4##(1995-11#1)(2006-6#1)(2006-8#1)
the spinal cord##209##3##(1990-2#1)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#5)(1991-10#1)(1991-3#2)(1991-5#5)(1991-6#6)(1992-10#2)(1992-12#1)(1992-8#3)(1992-9#3)(1993-11#1)(1993-12#2)(1993-4#3)(1993-7#3)(1994-2#1)(1994-8#5)(1994-9#3)(1995-1#1)(1995-11#3)(1995-12#5)(1995-3#1)(1995-5#4)(1995-7#8)(1996-11#4)(1996-12#7)(1996-2#2)(1996-3#1)(1996-5#6)(1996-6#2)(1996-7#1)(1996-9#5)(1997-3#1)(2006-10#2)(2006-11#2)(2006-12#5)(2006-2#4)(2006-5#6)(2006-6#2)(2006-8#8)(2007-1#4)(2007-10#3)(2007-11#10)(2007-12#1)(2007-2#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#9)(2008-7#11)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#7)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#4)
the spinal gray matter##3##4##(1991-5#1)(1995-11#2)
the spinal gray##4##3##(1991-5#2)(1995-11#2)
the spinal level##3##3##(1990-2#1)(1991-3#1)(1996-1#1)
the spinal motor output##2##4##(1996-1#1)(1997-7#1)
the spinal motor##3##3##(1996-1#1)(1997-7#1)(2012-12#1)
the spinal nerve##3##3##(1993-11#1)(2008-4#1)(2011-2#1)
the spinal nerves by##2##4##(2008-7#2)
the spinal nerves##3##3##(1994-2#1)(2008-7#2)
the spinal subarachnoid space##5##4##(1995-7#2)(1996-8#1)(2006-5#1)(2008-12#1)
the spinal tract of the trigeminal nerve##2##7##(1996-5#2)
the spinal trigeminal nucleus##5##4##(1990-4#2)(1996-9#1)(1997-1#1)(2012-2#1)
the spinal trigeminal##6##3##(1990-4#2)(1991-11#1)(1996-9#1)(1997-1#1)(2012-2#1)
the spinal##321##2##(1990-2#2)(1990-4#4)(1990-5#4)(1990-6#1)(1990-7#5)(1991-10#1)(1991-11#1)(1991-3#3)(1991-5#7)(1991-6#6)(1991-8#2)(1992-10#3)(1992-11#1)(1992-12#2)(1992-8#3)(1992-9#4)(1993-11#2)(1993-12#2)(1993-4#4)(1993-7#5)(1994-10#2)(1994-2#2)(1994-8#5)(1994-9#3)(1995-1#1)(1995-11#5)(1995-12#5)(1995-3#1)(1995-5#7)(1995-7#11)(1996-1#3)(1996-11#5)(1996-12#9)(1996-2#2)(1996-3#1)(1996-5#8)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#7)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#2)(2006-10#5)(2006-11#5)(2006-12#6)(2006-2#4)(2006-5#9)(2006-6#3)(2006-8#13)(2007-1#4)(2007-10#3)(2007-11#15)(2007-12#2)(2007-2#2)(2007-7#3)(2007-8#9)(2008-1#2)(2008-11#1)(2008-12#4)(2008-2#1)(2008-4#4)(2008-5#9)(2008-7#19)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#3)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#3)(2011-2#8)(2012-1#8)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#5)
the spindle pole body##3##4##(1990-6#2)(1991-5#1)
the spindle##11##2##(1990-6#2)(1990-7#1)(1991-5#1)(2008-10#1)(2008-2#1)(2008-8#2)(2009-3#1)(2011-2#2)
the spindle-shaped##2##2##(2007-12#1)(2012-12#1)
the spine and hip##2##4##(1994-8#1)(2008-3#1)
the spine and spinal cord##2##5##(2007-11#1)(2011-2#1)
the spine and##23##3##(1991-11#1)(1993-11#2)(1993-12#1)(1994-8#1)(2006-9#1)(2007-11#6)(2007-6#1)(2008-1#1)(2008-3#2)(2008-8#1)(2009-5#1)(2010-1#1)(2010-5#1)(2011-2#2)(2012-2#1)
the spine are##5##3##(2006-2#2)(2007-6#2)(2008-6#1)
the spine can##2##3##(2006-8#1)(2008-1#1)
the spine head volume##2##4##(2008-11#2)
the spine in an##2##4##(2007-8#1)(2011-2#1)
the spine in the##3##4##(2007-11#3)
the spine in##8##3##(1990-12#1)(2007-11#4)(2007-8#1)(2011-2#1)(2012-2#1)
the spine was##3##3##(2006-7#1)(2007-11#1)(2010-12#1)
the spine with##3##3##(1993-1#1)(2006-7#1)(2007-6#1)
the spine##129##2##(1990-12#1)(1990-6#2)(1991-11#1)(1991-6#1)(1992-10#1)(1993-1#1)(1993-11#2)(1993-12#1)(1994-8#1)(1995-7#1)(1996-6#1)(2005-2#1)(2006-10#2)(2006-2#6)(2006-5#1)(2006-7#7)(2006-8#9)(2006-9#1)(2007-11#33)(2007-3#1)(2007-4#1)(2007-6#5)(2007-7#5)(2007-8#3)(2008-1#8)(2008-11#4)(2008-12#1)(2008-3#2)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-5#1)(2010-1#1)(2010-12#4)(2010-3#1)(2010-5#1)(2011-2#6)(2012-2#3)(2013-1#1)
the spinocerebellar projection in##2##4##(1991-3#1)(1991-8#1)
the spinocerebellar projection##3##3##(1991-3#1)(1991-8#2)
the spinothalamic tract##2##3##(1992-5#1)(1996-7#1)
the spinous processes##5##3##(2007-1#1)(2007-11#2)(2007-5#2)
the spinous##6##2##(2007-1#1)(2007-11#2)(2007-5#2)(2011-2#1)
the spiny##2##2##(2007-12#1)(2010-11#1)
the spiral gradient dilution method##2##5##(2008-10#2)
the spiral##13##2##(1994-9#1)(1995-5#1)(2005-10#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)
the spiralin##2##2##(2008-10#2)
the spirit of the##5##4##(1992-12#1)(1993-5#1)(1997-8#1)(2006-8#2)
the spirit of##10##3##(1992-12#1)(1993-5#1)(1994-11#1)(1997-8#1)(2006-7#1)(2006-8#2)(2007-6#1)(2008-2#1)(2009-10#1)
the spirit##14##2##(1992-12#1)(1993-5#1)(1994-11#1)(1997-8#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-6#1)(2008-2#3)(2009-10#1)(2010-7#1)
the spiritual needs of##3##4##(2008-11#2)(2011-1#1)
the spiritual##8##2##(1995-5#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-12#1)(2011-1#2)
the spirochete##3##2##(1996-2#2)(2009-10#1)
the spirochetes##2##2##(1997-4#1)(2008-9#1)
the spittle bug Philaenus spumarius##2##5##(2007-12#2)
the splanchnic##5##2##(1996-3#1)(1997-5#1)(1997-8#1)(2008-12#1)(2008-6#1)
the spleen after##3##3##(2006-1#1)(2010-12#1)(2010-5#1)
the spleen and peripheral blood##2##5##(2006-1#1)(2008-10#1)
the spleen and pronephros was##2##5##(1997-3#2)
the spleen and pronephros##3##4##(1997-3#3)
the spleen and the##2##4##(1990-3#1)(2011-2#1)
the spleen and thymus##4##4##(1990-2#1)(2012-1#1)(2013-8#2)
the spleen and##25##3##(1990-12#2)(1990-2#1)(1990-3#1)(1992-10#1)(1995-3#1)(1997-3#3)(1997-6#1)(2005-10#1)(2006-1#1)(2006-6#1)(2008-10#3)(2008-7#1)(2010-12#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#1)(2013-8#2)
the spleen cells stimulated with LPS-A##2##6##(2006-8#2)
the spleen cells##4##3##(2006-8#3)(2008-4#1)
the spleen of##2##3##(2008-5#1)(2008-9#1)
the spleen or##2##3##(1996-12#1)(2008-4#1)
the spleen that##2##3##(1994-3#1)(2008-7#1)
the spleen was markedly##2##4##(1991-11#1)(2006-1#1)
the spleen was##3##3##(1991-11#1)(2006-1#1)(2008-9#1)
the spleen were##4##3##(1992-3#1)(1995-12#1)(1995-2#1)(2008-10#1)
the spleen##121##2##(1990-10#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#2)(1990-7#1)(1991-11#1)(1991-12#3)(1991-3#1)(1991-6#1)(1992-10#2)(1992-2#1)(1992-3#1)(1992-5#2)(1992-7#1)(1992-9#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#2)(1995-2#4)(1995-3#1)(1996-10#1)(1996-12#2)(1997-3#5)(1997-6#1)(2004-2#1)(2005-10#2)(2006-1#3)(2006-6#5)(2006-8#3)(2007-2#1)(2007-3#1)(2007-6#1)(2008-10#7)(2008-11#2)(2008-4#2)(2008-5#4)(2008-7#4)(2008-8#1)(2008-9#6)(2009-2#1)(2010-12#6)(2010-5#1)(2011-12#3)(2011-2#1)(2012-1#3)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#4)
the spleens of##4##3##(1994-2#1)(2008-10#1)(2013-8#2)
the spleens##9##2##(1992-7#1)(1994-2#3)(2008-10#1)(2008-11#1)(2010-12#1)(2013-8#2)
the splenectomy##2##2##(1994-9#2)
the splenic PFC response to SRBCs##2##6##(1993-12#2)
the splenic artery and##2##4##(1993-10#1)(2006-2#1)
the splenic artery aneurysm##2##4##(2011-2#2)
the splenic artery##10##3##(1990-10#1)(1993-10#3)(2006-2#1)(2006-6#1)(2008-7#1)(2011-2#3)
the splenic flexure##4##3##(2006-6#1)(2008-12#1)(2013-8#2)
the splenic##22##2##(1990-10#1)(1992-10#1)(1992-3#1)(1992-5#1)(1993-10#3)(1993-12#3)(2006-2#1)(2006-6#2)(2008-12#1)(2008-7#1)(2011-2#4)(2012-2#1)(2013-8#2)
the splenocytes##3##2##(2008-11#2)(2008-8#1)
the splice acceptor site##3##4##(1990-6#1)(1993-11#1)(1995-12#1)
the splice junction##2##3##(1991-2#2)
the splice junctions##2##3##(1991-12#1)(1996-7#1)
the splice site##3##3##(1994-9#1)(1995-12#2)
the splice sites##3##3##(1992-1#2)(1995-8#1)
the splice variant##2##3##(1996-11#1)(1997-7#1)
the splice##18##2##(1990-2#1)(1990-6#1)(1991-12#1)(1991-2#2)(1992-1#2)(1993-11#1)(1994-8#1)(1994-9#1)(1995-12#3)(1995-8#1)(1996-11#1)(1996-7#1)(1997-7#1)(2011-1#1)
the spliced##3##2##(1990-7#1)(1991-9#2)
the splicing apparatus##2##3##(1991-6#1)(1993-9#1)
the splicing of##7##3##(1991-5#1)(1991-9#1)(1993-12#1)(1993-8#1)(1994-2#1)(1995-1#1)(1995-6#1)
the splicing process##3##3##(1991-9#2)(1996-7#1)
the splicing##16##2##(1991-5#1)(1991-6#1)(1991-9#3)(1992-1#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-2#2)(1994-8#1)(1995-1#2)(1995-6#1)(1996-7#1)
the splint##6##2##(1991-6#2)(2007-11#1)(2009-3#3)
the split between##3##3##(1993-6#1)(2013-8#2)
the split of##3##3##(1995-11#1)(2008-1#1)(2009-10#1)
the split##16##2##(1993-6#1)(1994-3#1)(1995-11#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#2)(2009-10#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-8#2)
the split-window##2##2##(2008-2#1)(2008-3#1)
the splitting of the##2##4##(2006-5#1)(2007-12#1)
the splitting of##4##3##(1990-5#1)(2006-5#1)(2007-12#1)(2008-2#1)
the splitting##6##2##(1990-5#1)(2006-5#1)(2007-12#1)(2008-2#3)
the spo0F promoter region##3##4##(1995-6#3)
the spo0F##4##2##(1995-6#4)
the spoIIID##3##2##(1995-2#3)
the spondarthritides##2##2##(1990-6#2)
the spondyloarthropathies##2##2##(1990-11#1)(2006-10#1)
the sponge##5##2##(2004-9#1)(2006-9#1)(2010-6#1)(2011-2#1)(2012-2#1)
the sponge-like mycelial mass##2##4##(2008-10#2)
the sponges##5##2##(1994-3#3)(2006-9#2)
the spongy##2##2##(2005-10#1)(2010-8#1)
the sponsoring##2##2##(2005-8#1)(2008-11#1)
the sponsorship##3##2##(2005-12#1)(2007-1#1)(2008-12#1)
the spontaneous activity of##6##4##(1993-4#3)(1993-5#1)(1995-3#1)(1997-7#1)
the spontaneous activity##8##3##(1992-9#1)(1993-4#3)(1993-5#1)(1995-3#1)(1997-7#1)(2008-11#1)
the spontaneous and##3##3##(1991-11#1)(1991-6#1)(1992-6#1)
the spontaneous contractions##2##3##(1991-10#2)
the spontaneous decomposition##2##3##(1990-11#2)
the spontaneous emission##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
the spontaneous evacuation of##2##4##(1993-10#2)
the spontaneous firing rate##3##4##(1997-8#3)
the spontaneous firing##6##3##(1997-8#4)(2008-6#2)
the spontaneous formation of##2##4##(1990-5#1)(2007-12#1)
the spontaneous level##4##3##(1994-2#1)(2008-7#3)
the spontaneous metastasis of BL6##2##5##(2008-8#2)
the spontaneous polarization##2##3##(2008-2#1)(2008-3#1)
the spontaneous regression of a hypervascular##2##6##(2008-1#2)
the spontaneous theta rhythm in the cat##2##7##(1993-9#2)
the spontaneous transfer of##2##4##(1992-3#2)
the spontaneous##97##2##(1990-11#2)(1990-3#1)(1990-5#3)(1990-7#1)(1991-10#3)(1991-11#2)(1991-5#2)(1991-6#1)(1992-3#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-10#2)(1993-11#1)(1993-4#3)(1993-5#2)(1993-9#3)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-7#1)(1996-5#1)(1997-7#2)(1997-8#4)(2006-10#1)(2006-2#1)(2006-3#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-6#1)(2007-8#1)(2008-1#5)(2008-10#1)(2008-11#4)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#6)(2008-8#2)(2008-9#1)(2009-2#2)(2009-5#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)
the spontaneous-delivery group##2##3##(1991-6#2)
the spontaneously active##2##3##(1991-6#1)(1992-9#1)
the spontaneously hypertensive rat (SHR) is##2##6##(1990-7#1)(1994-8#1)
the spontaneously hypertensive rat (SHR)##3##5##(1990-7#1)(1993-2#1)(1994-8#1)
the spontaneously hypertensive rat##8##4##(1990-7#2)(1992-9#2)(1993-2#2)(1994-8#1)(1997-2#1)
the spontaneously hypertensive##9##3##(1990-7#2)(1992-9#2)(1993-2#2)(1994-8#1)(1997-2#1)(2009-9#1)
the spontaneously immortalized##2##3##(1992-9#1)(1994-12#1)
the spontaneously##18##2##(1990-7#2)(1991-6#1)(1991-9#1)(1992-9#5)(1993-2#2)(1994-12#1)(1994-6#1)(1994-8#1)(1997-2#1)(2008-4#1)(2009-3#1)(2009-9#1)
the sporadic and the##2##4##(2004-12#1)(2007-11#1)
the sporadic form##2##3##(1997-3#1)(2008-7#1)
the sporadic##8##2##(1990-11#1)(1990-12#1)(1997-3#1)(2004-12#1)(2007-11#1)(2008-11#1)(2008-7#2)
the spore production##2##3##(2008-10#2)
the spore##17##2##(1993-6#1)(1995-6#1)(2008-10#11)(2008-12#1)(2008-3#1)(2010-1#1)(2011-2#1)
the spores##8##2##(2008-10#6)(2010-3#1)(2011-2#1)
the sport##5##2##(2006-6#2)(2006-8#1)(2007-3#1)(2012-1#1)
the sports##3##2##(1995-8#1)(2008-5#1)(2012-1#1)
the sporulating##2##2##(2008-10#2)
the sporulation curve##2##3##(2008-10#2)
the sporulation of##3##3##(2008-10#3)
the sporulation##11##2##(2008-10#10)(2011-2#1)
the spot dislocations##2##3##(2007-12#2)
the spot size##6##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
the spot urinary concentrations of NTx##2##6##(2007-3#2)
the spot urinary##4##3##(2007-3#2)(2008-5#2)
the spot##20##2##(2006-5#1)(2007-12#4)(2007-3#2)(2008-10#2)(2008-2#4)(2008-3#3)(2008-5#2)(2011-1#1)(2013-8#1)
the spotlight##4##2##(2007-10#1)(2008-7#1)(2009-7#1)(2010-5#1)
the spots of##2##3##(2008-10#1)(2008-3#1)
the spots##11##2##(1997-6#1)(2006-5#2)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#3)
the spotted dolphin##2##3##(2007-5#2)
the spotted##6##2##(2006-2#1)(2007-3#2)(2007-5#2)(2008-10#1)
the spouse and##2##3##(2009-5#1)(2012-3#1)
the spouse or##2##3##(2007-7#1)(2009-5#1)
the spouse##6##2##(1993-3#1)(2006-9#1)(2007-7#1)(2009-5#2)(2012-3#1)
the spout##2##2##(2008-4#2)
the spray is##2##3##(2008-2#1)(2008-3#1)
the spray##8##2##(1996-3#1)(2008-10#3)(2008-2#2)(2008-3#2)
the spray-drying process##2##3##(2008-5#2)
the sprayed##3##2##(2004-12#1)(2005-8#1)(2008-10#1)
the spread and##2##3##(1993-2#1)(2008-10#1)
the spread of AIDS in##2##5##(1997-6#2)
the spread of AIDS##9##4##(1990-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-3#1)(1996-6#1)(1997-6#3)
the spread of HIV infection##2##5##(2007-7#1)(2011-1#1)
the spread of HIV##13##4##(1996-11#1)(1996-6#1)(1997-5#1)(1997-6#3)(2007-7#1)(2008-1#1)(2010-12#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-3#1)
the spread of HIV/AIDS##3##4##(2007-7#2)(2010-8#1)
the spread of a disease##2##5##(2008-10#1)(2011-2#1)
the spread of a##3##4##(2008-10#1)(2008-9#1)(2011-2#1)
the spread of disease##7##4##(2006-5#1)(2008-10#4)(2008-8#1)(2013-8#1)
the spread of infection##8##4##(1994-10#1)(2007-6#1)(2007-7#1)(2010-12#1)(2010-3#2)(2011-2#1)(2012-12#1)
the spread of infectious diseases##3##5##(2010-5#1)(2011-1#1)(2013-8#1)
the spread of infectious##4##4##(1996-12#1)(2010-5#1)(2011-1#1)(2013-8#1)
the spread of resistance##3##4##(1997-6#1)(2005-8#2)
the spread of resistant##2##4##(1995-5#1)(2012-2#1)
the spread of sexually transmitted diseases##2##6##(1994-3#1)(2010-2#1)
the spread of sexually transmitted##3##5##(1994-3#1)(2010-2#1)(2011-2#1)
the spread of the disease##6##5##(1993-3#1)(2007-7#2)(2008-10#1)(2010-4#1)(2010-8#1)
the spread of the##16##4##(1990-6#1)(1990-9#1)(1993-3#1)(1994-6#1)(1996-1#1)(1997-8#1)(2005-12#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-8#1)(2010-4#1)(2010-8#1)(2011-1#1)
the spread of this disease##2##5##(1995-1#1)(2007-7#1)
the spread of this##3##4##(1994-7#1)(1995-1#1)(2007-7#1)
the spread of tuberculosis##2##4##(2009-7#1)(2011-2#1)
the spread of##137##3##(1990-2#1)(1990-3#1)(1990-6#3)(1990-9#1)(1991-6#1)(1992-5#1)(1993-10#1)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#2)(1994-3#2)(1994-6#1)(1994-7#1)(1995-1#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#7)(1997-8#1)(2005-12#1)(2005-7#1)(2005-8#3)(2006-2#1)(2006-5#1)(2007-11#1)(2007-3#1)(2007-6#1)(2007-7#8)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#20)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#6)(2008-9#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#7)(2012-11#2)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#1)(2013-8#3)
the spread##146##2##(1990-2#1)(1990-3#1)(1990-6#3)(1990-9#1)(1991-6#1)(1992-2#1)(1992-5#1)(1993-10#1)(1993-2#1)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#2)(1994-3#2)(1994-6#1)(1994-7#1)(1995-1#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#7)(1997-8#1)(2005-12#1)(2005-7#1)(2005-8#3)(2006-2#1)(2006-5#1)(2007-11#1)(2007-3#1)(2007-6#1)(2007-7#8)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#22)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#6)(2008-9#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-8#2)(2011-1#4)(2011-2#8)(2012-11#2)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#1)(2013-8#3)
the spreading of the##2##4##(2005-11#1)(2007-12#1)
the spreading of##8##3##(1990-12#1)(2005-11#4)(2007-11#1)(2007-12#1)(2009-10#1)
the spreading panicle##2##3##(2009-10#2)
the spreading##19##2##(1990-12#1)(1996-5#1)(1997-2#1)(2005-11#8)(2007-11#1)(2007-12#1)(2008-2#1)(2008-5#1)(2009-10#3)(2009-6#1)
the spring and autumn##2##4##(2011-2#1)(2013-1#1)
the spring and fall##4##4##(2007-2#1)(2008-10#3)
the spring and##10##3##(2007-2#1)(2008-10#5)(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
the spring in the##2##4##(1994-3#1)(2006-6#1)
the spring in##4##3##(1994-3#1)(2006-6#1)(2008-10#1)(2012-1#1)
the spring of 1991##2##4##(1992-4#1)(1996-12#1)
the spring of 1997##2##4##(2005-7#1)(2008-1#1)
the spring of 2000##3##4##(2008-10#3)
the spring of 2002##2##4##(2006-12#1)(2008-10#1)
the spring of 2003##2##4##(2007-2#1)(2008-11#1)
the spring of 2009##3##4##(2010-12#1)(2011-9#1)(2012-1#1)
the spring of##32##3##(1992-4#1)(1993-5#1)(1994-12#1)(1996-12#1)(1996-2#1)(2004-11#2)(2005-7#1)(2006-12#1)(2006-8#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#1)(2010-12#1)(2010-8#1)(2011-2#1)(2011-9#1)(2012-1#1)(2012-12#2)(2012-3#1)
the spring season##2##3##(2008-10#1)(2012-3#1)
the spring##66##2##(1992-4#1)(1993-5#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-12#1)(1996-2#1)(2004-11#3)(2005-7#1)(2006-12#2)(2006-6#1)(2006-8#1)(2007-2#2)(2007-3#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#1)(2010-12#1)(2010-8#3)(2011-12#1)(2011-2#4)(2011-9#1)(2012-1#4)(2012-12#2)(2012-3#3)(2013-1#1)(2013-8#1)
the sprouts##3##2##(2007-1#2)(2007-3#1)
the spurious##2##2##(2006-5#1)(2008-2#1)
the sputtering##2##2##(2008-3#1)(2009-5#1)
the sputum of a##2##4##(2011-2#2)
the sputum##10##2##(1991-12#1)(1992-5#1)(1997-1#1)(2007-3#2)(2008-3#2)(2008-5#1)(2011-2#2)
the squamous cell carcinoma##2##4##(2011-2#1)(2012-3#1)
the squamous##8##2##(1993-8#1)(1997-5#1)(2006-5#1)(2007-11#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
the square of the##19##4##(1990-7#1)(1995-6#1)(2005-11#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#7)(2012-11#1)
the square of##20##3##(1990-7#1)(1995-6#1)(2005-11#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#7)(2012-11#1)
the square root of the scan rate##2##7##(2008-10#2)
the square root of the##9##5##(1993-10#1)(2007-12#3)(2007-2#1)(2008-10#2)(2008-3#1)(2013-7#1)
the square root of time##2##5##(2005-11#1)(2006-6#1)
the square root of##14##4##(1993-10#1)(2005-11#1)(2006-6#1)(2007-12#4)(2007-2#1)(2008-10#2)(2008-3#2)(2008-9#1)(2013-7#1)
the square root##15##3##(1993-10#1)(2005-11#1)(2006-11#1)(2006-6#1)(2007-12#4)(2007-2#1)(2008-10#2)(2008-3#2)(2008-9#1)(2013-7#1)
the square wave##6##3##(2008-10#5)(2011-2#1)
the square##52##2##(1990-7#1)(1993-10#1)(1995-6#1)(1997-7#1)(2005-11#3)(2006-11#1)(2006-6#1)(2007-11#2)(2007-12#6)(2007-2#1)(2007-8#1)(2008-10#9)(2008-12#1)(2008-2#3)(2008-3#14)(2008-5#2)(2008-9#1)(2011-2#1)(2012-11#1)(2013-7#1)
the square-wave##3##2##(2008-10#3)
the squared##4##2##(2007-12#1)(2008-12#1)(2008-2#1)(2011-3#1)
the squares of these##2##4##(2008-6#1)(2008-8#1)
the squares of##4##3##(2007-11#1)(2007-5#1)(2008-6#1)(2008-8#1)
the squid gene##2##3##(1994-3#2)
the squid giant axon##3##4##(1992-9#1)(2012-12#2)
the squid##11##2##(1992-9#1)(1994-3#2)(1995-5#2)(1995-8#2)(2008-7#1)(2012-12#2)(2013-8#1)
the squirrel Sciurus variegatoides##2##4##(2008-5#2)
the squirrel monkey (Saimiri sciureus)##3##5##(1991-5#1)(1995-11#1)(2008-7#1)
the squirrel monkey##6##3##(1991-5#2)(1995-11#3)(2008-7#1)
the squirrel##8##2##(1991-5#2)(1995-11#3)(2008-5#2)(2008-7#1)
the src family##5##3##(1990-12#2)(1991-11#1)(1991-5#1)(1992-9#1)
the src##7##2##(1990-12#2)(1991-11#1)(1991-5#1)(1992-9#1)(1993-9#1)(1994-9#1)
the ssDNA##2##2##(1991-5#1)(1995-2#1)
the sspE##2##2##(1996-8#2)
the stabilisation of the##3##4##(2006-10#1)(2007-8#1)(2008-5#1)
the stabilisation of##5##3##(2006-10#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-5#1)
the stabilisation##8##2##(2006-10#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)
the stabilities of the##3##4##(1993-11#1)(2007-10#1)(2008-4#1)
the stabilities of##4##3##(1992-1#1)(1993-11#1)(2007-10#1)(2008-4#1)
the stabilities##5##2##(1992-1#1)(1993-11#1)(2007-10#1)(2008-10#1)(2008-4#1)
the stability and dynamics of##2##5##(1995-1#1)(2013-8#1)
the stability and reproducibility of the##2##6##(2008-10#1)(2008-12#1)
the stability and reproducibility of##4##5##(2008-10#2)(2008-12#1)(2009-9#1)
the stability and structure of##2##5##(1994-8#1)(1995-5#1)
the stability and the##5##4##(1997-8#1)(2008-10#1)(2008-3#1)(2009-3#1)(2011-2#1)
the stability and##25##3##(1992-5#1)(1994-8#2)(1995-1#1)(1995-5#1)(1997-8#1)(2006-10#1)(2006-3#1)(2007-6#1)(2008-10#6)(2008-12#1)(2008-3#2)(2008-5#1)(2009-3#1)(2009-9#1)(2010-9#1)(2011-2#1)(2012-11#1)(2013-8#1)
the stability constant for##2##4##(2008-10#2)
the stability constant of the##2##5##(2008-10#2)
the stability constant of##3##4##(2008-10#3)
the stability constant##7##3##(2005-4#1)(2008-10#6)
the stability constants of the##8##5##(1996-8#1)(2008-10#6)(2008-3#1)
the stability constants of##12##4##(1996-8#1)(2008-10#10)(2008-3#1)
the stability constants##16##3##(1996-8#1)(2008-10#13)(2008-3#1)(2010-6#1)
the stability is##2##3##(2008-10#1)(2013-8#1)
the stability of DNA##2##4##(1996-4#2)
the stability of I##2##4##(1991-4#2)
the stability of a##10##4##(1990-4#1)(1991-1#1)(1991-4#1)(1993-9#1)(2005-11#1)(2006-7#1)(2008-5#2)(2008-9#1)(2012-2#1)
the stability of an##2##4##(1992-6#1)(2007-8#1)
the stability of antibody production by##2##6##(1994-3#2)
the stability of freeze-dried##2##4##(1996-1#1)(2008-6#1)
the stability of hermaphroditism##2##4##(2008-8#2)
the stability of its##2##4##(1997-5#1)(2008-11#1)
the stability of sludge flocs at##2##6##(2005-11#2)
the stability of sludge flocs##6##5##(2005-11#6)
the stability of the colloidal##2##5##(2005-11#1)(2006-5#1)
the stability of the duplex##2##5##(1990-5#1)(2006-12#1)
the stability of the electrode##2##5##(2008-10#2)
the stability of the ground state##2##6##(1994-9#2)
the stability of the hybrid##2##5##(2005-11#1)(2008-4#1)
the stability of the knee joint##2##6##(2007-8#2)
the stability of the mutant##2##5##(1993-11#1)(1995-1#1)
the stability of the native state of##2##7##(1992-6#1)(1993-11#1)
the stability of the native state##3##6##(1991-4#1)(1992-6#1)(1993-11#1)
the stability of the native##4##5##(1991-4#1)(1992-6#1)(1993-11#1)(1994-5#1)
the stability of the protein##2##5##(1992-4#1)(1997-2#1)
the stability of the proteins##2##5##(1993-11#1)(2010-7#1)
the stability of the system##2##5##(2008-10#1)(2010-11#1)
the stability of the vesicles##2##5##(1990-2#1)(2008-5#1)
the stability of the##109##4##(1990-2#1)(1990-5#3)(1990-8#1)(1991-11#2)(1991-4#2)(1991-9#3)(1992-2#1)(1992-4#1)(1992-6#4)(1993-11#3)(1993-3#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-9#2)(1995-1#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(2005-11#6)(2006-10#1)(2006-12#3)(2006-5#1)(2007-11#2)(2007-12#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#20)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#3)(2008-8#2)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#2)
the stability of these complexes##2##5##(1997-4#1)(2008-10#1)
the stability of these##9##4##(1997-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2010-12#1)(2010-4#1)(2011-2#1)
the stability of this##6##4##(1991-5#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-10#1)(2008-8#1)
the stability of##251##3##(1990-12#1)(1990-2#3)(1990-4#1)(1990-5#3)(1990-8#1)(1991-1#1)(1991-11#2)(1991-4#5)(1991-5#1)(1991-7#1)(1991-9#3)(1992-1#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#6)(1992-8#2)(1993-11#3)(1993-12#1)(1993-3#3)(1993-9#2)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#4)(1995-1#4)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#2)(1996-1#4)(1996-12#1)(1996-2#1)(1996-4#4)(1996-5#1)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(2004-9#1)(2005-11#17)(2006-10#1)(2006-12#4)(2006-5#1)(2006-7#1)(2007-11#5)(2007-12#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#38)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#6)(2008-4#2)(2008-5#8)(2008-6#3)(2008-7#3)(2008-8#8)(2008-9#4)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#6)(2012-1#2)(2012-2#5)(2012-3#2)(2013-1#1)(2013-8#1)
the stability##328##2##(1990-12#2)(1990-2#3)(1990-4#1)(1990-5#4)(1990-8#1)(1991-1#1)(1991-11#2)(1991-4#5)(1991-5#1)(1991-7#1)(1991-9#3)(1992-1#2)(1992-11#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#8)(1992-8#2)(1993-11#3)(1993-12#1)(1993-3#3)(1993-9#2)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-8#3)(1994-9#4)(1995-1#5)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#3)(1995-6#2)(1995-8#3)(1996-1#4)(1996-12#1)(1996-2#1)(1996-4#4)(1996-5#1)(1996-6#2)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-8#1)(2004-9#1)(2005-11#18)(2005-4#1)(2006-10#4)(2006-12#4)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#7)(2007-12#2)(2007-6#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#68)(2008-11#3)(2008-12#2)(2008-2#7)(2008-3#12)(2008-4#2)(2008-5#11)(2008-6#3)(2008-7#3)(2008-8#8)(2008-9#4)(2009-12#3)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#4)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-2#7)(2012-1#2)(2012-11#1)(2012-2#5)(2012-3#2)(2013-1#1)(2013-8#3)
the stability-indicating##3##2##(2011-1#1)(2012-12#2)
the stabilization and##3##3##(1990-8#1)(2005-11#1)(2008-12#1)
the stabilization of the##9##4##(1991-2#1)(1991-6#1)(1992-5#1)(1995-5#1)(1996-11#1)(2005-11#1)(2007-12#1)(2008-3#1)(2011-1#1)
the stabilization of##28##3##(1990-8#1)(1991-2#1)(1991-4#1)(1991-6#2)(1992-2#1)(1992-5#1)(1994-12#1)(1995-2#1)(1995-5#1)(1996-11#1)(2005-11#3)(2006-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-8#2)(2009-9#1)(2010-6#1)(2011-1#1)(2012-12#1)
the stabilization##41##2##(1990-12#1)(1990-8#2)(1991-2#1)(1991-4#1)(1991-6#2)(1992-2#1)(1992-3#1)(1992-5#1)(1993-3#2)(1994-11#1)(1994-12#1)(1995-2#1)(1995-5#1)(1996-11#1)(1997-2#1)(2004-9#1)(2005-11#5)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2009-8#2)(2009-9#1)(2010-6#1)(2011-1#1)(2012-12#1)
the stabilized##2##2##(2007-11#1)(2013-1#1)
the stabilizer##3##2##(2007-11#1)(2008-5#1)(2013-8#1)
the stabilizing effect of##2##4##(1995-2#1)(1996-11#1)
the stabilizing##14##2##(1991-7#1)(1992-3#1)(1992-6#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-11#1)(1997-4#1)(2005-11#1)(2006-10#2)(2007-11#1)(2007-7#1)(2008-5#1)
the stable and##2##3##(1990-3#1)(2007-1#1)
the stable association of##2##4##(1996-6#1)(2008-9#1)
the stable complex##4##3##(1991-6#3)(2008-10#1)
the stable conformation##2##3##(1990-7#1)(2012-2#1)
the stable fly##3##3##(2011-2#2)(2012-12#1)
the stable maximum##2##3##(2007-12#1)(2008-10#1)
the stable metabolite of prostacyclin##2##5##(1991-5#1)(1991-8#1)
the stable##58##2##(1990-3#1)(1990-7#1)(1991-11#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-8#1)(1992-3#1)(1992-7#3)(1992-9#1)(1993-3#1)(1994-11#1)(1995-2#2)(1995-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-5#1)(2006-12#1)(2007-1#1)(2007-12#3)(2007-7#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-3#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-7#1)(2013-8#1)
the stably##2##2##(2008-11#2)
the stack##2##2##(2008-2#1)(2008-3#1)
the stacking gel##3##3##(1991-2#1)(2008-2#1)(2008-4#1)
the stacking of##2##3##(1990-8#1)(2010-7#1)
the stacking##9##2##(1990-8#1)(1991-2#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-7#1)(2012-12#2)
the staff and##4##3##(1992-2#1)(1996-3#1)(2008-11#1)(2008-12#1)
the staff at the##3##4##(1991-4#1)(2008-4#1)(2009-7#1)
the staff in##4##3##(1991-12#1)(1996-2#1)(2006-6#1)(2011-1#1)
the staff is##2##3##(1991-1#1)(2004-12#1)
the staff of the##2##4##(1996-1#1)(2007-7#1)
the staff of##4##3##(1991-2#1)(1991-4#1)(1996-1#1)(2007-7#1)
the staff##34##2##(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-9#1)(1992-12#1)(1992-2#1)(1994-7#1)(1995-3#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-8#1)(2004-12#1)(2005-7#1)(2006-6#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-11#2)(2008-12#3)(2008-4#1)(2009-7#1)(2010-12#1)(2011-1#1)(2012-1#1)(2013-1#1)
the stage I##4##3##(1993-11#1)(2007-8#1)(2013-8#2)
the stage and the##2##4##(1995-11#1)(2013-8#1)
the stage and##6##3##(1995-11#1)(2006-11#1)(2008-5#1)(2008-7#1)(2010-12#1)(2013-8#1)
the stage for the##4##4##(2008-7#2)(2008-9#1)(2011-2#1)
the stage for##17##3##(1994-4#1)(1995-12#1)(1996-2#1)(1997-2#1)(2006-2#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-11#1)(2008-7#2)(2008-9#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
the stage is##2##3##(2008-2#1)(2008-3#1)
the stage of allantois formation##2##5##(2008-11#2)
the stage of cell##2##4##(1992-9#1)(2008-9#1)
the stage of development##3##4##(1996-8#1)(2007-12#1)(2008-8#1)
the stage of disease##5##4##(1991-4#1)(1991-5#1)(2008-11#1)(2008-2#1)(2009-11#1)
the stage of dyspnea##4##4##(1996-6#4)
the stage of its##2##4##(1992-2#1)(2008-10#1)
the stage of malignancy##2##4##(2008-2#2)
the stage of the disease and##2##6##(1991-6#1)(2005-11#1)
the stage of the disease##9##5##(1990-10#1)(1991-6#1)(1991-9#2)(1992-8#1)(1995-8#1)(2005-11#1)(2007-7#1)(2008-6#1)
the stage of the##15##4##(1990-10#1)(1990-8#1)(1991-6#1)(1991-9#2)(1992-8#1)(1995-1#1)(1995-8#1)(2005-11#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-6#1)(2009-5#1)(2012-1#1)
the stage of their##2##4##(2010-12#1)(2012-3#1)
the stage of##75##3##(1990-10#1)(1990-12#1)(1990-8#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-2#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-11#1)(1995-1#2)(1995-12#1)(1995-8#1)(1996-1#1)(1996-6#5)(1996-8#1)(2005-11#1)(2005-7#1)(2007-11#1)(2007-12#2)(2007-7#3)(2007-8#2)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-5#1)(2010-12#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2012-8#1)(2013-1#4)(2013-8#2)
the stage##115##2##(1990-10#1)(1990-12#1)(1990-8#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-2#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-2#2)(1994-11#1)(1994-4#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-6#5)(1996-8#1)(1997-2#1)(2005-11#1)(2005-7#1)(2006-11#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-12#2)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#3)(2009-11#1)(2009-5#1)(2010-12#2)(2010-3#3)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2012-8#1)(2013-1#4)(2013-8#5)
the stage-specific##2##2##(1994-12#1)(2008-8#1)
the staged##4##2##(2006-12#1)(2007-12#1)(2007-8#1)(2011-2#1)
the stages and##2##3##(2007-2#1)(2008-4#1)
the stages in the development of##2##6##(2007-11#1)(2010-8#1)
the stages in the##4##4##(2007-11#1)(2007-8#1)(2010-2#1)(2010-8#1)
the stages of##20##3##(1990-6#1)(1992-1#1)(1993-11#1)(1993-6#1)(1995-1#1)(1997-4#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-12#1)(2008-4#2)(2008-7#1)(2009-2#3)(2011-1#1)(2012-1#1)(2013-1#2)
the stages##32##2##(1990-6#1)(1992-1#1)(1993-11#1)(1993-6#1)(1995-1#1)(1995-11#1)(1997-4#1)(2004-8#1)(2006-11#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-2#3)(2010-2#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#2)
the staging and restaging of##2##5##(2012-12#1)(2012-2#1)
the staging and##4##3##(1990-9#1)(2010-3#1)(2012-12#1)(2012-2#1)
the staging of patients with##2##5##(2007-4#1)(2007-6#1)
the staging of##12##3##(2006-10#1)(2006-6#1)(2007-4#2)(2007-6#2)(2008-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
the staging system##3##3##(2009-3#1)(2010-12#1)(2011-2#1)
the staging##24##2##(1990-12#1)(1990-9#1)(2006-10#1)(2006-6#1)(2007-4#2)(2007-6#2)(2007-8#1)(2008-10#1)(2008-2#2)(2008-7#1)(2009-3#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#4)(2012-2#2)(2013-1#1)
the stain##3##2##(2006-2#1)(2008-9#1)(2010-5#1)
the stained cells##2##3##(2007-3#1)(2008-9#1)
the stained##7##2##(1995-4#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-3#1)(2008-4#1)(2008-9#1)
the staining intensity##4##3##(1990-12#1)(1991-5#1)(1992-6#1)(1996-2#1)
the staining of##3##3##(1991-2#1)(1996-9#1)(2008-4#1)
the staining was##3##3##(1991-10#2)(1992-11#1)
the staining##18##2##(1990-12#1)(1991-10#2)(1991-2#1)(1991-5#1)(1992-11#1)(1992-6#1)(1996-2#1)(1996-9#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-9#3)(2010-2#1)
the stains##3##2##(1990-7#1)(1996-11#1)(2011-2#1)
the staircase approximation##2##3##(2007-12#2)
the staircase procedure##2##3##(1990-11#2)
the staircase##6##2##(1990-11#2)(2007-10#1)(2007-12#2)(2008-2#1)
the stakeholder##4##2##(1995-1#1)(2008-1#1)(2008-10#1)(2012-3#1)
the stakeholders in##3##3##(2008-10#1)(2008-6#1)(2012-12#1)
the stakeholders##8##2##(1991-12#1)(2008-10#1)(2008-12#1)(2008-6#1)(2012-12#3)(2013-8#1)
the stalk##16##2##(1993-6#1)(1994-9#2)(1995-5#2)(1997-3#2)(1997-8#1)(2008-10#2)(2010-12#5)(2011-2#1)
the stallions##2##2##(2006-5#1)(2012-3#1)
the stamping process##2##3##(2006-5#2)
the stance##5##2##(2007-10#1)(2007-8#1)(2008-11#1)(2012-1#1)(2013-1#1)
the stand##2##2##(2008-6#1)(2013-8#1)
the standard DNA##2##3##(2008-10#1)(2011-12#1)
the standard FVC maneuver##2##4##(2008-7#2)
the standard Laemmli method is described for discontinuous gel electrophoresis under denaturing conditions##2##13##(2008-2#1)(2008-4#1)
the standard Perimount##2##3##(2007-8#2)
the standard SVM##4##3##(2008-2#4)
the standard addition method was##2##5##(2008-10#2)
the standard addition method##17##4##(1992-1#1)(2008-10#16)
the standard addition methodology##4##4##(2008-10#4)
the standard addition technique were##2##5##(2007-8#1)(2008-10#1)
the standard addition technique##8##4##(1991-12#1)(2007-8#1)(2008-10#5)(2010-4#1)
the standard addition##34##3##(1991-12#1)(1992-1#1)(2007-10#1)(2007-8#1)(2008-10#28)(2010-4#1)(2013-8#1)
the standard additions method##11##4##(2008-10#11)
the standard algorithm##3##3##(2008-1#1)(2008-3#1)(2013-1#1)
the standard and##11##3##(1990-6#1)(1996-4#1)(2007-12#1)(2009-2#1)(2009-5#1)(2011-1#3)(2011-2#1)(2012-3#1)(2013-1#1)
the standard approach##4##3##(1990-6#1)(2008-11#1)(2008-8#2)
the standard approaches of##2##4##(2009-3#1)(2010-6#1)
the standard approaches##3##3##(1993-4#1)(2009-3#1)(2010-6#1)
the standard buffers are replaced with either a Tris-tricine buffer system or a modified Tris buffer in the absence of urea##2##21##(2008-2#1)(2008-4#1)
the standard case##4##3##(2005-11#2)(2008-2#1)(2008-3#1)
the standard coronary##2##3##(2006-9#1)(2010-7#1)
the standard culture##3##3##(1994-9#1)(2011-2#1)(2013-8#1)
the standard curve was##4##4##(1992-2#1)(2008-10#3)
the standard curve##8##3##(1992-2#1)(1995-1#1)(2007-8#1)(2008-10#3)(2008-2#1)(2010-11#1)
the standard design##2##3##(1994-9#2)
the standard deviation (S##2##4##(2008-10#2)
the standard deviation (SD)##3##4##(2008-5#1)(2009-11#1)(2012-5#1)
the standard deviation of blank##2##5##(2008-10#2)
the standard deviation of the blank##8##6##(2007-8#1)(2008-10#7)
the standard deviation of the distribution##2##6##(2012-12#2)
the standard deviation of the##26##5##(2007-11#1)(2007-8#1)(2008-10#14)(2008-2#2)(2008-3#6)(2012-12#2)
the standard deviation of##32##4##(2007-11#1)(2007-8#1)(2008-10#19)(2008-2#3)(2008-3#6)(2012-12#2)
the standard deviation##53##3##(1995-6#1)(2007-11#1)(2007-8#1)(2008-10#28)(2008-11#1)(2008-2#6)(2008-3#6)(2008-5#1)(2008-9#1)(2009-11#1)(2010-9#1)(2012-12#2)(2012-5#1)(2013-8#2)
the standard deviations of##3##4##(1993-9#1)(2007-12#1)(2008-4#1)
the standard deviations##5##3##(1993-9#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-4#1)
the standard diffusion##2##3##(2008-2#2)
the standard drug##5##3##(2006-10#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-5#1)
the standard error of##2##4##(2007-8#1)(2012-12#1)
the standard error##4##3##(2007-10#1)(2007-8#1)(2008-10#1)(2012-12#1)
the standard errors of##2##4##(2008-10#1)(2008-7#1)
the standard errors##3##3##(1995-9#1)(2008-10#1)(2008-7#1)
the standard first-line treatment##2##4##(2006-11#1)(2006-2#1)
the standard first-line##4##3##(2006-11#1)(2006-2#1)(2010-12#1)(2013-1#1)
the standard for##6##3##(1991-1#1)(1996-12#1)(2007-10#1)(2007-8#1)(2008-11#1)(2010-5#1)
the standard formulation##2##3##(1993-10#1)(2006-1#1)
the standard free energy of adsorption##2##6##(2005-11#2)
the standard free energy of##3##5##(2005-11#3)
the standard iterative##2##3##(2007-12#1)(2008-3#1)
the standard medical##2##3##(2006-8#1)(2008-12#1)
the standard method for##3##4##(2008-3#1)(2008-4#1)(2010-3#1)
the standard method of##3##4##(2007-8#1)(2009-6#1)(2011-2#1)
the standard method##15##3##(1992-12#1)(1996-3#1)(2007-8#3)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2009-6#1)(2010-3#1)(2011-2#2)
the standard methods##4##3##(2007-10#1)(2007-9#1)(2008-10#2)
the standard nozzle##2##3##(2010-9#2)
the standard of care for patients with##4##7##(2008-6#2)(2009-11#1)(2009-12#1)
the standard of care for##15##5##(1993-12#1)(2004-1#1)(2005-3#1)(2006-10#1)(2006-11#1)(2007-10#3)(2007-12#1)(2008-6#2)(2009-11#1)(2009-12#2)(2013-7#1)
the standard of care in##3##5##(2006-10#1)(2006-12#1)(2010-12#1)
the standard of care of##2##5##(2008-3#1)(2010-5#1)
the standard of care##33##4##(1991-12#1)(1993-12#1)(1993-5#1)(2004-1#1)(2005-10#1)(2005-3#1)(2006-10#4)(2006-11#1)(2006-12#1)(2007-10#5)(2007-12#1)(2007-7#1)(2008-3#1)(2008-6#3)(2008-7#1)(2009-11#1)(2009-12#2)(2009-5#1)(2010-12#1)(2010-5#1)(2012-1#1)(2012-11#1)(2013-7#1)
the standard of practice##3##4##(2007-10#1)(2007-4#1)(2008-8#1)
the standard of##44##3##(1990-11#1)(1991-12#1)(1993-12#1)(1993-5#1)(2004-1#1)(2005-10#1)(2005-3#1)(2006-10#6)(2006-11#1)(2006-12#1)(2007-10#6)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-6#3)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#1)(2010-12#1)(2010-5#1)(2012-1#1)(2012-11#1)(2013-7#1)
the standard plate count##2##4##(1997-4#2)
the standard preparation##3##3##(1993-10#1)(2008-7#1)(2012-1#1)
the standard procedure##7##3##(1997-5#1)(2007-8#1)(2008-10#2)(2008-11#2)(2012-3#1)
the standard product##2##3##(1992-10#1)(2012-1#1)
the standard program##2##3##(2007-11#1)(2007-7#1)
the standard protocol##3##3##(2008-6#1)(2011-12#1)(2012-3#1)
the standard quantum limit##2##4##(2007-12#2)
the standard reference material##4##4##(2008-10#4)
the standard reference##8##3##(2008-1#1)(2008-10#5)(2010-3#1)(2011-1#1)
the standard samples##2##3##(2005-4#2)
the standard scoring##2##3##(2007-12#2)
the standard slurries##2##3##(2008-10#2)
the standard solution##2##3##(2008-10#2)
the standard solutions##2##3##(2008-10#2)
the standard spectrophotometric##2##3##(2008-10#2)
the standard technique for##2##4##(2008-2#1)(2012-12#1)
the standard technique##5##3##(2007-7#1)(2008-2#1)(2011-7#1)(2012-12#1)(2012-2#1)
the standard test##2##3##(2006-10#1)(2010-1#1)
the standard theory##2##3##(2006-4#1)(2006-7#1)
the standard therapy for##3##4##(1994-12#1)(2005-8#1)(2012-1#1)
the standard therapy##5##3##(1991-9#1)(1994-12#1)(2005-8#1)(2010-7#1)(2012-1#1)
the standard treatment for patients with##2##6##(2008-6#1)(2012-3#1)
the standard treatment for##14##4##(1997-5#1)(2004-3#1)(2005-1#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#2)(2008-5#1)(2008-6#2)(2011-2#2)(2012-3#1)
the standard treatment in##3##4##(1991-8#1)(2007-11#1)(2011-2#1)
the standard treatment##26##3##(1991-8#1)(1995-9#1)(1997-3#1)(1997-5#1)(2004-3#1)(2005-1#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#4)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#2)(2009-6#1)(2011-2#4)(2012-3#2)
the standard tube agglutination test##2##5##(2005-9#1)(2007-2#1)
the standard version of the##2##5##(1993-12#1)(1995-1#1)
the standard##620##2##(1990-11#2)(1990-2#1)(1990-5#1)(1990-6#2)(1990-7#2)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#2)(1992-12#2)(1992-2#4)(1992-5#1)(1992-7#1)(1992-8#1)(1993-10#2)(1993-11#1)(1993-12#4)(1993-2#1)(1993-4#1)(1993-5#3)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#2)(1994-6#1)(1994-9#4)(1995-1#2)(1995-10#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-9#2)(1996-1#2)(1996-11#4)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-7#3)(1996-8#1)(1996-9#1)(1997-3#4)(1997-4#2)(1997-5#2)(1997-6#1)(1997-8#2)(2004-1#1)(2004-3#1)(2005-1#1)(2005-10#1)(2005-11#9)(2005-3#1)(2005-4#4)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#14)(2006-11#3)(2006-12#4)(2006-2#3)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#13)(2007-11#13)(2007-12#15)(2007-2#6)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#7)(2007-8#18)(2007-9#3)(2008-1#7)(2008-10#137)(2008-11#13)(2008-12#5)(2008-2#36)(2008-3#30)(2008-4#10)(2008-5#8)(2008-6#6)(2008-7#11)(2008-8#10)(2008-9#5)(2009-11#2)(2009-12#3)(2009-2#3)(2009-3#4)(2009-4#3)(2009-5#2)(2009-6#3)(2010-1#2)(2010-11#2)(2010-12#2)(2010-2#3)(2010-3#2)(2010-4#4)(2010-5#3)(2010-6#2)(2010-7#4)(2010-8#1)(2010-9#3)(2011-1#10)(2011-12#2)(2011-2#9)(2011-7#1)(2012-1#5)(2012-11#2)(2012-12#6)(2012-2#4)(2012-3#9)(2012-5#1)(2013-1#9)(2013-7#1)(2013-8#6)
the standardised mortality ratio (SMR)##2##5##(1993-7#1)(2008-8#1)
the standardised mortality ratio##3##4##(1993-7#1)(2008-8#2)
the standardised##5##2##(1993-7#1)(2008-8#2)(2009-8#1)(2011-1#1)
the standardization and##3##3##(2008-10#1)(2013-1#2)
the standardization of the##3##4##(2006-6#1)(2008-4#1)(2013-8#1)
the standardization of##12##3##(1996-2#1)(1996-3#1)(2006-10#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-11#1)(2013-7#1)(2013-8#1)
the standardization##17##2##(1996-2#1)(1996-3#1)(2006-10#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-4#1)(2011-2#1)(2012-11#1)(2013-1#2)(2013-7#1)(2013-8#1)
the standardized area under##2##4##(2008-10#2)
the standardized patients' rating of##2##5##(2008-8#2)
the standardized terminology provided the nurses greater ease in their selection of nursing diagnoses and interventions in planning patient care##2##20##(2013-1#2)
the standardized variance##2##3##(2008-10#1)(2008-8#1)
the standardized##24##2##(1991-3#1)(1993-9#1)(1995-4#1)(1997-1#1)(2006-2#1)(2006-8#3)(2007-12#1)(2008-10#3)(2008-5#1)(2008-8#4)(2009-8#1)(2011-2#2)(2012-2#1)(2013-1#3)
the standards for##7##3##(1996-3#1)(2005-5#1)(2007-11#1)(2007-4#1)(2008-3#1)(2010-4#1)(2011-2#1)
the standards of the##2##4##(1991-8#1)(2011-2#1)
the standards of##9##3##(1991-3#1)(1991-8#1)(1992-2#1)(1997-8#1)(2006-10#1)(2007-3#1)(2008-9#1)(2011-2#2)
the standards##35##2##(1991-3#1)(1991-8#1)(1992-2#1)(1992-3#1)(1994-3#2)(1995-2#2)(1996-1#1)(1996-3#1)(1997-8#1)(2005-5#2)(2006-10#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#2)(2009-6#1)(2010-4#1)(2011-2#3)(2013-1#1)
the standing position##2##3##(1990-6#1)(1997-4#1)
the standing##12##2##(1990-6#1)(1995-10#1)(1997-4#1)(2004-2#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-5#1)(2013-8#1)
the standpoint of##20##3##(1995-12#1)(1996-12#1)(2006-10#3)(2006-6#1)(2007-1#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#2)(2010-7#1)(2010-8#2)(2011-2#1)(2012-2#1)
the stands##2##2##(1995-3#1)(2007-3#1)
the staphylococcal##2##2##(1993-3#1)(1995-12#1)
the staple food##2##3##(1991-11#1)(2006-12#1)
the staple##5##2##(1990-6#1)(1991-11#2)(1991-12#1)(2006-12#1)
the stapled group##3##3##(2006-6#2)(2009-2#1)
the star##5##2##(1994-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-2#1)
the starch branching enzyme##2##4##(2006-12#2)
the starch granules were##2##4##(2006-12#1)(2013-8#1)
the starch granules##4##3##(2006-12#2)(2009-8#1)(2013-8#1)
the starch##16##2##(1991-12#1)(1995-6#1)(2006-11#3)(2006-12#4)(2007-11#1)(2008-10#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-4#1)(2013-8#1)
the starfish##6##2##(1991-10#1)(1992-8#3)(1997-6#1)(2007-5#1)
the stars##6##2##(1990-3#1)(1991-6#1)(2007-8#1)(2008-2#1)(2008-3#1)(2011-2#1)
the start codon of the##4##5##(1996-10#1)(2008-10#1)(2008-8#1)(2009-5#1)
the start codon##18##3##(1990-3#1)(1990-5#1)(1990-9#7)(1991-6#2)(1993-4#1)(1996-10#1)(1997-4#1)(2005-11#1)(2008-10#1)(2008-8#1)(2009-5#1)
the start of a new##3##5##(1996-6#1)(2005-9#1)(2008-11#1)
the start of a##10##4##(1993-6#1)(1996-1#1)(1996-6#1)(1997-1#1)(2005-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)
the start of on-orbit operations##2##5##(2008-3#2)
the start of the 20th century##2##6##(1994-12#1)(2011-2#1)
the start of the growth cycle##2##6##(2009-8#2)
the start of the infusion##2##5##(1993-7#1)(1997-1#1)
the start of the study and##3##6##(2012-2#1)(2013-1#1)(2013-8#1)
the start of the study##10##5##(1994-7#1)(2004-3#1)(2008-5#2)(2010-11#1)(2010-3#1)(2012-2#2)(2013-1#1)(2013-8#1)
the start of the trial##3##5##(2008-10#1)(2008-3#1)(2011-2#1)
the start of the##48##4##(1990-12#1)(1990-6#1)(1991-2#1)(1991-5#1)(1993-2#1)(1993-7#1)(1994-12#1)(1994-3#1)(1994-7#1)(1996-10#1)(1997-1#1)(2004-3#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-8#2)(2010-11#1)(2010-3#2)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#2)
the start of therapy was##2##5##(2005-7#1)(2008-1#1)
the start of therapy##3##4##(1993-7#1)(2005-7#1)(2008-1#1)
the start of transcription##3##4##(1992-9#1)(1994-3#1)(2008-9#1)
the start of treatment##13##4##(1990-2#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-12#3)
the start of##133##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#2)(1992-12#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-7#2)(1994-12#1)(1994-3#3)(1994-4#2)(1994-6#2)(1994-7#1)(1995-12#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#3)(1997-2#1)(2004-2#1)(2004-3#1)(2004-9#1)(2005-1#1)(2005-5#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-12#3)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#6)(2008-1#2)(2008-10#7)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-12#1)(2009-8#3)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-12#4)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#3)
the start position of##2##4##(1991-1#1)(2008-6#1)
the start position##4##3##(1991-1#1)(2008-6#3)
the start site of##4##4##(1991-5#1)(1992-3#1)(1992-8#1)(1996-7#1)
the start site##6##3##(1991-5#1)(1992-3#1)(1992-8#1)(1996-7#1)(1997-5#2)
the start##173##2##(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#8)(1991-1#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#4)(1991-7#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-12#3)(1993-2#1)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#2)(1994-12#1)(1994-3#3)(1994-4#2)(1994-6#2)(1994-7#1)(1995-12#2)(1995-8#1)(1996-1#1)(1996-10#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#2)(1997-1#3)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2004-2#1)(2004-3#1)(2004-9#1)(2005-1#1)(2005-11#2)(2005-5#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-10#2)(2007-12#3)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#7)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-1#1)(2009-12#1)(2009-5#1)(2009-8#3)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-12#4)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#3)
the starting and##2##3##(2008-10#2)
the starting material##11##3##(1990-12#1)(1996-5#1)(1997-2#2)(2007-11#1)(2008-10#3)(2008-2#1)(2008-5#1)(2009-7#1)
the starting materials##6##3##(2004-9#2)(2007-11#1)(2008-1#1)(2008-11#1)(2008-4#1)
the starting of##2##3##(1997-2#1)(2009-3#1)
the starting point for the##2##5##(2008-11#1)(2010-12#1)
the starting point for##4##4##(1994-9#1)(1996-12#1)(2008-11#1)(2010-12#1)
the starting point of##2##4##(1990-10#1)(2009-10#1)
the starting point##8##3##(1990-10#1)(1994-9#1)(1996-12#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-12#1)(2013-1#1)
the starting values##2##3##(2008-2#2)
the starting##57##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1991-11#1)(1991-5#1)(1992-2#1)(1994-2#1)(1994-9#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#1)(2004-9#2)(2005-11#1)(2006-12#1)(2007-1#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#3)(2008-4#2)(2008-5#4)(2008-8#1)(2009-10#1)(2009-3#1)(2009-7#2)(2010-12#1)(2010-4#1)(2010-7#1)(2012-3#1)(2013-1#1)
the startle correlated potential##3##4##(1991-11#3)
the startle response##5##3##(1991-11#2)(2008-11#1)(2008-4#2)
the startle##13##2##(1991-11#5)(1991-12#1)(2008-11#4)(2008-4#3)
the state and federal##4##4##(1994-3#1)(2008-2#1)(2010-9#1)(2013-8#1)
the state and local level##4##5##(1996-12#1)(1997-2#2)(2011-9#1)
the state and local##5##4##(1996-12#1)(1996-2#1)(1997-2#2)(2011-9#1)
the state and##14##3##(1994-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#2)(2005-1#1)(2007-11#1)(2008-2#1)(2010-9#1)(2011-9#1)(2012-3#1)(2013-8#1)
the state in which##2##4##(1991-11#1)(2011-1#1)
the state in##5##3##(1991-11#1)(1995-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
the state legislature##3##3##(1991-7#1)(1991-8#1)(1995-2#1)
the state of Espírito##2##4##(2007-5#2)
the state of São Paulo##5##5##(2006-5#1)(2006-8#2)(2008-10#1)(2011-2#1)
the state of advancement##2##4##(2007-11#1)(2007-8#1)
the state of enzyme##2##4##(1991-12#1)(2012-1#1)
the state of health##2##4##(1992-3#1)(1994-9#1)
the state of insulin resistance##3##5##(1996-5#1)(2007-8#2)
the state of knowledge##2##4##(2008-10#1)(2010-5#1)
the state of oxidation of##2##5##(1991-7#1)(2008-10#1)
the state of polarization and the##3##6##(2007-12#1)(2008-2#2)
the state of polarization of the incident##2##7##(2007-12#1)(2008-3#1)
the state of polarization of the##5##6##(2007-12#1)(2008-2#3)(2008-3#1)
the state of polarization##17##4##(2007-11#1)(2007-12#5)(2008-2#7)(2008-3#4)
the state of the art and##2##6##(1993-3#1)(2013-1#1)
the state of the art in##6##6##(2004-2#1)(2006-6#1)(2007-8#1)(2008-7#1)(2010-9#2)
the state of the art of##6##6##(1991-4#1)(2007-8#1)(2008-5#1)(2009-12#1)(2012-2#1)(2012-3#1)
the state of the art##18##5##(1991-4#1)(1993-3#1)(1995-2#1)(2004-2#1)(2006-6#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-12#2)(2010-9#2)(2012-2#1)(2012-3#1)(2013-1#1)
the state of the patient##2##5##(1990-10#1)(1993-5#1)
the state of the science##2##5##(1992-3#1)(2007-9#1)
the state of the##45##4##(1990-10#1)(1990-2#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-4#1)(1992-3#1)(1993-3#1)(1993-5#1)(1995-2#1)(2004-2#1)(2005-1#1)(2006-6#2)(2006-7#2)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-12#1)(2009-5#1)(2010-12#2)(2010-6#1)(2010-7#1)(2010-9#2)(2011-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the state of##172##3##(1990-10#2)(1990-2#2)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-3#2)(1992-5#1)(1993-2#1)(1993-3#2)(1993-5#2)(1993-6#1)(1993-8#4)(1994-2#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-2#2)(2004-2#1)(2005-1#1)(2005-11#2)(2005-7#1)(2006-10#2)(2006-5#2)(2006-6#2)(2006-7#3)(2006-8#3)(2007-10#2)(2007-11#2)(2007-12#7)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-2#10)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2010-12#4)(2010-2#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#3)(2011-1#2)(2011-11#1)(2011-2#6)(2012-1#1)(2012-2#2)(2012-3#5)(2013-1#5)(2013-8#3)
the state public health regulations##2##5##(1995-2#2)
the state space##3##3##(2008-11#2)(2008-2#1)
the state to##2##3##(1992-12#1)(2008-2#1)
the state##260##2##(1990-10#2)(1990-12#1)(1990-2#2)(1990-8#2)(1991-1#2)(1991-11#2)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-5#2)(1993-6#2)(1993-8#4)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#5)(1995-2#5)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#2)(1997-1#1)(1997-2#4)(1997-3#1)(2004-2#1)(2005-1#2)(2005-11#2)(2005-12#1)(2005-7#1)(2006-10#2)(2006-5#2)(2006-6#2)(2006-7#3)(2006-8#3)(2007-10#2)(2007-11#3)(2007-12#8)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#3)(2008-1#1)(2008-10#16)(2008-11#6)(2008-12#1)(2008-2#18)(2008-3#4)(2008-4#2)(2008-5#7)(2008-6#4)(2008-7#2)(2008-8#6)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2010-12#4)(2010-2#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#4)(2011-1#3)(2011-11#1)(2011-2#11)(2011-9#1)(2012-1#1)(2012-2#3)(2012-3#8)(2013-1#8)(2013-8#4)
the state's##17##2##(1990-2#1)(1991-8#1)(1992-6#4)(1992-8#1)(1995-9#1)(1996-12#1)(1996-5#1)(1996-9#1)(2007-9#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#2)
the state-of-the-art in##2##3##(2008-10#1)(2008-11#1)
the state-of-the-art of##4##3##(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)
the state-of-the-art##10##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2012-2#1)
the stated##4##2##(2007-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
the statement##6##2##(1992-12#1)(2008-11#1)(2008-6#1)(2009-8#1)(2013-1#2)
the statements##4##2##(1996-11#2)(2007-3#1)(2007-7#1)
the states of##12##3##(1990-2#1)(1991-12#1)(1991-4#1)(1994-3#1)(1997-8#1)(2008-2#2)(2008-3#2)(2008-5#2)(2010-3#1)
the states##30##2##(1990-2#1)(1991-12#2)(1991-4#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-9#1)(1996-1#1)(1997-2#1)(1997-3#2)(1997-8#1)(2007-1#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#4)(2008-3#2)(2008-5#2)(2010-3#1)(2010-8#1)(2010-9#1)
the static and dynamic##2##4##(1995-12#1)(2004-9#1)
the static and the dynamic##2##5##(2008-2#1)(2008-3#1)
the static and##6##3##(1995-12#1)(2004-9#1)(2008-2#2)(2008-3#2)
the static culture##4##3##(2008-11#2)(2008-5#2)
the static images##2##3##(2013-1#2)
the static imaging##2##3##(2008-10#2)
the static interference##2##3##(2013-8#2)
the static mercury drop electrode##4##5##(2008-10#4)
the static##45##2##(1993-9#1)(1994-8#1)(1995-10#1)(1995-12#1)(1997-1#1)(2004-9#1)(2005-11#5)(2006-11#1)(2008-10#9)(2008-11#2)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#2)(2010-5#1)(2011-2#1)(2013-1#2)(2013-8#3)
the statin##3##2##(2006-10#2)(2010-12#1)
the statins##3##2##(2006-5#3)
the station##5##2##(2006-5#1)(2007-5#2)(2008-2#1)(2011-2#1)
the stationarity assumption##2##3##(2008-8#2)
the stationary phase and##5##4##(1996-8#1)(1997-3#1)(1997-5#1)(2008-10#1)(2008-7#1)
the stationary phase of growth##3##5##(1990-12#1)(2006-8#1)(2006-9#1)
the stationary phase of##6##4##(1990-12#1)(2005-12#1)(2006-8#1)(2006-9#1)(2008-10#1)(2008-11#1)
the stationary phase was##4##4##(2008-10#3)(2008-7#1)
the stationary phase##50##3##(1990-12#1)(1990-7#1)(1991-3#1)(1992-2#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-5#2)(2005-12#2)(2006-8#1)(2006-9#1)(2007-12#1)(2008-10#21)(2008-11#2)(2008-5#1)(2008-7#6)(2011-1#2)(2011-2#2)(2012-12#1)
the stationary##59##2##(1990-12#1)(1990-7#1)(1991-3#1)(1992-2#1)(1996-5#2)(1996-8#1)(1997-2#2)(1997-3#1)(1997-5#2)(2005-12#2)(2006-8#1)(2006-9#1)(2007-12#1)(2008-10#22)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#7)(2008-8#1)(2011-1#2)(2011-2#2)(2012-12#1)
the statistic is##2##3##(1997-3#1)(2013-8#1)
the statistic##10##2##(1992-6#1)(1997-3#2)(2008-10#2)(2009-12#1)(2011-2#1)(2013-8#3)
the statistical analysis of the##2##5##(2008-10#1)(2009-11#1)
the statistical analysis of##8##4##(1994-6#1)(1997-4#1)(2008-10#1)(2008-4#1)(2009-11#1)(2009-2#1)(2012-12#1)(2012-3#1)
the statistical analysis##19##3##(1994-6#1)(1996-7#1)(1997-4#1)(2005-10#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2012-12#1)(2012-3#1)(2013-8#3)
the statistical artifact##2##3##(2008-8#2)
the statistical data##2##3##(2008-7#1)(2009-4#1)
the statistical distribution of##2##4##(2008-1#1)(2009-10#1)
the statistical error##2##3##(2008-2#2)
the statistical evaluation##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
the statistical methodology##2##3##(2008-10#1)(2010-9#1)
the statistical methods##2##3##(1993-11#1)(2012-2#1)
the statistical model##3##3##(2008-2#1)(2010-5#1)(2013-8#1)
the statistical parameters##2##3##(2008-2#1)(2008-3#1)
the statistical power of the##2##5##(1992-9#1)(1994-2#1)
the statistical power of##3##4##(1992-9#1)(1994-2#1)(2012-3#1)
the statistical power##7##3##(1992-9#1)(1994-2#1)(1994-4#1)(2004-1#1)(2008-8#1)(2012-3#2)
the statistical properties of the##5##5##(2007-11#2)(2008-2#1)(2010-8#1)(2012-3#1)
the statistical properties of##9##4##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#1)(2010-8#1)(2012-3#2)
the statistical results##2##3##(2008-12#1)(2012-2#1)
the statistical sampling##2##3##(1992-2#2)
the statistical significance of the##2##5##(2009-5#1)(2010-8#1)
the statistical significance of##5##4##(1990-6#1)(2007-7#1)(2008-4#1)(2009-5#1)(2010-8#1)
the statistical significance##7##3##(1990-6#1)(2007-7#1)(2008-4#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-3#1)
the statistical techniques##2##3##(2008-4#1)(2012-12#1)
the statistical test##3##3##(2007-10#1)(2010-2#1)(2012-2#1)
the statistical uncertainty##2##3##(2008-10#2)
the statistical##118##2##(1990-6#1)(1990-8#1)(1990-9#1)(1992-2#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#2)(1994-2#1)(1994-3#2)(1994-4#1)(1994-6#1)(1994-8#1)(1995-6#1)(1996-2#1)(1996-7#1)(1997-3#1)(1997-4#2)(1997-7#1)(2004-1#1)(2005-10#1)(2006-10#1)(2006-5#2)(2007-10#2)(2007-11#4)(2007-12#1)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#8)(2008-3#5)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#5)(2008-9#3)(2009-10#2)(2009-11#3)(2009-2#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#7)(2013-1#1)(2013-8#6)
the statistically significant##3##3##(2008-8#1)(2009-8#1)(2011-2#1)
the statistically##6##2##(2006-6#1)(2007-12#1)(2008-8#1)(2009-8#1)(2011-12#1)(2011-2#1)
the statistics are##2##3##(2008-2#1)(2009-5#1)
the statistics of the##5##4##(1990-9#1)(1997-8#1)(2008-2#2)(2008-3#1)
the statistics of##9##3##(1990-9#1)(1995-7#1)(1997-8#1)(2008-2#3)(2008-3#2)(2008-8#1)
the statistics##15##2##(1990-9#1)(1991-2#1)(1995-7#1)(1997-2#1)(1997-8#1)(2008-2#5)(2008-3#2)(2008-8#1)(2009-5#1)(2010-8#1)
the statocysts##2##2##(2008-7#1)(2011-2#1)
the stator arginine##3##3##(2008-4#3)
the stator##4##2##(2008-4#4)
the status and##3##3##(1997-5#1)(2006-2#1)(2011-9#1)
the status exchange hypothesis##2##4##(2012-12#2)
the status of a##3##4##(2005-11#1)(2008-9#1)(2009-2#1)
the status of soft##2##4##(1990-3#1)(2007-8#1)
the status of the debate##2##5##(2006-11#2)
the status of the embryo##3##5##(2007-10#3)
the status of the##29##4##(1993-11#1)(1994-12#1)(1994-2#1)(1995-3#1)(2006-10#1)(2006-11#2)(2007-1#1)(2007-10#4)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-12#2)(2008-4#1)(2008-6#1)(2009-12#1)(2012-1#1)(2012-12#1)(2013-8#1)
the status of these##5##4##(1994-1#1)(1995-3#1)(2007-3#1)(2007-8#1)(2008-11#1)
the status of women##2##4##(2006-12#1)(2007-7#1)
the status of##101##3##(1990-3#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-1#1)(1994-10#1)(1994-12#2)(1994-2#2)(1995-1#1)(1995-3#2)(1995-4#1)(1996-1#1)(1997-3#1)(1997-7#1)(2005-11#1)(2005-6#1)(2006-10#2)(2006-11#2)(2006-12#2)(2006-2#1)(2006-4#1)(2006-7#1)(2007-1#1)(2007-10#4)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#3)(2008-2#2)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-7#1)(2010-12#4)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#6)
the status quo##3##3##(2008-7#1)(2009-6#1)(2010-12#1)
the status##112##2##(1990-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-1#1)(1994-10#1)(1994-12#2)(1994-2#2)(1995-1#1)(1995-3#2)(1995-4#1)(1996-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(2005-11#1)(2005-6#1)(2006-10#2)(2006-11#2)(2006-12#2)(2006-2#2)(2006-4#1)(2006-7#1)(2007-1#1)(2007-10#4)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#3)(2008-2#2)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-12#5)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-9#1)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#6)
the statute and##2##3##(1993-1#1)(1994-2#1)
the statute of limitations##3##4##(1996-5#1)(1996-6#2)
the statute of##4##3##(1996-5#2)(1996-6#2)
the statute was##2##3##(1990-12#1)(2006-8#1)
the statute##16##2##(1990-12#2)(1993-1#3)(1993-2#1)(1994-2#1)(1996-5#3)(1996-6#2)(1997-1#2)(2006-7#1)(2006-8#1)
the statute's##2##2##(1990-12#1)(1992-6#1)
the statutory framework in New York State for the issuance of DNR orders##2##13##(1992-12#1)(1992-3#1)
the statutory##9##2##(1992-12#3)(1992-3#1)(1992-5#1)(1995-1#1)(1997-7#1)(2007-10#1)(2008-10#1)
the stay##5##2##(1990-5#1)(1992-12#4)
the stayers##2##2##(2008-7#2)
the steady growth##2##3##(2007-11#1)(2012-1#1)
the steady increase of##2##4##(2006-12#1)(2006-9#1)
the steady state fluorescence##2##4##(1994-8#1)(2008-10#1)
the steady state level of##3##5##(1994-12#2)(1996-5#1)
the steady state levels of the##2##6##(1991-12#1)(1994-8#1)
the steady state levels of##5##5##(1990-3#1)(1991-12#1)(1994-3#1)(1994-8#1)(1997-2#1)
the steady state##35##3##(1990-3#1)(1990-5#1)(1991-12#1)(1991-7#2)(1992-9#1)(1994-12#2)(1994-3#5)(1994-8#2)(1996-11#2)(1996-5#1)(1997-2#1)(1997-6#1)(2007-10#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#4)(2010-6#1)(2012-12#1)
the steady##42##2##(1990-3#1)(1990-5#1)(1991-12#1)(1991-7#2)(1992-9#1)(1994-12#2)(1994-3#6)(1994-8#2)(1996-11#2)(1996-5#1)(1997-2#1)(1997-6#1)(2005-11#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#4)(2010-6#1)(2012-1#1)(2012-12#1)
the steady-state and time-resolved emission##2##5##(1996-11#1)(2006-10#1)
the steady-state and##3##3##(1994-8#1)(1996-11#1)(2006-10#1)
the steady-state concentration of##3##4##(1990-8#2)(2008-6#1)
the steady-state concentration##4##3##(1990-8#2)(2008-10#1)(2008-6#1)
the steady-state fluorescence##2##3##(1991-9#1)(2009-2#1)
the steady-state inactivation curve##3##4##(1992-9#1)(1996-10#1)(1997-5#1)
the steady-state kinetics##2##3##(1990-8#1)(1995-2#1)
the steady-state level of the mRNAs##2##6##(1991-2#2)
the steady-state level of the##3##5##(1991-2#2)(1992-1#1)
the steady-state level of##11##4##(1991-2#3)(1992-1#1)(1992-9#1)(1993-6#1)(1994-12#1)(1996-10#1)(1996-5#1)(1997-1#1)(2008-10#1)
the steady-state levels of LPH##2##5##(1992-11#2)
the steady-state levels of its##2##5##(1992-11#1)(1992-5#1)
the steady-state levels of##13##4##(1991-5#1)(1992-11#3)(1992-5#1)(1993-9#1)(1994-5#1)(1994-6#2)(1995-3#1)(1997-7#1)(2005-8#1)(2008-8#1)
the steady-state rate##2##3##(1994-3#1)(1997-6#1)
the steady-state response##2##3##(2007-9#2)
the steady-state stability##2##3##(2007-12#2)
the steady-state##76##2##(1990-3#1)(1990-5#2)(1990-8#3)(1991-1#1)(1991-2#3)(1991-5#2)(1991-7#1)(1991-9#1)(1992-1#2)(1992-11#3)(1992-12#1)(1992-5#1)(1992-8#1)(1992-9#3)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#2)(1996-11#1)(1996-3#1)(1996-5#1)(1997-1#3)(1997-5#1)(1997-6#3)(1997-7#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#4)(2007-9#2)(2008-10#4)(2008-2#2)(2008-3#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2012-12#1)
the steam##2##2##(1993-2#1)(2008-5#1)
the steel##5##2##(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#1)
the steep slopes##2##3##(2008-10#1)(2008-12#1)
the steep##9##2##(1995-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-8#1)(2009-12#1)(2010-12#1)
the steepest##2##2##(2007-8#1)(2008-3#1)
the steering committee##3##3##(1995-12#1)(1997-3#1)(2007-10#1)
the steering##5##2##(1995-12#1)(1997-3#1)(2006-11#2)(2007-10#1)
the stellar##2##2##(2008-3#1)(2009-10#1)
the stellate ganglia##2##3##(1995-5#2)
the stellate##4##2##(1995-5#2)(2008-11#1)(2009-2#1)
the stem and##2##3##(1994-5#1)(2008-10#1)
the stem bark of##6##4##(2007-1#1)(2007-11#1)(2008-8#1)(2010-12#2)(2011-2#1)
the stem bark##7##3##(2007-1#1)(2007-11#1)(2008-8#1)(2010-12#2)(2010-2#1)(2011-2#1)
the stem cell compartment##2##4##(2008-10#1)(2008-7#1)
the stem cell niche##7##4##(2007-10#1)(2007-12#1)(2009-3#1)(2009-8#1)(2012-12#1)(2012-2#2)
the stem cell population##4##4##(2008-11#2)(2008-4#1)(2010-7#1)
the stem cell proteome##3##4##(2008-1#3)
the stem cell##26##3##(1992-12#1)(1994-11#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#1)(2008-11#4)(2008-4#1)(2008-7#1)(2009-10#1)(2009-3#2)(2009-4#2)(2009-8#1)(2010-7#1)(2012-12#1)(2012-2#2)
the stem cells##5##3##(1993-12#1)(2006-8#1)(2008-11#1)(2012-12#1)(2012-2#1)
the stem of##3##3##(2008-10#1)(2008-9#1)(2009-6#1)
the stem regions##2##3##(1990-7#1)(1995-1#1)
the stem to##3##3##(2008-10#3)
the stem were##2##3##(2007-11#1)(2008-10#1)
the stem##85##2##(1990-4#1)(1990-7#1)(1992-12#1)(1992-3#2)(1993-12#1)(1994-11#1)(1994-5#1)(1995-1#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#24)(2008-11#7)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#2)(2009-4#4)(2009-6#3)(2009-8#1)(2010-12#2)(2010-2#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#3)(2013-1#1)(2013-7#1)
the stem-bark##2##2##(2006-12#1)(2008-10#1)
the stem-loop##3##2##(1991-2#1)(1996-7#2)
the stems were##2##3##(1991-8#1)(2008-3#1)
the stems##8##2##(1991-8#1)(2005-4#1)(2007-1#1)(2008-10#3)(2008-11#1)(2008-3#1)
the stenosis and the##3##4##(1992-1#1)(2008-4#1)(2008-8#1)
the stenosis in##2##3##(1991-3#1)(2007-8#1)
the stenosis of the##2##4##(1990-3#1)(1995-3#1)
the stenosis was##3##3##(2009-9#1)(2013-1#2)
the stenosis##22##2##(1990-3#3)(1991-3#1)(1992-1#1)(1995-3#1)(2007-10#3)(2007-11#1)(2007-5#2)(2007-8#2)(2007-9#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-9#1)(2013-1#2)
the stenotic##6##2##(2006-7#1)(2007-11#1)(2008-3#1)(2008-5#2)(2012-2#1)
the stent caused##2##3##(2008-1#1)(2010-12#1)
the stent in##2##3##(1990-8#1)(2007-8#1)
the stent##18##2##(1990-8#1)(1992-3#1)(1994-11#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#5)(2009-10#1)(2010-12#3)(2013-1#1)
the stenting##2##2##(2007-8#1)(2009-5#1)
the stents##3##2##(2007-8#1)(2008-7#1)(2013-1#1)
the step cycle##2##3##(1997-2#1)(2007-12#1)
the step height of incremental flux##2##6##(2011-2#2)
the step height##3##3##(2008-3#1)(2011-2#2)
the step involving##2##3##(1991-5#1)(1991-9#1)
the step size##4##3##(1995-3#1)(1996-4#1)(2008-3#1)(2011-2#1)
the step##20##2##(1990-11#1)(1991-5#1)(1991-9#1)(1995-10#1)(1995-3#1)(1996-3#1)(1996-4#1)(1997-2#1)(2007-12#2)(2008-10#1)(2008-3#4)(2011-2#4)(2012-1#1)
the step-by-step##3##2##(2005-2#1)(2006-2#1)(2010-12#1)
the step-index##3##2##(2008-1#1)(2008-3#2)
the stepping##3##2##(1993-12#1)(1995-5#1)(2013-1#1)
the steps and the##2##4##(2008-7#1)(2010-1#1)
the steps and##3##3##(2008-7#1)(2010-1#1)(2011-2#1)
the steps for##4##3##(2008-2#1)(2008-4#1)(2012-12#1)(2012-3#1)
the steps in the##4##4##(1992-8#1)(1996-1#1)(2008-1#1)(2008-10#1)
the steps in##6##3##(1992-1#1)(1992-8#1)(1996-1#1)(2007-4#1)(2008-1#1)(2008-10#1)
the steps involved in##7##4##(1992-3#1)(1994-2#1)(2008-10#1)(2008-2#1)(2008-4#2)(2009-8#1)
the steps involved##8##3##(1992-3#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2009-8#1)
the steps leading to##2##4##(2007-1#1)(2012-12#1)
the steps leading##3##3##(2007-1#1)(2010-2#1)(2012-12#1)
the steps of the##6##4##(1995-9#1)(2005-11#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-9#1)
the steps of##10##3##(1995-9#1)(2005-11#2)(2006-5#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-9#1)
the steps required##2##3##(2007-4#1)(2008-11#1)
the steps taken by the##2##5##(2008-9#1)(2011-2#1)
the steps taken to develop##3##5##(1993-1#1)(2007-9#1)(2010-11#1)
the steps taken to##4##4##(1993-1#1)(2007-9#1)(2010-11#1)(2012-12#1)
the steps taken##7##3##(1993-1#1)(2007-2#1)(2007-9#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-12#1)
the steps to##3##3##(2007-7#1)(2011-2#1)(2012-12#1)
the steps##62##2##(1992-1#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-2#1)(1994-2#1)(1995-3#1)(1995-9#1)(1996-1#1)(1997-1#1)(2005-11#2)(2005-8#1)(2006-5#1)(2007-1#1)(2007-2#3)(2007-4#3)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#6)(2008-7#1)(2008-9#2)(2009-11#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-2#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#5)(2012-3#1)(2013-1#3)
the stepwise##11##2##(1992-12#1)(1995-6#1)(1996-7#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-5#1)
the stereo##3##2##(1991-1#1)(2008-2#2)
the stereochemical configuration of##2##4##(1994-8#2)
the stereochemical outcome of##2##4##(2008-7#1)(2010-7#1)
the stereochemical outcome##3##3##(1995-5#1)(2008-7#1)(2010-7#1)
the stereochemical structure##2##3##(1990-7#1)(2008-10#1)
the stereochemical##12##2##(1990-7#2)(1991-2#1)(1991-5#1)(1992-7#1)(1992-8#1)(1994-8#2)(1995-5#1)(2008-10#1)(2008-7#1)(2010-7#1)
the stereochemistry of the##4##4##(1990-10#1)(1990-8#1)(1995-5#1)(2007-1#1)
the stereochemistry of##6##3##(1990-10#1)(1990-8#1)(1995-5#1)(1996-5#1)(2007-1#1)(2011-2#1)
the stereochemistry##7##2##(1990-10#1)(1990-8#1)(1992-6#1)(1995-5#1)(1996-5#1)(2007-1#1)(2011-2#1)
the stereocilia of##2##3##(1993-9#2)
the stereoisomeric##5##2##(1990-6#2)(1995-1#1)(1996-7#1)(2008-5#1)
the stereoisomers##5##2##(1990-6#1)(1995-3#1)(1995-7#1)(2010-2#2)
the stereological##3##2##(1996-10#1)(1996-12#1)(2007-12#1)
the stereoselective disposition of##2##4##(1993-2#2)
the stereoselective##9##2##(1990-6#1)(1992-7#1)(1993-2#2)(1996-5#1)(1996-9#1)(2006-12#1)(2007-11#1)(2009-12#1)
the stereoselectivity of L-glutamate receptors##2##5##(1993-2#2)
the stereoselectivity of##5##3##(1993-2#2)(1995-5#1)(2006-12#1)(2008-10#1)
the stereoselectivity##6##2##(1993-2#2)(1995-5#1)(1996-5#1)(2006-12#1)(2008-10#1)
the stereospecific##5##2##(1994-5#1)(1996-7#1)(1996-9#1)(2006-9#1)(2008-10#1)
the stereospecificity in lipase##2##4##(1990-4#2)
the stereospecificity of##2##3##(1990-5#1)(1996-7#1)
the stereospecificity##6##2##(1990-4#2)(1990-5#1)(1993-6#2)(1996-7#1)
the stereotype##4##2##(1994-8#1)(2009-9#1)(2010-12#1)(2011-2#1)
the steric environment##2##3##(1991-5#1)(2010-7#1)
the steric hindrance of##2##4##(2008-10#1)(2013-7#1)
the steric hindrance##5##3##(2004-9#1)(2008-10#1)(2012-2#2)(2013-7#1)
the steric repulsion##3##3##(1997-1#2)(1997-7#1)
the steric##20##2##(1991-4#1)(1991-5#1)(1992-11#1)(1994-8#1)(1996-2#1)(1996-5#1)(1997-1#2)(1997-7#1)(2004-9#1)(2008-10#3)(2008-8#1)(2010-5#1)(2010-7#1)(2012-2#2)(2013-1#1)(2013-7#1)
the sterically encumbered##2##3##(2010-5#2)
the sterically##5##2##(2008-11#1)(2008-5#1)(2010-5#3)
the sterile production##2##3##(2012-2#2)
the sterile##10##2##(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2012-12#1)(2012-2#2)(2013-8#1)
the sterilisation##2##2##(2005-9#2)
the sterilization of##2##3##(2008-3#1)(2012-2#1)
the sterilization##3##2##(1996-8#1)(2008-3#1)(2012-2#1)
the sternal##4##2##(2006-11#1)(2007-12#1)(2007-8#2)
the sternoclavicular joint##7##3##(2007-1#1)(2007-4#1)(2007-8#2)(2009-3#3)
the sternocleidomastoid muscle##2##3##(2007-1#1)(2007-11#1)
the sternocleidomastoid##6##2##(2006-12#1)(2007-1#3)(2007-11#1)(2010-9#1)
the sternum and##3##3##(2007-1#1)(2007-8#2)
the sternum was##2##3##(2007-8#2)
the sternum##19##2##(2006-11#2)(2007-1#1)(2007-11#1)(2007-4#1)(2007-8#11)(2008-4#1)(2012-2#2)
the steroid and##3##3##(1993-11#1)(1995-8#1)(2010-2#1)
the steroid binding domain of##2##5##(1991-12#1)(1992-12#1)
the steroid binding domain##3##4##(1991-12#2)(1992-12#1)
the steroid binding##6##3##(1990-12#1)(1991-12#2)(1992-12#1)(1996-5#1)(2006-10#1)
the steroid hormone receptor##4##4##(1992-2#1)(1995-2#1)(1995-6#1)(2008-4#1)
the steroid hormone##7##3##(1991-4#1)(1992-2#1)(1994-5#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-4#1)
the steroid nucleus##3##3##(1994-8#1)(1996-5#1)(2006-12#1)
the steroid receptor##3##3##(1993-9#1)(1996-5#1)(2010-3#1)
the steroid regulation of##2##4##(1991-5#1)(1994-5#1)
the steroid to##2##3##(1990-11#1)(1993-11#1)
the steroid##52##2##(1990-11#3)(1990-12#1)(1991-12#2)(1991-4#1)(1991-5#3)(1992-12#1)(1992-2#1)(1992-8#1)(1993-11#2)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#4)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-4#1)(1996-5#3)(1997-1#2)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#1)(2008-10#2)(2008-11#3)(2008-4#2)(2010-2#1)(2010-3#1)(2012-2#1)
the steroidal##3##2##(2007-1#2)(2008-10#1)
the steroidogenic acute regulatory protein##2##5##(2006-9#2)
the steroidogenic acute regulatory##3##4##(1995-12#1)(2006-9#2)
the steroidogenic enzymes##2##3##(1990-11#1)(2010-10#1)
the steroidogenic##11##2##(1990-10#2)(1990-11#1)(1995-11#1)(1995-12#1)(1995-3#3)(2006-9#2)(2010-10#1)
the steroids tested##3##3##(1990-11#1)(1994-9#1)(1996-2#1)
the steroids##6##2##(1990-11#1)(1993-11#1)(1994-9#1)(1996-2#1)(2006-8#1)(2011-1#1)
the sterol##12##2##(1990-11#1)(1991-10#1)(1992-3#1)(1996-5#1)(1997-7#2)(2006-12#2)(2008-10#3)(2008-12#1)
the stethoscope##2##2##(1996-12#1)(2010-8#1)
the stevia##2##2##(2008-10#1)(2013-1#1)
the stick insect##3##3##(2007-12#3)
the stick##7##2##(2007-12#3)(2008-5#2)(2009-2#2)
the stiffening##2##2##(2007-1#1)(2012-2#1)
the stiffness and##4##3##(2006-6#1)(2008-11#1)(2008-5#1)(2009-7#1)
the stiffness of the knee##2##5##(2007-1#2)
the stiffness of the##5##4##(2006-11#1)(2007-1#2)(2008-2#1)(2012-1#1)
the stiffness of##10##3##(2006-11#1)(2007-1#2)(2008-2#1)(2008-8#1)(2009-4#1)(2010-4#1)(2012-1#2)(2013-7#1)
the stiffness##23##2##(1996-5#1)(2006-11#1)(2006-6#1)(2007-1#3)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-7#2)(2010-4#1)(2012-1#2)(2012-2#1)(2013-1#4)(2013-7#1)
the stigma and style##3##4##(2008-10#1)(2009-12#2)
the stigma and##6##3##(2006-9#1)(2008-10#2)(2009-12#2)(2010-8#1)
the stigma of##4##3##(1992-8#1)(2007-12#1)(2008-1#1)(2008-6#1)
the stigma##18##2##(1992-8#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-6#1)(2009-12#4)(2010-8#1)(2011-7#1)(2012-12#1)(2012-2#1)(2013-7#1)
the stigmas##2##2##(2008-10#2)
the stigmata of##2##3##(2008-3#1)(2010-6#1)
the stigmata##3##2##(2008-3#1)(2009-2#1)(2010-6#1)
the stilbene##3##2##(1992-12#1)(1997-1#1)(2008-10#1)
the still##5##2##(1990-4#1)(1996-11#1)(2007-12#1)(2009-7#1)(2010-12#1)
the stillage##2##2##(2008-6#1)(2011-2#1)
the stimulant##5##2##(1992-3#1)(1993-3#3)(2008-7#1)
the stimulated Brillouin##2##3##(2007-12#2)
the stimulated Raman##4##3##(2006-12#1)(2007-11#2)(2007-12#1)
the stimulated [Na+]i increase##3##4##(1997-6#3)
the stimulated cells##2##3##(1994-3#1)(1997-4#1)
the stimulated emission##2##3##(2008-10#1)(2008-2#1)
the stimulated##30##2##(1990-5#1)(1990-7#1)(1991-8#1)(1992-9#1)(1993-11#1)(1994-3#1)(1994-9#1)(1995-3#1)(1995-8#3)(1996-1#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#3)(2006-1#1)(2006-12#1)(2006-3#1)(2006-4#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#1)(2008-5#1)
the stimulated-emission##4##2##(1992-9#1)(2007-11#2)(2008-3#1)
the stimulating effect of##2##4##(1994-8#1)(1996-10#1)
the stimulating effect##4##3##(1994-8#1)(1996-10#1)(2008-11#1)(2012-3#1)
the stimulating##10##2##(1990-4#1)(1990-7#1)(1992-12#1)(1994-8#1)(1996-10#1)(2008-10#1)(2008-11#1)(2008-9#2)(2012-3#1)
the stimulation by##7##3##(1991-9#1)(1992-11#1)(1994-6#1)(1995-8#2)(1997-6#1)(2008-4#1)
the stimulation of Ca2+##2##4##(1995-3#1)(1996-2#1)
the stimulation of DNA synthesis##2##5##(1991-10#1)(1997-1#1)
the stimulation of DNA##3##4##(1991-10#1)(1994-2#1)(1997-1#1)
the stimulation of both##2##4##(1993-11#1)(1997-1#1)
the stimulation of cardio-pulmonary vagal afferent C fiber endings##3##9##(1993-7#3)
the stimulation of different##2##4##(2013-1#2)
the stimulation of gene##3##4##(1991-6#1)(1994-11#1)(1997-6#1)
the stimulation of glucose utilization##2##5##(1994-8#2)
the stimulation of human##2##4##(1992-3#1)(1994-11#1)
the stimulation of the##9##4##(1990-2#1)(1992-6#1)(1992-9#1)(1993-7#1)(1996-12#1)(1996-5#2)(1997-2#1)(2012-12#1)
the stimulation of these##3##4##(1993-7#1)(1994-12#1)(1996-7#1)
the stimulation of which##2##4##(1990-2#1)(1994-6#1)
the stimulation of##90##3##(1990-12#2)(1990-2#3)(1990-5#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#4)(1993-12#1)(1993-3#2)(1993-7#5)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#3)(1994-8#2)(1995-12#4)(1995-2#1)(1995-3#3)(1995-6#2)(1996-12#1)(1996-2#1)(1996-5#2)(1996-7#1)(1997-1#3)(1997-2#2)(1997-5#2)(1997-6#3)(1997-8#1)(2005-10#1)(2005-7#1)(2006-3#1)(2008-11#5)(2008-7#1)(2008-9#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-12#1)(2013-1#2)
the stimulation site##3##3##(1996-5#2)(2008-9#1)
the stimulation##134##2##(1990-12#2)(1990-2#3)(1990-5#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-6#2)(1992-7#1)(1992-9#1)(1993-11#4)(1993-12#1)(1993-3#4)(1993-7#5)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#5)(1994-3#1)(1994-6#4)(1994-8#2)(1994-9#1)(1995-12#4)(1995-2#1)(1995-3#3)(1995-6#2)(1995-8#2)(1996-12#2)(1996-2#2)(1996-5#4)(1996-7#1)(1997-1#3)(1997-2#2)(1997-5#2)(1997-6#4)(1997-8#1)(2005-10#1)(2005-7#1)(2006-3#1)(2006-9#1)(2008-10#1)(2008-11#6)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#5)(2009-8#3)(2010-1#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#2)
the stimulation-paired environment##2##3##(1992-9#2)
the stimulator##3##2##(2008-5#1)(2010-7#1)(2012-3#1)
the stimulatory action of L-histidine on protein synthesis##2##8##(2008-11#2)
the stimulatory action of##4##4##(1992-5#1)(1994-9#1)(2008-11#2)
the stimulatory actions of L-leucine and KIC##3##7##(2008-11#3)
the stimulatory and inhibitory##2##4##(1991-5#1)(1994-3#1)
the stimulatory effect of captopril##2##5##(1991-5#2)
the stimulatory effect of##15##4##(1990-11#1)(1990-2#1)(1990-9#1)(1991-3#1)(1991-5#2)(1993-3#2)(1994-5#1)(1994-6#1)(1997-6#1)(1997-8#1)(2010-10#1)(2011-2#1)(2013-1#1)
the stimulatory effect##21##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-3#1)(1991-5#2)(1992-3#1)(1993-3#2)(1994-5#1)(1994-6#1)(1997-6#1)(1997-8#2)(2008-11#1)(2010-10#1)(2011-2#1)(2013-1#1)(2013-8#2)
the stimulatory effects of estrogen on##2##6##(1991-5#1)(2008-6#1)
the stimulatory effects of##5##4##(1991-5#1)(1991-9#1)(1995-5#1)(2007-11#1)(2008-6#1)
the stimulatory potency of##2##4##(1992-6#1)(1994-8#1)
the stimulatory role of##2##4##(2006-10#1)(2013-1#1)
the stimulatory##48##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-9#1)(1991-3#1)(1991-5#4)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-3#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-5#1)(1997-2#1)(1997-6#1)(1997-8#2)(2006-10#1)(2007-11#1)(2008-11#6)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#1)(2013-1#2)(2013-8#2)
the stimuli and##3##3##(2008-7#1)(2008-9#1)(2009-10#1)
the stimuli at##2##3##(1992-11#2)
the stimuli for##2##3##(2007-3#1)(2008-5#1)
the stimuli that##2##3##(1992-6#1)(2007-1#1)
the stimuli were presented##3##4##(1992-11#1)(1993-2#1)(2008-5#1)
the stimuli were##6##3##(1992-11#1)(1993-2#1)(1993-3#1)(1995-11#1)(2008-5#1)(2008-9#1)
the stimuli##36##2##(1991-11#1)(1992-11#4)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1997-2#1)(2007-1#1)(2007-3#1)(2007-5#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-6#1)(2009-8#1)(2011-2#2)(2012-12#1)(2013-8#1)
the stimulus intensity##3##3##(2008-4#1)(2008-7#2)
the stimulus is##2##3##(1991-9#1)(2008-11#1)
the stimulus object##2##3##(1994-6#2)
the stimulus to##2##3##(2008-4#1)(2010-5#1)
the stimulus was##3##3##(1990-5#1)(1997-1#1)(2008-5#1)
the stimulus##63##2##(1990-5#2)(1991-1#2)(1991-2#1)(1991-3#3)(1991-9#2)(1992-4#2)(1992-6#1)(1993-12#1)(1993-7#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-5#1)(1997-8#3)(2005-10#1)(2006-7#2)(2006-9#1)(2007-12#1)(2007-8#1)(2007-9#5)(2008-1#1)(2008-11#3)(2008-4#3)(2008-5#2)(2008-7#4)(2008-8#2)(2009-9#1)(2010-4#1)(2010-5#2)(2010-8#1)(2013-1#1)(2013-8#1)
the stimulus-evoked##2##2##(1995-7#1)(2007-9#1)
the sting base##2##3##(2007-12#2)
the stipe##2##2##(1995-2#1)(2008-5#1)
the stipule##2##2##(2008-5#2)
the stir bar##3##3##(2008-10#3)
the stirred tank##3##3##(2008-10#1)(2008-11#2)
the stirred##5##2##(2008-10#2)(2008-11#3)
the stirring##4##2##(2005-11#1)(2008-10#1)(2008-11#1)(2010-2#1)
the stochastic GMM sampler##2##4##(2012-3#2)
the stochastic circulatory models##3##4##(2007-9#3)
the stochastic nature of##3##4##(1997-5#1)(2008-8#1)(2008-9#1)
the stochastic##29##2##(1991-6#1)(1992-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-5#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-9#4)(2008-10#1)(2008-2#5)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-1#1)(2012-2#1)(2012-3#2)
the stock##7##2##(1991-1#1)(2007-5#2)(2008-5#1)(2010-3#2)(2010-8#1)
the stoichiometric composition of the chelate is 1##2##8##(2008-10#2)
the stoichiometric equation##2##3##(2006-8#1)(2008-7#1)
the stoichiometric##25##2##(1990-7#1)(1991-1#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-9#1)(1996-2#1)(1997-2#1)(1997-6#1)(2005-11#1)(2006-3#1)(2006-8#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-7#3)
the stoichiometry and##4##3##(1991-11#1)(2008-10#1)(2010-5#1)(2012-2#1)
the stoichiometry between the##2##4##(1996-11#1)(1996-2#1)
the stoichiometry is##2##3##(1992-2#1)(1994-11#1)
the stoichiometry of binding##2##4##(1991-5#1)(1995-3#1)
the stoichiometry of the complex##2##5##(2006-10#1)(2008-10#1)
the stoichiometry of the##10##4##(1990-2#1)(1991-1#1)(1993-8#1)(1995-3#1)(2006-10#1)(2008-10#4)(2008-7#1)
the stoichiometry of##20##3##(1990-2#1)(1991-1#1)(1991-5#2)(1993-8#1)(1994-8#1)(1995-11#1)(1995-3#2)(1995-6#1)(1995-8#1)(2006-10#1)(2007-12#1)(2008-10#5)(2008-4#1)(2008-7#1)
the stoichiometry##34##2##(1990-2#1)(1991-1#1)(1991-11#1)(1991-5#3)(1992-2#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-11#2)(1995-3#3)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-10#7)(2008-4#1)(2008-7#1)(2010-5#1)(2012-2#1)
the stolbur phytoplasma##3##3##(2008-10#3)
the stoma##5##2##(2006-5#4)(2007-8#1)
the stomach and duodenum##6##4##(2006-10#5)(2011-2#1)
the stomach and pancreas##2##4##(1992-2#1)(2008-7#1)
the stomach and##22##3##(1991-4#1)(1991-9#1)(1992-2#1)(1994-2#1)(1996-11#1)(1996-3#1)(1997-1#1)(2006-10#5)(2006-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2011-2#3)
the stomach are##2##3##(2008-4#1)(2012-2#1)
the stomach content##2##3##(2007-3#1)(2008-5#1)
the stomach contents##5##3##(1992-12#1)(2007-3#3)(2011-2#1)
the stomach for##4##3##(2006-10#1)(2011-1#1)(2012-2#2)
the stomach in the##3##4##(1994-4#1)(2006-10#1)(2008-7#1)
the stomach in##11##3##(1990-8#1)(1991-6#1)(1993-10#1)(1993-9#1)(1994-4#1)(1997-1#1)(2006-10#2)(2008-4#1)(2008-7#1)(2009-2#1)
the stomach is##3##3##(1993-2#1)(1994-4#1)(2012-2#1)
the stomach mucosa##2##3##(1992-9#2)
the stomach of##4##3##(1993-4#1)(1997-1#1)(2010-8#1)(2011-2#1)
the stomach the##2##3##(2006-2#1)(2013-1#1)
the stomach was##2##3##(2008-5#1)(2011-12#1)
the stomach##182##2##(1990-11#1)(1990-3#1)(1990-8#2)(1990-9#1)(1991-2#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#3)(1992-10#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-5#3)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#4)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#3)(1993-6#1)(1993-7#1)(1993-9#2)(1994-2#1)(1994-3#1)(1994-4#2)(1995-11#1)(1995-12#1)(1996-11#2)(1996-2#1)(1996-3#1)(1997-1#5)(2005-12#1)(2005-3#1)(2005-8#2)(2006-1#1)(2006-10#19)(2006-2#3)(2006-4#1)(2007-2#2)(2007-3#5)(2007-5#2)(2007-8#4)(2008-1#1)(2008-11#1)(2008-12#3)(2008-4#3)(2008-5#9)(2008-6#2)(2008-7#14)(2008-8#3)(2008-9#2)(2009-2#2)(2009-3#3)(2009-5#1)(2009-8#2)(2010-1#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-12#3)(2011-2#7)(2012-1#3)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
the stomach]##7##2##(1990-11#1)(1990-6#1)(1991-11#1)(1992-3#2)(2009-2#1)(2012-11#1)
the stomachs of##2##3##(2008-5#1)(2010-8#1)
the stomata##5##2##(1993-6#1)(2007-12#1)(2008-10#2)(2013-8#1)
the stomatal conductance##2##3##(2013-8#2)
the stomatal##3##2##(2009-8#1)(2013-8#2)
the stomatopod##2##2##(2007-12#2)
the stone loach##3##3##(1997-2#3)
the stone##17##2##(1992-5#1)(1993-10#2)(1994-5#1)(1994-6#1)(1997-2#3)(1997-4#3)(2007-3#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-7#1)
the stones were##2##3##(1991-3#1)(2013-7#1)
the stones##5##2##(1991-3#1)(2006-9#1)(2009-6#1)(2011-2#1)(2013-7#1)
the stool##8##2##(1992-2#1)(1996-1#1)(2006-6#1)(2008-6#1)(2010-4#1)(2010-9#1)(2011-2#1)(2013-8#1)
the stools##7##2##(1991-6#1)(1993-10#1)(1995-1#1)(2008-8#1)(2009-1#1)(2010-12#1)(2011-1#1)
the stop band and##2##4##(2007-12#1)(2008-2#1)
the stop band of##2##4##(2007-12#2)
the stop band##5##3##(2007-12#3)(2008-2#2)
the stop codon of##3##4##(1994-12#1)(1997-6#1)(1997-7#1)
the stop codon##15##3##(1990-5#1)(1991-12#1)(1993-11#1)(1994-12#2)(1996-7#3)(1996-8#1)(1997-4#2)(1997-6#1)(1997-7#1)(2008-9#1)(2009-5#1)
the stop signal##3##3##(1994-12#3)
the stop##28##2##(1990-5#1)(1991-12#1)(1993-11#1)(1994-12#5)(1996-7#4)(1996-8#1)(1997-4#2)(1997-6#1)(1997-7#1)(2007-12#4)(2008-2#4)(2008-3#1)(2008-9#1)(2009-5#1)
the stopped flow##2##3##(1991-7#1)(2008-10#1)
the stopped-flow and##2##3##(2008-10#2)
the stopped-flow mixing technique was used##2##6##(2008-10#2)
the stopped-flow mixing technique##5##4##(2008-10#5)
the stopped-flow##10##2##(1995-3#1)(2008-10#9)
the storage and##3##3##(2006-8#1)(2008-10#1)(2008-7#1)
the storage capacity and##2##4##(2007-12#1)(2008-3#1)
the storage capacity of##2##4##(2007-12#1)(2008-3#1)
the storage capacity##4##3##(2007-12#2)(2008-3#2)
the storage density##2##3##(2007-12#1)(2008-1#1)
the storage for##2##3##(1993-12#1)(2013-7#1)
the storage modulus##2##3##(2007-1#1)(2009-7#1)
the storage of##13##3##(1995-11#1)(2004-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-2#1)(2010-12#1)(2010-4#1)(2013-8#1)
the storage period##3##3##(1997-8#1)(2008-11#1)(2012-2#1)
the storage ring##4##3##(2006-5#4)
the storage stability of the##2##5##(2008-10#1)(2008-5#1)
the storage temperature##3##3##(2006-5#1)(2008-10#1)(2012-2#1)
the storage time of##2##4##(2007-12#1)(2008-3#1)
the storage time##5##3##(2007-12#1)(2007-3#1)(2008-10#1)(2008-3#1)(2010-4#1)
the storage##73##2##(1990-4#1)(1991-8#1)(1993-12#1)(1995-11#1)(1995-12#1)(1997-7#1)(1997-8#1)(2004-12#1)(2006-5#6)(2006-8#1)(2007-1#1)(2007-12#5)(2007-3#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#3)(2008-7#3)(2009-2#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#2)(2012-1#1)(2012-2#6)(2013-1#1)(2013-7#1)(2013-8#1)
the store-operated Ca2+ influx##2##4##(1996-9#2)
the store-operated Ca2+##3##3##(1996-12#1)(1996-9#2)
the stored information##2##3##(1993-5#1)(2008-3#1)
the stored##13##2##(1990-11#1)(1993-5#1)(1994-8#1)(1995-8#1)(2006-5#2)(2008-1#1)(2008-2#2)(2008-3#2)(2008-7#1)(2011-2#1)
the stories of##3##3##(2008-9#1)(2010-12#1)(2011-1#1)
the stories##6##2##(2006-9#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-12#1)(2011-1#1)
the storm##6##2##(1993-3#1)(1995-10#1)(2007-3#1)(2008-11#1)(2011-2#2)
the story of a##2##4##(2007-2#1)(2008-11#1)
the story of how##2##4##(2007-2#1)(2011-2#1)
the story of##14##3##(1991-4#1)(2005-11#1)(2005-8#1)(2007-2#2)(2008-1#1)(2008-11#1)(2008-3#1)(2010-12#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-8#1)
the story so far##2##4##(1991-8#1)(2008-7#1)
the story##22##2##(1991-4#1)(1991-8#1)(1993-12#1)(1997-3#1)(2005-11#1)(2005-8#1)(2007-2#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)(2010-12#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-8#2)
the straight line##5##3##(2008-10#4)(2008-3#1)
the straight portion and the lateral side of the bifurcation##2##10##(2007-9#2)
the straight portion##4##3##(1997-8#1)(2007-9#3)
the straight##18##2##(1991-8#1)(1996-5#1)(1996-6#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-9#3)(2008-10#5)(2008-3#1)(2008-7#1)(2008-8#1)(2009-6#1)
the strain T21##2##3##(2008-8#2)
the strain and##3##3##(2005-10#1)(2008-11#1)(2008-5#1)
the strain differences in##2##4##(1993-3#1)(2013-1#1)
the strain is##2##3##(1993-3#1)(2008-6#1)
the strain of##8##3##(2006-10#1)(2006-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#2)
the strain or the##2##4##(2008-3#1)(2008-5#1)
the strain rate##2##3##(1996-4#1)(2009-7#1)
the strain sensitivity of##2##4##(2008-2#1)(2008-3#1)
the strain sensitivity##3##3##(2008-2#1)(2008-3#1)(2013-8#1)
the strain was cultured##2##4##(2006-8#1)(2010-2#1)
the strain##73##2##(1990-7#1)(1991-9#1)(1993-11#1)(1993-3#2)(1996-12#1)(1996-4#1)(1996-9#1)(1997-5#1)(2005-10#1)(2005-11#2)(2006-10#2)(2006-12#1)(2006-4#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#1)(2008-8#4)(2009-7#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#4)
the strain-induced##2##2##(2008-3#2)
the strains and##4##3##(2008-10#2)(2008-5#1)(2010-4#1)
the strains could be##2##4##(2006-8#1)(2013-8#1)
the strains could##3##3##(2006-8#1)(2008-5#1)(2013-8#1)
the strains examined##2##3##(1997-4#1)(2008-10#1)
the strains from##4##3##(1992-2#1)(2008-10#2)(2008-7#1)
the strains in##3##3##(2008-10#2)(2008-5#1)
the strains into##2##3##(2008-10#2)
the strains isolated in##2##4##(2008-11#1)(2011-1#1)
the strains isolated##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)
the strains of##6##3##(2006-8#1)(2008-10#1)(2008-11#2)(2012-12#1)(2013-1#1)
the strains tested##3##3##(2006-8#2)(2007-12#1)
the strains that were##2##4##(2008-10#2)
the strains that##3##3##(2008-10#3)
the strains was##3##3##(1991-3#1)(2007-8#1)(2008-10#1)
the strains were resistant to##3##5##(2006-8#1)(2007-8#1)(2008-12#1)
the strains were##17##3##(1996-12#1)(2006-10#1)(2006-3#1)(2006-8#3)(2007-10#1)(2007-8#1)(2008-10#4)(2008-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
the strains with##2##3##(2006-10#1)(2006-8#1)
the strains##112##2##(1991-3#1)(1991-4#1)(1992-2#1)(1993-11#1)(1993-12#1)(1996-12#3)(1997-4#1)(1997-5#1)(1997-9#1)(2005-11#3)(2006-10#3)(2006-3#2)(2006-5#1)(2006-8#9)(2007-10#1)(2007-12#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-10#41)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#10)(2008-6#1)(2008-7#3)(2009-6#1)(2010-4#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#2)(2013-1#3)(2013-8#1)
the strains'##4##2##(2008-10#3)(2008-6#1)
the strand##7##2##(1993-12#1)(1994-9#1)(1995-8#1)(1997-4#1)(2006-10#1)(2008-10#1)(2009-11#1)
the strands##4##2##(1991-1#1)(1995-8#1)(1997-1#1)(2009-10#1)
the strapped##2##2##(2011-1#2)
the strata##2##2##(1997-7#1)(2008-5#1)
the strategic plan##5##3##(1992-3#3)(1994-2#1)(1997-1#1)
the strategic planning process of##2##5##(1994-2#1)(1996-1#1)
the strategic planning process##9##4##(1991-2#1)(1994-2#4)(1996-1#1)(1997-1#2)(2013-7#1)
the strategic planning##11##3##(1991-2#1)(1994-2#5)(1994-3#1)(1996-1#1)(1997-1#2)(2013-7#1)
the strategic##34##2##(1991-2#1)(1991-8#1)(1992-3#3)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#9)(1994-3#1)(1994-8#1)(1995-12#1)(1996-1#1)(1997-1#4)(2007-4#2)(2007-7#1)(2008-4#1)(2008-5#1)(2008-6#1)(2012-3#1)(2013-1#1)(2013-7#1)
the strategies adopted to##2##4##(2006-1#1)(2012-3#1)
the strategies and##4##3##(1995-3#1)(1996-1#1)(1997-7#1)(2008-11#1)
the strategies employed to##2##4##(2008-10#1)(2011-2#1)
the strategies employed##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
the strategies for##8##3##(1995-7#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#2)(2012-3#1)(2013-8#1)
the strategies of##5##3##(2004-12#1)(2007-2#1)(2007-8#1)(2010-8#1)(2011-3#1)
the strategies that##3##3##(2007-3#1)(2008-4#1)(2011-2#1)
the strategies used##4##3##(2008-5#1)(2010-11#1)(2010-9#1)(2011-1#1)
the strategies##46##2##(1991-12#1)(1992-1#1)(1994-2#2)(1994-3#1)(1995-3#1)(1995-7#1)(1996-1#1)(1997-7#1)(2004-12#1)(2005-6#1)(2005-8#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-3#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-12#2)(2009-5#2)(2010-11#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
the strategy and##2##3##(1996-1#1)(2008-2#1)
the strategy for the##3##4##(1990-12#1)(1992-8#1)(1995-4#1)
the strategy of##14##3##(1990-6#1)(1991-1#1)(1994-3#1)(1995-6#1)(1996-3#1)(2005-10#1)(2005-6#1)(2006-12#2)(2007-9#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)
the strategy to##4##3##(1994-4#1)(2006-12#1)(2006-5#1)(2009-3#1)
the strategy used for##2##4##(2007-7#1)(2008-9#1)
the strategy used##3##3##(1995-8#1)(2007-7#1)(2008-9#1)
the strategy##55##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-1#1)(1992-1#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-3#2)(1994-4#1)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-5#1)(2005-10#1)(2005-6#1)(2006-10#1)(2006-12#3)(2006-5#1)(2007-7#1)(2007-9#2)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-3#1)(2010-7#4)(2011-2#3)
the stratification of##3##3##(2011-2#1)(2013-8#2)
the stratification##4##2##(2007-7#1)(2011-2#1)(2013-8#2)
the stratified##5##2##(1995-8#1)(1996-8#1)(2010-7#1)(2012-11#1)(2012-3#1)
the stratigraphic record##2##3##(1997-5#2)
the stratigraphic##3##2##(1997-5#2)(2010-6#1)
the stratosphere##10##2##(1991-5#1)(1991-6#1)(1996-5#1)(2007-9#1)(2008-1#1)(2008-2#2)(2008-3#2)(2012-12#1)
the stratospheric aerosol##6##3##(2008-2#6)
the stratospheric##8##2##(1996-1#1)(2008-2#6)(2008-3#1)
the stratum corneum (SC)##5##4##(2008-10#1)(2008-5#4)
the stratum corneum and##3##4##(2008-5#3)
the stratum corneum intercellular lipid##2##5##(1991-9#1)(2008-5#1)
the stratum corneum intercellular##3##4##(1991-9#2)(2008-5#1)
the stratum corneum lipids##6##4##(2008-5#6)
the stratum corneum of human skin##2##6##(2008-10#1)(2008-5#1)
the stratum corneum of##4##4##(2008-10#1)(2008-5#3)
the stratum corneum was##3##4##(1992-8#2)(2008-5#1)
the stratum corneum water##2##4##(2008-5#2)
the stratum corneum were##2##4##(2008-5#1)(2012-2#1)
the stratum corneum with##2##4##(2008-5#2)
the stratum corneum##78##3##(1991-9#3)(1992-8#2)(1993-5#1)(2005-11#1)(2007-7#2)(2008-10#2)(2008-5#64)(2010-8#1)(2012-2#2)
the stratum pyramidale##2##3##(1997-5#1)(1997-7#1)
the stratum radiatum of##2##4##(1991-9#1)(1995-12#1)
the stratum radiatum##7##3##(1990-4#1)(1991-9#1)(1994-10#1)(1995-12#1)(1995-3#1)(1997-5#1)(2007-10#1)
the stratum##94##2##(1990-4#2)(1990-7#1)(1991-9#4)(1992-7#1)(1992-8#2)(1993-5#1)(1994-10#2)(1995-12#1)(1995-3#1)(1997-1#2)(1997-5#2)(1997-7#1)(2005-11#1)(2007-10#1)(2007-7#2)(2008-10#2)(2008-5#65)(2010-8#1)(2012-2#2)
the straw##3##2##(2008-10#1)(2013-1#2)
the stray##2##2##(2008-2#1)(2008-3#1)
the streak##6##2##(1996-12#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)
the stream of##5##3##(2008-10#1)(2008-9#1)(2010-10#3)
the stream was##2##3##(2008-10#2)
the stream##15##2##(1995-3#1)(1995-6#1)(2008-1#1)(2008-10#6)(2008-9#1)(2009-8#1)(2010-10#3)(2012-12#1)
the streams of##2##3##(2007-9#1)(2010-8#1)
the streams##9##2##(1993-6#1)(2004-4#3)(2007-9#1)(2008-10#3)(2010-8#1)
the street##4##2##(1996-5#1)(2006-8#1)(2007-1#1)(2008-11#1)
the streets and##2##3##(2006-8#1)(2007-2#1)
the streets##6##2##(1992-5#1)(1994-12#1)(1995-8#1)(2006-8#1)(2007-2#1)(2012-2#1)
the strength and direction of##2##5##(1994-8#1)(2008-8#1)
the strength and##10##3##(1994-8#1)(1996-2#1)(2006-7#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-2#1)(2009-9#1)(2013-8#1)
the strength of an##3##4##(2007-9#1)(2008-3#1)(2010-4#1)
the strength of association between the##2##6##(2007-7#1)(2013-8#1)
the strength of association between##5##5##(2007-7#1)(2008-3#1)(2013-1#2)(2013-8#1)
the strength of association##8##4##(2005-10#1)(2007-7#1)(2008-3#3)(2013-1#2)(2013-8#1)
the strength of evidence##5##4##(2009-6#1)(2011-1#1)(2012-12#3)
the strength of local##2##4##(2008-8#1)(2009-10#1)
the strength of selection on##2##5##(2008-8#1)(2008-9#1)
the strength of selection##7##4##(2008-8#4)(2008-9#1)(2010-4#1)(2013-1#1)
the strength of surface convection##2##5##(2005-11#2)
the strength of synaptic##2##4##(1997-5#1)(2008-4#1)
the strength of the HA ceramic scaffolds##2##7##(2008-5#2)
the strength of the adhesive bond##2##6##(2010-4#2)
the strength of the adhesive##3##5##(2010-4#3)
the strength of the antigravitational muscles##2##6##(2007-8#2)
the strength of the antigravitational##3##5##(2007-8#3)
the strength of the dispersion management##2##6##(2007-12#2)
the strength of the evidence##2##5##(2008-7#1)(2008-8#1)
the strength of the interaction##2##5##(1997-4#1)(2008-4#1)
the strength of the relationship between##3##6##(1994-11#1)(2009-7#1)(2011-1#1)
the strength of the thermal lens##2##6##(2008-3#2)
the strength of the##65##4##(1990-4#1)(1990-5#2)(1991-3#1)(1992-3#1)(1993-1#1)(1994-11#1)(1996-4#1)(1997-1#1)(1997-4#1)(1997-8#3)(2005-11#2)(2006-10#1)(2006-9#1)(2007-11#2)(2007-12#4)(2007-7#1)(2007-8#5)(2007-9#1)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#3)(2010-10#1)(2010-2#2)(2010-4#3)(2010-7#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#2)
the strength of their##3##4##(1995-10#1)(1997-1#1)(2008-4#1)
the strength of these muscles##2##5##(2007-8#2)
the strength of this##6##4##(2006-10#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-2#1)
the strength of##146##3##(1990-4#1)(1990-5#3)(1991-3#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-3#1)(1994-11#1)(1994-4#1)(1995-10#1)(1995-5#1)(1996-12#1)(1996-4#1)(1996-6#2)(1997-1#2)(1997-4#1)(1997-5#1)(1997-8#4)(2005-10#1)(2005-11#6)(2006-10#2)(2006-12#1)(2006-9#1)(2007-11#3)(2007-12#7)(2007-7#2)(2007-8#10)(2007-9#3)(2008-10#1)(2008-11#3)(2008-2#4)(2008-3#9)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#13)(2008-9#3)(2009-10#2)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#2)(2009-7#3)(2010-10#1)(2010-2#2)(2010-4#6)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#1)
the strength or##2##3##(1991-8#1)(2009-3#1)
the strength to##2##3##(2007-8#1)(2008-4#1)
the strength##172##2##(1990-4#1)(1990-5#3)(1991-3#1)(1991-8#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-3#1)(1994-11#1)(1994-4#1)(1994-8#1)(1995-10#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#2)(1997-1#2)(1997-4#1)(1997-5#1)(1997-8#4)(2004-1#1)(2005-10#1)(2005-11#6)(2006-10#2)(2006-12#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#4)(2007-12#8)(2007-2#1)(2007-7#3)(2007-8#11)(2007-9#3)(2008-10#2)(2008-11#3)(2008-2#4)(2008-3#10)(2008-4#6)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#14)(2008-9#3)(2009-10#2)(2009-11#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#3)(2009-9#1)(2010-10#1)(2010-2#2)(2010-4#7)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#3)
the strengthening of the##2##4##(1997-8#1)(2008-1#1)
the strengthening of##5##3##(1997-8#1)(2005-5#1)(2008-1#1)(2011-2#2)
the strengthening##7##2##(1997-8#1)(2005-5#1)(2008-1#1)(2009-7#2)(2011-2#2)
the strengths and challenges of##2##5##(2008-12#2)
the strengths and limitations of the##3##6##(2005-10#1)(2012-2#1)(2013-1#1)
the strengths and limitations of##7##5##(2005-10#1)(2006-10#2)(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#1)
the strengths and limitations##8##4##(2005-10#1)(2006-10#2)(2008-10#1)(2008-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
the strengths and the##2##4##(2005-11#1)(2006-10#1)
the strengths and weakness of the##2##6##(2009-1#1)(2012-2#1)
the strengths and weaknesses of each##2##6##(2011-12#1)(2011-2#1)
the strengths and weaknesses of the##6##6##(1992-12#1)(1994-1#1)(2006-12#1)(2007-1#1)(2007-8#1)(2012-1#1)
the strengths and weaknesses of##15##5##(1992-12#1)(1994-1#1)(1994-6#1)(1996-3#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-8#1)(2008-11#1)(2008-4#1)(2010-2#1)(2011-12#1)(2011-2#2)(2012-1#1)
the strengths and weaknesses##16##4##(1992-12#1)(1994-1#1)(1994-6#1)(1996-3#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-8#1)(2008-11#1)(2008-4#1)(2009-4#1)(2010-2#1)(2011-12#1)(2011-2#2)(2012-1#1)
the strengths and##31##3##(1992-12#1)(1994-1#1)(1994-6#1)(1996-3#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#1)(2009-1#1)(2009-4#1)(2010-2#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-2#2)(2013-1#1)
the strengths of the##3##4##(1995-9#1)(1996-2#1)(2008-8#1)
the strengths of these##2##4##(2010-3#1)(2012-2#1)
the strengths of this##2##4##(2011-1#1)(2013-1#1)
the strengths of##12##3##(1995-9#1)(1996-2#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-4#1)(2008-8#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
the strengths##45##2##(1991-1#1)(1992-12#1)(1994-1#1)(1994-6#1)(1995-9#1)(1996-2#1)(1996-3#1)(2005-10#1)(2005-11#1)(2006-10#4)(2006-12#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-4#2)(2008-7#1)(2008-8#1)(2009-1#1)(2009-4#1)(2010-2#2)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-2#3)(2013-1#2)
the streptavidin##6##2##(1991-4#2)(2008-10#2)(2008-7#1)(2009-12#1)
the streptavidin-biotin system##3##3##(1991-10#2)(1991-4#1)
the streptavidin-biotin##4##2##(1991-10#2)(1991-4#1)(1995-2#1)
the streptococcal species##2##3##(2011-1#2)
the streptococci##3##2##(1994-8#2)(1997-4#1)
the streptokinase##3##2##(1993-9#1)(1995-6#1)(2012-2#1)
the streptomycete##2##2##(1993-11#1)(2008-10#1)
the stress and strain characteristics##2##5##(2009-4#2)
the stress and strain##4##4##(2007-4#1)(2008-7#1)(2009-4#2)
the stress and##7##3##(1992-1#1)(1995-1#1)(2007-4#1)(2008-7#1)(2009-4#2)(2013-7#1)
the stress associated with##2##4##(2006-3#2)
the stress axis and##2##4##(1995-12#2)
the stress axis##3##3##(1995-12#3)
the stress conditions##3##3##(2011-2#1)(2012-12#1)(2013-7#1)
the stress field##3##3##(1996-4#1)(2008-2#1)(2008-7#1)
the stress hormone##2##3##(2007-2#1)(2008-5#1)
the stress in the##2##4##(2009-7#1)(2010-11#1)
the stress in##3##3##(2009-7#1)(2010-11#1)(2011-2#1)
the stress is##2##3##(2005-11#1)(2008-12#1)
the stress levels of##2##4##(2010-10#1)(2010-2#1)
the stress of##19##3##(1991-4#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-1#1)(2004-11#1)(2005-9#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2012-1#1)(2013-7#1)(2013-8#2)
the stress reaction##4##3##(2006-3#1)(2008-5#2)(2009-7#1)
the stress regimen##4##3##(2008-11#4)
the stress response to##7##4##(1995-8#3)(1997-2#1)(2008-10#1)(2008-11#1)(2012-3#1)
the stress response##22##3##(1995-12#6)(1995-8#3)(1996-4#1)(1997-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2010-12#3)(2012-12#2)(2012-3#1)
the stress studies##3##3##(2010-12#1)(2010-2#1)(2012-12#1)
the stress tensor##3##3##(2007-11#2)(2008-3#1)
the stress test##2##3##(2008-10#1)(2009-5#1)
the stress##133##2##(1990-12#1)(1991-4#1)(1992-1#5)(1992-2#1)(1993-2#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#12)(1995-8#3)(1996-1#1)(1996-4#4)(1997-2#1)(2004-11#1)(2004-9#1)(2005-11#2)(2005-9#1)(2006-10#1)(2006-3#3)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#6)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2011-2#2)(2012-1#2)(2012-12#5)(2012-3#4)(2013-1#1)(2013-7#4)(2013-8#4)
the stress-associated##3##2##(2006-10#2)(2009-10#1)
the stress-induced activation of the##2##5##(1994-2#1)(1996-11#1)
the stress-induced##6##2##(1994-2#2)(1995-12#1)(1996-11#1)(2007-11#1)(2009-10#1)
the stress-inducible##2##2##(1996-5#1)(2007-1#1)
the stress-related##4##2##(1996-11#1)(2009-2#1)(2009-8#1)(2012-1#1)
the stress/strain##2##2##(2004-9#1)(2007-4#1)
the stressed##12##2##(1994-6#2)(1995-12#1)(1995-6#1)(2007-12#3)(2008-11#1)(2008-3#1)(2009-7#1)(2013-1#2)
the stresses##10##2##(1996-9#1)(2004-9#1)(2006-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-5#1)(2012-2#1)
the stressful##3##2##(2008-11#2)(2012-3#1)
the stressor is##2##3##(1993-6#1)(2008-6#1)
the stressor##11##2##(1993-6#2)(1994-12#1)(2006-8#1)(2008-11#2)(2008-4#1)(2008-6#1)(2010-4#1)(2010-8#1)(2013-8#1)
the stressors##5##2##(1993-6#1)(1995-12#2)(2011-2#1)(2012-3#1)
the stressosome##4##2##(2009-8#4)
the stretch of##2##3##(1994-12#1)(1994-5#1)
the stretch##8##2##(1990-2#1)(1990-7#1)(1992-8#1)(1993-9#1)(1994-12#1)(1994-5#1)(2008-3#1)(2008-8#1)
the stretch-induced phosphorylation##2##3##(1990-11#2)
the stretch-induced##4##2##(1990-11#2)(1990-12#1)(1990-8#1)
the stretched##2##2##(2008-3#1)(2012-2#1)
the stretcher##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
the stretching and##2##3##(1992-8#1)(2008-2#1)
the stretching of##2##3##(2007-11#1)(2008-7#1)
the stretching vibration##2##3##(1994-11#1)(2008-10#1)
the stretching##10##2##(1992-8#1)(1994-11#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-1#1)(2011-1#1)
the stria##13##2##(1992-8#1)(1993-12#1)(1994-2#1)(1995-5#1)(1995-6#2)(1996-4#1)(1997-3#1)(1997-8#3)(2008-9#1)(2009-8#1)
the striatal DA##2##3##(1997-2#1)(1997-8#1)
the striatal compartment is##2##4##(1997-6#2)
the striatal compartment##3##3##(1997-6#3)
the striatal dopamine transporter##3##4##(1996-2#3)
the striatal dopamine##4##3##(1993-4#1)(1996-2#3)
the striatal dopaminergic##3##3##(1996-10#1)(1997-8#1)(2008-7#1)
the striatal slice##2##3##(1995-9#2)
the striatal target##2##3##(1995-9#1)(2008-11#1)
the striatal##27##2##(1990-2#1)(1993-4#1)(1993-9#1)(1994-8#1)(1995-9#3)(1996-1#1)(1996-10#1)(1996-2#4)(1996-3#1)(1996-5#1)(1997-2#1)(1997-6#3)(1997-8#5)(2008-11#1)(2008-7#2)
the striate cortex##4##3##(1994-8#1)(1997-7#2)(2008-11#1)
the striate##10##2##(1994-8#1)(1995-8#1)(1997-7#2)(2008-11#1)(2008-8#1)(2009-4#4)
the striated muscle fibers##2##4##(1995-3#2)
the striated##4##2##(1995-3#3)(2012-12#1)
the striatum and nucleus accumbens##2##5##(1993-12#1)(1996-10#1)
the striatum and the nucleus accumbens##5##6##(1996-12#2)(1996-6#1)(1997-3#2)
the striatum and the##9##4##(1991-6#1)(1996-12#2)(1996-5#1)(1996-6#1)(1997-3#2)(2008-4#1)(2011-1#1)
the striatum and##23##3##(1991-6#2)(1993-12#1)(1993-2#1)(1993-5#1)(1993-7#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-5#2)(1996-6#1)(1997-2#1)(1997-3#2)(1997-8#1)(2008-4#1)(2008-7#1)(2010-7#2)(2011-1#1)
the striatum as##2##3##(1993-5#1)(1996-10#1)
the striatum by##3##3##(1992-7#1)(1994-10#2)
the striatum of##27##3##(1990-5#1)(1991-5#1)(1991-9#2)(1993-2#9)(1993-3#1)(1993-4#1)(1995-12#2)(1996-1#1)(1996-10#1)(1996-3#1)(1996-5#2)(2008-10#1)(2008-7#1)(2009-8#1)(2010-7#1)(2013-8#1)
the striatum was##3##3##(1992-7#1)(1996-10#1)(2006-11#1)
the striatum##138##2##(1990-2#3)(1990-5#1)(1990-7#3)(1991-4#1)(1991-5#1)(1991-6#7)(1991-9#5)(1992-10#1)(1992-7#2)(1992-8#1)(1993-12#2)(1993-2#17)(1993-3#2)(1993-4#1)(1993-5#2)(1993-7#1)(1993-9#1)(1994-10#4)(1994-2#2)(1994-6#1)(1995-11#3)(1995-12#5)(1995-3#1)(1995-6#2)(1995-7#4)(1996-1#6)(1996-10#4)(1996-12#4)(1996-3#2)(1996-5#6)(1996-6#1)(1997-2#3)(1997-3#3)(1997-8#3)(2006-11#4)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-7#7)(2009-12#1)(2009-8#1)(2010-7#5)(2011-1#1)(2011-2#1)(2012-1#1)(2013-7#1)(2013-8#3)
the strict control of##2##4##(1994-12#1)(2008-10#1)
the strict spectral limitations imposed by##2##6##(2007-12#2)
the strict stereospecificity of##2##4##(1994-8#1)(1997-4#1)
the strict##18##2##(1990-4#1)(1990-8#1)(1994-12#1)(1994-8#1)(1997-4#1)(2005-11#1)(2006-6#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-11#3)(2008-3#1)(2010-12#1)(2012-2#1)(2013-8#1)
the strictly##6##2##(1992-4#1)(1996-6#1)(2007-8#1)(2008-2#1)(2008-5#1)(2009-7#1)
the stricture##3##2##(2007-5#1)(2008-2#1)(2010-12#1)
the striking##17##2##(1994-3#1)(1995-1#2)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
the strikingly##2##2##(1990-5#1)(2008-7#1)
the string##3##2##(2005-10#1)(2007-7#1)(2013-1#1)
the stringency of##2##3##(1995-5#1)(2010-12#1)
the stringency##3##2##(1990-12#1)(1995-5#1)(2010-12#1)
the stringent requirements##2##3##(1996-1#1)(2009-5#1)
the stringent##6##2##(1994-5#1)(1996-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-5#1)
the strip##6##2##(1997-3#1)(2007-12#1)(2008-10#2)(2008-5#1)(2012-3#1)
the stripe rust##2##3##(2008-10#2)
the stripe test##2##3##(2009-8#2)
the stripe wear##2##3##(2009-7#2)
the stripe##12##2##(1991-11#3)(1995-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2009-7#2)(2009-8#2)
the stripping chronopotentiometric##2##3##(2008-10#2)
the stripping of##3##3##(2008-10#3)
the stripping response##2##3##(2008-10#2)
the stripping##15##2##(2008-10#15)
the strobilurin##2##2##(2008-10#2)
the stroboscopic##2##2##(2007-12#2)
the stroke patient##2##3##(1995-5#1)(2005-8#1)
the stroke##38##2##(1995-5#1)(2005-10#1)(2005-8#1)(2007-10#9)(2007-8#1)(2007-9#9)(2008-11#2)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#4)
the stroma of##5##3##(1996-4#2)(1996-9#1)(1997-3#1)(2011-2#1)
the stroma##17##2##(1992-12#1)(1993-12#1)(1994-2#1)(1996-4#4)(1996-9#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-2#1)(2011-2#1)(2012-12#2)(2013-8#1)
the stromal cells##6##3##(1993-7#1)(1994-9#1)(2008-6#1)(2008-9#1)(2009-2#1)(2011-1#1)
the stromal tissue##2##3##(1990-5#1)(1996-4#1)
the stromal##14##2##(1990-5#1)(1993-12#1)(1993-7#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1996-4#1)(2007-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2011-1#1)
the strong absorption##3##3##(2005-4#1)(2008-10#1)(2008-3#1)
the strong affinity##2##3##(1996-7#1)(2011-2#1)
the strong and the weak##2##5##(2007-11#1)(2007-12#1)
the strong and##7##3##(1991-4#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-5#1)(2010-5#1)
the strong association between##2##4##(1994-3#1)(1997-8#1)
the strong association##4##3##(1994-3#1)(1997-8#1)(2004-11#1)(2008-3#1)
the strong binding of##2##4##(1990-5#1)(2010-6#1)
the strong constitutive##2##3##(2005-11#1)(2008-11#1)
the strong correlation between##2##4##(2006-10#1)(2008-10#1)
the strong correlation##3##3##(1993-8#1)(2006-10#1)(2008-10#1)
the strong coupling##2##3##(1995-10#1)(2013-7#1)
the strong impact##2##3##(2008-2#1)(2011-1#1)
the strong influence of the##3##5##(2007-12#1)(2008-1#1)(2010-5#1)
the strong influence of##7##4##(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-5#1)(2012-3#1)
the strong inhibitory##2##3##(1992-5#1)(2011-3#1)
the strong selection##2##3##(1991-8#1)(2010-8#1)
the strong spectral##2##3##(2008-10#2)
the strong##123##2##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-4#1)(2006-10#2)(2006-2#2)(2006-3#1)(2006-7#2)(2007-11#4)(2007-12#4)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#17)(2008-11#2)(2008-2#6)(2008-3#8)(2008-5#9)(2008-7#2)(2008-8#5)(2009-5#2)(2009-6#1)(2010-12#1)(2010-5#3)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-7#2)
the stronger##9##2##(1990-12#1)(1995-2#1)(2006-4#1)(2006-7#1)(2008-10#2)(2008-3#1)(2010-5#1)(2012-3#1)
the strongest and most##2##4##(1996-2#1)(2007-1#1)
the strongest and##3##3##(1996-2#1)(2007-1#1)(2009-5#1)
the strongest association with##2##4##(2008-10#1)(2012-11#1)
the strongest association##5##3##(2007-10#1)(2008-10#2)(2008-6#1)(2012-11#1)
the strongest evidence##3##3##(2006-9#1)(2007-9#1)(2008-6#1)
the strongest in##2##3##(1992-4#1)(2008-10#1)
the strongest inhibition##2##3##(2006-3#1)(2010-2#1)
the strongest inhibitor##3##3##(1993-4#1)(1995-5#1)(2011-2#1)
the strongest inhibitory##3##3##(1990-2#1)(2008-10#1)(2011-12#1)
the strongest predictor of##11##4##(1995-5#1)(2005-8#1)(2007-10#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-3#1)
the strongest predictor##12##3##(1995-5#1)(2005-8#1)(2007-10#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-3#2)
the strongest predictors of##2##4##(2007-12#1)(2012-12#1)
the strongest predictors##3##3##(2007-12#1)(2009-9#1)(2012-12#1)
the strongest##92##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-4#1)(1992-7#1)(1993-4#1)(1995-5#2)(1995-8#1)(1996-2#2)(1997-3#1)(1997-4#1)(2005-11#2)(2005-8#1)(2006-1#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-12#2)(2007-8#1)(2007-9#2)(2008-10#14)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-12#3)(2010-2#2)(2011-1#1)(2011-12#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#5)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
the strongly absorbing##2##3##(2010-4#1)(2013-1#1)
the strongly localized##2##3##(1993-3#1)(2009-5#1)
the strongly##21##2##(1991-2#1)(1993-11#1)(1993-3#1)(1994-9#1)(1995-4#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-5#1)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
the strontium##2##2##(2008-10#2)
the structural alterations##2##3##(2008-8#1)(2011-2#1)
the structural analysis of##3##4##(1990-3#1)(1990-4#1)(1993-8#1)
the structural and behavioral##2##4##(2012-1#1)(2012-2#1)
the structural and functional integrity of##2##6##(1997-4#1)(2006-12#1)
the structural and functional properties of##2##6##(1994-9#1)(2008-8#1)
the structural and functional##17##4##(1991-11#1)(1994-8#1)(1994-9#1)(1996-3#1)(1997-4#1)(1997-6#1)(2006-12#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-3#1)
the structural and the##3##4##(1991-1#1)(2006-10#1)(2008-3#1)
the structural and##32##3##(1990-2#1)(1991-1#1)(1991-11#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-4#1)(1997-4#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-3#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
the structural aspects of##2##4##(2008-5#1)(2013-1#1)
the structural barriers##2##3##(1996-2#1)(2012-3#1)
the structural basis for the##2##5##(1992-10#1)(2011-1#1)
the structural basis for##8##4##(1992-10#1)(1992-11#2)(1992-4#1)(1995-2#1)(1997-2#1)(1997-4#1)(2011-1#1)
the structural basis of##8##4##(1994-8#1)(1995-3#1)(1997-9#2)(2007-12#1)(2008-4#1)(2008-9#1)(2009-7#1)
the structural basis##18##3##(1992-10#1)(1992-11#2)(1992-4#1)(1993-8#1)(1994-8#1)(1995-2#1)(1995-3#1)(1997-2#1)(1997-4#1)(1997-9#2)(2007-12#1)(2008-4#2)(2008-9#1)(2009-7#1)(2011-1#1)
the structural behavior##2##3##(2008-10#1)(2008-2#1)
the structural change of the##3##5##(1990-5#1)(2008-10#1)(2008-8#1)
the structural change of##5##4##(1990-5#1)(2008-10#1)(2008-3#1)(2008-8#2)
the structural change##6##3##(1990-5#1)(1991-4#1)(2008-10#1)(2008-3#1)(2008-8#2)
the structural changes occurring##2##4##(1991-3#1)(1994-2#1)
the structural changes of##3##4##(2006-6#2)(2011-2#1)
the structural changes that occur##3##5##(1996-11#1)(2008-3#1)(2012-12#1)
the structural changes##13##3##(1991-3#1)(1991-4#1)(1993-9#1)(1994-2#1)(1996-11#1)(1997-6#1)(2006-6#2)(2007-11#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-12#1)
the structural characteristics of##2##4##(2008-4#1)(2008-8#1)
the structural characteristics##3##3##(2008-4#1)(2008-8#1)(2009-7#1)
the structural characterization of the##2##5##(1997-2#1)(2008-4#1)
the structural characterization of##3##4##(1992-8#1)(1997-2#1)(2008-4#1)
the structural characterization##4##3##(1992-8#1)(1997-2#1)(2008-10#1)(2008-4#1)
the structural components of the##2##5##(1997-8#1)(2008-4#1)
the structural components##4##3##(1997-8#1)(2008-4#1)(2009-10#2)
the structural composition of##2##4##(1995-6#1)(2008-3#1)
the structural data available for the##2##6##(1990-12#1)(1996-7#1)
the structural data##3##3##(1990-12#1)(1996-7#1)(2009-2#1)
the structural design of##2##4##(2008-3#1)(2008-7#1)
the structural determinants for##2##4##(1993-6#1)(2008-8#1)
the structural determinants##4##3##(1992-12#1)(1993-6#1)(1994-11#1)(2008-8#1)
the structural differences##3##3##(1992-5#1)(1997-7#1)(2007-11#1)
the structural dynamics##3##3##(2006-3#1)(2008-10#2)
the structural elements of the##2##5##(1994-5#1)(1996-5#1)
the structural elements of##3##4##(1994-11#1)(1994-5#1)(1996-5#1)
the structural elements##7##3##(1994-11#1)(1994-5#1)(1996-5#1)(2006-10#1)(2007-11#1)(2008-9#1)(2010-4#1)
the structural elucidation of##2##4##(2007-1#2)
the structural encoding of faces##2##5##(2009-4#2)
the structural features of this##2##5##(1996-10#1)(2008-4#1)
the structural features of##12##4##(1992-10#1)(1994-11#1)(1994-9#2)(1996-10#1)(1996-12#1)(1996-5#1)(1997-1#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-5#1)
the structural features that##2##4##(1994-5#1)(2008-5#1)
the structural features##17##3##(1992-10#1)(1994-11#1)(1994-5#1)(1994-9#2)(1996-10#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-7#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-5#1)
the structural formula of##2##4##(1992-9#1)(1995-6#1)
the structural gene coding for##4##5##(1990-4#1)(1991-1#1)(1997-4#1)(2011-1#1)
the structural gene encoding##4##4##(1991-12#1)(1993-9#1)(2007-12#1)(2008-5#1)
the structural gene for the##2##5##(1994-12#2)
the structural gene for yeast transaldolase##2##6##(1990-3#2)
the structural gene for##6##4##(1990-3#2)(1994-12#3)(1996-7#1)
the structural gene of CS3 subunit##2##6##(2008-8#2)
the structural gene of##3##4##(1992-4#1)(2008-8#2)
the structural gene##22##3##(1990-3#3)(1990-4#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-4#1)(1992-4#1)(1993-9#1)(1994-12#3)(1995-6#1)(1996-7#1)(1997-4#1)(2007-12#1)(2008-5#1)(2008-8#2)(2011-1#1)
the structural genomics##2##3##(2008-4#1)(2011-1#1)
the structural heterogeneity##3##3##(1997-1#2)(2006-12#1)
the structural inequalities##2##3##(2008-11#1)(2012-3#1)
the structural information available for##2##5##(1994-11#1)(2013-1#1)
the structural information##5##3##(1994-11#1)(2007-12#1)(2010-2#1)(2012-2#1)(2013-1#1)
the structural integrity of the##5##5##(1990-12#1)(1994-2#1)(2006-10#1)(2008-7#1)(2010-12#1)
the structural integrity of##9##4##(1990-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-8#1)(2006-10#1)(2008-7#1)(2008-9#1)(2010-12#1)
the structural interactions##2##3##(2012-2#2)
the structural level##5##3##(1992-6#1)(1994-2#1)(1995-8#1)(2008-5#1)(2011-1#1)
the structural organization and##2##4##(1990-5#1)(2006-10#1)
the structural organization of the##4##5##(1992-9#1)(2008-10#1)(2008-5#1)(2009-8#1)
the structural organization of##10##4##(1992-9#1)(1993-2#1)(1995-2#1)(2006-12#1)(2008-10#1)(2008-5#1)(2009-2#1)(2009-8#1)(2010-8#1)(2012-12#1)
the structural organization##14##3##(1990-5#1)(1991-12#1)(1992-9#1)(1993-2#1)(1995-2#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-8#1)(2012-12#1)
the structural parameters of##2##4##(2008-10#1)(2008-3#1)
the structural parameters##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
the structural priors##2##3##(2011-1#2)
the structural properties of##6##4##(1990-2#1)(1996-5#1)(1996-9#1)(2006-10#1)(2006-12#1)(2007-12#1)
the structural properties##8##3##(1990-2#1)(1993-12#1)(1993-9#1)(1996-5#1)(1996-9#1)(2006-10#1)(2006-12#1)(2007-12#1)
the structural protein##5##3##(1993-9#1)(1994-3#1)(1995-2#1)(2008-10#1)(2008-4#1)
the structural reliability of Ti6Al4V##2##5##(2010-8#2)
the structural requirement##2##3##(1993-9#1)(1996-2#1)
the structural requirements for##4##4##(1992-9#1)(1997-1#1)(1997-2#1)(2011-2#1)
the structural requirements of##4##4##(1991-7#1)(1992-3#1)(1994-9#1)(1995-5#1)
the structural requirements to##2##4##(1994-9#1)(2006-12#1)
the structural requirements##11##3##(1991-7#1)(1992-3#1)(1992-9#1)(1994-5#1)(1994-9#2)(1995-5#1)(1997-1#1)(1997-2#1)(2006-12#1)(2011-2#1)
the structural rigidity of##2##4##(1995-1#1)(2008-10#1)
the structural similarity of##2##4##(1991-6#1)(2008-10#1)
the structural similarity##3##3##(1991-6#1)(2008-10#1)(2010-8#1)
the structural specificity##2##3##(1994-8#1)(1994-9#1)
the structural stability of##3##4##(1995-8#3)
the structural##348##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#5)(1990-4#2)(1990-5#2)(1990-7#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#3)(1991-3#2)(1991-4#3)(1991-6#2)(1991-7#1)(1992-10#2)(1992-11#2)(1992-12#3)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#3)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#3)(1993-9#6)(1994-11#5)(1994-12#3)(1994-2#3)(1994-3#2)(1994-5#3)(1994-8#6)(1994-9#7)(1995-1#3)(1995-10#1)(1995-12#2)(1995-2#5)(1995-3#3)(1995-5#2)(1995-6#3)(1995-8#7)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#3)(1996-7#2)(1996-8#1)(1996-9#4)(1997-1#5)(1997-2#4)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#2)(1997-9#2)(2005-11#5)(2005-4#1)(2005-8#1)(2006-10#6)(2006-11#2)(2006-12#8)(2006-3#2)(2006-6#4)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#7)(2007-2#1)(2007-8#2)(2008-10#17)(2008-11#3)(2008-2#3)(2008-3#6)(2008-4#9)(2008-5#8)(2008-6#1)(2008-7#6)(2008-8#10)(2008-9#3)(2009-10#5)(2009-12#1)(2009-2#6)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#2)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#3)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#4)(2011-1#8)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#8)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#2)
the structurally homologous##3##3##(1992-12#1)(1993-2#1)(1995-6#1)
the structurally normal heart##2##4##(2009-5#1)(2009-7#1)
the structurally related##12##3##(1990-5#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-12#1)(2008-10#1)(2011-2#1)
the structurally similar##3##3##(1990-5#1)(1994-6#1)(1995-3#1)
the structurally##24##2##(1990-5#2)(1991-3#1)(1992-12#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(2008-10#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-4#1)(2011-2#1)
the structure [formula##2##3##(1991-12#2)
the structure and activity of##2##5##(1990-2#1)(2008-5#1)
the structure and activity##3##4##(1990-2#1)(2008-5#1)(2013-1#1)
the structure and biological##2##4##(2006-12#1)(2008-5#1)
the structure and composition of##2##5##(1994-9#1)(2010-7#1)
the structure and contents of##2##5##(1992-12#1)(1994-6#1)
the structure and dynamics of polymeric##2##6##(1997-7#1)(2008-2#1)
the structure and dynamics of the##3##6##(1991-5#1)(1991-7#1)(2008-4#1)
the structure and dynamics of##11##5##(1991-5#2)(1991-7#1)(1992-3#1)(1997-7#1)(2004-4#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-4#2)
the structure and dynamics##12##4##(1991-5#2)(1991-7#1)(1992-3#1)(1997-7#1)(2004-4#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-2#1)(2008-4#2)
the structure and expression##2##4##(1992-6#1)(1997-6#1)
the structure and function of proteins and##2##7##(1997-4#1)(2006-10#1)
the structure and function of proteins##4##6##(1997-4#1)(2006-10#1)(2008-2#1)(2008-4#1)
the structure and function of the protein##3##7##(1996-8#2)(2008-7#1)
the structure and function of the skin##2##7##(2012-2#2)
the structure and function of the##17##6##(1994-9#1)(1996-8#2)(2005-10#2)(2006-10#1)(2007-1#1)(2008-10#2)(2008-5#1)(2008-7#2)(2009-10#1)(2010-12#1)(2012-11#1)(2012-2#2)
the structure and function of these##5##6##(1990-5#1)(1994-8#1)(2005-1#1)(2008-5#1)(2010-5#1)
the structure and function of##51##5##(1990-5#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-3#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-6#2)(1996-8#2)(1997-2#1)(1997-4#1)(2005-1#1)(2005-10#2)(2005-7#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-1#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#6)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-5#1)(2011-1#2)(2012-11#1)(2012-2#2)
the structure and functions of the##2##6##(2005-5#1)(2011-2#1)
the structure and functions of##5##5##(1994-1#1)(2003-11#1)(2005-5#1)(2007-11#1)(2011-2#1)
the structure and functions##6##4##(1994-1#1)(2003-11#1)(2005-5#1)(2007-11#1)(2011-2#2)
the structure and morphology of##2##5##(2005-10#1)(2008-10#1)
the structure and phase##2##4##(2006-10#2)
the structure and stability of##4##5##(1993-3#1)(2007-11#1)(2008-1#2)
the structure and the##9##4##(1995-10#1)(1995-6#2)(2006-9#1)(2008-10#1)(2008-3#2)(2009-2#1)(2009-3#1)
the structure and##144##3##(1990-2#2)(1990-5#2)(1991-1#1)(1991-3#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-6#1)(1993-3#1)(1993-7#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-6#4)(1996-4#1)(1996-8#2)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#3)(2003-11#1)(2004-4#1)(2004-9#1)(2005-1#1)(2005-10#3)(2005-11#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#6)(2006-12#2)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-1#4)(2008-10#9)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#8)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#4)
the structure are##3##3##(1990-7#1)(2007-11#1)(2011-1#1)
the structure at##3##3##(2006-10#1)(2008-10#1)(2008-2#1)
the structure by##2##3##(2008-3#1)(2008-5#1)
the structure determination of##2##4##(2008-4#1)(2012-8#1)
the structure determination##4##3##(1994-6#1)(2007-5#1)(2008-4#1)(2012-8#1)
the structure edges##3##3##(2007-12#2)(2008-3#1)
the structure evolves##2##3##(1994-7#1)(2005-11#1)
the structure in the##2##4##(2008-4#1)(2008-5#1)
the structure in##5##3##(1994-7#1)(2008-4#1)(2008-5#2)(2010-6#1)
the structure is not##2##4##(2008-8#1)(2010-2#1)
the structure is##9##3##(1992-4#1)(1996-2#1)(2007-11#1)(2007-12#2)(2008-3#2)(2008-8#1)(2010-2#1)
the structure of DNA##2##4##(2007-11#1)(2008-4#1)
the structure of Escherichia coli##2##5##(1991-5#1)(1994-3#1)
the structure of a typical plant MADS box gene##2##9##(1997-2#1)(1997-8#1)
the structure of a##14##4##(1990-7#1)(1992-9#1)(1994-2#1)(1995-11#1)(1995-5#1)(1995-8#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)
the structure of an##4##4##(1990-9#1)(1996-7#1)(1997-5#1)(2008-10#1)
the structure of biological molecules##2##5##(2006-10#1)(2008-7#1)
the structure of biological##3##4##(1994-5#1)(2006-10#1)(2008-7#1)
the structure of both##2##4##(2008-10#1)(2008-12#1)
the structure of cartilage##2##4##(1991-10#1)(2007-11#1)
the structure of functional systems##2##5##(2012-1#2)
the structure of glycine##2##4##(2006-2#2)
the structure of its##3##4##(1990-5#1)(2007-12#1)(2011-2#1)
the structure of several##2##4##(1990-8#1)(2011-2#1)
the structure of the N-terminal##3##5##(1990-7#1)(1996-11#1)(1996-7#1)
the structure of the activated##2##5##(1991-4#1)(1997-1#1)
the structure of the complex##2##5##(1990-4#1)(1991-5#1)
the structure of the enzyme##2##5##(1991-2#1)(1994-12#1)
the structure of the gene##2##5##(1993-2#1)(1993-4#1)
the structure of the human##4##5##(1991-12#1)(1994-3#1)(1997-2#1)(2008-11#1)
the structure of the liquid##2##5##(2005-11#1)(2010-8#1)
the structure of the new##2##5##(2007-1#2)
the structure of the peptide##5##5##(1990-3#1)(1991-3#1)(1994-2#1)(1996-8#1)(2006-12#1)
the structure of the protein##3##5##(2010-2#2)(2010-7#1)
the structure of the receptor##2##5##(1994-12#1)(2006-12#1)
the structure of the##171##4##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#4)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#3)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#3)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#4)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-6#1)(1995-7#2)(1995-9#1)(1996-11#3)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#4)(1996-8#3)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(2005-1#1)(2005-11#8)(2005-12#2)(2006-11#1)(2006-12#2)(2006-2#1)(2007-1#2)(2007-11#2)(2007-12#4)(2007-3#1)(2007-6#1)(2008-10#8)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#6)(2008-6#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-11#1)(2010-12#3)(2010-2#3)(2010-4#3)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-2#1)(2012-3#2)(2013-1#2)
the structure of these##5##4##(1996-2#1)(2007-11#1)(2009-9#1)(2010-4#1)(2012-12#1)
the structure of this##6##4##(1990-5#1)(1994-6#1)(2006-2#1)(2006-3#1)(2011-12#1)(2011-2#1)
the structure of two##4##4##(1992-4#1)(2005-11#1)(2006-12#1)(2008-3#1)
the structure of which##2##4##(2008-11#1)(2008-7#1)
the structure of##356##3##(1990-1#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#4)(1990-7#5)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-4#3)(1991-5#5)(1991-6#2)(1991-7#1)(1991-8#3)(1992-1#2)(1992-11#2)(1992-12#8)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#4)(1993-11#3)(1993-2#4)(1993-3#2)(1993-4#1)(1993-6#3)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#3)(1994-3#7)(1994-5#4)(1994-6#2)(1994-8#2)(1994-9#4)(1995-1#2)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#6)(1995-5#2)(1995-6#2)(1995-7#3)(1995-8#4)(1995-9#1)(1996-11#4)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#6)(1996-8#3)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#2)(1997-8#1)(2004-12#1)(2004-4#1)(2005-1#1)(2005-11#10)(2005-12#2)(2005-4#2)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#4)(2006-2#5)(2006-3#1)(2006-4#1)(2006-5#1)(2007-1#4)(2007-11#7)(2007-12#8)(2007-3#2)(2007-6#1)(2008-1#2)(2008-10#15)(2008-11#7)(2008-12#6)(2008-2#3)(2008-3#5)(2008-4#9)(2008-5#8)(2008-6#5)(2008-7#4)(2008-8#5)(2008-9#3)(2009-11#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#4)(2010-5#1)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#7)(2011-3#1)(2012-1#5)(2012-11#3)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#4)
the structure or function of the##2##6##(2008-4#2)
the structure or##4##3##(2008-4#3)(2008-9#1)
the structure prediction##2##3##(1993-6#1)(2010-7#1)
the structure shows##2##3##(1995-5#1)(2007-12#1)
the structure to##3##3##(2005-11#1)(2007-10#1)(2007-9#1)
the structure was##6##3##(1991-6#2)(1992-3#1)(1995-5#1)(2007-11#1)(2010-10#1)
the structure##653##2##(1990-1#1)(1990-11#3)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#6)(1990-7#9)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#3)(1991-4#5)(1991-5#8)(1991-6#6)(1991-7#3)(1991-8#4)(1992-1#2)(1992-11#3)(1992-12#12)(1992-3#7)(1992-4#3)(1992-5#1)(1992-6#3)(1992-7#2)(1992-9#4)(1993-11#4)(1993-2#4)(1993-3#4)(1993-4#1)(1993-6#5)(1993-7#1)(1993-8#3)(1993-9#1)(1994-1#4)(1994-11#2)(1994-12#4)(1994-2#4)(1994-3#8)(1994-5#4)(1994-6#4)(1994-7#3)(1994-8#3)(1994-9#7)(1995-1#3)(1995-10#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#11)(1995-5#4)(1995-6#7)(1995-7#3)(1995-8#6)(1995-9#1)(1996-11#4)(1996-12#4)(1996-2#4)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#8)(1996-8#5)(1997-1#3)(1997-2#5)(1997-3#4)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#6)(1997-8#1)(2003-11#1)(2004-12#1)(2004-4#2)(2004-9#1)(2005-1#2)(2005-10#3)(2005-11#13)(2005-12#2)(2005-4#3)(2005-5#1)(2005-7#1)(2005-8#2)(2006-10#12)(2006-11#1)(2006-12#8)(2006-2#5)(2006-3#1)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#5)(2007-10#3)(2007-11#14)(2007-12#19)(2007-2#1)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#6)(2008-10#31)(2008-11#11)(2008-12#6)(2008-2#11)(2008-3#17)(2008-4#28)(2008-5#16)(2008-6#5)(2008-7#10)(2008-8#8)(2008-9#9)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#3)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#4)(2010-3#2)(2010-4#6)(2010-5#4)(2010-6#1)(2010-7#7)(2010-8#1)(2010-9#1)(2011-1#7)(2011-12#2)(2011-2#9)(2011-3#1)(2012-1#6)(2012-11#4)(2012-12#2)(2012-2#7)(2012-3#4)(2012-8#1)(2013-1#13)(2013-7#1)(2013-8#8)
the structure-activity relationship##2##3##(1994-11#1)(1997-3#1)
the structure-activity relationships of##2##4##(1992-5#1)(1996-8#1)
the structure-activity relationships##6##3##(1991-3#1)(1992-5#1)(1996-8#1)(1997-1#1)(2008-11#1)(2008-4#1)
the structure-activity##9##2##(1991-3#1)(1992-5#1)(1994-11#2)(1996-8#1)(1997-1#1)(1997-3#1)(2008-11#1)(2008-4#1)
the structure-function relationship of##6##4##(1993-10#1)(1994-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
the structure-function relationship##7##3##(1993-10#1)(1994-11#1)(1997-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
the structure-function relationships in##2##4##(1990-7#1)(1994-8#1)
the structure-function relationships of##3##4##(1992-8#1)(1994-3#1)(2006-10#1)
the structure-function relationships##5##3##(1990-7#1)(1992-8#1)(1994-3#1)(1994-8#1)(2006-10#1)
the structure-function##15##2##(1990-7#1)(1990-8#1)(1992-8#1)(1993-10#1)(1994-11#1)(1994-3#1)(1994-8#1)(1997-2#1)(1997-4#1)(2006-10#1)(2008-5#2)(2008-8#1)(2008-9#1)(2011-2#1)
the structure-property relationships##3##3##(2007-11#1)(2010-4#2)
the structure-property##4##2##(2007-11#1)(2009-7#1)(2010-4#2)
the structure/function relationship##2##3##(1996-5#1)(2006-2#1)
the structure/function relationships##2##3##(1990-5#1)(1997-2#1)
the structure/function##4##2##(1990-5#1)(1996-5#1)(1997-2#1)(2006-2#1)
the structured clinical interview for##2##5##(1996-1#1)(2011-1#1)
the structured##11##2##(1992-9#1)(1994-8#1)(1995-1#1)(1996-1#1)(2005-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-3#1)(2010-8#1)(2011-1#1)
the structures and emulsifying properties of caseins##3##7##(2013-8#3)
the structures and functions of the##2##6##(1991-2#1)(2008-9#1)
the structures and functions of##3##5##(1991-2#1)(2005-5#1)(2008-9#1)
the structures and properties of##2##5##(2009-2#1)(2010-12#1)
the structures and##13##3##(1991-2#1)(1993-6#1)(1997-1#1)(2005-5#1)(2006-12#1)(2007-5#1)(2008-3#1)(2008-9#1)(2009-2#1)(2010-12#1)(2013-8#3)
the structures are##2##3##(1994-11#1)(2006-12#1)
the structures in##2##3##(1990-5#1)(1997-4#1)
the structures involved##2##3##(2008-5#1)(2011-2#1)
the structures of both##2##4##(1990-12#1)(1992-9#1)
the structures of proteins##2##4##(2008-4#1)(2008-7#1)
the structures of substrates##2##4##(1994-8#1)(2008-10#1)
the structures of the##21##4##(1992-6#1)(1995-1#1)(1995-6#1)(1996-11#1)(1996-5#1)(1996-9#1)(1997-4#2)(1997-7#1)(2006-3#1)(2007-1#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-4#2)(2009-2#1)(2012-12#1)(2013-1#2)
the structures of these##3##4##(1994-3#1)(1995-3#1)(2008-4#1)
the structures of##57##3##(1990-12#1)(1990-7#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-11#1)(1996-5#2)(1996-9#1)(1997-4#2)(1997-7#1)(2005-11#1)(2005-4#1)(2006-12#1)(2006-3#1)(2007-1#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#5)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2010-11#2)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
the structures that##6##3##(1992-11#1)(1997-3#1)(2006-10#1)(2007-1#1)(2008-7#1)(2010-12#1)
the structures were##3##3##(2007-1#2)(2008-12#1)
the structures##110##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-12#2)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-3#3)(1994-8#3)(1994-9#2)(1995-1#1)(1995-11#1)(1995-3#2)(1995-4#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#4)(1997-7#1)(2004-9#1)(2005-11#1)(2005-4#1)(2005-5#1)(2006-10#2)(2006-12#3)(2006-3#1)(2007-1#5)(2007-12#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#5)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-2#3)(2010-11#2)(2010-12#3)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#3)
the structuring of##6##3##(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1995-3#1)(2008-10#1)
the structuring##11##2##(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)
the struggle for##2##3##(1995-2#1)(2009-4#1)
the struggle##3##2##(1995-2#1)(2009-10#1)(2009-4#1)
the struts##4##2##(2007-9#2)(2008-5#2)
the strychnine binding##2##3##(1990-7#2)
the strychnine-insensitive##5##2##(1990-7#1)(1991-11#1)(1994-2#3)
the student and the##2##4##(2008-11#2)
the student and##3##3##(2008-11#2)(2011-1#1)
the student experience##4##3##(2008-11#4)
the student nurse##2##3##(2008-11#2)
the student to##4##3##(2008-12#1)(2010-5#1)(2011-2#1)(2012-2#1)
the student##40##2##(1993-1#1)(1995-4#1)(1996-2#1)(2005-8#1)(2006-5#1)(2007-1#1)(2007-4#1)(2008-11#18)(2008-12#3)(2008-7#2)(2010-3#1)(2010-5#2)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-7#1)
the student's learning##2##3##(2008-11#1)(2013-1#1)
the student's##7##2##(2008-11#4)(2009-7#1)(2011-2#1)(2013-1#1)
the students and##9##3##(1994-6#1)(2006-7#1)(2008-11#2)(2008-12#1)(2009-11#1)(2010-3#1)(2013-8#2)
the students delivered between##2##4##(2013-1#2)
the students in the##2##4##(2005-10#1)(2008-12#1)
the students in##6##3##(1992-6#1)(2005-10#1)(2008-11#3)(2008-12#1)
the students is##2##3##(2008-11#1)(2011-2#1)
the students of the##2##4##(2008-9#1)(2013-1#1)
the students of##4##3##(2007-2#1)(2008-9#1)(2010-2#1)(2013-1#1)
the students presenting to##2##4##(2011-1#2)
the students should##2##3##(1992-6#1)(2005-10#1)
the students to##7##3##(1993-1#1)(2006-2#1)(2007-1#1)(2008-11#1)(2012-2#1)(2013-8#2)
the students was##3##3##(2007-10#2)(2013-1#1)
the students were##6##3##(2007-2#1)(2008-11#1)(2008-12#1)(2010-3#1)(2011-2#2)
the students##110##2##(1991-9#1)(1992-5#1)(1992-6#7)(1993-1#1)(1993-3#4)(1994-6#2)(2005-10#5)(2005-7#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-1#1)(2007-10#4)(2007-12#1)(2007-2#2)(2008-11#24)(2008-12#4)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-3#3)(2011-1#5)(2011-2#7)(2012-1#3)(2012-2#2)(2012-3#1)(2013-1#8)(2013-8#13)
the students' experiences##5##3##(2005-8#1)(2008-11#2)(2008-12#1)(2009-8#1)
the students' feedback##2##3##(2013-8#2)
the students' needs##3##3##(1995-1#1)(2008-12#1)(2012-3#1)
the students' perceptions of##3##4##(2008-11#2)(2012-3#1)
the students' perceptions##5##3##(2008-11#2)(2009-7#1)(2012-3#1)(2013-8#1)
the students'##32##2##(1995-1#1)(2005-10#1)(2005-8#1)(2006-12#1)(2007-12#1)(2008-11#9)(2008-12#3)(2009-7#1)(2009-8#1)(2010-10#1)(2010-3#2)(2012-3#5)(2013-8#5)
the studied HS##2##3##(2008-10#2)
the studied area##2##3##(1991-6#1)(2008-10#1)
the studied areas##2##3##(2008-10#1)(2011-1#1)
the studied case##2##3##(2008-10#1)(2008-2#1)
the studied compounds##5##3##(2008-10#4)(2008-5#1)
the studied conditions##2##3##(2008-10#1)(2013-1#1)
the studied drugs with##2##4##(2008-10#2)
the studied drugs##5##3##(2008-10#5)
the studied gene##4##3##(2008-2#1)(2008-4#1)(2010-12#1)(2012-3#1)
the studied isolates##2##3##(2010-4#2)
the studied metals##3##3##(2008-10#3)
the studied parameters##4##3##(2008-12#1)(2008-4#1)(2008-7#1)(2009-6#1)
the studied period##2##3##(2007-11#1)(2008-10#1)
the studied population##8##3##(2006-10#1)(2007-7#2)(2008-3#1)(2009-1#1)(2010-8#1)(2010-9#1)(2013-1#1)
the studied species##3##3##(2008-7#1)(2009-2#1)(2012-2#1)
the studied strains##3##3##(2007-10#1)(2007-7#1)(2010-4#1)
the studied##149##2##(1990-10#1)(1990-3#1)(1990-6#1)(1991-6#1)(1992-2#1)(1993-2#1)(1994-2#2)(1995-2#1)(1996-5#1)(1997-2#1)(2004-12#1)(2005-11#3)(2006-10#4)(2006-12#1)(2007-1#1)(2007-10#4)(2007-11#3)(2007-12#2)(2007-2#1)(2007-7#3)(2007-8#3)(2008-10#49)(2008-11#1)(2008-12#4)(2008-2#3)(2008-3#5)(2008-4#4)(2008-5#5)(2008-7#2)(2009-1#2)(2009-2#4)(2009-3#1)(2009-5#1)(2009-6#1)(2010-12#3)(2010-3#2)(2010-4#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#3)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#3)
the studies aimed at##2##4##(1994-5#1)(2008-7#1)
the studies are##4##3##(1992-3#1)(2006-2#1)(2008-12#1)(2011-2#1)
the studies have##5##3##(2006-4#1)(2007-1#1)(2008-10#1)(2008-3#1)(2012-3#1)
the studies in the##2##4##(2008-12#1)(2011-1#1)
the studies in##4##3##(2006-1#1)(2006-10#1)(2008-12#1)(2011-1#1)
the studies included##2##3##(2008-10#1)(2013-8#1)
the studies involved##3##3##(2008-4#1)(2011-1#1)(2011-2#1)
the studies is##3##3##(1996-9#1)(2011-1#1)(2011-2#1)
the studies of the##3##4##(1996-2#1)(2008-3#1)(2008-4#1)
the studies of##25##3##(1992-3#1)(1995-2#1)(1995-6#1)(1996-2#1)(2005-4#1)(2006-10#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-2#1)(2013-1#1)
the studies on##12##3##(1991-4#1)(1992-4#1)(1994-6#1)(2006-8#1)(2007-8#1)(2008-10#3)(2008-8#1)(2010-4#1)(2012-1#1)(2013-7#1)
the studies performed##2##3##(2008-10#1)(2012-12#1)
the studies presented here##2##4##(1992-11#1)(2011-2#1)
the studies presented##4##3##(1992-11#1)(2008-12#1)(2008-3#1)(2011-2#1)
the studies reported##2##3##(2008-10#1)(2011-2#1)
the studies reviewed in this article##2##6##(2009-6#1)(2011-12#1)
the studies reviewed##4##3##(2008-7#1)(2009-4#1)(2009-6#1)(2011-12#1)
the studies suggest##2##3##(1990-6#1)(2012-3#1)
the studies that have##2##4##(1992-3#1)(2007-8#1)
the studies that##3##3##(1992-3#1)(2007-8#1)(2010-12#1)
the studies to##2##3##(1997-4#1)(2009-7#1)
the studies was##2##3##(2008-10#1)(2011-2#1)
the studies we##2##3##(2008-3#2)
the studies were##3##3##(2008-11#1)(2008-8#1)(2009-2#1)
the studies which##2##3##(2013-8#2)
the studies##159##2##(1990-6#1)(1991-4#1)(1992-11#3)(1992-3#4)(1992-4#1)(1992-8#1)(1993-11#1)(1993-8#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-5#2)(1996-9#5)(1997-1#1)(1997-4#1)(1997-5#1)(2005-10#2)(2005-3#1)(2005-4#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-11#4)(2007-12#1)(2007-2#3)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#13)(2008-11#6)(2008-12#4)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-2#2)(2009-4#1)(2009-6#3)(2009-7#1)(2009-9#2)(2010-12#5)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#12)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#4)
the study (age##2##3##(2008-3#1)(2008-4#1)
the study (n =##3##4##(2008-11#1)(2010-2#1)(2013-1#1)
the study also##2##3##(1997-7#1)(2006-10#1)
the study and application of##2##5##(2008-10#1)(2008-5#1)
the study and control##2##4##(2011-11#1)(2013-8#1)
the study and randomly##2##4##(2007-9#1)(2009-5#1)
the study and the##5##4##(1991-12#1)(1993-12#1)(2007-8#1)(2008-6#1)(2008-9#1)
the study and therapy of testicular##2##6##(2007-5#2)
the study and therapy of##3##5##(2006-10#1)(2007-5#2)
the study and were##5##4##(1992-10#1)(2008-11#1)(2010-4#1)(2011-2#2)
the study and##52##3##(1990-10#2)(1991-12#1)(1992-10#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-5#1)(1994-3#1)(1995-2#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-5#2)(2007-8#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#2)(2009-11#1)(2009-5#1)(2010-4#1)(2011-11#1)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
the study are##7##3##(1997-8#1)(2007-10#1)(2008-11#2)(2008-7#1)(2011-2#1)(2013-1#1)
the study area##26##3##(1995-9#2)(2007-10#3)(2007-2#2)(2007-5#1)(2007-6#1)(2008-12#4)(2008-5#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
the study areas##3##3##(1995-3#1)(2011-1#1)(2013-1#1)
the study as##3##3##(1992-11#1)(1997-5#1)(2006-11#1)
the study because##2##3##(1992-8#1)(2010-1#1)
the study by##15##3##(2006-10#1)(2007-1#1)(2007-7#1)(2007-8#1)(2007-9#6)(2008-10#2)(2008-12#1)(2008-7#1)(2009-6#1)
the study clearly##4##3##(1993-1#1)(1994-6#1)(2006-1#1)(2008-11#1)
the study cohort and a##2##5##(2009-10#2)
the study cohort and##3##4##(2009-10#3)
the study cohort##6##3##(2006-8#1)(2008-2#1)(2009-10#4)
the study compares the##2##4##(2007-4#1)(2008-8#1)
the study concludes that##2##4##(1994-3#1)(2007-3#1)
the study consisted of##2##4##(2008-10#1)(2012-1#1)
the study counties##2##3##(1991-3#2)
the study demonstrated that the##2##5##(1996-1#1)(2012-12#1)
the study demonstrated that##4##4##(1996-1#1)(2012-12#2)(2012-2#1)
the study described here##2##4##(2011-2#1)(2012-1#1)
the study described##3##3##(1991-2#1)(2011-2#1)(2012-1#1)
the study design and##4##4##(1996-11#1)(2007-7#1)(2009-4#1)(2011-1#1)
the study design##13##3##(1994-5#1)(1996-11#1)(1997-7#1)(2005-7#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-7#2)(2009-4#1)(2010-2#1)(2011-1#1)(2011-2#1)
the study due to##3##4##(1990-5#1)(2008-3#1)(2008-9#1)
the study duration##3##3##(2008-5#1)(2012-3#2)
the study findings##5##3##(1991-12#1)(1993-12#1)(2008-7#1)(2011-1#2)
the study focuses on##2##4##(2008-11#1)(2010-12#1)
the study for##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
the study found##2##3##(1995-3#1)(2011-2#1)
the study group and##2##4##(2009-10#1)(2011-1#1)
the study group as compared to those##2##7##(2013-8#2)
the study group as##3##4##(2008-6#1)(2013-8#2)
the study group because##2##4##(2007-9#1)(2011-1#1)
the study group had##2##4##(2006-8#1)(2008-6#1)
the study group was##3##4##(2007-7#1)(2008-1#1)(2011-2#1)
the study group##50##3##(1991-12#2)(1993-12#3)(1993-8#1)(2004-10#2)(2006-10#1)(2006-7#2)(2006-8#5)(2007-10#1)(2007-6#1)(2007-7#6)(2007-8#1)(2007-9#3)(2008-1#2)(2008-4#1)(2008-6#2)(2008-7#1)(2009-10#4)(2009-3#1)(2011-1#5)(2011-2#1)(2013-1#1)(2013-8#4)
the study groups were##2##4##(2007-7#1)(2013-8#1)
the study groups##7##3##(1995-11#1)(1997-2#1)(2007-7#1)(2008-7#1)(2009-8#1)(2013-8#2)
the study has##5##3##(1997-3#1)(2007-10#1)(2008-12#1)(2010-6#1)(2011-2#1)
the study have been##2##4##(1994-3#1)(2007-1#1)
the study have since##2##4##(1997-1#1)(2007-10#1)
the study have##5##3##(1994-3#1)(1997-1#1)(2007-1#1)(2007-10#1)(2011-1#1)
the study identified a##2##4##(2007-9#1)(2009-4#1)
the study identified##3##3##(2007-9#1)(2009-4#1)(2012-2#1)
the study in the##3##4##(1996-6#1)(2008-7#1)(2011-2#1)
the study in which##3##4##(2010-9#1)(2012-2#1)(2013-8#1)
the study in##13##3##(1990-9#1)(1995-1#1)(1996-6#1)(2006-6#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
the study included##9##3##(1992-2#1)(1996-1#2)(1997-8#1)(2006-10#1)(2007-10#1)(2008-11#1)(2010-12#1)(2010-3#1)
the study indicated that##3##4##(1993-5#1)(2007-10#1)(2008-1#1)
the study indicates the##2##4##(1990-2#1)(2007-3#1)
the study indicates##3##3##(1990-2#1)(2007-3#1)(2013-8#1)
the study interval##3##3##(2006-10#3)
the study into the##2##4##(2006-6#2)
the study is the##3##4##(2007-11#1)(2009-2#1)(2010-11#1)
the study is##40##3##(1990-2#1)(1993-3#1)(1997-3#1)(2006-11#1)(2006-6#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-8#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-2#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2011-3#2)(2012-12#2)(2012-3#3)(2013-1#3)(2013-8#1)
the study objective##2##3##(2008-5#1)(2010-10#1)
the study of a variety of##3##6##(2008-4#1)(2012-1#1)(2012-3#1)
the study of a##9##4##(1990-8#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-4#2)(2012-1#1)(2012-3#1)
the study of an organic##2##5##(2008-3#1)(2008-7#1)
the study of an##4##4##(2008-3#1)(2008-7#1)(2013-8#2)
the study of ancient##2##4##(2008-10#2)
the study of biofilms##2##4##(2008-9#2)
the study of biological##3##4##(1993-4#1)(2006-5#1)(2011-3#1)
the study of bladder tumors and##2##6##(2007-10#2)
the study of both##3##4##(1990-5#1)(1996-8#1)(2008-2#1)
the study of cancer##5##4##(1994-2#2)(2007-10#1)(2007-6#1)(2009-5#1)
the study of cell##3##4##(2007-12#1)(2008-1#1)(2008-9#1)
the study of cerebral##2##4##(1990-5#1)(2008-7#1)
the study of cholesterol##2##4##(1993-3#1)(2013-1#1)
the study of colloidal##2##4##(2007-11#1)(2008-3#1)
the study of complex##3##4##(2007-12#2)(2011-1#1)
the study of developmental biology##2##5##(2008-11#1)(2008-9#1)
the study of different##2##4##(2004-10#1)(2008-11#1)
the study of differentiation##2##4##(1991-10#1)(2009-4#1)
the study of environmental##2##4##(1996-3#1)(2012-1#1)
the study of enzyme##2##4##(1990-10#1)(1997-1#1)
the study of evolution##2##4##(2008-8#1)(2010-5#1)
the study of functional##3##4##(2006-12#1)(2008-7#1)(2009-5#1)
the study of fundamental##2##4##(2007-11#1)(2008-7#1)
the study of gene expression and##2##6##(2008-4#1)(2008-9#1)
the study of gene expression##4##5##(1994-3#1)(2008-4#2)(2008-9#1)
the study of gene##8##4##(1990-10#1)(1994-3#1)(2006-10#1)(2007-6#1)(2008-4#2)(2008-8#1)(2008-9#1)
the study of genetic##2##4##(1990-12#1)(1993-9#1)
the study of genetics##2##4##(2008-4#2)
the study of heart##2##4##(2007-9#1)(2013-1#1)
the study of how##4##4##(1990-8#1)(2008-8#2)(2009-5#1)
the study of human development##2##5##(1993-12#1)(2006-3#1)
the study of human disease##2##5##(2008-4#1)(2008-7#1)
the study of human##16##4##(1991-10#1)(1993-12#1)(1997-6#1)(2006-10#1)(2006-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#3)(2008-7#1)(2008-8#1)(2012-1#1)(2012-3#1)
the study of individual differences##2##5##(2004-3#1)(2011-12#1)
the study of its##7##4##(1990-4#1)(1990-7#1)(2005-8#1)(2006-12#1)(2008-4#1)(2008-5#1)(2008-7#1)
the study of local##3##4##(1991-9#1)(2008-7#1)(2013-8#1)
the study of metabolic##2##4##(1996-2#1)(2008-3#1)
the study of microbial##2##4##(2005-11#1)(2008-9#1)
the study of neural##2##4##(2008-4#1)(2008-7#1)
the study of other##5##4##(2007-12#1)(2007-6#1)(2008-3#1)(2008-4#1)(2012-3#1)
the study of plant##3##4##(2008-9#1)(2013-8#2)
the study of post-translational##2##4##(1993-6#1)(2008-4#1)
the study of protein##3##4##(1991-12#1)(2011-1#1)(2012-1#1)
the study of small##2##4##(2006-10#1)(2010-12#1)
the study of specific##3##4##(1995-6#1)(2008-7#1)(2010-5#1)
the study of the dynamics of##2##6##(1994-3#1)(2007-11#1)
the study of the mechanism of##2##6##(1991-5#1)(2008-9#1)
the study of the mechanisms of##2##6##(2009-10#1)(2010-12#1)
the study of the mechanisms##3##5##(2007-11#1)(2009-10#1)(2010-12#1)
the study of the optical##3##5##(2008-3#3)
the study of the plasma levels of HCII was undertaken in women taking##2##13##(1990-11#2)
the study of the regulation of##2##6##(1991-9#1)(2008-11#1)
the study of the relationship between##2##6##(2007-2#1)(2008-8#1)
the study of the relationship##3##5##(2007-2#1)(2008-10#1)(2008-8#1)
the study of the relationships between##2##6##(1991-6#1)(2010-8#1)
the study of the##106##4##(1990-11#2)(1990-4#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-5#1)(2004-9#1)(2005-11#3)(2005-9#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#15)(2008-11#3)(2008-2#4)(2008-3#6)(2008-4#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-8#1)(2011-1#3)(2011-10#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
the study of their##3##4##(1994-6#1)(1996-12#1)(2009-2#1)
the study of these##6##4##(1994-8#1)(2006-10#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)
the study of turbulent##2##4##(2008-2#1)(2008-3#1)
the study of two##4##4##(1990-3#1)(2008-10#1)(2011-1#1)(2012-2#1)
the study of type##2##4##(1993-6#1)(2008-1#1)
the study of##577##3##(1990-1#1)(1990-10#2)(1990-11#3)(1990-12#3)(1990-3#1)(1990-4#5)(1990-5#4)(1990-7#1)(1990-8#4)(1991-10#3)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#7)(1991-6#1)(1991-9#5)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-4#3)(1993-6#3)(1993-7#1)(1993-9#3)(1994-1#2)(1994-10#2)(1994-11#2)(1994-2#3)(1994-3#4)(1994-5#1)(1994-6#4)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#1)(1996-1#1)(1996-12#4)(1996-2#1)(1996-3#4)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#2)(2004-10#2)(2004-3#1)(2004-9#4)(2005-10#1)(2005-11#5)(2005-4#2)(2005-6#1)(2005-7#1)(2005-8#2)(2005-9#4)(2006-10#15)(2006-11#1)(2006-12#4)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#2)(2006-8#1)(2006-9#2)(2007-10#3)(2007-11#6)(2007-12#13)(2007-2#2)(2007-4#2)(2007-6#3)(2007-7#9)(2007-8#4)(2007-9#5)(2008-1#12)(2008-10#53)(2008-11#21)(2008-12#2)(2008-2#19)(2008-3#19)(2008-4#31)(2008-5#5)(2008-6#3)(2008-7#23)(2008-8#16)(2008-9#19)(2009-10#3)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#5)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#5)(2010-1#1)(2010-11#4)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#5)(2010-6#3)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#14)(2011-10#1)(2011-12#1)(2011-2#9)(2011-3#3)(2012-1#6)(2012-12#1)(2012-2#10)(2012-3#10)(2013-1#8)(2013-7#1)(2013-8#8)
the study on the##3##4##(1991-2#1)(2006-2#1)(2010-12#1)
the study on##7##3##(1991-2#1)(2006-2#1)(2008-10#2)(2008-9#1)(2010-12#1)(2010-3#1)
the study participants##6##3##(2007-11#1)(2008-12#1)(2009-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
the study patients and controls##2##5##(2008-1#2)
the study patients were##4##4##(2007-7#1)(2008-1#3)
the study patients##19##3##(2007-7#4)(2008-1#14)(2013-1#1)
the study period and##5##4##(2007-7#2)(2008-10#1)(2013-1#2)
the study period for##2##4##(2006-8#2)
the study period the##3##4##(2006-10#1)(2008-4#1)(2013-7#1)
the study period was##3##4##(2006-8#1)(2010-3#1)(2012-12#1)
the study period were##4##4##(2006-8#1)(2007-12#1)(2010-9#1)(2013-1#1)
the study period##120##3##(1990-8#1)(1991-8#1)(1992-5#1)(1993-9#1)(1994-12#1)(1997-5#1)(2006-10#11)(2006-12#3)(2006-7#1)(2006-8#13)(2007-10#2)(2007-12#1)(2007-2#2)(2007-3#4)(2007-5#2)(2007-7#5)(2007-8#4)(2007-9#3)(2008-1#2)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-7#1)(2010-3#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#6)(2012-2#7)(2012-3#1)(2013-1#10)(2013-7#3)(2013-8#4)
the study population had##2##4##(1990-2#1)(2006-2#1)
the study population of##2##4##(2011-2#2)
the study population was##6##4##(1997-2#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-7#1)(2013-1#1)
the study population were##3##4##(2007-8#1)(2008-5#1)(2011-2#1)
the study population##36##3##(1990-2#1)(1993-12#1)(1993-9#1)(1996-3#1)(1997-2#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-3#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-2#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#2)
the study protocol##3##3##(1992-11#1)(2008-8#1)(2013-1#1)
the study provided##2##3##(1992-12#1)(2007-7#1)
the study region##4##3##(1991-2#1)(1995-4#1)(2007-2#1)(2008-5#1)
the study reported##9##3##(1992-3#1)(1995-8#1)(2007-9#1)(2009-4#1)(2011-2#4)(2013-8#1)
the study results##4##3##(1992-12#1)(2007-7#1)(2007-8#1)(2008-7#1)
the study seeks to##2##4##(2005-2#1)(2011-1#1)
the study show that##4##4##(1991-5#1)(1995-10#1)(2008-7#1)(2010-7#1)
the study showed good##2##4##(1990-6#1)(2008-10#1)
the study showed that##11##4##(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
the study showed##17##3##(1990-6#1)(1996-2#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-5#1)(2008-6#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
the study shows how##2##4##(1993-2#1)(2013-1#1)
the study shows##3##3##(1993-2#1)(2007-7#1)(2013-1#1)
the study site##6##3##(2004-11#1)(2007-3#1)(2008-10#2)(2008-5#1)(2011-12#1)
the study sites##6##3##(2006-8#1)(2007-2#1)(2008-12#2)(2008-5#1)(2012-12#1)
the study so that##2##4##(1994-3#1)(2007-3#1)
the study subjects##7##3##(1990-8#1)(1992-12#1)(1994-2#1)(2007-2#1)(2008-1#1)(2011-2#1)(2013-1#1)
the study successfully##2##3##(2010-12#1)(2012-2#1)
the study suggests##3##3##(1990-5#1)(2007-7#1)(2010-8#1)
the study that##4##3##(2006-8#1)(2007-12#1)(2007-6#1)(2008-7#1)
the study the##6##3##(2007-2#1)(2007-8#1)(2008-12#2)(2008-5#1)(2008-8#1)
the study to assess the##3##5##(2005-8#1)(2007-10#1)(2007-7#1)
the study to##13##3##(1991-2#1)(1992-12#1)(1992-3#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2009-5#1)(2012-3#1)
the study using##2##3##(2008-3#1)(2008-7#1)
the study was closed##2##4##(1992-2#1)(2008-6#1)
the study was conducted##2##4##(2008-3#1)(2013-1#1)
the study was descriptive##2##4##(1993-3#1)(2010-3#1)
the study was retrospective##2##4##(2007-11#1)(2012-3#1)
the study was to analyze##6##5##(1997-8#1)(2007-8#2)(2008-12#1)(2011-2#1)(2012-3#1)
the study was to investigate the##11##6##(1991-10#1)(1994-6#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-5#1)(2009-6#1)(2010-1#1)(2010-12#2)(2010-3#1)
the study was to investigate##17##5##(1991-10#1)(1994-6#1)(1995-1#1)(2005-10#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-5#2)(2008-9#1)(2009-6#1)(2010-1#1)(2010-12#2)(2010-3#1)
the study was to##188##4##(1990-10#1)(1990-2#2)(1990-8#2)(1991-10#1)(1991-12#1)(1991-5#1)(1992-3#1)(1993-1#1)(1993-2#2)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#3)(1997-3#1)(1997-8#3)(2004-10#2)(2004-12#1)(2005-1#1)(2005-10#2)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#6)(2007-1#2)(2007-10#4)(2007-11#4)(2007-12#2)(2007-2#3)(2007-3#1)(2007-5#1)(2007-7#7)(2007-8#11)(2007-9#4)(2008-1#2)(2008-11#5)(2008-12#4)(2008-3#1)(2008-4#5)(2008-5#8)(2008-6#2)(2008-7#6)(2008-9#3)(2009-2#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#6)(2011-12#4)(2011-2#9)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#11)(2013-7#1)(2013-8#4)
the study was##238##3##(1990-10#1)(1990-2#2)(1990-8#2)(1991-10#1)(1991-12#2)(1991-5#1)(1991-6#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-2#2)(1993-3#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-6#1)(1995-9#1)(1996-12#2)(1996-3#2)(1996-4#1)(1996-6#1)(1996-9#3)(1997-3#1)(1997-8#3)(2004-10#2)(2004-12#1)(2005-1#1)(2005-10#2)(2006-10#3)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#2)(2006-7#4)(2006-8#6)(2007-1#2)(2007-10#4)(2007-11#9)(2007-12#2)(2007-2#4)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#9)(2007-8#15)(2007-9#4)(2008-1#3)(2008-10#2)(2008-11#6)(2008-12#5)(2008-3#3)(2008-4#5)(2008-5#9)(2008-6#3)(2008-7#7)(2008-9#3)(2009-2#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#2)(2010-8#2)(2010-9#1)(2011-1#8)(2011-12#4)(2011-2#13)(2012-1#2)(2012-12#5)(2012-2#6)(2012-3#4)(2013-1#12)(2013-7#1)(2013-8#4)
the study we##3##3##(1990-4#1)(1995-5#1)(2008-9#1)
the study were as follows##4##5##(1990-10#1)(2004-11#1)(2007-8#1)(2007-9#1)
the study were included##2##4##(2006-8#1)(2008-4#1)
the study were##47##3##(1990-10#2)(1991-1#1)(1991-10#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-9#1)(1994-6#1)(1995-9#1)(1996-1#1)(2004-11#1)(2005-10#1)(2006-7#1)(2006-8#3)(2007-10#1)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#3)(2008-8#2)(2010-1#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
the study which##2##3##(2009-4#1)(2013-8#1)
the study will be##2##4##(2007-3#1)(2007-7#1)
the study will##3##3##(2007-3#1)(2007-7#1)(2011-2#1)
the study with a mean##2##5##(2006-1#1)(2007-7#1)
the study with a##4##4##(2006-1#1)(2007-1#1)(2007-7#1)(2008-4#1)
the study with##9##3##(2006-1#1)(2007-1#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2013-8#1)
the study would##3##3##(1994-5#1)(1994-9#1)(2013-1#1)
the study##2162##2##(1990-1#1)(1990-10#8)(1990-11#4)(1990-12#5)(1990-2#6)(1990-3#2)(1990-4#7)(1990-5#8)(1990-6#2)(1990-7#2)(1990-8#9)(1990-9#4)(1991-1#2)(1991-10#9)(1991-11#1)(1991-12#10)(1991-2#8)(1991-3#4)(1991-4#1)(1991-5#10)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#5)(1992-1#3)(1992-10#4)(1992-11#6)(1992-12#8)(1992-2#4)(1992-3#6)(1992-4#3)(1992-5#7)(1992-6#3)(1992-7#2)(1992-8#2)(1992-9#2)(1993-1#7)(1993-10#1)(1993-11#2)(1993-12#13)(1993-2#3)(1993-3#4)(1993-4#3)(1993-5#2)(1993-6#3)(1993-7#2)(1993-8#1)(1993-9#8)(1994-1#2)(1994-10#2)(1994-11#2)(1994-12#3)(1994-2#7)(1994-3#12)(1994-5#3)(1994-6#8)(1994-7#2)(1994-8#2)(1994-9#3)(1995-1#7)(1995-10#1)(1995-11#3)(1995-2#6)(1995-3#3)(1995-4#2)(1995-5#2)(1995-6#4)(1995-7#1)(1995-8#3)(1995-9#4)(1996-1#11)(1996-11#2)(1996-12#7)(1996-2#3)(1996-3#9)(1996-4#2)(1996-5#5)(1996-6#3)(1996-8#3)(1996-9#4)(1997-1#2)(1997-2#5)(1997-3#3)(1997-4#2)(1997-5#6)(1997-6#2)(1997-7#5)(1997-8#8)(2004-1#1)(2004-10#8)(2004-11#5)(2004-12#5)(2004-2#2)(2004-3#3)(2004-9#5)(2005-1#1)(2005-10#5)(2005-11#6)(2005-12#1)(2005-2#1)(2005-4#2)(2005-5#1)(2005-6#1)(2005-7#2)(2005-8#3)(2005-9#5)(2006-1#2)(2006-10#51)(2006-11#3)(2006-12#14)(2006-2#13)(2006-3#1)(2006-4#1)(2006-5#6)(2006-6#12)(2006-7#13)(2006-8#43)(2006-9#4)(2007-1#9)(2007-10#35)(2007-11#26)(2007-12#26)(2007-2#32)(2007-3#21)(2007-4#6)(2007-5#7)(2007-6#9)(2007-7#79)(2007-8#48)(2007-9#29)(2008-1#48)(2008-10#106)(2008-11#51)(2008-12#31)(2008-2#24)(2008-3#36)(2008-4#50)(2008-5#59)(2008-6#17)(2008-7#76)(2008-8#35)(2008-9#66)(2009-10#12)(2009-11#2)(2009-12#4)(2009-2#5)(2009-3#5)(2009-4#10)(2009-5#12)(2009-6#6)(2009-7#7)(2009-8#5)(2009-9#5)(2010-1#9)(2010-10#6)(2010-11#9)(2010-12#14)(2010-2#10)(2010-3#13)(2010-4#10)(2010-5#9)(2010-6#6)(2010-7#5)(2010-8#18)(2010-9#9)(2011-1#66)(2011-10#1)(2011-11#2)(2011-12#9)(2011-2#88)(2011-3#5)(2012-1#18)(2012-11#1)(2012-12#46)(2012-2#51)(2012-3#33)(2013-1#77)(2013-7#9)(2013-8#42)
the study's results##2##3##(1992-10#1)(1996-1#1)
the study's##9##2##(1991-2#1)(1992-10#1)(1995-1#2)(1996-1#1)(2007-12#2)(2012-3#1)(2013-1#1)
the study)##4##2##(1993-7#1)(2006-10#1)(2008-4#1)(2013-1#1)
the stump of the##2##4##(2007-11#1)(2007-8#1)
the stump##7##2##(1991-6#1)(2007-11#3)(2007-7#1)(2007-8#1)(2011-2#1)
the stunned##2##2##(1996-9#2)
the stunning##3##2##(1996-9#1)(2011-1#2)
the style and##2##3##(2008-10#2)
the style##7##2##(2008-10#3)(2009-12#4)
the stylet is##2##3##(2010-8#2)
the stylet##6##2##(1997-5#2)(2008-10#2)(2010-8#2)
the styrene ring##2##3##(1995-10#2)
the sub##6##2##(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)
the sub-groups##3##2##(2007-7#1)(2008-2#2)
the sub-isoforms of##2##3##(2008-10#2)
the sub-nanogram##2##2##(2008-10#2)
the sub-picosecond##2##2##(1995-1#2)
the sub-sample##2##2##(1997-2#1)(2008-10#1)
the sub-surface##2##2##(2009-7#2)
the subacromial##3##2##(1995-5#1)(2007-11#1)(2008-7#1)
the subacute phase##3##3##(1995-9#2)(2007-10#1)
the subacute##8##2##(1994-12#1)(1995-9#2)(2006-7#1)(2007-10#1)(2008-8#1)(2011-2#2)
the subapical##3##2##(2008-10#1)(2008-7#1)(2009-8#1)
the subarachnoid and##2##3##(2006-12#1)(2007-10#1)
the subarachnoid space##14##3##(1992-8#1)(2006-12#2)(2006-5#2)(2008-7#9)
the subarachnoid##22##2##(1992-8#1)(1995-11#1)(2006-12#3)(2006-5#3)(2007-10#1)(2008-7#12)(2009-6#1)
the subcapsular space##2##3##(2013-1#2)
the subcapsular##4##2##(2012-2#1)(2012-3#1)(2013-1#2)
the subcellular distribution of the##3##5##(1993-9#1)(1996-5#1)(1997-6#1)
the subcellular distribution of##11##4##(1991-7#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-3#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-6#1)(2005-7#1)
the subcellular distribution##14##3##(1991-7#1)(1993-2#1)(1993-9#1)(1994-10#2)(1994-12#2)(1994-3#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-6#1)(2005-7#1)
the subcellular localization of the##4##5##(1993-9#1)(1997-4#1)(2009-8#1)(2011-1#1)
the subcellular localization of##14##4##(1992-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-7#1)(1997-4#1)(1997-6#1)(2006-7#1)(2007-12#1)(2008-7#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#1)
the subcellular localization##15##3##(1992-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-5#1)(1995-7#1)(1997-4#1)(1997-6#1)(2006-7#1)(2007-12#1)(2008-7#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#1)
the subcellular locations of##2##4##(2008-4#1)(2011-2#1)
the subcellular targeting##2##3##(2012-12#2)
the subcellular##41##2##(1991-5#1)(1991-7#1)(1992-6#1)(1993-2#1)(1993-9#2)(1994-10#2)(1994-11#1)(1994-12#3)(1994-3#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-6#2)(1997-7#1)(2005-7#1)(2006-7#1)(2007-12#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#3)
the subchannel##2##2##(2007-11#2)
the subchondral bone##6##3##(2006-3#1)(2007-11#3)(2008-5#1)(2008-8#1)
the subchondral##11##2##(2006-3#1)(2007-11#6)(2008-5#2)(2008-8#1)(2011-2#1)
the subclass of##2##3##(1991-4#1)(2009-9#1)
the subclass##5##2##(1991-4#1)(1993-12#1)(1993-6#1)(2008-8#1)(2009-9#1)
the subclavian artery##6##3##(1993-3#2)(2007-11#1)(2008-7#2)(2009-3#1)
the subclavian vein##7##3##(2007-7#4)(2008-1#1)(2012-2#2)
the subclavian##16##2##(1993-3#2)(2007-11#1)(2007-12#1)(2007-7#4)(2007-9#1)(2008-1#1)(2008-7#3)(2009-3#1)(2012-2#2)
the subclavicular approach##4##3##(2012-12#4)
the subclavicular##6##2##(2012-12#6)
the subclinical##3##2##(2006-2#1)(2008-5#1)(2013-4#1)
the subcommissural##2##2##(1993-6#1)(1997-5#1)
the subcontinent##3##2##(2007-2#1)(2008-10#1)(2008-4#1)
the subcortex##3##2##(2007-9#2)(2008-3#1)
the subcortical##5##2##(1991-11#1)(1992-10#1)(1992-7#1)(1993-4#1)(2009-6#1)
the subcutaneous adipocytes##2##3##(2007-7#1)(2008-1#1)
the subcutaneous fat##3##3##(2007-6#1)(2010-11#1)(2011-2#1)
the subcutaneous tissue##6##3##(2004-9#1)(2007-7#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-12#1)
the subcutaneous tissues##3##3##(1990-12#1)(2006-10#1)(2006-9#1)
the subcutaneous##31##2##(1990-12#1)(1995-5#2)(1996-8#2)(1997-4#1)(1997-7#1)(2004-9#3)(2006-10#2)(2006-9#1)(2007-11#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-9#1)(2009-6#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
the subcutis and##2##3##(2005-7#1)(2008-5#1)
the subcutis##5##2##(2005-7#2)(2007-12#1)(2008-5#1)(2008-6#1)
the subdomain##3##2##(1991-4#1)(1997-5#2)
the subdural hematoma##2##3##(2006-8#1)(2008-7#1)
the subdural##4##2##(2006-8#1)(2008-5#1)(2008-7#1)(2010-12#1)
the subendocardial##2##2##(2009-12#1)(2009-4#1)
the subendothelial##2##2##(2008-11#1)(2013-8#1)
the subepithelial location of the##2##5##(1992-7#1)(2009-8#1)
the subepithelial##8##2##(1991-2#1)(1992-7#2)(2007-8#1)(2009-8#1)(2011-12#1)(2013-1#1)(2013-7#1)
the subesophageal ganglion##5##3##(1995-5#1)(2007-12#1)(2008-5#2)(2008-9#1)
the subfamily Pooideae##3##3##(2008-10#2)(2008-8#1)
the subfamily##15##2##(1995-11#2)(1997-4#1)(2006-8#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-8#1)(2010-3#1)(2012-12#1)(2013-7#2)(2013-8#1)
the subfields##2##2##(1995-3#2)
the subfornical organ##4##3##(1994-2#2)(1995-6#1)(2008-4#1)
the subgel phase of##2##4##(2006-10#2)
the subgel phase##3##3##(2006-10#3)
the subgel##4##2##(2006-10#4)
the subgenus##3##2##(1997-4#2)(2008-6#1)
the subgingival microbiota##2##3##(2008-5#1)(2012-12#1)
the subgingival##3##2##(2008-12#1)(2008-5#1)(2012-12#1)
the subglottic##3##2##(2007-9#1)(2012-12#1)(2013-1#1)
the subgroup I##2##3##(2008-10#2)
the subgroup of patients with occluded &quot##2##7##(1997-8#2)
the subgroup of patients with##3##5##(1997-8#2)(2008-8#1)
the subgroup of patients##4##4##(1994-6#1)(1997-8#2)(2008-8#1)
the subgroup of##10##3##(1990-11#1)(1994-6#1)(1997-8#2)(2006-10#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-8#1)
the subgroup with##2##3##(2005-1#1)(2008-7#1)
the subgroup##25##2##(1990-11#1)(1994-12#1)(1994-6#1)(1997-8#2)(2005-1#3)(2006-10#2)(2007-10#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-1#1)(2011-12#1)(2012-2#1)
the subgroups of dementia##2##4##(1994-11#2)
the subgroups of##3##3##(1994-11#2)(2010-9#1)
the subgroups##13##2##(1991-4#1)(1991-6#1)(1994-11#2)(1995-8#1)(2005-10#1)(2006-10#2)(2008-10#1)(2008-7#1)(2010-10#1)(2010-9#1)(2011-2#1)
the subiculum##3##2##(1990-5#1)(1992-7#1)(1995-3#1)
the subisolates##2##2##(2008-10#2)
the subitizing##2##2##(2012-1#2)
the subjacent##2##2##(1997-3#1)(2008-1#1)
the subject and the##3##4##(2007-1#1)(2007-8#1)(2008-9#1)
the subject and##10##3##(1993-10#1)(1995-12#1)(1997-2#1)(1997-6#1)(2007-1#1)(2007-6#1)(2007-8#2)(2008-11#1)(2008-9#1)
the subject at the##2##4##(2006-11#1)(2013-8#1)
the subject group##2##3##(2007-10#2)
the subject has##3##3##(1991-4#1)(2008-11#1)(2011-2#1)
the subject have##2##3##(2008-11#1)(2012-2#1)
the subject in##4##3##(1991-4#1)(2009-6#1)(2011-1#1)(2011-2#1)
the subject is##12##3##(1991-5#1)(1992-8#1)(1994-11#1)(1996-12#1)(2007-1#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2012-1#1)
the subject matter##4##3##(1993-1#1)(2008-11#1)(2008-12#1)(2008-6#1)
the subject of a##3##4##(2008-1#1)(2008-11#1)(2008-2#1)
the subject of an##2##4##(2005-8#1)(2011-2#1)
the subject of considerable##2##4##(2007-11#1)(2008-6#1)
the subject of controversy##3##4##(1993-11#1)(1996-11#1)(2007-11#1)
the subject of few##2##4##(2007-3#1)(2008-12#1)
the subject of further##2##4##(1991-4#1)(2005-8#1)
the subject of increasing##2##4##(1996-3#1)(2011-2#1)
the subject of intense research##5##5##(2005-1#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-1#1)
the subject of intense##8##4##(2005-1#1)(2005-10#1)(2005-7#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)
the subject of intensive research##2##5##(2005-10#1)(2008-8#1)
the subject of intensive##4##4##(2005-10#1)(2005-7#1)(2008-5#1)(2008-8#1)
the subject of many publications##2##5##(2007-6#1)(2008-12#1)
the subject of many studies##2##5##(2008-7#1)(2010-12#1)
the subject of many##5##4##(2005-8#1)(2007-6#1)(2008-12#1)(2008-7#1)(2010-12#1)
the subject of much##2##4##(2007-8#1)(2013-7#1)
the subject of numerous##3##4##(2005-10#1)(2005-8#1)(2008-12#1)
the subject of research##3##4##(1994-2#1)(2012-1#1)(2013-7#1)
the subject of the present review##2##6##(2010-4#1)(2011-1#1)
the subject of the present study##2##6##(1991-9#1)(1993-6#1)
the subject of the present##4##5##(1991-9#1)(1993-6#1)(2010-4#1)(2011-1#1)
the subject of the##6##4##(1991-9#1)(1992-2#1)(1993-6#1)(2009-7#1)(2010-4#1)(2011-1#1)
the subject of this review##3##5##(2006-10#1)(2007-12#1)(2008-3#1)
the subject of this##7##4##(2006-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-2#1)(2011-2#1)(2013-7#1)
the subject of##95##3##(1990-2#1)(1991-1#1)(1991-4#1)(1991-9#1)(1992-2#2)(1993-11#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-11#1)(1996-3#1)(1996-8#1)(2005-1#1)(2005-10#4)(2005-7#3)(2005-8#4)(2006-10#6)(2007-11#3)(2007-12#1)(2007-3#1)(2007-6#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#4)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#4)(2011-2#4)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#3)
the subject should##2##3##(1990-6#1)(1996-1#1)
the subject to relax in the later part of expiration##2##10##(2008-7#2)
the subject to##6##3##(1995-12#1)(2008-7#2)(2009-8#1)(2012-1#1)(2013-1#1)
the subject was##4##3##(1991-3#1)(1996-3#1)(2008-12#1)(2008-9#1)
the subject were##3##3##(2006-11#1)(2008-9#1)(2013-1#1)
the subject who##2##3##(1994-6#2)
the subject with##2##3##(1993-9#1)(2012-1#1)
the subject##229##2##(1990-10#1)(1990-2#1)(1990-5#2)(1990-6#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-4#3)(1991-5#1)(1991-9#1)(1992-1#1)(1992-2#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-12#2)(1995-2#1)(1995-3#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-3#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-6#1)(2005-1#1)(2005-10#5)(2005-12#1)(2005-7#3)(2005-8#4)(2005-9#1)(2006-10#8)(2006-11#3)(2006-4#2)(2007-1#3)(2007-10#2)(2007-11#4)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#4)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#5)(2008-11#8)(2008-12#6)(2008-2#4)(2008-3#4)(2008-4#6)(2008-5#3)(2008-6#2)(2008-7#14)(2008-8#2)(2008-9#6)(2009-1#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#3)(2010-12#3)(2010-2#4)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#9)(2011-2#8)(2012-1#10)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#4)(2013-8#1)
the subject's own##4##3##(1997-8#1)(2007-6#1)(2012-2#1)(2013-8#1)
the subject's y-axis##2##3##(2006-11#2)
the subject's##22##2##(1990-12#1)(1990-5#1)(1992-1#1)(1994-2#1)(1994-8#1)(1995-11#1)(1996-5#1)(1997-8#1)(2006-11#2)(2007-5#1)(2007-6#2)(2008-11#1)(2009-11#1)(2009-12#1)(2010-7#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-8#1)
the subjective and##4##3##(2008-9#1)(2009-9#2)(2010-8#1)
the subjective assessment##2##3##(2008-3#1)(2010-4#1)
the subjective evaluation of##3##4##(1990-3#1)(2006-6#1)(2012-12#1)
the subjective experience of##3##4##(2007-8#1)(2008-7#1)(2012-2#1)
the subjective feeling of##3##4##(2007-11#1)(2012-1#1)(2013-8#1)
the subjective fluctuation##2##3##(2013-1#2)
the subjective magnitude of##2##4##(1992-12#2)
the subjective night##4##3##(1994-2#2)(1995-12#1)(2008-5#1)
the subjective norm##2##3##(1993-12#2)
the subjective quality of life##2##5##(2010-8#1)(2012-12#1)
the subjective rating of##2##4##(1996-12#1)(2007-12#1)
the subjective##45##2##(1990-3#1)(1992-12#2)(1993-12#2)(1994-2#2)(1995-12#2)(1996-12#1)(1996-5#1)(1996-9#1)(1997-8#1)(2006-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#2)(2009-9#3)(2010-4#1)(2010-8#2)(2010-9#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
the subjectivity of##2##3##(2007-3#1)(2010-4#1)
the subjectivity##3##2##(2007-12#1)(2007-3#1)(2010-4#1)
the subjects and##3##3##(1991-2#1)(2007-1#1)(2008-9#1)
the subjects can##2##3##(2008-9#1)(2012-1#1)
the subjects had##6##3##(2007-2#1)(2008-6#1)(2008-7#1)(2012-12#2)(2013-1#1)
the subjects have##2##3##(1992-3#1)(2008-3#1)
the subjects in##4##3##(1996-2#1)(2008-1#1)(2012-12#1)(2013-8#1)
the subjects of the study##2##5##(2007-7#1)(2011-1#1)
the subjects of this study##2##5##(2007-7#2)
the subjects of this##4##4##(1991-2#1)(2006-9#1)(2007-7#2)
the subjects of##9##3##(1991-2#1)(2006-9#1)(2007-2#1)(2007-7#3)(2008-8#1)(2011-1#1)(2012-3#1)
the subjects underwent a##2##4##(2010-5#1)(2013-8#1)
the subjects were asked to##3##5##(1996-2#1)(2005-10#1)(2013-8#1)
the subjects were##24##3##(1991-2#1)(1992-1#1)(1993-9#1)(1994-12#1)(1995-11#1)(1996-2#1)(1996-5#1)(1996-8#1)(2005-10#1)(2007-2#2)(2007-5#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
the subjects who##2##3##(1995-9#1)(2008-5#1)
the subjects with acne##2##4##(2010-5#2)
the subjects with##11##3##(2007-10#1)(2007-4#2)(2008-5#3)(2008-7#3)(2010-5#2)
the subjects##155##2##(1990-10#4)(1990-3#2)(1991-2#5)(1991-3#1)(1992-1#1)(1992-11#1)(1992-3#2)(1992-8#1)(1993-1#1)(1993-7#1)(1993-9#3)(1994-10#1)(1994-12#1)(1995-11#2)(1995-12#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-7#1)(2004-11#1)(2004-12#1)(2004-3#1)(2005-10#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-8#2)(2006-9#1)(2007-1#4)(2007-10#1)(2007-12#1)(2007-2#6)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#6)(2008-1#1)(2008-11#1)(2008-12#3)(2008-3#3)(2008-4#3)(2008-5#8)(2008-6#2)(2008-7#9)(2008-8#1)(2008-9#4)(2009-10#1)(2009-2#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#3)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#7)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#12)
the subjects'##15##2##(1991-1#1)(1993-7#1)(2006-3#1)(2007-1#2)(2007-10#1)(2008-11#1)(2008-12#3)(2008-4#1)(2011-2#1)(2012-1#2)(2013-8#1)
the sublethal Cd##2##3##(2004-4#1)(2008-7#1)
the subliminal fringe##2##3##(1991-3#2)
the sublingual##3##2##(2010-12#3)
the submandibular gland and##2##4##(2007-3#1)(2011-1#1)
the submandibular gland##9##3##(1992-5#3)(2007-11#2)(2007-3#1)(2008-8#1)(2011-1#1)(2011-2#1)
the submandibular glands##2##3##(2007-3#1)(2012-1#1)
the submandibular##14##2##(1992-5#3)(1995-11#1)(2005-7#1)(2007-11#2)(2007-3#2)(2008-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#1)
the submental region##2##3##(2010-11#2)
the submental##9##2##(2010-11#3)(2013-1#6)
the submerged##2##2##(2008-5#1)(2011-2#1)
the submicrometer##7##2##(1992-1#1)(2006-5#1)(2008-10#2)(2008-2#1)(2008-3#2)
the submicrostructure##2##2##(2005-11#2)
the submillimeter##6##2##(2008-2#4)(2008-3#2)
the submission##2##2##(1996-1#1)(1996-8#1)
the submitted work##3##3##(1996-1#1)(2005-1#1)(2006-6#1)
the submitted##8##2##(1991-11#1)(1995-5#1)(1996-1#1)(2005-1#1)(2006-6#3)(2011-1#1)
the submucosa of the##2##4##(1993-12#1)(1996-11#1)
the submucosa##9##2##(1993-12#1)(1995-3#1)(1996-11#1)(2005-8#1)(2006-10#1)(2008-1#1)(2008-8#1)(2011-12#1)(2011-2#1)
the submucosal layer##6##3##(1991-9#1)(2008-5#3)(2013-7#2)
the submucosal plane##2##3##(1993-9#2)
the submucosal##13##2##(1991-9#1)(1992-2#1)(1993-9#2)(2006-9#1)(2008-1#1)(2008-12#1)(2008-5#4)(2013-7#2)
the subnuclei##3##2##(1993-12#1)(1995-7#1)(2010-12#1)
the suboccipital craniotomy##3##3##(2006-5#3)
the suboccipital##6##2##(2006-5#3)(2006-7#1)(2008-7#1)(2010-9#1)
the subodontoblastic layer at the roof of the pulp chamber and pulp horn##2##13##(1994-5#2)
the subodontoblastic layer##4##3##(1994-5#4)
the subodontoblastic##5##2##(1994-5#5)
the suboesophageal ganglion##3##3##(2007-12#2)(2008-8#1)
the suboptimal##4##2##(2009-10#1)(2011-2#1)(2013-1#2)
the suborder##3##2##(1993-3#1)(2011-2#1)(2012-12#1)
the subordinate##3##2##(1997-5#1)(2008-8#2)
the subordination of##2##3##(2013-1#2)
the subparafascicular parvocellular nucleus##4##4##(2010-10#4)
the subparafascicular parvocellular##5##3##(2010-10#5)
the subparafascicular##6##2##(2010-10#6)
the subphase containing##2##3##(2005-11#2)
the subphase##13##2##(1990-4#1)(1991-3#1)(1994-3#1)(1994-5#1)(1994-6#1)(1997-2#2)(2005-11#3)(2007-9#1)(2009-7#2)
the subphases##3##2##(1990-2#1)(2005-11#2)
the subpicosecond##3##2##(2007-12#2)(2008-1#1)
the subplate##2##2##(1993-12#1)(1997-6#1)
the subpopulation of##4##3##(1992-7#1)(1996-3#1)(2008-5#1)(2011-2#1)
the subpopulation##7##2##(1992-7#1)(1996-3#1)(2007-6#1)(2008-10#2)(2008-5#1)(2011-2#1)
the subpopulations##5##2##(1995-12#1)(2006-6#1)(2008-10#2)(2012-3#1)
the subregions##4##2##(2007-8#1)(2008-3#3)
the subretinal space##5##3##(1997-3#3)(2008-3#2)
the subscale##4##2##(2006-10#2)(2006-12#1)(2012-2#1)
the subscales##5##2##(2006-12#1)(2007-2#1)(2009-6#1)(2010-11#1)(2012-2#1)
the subscapular region##2##3##(2006-10#2)
the subscapular##3##2##(2006-10#2)(2008-7#1)
the subscapularis and infraspinatus insertions##2##5##(2012-12#2)
the subscapularis##3##2##(2012-12#3)
the subscripts s and p##2##5##(2008-3#2)
the subscripts##3##2##(2008-10#1)(2008-3#2)
the subsequent 12##2##3##(2008-1#1)(2011-2#1)
the subsequent 2##2##3##(1996-2#1)(2011-1#1)
the subsequent addition of##2##4##(1990-3#1)(1991-1#1)
the subsequent binding of##5##4##(1991-1#1)(1991-2#1)(1994-9#1)(1995-1#1)(2010-1#1)
the subsequent binding##6##3##(1991-1#1)(1991-2#1)(1994-9#1)(1995-1#1)(1997-2#1)(2010-1#1)
the subsequent changes##2##3##(2007-10#1)(2008-5#1)
the subsequent course of##2##4##(1996-10#1)(2006-6#1)
the subsequent course##3##3##(1996-10#1)(2006-3#1)(2006-6#1)
the subsequent detection of##2##4##(2008-10#1)(2008-7#1)
the subsequent development of##13##4##(1991-12#1)(1992-10#1)(1993-6#1)(1995-3#1)(1997-6#1)(2005-6#1)(2006-10#2)(2006-9#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-11#1)
the subsequent discovery of##2##4##(2005-9#1)(2008-11#1)
the subsequent generation##2##3##(1996-6#1)(2011-2#1)
the subsequent identification of##2##4##(2008-1#1)(2010-2#1)
the subsequent immune response##2##4##(2008-4#2)
the subsequent increase in##3##4##(1991-12#1)(1992-11#1)(2007-11#1)
the subsequent increase##4##3##(1991-12#1)(1992-11#1)(1996-1#1)(2007-11#1)
the subsequent oxidation##2##3##(1996-2#1)(2008-10#1)
the subsequent oxidative##2##3##(2008-10#1)(2008-11#1)
the subsequent pregnancy##2##3##(2007-2#2)
the subsequent reaction of the##2##5##(1992-8#1)(2008-10#1)
the subsequent reaction of##3##4##(1992-8#1)(2008-10#2)
the subsequent reaction##5##3##(1991-11#1)(1992-8#1)(1993-3#1)(2008-10#2)
the subsequent reactions##2##3##(1991-3#1)(1997-4#1)
the subsequent reoxygenation period##2##4##(2011-12#2)
the subsequent response##2##3##(1991-9#1)(2007-12#1)
the subsequent six##2##3##(2008-7#1)(2012-12#1)
the subsequent steps of##2##4##(1995-3#1)(2009-3#1)
the subsequent transport##2##3##(1996-8#1)(2009-8#1)
the subsequent vegetation period##2##4##(2008-7#2)
the subsequent year##2##3##(2008-1#1)(2010-4#1)
the subsequent##251##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#3)(1991-1#2)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#2)(1991-7#1)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#3)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-12#1)(1995-2#4)(1995-3#3)(1996-1#1)(1996-10#2)(1996-11#2)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#2)(1997-2#2)(1997-4#1)(1997-6#3)(1997-7#1)(2005-10#1)(2005-3#1)(2005-6#1)(2005-7#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#5)(2007-11#5)(2007-12#3)(2007-2#5)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-8#3)(2008-1#5)(2008-10#24)(2008-11#7)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#9)(2008-5#3)(2008-6#3)(2008-7#10)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-5#1)(2011-1#3)(2011-12#4)(2011-2#7)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
the subsequently##2##2##(1995-6#1)(2008-10#1)
the subset of patients##3##4##(2006-10#2)(2011-2#1)
the subset of##13##3##(1992-10#1)(2006-10#3)(2007-12#2)(2008-3#1)(2008-7#1)(2009-11#1)(2009-12#1)(2010-2#1)(2011-2#1)(2012-12#1)
the subset##16##2##(1990-12#1)(1992-10#1)(2006-10#3)(2007-12#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
the subsets of##2##3##(1992-10#1)(2006-6#1)
the subsite##3##2##(1990-12#1)(1996-11#1)(1996-2#1)
the subspecialty##3##2##(2006-10#1)(2007-4#1)(2011-1#1)
the subspecies##3##2##(2008-10#2)(2008-5#1)
the subspecies-specific##2##2##(2008-10#1)(2011-1#1)
the substance P antagonist##4##4##(1990-11#1)(1990-2#1)(1991-9#1)(1994-2#1)
the substance P##8##3##(1990-11#1)(1990-2#1)(1991-9#1)(1992-3#1)(1993-8#1)(1994-2#1)(1997-4#1)(2013-8#1)
the substance in##2##3##(2008-10#1)(2008-5#1)
the substance is##2##3##(1991-6#1)(2008-4#1)
the substance of the##2##4##(1992-3#1)(2008-5#1)
the substance of##5##3##(1992-3#1)(1993-12#1)(2008-5#1)(2008-9#1)(2013-1#1)
the substance##36##2##(1990-11#1)(1990-2#1)(1990-6#2)(1991-11#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#2)(1993-12#1)(1993-8#1)(1994-2#1)(1995-1#1)(1996-1#1)(1997-1#1)(1997-4#1)(2005-10#2)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#3)(2008-9#2)(2009-9#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
the substances##20##2##(1992-10#1)(1992-5#1)(1993-1#1)(1993-12#1)(1994-12#1)(1995-2#2)(1997-2#1)(2006-2#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-5#1)(2010-10#1)(2010-4#1)(2010-8#1)(2013-1#2)(2013-8#1)
the substantia innominata##6##3##(1991-1#2)(1994-10#1)(1997-2#1)(1997-3#2)
the substantia nigra (SN) and##3##5##(1992-11#1)(1994-2#1)(2012-2#1)
the substantia nigra (SN)##6##4##(1992-11#1)(1994-2#2)(1996-9#1)(2008-7#1)(2012-2#1)
the substantia nigra and the ventral##2##6##(1996-12#1)(2008-7#1)
the substantia nigra and the##4##5##(1996-12#1)(2008-7#3)
the substantia nigra and##8##4##(1991-11#1)(1996-12#1)(2008-11#1)(2008-7#5)
the substantia nigra in##3##4##(1992-10#1)(1992-9#1)(1995-5#1)
the substantia nigra of##3##4##(1993-4#1)(1994-2#1)(1996-9#1)
the substantia nigra pars compacta (SNpc)##4##6##(1994-12#1)(1995-3#1)(1996-1#1)(1996-12#1)
the substantia nigra pars compacta##9##5##(1991-11#1)(1991-9#1)(1994-12#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#2)(2008-7#1)
the substantia nigra pars reticulata##4##5##(1995-12#1)(1995-2#1)(2008-12#1)(2009-10#1)
the substantia nigra pars##13##4##(1991-11#1)(1991-9#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#2)(2008-12#1)(2008-7#1)(2009-10#1)
the substantia nigra with##2##4##(1990-5#1)(1991-2#1)
the substantia nigra##68##3##(1990-2#1)(1990-4#1)(1990-5#5)(1991-1#1)(1991-11#3)(1991-2#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-9#2)(1993-12#4)(1993-4#1)(1994-10#1)(1994-12#1)(1994-2#3)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-12#4)(1996-4#1)(1996-9#2)(1997-3#1)(1997-6#1)(1997-7#1)(2005-8#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#9)(2009-10#1)(2012-1#1)(2012-12#1)(2012-2#1)
the substantia##75##2##(1990-2#1)(1990-4#1)(1990-5#5)(1991-1#3)(1991-11#3)(1991-2#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-9#2)(1993-12#4)(1993-4#1)(1994-10#2)(1994-12#1)(1994-2#3)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-12#4)(1996-4#1)(1996-9#2)(1997-2#1)(1997-3#3)(1997-6#1)(1997-7#1)(2005-8#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#9)(2009-10#1)(2012-1#1)(2012-12#1)(2012-2#1)
the substantial impact##2##3##(2008-8#1)(2012-12#1)
the substantial number of##2##4##(1994-6#1)(2009-2#1)
the substantial##18##2##(1991-2#1)(1991-3#1)(1991-5#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-8#1)(1997-1#1)(2006-10#1)(2007-11#1)(2008-3#1)(2008-8#1)(2009-2#1)(2009-7#1)(2011-2#1)(2012-12#2)(2012-2#1)
the substantially lower##2##3##(1993-9#1)(1995-5#1)
the substituent##12##2##(1992-3#1)(1994-5#1)(1994-9#1)(1996-5#1)(1997-1#1)(2005-11#1)(2007-11#2)(2008-10#3)(2010-5#1)
the substituents at##3##3##(1997-1#2)(2007-11#1)
the substituents of##4##3##(1997-7#1)(2007-11#1)(2008-10#1)(2008-5#1)
the substituents##12##2##(1992-8#1)(1994-9#1)(1996-2#1)(1997-1#2)(1997-7#2)(2007-11#2)(2008-10#1)(2008-5#1)(2009-7#1)
the substitute##2##2##(1991-6#1)(2008-10#1)
the substituted##8##2##(1993-11#1)(1994-2#1)(1995-2#1)(1996-10#1)(1996-5#1)(1997-6#1)(2008-10#1)(2009-3#1)
the substitution degree##2##3##(2008-10#1)(2008-5#1)
the substitution of a##3##4##(1991-7#1)(1993-3#1)(1995-3#1)
the substitution of##23##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1991-7#2)(1991-9#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-3#1)(1995-10#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-6#1)(2006-8#1)(2007-9#1)(2008-10#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
the substitution pattern of##3##4##(1996-8#1)(2007-1#1)(2009-9#1)
the substitution pattern##8##3##(1990-12#1)(1996-8#1)(2005-7#1)(2007-1#1)(2008-10#2)(2009-9#1)(2012-12#1)
the substitution reaction##2##3##(2008-10#2)
the substitution##44##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-7#1)(1991-7#2)(1991-9#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1995-10#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-5#1)(2005-7#1)(2006-8#1)(2007-1#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-3#1)(2010-5#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
the substitutional##2##2##(2008-10#1)(2008-8#1)
the substitutions##9##2##(1990-12#1)(1990-2#1)(1992-2#1)(1992-6#1)(1994-3#1)(1994-9#1)(1996-2#1)(1997-7#1)(2013-1#1)
the substomatal chamber##2##3##(2007-7#2)
the substomatal##5##2##(2007-7#2)(2008-10#3)
the substrate activity##2##3##(1994-9#1)(1997-6#1)
the substrate and contact with##2##5##(1994-6#1)(2010-4#1)
the substrate and the##8##4##(1992-5#1)(1994-5#1)(2007-8#1)(2008-2#1)(2008-4#1)(2012-2#1)(2013-7#1)(2013-8#1)
the substrate and therefore##2##4##(1990-12#1)(2007-8#1)
the substrate and##23##3##(1990-12#1)(1992-5#1)(1994-5#1)(1994-6#1)(1995-3#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-5#1)(2010-4#2)(2012-2#1)(2013-7#1)(2013-8#1)
the substrate are##3##3##(1992-3#1)(2007-12#1)(2008-2#1)
the substrate as##3##3##(1995-5#1)(2008-10#1)(2008-2#1)
the substrate at the##2##4##(1991-9#1)(1995-10#1)
the substrate at##4##3##(1991-9#1)(1995-10#1)(2007-12#1)(2008-10#1)
the substrate binding cleft##2##4##(1991-4#2)
the substrate binding domain##2##4##(1996-5#1)(2007-11#1)
the substrate binding pocket##3##4##(1994-5#1)(1995-5#1)(2013-8#1)
the substrate binding site##4##4##(1992-11#1)(1994-12#1)(1995-3#1)(1996-7#1)
the substrate binding##14##3##(1991-4#2)(1992-11#1)(1992-2#1)(1992-6#1)(1992-9#1)(1994-12#1)(1994-5#1)(1995-3#1)(1995-5#1)(1996-5#1)(1996-7#1)(2007-11#1)(2013-8#1)
the substrate but##2##3##(1993-6#1)(2010-4#1)
the substrate by##4##3##(1990-8#1)(1991-8#1)(2008-2#1)(2008-3#1)
the substrate catechol##2##3##(2008-10#2)
the substrate characteristics##3##3##(2008-5#3)
the substrate cleft##2##3##(1991-4#2)
the substrate concentration##3##3##(2008-5#2)(2010-10#1)
the substrate during##2##3##(1992-3#1)(2008-5#1)
the substrate for the##2##4##(1992-9#1)(1995-11#1)
the substrate for##10##3##(1991-1#1)(1992-9#1)(1993-2#1)(1995-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-3#1)
the substrate from##2##3##(2008-10#2)
the substrate in a##2##4##(1990-5#1)(1997-1#1)
the substrate in the##5##4##(1993-2#1)(1995-8#1)(1997-1#1)(2007-12#1)(2008-7#1)
the substrate in##13##3##(1990-5#1)(1993-2#1)(1994-5#1)(1995-8#1)(1997-1#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-2#1)
the substrate into##3##3##(1990-5#1)(1990-8#1)(1994-11#1)
the substrate is consumed##2##4##(1991-5#1)(1996-7#1)
the substrate is##13##3##(1991-5#1)(1992-6#1)(1994-3#1)(1994-9#1)(1995-10#1)(1996-7#1)(2008-1#1)(2008-2#4)(2008-3#1)(2008-4#1)
the substrate molecule##2##3##(1995-5#1)(2010-7#1)
the substrate molecules##2##3##(1992-3#1)(1994-8#1)
the substrate of##7##3##(2005-11#1)(2008-10#3)(2009-9#1)(2011-2#1)(2013-1#1)
the substrate on##5##3##(1990-10#1)(2006-12#2)(2007-11#1)(2007-8#1)
the substrate reactivity##2##3##(2008-7#2)
the substrate specificities of the##2##5##(1994-12#1)(1994-8#1)
the substrate specificities of##3##4##(1991-4#1)(1994-12#1)(1994-8#1)
the substrate specificities##5##3##(1991-4#1)(1994-12#2)(1994-8#1)(2010-3#1)
the substrate specificity of this##2##5##(1994-2#1)(2013-1#1)
the substrate specificity of##15##4##(1990-5#1)(1990-8#1)(1992-2#1)(1992-9#1)(1994-2#1)(1994-9#2)(1995-1#2)(1995-3#1)(2008-4#2)(2008-7#1)(2013-1#2)
the substrate specificity##23##3##(1990-5#3)(1990-8#1)(1991-1#1)(1992-2#1)(1992-9#1)(1994-2#1)(1994-9#2)(1995-1#2)(1995-3#1)(1996-7#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-7#1)(2013-1#2)
the substrate surface##6##3##(2005-11#1)(2005-4#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-4#1)
the substrate to the##7##4##(1991-3#1)(1993-6#1)(1994-5#1)(1997-2#1)(2006-12#1)(2008-2#1)(2011-1#1)
the substrate to##16##3##(1991-3#1)(1992-4#1)(1993-6#1)(1994-5#1)(1995-1#1)(1995-11#1)(1997-2#1)(2005-11#1)(2006-12#1)(2007-8#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2011-1#1)
the substrate uptake##3##3##(1992-6#2)(1996-2#1)
the substrate was##4##3##(2008-10#1)(2008-3#2)(2008-6#1)
the substrate with the##2##4##(2008-10#1)(2008-5#1)
the substrate with##6##3##(1992-2#1)(1994-8#1)(1996-7#1)(2008-10#1)(2008-3#1)(2008-5#1)
the substrate##367##2##(1990-10#1)(1990-11#2)(1990-12#5)(1990-3#1)(1990-4#1)(1990-5#9)(1990-7#2)(1990-8#5)(1990-9#3)(1991-1#4)(1991-2#4)(1991-3#2)(1991-4#5)(1991-5#4)(1991-8#3)(1991-9#4)(1992-11#2)(1992-12#2)(1992-2#5)(1992-3#6)(1992-4#1)(1992-5#2)(1992-6#6)(1992-9#3)(1993-11#1)(1993-2#3)(1993-3#1)(1993-6#3)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#3)(1994-5#5)(1994-6#1)(1994-8#4)(1994-9#5)(1995-1#4)(1995-10#3)(1995-11#3)(1995-2#3)(1995-3#4)(1995-5#6)(1995-8#1)(1996-11#1)(1996-2#2)(1996-5#1)(1996-7#8)(1997-1#3)(1997-2#2)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(2004-8#1)(2005-11#5)(2005-12#1)(2005-4#1)(2006-12#3)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#7)(2007-12#8)(2007-8#6)(2008-1#2)(2008-10#28)(2008-11#7)(2008-2#17)(2008-3#26)(2008-4#16)(2008-5#14)(2008-6#5)(2008-7#13)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#4)(2010-7#2)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
the substrate's##4##2##(1996-2#1)(2008-3#3)
the substrate-binding site of##3##4##(1992-8#2)(1995-3#1)
the substrate-binding site##4##3##(1992-6#1)(1992-8#2)(1995-3#1)
the substrate-binding##6##2##(1992-6#1)(1992-8#2)(1995-3#1)(1996-4#1)(2008-6#1)
the substrates and##3##3##(1991-3#1)(1992-3#1)(1994-9#1)
the substrates for##3##3##(1994-12#1)(2008-10#1)(2008-11#1)
the substrates is##2##3##(1990-7#1)(2008-10#1)
the substrates to the##2##4##(1993-12#1)(1994-5#1)
the substrates##34##2##(1990-12#1)(1990-7#3)(1991-3#1)(1991-7#1)(1992-3#1)(1993-12#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#4)(1994-6#1)(1994-9#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-7#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2010-12#1)(2010-4#1)
the substratum and##2##3##(1994-2#1)(2007-5#1)
the substratum##5##2##(1994-2#1)(1995-5#1)(2007-5#1)(2008-11#1)(2008-9#1)
the subsurface water##3##3##(2008-1#1)(2009-8#2)
the subsurface##8##2##(1997-5#1)(1997-7#2)(2005-11#1)(2008-1#1)(2008-2#1)(2009-8#2)
the subsynovial connective tissue (SSCT)##2##5##(2008-9#2)
the subsynovial connective tissue##3##4##(2008-9#3)
the subtalar joint##4##3##(2008-4#1)(2010-3#1)(2011-2#1)(2012-2#1)
the subterranean##2##2##(2007-12#1)(2008-10#1)
the subthalamic nucleus (STN) and##2##5##(1997-7#1)(2009-8#1)
the subthalamic nucleus (STN)##5##4##(1997-7#1)(2008-11#1)(2009-8#1)(2010-12#1)(2012-1#1)
the subthalamic nucleus##11##3##(1997-7#1)(2008-11#4)(2008-2#1)(2008-7#1)(2009-8#1)(2010-12#1)(2012-1#1)(2012-2#1)
the subthalamic region##2##3##(2012-1#2)
the subthalamic##13##2##(1997-7#1)(2008-11#4)(2008-2#1)(2008-7#1)(2009-8#1)(2010-12#1)(2012-1#3)(2012-2#1)
the subthreshold##2##2##(2007-12#1)(2008-3#1)
the subtilisin##3##2##(1994-12#1)(1995-11#1)(1995-3#1)
the subtle##5##2##(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2013-8#1)
the subtracted##2##2##(1992-11#1)(2007-11#1)
the subtraction of##3##3##(2008-2#1)(2008-3#2)
the subtraction##8##2##(1995-4#2)(2008-2#3)(2008-3#3)
the subtropical region of Argentina##2##5##(2010-10#2)
the subtropical##4##2##(2008-10#1)(2008-5#1)(2010-10#2)
the subtype of##3##3##(2007-10#1)(2008-4#1)(2013-8#1)
the subtype##4##2##(2007-10#1)(2007-12#1)(2008-4#1)(2013-8#1)
the subtypes##3##2##(1991-11#1)(1993-8#1)(1997-2#1)
the subunit 8##2##3##(1992-11#1)(1994-9#1)
the subunit composition of the##2##5##(1990-5#1)(1991-5#1)
the subunit composition of##4##4##(1990-5#1)(1991-10#1)(1991-5#1)(2008-4#1)
the subunit interactions of##2##4##(1996-7#1)(2005-10#1)
the subunit interface##5##3##(1990-8#2)(1993-6#1)(1995-2#1)(1995-8#1)
the subunit protein of##2##4##(1991-12#1)(1993-11#1)
the subunit transport##2##3##(2007-8#2)
the subunit##40##2##(1990-5#1)(1990-7#1)(1990-8#4)(1991-10#1)(1991-12#2)(1991-5#1)(1991-7#1)(1992-11#1)(1992-2#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-6#1)(1994-12#3)(1994-8#1)(1994-9#1)(1995-2#1)(1995-8#3)(1996-7#2)(1997-1#1)(1997-2#1)(1997-7#1)(2005-10#1)(2007-8#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-11#1)
the subunits of##9##3##(1991-2#1)(1994-8#1)(1995-3#1)(1997-6#1)(2005-11#1)(2006-8#1)(2008-2#1)(2011-2#1)(2012-2#1)
the subunits##25##2##(1990-8#1)(1991-12#1)(1991-2#1)(1992-3#3)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-3#1)(1995-5#1)(1997-2#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-8#1)(2008-2#1)(2008-5#1)(2008-9#2)(2009-9#1)(2011-2#1)(2012-2#1)
the suburban##3##2##(2006-10#1)(2008-10#1)(2008-3#1)
the subventricular zone (SVZ)##2##4##(2008-7#1)(2010-12#1)
the subventricular zone##5##3##(2008-7#1)(2009-10#1)(2010-12#3)
the subwavelength##3##2##(2007-11#2)(2008-1#1)
the succeeding##6##2##(1995-6#1)(1996-6#1)(2006-11#1)(2008-10#1)(2008-2#1)(2012-1#1)
the success and the##2##4##(1997-6#1)(2007-7#1)
the success and##9##3##(1997-6#1)(2007-12#1)(2007-7#1)(2008-7#1)(2008-8#1)(2010-11#2)(2011-12#1)(2012-1#1)
the success of TQM applications##2##5##(2008-12#2)
the success of a##3##4##(1991-2#1)(2008-12#1)(2010-9#1)
the success of an##6##4##(2007-4#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#1)(2013-1#1)
the success of new##2##4##(2007-4#1)(2008-1#1)
the success of our##3##4##(1993-3#1)(2007-4#2)
the success of percutaneous##2##4##(1990-8#1)(2008-12#1)
the success of renal##2##4##(2009-5#1)(2010-7#1)
the success of restoration##2##4##(2011-2#1)(2013-7#1)
the success of the procedure##2##5##(2007-5#1)(2011-1#1)
the success of the##11##4##(1990-9#1)(1994-2#1)(1996-3#1)(2007-2#1)(2007-5#1)(2008-11#1)(2009-4#1)(2010-8#1)(2011-1#1)(2012-2#2)
the success of their##3##4##(1991-8#1)(1992-3#1)(1994-12#1)
the success of these##7##4##(1990-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-8#1)(2013-1#2)
the success of this approach##2##5##(2008-11#1)(2009-6#1)
the success of this##11##4##(1996-12#1)(2006-3#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-12#1)(2013-8#1)
the success of treatment##4##4##(1992-2#1)(2008-11#1)(2008-5#1)(2011-2#1)
the success of##142##3##(1990-12#4)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-3#1)(1994-12#3)(1994-2#3)(1994-4#2)(1994-9#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-12#1)(1996-3#4)(1996-5#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-7#1)(2006-9#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#4)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#9)(2008-12#5)(2008-2#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#3)(2011-2#7)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#3)
the success or failure of##7##5##(2005-8#2)(2008-10#2)(2008-12#1)(2008-4#1)(2012-2#1)
the success or##8##3##(1991-8#1)(2005-8#2)(2008-10#2)(2008-12#1)(2008-4#1)(2012-2#1)
the success rate for##5##4##(1991-12#1)(2006-10#1)(2006-11#1)(2008-3#1)(2011-2#1)
the success rate in##2##4##(1993-5#1)(2012-2#1)
the success rate is##2##4##(1995-7#1)(2006-10#1)
the success rate of##5##4##(1994-5#1)(2007-5#1)(2007-7#1)(2009-6#1)(2012-2#1)
the success rate over##2##4##(2008-11#2)
the success rate was##2##4##(2006-8#1)(2007-10#1)
the success rate##22##3##(1991-12#1)(1993-5#1)(1994-3#1)(1994-5#1)(1995-7#1)(2006-10#2)(2006-11#1)(2006-8#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)
the success rates##2##3##(2008-10#1)(2010-7#1)
the success with##2##3##(1995-8#1)(2007-6#1)
the success##189##2##(1990-12#4)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-8#2)(1992-2#1)(1992-3#1)(1992-8#2)(1993-3#1)(1993-5#1)(1994-12#3)(1994-2#4)(1994-3#1)(1994-4#2)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#3)(1996-12#1)(1996-3#4)(1996-5#1)(1997-6#1)(2005-7#1)(2005-8#2)(2006-10#5)(2006-11#1)(2006-12#1)(2006-3#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#4)(2007-5#2)(2007-6#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#11)(2008-12#6)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#6)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#8)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#8)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#3)
the successes and##3##3##(1992-1#1)(2006-10#1)(2007-11#1)
the successes of##4##3##(1992-5#1)(1995-1#1)(2006-10#1)(2007-11#1)
the successes##8##2##(1992-1#1)(1992-5#1)(1995-1#1)(2006-10#2)(2007-11#2)(2009-4#1)
the successful adaptation of the##2##5##(2007-7#1)(2008-12#1)
the successful and##2##3##(1993-7#1)(2008-1#1)
the successful application of##8##4##(1995-11#1)(1995-2#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2012-3#1)
the successful cloning##2##3##(1991-5#1)(2010-6#1)
the successful conjugation##2##3##(1996-5#1)(2008-10#1)
the successful development of##2##4##(2008-1#1)(2008-12#1)
the successful implementation of a##2##5##(1994-3#1)(2008-8#1)
the successful implementation of##7##4##(1992-1#1)(1994-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-3#1)(2013-8#1)
the successful implementation##8##3##(1992-1#1)(1994-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-3#1)(2013-8#1)
the successful integration of##2##4##(2006-10#1)(2008-3#1)
the successful management of a##3##5##(2007-8#2)(2008-10#1)
the successful management of patients##2##5##(2007-12#1)(2012-2#1)
the successful management of##9##4##(1994-3#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-4#1)(2011-2#2)(2012-2#1)
the successful operation of##2##4##(2008-3#2)
the successful outcome of##2##4##(1991-6#1)(2008-11#1)
the successful outcome##3##3##(1991-6#1)(2008-11#1)(2010-9#1)
the successful translation of##2##4##(2005-2#1)(2012-12#1)
the successful treatment of a##3##5##(1994-6#1)(2010-6#1)(2012-2#1)
the successful treatment of##10##4##(1993-3#1)(1994-6#1)(2005-7#1)(2007-7#1)(2007-8#1)(2009-10#1)(2010-6#1)(2012-2#2)(2013-1#1)
the successful use of the##2##5##(2008-10#1)(2010-12#1)
the successful use of##7##4##(1990-8#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-11#1)(2010-12#1)
the successful##125##2##(1990-8#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-2#1)(1993-10#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-3#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-2#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#6)(2007-9#2)(2008-1#3)(2008-10#14)(2008-11#4)(2008-12#4)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#4)
the successive cultures##2##3##(2008-11#2)
the successive determination of##4##4##(2008-10#4)
the successive reaction##3##3##(1995-8#2)(1996-5#1)
the successive##19##2##(1990-11#2)(1990-6#1)(1995-12#1)(1995-8#3)(1996-10#1)(1996-5#1)(1997-6#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#1)
the successive-order-of-scattering##2##2##(2008-3#2)
the succinate##3##2##(1990-11#1)(1993-11#1)(2006-9#1)
the succinimidyl ester group##2##4##(1992-9#1)(1994-9#1)
the succinimidyl ester##3##3##(1992-9#1)(1994-9#1)(2013-8#1)
the such##2##2##(2008-10#1)(2008-12#1)
the suckling stimulus##5##3##(1993-2#3)(2010-10#2)
the suckling##8##2##(1992-11#1)(1993-2#3)(1993-7#1)(2010-10#2)(2013-1#1)
the sucrose##4##2##(1995-12#1)(2007-2#1)(2008-10#2)
the sudden appearance##2##3##(1996-12#1)(2010-5#1)
the sudden death##2##3##(2008-10#1)(2013-1#1)
the sudden infant death syndrome (SIDS)##4##6##(1991-11#1)(1991-2#1)(1992-11#1)(1993-12#1)
the sudden infant death syndrome##7##5##(1991-11#1)(1991-2#1)(1992-11#1)(1993-12#2)(2009-8#1)(2013-1#1)
the sudden##21##2##(1991-11#1)(1991-2#2)(1991-9#1)(1992-11#2)(1993-12#2)(1996-11#2)(1996-12#1)(2006-7#1)(2008-10#4)(2009-8#1)(2010-12#1)(2010-5#1)(2013-1#2)
the sufferers##2##2##(2009-7#1)(2010-8#1)
the suffering of##3##3##(1991-8#1)(2008-9#1)(2011-2#1)
the suffering##6##2##(1991-8#1)(2006-10#1)(2006-3#1)(2008-12#1)(2008-9#1)(2011-2#1)
the sufficient##2##2##(2008-10#1)(2012-12#1)
the sugar and##3##3##(1991-5#1)(2009-6#1)(2009-9#1)
the sugar beet##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
the sugar cane##2##3##(2008-5#2)
the sugar chain composition at the C-3##2##7##(2012-11#2)
the sugar chain##5##3##(1991-2#1)(2008-11#1)(2012-11#3)
the sugar moiety##5##3##(1992-6#1)(1993-4#1)(1995-12#1)(2008-3#1)(2008-4#1)
the sugar recovery##2##3##(2013-1#2)
the sugar ring##2##3##(1991-4#1)(1991-8#1)
the sugar##55##2##(1991-10#1)(1991-2#3)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#2)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-4#1)(1994-3#1)(1995-12#1)(1996-7#2)(1997-1#1)(2005-11#3)(2006-10#1)(2007-1#1)(2007-11#1)(2007-3#2)(2007-6#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#4)(2009-6#1)(2009-9#1)(2010-2#1)(2011-1#1)(2012-11#3)(2013-1#2)
the sugar-binding##2##2##(1995-11#1)(2011-1#1)
the sugar-urea bond##2##3##(1997-8#2)
the sugarcane bagasse##2##3##(2008-5#2)
the sugarcane##4##2##(2007-12#2)(2008-5#2)
the sugars##7##2##(1990-2#1)(2008-10#2)(2008-5#1)(2008-6#1)(2011-1#1)(2012-12#1)
the suggested design##2##3##(2007-11#1)(2008-10#1)
the suggested##23##2##(1990-10#1)(1992-2#1)(1992-8#2)(1993-11#1)(1993-2#1)(1996-8#1)(1997-1#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-8#1)(2010-2#1)(2011-1#2)(2013-1#1)
the suggestion of##4##3##(2006-8#1)(2008-10#1)(2008-6#1)(2011-2#1)
the suggestion that the##5##4##(1990-11#1)(1990-12#1)(1992-1#1)(1993-12#1)(1995-6#1)
the suggestion that##23##3##(1990-11#1)(1990-12#1)(1990-8#1)(1991-10#1)(1991-8#1)(1992-1#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#2)(1995-6#1)(1995-8#1)(1997-4#1)(2006-3#1)(2007-12#2)(2008-1#1)(2008-7#1)(2009-4#1)(2010-2#1)(2011-2#1)(2013-1#1)
the suggestion##30##2##(1990-11#2)(1990-12#1)(1990-8#1)(1991-10#1)(1991-8#1)(1992-1#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#2)(1995-6#1)(1995-8#1)(1996-5#1)(1997-4#1)(2006-3#1)(2006-8#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-2#1)(2011-2#2)(2013-1#1)
the suggestions made by##2##4##(1991-9#1)(1994-11#1)
the suggestions made##3##3##(1991-9#1)(1994-11#1)(2011-2#1)
the suggestions##4##2##(1991-9#1)(1994-11#1)(2006-7#1)(2011-2#1)
the suicidal act##3##3##(2010-6#3)
the suicidal##8##2##(2008-7#1)(2010-6#7)
the suicide rate##2##3##(1990-3#1)(2007-10#1)
the suicide rates of##2##4##(2013-1#2)
the suicide rates##4##3##(1991-12#1)(1996-1#1)(2013-1#2)
the suicide##12##2##(1990-3#1)(1991-12#1)(1991-5#1)(1996-1#1)(2005-6#1)(2007-10#1)(2007-12#1)(2008-9#1)(2009-4#1)(2010-6#1)(2013-1#2)
the suitability of a##2##4##(1992-6#1)(2007-11#1)
the suitability of different##2##4##(2008-10#1)(2013-1#1)
the suitability of the##21##4##(1997-2#1)(1997-6#1)(2006-2#1)(2007-11#2)(2007-8#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-4#1)(2010-9#1)(2013-1#1)(2013-7#1)
the suitability of these##2##4##(1996-3#1)(2008-2#1)
the suitability of this##4##4##(2008-10#1)(2008-2#1)(2011-1#1)(2011-2#1)
the suitability of##64##3##(1992-6#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-6#1)(2005-5#2)(2006-2#1)(2007-10#1)(2007-11#3)(2007-8#4)(2008-10#12)(2008-11#3)(2008-2#3)(2008-3#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-7#1)
the suitability##66##2##(1992-6#2)(1994-5#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-6#1)(2005-5#3)(2006-2#1)(2007-10#1)(2007-11#3)(2007-8#4)(2008-10#12)(2008-11#3)(2008-2#3)(2008-3#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-7#1)
the suitable##11##2##(1993-9#1)(2007-11#1)(2008-10#5)(2008-3#1)(2008-8#1)(2012-12#2)
the sulcal##4##2##(1994-3#3)(1996-5#1)
the sulci and gyri##2##4##(1992-8#1)(2010-12#1)
the sulci##5##2##(1992-8#3)(2008-9#1)(2010-12#1)
the sulfate anion##2##3##(2008-10#2)
the sulfate binding site##2##4##(1994-9#2)
the sulfate groups##2##3##(1994-8#1)(1996-5#1)
the sulfate ion##6##3##(1995-11#1)(2007-12#1)(2008-10#4)
the sulfate##19##2##(1992-12#1)(1993-2#1)(1994-8#1)(1994-9#3)(1995-11#2)(1996-5#1)(2006-8#1)(2007-12#1)(2008-10#6)(2008-7#1)(2011-2#1)
the sulfated and sialyl ligands##2##5##(1997-4#2)
the sulfated ligands##2##3##(1997-4#2)
the sulfated##8##2##(1991-2#1)(1992-10#1)(1995-4#1)(1997-4#5)
the sulfation##5##2##(1990-5#1)(1991-7#2)(1995-12#1)(2008-1#1)
the sulfhydryl group of##2##4##(1995-5#1)(2009-11#1)
the sulfhydryl group##4##3##(1995-5#1)(1995-6#1)(2008-10#1)(2009-11#1)
the sulfhydryl groups##6##3##(1990-12#1)(1991-2#1)(1992-6#1)(1993-4#2)(1994-9#1)
the sulfhydryl redox##2##3##(1996-2#1)(1997-1#1)
the sulfhydryl##17##2##(1990-12#1)(1990-6#1)(1991-2#1)(1992-12#1)(1992-6#2)(1993-11#1)(1993-4#2)(1994-9#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-7#1)(2009-11#1)
the sulfide##3##2##(1991-8#1)(2008-10#1)(2011-1#1)
the sulfinyl##3##2##(1995-2#1)(2010-6#2)
the sulfite##2##2##(2007-8#1)(2008-10#1)
the sulfonate##2##2##(1995-8#1)(2007-11#1)
the sulfonic##2##2##(2008-10#2)
the sulfonylureas##2##2##(1992-3#2)
the sulfoxide and sulfone##2##4##(1994-9#1)(1996-8#1)
the sulfoxide##3##2##(1994-9#1)(1996-8#1)(1997-2#1)
the sulfur atom in##4##4##(2007-8#4)
the sulfur atom##6##3##(2007-10#1)(2007-8#5)
the sulfur atoms##2##3##(1995-3#1)(1996-5#1)
the sulfur##20##2##(1990-2#1)(1991-9#1)(1994-9#2)(1995-3#1)(1996-5#1)(1997-7#1)(2007-10#1)(2007-8#5)(2008-1#1)(2008-10#2)(2008-11#1)(2010-11#1)(2010-5#1)(2011-12#1)
the sulfur-iron##2##2##(1995-10#2)
the sulphate##2##2##(2012-7#2)
the sulphonylurea##2##2##(1992-8#1)(2008-3#1)
the sulphonylureas##2##2##(1994-8#2)
the sulphur##4##2##(1997-5#1)(2008-10#2)(2010-4#1)
the sulphuric acid##2##3##(2008-10#2)
the sum frequency##3##3##(2007-12#2)(2008-2#1)
the sum of all the##2##5##(1991-12#1)(2007-8#1)
the sum of all##6##4##(1991-12#1)(1995-3#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#1)
the sum of its##2##4##(2008-11#1)(2008-3#1)
the sum of the concentrations of##4##6##(1996-11#2)(2008-10#2)
the sum of the concentrations##5##5##(1996-11#2)(2008-10#3)
the sum of the individual##3##5##(1995-11#1)(2008-4#1)(2010-2#1)
the sum of the##40##4##(1990-6#1)(1991-12#1)(1993-6#1)(1995-11#1)(1995-12#1)(1996-11#2)(1996-3#1)(1996-5#1)(1997-1#3)(1997-2#1)(1997-5#1)(2005-12#1)(2006-11#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-2#3)(2008-3#1)(2008-4#1)(2008-8#1)(2009-1#1)(2009-10#1)(2010-2#1)(2010-3#1)(2010-8#1)(2013-1#1)
the sum of two##7##4##(1991-12#1)(1994-11#1)(1995-3#1)(1997-7#1)(1997-8#1)(2005-11#1)(2008-10#1)
the sum of##81##3##(1990-6#1)(1991-12#3)(1991-7#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-11#2)(1995-12#1)(1995-3#2)(1996-11#3)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#3)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#2)(2005-11#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-8#2)(2008-10#16)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-8#1)(2009-1#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
the sum##95##2##(1990-6#1)(1991-12#3)(1991-7#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-11#2)(1995-12#1)(1995-3#2)(1996-11#3)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#4)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#2)(2005-11#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-12#4)(2007-6#1)(2007-8#2)(2008-10#17)(2008-11#2)(2008-2#4)(2008-3#8)(2008-4#1)(2008-8#1)(2009-1#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-8#1)(2011-2#1)(2013-1#1)
the summary of##4##3##(1994-11#1)(2006-12#2)(2012-3#1)
the summary##6##2##(1994-11#1)(1997-2#1)(2006-12#2)(2008-5#1)(2012-3#1)
the summation of the##2##4##(2007-11#2)
the summation of##5##3##(2007-11#2)(2008-10#1)(2008-2#1)(2009-8#1)
the summation##8##2##(2007-11#2)(2008-10#1)(2008-2#3)(2008-4#1)(2009-8#1)
the summed length of all##2##5##(1990-7#1)(2012-2#1)
the summed##8##2##(1990-7#1)(1991-12#1)(1996-5#1)(2005-12#3)(2008-12#1)(2012-2#1)
the summer and##6##3##(1995-1#1)(2004-11#1)(2008-5#2)(2009-5#1)(2012-2#1)
the summer months##7##3##(1996-3#1)(2006-8#1)(2008-11#1)(2008-5#2)(2011-1#1)(2013-8#1)
the summer of 1991##2##4##(1995-11#1)(1997-1#1)
the summer of 2000##2##4##(2008-10#1)(2008-11#1)
the summer of 2001##2##4##(2006-10#1)(2008-8#1)
the summer of 2004##3##4##(2007-1#1)(2008-10#1)(2012-2#1)
the summer of##23##3##(1990-9#1)(1991-1#1)(1994-3#1)(1995-11#1)(1997-1#1)(2006-10#1)(2007-1#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-8#1)(2010-1#1)(2012-2#2)(2012-3#1)
the summer##55##2##(1990-9#1)(1991-1#1)(1994-3#1)(1995-1#2)(1995-11#2)(1996-1#3)(1996-3#1)(1997-1#1)(1997-3#1)(2004-11#1)(2006-10#1)(2006-8#1)(2007-1#2)(2007-2#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#8)(2008-7#1)(2008-8#2)(2009-5#1)(2009-8#1)(2010-1#1)(2011-1#1)(2012-2#3)(2012-3#1)(2013-8#3)
the summit##3##2##(2005-8#1)(2010-3#1)(2011-2#1)
the sun and the##2##4##(2007-9#1)(2008-3#1)
the sun and##6##3##(1991-6#1)(1994-3#2)(2007-9#1)(2008-2#1)(2008-3#1)
the sun can be##2##4##(1992-1#1)(1996-5#1)
the sun protection factor##2##4##(2008-5#2)
the sun protection##3##3##(2008-5#3)
the sun##39##2##(1991-6#3)(1992-1#1)(1992-7#1)(1993-3#1)(1994-3#2)(1996-11#1)(1996-5#9)(2007-11#1)(2007-9#2)(2008-10#1)(2008-2#3)(2008-3#2)(2008-5#4)(2008-8#1)(2010-12#1)(2010-7#1)(2011-2#4)(2013-1#1)
the sun's##7##2##(1991-8#1)(1996-5#4)(2007-9#1)(2009-8#1)
the sunburn##2##2##(2008-5#2)
the sunflower stem##2##3##(2008-10#1)(2011-12#1)
the sunflower##4##2##(2008-10#2)(2011-12#2)
the sunlight intensity##4##3##(2008-6#4)
the sunlight##6##2##(2008-5#1)(2008-6#4)(2011-2#1)
the sunny side and upper body sample units##2##8##(2004-11#2)
the sunny side##4##3##(2004-11#4)
the sunny##7##2##(2004-11#5)(2008-10#1)(2012-1#1)
the sunscreen derived from##2##4##(2008-5#2)
the sunscreen film##2##3##(2012-12#2)
the sunscreen tester##2##3##(2008-5#2)
the sunscreen##12##2##(1996-6#2)(2008-5#8)(2012-12#2)
the super family##2##3##(2009-10#1)(2013-8#1)
the super modified simplex##2##4##(2008-10#2)
the super##6##2##(1991-12#1)(2007-12#1)(2008-10#2)(2009-10#1)(2013-8#1)
the superconducting##7##2##(1990-9#1)(1992-5#1)(1992-8#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-8#1)
the supercontinuum from##2##3##(2007-11#2)
the supercontinuum##4##2##(2007-11#4)
the supercooling##2##2##(2008-8#1)(2011-12#1)
the supercritical##3##2##(2008-10#1)(2009-6#1)(2012-2#1)
the superfamily of nuclear hormone receptors##2##6##(1995-3#1)(2008-1#1)
the superfamily of##10##3##(1992-11#1)(1993-12#1)(1994-11#1)(1995-12#1)(1995-3#1)(1996-9#1)(1997-7#1)(2008-1#1)(2008-11#1)(2012-12#1)
the superfamily##13##2##(1992-11#1)(1993-12#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-5#1)(1996-9#1)(1997-7#1)(2008-1#1)(2008-11#1)(2012-12#1)(2013-1#1)
the superficial and deep##5##4##(1990-2#1)(1993-12#1)(1995-3#1)(2005-11#1)(2011-2#1)
the superficial and mid-depth zones of the##3##7##(1991-10#3)
the superficial and##8##3##(1990-2#1)(1991-10#3)(1993-12#1)(1995-3#1)(2005-11#1)(2011-2#1)
the superficial branch of the##2##5##(1992-6#1)(2006-3#1)
the superficial dermis##2##3##(2005-7#1)(2011-2#1)
the superficial femoral artery##2##4##(2007-8#2)
the superficial femoral vein##2##4##(2007-7#1)(2008-1#1)
the superficial femoral##6##3##(2007-7#1)(2007-8#2)(2008-1#1)(2010-11#1)(2011-2#1)
the superficial layer of##2##4##(1994-10#1)(2009-2#1)
the superficial layer##6##3##(1994-10#2)(1996-12#1)(2008-2#2)(2009-2#1)
the superficial layers of the##3##5##(1992-2#1)(1997-2#1)(2008-5#1)
the superficial layers of##5##4##(1992-2#2)(1997-2#1)(2008-11#1)(2008-5#1)
the superficial layers##10##3##(1990-2#1)(1990-4#1)(1992-2#2)(1993-12#1)(1997-2#1)(2008-11#2)(2008-5#2)
the superficial part of the##2##5##(2008-5#1)(2011-2#1)
the superficial zone decreased##2##4##(1991-10#2)
the superficial zone##4##3##(1991-10#2)(2007-11#2)
the superficial##74##2##(1990-2#2)(1990-4#1)(1990-5#1)(1991-10#7)(1991-5#1)(1992-2#2)(1992-6#1)(1993-12#2)(1993-4#1)(1994-10#3)(1994-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(2005-11#1)(2005-7#1)(2006-11#1)(2006-3#1)(2006-9#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-1#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#11)(2008-9#2)(2009-2#1)(2009-6#1)(2009-8#1)(2010-11#6)(2011-2#4)(2011-3#1)(2013-8#2)
the superfluid##2##2##(1992-6#1)(2008-7#1)
the superfusate##3##2##(1990-3#1)(1992-7#1)(1995-12#1)
the superfused##2##2##(1992-8#2)
the superfusion##3##2##(1990-2#1)(1993-11#1)(1994-10#1)
the superheated liquid##2##3##(2008-2#2)
the superheated##3##2##(2008-10#1)(2008-2#2)
the superimposed##3##2##(2006-10#1)(2007-12#1)(2009-5#1)
the superior and inferior##5##4##(1994-6#1)(1996-3#1)(2007-7#1)(2010-5#1)(2011-2#1)
the superior and##8##3##(1994-2#2)(1994-6#1)(1995-6#1)(1996-3#1)(2007-7#1)(2010-5#1)(2011-2#1)
the superior cerebellar peduncle##4##4##(1991-8#3)(1992-11#1)
the superior cervical ganglion##2##4##(1992-1#1)(1994-5#1)
the superior cervical##3##3##(1992-1#1)(1993-5#1)(1994-5#1)
the superior characteristics of##2##4##(2007-12#1)(2007-8#1)
the superior colliculus##10##3##(1991-11#1)(1991-3#2)(1991-5#3)(1993-3#1)(1994-2#3)
the superior competitor##2##3##(2008-8#2)
the superior hypogastric plexus##3##4##(2006-11#3)
the superior lumbar space##2##4##(1993-9#2)
the superior mesenteric artery##14##4##(1990-10#1)(1991-5#1)(1991-9#3)(1992-8#1)(2006-10#2)(2007-5#1)(2013-1#5)
the superior mesenteric##18##3##(1990-10#2)(1990-3#1)(1991-5#1)(1991-9#3)(1992-8#2)(2006-10#2)(2007-5#1)(2012-3#1)(2013-1#5)
the superior nasal meatus##2##4##(1995-7#2)
the superior nasal##3##3##(1995-7#2)(2008-11#1)
the superior parietal lobule##2##4##(1996-2#1)(1996-5#1)
the superior performance of##4##4##(2007-12#1)(2007-8#1)(2008-2#1)(2010-4#1)
the superior performance##5##3##(2007-12#1)(2007-8#1)(2008-2#2)(2010-4#1)
the superior sagittal sinus and##2##5##(2007-9#1)(2008-7#1)
the superior sagittal sinus##5##4##(1997-3#1)(2006-5#1)(2007-10#1)(2007-9#1)(2008-7#1)
the superior semicircular canal##2##4##(2006-12#2)
the superior temporal sulcus (STS)##3##5##(2007-12#1)(2008-11#1)(2009-4#1)
the superior temporal sulcus##5##4##(2007-12#1)(2008-11#2)(2009-10#1)(2009-4#1)
the superior temporal##9##3##(1992-5#1)(1996-7#1)(1997-1#1)(1997-8#1)(2007-12#1)(2008-11#2)(2009-10#1)(2009-4#1)
the superior vena cava (SVC)##2##5##(2007-8#1)(2011-2#1)
the superior vena cava##11##4##(1996-3#1)(2007-7#1)(2007-8#6)(2008-12#1)(2008-7#1)(2011-2#1)
the superior##128##2##(1990-10#2)(1990-11#1)(1990-3#1)(1991-11#1)(1991-3#2)(1991-5#4)(1991-6#1)(1991-8#3)(1991-9#3)(1992-1#1)(1992-11#1)(1992-5#1)(1992-8#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#2)(1994-2#5)(1994-5#1)(1994-6#1)(1995-6#2)(1995-7#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-5#1)(2006-10#2)(2006-11#3)(2006-12#2)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#12)(2007-9#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#2)(2009-4#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#8)
the superiority of one##2##4##(1996-9#1)(2012-12#1)
the superiority of the proposed##2##5##(2008-2#1)(2012-3#1)
the superiority of the##6##4##(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2012-3#1)
the superiority of##21##3##(1994-6#1)(1995-2#1)(1996-9#1)(1997-3#1)(2006-10#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#3)(2009-11#1)(2009-8#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#2)
the superiority##25##2##(1994-6#1)(1995-2#1)(1996-9#1)(1997-3#1)(2006-10#1)(2006-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#4)(2009-11#1)(2009-8#1)(2010-12#1)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
the superlattice##2##2##(2007-12#2)
the supermodes##2##2##(2007-11#1)(2008-3#1)
the supernatant and##3##3##(2008-11#3)
the supernatant by##3##3##(1990-12#1)(1990-2#1)(1992-3#1)
the supernatant fraction##4##3##(1992-12#2)(1995-3#1)(2008-10#1)
the supernatant is##2##3##(2008-10#1)(2008-4#1)
the supernatant of the##3##4##(1996-8#1)(2008-10#1)(2008-2#1)
the supernatant of##10##3##(1994-12#1)(1994-2#1)(1996-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-9#1)(2010-10#1)(2013-1#1)
the supernatant was analyzed by##2##5##(1995-3#1)(2013-8#1)
the supernatant was##9##3##(1990-2#1)(1995-3#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2013-8#1)
the supernatant##58##2##(1990-12#1)(1990-2#2)(1990-9#1)(1991-2#2)(1991-5#1)(1991-7#1)(1992-12#2)(1992-3#1)(1994-12#1)(1994-2#3)(1995-3#2)(1995-6#1)(1995-7#1)(1996-11#1)(1996-8#1)(1997-8#1)(2008-10#7)(2008-11#10)(2008-2#1)(2008-4#5)(2008-5#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-10#5)(2013-1#1)(2013-8#2)
the supernatants of the##3##4##(1991-12#1)(1991-9#1)(1992-5#1)
the supernatants of##8##3##(1991-11#1)(1991-12#1)(1991-9#1)(1992-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-12#1)
the supernatants##11##2##(1991-11#1)(1991-12#1)(1991-9#1)(1992-5#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-12#1)(2012-12#1)
the supernumerary spacing##2##3##(2008-3#2)
the supernumerary##4##2##(1990-5#1)(2008-3#3)
the superovulatory##2##2##(2006-5#2)
the superoxide anion and##2##4##(1990-5#1)(2008-11#1)
the superoxide anion##12##3##(1990-3#2)(1990-5#2)(1991-2#1)(1993-3#1)(1993-7#1)(2006-12#1)(2008-10#1)(2008-11#2)(2008-5#1)
the superoxide dismutase activity##2##4##(2006-8#1)(2013-8#1)
the superoxide dismutase and catalase##2##5##(2010-7#1)(2010-8#1)
the superoxide dismutase and##3##4##(1990-5#1)(2010-7#1)(2010-8#1)
the superoxide dismutase##8##3##(1990-11#2)(1990-5#1)(1991-10#1)(2006-8#1)(2010-7#1)(2010-8#1)(2013-8#1)
the superoxide radical and##2##4##(1990-5#1)(1997-8#1)
the superoxide radical##3##3##(1990-5#1)(1992-12#1)(1997-8#1)
the superoxide radicals##2##3##(2005-8#1)(2013-1#1)
the superoxide##28##2##(1990-11#2)(1990-3#2)(1990-5#5)(1991-10#1)(1991-12#1)(1991-2#1)(1992-12#1)(1993-3#1)(1993-7#1)(1994-11#1)(1997-8#1)(2005-8#1)(2006-12#1)(2006-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-7#1)(2010-8#1)(2013-1#1)(2013-8#1)
the superposition of##9##3##(1991-12#2)(1996-2#1)(2005-10#1)(2007-12#1)(2008-3#4)
the superposition##11##2##(1991-12#3)(1996-2#1)(2005-10#1)(2007-12#1)(2008-3#5)
the supersaturation##3##2##(2005-11#2)(2008-10#1)
the supersonic##2##2##(2008-3#2)
the superstrate##6##2##(2006-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
the superstructure##2##2##(2008-2#1)(2008-3#1)
the supervised##2##2##(2008-3#1)(2010-9#1)
the supervision of a##3##4##(2006-2#1)(2008-11#1)(2012-12#1)
the supervision of##6##3##(1991-10#1)(2006-2#1)(2006-8#1)(2008-11#1)(2008-12#1)(2012-12#1)
the supervision##9##2##(1991-10#1)(1991-9#1)(1992-11#1)(1995-6#1)(2006-2#1)(2006-8#1)(2008-11#1)(2008-12#1)(2012-12#1)
the supervisory controller##2##3##(2008-2#2)
the supervisory##3##2##(2008-2#2)(2010-12#1)
the supine position##6##3##(2007-2#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-3#1)
the supine##10##2##(1992-12#1)(1992-4#1)(1994-3#1)(2006-10#1)(2007-2#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-3#1)
the supplement on##2##3##(2008-9#1)(2011-1#1)
the supplement##8##2##(2008-10#1)(2008-5#1)(2008-9#1)(2011-1#1)(2013-8#4)
the supplemental instruction##2##3##(2007-3#2)
the supplemental##8##2##(1994-1#1)(2007-2#1)(2007-3#3)(2008-7#1)(2009-1#1)(2013-7#1)
the supplementary motor area##3##4##(2007-9#1)(2008-9#1)(2010-2#1)
the supplementary##4##2##(2006-9#1)(2007-9#1)(2008-9#1)(2010-2#1)
the supplementation of##3##3##(2008-11#2)(2010-8#1)
the supplementation##8##2##(2006-2#1)(2008-11#3)(2008-5#1)(2008-8#1)(2010-8#1)(2011-1#1)
the supplemented##6##2##(1995-5#1)(1997-2#1)(2008-3#3)(2012-12#1)
the supply and##2##3##(2004-11#1)(2010-3#1)
the supply of transplantable##2##4##(1991-3#2)
the supply of volunteers##2##4##(1994-3#2)
the supply of##33##3##(1990-12#1)(1991-2#1)(1991-3#4)(1991-9#1)(1992-3#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-3#4)(1994-6#1)(1995-8#1)(1996-3#3)(1997-1#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-9#2)(2010-1#1)(2010-5#1)(2012-2#1)
the supply##41##2##(1990-12#1)(1991-2#1)(1991-3#4)(1991-9#1)(1992-3#1)(1993-2#1)(1994-1#2)(1994-12#1)(1994-3#4)(1994-6#1)(1995-8#1)(1996-3#3)(1997-1#1)(2004-11#1)(2005-11#1)(2006-4#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-9#2)(2010-1#1)(2010-3#2)(2010-5#1)(2012-2#1)(2013-8#1)
the support and##3##3##(1992-12#1)(1994-12#1)(2009-8#1)
the support for##4##3##(2007-2#1)(2008-11#1)(2010-8#1)(2013-1#1)
the support given##2##3##(2007-2#1)(2011-2#1)
the support group##2##3##(2007-8#1)(2008-11#1)
the support of a##4##4##(1991-2#1)(2007-2#1)(2007-8#1)(2008-2#1)
the support of the##7##4##(1996-12#1)(1997-6#1)(2007-10#1)(2008-1#1)(2008-6#1)(2008-9#1)(2011-12#1)
the support of##27##3##(1991-2#1)(1992-12#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-6#1)(2007-10#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-5#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-1#1)
the support received##2##3##(1992-3#1)(2011-2#1)
the support reduction##2##3##(2009-9#1)(2010-3#1)
the support##77##2##(1990-2#1)(1990-7#2)(1991-2#1)(1991-7#1)(1992-12#2)(1992-3#2)(1994-12#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-6#2)(2005-11#1)(2007-10#1)(2007-2#3)(2007-6#2)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-8#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#2)
the supported bilayer##4##3##(1994-11#3)(2008-4#1)
the supported##6##2##(1994-11#3)(2008-10#1)(2008-4#1)(2008-7#1)
the supporting electrolyte was##2##4##(2008-10#2)
the supporting electrolyte##10##3##(2008-10#9)(2008-5#1)
the supporting literature##2##3##(2006-2#1)(2008-6#1)
the supporting structures of##2##4##(2006-2#1)(2012-3#1)
the supporting##28##2##(1994-12#1)(1994-3#1)(1995-11#1)(1996-1#1)(2006-2#2)(2006-6#1)(2007-8#1)(2008-10#12)(2008-5#2)(2008-6#1)(2009-3#1)(2009-4#1)(2010-5#1)(2012-3#1)(2013-1#1)
the supportive##7##2##(1997-2#1)(2008-10#1)(2008-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
the supports##3##2##(1997-3#1)(2007-9#1)(2008-10#1)
the supposed##6##2##(1991-10#1)(1994-11#1)(1997-3#1)(2006-7#1)(2007-7#1)(2008-10#1)
the supposition##3##2##(1990-8#1)(2008-9#1)(2010-7#1)
the suppressant##3##2##(1992-10#1)(2008-6#2)
the suppressed##4##2##(1990-2#1)(1994-8#1)(2008-10#1)(2008-11#1)
the suppression effect##2##3##(2008-10#1)(2013-8#1)
the suppression of B##2##4##(2008-10#2)
the suppression of cell##3##4##(1992-8#1)(1996-10#1)(2008-6#1)
the suppression of disease##3##4##(1997-8#1)(2008-10#2)
the suppression of its##3##4##(1991-9#1)(1992-11#1)(2011-2#1)
the suppression of the##8##4##(1993-12#2)(1996-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)
the suppression of##83##3##(1990-12#1)(1990-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#3)(1992-12#1)(1992-4#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-8#1)(2005-7#1)(2006-1#2)(2006-12#1)(2006-3#1)(2006-9#1)(2007-11#3)(2008-10#19)(2008-11#6)(2008-3#2)(2008-5#3)(2008-6#1)(2008-8#4)(2009-2#1)(2009-8#1)(2010-1#1)(2010-2#2)(2011-2#1)
the suppression##92##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#3)(1992-12#1)(1992-4#1)(1992-8#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-7#1)(2006-1#2)(2006-12#1)(2006-3#1)(2006-9#1)(2007-11#3)(2008-10#20)(2008-11#7)(2008-3#2)(2008-5#3)(2008-6#1)(2008-8#5)(2009-2#1)(2009-8#1)(2010-1#1)(2010-2#2)(2011-2#1)(2013-8#1)
the suppressive effect of beta-EP##2##5##(1991-3#2)
the suppressive effect of##10##4##(1991-3#4)(1991-5#1)(1994-3#1)(1996-12#1)(2006-8#1)(2008-10#1)(2008-5#1)
the suppressive effect##12##3##(1991-3#4)(1991-5#1)(1994-3#1)(1996-12#1)(2006-8#1)(2008-10#1)(2008-5#2)(2009-8#1)
the suppressive effects of##4##4##(1994-10#1)(1996-5#1)(2008-10#1)(2008-5#1)
the suppressive effects##5##3##(1994-10#1)(1996-5#1)(2008-10#2)(2008-5#1)
the suppressive soil##4##3##(2008-10#4)
the suppressive##27##2##(1991-3#4)(1991-5#1)(1994-10#1)(1994-11#1)(1994-3#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-6#1)(2006-8#1)(2008-10#8)(2008-4#1)(2008-5#3)(2009-8#1)(2011-12#1)
the suppressiveness of##2##3##(2008-10#2)
the suppressor##6##2##(1990-5#1)(1991-12#1)(1997-8#1)(2007-11#1)(2009-5#1)(2010-12#1)
the suprachiasmatic nuclei##2##3##(1994-2#1)(2006-1#1)
the suprachiasmatic nucleus (SCN) of##2##5##(1992-8#1)(1994-5#1)
the suprachiasmatic nucleus (SCN)##8##4##(1992-8#1)(1994-10#1)(1994-5#1)(1995-7#1)(1997-1#1)(1997-5#2)(2008-1#1)
the suprachiasmatic nucleus##17##3##(1992-3#1)(1992-8#2)(1993-12#1)(1994-10#2)(1994-5#1)(1995-7#1)(1996-1#2)(1996-9#1)(1997-1#2)(1997-5#2)(1997-6#1)(2008-1#1)
the suprachiasmatic##19##2##(1992-3#1)(1992-8#2)(1993-12#1)(1994-10#2)(1994-2#1)(1994-5#1)(1995-7#1)(1996-1#2)(1996-9#1)(1997-1#2)(1997-5#2)(1997-6#1)(2006-1#1)(2008-1#1)
the supraclavicular##4##2##(1997-8#1)(2008-7#2)(2011-2#1)
the supraglottic##4##2##(1996-1#1)(2009-10#1)(2012-2#2)
the suprahepatic inferior vena cava##2##5##(1992-9#2)
the supramammillary nucleus##2##3##(1991-12#1)(1995-6#1)
the supramammillary##3##2##(1991-11#1)(1991-12#1)(1995-6#1)
the supramaximal inhibition of pancreatic##2##5##(1992-8#2)
the supramaximal##3##2##(1992-8#2)(2013-8#1)
the supramolecular##8##2##(1992-7#1)(2006-10#1)(2006-12#1)(2008-10#4)(2010-4#1)
the supraoptic nucleus (SON) and##2##5##(1995-12#1)(1996-8#1)
the supraoptic nucleus and##3##4##(1994-10#1)(1996-9#2)
the supraoptic nucleus##11##3##(1993-12#1)(1994-10#2)(1995-12#2)(1996-8#2)(1996-9#4)
the supraoptic##13##2##(1993-12#1)(1994-10#4)(1995-12#2)(1996-8#2)(1996-9#4)
the suprapubic##2##2##(1994-9#1)(2008-10#1)
the suprascapular nerve##3##3##(2006-7#1)(2008-9#2)
the supraslice region##2##3##(2012-1#2)
the supraspinal##3##2##(1992-1#1)(1997-2#2)
the supraspinatus##4##2##(1991-4#1)(1992-9#1)(2008-7#2)
the supratrigeminal##3##2##(1990-4#1)(1996-9#2)
the supravalvular##2##2##(1990-9#1)(2008-4#1)
the sural nerve was##2##4##(1993-12#1)(1995-12#1)
the sural nerve##7##3##(1992-9#1)(1993-12#5)(1995-12#1)
the sural##9##2##(1992-9#2)(1993-12#6)(1995-12#1)
the suramin##2##2##(1993-11#1)(1994-9#1)
the surface LIDT##2##3##(2007-11#2)
the surface OH##2##3##(2005-11#2)
the surface active##4##3##(2004-12#3)(2005-11#1)
the surface activity at the##2##5##(2004-12#1)(2005-11#1)
the surface activity##6##3##(1990-11#2)(2004-12#2)(2005-11#2)
the surface adsorption of human hair keratins##2##7##(2012-11#2)
the surface after exposure to##2##5##(2005-11#1)(2008-11#1)
the surface and in##2##4##(2005-11#1)(2008-3#1)
the surface and the##6##4##(2005-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2013-7#1)
the surface and##26##3##(1997-1#1)(2004-9#1)(2005-11#3)(2006-6#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#5)(2008-5#2)(2008-9#2)(2009-12#1)(2009-3#1)(2013-1#1)(2013-7#1)
the surface are##2##3##(2008-3#2)
the surface area and##5##4##(1994-8#1)(2004-9#1)(2005-11#1)(2006-10#1)(2010-4#1)
the surface area of the##2##5##(1997-2#1)(2008-9#1)
the surface area of##6##4##(1997-2#1)(2005-11#1)(2006-10#1)(2008-5#1)(2008-9#1)(2012-2#1)
the surface area##23##3##(1990-11#1)(1992-5#1)(1994-3#1)(1994-8#1)(1997-2#1)(2004-9#1)(2005-11#5)(2006-10#3)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-9#1)(2010-4#2)(2012-2#1)
the surface areas##3##3##(2010-1#2)(2010-4#1)
the surface as##3##3##(2008-11#1)(2008-8#1)(2012-11#1)
the surface at##3##3##(2005-11#1)(2008-7#2)
the surface boron doped diamond electrode##2##6##(2008-10#2)
the surface by##5##3##(2005-11#2)(2008-3#1)(2008-5#1)(2010-12#1)
the surface can be##2##4##(2008-2#1)(2008-5#1)
the surface characteristics of the##3##5##(1992-3#1)(2008-11#1)(2008-3#1)
the surface charge density##2##4##(1990-3#1)(2009-8#1)
the surface charge of##2##4##(2005-11#1)(2007-8#1)
the surface charge##12##3##(1990-3#2)(1996-1#1)(1996-7#1)(2005-11#4)(2007-8#1)(2009-8#1)(2010-2#1)(2011-2#1)
the surface chemical stoichiometry of the##2##6##(2008-5#2)
the surface concentration of##4##4##(1990-12#1)(1991-8#1)(1993-12#1)(2008-10#1)
the surface concentration##5##3##(1990-12#1)(1991-8#1)(1993-12#1)(2007-8#1)(2008-10#1)
the surface coverage##3##3##(2005-11#1)(2008-10#2)
the surface density of##2##4##(1994-9#1)(2005-11#1)
the surface diffuse reflectance ultraviolet-visible spectra##2##6##(2005-4#2)
the surface dose##3##3##(2008-3#3)
the surface expression of the chemokine receptors CXCR3 and CCR5 on##2##11##(2008-8#2)
the surface expression of the##4##5##(1993-6#1)(1994-5#1)(2008-8#2)
the surface expression of##6##4##(1993-12#1)(1993-6#1)(1994-5#1)(1994-6#1)(2008-8#2)
the surface figure##2##3##(2008-3#2)
the surface flux density##2##4##(2008-2#2)
the surface flux##3##3##(2008-10#1)(2008-2#2)
the surface forces##2##3##(2005-11#1)(2008-10#1)
the surface free energy of##2##5##(2005-11#2)
the surface from##2##3##(2008-2#1)(2008-5#1)
the surface in a##2##4##(2005-11#1)(2010-4#1)
the surface in the##2##4##(1994-5#1)(2008-10#1)
the surface in##5##3##(1994-5#1)(2005-11#1)(2008-10#1)(2008-3#1)(2010-4#1)
the surface is##11##3##(1996-5#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#3)(2008-5#1)
the surface layer##4##3##(2005-11#3)(2008-3#1)
the surface layers##3##3##(2008-3#1)(2008-5#2)
the surface may be##2##4##(1996-4#1)(2008-3#1)
the surface modification##4##3##(2005-11#1)(2008-10#3)
the surface modified##2##3##(2005-4#1)(2008-10#1)
the surface morphologies of##2##4##(2008-10#1)(2008-2#1)
the surface morphology of##4##4##(2005-11#2)(2008-3#1)(2008-7#1)
the surface morphology##7##3##(2004-9#1)(2005-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-7#1)
the surface of Au##2##4##(2008-8#1)(2009-11#1)
the surface of CCPE##2##4##(2008-10#2)
the surface of a disposable carbon screen-printed electrode##2##8##(2008-10#2)
the surface of a glass##2##5##(2007-8#1)(2008-2#1)
the surface of a glassy carbon electrode##5##7##(1990-12#1)(2008-10#4)
the surface of a thin##2##5##(2008-2#1)(2008-3#1)
the surface of a##54##4##(1990-12#1)(1990-5#1)(1995-4#1)(1996-5#1)(2005-11#1)(2006-4#2)(2006-5#1)(2007-12#4)(2007-3#1)(2007-8#3)(2008-1#2)(2008-10#16)(2008-2#5)(2008-3#4)(2008-4#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-4#1)(2010-7#1)
the surface of activated##6##4##(1992-12#1)(1993-3#1)(1995-3#1)(2005-11#3)
the surface of an##10##4##(2006-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-3#2)(2010-5#1)
the surface of both##2##4##(1993-6#1)(2008-10#1)
the surface of cells##2##4##(1997-3#1)(2006-10#1)
the surface of cultured##2##4##(1995-6#1)(2008-11#1)
the surface of human##7##4##(1994-11#1)(1994-8#1)(1995-2#1)(1996-2#2)(1997-6#1)(2007-11#1)
the surface of infected##5##4##(1990-3#1)(1991-7#1)(2008-10#3)
the surface of liposomes##3##4##(1990-2#1)(2005-11#2)
the surface of lipstick##2##4##(2008-5#2)
the surface of one of##2##5##(2008-1#1)(2008-3#1)
the surface of one##3##4##(1991-7#1)(2008-1#1)(2008-3#1)
the surface of platelets and##2##5##(1990-9#1)(1991-12#1)
the surface of poly(ethylene##2##4##(2010-12#1)(2010-7#1)
the surface of polyaniline##2##4##(2005-11#2)
the surface of silica gel##4##5##(2008-10#3)(2013-8#1)
the surface of silica##6##4##(2005-11#2)(2008-10#3)(2013-8#1)
the surface of sodium##2##4##(2005-11#2)
the surface of solid##2##4##(1994-8#1)(2008-11#1)
the surface of target cells and##2##6##(2010-10#1)(2011-1#1)
the surface of target cells##3##5##(2006-10#1)(2010-10#1)(2011-1#1)
the surface of the alumina##2##5##(2005-11#2)
the surface of the beating heart##2##6##(2010-2#2)
the surface of the carriers##2##5##(2005-11#1)(2008-11#1)
the surface of the cells##2##5##(2008-10#1)(2013-1#1)
the surface of the cover glass##2##6##(2008-1#2)
the surface of the eye##3##5##(2007-1#3)
the surface of the host##3##5##(2008-10#2)(2013-1#1)
the surface of the lipid##2##5##(1994-3#1)(2008-11#1)
the surface of the membrane##6##5##(1994-2#1)(2008-10#2)(2008-2#1)(2008-4#2)
the surface of the modified electrodes##2##6##(2008-10#2)
the surface of the modified##3##5##(2008-10#3)
the surface of the molecule##4##5##(1993-3#1)(1994-11#1)(2008-4#2)
the surface of the nanotubes##2##5##(2006-12#1)(2010-7#1)
the surface of the object##2##5##(2007-12#1)(2008-2#1)
the surface of the protein##3##5##(1992-9#1)(1996-8#1)(1997-5#1)
the surface of the skin##7##5##(2006-7#2)(2008-3#1)(2008-5#2)(2010-3#2)
the surface of the solid##2##5##(1990-12#1)(2008-10#1)
the surface of the virus##3##5##(1992-12#1)(1994-9#2)
the surface of the##189##4##(1990-12#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-11#4)(1994-2#1)(1994-3#1)(1994-9#3)(1995-10#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-5#2)(1997-7#1)(2005-11#7)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#2)(2007-1#3)(2007-11#2)(2007-12#4)(2007-5#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#46)(2008-11#7)(2008-12#1)(2008-2#7)(2008-3#7)(2008-4#5)(2008-5#8)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-2#3)(2010-3#2)(2010-4#4)(2010-7#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#3)
the surface of these##4##4##(1993-8#1)(2007-11#1)(2008-11#1)(2009-12#1)
the surface of tumor cells##2##5##(1997-4#1)(2010-1#1)
the surface of water##2##4##(2008-2#1)(2013-1#1)
the surface of zoosporangia##2##4##(2008-10#2)
the surface of##504##3##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#4)(1991-2#3)(1991-3#1)(1991-4#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#6)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#7)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#3)(1994-9#3)(1995-10#1)(1995-2#5)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#5)(1995-7#1)(1995-8#1)(1996-11#1)(1996-2#3)(1996-3#3)(1996-4#1)(1996-5#5)(1996-8#2)(1996-9#2)(1997-1#3)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#1)(2004-9#2)(2005-10#1)(2005-11#25)(2005-8#1)(2006-1#2)(2006-10#8)(2006-12#1)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#2)(2006-9#1)(2007-1#3)(2007-11#9)(2007-12#11)(2007-2#1)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#11)(2007-9#2)(2008-1#6)(2008-10#113)(2008-11#12)(2008-12#1)(2008-2#15)(2008-3#17)(2008-4#11)(2008-5#21)(2008-6#2)(2008-7#9)(2008-8#7)(2008-9#3)(2009-11#3)(2009-12#4)(2009-2#3)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#4)(2010-2#3)(2010-3#2)(2010-4#7)(2010-5#1)(2010-7#6)(2010-9#2)(2011-1#2)(2011-12#2)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#3)(2013-1#7)(2013-8#6)
the surface or the##2##4##(2007-11#1)(2008-2#1)
the surface or##4##3##(1990-3#1)(2007-11#1)(2008-2#1)(2008-7#1)
the surface oxide##2##3##(2005-11#1)(2008-3#1)
the surface plane##2##3##(2007-12#1)(2008-3#1)
the surface plasmon resonance##3##4##(1994-8#1)(1995-12#1)(2008-10#1)
the surface potential of the particle##2##6##(2005-11#2)
the surface potential of the##3##5##(2005-11#3)
the surface potential##9##3##(1990-3#1)(2005-11#7)(2008-10#1)
the surface pressure##7##3##(1992-12#2)(1994-3#1)(1994-6#1)(1997-2#1)(2005-11#1)(2009-7#1)
the surface profile of##3##4##(1992-7#1)(2007-12#1)(2008-2#1)
the surface profile##10##3##(1992-7#1)(2005-10#1)(2007-12#2)(2008-2#4)(2008-3#1)(2008-5#1)
the surface properties of the##2##5##(2005-11#1)(2011-2#1)
the surface properties of##5##4##(1990-12#1)(1990-2#1)(2005-11#2)(2011-2#1)
the surface reactions##2##3##(2005-11#1)(2007-8#1)
the surface reflectance##5##3##(2008-2#2)(2008-3#3)
the surface residues##2##3##(2008-10#2)
the surface roughness of a##3##5##(2007-12#1)(2008-2#2)
the surface roughness of the##2##5##(2008-3#2)
the surface roughness of##8##4##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2011-2#2)
the surface roughness parameters##2##4##(2009-7#2)
the surface roughness##16##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#5)(2008-3#3)(2009-7#2)(2011-2#2)
the surface shape of##2##4##(2008-3#2)
the surface shape##3##3##(2005-11#1)(2008-3#2)
the surface species##2##3##(2008-10#1)(2008-2#1)
the surface structure and the##2##5##(2007-12#1)(2013-1#1)
the surface structure of##2##4##(1997-6#1)(2008-11#1)
the surface structure##5##3##(1997-6#1)(2006-12#1)(2007-12#1)(2008-11#1)(2013-1#1)
the surface temperature##3##3##(2007-9#1)(2008-7#2)
the surface tension and the##2##5##(2005-11#1)(2008-2#1)
the surface tension and viscosity of##2##6##(2008-3#1)(2013-8#1)
the surface tension and##4##4##(2005-11#1)(2008-2#1)(2008-3#1)(2013-8#1)
the surface tension is higher##2##5##(1992-5#1)(2005-11#1)
the surface tension is##3##4##(1992-5#1)(2005-11#2)
the surface tension lowering of##2##5##(2008-10#2)
the surface tension lowering##3##4##(2008-10#3)
the surface tension of molten silicon##3##6##(2005-11#3)
the surface tension of the##2##5##(2005-11#2)
the surface tension of##6##4##(2005-11#5)(2008-5#1)
the surface tension##26##3##(1992-5#1)(2005-11#11)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-2#1)(2013-8#1)
the surface through##2##3##(2008-2#1)(2008-3#1)
the surface to be##2##4##(2008-3#1)(2010-4#1)
the surface to the##3##4##(2008-3#1)(2008-6#1)(2009-12#1)
the surface to##6##3##(2006-10#1)(2008-3#2)(2008-6#1)(2009-12#1)(2010-4#1)
the surface topology##2##3##(2008-10#1)(2008-2#1)
the surface under##2##3##(2008-5#1)(2010-4#1)
the surface velocity of##4##4##(2008-2#2)(2008-3#2)
the surface was determined##3##4##(1990-2#1)(2008-10#1)(2008-3#1)
the surface was##14##3##(1990-2#1)(1991-5#1)(2004-9#1)(2005-11#3)(2006-5#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)
the surface water##2##3##(2008-10#1)(2010-9#1)
the surface were analyzed##2##4##(2005-11#1)(2009-7#1)
the surface were##5##3##(2005-11#2)(2007-7#1)(2008-11#1)(2009-7#1)
the surface which##4##3##(2008-5#2)(2009-7#1)(2013-8#1)
the surface with a##2##4##(2008-10#1)(2008-3#1)
the surface with##4##3##(2008-10#1)(2008-3#2)(2008-5#1)
the surface##1117##2##(1990-11#4)(1990-12#6)(1990-2#4)(1990-3#6)(1990-5#3)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#7)(1991-2#4)(1991-3#4)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#9)(1992-3#3)(1992-4#1)(1992-5#3)(1992-6#3)(1992-7#2)(1992-8#1)(1992-9#4)(1993-11#1)(1993-12#4)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#2)(1994-11#7)(1994-12#1)(1994-2#1)(1994-3#5)(1994-5#3)(1994-6#4)(1994-8#5)(1994-9#5)(1995-10#2)(1995-12#2)(1995-2#5)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#6)(1995-7#2)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#3)(1996-4#3)(1996-5#11)(1996-7#1)(1996-8#4)(1996-9#2)(1997-1#6)(1997-2#2)(1997-3#1)(1997-4#4)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#1)(2004-12#5)(2004-9#9)(2005-10#2)(2005-11#126)(2005-4#3)(2005-7#1)(2005-8#2)(2006-1#2)(2006-10#12)(2006-12#4)(2006-3#1)(2006-4#3)(2006-5#5)(2006-6#3)(2006-7#2)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#19)(2007-12#34)(2007-2#1)(2007-3#2)(2007-5#3)(2007-6#2)(2007-7#2)(2007-8#18)(2007-9#6)(2008-1#7)(2008-10#177)(2008-11#21)(2008-12#1)(2008-2#60)(2008-3#94)(2008-4#19)(2008-5#54)(2008-6#7)(2008-7#19)(2008-8#13)(2008-9#6)(2009-11#5)(2009-12#8)(2009-2#3)(2009-3#4)(2009-4#2)(2009-6#3)(2009-7#13)(2009-8#4)(2009-9#1)(2010-1#3)(2010-10#1)(2010-12#6)(2010-2#5)(2010-3#2)(2010-4#22)(2010-5#1)(2010-6#1)(2010-7#6)(2010-8#3)(2010-9#3)(2011-1#3)(2011-12#4)(2011-2#9)(2012-1#3)(2012-11#4)(2012-12#4)(2012-2#11)(2013-1#11)(2013-7#1)(2013-8#14)
the surface-enhanced##2##2##(2007-8#1)(2013-8#1)
the surface-plasmon resonance (SPR)##2##4##(2008-3#2)
the surface-plasmon resonance##3##3##(2008-3#3)
the surface-plasmon##5##2##(2008-2#1)(2008-3#4)
the surface-reflected radiance##2##3##(2008-3#2)
the surfaces and##5##3##(2008-1#1)(2008-2#1)(2008-7#1)(2013-8#2)
the surfaces are##2##3##(2008-11#1)(2008-2#1)
the surfaces of contact between##2##5##(1994-5#2)
the surfaces of the##13##4##(1992-11#1)(2004-9#1)(2005-11#3)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#3)(2013-1#1)
the surfaces of these##2##4##(2008-10#1)(2008-5#1)
the surfaces of##32##3##(1992-11#1)(1994-11#1)(1994-12#1)(1994-5#2)(2004-9#1)(2005-11#4)(2005-12#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#1)(2009-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2013-1#1)
the surfaces that##2##3##(2008-12#1)(2010-7#1)
the surfaces##66##2##(1990-4#1)(1992-11#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-6#1)(1996-8#1)(2004-9#1)(2005-10#1)(2005-11#8)(2005-12#1)(2006-12#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#6)(2008-3#7)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-10#1)(2010-4#3)(2010-7#2)(2010-8#1)(2013-1#1)(2013-8#2)
the surfactant and the##2##4##(2008-10#1)(2008-5#1)
the surfactant and##5##3##(2008-10#1)(2008-5#2)(2009-12#2)
the surfactant chains##2##3##(1991-2#2)
the surfactant concentration##5##3##(2005-11#3)(2008-10#2)
the surfactant in the##3##4##(1996-5#1)(2005-11#1)(2008-10#1)
the surfactant is##3##3##(2005-11#3)
the surfactant layer##2##3##(2005-11#1)(2008-10#1)
the surfactant protein##3##3##(1992-9#2)(1995-4#1)
the surfactant solution##3##3##(2007-10#1)(2008-10#1)(2008-5#1)
the surfactant##73##2##(1990-11#1)(1990-12#1)(1990-3#1)(1991-2#3)(1992-11#1)(1992-5#1)(1992-9#2)(1994-12#1)(1994-9#1)(1995-4#1)(1996-1#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-8#1)(2005-11#24)(2007-1#1)(2007-10#1)(2008-10#15)(2008-5#6)(2008-7#1)(2009-12#3)(2010-1#1)(2010-2#1)(2013-8#1)
the surfactant-rich phase##7##3##(2008-10#5)(2008-7#2)
the surfactants and the##2##4##(1992-11#1)(2012-2#1)
the surfactants and##5##3##(1992-1#1)(1992-11#1)(2008-10#2)(2012-2#1)
the surfactants##17##2##(1992-1#1)(1992-11#1)(1996-5#2)(2005-11#3)(2007-11#1)(2008-10#3)(2008-5#5)(2012-2#1)
the surficial##2##2##(1990-11#1)(2004-4#1)
the surge of##4##3##(2007-11#1)(2007-9#1)(2011-1#1)(2012-2#1)
the surgeon an##2##3##(2006-10#1)(2007-5#1)
the surgeon and the##2##4##(2006-6#1)(2007-11#1)
the surgeon and##8##3##(2006-6#2)(2007-11#1)(2007-12#2)(2007-5#1)(2008-4#1)(2008-9#1)
the surgeon as##2##3##(2007-7#1)(2008-6#1)
the surgeon can##5##3##(1995-4#1)(2007-5#2)(2007-7#1)(2007-8#1)
the surgeon in##5##3##(1993-9#1)(2008-10#1)(2009-9#1)(2011-2#1)(2012-12#1)
the surgeon is##2##3##(1993-11#1)(2007-12#1)
the surgeon should##2##3##(2007-3#1)(2013-1#1)
the surgeon the##2##3##(2006-3#1)(2008-10#1)
the surgeon to perform##3##4##(2010-8#2)(2013-7#1)
the surgeon to the##2##4##(2006-6#1)(2012-12#1)
the surgeon to##23##3##(1992-12#2)(2004-2#1)(2006-3#1)(2006-6#2)(2007-12#1)(2007-5#2)(2007-7#2)(2007-8#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#1)
the surgeon with##2##3##(2006-6#1)(2012-2#1)
the surgeon##107##2##(1991-8#1)(1992-10#1)(1992-12#2)(1992-2#1)(1993-1#1)(1993-11#1)(1993-9#1)(1995-4#1)(1996-12#1)(1997-6#1)(2004-2#1)(2006-10#3)(2006-3#3)(2006-6#9)(2006-9#1)(2007-11#3)(2007-12#9)(2007-3#1)(2007-5#16)(2007-7#4)(2007-8#5)(2007-9#1)(2008-10#4)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
the surgeon's ability to perform##2##5##(2006-3#1)(2006-6#1)
the surgeon's ability to##3##4##(2006-12#1)(2006-3#1)(2006-6#1)
the surgeon's experience and##3##4##(2007-11#1)(2007-12#1)(2011-2#1)
the surgeon's experience##6##3##(2006-6#1)(2007-11#2)(2007-12#1)(2007-8#1)(2011-2#1)
the surgeon's hand movements##2##4##(2006-6#2)
the surgeon's##25##2##(1990-5#1)(1994-2#1)(2006-12#1)(2006-3#1)(2006-5#2)(2006-6#11)(2007-11#2)(2007-12#1)(2007-8#1)(2008-4#1)(2009-5#1)(2011-2#2)
the surgeons##17##2##(1993-9#1)(1996-1#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-7#2)(2008-9#1)(2009-7#1)(2013-1#1)
the surgeons'##2##2##(1993-10#1)(2008-9#1)
the surgery and the##2##4##(2008-7#1)(2009-4#1)
the surgery and##5##3##(1995-7#1)(2006-7#1)(2008-7#1)(2009-4#1)(2011-2#1)
the surgery is##2##3##(2007-8#1)(2008-1#1)
the surgery of##5##3##(2008-7#2)(2008-9#2)(2012-12#1)
the surgery was##2##3##(1993-9#1)(2006-12#1)
the surgery##80##2##(1990-3#1)(1990-9#1)(1991-4#1)(1993-9#1)(1994-2#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-8#2)(2006-10#1)(2006-12#1)(2006-2#2)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#7)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-2#3)(2009-4#3)(2009-7#1)(2010-12#1)(2010-8#2)(2011-12#2)(2011-2#3)(2011-3#1)(2012-12#5)(2013-1#5)(2013-8#4)
the surgical and anesthetic##2##4##(2006-10#1)(2011-2#1)
the surgical and##6##3##(1993-1#1)(2006-10#1)(2006-2#1)(2008-9#1)(2011-2#1)(2013-1#1)
the surgical approach of##2##4##(2007-5#1)(2008-12#1)
the surgical approach to##3##4##(2006-10#1)(2008-10#1)(2010-8#1)
the surgical approach##13##3##(1990-6#1)(2006-10#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-9#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the surgical area##2##3##(2006-6#1)(2009-8#1)
the surgical aspects##2##3##(2008-10#1)(2012-2#1)
the surgical correction of##2##4##(2008-8#1)(2009-10#1)
the surgical correction##3##3##(2008-8#1)(2009-10#1)(2012-2#1)
the surgical exposure##2##3##(2005-9#1)(2007-8#1)
the surgical field in##2##4##(2008-7#1)(2010-8#1)
the surgical field##10##3##(1996-1#1)(2006-10#1)(2006-12#2)(2006-4#1)(2008-7#1)(2008-9#2)(2010-8#1)(2012-12#1)
the surgical glove##2##3##(1993-6#1)(2009-2#1)
the surgical group##4##3##(2006-11#1)(2007-8#3)
the surgical implantation of human fetal##2##6##(2008-4#2)
the surgical indications##5##3##(1990-6#1)(1991-6#1)(2007-10#1)(2010-12#1)(2013-1#1)
the surgical intervention in##2##4##(2008-8#1)(2012-3#1)
the surgical intervention is##2##4##(1991-3#1)(1995-5#1)
the surgical intervention##8##3##(1991-3#1)(1993-5#1)(1995-5#1)(2007-8#1)(2008-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
the surgical management of a##2##5##(2006-9#1)(2012-12#1)
the surgical management of breast carcinoma##2##6##(1994-12#2)
the surgical management of breast##3##5##(1994-12#2)(2008-1#1)
the surgical management of the##3##5##(2010-3#1)(2013-1#2)
the surgical management of##26##4##(1993-10#1)(1993-5#1)(1994-12#2)(2005-12#1)(2006-12#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-12#2)(2013-1#4)
the surgical management##30##3##(1990-9#1)(1992-1#1)(1993-10#1)(1993-5#1)(1994-12#2)(2005-12#1)(2006-12#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-12#2)(2013-1#4)(2013-8#1)
the surgical margin achieved##2##4##(2008-6#2)
the surgical methods##4##3##(2007-11#1)(2007-7#1)(2007-8#1)(2008-9#1)
the surgical microscope##2##3##(2006-10#2)
the surgical option##2##3##(2009-5#1)(2011-2#1)
the surgical outcome##3##3##(1991-2#1)(2010-3#1)(2013-8#1)
the surgical patient##4##3##(2005-12#1)(2007-12#1)(2009-2#1)(2011-12#1)
the surgical procedure and##2##4##(2007-11#1)(2008-8#1)
the surgical procedure for##2##4##(2007-11#1)(2007-7#1)
the surgical procedure with##2##4##(2008-8#1)(2012-3#1)
the surgical procedure##33##3##(1990-9#1)(1994-12#1)(1996-9#1)(2004-2#1)(2005-9#1)(2006-10#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#2)(2007-7#2)(2007-8#1)(2008-7#1)(2008-8#4)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
the surgical procedures##8##3##(1991-4#1)(1996-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
the surgical reconstruction of##2##4##(2007-11#1)(2007-12#1)
the surgical removal of the##3##5##(2006-5#1)(2008-4#1)(2010-12#1)
the surgical removal of##4##4##(2006-5#1)(2007-8#1)(2008-4#1)(2010-12#1)
the surgical removal##6##3##(2006-5#1)(2007-8#1)(2008-4#3)(2010-12#1)
the surgical repair of##3##4##(2006-10#1)(2007-8#2)
the surgical repair##5##3##(2006-10#1)(2007-8#2)(2010-3#1)(2013-1#1)
the surgical results of##2##4##(2006-12#2)
the surgical results##3##3##(2006-12#2)(2007-7#1)
the surgical risk##3##3##(1993-9#1)(2007-10#1)(2007-8#1)
the surgical site##8##3##(2007-1#1)(2007-11#2)(2008-10#1)(2008-5#1)(2009-6#1)(2010-3#1)(2010-6#1)
the surgical specimen##7##3##(1991-12#1)(1991-9#1)(1992-4#1)(2006-8#1)(2007-8#1)(2011-2#1)(2013-1#1)
the surgical stratification of patients with##2##6##(2006-10#2)
the surgical stratification##3##3##(2006-10#3)
the surgical stress##2##3##(2007-7#1)(2013-1#1)
the surgical team##2##3##(2011-3#1)(2012-12#1)
the surgical technique and##2##4##(1997-2#1)(2013-1#1)
the surgical technique of##3##4##(1992-8#1)(2006-3#1)(2009-3#1)
the surgical technique##10##3##(1992-8#1)(1997-2#1)(2005-7#1)(2006-3#2)(2006-5#1)(2007-7#2)(2009-3#1)(2013-1#1)
the surgical techniques##5##3##(1990-3#1)(1990-6#2)(1992-9#1)(2006-4#1)
the surgical therapy is##2##4##(2007-8#1)(2011-2#1)
the surgical treatment by##2##4##(1990-5#1)(2010-7#1)
the surgical treatment is##2##4##(2009-9#1)(2012-12#1)
the surgical treatment of a##2##5##(2007-8#1)(2012-12#1)
the surgical treatment of acute##2##5##(2006-10#1)(2009-2#1)
the surgical treatment of cancer of the##2##7##(1990-3#1)(1990-9#1)
the surgical treatment of primary##2##5##(2007-7#2)
the surgical treatment of the##2##5##(2007-11#1)(2008-8#1)
the surgical treatment of these patients##2##6##(2007-11#1)(2007-7#1)
the surgical treatment of these##3##5##(2006-2#1)(2007-11#1)(2007-7#1)
the surgical treatment of##51##4##(1990-3#2)(1990-9#2)(1991-3#1)(1992-10#1)(1992-4#1)(1992-6#1)(2006-10#1)(2006-11#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#9)(2007-7#7)(2007-8#3)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#5)(2009-2#1)(2010-3#1)(2011-2#1)(2012-12#2)(2013-8#2)
the surgical treatment was##2##4##(1990-3#1)(1993-9#1)
the surgical treatment##70##3##(1990-3#3)(1990-5#1)(1990-9#2)(1991-3#1)(1992-10#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-9#1)(1995-5#1)(2006-10#1)(2006-11#1)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#10)(2007-7#7)(2007-8#3)(2008-10#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#5)(2009-2#2)(2009-4#1)(2009-9#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#3)(2013-1#1)(2013-8#2)
the surgical ward##4##3##(1990-8#1)(2006-4#1)(2007-4#1)(2009-6#1)
the surgical##364##2##(1990-3#4)(1990-5#2)(1990-6#4)(1990-8#1)(1990-9#4)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-10#3)(1992-2#2)(1992-3#1)(1992-4#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-10#1)(1993-5#2)(1993-6#1)(1993-9#2)(1994-12#3)(1995-4#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-9#3)(1997-2#1)(2004-10#1)(2004-2#1)(2005-12#4)(2005-5#1)(2005-7#1)(2005-9#2)(2006-10#13)(2006-11#4)(2006-12#6)(2006-2#4)(2006-3#5)(2006-4#5)(2006-5#4)(2006-6#8)(2006-7#1)(2006-8#4)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#20)(2007-12#8)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#17)(2007-8#24)(2007-9#2)(2008-1#2)(2008-10#5)(2008-12#1)(2008-3#3)(2008-4#5)(2008-5#1)(2008-6#6)(2008-7#7)(2008-8#11)(2008-9#12)(2009-10#1)(2009-12#1)(2009-2#4)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#3)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#6)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-12#2)(2011-2#20)(2011-3#2)(2012-12#10)(2012-2#6)(2012-3#4)(2013-1#18)(2013-8#6)
the surgically resected##2##3##(2008-7#2)
the surgically treated##4##3##(1992-9#1)(2006-11#1)(2007-8#1)(2008-9#1)
the surgically##9##2##(1990-6#1)(1992-9#1)(2006-11#1)(2007-8#1)(2007-9#1)(2008-7#2)(2008-9#1)(2010-3#1)
the surprising##3##2##(1997-1#1)(2008-10#1)(2012-2#1)
the surrogate mother##4##3##(1991-7#4)
the surrogate##8##2##(1991-7#4)(1995-6#1)(2006-5#1)(2007-8#1)(2008-10#1)
the surrounding area##4##3##(1995-11#2)(2005-8#1)(2007-11#1)
the surrounding bone##2##3##(2007-2#1)(2012-2#1)
the surrounding community##10##3##(2010-2#10)
the surrounding environment##9##3##(1993-3#1)(1995-6#1)(2006-10#1)(2008-7#1)(2010-10#1)(2010-7#1)(2012-2#1)(2013-1#2)
the surrounding fibrous##2##3##(2005-12#1)(2006-3#1)
the surrounding fluid##3##3##(2005-11#1)(2007-11#1)(2011-1#1)
the surrounding liver##3##3##(1994-6#3)
the surrounding matrix##6##3##(2008-2#1)(2008-8#2)(2009-12#2)(2010-2#1)
the surrounding media##3##3##(2008-3#1)(2010-2#1)(2011-1#1)
the surrounding medium##7##3##(1991-7#1)(2008-2#3)(2008-3#1)(2009-2#1)(2012-1#1)
the surrounding microenvironment##2##3##(2009-3#1)(2011-1#1)
the surrounding normal tissue##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
the surrounding normal##5##3##(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
the surrounding protein##2##3##(2006-10#1)(2009-2#1)
the surrounding soft tissue##2##4##(2007-8#1)(2008-9#1)
the surrounding soft tissues##2##4##(2007-6#1)(2008-9#1)
the surrounding soft##4##3##(2007-6#1)(2007-8#1)(2008-9#2)
the surrounding solvent##2##3##(1993-8#1)(2006-10#1)
the surrounding structures##3##3##(1993-6#1)(2007-12#1)(2012-2#1)
the surrounding tissue##6##3##(1990-11#1)(1997-4#1)(2006-6#1)(2006-9#1)(2007-11#1)(2013-1#1)
the surrounding tissues##9##3##(1990-6#1)(1993-11#1)(1996-3#1)(2006-6#1)(2007-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)
the surrounding water##2##3##(1993-3#1)(2008-2#1)
the surrounding##161##2##(1990-11#1)(1990-6#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-4#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#1)(1994-6#3)(1994-9#1)(1995-11#4)(1995-3#1)(1995-6#3)(1995-9#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-7#1)(1997-4#2)(2005-11#2)(2005-12#2)(2005-8#1)(2006-10#4)(2006-11#1)(2006-3#1)(2006-5#2)(2006-6#3)(2006-9#1)(2007-11#7)(2007-12#4)(2007-2#1)(2007-3#1)(2007-5#2)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-2#7)(2008-3#6)(2008-4#1)(2008-5#3)(2008-7#8)(2008-8#5)(2008-9#2)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-6#2)(2010-10#1)(2010-2#14)(2010-7#1)(2011-1#5)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#5)(2013-1#7)
the surroundings##5##2##(1995-2#1)(1996-3#1)(2005-10#1)(2008-3#1)(2009-7#1)
the surveillance and##3##3##(2010-4#1)(2011-1#1)(2011-12#1)
the surveillance network of schistosomiasis##2##5##(2011-12#2)
the surveillance of##9##3##(1993-6#1)(1995-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-4#1)(2011-2#1)(2012-3#1)
the surveillance system##4##3##(1994-2#2)(2008-1#1)(2012-12#1)
the surveillance##33##2##(1991-8#1)(1992-9#2)(1993-6#1)(1994-2#2)(1994-6#1)(1995-3#1)(1996-11#1)(1996-3#1)(2005-5#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-5#1)(2010-4#2)(2011-1#1)(2011-12#4)(2011-2#2)(2012-12#2)(2012-3#3)(2013-8#2)
the survey and##5##3##(2007-2#1)(2008-10#1)(2008-9#1)(2010-3#1)(2013-1#1)
the survey data##2##3##(2008-10#1)(2013-8#1)
the survey findings##2##3##(2008-9#1)(2012-3#1)
the survey of##4##3##(1996-1#1)(2006-6#1)(2007-2#1)(2008-11#1)
the survey on##2##3##(1995-8#1)(2007-1#1)
the survey responses##3##3##(1993-1#1)(1995-1#1)(2008-12#1)
the survey results##3##3##(2006-2#2)(2007-4#1)
the survey were##8##3##(1991-12#1)(1991-2#1)(1996-1#1)(2007-7#1)(2008-10#1)(2010-8#1)(2012-12#1)(2012-2#1)
the survey##116##2##(1990-10#1)(1990-3#4)(1991-12#1)(1991-2#3)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-3#1)(1993-5#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#1)(1995-1#3)(1995-12#3)(1995-3#1)(1995-8#1)(1996-1#4)(1997-1#1)(2005-11#2)(2006-10#1)(2006-2#3)(2006-6#1)(2007-1#1)(2007-10#1)(2007-2#3)(2007-4#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#3)(2009-2#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#11)(2013-8#1)
the surveyed##4##2##(2007-11#1)(2008-10#1)(2012-2#1)(2013-1#1)
the surveys##4##2##(2010-12#2)(2013-8#2)
the survival advantage##2##3##(2007-9#1)(2011-2#1)
the survival and growth of##4##5##(1995-11#1)(2008-10#1)(2008-5#1)(2008-7#1)
the survival and quality of life of##2##7##(1990-10#1)(2008-7#1)
the survival and##22##3##(1990-10#1)(1993-11#1)(1993-9#1)(1995-11#1)(1995-7#1)(1996-12#1)(2004-4#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#3)(2009-10#1)(2009-3#1)(2010-2#1)(2010-7#1)(2010-8#1)(2012-12#1)
the survival benefit##3##3##(2007-11#1)(2008-10#1)(2010-12#1)
the survival curve##5##3##(1995-3#4)(1997-4#1)
the survival curves##3##3##(1992-2#1)(1993-5#2)
the survival function##4##3##(1995-12#1)(1996-1#1)(2008-10#1)(2008-3#1)
the survival in##2##3##(1991-10#1)(2008-1#1)
the survival of both##3##4##(1996-3#1)(1997-7#1)(2012-12#1)
the survival of cultured##3##4##(1994-5#1)(1996-5#1)(2013-7#1)
the survival of mice fed##2##5##(2006-8#2)
the survival of mice##3##4##(2006-8#3)
the survival of neurons##3##4##(1991-3#1)(1992-8#1)(1996-2#1)
the survival of offspring##2##4##(2004-2#1)(2008-8#1)
the survival of patients with##6##5##(2005-1#1)(2008-11#1)(2008-2#1)(2008-6#1)(2010-12#1)(2010-3#1)
the survival of patients##9##4##(2005-1#1)(2006-6#1)(2008-11#1)(2008-2#1)(2008-6#1)(2010-12#2)(2010-3#1)(2013-8#1)
the survival of the Escherichia coli##2##6##(1990-8#1)(2013-1#1)
the survival of the##21##4##(1990-8#1)(1991-9#1)(1993-5#1)(1993-7#1)(2004-4#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
the survival of these##2##4##(2005-12#1)(2008-10#1)
the survival of two##2##4##(2004-4#1)(2008-10#1)
the survival of##121##3##(1990-3#1)(1990-8#1)(1991-12#1)(1991-3#3)(1991-4#1)(1991-6#1)(1991-9#1)(1992-6#1)(1992-8#4)(1993-11#3)(1993-5#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-5#3)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#1)(1997-4#2)(1997-6#1)(1997-7#1)(2004-2#1)(2004-4#2)(2005-1#1)(2005-12#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#4)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#6)(2008-6#2)(2008-8#5)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#2)(2010-12#4)(2010-3#1)(2010-8#3)(2011-2#3)(2012-12#3)(2012-2#1)(2012-5#1)(2013-1#2)(2013-7#2)(2013-8#1)
the survival period of##2##4##(2006-6#1)(2008-6#1)
the survival probability during migration##3##5##(2007-9#3)
the survival probability##5##3##(2007-9#5)
the survival rate for##2##4##(2008-6#1)(2009-10#1)
the survival rate of##6##4##(1991-12#1)(1994-6#1)(2006-7#1)(2007-8#1)(2010-8#1)(2011-2#1)
the survival rate##20##3##(1991-10#1)(1991-12#1)(1991-2#1)(1994-5#1)(1994-6#1)(1995-3#1)(1997-7#2)(2006-6#1)(2006-7#1)(2007-8#1)(2008-11#1)(2008-6#1)(2009-10#1)(2010-3#1)(2010-8#1)(2011-2#3)(2013-7#1)
the survival rates##2##3##(2006-10#1)(2007-11#1)
the survival time of##5##4##(1992-3#1)(1997-5#1)(2007-11#1)(2008-8#1)(2013-1#1)
the survival time##11##3##(1992-3#1)(1992-7#1)(1992-8#1)(1997-4#1)(1997-5#1)(2006-12#1)(2007-11#1)(2007-6#1)(2008-3#1)(2008-8#1)(2013-1#1)
the survival was##3##3##(2006-8#1)(2008-9#1)(2013-7#1)
the survival##242##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-8#1)(1991-10#2)(1991-12#2)(1991-2#1)(1991-3#3)(1991-4#1)(1991-6#1)(1991-9#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#5)(1993-11#4)(1993-5#3)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-5#4)(1994-6#1)(1994-7#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#6)(1995-7#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#4)(1996-5#2)(1997-2#1)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#3)(2004-2#1)(2004-4#4)(2005-1#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#6)(2006-7#2)(2006-8#5)(2007-11#6)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#3)(2007-9#7)(2008-1#3)(2008-10#21)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#8)(2008-6#5)(2008-7#4)(2008-8#8)(2008-9#2)(2009-10#3)(2009-12#1)(2009-3#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-12#5)(2010-2#1)(2010-3#3)(2010-7#1)(2010-8#5)(2011-12#1)(2011-2#7)(2012-12#5)(2012-2#2)(2012-5#1)(2013-1#3)(2013-7#4)(2013-8#2)
the survivin##2##2##(2008-4#1)(2010-1#1)
the surviving##17##2##(1991-9#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-3#1)(1994-5#1)(1997-4#1)(2007-3#1)(2007-7#1)(2008-5#1)(2008-9#4)(2010-10#1)(2010-11#1)(2010-4#1)
the survivor##3##2##(2008-10#1)(2008-6#1)(2013-1#1)
the survivors##10##2##(1993-11#1)(1994-6#1)(1995-5#1)(2004-11#1)(2007-6#1)(2007-8#1)(2007-9#1)(2011-1#1)(2011-2#2)
the survivorship##5##2##(2008-8#1)(2008-9#2)(2011-2#2)
the susceptibility levels##2##3##(2008-12#1)(2012-12#1)
the susceptibility of LDL to##2##5##(1995-12#1)(2004-11#1)
the susceptibility of the##8##4##(1991-2#1)(1992-10#1)(1995-2#1)(1997-2#1)(2006-10#1)(2008-10#1)(2008-5#1)(2011-2#1)
the susceptibility of these##3##4##(1991-12#1)(1993-4#1)(1994-5#1)
the susceptibility of##53##3##(1990-11#2)(1991-12#2)(1991-2#1)(1992-10#2)(1992-9#1)(1993-11#2)(1993-4#1)(1994-11#2)(1994-5#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-8#1)(1997-2#1)(1997-3#1)(2004-11#2)(2005-10#1)(2006-10#1)(2006-8#2)(2007-7#1)(2008-10#8)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#2)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
the susceptibility patterns of##2##4##(2007-7#1)(2008-5#1)
the susceptibility patterns##3##3##(2006-10#1)(2007-7#1)(2008-5#1)
the susceptibility profile##2##3##(2006-8#1)(2009-2#1)
the susceptibility tests##2##3##(2006-8#1)(2008-12#1)
the susceptibility to the##2##4##(1993-3#1)(2008-11#1)
the susceptibility to##25##3##(1990-6#1)(1991-2#1)(1993-3#1)(1996-5#1)(1997-8#1)(2004-12#1)(2006-10#1)(2006-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-1#5)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
the susceptibility##100##2##(1990-11#2)(1990-6#1)(1991-12#2)(1991-2#2)(1991-7#1)(1992-10#2)(1992-9#1)(1993-11#2)(1993-3#1)(1993-4#1)(1994-11#2)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#2)(2004-11#2)(2004-12#1)(2005-10#1)(2006-10#3)(2006-11#1)(2006-8#4)(2007-10#1)(2007-12#2)(2007-7#3)(2008-10#11)(2008-11#1)(2008-12#3)(2008-5#2)(2008-7#3)(2008-9#2)(2009-2#3)(2009-4#1)(2009-6#1)(2009-7#1)(2010-12#1)(2011-1#8)(2011-2#5)(2012-12#4)(2012-3#1)(2013-1#1)(2013-8#1)
the susceptible and resistant cultivars##2##5##(2008-10#2)
the susceptible and resistant##4##4##(2008-10#4)
the susceptible and##5##3##(2008-10#5)
the susceptible check##2##3##(2008-10#2)
the susceptible control##2##3##(2008-10#2)
the susceptible controls##2##3##(2008-10#1)(2011-2#1)
the susceptible cultivar##15##3##(2008-10#13)(2009-8#1)(2012-11#1)
the susceptible cultivars##2##3##(2008-10#2)
the susceptible cv##8##3##(2008-10#8)
the susceptible genotype##4##3##(2008-10#4)
the susceptible genotypes##4##3##(2008-10#4)
the susceptible inbred B73 and##2##5##(2008-10#2)
the susceptible line##2##3##(2008-10#2)
the susceptible parent B73##2##4##(2008-10#2)
the susceptible parent##7##3##(2008-10#7)
the susceptible plants##2##3##(2008-10#2)
the susceptible##88##2##(1994-9#1)(1996-12#1)(2006-9#1)(2007-6#1)(2008-10#75)(2008-5#2)(2009-8#2)(2011-10#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-7#1)
the suspect##4##2##(1996-11#1)(2005-8#1)(2008-12#1)(2013-1#1)
the suspected##14##2##(1990-6#1)(1997-1#1)(1997-3#1)(2005-10#2)(2006-10#1)(2007-12#1)(2007-7#1)(2008-4#1)(2009-1#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)
the suspended particulate##2##3##(2008-10#1)(2008-2#1)
the suspended solid##2##3##(2011-2#2)
the suspended##12##2##(2007-11#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#3)(2009-7#1)(2011-2#2)
the suspension and##2##3##(2005-11#1)(2007-8#1)
the suspension culture##5##3##(2008-11#5)
the suspension##28##2##(1990-12#1)(1991-8#1)(1994-11#1)(1995-8#1)(1997-1#2)(2004-9#3)(2005-11#3)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#8)(2008-6#1)(2008-8#1)(2010-4#1)
the suspensions of##2##3##(1990-3#1)(2005-11#1)
the suspensions##5##2##(1990-3#1)(1990-4#1)(2005-11#3)
the suspensor##2##2##(2009-8#2)
the suspicion of an##2##4##(2008-12#1)(2010-2#1)
the suspicion of##9##3##(1991-10#1)(2007-10#1)(2007-8#1)(2008-12#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-12#1)
the suspicion##10##2##(1991-10#1)(2007-10#1)(2007-8#1)(2008-12#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
the sustainability of the##4##4##(2007-4#1)(2008-10#1)(2011-2#2)
the sustainability of treatment programs##2##5##(2012-2#2)
the sustainability of##10##3##(1997-7#1)(2007-4#1)(2008-10#1)(2009-8#1)(2011-2#2)(2012-2#4)
the sustainable growth rate system##2##5##(2008-4#2)
the sustainable##5##2##(2006-12#1)(2007-3#1)(2008-12#1)(2008-4#2)
the sustained phase was##2##4##(1990-3#1)(1991-10#1)
the sustained phase##5##3##(1990-10#1)(1990-3#1)(1991-10#2)(1992-7#1)
the sustained release##3##3##(2007-10#1)(2011-2#2)
the sustained response##2##3##(2008-2#1)(2008-9#1)
the sustained##29##2##(1990-10#1)(1990-3#1)(1990-4#1)(1991-10#2)(1991-8#1)(1991-9#2)(1992-7#1)(1993-12#1)(1994-6#1)(1995-3#1)(1996-6#1)(1997-1#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-12#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-4#1)(2011-2#2)(2013-8#1)
the sustained-release##3##2##(1993-10#2)(2007-8#1)
the suture exocuticle##2##3##(2007-5#2)
the suture##12##2##(1996-3#1)(1996-9#1)(2004-9#1)(2006-9#1)(2007-5#6)(2008-5#1)(2008-8#1)
the sutured##2##2##(2004-9#1)(2008-5#1)
the sutures##3##2##(2007-12#1)(2007-7#1)(2011-2#1)
the swab##2##2##(1997-3#1)(2008-12#1)
the swallowing##2##2##(2011-1#1)(2013-8#1)
the swamp##2##2##(2007-3#1)(2007-5#1)
the swarming##3##2##(2005-8#1)(2009-6#2)
the sweat##6##2##(1995-12#2)(2006-12#1)(2008-5#2)(2013-7#1)
the sweating##2##2##(2008-5#1)(2009-12#1)
the sweep rate was##2##4##(2008-10#2)
the sweep##3##2##(2007-12#1)(2008-10#2)
the sweeteners##2##2##(1992-11#1)(2013-7#1)
the sweetness of##2##3##(2008-10#1)(2008-5#1)
the sweetpotato##3##2##(2008-10#1)(2011-12#1)(2011-2#1)
the swelling of##2##3##(2006-4#1)(2008-10#1)
the swelling properties of the##2##5##(2005-11#1)(2013-7#1)
the swelling was##3##3##(1991-10#2)(2010-11#1)
the swelling##12##2##(1991-10#2)(2004-12#1)(2005-11#1)(2006-4#1)(2007-10#1)(2008-10#1)(2008-5#1)(2010-11#1)(2010-9#1)(2013-7#1)(2013-8#1)
the swim##3##2##(1990-8#1)(1997-4#1)(2010-5#1)
the swimming##7##2##(1995-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2013-8#1)
the swine##4##2##(1992-12#2)(2008-7#1)(2010-4#1)
the swing phase of##3##4##(1995-5#1)(2010-3#1)(2012-1#1)
the swing##5##2##(1995-5#1)(2010-3#1)(2011-2#2)(2012-1#1)
the swing-bed##2##2##(1991-1#1)(1994-2#1)
the swinging##2##2##(1996-4#1)(2009-3#1)
the switch II region of##2##5##(1993-3#1)(1995-5#1)
the switch between##4##3##(1990-11#1)(2008-10#1)(2009-8#1)(2013-7#1)
the switch from##3##3##(1997-4#1)(2008-1#1)(2011-1#1)
the switch in##2##3##(1992-11#1)(1997-2#1)
the switch to##5##3##(2008-11#1)(2009-3#1)(2010-10#1)(2012-1#1)(2013-1#1)
the switch##27##2##(1990-11#1)(1990-5#2)(1992-11#1)(1993-3#2)(1995-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-3#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#3)(2013-7#1)
the switched##4##2##(1992-3#1)(1994-2#2)(2008-2#1)
the switching of##2##3##(1997-2#1)(2008-1#1)
the switching voltage##2##3##(2008-2#1)(2008-7#1)
the switching##19##2##(1997-2#1)(1997-3#1)(2007-11#2)(2007-12#5)(2008-1#3)(2008-2#3)(2008-3#1)(2008-7#2)(2011-1#1)
the swollen lamellar##2##3##(2008-5#2)
the swollen##11##2##(2005-11#2)(2008-10#1)(2008-12#1)(2008-5#3)(2009-5#1)(2011-2#1)(2012-12#2)
the syconia of##2##3##(2008-10#2)
the syllable##3##2##(2013-8#3)
the sylvatic##2##2##(2009-7#2)
the sylvian fissure##2##3##(1995-12#1)(2011-1#1)
the symbiont##4##2##(2007-12#1)(2008-10#1)(2011-2#2)
the symbiosis##4##2##(2006-3#1)(2008-11#1)(2008-8#1)(2009-8#1)
the symbiotic##9##2##(1996-7#1)(2006-3#3)(2007-12#2)(2008-11#3)
the symbolic##7##2##(1991-12#1)(1993-2#1)(2004-3#1)(2008-2#1)(2008-3#1)(2011-2#1)(2011-3#1)
the symmetric and##2##3##(2005-4#1)(2007-11#1)
the symmetric##14##2##(1990-4#1)(1991-5#1)(1997-6#1)(2005-4#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2012-1#1)
the symmetrical selection##3##3##(1997-5#3)
the symmetrical##7##2##(1993-11#1)(1997-4#1)(1997-5#3)(2007-12#1)(2008-10#1)
the symmetrically##2##2##(2009-2#1)(2012-3#1)
the symmetry constraint##2##3##(2008-3#2)
the symmetry of the##4##4##(1997-7#1)(2007-11#1)(2007-7#1)(2008-2#1)
the symmetry of##11##3##(1993-2#1)(1997-7#1)(2006-11#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-2#2)(2008-3#1)(2008-8#1)(2013-8#1)
the symmetry##22##2##(1993-2#1)(1994-9#1)(1997-2#2)(1997-7#1)(2006-10#1)(2006-11#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-2#4)(2008-3#3)(2008-8#1)(2012-1#1)(2013-8#1)
the sympathetic and parasympathetic##2##4##(2008-10#1)(2009-10#1)
the sympathetic and##3##3##(2007-8#1)(2008-10#1)(2009-10#1)
the sympathetic chain##2##3##(1996-3#1)(2006-9#1)
the sympathetic innervation to the##2##5##(1994-10#1)(1995-3#1)
the sympathetic innervation##5##3##(1994-10#1)(1994-5#3)(1995-3#1)
the sympathetic nerve##4##3##(1993-1#1)(1994-5#1)(1997-5#1)(2007-8#1)
the sympathetic nerves##2##3##(1990-12#1)(1995-12#1)
the sympathetic nervous system in##3##5##(1990-5#1)(1995-12#1)(2005-10#1)
the sympathetic nervous system is##3##5##(1991-3#1)(2005-10#1)(2006-10#1)
the sympathetic nervous system##17##4##(1990-4#1)(1990-5#1)(1991-2#1)(1991-3#1)(1995-12#2)(1997-2#1)(2005-10#3)(2006-10#1)(2006-12#3)(2009-10#1)(2012-2#1)(2013-1#1)
the sympathetic nervous##19##3##(1990-4#1)(1990-5#1)(1991-2#1)(1991-3#1)(1995-12#2)(1997-2#1)(2005-10#4)(2006-10#1)(2006-12#3)(2008-5#1)(2009-10#1)(2012-2#1)(2013-1#1)
the sympathetic response to progressive hypoglycemia##2##6##(1994-3#2)
the sympathetic response##3##3##(1994-3#3)
the sympathetic sprouting in the##2##5##(2008-9#2)
the sympathetic system##2##3##(1991-2#1)(1993-5#1)
the sympathetic##59##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-2#2)(1991-3#2)(1992-1#2)(1992-8#1)(1993-1#1)(1993-5#2)(1994-10#1)(1994-3#3)(1994-5#4)(1995-12#5)(1995-3#2)(1996-12#1)(1996-3#1)(1997-2#1)(1997-5#1)(2005-10#5)(2006-10#1)(2006-12#4)(2006-8#1)(2006-9#1)(2007-1#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-10#2)(2011-2#1)(2012-2#1)(2013-1#1)
the sympathoadrenal##3##2##(1994-3#1)(1995-12#2)
the sympathovagal balance##2##3##(2011-2#1)(2013-8#1)
the sympathovagal##3##2##(2011-2#1)(2012-2#1)(2013-8#1)
the symphysis pubis##3##3##(1994-3#1)(2012-12#2)
the symphysis##4##2##(1990-6#1)(1994-3#1)(2012-12#2)
the symposium on##2##3##(2005-8#1)(2008-5#1)
the symposium##12##2##(1990-12#1)(2005-8#1)(2008-10#2)(2008-5#7)(2011-12#1)
the symptom complex##3##3##(1991-11#1)(1997-2#1)(2006-8#1)
the symptom of##3##3##(2010-12#1)(2013-8#2)
the symptom severity##2##3##(2008-10#2)
the symptom##20##2##(1991-11#1)(1991-4#1)(1995-9#1)(1997-2#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2008-10#3)(2008-5#1)(2008-9#1)(2010-12#1)(2011-2#3)(2013-8#3)
the symptom-free##2##2##(1990-6#1)(1991-9#1)
the symptomatic and##2##3##(2006-10#1)(2008-10#1)
the symptomatic treatment of##4##4##(2005-8#1)(2006-10#1)(2007-8#1)(2011-2#1)
the symptomatic##25##2##(1990-12#1)(1990-6#1)(1991-4#1)(1993-1#1)(1994-12#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-8#2)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#2)(2009-8#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
the symptomatology of##5##3##(1990-8#1)(1997-8#1)(2006-9#1)(2007-11#1)(2009-10#1)
the symptomatology##16##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-3#1)(1991-9#1)(1992-11#1)(1996-9#1)(1997-8#1)(2006-9#1)(2007-11#2)(2008-10#1)(2009-10#1)(2009-9#1)(2011-2#1)(2013-1#1)
the symptoms and signs of##5##5##(1990-2#1)(1990-5#1)(2008-10#1)(2010-5#1)(2011-3#1)
the symptoms and signs##6##4##(1990-2#1)(1990-5#1)(2006-5#1)(2008-10#1)(2010-5#1)(2011-3#1)
the symptoms and the##5##4##(1991-11#1)(1991-12#1)(2006-10#1)(2008-1#1)(2012-2#1)
the symptoms and##18##3##(1990-2#1)(1990-5#1)(1991-11#1)(1991-12#1)(1992-9#1)(1996-11#1)(2006-10#1)(2006-5#1)(2008-1#2)(2008-10#1)(2008-7#1)(2010-3#1)(2010-5#1)(2011-2#1)(2011-3#2)(2012-2#1)
the symptoms are##6##3##(1992-3#1)(1994-5#1)(1995-8#1)(2006-2#1)(2010-8#1)(2012-2#1)
the symptoms as##3##3##(2007-7#1)(2011-1#1)(2011-2#1)
the symptoms did not##3##4##(1990-11#1)(1992-4#1)(2012-2#1)
the symptoms disappeared after##2##4##(1997-6#1)(2008-5#1)
the symptoms disappeared##6##3##(1991-2#1)(1992-12#1)(1997-6#2)(2007-10#1)(2008-5#1)
the symptoms had##2##3##(1992-2#1)(2013-1#1)
the symptoms in##4##3##(1992-8#1)(1993-10#1)(1997-8#1)(2008-10#1)
the symptoms may##3##3##(2010-8#1)(2013-1#2)
the symptoms of conversion hysteria and##2##6##(2006-3#2)
the symptoms of psychosis##3##4##(2007-6#3)
the symptoms of schizophrenia##2##4##(2005-10#1)(2008-1#1)
the symptoms of the##2##4##(2007-6#1)(2008-7#1)
the symptoms of this##2##4##(1997-3#1)(2008-7#1)
the symptoms of##65##3##(1991-2#1)(1992-11#1)(1992-12#1)(1993-10#1)(1993-12#1)(1993-6#1)(1994-12#1)(1996-4#2)(1997-3#1)(2004-3#1)(2005-10#2)(2005-11#1)(2006-3#2)(2006-8#3)(2006-9#1)(2007-11#4)(2007-4#1)(2007-6#4)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#3)(2010-12#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-8#2)
the symptoms reported##2##3##(2004-9#1)(2006-10#1)
the symptoms##186##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#4)(1992-8#2)(1992-9#1)(1993-10#2)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-4#2)(1997-3#2)(1997-6#2)(1997-8#2)(2004-3#1)(2004-9#1)(2005-10#2)(2005-11#1)(2006-10#4)(2006-2#2)(2006-3#2)(2006-5#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#5)(2007-4#1)(2007-6#4)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#6)(2008-10#14)(2008-11#1)(2008-12#2)(2008-2#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#1)(2009-11#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#6)(2011-12#1)(2011-2#6)(2011-3#3)(2012-1#2)(2012-12#3)(2012-2#9)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#4)
the syn conformation##3##3##(1997-4#1)(2007-11#2)
the syn##4##2##(1997-4#1)(2007-11#3)
the synapse##17##2##(1991-12#1)(1992-6#1)(1996-1#1)(1996-7#1)(1997-2#1)(2006-8#1)(2007-11#1)(2008-2#3)(2008-3#1)(2008-7#2)(2009-11#1)(2009-8#2)(2009-9#1)
the synapses##6##2##(1995-12#1)(2008-2#3)(2008-4#1)(2008-7#1)
the synapsin##2##2##(1994-8#1)(2007-10#1)
the synapsins##4##2##(1990-12#1)(1994-8#3)
the synaptic basal lamina##2##4##(1991-11#1)(1997-8#1)
the synaptic cleft##6##3##(1991-12#1)(1997-7#2)(2007-9#1)(2008-3#1)(2008-7#1)
the synaptic plasticity##3##3##(1997-7#1)(2008-11#1)(2013-8#1)
the synaptic transmission##2##3##(1997-2#1)(2008-8#1)
the synaptic vesicle membrane##2##4##(1993-6#1)(1997-6#1)
the synaptic vesicle##7##3##(1992-6#1)(1993-6#1)(1996-12#1)(1997-6#1)(2007-10#1)(2007-12#1)(2008-1#1)
the synaptic vesicles##2##3##(1990-11#1)(1994-12#1)
the synaptic##51##2##(1990-11#1)(1990-12#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-6#1)(1992-7#3)(1993-4#1)(1993-6#1)(1994-10#1)(1994-12#1)(1995-11#2)(1996-12#1)(1996-2#2)(1996-8#2)(1997-2#1)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#1)(2007-10#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-8#1)(2012-12#2)(2013-1#1)(2013-8#1)
the synaptonemal##2##2##(1995-8#1)(2008-7#1)
the synaptosomal##3##2##(1992-3#1)(1994-12#1)(1995-1#1)
the synaptosomes##4##2##(1992-3#1)(1995-11#1)(1995-5#1)(1995-9#1)
the synchronization of##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)
the synchronization##11##2##(2006-10#2)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)
the synchronized##8##2##(2006-5#2)(2007-11#1)(2008-11#1)(2010-2#1)(2013-1#2)(2013-8#1)
the synchronous and##2##3##(2008-3#1)(2008-7#1)
the synchronous##8##2##(2005-4#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-7#1)
the synchrony of##2##3##(2010-9#1)(2011-2#1)
the synchrotron##5##2##(2006-4#1)(2006-5#2)(2008-3#1)(2008-4#1)
the syncytial##4##2##(1995-8#1)(2008-7#1)(2009-2#1)(2012-12#1)
the syndrome and in##3##4##(1996-12#1)(2008-1#1)(2008-3#1)
the syndrome and##7##3##(1990-2#1)(1992-5#1)(1996-12#1)(2007-11#1)(2008-1#1)(2008-3#1)(2009-7#1)
the syndrome is not##2##4##(1990-2#1)(2011-12#1)
the syndrome is##10##3##(1990-2#1)(1993-5#1)(2006-10#1)(2007-7#2)(2008-7#1)(2008-8#1)(2009-7#2)(2011-12#1)
the syndrome of inadequate antidiuretic hormone secretion##2##7##(2006-6#2)
the syndrome of inappropriate##4##4##(1991-5#1)(2005-7#1)(2006-4#1)(2009-10#1)
the syndrome of##18##3##(1990-9#1)(1991-5#1)(1993-11#1)(1993-7#1)(1995-5#1)(1997-3#1)(2005-7#1)(2006-10#2)(2006-4#1)(2006-6#2)(2006-9#1)(2007-10#1)(2008-6#1)(2009-10#1)(2011-1#1)(2013-8#1)
the syndrome was##3##3##(1997-3#1)(2007-3#1)(2010-2#1)
the syndrome##95##2##(1990-10#1)(1990-12#1)(1990-2#4)(1990-5#2)(1990-9#2)(1991-11#1)(1991-12#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-5#2)(1993-11#2)(1993-5#2)(1993-7#1)(1993-9#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-3#2)(1996-6#1)(1996-8#1)(1997-1#3)(1997-3#3)(2005-7#1)(2006-10#9)(2006-2#1)(2006-4#1)(2006-6#2)(2006-9#1)(2007-10#3)(2007-11#1)(2007-3#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#8)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#2)(2009-4#1)(2009-7#4)(2010-2#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-11#2)(2012-12#1)(2012-2#1)(2013-8#1)
the syndromes of##3##3##(1997-8#1)(2006-9#1)(2007-8#1)
the syndromes##7##2##(1990-5#1)(1993-7#1)(1997-8#1)(2006-9#1)(2007-8#1)(2008-10#1)(2011-1#1)
the synergic effect##2##3##(2008-10#1)(2008-11#1)
the synergies##2##2##(2007-4#1)(2007-8#1)
the synergism of##3##3##(1994-6#1)(1996-7#1)(2008-8#1)
the synergism##8##2##(1994-6#1)(1996-7#1)(2008-10#2)(2008-2#1)(2008-8#1)(2010-1#1)(2011-2#1)
the synergistic action of##3##4##(1992-9#1)(2008-11#1)(2008-4#1)
the synergistic activation of transcription##2##5##(1995-2#1)(1996-4#1)
the synergistic effect of##7##4##(1997-1#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-4#1)(2012-6#1)
the synergistic effect##9##3##(1997-1#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-4#1)(2012-6#1)
the synergistic effects of##3##4##(1996-12#1)(2012-2#1)(2013-1#1)
the synergistic effects##4##3##(1995-8#1)(1996-12#1)(2012-2#1)(2013-1#1)
the synergistic interaction between##2##4##(1995-12#1)(1996-10#1)
the synergistic interaction##3##3##(1995-12#1)(1996-10#1)(1996-7#1)
the synergistic##31##2##(1992-11#1)(1992-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-7#1)(2005-4#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-8#1)(2009-7#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-6#1)(2013-1#1)(2013-8#1)
the synergy between##4##3##(2007-4#1)(2008-10#1)(2008-5#1)(2010-3#1)
the synergy##6##2##(2007-4#1)(2008-10#1)(2008-5#1)(2010-3#1)(2010-4#1)(2012-12#1)
the syngeneic##3##2##(1992-9#2)(2008-4#1)
the synonymy of##2##3##(2008-10#2)
the synovia##2##2##(2006-7#1)(2007-11#1)
the synovial fluid##5##3##(1991-7#1)(2006-10#1)(2007-11#1)(2011-1#2)
the synovial fluids##2##3##(1993-2#1)(1995-3#1)
the synovial joints##2##3##(2012-2#1)(2012-3#1)
the synovial lining##2##3##(2008-5#1)(2013-1#1)
the synovial membrane and##3##4##(1996-6#1)(2009-3#1)(2010-12#1)
the synovial membrane##8##3##(1992-4#1)(1996-6#1)(2007-11#1)(2009-3#1)(2010-12#4)
the synovial##28##2##(1991-7#1)(1992-3#1)(1992-4#1)(1993-2#1)(1994-8#1)(1995-3#1)(1996-6#1)(2006-10#1)(2007-11#3)(2008-5#1)(2008-6#1)(2009-3#1)(2010-12#4)(2011-1#2)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#3)
the synovium##3##2##(2006-11#1)(2006-12#1)(2008-7#1)
the syntactic##5##2##(2006-2#1)(2007-3#4)
the syntax##2##2##(1997-3#1)(2006-3#1)
the syntenic##3##2##(2008-10#2)(2008-7#1)
the syntheses of##4##3##(1991-6#1)(2008-10#1)(2008-12#1)(2009-5#1)
the syntheses##7##2##(1991-6#1)(2005-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-10#1)(2009-5#1)
the synthesis and characterization of a##4##6##(2008-10#1)(2009-3#1)(2010-4#1)(2013-7#1)
the synthesis and characterization of##8##5##(2008-1#1)(2008-10#2)(2008-4#2)(2009-3#1)(2010-4#1)(2013-7#1)
the synthesis and degradation of##2##5##(2011-2#1)(2013-1#1)
the synthesis and release of##7##5##(1991-10#1)(1994-2#1)(1994-9#1)(1995-11#1)(2007-9#1)(2008-9#1)(2013-7#1)
the synthesis and screening of##2##5##(2008-4#1)(2012-12#1)
the synthesis and secretion of##6##5##(1990-4#1)(1994-12#1)(1994-2#1)(1994-3#1)(1997-4#2)
the synthesis and secretion##7##4##(1990-4#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-1#1)(1997-4#2)
the synthesis and##54##3##(1990-4#1)(1991-10#1)(1992-11#1)(1992-6#2)(1993-12#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-3#2)(1996-1#1)(1996-2#1)(1996-8#1)(1997-4#2)(2006-5#1)(2007-11#2)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#2)
the synthesis is##4##3##(1990-12#1)(2006-12#1)(2008-4#1)(2010-6#1)
the synthesis of 5'-deoxyxanthosine##2##4##(1990-8#2)
the synthesis of IL-1##2##4##(1992-1#1)(1993-7#1)
the synthesis of TxB2##2##4##(1995-3#2)
the synthesis of a new family of##2##7##(1991-1#1)(2012-2#1)
the synthesis of a new##3##5##(1991-1#1)(2007-11#1)(2012-2#1)
the synthesis of a series of##2##6##(2008-12#1)(2009-12#1)
the synthesis of a single##2##5##(1994-3#1)(1995-3#1)
the synthesis of a##25##4##(1990-10#1)(1991-1#1)(1991-2#1)(1991-3#1)(1992-11#2)(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-4#1)(1997-1#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-9#1)(2012-2#1)
the synthesis of an intermediate##2##5##(1991-10#1)(2009-5#1)
the synthesis of an##10##4##(1991-10#1)(1992-7#1)(1995-3#1)(1996-11#1)(1996-5#1)(2008-4#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-4#1)
the synthesis of any##2##4##(2007-12#1)(2007-8#1)
the synthesis of bioactive##2##4##(2005-8#1)(2008-5#1)
the synthesis of both##3##4##(1990-11#1)(1996-2#1)(2008-5#1)
the synthesis of cell##2##4##(2008-10#1)(2008-6#1)
the synthesis of collagen##2##4##(2007-11#1)(2008-5#1)
the synthesis of complementary##2##4##(1991-3#1)(2008-9#1)
the synthesis of ferritin##2##4##(1995-6#1)(1996-7#1)
the synthesis of hybrid##2##4##(1991-4#1)(1991-5#1)
the synthesis of large##2##4##(1997-4#1)(2007-11#1)
the synthesis of modified##2##4##(2008-2#1)(2012-2#1)
the synthesis of natural##3##4##(1992-11#2)(2009-10#1)
the synthesis of new##7##4##(1992-7#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-4#1)(2010-5#1)
the synthesis of novel##3##4##(1992-9#1)(2009-9#1)(2010-12#1)
the synthesis of nucleoside##2##4##(2008-4#2)
the synthesis of oligodeoxyribonucleotides##2##4##(2008-4#2)
the synthesis of osteocalcin##2##4##(1990-2#2)
the synthesis of other##5##4##(1992-6#1)(2006-12#1)(2007-11#1)(2008-7#1)(2009-8#1)
the synthesis of p58-M2##7##4##(1992-11#7)
the synthesis of peptide##2##4##(1997-3#1)(2012-2#1)
the synthesis of polypeptides##3##4##(1990-8#1)(2008-7#1)(2008-9#1)
the synthesis of potent##2##4##(2005-8#1)(2008-12#1)
the synthesis of prostaglandin E2##2##5##(1990-2#1)(1994-12#1)
the synthesis of proteins##2##4##(1995-7#1)(1997-2#1)
the synthesis of several##6##4##(1991-9#1)(1995-11#1)(2007-10#1)(2007-11#1)(2008-11#1)(2010-12#1)
the synthesis of some aromatic esters##2##6##(2008-5#2)
the synthesis of some##7##4##(1992-7#1)(1994-9#1)(2007-11#2)(2008-4#1)(2008-5#2)
the synthesis of the corresponding##2##5##(2007-11#2)
the synthesis of the other##2##5##(1991-4#1)(1993-9#1)
the synthesis of the##43##4##(1990-11#2)(1990-3#1)(1990-5#2)(1990-7#1)(1991-10#1)(1991-11#1)(1991-4#1)(1991-5#1)(1991-9#2)(1992-12#1)(1992-3#2)(1993-9#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-8#1)(1997-2#1)(1997-6#1)(2005-8#1)(2007-10#1)(2007-11#5)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-11#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-6#1)(2012-1#1)
the synthesis of their##2##4##(1994-8#1)(1997-7#1)
the synthesis of these##4##4##(1991-10#1)(1994-10#1)(1994-9#1)(2008-12#1)
the synthesis of this##2##4##(1993-3#1)(2006-12#1)
the synthesis of three##2##4##(1995-3#1)(1997-5#1)
the synthesis of two##2##4##(1993-4#1)(2007-10#1)
the synthesis of tyrosinase##2##4##(2008-5#1)(2013-1#1)
the synthesis of various##4##4##(1993-8#1)(2007-10#2)(2008-4#1)
the synthesis of##438##3##(1990-10#1)(1990-11#5)(1990-12#1)(1990-2#6)(1990-3#2)(1990-5#5)(1990-7#4)(1990-8#5)(1991-1#2)(1991-10#5)(1991-11#3)(1991-2#2)(1991-3#3)(1991-4#2)(1991-5#3)(1991-6#2)(1991-8#3)(1991-9#4)(1992-1#2)(1992-11#13)(1992-12#3)(1992-3#2)(1992-6#3)(1992-7#5)(1992-8#1)(1992-9#4)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#4)(1994-10#2)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#5)(1994-5#1)(1994-8#2)(1994-9#4)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#8)(1995-6#3)(1995-7#1)(1995-8#4)(1996-11#2)(1996-12#3)(1996-2#2)(1996-4#2)(1996-5#6)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#3)(1997-5#4)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2004-9#1)(2005-11#3)(2005-12#1)(2005-7#1)(2005-8#5)(2006-10#3)(2006-12#12)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#6)(2007-11#31)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#13)(2008-11#5)(2008-12#4)(2008-2#5)(2008-3#3)(2008-4#28)(2008-5#17)(2008-6#5)(2008-7#9)(2008-8#4)(2008-9#6)(2009-10#5)(2009-11#4)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#4)(2009-9#5)(2010-10#1)(2010-11#2)(2010-12#5)(2010-4#3)(2010-5#2)(2010-6#3)(2010-7#1)(2010-9#2)(2011-1#4)(2011-2#6)(2012-1#1)(2012-11#2)(2012-2#5)(2012-3#2)(2013-1#5)(2013-8#1)
the synthesis or##2##3##(2006-8#1)(2008-10#1)
the synthesis process##3##3##(2008-10#3)
the synthesis was##2##3##(1992-9#1)(2008-10#1)
the synthesis##545##2##(1990-10#1)(1990-11#5)(1990-12#2)(1990-2#6)(1990-3#2)(1990-4#1)(1990-5#5)(1990-7#4)(1990-8#5)(1991-1#2)(1991-10#6)(1991-11#3)(1991-2#2)(1991-3#3)(1991-4#2)(1991-5#3)(1991-6#3)(1991-8#3)(1991-9#4)(1992-1#2)(1992-11#14)(1992-12#4)(1992-3#2)(1992-5#1)(1992-6#5)(1992-7#5)(1992-8#1)(1992-9#6)(1993-12#4)(1993-2#1)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#4)(1994-10#2)(1994-11#3)(1994-12#6)(1994-2#3)(1994-3#6)(1994-5#1)(1994-8#3)(1994-9#5)(1995-1#2)(1995-11#4)(1995-12#1)(1995-2#3)(1995-3#10)(1995-6#3)(1995-7#1)(1995-8#4)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#4)(1996-4#2)(1996-5#7)(1996-7#1)(1996-8#5)(1997-1#2)(1997-2#3)(1997-3#4)(1997-4#5)(1997-5#4)(1997-6#1)(1997-7#1)(1997-8#3)(2004-11#1)(2004-9#1)(2005-11#3)(2005-12#1)(2005-7#1)(2005-8#5)(2006-10#3)(2006-12#15)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#6)(2007-11#34)(2007-12#3)(2007-2#1)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#24)(2008-11#7)(2008-12#4)(2008-2#6)(2008-3#5)(2008-4#34)(2008-5#19)(2008-6#6)(2008-7#11)(2008-8#4)(2008-9#7)(2009-10#5)(2009-11#5)(2009-12#2)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#4)(2009-8#5)(2009-9#5)(2010-10#1)(2010-11#2)(2010-12#7)(2010-2#1)(2010-4#5)(2010-5#3)(2010-6#4)(2010-7#3)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#8)(2012-1#1)(2012-11#3)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#8)(2013-7#3)(2013-8#2)
the synthesized WCX##2##3##(2008-10#2)
the synthesized compounds was##3##4##(2008-5#2)(2012-11#1)
the synthesized compounds were confirmed by elemental analyses##2##8##(2007-11#2)
the synthesized compounds were##6##4##(2007-11#4)(2008-4#1)(2008-5#1)
the synthesized compounds##15##3##(2007-11#6)(2008-4#1)(2008-5#3)(2010-12#1)(2012-11#2)(2012-2#1)(2012-3#1)
the synthesized proteins##3##3##(1993-2#1)(2008-1#1)(2008-7#1)
the synthesized resin##3##3##(2008-10#3)
the synthesized##50##2##(1990-4#1)(1992-1#1)(1993-2#1)(1995-1#1)(1997-6#1)(2004-9#1)(2006-12#1)(2007-1#1)(2007-11#7)(2008-1#1)(2008-10#8)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#1)(2009-3#2)(2010-12#1)(2010-5#2)(2011-2#2)(2012-11#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
the synthetase##5##2##(1990-2#1)(1992-7#1)(1994-11#1)(1994-6#1)(1994-9#1)
the synthetic SOD/catalase mimetic##2##4##(2008-5#2)
the synthetic activity of##2##4##(1993-12#1)(1994-8#1)
the synthetic analogue of the##2##5##(1993-7#1)(2008-8#1)
the synthetic analogue##3##3##(1993-7#1)(1995-9#1)(2008-8#1)
the synthetic antioxidant##3##3##(2007-1#1)(2008-10#2)
the synthetic aperture##2##3##(2007-11#1)(2008-2#1)
the synthetic discriminant function##3##4##(2007-12#1)(2008-2#2)
the synthetic enzyme for##2##4##(1992-8#1)(1996-2#1)
the synthetic glucocorticoid##5##3##(1991-5#1)(1992-12#1)(1993-7#1)(1995-8#1)(2011-2#1)
the synthetic hD4 gene##2##4##(1994-5#2)
the synthetic mixtures##2##3##(2008-10#2)
the synthetic pathway##2##3##(1992-8#1)(2013-1#1)
the synthetic peptide to a carrier protein##3##7##(2008-2#1)(2008-4#2)
the synthetic peptide##19##3##(1990-2#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-7#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-5#1)(1996-2#1)(1996-8#1)(2008-2#1)(2008-4#3)
the synthetic peptides##4##3##(1990-7#1)(1991-5#1)(1992-8#1)(1997-8#1)
the synthetic reaction##2##3##(1990-8#1)(2008-10#1)
the synthetic substrates##2##3##(1990-11#1)(1993-12#1)
the synthetic sunscreen##4##3##(2008-5#4)
the synthetic##132##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-7#3)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#2)(1991-3#1)(1991-5#3)(1991-6#1)(1991-7#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-6#1)(1993-7#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#4)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#4)(1995-9#1)(1996-2#3)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#2)(2005-11#4)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#3)(2007-12#1)(2008-10#11)(2008-11#1)(2008-2#7)(2008-3#4)(2008-4#8)(2008-5#7)(2008-8#1)(2009-12#2)(2009-3#1)(2010-1#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#3)
the syphilis##2##2##(1993-3#1)(2008-10#1)
the syrB gene##4##3##(2008-10#4)
the syringe pump##2##3##(2008-10#1)(2009-6#1)
the syringe##9##2##(2008-10#4)(2008-11#2)(2009-6#1)(2012-2#1)(2013-1#1)
the syrinx##3##2##(2005-5#1)(2006-5#2)
the syrup##2##2##(2012-1#2)
the system achieved a detection limit##2##6##(2008-10#2)
the system allows##3##3##(2008-2#1)(2008-3#1)(2012-1#1)
the system and its##3##4##(1994-2#1)(2005-11#1)(2006-6#1)
the system and the##10##4##(1996-1#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-7#1)(2012-3#1)(2013-1#2)
the system and to##6##4##(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)
the system and##40##3##(1991-2#1)(1992-11#1)(1994-12#1)(1994-2#1)(1996-1#1)(1996-3#1)(2005-11#1)(2006-6#2)(2007-12#5)(2007-6#1)(2008-10#9)(2008-11#1)(2008-2#4)(2008-3#3)(2008-7#1)(2009-9#1)(2010-12#1)(2012-3#1)(2013-1#4)
the system are set##2##4##(2006-3#1)(2007-11#1)
the system are##13##3##(1993-3#1)(1995-2#1)(2005-11#1)(2006-3#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-2#1)(2008-3#2)(2012-1#1)(2012-12#1)
the system as a##4##4##(2008-10#2)(2008-5#1)(2012-2#1)
the system as##12##3##(1991-2#1)(1994-1#1)(2007-11#1)(2008-10#4)(2008-5#1)(2010-4#1)(2012-2#1)(2013-1#2)
the system at##4##3##(2006-10#1)(2007-12#1)(2008-10#2)
the system based on##2##4##(2008-3#1)(2008-4#1)
the system behavior##4##3##(2005-11#2)(2008-11#1)(2008-5#1)
the system blank##2##3##(2005-11#2)
the system by##10##3##(1991-2#1)(1992-2#1)(1996-8#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#2)
the system can be##8##4##(1990-2#1)(2006-5#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#2)(2008-3#1)
the system can##19##3##(1990-2#1)(1995-2#1)(2006-5#1)(2007-12#3)(2007-5#1)(2008-10#3)(2008-2#4)(2008-3#3)(2008-9#1)(2013-1#1)
the system components##3##3##(2008-3#2)(2008-9#1)
the system containing##2##3##(2008-10#1)(2009-2#1)
the system could##2##3##(2008-10#2)
the system described in this##2##5##(2008-10#1)(2012-1#1)
the system described##3##3##(1990-12#1)(2008-10#1)(2012-1#1)
the system design##2##3##(2008-2#1)(2008-3#1)
the system directly##3##3##(1996-1#1)(2008-3#1)(2008-5#1)
the system does not##2##4##(2008-3#1)(2009-4#1)
the system evolves##4##3##(1991-7#1)(1993-2#1)(2007-9#2)
the system for the##4##4##(2008-2#1)(2008-5#2)(2008-9#1)
the system for##18##3##(1990-8#1)(1993-3#1)(2005-4#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2012-2#1)
the system from##5##3##(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
the system geometry##2##3##(2005-11#1)(2007-12#1)
the system has been applied to the##2##7##(1994-12#1)(2008-10#1)
the system has been##7##4##(1992-9#1)(1994-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-8#1)
the system has the potential to be##2##7##(2007-11#1)(2008-2#1)
the system has the potential to##3##6##(2007-11#1)(2008-2#2)
the system has the##4##4##(1993-12#1)(2007-11#1)(2008-2#2)
the system has##16##3##(1992-9#1)(1993-12#1)(1994-12#2)(2007-11#1)(2008-10#3)(2008-2#3)(2008-3#2)(2008-6#1)(2010-8#1)(2013-8#1)
the system have##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
the system in order to##2##5##(1995-3#1)(2011-1#1)
the system in the##4##4##(2008-10#1)(2008-5#1)(2013-1#2)
the system in##17##3##(1990-2#1)(1992-1#1)(1994-2#1)(1995-3#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-5#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#2)
the system include##5##3##(1994-12#1)(2006-1#1)(2007-12#2)(2007-8#1)
the system increased##2##3##(2005-11#1)(2008-7#1)
the system is a##3##4##(2005-11#1)(2008-11#1)(2008-2#1)
the system is applied##2##4##(2008-2#2)
the system is capable of##2##5##(2008-10#1)(2008-3#1)
the system is in##3##4##(2008-10#2)(2009-12#1)
the system is used to##2##5##(2007-12#1)(2008-2#1)
the system is##63##3##(1994-1#1)(2005-11#2)(2005-5#1)(2006-6#2)(2007-11#2)(2007-12#8)(2007-8#1)(2008-10#12)(2008-11#4)(2008-2#15)(2008-3#8)(2008-5#1)(2008-8#1)(2009-12#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-1#1)
the system level##3##3##(1993-2#1)(2008-2#1)(2008-3#1)
the system measures##2##3##(2007-12#1)(2008-10#1)
the system modulation transfer function##2##5##(2008-2#1)(2008-3#1)
the system nonuniformity##3##3##(2008-3#3)
the system of care for##2##5##(1996-1#1)(2013-1#1)
the system of care##3##4##(1996-1#1)(2009-10#1)(2013-1#1)
the system of choice##2##4##(1997-4#1)(2008-11#1)
the system of reversed##2##4##(1990-5#2)
the system of service capacity and activities##2##7##(2013-8#2)
the system of service capacity and##10##6##(2013-8#10)
the system of##55##3##(1990-3#1)(1990-5#2)(1991-5#1)(1994-4#1)(1995-5#1)(1995-9#2)(1996-1#1)(1996-2#1)(1996-4#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-1#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#21)
the system offers##2##3##(1993-3#1)(2007-6#1)
the system on##5##3##(1992-11#1)(2006-12#1)(2010-6#2)(2010-8#1)
the system output##3##3##(2007-11#1)(2008-2#1)(2008-9#1)
the system over the##2##4##(2008-10#1)(2008-11#1)
the system over##3##3##(2008-10#2)(2008-11#1)
the system parameters and##3##4##(2008-2#1)(2008-3#2)
the system parameters##6##3##(2006-10#1)(2008-2#1)(2008-3#4)
the system performance##6##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)(2013-1#1)
the system produces##2##3##(2007-11#1)(2008-10#1)
the system proved##2##3##(1995-11#1)(2006-5#1)
the system provides##4##3##(2007-5#1)(2008-11#1)(2008-2#1)(2008-3#1)
the system response##2##3##(2007-11#1)(2008-2#1)
the system size##3##3##(2008-2#3)
the system such##2##3##(2008-10#1)(2008-3#1)
the system the##2##3##(1993-8#1)(2007-7#1)
the system to the##3##4##(2006-10#1)(2007-11#1)(2008-4#1)
the system to##29##3##(1990-8#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-3#1)(1995-3#1)(1996-1#1)(1997-1#1)(1997-3#1)(1997-8#1)(2006-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2009-10#1)(2009-12#1)(2010-10#1)(2012-1#1)
the system using a##4##4##(2008-10#2)(2008-3#2)
the system was applied to##3##5##(2006-12#1)(2006-6#1)(2007-8#1)
the system was evaluated##2##4##(2008-7#1)(2012-1#1)
the system was illustrated##2##4##(2008-10#1)(2012-3#1)
the system was##42##3##(1990-2#1)(1991-8#1)(1994-1#1)(1994-12#1)(1995-3#1)(1997-1#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#4)(2008-10#19)(2008-11#1)(2008-2#1)(2008-7#1)(2010-6#1)(2012-1#1)(2012-3#1)(2013-8#1)
the system were optimized##4##4##(2008-10#3)(2010-5#1)
the system were##13##3##(1992-12#1)(2006-8#1)(2007-12#1)(2008-10#8)(2008-12#1)(2010-5#1)
the system will be##4##4##(1992-12#1)(1994-3#1)(2008-10#1)(2008-2#1)
the system will##9##3##(1992-12#2)(1992-3#1)(1994-3#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
the system with delay and##2##5##(2013-8#2)
the system with##14##3##(1990-5#1)(2006-10#1)(2008-10#4)(2008-2#1)(2008-3#2)(2009-4#1)(2012-1#1)(2013-8#3)
the system without##4##3##(2005-11#1)(2008-10#3)
the system##827##2##(1990-12#2)(1990-2#4)(1990-3#1)(1990-5#5)(1990-8#3)(1991-1#1)(1991-12#1)(1991-2#5)(1991-5#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#3)(1992-12#5)(1992-2#2)(1992-3#3)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#8)(1993-8#1)(1994-1#5)(1994-11#1)(1994-12#5)(1994-2#5)(1994-3#5)(1994-4#1)(1994-6#3)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#5)(1995-3#4)(1995-5#1)(1995-9#2)(1996-1#4)(1996-12#2)(1996-2#5)(1996-3#2)(1996-4#2)(1996-5#2)(1996-7#1)(1996-8#4)(1997-1#2)(1997-3#1)(1997-4#1)(1997-7#3)(1997-8#3)(2004-9#1)(2005-11#24)(2005-4#3)(2005-5#1)(2005-7#1)(2006-1#1)(2006-10#15)(2006-12#2)(2006-3#2)(2006-5#4)(2006-6#7)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#17)(2007-12#48)(2007-2#2)(2007-3#2)(2007-4#2)(2007-5#9)(2007-6#2)(2007-7#5)(2007-8#9)(2007-9#5)(2008-1#3)(2008-10#151)(2008-11#19)(2008-12#3)(2008-2#82)(2008-3#78)(2008-4#4)(2008-5#18)(2008-6#9)(2008-7#6)(2008-8#10)(2008-9#11)(2009-10#2)(2009-11#1)(2009-12#4)(2009-2#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#3)(2010-8#3)(2011-1#7)(2011-2#4)(2012-1#22)(2012-11#1)(2012-12#6)(2012-2#6)(2012-3#8)(2013-1#17)(2013-7#1)(2013-8#27)
the system's ability to##4##4##(2007-9#1)(2008-2#2)(2012-1#1)
the system's##29##2##(1991-12#1)(1991-8#1)(1994-1#2)(1995-1#1)(2007-1#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#5)(2008-3#4)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#2)
the system)##2##2##(2007-10#1)(2010-6#1)
the systematic analysis of##2##4##(1993-3#1)(2008-7#1)
the systematic classification of##2##4##(2010-12#1)(2013-7#1)
the systematic error##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
the systematic errors##5##3##(1990-8#1)(2008-2#1)(2008-3#3)
the systematic review##4##3##(2006-8#1)(2007-11#1)(2012-2#1)(2013-1#1)
the systematic##40##2##(1990-8#1)(1991-3#1)(1992-6#1)(1993-10#1)(1993-3#1)(1994-12#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#3)(2009-10#1)(2010-12#1)(2011-1#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
the systematization of##2##3##(2012-3#1)(2013-1#1)
the systemic acquired##2##3##(2008-10#2)
the systemic administration of##4##4##(1996-12#1)(2007-11#2)(2008-2#1)
the systemic and pulmonary##2##4##(2005-1#1)(2007-11#1)
the systemic and##4##3##(2005-1#1)(2005-8#1)(2007-11#1)(2009-2#1)
the systemic circulation##7##3##(1990-3#1)(1990-5#1)(2008-10#1)(2008-3#1)(2010-6#1)(2011-2#1)(2012-2#1)
the systemic condition##2##3##(2009-2#1)(2010-3#1)
the systemic development of symptoms##2##5##(2008-10#2)
the systemic effects of##3##4##(2006-10#1)(2009-6#1)(2010-12#1)
the systemic effects##5##3##(1996-9#1)(2006-10#1)(2009-6#1)(2010-12#1)(2011-2#1)
the systemic inflammatory response and##2##5##(2006-10#2)
the systemic inflammatory response syndrome##2##5##(2006-10#1)(2007-11#1)
the systemic inflammatory response##5##4##(2006-10#4)(2007-11#1)
the systemic level##2##3##(1994-12#1)(1996-12#1)
the systemic nature of##3##4##(2004-1#1)(2007-11#1)(2008-10#1)
the systemic response##2##3##(2008-3#1)(2008-9#1)
the systemic route##2##3##(2006-10#2)
the systemic therapy##3##3##(2008-5#1)(2009-2#1)(2011-2#1)
the systemic treatment of##3##4##(2005-11#1)(2007-11#1)(2009-2#1)
the systemic vasculitides##2##3##(2005-8#1)(2012-3#1)
the systemic##91##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-9#1)(1996-12#2)(1996-3#1)(1996-9#1)(2004-1#1)(2005-1#1)(2005-11#2)(2005-8#2)(2006-10#9)(2006-4#1)(2007-11#7)(2007-12#1)(2007-6#1)(2007-8#2)(2007-9#2)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#5)(2009-6#2)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-8#1)
the systemically##2##2##(1994-10#1)(2008-10#1)
the systems and##4##3##(2008-7#2)(2013-1#2)
the systems can##2##3##(2006-6#1)(2012-12#1)
the systems for##2##3##(1990-5#1)(1993-5#1)
the systems investigated##2##3##(2005-11#1)(2008-2#1)
the systems of##3##3##(2008-5#1)(2013-1#2)
the systems studied##2##3##(2005-11#2)
the systems under##2##3##(2008-10#2)
the systems were##3##3##(2008-10#2)(2008-8#1)
the systems with AN##2##4##(2005-11#2)
the systems with##4##3##(1994-3#1)(2005-11#2)(2008-8#1)
the systems##63##2##(1990-5#1)(1991-1#2)(1991-2#1)(1993-5#1)(1994-1#1)(1994-3#1)(1995-12#1)(1996-1#1)(2005-11#8)(2006-10#2)(2006-6#3)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#3)(2009-3#1)(2010-4#1)(2010-5#2)(2010-9#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#4)
the systems'##2##2##(2008-10#1)(2008-11#1)
the systolic and diastolic blood pressure##2##6##(2008-12#1)(2011-1#1)
the systolic and diastolic blood##3##5##(2008-12#1)(2008-3#1)(2011-1#1)
the systolic and diastolic pressures##2##5##(1990-8#1)(2010-4#1)
the systolic and diastolic##8##4##(1990-8#1)(1996-3#1)(1996-6#1)(2008-12#1)(2008-3#1)(2010-4#1)(2010-7#1)(2011-1#1)
the systolic and##9##3##(1990-8#1)(1994-6#1)(1996-3#1)(1996-6#1)(2008-12#1)(2008-3#1)(2010-4#1)(2010-7#1)(2011-1#1)
the systolic blood pressure##2##4##(1992-8#1)(1995-9#1)
the systolic##13##2##(1990-8#1)(1992-8#1)(1994-6#1)(1995-9#1)(1996-3#1)(1996-6#1)(1997-6#1)(2008-12#1)(2008-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2013-8#1)
the t protein##2##3##(1992-5#2)
the t##5##2##(1992-2#1)(1992-5#2)(2007-8#1)(2008-10#1)
the t(14##2##2##(1996-10#1)(2010-11#1)
the t(2g) and e(g) orbitals##3##5##(1997-7#3)
the t(2g)##7##2##(1997-7#7)
the t-PA secretion##2##3##(2008-11#2)
the t-PA##8##2##(1990-11#1)(1990-12#2)(1994-3#1)(1995-3#1)(2007-10#1)(2008-11#2)
the t-SNAREs##2##2##(1997-3#1)(1997-6#1)
the t-test and##2##3##(2008-11#1)(2010-2#1)
the t-test##7##2##(2007-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-2#2)
the tMCAO##2##2##(2011-2#2)
the tPA##4##2##(1990-11#1)(1992-12#2)(2008-5#1)
the tRNA##10##2##(1990-4#1)(1991-1#1)(1991-11#1)(1992-11#1)(1992-6#2)(1993-11#1)(1995-8#1)(1996-11#1)(1997-1#1)
the tRNA[Ser]Sec gene##2##3##(1997-2#2)
the tRNA[Ser]Sec##4##2##(1995-8#1)(1997-2#3)
the tSSEPs##2##2##(2007-8#2)
the table facet##2##3##(2007-11#1)(2007-8#1)
the table of##2##3##(2008-9#1)(2013-1#1)
the table##23##2##(1993-2#1)(1995-2#1)(1997-3#1)(2006-10#1)(2006-8#2)(2007-10#2)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-1#1)(2013-1#2)
the tables##6##2##(1991-11#1)(1996-1#2)(1996-2#1)(1996-5#1)(2006-5#1)
the tablet##8##2##(1990-10#1)(1993-11#1)(2008-10#2)(2008-5#1)(2010-2#1)(2010-5#2)
the tablets##8##2##(2007-8#1)(2008-10#3)(2008-5#1)(2010-12#1)(2012-2#2)
the tac promoter##3##3##(1990-5#1)(1995-1#2)
the tac##5##2##(1990-5#1)(1995-1#2)(1995-8#1)(2013-8#1)
the tachykinin NK1 receptor##2##4##(1996-12#2)
the tachykinin NK2 receptor##5##4##(1993-11#1)(1993-3#1)(1996-12#3)
the tachykinin family##3##3##(1990-12#1)(1991-5#2)
the tachykinin##15##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-5#2)(1993-11#1)(1993-3#1)(1994-10#1)(1996-12#7)
the tacrolimus##4##2##(2007-11#4)
the tactics of##2##3##(2005-1#1)(2006-6#1)
the tactile perception in the##2##5##(2007-5#1)(2008-5#1)
the tactile perception##3##3##(2007-5#1)(2008-5#2)
the tactile##9##2##(1997-2#1)(2006-6#1)(2007-5#1)(2008-5#4)(2009-10#1)(2009-8#1)
the tadpoles##4##2##(2007-3#1)(2008-5#1)(2012-12#2)
the taenia cecum##2##3##(1990-7#2)
the taeniosis##2##2##(2011-2#2)
the tag##8##2##(1992-5#1)(1994-12#1)(1995-2#1)(2007-9#1)(2008-11#1)(2012-3#2)(2013-8#1)
the tagged##6##2##(1997-8#3)(2007-11#1)(2007-12#1)(2007-9#1)
the tagging##4##2##(2008-10#2)(2008-7#1)(2012-3#1)
the tai chi##2##3##(2008-10#1)(2011-12#1)
the tail assembly##2##3##(2011-12#2)
the tail base##2##3##(1995-12#1)(2005-7#1)
the tail domain of##4##4##(1990-11#2)(1997-6#1)(2009-7#1)
the tail domain##5##3##(1990-11#3)(1997-6#1)(2009-7#1)
the tail flick##2##3##(1990-2#1)(1996-10#1)
the tail of a##2##4##(1993-1#1)(1994-4#1)
the tail of the##4##4##(2008-5#1)(2008-9#1)(2011-1#1)(2013-1#1)
the tail of##8##3##(1993-1#1)(1994-4#1)(2006-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-1#1)(2013-1#1)
the tail portion of##2##4##(1995-8#1)(2008-3#1)
the tail region##2##3##(2011-1#2)
the tail sheath##5##3##(1990-5#5)
the tail vein and##2##4##(2008-1#1)(2011-2#1)
the tail vein##9##3##(1994-9#1)(1995-8#1)(1997-2#1)(2008-1#1)(2008-11#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#1)
the tail was##2##3##(2004-11#1)(2011-12#1)
the tail##68##2##(1990-11#3)(1990-2#1)(1990-4#1)(1990-5#6)(1990-6#1)(1992-4#2)(1992-9#2)(1993-1#2)(1993-5#1)(1993-9#2)(1994-3#1)(1994-4#1)(1994-9#1)(1995-12#3)(1995-3#1)(1995-8#2)(1996-10#1)(1997-2#2)(1997-6#1)(1997-7#1)(2004-11#1)(2005-7#1)(2006-10#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#1)(2011-1#4)(2011-12#4)(2011-2#1)(2012-2#2)(2013-1#1)
the tail-flick response##6##3##(1992-3#3)(1997-8#3)
the tail-flick test##5##3##(1993-5#2)(1997-8#2)(2008-2#1)
the tail-flick##16##2##(1991-5#1)(1992-3#4)(1992-7#1)(1993-5#2)(1994-9#2)(1997-8#5)(2008-2#1)
the tailored##3##2##(2006-10#1)(2009-6#1)(2010-10#1)
the tails of the##2##4##(2007-12#1)(2012-3#1)
the tails of##3##3##(1997-4#1)(2007-12#1)(2012-3#1)
the tails##6##2##(1994-3#1)(1997-4#2)(2007-12#1)(2012-1#1)(2012-3#1)
the take-all##2##2##(2008-10#2)
the taken-for-granted##2##2##(2008-12#1)(2013-1#1)
the talar##4##2##(2006-3#1)(2007-9#1)(2008-12#1)(2009-1#1)
the talin purified by the##2##5##(1990-9#2)
the talks##3##2##(2008-7#3)
the tall fescue endophytes##2##4##(1994-3#2)
the tall##4##2##(1994-3#2)(2008-10#1)(2009-5#1)
the talo-crural joint##3##3##(2007-11#2)(2007-8#1)
the talocalcaneal surface##2##3##(2007-9#2)
the talocalcaneal##3##2##(2007-9#2)(2008-12#1)
the talonavicular joint##2##3##(2010-3#2)
the talonavicular##3##2##(2009-10#1)(2010-3#2)
the talpid3 mutant##2##3##(2003-11#2)
the talpid3##4##2##(2003-11#4)
the talus of the ankle##3##5##(1991-10#3)
the talus##15##2##(1991-10#3)(2006-11#2)(2008-12#1)(2009-1#1)(2009-10#1)(2009-5#1)(2010-3#2)(2010-5#3)(2012-2#1)
the tamarillo isolates##2##3##(2008-10#2)
the tammar wallaby##2##3##(1992-8#1)(1996-5#1)
the tandem affinity purification (TAP)##2##5##(2008-7#2)
the tandem repeat##3##3##(1992-11#1)(1992-5#1)(1997-7#1)
the tandem repeats##2##3##(1991-2#1)(1992-11#1)
the tandem##15##2##(1991-10#1)(1991-2#1)(1992-11#2)(1992-5#1)(1994-10#1)(1995-1#1)(1996-5#2)(1997-7#1)(2007-8#1)(2008-10#2)(2008-7#2)
the tandemly##3##2##(1990-8#1)(1993-12#1)(1995-8#1)
the tangent##4##2##(2006-4#1)(2008-1#1)(2008-3#1)(2012-2#1)
the tangential and sagittal##2##4##(2007-11#1)(2008-2#1)
the tangential plane and##2##4##(2007-12#1)(2008-10#1)
the tangential view##2##3##(2005-7#2)
the tangential##10##2##(2005-7#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2010-8#1)
the tangerine##2##2##(2008-10#2)
the tank##4##2##(2007-10#1)(2008-8#1)(2009-9#2)
the tannin##2##2##(2007-10#1)(2008-10#1)
the tantalizing possibility that##3##4##(2008-5#1)(2008-8#1)(2009-8#1)
the tantalizing possibility##4##3##(2007-7#1)(2008-5#1)(2008-8#1)(2009-8#1)
the tantalizing##5##2##(2007-7#1)(2008-5#1)(2008-8#1)(2009-8#1)(2012-2#1)
the tap test and the turbidity test##2##7##(2006-2#2)
the tap water group##2##4##(2008-5#2)
the tap##4##2##(2006-2#2)(2008-5#2)
the tape##3##2##(2007-7#1)(2008-10#1)(2008-5#1)
the taper angle##2##3##(2008-2#2)
the taper##6##2##(2007-12#2)(2008-2#3)(2008-3#1)
the tapered##7##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)
the tapering##2##2##(2008-2#1)(2008-7#1)
the tapers and##2##3##(2007-12#2)
the tapers##3##2##(2007-12#3)
the tapestry chamber##2##3##(2012-2#2)
the tapestry##3##2##(2012-2#3)
the tapetum##2##2##(2007-12#1)(2011-2#1)
the tapeworm##2##2##(1993-6#1)(1993-9#1)
the taproot##2##2##(2008-10#2)
the target DNA and##2##4##(1992-3#1)(2008-10#1)
the target DNA##9##3##(1990-9#1)(1992-3#1)(2008-1#1)(2008-10#4)(2008-4#2)
the target Hb##2##3##(2005-10#1)(2007-7#1)
the target RNA and##2##4##(2008-10#1)(2009-10#1)
the target RNA##4##3##(2004-1#1)(2008-10#1)(2009-10#1)(2011-1#1)
the target VOCs##2##3##(2008-10#2)
the target amount##2##3##(1993-12#2)
the target analyte##9##3##(2006-12#1)(2007-8#1)(2008-10#5)(2008-7#1)(2011-1#1)
the target analytes in##2##4##(2007-8#1)(2008-10#1)
the target analytes##7##3##(2007-8#2)(2008-10#4)(2013-1#1)
the target and background##2##4##(2008-3#1)(2009-12#1)
the target and the##4##4##(1995-1#1)(2008-1#1)(2008-7#1)(2010-5#1)
the target and##13##3##(1993-4#1)(1995-1#1)(2006-3#1)(2007-12#1)(2008-1#4)(2008-3#2)(2008-7#1)(2009-12#1)(2010-5#1)
the target antigen##2##3##(1991-2#1)(2005-10#1)
the target area##4##3##(1994-8#1)(2006-8#1)(2008-10#1)(2008-5#1)
the target cell##11##3##(1993-12#1)(1993-6#1)(1996-8#1)(1997-7#1)(2006-10#1)(2008-11#2)(2008-5#1)(2011-1#2)(2011-2#1)
the target cells##13##3##(1990-12#1)(1990-7#1)(1993-12#1)(1993-6#1)(1994-3#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#2)(2010-12#1)
the target compounds##7##3##(2007-11#1)(2008-10#5)(2013-1#1)
the target enzyme##2##3##(1996-8#1)(1997-4#1)
the target for a##2##4##(1992-9#1)(2006-10#1)
the target for##11##3##(1990-3#1)(1991-8#1)(1992-9#1)(1993-9#1)(2005-7#1)(2006-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)
the target gas##2##3##(2008-3#2)
the target gene as##2##4##(2008-10#2)
the target gene##11##3##(1995-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2011-12#1)
the target genes of##2##4##(2008-9#1)(2012-12#1)
the target genes##4##3##(2008-8#2)(2008-9#1)(2012-12#1)
the target group##6##3##(1991-4#1)(1996-12#1)(2004-2#1)(2006-2#1)(2010-12#1)(2012-2#1)
the target haematocrit##2##3##(2007-11#2)
the target image##4##3##(2008-2#1)(2008-3#2)(2012-1#1)
the target in##3##3##(2008-11#1)(2008-3#1)(2009-8#1)
the target is##6##3##(1993-4#1)(1997-1#1)(2008-2#1)(2008-3#2)(2009-11#1)
the target leaf layer##4##4##(2008-10#4)
the target level##2##3##(2007-10#1)(2008-8#1)
the target location##3##3##(2007-11#1)(2008-1#1)(2012-1#1)
the target mRNA##3##3##(2006-12#1)(2008-1#1)(2013-1#1)
the target muscle##2##3##(2007-11#1)(2008-6#1)
the target object##6##3##(1997-8#1)(2007-11#1)(2008-3#1)(2008-4#1)(2009-2#1)(2012-2#1)
the target of a##2##4##(2010-12#1)(2010-7#1)
the target of the##2##4##(1992-4#1)(1996-9#1)
the target of##26##3##(1991-11#1)(1992-11#1)(1992-4#1)(1995-1#1)(1996-7#1)(1996-9#1)(1997-8#1)(2006-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
the target organ##8##3##(1990-4#1)(1990-8#1)(1994-11#1)(1997-4#1)(2008-11#1)(2008-7#1)(2010-1#1)(2013-1#1)
the target organism##2##3##(2008-10#1)(2012-3#1)
the target peptide##2##3##(1991-10#1)(1994-9#1)
the target population of##2##4##(2008-9#1)(2011-1#1)
the target population##16##3##(1996-12#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
the target protein and##3##4##(2008-4#2)(2010-7#1)
the target protein in##2##4##(1991-4#1)(2008-4#1)
the target protein to##2##4##(2007-9#1)(2008-2#1)
the target protein##20##3##(1991-4#2)(1997-2#1)(2006-11#1)(2007-8#4)(2007-9#2)(2008-11#2)(2008-2#2)(2008-4#4)(2009-9#1)(2010-7#1)
the target proteins##4##3##(2007-8#1)(2008-8#1)(2009-10#1)(2013-1#1)
the target region##4##3##(1995-12#1)(2008-10#1)(2010-2#1)(2011-2#1)
the target rocks##2##3##(1993-7#2)
the target sequence is##2##4##(2008-2#1)(2011-1#1)
the target sequence##11##3##(1993-11#1)(1994-12#2)(2008-10#2)(2008-2#2)(2008-4#2)(2008-9#1)(2011-1#1)
the target sequences##3##3##(2008-10#1)(2009-8#1)(2013-8#1)
the target site of##3##4##(1994-8#1)(1996-7#1)(2007-8#1)
the target site##8##3##(1990-11#2)(1993-12#1)(1994-8#1)(1995-8#1)(1996-7#1)(2007-8#1)(2010-12#1)
the target surface##2##3##(2008-2#1)(2008-3#1)
the target therapy of##2##4##(2010-8#1)(2011-2#1)
the target tissue##8##3##(1991-10#1)(1996-3#1)(1997-2#1)(2007-11#1)(2007-7#1)(2008-10#1)(2009-11#1)(2009-7#1)
the target to##2##3##(2005-7#1)(2008-10#1)
the target value##3##3##(1990-12#1)(1993-9#1)(2011-2#1)
the target volume##10##3##(1993-4#2)(2008-2#1)(2008-3#2)(2008-6#1)(2009-11#2)(2010-9#2)
the target was presented##2##4##(1994-2#1)(1996-6#1)
the target was##7##3##(1994-2#1)(1996-6#2)(1997-1#1)(2008-10#1)(2012-1#1)(2012-2#1)
the target were##2##3##(1996-6#1)(2007-12#1)
the target with a##2##4##(1996-1#1)(2007-12#1)
the target with##5##3##(1996-1#1)(2007-12#1)(2008-4#3)
the target word##2##3##(2009-8#2)
the target##517##2##(1990-11#3)(1990-12#3)(1990-3#2)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#3)(1991-6#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#5)(1993-2#2)(1993-3#1)(1993-4#5)(1993-6#2)(1993-7#2)(1993-9#3)(1994-11#1)(1994-12#2)(1994-2#4)(1994-3#1)(1994-8#2)(1994-9#1)(1995-1#4)(1995-12#3)(1995-5#2)(1995-8#2)(1996-1#6)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#4)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#6)(1997-2#5)(1997-4#2)(1997-7#2)(1997-8#2)(2004-1#1)(2004-2#1)(2005-10#2)(2005-7#3)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-11#2)(2006-12#3)(2006-2#1)(2006-3#1)(2006-5#3)(2006-6#3)(2006-8#1)(2007-10#2)(2007-11#14)(2007-12#7)(2007-2#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#16)(2007-9#4)(2008-1#13)(2008-10#66)(2008-11#15)(2008-2#23)(2008-3#30)(2008-4#21)(2008-5#7)(2008-6#6)(2008-7#12)(2008-8#9)(2008-9#7)(2009-1#1)(2009-10#3)(2009-11#6)(2009-12#1)(2009-2#2)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#8)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#6)(2010-2#4)(2010-5#2)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#16)(2011-12#1)(2011-2#9)(2012-1#10)(2012-12#9)(2012-2#8)(2012-3#3)(2013-1#12)(2013-8#5)
the target's##5##2##(1993-2#1)(2008-11#1)(2008-3#1)(2009-10#1)(2010-7#1)
the target-site##2##2##(2008-10#2)
the targeted region##2##3##(2006-9#1)(2008-10#1)
the targeted##26##2##(1994-12#1)(1994-2#1)(1995-3#1)(1995-6#1)(1996-4#1)(2006-11#1)(2006-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-7#1)
the targeting of##10##3##(1995-5#1)(1996-11#1)(1996-5#1)(1997-3#1)(2007-1#1)(2008-11#2)(2009-7#1)(2009-8#1)(2012-1#1)
the targeting##27##2##(1991-12#1)(1991-8#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-10#2)(1996-11#2)(1996-5#1)(1997-3#1)(2005-8#1)(2007-1#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-5#1)(2012-1#1)(2012-11#2)(2012-12#1)
the targets for##7##3##(1994-9#1)(1995-3#1)(1995-8#1)(1997-2#1)(2008-4#2)(2011-3#1)
the targets of##7##3##(1991-5#1)(2008-1#1)(2008-11#3)(2008-5#1)(2010-12#1)
the targets set##2##3##(1996-2#1)(2010-12#1)
the targets##32##2##(1991-5#1)(1992-10#1)(1993-7#1)(1994-2#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-2#1)(2007-8#2)(2008-1#1)(2008-11#6)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2010-12#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)
the tarnished##3##2##(2007-12#2)(2009-12#1)
the tarsal##2##2##(2007-9#1)(2009-10#1)
the task at##4##3##(1994-8#3)(2009-4#1)
the task force##3##3##(1994-1#1)(2007-4#1)(2010-8#1)
the task is##4##3##(1990-12#1)(2008-10#1)(2008-3#1)(2012-1#1)
the task of identifying##2##4##(1997-8#1)(2013-1#1)
the task of##25##3##(1992-7#1)(1996-1#1)(1996-12#1)(1997-8#1)(2006-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#4)(2013-8#1)
the task to##3##3##(1995-5#1)(2010-12#1)(2011-2#1)
the task was##3##3##(1993-3#1)(2008-4#1)(2008-6#1)
the task##92##2##(1990-12#1)(1991-1#2)(1991-2#3)(1991-3#1)(1991-9#1)(1992-7#2)(1993-3#1)(1994-1#1)(1994-3#2)(1994-8#4)(1995-1#2)(1995-12#3)(1995-5#1)(1996-1#1)(1996-12#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-6#1)(2007-12#2)(2007-3#1)(2007-4#2)(2007-6#2)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#4)(2008-6#1)(2008-7#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-2#3)(2012-1#7)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#3)
the task-relevant##2##2##(2007-8#1)(2008-11#1)
the tasks in##3##3##(2006-4#1)(2009-10#1)(2012-1#1)
the tasks of the##2##4##(1990-3#1)(1995-4#1)
the tasks of##4##3##(1990-3#1)(1995-4#1)(2008-7#1)(2011-2#1)
the tasks were##3##3##(1991-6#1)(2007-9#1)(2008-11#1)
the tasks##31##2##(1990-3#1)(1991-6#1)(1992-11#1)(1993-12#1)(1995-12#1)(1995-4#1)(2005-5#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-2#1)(2007-9#3)(2008-11#3)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#3)(2012-1#3)(2012-2#1)
the taste sensing##2##3##(2008-10#2)
the taste system##3##3##(1990-9#1)(2007-12#1)(2010-2#1)
the taste##19##2##(1990-9#1)(1991-3#2)(1992-11#1)(1993-12#1)(1994-5#1)(1996-5#1)(2006-10#2)(2007-12#1)(2008-10#5)(2010-2#1)(2010-5#1)(2012-1#1)(2013-1#1)
the tau 1 core##3##4##(1995-2#3)
the tau b method##2##4##(1995-2#2)
the tau kinase##2##3##(1997-1#1)(2013-1#1)
the tau neutrino##2##3##(2007-9#2)
the tau##14##2##(1992-9#1)(1993-6#1)(1994-12#1)(1995-2#5)(1996-9#1)(1997-1#1)(2007-9#2)(2008-9#1)(2013-1#1)
the taurine##4##2##(1992-1#1)(1994-3#1)(1995-1#1)(2008-10#1)
the tautomeric equilibrium of##2##4##(2008-3#2)
the tautomeric##5##2##(2006-12#2)(2007-10#1)(2008-3#2)
the tax##4##2##(2008-6#1)(2008-8#2)(2009-12#1)
the taxa##3##2##(2008-10#1)(2010-3#1)(2012-2#1)
the taxoid##2##2##(1994-5#1)(2005-7#1)
the taxonomic status of##5##4##(2007-3#1)(2008-5#2)(2010-8#2)
the taxonomic status##6##3##(2007-3#1)(2008-5#2)(2010-8#3)
the taxonomic##19##2##(1994-3#2)(1997-4#1)(2006-5#1)(2007-11#1)(2007-3#1)(2008-10#3)(2008-12#1)(2008-5#2)(2010-10#1)(2010-8#3)(2012-2#1)(2013-7#1)(2013-8#1)
the taxonomy of the##3##4##(2008-10#2)(2013-7#1)
the taxonomy of##7##3##(2008-10#3)(2008-5#1)(2008-7#1)(2010-10#1)(2013-7#1)
the taxonomy##12##2##(2008-10#3)(2008-5#1)(2008-7#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-7#1)
the tea##4##2##(1990-5#1)(1995-9#1)(2008-10#2)
the teacher##5##2##(1992-9#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-3#1)
the teacher's##3##2##(2008-11#2)(2011-2#1)
the teachers##7##2##(1991-12#1)(1994-6#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-9#1)
the teaching and learning of##4##5##(2008-11#2)(2008-12#1)(2010-6#1)
the teaching and learning##10##4##(2008-11#4)(2008-12#2)(2010-6#1)(2012-1#1)(2013-8#2)
the teaching and training of##2##5##(1997-7#1)(2008-11#1)
the teaching and##13##3##(1997-7#1)(2008-11#5)(2008-12#2)(2008-4#1)(2010-6#1)(2012-1#1)(2013-8#2)
the teaching of Ethics##2##4##(2012-12#2)
the teaching of posterior composites##2##5##(2009-2#2)
the teaching of##15##3##(2006-7#2)(2008-11#2)(2009-2#5)(2010-1#1)(2010-11#1)(2011-2#1)(2012-12#2)(2013-1#1)
the teaching##46##2##(1992-1#1)(1995-1#1)(1997-7#1)(2006-7#2)(2007-12#1)(2007-2#1)(2007-4#2)(2007-6#1)(2008-10#1)(2008-11#8)(2008-12#5)(2008-4#1)(2009-2#5)(2010-1#1)(2010-11#1)(2010-6#2)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
the team and the##2##4##(2008-2#1)(2009-6#1)
the team and##4##3##(1993-3#1)(2006-8#1)(2008-2#1)(2009-6#1)
the team concept##2##3##(2008-10#2)
the team in the##2##4##(1992-2#1)(2006-8#1)
the team is##2##3##(2011-1#1)(2012-1#1)
the team leader##2##3##(2007-8#1)(2011-12#1)
the team members##2##3##(2007-5#1)(2007-8#1)
the team##50##2##(1990-3#1)(1991-2#1)(1992-2#1)(1993-3#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-1#4)(1996-3#1)(1997-2#1)(1997-3#1)(2006-3#1)(2006-7#1)(2006-8#4)(2007-5#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-1#4)(2011-12#1)(2011-2#1)(2011-8#1)(2012-1#1)(2013-1#2)(2013-7#2)
the team's##3##2##(1993-12#1)(1997-2#1)(2007-8#1)
the teams##4##2##(1994-1#1)(2007-12#2)(2012-3#1)
the tear film and##3##4##(2006-11#1)(2007-1#1)(2011-2#1)
the tear film is##2##4##(2005-11#1)(2007-1#1)
the tear film##8##3##(2005-11#1)(2006-11#2)(2007-1#2)(2009-4#1)(2009-6#1)(2011-2#1)
the tear##12##2##(2005-11#1)(2006-11#3)(2007-1#2)(2009-4#2)(2009-6#1)(2011-2#1)(2013-8#2)
the technical advances##2##3##(2008-6#1)(2010-9#1)
the technical and##6##3##(2005-5#1)(2007-11#1)(2007-4#1)(2007-5#1)(2009-8#1)(2011-2#1)
the technical aspects of##7##4##(1991-4#1)(1997-8#1)(2006-10#1)(2006-6#1)(2006-8#1)(2010-12#1)(2013-8#1)
the technical characteristics of##2##4##(2007-1#1)(2007-8#1)
the technical characteristics##3##3##(1996-1#1)(2007-1#1)(2007-8#1)
the technical details of##2##4##(2007-12#1)(2012-3#1)
the technical details##4##3##(2007-12#1)(2008-9#1)(2010-8#1)(2012-3#1)
the technical development##2##3##(1990-4#1)(2006-6#1)
the technical evolutions and the current place of Aspergillus serology in France##2##12##(2012-11#2)
the technical feasibility of##2##4##(2008-2#1)(2008-5#1)
the technical limitations of##2##4##(2006-10#1)(2006-5#1)
the technical principles##2##3##(2007-11#1)(2008-7#1)
the technical problems##2##3##(1997-2#1)(2007-8#1)
the technical##72##2##(1990-12#1)(1990-4#1)(1991-4#1)(1992-11#1)(1992-3#1)(1994-3#1)(1995-5#1)(1996-1#1)(1997-2#1)(1997-6#1)(1997-8#2)(2005-5#2)(2006-10#3)(2006-5#1)(2006-6#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-8#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-2#4)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
the technician and##2##3##(2006-5#1)(2012-1#1)
the technician##4##2##(2006-5#1)(2007-10#2)(2012-1#1)
the technique allowed##2##3##(2008-10#1)(2010-12#1)
the technique allows for##2##4##(2007-12#1)(2008-3#1)
the technique allows##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)
the technique and outcomes of##3##5##(2005-10#1)(2007-7#1)(2009-10#1)
the technique and the##3##4##(1990-10#1)(1994-2#1)(2006-6#1)
the technique and##21##3##(1990-10#1)(1990-11#1)(1992-12#1)(1994-2#1)(2005-10#1)(2005-9#1)(2006-12#1)(2006-3#1)(2006-6#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-3#3)(2008-4#1)(2008-7#1)(2009-10#1)(2010-7#1)
the technique are##13##3##(1990-4#1)(1992-7#1)(1995-11#1)(1996-5#1)(1997-3#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-1#1)
the technique by##12##3##(2007-12#8)(2008-1#1)(2008-3#2)(2011-2#1)
the technique can be used##2##5##(2007-11#1)(2008-3#1)
the technique can be##8##4##(1993-2#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-8#1)
the technique can##13##3##(1992-10#1)(1993-2#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2010-8#1)(2011-1#1)
the technique could##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
the technique described##3##3##(1996-12#1)(2007-12#1)(2008-2#1)
the technique employed##3##3##(2007-7#1)(2008-10#1)(2010-4#1)
the technique for##7##3##(2007-7#1)(2008-2#2)(2008-3#1)(2009-12#1)(2012-12#1)(2013-7#1)
the technique has##5##3##(2004-2#1)(2006-5#1)(2008-2#1)(2010-7#1)(2012-2#1)
the technique in both##2##4##(2007-12#1)(2008-10#1)
the technique in##12##3##(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-8#1)(2010-1#1)(2012-12#3)(2013-8#1)
the technique is performed##2##4##(2008-11#1)(2010-9#1)
the technique is the##2##4##(1995-4#1)(2008-4#1)
the technique is##38##3##(1992-7#1)(1995-4#1)(2006-3#1)(2006-4#1)(2006-5#1)(2007-11#3)(2007-12#4)(2008-10#1)(2008-11#2)(2008-2#8)(2008-3#7)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-9#1)(2011-1#2)(2012-1#1)
the technique may##3##3##(1992-2#1)(2006-6#1)(2008-3#1)
the technique of choice for##5##5##(1991-5#1)(2007-8#1)(2010-6#1)(2011-2#1)(2012-2#1)
the technique of choice in##2##5##(1995-11#1)(2010-2#1)
the technique of choice##7##4##(1991-5#1)(1995-11#1)(2007-8#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-2#1)
the technique of laser##2##4##(1991-12#1)(2008-3#1)
the technique of microdialysis##2##4##(2007-9#1)(2008-10#1)
the technique of optical##2##4##(2007-12#2)
the technique of the##2##4##(2007-7#1)(2009-8#1)
the technique of##85##3##(1990-10#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-5#1)(1992-5#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-5#1)(2005-4#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2007-12#7)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#6)(2008-11#3)(2008-2#3)(2008-3#5)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-12#1)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)
the technique offers##2##3##(2008-7#1)(2008-8#1)
the technique on##3##3##(2008-2#1)(2009-2#1)(2010-5#1)
the technique presented here##2##4##(2008-3#1)(2008-6#1)
the technique presented##4##3##(2006-3#1)(2008-3#1)(2008-6#1)(2010-3#1)
the technique proposed here##2##4##(2007-12#1)(2008-2#1)
the technique proposed##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
the technique remains##2##3##(2007-8#1)(2008-3#1)
the technique requires##2##3##(1996-12#1)(2007-11#1)
the technique should##2##3##(2006-12#1)(2008-10#1)
the technique that##2##3##(2006-10#1)(2008-2#1)
the technique to measure##2##4##(2008-2#1)(2008-3#1)
the technique to##10##3##(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2011-12#1)
the technique used for##2##4##(2006-5#1)(2008-11#1)
the technique used to##3##4##(1990-8#1)(2008-10#1)(2008-3#1)
the technique used##9##3##(1990-8#1)(1990-9#1)(1997-5#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
the technique was the##2##4##(1992-8#1)(2006-10#1)
the technique was used##2##4##(2008-10#1)(2008-5#1)
the technique was##15##3##(1991-2#1)(1991-5#1)(1992-8#1)(1993-12#1)(1997-3#1)(2006-10#2)(2007-11#2)(2008-10#3)(2008-2#2)(2008-5#1)
the technique were##3##3##(2006-5#1)(2008-5#1)(2008-7#1)
the technique will##2##3##(2008-2#1)(2008-7#1)
the technique with##4##3##(1997-4#1)(2006-10#1)(2008-10#1)(2008-5#1)
the technique##374##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-4#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-7#2)(1992-8#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-2#2)(1995-11#2)(1995-12#1)(1995-4#1)(1995-8#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(2004-2#1)(2005-10#1)(2005-12#1)(2005-4#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#8)(2006-12#5)(2006-2#1)(2006-3#4)(2006-4#2)(2006-5#7)(2006-6#2)(2006-7#1)(2007-1#1)(2007-11#9)(2007-12#37)(2007-2#1)(2007-5#2)(2007-7#5)(2007-8#11)(2007-9#2)(2008-1#6)(2008-10#29)(2008-11#10)(2008-12#2)(2008-2#32)(2008-3#43)(2008-4#9)(2008-5#5)(2008-6#4)(2008-7#9)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#2)(2010-1#2)(2010-11#1)(2010-12#3)(2010-2#4)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#3)(2011-2#6)(2011-7#1)(2012-1#1)(2012-12#9)(2012-2#7)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
the technique's##5##2##(1997-7#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)
the techniques and the##2##4##(2006-10#1)(2006-12#1)
the techniques and##11##3##(1996-3#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2009-4#2)
the techniques are##6##3##(1991-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-2#1)
the techniques available##2##3##(2008-10#1)(2008-4#1)
the techniques can be##3##4##(1990-9#1)(2008-11#1)(2008-2#1)
the techniques described##2##3##(1990-9#1)(2008-2#1)
the techniques employed##2##3##(2006-3#1)(2008-7#1)
the techniques for the##3##4##(2008-2#1)(2008-4#2)
the techniques for##7##3##(2005-11#1)(2008-2#1)(2008-4#2)(2008-9#2)(2011-2#1)
the techniques involved##2##3##(2008-11#1)(2008-9#1)
the techniques of##28##3##(1990-4#1)(1991-4#1)(1995-2#1)(1996-1#1)(1997-4#2)(2006-10#2)(2006-3#1)(2006-5#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-2#1)(2010-8#1)(2012-12#1)(2012-2#2)
the techniques that##4##3##(1995-5#1)(2006-9#1)(2008-10#1)(2008-9#1)
the techniques used in##2##4##(2007-7#1)(2008-2#1)
the techniques used##7##3##(2007-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-10#1)(2010-8#1)(2012-3#1)
the techniques were##2##3##(2008-10#1)(2008-8#1)
the techniques##97##2##(1990-4#1)(1990-9#2)(1991-2#1)(1991-4#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-3#1)(1996-8#1)(1997-4#2)(2005-11#1)(2006-10#6)(2006-12#1)(2006-3#3)(2006-5#1)(2006-6#1)(2006-9#1)(2007-12#4)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-2#6)(2008-3#3)(2008-4#7)(2008-7#5)(2008-8#3)(2008-9#6)(2009-10#1)(2009-2#1)(2009-4#2)(2009-8#2)(2010-2#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#2)
the technological and##3##3##(1992-2#1)(2009-9#1)(2012-3#1)
the technological challenges to##2##4##(2007-5#1)(2010-7#1)
the technological challenges##3##3##(2007-5#2)(2010-7#1)
the technological development of##3##4##(2006-10#1)(2008-12#1)(2010-8#1)
the technological evolution##2##3##(1993-12#1)(2006-10#1)
the technological##23##2##(1992-11#1)(1992-2#1)(1993-12#1)(2006-10#2)(2006-6#1)(2007-12#1)(2007-5#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-9#1)(2010-7#1)(2010-8#1)(2010-9#1)(2012-3#1)(2013-1#1)
the technologically important##2##3##(2007-12#1)(2010-4#1)
the technologically##3##2##(2007-12#1)(2010-4#1)(2011-1#1)
the technologies##6##2##(2006-10#1)(2008-1#1)(2008-11#2)(2011-1#1)(2011-3#1)
the technologist##3##2##(1994-6#1)(1995-3#1)(2007-4#1)
the technology and##3##3##(2007-2#1)(2008-4#1)(2008-7#1)
the technology could##2##3##(1992-11#1)(2006-6#1)
the technology for##3##3##(2007-11#1)(2008-1#1)(2008-4#1)
the technology has##2##3##(2005-11#1)(2008-9#1)
the technology in##2##3##(2008-10#2)
the technology is not yet##2##5##(2007-11#1)(2011-2#1)
the technology is##6##3##(2007-11#1)(2008-11#2)(2008-3#1)(2011-2#1)(2012-11#1)
the technology itself##2##3##(1994-2#1)(2007-10#1)
the technology of choice##2##4##(2007-11#1)(2009-6#1)
the technology of gene targeting and nuclear transfer##2##8##(2005-6#2)
the technology of##10##3##(1991-11#1)(1997-5#1)(2005-6#2)(2007-1#1)(2007-11#1)(2008-3#1)(2009-6#1)(2013-8#2)
the technology that##2##3##(2005-7#1)(2008-1#1)
the technology to##4##3##(2008-10#2)(2008-9#2)
the technology##63##2##(1991-11#1)(1992-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1997-5#2)(2005-11#1)(2005-6#2)(2005-7#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-2#1)(2007-4#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#2)(2008-7#3)(2008-9#4)(2009-12#1)(2009-6#2)(2010-5#1)(2011-2#2)(2012-11#1)(2013-1#2)(2013-8#2)
the teenage years##2##3##(2006-7#1)(2009-7#1)
the teenage##5##2##(2006-7#2)(2006-8#1)(2008-9#1)(2009-7#1)
the teens##2##2##(2009-7#1)(2013-8#1)
the teeth and##4##3##(1995-6#1)(1995-9#1)(2006-2#1)(2013-8#1)
the teeth in##3##3##(1997-5#1)(2012-3#1)(2013-1#1)
the teeth of##3##3##(1997-4#1)(2010-5#2)
the teeth were##3##3##(2008-5#1)(2009-7#1)(2013-1#1)
the teeth##26##2##(1995-3#1)(1995-6#1)(1995-9#1)(1997-4#2)(1997-5#1)(2006-2#1)(2006-8#1)(2007-12#1)(2008-5#2)(2009-7#1)(2010-5#2)(2011-1#4)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#1)
the teicoplanin##3##2##(2008-10#3)
the telencephalon##22##2##(1990-10#1)(1991-9#1)(1992-1#1)(1993-2#2)(1994-3#2)(1995-12#1)(1996-5#8)(1997-6#2)(2008-11#1)(2008-6#1)(2012-3#1)(2013-8#1)
the teleost##8##2##(1991-9#1)(1993-5#1)(1995-2#1)(1995-7#1)(2008-7#1)(2008-8#1)(2009-4#2)
the telephone##6##2##(1994-6#1)(1996-5#1)(2006-8#1)(2008-9#1)(2013-1#2)
the telephone-administered HUI2/3##2##3##(2007-10#2)
the telescope s##2##3##(2008-3#2)
the telescope##15##2##(1991-2#1)(2007-12#1)(2007-7#1)(2008-2#3)(2008-3#9)
the telescopes##2##2##(2007-12#1)(2008-3#1)
the telia##2##2##(2008-10#2)
the telomerase activity in##2##4##(2008-9#2)
the telomerase activity##4##3##(2008-9#3)(2010-2#1)
the telomerase complex##2##3##(2008-11#2)
the telomerase##7##2##(1990-8#1)(2008-11#2)(2008-9#3)(2010-2#1)
the telomere of##2##3##(1993-9#1)(1997-5#1)
the telomere##8##2##(1990-8#2)(1991-9#1)(1993-9#1)(1997-5#1)(2008-11#1)(2008-8#1)(2011-1#1)
the telomeres and##2##3##(1995-1#2)
the telomeres of##4##3##(1992-12#1)(1997-6#2)(2011-12#1)
the telomeres##9##2##(1991-7#1)(1992-12#1)(1995-1#3)(1997-6#2)(2006-5#1)(2011-12#1)
the telomeric region of##2##4##(1994-11#1)(1995-2#1)
the telomeric region##6##3##(1994-11#1)(1995-2#1)(1996-4#1)(2008-11#2)(2010-8#1)
the telomeric##15##2##(1993-3#1)(1994-11#1)(1995-2#1)(1996-4#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-8#1)(2010-12#2)(2010-2#2)(2010-8#1)
the telomerized##2##2##(2008-11#2)
the temperament##2##2##(2004-2#1)(2009-2#1)
the temperate and tropical isolates##3##5##(2008-10#3)
the temperate and##4##3##(2008-10#3)(2008-8#1)
the temperate isolates##3##3##(2008-10#3)
the temperate zone##2##3##(2008-10#1)(2012-3#1)
the temperate##12##2##(2007-7#1)(2008-10#7)(2008-8#2)(2012-2#1)(2012-3#1)
the temperature and pressure##3##4##(2008-2#1)(2008-3#2)
the temperature and the##7##4##(1996-7#1)(2007-3#1)(2008-10#2)(2008-2#2)(2008-3#1)
the temperature and time##2##4##(2008-5#1)(2011-1#1)
the temperature and##23##3##(1990-2#1)(1992-2#1)(1996-7#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#4)(2008-2#3)(2008-3#4)(2008-5#1)(2011-1#1)(2011-12#1)
the temperature at which the##2##5##(1990-5#1)(2008-10#1)
the temperature at which##3##4##(1990-5#1)(1996-1#1)(2008-10#1)
the temperature attained in the##2##5##(1995-6#1)(2008-10#1)
the temperature characteristics of##3##4##(2007-12#1)(2008-2#2)
the temperature dependence of the fluorescence##2##6##(1991-4#1)(2008-2#1)
the temperature dependence of the heat##2##6##(2005-11#2)
the temperature dependence of the refractive index##2##7##(2008-2#1)(2008-3#1)
the temperature dependence of the##26##5##(1990-3#1)(1991-4#1)(1992-4#1)(1994-12#1)(1995-5#1)(1997-6#1)(1997-7#1)(2005-11#3)(2006-10#1)(2007-12#3)(2008-10#1)(2008-2#5)(2008-3#5)(2008-5#1)
the temperature dependence of##42##4##(1990-3#1)(1990-7#1)(1991-4#1)(1992-4#1)(1994-12#1)(1995-5#1)(1996-12#1)(1997-4#2)(1997-6#1)(1997-7#1)(2004-9#1)(2005-11#3)(2006-10#2)(2006-4#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-10#1)(2008-2#7)(2008-3#9)(2008-5#1)(2009-12#1)
the temperature distribution##5##3##(2008-2#1)(2008-3#3)(2008-7#1)
the temperature during##3##3##(1994-8#1)(1997-5#1)(2008-10#1)
the temperature effect on##2##4##(2013-7#2)
the temperature effect##9##3##(1996-2#1)(2007-11#1)(2008-10#3)(2008-3#1)(2012-5#1)(2013-7#2)
the temperature field##3##3##(2008-3#3)
the temperature in the capillary##2##5##(2008-10#2)
the temperature in the##7##4##(1991-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2012-3#1)
the temperature in##8##3##(1991-8#1)(1994-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2012-3#1)
the temperature increase##2##3##(2007-12#1)(2009-4#1)
the temperature increased##3##3##(2007-6#1)(2008-3#1)(2011-12#1)
the temperature increases to##2##4##(2007-12#2)
the temperature increases##5##3##(1995-1#1)(2007-12#2)(2008-10#1)(2013-8#1)
the temperature is increased##3##4##(2005-11#2)(2008-10#1)
the temperature is raised##3##4##(1990-3#1)(1995-2#1)(2008-11#1)
the temperature is##12##3##(1990-3#1)(1995-2#3)(1997-7#1)(2005-11#2)(2005-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
the temperature of the cold##2##5##(2007-12#1)(2012-3#1)
the temperature of the fiber##3##5##(2007-12#2)(2008-3#1)
the temperature of the##21##4##(1990-4#1)(1991-7#1)(1996-1#1)(1996-2#1)(2005-11#2)(2006-3#1)(2007-11#1)(2007-12#4)(2007-6#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#1)(2010-11#1)(2010-9#1)(2012-3#1)
the temperature of##32##3##(1990-4#1)(1990-8#1)(1991-7#3)(1993-5#1)(1994-6#1)(1995-11#1)(1996-1#1)(1996-2#1)(2005-11#2)(2006-3#1)(2006-4#1)(2007-11#1)(2007-12#4)(2007-6#1)(2008-1#1)(2008-10#2)(2008-3#3)(2008-4#1)(2010-11#1)(2010-9#1)(2012-12#1)(2012-3#1)(2013-8#1)
the temperature profile##2##3##(2007-12#1)(2008-3#1)
the temperature profiles##2##3##(2008-2#2)
the temperature program##5##3##(2007-10#1)(2007-8#1)(2008-10#1)(2008-6#1)(2012-1#1)
the temperature range of the##2##5##(1991-2#1)(1996-1#1)
the temperature range of##13##4##(1991-2#1)(1994-12#1)(1996-1#1)(1996-5#1)(1996-7#1)(2005-11#2)(2007-1#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-9#1)
the temperature range##35##3##(1990-2#1)(1990-5#1)(1991-2#2)(1991-7#1)(1991-9#1)(1992-12#1)(1994-12#2)(1994-5#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-4#1)(2005-11#3)(2006-10#4)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2009-9#1)
the temperature ranges##2##3##(2008-10#2)
the temperature rise##3##3##(2008-3#2)(2008-5#1)
the temperature sensitivity for cell growth##2##6##(1991-1#2)
the temperature sensitivity for##3##4##(1991-1#3)
the temperature sensitivity of##4##4##(2008-3#1)(2008-8#1)(2008-9#2)
the temperature sensitivity##9##3##(1991-1#3)(1995-2#1)(2008-3#2)(2008-8#1)(2008-9#2)
the temperature shift##2##3##(1995-6#1)(2007-6#1)
the temperature to##6##3##(1995-1#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-10#1)
the temperature variation##2##3##(1997-2#1)(2005-11#1)
the temperature was reduced##2##4##(1992-2#1)(2006-1#1)
the temperature was##12##3##(1992-2#1)(2005-11#1)(2006-1#1)(2008-10#4)(2008-4#1)(2008-5#1)(2009-2#1)(2011-2#1)(2012-3#1)
the temperature were##3##3##(2008-10#1)(2008-2#1)(2012-2#1)
the temperature##329##2##(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#2)(1990-5#3)(1990-7#1)(1990-8#1)(1991-1#3)(1991-2#2)(1991-4#1)(1991-7#4)(1991-8#2)(1991-9#1)(1992-12#2)(1992-2#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#4)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1995-1#2)(1995-11#1)(1995-2#5)(1995-5#1)(1995-6#3)(1996-1#3)(1996-12#1)(1996-2#3)(1996-5#1)(1996-7#2)(1997-2#3)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#4)(2004-9#1)(2005-11#20)(2005-8#1)(2006-1#1)(2006-10#7)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#1)(2007-1#2)(2007-10#1)(2007-11#6)(2007-12#16)(2007-3#1)(2007-6#4)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#40)(2008-11#3)(2008-12#1)(2008-2#26)(2008-3#47)(2008-4#2)(2008-5#10)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#3)(2012-5#3)(2013-7#5)(2013-8#3)
the temperature-##2##2##(1993-3#1)(2013-8#1)
the temperature-dependent##7##2##(1991-9#1)(2006-12#1)(2007-12#1)(2008-3#2)(2013-7#1)(2013-8#1)
the temperature-induced##3##2##(1990-2#1)(2008-3#2)
the temperature-sensitive (ts) phenotype##2##4##(1994-12#1)(2008-10#1)
the temperature-sensitive (ts)##3##3##(1990-5#1)(1994-12#1)(2008-10#1)
the temperature-sensitive phenotype##2##3##(1994-12#1)(1997-3#1)
the temperature-sensitive##9##2##(1990-5#1)(1994-11#1)(1994-12#2)(1996-9#1)(1997-3#1)(2008-10#1)(2008-11#1)(2013-1#1)
the temperatures of##3##3##(1991-2#1)(2008-5#1)(2012-2#1)
the temperatures##11##2##(1991-2#3)(2008-2#3)(2008-3#1)(2008-5#2)(2011-2#1)(2012-2#1)
the template DNA##3##3##(1993-12#1)(1993-3#1)(2008-8#1)
the template for##2##3##(1991-8#1)(2008-2#1)
the template molecule##3##3##(2008-10#3)
the template strand##4##3##(1991-7#3)(2008-9#1)
the template was##2##3##(1994-8#1)(2007-8#1)
the template##57##2##(1990-5#1)(1991-2#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-7#1)(1993-12#1)(1993-3#2)(1994-12#1)(1994-8#3)(1994-9#2)(1995-8#1)(1997-2#1)(1997-6#2)(2005-11#3)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-2#4)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#2)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
the tempo and##2##3##(1995-11#1)(2007-12#1)
the tempo of##2##3##(1994-9#1)(2008-8#1)
the tempo##4##2##(1994-9#1)(1995-11#1)(2007-12#1)(2008-8#1)
the temporal Talbot effect##4##4##(2007-11#1)(2007-12#2)(2008-3#1)
the temporal and geographical##2##4##(1990-8#1)(2008-10#1)
the temporal and spatial dynamics of##2##6##(2008-10#2)
the temporal and spatial expression##2##5##(1996-12#1)(1997-8#1)
the temporal and spatial##10##4##(1996-12#1)(1997-8#1)(2007-10#1)(2007-12#2)(2008-10#4)(2010-9#1)
the temporal and spectral features of##2##6##(2007-11#2)
the temporal and##20##3##(1990-8#1)(1993-11#1)(1995-11#1)(1996-12#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#3)(2008-10#5)(2008-11#1)(2008-8#1)(2009-10#1)(2010-9#1)
the temporal aspects of##3##4##(1995-12#1)(1997-2#1)(2008-2#1)
the temporal bone##14##3##(2005-5#2)(2006-12#5)(2008-6#1)(2008-8#2)(2008-9#2)(2011-2#2)
the temporal broadening of##2##4##(2008-3#2)
the temporal changes in##2##4##(1997-2#1)(2010-5#1)
the temporal changes##3##3##(1997-2#1)(2008-7#1)(2010-5#1)
the temporal characteristics of##2##4##(2008-4#1)(2008-5#1)
the temporal coherence of##2##4##(2007-11#1)(2008-3#1)
the temporal coherence##4##3##(2007-11#2)(2008-2#1)(2008-3#1)
the temporal correlation##2##3##(1992-3#1)(2008-3#1)
the temporal cortex##9##3##(1992-5#1)(1993-12#1)(1993-6#1)(1994-10#1)(1995-11#1)(1996-12#1)(1997-2#1)(2008-9#1)(2010-3#1)
the temporal course of##2##4##(1996-7#1)(2009-8#1)
the temporal data##2##3##(2007-12#2)
the temporal decay##3##3##(2007-11#1)(2007-8#1)(2008-3#1)
the temporal distribution of##3##4##(2008-2#1)(2008-8#1)(2008-9#1)
the temporal dynamics of##5##4##(2008-10#3)(2008-8#1)(2009-8#1)
the temporal dynamics##6##3##(1995-12#1)(2008-10#3)(2008-8#1)(2009-8#1)
the temporal evolution of the##7##5##(2007-12#2)(2008-10#1)(2008-2#4)
the temporal evolution of##11##4##(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#1)(2008-4#1)
the temporal expression##4##3##(2008-10#1)(2012-3#1)(2013-1#2)
the temporal features of##2##4##(1993-2#1)(1996-7#1)
the temporal frequency##2##3##(2007-12#2)
the temporal instability##2##3##(2007-12#1)(2008-9#1)
the temporal lobe##16##3##(1991-12#1)(1991-3#3)(1993-9#1)(1994-2#1)(1995-12#1)(1996-7#1)(1996-9#1)(2007-12#1)(2007-9#1)(2008-4#1)(2008-7#1)(2011-2#2)(2012-2#1)
the temporal lobes##2##3##(1995-12#1)(1996-7#1)
the temporal muscle##3##3##(1991-11#2)(2008-9#1)
the temporal organization of sleep spindles##2##6##(2009-8#2)
the temporal organization of##3##4##(1995-12#1)(2009-8#2)
the temporal oscillations##2##3##(2007-11#1)(2008-2#1)
the temporal pattern of##2##4##(1992-3#1)(1997-8#1)
the temporal pole##3##3##(1993-9#2)(1996-7#1)
the temporal position of##2##4##(2007-11#1)(2007-12#1)
the temporal position##3##3##(2007-11#1)(2007-12#2)
the temporal profile of the##6##5##(1996-1#1)(2006-3#1)(2008-2#1)(2008-3#2)(2011-1#1)
the temporal profile##8##3##(1996-1#1)(2006-3#1)(2008-2#2)(2008-3#3)(2011-1#1)
the temporal region##4##3##(2008-9#2)(2009-1#1)(2012-12#1)
the temporal relationship between##3##4##(1994-2#1)(1996-3#1)(2006-6#1)
the temporal relationship##4##3##(1990-7#1)(1994-2#1)(1996-3#1)(2006-6#1)
the temporal relationships##2##3##(1995-2#1)(1995-5#1)
the temporal resolution of##3##4##(1995-2#1)(2007-11#1)(2007-12#1)
the temporal resolution##7##3##(1995-2#1)(2007-11#1)(2007-12#2)(2008-3#1)(2008-7#1)(2008-9#1)
the temporal response of##2##4##(2007-12#2)
the temporal response##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
the temporal separation##2##3##(1992-11#1)(2007-12#1)
the temporal sequence of##3##4##(1995-3#1)(2012-12#2)
the temporal sequence##4##3##(1995-3#1)(2012-12#2)(2012-2#1)
the temporal shape##2##3##(2008-2#2)
the temporal turning point##2##4##(1993-1#2)
the temporal variation of##2##4##(2007-3#1)(2013-8#1)
the temporal variation##3##3##(2007-3#1)(2008-9#1)(2013-8#1)
the temporal wavelet transform##2##4##(2008-2#2)
the temporal##268##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-3#4)(1992-11#2)(1992-3#3)(1992-5#1)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#2)(1993-6#1)(1993-9#3)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-7#1)(1994-9#1)(1995-11#2)(1995-12#5)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-7#5)(1996-9#1)(1997-2#3)(1997-5#1)(1997-8#3)(2004-11#1)(2005-5#2)(2006-10#2)(2006-11#1)(2006-12#6)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#5)(2007-10#2)(2007-11#17)(2007-12#31)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#27)(2008-3#18)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#10)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-8#5)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
the temporalis##3##2##(1990-4#1)(2007-12#1)(2008-8#1)
the temporally##5##2##(1991-8#1)(2007-12#1)(2008-11#1)(2008-2#1)(2010-5#1)
the temporary##12##2##(1991-10#1)(1991-8#1)(1992-9#1)(1997-3#1)(2006-10#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-8#1)(2009-11#1)(2009-3#1)
the temporo-basal##2##2##(1991-3#2)
the temporo-parietal##2##2##(2008-11#2)
the temporomandibular joint##10##3##(1993-1#1)(1996-2#1)(2007-12#2)(2007-6#1)(2007-7#1)(2011-12#1)(2012-2#1)(2013-1#2)
the temporomandibular##12##2##(1993-1#1)(1996-2#1)(2007-12#2)(2007-6#1)(2007-7#3)(2011-12#1)(2012-2#1)(2013-1#2)
the temporoparietal and##2##3##(2007-4#1)(2012-12#1)
the ten patients##6##3##(2006-7#1)(2007-11#1)(2007-7#1)(2008-6#1)(2008-7#2)
the ten were##2##3##(1990-2#1)(2007-8#1)
the ten year##2##3##(1992-9#1)(2010-5#1)
the ten##31##2##(1990-11#1)(1990-2#1)(1990-4#1)(1992-8#1)(1992-9#1)(1995-12#1)(1996-2#1)(1997-2#1)(2005-8#1)(2006-12#1)(2006-7#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-2#1)(2010-2#1)(2010-3#1)(2010-5#1)(2012-12#1)(2013-7#1)(2013-8#2)
the ten-year OS rate was##3##5##(1993-1#3)
the ten-year##4##2##(1993-1#3)(2005-9#1)
the tenants##2##2##(1993-1#2)
the tendencies##3##2##(1993-5#2)(2008-12#1)
the tendency for the##2##4##(1994-3#1)(2008-1#1)
the tendency for##7##3##(1992-6#1)(1993-9#1)(1994-3#1)(1997-4#1)(2004-3#1)(2008-1#1)(2012-11#1)
the tendency of a##2##4##(1997-6#1)(2008-7#1)
the tendency of##12##3##(1994-2#1)(1996-8#1)(1997-2#1)(1997-6#2)(2006-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-8#1)
the tendency to form##3##4##(1991-2#2)(2005-11#1)
the tendency to##10##3##(1991-2#2)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-4#1)(2011-2#1)(2012-2#1)
the tendency##33##2##(1991-2#2)(1992-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-8#1)(2004-3#1)(2005-11#1)(2006-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#1)
the tender##2##2##(2006-10#1)(2007-6#1)
the tendinous##3##2##(2007-8#1)(2008-6#1)(2012-12#1)
the tendon of the##4##4##(2007-2#1)(2007-7#1)(2007-8#1)(2008-8#1)
the tendon sheath##2##3##(2006-4#1)(2008-10#1)
the tendon##21##2##(2006-10#1)(2006-3#4)(2006-4#1)(2007-2#2)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#1)(2013-7#5)
the tendons are##2##3##(2008-11#2)
the tendons##7##2##(1990-6#1)(1993-1#1)(2007-7#1)(2008-11#2)(2011-2#1)(2012-1#1)
the tenets of##4##3##(1994-12#1)(2009-2#1)(2010-4#1)(2011-1#1)
the tennis##4##2##(2011-2#3)(2012-1#1)
the tensed volunteer##2##3##(2006-11#2)
the tensile properties of the##3##5##(1991-10#1)(2008-5#1)(2009-7#1)
the tensile properties of##6##4##(1991-10#2)(2008-5#2)(2009-7#2)
the tensile strength of##3##4##(2006-12#1)(2008-5#1)(2008-7#1)
the tensile strength##5##3##(2006-12#2)(2008-5#2)(2008-7#1)
the tensile##22##2##(1991-10#3)(2006-12#3)(2007-4#4)(2008-12#1)(2008-2#1)(2008-5#6)(2008-7#1)(2009-7#3)
the tension between the##2##4##(2005-7#1)(2007-3#1)
the tension between##6##3##(2005-7#1)(2007-10#1)(2007-3#1)(2008-7#1)(2009-5#1)(2010-11#1)
the tension of##3##3##(1991-10#1)(1991-12#1)(2012-3#1)
the tension##19##2##(1990-8#1)(1991-10#1)(1991-12#1)(2005-11#2)(2005-7#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-3#1)(2008-5#2)(2008-7#1)(2009-5#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
the tensions that##3##3##(2005-7#1)(2008-8#1)(2012-3#1)
the tensions##6##2##(2005-7#1)(2008-8#1)(2009-10#2)(2011-2#1)(2012-3#1)
the tensor fasciae##2##3##(2009-3#2)
the tensor##6##2##(2007-11#1)(2008-5#3)(2009-3#2)
the tentative##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
the tenth day##2##3##(2008-12#1)(2011-1#1)
the tenth in a series##2##5##(2008-5#2)
the tenth##8##2##(1996-12#1)(1996-2#1)(2008-12#1)(2008-5#2)(2011-1#1)(2011-2#1)(2012-12#1)
the tentorium cerebelli##2##3##(1997-3#1)(2011-2#1)
the tentorium##4##2##(1991-12#1)(1997-3#1)(2007-12#1)(2011-2#1)
the terahertz##12##2##(2007-11#2)(2007-12#5)(2007-9#1)(2008-2#3)(2012-2#1)
the terahertz-band##2##2##(2013-8#2)
the teratogenic##3##2##(2008-8#1)(2010-2#1)(2013-1#1)
the teratogenicity of##3##3##(1993-12#1)(1993-3#1)(2013-1#1)
the terbium##4##2##(1995-5#1)(2005-4#1)(2008-10#2)
the term &quot##27##3##(1990-11#1)(1990-3#1)(1990-6#1)(1991-12#1)(1992-5#1)(1994-3#1)(1997-2#1)(2005-5#1)(2006-9#2)(2007-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#1)(2013-1#2)(2013-7#1)
the term 'scalp'##2##3##(2008-9#2)
the term that##2##3##(2004-11#1)(2007-12#1)
the term##105##2##(1990-11#2)(1990-2#1)(1990-3#1)(1990-6#1)(1991-12#1)(1992-11#1)(1992-5#1)(1993-2#1)(1993-7#1)(1993-8#3)(1994-3#1)(1996-1#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-11#2)(2005-5#1)(2005-8#5)(2006-10#3)(2006-12#2)(2006-2#2)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#7)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#5)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#1)(2013-1#14)(2013-7#1)(2013-8#2)
the terminal 8-bp##2##3##(1995-8#2)
the terminal alpha-D-galactosyl##2##3##(1991-12#1)(1996-3#1)
the terminal amino group of##2##5##(1990-12#1)(2005-11#1)
the terminal amino##4##3##(1990-12#1)(1991-7#1)(2005-11#1)(2006-10#1)
the terminal branches of the##3##5##(2007-12#1)(2010-12#1)(2012-3#1)
the terminal branches##4##3##(2007-12#1)(2010-12#2)(2012-3#1)
the terminal differentiation of##2##4##(1993-6#1)(1997-4#1)
the terminal differentiation##3##3##(1993-6#1)(1997-4#1)(2008-5#1)
the terminal electron acceptor##3##4##(1990-3#1)(1990-7#1)(1997-6#1)
the terminal electron##4##3##(1990-3#1)(1990-7#1)(1997-6#1)(2006-8#1)
the terminal ends of the ILSs##2##6##(2008-7#2)
the terminal galactose##2##3##(1992-1#1)(1993-11#1)
the terminal globular domain##2##4##(1990-7#1)(1997-4#1)
the terminal ileum##5##3##(1992-5#1)(1996-2#1)(1997-1#1)(2007-8#1)(2008-12#1)
the terminal methyl groups##2##4##(1990-3#1)(1991-5#1)
the terminal patient##2##3##(1993-2#1)(1995-3#1)
the terminal phalanx##2##3##(1990-9#2)
the terminal phase of##4##4##(1992-9#1)(1994-4#1)(1996-11#1)(2010-11#1)
the terminal region of the short##2##6##(2008-7#1)(2012-3#1)
the terminal region of the##3##5##(2008-7#1)(2008-9#1)(2012-3#1)
the terminal rhamnosyl group##2##4##(1996-10#2)
the terminal##133##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#1)(1990-7#2)(1990-9#3)(1991-12#2)(1991-5#2)(1991-7#1)(1991-9#2)(1992-1#2)(1992-12#2)(1992-4#1)(1992-5#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-2#3)(1993-4#1)(1993-6#2)(1994-2#1)(1994-4#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-10#3)(1996-11#4)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#3)(1997-5#1)(1997-6#1)(2005-11#4)(2006-10#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-8#2)(2008-10#8)(2008-11#3)(2008-12#3)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#2)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-5#2)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#4)
the terminally ill##5##3##(1990-10#1)(1990-12#1)(1991-2#1)(1996-2#2)
the terminally##6##2##(1990-10#1)(1990-12#1)(1991-2#1)(1996-2#2)(2008-5#1)
the terminals##3##2##(1991-12#1)(1994-2#1)(1995-11#1)
the terminating electrolyte##2##3##(2008-10#2)
the terminating##3##2##(1997-4#1)(2008-10#2)
the termination of each##2##4##(1994-9#1)(2008-3#1)
the termination of pregnancy##2##4##(2011-1#1)(2011-2#1)
the termination of the##4##4##(1994-12#1)(1996-11#1)(1996-6#1)(2007-8#1)
the termination of##19##3##(1993-2#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-8#1)(2006-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)
the termination##26##2##(1992-11#1)(1992-5#1)(1993-2#1)(1993-4#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2011-1#1)(2011-2#1)
the termini of the##2##4##(1992-6#1)(2013-8#1)
the termini of##4##3##(1990-5#1)(1992-6#1)(1997-8#1)(2013-8#1)
the termini##7##2##(1990-5#1)(1991-8#1)(1992-6#1)(1997-8#1)(2005-11#1)(2006-10#1)(2013-8#1)
the terminology of##4##3##(1990-11#1)(2013-1#2)(2013-7#1)
the terminology##8##2##(1990-11#1)(2005-9#1)(2008-5#1)(2008-7#1)(2010-5#1)(2013-1#2)(2013-7#1)
the terminus region##3##3##(1995-2#3)
the terminus##4##2##(1995-2#3)(1996-10#1)
the termite##8##2##(2007-12#1)(2008-11#6)(2011-2#1)
the termites##2##2##(2011-2#1)(2013-8#1)
the terms &quot##5##3##(2006-8#1)(2009-9#1)(2011-12#1)(2011-2#2)
the terms and##4##3##(2006-8#1)(2010-9#1)(2013-1#2)
the terms in the##2##4##(2008-11#1)(2008-7#1)
the terms in##4##3##(2008-11#1)(2008-7#1)(2013-1#2)
the terms of the##6##4##(1990-10#1)(1993-12#1)(1995-12#1)(1996-1#1)(2005-8#1)(2008-3#1)
the terms of##11##3##(1990-10#1)(1993-12#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-1#1)(2005-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-7#1)
the terms##37##2##(1990-10#1)(1993-12#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-6#1)(2005-8#1)(2006-8#2)(2006-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#3)(2008-8#1)(2009-9#1)(2010-7#2)(2010-9#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#7)
the ternary complex was##3##4##(1996-5#1)(2006-12#1)(2008-10#1)
the ternary complex##21##3##(1991-2#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-5#2)(1996-5#1)(1996-7#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-12#1)(2008-10#3)(2008-3#1)
the ternary complexes##5##3##(1994-9#1)(2008-10#3)(2010-6#1)
the ternary system##5##3##(1990-5#1)(2008-10#3)(2008-3#1)
the ternary##44##2##(1990-5#1)(1991-2#2)(1991-7#2)(1992-9#3)(1993-6#2)(1993-8#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-5#2)(1996-5#1)(1996-7#1)(2005-11#1)(2005-12#1)(2005-4#1)(2006-10#1)(2006-12#1)(2008-10#12)(2008-2#1)(2008-3#2)(2008-6#1)(2009-11#1)(2010-6#1)
the terpenoid##2##2##(2007-1#1)(2008-10#1)
the terrestrial##11##2##(1990-5#1)(1995-3#1)(1995-6#1)(1997-5#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#2)
the territory of the##6##4##(1992-2#1)(1992-7#1)(1995-12#1)(1996-3#1)(2007-9#1)(2008-7#1)
the territory of##13##3##(1990-7#1)(1992-2#1)(1992-7#1)(1995-12#1)(1996-3#1)(2007-9#1)(2008-10#1)(2008-7#2)(2008-8#1)(2011-2#1)(2013-8#2)
the territory##21##2##(1990-7#1)(1992-2#1)(1992-7#1)(1995-12#1)(1996-3#1)(2007-2#1)(2007-9#2)(2008-10#1)(2008-7#2)(2008-8#3)(2010-8#2)(2011-2#3)(2013-8#2)
the terrorist##2##2##(2004-7#1)(2007-3#1)
the tertiary alcohol##2##3##(2008-10#2)
the tertiary and quaternary##2##4##(1997-2#2)
the tertiary and##3##3##(1992-8#1)(1997-2#2)
the tertiary structure as##2##4##(1991-5#1)(2008-6#1)
the tertiary structure of the##11##5##(1990-12#1)(1990-5#1)(1991-1#1)(1991-2#2)(1994-8#1)(1995-1#1)(1996-5#1)(1996-7#1)(2005-11#1)(2008-10#1)
the tertiary structure of##15##4##(1990-12#1)(1990-5#1)(1991-1#1)(1991-2#2)(1992-12#1)(1992-6#1)(1994-8#1)(1995-1#1)(1996-5#1)(1996-7#1)(2005-11#2)(2006-12#1)(2008-10#1)
the tertiary structure##21##3##(1990-12#1)(1990-5#1)(1991-1#1)(1991-2#2)(1991-5#2)(1992-12#1)(1992-6#1)(1992-9#1)(1994-8#1)(1995-1#1)(1996-5#1)(1996-7#1)(1997-4#1)(2005-11#2)(2006-12#1)(2008-10#1)(2008-4#1)(2008-6#1)
the tertiary##38##2##(1990-12#1)(1990-5#1)(1991-1#1)(1991-2#2)(1991-5#3)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#2)(1997-4#1)(2005-11#2)(2005-8#1)(2006-12#1)(2006-4#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-6#1)(2012-2#1)
the tertiles##3##2##(2008-3#3)
the test SNP##5##3##(2012-3#5)
the test agent##2##3##(1997-4#1)(2008-10#1)
the test and control##3##4##(2007-1#1)(2007-7#1)(2011-2#1)
the test and the##3##4##(2008-1#1)(2008-3#2)
the test and##8##3##(2006-11#1)(2007-1#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-3#2)(2011-2#1)
the test animals##3##3##(2010-2#1)(2012-3#1)(2013-7#1)
the test apparatus##3##3##(1990-10#1)(2007-4#1)(2008-4#1)
the test beam##2##3##(2008-3#2)
the test can##2##3##(1996-12#1)(2008-10#1)
the test case##2##3##(1992-3#1)(2008-3#1)
the test compounds##5##3##(1996-5#1)(2008-11#1)(2008-4#2)(2011-1#1)
the test concentration of##2##4##(2005-11#1)(2008-9#1)
the test conditions##4##3##(2006-11#2)(2006-12#1)(2008-7#1)
the test data##2##3##(2008-10#2)
the test did##2##3##(1990-6#1)(2007-2#1)
the test dose##2##3##(1992-2#1)(2008-7#1)
the test for##2##3##(1991-12#1)(2010-12#1)
the test group##4##3##(1994-8#1)(2006-2#1)(2007-7#1)(2008-12#1)
the test groups##2##3##(2008-4#1)(2010-7#1)
the test in##2##3##(2008-10#1)(2008-7#1)
the test is##8##3##(1990-11#1)(1990-4#1)(1997-3#1)(2007-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2012-1#1)
the test material##2##3##(1990-12#1)(2008-11#1)
the test of choice for##2##5##(1990-11#1)(2008-10#1)
the test of choice##3##4##(1990-11#1)(2006-10#1)(2008-10#1)
the test of time##4##4##(2006-9#1)(2007-9#1)(2008-1#1)(2008-2#1)
the test of##16##3##(1990-11#1)(1992-6#1)(1997-5#1)(2006-10#2)(2006-9#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
the test organisms##2##3##(2004-4#1)(2008-5#1)
the test period##4##3##(1996-4#1)(1997-5#1)(2008-10#1)(2011-1#1)
the test plant##2##3##(2004-2#1)(2011-12#1)
the test population##3##3##(1997-5#1)(2008-3#1)(2012-1#1)
the test procedure##5##3##(2007-2#1)(2013-1#4)
the test response##2##3##(1997-5#2)
the test results##8##3##(2006-11#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2013-1#1)(2013-8#1)
the test sample##13##3##(1992-2#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-9#1)(2011-1#4)
the test samples##9##3##(1990-12#1)(1996-8#1)(2006-5#1)(2007-12#1)(2008-10#4)(2008-4#1)
the test section and##2##4##(2008-2#1)(2008-3#1)
the test section##5##3##(2008-2#2)(2008-3#3)
the test set##5##3##(2008-10#2)(2008-6#1)(2010-12#1)(2010-2#1)
the test site##2##3##(2008-10#1)(2008-5#1)
the test sites##4##3##(1992-6#3)(2007-1#1)
the test solution##4##3##(2008-10#3)(2008-5#1)
the test solutions##3##3##(2008-10#3)
the test statistic##5##3##(1992-9#1)(1995-9#1)(1997-2#1)(2010-2#1)(2012-1#1)
the test statistics##3##3##(1995-2#1)(2012-3#2)
the test strains##2##3##(1993-11#2)
the test subject##2##3##(1997-5#2)
the test subject's##2##3##(1997-5#2)
the test subjects##2##3##(2007-1#1)(2008-5#1)
the test substance##6##3##(2005-10#5)(2008-10#1)
the test substrate##2##3##(2008-11#1)(2010-9#1)
the test surface##2##3##(2008-2#2)
the test system##5##3##(1992-9#1)(1997-2#1)(2008-10#1)(2008-11#1)(2010-12#1)
the test to##3##3##(1996-12#1)(1996-3#1)(1997-2#1)
the test using##3##3##(2008-11#1)(2008-12#1)(2012-12#1)
the test was##6##3##(1996-12#1)(2006-10#1)(2006-7#1)(2008-2#1)(2012-2#1)(2013-7#1)
the test were##2##3##(1991-12#1)(2012-12#1)
the test with the##3##4##(1993-6#1)(1996-3#1)(2008-11#1)
the test with##7##3##(1990-4#1)(1992-9#1)(1993-6#1)(1996-12#1)(1996-3#1)(2008-11#1)(2012-3#1)
the test word##3##3##(2008-10#3)
the test##361##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-4#2)(1990-6#2)(1990-7#1)(1991-12#4)(1991-3#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-2#3)(1992-3#2)(1992-6#4)(1992-7#2)(1992-9#4)(1993-11#3)(1993-6#2)(1993-7#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#4)(1996-3#2)(1996-4#1)(1996-5#5)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#9)(2004-12#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-10#5)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-11#6)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#4)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#4)(2007-10#1)(2007-12#4)(2007-2#2)(2007-4#4)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#53)(2008-11#9)(2008-12#3)(2008-2#14)(2008-3#20)(2008-4#10)(2008-5#16)(2008-6#2)(2008-7#6)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#1)(2010-12#3)(2010-2#5)(2010-4#2)(2010-7#2)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#6)(2012-1#4)(2012-12#7)(2012-2#4)(2012-3#13)(2013-1#9)(2013-7#2)(2013-8#4)
the test's##4##2##(1996-5#1)(1997-3#1)(2004-12#1)(2009-12#1)
the test-EPSP was##2##3##(1997-5#2)
the test-retest##2##2##(2007-12#1)(2008-6#1)
the tested bacterial##2##3##(2010-3#1)(2012-3#1)
the tested compounds##15##3##(1995-12#1)(1997-1#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#2)(2009-6#2)(2011-2#1)(2012-11#2)(2012-3#1)
the tested concentrations##3##3##(2008-11#2)(2008-7#1)
the tested isolates##3##3##(2006-4#1)(2008-10#1)(2012-2#1)
the tested microorganisms##2##3##(2008-11#1)(2010-5#1)
the tested range##3##3##(2007-10#1)(2007-8#1)(2008-10#1)
the tested sample##2##3##(2008-10#2)
the tested samples##3##3##(1997-4#1)(2008-10#2)
the tested species were##2##4##(1997-1#1)(2012-2#1)
the tested species##4##3##(1997-1#3)(2012-2#1)
the tested substances##3##3##(2008-10#1)(2008-5#1)(2009-6#1)
the tested##107##2##(1990-8#1)(1991-5#1)(1992-10#1)(1994-3#1)(1995-12#2)(1995-5#1)(1996-4#1)(1996-7#1)(1997-1#4)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-10#21)(2008-11#8)(2008-12#4)(2008-2#3)(2008-3#2)(2008-5#7)(2008-7#3)(2008-8#1)(2009-6#4)(2009-7#1)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-11#2)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#2)
the tester strains##3##3##(2008-10#1)(2008-12#1)(2011-1#1)
the tester##5##2##(2008-10#2)(2008-12#1)(2008-2#1)(2011-1#1)
the testes and the##2##4##(1990-7#1)(2008-7#1)
the testes and##5##3##(1990-2#1)(1990-7#1)(2006-7#1)(2008-5#1)(2008-7#1)
the testes of##8##3##(1994-8#2)(1996-8#1)(1997-1#1)(2008-4#1)(2008-5#2)(2008-7#1)
the testes##30##2##(1990-2#1)(1990-7#1)(1992-5#1)(1994-8#2)(1996-8#1)(1997-1#1)(1997-6#1)(2006-5#1)(2006-7#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#4)(2008-9#1)(2009-10#6)(2012-1#1)
the testicle##3##2##(2006-10#2)(2008-10#1)
the testicles##2##2##(2008-10#2)
the testicular##11##2##(1993-2#1)(1995-11#1)(1996-5#1)(2008-10#1)(2008-3#1)(2009-11#1)(2009-5#1)(2010-4#1)(2010-5#1)(2012-1#1)(2013-8#1)
the testimony##4##2##(1994-2#1)(1996-2#1)(2007-4#1)(2011-2#1)
the testing methodologies##2##3##(2008-10#1)(2012-12#1)
the testing of a##2##4##(2008-10#1)(2010-2#1)
the testing of mouse##2##4##(2008-4#2)
the testing of##28##3##(1993-3#1)(1993-9#1)(1995-9#1)(2006-10#1)(2006-11#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#2)(2009-3#1)(2010-2#1)(2012-12#1)(2012-2#1)
the testing##59##2##(1990-11#1)(1990-12#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-2#1)(1994-3#2)(1995-9#1)(1996-11#1)(1996-6#1)(2004-12#1)(2006-10#1)(2006-11#4)(2006-7#1)(2006-8#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#3)(2008-7#2)(2009-11#1)(2009-3#1)(2010-2#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-8#1)
the testis and in##2##4##(1995-10#1)(2012-2#1)
the testis and ovary##2##4##(1995-5#1)(2008-7#1)
the testis and##11##3##(1991-1#1)(1992-12#1)(1994-3#1)(1995-10#1)(1995-5#1)(2008-10#2)(2008-7#1)(2010-12#1)(2012-2#2)
the testis are##2##3##(2008-4#1)(2012-2#1)
the testis determining##3##3##(1994-11#1)(1995-11#2)
the testis during##3##3##(2007-9#2)(2008-11#1)
the testis is a##5##4##(1992-12#1)(2007-8#1)(2011-2#1)(2012-2#2)
the testis is an##2##4##(2007-6#1)(2009-10#1)
the testis is##11##3##(1992-12#1)(2006-10#1)(2007-6#1)(2007-8#1)(2009-10#2)(2011-2#1)(2012-2#4)
the testis was##5##3##(1992-12#1)(2006-7#1)(2008-9#1)(2011-2#2)
the testis##108##2##(1990-11#1)(1991-1#2)(1991-2#1)(1991-6#1)(1991-9#1)(1992-12#4)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-4#1)(1995-10#1)(1995-11#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#1)(1997-3#1)(2005-8#1)(2006-10#3)(2006-7#1)(2007-3#1)(2007-5#2)(2007-6#4)(2007-8#1)(2007-9#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-9#3)(2009-10#8)(2009-11#1)(2009-9#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-2#4)(2012-12#5)(2012-2#22)(2013-7#1)(2013-8#2)
the testis-determining factor##2##3##(1990-11#1)(1991-11#1)
the testis-determining gene##2##3##(1991-11#1)(1995-11#1)
the testis-determining##5##2##(1990-11#1)(1991-11#2)(1995-11#2)
the testis-specific##2##2##(1992-8#1)(2012-12#1)
the testosterone displacement##3##3##(2008-10#3)
the testosterone##4##2##(1995-2#1)(2008-10#3)
the tests conducted##2##3##(2006-11#1)(2008-3#1)
the tests is##2##3##(2007-4#1)(2008-10#1)
the tests of##5##3##(2006-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)
the tests performed##2##3##(2006-11#1)(2012-12#1)
the tests to##3##3##(1996-6#1)(2006-6#1)(2007-4#1)
the tests using##2##3##(2008-10#1)(2012-12#1)
the tests was##2##3##(1992-11#1)(2007-11#1)
the tests were##4##3##(1990-10#1)(2006-11#1)(2008-5#1)(2011-1#1)
the tests which##2##3##(2011-2#1)(2013-8#1)
the tests##59##2##(1990-10#1)(1990-3#1)(1990-9#1)(1992-11#1)(1995-4#2)(1996-1#2)(1996-6#1)(1997-2#2)(2004-9#1)(2005-8#1)(2006-10#1)(2006-11#4)(2006-6#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#3)(2007-7#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#1)(2008-9#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
the tet gene##3##3##(1990-9#2)(1996-2#1)
the tet##5##2##(1990-9#2)(1994-12#1)(1994-7#1)(1996-2#1)
the tet(K)##3##2##(1995-5#1)(1997-7#2)
the tetanic##2##2##(1991-12#1)(1997-5#1)
the tetanus toxoid##3##3##(1995-5#2)(2008-4#1)
the tetanus##4##2##(1995-5#3)(2008-4#1)
the tether##3##2##(1995-1#1)(1996-5#1)(2012-1#1)
the tethered##2##2##(2008-5#1)(2012-3#1)
the tetracycline antibiotics##2##3##(2008-10#2)
the tetracycline##7##2##(1994-12#1)(1997-7#1)(2008-10#3)(2008-11#1)(2011-1#1)
the tetracycline-inducible##2##2##(2008-11#1)(2009-10#1)
the tetragonal lysozyme crystal##2##4##(2006-10#2)
the tetragonal##4##2##(1996-2#1)(2006-10#2)(2008-10#1)
the tetrahedra##2##2##(2005-11#1)(2011-2#1)
the tetraheme cytochrome subunit##2##4##(1993-8#2)
the tetraheme cytochrome##4##3##(1993-8#2)(1994-5#1)(1994-8#1)
the tetrahydro-beta-carboline##2##2##(2006-12#2)
the tetrahydropyridine##3##2##(1992-11#1)(1996-12#1)(2007-11#1)
the tetramer##15##2##(1990-12#1)(1990-4#1)(1991-4#1)(1992-8#1)(1993-4#1)(1993-9#1)(1994-11#2)(1996-11#1)(1997-4#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-9#2)
the tetrameric Adair##2##3##(1990-8#2)
the tetrameric enzyme##2##3##(1993-7#1)(1994-11#1)
the tetrameric##10##2##(1990-2#1)(1990-8#2)(1992-3#1)(1993-7#1)(1994-11#1)(1995-12#1)(1996-2#1)(2008-10#1)(2008-8#1)
the tetramerization mechanism##2##3##(1993-8#2)
the tetramerization##3##2##(1993-8#3)
the tetramers##2##2##(1990-8#1)(1997-1#1)
the tetrangle inequality##2##3##(2007-9#2)
the tetrangle##4##2##(2007-9#4)
the tetrapeptide##12##2##(1990-11#1)(1990-6#1)(1990-7#1)(1991-5#2)(1992-9#1)(1993-9#1)(1994-5#1)(1997-3#2)(2006-12#2)
the tetraploid##9##2##(2006-12#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2009-9#1)(2011-12#1)
the tetraploids##2##2##(2008-5#2)
the tetraspanin##2##2##(2009-8#2)
the tetratricopeptide repeat##2##3##(1995-3#1)(1996-2#1)
the tetrazolium salt##2##3##(1992-6#1)(2012-2#1)
the text of##5##3##(1991-10#1)(2005-7#1)(2007-5#1)(2011-1#1)(2011-2#1)
the text##23##2##(1991-10#1)(1992-2#1)(1995-11#1)(1996-1#1)(2005-7#1)(2006-3#1)(2007-5#3)(2008-1#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
the textile##6##2##(2005-10#1)(2008-1#2)(2008-5#2)(2010-8#1)
the textiles##2##2##(1995-5#1)(2010-5#1)
the texts##2##2##(2007-5#1)(2010-7#1)
the textual##2##2##(2011-1#1)(2012-2#1)
the textural##5##2##(2005-11#2)(2007-3#1)(2008-5#1)(2008-6#1)
the texture##6##2##(1996-12#1)(2006-4#1)(2008-2#2)(2011-1#1)(2013-8#1)
the thalamic##10##2##(1991-5#1)(1993-12#1)(1994-6#1)(1996-1#1)(1997-2#2)(1997-5#1)(1997-8#1)(2008-1#1)(2010-1#1)
the thalamo-cortical##2##2##(1991-3#1)(2008-11#1)
the thalamocortical##3##2##(1991-5#1)(1994-5#1)(2008-1#1)
the thalamus and basal ganglia##2##5##(2008-7#1)(2009-6#1)
the thalamus and hypothalamus##2##4##(1997-5#2)
the thalamus and##9##3##(1995-11#1)(1996-7#2)(1997-3#1)(1997-5#2)(2008-1#1)(2008-7#1)(2009-6#1)
the thalamus of the rat following##2##6##(1996-1#2)
the thalamus of the##3##4##(1993-2#1)(1996-1#2)
the thalamus of##4##3##(1993-2#1)(1993-4#1)(1996-1#2)
the thalamus##39##2##(1991-5#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#2)(1993-2#2)(1993-4#1)(1993-7#1)(1994-2#1)(1995-11#2)(1995-5#1)(1996-1#4)(1996-12#1)(1996-7#3)(1996-9#1)(1997-3#2)(1997-5#2)(2006-4#1)(2007-1#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-6#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)
the thallium##3##2##(1996-2#2)(2008-10#1)
the thawing##4##2##(2006-8#1)(2008-10#2)(2010-4#1)
the the##22##2##(1990-5#1)(1990-7#1)(1991-12#1)(1993-12#1)(1993-2#1)(1995-6#1)(1995-9#1)(1996-9#1)(1997-6#1)(1997-7#1)(2005-7#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-4#2)(2008-7#1)(2010-2#1)(2011-12#1)(2013-7#1)(2013-8#1)
the theca interna##2##3##(1995-12#2)
the theca##4##2##(1995-12#2)(2008-12#1)(2008-8#1)
the theca-interstitial cells##2##3##(2008-5#2)
the theca-interstitial##3##2##(2008-5#3)
the thecal sac##2##3##(2006-8#2)
the thecogen cell##3##3##(2007-12#3)
the their##2##2##(1997-3#1)(2007-12#1)
the thematic##3##2##(2008-5#1)(2011-2#1)(2012-2#1)
the theme of the##2##4##(2008-11#1)(2009-10#1)
the theme of##6##3##(2006-12#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-4#1)(2011-2#1)
the theme##14##2##(1996-1#2)(2006-12#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#1)(2011-2#4)(2012-2#1)
the themes identified##2##3##(2008-11#2)
the themes of##3##3##(2005-8#1)(2007-8#1)(2010-9#1)
the themes that were##2##4##(2008-11#1)(2012-12#1)
the themes that##5##3##(1995-12#1)(2007-11#1)(2008-11#1)(2008-12#1)(2012-12#1)
the themes##11##2##(1995-12#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#3)(2008-12#1)(2010-9#1)(2012-12#1)
the then##7##2##(2007-7#1)(2008-1#1)(2008-10#1)(2009-2#1)(2011-1#1)(2012-12#2)
the thenar##3##2##(2006-3#1)(2008-5#1)(2009-1#1)
the theological##2##2##(2008-4#1)(2013-1#1)
the theorems##3##2##(1990-7#2)(2010-3#1)
the theoretic##3##2##(2005-4#1)(2008-10#1)(2008-2#1)
the theoretical accuracy##2##3##(2005-11#1)(2008-2#1)
the theoretical advantages of##2##4##(2008-1#1)(2008-3#1)
the theoretical analyses##3##3##(2008-3#2)(2010-2#1)
the theoretical analysis and the##2##5##(2008-2#1)(2013-7#1)
the theoretical analysis and##4##4##(2008-2#1)(2008-3#2)(2013-7#1)
the theoretical analysis##11##3##(2007-11#1)(2008-2#4)(2008-3#4)(2013-7#1)(2013-8#1)
the theoretical and empirical##3##4##(1993-3#1)(1996-6#1)(2008-7#1)
the theoretical and experimental results##3##5##(2007-11#2)(2008-10#1)
the theoretical and experimental##6##4##(1996-11#1)(1997-2#1)(2007-11#3)(2008-10#1)
the theoretical and practical##3##4##(1997-4#1)(2008-9#1)(2010-8#1)
the theoretical and##16##3##(1993-3#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-4#1)(2007-11#4)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-8#1)(2011-2#1)
the theoretical approaches##2##3##(2004-12#1)(2006-10#1)
the theoretical basis##4##3##(2006-12#1)(2007-8#1)(2013-7#1)(2013-8#1)
the theoretical calculations##3##3##(1993-9#1)(2008-2#1)(2008-3#1)
the theoretical concepts##2##3##(2008-7#1)(2011-2#1)
the theoretical construction of##2##4##(1991-6#1)(2008-3#1)
the theoretical description##2##3##(2008-1#1)(2008-3#1)
the theoretical design##3##3##(2008-3#3)
the theoretical development##2##3##(2007-4#1)(2009-12#1)
the theoretical expressions##2##3##(2008-2#1)(2010-2#1)
the theoretical findings##2##3##(2008-3#1)(2013-8#1)
the theoretical framework for##2##4##(2008-4#1)(2009-4#1)
the theoretical framework of##3##4##(2008-4#1)(2009-11#1)(2011-2#1)
the theoretical framework##9##3##(2008-12#1)(2008-4#2)(2008-7#1)(2009-11#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-1#1)
the theoretical frameworks##3##3##(2008-12#1)(2012-2#1)(2013-7#1)
the theoretical knowledge of holistic care##2##6##(2008-11#2)
the theoretical knowledge##4##3##(2008-11#3)(2011-2#1)
the theoretical limit for##2##4##(1996-8#1)(2008-2#1)
the theoretical limit##4##3##(1996-8#1)(2007-12#2)(2008-2#1)
the theoretical maximum##4##3##(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#1)
the theoretical minimum##2##3##(1995-4#1)(2008-3#1)
the theoretical model##6##3##(2005-11#1)(2008-3#2)(2010-2#1)(2013-8#2)
the theoretical models##2##3##(2008-2#2)
the theoretical performance##2##3##(2008-2#1)(2008-3#1)
the theoretical prediction##16##3##(1996-11#1)(2005-11#1)(2007-11#2)(2007-12#4)(2008-2#3)(2008-3#4)(2012-3#1)
the theoretical predictions##10##3##(1992-6#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-5#1)(2010-2#1)
the theoretical properties of##2##4##(2010-1#1)(2012-3#1)
the theoretical resolution##2##3##(2008-2#1)(2008-3#1)
the theoretical results from##2##4##(2008-2#1)(2008-9#1)
the theoretical results##13##3##(2006-10#1)(2007-11#1)(2008-2#4)(2008-3#2)(2008-8#1)(2008-9#2)(2010-2#1)(2010-5#1)
the theoretical treatment##3##3##(2005-11#1)(2008-2#2)
the theoretical underpinnings of the approach and##2##7##(1996-1#1)(1996-2#1)
the theoretical underpinnings of##3##4##(1991-12#1)(1996-1#1)(1996-2#1)
the theoretical underpinnings##4##3##(1991-12#1)(1996-1#1)(1996-2#1)(2009-6#1)
the theoretical value of##2##4##(1996-2#1)(2008-3#1)
the theoretical value##5##3##(1994-3#1)(1996-2#1)(2007-12#1)(2008-3#2)
the theoretical values##6##3##(1990-6#1)(2008-10#1)(2008-2#2)(2008-9#2)
the theoretical##240##2##(1990-5#1)(1990-6#1)(1991-10#1)(1991-12#2)(1991-6#2)(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-3#1)(1995-3#1)(1995-4#1)(1996-1#1)(1996-11#3)(1996-2#3)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-12#1)(2004-8#1)(2005-11#6)(2005-4#1)(2006-10#3)(2006-12#2)(2007-10#1)(2007-11#9)(2007-12#15)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#12)(2008-11#6)(2008-12#2)(2008-2#34)(2008-3#38)(2008-4#2)(2008-5#4)(2008-6#5)(2008-7#6)(2008-8#2)(2008-9#8)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2010-1#2)(2010-11#1)(2010-2#5)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#3)(2013-8#6)
the theoretically expected##4##3##(1997-3#1)(2008-10#1)(2008-2#2)
the theoretically##10##2##(1995-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#2)(2012-12#1)
the theories and##2##3##(2010-1#1)(2012-3#1)
the theories of##6##3##(1993-2#1)(1993-6#1)(2008-2#1)(2010-10#1)(2013-1#2)
the theories##11##2##(1993-2#1)(1993-6#1)(1997-6#1)(2008-2#1)(2008-4#1)(2009-4#1)(2010-1#1)(2010-10#1)(2012-3#1)(2013-1#2)
the theory and practice of##2##5##(1995-1#1)(1997-3#1)
the theory and present##2##4##(2008-2#2)
the theory and show the utility of the##2##8##(2008-3#2)
the theory and the experiment##3##5##(2008-3#3)
the theory and the experimental results##2##6##(1990-12#1)(2008-2#1)
the theory and the##5##4##(1990-12#1)(2008-2#1)(2008-3#3)
the theory and##18##3##(1990-12#1)(1994-6#1)(1995-1#1)(1997-3#1)(2005-6#1)(2007-4#1)(2008-2#4)(2008-3#6)(2008-8#1)(2012-3#1)
the theory behind the##2##4##(2010-6#1)(2013-8#1)
the theory behind##3##3##(2007-11#1)(2010-6#1)(2013-8#1)
the theory by##3##3##(2008-2#2)(2008-3#1)
the theory developed by##2##4##(2005-11#2)
the theory developed##6##3##(2005-11#2)(2006-4#1)(2007-10#1)(2008-3#1)(2008-8#1)
the theory has##3##3##(1992-8#1)(2008-11#1)(2010-2#1)
the theory in##2##3##(2008-3#1)(2009-5#1)
the theory is##4##3##(1991-1#1)(2007-12#1)(2008-2#1)(2008-3#1)
the theory of evolution##3##4##(2009-2#2)(2012-2#1)
the theory of nonlinear dynamical systems##2##6##(1993-9#1)(2009-8#1)
the theory of the##3##4##(2008-3#1)(2011-2#1)(2012-3#1)
the theory of##63##3##(1990-3#1)(1990-8#1)(1991-3#1)(1992-8#1)(1993-9#1)(1996-4#1)(2005-11#2)(2005-4#2)(2006-10#2)(2006-12#2)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#4)(2008-3#8)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#3)
the theory that a##2##4##(2007-12#1)(2010-4#1)
the theory that creativity is a##2##6##(1995-1#2)
the theory that the##3##4##(1992-4#1)(1994-4#1)(2007-6#1)
the theory that##24##3##(1991-11#1)(1992-4#1)(1994-4#1)(1995-1#2)(2004-2#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-6#3)(2007-9#1)(2008-1#2)(2008-7#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-12#1)
the theory to##5##3##(1991-6#1)(2007-12#2)(2007-8#1)(2008-8#1)
the theory##177##2##(1990-11#1)(1990-12#1)(1990-3#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-4#1)(1992-6#1)(1992-8#2)(1993-9#1)(1994-4#1)(1994-6#2)(1995-1#3)(1995-2#1)(1995-8#1)(1996-4#1)(1997-2#1)(1997-3#1)(2004-2#1)(2005-11#8)(2005-4#2)(2005-6#1)(2006-10#2)(2006-12#3)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#6)(2007-12#9)(2007-4#1)(2007-6#3)(2007-8#2)(2007-9#2)(2008-1#6)(2008-10#7)(2008-11#3)(2008-2#15)(2008-3#22)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#3)(2009-10#1)(2009-2#4)(2009-3#2)(2009-4#3)(2009-5#2)(2009-7#3)(2009-8#2)(2010-1#2)(2010-2#2)(2010-4#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#4)
the theory-practice gap##7##3##(2008-11#7)
the theory-practice##8##2##(2008-11#7)(2012-3#1)
the therapeutic action of##2##4##(1994-8#1)(2012-1#1)
the therapeutic administration of##2##4##(1991-12#1)(1992-2#1)
the therapeutic application of##2##4##(2007-10#1)(2010-3#1)
the therapeutic applications of##2##4##(2010-5#1)(2013-1#1)
the therapeutic applications##3##3##(2008-5#1)(2010-5#1)(2013-1#1)
the therapeutic approach is##2##4##(1990-12#2)
the therapeutic approach to##3##4##(1990-3#1)(1996-9#1)(2008-1#1)
the therapeutic approach##8##3##(1990-12#2)(1990-3#1)(1991-6#1)(1996-9#1)(1997-7#1)(2008-1#1)(2008-10#1)
the therapeutic arena##2##3##(2006-10#1)(2011-2#1)
the therapeutic armamentarium##6##3##(1990-1#1)(1990-12#1)(2008-7#1)(2009-11#1)(2010-11#1)(2012-12#1)
the therapeutic arsenal##2##3##(1990-5#1)(2009-9#1)
the therapeutic benefit of##3##4##(2007-11#1)(2008-2#1)(2012-1#1)
the therapeutic benefit##5##3##(1994-3#1)(2007-11#1)(2008-2#1)(2012-1#2)
the therapeutic consequences##2##3##(1990-11#1)(2005-11#1)
the therapeutic decision-making process##2##4##(1992-2#1)(2009-9#1)
the therapeutic effect of nicotine##2##5##(1994-10#2)
the therapeutic effect of##11##4##(1994-10#2)(1994-11#1)(1994-9#1)(2006-4#1)(2007-2#1)(2008-3#1)(2012-1#1)(2012-2#3)
the therapeutic effect##13##3##(1991-3#1)(1994-10#2)(1994-11#1)(1994-9#1)(1997-4#1)(2006-4#1)(2007-2#1)(2008-3#1)(2012-1#1)(2012-2#3)
the therapeutic effectiveness of##3##4##(1992-6#1)(1996-12#1)(2006-8#1)
the therapeutic effects of the##2##5##(2006-6#1)(2013-1#1)
the therapeutic effects of##11##4##(1996-1#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-7#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#2)(2013-1#1)
the therapeutic effects on##2##4##(2010-12#1)(2013-1#1)
the therapeutic effects##13##3##(1996-1#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-7#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#2)(2013-1#2)
the therapeutic efficacy and##2##4##(1990-3#1)(2013-1#1)
the therapeutic efficacy of the##2##5##(2006-2#1)(2012-12#1)
the therapeutic efficacy of these drugs in##2##7##(1991-8#1)(2005-7#1)
the therapeutic efficacy of##12##4##(1990-1#1)(1991-8#1)(1995-6#1)(2005-7#1)(2006-10#2)(2006-2#1)(2009-10#2)(2011-2#1)(2012-12#1)(2013-1#1)
the therapeutic efficacy##14##3##(1990-1#1)(1990-3#1)(1991-8#1)(1995-6#1)(2005-7#1)(2006-10#2)(2006-2#1)(2009-10#2)(2011-2#1)(2012-12#1)(2013-1#2)
the therapeutic gene##3##3##(2006-6#1)(2008-11#1)(2008-5#1)
the therapeutic goal##2##3##(2008-12#1)(2011-1#1)
the therapeutic implications##3##3##(2008-5#1)(2008-7#1)(2012-12#1)
the therapeutic index of##3##4##(1995-5#1)(2005-8#1)(2007-3#1)
the therapeutic index##6##3##(1995-5#1)(1995-6#1)(1997-1#1)(2005-11#1)(2005-8#1)(2007-3#1)
the therapeutic indications##2##3##(2007-5#2)
the therapeutic intervention##2##3##(2010-12#1)(2012-12#1)
the therapeutic interventions##2##3##(2006-10#1)(2008-10#1)
the therapeutic management of##5##4##(1997-6#1)(2005-8#1)(2007-11#1)(2008-3#1)(2012-2#1)
the therapeutic management##6##3##(1997-6#1)(2005-8#1)(2007-11#1)(2008-3#1)(2010-9#1)(2012-2#1)
the therapeutic milieu and##2##4##(1993-2#1)(2010-5#1)
the therapeutic milieu##3##3##(1993-2#2)(2010-5#1)
the therapeutic needs##2##3##(1992-3#1)(2008-12#1)
the therapeutic one##2##3##(2008-10#1)(2008-8#1)
the therapeutic options available for the treatment of##2##8##(2005-6#1)(2005-7#1)
the therapeutic options available for the##3##6##(2005-6#1)(2005-7#1)(2008-11#1)
the therapeutic options available for##4##5##(2005-6#1)(2005-7#1)(2008-11#1)(2010-12#1)
the therapeutic options##12##3##(1993-5#1)(2005-6#1)(2005-7#1)(2006-10#2)(2007-10#1)(2007-11#1)(2008-11#1)(2008-5#1)(2010-12#2)(2010-8#1)
the therapeutic outcome##4##3##(1992-5#1)(2011-2#1)(2012-12#2)
the therapeutic paradigm##2##3##(2007-8#1)(2012-12#1)
the therapeutic potential of##18##4##(1997-7#1)(2005-7#1)(2007-11#2)(2007-6#1)(2008-1#1)(2008-11#2)(2008-8#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-8#1)
the therapeutic protein##4##3##(1996-8#1)(2008-10#1)(2008-5#1)(2012-2#1)
the therapeutic range##9##3##(1992-2#2)(1992-8#1)(1995-2#1)(1996-10#1)(1997-5#2)(2009-4#1)(2010-12#1)
the therapeutic ratio##5##3##(1992-3#1)(1997-1#1)(2005-8#1)(2007-4#1)(2008-10#1)
the therapeutic regimen##4##3##(1994-9#1)(2007-7#1)(2009-1#1)(2012-2#1)
the therapeutic relationship##3##3##(2008-2#1)(2008-3#1)(2011-1#1)
the therapeutic response to##2##4##(2008-10#1)(2009-11#1)
the therapeutic response##5##3##(1991-2#1)(2006-2#1)(2007-7#1)(2008-10#1)(2009-11#1)
the therapeutic role of##4##4##(1993-12#1)(1994-6#1)(2005-3#1)(2013-1#1)
the therapeutic role##5##3##(1993-12#1)(1994-6#1)(2005-3#1)(2006-10#1)(2013-1#1)
the therapeutic spectrum of##2##4##(1991-8#1)(2008-5#1)
the therapeutic strategies of##2##4##(1994-8#1)(2008-5#1)
the therapeutic strategies##3##3##(1994-8#1)(2008-5#1)(2012-3#1)
the therapeutic strategy##3##3##(1992-6#1)(2007-8#1)(2008-4#1)
the therapeutic tools##2##3##(2006-10#1)(2011-2#1)
the therapeutic use of##9##4##(1991-5#1)(1993-12#1)(1994-5#1)(1996-11#1)(2006-12#1)(2007-11#2)(2009-9#1)(2013-8#1)
the therapeutic utility of##2##4##(2005-8#2)
the therapeutic value of##2##4##(1996-9#1)(1997-4#1)
the therapeutic window of##2##4##(2008-3#1)(2010-8#1)
the therapeutic##275##2##(1990-1#2)(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#2)(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-2#4)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#1)(1993-12#2)(1993-2#4)(1993-5#1)(1994-10#2)(1994-11#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#2)(2004-12#1)(2005-10#1)(2005-11#2)(2005-3#1)(2005-6#1)(2005-7#4)(2005-8#5)(2006-10#12)(2006-12#2)(2006-2#3)(2006-4#2)(2006-6#3)(2006-8#1)(2006-9#2)(2007-10#2)(2007-11#9)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#3)(2007-8#4)(2008-1#6)(2008-10#7)(2008-11#6)(2008-12#2)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#10)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-1#1)(2009-10#2)(2009-11#2)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#4)(2010-11#1)(2010-12#7)(2010-3#2)(2010-5#3)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#6)(2012-1#6)(2012-11#1)(2012-12#11)(2012-2#10)(2012-3#2)(2013-1#9)(2013-8#4)
the therapeutical##4##2##(1990-5#1)(1995-12#1)(2008-8#1)(2012-7#1)
the therapeutics##4##2##(2008-10#3)(2011-2#1)
the therapies for##2##3##(2009-9#1)(2012-2#1)
the therapies##5##2##(2006-3#1)(2007-8#1)(2009-9#1)(2010-7#1)(2012-2#1)
the therapist and##3##3##(1994-4#1)(2009-6#1)(2009-9#1)
the therapist with##2##3##(1991-2#1)(1991-4#1)
the therapist##22##2##(1991-12#1)(1991-2#1)(1991-4#1)(1994-4#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-10#1)(2008-12#1)(2008-2#1)(2009-6#7)(2009-9#2)(2012-1#1)(2012-2#2)
the therapist's##2##2##(2006-7#1)(2009-3#1)
the therapists##4##2##(1993-5#2)(1996-2#1)(2007-10#1)
the therapy and##3##3##(1993-8#1)(2008-1#1)(2008-5#1)
the therapy as##2##3##(1990-8#1)(2007-7#1)
the therapy has been##2##4##(1994-2#1)(1996-8#1)
the therapy has##4##3##(1994-2#1)(1996-8#1)(2006-10#1)(2008-1#1)
the therapy in##3##3##(2007-7#1)(2007-8#1)(2011-1#1)
the therapy is##5##3##(1991-12#1)(1997-3#1)(2006-2#1)(2006-8#1)(2008-4#1)
the therapy level##2##3##(2007-11#2)
the therapy of cancer##3##4##(1994-5#1)(2007-7#1)(2013-8#1)
the therapy of choice for##2##5##(2005-11#1)(2006-10#1)
the therapy of choice##4##4##(1997-1#1)(2005-11#1)(2006-10#2)
the therapy of patients affected##2##5##(1993-6#1)(2008-1#1)
the therapy of patients with##2##5##(2006-6#2)
the therapy of patients##6##4##(1993-6#1)(2006-6#2)(2008-1#1)(2009-8#1)(2013-7#1)
the therapy of the##5##4##(1992-2#1)(1995-8#1)(2008-1#2)(2012-1#1)
the therapy of##73##3##(1990-2#1)(1990-3#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-2#1)(1993-6#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-8#3)(1996-2#1)(1996-4#1)(1997-1#2)(1997-7#1)(2004-12#1)(2005-11#2)(2005-7#5)(2005-9#1)(2006-10#4)(2006-6#2)(2007-10#1)(2007-11#3)(2007-7#4)(2008-1#5)(2008-10#1)(2008-12#1)(2008-5#4)(2008-7#2)(2008-9#1)(2009-8#2)(2010-2#1)(2011-3#3)(2012-1#2)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
the therapy program##3##3##(1991-2#2)(2007-7#1)
the therapy were##2##3##(1995-9#1)(2012-2#1)
the therapy with##4##3##(1995-10#1)(2005-1#1)(2006-2#1)(2013-8#1)
the therapy##135##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#2)(1993-4#1)(1993-6#1)(1993-8#1)(1994-2#3)(1994-5#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-8#3)(1995-9#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-1#2)(1997-3#1)(1997-7#1)(2004-12#1)(2005-1#1)(2005-11#2)(2005-7#5)(2005-9#1)(2006-10#6)(2006-2#2)(2006-4#1)(2006-6#2)(2006-8#1)(2007-10#2)(2007-11#6)(2007-7#10)(2007-8#2)(2008-1#7)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#5)(2008-7#3)(2008-9#1)(2009-8#4)(2009-9#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#4)(2011-3#3)(2012-1#2)(2012-12#3)(2012-2#3)(2013-1#1)(2013-7#3)(2013-8#3)
the thermal behavior of##3##4##(1994-5#1)(2005-11#1)(2008-9#1)
the thermal conductivities##2##3##(2008-3#2)
the thermal conductivity of##2##4##(2008-3#2)
the thermal damping function##2##4##(2006-4#2)
the thermal decomposition##2##3##(2008-10#1)(2010-7#1)
the thermal degradation##2##3##(2008-10#1)(2008-3#1)
the thermal denaturation of##4##4##(1991-2#2)(1996-11#1)(2008-4#1)
the thermal denaturation temperature##2##4##(1994-9#1)(2007-11#1)
the thermal denaturation##6##3##(1991-2#2)(1994-9#1)(1996-11#1)(2007-11#1)(2008-4#1)
the thermal diffusivity##4##3##(2008-3#4)
the thermal effect in the##2##5##(2008-3#2)
the thermal effect##3##3##(2008-3#3)
the thermal inactivation of the##2##5##(1991-2#1)(2008-10#1)
the thermal inactivation##3##3##(1991-2#2)(2008-10#1)
the thermal infrared##3##3##(2008-3#3)
the thermal lens and the##2##5##(2008-2#1)(2008-3#1)
the thermal lens##11##3##(2007-11#2)(2008-2#4)(2008-3#5)
the thermal loading##3##3##(2007-12#1)(2008-2#2)
the thermal offset##2##3##(2008-3#2)
the thermal phase##3##3##(1994-3#1)(1996-1#1)(2008-10#1)
the thermal processing of##2##4##(2008-5#1)(2011-2#1)
the thermal properties of##2##4##(2008-3#1)(2012-12#1)
the thermal properties##3##3##(2004-9#1)(2008-3#1)(2012-12#1)
the thermal range##3##3##(2004-9#1)(2008-8#2)
the thermal reaction##2##3##(2008-3#1)(2011-12#1)
the thermal stability of the##4##5##(1993-6#1)(2006-10#1)(2007-12#1)(2009-3#1)
the thermal stability of##10##4##(1993-6#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-3#1)(2010-4#1)(2011-1#1)
the thermal stability##11##3##(1993-6#1)(1994-8#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-3#1)(2010-4#1)(2011-1#1)
the thermal stress##3##3##(2006-6#2)(2013-7#1)
the thermal transients##2##3##(2007-12#1)(2008-2#1)
the thermal treatment##2##3##(2005-11#1)(2009-3#1)
the thermal##138##2##(1990-2#1)(1990-3#1)(1990-4#1)(1991-2#4)(1992-5#1)(1992-7#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-10#1)(1996-1#1)(1996-11#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-7#1)(2004-9#2)(2005-11#3)(2006-10#1)(2006-4#3)(2006-6#2)(2007-11#6)(2007-12#6)(2007-6#1)(2007-8#1)(2008-10#8)(2008-2#17)(2008-3#35)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-3#2)(2009-6#2)(2010-4#3)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-6#1)(2013-7#1)(2013-8#1)
the thermal-lens interference##2##3##(2008-3#2)
the thermal-lens##3##2##(2008-10#1)(2008-3#2)
the thermally inactivated enzyme##2##4##(1997-4#2)
the thermally inactivated##3##3##(1997-4#3)
the thermally induced##5##3##(1992-6#1)(2005-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
the thermally##12##2##(1992-6#1)(1994-2#1)(1997-4#3)(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)
the thermistor bolometer dynamic electrothermal module##2##6##(2008-2#2)
the thermo-optic coefficients##2##3##(2007-11#1)(2008-2#1)
the thermo-optic effect##2##3##(2008-3#2)
the thermo-optic##8##2##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#3)
the thermo-optical##2##2##(2007-12#1)(2008-3#1)
the thermoacidophilic archebacterium Sulfolobus acidocaldarius##2##5##(1991-9#2)
the thermoacidophilic##6##2##(1990-12#1)(1990-3#1)(1990-9#1)(1991-9#2)(1997-7#1)
the thermocline##3##2##(1991-11#1)(1993-2#1)(2007-5#1)
the thermodynamic activation parameters of##3##5##(1994-8#2)(2008-10#1)
the thermodynamic activity of##3##4##(1991-11#1)(2008-5#2)
the thermodynamic and##2##3##(1996-5#1)(2008-4#1)
the thermodynamic data##3##3##(2008-10#3)
the thermodynamic driving##2##3##(2005-11#1)(2009-11#1)
the thermodynamic equilibrium##2##3##(2008-10#2)
the thermodynamic limit with##2##4##(2008-2#2)
the thermodynamic limit##4##3##(2008-11#1)(2008-2#2)(2008-3#1)
the thermodynamic parameters (Tm##2##4##(1990-7#2)
the thermodynamic parameters were##2##4##(1993-8#1)(2008-10#1)
the thermodynamic parameters##10##3##(1990-7#2)(1991-4#1)(1993-8#1)(1994-11#1)(1995-5#1)(1997-1#1)(2006-10#1)(2008-10#2)
the thermodynamic properties of the##2##5##(1990-7#1)(1993-3#1)
the thermodynamic properties##3##3##(1990-7#1)(1992-6#1)(1993-3#1)
the thermodynamic quantities##3##3##(2005-11#1)(2008-10#1)(2010-2#1)
the thermodynamic relationships##2##3##(1994-8#1)(1997-6#1)
the thermodynamic results##2##3##(2008-10#1)(2010-2#1)
the thermodynamic stability of the##2##5##(1995-10#1)(2006-10#1)
the thermodynamic stability of##3##4##(1992-4#1)(1995-10#1)(2006-10#1)
the thermodynamic stability##6##3##(1992-4#1)(1995-10#1)(2006-10#2)(2006-6#1)(2007-11#1)
the thermodynamic##69##2##(1990-7#3)(1990-8#2)(1991-11#1)(1991-4#3)(1991-7#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-8#4)(1995-10#1)(1995-5#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-11#4)(2006-10#3)(2006-6#1)(2007-11#1)(2008-10#15)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-8#1)(2009-11#2)(2009-5#1)(2010-2#2)
the thermodynamical molar absorptivity of the##2##6##(2005-4#2)
the thermodynamically##5##2##(1996-2#1)(2008-10#1)(2009-3#1)(2009-9#1)(2012-2#1)
the thermodynamics and dynamics of##2##5##(1992-9#1)(2011-1#1)
the thermodynamics and##3##3##(1992-9#1)(1997-2#1)(2011-1#1)
the thermodynamics of the binding##3##5##(1996-11#2)(2007-8#1)
the thermodynamics of the##5##4##(1991-8#1)(1995-4#1)(1996-11#2)(2007-8#1)
the thermodynamics of##10##3##(1991-4#1)(1991-8#1)(1992-5#1)(1992-9#1)(1995-4#1)(1996-11#3)(2007-8#1)(2008-10#1)
the thermodynamics##14##2##(1991-4#1)(1991-7#1)(1991-8#1)(1992-5#1)(1992-9#2)(1995-4#1)(1996-11#3)(1997-2#1)(2007-8#1)(2008-10#1)(2011-1#1)
the thermoelastic response of##2##4##(2007-12#2)
the thermoelastic##3##2##(2007-12#2)(2008-3#1)
the thermogenic##2##2##(1994-2#1)(1995-3#1)
the thermograms##2##2##(1997-7#2)
the thermolabile##2##2##(1994-12#1)(2008-4#1)
the thermolytic##2##2##(2008-10#1)(2008-4#1)
the thermometer##3##2##(1990-8#1)(2008-2#2)
the thermophilic bacterium##3##3##(1993-11#1)(1994-12#1)(1996-7#1)
the thermophilic##9##2##(1990-12#1)(1993-11#1)(1994-12#2)(1996-7#3)(1997-7#1)(2006-8#1)
the thermoregulatory effects of##2##4##(1994-2#1)(1997-3#1)
the thermoregulatory##6##2##(1990-2#1)(1994-2#2)(1997-3#1)(2006-10#2)
the thermosensitive##2##2##(1997-2#1)(2007-12#1)
the thermostability of proteins in##2##5##(1991-5#1)(2006-10#1)
the thermostability of##6##3##(1991-5#1)(1995-5#1)(2006-10#1)(2007-12#1)(2008-10#1)(2010-9#1)
the thermostable##4##2##(1991-9#1)(1994-2#1)(1995-8#1)(1997-4#1)
the thermotropic phase behavior of##2##5##(1990-7#1)(2006-10#1)
the thermotropic phase behavior##3##4##(1990-7#2)(2006-10#1)
the thermotropic phase##5##3##(1990-7#2)(2006-10#3)
the thermotropic##9##2##(1990-4#1)(1990-7#2)(1993-7#1)(1994-2#1)(2006-10#3)(2008-5#1)
the thesis is##2##3##(2008-3#1)(2009-2#1)
the thesis that the##3##4##(1991-1#1)(1996-12#1)(2010-2#1)
the thesis that##6##3##(1991-1#1)(1996-12#1)(2007-12#1)(2008-11#1)(2010-2#1)(2012-2#1)
the thesis##14##2##(1991-1#1)(1996-12#1)(2006-7#2)(2007-12#1)(2008-11#1)(2008-3#1)(2008-8#2)(2009-2#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)
the theta parameter of the beta-binomial distribution##2##7##(2008-10#2)
the theta phase coding##2##4##(2008-11#2)
the theta phase##3##3##(2008-11#3)
the theta##9##2##(1994-9#1)(2008-10#2)(2008-11#5)(2012-1#1)
the theta-pulse stimulation with the parameter of##2##7##(2008-9#2)
the thiadiazole##2##2##(1992-10#1)(2007-11#1)
the thiamazole##2##2##(1994-3#2)
the thiamin##2##2##(1990-2#1)(1995-10#1)
the thiamine concentration##2##3##(2008-10#2)
the thiamine##4##2##(1990-9#1)(2008-1#1)(2008-10#2)
the thiazolidine##2##2##(1995-3#1)(2008-10#1)
the thick ascending##2##3##(1990-2#1)(1995-2#1)
the thick##13##2##(1990-2#1)(1991-9#1)(1995-2#1)(1996-11#1)(1997-4#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2010-8#1)(2011-2#1)(2013-7#1)
the thickened##3##2##(2008-5#2)(2011-2#1)
the thickening of##2##3##(2005-3#1)(2008-10#1)
the thickening##3##2##(2005-3#1)(2008-10#1)(2010-10#1)
the thicker the##2##3##(2007-2#1)(2008-5#1)
the thicker##4##2##(2006-6#1)(2007-2#1)(2007-4#1)(2008-5#1)
the thickness and the##7##4##(2008-10#1)(2008-2#1)(2008-3#5)
the thickness and##11##3##(2008-10#2)(2008-2#2)(2008-3#6)(2008-5#1)
the thickness at##2##3##(2008-3#1)(2012-2#1)
the thickness distribution##2##3##(2007-12#1)(2008-7#1)
the thickness of the GaAs crystal##2##6##(2008-2#2)
the thickness of the cuticle##2##5##(2007-5#1)(2008-10#1)
the thickness of the film##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
the thickness of the final##2##5##(2007-11#2)
the thickness of the first layer##4##6##(2008-2#4)
the thickness of the hologram##2##5##(2007-12#1)(2008-3#1)
the thickness of the layer##2##5##(1991-5#1)(2008-3#1)
the thickness of the unstirred layer in the##4##8##(1991-5#4)
the thickness of the unstirred##5##5##(1991-5#5)
the thickness of the##61##4##(1991-5#6)(1994-3#1)(1996-5#1)(2005-1#1)(2005-11#2)(2007-11#4)(2007-12#4)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#12)(2008-3#9)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-2#1)(2012-12#1)(2012-2#3)
the thickness of##85##3##(1990-4#1)(1991-5#6)(1994-11#1)(1994-3#1)(1996-5#1)(2005-1#1)(2005-11#2)(2007-11#4)(2007-12#5)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#9)(2008-11#1)(2008-2#17)(2008-3#14)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#2)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-2#3)(2013-7#1)(2013-8#1)
the thickness or the refractive index##2##6##(2007-12#1)(2008-3#1)
the thickness##122##2##(1990-4#1)(1991-5#6)(1994-11#1)(1994-3#1)(1996-5#1)(2005-1#1)(2005-11#2)(2007-11#6)(2007-12#10)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-10#12)(2008-11#1)(2008-2#26)(2008-3#27)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#2)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-2#4)(2013-7#1)(2013-8#1)
the thicknesses and##2##3##(2008-2#1)(2008-3#1)
the thicknesses of##5##3##(2005-11#2)(2008-3#3)
the thicknesses##7##2##(2005-11#2)(2008-2#1)(2008-3#4)
the thigh and##3##3##(2007-11#1)(2007-6#1)(2012-2#1)
the thigh in##2##3##(2007-11#1)(2009-3#1)
the thigh muscles##3##3##(2008-5#1)(2010-12#2)
the thigh##30##2##(1991-3#2)(1991-6#1)(1993-9#1)(1994-10#1)(1997-3#1)(2006-11#1)(2006-6#1)(2007-11#6)(2007-2#1)(2007-6#1)(2007-7#1)(2008-12#1)(2008-5#2)(2008-6#4)(2009-3#1)(2010-12#2)(2012-1#1)(2012-2#1)(2013-1#1)
the thighs and##2##3##(2006-8#1)(2008-5#1)
the thighs##3##2##(2006-10#1)(2006-8#1)(2008-5#1)
the thin PDMS membrane##2##4##(2008-11#2)
the thin filament##7##3##(1990-12#1)(1996-5#3)(2008-2#1)(2008-6#1)(2010-5#1)
the thin filaments##3##3##(1991-5#1)(1997-4#2)
the thin film##3##3##(2008-10#2)(2008-2#1)
the thin films##7##3##(2007-12#1)(2008-3#4)(2009-4#1)(2010-1#1)
the thin ideal##4##3##(2007-12#4)
the thin layer##2##3##(2008-12#1)(2008-3#1)
the thin##44##2##(1990-12#1)(1991-5#1)(1993-3#1)(1994-2#2)(1996-5#3)(1997-4#2)(2005-11#1)(2007-11#1)(2007-12#8)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#3)(2008-6#1)(2009-11#1)(2009-4#1)(2010-1#1)(2010-5#1)(2011-1#2)
the thin-film##6##2##(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
the thin-layer##2##2##(2008-10#1)(2013-1#1)
the things##2##2##(2004-10#1)(2008-7#1)
the thinking##2##2##(1992-3#1)(2011-1#1)
the thinned##2##2##(1997-3#1)(2006-12#1)
the thinnest##4##2##(2007-12#1)(2008-5#1)(2009-7#1)(2011-1#1)
the thiobarbituric acid method##2##4##(1990-8#1)(1992-11#1)
the thiobarbituric acid##5##3##(1990-8#1)(1991-7#1)(1992-11#1)(1994-3#1)(2008-5#1)
the thiocyanate concentration##2##3##(2008-10#2)
the thiocyanate##7##2##(1995-11#1)(2008-10#6)
the thiocyanato-complexes formed##2##3##(2008-10#2)
the thiocyanato-complexes##3##2##(2008-10#3)
the thiol group##2##3##(1994-8#1)(1995-6#1)
the thiol groups##3##3##(2007-8#1)(2008-10#1)(2011-2#1)
the thiol##12##2##(1990-6#1)(1991-9#2)(1994-8#1)(1995-6#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2011-2#1)
the thiol-activated##2##2##(1992-2#1)(1996-12#1)
the thiolate##2##2##(2008-5#2)
the thiols##4##2##(1993-12#1)(2008-10#3)
the thione##2##2##(2008-5#1)(2010-11#1)
the thiopurine##3##2##(2008-8#1)(2010-12#2)
the thioredoxin##8##2##(1991-4#1)(1992-2#1)(1994-9#2)(1996-2#2)(2009-10#1)(2010-3#1)
the thiourea##4##2##(2005-4#2)(2007-9#2)
the third SH3 domain##2##4##(1997-4#2)
the third amino acid##2##4##(1991-8#1)(1992-8#1)
the third and fourth derivatives##2##5##(2008-10#2)
the third and fourth##13##4##(1990-4#1)(1990-8#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-5#2)(2009-9#1)(2011-1#1)
the third and lateral ventricles##2##5##(2006-5#2)
the third and sixth##2##4##(1996-1#1)(1997-2#1)
the third and##20##3##(1990-4#1)(1990-8#1)(1993-8#1)(1996-1#1)(1997-2#2)(2006-5#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-5#2)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
the third approach##2##3##(1993-4#1)(2008-3#1)
the third axillary##2##3##(2007-12#2)
the third base##2##3##(1993-9#2)
the third brain##2##3##(2007-12#2)
the third case##7##3##(1991-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
the third cause of##4##4##(1991-9#1)(2008-10#1)(2011-1#1)(2013-1#1)
the third chromosome##3##3##(1992-12#1)(1993-5#1)(1996-5#1)
the third completed genome sequence of a member of the##2##10##(2011-2#2)
the third component of complement##2##5##(1992-12#1)(1992-7#1)
the third component of##3##4##(1992-12#1)(1992-7#1)(2009-11#1)
the third component##5##3##(1992-12#1)(1992-7#1)(2008-10#1)(2009-11#1)(2010-4#1)
the third cycle##4##3##(1990-8#1)(2012-12#2)(2013-8#1)
the third day and##2##4##(1997-2#1)(2007-3#1)
the third day of##5##4##(1990-10#1)(1995-3#1)(2005-8#1)(2007-9#1)(2011-12#1)
the third day##10##3##(1990-10#1)(1990-11#1)(1993-12#1)(1995-3#1)(1995-8#1)(1997-2#1)(2005-8#1)(2007-3#1)(2007-9#1)(2011-12#1)
the third decade##2##3##(2007-3#1)(2008-4#1)
the third degree##3##3##(1996-5#1)(2006-7#1)(2011-2#1)
the third dose##5##3##(1991-5#1)(1995-3#2)(2007-2#2)
the third examination##2##3##(2007-8#1)(2010-2#1)
the third exon##2##3##(1992-3#1)(1993-6#1)
the third experiment##4##3##(2007-6#1)(2008-10#3)
the third extraction##2##3##(2008-10#2)
the third generation##3##3##(2007-7#1)(2008-10#2)
the third group were##2##4##(1994-6#1)(2010-12#1)
the third group##16##3##(1991-10#1)(1994-6#1)(2006-5#1)(2006-7#1)(2008-10#1)(2008-4#1)(2008-5#2)(2009-5#2)(2010-12#1)(2010-3#1)(2011-2#2)(2012-11#1)(2012-3#1)
the third harmonic of a##2##5##(2007-11#1)(2007-12#1)
the third harmonic of##4##4##(2007-11#2)(2007-12#2)
the third harmonic##8##3##(2007-11#3)(2007-12#3)(2008-1#1)(2008-3#1)
the third hypervariable##2##3##(1993-8#1)(1995-3#1)
the third in##4##3##(1993-12#1)(1997-5#1)(2005-7#1)(2008-5#1)
the third injection##4##3##(2011-1#1)(2013-1#1)(2013-8#2)
the third instar larvae of transgenic D##2##7##(2013-1#2)
the third instar##4##3##(2005-11#1)(2007-12#1)(2013-1#2)
the third is a##2##4##(1996-4#1)(2012-3#1)
the third is an##2##4##(1997-1#1)(2007-3#1)
the third is##9##3##(1991-11#1)(1996-4#1)(1997-1#1)(1997-7#1)(2007-3#1)(2008-2#1)(2008-7#1)(2008-8#1)(2012-3#1)
the third layer##3##3##(1997-8#1)(2008-12#2)
the third leading cause of death in##2##7##(2006-10#1)(2010-10#1)
the third leading cause of death##5##6##(1996-8#1)(2006-10#1)(2008-10#1)(2010-10#2)
the third leading cause of##8##5##(1996-8#1)(2006-10#1)(2007-7#1)(2008-10#1)(2010-10#2)(2010-12#1)(2013-7#1)
the third leading cause##10##4##(1996-8#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-4#1)(2010-10#2)(2010-12#1)(2013-1#1)(2013-7#1)
the third major##2##3##(1994-3#1)(2012-2#1)
the third member of the##2##5##(1991-5#1)(2008-2#1)
the third member of##3##4##(1991-5#1)(1994-12#1)(2008-2#1)
the third method is##2##4##(2008-2#1)(2008-8#1)
the third method##3##3##(1992-2#1)(2008-2#1)(2008-8#1)
the third molar##4##3##(2007-12#1)(2013-8#3)
the third molars##3##3##(2013-8#3)
the third month of##2##4##(1996-6#1)(2006-9#1)
the third month##5##3##(1996-6#1)(2006-9#1)(2007-11#1)(2011-1#1)(2012-2#1)
the third most common cause of death##2##7##(1991-6#1)(2008-5#1)
the third most common cause of##3##6##(1991-6#1)(2008-5#1)(2012-2#1)
the third most common cause##4##5##(1991-6#1)(1992-5#1)(2008-5#1)(2012-2#1)
the third most common##8##4##(1991-6#1)(1992-5#1)(2007-4#1)(2008-5#1)(2010-11#1)(2010-2#1)(2010-8#1)(2012-2#1)
the third most commonly##3##4##(2008-10#1)(2010-11#1)(2011-2#1)
the third most##15##3##(1991-6#1)(1992-5#1)(2006-4#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-11#2)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
the third of##3##3##(1990-5#1)(1994-3#1)(1997-3#1)
the third one##4##3##(1991-8#1)(2007-1#1)(2007-12#1)(2008-10#1)
the third or fourth##3##4##(2005-7#1)(2007-7#1)(2010-6#1)
the third or##4##3##(2005-7#1)(2006-5#1)(2007-7#1)(2010-6#1)
the third order##2##3##(2008-2#1)(2009-7#1)
the third overall Adair##2##4##(1990-8#2)
the third part of##4##4##(2008-10#1)(2008-7#1)(2011-1#1)(2013-8#1)
the third part##7##3##(2008-10#1)(2008-7#2)(2009-8#1)(2011-1#1)(2013-8#2)
the third patient the##2##4##(1996-9#1)(2009-9#1)
the third patient##4##3##(1996-9#1)(2008-3#1)(2008-7#1)(2009-9#1)
the third phase##3##3##(2007-12#1)(2008-10#1)(2008-8#1)
the third place##2##3##(1995-5#1)(2005-10#1)
the third position of the##2##5##(1993-7#1)(1997-4#1)
the third position of##3##4##(1990-12#1)(1993-7#1)(1997-4#1)
the third position##4##3##(1990-12#1)(1993-7#1)(1997-4#1)(2008-11#1)
the third pregnancy##3##3##(1991-12#1)(2010-12#1)(2012-2#1)
the third quartile##2##3##(2007-10#1)(2011-2#1)
the third soaking period##2##4##(2006-7#2)
the third stage of##2##4##(1992-1#1)(2005-11#1)
the third stage##7##3##(1990-3#1)(1992-1#1)(1992-8#1)(2005-11#2)(2008-12#1)(2009-5#1)
the third step in##2##4##(1995-1#1)(1995-5#1)
the third step##4##3##(1995-1#1)(1995-5#1)(2009-8#1)(2011-1#1)
the third strand was##2##4##(1995-3#1)(2006-10#1)
the third strand##6##3##(1992-9#1)(1993-3#1)(1995-3#3)(2006-10#1)
the third study##3##3##(1994-2#1)(2011-2#1)(2013-1#1)
the third thoracic##3##3##(1991-3#1)(2007-12#1)(2013-1#1)
the third to the##3##4##(1992-6#1)(2008-3#1)(2008-6#1)
the third to##4##3##(1992-6#1)(2007-8#1)(2008-3#1)(2008-6#1)
the third transmembrane segment##3##4##(1994-9#1)(1997-2#2)
the third transmembrane##5##3##(1993-8#1)(1994-9#1)(1997-2#2)(2008-4#1)
the third trimester of pregnancy##8##5##(1990-12#1)(1991-12#2)(1992-2#2)(1992-4#1)(2007-2#1)(2011-2#1)
the third trimester of##9##4##(1990-12#1)(1991-12#2)(1992-2#2)(1992-4#1)(2007-2#1)(2010-6#1)(2011-2#1)
the third trimester##23##3##(1990-12#2)(1990-6#1)(1990-9#1)(1991-12#2)(1992-2#2)(1992-4#1)(1993-12#1)(1993-3#1)(1994-2#1)(1997-8#1)(2007-12#1)(2007-2#3)(2008-1#1)(2009-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)
the third ventricle and##4##4##(1996-2#1)(1997-5#1)(1997-8#1)(2012-1#1)
the third ventricle##21##3##(1990-7#1)(1991-8#2)(1996-2#1)(1996-7#2)(1997-5#1)(1997-8#2)(2006-5#3)(2006-8#1)(2008-7#5)(2012-1#3)
the third week##9##3##(1991-5#1)(1993-12#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-5#1)(2008-5#2)(2012-2#1)
the third world##5##3##(1990-12#1)(1991-4#1)(1995-6#1)(2006-8#1)(2008-10#1)
the third year of##3##4##(1992-12#1)(2008-10#1)(2012-1#1)
the third year##8##3##(1990-5#1)(1992-12#2)(2008-10#3)(2008-11#1)(2012-1#1)
the third zinc##4##3##(1991-2#1)(1994-10#2)(1995-5#1)
the third zone##2##3##(2006-12#2)
the third##500##2##(1990-10#3)(1990-11#1)(1990-12#4)(1990-3#3)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#5)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#6)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#4)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#4)(1992-2#4)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-12#6)(1993-2#1)(1993-3#4)(1993-4#2)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#2)(1994-10#2)(1994-12#2)(1994-2#3)(1994-3#3)(1994-6#3)(1994-9#2)(1995-1#1)(1995-2#1)(1995-3#13)(1995-4#1)(1995-5#7)(1995-6#1)(1995-8#2)(1996-1#2)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#7)(1997-3#2)(1997-4#5)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#6)(2004-4#1)(2005-10#2)(2005-11#3)(2005-12#1)(2005-6#1)(2005-7#2)(2005-8#3)(2006-10#5)(2006-12#3)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#8)(2006-6#2)(2006-7#4)(2006-8#3)(2006-9#3)(2007-1#2)(2007-10#2)(2007-11#8)(2007-12#17)(2007-2#5)(2007-3#4)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#7)(2007-8#5)(2007-9#2)(2008-1#4)(2008-10#37)(2008-11#5)(2008-12#4)(2008-2#8)(2008-3#10)(2008-4#6)(2008-5#11)(2008-6#4)(2008-7#9)(2008-8#7)(2008-9#1)(2009-11#2)(2009-4#1)(2009-5#3)(2009-7#3)(2009-8#3)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#5)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#5)(2010-7#1)(2010-8#2)(2011-1#9)(2011-12#2)(2011-2#18)(2012-1#4)(2012-11#3)(2012-12#6)(2012-2#6)(2012-3#3)(2012-5#1)(2013-1#11)(2013-7#2)(2013-8#12)
the third- and fifth-order##2##4##(2007-11#2)
the third- and##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
the third-harmonic##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
the third-order nonlinear optical response##2##5##(2007-11#1)(2007-12#1)
the third-order nonlinear optical##5##4##(2007-11#1)(2007-12#4)
the third-order nonlinear##7##3##(2007-11#2)(2007-12#5)
the third-order nonlinearities##2##3##(2007-12#2)
the third-order##21##2##(2007-11#3)(2007-12#11)(2008-2#2)(2008-3#3)(2008-7#1)(2010-7#1)
the thirty##4##2##(1995-6#1)(2008-12#3)
the thoracic and##5##3##(2007-11#1)(2007-4#1)(2010-8#1)(2011-2#1)(2012-2#1)
the thoracic aorta##15##3##(1990-6#1)(1991-11#1)(1997-8#1)(2007-2#1)(2007-8#3)(2008-10#1)(2008-12#1)(2008-7#2)(2009-10#1)(2009-8#1)(2011-2#1)(2012-2#1)
the thoracic cage##3##3##(2005-11#1)(2006-11#1)(2013-1#1)
the thoracic cavity and##2##4##(2012-2#1)(2013-1#1)
the thoracic cavity##6##3##(2004-2#1)(2006-12#1)(2007-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
the thoracic descending aorta##2##4##(1997-8#1)(2010-8#1)
the thoracic duct##4##3##(2008-4#1)(2010-12#1)(2011-2#1)(2012-3#1)
the thoracic inlet##3##3##(1990-3#1)(2007-8#1)(2011-2#1)
the thoracic spinal##2##3##(1993-12#1)(2006-7#1)
the thoracic spine and##2##4##(2006-10#1)(2008-8#1)
the thoracic spine are##3##4##(1997-4#1)(2007-1#1)(2007-11#1)
the thoracic spine##25##3##(1997-4#1)(2006-10#2)(2006-11#2)(2006-7#3)(2006-8#1)(2007-1#2)(2007-11#6)(2007-4#1)(2007-7#3)(2008-12#1)(2008-8#2)(2009-3#1)
the thoracic stiffness##2##3##(2008-9#2)
the thoracic vertebrae##3##3##(1993-3#1)(2010-12#1)(2011-2#1)
the thoracic wall##4##3##(1992-6#1)(2007-8#2)(2012-2#1)
the thoracic##114##2##(1990-12#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-3#1)(1991-5#3)(1992-6#1)(1993-10#2)(1993-12#1)(1993-3#1)(1993-9#1)(1995-12#2)(1995-3#1)(1996-11#1)(1996-3#1)(1997-4#1)(1997-8#4)(2004-2#1)(2005-11#1)(2006-10#2)(2006-11#3)(2006-12#1)(2006-7#6)(2006-8#1)(2007-1#2)(2007-11#7)(2007-12#1)(2007-2#2)(2007-4#3)(2007-7#9)(2007-8#11)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-8#5)(2011-2#6)(2012-1#2)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)
the thoraco-lumbar spine##5##3##(2007-11#1)(2007-7#4)
the thoraco-lumbar##7##2##(2007-11#2)(2007-7#5)
the thoracoabdominal##2##2##(2007-8#1)(2010-8#1)
the thoracolumbar spine##10##3##(2006-8#6)(2008-7#1)(2008-8#1)(2012-12#1)(2012-3#1)
the thoracolumbar##15##2##(1995-11#1)(1997-6#1)(2006-10#1)(2006-8#6)(2007-7#1)(2008-7#1)(2008-8#2)(2012-12#1)(2012-3#1)
the thoracotomy##3##2##(2007-8#2)(2013-7#1)
the thorax and abdomen##2##4##(2006-11#1)(2007-12#1)
the thorax and##5##3##(2006-11#1)(2006-2#1)(2007-12#1)(2007-4#1)(2012-2#1)
the thorax in##3##3##(1991-11#1)(2007-4#1)(2012-12#1)
the thorax of the##3##4##(1992-6#1)(2008-6#1)(2013-1#1)
the thorax##42##2##(1991-11#1)(1991-12#1)(1991-3#1)(1992-6#1)(1993-10#1)(1993-3#1)(1996-1#1)(1997-8#2)(2006-11#5)(2006-2#1)(2007-12#3)(2007-2#1)(2007-4#3)(2007-8#4)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#2)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#1)
the thorny skate##2##3##(2009-4#1)(2010-8#1)
the thorny##3##2##(1994-10#1)(2009-4#1)(2010-8#1)
the thorough##2##2##(1994-5#1)(1997-8#1)
the thoughts##2##2##(2008-1#1)(2008-7#1)
the thousands of##4##3##(1992-11#1)(2007-8#1)(2008-7#1)(2009-12#1)
the threat of##19##3##(1991-4#1)(1994-2#1)(1996-12#1)(1997-5#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-3#1)
the threat that##2##3##(2007-9#1)(2008-10#1)
the threat##26##2##(1991-4#1)(1994-2#1)(1996-12#1)(1997-5#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-8#1)(2007-9#2)(2008-10#3)(2008-11#1)(2008-5#3)(2009-9#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-3#1)
the threats of##2##3##(2008-10#1)(2011-2#1)
the threats##4##2##(1991-1#1)(2008-10#1)(2011-2#2)
the three &quot##3##3##(1991-2#1)(1995-10#1)(1996-1#1)
the three BCTV strains##2##4##(2008-10#2)
the three DNA##2##3##(1993-3#1)(1996-6#1)
the three European subspecies##2##4##(2007-1#2)
the three P proteins##2##4##(1995-2#2)
the three Rs##2##3##(1992-3#1)(2013-8#1)
the three age groups##5##4##(1994-11#1)(2007-1#1)(2008-7#1)(2010-12#1)(2012-12#1)
the three agents##2##3##(2008-10#1)(2008-7#1)
the three amino acid##2##4##(2008-10#1)(2008-8#1)
the three analytes##6##3##(2008-10#5)(2010-5#1)
the three antagonists##2##3##(1990-11#1)(1996-12#1)
the three approaches##3##3##(2004-2#1)(2008-10#1)(2010-3#1)
the three basic##4##3##(1991-6#1)(1994-9#1)(2007-12#1)(2007-4#1)
the three bilirubins##2##3##(2008-10#2)
the three cases##4##3##(2007-12#2)(2008-5#1)(2012-3#1)
the three castes##3##3##(2008-8#3)
the three categories##2##3##(1994-12#1)(2006-11#1)
the three cell lines##4##4##(1993-11#1)(1995-5#1)(2008-5#1)(2012-2#1)
the three cell##5##3##(1993-11#1)(1995-5#1)(2008-5#1)(2012-2#2)
the three clades##2##3##(2008-10#1)(2009-6#1)
the three classes##2##3##(2008-11#1)(2010-8#1)
the three clonal lineages##3##4##(2008-10#1)(2009-2#2)
the three codon positions##2##4##(1994-3#1)(2008-7#1)
the three common##3##3##(1995-1#1)(2007-12#1)(2012-1#1)
the three components of the##3##5##(1992-6#1)(2008-10#1)(2008-2#1)
the three components of##4##4##(1992-6#1)(2007-12#1)(2008-10#1)(2008-2#1)
the three components##9##3##(1992-6#1)(1993-10#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2010-5#1)(2013-1#1)
the three compounds##7##3##(1992-11#2)(1993-2#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-12#1)
the three conditions##5##3##(2006-7#1)(2008-11#3)(2012-1#1)
the three core functions##2##4##(1996-3#2)
the three counties##3##3##(2007-7#1)(2013-1#2)
the three countries##3##3##(2008-10#1)(2008-7#1)(2010-12#1)
the three criteria##3##3##(2008-2#1)(2008-8#1)(2012-2#1)
the three cultivars##2##3##(2008-10#1)(2008-12#1)
the three degrees of##2##4##(1993-9#1)(2008-10#1)
the three diagnostic##2##3##(1996-1#1)(2008-4#1)
the three different methods##2##4##(2008-10#2)
the three different##14##3##(1993-9#1)(2006-12#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-7#1)(2011-1#1)(2011-2#1)
the three diseases##2##3##(2008-10#2)
the three distinct##2##3##(2008-10#2)
the three domains of##2##4##(1997-7#1)(2011-12#1)
the three drugs##2##3##(1996-6#1)(2007-8#1)
the three dummies##2##3##(2006-11#2)
the three dyes##4##3##(2008-10#3)(2008-5#1)
the three environments##2##3##(2008-10#2)
the three essential##2##3##(1991-2#1)(2007-11#1)
the three experimental groups##3##4##(1997-2#1)(1997-6#1)(2011-1#1)
the three experimental##4##3##(1997-2#1)(1997-6#1)(2008-10#1)(2011-1#1)
the three families of##2##4##(2008-7#1)(2011-12#1)
the three families##4##3##(1991-6#1)(2008-7#1)(2008-8#1)(2011-12#1)
the three fractions##3##3##(1992-12#1)(1993-8#1)(2008-10#1)
the three gene##2##3##(1996-10#1)(1996-5#1)
the three genera##4##3##(1996-6#2)(1997-4#1)(2008-10#1)
the three generations##2##3##(2004-4#1)(2005-7#1)
the three genes##4##3##(1995-6#1)(1996-5#1)(2008-10#1)(2009-12#1)
the three genotypes##3##3##(1995-11#1)(1997-7#1)(2013-8#1)
the three groups in the##2##5##(1994-12#1)(2006-9#1)
the three groups in##6##4##(1994-12#1)(1997-6#1)(2006-9#1)(2008-1#1)(2009-10#1)(2012-2#1)
the three groups of patients##3##5##(2010-7#2)(2013-1#1)
the three groups of##10##4##(1991-10#1)(1995-12#1)(2008-10#3)(2008-5#1)(2010-7#2)(2011-1#1)(2013-1#1)
the three groups were##3##4##(1993-1#1)(2008-10#2)
the three groups##61##3##(1990-11#1)(1991-10#1)(1991-9#1)(1993-1#1)(1993-2#1)(1993-4#1)(1994-12#1)(1995-12#2)(1996-12#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(2004-12#1)(2006-6#1)(2006-7#2)(2006-9#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#4)(2009-10#3)(2009-9#1)(2010-3#1)(2010-4#1)(2010-7#2)(2011-1#2)(2011-12#2)(2012-2#5)(2012-5#1)(2013-1#2)(2013-8#2)
the three human##5##3##(1993-12#1)(1994-6#2)(2008-10#1)(2008-3#1)
the three independent##2##3##(1995-8#1)(2008-9#1)
the three individual##2##3##(1996-9#1)(2007-10#1)
the three isolates were##2##4##(2008-10#1)(2008-5#1)
the three isolates##3##3##(2008-10#2)(2008-5#1)
the three kinds of##4##4##(2005-4#1)(2008-10#2)(2008-9#1)
the three known##4##3##(1993-4#1)(1994-12#1)(1995-5#1)(2005-11#1)
the three largest cities in##2##5##(2008-10#2)
the three largest##3##3##(2008-10#2)(2008-12#1)
the three layers of the##2##5##(1994-2#1)(2010-8#1)
the three layers##3##3##(1994-2#1)(2010-8#1)(2013-1#1)
the three lineages##2##3##(2009-2#2)
the three lowland##3##3##(1993-9#3)
the three main strategies##2##4##(2008-1#1)(2009-12#1)
the three main##19##3##(1994-5#1)(1996-3#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-8#1)(2009-10#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)
the three major classes of ionotropic glutamate receptors##2##8##(1995-11#2)
the three major classes of##3##5##(1995-11#2)(2008-4#1)
the three major classes##4##4##(1994-2#1)(1995-11#2)(2008-4#1)
the three major groups##2##4##(1995-11#1)(2006-6#1)
the three major types of##2##5##(2006-8#1)(2007-12#1)
the three major##28##3##(1990-5#1)(1991-1#1)(1992-11#1)(1992-7#1)(1993-11#1)(1994-2#1)(1995-11#3)(1997-3#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#2)(2010-6#1)(2012-2#1)(2013-1#1)
the three markers##3##3##(1991-2#2)(1995-12#1)
the three measurements##2##3##(2008-1#2)
the three metals##3##3##(2008-10#3)
the three methods are##2##4##(2008-10#2)
the three methods for##2##4##(2007-8#1)(2013-8#1)
the three methods of##2##4##(2008-10#1)(2010-6#1)
the three methods to##2##4##(1995-1#1)(2012-3#1)
the three methods used##3##4##(1993-5#1)(2008-10#1)(2012-3#1)
the three methods##24##3##(1992-2#2)(1993-2#1)(1993-5#1)(1995-1#2)(1996-5#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-2#1)(2010-6#1)(2012-1#1)(2012-2#1)(2012-3#3)(2013-8#2)
the three microsatellite##2##3##(2008-4#1)(2008-5#1)
the three models and##2##4##(2010-12#1)(2012-1#1)
the three molecules##2##3##(1990-4#1)(1992-4#1)
the three most common##3##4##(1997-6#1)(2007-2#1)(2011-2#1)
the three most commonly used##2##5##(2006-4#1)(2008-2#1)
the three most commonly##3##4##(1990-4#1)(2006-4#1)(2008-2#1)
the three most##12##3##(1990-12#1)(1990-4#1)(1997-6#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-6#1)(2011-2#1)
the three novel##2##3##(1997-5#1)(2008-1#1)
the three or##2##3##(1993-12#1)(1995-12#1)
the three other##4##3##(1993-3#1)(1995-2#1)(1996-12#1)(2008-10#1)
the three patients##11##3##(1995-1#1)(1995-6#1)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#1)(2008-3#1)(2011-2#2)(2013-1#1)(2013-8#1)
the three peptides##2##3##(1992-2#1)(2012-1#1)
the three periods after surgery##2##5##(1995-4#2)
the three periods##3##3##(1995-4#2)(2013-8#1)
the three phases of the##2##5##(2008-11#1)(2013-8#1)
the three phases of##3##4##(1991-3#1)(2008-11#1)(2013-8#1)
the three phases##4##3##(1991-3#1)(2008-11#1)(2010-4#1)(2013-8#1)
the three polypeptides##2##3##(1990-4#1)(1991-10#1)
the three populations##3##3##(2007-3#1)(2009-7#1)(2012-7#1)
the three possible##2##3##(1993-8#1)(2008-10#1)
the three practices##3##3##(2010-11#3)
the three principal##3##3##(1997-7#1)(2007-12#1)(2008-3#1)
the three products##2##3##(1990-7#1)(1996-3#1)
the three proteins##5##3##(1991-2#1)(1994-8#2)(1995-5#1)(1997-2#1)
the three receptor subtypes##2##4##(1994-6#1)(2007-11#1)
the three regions##4##3##(1990-7#1)(1991-7#1)(2013-1#2)
the three remaining##3##3##(1992-11#1)(1992-5#1)(1993-2#1)
the three representative##2##3##(1994-9#1)(1996-5#1)
the three samples##2##3##(1992-6#1)(2008-10#1)
the three sampling sites##2##4##(2007-2#1)(2008-5#1)
the three sampling##3##3##(2007-2#1)(2008-5#1)(2008-7#1)
the three scales##3##3##(2008-10#2)(2011-1#1)
the three sites##2##3##(1994-1#1)(1996-7#1)
the three species of##2##4##(1992-8#1)(2007-3#1)
the three species##9##3##(1992-8#1)(2007-1#1)(2007-3#1)(2007-8#1)(2011-3#3)(2012-8#1)(2012-9#1)
the three stages##2##3##(2012-12#1)(2013-8#1)
the three strains were##2##4##(2004-11#1)(2008-7#1)
the three strains##6##3##(1993-9#1)(1995-6#1)(2004-11#1)(2008-10#1)(2008-7#1)(2010-4#1)
the three studied##5##3##(2005-11#1)(2008-10#3)(2009-9#1)
the three subunits of##2##4##(1994-12#1)(2009-2#1)
the three subunits##4##3##(1994-12#2)(1995-3#1)(2009-2#1)
the three surveys##2##3##(1991-9#1)(2013-8#1)
the three techniques##2##3##(1992-1#1)(2008-10#1)
the three tests##2##3##(1992-10#1)(2008-12#1)
the three tissues##3##3##(1990-11#1)(1990-4#1)(2009-12#1)
the three traits##2##3##(2008-10#1)(2011-12#1)
the three treatment groups##2##4##(1990-11#1)(1997-3#1)
the three treatment##4##3##(1990-11#1)(1997-3#1)(2008-10#1)(2009-7#1)
the three trials##2##3##(2007-7#1)(2008-12#1)
the three types of##19##4##(1990-6#1)(1994-12#1)(1995-11#1)(1996-2#2)(1997-4#1)(2007-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2009-7#2)(2009-9#1)(2010-12#1)(2012-11#1)(2012-2#1)
the three types##22##3##(1990-6#1)(1992-1#1)(1994-12#1)(1995-11#1)(1995-6#1)(1996-11#1)(1996-2#2)(1997-4#1)(2007-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2009-7#2)(2009-9#1)(2010-12#1)(2012-11#1)(2012-2#1)
the three uplift intervals of the##2##6##(2008-9#2)
the three viruses##2##3##(2008-10#2)
the three well-known##2##3##(2006-12#1)(2008-2#1)
the three years##2##3##(2010-8#1)(2011-2#1)
the three zones##2##3##(1993-7#1)(2012-2#1)
the three##1011##2##(1990-11#6)(1990-12#6)(1990-2#1)(1990-3#2)(1990-4#5)(1990-5#5)(1990-6#2)(1990-7#5)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#2)(1991-12#1)(1991-2#10)(1991-3#4)(1991-4#5)(1991-5#1)(1991-6#4)(1991-7#4)(1991-8#1)(1991-9#5)(1992-1#4)(1992-10#1)(1992-11#5)(1992-12#2)(1992-2#5)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#5)(1993-1#1)(1993-10#1)(1993-11#5)(1993-12#4)(1993-2#5)(1993-3#6)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#10)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#10)(1994-2#3)(1994-3#4)(1994-4#1)(1994-5#2)(1994-6#5)(1994-8#5)(1994-9#8)(1995-1#6)(1995-10#1)(1995-11#5)(1995-12#7)(1995-2#5)(1995-3#5)(1995-4#2)(1995-5#7)(1995-6#8)(1995-8#6)(1996-1#4)(1996-10#4)(1996-11#3)(1996-12#6)(1996-2#9)(1996-3#7)(1996-4#2)(1996-5#9)(1996-6#5)(1996-7#6)(1996-8#4)(1996-9#3)(1997-1#4)(1997-2#3)(1997-3#3)(1997-4#7)(1997-5#2)(1997-6#7)(1997-7#5)(1997-8#2)(1997-9#1)(2004-1#1)(2004-11#3)(2004-12#1)(2004-2#1)(2004-4#3)(2005-1#1)(2005-11#5)(2005-12#1)(2005-4#2)(2005-5#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-11#4)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#5)(2006-6#3)(2006-7#5)(2006-8#3)(2006-9#1)(2007-1#11)(2007-10#1)(2007-11#9)(2007-12#19)(2007-2#4)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#3)(2007-7#5)(2007-8#10)(2007-9#2)(2008-1#9)(2008-10#169)(2008-11#14)(2008-12#15)(2008-2#23)(2008-3#19)(2008-4#11)(2008-5#29)(2008-6#2)(2008-7#19)(2008-8#16)(2008-9#14)(2009-10#8)(2009-12#3)(2009-2#5)(2009-4#3)(2009-6#1)(2009-7#7)(2009-8#1)(2009-9#3)(2010-11#5)(2010-12#7)(2010-2#1)(2010-3#4)(2010-4#7)(2010-5#4)(2010-6#3)(2010-7#6)(2010-8#6)(2011-1#12)(2011-12#6)(2011-2#21)(2011-3#4)(2012-1#9)(2012-11#1)(2012-12#14)(2012-2#19)(2012-3#8)(2012-5#1)(2012-7#1)(2012-8#1)(2012-9#1)(2013-1#22)(2013-7#1)(2013-8#18)
the three-##2##2##(1995-11#1)(2007-12#1)
the three-dimensional (3-D)##4##3##(2008-2#2)(2008-3#1)(2008-8#1)
the three-dimensional (3D)##2##3##(2007-11#1)(2012-2#1)
the three-dimensional distribution of##2##4##(2007-12#1)(2008-2#1)
the three-dimensional intensity distribution##2##4##(2008-2#1)(2008-3#1)
the three-dimensional organization of the##2##5##(1993-6#1)(2008-11#1)
the three-dimensional protein##2##3##(1995-2#1)(2008-4#1)
the three-dimensional shape##4##3##(1994-4#2)(2008-2#1)(2008-3#1)
the three-dimensional shapes of##2##4##(2008-1#1)(2008-3#1)
the three-dimensional structural##2##3##(1994-11#1)(2008-8#1)
the three-dimensional structure of the##11##5##(1990-7#1)(1990-8#1)(1993-3#1)(1993-8#1)(1995-1#1)(1995-11#1)(1995-6#1)(1997-4#1)(1997-5#1)(2006-10#1)(2011-1#1)
the three-dimensional structure of##20##4##(1990-7#1)(1990-8#1)(1990-9#2)(1991-4#1)(1993-3#1)(1993-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-11#1)(1997-4#1)(1997-5#1)(2006-10#1)(2008-4#1)(2008-8#1)(2011-1#1)(2013-1#1)
the three-dimensional structure##29##3##(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-4#1)(1991-8#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-7#1)(1997-4#1)(1997-5#1)(2006-10#1)(2008-4#2)(2008-8#1)(2008-9#1)(2011-1#1)(2013-1#1)
the three-dimensional structures of##4##4##(1995-2#1)(1996-7#1)(1997-4#1)(2008-9#1)
the three-dimensional structures##6##3##(1992-9#1)(1995-2#1)(1996-7#1)(1997-4#1)(2008-9#1)(2012-12#1)
the three-dimensional##102##2##(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-4#1)(1991-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#2)(1994-3#3)(1994-4#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-2#3)(1995-6#1)(1995-8#1)(1996-11#1)(1996-7#2)(1997-4#2)(1997-5#1)(2006-10#2)(2006-12#1)(2007-11#5)(2007-12#6)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#11)(2008-3#14)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
the three-line##2##2##(1993-9#1)(2008-2#1)
the three-month period##3##3##(1993-7#1)(2012-11#1)(2013-1#1)
the three-month##5##2##(1991-6#1)(1993-7#1)(2008-5#1)(2012-11#1)(2013-1#1)
the three-phase##4##2##(2005-11#1)(2007-12#1)(2008-10#1)(2008-5#1)
the three-spined stickleback Gasterosteus aculeatus##5##5##(2010-8#5)
the three-stage##2##2##(1993-11#1)(2008-10#1)
the three-step technique##3##3##(2009-8#3)
the three-step##8##2##(1994-8#1)(1997-2#2)(2006-5#1)(2008-10#1)(2009-8#3)
the three-stranded##2##2##(1995-6#1)(1997-9#1)
the three-way data##2##3##(2008-10#2)
the three-way junction##2##3##(1996-8#2)
the three-way##5##2##(1996-8#2)(2008-10#3)
the three-year period##5##3##(1997-3#1)(2007-1#1)(2011-2#1)(2013-1#2)
the three-year##10##2##(1997-3#1)(2007-1#1)(2007-4#1)(2008-11#1)(2008-12#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#2)
the threefold##2##2##(2008-10#1)(2008-2#1)
the threonine##3##2##(1994-11#1)(1994-9#1)(1997-2#1)
the threonine203##2##2##(1994-5#2)
the threshold and the##2##4##(2007-12#1)(2008-8#1)
the threshold and##4##3##(1997-5#1)(2007-12#2)(2008-8#1)
the threshold concentration##2##3##(1993-12#2)
the threshold condition for##2##4##(2006-10#1)(2008-2#1)
the threshold current##3##3##(2007-12#1)(2008-3#2)
the threshold dissociation##2##3##(2006-3#1)(2006-4#1)
the threshold dose of##2##4##(2008-10#1)(2008-4#1)
the threshold dose##4##3##(2008-10#2)(2008-4#1)(2008-7#1)
the threshold energy##2##3##(2007-12#1)(2008-3#1)
the threshold fluence##2##3##(2008-3#2)
the threshold for induction of##2##5##(1994-2#1)(1995-2#1)
the threshold for##27##3##(1991-12#1)(1992-8#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-2#2)(1997-2#1)(1997-3#1)(2005-11#1)(2006-11#1)(2007-11#1)(2007-12#2)(2007-4#1)(2008-10#3)(2008-3#1)(2008-4#1)(2010-4#1)(2011-2#1)(2012-1#1)
the threshold if the##2##4##(2008-10#2)
the threshold if##3##3##(2008-10#2)(2008-8#1)
the threshold is##2##3##(2008-9#1)(2009-9#1)
the threshold level of##2##4##(1997-8#1)(2009-2#1)
the threshold level##4##3##(1997-8#1)(2008-1#1)(2009-2#1)(2011-1#1)
the threshold of detection##2##4##(1990-4#1)(2008-10#1)
the threshold of##16##3##(1990-4#1)(1990-7#2)(1997-6#1)(2006-10#2)(2006-4#2)(2006-5#1)(2006-7#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-7#2)(2010-4#1)
the threshold power for##2##4##(2007-12#2)
the threshold power##3##3##(2007-12#3)
the threshold pump power##2##4##(2007-12#2)
the threshold required##2##3##(1997-5#1)(2006-10#1)
the threshold value##6##3##(1996-8#1)(2005-11#1)(2008-10#2)(2009-8#1)(2010-9#1)
the threshold voltage##2##3##(2008-7#1)(2009-5#1)
the threshold was##2##3##(2008-10#1)(2012-2#1)
the threshold##126##2##(1990-11#1)(1990-4#1)(1990-7#2)(1991-12#1)(1991-3#1)(1991-4#1)(1992-8#1)(1993-12#2)(1993-9#3)(1994-2#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-2#2)(1996-11#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-5#2)(1997-6#1)(1997-8#1)(2005-11#2)(2005-8#1)(2006-10#5)(2006-11#1)(2006-3#1)(2006-4#3)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#14)(2007-4#2)(2008-1#1)(2008-10#15)(2008-2#3)(2008-3#13)(2008-4#2)(2008-7#5)(2008-8#3)(2008-9#4)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-4#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
the thresholds for##3##3##(1990-2#1)(2007-12#1)(2008-8#1)
the thresholds##8##2##(1990-2#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-4#2)(2008-8#1)(2012-2#1)
the thrips##4##2##(2008-10#4)
the throat##4##2##(2005-1#1)(2006-10#1)(2008-10#1)(2010-12#1)
the thrombin aptamer##4##3##(2009-3#3)(2010-5#1)
the thrombin receptor in##2##4##(1996-8#1)(1997-7#1)
the thrombin receptor##8##3##(1994-8#1)(1995-3#1)(1996-8#4)(1997-5#1)(1997-7#1)
the thrombin time##2##3##(1994-4#2)
the thrombin##25##2##(1990-7#2)(1991-9#1)(1994-4#2)(1994-8#1)(1995-11#1)(1995-3#1)(1995-5#3)(1996-8#4)(1997-1#1)(1997-5#1)(1997-7#1)(2007-10#1)(2007-11#1)(2009-3#3)(2009-4#1)(2010-5#1)
the thrombin-mediated##2##2##(1990-11#2)
the thrombocyte##3##2##(1995-3#1)(1996-1#1)(2007-10#1)
the thrombocytes##3##2##(2007-9#3)
the thrombogenic##2##2##(1994-5#1)(2008-8#1)
the thrombolytic group##3##3##(2008-3#3)
the thrombolytic##8##2##(1990-12#1)(1994-3#1)(1997-8#1)(2007-9#1)(2008-3#3)(2008-8#1)
the thrombosis of##2##3##(1997-6#1)(2008-5#1)
the thrombosis##5##2##(1995-9#1)(1997-2#1)(1997-6#1)(2006-5#1)(2008-5#1)
the thrombotic##9##2##(1990-3#1)(1997-1#1)(2006-6#2)(2007-7#1)(2008-3#1)(2008-7#1)(2010-6#1)(2012-3#1)
the thromboxane A2 mimetic##2##4##(1990-11#1)(1996-10#1)
the thromboxane A2##3##3##(1990-11#1)(1992-9#1)(1996-10#1)
the thromboxane##5##2##(1990-11#1)(1990-6#1)(1992-9#1)(1996-10#1)(2007-9#1)
the thrombus was##6##3##(1990-8#2)(2005-1#1)(2011-2#1)(2013-1#2)
the thrombus##14##2##(1990-8#4)(2005-1#1)(2007-3#1)(2007-8#1)(2007-9#2)(2010-6#1)(2011-2#1)(2013-1#2)(2013-7#1)
the through-thickness##3##2##(2009-7#3)
the throughput of##3##3##(2008-2#1)(2008-3#2)
the throughput was##2##3##(2007-9#1)(2008-10#1)
the throughput##12##2##(2007-9#1)(2008-10#2)(2008-2#4)(2008-3#5)
the thrower's elbow is##2##4##(2008-8#2)
the thrust##3##2##(2008-2#1)(2009-3#1)(2009-9#1)
the thumb MP joint and##2##5##(2006-3#2)
the thumb MP joint##3##4##(2006-3#3)
the thumb##26##2##(1990-8#1)(1996-9#1)(1997-1#2)(2006-10#2)(2006-3#10)(2008-9#6)(2009-3#1)(2009-5#2)(2010-7#1)
the thylakoid membrane##6##3##(1991-3#1)(1992-3#1)(1992-4#1)(1993-6#1)(1994-12#1)(2005-10#1)
the thylakoid##15##2##(1990-5#1)(1991-3#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-6#2)(1994-10#1)(1994-12#2)(1997-4#1)(2005-10#1)(2008-10#1)(2008-11#2)
the thylakoids##3##2##(1991-12#1)(1992-6#1)(2009-7#1)
the thymic function##2##3##(1993-12#1)(2010-10#1)
the thymic microenvironment##3##3##(1992-12#1)(1992-5#1)(1995-6#1)
the thymic stroma##2##3##(1991-8#1)(1992-12#1)
the thymic##19##2##(1991-8#2)(1992-12#3)(1992-5#1)(1993-12#1)(1995-1#1)(1995-5#1)(1995-6#1)(1997-4#1)(2007-8#1)(2008-8#2)(2010-10#1)(2013-7#4)
the thymidine analogue##2##3##(1993-11#1)(1996-5#1)
the thymidine kinase##3##3##(1992-12#1)(1994-9#1)(2007-11#1)
the thymidine uptake##2##3##(1994-3#1)(2008-5#1)
the thymidine##12##2##(1991-10#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-3#1)(1994-9#1)(1995-3#2)(1996-5#1)(2007-11#1)(2008-4#1)(2008-5#1)
the thymine##7##2##(1991-7#1)(1992-3#1)(1992-6#1)(1994-12#1)(2005-11#1)(2006-10#1)(2007-8#1)
the thymocyte##2##2##(1991-1#1)(2008-10#1)
the thymus and##8##3##(1991-12#1)(1993-3#2)(1996-4#1)(1997-9#2)(2008-10#1)(2008-4#1)
the thymus are##2##3##(1995-8#1)(2013-1#1)
the thymus gland##2##3##(2008-7#1)(2013-7#1)
the thymus is##3##3##(1996-3#1)(1997-5#1)(2010-2#1)
the thymus of##7##3##(1991-12#1)(1991-3#1)(1992-5#1)(1994-5#1)(1997-7#1)(2013-1#2)
the thymus##63##2##(1990-12#1)(1990-9#1)(1991-11#3)(1991-12#4)(1991-3#1)(1991-8#1)(1992-12#2)(1992-5#1)(1993-3#2)(1994-5#2)(1995-2#1)(1995-8#1)(1996-10#1)(1996-3#1)(1996-4#2)(1997-5#2)(1997-7#3)(1997-9#3)(2006-1#1)(2008-10#7)(2008-4#3)(2008-5#4)(2008-7#1)(2008-9#2)(2009-2#1)(2009-9#1)(2010-10#1)(2010-2#2)(2012-1#1)(2012-2#1)(2013-1#4)(2013-7#2)
the thyroid and##10##3##(1992-4#2)(2006-6#2)(2007-8#1)(2008-4#1)(2009-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
the thyroid function##2##3##(2006-11#1)(2012-2#1)
the thyroid gland and##2##4##(2008-9#1)(2012-1#1)
the thyroid gland are##3##4##(2006-2#1)(2007-10#1)(2013-1#1)
the thyroid gland is rare##2##5##(2006-2#1)(2008-6#1)
the thyroid gland was##5##4##(2005-12#1)(2009-5#1)(2010-11#1)(2011-1#2)
the thyroid gland##53##3##(1990-3#1)(1990-4#3)(1990-5#1)(1990-6#1)(1990-8#1)(1992-1#1)(1992-2#1)(1992-4#1)(1993-4#3)(1993-5#2)(1994-6#1)(1996-3#1)(1997-2#1)(2005-12#1)(2006-10#1)(2006-2#3)(2006-6#1)(2007-10#3)(2007-3#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-5#1)(2009-7#1)(2010-11#1)(2011-1#3)(2012-1#8)(2012-12#1)(2012-2#1)(2013-1#3)
the thyroid glands of##2##4##(1990-2#1)(1995-12#1)
the thyroid hormone receptor beta##2##5##(1991-7#1)(1997-7#1)
the thyroid hormone receptor##5##4##(1991-7#1)(1993-10#1)(1994-11#1)(1996-5#1)(1997-7#1)
the thyroid hormone##13##3##(1990-8#1)(1991-7#1)(1993-10#1)(1994-11#2)(1995-7#1)(1996-5#1)(1997-3#1)(1997-7#2)(2006-9#1)(2007-1#1)(2008-1#1)
the thyroid hormones##3##3##(1991-5#1)(1992-2#1)(2012-1#1)
the thyroid is an##2##4##(2011-2#1)(2012-1#1)
the thyroid is##5##3##(2006-9#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-1#1)
the thyroid nodule##2##3##(2006-10#1)(2011-1#1)
the thyroid state##2##3##(2007-8#2)
the thyroid was##3##3##(1990-2#1)(1991-10#1)(2006-2#1)
the thyroid##147##2##(1990-2#2)(1990-3#1)(1990-4#3)(1990-5#2)(1990-6#2)(1990-8#2)(1991-10#2)(1991-5#1)(1991-7#2)(1992-1#1)(1992-10#2)(1992-11#1)(1992-2#5)(1992-4#3)(1992-8#4)(1993-10#1)(1993-4#3)(1993-5#2)(1994-11#2)(1994-6#1)(1995-12#1)(1995-7#1)(1996-11#2)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-7#2)(2005-1#1)(2005-12#1)(2006-10#6)(2006-11#1)(2006-2#4)(2006-6#5)(2006-9#3)(2007-1#1)(2007-10#5)(2007-3#1)(2007-8#4)(2008-1#1)(2008-12#2)(2008-2#1)(2008-4#2)(2008-6#3)(2008-7#5)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#3)(2009-5#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#5)(2011-2#5)(2012-1#11)(2012-12#4)(2012-2#3)(2013-1#4)(2013-8#4)
the thyroidal##2##2##(1991-5#1)(1994-9#1)
the thyroids##3##2##(2008-7#2)(2012-1#1)
the thyrotropic function##2##3##(1994-6#1)(2006-6#1)
the thyrotropin (TSH) receptor##3##4##(1991-7#2)(1992-12#1)
the thyrotropin receptor (TSHR)##2##4##(1991-8#1)(1994-3#1)
the thyrotropin receptor (TSHr)##2##4##(1994-11#1)(2008-4#1)
the thyrotropin receptor##10##3##(1991-8#2)(1994-11#4)(1994-3#2)(1996-5#1)(2008-4#1)
the thyrotropin##13##2##(1991-7#2)(1991-8#2)(1992-12#1)(1994-11#4)(1994-3#2)(1996-5#1)(2008-4#1)
the tibia and##6##3##(2007-1#1)(2007-7#1)(2007-8#1)(2009-3#1)(2010-12#2)
the tibia##64##2##(1993-11#1)(2006-10#3)(2006-11#1)(2006-6#2)(2007-1#6)(2007-11#3)(2007-12#2)(2007-4#4)(2007-5#1)(2007-7#2)(2007-8#4)(2008-12#1)(2008-4#1)(2008-6#7)(2008-8#3)(2008-9#1)(2009-3#7)(2009-7#1)(2009-9#5)(2010-12#2)(2010-3#2)(2011-2#2)(2013-1#1)(2013-8#2)
the tibial metaphysis##5##3##(2007-1#2)(2012-2#1)(2013-1#2)
the tibial nerve##5##3##(2007-7#3)(2010-12#1)(2012-2#1)
the tibial plateau##4##3##(2005-7#1)(2007-4#2)(2008-10#1)
the tibial shaft##3##3##(2007-8#1)(2009-9#2)
the tibial tuberosity##5##3##(2007-1#4)(2008-12#1)
the tibial##38##2##(1990-6#1)(1991-12#1)(2005-12#1)(2005-7#2)(2007-1#7)(2007-11#1)(2007-4#2)(2007-5#1)(2007-7#3)(2007-8#3)(2008-10#1)(2008-12#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-9#2)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#2)(2013-1#3)
the tibialis anterior muscle##3##4##(1995-12#1)(2006-10#1)(2012-1#1)
the tibialis anterior##4##3##(1991-6#1)(1995-12#1)(2006-10#1)(2012-1#1)
the tibialis##5##2##(1991-6#1)(1995-12#1)(2006-10#1)(2008-5#1)(2012-1#1)
the tick##9##2##(1994-3#1)(1994-6#1)(2008-10#1)(2008-12#1)(2010-1#2)(2010-10#1)(2010-2#1)(2013-8#1)
the tick's##2##2##(2004-11#1)(2008-8#1)
the tick-borne##3##2##(1993-9#1)(2013-8#2)
the ticks##3##2##(2004-11#1)(2010-1#1)(2012-12#1)
the tidal cycles##3##3##(2007-5#3)
the tidal volume##2##3##(2006-9#1)(2007-9#1)
the tidal##9##2##(2006-9#1)(2007-5#3)(2007-9#1)(2008-5#1)(2010-8#2)(2013-7#1)
the tide of##2##3##(1991-1#1)(2009-5#1)
the tide##7##2##(1991-1#1)(2007-11#1)(2007-5#3)(2008-3#1)(2009-5#1)
the tied##2##2##(2006-11#2)
the tight and##2##3##(1990-7#1)(2008-4#1)
the tight association##2##3##(1990-2#1)(2009-2#1)
the tight binding##2##3##(1995-11#1)(1997-1#1)
the tight correlation between##2##4##(2008-3#1)(2012-1#1)
the tight junction##2##3##(2008-11#1)(2012-2#1)
the tight skin (TSK)##2##4##(1997-8#2)
the tight##26##2##(1990-2#1)(1990-7#2)(1992-3#1)(1993-11#1)(1995-11#1)(1996-5#1)(1997-1#1)(1997-8#2)(2005-10#1)(2006-7#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#2)(2009-2#2)(2010-12#1)(2012-1#1)(2012-2#1)
the tight-binding method##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
the tight-binding##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2010-7#1)
the tight-junctional (TJ) permeability##2##4##(1997-1#1)(2008-11#1)
the tight-junctional##3##2##(1997-1#1)(2008-11#2)
the tightly bound##2##3##(1992-3#1)(1992-6#1)
the tightly##9##2##(1992-3#1)(1992-6#3)(1994-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-5#1)
the tightness##2##2##(2007-7#1)(2008-2#1)
the tilapia##4##2##(1993-3#2)(1996-7#1)(2008-5#1)
the tiled regression method##2##4##(2012-3#2)
the tiling path##2##3##(2008-5#1)(2008-7#1)
the tillage##3##2##(2008-10#2)(2011-12#1)
the tilt and the##2##4##(2008-2#1)(2008-3#1)
the tilt angle of##3##4##(2008-2#1)(2008-3#2)
the tilt angle##7##3##(1994-11#1)(2007-11#1)(2008-2#3)(2008-3#2)
the tilt estimator##2##3##(2008-2#2)
the tilt for##2##3##(2007-12#1)(2008-3#1)
the tilt of the##4##4##(1994-5#1)(2008-2#2)(2008-3#1)
the tilt##25##2##(1994-11#1)(1994-5#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-2#10)(2008-3#9)
the tilted##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
the tilting angle##3##3##(2008-2#3)
the timber##2##2##(2006-5#1)(2008-9#1)
the time a##2##3##(1993-3#1)(1996-3#1)
the time after the##2##4##(1996-6#1)(2008-7#1)
the time after##5##3##(1991-1#1)(1994-10#1)(1996-6#1)(2006-5#1)(2008-7#1)
the time and cost of##2##5##(2008-10#1)(2013-1#1)
the time and effort needed for acquiring training data are hence significantly reduced##2##13##(2013-1#2)
the time and effort##3##4##(2007-12#1)(2013-1#2)
the time and frequency##3##4##(2006-7#1)(2007-11#1)(2008-3#1)
the time and resources##2##4##(2010-9#1)(2013-1#1)
the time and the frequency##2##5##(2007-12#1)(2008-2#1)
the time and the##3##4##(1996-5#1)(2007-12#1)(2008-2#1)
the time and##31##3##(1990-3#1)(1990-9#1)(1992-12#1)(1994-1#1)(1994-3#1)(1995-2#1)(1996-11#1)(1996-5#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-9#1)(2013-1#4)
the time at which##2##4##(2008-7#1)(2012-1#1)
the time at##3##3##(2008-7#1)(2012-1#1)(2012-2#1)
the time available##2##3##(1996-12#2)
the time being##2##3##(2008-10#1)(2013-7#1)
the time between##4##3##(1996-7#1)(2006-5#1)(2008-11#1)(2008-7#1)
the time but##2##3##(2008-11#1)(2008-7#1)
the time constant of##3##4##(1997-7#1)(2007-9#1)(2013-8#1)
the time constant##6##3##(1991-2#1)(1994-5#1)(1997-7#1)(2007-12#1)(2007-9#1)(2013-8#1)
the time constants##3##3##(2008-11#1)(2008-3#1)(2008-8#1)
the time constraints of a##2##5##(2006-9#1)(2010-8#1)
the time constraints of##3##4##(2006-9#1)(2007-10#1)(2010-8#1)
the time course and##5##4##(1993-7#1)(1994-9#1)(2008-9#1)(2010-3#1)(2013-1#1)
the time course for##5##4##(1995-2#1)(1997-6#1)(2007-9#1)(2008-6#1)(2009-12#1)
the time course of ChL##2##5##(2008-10#2)
the time course of changes##2##5##(1997-3#1)(2013-1#1)
the time course of the##11##5##(1991-4#1)(1995-11#1)(1996-1#1)(1996-7#1)(1997-4#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-1#1)(2011-2#1)
the time course of##46##4##(1990-5#1)(1990-9#1)(1991-4#1)(1991-5#1)(1992-8#3)(1992-9#1)(1993-9#2)(1994-11#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#1)(2004-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#2)(2009-12#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#2)
the time course##64##3##(1990-5#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-8#3)(1992-9#1)(1993-7#1)(1993-9#2)(1994-11#1)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#2)(1996-1#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#2)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-12#1)(2007-10#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#2)(2009-12#2)(2009-8#1)(2010-11#1)(2010-3#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#3)
the time courses of##3##4##(1994-2#1)(2008-10#1)(2008-7#1)
the time courses##5##3##(1994-2#1)(1994-9#1)(1995-11#1)(2008-10#1)(2008-7#1)
the time delay between##2##4##(2007-12#1)(2008-2#1)
the time delay of##3##4##(2007-11#2)(2007-12#1)
the time delay##8##3##(1996-6#1)(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)(2009-9#1)
the time delays##2##3##(2007-7#1)(2010-12#1)
the time dependence of the##7##5##(1993-8#1)(2005-11#1)(2007-12#2)(2007-2#1)(2008-2#2)
the time dependence of##8##4##(1993-8#1)(2005-11#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-2#2)
the time dependence##9##3##(1993-8#1)(2005-11#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-2#3)
the time dependency##3##3##(1991-2#1)(1992-3#1)(1995-6#1)
the time dependent##2##3##(1991-12#1)(1992-2#1)
the time difference between the##2##5##(1994-3#1)(2008-2#1)
the time difference between##3##4##(1994-3#1)(2008-10#1)(2008-2#1)
the time distribution##2##3##(2006-4#1)(2010-12#1)
the time domain##9##3##(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#1)(2008-9#1)
the time duration of##2##4##(1992-8#1)(2008-10#1)
the time duration##4##3##(1992-8#1)(2006-10#1)(2008-10#1)(2012-11#1)
the time during##2##3##(2008-10#1)(2008-5#1)
the time elapsed from##2##4##(2008-10#2)
the time elapsed since the##2##5##(1990-3#1)(2007-3#1)
the time elapsed since##4##4##(1990-3#1)(2007-3#1)(2008-2#1)(2009-9#1)
the time elapsed##7##3##(1990-3#1)(2007-3#1)(2008-10#2)(2008-2#1)(2009-9#1)(2011-2#1)
the time elapsing between##2##4##(1994-3#2)
the time evolution of the##3##5##(1995-11#1)(2008-1#1)(2013-8#1)
the time evolution of##5##4##(1995-11#1)(2008-1#1)(2008-2#1)(2010-4#1)(2013-8#1)
the time factor in##2##4##(1991-10#1)(2008-10#1)
the time factor##3##3##(1991-10#1)(1994-11#1)(2008-10#1)
the time for##14##3##(1994-1#1)(1996-7#1)(1996-8#1)(1997-4#1)(2006-12#1)(2006-6#1)(2007-4#1)(2008-10#3)(2008-12#1)(2009-3#1)(2010-9#1)(2012-12#1)
the time frame##4##3##(2008-11#1)(2008-3#1)(2010-8#1)(2012-3#1)
the time from muzzle##2##4##(1997-6#2)
the time from the##3##4##(1997-6#2)(2007-9#1)
the time from##12##3##(1990-4#1)(1997-6#4)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)(2013-1#2)
the time has come to##2##5##(1996-3#1)(2007-12#1)
the time in which##2##4##(1991-12#1)(2009-2#1)
the time in##4##3##(1991-12#1)(2008-8#1)(2008-9#1)(2009-2#1)
the time interval between##5##4##(1996-1#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-9#1)
the time interval from##2##4##(2008-3#1)(2013-1#1)
the time interval##10##3##(1996-1#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-3#2)(2008-9#2)(2013-1#1)
the time intervals between##5##4##(1997-6#1)(2007-12#1)(2008-3#1)(2010-8#1)(2011-1#1)
the time intervals##6##3##(1997-6#1)(2007-12#1)(2008-3#1)(2010-8#1)(2011-1#1)(2012-1#1)
the time involved in##2##4##(1993-9#1)(1995-2#1)
the time is ripe to##2##5##(2009-5#1)(2013-1#1)
the time is##3##3##(2008-9#1)(2009-5#1)(2013-1#1)
the time it takes to##3##5##(1993-3#1)(2010-5#1)(2010-9#1)
the time it##5##3##(1990-10#1)(1993-3#1)(2010-5#1)(2010-9#1)(2012-12#1)
the time lapse##2##3##(1990-12#1)(1994-3#1)
the time necessary for the##3##5##(2008-10#2)(2008-4#1)
the time necessary for##5##4##(2006-3#1)(2008-10#2)(2008-4#1)(2010-4#1)
the time necessary##6##3##(2006-3#1)(2008-10#3)(2008-4#1)(2010-4#1)
the time needed for##5##4##(1991-3#1)(1995-3#1)(2008-10#2)(2008-3#1)
the time needed to##4##4##(1993-9#1)(1997-2#1)(2007-7#1)(2012-2#1)
the time needed##9##3##(1991-3#1)(1993-9#1)(1995-3#1)(1997-2#1)(2007-7#1)(2008-10#2)(2008-3#1)(2012-2#1)
the time of a##4##4##(2008-1#1)(2008-10#2)(2012-12#1)
the time of administration##3##4##(1993-3#1)(1993-5#1)(1995-2#1)
the time of admission to##4##5##(1992-3#1)(2005-1#1)(2007-9#1)(2012-2#1)
the time of admission##9##4##(1991-8#1)(1992-3#1)(1997-8#1)(2005-1#1)(2007-7#1)(2007-9#1)(2012-2#3)
the time of appearance##2##4##(1991-12#1)(2007-11#1)
the time of arrival of##2##5##(2010-3#1)(2013-1#1)
the time of arterial##2##4##(1992-2#1)(2008-8#1)
the time of birth##7##4##(1992-3#1)(2008-11#1)(2008-5#1)(2009-2#3)(2012-3#1)
the time of bone healing was##2##6##(2008-4#2)
the time of contact##2##4##(2008-10#1)(2008-11#1)
the time of current##2##4##(1996-12#1)(2008-10#1)
the time of day##6##4##(2005-9#1)(2008-10#1)(2008-5#1)(2009-8#2)(2012-5#1)
the time of delivery##4##4##(1994-6#1)(2007-8#1)(2008-4#2)
the time of diagnosis and##6##5##(1996-3#1)(1997-1#1)(2006-10#1)(2007-7#1)(2008-6#1)(2011-2#1)
the time of diagnosis of##4##5##(1994-7#1)(2007-8#1)(2008-4#1)(2011-2#1)
the time of diagnosis##36##4##(1990-10#2)(1992-3#1)(1993-1#1)(1993-5#1)(1994-10#1)(1994-12#1)(1994-7#1)(1996-3#1)(1997-1#1)(1997-5#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-4#1)(2008-6#2)(2008-7#2)(2010-12#2)(2010-3#1)(2011-2#6)(2012-12#1)(2013-7#1)
the time of discharge##6##4##(2007-8#2)(2007-9#1)(2008-11#1)(2008-3#1)(2012-12#1)
the time of disease onset##2##5##(2008-10#2)
the time of enrollment##2##4##(1991-12#1)(2011-1#1)
the time of entry to##2##5##(1990-12#1)(2006-2#1)
the time of exposure##2##4##(2007-12#1)(2012-2#1)
the time of extraction##2##4##(1996-7#1)(2007-12#1)
the time of first##3##4##(1991-10#1)(1995-8#1)(2007-7#1)
the time of follow up##3##5##(1990-8#2)(2008-1#1)
the time of gestation##2##4##(1995-1#1)(2008-4#1)
the time of harvest##2##4##(1994-11#1)(2006-12#1)
the time of her##2##4##(1992-9#1)(1996-6#1)
the time of immobilization##2##4##(2005-11#2)
the time of induction##2##4##(1994-2#1)(2008-7#1)
the time of infection##3##4##(1995-1#1)(2008-10#1)(2008-11#1)
the time of initial##9##4##(1992-2#1)(2007-11#1)(2008-5#3)(2008-6#2)(2008-8#1)(2012-3#1)
the time of injection##3##4##(1995-5#1)(1996-8#1)(2010-7#1)
the time of injury##5##4##(2006-5#1)(2008-9#2)(2009-6#1)(2011-2#1)
the time of investigation##3##4##(1995-9#1)(2008-5#1)(2009-4#1)
the time of its##2##4##(2007-7#1)(2008-3#1)
the time of maximum##2##4##(1995-1#1)(2008-11#1)
the time of onset of##2##5##(1990-5#1)(1997-3#1)
the time of onset##4##4##(1990-5#1)(1997-3#1)(2008-10#1)(2008-4#1)
the time of presentation##14##4##(1995-10#1)(1997-8#1)(2005-8#2)(2006-10#2)(2007-7#2)(2008-8#1)(2009-6#2)(2010-12#1)(2011-12#1)(2012-3#1)
the time of primary##2##4##(1997-4#1)(2007-12#1)
the time of sampling##5##4##(1991-5#1)(1992-12#1)(2006-4#1)(2008-10#1)(2008-5#1)
the time of study##2##4##(2007-2#1)(2011-2#1)
the time of surgery##12##4##(1990-8#1)(1991-3#1)(1993-11#1)(2004-10#1)(2005-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-7#1)(2011-2#2)
the time of surgical##2##4##(1990-8#1)(1992-5#1)
the time of testing##3##4##(1992-7#1)(2008-9#1)(2009-11#1)
the time of the analysis##2##5##(1990-6#1)(2010-3#1)
the time of the diagnosis##7##5##(1996-9#1)(2006-2#1)(2007-5#1)(2007-8#1)(2011-12#1)(2011-2#1)(2012-2#1)
the time of the first##5##5##(1995-12#1)(1995-9#1)(1996-3#1)(2006-12#1)(2013-1#1)
the time of the second##2##5##(1997-7#1)(2008-5#1)
the time of the study##4##5##(2005-9#1)(2007-2#1)(2008-11#1)(2013-1#1)
the time of the whole##2##5##(2008-10#2)
the time of the##75##4##(1990-3#1)(1990-5#2)(1990-6#2)(1991-12#2)(1991-2#1)(1992-10#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-9#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-9#1)(1997-5#1)(1997-7#2)(2004-11#1)(2005-10#1)(2005-9#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#3)(2007-1#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-1#1)(2009-2#1)(2009-4#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#7)(2013-8#1)
the time of their first##2##5##(2006-12#1)(2008-7#1)
the time of their##13##4##(1995-6#1)(1996-12#1)(1996-8#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-10#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-1#1)(2012-3#1)(2013-8#1)
the time of this##3##4##(1991-12#1)(1991-3#1)(2006-7#1)
the time of transplantation##6##4##(2007-8#1)(2008-1#1)(2008-4#1)(2008-9#1)(2010-12#1)(2012-12#1)
the time of treatment##3##4##(2006-8#1)(2007-3#1)(2008-2#1)
the time of weaning##2##4##(1992-11#1)(1996-2#1)
the time of writing##2##4##(1992-9#1)(2011-2#1)
the time of##506##3##(1990-1#1)(1990-10#3)(1990-11#3)(1990-12#1)(1990-3#2)(1990-5#3)(1990-6#2)(1990-8#4)(1991-10#1)(1991-12#6)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#5)(1992-5#1)(1992-7#2)(1992-8#2)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#3)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#3)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#4)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#2)(1994-7#2)(1994-8#1)(1994-9#2)(1995-1#4)(1995-10#1)(1995-12#2)(1995-2#3)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#3)(1996-12#3)(1996-2#1)(1996-3#3)(1996-4#2)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#7)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#2)(1997-7#2)(1997-8#3)(2004-10#2)(2004-11#1)(2005-1#1)(2005-10#3)(2005-11#4)(2005-8#2)(2005-9#2)(2006-10#7)(2006-11#3)(2006-12#9)(2006-2#2)(2006-3#2)(2006-4#6)(2006-5#10)(2006-6#3)(2006-7#1)(2006-8#6)(2006-9#4)(2007-1#1)(2007-10#6)(2007-11#6)(2007-12#10)(2007-2#3)(2007-3#2)(2007-4#2)(2007-5#2)(2007-7#11)(2007-8#14)(2007-9#4)(2008-1#9)(2008-10#35)(2008-11#8)(2008-2#1)(2008-3#3)(2008-4#9)(2008-5#10)(2008-6#8)(2008-7#10)(2008-8#10)(2008-9#8)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#6)(2009-4#5)(2009-6#5)(2009-8#2)(2010-1#1)(2010-12#7)(2010-2#3)(2010-3#4)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#3)(2011-2#17)(2012-1#1)(2012-12#10)(2012-2#11)(2012-3#6)(2012-5#1)(2013-1#16)(2013-7#1)(2013-8#8)
the time period of##3##4##(2006-6#1)(2010-4#1)(2011-2#1)
the time period studied##2##4##(2008-10#1)(2010-11#1)
the time period##19##3##(1991-4#1)(1991-8#1)(1996-5#1)(2004-4#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#2)(2009-2#2)(2009-4#1)(2010-11#1)(2010-4#1)(2011-2#1)(2013-7#1)(2013-8#1)
the time periods##4##3##(1993-7#1)(2007-2#1)(2007-8#1)(2012-3#1)
the time point##2##3##(2009-1#1)(2012-2#1)
the time range of##2##4##(1995-1#1)(2008-5#1)
the time range##4##3##(1991-2#1)(1995-1#1)(2005-11#1)(2008-5#1)
the time ratio##2##3##(2007-11#1)(2008-3#1)
the time relaxation##2##3##(2007-1#1)(2007-4#1)
the time required for the##3##5##(2008-10#3)
the time required for##17##4##(2007-12#1)(2008-10#10)(2008-4#1)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#2)
the time required to complete##2##5##(1993-12#1)(2008-10#1)
the time required to reach##2##5##(2009-9#1)(2013-8#1)
the time required to##20##4##(1993-12#1)(1995-1#1)(1995-12#1)(1997-4#1)(2005-11#1)(2005-4#1)(2006-10#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-6#1)(2008-8#1)(2009-9#1)(2011-2#2)(2013-8#1)
the time required##38##3##(1993-12#1)(1995-1#1)(1995-12#1)(1997-4#1)(2005-11#1)(2005-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#14)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#4)(2013-8#1)
the time resolution##2##3##(2006-5#1)(2008-3#1)
the time scale of##9##4##(1994-12#1)(1994-8#1)(1995-8#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-10#1)(2009-4#1)(2011-2#1)
the time scale##11##3##(1994-12#1)(1994-8#1)(1995-8#1)(1996-7#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-10#1)(2009-4#1)(2010-8#1)(2011-2#1)
the time separation##2##3##(2007-12#1)(2008-2#1)
the time series of the scattered light##2##7##(2008-3#2)
the time series of the##3##5##(1996-3#1)(2008-3#2)
the time series of##5##4##(1996-3#1)(2008-2#1)(2008-3#2)(2010-12#1)
the time series##6##3##(1996-3#1)(2008-2#1)(2008-3#2)(2010-12#1)(2010-8#1)
the time since the##2##4##(1991-11#1)(2008-10#1)
the time since##4##3##(1991-11#1)(2008-10#1)(2010-12#1)(2012-11#1)
the time spent in the##2##5##(1992-8#1)(2011-2#1)
the time spent in##6##4##(1992-8#1)(1996-10#1)(2007-10#1)(2007-7#1)(2009-10#1)(2011-2#1)
the time spent on##4##4##(1993-12#1)(1993-9#1)(2013-1#2)
the time spent##15##3##(1992-8#1)(1993-12#1)(1993-9#1)(1995-4#1)(1996-10#1)(1996-2#1)(2006-12#1)(2007-10#1)(2007-7#1)(2009-10#1)(2009-4#1)(2011-2#2)(2013-1#2)
the time structure##2##3##(2008-11#2)
the time taken for the##3##5##(2008-10#1)(2013-1#2)
the time taken for##6##4##(2008-10#2)(2010-7#1)(2011-2#1)(2013-1#2)
the time taken to##2##4##(1990-11#1)(2007-7#1)
the time taken##10##3##(1990-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-7#1)(2011-2#1)(2013-1#2)
the time that##7##3##(1997-2#1)(2005-7#1)(2007-11#1)(2007-4#1)(2008-10#1)(2009-9#1)(2012-3#1)
the time the##17##3##(1991-2#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-6#1)(1996-1#1)(1996-5#1)(1996-9#1)(2006-3#1)(2006-8#1)(2008-3#1)(2009-6#1)(2010-9#1)(2011-2#1)(2013-8#1)
the time their##2##3##(2007-8#1)(2010-10#1)
the time to complete##4##4##(1993-2#1)(2007-11#1)(2011-2#2)
the time to extinction of##2##5##(2008-9#2)
the time to onset of convulsions##2##6##(1993-12#2)
the time to onset of##3##5##(1993-12#2)(2007-11#1)
the time to reach##2##4##(2008-8#1)(2011-2#1)
the time to the##3##4##(1996-3#1)(1996-4#1)(2008-4#1)
the time to##47##3##(1990-7#1)(1991-2#1)(1991-5#1)(1993-12#2)(1993-2#1)(1994-3#1)(1995-12#1)(1996-3#1)(1996-4#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#3)(2010-12#1)(2010-3#1)(2010-7#1)(2011-12#2)(2011-2#5)(2012-12#2)(2012-3#2)(2013-1#2)
the time used##2##3##(1991-8#1)(2007-11#1)
the time value of money##2##5##(2007-4#2)
the time variation of the##2##5##(2008-2#1)(2011-2#1)
the time variation of##3##4##(2008-2#1)(2008-3#1)(2011-2#1)
the time when the##5##4##(1992-7#1)(2007-8#1)(2008-10#3)
the time when##17##3##(1992-7#1)(1995-11#1)(2005-11#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-9#2)(2009-2#1)(2011-2#2)
the time window is short##2##5##(2006-11#1)(2007-9#1)
the time window##4##3##(2006-11#1)(2007-9#1)(2008-10#1)(2008-3#1)
the time##1149##2##(1990-1#2)(1990-10#4)(1990-11#4)(1990-12#2)(1990-2#2)(1990-3#4)(1990-4#1)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#4)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#8)(1991-2#7)(1991-3#4)(1991-4#3)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#6)(1991-9#2)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#5)(1992-2#5)(1992-3#7)(1992-5#1)(1992-7#3)(1992-8#8)(1992-9#4)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#5)(1993-2#3)(1993-3#4)(1993-4#1)(1993-5#3)(1993-6#1)(1993-7#3)(1993-8#1)(1993-9#6)(1994-1#2)(1994-10#2)(1994-11#5)(1994-12#4)(1994-2#5)(1994-3#9)(1994-4#2)(1994-5#2)(1994-6#3)(1994-7#3)(1994-8#2)(1994-9#5)(1995-1#6)(1995-10#1)(1995-11#7)(1995-12#9)(1995-2#7)(1995-3#3)(1995-4#1)(1995-5#4)(1995-6#3)(1995-8#2)(1995-9#4)(1996-1#4)(1996-10#1)(1996-11#2)(1996-12#6)(1996-2#3)(1996-3#8)(1996-4#4)(1996-5#5)(1996-6#4)(1996-7#7)(1996-8#4)(1996-9#10)(1997-1#2)(1997-2#6)(1997-3#3)(1997-4#5)(1997-5#2)(1997-6#8)(1997-7#4)(1997-8#5)(2004-10#2)(2004-11#2)(2004-12#1)(2004-4#2)(2005-1#1)(2005-10#4)(2005-11#12)(2005-4#1)(2005-7#1)(2005-8#3)(2005-9#2)(2006-10#12)(2006-11#5)(2006-12#12)(2006-2#4)(2006-3#4)(2006-4#7)(2006-5#16)(2006-6#6)(2006-7#3)(2006-8#8)(2006-9#5)(2007-1#5)(2007-10#9)(2007-11#19)(2007-12#32)(2007-2#6)(2007-3#3)(2007-4#8)(2007-5#3)(2007-6#2)(2007-7#21)(2007-8#21)(2007-9#10)(2008-1#15)(2008-10#104)(2008-11#24)(2008-12#4)(2008-2#18)(2008-3#26)(2008-4#14)(2008-5#19)(2008-6#12)(2008-7#18)(2008-8#21)(2008-9#24)(2009-1#2)(2009-10#4)(2009-11#3)(2009-12#2)(2009-2#12)(2009-3#1)(2009-4#9)(2009-5#1)(2009-6#6)(2009-7#1)(2009-8#4)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#12)(2010-2#4)(2010-3#7)(2010-4#4)(2010-5#1)(2010-6#2)(2010-7#5)(2010-8#9)(2010-9#5)(2011-1#9)(2011-12#5)(2011-2#42)(2011-3#1)(2012-1#5)(2012-11#2)(2012-12#18)(2012-2#15)(2012-3#13)(2012-5#1)(2013-1#38)(2013-7#4)(2013-8#13)
the time- and##4##3##(1996-5#1)(2008-3#3)
the time-averaged total##2##3##(2007-12#1)(2012-3#1)
the time-averaged##7##2##(1992-1#1)(2007-12#2)(2008-3#2)(2008-8#1)(2012-3#1)
the time-averaging##2##2##(2008-3#2)
the time-consuming##4##2##(1995-6#1)(2008-10#2)(2011-1#1)
the time-correlated single-photon-counting technique##2##4##(2007-11#1)(2008-2#1)
the time-correlated##4##2##(2007-11#2)(2008-2#1)(2008-3#1)
the time-course of remaining enzyme activity##3##6##(1991-5#3)
the time-course of the##2##4##(1995-12#1)(1997-6#1)
the time-course of##8##3##(1991-5#3)(1995-12#2)(1997-6#2)(2010-2#1)
the time-course##11##2##(1991-5#3)(1994-3#1)(1994-8#1)(1995-12#2)(1997-6#2)(2010-2#1)(2013-8#1)
the time-dependence##2##2##(1992-12#1)(2008-7#1)
the time-dependent changes in the##2##5##(1992-4#1)(2010-11#1)
the time-dependent changes##3##3##(1992-4#1)(2008-3#1)(2010-11#1)
the time-dependent response##2##3##(1997-7#1)(2010-2#1)
the time-dependent##30##2##(1992-11#1)(1992-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1997-3#1)(1997-7#1)(2004-9#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#4)(2008-5#2)(2008-7#1)(2009-9#1)(2010-11#1)(2010-2#1)(2011-2#1)
the time-depth dependence of##2##4##(2008-3#2)
the time-depth##3##2##(2008-3#3)
the time-derivative##2##2##(2008-2#2)
the time-domain demodulation technique##2##4##(2007-11#1)(2007-12#1)
the time-domain##7##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#2)
the time-gating##2##2##(2007-12#2)
the time-related course of##2##4##(2006-6#2)
the time-resolved reflectance##2##3##(2008-2#2)
the time-resolved##11##2##(1993-3#1)(1997-1#1)(2005-11#1)(2006-5#1)(2008-2#4)(2008-3#3)
the time-scales##2##2##(1997-8#1)(2008-11#1)
the time-space##2##2##(1996-4#1)(2008-5#1)
the time-varying##6##2##(2008-1#1)(2008-2#2)(2008-3#2)(2009-2#1)
the timecourse of responses##2##4##(2008-11#2)
the timecourse of the##2##4##(2008-11#2)
the timecourse of##6##3##(1993-8#1)(2008-11#5)
the timeline##3##2##(2008-1#1)(2008-9#1)(2010-12#1)
the timeliness of the##2##4##(2008-9#1)(2012-2#1)
the timeliness of##3##3##(2008-9#1)(2012-2#2)
the timely and##2##3##(2007-4#1)(2010-12#1)
the timely##11##2##(1997-7#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-2#2)(2013-8#1)
the times at which##3##4##(1994-6#1)(1995-8#2)
the times for##3##3##(1995-8#2)(2008-10#1)
the times of##5##3##(1995-8#1)(2005-6#1)(2006-12#1)(2009-2#1)(2013-1#1)
the times that##2##3##(2008-9#1)(2009-9#1)
the times##22##2##(1991-4#1)(1992-2#1)(1994-6#1)(1995-8#5)(1996-4#1)(1997-4#1)(2005-6#1)(2006-12#1)(2006-8#1)(2008-10#2)(2008-9#1)(2009-2#1)(2009-9#1)(2010-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
the timescale of##3##3##(1990-8#1)(2006-3#1)(2012-2#1)
the timescale##5##2##(1990-8#1)(2006-3#1)(2008-10#1)(2012-2#2)
the timescales of##2##3##(1997-5#1)(2008-8#1)
the timing and tempo of puberty in Icelandic##2##8##(2006-10#2)
the timing and##16##3##(1992-3#1)(1993-2#1)(2006-10#3)(2007-12#2)(2007-2#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-8#1)(2012-2#2)(2013-8#1)
the timing error of##2##4##(2007-12#2)
the timing jitter is##3##4##(2007-11#1)(2007-12#1)(2008-1#1)
the timing jitter of##2##4##(2007-11#1)(2008-1#1)
the timing jitter##6##3##(2007-11#2)(2007-12#2)(2008-1#2)
the timing mechanism##2##3##(1990-5#1)(1996-11#1)
the timing of administration##2##4##(2006-10#1)(2008-5#1)
the timing of apothecium##2##4##(2008-10#2)
the timing of appearance of##2##5##(1994-3#1)(2013-1#1)
the timing of medication##2##4##(2008-2#1)(2010-10#1)
the timing of surgery##2##4##(2007-12#1)(2010-8#1)
the timing of the##18##4##(1992-3#1)(1994-10#1)(1995-12#1)(1995-3#1)(1997-2#1)(1997-6#2)(2005-8#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-8#1)(2011-2#1)
the timing of their use##2##5##(1994-4#1)(2009-3#1)
the timing of their##4##4##(1994-4#1)(1994-7#1)(1995-5#1)(2009-3#1)
the timing of##84##3##(1991-10#1)(1991-11#1)(1991-3#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-7#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#1)(1996-11#1)(1997-2#3)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(2005-8#2)(2006-10#3)(2006-2#1)(2006-9#1)(2007-12#5)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#8)(2008-11#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#3)(2011-2#1)(2012-12#2)(2012-3#1)(2012-6#1)(2013-1#1)
the timing shift is##2##4##(2007-12#2)
the timing shift##3##3##(2007-12#3)
the timing##126##2##(1990-4#1)(1990-5#1)(1991-10#1)(1991-11#1)(1991-3#1)(1992-12#1)(1992-3#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-7#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#1)(1996-11#2)(1997-2#3)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(2005-8#2)(2006-10#7)(2006-2#1)(2006-4#1)(2006-9#1)(2007-11#2)(2007-12#14)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#8)(2008-11#3)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#2)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#5)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2012-6#1)(2013-1#3)(2013-8#1)
the tinea unguium of the toenails##2##6##(2008-5#2)
the tinnitus##4##2##(1996-6#2)(2010-12#1)(2010-7#1)
the tiny##4##2##(1994-9#1)(2008-9#1)(2010-2#1)(2013-1#1)
the tip and##2##3##(2006-8#1)(2008-7#1)
the tip is##3##3##(2007-11#2)(2008-2#1)
the tip of a##14##4##(1990-9#1)(2005-11#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)
the tip of an##3##4##(2006-2#1)(2007-12#1)(2008-10#1)
the tip of the breast##2##5##(1994-12#2)
the tip of the fiber##2##5##(1992-1#1)(2007-12#1)
the tip of the iceberg##3##5##(1994-2#1)(2006-9#1)(2007-8#1)
the tip of the microsyringe##2##5##(2008-10#2)
the tip of the sensillum##2##5##(2007-12#1)(2010-11#1)
the tip of the##51##4##(1990-8#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-12#1)(1993-5#1)(1994-12#2)(1994-2#1)(1995-3#1)(1996-7#1)(1997-5#1)(1997-6#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#7)(2007-5#1)(2007-7#2)(2007-8#3)(2008-10#6)(2008-4#1)(2008-5#4)(2009-2#2)(2009-4#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#2)(2012-12#1)
the tip of##74##3##(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-12#1)(1993-5#1)(1994-12#2)(1994-2#1)(1995-1#1)(1995-3#1)(1996-7#1)(1997-5#1)(1997-6#1)(2005-11#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#9)(2007-5#1)(2007-7#3)(2007-8#3)(2008-10#15)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#1)(2009-2#2)(2009-4#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#2)(2012-1#1)(2012-12#1)
the tip##110##2##(1990-10#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-12#1)(1993-5#1)(1994-12#2)(1994-2#1)(1995-1#1)(1995-2#2)(1995-3#1)(1996-5#1)(1996-7#1)(1997-5#1)(1997-6#1)(2005-11#2)(2006-12#1)(2006-2#1)(2006-6#5)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#4)(2007-12#13)(2007-5#1)(2007-7#7)(2007-8#3)(2008-10#17)(2008-11#1)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#7)(2008-7#2)(2009-2#3)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#2)(2012-1#1)(2012-12#1)(2012-2#1)
the tip-sample##4##2##(2007-12#2)(2008-3#1)(2012-2#1)
the tip-tilt##2##2##(2007-12#1)(2008-1#1)
the tipping point##2##3##(2012-2#2)
the tips of the##6##4##(1991-12#1)(1994-7#1)(2006-6#1)(2008-5#1)(2008-7#2)
the tips of##9##3##(1991-12#1)(1994-7#1)(1997-6#1)(2006-6#1)(2008-10#1)(2008-5#1)(2008-7#2)(2010-3#1)
the tips##11##2##(1991-12#1)(1994-7#1)(1997-6#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#2)(2010-3#1)(2011-2#1)
the tissue and##7##3##(1994-11#1)(2006-6#1)(2007-12#1)(2008-2#1)(2008-3#1)(2011-1#1)(2012-2#1)
the tissue as the##2##4##(1992-12#1)(2008-2#1)
the tissue as##3##3##(1992-12#1)(2008-2#1)(2008-6#1)
the tissue compatibility of##2##4##(2012-3#2)
the tissue content of##2##4##(1994-3#1)(1997-7#1)
the tissue culture##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2009-2#1)
the tissue damage##3##3##(2006-10#1)(2007-11#1)(2008-4#1)
the tissue distribution of##6##4##(1990-2#2)(1991-9#1)(1992-9#1)(1994-9#1)(2008-4#1)
the tissue distribution##8##3##(1990-2#2)(1991-9#1)(1992-9#1)(1994-3#1)(1994-9#1)(2008-4#1)(2008-7#1)
the tissue distributions##2##3##(1991-9#1)(1994-8#1)
the tissue engineering##3##3##(2007-11#1)(2010-1#1)(2012-2#1)
the tissue from which##2##4##(1992-9#1)(2008-11#1)
the tissue from##3##3##(1992-9#1)(1996-9#1)(2008-11#1)
the tissue homogenates##2##3##(1995-6#1)(2010-8#1)
the tissue inhibitor of##2##4##(2008-9#1)(2009-4#1)
the tissue is##9##3##(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#4)(2012-12#1)
the tissue level##6##3##(1992-1#1)(1994-11#1)(2006-11#2)(2007-12#1)(2008-7#1)
the tissue levels of##2##4##(1990-2#1)(2006-9#1)
the tissue of origin##3##4##(1990-7#1)(2006-6#1)(2008-11#1)
the tissue of##7##3##(1990-7#1)(2006-6#1)(2007-12#1)(2007-3#1)(2008-11#1)(2012-2#2)
the tissue optical response##2##4##(2011-1#2)
the tissue or##2##3##(2007-3#1)(2008-10#1)
the tissue origin of the FABP##2##6##(1994-9#2)
the tissue pathology##2##3##(1996-10#1)(2007-12#1)
the tissue polypeptide antigen (TPA)##2##5##(1990-10#2)
the tissue reaction##4##3##(2013-1#4)
the tissue sample##7##3##(1991-8#1)(1996-12#1)(2006-6#1)(2007-12#1)(2008-3#1)(2009-8#1)(2010-12#1)
the tissue samples##2##3##(2007-8#1)(2008-11#1)
the tissue section##2##3##(2008-11#2)
the tissue sections##4##3##(1995-9#1)(2007-8#2)(2008-5#1)
the tissue source##2##3##(2004-11#1)(2008-1#1)
the tissue specific expression##2##4##(1994-11#1)(2008-8#1)
the tissue specific##3##3##(1994-11#1)(2008-8#1)(2008-9#1)
the tissue specificity of the##2##5##(1995-8#1)(1997-2#1)
the tissue structure##2##3##(2007-8#1)(2008-3#1)
the tissue surface##14##3##(2008-2#4)(2008-3#5)(2009-11#1)(2011-1#2)(2013-1#2)
the tissue that##2##3##(2006-5#1)(2011-1#1)
the tissue to##4##3##(1990-5#1)(1993-12#1)(2008-11#1)(2008-3#1)
the tissue types##2##3##(1991-11#2)
the tissue under##2##3##(1990-10#1)(2011-1#1)
the tissue was##4##3##(1994-9#1)(2003-11#1)(2008-11#1)(2008-9#1)
the tissue##257##2##(1990-10#3)(1990-11#1)(1990-2#3)(1990-4#1)(1990-5#2)(1990-7#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-6#2)(1992-7#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#3)(1994-2#1)(1994-3#3)(1994-8#1)(1994-9#4)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#4)(1997-5#1)(1997-7#1)(2003-11#1)(2004-11#1)(2004-9#1)(2005-11#1)(2006-10#2)(2006-11#2)(2006-12#1)(2006-5#1)(2006-6#7)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#4)(2007-12#12)(2007-3#3)(2007-4#2)(2007-5#2)(2007-8#5)(2008-1#2)(2008-10#5)(2008-11#12)(2008-2#15)(2008-3#23)(2008-4#5)(2008-5#7)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-4#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-12#3)(2010-4#2)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#8)(2011-2#7)(2012-11#2)(2012-12#1)(2012-2#8)(2012-3#2)(2013-1#10)(2013-8#1)
the tissue's##2##2##(2007-3#1)(2009-7#1)
the tissue-engineered##2##2##(2005-7#1)(2010-3#1)
the tissue-specific expression of##2##4##(1997-4#1)(2008-5#1)
the tissue-specific expression##4##3##(1995-3#1)(1997-4#1)(2008-5#1)(2010-7#1)
the tissue-specific##11##2##(1992-11#1)(1993-12#1)(1994-2#1)(1994-9#1)(1995-3#2)(1997-4#1)(1997-6#1)(2008-10#1)(2008-5#1)(2010-7#1)
the tissues adjacent to##2##4##(2008-10#1)(2009-4#1)
the tissues and##6##3##(1996-10#1)(1996-3#1)(2006-7#1)(2008-11#1)(2008-3#1)(2008-8#1)
the tissues examined##5##3##(1991-5#1)(1992-1#1)(1993-12#1)(2008-10#2)
the tissues of the##3##4##(1990-5#1)(1997-2#1)(2007-11#1)
the tissues of##19##3##(1990-5#1)(1991-5#1)(1993-12#1)(1994-8#1)(1995-1#2)(1996-8#1)(1997-2#3)(2007-11#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-7#1)(2009-7#1)(2011-1#1)
the tissues or organs##2##4##(2008-5#1)(2010-8#1)
the tissues screened were##2##4##(2013-8#2)
the tissues studied##4##3##(1994-10#1)(1995-10#1)(1996-5#1)(2008-5#1)
the tissues##92##2##(1990-12#1)(1990-4#1)(1990-5#2)(1991-5#3)(1992-1#1)(1992-9#1)(1993-1#1)(1993-12#2)(1994-10#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-5#1)(1995-6#4)(1995-8#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#5)(2006-11#1)(2006-6#1)(2006-7#2)(2006-9#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2013-1#2)(2013-8#4)
the titania##2##2##(2007-11#1)(2008-10#1)
the titanium implant##2##3##(2013-1#2)
the titanium surface##2##3##(2013-1#2)
the titanium##16##2##(1991-1#1)(2004-9#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#2)(2009-11#1)(2010-4#1)(2010-8#1)(2013-1#4)(2013-8#1)
the titer of##7##3##(1992-12#1)(1995-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-12#1)
the titer##13##2##(1992-12#1)(1992-9#1)(1995-12#1)(1997-1#1)(2007-2#2)(2008-10#1)(2008-2#1)(2008-9#1)(2010-12#1)(2013-8#3)
the titers of##4##3##(2008-4#2)(2008-9#1)(2010-3#1)
the titers##5##2##(2008-4#2)(2008-8#1)(2008-9#1)(2010-3#1)
the title &quot##3##3##(1993-2#2)(1995-3#1)
the title and##3##3##(2008-4#2)(2013-1#1)
the title compound##9##3##(1996-7#1)(2004-7#2)(2007-11#3)(2008-10#1)(2008-11#1)(2013-1#1)
the title compounds were##2##4##(2007-11#2)
the title compounds##12##3##(1994-3#1)(1997-4#1)(2006-10#1)(2007-11#3)(2008-10#1)(2008-3#1)(2008-5#1)(2009-7#1)(2011-1#1)(2012-3#1)
the title of##6##3##(2007-5#1)(2008-8#1)(2010-11#1)(2010-12#2)(2011-1#1)
the title##44##2##(1991-12#1)(1992-3#1)(1993-1#1)(1993-2#2)(1994-3#1)(1995-3#1)(1996-5#1)(1996-7#1)(1997-4#1)(2004-7#2)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-5#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-8#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-1#2)(2012-3#1)(2013-1#2)
the titrant solution##4##3##(2008-10#4)
the titrant##21##2##(2008-10#21)
the titrants##2##2##(2004-9#1)(2008-10#1)
the titrated##2##2##(2008-10#2)
the titration cell##2##3##(2008-10#2)
the titration curve##3##3##(1997-2#1)(2008-10#2)
the titration curves##3##3##(1991-8#1)(1997-2#1)(2008-10#1)
the titration data##2##3##(2008-10#1)(2008-5#1)
the titration of a##2##4##(1991-4#1)(1991-9#1)
the titration of##7##3##(1991-4#1)(1991-9#1)(1992-7#1)(1996-12#1)(2008-10#3)
the titration to##2##3##(2008-10#2)
the titration##41##2##(1991-4#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-7#1)(1996-12#1)(1997-2#2)(2006-6#1)(2007-12#1)(2008-10#28)(2008-5#1)(2009-3#2)
the titre##4##2##(1992-10#2)(1995-6#1)(2007-11#1)
the titres##2##2##(1995-6#1)(2008-5#1)
the toad##8##2##(1992-11#1)(1993-5#2)(2007-1#3)(2008-5#1)(2008-6#1)
the tobacco growers##2##3##(2009-12#2)
the tobacco hornworm##3##3##(1991-12#1)(1992-3#1)(2008-7#1)
the tobacco industry##2##3##(2009-12#1)(2009-7#1)
the tobacco plant##2##3##(1990-5#1)(2006-12#1)
the tobacco##37##2##(1990-4#2)(1990-5#1)(1991-12#1)(1991-6#1)(1992-2#1)(1992-3#1)(1993-10#1)(1993-6#1)(1995-3#3)(1996-4#1)(1996-8#1)(1997-4#1)(2006-10#1)(2006-12#3)(2007-11#2)(2008-10#4)(2008-11#1)(2008-7#2)(2009-12#3)(2009-3#1)(2009-7#1)(2010-9#1)(2011-2#3)
the toe##2##2##(1992-3#1)(1993-12#1)
the toilet##2##2##(2007-12#1)(2008-1#1)
the tolerability of an##2##4##(1992-11#1)(1992-4#1)
the tolerability of##6##3##(1991-2#1)(1991-7#1)(1992-11#1)(1992-4#1)(1994-6#1)(2008-3#1)
the tolerability##11##2##(1990-7#1)(1991-2#2)(1991-7#1)(1992-11#1)(1992-4#1)(1994-6#1)(2008-3#1)(2008-4#1)(2009-8#1)(2013-1#1)
the tolerable##3##2##(2008-2#1)(2013-8#2)
the tolerance amount of other##2##5##(2008-10#2)
the tolerance limits##2##3##(2008-10#2)
the tolerance of the cervical spine##2##6##(2006-11#1)(2007-4#1)
the tolerance of the##10##4##(1992-2#1)(2006-11#6)(2007-4#2)(2008-3#1)
the tolerance of##19##3##(1992-2#1)(2004-4#2)(2005-11#1)(2006-11#6)(2007-4#3)(2008-2#1)(2008-3#2)(2008-6#1)(2011-1#1)(2013-1#1)
the tolerance to the##2##4##(1997-2#1)(2013-1#1)
the tolerance to##3##3##(1997-2#1)(2008-2#1)(2013-1#1)
the tolerance##40##2##(1990-5#1)(1991-11#1)(1992-2#1)(1995-4#2)(1997-2#1)(2004-4#2)(2005-11#1)(2006-11#6)(2007-11#1)(2007-4#3)(2008-10#10)(2008-2#2)(2008-3#4)(2008-5#1)(2008-6#1)(2011-1#1)(2013-1#2)
the tolerant mice##2##3##(1994-3#2)
the tolerant##7##2##(1994-3#2)(2008-10#3)(2009-8#1)(2011-10#1)
the toll-like receptor##3##3##(2008-3#1)(2009-8#1)(2013-8#1)
the toll-like##4##2##(2008-1#1)(2008-3#1)(2009-8#1)(2013-8#1)
the toluene layer##2##3##(2008-10#1)(2009-10#1)
the toluene##4##2##(2007-8#1)(2008-10#1)(2009-10#1)(2011-2#1)
the tomato and##2##3##(2008-10#2)
the tomato##14##2##(1990-3#1)(1995-2#1)(2006-12#1)(2008-10#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#1)(2011-2#1)
the tomographic##3##2##(2007-11#1)(2008-2#2)
the tone of##2##3##(1991-9#1)(2006-6#1)
the tone##4##2##(1991-9#1)(2006-6#1)(2008-10#1)(2008-2#1)
the tone-dependent##2##2##(2008-2#2)
the tongue and##8##3##(1993-1#2)(1997-6#1)(2006-2#1)(2007-2#1)(2007-3#1)(2013-1#2)
the tongue dorsum##2##3##(2006-8#2)
the tongue in two##2##4##(2007-3#1)(2013-1#1)
the tongue in##4##3##(2007-3#1)(2011-12#1)(2013-1#1)(2013-7#1)
the tongue is##2##3##(2007-8#1)(2010-9#1)
the tongue##55##2##(1990-1#1)(1993-1#3)(1994-5#1)(1995-9#1)(1997-4#1)(1997-6#1)(2006-2#8)(2006-8#4)(2007-11#1)(2007-2#1)(2007-3#3)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-8#2)(2009-10#1)(2009-12#1)(2010-12#1)(2010-6#2)(2010-9#2)(2011-12#3)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#3)(2013-1#4)(2013-7#1)
the tonic##8##2##(1991-9#1)(1992-8#1)(1995-12#1)(1997-7#1)(2004-12#1)(2007-1#1)(2008-1#1)(2008-8#1)
the tonic-clonic component##2##3##(1992-11#2)
the tonoplast##4##2##(1996-5#1)(2008-10#2)(2008-11#1)
the tonsils##7##2##(1995-2#1)(2008-4#1)(2010-4#5)
the tool for##3##3##(2007-11#1)(2008-10#1)(2011-1#1)
the tool was##4##3##(2007-12#2)(2008-11#1)(2008-12#1)
the tool##25##2##(1994-6#1)(2007-11#1)(2007-12#4)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-8#1)(2011-1#1)(2012-2#4)
the toolkit##6##2##(2009-12#1)(2013-1#5)
the tools and##2##3##(2011-11#1)(2012-12#1)
the tools for##2##3##(1993-6#1)(1996-6#1)
the tools of##5##3##(2007-10#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-9#1)
the tools that are##2##4##(2008-3#1)(2008-9#1)
the tools that##5##3##(1996-12#1)(2007-2#1)(2008-3#1)(2008-9#1)(2010-2#1)
the tools to##10##3##(1993-12#2)(1996-10#1)(1996-12#1)(2006-6#1)(2008-10#1)(2009-8#1)(2010-11#1)(2011-2#1)(2013-8#1)
the tools used##2##3##(1996-3#1)(2011-2#1)
the tools##38##2##(1993-12#2)(1993-6#1)(1996-1#2)(1996-10#1)(1996-12#2)(1996-3#1)(1996-6#1)(1997-7#1)(2005-10#2)(2006-6#1)(2007-10#1)(2007-2#1)(2007-4#1)(2007-6#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-9#3)(2009-10#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#1)(2011-11#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
the tooth pulp##2##3##(1994-5#1)(1996-2#1)
the tooth structure##2##3##(2008-7#1)(2010-10#1)
the tooth was disinfected with intracanal triple antibiotic paste for 2 weeks##2##12##(2013-1#2)
the tooth with##2##3##(2008-7#1)(2011-2#1)
the tooth##29##2##(1991-2#1)(1994-5#1)(1996-2#1)(1997-4#2)(2005-11#1)(2006-10#1)(2007-2#1)(2008-5#3)(2008-7#6)(2009-4#1)(2010-10#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#1)
the toothpaste##2##2##(2011-1#1)(2012-2#1)
the toothpick##2##2##(2008-10#1)(2013-7#1)
the top 10##3##3##(2005-11#1)(2009-9#1)(2013-8#1)
the top 10% of##3##4##(2008-1#1)(2010-2#2)
the top 10%##4##3##(2008-1#1)(2010-2#2)(2013-7#1)
the top 15##2##3##(2009-3#1)(2013-7#1)
the top and bottom##4##4##(2007-1#1)(2008-12#1)(2009-4#1)(2010-2#1)
the top and the bottom##5##5##(2008-2#3)(2008-3#2)
the top and##10##3##(2007-1#1)(2007-10#1)(2008-12#1)(2008-2#3)(2008-3#2)(2009-4#1)(2010-2#1)
the top component##2##3##(1992-8#1)(2008-9#1)
the top five##2##3##(2008-12#1)(2012-2#1)
the top of the atmosphere##2##5##(2008-2#2)
the top of the##25##4##(1990-7#1)(1992-12#1)(1994-3#1)(1994-9#1)(1995-6#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-2#1)(2006-11#1)(2006-12#2)(2006-6#1)(2007-10#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-8#1)(2010-6#1)
the top of transmembrane##2##4##(1994-9#2)
the top of##39##3##(1990-7#1)(1990-8#1)(1992-12#1)(1994-3#1)(1994-5#1)(1994-9#4)(1995-6#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-4#1)(2006-11#1)(2006-12#2)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-2#4)(2008-3#4)(2008-4#2)(2008-8#1)(2010-6#1)(2013-8#1)
the top port##2##3##(2008-6#2)
the top predator##2##3##(2008-8#1)(2008-9#1)
the top surface of the##3##5##(2007-12#1)(2008-3#1)(2008-7#1)
the top surface##4##3##(2007-12#1)(2008-3#1)(2008-7#1)(2013-8#1)
the top three countries##2##4##(1996-3#1)(2011-1#1)
the top three##5##3##(1996-3#1)(2006-4#1)(2008-10#1)(2011-1#1)(2013-1#1)
the top##133##2##(1990-7#1)(1990-8#1)(1992-12#1)(1992-8#2)(1993-12#1)(1993-3#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#4)(1995-10#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(2004-3#1)(2005-11#1)(2005-5#1)(2006-11#1)(2006-12#2)(2006-4#1)(2006-6#3)(2007-1#2)(2007-10#3)(2007-11#2)(2007-12#4)(2007-5#1)(2007-7#3)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#12)(2008-3#10)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#3)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#5)
the top-down modulation of##2##4##(2013-8#2)
the top-down##4##2##(2008-12#1)(2013-8#3)
the top-layer optical properties##2##4##(2008-2#1)(2008-3#1)
the top-layer##3##2##(2008-2#1)(2008-3#2)
the top1##2##2##(1995-5#2)
the topic and##2##3##(2007-4#1)(2009-4#1)
the topic for##2##3##(1992-2#1)(2005-8#1)
the topic in##2##3##(2006-2#1)(2012-12#1)
the topic is##3##3##(1994-2#1)(1996-2#1)(2012-2#1)
the topic model-based method performed the best in terms of recall and F-measure##2##13##(2013-1#2)
the topic of noneconomic damages in medical malpractice cases##2##9##(1991-1#1)(1992-1#1)
the topic of##24##3##(1990-10#1)(1991-1#1)(1992-1#1)(2006-10#2)(2006-11#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-4#3)(2012-2#1)(2013-1#1)(2013-7#1)
the topic was##2##3##(2008-10#1)(2012-3#1)
the topic with##2##3##(2007-1#1)(2013-8#1)
the topic##59##2##(1990-10#1)(1991-1#1)(1991-10#1)(1991-9#1)(1992-1#1)(1992-2#1)(1994-2#3)(1996-12#1)(1996-2#1)(1996-4#1)(2005-8#1)(2006-10#5)(2006-11#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#3)(2008-1#2)(2008-10#2)(2008-11#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#4)(2009-6#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
the topical application of##4##4##(1991-8#1)(2008-5#2)(2008-8#1)
the topical application##6##3##(1991-8#1)(2008-12#1)(2008-5#3)(2008-8#1)
the topical treatment of skin lesions##2##6##(1990-6#1)(1992-10#1)
the topical treatment of##5##4##(1990-6#2)(1992-10#1)(2007-11#1)(2010-8#1)
the topical##18##2##(1990-6#2)(1991-8#1)(1992-10#1)(1994-2#1)(2005-7#1)(2005-8#1)(2006-12#1)(2007-11#1)(2008-12#1)(2008-5#3)(2008-8#1)(2010-4#1)(2010-8#2)(2012-2#1)
the topics in##3##3##(2006-2#1)(2011-1#2)
the topics of##4##3##(1995-2#1)(1996-2#1)(2006-10#1)(2011-1#1)
the topics##19##2##(1990-5#1)(1994-2#2)(1995-2#1)(1996-2#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2008-11#1)(2008-4#1)(2008-5#2)(2011-1#3)(2011-2#1)(2012-3#1)
the topmost##3##2##(1990-4#1)(2007-12#1)(2008-2#1)
the topographic##5##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
the topographical organization of##2##4##(1994-2#1)(2010-12#1)
the topographical##9##2##(1991-9#1)(1992-7#1)(1994-2#2)(2007-9#1)(2008-3#2)(2010-12#1)(2012-1#1)
the topographically##3##2##(2010-1#1)(2012-12#2)
the topography of the##3##4##(1991-2#1)(1995-12#1)(2008-10#1)
the topography of##11##3##(1990-11#1)(1991-2#1)(1992-11#1)(1993-10#1)(1994-5#1)(1995-12#1)(2004-11#1)(2008-10#2)(2008-11#1)(2008-7#1)
the topography##20##2##(1990-11#1)(1991-2#1)(1992-11#1)(1993-10#1)(1994-5#1)(1995-12#1)(1995-6#1)(2004-11#1)(2006-4#1)(2008-10#2)(2008-11#1)(2008-3#4)(2008-7#2)(2011-2#1)(2012-1#1)
the topoisomerase I##2##3##(1992-8#1)(1995-3#1)
the topoisomerase II##3##3##(1990-2#1)(1994-6#1)(1994-8#1)
the topoisomerase##8##2##(1990-2#1)(1992-8#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-6#1)(1997-4#1)(2008-5#1)
the topological charges of##2##4##(2007-11#1)(2007-12#1)
the topological structure of##2##4##(1996-7#1)(2005-11#1)
the topological##11##2##(1996-7#1)(2005-11#1)(2006-12#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-4#1)(2012-2#1)
the topologically##6##2##(1997-1#1)(1997-7#1)(2007-12#1)(2008-2#1)(2010-12#1)(2010-2#1)
the topology and##5##3##(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-5#1)
the topology of the##9##4##(1990-11#1)(1992-11#1)(1995-6#1)(1995-8#1)(1996-4#1)(2006-10#1)(2008-7#1)(2013-1#1)(2013-8#1)
the topology of##12##3##(1990-11#1)(1990-8#1)(1992-11#1)(1992-4#1)(1995-6#1)(1995-8#1)(1996-4#1)(2006-10#1)(2008-3#1)(2008-7#1)(2013-1#1)(2013-8#1)
the topology##19##2##(1990-11#1)(1990-8#1)(1992-11#1)(1992-4#1)(1995-6#1)(1995-8#1)(1996-4#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
the torch##2##2##(2008-10#1)(2010-9#1)
the torcular##2##2##(1996-9#2)
the torque##6##2##(1993-12#1)(1995-8#1)(2008-3#2)(2012-1#1)(2013-1#1)
the torsion angles##2##3##(1990-9#1)(2008-4#1)
the torsion##5##2##(1990-9#1)(1996-8#1)(2008-4#1)(2011-2#1)(2012-2#1)
the torsional##4##2##(1996-2#1)(1996-5#1)(1996-8#1)(2012-1#1)
the torture##2##2##(1996-3#1)(2013-1#1)
the torus semicircularis##2##3##(1995-5#1)(1997-3#1)
the total ATP##2##3##(1996-2#1)(1996-5#1)
the total Bohr##2##3##(1994-8#2)
the total DNA polymerase##2##4##(1991-7#2)
the total DNA##5##3##(1991-7#2)(2008-10#1)(2008-4#1)(2008-5#1)
the total Medicaid##2##3##(1991-3#1)(1992-3#1)
the total N##2##3##(2007-7#1)(2013-8#1)
the total RNA##5##3##(2005-11#1)(2007-1#1)(2008-10#2)(2008-7#1)
the total TEQ##2##3##(2008-10#2)
the total absence of##2##4##(2008-5#1)(2008-7#1)
the total absence##3##3##(1997-7#1)(2008-5#1)(2008-7#1)
the total absorption##3##3##(2008-3#3)
the total acid##2##3##(2008-10#1)(2008-3#1)
the total acidity##2##3##(2008-10#2)
the total activity of##2##4##(1994-9#1)(2009-8#1)
the total activity##3##3##(1992-6#1)(1994-9#1)(2009-8#1)
the total amino acid##2##4##(1990-6#1)(2010-4#1)
the total amino##3##3##(1990-6#1)(2010-4#2)
the total amount of food##3##5##(2009-5#2)(2011-2#1)
the total amount of##40##4##(1990-7#1)(1991-2#1)(1991-6#1)(1991-9#1)(1993-9#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-12#3)(1996-2#1)(1997-3#1)(2004-11#1)(2006-10#1)(2006-4#1)(2007-1#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-3#1)(2008-6#1)(2008-8#4)(2009-5#2)(2010-2#1)(2010-4#1)(2011-2#1)
the total amount##44##3##(1990-7#1)(1991-2#1)(1991-6#1)(1991-9#1)(1993-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-5#1)(1997-3#1)(2004-11#1)(2006-10#1)(2006-4#1)(2007-1#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-3#1)(2008-6#1)(2008-8#4)(2009-5#2)(2010-2#1)(2010-4#1)(2011-2#1)
the total analysis time##2##4##(2008-10#2)
the total analytical system##2##4##(2010-7#2)
the total and##5##3##(1993-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)
the total annual##2##3##(2012-12#1)(2013-8#1)
the total antioxidant activity##2##4##(2008-10#2)
the total antioxidant capacity of##3##5##(2008-10#1)(2009-6#1)(2013-8#1)
the total antioxidant capacity##6##4##(2008-10#2)(2009-6#1)(2013-1#1)(2013-8#2)
the total antioxidant##10##3##(2008-10#4)(2009-6#1)(2013-1#1)(2013-8#4)
the total area of erosions and the level of thiobarbituric acid-reactive substances##2##12##(1995-12#2)
the total area of erosions and##4##6##(1995-12#4)
the total area of##6##4##(1995-12#4)(2008-4#1)(2008-6#1)
the total area##9##3##(1995-12#4)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2012-1#1)
the total arsenic##2##3##(2008-10#2)
the total assay time##4##4##(1996-12#1)(2007-8#1)(2008-10#1)(2010-5#1)
the total atmospheric##2##3##(1991-6#1)(2008-3#1)
the total backscattering coefficient##2##4##(2008-2#1)(2008-3#1)
the total backscattering##4##3##(2008-2#2)(2008-3#2)
the total bacterial##4##3##(1992-2#1)(2005-11#1)(2008-8#1)(2010-4#1)
the total biomass##4##3##(2007-3#1)(2008-7#3)
the total body##2##3##(1992-2#1)(2013-1#1)
the total burden of##2##4##(1992-2#1)(2007-11#1)
the total care##2##3##(1992-2#1)(2012-2#1)
the total cell concentration##2##4##(1990-2#1)(2008-11#1)
the total cell##7##3##(1990-2#1)(1994-12#1)(1994-8#1)(2008-1#1)(2008-11#2)(2012-1#1)
the total cellular ATP metabolic rate##2##6##(1996-5#2)
the total cellular drug content and##2##6##(1996-1#2)
the total cellular##13##3##(1990-3#2)(1991-1#1)(1992-4#1)(1995-11#1)(1996-1#2)(1996-5#2)(1996-8#1)(2007-2#1)(2008-8#1)(2008-9#1)
the total chemical##2##3##(2008-1#1)(2013-1#1)
the total cholesterol##2##3##(1990-8#1)(2012-2#1)
the total chromatography##2##3##(2008-10#2)
the total concentration of the##3##5##(2005-11#1)(2008-10#2)
the total concentration of##12##4##(1994-2#1)(1994-9#1)(2005-11#1)(2008-10#8)(2012-1#1)
the total concentration##13##3##(1994-2#1)(1994-9#1)(2005-11#1)(2008-10#9)(2012-1#1)
the total concentrations of##2##4##(1995-2#1)(2008-10#1)
the total concentrations##3##3##(1990-11#1)(1995-2#1)(2008-10#1)
the total consumption##2##3##(2010-12#2)
the total content of##4##4##(1992-6#1)(2004-2#1)(2007-1#1)(2008-10#1)
the total content##5##3##(1992-6#1)(2004-2#1)(2007-1#1)(2008-10#2)
the total cost of##2##4##(2006-12#1)(2006-8#1)
the total cost##4##3##(1994-12#1)(2006-12#2)(2006-8#1)
the total costs of the##2##5##(1992-12#1)(2007-7#1)
the total costs##3##3##(1992-12#1)(2007-7#1)(2011-1#1)
the total current##2##3##(2006-6#1)(2008-8#1)
the total decomposition##2##3##(2008-10#2)
the total density##2##3##(2008-10#1)(2008-8#1)
the total depolarization##2##3##(2008-3#2)
the total dissolved##2##3##(2008-10#2)
the total distance##3##3##(2007-4#1)(2008-3#2)
the total dose of##2##4##(2007-9#1)(2010-7#1)
the total dose##8##3##(2006-12#1)(2007-10#2)(2007-9#1)(2008-7#1)(2010-7#1)(2013-1#2)
the total dye content##2##4##(2008-10#2)
the total effect##2##3##(2007-11#1)(2008-1#1)
the total effective rate was##2##5##(2006-4#2)
the total effective rate##3##4##(2006-4#3)
the total endoscopic##2##3##(2007-8#1)(2008-11#1)
the total energy##5##3##(1997-7#1)(2006-10#1)(2007-12#1)(2008-8#1)(2008-9#1)
the total enthalpy of##2##4##(1997-7#1)(2008-2#1)
the total enthalpy##5##3##(1994-3#1)(1997-7#2)(2006-10#1)(2008-2#1)
the total error##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
the total evaporation##2##3##(2008-10#2)
the total extractable##2##3##(2006-12#1)(2010-3#1)
the total family##2##3##(1993-12#1)(2010-9#1)
the total fatty acid content##2##5##(1997-2#1)(2007-11#1)
the total fatty##4##3##(1997-2#1)(2005-12#2)(2007-11#1)
the total field##2##3##(1992-12#1)(2007-12#1)
the total flow##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
the total foamate volume##2##4##(2008-6#2)
the total free##2##3##(2006-10#1)(2007-3#1)
the total global##2##3##(2005-7#1)(2010-12#1)
the total glucose metabolism##2##4##(2008-3#2)
the total graftectomy (TGE)##2##4##(2011-3#2)
the total group##6##3##(1994-11#1)(2006-10#2)(2006-7#1)(2008-8#1)(2009-1#1)
the total hemoglobin concentration##2##4##(2008-2#1)(2008-3#1)
the total hip##2##3##(2010-3#1)(2013-1#1)
the total immunoreactive##2##3##(1991-7#1)(1996-12#1)
the total impact of##2##4##(2006-12#1)(2010-9#1)
the total incidence of##2##4##(1992-2#1)(2007-8#1)
the total internal reflection##5##4##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
the total internal##6##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)
the total intracellular##3##3##(1990-12#1)(1994-3#1)(1995-11#1)
the total ion current##2##4##(2005-12#1)(2008-10#1)
the total ion##3##3##(2005-12#1)(2008-10#2)
the total length of the sequences##2##6##(1997-8#1)(2006-10#1)
the total length##4##3##(1996-10#1)(1997-8#1)(2006-10#1)(2008-5#1)
the total level of##2##4##(1994-9#1)(1997-8#1)
the total light intensity##2##4##(2008-1#1)(2010-9#1)
the total light##4##3##(1991-8#1)(2007-12#1)(2008-1#1)(2010-9#1)
the total lipid##2##3##(1990-5#1)(1991-10#1)
the total mass##2##3##(1994-12#1)(2008-10#1)
the total measured##2##3##(2007-8#1)(2008-3#1)
the total membrane##4##3##(1990-2#1)(1991-3#1)(1992-3#1)(1993-3#1)
the total molecular##2##3##(1993-4#1)(2008-10#1)
the total mortality##2##3##(1992-2#1)(2013-8#1)
the total muscle##2##3##(2006-11#1)(2008-5#1)
the total nitrogen##6##3##(2008-11#1)(2013-1#1)(2013-8#4)
the total nuclear NMN adenylyltransferase##2##5##(1992-12#2)
the total nuclear##3##3##(1990-7#1)(1992-12#2)
the total nucleated cell count was increased (P &lt##2##9##(2006-5#2)
the total number of carbon atoms in##2##7##(1990-7#1)(2008-10#1)
the total number of cardiac##2##5##(1995-12#1)(2006-10#1)
the total number of cells in embryos##2##7##(2006-5#2)
the total number of cells in hatched blastocysts##2##8##(2006-5#2)
the total number of cells in##4##6##(2006-5#4)
the total number of cells##6##5##(2006-5#5)(2008-1#1)
the total number of citations##2##5##(2012-2#1)(2013-1#1)
the total number of deaths in##2##6##(1991-9#1)(2011-3#1)
the total number of eggs##2##5##(2008-3#1)(2008-4#1)
the total number of gazing points##2##6##(2004-11#2)
the total number of individuals##2##5##(1993-9#1)(2007-9#1)
the total number of offspring##2##5##(2008-8#1)(2008-9#1)
the total number of patients##5##5##(1991-4#1)(1992-6#1)(1993-1#1)(1995-2#1)(2009-3#1)
the total number of sensor-reference data pairs was approximately##2##9##(2009-9#2)
the total number of##103##4##(1990-12#1)(1990-6#1)(1990-7#1)(1991-4#2)(1991-5#2)(1991-9#1)(1992-1#1)(1992-6#2)(1993-1#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-7#1)(1997-3#1)(1997-6#3)(1997-7#1)(2004-11#2)(2005-10#2)(2005-11#1)(2005-8#1)(2005-9#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#5)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-3#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
the total number##105##3##(1990-12#1)(1990-6#1)(1990-7#1)(1991-4#2)(1991-5#2)(1991-9#1)(1992-1#1)(1992-6#2)(1993-1#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-7#1)(1997-3#1)(1997-6#3)(1997-7#1)(2004-11#2)(2005-10#2)(2005-11#1)(2005-8#1)(2005-9#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#5)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-3#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
the total numbers##3##3##(1993-7#1)(2007-5#1)(2011-2#1)
the total of the##2##4##(1992-6#1)(2008-12#1)
the total of##20##3##(1990-10#1)(1991-8#1)(1992-6#1)(1997-6#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-2#2)(2010-1#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-11#1)(2013-1#1)
the total optical##2##3##(2008-3#1)(2010-12#1)
the total organic carbon content##3##5##(2005-11#2)(2008-10#1)
the total organic carbon##4##4##(2005-11#2)(2008-10#1)(2011-1#1)
the total organic##6##3##(2005-11#2)(2007-7#1)(2008-10#2)(2011-1#1)
the total phenolic content##2##4##(2004-2#1)(2008-11#1)
the total plasma##3##3##(1990-3#1)(1993-11#1)(2006-12#1)
the total pool of##2##4##(1996-8#2)
the total population of Antioquia##2##5##(2012-12#2)
the total population of##8##4##(1995-3#2)(1996-5#1)(2007-9#1)(2008-1#1)(2008-5#1)(2012-12#2)
the total population size##3##4##(2004-11#2)(2008-8#1)
the total population was##2##4##(2007-3#1)(2008-10#1)
the total population##29##3##(1994-2#1)(1994-3#1)(1995-3#2)(1996-5#1)(1996-6#1)(2004-11#2)(2007-3#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-2#1)(2012-12#2)(2013-1#1)(2013-8#4)
the total power launched##2##4##(2007-11#1)(2007-12#1)
the total power##4##3##(2006-6#1)(2007-11#1)(2007-12#1)(2010-8#1)
the total process##2##3##(2007-7#1)(2008-5#1)
the total production of##2##4##(1992-3#1)(2007-12#1)
the total production##3##3##(1991-11#1)(1992-3#1)(2007-12#1)
the total protein##13##3##(1990-11#1)(1991-7#1)(1993-12#1)(1995-2#1)(1996-2#1)(2006-12#1)(2008-10#3)(2008-6#3)(2012-11#1)
the total proteins##4##3##(1996-8#1)(2008-8#3)
the total quality management process##2##5##(1994-1#1)(1994-2#1)
the total quality management##3##4##(1994-1#1)(1994-2#1)(1995-3#1)
the total quality##4##3##(1992-12#1)(1994-1#1)(1994-2#1)(1995-3#1)
the total radiance##2##3##(2008-2#1)(2008-3#1)
the total radioactivity##5##3##(1992-2#2)(1993-11#1)(1996-6#1)(1997-8#1)
the total recovery of##2##4##(1993-2#1)(2010-12#1)
the total recovery was##3##4##(2008-10#1)(2008-5#1)(2013-8#1)
the total recovery##5##3##(1993-2#1)(2008-10#1)(2008-5#1)(2010-12#1)(2013-8#1)
the total reflectance##3##3##(2008-2#1)(2008-3#2)
the total reimbursement##2##3##(1990-10#1)(2007-4#1)
the total sample and##3##4##(2008-5#2)(2013-7#1)
the total sample of##2##4##(1996-3#1)(2006-8#1)
the total sample##14##3##(1993-8#1)(1994-3#1)(1996-3#1)(2006-6#1)(2006-8#2)(2008-10#1)(2008-5#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
the total score and##2##4##(2007-12#1)(2011-1#1)
the total score of##3##4##(2004-3#1)(2011-1#2)
the total score##8##3##(1991-9#1)(1996-8#1)(2004-3#1)(2007-12#1)(2010-10#1)(2011-1#3)
the total selenium content##2##4##(2008-10#2)
the total serum##7##3##(1990-2#1)(1993-12#1)(1993-2#1)(1994-5#1)(2006-6#1)(2007-1#1)(2011-1#1)
the total soluble##4##3##(1993-12#1)(1993-3#1)(1994-5#1)(2008-9#1)
the total spin##2##3##(1997-7#1)(2008-10#1)
the total study##3##3##(1991-9#1)(2006-4#1)(2007-7#1)
the total sulphur content##2##4##(2008-10#2)
the total surface area##3##4##(1997-1#1)(2008-3#1)(2010-10#1)
the total surfactant concentration##2##4##(2008-10#1)(2008-5#1)
the total surfactant##3##3##(2005-11#1)(2008-10#1)(2008-5#1)
the total synthesis of##4##4##(1995-6#1)(2007-11#1)(2008-7#1)(2010-12#1)
the total synthesis##5##3##(1995-6#1)(2007-11#1)(2008-7#2)(2010-12#1)
the total time##3##3##(1991-2#1)(1993-9#1)(2007-8#1)
the total tin##2##3##(2004-4#1)(2005-4#1)
the total tissue##2##3##(1994-5#1)(2008-7#1)
the total trace metal##2##4##(2007-5#1)(2007-8#1)
the total uncertainty##2##3##(2008-10#1)(2008-3#1)
the total uptake##3##3##(1990-5#1)(1992-3#1)(2010-12#1)
the total variability##3##3##(1994-3#1)(2008-10#2)
the total variance##21##3##(1993-8#1)(1997-5#1)(2007-10#1)(2008-10#11)(2008-11#1)(2008-5#1)(2008-8#1)(2010-12#2)(2010-2#1)(2011-2#1)
the total variation##7##3##(2008-10#2)(2008-2#1)(2008-8#1)(2010-12#2)(2013-1#1)
the total viable##2##3##(1997-5#1)(2010-4#1)
the total volume of the Golgi apparatus##2##7##(2007-9#2)
the total volume of the##4##5##(1990-5#1)(1996-6#1)(2007-9#2)
the total volume of##8##4##(1990-5#1)(1996-6#1)(2007-11#1)(2007-9#2)(2012-12#2)(2013-7#1)
the total volume##9##3##(1990-5#1)(1996-6#1)(2007-11#1)(2007-9#2)(2008-11#1)(2012-12#2)(2013-7#1)
the total work##3##3##(1996-1#1)(2008-11#1)(2009-9#1)
the total##1124##2##(1990-1#1)(1990-10#4)(1990-11#3)(1990-12#2)(1990-2#5)(1990-3#6)(1990-4#1)(1990-5#3)(1990-6#3)(1990-7#5)(1990-8#4)(1991-1#2)(1991-10#2)(1991-11#3)(1991-12#2)(1991-2#2)(1991-3#5)(1991-4#3)(1991-5#5)(1991-6#5)(1991-7#4)(1991-8#4)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#6)(1992-2#10)(1992-3#10)(1992-4#1)(1992-6#7)(1992-8#2)(1992-9#1)(1993-1#2)(1993-11#4)(1993-12#4)(1993-2#3)(1993-3#3)(1993-4#3)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#5)(1993-9#5)(1994-1#2)(1994-10#1)(1994-11#2)(1994-12#5)(1994-2#7)(1994-3#8)(1994-5#6)(1994-6#2)(1994-8#7)(1994-9#5)(1995-1#4)(1995-11#2)(1995-12#7)(1995-2#5)(1995-3#8)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#4)(1996-10#2)(1996-11#1)(1996-12#7)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#5)(1996-6#4)(1996-7#2)(1996-8#5)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#4)(1997-4#4)(1997-5#4)(1997-6#6)(1997-7#7)(1997-8#4)(2004-11#6)(2004-12#1)(2004-2#4)(2004-3#1)(2004-4#3)(2004-9#1)(2005-10#2)(2005-11#13)(2005-12#5)(2005-4#3)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#17)(2006-11#2)(2006-12#9)(2006-4#8)(2006-5#8)(2006-6#7)(2006-7#2)(2006-8#8)(2007-1#7)(2007-10#4)(2007-11#14)(2007-12#22)(2007-2#3)(2007-3#8)(2007-4#4)(2007-5#7)(2007-6#3)(2007-7#13)(2007-8#13)(2007-9#6)(2008-1#13)(2008-10#168)(2008-11#25)(2008-12#4)(2008-2#28)(2008-3#46)(2008-4#8)(2008-5#28)(2008-6#13)(2008-7#22)(2008-8#28)(2008-9#6)(2009-1#1)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#5)(2009-8#4)(2009-9#6)(2010-1#3)(2010-10#2)(2010-11#3)(2010-12#12)(2010-2#8)(2010-3#2)(2010-4#6)(2010-5#2)(2010-7#5)(2010-8#2)(2010-9#3)(2011-1#16)(2011-10#1)(2011-12#2)(2011-2#23)(2011-3#3)(2012-1#6)(2012-11#3)(2012-12#12)(2012-2#8)(2012-3#7)(2012-8#1)(2013-1#23)(2013-7#7)(2013-8#32)
the total-internal-reflection##3##2##(2008-2#2)(2008-3#1)
the totality of the##4##4##(1993-8#1)(1996-6#1)(2007-10#1)(2009-8#1)
the totality of##5##3##(1993-8#1)(1996-6#1)(2006-3#1)(2007-10#1)(2009-8#1)
the totally##5##2##(1990-3#2)(2007-7#1)(2008-9#1)(2011-1#1)
the touch##2##2##(1991-3#1)(2007-5#1)
the tough##4##2##(1994-12#1)(1996-1#1)(1996-3#1)(2008-8#1)
the toughness of##2##3##(1997-4#1)(2004-9#1)
the toughness##3##2##(1997-4#1)(2004-9#1)(2005-10#1)
the town of Cabar##3##4##(2011-2#3)
the town of##14##3##(1994-11#1)(1995-1#1)(2005-9#1)(2006-7#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#5)(2012-12#1)
the town##19##2##(1990-2#1)(1994-11#1)(1995-1#1)(2005-9#1)(2006-7#1)(2007-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#5)(2012-12#2)(2013-8#1)
the tox(-) isolates##2##3##(2008-10#2)
the toxA promoter##2##3##(1995-2#2)
the toxic action of##3##4##(1992-11#1)(1996-8#1)(2010-2#1)
the toxic and##2##3##(1994-12#1)(2008-5#1)
the toxic effect of##8##4##(1990-7#1)(1992-6#1)(1993-12#1)(1993-5#1)(1997-3#1)(2008-7#1)(2010-2#1)(2011-12#1)
the toxic effect on##2##4##(2008-4#1)(2012-1#1)
the toxic effect##12##3##(1990-7#1)(1992-6#1)(1993-12#1)(1993-5#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-2#1)(2011-12#1)(2012-1#2)
the toxic effects of beta-amyloid##2##5##(1995-12#2)
the toxic effects of hydrogen peroxide##2##6##(1991-9#2)
the toxic effects of hyperglycemia##2##5##(2005-10#1)(2008-1#1)
the toxic effects of the##3##5##(1996-10#1)(2008-12#1)(2009-6#1)
the toxic effects of##24##4##(1990-5#1)(1991-9#2)(1992-8#1)(1993-9#2)(1994-5#2)(1995-12#2)(1996-1#1)(1996-10#1)(2005-10#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-6#1)(2010-4#1)(2012-12#1)(2013-1#1)
the toxic effects##27##3##(1990-5#1)(1991-9#2)(1992-8#1)(1993-9#2)(1994-5#2)(1995-12#2)(1996-1#1)(1996-10#1)(1997-8#1)(2005-10#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#2)(2009-6#1)(2010-4#1)(2011-12#1)(2012-12#1)(2013-1#1)
the toxic fraction##2##3##(2008-10#2)
the toxic nature of##2##4##(2008-10#1)(2013-7#1)
the toxic potency of the##2##5##(1996-12#2)
the toxic potency##4##3##(1996-12#4)
the toxic potential##2##3##(1997-3#1)(2005-10#1)
the toxic substance##2##3##(2008-5#2)
the toxic substances##2##3##(2008-11#1)(2008-5#1)
the toxic##84##2##(1990-5#1)(1990-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-5#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-5#2)(1995-12#2)(1995-3#1)(1996-1#1)(1996-10#1)(1996-12#4)(1996-8#1)(1997-3#2)(1997-8#1)(2004-2#1)(2005-10#2)(2006-12#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#4)(2009-6#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
the toxicities of##3##3##(2008-11#1)(2009-2#1)(2009-7#1)
the toxicities##6##2##(1995-7#1)(2008-11#1)(2009-2#1)(2009-3#1)(2009-7#1)(2013-1#1)
the toxicity and##6##3##(1994-11#1)(1995-8#1)(2005-11#1)(2008-5#1)(2008-6#1)(2008-7#1)
the toxicity associated with##4##4##(1995-1#1)(2006-10#1)(2007-11#2)
the toxicity of Hg2+##3##4##(1992-11#3)
the toxicity of a number of##2##6##(1992-3#1)(1993-11#1)
the toxicity of a##5##4##(1992-3#1)(1993-11#1)(1994-5#1)(2006-5#1)(2011-2#1)
the toxicity of butylated hydroxyanisole##2##5##(1992-11#2)
the toxicity of dichloropropanol##2##4##(1997-3#2)
the toxicity of free radicals##2##5##(1990-3#1)(2008-10#1)
the toxicity of heavy metal##2##5##(2008-7#1)(2013-8#1)
the toxicity of some##2##4##(1993-11#1)(1996-2#1)
the toxicity of the##14##4##(1995-3#1)(1995-5#1)(1996-10#1)(1996-12#1)(1997-2#1)(2006-5#2)(2007-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-10#1)(2013-1#1)
the toxicity of these drugs##2##5##(2008-3#1)(2010-4#1)
the toxicity of these herbicides##2##5##(2006-5#2)
the toxicity of these##6##4##(1993-6#1)(2006-5#2)(2008-3#1)(2008-5#1)(2010-4#1)
the toxicity of this##4##4##(1991-10#1)(1995-2#1)(1996-7#1)(2010-12#1)
the toxicity of##88##3##(1990-3#1)(1990-4#1)(1990-7#1)(1991-10#1)(1992-11#5)(1992-3#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-6#1)(1994-3#1)(1994-5#3)(1995-1#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#3)(1996-10#1)(1996-12#3)(1996-2#1)(1996-4#2)(1996-6#2)(1996-7#1)(1997-2#3)(1997-3#4)(2005-8#1)(2006-10#1)(2006-5#6)(2007-2#1)(2007-9#1)(2008-10#6)(2008-12#2)(2008-3#1)(2008-5#4)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#2)
the toxicity##123##2##(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-10#1)(1992-11#5)(1992-3#1)(1992-5#1)(1993-11#2)(1993-12#1)(1993-3#3)(1993-6#1)(1994-11#1)(1994-3#1)(1994-5#3)(1995-1#2)(1995-2#1)(1995-3#3)(1995-5#2)(1995-8#4)(1996-10#1)(1996-12#4)(1996-2#1)(1996-4#2)(1996-6#2)(1996-7#1)(1997-2#4)(1997-3#4)(2005-11#1)(2005-8#2)(2005-9#1)(2006-10#2)(2006-5#6)(2007-11#3)(2007-2#1)(2007-9#1)(2008-10#10)(2008-12#3)(2008-3#1)(2008-5#6)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#2)(2009-10#1)(2009-4#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#3)
the toxicity-based SQG##2##3##(2012-1#2)
the toxicological and##2##3##(2008-11#1)(2013-1#1)
the toxicological##11##2##(1996-12#1)(1996-8#1)(2005-10#1)(2008-10#4)(2008-11#1)(2012-11#1)(2013-1#2)
the toxicologically relevant##2##3##(1996-8#1)(2008-3#1)
the toxicology of##4##3##(1996-8#1)(2008-5#1)(2008-7#2)
the toxicology##12##2##(1990-5#1)(1996-8#1)(2007-7#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2013-1#2)
the toxin also##2##3##(1994-2#1)(2008-10#1)
the toxin binding##2##3##(1994-3#2)
the toxin by##2##3##(1990-5#1)(1997-6#1)
the toxin has been##2##4##(2008-10#1)(2008-8#1)
the toxin has##3##3##(1991-5#1)(2008-10#1)(2008-8#1)
the toxin in##6##3##(1990-2#1)(1990-5#1)(1994-12#1)(2008-10#2)(2008-8#1)
the toxin is able to##2##5##(2006-8#2)
the toxin is##7##3##(1991-5#1)(1994-2#1)(2006-8#2)(2007-12#1)(2008-10#2)
the toxin produced by##2##4##(2008-10#2)
the toxin sequence##3##3##(1994-2#1)(2010-6#2)
the toxin##74##2##(1990-10#1)(1990-2#2)(1990-3#2)(1990-5#2)(1991-10#1)(1991-12#2)(1991-5#2)(1991-9#2)(1992-9#1)(1993-7#1)(1994-12#1)(1994-2#7)(1994-3#2)(1994-9#1)(1995-2#1)(1995-7#2)(1995-8#1)(1996-8#1)(1996-9#1)(1997-6#2)(2006-7#1)(2006-8#4)(2007-12#1)(2007-8#1)(2008-10#22)(2008-11#1)(2008-5#1)(2008-8#3)(2010-10#1)(2010-6#2)(2011-2#1)(2012-12#1)
the toxins against##2##3##(1994-3#1)(2004-11#1)
the toxins that##2##3##(2006-10#1)(2008-5#1)
the toxins to##2##3##(2008-11#1)(2009-2#1)
the toxins##17##2##(1990-5#1)(1992-8#2)(1993-12#1)(1994-3#3)(1995-1#1)(1997-4#1)(2004-11#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-2#1)
the toy##2##2##(2011-2#1)(2013-8#1)
the traT gene and##2##4##(1991-8#2)
the traT gene##7##3##(1991-8#7)
the trabecular meshwork##2##3##(2011-2#2)
the trabecular structure##2##3##(2012-2#1)(2013-8#1)
the trabecular##8##2##(2008-7#1)(2009-7#1)(2010-10#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
the trace amounts of##2##4##(2005-4#1)(2008-10#1)
the trace analysis of##6##4##(2008-10#3)(2008-3#1)(2012-12#1)(2013-7#1)
the trace determination of##4##4##(2008-10#4)
the trace element status of farmed##2##6##(2005-7#2)
the trace element##5##3##(2005-7#2)(2008-10#2)(2011-2#1)
the trace elements##5##3##(2005-11#1)(2008-10#2)(2008-5#1)(2013-8#1)
the trace level##4##3##(2008-1#1)(2008-10#2)(2013-7#1)
the trace maker##2##3##(2013-1#2)
the trace metal extraction by EDTA##2##6##(2008-10#2)
the trace metal##3##3##(2008-10#2)(2008-5#1)
the trace metals##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
the trace##44##2##(2005-11#1)(2005-4#1)(2005-7#2)(2008-1#1)(2008-10#21)(2008-3#2)(2008-5#4)(2009-5#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#2)(2013-8#1)
the trace-back operation##2##3##(2008-3#2)
the tracer and##3##3##(2008-2#2)(2010-5#1)
the tracer at##2##3##(1990-5#1)(1991-12#1)
the tracer##20##2##(1990-12#1)(1990-5#2)(1991-12#1)(1991-7#1)(1995-12#1)(1996-12#1)(2006-5#1)(2008-10#1)(2008-2#5)(2008-5#1)(2010-12#2)(2010-2#1)(2010-5#1)(2012-2#1)
the trachea and##8##3##(1993-8#1)(2007-8#2)(2008-5#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-12#1)
the trachea##41##2##(1991-11#1)(1992-10#1)(1993-8#1)(1994-3#1)(1994-5#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(2006-10#1)(2007-8#7)(2008-10#1)(2008-5#6)(2008-8#3)(2008-9#1)(2009-2#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-5#2)(2011-1#4)(2013-1#1)
the tracheae##3##2##(2007-12#3)
the tracheal bronchial##2##3##(1997-1#2)
the tracheal epithelium##2##3##(1990-4#1)(2008-1#1)
the tracheal investment of the##2##5##(2007-12#2)
the tracheal lumen##4##3##(1990-4#2)(2008-10#1)(2008-5#1)
the tracheal system of##2##4##(2007-12#2)
the tracheal wall##3##3##(1993-7#2)(2008-5#1)
the tracheal walls##3##3##(2007-12#3)
the tracheal wound##3##3##(2009-6#3)
the tracheal##30##2##(1990-4#3)(1993-7#3)(1993-8#1)(1996-3#2)(1997-1#2)(1997-6#1)(2007-12#7)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-5#2)(2009-6#3)(2013-1#1)
the tracheo-bronchial tree##2##3##(2007-8#1)(2009-4#1)
the tracheo-bronchial##3##2##(2007-8#1)(2008-5#1)(2009-4#1)
the tracheobronchial tree##6##3##(1991-4#1)(2007-8#1)(2008-5#3)(2010-12#1)
the tracheobronchial##9##2##(1991-4#1)(1996-1#1)(1997-1#1)(2007-8#1)(2008-5#4)(2010-12#1)
the tracheostomy##3##2##(2006-4#1)(2008-2#1)(2009-6#1)
the tracings##2##2##(1994-3#1)(2008-4#1)
the track using##2##3##(2008-3#1)(2010-12#1)
the track##8##2##(1994-7#1)(2008-2#2)(2008-3#4)(2010-12#1)
the tracked##6##2##(2007-11#1)(2008-6#1)(2009-12#2)(2011-1#1)(2012-2#1)
the tracking and##2##3##(2008-2#1)(2008-3#1)
the tracking system is##2##4##(2008-2#2)
the tracking system##3##3##(2008-2#3)
the tracking##18##2##(1992-6#1)(2008-2#10)(2008-3#2)(2010-2#2)(2012-1#1)(2013-1#2)
the tracks##2##2##(2008-2#1)(2011-12#1)
the tract of##2##3##(1996-12#1)(1996-3#1)
the tract##5##2##(1990-4#1)(1996-12#1)(1996-3#1)(1997-3#1)(2007-1#1)
the traction##2##2##(2005-10#1)(2008-10#1)
the trade union##2##3##(1993-3#2)
the trade##9##2##(1990-7#1)(1993-3#2)(2006-1#1)(2007-5#1)(2007-8#1)(2009-4#1)(2010-11#1)(2013-8#1)
the trade-off between the##3##4##(2008-2#1)(2008-3#2)
the trade-off between##12##3##(1991-5#1)(1995-2#1)(2007-3#1)(2008-2#3)(2008-3#3)(2008-8#1)(2008-9#1)(2012-3#1)
the trade-off##16##2##(1991-5#1)(1994-3#1)(1995-2#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-8#1)(2008-9#1)(2010-8#1)(2012-3#1)
the trade-offs between##5##3##(1994-2#1)(1996-1#1)(2008-3#1)(2008-9#1)(2013-8#1)
the trade-offs that##2##3##(2008-3#1)(2010-3#1)
the trade-offs##10##2##(1994-2#1)(1996-1#1)(2008-3#2)(2008-8#2)(2008-9#2)(2010-3#1)(2013-8#1)
the tradeoff between##2##3##(2008-2#1)(2012-1#1)
the tradeoff##3##2##(2008-2#1)(2008-9#1)(2012-1#1)
the tradition of##3##3##(2008-2#1)(2008-8#1)(2009-4#1)
the tradition##4##2##(2007-8#1)(2008-2#1)(2008-8#1)(2009-4#1)
the traditional &quot##5##3##(1995-8#1)(2007-10#1)(2007-5#2)(2012-2#1)
the traditional Chinese##4##3##(1992-2#1)(2006-10#1)(2010-2#1)(2013-7#1)
the traditional International Union of Pure and Applied Chemistry##2##9##(2008-5#2)
the traditional absorbance##4##3##(2008-2#1)(2008-4#2)(2008-9#1)
the traditional analysis##2##3##(1993-7#1)(2008-7#1)
the traditional approach of##2##4##(2008-11#1)(2008-4#1)
the traditional approach##4##3##(2006-5#1)(2007-5#1)(2008-11#1)(2008-4#1)
the traditional case-control##2##3##(2008-4#1)(2012-3#1)
the traditional clinical##3##3##(1994-1#1)(2008-1#1)(2010-11#1)
the traditional concept of##3##4##(2006-5#1)(2008-1#1)(2008-7#1)
the traditional concept##4##3##(2006-5#1)(2008-1#1)(2008-7#1)(2008-8#1)
the traditional cost-based approach in##2##5##(1992-1#2)
the traditional curriculum##2##3##(2012-3#2)
the traditional financial and management subjects##2##6##(1996-1#2)
the traditional framework of##2##4##(2009-4#1)(2012-3#1)
the traditional liquid-liquid separation##2##4##(2008-10#2)
the traditional means of##3##4##(2006-12#1)(2008-4#1)(2008-9#1)
the traditional method based on##2##5##(2007-8#1)(2012-1#1)
the traditional method for##2##4##(2007-4#1)(2008-5#1)
the traditional method of##2##4##(2007-11#1)(2008-11#1)
the traditional method##10##3##(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#2)(2008-11#1)(2008-2#1)(2008-5#1)(2010-8#1)(2012-1#1)
the traditional methods of##4##4##(1991-12#1)(2006-10#1)(2008-10#1)(2010-11#1)
the traditional methods##10##3##(1991-12#1)(1991-4#1)(2005-12#1)(2006-10#1)(2008-10#3)(2008-4#1)(2010-11#1)(2010-8#1)
the traditional model of##2##4##(2008-8#1)(2010-5#1)
the traditional model##4##3##(2008-4#2)(2008-8#1)(2010-5#1)
the traditional one##2##3##(2007-1#1)(2008-10#1)
the traditional pretreatments of a sample for metal analysis##2##9##(2007-10#1)(2008-10#1)
the traditional quantitative##2##3##(2007-8#1)(2008-10#1)
the traditional relationship##2##3##(1995-1#1)(2012-2#1)
the traditional risk factors##3##4##(2008-4#1)(2011-2#1)(2013-1#1)
the traditional risk##4##3##(2008-3#1)(2008-4#1)(2011-2#1)(2013-1#1)
the traditional structure##2##3##(2008-3#1)(2010-5#1)
the traditional surgical treatment##2##4##(1991-12#1)(2006-5#1)
the traditional technique##5##3##(2006-7#1)(2011-2#3)(2013-1#1)
the traditional techniques##3##3##(2006-10#1)(2008-10#1)(2008-4#1)
the traditional treatment##3##3##(2006-8#1)(2007-11#1)(2008-11#1)
the traditional use of##2##4##(2004-10#1)(2013-7#1)
the traditional view of##2##4##(2008-10#1)(2012-12#1)
the traditional view##4##3##(1995-12#1)(2007-8#1)(2008-10#1)(2012-12#1)
the traditional##268##2##(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#3)(1992-2#1)(1992-5#2)(1992-8#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-1#2)(1994-11#1)(1994-2#2)(1994-3#1)(1995-1#2)(1995-12#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-10#1)(2004-2#2)(2005-1#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-4#1)(2005-8#1)(2006-10#7)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#8)(2006-6#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#1)(2007-2#2)(2007-4#3)(2007-5#4)(2007-7#1)(2007-8#7)(2008-1#5)(2008-10#27)(2008-11#9)(2008-12#2)(2008-2#10)(2008-3#10)(2008-4#12)(2008-5#6)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#5)(2009-10#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-11#4)(2010-12#4)(2010-2#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#2)(2011-2#8)(2012-1#3)(2012-12#4)(2012-2#7)(2012-3#8)(2013-1#5)(2013-7#3)(2013-8#2)
the traditionally##2##2##(2008-1#1)(2008-10#1)
the traditions of##3##3##(2009-10#1)(2009-6#1)(2009-7#1)
the traffic of##2##3##(2008-8#1)(2013-1#1)
the traffic##11##2##(1992-6#1)(2004-4#1)(2008-10#1)(2008-2#2)(2008-8#4)(2012-12#1)(2013-1#1)
the trafficking and##3##3##(2006-10#1)(2008-5#1)(2008-8#1)
the trafficking of##6##3##(1990-2#1)(1995-11#1)(1997-1#1)(2008-7#1)(2011-1#1)(2012-2#1)
the trafficking routes##2##3##(2013-7#2)
the trafficking##13##2##(1990-2#1)(1995-11#1)(1997-1#1)(2006-10#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-1#1)(2012-2#1)(2013-7#2)
the tragedy of##2##3##(2007-8#1)(2010-1#1)
the tragedy##4##2##(1991-12#1)(2006-4#1)(2007-8#1)(2010-1#1)
the trail of##2##3##(1992-2#1)(2013-8#1)
the trail pheromone##2##3##(1995-1#2)
the trail##8##2##(1992-2#1)(1995-1#2)(2004-11#1)(2007-3#1)(2008-8#1)(2013-8#2)
the trailing edge##2##3##(2005-10#1)(2007-12#1)
the trailing film##5##3##(2009-6#5)
the trailing##9##2##(1997-6#2)(2005-10#1)(2007-12#1)(2009-6#5)
the train##8##2##(1996-7#1)(2006-5#3)(2007-12#2)(2008-1#1)(2008-2#1)
the trained and##3##3##(2013-1#2)(2013-7#1)
the trained female rats##2##4##(2013-1#2)
the trained group##3##3##(2013-1#2)(2013-7#1)
the trained orientation##2##3##(2012-2#2)
the trained##22##2##(1995-1#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2010-8#1)(2012-2#5)(2013-1#8)(2013-7#2)
the trainee##3##2##(2007-7#1)(2010-3#1)(2012-1#1)
the trainees##3##2##(1992-12#1)(2013-1#2)
the training and##10##3##(1996-12#1)(2006-6#3)(2007-11#1)(2008-12#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-2#1)
the training content##2##3##(2007-12#1)(2008-9#1)
the training context##2##3##(2008-10#1)(2008-5#1)
the training data set##3##4##(2008-10#2)(2008-2#1)
the training data##9##3##(2008-10#2)(2008-2#2)(2010-2#1)(2010-9#1)(2013-1#3)
the training effort##2##3##(1993-2#1)(2012-1#1)
the training frequency##2##3##(1991-5#2)
the training groups##2##3##(1997-2#1)(2013-8#1)
the training images##2##3##(2008-3#2)
the training is##2##3##(1990-4#1)(2008-3#1)
the training of medical graduates##3##5##(1992-1#1)(1994-12#1)(2009-10#1)
the training of medical##7##4##(1992-1#2)(1994-12#2)(1994-6#1)(2009-10#1)(2012-3#1)
the training of nurses##2##4##(2011-2#1)(2013-1#1)
the training of the##2##4##(2006-9#1)(2008-1#1)
the training of##34##3##(1991-12#1)(1992-1#2)(1993-1#1)(1993-11#1)(1993-3#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-6#1)(1996-1#1)(1996-9#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-3#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
the training or##2##3##(1994-1#1)(2008-3#1)
the training process##2##3##(2008-2#2)
the training program was##2##4##(1991-2#1)(2008-4#1)
the training program##5##3##(1991-2#1)(1996-6#1)(2007-4#1)(2008-1#1)(2008-4#1)
the training requirements of##2##4##(1996-2#2)
the training sample##3##3##(1994-5#1)(2010-5#1)(2013-8#1)
the training sessions##3##3##(1995-10#1)(2008-2#1)(2010-12#1)
the training set and##3##4##(2008-10#1)(2008-2#2)
the training set##8##3##(2008-10#2)(2008-2#4)(2008-4#1)(2008-9#1)
the training##141##2##(1990-12#1)(1990-4#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#3)(1992-1#2)(1992-11#1)(1992-12#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(2004-3#1)(2005-1#1)(2006-10#1)(2006-2#1)(2006-6#3)(2006-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#9)(2008-11#3)(2008-12#4)(2008-2#10)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#2)(2009-2#1)(2009-4#2)(2009-6#2)(2010-1#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-1#11)(2012-2#3)(2012-3#2)(2013-1#7)(2013-8#2)
the trait is##2##3##(1997-7#1)(2012-3#1)
the trait of##2##3##(1996-3#1)(2008-10#1)
the trait##22##2##(1996-3#1)(1997-7#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#6)(2009-4#1)(2012-3#8)(2013-1#1)
the traits of##3##3##(1996-3#1)(1997-4#1)(2008-9#1)
the traits under##2##3##(1997-4#1)(2008-8#1)
the traits##15##2##(1996-3#1)(1997-4#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#2)(2008-9#3)(2012-3#1)(2013-8#1)
the trajectories of the##2##4##(1993-12#1)(2013-7#1)
the trajectories of##6##3##(1993-11#1)(1993-12#1)(1996-12#1)(2008-3#1)(2011-1#1)(2013-7#1)
the trajectories##7##2##(1993-11#1)(1993-12#1)(1996-12#1)(2006-10#1)(2008-3#1)(2011-1#1)(2013-7#1)
the trajectory and##2##3##(2009-7#1)(2011-2#1)
the trajectory at the L5-S1 than at the L4-L5 level##2##10##(1996-6#2)
the trajectory of HIV##2##4##(1997-2#1)(2007-7#1)
the trajectory of the##7##4##(2007-11#1)(2008-2#2)(2008-3#1)(2009-4#1)(2010-6#1)(2010-8#1)
the trajectory of##13##3##(1996-12#1)(1997-2#1)(2007-11#1)(2007-7#1)(2008-2#2)(2008-3#3)(2009-4#1)(2010-6#1)(2010-8#1)(2011-12#1)
the trajectory##22##2##(1996-12#1)(1996-6#3)(1997-2#1)(2006-3#1)(2007-11#1)(2007-7#1)(2008-2#2)(2008-3#4)(2009-4#1)(2009-7#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#2)
the trance##2##2##(2009-10#2)
the trans Golgi network##3##4##(1990-12#1)(1992-11#1)(1992-12#1)
the trans Golgi##5##3##(1990-12#2)(1992-11#1)(1992-12#1)(1993-6#1)
the trans conformation##3##3##(1990-10#1)(2008-8#1)(2010-5#1)
the trans isomer##8##3##(1991-5#3)(1996-5#1)(2007-10#1)(2008-5#2)(2010-5#1)
the trans side##2##3##(1991-5#1)(1994-3#1)
the trans##26##2##(1990-10#1)(1990-12#2)(1990-8#1)(1990-9#1)(1991-5#4)(1992-11#1)(1992-12#1)(1992-4#2)(1993-6#1)(1994-3#1)(1996-5#1)(2007-10#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-2#2)(2010-5#2)
the trans-##2##2##(2007-11#1)(2009-9#1)
the trans-4-(trifluoromethyl)-2##2##2##(1996-5#2)
the trans-Golgi network and##2##4##(1993-6#1)(2012-12#1)
the trans-Golgi network to the##2##5##(2008-1#1)(2012-12#1)
the trans-Golgi network to##3##4##(1996-4#1)(2008-1#1)(2012-12#1)
the trans-Golgi network##15##3##(1992-11#1)(1992-12#1)(1993-6#1)(1996-4#2)(2008-1#4)(2009-10#1)(2010-2#1)(2012-12#3)(2012-2#1)
the trans-Golgi##18##2##(1991-1#1)(1992-11#1)(1992-12#1)(1993-6#1)(1996-4#2)(1997-2#1)(2008-1#4)(2009-10#1)(2010-2#1)(2011-1#1)(2012-12#3)(2012-2#1)
the trans-acting##4##2##(1995-6#1)(2008-10#1)(2008-9#1)(2013-8#1)
the trans-membrane##2##2##(2008-11#1)(2008-8#1)
the trans-sinusal frontal approach##2##4##(2006-12#2)
the transabdominal##3##2##(1992-8#1)(2012-12#2)
the transacting##2##2##(1994-3#1)(2008-9#1)
the transaction##2##2##(2006-8#1)(2008-11#1)
the transactivating##3##2##(1993-12#1)(1994-3#1)(1995-3#1)
the transactivation function of##2##4##(1993-11#1)(1993-12#1)
the transactivation of##2##3##(1992-7#1)(1993-8#1)
the transactivation potential of##2##4##(1995-6#1)(1996-5#1)
the transactivation##11##2##(1992-7#1)(1993-11#1)(1993-12#1)(1993-8#4)(1995-6#2)(1996-5#1)(1997-1#1)
the transactivators##2##2##(2008-11#2)
the transamination of##4##3##(1990-3#1)(1991-7#2)(1996-7#1)
the transbilayer##3##2##(1990-2#1)(1990-3#1)(1996-5#1)
the transcatheter##7##2##(1997-8#1)(2006-10#1)(2009-10#2)(2010-8#1)(2013-1#2)
the transconjugant##2##2##(2008-10#2)
the transcranial##5##2##(2006-12#1)(2010-5#2)(2011-2#1)(2012-1#1)
the transcribed RNA##2##3##(1996-4#1)(2008-11#1)
the transcribed strand of##3##4##(1994-8#2)(1996-11#1)
the transcribed##12##2##(1993-6#1)(1994-8#2)(1995-10#1)(1996-11#2)(1996-4#1)(1996-5#1)(1997-4#1)(1997-5#1)(2008-11#2)
the transcript and##2##3##(1994-6#1)(2012-12#1)
the transcript level##2##3##(1990-5#1)(1993-11#1)
the transcript levels of##2##4##(1997-7#1)(2011-1#1)
the transcript of##8##3##(1991-5#1)(1991-6#1)(1992-12#2)(1992-7#1)(1997-2#1)(1997-6#1)(2008-6#1)
the transcript##28##2##(1990-5#1)(1990-9#1)(1991-5#3)(1991-6#1)(1991-9#2)(1992-12#2)(1992-7#1)(1993-11#1)(1993-12#1)(1994-6#1)(1995-4#1)(1995-8#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-6#1)(1997-7#2)(2008-6#1)(2009-4#1)(2009-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
the transcription activator protein##2##4##(1990-7#1)(1997-4#1)
the transcription and##3##3##(1991-12#1)(1993-5#1)(1997-1#1)
the transcription complex##3##3##(1990-4#1)(1990-8#1)(1996-7#1)
the transcription cycle##3##3##(1990-8#3)
the transcription factor AP-1##2##4##(1992-4#1)(2008-5#1)
the transcription factor NF kappa B##2##6##(1991-9#1)(1995-6#1)
the transcription factor NF-kappa B##2##5##(1990-3#1)(1994-8#1)
the transcription factor NF-kappaB is##2##5##(1996-5#1)(2010-3#1)
the transcription factor Sp1##4##4##(1990-6#1)(1991-4#1)(1992-12#1)(1994-12#1)
the transcription factor nuclear##2##4##(2006-9#1)(2012-3#1)
the transcription factor##56##3##(1990-3#1)(1990-6#1)(1991-11#1)(1991-12#2)(1991-4#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-4#1)(1992-8#2)(1993-12#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#2)(1994-9#1)(1995-3#1)(1995-6#2)(1995-9#1)(1996-5#3)(1996-8#2)(2006-9#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#2)(2010-11#4)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#2)
the transcription factors##8##3##(1991-12#1)(1993-6#1)(1995-6#1)(1997-7#2)(2008-1#1)(2009-4#1)(2010-1#1)
the transcription initiation complex##2##4##(1992-5#2)
the transcription initiation site is##2##5##(1993-4#1)(1997-7#1)
the transcription initiation site of the##2##6##(1990-5#1)(1992-12#1)
the transcription initiation site of##3##5##(1990-12#1)(1990-5#1)(1992-12#1)
the transcription initiation site##7##4##(1990-12#1)(1990-5#1)(1992-12#1)(1993-4#1)(1995-3#1)(1997-4#1)(1997-7#1)
the transcription initiation sites##2##4##(1992-4#1)(1994-8#1)
the transcription initiation##14##3##(1990-12#1)(1990-5#1)(1992-12#1)(1992-4#1)(1992-5#3)(1993-4#1)(1994-12#1)(1994-8#1)(1995-3#1)(1995-6#1)(1997-4#1)(1997-7#1)
the transcription level##6##3##(1990-3#1)(1991-7#1)(1995-3#1)(2008-11#1)(2008-8#1)(2012-1#1)
the transcription of a##2##4##(1994-9#1)(2011-1#1)
the transcription of genes that##2##5##(1990-8#1)(2008-4#1)
the transcription of genes##3##4##(1990-8#1)(2008-4#1)(2008-9#1)
the transcription of several##2##4##(1992-9#1)(2008-10#1)
the transcription of the 7alpha-hydroxylase gene##2##6##(1997-1#2)
the transcription of the human##2##5##(1992-8#1)(1997-1#1)
the transcription of the##22##4##(1991-12#2)(1992-8#1)(1993-3#1)(1994-11#2)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-6#2)(1996-4#1)(1997-1#4)(1997-8#2)(2008-11#1)
the transcription of##54##3##(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#2)(1992-10#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#4)(1995-10#1)(1995-11#1)(1995-12#1)(1995-6#2)(1996-10#2)(1996-4#1)(1997-1#5)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-1#1)
the transcription rate of alpha(1B)-AR##2##5##(2008-4#2)
the transcription rate of the IL-11 gene##2##7##(1994-12#2)
the transcription rate of the##3##5##(1992-9#1)(1994-12#2)
the transcription rate of##7##4##(1992-3#1)(1992-9#1)(1994-12#3)(2008-4#2)
the transcription rate##8##3##(1992-3#1)(1992-9#1)(1994-12#3)(2008-11#1)(2008-4#2)
the transcription rates##2##3##(1991-12#1)(1994-3#1)
the transcription start point (tsp)##10##5##(1991-12#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#2)(1995-2#1)(1995-8#1)
the transcription start point##22##4##(1990-11#1)(1990-5#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-9#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#1)(1994-12#2)(1995-2#1)(1995-8#2)(1997-4#1)(1997-6#1)
the transcription start site of the##2##6##(1994-5#1)(2006-12#1)
the transcription start site was##2##5##(1991-7#1)(2008-9#1)
the transcription start site##15##4##(1990-5#1)(1991-11#1)(1991-3#1)(1991-7#1)(1992-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-2#2)(1996-4#1)(2006-12#1)(2008-9#1)
the transcription start sites##2##4##(1992-4#1)(1997-2#1)
the transcription start##41##3##(1990-11#1)(1990-5#2)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-4#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#2)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-2#3)(1995-8#2)(1996-4#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-12#1)(2008-9#1)
the transcription unit##2##3##(1990-5#1)(1991-12#1)
the transcription##225##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#2)(1990-4#1)(1990-5#6)(1990-6#1)(1990-7#2)(1990-8#5)(1991-11#2)(1991-12#10)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#3)(1992-5#3)(1992-8#3)(1992-9#2)(1993-12#4)(1993-2#1)(1993-3#4)(1993-4#1)(1993-5#2)(1993-6#4)(1993-9#1)(1994-11#5)(1994-12#8)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#6)(1994-9#7)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#3)(1995-6#7)(1995-8#2)(1995-9#1)(1996-10#3)(1996-4#3)(1996-5#3)(1996-7#1)(1996-8#3)(1997-1#6)(1997-2#1)(1997-4#4)(1997-6#3)(1997-7#7)(1997-8#2)(2004-9#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#6)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#5)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#2)(2012-3#2)
the transcription-coupled repair (TCR)##2##4##(1997-4#1)(2008-11#1)
the transcriptional activation of##7##4##(1995-11#2)(1995-8#1)(1996-12#2)(2008-10#1)(2009-8#1)
the transcriptional activation##9##3##(1990-6#1)(1994-9#1)(1995-11#2)(1995-8#1)(1996-12#2)(2008-10#1)(2009-8#1)
the transcriptional activator##4##3##(1990-11#1)(2012-3#2)(2013-1#1)
the transcriptional activity of nuclear##2##5##(2008-3#1)(2012-3#1)
the transcriptional activity of the receptor##2##6##(1996-5#2)
the transcriptional activity of the##8##5##(1995-3#1)(1996-10#1)(1996-5#2)(1997-7#2)(2012-12#2)
the transcriptional activity of##19##4##(1994-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-10#2)(1996-4#2)(1996-5#2)(1997-7#2)(2008-11#1)(2008-3#2)(2012-12#2)(2012-3#1)(2013-7#1)
the transcriptional activity##23##3##(1992-11#1)(1993-12#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-10#2)(1996-4#2)(1996-5#2)(1997-7#3)(2008-11#1)(2008-3#2)(2012-12#2)(2012-3#1)(2013-7#1)
the transcriptional and##4##3##(1991-5#1)(1991-6#1)(1993-8#1)(1994-11#1)
the transcriptional co-activator##2##3##(2011-2#1)(2013-1#1)
the transcriptional coactivator##2##3##(1997-4#2)
the transcriptional control of##7##4##(1993-12#1)(1994-12#1)(1995-2#1)(1995-3#1)(1997-4#1)(2006-10#1)(2011-2#1)
the transcriptional induction of the##3##5##(1994-9#1)(2008-11#1)(2011-1#1)
the transcriptional induction of##4##4##(1994-9#2)(2008-11#1)(2011-1#1)
the transcriptional machinery##4##3##(1991-5#1)(1997-6#1)(2008-6#1)(2013-1#1)
the transcriptional process##2##3##(1993-11#1)(1997-4#1)
the transcriptional profiles of##2##4##(2008-7#1)(2009-9#1)
the transcriptional profiles##3##3##(2008-6#1)(2008-7#1)(2009-9#1)
the transcriptional rate of the##2##5##(1995-2#1)(1995-9#1)
the transcriptional rate##3##3##(1990-3#1)(1995-2#1)(1995-9#1)
the transcriptional rates##2##3##(1990-3#1)(1991-1#1)
the transcriptional regulation of the##3##5##(1993-6#1)(1996-10#1)(2008-11#1)
the transcriptional regulation of##11##4##(1991-12#1)(1993-6#1)(1994-3#1)(1996-10#1)(1996-12#1)(2008-1#1)(2008-11#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-12#1)
the transcriptional regulation##14##3##(1991-12#1)(1992-12#1)(1993-6#1)(1994-3#1)(1996-10#1)(1996-12#1)(1996-7#1)(2008-1#1)(2008-11#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
the transcriptional regulatory##4##3##(1990-8#1)(1992-3#1)(1997-2#1)(2007-3#1)
the transcriptional repressor##3##3##(1995-6#1)(2007-12#1)(2011-1#1)
the transcriptional response##2##3##(1994-8#1)(2011-2#1)
the transcriptional start site##5##4##(1995-11#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-2#1)
the transcriptional start sites##2##4##(1990-11#1)(1991-4#1)
the transcriptional start##9##3##(1990-11#1)(1990-3#1)(1991-2#1)(1991-4#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-2#1)
the transcriptional status of the##2##5##(1995-2#1)(1997-7#1)
the transcriptional status of##3##4##(1995-2#1)(1997-7#1)(2013-1#1)
the transcriptional##155##2##(1990-1#1)(1990-11#3)(1990-3#4)(1990-6#1)(1990-8#1)(1991-1#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-12#2)(1993-4#1)(1993-6#3)(1993-8#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-3#4)(1994-8#2)(1994-9#6)(1995-1#1)(1995-11#3)(1995-2#5)(1995-3#4)(1995-6#2)(1995-8#5)(1995-9#1)(1996-10#3)(1996-12#4)(1996-2#2)(1996-4#3)(1996-5#2)(1996-6#1)(1996-7#2)(1997-2#3)(1997-4#5)(1997-6#2)(1997-7#4)(2006-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-9#2)(2009-12#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-12#2)(2011-1#2)(2011-2#4)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#6)(2013-7#1)
the transcriptionally active##4##3##(1990-12#1)(1991-12#1)(1994-12#1)(1994-3#1)
the transcriptionally##5##2##(1990-12#1)(1991-12#1)(1994-12#1)(1994-3#2)
the transcriptome and##2##3##(2008-10#1)(2011-2#1)
the transcriptome##9##2##(2006-12#1)(2008-10#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-2#3)(2013-8#1)
the transcriptomes##2##2##(2008-7#1)(2013-8#1)
the transcripts in##2##3##(1996-8#1)(1997-7#1)
the transcripts of the##6##4##(1990-11#1)(1990-8#1)(1993-11#1)(1995-3#2)(1997-2#1)
the transcripts of##7##3##(1990-11#1)(1990-8#1)(1993-11#1)(1995-3#2)(1997-2#2)
the transcripts##20##2##(1990-11#1)(1990-8#1)(1991-9#1)(1992-8#1)(1993-11#1)(1994-12#3)(1995-3#2)(1995-4#1)(1995-8#1)(1996-2#1)(1996-8#1)(1997-2#3)(1997-7#2)(2009-10#1)
the transcultural##2##2##(2008-2#2)
the transdermal delivery of##2##4##(2007-2#1)(2008-5#1)
the transdermal transport of drugs##2##5##(1991-6#2)
the transdermal transport##3##3##(1991-6#3)
the transdermal##8##2##(1991-6#3)(1992-8#1)(2007-2#1)(2008-3#2)(2008-5#1)
the transdifferentiation of##2##3##(2009-3#1)(2012-12#1)
the transduced genes##2##3##(1997-8#1)(2008-8#1)
the transduced##3##2##(1997-8#1)(2008-8#1)(2012-12#1)
the transducer surface by##2##4##(2008-10#1)(2008-2#1)
the transducer surface##3##3##(2008-10#2)(2008-2#1)
the transducer##11##2##(2006-12#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#2)
the transducers##2##2##(2008-10#1)(2009-5#1)
the transduction of signals##3##4##(1991-5#1)(1992-3#1)(1995-2#1)
the transduction of##12##3##(1990-12#1)(1991-5#1)(1992-3#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-7#1)(1996-10#1)(1996-7#1)(1997-5#1)(2010-10#2)
the transduction##18##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-5#1)(1992-3#1)(1992-9#1)(1994-11#2)(1994-8#1)(1995-2#1)(1995-7#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-5#1)(2010-10#2)
the transection##3##2##(1991-2#1)(1993-7#1)(2013-1#1)
the transects##2##2##(2005-10#1)(2013-7#1)
the transepithelial##3##2##(2006-10#1)(2008-5#1)(2011-2#1)
the transesophageal##2##2##(2010-7#1)(2012-3#1)
the transesterification reaction##2##3##(2008-5#1)(2013-1#1)
the transesterification##7##2##(1994-2#3)(2007-6#1)(2008-5#1)(2008-7#1)(2013-1#1)
the transfectant##4##2##(1993-8#1)(1995-5#1)(1997-2#1)(2008-11#1)
the transfectants##3##2##(1992-5#1)(1992-9#1)(1993-1#1)
the transfected CHO cells##2##4##(1991-7#1)(2008-11#1)
the transfected DNA##2##3##(1995-2#1)(2008-2#1)
the transfected cell##3##3##(2005-10#1)(2008-4#1)(2013-8#1)
the transfected cells in##2##4##(1992-9#1)(2007-11#1)
the transfected cells were##3##4##(1993-12#1)(1994-8#1)(2005-10#1)
the transfected cells##15##3##(1991-2#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-8#4)(1994-9#1)(1995-5#1)(2005-10#1)(2007-11#1)(2008-11#1)
the transfected##40##2##(1991-2#1)(1991-7#1)(1992-2#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-8#6)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-5#2)(1996-6#2)(1996-8#1)(1997-5#1)(1997-6#1)(2005-10#2)(2007-11#1)(2008-11#2)(2008-2#2)(2008-4#1)(2013-8#1)
the transfection efficiency of##4##4##(2008-11#1)(2008-9#1)(2010-1#1)(2012-3#1)
the transfection of an##2##4##(1994-11#1)(1994-3#1)
the transfection of cells##2##4##(1994-10#1)(2005-7#1)
the transfection of##9##3##(1994-10#1)(1994-11#1)(1994-3#1)(1994-5#1)(2005-7#1)(2008-1#1)(2008-11#2)(2008-2#1)
the transfection##19##2##(1991-5#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-2#1)(2005-7#1)(2008-1#3)(2008-11#5)(2008-2#1)(2008-9#1)(2010-1#1)(2012-3#1)
the transfer and##2##3##(1992-9#1)(2004-2#1)
the transfer coefficient##2##3##(1991-5#1)(2008-10#1)
the transfer efficiency##3##3##(2008-10#1)(2008-9#2)
the transfer function of the##3##5##(2007-12#1)(2008-2#2)
the transfer function of##4##4##(2007-12#1)(2008-2#3)
the transfer function##6##3##(2007-12#2)(2008-2#4)
the transfer matrix##2##3##(2006-10#1)(2009-11#1)
the transfer of [3H]cholesteryl##2##4##(1993-11#1)(1996-4#1)
the transfer of a##5##4##(1992-10#1)(1994-9#1)(1996-7#1)(2008-9#1)(2013-7#1)
the transfer of aminoacyl-tRNA from aminoacyl-tRNA synthetase to the elongation factor 1 alpha##2##13##(1994-12#2)
the transfer of an##2##4##(1997-4#1)(2008-11#1)
the transfer of hydrocarbons from##2##5##(1991-4#2)
the transfer of hydrocarbons##3##4##(1991-4#2)(1992-5#1)
the transfer of information##4##4##(2008-4#1)(2012-11#1)(2012-12#2)
the transfer of material from##2##5##(2008-3#2)
the transfer of the radical to acetylphosphinate##2##7##(1995-2#2)
the transfer of the##15##4##(1990-11#3)(1993-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-2#2)(2005-11#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-2#1)
the transfer of this element##2##5##(1994-6#1)(2008-10#1)
the transfer of##90##3##(1990-11#3)(1990-6#1)(1990-8#1)(1991-10#1)(1991-4#2)(1992-10#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-8#4)(1993-11#2)(1994-12#5)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-2#2)(1996-4#1)(1996-5#2)(1996-7#1)(1997-4#3)(1997-6#1)(2004-4#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-8#1)(2007-9#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-11#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-7#1)
the transfer origin##2##3##(1991-9#1)(1996-5#1)
the transfer process##3##3##(1992-3#1)(2007-12#2)
the transfer samples##2##3##(2008-10#2)
the transfer##145##2##(1990-11#3)(1990-6#1)(1990-8#1)(1991-10#1)(1991-2#4)(1991-4#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#2)(1992-5#1)(1992-8#4)(1992-9#1)(1993-11#2)(1993-12#1)(1993-8#1)(1994-11#2)(1994-12#5)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-2#2)(1995-5#1)(1996-4#1)(1996-5#4)(1996-7#1)(1997-2#1)(1997-4#3)(1997-6#3)(1997-7#1)(2004-2#1)(2004-4#1)(2005-11#2)(2005-7#1)(2006-10#4)(2006-12#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#6)(2007-9#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#3)(2008-5#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#2)(2009-2#2)(2009-3#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-11#3)(2012-12#4)(2012-2#1)(2012-3#1)(2013-7#1)
the transferability of##4##3##(2008-10#1)(2008-5#2)(2012-2#1)
the transferability##5##2##(2008-10#1)(2008-5#2)(2011-12#1)(2012-2#1)
the transferase##4##2##(1991-10#1)(1995-5#3)
the transference##2##2##(2007-3#1)(2008-11#1)
the transferred##13##2##(1990-7#1)(1992-5#1)(1993-3#1)(1995-7#1)(1996-11#1)(2005-11#1)(2006-3#1)(2007-12#2)(2008-10#1)(2008-8#1)(2009-12#1)(2012-11#1)
the transferrin receptor and##2##4##(1996-7#1)(2006-10#1)
the transferrin receptor##8##3##(1990-8#1)(1992-4#1)(1992-8#1)(1993-11#2)(1994-6#1)(1996-7#1)(2006-10#1)
the transferrin##15##2##(1990-11#1)(1990-8#1)(1992-4#2)(1992-8#1)(1993-11#2)(1994-3#2)(1994-6#2)(1994-9#1)(1996-5#1)(1996-7#1)(2006-10#1)
the transferring##2##2##(1996-7#1)(2008-8#1)
the transfersomal suspension##2##3##(2012-12#2)
the transfersomal##4##2##(2012-12#4)
the transflectance##2##2##(2007-11#1)(2007-8#1)
the transform limit##2##3##(2007-12#2)
the transform of##2##3##(1996-9#1)(2008-2#1)
the transform##10##2##(1996-9#1)(2007-12#3)(2008-1#1)(2008-2#3)(2008-3#2)
the transform-limited##2##2##(2008-3#1)(2012-11#1)
the transformant##8##2##(1991-9#1)(1993-3#1)(1994-12#3)(1995-12#1)(2011-1#2)
the transformants and the wild type##2##6##(2008-10#2)
the transformants was##2##3##(1997-2#1)(2008-10#1)
the transformants##17##2##(1990-5#1)(1990-8#1)(1994-9#1)(1995-4#1)(1996-7#1)(1997-2#1)(1997-8#1)(2008-10#7)(2008-8#2)(2012-2#1)
the transformation and##2##3##(1996-7#1)(2008-2#1)
the transformation efficiency##2##3##(1996-4#2)
the transformation frequency##4##3##(2008-10#1)(2008-7#3)
the transformation from##2##3##(2004-9#1)(2008-3#1)
the transformation occurs##2##3##(2012-12#1)(2013-1#1)
the transformation of episodic to chronic##2##6##(2008-9#1)(2010-12#1)
the transformation of the##4##4##(1995-4#1)(2005-11#1)(2008-2#2)
the transformation of##39##3##(1990-1#2)(1990-5#2)(1991-7#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-7#1)(1995-4#1)(1995-6#1)(2004-9#2)(2005-11#2)(2006-12#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-2#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
the transformation processes##2##3##(2008-10#1)(2008-3#1)
the transformation##71##2##(1990-1#2)(1990-5#2)(1990-7#1)(1991-7#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-12#1)(1994-2#2)(1994-9#1)(1995-4#1)(1995-6#1)(1996-2#1)(1996-4#2)(1996-7#1)(2004-9#3)(2005-11#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-2#6)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#4)
the transformations of##3##3##(2007-6#1)(2008-10#1)(2010-4#1)
the transformations##9##2##(2004-4#2)(2007-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2010-4#1)
the transformed cell##4##3##(1993-6#1)(1994-11#1)(2008-11#1)(2008-8#1)
the transformed cells are##2##4##(2008-11#2)
the transformed cells##11##3##(1990-12#1)(1990-5#1)(1991-2#3)(1992-9#1)(1993-2#1)(1993-7#1)(2008-11#3)
the transformed data##2##3##(1994-11#1)(2008-7#1)
the transformed morphology of##3##4##(1996-4#3)
the transformed morphology##4##3##(1990-7#1)(1996-4#3)
the transformed phenotype of##2##4##(1995-6#1)(1997-1#1)
the transformed phenotype##8##3##(1990-7#1)(1994-9#1)(1995-6#2)(1997-1#2)(1997-2#1)(2008-8#1)
the transformed signals##2##3##(2008-10#2)
the transformed state##2##3##(1990-8#1)(1995-2#1)
the transformed yeast##2##3##(1990-8#1)(1995-2#1)
the transformed##54##2##(1990-12#1)(1990-5#1)(1990-7#2)(1990-8#3)(1991-2#3)(1991-7#1)(1991-9#1)(1992-11#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-11#2)(1994-9#1)(1995-2#2)(1995-6#2)(1996-4#3)(1996-5#1)(1997-1#2)(1997-2#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-2#3)(2008-3#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-12#2)
the transforming DNA##3##3##(1990-5#1)(2008-10#2)
the transforming activity##3##3##(1992-7#1)(1993-11#1)(1996-5#1)
the transforming growth factor beta (TGF-beta)##2##6##(1995-8#1)(2008-1#1)
the transforming growth factor beta family##2##6##(1991-10#1)(2007-8#1)
the transforming growth factor beta##4##5##(1991-10#1)(1995-8#1)(2007-8#1)(2008-1#1)
the transforming growth factor##10##4##(1991-10#1)(1994-10#1)(1995-8#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-2#1)(2011-2#1)(2012-12#1)
the transforming growth factor-beta (TGF-beta)##2##5##(1992-11#1)(1995-11#1)
the transforming growth factor-beta##7##4##(1992-11#1)(1992-4#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-11#1)(2007-12#1)
the transforming growth##20##3##(1991-10#1)(1992-11#1)(1992-4#1)(1993-12#1)(1994-10#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-12#2)
the transforming plasmid##2##3##(2008-10#2)
the transforming potential of##2##4##(1994-8#1)(1995-2#1)
the transforming##40##2##(1990-5#1)(1990-7#1)(1991-10#1)(1991-6#1)(1992-11#2)(1992-4#1)(1992-7#1)(1993-11#2)(1993-12#1)(1993-2#1)(1994-10#1)(1994-11#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-5#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-12#2)
the transfusion of##3##3##(1996-9#1)(2006-10#2)
the transfusion##9##2##(1991-11#1)(1996-9#3)(1997-5#1)(2006-10#2)(2010-11#1)(2012-2#1)
the transgene expression pattern##2##4##(2008-11#1)(2012-2#1)
the transgene in##4##3##(1995-12#1)(1995-2#1)(2008-10#2)
the transgene product##2##3##(2008-10#2)
the transgene was##3##3##(1990-8#1)(1995-2#1)(2008-12#1)
the transgene##40##2##(1990-8#1)(1993-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1996-3#1)(1997-4#1)(2005-6#1)(2006-12#3)(2008-10#15)(2008-11#2)(2008-12#1)(2008-8#2)(2009-8#2)(2012-12#1)(2012-2#1)(2012-3#1)
the transgenes and the##2##4##(2008-11#1)(2008-9#1)
the transgenes and##3##3##(1994-5#1)(2008-11#1)(2008-9#1)
the transgenes can be##2##4##(2008-10#1)(2011-1#1)
the transgenes##11##2##(1994-5#1)(2006-12#5)(2008-10#1)(2008-11#1)(2008-9#1)(2010-12#1)(2011-1#1)
the transgenic animals##4##3##(1992-11#1)(1992-8#1)(1994-8#1)(1995-8#1)
the transgenic line##2##3##(2008-10#2)
the transgenic lines##4##3##(2006-12#1)(2008-10#3)
the transgenic mice##13##3##(1990-11#1)(1990-8#1)(1992-11#2)(1992-7#1)(1994-2#1)(1994-6#1)(1995-2#2)(1995-8#2)(2007-10#2)
the transgenic plant##2##3##(2007-1#1)(2007-11#1)
the transgenic plants##5##3##(1994-3#2)(2006-12#2)(2009-8#1)
the transgenic tobacco##2##3##(2008-8#1)(2008-9#1)
the transgenic##52##2##(1990-11#1)(1990-8#1)(1992-11#3)(1992-7#1)(1992-8#1)(1993-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#3)(1995-8#4)(1997-4#1)(2006-11#2)(2006-12#7)(2007-1#1)(2007-10#2)(2007-11#1)(2008-10#7)(2008-8#4)(2008-9#3)(2009-8#1)(2010-5#1)
the transglutaminase##2##2##(1992-8#1)(1997-4#1)
the transient absorbance##2##3##(1993-3#1)(2011-1#1)
the transient absorption##3##3##(2006-4#1)(2008-8#1)(2008-9#1)
the transient association of##2##4##(1994-11#1)(2008-9#1)
the transient behavior##2##3##(2008-3#1)(2008-7#1)
the transient chloramphenicol acetyltransferase##2##4##(1991-6#1)(1992-11#1)
the transient dynamics##2##3##(2008-8#1)(2009-5#1)
the transient expression of the##2##5##(1992-4#1)(2008-11#1)
the transient expression of##3##4##(1992-4#1)(1994-2#1)(2008-11#1)
the transient expression##4##3##(1992-4#1)(1994-2#1)(2008-11#2)
the transient increase in##5##4##(1991-10#1)(1993-12#1)(1993-3#1)(1994-12#1)(1997-2#1)
the transient increase##6##3##(1991-10#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-12#1)(1997-2#1)
the transient inhibition##2##3##(1993-11#1)(1995-7#1)
the transient inward##2##3##(1994-2#1)(2008-4#1)
the transient nature of##2##4##(1996-2#1)(2008-10#1)
the transient negative##2##3##(1991-3#1)(2007-8#1)
the transient potential change##2##4##(2008-10#2)
the transient response of##3##4##(2008-2#1)(2008-3#1)(2012-2#1)
the transient response##6##3##(2008-2#2)(2008-3#3)(2012-2#1)
the transient temperature##2##3##(2006-6#1)(2008-11#1)
the transient##94##2##(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-11#2)(1992-4#1)(1992-6#2)(1992-7#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#4)(1995-12#1)(1995-3#2)(1995-7#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(2005-11#1)(2005-4#1)(2006-10#2)(2006-4#1)(2006-6#2)(2006-9#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#4)(2008-2#9)(2008-3#10)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#1)(2010-3#1)(2011-1#1)(2012-2#2)
the transients##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
the transit of preleptotene spermatocytes##2##5##(2012-2#2)
the transit of the##2##4##(1992-3#1)(2008-7#1)
the transit of##7##3##(1992-3#1)(1997-7#1)(2008-7#1)(2011-1#1)(2012-2#3)
the transit peptide sequence##2##4##(1996-10#1)(2006-12#1)
the transit peptide##4##3##(1992-12#1)(1994-12#1)(1996-10#1)(2006-12#1)
the transit time##3##3##(2007-11#1)(2008-10#1)(2008-11#1)
the transit times##2##3##(2007-11#2)
the transit##20##2##(1990-2#1)(1992-12#1)(1992-3#2)(1992-9#1)(1994-12#1)(1996-10#1)(1997-7#1)(2006-12#1)(2007-11#3)(2008-10#1)(2008-11#1)(2008-7#2)(2011-1#1)(2012-2#3)
the transition between the two##2##5##(1996-6#1)(2008-1#1)
the transition between the##5##4##(1996-6#1)(2007-12#1)(2008-1#1)(2009-12#1)(2012-3#1)
the transition between##13##3##(1990-6#1)(1996-6#1)(2005-11#1)(2006-7#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-7#1)(2009-12#1)(2009-7#1)(2009-8#1)(2012-3#1)
the transition from a##4##4##(1996-1#1)(1996-3#1)(2005-11#1)(2007-12#1)
the transition from one##3##4##(2006-10#1)(2008-7#1)(2010-8#1)
the transition from stimulation to inhibition occurred when an average of##2##11##(2008-10#2)
the transition from the##6##4##(1990-12#1)(1992-7#1)(2005-11#1)(2008-11#1)(2008-2#1)(2009-12#1)
the transition from thinking to acting##2##6##(2007-11#2)
the transition from##48##3##(1990-12#1)(1992-6#1)(1992-7#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-3#1)(1997-7#1)(2004-1#1)(2005-11#2)(2006-10#1)(2006-9#2)(2007-11#2)(2007-12#3)(2007-5#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
the transition is##4##3##(1994-8#1)(1995-1#1)(1995-2#1)(2009-12#1)
the transition matrix of##2##4##(1991-12#1)(2008-3#1)
the transition matrix##3##3##(1991-12#1)(2008-3#2)
the transition metal and the##2##5##(2008-10#1)(2010-12#1)
the transition metal##6##3##(1990-9#1)(1997-7#1)(2008-10#2)(2008-5#1)(2010-12#1)
the transition metals##2##3##(2006-12#1)(2008-2#1)
the transition of##8##3##(1997-2#1)(1997-5#1)(2006-5#1)(2007-8#2)(2008-11#1)(2008-3#2)
the transition probability##2##3##(1991-12#1)(2011-2#1)
the transition state for the##4##5##(1994-9#1)(1995-1#1)(1995-2#1)(1996-11#1)
the transition state for##9##4##(1991-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#2)(1996-11#2)(2009-5#1)
the transition state is##2##4##(1995-4#1)(1997-4#1)
the transition state of CI2##2##5##(1996-11#2)
the transition state of the##3##5##(1995-10#1)(2010-4#1)(2010-5#1)
the transition state of##6##4##(1991-9#1)(1995-10#1)(1996-11#2)(2010-4#1)(2010-5#1)
the transition state##33##3##(1990-5#3)(1991-2#1)(1991-7#2)(1991-9#1)(1994-8#1)(1994-9#3)(1995-1#2)(1995-10#2)(1995-2#2)(1995-4#1)(1996-11#6)(1996-5#1)(1997-4#2)(2007-11#2)(2008-4#1)(2009-5#1)(2010-4#1)(2010-5#1)
the transition states##4##3##(1992-6#1)(1995-1#1)(1996-5#1)(2012-12#1)
the transition temperature##5##3##(1990-2#1)(1990-3#1)(1997-7#1)(2005-11#1)(2007-12#1)
the transition time from##2##4##(2008-11#1)(2010-5#1)
the transition time##4##3##(2008-11#1)(2009-6#2)(2010-5#1)
the transition to a##2##4##(2005-11#1)(2008-11#1)
the transition to adulthood##3##4##(2009-7#2)(2011-2#1)
the transition to parenthood##6##4##(2007-2#5)(2009-4#1)
the transition to specialist##2##4##(2008-11#2)
the transition to##35##3##(1991-11#1)(1991-12#1)(1993-11#1)(1996-12#1)(1997-2#2)(1997-6#1)(2005-11#1)(2007-12#1)(2007-2#5)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2009-4#1)(2009-7#2)(2009-9#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#4)
the transition zone between the##2##5##(2006-4#1)(2008-2#1)
the transition zone between##3##4##(1991-5#1)(2006-4#1)(2008-2#1)
the transition zone is##2##4##(2009-2#2)
the transition zone##10##3##(1990-7#2)(1991-5#1)(1993-2#1)(2006-4#1)(2008-2#1)(2009-2#3)(2013-7#1)
the transition##231##2##(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-9#1)(1991-11#2)(1991-12#6)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-6#3)(1992-7#1)(1992-9#1)(1993-11#3)(1993-2#1)(1993-6#1)(1994-8#4)(1994-9#3)(1995-1#6)(1995-10#2)(1995-2#4)(1995-4#1)(1995-9#1)(1996-1#2)(1996-11#7)(1996-12#2)(1996-3#1)(1996-5#2)(1996-6#1)(1997-2#3)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#3)(2004-1#1)(2005-11#6)(2005-4#2)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-9#2)(2007-11#7)(2007-12#7)(2007-2#6)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#10)(2008-11#10)(2008-12#1)(2008-2#6)(2008-3#8)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#3)(2009-12#4)(2009-2#4)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#3)(2009-8#1)(2009-9#1)(2010-12#2)(2010-4#1)(2010-5#4)(2010-6#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)
the transition-state complex##2##3##(1991-2#2)
the transition-state##5##2##(1991-2#2)(1994-5#1)(1996-8#1)(2006-4#1)
the transitional zone##2##3##(2008-11#1)(2008-5#1)
the transitional##8##2##(1990-12#1)(1991-4#1)(2006-5#1)(2008-11#1)(2008-5#1)(2009-7#1)(2010-4#1)(2010-5#1)
the transitions between##2##3##(1992-8#1)(2008-2#1)
the transitions in##2##3##(1992-9#1)(2013-7#1)
the transitions##11##2##(1991-2#1)(1992-8#1)(1992-9#1)(1995-8#1)(2006-12#1)(2006-5#1)(2008-2#3)(2011-3#1)(2013-7#1)
the transketolase##4##2##(1992-12#1)(1992-3#2)(1996-2#1)
the translabyrinthine approach##2##3##(1991-12#1)(2005-5#1)
the translated##6##2##(1992-1#1)(1992-12#1)(1994-6#1)(1997-7#1)(2008-2#1)(2009-12#1)
the translateral##2##2##(2013-7#2)
the translation and##2##3##(2009-9#2)
the translation control##2##3##(1990-9#1)(2009-9#1)
the translation initiation codon ATG##2##5##(1990-5#1)(1992-11#1)
the translation initiation codon##7##4##(1990-5#1)(1990-9#1)(1992-11#2)(1993-3#1)(1997-6#2)
the translation initiation factor##2##4##(1995-2#1)(2013-7#1)
the translation initiation site##4##4##(1996-5#1)(1997-2#2)(1997-7#1)
the translation initiation sites of##4##5##(1996-8#1)(1997-2#1)(1997-6#2)
the translation initiation sites##9##4##(1996-8#4)(1997-2#2)(1997-6#3)
the translation initiation##24##3##(1990-5#1)(1990-7#1)(1990-9#1)(1992-11#2)(1993-3#1)(1995-2#1)(1996-5#1)(1996-8#4)(1997-2#4)(1997-6#5)(1997-7#2)(2013-7#1)
the translation of the##5##4##(1990-4#1)(1997-8#1)(2008-7#1)(2009-11#1)(2012-2#1)
the translation of these##3##4##(2007-7#1)(2008-10#1)(2010-6#1)
the translation of this##2##4##(2008-8#1)(2012-1#1)
the translation of##29##3##(1990-4#1)(1993-10#1)(1993-4#1)(1995-12#1)(1996-1#1)(1997-8#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#2)(2009-11#1)(2010-11#2)(2010-12#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
the translation start site##6##4##(1992-6#1)(1997-2#2)(1997-8#1)(2008-11#1)(2008-9#1)
the translation start##10##3##(1990-11#1)(1992-6#1)(1995-12#1)(1997-2#3)(1997-8#1)(2008-11#1)(2008-9#1)(2012-2#1)
the translation termination##2##3##(1997-1#1)(2008-9#1)
the translation##90##2##(1990-11#1)(1990-4#1)(1990-5#2)(1990-7#2)(1990-9#2)(1991-4#1)(1992-11#2)(1992-2#1)(1992-6#1)(1993-10#1)(1993-3#1)(1993-4#1)(1994-9#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-4#1)(1996-5#1)(1996-8#4)(1997-1#1)(1997-2#9)(1997-3#1)(1997-6#5)(1997-7#2)(1997-8#2)(2005-10#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-2#4)(2008-7#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-9#3)(2010-11#2)(2010-12#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
the translational activity of##2##4##(1990-3#1)(2006-11#1)
the translational initiation codon##2##4##(1994-11#1)(1994-8#1)
the translational level##9##3##(1990-4#1)(1991-12#2)(1991-5#1)(1992-5#1)(1992-8#1)(1995-5#1)(2006-12#1)(2007-8#1)
the translational machinery##3##3##(1994-8#1)(2008-9#1)(2009-3#1)
the translational motion of##2##4##(2008-3#1)(2010-4#1)
the translational start codon##2##4##(1997-7#1)(2006-8#1)
the translational start site##2##4##(1990-3#1)(1992-10#1)
the translational start##7##3##(1990-11#1)(1990-3#1)(1991-11#1)(1992-10#1)(1997-7#1)(2006-8#1)(2008-4#1)
the translational temperature##2##3##(2007-11#1)(2008-2#1)
the translational##41##2##(1990-11#1)(1990-3#2)(1990-4#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-5#1)(1992-10#1)(1992-5#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-8#3)(1995-5#1)(1997-4#1)(1997-7#1)(2005-8#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#2)(2010-4#2)(2010-5#1)(2011-1#1)(2012-12#1)
the translocase activity was##2##4##(1992-11#2)
the translocase activity##3##3##(1992-11#3)
the translocated##4##2##(1993-2#2)(2011-1#1)(2011-2#1)
the translocation ATPase##2##3##(1993-9#2)
the translocation breakpoint in##2##4##(1991-5#1)(1997-1#1)
the translocation of protein kinase C##3##6##(1990-4#1)(1990-6#1)(1991-7#1)
the translocation of protein##4##4##(1990-4#1)(1990-6#1)(1991-7#1)(1997-2#1)
the translocation of rac##2##4##(1993-8#1)(1996-2#1)
the translocation of the##8##4##(1990-12#1)(1990-7#1)(1991-10#1)(1994-12#1)(1995-3#1)(2008-10#1)(2009-8#1)(2012-2#1)
the translocation of toxin B##2##5##(2007-12#2)
the translocation of##40##3##(1990-12#2)(1990-4#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-5#1)(1991-7#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-3#2)(1995-5#1)(1996-2#2)(1997-2#1)(1997-4#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-2#2)
the translocation sites##2##3##(1993-9#2)
the translocation was##2##3##(1993-4#1)(2008-10#1)
the translocation##68##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-5#3)(1991-7#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-4#1)(1993-6#1)(1993-8#3)(1993-9#5)(1994-11#1)(1994-12#2)(1994-3#2)(1994-9#1)(1995-3#2)(1995-5#1)(1996-2#2)(1996-6#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-12#3)(2008-1#2)(2008-10#4)(2008-11#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#3)
the translucency##2##2##(2012-2#2)
the transmembrane Na+ gradient##2##4##(1990-8#1)(1996-9#1)
the transmembrane and cytoplasmic domains##3##5##(1991-4#1)(1995-3#2)
the transmembrane and cytoplasmic##4##4##(1991-4#1)(1995-3#2)(1997-4#1)
the transmembrane and##8##3##(1990-9#1)(1991-4#1)(1992-11#1)(1995-3#2)(1997-4#2)(2012-2#1)
the transmembrane domain of the##3##5##(1992-12#2)(1995-1#1)
the transmembrane domain of##5##4##(1992-12#2)(1995-1#1)(1997-7#1)(2008-11#1)
the transmembrane domain##17##3##(1990-7#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-12#2)(1994-11#1)(1994-9#2)(1995-1#1)(1995-2#1)(1996-5#1)(1997-7#1)(2008-11#1)(2009-10#2)(2012-2#1)
the transmembrane domains##2##3##(1996-5#1)(2008-4#1)
the transmembrane electron##2##3##(1992-6#1)(1994-3#1)
the transmembrane glycoprotein##2##3##(1992-3#1)(2005-7#1)
the transmembrane helices##3##3##(1997-4#1)(2008-4#2)
the transmembrane helix##2##3##(1992-12#1)(1997-3#1)
the transmembrane pH gradient (delta##2##5##(1990-3#1)(1996-9#1)
the transmembrane pH gradient##4##4##(1990-3#3)(1996-9#1)
the transmembrane potential##4##3##(1994-12#2)(1997-1#1)(2007-3#1)
the transmembrane region of the##2##5##(1991-2#1)(1991-8#1)
the transmembrane region##6##3##(1990-11#1)(1991-2#1)(1991-8#1)(1991-9#1)(1994-3#1)(1997-2#1)
the transmembrane regions##2##3##(1994-8#1)(2012-2#1)
the transmembrane segments of##3##4##(1990-5#1)(1997-2#1)(2012-2#1)
the transmembrane segments##4##3##(1990-5#1)(1995-6#1)(1997-2#1)(2012-2#1)
the transmembrane signaling##2##3##(1991-4#1)(1996-10#1)
the transmembrane transport##2##3##(1992-6#1)(1995-12#1)
the transmembrane##84##2##(1990-11#2)(1990-12#1)(1990-3#3)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-7#1)(1991-8#1)(1991-9#3)(1992-11#2)(1992-12#4)(1992-3#1)(1992-6#2)(1994-11#3)(1994-12#2)(1994-3#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-4#1)(1996-5#2)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-7#2)(2005-7#1)(2006-12#1)(2007-10#1)(2007-3#1)(2008-11#2)(2008-4#3)(2008-7#1)(2008-8#1)(2009-10#2)(2012-2#4)
the transmissibility of##2##3##(2008-10#2)
the transmissible##3##2##(2008-10#3)
the transmission and##4##3##(1991-9#1)(2007-12#1)(2008-3#2)
the transmission coefficient##2##3##(2008-2#1)(2008-3#1)
the transmission dynamics of HIV-1##2##5##(1992-9#2)
the transmission efficiency of##3##4##(2008-10#2)(2008-3#1)
the transmission electron microscope##2##4##(2008-7#1)(2009-7#1)
the transmission electron##4##3##(2008-5#1)(2008-7#1)(2009-11#1)(2009-7#1)
the transmission grating##2##3##(2007-12#2)
the transmission intensity of the coherent beam##2##7##(2008-1#2)
the transmission intensity of the##3##5##(2008-1#2)(2008-8#1)
the transmission intensity##5##3##(2006-10#1)(2008-1#2)(2008-10#1)(2008-8#1)
the transmission is##5##3##(2007-12#1)(2008-2#3)(2008-3#1)
the transmission mode##3##3##(2008-2#2)(2012-11#1)
the transmission of HIV##3##4##(1991-5#1)(2010-12#1)(2012-3#1)
the transmission of S##2##4##(2008-10#1)(2008-8#1)
the transmission of a##4##4##(2008-3#3)(2009-2#1)
the transmission of human##3##4##(2006-10#1)(2007-7#2)
the transmission of infectious##2##4##(2011-2#1)(2013-8#1)
the transmission of light##2##4##(2008-2#1)(2008-3#1)
the transmission of prion##2##4##(1997-3#1)(2008-11#1)
the transmission of the##8##4##(1991-11#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-2#1)(2011-1#1)
the transmission of##95##3##(1990-11#1)(1990-5#1)(1991-11#2)(1991-5#1)(1992-7#1)(1992-9#1)(1993-1#1)(1994-8#1)(1996-7#1)(1997-3#1)(1997-4#2)(1997-7#2)(2004-11#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-8#3)(2007-11#1)(2007-12#1)(2007-7#4)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#12)(2008-4#2)(2008-5#3)(2008-8#1)(2008-9#1)(2009-2#5)(2009-8#1)(2010-1#3)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
the transmission phenotype##3##3##(2008-10#3)
the transmission properties of##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
the transmission properties##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
the transmission rate##4##3##(2006-10#1)(2008-10#1)(2008-8#1)(2008-9#1)
the transmission rates##2##3##(2008-5#1)(2013-8#1)
the transmission spectra of the##2##5##(2007-11#1)(2008-3#1)
the transmission spectra of##4##4##(2007-11#1)(2008-2#1)(2008-3#2)
the transmission spectra##5##3##(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#2)
the transmission spectrum of a##2##5##(2007-12#1)(2008-2#1)
the transmission spectrum of##5##4##(2007-12#2)(2008-2#1)(2008-3#2)
the transmission spectrum##7##3##(2007-12#4)(2008-2#1)(2008-3#2)
the transmission##197##2##(1990-11#1)(1990-5#1)(1991-11#2)(1991-5#1)(1991-9#1)(1992-7#1)(1992-9#3)(1993-1#1)(1994-2#1)(1994-8#1)(1995-6#1)(1996-7#1)(1997-3#1)(1997-4#2)(1997-7#2)(2004-11#1)(2005-8#2)(2006-10#6)(2006-11#1)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#3)(2007-11#8)(2007-12#19)(2007-2#1)(2007-7#4)(2007-9#1)(2008-1#5)(2008-10#24)(2008-11#1)(2008-12#1)(2008-2#20)(2008-3#31)(2008-4#2)(2008-5#7)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-2#5)(2009-7#1)(2009-8#1)(2010-1#3)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
the transmissivity of the##2##4##(2008-1#1)(2008-3#1)
the transmissivity of##4##3##(2007-11#1)(2008-1#2)(2008-3#1)
the transmittance and the##3##4##(2008-2#1)(2008-3#2)
the transmittance and##4##3##(2008-2#2)(2008-3#2)
the transmittance of a##2##4##(2008-2#1)(2008-3#1)
the transmittance of the##2##4##(2007-12#1)(2008-3#1)
the transmittance of##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
the transmittance##16##2##(2006-8#1)(2007-12#1)(2008-2#8)(2008-3#6)
the transmitted and backscattered##2##4##(2008-10#1)(2008-2#1)
the transmitted and reflected##2##4##(2007-11#1)(2008-3#1)
the transmitted and the##3##4##(2008-2#1)(2008-3#2)
the transmitted and##7##3##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#3)
the transmitted beam##6##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
the transmitted field##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
the transmitted intensities##2##3##(2007-12#1)(2008-3#1)
the transmitted laser##3##3##(2007-12#1)(2008-3#2)
the transmitted light of the FBG##2##6##(2007-12#2)
the transmitted light##11##3##(1997-6#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#1)
the transmitted optical power##2##4##(2008-1#1)(2008-3#1)
the transmitted optical##4##3##(2008-1#1)(2008-2#2)(2008-3#1)
the transmitted pulse##2##3##(2007-12#2)
the transmitted##55##2##(1997-6#1)(2007-11#4)(2007-12#14)(2008-1#5)(2008-10#3)(2008-2#12)(2008-3#15)(2013-8#1)
the transmitter and receiver##2##4##(2008-2#1)(2008-3#1)
the transmitter and the receiver##2##5##(2007-11#2)
the transmitter and##5##3##(2007-11#2)(2008-2#1)(2008-3#2)
the transmitter beam##2##3##(2008-2#2)
the transmitter is##2##3##(2007-11#1)(2008-1#1)
the transmitter##20##2##(1990-7#1)(2007-11#4)(2007-12#4)(2008-1#1)(2008-2#5)(2008-3#3)(2010-12#1)(2013-7#1)
the transmitters##2##2##(2007-10#1)(2013-8#1)
the transmitting tissue##3##3##(2008-8#1)(2009-12#2)
the transmitting##4##2##(2008-8#1)(2009-12#2)(2012-2#1)
the transmittivity##2##2##(2005-4#2)
the transmucosal##2##2##(1997-2#2)
the transmural dispersion of repolarization##2##5##(2007-9#2)
the transnasal##2##2##(2006-7#1)(2011-2#1)
the transnitrosation reaction##2##3##(1995-5#2)
the transoral##2##2##(2006-9#2)
the transparency of the##2##4##(2008-7#1)(2011-1#1)
the transparency##6##2##(2007-12#2)(2007-3#1)(2008-7#1)(2010-4#1)(2011-1#1)
the transparent and##3##3##(1995-5#1)(2009-12#1)(2009-9#1)
the transparent##11##2##(1995-5#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#1)(2009-12#2)(2009-9#1)(2013-8#1)
the transpedicular##2##2##(2007-11#1)(2007-7#1)
the transpetrosal approach##3##3##(2006-12#1)(2008-7#2)
the transpetrosal##4##2##(2006-12#1)(2008-7#3)
the transplacental##2##2##(1991-3#1)(2011-2#1)
the transplant renal##2##3##(2008-1#1)(2008-4#1)
the transplant team##2##3##(2007-11#1)(2011-3#1)
the transplant teams##2##3##(2011-2#1)(2011-3#1)
the transplant##25##2##(1994-3#2)(1994-6#1)(1995-2#3)(1996-6#1)(1996-8#1)(1997-8#1)(2006-10#2)(2007-11#1)(2008-1#2)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#4)(2011-3#3)(2013-1#1)
the transplantable##3##2##(1992-1#1)(1993-4#1)(2011-2#1)
the transplantation of##11##3##(1995-7#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-5#1)(2008-6#1)(2010-2#2)(2012-12#2)(2012-2#1)
the transplantation##24##2##(1995-7#1)(1995-9#1)(1996-9#1)(1997-6#1)(2005-10#1)(2007-11#2)(2008-1#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-11#1)(2010-2#2)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)
the transplanted cells##3##3##(1993-12#1)(2010-11#1)(2012-12#1)
the transplanted kidney##4##3##(1992-2#2)(2007-7#2)
the transplanted peptide##2##3##(1995-3#2)
the transplanted##24##2##(1991-5#1)(1992-2#2)(1992-3#1)(1993-12#1)(1995-3#2)(2006-10#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-3#2)(2008-9#1)(2010-11#1)(2010-2#1)(2011-2#1)(2011-3#1)(2012-12#5)
the transplasma membrane electron transport##2##5##(1992-11#1)(1993-4#1)
the transport activity of##2##4##(2008-11#1)(2010-12#1)
the transport activity##8##3##(1990-11#1)(1992-4#4)(1995-8#1)(2008-11#1)(2010-12#1)
the transport and##6##3##(1991-6#1)(1992-6#1)(2008-10#1)(2008-7#1)(2009-7#1)(2013-1#1)
the transport cycle##2##3##(1991-5#1)(1996-5#1)
the transport group##2##3##(2013-1#2)
the transport mean free path and##2##6##(2007-12#1)(2008-2#1)
the transport mean free path##7##5##(2007-12#2)(2008-2#2)(2008-3#3)
the transport of a##2##4##(1992-6#1)(1997-8#1)
the transport of the##6##4##(1992-11#1)(1994-11#1)(1995-6#1)(1996-9#1)(2005-1#1)(2010-11#1)
the transport of this##2##4##(2007-8#1)(2008-3#1)
the transport of##65##3##(1990-12#2)(1990-3#2)(1990-8#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-6#2)(1996-6#1)(1996-9#1)(1997-8#1)(2004-12#1)(2005-1#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-9#1)(2010-11#2)(2011-2#1)(2011-3#5)(2012-1#1)(2012-2#2)
the transport pathway##2##3##(1996-8#1)(2009-8#1)
the transport phase##2##3##(1992-9#1)(2008-7#1)
the transport process##4##3##(1991-5#1)(1992-6#2)(1994-2#1)
the transport rate of##2##4##(1994-11#1)(2008-11#1)
the transport scattering coefficient##2##4##(2007-12#1)(2008-3#1)
the transport scattering##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
the transport system for##3##4##(1990-11#1)(1990-3#1)(1992-3#1)
the transport system##6##3##(1990-11#1)(1990-3#1)(1992-3#1)(1997-1#1)(2008-10#1)(2013-7#1)
the transport##139##2##(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#3)(1990-8#2)(1991-4#1)(1991-5#3)(1991-6#3)(1991-7#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-4#4)(1992-6#5)(1992-7#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-11#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-8#1)(2004-12#1)(2005-1#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#6)(2007-8#3)(2008-1#2)(2008-10#6)(2008-11#2)(2008-2#7)(2008-3#6)(2008-6#2)(2008-7#5)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-8#1)(2011-2#1)(2011-3#6)(2012-1#1)(2012-12#1)(2012-2#3)(2012-8#1)(2013-1#3)(2013-7#1)
the transportation of##2##3##(1991-11#1)(2010-12#1)
the transportation##4##2##(1991-11#1)(1994-1#1)(2010-12#1)(2012-12#1)
the transported##3##2##(1992-6#1)(2008-5#1)(2010-4#1)
the transporter is##2##3##(1994-6#1)(1996-4#1)
the transporter##11##2##(1990-2#1)(1992-1#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-4#2)(1996-6#1)(2008-8#2)
the transporters##3##2##(2008-7#2)(2008-8#1)
the transporting##2##2##(1997-7#1)(2008-3#1)
the transposable element##5##3##(1994-3#1)(1995-8#1)(2008-10#2)(2008-9#1)
the transposase##4##2##(1990-3#1)(1994-9#1)(1995-8#1)(2012-3#1)
the transposed##3##2##(2007-7#2)(2008-9#1)
the transposition properties##2##3##(1991-9#2)
the transposition##4##2##(1991-9#2)(1995-8#1)(2005-11#1)
the transposon##9##2##(1993-12#1)(1997-2#2)(2008-10#5)(2008-9#1)
the transradial access##2##3##(2011-2#2)
the transradial##5##2##(2011-2#5)
the transtheoretical model##3##3##(2008-9#1)(2013-1#2)
the transthoracic##3##2##(2006-7#2)(2010-7#1)
the transthyretin##4##2##(1991-3#1)(1992-1#1)(1992-8#2)
the transverse and longitudinal##3##4##(2006-5#1)(2007-12#2)
the transverse and the longitudinal##4##5##(2007-12#2)(2008-3#2)
the transverse and##8##3##(2006-5#1)(2007-12#4)(2008-3#2)(2009-3#1)
the transverse carpal ligament##4##4##(2006-3#1)(2008-9#2)(2012-2#1)
the transverse coherence properties##2##4##(2007-12#1)(2008-3#1)
the transverse coherence##3##3##(2007-12#1)(2008-3#2)
the transverse colon##4##3##(1993-9#2)(2008-9#1)(2010-2#1)
the transverse concentration gradient##2##4##(2008-10#2)
the transverse diameter of the##3##5##(2011-2#2)(2012-2#1)
the transverse momenta##2##3##(2007-11#2)
the transverse processes and the spinous processes##2##7##(2007-5#2)
the transverse processes##3##3##(2007-11#1)(2007-5#2)
the transverse resolution of three-dimensional##2##5##(2007-12#2)
the transverse resolution##3##3##(2007-12#2)(2008-3#1)
the transverse sinus##5##3##(1996-9#1)(2006-12#1)(2008-7#2)(2012-1#1)
the transverse spatial distribution of the##2##6##(2007-12#1)(2008-1#1)
the transverse tubule##2##3##(1991-2#1)(1993-12#1)
the transverse##82##2##(1991-2#1)(1991-9#1)(1993-12#1)(1993-3#1)(1993-9#2)(1995-6#1)(1996-9#1)(1997-5#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-9#1)(2007-11#6)(2007-12#20)(2007-5#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#4)(2008-3#12)(2008-7#2)(2008-9#3)(2009-3#1)(2009-6#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#4)(2013-1#2)
the transverse-sigmoid sinus##2##3##(2006-12#1)(2007-10#1)
the transversely heated graphite atomizer##2##5##(2008-10#2)
the trap and##2##3##(2008-10#1)(2009-8#1)
the trap##11##2##(1997-4#1)(2007-11#2)(2008-10#4)(2008-2#2)(2009-8#2)
the trapezoidal##2##2##(1996-11#1)(2008-3#1)
the trapped pulse##2##3##(2007-11#2)
the trapped##9##2##(1995-3#1)(1996-8#1)(2004-7#1)(2005-11#1)(2007-11#2)(2007-12#1)(2008-10#1)(2010-8#1)
the trapping of##4##3##(1992-3#1)(1993-9#1)(2008-10#1)(2008-3#1)
the trapping theory##2##3##(2008-11#2)
the trapping##16##2##(1992-3#1)(1992-9#1)(1993-9#1)(1996-4#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#2)
the traps##2##2##(1991-3#1)(2013-7#1)
the trauma of##5##3##(1991-7#1)(1994-2#1)(2008-10#1)(2008-6#1)(2010-5#1)
the trauma patient is##2##4##(2006-10#2)
the trauma patient##11##3##(2006-10#9)(2009-6#1)(2013-1#1)
the trauma program manager##2##4##(2006-2#2)
the trauma with##2##3##(2010-1#1)(2011-1#1)
the trauma##37##2##(1991-7#1)(1992-2#1)(1993-11#1)(1993-5#1)(1994-2#1)(1996-1#1)(2005-7#1)(2006-10#10)(2006-11#1)(2006-2#3)(2007-10#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-6#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-5#1)(2011-1#1)(2012-12#2)(2013-1#1)
the traumatic lesions##3##3##(2007-11#1)(2007-7#1)(2008-8#1)
the traumatic##12##2##(2005-10#1)(2007-11#1)(2007-7#2)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-1#2)(2012-12#1)(2012-2#1)
the travel##4##2##(1991-3#1)(2006-10#1)(2007-2#1)(2009-8#1)
the traveler##2##2##(2007-2#2)
the traveling##2##2##(1992-12#1)(2006-4#1)
the traveling-wave##2##2##(2007-12#2)
the traveller##5##2##(1993-8#2)(2007-2#2)(2008-11#1)
the travelling##4##2##(2006-4#1)(2007-7#1)(2010-8#1)(2011-2#1)
the trays##3##2##(2007-7#2)(2008-11#1)
the trc promoter##2##3##(1993-6#1)(2006-12#1)
the treadmill##3##2##(2012-1#3)
the treated animals##3##3##(2009-4#1)(2010-12#1)(2012-12#1)
the treated cells##3##3##(1990-9#1)(1991-5#1)(1992-6#1)
the treated embryos##3##3##(2008-11#2)(2008-12#1)
the treated fish##2##3##(2008-10#1)(2008-7#1)
the treated group was##2##4##(2009-8#2)
the treated group##10##3##(1990-11#1)(1991-5#1)(2006-5#1)(2007-8#1)(2008-5#3)(2009-4#1)(2009-8#2)
the treated groups##3##3##(2008-4#1)(2008-5#1)(2009-7#1)
the treated mice##6##3##(1995-12#1)(2006-8#1)(2008-4#1)(2008-8#1)(2008-9#2)
the treated or##2##3##(2007-11#1)(2008-4#1)
the treated patients and##2##4##(2006-8#1)(2013-8#1)
the treated patients##5##3##(1996-3#1)(2006-10#1)(2006-8#1)(2007-7#1)(2013-8#1)
the treated rats##12##3##(1991-5#1)(1992-9#1)(1995-1#1)(1996-10#4)(2007-1#3)(2009-4#1)(2013-1#1)
the treated specimens##2##3##(2009-7#1)(2013-1#1)
the treated tissue##2##3##(2008-3#1)(2009-11#1)
the treated women##2##3##(1994-12#2)
the treated##121##2##(1990-11#1)(1990-9#1)(1991-5#3)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-9#1)(1994-12#2)(1994-5#2)(1995-1#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-10#4)(1996-3#1)(1996-7#1)(2005-11#3)(2005-7#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-1#3)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#5)(2007-8#3)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#12)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-11#1)(2009-2#1)(2009-4#3)(2009-6#1)(2009-7#2)(2009-8#3)(2010-10#1)(2010-12#1)(2010-2#2)(2011-1#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#3)
the treating oncologists##2##3##(2010-2#1)(2013-8#1)
the treating physician and##2##4##(2006-8#1)(2008-8#1)
the treating physician to##3##4##(2007-8#1)(2011-1#1)(2011-2#1)
the treating physician##13##3##(1992-8#1)(1993-12#1)(1996-3#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-7#1)(2008-8#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-8#1)
the treating surgeon##6##3##(2007-12#2)(2009-10#1)(2009-9#1)(2010-3#1)(2013-1#1)
the treating##30##2##(1992-8#1)(1993-12#2)(1996-10#1)(1996-3#1)(2005-12#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-12#3)(2007-8#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
the treatise##3##2##(1995-4#1)(2007-5#2)
the treatment and care##2##4##(2010-12#1)(2010-5#1)
the treatment and diagnosis of##2##5##(2007-11#1)(2010-6#1)
the treatment and management of patients with##2##7##(2008-4#1)(2013-8#1)
the treatment and management of##5##5##(2007-2#1)(2008-4#1)(2009-10#1)(2011-1#1)(2013-8#1)
the treatment and prevention of##19##5##(1993-10#1)(2006-10#3)(2007-11#2)(2007-12#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-12#2)
the treatment and prognosis of##2##5##(1993-3#1)(2006-8#1)
the treatment and prophylaxis of##3##5##(2006-6#1)(2008-5#1)(2010-6#1)
the treatment and the##8##4##(1990-3#1)(1992-6#1)(2007-8#1)(2011-12#1)(2011-2#3)(2013-1#1)
the treatment and triage of patients##2##6##(2008-3#2)
the treatment and##75##3##(1990-3#1)(1991-11#1)(1991-4#1)(1991-7#1)(1992-12#2)(1992-6#1)(1993-10#1)(1993-11#1)(1993-3#1)(1993-8#1)(2006-10#4)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#5)(2007-12#3)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#5)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#4)(2008-7#2)(2009-10#2)(2010-11#1)(2010-12#2)(2010-5#2)(2010-6#2)(2011-1#2)(2011-12#1)(2011-2#5)(2012-12#2)(2013-1#2)(2013-8#2)
the treatment approaches##3##3##(1996-4#1)(2005-7#1)(2006-2#1)
the treatment are##2##3##(2008-2#1)(2008-5#1)
the treatment arm##5##3##(2008-5#1)(2009-10#1)(2010-12#3)
the treatment armamentarium for##2##4##(1991-12#1)(2008-9#1)
the treatment as well as##2##5##(1990-3#1)(2008-11#1)
the treatment as##7##3##(1990-3#1)(1992-2#1)(2004-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-6#1)
the treatment choice##2##3##(1995-11#1)(2012-2#1)
the treatment comparison##3##3##(1993-5#1)(2008-8#2)
the treatment course##2##3##(2008-10#1)(2008-5#1)
the treatment difference##2##3##(1994-9#1)(1996-12#1)
the treatment effect##12##3##(1992-6#1)(1994-11#1)(1996-6#2)(1996-8#2)(1997-4#1)(2006-6#1)(2008-10#1)(2012-1#1)(2012-12#1)(2012-2#1)
the treatment effects##2##3##(2011-2#1)(2012-2#1)
the treatment efficacy and##2##4##(2008-11#1)(2009-3#1)
the treatment efficacy##4##3##(2007-7#1)(2008-11#1)(2009-3#1)(2011-1#1)
the treatment even##2##3##(1993-4#1)(2012-12#1)
the treatment facilities available##2##4##(1996-11#1)(1997-8#1)
the treatment field##3##3##(2007-10#1)(2008-3#1)(2008-6#1)
the treatment for##11##3##(1992-12#1)(1994-6#1)(1996-3#1)(1997-3#1)(2005-11#1)(2007-11#2)(2008-1#1)(2008-5#1)(2009-8#1)(2010-1#1)
the treatment group and##3##4##(2008-5#1)(2009-4#1)(2013-8#1)
the treatment group had substantively and statistically significantly higher health care utilization (including primary and preventive care as well as hospitalizations)##2##21##(2013-1#2)
the treatment group had##4##4##(2006-10#1)(2009-4#1)(2013-1#2)
the treatment group selected by the lottery was about 25 percentage points more likely to have insurance than the control group that was not selected##2##25##(2013-1#2)
the treatment group was##4##4##(2006-4#1)(2006-8#1)(2007-7#1)(2012-1#1)
the treatment group##28##3##(1995-9#1)(1997-8#1)(2004-3#1)(2006-10#1)(2006-4#4)(2006-8#2)(2006-9#1)(2007-7#2)(2008-10#1)(2008-5#1)(2008-8#1)(2009-4#2)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#1)(2013-1#4)(2013-8#1)
the treatment groups were##2##4##(1991-8#1)(2008-10#1)
the treatment groups##15##3##(1991-2#1)(1991-8#1)(1992-5#1)(1994-12#3)(1996-10#1)(2004-1#1)(2007-1#1)(2007-8#1)(2008-10#2)(2011-2#1)(2012-12#1)(2012-2#1)
the treatment head##2##3##(2008-3#1)(2009-11#1)
the treatment is##12##3##(1993-3#1)(1994-4#2)(1996-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2009-10#1)(2011-1#1)(2011-2#1)(2013-7#1)
the treatment method##4##3##(2007-11#1)(2007-7#2)(2007-8#1)
the treatment methods##3##3##(2007-11#2)(2012-12#1)
the treatment modalities##3##3##(2007-12#1)(2008-7#1)(2013-7#1)
the treatment must be##2##4##(1995-4#1)(2008-3#1)
the treatment of ADHD##2##4##(2008-2#1)(2010-11#1)
the treatment of Alzheimer's disease##4##5##(1993-11#1)(1996-8#1)(2005-6#1)(2006-12#1)
the treatment of Alzheimer's##5##4##(1991-8#1)(1993-11#1)(1996-8#1)(2005-6#1)(2006-12#1)
the treatment of B##2##4##(2010-4#2)
the treatment of B-cell##2##4##(2008-7#1)(2013-8#1)
the treatment of CML##2##4##(1997-3#1)(2012-12#1)
the treatment of CNS##2##4##(2008-7#1)(2012-2#1)
the treatment of COPD##2##4##(2007-11#1)(2011-2#1)
the treatment of Crohn's disease##5##5##(1994-6#1)(2007-11#2)(2010-12#1)(2013-1#1)
the treatment of HIV and##3##5##(2005-9#1)(2008-1#1)(2008-8#1)
the treatment of HIV##12##4##(1995-12#1)(1995-3#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-5#2)(2008-8#1)(2009-4#1)
the treatment of HIV-1 infection##2##5##(1991-2#1)(2008-5#1)
the treatment of Hodgkin's##3##4##(1991-9#1)(2008-4#2)
the treatment of Kienböck disease##2##5##(2006-3#1)(2006-4#1)
the treatment of MM##2##4##(2008-1#1)(2009-8#1)
the treatment of MS##3##4##(2007-11#2)(2013-1#1)
the treatment of NASH##2##4##(2008-9#1)(2013-1#1)
the treatment of NSCLC##4##4##(2010-8#1)(2011-12#1)(2012-1#1)(2013-8#1)
the treatment of OCD##4##4##(2006-9#1)(2008-3#1)(2008-6#2)
the treatment of PD##7##4##(2008-11#1)(2008-7#5)(2012-1#1)
the treatment of Parkinson's disease##13##5##(1992-3#1)(1995-12#1)(1996-1#1)(1996-3#2)(2005-7#2)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#2)
the treatment of Peyronie's disease##2##5##(2006-10#1)(2007-9#1)
the treatment of RA##5##4##(2007-11#1)(2008-5#2)(2013-8#2)
the treatment of T##3##4##(1991-12#1)(2007-11#1)(2009-4#1)
the treatment of Wuchereria bancrofti##2##5##(2008-2#2)
the treatment of a variety of##4##6##(1996-4#1)(2006-8#1)(2008-5#1)(2013-8#1)
the treatment of a##17##4##(1991-2#1)(1992-6#1)(1994-2#1)(1996-4#1)(2006-8#1)(2007-11#2)(2007-12#1)(2008-5#2)(2009-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
the treatment of acne vulgaris##9##5##(1997-8#1)(2007-7#2)(2008-5#3)(2010-5#1)(2010-8#2)
the treatment of acne##13##4##(1997-8#1)(2007-10#1)(2007-7#2)(2008-3#1)(2008-5#3)(2010-5#3)(2010-8#2)
the treatment of active##2##4##(2012-3#1)(2013-8#1)
the treatment of acute exacerbations##3##5##(1991-12#1)(1991-6#2)
the treatment of acute gout##4##5##(2007-11#4)
the treatment of acute ischemic stroke##2##6##(2007-9#2)
the treatment of acute ischemic##4##5##(2005-9#1)(2007-10#1)(2007-9#2)
the treatment of acute low back pain##2##7##(1991-4#2)
the treatment of acute promyelocytic##2##5##(2010-12#1)(2012-12#1)
the treatment of acute stroke##3##5##(2007-10#2)(2009-11#1)
the treatment of acute##51##4##(1990-5#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-4#2)(1991-6#2)(1992-2#1)(1992-3#1)(1993-8#1)(1994-2#1)(1994-4#1)(1995-6#1)(1995-9#1)(1996-3#1)(1997-7#1)(2005-1#1)(2005-10#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-12#1)(2006-9#1)(2007-10#3)(2007-11#5)(2007-8#1)(2007-9#2)(2008-2#1)(2008-3#3)(2008-5#1)(2009-10#1)(2009-11#1)(2010-12#3)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
the treatment of adult##4##4##(1996-1#1)(2006-8#1)(2007-11#1)(2008-3#1)
the treatment of adults with##2##5##(2007-11#1)(2008-3#1)
the treatment of adults##3##4##(2007-11#1)(2008-3#1)(2009-3#1)
the treatment of advanced##20##4##(1990-12#3)(1991-4#1)(1993-6#1)(1994-7#1)(1996-3#1)(2006-10#1)(2006-6#2)(2007-11#2)(2007-8#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-8#1)(2012-1#1)
the treatment of alcohol dependence##2##5##(1991-12#1)(2008-2#1)
the treatment of all##2##4##(2008-5#1)(2009-8#1)
the treatment of allergic##7##4##(2007-11#4)(2007-2#1)(2010-6#1)(2011-2#1)
the treatment of an##7##4##(2007-11#1)(2008-10#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
the treatment of anemia in##2##5##(2007-7#1)(2008-1#1)
the treatment of angina pectoris##2##5##(2011-2#1)(2013-1#1)
the treatment of anxiety##5##4##(2008-6#1)(2009-9#3)(2012-12#1)
the treatment of any##2##4##(1996-9#1)(2007-8#1)
the treatment of arterial##4##4##(1993-11#1)(1995-4#1)(1996-3#1)(2011-2#1)
the treatment of asthma and##2##5##(1996-1#1)(2013-7#1)
the treatment of asthma is##2##5##(2005-8#1)(2008-3#1)
the treatment of asthma##16##4##(1991-4#1)(1992-2#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-8#2)(2007-11#2)(2008-3#3)(2013-7#1)
the treatment of atherosclerosis##4##4##(2005-3#1)(2006-6#1)(2009-5#2)
the treatment of atopic dermatitis##7##5##(2005-8#2)(2007-11#1)(2007-8#1)(2008-3#1)(2010-8#2)
the treatment of atopic##8##4##(2005-8#2)(2007-11#1)(2007-8#1)(2008-3#1)(2008-5#1)(2010-8#2)
the treatment of attention deficit hyperactivity disorder (ADHD) in##2##9##(2006-12#1)(2008-6#1)
the treatment of autoimmune##4##4##(1991-12#1)(1993-11#1)(2012-2#1)(2012-3#1)
the treatment of benign##7##4##(1990-6#1)(1992-2#1)(1994-11#1)(2006-9#1)(2007-8#1)(2008-5#1)(2011-2#1)
the treatment of bipolar disorder##3##5##(2008-8#2)(2011-12#1)
the treatment of bipolar##5##4##(2008-3#1)(2008-8#2)(2011-12#1)(2013-8#1)
the treatment of bleeding esophageal##2##5##(2006-10#1)(2013-1#1)
the treatment of bleeding##3##4##(1992-6#1)(2006-10#1)(2013-1#1)
the treatment of bone metastases##3##5##(1993-10#1)(2007-11#1)(2008-7#1)
the treatment of bone##9##4##(1993-10#1)(1993-11#1)(2006-10#1)(2007-11#3)(2008-5#1)(2008-7#1)(2009-8#1)
the treatment of both##6##4##(1991-3#1)(2005-8#1)(2007-11#1)(2008-3#1)(2010-1#1)(2013-1#1)
the treatment of brain tumors in##2##6##(1990-5#1)(1995-2#1)
the treatment of brain tumors##4##5##(1990-5#1)(1995-2#1)(2008-11#1)(2008-5#1)
the treatment of brain##6##4##(1990-5#1)(1995-2#1)(2005-8#1)(2008-11#1)(2008-5#1)(2008-8#1)
the treatment of breast cancer##13##5##(1992-5#1)(1993-1#1)(1993-11#2)(1995-11#1)(1995-12#1)(1996-11#1)(2005-10#3)(2008-5#1)(2011-1#1)(2012-1#1)
the treatment of breast##16##4##(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-6#1)(1995-11#1)(1995-12#1)(1996-11#1)(2005-10#3)(2008-3#1)(2008-5#1)(2011-1#1)(2012-1#1)
the treatment of bronchial asthma]##2##5##(1996-7#1)(2013-8#1)
the treatment of bronchial##3##4##(1996-7#1)(2008-1#1)(2013-8#1)
the treatment of cachexia##2##4##(2008-10#1)(2008-5#1)
the treatment of cancer in##3##5##(1993-3#1)(2007-12#1)(2013-1#1)
the treatment of cancer##30##4##(1993-3#1)(1995-8#1)(2005-6#1)(2005-8#1)(2006-11#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-4#1)(2008-1#2)(2008-10#2)(2008-5#5)(2008-7#2)(2009-11#1)(2009-12#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
the treatment of cardiac arrhythmias##2##5##(1990-9#1)(2005-8#1)
the treatment of cardiac##4##4##(1990-9#1)(1991-9#1)(2005-8#1)(2008-5#1)
the treatment of cardiovascular disease##7##5##(2006-5#1)(2008-1#2)(2010-6#1)(2011-2#2)(2012-1#1)
the treatment of cardiovascular##10##4##(2006-5#1)(2007-8#1)(2008-1#3)(2008-3#1)(2010-6#1)(2011-2#2)(2012-1#1)
the treatment of cells with##2##5##(2007-3#1)(2008-8#1)
the treatment of cellulite##2##4##(2008-5#2)
the treatment of central##2##4##(2008-7#1)(2010-6#1)
the treatment of cerebral##3##4##(1990-3#1)(1991-11#1)(1997-4#1)
the treatment of certain forms of##2##6##(2009-3#1)(2011-2#1)
the treatment of certain types of##2##6##(2008-6#1)(2008-9#1)
the treatment of certain##6##4##(1992-9#1)(2006-12#1)(2008-6#1)(2008-9#1)(2009-3#1)(2011-2#1)
the treatment of cervical disk##2##5##(1996-3#1)(2008-9#1)
the treatment of cervical##6##4##(1991-1#1)(1994-12#1)(1996-3#1)(2005-10#1)(2007-10#1)(2008-9#1)
the treatment of childhood obesity##2##5##(2008-3#1)(2011-2#1)
the treatment of childhood##4##4##(2008-11#2)(2008-3#1)(2011-2#1)
the treatment of children with##9##5##(2006-10#3)(2006-11#1)(2007-12#1)(2008-9#2)(2010-9#1)(2011-2#1)
the treatment of children##11##4##(2006-10#3)(2006-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-9#2)(2010-9#1)(2011-2#1)
the treatment of choice for most patients##2##7##(2006-10#2)
the treatment of choice for most##4##6##(2006-10#2)(2007-7#1)(2008-11#1)
the treatment of choice for patients with##6##7##(2006-11#1)(2006-5#1)(2006-9#1)(2007-11#1)(2009-12#1)(2010-10#1)
the treatment of choice for patients##7##6##(2006-11#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-4#1)(2009-12#1)(2010-10#1)
the treatment of choice for##32##5##(1991-9#1)(1994-12#1)(1994-6#1)(1995-8#1)(1997-3#1)(2006-10#4)(2006-11#1)(2006-5#2)(2006-9#1)(2007-11#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-3#1)(2010-10#1)(2010-6#2)(2010-8#1)(2011-2#1)(2013-1#2)
the treatment of choice in patients with##2##7##(2006-10#1)(2010-6#1)
the treatment of choice in some##2##6##(2007-11#1)(2009-5#1)
the treatment of choice in symptomatic##2##6##(2009-4#1)(2012-2#1)
the treatment of choice in the##2##6##(1991-9#1)(2013-1#1)
the treatment of choice in##22##5##(1990-9#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1993-8#1)(1994-3#1)(1994-4#1)(2006-1#1)(2006-10#1)(2007-11#2)(2007-7#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
the treatment of choice is##3##5##(1991-9#1)(2007-11#1)(2010-12#1)
the treatment of choice when##2##5##(1990-2#1)(1997-2#1)
the treatment of choice##95##4##(1990-2#1)(1990-6#2)(1990-9#1)(1991-10#1)(1991-6#1)(1991-9#4)(1992-10#1)(1992-12#1)(1992-3#1)(1992-9#2)(1993-10#1)(1993-5#2)(1993-8#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-5#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-5#2)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#7)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#4)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
the treatment of chronic hepatitis C##5##6##(2007-11#2)(2009-5#1)(2009-7#1)(2012-12#1)
the treatment of chronic hepatitis##8##5##(2006-10#1)(2007-11#3)(2009-5#1)(2009-7#1)(2009-8#1)(2012-12#1)
the treatment of chronic myeloid leukemia (CML)##2##7##(2009-3#1)(2010-11#1)
the treatment of chronic myeloid leukemia##3##6##(2009-3#1)(2010-11#2)
the treatment of chronic obstructive pulmonary disease##3##7##(1991-12#1)(2006-10#1)(2010-5#1)
the treatment of chronic pain patients##2##6##(2006-12#1)(2006-8#1)
the treatment of chronic pain##8##5##(1991-2#1)(1996-7#1)(2005-7#1)(2006-12#2)(2006-8#3)
the treatment of chronic spinal pain##2##6##(2006-7#1)(2006-8#1)
the treatment of chronic##60##4##(1991-12#1)(1991-2#1)(1993-5#1)(1996-2#1)(1996-7#1)(1997-4#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-12#2)(2006-6#1)(2006-7#3)(2006-8#5)(2007-11#3)(2007-7#3)(2007-8#1)(2008-1#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#4)(2008-7#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
the treatment of cocaine##2##4##(1991-1#2)
the treatment of colon##3##4##(2007-3#1)(2011-2#2)
the treatment of colorectal cancer##2##5##(2008-5#2)
the treatment of colorectal cancer]##3##5##(2012-1#3)
the treatment of colorectal##8##4##(2008-5#2)(2010-11#2)(2012-1#4)
the treatment of comorbid##2##4##(2007-6#1)(2008-6#1)
the treatment of complex##4##4##(2006-10#2)(2006-3#1)(2007-8#1)
the treatment of congenital##4##4##(1990-9#1)(1993-10#1)(2006-4#1)(2009-5#1)
the treatment of congestive heart failure##2##6##(1992-6#1)(2007-11#1)
the treatment of corneal##2##4##(2005-7#1)(2012-12#1)
the treatment of coronary artery disease##2##6##(2006-11#1)(2008-8#1)
the treatment of coronary artery##3##5##(2006-11#1)(2007-8#1)(2008-8#1)
the treatment of cutaneous cysticercosis##2##5##(2007-2#2)
the treatment of cystic fibrosis##2##5##(1991-2#1)(2007-6#1)
the treatment of decompensated heart failure##2##6##(2008-1#1)(2008-10#1)
the treatment of deep##4##4##(1990-12#1)(2005-8#1)(2010-5#1)(2012-3#1)
the treatment of delirium##2##4##(2009-9#2)
the treatment of dementia##2##4##(2008-11#2)
the treatment of dental##4##4##(1991-5#1)(1995-9#1)(2008-7#1)(2013-1#1)
the treatment of depression and##2##5##(2012-12#1)(2012-2#1)
the treatment of depression##24##4##(1994-8#1)(1995-7#1)(1996-12#1)(2005-9#5)(2006-6#1)(2008-2#3)(2008-4#1)(2008-6#1)(2009-10#1)(2010-2#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#4)
the treatment of developmental dysplasia of the hip##2##8##(2007-8#2)
the treatment of developmental##5##4##(2007-7#1)(2007-8#4)
the treatment of diabetes##15##4##(2005-7#1)(2005-8#2)(2007-5#2)(2008-1#2)(2008-4#4)(2008-5#1)(2010-12#1)(2010-4#1)(2012-3#1)
the treatment of diabetic macular edema##2##6##(2008-1#2)
the treatment of diabetic##10##4##(1991-11#1)(2005-7#1)(2006-1#2)(2008-1#4)(2011-2#1)(2013-1#1)
the treatment of different##5##4##(2008-1#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
the treatment of direct##2##4##(1990-6#1)(1996-1#1)
the treatment of disease##4##4##(2007-4#1)(2008-10#1)(2009-3#1)(2009-7#1)
the treatment of diseases##10##4##(1994-4#1)(2005-7#1)(2006-10#1)(2007-7#2)(2007-8#1)(2008-3#1)(2008-4#1)(2010-4#1)(2013-1#1)
the treatment of distal##4##4##(2008-12#1)(2011-2#1)(2013-8#2)
the treatment of dry##2##4##(2006-10#1)(2008-5#1)
the treatment of dyslipidemia##2##4##(2008-1#1)(2008-10#1)
the treatment of early PD##2##5##(2005-7#1)(2008-7#1)
the treatment of early##11##4##(1995-8#1)(2005-7#1)(2006-10#2)(2007-11#1)(2008-5#2)(2008-7#2)(2011-2#2)
the treatment of early-stage##2##4##(1995-8#1)(2007-12#1)
the treatment of edentulous patients##2##5##(2007-9#1)(2011-7#1)
the treatment of end-stage##4##4##(2007-2#1)(2007-4#1)(2010-12#1)(2010-6#1)
the treatment of endocarditis##3##4##(2007-12#1)(2013-1#2)
the treatment of epilepsy##7##4##(2006-10#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2013-7#1)
the treatment of erectile dysfunction##4##5##(2005-7#2)(2006-12#1)(2007-10#1)
the treatment of erythema nodosum leprosum##2##6##(2007-11#1)(2008-5#1)
the treatment of esophageal##5##4##(1993-2#1)(2006-10#3)(2009-3#1)
the treatment of essential##3##4##(1990-9#1)(1992-8#1)(2008-7#1)
the treatment of established##2##4##(2006-10#1)(2007-11#1)
the treatment of ethylene glycol poisoning##2##6##(2005-7#1)(2007-7#1)
the treatment of experimental##3##4##(1993-4#1)(2008-5#1)(2009-6#1)
the treatment of familial hypercholesterolemia##2##5##(1991-9#1)(1993-9#1)
the treatment of femoral##3##4##(2007-11#1)(2007-8#1)(2008-7#1)
the treatment of fibromyalgia##3##4##(1996-2#1)(2006-10#1)(2010-12#1)
the treatment of focal##2##4##(2007-8#2)
the treatment of fractures of the##3##6##(2006-10#1)(2007-8#1)(2008-9#1)
the treatment of fractures with##2##5##(2007-8#2)
the treatment of fractures##5##4##(2006-10#1)(2007-8#3)(2008-9#1)
the treatment of full thickness patellar cartilage defects##2##8##(2007-11#2)
the treatment of fungal infections##2##5##(2005-7#1)(2006-4#1)
the treatment of fungal##3##4##(2005-7#1)(2006-4#1)(2008-3#1)
the treatment of gastric##3##4##(2005-9#1)(2006-2#1)(2008-5#1)
the treatment of gastroesophageal reflux disease (GERD)##2##7##(2008-5#2)
the treatment of gastroesophageal reflux disease##3##6##(2008-3#1)(2008-5#2)
the treatment of gastroesophageal reflux##4##5##(1992-11#1)(2008-3#1)(2008-5#2)
the treatment of glaucoma and ocular hypertension##2##7##(2008-3#2)
the treatment of glaucoma##3##4##(1990-11#1)(2008-3#2)
the treatment of glioblastoma multiforme##2##5##(1995-9#1)(2011-3#1)
the treatment of glioblastoma##4##4##(1995-9#1)(2011-3#1)(2012-11#2)
the treatment of glioma##2##4##(2011-11#1)(2013-1#1)
the treatment of gout##3##4##(1990-11#1)(1991-8#1)(2007-11#1)
the treatment of heart failure##10##5##(1990-3#2)(1996-6#1)(2005-7#1)(2006-6#1)(2008-5#2)(2009-10#2)(2012-3#1)
the treatment of heart##12##4##(1990-3#2)(1991-8#1)(1994-8#1)(1996-6#1)(2005-7#1)(2006-6#1)(2008-5#2)(2009-10#2)(2012-3#1)
the treatment of hepatocellular carcinoma##6##5##(2008-2#1)(2008-4#1)(2008-8#1)(2009-8#1)(2013-7#1)(2013-8#1)
the treatment of heterozygous familial hypercholesterolemia##2##6##(1993-9#2)
the treatment of high##3##4##(1992-1#2)(2013-8#1)
the treatment of high-grade##3##4##(2008-6#1)(2013-7#2)
the treatment of human##9##4##(1995-3#1)(2006-6#1)(2006-8#1)(2008-5#1)(2010-12#1)(2010-3#1)(2010-7#1)(2013-1#1)(2013-7#1)
the treatment of hypercholesterolemia##2##4##(1991-6#1)(2006-5#1)
the treatment of hyperhomocysteinemia##2##4##(2008-3#2)
the treatment of hypertension and##2##5##(1992-4#1)(2008-1#1)
the treatment of hypertension in##2##5##(1990-1#1)(2008-1#1)
the treatment of hypertension##26##4##(1990-1#1)(1990-12#1)(1990-6#1)(1991-5#1)(1992-4#1)(1992-8#4)(1993-11#1)(1993-12#1)(1993-3#1)(1995-11#1)(1996-9#2)(2005-7#1)(2005-8#1)(2006-10#1)(2007-8#1)(2008-1#3)(2008-8#1)(2009-4#1)(2010-12#1)(2011-2#1)
the treatment of hypertriglyceridemia##3##4##(2006-7#1)(2013-1#2)
the treatment of idiopathic scoliosis##3##5##(2007-7#2)(2007-8#1)
the treatment of idiopathic##7##4##(1993-11#1)(2005-6#1)(2007-7#2)(2007-8#1)(2008-8#2)
the treatment of infection##6##4##(1994-11#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#1)(2013-1#1)
the treatment of infections caused by##2##6##(2012-12#1)(2013-8#1)
the treatment of infections##4##4##(2008-3#1)(2008-5#1)(2012-12#1)(2013-8#1)
the treatment of infectious diseases##3##5##(1996-11#1)(2008-3#1)(2008-4#1)
the treatment of infectious##4##4##(1990-2#1)(1996-11#1)(2008-3#1)(2008-4#1)
the treatment of inflammatory bowel disease##2##6##(2005-6#1)(2005-8#1)
the treatment of inflammatory disease##2##5##(1993-11#1)(2012-12#1)
the treatment of inflammatory pain and##2##6##(2005-7#1)(2006-12#1)
the treatment of inflammatory pain##4##5##(2005-7#3)(2006-12#1)
the treatment of inflammatory skin disorders##2##6##(2007-11#1)(2008-3#1)
the treatment of inflammatory##17##4##(1993-11#1)(1995-12#1)(2005-6#1)(2005-7#3)(2005-8#1)(2006-12#1)(2007-11#2)(2008-3#1)(2008-5#1)(2009-1#1)(2010-5#1)(2011-1#2)(2012-12#1)
the treatment of injuries##2##4##(2007-11#1)(2007-8#1)
the treatment of insomnia##2##4##(2011-2#1)(2013-1#1)
the treatment of instability of the##2##6##(2007-11#2)
the treatment of instability##3##4##(2006-9#1)(2007-11#2)
the treatment of insulin resistance and##2##6##(2005-7#1)(2009-4#1)
the treatment of insulin resistance##3##5##(2005-7#1)(2008-1#1)(2009-4#1)
the treatment of insulin-dependent diabetes mellitus##2##6##(1992-6#2)
the treatment of insulin-dependent diabetes##3##5##(1992-6#2)(2008-1#1)
the treatment of interstitial##2##4##(1992-1#1)(2007-8#1)
the treatment of invasive aspergillosis##3##5##(2007-12#1)(2008-3#1)(2008-7#1)
the treatment of invasive##5##4##(2007-12#1)(2008-3#1)(2008-7#1)(2010-11#1)(2011-2#1)
the treatment of ischemic heart disease##2##6##(2010-6#2)
the treatment of ischemic##5##4##(2005-7#1)(2010-6#2)(2012-12#1)(2013-1#1)
the treatment of knee##3##4##(1995-8#1)(2007-5#1)(2011-1#1)
the treatment of lead##2##4##(2007-4#1)(2013-8#1)
the treatment of lichen##2##4##(2005-11#1)(2011-1#1)
the treatment of limited##2##4##(2007-11#1)(2009-1#1)
the treatment of liver metastases##2##5##(1995-4#1)(2008-8#1)
the treatment of liver##8##4##(1995-4#1)(2005-10#2)(2006-10#1)(2006-6#1)(2008-1#1)(2008-8#1)(2009-8#1)
the treatment of localized##3##4##(1995-2#1)(2012-3#1)(2013-1#1)
the treatment of locally advanced##5##5##(1992-3#1)(1995-9#1)(2008-2#1)(2009-5#1)(2010-12#1)
the treatment of locally##6##4##(1992-3#1)(1995-9#1)(2008-2#1)(2008-6#1)(2009-5#1)(2010-12#1)
the treatment of low back pain##2##6##(1993-11#1)(2007-8#1)
the treatment of lower##4##4##(2006-10#1)(2006-9#1)(2007-11#1)(2007-6#1)
the treatment of lumbar disc disease##2##6##(2007-8#2)
the treatment of lumbar disc##3##5##(2007-1#1)(2007-8#2)
the treatment of lumbar##9##4##(2006-12#1)(2006-7#1)(2007-1#1)(2007-8#4)(2008-8#1)(2009-5#1)
the treatment of lung cancer##3##5##(2004-1#1)(2007-8#2)
the treatment of lung##5##4##(2004-1#1)(2007-8#2)(2008-11#1)(2008-7#1)
the treatment of major##2##4##(2006-10#1)(2011-12#1)
the treatment of malaria as well as##2##7##(2008-10#1)(2008-2#1)
the treatment of malaria##9##4##(2006-10#1)(2007-6#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-6#1)(2011-2#2)
the treatment of male erectile dysfunction (MED)##2##7##(2005-7#1)(2005-8#1)
the treatment of male##5##4##(1996-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-10#1)
the treatment of malignant##12##4##(1991-2#1)(1991-6#1)(1992-12#2)(1993-9#1)(1994-12#1)(1997-5#1)(2007-1#1)(2007-11#1)(2007-5#1)(2011-2#1)(2012-12#1)
the treatment of mantle cell lymphoma##2##6##(2010-11#2)
the treatment of many##8##4##(1991-12#1)(2006-8#1)(2007-2#1)(2007-6#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-3#1)
the treatment of mental disorders##2##5##(2008-6#1)(2011-2#1)
the treatment of mental illness##2##5##(2011-2#2)
the treatment of mental##4##4##(2008-6#1)(2011-2#3)
the treatment of metabolic##2##4##(1997-4#1)(2008-3#1)
the treatment of metastatic breast cancer##3##6##(2009-8#3)
the treatment of metastatic##17##4##(1990-2#1)(1994-4#1)(1994-5#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#2)(2009-11#2)(2009-4#1)(2009-8#3)(2010-3#1)(2010-7#1)(2012-3#1)
the treatment of mice##2##4##(1992-3#1)(1996-10#1)
the treatment of migraine##6##4##(1994-11#1)(2004-12#1)(2005-7#1)(2008-9#1)(2009-9#2)
the treatment of mild to moderate##2##6##(1991-9#1)(1994-8#1)
the treatment of mild##3##4##(1991-9#1)(1992-6#1)(1994-8#1)
the treatment of mixed##2##4##(2004-3#1)(2008-6#1)
the treatment of moderate to severe cancer pain##2##8##(2008-3#1)(2008-7#1)
the treatment of moderate to severe chronic plaque psoriasis##2##9##(2008-5#1)(2012-2#1)
the treatment of moderate to severe##5##6##(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-2#1)
the treatment of moderate to##6##5##(2008-3#1)(2008-5#2)(2008-7#1)(2009-8#1)(2012-2#1)
the treatment of moderate##8##4##(2006-10#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-8#1)(2012-2#1)
the treatment of multidrug-resistant##2##4##(2006-10#1)(2007-11#1)
the treatment of multiple myeloma##4##5##(2007-8#1)(2008-1#1)(2008-3#2)
the treatment of multiple##10##4##(1994-12#1)(2005-1#1)(2005-7#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-3#2)
the treatment of myelodysplastic##2##4##(2008-3#1)(2008-5#1)
the treatment of myeloma##2##4##(2008-1#1)(2008-3#1)
the treatment of myocardial ischemia##2##5##(1990-11#1)(2008-1#1)
the treatment of myocardial##3##4##(1990-11#1)(2005-8#1)(2008-1#1)
the treatment of neonatal##2##4##(1996-1#1)(2009-9#1)
the treatment of neoplastic##3##4##(1990-12#1)(2006-12#1)(2007-8#1)
the treatment of neurodegenerative and##2##5##(2008-3#1)(2008-4#1)
the treatment of neurodegenerative##7##4##(2005-8#2)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)
the treatment of neurological and neuropsychiatric disorders##2##7##(2008-1#2)
the treatment of neurological disorders##2##5##(2007-11#1)(2011-1#1)
the treatment of neurological##6##4##(2006-7#1)(2007-11#2)(2008-1#2)(2011-1#1)
the treatment of neuropathic pain##9##5##(1997-3#1)(2006-12#1)(2008-1#2)(2008-7#1)(2008-9#3)(2010-7#1)
the treatment of non-small cell lung##2##6##(1997-5#1)(2005-8#1)
the treatment of numerous##2##4##(2005-11#1)(2012-2#1)
the treatment of open tibial##2##5##(2007-8#1)(2009-9#1)
the treatment of open##4##4##(2007-8#1)(2009-8#1)(2009-9#2)
the treatment of opioid##3##4##(2006-10#1)(2008-11#1)(2008-6#1)
the treatment of organ##2##4##(2005-7#1)(2005-9#1)
the treatment of osteoarthritis##5##4##(2006-3#1)(2007-11#2)(2007-7#1)(2011-1#1)
the treatment of osteomyelitis##3##4##(2010-6#3)
the treatment of osteoporosis##18##4##(1991-11#1)(1993-11#1)(1997-6#1)(2005-1#2)(2005-3#1)(2005-7#1)(2007-11#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-12#2)(2013-1#1)
the treatment of osteosarcoma##3##4##(2010-3#3)
the treatment of other##4##4##(2005-7#1)(2006-10#1)(2008-2#1)(2008-7#1)
the treatment of ovarian##2##4##(1991-8#1)(2005-11#1)
the treatment of pain and##5##5##(2006-10#1)(2006-11#1)(2007-8#1)(2010-6#1)(2011-1#1)
the treatment of pain associated with##3##6##(2005-8#1)(2006-10#1)(2007-11#1)
the treatment of pain##14##4##(1996-7#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-8#1)(2010-6#2)(2011-1#1)
the treatment of painful##4##4##(2006-8#1)(2008-7#1)(2008-8#1)(2013-1#1)
the treatment of palmar hyperhidrosis##2##5##(2005-11#1)(2007-1#1)
the treatment of palmar##3##4##(2005-11#1)(2007-1#1)(2012-1#1)
the treatment of pancreatic##4##4##(1990-9#1)(1991-8#1)(1992-4#1)(1993-6#1)
the treatment of patients by a mixture of oxygen and ozone - has been used for many years as a method ancillary to basic treatment##2##25##(2007-11#1)(2007-8#1)
the treatment of patients with active##2##6##(2012-2#2)
the treatment of patients with advanced##5##6##(1991-6#1)(1993-12#1)(1997-6#1)(2008-6#2)
the treatment of patients with chronic##5##6##(1992-10#1)(2007-12#1)(2010-12#1)(2011-2#1)(2012-3#1)
the treatment of patients with metastatic##2##6##(2007-11#1)(2010-12#1)
the treatment of patients with multiple##2##6##(2006-7#1)(2011-1#1)
the treatment of patients with relapsed##2##6##(1992-10#1)(2008-1#1)
the treatment of patients with renal##2##6##(1990-12#1)(2006-9#1)
the treatment of patients with severe##2##6##(1992-1#1)(1993-1#1)
the treatment of patients with upper##2##6##(2006-9#1)(2008-9#1)
the treatment of patients with##83##5##(1990-12#1)(1991-11#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-10#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-6#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-7#1)(1996-9#1)(1997-6#1)(2004-1#1)(2005-11#1)(2005-6#1)(2006-10#4)(2006-11#2)(2006-12#1)(2006-3#2)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#3)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-3#1)(2008-5#2)(2008-6#3)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#4)(2010-2#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
the treatment of patients##94##4##(1990-12#1)(1991-11#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-10#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-6#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-7#1)(1996-9#1)(1997-6#1)(2004-1#1)(2005-1#1)(2005-11#1)(2005-6#1)(2005-9#2)(2006-10#4)(2006-11#2)(2006-12#1)(2006-3#2)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#3)(2007-10#1)(2007-11#4)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#3)(2008-3#1)(2008-5#3)(2008-6#3)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#4)(2010-2#1)(2011-1#4)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
the treatment of peptic ulcer disease##3##6##(1995-4#1)(1997-1#1)(2006-10#1)
the treatment of peripheral nerves##2##5##(2006-12#2)
the treatment of peripheral##4##4##(1991-5#1)(1994-10#1)(2006-12#2)
the treatment of persistent##3##4##(2006-12#1)(2010-12#1)(2011-2#1)
the treatment of personality disorders##2##5##(2005-7#2)
the treatment of pilon fractures##2##5##(2007-8#2)
the treatment of plantar##2##4##(2010-11#1)(2010-3#1)
the treatment of postmenopausal osteoporosis##5##5##(1993-11#1)(2008-8#3)(2012-2#1)
the treatment of pregnant##2##4##(2009-1#1)(2010-12#1)
the treatment of primary and##3##5##(1992-11#1)(2006-6#1)(2013-1#1)
the treatment of primary biliary cirrhosis##3##6##(2004-11#3)
the treatment of primary##13##4##(1990-3#1)(1992-11#1)(2004-11#4)(2006-6#1)(2007-7#1)(2008-4#1)(2008-8#1)(2012-12#1)(2013-1#2)
the treatment of pseudoexfoliation glaucoma##2##5##(2011-2#2)
the treatment of psoriasis##16##4##(2005-11#1)(2006-10#1)(2007-11#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-12#1)(2008-5#4)(2008-6#1)(2011-1#1)
the treatment of psoriatic arthritis##5##5##(1990-6#1)(2006-10#2)(2008-3#2)
the treatment of psoriatic##6##4##(1990-6#1)(2006-10#2)(2008-3#2)(2009-11#1)
the treatment of psychiatric disorders##2##5##(2008-8#1)(2013-8#1)
the treatment of psychiatric##5##4##(2008-7#1)(2008-8#1)(2013-1#1)(2013-8#2)
the treatment of psychosis##2##4##(1992-12#1)(2005-8#1)
the treatment of pulmonary and##2##5##(1997-1#1)(2010-10#1)
the treatment of pulmonary hypertension##2##5##(2006-10#1)(2010-5#1)
the treatment of pulmonary##8##4##(1997-1#1)(2005-8#2)(2006-10#1)(2008-1#1)(2008-4#1)(2010-10#1)(2010-5#1)
the treatment of pyelonephritis##2##4##(2009-1#1)(2011-2#1)
the treatment of recalcitrant##3##4##(2006-10#2)(2013-1#1)
the treatment of rectal##2##4##(2009-12#1)(2011-2#1)
the treatment of recurrent and##2##5##(2006-10#1)(2007-11#1)
the treatment of recurrent##8##4##(1992-10#1)(1996-9#1)(2006-10#2)(2007-11#1)(2008-5#1)(2009-3#1)(2012-3#1)
the treatment of refractory##11##4##(2006-12#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-5#1)(2009-11#1)(2012-3#1)(2013-8#2)
the treatment of relapsing-remitting MS##2##5##(2005-7#1)(2007-11#1)
the treatment of renal anemia##2##5##(2008-10#1)(2008-5#1)
the treatment of renal##8##4##(1992-5#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-2#2)(2012-2#2)
the treatment of respiratory##7##4##(1990-7#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-2#1)(2011-2#1)
the treatment of restenosis##2##4##(2007-11#1)(2008-5#1)
the treatment of rheumatoid arthritis##20##5##(1990-6#1)(1991-8#1)(1992-11#1)(2006-10#2)(2007-11#4)(2007-7#1)(2008-3#5)(2008-5#3)(2008-8#1)(2010-4#1)
the treatment of rheumatoid##21##4##(1990-6#1)(1991-8#1)(1992-10#1)(1992-11#1)(2006-10#2)(2007-11#4)(2007-7#1)(2008-3#5)(2008-5#3)(2008-8#1)(2010-4#1)
the treatment of schizophrenia and related psychotic disorders##2##8##(2008-6#2)
the treatment of schizophrenia and##8##5##(2005-7#1)(2005-8#1)(2008-5#1)(2008-6#2)(2008-8#2)(2011-2#1)
the treatment of schizophrenia##20##4##(2005-7#2)(2005-8#1)(2006-12#1)(2006-9#1)(2008-5#1)(2008-6#3)(2008-8#2)(2008-9#1)(2009-12#1)(2010-7#1)(2011-1#4)(2011-2#1)(2012-12#1)
the treatment of scoliosis##3##4##(2007-7#1)(2007-8#2)
the treatment of selected##2##4##(1990-5#1)(2006-5#1)
the treatment of sepsis and septic shock##2##7##(2006-10#1)(2007-12#1)
the treatment of sepsis##4##4##(2006-10#1)(2007-12#1)(2008-8#1)(2011-1#1)
the treatment of several##11##4##(2005-8#1)(2007-4#1)(2008-1#1)(2008-11#2)(2008-12#1)(2009-1#1)(2009-10#1)(2010-11#1)(2010-12#1)(2011-1#1)
the treatment of severe coxarthrosis##2##5##(2013-1#2)
the treatment of severe haemorrhage##2##5##(2006-10#2)
the treatment of severe sepsis##5##5##(2007-12#3)(2008-8#1)(2011-2#1)
the treatment of severe##31##4##(1990-2#1)(1990-8#1)(1991-8#1)(1992-6#1)(1995-5#1)(2006-10#2)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-3#1)(2008-5#2)(2008-8#2)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
the treatment of sickle cell crisis##2##6##(2005-9#1)(2006-10#1)
the treatment of sickle cell##6##5##(2005-7#1)(2005-9#1)(2006-10#1)(2007-3#3)
the treatment of skin and skin structure infections##2##8##(2008-3#2)
the treatment of skin##5##4##(2007-7#1)(2008-3#2)(2011-1#1)(2012-3#1)
the treatment of small##2##4##(1995-12#1)(1996-6#1)
the treatment of small-cell lung cancer##2##6##(2004-1#1)(2005-11#1)
the treatment of soil moisture content being##2##7##(2013-8#2)
the treatment of solid tumors##2##5##(2006-11#1)(2008-7#1)
the treatment of solid##5##4##(1992-6#1)(2005-7#1)(2006-11#1)(2008-7#1)(2008-8#1)
the treatment of some##5##4##(2006-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2013-1#1)
the treatment of spinal metastases##2##5##(2006-2#1)(2008-7#1)
the treatment of spinal##8##4##(2005-8#1)(2006-2#1)(2007-11#2)(2007-7#2)(2007-8#1)(2008-7#1)
the treatment of stage I##2##5##(2007-8#2)
the treatment of stage II##2##5##(2006-6#1)(2009-10#1)
the treatment of stage##6##4##(1994-8#1)(2006-6#1)(2007-11#1)(2007-8#2)(2009-10#1)
the treatment of stress urinary incontinence##8##6##(2006-10#2)(2006-9#5)(2008-3#1)
the treatment of such##7##4##(1990-9#1)(2004-10#1)(2005-6#1)(2006-6#1)(2011-1#1)(2013-1#2)
the treatment of superficial##2##4##(2011-1#1)(2012-3#1)
the treatment of symptomatic and asymptomatic##2##6##(1993-8#1)(2006-11#1)
the treatment of symptomatic##6##4##(1993-8#1)(2006-11#2)(2008-7#1)(2008-8#1)(2013-7#1)
the treatment of systemic##7##4##(1992-4#1)(1992-5#1)(1997-2#1)(2007-11#2)(2008-11#1)(2008-7#1)
the treatment of temporomandibular##3##4##(2008-10#1)(2013-1#2)
the treatment of the chronic##3##5##(2007-8#1)(2008-5#2)
the treatment of the underlying disease##2##6##(2007-11#2)
the treatment of the##49##4##(1990-4#1)(1990-8#1)(1991-12#1)(1991-2#1)(1993-12#1)(1996-2#1)(1996-6#1)(2005-3#1)(2005-7#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#5)(2008-3#1)(2008-5#6)(2008-8#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#3)(2011-7#1)(2013-7#2)
the treatment of these infections##2##5##(2008-3#1)(2010-4#1)
the treatment of these patients##5##5##(1995-2#1)(2007-7#1)(2007-8#2)(2011-1#1)
the treatment of these two##2##5##(2004-11#1)(2010-4#1)
the treatment of these##25##4##(1995-2#1)(1997-3#1)(2004-11#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-3#2)(2008-4#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-4#2)(2011-1#1)(2011-2#1)(2013-7#1)
the treatment of this condition##3##5##(1992-3#1)(2008-2#1)(2009-10#1)
the treatment of this disease##7##5##(1993-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2009-7#1)(2009-8#1)(2010-3#1)
the treatment of this disorder##2##5##(2006-8#1)(2010-12#1)
the treatment of this##23##4##(1991-9#1)(1992-3#2)(1993-6#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#2)(2013-1#1)
the treatment of thoracic disc##4##5##(2006-7#4)
the treatment of thoracic##6##4##(2006-7#4)(2013-7#2)
the treatment of total##2##4##(1991-8#1)(2007-7#1)
the treatment of traumatic injuries##2##5##(2008-8#1)(2012-2#1)
the treatment of traumatic##3##4##(2007-11#1)(2008-8#1)(2012-2#1)
the treatment of treatment-resistant##3##4##(2008-12#1)(2012-12#2)
the treatment of tuberculosis##5##4##(1996-3#1)(2008-10#1)(2008-8#2)(2010-12#1)
the treatment of type 2 diabetes mellitus##5##7##(2006-12#1)(2007-5#1)(2011-2#2)(2013-7#1)
the treatment of type 2 diabetes##9##6##(1994-4#1)(1996-11#1)(2006-12#1)(2007-5#1)(2008-1#1)(2011-2#3)(2013-7#1)
the treatment of type##11##4##(1994-4#1)(1996-11#1)(2006-1#1)(2006-12#1)(2007-5#1)(2008-1#1)(2011-2#3)(2011-3#1)(2013-7#1)
the treatment of ulcerative colitis##5##5##(2006-10#5)
the treatment of unstable##4##4##(2006-8#2)(2007-11#1)(2008-9#1)
the treatment of urinary tract infections##5##6##(1991-12#2)(2007-7#1)(2010-3#1)(2013-8#1)
the treatment of urinary##8##4##(1991-12#2)(1997-5#1)(2005-9#1)(2007-7#1)(2010-3#1)(2010-8#1)(2013-8#1)
the treatment of uterine##3##4##(1994-8#1)(2010-1#1)(2011-2#1)
the treatment of uveitis##4##4##(2007-11#1)(2013-7#3)
the treatment of various autoimmune##2##5##(2006-10#1)(2007-11#1)
the treatment of various diseases##5##5##(1997-6#1)(2005-3#1)(2008-10#2)(2008-8#1)
the treatment of various##14##4##(1997-6#1)(2005-3#2)(2006-10#2)(2006-12#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-8#1)(2010-5#1)(2011-1#1)
the treatment of vascular##2##4##(2007-6#1)(2008-5#1)
the treatment of vesicoureteral reflux##2##5##(2007-9#1)(2008-10#1)
the treatment of viral##2##4##(1995-6#1)(2012-2#1)
the treatment of wastewater##2##4##(2008-12#1)(2008-7#1)
the treatment of women with##2##5##(1995-5#1)(2007-8#1)
the treatment of women##3##4##(1995-5#1)(2007-8#1)(2009-9#1)
the treatment of wounds##3##4##(2006-6#1)(2008-4#1)(2008-5#1)
the treatment of##2571##3##(1990-1#2)(1990-10#2)(1990-11#3)(1990-12#10)(1990-2#6)(1990-3#7)(1990-4#3)(1990-5#5)(1990-6#11)(1990-7#3)(1990-8#2)(1990-9#8)(1991-1#3)(1991-10#1)(1991-11#7)(1991-12#16)(1991-2#8)(1991-3#7)(1991-4#7)(1991-5#4)(1991-6#8)(1991-8#9)(1991-9#12)(1992-1#5)(1992-10#8)(1992-11#5)(1992-12#5)(1992-2#6)(1992-3#9)(1992-4#5)(1992-5#3)(1992-6#8)(1992-8#9)(1992-9#7)(1993-1#3)(1993-10#4)(1993-11#16)(1993-12#3)(1993-2#3)(1993-3#3)(1993-4#2)(1993-5#7)(1993-6#5)(1993-7#1)(1993-8#7)(1993-9#10)(1994-10#1)(1994-11#4)(1994-12#4)(1994-2#4)(1994-3#2)(1994-4#6)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#7)(1994-9#3)(1995-11#4)(1995-12#8)(1995-2#4)(1995-3#3)(1995-4#8)(1995-5#8)(1995-6#2)(1995-7#1)(1995-8#7)(1995-9#8)(1996-1#7)(1996-10#2)(1996-11#6)(1996-12#4)(1996-2#8)(1996-3#9)(1996-4#3)(1996-6#4)(1996-7#4)(1996-8#4)(1996-9#8)(1997-1#4)(1997-2#4)(1997-3#7)(1997-4#4)(1997-5#5)(1997-6#3)(1997-7#4)(1997-8#2)(2004-1#3)(2004-10#2)(2004-11#5)(2004-12#3)(2004-3#1)(2005-1#6)(2005-10#16)(2005-11#11)(2005-12#2)(2005-3#6)(2005-5#1)(2005-6#11)(2005-7#58)(2005-8#38)(2005-9#16)(2006-1#5)(2006-10#98)(2006-11#15)(2006-12#31)(2006-2#9)(2006-3#7)(2006-4#9)(2006-5#7)(2006-6#34)(2006-7#17)(2006-8#32)(2006-9#22)(2007-1#6)(2007-10#13)(2007-11#146)(2007-12#26)(2007-2#7)(2007-3#11)(2007-4#13)(2007-5#6)(2007-6#14)(2007-7#56)(2007-8#102)(2007-9#11)(2008-1#60)(2008-10#38)(2008-11#30)(2008-12#13)(2008-2#21)(2008-3#84)(2008-4#26)(2008-5#117)(2008-6#35)(2008-7#54)(2008-8#53)(2008-9#23)(2009-1#7)(2009-10#11)(2009-11#7)(2009-12#6)(2009-2#1)(2009-3#15)(2009-4#12)(2009-5#12)(2009-6#5)(2009-7#5)(2009-8#20)(2009-9#16)(2010-1#3)(2010-10#6)(2010-11#18)(2010-12#44)(2010-2#5)(2010-3#13)(2010-4#10)(2010-5#10)(2010-6#20)(2010-7#6)(2010-8#17)(2010-9#6)(2011-1#32)(2011-10#1)(2011-11#1)(2011-12#10)(2011-2#97)(2011-3#6)(2011-7#2)(2012-1#15)(2012-11#2)(2012-12#35)(2012-2#49)(2012-3#24)(2013-1#69)(2013-7#24)(2013-8#39)
the treatment on##3##3##(2006-11#1)(2008-5#1)(2012-2#1)
the treatment option##3##3##(2008-12#1)(2012-12#1)(2012-2#1)
the treatment options and##4##4##(1996-9#1)(2006-7#1)(2008-3#1)(2008-6#1)
the treatment options available##3##4##(2006-8#1)(2007-11#1)(2007-8#1)
the treatment options##14##3##(1993-8#1)(1996-9#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-3#1)(2011-2#1)(2013-1#2)
the treatment or##4##3##(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
the treatment outcome##6##3##(2007-11#1)(2007-8#1)(2008-11#1)(2010-1#1)(2011-2#1)(2012-12#1)
the treatment outcomes##2##3##(2011-2#2)
the treatment period##14##3##(1990-11#1)(1992-11#1)(1997-5#1)(2006-10#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#1)
the treatment phase##2##3##(2007-9#1)(2008-3#1)
the treatment plan##8##3##(1992-10#1)(2008-2#1)(2008-6#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
the treatment planning##4##3##(1991-4#1)(1994-12#1)(2008-3#1)(2009-3#1)
the treatment process##6##3##(1992-5#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-6#1)(2011-1#1)
the treatment program for##2##4##(1994-6#1)(2011-1#1)
the treatment program##4##3##(1993-1#1)(1994-6#1)(2007-2#1)(2011-1#1)
the treatment programs for##2##4##(2004-3#1)(2008-11#1)
the treatment protocol was##2##4##(2008-10#1)(2012-2#1)
the treatment protocol##6##3##(2007-8#1)(2008-10#1)(2012-2#1)(2013-1#2)(2013-8#1)
the treatment protocols##2##3##(2013-1#1)(2013-8#1)
the treatment received##2##3##(1993-1#1)(2012-12#1)
the treatment regime##5##3##(2011-1#2)(2011-2#1)(2012-12#2)
the treatment regimen is##2##4##(1993-9#1)(2007-11#1)
the treatment regimen of##2##4##(2011-2#1)(2012-3#1)
the treatment regimen##13##3##(1991-2#1)(1992-1#1)(1993-9#1)(1994-12#1)(2005-10#1)(2006-7#1)(2007-11#1)(2007-12#2)(2008-7#1)(2010-2#1)(2011-2#1)(2012-3#1)
the treatment regimens##3##3##(1993-7#1)(1995-12#1)(2005-8#1)
the treatment response##3##3##(2006-10#1)(2008-12#1)(2012-3#1)
the treatment results in##3##4##(2011-2#3)
the treatment results of patients##2##5##(2007-11#1)(2011-2#1)
the treatment results of##6##4##(2007-11#2)(2008-7#1)(2011-2#3)
the treatment results##14##3##(2007-11#2)(2008-7#2)(2011-2#10)
the treatment room##2##3##(2009-6#2)
the treatment schedule##2##3##(1991-8#1)(2007-11#1)
the treatment setting##2##3##(1995-12#1)(2007-10#1)
the treatment should be##3##4##(1991-9#1)(1997-6#1)(2013-1#1)
the treatment showed that##2##4##(2008-11#1)(2008-5#1)
the treatment site##2##3##(2008-7#1)(2011-2#1)
the treatment strategies##2##3##(2009-6#1)(2010-2#1)
the treatment strategy##2##3##(1993-3#1)(1997-7#1)
the treatment team##3##3##(1992-3#1)(2007-12#1)(2008-1#1)
the treatment that##2##3##(2006-9#1)(2008-7#1)
the treatment the##2##3##(1990-9#1)(1991-9#1)
the treatment to##5##3##(1991-12#1)(1994-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
the treatment variable##2##3##(2006-5#2)
the treatment volume##2##3##(2008-6#1)(2009-8#1)
the treatment was stopped##2##4##(1990-10#1)(2010-1#1)
the treatment was unsuccessful##2##4##(1995-11#1)(2012-3#1)
the treatment was##23##3##(1990-10#1)(1992-3#1)(1993-5#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-7#3)(2008-6#1)(2009-7#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
the treatment with 10##2##4##(1994-5#1)(2011-12#1)
the treatment with the##3##4##(1990-2#1)(2008-11#1)(2008-5#1)
the treatment with vitamin C##2##5##(2013-8#2)
the treatment with##39##3##(1990-12#1)(1990-2#1)(1990-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-8#2)(1993-3#1)(1994-5#1)(1996-12#2)(1996-3#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-2#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-7#1)(2011-12#1)(2011-2#2)(2013-1#1)(2013-8#3)
the treatment##3227##2##(1990-1#2)(1990-10#7)(1990-11#4)(1990-12#13)(1990-2#7)(1990-3#10)(1990-4#4)(1990-5#5)(1990-6#11)(1990-7#5)(1990-8#5)(1990-9#9)(1991-1#4)(1991-10#2)(1991-11#11)(1991-12#19)(1991-2#11)(1991-3#7)(1991-4#10)(1991-5#4)(1991-6#9)(1991-7#2)(1991-8#14)(1991-9#14)(1992-1#6)(1992-10#9)(1992-11#8)(1992-12#9)(1992-2#7)(1992-3#11)(1992-4#7)(1992-5#7)(1992-6#11)(1992-8#13)(1992-9#7)(1993-1#6)(1993-10#5)(1993-11#18)(1993-12#4)(1993-2#4)(1993-3#7)(1993-4#3)(1993-5#11)(1993-6#5)(1993-7#2)(1993-8#9)(1993-9#15)(1994-10#1)(1994-11#6)(1994-12#9)(1994-2#5)(1994-3#3)(1994-4#8)(1994-5#4)(1994-6#5)(1994-7#2)(1994-8#8)(1994-9#4)(1995-11#8)(1995-12#12)(1995-2#4)(1995-3#3)(1995-4#11)(1995-5#8)(1995-6#2)(1995-7#1)(1995-8#7)(1995-9#9)(1996-1#7)(1996-10#3)(1996-11#8)(1996-12#8)(1996-2#8)(1996-3#11)(1996-4#5)(1996-5#1)(1996-6#6)(1996-7#6)(1996-8#6)(1996-9#10)(1997-1#4)(1997-2#5)(1997-3#11)(1997-4#6)(1997-5#7)(1997-6#5)(1997-7#5)(1997-8#5)(2004-1#5)(2004-10#2)(2004-11#5)(2004-12#4)(2004-3#3)(2005-1#6)(2005-10#19)(2005-11#13)(2005-12#2)(2005-3#6)(2005-5#1)(2005-6#11)(2005-7#61)(2005-8#39)(2005-9#16)(2006-1#5)(2006-10#109)(2006-11#16)(2006-12#34)(2006-2#10)(2006-3#7)(2006-4#16)(2006-5#9)(2006-6#39)(2006-7#21)(2006-8#38)(2006-9#24)(2007-1#8)(2007-10#16)(2007-11#176)(2007-12#37)(2007-2#12)(2007-3#12)(2007-4#14)(2007-5#7)(2007-6#16)(2007-7#79)(2007-8#122)(2007-9#17)(2008-1#68)(2008-10#54)(2008-11#37)(2008-12#20)(2008-2#25)(2008-3#99)(2008-4#32)(2008-5#133)(2008-6#44)(2008-7#70)(2008-8#59)(2008-9#29)(2009-1#7)(2009-10#15)(2009-11#9)(2009-12#7)(2009-2#2)(2009-3#18)(2009-4#15)(2009-5#16)(2009-6#10)(2009-7#7)(2009-8#22)(2009-9#16)(2010-1#6)(2010-10#6)(2010-11#21)(2010-12#54)(2010-2#8)(2010-3#14)(2010-4#11)(2010-5#12)(2010-6#22)(2010-7#9)(2010-8#20)(2010-9#8)(2011-1#49)(2011-10#1)(2011-11#1)(2011-12#12)(2011-2#139)(2011-3#6)(2011-7#2)(2012-1#20)(2012-11#2)(2012-12#53)(2012-2#69)(2012-3#33)(2013-1#97)(2013-7#29)(2013-8#52)
the treatment)##4##2##(1990-3#1)(1992-4#2)(2010-7#1)
the treatments administered##2##3##(2006-6#2)
the treatments and##2##3##(2010-12#1)(2012-5#1)
the treatments of##2##3##(1996-12#1)(2013-8#1)
the treatments that##3##3##(2005-11#1)(2008-10#2)
the treatments with##3##3##(2007-11#1)(2008-10#2)
the treatments##56##2##(1992-3#1)(1992-8#1)(1993-3#2)(1993-5#1)(1995-11#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-12#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-6#2)(2007-11#1)(2007-8#1)(2008-10#10)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2012-2#1)(2012-5#1)(2012-9#1)(2013-1#1)(2013-8#2)
the tree canopy##7##3##(2008-10#7)
the tree to##2##3##(2007-3#1)(2008-2#1)
the tree was##2##3##(1995-3#1)(2008-10#1)
the tree##41##2##(1991-1#1)(1994-11#1)(1995-3#1)(2004-2#1)(2006-11#1)(2007-3#2)(2008-10#18)(2008-2#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-3#1)(2010-6#2)(2011-2#1)(2012-3#1)(2013-7#1)
the trees##10##2##(2006-11#1)(2008-10#6)(2008-5#1)(2008-8#1)(2011-2#1)
the trehalose##9##2##(1991-9#3)(1993-8#2)(2008-10#1)(2011-1#2)(2013-1#1)
the trellis diagram##2##3##(2008-3#2)
the trellis##4##2##(2008-10#1)(2008-3#3)
the tremendous##5##2##(1990-10#1)(2006-10#2)(2006-8#1)(2008-5#1)
the tremor##2##2##(2006-6#1)(2013-8#1)
the trenches##6##2##(1991-3#1)(2006-4#1)(2006-8#1)(2007-12#1)(2007-4#2)
the trend and##2##3##(1990-11#1)(2005-12#1)
the trend for##2##3##(2011-1#1)(2013-1#1)
the trend in##10##3##(1993-2#1)(1995-12#1)(1995-9#1)(1996-3#2)(2006-12#1)(2007-9#1)(2008-11#1)(2008-8#2)
the trend observed in the##2##5##(2007-6#1)(2007-7#1)
the trend observed##3##3##(2007-6#1)(2007-7#1)(2010-4#1)
the trend of the##2##4##(2007-6#1)(2008-4#1)
the trend of##12##3##(1991-11#1)(1995-6#1)(2005-11#2)(2006-10#1)(2007-6#3)(2007-8#1)(2007-9#1)(2008-4#1)(2009-12#1)
the trend to##2##3##(1990-3#1)(2008-11#1)
the trend toward##3##3##(1993-2#1)(2006-7#1)(2007-12#1)
the trend was##2##3##(2008-10#1)(2008-6#1)
the trend##57##2##(1990-11#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-3#1)(1992-8#1)(1993-2#2)(1995-10#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-6#1)(2005-11#2)(2005-12#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-6#4)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-2#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
the trends and##5##3##(1993-2#1)(1995-1#1)(2007-7#1)(2008-1#1)(2011-2#1)
the trends in the##4##4##(1996-9#1)(2008-3#1)(2008-5#1)(2012-12#1)
the trends in##18##3##(1990-12#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-7#1)(1993-9#1)(1996-9#1)(2004-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-5#1)(2012-1#1)(2012-12#1)(2012-3#1)
the trends of the##2##4##(2005-11#1)(2012-12#1)
the trends of##4##3##(1994-12#1)(2005-11#1)(2012-12#1)(2012-2#1)
the trends that##2##3##(2008-12#1)(2008-5#1)
the trends##38##2##(1990-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-7#1)(1993-2#1)(1993-9#1)(1994-12#1)(1995-1#1)(1996-2#1)(1996-6#1)(1996-9#1)(2004-10#1)(2005-11#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#2)(2009-12#1)(2009-3#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
the triad of##6##3##(2006-10#2)(2007-9#1)(2008-8#1)(2011-1#1)(2012-2#1)
the triad##9##2##(1996-7#1)(2006-10#2)(2007-9#1)(2008-8#1)(2009-4#1)(2010-1#1)(2011-1#1)(2012-2#1)
the triadic junction##2##3##(1992-1#1)(1994-5#1)
the triadic##3##2##(1992-1#1)(1992-3#1)(1994-5#1)
the triage##3##2##(2007-12#1)(2007-9#1)(2008-3#1)
the trial and##2##3##(2007-7#1)(2008-7#1)
the trial are##3##3##(1991-10#1)(1994-4#1)(1994-9#1)
the trial court##3##3##(1990-11#1)(1992-12#1)(1997-5#1)
the trial had##2##3##(1990-2#1)(2011-2#1)
the trial if##2##3##(1993-5#1)(1994-11#1)
the trial is##2##3##(2012-2#2)
the trial the##2##3##(2008-3#1)(2009-11#1)
the trial to##3##3##(1995-5#2)(2012-2#1)
the trial was##5##3##(2004-1#1)(2005-11#1)(2005-8#1)(2008-8#1)(2009-4#1)
the trial were##2##3##(1993-9#1)(2007-5#1)
the trial would##3##3##(2008-3#1)(2009-6#1)(2012-2#1)
the trial##107##2##(1990-11#1)(1990-2#2)(1990-3#1)(1991-10#1)(1991-3#3)(1991-6#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-5#2)(1993-9#1)(1994-11#1)(1994-4#1)(1994-6#2)(1994-9#1)(1995-5#2)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#4)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(2004-1#1)(2005-11#1)(2005-8#4)(2006-10#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-10#5)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#6)(2009-11#5)(2009-4#2)(2009-6#2)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#1)(2013-8#3)
the trials and##2##3##(1996-6#1)(2007-11#1)
the trials have##2##3##(1993-9#1)(1997-1#1)
the trials##31##2##(1992-10#1)(1993-8#2)(1993-9#1)(1994-5#1)(1994-9#1)(1995-1#1)(1996-6#1)(1997-1#1)(1997-8#2)(2006-4#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2013-1#2)(2013-8#2)
the triangle##8##2##(2007-9#2)(2008-6#4)(2010-12#1)(2011-2#1)
the triangular distal wedge##2##4##(2012-12#2)
the triangular##9##2##(1994-5#1)(2006-3#1)(2006-4#2)(2007-12#1)(2008-10#1)(2008-3#1)(2012-12#2)
the triatomine##2##2##(2012-12#2)
the triazole##4##2##(2006-11#2)(2007-11#1)(2010-12#1)
the triazoles##2##2##(2005-7#1)(2011-12#1)
the tribal##3##2##(2008-8#1)(2012-2#1)(2013-1#1)
the tribe##3##2##(2008-5#1)(2013-7#2)
the tricarboxylic acid (TCA) cycle##2##5##(1993-6#1)(2012-1#1)
the tricarboxylic acid cycle##4##4##(2008-7#4)
the tricarboxylic acid##6##3##(1993-6#1)(2008-7#4)(2012-1#1)
the triceps brachii and##2##4##(2012-1#1)(2012-3#1)
the triceps brachii##3##3##(2008-5#1)(2012-1#1)(2012-3#1)
the triceps surae muscle##2##4##(1990-7#1)(2007-11#1)
the triceps surae##4##3##(1990-7#1)(1991-5#1)(2007-11#1)(2010-3#1)
the triceps##11##2##(1990-7#1)(1991-5#1)(2006-3#1)(2007-11#3)(2008-5#1)(2008-9#1)(2010-3#1)(2012-1#1)(2012-3#1)
the trichloromethyl radical##3##3##(1993-3#3)
the trichothecenes##2##2##(2008-10#1)(2008-8#1)
the triclinic space group P&amp##2##5##(1996-2#1)(1997-7#1)
the triclinic space group##4##4##(1996-2#1)(1997-7#1)(2007-11#2)
the triclinic##6##2##(1996-2#1)(1997-7#2)(2007-11#3)
the tricuspid and mitral valves##2##5##(1991-3#1)(2011-1#1)
the tricuspid and##3##3##(1991-3#1)(2011-1#2)
the tricuspid annulus##2##3##(2006-9#1)(2007-8#1)
the tricuspid valve##6##3##(1997-1#1)(1997-2#1)(2007-12#1)(2007-7#1)(2007-8#1)(2012-12#1)
the tricuspid##12##2##(1991-3#1)(1997-1#1)(1997-2#1)(2006-9#1)(2007-12#1)(2007-7#1)(2007-8#3)(2011-1#2)(2012-12#1)
the tricyclic antidepressant##2##3##(1996-12#1)(2007-4#1)
the tricyclic##8##2##(1996-12#1)(1996-5#3)(1997-2#1)(2006-12#1)(2007-4#1)(2008-2#1)
the tridentate##3##2##(1994-9#1)(1997-7#2)
the trifluoromethyl##2##2##(2007-12#1)(2008-10#1)
the trifunctional##5##2##(1993-12#2)(1995-1#2)(2008-10#1)
the trigeminal (V)##2##3##(1996-5#1)(1997-6#1)
the trigeminal and##3##3##(1991-11#1)(2006-11#2)
the trigeminal ganglion##10##3##(1991-8#1)(1996-2#1)(1997-3#2)(2006-7#2)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)
the trigeminal mesencephalic nucleus##2##4##(1990-4#1)(1995-11#1)
the trigeminal motor nucleus##5##4##(1990-4#1)(1990-9#1)(1995-7#1)(1996-9#2)
the trigeminal motor##6##3##(1990-4#2)(1990-9#1)(1995-7#1)(1996-9#2)
the trigeminal nerve and##2##4##(1996-5#1)(2006-12#1)
the trigeminal nerve##19##3##(1990-12#1)(1991-8#2)(1992-8#1)(1995-11#2)(1996-5#2)(1997-8#1)(2006-11#2)(2006-12#1)(2007-3#1)(2011-2#5)(2013-7#1)
the trigeminal sensory##4##3##(1990-4#2)(1995-7#1)(1997-3#1)
the trigeminal##62##2##(1990-12#1)(1990-4#7)(1990-9#1)(1991-11#2)(1991-8#5)(1992-10#1)(1992-8#1)(1993-1#1)(1993-12#1)(1995-11#4)(1995-7#2)(1996-2#1)(1996-5#3)(1996-9#2)(1997-2#2)(1997-3#3)(1997-6#1)(1997-8#1)(2006-11#4)(2006-12#1)(2006-3#1)(2006-7#2)(2007-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-12#2)(2011-2#6)(2012-2#1)(2013-7#1)
the trigeminally induced apnoea##2##4##(1996-5#2)
the trigeminovascular system##3##3##(1994-9#1)(2007-10#1)(2008-5#1)
the trigger for##2##3##(2008-11#1)(2008-9#1)
the trigger##9##2##(1996-2#1)(2006-2#1)(2006-6#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-3#1)
the triggering event##3##3##(1990-7#1)(1992-3#1)(2008-10#1)
the triggering of##12##3##(1993-11#1)(2006-10#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#2)(2010-6#1)(2013-1#2)
the triggering##21##2##(1990-7#1)(1992-3#1)(1993-11#1)(1995-11#1)(2006-10#4)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-8#2)(2010-5#1)(2010-6#1)(2013-1#2)
the triggers##4##2##(1997-1#1)(2006-7#1)(2008-11#1)(2011-12#1)
the triglyceride and##2##3##(1996-4#1)(2009-11#1)
the triglyceride levels##4##3##(1993-9#1)(2008-1#1)(2013-1#2)
the triglyceride##9##2##(1991-11#1)(1993-9#1)(1995-6#1)(1996-4#1)(2008-1#1)(2009-11#1)(2013-1#2)(2013-8#1)
the triiodide##3##2##(2008-10#2)(2010-4#1)
the trimer##9##2##(1993-3#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-6#1)(1996-7#2)(2006-3#1)(2008-8#1)
the trimeric##6##2##(1991-12#1)(1994-9#1)(1996-7#2)(2006-9#1)(2008-8#1)
the trimester##3##2##(1992-6#1)(1996-7#2)
the trio of##2##3##(1996-11#1)(2012-1#1)
the triose-phosphate isomerase gene##2##4##(1995-8#2)
the triose-phosphate isomerase##3##3##(1995-8#3)
the trioses##2##2##(1995-1#2)
the tripartite model##2##3##(2007-12#1)(2008-4#1)
the tripartite##5##2##(1990-6#1)(2007-12#2)(2008-4#1)(2013-1#1)
the tripeptide motif##2##3##(1991-9#1)(1992-10#1)
the tripeptide##8##2##(1991-9#1)(1992-10#1)(1992-12#1)(1992-5#1)(1992-6#1)(2006-12#1)(2008-4#1)(2011-1#1)
the tripeptides##3##2##(1990-12#1)(1990-8#1)(1994-5#1)
the triphosphate##4##2##(1991-4#1)(1992-8#1)(1996-5#1)(1997-6#1)
the triple combination of##2##4##(1995-5#2)
the triple combination##3##3##(1995-5#2)(2008-5#1)
the triple helix##7##3##(1992-2#1)(1997-4#1)(2008-4#1)(2009-7#2)(2013-1#2)
the triple integration##2##3##(2008-10#2)
the triple mutation##2##3##(1995-3#1)(2008-8#1)
the triple##27##2##(1990-10#2)(1992-2#1)(1993-10#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#2)(1996-12#1)(1996-2#1)(1996-7#1)(1997-4#2)(1997-6#1)(2005-11#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-7#2)(2013-1#2)
the triplet lifetime##2##3##(1995-1#1)(2008-10#1)
the triplet state##2##3##(1995-1#1)(2008-8#1)
the triplet##16##2##(1992-7#1)(1992-9#1)(1994-12#1)(1995-1#3)(1996-2#1)(1997-7#1)(2004-1#1)(2006-11#3)(2008-10#1)(2008-8#1)(2009-2#1)(2010-4#1)
the triplex formation##2##3##(1993-8#2)
the triplex is##2##3##(1992-9#1)(1993-8#1)
the triplex##10##2##(1992-9#1)(1993-8#3)(1995-1#1)(1995-5#3)(1996-4#1)(2006-12#1)
the triplex-to-duplex transition##2##3##(1992-9#2)
the triplexes##2##2##(1994-12#1)(2006-12#1)
the triploid##4##2##(2008-5#2)(2009-12#1)(2013-8#1)
the trisaccharide##3##2##(1994-5#2)(1995-3#1)
the trithorax##2##2##(1996-10#1)(1997-7#1)
the tritocerebral commissure##2##3##(2007-12#2)
the tritocerebral##4##2##(2007-12#4)
the tritocerebrum##4##2##(2007-12#3)(2008-9#1)
the trivalent cation##2##3##(1997-2#1)(2008-10#1)
the trivalent ion##2##3##(2008-10#2)
the trivalent##13##2##(1997-2#1)(2008-10#9)(2008-12#1)(2010-11#1)(2010-5#1)
the trivial##2##2##(1994-2#1)(1996-10#1)
the trk family of##2##4##(1991-5#1)(1996-3#1)
the trk family##3##3##(1991-5#1)(1996-3#2)
the trk##4##2##(1991-5#1)(1995-11#1)(1996-3#2)
the trkB##2##2##(1991-5#2)
the trocar##3##2##(2007-8#2)(2009-3#1)
the trochanteric fatty pad##3##4##(2011-12#3)
the trochanteric##5##2##(2007-11#1)(2011-12#4)
the trochlea##2##2##(2011-2#2)
the trolox##2##2##(2008-10#1)(2008-5#1)
the tropharium is##2##3##(2007-12#2)
the tropharium##3##2##(2007-12#3)
the trophectoderm##5##2##(2008-11#1)(2012-12#4)
the trophic ecology of##2##4##(2007-3#1)(2013-7#1)
the trophic effect of##2##4##(1990-7#1)(1997-1#1)
the trophic##16##2##(1990-7#1)(1991-12#1)(1993-3#1)(1995-5#1)(1997-1#1)(1997-2#1)(2004-4#1)(2007-12#1)(2007-3#2)(2008-10#1)(2008-5#2)(2008-8#1)(2013-7#1)(2013-8#1)
the trophoblast and##2##3##(1992-1#1)(2012-1#1)
the trophoblast##6##2##(1992-1#1)(1995-8#1)(2007-4#1)(2012-1#1)(2012-12#2)
the trophozoite##2##2##(1994-5#1)(1997-7#1)
the tropical Pacific##4##3##(1990-8#1)(2006-7#1)(2007-12#1)(2007-5#1)
the tropical and subtropical##4##4##(2008-10#1)(2008-11#1)(2008-5#1)(2010-5#1)
the tropical and##6##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-5#1)(2010-7#1)
the tropical dry forest##3##4##(2007-3#1)(2008-5#1)(2013-7#1)
the tropical isolates##3##3##(2008-10#3)
the tropical marine sponge##4##4##(2007-1#3)(2007-11#1)
the tropical rainforest##3##3##(1992-8#1)(2007-12#1)(2007-3#1)
the tropical##50##2##(1990-8#1)(1991-11#1)(1991-12#1)(1992-8#1)(1996-12#1)(1996-2#1)(2006-11#1)(2006-7#2)(2006-8#1)(2007-1#3)(2007-11#1)(2007-12#2)(2007-3#4)(2007-5#2)(2007-9#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-5#7)(2008-8#1)(2008-9#1)(2010-5#1)(2010-7#1)(2012-2#1)(2013-7#4)
the tropics and subtropics##3##4##(2008-10#1)(2011-2#1)(2012-3#1)
the tropics and##5##3##(2008-10#1)(2010-12#1)(2011-2#2)(2012-3#1)
the tropics##27##2##(1995-12#2)(1996-12#1)(2006-4#1)(2006-5#1)(2007-2#2)(2007-9#1)(2008-10#4)(2008-3#1)(2008-4#4)(2008-5#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-7#2)(2013-8#1)
the troponin complex##2##3##(1990-12#1)(1995-6#1)
the troponin##8##2##(1990-12#1)(1991-12#1)(1991-2#2)(1994-3#1)(1995-6#1)(2008-3#1)(2008-7#1)
the tropopause##2##2##(2008-3#2)
the troposphere and##4##3##(2008-2#1)(2008-3#3)
the troposphere is##2##3##(1996-5#1)(2008-2#1)
the troposphere##10##2##(1992-3#1)(1996-5#1)(2007-11#1)(2008-2#4)(2008-3#3)
the tropospheric infrared interferometric sounder##2##5##(2008-2#1)(2008-3#1)
the tropospheric##5##2##(2008-2#2)(2008-3#3)
the trout##5##2##(1991-9#1)(1995-7#2)(1997-9#1)(2005-8#1)
the trp operator##3##3##(1992-6#1)(1994-3#2)
the trp repressor##7##3##(1992-6#3)(1992-8#4)
the trp##13##2##(1990-9#1)(1992-6#4)(1992-8#4)(1994-3#3)(1994-6#1)
the true &quot##2##3##(1995-12#1)(2011-2#1)
the true absorption and endogenous fecal excretion of zinc##2##9##(2010-2#2)
the true absorption##3##3##(2010-2#3)
the true and processed genes for##2##6##(1994-9#2)
the true and processed genes##3##5##(1994-9#3)
the true and##5##3##(1994-9#3)(1995-6#1)(2011-2#1)
the true colonization incidence of blossoms##2##6##(2008-10#2)
the true complexity of the##2##5##(2006-4#1)(2011-2#1)
the true complexity of##3##4##(2006-4#1)(2011-2#2)
the true effect of##2##4##(1995-9#1)(2007-6#1)
the true exposure response is##2##5##(2008-7#2)
the true free##2##3##(1990-10#1)(1993-6#1)
the true impact of##3##4##(2007-11#1)(2008-5#1)(2012-2#1)
the true incidence of##5##4##(2006-8#1)(2007-2#1)(2008-8#1)(2013-1#2)
the true incidence##6##3##(2006-8#1)(2007-2#1)(2008-8#1)(2011-1#1)(2013-1#2)
the true intraocular pressure and modulus of elasticity of the human cornea in vivo##2##14##(2007-9#2)
the true intraocular pressure##3##4##(2007-9#3)
the true level of significance##2##5##(1995-4#2)
the true lumen##7##3##(2007-8#4)(2008-11#2)(2012-2#1)
the true model##3##3##(2010-11#1)(2012-1#1)(2012-3#1)
the true offset##2##3##(2008-3#2)
the true phase##2##3##(2008-2#2)
the true prevalence##2##3##(1991-5#1)(2012-3#1)
the true risk##2##3##(1992-3#1)(1993-9#1)
the true surface or wave-front deformation##2##6##(2008-3#2)
the true value of the##3##5##(1993-6#1)(2006-12#1)(2008-9#1)
the true value of this##2##5##(2006-10#2)
the true value of##5##4##(1993-6#1)(2006-10#2)(2006-12#1)(2008-9#1)
the true value##7##3##(1993-6#1)(2006-10#2)(2006-12#1)(2008-10#1)(2008-2#1)(2008-9#1)
the true vocal##3##3##(2008-5#1)(2011-2#1)(2012-2#1)
the true##164##2##(1990-10#1)(1990-3#1)(1990-6#1)(1990-8#2)(1991-1#1)(1991-5#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-6#3)(1993-9#1)(1994-11#1)(1994-8#1)(1994-9#4)(1995-11#2)(1995-12#3)(1995-4#2)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#2)(1996-3#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-4#1)(2006-10#4)(2006-12#1)(2006-4#2)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#6)(2007-9#3)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#10)(2008-3#14)(2008-5#3)(2008-7#6)(2008-8#2)(2008-9#2)(2009-11#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#3)(2010-2#4)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-1#2)(2012-2#5)(2012-3#8)(2012-7#1)(2013-1#5)(2013-7#1)
the true-time delay##2##3##(2007-12#1)(2008-2#1)
the truly##5##2##(1994-2#1)(1995-6#1)(1996-12#1)(2008-10#2)
the truncated##21##2##(1990-10#1)(1991-11#1)(1992-1#1)(1992-2#2)(1992-9#1)(1993-6#2)(1994-8#1)(1995-10#1)(1995-5#1)(1996-1#1)(1996-12#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-4#1)(2008-8#1)(2010-12#1)(2011-2#1)
the truncation##4##2##(1991-5#1)(1993-11#1)(1997-4#1)(2007-12#1)
the trunk and extremities##3##4##(2007-7#1)(2008-6#1)(2010-6#1)
the trunk and limbs##3##4##(2007-6#1)(2008-5#1)(2013-8#1)
the trunk and##13##3##(2006-4#1)(2007-11#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-5#1)(2008-6#1)(2009-10#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-8#1)
the trunk in the##2##4##(2007-7#1)(2008-10#1)
the trunk in##4##3##(1995-8#1)(2007-7#1)(2007-8#1)(2008-10#1)
the trunk of the##3##4##(2008-4#1)(2008-7#1)(2012-2#1)
the trunk of##5##3##(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
the trunk since##2##3##(2007-7#1)(2007-8#1)
the trunk site##2##3##(2011-1#2)
the trunk##51##2##(1991-12#1)(1995-8#5)(2006-4#1)(2007-1#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#6)(2007-8#4)(2008-10#3)(2008-4#1)(2008-5#4)(2008-6#5)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-2#1)(2010-6#2)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
the trust of##2##3##(2008-8#1)(2012-3#1)
the trust##6##2##(1996-1#1)(1997-4#1)(2008-8#1)(2012-3#2)(2013-8#1)
the truth to##2##3##(2010-2#1)(2010-8#1)
the truth##4##2##(2006-3#1)(2010-2#1)(2010-8#1)(2012-3#1)
the trypanosome##3##2##(1995-8#1)(2007-6#2)
the trypsin inhibitor##2##3##(1991-9#1)(1994-3#1)
the trypsin##6##2##(1990-11#1)(1990-12#1)(1991-9#1)(1994-3#1)(1994-9#1)(2008-5#1)
the trypsin-like peptidase##2##3##(2008-5#2)
the trypsin-like##3##2##(2008-5#3)
the trypsin-resistant fragment##2##3##(1990-5#2)
the trypsin-resistant##3##2##(1990-5#3)
the trypsin-sensitive##2##2##(1990-8#1)(1996-7#1)
the tryptic digest of##2##4##(1990-8#1)(1997-2#1)
the tryptic fragments##2##3##(1990-2#1)(2008-10#1)
the tryptic##9##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-7#1)(1992-10#1)(1993-8#1)(1997-2#1)(2008-10#1)
the tryptophan residue##2##3##(1990-7#1)(2008-10#1)
the tryptophan residues of##2##4##(1992-12#1)(1997-8#1)
the tryptophan residues##11##3##(1990-8#1)(1991-7#1)(1991-8#1)(1992-12#1)(1994-11#1)(1994-9#1)(1997-8#2)(2006-10#2)(2008-10#1)
the tryptophan##28##2##(1990-7#1)(1990-8#1)(1991-6#1)(1991-7#3)(1991-8#1)(1992-12#2)(1992-6#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-11#2)(1994-6#1)(1994-9#1)(1995-1#1)(1996-8#1)(1997-4#1)(1997-8#2)(2006-10#2)(2008-10#2)(2008-3#1)(2010-5#1)
the tryptophans##4##2##(1991-7#1)(1994-11#3)
the ts##4##2##(1990-5#3)(1994-12#1)
the tsetse##2##2##(2006-10#1)(2006-5#1)
the tsp is##2##3##(1995-8#2)
the tsp##6##2##(1991-12#1)(1991-8#1)(1993-5#1)(1995-8#2)(1996-8#1)
the tsunami##2##2##(2010-8#1)(2013-1#1)
the tsx##3##2##(1990-11#3)
the tuatara##3##2##(2010-3#3)
the tubal##3##2##(1990-2#2)(1995-7#1)
the tube and##5##3##(2005-4#1)(2006-6#1)(2008-7#1)(2010-5#1)(2011-1#1)
the tube can be##2##4##(1997-5#2)
the tube is##6##3##(1997-5#3)(2006-10#1)(2008-10#1)(2008-3#1)
the tube lifetime##2##3##(2008-10#2)
the tube test##5##3##(2011-1#5)
the tube wall has the effect of##2##7##(2005-11#2)
the tube wall##4##3##(1994-9#1)(2005-11#3)
the tube walls##2##3##(1993-4#1)(2008-10#1)
the tube##54##2##(1991-11#2)(1993-2#3)(1993-4#1)(1993-9#1)(1994-9#2)(1997-5#8)(2005-11#3)(2005-4#1)(2006-10#1)(2006-6#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-7#3)(2008-8#3)(2009-6#2)(2009-8#1)(2010-12#2)(2010-5#1)(2011-1#6)(2013-1#1)(2013-8#1)
the tuber##3##2##(2008-10#2)(2008-5#1)
the tubercle bacillus##2##3##(2008-9#1)(2013-1#1)
the tubercle##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
the tuberculin skin test##3##4##(1990-6#1)(2007-2#1)(2012-12#1)
the tuberculin test##3##3##(1994-4#1)(1996-12#1)(2013-1#1)
the tuberculin##7##2##(1990-6#1)(1991-5#1)(1994-4#1)(1996-12#1)(2007-2#1)(2012-12#1)(2013-1#1)
the tuberculosis (TB)##2##3##(2010-4#2)
the tuberculosis##6##2##(2007-8#1)(2008-10#1)(2010-12#1)(2010-4#2)(2013-8#1)
the tubers of##2##3##(2007-1#1)(2012-12#1)
the tubers##3##2##(2007-1#1)(2008-10#1)(2012-12#1)
the tubes and##2##3##(2008-7#1)(2009-2#1)
the tubes through##2##3##(1996-8#1)(2008-7#1)
the tubes##15##2##(1992-6#1)(1993-2#1)(1993-4#1)(1996-8#1)(2006-12#2)(2008-7#4)(2009-2#1)(2011-1#2)(2012-2#2)
the tubing##5##2##(1991-4#1)(2008-10#2)(2008-11#1)(2011-1#1)
the tubing)##2##2##(2007-1#2)
the tubular electrode##3##3##(2008-10#3)
the tubular reabsorption of##2##4##(1993-4#1)(2006-10#1)
the tubular structure##2##3##(2007-9#1)(2008-2#1)
the tubular##17##2##(1991-11#1)(1993-4#1)(1994-9#1)(1997-4#1)(2006-10#1)(2007-9#2)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2009-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
the tubule##4##2##(1994-7#1)(2007-12#1)(2008-7#1)(2012-2#1)
the tubules##2##2##(2007-7#1)(2012-2#1)
the tubulin##9##2##(1990-10#1)(1990-6#1)(1991-5#2)(1993-8#2)(1994-12#1)(1995-5#1)(2008-11#1)
the tubulo-interstitial##2##2##(2008-1#1)(2008-4#1)
the tumor and its##3##4##(1990-9#1)(2005-9#1)(2012-2#1)
the tumor and the##5##4##(1991-10#1)(1993-11#1)(1996-11#1)(2006-10#1)(2006-6#1)
the tumor and tumor##2##4##(2005-8#1)(2006-11#1)
the tumor and##29##3##(1990-2#1)(1990-9#1)(1991-10#1)(1992-9#1)(1993-11#1)(1993-6#1)(1996-11#1)(1996-6#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-11#2)(2006-6#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-11#1)(2009-3#1)(2009-5#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
the tumor area##2##3##(1990-8#1)(2008-5#1)
the tumor as a##2##4##(2007-8#1)(2008-6#1)
the tumor at##2##3##(2007-10#1)(2013-1#1)
the tumor bed was##3##4##(1994-3#1)(1995-10#1)(2007-6#1)
the tumor bed##9##3##(1994-3#1)(1995-10#1)(2006-12#1)(2006-7#1)(2007-11#2)(2007-6#2)(2008-6#1)
the tumor cell lines##2##4##(1994-9#1)(2008-11#1)
the tumor cell##11##3##(1991-8#1)(1993-11#1)(1994-3#1)(1994-9#1)(1995-8#1)(2006-12#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-3#2)
the tumor cells had##3##4##(2006-12#1)(2007-12#2)
the tumor cells of##2##4##(1990-12#1)(1991-5#1)
the tumor cells showed##2##4##(2007-12#1)(2012-1#1)
the tumor cells were positive for##3##6##(1996-9#1)(2010-7#1)(2012-1#1)
the tumor cells were##7##4##(1996-9#1)(2007-5#1)(2008-5#1)(2009-8#1)(2010-6#1)(2010-7#1)(2012-1#1)
the tumor cells##48##3##(1990-12#2)(1991-5#2)(1991-6#1)(1992-7#1)(1992-9#2)(1993-8#1)(1994-5#1)(1994-7#1)(1995-10#1)(1995-8#1)(1996-3#1)(1996-9#1)(1997-1#2)(1997-5#1)(1997-7#3)(2006-12#1)(2006-6#1)(2006-7#1)(2007-12#3)(2007-2#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-6#3)(2008-8#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-7#1)(2012-1#2)(2012-2#1)
the tumor demonstrated##2##3##(2006-12#1)(2009-1#1)
the tumor does not##2##4##(1991-7#1)(2010-12#1)
the tumor environment##3##3##(2005-7#1)(2007-10#1)(2009-3#1)
the tumor group##3##3##(2011-2#3)
the tumor growth##3##3##(1994-12#1)(1994-9#1)(2010-1#1)
the tumor had a##2##4##(1993-6#1)(2013-7#1)
the tumor had##5##3##(1993-6#1)(1994-12#1)(1995-4#1)(2006-12#1)(2013-7#1)
the tumor in##12##3##(1990-10#1)(1993-5#1)(2006-6#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-5#1)(2010-12#1)(2011-2#2)(2013-1#1)
the tumor incidence##2##3##(1993-7#1)(2011-2#1)
the tumor increased##2##3##(2008-2#1)(2008-5#1)
the tumor is a##2##4##(2007-8#1)(2008-2#1)
the tumor is##18##3##(1991-7#1)(1992-2#1)(1992-8#1)(1996-9#1)(2005-5#1)(2006-6#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2010-12#1)(2010-2#2)(2011-2#1)(2012-11#1)(2012-2#1)
the tumor itself##3##3##(2007-3#2)(2007-8#1)
the tumor marker##2##3##(1991-4#1)(1995-10#1)
the tumor mass##9##3##(1990-9#1)(1993-11#1)(2006-12#1)(2007-10#2)(2007-3#1)(2009-4#1)(2011-1#1)(2012-12#1)
the tumor microenvironment in##2##4##(2011-1#1)(2013-1#1)
the tumor microenvironment##20##3##(1997-7#1)(2005-10#1)(2009-3#4)(2010-11#2)(2010-12#1)(2010-3#1)(2011-1#4)(2013-1#5)(2013-8#1)
the tumor necrosis factor (TNF)##2##5##(1996-5#2)
the tumor necrosis factor##5##4##(1995-1#1)(1996-5#4)
the tumor necrosis factor-alpha (TNF-alpha)##3##5##(1992-8#1)(2008-10#1)(2008-3#1)
the tumor necrosis##10##3##(1992-8#1)(1995-1#1)(1996-5#4)(2008-10#1)(2008-3#1)(2013-1#1)(2013-7#1)
the tumor of a##2##4##(1995-1#1)(1996-4#1)
the tumor promoter##2##3##(1991-5#1)(2012-3#1)
the tumor recurred##2##3##(2007-4#1)(2011-2#1)
the tumor remained##2##3##(2006-5#1)(2011-1#1)
the tumor response##2##3##(2008-5#1)(2009-4#1)
the tumor showed##6##3##(1996-3#1)(2007-10#1)(2008-11#1)(2008-5#1)(2012-12#2)
the tumor site##6##3##(1990-10#1)(1997-7#1)(2005-10#1)(2006-7#1)(2008-1#1)(2008-12#1)
the tumor size and the##2##5##(1996-6#2)
the tumor size##7##3##(1996-6#3)(2006-11#1)(2008-9#1)(2009-2#1)(2012-2#1)
the tumor spheroid##3##3##(2008-11#3)
the tumor spread##2##3##(2009-5#1)(2013-8#1)
the tumor stroma##3##3##(1994-2#1)(2007-9#1)(2011-1#1)
the tumor suppressor gene p53##3##5##(1994-9#1)(2008-10#1)(2010-12#1)
the tumor suppressor gene##6##4##(1994-9#1)(1996-5#1)(2008-10#1)(2010-12#1)(2011-2#2)
the tumor suppressor p53##4##4##(1996-4#2)(2007-8#1)(2009-7#1)
the tumor suppressor protein p53##2##5##(2009-9#2)
the tumor suppressor protein##3##4##(2009-9#2)(2010-12#1)
the tumor suppressor##16##3##(1994-9#1)(1996-4#2)(1996-5#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-7#1)(2009-9#2)(2010-12#2)(2010-2#1)(2011-2#2)(2013-1#1)
the tumor tissue##8##3##(1992-9#2)(1996-2#1)(1997-7#1)(2008-1#1)(2010-12#1)(2012-1#1)(2012-2#1)
the tumor type##3##3##(2008-7#1)(2010-2#1)(2012-12#1)
the tumor vasculature##6##3##(1993-9#1)(1994-5#1)(2008-5#1)(2009-3#1)(2010-2#2)
the tumor volumes##3##3##(1992-9#1)(1994-12#1)(2013-1#1)
the tumor was a##4##4##(1991-10#1)(1992-2#1)(2011-2#1)(2013-7#1)
the tumor was composed of a##2##6##(2013-1#1)(2013-8#1)
the tumor was composed of##7##5##(1991-8#1)(2009-7#1)(2010-12#1)(2010-6#1)(2012-1#1)(2013-1#1)(2013-8#1)
the tumor was composed##8##4##(1991-8#1)(2008-12#1)(2009-7#1)(2010-12#1)(2010-6#1)(2012-1#1)(2013-1#1)(2013-8#1)
the tumor was diagnosed as##4##5##(1994-7#1)(1995-4#1)(1996-3#1)(2013-8#1)
the tumor was found to##2##5##(1993-10#1)(2009-3#1)
the tumor was found##3##4##(1993-10#1)(2007-11#1)(2009-3#1)
the tumor was located in##2##5##(2008-5#2)
the tumor was on the left##2##6##(2011-2#2)
the tumor was on the##3##5##(2011-2#3)
the tumor was performed in##2##5##(2006-12#1)(2006-8#1)
the tumor was performed##5##4##(2006-12#1)(2006-8#1)(2006-9#1)(2010-9#1)(2013-1#1)
the tumor was removed##2##4##(2006-12#2)
the tumor was surgically##2##4##(2011-1#1)(2011-2#1)
the tumor was##75##3##(1990-5#1)(1990-9#1)(1991-10#1)(1991-8#1)(1992-10#1)(1992-2#1)(1993-10#1)(1993-11#1)(1993-4#1)(1994-3#1)(1994-7#5)(1995-4#1)(1996-3#2)(1996-4#1)(1996-6#1)(2005-10#1)(2005-5#1)(2006-12#8)(2006-2#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#3)(2007-7#2)(2008-12#3)(2008-5#3)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-7#1)(2010-12#3)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#2)
the tumor##569##2##(1990-10#3)(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#3)(1990-6#3)(1990-8#1)(1990-9#4)(1991-10#2)(1991-12#4)(1991-2#1)(1991-4#1)(1991-5#3)(1991-6#3)(1991-7#5)(1991-8#6)(1991-9#3)(1992-1#1)(1992-10#1)(1992-2#2)(1992-7#1)(1992-8#2)(1992-9#13)(1993-10#1)(1993-11#5)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#4)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#4)(1994-6#1)(1994-7#6)(1994-9#4)(1995-1#3)(1995-10#3)(1995-11#1)(1995-4#4)(1995-5#2)(1995-7#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#6)(1996-4#5)(1996-5#5)(1996-6#6)(1996-9#2)(1997-1#3)(1997-5#1)(1997-7#6)(1997-8#1)(2005-10#3)(2005-5#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#7)(2006-11#3)(2006-12#24)(2006-2#2)(2006-4#1)(2006-5#3)(2006-6#8)(2006-7#8)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#7)(2007-11#12)(2007-12#9)(2007-2#3)(2007-3#4)(2007-4#3)(2007-5#2)(2007-6#4)(2007-7#5)(2007-8#13)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#12)(2008-12#7)(2008-2#6)(2008-3#2)(2008-4#3)(2008-5#14)(2008-6#12)(2008-7#3)(2008-8#5)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#4)(2009-2#4)(2009-3#16)(2009-4#3)(2009-5#7)(2009-7#3)(2009-8#1)(2009-9#2)(2010-1#2)(2010-11#2)(2010-12#22)(2010-2#6)(2010-3#4)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#2)(2010-9#5)(2011-1#11)(2011-12#2)(2011-2#25)(2012-1#7)(2012-11#2)(2012-12#8)(2012-2#11)(2012-3#6)(2013-1#21)(2013-7#5)(2013-8#10)
the tumor's microenvironment in##2##4##(2008-6#1)(2011-1#1)
the tumor's##8##2##(2006-12#1)(2006-6#1)(2007-5#1)(2008-5#1)(2008-6#3)(2011-1#1)
the tumor-associated##4##2##(1993-9#2)(2005-11#1)(2008-11#1)
the tumor-bearing mice##3##3##(2008-5#1)(2008-6#1)(2008-8#1)
the tumor-bearing##7##2##(1994-11#2)(1995-8#1)(2008-5#1)(2008-6#1)(2008-8#1)(2013-8#1)
the tumoral##5##2##(2010-12#3)(2010-9#1)(2011-2#1)
the tumorigenesis of##2##3##(2010-3#1)(2011-2#1)
the tumorigenesis##9##2##(1995-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#4)
the tumorigenic phenotype##2##3##(1992-9#2)
the tumorigenic##9##2##(1990-11#1)(1991-2#1)(1992-9#3)(1993-7#1)(1994-12#1)(1995-5#1)(2008-11#1)
the tumors are##2##3##(2006-10#1)(2006-6#1)
the tumors of##2##3##(1990-5#1)(2008-6#1)
the tumors that##2##3##(2006-12#1)(2011-2#1)
the tumors were located in the##3##6##(2006-8#1)(2009-7#1)(2013-1#1)
the tumors were##12##3##(1992-4#1)(1993-1#1)(1993-5#1)(1993-7#1)(2005-5#1)(2006-5#1)(2006-8#1)(2008-6#1)(2009-5#1)(2009-7#1)(2013-1#2)
the tumors##65##2##(1990-12#1)(1990-5#2)(1990-7#1)(1991-12#1)(1991-5#2)(1992-2#1)(1992-4#1)(1992-9#4)(1993-1#1)(1993-11#1)(1993-5#1)(1993-7#2)(1994-11#1)(1994-6#1)(1995-5#2)(2004-9#2)(2005-11#1)(2005-5#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-12#3)(2006-5#2)(2006-6#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-6#4)(2009-3#1)(2009-5#4)(2009-7#3)(2010-1#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#6)(2013-8#1)
the tumour and the##3##4##(1991-11#1)(2008-7#2)
the tumour and##11##3##(1991-11#1)(1992-6#1)(1992-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2012-12#1)
the tumour cells and##2##4##(1995-12#1)(2008-5#1)
the tumour cells##6##3##(1991-6#1)(1995-12#1)(2008-5#1)(2008-6#2)(2009-4#1)
the tumour in the##3##4##(1991-5#1)(1995-12#1)(2008-5#1)
the tumour in##4##3##(1991-5#1)(1995-12#1)(2007-11#1)(2008-5#1)
the tumour is##9##3##(1997-3#1)(2004-1#1)(2006-6#1)(2007-4#1)(2007-9#1)(2008-6#1)(2008-7#1)(2011-1#1)(2013-8#1)
the tumour marker##2##3##(1990-1#1)(2006-10#1)
the tumour microenvironment##4##3##(2009-3#1)(2009-4#1)(2010-7#1)(2012-12#1)
the tumour necrosis##2##3##(2008-7#1)(2013-1#1)
the tumour periphery##4##3##(1991-7#4)
the tumour stage##2##3##(1992-1#1)(2006-10#1)
the tumour suppressor gene##3##4##(1996-10#1)(1997-5#1)(2007-9#1)
the tumour suppressor##6##3##(1991-11#1)(1996-10#1)(1997-5#1)(2003-11#1)(2007-9#1)(2011-2#1)
the tumour to##5##3##(1990-2#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-4#1)
the tumour was##12##3##(2006-6#1)(2008-6#1)(2008-7#4)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
the tumour were##2##3##(2007-2#1)(2010-9#1)
the tumour##164##2##(1990-1#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-8#1)(1990-9#2)(1991-11#2)(1991-5#1)(1991-6#2)(1991-7#6)(1992-1#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-10#2)(1993-8#1)(1994-4#1)(1995-12#3)(1996-10#1)(1996-4#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(2003-11#1)(2004-1#2)(2005-11#1)(2005-7#1)(2006-10#3)(2006-6#4)(2007-11#6)(2007-2#1)(2007-4#2)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#6)(2008-6#19)(2008-7#24)(2008-9#2)(2009-3#1)(2009-4#3)(2010-12#1)(2010-7#1)(2010-9#2)(2011-1#4)(2011-12#2)(2011-2#4)(2012-12#10)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#5)
the tumour-associated microvasculature##2##3##(2007-11#2)
the tumour-associated##3##2##(2007-11#3)
the tumour-bearing##5##2##(1992-1#1)(1993-8#1)(1996-1#1)(2006-6#1)(2007-11#1)
the tumours##20##2##(1990-12#2)(1990-5#1)(1991-11#1)(1993-5#1)(2006-10#1)(2006-8#8)(2007-12#1)(2007-8#1)(2008-10#1)(2008-6#2)(2013-1#1)
the tunability of the##2##4##(2007-12#1)(2008-10#1)
the tunability##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
the tunable output##4##3##(2008-2#2)(2008-3#1)(2013-8#1)
the tunable##7##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-4#1)(2013-8#1)
the tungsten coil##3##3##(2008-10#3)
the tungsten wire##3##3##(2008-10#3)
the tungsten##12##2##(2007-12#1)(2008-10#11)
the tungsten-substituted molybdenum##2##3##(1992-8#2)
the tunic##4##2##(2008-5#2)(2008-7#2)
the tunica albuginea and the##2##5##(2011-1#1)(2011-2#1)
the tunica media##3##3##(1992-12#1)(1996-7#1)(2008-11#1)
the tunica propria##3##3##(2009-10#3)
the tunica##9##2##(1992-12#1)(1996-7#1)(2008-10#1)(2008-11#1)(2009-10#3)(2011-1#1)(2011-2#1)
the tuning element##2##3##(2008-2#2)
the tuning of the##2##4##(2008-1#1)(2008-2#1)
the tuning of##5##3##(2006-12#1)(2008-1#1)(2008-2#1)(2009-2#1)(2010-2#1)
the tuning range of##4##4##(2007-12#1)(2008-2#3)
the tuning range##9##3##(2007-11#1)(2007-12#1)(2008-2#5)(2008-3#2)
the tuning##20##2##(2006-12#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#10)(2008-3#2)(2009-2#1)(2010-2#1)(2012-3#1)
the tunnel##16##2##(1991-11#1)(1991-12#1)(1994-11#2)(1995-1#1)(1997-1#1)(2005-12#1)(2007-12#2)(2009-10#1)(2010-4#1)(2011-3#1)(2012-12#3)(2013-7#1)
the tunneling##9##2##(1995-2#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-1#1)(2008-2#1)(2008-3#1)(2010-4#1)
the turbid media##4##3##(2008-2#2)(2008-3#2)
the turbid medium##5##3##(2007-11#1)(2007-12#1)(2008-3#3)
the turbid##13##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#6)
the turbidity of the membrane##2##5##(2008-10#2)
the turbidity of the##4##4##(1990-12#1)(2005-11#1)(2008-10#2)
the turbidity test##3##3##(2006-2#3)
the turbidity##13##2##(1990-12#1)(1990-7#1)(1993-9#1)(2005-11#2)(2006-2#3)(2008-10#2)(2008-6#1)(2008-8#1)(2013-8#1)
the turbulence outer scale##2##4##(2008-2#1)(2008-3#1)
the turbulence##8##2##(2007-12#2)(2007-2#1)(2008-2#1)(2008-3#4)
the turbulence-induced##2##2##(2008-2#1)(2008-3#1)
the turbulent##11##2##(1994-5#1)(2007-12#3)(2007-9#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)
the turkey GH##2##3##(1990-12#2)
the turkey##4##2##(1990-12#2)(1996-3#1)(2008-5#1)
the turn of the century##6##5##(1997-3#1)(2006-10#1)(2007-4#1)(2008-5#2)(2013-7#1)
the turn of the year##2##5##(1990-12#1)(1997-3#1)
the turn of the##12##4##(1990-12#1)(1997-3#2)(2006-10#2)(2007-4#1)(2008-5#2)(2008-7#1)(2010-1#1)(2011-2#1)(2013-7#1)
the turn of##15##3##(1990-12#1)(1997-3#3)(2006-10#2)(2007-4#1)(2008-1#1)(2008-2#1)(2008-5#2)(2008-7#1)(2010-1#1)(2011-2#1)(2013-7#1)
the turn region##2##3##(1993-6#1)(1994-9#1)
the turn##26##2##(1990-12#1)(1993-6#4)(1994-12#1)(1994-5#1)(1994-9#1)(1995-6#1)(1997-3#3)(2006-10#2)(2007-12#2)(2007-4#1)(2008-1#1)(2008-2#1)(2008-5#2)(2008-7#1)(2010-1#1)(2011-1#1)(2011-2#1)(2013-7#1)
the turn-taking rule##2##3##(2012-2#2)
the turning behaviour of##2##4##(1993-4#1)(1995-12#1)
the turning point##4##3##(1993-1#1)(1995-7#1)(1997-6#1)(2008-12#1)
the turning##7##2##(1993-1#1)(1993-4#1)(1995-12#1)(1995-7#1)(1997-6#1)(2008-12#1)(2012-12#1)
the turnip##2##2##(1996-9#1)(2008-10#1)
the turnover of DA##2##4##(1993-2#2)
the turnover of LH beta mRNA##2##6##(1997-2#2)
the turnover of the##2##4##(1990-8#1)(2008-4#1)
the turnover of##17##3##(1990-10#1)(1990-12#1)(1990-8#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-8#1)(1997-1#1)(1997-2#2)(2005-7#1)(2006-12#1)(2006-8#1)(2008-10#1)(2008-4#1)(2012-12#1)
the turnover rate of##3##4##(1995-3#1)(1996-3#1)(1996-4#1)
the turnover rates##3##3##(1990-3#1)(2004-11#1)(2013-1#1)
the turnover##28##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-8#1)(1991-1#1)(1991-11#1)(1992-9#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-8#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#2)(2004-11#1)(2005-7#1)(2006-12#1)(2006-8#1)(2008-10#2)(2008-4#1)(2012-12#1)(2013-1#1)
the twelve##6##2##(1993-12#1)(1994-9#1)(1996-6#1)(2007-12#1)(2008-8#1)(2011-3#1)
the twentieth century##25##3##(2005-7#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#3)(2008-8#2)(2009-2#1)(2009-4#2)(2009-7#2)(2010-1#2)(2010-7#1)(2011-2#3)(2012-2#2)(2013-8#1)
the twentieth##27##2##(2005-7#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#3)(2008-8#2)(2009-2#1)(2009-4#2)(2009-7#2)(2010-1#3)(2010-7#1)(2011-2#3)(2012-2#2)(2013-8#1)
the twenty##5##2##(1990-11#1)(1997-7#1)(2007-1#1)(2008-1#1)(2009-8#1)
the twenty-first century##13##3##(1994-2#1)(1995-2#1)(1996-12#2)(1997-1#1)(1997-3#1)(2005-11#1)(2006-7#3)(2008-12#1)(2011-1#1)(2012-2#1)
the twin##12##2##(1996-12#1)(1997-1#1)(1997-5#1)(2004-10#1)(2005-11#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)
the twins##2##2##(1992-12#1)(1993-1#1)
the twist of##2##3##(1993-3#1)(2007-9#1)
the twist rate##2##3##(2007-12#1)(2008-2#1)
the twist##6##2##(1993-3#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-2#2)
the twisted##6##2##(1990-9#2)(1993-11#2)(2007-12#2)
the twitch responses of the electrically stimulated##2##7##(1990-5#2)
the twitch##4##2##(1990-5#2)(1993-11#1)(2013-8#1)
the two ATP-binding motifs##2##4##(1996-2#2)
the two ATP-binding##3##3##(1990-10#1)(1996-2#2)
the two DNA##3##3##(1991-6#1)(1993-8#1)(2007-8#1)
the two DNLL divisions##2##4##(1996-9#2)
the two GC##2##3##(1994-5#1)(2006-10#1)
the two IGF-I##2##3##(1992-9#1)(1994-2#1)
the two States##3##3##(1992-3#3)
the two aberrated wave fronts##2##5##(2008-3#2)
the two above##3##3##(1996-3#1)(2008-10#2)
the two active sites##3##4##(2011-1#3)
the two active##4##3##(1996-12#1)(2011-1#3)
the two activities##2##3##(1991-10#1)(1991-9#1)
the two additional##2##3##(1996-5#1)(1997-5#1)
the two adjacent##3##3##(1990-5#1)(1994-2#1)(2008-3#1)
the two age groups##5##4##(1996-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2012-1#1)
the two agents##5##3##(1992-1#1)(1997-1#1)(2008-3#1)(2008-8#2)
the two ages##3##3##(1991-11#1)(1993-2#1)(2006-12#1)
the two alleles##5##3##(1992-5#1)(1993-6#1)(1994-9#1)(1995-1#1)(2006-2#1)
the two alpha-helices##2##3##(1992-9#1)(1997-4#1)
the two alternative##2##3##(1997-4#1)(2008-8#1)
the two amino groups##3##4##(2006-10#2)(2008-5#1)
the two amino##5##3##(2006-10#2)(2006-3#1)(2008-10#1)(2008-5#1)
the two anomers##3##3##(1991-10#1)(1994-8#2)
the two antibodies##3##3##(1991-2#1)(1995-10#1)(1995-6#1)
the two antigens##2##3##(1992-8#1)(2008-10#1)
the two approaches to##2##4##(2008-5#1)(2011-2#1)
the two approaches##8##3##(1996-11#1)(2008-4#2)(2008-5#1)(2010-11#1)(2011-2#1)(2012-2#2)
the two are##4##3##(2008-3#2)(2008-4#1)(2012-3#1)
the two areas##6##3##(1991-11#1)(2005-9#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-8#1)
the two arms are##2##4##(2007-12#1)(2008-2#1)
the two arms of##3##4##(2008-2#3)
the two arms##9##3##(2007-12#2)(2008-2#5)(2008-3#1)(2010-3#1)
the two assays##2##3##(2006-7#1)(2012-2#1)
the two axes##2##3##(2008-3#2)
the two bacterial##3##3##(1991-8#1)(1994-3#1)(2006-5#1)
the two basic types of##2##5##(2005-10#1)(2009-4#1)
the two basic##5##3##(2005-10#1)(2008-3#1)(2008-4#1)(2009-4#1)(2013-1#1)
the two beams##7##3##(2007-12#2)(2008-2#2)(2008-3#3)
the two beta##2##3##(1994-5#1)(1994-9#1)
the two binding sites##3##4##(1991-4#1)(1992-9#1)(1996-4#1)
the two binding##6##3##(1991-4#1)(1992-1#1)(1992-9#1)(1995-8#2)(1996-4#1)
the two bladder##2##3##(2008-10#2)
the two breakpoints of##2##4##(2013-1#2)
the two broken loci##2##4##(2011-1#2)
the two can be##2##4##(2008-10#1)(2010-8#1)
the two can##3##3##(2007-4#1)(2008-10#1)(2010-8#1)
the two carbonyls##2##3##(1996-8#1)(2013-1#1)
the two case##3##3##(1993-12#1)(2008-4#1)(2013-8#1)
the two cases##9##3##(1991-5#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2009-12#1)(2011-1#1)
the two catalytic##2##3##(1991-9#1)(1995-5#1)
the two categories of##3##4##(2007-12#1)(2008-10#1)(2013-1#1)
the two cell lines were##2##5##(2008-11#1)(2008-9#1)
the two cell lines##13##4##(1990-11#1)(1991-10#1)(1991-7#1)(2008-11#3)(2008-7#1)(2008-9#4)(2011-2#1)(2012-12#1)
the two cell populations##2##4##(1995-11#1)(2008-1#1)
the two cell types##4##4##(1992-1#1)(1993-3#1)(1995-3#2)
the two cell##20##3##(1990-11#2)(1991-10#1)(1991-7#1)(1992-1#1)(1993-3#1)(1995-11#1)(1995-3#2)(2008-1#1)(2008-11#3)(2008-7#1)(2008-9#4)(2011-2#1)(2012-12#1)
the two central##2##3##(2008-2#1)(2012-1#1)
the two chains##2##3##(1995-6#1)(2006-12#1)
the two chambers##2##3##(2008-8#1)(2011-2#1)
the two chicken##3##3##(1990-2#1)(1996-5#2)
the two chromium##2##3##(2008-10#2)
the two classes of##7##4##(1990-9#1)(1991-6#1)(1994-6#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-2#1)
the two classes##8##3##(1990-9#1)(1991-6#1)(1992-2#1)(1994-6#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-2#1)
the two classifications may benefit each other and help improve performance through joint inference algorithms##2##15##(2013-1#2)
the two clinical##2##3##(1992-9#1)(2006-8#1)
the two clones##2##3##(2008-10#2)
the two closed##2##3##(1994-5#1)(2012-3#1)
the two colors##3##3##(2008-2#1)(2008-9#2)
the two commercially available##2##4##(1996-6#1)(2011-1#1)
the two common##2##3##(2007-9#1)(2008-10#1)
the two communities##2##3##(2010-3#1)(2012-2#1)
the two compared##2##3##(1991-3#1)(2008-10#1)
the two comparison groups##2##4##(1996-3#1)(2006-3#1)
the two complexes##7##3##(1992-4#1)(1992-6#1)(1992-9#1)(1996-2#1)(2005-4#2)(2008-10#1)
the two component regulatory##2##4##(2008-8#1)(2010-10#1)
the two component##3##3##(1994-2#1)(2008-8#1)(2010-10#1)
the two components of polarization##2##5##(2008-2#1)(2008-3#1)
the two components of##6##4##(2008-2#2)(2008-3#1)(2008-8#1)(2012-11#2)
the two components##14##3##(1991-7#1)(1995-3#1)(2005-11#2)(2007-12#2)(2007-8#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#1)(2012-11#2)
the two compounds in##2##4##(2008-10#2)
the two compounds##6##3##(1994-3#1)(1997-2#1)(2007-8#1)(2008-10#3)
the two conditions were##2##4##(1992-11#1)(2008-8#1)
the two conditions##12##3##(1990-2#1)(1992-11#1)(1993-2#1)(1993-6#1)(1996-10#1)(2007-10#1)(2007-9#1)(2008-4#1)(2008-8#1)(2009-11#1)(2010-6#1)(2011-2#1)
the two consensus##2##3##(1993-11#1)(1994-9#1)
the two conserved regions##2##4##(1993-11#1)(1997-4#1)
the two conserved##3##3##(1992-11#1)(1993-11#1)(1997-4#1)
the two constituent##2##3##(2007-12#1)(2008-7#1)
the two constituents##3##3##(2008-10#2)(2008-3#1)
the two copies of##2##4##(1997-3#1)(2012-2#1)
the two copies##3##3##(1995-11#1)(1997-3#1)(2012-2#1)
the two culture##2##3##(1993-7#1)(2008-11#1)
the two cytokines##2##3##(1991-3#1)(1995-12#1)
the two cytologists##2##3##(2008-6#2)
the two data##4##3##(2007-10#1)(2008-2#1)(2013-1#2)
the two days##4##3##(2008-3#2)(2008-5#2)
the two dietary treatments##2##4##(2008-12#1)(2010-8#1)
the two dietary##3##3##(1991-12#1)(2008-12#1)(2010-8#1)
the two different forms of##2##5##(1994-8#1)(2012-12#1)
the two different##23##3##(1991-6#1)(1992-4#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-8#1)(2008-9#1)(2012-12#2)
the two dimensions##2##3##(2008-2#2)
the two diseases were##2##4##(2007-7#1)(2007-8#1)
the two diseases##13##3##(1994-8#1)(1997-7#1)(2006-10#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#7)
the two distinct##6##3##(1990-4#1)(1991-4#1)(1994-8#1)(1996-2#1)(2006-7#1)(2008-10#1)
the two districts##3##3##(2008-2#3)
the two divisions##2##3##(1996-9#2)
the two domains##11##3##(1991-2#1)(1991-9#2)(1992-3#1)(1994-2#1)(1995-1#1)(1995-6#2)(1996-11#1)(1996-7#1)(2008-4#1)
the two drug##3##3##(1990-2#1)(1993-6#1)(2010-3#1)
the two drugs are##2##4##(1992-3#1)(1995-3#1)
the two drugs in the##2##5##(1997-4#1)(2011-2#1)
the two drugs in##5##4##(1993-2#1)(1997-4#1)(2008-10#1)(2011-2#2)
the two drugs##24##3##(1990-5#1)(1990-9#1)(1992-1#1)(1992-3#1)(1993-2#1)(1995-3#2)(1995-6#1)(1995-7#1)(1997-4#2)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#4)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
the two duplicated##2##3##(2008-7#1)(2012-3#1)
the two dyes##3##3##(2005-4#1)(2008-2#2)
the two earlier##2##3##(1994-2#1)(2008-10#1)
the two effects##2##3##(1990-8#1)(2008-5#1)
the two electrode##2##3##(1993-12#1)(2007-12#1)
the two electrodes##6##3##(2007-12#1)(2008-10#4)(2013-1#1)
the two enantiomers of##2##4##(1996-9#1)(2008-10#1)
the two enantiomers##4##3##(1993-11#1)(1996-9#1)(2008-10#2)
the two ends of##3##4##(1995-11#1)(2005-11#1)(2005-8#1)
the two ends##4##3##(1995-11#1)(1995-8#1)(2005-11#1)(2005-8#1)
the two entities##2##3##(1990-12#1)(2006-12#1)
the two environments##2##3##(2008-8#1)(2010-5#1)
the two enzyme activities##2##4##(1995-8#1)(2005-7#1)
the two enzyme##3##3##(1995-11#1)(1995-8#1)(2005-7#1)
the two enzymes are##2##4##(1991-5#1)(1994-3#1)
the two enzymes##18##3##(1990-5#1)(1990-9#1)(1991-5#1)(1992-4#1)(1993-12#1)(1994-3#2)(1995-10#1)(1995-5#1)(1995-7#2)(1996-7#1)(1996-9#2)(1997-7#1)(2008-10#1)(2008-11#1)(2009-8#1)
the two etched##2##3##(2008-3#1)(2008-5#1)
the two events##3##3##(1991-8#1)(1995-12#1)(1995-6#1)
the two examinations##4##3##(1996-11#1)(2008-11#1)(2008-3#1)(2008-4#1)
the two excitation beams##2##4##(2008-3#2)
the two excitation##3##3##(2008-3#3)
the two experimental##4##3##(1996-1#1)(2008-10#1)(2009-12#1)(2012-2#1)
the two experiments##2##3##(2008-10#2)
the two extreme cases##2##4##(1991-2#1)(2008-11#1)
the two extreme##4##3##(1991-2#1)(1996-11#1)(2008-11#1)(2008-2#1)
the two extremes##4##3##(1997-6#1)(2007-2#1)(2008-10#1)(2008-9#1)
the two eyes##5##3##(1992-7#1)(1994-2#1)(1994-8#1)(2011-1#2)
the two faces of##2##4##(2008-5#1)(2010-12#1)
the two factors##5##3##(1992-11#1)(1997-4#1)(2007-9#1)(2008-10#1)(2008-7#1)
the two families of##2##4##(2007-12#1)(2008-7#1)
the two families##3##3##(1994-2#1)(2007-12#1)(2008-7#1)
the two fetuses##2##3##(1992-6#2)
the two field##2##3##(2007-11#1)(2008-10#1)
the two fields##4##3##(1991-2#1)(1997-3#1)(2007-1#1)(2007-11#1)
the two filters##2##3##(1996-12#1)(2005-12#1)
the two first##4##3##(1995-9#2)(2007-12#1)(2008-3#1)
the two first-order reactions model##3##5##(2008-10#3)
the two fish species##2##4##(2008-12#1)(2010-8#1)
the two forms of the##2##5##(1997-4#1)(2008-10#1)
the two forms of##10##4##(1990-2#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-11#1)(1997-4#1)(2007-11#1)(2008-10#2)(2010-5#1)
the two forms##14##3##(1990-2#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-11#1)(1995-5#1)(1997-4#1)(2007-11#1)(2008-10#2)(2009-3#1)(2010-5#1)(2012-1#2)
the two formulations of##2##4##(1996-1#2)
the two formulations##6##3##(1993-6#1)(1995-2#1)(1996-1#2)(1996-12#1)(2010-2#1)
the two functionally##2##3##(1997-6#1)(2008-9#1)
the two fundamental##3##3##(2008-1#3)
the two fungi##3##3##(2008-10#3)
the two genders##2##3##(2008-1#1)(2013-1#1)
the two generated##2##3##(2007-12#1)(2008-3#1)
the two genes are##4##4##(1990-4#1)(1993-3#1)(1994-11#1)(2008-10#1)
the two genes##21##3##(1990-11#1)(1990-4#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-7#1)(1991-9#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-8#2)(1996-11#1)(1996-3#1)(1996-7#1)(1997-7#2)(2008-10#1)(2008-9#1)(2009-8#1)
the two genotypes##3##3##(2008-10#2)(2008-4#1)
the two grasses##2##3##(2008-5#2)
the two grating planes##5##4##(2008-3#5)
the two gratings##2##3##(1997-8#1)(2008-3#1)
the two groups (P=0##3##4##(2007-8#2)(2012-2#1)
the two groups (p = 0##2##6##(2010-8#1)(2012-2#1)
the two groups after##2##4##(1992-8#1)(2013-8#1)
the two groups and##2##4##(2008-10#1)(2012-2#1)
the two groups are##2##4##(2005-1#1)(2008-1#1)
the two groups did not differ significantly##3##7##(1990-6#1)(1992-4#1)(2011-1#1)
the two groups did not differ##5##6##(1990-6#1)(1991-3#1)(1992-4#1)(2010-4#1)(2011-1#1)
the two groups during##2##4##(2007-10#1)(2007-2#1)
the two groups had##2##4##(1990-2#1)(2011-1#1)
the two groups in##12##4##(1990-2#1)(1990-6#1)(1995-4#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-2#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#1)
the two groups of animals##2##5##(1992-11#1)(2008-5#1)
the two groups of isolates##2##5##(2008-10#2)
the two groups of patients##9##5##(1990-11#1)(1990-12#1)(1990-5#1)(1996-4#1)(2006-6#1)(2007-2#1)(2007-8#1)(2008-10#1)(2013-8#1)
the two groups of welders##2##5##(2008-4#2)
the two groups of##32##4##(1990-11#1)(1990-12#1)(1990-5#1)(1992-11#1)(1993-11#1)(1994-5#1)(1995-10#1)(1995-12#1)(1995-5#1)(1996-4#1)(2005-10#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-8#1)(2013-8#1)
the two groups was##15##4##(1991-3#1)(1993-1#1)(1996-5#1)(2006-4#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-7#2)(2008-8#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#2)
the two groups were comparable##2##5##(2007-7#1)(2009-11#1)
the two groups were##13##4##(1992-12#1)(1995-10#1)(1996-5#1)(1997-8#1)(2005-4#1)(2007-7#1)(2008-10#1)(2008-6#1)(2009-11#1)(2009-12#1)(2013-1#2)(2013-8#1)
the two groups with##4##4##(1995-10#1)(2007-7#1)(2007-8#1)(2013-1#1)
the two groups##247##3##(1990-11#2)(1990-12#2)(1990-2#2)(1990-5#1)(1990-6#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#3)(1991-4#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-11#4)(1992-12#4)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#4)(1993-11#2)(1993-12#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-7#1)(1995-10#3)(1995-11#2)(1995-12#3)(1995-4#1)(1995-5#1)(1995-7#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#1)(1996-9#2)(1997-2#1)(1997-3#2)(1997-6#3)(1997-7#1)(1997-8#2)(2004-12#1)(2005-1#1)(2005-10#1)(2005-4#2)(2006-10#3)(2006-2#2)(2006-4#2)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#3)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#4)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#13)(2007-9#5)(2008-1#2)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#4)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#1)(2009-11#2)(2009-12#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#7)(2011-2#11)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#10)(2013-8#6)
the two growth##2##3##(1996-6#1)(2007-7#1)
the two habitat types##2##4##(2004-2#1)(2008-8#1)
the two halves of the##3##5##(1990-11#1)(1990-4#1)(1994-3#1)
the two halves of##4##4##(1990-11#1)(1990-4#1)(1991-10#1)(1994-3#1)
the two halves##5##3##(1990-11#1)(1990-4#1)(1991-10#1)(1994-3#1)(1997-7#1)
the two helices##7##3##(1991-5#1)(1993-1#3)(1993-6#2)(1995-11#1)
the two hemispheres##3##3##(1997-8#2)(2009-9#1)
the two higher##2##3##(1992-11#1)(2008-3#1)
the two highest##3##3##(1994-2#1)(2006-9#1)(2008-1#1)
the two homologous halves of##2##5##(1994-5#1)(1995-10#1)
the two homologous##4##3##(1993-11#1)(1994-3#1)(1994-5#1)(1995-10#1)
the two hormones##2##3##(1995-12#1)(2008-11#1)
the two hospitals##2##3##(1993-6#1)(1994-1#1)
the two hosts##4##3##(2008-10#3)(2010-2#1)
the two human##3##3##(1991-12#1)(1992-12#1)(1992-6#1)
the two identical##3##3##(1991-11#1)(2005-8#1)(2008-3#1)
the two images##3##3##(2008-2#1)(2008-3#1)(2008-6#1)
the two in##2##3##(2005-11#1)(2009-6#1)
the two independent##3##3##(1997-1#1)(2007-11#1)(2008-3#1)
the two indices##3##3##(2008-3#1)(2008-8#2)
the two input##5##3##(2007-12#3)(2008-2#1)(2008-3#1)
the two instruments##6##3##(2008-10#1)(2008-3#5)
the two interfering beams##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
the two introns##2##3##(1990-5#1)(1997-4#1)
the two irrigation##2##3##(2008-10#2)
the two is##4##3##(1991-3#1)(2010-7#1)(2011-2#2)
the two isoforms of##3##4##(1991-12#1)(1995-2#1)(1997-2#1)
the two isoforms##6##3##(1991-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-2#1)(2012-2#1)
the two isolated##3##3##(1990-12#1)(1992-4#1)(1994-12#1)
the two isolates of##2##4##(2008-10#1)(2008-5#1)
the two isolates were##2##4##(2008-10#2)
the two isolates##10##3##(2008-10#7)(2008-5#1)(2009-6#1)(2012-12#1)
the two isomeric 11alpha##2##4##(2007-1#2)
the two isomers##4##3##(1990-12#1)(1991-4#1)(2009-3#1)(2010-5#1)
the two key##3##3##(1994-9#1)(1997-2#1)(2012-2#1)
the two kinds of NK cells##2##6##(2008-8#2)
the two kinds of##11##4##(1992-8#1)(1996-9#1)(2006-12#1)(2007-4#1)(2008-10#3)(2008-5#1)(2008-8#3)
the two known##5##3##(1991-12#1)(1992-3#1)(2006-12#2)(2009-8#1)
the two largest lineages##2##4##(2008-10#2)
the two largest##5##3##(1992-7#1)(1995-6#1)(2008-10#2)(2011-1#1)
the two laser##4##3##(2007-11#2)(2008-2#1)(2008-5#1)
the two lasers##6##3##(2007-12#3)(2008-3#2)(2011-1#1)
the two layers##5##3##(2008-12#1)(2008-2#2)(2008-3#2)
the two lesions##2##3##(1996-6#1)(2008-5#1)
the two levels##2##3##(2008-7#1)(2008-8#1)
the two ligands##5##3##(1995-1#1)(1996-2#1)(1997-2#2)(2008-10#1)
the two linear##2##3##(1995-2#1)(2008-2#1)
the two lines##3##3##(2006-12#1)(2008-10#1)(2008-3#1)
the two lipovitellin subunits##2##4##(1995-8#2)
the two locations##3##3##(2008-1#1)(2008-10#2)
the two loci##2##3##(2004-11#1)(2008-10#1)
the two loops##2##3##(1992-11#1)(1996-10#1)
the two low##3##3##(1991-5#1)(2008-10#1)(2012-2#1)
the two main methods##3##4##(1992-2#1)(2007-12#1)(2008-4#1)
the two main##24##3##(1992-2#1)(1992-3#1)(1993-8#1)(1994-2#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#6)(2008-6#1)(2008-9#2)(2009-8#1)(2010-12#1)(2010-8#1)(2012-1#2)
the two major production areas##2##5##(2008-10#2)
the two major##48##3##(1990-12#3)(1990-2#1)(1990-3#1)(1990-6#1)(1991-12#1)(1991-3#1)(1992-6#1)(1993-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#1)(2004-12#1)(2005-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-8#1)(2009-6#2)(2010-5#1)(2011-2#1)
the two markers##2##3##(2010-12#1)(2012-2#1)
the two materials##6##3##(2004-9#2)(2007-12#1)(2008-2#1)(2008-7#1)(2013-1#1)
the two matrix##2##3##(1994-12#2)
the two measurements##2##3##(1995-9#1)(2008-3#1)
the two measures##4##3##(2008-6#1)(2009-4#1)(2010-8#1)(2012-2#1)
the two mechanisms##6##3##(1995-11#1)(2008-10#2)(2008-3#1)(2008-9#2)
the two membranes##2##3##(2005-11#2)
the two mentioned##2##3##(2008-10#1)(2008-12#1)
the two metal ions##2##4##(1991-4#1)(1995-2#1)
the two metal##3##3##(1991-4#1)(1995-2#1)(2011-1#1)
the two metals##6##3##(1991-5#1)(2004-4#1)(2008-10#4)
the two methods are##4##4##(2008-10#1)(2008-2#1)(2008-3#2)
the two methods of analysis##3##5##(2008-10#2)(2012-7#1)
the two methods of##5##4##(2006-8#1)(2007-8#1)(2008-10#2)(2012-7#1)
the two methods was##4##4##(1992-8#1)(1995-2#1)(2007-12#1)(2008-10#1)
the two methods were##8##4##(2008-10#5)(2009-6#1)(2011-2#1)(2013-7#1)
the two methods##61##3##(1990-12#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-5#1)(2005-4#1)(2006-1#2)(2006-8#1)(2007-10#1)(2007-12#1)(2007-7#3)(2007-8#3)(2008-10#20)(2008-11#1)(2008-2#5)(2008-3#4)(2009-10#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-7#1)(2013-1#1)(2013-7#1)
the two microbial##2##3##(1997-8#1)(2008-10#1)
the two mirrors##2##3##(2006-5#1)(2008-3#1)
the two mixtures##2##3##(2005-11#1)(2008-10#1)
the two modalities##2##3##(2008-8#1)(2012-1#1)
the two models are##3##4##(2005-11#1)(2008-10#1)(2011-12#1)
the two models##9##3##(2005-11#1)(2007-10#1)(2008-10#3)(2008-2#1)(2008-5#1)(2009-8#1)(2011-12#1)
the two modes of##3##4##(2008-11#1)(2008-8#1)(2008-9#1)
the two modes##4##3##(2007-11#1)(2008-11#1)(2008-8#1)(2008-9#1)
the two molecules##6##3##(1990-4#1)(1992-6#1)(1993-4#1)(1994-8#1)(1995-3#1)(2008-8#1)
the two monolayers##3##3##(1990-11#1)(2007-12#2)
the two monomers##2##3##(1992-4#1)(2012-2#1)
the two morphologically##2##3##(2008-10#1)(2008-8#1)
the two mosquito species##2##4##(2004-11#1)(2008-2#1)
the two most common##7##4##(1991-8#1)(2005-8#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-3#1)(2012-12#1)
the two most frequent##2##4##(2008-2#1)(2011-2#1)
the two most important##5##4##(1991-2#1)(1992-5#1)(2007-8#2)(2008-5#1)
the two most significant##2##4##(2011-2#1)(2012-12#1)
the two most widely used##2##5##(2005-9#1)(2008-9#1)
the two most##30##3##(1991-2#1)(1991-8#1)(1992-5#1)(2005-8#1)(2005-9#1)(2006-3#2)(2006-4#1)(2007-12#2)(2007-5#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#2)(2008-9#1)(2009-12#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#2)
the two mutant##2##3##(1994-11#1)(1995-8#1)
the two mutants##2##3##(1994-12#1)(1995-5#1)
the two mutations##2##3##(1994-12#1)(1994-9#1)
the two myosin isozymes##2##4##(1996-9#2)
the two neurons##2##3##(1990-4#1)(1991-11#1)
the two new##4##3##(2006-12#1)(2007-1#1)(2008-11#1)(2008-5#1)
the two objects##2##3##(1993-7#1)(2012-1#1)
the two observation##2##3##(1991-6#1)(2008-2#1)
the two opposite##3##3##(2005-11#1)(2008-11#1)(2011-1#1)
the two organisms##4##3##(1993-11#1)(1997-2#1)(2008-10#1)(2008-7#1)
the two orthogonal##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
the two other species##2##4##(2007-6#1)(2011-2#1)
the two other##16##3##(1990-5#1)(1992-11#1)(1992-7#1)(1994-12#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(2006-12#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
the two others##2##3##(1993-1#1)(1997-5#1)
the two pairs of phycocyanobilins##2##5##(1994-5#2)
the two pairs of##4##4##(1994-5#2)(1995-2#1)(2012-11#1)
the two parameters alpha and gamma##2##6##(2008-6#2)
the two parameters##5##3##(1994-8#1)(2008-11#1)(2008-2#1)(2008-6#2)
the two parties##3##3##(1991-6#1)(1994-1#1)(2008-8#1)
the two patches##2##3##(1992-10#2)
the two pathogens##5##3##(2008-10#4)(2010-4#1)
the two pathways##4##3##(1994-11#1)(2008-2#1)(2008-4#1)(2011-1#1)
the two patient groups##5##4##(1992-5#1)(1996-5#1)(2006-7#1)(2007-4#1)(2008-3#1)
the two patients with##2##4##(1991-10#1)(2007-8#1)
the two patients##9##3##(1990-4#1)(1991-10#1)(1992-11#1)(1993-10#1)(1996-9#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-4#1)
the two peptides in the##2##5##(1991-2#1)(1992-11#1)
the two peptides were##2##4##(1995-11#1)(2008-7#1)
the two peptides##13##3##(1990-10#2)(1990-11#1)(1991-2#1)(1992-11#1)(1992-12#1)(1994-11#1)(1994-12#1)(1995-11#1)(2006-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
the two periods##7##3##(2006-7#1)(2006-8#1)(2010-4#2)(2011-2#2)(2012-3#1)
the two perpendicular##2##3##(2008-2#1)(2008-3#1)
the two phase##2##3##(2007-12#1)(2008-2#1)
the two phases was##2##4##(1991-6#1)(2008-10#1)
the two phases##11##3##(1990-10#1)(1991-6#1)(1994-12#1)(2004-12#1)(2008-10#3)(2008-5#2)(2008-7#1)(2010-12#1)
the two point##2##3##(1993-8#1)(2008-2#1)
the two polarization##6##3##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)
the two polymers in##2##4##(1991-7#1)(2005-11#1)
the two polymers##4##3##(1991-7#1)(2005-11#1)(2008-10#2)
the two populations##11##3##(1992-10#1)(1994-3#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-8#1)(2010-8#1)(2011-2#1)
the two positions##3##3##(1994-5#1)(1997-4#1)(2007-8#1)
the two possible##3##3##(1992-2#1)(1992-3#1)(2008-10#1)
the two potential##2##3##(1991-8#1)(1992-12#1)
the two powders##2##3##(2004-9#2)
the two preparations were##3##4##(1992-2#1)(1996-2#1)(2004-12#1)
the two preparations##7##3##(1992-2#2)(1992-8#1)(1992-9#1)(1996-2#1)(2004-12#2)
the two previously##4##3##(1991-12#1)(2008-2#1)(2008-5#1)(2008-9#1)
the two primary##3##3##(2008-4#1)(2013-1#2)
the two principal##2##3##(1995-1#1)(2010-5#1)
the two procedures##14##3##(1992-4#1)(1995-1#1)(1996-2#1)(2005-5#1)(2006-10#1)(2008-10#5)(2008-3#1)(2012-12#2)(2012-2#1)
the two processes##5##3##(1996-11#1)(2005-11#2)(2009-8#1)(2012-2#1)
the two products##5##3##(1992-11#1)(1994-8#1)(1995-6#1)(2008-10#1)(2008-5#1)
the two projects##4##3##(2013-1#4)
the two protein##5##3##(1990-4#1)(1992-6#1)(1994-12#1)(1994-3#1)(1995-8#1)
the two proteins are##2##4##(1991-9#1)(2008-4#1)
the two proteins share##2##4##(1994-9#1)(1995-6#1)
the two proteins that##2##4##(1993-6#1)(1995-3#1)
the two proteins##28##3##(1990-11#2)(1990-12#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-9#2)(1992-2#2)(1993-6#2)(1993-8#1)(1994-11#2)(1994-5#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-4#1)(1997-1#1)(1997-2#1)(2005-11#1)(2008-2#1)(2008-4#2)(2009-10#1)(2012-2#1)
the two protocols##4##3##(1994-3#1)(2008-4#2)(2008-9#1)
the two psychostimulants##2##3##(1996-10#2)
the two pulses##2##3##(2007-12#2)
the two quinones##2##3##(1994-11#2)
the two rRNA operons##2##4##(1990-5#2)
the two races##2##3##(2008-10#2)
the two receptor domains##3##4##(1991-4#1)(1993-6#2)
the two receptor populations##2##4##(1990-8#2)
the two receptor subtypes##2##4##(1996-12#2)
the two receptor##9##3##(1990-8#2)(1991-12#1)(1991-4#1)(1993-6#2)(1996-12#2)(2008-11#1)
the two receptors##2##3##(1992-5#1)(1995-1#1)
the two regions are##2##4##(2006-1#1)(2008-8#1)
the two regions##7##3##(1990-10#1)(1996-8#1)(2006-1#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-8#1)
the two remaining##5##3##(1996-11#1)(2008-10#1)(2008-8#2)(2012-2#1)
the two residues##2##3##(1991-2#1)(1993-3#1)
the two resistance genes##2##4##(2008-10#2)
the two resistance##3##3##(2008-10#3)
the two responses studied##2##4##(1990-8#2)
the two responses##7##3##(1990-8#2)(1995-4#2)(1997-4#2)(2008-10#1)
the two samples##6##3##(2004-10#1)(2008-10#1)(2008-2#1)(2009-7#1)(2010-1#1)(2011-2#1)
the two scales##2##3##(2008-2#1)(2010-4#1)
the two screening methods##2##4##(1996-4#1)(2013-1#1)
the two seasonal##2##3##(2008-5#1)(2013-7#1)
the two seasons##5##3##(2008-10#3)(2008-5#2)
the two sectors##3##3##(1992-3#1)(2005-9#1)(2007-8#1)
the two senior authors##2##4##(2008-9#1)(2012-2#1)
the two sequences##2##3##(1993-3#1)(2008-4#1)
the two series of##3##4##(1995-11#1)(1995-3#1)(2008-10#1)
the two series##5##3##(1995-11#1)(1995-3#1)(1997-7#1)(2008-10#1)(2008-4#1)
the two serological##2##3##(1992-5#1)(2008-5#1)
the two sets of data##2##5##(2008-10#1)(2008-11#1)
the two sets of##8##4##(1994-9#1)(1995-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2013-1#1)
the two sexes##3##3##(1991-6#1)(2007-12#1)(2008-5#1)
the two signals (e##2##4##(1991-4#1)(2008-2#1)
the two signals##5##3##(1991-4#1)(1996-1#1)(2008-2#2)(2008-3#1)
the two single##4##3##(1995-6#2)(1996-4#1)(2008-10#1)
the two sites was##3##4##(1990-7#1)(1995-1#1)(2008-10#1)
the two sites##19##3##(1990-3#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-3#1)(1993-3#1)(1994-11#1)(1994-4#1)(1994-9#1)(1995-1#1)(1995-3#1)(1997-7#1)(2008-10#1)(2008-5#1)(2011-12#1)(2012-12#2)(2013-7#1)
the two soils##7##3##(1993-8#1)(2005-10#1)(2008-10#2)(2008-6#1)(2013-8#2)
the two solvents##2##3##(2006-10#2)
the two sources##2##3##(1990-11#1)(2008-3#1)
the two species and##2##4##(1991-6#1)(2008-10#1)
the two species are##3##4##(2008-10#2)(2011-2#1)
the two species exhibit##2##4##(2008-9#1)(2010-8#1)
the two species indicated that##2##5##(1990-11#1)(2008-9#1)
the two species of##4##4##(1991-7#1)(2008-1#1)(2008-10#1)(2008-8#1)
the two species were##4##4##(1994-11#1)(2008-10#2)(2008-6#1)
the two species##68##3##(1990-10#1)(1990-11#1)(1990-9#1)(1991-11#1)(1991-5#1)(1991-6#2)(1991-7#2)(1993-12#1)(1993-2#1)(1994-11#2)(1994-3#1)(1995-10#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-5#1)(2006-12#1)(2007-1#1)(2007-6#1)(2008-1#1)(2008-10#16)(2008-12#1)(2008-5#3)(2008-6#1)(2008-8#4)(2008-9#6)(2010-8#6)(2011-12#3)(2011-2#2)(2012-3#1)(2012-5#1)(2012-8#1)
the two specific##2##3##(2008-11#1)(2009-2#1)
the two states##3##3##(1991-4#1)(2007-11#1)(2012-3#1)
the two sterols##4##3##(1997-2#1)(2006-10#3)
the two stimuli##2##3##(1991-12#1)(1992-7#1)
the two strains in a##2##5##(1996-1#1)(2008-10#1)
the two strains in##3##4##(1991-6#1)(1996-1#1)(2008-10#1)
the two strains of mice##2##5##(1992-4#1)(2008-10#1)
the two strains##19##3##(1990-12#1)(1991-6#3)(1992-4#1)(1993-11#1)(1994-2#1)(1996-1#1)(1996-10#1)(1996-5#1)(1997-2#1)(2007-6#1)(2008-10#3)(2009-6#1)(2010-8#1)(2011-1#1)(2013-1#1)
the two strategies##4##3##(1997-4#1)(2007-8#1)(2007-9#1)(2010-7#1)
the two stressors##2##3##(2009-7#1)(2009-8#1)
the two strongest##2##3##(2008-10#1)(2010-12#1)
the two structures in##2##4##(1995-7#1)(2008-10#1)
the two structures##7##3##(1994-3#1)(1995-7#2)(1997-4#1)(2008-10#1)(2010-6#1)(2012-2#1)
the two studies##2##3##(2007-9#1)(2013-8#1)
the two study##4##3##(1991-11#1)(2007-2#1)(2010-4#1)(2013-7#1)
the two subgroups of RA##2##5##(2008-7#2)
the two subgroups of patients##2##5##(1994-3#1)(2008-7#1)
the two subgroups of##5##4##(1994-3#1)(2006-6#1)(2008-7#3)
the two subgroups##8##3##(1993-11#1)(1994-3#1)(2006-6#1)(2008-10#2)(2008-7#3)
the two substrate molecules##2##4##(1992-3#2)
the two substrate##3##3##(1992-3#2)(1994-5#1)
the two substrates##5##3##(1994-5#2)(1997-2#1)(2008-7#2)
the two subunits at##3##4##(2006-10#2)(2011-1#1)
the two subunits of the##2##5##(1992-9#1)(2006-8#1)
the two subunits of##3##4##(1992-9#1)(1993-8#1)(2006-8#1)
the two subunits##18##3##(1990-8#1)(1991-10#1)(1991-12#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(2006-10#4)(2006-8#1)(2008-4#1)(2010-5#3)(2011-1#1)
the two surfaces was##2##4##(2010-10#2)
the two surfaces##3##3##(2008-12#1)(2010-10#2)
the two surveys##3##3##(1993-8#1)(2012-3#1)(2013-7#1)
the two systems##10##3##(2006-6#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2011-2#1)
the two tasks##4##3##(1991-2#1)(1994-8#1)(2008-11#1)(2008-9#1)
the two taxa are##2##4##(2008-10#1)(2008-7#1)
the two taxa##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
the two techniques are##2##4##(1996-5#1)(1997-6#1)
the two techniques in##2##4##(1997-8#1)(2008-8#1)
the two techniques##16##3##(1995-5#1)(1995-9#1)(1996-5#1)(1997-6#1)(1997-8#1)(2006-3#1)(2006-8#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#1)(2010-5#1)(2010-9#1)(2011-2#1)
the two technologies##2##3##(2008-9#1)(2011-2#1)
the two terminal##5##3##(1990-7#1)(1993-11#1)(1997-3#1)(2008-10#2)
the two ternary complexes##2##4##(1992-9#2)
the two terrestrial##2##3##(2008-7#2)
the two tests were##2##4##(1990-11#1)(2012-12#1)
the two tests##9##3##(1990-11#1)(1991-6#1)(1993-6#1)(1994-8#1)(1996-2#1)(2006-10#3)(2012-12#1)
the two time periods##4##4##(1996-11#1)(2013-1#3)
the two time##5##3##(1996-11#1)(2008-3#1)(2013-1#3)
the two toxins##2##3##(1993-12#1)(2011-1#1)
the two training approaches##2##4##(2013-8#2)
the two treatment##10##3##(1992-6#1)(1992-9#1)(1995-4#1)(1995-9#1)(1997-7#1)(2004-12#1)(2006-11#1)(2008-3#1)(2008-5#1)(2008-6#1)
the two treatments##5##3##(2007-2#1)(2008-10#1)(2009-6#1)(2009-8#1)(2011-12#1)
the two trials##4##3##(1993-12#1)(2005-7#1)(2008-10#2)
the two tryptophan residues in##2##5##(1991-5#1)(1992-6#1)
the two tryptophan residues##3##4##(1991-5#1)(1992-6#1)(1993-11#1)
the two two-chain forms##2##4##(1991-8#2)
the two types of##40##4##(1990-2#1)(1990-7#1)(1991-12#1)(1991-3#2)(1991-4#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-4#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#2)(2007-11#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#4)(2008-7#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-7#1)(2013-8#1)
the two types were##2##4##(1990-6#1)(2008-3#1)
the two types##45##3##(1990-2#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-3#2)(1991-4#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-4#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-11#1)(2006-12#2)(2007-11#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#4)(2008-7#2)(2011-2#1)(2012-11#1)(2013-1#1)(2013-7#1)(2013-8#1)
the two variables##3##3##(1993-11#1)(2008-7#1)(2013-7#1)
the two variants##3##3##(1990-6#3)
the two varieties of##3##4##(2007-7#1)(2008-10#1)(2008-5#1)
the two versions##2##3##(2010-12#1)(2012-12#1)
the two viruses##9##3##(2007-6#1)(2008-10#6)(2008-9#1)(2013-8#1)
the two waveguides##3##3##(2007-11#1)(2008-3#2)
the two wavelengths is##3##4##(2007-12#1)(2008-3#1)(2011-1#1)
the two wavelengths##9##3##(2007-12#1)(2008-1#1)(2008-2#3)(2008-3#3)(2011-1#1)
the two weeks preceding##2##4##(1992-5#1)(2006-12#1)
the two weeks##3##3##(1992-5#1)(1993-3#1)(2006-12#1)
the two were##2##3##(1996-5#1)(2012-2#1)
the two world##2##3##(2007-7#1)(2012-2#1)
the two writing beams##2##4##(2007-11#1)(2008-2#1)
the two years##6##3##(2004-9#1)(2008-10#2)(2008-5#1)(2009-2#1)(2013-1#1)
the two zinc##2##3##(1991-6#1)(2010-5#1)
the two##2898##2##(1990-1#2)(1990-10#10)(1990-11#18)(1990-12#19)(1990-2#16)(1990-3#6)(1990-4#10)(1990-5#13)(1990-6#7)(1990-7#15)(1990-8#14)(1990-9#5)(1991-1#3)(1991-10#8)(1991-11#10)(1991-12#19)(1991-2#15)(1991-3#14)(1991-4#13)(1991-5#9)(1991-6#22)(1991-7#9)(1991-8#12)(1991-9#11)(1992-1#7)(1992-10#5)(1992-11#16)(1992-12#13)(1992-2#13)(1992-3#20)(1992-4#9)(1992-5#7)(1992-6#15)(1992-7#5)(1992-8#8)(1992-9#15)(1993-1#9)(1993-10#1)(1993-11#19)(1993-12#14)(1993-2#8)(1993-3#17)(1993-4#2)(1993-5#1)(1993-6#19)(1993-7#2)(1993-8#11)(1993-9#1)(1994-1#2)(1994-10#2)(1994-11#19)(1994-12#17)(1994-2#16)(1994-3#17)(1994-4#2)(1994-5#19)(1994-6#9)(1994-7#1)(1994-8#18)(1994-9#16)(1995-1#14)(1995-10#10)(1995-11#14)(1995-12#11)(1995-2#15)(1995-3#18)(1995-4#4)(1995-5#12)(1995-6#16)(1995-7#6)(1995-8#20)(1995-9#7)(1996-1#10)(1996-10#9)(1996-11#17)(1996-12#13)(1996-2#22)(1996-3#8)(1996-4#13)(1996-5#20)(1996-6#6)(1996-7#11)(1996-8#7)(1996-9#20)(1997-1#9)(1997-2#21)(1997-3#6)(1997-4#17)(1997-5#4)(1997-6#13)(1997-7#16)(1997-8#15)(2004-10#4)(2004-11#6)(2004-12#6)(2004-2#3)(2004-4#4)(2004-9#6)(2005-1#1)(2005-10#3)(2005-11#25)(2005-12#3)(2005-4#10)(2005-5#3)(2005-7#7)(2005-8#4)(2005-9#3)(2006-1#4)(2006-10#28)(2006-11#5)(2006-12#25)(2006-2#3)(2006-3#7)(2006-4#7)(2006-5#4)(2006-6#10)(2006-7#7)(2006-8#11)(2006-9#3)(2007-1#12)(2007-10#6)(2007-11#30)(2007-12#69)(2007-2#10)(2007-4#5)(2007-5#4)(2007-6#9)(2007-7#19)(2007-8#36)(2007-9#22)(2008-1#27)(2008-10#343)(2008-11#43)(2008-12#18)(2008-2#105)(2008-3#132)(2008-4#49)(2008-5#68)(2008-6#22)(2008-7#47)(2008-8#60)(2008-9#44)(2009-10#6)(2009-11#3)(2009-12#7)(2009-2#2)(2009-3#7)(2009-4#5)(2009-5#2)(2009-6#9)(2009-7#6)(2009-8#16)(2009-9#3)(2010-1#1)(2010-10#6)(2010-11#3)(2010-12#11)(2010-2#7)(2010-3#9)(2010-4#8)(2010-5#15)(2010-6#2)(2010-7#3)(2010-8#19)(2010-9#1)(2011-1#40)(2011-12#10)(2011-2#52)(2011-3#1)(2012-1#14)(2012-11#8)(2012-12#23)(2012-2#39)(2012-3#18)(2012-5#5)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#57)(2013-7#12)(2013-8#24)
the two-beam##3##2##(2007-12#2)(2008-3#1)
the two-chain##2##2##(1994-11#1)(2012-3#1)
the two-class case##2##3##(2008-6#2)
the two-color##4##2##(2008-2#1)(2008-3#2)(2008-9#1)
the two-component##4##2##(1995-5#1)(1996-12#2)(1997-4#1)
the two-dimensional Fourier transformation of##2##5##(2008-2#1)(2008-3#1)
the two-dimensional MTF##4##3##(2010-12#4)
the two-dimensional case##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
the two-dimensional imaging##2##3##(2008-2#1)(2008-7#1)
the two-dimensional measurement principle##2##4##(2008-3#2)
the two-dimensional measurement##3##3##(2008-3#3)
the two-dimensional shadowing function##2##4##(2008-3#2)
the two-dimensional system##2##3##(2008-3#2)
the two-dimensional##67##2##(1990-4#1)(1990-9#1)(1995-2#1)(1995-5#2)(2007-11#5)(2007-12#11)(2007-8#1)(2008-10#2)(2008-2#12)(2008-3#18)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-12#4)(2010-5#1)(2011-1#2)(2012-2#1)(2013-8#1)
the two-drug##2##2##(1995-3#1)(2006-2#1)
the two-electron##3##2##(1990-2#1)(1995-1#1)(2008-10#1)
the two-electron-reduced state##2##3##(1990-12#2)
the two-electron-reduced##3##2##(1990-12#2)(1995-10#1)
the two-hybrid system##5##3##(1992-7#3)(1995-3#1)(2008-8#1)
the two-hybrid##8##2##(1992-7#3)(1995-3#1)(2008-4#3)(2008-8#1)
the two-kernel approach##2##3##(2008-3#2)
the two-layer##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
the two-lens##2##2##(2008-2#2)
the two-mirror##3##2##(2007-12#1)(2008-1#1)(2008-2#1)
the two-month##3##2##(1994-3#1)(2006-10#1)(2013-1#1)
the two-peptide lantibiotic lacticin 3147##2##5##(2011-1#2)
the two-phase solvent system##2##4##(2011-1#1)(2013-7#1)
the two-phase##11##2##(1990-2#1)(2007-12#2)(2008-10#6)(2011-1#1)(2013-7#1)
the two-photon absorption##3##3##(2007-11#1)(2008-2#1)(2009-11#1)
the two-photon fluorescence##3##3##(2008-3#3)
the two-photon interaction##2##3##(2008-3#2)
the two-photon process##2##3##(2007-12#1)(2008-3#1)
the two-photon transition##2##3##(2007-12#1)(2008-3#1)
the two-photon##24##2##(2007-11#4)(2007-12#4)(2008-1#1)(2008-2#5)(2008-3#9)(2009-11#1)
the two-point equal-time##2##3##(2007-12#2)
the two-point##5##2##(2007-11#2)(2007-12#2)(2008-3#1)
the two-sample##2##2##(1997-4#1)(2010-7#1)
the two-site##2##2##(2013-8#2)
the two-sphere##2##2##(1995-5#2)
the two-stage##6##2##(2008-10#1)(2008-11#1)(2008-3#1)(2009-5#1)(2012-2#2)
the two-state model##7##3##(1990-7#1)(1990-8#3)(1992-9#1)(1997-2#2)
the two-state unfolding model##2##4##(1990-5#1)(1993-11#1)
the two-state##14##2##(1990-5#1)(1990-7#1)(1990-8#4)(1991-4#2)(1991-5#1)(1992-9#1)(1993-11#1)(1995-4#1)(1997-2#2)
the two-step##12##2##(1991-8#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2012-12#1)(2013-8#1)
the two-wave mixing##2##3##(2008-3#2)
the two-wave##4##2##(2008-3#3)(2009-7#1)
the two-wavelength##3##2##(2008-2#1)(2008-3#2)
the two-way text##2##3##(2010-8#2)
the two-way##5##2##(2008-10#1)(2010-10#1)(2010-8#2)(2011-1#1)
the two-year##5##2##(1995-2#1)(1995-5#1)(1996-3#1)(2007-3#1)(2008-5#1)
the twofold##4##2##(1990-12#1)(1996-2#1)(2008-3#1)(2008-7#1)
the tympanic membrane##5##3##(1991-3#2)(1995-4#1)(2007-10#1)(2012-12#1)
the tympanic##10##2##(1991-3#2)(1991-8#1)(1995-4#2)(2006-12#1)(2007-10#1)(2008-2#1)(2008-4#1)(2012-12#1)
the tympanum##2##2##(2006-12#1)(2008-2#1)
the type 1 human immunodeficiency virus##3##6##(1994-12#1)(1996-4#1)(2007-11#1)
the type 1 receptor##2##4##(1992-3#1)(2013-1#1)
the type 1 repeats of##3##5##(1995-3#3)
the type 1##15##3##(1992-2#1)(1992-3#1)(1992-7#1)(1994-12#2)(1994-2#1)(1995-3#3)(1996-4#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-3#1)(2013-1#1)
the type 1A##2##3##(1995-10#1)(1996-5#1)
the type 2##8##3##(1990-8#1)(1992-9#1)(2005-10#1)(2007-12#1)(2008-1#1)(2012-12#2)(2013-1#1)
the type A##5##3##(1994-3#2)(1997-6#1)(2008-2#1)(2009-9#1)
the type I (III) beta-turn##2##5##(1992-5#2)
the type I IGF receptor##2##5##(2008-11#1)(2008-6#1)
the type I IGF receptors##2##5##(2008-6#2)
the type I IGF##4##4##(2008-11#1)(2008-6#3)
the type I and II##2##5##(1990-6#1)(1996-5#1)
the type I and type II##2##6##(1996-5#2)
the type I and##5##4##(1990-6#1)(1994-10#1)(1996-5#3)
the type I enzyme##2##4##(1995-3#2)
the type I error rate##2##5##(1993-5#1)(2012-3#1)
the type I error rates##2##5##(2013-1#2)
the type I error##6##4##(1992-2#1)(1993-5#1)(2012-3#2)(2013-1#2)
the type I receptor##2##4##(1990-9#1)(1996-5#1)
the type I##35##3##(1990-2#2)(1990-6#1)(1990-9#1)(1992-2#1)(1992-3#1)(1992-5#2)(1993-5#1)(1994-10#1)(1995-12#1)(1995-2#1)(1995-3#3)(1996-10#1)(1996-11#1)(1996-5#5)(2006-10#1)(2008-11#1)(2008-3#1)(2008-6#3)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#3)
the type II enzyme##6##4##(1995-3#2)(1997-2#4)
the type II receptor##3##4##(1996-5#1)(1997-2#1)(2008-9#1)
the type II##29##3##(1991-10#1)(1992-5#1)(1993-9#1)(1994-10#2)(1994-12#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#3)(1995-3#2)(1996-4#1)(1996-5#2)(1997-2#5)(1997-4#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-9#1)
the type III secretion system##4##5##(1996-8#1)(2007-12#1)(2009-8#1)(2013-1#1)
the type III##8##3##(1990-6#2)(1992-9#1)(1996-8#1)(2007-12#2)(2009-8#1)(2013-1#1)
the type X##2##3##(1992-8#1)(1995-1#1)
the type and concentration of##4##5##(1992-8#1)(2006-5#1)(2008-10#2)
the type and duration of##2##5##(2006-10#1)(2008-7#1)
the type and extent of##3##5##(1995-12#1)(2007-11#1)(2010-2#1)
the type and frequency of##4##5##(1993-5#1)(2007-10#1)(2009-6#1)(2012-2#1)
the type and only species##2##5##(2011-2#1)(2013-7#1)
the type and severity of##3##5##(2007-11#1)(2008-2#1)(2013-1#1)
the type and the concentration of##2##6##(1992-7#1)(2008-5#1)
the type and the##3##4##(1992-4#1)(1992-7#1)(2008-5#1)
the type and##47##3##(1990-4#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-5#1)(1995-12#1)(1997-3#2)(1997-7#1)(2006-1#1)(2006-10#1)(2006-5#2)(2006-6#1)(2007-10#1)(2007-11#3)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
the type genus of the family##3##6##(2011-2#3)
the type locality of E##2##5##(2008-4#2)
the type of TH cell##2##5##(1995-5#2)
the type of anesthesia##2##4##(1993-4#1)(2007-12#1)
the type of bone##2##4##(2007-12#1)(2008-4#1)
the type of column and##2##5##(1990-6#2)
the type of diabetes##2##4##(1993-2#2)
the type of equipment##3##4##(2008-10#1)(2008-2#1)(2008-4#1)
the type of error##2##4##(2008-2#1)(2008-6#1)
the type of event##2##4##(2007-11#1)(2008-9#1)
the type of fracture##4##4##(2007-8#2)(2011-2#2)
the type of gel##2##4##(2008-11#2)
the type of graft##2##4##(2009-9#2)
the type of health##2##4##(2005-12#1)(2008-7#1)
the type of information##5##4##(1990-12#1)(2006-7#1)(2008-11#1)(2008-4#1)(2012-12#1)
the type of interaction##4##4##(1995-11#1)(1997-2#1)(2008-10#1)(2008-7#1)
the type of malignancy##3##4##(2005-12#1)(2008-10#1)(2008-7#1)
the type of metal##2##4##(2008-5#1)(2008-7#1)
the type of nanomaterial used##2##5##(2008-10#2)
the type of neuron##2##4##(1994-10#1)(2008-10#1)
the type of oligosaccharide##3##4##(1990-7#1)(1997-4#2)
the type of operation performed and##2##6##(1990-3#1)(1992-10#1)
the type of operation##4##4##(1990-3#2)(1992-10#1)(2007-7#1)
the type of organic modifier##2##5##(1990-6#2)
the type of patient##2##4##(2007-9#1)(2011-12#1)
the type of program##2##4##(1993-12#1)(1997-1#1)
the type of response##3##4##(2006-10#1)(2008-10#1)(2012-3#1)
the type of sport##2##4##(2009-9#2)
the type of stunning##2##4##(2010-4#2)
the type of surgery##2##4##(2006-10#1)(2009-5#1)
the type of surgical##4##4##(1990-12#1)(1997-2#1)(2007-7#1)(2013-1#1)
the type of symptom##2##4##(2008-10#1)(2009-9#1)
the type of the lesion##2##5##(1995-11#1)(2007-12#1)
the type of the##20##4##(1992-3#1)(1992-9#1)(1993-12#1)(1995-11#1)(1996-3#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
the type of treatment used##2##5##(2007-3#1)(2007-7#1)
the type of treatment##5##4##(1993-11#1)(1993-6#1)(2007-3#1)(2007-7#1)(2011-2#1)
the type of vaccine##2##4##(2007-2#1)(2007-7#1)
the type of work##3##4##(2008-4#1)(2009-9#1)(2011-1#1)
the type of##335##3##(1990-10#1)(1990-11#2)(1990-12#4)(1990-3#2)(1990-5#1)(1990-6#4)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#4)(1991-5#1)(1992-10#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-1#1)(1993-10#2)(1993-11#4)(1993-12#5)(1993-2#3)(1993-4#2)(1993-6#1)(1993-9#3)(1994-10#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#1)(1994-7#1)(1995-11#5)(1995-5#2)(1995-7#2)(1995-8#1)(1996-1#2)(1996-12#1)(1996-3#2)(1996-4#3)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#4)(1997-2#6)(1997-3#1)(1997-4#4)(1997-6#3)(2004-9#1)(2005-10#1)(2005-11#3)(2005-12#2)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-3#1)(2006-5#1)(2006-7#2)(2006-8#2)(2006-9#2)(2007-1#2)(2007-11#10)(2007-12#6)(2007-2#4)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#3)(2007-7#10)(2007-8#5)(2007-9#3)(2008-1#4)(2008-10#25)(2008-11#11)(2008-12#4)(2008-2#5)(2008-3#7)(2008-4#7)(2008-5#7)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#3)(2009-4#2)(2009-5#2)(2009-7#3)(2009-9#7)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#12)(2012-1#3)(2012-11#3)(2012-12#6)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#3)(2013-8#2)
the type or##4##3##(1996-6#1)(2008-10#1)(2009-7#1)(2010-7#1)
the type species of the genus##27##6##(1997-2#1)(2007-2#1)(2008-10#1)(2011-2#24)
the type species of the##30##5##(1997-2#1)(2007-2#1)(2008-10#2)(2011-2#26)
the type species##36##3##(1997-2#1)(2007-2#1)(2008-10#3)(2008-9#1)(2011-2#28)(2013-7#2)
the type strain of a##2##5##(2006-8#1)(2011-2#1)
the type strain of##7##4##(1997-3#1)(2006-8#1)(2008-10#1)(2011-2#4)
the type strain was##2##4##(2006-8#1)(2012-2#1)
the type strain##12##3##(1997-3#1)(2006-8#2)(2008-10#2)(2011-2#4)(2012-2#2)(2012-3#1)
the type##591##2##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#7)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#5)(1991-5#1)(1991-8#1)(1992-10#2)(1992-12#1)(1992-2#4)(1992-3#4)(1992-4#1)(1992-5#4)(1992-6#2)(1992-7#3)(1992-8#2)(1992-9#4)(1993-1#1)(1993-10#2)(1993-11#5)(1993-12#5)(1993-2#4)(1993-4#2)(1993-5#2)(1993-6#1)(1993-9#4)(1994-10#5)(1994-11#1)(1994-12#6)(1994-2#2)(1994-3#4)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#6)(1995-12#2)(1995-2#4)(1995-3#8)(1995-5#2)(1995-7#2)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-4#6)(1996-5#11)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#12)(1997-3#4)(1997-4#5)(1997-6#4)(1997-7#2)(2004-9#1)(2005-10#3)(2005-11#4)(2005-12#2)(2006-1#2)(2006-10#8)(2006-11#1)(2006-12#2)(2006-3#1)(2006-5#3)(2006-6#1)(2006-7#2)(2006-8#4)(2006-9#3)(2007-1#2)(2007-10#1)(2007-11#16)(2007-12#10)(2007-2#5)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#3)(2007-7#11)(2007-8#5)(2007-9#3)(2008-1#6)(2008-10#43)(2008-11#16)(2008-12#4)(2008-2#9)(2008-3#13)(2008-4#12)(2008-5#14)(2008-6#7)(2008-7#8)(2008-8#5)(2008-9#5)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#5)(2009-8#1)(2009-9#9)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#51)(2012-1#4)(2012-11#3)(2012-12#9)(2012-2#9)(2012-3#4)(2013-1#13)(2013-7#7)(2013-8#2)
the type(s) of##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
the type-1##2##2##(1992-5#1)(2008-5#1)
the type-2 copper##4##3##(1992-12#4)
the type-I##5##2##(1993-5#2)(2007-2#1)(2008-5#1)(2012-2#1)
the types and amounts of##2##5##(1992-3#1)(2008-5#1)
the types and frequency of##2##5##(2007-11#1)(2007-7#1)
the types and##11##3##(1992-3#1)(2007-11#1)(2007-7#1)(2008-2#1)(2008-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-3#1)(2013-1#1)
the types of commands##2##4##(2011-2#2)
the types of errors##3##4##(2011-2#1)(2013-1#2)
the types of injuries##2##4##(1997-2#1)(2007-12#1)
the types of medical##2##4##(1993-1#1)(2007-4#1)
the types of surgical##2##4##(1991-3#1)(2011-1#1)
the types of the##4##4##(1991-4#1)(2004-9#1)(2005-4#1)(2007-7#1)
the types of##102##3##(1990-6#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-1#1)(1992-12#3)(1993-1#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-11#1)(1996-4#1)(1997-2#2)(1997-3#1)(1997-5#1)(2004-9#1)(2005-11#1)(2005-4#1)(2005-6#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-5#2)(2006-9#1)(2007-10#1)(2007-12#3)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#6)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-3#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
the types##119##2##(1990-6#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-1#1)(1992-12#3)(1992-3#1)(1993-1#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-11#1)(1996-4#1)(1997-2#2)(1997-3#1)(1997-5#1)(2004-9#1)(2005-11#1)(2005-4#1)(2005-6#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-5#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-4#1)(2007-7#4)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#6)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-3#2)(2009-7#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#1)
the typical TATA box##2##4##(1994-12#1)(1997-6#1)
the typical and beneficial ratings##2##5##(2011-1#2)
the typical and##4##3##(2007-8#1)(2009-9#1)(2011-1#2)
the typical appearance of##3##4##(2007-3#1)(2007-4#1)(2012-2#1)
the typical case##2##3##(2010-9#1)(2012-3#1)
the typical clinical and##2##4##(2008-7#2)
the typical clinical signs of##2##5##(2008-5#2)
the typical clinical##8##3##(1993-3#1)(1995-2#1)(2007-7#1)(2008-10#1)(2008-5#2)(2008-7#2)
the typical features of##3##4##(1991-5#1)(1993-7#1)(2007-12#1)
the typical form of##2##4##(2008-4#1)(2008-7#1)
the typical imaging##2##3##(2006-5#1)(2010-2#1)
the typical medical practice##2##4##(1996-2#1)(1996-3#1)
the typical pattern of##5##4##(1995-8#1)(2007-3#1)(2007-9#1)(2008-10#1)(2010-10#1)
the typical sequence of##2##4##(2010-9#1)(2012-12#1)
the typical symptoms##2##3##(1995-2#1)(2012-12#1)
the typical##144##2##(1991-5#1)(1991-7#1)(1992-11#1)(1992-2#3)(1992-6#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-7#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-2#3)(1995-6#2)(1995-8#1)(1996-2#1)(1996-3#2)(1996-4#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-8#3)(2004-9#1)(2005-10#1)(2005-12#1)(2005-3#1)(2005-5#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-2#1)(2007-3#3)(2007-4#3)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#15)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#4)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#4)(2009-1#1)(2009-11#1)(2009-6#1)(2009-9#2)(2010-10#1)(2010-2#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#1)
the typically##4##2##(1991-4#1)(2008-10#1)(2009-4#1)(2011-1#1)
the typing of##3##3##(2007-12#1)(2008-10#1)(2010-4#1)
the typology##4##2##(1991-6#1)(1994-2#1)(2010-10#1)(2010-5#1)
the tyrosinase##9##2##(1994-12#2)(1994-3#1)(1996-2#1)(1997-4#2)(2007-8#1)(2008-10#1)(2008-5#1)
the tyrosinase-related##2##2##(1992-4#1)(1995-2#1)
the tyrosine and##2##3##(1990-10#1)(1991-2#1)
the tyrosine hydroxylase (TH) gene##2##5##(1997-2#1)(1997-5#1)
the tyrosine hydroxylase (TH)##5##4##(1991-12#1)(1994-12#1)(1997-2#1)(1997-5#1)(2008-7#1)
the tyrosine hydroxylase##10##3##(1991-12#1)(1991-7#1)(1994-12#1)(1995-9#1)(1996-10#1)(1997-2#2)(1997-5#2)(2008-7#1)
the tyrosine kinase activity of the##2##6##(1992-8#1)(1996-5#1)
the tyrosine kinase activity of##6##5##(1990-9#1)(1992-8#1)(1995-2#1)(1996-5#1)(2009-7#1)(2011-2#1)
the tyrosine kinase domain of the##2##6##(1996-11#1)(2010-12#1)
the tyrosine kinase domain of##3##5##(1996-11#1)(1996-5#1)(2010-12#1)
the tyrosine kinase domain##8##4##(1995-2#1)(1996-11#1)(1996-5#1)(1997-6#1)(2008-5#2)(2010-12#1)(2010-4#1)
the tyrosine kinase inhibitor##10##4##(1991-8#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-6#2)(1994-8#1)(1995-5#1)(1996-12#1)(2008-6#1)
the tyrosine kinase inhibitors##4##4##(1994-9#1)(2009-11#1)(2012-12#1)(2013-8#1)
the tyrosine kinase##38##3##(1990-9#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-8#1)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-2#2)(1995-5#1)(1996-11#1)(1996-12#2)(1996-5#2)(1997-6#1)(2007-12#1)(2008-5#2)(2008-6#2)(2009-11#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
the tyrosine kinases##2##3##(2006-10#1)(2008-5#1)
the tyrosine phosphatase##3##3##(1995-5#1)(1996-5#1)(2007-8#1)
the tyrosine phosphorylation and activation of##3##6##(1992-8#1)(1995-3#1)(1996-2#1)
the tyrosine phosphorylation and##4##4##(1992-8#1)(1995-3#1)(1995-6#1)(1996-2#1)
the tyrosine phosphorylation induced by##2##5##(1990-9#1)(1996-5#1)
the tyrosine phosphorylation of a##2##5##(1992-3#1)(1997-7#1)
the tyrosine phosphorylation of the##2##5##(1995-3#1)(1997-6#1)
the tyrosine phosphorylation of##17##4##(1992-3#1)(1992-6#2)(1992-8#1)(1994-6#1)(1994-9#1)(1995-3#4)(1996-5#2)(1997-6#1)(1997-7#3)(2012-12#1)
the tyrosine phosphorylation##24##3##(1990-9#1)(1992-3#1)(1992-6#2)(1992-8#2)(1994-6#1)(1994-9#1)(1995-3#5)(1995-5#1)(1995-6#1)(1996-2#1)(1996-5#3)(1997-6#1)(1997-7#3)(2012-12#1)
the tyrosine protein kinase activity##2##5##(1991-11#1)(1992-3#1)
the tyrosine protein##3##3##(1990-12#1)(1991-11#1)(1992-3#1)
the tyrosine residues##3##3##(1994-2#1)(2006-6#1)(2008-8#1)
the tyrosine##100##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-3#3)(1992-4#1)(1992-6#2)(1992-8#3)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-2#2)(1995-3#5)(1995-5#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-5#8)(1996-9#1)(1997-2#2)(1997-5#3)(1997-6#3)(1997-7#3)(2006-10#1)(2006-6#1)(2007-12#1)(2007-8#2)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
the tyrosine-phosphorylated##3##2##(1995-2#1)(1995-6#1)(2007-8#1)
the tyrosines##2##2##(1992-9#1)(2006-10#1)
the tyrosyl radical is##2##4##(1993-11#1)(1997-7#1)
the tyrosyl radical##8##3##(1991-7#1)(1993-11#2)(1995-10#2)(1997-7#3)
the tyrosyl radical-dinuclear iron cluster cofactor##2##6##(1991-7#2)
the tyrosyl##15##2##(1990-2#1)(1991-12#1)(1991-7#4)(1992-12#1)(1993-11#2)(1995-10#2)(1997-3#1)(1997-7#3)
the u##2##2##(2007-8#1)(2008-10#1)
the u-PA##3##2##(1991-10#1)(1993-12#1)(1994-3#1)
the ubiquinone of the##2##4##(1992-3#2)
the ubiquinone to##2##3##(1990-7#1)(1995-6#1)
the ubiquinone##9##2##(1990-7#2)(1990-8#1)(1992-11#1)(1992-3#2)(1995-3#1)(1995-6#1)(1997-3#1)
the ubiquitin ligase##2##3##(2011-3#1)(2012-12#1)
the ubiquitin pathway##2##3##(1995-12#1)(2009-8#1)
the ubiquitin##11##2##(1995-12#1)(1996-10#1)(2008-1#3)(2008-9#2)(2009-8#1)(2011-3#1)(2012-12#1)(2012-3#1)
the ubiquitin-activating enzyme##2##3##(1992-4#2)
the ubiquitin-binding##2##2##(1997-7#2)
the ubiquitin-dependent protease##2##3##(1991-7#2)
the ubiquitin-dependent##7##2##(1991-7#2)(1992-11#1)(1994-9#1)(1995-6#1)(2009-7#2)
the ubiquitin-extension protein##2##3##(1997-2#2)
the ubiquitin-proteasome system and##2##4##(2010-4#1)(2012-2#1)
the ubiquitin-proteasome system##4##3##(2007-12#1)(2010-4#1)(2011-2#1)(2012-2#1)
the ubiquitous transcription factor##2##4##(1991-12#1)(1992-11#1)
the ubiquitous##20##2##(1991-10#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-6#1)(1996-2#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-2#1)(2011-2#1)
the ubiquitously expressed##2##3##(1995-1#1)(2009-10#1)
the ubiquitously##3##2##(1995-1#1)(2006-6#1)(2009-10#1)
the ubiquity of##2##3##(1993-3#1)(2011-12#1)
the ugly##6##2##(2006-12#1)(2007-8#1)(2008-7#3)(2011-2#1)
the uidA##2##2##(1994-3#1)(2008-10#1)
the ulcer bed##2##3##(2006-9#1)(2008-12#1)
the ulcer edge##2##3##(1990-12#1)(2006-9#1)
the ulcer##20##2##(1990-12#2)(1991-2#1)(1996-11#1)(2005-11#2)(2006-9#4)(2007-11#2)(2007-7#1)(2008-12#1)(2008-5#1)(2013-1#2)(2013-8#3)
the ulceration##3##2##(2007-10#1)(2010-12#1)(2012-12#1)
the ulcerative colitis##2##3##(1994-2#1)(2006-10#1)
the ulcerative##3##2##(1994-2#1)(2006-10#1)(2012-11#1)
the ulna and##2##3##(2006-11#1)(2009-3#1)
the ulna##9##2##(1995-6#1)(2006-11#1)(2006-3#2)(2007-11#1)(2009-3#1)(2011-2#2)(2013-1#1)
the ulnar border##2##3##(1997-3#1)(2006-3#1)
the ulnar nerve and##3##4##(1992-6#1)(2007-11#1)(2008-9#1)
the ulnar nerve##19##3##(1992-6#2)(1993-11#1)(1996-9#1)(2007-10#1)(2007-11#3)(2007-6#1)(2008-12#1)(2008-4#1)(2008-9#8)
the ulnar side of the thumb MP joint##2##8##(2006-3#2)
the ulnar##37##2##(1992-6#2)(1993-11#1)(1996-9#1)(1997-3#1)(2006-3#8)(2007-10#1)(2007-11#6)(2007-6#2)(2008-12#1)(2008-4#1)(2008-9#12)(2009-2#1)
the ultimate coverage##2##3##(2005-11#2)
the ultimate goal is##2##4##(1992-1#1)(2005-7#1)
the ultimate goal of the##2##5##(2004-4#1)(2008-7#1)
the ultimate goal of##10##4##(1994-3#1)(2004-4#1)(2006-1#1)(2006-2#1)(2006-4#1)(2008-7#1)(2010-9#1)(2011-12#1)(2012-1#1)(2012-2#1)
the ultimate goal##17##3##(1992-1#1)(1994-3#1)(1996-12#1)(2004-4#1)(2005-7#1)(2006-1#1)(2006-2#1)(2006-4#1)(2008-7#3)(2009-6#1)(2009-9#1)(2010-9#1)(2011-12#1)(2012-1#1)(2012-2#1)
the ultimate goals of##2##4##(2007-4#1)(2010-2#1)
the ultimate goals##3##3##(2007-4#1)(2008-7#1)(2010-2#1)
the ultimate outcome of##2##4##(1994-6#1)(1997-3#1)
the ultimate outcome##5##3##(1994-6#1)(1997-3#2)(2007-7#1)(2008-11#1)
the ultimate primary reason for admission to##2##7##(2007-12#2)
the ultimate role of##2##4##(1991-9#1)(2010-3#1)
the ultimate##79##2##(1990-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-6#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-5#2)(1996-1#1)(1996-12#1)(1997-1#3)(1997-3#2)(2004-4#1)(2005-11#2)(2005-7#1)(2005-9#1)(2006-1#2)(2006-10#1)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-4#4)(2007-7#1)(2007-9#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)
the ultimately##2##2##(2008-7#1)(2009-6#1)
the ultimobranchial gland was##2##4##(2008-5#2)
the ultimobranchial gland##3##3##(2008-5#3)
the ultra##3##2##(2008-10#2)(2008-11#1)
the ultra-high##2##2##(1994-3#1)(2009-3#1)
the ultra-sensitive##2##2##(1997-5#1)(2007-8#1)
the ultrabroadband##2##2##(2007-11#1)(2008-2#1)
the ultradian##5##2##(1993-12#1)(1996-3#2)(2005-8#2)
the ultrafast nonlinear interferometer##3##4##(2007-12#1)(2008-2#2)
the ultrafast nonlinear##4##3##(2007-12#1)(2008-1#1)(2008-2#2)
the ultrafast##8##2##(2007-12#3)(2008-1#1)(2008-2#2)(2008-3#1)(2012-8#1)
the ultrafiltration##5##2##(1996-12#1)(2008-1#1)(2008-5#1)(2011-2#2)
the ultrahigh##3##2##(1995-2#1)(2007-12#2)
the ultramarathon##3##2##(2013-8#3)
the ultrashort##3##2##(2007-11#1)(2008-3#2)
the ultrasmall##2##2##(2007-11#1)(2007-12#1)
the ultrasonic axis##3##3##(2007-12#3)
the ultrasonic beam##4##3##(2007-12#2)(2008-3#2)
the ultrasonic field##2##3##(2008-2#2)
the ultrasonic inhaler##2##3##(1993-2#2)
the ultrasonic method##2##3##(1997-6#2)
the ultrasonic modulation of the##2##5##(2007-12#2)
the ultrasonic modulation of##3##4##(2007-12#3)
the ultrasonic power##3##3##(2008-10#1)(2013-8#2)
the ultrasonic treatments##2##3##(2007-2#2)
the ultrasonic##39##2##(1991-1#3)(1993-2#2)(1993-5#1)(1997-6#2)(2006-5#1)(2007-11#1)(2007-12#10)(2007-2#2)(2008-10#5)(2008-11#3)(2008-2#3)(2008-3#2)(2010-8#1)(2013-8#3)
the ultrasonographic test##2##3##(2006-5#2)
the ultrasonographic##4##2##(1990-9#1)(1993-12#1)(2006-5#2)
the ultrasound examination##3##3##(1993-5#1)(2007-11#2)
the ultrasound semiotics of##2##4##(2008-7#1)(2013-7#1)
the ultrasound technique##2##3##(2007-8#2)
the ultrasound##22##2##(1993-5#1)(1996-11#1)(2006-12#1)(2006-6#3)(2007-11#2)(2007-12#2)(2007-8#2)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
the ultrasound-assisted##2##2##(2008-10#2)
the ultrastructural changes##3##3##(1995-11#1)(1995-6#1)(2007-9#1)
the ultrastructural characteristics##2##3##(2008-5#2)
the ultrastructural level##8##3##(1991-9#1)(1995-6#1)(1996-1#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)
the ultrastructural##25##2##(1990-4#1)(1991-9#1)(1992-3#1)(1992-6#1)(1995-11#2)(1995-6#2)(1996-1#1)(1997-5#1)(2007-9#2)(2008-1#2)(2008-10#1)(2008-5#3)(2008-7#3)(2009-11#1)(2011-2#3)
the ultrastructure and##4##3##(1995-6#1)(2008-10#1)(2008-5#1)(2012-2#1)
the ultrastructure of the##10##4##(2007-12#6)(2007-9#1)(2008-5#2)(2012-2#1)
the ultrastructure of##25##3##(1995-7#1)(1996-6#2)(2007-12#6)(2007-3#2)(2007-5#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-3#1)(2012-1#1)(2012-2#1)
the ultrastructure##34##2##(1995-6#1)(1995-7#1)(1996-6#2)(2007-12#6)(2007-3#3)(2007-5#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-3#1)(2012-1#1)(2012-2#3)(2013-7#2)
the ultrathin##2##2##(2007-9#1)(2008-10#1)
the ultratrace##3##2##(1992-4#1)(2008-10#1)(2008-3#1)
the ultraviolet absorbance##2##3##(2005-4#1)(2008-10#1)
the ultraviolet light##2##3##(2007-12#1)(2008-3#1)
the ultraviolet region of##4##4##(1995-1#1)(2008-2#3)
the ultraviolet region##12##3##(1990-5#1)(1994-2#1)(1995-1#1)(2007-11#2)(2008-10#1)(2008-2#5)(2008-3#1)
the ultraviolet zenith##2##3##(2008-3#2)
the ultraviolet##44##2##(1990-5#1)(1991-12#1)(1991-8#1)(1994-2#1)(1995-1#1)(2005-11#1)(2005-4#4)(2007-11#5)(2007-12#4)(2008-1#2)(2008-10#3)(2008-2#6)(2008-3#12)(2008-5#1)(2011-2#1)
the umbilical area##2##3##(2008-10#2)
the umbilical artery PI##2##4##(1992-1#2)
the umbilical artery pulsatility index##2##5##(1992-1#2)
the umbilical artery##7##3##(1990-8#1)(1990-9#1)(1992-1#4)(1995-6#1)
the umbilical cord arteries##2##4##(2009-8#2)
the umbilical cord ulceration##2##4##(1996-12#2)
the umbilical cord##9##3##(1996-12#2)(1997-3#1)(2004-10#1)(2008-6#1)(2009-8#3)(2009-9#1)
the umbilical profile##2##3##(2013-1#2)
the umbilical ring and##2##4##(2013-1#2)
the umbilical ring##3##3##(2013-1#3)
the umbilical vein##4##3##(1990-8#2)(1996-3#1)(2004-9#1)
the umbilical##31##2##(1990-8#3)(1990-9#1)(1992-1#4)(1995-6#1)(1996-12#2)(1996-3#1)(1997-3#1)(2004-10#1)(2004-9#1)(2006-5#1)(2008-10#4)(2008-6#1)(2009-8#3)(2009-9#1)(2010-9#1)(2013-1#5)
the umbilicus##5##2##(2007-8#1)(2010-6#2)(2011-2#1)(2012-12#1)
the umbo##2##2##(2007-3#1)(2007-5#1)
the umbrella##9##2##(1997-8#1)(2006-10#1)(2008-1#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2011-2#1)
the unadjusted##2##2##(2007-8#1)(2011-1#1)
the unaffected##10##2##(1992-10#1)(1994-12#1)(2007-10#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-9#1)(2010-3#1)
the unambiguous##6##2##(1991-9#1)(1995-11#1)(1995-8#1)(2012-1#1)(2012-2#2)
the unamplified##2##2##(2008-10#1)(2008-2#1)
the unattended##4##2##(2010-5#4)
the unavailability of##5##3##(2008-3#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-3#1)
the unavailability##6##2##(2008-3#1)(2008-7#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#1)
the unavoidable##5##2##(2006-2#1)(2006-5#1)(2007-7#1)(2008-2#1)(2008-3#1)
the unbalanced##5##2##(1996-9#1)(2008-2#1)(2008-5#2)(2010-11#1)
the unbiased##3##2##(2008-4#1)(2008-9#1)(2009-12#1)
the unblocked##3##2##(1994-5#2)(2008-4#1)
the unborn child##3##3##(2008-2#2)(2010-2#1)
the unbound fraction of drugs##2##5##(2008-8#2)
the unbound fraction##3##3##(1990-12#1)(2008-8#2)
the unbound radioactivity##2##3##(1990-12#1)(2008-4#1)
the unbound##11##2##(1990-12#3)(1993-12#1)(1994-9#1)(1996-5#1)(1997-4#1)(2008-4#1)(2008-8#2)(2009-12#1)
the unbranched##2##2##(2007-5#2)
the unbudded period of the old cells##2##7##(1992-3#2)
the unbudded period of##3##4##(1992-3#3)
the unbudded period##4##3##(1992-3#4)
the uncertain nature of##2##4##(2008-5#1)(2008-7#1)
the uncertain##4##2##(2008-5#1)(2008-7#1)(2011-2#1)(2013-7#1)
the uncertainties and##2##3##(1995-12#1)(2008-3#1)
the uncertainties in the##3##4##(1995-6#1)(2006-10#1)(2008-3#1)
the uncertainties in##4##3##(1995-6#1)(1996-12#1)(2006-10#1)(2008-3#1)
the uncertainties of the##2##4##(2005-7#1)(2008-3#1)
the uncertainties regarding##2##3##(1996-8#1)(2007-11#1)
the uncertainties##20##2##(1995-12#1)(1995-6#1)(1996-12#1)(1996-8#1)(2005-7#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-2#2)(2008-3#7)(2009-3#1)(2010-7#1)
the uncertainty about##2##3##(2006-5#1)(2008-9#1)
the uncertainty associated with the##3##5##(2008-10#3)
the uncertainty associated##4##3##(2008-10#4)
the uncertainty in the##3##4##(2008-10#1)(2008-2#2)
the uncertainty in##10##3##(1991-2#1)(1992-5#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2011-12#1)(2012-2#1)
the uncertainty of the##9##4##(1992-5#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-3#3)(2012-1#1)(2012-12#1)
the uncertainty of##17##3##(1992-5#1)(1993-4#1)(1994-1#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-3#4)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)
the uncertainty regarding##3##3##(2008-8#1)(2012-1#1)(2012-2#1)
the uncertainty##49##2##(1991-2#1)(1992-5#2)(1993-4#1)(1994-1#1)(1996-12#2)(2006-10#1)(2006-5#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#12)(2008-2#3)(2008-3#6)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#2)(2013-7#1)
the unchanged##3##2##(1992-11#1)(2008-10#1)(2011-2#1)
the uncharged##3##2##(2005-11#1)(2007-10#1)(2008-5#1)
the uncinate##2##2##(2007-11#1)(2008-7#1)
the uncleaved##2##2##(1991-10#1)(1993-12#1)
the uncoated TMFE##2##3##(2008-10#2)
the uncoated##6##2##(2008-10#3)(2008-2#1)(2008-3#1)(2009-4#1)
the uncommon##7##2##(1991-9#1)(1995-8#1)(1996-12#1)(2007-7#1)(2008-6#1)(2012-2#1)(2013-1#1)
the uncomplexed Schiff bases##2##4##(2008-5#2)
the uncomplexed tetrol I-1##2##4##(2008-10#2)
the uncomplexed tetrol##3##3##(2008-10#3)
the uncomplexed##13##2##(1990-2#1)(1994-2#1)(1996-6#3)(2008-10#4)(2008-5#4)
the uncomplicated##2##2##(2005-9#1)(2008-11#1)
the unconditional##4##2##(1992-2#2)(1992-6#1)(2008-9#1)
the unconditioned stimulus##3##3##(1993-12#1)(1995-12#1)(2013-8#1)
the unconjugated##5##2##(1990-11#1)(1992-3#1)(1996-4#1)(2006-5#1)(2008-10#1)
the unconstrained##3##2##(1994-12#1)(2007-4#2)
the uncontrolled##6##2##(1997-2#1)(2008-4#1)(2009-11#1)(2009-2#1)(2012-12#1)(2013-8#1)
the unconventional##2##2##(2007-2#1)(2010-12#1)
the uncorrected##7##2##(1990-3#1)(1993-4#1)(2008-10#1)(2008-2#1)(2008-3#3)
the uncoupled##2##2##(1996-2#1)(2012-2#1)
the uncoupling effect of##2##4##(1992-3#1)(1997-7#1)
the uncoupling protein##4##3##(1991-3#3)(1997-6#1)
the uncoupling##8##2##(1991-3#3)(1992-3#1)(1997-6#1)(1997-7#1)(2008-9#1)(2010-5#1)
the undepleted ground-state population density##2##5##(2008-3#2)
the under##5##2##(1991-3#1)(2005-11#1)(2008-1#1)(2008-11#1)(2013-8#1)
the under-axilla grasp method##2##4##(2006-5#2)
the under-five syntactic categories##2##4##(2008-2#2)
the under-five##3##2##(2008-2#3)
the undergraduate curriculum##4##3##(2011-2#3)(2013-1#1)
the undergraduate medical curriculum##2##4##(2008-7#1)(2010-2#1)
the undergraduate##16##2##(1991-1#1)(1991-6#1)(2005-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2009-5#1)(2010-2#1)(2011-2#3)(2012-1#2)(2012-11#1)(2013-1#1)
the underground##5##2##(2007-1#1)(2008-1#2)(2008-8#1)(2010-4#1)
the underivatized##4##2##(1990-7#2)(1996-8#1)(1996-9#1)
the underlined##2##2##(1995-8#1)(2008-8#1)
the underlying abnormality##2##3##(2007-12#2)
the underlying actin cytoskeleton##2##4##(1991-11#1)(2009-5#1)
the underlying assumptions##3##3##(1995-1#1)(2010-8#1)(2012-2#1)
the underlying biological##3##3##(2008-11#1)(2009-10#1)(2011-1#1)
the underlying biology##5##3##(2007-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-2#1)
the underlying cause for##3##4##(2006-10#1)(2008-1#1)(2010-6#1)
the underlying cause of the##3##5##(1994-11#1)(2008-11#1)(2010-2#1)
the underlying cause of##10##4##(1991-12#1)(1994-11#1)(1995-11#1)(1995-2#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-10#1)(2010-2#1)
the underlying cause##21##3##(1991-12#1)(1991-8#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-2#1)(2005-11#1)(2006-10#2)(2007-3#1)(2008-1#3)(2008-11#1)(2008-3#1)(2010-10#2)(2010-2#2)(2010-6#1)
the underlying causes of##4##4##(1991-12#1)(2007-4#1)(2012-2#1)(2013-1#1)
the underlying cellular##2##3##(1997-3#1)(2008-1#1)
the underlying chemical##2##3##(1991-8#1)(2008-10#1)
the underlying collagen network##2##4##(2009-10#2)
the underlying condition##4##3##(2006-3#1)(2007-7#1)(2008-11#1)(2008-3#1)
the underlying data##3##3##(2012-3#1)(2013-1#2)
the underlying defect in##2##4##(1997-7#1)(2004-11#1)
the underlying determinants of##2##4##(2008-2#1)(2008-3#1)
the underlying differences##2##3##(2008-5#1)(2008-7#1)
the underlying disease and##4##4##(2005-10#1)(2006-11#1)(2007-11#1)(2011-3#1)
the underlying disease mechanisms##4##4##(2006-10#2)(2008-2#1)(2010-6#1)
the underlying disease process##7##4##(1997-4#1)(2008-3#1)(2008-7#2)(2009-12#1)(2011-2#1)(2013-8#1)
the underlying disease##30##3##(1995-9#1)(1997-4#1)(2005-10#1)(2006-10#3)(2006-11#1)(2006-6#1)(2007-11#2)(2007-2#1)(2008-2#1)(2008-3#2)(2008-7#3)(2009-12#1)(2010-12#1)(2010-6#1)(2011-2#4)(2011-3#2)(2012-2#2)(2013-7#1)(2013-8#1)
the underlying distribution##2##3##(2011-2#1)(2013-8#1)
the underlying evolutionary##2##3##(2008-7#2)
the underlying gene##2##3##(2008-6#1)(2010-6#1)
the underlying genetic basis##2##4##(2007-10#1)(2008-6#1)
the underlying genetic##11##3##(1997-3#1)(2004-11#1)(2006-5#1)(2007-10#1)(2008-4#1)(2008-6#1)(2009-10#1)(2012-11#1)(2012-12#2)(2012-3#1)
the underlying genetics##2##3##(2008-10#1)(2008-8#1)
the underlying heart##2##3##(1995-4#1)(2010-12#1)
the underlying immune mechanisms##3##4##(2006-10#1)(2008-10#2)
the underlying immune##4##3##(1994-6#1)(2006-10#1)(2008-10#2)
the underlying liver disease##3##4##(2006-10#1)(2011-2#1)(2013-8#1)
the underlying mechanism of##6##4##(1990-4#1)(1993-9#1)(1995-12#1)(2008-7#1)(2009-12#1)(2010-7#1)
the underlying mechanism was##2##4##(1991-3#1)(2008-2#1)
the underlying mechanism##21##3##(1990-4#1)(1991-3#1)(1993-9#1)(1995-1#1)(1995-12#1)(1995-9#1)(2006-7#1)(2007-10#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-2#3)(2013-1#1)
the underlying mechanisms by which##2##5##(2007-12#1)(2008-12#1)
the underlying mechanisms have remained##2##5##(1997-6#1)(2012-12#1)
the underlying mechanisms have##3##4##(1993-1#1)(1997-6#1)(2012-12#1)
the underlying mechanisms of the##2##5##(1996-7#1)(2008-10#1)
the underlying mechanisms of##13##4##(1995-12#1)(1996-7#1)(2006-10#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
the underlying mechanisms remain##2##4##(1994-8#1)(2008-9#1)
the underlying mechanisms##32##3##(1993-1#1)(1994-8#1)(1995-12#1)(1996-7#1)(1997-6#1)(2005-11#1)(2006-10#2)(2007-12#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#3)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
the underlying metabolic syndrome##2##4##(2008-3#2)
the underlying molecular mechanism##2##4##(1997-5#1)(2012-2#1)
the underlying molecular##7##3##(1997-5#1)(2007-7#2)(2008-11#1)(2009-8#1)(2012-2#2)
the underlying pathology##3##3##(1996-1#1)(2008-11#1)(2008-8#1)
the underlying pathophysiological##2##3##(1990-2#1)(2008-3#1)
the underlying pathophysiology of##5##4##(2008-7#1)(2009-10#1)(2012-2#2)(2012-3#1)
the underlying pathophysiology##7##3##(2006-10#1)(2008-10#1)(2008-7#1)(2009-10#1)(2012-2#2)(2012-3#1)
the underlying principles##3##3##(2008-9#3)
the underlying problem##2##3##(2008-8#1)(2013-1#1)
the underlying regulatory##3##3##(1994-8#1)(2007-11#1)(2010-3#1)
the underlying risk##2##3##(2007-10#1)(2012-12#1)
the underlying silica structure##2##4##(2010-4#2)
the underlying structure##2##3##(2008-1#1)(2008-2#1)
the underlying structures##2##3##(2007-12#1)(2007-8#1)
the underlying survival##2##3##(1992-6#1)(1996-1#1)
the underlying theory##2##3##(2007-11#1)(2010-7#1)
the underlying tumor is##2##4##(1992-12#1)(2012-12#1)
the underlying vascular##2##3##(1992-11#1)(2007-10#1)
the underlying##402##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-9#3)(1993-1#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#4)(1995-1#2)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#1)(1995-4#2)(1995-5#1)(1995-9#3)(1996-1#4)(1996-12#2)(1996-3#1)(1996-7#4)(1996-8#1)(1997-1#1)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#1)(2004-11#2)(2004-4#1)(2005-10#2)(2005-11#3)(2005-8#1)(2006-10#12)(2006-11#3)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#3)(2007-10#4)(2007-11#9)(2007-12#14)(2007-2#2)(2007-3#1)(2007-4#2)(2007-7#6)(2007-8#5)(2007-9#2)(2008-1#10)(2008-10#10)(2008-11#10)(2008-12#3)(2008-2#10)(2008-3#13)(2008-4#6)(2008-5#8)(2008-6#5)(2008-7#17)(2008-8#3)(2008-9#7)(2009-10#5)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#5)(2009-9#4)(2010-10#4)(2010-11#5)(2010-12#7)(2010-2#9)(2010-3#2)(2010-4#2)(2010-6#5)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#8)(2011-3#2)(2012-1#3)(2012-11#1)(2012-12#10)(2012-2#19)(2012-3#7)(2013-1#11)(2013-7#1)(2013-8#9)
the underprivileged##2##2##(1991-5#1)(2011-12#1)
the underreporting##2##2##(2012-12#2)
the underserved##3##2##(2008-11#2)(2013-8#1)
the understanding and treatment of##3##5##(1994-5#1)(1995-6#1)(2008-4#1)
the understanding and##8##3##(1994-5#1)(1995-6#1)(2006-9#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-12#1)(2011-2#1)
the understanding of disease##2##4##(2007-10#1)(2011-7#1)
the understanding of how these##2##5##(2008-10#1)(2008-7#1)
the understanding of how##5##4##(1992-2#1)(2008-10#2)(2008-5#1)(2008-7#1)
the understanding of its##4##4##(1997-1#1)(2006-2#1)(2008-4#1)(2013-1#1)
the understanding of molecular##2##4##(2005-7#1)(2006-10#1)
the understanding of the biology##2##5##(2006-8#1)(2012-3#1)
the understanding of the complex##2##5##(2008-4#1)(2009-8#1)
the understanding of the effects of##2##6##(2009-7#1)(2010-2#1)
the understanding of the evolution of##2##6##(2010-5#1)(2010-8#1)
the understanding of the mechanism##3##5##(1990-8#1)(1994-9#1)(2009-4#1)
the understanding of the mechanisms involved in the##2##8##(1997-3#1)(2006-10#1)
the understanding of the mechanisms##5##5##(1997-3#1)(2006-10#2)(2007-4#1)(2009-1#1)
the understanding of the nature of##3##6##(1994-11#1)(1995-1#1)(2008-6#1)
the understanding of the pathogenesis of##9##6##(1994-3#1)(1997-5#1)(2005-8#2)(2008-3#1)(2008-7#1)(2008-9#1)(2013-1#2)
the understanding of the pathogenesis##10##5##(1994-3#1)(1997-5#1)(2005-8#2)(2006-8#1)(2008-3#1)(2008-7#1)(2008-9#1)(2013-1#2)
the understanding of the pathological##2##5##(2006-8#1)(2008-9#1)
the understanding of the pathophysiology of##2##6##(2005-10#1)(2005-11#1)
the understanding of the pathophysiology##3##5##(2005-10#1)(2005-11#1)(2008-8#1)
the understanding of the physiological##2##5##(1997-8#1)(2006-10#1)
the understanding of the potential##2##5##(2005-7#1)(2006-10#1)
the understanding of the regulation of##2##6##(1995-2#1)(2008-1#1)
the understanding of the relationship between##3##6##(2006-5#1)(2006-7#1)(2013-7#1)
the understanding of the role of##2##6##(1993-3#1)(2008-10#1)
the understanding of the##96##4##(1990-1#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#3)(2006-10#5)(2006-11#2)(2006-4#2)(2006-5#1)(2006-7#2)(2006-8#3)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#4)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
the understanding of this##2##4##(2006-10#1)(2011-1#1)
the understanding of##183##3##(1990-1#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-2#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#2)(1995-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#2)(2004-2#1)(2005-10#2)(2005-11#1)(2005-7#2)(2005-8#3)(2006-10#11)(2006-11#3)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#3)(2007-10#1)(2007-12#7)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#5)(2008-10#7)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#3)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#3)(2011-7#1)(2012-12#2)(2012-2#6)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#4)
the understanding that##5##3##(1996-3#1)(2006-12#1)(2007-11#1)(2011-1#1)(2011-12#1)
the understanding##200##2##(1990-1#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-2#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#2)(1995-6#2)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#2)(2004-2#1)(2005-10#2)(2005-11#1)(2005-7#2)(2005-8#3)(2006-10#11)(2006-11#3)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#7)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#5)(2008-10#7)(2008-11#8)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#6)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#3)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#3)(2011-12#2)(2011-2#4)(2011-7#2)(2012-12#2)(2012-2#6)(2012-3#6)(2013-1#5)(2013-7#1)(2013-8#4)
the understory##7##2##(2007-3#1)(2008-5#1)(2008-8#2)(2008-9#3)
the underutilization of##2##3##(2010-4#1)(2011-2#1)
the underwater##2##2##(2008-10#1)(2008-3#1)
the underweight women##2##3##(1991-12#1)(2007-7#1)
the undesirable##2##2##(2008-2#1)(2010-6#1)
the undesired##3##2##(2008-10#1)(2008-9#1)(2013-8#1)
the undifferentiated and##2##3##(1997-2#1)(2008-11#1)
the undifferentiated state##2##3##(1996-5#1)(2008-11#1)
the undifferentiated##7##2##(1996-5#1)(1997-2#1)(2006-10#1)(2008-11#2)(2008-9#1)(2009-4#1)
the undiluted##2##2##(1991-12#1)(2008-10#1)
the undrugged##2##2##(1992-7#1)(1993-3#1)
the unedited##2##2##(1993-12#2)
the unemployed##5##2##(1992-2#1)(2007-11#1)(2010-2#2)(2013-1#1)
the unequivocal##2##2##(1991-3#1)(2008-11#1)
the uneven distribution of birth months##2##6##(2007-7#2)
the uneven distribution of##3##4##(1994-6#1)(2007-7#2)
the uneven distribution##4##3##(1994-6#1)(2007-7#2)(2008-1#1)
the uneven##8##2##(1994-6#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-2#1)(2012-12#1)
the unexpected##13##2##(1991-4#1)(1992-3#1)(1996-3#1)(2004-4#1)(2006-12#1)(2007-11#1)(2007-9#2)(2008-4#1)(2009-8#1)(2010-2#1)(2010-3#1)(2011-1#1)
the unexpectedly##4##2##(1991-1#1)(1996-12#1)(2007-4#1)(2009-6#1)
the unexposed##5##2##(1994-6#1)(2008-3#1)(2008-9#1)(2009-5#2)
the unfavorable interaction##2##3##(1997-7#1)(2011-2#1)
the unfavorable##8##2##(1992-2#1)(1996-10#1)(1997-7#1)(2008-7#2)(2009-8#1)(2011-2#1)(2013-8#1)
the unfit patients##2##3##(1991-3#2)
the unfolded protein response##2##4##(1997-1#1)(1997-4#1)
the unfolded protein##6##3##(1993-11#1)(1997-1#1)(1997-2#2)(1997-4#2)
the unfolded state##5##3##(1993-11#2)(1995-4#1)(1997-2#2)
the unfolded##15##2##(1990-7#2)(1992-6#1)(1993-11#3)(1995-4#1)(1997-1#1)(1997-2#4)(1997-4#2)(2005-10#1)
the unfolding of the monomers##2##5##(1994-8#2)
the unfolding of the##4##4##(1994-8#2)(2007-11#1)(2008-4#1)
the unfolding of##9##3##(1993-3#1)(1993-6#1)(1994-8#2)(1995-5#1)(1997-4#1)(2007-11#1)(2008-4#2)
the unfolding transition##3##3##(1994-8#1)(1995-5#1)(2008-4#1)
the unfolding##25##2##(1990-5#3)(1992-6#1)(1993-3#1)(1993-6#1)(1994-8#4)(1995-2#1)(1995-3#2)(1995-5#3)(1997-4#2)(2007-11#1)(2007-12#1)(2008-4#3)(2008-9#1)(2011-1#1)
the unfortunate##2##2##(2005-7#1)(2008-11#1)
the unfractionated bone cells##2##4##(2008-11#2)
the unfractionated##3##2##(1991-2#1)(2008-11#2)
the unglycosylated##2##2##(1994-9#1)(2008-11#1)
the unheated##2##2##(2008-2#1)(2008-3#1)
the uniaxial rotation of##2##4##(1991-7#2)
the unicellular cyanobacterium##7##3##(1994-12#1)(1995-6#1)(1995-8#1)(1996-6#3)(1996-9#1)
the unicellular##12##2##(1990-3#1)(1991-5#1)(1994-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-6#3)(1996-9#2)
the unidentified bacterium##2##3##(2006-5#2)
the unidentified##7##2##(1991-7#1)(1995-10#1)(1995-2#1)(1997-3#1)(2006-5#2)(2013-1#1)
the unidirectional##4##2##(2006-12#1)(2008-3#1)(2011-1#1)(2011-2#1)
the unification of##2##3##(1994-10#1)(2009-10#1)
the unified concept##2##3##(2008-7#2)
the unified##6##2##(2008-4#1)(2008-7#3)(2010-11#1)(2012-2#1)
the uniform distribution##2##3##(1993-2#1)(2008-11#1)
the uniform migration case the##2##5##(2007-9#2)
the uniform projection algorithm##2##4##(2006-10#2)
the uniform##18##2##(1992-2#1)(1993-2#1)(1996-4#1)(1997-8#1)(2006-10#2)(2007-11#1)(2007-12#3)(2007-9#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-9#1)
the uniformity and##2##3##(2008-12#1)(2008-5#1)
the uniformity of the##4##4##(2008-2#1)(2008-3#2)(2010-7#1)
the uniformity of##8##3##(1996-12#1)(2007-6#1)(2008-2#2)(2008-3#3)(2010-7#1)
the uniformity##13##2##(1996-12#1)(2007-6#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#1)(2010-7#1)(2013-1#1)
the uniformly 15N-labeled##2##3##(1992-9#1)(1996-7#1)
the uniformly##6##2##(1992-9#1)(1996-7#1)(2008-1#1)(2009-7#2)(2012-2#1)
the unilateral##10##2##(1991-6#1)(1995-7#1)(1996-10#1)(1996-12#2)(2007-1#1)(2007-7#1)(2008-11#1)(2009-2#1)(2012-1#1)
the unimodal##2##2##(2008-10#2)
the unimpacted##3##2##(2006-12#2)(2009-7#1)
the uninduced##4##2##(1992-1#2)(1997-4#1)(2007-6#1)
the uninfected##4##2##(1991-12#1)(1997-3#1)(2008-10#1)(2011-12#1)
the uninitiated##3##2##(1996-2#1)(2008-9#1)(2010-2#1)
the uninoculated control##2##3##(2008-10#2)
the uninoculated##3##2##(1996-2#1)(2008-10#2)
the uninsured and##3##3##(1994-2#1)(1995-12#1)(2008-11#1)
the uninsured##21##2##(1990-12#1)(1991-4#1)(1992-2#2)(1993-2#1)(1994-2#1)(1995-1#2)(1995-12#2)(1996-1#1)(2007-11#1)(2008-11#8)(2008-6#1)
the unintended##2##2##(1995-1#1)(2007-3#1)
the unintentional##3##2##(2007-5#1)(2013-1#1)(2013-8#1)
the uninvolved##3##2##(1992-6#1)(2007-10#1)(2009-10#1)
the union of surgeon and machine##2##6##(2011-2#2)
the union of##3##3##(1995-3#1)(2011-2#2)
the union##12##2##(1995-12#4)(1995-3#1)(1996-3#1)(2006-3#1)(2007-8#1)(2009-10#1)(2011-2#2)(2013-1#1)
the unique ability of##5##4##(1994-10#1)(1997-1#1)(2008-2#1)(2008-3#1)(2008-4#1)
the unique ability to##5##4##(2008-9#1)(2010-11#1)(2011-1#1)(2012-12#1)(2012-2#1)
the unique ability##10##3##(1994-10#1)(1997-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-11#1)(2011-1#1)(2012-12#1)(2012-2#1)
the unique advantages of##2##4##(2007-12#1)(2008-3#1)
the unique and##4##3##(2006-10#1)(2009-12#1)(2010-2#1)(2012-3#1)
the unique aspects of##2##4##(2010-6#1)(2010-8#1)
the unique biology of##2##4##(2008-5#1)(2010-4#1)
the unique capability of##4##4##(2008-4#1)(2011-1#1)(2012-11#2)
the unique capability##5##3##(2008-4#1)(2011-1#1)(2011-7#1)(2012-11#2)
the unique challenges of##3##4##(2006-5#1)(2013-1#2)
the unique challenges##6##3##(2006-5#1)(2007-10#1)(2010-12#1)(2013-1#2)(2013-8#1)
the unique characteristics of the##3##5##(2006-3#1)(2008-8#1)(2011-2#1)
the unique characteristics of##9##4##(1990-11#1)(1996-3#1)(2006-10#1)(2006-3#1)(2008-2#1)(2008-8#1)(2011-2#1)(2013-1#2)
the unique combination of##2##4##(2006-12#1)(2010-6#1)
the unique dynamics of##2##4##(2006-4#1)(2007-12#1)
the unique experience##2##3##(2006-11#1)(2008-7#1)
the unique features of such a device for scientific aims##2##10##(2007-12#1)(2008-2#1)
the unique features of this##2##5##(2009-6#1)(2011-1#1)
the unique features of##7##4##(1994-3#1)(2007-12#1)(2008-2#1)(2009-6#1)(2011-1#1)(2012-12#1)(2012-2#1)
the unique features##9##3##(1991-12#1)(1994-3#1)(2007-12#1)(2008-11#1)(2008-2#1)(2009-6#1)(2011-1#1)(2012-12#1)(2012-2#1)
the unique iron-binding stability of##2##5##(1996-5#2)
the unique iron-binding##3##3##(1996-5#3)
the unique metabolic##2##3##(2013-8#2)
the unique nature of##5##4##(2007-1#1)(2008-4#1)(2008-8#1)(2009-4#1)(2013-8#1)
the unique needs of##4##4##(1994-3#2)(2010-11#1)(2010-8#1)
the unique opportunities##2##3##(2009-9#1)(2012-12#1)
the unique problems##2##3##(2005-8#1)(2006-10#1)
the unique propensity##2##3##(2005-8#1)(2009-1#1)
the unique properties of##10##4##(2007-11#2)(2007-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2011-1#1)(2013-7#1)
the unique properties##11##3##(2007-11#2)(2007-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2011-1#1)(2011-2#1)(2013-7#1)
the unique property of##4##4##(1994-3#1)(1995-2#1)(1996-2#1)(2007-11#1)
the unique region##2##3##(1990-5#1)(1994-8#1)
the unique requirements##3##3##(2006-10#1)(2008-11#1)(2008-3#1)
the unique segments##2##3##(1996-7#2)
the unique##202##2##(1990-11#1)(1990-3#1)(1990-5#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-10#1)(1994-2#1)(1994-3#4)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#4)(1996-7#4)(1996-8#1)(1997-1#1)(1997-6#1)(1997-7#1)(2004-9#1)(2005-8#3)(2006-10#6)(2006-11#1)(2006-12#3)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#7)(2007-12#6)(2007-2#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#6)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-6#1)(2009-7#2)(2009-9#3)(2010-1#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#3)(2011-1#7)(2011-2#4)(2011-7#1)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#7)(2012-3#4)(2012-5#1)(2013-1#8)(2013-7#2)(2013-8#7)
the uniqueness and##3##3##(2006-12#1)(2007-11#1)(2012-12#1)
the uniqueness constraint is##2##4##(2008-9#2)
the uniqueness constraint##4##3##(2008-9#4)
the uniqueness of each##2##4##(2008-11#1)(2008-9#1)
the uniqueness of the##4##4##(2008-10#1)(2008-11#1)(2008-2#1)(2012-3#1)
the uniqueness of##9##3##(1993-4#1)(2005-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-9#1)(2012-3#1)
the uniqueness##17##2##(1993-4#1)(2005-8#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-9#5)(2012-12#1)(2012-3#1)
the unirradiated##3##2##(2008-6#3)
the unit and##2##3##(2007-10#2)
the unit cell##7##3##(1992-9#1)(1994-9#2)(1996-11#1)(1996-2#1)(2008-3#1)(2008-7#1)
the unit for##3##3##(1996-1#1)(2010-2#1)(2010-3#1)
the unit is##6##3##(2008-11#1)(2008-4#4)(2008-9#1)
the unit of analysis##7##4##(1994-5#2)(1996-3#1)(1997-1#1)(2012-2#1)(2013-1#2)
the unit of##15##3##(1992-12#1)(1994-5#2)(1995-2#1)(1996-12#1)(1996-3#1)(1997-1#1)(2004-10#1)(2006-11#1)(2009-4#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
the unit provides##2##3##(2008-9#2)
the unit##80##2##(1990-9#2)(1992-1#1)(1992-12#1)(1992-9#1)(1993-5#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1997-1#1)(2004-10#1)(2005-10#1)(2005-5#1)(2006-10#2)(2006-11#1)(2007-10#4)(2007-3#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#11)(2008-7#3)(2008-8#1)(2008-9#4)(2009-4#1)(2009-8#1)(2010-2#2)(2010-3#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)
the unitary##4##2##(1997-7#1)(2008-3#1)(2008-4#1)(2010-4#1)
the united##3##2##(1990-4#1)(2005-4#1)(2007-9#1)
the units of##7##3##(2006-12#2)(2007-12#1)(2008-5#1)(2008-9#1)(2009-4#1)(2011-2#1)
the units##21##2##(1993-2#1)(1995-6#3)(2006-12#2)(2007-12#1)(2008-1#2)(2008-5#1)(2008-9#2)(2009-4#1)(2010-5#3)(2011-2#5)
the unity of##3##3##(2008-4#1)(2010-4#1)(2010-8#1)
the univalent##3##2##(1990-3#1)(2008-10#2)
the univariate analysis##2##3##(2006-10#1)(2006-6#1)
the univariate model##3##3##(2009-8#3)
the univariate##10##2##(1994-11#1)(2006-10#1)(2006-6#1)(2008-10#3)(2009-8#4)
the universal standardization project##2##4##(1997-8#2)
the universal##29##2##(1993-4#1)(1995-8#1)(1996-3#1)(1997-8#2)(2006-5#1)(2006-6#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)
the universalist##2##2##(2011-2#2)
the universality##2##2##(2008-4#2)
the universally distributed##2##3##(2008-9#1)(2009-6#1)
the universally##5##2##(1994-5#1)(1995-8#1)(2008-11#1)(2008-9#1)(2009-6#1)
the universe is##2##3##(2007-8#1)(2008-12#1)
the universe##17##2##(1995-6#1)(1996-12#1)(2007-8#4)(2007-9#1)(2008-12#3)(2008-4#2)(2008-5#1)(2010-3#1)(2010-9#1)(2011-2#1)(2013-1#1)
the universities of##3##3##(1992-3#1)(2008-1#1)(2013-8#1)
the universities##5##2##(1992-3#1)(2008-1#1)(2008-10#1)(2009-4#1)(2013-8#1)
the university and##2##3##(1995-1#1)(2006-8#1)
the university for##2##3##(2008-5#1)(2012-3#1)
the university health##2##3##(2010-5#1)(2011-2#1)
the university hospital##4##3##(1994-4#1)(2007-7#1)(2008-9#1)(2012-2#1)
the university in##2##3##(2009-4#1)(2010-12#1)
the university of##6##3##(2006-2#1)(2008-1#1)(2008-11#2)(2012-12#1)(2013-1#1)
the university##41##2##(1990-12#1)(1991-2#1)(1993-2#1)(1993-5#1)(1994-4#1)(1995-1#1)(1996-12#1)(2006-2#1)(2006-8#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-11#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
the university's##2##2##(2012-1#1)(2013-1#1)
the unknown parameters##6##3##(2008-10#1)(2008-2#3)(2008-3#1)(2009-11#1)
the unknown##37##2##(1990-12#1)(1991-3#1)(1992-2#1)(1992-8#1)(1993-3#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-6#1)(2006-5#2)(2007-11#1)(2007-12#4)(2008-10#6)(2008-2#5)(2008-3#3)(2009-11#1)(2010-11#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)
the unknowns of##2##3##(2008-2#1)(2008-3#1)
the unknowns##4##2##(1993-11#1)(2008-2#1)(2008-3#2)
the unlabeled##9##2##(1990-5#1)(1992-11#1)(1993-4#1)(1995-10#1)(1995-3#2)(2008-10#1)(2008-2#2)
the unlabelled##3##2##(1992-9#1)(1996-11#1)(2012-12#1)
the unlesioned brain side##2##4##(1994-12#2)
the unlesioned neostriatum##2##3##(1994-10#2)
the unlesioned##7##2##(1994-10#5)(1994-12#2)
the unliganded form##2##3##(1995-5#2)
the unliganded##7##2##(1990-8#1)(1990-9#1)(1992-8#1)(1994-8#1)(1995-5#3)
the unligated##2##2##(1990-9#1)(1997-2#1)
the unlimited##2##2##(1993-2#1)(2005-7#1)
the unlinked##5##2##(1991-7#1)(1995-1#1)(1995-6#1)(1995-8#1)(2008-5#1)
the unloaded foam column##2##4##(1997-1#2)
the unloaded##6##2##(1991-5#1)(1997-1#3)(2008-10#1)(2010-1#1)
the unmarried##2##2##(2007-7#1)(2011-2#1)
the unmasking of##2##3##(1996-5#1)(2008-8#1)
the unmet##3##2##(2005-7#1)(2008-7#1)(2009-12#1)
the unmethylated##2##2##(1995-2#1)(2008-4#1)
the unmodified##15##2##(1991-9#1)(1995-1#1)(1995-2#2)(1997-1#1)(1997-6#1)(2005-11#1)(2006-10#1)(2008-10#4)(2008-3#1)(2009-7#1)(2010-4#1)
the unnatural##5##2##(1991-8#1)(1992-12#1)(1994-6#1)(2006-6#1)(2012-12#1)
the unnecessary treatment of##2##4##(2006-9#1)(2007-3#1)
the unnecessary##6##2##(2006-10#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-3#1)(2007-7#1)
the unobserved##3##2##(1995-6#1)(2005-11#1)(2012-3#1)
the unoccupied##2##2##(2008-8#2)
the unoperated control##2##3##(1993-12#1)(1995-12#1)
the unpaired##6##2##(1994-6#1)(1997-7#1)(2007-10#1)(2007-12#1)(2012-2#1)(2013-8#1)
the unperturbed##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
the unphosphorylated and phosphorylated##2##4##(1990-7#1)(2006-12#1)
the unphosphorylated and##3##3##(1990-7#1)(1995-3#1)(2006-12#1)
the unphosphorylated myosin##3##3##(1990-7#3)
the unphosphorylated peptides##2##3##(2013-8#2)
the unphosphorylated##12##2##(1990-7#6)(1994-9#1)(1995-3#1)(2006-12#1)(2010-12#1)(2013-8#2)
the unpolluted##3##2##(2006-12#1)(2008-5#2)
the unprecedented##4##2##(1996-2#1)(2009-5#1)(2011-1#1)(2012-2#1)
the unpredictable##7##2##(2007-8#1)(2008-10#1)(2008-11#2)(2010-10#1)(2011-2#1)(2012-3#1)
the unprocessed alpha 1-AT preparation##2##5##(1997-8#2)
the unprocessed##4##2##(1991-9#1)(1997-8#3)
the unprotected##5##2##(1996-8#1)(2008-3#1)(2010-2#1)(2013-7#2)
the unproteolyzed##3##2##(1995-11#3)
the unprotonated##5##2##(1991-9#2)(1992-2#1)(2008-10#1)(2010-5#1)
the unpurified##3##2##(1994-8#1)(2007-1#1)(2008-10#1)
the unquantified##3##2##(2008-4#3)
the unraveling of##2##3##(2006-12#1)(2008-10#1)
the unreamed##2##2##(2009-3#1)(2013-8#1)
the unrecognized##3##2##(1994-7#1)(2012-11#1)(2013-1#1)
the unreinforced licks##2##3##(2008-11#2)
the unrelated individuals data##2##4##(2012-3#2)
the unrelated individuals##3##3##(2012-3#3)
the unrelated##9##2##(1995-2#1)(1996-4#1)(1997-3#1)(2012-3#6)
the unrestrained##4##2##(1990-8#1)(1991-11#1)(1993-9#1)(2007-8#1)
the unrestricted##2##2##(2007-12#1)(2009-10#1)
the unresurfaced patella##2##3##(2013-1#2)
the unretained##3##2##(2008-10#3)
the unsatisfactory##5##2##(1990-6#1)(1991-3#1)(1992-8#1)(2007-2#1)(2008-10#1)
the unsaturated fatty acids##3##4##(1990-11#1)(1991-12#1)(1995-11#1)
the unsaturated fatty##4##3##(1990-11#1)(1991-12#1)(1995-11#1)(1997-2#1)
the unsaturated##11##2##(1990-11#2)(1990-2#1)(1991-12#1)(1994-9#2)(1995-11#1)(1997-2#1)(2009-9#1)(2011-1#1)(2012-12#1)
the unsaturation##3##2##(1992-6#1)(1994-3#1)(2008-10#1)
the unscreened control and the symmetrical selection methods##2##8##(1997-5#2)
the unspliced##2##2##(1990-6#1)(1993-8#1)
the unsprayed##2##2##(2008-10#1)(2011-2#1)
the unstable resonator##2##3##(2007-12#1)(2008-3#1)
the unstable##11##2##(1990-6#1)(1992-2#1)(1995-5#1)(2006-4#1)(2007-1#2)(2007-12#1)(2007-6#1)(2008-3#2)(2009-4#1)
the unsteady##3##2##(2005-10#2)(2008-7#1)
the unstimulated##2##2##(1994-10#1)(2006-7#1)
the unstructured##4##2##(2008-11#1)(2010-5#1)(2013-1#2)
the unsubstituted##3##2##(1997-2#1)(2008-3#1)(2009-3#1)
the unsuccessful##2##2##(1995-6#1)(2008-11#1)
the untrained female rats##2##4##(2013-1#2)
the untrained##4##2##(2013-1#3)(2013-8#1)
the untransformed A31##2##3##(1991-7#2)
the untransformed C127 cells##2##4##(1991-7#2)
the untransformed##6##2##(1991-7#4)(1991-9#1)(2009-12#1)
the untranslated leader##2##3##(1994-8#1)(1997-2#1)
the untranslated regions##2##3##(1995-2#1)(2008-10#1)
the untranslated##6##2##(1994-8#1)(1995-2#1)(1995-8#1)(1997-2#1)(2008-10#2)
the untreated and##2##3##(1996-8#1)(2005-11#1)
the untreated control##7##3##(1992-12#1)(2008-10#2)(2008-11#1)(2008-5#2)(2013-7#1)
the untreated controls##4##3##(1997-4#2)(2008-10#1)(2008-5#1)
the untreated diabetic animals##2##4##(1992-3#1)(2008-4#1)
the untreated diabetic##3##3##(1992-3#1)(2008-4#1)(2012-2#1)
the untreated dwarf##2##3##(1995-12#2)
the untreated group##5##3##(1992-12#1)(1994-6#1)(2006-8#1)(2012-1#1)(2012-2#1)
the untreated rats##2##3##(1996-10#2)
the untreated##56##2##(1990-11#1)(1990-3#1)(1991-12#1)(1991-4#1)(1992-11#1)(1992-12#2)(1992-3#1)(1994-6#1)(1995-12#2)(1995-6#2)(1995-9#1)(1996-10#2)(1996-12#1)(1996-8#1)(1996-9#3)(1997-4#3)(2004-9#1)(2005-11#4)(2006-8#1)(2007-1#1)(2007-7#1)(2008-10#5)(2008-11#3)(2008-4#2)(2008-5#6)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-7#2)
the unusual presentation of##2##4##(2007-8#1)(2008-6#1)
the unusual presentation##3##3##(2007-3#1)(2007-8#1)(2008-6#1)
the unusual property of##2##4##(1993-3#1)(2008-11#1)
the unusual##51##2##(1990-8#1)(1991-3#1)(1991-9#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-3#1)(1994-8#1)(1995-12#1)(1996-10#1)(1997-3#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#3)(2008-10#3)(2008-11#2)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-3#2)(2009-5#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-8#1)
the unusually large##2##3##(1992-12#1)(2008-10#1)
the unusually##6##2##(1992-12#1)(2006-10#1)(2006-4#1)(2008-10#1)(2008-5#1)(2008-8#1)
the unvaccinated##3##2##(1995-9#1)(2008-5#1)(2011-2#1)
the unwanted side effects of##3##5##(1995-2#1)(2006-10#1)(2008-9#1)
the unwanted##19##2##(1992-1#1)(1995-2#1)(1997-2#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-12#2)(2008-2#3)(2008-3#3)(2008-9#4)(2012-2#1)
the unweighted pair group method##2##5##(2008-10#2)
the unweighted##3##2##(1992-12#1)(2008-10#2)
the unwillingness##2##2##(2008-1#1)(2011-1#1)
the unwinding of##2##3##(1995-11#1)(1997-7#1)
the unwinding##3##2##(1995-11#1)(1995-3#1)(1997-7#1)
the unwrapped phase##2##3##(2008-2#1)(2008-3#1)
the unwrapped##4##2##(2008-2#2)(2008-3#2)
the unwrapping process##2##3##(2008-2#1)(2008-3#1)
the unwrapping##4##2##(2008-2#1)(2008-3#3)
the up-date##2##2##(1996-9#1)(2007-11#1)
the up-regulation of these##2##4##(1994-9#1)(2008-11#1)
the up-regulation of##17##3##(1992-11#1)(1993-4#1)(1994-9#2)(1995-10#1)(1995-2#1)(1995-6#1)(1995-7#1)(1996-12#1)(2006-12#2)(2008-11#1)(2009-3#1)(2012-12#1)(2013-1#3)
the up-regulation##18##2##(1990-10#1)(1992-11#1)(1993-4#1)(1994-9#2)(1995-10#1)(1995-2#1)(1995-6#1)(1995-7#1)(1996-12#1)(2006-12#2)(2008-11#1)(2009-3#1)(2012-12#1)(2013-1#3)
the up-to-date##3##2##(1993-5#1)(2009-8#1)(2012-1#1)
the upcoming tastant##3##3##(2008-11#3)
the upcoming##10##2##(2004-12#1)(2007-11#1)(2008-11#3)(2008-12#1)(2008-3#1)(2010-12#1)(2010-7#1)(2012-2#1)
the upconversion##3##2##(2007-12#1)(2008-3#2)
the updated##7##2##(2006-10#2)(2008-2#1)(2008-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
the updating##2##2##(2007-11#1)(2012-11#1)
the upland##2##2##(1993-9#1)(1997-4#1)
the uplink##2##2##(2007-12#1)(2008-3#1)
the upper Keys##4##3##(2007-5#4)
the upper abdomen##7##3##(1990-3#1)(1990-8#1)(1991-6#1)(1993-10#1)(2008-3#1)(2008-4#1)(2010-12#1)
the upper aerodigestive tract##9##4##(1993-5#2)(2008-1#1)(2008-5#3)(2009-5#1)(2012-12#1)(2013-1#1)
the upper airway and##2##4##(2005-11#1)(2012-3#1)
the upper airway##4##3##(1990-6#1)(2005-11#1)(2007-12#1)(2012-3#1)
the upper airways##7##3##(1991-6#1)(1992-4#1)(1996-6#1)(1997-4#1)(2005-11#1)(2008-8#1)(2008-9#1)
the upper and lower airways##3##5##(1992-11#1)(2012-12#2)
the upper and lower extremities##4##5##(2006-11#1)(2006-9#1)(2007-4#1)(2009-5#1)
the upper and lower extremity##2##5##(2007-11#1)(2012-3#1)
the upper and lower limb##2##5##(1990-11#1)(2007-8#1)
the upper and lower parts of the##4##7##(2006-10#1)(2006-8#1)(2008-10#2)
the upper and lower parts##5##5##(2006-10#1)(2006-8#1)(2008-10#2)(2008-12#1)
the upper and lower respiratory##2##5##(1992-11#1)(2008-1#1)
the upper and lower##31##4##(1990-11#1)(1991-4#1)(1991-6#1)(1992-11#2)(1992-12#1)(1994-12#1)(2006-10#1)(2006-11#3)(2006-8#1)(2006-9#1)(2007-11#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-5#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)
the upper and the lower part of##2##7##(2008-12#1)(2008-2#1)
the upper and the lower##4##5##(1992-7#1)(2006-11#1)(2008-12#1)(2008-2#1)
the upper and##38##3##(1990-11#1)(1991-4#1)(1991-6#1)(1992-11#2)(1992-12#1)(1992-7#1)(1994-12#1)(2006-10#1)(2006-11#4)(2006-8#1)(2006-9#1)(2007-11#3)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)
the upper area of##2##4##(2009-4#2)
the upper arm##9##3##(1991-1#1)(1996-9#1)(2006-6#2)(2007-12#1)(2007-7#3)(2008-5#1)
the upper atmosphere##4##3##(2008-2#1)(2008-3#3)
the upper back##3##3##(2007-7#1)(2012-2#2)
the upper band##3##3##(1990-2#1)(1994-3#1)(2009-11#1)
the upper body##4##3##(2004-11#3)(2010-6#1)
the upper bound is##2##4##(1993-2#1)(2010-2#1)
the upper bound##3##3##(1993-2#1)(2008-2#1)(2010-2#1)
the upper boundary##2##3##(2007-12#1)(2008-2#1)
the upper cervical levels##2##4##(1990-4#1)(2007-4#1)
the upper cervical spine##6##4##(2006-11#1)(2007-1#3)(2007-4#1)(2009-3#1)
the upper cervical##12##3##(1990-4#1)(1992-3#3)(2006-11#1)(2007-1#3)(2007-4#2)(2008-7#1)(2009-3#1)
the upper chamber##2##3##(2008-11#2)
the upper chest##2##3##(2007-7#1)(2008-1#1)
the upper classes##2##3##(2007-10#2)
the upper crust fault zone##2##5##(1996-4#2)
the upper crust##5##3##(1996-4#5)
the upper dermis##2##3##(2010-6#2)
the upper digestive tract##4##4##(1993-9#1)(1995-5#1)(2007-5#1)(2011-2#1)
the upper digestive##5##3##(1991-5#1)(1993-9#1)(1995-5#1)(2007-5#1)(2011-2#1)
the upper end of the##2##5##(1994-9#1)(1996-6#1)
the upper extremities and##2##4##(2008-6#1)(2012-12#1)
the upper extremities##15##3##(1991-4#1)(1992-1#1)(1993-12#1)(1997-4#1)(2005-1#1)(2006-11#1)(2007-10#1)(2007-4#1)(2007-7#3)(2007-8#1)(2008-6#1)(2010-3#1)(2012-12#1)
the upper extremity is##2##4##(2006-3#1)(2011-2#1)
the upper extremity of##2##4##(1991-11#1)(2007-7#1)
the upper extremity##29##3##(1990-11#1)(1991-11#1)(2005-1#1)(2006-3#3)(2006-8#1)(2007-11#3)(2007-7#1)(2008-10#1)(2008-12#1)(2008-9#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-8#1)(2011-2#4)(2012-1#4)(2012-2#1)
the upper gastrointestinal tract##16##4##(1991-9#1)(1993-5#1)(2005-7#1)(2006-10#6)(2007-3#1)(2007-5#1)(2007-8#1)(2008-5#1)(2012-1#2)(2013-1#1)
the upper gastrointestinal##19##3##(1991-2#1)(1991-9#1)(1993-5#1)(1996-3#1)(2005-7#1)(2006-10#6)(2007-3#1)(2007-5#1)(2007-8#1)(2008-5#1)(2008-8#1)(2012-1#2)(2013-1#1)
the upper incisors##2##3##(1991-4#1)(1995-11#1)
the upper jaw##5##3##(1991-1#2)(2010-2#1)(2013-1#1)(2013-7#1)
the upper lasing level##3##4##(2008-3#3)
the upper layer##5##3##(2008-10#2)(2008-2#1)(2008-3#1)(2009-4#1)
the upper layers of the##2##5##(1992-3#1)(1994-5#1)
the upper layers##3##3##(1992-3#1)(1994-5#1)(2010-12#1)
the upper limb##10##3##(1991-4#1)(2007-11#1)(2007-8#1)(2008-7#1)(2008-9#1)(2009-1#2)(2012-1#3)
the upper limbs is##2##4##(2006-10#1)(2013-7#1)
the upper limbs##6##3##(1993-12#1)(2006-10#3)(2007-10#1)(2013-7#1)
the upper limit for the##2##5##(2006-10#1)(2006-12#1)
the upper limit of normal##6##5##(1991-7#2)(1995-4#1)(2007-9#1)(2008-1#1)(2012-3#1)
the upper limit of the normal range##2##7##(1995-10#2)
the upper limit of the##8##5##(1992-2#1)(1993-2#1)(1995-10#2)(1996-1#1)(2008-2#2)(2013-1#1)
the upper limit of##17##4##(1991-7#3)(1992-2#1)(1993-2#1)(1995-10#2)(1995-4#1)(1996-1#1)(1997-8#2)(2007-9#1)(2008-1#1)(2008-2#2)(2012-3#1)(2013-1#1)
the upper limit##25##3##(1991-7#3)(1992-2#1)(1993-2#1)(1995-10#2)(1995-4#1)(1996-1#1)(1997-8#2)(2006-10#1)(2006-12#1)(2006-4#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#2)(2009-2#1)(2012-3#1)(2013-1#2)
the upper lip##4##3##(1995-12#1)(2010-8#1)(2011-2#1)(2013-7#1)
the upper lobe##3##3##(1991-9#1)(2008-4#1)(2013-1#1)
the upper lumbar spine##3##4##(2009-3#3)
the upper lumbar##4##3##(2008-5#1)(2009-3#3)
the upper mantle due to##2##5##(1991-6#1)(1991-8#1)
the upper mantle##5##3##(1991-6#3)(1991-8#1)(1995-6#1)
the upper neck##2##3##(2007-4#2)
the upper ocean##3##3##(2008-2#1)(2008-3#2)
the upper or lower##3##4##(2007-8#1)(2008-10#1)(2008-12#1)
the upper part of the##8##5##(1991-9#1)(1997-5#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-5#2)(2009-4#1)
the upper part of##12##4##(1991-11#1)(1991-9#1)(1993-5#2)(1997-5#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-5#2)(2009-4#1)(2011-2#1)
the upper part##14##3##(1991-11#1)(1991-9#1)(1993-5#2)(1993-9#1)(1997-5#1)(2006-10#1)(2006-2#1)(2007-9#1)(2008-10#1)(2008-5#2)(2009-4#1)(2011-2#1)
the upper phase##7##3##(1990-3#1)(2008-10#4)(2011-1#2)
the upper pole of the kidney##2##6##(1992-8#1)(2008-7#1)
the upper pole##3##3##(1992-3#1)(1992-8#1)(2008-7#1)
the upper portion of the##5##5##(1992-1#1)(2006-6#1)(2007-1#1)(2008-5#1)(2009-9#1)
the upper reaches of the##2##5##(2012-12#1)(2013-8#1)
the upper reaches##3##3##(2010-8#1)(2012-12#1)(2013-8#1)
the upper respiratory tract and##4##5##(1992-4#1)(2008-5#2)(2012-12#1)
the upper respiratory tract##11##4##(1990-8#1)(1992-4#1)(1995-12#1)(2007-4#1)(2008-10#1)(2008-5#2)(2012-12#2)(2013-1#1)(2013-8#1)
the upper respiratory##12##3##(1990-8#1)(1992-4#1)(1995-12#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-5#2)(2012-12#2)(2013-1#1)(2013-8#1)
the upper side of the##4##5##(2005-10#1)(2007-11#1)(2008-10#2)
the upper small intestine##4##4##(1990-2#1)(1995-11#1)(1995-3#1)(2006-10#1)
the upper spinal##2##3##(1991-9#1)(2010-12#1)
the upper surface of the##3##5##(2008-3#1)(2008-5#1)(2011-1#1)
the upper surface of##4##4##(2008-10#1)(2008-3#1)(2008-5#1)(2011-1#1)
the upper tail##2##3##(1993-9#2)
the upper third of the##3##5##(2008-10#1)(2011-12#1)(2012-1#1)
the upper thoracic##3##3##(1991-6#1)(2006-11#1)(2008-5#1)
the upper trapezium muscle with##2##5##(2010-6#1)(2010-9#1)
the upper trapezius muscle##2##4##(2010-9#2)
the upper trapezius##5##3##(2010-9#5)
the upper troposphere##4##3##(2008-2#1)(2008-3#3)
the upper trunk##2##3##(2007-7#1)(2011-2#1)
the upper urinary tract##7##4##(1991-9#1)(1992-3#1)(2006-10#1)(2006-9#1)(2011-2#2)(2013-1#1)
the upper urinary##8##3##(1991-9#1)(1992-3#1)(2006-10#1)(2006-7#1)(2006-9#1)(2011-2#2)(2013-1#1)
the upper zone##2##3##(2006-5#2)
the upper##497##2##(1990-11#2)(1990-2#2)(1990-3#3)(1990-4#1)(1990-6#1)(1990-8#3)(1991-1#3)(1991-11#2)(1991-12#1)(1991-2#1)(1991-4#4)(1991-5#5)(1991-6#7)(1991-7#3)(1991-8#1)(1991-9#7)(1992-1#2)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#6)(1992-4#2)(1992-6#2)(1992-7#2)(1992-8#1)(1993-10#1)(1993-12#2)(1993-2#3)(1993-4#1)(1993-5#6)(1993-9#5)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-7#3)(1994-9#2)(1995-10#2)(1995-11#2)(1995-12#3)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-4#5)(1996-6#2)(1996-9#2)(1997-1#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-8#2)(2004-11#3)(2004-4#1)(2005-1#2)(2005-10#2)(2005-11#4)(2005-5#1)(2005-7#1)(2006-10#14)(2006-11#7)(2006-12#3)(2006-2#1)(2006-3#5)(2006-4#1)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#2)(2006-9#2)(2007-1#6)(2007-10#6)(2007-11#9)(2007-12#7)(2007-3#3)(2007-4#8)(2007-5#10)(2007-7#12)(2007-8#7)(2007-9#3)(2008-1#5)(2008-10#41)(2008-11#2)(2008-12#5)(2008-2#14)(2008-3#15)(2008-4#2)(2008-5#15)(2008-6#3)(2008-7#7)(2008-8#4)(2008-9#8)(2009-1#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#4)(2009-4#7)(2009-5#4)(2009-6#2)(2009-9#2)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#3)(2010-6#4)(2010-8#3)(2010-9#6)(2011-1#5)(2011-12#1)(2011-2#14)(2012-1#11)(2012-12#8)(2012-2#7)(2012-3#3)(2013-1#12)(2013-7#4)(2013-8#8)
the upper-half of the face##5##5##(2010-1#5)
the uppermost##7##2##(2005-10#1)(2007-7#1)(2008-10#3)(2008-5#2)
the upregulation of GFAP mRNA##2##5##(1993-7#1)(1997-3#1)
the upregulation of the##3##4##(2007-12#1)(2012-12#1)(2012-2#1)
the upregulation of##20##3##(1993-3#1)(1993-7#1)(1994-6#1)(1996-3#1)(1996-4#1)(1997-3#1)(2006-10#1)(2007-12#1)(2008-3#1)(2008-4#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2012-12#2)(2012-2#1)(2013-1#2)
the upregulation##21##2##(1993-3#1)(1993-7#2)(1994-6#1)(1996-3#1)(1996-4#1)(1997-3#1)(2006-10#1)(2007-12#1)(2008-3#1)(2008-4#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2012-12#2)(2012-2#1)(2013-1#2)
the upright and##2##3##(1993-2#1)(2010-2#1)
the upright##5##2##(1993-2#1)(2007-8#1)(2008-5#2)(2010-2#1)
the upstream NF-kappaB site##3##4##(1997-7#3)
the upstream activating sequence##2##4##(1991-9#1)(1996-3#1)
the upstream activating##3##3##(1991-9#1)(1996-3#1)(1997-4#1)
the upstream and downstream##2##4##(2008-2#1)(2008-8#1)
the upstream of##2##3##(1997-6#1)(2008-9#1)
the upstream region of the##4##5##(1991-8#1)(1993-3#1)(1995-3#1)(1996-11#1)
the upstream region of##6##4##(1991-8#1)(1993-3#1)(1993-4#1)(1995-3#2)(1996-11#1)
the upstream region##9##3##(1991-8#1)(1991-9#1)(1993-3#1)(1993-4#1)(1994-12#1)(1995-3#2)(1996-11#1)(1997-2#1)
the upstream regulatory element##2##4##(1997-2#1)(1997-6#1)
the upstream regulatory region of##2##5##(1994-10#1)(2009-5#1)
the upstream regulatory region##3##4##(1993-2#1)(1994-10#1)(2009-5#1)
the upstream regulatory##5##3##(1993-2#1)(1994-10#1)(1997-2#1)(1997-6#1)(2009-5#1)
the upstream##53##2##(1990-8#1)(1990-9#1)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#3)(1992-6#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-10#1)(1994-12#1)(1995-2#2)(1995-3#3)(1995-8#2)(1996-11#1)(1996-3#1)(1996-8#1)(1997-2#3)(1997-4#2)(1997-6#2)(1997-7#3)(2005-11#1)(2006-11#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#4)(2009-5#1)(2010-6#1)(2013-1#1)
the uptake and##11##3##(1990-11#1)(1991-5#1)(1992-6#1)(1993-8#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#2)
the uptake capacity##2##3##(2008-5#1)(2012-3#1)
the uptake in the##2##4##(1992-4#1)(1993-12#1)
the uptake of Ca2+ and##2##5##(1994-11#2)
the uptake of Ca2+##3##4##(1993-4#1)(1994-11#2)
the uptake of LDL##3##4##(1991-1#1)(1995-10#1)(2011-2#1)
the uptake of a##2##4##(1994-8#1)(2007-11#1)
the uptake of bile acids##2##5##(1992-3#1)(1994-12#1)
the uptake of glucose##2##4##(1992-6#1)(2008-11#1)
the uptake of iron from##2##5##(1992-4#1)(2008-10#1)
the uptake of iron##3##4##(1992-1#1)(1992-4#1)(2008-10#1)
the uptake of labelled##2##4##(1996-9#1)(1997-8#1)
the uptake of mercury from amalgam fillings based on urinary##2##10##(1995-6#2)
the uptake of radiolabelled methionine##2##5##(1996-2#2)
the uptake of small##2##4##(1990-11#1)(2009-4#1)
the uptake of the##5##4##(1997-1#1)(2008-11#1)(2011-1#1)(2013-7#2)
the uptake of these##2##4##(1991-10#1)(2008-10#1)
the uptake of##98##3##(1990-1#1)(1990-11#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#2)(1991-10#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#4)(1993-11#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-11#2)(1994-12#2)(1994-5#1)(1994-6#2)(1994-8#2)(1995-1#1)(1995-10#1)(1995-11#3)(1995-2#1)(1995-5#1)(1995-6#3)(1996-1#2)(1996-12#1)(1996-2#2)(1996-6#2)(1996-9#1)(1997-1#1)(1997-8#2)(2005-11#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-4#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#2)
the uptake process##3##3##(1990-11#1)(2006-10#1)(2008-7#1)
the uptake rate##2##3##(1990-8#1)(2008-11#1)
the uptake rates##3##3##(1994-8#1)(2008-10#2)
the uptake site##3##3##(1993-4#2)(1996-10#1)
the uptake system is##2##4##(1992-8#1)(2008-10#1)
the uptake system##4##3##(1990-11#1)(1992-8#1)(2008-10#2)
the uptake was##2##3##(1990-2#1)(1997-2#1)
the uptake##149##2##(1990-1#1)(1990-11#5)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#3)(1992-5#1)(1992-6#6)(1992-7#1)(1992-8#1)(1993-11#3)(1993-12#2)(1993-3#1)(1993-4#4)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-5#1)(1994-6#2)(1994-8#3)(1995-1#3)(1995-10#1)(1995-11#3)(1995-2#4)(1995-5#1)(1995-6#3)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#2)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-8#3)(2005-11#1)(2005-4#1)(2006-1#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#17)(2008-11#4)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#4)(2009-4#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)
the upward and downward##2##4##(2008-2#1)(2008-3#1)
the upward##6##2##(1994-8#1)(1997-1#1)(2008-2#1)(2008-3#2)(2008-5#1)
the upwelling irradiance##2##3##(2008-2#1)(2008-3#1)
the upwelling radiance##5##3##(2008-2#3)(2008-3#2)
the upwelling spectral radiance##2##4##(2008-2#2)
the upwelling##11##2##(2008-2#7)(2008-3#4)
the ura5 mutation##2##3##(1995-4#2)
the uracil ring##2##3##(1990-4#1)(2010-2#1)
the uracil##8##2##(1990-4#2)(1992-12#1)(1996-6#1)(1996-7#1)(2008-10#1)(2008-5#1)(2010-2#1)
the uranium##4##2##(2005-11#1)(2008-10#3)
the urban and rural areas##2##5##(1996-3#1)(2007-7#1)
the urban and##6##3##(1991-6#1)(1996-3#1)(2007-2#2)(2007-7#1)(2008-3#1)
the urban area of##8##4##(2008-11#1)(2008-6#2)(2009-10#1)(2012-12#3)(2013-1#1)
the urban area##11##3##(2008-11#1)(2008-3#1)(2008-6#3)(2009-10#1)(2012-12#3)(2012-3#1)(2013-1#1)
the urban areas of##3##4##(1991-6#1)(2008-3#1)(2011-12#1)
the urban areas##5##3##(1991-6#1)(2007-7#1)(2008-3#1)(2008-4#1)(2011-12#1)
the urban diabetics##2##3##(2008-6#2)
the urban environment##2##3##(2007-10#1)(2008-10#1)
the urban population##2##3##(2008-4#1)(2012-2#1)
the urban region##2##3##(2007-9#1)(2008-1#1)
the urban##50##2##(1990-2#1)(1991-12#1)(1991-6#2)(1996-3#1)(2006-2#1)(2007-10#1)(2007-2#3)(2007-7#3)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#4)(2008-4#2)(2008-6#5)(2008-8#1)(2009-10#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-11#2)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
the urchin Diadema##2##3##(2007-3#1)(2008-5#1)
the urea##13##2##(1991-9#1)(1992-7#1)(1993-11#1)(1993-3#1)(1995-6#2)(1996-5#1)(2008-1#1)(2008-10#2)(2008-7#1)(2010-5#1)(2013-8#1)
the urea-induced unfolding##3##3##(1990-2#1)(1990-7#1)(1994-8#1)
the urea-induced##4##2##(1990-2#1)(1990-7#1)(1994-8#1)(1995-5#1)
the urease tests##2##3##(1991-12#2)
the urease##5##2##(1991-12#2)(1991-4#1)(1996-2#1)(2008-10#1)
the uremic##2##2##(2008-1#1)(2008-5#1)
the ureter and##2##3##(2006-9#1)(2011-2#1)
the ureter is a##2##4##(2007-10#1)(2009-5#1)
the ureter is##4##3##(1990-12#1)(2006-7#1)(2007-10#1)(2009-5#1)
the ureter##27##2##(1990-12#2)(1992-3#1)(1996-12#2)(1997-3#3)(1997-4#1)(2006-7#3)(2006-9#2)(2007-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#2)(2009-5#3)(2011-2#1)(2013-7#3)
the ureteric orifices##2##3##(2008-10#2)
the ureters##3##2##(1996-3#1)(2006-6#1)(2008-3#1)
the urethane-anaesthetized rat##2##3##(1996-12#1)(1996-3#1)
the urethra and##5##3##(2008-10#2)(2012-2#1)(2013-1#2)
the urethra##24##2##(1990-7#2)(1991-2#1)(1996-11#3)(1996-12#1)(1997-7#2)(2005-7#1)(2006-8#1)(2008-10#4)(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
the urethral cases##2##3##(2008-10#2)
the urethral cotton swab##2##4##(2006-8#2)
the urethral meatus##2##3##(1992-1#2)
the urethral plate is##2##4##(2008-10#1)(2009-5#1)
the urethral plate##4##3##(2008-10#2)(2009-5#2)
the urethral##20##2##(1990-4#2)(1990-7#1)(1992-1#2)(1996-11#1)(2006-10#1)(2006-8#2)(2008-10#6)(2008-7#1)(2009-5#2)(2013-1#2)
the urgency of the##2##4##(2007-7#1)(2013-1#1)
the urgency of##5##3##(1996-1#1)(2006-10#1)(2007-7#1)(2012-2#1)(2013-1#1)
the urgency##7##2##(1996-1#1)(2006-10#1)(2007-7#1)(2008-10#1)(2011-3#1)(2012-2#1)(2013-1#1)
the urgent need for##2##4##(2010-12#1)(2012-12#1)
the urgent need##3##3##(1994-2#1)(2010-12#1)(2012-12#1)
the urgent##8##2##(1990-12#1)(1994-2#1)(1996-2#1)(2007-10#1)(2008-10#1)(2010-12#1)(2012-1#1)(2012-12#1)
the uric acid##3##3##(1990-11#1)(2008-10#1)(2010-4#1)
the uridine##5##2##(1993-8#1)(1995-8#1)(2006-11#1)(2008-11#1)(2010-2#1)
the urinary LH##2##3##(1992-1#1)(1995-12#1)
the urinary and##2##3##(1992-12#1)(1994-5#1)
the urinary bladder and the urethra##2##6##(1996-11#2)
the urinary bladder and##6##4##(1992-8#1)(1996-11#3)(2011-2#1)(2013-7#1)
the urinary bladder cancer##3##4##(2011-2#3)
the urinary bladder in##2##4##(1994-4#1)(1997-2#1)
the urinary bladder is a##3##5##(1991-4#1)(1992-4#1)(2009-7#1)
the urinary bladder is##4##4##(1991-4#1)(1992-4#1)(2009-7#2)
the urinary bladder of##4##4##(1992-12#1)(2007-7#2)(2012-2#1)
the urinary bladder was##3##4##(1993-2#1)(2012-12#1)(2012-2#1)
the urinary bladder##47##3##(1991-4#1)(1991-6#1)(1992-12#2)(1992-4#1)(1992-8#1)(1993-2#2)(1993-9#2)(1994-4#1)(1995-5#1)(1996-11#3)(1996-12#1)(1997-2#2)(2004-2#1)(2006-9#1)(2007-11#3)(2007-4#2)(2007-7#2)(2008-10#1)(2008-7#1)(2009-5#1)(2009-7#3)(2011-2#6)(2012-12#2)(2012-2#5)(2013-7#1)
the urinary excretion of albumin##2##5##(1990-4#1)(2008-7#1)
the urinary excretion of##13##4##(1990-4#1)(1990-5#1)(1991-12#1)(1992-1#1)(1992-8#1)(1994-5#4)(1994-6#1)(1995-3#1)(2007-4#1)(2008-7#1)
the urinary excretion##15##3##(1990-4#1)(1990-5#1)(1991-12#1)(1992-1#1)(1992-8#1)(1994-5#4)(1994-6#2)(1995-3#1)(2007-4#1)(2008-7#1)(2009-11#1)
the urinary mutagenicity##3##3##(1993-9#3)
the urinary sediment##2##3##(1997-7#2)
the urinary tract and##3##4##(1992-9#1)(1996-12#1)(2008-10#1)
the urinary tract##32##3##(1990-11#2)(1991-12#1)(1992-12#1)(1992-9#3)(1996-12#2)(2006-10#1)(2006-6#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-7#1)(2008-9#1)(2009-1#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
the urinary##137##2##(1990-11#2)(1990-4#1)(1990-5#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-1#3)(1992-12#4)(1992-3#1)(1992-4#1)(1992-8#2)(1992-9#3)(1993-2#3)(1993-8#2)(1993-9#5)(1994-4#2)(1994-5#5)(1994-6#3)(1995-12#1)(1995-3#1)(1995-5#1)(1996-11#3)(1996-12#4)(1996-3#1)(1997-2#2)(1997-3#1)(1997-7#2)(1997-8#1)(2004-2#1)(2006-10#1)(2006-6#1)(2006-7#3)(2006-9#1)(2007-11#3)(2007-12#1)(2007-4#3)(2007-5#2)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#7)(2008-7#4)(2008-9#1)(2009-1#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#3)(2009-8#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#7)(2012-11#1)(2012-12#5)(2012-2#7)(2013-1#6)(2013-7#1)(2013-8#2)
the urine by##2##3##(1994-8#1)(2007-2#1)
the urine culture##4##3##(1996-1#1)(2007-7#1)(2008-1#1)(2010-12#1)
the urine from a patient with ASLD##2##7##(1993-11#2)
the urine from patients with##2##5##(1993-11#1)(1993-9#1)
the urine from##6##3##(1991-9#2)(1993-11#3)(1993-9#1)
the urine matrix##3##3##(2007-8#1)(2008-10#2)
the urine of hard metal workers##2##6##(1994-6#2)
the urine of healthy##3##4##(1991-12#1)(1995-3#1)(1996-8#1)
the urine of patients with##5##5##(1992-7#2)(1993-11#2)(1997-2#1)
the urine of patients##9##4##(1990-4#1)(1992-7#2)(1993-11#2)(1996-2#1)(1997-2#1)(2006-10#1)(2009-5#1)
the urine of the##2##4##(2007-7#1)(2008-7#1)
the urine of##29##3##(1990-12#1)(1990-4#1)(1991-12#1)(1992-3#1)(1992-7#2)(1993-11#2)(1993-8#1)(1994-5#1)(1994-6#6)(1995-11#1)(1995-3#1)(1996-12#2)(1996-2#1)(1996-8#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-7#1)(2008-7#1)(2009-3#1)(2009-5#1)
the urine sample##8##3##(1990-2#1)(1996-12#1)(2005-12#1)(2005-8#1)(2007-1#1)(2008-10#3)
the urine samples##6##3##(1996-2#1)(2008-10#3)(2010-12#2)
the urine was##2##3##(1992-7#1)(1997-3#1)
the urine were##3##3##(1992-5#1)(2010-8#1)(2013-1#1)
the urine##122##2##(1990-12#5)(1990-2#1)(1990-3#2)(1990-4#2)(1991-11#1)(1991-12#2)(1991-9#2)(1992-3#2)(1992-5#1)(1992-7#3)(1993-11#5)(1993-2#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-6#9)(1994-8#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#4)(1995-4#1)(1996-1#2)(1996-12#3)(1996-2#2)(1996-8#3)(1997-2#1)(1997-3#3)(1997-7#1)(1997-8#1)(2004-11#2)(2004-12#1)(2005-12#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-7#4)(2007-8#5)(2008-1#1)(2008-10#15)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#4)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-12#4)(2010-8#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
the urogenital sinus##4##3##(2006-8#2)(2008-10#2)
the urogenital tract##8##3##(1993-1#1)(1995-5#1)(1997-2#1)(1997-5#1)(1997-6#1)(2007-11#1)(2008-5#2)
the urogenital##14##2##(1993-1#1)(1995-5#1)(1997-2#1)(1997-5#1)(1997-6#1)(2006-7#1)(2006-8#2)(2007-11#1)(2008-10#2)(2008-5#2)(2012-3#1)
the urological##6##2##(2006-7#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-11#1)
the urologist##4##2##(2006-7#1)(2008-10#1)(2008-3#1)(2011-1#1)
the uroporphyrin photosensitivity##2##3##(1991-10#2)
the uroporphyrin##4##2##(1991-10#4)
the urothelium and##2##3##(1992-12#1)(2013-8#1)
the urothelium##5##2##(1992-12#1)(1995-1#1)(2011-12#1)(2012-1#1)(2013-8#1)
the usability of##2##3##(2007-12#1)(2012-12#1)
the usability##5##2##(2007-12#1)(2007-5#1)(2012-12#1)(2013-1#2)
the usable life of##2##4##(2007-7#1)(2007-8#1)
the usable##3##2##(2007-7#1)(2007-8#1)(2008-2#1)
the usage of a##3##4##(2007-7#1)(2008-2#1)(2012-12#1)
the usage of the##6##4##(1993-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-3#1)(2011-2#1)
the usage of this##2##4##(2009-3#1)(2011-2#1)
the usage of##32##3##(1993-3#1)(1993-5#1)(1993-6#1)(1996-2#1)(1996-3#1)(1997-2#2)(2005-10#1)(2005-11#1)(2005-3#1)(2006-2#1)(2007-11#2)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-3#2)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)
the usage##34##2##(1993-3#1)(1993-5#1)(1993-6#1)(1996-2#1)(1996-3#1)(1997-2#2)(2005-10#1)(2005-11#1)(2005-3#1)(2006-2#1)(2007-11#2)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-3#2)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
the use and contents of free-text##4##6##(2013-1#4)
the use and effectiveness of##2##5##(1994-7#1)(1997-3#1)
the use and monitoring of##2##5##(2007-7#1)(2012-12#1)
the use and##31##3##(1994-7#1)(1996-9#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-12#2)(2013-1#9)(2013-7#1)(2013-8#2)
the use in##7##3##(2006-10#1)(2007-7#1)(2008-10#2)(2008-11#1)(2009-3#1)(2012-1#1)
the use of &quot##6##4##(1992-10#1)(1996-3#1)(2006-10#1)(2010-12#1)(2010-5#1)(2012-12#1)
the use of AEDs##2##4##(2006-10#1)(2007-4#1)
the use of CBT##2##4##(2007-6#2)
the use of CT##4##4##(2006-10#1)(2007-7#1)(2008-3#1)(2011-2#1)
the use of DNA as##2##5##(2008-11#1)(2013-8#1)
the use of DNA##6##4##(2008-10#1)(2008-11#1)(2008-4#1)(2012-3#2)(2013-8#1)
the use of Fourier##2##4##(2008-10#1)(2008-2#1)
the use of GFP##2##4##(1996-6#1)(2008-11#1)
the use of Gaussian##2##4##(1993-9#1)(2008-6#1)
the use of HGF##2##4##(2007-11#2)
the use of HH therapy##2##5##(2007-10#2)
the use of HPLC##2##4##(1991-5#2)
the use of HRT##2##4##(2008-4#2)
the use of IR-photoactivated TiO(2) nanocoatings on titanium implants to mitigate the onset of surgical site infections is described##2##19##(2012-11#2)
the use of IV##2##4##(2005-10#1)(2007-7#1)
the use of IVIG in dermatologic diseases##2##7##(2005-11#2)
the use of IVIG in##4##5##(2005-11#3)(2007-12#1)
the use of IVIG##5##4##(2005-11#4)(2007-12#1)
the use of IVIg##2##4##(2007-11#2)
the use of KT following musculoskeletal injury##2##7##(2013-1#2)
the use of KT##3##4##(2013-1#3)
the use of MRI##3##4##(1995-1#1)(2007-11#1)(2007-4#1)
the use of Medicare##2##4##(1994-2#1)(1994-3#1)
the use of Mersilene mesh##2##5##(1990-4#2)
the use of N##3##4##(2007-1#1)(2008-10#1)(2011-1#1)
the use of NSAIDs##2##4##(2006-10#1)(2008-12#1)
the use of OPV##2##4##(1995-5#1)(2004-12#1)
the use of PCR##3##4##(1995-1#1)(2008-4#1)(2008-5#1)
the use of SIT##3##4##(2011-2#3)
the use of SPC##2##4##(1995-2#2)
the use of TCAM##2##4##(2009-6#2)
the use of Xenopus oocytes##2##5##(2007-12#2)
the use of a TD##2##5##(2007-7#2)
the use of a Western model of adolescent development##2##9##(2010-7#2)
the use of a combination of##7##6##(1996-9#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-7#1)
the use of a commercial##4##5##(1991-8#1)(2007-8#1)(2008-10#1)(2013-8#1)
the use of a comparative##2##5##(2008-10#1)(2009-5#1)
the use of a computer##2##5##(2008-11#1)(2008-3#1)
the use of a continuous##2##5##(1994-3#1)(2013-8#1)
the use of a different##2##5##(1990-7#1)(1992-2#1)
the use of a diode##2##5##(2008-3#1)(2008-4#1)
the use of a high-speed##2##5##(2008-1#1)(2008-3#1)
the use of a highly##2##5##(2007-8#1)(2008-3#1)
the use of a homologous promoter##3##6##(2006-11#3)
the use of a laser##2##5##(2008-2#2)
the use of a less##3##5##(2007-11#1)(2008-1#1)(2008-10#1)
the use of a linear##2##5##(1993-10#1)(2011-12#1)
the use of a measure##2##5##(2008-8#1)(2009-11#1)
the use of a new##5##5##(1991-1#1)(1997-5#1)(2006-7#1)(2006-8#1)(2009-2#1)
the use of a novel technique##3##6##(2007-11#1)(2007-12#2)
the use of a novel##4##5##(2007-11#1)(2007-12#2)(2008-9#1)
the use of a patient##2##5##(1995-2#1)(2008-12#1)
the use of a phase mask##2##6##(2007-12#1)(2008-2#1)
the use of a polymerase chain##3##6##(2008-5#2)(2012-2#1)
the use of a protocol##2##5##(1997-1#1)(2007-11#1)
the use of a set of##3##6##(2007-9#1)(2008-10#2)
the use of a simple##4##5##(1992-6#1)(2006-12#1)(2008-2#1)(2008-3#1)
the use of a single##5##5##(1995-8#1)(2008-10#2)(2008-6#1)(2009-10#1)
the use of a spinal##2##5##(2007-7#1)(2008-7#1)
the use of a structured questionnaire##2##6##(2007-2#1)(2010-3#1)
the use of a suitable##3##5##(1990-11#1)(2008-2#1)(2008-7#1)
the use of a two-step##2##5##(2008-9#1)(2013-8#1)
the use of a##305##4##(1990-11#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-12#4)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-10#1)(1993-2#1)(1993-3#3)(1993-4#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-11#1)(1996-2#1)(1996-5#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-5#1)(2004-9#1)(2005-11#2)(2005-8#1)(2006-10#3)(2006-11#3)(2006-12#2)(2006-3#1)(2006-4#2)(2006-5#4)(2006-6#2)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#10)(2007-12#20)(2007-2#1)(2007-7#10)(2007-8#4)(2007-9#3)(2008-1#4)(2008-10#38)(2008-11#5)(2008-12#4)(2008-2#14)(2008-3#25)(2008-4#7)(2008-5#5)(2008-6#5)(2008-7#5)(2008-8#1)(2008-9#4)(2009-10#2)(2009-11#3)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#2)(2010-10#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#5)(2013-7#3)(2013-8#6)
the use of adaptive optics##2##5##(2007-12#1)(2011-1#1)
the use of adjuvant##5##4##(1994-8#1)(1995-4#1)(2007-2#1)(2008-7#1)(2010-5#1)
the use of alefacept in##2##5##(2008-5#2)
the use of alternative treatment by##2##6##(1990-4#2)
the use of alternative##6##4##(1990-4#2)(1995-3#1)(2005-8#1)(2006-10#1)(2008-12#1)
the use of amantadine##2##4##(2007-12#1)(2011-10#1)
the use of ambiguous##2##4##(2011-2#1)(2011-3#1)
the use of an antibody##2##5##(1993-8#1)(2008-4#1)
the use of an intravenous##2##5##(2006-10#1)(2009-1#1)
the use of an##70##4##(1990-3#1)(1991-10#1)(1991-3#1)(1992-2#1)(1993-2#1)(1993-8#1)(1994-9#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(2004-12#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-3#1)(2007-5#1)(2007-6#1)(2008-1#3)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#2)(2008-5#5)(2009-1#1)(2009-12#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#3)
the use of and##3##4##(1990-12#1)(1991-3#1)(1996-2#1)
the use of animal models##2##5##(2005-8#1)(2008-7#1)
the use of animal##4##4##(2005-8#1)(2008-11#1)(2008-7#1)(2013-1#1)
the use of animals in##4##5##(1996-12#1)(2007-3#1)(2008-10#1)(2012-2#1)
the use of animals##5##4##(1990-12#1)(1996-12#1)(2007-3#1)(2008-10#1)(2012-2#1)
the use of antibiotics covering both aerobic and anaerobic bacterial spectrum and the good coordination between otolaryngologists##2##17##(2008-8#1)(2008-9#1)
the use of antibiotics##6##4##(1997-5#1)(2006-2#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#1)
the use of anticoagulants##5##4##(1995-4#1)(2006-10#1)(2011-1#1)(2012-12#2)
the use of anticoagulation in patients with##2##7##(2006-8#1)(2007-9#1)
the use of anticoagulation in##3##5##(2005-12#1)(2006-8#1)(2007-9#1)
the use of antidepressants##3##4##(2006-7#1)(2006-9#1)(2013-8#1)
the use of antimicrobial drugs##2##5##(1997-5#1)(2008-11#1)
the use of antimicrobial##3##4##(1997-5#1)(2008-11#1)(2008-5#1)
the use of antiplatelet agents##2##5##(2006-4#1)(2008-8#1)
the use of antiplatelet##3##4##(2006-4#1)(2007-8#1)(2008-8#1)
the use of antisense##2##4##(2006-12#1)(2008-5#1)
the use of any##4##4##(2004-4#1)(2006-10#1)(2008-10#1)(2008-4#1)
the use of appropriate##8##4##(1994-9#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2012-12#1)
the use of aqueous standards for calibration##2##7##(2007-8#1)(2008-10#1)
the use of aqueous##3##4##(1996-11#1)(2007-8#1)(2008-10#1)
the use of artificial##4##4##(2006-10#1)(2007-1#1)(2009-3#1)(2009-4#1)
the use of aspirin in##3##5##(1990-3#1)(1996-2#1)(2010-6#1)
the use of assisted reproductive technology##2##6##(2009-4#2)
the use of autogenous##2##4##(2007-8#1)(2011-3#1)
the use of autologous##4##4##(2008-1#1)(2009-3#1)(2011-12#1)(2012-12#1)
the use of automated##5##4##(1995-1#1)(1995-11#1)(1996-12#1)(2008-10#1)(2008-3#1)
the use of bacterial##2##4##(1990-9#1)(2012-2#1)
the use of balloon##2##4##(1991-4#1)(2012-3#1)
the use of bare##2##4##(1997-4#1)(2008-12#1)
the use of beta##2##4##(2005-9#1)(2008-10#1)
the use of bispecific##2##4##(2008-3#2)
the use of blood##2##4##(2010-2#1)(2010-8#1)
the use of bone marrow-derived##2##5##(2010-6#1)(2012-12#1)
the use of bone##7##4##(2007-11#1)(2007-4#1)(2008-1#1)(2008-8#1)(2010-6#1)(2012-12#2)
the use of both##15##4##(1997-2#1)(1997-8#1)(2006-10#1)(2007-10#1)(2008-10#2)(2008-2#2)(2008-8#1)(2009-5#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
the use of calcium##6##4##(1990-3#1)(1997-1#1)(2005-4#1)(2007-7#1)(2008-4#1)(2012-12#1)
the use of carbon dioxide##2##5##(2007-8#2)
the use of carbon##3##4##(2007-8#2)(2008-5#1)
the use of cardiac##3##4##(1995-8#1)(2008-3#1)(2009-4#1)
the use of cardiopulmonary bypass##4##5##(2006-10#1)(2007-8#3)
the use of cell##2##4##(1997-1#1)(2011-2#1)
the use of centrifugal##2##4##(1996-12#1)(2013-1#1)
the use of certain##2##4##(1992-8#1)(1994-12#1)
the use of cervical##2##4##(2007-11#1)(2007-7#1)
the use of chemical##3##4##(2007-8#1)(2012-2#1)(2013-8#1)
the use of chemotherapy##2##4##(2005-11#1)(2012-3#1)
the use of chloroquine##2##4##(2010-12#2)
the use of chromatographic##2##4##(2008-10#1)(2010-9#1)
the use of clinical##2##4##(1994-5#1)(2006-2#1)
the use of clonidine for regional##2##6##(2006-10#2)
the use of clonidine##3##4##(2006-10#3)
the use of combination therapy##2##5##(2008-2#1)(2012-2#1)
the use of combination##7##4##(2008-2#1)(2008-6#1)(2010-11#1)(2012-11#1)(2012-2#1)(2012-3#2)
the use of combined##4##4##(1993-6#1)(2008-10#2)(2008-5#1)
the use of communication strategies##2##5##(2012-3#2)
the use of community##2##4##(1996-1#1)(2012-12#1)
the use of complex##2##4##(2006-6#1)(2007-12#1)
the use of computer software##2##5##(2008-9#2)
the use of computer##3##4##(2008-9#2)(2010-8#1)
the use of computer-aided##2##4##(2007-12#1)(2010-11#1)
the use of computerized tomography##2##5##(1991-1#1)(1996-8#1)
the use of computers in##2##5##(1993-3#1)(2006-10#1)
the use of condoms##4##4##(2006-7#2)(2008-2#1)(2009-5#1)
the use of contact##2##4##(2005-11#1)(2012-12#1)
the use of contrast agents##4##5##(2006-10#1)(2008-7#3)
the use of contrast##6##4##(2006-10#1)(2006-6#1)(2008-7#3)(2008-9#1)
the use of controlled substances##3##5##(2006-8#3)
the use of conventional##6##4##(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2013-7#1)
the use of cord blood##2##5##(2008-1#1)(2008-11#1)
the use of cosmetics##2##4##(2008-5#2)
the use of critical##2##4##(1995-12#2)
the use of cross-linking##2##4##(1990-5#1)(2008-1#1)
the use of cuffed endotracheal tubes##2##6##(2006-10#1)(2013-1#1)
the use of cultivars##2##4##(2008-10#2)
the use of cyclophosphamide##2##4##(2006-10#1)(2007-7#1)
the use of cyclosporin##4##4##(2005-8#1)(2007-11#3)
the use of data##3##4##(1996-3#1)(2010-8#1)(2011-2#1)
the use of dendrimers##2##4##(2008-1#2)
the use of detergents##3##4##(1990-12#1)(1992-6#1)(2008-4#1)
the use of different methods##3##5##(2008-10#1)(2008-5#1)(2012-2#1)
the use of different polyadenylation site signals##2##7##(1990-2#2)
the use of different types of##2##6##(2008-6#1)(2010-4#1)
the use of different##25##4##(1990-2#2)(2005-10#1)(2005-11#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#2)(2008-9#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)
the use of digital##3##4##(2008-3#1)(2008-7#1)(2010-8#1)
the use of direct##6##4##(1990-12#1)(2007-11#1)(2007-12#2)(2008-10#1)(2010-8#1)
the use of diuretics and##2##5##(1992-9#1)(1995-10#1)
the use of dried##2##4##(1994-6#1)(2010-11#1)
the use of drugs and##2##5##(1990-4#1)(2006-8#1)
the use of drugs##9##4##(1990-4#2)(1993-5#1)(1997-2#1)(2006-10#1)(2006-8#1)(2008-4#1)(2010-12#1)(2011-2#1)
the use of dual##2##4##(2008-10#1)(2008-8#1)
the use of e-mail##2##4##(2007-10#1)(2012-3#1)
the use of early##4##4##(1991-3#1)(1997-1#1)(2007-8#1)(2008-11#1)
the use of either##6##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-12#1)(2013-8#1)
the use of electronic##4##4##(2008-1#1)(2008-8#1)(2009-10#1)(2010-8#1)
the use of electrospinning for TE applications##2##7##(2010-10#2)
the use of embryonic stem cells for medical purposes##3##9##(2006-7#1)(2006-8#2)
the use of embryonic stem cells for therapeutical purposes##3##9##(2006-8#3)
the use of embryonic stem cells for##7##7##(2006-7#1)(2006-8#6)
the use of embryonic stem cells##10##6##(2006-7#2)(2006-8#8)
the use of embryonic##11##4##(2006-7#2)(2006-8#8)(2008-9#1)
the use of endoscopic##3##4##(2006-10#2)(2012-12#1)
the use of enoxaparin in##2##5##(2008-3#2)
the use of enoxaparin##3##4##(2007-10#1)(2008-3#2)
the use of enteral##2##4##(2006-10#2)
the use of evidence##2##4##(2010-9#1)(2012-3#1)
the use of evidence-based##2##4##(2008-10#1)(2012-1#1)
the use of excimer##2##4##(2008-3#1)(2012-2#1)
the use of existing##4##4##(2006-9#1)(2008-11#1)(2012-12#1)(2012-3#1)
the use of experimental##3##4##(2008-8#1)(2010-2#1)(2012-11#1)
the use of fast##3##4##(1997-2#1)(2008-3#1)(2008-6#1)
the use of feedback##2##4##(2009-10#2)
the use of figural rating scales to##2##7##(2007-12#2)
the use of first##3##4##(1991-12#1)(2008-10#1)(2008-2#1)
the use of flow cytometry##2##5##(2008-9#2)
the use of flow##3##4##(2008-10#1)(2008-9#2)
the use of fluorescence##2##4##(1993-3#1)(2005-11#1)
the use of fluorescent##3##4##(2007-3#1)(2008-4#1)(2008-9#1)
the use of fluoroquinolones##2##4##(1991-12#1)(2010-11#1)
the use of food##2##4##(1991-12#1)(1996-12#1)
the use of force##2##4##(1995-5#1)(1995-6#1)
the use of four##3##4##(1995-2#1)(2007-11#1)(2007-8#1)
the use of functional##5##4##(2006-3#2)(2007-10#1)(2008-5#1)(2008-9#1)
the use of galactography##2##4##(1990-11#1)(1991-9#1)
the use of gamma##2##4##(2008-11#1)(2011-2#1)
the use of gene therapy##2##5##(2007-11#1)(2007-8#1)
the use of gene##5##4##(1991-9#1)(2007-11#2)(2007-8#1)(2009-5#1)
the use of general##3##4##(2006-10#1)(2008-10#1)(2008-9#1)
the use of genetic##2##4##(1997-8#1)(2006-12#1)
the use of genetically engineered##2##5##(2007-8#1)(2011-1#1)
the use of genetically##4##4##(2007-8#1)(2008-8#1)(2008-9#1)(2011-1#1)
the use of geospatial data##3##5##(2008-8#3)
the use of global##2##4##(1994-1#1)(2013-1#1)
the use of glycoprotein IIb/IIIa inhibitors##2##6##(2008-3#2)
the use of glycoprotein IIb/IIIa##3##5##(2008-3#3)
the use of green fluorescent##2##5##(2007-8#1)(2008-9#1)
the use of heating##2##4##(1990-2#2)
the use of herbal medicines##2##5##(2006-8#2)
the use of herbal##4##4##(2006-8#3)(2013-1#1)
the use of high performance##2##5##(2008-10#1)(2008-7#1)
the use of high##13##4##(2005-11#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2013-1#1)
the use of high-dose##2##4##(2006-10#1)(2007-11#1)
the use of highly sensitive##2##5##(2007-5#1)(2008-3#1)
the use of highly##6##4##(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-3#1)(2009-5#1)
the use of home health services##2##6##(1995-3#2)
the use of home##3##4##(1995-3#2)(2009-6#1)
the use of homologous blood##3##5##(1992-3#1)(1996-9#2)
the use of homologous##5##4##(1992-3#1)(1993-11#1)(1996-9#2)(2010-8#1)
the use of hormonal##2##4##(1994-9#1)(2005-1#1)
the use of hospital##5##4##(1991-1#1)(1991-2#1)(1993-11#1)(1994-2#2)
the use of host##2##4##(1991-9#1)(2008-10#1)
the use of human##6##4##(1992-5#1)(2005-12#1)(2008-4#1)(2012-11#1)(2012-12#1)(2013-1#1)
the use of image##2##4##(1996-2#1)(2008-4#1)
the use of imaging##2##4##(2007-11#1)(2007-4#1)
the use of immunohistochemical and##2##5##(1992-11#1)(1996-9#1)
the use of immunohistochemical##3##4##(1992-11#1)(1996-9#1)(2007-2#1)
the use of immunosuppressive##2##4##(1994-5#1)(2006-10#1)
the use of implants##4##4##(1996-3#1)(2007-11#2)(2007-12#1)
the use of in situ##2##5##(1993-7#1)(2008-2#1)
the use of in##3##4##(1993-7#1)(2008-2#1)(2008-4#1)
the use of inexpensive##2##4##(1991-9#1)(2008-10#1)
the use of information technology in##2##6##(2008-10#2)
the use of information##7##4##(1992-2#1)(1996-12#1)(1997-8#1)(2006-2#1)(2008-10#2)(2013-1#1)
the use of infrared##2##4##(2007-12#1)(2008-10#1)
the use of inhalational##2##4##(2006-10#1)(2011-2#1)
the use of injection##2##4##(1994-4#1)(2008-1#1)
the use of insulin##2##4##(2008-1#1)(2009-11#1)
the use of internal##2##4##(1991-2#1)(2008-12#1)
the use of interventions to prevent infections after knee arthroplasty##2##10##(2011-2#2)
the use of interventions to prevent infections##3##7##(2011-2#3)
the use of interventions##4##4##(2007-10#1)(2011-2#3)
the use of intraoperative##2##4##(2012-12#1)(2013-7#1)
the use of intravenous##5##4##(2005-8#1)(2006-11#1)(2007-9#2)(2010-3#1)
the use of invasive##3##4##(2005-8#1)(2007-4#1)(2011-2#1)
the use of iodized salt##2##5##(2006-10#1)(2013-1#1)
the use of irony in young men's stories about romantic##2##10##(2009-5#2)
the use of ketamine##3##4##(2010-2#1)(2010-7#1)(2012-12#1)
the use of knowledge for the##2##6##(2008-2#2)
the use of labels##3##4##(1992-3#1)(2008-4#2)
the use of laboratory animals##2##5##(1993-8#1)(2008-10#1)
the use of laboratory tests##2##5##(1991-2#1)(1994-12#1)
the use of laboratory##6##4##(1991-2#1)(1993-2#1)(1993-8#1)(1994-12#1)(1995-5#1)(2008-10#1)
the use of laparoscopic##2##4##(1993-3#1)(2011-2#1)
the use of laparoscopy##3##4##(2008-3#1)(2011-2#2)
the use of large quantities##2##5##(2007-11#1)(2012-12#1)
the use of large##3##4##(2007-11#1)(2008-12#1)(2012-12#1)
the use of laser##3##4##(1991-9#1)(2008-10#2)
the use of learning##2##4##(2008-11#1)(2008-2#1)
the use of left##2##4##(2007-8#2)
the use of less##4##4##(2007-12#1)(2008-3#1)(2011-1#1)(2011-2#1)
the use of limited##3##4##(2008-10#1)(2008-3#1)(2008-7#1)
the use of liquid##3##4##(2008-10#1)(2008-4#1)(2010-7#1)
the use of live##3##4##(2009-5#1)(2010-8#1)(2011-2#1)
the use of living##3##4##(1991-3#1)(2006-10#1)(2008-11#1)
the use of long-term##2##4##(1996-6#1)(2008-4#1)
the use of low##3##4##(1990-2#1)(2008-2#1)(2012-3#1)
the use of low-melting##2##4##(2008-2#1)(2009-2#1)
the use of machine learning##2##5##(2008-7#1)(2010-2#1)
the use of magnetic resonance##2##5##(1991-5#1)(2007-7#1)
the use of magnetic##3##4##(1991-5#1)(2007-7#1)(2010-11#1)
the use of magneto-optical modulation##2##5##(2008-3#2)
the use of manual##2##4##(2007-1#1)(2010-3#1)
the use of matrix##2##4##(2005-4#1)(2007-3#1)
the use of medical##9##4##(1992-12#1)(1993-6#1)(1996-6#1)(2004-7#1)(2007-10#2)(2008-11#2)(2008-4#1)
the use of medications##4##4##(1993-9#1)(2005-6#1)(2007-6#1)(2008-8#1)
the use of medicinal##2##4##(2007-7#1)(2009-10#1)
the use of medicines##2##4##(2008-8#1)(2011-1#1)
the use of metformin##2##4##(2008-1#1)(2012-3#1)
the use of microteaching##3##4##(2008-11#3)
the use of mild##2##4##(1997-2#1)(2010-2#1)
the use of milnacipran##2##4##(2008-6#1)(2011-1#1)
the use of mixed##2##4##(2008-10#1)(2008-2#1)
the use of models##3##4##(1997-8#1)(2008-10#1)(2008-3#1)
the use of modern##5##4##(1990-6#1)(2006-2#1)(2007-6#1)(2008-10#1)(2009-5#1)
the use of modified##3##4##(2008-10#1)(2010-9#1)(2011-2#1)
the use of molecular techniques##3##5##(1991-5#1)(2009-8#1)(2012-2#1)
the use of molecular##7##4##(1991-5#1)(2006-10#1)(2008-10#1)(2008-9#1)(2009-8#1)(2012-2#1)(2013-1#1)
the use of monoclonal antibodies##2##5##(1993-6#1)(1995-3#1)
the use of monoclonal##4##4##(1993-6#1)(1995-3#1)(1997-7#1)(2010-12#1)
the use of more effective##4##5##(2006-10#1)(2008-4#1)(2012-11#1)(2013-1#1)
the use of more##12##4##(1997-8#1)(2006-10#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-2#1)(2011-2#1)(2012-11#1)(2013-1#1)
the use of mosquito nets##2##5##(2007-2#1)(2013-8#1)
the use of most##3##4##(2007-11#1)(2008-7#1)(2013-8#1)
the use of multidimensional##2##4##(1995-5#1)(2012-3#1)
the use of multimodality##2##4##(2006-7#1)(2009-11#1)
the use of multinuclear MRS##2##5##(2012-2#2)
the use of multiple drugs##2##5##(1990-8#1)(2006-8#1)
the use of multiple logistic regression##2##6##(1991-3#1)(1995-4#1)
the use of multiple##14##4##(1990-8#1)(1991-3#1)(1993-6#1)(1995-4#1)(2006-10#1)(2006-8#1)(2008-10#3)(2008-4#1)(2008-7#1)(2009-8#1)(2010-11#1)(2011-12#1)
the use of multivariate##2##4##(2008-10#2)
the use of nanomaterials##2##4##(2007-8#1)(2010-7#1)
the use of nanoparticles##2##4##(2007-11#1)(2013-1#1)
the use of nasal##2##4##(2010-8#1)(2011-2#1)
the use of neoadjuvant##3##4##(2006-10#1)(2013-8#2)
the use of neuroleptic##2##4##(2007-6#1)(2012-2#1)
the use of neuromuscular blocking agents##2##6##(2007-9#1)(2010-11#1)
the use of neuromuscular##3##4##(2006-8#1)(2007-9#1)(2010-11#1)
the use of new##3##4##(1991-12#1)(2008-11#1)(2013-8#1)
the use of nine##2##4##(1991-1#1)(2008-10#1)
the use of nitrous oxide##3##5##(2006-10#3)
the use of non-peer-reviewed##2##4##(2005-7#2)
the use of non-steroidal anti-inflammatory drugs (NSAIDs)##2##7##(2006-7#1)(2008-12#1)
the use of nonlinear##2##4##(2007-11#2)
the use of nonsteroidal anti-inflammatory drugs##2##6##(2007-2#1)(2012-12#1)
the use of novel##5##4##(2006-8#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-11#1)
the use of objective##2##4##(2008-11#1)(2009-2#1)
the use of omega-3##2##4##(1990-2#1)(2006-7#1)
the use of on-line##2##4##(2008-10#1)(2010-4#1)
the use of one##2##4##(2008-4#1)(2012-12#1)
the use of only##6##4##(2008-10#1)(2008-3#2)(2008-4#1)(2008-9#1)(2010-6#1)
the use of opioids##4##4##(2006-10#2)(2008-7#1)(2010-2#1)
the use of optical##3##4##(2005-11#1)(2007-5#1)(2008-3#1)
the use of optimal##3##4##(1996-2#1)(2005-8#1)(2008-3#1)
the use of oral contraceptives (OC)##2##6##(1990-11#1)(2008-11#1)
the use of oral contraceptives##6##5##(1990-11#3)(1991-8#1)(2008-11#2)
the use of oral##14##4##(1990-11#3)(1991-8#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-11#2)(2008-3#1)(2008-8#1)(2012-2#1)
the use of organic solvents##3##5##(2006-6#1)(2008-10#1)(2008-5#1)
the use of organic##5##4##(2006-6#1)(2007-11#1)(2008-10#2)(2008-5#1)
the use of other##5##4##(1993-9#1)(2005-10#1)(2005-7#1)(2006-9#1)(2011-2#1)
the use of our##3##4##(1990-3#1)(2008-10#1)(2008-2#1)
the use of pathways##2##4##(2008-3#2)
the use of patient satisfaction##2##5##(1996-1#2)
the use of patient##3##4##(1996-1#2)(2006-10#1)
the use of pediatric medicines and##3##6##(2008-9#3)
the use of personal##2##4##(1994-3#1)(2009-5#1)
the use of pharmacological##2##4##(2005-10#1)(2008-1#1)
the use of placebo##2##4##(2007-12#1)(2008-5#1)
the use of plain##2##4##(2008-5#1)(2008-7#1)
the use of planar##2##4##(2007-12#1)(2008-3#1)
the use of plants##2##4##(2012-12#1)(2013-8#1)
the use of polymerase chain reaction for##2##7##(2006-10#1)(2007-8#1)
the use of polymerase chain##3##5##(1995-6#1)(2006-10#1)(2007-8#1)
the use of positron emission tomography##2##6##(1995-11#1)(2006-2#1)
the use of postmenopausal##2##4##(1993-6#1)(2008-3#1)
the use of potent##2##4##(2006-10#1)(2007-11#1)
the use of practice##2##4##(1993-3#1)(2007-4#1)
the use of prenatal care##3##5##(1992-2#1)(1993-3#2)
the use of preventive##2##4##(1994-2#1)(2013-8#1)
the use of principal##3##4##(2008-10#1)(2009-9#1)(2010-5#1)
the use of probiotic##2##4##(2008-5#1)(2009-12#1)
the use of prophylactic##6##4##(2006-9#1)(2008-3#1)(2008-7#2)(2012-1#1)(2012-3#1)
the use of propofol##2##4##(2006-10#1)(2011-2#1)
the use of psychoactive substances##2##5##(2008-1#1)(2013-1#1)
the use of psychotherapeutic interventions##2##5##(2008-6#1)(2013-8#1)
the use of psychotropic drugs##2##5##(2009-3#1)(2011-2#1)
the use of pulsed##4##4##(1992-3#1)(1995-4#1)(2006-12#1)(2012-3#1)
the use of radiotherapy##3##4##(2008-7#1)(2012-2#2)
the use of real-time##2##4##(2007-10#1)(2008-6#1)
the use of recombinant##4##4##(2007-11#1)(2007-7#1)(2008-11#1)(2013-1#1)
the use of reference##2##4##(1995-1#1)(1996-10#1)
the use of regional anaesthesia##3##5##(2006-10#3)
the use of regional##5##4##(1993-4#2)(2006-10#3)
the use of regular##2##4##(1995-9#1)(2008-7#1)
the use of research##3##4##(1996-1#1)(2008-12#1)(2009-2#1)
the use of resistant cultivars##2##5##(2008-10#2)
the use of resources##3##4##(1995-12#1)(2006-10#1)(2011-2#1)
the use of robots in##2##5##(2012-1#1)(2013-1#1)
the use of routine##2##4##(2008-7#1)(2009-4#1)
the use of satellite##2##4##(2008-10#1)(2008-9#1)
the use of screening##2##4##(1995-4#1)(2008-11#1)
the use of selective##4##4##(1997-5#2)(2008-10#1)(2008-12#1)
the use of serum##4##4##(1994-11#1)(2008-11#1)(2009-10#1)(2013-8#1)
the use of services and##2##5##(1991-2#1)(1993-3#1)
the use of services##4##4##(1991-2#1)(1993-3#1)(1995-3#1)(2008-9#1)
the use of several different##3##5##(1995-2#1)(2006-10#1)(2008-1#1)
the use of several##10##4##(1995-2#1)(1996-12#1)(1996-3#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-3#1)
the use of short##2##4##(2006-11#1)(2007-8#1)
the use of short-acting##2##4##(2006-10#1)(2007-11#1)
the use of simple##6##4##(1992-9#1)(1994-11#1)(2008-10#1)(2008-11#1)(2010-4#1)(2011-1#1)
the use of simulation##2##4##(1991-5#1)(2006-6#1)
the use of simulations##2##4##(2008-12#1)(2008-3#1)
the use of single-agent##2##4##(2008-8#1)(2009-3#1)
the use of single-mode##3##4##(2008-2#2)(2008-3#1)
the use of skills training in##2##6##(2005-7#2)
the use of small##3##4##(2008-3#1)(2008-5#1)(2009-7#1)
the use of smaller##2##4##(2006-10#1)(2011-2#1)
the use of snus##2##4##(2012-12#2)
the use of social##4##4##(2009-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
the use of sodium##3##4##(1994-9#1)(2006-4#1)(2007-8#1)
the use of special##2##4##(1991-11#1)(1992-7#1)
the use of specialized##2##4##(2005-8#1)(2010-4#1)
the use of specific##8##4##(1990-6#1)(2006-7#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-11#1)(2009-9#1)(2012-12#1)
the use of stable##2##4##(2006-5#1)(2008-6#1)
the use of standard##4##4##(2007-12#1)(2013-1#2)(2013-8#1)
the use of statins in the##2##6##(2009-11#1)(2013-1#1)
the use of statins##3##4##(2009-11#1)(2009-6#1)(2013-1#1)
the use of statistical##2##4##(1993-3#1)(2009-7#1)
the use of stem cells##2##5##(2006-8#1)(2012-12#1)
the use of stem##3##4##(2006-6#1)(2006-8#1)(2012-12#1)
the use of sterile##2##4##(2009-2#1)(2012-12#1)
the use of steroids##2##4##(2005-8#1)(2007-9#1)
the use of stopped-flow##2##4##(2008-10#2)
the use of storytelling and narrative in medicine##2##8##(2008-11#2)
the use of storytelling##3##4##(2008-11#3)
the use of such a##2##5##(2007-12#1)(2012-3#1)
the use of such##14##4##(1990-8#1)(1993-12#1)(2004-9#1)(2005-8#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-12#1)(2007-2#1)(2008-11#1)(2012-12#2)(2012-2#1)(2012-3#1)
the use of surfactant##3##4##(2006-7#1)(2008-6#2)
the use of surgical##4##4##(2006-2#1)(2006-6#1)(2007-8#1)(2012-3#1)
the use of symptomatic##2##4##(1995-12#1)(2012-2#1)
the use of synchronous##2##4##(2008-10#1)(2008-6#1)
the use of synchrotron radiation##2##5##(2006-4#1)(2006-5#1)
the use of synthetic peptides##4##5##(1995-3#1)(2008-2#1)(2008-4#2)
the use of synthetic##7##4##(1995-3#1)(2005-10#1)(2008-2#1)(2008-4#2)(2008-8#1)(2011-2#1)
the use of systemic##3##4##(1997-3#1)(2008-11#1)(2008-7#1)
the use of t-PA##2##4##(2007-9#2)
the use of targeted##4##4##(2008-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
the use of techniques##3##4##(2006-8#1)(2007-12#1)(2009-12#1)
the use of technology in##2##5##(1990-12#1)(2008-12#1)
the use of technology##5##4##(1990-12#1)(1993-5#1)(2008-11#2)(2008-12#1)
the use of temporal##2##4##(2008-3#1)(2008-9#1)
the use of tests##2##4##(1994-5#1)(2008-7#1)
the use of thalidomide##2##4##(2007-11#1)(2008-5#1)
the use of the Symmetry aortic connector##2##7##(2007-8#2)
the use of the Symmetry##3##5##(2007-8#3)
the use of the device##2##5##(2007-11#1)(2007-7#1)
the use of the initial##2##5##(2009-6#2)
the use of the mass##2##5##(2006-7#1)(2008-10#1)
the use of the modified##2##5##(2007-12#1)(2011-2#1)
the use of the new##2##5##(2007-7#1)(2008-11#1)
the use of the polymerase chain reaction (PCR) to##2##9##(2008-4#2)
the use of the polymerase chain reaction (PCR)##3##8##(1990-3#1)(2008-4#2)
the use of the standard##2##5##(2008-10#2)
the use of the surface##2##5##(2005-10#1)(2011-2#1)
the use of the technique##4##5##(2006-10#1)(2007-11#1)(2009-5#1)(2012-12#1)
the use of the tool##2##5##(2008-11#2)
the use of the##272##4##(1990-12#2)(1990-3#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-10#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#2)(1995-3#2)(1995-5#2)(1995-6#2)(1996-1#1)(1996-3#2)(1996-5#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-5#1)(2004-12#1)(2005-10#1)(2005-5#1)(2005-7#1)(2006-10#8)(2006-11#2)(2006-12#1)(2006-5#2)(2006-6#1)(2006-7#3)(2006-8#1)(2007-10#3)(2007-11#9)(2007-12#11)(2007-2#3)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#6)(2007-8#11)(2007-9#3)(2008-1#1)(2008-10#39)(2008-11#11)(2008-12#4)(2008-2#6)(2008-3#6)(2008-4#14)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-10#3)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#2)
the use of their##6##4##(2006-10#1)(2007-9#1)(2008-10#1)(2008-5#1)(2010-5#1)(2012-3#1)
the use of theory##2##4##(1996-3#1)(2013-8#1)
the use of these agents in##4##6##(2005-6#1)(2006-10#1)(2007-11#1)(2008-3#1)
the use of these agents##9##5##(1996-7#1)(2005-6#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#2)
the use of these drugs in##2##6##(2007-11#1)(2010-6#1)
the use of these drugs##4##5##(1996-4#1)(2006-5#1)(2007-11#1)(2010-6#1)
the use of these medications##2##5##(2004-12#1)(2006-10#1)
the use of these methods##2##5##(1996-2#1)(2008-7#1)
the use of these second-generation##2##5##(1991-12#1)(2006-2#1)
the use of these substances##2##5##(1991-11#1)(2006-8#1)
the use of these systems##2##5##(2008-10#2)
the use of these##61##4##(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-2#1)(1995-12#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-4#1)(2004-12#1)(2004-4#1)(2005-10#1)(2005-6#1)(2006-10#5)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-2#4)(2008-3#3)(2008-4#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2010-4#1)(2010-6#1)(2012-12#1)(2012-3#1)(2013-1#3)
the use of this device##2##5##(2007-8#1)(2008-3#1)
the use of this drug in the##2##7##(2007-7#1)(2008-6#1)
the use of this instrument##3##5##(1990-4#1)(2007-8#1)(2008-11#1)
the use of this method##2##5##(1995-2#1)(2007-8#1)
the use of this model##2##5##(2008-10#1)(2008-11#1)
the use of this protein in##2##6##(1992-12#1)(2012-2#1)
the use of this system##2##5##(1997-3#1)(1997-4#1)
the use of this technique##4##5##(2007-8#1)(2008-2#1)(2010-12#1)(2011-2#1)
the use of this technology for##2##6##(2008-7#2)
the use of this technology##5##5##(2008-7#2)(2013-1#3)
the use of this treatment##2##5##(1992-1#1)(2007-7#1)
the use of this##65##4##(1990-4#1)(1990-9#1)(1991-5#1)(1992-1#2)(1992-12#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-10#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-12#1)(2006-5#1)(2006-8#2)(2007-11#3)(2007-12#4)(2007-5#1)(2007-7#3)(2007-8#4)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#2)(2009-6#1)(2010-12#2)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#4)
the use of three##3##4##(1991-12#1)(2008-10#1)(2013-1#1)
the use of three-way##2##4##(2008-10#2)
the use of thrombolytic therapy##2##5##(1997-1#1)(2007-5#1)
the use of time-consuming##2##4##(2008-10#1)(2008-4#1)
the use of time-resolved##2##4##(2008-3#1)(2009-5#1)
the use of tissue##4##4##(1992-8#1)(1997-8#1)(2007-11#1)(2007-9#1)
the use of titanium##2##4##(2008-10#1)(2008-6#1)
the use of topical tranexamic acid##2##6##(2007-8#2)
the use of topical##3##4##(2005-8#1)(2007-8#2)
the use of total##4##4##(1995-3#1)(2004-11#1)(2008-1#1)(2008-3#1)
the use of toxic##3##4##(2007-11#1)(2008-2#1)(2009-12#1)
the use of traditional##6##4##(2005-12#1)(2005-6#1)(2008-12#2)(2009-11#1)(2013-1#1)
the use of tranilast for##2##5##(2008-5#2)
the use of transgenic##3##4##(2005-8#2)(2013-1#1)
the use of transient##3##4##(1995-3#1)(2008-2#1)(2008-4#1)
the use of treatment##2##4##(2006-10#1)(2011-2#1)
the use of treatments##2##4##(2007-11#1)(2010-8#1)
the use of tricyclic antidepressants##2##5##(2006-10#1)(2012-2#1)
the use of tumor necrosis##3##5##(2006-10#1)(2013-1#2)
the use of tumor##4##4##(1996-2#1)(2006-10#1)(2013-1#2)
the use of two types of##2##6##(2006-5#1)(2008-10#1)
the use of two##18##4##(1990-12#1)(1991-3#1)(1991-5#1)(1997-6#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#1)(2010-5#1)(2010-6#1)(2012-2#1)
the use of two-dimensional##3##4##(1992-1#1)(1997-6#1)(2007-12#1)
the use of two-photon excitation##2##5##(2007-11#1)(2008-2#1)
the use of two-photon##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
the use of ultrasound##7##4##(1990-3#1)(2006-10#1)(2006-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2013-1#1)
the use of unhealthy weight control methods##3##7##(2012-2#3)
the use of unnecessary##2##4##(1995-12#1)(2007-4#1)
the use of urban##2##4##(1992-12#1)(1995-11#1)
the use of vaccines##5##4##(2006-10#1)(2007-6#1)(2010-2#1)(2013-8#2)
the use of various##9##4##(2007-11#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-5#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)
the use of vasopressin##2##4##(2007-9#1)(2009-8#1)
the use of venous##2##4##(2007-7#1)(2011-2#1)
the use of viral##2##4##(2007-11#1)(2008-11#1)
the use of vitamin##7##4##(1992-9#2)(2007-7#2)(2008-1#2)(2008-7#1)
the use of vitamins##2##4##(2008-6#1)(2011-2#1)
the use of water##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
the use of well##2##4##(2007-11#1)(2008-7#1)
the use of yeast##2##4##(1995-9#1)(1996-9#1)
the use of##3425##3##(1990-10#1)(1990-11#9)(1990-12#13)(1990-2#6)(1990-3#6)(1990-4#8)(1990-5#8)(1990-6#4)(1990-7#4)(1990-8#8)(1990-9#6)(1991-1#4)(1991-10#3)(1991-11#4)(1991-12#18)(1991-2#12)(1991-3#10)(1991-4#2)(1991-5#11)(1991-6#3)(1991-7#4)(1991-8#8)(1991-9#8)(1992-1#10)(1992-10#3)(1992-11#4)(1992-12#7)(1992-2#10)(1992-3#9)(1992-4#3)(1992-5#4)(1992-6#7)(1992-7#7)(1992-8#5)(1992-9#7)(1993-1#4)(1993-10#2)(1993-11#2)(1993-12#8)(1993-2#10)(1993-3#15)(1993-4#6)(1993-5#4)(1993-6#6)(1993-7#1)(1993-8#3)(1993-9#8)(1994-1#1)(1994-10#1)(1994-11#6)(1994-12#7)(1994-2#12)(1994-3#15)(1994-4#3)(1994-5#5)(1994-6#9)(1994-7#1)(1994-8#3)(1994-9#9)(1995-1#8)(1995-10#2)(1995-11#6)(1995-12#12)(1995-2#15)(1995-3#20)(1995-4#5)(1995-5#9)(1995-6#7)(1995-8#4)(1995-9#4)(1996-1#11)(1996-10#2)(1996-11#7)(1996-12#11)(1996-2#12)(1996-3#11)(1996-4#2)(1996-5#13)(1996-6#9)(1996-7#2)(1996-8#6)(1996-9#10)(1997-1#9)(1997-2#11)(1997-3#13)(1997-4#10)(1997-5#6)(1997-6#6)(1997-7#6)(1997-8#8)(2004-1#2)(2004-10#2)(2004-11#1)(2004-12#5)(2004-4#3)(2004-7#1)(2004-9#3)(2005-1#1)(2005-10#11)(2005-11#19)(2005-12#8)(2005-4#2)(2005-5#3)(2005-6#7)(2005-7#16)(2005-8#23)(2005-9#3)(2006-1#1)(2006-10#120)(2006-11#10)(2006-12#13)(2006-2#17)(2006-3#5)(2006-4#15)(2006-5#20)(2006-6#17)(2006-7#20)(2006-8#32)(2006-9#9)(2007-1#9)(2007-10#25)(2007-11#98)(2007-12#96)(2007-2#20)(2007-3#11)(2007-4#15)(2007-5#9)(2007-6#16)(2007-7#44)(2007-8#80)(2007-9#24)(2008-1#48)(2008-10#340)(2008-11#106)(2008-12#36)(2008-2#109)(2008-3#134)(2008-4#109)(2008-5#69)(2008-6#47)(2008-7#80)(2008-8#38)(2008-9#44)(2009-1#3)(2009-10#18)(2009-11#12)(2009-12#10)(2009-2#13)(2009-3#10)(2009-4#13)(2009-5#18)(2009-6#10)(2009-7#7)(2009-8#12)(2009-9#4)(2010-1#2)(2010-10#9)(2010-11#17)(2010-12#29)(2010-2#18)(2010-3#12)(2010-4#19)(2010-5#18)(2010-6#12)(2010-7#8)(2010-8#25)(2010-9#8)(2011-1#35)(2011-10#2)(2011-12#8)(2011-2#86)(2011-3#5)(2011-7#1)(2012-1#14)(2012-11#10)(2012-12#64)(2012-2#52)(2012-3#46)(2012-7#1)(2013-1#110)(2013-7#10)(2013-8#44)
the use rates##2##3##(1990-12#1)(1994-2#1)
the use##3488##2##(1990-10#1)(1990-11#9)(1990-12#14)(1990-2#6)(1990-3#6)(1990-4#8)(1990-5#8)(1990-6#4)(1990-7#5)(1990-8#8)(1990-9#6)(1991-1#4)(1991-10#3)(1991-11#4)(1991-12#18)(1991-2#12)(1991-3#10)(1991-4#2)(1991-5#11)(1991-6#3)(1991-7#4)(1991-8#8)(1991-9#8)(1992-1#10)(1992-10#3)(1992-11#4)(1992-12#7)(1992-2#10)(1992-3#9)(1992-4#3)(1992-5#4)(1992-6#7)(1992-7#7)(1992-8#5)(1992-9#7)(1993-1#4)(1993-10#2)(1993-11#2)(1993-12#8)(1993-2#10)(1993-3#15)(1993-4#6)(1993-5#4)(1993-6#6)(1993-7#1)(1993-8#3)(1993-9#8)(1994-1#1)(1994-10#1)(1994-11#6)(1994-12#7)(1994-2#13)(1994-3#15)(1994-4#3)(1994-5#5)(1994-6#9)(1994-7#2)(1994-8#3)(1994-9#9)(1995-1#8)(1995-10#2)(1995-11#6)(1995-12#12)(1995-2#15)(1995-3#20)(1995-4#6)(1995-5#9)(1995-6#7)(1995-8#4)(1995-9#4)(1996-1#11)(1996-10#2)(1996-11#7)(1996-12#11)(1996-2#12)(1996-3#11)(1996-4#2)(1996-5#13)(1996-6#9)(1996-7#2)(1996-8#6)(1996-9#11)(1997-1#9)(1997-2#11)(1997-3#14)(1997-4#10)(1997-5#6)(1997-6#6)(1997-7#6)(1997-8#8)(2004-1#2)(2004-10#2)(2004-11#1)(2004-12#5)(2004-4#3)(2004-7#1)(2004-9#3)(2005-1#1)(2005-10#11)(2005-11#19)(2005-12#8)(2005-4#2)(2005-5#3)(2005-6#7)(2005-7#16)(2005-8#24)(2005-9#3)(2006-1#1)(2006-10#122)(2006-11#10)(2006-12#13)(2006-2#17)(2006-3#5)(2006-4#15)(2006-5#20)(2006-6#17)(2006-7#20)(2006-8#34)(2006-9#9)(2007-1#9)(2007-10#25)(2007-11#99)(2007-12#96)(2007-2#20)(2007-3#11)(2007-4#15)(2007-5#9)(2007-6#16)(2007-7#46)(2007-8#82)(2007-9#24)(2008-1#50)(2008-10#345)(2008-11#109)(2008-12#36)(2008-2#109)(2008-3#135)(2008-4#112)(2008-5#69)(2008-6#49)(2008-7#80)(2008-8#39)(2008-9#45)(2009-1#3)(2009-10#18)(2009-11#12)(2009-12#10)(2009-2#13)(2009-3#12)(2009-4#14)(2009-5#18)(2009-6#10)(2009-7#7)(2009-8#12)(2009-9#4)(2010-1#2)(2010-10#9)(2010-11#17)(2010-12#30)(2010-2#18)(2010-3#12)(2010-4#19)(2010-5#18)(2010-6#12)(2010-7#8)(2010-8#25)(2010-9#9)(2011-1#35)(2011-10#2)(2011-12#8)(2011-2#88)(2011-3#5)(2011-7#1)(2012-1#15)(2012-11#10)(2012-12#69)(2012-2#52)(2012-3#46)(2012-7#1)(2013-1#120)(2013-7#12)(2013-8#47)
the used##14##2##(1993-2#1)(1994-11#1)(2005-11#2)(2008-10#4)(2008-11#1)(2008-8#1)(2009-6#1)(2010-4#1)(2010-8#1)(2011-2#1)
the useful life##2##3##(2008-10#1)(2008-2#1)
the useful lifetime of##2##4##(2008-10#1)(2009-11#1)
the useful range##2##3##(1995-1#1)(2008-2#1)
the useful##14##2##(1995-1#1)(1996-3#1)(2006-6#1)(2007-7#1)(2008-10#3)(2008-2#5)(2009-11#1)(2013-8#1)
the usefulness and efficacy of##2##5##(1992-5#1)(2006-8#1)
the usefulness and limitations of##2##5##(2008-4#1)(2012-12#1)
the usefulness and##10##3##(1990-2#1)(1992-5#1)(2006-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
the usefulness of US##2##4##(2010-12#1)(2012-2#1)
the usefulness of a##4##4##(2008-5#1)(2011-2#1)(2012-11#1)(2012-12#1)
the usefulness of antibiotic prophylaxis##2##5##(1992-6#2)
the usefulness of conventional##2##4##(2006-10#1)(2008-4#1)
the usefulness of flow cytometry##2##5##(1995-2#1)(2008-4#1)
the usefulness of our method##2##5##(2008-3#2)
the usefulness of our##4##4##(2007-8#1)(2008-11#1)(2008-3#2)
the usefulness of such##3##4##(1992-1#1)(2006-3#1)(2009-6#1)
the usefulness of the integration##2##5##(2007-12#1)(2013-1#1)
the usefulness of the proposed method##2##6##(2007-11#1)(2008-3#1)
the usefulness of the proposed##8##5##(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2013-1#2)
the usefulness of the##38##4##(1990-4#1)(1990-5#1)(1991-3#1)(1991-4#1)(1993-3#1)(1994-10#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-2#3)(2008-3#2)(2008-7#1)(2008-8#1)(2010-5#1)(2011-12#1)(2011-2#1)(2013-1#4)(2013-8#1)
the usefulness of this approach##2##5##(1997-6#1)(2011-1#1)
the usefulness of this method for##2##6##(1993-12#1)(2012-3#1)
the usefulness of this method##3##5##(1993-12#1)(2007-7#1)(2012-3#1)
the usefulness of this##16##4##(1993-12#1)(1993-9#1)(1997-2#1)(1997-6#1)(2006-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
the usefulness of two-dimensional##2##4##(1993-9#1)(2011-2#1)
the usefulness of##164##3##(1990-4#2)(1990-5#2)(1990-9#1)(1991-3#2)(1991-4#2)(1991-6#1)(1992-1#1)(1992-6#3)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#2)(1994-10#1)(1994-12#1)(1994-6#2)(1994-7#1)(1995-11#1)(1995-2#1)(1995-4#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#2)(2005-1#1)(2005-11#1)(2005-12#1)(2006-10#4)(2006-12#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#4)(2007-8#2)(2007-9#2)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#8)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#11)(2013-7#2)(2013-8#3)
the usefulness##177##2##(1990-2#1)(1990-4#2)(1990-5#2)(1990-9#1)(1991-3#2)(1991-4#2)(1991-6#1)(1992-1#1)(1992-5#1)(1992-6#3)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#2)(1994-10#1)(1994-12#1)(1994-6#2)(1994-7#1)(1995-11#1)(1995-2#1)(1995-4#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#2)(2005-1#1)(2005-11#1)(2005-12#1)(2006-10#4)(2006-12#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#4)(2007-2#1)(2007-3#2)(2007-7#4)(2007-8#2)(2007-9#2)(2008-10#17)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#9)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#12)(2013-7#2)(2013-8#3)
the user a##5##3##(1996-12#1)(2006-5#1)(2008-10#1)(2008-4#2)
the user and##6##3##(1991-11#1)(1996-10#1)(1996-7#1)(2007-4#1)(2008-6#1)(2012-3#1)
the user can##2##3##(2008-2#1)(2008-4#1)
the user controls##3##3##(1996-10#1)(1996-7#2)
the user from##2##3##(2008-6#1)(2012-1#1)
the user interface##2##3##(2010-8#2)
the user may be##2##4##(1993-3#1)(2011-2#1)
the user may##4##3##(1993-3#1)(2008-4#2)(2011-2#1)
the user to take advantage of##2##6##(2008-4#1)(2008-9#1)
the user to##27##3##(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#5)(2008-6#3)(2008-7#1)(2008-9#2)(2009-12#1)(2011-2#1)(2012-1#3)(2013-1#2)
the user will##2##3##(2006-6#1)(2008-10#1)
the user##90##2##(1991-1#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-1#1)(1993-3#2)(1996-10#2)(1996-12#1)(1996-4#1)(1996-7#3)(1997-1#2)(2006-10#1)(2006-5#1)(2006-6#1)(2007-4#2)(2007-5#2)(2008-10#6)(2008-11#1)(2008-2#7)(2008-3#4)(2008-4#14)(2008-6#5)(2008-7#2)(2008-9#3)(2009-12#1)(2009-6#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-1#8)(2012-3#1)(2013-1#6)(2013-8#1)
the user's head and##2##4##(2008-3#1)(2012-1#1)
the user's motion##4##3##(2012-1#4)
the user's##19##2##(1993-10#1)(1993-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-1#13)
the users and the##2##4##(1995-2#1)(2013-1#1)
the users and##3##3##(1995-2#1)(1996-1#1)(2013-1#1)
the users of##6##3##(1997-6#1)(2006-10#1)(2008-11#2)(2012-12#1)(2013-1#1)
the users##23##2##(1991-1#1)(1992-1#1)(1992-2#1)(1993-10#2)(1995-2#1)(1996-1#1)(1996-4#1)(1997-1#1)(1997-6#2)(2006-10#1)(2008-10#1)(2008-11#2)(2012-12#1)(2012-2#4)(2013-1#3)
the users'##3##2##(1997-3#1)(2012-3#2)
the uses and##3##3##(1993-2#1)(2007-9#1)(2009-9#1)
the uses of##16##3##(1991-12#1)(1995-2#1)(1996-1#1)(2006-10#2)(2007-12#1)(2007-2#1)(2008-1#1)(2008-3#1)(2008-8#2)(2009-4#1)(2009-5#1)(2010-12#1)(2010-5#1)(2012-11#1)
the uses##21##2##(1991-12#1)(1993-2#1)(1995-2#1)(1996-1#1)(1997-3#1)(1997-8#1)(2006-10#2)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-8#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-5#1)(2012-11#1)
the using##2##2##(2008-3#1)(2010-8#1)
the usual assumptions##3##3##(1997-8#1)(2008-2#1)(2009-12#1)
the usual care##3##3##(2008-9#1)(2010-10#1)(2011-1#1)
the usual complication##2##3##(1991-3#1)(2008-12#1)
the usual dose of##2##4##(2005-3#1)(2007-11#1)
the usual dose##3##3##(1996-4#1)(2005-3#1)(2007-11#1)
the usual fee##3##3##(1997-6#3)
the usual method for##2##4##(2005-11#1)(2008-12#1)
the usual method##4##3##(1996-9#1)(2005-11#1)(2008-10#1)(2008-12#1)
the usual methods##2##3##(1993-5#1)(2008-10#1)
the usual nasal cannula##2##4##(1992-11#2)
the usual pattern##2##3##(2006-1#1)(2008-8#1)
the usual procedure##3##3##(1990-8#1)(2008-3#1)(2010-6#1)
the usual recommended##2##3##(1991-12#1)(2006-4#1)
the usual##165##2##(1990-11#1)(1990-3#2)(1990-5#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-3#1)(1991-4#1)(1991-7#1)(1992-11#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-8#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-4#3)(1996-9#2)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#3)(1997-8#4)(2005-10#1)(2005-11#4)(2005-3#1)(2005-6#1)(2005-8#2)(2006-1#1)(2006-10#4)(2006-11#1)(2006-4#2)(2006-7#1)(2006-8#1)(2007-11#7)(2007-12#7)(2007-2#1)(2007-4#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#11)(2008-11#1)(2008-12#2)(2008-2#10)(2008-3#10)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#2)(2009-2#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-12#1)(2012-12#1)(2012-2#2)(2012-3#1)
the usually##9##2##(1990-12#1)(1992-6#1)(1995-2#1)(2004-11#1)(2008-3#1)(2008-7#1)(2009-6#1)(2009-9#1)(2010-11#1)
the uterine cavity is##3##4##(2010-9#1)(2011-2#2)
the uterine cavity##9##3##(1993-12#1)(1994-9#1)(1996-1#1)(2007-9#1)(2010-9#1)(2011-2#3)(2012-3#1)
the uterine cervix##25##3##(1990-4#1)(1990-6#1)(1992-3#1)(1993-8#2)(1993-9#1)(1994-4#1)(1994-7#2)(2006-10#4)(2007-12#1)(2007-7#1)(2008-11#1)(2008-4#1)(2009-11#2)(2009-5#1)(2011-1#1)(2011-2#3)(2012-2#1)
the uterine fluid##2##3##(2007-9#1)(2013-1#1)
the uterine horn##4##3##(1991-3#1)(1994-6#2)(2012-1#1)
the uterine smooth muscle##2##4##(1994-9#1)(2008-4#1)
the uterine wall##3##3##(1994-9#1)(2007-9#1)(2010-2#1)
the uterine##74##2##(1990-4#1)(1990-6#2)(1991-3#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-12#3)(1993-6#1)(1993-8#2)(1993-9#1)(1994-4#2)(1994-6#2)(1994-7#2)(1994-9#5)(1995-12#1)(1995-3#1)(1996-1#1)(1996-5#1)(1996-8#1)(2006-10#4)(2006-5#1)(2006-9#1)(2007-12#3)(2007-4#1)(2007-7#1)(2007-9#3)(2008-1#1)(2008-11#4)(2008-4#3)(2008-6#1)(2009-11#2)(2009-5#1)(2009-8#1)(2010-2#1)(2010-9#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)
the uteroplacental##5##2##(1990-6#1)(1992-1#1)(1992-2#1)(1992-4#1)(1994-3#1)
the uterus and ovaries##3##4##(2006-10#1)(2009-4#1)(2012-3#1)
the uterus and##7##3##(1993-1#1)(2006-10#1)(2009-4#1)(2009-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
the uterus in a##2##4##(2008-10#1)(2012-1#1)
the uterus in##3##3##(2007-11#1)(2008-10#1)(2012-1#1)
the uterus is##4##3##(1993-10#1)(2007-11#1)(2009-8#1)(2011-2#1)
the uterus of##2##3##(2006-5#1)(2008-10#1)
the uterus was##2##3##(2006-10#1)(2007-9#1)
the uterus##64##2##(1990-10#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-1#2)(1993-10#1)(1993-7#1)(1994-6#3)(1994-9#3)(1995-10#1)(1995-11#1)(1995-5#1)(1996-11#1)(2006-10#3)(2006-5#1)(2006-6#2)(2007-11#4)(2007-12#1)(2007-3#1)(2007-8#2)(2007-9#5)(2008-1#1)(2008-10#3)(2008-4#3)(2008-6#1)(2008-8#1)(2009-4#2)(2009-6#2)(2009-8#2)(2010-12#1)(2011-2#2)(2012-1#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)
the uterus)##2##2##(2011-2#2)
the utilisation of##12##3##(1990-10#1)(1993-8#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2012-12#1)(2012-2#1)
the utility and safety of##2##5##(2006-8#2)
the utility and##7##3##(1993-1#1)(1995-1#2)(2005-10#1)(2006-8#2)(2009-8#1)
the utility of a##4##4##(1996-7#1)(2009-11#1)(2011-2#1)(2012-3#1)
the utility of having##2##4##(2011-2#1)(2013-1#1)
the utility of microarray##2##4##(2008-7#1)(2012-12#1)
the utility of new##2##4##(1997-6#1)(2008-6#1)
the utility of studying##2##4##(2008-8#1)(2009-10#1)
the utility of such a##2##5##(1997-8#1)(2008-3#1)
the utility of such##3##4##(1997-8#1)(2008-3#1)(2008-7#1)
the utility of the method##3##5##(1993-2#1)(2008-3#2)
the utility of the new##2##5##(2008-3#2)
the utility of the proposed##2##5##(2008-3#2)
the utility of the##49##4##(1992-9#1)(1993-2#1)(1994-2#1)(1994-3#1)(1995-2#1)(2004-9#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-3#1)(2007-12#3)(2007-3#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#8)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-3#1)(2010-7#1)(2011-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
the utility of these##6##4##(1991-7#1)(1996-4#1)(1996-8#1)(2008-10#1)(2013-1#2)
the utility of this approach##2##5##(2008-3#1)(2010-5#1)
the utility of this method in##3##6##(1990-4#1)(2008-10#1)(2008-11#1)
the utility of this method##6##5##(1990-4#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-2#1)
the utility of this##18##4##(1990-4#1)(1991-12#1)(1991-5#1)(1994-12#1)(1997-5#1)(1997-8#1)(2006-7#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#2)(2010-2#2)(2010-5#1)(2013-8#1)
the utility of##167##3##(1990-10#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-9#2)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-4#2)(1996-7#1)(1996-8#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-9#1)(2005-10#1)(2005-7#3)(2005-8#4)(2006-10#4)(2006-3#1)(2006-4#1)(2006-7#1)(2007-11#3)(2007-12#10)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#9)(2008-11#9)(2008-2#2)(2008-3#12)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#5)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-8#2)(2010-12#2)(2010-2#4)(2010-3#2)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#6)(2013-1#8)(2013-8#1)
the utility##181##2##(1990-10#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-9#2)(1993-1#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-2#1)(1996-4#2)(1996-7#1)(1996-8#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-9#1)(2005-10#2)(2005-7#3)(2005-8#4)(2006-10#4)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#2)(2007-11#3)(2007-12#10)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#10)(2008-11#9)(2008-2#2)(2008-3#12)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#5)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#3)(2010-12#2)(2010-2#5)(2010-3#2)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#7)(2013-1#10)(2013-8#1)
the utilization and##2##3##(2005-11#1)(2011-2#1)
the utilization of a##4##4##(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
the utilization of amino acids##2##5##(1996-11#1)(2013-8#1)
the utilization of medical##2##4##(1996-2#1)(1996-6#1)
the utilization of the##14##4##(1990-5#1)(1991-4#1)(1991-5#1)(1992-10#1)(2006-8#1)(2006-9#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#3)(2011-2#1)
the utilization of this##2##4##(1991-7#1)(2008-7#1)
the utilization of##74##3##(1990-5#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-10#1)(1992-3#1)(1994-11#1)(1994-9#1)(1995-3#2)(1996-11#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-5#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-4#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#3)
the utilization##84##2##(1990-5#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-10#1)(1992-3#2)(1994-11#1)(1994-9#1)(1995-2#1)(1995-3#2)(1996-11#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-5#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-4#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#4)
the utilized##3##2##(2007-12#1)(2007-5#1)(2007-8#1)
the utmost importance##6##3##(1990-9#1)(2006-10#2)(2007-12#1)(2011-2#1)(2012-3#1)
the utmost##8##2##(1990-12#1)(1990-9#1)(2006-10#2)(2007-12#1)(2008-3#1)(2011-2#1)(2012-3#1)
the uveitis patients##2##3##(2013-7#2)
the uveitis##3##2##(2006-10#1)(2013-7#2)
the uveoscleral pathway##2##3##(2011-2#2)
the uveoscleral##3##2##(2009-8#1)(2011-2#2)
the uvsX protein##2##3##(1990-10#2)
the uvsY##3##2##(1990-10#2)(1991-8#1)
the v-Ha-ras gene##2##3##(1992-12#2)
the v-Ha-ras##4##2##(1991-7#1)(1992-12#3)
the vWF gene##2##3##(2008-12#2)
the vacancy##4##2##(1993-1#1)(1994-9#1)(2008-9#2)
the vaccinal strain (H8)##2##4##(1997-6#2)
the vaccinal strain##3##3##(1997-6#3)
the vaccinated chickens##3##3##(1997-6#1)(2008-5#1)(2013-8#1)
the vaccinated individuals##2##3##(1994-11#1)(1995-5#1)
the vaccinated##17##2##(1992-8#1)(1994-11#1)(1994-2#3)(1995-5#1)(1995-9#2)(1997-6#1)(2007-2#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-8#4)
the vaccination schedule##2##3##(1992-8#1)(2009-12#1)
the vaccination##14##2##(1992-8#2)(1993-3#1)(1995-9#1)(2007-2#1)(2007-3#1)(2009-12#1)(2009-4#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#1)
the vaccine and##6##3##(1990-2#1)(1992-10#1)(2007-11#1)(2008-11#1)(2008-5#1)(2013-1#1)
the vaccine components##2##3##(1995-5#1)(2008-4#1)
the vaccine in##4##3##(1990-9#1)(1992-10#2)(1995-5#1)
the vaccine is##7##3##(1994-9#1)(2005-7#1)(2007-11#3)(2008-5#1)(2010-12#1)
the vaccine mixture and S##2##5##(2013-1#2)
the vaccine strain A/PER/16/09##2##4##(2013-8#2)
the vaccine strain##5##3##(1997-6#1)(2012-3#1)(2013-8#3)
the vaccine type strain##3##4##(1992-10#3)
the vaccine type##4##3##(1992-10#3)(2005-9#1)
the vaccine virus##2##3##(1995-9#1)(2013-8#1)
the vaccine was##5##3##(1992-10#1)(2005-7#1)(2006-7#1)(2008-5#1)(2011-2#1)
the vaccine with##3##3##(2012-12#1)(2013-1#2)
the vaccine##96##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-12#1)(1992-10#8)(1993-3#1)(1993-9#1)(1994-2#1)(1994-9#3)(1995-5#6)(1995-9#1)(1996-1#1)(1996-12#1)(1997-6#3)(2005-7#4)(2005-9#2)(2006-10#1)(2006-7#2)(2007-11#13)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#3)(2008-5#3)(2010-10#1)(2010-12#4)(2010-2#1)(2010-4#1)(2011-2#7)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#9)(2013-8#5)
the vaccine-derived##2##2##(2007-10#2)
the vaccines were##3##3##(1995-5#1)(2008-4#1)(2012-2#1)
the vaccines##11##2##(1995-5#2)(2006-1#1)(2008-3#1)(2008-4#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-8#2)
the vaccinia virus##4##3##(1991-7#1)(1994-9#1)(2008-2#2)
the vaccinia##6##2##(1991-7#2)(1994-9#1)(1997-3#1)(2008-2#2)
the vacuolar H(+)-ATPase of##2##4##(1990-3#2)
the vacuolar H(+)-ATPase##7##3##(1990-3#4)(1994-9#1)(1995-3#2)
the vacuolar component##2##3##(1995-3#2)
the vacuolar enzyme##2##3##(1991-2#2)
the vacuolar membrane##5##3##(1991-12#1)(1994-9#1)(1995-3#2)(2009-10#1)
the vacuolar pyrophosphatase##3##3##(1991-2#2)(2008-11#1)
the vacuolar##29##2##(1990-3#4)(1991-12#2)(1991-2#4)(1994-6#2)(1994-8#1)(1994-9#3)(1995-3#6)(1996-5#1)(1997-1#2)(2008-11#1)(2009-10#2)(2009-8#1)
the vacuole and##2##3##(2009-10#1)(2009-8#1)
the vacuole##17##2##(1993-3#1)(1996-10#1)(1997-6#3)(2008-1#1)(2008-11#1)(2008-9#1)(2009-10#6)(2009-8#2)(2011-2#1)
the vacuoles##4##2##(1991-2#1)(2008-5#1)(2008-7#2)
the vacuum chamber##2##3##(2006-4#1)(2006-5#1)
the vacuum disc##3##3##(2012-2#3)
the vacuum ultraviolet##3##3##(2007-12#2)(2008-1#1)
the vacuum##13##2##(1991-6#1)(1995-11#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-2#1)(2012-2#3)
the vacuum-assisted socket##2##3##(2007-10#2)
the vacuum-assisted##3##2##(2007-10#2)(2007-8#1)
the vagal hepatic##2##3##(1996-5#2)
the vagal lobe##2##3##(2010-2#2)
the vagal regulation##2##3##(2013-1#2)
the vagal##13##2##(1993-11#1)(1996-1#1)(1996-5#2)(2006-10#1)(2007-12#1)(2010-2#4)(2012-2#1)(2013-1#2)
the vagina and the##4##4##(1996-12#2)(2008-9#2)
the vagina is an##2##4##(1992-2#1)(1996-12#1)
the vagina of##2##3##(2006-10#1)(2007-7#1)
the vagina##39##2##(1990-10#1)(1990-12#2)(1990-2#1)(1991-12#2)(1992-12#1)(1992-2#2)(1993-1#1)(1994-1#1)(1994-7#1)(1995-11#1)(1996-12#6)(1996-9#1)(1997-7#4)(2006-10#3)(2006-12#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-9#3)(2009-10#1)(2009-6#1)(2011-1#1)(2013-1#1)
the vaginal apex##2##3##(2009-2#1)(2010-12#1)
the vaginal sensilla##2##3##(2008-8#2)
the vaginal wall##3##3##(1991-12#1)(1996-12#1)(2010-2#1)
the vaginal##29##2##(1991-12#2)(1991-3#1)(1991-4#1)(1992-12#1)(1992-9#1)(1993-1#1)(1995-1#1)(1996-12#1)(1996-9#1)(2006-5#3)(2006-8#1)(2008-10#3)(2008-5#1)(2008-8#2)(2008-9#1)(2009-2#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#1)(2013-1#1)
the vagueness of##2##3##(2006-10#1)(2008-1#1)
the vagus nerve##18##3##(1991-10#1)(1993-12#2)(1994-6#4)(1995-12#1)(1995-3#1)(1996-1#1)(1997-3#1)(2006-10#1)(2008-1#1)(2008-4#1)(2009-10#1)(2010-12#1)(2012-1#1)(2013-1#1)
the vagus##22##2##(1991-10#1)(1993-12#5)(1994-2#1)(1994-6#4)(1995-12#1)(1995-3#1)(1996-1#1)(1997-3#1)(2006-10#1)(2008-1#1)(2008-4#1)(2009-10#1)(2010-12#1)(2012-1#1)(2013-1#1)
the valence of the##3##4##(2005-11#1)(2008-2#1)(2009-12#1)
the valence of##5##3##(2005-11#1)(2008-2#3)(2009-12#1)
the valence states##2##3##(2007-5#1)(2008-10#1)
the valence##15##2##(1997-7#1)(2005-11#2)(2006-4#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#3)(2009-12#1)(2009-7#1)(2012-12#1)
the valgus##2##2##(2009-4#1)(2012-3#1)
the valid##2##2##(2008-3#1)(2008-7#1)
the validated##5##2##(2007-4#1)(2008-10#1)(2008-7#1)(2010-12#1)(2013-1#1)
the validation and##2##3##(1995-1#1)(2007-12#1)
the validation data##2##3##(2008-10#2)
the validation of a##4##4##(1997-2#1)(2008-10#1)(2009-7#1)(2013-1#1)
the validation of analytical##2##4##(1992-8#1)(2008-10#1)
the validation of the##4##4##(2007-12#1)(2008-10#1)(2011-1#1)(2012-3#1)
the validation of this method##2##5##(2007-12#1)(2012-12#1)
the validation of this##4##4##(2007-12#1)(2008-10#1)(2008-5#1)(2012-12#1)
the validation of##17##3##(1992-8#1)(1997-2#1)(2005-11#1)(2007-12#2)(2008-10#5)(2008-2#1)(2008-5#1)(2009-7#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
the validation process##4##3##(2007-12#1)(2007-5#1)(2008-8#1)(2008-9#1)
the validation results of##2##4##(2008-10#2)
the validation set##4##3##(1990-12#1)(1995-9#1)(2008-10#1)(2008-4#1)
the validation study##4##3##(2007-8#1)(2008-3#1)(2010-8#2)
the validation##48##2##(1990-12#1)(1992-8#1)(1995-1#1)(1995-9#1)(1997-2#1)(2005-11#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-5#1)(2007-8#3)(2008-10#14)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-8#2)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
the validity and reliability of a##2##6##(2010-12#1)(2010-9#1)
the validity and reliability of the##4##6##(1994-2#1)(2007-12#1)(2007-7#1)(2007-9#1)
the validity and reliability of##8##5##(1994-2#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-9#1)(2010-12#1)(2010-9#1)
the validity and##13##3##(1994-2#1)(2006-2#1)(2007-10#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-8#1)
the validity of a##7##4##(1992-7#1)(2008-3#1)(2009-9#1)(2010-3#1)(2013-1#2)(2013-8#1)
the validity of certain of the research data identified in the articles##3##12##(2008-10#3)
the validity of fetometry in the diagnosis of a large fetus##2##11##(2008-4#2)
the validity of fetometry in the##3##6##(2008-4#3)
the validity of our##2##4##(1991-2#1)(2006-8#1)
the validity of results##2##4##(2008-10#1)(2008-11#1)
the validity of such a##2##5##(2008-10#1)(2008-3#1)
the validity of such an##2##5##(2008-11#1)(2008-3#1)
the validity of such##5##4##(1995-4#1)(2008-10#1)(2008-11#1)(2008-3#2)
the validity of the algorithm##2##5##(2007-12#1)(2008-2#1)
the validity of the diffusion approximation##2##6##(2008-2#1)(2008-3#1)
the validity of the method##5##5##(2007-12#2)(2008-10#3)
the validity of the model##6##5##(1994-2#1)(2005-11#1)(2007-4#1)(2008-2#1)(2008-3#1)(2008-7#1)
the validity of the modified##2##5##(2010-2#1)(2012-1#1)
the validity of the technique##3##5##(1990-10#1)(1993-10#1)(2010-2#1)
the validity of the two-state model##2##6##(1997-2#2)
the validity of the##67##4##(1990-10#1)(1990-8#1)(1992-6#1)(1993-10#1)(1994-2#1)(1996-1#1)(1996-11#1)(1996-5#1)(1997-2#2)(1997-4#1)(2005-11#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-12#6)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#9)(2008-11#1)(2008-2#8)(2008-3#8)(2008-4#1)(2008-6#1)(2008-7#4)(2009-10#1)(2009-2#1)(2010-2#2)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#1)
the validity of their##2##4##(1996-10#1)(2007-11#1)
the validity of these##5##4##(2004-9#1)(2008-3#1)(2010-11#1)(2010-12#1)(2012-2#1)
the validity of this approach##3##5##(2007-12#1)(2008-2#1)(2008-5#1)
the validity of this##12##4##(1990-2#1)(1995-8#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-4#1)(2008-5#1)(2009-11#1)
the validity of using##2##4##(1990-1#1)(2006-5#1)
the validity of various##2##4##(2007-2#1)(2008-2#1)
the validity of##164##3##(1990-1#1)(1990-10#2)(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#3)(1991-10#1)(1991-12#2)(1991-2#1)(1991-7#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-10#1)(1993-3#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-5#1)(1997-2#2)(1997-4#1)(2004-9#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-2#2)(2006-5#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#10)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#16)(2008-11#5)(2008-12#2)(2008-2#13)(2008-3#15)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#3)
the validity##185##2##(1990-1#1)(1990-10#2)(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#3)(1991-10#1)(1991-12#2)(1991-2#1)(1991-7#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-10#1)(1993-3#1)(1994-2#2)(1995-11#1)(1995-2#1)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-5#1)(1997-2#2)(1997-4#1)(2004-9#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-2#4)(2006-5#3)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#5)(2007-12#12)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-10#18)(2008-11#5)(2008-12#2)(2008-2#14)(2008-3#15)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#4)
the valley##7##2##(2008-10#6)(2008-5#1)
the valorization of cultural differences##2##5##(2007-5#2)
the valorization of##3##3##(2007-5#2)(2011-2#1)
the valuable contribution##2##3##(1992-2#1)(1997-3#1)
the valuable##7##2##(1992-2#1)(1997-3#1)(2007-12#1)(2007-3#1)(2008-12#1)(2008-4#1)(2013-1#1)
the value and##6##3##(1992-6#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
the value at##4##3##(1995-8#1)(2005-1#1)(2008-10#1)(2011-1#1)
the value chain model##2##4##(1997-3#2)
the value chain##3##3##(1997-3#2)(2008-10#1)
the value determined##3##3##(1994-9#1)(2005-11#1)(2008-10#1)
the value during##2##3##(1996-6#1)(2007-8#1)
the value expected for##3##4##(1992-3#1)(1992-9#1)(2007-11#1)
the value for the##2##4##(1991-7#1)(2008-10#1)
the value for##8##3##(1990-9#1)(1991-1#1)(1991-7#1)(1994-2#1)(2005-11#1)(2006-4#1)(2008-10#1)(2009-12#1)
the value in##2##3##(1992-2#1)(2010-9#1)
the value measured##2##3##(1997-2#1)(2008-2#1)
the value observed in##2##4##(2008-10#2)
the value obtained for##2##4##(1995-11#1)(2008-10#1)
the value obtained##8##3##(1990-8#1)(1995-11#1)(1995-6#1)(1997-4#1)(2008-10#2)(2008-11#1)(2012-2#1)
the value of 0##3##4##(1990-5#1)(1996-11#1)(1996-7#1)
the value of a##5##4##(1990-7#1)(1991-9#1)(2006-9#1)(2008-11#1)(2012-1#1)
the value of an organizational routines perspective##2##7##(2013-1#2)
the value of an##3##4##(1991-4#1)(2013-1#2)
the value of bone##2##4##(1992-6#1)(2005-1#1)
the value of considering##2##4##(2006-8#1)(2013-7#1)
the value of delta C/CL##2##5##(1990-7#2)
the value of future reproduction##2##5##(2008-8#2)
the value of future##3##4##(2007-5#1)(2008-8#2)
the value of information##2##4##(1992-12#1)(2013-8#1)
the value of measuring##2##4##(1995-10#1)(2010-2#1)
the value of medical##2##4##(1992-5#1)(2012-2#1)
the value of monitoring##2##4##(1994-7#1)(1995-3#1)
the value of previous##2##4##(2005-8#1)(2007-12#1)
the value of role modelling##2##5##(2008-12#2)
the value of screening##2##4##(2007-12#1)(2008-1#1)
the value of such##2##4##(2008-10#1)(2008-12#1)
the value of the apparent##2##5##(1990-11#1)(2008-10#1)
the value of the input##2##5##(2008-10#1)(2012-2#1)
the value of the method##2##5##(2007-3#1)(2007-5#1)
the value of the salivary rate flow was##2##8##(2007-9#2)
the value of the threshold##2##5##(2006-4#1)(2008-7#1)
the value of the##67##4##(1990-11#1)(1990-2#1)(1990-8#1)(1992-5#1)(1992-9#1)(1993-9#1)(1995-1#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-9#2)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#9)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-2#1)(2009-4#1)(2010-4#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
the value of their##2##4##(1996-2#1)(2011-1#1)
the value of these##2##4##(1994-3#1)(2008-8#1)
the value of this approach##2##5##(1993-11#1)(2008-2#1)
the value of this##6##4##(1990-6#1)(1993-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)
the value of using##3##4##(1992-2#1)(1995-2#1)(2008-11#1)
the value of which is##2##5##(1993-3#1)(2008-3#1)
the value of##302##3##(1990-10#1)(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#3)(1990-7#3)(1990-8#2)(1991-11#1)(1991-4#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-5#4)(1992-6#2)(1992-9#1)(1993-10#2)(1993-11#4)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#4)(1994-4#1)(1994-7#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-7#3)(1997-8#2)(2004-1#1)(2004-9#1)(2005-1#1)(2005-10#3)(2005-11#7)(2005-12#1)(2005-8#1)(2006-10#5)(2006-4#2)(2006-7#4)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#6)(2007-2#5)(2007-3#3)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#4)(2007-9#3)(2008-1#5)(2008-10#11)(2008-11#14)(2008-12#8)(2008-2#9)(2008-3#19)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#8)(2008-8#13)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#6)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#3)(2012-12#4)(2012-2#3)(2012-3#5)(2013-1#8)(2013-7#2)(2013-8#3)
the value that##4##3##(1993-2#1)(2007-12#1)(2007-7#1)(2008-3#1)
the value was##2##3##(2008-5#1)(2013-1#1)
the value##379##2##(1990-10#1)(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#3)(1990-7#3)(1990-8#3)(1990-9#2)(1991-1#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#4)(1992-6#3)(1992-9#2)(1993-10#2)(1993-11#4)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-4#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#3)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#3)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#3)(1997-8#2)(2004-1#1)(2004-4#1)(2004-9#1)(2005-1#2)(2005-10#3)(2005-11#11)(2005-12#1)(2005-8#1)(2006-10#5)(2006-4#3)(2006-7#4)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#7)(2007-2#5)(2007-3#3)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#6)(2007-8#6)(2007-9#3)(2008-1#5)(2008-10#21)(2008-11#17)(2008-12#8)(2008-2#11)(2008-3#20)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#8)(2008-8#13)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#6)(2010-5#2)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#6)(2012-1#3)(2012-12#4)(2012-2#8)(2012-3#6)(2013-1#9)(2013-7#2)(2013-8#3)
the values are##3##3##(2008-10#2)(2010-12#1)
the values between##2##3##(2011-2#1)(2012-3#1)
the values calculated##2##3##(1995-3#1)(2008-6#1)
the values determined for##2##4##(2008-2#1)(2008-5#1)
the values determined##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
the values for other##2##4##(1997-1#1)(2008-5#1)
the values for the##3##4##(1994-11#1)(1997-2#1)(2008-2#1)
the values for##23##3##(1990-5#1)(1991-5#1)(1991-7#1)(1992-11#1)(1993-2#1)(1994-11#1)(1994-5#1)(1994-8#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-7#2)(2004-4#1)(2008-2#1)(2008-3#1)(2008-5#3)(2010-12#1)(2013-1#1)(2013-8#1)
the values found for##2##4##(1993-6#1)(2006-12#1)
the values found##3##3##(1993-2#1)(1993-6#1)(2006-12#1)
the values from the##2##4##(1990-12#1)(2011-2#1)
the values from##4##3##(1990-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
the values measured##3##3##(1990-9#1)(1995-8#1)(2011-2#1)
the values observed##2##3##(1990-2#1)(1992-3#1)
the values obtained by the##2##5##(1996-7#1)(2010-4#1)
the values obtained by##7##4##(1996-7#1)(2006-1#1)(2008-10#3)(2008-3#1)(2010-4#1)
the values obtained for##2##4##(2005-10#1)(2008-10#1)
the values obtained from##8##4##(1992-2#1)(1992-6#1)(1996-11#1)(2008-10#3)(2008-3#1)(2012-3#1)
the values obtained in the##2##5##(2008-10#1)(2008-5#1)
the values obtained in##4##4##(2005-10#1)(2008-10#1)(2008-12#1)(2008-5#1)
the values obtained with##4##4##(1992-6#1)(1995-4#1)(1996-7#1)(2008-10#1)
the values obtained##30##3##(1992-2#1)(1992-6#2)(1995-4#2)(1996-11#1)(1996-7#2)(2005-10#2)(2006-1#1)(2007-4#1)(2008-10#12)(2008-12#1)(2008-3#2)(2008-5#1)(2010-4#1)(2012-3#1)
the values of K(f)##2##4##(2008-10#2)
the values of both##2##4##(2005-11#1)(2007-11#1)
the values of the control coefficients##2##6##(1990-7#2)
the values of the control##4##5##(1990-7#2)(2008-12#1)(2008-4#1)
the values of the correlation function##2##6##(2008-3#2)
the values of the distribution##2##5##(2008-10#2)
the values of the limiting current density##2##7##(2005-11#2)
the values of the##43##4##(1990-7#2)(1991-2#1)(1994-1#1)(1994-3#1)(1995-5#1)(1997-1#1)(2005-11#5)(2006-11#1)(2006-4#1)(2007-11#3)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#1)(2010-8#1)(2011-11#1)(2013-8#1)
the values of these##4##4##(1991-2#1)(2007-6#1)(2008-12#2)
the values of which##2##4##(1991-12#1)(2008-10#1)
the values of##99##3##(1990-5#1)(1990-6#1)(1990-7#3)(1991-12#2)(1991-2#3)(1992-8#1)(1993-1#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-5#1)(1997-1#2)(1997-3#1)(2005-10#1)(2005-11#7)(2006-11#1)(2006-4#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-6#2)(2007-7#1)(2008-1#1)(2008-10#16)(2008-12#3)(2008-2#10)(2008-3#8)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-6#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-11#1)(2012-12#1)(2013-1#2)(2013-8#1)
the values predicted by##2##4##(2008-5#1)(2008-8#1)
the values predicted##3##3##(2007-11#1)(2008-5#1)(2008-8#1)
the values were still##2##4##(1996-12#1)(2006-4#1)
the values were##12##3##(1991-11#1)(1993-2#1)(1996-11#1)(1996-12#1)(2006-4#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#2)(2012-12#1)(2013-1#1)
the values which##2##3##(1993-12#1)(2006-5#1)
the values##222##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#3)(1990-9#2)(1991-11#1)(1991-12#2)(1991-2#4)(1991-5#1)(1991-7#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#3)(1993-6#1)(1993-7#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-4#2)(1995-5#1)(1995-8#1)(1996-11#2)(1996-12#1)(1996-5#1)(1996-7#2)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#2)(2004-4#1)(2004-9#1)(2005-10#3)(2005-11#8)(2006-1#1)(2006-11#1)(2006-12#1)(2006-4#2)(2006-5#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#1)(2007-2#3)(2007-4#1)(2007-6#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#37)(2008-11#1)(2008-12#4)(2008-2#14)(2008-3#15)(2008-4#2)(2008-5#11)(2008-6#2)(2008-7#2)(2008-8#3)(2009-3#2)(2009-4#1)(2009-6#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-11#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#2)
the valve and##2##3##(2006-8#1)(2007-8#1)
the valve body is positioned##3##5##(2006-8#3)
the valve body##4##3##(2006-8#4)
the valve pressure##3##3##(2006-8#3)
the valve##31##2##(1990-11#1)(1990-3#1)(1991-12#1)(1997-3#1)(1997-5#1)(2006-8#12)(2007-8#2)(2008-10#3)(2008-5#2)(2010-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
the valves##5##2##(1997-2#1)(2006-8#1)(2008-10#1)(2009-10#1)(2011-1#1)
the valvula cerebelli##2##3##(1993-12#2)
the vampire's##2##2##(2008-5#2)
the van Cittert-Zernike theorem##5##4##(2007-12#3)(2008-1#1)(2008-2#1)
the van der Waals and##2##5##(2005-11#1)(2008-3#1)
the van der Waals interaction##4##5##(1992-3#1)(2005-11#1)(2006-10#2)
the van der Waals surface##2##5##(2013-1#2)
the van der Waals##12##4##(1992-3#1)(1995-3#1)(2005-11#3)(2006-10#2)(2007-11#2)(2008-3#1)(2013-1#2)
the van##18##2##(1992-3#1)(1995-3#1)(2005-11#3)(2005-12#1)(2006-10#2)(2007-11#2)(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#1)(2013-1#2)
the van't Hoff##2##3##(1991-2#1)(2008-10#1)
the vanadate##2##2##(1994-5#1)(2008-10#1)
the vanadium adsorption##2##3##(2008-10#2)
the vanadium##9##2##(2008-10#8)(2008-5#1)
the vanadium(V)-catalyzed##2##2##(2008-10#2)
the vanguard of##4##3##(1991-2#1)(2008-9#1)(2013-8#2)
the vanishing##4##2##(1997-3#1)(2007-7#2)(2008-10#1)
the vapor phase##2##3##(2008-10#1)(2008-8#1)
the vapor##8##2##(1991-3#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-8#1)(2011-2#1)
the vaporization group##2##3##(1992-3#2)
the vaporization of##2##3##(2005-4#2)
the vaporization##10##2##(1992-3#2)(2005-4#2)(2007-8#1)(2008-10#4)(2008-3#1)
the vapour pressure of the##4##5##(2008-5#3)(2009-11#1)
the vapour pressure of##5##4##(2008-5#4)(2009-11#1)
the vapour pressure##6##3##(2008-5#5)(2009-11#1)
the vapour##9##2##(1992-11#1)(2008-10#1)(2008-5#5)(2008-7#1)(2009-11#1)
the vapours##2##2##(1991-6#1)(2008-10#1)
the var##3##2##(2008-12#1)(2008-5#2)
the variability among##2##3##(2008-10#2)
the variability and##3##3##(1997-7#1)(2008-10#2)
the variability between different tests based on the same principle##2##10##(2008-10#2)
the variability between##6##3##(1993-12#1)(2006-10#1)(2008-10#4)
the variability in disease##2##4##(2008-10#2)
the variability in the##7##4##(1991-12#1)(1997-8#1)(2008-10#2)(2009-4#1)(2010-2#1)(2011-2#1)
the variability in##32##3##(1991-12#1)(1992-5#1)(1992-6#1)(1993-12#1)(1995-11#1)(1995-3#2)(1996-1#1)(1996-3#1)(1997-8#1)(2005-10#2)(2007-12#1)(2007-3#1)(2007-9#1)(2008-10#6)(2008-3#1)(2008-8#2)(2009-4#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-7#1)
the variability of in vivo##2##5##(2008-11#1)(2011-1#1)
the variability of the clinical##2##5##(2006-8#1)(2007-7#1)
the variability of the least squares mean of the reference formulation##2##11##(1995-4#2)
the variability of the##15##4##(1990-11#2)(1994-11#1)(1994-9#1)(1995-4#2)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-7#1)
the variability of##48##3##(1990-11#2)(1992-3#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-4#2)(1996-7#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-6#1)(2006-8#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
the variability##107##2##(1990-11#2)(1990-8#1)(1991-12#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-12#2)(1993-6#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#2)(1995-4#2)(1996-1#1)(1996-3#1)(1996-7#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#2)(2006-10#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#29)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#4)(2009-4#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#3)(2013-1#1)(2013-7#1)
the variable (V)##3##3##(1990-11#1)(1997-1#1)(2008-4#1)
the variable Zagreb##2##3##(2007-11#2)
the variable clinical##3##3##(2011-2#3)
the variable loop##2##3##(1993-11#2)
the variable number##2##3##(1991-7#1)(2008-7#1)
the variable region of the##2##5##(2008-10#1)(2008-8#1)
the variable region##11##3##(1990-5#2)(1992-7#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-8#1)(2012-12#2)
the variable regions of##2##4##(1990-5#1)(1993-5#1)
the variable regions##4##3##(1990-5#1)(1993-5#1)(1996-11#2)
the variable substrate##4##3##(1991-2#1)(1992-3#3)
the variable##74##2##(1990-11#1)(1990-5#3)(1990-8#1)(1991-2#1)(1991-4#1)(1991-7#2)(1992-1#1)(1992-3#4)(1992-4#1)(1992-6#1)(1992-7#1)(1993-11#3)(1993-5#1)(1993-6#1)(1994-11#1)(1994-9#2)(1995-12#1)(1996-11#2)(1996-5#1)(1997-1#1)(1997-6#1)(2006-11#1)(2007-11#4)(2007-2#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-3#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-2#3)(2012-12#4)(2012-2#2)(2013-8#2)
the variables affecting the##3##4##(2007-4#1)(2008-10#2)
the variables affecting##4##3##(2007-4#1)(2008-10#3)
the variables and##3##3##(1995-10#1)(2008-10#2)
the variables associated with##3##4##(2011-2#2)(2013-8#1)
the variables considered##2##3##(2008-10#1)(2012-12#1)
the variables examined were##2##4##(1993-8#1)(2011-2#1)
the variables examined##3##3##(1993-8#1)(2006-7#1)(2011-2#1)
the variables have been##3##4##(2008-10#3)
the variables investigated##3##3##(2007-7#1)(2010-9#1)(2011-2#1)
the variables involved##2##3##(2008-10#1)(2008-2#1)
the variables of the##2##4##(2004-9#1)(2008-10#1)
the variables of##3##3##(2004-9#1)(2008-10#1)(2010-2#1)
the variables related to##2##4##(1995-2#1)(2008-10#1)
the variables studied were##2##4##(2008-10#1)(2008-11#1)
the variables studied##3##3##(2008-10#1)(2008-11#1)(2012-1#1)
the variables that##7##3##(1991-12#1)(1994-7#1)(1995-1#1)(2008-10#1)(2008-3#1)(2010-5#1)(2012-12#1)
the variables to be optimized and##2##6##(2008-10#1)(2008-11#1)
the variables to be##3##4##(2008-10#2)(2008-11#1)
the variables were found##2##4##(2004-11#1)(2011-2#1)
the variables were##5##3##(2004-11#1)(2004-12#1)(2007-3#1)(2008-10#1)(2011-2#1)
the variables with##2##3##(2004-12#1)(2007-8#1)
the variables##78##2##(1991-12#1)(1991-2#1)(1992-7#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-10#2)(1995-2#1)(1997-6#1)(2004-11#1)(2004-12#2)(2004-9#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#21)(2008-11#3)(2008-2#3)(2008-3#1)(2008-5#3)(2008-6#1)(2009-4#1)(2010-2#1)(2010-5#2)(2010-9#1)(2011-2#5)(2012-1#2)(2012-12#4)(2012-2#1)(2013-7#1)(2013-8#1)
the variance accounted for##2##4##(2007-9#1)(2008-9#1)
the variance and##3##3##(2008-10#1)(2008-8#1)(2009-9#1)
the variance between##2##3##(2011-1#1)(2013-1#1)
the variance estimated from a standard formula##2##7##(2012-1#2)
the variance in both##2##4##(2007-1#1)(2009-10#1)
the variance in the##12##4##(1991-12#1)(1995-3#1)(1995-7#1)(2007-10#2)(2007-11#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-12#1)(2010-9#1)(2012-3#1)
the variance in##52##3##(1991-12#1)(1994-3#1)(1994-9#1)(1995-3#1)(1995-7#1)(1996-1#2)(2007-1#1)(2007-10#6)(2007-11#1)(2007-7#1)(2007-9#2)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#4)(2010-2#1)(2010-3#1)(2010-6#1)(2010-9#4)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
the variance of area estimates was##2##6##(1997-3#2)
the variance of the noise##2##5##(2008-1#1)(2008-2#1)
the variance of the number of infected plants##2##8##(2008-10#2)
the variance of the##24##4##(1992-6#1)(1993-12#1)(1995-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#9)(2008-3#1)(2010-2#1)(2010-3#1)(2012-3#1)
the variance of##33##3##(1992-6#1)(1993-12#1)(1995-4#1)(1997-3#2)(1997-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-2#10)(2008-3#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-2#1)(2010-3#1)(2012-12#1)(2012-3#1)
the variance was##2##3##(2008-10#1)(2008-6#1)
the variance##127##2##(1991-12#1)(1992-6#1)(1993-12#2)(1993-2#1)(1994-3#1)(1994-9#1)(1995-3#1)(1995-4#1)(1995-7#1)(1996-1#2)(1997-2#2)(1997-3#2)(1997-6#1)(2006-10#1)(2007-1#1)(2007-10#7)(2007-11#2)(2007-12#2)(2007-7#1)(2007-9#4)(2008-1#1)(2008-10#15)(2008-12#1)(2008-2#12)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#5)(2009-10#1)(2009-12#4)(2009-2#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-10#2)(2010-2#3)(2010-3#2)(2010-5#1)(2010-6#1)(2010-9#5)(2011-1#7)(2011-2#1)(2012-1#5)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#4)(2013-8#1)
the variances of##3##3##(1997-2#1)(2008-10#1)(2012-3#1)
the variances##5##2##(1997-2#1)(2008-10#2)(2012-3#2)
the variant A LOS is##2##5##(1992-12#2)
the variant A LOS##4##4##(1992-12#4)
the variant A##5##3##(1992-12#5)
the variant form of##2##4##(1991-3#1)(2009-10#1)
the variant pI6##2##3##(1991-12#2)
the variant proteins##2##3##(1995-5#1)(2008-7#1)
the variant receptor##2##3##(1993-3#1)(1994-12#1)
the variant##41##2##(1990-10#1)(1990-8#2)(1991-12#2)(1991-3#1)(1992-12#6)(1992-6#1)(1992-7#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-11#2)(1994-12#1)(1994-2#1)(1995-5#1)(1995-8#2)(1996-11#1)(2006-12#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-10#1)(2010-12#1)(2010-2#1)(2011-2#4)(2012-12#1)(2012-3#1)
the variants in##3##3##(2012-12#1)(2012-3#1)(2013-7#1)
the variants##10##2##(1991-2#1)(1992-2#1)(1995-6#1)(1997-1#1)(1997-4#1)(2006-9#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
the variation among##5##3##(1994-5#1)(2009-10#1)(2009-6#1)(2012-12#2)
the variation between##3##3##(1994-3#1)(1996-11#1)(2010-2#1)
the variation due to the##2##5##(2008-10#1)(2011-1#1)
the variation in Bragg wavelength is 0##2##7##(2013-8#2)
the variation in cell##2##4##(2007-7#1)(2008-7#1)
the variation in expression##2##4##(2006-12#1)(2010-10#1)
the variation in susceptibility##2##4##(1997-5#1)(2012-12#1)
the variation in the##12##4##(1995-11#1)(1995-9#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2011-1#1)(2013-1#1)
the variation in time of##2##5##(1996-12#1)(2008-10#1)
the variation in##84##3##(1990-9#1)(1992-2#1)(1993-3#1)(1993-6#1)(1994-2#2)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-12#2)(1997-4#1)(1997-5#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-3#2)(2007-7#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#6)(2008-5#2)(2008-7#3)(2008-8#4)(2009-11#1)(2010-10#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
the variation observed in##2##4##(1990-4#1)(1995-3#1)
the variation observed##4##3##(1990-4#1)(1995-3#1)(2008-10#1)(2009-12#1)
the variation of a##3##4##(2008-2#1)(2009-5#1)(2012-3#1)
the variation of the refractive-index##2##5##(2008-2#2)
the variation of the##27##4##(1990-2#1)(1997-7#1)(2005-11#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-2#7)(2008-3#3)(2008-5#1)(2011-1#1)(2013-1#2)(2013-8#2)
the variation of##59##3##(1990-2#1)(1991-11#1)(1991-7#1)(1996-1#1)(1996-5#1)(1997-7#1)(2004-9#1)(2005-11#2)(2006-6#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-2#12)(2008-3#4)(2008-5#1)(2008-8#1)(2009-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#6)
the variation was##5##3##(1994-5#1)(1997-2#1)(2004-2#1)(2008-10#1)(2013-8#1)
the variation with##2##3##(2005-11#1)(2008-10#1)
the variation within a##2##4##(2008-10#1)(2008-4#1)
the variation within##4##3##(1994-3#1)(2008-10#2)(2008-4#1)
the variation##193##2##(1990-2#1)(1990-4#1)(1990-9#1)(1991-11#1)(1991-7#1)(1992-1#1)(1992-2#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#3)(2005-8#1)(2006-10#1)(2006-12#2)(2006-6#2)(2006-9#1)(2007-1#2)(2007-11#2)(2007-12#1)(2007-3#3)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#36)(2008-11#1)(2008-12#3)(2008-2#16)(2008-3#10)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#7)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#10)(2013-7#1)(2013-8#10)
the variational##7##2##(2007-12#2)(2007-8#1)(2008-2#1)(2009-9#2)(2012-3#1)
the variations in the##10##4##(1993-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-6#1)(2011-12#1)(2013-8#3)
the variations in##22##3##(1990-8#1)(1991-11#1)(1993-2#1)(1994-9#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-9#2)(2009-5#1)(2009-6#1)(2009-7#1)(2011-12#1)(2011-2#1)(2012-11#1)(2013-8#3)
the variations of these##3##4##(2007-12#1)(2008-10#1)(2008-12#1)
the variations of##9##3##(1992-3#1)(2005-10#1)(2005-4#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2013-8#1)
the variations##36##2##(1990-8#1)(1991-11#1)(1992-3#1)(1993-2#1)(1994-9#1)(2005-10#1)(2005-4#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-9#3)(2009-5#1)(2009-6#1)(2009-7#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-11#1)(2013-8#4)
the varicella vaccine##2##3##(2007-11#1)(2010-10#1)
the varicella##4##2##(2007-11#1)(2008-11#1)(2008-7#1)(2010-10#1)
the varices##2##2##(2011-2#2)
the varicocele##2##2##(1990-3#2)
the varicosities'##2##2##(2007-10#2)
the varied##6##2##(1991-12#1)(1993-9#1)(2007-11#1)(2008-9#1)(2009-4#1)(2010-11#1)
the varieties of##4##3##(1997-3#1)(2008-10#1)(2008-12#1)(2013-8#1)
the varieties##8##2##(1997-3#1)(2008-10#2)(2008-12#3)(2013-8#2)
the variety and##2##3##(1990-6#1)(2007-2#1)
the variety gattii##2##3##(2007-7#2)
the variety of options##2##4##(2007-9#1)(2011-2#1)
the variety of##32##3##(1990-6#1)(1990-8#1)(1992-1#1)(1993-7#1)(1994-8#1)(1996-12#2)(2005-11#1)(2006-1#1)(2006-10#2)(2006-12#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-2#3)(2013-1#1)
the variety##39##2##(1990-6#2)(1990-8#1)(1992-1#1)(1993-7#1)(1994-8#1)(1996-12#2)(2005-11#1)(2006-1#1)(2006-10#2)(2006-12#1)(2007-2#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-5#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-2#3)(2013-1#1)
the various activities of##4##4##(1996-5#1)(2007-2#3)
the various agents##2##3##(2007-11#1)(2009-8#1)
the various anxiety disorders##2##4##(1991-2#1)(2013-8#1)
the various approaches##4##3##(2005-5#1)(2008-4#1)(2009-12#1)(2010-5#1)
the various aspects of the##3##5##(1996-12#1)(2007-7#1)(2011-2#1)
the various aspects of##10##4##(1996-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-7#1)(2009-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
the various available##2##3##(2006-1#1)(2008-4#1)
the various biological##2##3##(2011-2#1)(2013-8#1)
the various branches of##2##4##(2012-2#2)
the various cDNA##2##3##(1993-5#1)(1993-8#1)
the various categories of##2##4##(1992-8#1)(2011-2#1)
the various categories##4##3##(1992-8#1)(2006-9#1)(2007-11#1)(2011-2#1)
the various causes and the##2##5##(2008-1#1)(2011-1#1)
the various causes of##2##4##(2005-8#1)(2012-2#1)
the various causes##7##3##(2005-8#2)(2007-11#1)(2008-1#1)(2008-7#1)(2011-1#1)(2012-2#1)
the various cell types of##2##5##(1991-10#2)
the various cell##5##3##(1991-10#2)(1992-8#1)(2008-10#1)(2008-6#1)
the various challenges##2##3##(2009-9#1)(2011-2#1)
the various components of the##4##5##(2006-10#1)(2008-3#1)(2008-4#1)(2008-6#1)
the various components of##12##4##(1994-8#1)(1995-3#1)(1996-3#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2011-2#1)
the various components##15##3##(1994-8#1)(1995-3#1)(1996-3#1)(2006-10#1)(2006-4#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-6#1)(2011-2#1)
the various compounds##3##3##(2006-12#1)(2006-2#1)(2007-11#1)
the various definitions##2##3##(2007-3#1)(2009-7#1)
the various diagnostic##2##3##(1992-3#1)(2007-8#1)
the various dietary##2##3##(1990-5#1)(2006-9#1)
the various dimensions of##2##4##(2008-11#1)(2008-2#1)
the various dose##2##3##(1994-3#1)(2009-5#1)
the various drugs##4##3##(1990-8#1)(2007-11#2)(2010-11#1)
the various effects##2##3##(2009-1#1)(2013-1#1)
the various elements##3##3##(1994-3#2)(2008-4#1)
the various environmental##2##3##(2008-10#1)(2012-1#1)
the various factors involved in the##2##6##(2006-5#1)(2008-3#1)
the various factors involved in##3##5##(2005-10#1)(2006-5#1)(2008-3#1)
the various factors that contribute to##2##6##(2007-10#1)(2013-1#1)
the various factors that##4##4##(1990-3#1)(1992-2#1)(2007-10#1)(2013-1#1)
the various factors##12##3##(1990-3#1)(1992-2#1)(1996-2#1)(2005-10#1)(2006-5#1)(2007-10#2)(2007-7#1)(2008-3#1)(2009-9#1)(2012-12#1)(2013-1#1)
the various forms of##10##4##(1991-4#1)(1992-11#1)(1994-11#1)(1996-12#1)(2006-11#1)(2007-8#1)(2008-4#1)(2010-10#1)(2011-1#1)(2013-8#1)
the various forms##12##3##(1991-4#1)(1992-11#1)(1994-11#1)(1994-9#1)(1996-12#1)(2005-2#1)(2006-11#1)(2007-8#1)(2008-4#1)(2010-10#1)(2011-1#1)(2013-8#1)
the various groups of##3##4##(1994-11#1)(2006-9#1)(2012-2#1)
the various groups##4##3##(1994-11#1)(2006-9#1)(2008-7#1)(2012-2#1)
the various health services##2##4##(2005-5#2)
the various healthcare##2##3##(1992-12#1)(1993-12#1)
the various highly##2##3##(1992-9#1)(2008-10#1)
the various histological##3##3##(1996-9#2)(2012-1#1)
the various hypotheses##2##3##(2005-10#1)(2009-12#1)
the various interventions##2##3##(2007-1#1)(2008-10#1)
the various intracellular##2##3##(1996-7#1)(2008-5#1)
the various isolates##3##3##(2008-10#2)(2008-5#1)
the various levels of##3##4##(1991-11#1)(2008-10#1)(2008-2#1)
the various levels##5##3##(1991-11#1)(1992-3#1)(2008-10#1)(2008-2#1)(2012-2#1)
the various locations##2##3##(2007-12#1)(2008-7#1)
the various methodologies##2##3##(1995-2#1)(2008-10#1)
the various methods in##2##4##(2007-7#1)(2008-2#1)
the various methods of##3##4##(1992-9#1)(2004-3#1)(2007-9#1)
the various methods##13##3##(1992-9#1)(1994-6#1)(2004-3#1)(2005-10#1)(2006-2#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-11#1)(2008-2#1)(2008-5#1)(2009-7#1)
the various modalities##2##3##(2007-12#1)(2009-4#1)
the various models##3##3##(1990-12#1)(2008-11#1)(2008-2#1)
the various modes##2##3##(2005-8#1)(2008-3#1)
the various options##3##3##(1993-9#1)(2005-10#1)(2008-10#1)
the various outputs##2##3##(1992-2#1)(2008-2#1)
the various parameters##4##3##(2008-10#2)(2008-3#1)(2011-7#1)
the various participants##2##3##(1995-1#1)(2007-12#1)
the various parts of##2##4##(1992-11#1)(2010-7#1)
the various peptides##3##3##(1991-5#3)
the various phases##2##3##(1992-9#1)(2007-11#1)
the various physical##2##3##(2008-3#1)(2009-11#1)
the various populations##2##3##(2007-1#2)
the various preparations##3##3##(2006-9#1)(2007-11#2)
the various procedures##3##3##(1990-10#1)(2007-2#1)(2008-5#1)
the various processes involved in##2##5##(1994-8#1)(2007-11#1)
the various proteins##2##3##(1993-3#1)(1995-5#1)
the various proteomic##2##3##(2009-4#1)(2010-12#1)
the various regions##2##3##(2007-1#1)(2007-12#1)
the various scattering##2##3##(2008-2#1)(2008-3#1)
the various signal transduction pathways##2##5##(1994-3#1)(2008-5#1)
the various sites##2##3##(2008-10#1)(2008-5#1)
the various species##3##3##(1996-2#1)(2008-10#1)(2010-12#1)
the various spectral##2##3##(1997-6#1)(2008-2#1)
the various stages of##4##4##(1993-11#1)(1997-4#1)(2006-10#2)
the various stages##5##3##(1993-11#1)(1997-4#1)(2006-10#2)(2009-10#1)
the various structures##2##3##(2009-12#1)(2012-12#1)
the various studies##6##3##(1990-11#1)(1994-2#1)(2005-7#1)(2007-11#1)(2008-9#1)(2010-10#1)
the various subgroups##2##3##(1994-1#1)(2007-11#1)
the various surgical techniques##2##4##(1992-6#1)(2006-7#1)
the various surgical##4##3##(1990-9#1)(1992-6#1)(2006-7#2)
the various techniques##5##3##(2008-10#2)(2008-11#2)(2009-1#1)
the various tests##3##3##(1990-8#1)(1991-5#1)(2011-2#1)
the various therapeutic options##2##4##(1992-6#1)(1993-10#1)
the various therapeutic##4##3##(1990-12#1)(1992-6#1)(1993-10#1)(2006-8#1)
the various tissues##3##3##(1996-4#1)(2009-10#1)(2012-1#1)
the various treatment##4##3##(1997-3#1)(2006-10#1)(2006-9#1)(2008-10#1)
the various treatments##3##3##(1992-8#1)(2006-12#1)(2006-7#1)
the various types of##11##4##(1992-12#1)(1994-12#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
the various types##13##3##(1992-12#1)(1993-3#1)(1994-12#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
the various ways##6##3##(1996-2#1)(2004-12#1)(2008-12#1)(2008-5#1)(2013-1#2)
the various##607##2##(1990-10#1)(1990-11#2)(1990-12#5)(1990-2#1)(1990-3#2)(1990-5#4)(1990-7#2)(1990-8#7)(1990-9#1)(1991-10#4)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#2)(1991-4#2)(1991-5#5)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#3)(1992-3#2)(1992-4#2)(1992-6#3)(1992-8#4)(1992-9#4)(1993-1#2)(1993-10#2)(1993-11#2)(1993-12#2)(1993-3#3)(1993-5#3)(1993-6#3)(1993-8#2)(1993-9#2)(1994-1#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#6)(1994-6#3)(1994-7#1)(1994-8#5)(1994-9#4)(1995-1#3)(1995-10#2)(1995-2#4)(1995-3#3)(1995-5#3)(1995-6#2)(1995-8#1)(1996-1#2)(1996-12#5)(1996-2#4)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#4)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#5)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#3)(2004-12#1)(2004-3#1)(2005-10#6)(2005-11#2)(2005-12#1)(2005-2#2)(2005-3#1)(2005-4#1)(2005-5#4)(2005-7#2)(2005-8#9)(2005-9#1)(2006-1#2)(2006-10#12)(2006-11#2)(2006-12#6)(2006-2#4)(2006-3#2)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#1)(2006-9#9)(2007-1#6)(2007-10#4)(2007-11#22)(2007-12#17)(2007-2#6)(2007-3#3)(2007-4#2)(2007-5#1)(2007-7#5)(2007-8#8)(2007-9#5)(2008-1#4)(2008-10#48)(2008-11#12)(2008-12#3)(2008-2#11)(2008-3#17)(2008-4#10)(2008-5#19)(2008-6#5)(2008-7#10)(2008-8#3)(2008-9#8)(2009-1#3)(2009-10#3)(2009-11#2)(2009-12#3)(2009-4#5)(2009-5#2)(2009-7#4)(2009-8#2)(2009-9#6)(2010-10#2)(2010-11#2)(2010-12#5)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#9)(2011-2#17)(2011-7#1)(2012-1#6)(2012-12#3)(2012-2#8)(2012-3#3)(2013-1#15)(2013-7#2)(2013-8#9)
the varnish##2##2##(2008-3#2)
the varying##15##2##(1992-3#1)(1993-8#1)(1994-6#1)(1997-5#1)(2005-8#1)(2007-2#1)(2007-4#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-11#1)(2010-7#1)
the vas deferens and##3##4##(1992-5#1)(1995-11#1)(1997-8#1)
the vas deferens##15##3##(1990-12#1)(1992-5#1)(1994-8#2)(1995-11#1)(1996-12#1)(1997-8#1)(2007-12#1)(2007-9#2)(2008-10#4)(2013-8#1)
the vas##20##2##(1990-12#1)(1992-5#1)(1994-8#7)(1995-11#1)(1996-12#1)(1997-8#1)(2007-12#1)(2007-9#2)(2008-10#4)(2013-8#1)
the vasa nervorum##3##3##(1993-11#1)(1993-12#2)
the vasa##4##2##(1993-11#1)(1993-12#2)(2010-9#1)
the vascular access##7##3##(2007-11#1)(2007-7#6)
the vascular anastomosis##2##3##(2008-1#1)(2012-12#1)
the vascular anatomy of the distal radius##2##7##(2006-3#2)
the vascular anatomy##3##3##(2006-3#2)(2007-10#1)
the vascular bed##4##3##(1997-1#1)(2007-7#2)(2008-3#1)
the vascular bundles and##2##4##(2008-10#2)
the vascular bundles##4##3##(2008-10#4)
the vascular cambium##3##3##(2008-10#3)
the vascular complications of##2##4##(1993-12#1)(2013-8#1)
the vascular complications##3##3##(1991-12#1)(1993-12#1)(2013-8#1)
the vascular cylinder##2##3##(2008-10#2)
the vascular elements##2##3##(2008-10#2)
the vascular endothelial cell##4##4##(1991-9#1)(2008-1#1)(2009-7#1)(2013-1#1)
the vascular endothelial growth factor##6##5##(1992-3#1)(2008-1#1)(2008-6#1)(2009-11#1)(2012-1#1)(2012-3#1)
the vascular endothelial##12##3##(1991-9#1)(1992-3#1)(1997-1#1)(2008-1#2)(2008-6#1)(2009-11#1)(2009-7#1)(2010-12#1)(2012-1#1)(2012-3#1)(2013-1#1)
the vascular endothelium##9##3##(1990-10#1)(1990-4#1)(2005-11#1)(2008-1#1)(2008-3#1)(2009-3#1)(2012-1#2)(2012-2#1)
the vascular lesion##2##3##(2006-4#1)(2007-9#1)
the vascular network of##2##4##(2008-5#1)(2011-2#1)
the vascular network##5##3##(2008-11#3)(2008-5#1)(2011-2#1)
the vascular permeability##2##3##(1991-9#1)(1992-12#1)
the vascular reactivity of##2##4##(1994-2#1)(1995-12#1)
the vascular reactivity##3##3##(1990-3#1)(1994-2#1)(1995-12#1)
the vascular response to##2##4##(1996-12#1)(2008-6#1)
the vascular response##4##3##(1996-12#1)(1997-5#1)(2008-6#1)(2011-1#1)
the vascular smooth muscle cells##3##5##(1995-11#1)(2008-7#1)(2009-1#1)
the vascular smooth muscle##7##4##(1990-10#1)(1990-11#1)(1991-9#1)(1995-11#1)(1995-12#1)(2008-7#1)(2009-1#1)
the vascular supply to the##2##5##(2006-6#1)(2007-11#1)
the vascular supply##5##3##(1992-1#1)(2005-11#1)(2006-6#1)(2007-11#1)(2007-12#1)
the vascular surface##2##3##(1990-5#2)
the vascular system of the##2##5##(2008-10#2)
the vascular system##11##3##(1991-4#1)(2005-10#1)(2006-10#1)(2006-5#1)(2008-10#4)(2008-9#1)(2009-2#1)(2010-8#1)
the vascular territory##2##3##(2007-10#1)(2012-3#1)
the vascular tissue##4##3##(2006-12#2)(2008-10#2)
the vascular tissues##6##3##(2008-10#6)
the vascular wall##9##3##(1990-8#1)(1992-9#1)(1993-12#1)(2005-6#1)(2008-7#1)(2009-2#1)(2010-12#1)(2010-5#1)(2012-12#1)
the vascular walls##2##3##(1991-6#1)(2012-1#1)
the vascular##175##2##(1990-10#3)(1990-11#1)(1990-3#2)(1990-4#1)(1990-5#3)(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-6#4)(1991-7#1)(1991-9#3)(1992-1#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-8#1)(1994-12#2)(1994-2#1)(1995-11#1)(1995-12#2)(1996-10#1)(1996-11#2)(1996-12#2)(1997-1#3)(1997-3#1)(1997-5#1)(1997-6#2)(2004-4#1)(2005-1#1)(2005-10#1)(2005-11#3)(2005-6#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-3#2)(2006-4#1)(2006-5#2)(2006-6#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#10)(2007-9#1)(2008-1#5)(2008-10#27)(2008-11#4)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-2#2)(2009-3#2)(2009-5#2)(2009-7#1)(2010-12#3)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#4)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#3)
the vascularity of the##2##4##(1996-3#1)(2006-3#1)
the vascularity of##3##3##(1996-3#1)(2006-3#1)(2010-8#1)
the vascularization of##2##3##(1990-6#1)(2007-11#1)
the vascularized##4##2##(2006-3#2)(2008-9#1)(2009-3#1)
the vasculature and##4##3##(1991-9#1)(1995-1#1)(2008-3#1)(2011-1#1)
the vasculature for the##2##4##(2005-9#1)(2008-7#1)
the vasculature in##2##3##(2008-7#1)(2013-1#1)
the vasculature of##2##3##(1997-3#1)(2009-2#1)
the vasculature to##2##3##(1991-2#1)(2013-1#1)
the vasculature##25##2##(1991-2#1)(1991-9#1)(1994-2#1)(1995-1#1)(1995-10#1)(1997-3#1)(2005-9#1)(2006-11#1)(2007-1#1)(2007-9#1)(2008-3#2)(2008-4#1)(2008-7#2)(2009-2#1)(2009-4#4)(2009-6#1)(2011-1#1)(2013-1#2)(2013-8#1)
the vasoactive intestinal##2##3##(1994-3#1)(1995-6#1)
the vasoactive##4##2##(1992-3#1)(1994-3#1)(1995-6#1)(1996-5#1)
the vasoconstriction of##2##3##(1991-6#1)(1993-3#1)
the vasoconstriction##5##2##(1990-10#1)(1991-6#1)(1993-3#2)(1995-12#1)
the vasoconstrictor##6##2##(1990-2#1)(1992-5#1)(1992-8#1)(1993-3#1)(1996-10#1)(2007-10#1)
the vasodepressor##2##2##(1996-12#1)(1997-2#1)
the vasodilatation##2##2##(1990-2#1)(1995-12#1)
the vasodilating##3##2##(2007-10#1)(2007-9#1)(2008-5#1)
the vasodilation##3##2##(2004-12#1)(2011-1#1)(2011-2#1)
the vasodilator effect of##2##4##(1993-3#1)(2011-2#1)
the vasodilator effect##3##3##(1993-3#1)(2010-6#1)(2011-2#1)
the vasodilator##7##2##(1993-3#2)(2008-10#1)(2009-5#1)(2010-6#1)(2011-2#2)
the vasodilatory##3##2##(1990-11#1)(1995-2#1)(1997-5#1)
the vasomotor##2##2##(1991-12#1)(2008-7#1)
the vasopressin V1 receptor antagonist##2##5##(1995-12#2)
the vasopressin V1##3##3##(1995-12#3)
the vasopressin##9##2##(1990-5#1)(1994-11#2)(1994-2#1)(1995-12#3)(1995-5#1)(1996-10#1)
the vasorelaxant effect of##2##4##(2009-5#2)
the vasorelaxant##5##2##(1990-11#1)(1994-5#1)(2009-5#3)
the vast amount of information##4##5##(1993-12#1)(2006-1#1)(2008-10#1)(2008-7#1)
the vast amount of##8##4##(1993-12#1)(2006-1#1)(2006-10#1)(2008-10#1)(2008-7#2)(2009-12#1)(2012-3#1)
the vast majority of patients##4##5##(1997-1#1)(2006-7#1)(2007-11#1)(2008-7#1)
the vast majority of the##2##5##(1997-6#1)(2008-1#1)
the vast majority of these##2##5##(2007-12#1)(2008-11#1)
the vast majority of##43##4##(1994-3#1)(1995-1#1)(1995-3#1)(1995-7#1)(1996-3#1)(1997-1#1)(1997-6#2)(1997-7#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#2)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-12#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#1)
the vast majority##49##3##(1991-8#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-7#1)(1996-3#1)(1997-1#1)(1997-6#2)(1997-7#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-3#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the vast number of##2##4##(2006-10#1)(2008-7#1)
the vast##73##2##(1991-8#1)(1993-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-7#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-6#2)(1997-7#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-7#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#3)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
the vastus lateralis##6##3##(2007-6#1)(2008-1#1)(2010-4#4)
the vastus medialis oblique##2##4##(2006-3#1)(2007-6#1)
the vastus medialis##3##3##(2006-3#1)(2007-6#1)(2008-2#1)
the vastus##9##2##(2006-3#1)(2007-6#2)(2008-1#1)(2008-2#1)(2010-4#4)
the vault##3##2##(2007-11#1)(2008-5#2)
the vav##2##2##(1995-3#2)
the vector and the##3##4##(1990-7#1)(1994-11#1)(2008-11#1)
the vector and##5##3##(1990-7#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-8#1)
the vector field##2##3##(2007-12#1)(2008-6#1)
the vector in##2##3##(1997-4#1)(2007-6#1)
the vector into##2##3##(1991-7#1)(1993-8#1)
the vector moment##2##3##(1990-5#1)(2004-11#1)
the vector of##6##3##(1996-10#1)(2004-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2010-1#1)
the vector space##4##3##(2008-2#1)(2011-1#1)(2013-1#2)
the vector specificity##3##3##(2008-10#3)
the vector##104##2##(1990-11#1)(1990-12#1)(1990-3#2)(1990-5#2)(1990-7#1)(1990-9#2)(1991-6#1)(1991-7#7)(1991-9#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-1#1)(1996-10#1)(1996-2#1)(1997-1#1)(1997-4#3)(1997-6#1)(1997-7#1)(2004-11#2)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#20)(2008-11#2)(2008-2#9)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#2)(2009-10#1)(2009-2#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#2)(2013-1#4)
the vector's##3##2##(1997-2#1)(2008-8#2)
the vector-only##2##2##(2007-1#2)
the vectorial##6##2##(1993-6#1)(2007-11#1)(2007-12#1)(2008-3#2)(2012-12#1)
the vectors from##3##3##(1990-9#1)(2012-12#2)
the vectors of##3##3##(1990-6#1)(2007-6#1)(2008-2#1)
the vectors##19##2##(1990-3#1)(1990-6#1)(1990-9#2)(1991-12#1)(1993-12#2)(1995-8#1)(2006-10#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-12#4)(2013-8#2)
the vegetable cheese natto##2##4##(1993-12#2)
the vegetable tanning##2##3##(2007-10#2)
the vegetable##6##2##(1993-12#2)(2007-10#2)(2008-10#1)(2012-12#1)
the vegetal and##2##3##(2007-8#1)(2008-5#1)
the vegetal plate##2##3##(2008-4#2)
the vegetal##6##2##(1993-6#1)(2007-8#1)(2008-4#3)(2008-5#1)
the vegetation and soil##2##4##(1997-4#1)(2013-7#1)
the vegetation##13##2##(1997-4#1)(2004-11#1)(2008-5#1)(2008-8#2)(2009-8#1)(2010-8#1)(2011-12#1)(2011-2#1)(2013-7#1)(2013-8#3)
the vegetative and reproductive##2##4##(2008-5#1)(2008-8#1)
the vegetative growth##2##3##(2008-5#1)(2012-12#1)
the vegetative mycelium##3##3##(1995-2#1)(1996-7#2)
the vegetative state##2##3##(2008-11#1)(2012-1#1)
the vegetative##21##2##(1995-2#1)(1996-7#2)(2007-1#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#3)(2009-12#1)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#2)
the vehicle control group##5##4##(2008-5#1)(2008-9#4)
the vehicle control groups##9##4##(2008-9#9)
the vehicle control##16##3##(2008-5#1)(2008-9#14)(2010-1#1)
the vehicle controls##39##3##(2008-9#39)
the vehicle for##3##3##(1992-12#1)(1992-6#1)(2010-10#1)
the vehicle group##4##3##(1995-3#1)(2011-2#1)(2013-8#2)
the vehicle in##3##3##(2006-11#1)(2008-5#2)
the vehicle##96##2##(1990-2#1)(1991-2#1)(1992-12#1)(1992-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-9#1)(1997-6#1)(2005-11#1)(2006-11#4)(2007-11#1)(2007-4#1)(2008-11#1)(2008-3#1)(2008-4#4)(2008-5#10)(2008-9#53)(2009-5#1)(2010-1#1)(2010-10#1)(2010-5#1)(2011-2#1)(2013-1#3)(2013-8#3)
the vehicle-treated group##2##3##(1995-3#1)(2008-5#1)
the vehicles##9##2##(1991-3#1)(2004-4#2)(2007-4#1)(2008-5#3)(2010-5#2)
the vein and##2##3##(1992-12#1)(2008-1#1)
the vein graft##2##3##(2005-10#1)(2008-12#1)
the vein of Labbé##2##4##(2006-12#2)
the vein of##3##3##(1996-6#1)(2006-12#2)
the vein pouch##2##3##(2010-12#2)
the vein##24##2##(1991-10#2)(1992-12#1)(1996-6#1)(2005-10#1)(2006-12#2)(2006-6#1)(2007-7#7)(2007-8#2)(2008-1#1)(2008-12#1)(2008-7#1)(2010-12#2)(2012-3#2)
the veins##5##2##(1990-10#1)(1995-11#1)(2004-9#1)(2007-8#1)(2008-10#1)
the velocity and the##4##4##(2007-12#1)(2008-3#3)
the velocity contrast##2##3##(1991-3#1)(2011-2#1)
the velocity difference##4##3##(2008-2#2)(2008-3#2)
the velocity field in a##2##5##(2008-2#2)
the velocity field in##3##4##(2008-2#3)
the velocity field##7##3##(2007-12#1)(2008-2#3)(2009-5#3)
the velocity gradient##3##3##(2008-3#3)
the velocity is##2##3##(2007-11#1)(2008-3#1)
the velocity of the##4##4##(2008-11#1)(2008-3#2)(2008-8#1)
the velocity of##17##3##(1990-7#1)(1993-9#1)(1994-5#1)(2005-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-8#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-1#2)
the velocity##58##2##(1990-7#1)(1991-3#1)(1992-9#1)(1993-9#1)(1994-5#1)(1996-3#1)(1997-7#1)(2005-10#1)(2005-11#2)(2007-11#2)(2007-12#4)(2008-10#1)(2008-11#3)(2008-2#8)(2008-3#17)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#3)(2009-8#1)(2011-1#1)(2011-2#2)(2012-1#3)
the velogenic##2##2##(2005-9#1)(2008-11#1)
the velvet##3##2##(1997-3#1)(2005-7#1)(2008-5#1)
the vena cava##5##3##(1992-9#1)(2007-8#1)(2008-6#1)(2010-4#2)
the vena##6##2##(1992-5#1)(1992-9#1)(2007-8#1)(2008-6#1)(2010-4#2)
the vendor##2##2##(2004-9#1)(2009-10#1)
the venom gland##2##3##(2007-12#1)(2008-7#1)
the venom of the##12##4##(1990-12#2)(1990-2#1)(1990-5#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-5#1)(1994-8#1)(1995-5#1)(1996-11#2)
the venom of##29##3##(1990-12#2)(1990-2#3)(1990-5#1)(1991-7#1)(1992-12#2)(1992-5#2)(1993-3#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-5#2)(1995-8#1)(1996-11#2)(1996-2#1)(2008-5#2)(2008-8#2)
the venom reservoir##2##3##(2007-12#1)(2008-8#1)
the venom##44##2##(1990-12#2)(1990-2#3)(1990-5#1)(1991-7#1)(1992-12#2)(1992-5#2)(1993-3#2)(1993-6#2)(1993-7#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-5#2)(1995-8#1)(1996-11#2)(1996-2#1)(1997-7#1)(2007-12#4)(2008-5#3)(2008-7#3)(2008-8#3)(2009-6#1)
the venous blood##2##3##(2008-2#2)
the venous catheter##2##3##(2007-7#2)
the venous circulation##3##3##(1993-2#1)(2006-3#1)(2007-8#1)
the venous plasma##2##3##(1990-11#2)
the venous side##2##3##(2007-7#1)(2008-3#1)
the venous space##2##3##(2006-12#2)
the venous system##8##3##(1990-6#1)(2005-12#1)(2007-7#1)(2008-12#1)(2008-6#1)(2009-3#1)(2011-2#2)
the venous##49##2##(1990-10#2)(1990-11#3)(1990-6#1)(1993-2#1)(1994-9#1)(1995-1#1)(1996-4#1)(1996-9#3)(1997-5#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-12#2)(2006-3#1)(2007-7#7)(2007-8#3)(2007-9#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#2)(2009-3#1)(2010-5#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#1)
the ventilated##4##2##(1992-6#1)(1993-10#1)(2006-10#1)(2008-6#1)
the ventilation##2##2##(1996-12#1)(2007-9#1)
the ventilator and##2##3##(1997-3#1)(2009-6#1)
the ventilator##15##2##(1993-10#1)(1995-12#1)(1996-12#1)(1997-3#1)(1997-4#2)(2007-11#1)(2007-8#1)(2009-6#2)(2011-1#1)(2011-2#1)(2012-2#3)
the ventilatory##6##2##(1994-6#1)(1995-12#1)(1995-7#1)(2006-10#1)(2008-6#1)(2010-7#1)
the ventral PAG##2##3##(1991-3#2)
the ventral and dorsal##4##4##(2006-5#1)(2007-12#1)(2007-5#1)(2012-2#1)
the ventral aorta##2##3##(1990-4#1)(2008-7#1)
the ventral aspect of the spinal cord dura mater##2##9##(2007-1#2)
the ventral aspect of the##3##5##(2007-1#2)(2009-5#1)
the ventral cord motor neurons##2##5##(2007-12#2)
the ventral diverticulum of##2##4##(2007-8#1)(2008-5#1)
the ventral forearm##2##3##(2008-5#2)
the ventral ganglion##2##3##(1995-5#2)
the ventral hippocampus##5##3##(1995-12#4)(2013-8#1)
the ventral horn##7##3##(1990-7#1)(1992-7#2)(1995-11#1)(1995-5#1)(1995-7#1)(1996-9#1)
the ventral lateral geniculate nucleus of the##2##7##(1992-9#1)(1996-7#1)
the ventral medulla oblongata##2##4##(1993-7#1)(1993-9#1)
the ventral mesencephalon##3##3##(1995-9#2)(1996-12#1)
the ventral nerve cord##7##4##(1997-7#1)(2007-12#4)(2008-5#1)(2008-9#1)
the ventral nerve##8##3##(1997-7#1)(2007-12#5)(2008-5#1)(2008-9#1)
the ventral nucleus##2##3##(1991-3#1)(1996-9#1)
the ventral part of the##4##5##(1992-9#1)(1994-12#1)(1995-8#1)(1996-11#1)
the ventral posterior lateral##2##4##(1995-12#1)(1995-6#1)
the ventral posterior##4##3##(1995-11#1)(1995-12#1)(1995-6#1)(2007-12#1)
the ventral radius##2##3##(2009-5#2)
the ventral root##3##3##(1991-6#1)(1992-8#1)(1993-12#1)
the ventral roots##4##3##(1993-12#1)(1996-12#3)
the ventral side of the##6##5##(1991-5#1)(2007-12#2)(2008-5#3)
the ventral striatum##11##3##(1992-10#1)(1993-6#7)(1997-8#1)(2009-2#1)(2010-8#1)
the ventral surface of the##2##5##(2007-3#1)(2009-6#1)
the ventral surface##4##3##(2007-3#1)(2008-5#1)(2009-6#1)(2011-2#1)
the ventral tegmental area (VTA) and##3##6##(1994-12#1)(1996-5#1)(2009-8#1)
the ventral tegmental area (VTA)##11##5##(1991-8#1)(1993-12#3)(1993-6#1)(1994-12#1)(1996-12#1)(1996-5#1)(2008-7#2)(2009-8#1)
the ventral tegmental area of##3##5##(1997-3#1)(1997-5#1)(1997-7#1)
the ventral tegmental area##41##4##(1990-4#1)(1991-11#3)(1991-8#1)(1992-10#1)(1993-12#6)(1993-6#2)(1994-12#1)(1994-2#4)(1996-12#2)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#3)(1997-8#8)(2008-4#1)(2008-7#3)(2009-8#1)
the ventral tegmental##42##3##(1990-4#1)(1991-11#3)(1991-8#1)(1992-10#2)(1993-12#6)(1993-6#2)(1994-12#1)(1994-2#4)(1996-12#2)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#3)(1997-8#8)(2008-4#1)(2008-7#3)(2009-8#1)
the ventral##190##2##(1990-11#1)(1990-4#2)(1990-7#3)(1991-11#3)(1991-3#3)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-10#3)(1992-7#2)(1992-8#1)(1992-9#2)(1993-12#12)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#10)(1993-7#2)(1993-9#2)(1994-12#3)(1994-2#5)(1994-5#1)(1995-11#2)(1995-12#6)(1995-5#4)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#2)(1996-11#3)(1996-12#8)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-2#2)(1997-3#5)(1997-5#1)(1997-7#6)(1997-8#10)(2005-5#1)(2006-5#3)(2006-7#1)(2007-1#2)(2007-10#1)(2007-12#13)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#14)(2008-7#5)(2008-9#3)(2009-10#1)(2009-12#2)(2009-2#1)(2009-5#3)(2009-6#1)(2009-8#2)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-8#1)
the ventricle##4##2##(1996-6#1)(2006-5#2)(2008-5#1)
the ventricles of##2##3##(1992-11#1)(2008-7#1)
the ventricles##11##2##(1992-11#1)(2006-5#1)(2006-9#1)(2007-8#1)(2007-9#1)(2008-6#1)(2008-7#2)(2010-9#1)(2011-1#1)(2013-1#1)
the ventricular rate##3##3##(2010-12#2)(2012-3#1)
the ventricular system in##2##4##(2006-5#1)(2008-7#1)
the ventricular system##5##3##(2006-5#4)(2008-7#1)
the ventricular wall##3##3##(1991-12#1)(1997-5#1)(2007-9#1)
the ventricular##39##2##(1990-9#1)(1991-12#1)(1991-4#1)(1991-9#1)(1993-3#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-5#2)(2005-1#2)(2006-4#1)(2006-5#5)(2007-8#2)(2007-9#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-9#1)(2012-3#1)(2013-1#1)
the ventriculostomy##2##2##(2006-8#1)(2007-10#1)
the ventro-lateral##2##2##(2008-5#2)
the ventrobasal thalamus##3##3##(1997-1#2)(1997-3#1)
the ventrobasal##8##2##(1992-8#1)(1994-2#2)(1995-6#1)(1996-12#1)(1997-1#2)(1997-3#1)
the ventrolateral hypothalamus (VLH)##2##4##(1991-11#1)(1995-5#1)
the ventrolateral hypothalamus##3##3##(1991-11#1)(1995-5#2)
the ventrolateral orbital cortex##2##4##(1994-3#2)
the ventrolateral part##3##3##(1993-9#1)(1996-11#1)(2010-10#1)
the ventrolateral striatum##3##3##(1993-12#1)(1997-6#2)
the ventrolateral##24##2##(1990-7#1)(1991-11#1)(1991-5#1)(1991-6#1)(1992-11#1)(1993-12#1)(1993-3#1)(1993-9#2)(1994-2#2)(1994-3#2)(1995-5#2)(1995-6#1)(1996-11#1)(1996-4#2)(1996-6#1)(1997-6#2)(2010-10#1)(2012-2#1)
the ventromedial and lateral hypothalamus##2##5##(1990-7#2)
the ventromedial and##4##3##(1990-7#2)(1991-2#1)(1994-2#1)
the ventromedial hypothalamic##3##3##(1994-6#1)(1995-11#1)(1995-5#1)
the ventromedial hypothalamus (VMH)##2##4##(1993-2#1)(1995-10#1)
the ventromedial hypothalamus and##2##4##(1994-6#2)
the ventromedial hypothalamus##7##3##(1991-8#1)(1993-2#1)(1994-6#2)(1995-10#1)(1997-5#2)
the ventromedial nucleus of the hypothalamus##3##6##(1990-4#1)(1993-7#1)(1994-2#1)
the ventromedial nucleus##4##3##(1990-4#1)(1993-7#1)(1994-2#2)
the ventromedial prefrontal cortex##3##4##(2008-11#2)(2013-1#1)
the ventromedial##27##2##(1990-4#1)(1990-7#2)(1991-2#1)(1991-8#1)(1993-2#1)(1993-7#1)(1994-2#4)(1994-6#3)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-5#1)(1997-5#2)(1997-7#1)(2008-11#2)(2008-4#1)(2013-1#1)
the venture##3##2##(2007-1#2)(2008-9#1)
the venue##4##2##(2005-8#1)(2008-5#1)(2012-2#1)(2013-8#1)
the veracity of##2##3##(1997-1#1)(2010-3#1)
the verbal interaction##2##3##(2007-10#2)
the verbal monitoring tasks##2##4##(2012-12#2)
the verbal##13##2##(1996-12#1)(2004-9#1)(2005-10#1)(2006-7#1)(2007-10#2)(2007-12#2)(2008-10#1)(2012-12#3)(2013-1#1)
the verdict and##2##3##(1995-12#1)(1997-5#1)
the verdict##3##2##(1995-12#1)(1997-5#1)(2012-2#1)
the verification of the##2##4##(2007-10#1)(2008-3#1)
the verification of##8##3##(2006-3#1)(2007-10#1)(2008-2#1)(2008-3#3)(2008-8#1)(2013-1#1)
the verification##14##2##(1997-6#1)(2006-3#1)(2007-10#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-8#1)(2011-12#1)(2012-12#1)(2013-1#1)
the verified##2##2##(2007-7#1)(2010-8#1)
the vernalization##2##2##(2009-8#1)(2012-3#1)
the versatile##2##2##(2008-4#1)(2009-2#1)
the versatility and##4##3##(2008-10#2)(2008-2#1)(2009-11#1)
the versatility of the##6##4##(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#1)(2012-1#1)(2012-6#1)
the versatility of##14##3##(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-7#1)(2009-10#1)(2010-12#1)(2012-1#1)(2012-6#1)
the versatility##19##2##(2007-12#1)(2008-10#7)(2008-2#3)(2008-3#2)(2008-7#1)(2009-10#1)(2009-11#1)(2010-12#1)(2012-1#1)(2012-6#1)
the versican proteoglycan##2##3##(2008-11#2)
the vertebra##4##2##(1992-1#3)(2009-3#1)
the vertebrae##13##2##(1991-11#1)(2006-8#2)(2007-11#6)(2007-4#1)(2007-8#1)(2008-11#1)(2008-7#1)
the vertebral arteries##4##3##(1995-3#2)(2007-10#1)(2007-9#1)
the vertebral artery##14##3##(1990-7#1)(1991-8#1)(1993-3#2)(2006-11#1)(2006-12#3)(2007-11#2)(2008-12#1)(2008-7#2)(2012-12#1)
the vertebral bodies in##2##4##(1997-3#1)(2007-7#1)
the vertebral bodies##12##3##(1995-9#1)(1996-12#1)(1997-3#1)(2007-1#1)(2007-11#3)(2007-7#1)(2007-8#2)(2008-7#1)(2012-1#1)
the vertebral body and##3##4##(2006-8#1)(2007-11#1)(2007-8#1)
the vertebral body##14##3##(2006-8#4)(2007-11#3)(2007-8#3)(2008-7#1)(2009-6#1)(2012-1#1)(2012-2#1)
the vertebral canal##13##3##(1995-3#1)(2007-11#9)(2007-7#1)(2007-8#1)(2008-12#1)
the vertebral column##17##3##(1990-10#1)(1997-2#1)(2006-4#1)(2006-8#1)(2007-11#4)(2007-8#2)(2008-4#1)(2008-7#1)(2009-2#1)(2011-2#2)(2013-1#2)
the vertebral venous plexus##2##4##(2011-2#2)
the vertebral venous plexuses##2##4##(2011-2#2)
the vertebral venous##4##3##(2011-2#4)
the vertebral##87##2##(1990-10#1)(1990-7#1)(1991-11#1)(1991-8#2)(1993-3#2)(1995-3#3)(1995-9#1)(1996-12#1)(1997-2#1)(1997-3#1)(2006-11#1)(2006-12#3)(2006-4#1)(2006-6#1)(2006-8#5)(2007-1#1)(2007-10#1)(2007-11#21)(2007-7#3)(2007-8#8)(2007-9#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#6)(2009-2#1)(2009-4#1)(2009-6#1)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#2)
the vertebrate lineage##3##3##(1994-10#1)(2008-1#1)(2012-12#1)
the vertebrate retina##5##3##(1994-12#1)(1995-5#1)(2008-2#3)
the vertebrate##38##2##(1990-11#1)(1990-2#2)(1990-5#1)(1991-3#1)(1991-6#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-12#1)(1995-11#1)(1995-5#1)(1995-7#1)(1996-3#1)(1996-4#1)(1997-7#2)(2006-10#2)(2007-3#1)(2008-1#1)(2008-2#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-8#1)(2010-9#1)(2012-12#5)(2013-1#1)
the vertebrates##6##2##(1992-5#1)(1995-6#1)(1997-2#1)(2007-7#1)(2008-7#1)(2011-1#1)
the vertebrobasilar artery##3##3##(1997-3#1)(2008-7#1)(2012-3#1)
the vertebrobasilar system##4##3##(2006-1#1)(2007-9#3)
the vertebrobasilar##12##2##(1991-3#1)(1996-2#1)(1997-3#1)(2006-1#1)(2007-10#1)(2007-9#3)(2008-2#1)(2008-7#1)(2012-3#2)
the vertex##10##2##(1997-1#1)(2004-10#1)(2007-1#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
the vertical and horizontal##4##4##(1997-6#1)(2006-5#1)(2006-9#1)(2008-5#1)
the vertical and##6##3##(1992-2#1)(1997-6#1)(2006-5#1)(2006-9#1)(2008-3#1)(2008-5#1)
the vertical axis##4##3##(1996-1#1)(2008-8#1)(2009-9#1)(2013-7#1)
the vertical column##2##3##(1991-5#1)(2008-3#1)
the vertical dimension of##2##4##(2007-8#1)(2009-11#1)
the vertical dimension##3##3##(2007-8#1)(2009-11#1)(2010-3#1)
the vertical direction##5##3##(2008-2#3)(2008-3#1)(2013-7#1)
the vertical distribution of##4##4##(2007-5#1)(2008-11#1)(2008-3#2)
the vertical distribution##5##3##(2007-5#1)(2008-11#1)(2008-3#2)(2013-8#1)
the vertical force##2##3##(2009-7#1)(2013-7#1)
the vertical lobe##2##3##(2008-7#1)(2009-8#1)
the vertical meridian##2##3##(1993-7#1)(2008-1#1)
the vertical position##2##3##(2007-11#1)(2007-5#1)
the vertical profiles of##2##4##(2008-11#1)(2008-3#1)
the vertical profiles##3##3##(2008-11#1)(2008-3#2)
the vertical resolution##3##3##(2008-3#3)
the vertical section##2##3##(2009-7#2)
the vertical smoothing##2##3##(2008-2#1)(2008-3#1)
the vertical structure of the##2##5##(2007-5#1)(2008-2#1)
the vertical structure of##3##4##(2007-5#1)(2008-2#2)
the vertical transmission of##2##4##(2006-10#1)(2008-10#1)
the vertical viewing##2##3##(2008-2#1)(2008-3#1)
the vertical##88##2##(1991-3#1)(1991-5#1)(1992-10#1)(1992-2#1)(1993-7#1)(1996-1#1)(1997-3#1)(1997-6#1)(2005-5#1)(2006-10#1)(2006-5#2)(2006-8#1)(2006-9#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#4)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#10)(2008-3#20)(2008-5#3)(2008-7#1)(2008-8#4)(2009-11#1)(2009-7#6)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-7#3)(2013-8#1)
the vertically##3##2##(2008-3#2)(2010-8#1)
the vertiginous##3##2##(2008-2#2)(2013-1#1)
the very beginning##2##3##(2007-11#1)(2011-2#1)
the very early##8##3##(1990-4#1)(1995-8#1)(2007-11#1)(2008-10#2)(2008-5#1)(2009-7#1)(2009-8#1)
the very elderly##2##3##(1993-12#1)(2006-10#1)
the very existence of##2##4##(2006-9#1)(2009-7#1)
the very few##2##3##(2009-7#1)(2013-8#1)
the very first##5##3##(1990-7#1)(1994-1#1)(2008-12#1)(2010-8#1)(2012-1#1)
the very heterogeneous##2##3##(1997-8#1)(2010-12#1)
the very high##10##3##(1991-12#1)(1991-7#1)(1992-5#1)(1993-8#1)(1997-7#1)(2007-10#1)(2008-10#2)(2008-4#1)(2012-1#1)
the very humid tropical forest##2##5##(2008-5#2)
the very important##5##3##(2006-5#1)(2006-6#1)(2007-5#1)(2008-5#1)(2009-6#1)
the very large##3##3##(1991-8#1)(2008-3#1)(2009-12#1)
the very latest##2##3##(2007-10#1)(2013-8#1)
the very low density lipoprotein##2##5##(1995-6#2)
the very low density##3##4##(1992-2#1)(1995-6#2)
the very low##16##3##(1990-6#1)(1990-9#1)(1991-12#1)(1992-10#1)(1992-2#1)(1995-6#2)(1996-8#1)(1997-2#1)(2006-5#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-6#1)(2013-1#1)
the very nature of##3##4##(2007-11#1)(2008-8#1)(2009-4#1)
the very near future##4##4##(1991-12#1)(1997-6#1)(2008-10#1)(2013-1#1)
the very notion of##2##4##(2007-10#1)(2008-2#1)
the very old##6##3##(1992-12#1)(1993-11#2)(1994-6#1)(2008-1#1)(2009-5#1)
the very outset##2##3##(2007-7#1)(2010-3#1)
the very preterm##2##3##(1993-12#1)(1994-6#1)
the very rapid development of##2##5##(1990-2#1)(2008-5#1)
the very rapid##3##3##(1990-2#1)(1995-10#1)(2008-5#1)
the very rare##2##3##(1996-10#1)(2006-12#1)
the very real##2##3##(1994-2#1)(1997-6#1)
the very recent##2##3##(2006-5#1)(2008-8#1)
the very same##3##3##(1992-4#1)(2008-7#1)(2009-4#1)
the very short##2##3##(1990-5#1)(2006-2#1)
the very specific##2##3##(2008-1#1)(2008-10#1)
the very virulent MDV strain##2##5##(2013-8#2)
the very virulent##5##3##(2013-8#5)
the very young##6##3##(1993-10#1)(1994-9#1)(2005-10#2)(2007-2#1)(2013-1#1)
the very##162##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-12#3)(1991-3#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-5#2)(1992-6#1)(1993-10#2)(1993-11#2)(1993-12#2)(1993-8#1)(1994-1#1)(1994-2#2)(1994-6#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-1#1)(2005-10#2)(2005-11#1)(2006-1#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#4)(2006-6#1)(2006-7#2)(2006-9#1)(2007-10#3)(2007-11#3)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#12)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#3)(2008-5#7)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#6)(2009-12#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#7)
the vesamicol receptor##3##3##(1992-6#2)(1993-9#1)
the vesamicol##4##2##(1992-6#3)(1993-9#1)
the vesicle fusion##2##3##(1994-12#1)(2010-4#1)
the vesicle membrane##3##3##(1992-6#1)(2006-10#1)(2008-11#1)
the vesicle##21##2##(1990-2#1)(1990-4#1)(1991-10#1)(1991-2#2)(1992-10#1)(1992-3#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-10#2)(1995-8#1)(2006-10#1)(2007-10#1)(2008-11#2)(2009-10#1)(2010-4#1)
the vesicles and##5##3##(1992-6#2)(2006-10#1)(2008-10#1)(2008-8#1)
the vesicles are##2##3##(1992-10#1)(2008-1#1)
the vesicles in the##2##4##(1995-11#1)(2005-11#1)
the vesicles in##3##3##(1990-2#1)(1995-11#1)(2005-11#1)
the vesicles increased##2##3##(1992-12#1)(2008-5#1)
the vesicles was##2##3##(1994-11#1)(1994-3#1)
the vesicles were##3##3##(1990-11#1)(1990-4#1)(1992-3#1)
the vesicles##51##2##(1990-11#3)(1990-12#1)(1990-2#2)(1990-4#2)(1990-9#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-9#2)(1992-10#1)(1992-12#3)(1992-3#1)(1992-6#3)(1992-8#1)(1994-11#1)(1994-12#4)(1994-3#3)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-8#1)(1997-1#1)(1997-7#1)(2005-11#2)(2006-10#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-8#2)
the vesicular monoamine transporter##3##4##(1995-12#2)(2008-11#1)
the vesicular monoamine##4##3##(1995-12#2)(2008-11#1)(2010-6#1)
the vesicular stomatitis virus##3##4##(1994-8#1)(1997-4#2)
the vesicular##16##2##(1991-10#1)(1992-7#1)(1994-8#1)(1995-12#2)(1997-4#2)(1997-6#1)(2007-12#1)(2008-11#2)(2008-5#1)(2009-8#3)(2010-6#1)
the vesiculated nerve endings##2##4##(1991-9#2)
the vesiculated##4##2##(1991-9#4)
the vessel and##3##3##(1993-8#1)(2011-1#1)(2012-3#1)
the vessel density was##2##4##(1993-9#2)
the vessel density##5##3##(1993-9#5)
the vessel lumen##2##3##(2011-1#1)(2012-1#1)
the vessel lumen)##2##3##(2006-10#1)(2008-5#1)
the vessel size##2##3##(2006-10#1)(2013-1#1)
the vessel wall and##4##4##(2006-10#1)(2008-3#1)(2008-4#2)
the vessel wall##15##3##(1991-10#1)(1996-2#1)(2006-10#2)(2007-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2009-4#1)(2011-1#1)(2012-3#1)
the vessel walls##2##3##(1990-8#1)(2009-9#1)
the vessel##65##2##(1990-8#1)(1991-10#1)(1991-8#1)(1993-8#1)(1993-9#6)(1994-11#1)(1996-2#1)(1996-9#1)(1997-3#1)(2006-10#4)(2006-6#2)(2007-10#1)(2007-5#4)(2007-7#4)(2007-9#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-10#2)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-6#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#3)
the vessel's##2##2##(2007-7#1)(2013-8#1)
the vessels and##2##3##(2004-12#1)(2010-8#1)
the vessels in##2##3##(1996-12#1)(2013-8#1)
the vessels##21##2##(1991-4#1)(1996-12#1)(2004-12#1)(2006-6#1)(2007-10#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-6#1)(2008-7#1)(2009-2#1)(2010-8#1)(2011-2#1)(2013-8#1)
the vestibular and##2##3##(1991-2#2)
the vestibular ganglion##2##3##(1997-7#2)
the vestibular system##4##3##(1994-10#1)(1995-8#2)(2009-9#1)
the vestibular##16##2##(1990-10#1)(1990-6#1)(1991-2#2)(1994-10#2)(1995-5#1)(1995-8#2)(1996-3#1)(1997-7#2)(2007-10#1)(2009-9#1)(2011-2#2)
the vestibulo-ocular reflex##2##3##(1992-9#2)
the veterinary##10##2##(2004-2#1)(2006-12#1)(2007-2#1)(2007-4#3)(2011-1#1)(2012-2#2)(2013-1#1)
the vetispiradiene synthase##3##3##(1995-3#3)
the viability and##17##3##(1990-6#1)(1991-10#1)(1992-2#1)(1994-1#1)(2004-9#1)(2006-10#1)(2006-2#1)(2007-6#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-9#1)(2012-6#1)(2013-1#1)(2013-7#1)
the viability of a##4##4##(1992-7#1)(2007-8#1)(2008-10#1)(2013-8#1)
the viability of cells##4##4##(2006-12#1)(2008-4#1)(2009-12#1)(2013-1#1)
the viability of human##3##4##(2008-7#2)(2013-1#1)
the viability of sclerotia##3##4##(2008-10#3)
the viability of sporangia##2##4##(2008-10#2)
the viability of the cultures##2##5##(2008-11#2)
the viability of the method##3##5##(2008-10#3)
the viability of the##19##4##(1991-2#1)(1992-1#1)(1992-5#1)(1993-9#1)(1996-12#1)(1997-4#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-11#4)(2011-2#1)(2012-1#1)(2013-7#1)
the viability of using eSRT##2##5##(2008-9#2)
the viability of##65##3##(1991-2#1)(1992-1#1)(1992-5#1)(1992-7#1)(1993-9#1)(1995-12#1)(1995-9#2)(1996-12#1)(1997-2#2)(1997-4#1)(2005-12#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#10)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-12#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-11#2)(2013-1#3)(2013-7#1)(2013-8#1)
the viability or##2##3##(1994-9#2)
the viability test##2##3##(2008-11#1)(2012-12#1)
the viability was##3##3##(2006-10#1)(2008-11#2)
the viability##102##2##(1990-6#1)(1991-10#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-5#1)(1994-9#2)(1995-12#1)(1995-7#1)(1995-9#2)(1996-12#1)(1997-2#2)(1997-4#1)(2004-9#1)(2005-12#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-5#3)(2007-1#1)(2007-11#1)(2007-12#1)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#12)(2008-11#10)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#4)(2008-9#4)(2009-12#1)(2009-9#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#1)(2012-6#1)(2013-1#4)(2013-7#2)(2013-8#1)
the viable cell concentration##2##4##(2008-11#1)(2008-7#1)
the viable cell density##3##4##(1994-5#1)(2008-11#2)
the viable cell##7##3##(1994-5#1)(2008-11#5)(2008-7#1)
the viable##13##2##(1994-5#1)(2007-12#1)(2008-10#1)(2008-11#7)(2008-7#1)(2012-2#1)(2012-3#1)
the vial##5##2##(2008-3#3)(2008-8#1)(2012-2#1)
the vibrating##2##2##(2008-2#1)(2008-7#1)
the vibration frequency##2##3##(2005-4#1)(2008-2#1)
the vibration of the##4##4##(1995-5#1)(2008-2#1)(2008-3#2)
the vibration##12##2##(1995-5#1)(2005-4#1)(2007-11#1)(2008-2#4)(2008-3#5)
the vibrational spectrum##2##3##(2007-11#1)(2010-7#1)
the vibrational state of the##2##5##(1995-1#2)
the vibrational structure of##2##4##(2006-4#1)(2006-5#1)
the vibrational structure##3##3##(2006-4#2)(2006-5#1)
the vibrational##20##2##(1990-8#1)(1992-9#1)(1995-1#2)(2006-4#2)(2006-5#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-8#2)(2010-7#3)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
the vibratory##2##2##(1995-5#1)(2008-5#1)
the vibrissae##3##2##(1991-5#1)(1994-2#1)(2013-1#1)
the vibronic##3##2##(2005-11#1)(2007-12#2)
the vicarious calibration of the##2##5##(2008-3#2)
the vice president and##2##4##(2006-7#2)
the vicinity of the##60##4##(1990-11#2)(1990-12#1)(1990-2#2)(1990-7#1)(1991-4#2)(1991-5#1)(1991-6#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-6#1)(2005-11#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#6)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#1)(2009-12#1)(2009-7#1)(2012-12#1)(2013-8#1)
the vicinity of this##2##4##(1995-3#1)(2008-3#1)
the vicinity of##119##3##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-11#1)(1996-2#1)(1996-4#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-6#1)(1997-7#2)(2005-11#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#8)(2007-12#2)(2007-6#1)(2007-7#2)(2007-8#5)(2008-10#11)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-12#1)(2009-6#1)(2009-7#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
the vicinity##123##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-11#2)(1996-2#1)(1996-4#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-6#1)(1997-7#2)(2005-11#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#8)(2007-12#2)(2007-6#1)(2007-7#2)(2007-8#5)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-12#1)(2009-6#1)(2009-7#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-8#2)
the vicious##2##2##(2006-8#1)(2008-9#1)
the victim tigress##2##3##(2011-1#2)
the victim was##3##3##(1992-5#1)(1995-3#1)(2011-2#1)
the victim##13##2##(1992-5#2)(1993-5#1)(1995-12#1)(1995-3#1)(2005-9#1)(2008-10#1)(2008-12#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-1#1)
the victim's##6##2##(1996-3#1)(2008-4#1)(2009-4#2)(2010-12#1)(2010-4#1)
the victims of a mass disaster##2##6##(1995-11#2)
the victims of the##2##4##(2009-6#1)(2011-2#1)
the victims of violence##2##4##(1993-3#1)(2011-2#1)
the victims of##14##3##(1991-12#1)(1992-12#1)(1993-3#1)(1995-11#2)(2007-3#1)(2007-4#1)(2007-9#1)(2009-6#1)(2011-2#3)(2012-12#1)(2013-1#1)
the victims##27##2##(1991-12#1)(1991-2#1)(1992-12#1)(1993-3#2)(1993-5#1)(1995-11#2)(1996-11#1)(1996-5#1)(1996-6#1)(2005-8#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-9#1)(2008-2#1)(2009-6#3)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)
the victory##2##2##(1995-11#1)(2006-5#1)
the video rate##2##3##(2008-2#1)(2008-3#1)
the video##18##2##(1992-12#1)(1992-8#1)(1995-12#1)(2008-10#1)(2008-11#5)(2008-2#3)(2008-3#3)(2008-4#1)(2012-2#1)(2013-1#1)
the videos##2##2##(1993-12#1)(2008-10#1)
the videotape##2##2##(1995-12#2)
the videotapes##2##2##(1993-2#2)
the view of a##3##4##(1994-1#1)(1995-2#1)(2008-6#1)
the view of the##5##4##(1994-8#2)(2012-12#1)(2012-3#1)(2013-1#1)
the view of##15##3##(1994-1#1)(1994-8#2)(1995-1#1)(1995-2#1)(1996-5#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-6#1)(2009-7#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
the view point##2##3##(2005-3#1)(2007-8#1)
the view that a##3##4##(1993-3#1)(1994-12#1)(2009-4#1)
the view that both##2##4##(1995-8#1)(2008-4#1)
the view that the major##2##5##(1995-5#1)(1997-9#1)
the view that the##17##4##(1990-10#1)(1990-12#2)(1990-5#2)(1992-12#1)(1994-11#1)(1995-1#1)(1995-12#1)(1995-5#1)(1997-6#1)(1997-9#1)(2007-8#2)(2008-1#2)(2009-9#1)
the view that this##3##4##(1990-8#1)(1996-5#1)(2009-4#1)
the view that##90##3##(1990-10#1)(1990-12#2)(1990-2#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-10#1)(1996-3#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#1)(1997-9#1)(2004-3#1)(2004-9#1)(2005-10#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-6#1)(2007-8#4)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-2#1)(2009-4#3)(2009-9#1)(2010-4#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
the view to##3##3##(2008-1#1)(2008-10#1)(2011-2#1)
the view##115##2##(1990-10#1)(1990-12#2)(1990-2#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-7#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#3)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-8#1)(1996-10#1)(1996-3#1)(1996-5#3)(1996-7#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#1)(1997-9#1)(2004-3#1)(2004-9#1)(2005-10#1)(2005-3#1)(2006-10#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-6#1)(2007-8#6)(2008-1#4)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2009-11#2)(2009-2#1)(2009-4#3)(2009-7#1)(2009-9#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#2)
the viewer##2##2##(2008-11#1)(2008-3#1)
the viewing angle of##3##4##(2007-11#2)(2008-2#1)
the viewing angle##4##3##(2007-11#2)(2008-1#1)(2008-2#1)
the viewing area##2##3##(2008-2#1)(2008-3#1)
the viewing distance##2##3##(1991-1#1)(2008-3#1)
the viewing resolution##2##3##(2007-11#2)
the viewing##14##2##(1991-1#1)(2007-11#4)(2008-1#1)(2008-2#2)(2008-3#6)
the viewpoint of the##6##4##(1990-6#1)(1991-2#1)(1993-5#1)(1996-9#1)(1997-4#1)(2013-8#1)
the viewpoint of##35##3##(1990-6#1)(1991-2#1)(1991-3#1)(1992-3#1)(1993-5#1)(1994-6#1)(1995-7#1)(1996-5#1)(1996-9#1)(1997-3#2)(1997-4#2)(2003-11#1)(2005-11#1)(2005-3#2)(2006-10#2)(2006-7#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#3)
the viewpoint##38##2##(1990-6#1)(1991-2#1)(1991-3#1)(1992-3#1)(1993-5#1)(1994-6#1)(1995-7#1)(1996-5#1)(1996-9#1)(1997-3#2)(1997-4#2)(2003-11#1)(2005-11#1)(2005-3#2)(2006-10#2)(2006-7#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#3)
the viewpoints of the##2##4##(2007-6#1)(2008-6#1)
the viewpoints of##5##3##(1995-10#1)(2007-6#1)(2008-3#1)(2008-6#1)(2008-7#1)
the views and##2##3##(2008-11#1)(2010-10#1)
the views of health workers##2##5##(2012-3#2)
the views of the##7##4##(1991-1#1)(1996-9#1)(1997-3#1)(2007-3#1)(2009-2#1)(2011-1#1)(2012-3#1)
the views of##20##3##(1990-12#1)(1991-1#1)(1996-9#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-3#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-2#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#4)
the views##26##2##(1990-12#1)(1991-1#1)(1996-9#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-3#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-4#2)(2010-10#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#2)(2012-3#4)
the vignette##2##2##(2005-7#1)(2007-12#1)
the vigor##2##2##(2007-5#1)(2008-10#1)
the village of##5##3##(2006-4#1)(2007-2#1)(2008-10#1)(2012-12#2)
the village##10##2##(1994-3#1)(2005-8#1)(2006-4#1)(2007-2#1)(2008-10#1)(2008-8#2)(2012-12#2)(2013-8#1)
the villages in##2##3##(2008-4#1)(2012-1#1)
the villages of##4##3##(2007-2#2)(2008-4#1)(2012-12#1)
the villages##11##2##(1991-12#1)(1996-12#1)(2007-10#1)(2007-2#3)(2007-7#1)(2008-4#2)(2012-1#1)(2012-12#1)
the villi##2##2##(2009-2#1)(2013-1#1)
the villus tip##2##3##(1990-12#1)(1991-12#1)
the villus##6##2##(1990-12#1)(1991-12#4)(1997-2#1)
the villus-crypt junctional area##2##4##(1997-8#2)
the villus-crypt##3##2##(1997-8#3)
the vinca alkaloids##2##3##(1994-6#1)(1995-5#1)
the vinca##3##2##(1994-6#1)(1995-5#2)
the vinegar##2##2##(2008-10#1)(2008-5#1)
the vines##2##2##(2008-10#2)
the vinyl group##4##3##(1994-9#1)(2008-10#2)(2013-1#1)
the vinyl##6##2##(1994-9#1)(2006-4#1)(2008-10#3)(2013-1#1)
the vinylic##3##2##(2007-11#1)(2009-6#2)
the violation of the##2##4##(1994-7#1)(2005-11#1)
the violation of##5##3##(1994-7#1)(2005-11#1)(2012-2#1)(2013-8#2)
the violence##4##2##(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
the violent##8##2##(1991-9#2)(1997-8#4)(2009-5#1)(2011-2#1)
the viral DNA polymerase##5##4##(1990-7#3)(1997-3#1)(1997-5#1)
the viral DNA##7##3##(1990-7#3)(1991-5#1)(1997-1#1)(1997-3#1)(1997-5#1)
the viral E1 helicase##2##4##(1994-8#2)
the viral E1##3##3##(1994-8#2)(2008-9#1)
the viral G protein##2##4##(1993-6#2)
the viral RNA genome##2##4##(1990-9#1)(2009-11#1)
the viral RNA##9##3##(1990-2#1)(1990-9#1)(1997-2#1)(2008-10#3)(2008-9#2)(2009-11#1)
the viral assembly##2##3##(1991-5#1)(2013-1#1)
the viral capsid protein##2##4##(2008-10#1)(2009-8#1)
the viral capsid##5##3##(1995-2#3)(2008-10#1)(2009-8#1)
the viral coat protein##4##4##(1993-5#1)(2008-10#2)(2008-8#1)
the viral content##2##3##(2006-1#1)(2008-5#1)
the viral early##3##3##(1995-2#1)(1997-1#2)
the viral envelope and##2##4##(1994-8#1)(2009-12#1)
the viral envelope##3##3##(1994-8#2)(2009-12#1)
the viral etiology of##2##4##(2013-1#1)(2013-7#1)
the viral fusion##3##3##(2008-1#2)(2009-8#1)
the viral genome##23##3##(1991-6#1)(1994-11#1)(1994-12#1)(1995-8#3)(1997-2#1)(1997-6#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-9#3)(2011-2#1)(2012-2#1)(2013-8#2)
the viral genomic RNA##2##4##(1992-6#1)(2008-11#1)
the viral infection##2##3##(2008-10#1)(2010-6#1)
the viral life cycle##5##4##(1994-8#1)(1995-2#1)(2005-7#1)(2007-3#1)(2010-1#1)
the viral load##3##3##(2008-5#1)(2012-3#1)(2013-8#1)
the viral long terminal repeat##2##5##(1995-2#1)(1997-6#1)
the viral mRNA##2##3##(1992-12#2)
the viral membrane##3##3##(1993-12#1)(2011-1#2)
the viral nucleocapsid##2##3##(1992-12#1)(2008-10#1)
the viral polyhedrin##2##3##(1991-1#1)(1997-4#1)
the viral promoter##2##3##(2008-3#1)(2012-12#1)
the viral protease##2##3##(1991-5#1)(1994-5#1)
the viral protein##5##3##(1990-11#1)(2008-10#1)(2008-8#1)(2009-8#1)(2012-2#1)
the viral proteins##5##3##(1997-5#1)(2007-11#1)(2008-10#1)(2008-8#1)(2013-1#1)
the viral replication##3##3##(1994-8#1)(2008-10#2)
the viral##195##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-5#4)(1991-6#1)(1992-12#6)(1992-2#1)(1992-6#3)(1992-9#1)(1993-11#2)(1993-12#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-5#1)(1994-8#7)(1994-9#1)(1995-2#9)(1995-7#1)(1995-8#3)(1996-10#1)(1997-1#4)(1997-2#3)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#2)(2005-7#1)(2006-1#1)(2006-10#5)(2006-6#2)(2007-10#2)(2007-11#3)(2007-3#1)(2007-6#1)(2007-7#1)(2008-1#4)(2008-10#31)(2008-11#2)(2008-3#1)(2008-4#7)(2008-5#3)(2008-8#5)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#7)
the virga##3##2##(2008-6#3)
the virion##5##2##(1992-8#1)(1993-12#1)(1996-10#1)(2008-10#1)(2011-1#1)
the virions##2##2##(1992-8#1)(1994-7#1)
the viroid##3##2##(2008-10#3)
the virological response to##2##4##(2012-12#1)(2013-7#1)
the virosomal##3##2##(2007-11#3)
the virtual##17##2##(1990-5#1)(1991-4#1)(1993-6#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-5#1)(2007-7#1)(2008-11#3)(2008-3#2)(2010-4#1)(2010-8#1)(2012-3#1)(2013-8#1)
the virtue of##2##3##(2008-12#1)(2008-4#1)
the virtues of##2##3##(1995-6#1)(2007-4#1)
the virtues##4##2##(1991-12#1)(1995-6#1)(2007-4#1)(2012-2#1)
the virulence and##3##3##(2008-10#2)(2008-7#1)
the virulence factors##4##3##(2007-10#1)(2008-10#1)(2008-9#1)(2009-6#1)
the virulence of a##2##4##(1996-12#1)(2008-10#1)
the virulence of the##3##4##(2008-10#2)(2008-7#1)
the virulence of these##2##4##(2005-8#1)(2008-9#1)
the virulence of##20##3##(1995-1#1)(1996-12#2)(2005-8#1)(2008-10#9)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-6#1)(2013-1#1)
the virulence or avirulence genes##2##5##(2008-10#2)
the virulence or##3##3##(2008-10#3)
the virulence spectrum##2##3##(2008-10#2)
the virulence##45##2##(1995-1#1)(1996-12#2)(2005-8#1)(2007-10#1)(2007-12#1)(2008-10#24)(2008-5#1)(2008-7#2)(2008-9#2)(2009-2#1)(2009-5#1)(2009-6#2)(2009-8#2)(2011-2#1)(2013-1#1)(2013-8#2)
the virulent genotype##2##3##(2008-10#2)
the virulent isolates##3##3##(2008-10#3)
the virulent virus##2##3##(2008-10#1)(2008-8#1)
the virulent##18##2##(1994-12#1)(2008-10#12)(2008-8#2)(2008-9#1)(2013-8#2)
the virus (strain) with the##2##5##(2008-10#2)
the virus and the##3##4##(1996-11#1)(2006-10#1)(2009-9#1)
the virus and##11##3##(1994-8#1)(1996-11#1)(2006-10#2)(2008-10#2)(2008-5#1)(2009-9#1)(2011-1#2)(2012-2#1)
the virus as freshly emerged##2##5##(2008-10#2)
the virus as##5##3##(1990-2#1)(2008-10#3)(2008-11#1)
the virus by##5##3##(1990-11#1)(2008-10#4)
the virus challenge dose##2##4##(1992-6#2)
the virus could be##2##4##(2008-5#1)(2013-8#1)
the virus does not##2##4##(2008-10#1)(2008-8#1)
the virus for##3##3##(2007-9#1)(2008-10#1)(2008-4#1)
the virus from the##2##4##(2008-10#1)(2011-1#1)
the virus from##8##3##(1990-11#1)(1992-11#1)(2007-6#1)(2008-10#4)(2011-1#1)
the virus genome##4##3##(1991-12#1)(2007-3#1)(2008-10#2)
the virus has been##2##4##(2008-8#1)(2011-1#1)
the virus has##4##3##(2007-12#1)(2008-10#1)(2008-8#1)(2011-1#1)
the virus in a##2##4##(2008-10#2)
the virus in the##5##4##(1991-2#1)(2008-1#1)(2008-11#1)(2012-2#1)(2012-3#1)
the virus in##26##3##(1991-2#1)(1991-8#1)(1995-8#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-8#2)
the virus infection##2##3##(2008-5#1)(2008-8#1)
the virus inoculum##2##3##(2005-9#1)(2008-11#1)
the virus is##11##3##(1993-11#1)(1997-1#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-9#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-1#1)
the virus itself##2##3##(1991-6#1)(2006-4#1)
the virus moved to##2##4##(2008-10#2)
the virus or##2##3##(2005-12#1)(2009-7#1)
the virus per plant visit##2##5##(2008-10#2)
the virus population##2##3##(2008-10#2)
the virus replication##2##3##(1997-4#1)(1997-6#1)
the virus that causes##2##4##(1994-3#1)(2010-10#1)
the virus that##3##3##(1994-3#1)(2007-12#1)(2010-10#1)
the virus through##3##3##(1997-7#1)(2007-11#1)(2008-10#1)
the virus titration experiment##3##4##(1992-6#3)
the virus titration##4##3##(1992-6#4)
the virus to the##3##4##(1992-5#1)(1994-9#1)(2013-8#1)
the virus to##6##3##(1992-5#1)(1994-9#1)(2008-10#2)(2011-3#1)(2013-8#1)
the virus was detected##2##4##(2008-10#1)(2008-8#1)
the virus was##16##3##(1991-2#1)(1997-6#2)(2008-10#10)(2008-8#1)(2010-12#1)(2012-3#1)
the virus were##2##3##(2004-11#1)(2011-1#1)
the virus##304##2##(1990-11#3)(1990-2#3)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-5#1)(1992-6#7)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-7#2)(1993-8#1)(1994-10#2)(1994-3#1)(1994-8#4)(1994-9#4)(1995-12#1)(1995-8#2)(1996-11#2)(1996-2#1)(1996-5#2)(1997-1#5)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#5)(1997-7#1)(2004-11#1)(2005-12#1)(2005-7#1)(2005-9#3)(2006-1#1)(2006-10#3)(2006-2#4)(2006-4#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#5)(2007-2#1)(2007-3#1)(2007-6#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#6)(2008-10#99)(2008-11#9)(2008-12#4)(2008-3#2)(2008-4#2)(2008-5#10)(2008-7#1)(2008-8#7)(2008-9#8)(2009-11#2)(2009-7#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-12#3)(2010-4#1)(2011-1#12)(2011-2#1)(2011-3#3)(2012-1#1)(2012-12#6)(2012-2#5)(2012-3#4)(2013-1#6)(2013-8#7)
the virus-cell##2##2##(1993-12#1)(1994-6#1)
the virus-encoded##2##2##(2008-8#1)(2013-8#1)
the virus-host##2##2##(1991-1#1)(2013-8#1)
the virus-induced##2##2##(1990-12#1)(2008-10#1)
the virus-infected##4##2##(1990-3#1)(1995-1#1)(2008-10#2)
the viruses were##5##3##(2007-12#3)(2008-10#1)(2011-2#1)
the viruses##27##2##(1995-5#1)(2007-10#1)(2007-12#3)(2007-6#1)(2008-10#11)(2008-5#3)(2009-10#1)(2009-6#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-2#1)
the visceral and##2##3##(1991-8#1)(2007-8#1)
the visceral##12##2##(1990-2#1)(1990-8#1)(1991-8#3)(1995-1#1)(1995-3#1)(1997-6#1)(2007-12#1)(2007-5#1)(2007-8#1)(2011-2#1)
the viscoelastic properties of##4##4##(1994-9#1)(2008-3#1)(2012-2#1)(2013-1#1)
the viscoelastic properties##5##3##(1994-9#1)(2005-11#1)(2008-3#1)(2012-2#1)(2013-1#1)
the viscoelastic##8##2##(1994-9#1)(2005-11#2)(2007-12#1)(2008-3#1)(2009-7#1)(2012-2#1)(2013-1#1)
the viscoelasticity of##2##3##(2007-11#1)(2008-10#1)
the viscoelasticity##3##2##(2007-11#1)(2008-10#2)
the viscosity and##5##3##(2008-1#1)(2008-10#1)(2008-5#3)
the viscosity of shampoo##3##4##(2008-5#3)
the viscosity of the##12##4##(1990-2#1)(1991-7#2)(2008-10#4)(2008-6#2)(2008-7#1)(2010-1#1)(2013-1#1)
the viscosity of##23##3##(1990-2#1)(1991-7#2)(1994-11#3)(2008-1#1)(2008-10#4)(2008-2#1)(2008-5#4)(2008-6#2)(2008-7#1)(2010-1#2)(2013-1#2)
the viscosity##45##2##(1990-2#1)(1991-12#1)(1991-7#2)(1994-11#3)(1994-8#1)(2005-11#5)(2007-11#3)(2008-1#2)(2008-10#8)(2008-2#1)(2008-5#9)(2008-6#2)(2008-7#1)(2010-1#2)(2010-4#1)(2011-1#1)(2013-1#2)
the viscous##4##2##(2006-11#1)(2008-12#1)(2008-7#1)(2009-6#1)
the visibility depth##2##3##(2008-3#2)
the visibility of the##4##4##(1994-12#1)(1995-3#1)(2008-2#1)(2008-3#1)
the visibility of##8##3##(1994-12#1)(1995-3#1)(2007-12#1)(2007-7#1)(2008-2#1)(2008-3#2)(2010-7#1)
the visibility##13##2##(1994-12#1)(1995-3#1)(2007-12#2)(2007-7#1)(2008-2#1)(2008-3#6)(2010-7#1)
the visible absorption spectrum##3##4##(1993-11#1)(1995-10#1)(2008-10#1)
the visible absorption##4##3##(1992-1#1)(1993-11#1)(1995-10#1)(2008-10#1)
the visible and infrared##2##4##(2008-3#1)(2013-8#1)
the visible and near-infrared##6##4##(2007-11#1)(2008-2#4)(2008-3#1)
the visible and the infrared##2##5##(2007-11#1)(2008-3#1)
the visible and the near infrared##3##6##(2007-12#1)(2008-3#2)
the visible and the##12##4##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#6)
the visible and##28##3##(2007-11#2)(2007-12#3)(2008-2#10)(2008-3#11)(2008-6#1)(2013-8#1)
the visible band##2##3##(2008-3#2)
the visible light##2##3##(2008-3#1)(2010-7#1)
the visible range##14##3##(1990-3#1)(1993-11#1)(1995-1#1)(2007-11#2)(2007-12#1)(2008-2#4)(2008-3#2)(2008-6#1)(2009-11#1)
the visible region of the spectrum##4##6##(2007-10#1)(2007-11#1)(2008-10#1)(2011-1#1)
the visible region of the##6##5##(1990-3#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2011-1#1)
the visible region##28##3##(1990-3#1)(1992-9#1)(1995-10#1)(2007-10#1)(2007-11#5)(2007-12#1)(2008-10#5)(2008-2#7)(2008-3#1)(2008-5#1)(2010-4#2)(2010-5#1)(2011-1#1)
the visible spectral range##3##4##(2007-11#1)(2008-3#2)
the visible spectral##5##3##(2007-11#1)(2008-3#3)(2013-8#1)
the visible spectrum are##2##4##(2007-12#1)(2009-4#1)
the visible spectrum of##2##4##(2008-10#2)
the visible spectrum##13##3##(1990-3#1)(2006-7#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#3)(2009-4#1)
the visible to the##2##4##(2007-12#1)(2008-2#1)
the visible to##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
the visible##160##2##(1990-3#3)(1992-1#1)(1992-9#1)(1993-11#2)(1994-5#1)(1994-7#1)(1995-1#1)(1995-10#2)(1997-7#1)(2006-7#1)(2007-10#1)(2007-11#13)(2007-12#30)(2008-1#5)(2008-10#11)(2008-11#1)(2008-2#30)(2008-3#40)(2008-5#2)(2008-6#2)(2009-11#1)(2009-12#1)(2009-4#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#1)(2013-1#1)(2013-8#2)
the vision for the##2##4##(1994-3#1)(2008-6#1)
the vision into##2##3##(1992-12#1)(2008-12#1)
the vision of##4##3##(2008-3#1)(2009-12#1)(2011-1#1)(2013-1#1)
the vision##14##2##(1991-3#1)(1992-12#1)(1994-3#1)(2008-12#4)(2008-3#1)(2008-6#1)(2009-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
the visionary##2##2##(2008-7#1)(2013-1#1)
the visit of##3##3##(1992-2#1)(2008-7#1)(2012-12#1)
the visit was##3##3##(2012-3#1)(2013-1#2)
the visit##10##2##(1992-2#2)(1996-1#1)(2004-2#1)(2008-1#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#2)
the visits##2##2##(1992-2#1)(2010-12#1)
the visual acuity##3##3##(2005-11#1)(2011-12#1)(2013-8#1)
the visual analog scale (VAS)##3##5##(2006-12#1)(2007-2#1)(2008-6#1)
the visual analog scale##5##4##(2005-9#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-6#1)
the visual analog##6##3##(2005-9#1)(2006-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-6#1)
the visual analogue scale (VAS)##2##5##(2007-7#1)(2013-1#1)
the visual analogue scale##3##4##(2007-7#1)(2011-2#1)(2013-1#1)
the visual analogue##5##3##(1996-12#1)(2007-11#1)(2007-7#1)(2011-2#1)(2013-1#1)
the visual and the##2##4##(2008-3#1)(2013-8#1)
the visual and##7##3##(2007-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-6#1)(2013-8#1)
the visual axis##2##3##(2007-3#1)(2009-8#1)
the visual cortex and##3##4##(1993-7#1)(1995-12#1)(2011-2#1)
the visual cortex of adult##2##5##(1995-12#2)
the visual cortex of##4##4##(1990-2#1)(1992-9#1)(1995-12#2)
the visual cortex##29##3##(1990-2#1)(1990-4#1)(1990-8#2)(1991-6#1)(1992-10#1)(1992-9#1)(1993-7#2)(1995-11#2)(1995-12#3)(1996-1#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-3#2)(1997-6#1)(2007-8#1)(2008-11#1)(2008-4#2)(2009-5#1)(2011-2#3)
the visual cortical##2##3##(1992-9#1)(2011-2#1)
the visual environment##2##3##(1995-5#1)(2008-2#1)
the visual feedback##2##3##(2007-9#1)(2008-4#1)
the visual field and##5##4##(1996-3#1)(2007-6#1)(2011-2#2)(2012-11#1)
the visual field##16##3##(1990-4#1)(1992-6#1)(1992-9#1)(1993-7#2)(1994-2#1)(1996-2#1)(1996-3#1)(2007-12#1)(2007-6#2)(2008-9#1)(2011-2#2)(2012-11#1)(2012-3#1)
the visual imagery##2##3##(2007-2#1)(2008-11#1)
the visual input##7##3##(1991-2#7)
the visual learning and##2##4##(2008-8#1)(2009-4#1)
the visual learning##3##3##(2008-8#2)(2009-4#1)
the visual pathway##5##3##(1991-2#1)(1991-8#1)(2007-3#2)(2008-2#1)
the visual pathways##2##3##(2007-3#1)(2013-7#1)
the visual process##2##3##(2008-3#2)
the visual system and##3##4##(2007-12#1)(2008-1#1)(2008-3#1)
the visual system in##2##4##(1996-1#1)(2008-8#1)
the visual system is##3##4##(1996-10#2)(1997-8#1)
the visual system of##2##4##(1996-1#1)(2008-11#1)
the visual system##32##3##(1991-11#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-5#3)(1996-1#2)(1996-10#3)(1997-3#1)(1997-8#2)(2007-12#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-8#1)(2009-12#2)(2012-1#1)(2012-2#1)
the visual task##2##3##(1997-7#1)(2012-1#1)
the visual world##4##3##(1993-9#1)(2008-2#1)(2009-2#1)(2012-3#1)
the visual##221##2##(1990-10#1)(1990-2#2)(1990-4#2)(1990-8#2)(1991-11#1)(1991-2#10)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#3)(1992-12#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#7)(1993-12#2)(1993-2#3)(1993-3#1)(1993-7#6)(1993-9#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#5)(1995-5#4)(1995-8#1)(1996-1#3)(1996-10#3)(1996-12#1)(1996-2#3)(1996-3#2)(1996-9#1)(1997-3#4)(1997-6#1)(1997-7#1)(1997-8#4)(2005-11#1)(2005-12#1)(2005-9#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#7)(2007-2#2)(2007-3#4)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#9)(2008-10#7)(2008-11#4)(2008-2#8)(2008-3#7)(2008-4#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#1)(2010-6#1)(2010-9#3)(2011-1#1)(2011-12#2)(2011-2#8)(2012-1#2)(2012-11#3)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#6)
the visualisation of##2##3##(2008-1#1)(2012-2#1)
the visualisation##3##2##(2008-1#1)(2008-10#1)(2012-2#1)
the visualization and##2##3##(2006-5#1)(2013-8#1)
the visualization of the##7##4##(1991-9#1)(2007-12#1)(2007-9#1)(2008-10#1)(2009-8#1)(2013-1#2)
the visualization of##23##3##(1990-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1997-6#2)(1997-8#1)(2005-5#1)(2006-6#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-8#1)(2009-6#1)(2009-8#1)(2011-1#1)(2013-1#2)
the visualization##30##2##(1990-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1997-6#2)(1997-8#1)(2005-11#1)(2005-5#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-6#2)(2008-8#1)(2009-6#1)(2009-8#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
the visualized##4##2##(1994-3#1)(2005-11#1)(2007-4#1)(2008-10#1)
the visually##5##2##(2006-11#1)(2008-11#1)(2008-2#2)(2008-7#1)
the visuospatial##2##2##(1992-1#1)(2012-2#1)
the vital dye neutral red##2##5##(1992-11#1)(1995-8#1)
the vital dye##4##3##(1992-11#1)(1995-8#1)(2008-11#1)(2008-9#1)
the vital organs##2##3##(2006-10#1)(2012-2#1)
the vital records database##2##4##(2012-12#2)
the vital role##3##3##(1993-12#1)(2009-4#1)(2013-1#1)
the vital signs of##2##4##(2013-1#2)
the vital signs##3##3##(2005-8#1)(2013-1#2)
the vital##31##2##(1992-11#1)(1993-12#1)(1994-2#2)(1994-7#1)(1995-8#1)(1996-12#1)(1997-3#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-9#1)(2009-4#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)
the vitality of the##5##4##(1990-3#1)(1991-5#2)(2007-8#1)(2008-11#1)
the vitality of##6##3##(1990-3#1)(1991-5#2)(1994-7#1)(2007-8#1)(2008-11#1)
the vitality##8##2##(1990-3#1)(1991-5#2)(1994-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2011-2#1)
the vitamin A##4##3##(1992-2#1)(1994-12#1)(1995-3#1)(2012-1#1)
the vitamin B12##2##3##(1992-1#2)
the vitamin C##4##3##(1992-9#1)(2008-10#2)(2011-1#1)
the vitamin D analogue##2##4##(1993-11#2)
the vitamin D receptor (VDR)##4##5##(1995-2#1)(2005-11#1)(2008-7#1)(2012-12#1)
the vitamin D receptor##7##4##(1995-2#2)(2005-11#1)(2008-1#1)(2008-7#1)(2010-3#1)(2012-12#1)
the vitamin D status of the animal##2##7##(1990-4#2)
the vitamin D status of##3##5##(1990-4#2)(2012-1#1)
the vitamin D##23##3##(1990-4#2)(1991-1#1)(1992-1#1)(1993-11#2)(1994-11#1)(1994-9#1)(1995-2#2)(2005-11#1)(2007-11#1)(2008-1#2)(2008-4#1)(2008-7#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
the vitamin D3##2##3##(1992-5#1)(2005-1#1)
the vitamin K-dependent##5##3##(1994-11#2)(1994-4#1)(1995-8#1)(2009-11#1)
the vitamin##60##2##(1990-4#2)(1991-1#1)(1991-12#1)(1992-1#3)(1992-2#1)(1992-5#1)(1992-9#3)(1993-11#3)(1994-11#3)(1994-12#1)(1994-4#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-6#1)(1997-7#1)(2004-11#1)(2005-1#1)(2005-11#1)(2005-8#1)(2007-11#1)(2008-1#2)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#4)(2009-9#1)(2010-3#1)(2011-1#2)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
the vitamins have##2##3##(2005-10#1)(2006-10#1)
the vitamins##7##2##(1997-8#1)(2005-10#1)(2006-10#2)(2008-10#1)(2008-5#1)(2012-12#1)
the vitelline coat##3##3##(1993-6#2)(2008-6#1)
the vitelline envelope##2##3##(1994-5#1)(2008-12#1)
the vitelline##6##2##(1993-6#2)(1994-5#1)(2008-10#1)(2008-12#1)(2008-6#1)
the vitiligo-like depigmentation##2##3##(2010-6#2)
the vitreous and##3##3##(2007-7#1)(2008-1#1)(2011-2#1)
the vitreous##9##2##(1992-5#1)(1997-7#2)(2007-11#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-2#1)(2011-2#1)
the vitro##2##2##(1990-5#1)(1996-4#1)
the vitronectin##5##2##(1990-3#4)(1994-6#1)
the viviparous##2##2##(2007-12#1)(2008-7#1)
the vlPAG##2##2##(1996-1#2)
the vocabulary intervention##2##3##(2011-2#2)
the vocabulary##6##2##(2008-7#2)(2008-9#1)(2011-2#3)
the vocal cord and##2##4##(1991-4#1)(2008-2#1)
the vocal cord##3##3##(1991-4#2)(2008-2#1)
the vocal pattern##2##3##(2008-8#2)
the vocal response to social separation##2##6##(1997-5#2)
the vocal response to##3##4##(1997-5#3)
the vocal##20##2##(1990-4#1)(1991-4#2)(1992-9#1)(1996-7#1)(1997-4#1)(1997-5#3)(2007-9#2)(2008-11#1)(2008-2#1)(2008-8#3)(2009-10#1)(2009-9#1)(2012-12#1)(2012-2#1)
the vocalization##4##2##(1996-12#1)(2010-2#3)
the vocational##3##2##(1995-5#1)(2006-8#2)
the voice of##3##3##(2008-11#1)(2008-9#1)(2009-5#1)
the voice##10##2##(1996-12#1)(2008-11#1)(2008-2#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#1)(2010-8#1)(2011-1#1)
the voices of##2##3##(2008-11#1)(2008-8#1)
the void space##2##3##(2008-11#1)(2008-7#1)
the void volume of##2##4##(1990-12#1)(2008-10#1)
the void volume##3##3##(1990-12#1)(1991-2#1)(2008-10#1)
the void##8##2##(1990-12#1)(1991-2#1)(1992-12#1)(2005-11#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
the voids##2##2##(2005-11#1)(2007-12#1)
the volar forearm##6##3##(2008-5#6)
the volar##16##2##(1996-7#1)(2006-3#2)(2008-10#1)(2008-5#6)(2008-9#4)(2011-2#1)(2013-7#1)
the volatile compounds of##3##4##(2006-12#1)(2008-10#1)(2010-12#1)
the volatile compounds##5##3##(2006-12#1)(2008-10#3)(2010-12#1)
the volatile fraction of the infusion##2##6##(2010-12#2)
the volatile fraction of##3##4##(2007-1#1)(2010-12#2)
the volatile fraction##4##3##(2007-1#1)(2008-3#1)(2010-12#2)
the volatile oil of##2##4##(2007-1#1)(2008-11#1)
the volatile organic##2##3##(2008-3#1)(2012-12#1)
the volatile profiles of##2##4##(2011-10#2)
the volatile##34##2##(1990-9#1)(1991-8#1)(1995-12#1)(1996-1#1)(1997-4#1)(1997-8#1)(2006-12#2)(2006-8#1)(2007-1#3)(2007-12#1)(2008-10#9)(2008-11#1)(2008-3#2)(2008-5#1)(2009-8#1)(2010-12#3)(2011-10#2)(2012-12#1)(2012-3#1)
the volatiles##4##2##(2007-1#1)(2008-10#3)
the volatility matrix##2##3##(2012-12#2)
the volatility of##2##3##(1991-12#1)(2008-10#1)
the volatility##6##2##(1991-12#1)(2008-10#1)(2008-2#1)(2012-12#2)(2013-7#1)
the volcanic##3##2##(2007-9#1)(2008-2#2)
the volcano##2##2##(1997-3#1)(2008-10#1)
the voltage axis##2##3##(1993-12#1)(1995-12#1)
the voltage clamp##2##3##(1993-2#1)(2008-1#1)
the voltage dependence of##2##4##(1997-7#1)(2008-8#1)
the voltage responses##2##3##(1991-8#1)(2008-11#1)
the voltage sensor in domain-2##2##5##(2008-8#2)
the voltage sensor paddle##2##4##(2010-12#2)
the voltage sensor##6##3##(1993-12#1)(2008-8#2)(2010-12#3)
the voltage##24##2##(1991-1#1)(1991-8#1)(1992-8#1)(1993-12#2)(1993-2#1)(1995-12#1)(1996-10#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#3)(2010-12#3)
the voltage-controlled photorefractive effect##2##4##(2007-12#1)(2008-3#1)
the voltage-dependent Ca2+##2##3##(1992-7#1)(1995-12#1)
the voltage-dependent L-type Ca2+ current in vascular smooth muscle cells##2##10##(1995-12#1)(1997-5#1)
the voltage-dependent L-type Ca2+##4##4##(1995-12#3)(1997-5#1)
the voltage-dependent sodium##2##3##(2004-11#1)(2008-8#1)
the voltage-dependent##10##2##(1992-7#1)(1995-10#1)(1995-11#1)(1995-12#4)(1997-5#1)(2004-11#1)(2008-8#1)
the voltage-gated Na(+) channel##2##4##(2008-8#2)
the voltage-gated sodium channel##3##4##(2006-10#1)(2010-12#1)(2010-2#1)
the voltage-gated##10##2##(1990-7#1)(1994-10#1)(1997-4#1)(2006-10#1)(2008-8#4)(2010-12#1)(2010-2#1)
the voltage-sensitive calcium channels##2##4##(2007-9#2)
the voltage-sensitive##5##2##(1994-3#1)(1995-3#2)(2007-9#2)
the voltages applied##2##3##(2007-12#1)(2008-2#1)
the voltammetric behavior of##3##4##(2008-10#3)
the voltammetric behavior##4##3##(2008-10#4)
the voltammetric behaviour of##2##4##(2008-10#2)
the voltammetric behaviour##3##3##(2008-10#3)
the voltammetric data##2##3##(2008-10#2)
the voltammetric determination of##4##4##(2008-10#4)
the voltammetric method##3##3##(2008-10#3)
the voltammetric peak##2##3##(2008-10#2)
the voltammetric response##4##3##(2008-10#4)
the voltammetric##35##2##(2006-6#1)(2008-10#34)
the voltammogram##2##2##(1992-7#1)(2008-10#1)
the voltammograms##3##2##(2008-10#3)
the volume absorption coefficient##2##4##(2008-2#2)
the volume and metabolic capacity of##2##6##(1997-5#2)
the volume and##7##3##(1997-5#2)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2010-2#1)
the volume flow##3##3##(2007-7#1)(2008-11#2)
the volume fraction of the##3##5##(2007-12#1)(2008-11#1)(2009-5#1)
the volume fraction of##8##4##(2005-12#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-5#1)(2010-9#1)(2012-12#1)
the volume fraction##9##3##(2005-12#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-3#1)(2009-5#1)(2010-9#1)(2012-12#1)
the volume fractions of the##2##5##(2008-2#1)(2008-3#1)
the volume holographic##2##3##(2007-11#1)(2007-12#1)
the volume occupied by##3##4##(1995-11#1)(2007-3#2)
the volume of CABG##2##4##(2011-2#2)
the volume of a##2##4##(1992-12#1)(2005-11#1)
the volume of blood##2##4##(2009-6#1)(2011-1#1)
the volume of distribution##2##4##(1992-8#1)(2009-4#1)
the volume of ejaculate##2##4##(1997-8#2)
the volume of ischemic injury##2##5##(2007-9#2)
the volume of ischemic##3##4##(2007-9#2)(2010-12#1)
the volume of one##2##4##(1990-4#1)(2008-11#1)
the volume of the##30##4##(1990-11#1)(1990-12#1)(1990-5#1)(1993-2#2)(1994-9#1)(1995-1#1)(1995-12#1)(1996-4#1)(1996-7#1)(1997-5#1)(2005-5#1)(2006-5#1)(2007-10#1)(2007-12#2)(2008-10#4)(2008-3#1)(2008-4#1)(2008-6#2)(2009-2#1)(2009-5#1)(2011-2#1)(2012-12#2)(2013-1#1)
the volume of these##3##4##(1992-12#1)(2008-2#1)(2011-2#1)
the volume of tissue##2##4##(1991-2#1)(1996-5#1)
the volume of##99##3##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#2)(1990-8#1)(1991-2#1)(1991-9#1)(1992-12#3)(1992-2#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#2)(1994-3#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-3#2)(1996-4#1)(1996-5#1)(1996-7#3)(1997-5#1)(1997-8#3)(2005-10#1)(2005-11#1)(2005-5#1)(2006-5#1)(2007-10#2)(2007-12#3)(2007-2#1)(2007-9#4)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#3)(2008-8#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#7)(2012-12#4)(2012-2#1)(2013-1#1)
the volume ratio##2##3##(2008-10#2)
the volume regulation of human##2##5##(1990-2#2)
the volume regulation of##3##4##(1990-2#2)(2008-4#1)
the volume scattering function##2##4##(2008-2#1)(2008-3#1)
the volume scattering##3##3##(2008-2#2)(2008-3#1)
the volume was##2##3##(2007-12#1)(2008-10#1)
the volume which is##2##4##(2007-12#1)(2008-11#1)
the volume##178##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#3)(1990-8#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-12#3)(1992-2#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#2)(1994-3#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-3#2)(1996-4#1)(1996-5#1)(1996-7#3)(1997-5#3)(1997-8#3)(2005-10#1)(2005-11#4)(2005-12#2)(2005-5#1)(2006-10#3)(2006-5#1)(2006-9#1)(2007-10#3)(2007-11#2)(2007-12#12)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#1)(2007-9#4)(2008-10#20)(2008-11#8)(2008-12#2)(2008-2#11)(2008-3#9)(2008-4#2)(2008-6#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
the volumes of extreme precipitation##2##5##(2013-8#2)
the volumes of the##3##4##(1990-5#1)(1996-10#1)(2013-8#1)
the volumes of##11##3##(1990-5#1)(1991-8#1)(1996-10#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-8#3)
the volumes##16##2##(1990-5#1)(1991-8#1)(1995-8#1)(1996-10#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-3#2)(2009-11#1)(2009-2#1)(2011-2#1)(2012-1#1)(2013-8#3)
the volumetric productivity##2##3##(2008-11#2)
the volumetric spatial decomposition##2##4##(2008-7#2)
the volumetric thickness profile##2##4##(2007-11#2)
the volumetric titration##2##3##(2008-10#2)
the volumetric##17##2##(2004-8#1)(2007-11#2)(2008-10#5)(2008-11#5)(2008-2#1)(2008-7#2)(2011-1#1)
the voluminous##2##2##(2008-11#1)(2008-12#1)
the voluntary##13##2##(1990-12#2)(1991-3#1)(1993-12#2)(1993-7#1)(1994-2#1)(1996-2#1)(1996-9#1)(2008-11#1)(2009-4#1)(2013-1#1)(2013-8#1)
the volunteer experience##2##3##(1992-3#1)(1994-3#1)
the volunteer##16##2##(1991-1#1)(1991-2#3)(1992-3#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-2#1)(1994-3#2)(1996-3#2)(2006-11#1)(2008-12#1)(2008-5#1)
the volunteer's##3##2##(1991-2#1)(2005-12#1)(2007-1#1)
the volunteers were##3##3##(1996-5#1)(2008-5#1)(2011-1#1)
the volunteers##9##2##(1995-11#1)(1996-3#1)(1996-5#1)(1996-7#1)(2008-10#1)(2008-5#3)(2011-1#1)
the volunteers'##2##2##(2008-5#1)(2013-1#1)
the vomeronasal system##2##3##(1993-2#1)(1997-7#1)
the vomeronasal##5##2##(1992-8#1)(1993-2#2)(1997-7#1)(2008-6#1)
the vomiting##2##2##(1996-1#1)(2008-8#1)
the von Bertalanffy##2##3##(2008-5#1)(2010-8#1)
the von Hippel-Lindau protein##2##4##(2012-12#2)
the von Hippel-Lindau##5##3##(2008-6#1)(2009-11#2)(2012-12#2)
the von Willebrand factor##2##4##(1993-9#1)(2007-12#1)
the von Willebrand##3##3##(1993-9#1)(2007-12#1)(2008-12#1)
the von##13##2##(1993-9#1)(2005-10#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-11#2)(2010-8#1)(2012-12#2)
the vortex structure of##2##4##(2007-12#2)
the vortex structure##3##3##(1995-7#1)(2007-12#2)
the vortex##7##2##(1991-12#1)(1995-7#1)(2007-12#2)(2008-1#1)(2008-2#2)
the vote##2##2##(2006-7#1)(2013-1#1)
the voxel##4##2##(2008-2#3)(2011-1#1)
the vpr##3##2##(1994-10#3)
the vulnerability of the##6##4##(1995-11#1)(1996-10#1)(2007-1#1)(2009-4#1)(2012-2#1)(2013-7#1)
the vulnerability of##15##3##(1990-5#1)(1990-7#1)(1995-11#1)(1996-10#1)(1996-9#1)(1997-2#1)(2007-1#1)(2007-9#1)(2008-5#1)(2009-4#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
the vulnerability to##2##3##(2008-10#1)(2013-7#1)
the vulnerability##18##2##(1990-5#1)(1990-7#1)(1995-11#1)(1996-10#1)(1996-9#1)(1997-2#1)(2007-1#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-4#2)(2011-1#1)(2012-2#1)(2013-1#2)(2013-7#2)
the vulnerable##12##2##(1991-4#1)(1995-12#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-8#2)(2012-12#1)(2012-2#3)(2013-1#1)
the vulva and##2##3##(2007-7#1)(2008-10#1)
the vulva##33##2##(1992-3#4)(1993-6#1)(1993-8#1)(1994-1#1)(1996-12#3)(1997-7#2)(2004-10#1)(2005-11#2)(2005-7#1)(2006-10#9)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-7#2)
the w##3##2##(1991-5#3)
the wafer##5##2##(1992-6#2)(2007-12#1)(2008-7#1)(2010-4#1)
the wafers##2##2##(1992-6#1)(2008-3#1)
the waggle##4##2##(2012-12#4)
the waist##5##2##(2007-12#2)(2007-7#1)(2008-2#2)
the waist-to-hip ratio (WHR)##2##4##(2007-12#2)
the waist-to-hip ratio##4##3##(1990-9#1)(1991-10#1)(2007-12#2)
the waiting list##12##3##(1990-5#2)(1991-11#1)(1991-4#1)(1993-2#1)(1997-1#2)(2007-7#1)(2007-8#2)(2011-2#1)(2011-3#1)
the waiting period##2##3##(1991-4#1)(2008-5#1)
the waiting room##3##3##(2006-8#1)(2008-7#1)(2010-4#1)
the waiting time##7##3##(1991-11#2)(1991-4#1)(2008-5#1)(2011-1#1)(2012-12#1)(2012-2#1)
the waiting##28##2##(1990-5#2)(1991-11#5)(1991-4#3)(1993-2#1)(1996-2#1)(1997-1#2)(2006-8#1)(2007-7#1)(2007-8#2)(2008-5#2)(2008-7#1)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)
the waiver##11##2##(1991-1#1)(1992-2#4)(1993-1#1)(1993-9#1)(1996-12#1)(1997-2#3)
the wake of the##5##4##(2006-6#1)(2008-1#1)(2008-4#1)(2008-7#1)(2013-1#1)
the wake of##14##3##(1991-3#1)(1993-2#1)(1995-1#1)(2005-8#1)(2006-6#1)(2007-4#1)(2007-9#2)(2008-1#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-1#1)(2013-1#1)
the wake##15##2##(1991-3#1)(1993-2#1)(1995-1#1)(2005-11#1)(2005-8#1)(2006-6#1)(2007-4#1)(2007-9#2)(2008-1#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-1#1)(2013-1#1)
the walk##2##2##(2007-7#1)(2009-4#1)
the walker##2##2##(2012-11#1)(2013-7#1)
the walking legs of a scorpion##2##6##(2007-12#2)
the walking legs##4##3##(2007-12#4)
the walking##12##2##(1991-12#1)(2004-11#1)(2007-12#7)(2011-12#2)(2012-1#1)
the wall acceleration##2##3##(2009-6#2)
the wall of a##2##4##(2005-11#1)(2008-9#1)
the wall of the gut##2##5##(1993-8#1)(2006-10#1)
the wall of the##19##4##(1990-11#1)(1992-8#1)(1993-8#1)(1993-9#1)(1995-8#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-4#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-7#2)(2009-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
the wall of##26##3##(1990-11#1)(1991-5#1)(1992-4#1)(1992-8#1)(1993-8#1)(1993-9#1)(1995-8#1)(1997-2#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
the wall shear stress##2##4##(2007-9#1)(2008-11#1)
the wall shear##3##3##(2007-9#1)(2008-11#2)
the wall surface##2##3##(2008-10#1)(2008-7#1)
the wall##66##2##(1990-11#1)(1990-9#1)(1991-5#1)(1992-4#1)(1992-8#1)(1993-8#1)(1993-9#1)(1995-8#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-11#3)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-8#3)(2007-9#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-3#3)(2008-5#1)(2008-7#5)(2008-9#1)(2009-1#1)(2009-11#2)(2009-2#1)(2009-4#1)(2009-6#6)(2009-7#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
the wall-less##2##2##(1992-11#1)(2008-10#1)
the walls are##2##3##(2007-12#1)(2008-5#1)
the walls of all##2##4##(2007-12#2)
the walls of the lateral##3##5##(1996-5#1)(2008-11#2)
the walls of the##15##4##(1994-9#1)(1996-5#1)(2006-10#1)(2007-12#2)(2007-9#1)(2008-10#3)(2008-11#3)(2008-9#1)(2009-8#1)(2011-1#1)
the walls of##28##3##(1994-9#1)(1996-5#1)(2005-10#1)(2006-10#3)(2007-12#4)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#3)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
the walls##40##2##(1994-3#1)(1994-9#1)(1996-5#2)(1997-6#1)(2005-10#1)(2006-10#3)(2006-5#1)(2007-10#1)(2007-12#6)(2007-8#1)(2007-9#2)(2008-10#8)(2008-11#3)(2008-12#1)(2008-5#1)(2008-9#2)(2009-11#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
the war against the##2##4##(2006-10#1)(2008-1#1)
the war and##4##3##(1995-4#1)(2013-1#2)(2013-8#1)
the war on##3##3##(2007-3#2)(2009-9#1)
the war##21##2##(1990-6#2)(1995-4#5)(2006-10#1)(2007-3#2)(2008-1#1)(2008-10#2)(2008-6#1)(2009-2#1)(2009-7#1)(2009-9#1)(2013-1#2)(2013-8#2)
the ward and##3##3##(2008-11#2)(2012-2#1)
the ward##9##2##(2007-11#3)(2008-11#2)(2010-8#2)(2011-12#1)(2012-2#1)
the wards and##2##3##(2008-8#1)(2013-8#1)
the wards of##2##3##(2010-8#1)(2011-2#1)
the wards##18##2##(1990-8#1)(2007-8#1)(2008-8#1)(2010-3#7)(2010-8#1)(2011-2#2)(2013-1#4)(2013-8#1)
the warfarin##4##2##(1994-5#1)(2008-5#1)(2011-1#1)(2012-12#1)
the warm climate##2##3##(2006-1#1)(2007-5#1)
the warm##6##2##(1995-3#1)(2006-1#1)(2007-5#1)(2008-10#1)(2008-9#1)(2012-2#1)
the warmer##3##2##(2008-10#2)(2012-2#1)
the warming##4##2##(2005-1#1)(2006-5#1)(2007-8#2)
the warning index##2##3##(2008-8#2)
the warning signs of##2##4##(2007-9#1)(2011-1#1)
the warning signs##3##3##(2007-9#1)(2009-6#1)(2011-1#1)
the warning##9##2##(1990-12#1)(1995-5#1)(2007-9#1)(2008-8#2)(2009-6#1)(2011-1#1)(2012-3#1)(2013-8#1)
the wash-out rate of##2##4##(2008-5#2)
the wash-out##3##2##(1990-5#1)(2008-5#2)
the washed water##2##3##(2008-10#2)
the washing of##2##3##(1993-3#1)(2008-7#1)
the washing##4##2##(1993-3#1)(1997-2#1)(2007-3#1)(2008-7#1)
the washout##3##2##(1996-3#1)(2008-11#1)(2008-7#1)
the wastage of##3##3##(1996-9#1)(2008-11#1)(2012-3#1)
the waste##9##2##(1997-2#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2009-6#1)(2010-8#1)
the wastewater##7##2##(2005-11#1)(2008-10#4)(2013-1#2)
the water activity and##2##4##(2005-12#1)(2008-7#1)
the water activity##3##3##(2005-12#1)(2008-7#2)
the water analysis##2##3##(2008-1#1)(2008-10#1)
the water and##3##3##(2004-12#1)(2008-10#1)(2010-4#1)
the water barrier##3##3##(2008-5#3)
the water body##4##3##(2008-2#1)(2008-3#1)(2008-5#1)(2013-8#1)
the water column##12##3##(2006-3#1)(2007-5#4)(2008-2#3)(2008-3#2)(2008-8#1)(2012-2#1)
the water content in the##3##5##(2008-10#2)(2008-5#1)
the water content is##2##4##(2008-10#2)
the water content of the stratum corneum##2##7##(2008-5#2)
the water content of the##5##5##(2007-10#1)(2008-10#1)(2008-3#1)(2008-5#2)
the water content of##8##4##(2005-11#2)(2007-10#1)(2008-10#1)(2008-3#1)(2008-5#3)
the water content##20##3##(2005-11#2)(2007-10#1)(2008-10#11)(2008-3#2)(2008-5#4)
the water diffusion##2##3##(1991-5#1)(2010-9#1)
the water extract##2##3##(2008-10#1)(2008-5#1)
the water extracts of propolis##2##5##(2008-11#2)
the water extracts of##3##4##(2008-10#1)(2008-11#2)
the water flow##3##3##(2005-11#1)(2008-11#1)(2013-1#1)
the water fraction##3##3##(2007-5#1)(2008-10#2)
the water from##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
the water is removed##2##4##(2005-11#1)(2008-11#1)
the water is##4##3##(1990-10#1)(2005-11#1)(2008-11#1)(2008-2#1)
the water level##3##3##(2005-10#2)(2007-3#1)
the water maze and passive avoidance##2##6##(1993-11#1)(1996-12#1)
the water maze and##4##4##(1993-11#1)(1996-12#2)(2008-9#1)
the water maze task##5##4##(1993-2#1)(1994-3#1)(1997-2#1)(2008-4#2)
the water maze##17##3##(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-3#1)(1996-12#3)(1997-2#1)(2008-10#1)(2008-4#2)(2008-9#2)(2012-3#1)
the water molecule##2##3##(1997-1#1)(2008-3#1)
the water molecules in the##2##5##(1995-5#1)(2006-10#1)
the water molecules in##3##4##(1995-10#1)(1995-5#1)(2006-10#1)
the water molecules##12##3##(1992-9#1)(1995-10#1)(1995-5#1)(2005-11#1)(2005-4#1)(2006-1#1)(2006-10#4)(2008-10#1)(2009-6#1)
the water permeability##2##3##(1991-5#1)(1993-3#1)
the water phase##3##3##(1991-5#1)(1993-11#1)(1994-9#1)
the water potential##2##3##(2008-10#1)(2013-8#1)
the water quality of the Lake##2##6##(2013-8#2)
the water quality of the##3##5##(2008-10#1)(2013-8#2)
the water quality of##6##4##(2008-1#1)(2008-10#2)(2013-8#3)
the water quality##12##3##(1996-3#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#4)
the water rat##3##3##(2008-5#3)
the water resistance of##2##4##(2008-5#2)
the water sample and##2##4##(2008-10#2)
the water sample##5##3##(2008-10#5)
the water samples were##2##4##(2007-10#1)(2008-10#1)
the water samples##9##3##(2007-10#1)(2008-10#6)(2008-5#1)(2013-8#1)
the water source##2##3##(2007-7#1)(2011-12#1)
the water structure in the##2##5##(2006-10#1)(2008-5#1)
the water surface tension (gamma(H(2)O))##2##5##(2008-5#2)
the water surface##7##3##(1990-11#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-5#2)
the water tank##3##3##(1996-9#2)(2011-2#1)
the water temperature##2##3##(2008-5#1)(2013-8#1)
the water to##2##3##(1994-12#1)(2008-10#1)
the water uptake##2##3##(2008-5#1)(2009-8#1)
the water used##2##3##(2008-10#1)(2012-3#1)
the water vapor##2##3##(1991-5#1)(2008-3#1)
the water was##2##3##(1992-11#1)(2008-10#1)
the water window##6##3##(2008-2#6)
the water##276##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-7#3)(1990-9#1)(1991-11#2)(1991-2#2)(1991-5#4)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#2)(1993-11#3)(1993-12#3)(1993-2#2)(1993-3#2)(1993-4#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-10#2)(1995-3#1)(1995-5#3)(1995-8#1)(1996-12#3)(1996-3#1)(1996-6#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-6#1)(1997-7#3)(2004-12#1)(2004-4#1)(2005-10#2)(2005-11#8)(2005-12#1)(2005-4#1)(2006-1#1)(2006-10#6)(2006-3#2)(2006-8#1)(2007-10#3)(2007-12#3)(2007-3#2)(2007-5#6)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#51)(2008-11#8)(2008-2#17)(2008-3#18)(2008-4#2)(2008-5#31)(2008-7#2)(2008-8#4)(2008-9#3)(2009-3#1)(2009-6#3)(2009-8#1)(2010-4#3)(2010-8#3)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#2)(2012-5#1)(2012-9#1)(2013-1#3)(2013-7#1)(2013-8#8)
the water-accessible nonpolar surface##2##4##(1991-4#2)
the water-accessible##3##2##(1991-4#2)(1992-4#1)
the water-filled##2##2##(1995-1#1)(2008-10#1)
the water-immersion##2##2##(2008-3#2)
the water-in-oil microemulsion##2##3##(2005-11#1)(2008-5#1)
the water-insoluble Curdlan##3##3##(2007-8#3)
the water-insoluble##5##2##(2007-8#4)(2008-10#1)
the water-leaving radiance##3##3##(2008-3#3)
the water-leaving reflectance##2##3##(2008-2#2)
the water-leaving##6##2##(2008-2#2)(2008-3#4)
the water-miscible##2##2##(2008-10#2)
the water-oxidation complex##2##3##(1990-5#2)
the water-oxidizing##3##2##(1990-5#1)(1994-8#1)(1997-7#1)
the water-soluble fraction of##4##4##(2007-8#1)(2008-11#3)
the water-soluble fraction##7##3##(1990-11#1)(1991-9#1)(2007-8#1)(2008-11#4)
the water-soluble##17##2##(1990-11#1)(1990-2#2)(1991-1#1)(1991-9#1)(1992-2#1)(1995-10#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-5#2)
the water-vapor mixing ratio##4##4##(2008-3#4)
the water-vapor##8##2##(2008-2#1)(2008-3#7)
the water-window##2##2##(2007-12#1)(2008-3#1)
the waters##3##2##(2009-4#1)(2011-12#1)(2013-8#1)
the watershed##5##2##(2006-5#1)(2008-2#3)(2008-9#1)
the wave aberration##4##3##(2007-12#2)(2008-2#2)
the wave equation##3##3##(2007-12#2)(2008-2#1)
the wave front is##2##4##(2007-12#1)(2008-3#1)
the wave front of##2##4##(1995-10#1)(2007-12#1)
the wave front under test##2##5##(2008-3#2)
the wave front under##4##4##(2008-3#4)
the wave front##26##3##(1995-10#1)(2007-12#5)(2008-2#8)(2008-3#12)
the wave fronts##9##3##(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#3)
the wave propagation##4##3##(2008-2#2)(2008-3#1)(2008-7#1)
the wave##63##2##(1991-5#1)(1995-10#1)(2005-11#1)(2007-11#4)(2007-12#12)(2008-10#1)(2008-2#17)(2008-3#23)(2008-7#2)(2009-1#1)
the wave-front aberrations##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
the wave-front corrector##2##3##(2007-11#1)(2008-2#1)
the wave-front curvature##2##3##(2007-12#1)(2008-3#1)
the wave-front distortion##2##3##(2007-12#1)(2008-2#1)
the wave-front phase##2##3##(2008-3#2)
the wave-front quality##2##3##(2008-3#2)
the wave-front sensor##2##3##(2008-2#2)
the wave-front shape##3##3##(2008-2#1)(2008-3#2)
the wave-front##34##2##(2007-11#5)(2007-12#2)(2008-2#13)(2008-3#14)
the wave-number##2##2##(2008-2#1)(2008-3#1)
the waveform of##3##3##(1994-2#1)(1996-11#1)(2005-11#1)
the waveform##6##2##(1994-2#1)(1996-11#1)(2005-11#1)(2008-10#1)(2008-5#1)(2012-1#1)
the waveforms##2##2##(2005-11#1)(2012-1#1)
the waveguide at##2##3##(2007-11#1)(2008-3#1)
the waveguide birefringence##2##3##(2008-2#2)
the waveguide can be##2##4##(2008-3#2)
the waveguide can##3##3##(2007-12#1)(2008-3#2)
the waveguide diffractive##2##3##(2008-2#2)
the waveguide dimension##2##3##(2007-12#1)(2008-2#1)
the waveguide is##3##3##(2007-12#1)(2008-3#2)
the waveguide structure##2##3##(2007-11#1)(2007-12#1)
the waveguide surface##8##3##(2007-12#2)(2008-10#3)(2008-3#3)
the waveguide was##3##3##(2007-11#2)(2008-2#1)
the waveguide width##2##3##(2007-12#1)(2008-3#1)
the waveguide##78##2##(1992-3#1)(2007-11#7)(2007-12#23)(2007-9#1)(2008-1#3)(2008-10#5)(2008-2#14)(2008-3#23)(2012-11#1)
the waveguides were##2##3##(2008-2#2)
the waveguides##20##2##(2007-11#1)(2007-12#5)(2008-1#1)(2008-2#8)(2008-3#3)(2013-8#2)
the waveguiding properties##2##3##(2008-2#2)
the waveguiding##7##2##(2007-11#1)(2008-2#5)(2008-3#1)
the wavelength accuracy##2##3##(2008-2#2)
the wavelength and##5##3##(2007-11#2)(2008-3#2)(2009-5#1)
the wavelength at which##2##4##(2008-2#1)(2008-3#1)
the wavelength at##3##3##(2008-2#1)(2008-3#2)
the wavelength dependence of the##8##5##(1997-1#1)(2007-11#1)(2008-2#2)(2008-3#3)(2011-1#1)
the wavelength dependence of##11##4##(1997-1#1)(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#3)(2011-1#1)
the wavelength in##2##3##(2008-2#1)(2008-3#1)
the wavelength interval##3##3##(2008-10#1)(2008-3#2)
the wavelength is##4##3##(2006-5#1)(2008-2#1)(2008-3#2)
the wavelength may##2##3##(2008-10#1)(2008-2#1)
the wavelength of a##2##4##(2008-3#2)
the wavelength of light##5##4##(2005-7#1)(2007-11#2)(2008-3#2)
the wavelength of the diode##2##5##(2007-12#2)
the wavelength of the incident beam##2##6##(2007-11#1)(2007-12#1)
the wavelength of the incident light##2##6##(2007-11#1)(2008-1#1)
the wavelength of the incident##6##5##(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
the wavelength of the laser##3##5##(2008-2#2)(2008-3#1)
the wavelength of the light source##2##6##(2007-11#1)(2008-3#1)
the wavelength of the light##4##5##(2007-11#1)(2007-12#1)(2008-3#2)
the wavelength of the pump##2##5##(2007-11#1)(2007-12#1)
the wavelength of the radiation##2##5##(2006-4#1)(2008-3#1)
the wavelength of the##34##4##(1995-5#1)(2006-4#1)(2007-11#6)(2007-12#10)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#9)
the wavelength of##60##3##(1995-5#1)(1996-8#1)(2005-7#1)(2006-4#1)(2007-1#1)(2007-11#9)(2007-12#13)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#9)(2008-3#15)
the wavelength range 0##2##4##(2007-11#1)(2008-3#1)
the wavelength range from 53##2##5##(2008-2#1)(2008-3#1)
the wavelength range from##8##4##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#1)(2008-5#1)
the wavelength range of 200-700##2##5##(2006-12#2)
the wavelength range of##10##4##(2006-12#3)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#2)
the wavelength range##48##3##(2006-12#3)(2007-11#9)(2007-12#3)(2008-10#3)(2008-2#16)(2008-3#13)(2008-5#1)
the wavelength region##5##3##(2007-11#1)(2008-2#2)(2008-3#2)
the wavelength to be##2##4##(2007-12#1)(2008-3#1)
the wavelength used##2##3##(2008-2#1)(2008-3#1)
the wavelength was##3##3##(2007-11#1)(2008-10#2)
the wavelength##210##2##(1995-5#1)(1996-8#1)(1997-1#2)(1997-3#1)(2005-7#1)(2006-12#3)(2006-4#2)(2006-5#1)(2007-1#1)(2007-11#29)(2007-12#29)(2008-1#4)(2008-10#18)(2008-11#1)(2008-2#50)(2008-3#63)(2008-5#1)(2009-5#1)(2011-1#1)
the wavelength-dependent phase##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
the wavelength-dependent##7##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)
the wavelength-scanning##3##2##(2007-12#2)(2008-2#1)
the wavelengths corresponding to##2##4##(2008-10#1)(2008-3#1)
the wavelengths of the##4##4##(2006-12#1)(2007-12#3)
the wavelengths of##8##3##(2006-12#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
the wavelengths##20##2##(1990-2#1)(2005-4#1)(2006-12#1)(2006-3#1)(2007-12#6)(2008-10#3)(2008-2#2)(2008-3#4)(2012-2#1)
the wavelet coefficients##3##3##(2008-2#3)
the wavelet graph model##2##4##(2008-2#2)
the wavelet graph##3##3##(2008-2#3)
the wavelet transform to##2##4##(2007-12#1)(2008-2#1)
the wavelet transform##6##3##(2007-12#2)(2008-10#1)(2008-2#3)
the wavelet##27##2##(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#19)(2008-3#2)
the wavelet-based##2##2##(2008-2#2)
the wavelet-packet noise-reduction process##2##4##(2008-3#2)
the wavenumber##4##2##(2008-1#1)(2008-10#2)(2009-5#1)
the waves##4##2##(2008-10#1)(2008-3#1)(2011-2#1)(2012-3#1)
the wax covering##2##3##(2007-12#2)
the wax matrix in##2##4##(2008-5#2)
the wax matrix was##3##4##(2008-5#3)
the wax matrix##9##3##(2008-5#9)
the wax##11##2##(2007-12#2)(2008-5#9)
the way and##2##3##(2010-12#1)(2011-2#1)
the way for a new##2##5##(1995-4#1)(2010-12#1)
the way for a##8##4##(1992-1#1)(1994-11#1)(1995-3#1)(1995-4#1)(2007-12#1)(2010-12#1)(2010-2#1)(2011-1#1)
the way for the##7##4##(2005-8#1)(2007-10#1)(2007-2#1)(2008-8#1)(2009-8#1)(2011-1#1)(2012-2#1)
the way for##32##3##(1992-1#1)(1992-8#1)(1994-11#1)(1995-3#1)(1995-4#1)(2005-11#1)(2005-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#4)(2011-2#2)(2012-2#1)
the way forward##6##3##(1991-10#1)(2004-10#1)(2008-8#1)(2009-10#1)(2010-5#1)(2012-12#1)
the way health##2##3##(1995-2#1)(2006-4#1)
the way in which the##12##5##(1992-1#1)(1993-8#1)(1997-7#1)(2006-4#1)(2007-12#1)(2007-9#1)(2008-11#2)(2008-5#1)(2008-9#1)(2011-1#1)(2012-3#1)
the way in which they##6##5##(1997-4#1)(2006-5#1)(2008-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
the way in which we##2##5##(2008-7#1)(2008-8#1)
the way in which##49##4##(1992-1#2)(1993-2#1)(1993-8#1)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#2)(2006-3#1)(2006-4#1)(2006-5#3)(2006-9#1)(2007-12#1)(2007-9#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-5#2)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#2)(2012-3#2)(2013-1#1)
the way in##56##3##(1992-1#2)(1993-2#1)(1993-8#1)(1995-12#1)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-3#1)(2006-4#1)(2006-5#3)(2006-8#1)(2006-9#1)(2007-12#1)(2007-9#2)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-3#1)(2009-5#2)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-2#2)(2012-3#2)(2013-1#1)
the way it is##2##4##(1992-3#1)(2009-10#1)
the way it##3##3##(1992-12#1)(1992-3#1)(2009-10#1)
the way of##15##3##(1995-5#1)(1996-9#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2009-1#1)(2009-7#2)(2010-5#1)(2013-8#1)
the way scientists view##2##4##(2006-10#1)(2007-9#1)
the way that health care##2##5##(1996-2#1)(1997-5#1)
the way that##15##3##(1991-1#1)(1991-5#1)(1996-2#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-11#2)(2008-4#1)(2008-8#2)(2010-5#1)(2011-12#1)(2012-12#1)
the way the##15##3##(1997-4#1)(2006-10#1)(2007-8#1)(2008-1#2)(2008-11#3)(2008-3#1)(2008-6#1)(2010-11#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
the way they are##2##4##(2008-1#1)(2008-12#1)
the way they were##2##4##(2006-5#1)(2012-3#1)
the way they##18##3##(1994-2#1)(1997-2#1)(2005-8#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2012-3#1)(2013-8#1)
the way this##2##3##(1994-6#1)(2010-2#1)
the way to a new##2##5##(2005-11#1)(2008-7#1)
the way to a##6##4##(1991-1#1)(1996-1#1)(2005-11#1)(2007-11#1)(2007-6#1)(2008-7#1)
the way to the##2##4##(2010-7#1)(2011-1#1)
the way to##38##3##(1990-6#1)(1991-1#1)(1995-1#1)(1996-1#1)(2004-4#1)(2005-11#1)(2006-11#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#2)(2007-8#2)(2007-9#1)(2008-10#1)(2008-2#2)(2008-7#2)(2008-9#1)(2009-3#1)(2009-7#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-12#1)
the way toward##3##3##(1990-11#1)(1992-12#1)(2008-8#1)
the way towards##2##3##(1993-11#1)(2010-12#1)
the way we##10##3##(2005-7#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-12#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-7#1)
the way?##3##2##(2007-9#1)(2011-1#1)(2012-2#1)
the ways in which it can be##2##7##(2008-8#1)(2012-3#1)
the ways in which it##3##5##(2007-5#1)(2008-8#1)(2012-3#1)
the ways in which the##4##5##(1994-11#1)(1994-3#1)(1995-3#1)(2009-5#1)
the ways in which these##2##5##(2006-10#1)(2008-2#1)
the ways in which##35##4##(1991-3#1)(1992-12#1)(1992-2#1)(1994-11#1)(1994-3#1)(1995-3#1)(2005-11#1)(2006-10#3)(2006-11#1)(2006-7#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)
the ways of##4##3##(1992-11#1)(2006-2#1)(2008-8#1)(2011-1#1)
the ways that##6##3##(2007-4#1)(2009-4#1)(2010-12#1)(2012-3#1)(2013-1#2)
the ways to##3##3##(2008-2#1)(2008-5#1)(2008-8#1)
the ways##60##2##(1991-3#1)(1992-11#1)(1992-12#1)(1992-2#1)(1994-11#1)(1994-3#1)(1995-3#1)(1997-2#1)(2005-11#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-4#2)(2007-5#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#4)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-12#2)(2010-4#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#2)
the weak RLS of##2##4##(2008-10#2)
the weak coupling##2##3##(2007-11#1)(2008-3#1)
the weak interaction##2##3##(1993-6#1)(2008-10#1)
the weak link##2##3##(2008-12#1)(2013-1#1)
the weak points of##2##4##(2006-6#1)(2008-5#1)
the weak signal##3##3##(2008-10#3)
the weak##57##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-8#1)(1997-7#1)(2005-11#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#15)(2008-12#1)(2008-3#5)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
the weak-scattering##2##2##(2007-11#1)(2007-12#1)
the weakened##2##2##(1995-9#1)(2008-10#1)
the weaker##15##2##(1990-11#1)(1991-5#1)(1991-6#1)(1994-6#1)(1995-5#1)(1995-6#1)(1996-6#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-9#1)(2009-4#1)(2012-12#1)(2012-3#2)
the weakest part of the KTH complex##2##7##(2006-11#2)
the weakest##13##2##(1995-12#1)(1996-12#1)(1996-2#1)(1997-5#1)(2006-11#2)(2007-12#1)(2008-5#2)(2008-7#1)(2010-12#1)(2012-3#2)
the weakly emetic strain IH41385##2##5##(2011-2#2)
the weakly##9##2##(1992-9#1)(1995-5#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-2#2)
the weakness of the##2##4##(2007-11#1)(2008-2#1)
the weakness of##4##3##(2007-11#1)(2008-2#1)(2010-4#1)(2012-12#1)
the weakness##7##2##(2005-11#1)(2007-11#1)(2008-12#1)(2008-2#1)(2010-4#1)(2012-12#1)(2012-2#1)
the weaknesses of the##3##4##(2007-4#1)(2007-8#1)(2010-2#1)
the weaknesses of##7##3##(1997-3#1)(2007-4#1)(2007-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)
the weaknesses##9##2##(1991-12#1)(1997-3#1)(2007-4#1)(2007-8#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
the wealth of information##2##4##(2009-5#1)(2011-10#1)
the wealth of##9##3##(1993-1#1)(2006-10#1)(2007-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#2)(2011-10#1)
the wealth##11##2##(1993-1#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-5#2)(2011-10#1)
the weaning##3##2##(1990-5#1)(1997-4#1)(2012-2#1)
the weapon##6##2##(1995-11#1)(2007-12#1)(2008-10#1)(2013-7#3)
the wear debris##3##3##(2004-9#3)
the wear rate of##3##4##(2004-9#1)(2008-5#1)(2009-3#1)
the wear rate##4##3##(2004-9#2)(2008-5#1)(2009-3#1)
the wear##10##2##(2004-9#6)(2007-8#1)(2008-5#1)(2009-3#1)(2009-7#1)
the wearer's##3##2##(2010-8#2)(2012-1#1)
the wearing of gowns and gloves for all contacts##2##9##(1992-10#2)
the wearing of##3##3##(1991-2#1)(1992-10#2)
the weather variables##2##3##(2008-10#2)
the weather##5##2##(1992-3#1)(2008-10#3)(2008-3#1)
the web (http##3##3##(2008-7#1)(2013-1#2)
the web of the spider Nephila clavipes##2##7##(2006-12#2)
the web of##4##3##(2006-12#3)(2008-5#1)
the web##25##2##(2006-10#5)(2006-12#4)(2006-3#1)(2006-6#1)(2007-10#1)(2007-4#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-9#1)(2009-2#1)(2013-1#2)
the web-based##3##2##(2008-7#1)(2008-8#1)(2010-10#1)
the wedge angle##2##3##(2008-2#2)
the wedge##7##2##(2008-2#5)(2008-3#2)
the wedging of##2##3##(2006-9#1)(2007-11#1)
the wee1+##2##2##(1991-2#1)(1994-12#1)
the weed##10##2##(1993-2#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-5#1)(2010-12#2)(2011-2#1)
the weeds##2##2##(2008-10#1)(2008-12#1)
the week after the booster##2##5##(1992-7#2)
the week and##2##3##(2007-12#1)(2013-8#1)
the week before##2##3##(1991-2#1)(1996-3#1)
the week ending January##2##4##(1992-1#1)(1997-2#1)
the week ending##3##3##(1992-1#1)(1997-2#2)
the week following##2##3##(1990-12#1)(1996-8#1)
the week of##3##3##(1995-6#2)(1996-5#1)
the week##23##2##(1990-12#1)(1991-2#2)(1992-1#1)(1992-7#2)(1995-6#2)(1996-1#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#2)(2005-10#1)(2005-9#1)(2006-12#1)(2007-12#1)(2008-8#1)(2009-11#2)(2011-1#1)(2013-8#1)
the weekend##5##2##(1993-10#1)(1994-3#3)(1996-5#1)
the weekly##6##2##(2008-11#1)(2008-3#1)(2009-4#1)(2013-1#3)
the weeks following##2##3##(2007-10#1)(2009-6#1)
the weeks##4##2##(1993-10#1)(1996-6#1)(2007-10#1)(2009-6#1)
the weevil##3##2##(2008-10#3)
the weighing##2##2##(2008-10#1)(2008-7#1)
the weight and##4##3##(1996-8#1)(2006-1#1)(2008-5#1)(2012-3#1)
the weight change##2##3##(1990-4#1)(1991-2#1)
the weight concentration##2##3##(1996-3#2)
the weight factors##2##3##(2008-3#2)
the weight loss##2##3##(2008-6#1)(2012-2#1)
the weight of a##3##4##(1996-8#2)(2010-9#1)
the weight of evidence##2##4##(2007-11#1)(2010-9#1)
the weight of the##17##4##(1991-12#1)(1996-6#1)(2006-2#1)(2006-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-1#1)(2012-12#5)(2013-1#1)
the weight of##31##3##(1991-12#1)(1996-6#1)(1996-8#2)(1997-1#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-12#1)(2009-9#1)(2010-9#2)(2012-12#5)(2013-1#1)
the weight##67##2##(1990-12#1)(1990-4#1)(1991-12#1)(1991-2#2)(1992-12#1)(1993-2#1)(1993-5#1)(1996-3#2)(1996-6#1)(1996-8#3)(1997-1#1)(2006-1#1)(2006-2#1)(2006-3#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-7#1)(2010-9#2)(2011-1#1)(2012-1#3)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#1)
the weight-bearing##4##2##(2005-7#1)(2008-3#1)(2008-4#1)(2011-2#1)
the weighted Krawtchouk polynomials##2##4##(2008-2#2)
the weighted average##3##3##(1992-12#1)(2011-2#1)(2013-8#1)
the weighted kappa##2##3##(2007-7#1)(2012-1#1)
the weighted mean of##3##4##(2007-4#1)(2008-10#2)
the weighted mean##5##3##(2007-10#1)(2007-4#1)(2008-10#2)(2011-2#1)
the weighted##25##2##(1992-12#1)(1997-3#1)(2007-10#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-10#4)(2008-2#5)(2008-3#2)(2008-4#1)(2008-9#1)(2011-2#2)(2012-1#2)(2013-8#1)
the weighting##5##2##(1994-5#1)(2008-2#2)(2008-3#1)(2010-8#1)
the weights and##2##3##(2007-6#1)(2008-2#1)
the weights of the##5##4##(1997-3#1)(2007-12#2)(2008-3#1)(2010-2#1)
the weights of##12##3##(1994-8#1)(1995-8#1)(1996-12#1)(1997-3#1)(1997-4#1)(2007-12#2)(2008-3#2)(2008-5#1)(2008-8#1)(2010-2#1)
the weights##23##2##(1992-12#1)(1993-1#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-3#1)(1997-4#1)(2007-11#2)(2007-12#2)(2007-6#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-8#1)(2010-2#1)(2010-8#1)(2011-1#1)
the welding##3##2##(1994-6#1)(2008-3#1)(2008-4#1)
the welfare and##3##3##(2005-5#1)(2008-3#1)(2012-2#1)
the welfare of children##2##4##(1991-10#1)(2013-1#1)
the welfare of the child##2##5##(1991-10#1)(2006-6#1)
the welfare of##12##3##(1991-10#2)(1996-9#1)(2005-5#1)(2005-7#2)(2006-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2013-1#1)(2013-8#1)
the welfare state##2##3##(1996-8#1)(2006-2#1)
the welfare##26##2##(1991-10#2)(1994-4#1)(1996-8#3)(1996-9#1)(2005-5#2)(2005-7#2)(2006-2#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
the well characterized##2##3##(1991-2#1)(1995-2#1)
the well differentiated##2##3##(1991-7#1)(1994-9#1)
the well documented##3##3##(1991-2#1)(1992-12#1)(1995-12#1)
the well established##4##3##(2006-10#1)(2007-7#1)(2008-11#1)(2010-12#1)
the well known##10##3##(1991-2#1)(1992-3#1)(1995-12#1)(2006-2#1)(2006-4#1)(2006-7#1)(2007-3#1)(2008-10#1)(2008-11#1)(2012-2#1)
the well##43##2##(1990-2#1)(1990-9#1)(1991-2#3)(1991-7#2)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-4#2)(2006-7#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-10#2)(2008-11#7)(2008-5#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#1)
the well-being of the##2##4##(2011-2#1)(2013-8#1)
the well-being of##13##3##(1992-3#2)(1995-12#2)(2006-8#1)(2007-2#1)(2009-3#2)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
the well-characterized##5##2##(1997-4#1)(1997-6#1)(2006-12#1)(2008-4#1)(2009-8#1)
the well-defined##2##2##(1995-1#1)(2009-2#1)
the well-differentiated##3##2##(1990-3#1)(1992-2#1)(2007-2#1)
the well-documented##3##2##(1994-9#1)(1996-1#1)(2009-7#1)
the well-established##11##2##(1991-5#1)(1993-12#1)(1994-2#1)(2006-6#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-5#1)
the well-known Fourier-transform##2##3##(2007-12#1)(2008-2#1)
the well-known class of##2##4##(1994-9#1)(2010-12#1)
the well-known endemic##2##3##(1996-11#2)
the well-known inhibitory##2##3##(1995-1#1)(2010-12#1)
the well-known##80##2##(1990-7#1)(1991-7#1)(1991-8#1)(1994-2#1)(1994-5#1)(1994-6#3)(1994-9#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-10#2)(1996-11#2)(1997-7#2)(2005-11#6)(2005-5#1)(2006-10#1)(2006-6#2)(2007-11#3)(2007-12#7)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#14)(2008-3#6)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#2)(2010-12#4)(2011-1#1)(2012-3#1)(2013-1#1)
the well-proven##2##2##(1990-10#1)(1997-6#1)
the well-studied##5##2##(1995-8#1)(1997-7#1)(2008-9#1)(2010-2#1)(2011-1#1)
the well-type##2##2##(2007-11#2)
the wellbeing of##3##3##(1991-3#1)(2011-2#1)(2012-12#1)
the wells and##2##3##(2007-10#1)(2008-11#1)
the wells of a##2##4##(1990-12#1)(1994-8#1)
the wells of##5##3##(1990-12#2)(1992-6#1)(1994-8#1)(2008-11#1)
the wells##9##2##(1990-12#2)(1992-6#1)(1994-8#1)(1994-9#1)(2007-10#1)(2008-11#2)(2013-1#1)
the west coast of North America##2##6##(2007-7#1)(2010-10#1)
the west coast of the##2##5##(2010-8#2)
the west coast of##5##4##(2007-7#1)(2009-12#1)(2010-10#1)(2010-8#2)
the west coast##6##3##(2007-5#1)(2007-7#1)(2009-12#1)(2010-10#1)(2010-8#2)
the west of##5##3##(1992-10#1)(1996-11#1)(2008-10#1)(2012-12#1)(2013-8#1)
the west##27##2##(1992-10#1)(1992-6#1)(1995-10#1)(1996-11#1)(1997-3#1)(2006-12#1)(2006-9#6)(2007-3#1)(2007-5#3)(2007-7#1)(2008-10#3)(2009-12#1)(2010-10#1)(2010-8#3)(2012-12#1)(2013-8#1)
the western Atlantic##2##3##(1992-8#1)(2008-5#1)
the western North Atlantic##2##4##(2008-2#1)(2008-3#1)
the western Pacific##3##3##(1995-7#1)(1996-6#1)(2008-1#1)
the western and##3##3##(2006-10#1)(2008-1#1)(2011-2#1)
the western as well as##2##5##(1997-7#1)(2008-2#1)
the western countries##3##3##(2005-11#1)(2007-10#1)(2011-2#1)
the western flower thrips (Frankliniella occidentalis)##2##6##(2008-10#1)(2009-8#1)
the western flower thrips##4##4##(2008-10#2)(2009-8#1)(2011-2#1)
the western part##4##3##(1993-5#2)(2006-4#1)(2008-10#1)
the western world##13##3##(1990-2#1)(1990-7#1)(1991-11#1)(1996-2#1)(2007-1#1)(2008-1#3)(2008-11#1)(2008-2#2)(2011-12#2)
the western##64##2##(1990-2#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-12#1)(1992-8#1)(1993-11#1)(1993-5#2)(1994-8#1)(1995-7#1)(1996-2#1)(1996-6#1)(1997-7#1)(2005-11#1)(2006-10#4)(2006-4#1)(2006-7#2)(2007-1#1)(2007-10#1)(2007-5#4)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#9)(2008-11#2)(2008-2#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-12#3)(2011-2#3)(2013-1#1)
the wet and dry##2##4##(2006-4#1)(2008-10#1)
the wet chemistry##2##3##(1992-12#2)
the wet period##5##3##(2008-10#4)(2008-5#1)
the wet season##12##3##(2007-3#1)(2007-5#8)(2008-5#3)
the wet##30##2##(1992-12#2)(1994-6#1)(1997-2#1)(2005-4#1)(2006-10#1)(2006-4#1)(2007-3#1)(2007-5#8)(2008-10#7)(2008-5#5)(2010-8#1)(2013-1#1)
the wetland landscape pattern change##2##5##(2013-8#2)
the wetland landscape##3##3##(2013-8#3)
the wetland##10##2##(1997-4#1)(2007-3#1)(2007-5#4)(2012-2#1)(2013-8#3)
the wetness##2##2##(2008-10#2)
the wettability of##3##3##(2008-5#3)
the wettability##4##2##(2005-11#1)(2008-5#3)
the wetted area inside the porous substrate##2##7##(2005-11#2)
the wetted area##3##3##(2005-11#3)
the wetted region inside the porous layer##4##7##(2005-11#4)
the wetted##10##2##(2005-11#10)
the wetting##10##2##(2005-11#2)(2008-10#3)(2008-5#2)(2009-11#1)(2010-4#1)(2012-2#1)
the what##2##2##(2007-12#2)
the wheat chromosomes##2##3##(2008-5#1)(2008-8#1)
the wheat cv##2##3##(2008-10#2)
the wheat germ##3##3##(1992-9#1)(2008-10#2)
the wheat glutenin subunits##2##4##(1992-7#2)
the wheat leaf##2##3##(2008-10#2)
the wheat rhizosphere##6##3##(2008-10#6)
the wheat##48##2##(1991-12#1)(1992-3#2)(1992-7#3)(1992-9#1)(2006-12#1)(2008-10#27)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2013-7#1)(2013-8#7)
the wheel##7##2##(1994-6#1)(2008-7#1)(2009-11#1)(2012-12#4)
the wheelchair##7##2##(2007-7#2)(2009-3#1)(2012-1#1)(2013-1#3)
the wheels##2##2##(2012-11#1)(2012-12#1)
the whi2##2##2##(1997-6#2)
the whiplash##4##2##(1993-3#1)(2006-10#1)(2006-11#1)(2007-11#1)
the whisking frequency##3##3##(2013-1#3)
the whisking##4##2##(2013-1#4)
the whispering gallery modes##2##4##(2006-12#1)(2007-12#1)
the whispering-gallery modes of a##2##5##(2007-11#1)(2007-12#1)
the whispering-gallery modes of##3##4##(2007-11#2)(2007-12#1)
the whispering-gallery modes##5##3##(2007-11#3)(2007-12#2)
the whispering-gallery##6##2##(2007-11#3)(2007-12#2)(2011-1#1)
the white and##2##3##(1992-2#1)(2011-1#1)
the white blood cell content of the##2##7##(2008-5#2)
the white blood cell##3##4##(1994-6#1)(2008-5#2)
the white blood##5##3##(1992-4#1)(1994-6#1)(2008-1#1)(2008-5#2)
the white cloud mountain minnow##2##5##(2010-5#2)
the white matter and##3##4##(1991-12#1)(1995-5#1)(2012-1#1)
the white matter of the cerebellum##2##6##(1996-7#1)(2008-6#1)
the white matter of the##4##5##(1996-7#1)(2008-6#1)(2008-9#1)(2011-1#1)
the white matter tracts##2##4##(1996-1#1)(1996-7#1)
the white matter##27##3##(1990-5#1)(1991-10#1)(1991-12#2)(1992-7#1)(1995-12#1)(1995-5#2)(1996-1#1)(1996-11#2)(1996-7#2)(1997-5#1)(2007-1#1)(2007-10#2)(2008-11#1)(2008-6#1)(2008-9#1)(2010-12#3)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#1)
the white oaks growing##2##4##(2004-4#2)
the white pine blister rust##3##5##(2008-10#3)
the white pine##4##3##(2008-10#4)
the white piranha Serrasalmus brandtii##2##5##(2010-8#2)
the white pulp##2##3##(2008-7#1)(2010-12#1)
the white rot fungus##3##4##(1991-2#1)(2005-12#1)(2008-6#1)
the white rot##4##3##(1991-2#1)(2005-12#1)(2008-6#1)(2009-9#1)
the white##69##2##(1990-5#1)(1991-10#1)(1991-12#2)(1991-2#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-11#2)(1996-7#2)(1997-5#2)(2004-4#2)(2005-12#1)(2007-1#1)(2007-10#2)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-12#4)(2010-5#2)(2010-8#3)(2010-9#1)(2011-1#2)(2012-1#1)(2012-12#2)(2012-2#2)(2013-7#1)
the white-rot fungus##3##3##(1991-8#2)(2008-11#1)
the white-rot##4##2##(1990-4#1)(1991-8#2)(2008-11#1)
the whitefly Bemisia tabaci##3##4##(2008-10#2)(2011-2#1)
the whitefly##6##2##(2008-10#5)(2011-2#1)
the whitening##4##2##(2008-3#1)(2008-5#2)(2011-2#1)
the whole analysis##2##3##(2008-10#2)
the whole analytical procedure##3##4##(2008-10#3)
the whole analytical##4##3##(2008-10#4)
the whole analyzed group##2##4##(2011-2#2)
the whole and##3##3##(2009-8#1)(2009-9#1)(2013-8#1)
the whole angular##2##3##(2008-2#1)(2008-3#1)
the whole animal##4##3##(1991-9#1)(2004-11#1)(2007-1#1)(2008-7#1)
the whole area##2##3##(2006-6#1)(2009-5#1)
the whole blood##7##3##(1996-11#1)(2008-10#2)(2008-4#2)(2011-2#1)(2012-2#1)
the whole body##10##3##(1992-3#1)(1996-9#1)(2004-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-6#1)(2012-2#1)
the whole brain##7##3##(1991-6#1)(2006-8#1)(2008-11#2)(2010-12#1)(2010-2#1)(2013-7#1)
the whole cell patch##2##4##(1993-12#1)(1993-2#1)
the whole cell##12##3##(1990-2#1)(1990-7#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-9#1)(1997-5#1)(1997-6#1)(2006-12#1)(2006-2#1)(2008-11#1)
the whole coding##2##3##(1997-4#1)(2008-8#1)
the whole cohort##2##3##(2008-5#1)(2010-8#1)
the whole complex##2##3##(1993-8#1)(1997-1#1)
the whole concentration range##2##4##(1990-11#1)(1994-9#1)
the whole concentration##3##3##(1990-11#1)(1994-9#1)(2008-10#1)
the whole country##9##3##(1992-2#2)(1992-5#1)(2004-4#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#1)(2012-2#1)
the whole enzyme##2##3##(1991-8#1)(2006-8#1)
the whole experiment##4##3##(1995-5#1)(1997-8#1)(2008-5#1)(2012-2#1)
the whole family##4##3##(1997-4#1)(2008-10#1)(2008-2#1)(2009-8#1)
the whole field##4##3##(2008-3#2)(2011-2#1)(2012-2#1)
the whole genome of##2##4##(2007-3#1)(2010-3#1)
the whole genome sequence##2##4##(2011-1#2)
the whole genome##20##3##(1990-9#1)(2007-10#1)(2007-3#1)(2008-10#1)(2008-7#4)(2008-8#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#2)(2012-3#3)(2013-8#2)
the whole group of##2##4##(1990-6#1)(2007-11#1)
the whole group was##4##4##(2006-6#1)(2007-7#1)(2008-6#1)(2010-3#1)
the whole group##24##3##(1990-6#1)(1992-7#1)(1992-8#1)(1993-12#2)(2006-6#3)(2006-7#1)(2006-8#2)(2007-11#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-4#2)(2008-6#1)(2010-3#2)(2011-2#1)(2012-12#1)
the whole head##5##3##(1996-5#1)(2007-1#1)(2011-1#3)
the whole image##4##3##(2008-2#1)(2008-3#1)(2010-8#2)
the whole is more than the##2##6##(2007-9#1)(2009-10#1)
the whole is more than##3##5##(2007-9#2)(2009-10#1)
the whole length of##2##4##(2007-12#1)(2008-10#1)
the whole lesion##2##3##(1993-1#1)(2008-5#1)
the whole life##3##3##(1994-6#1)(2010-8#1)(2012-2#1)
the whole method##3##3##(2008-10#2)(2008-11#1)
the whole molecule or##2##4##(1990-11#1)(1997-8#1)
the whole molecule##4##3##(1990-11#1)(1990-8#1)(1991-9#1)(1997-8#1)
the whole object##2##3##(2008-2#1)(2008-3#1)
the whole of its##2##4##(1991-11#1)(2009-2#1)
the whole of the##6##4##(2004-1#1)(2004-7#1)(2006-6#1)(2007-8#1)(2009-2#1)(2011-1#1)
the whole of##19##3##(1990-7#1)(1991-11#1)(2004-1#1)(2004-7#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-5#1)(2007-8#1)(2008-10#2)(2009-2#2)(2009-4#1)(2010-6#1)(2010-9#3)(2011-1#1)
the whole organism##9##3##(2006-10#1)(2006-5#1)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-9#1)(2012-3#1)
the whole patient##2##3##(1996-12#1)(2008-6#1)
the whole pelvis##2##3##(2007-7#1)(2011-2#1)
the whole period of##4##4##(1992-5#1)(2007-8#1)(2008-8#1)(2013-1#1)
the whole period##7##3##(1992-5#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-5#1)(2008-8#1)(2013-1#1)
the whole picture##2##3##(1994-2#1)(2011-1#1)
the whole plant of##3##4##(2006-12#1)(2007-1#1)(2007-11#1)
the whole plant##6##3##(2006-12#1)(2007-1#1)(2007-11#1)(2008-10#3)
the whole plants of##3##4##(2007-1#3)
the whole plants##4##3##(2007-1#4)
the whole plasma##2##3##(1990-5#1)(2005-8#1)
the whole population and##3##4##(2008-3#1)(2011-2#2)
the whole population##16##3##(1992-5#1)(1993-5#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)
the whole procedure##7##3##(2008-10#4)(2008-11#1)(2009-5#1)(2011-2#1)
the whole process of CAT fusion in##2##7##(2010-10#2)
the whole process of##8##4##(1995-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-10#2)(2013-8#1)
the whole process##10##3##(1995-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-10#2)(2013-8#1)
the whole processes##2##3##(1994-3#1)(2008-11#1)
the whole range of##4##4##(2005-12#1)(2007-12#1)(2007-7#1)(2012-2#1)
the whole region##4##3##(1994-3#1)(1997-7#1)(2007-10#1)(2008-2#1)
the whole series of##4##4##(1991-10#1)(1992-10#1)(2007-8#1)(2009-7#1)
the whole series##5##3##(1991-10#1)(1992-10#1)(2006-7#1)(2007-8#1)(2009-7#1)
the whole set of##4##4##(1994-11#1)(2008-10#2)(2008-3#1)
the whole set##5##3##(1994-11#1)(2008-10#2)(2008-3#1)(2010-2#1)
the whole society##2##3##(1996-8#1)(2013-1#1)
the whole spectral range##2##4##(2007-11#1)(2007-12#1)
the whole spectrum of##3##4##(2008-10#1)(2008-4#1)(2008-5#1)
the whole sperm population##2##4##(2007-9#2)
the whole structure##2##3##(1994-12#1)(1995-2#1)
the whole study period##3##4##(2007-7#2)(2012-12#1)
the whole study##8##3##(1992-12#1)(1993-7#1)(1993-8#1)(2007-7#2)(2008-4#1)(2008-8#1)(2012-12#1)
the whole system of##2##4##(1995-12#1)(2008-3#1)
the whole system##6##3##(1995-12#1)(2007-12#1)(2007-8#1)(2008-2#2)(2008-3#1)
the whole tuning range from##2##5##(2007-11#1)(2007-12#1)
the whole tuning range##3##4##(2007-11#1)(2007-12#2)
the whole working##2##3##(2008-10#1)(2013-8#1)
the whole world##4##3##(2007-7#1)(2008-10#1)(2011-2#1)(2013-8#1)
the whole##541##2##(1990-11#2)(1990-12#1)(1990-2#4)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#3)(1991-9#3)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-5#5)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#1)(1993-5#2)(1993-7#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#4)(1994-5#2)(1994-6#2)(1994-9#4)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2004-1#1)(2004-11#2)(2004-4#2)(2004-7#1)(2005-1#1)(2005-11#4)(2005-12#1)(2005-8#1)(2006-10#3)(2006-12#4)(2006-2#2)(2006-4#1)(2006-5#2)(2006-6#7)(2006-7#2)(2006-8#8)(2006-9#1)(2007-1#10)(2007-10#3)(2007-11#11)(2007-12#15)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#10)(2007-8#8)(2007-9#6)(2008-1#5)(2008-10#62)(2008-11#9)(2008-12#1)(2008-2#22)(2008-3#18)(2008-4#6)(2008-5#13)(2008-6#3)(2008-7#13)(2008-8#10)(2008-9#5)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#2)(2009-4#5)(2009-5#2)(2009-7#2)(2009-8#4)(2009-9#2)(2010-10#5)(2010-11#1)(2010-12#10)(2010-2#3)(2010-3#6)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#8)(2010-9#5)(2011-1#12)(2011-2#13)(2012-1#3)(2012-11#2)(2012-12#6)(2012-2#12)(2012-3#6)(2012-9#1)(2013-1#6)(2013-7#2)(2013-8#12)
the whole-cell configuration##2##3##(1993-3#1)(1995-5#1)
the whole-cell patch-clamp method##3##4##(1990-7#1)(1996-9#1)(2008-8#1)
the whole-cell patch-clamp##6##3##(1990-5#1)(1990-7#1)(1995-10#1)(1996-10#1)(1996-9#1)(2008-8#1)
the whole-cell pertussis vaccines##3##4##(2007-11#3)
the whole-cell##27##2##(1990-5#1)(1990-7#1)(1992-11#1)(1993-3#1)(1993-7#1)(1994-2#2)(1995-10#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-7#1)(1997-8#1)(2007-11#3)(2008-5#1)(2008-8#2)(2009-12#1)(2011-3#1)
the whole-mount preparation##2##3##(2008-8#2)
the whole-wheat flour hydrolysate was##2##5##(2004-8#2)
the wide &quot##2##3##(1993-3#2)
the wide applicability of this##2##5##(1996-11#1)(2008-7#1)
the wide distribution of##2##4##(2005-11#1)(2007-4#1)
the wide excision group##4##4##(2004-1#4)
the wide excision##6##3##(1995-4#1)(2004-1#4)(2011-12#1)
the wide pH range##3##4##(2008-10#3)
the wide range of applications##2##5##(2008-10#1)(2008-7#1)
the wide range of##26##4##(1990-2#1)(1991-11#1)(1992-3#1)(1994-6#1)(1996-3#2)(1997-7#1)(2006-10#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#2)(2012-12#2)(2012-2#4)(2013-1#1)
the wide range##30##3##(1990-2#1)(1991-11#1)(1992-3#1)(1994-6#1)(1996-3#2)(1997-7#1)(2006-10#1)(2007-11#3)(2008-1#1)(2008-10#6)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#2)(2012-12#2)(2012-2#4)(2013-1#1)
the wide spectrum of##5##4##(1990-6#1)(1991-2#1)(2007-11#1)(2008-7#1)(2008-8#1)
the wide use of##3##4##(2007-8#1)(2008-1#1)(2008-2#1)
the wide variety of##9##4##(1994-6#1)(2007-12#1)(2007-2#2)(2008-11#1)(2008-8#1)(2008-9#1)(2010-2#1)(2012-2#1)
the wide##103##2##(1990-2#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-3#2)(1993-3#2)(1993-7#1)(1994-2#1)(1994-3#2)(1994-6#2)(1995-4#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-7#1)(2004-1#4)(2005-11#1)(2006-10#1)(2006-6#2)(2006-7#1)(2007-11#6)(2007-12#3)(2007-2#2)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#1)(2009-2#2)(2010-11#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-12#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#2)
the wide-angle airborne laser ranging system##2##6##(2008-3#2)
the wide-field##2##2##(1990-12#1)(2008-2#1)
the wide-spread##3##2##(1992-6#1)(2009-4#1)(2013-8#1)
the widely accepted##6##3##(1990-10#1)(1993-8#1)(2004-1#1)(2008-10#1)(2008-2#1)(2012-3#1)
the widely assumed##3##3##(1990-6#1)(2013-1#2)
the widely held view that##2##5##(1994-6#1)(2007-11#1)
the widely held##3##3##(1994-6#1)(2007-11#1)(2008-7#1)
the widely used##25##3##(1994-1#1)(1995-1#1)(1995-2#1)(1996-9#1)(2005-11#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
the widely##54##2##(1990-10#1)(1990-6#1)(1992-5#1)(1992-8#1)(1993-8#1)(1994-1#1)(1994-6#1)(1995-1#1)(1995-2#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-1#1)(2005-10#1)(2005-11#1)(2006-12#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)
the widened##2##2##(1995-8#1)(2007-8#1)
the widening gap between##2##4##(2007-7#1)(2008-9#1)
the widening##4##2##(2005-11#1)(2007-11#1)(2007-7#1)(2008-9#1)
the wider church##2##3##(2010-2#2)
the wider community##4##3##(2005-7#1)(2010-4#1)(2011-2#1)(2012-3#1)
the wider impacts of##2##4##(2011-1#2)
the wider use of##2##4##(2006-10#1)(2011-12#1)
the wider use##3##3##(2006-10#1)(2007-12#1)(2011-12#1)
the wider##32##2##(1994-8#1)(1995-5#1)(1996-11#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-6#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
the widespread availability of##2##4##(2006-12#1)(2006-6#1)
the widespread distribution of##5##4##(2008-10#1)(2008-11#1)(2008-4#3)
the widespread nature of##2##4##(2006-12#1)(2008-8#1)
the widespread occurrence##2##3##(2008-10#1)(2008-9#1)
the widespread presence of##2##4##(1994-8#1)(2008-7#1)
the widespread use of abdominal imaging##2##6##(2008-6#1)(2012-2#1)
the widespread use of the##3##5##(1993-12#1)(2011-2#1)(2012-2#1)
the widespread use of##32##4##(1991-4#1)(1993-12#1)(1996-2#1)(1997-8#2)(2005-9#2)(2006-10#2)(2006-5#2)(2006-6#1)(2006-8#1)(2007-8#2)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-11#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#1)
the widespread use##33##3##(1991-4#1)(1993-12#1)(1996-2#1)(1997-8#2)(2005-9#2)(2006-10#2)(2006-5#2)(2006-6#1)(2006-8#1)(2007-8#2)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-11#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
the widespread##75##2##(1990-7#1)(1991-4#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-8#2)(2004-1#1)(2005-9#2)(2006-10#5)(2006-12#2)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#1)(2007-11#1)(2007-8#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#4)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#1)(2009-11#1)(2010-12#4)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#2)
the widest range of##3##4##(1992-8#1)(2004-4#1)(2006-5#1)
the widest##12##2##(1992-2#1)(1992-8#1)(1993-10#1)(1995-5#1)(2004-4#1)(2006-5#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)
the width of attached gingiva##2##5##(2013-7#2)
the width of the 95%##2##5##(2008-10#2)
the width of the##40##4##(1990-3#1)(1990-5#1)(1991-1#1)(1991-9#1)(1993-12#1)(1993-9#1)(1994-8#1)(1997-1#1)(1997-3#1)(1997-7#1)(2005-11#1)(2007-11#4)(2007-12#3)(2008-1#1)(2008-10#6)(2008-2#2)(2008-3#9)(2008-4#1)(2008-5#1)(2011-2#1)(2013-8#1)
the width of##48##3##(1990-3#1)(1990-5#1)(1991-1#1)(1991-9#1)(1993-12#1)(1993-9#1)(1994-8#1)(1994-9#1)(1997-1#1)(1997-3#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-11#4)(2007-12#3)(2008-1#1)(2008-10#7)(2008-2#2)(2008-3#10)(2008-4#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-7#3)(2013-8#1)
the width##56##2##(1990-3#1)(1990-5#1)(1991-1#1)(1991-9#1)(1993-12#1)(1993-9#1)(1994-8#1)(1994-9#1)(1997-1#1)(1997-3#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-11#5)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#8)(2008-2#3)(2008-3#12)(2008-4#1)(2008-5#1)(2008-9#1)(2010-10#1)(2011-2#1)(2013-1#1)(2013-7#3)(2013-8#1)
the width-weight relation##2##3##(2008-5#2)
the widths##2##2##(1994-9#1)(2008-3#1)
the wigner distribution##2##3##(2008-2#2)
the wild and##5##3##(1996-12#1)(1997-7#1)(2006-10#1)(2010-5#1)(2012-3#1)
the wild are##3##3##(2008-11#2)(2013-8#1)
the wild cell##2##3##(2008-8#2)
the wild in##2##3##(2007-2#2)
the wild species##2##3##(2008-5#1)(2010-10#1)
the wild strain##4##3##(1997-2#1)(2005-11#1)(2008-10#1)(2010-8#1)
the wild type (WT)##2##4##(1995-11#1)(1997-1#1)
the wild type and mutant##2##5##(1991-7#1)(2008-8#1)
the wild type and the mutant##2##6##(2006-8#1)(2008-8#1)
the wild type and the##4##5##(2006-8#1)(2008-10#1)(2008-6#1)(2008-8#1)
the wild type and##15##4##(1991-7#1)(1993-3#1)(1994-9#1)(1995-10#1)(2005-11#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#2)(2008-8#2)(2010-12#1)
the wild type enzyme##2##4##(1991-4#1)(1991-8#1)
the wild type in##2##4##(2008-10#2)
the wild type protein L7/L12##2##5##(1996-11#2)
the wild type protein##9##4##(1991-4#1)(1992-8#1)(1994-2#1)(1995-10#1)(1996-11#2)(1996-8#1)(2008-11#2)
the wild type receptor##3##4##(1996-11#1)(1996-5#1)(1996-8#1)
the wild type strain IRC-3##2##5##(2008-8#2)
the wild type strain##6##4##(1991-2#1)(2006-8#2)(2008-8#2)(2008-9#1)
the wild type under##2##4##(2008-10#1)(2010-10#1)
the wild type was##4##4##(1990-5#1)(1997-8#1)(2008-10#2)
the wild type##117##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#2)(1990-7#1)(1991-2#4)(1991-4#3)(1991-7#5)(1991-8#1)(1992-6#2)(1992-8#2)(1993-11#3)(1993-3#5)(1993-6#1)(1993-8#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#3)(1995-10#2)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-11#4)(1996-4#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#4)(1997-7#1)(1997-8#3)(2005-11#1)(2006-8#4)(2007-12#1)(2008-10#17)(2008-11#3)(2008-5#2)(2008-6#3)(2008-8#8)(2008-9#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#1)(2013-8#1)
the wild##172##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#2)(1990-7#1)(1991-2#4)(1991-4#3)(1991-7#5)(1991-8#2)(1992-11#1)(1992-6#2)(1992-8#2)(1993-11#3)(1993-3#5)(1993-6#1)(1993-8#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#3)(1995-10#2)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-11#4)(1996-12#3)(1996-4#1)(1996-5#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-4#5)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#3)(2005-11#2)(2006-10#2)(2006-12#1)(2006-8#4)(2007-1#1)(2007-12#1)(2007-2#3)(2008-10#24)(2008-11#6)(2008-4#3)(2008-5#6)(2008-6#3)(2008-8#11)(2008-9#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-4#3)(2010-5#1)(2010-8#2)(2012-12#2)(2012-3#1)(2013-8#4)
the wild-type (wt) protein##2##4##(1990-3#1)(1990-5#1)
the wild-type (wt)##3##3##(1990-3#1)(1990-5#2)
the wild-type A##2##3##(2008-10#2)
the wild-type CRP##2##3##(1995-8#2)
the wild-type E##2##3##(1994-9#2)
the wild-type ER##3##3##(1996-2#3)
the wild-type GLUT1##3##3##(1991-4#1)(1992-4#2)
the wild-type Kulm##2##3##(2008-10#2)
the wild-type LCAT##3##3##(1993-3#1)(1993-8#2)
the wild-type and a##2##4##(1996-10#1)(1997-5#1)
the wild-type and mutant##4##4##(1992-8#1)(1995-10#1)(2008-10#2)
the wild-type and the##5##4##(1992-3#1)(1994-11#1)(1997-8#1)(2008-8#2)
the wild-type and##24##3##(1992-3#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-10#1)(1995-2#2)(1995-3#1)(1996-10#1)(1996-8#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-8#3)(2010-12#1)
the wild-type enzyme##64##3##(1990-10#4)(1990-12#2)(1990-8#3)(1991-12#2)(1991-5#1)(1992-3#5)(1992-6#4)(1992-9#3)(1993-6#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#5)(1995-1#2)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#6)(1995-8#4)(1996-11#1)(1996-2#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#1)(2008-4#2)
the wild-type factor##2##3##(2006-12#2)
the wild-type gene##3##3##(1991-12#1)(1993-3#1)(1994-12#1)
the wild-type isolate##4##3##(2008-10#4)
the wild-type level of##3##4##(1995-2#2)(2006-11#1)
the wild-type level##6##3##(1995-2#2)(1997-4#2)(2006-11#1)(2009-6#1)
the wild-type mice##2##3##(1996-12#1)(1997-7#1)
the wild-type native##2##3##(1992-6#1)(1995-11#1)
the wild-type p53##5##3##(1990-8#2)(1991-5#1)(1993-9#2)
the wild-type plant##2##3##(1995-8#1)(2006-9#1)
the wild-type promoter##2##3##(1996-7#2)
the wild-type protein and##2##4##(1994-11#1)(1997-4#1)
the wild-type protein at##2##4##(1990-5#1)(1991-4#1)
the wild-type protein with##2##4##(1992-9#1)(2011-2#1)
the wild-type protein##20##3##(1990-2#1)(1990-5#3)(1991-2#1)(1991-4#1)(1992-3#2)(1992-9#1)(1994-11#2)(1994-5#1)(1994-6#1)(1994-9#1)(1997-4#1)(1997-5#3)(2011-1#1)(2011-2#1)
the wild-type receptor##2##3##(1995-10#1)(1995-3#1)
the wild-type sequence##3##3##(1991-9#1)(1997-3#1)(1997-4#1)
the wild-type strain on soybean and##2##6##(2008-10#2)
the wild-type strain on##3##4##(2008-10#3)
the wild-type strain##25##3##(1992-3#1)(1993-2#1)(1997-4#1)(2006-8#1)(2006-9#1)(2008-10#16)(2008-6#1)(2008-7#2)(2009-6#1)
the wild-type strains##2##3##(2008-10#2)
the wild-type virus##4##3##(1996-4#1)(2008-10#3)
the wild-type##315##2##(1990-10#4)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#6)(1990-8#5)(1990-9#1)(1991-10#1)(1991-12#5)(1991-2#4)(1991-4#2)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#3)(1992-11#4)(1992-2#2)(1992-3#9)(1992-4#3)(1992-6#8)(1992-7#1)(1992-8#1)(1992-9#4)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#3)(1993-9#2)(1994-11#7)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#5)(1994-6#2)(1994-8#2)(1994-9#13)(1995-1#6)(1995-10#4)(1995-11#1)(1995-12#1)(1995-2#14)(1995-3#6)(1995-5#6)(1995-6#6)(1995-8#11)(1996-10#1)(1996-11#3)(1996-12#1)(1996-2#5)(1996-4#2)(1996-5#1)(1996-7#7)(1996-8#5)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#11)(1997-5#4)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-11#1)(2006-12#8)(2006-8#1)(2006-9#2)(2007-12#4)(2007-6#1)(2008-10#37)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#1)(2009-2#2)(2009-6#4)(2009-8#1)(2010-12#3)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#2)(2013-8#2)
the wildtype##4##2##(1994-12#1)(2008-7#2)(2012-2#1)
the will to##3##3##(2008-11#1)(2008-4#1)(2011-2#1)
the will##4##2##(2008-11#1)(2008-4#1)(2009-11#1)(2011-2#1)
the willingness of parents to pay for##2##7##(2006-12#2)
the willingness of##8##3##(1996-2#1)(2006-12#2)(2007-10#2)(2007-7#1)(2008-1#1)(2011-2#1)
the willingness to experience##2##4##(2011-1#2)
the willingness to pay##4##4##(2007-7#1)(2012-12#2)(2013-8#1)
the willingness to##7##3##(2007-7#1)(2011-1#2)(2012-12#3)(2013-8#1)
the willingness##15##2##(1996-2#1)(2006-12#2)(2007-10#2)(2007-7#2)(2008-1#1)(2011-1#2)(2011-2#1)(2012-12#3)(2013-8#1)
the wilt##2##2##(2008-10#2)
the wilt-resistant one##2##3##(2008-10#2)
the wilt-susceptible##2##2##(2008-10#2)
the wind speed##2##3##(2008-2#1)(2008-5#1)
the wind##17##2##(2007-3#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#2)(2008-8#2)
the window for##3##3##(2008-8#1)(2010-12#1)(2013-7#1)
the window group##2##3##(2006-9#2)
the window of opportunity##3##4##(2009-10#1)(2009-4#1)(2010-5#1)
the window of##10##3##(1993-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2009-10#1)(2009-4#1)(2010-5#1)(2012-2#1)
the window##25##2##(1993-7#1)(1996-11#1)(2006-9#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-5#2)(2012-2#1)(2013-1#4)(2013-7#1)
the windowed##2##2##(2007-11#1)(2008-1#1)
the windows of##2##3##(2008-3#1)(2013-1#1)
the windows##7##2##(2007-3#1)(2008-3#2)(2008-6#1)(2012-2#2)(2013-1#1)
the winds##2##2##(1992-3#1)(2008-2#1)
the wine samples##2##3##(2008-10#2)
the wine##10##2##(2008-10#9)(2008-6#1)
the wing##18##2##(2005-10#2)(2007-12#10)(2007-3#1)(2007-9#1)(2009-4#1)(2009-5#1)(2012-12#2)
the wings of the##5##4##(2006-7#1)(2007-11#1)(2008-2#1)(2008-3#2)
the wings##11##2##(1990-9#1)(1991-12#1)(2006-7#1)(2007-11#1)(2008-2#1)(2008-3#3)(2009-12#1)(2013-8#2)
the winner's curse##3##3##(2011-2#1)(2012-3#2)
the winners##3##2##(2006-7#1)(2007-9#1)(2008-8#1)
the winter and spring##2##4##(2008-10#1)(2008-11#1)
the winter and##4##3##(1995-11#1)(2008-10#2)(2008-11#1)
the winter months of##3##4##(1992-10#1)(1996-3#1)(2008-5#1)
the winter months##11##3##(1991-8#1)(1992-10#1)(1996-3#1)(2006-8#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-11#1)(2011-1#1)
the winter of##8##3##(1991-8#1)(1992-6#1)(1996-9#1)(2006-8#1)(2007-6#1)(2008-2#1)(2008-5#1)(2010-8#1)
the winter season##4##3##(2008-5#3)(2010-8#1)
the winter skate##2##3##(2009-4#1)(2010-8#1)
the winter wheat##4##3##(1990-11#1)(2008-10#2)(2013-8#1)
the winter##60##2##(1990-11#1)(1991-2#1)(1991-8#2)(1992-10#1)(1992-6#1)(1995-11#3)(1995-2#1)(1996-1#2)(1996-3#1)(1996-9#1)(1997-3#1)(1997-6#1)(2006-8#2)(2007-11#1)(2007-3#1)(2007-6#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#7)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-8#4)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#5)
the winters##2##2##(2008-9#1)(2010-8#1)
the wire closure##2##3##(2007-8#2)
the wire diameter##2##3##(2009-2#2)
the wire nut technique resulted in significantly higher number of##2##10##(2011-2#2)
the wire nut technique##4##4##(2011-2#4)
the wire##17##2##(2007-8#3)(2008-3#1)(2009-2#3)(2010-10#2)(2011-2#4)(2012-1#3)(2013-8#1)
the wireless link##3##3##(2010-10#2)(2013-7#1)
the wireless##7##2##(2010-10#2)(2010-2#1)(2010-8#3)(2013-7#1)
the wires##6##2##(2007-8#1)(2007-9#1)(2008-3#1)(2009-2#1)(2013-8#2)
the wisdom##2##2##(2005-10#1)(2008-9#1)
the wish##3##2##(1991-11#1)(2008-9#1)(2013-1#1)
the wishes of the patient##2##5##(1990-11#1)(1991-2#1)
the wishes of##3##3##(1990-11#1)(1991-2#1)(1993-3#1)
the witches'-broom##2##2##(2008-10#2)
the withdrawal of the##5##4##(1992-11#1)(1992-6#1)(1997-6#1)(2006-6#1)(2013-1#1)
the withdrawal of##16##3##(1992-11#1)(1992-6#1)(1993-11#1)(1996-2#2)(1997-6#1)(2005-1#1)(2006-4#1)(2006-6#1)(2007-2#1)(2008-11#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
the withdrawal##22##2##(1991-12#3)(1992-11#1)(1992-6#1)(1993-11#1)(1996-2#2)(1997-6#1)(2005-1#1)(2006-4#1)(2006-6#1)(2007-2#2)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
the within day##2##3##(2008-10#1)(2010-12#1)
the within##4##2##(1992-2#1)(1993-5#1)(2008-10#1)(2010-12#1)
the within- and##5##3##(1995-3#1)(1996-12#1)(2008-8#2)(2010-5#1)
the within-patient##2##2##(1994-4#1)(1997-3#1)
the wobble modification##2##3##(2006-11#2)
the wobble##5##2##(1992-9#1)(1994-12#1)(2005-11#1)(2006-11#2)
the wobbler##2##2##(1996-12#1)(2006-11#1)
the woman##15##2##(1991-6#2)(1993-3#1)(1993-8#1)(1993-9#1)(1995-1#1)(1995-8#1)(1996-11#1)(2007-7#2)(2008-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
the woman's##8##2##(1992-6#1)(2006-9#1)(2007-2#2)(2007-7#1)(2008-1#1)(2009-5#1)(2013-1#1)
the women and##2##3##(2008-12#1)(2010-3#1)
the women had##8##3##(1990-8#1)(1995-8#1)(2006-10#1)(2006-7#1)(2007-3#1)(2008-11#1)(2008-4#1)(2011-1#1)
the women have##3##3##(2006-10#1)(2007-12#1)(2010-3#1)
the women in##6##3##(1992-1#1)(2006-4#1)(2006-8#1)(2008-11#1)(2009-11#1)(2012-12#1)
the women of the Malwa region of Punjab##2##8##(2013-8#2)
the women of##3##3##(2009-4#1)(2013-8#2)
the women reported##2##3##(1990-8#1)(2007-2#1)
the women the##2##3##(1992-3#1)(1994-2#1)
the women themselves##3##3##(1993-9#1)(1994-12#1)(2011-1#1)
the women was##6##3##(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2010-8#1)(2011-2#1)
the women were##15##3##(1991-6#1)(1996-12#1)(1996-6#1)(2006-4#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-8#2)
the women who had##2##4##(2006-10#1)(2006-8#1)
the women who##9##3##(1990-12#1)(1992-5#2)(2006-10#1)(2006-8#1)(2007-2#2)(2007-9#1)(2011-2#1)
the women with##4##3##(1992-9#1)(2006-10#1)(2007-9#1)(2011-1#1)
the women##120##2##(1990-12#1)(1990-8#3)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-5#2)(1992-9#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-6#2)(1997-2#1)(2006-10#6)(2006-2#1)(2006-4#2)(2006-7#3)(2006-8#4)(2006-9#1)(2007-11#2)(2007-12#3)(2007-2#7)(2007-3#3)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-4#3)(2009-7#1)(2010-3#3)(2010-8#2)(2011-1#9)(2011-12#1)(2011-2#7)(2012-12#3)(2013-1#2)(2013-8#6)
the women's experience of##2##4##(1996-1#1)(2008-1#1)
the women's health##2##3##(1994-12#1)(1997-1#1)
the women's knowledge of##2##4##(2006-8#2)
the women's lives were##2##4##(2006-7#1)(2012-12#1)
the women's personal##2##3##(1996-1#1)(2012-12#1)
the women's stories##2##3##(2012-12#2)
the women's##24##2##(1991-4#1)(1994-12#1)(1994-3#2)(1995-8#1)(1996-1#2)(1996-3#1)(1997-1#1)(1997-3#1)(2006-7#1)(2006-8#2)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#1)(2009-12#1)(2010-2#1)(2012-12#5)
the wood and##3##3##(1990-10#1)(2011-2#1)(2013-8#1)
the wood bark of Guarea guidonia##2##6##(2007-1#2)
the wood surface##2##3##(2010-4#2)
the wood##20##2##(1990-10#1)(1994-6#1)(2005-10#1)(2007-1#3)(2008-10#1)(2008-3#2)(2009-8#2)(2010-4#2)(2011-2#2)(2012-2#1)(2013-8#4)
the wood-feeding##3##2##(2007-12#1)(2013-7#2)
the wooden##2##2##(2008-10#1)(2013-1#1)
the wool##3##2##(2008-10#3)
the word &quot##4##3##(2004-10#1)(2007-10#1)(2007-12#1)(2008-1#1)
the word in##3##3##(2006-3#1)(2008-5#1)(2013-8#1)
the word type##2##3##(2009-11#2)
the word##37##2##(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-1#1)(1995-5#2)(2004-10#1)(2005-8#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-12#2)(2008-1#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-9#1)(2009-11#2)(2009-12#1)(2009-2#1)(2010-12#1)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#2)
the words of##2##3##(1994-1#1)(1994-3#1)
the words##8##2##(1994-1#1)(1994-3#1)(1997-7#1)(2007-5#1)(2008-2#1)(2008-4#1)(2010-8#1)(2012-12#1)
the work and##2##3##(2005-7#1)(2010-4#1)
the work by##4##3##(2007-8#2)(2007-9#2)
the work carried out##2##4##(2008-10#1)(2008-5#1)
the work conducted by##2##4##(2005-5#1)(2009-4#1)
the work done##3##3##(2006-11#1)(2008-9#1)(2009-11#1)
the work environment and the##2##5##(1993-6#1)(2012-12#1)
the work environment and##6##4##(1993-6#1)(2008-7#1)(2011-1#1)(2012-12#2)(2012-3#1)
the work environment in a healthcare setting##2##7##(2008-7#2)
the work environment in a##4##5##(2006-11#1)(2008-7#3)
the work environment##14##3##(1993-6#1)(1996-2#1)(1997-3#1)(2006-11#1)(2006-6#1)(2008-7#5)(2011-1#1)(2012-12#2)(2012-3#1)
the work force by the##2##5##(1997-2#2)
the work force to##2##4##(1992-12#1)(2007-12#1)
the work force##8##3##(1991-7#1)(1992-12#2)(1995-2#1)(1997-2#2)(2006-2#1)(2007-12#1)
the work from##2##3##(2008-10#1)(2011-3#1)
the work in##3##3##(1990-4#1)(2011-1#1)(2011-2#1)
the work of a##2##4##(1991-11#1)(1992-9#1)
the work of cavity creation##2##5##(2006-10#2)
the work of childbirth educators##2##5##(2007-2#2)
the work of other##2##4##(1995-2#1)(2007-11#1)
the work of the##10##4##(1990-12#1)(1997-3#1)(2006-3#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#3)(2009-11#1)
the work of##62##3##(1990-12#1)(1991-11#1)(1991-6#1)(1992-11#1)(1992-9#1)(1995-2#1)(1995-3#1)(1996-1#3)(1996-3#1)(1997-3#1)(2005-11#1)(2005-5#1)(2006-10#2)(2006-3#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#4)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-7#3)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)
the work place##5##3##(1993-12#1)(1995-2#1)(1997-1#1)(2007-12#1)(2009-12#1)
the work process##4##3##(1991-6#1)(2008-9#1)(2011-1#1)(2012-12#1)
the work related##2##3##(2008-11#1)(2008-12#1)
the work reported here##4##4##(1991-5#1)(1995-8#1)(2008-5#1)(2011-2#1)
the work setting##2##3##(1994-2#1)(1996-2#1)
the work shows##2##3##(2008-10#1)(2008-5#1)
the work situation##2##3##(2007-9#1)(2008-6#1)
the work that has been##2##5##(2006-10#1)(2012-2#1)
the work to##3##3##(2006-7#1)(2007-8#1)(2008-5#1)
the work was##7##3##(2005-1#1)(2006-3#1)(2007-11#1)(2008-10#1)(2008-9#1)(2010-2#1)(2013-1#1)
the work will##2##3##(2007-8#1)(2013-8#1)
the work without overstepping the mark'##2##6##(2007-10#2)
the work##200##2##(1990-12#1)(1990-4#2)(1990-8#1)(1991-11#1)(1991-12#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-9#1)(1993-12#1)(1993-6#1)(1994-2#2)(1994-6#1)(1995-1#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-2#2)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#4)(1997-4#1)(1997-8#1)(2005-1#1)(2005-11#1)(2005-5#2)(2005-7#1)(2006-1#1)(2006-10#4)(2006-11#2)(2006-2#1)(2006-3#2)(2006-6#1)(2006-7#2)(2007-1#1)(2007-10#4)(2007-11#4)(2007-12#2)(2007-2#4)(2007-3#1)(2007-8#9)(2007-9#5)(2008-1#3)(2008-10#9)(2008-11#7)(2008-12#4)(2008-2#3)(2008-3#3)(2008-5#4)(2008-6#2)(2008-7#11)(2008-8#1)(2008-9#7)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#4)(2009-5#1)(2009-7#3)(2010-2#2)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#4)(2011-3#1)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#8)(2013-8#1)
the work-related##4##2##(2007-10#1)(2008-7#2)(2010-5#1)
the work-up of##7##3##(1992-10#1)(2006-10#1)(2006-12#1)(2007-3#1)(2008-6#1)(2011-1#1)(2013-1#1)
the work-up##9##2##(1992-10#1)(1992-2#1)(2006-10#1)(2006-12#1)(2007-3#1)(2008-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
the worker##5##2##(1994-6#2)(2008-6#3)
the workers had##3##3##(1991-11#1)(1994-6#1)(2011-2#1)
the workers##22##2##(1991-11#1)(1993-6#1)(1994-6#5)(1995-3#1)(1996-3#2)(2006-1#1)(2006-10#2)(2006-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2009-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
the workers'##5##2##(1993-6#1)(2008-10#1)(2008-8#1)(2013-1#2)
the workflow##6##2##(2006-6#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-12#1)(2013-1#1)
the workforce for##2##3##(2009-5#1)(2011-1#1)
the workforce##19##2##(2007-2#1)(2007-4#2)(2008-10#1)(2008-12#1)(2008-4#1)(2009-5#1)(2011-1#3)(2012-12#8)(2012-2#1)
the workhorse##4##2##(2008-4#1)(2011-2#1)(2012-2#2)
the working alliance##2##3##(2008-4#2)
the working calibration curve##2##4##(2008-10#2)
the working calibration##4##3##(2008-10#4)
the working concentration range##2##4##(2007-8#1)(2008-10#1)
the working conditions##4##3##(1993-6#1)(1994-6#1)(2008-10#1)(2008-6#1)
the working electrode and the##2##5##(2008-10#2)
the working electrode and##3##4##(2008-10#3)
the working electrode in the##2##5##(2008-10#2)
the working electrode is##2##4##(2008-10#2)
the working electrode surface##2##4##(2008-10#2)
the working electrode##25##3##(1990-11#1)(2007-8#1)(2008-10#22)(2010-4#1)
the working electrodes##2##3##(2008-10#2)
the working environment##5##3##(1994-4#1)(1995-2#1)(1995-8#1)(1996-2#1)(2008-6#1)
the working group on##2##4##(1993-2#1)(2008-2#1)
the working group##3##3##(1993-2#1)(2008-2#1)(2008-5#1)
the working memory task##3##4##(1993-12#1)(1994-8#1)(1996-12#1)
the working memory##5##3##(1991-1#1)(1993-12#1)(1994-8#1)(1996-12#1)(1997-8#1)
the working of the##5##4##(2008-10#2)(2008-3#1)(2012-2#2)
the working of##6##3##(2008-10#3)(2008-3#1)(2012-2#2)
the working poor##2##3##(2007-11#1)(2008-11#1)
the working potentials##2##3##(2008-10#2)
the working range for##2##4##(2008-10#1)(2012-1#1)
the working range of the##3##5##(2008-10#2)(2008-3#1)
the working range of##4##4##(2008-10#3)(2008-3#1)
the working range##9##3##(2008-10#7)(2008-3#1)(2012-1#1)
the working relationship##2##3##(1992-9#1)(2010-9#1)
the working relationships##2##3##(2008-2#1)(2010-9#1)
the working space was##2##4##(2007-5#2)
the working surface of the##2##5##(2007-8#2)
the working surface##3##3##(2007-8#3)
the working temperature##2##3##(2005-4#1)(2006-6#1)
the working##112##2##(1990-11#1)(1990-9#1)(1991-1#1)(1991-3#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-4#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-4#1)(1997-8#1)(2005-11#2)(2005-4#1)(2006-6#1)(2007-11#2)(2007-5#2)(2007-8#5)(2008-10#45)(2008-11#3)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#1)(2008-6#2)(2008-9#2)(2009-2#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-9#2)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
the workings of##2##3##(2006-11#1)(2008-7#1)
the workload##4##2##(1995-2#1)(2007-7#1)(2008-10#1)(2012-12#1)
the workplace after##2##3##(1993-1#1)(2007-2#1)
the workplace and##5##3##(2007-1#1)(2007-2#1)(2008-11#1)(2008-3#1)(2012-12#1)
the workplace is##4##3##(1991-2#1)(2005-8#1)(2007-7#1)(2008-9#1)
the workplace of##2##3##(1994-6#1)(2008-10#1)
the workplace setting##2##3##(2008-11#1)(2008-12#1)
the workplace##72##2##(1991-12#2)(1991-2#1)(1991-5#1)(1992-2#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-2#2)(1994-4#1)(1994-6#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-2#2)(1997-4#1)(2005-8#1)(2006-1#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-2#2)(2007-7#2)(2007-9#2)(2008-10#2)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#4)(2008-9#4)(2009-4#1)(2010-12#1)(2010-8#2)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#3)(2013-7#1)
the works of##4##3##(2007-8#1)(2008-12#1)(2009-10#1)(2009-7#1)
the works##8##2##(2007-8#2)(2007-9#1)(2008-12#1)(2009-10#1)(2009-7#1)(2012-11#1)(2013-8#1)
the workshop model##2##3##(1992-5#2)
the workshop on##4##3##(1992-1#1)(2008-10#3)
the workshop##28##2##(1990-11#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-5#3)(1996-2#1)(1996-4#1)(2007-10#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-5#2)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#3)
the workshops##10##2##(2008-12#6)(2008-2#1)(2008-5#1)(2011-2#2)
the workup for##2##3##(2012-2#1)(2013-7#1)
the workup##5##2##(2008-11#1)(2008-3#1)(2012-12#1)(2012-2#1)(2013-7#1)
the world and are##2##4##(2009-5#1)(2010-5#1)
the world and it##2##4##(2005-11#1)(2007-11#1)
the world and the##2##4##(2007-11#1)(2010-10#1)
the world and##24##3##(2005-11#1)(2006-10#1)(2006-8#1)(2007-11#4)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2009-5#4)(2009-6#1)(2009-9#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-11#1)(2012-2#1)(2013-8#1)
the world are##12##3##(1991-11#1)(1993-4#1)(1996-8#1)(2005-10#1)(2007-9#1)(2008-11#1)(2008-6#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
the world as##7##3##(1992-2#1)(2007-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
the world at##3##3##(2005-7#1)(2008-2#1)(2012-3#1)
the world average##3##3##(2010-12#1)(2011-2#2)
the world by the year##2##5##(1994-9#2)
the world by##3##3##(1994-9#2)(2006-10#1)
the world due to##4##4##(2004-8#1)(2007-2#1)(2008-10#1)(2008-5#1)
the world fleet##2##3##(2008-11#2)
the world for the##2##4##(2006-10#2)
the world for##5##3##(1993-8#1)(2006-10#2)(2008-1#1)(2012-2#1)
the world has been##2##4##(2005-12#1)(2008-3#1)
the world has##5##3##(2005-12#1)(2007-8#1)(2008-3#2)(2008-9#1)
the world have##5##3##(1993-10#1)(2006-8#1)(2008-7#1)(2012-12#1)(2012-2#1)
the world in which##4##4##(2007-3#1)(2008-11#1)(2008-2#1)(2011-2#1)
the world in##18##3##(1996-7#1)(2006-9#1)(2007-12#1)(2007-3#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-1#1)
the world including##3##3##(2008-12#1)(2008-8#1)(2011-2#1)
the world is##5##3##(2008-12#1)(2008-8#1)(2009-10#1)(2011-2#1)(2013-1#1)
the world literature##8##3##(1992-2#1)(1994-10#1)(2006-10#2)(2007-8#1)(2008-6#1)(2011-2#1)(2012-2#1)
the world of the##2##4##(2006-12#1)(2008-2#1)
the world of work##2##4##(2008-12#1)(2013-1#1)
the world of##22##3##(1993-1#1)(1994-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-8#1)(2010-5#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
the world on the##2##4##(1991-7#1)(2008-1#1)
the world on##3##3##(1991-7#1)(2008-1#1)(2012-2#1)
the world over the past##2##5##(2007-2#1)(2008-10#1)
the world over##7##3##(1994-2#1)(2007-2#1)(2008-10#1)(2008-11#1)(2010-7#1)(2012-2#2)
the world population##8##3##(2005-3#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-2#1)(2011-2#1)
the world that##2##3##(1996-11#1)(2007-8#1)
the world to control##2##4##(2008-10#1)(2010-12#1)
the world to##12##3##(1991-11#1)(1997-2#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-9#1)(2012-1#1)(2012-12#1)
the world today##3##3##(2004-8#1)(2005-10#1)(2010-9#1)
the world were##2##3##(2007-2#1)(2008-10#1)
the world where##4##3##(1996-1#1)(2007-4#1)(2012-11#1)(2012-12#1)
the world with##3##3##(2007-7#1)(2008-7#1)(2010-4#1)
the world yet##2##3##(2008-5#1)(2013-1#1)
the world##546##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-9#1)(1991-11#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-2#3)(1992-5#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-4#1)(1993-8#1)(1994-1#2)(1994-10#1)(1994-2#3)(1994-3#1)(1994-9#6)(1995-3#1)(1995-4#1)(1995-5#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#3)(1997-4#2)(1997-6#2)(1997-8#3)(2004-11#1)(2004-8#2)(2005-10#3)(2005-11#3)(2005-12#1)(2005-3#1)(2005-6#1)(2005-7#8)(2005-8#1)(2006-10#16)(2006-12#5)(2006-2#7)(2006-4#5)(2006-5#1)(2006-7#2)(2006-8#2)(2006-9#3)(2007-1#1)(2007-10#5)(2007-11#9)(2007-12#7)(2007-2#12)(2007-3#5)(2007-4#6)(2007-5#2)(2007-7#7)(2007-8#14)(2007-9#10)(2008-1#17)(2008-10#44)(2008-11#19)(2008-12#13)(2008-2#5)(2008-3#5)(2008-4#2)(2008-5#13)(2008-6#5)(2008-7#9)(2008-8#6)(2008-9#6)(2009-10#6)(2009-12#1)(2009-2#4)(2009-3#1)(2009-4#1)(2009-5#5)(2009-6#8)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#5)(2010-11#1)(2010-12#12)(2010-2#6)(2010-3#1)(2010-4#5)(2010-5#6)(2010-6#1)(2010-7#3)(2010-8#6)(2010-9#3)(2011-1#16)(2011-11#1)(2011-12#2)(2011-2#28)(2012-1#4)(2012-11#2)(2012-12#9)(2012-2#14)(2012-3#8)(2012-6#1)(2013-1#15)(2013-7#3)(2013-8#12)
the world's biggest##2##3##(1995-12#1)(2008-1#1)
the world's largest##4##3##(2007-5#1)(2008-5#1)(2009-4#2)
the world's leading##2##3##(1995-2#1)(2011-2#1)
the world's most widely##2##4##(2008-12#1)(2013-8#1)
the world's most##8##3##(1994-3#1)(2005-8#1)(2008-10#1)(2008-12#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
the world's population##13##3##(1994-9#1)(2006-10#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-10#1)(2012-12#1)(2013-7#1)
the world's##56##2##(1990-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-3#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-12#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#5)(2006-12#1)(2006-4#1)(2006-5#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#2)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#4)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
the world)##4##2##(1990-6#1)(2011-3#2)(2013-1#1)
the world]##4##2##(1991-10#1)(1993-8#1)(2008-10#1)(2008-8#1)
the worldwide incidence of##2##4##(1993-12#1)(2009-10#1)
the worldwide population##2##3##(2008-10#1)(2009-9#1)
the worldwide prevalence of##2##4##(2006-9#1)(2008-3#1)
the worldwide##23##2##(1993-12#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#2)(2009-10#1)(2009-3#2)(2009-9#1)(2010-11#1)(2010-3#1)(2011-12#1)(2011-2#1)(2013-1#2)(2013-7#1)
the worm has##2##3##(2007-12#2)
the worm##7##2##(2006-10#1)(2007-12#4)(2007-6#1)(2010-2#1)
the worms##2##2##(1992-6#1)(1993-10#1)
the worse##2##2##(2008-10#1)(2009-4#1)
the worsening of the##2##4##(2007-11#1)(2013-1#1)
the worsening of##3##3##(2006-2#1)(2007-11#1)(2013-1#1)
the worsening##5##2##(2006-2#1)(2007-11#1)(2012-12#1)(2013-1#2)
the worst affected##2##3##(1993-3#1)(2008-1#1)
the worst case##2##3##(2007-7#1)(2008-3#1)
the worst images##2##3##(2007-11#2)
the worst of times##2##4##(1991-6#1)(2008-11#1)
the worst outcome##2##3##(2006-7#1)(2007-7#1)
the worst prognosis##3##3##(1991-10#1)(1995-8#1)(1996-9#1)
the worst##37##2##(1990-6#1)(1991-10#1)(1991-4#1)(1991-6#1)(1993-3#1)(1994-5#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-4#1)(2006-10#2)(2006-7#1)(2007-10#1)(2007-11#5)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-12#1)(2011-2#2)(2013-7#1)(2013-8#1)
the worst-case##4##2##(2006-10#1)(2007-11#1)(2008-1#1)(2008-3#1)
the worth of##2##3##(2012-2#2)
the worth##3##2##(2010-3#1)(2012-2#2)
the wound and##4##3##(1991-6#1)(2007-7#1)(2007-8#1)(2012-12#1)
the wound area##2##3##(2008-10#1)(2008-11#1)
the wound fluid##3##3##(2006-9#3)
the wound healing process##3##4##(2006-11#1)(2011-1#2)
the wound healing##7##3##(2006-11#1)(2007-12#1)(2008-11#1)(2009-12#1)(2011-1#2)(2012-12#1)
the wound repair##2##3##(1994-3#1)(2012-12#1)
the wound site##7##3##(2006-9#1)(2008-10#4)(2008-9#1)(2012-3#1)
the wound surface##3##3##(2007-8#1)(2010-12#2)
the wound was##5##3##(1991-6#1)(1996-8#1)(2008-11#1)(2011-1#2)
the wound with##2##3##(1996-8#1)(2011-1#1)
the wound##74##2##(1990-2#1)(1990-7#2)(1991-3#1)(1991-6#2)(1992-2#1)(1994-3#1)(1996-7#1)(1996-8#2)(1996-9#1)(2005-10#1)(2005-5#1)(2006-11#3)(2006-9#7)(2007-12#1)(2007-7#2)(2007-8#2)(2008-10#9)(2008-11#4)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#2)(2009-6#1)(2010-12#3)(2010-3#1)(2011-1#10)(2011-2#4)(2012-10#1)(2012-12#3)(2012-2#2)(2012-3#1)
the wound-healing process##3##3##(2004-9#1)(2008-7#1)(2012-12#1)
the wound-healing##5##2##(2004-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)
the wound-inducible##2##2##(2008-10#1)(2008-9#1)
the wounded##4##2##(1997-2#1)(2008-10#2)(2009-7#1)
the wounding of##2##3##(2008-10#1)(2008-7#1)
the wounding##4##2##(2006-9#1)(2008-10#1)(2008-7#2)
the wounds and##3##3##(2007-7#1)(2007-8#1)(2010-3#1)
the wounds of the##2##4##(2007-8#1)(2012-10#1)
the wounds of##5##3##(2007-8#1)(2008-10#2)(2010-6#1)(2012-10#1)
the wounds were covered with##2##5##(1992-10#1)(2008-5#1)
the wounds were##4##3##(1992-10#1)(2007-1#2)(2008-5#1)
the wounds##18##2##(1992-10#1)(1992-6#1)(2006-2#1)(2006-9#1)(2007-1#2)(2007-7#1)(2007-8#2)(2008-10#3)(2008-5#2)(2009-9#1)(2010-3#1)(2010-6#1)(2012-10#1)
the wr##2##2##(1996-12#2)
the wrapped phase gradient##2##4##(2008-2#1)(2008-3#1)
the wrapped phase##4##3##(2008-2#3)(2008-3#1)
the wrapped##7##2##(2008-2#5)(2008-3#1)(2010-7#1)
the wrapping##2##2##(2007-12#1)(2010-7#1)
the wrist and##5##3##(1996-3#1)(2007-7#1)(2008-12#1)(2012-1#1)(2012-3#1)
the wrist is##2##3##(2008-1#1)(2008-9#1)
the wrist to##2##3##(1991-1#1)(1996-3#1)
the wrist##37##2##(1991-1#1)(1996-3#5)(2006-3#6)(2006-4#2)(2007-7#4)(2008-1#4)(2008-12#1)(2008-7#1)(2008-9#4)(2009-5#1)(2011-2#2)(2012-1#3)(2012-2#1)(2012-3#2)
the write##4##2##(2008-1#1)(2008-2#1)(2008-3#2)
the writer##2##2##(1995-2#1)(2008-6#1)
the writing beams##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
the writing of this article##2##5##(1991-1#1)(2008-4#1)
the writing of this##3##4##(1991-1#1)(2008-4#1)(2011-2#1)
the writing of##6##3##(1991-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2011-2#1)(2013-7#1)
the writing power##2##3##(2008-3#2)
the writing##21##2##(1991-1#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#1)(2008-2#3)(2008-3#5)(2008-4#1)(2010-10#2)(2011-2#1)(2013-7#1)
the writings of##5##3##(2008-10#1)(2008-12#1)(2008-9#1)(2012-12#1)(2012-2#1)
the written##9##2##(1991-6#1)(1991-9#1)(1993-2#1)(2005-7#1)(2007-11#1)(2008-11#1)(2009-9#1)(2012-1#2)
the wrong##15##2##(1995-6#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-11#1)(2010-12#2)(2010-8#1)(2012-3#2)(2013-8#2)
the wt protein##2##3##(1990-3#1)(1990-5#1)
the wt##5##2##(1990-3#2)(1990-5#3)
the wv##2##2##(1996-12#2)
the x and##3##3##(2007-12#2)(2008-3#1)
the x rays##2##3##(2008-2#1)(2008-3#1)
the x##7##2##(2007-12#3)(2008-2#1)(2008-3#3)
the x-axis and##2##3##(2010-12#1)(2013-8#1)
the x-p##2##2##(2007-12#2)
the x-ray energy##2##3##(2008-3#2)
the x-ray radiographs##3##3##(2008-3#3)
the x-ray##21##2##(1990-2#1)(1991-6#1)(1995-1#1)(1996-5#1)(2007-11#1)(2008-2#3)(2008-3#8)(2010-1#2)(2012-1#1)(2012-12#1)(2012-2#1)
the xanthine oxidase##2##3##(1990-4#1)(2010-11#1)
the xanthine##3##2##(1990-4#1)(1994-9#1)(2010-11#1)
the xanthophyll##3##2##(2008-12#2)(2008-9#1)
the xenografted##2##2##(2008-11#2)
the xerogels##2##2##(1990-3#1)(2005-11#1)
the xhi1479 mutation##2##3##(1990-11#2)
the xlcaax-1 protein##2##3##(1991-9#2)
the xylE##2##2##(1990-5#1)(1993-11#1)
the xylanase##2##2##(1993-3#1)(2008-6#1)
the xylem vessels of##2##4##(2007-12#1)(2008-10#1)
the xylem vessels##5##3##(2007-12#2)(2008-10#3)
the xylem##15##2##(2007-12#2)(2008-10#10)(2008-11#3)
the xylose reductase##2##3##(2008-6#2)
the xylose##8##2##(2005-11#1)(2008-6#6)(2012-3#1)
the xylosyltransferase reaction##2##3##(1991-7#2)
the y##3##2##(2007-12#1)(2008-3#2)
the y-axis##3##2##(2010-12#2)(2013-8#1)
the yard##2##2##(2008-10#1)(2008-5#1)
the year 1976##2##3##(2006-8#2)
the year 1996##4##3##(2006-8#3)(2007-8#1)
the year 1998##2##3##(2005-9#1)(2007-8#1)
the year 2000 and beyond##3##5##(1993-2#1)(1997-3#1)(2008-1#1)
the year 2000 and##4##4##(1993-2#1)(1997-3#1)(2006-4#1)(2008-1#1)
the year 2000 targets##2##4##(1994-3#2)
the year 2000##53##3##(1990-2#1)(1991-5#1)(1991-9#1)(1992-3#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-3#3)(1994-9#3)(1995-6#1)(1996-11#1)(1996-2#1)(1997-2#3)(1997-3#3)(1997-6#4)(1997-7#1)(2006-10#3)(2006-4#1)(2006-8#3)(2007-12#1)(2007-3#1)(2007-8#2)(2008-1#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-5#2)(2011-1#3)(2012-2#1)(2013-1#1)
the year 2001##5##3##(2006-10#1)(2007-6#2)(2008-1#1)(2008-5#1)
the year 2002 and##2##4##(2006-2#1)(2008-12#1)
the year 2002##3##3##(2006-2#1)(2008-12#2)
the year 2003##2##3##(1990-12#1)(2011-2#1)
the year 2004##5##3##(1990-6#1)(1996-2#2)(2010-8#1)(2011-2#1)
the year 2005##4##3##(1996-2#1)(2007-10#1)(2008-11#1)(2009-6#1)
the year 2007##4##3##(2008-12#1)(2008-9#1)(2009-2#1)(2011-2#1)
the year 2008##2##3##(2010-3#1)(2010-9#1)
the year 2009##2##3##(2011-1#1)(2013-1#1)
the year 2010##9##3##(1990-12#2)(2007-2#1)(2007-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
the year 2015##3##3##(1994-9#1)(2008-8#2)
the year 2020##4##3##(2007-6#2)(2008-1#1)(2009-10#1)
the year 2035##2##3##(1994-7#1)(1994-9#1)
the year 2050##2##3##(2009-7#1)(2011-2#1)
the year after##3##3##(1994-4#1)(2013-1#2)
the year and the##4##4##(2006-10#1)(2007-2#1)(2008-5#2)
the year and##9##3##(1994-7#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-5#2)(2008-9#1)
the year before the##3##4##(1990-12#1)(1994-4#1)(2010-12#1)
the year following##5##3##(2004-11#1)(2007-12#1)(2008-10#1)(2008-6#1)(2010-3#1)
the year in review##2##4##(2007-3#1)(2008-12#1)
the year in which##2##4##(1994-3#1)(2011-2#1)
the year in##5##3##(1994-3#1)(2007-3#1)(2008-12#1)(2011-2#1)(2013-8#1)
the year of follow-up##2##4##(1990-5#1)(1995-2#1)
the year of study##2##4##(2008-12#1)(2009-7#1)
the year of the##4##4##(2008-10#2)(2008-7#1)(2013-8#1)
the year of##18##3##(1990-5#1)(1991-3#1)(1994-4#1)(1995-2#1)(2006-6#1)(2008-10#5)(2008-12#2)(2008-7#1)(2009-3#1)(2009-7#2)(2013-8#2)
the year offollow up##2##4##(2013-8#2)
the year preceding##2##3##(2011-2#1)(2013-8#1)
the year prior to##2##4##(1997-8#1)(2007-6#1)
the year under review##3##4##(2006-10#3)
the year was##2##3##(2007-6#1)(2011-2#1)
the year##269##2##(1990-12#5)(1990-2#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#2)(1992-3#2)(1993-2#2)(1993-3#3)(1993-5#1)(1993-6#1)(1993-9#1)(1994-3#5)(1994-4#3)(1994-6#1)(1994-7#2)(1994-9#5)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-2#4)(1997-2#3)(1997-3#4)(1997-4#2)(1997-6#4)(1997-7#1)(1997-8#1)(2004-11#1)(2004-2#3)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#10)(2006-2#1)(2006-4#4)(2006-5#1)(2006-6#1)(2006-8#10)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#3)(2007-3#7)(2007-4#1)(2007-5#2)(2007-6#7)(2007-8#5)(2008-1#4)(2008-10#18)(2008-11#4)(2008-12#9)(2008-2#1)(2008-3#5)(2008-5#15)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#3)(2010-12#2)(2010-3#2)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#10)(2011-2#14)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#9)
the year-end ethnic achievement gap##2##5##(2008-12#2)
the yearly##8##2##(1991-6#1)(1992-2#1)(1994-12#1)(1995-7#1)(1996-3#1)(1996-7#1)(2006-10#1)(2008-10#1)
the years 1976 and 1996##4##5##(2006-8#4)
the years 1980##2##3##(1997-1#1)(2013-1#1)
the years 1987-88##2##3##(1995-6#2)
the years 1989 and##3##4##(1992-8#1)(2007-11#1)(2008-1#1)
the years 1995##2##3##(1996-1#1)(2007-11#1)
the years 1996##2##3##(2007-10#1)(2008-11#1)
the years 1999##3##3##(2007-2#2)(2008-3#1)
the years 2000 and##3##4##(2006-8#1)(2007-5#1)(2012-12#1)
the years 2000##6##3##(2006-8#1)(2007-1#1)(2007-5#1)(2007-8#2)(2012-12#1)
the years 2000-2002##2##3##(2007-1#1)(2007-5#1)
the years 2002 and 2003##2##5##(2007-7#1)(2008-11#1)
the years ahead##5##3##(1992-2#1)(1994-3#1)(1995-1#1)(1996-9#1)(2007-8#1)
the years following##5##3##(1994-2#1)(2007-7#1)(2008-12#1)(2010-5#1)(2013-1#1)
the years from##2##3##(1993-3#1)(2011-2#1)
the years of##5##3##(1990-1#1)(1997-2#1)(2007-2#1)(2012-12#2)
the years to come##6##4##(1994-6#1)(1996-3#1)(1997-8#1)(2008-11#1)(2008-9#1)(2010-6#1)
the years to##10##3##(1994-6#1)(1996-3#1)(1997-8#1)(2006-3#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-6#1)(2010-8#1)
the years with##3##3##(2007-8#1)(2008-10#1)(2008-2#1)
the years##225##2##(1990-1#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#2)(1990-8#3)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#1)(1992-2#2)(1992-6#1)(1992-8#2)(1993-3#1)(1993-5#1)(1993-9#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-5#1)(1995-6#4)(1995-7#1)(1996-1#1)(1996-11#1)(1996-3#2)(1996-4#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#3)(2004-11#1)(2004-4#1)(2004-7#1)(2005-10#1)(2005-5#1)(2005-7#1)(2006-10#10)(2006-11#3)(2006-2#1)(2006-3#1)(2006-6#1)(2006-7#3)(2006-8#10)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#11)(2007-12#2)(2007-2#4)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#6)(2007-8#11)(2007-9#1)(2008-1#5)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#6)(2008-9#2)(2009-2#3)(2009-4#5)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#9)(2012-2#1)(2012-3#3)(2013-1#8)(2013-8#6)
the yeast Arxula adeninivorans##2##4##(1996-9#2)
the yeast Candida tropicalis##3##4##(1990-5#1)(1991-8#1)(1991-9#1)
the yeast Candida##8##3##(1990-5#1)(1991-8#1)(1991-9#1)(1996-9#2)(1997-2#1)(2008-10#2)
the yeast Coq3##2##3##(1996-7#2)
the yeast Kex2 protease##2##4##(1992-12#2)
the yeast Kluyveromyces lactis##2##4##(1995-4#1)(1996-7#1)
the yeast MAT alpha 2 transcriptional regulator##2##7##(1993-7#1)(1994-10#1)
the yeast MAT alpha 2##3##5##(1993-7#2)(1994-10#1)
the yeast S##5##3##(1994-10#2)(1994-9#1)(2006-12#1)(2009-12#1)
the yeast Saccharomyces cerevisiae and##2##5##(1991-12#1)(1994-9#1)
the yeast Saccharomyces cerevisiae has##2##5##(1990-7#1)(1991-7#1)
the yeast Saccharomyces cerevisiae##34##4##(1990-10#1)(1990-3#1)(1990-7#3)(1991-12#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-2#2)(1992-3#2)(1992-8#1)(1993-3#1)(1994-3#2)(1994-9#3)(1995-5#2)(1995-6#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#1)(2006-12#1)(2007-12#1)(2008-10#1)(2009-5#1)
the yeast Saccharomyces##35##3##(1990-10#1)(1990-3#1)(1990-7#3)(1991-12#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-2#2)(1992-3#2)(1992-8#1)(1993-3#1)(1994-3#2)(1994-9#3)(1995-5#2)(1995-6#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#1)(2006-12#1)(2007-12#1)(2008-10#1)(2009-5#1)
the yeast Schizosaccharomyces pombe##2##4##(1992-6#1)(1997-3#1)
the yeast and##5##3##(1990-11#1)(1991-9#1)(1994-8#1)(1996-5#1)(2008-6#1)
the yeast cell cycle##2##4##(1991-5#1)(2010-1#1)
the yeast cell##5##3##(1991-5#1)(1993-8#1)(1994-11#1)(2008-8#1)(2010-1#1)
the yeast enzyme##6##3##(1990-12#1)(1991-2#1)(1991-4#1)(1992-9#1)(1995-2#1)(1995-3#1)
the yeast expression vector##2##4##(1995-2#1)(2008-9#1)
the yeast genome##9##3##(1990-5#1)(1991-7#1)(1993-9#1)(1995-8#1)(1996-3#1)(2006-10#1)(2008-11#1)(2008-7#1)(2012-3#1)
the yeast invertase##2##3##(1994-5#1)(2008-7#1)
the yeast mitochondrial AspAT##2##4##(1992-12#2)
the yeast mitochondrial##5##3##(1992-12#2)(1995-6#1)(1996-9#1)(1997-1#1)
the yeast protein##3##3##(1991-1#1)(1993-11#1)(1996-9#1)
the yeast proteome##2##3##(2006-12#1)(2008-4#1)
the yeast strain##3##3##(2005-11#1)(2008-10#1)(2008-6#1)
the yeast temperature-sensitive##2##3##(1995-4#1)(1997-8#1)
the yeast tubulin##2##3##(1993-8#2)
the yeast two-hybrid system##4##4##(1996-5#2)(1997-1#1)(2008-8#1)
the yeast two-hybrid##5##3##(1995-6#1)(1996-5#2)(1997-1#1)(2008-8#1)
the yeast was##3##3##(1990-10#1)(2008-5#1)(2011-2#1)
the yeast##248##2##(1990-10#2)(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#3)(1990-7#4)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#6)(1991-8#3)(1991-9#3)(1992-11#4)(1992-12#5)(1992-2#5)(1992-3#2)(1992-6#3)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#3)(1993-3#3)(1993-5#2)(1993-6#1)(1993-7#2)(1993-8#4)(1993-9#3)(1994-10#4)(1994-11#2)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#9)(1995-2#4)(1995-3#1)(1995-4#5)(1995-5#3)(1995-6#5)(1995-8#5)(1996-2#5)(1996-3#2)(1996-5#4)(1996-6#1)(1996-7#4)(1996-8#1)(1996-9#8)(1997-1#3)(1997-2#5)(1997-3#4)(1997-4#5)(1997-5#1)(1997-6#6)(1997-7#5)(1997-8#3)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#4)(2006-3#2)(2007-12#1)(2008-10#17)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#1)(2009-12#2)(2009-5#2)(2010-1#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-3#2)
the yeast-phase##3##2##(2008-5#3)
the yeasts##5##2##(1993-3#1)(2007-12#1)(2007-9#1)(2008-10#1)(2012-3#1)
the yellow##9##2##(1990-5#1)(1997-1#1)(2005-12#1)(2007-1#1)(2007-10#1)(2007-12#3)(2010-5#1)
the yellow-naped amazon##2##3##(2009-9#2)
the yellow-ripe##2##2##(2008-10#2)
the yet##5##2##(1993-9#1)(1995-9#1)(2008-2#1)(2008-3#1)(2011-2#1)
the yield and##5##3##(1996-12#1)(2008-10#1)(2008-11#1)(2011-1#1)(2013-8#1)
the yield components##3##3##(2008-10#1)(2008-12#2)
the yield of DSB##3##4##(1995-2#3)
the yield of cross-linking##2##4##(2006-11#2)
the yield of enzymatic hydrolysis of short cattle tendons##2##9##(2008-5#2)
the yield of long transcripts in vitro##2##7##(1997-5#2)
the yield of long transcripts##3##5##(1997-5#3)
the yield of recombinant protein##3##5##(1990-3#1)(1993-2#1)(2011-2#1)
the yield of specific##2##4##(1992-8#1)(2008-2#1)
the yield of the##6##4##(1992-11#1)(1994-8#1)(1997-1#1)(2008-10#1)(2009-12#1)(2012-1#1)
the yield of##55##3##(1990-3#2)(1991-9#2)(1992-11#1)(1992-8#3)(1993-2#1)(1994-12#1)(1994-3#1)(1994-8#2)(1995-2#3)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-5#3)(2005-11#1)(2006-11#2)(2006-5#1)(2007-6#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-8#1)(2008-9#2)(2009-12#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-4#1)(2013-1#1)
the yield strength of##2##4##(2009-7#1)(2012-12#1)
the yield strength##3##3##(2009-7#1)(2012-12#1)(2012-2#1)
the yield was lower##2##4##(2008-11#1)(2011-1#1)
the yield was##4##3##(2008-11#2)(2011-1#1)(2011-2#1)
the yield##80##2##(1990-3#2)(1991-9#2)(1992-11#1)(1992-8#3)(1993-2#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#2)(1995-2#3)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-5#3)(2005-11#1)(2006-11#2)(2006-5#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-12#3)(2008-2#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-7#1)(2010-4#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#1)(2013-8#1)
the yielding period##2##3##(2008-6#2)
the yields of##10##3##(1990-8#1)(1994-1#1)(1996-12#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2013-1#1)
the yields were##3##3##(2007-11#2)(2008-10#1)
the yields##16##2##(1990-8#1)(1994-1#1)(1996-12#1)(1997-4#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#2)(2012-1#1)(2013-1#1)
the yolk sac of##2##4##(2008-5#1)(2008-9#1)
the yolk sac##9##3##(1995-1#3)(1997-4#1)(2007-12#1)(2008-5#1)(2008-9#1)(2010-1#1)(2012-2#1)
the yolk##13##2##(1994-2#1)(1995-1#3)(1997-4#1)(2007-12#2)(2008-5#2)(2008-9#1)(2010-1#1)(2010-5#1)(2012-2#1)
the yolk-sac membrane and body skin##4##6##(2008-5#4)
the yolk-sac membrane in##2##4##(2008-5#2)
the yolk-sac membrane##7##3##(2008-5#7)
the young adult##8##3##(1990-5#1)(1991-11#1)(1995-3#1)(1996-8#1)(2007-1#1)(2010-4#1)(2010-7#1)(2011-12#1)
the young adults##2##3##(1994-5#1)(2007-8#1)
the young age group##2##4##(2008-7#1)(2012-2#1)
the young and adult##3##4##(1991-11#1)(1997-6#1)(2011-2#1)
the young and middle-aged##2##4##(1996-4#1)(2005-1#1)
the young and old rats##2##5##(1990-3#1)(1991-12#1)
the young and old##4##4##(1990-3#1)(1991-12#1)(1997-3#1)(2008-6#1)
the young and the old##2##5##(1996-9#1)(2013-8#1)
the young and##13##3##(1990-3#1)(1991-11#1)(1991-12#1)(1996-4#1)(1996-9#1)(1997-3#1)(1997-6#1)(2005-1#1)(2005-3#1)(2008-6#1)(2010-4#1)(2011-2#1)(2013-8#1)
the young animals##3##3##(1990-3#1)(1993-2#1)(1995-6#1)
the young children##2##3##(1994-12#1)(2008-9#1)
the young group##4##3##(1991-12#1)(1992-10#1)(1996-8#1)(2007-9#1)
the young of##2##3##(1993-2#1)(2012-1#1)
the young patients and##2##4##(1992-6#2)
the young patients##5##3##(1992-6#4)(2007-7#1)
the young people##4##3##(1995-8#2)(2007-3#1)(2009-2#1)
the young population##2##3##(1992-12#1)(2007-9#1)
the young rats##2##3##(1990-3#1)(1993-4#1)
the young subjects##2##3##(1992-12#1)(2006-9#1)
the young woman##2##3##(1996-6#1)(1997-1#1)
the young##117##2##(1990-12#1)(1990-3#3)(1990-5#2)(1990-7#1)(1991-11#3)(1991-12#2)(1991-5#1)(1991-6#1)(1992-10#1)(1992-12#3)(1992-3#2)(1992-5#1)(1992-6#4)(1993-2#3)(1993-4#1)(1994-12#1)(1994-5#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#2)(1996-8#2)(1996-9#4)(1997-1#1)(1997-3#1)(1997-6#2)(1997-8#1)(2005-1#1)(2005-3#1)(2006-10#3)(2006-12#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#1)(2007-9#7)(2008-1#2)(2008-10#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#3)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#3)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#3)(2013-7#1)(2013-8#1)
the young-adult##2##2##(1997-1#1)(2012-12#1)
the younger age groups##5##4##(1991-2#1)(1996-4#1)(2009-4#1)(2012-12#1)(2013-1#1)
the younger age##9##3##(1991-2#1)(1992-4#1)(1996-4#1)(2006-10#1)(2007-3#1)(2008-9#1)(2009-4#1)(2012-12#1)(2013-1#1)
the younger and older age groups##2##6##(2011-2#1)(2013-1#1)
the younger and older##3##4##(2006-10#1)(2011-2#1)(2013-1#1)
the younger and##6##3##(1992-9#3)(2006-10#1)(2011-2#1)(2013-1#1)
the younger children##3##3##(2007-7#1)(2008-10#1)(2010-3#1)
the younger generation##2##3##(1995-11#1)(2008-5#1)
the younger group of##2##4##(2006-10#2)
the younger group##8##3##(1994-4#1)(2006-10#2)(2006-8#1)(2008-3#1)(2008-6#1)(2010-2#1)(2012-12#1)
the younger ones##2##3##(2012-1#1)(2012-2#1)
the younger patients##8##3##(1993-3#1)(1994-6#4)(1995-2#1)(2006-8#1)(2007-7#1)
the younger women##2##3##(1996-6#1)(2006-7#1)
the younger##64##2##(1990-5#1)(1991-1#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-4#1)(1992-8#1)(1992-9#3)(1993-3#1)(1994-4#1)(1994-6#4)(1995-11#1)(1995-12#1)(1995-2#1)(1996-4#1)(1996-6#1)(1997-5#1)(2006-10#5)(2006-12#1)(2006-7#1)(2006-8#2)(2007-3#1)(2007-7#4)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-2#2)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#2)
the youngest leaves##2##3##(2008-10#2)
the youngest##29##2##(1992-2#1)(1992-6#1)(1995-4#1)(1996-2#1)(2006-10#2)(2006-8#3)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-9#1)(2011-11#1)(2012-1#1)(2012-2#1)(2013-8#1)
the youngsters##2##2##(1993-2#1)(2005-3#1)
the youth centre##2##3##(2007-3#2)
the youth survey##2##3##(2012-3#2)
the youth themselves##2##3##(1990-5#1)(2008-9#1)
the youth who##2##3##(2007-7#1)(2008-2#1)
the youth##11##2##(1990-5#1)(2007-3#3)(2007-7#1)(2008-2#1)(2008-9#1)(2009-8#1)(2012-2#1)(2012-3#2)
the youths##2##2##(2008-12#1)(2009-7#1)
the yttrium##2##2##(1996-2#1)(2005-11#1)
the z axis##4##3##(2008-1#1)(2008-3#3)
the z##6##2##(2007-12#1)(2008-1#2)(2008-3#3)
the zNosetrade mark##3##3##(2008-10#3)
the zebra##3##2##(2007-2#1)(2010-1#1)(2013-8#1)
the zebrafish genome##2##3##(1991-9#1)(2008-8#1)
the zebrafish homologue of##2##4##(1991-9#1)(2011-1#1)
the zebrafish##19##2##(1991-9#2)(1993-12#1)(1997-2#1)(1997-4#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-7#4)(2008-8#2)(2011-1#1)(2012-11#1)(2012-12#2)(2012-3#1)
the zenith##7##2##(1990-7#1)(2008-2#3)(2008-3#3)
the zero order of the##3##5##(2008-2#3)
the zero order of##4##4##(2008-2#3)(2008-3#1)
the zero order##7##3##(2008-2#4)(2008-3#3)
the zero point##2##3##(2008-2#2)
the zero term##2##3##(2008-10#2)
the zero velocity##2##3##(2008-3#1)(2008-8#1)
the zero##27##2##(1990-10#1)(1991-5#1)(1994-8#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#5)(2008-8#1)(2008-9#1)
the zero-birefringence polymer##2##3##(2008-3#2)
the zero-crossing##3##2##(2008-10#3)
the zero-dispersion wavelength of##3##4##(2007-11#1)(2007-12#2)
the zero-dispersion wavelength##6##3##(2007-11#2)(2007-12#4)
the zero-dispersion##7##2##(2007-11#2)(2007-12#5)
the zero-order power##2##3##(2006-4#1)(2008-3#1)
the zero-order##12##2##(2006-4#1)(2007-12#1)(2008-2#4)(2008-3#6)
the zero-time##3##2##(1990-10#2)(2007-2#1)
the zeros##2##2##(2007-12#1)(2008-2#1)
the zeroth##3##2##(2008-2#2)(2008-3#1)
the zeta -potentials of##2##4##(2005-11#2)
the zeta potential obtained from##2##5##(2005-11#2)
the zeta potential of##3##4##(2005-11#1)(2008-5#1)(2013-8#1)
the zeta potential##12##3##(2005-11#9)(2008-5#2)(2013-8#1)
the zeta##18##2##(1993-6#1)(1994-12#1)(1995-6#1)(2005-11#12)(2008-5#2)(2013-8#1)
the zeta-potential of the##3##4##(1992-7#2)(2009-11#1)
the zeta-potential##4##2##(1992-7#2)(1997-6#1)(2009-11#1)
the zeta-potentials##2##2##(2008-6#2)
the zigzag##5##2##(2008-10#1)(2008-3#3)(2012-2#1)
the zinc and##2##3##(1991-5#1)(1993-3#1)
the zinc atom##2##3##(1991-5#1)(1997-7#1)
the zinc deficiency in##2##4##(2008-10#1)(2008-11#1)
the zinc extraction##3##3##(2008-10#3)
the zinc finger domain of the eukaryotic transcription factor Sp1##2##10##(1991-2#2)
the zinc finger domain##3##4##(1991-2#2)(2012-2#1)
the zinc finger protein##2##4##(1991-4#1)(2007-12#1)
the zinc finger region of the##2##6##(1990-11#1)(1994-3#1)
the zinc finger region of##3##5##(1990-11#1)(1991-10#1)(1994-3#1)
the zinc finger region##5##4##(1990-11#2)(1991-10#1)(1994-3#2)
the zinc finger##14##3##(1990-11#2)(1991-10#1)(1991-2#3)(1991-4#1)(1992-6#1)(1994-3#2)(2007-12#2)(2008-8#1)(2012-2#1)
the zinc hydroxide##3##3##(1990-8#3)
the zinc phosphate##2##3##(2004-9#2)
the zinc polycarboxylate##2##3##(2004-9#2)
the zinc##60##2##(1990-11#2)(1990-8#5)(1991-10#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#3)(1992-6#1)(1993-3#2)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-11#1)(1996-2#1)(1996-5#1)(1997-7#1)(2004-11#2)(2004-9#4)(2005-4#1)(2007-12#2)(2008-10#12)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-10#1)(2012-12#1)(2012-2#1)(2013-7#1)
the zinc-binding motif##2##3##(2008-1#2)
the zinc-binding##3##2##(2008-1#2)(2013-7#1)
the zinc-finger domain##2##3##(1995-2#2)
the zinc-finger##3##2##(1991-9#1)(1995-2#2)
the zip code##2##3##(2010-2#1)(2011-2#1)
the zircon##2##2##(2008-10#2)
the zirconia##2##2##(2008-10#1)(2009-8#1)
the zona fasciculata and##2##4##(1990-5#1)(1995-10#1)
the zona glomerulosa##4##3##(1990-5#1)(1994-2#1)(1995-10#1)(2008-4#1)
the zona incerta of the##2##5##(1991-5#1)(2009-2#1)
the zona incerta##6##3##(1991-5#2)(1995-5#1)(1996-6#1)(2009-2#2)
the zona pellucida##2##3##(1995-5#1)(2008-4#1)
the zona##17##2##(1990-5#3)(1991-5#2)(1994-2#1)(1995-10#2)(1995-12#1)(1995-5#2)(1996-6#1)(2008-4#2)(2008-8#1)(2009-2#2)
the zonal##3##2##(2008-10#1)(2008-2#1)(2008-4#1)
the zone of injury##2##4##(2008-9#2)
the zone of##14##3##(1992-12#1)(1993-12#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#3)(2010-12#1)
the zone plates##2##3##(2008-2#1)(2008-3#1)
the zone##28##2##(1990-6#1)(1991-3#1)(1992-12#1)(1993-12#1)(1994-12#1)(1996-2#1)(1996-4#1)(2007-12#1)(2007-5#1)(2008-10#7)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#3)(2010-12#2)(2011-2#1)(2012-12#1)
the zoo##4##2##(1991-11#1)(1996-12#2)(2007-2#1)
the zoological##2##2##(2007-6#1)(2011-1#1)
the zoonotic##2##2##(2010-10#1)(2013-1#1)
the zooplankton##2##2##(2007-3#1)(2008-5#1)
the zwitterionic detergent##2##3##(1990-5#1)(1994-9#1)
the zwitterionic##8##2##(1990-5#1)(1991-5#1)(1992-12#1)(1992-9#1)(1993-11#1)(1994-9#1)(2007-11#1)(2008-10#1)
the zygomatic arch##3##3##(2007-12#2)(2008-3#1)
the zygomatic##6##2##(2006-12#1)(2007-12#2)(2008-3#1)(2010-12#2)
the zygotic expression##2##3##(1996-7#2)
the zymogen##8##2##(1992-4#1)(1995-2#1)(1996-1#2)(1997-4#2)(2006-10#1)(2012-1#1)
the zymotic fluid##2##3##(2008-8#2)
the {010}##2##2##(2008-7#2)
the {110}##2##2##(2008-7#2)
the {Ru(NO)}(6)##3##2##(2008-5#3)
the ɛ subunit##2##3##(2011-1#2)
the α2A domain of integrin##2##5##(2011-1#2)
the β(2)-AR##2##2##(2009-9#2)
the β(2)-adrenergic receptor##3##3##(2009-9#1)(2012-2#2)
the β-cell##4##2##(2010-10#1)(2010-11#2)(2012-12#1)
the β-cells##2##2##(2010-11#2)
the β-sheet##2##2##(2012-2#2)
the δ(13)C##2##2##(2012-2#2)
the χ(2) rates##2##3##(2011-1#2)
the ϕTMA##3##2##(2011-12#3)
the##607989##1##(1990-1#229)(1990-10#1386)(1990-11#2371)(1990-12#2912)(1990-2#2370)(1990-3#2007)(1990-4#1478)(1990-5#2798)(1990-6#1272)(1990-7#2147)(1990-8#2122)(1990-9#1476)(1991-1#1326)(1991-10#1229)(1991-11#1555)(1991-12#2773)(1991-2#2891)(1991-3#2056)(1991-4#1482)(1991-5#2369)(1991-6#1762)(1991-7#1801)(1991-8#1790)(1991-9#2425)(1992-1#1487)(1992-10#864)(1992-11#1752)(1992-12#2546)(1992-2#1956)(1992-3#2751)(1992-4#1123)(1992-5#1428)(1992-6#2475)(1992-7#1326)(1992-8#2281)(1992-9#2226)(1993-1#921)(1993-10#572)(1993-11#2268)(1993-12#3149)(1993-2#2040)(1993-3#2767)(1993-4#962)(1993-5#1070)(1993-6#2287)(1993-7#900)(1993-8#1783)(1993-9#2058)(1994-1#568)(1994-10#852)(1994-11#2546)(1994-12#3587)(1994-2#2937)(1994-3#3329)(1994-4#352)(1994-5#2154)(1994-6#2276)(1994-7#429)(1994-8#3094)(1994-9#3092)(1995-1#2435)(1995-10#1092)(1995-11#2371)(1995-12#3051)(1995-2#3034)(1995-3#3174)(1995-4#820)(1995-5#2443)(1995-6#2805)(1995-7#768)(1995-8#2708)(1995-9#857)(1996-1#1792)(1996-10#1133)(1996-11#1721)(1996-12#3143)(1996-2#3017)(1996-3#2360)(1996-4#1541)(1996-5#3295)(1996-6#1747)(1996-7#1712)(1996-8#1962)(1996-9#1823)(1997-1#2431)(1997-2#3756)(1997-3#2664)(1997-4#3271)(1997-5#1822)(1997-6#2706)(1997-7#2979)(1997-8#2745)(1997-9#100)(2003-11#72)(2004-1#201)(2004-10#297)(2004-11#723)(2004-12#539)(2004-2#297)(2004-3#241)(2004-4#432)(2004-5#13)(2004-7#75)(2004-8#95)(2004-9#729)(2005-1#312)(2005-10#1585)(2005-11#5815)(2005-12#837)(2005-2#42)(2005-3#159)(2005-4#690)(2005-5#400)(2005-6#198)(2005-7#1472)(2005-8#1817)(2005-9#587)(2006-1#546)(2006-10#9604)(2006-11#1874)(2006-12#4145)(2006-2#1916)(2006-3#1122)(2006-4#1677)(2006-5#2217)(2006-6#2346)(2006-7#1583)(2006-8#3390)(2006-9#1385)(2007-1#2034)(2007-10#3118)(2007-11#11027)(2007-12#14854)(2007-2#2820)(2007-3#2081)(2007-4#2460)(2007-5#2203)(2007-6#1495)(2007-7#5432)(2007-8#8926)(2007-9#3541)(2008-1#6714)(2008-10#59570)(2008-11#13263)(2008-12#4748)(2008-2#17446)(2008-3#21249)(2008-4#9445)(2008-5#14921)(2008-6#5039)(2008-7#12154)(2008-8#9302)(2008-9#7795)(2009-1#381)(2009-10#2460)(2009-11#1312)(2009-12#1651)(2009-2#2145)(2009-3#2032)(2009-4#2691)(2009-5#2242)(2009-6#1832)(2009-7#1947)(2009-8#2905)(2009-9#1755)(2010-1#963)(2010-10#1393)(2010-11#1562)(2010-12#4991)(2010-2#2887)(2010-3#1823)(2010-4#2991)(2010-5#2535)(2010-6#1364)(2010-7#1757)(2010-8#3296)(2010-9#1564)(2011-1#7357)(2011-10#67)(2011-11#89)(2011-12#1579)(2011-2#14369)(2011-3#546)(2011-4#23)(2011-6#1)(2011-7#143)(2011-8#6)(2011-9#21)(2012-1#4155)(2012-10#24)(2012-11#1321)(2012-12#8138)(2012-2#9613)(2012-3#5952)(2012-4#29)(2012-5#90)(2012-6#57)(2012-7#72)(2012-8#40)(2012-9#31)(2013-1#13424)(2013-2#13)(2013-3#11)(2013-4#4)(2013-7#2974)(2013-8#8778)
the(15)N##2##1##(2008-11#2)
the- 10 proximal subsite##2##4##(1996-11#2)
the- 10 proximal##3##3##(1996-11#3)
the-##4##1##(1996-11#4)
the[Formula##2##1##(2008-2#2)
theaccuracy##2##1##(2008-2#2)
theadhesion##2##1##(2008-11#2)
theaflavin##2##1##(2008-11#2)
theanine##6##1##(2008-11#6)
theater and from##2##3##(2007-12#1)(2008-2#1)
theater##17##1##(1996-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-2#2)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
theatre for##3##2##(2006-6#1)(2007-4#1)(2007-8#1)
theatre in the##2##3##(2008-10#1)(2012-3#1)
theatre nurses##2##2##(1996-2#2)
theatre time##3##2##(1996-1#1)(2012-10#1)(2012-2#1)
theatre##40##1##(1991-7#1)(1992-3#1)(1995-4#1)(1996-1#5)(1996-2#2)(1996-9#1)(2006-10#2)(2006-6#3)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#4)(2008-2#1)(2009-10#1)(2010-7#1)(2011-2#1)(2012-10#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-8#1)
theatres##3##1##(2006-10#1)(2006-6#1)(2008-11#1)
thebasolateral##2##1##(2008-11#2)
theca and granulosa##2##3##(1995-8#1)(2008-12#1)
theca cells of##2##3##(2008-8#1)(2008-9#1)
theca cells##3##2##(1990-8#1)(2008-8#1)(2008-9#1)
theca interna and##2##3##(1995-12#1)(1995-8#1)
theca interna##3##2##(1995-12#2)(1995-8#1)
theca layers were##2##3##(2008-12#2)
theca##13##1##(1990-8#1)(1995-12#2)(1995-8#2)(2008-12#4)(2008-8#1)(2008-9#1)(2012-12#2)
theca-interstitial cells##3##2##(2008-5#2)(2010-10#1)
theca-interstitial##6##1##(2008-5#4)(2010-10#2)
thecal sac##3##2##(2006-8#2)(2012-12#1)
thecal##6##1##(1992-4#1)(1993-10#2)(2006-8#2)(2012-12#1)
thecontrol##2##1##(2008-11#1)(2011-1#1)
theculture##2##1##(2008-11#2)
thedevelopment of##2##2##(2008-11#2)
thedevice##2##1##(2008-11#2)
theeffect of the##2##3##(2008-11#2)
theeffect of##3##2##(2008-11#3)
theexperimental##2##1##(2008-11#1)(2008-2#1)
theexperiments##2##1##(2008-2#2)
thefrequency##2##1##(2013-8#2)
theft by##2##2##(1991-2#1)(1991-7#1)
theft##16##1##(1991-2#3)(1991-3#2)(1991-7#1)(1993-2#1)(1994-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(2008-3#1)(2008-9#2)(2012-1#1)(2012-12#1)
thefts##2##1##(1991-3#1)(1996-12#1)
thegdhA##3##1##(2008-8#3)
theileri##2##1##(2012-2#2)
thein vitro nucleosome reconstitution##2##4##(2008-8#2)
thein vitro##5##2##(2008-7#1)(2008-8#4)
theincubation##2##1##(2008-11#2)
theinitial##2##1##(2008-11#2)
their &quot##6##2##(1990-4#1)(1992-3#1)(2006-8#1)(2008-3#1)(2008-8#1)(2012-3#1)
their 3' termini##3##3##(1995-1#1)(2008-4#1)(2008-8#1)
their 3'##6##2##(1994-8#1)(1995-1#1)(1996-5#1)(2008-10#1)(2008-4#1)(2008-8#1)
their 3'-untranslated##2##2##(1994-5#1)(2009-3#1)
their 3-O-acetyl##2##2##(1996-9#2)
their 3-year##2##2##(1996-3#1)(2006-5#1)
their 3D structures##2##3##(2006-12#1)(2013-1#1)
their 401(k)##2##2##(2011-2#2)
their 5##3##2##(1994-6#1)(1995-3#1)(2011-2#1)
their 5' ends##3##3##(1994-12#1)(2008-10#1)(2008-4#1)
their 5' termini##3##3##(1995-1#1)(2008-4#1)(2008-8#1)
their 5'##10##2##(1992-9#1)(1993-8#1)(1994-12#1)(1995-1#1)(1996-2#1)(1997-6#1)(2008-10#1)(2008-4#2)(2008-8#1)
their 95% confidence intervals (CIs)##2##5##(2011-2#1)(2013-8#1)
their 95% confidence intervals##3##4##(2008-11#1)(2011-2#1)(2013-8#1)
their BAL fluid##2##3##(2008-10#2)
their BAL##3##2##(2008-10#3)
their BMI##2##2##(2006-9#1)(2008-3#1)
their C termini##2##3##(1990-1#1)(1997-4#1)
their C##5##2##(1990-1#1)(1990-6#1)(1997-4#1)(2008-2#1)(2013-8#1)
their C-terminal##4##2##(1993-11#1)(1993-8#1)(1994-5#1)(2010-7#1)
their C-termini##3##2##(1991-8#1)(1994-12#1)(2009-7#1)
their C-terminus##2##2##(1994-11#1)(2008-9#1)
their CD##2##2##(1990-4#1)(1997-6#1)
their CD4##3##2##(2006-4#2)(2012-2#1)
their CPs' leadership##2##3##(2009-5#2)
their Ca2+##5##2##(1992-11#1)(1993-7#1)(1995-11#1)(1995-2#1)(2009-3#1)
their Cu(II)##2##2##(2008-10#1)(2008-5#1)
their DNA and##2##3##(1994-11#1)(2008-1#1)
their DNA binding##4##3##(1991-12#1)(1992-11#1)(1995-8#1)(2013-1#1)
their DNA##19##2##(1990-11#1)(1991-12#1)(1992-11#1)(1992-2#1)(1994-11#1)(1994-8#1)(1995-5#1)(1995-8#1)(1997-7#1)(2005-7#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-12#2)(2013-1#2)
their ED##4##2##(2006-7#4)
their F1 hybrids##2##3##(2008-5#2)
their G-protein##2##2##(2008-7#1)(2009-8#1)
their GPs##2##2##(1997-4#1)(2011-1#1)
their HIV status to##2##4##(2007-12#1)(2010-4#1)
their HIV status##9##3##(1996-5#1)(2004-9#2)(2007-12#1)(2007-7#1)(2010-4#3)(2011-2#1)
their HIV##14##2##(1994-9#1)(1996-5#1)(1996-6#1)(2004-9#2)(2007-12#1)(2007-7#1)(2010-4#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
their HPLC##2##2##(1995-8#1)(2008-10#1)
their ICU stay##2##3##(2011-2#2)
their ICU##3##2##(2007-11#1)(2011-2#2)
their IR##3##2##(2007-1#1)(2007-11#1)(2008-5#1)
their Ki values for inhibition##2##5##(1991-9#1)(1992-6#1)
their Ki values##3##3##(1991-9#1)(1992-6#1)(1997-2#1)
their Medicare##5##2##(1996-3#2)(1997-2#1)(2007-2#1)(2010-2#1)
their MetS status##3##3##(2008-3#3)
their N-hydroxy##3##2##(1992-6#3)
their N-terminal##2##2##(1991-8#1)(1991-9#1)
their N-termini##2##2##(1993-11#1)(2009-5#1)
their PE model##2##3##(2006-5#2)
their PHC##3##2##(2013-1#3)
their PLC##2##2##(2007-11#2)
their Perspective##9##2##(2007-8#4)(2007-9#5)
their QOL##2##2##(2007-8#1)(2011-2#1)
their RNA##4##2##(1995-8#1)(2007-12#1)(2008-2#1)(2012-3#1)
their UV##3##2##(2008-10#1)(2008-4#1)(2010-4#1)
their White##2##2##(2007-12#1)(2011-2#1)
their Young's Modulus##2##3##(2008-8#1)(2008-9#1)
their abdomens##2##2##(1997-2#1)(2008-4#1)
their aberrant##2##2##(2008-4#1)(2012-1#1)
their abilities in##2##3##(2008-2#2)
their abilities to activate##3##4##(1990-12#1)(1991-8#1)(2009-12#1)
their abilities to bind##4##4##(1991-4#1)(1994-9#1)(1996-5#1)(1997-4#1)
their abilities to inhibit##5##4##(1993-4#1)(1993-8#1)(1994-3#1)(1994-9#1)(2008-10#1)
their abilities to stimulate##2##4##(1992-10#1)(2009-12#1)
their abilities to##26##3##(1990-12#1)(1990-3#1)(1991-4#1)(1991-8#1)(1992-10#1)(1993-4#1)(1993-8#1)(1994-3#1)(1994-9#2)(1995-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-7#2)(2008-10#3)(2008-8#1)(2008-9#1)(2009-12#2)(2009-8#1)(2012-12#1)
their abilities##30##2##(1990-12#1)(1990-3#1)(1991-4#1)(1991-8#1)(1992-10#1)(1993-4#1)(1993-8#1)(1994-3#1)(1994-9#2)(1995-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-7#2)(2008-10#5)(2008-2#2)(2008-8#1)(2008-9#1)(2009-12#2)(2009-8#1)(2012-12#1)
their ability for##2##3##(2004-11#1)(2008-7#1)
their ability to act as##4##5##(1990-11#1)(1995-3#1)(2008-10#1)(2008-5#1)
their ability to act##5##4##(1990-11#1)(1995-3#1)(2008-10#2)(2008-5#1)
their ability to activate a##2##5##(1991-8#1)(1996-3#1)
their ability to activate the##2##5##(1992-6#1)(2010-6#1)
their ability to activate##5##4##(1991-8#1)(1992-6#1)(1996-3#1)(1997-6#1)(2010-6#1)
their ability to antagonize##2##4##(1991-4#1)(2008-10#1)
their ability to assess##3##4##(2006-11#1)(2010-12#1)(2012-2#1)
their ability to be##5##4##(1992-12#1)(1994-5#1)(1995-1#1)(2008-10#1)(2008-9#1)
their ability to bind to##9##5##(1990-2#1)(1991-4#1)(1992-9#1)(1993-9#1)(1994-6#1)(1996-4#1)(1997-4#1)(2007-11#1)(2010-7#1)
their ability to bind##14##4##(1990-2#1)(1991-3#1)(1991-4#1)(1992-9#1)(1993-9#2)(1994-5#1)(1994-6#1)(1996-4#1)(1997-4#1)(2007-11#1)(2008-9#1)(2010-7#1)(2012-2#1)
their ability to block the##2##5##(1995-11#1)(1995-6#1)
their ability to block##3##4##(1995-11#1)(1995-6#1)(2005-7#1)
their ability to carry out##2##5##(1990-2#1)(1994-2#1)
their ability to cause##3##4##(1997-6#1)(2008-10#2)
their ability to compete with##2##5##(1993-3#1)(2013-7#1)
their ability to confer##2##4##(1994-11#1)(1995-1#1)
their ability to cope with##2##5##(2007-6#1)(2010-11#1)
their ability to detect a##3##5##(2008-3#1)(2013-1#2)
their ability to detect##10##4##(1992-7#1)(1997-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-2#2)(2013-1#2)
their ability to discriminate##2##4##(1993-9#1)(1995-1#1)
their ability to disrupt the##3##5##(1994-11#1)(2004-2#1)(2008-1#1)
their ability to elicit##2##4##(1990-12#1)(2005-8#1)
their ability to enhance##4##4##(1992-1#1)(1997-2#1)(2008-10#1)(2008-4#1)
their ability to extract information##2##5##(2008-2#1)(2009-8#1)
their ability to extract##3##4##(2008-10#1)(2008-2#1)(2009-8#1)
their ability to form##3##4##(1992-2#1)(2008-10#1)(2010-12#1)
their ability to function in##2##5##(1990-4#1)(1993-5#1)
their ability to functionally##2##4##(1993-11#1)(2012-3#1)
their ability to generate##4##4##(1990-10#1)(1996-9#1)(2006-12#1)(2011-2#1)
their ability to grow in##3##5##(1996-8#1)(2008-10#1)(2010-4#1)
their ability to grow##4##4##(1996-8#1)(2008-10#2)(2010-4#1)
their ability to increase the##2##5##(2009-4#1)(2013-8#1)
their ability to induce##12##4##(1990-11#1)(1990-5#1)(1991-8#1)(1995-6#1)(1996-8#1)(1997-4#1)(2007-11#1)(2008-10#4)(2008-4#1)
their ability to infect##4##4##(1990-4#1)(2008-10#2)(2010-10#1)
their ability to influence##3##4##(1995-12#1)(2009-3#1)(2013-7#1)
their ability to inhibit the growth##2##6##(2008-10#1)(2008-5#1)
their ability to inhibit the##8##5##(1992-5#1)(1995-11#1)(1995-3#1)(1997-1#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#1)
their ability to inhibit##29##4##(1990-2#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-11#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#4)(1995-11#1)(1995-3#2)(1997-1#2)(2005-7#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)
their ability to interact with##3##5##(1992-2#1)(1997-6#1)(2010-5#1)
their ability to lyse##2##4##(1994-2#1)(2013-1#1)
their ability to modulate##3##4##(1994-11#1)(1995-7#1)(2008-3#1)
their ability to move##2##4##(2007-12#1)(2008-10#1)
their ability to penetrate##2##4##(1997-1#1)(2009-10#1)
their ability to predict##4##4##(2006-10#1)(2006-2#1)(2009-4#1)(2010-1#1)
their ability to prevent##2##4##(1992-10#1)(1994-8#1)
their ability to produce##10##4##(1991-12#1)(1991-2#1)(1993-6#1)(2005-11#1)(2007-12#1)(2008-10#3)(2010-12#1)(2011-2#1)
their ability to promote##3##4##(1994-9#1)(1995-11#1)(1995-8#1)
their ability to provide##3##4##(1997-8#1)(2006-11#1)(2008-6#1)
their ability to recognize a##2##5##(1990-10#1)(1992-1#1)
their ability to reduce##5##4##(1991-2#1)(2005-11#1)(2008-5#1)(2008-7#1)(2010-12#1)
their ability to regulate##4##4##(2005-11#1)(2006-12#1)(2008-4#1)(2012-12#1)
their ability to respond to##4##5##(1991-10#1)(1992-11#1)(1995-1#1)(1997-3#1)
their ability to selectively##3##4##(2009-2#1)(2012-2#1)(2013-1#1)
their ability to serve as##2##5##(1992-9#1)(2008-10#1)
their ability to stimulate##4##4##(1991-1#1)(1996-4#1)(1996-8#1)(2010-12#1)
their ability to support##4##4##(1991-1#1)(1996-5#1)(2006-5#1)(2008-5#1)
their ability to survive##2##4##(1994-8#1)(2007-6#1)
their ability to transmit##6##4##(2008-10#5)(2008-4#1)
their ability to transport##2##4##(1996-1#1)(2008-5#1)
their ability to use##4##4##(2008-9#1)(2009-3#1)(2010-5#1)(2010-8#1)
their ability to utilize##2##4##(2011-1#2)
their ability to withstand##3##4##(2008-2#1)(2010-4#1)(2012-1#1)
their ability to##338##3##(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#3)(1990-3#2)(1990-4#2)(1990-5#3)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-7#1)(1991-8#3)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#1)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#6)(1993-11#3)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#3)(1994-2#2)(1994-5#4)(1994-6#6)(1994-8#4)(1994-9#5)(1995-1#5)(1995-11#4)(1995-12#2)(1995-2#2)(1995-3#3)(1995-4#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-7#1)(1996-8#4)(1996-9#1)(1997-1#6)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#3)(1997-8#2)(2004-2#1)(2004-4#1)(2005-11#6)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#3)(2006-11#2)(2006-12#3)(2006-2#1)(2006-5#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#40)(2008-11#6)(2008-12#2)(2008-2#5)(2008-3#4)(2008-4#4)(2008-5#9)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#7)(2009-10#2)(2009-2#1)(2009-3#3)(2009-4#2)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#3)(2011-2#7)(2012-1#3)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#3)
their ability##342##2##(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#3)(1990-3#2)(1990-4#2)(1990-5#3)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-7#1)(1991-8#3)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#1)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#6)(1993-11#3)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#3)(1994-2#2)(1994-5#4)(1994-6#6)(1994-8#4)(1994-9#5)(1995-1#5)(1995-11#4)(1995-12#2)(1995-2#2)(1995-3#3)(1995-4#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-7#1)(1996-8#4)(1996-9#1)(1997-1#6)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#3)(1997-8#2)(2004-11#1)(2004-2#1)(2004-4#1)(2005-11#6)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#3)(2006-11#2)(2006-12#3)(2006-2#1)(2006-5#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#40)(2008-11#6)(2008-12#2)(2008-2#5)(2008-3#4)(2008-4#4)(2008-5#10)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#8)(2009-10#2)(2009-2#1)(2009-3#3)(2009-4#2)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#3)(2011-2#7)(2012-1#3)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#3)
their abnormal##2##2##(1994-6#1)(2007-12#1)
their absence in##2##3##(2007-12#1)(2008-10#1)
their absence##6##2##(2005-11#1)(2006-3#1)(2007-12#1)(2008-10#1)(2008-8#1)(2011-2#1)
their absolute##3##2##(1990-11#1)(2007-8#1)(2012-11#1)
their absorption spectra##2##3##(1991-7#1)(1995-3#1)
their absorption##6##2##(1991-7#1)(1992-9#1)(1993-11#1)(1995-3#1)(2007-12#1)(2008-2#1)
their abundance and##2##3##(2007-8#1)(2008-10#1)
their abundance in##2##3##(2007-11#1)(2008-10#1)
their abundance increases##2##3##(1994-9#1)(2008-8#1)
their abundance##10##2##(1993-12#1)(1994-9#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-3#1)
their abundant##2##2##(2012-2#1)(2013-1#1)
their academic performance##2##3##(2006-8#1)(2013-8#1)
their academic##9##2##(2006-8#1)(2007-4#2)(2008-12#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-8#2)
their acceptance##5##2##(1993-2#1)(2005-1#1)(2008-8#1)(2009-8#1)(2013-7#1)
their access to health care##2##5##(2008-8#1)(2012-3#1)
their access to##12##3##(2007-2#1)(2007-3#1)(2008-1#1)(2008-7#1)(2008-8#2)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#3)
their accommodation##2##2##(1992-7#1)(1993-2#1)
their accumulation in##2##3##(1995-2#1)(2012-1#1)
their accuracy##10##2##(2006-2#1)(2006-7#1)(2007-4#1)(2008-10#3)(2008-7#1)(2010-12#1)(2011-7#1)(2012-2#1)
their acetylated##2##2##(1992-5#1)(2010-12#1)
their action by##2##3##(2010-10#1)(2012-1#1)
their action on the##2##4##(1996-12#1)(2004-12#1)
their action on##7##3##(1996-12#1)(2004-12#2)(2008-10#1)(2008-4#1)(2008-7#1)(2012-2#1)
their action##20##2##(1991-5#1)(1992-12#1)(1993-6#1)(1994-2#1)(1996-12#1)(2004-12#2)(2005-1#1)(2005-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2012-1#1)(2012-2#1)(2013-1#1)
their actions are##2##3##(2008-4#2)
their actions##17##2##(1992-8#2)(1993-5#1)(1993-8#1)(1995-12#1)(1995-3#1)(1996-3#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-4#2)(2008-7#1)(2010-3#1)(2010-5#1)(2011-1#1)(2013-7#1)
their activation and##3##3##(2008-10#1)(2010-12#1)(2010-8#1)
their activation##19##2##(1992-5#1)(1992-7#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-3#1)(2006-2#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#2)(2009-9#1)(2010-12#1)(2010-8#1)
their active metabolites##2##3##(1990-6#1)(2008-10#1)
their active site##2##3##(1994-2#1)(2007-7#1)
their active##12##2##(1990-6#1)(1990-8#1)(1994-2#1)(1997-1#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-8#1)(2013-7#1)
their activities as##2##3##(1992-5#1)(2005-7#1)
their activities in##2##3##(2007-12#1)(2012-3#1)
their activities were##2##3##(1993-6#1)(2008-5#1)
their activities##23##2##(1991-1#1)(1992-5#1)(1993-6#1)(1997-3#1)(1997-4#1)(2005-7#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-5#2)(2010-3#1)(2010-9#1)(2012-12#2)(2012-3#1)
their activity against human immunodeficiency virus##2##6##(1997-1#1)(1997-6#1)
their activity against some##2##4##(2008-5#1)(2012-11#1)
their activity against##5##3##(1995-6#1)(1997-1#1)(1997-6#1)(2008-5#1)(2012-11#1)
their activity as##2##3##(1994-11#1)(1996-8#1)
their activity in##3##3##(1990-6#1)(1995-2#1)(2008-1#1)
their activity to##3##3##(1994-12#1)(1995-6#1)(2008-5#1)
their activity##33##2##(1990-6#1)(1991-11#1)(1992-5#1)(1993-2#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-6#2)(1995-2#1)(1995-6#2)(1996-8#1)(1997-1#1)(1997-6#2)(1997-8#1)(2008-1#2)(2008-10#3)(2008-5#3)(2008-6#1)(2008-8#2)(2009-3#1)(2010-5#1)(2012-1#1)(2012-11#1)(2013-8#1)
their actual experiences##2##3##(2007-5#1)(2011-2#1)
their actual##16##2##(1995-3#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-3#1)(2009-5#1)(2009-9#1)(2011-2#1)(2013-7#2)
their acute##6##2##(1990-12#1)(1992-1#1)(1996-6#1)(2007-7#1)(2012-12#1)(2013-1#1)
their adaptation to the##2##4##(2011-1#1)(2012-12#1)
their adaptation to##3##3##(2011-1#1)(2012-12#1)(2012-2#1)
their addition##2##2##(2007-8#1)(2008-11#1)
their adequacy##3##2##(1992-12#1)(2008-5#2)
their adequate##3##2##(2008-10#1)(2011-2#2)
their adhesion to##3##3##(1997-7#1)(2008-3#1)(2008-4#1)
their adhesion##4##2##(1994-12#1)(1997-7#1)(2008-3#1)(2008-4#1)
their adhesive properties and##3##4##(1993-7#1)(2008-5#1)(2011-1#1)
their adhesive##4##2##(1991-5#1)(1993-7#1)(2008-5#1)(2011-1#1)
their adjustment##2##2##(2007-8#1)(2013-8#1)
their administration##4##2##(1996-1#1)(2007-7#1)(2008-1#1)(2011-3#1)
their admission to##2##3##(1990-3#1)(1995-1#1)
their admission##4##2##(1990-3#1)(1995-1#1)(2007-8#1)(2008-11#1)
their admixtures##2##2##(2004-9#1)(2008-10#1)
their adolescent##4##2##(2006-7#2)(2010-4#1)(2011-1#1)
their adoption is##3##3##(2011-2#1)(2013-1#2)
their adoption##4##2##(1994-12#1)(2011-2#1)(2013-1#2)
their adsorption##3##2##(1992-7#1)(2005-11#1)(2008-10#1)
their adult children##3##3##(2009-10#1)(2013-1#2)
their adult counterparts##3##3##(2006-4#1)(2008-1#1)(2008-9#1)
their adult lives##2##3##(2008-7#1)(2010-12#1)
their adult##16##2##(1992-7#1)(1995-1#1)(2006-1#1)(2006-4#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-9#1)(2012-11#1)(2013-1#2)
their advantage##2##2##(2008-2#1)(2008-3#1)
their advantages and disadvantages##5##4##(2007-12#1)(2008-12#1)(2008-2#1)(2012-2#1)(2012-3#1)
their advantages and##9##3##(1996-12#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2012-2#1)(2012-3#1)
their advantages over the##2##4##(2009-11#1)(2011-2#1)
their advantages##15##2##(1995-3#1)(1996-12#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-11#1)(2011-2#2)(2012-2#1)(2012-3#1)
their adverse##5##2##(2006-4#1)(2007-12#1)(2009-12#1)(2011-1#1)(2012-3#1)
their advice##2##2##(2008-11#1)(2009-2#1)
their advisors##2##2##(2008-11#1)(2010-3#1)
their affect on##2##3##(2008-10#1)(2012-2#1)
their affected##3##2##(2007-10#1)(2007-8#1)(2010-2#1)
their afferent and efferent projections##2##5##(2007-12#2)
their afferent and efferent##3##4##(1990-5#1)(2007-12#2)
their afferent##4##2##(1990-5#2)(2007-12#2)
their affinities to##2##3##(1996-8#1)(2008-5#1)
their affinities##3##2##(1990-6#1)(1996-8#1)(2008-5#1)
their affinity at##2##3##(2008-4#1)(2011-2#1)
their affinity for the##2##4##(1994-11#1)(1995-11#1)
their affinity for##7##3##(1994-11#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(2005-12#1)
their affinity to##2##3##(2008-10#1)(2008-11#1)
their affinity##15##2##(1991-1#1)(1992-5#1)(1992-6#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1997-2#1)(2005-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
their age and##4##3##(1990-8#1)(2008-12#1)(2012-12#2)
their age or##2##3##(1996-2#1)(2007-3#1)
their age ranged from##2##4##(2007-7#1)(2008-4#1)
their age##30##2##(1990-8#1)(1991-12#1)(1994-2#1)(1994-3#1)(1996-2#3)(2006-2#1)(2006-6#1)(2006-9#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-7#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
their aggressiveness##3##2##(2006-11#1)(2008-10#2)
their agreement with##2##3##(2007-11#1)(2008-3#1)
their agreement##3##2##(2007-11#1)(2007-2#1)(2008-3#1)
their alcohol use##2##3##(2008-11#1)(2009-8#1)
their alcohol##3##2##(2008-11#1)(2008-12#1)(2009-8#1)
their alkyl##2##2##(2005-11#1)(2008-5#1)
their all-trans isomers##2##3##(1991-5#2)
their alteration##4##2##(2005-10#1)(2007-1#2)(2010-5#1)
their amino acid composition##2##4##(2008-7#1)(2012-1#1)
their amino acid sequence##2##4##(1996-7#1)(1997-2#1)
their amino acid sequences##4##4##(1992-12#1)(1992-6#1)(1994-11#1)(2008-11#1)
their amino acid##9##3##(1991-3#1)(1992-12#1)(1992-6#1)(1994-11#1)(1996-7#1)(1997-2#1)(2008-11#1)(2008-7#1)(2012-1#1)
their amino termini##3##3##(1991-10#1)(1995-6#1)(1996-8#1)
their amino##15##2##(1991-10#1)(1991-3#1)(1992-12#1)(1992-6#1)(1994-11#1)(1995-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2012-1#1)
their amino-terminal##2##2##(1994-11#1)(1997-6#1)
their amount##2##2##(1997-2#1)(2006-10#1)
their amounts##2##2##(1994-11#1)(2008-12#1)
their amplification##2##2##(2007-11#1)(2007-12#1)
their anaesthetic##2##2##(2006-10#1)(2010-7#1)
their analgesic##5##2##(2006-10#3)(2008-11#1)(2010-6#1)
their analysis by##3##3##(2008-10#1)(2008-9#1)(2013-8#1)
their analysis is##2##3##(2009-9#1)(2012-2#1)
their analysis may##4##3##(1992-12#1)(1997-8#1)(2008-2#1)(2008-4#1)
their analysis##13##2##(1992-12#1)(1993-3#1)(1997-8#1)(2005-11#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)(2009-9#1)(2010-2#1)(2012-2#1)(2013-8#1)
their analytical##7##2##(2008-10#5)(2008-5#1)(2012-3#1)
their anatomic##2##2##(2008-12#1)(2008-9#1)
their anatomical location##2##3##(2008-1#1)(2011-2#1)
their anatomical##4##2##(2006-8#1)(2007-11#1)(2008-1#1)(2011-2#1)
their ancestor##2##2##(2008-8#1)(2010-8#1)
their ancestral##2##2##(1993-8#1)(1996-6#1)
their animal##2##2##(2012-2#1)(2013-8#1)
their animals##2##2##(2009-2#1)(2009-4#1)
their anisotropic##2##2##(2007-11#1)(2009-2#1)
their annual##4##2##(1995-2#1)(2007-9#1)(2008-11#1)(2009-10#1)
their answers##2##2##(2009-4#1)(2010-8#1)
their antagonism##2##2##(2008-10#2)
their antagonistic##2##2##(2005-11#1)(2008-10#1)
their anti-HIV activity##2##3##(1992-5#1)(1997-1#1)
their anti-atherogenic##3##2##(2005-7#1)(2008-1#2)
their anti-inflammatory activities##2##3##(2007-1#1)(2008-10#1)
their anti-inflammatory##3##2##(2007-1#1)(2008-10#1)(2009-9#1)
their anti-tumor activity##3##3##(2008-11#1)(2012-12#2)
their anti-tumor##4##2##(2008-11#1)(2012-12#2)(2013-1#1)
their antibacterial activities##4##3##(1994-2#1)(2010-3#1)(2012-3#2)
their antibacterial activity##9##3##(2006-9#1)(2008-3#3)(2008-5#4)(2010-2#1)
their antibacterial and antifungal activities##2##5##(2007-11#1)(2011-1#1)
their antibacterial and##4##3##(2006-12#1)(2006-2#1)(2007-11#1)(2011-1#1)
their antibacterial##19##2##(1994-2#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-4#1)(2008-3#3)(2008-5#5)(2010-2#1)(2010-3#1)(2011-1#1)(2012-3#2)
their antibiotic##4##2##(2008-10#1)(2010-8#1)(2011-2#1)(2013-8#1)
their antibody response to##2##4##(2010-12#2)
their antibody##4##2##(1995-5#1)(2008-11#1)(2010-12#2)
their anticancer##2##2##(1993-12#1)(1995-5#1)
their anticonvulsant activities##2##3##(1994-8#1)(2010-12#1)
their anticonvulsant##3##2##(1994-8#1)(2010-12#2)
their antifungal activity##2##3##(2008-5#1)(2011-2#1)
their antifungal##3##2##(2008-5#2)(2011-2#1)
their antigen##6##2##(1994-3#1)(2007-2#1)(2008-4#1)(2011-1#3)
their antigenic##2##2##(2005-7#1)(2007-11#1)
their antiinflammatory##4##2##(1993-11#1)(2007-9#1)(2008-4#1)(2008-5#1)
their antimicrobial activities##2##3##(2010-9#1)(2012-2#1)
their antimicrobial activity##7##3##(2007-1#1)(2007-11#2)(2009-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
their antimicrobial##14##2##(2007-1#1)(2007-11#2)(2007-7#2)(2008-10#1)(2009-3#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)
their antioxidant activity##2##3##(2006-12#1)(2008-11#1)
their antioxidant##8##2##(2006-12#2)(2008-10#1)(2008-11#4)(2012-1#1)
their antiproliferative activity##3##3##(2008-2#1)(2010-12#2)
their antiproliferative##6##2##(1991-8#1)(1995-2#1)(2008-2#1)(2010-12#2)(2013-1#1)
their antitumor activity##2##3##(2007-11#1)(2008-11#1)
their antitumor##4##2##(2007-11#1)(2008-11#1)(2010-7#1)(2011-1#1)
their antitumour##2##2##(2005-7#1)(2008-5#1)
their antiviral and##2##3##(2007-11#1)(2008-10#1)
their antiviral##6##2##(1994-8#1)(1996-8#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)
their anxiolytic##3##2##(1991-11#1)(1991-4#1)(1991-5#1)
their apical##8##2##(1996-3#1)(2007-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2012-2#1)
their apparent##10##2##(1991-8#1)(1996-12#1)(1997-2#1)(2005-8#1)(2006-7#1)(2008-1#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)
their appearance in##3##3##(2008-5#1)(2012-2#1)(2013-1#1)
their appearance##26##2##(1992-8#1)(2005-8#1)(2006-12#2)(2007-12#9)(2008-11#2)(2008-2#1)(2008-5#2)(2008-6#1)(2010-4#1)(2012-2#3)(2013-1#3)
their applicability for##2##3##(1991-1#1)(2008-10#1)
their applicability in##2##3##(2008-10#1)(2012-12#1)
their applicability to##4##3##(2008-1#1)(2008-10#1)(2008-8#1)(2012-3#1)
their applicability##12##2##(1991-1#1)(2008-1#2)(2008-10#3)(2008-5#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
their application as##5##3##(2008-2#1)(2008-5#1)(2010-2#1)(2012-11#2)
their application for##3##3##(2007-11#1)(2008-10#2)
their application in the##3##4##(1992-7#1)(1992-8#1)(2008-3#1)
their application in##23##3##(1992-10#1)(1992-7#1)(1992-8#1)(1995-2#1)(2006-7#1)(2007-8#3)(2007-9#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-6#1)(2010-1#1)(2010-7#1)(2012-11#1)
their application to photosynthetic organisms##2##5##(2009-10#2)
their application to the study of##2##6##(2006-3#1)(2009-12#1)
their application to the##7##4##(1995-6#1)(2006-3#1)(2007-12#1)(2008-10#3)(2009-12#1)
their application to##33##3##(1990-12#1)(1990-7#1)(1993-3#1)(1994-2#1)(1995-3#2)(1995-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2010-11#2)(2011-2#2)(2012-11#1)
their application##80##2##(1990-12#1)(1990-7#1)(1992-10#1)(1992-7#1)(1992-8#1)(1993-3#1)(1994-2#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1997-1#1)(1997-3#1)(1997-4#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-3#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-10#10)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#1)(2009-6#1)(2010-1#2)(2010-11#2)(2010-2#1)(2010-7#1)(2011-2#2)(2012-11#4)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
their applications as##3##3##(2006-12#2)(2007-11#1)
their applications to image coding##2##5##(2008-2#2)
their applications to##11##3##(1990-12#1)(1992-12#1)(1992-5#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-7#1)
their applications##35##2##(1990-12#1)(1990-3#1)(1992-11#1)(1992-12#1)(1992-5#1)(1996-11#1)(1997-2#1)(2004-9#1)(2005-11#1)(2006-12#2)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#3)(2008-7#2)(2008-9#1)(2010-2#1)(2010-7#1)(2012-12#1)(2013-8#1)
their appointments##4##2##(1995-1#1)(2008-3#1)(2012-3#2)
their approach to##3##3##(1993-1#1)(1994-12#1)(2007-10#1)
their approach##7##2##(1993-1#1)(1994-12#1)(1995-1#1)(1996-8#1)(2007-10#1)(2008-11#1)(2012-2#1)
their approaches to##2##3##(1993-3#1)(2011-1#1)
their appropriate management##3##3##(2005-11#1)(2006-2#1)(2007-2#1)
their appropriate use##2##3##(2010-11#1)(2010-8#1)
their appropriate##12##2##(1990-2#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-2#1)(2007-4#2)(2008-10#1)(2008-3#1)(2008-9#1)(2010-11#1)(2010-8#1)
their aqueous solutions under similar conditions##2##6##(2008-10#2)
their aqueous solutions##4##3##(2008-10#3)(2010-4#1)
their aqueous##5##2##(2008-10#4)(2010-4#1)
their area##3##2##(2007-3#1)(2008-5#1)(2008-7#1)
their areas of##2##3##(1996-2#1)(2013-8#1)
their areas##3##2##(1996-2#1)(2013-8#2)
their arm##3##2##(1992-10#1)(1996-7#1)(2006-9#1)
their arrival in##3##3##(2008-5#1)(2012-12#1)(2012-2#1)
their arrival##5##2##(1991-10#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
their articles##2##2##(2007-4#1)(2009-2#1)
their assessment of##2##3##(2010-5#1)(2013-7#1)
their assessment##4##2##(2010-12#1)(2010-5#1)(2012-2#1)(2013-7#1)
their assignment##2##2##(2008-11#1)(2009-7#1)
their associated##31##2##(1991-3#1)(1991-9#1)(1992-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1997-6#1)(1997-7#1)(2005-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-9#1)(2009-2#2)(2009-4#1)(2010-9#1)(2011-2#1)(2013-1#2)
their association and##2##3##(1991-5#1)(2008-8#1)
their association with the##7##4##(1991-4#1)(1996-12#1)(1996-2#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-2#1)
their association with##41##3##(1991-4#1)(1994-11#1)(1995-4#1)(1996-12#3)(1996-2#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#4)(2013-7#1)(2013-8#1)
their association##50##2##(1991-4#1)(1991-5#1)(1994-11#1)(1995-4#1)(1996-12#3)(1996-2#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#5)(2013-7#2)(2013-8#1)
their associations with##6##3##(1994-10#1)(2010-10#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
their assumption of##2##3##(1995-1#1)(2004-12#1)
their assumption##3##2##(1995-1#1)(2004-12#1)(2008-5#1)
their assumptions##3##2##(1996-10#1)(2008-10#1)(2010-9#1)
their asthma symptoms##2##3##(2009-6#1)(2012-12#1)
their asthma##5##2##(1993-12#1)(2008-3#1)(2008-8#1)(2009-6#1)(2012-12#1)
their asymptotic##2##2##(2008-2#1)(2010-2#1)
their atomic absorption spectrometric determinations##2##5##(2008-10#2)
their atomic absorption##3##3##(2008-10#3)
their atomic##4##2##(2008-10#3)(2011-2#1)
their attachment##2##2##(2005-11#1)(2012-4#1)
their attempts to##2##3##(2006-7#1)(2008-6#1)
their attendant##3##2##(2007-6#1)(2010-8#1)(2011-2#1)
their attention on the##2##4##(2006-10#1)(2008-10#1)
their attention on##5##3##(1993-6#1)(2006-10#1)(2008-10#1)(2012-12#2)
their attention to##2##3##(2008-7#1)(2012-3#1)
their attention##12##2##(1990-10#1)(1993-6#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-12#2)(2012-3#1)
their attenuation##2##2##(2005-11#1)(2007-10#1)
their attitude towards##4##3##(1996-9#1)(2006-10#1)(2010-11#1)(2010-3#1)
their attitude##7##2##(1996-9#1)(2006-10#1)(2008-5#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#1)
their attitudes and behaviors##2##4##(2008-12#1)(2008-3#1)
their attitudes and##5##3##(1994-2#1)(1997-1#1)(2008-12#1)(2008-3#1)(2010-12#1)
their attitudes toward eating and weight in the sport##2##9##(2006-6#2)
their attitudes toward##6##3##(1992-1#1)(2006-6#2)(2007-5#1)(2008-3#1)(2008-7#1)
their attitudes towards##5##3##(1996-1#1)(1996-6#1)(2007-7#1)(2008-4#1)(2010-4#1)
their attitudes were##2##3##(2007-7#1)(2008-7#1)
their attitudes##20##2##(1992-1#1)(1993-3#1)(1994-2#1)(1996-1#1)(1996-6#1)(1997-1#1)(2006-6#2)(2007-5#1)(2007-7#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-7#2)(2010-12#1)(2010-4#1)
their atypical morphology##2##3##(2008-10#1)(2012-12#1)
their authority##2##2##(2010-12#1)(2010-9#1)
their authorization##2##2##(1992-2#2)
their availability##6##2##(1994-6#1)(2007-2#1)(2008-4#1)(2008-7#1)(2010-9#1)(2013-1#1)
their average##6##2##(1991-4#1)(1993-12#1)(1996-11#1)(2006-12#1)(2008-9#1)(2010-3#1)
their avoidance##2##2##(2007-12#1)(2009-9#1)
their awareness of##4##3##(1993-12#1)(1995-12#1)(2010-8#1)(2011-2#1)
their awareness##6##2##(1993-12#1)(1995-12#1)(2007-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
their axon##3##2##(1990-2#1)(1997-3#1)(2007-12#1)
their axons reach##2##3##(1991-3#1)(1996-3#1)
their axons to##3##3##(1996-9#1)(1997-7#1)(2007-12#1)
their axons##13##2##(1990-7#2)(1991-10#1)(1991-3#1)(1995-5#1)(1996-3#1)(1996-9#1)(1997-6#1)(1997-7#1)(2004-11#1)(2007-12#3)
their babies##7##2##(2007-10#1)(2007-2#3)(2007-7#1)(2008-8#1)(2009-7#1)
their baby##3##2##(1990-2#1)(2004-10#1)(2007-2#1)
their baby's##5##2##(1991-6#1)(1994-2#2)(2011-2#1)(2012-11#1)
their background##3##2##(1996-2#1)(2008-10#1)(2008-11#1)
their bacterial##2##2##(2008-10#1)(2013-1#1)
their basal##5##2##(1997-2#1)(2007-12#1)(2008-7#2)(2013-1#1)
their base composition##2##3##(1992-2#1)(1993-2#1)
their basic##10##2##(1993-1#1)(1996-12#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
their beam##2##2##(2007-11#1)(2007-12#1)
their beds##3##2##(1997-6#1)(2006-7#1)(2007-11#1)
their beginnings##2##2##(2007-8#1)(2010-9#1)
their behavior and##3##3##(1997-1#1)(2009-6#1)(2010-2#1)
their behavior during##2##3##(1991-2#1)(1993-12#1)
their behavior in##3##3##(1994-9#1)(2008-7#1)(2010-2#1)
their behavior##18##2##(1990-7#1)(1991-2#2)(1993-12#1)(1994-9#1)(1997-1#2)(2006-7#1)(2007-12#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-2#2)(2013-1#2)
their behavioral##4##2##(1993-2#1)(1993-3#1)(1994-5#1)(2008-9#1)
their behaviors##3##2##(1996-11#1)(2011-2#1)(2013-8#1)
their behaviour and##2##3##(1991-2#1)(2010-5#1)
their behaviour##8##2##(1990-3#1)(1991-2#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-8#1)
their behavioural##3##2##(1990-10#1)(2008-9#2)
their being##6##2##(1991-9#1)(1995-12#1)(1995-3#1)(1995-8#1)(2008-4#1)(2010-1#1)
their belief that##3##3##(2008-12#2)(2010-3#1)
their belief##4##2##(1990-12#1)(2008-12#2)(2010-3#1)
their beliefs and behaviors##2##4##(2006-7#1)(2011-1#1)
their beliefs and##4##3##(2006-5#1)(2006-7#1)(2010-2#1)(2011-1#1)
their beliefs##8##2##(2006-5#1)(2006-7#2)(2007-12#1)(2008-1#1)(2010-2#1)(2011-1#1)(2012-12#1)
their beneficial effects##4##3##(1992-8#1)(2006-10#1)(2013-7#1)(2013-8#1)
their beneficial##7##2##(1992-8#1)(2006-10#1)(2008-10#2)(2008-5#1)(2013-7#1)(2013-8#1)
their benefit in##2##3##(1995-9#1)(2007-11#1)
their benefit##8##2##(1992-3#1)(1994-3#2)(1995-9#1)(2006-10#1)(2007-11#1)(2007-8#1)(2012-2#1)
their benefits and##3##3##(1990-1#1)(1992-1#1)(2005-10#1)
their benefits##14##2##(1990-1#1)(1992-1#1)(1995-3#1)(1997-1#1)(2005-10#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-9#1)(2013-1#2)
their best##4##2##(2006-12#1)(2007-4#1)(2009-7#1)(2012-12#1)
their binary mixtures##2##3##(2008-10#1)(2008-8#1)
their binding affinities to##2##4##(2006-12#1)(2008-8#1)
their binding affinities##3##3##(1995-11#1)(2006-12#1)(2008-8#1)
their binding affinity##4##3##(1991-2#1)(1991-5#1)(1992-11#1)(1997-6#1)
their binding site##2##3##(1992-6#1)(1995-12#1)
their binding sites##3##3##(1992-6#1)(1995-6#1)(2007-12#1)
their binding to the##3##4##(1991-7#1)(1993-6#1)(1994-3#1)
their binding to##11##3##(1991-4#1)(1991-7#1)(1993-3#1)(1993-6#2)(1994-10#1)(1994-3#1)(1994-5#1)(1995-8#1)(2008-5#1)(2009-5#1)
their binding##41##2##(1990-3#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-6#2)(1993-3#2)(1993-6#3)(1994-10#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-6#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-4#1)(2012-2#1)(2012-3#2)(2013-7#1)
their biochemical##4##2##(1990-7#1)(2008-1#1)(2008-10#1)(2012-2#1)
their biochemistry##2##2##(2006-11#1)(2010-7#1)
their biocompatibility##6##2##(1994-11#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-7#1)(2012-12#1)
their biocontrol potential##3##3##(2008-10#2)(2011-12#1)
their biocontrol##5##2##(2008-10#4)(2011-12#1)
their biodistribution##2##2##(1990-4#1)(2007-8#1)
their biodiversity##2##2##(2007-3#1)(2012-3#1)
their biofidelity##2##2##(2006-11#2)
their biologic##3##2##(1991-7#1)(2008-1#1)(2010-2#1)
their biological activities were##2##4##(2013-1#1)(2013-8#1)
their biological activities##7##3##(1991-9#1)(1995-8#1)(2006-12#1)(2008-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
their biological activity##6##3##(1991-5#1)(1995-2#1)(2005-10#1)(2005-11#1)(2008-5#2)
their biological control##2##3##(2008-10#1)(2011-12#1)
their biological effects##7##3##(1991-1#1)(1994-6#1)(1996-4#1)(1996-8#1)(2008-10#1)(2009-12#1)(2011-2#1)
their biological function##3##3##(1995-2#1)(2006-10#1)(2006-11#1)
their biological functions##5##3##(1993-9#1)(2008-9#1)(2009-2#1)(2010-10#1)(2013-1#1)
their biological properties##5##3##(2008-10#2)(2008-11#1)(2008-5#1)(2013-1#1)
their biological roles##3##3##(2008-11#1)(2008-7#1)(2011-12#1)
their biological##61##2##(1991-1#2)(1991-5#1)(1991-9#1)(1993-9#2)(1994-6#1)(1994-9#1)(1995-2#2)(1995-6#2)(1995-8#2)(1996-4#1)(1996-5#1)(1996-8#1)(1997-5#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#2)(2007-11#1)(2007-6#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
their biology and##3##3##(2007-5#1)(2009-5#1)(2010-8#1)
their biology##5##2##(2007-3#1)(2007-5#1)(2009-5#1)(2009-8#1)(2010-8#1)
their biomedical applications##2##3##(2008-5#1)(2010-12#1)
their biophysical##4##2##(1997-6#1)(2008-1#1)(2008-10#1)(2012-3#1)
their biosynthetic##3##2##(1994-11#1)(2012-3#2)
their birth##3##2##(1992-5#1)(2007-2#1)(2009-2#1)
their bladder##2##2##(2007-1#2)
their blastocysts##2##2##(1992-12#2)
their blood glucose##4##3##(1997-3#3)(2010-11#1)
their blood##13##2##(1990-1#1)(1990-11#1)(1992-11#1)(1996-3#1)(1997-3#3)(2006-10#1)(2008-5#1)(2010-11#1)(2012-2#2)(2013-8#1)
their boards##3##2##(1993-1#1)(1994-2#1)(1995-3#1)
their bodies and##5##3##(2007-12#3)(2009-5#1)(2012-3#1)
their bodies than##4##3##(2007-12#1)(2008-9#2)(2010-10#1)
their bodies##27##2##(2006-12#3)(2007-12#8)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#5)(2009-4#1)(2009-5#2)(2010-10#1)(2012-3#2)
their body image##3##3##(2007-12#3)
their body mass index (BMI)##2##5##(1991-11#1)(2012-2#1)
their body mass##4##3##(1991-11#1)(2007-12#1)(2009-4#1)(2012-2#1)
their body satisfaction##2##3##(2006-7#1)(2008-9#1)
their body size##6##3##(2007-12#5)(2012-2#1)
their body weight##5##3##(2006-10#1)(2008-5#1)(2008-7#1)(2012-1#1)(2013-1#1)
their body##35##2##(1991-11#1)(1991-12#1)(2006-10#1)(2006-7#1)(2007-12#14)(2007-3#1)(2007-8#1)(2008-11#2)(2008-5#3)(2008-7#1)(2008-9#1)(2009-4#1)(2011-12#1)(2012-1#1)(2012-2#3)(2013-1#2)
their bone marrow##4##3##(1994-10#1)(1994-5#1)(2010-1#1)(2011-1#1)
their bone##5##2##(1994-10#1)(1994-5#1)(2010-1#1)(2011-1#1)(2013-8#1)
their bound##3##2##(1993-12#1)(1994-11#1)(2006-10#1)
their brain##4##2##(1993-11#1)(2006-3#1)(2008-11#1)(2008-5#1)
their brains##4##2##(1996-6#2)(2007-9#2)
their branches##3##2##(1990-9#1)(1996-9#1)(1997-8#1)
their breast cancer##2##3##(2009-12#2)
their breastfeeding in##2##3##(2006-9#1)(2007-9#1)
their broad spectrum##2##3##(2008-10#1)(2011-2#1)
their broad##4##2##(1995-5#1)(2008-10#2)(2011-2#1)
their brood##2##2##(2008-6#1)(2008-9#1)
their bulk##3##2##(2005-11#1)(2007-11#1)(2008-3#1)
their burden##2##2##(2006-10#1)(2008-1#1)
their business##4##2##(1991-3#1)(1992-3#1)(1997-2#1)(2008-11#1)
their buying##2##2##(1994-12#1)(1994-3#1)
their cDNA##3##2##(1990-12#1)(1993-12#1)(2008-9#1)
their cDNAs##2##2##(1997-4#1)(1997-7#1)
their calculation##3##2##(1990-12#1)(1994-6#1)(2011-2#1)
their calls##2##2##(2013-7#2)
their cancer##3##2##(1992-5#1)(2005-10#1)(2007-11#1)
their capabilities##3##2##(1996-12#1)(2008-10#1)(2008-3#1)
their capability to##11##3##(1991-9#1)(1993-2#1)(1995-12#1)(1997-4#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
their capability##13##2##(1991-4#1)(1991-9#1)(1993-2#1)(1995-12#1)(1997-4#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-7#1)(2011-2#1)(2013-1#1)
their capacities to##3##3##(1991-4#1)(2008-5#2)
their capacities##7##2##(1991-4#1)(1994-3#1)(2007-6#1)(2008-11#1)(2008-5#2)(2008-6#1)
their capacity for##3##3##(1996-2#1)(1997-1#1)(2006-7#1)
their capacity to activate transcription##2##5##(1991-8#1)(1995-3#1)
their capacity to bind##2##4##(1996-8#1)(2008-4#1)
their capacity to differentiate into##3##5##(1991-11#1)(2012-12#2)
their capacity to differentiate##4##4##(1990-5#1)(1991-11#1)(2012-12#2)
their capacity to influence##2##4##(2010-9#1)(2012-2#1)
their capacity to produce##2##4##(2012-1#2)
their capacity to##39##3##(1990-5#2)(1991-11#2)(1991-2#2)(1991-8#1)(1992-12#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-3#1)(1996-8#1)(1997-1#1)(2005-9#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-4#1)(2010-9#1)(2011-1#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)
their capacity##44##2##(1990-5#2)(1991-11#2)(1991-2#2)(1991-8#1)(1992-1#1)(1992-12#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-3#1)(1996-2#1)(1996-8#1)(1997-1#2)(2005-9#1)(2006-12#1)(2006-6#1)(2006-7#2)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-4#1)(2010-9#1)(2011-1#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)
their carbohydrate##5##2##(1992-4#1)(1996-2#1)(2005-12#1)(2008-11#1)(2012-3#1)
their carcinogenic##2##2##(1990-11#1)(2007-10#1)
their cardiac##2##2##(1994-6#1)(2008-1#1)
their care in##2##3##(2010-3#1)(2011-2#1)
their care is##2##3##(2008-11#1)(2010-10#1)
their care##25##2##(1990-12#1)(1992-11#1)(1997-2#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-11#2)(2010-10#3)(2010-3#1)(2010-6#1)(2010-9#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
their care-givers##4##2##(2005-10#1)(2008-11#1)(2008-9#1)(2011-1#1)
their career##6##2##(2006-7#1)(2007-1#1)(2008-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
their careers##7##2##(1995-2#2)(2006-5#1)(2007-8#1)(2007-9#1)(2008-5#1)(2010-9#1)
their caregivers##14##2##(1992-3#1)(1996-11#1)(1996-3#1)(2006-2#2)(2008-8#1)(2010-10#2)(2010-2#1)(2011-2#1)(2013-1#1)(2013-8#3)
their caring role##2##3##(2011-1#2)
their caring roles##2##3##(2009-5#2)
their caring##4##2##(2009-5#2)(2011-1#2)
their cars##2##2##(2007-4#1)(2008-4#1)
their case##8##2##(1990-4#1)(1993-1#1)(1995-12#1)(1996-2#1)(2006-8#1)(2007-7#1)(2012-12#1)(2013-1#1)
their cases##2##2##(1997-5#1)(2005-11#1)
their catalytic activities##3##3##(1991-8#1)(1997-3#1)(2010-5#1)
their catalytic domains##3##3##(1992-6#1)(1992-7#1)(1993-5#1)
their catalytic properties##3##3##(1995-2#1)(1997-2#1)(2008-4#1)
their catalytic##14##2##(1991-8#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-5#1)(1993-6#1)(1995-2#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-12#1)(2010-5#1)
their causal##2##2##(2005-10#1)(2011-2#1)
their cause##2##2##(2006-10#1)(2008-1#1)
their causes and##2##3##(2006-8#1)(2011-2#1)
their causes##7##2##(2006-8#2)(2007-10#1)(2007-11#1)(2009-2#1)(2011-2#1)(2012-3#1)
their cell bodies##2##3##(1996-7#1)(2007-12#1)
their cell cycle##2##3##(1993-6#1)(2008-9#1)
their cell membranes##2##3##(2009-2#1)(2012-2#1)
their cell size##2##3##(2008-11#2)
their cell surface##2##3##(1994-3#1)(2008-11#1)
their cell##24##2##(1993-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1996-7#1)(2006-12#1)(2007-10#1)(2007-12#2)(2008-11#5)(2008-5#1)(2008-6#2)(2008-9#1)(2009-12#1)(2009-2#1)(2010-12#1)(2010-4#1)(2012-2#1)(2012-8#1)
their cellular and##2##3##(2009-3#1)(2011-1#1)
their cellular functions##2##3##(2008-8#1)(2009-8#1)
their cellular targets##2##3##(1995-12#1)(2012-12#1)
their cellular##12##2##(1995-12#1)(1995-5#1)(2005-7#1)(2005-9#1)(2008-7#1)(2008-8#1)(2009-3#2)(2009-4#1)(2009-8#1)(2011-1#1)(2012-12#1)
their center##4##2##(1991-3#1)(1995-5#1)(2006-3#1)(2012-2#1)
their central##7##2##(1992-8#1)(1996-1#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-3#1)
their chains##2##2##(2008-10#1)(2008-8#1)
their challenge##3##2##(2008-10#2)(2010-12#1)
their chances of##4##3##(2007-2#2)(2008-9#1)(2012-11#1)
their chances##5##2##(2007-2#2)(2008-10#1)(2008-9#1)(2012-11#1)
their changes during##2##3##(2008-10#1)(2012-2#1)
their changes in##2##3##(2008-10#1)(2010-11#1)
their changes##6##2##(1992-6#1)(2008-10#2)(2010-11#1)(2011-2#1)(2012-2#1)
their changing##4##2##(1995-6#1)(2005-4#1)(2006-7#1)(2010-12#1)
their characteristic##7##2##(1991-4#1)(1992-8#1)(2005-11#1)(2006-11#1)(2006-8#1)(2007-8#1)(2012-2#1)
their characteristics and##3##3##(2008-8#1)(2010-12#1)(2010-8#1)
their characteristics##9##2##(1994-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
their characterization##6##2##(1992-7#1)(1995-3#1)(2005-11#1)(2006-12#1)(2008-10#2)
their chelates##2##2##(2008-10#2)
their chemical and##2##3##(2006-10#1)(2009-7#1)
their chemical composition and##2##4##(2007-1#1)(2013-8#1)
their chemical composition##3##3##(2007-1#1)(2008-10#1)(2013-8#1)
their chemical properties##6##3##(1991-11#1)(2008-10#2)(2008-11#2)(2010-7#1)
their chemical synthesis##2##3##(2009-2#1)(2012-3#1)
their chemical##31##2##(1990-3#1)(1990-5#1)(1991-11#1)(1992-5#1)(1996-1#1)(1996-2#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-12#1)(2007-7#1)(2008-10#7)(2008-11#2)(2009-2#1)(2009-7#1)(2010-4#1)(2010-7#1)(2010-8#1)(2012-2#1)(2012-3#2)(2013-8#1)
their chemistry##2##2##(2008-10#1)(2008-5#1)
their chemotactic##2##2##(1990-6#1)(1992-6#1)
their child is##2##3##(2006-8#1)(2008-12#1)
their child##27##2##(1990-12#1)(1993-12#2)(1995-1#2)(1995-12#1)(1996-11#1)(1996-3#2)(1997-2#1)(2005-7#1)(2006-8#1)(2006-9#1)(2008-12#2)(2008-2#1)(2008-9#3)(2009-7#2)(2010-6#1)(2010-8#1)(2012-12#1)(2012-2#3)
their child's asthma##3##3##(2008-3#1)(2010-9#2)
their child's weight##3##3##(2007-12#2)(2009-6#1)
their child's##24##2##(1993-12#1)(1995-1#3)(1995-12#1)(2006-2#1)(2006-7#1)(2007-12#2)(2008-11#4)(2008-3#1)(2008-9#1)(2009-6#1)(2010-6#1)(2010-9#3)(2012-11#1)(2012-12#1)(2012-2#1)(2013-8#1)
their childbearing##2##2##(2009-12#1)(2013-1#1)
their childbirth##3##2##(2007-2#2)(2008-9#1)
their children about##2##3##(2013-1#2)
their children and##7##3##(1991-3#1)(1995-9#1)(2006-9#1)(2009-11#1)(2010-10#1)(2011-2#1)(2012-12#1)
their children as##2##3##(2008-2#1)(2010-10#1)
their children in order to##2##5##(2007-11#1)(2009-6#1)
their children in##7##3##(1994-2#1)(2007-11#1)(2008-12#1)(2008-8#1)(2009-6#3)
their children to##3##3##(1994-9#1)(2012-12#2)
their children with##5##3##(1993-1#1)(1993-3#1)(1996-1#1)(2006-10#1)(2013-1#1)
their children##82##2##(1990-12#1)(1990-2#1)(1991-11#2)(1991-12#1)(1991-3#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-1#2)(1995-9#1)(1996-1#2)(1996-12#1)(1996-6#1)(2004-12#1)(2004-3#1)(2006-10#1)(2006-4#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-12#3)(2008-2#1)(2008-6#1)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#3)(2009-7#3)(2010-10#3)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#3)(2010-9#3)(2011-1#2)(2011-2#1)(2012-12#6)(2012-2#3)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#1)
their children's teeth after##2##4##(2008-9#2)
their children's teeth##3##3##(2008-1#1)(2008-9#2)
their children's##18##2##(1994-3#1)(1995-1#4)(1996-5#1)(2007-12#1)(2008-1#1)(2008-9#2)(2009-7#4)(2010-3#1)(2010-7#1)(2012-12#1)(2013-1#1)
their choice of specialties##2##4##(1993-6#1)(2013-1#1)
their choice of##5##3##(1993-6#1)(1996-11#1)(2004-10#1)(2008-9#1)(2013-1#1)
their choice##9##2##(1993-6#1)(1996-11#1)(1996-2#1)(2004-10#1)(2008-9#2)(2010-10#1)(2012-3#1)(2013-1#1)
their choices##7##2##(1993-12#1)(1997-3#1)(2007-7#1)(2009-10#1)(2010-2#1)(2010-8#1)(2012-2#1)
their chosen##3##2##(2008-9#1)(2011-1#1)(2012-1#1)
their chromosomal##3##2##(1997-1#1)(1997-6#1)(2008-9#1)
their chronic##2##2##(1995-12#1)(2006-8#1)
their circular dichroism spectra##2##4##(1990-12#1)(1994-9#1)
their circular##3##2##(1990-12#1)(1994-9#1)(2011-2#1)
their claim##2##2##(1997-1#1)(2004-12#1)
their claims##2##2##(2008-1#1)(2009-7#1)
their class##2##2##(2007-2#1)(2008-6#1)
their classes##2##2##(2007-2#1)(2008-9#1)
their classical##3##2##(1995-11#2)(2008-4#1)
their classification##5##2##(1993-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2013-8#1)
their cleavage##3##2##(1996-9#1)(2006-3#1)(2008-4#1)
their clients##13##2##(1990-5#1)(1991-6#1)(1992-1#1)(1993-12#1)(1993-3#1)(2006-11#1)(2007-2#1)(2008-5#1)(2009-7#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)
their clinic##5##2##(2006-10#1)(2006-5#1)(2006-8#1)(2008-10#1)(2009-10#1)
their clinical and##7##3##(2006-6#1)(2007-9#1)(2008-11#1)(2009-6#1)(2010-10#1)(2011-2#2)
their clinical appearance##2##3##(1996-6#1)(2008-5#1)
their clinical application##2##3##(2006-10#1)(2011-1#1)
their clinical characteristics##3##3##(1995-10#1)(2013-1#2)
their clinical course##3##3##(2007-12#1)(2008-11#1)(2010-6#1)
their clinical effects##4##3##(2007-10#1)(2008-6#1)(2011-2#1)(2012-2#1)
their clinical efficacy##2##3##(2007-11#1)(2012-1#1)
their clinical experience in##3##4##(1991-9#1)(1993-9#1)(2007-7#1)
their clinical experience##5##3##(1991-9#1)(1993-9#1)(2007-7#1)(2008-12#1)(2012-12#1)
their clinical features##2##3##(2007-7#1)(2010-12#1)
their clinical implications##5##3##(2007-11#1)(2010-12#1)(2012-11#1)(2012-2#1)(2013-1#1)
their clinical importance##2##3##(1997-7#1)(2007-11#1)
their clinical manifestations##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
their clinical placement##2##3##(1996-2#1)(2007-10#1)
their clinical placements##4##3##(1995-3#1)(2008-12#2)(2010-3#1)
their clinical potential##2##3##(2005-8#1)(2008-1#1)
their clinical practice##5##3##(1992-10#1)(2008-11#1)(2009-11#1)(2012-2#1)(2013-1#1)
their clinical presentation##3##3##(1993-9#1)(2007-12#1)(2008-7#1)
their clinical relevance##3##3##(2006-2#1)(2008-4#1)(2010-5#1)
their clinical significance##3##3##(1991-9#1)(2006-10#1)(2012-12#1)
their clinical trials##2##3##(2008-10#1)(2008-8#1)
their clinical use is##2##4##(2006-10#1)(2012-12#1)
their clinical use##5##3##(2006-10#2)(2007-11#1)(2007-7#1)(2012-12#1)
their clinical usefulness##2##3##(2006-10#1)(2008-5#1)
their clinical utility##3##3##(2008-8#1)(2009-5#1)(2010-12#1)
their clinical##120##2##(1990-12#1)(1991-4#1)(1991-9#2)(1992-10#1)(1992-6#1)(1993-9#3)(1995-10#1)(1995-11#1)(1995-3#1)(1995-4#1)(1996-2#2)(1996-6#1)(1996-7#1)(1997-6#1)(1997-7#1)(2004-10#1)(2005-8#2)(2006-10#6)(2006-2#1)(2006-6#1)(2007-10#4)(2007-11#5)(2007-12#3)(2007-4#1)(2007-7#3)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#6)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#1)(2009-1#1)(2009-11#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#5)(2013-7#1)
their clonal##2##2##(1990-11#1)(2008-1#1)
their close proximity##2##3##(2008-4#1)(2010-5#1)
their close##5##2##(2006-10#1)(2007-7#1)(2008-10#1)(2008-4#1)(2010-5#1)
their clutch##2##2##(2008-8#1)(2009-10#1)
their co-expression in##2##3##(1994-9#1)(1995-12#1)
their coat protein##2##3##(1991-10#1)(2008-10#1)
their coevolutionary relationship##2##3##(2009-8#1)(2012-3#1)
their cognate G##2##3##(1997-6#1)(2008-4#1)
their cognate proteins##2##3##(2008-9#1)(2012-3#1)
their cognate##15##2##(1991-4#1)(1992-11#1)(1993-6#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-6#1)(2006-5#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-9#1)(2011-12#1)(2012-3#1)
their cognitive and##2##3##(1991-2#1)(2009-10#1)
their cognitive##12##2##(1991-2#1)(1991-6#1)(2007-5#1)(2008-11#2)(2009-10#3)(2010-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
their colleagues##7##2##(2007-10#1)(2007-7#1)(2007-9#1)(2008-1#1)(2010-11#1)(2011-1#1)(2011-2#1)
their collection##3##2##(1996-12#1)(2008-12#1)(2008-8#1)
their collective##3##2##(1996-12#1)(2008-12#1)(2012-2#1)
their colonization##2##2##(2008-10#1)(2008-5#1)
their colony##3##2##(2008-10#2)(2013-1#1)
their color perception##2##3##(2008-9#2)
their color##6##2##(2007-9#1)(2008-10#1)(2008-9#2)(2011-1#1)(2012-2#1)
their combination##18##2##(1992-2#1)(1992-4#1)(2005-1#2)(2005-10#1)(2006-9#1)(2008-10#2)(2008-9#1)(2009-6#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-11#1)(2012-12#1)(2012-5#1)(2012-7#1)(2012-9#1)
their combinations##6##2##(1996-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2012-1#1)(2012-3#1)
their combined##4##2##(1996-9#1)(2007-3#1)(2008-12#1)(2011-2#1)
their comments##3##2##(2008-11#1)(2008-2#1)(2008-9#1)
their commercial##6##2##(1996-12#1)(2005-11#1)(2007-2#1)(2008-5#1)(2010-5#1)(2011-2#1)
their commitment to the##2##4##(1992-12#1)(2005-7#1)
their commitment to##4##3##(1992-12#1)(1994-12#1)(2005-7#1)(2011-2#1)
their commitment##5##2##(1992-12#1)(1993-12#1)(1994-12#1)(2005-7#1)(2011-2#1)
their common features##2##3##(2008-12#1)(2010-2#1)
their common##14##2##(1994-12#1)(1997-8#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-2#1)(2010-5#1)(2011-2#1)
their communication with##4##3##(2006-10#1)(2006-2#1)(2008-12#1)(2011-2#1)
their communication##9##2##(1995-3#1)(2006-10#1)(2006-2#1)(2008-12#1)(2010-2#1)(2011-2#2)(2012-3#2)
their communities and##2##3##(1994-1#1)(2008-12#1)
their communities in##2##3##(1992-3#1)(2011-2#1)
their communities##20##2##(1992-12#1)(1992-3#1)(1994-1#1)(1995-1#1)(1995-2#1)(1995-3#3)(1996-12#1)(2004-12#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-6#1)(2009-6#1)(2010-2#1)(2011-2#1)(2013-1#3)
their community##9##2##(1991-3#1)(1995-3#1)(1997-3#1)(2007-2#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
their comparability##2##2##(2008-3#1)(2008-8#1)
their comparison with the##2##4##(2008-10#2)
their comparison with##3##3##(2008-10#2)(2008-3#1)
their comparison##6##2##(2008-10#4)(2008-3#2)
their compensation##2##2##(1991-12#1)(2008-4#1)
their competence##2##2##(1995-5#1)(1997-8#1)
their competitive##3##2##(1996-2#1)(1997-2#1)(2005-11#1)
their competitors##2##2##(1993-1#1)(1996-3#1)
their complementarity##2##2##(1994-8#1)(2008-10#1)
their complementary sequences##2##3##(2006-12#1)(2008-10#1)
their complementary##8##2##(1992-7#1)(1993-12#1)(2006-12#2)(2008-10#2)(2008-4#1)(2011-2#1)
their complete##7##2##(1996-10#1)(2004-4#1)(2007-12#1)(2007-8#1)(2008-10#1)(2010-3#1)(2012-1#1)
their complex##7##2##(1991-12#1)(1995-2#1)(1997-5#1)(2007-12#1)(2008-3#2)(2008-5#1)
their complexation with##2##3##(2008-10#2)
their complexation##3##2##(2008-10#3)
their complexes have been screened##2##5##(2008-5#2)
their complexes have been##3##4##(2008-5#3)
their complexes with##10##3##(1991-12#1)(1992-3#1)(2007-8#1)(2008-10#5)(2010-12#1)(2012-1#1)
their complexes##17##2##(1991-12#1)(1992-3#1)(2007-8#1)(2008-10#7)(2008-5#3)(2010-12#1)(2010-7#1)(2012-1#2)
their complexity##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-12#1)
their compliance with##3##3##(2006-2#1)(2011-2#1)(2013-8#1)
their compliance##4##2##(2006-2#1)(2007-1#1)(2011-2#1)(2013-8#1)
their complications##8##2##(1990-1#1)(1990-6#1)(2005-8#1)(2007-11#1)(2007-8#1)(2008-3#1)(2012-12#1)(2013-8#1)
their component##2##2##(2008-10#1)(2008-11#1)
their components##12##2##(1993-2#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-3#1)(2010-12#1)(2012-3#1)
their composite##3##2##(1996-1#1)(2008-10#1)(2008-5#1)
their composition and##2##3##(2008-10#1)(2011-2#1)
their composition##10##2##(1994-3#1)(1995-5#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)
their compounds##2##2##(1997-2#1)(2005-4#1)
their comprehension of##2##3##(1997-3#1)(2010-2#1)
their computational##2##2##(1990-5#1)(2008-7#1)
their computer##2##2##(1990-5#1)(1996-6#1)
their concentration in the##2##4##(2004-9#1)(2009-4#1)
their concentration in##4##3##(2004-9#1)(2006-10#1)(2007-8#1)(2009-4#1)
their concentration is##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
their concentration##14##2##(1995-6#1)(2004-9#1)(2005-11#1)(2006-10#1)(2007-8#1)(2008-10#5)(2008-11#1)(2009-4#1)(2010-7#1)(2011-2#1)
their concentrations in##3##3##(1991-8#1)(2008-10#2)
their concentrations were##4##3##(1992-5#1)(1992-6#1)(2012-2#1)(2013-1#1)
their concentrations##17##2##(1991-8#1)(1992-5#1)(1992-6#1)(2008-10#8)(2008-11#1)(2008-3#1)(2012-2#2)(2013-1#2)
their concept##2##2##(2005-5#1)(2008-2#1)
their concerns##8##2##(1991-2#1)(1995-2#1)(2005-9#1)(2007-2#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
their conclusions are##2##3##(2006-10#1)(2010-6#1)
their conclusions##4##2##(2006-10#1)(2008-8#1)(2010-12#1)(2010-6#1)
their concomitant##3##2##(1992-11#1)(2007-11#1)(2008-10#1)
their concurrent##2##2##(1997-7#1)(2007-7#1)
their condition##15##2##(1990-4#1)(1993-6#1)(1993-7#1)(2006-8#1)(2007-12#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
their conditioned##2##2##(1994-12#1)(1995-12#1)
their conduct##2##2##(1994-3#1)(1995-3#1)
their confidence intervals##2##3##(1997-2#1)(2008-10#1)
their confidence##3##2##(1997-2#1)(2008-10#2)
their conformational##9##2##(1992-8#1)(1993-6#3)(1994-6#1)(2008-3#1)(2010-7#1)(2011-2#1)(2013-1#1)
their conformations##4##2##(1990-8#1)(1995-2#1)(2005-11#1)(2006-10#1)
their conjugated##3##2##(1995-11#1)(2008-3#1)(2013-7#1)
their conjugation with##2##3##(2009-9#1)(2012-12#1)
their conjugation##3##2##(1991-11#1)(2009-9#1)(2012-12#1)
their connection to##3##3##(2007-4#1)(2010-7#1)(2012-1#1)
their connection with##2##3##(2007-11#1)(2012-12#1)
their connection##6##2##(1990-11#1)(2007-11#1)(2007-4#1)(2010-7#1)(2012-1#1)(2012-12#1)
their consent##10##2##(1991-6#1)(1993-6#1)(1994-4#1)(1995-12#1)(2009-4#2)(2009-6#3)(2011-2#1)
their consequences in##2##3##(2007-2#1)(2010-8#1)
their consequences##8##2##(2007-11#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-3#1)(2009-4#1)(2010-8#1)(2013-1#1)
their conservation##2##2##(2008-10#1)(2008-7#1)
their considerable##2##2##(1992-1#1)(2006-12#1)
their constant##2##2##(2006-5#1)(2007-2#1)
their constituent##5##2##(1990-11#1)(1996-4#1)(2005-11#1)(2010-5#1)(2011-12#1)
their constituents##3##2##(2007-11#1)(2007-9#1)(2008-10#1)
their constitutional##2##2##(2008-10#1)(2008-8#1)
their constitutive##3##2##(1992-2#1)(2011-1#1)(2012-2#1)
their construction##3##2##(1996-4#1)(2006-5#1)(2008-10#1)
their consumption##4##2##(1991-9#1)(2008-10#1)(2009-12#1)(2011-1#1)
their content is##2##3##(2007-5#1)(2008-10#1)
their content of##4##3##(1990-4#1)(2007-1#1)(2007-11#1)(2012-2#1)
their content was##3##3##(1990-6#1)(2007-11#1)(2008-10#1)
their content##12##2##(1990-4#1)(1990-6#1)(2006-1#1)(2007-1#1)(2007-11#2)(2007-5#1)(2008-10#3)(2010-2#1)(2012-2#1)
their contents and##3##3##(1992-12#1)(2009-2#1)(2012-3#1)
their contents##12##2##(1992-12#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
their continued##4##2##(1997-1#1)(2006-5#1)(2010-7#1)(2011-12#1)
their continuing##2##2##(1995-12#1)(2008-8#1)
their continuous##2##2##(1994-12#1)(2008-11#1)
their contrast##2##2##(2008-3#1)(2008-4#1)
their contrasting##2##2##(2008-1#1)(2008-8#1)
their contribution to the##8##4##(1994-10#1)(2006-10#1)(2008-10#2)(2008-12#1)(2008-5#1)(2011-1#1)(2012-12#1)
their contribution to##17##3##(1992-12#1)(1994-10#1)(1996-9#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
their contribution##22##2##(1992-12#1)(1994-10#1)(1994-3#1)(1996-9#1)(2006-10#1)(2006-8#1)(2007-12#2)(2008-10#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
their contributions to##3##3##(2008-9#2)(2011-1#1)
their contributions##5##2##(2007-10#1)(2008-9#2)(2011-1#1)(2012-3#1)
their control##16##2##(1991-5#1)(1992-12#1)(1993-5#1)(2004-10#1)(2007-1#2)(2008-12#3)(2008-4#2)(2008-5#1)(2008-6#1)(2010-12#1)(2011-1#1)(2012-2#1)
their controls##8##2##(1991-1#2)(1991-3#1)(1996-5#1)(2006-8#2)(2008-10#1)(2008-7#1)
their conventional##4##2##(2007-12#1)(2007-9#1)(2009-3#1)(2012-2#1)
their conversion to##2##3##(1995-8#1)(2011-2#1)
their conversion##3##2##(1995-8#1)(2007-11#1)(2011-2#1)
their cooperation##3##2##(1993-10#1)(1997-6#1)(2011-1#1)
their coordination##2##2##(2008-10#1)(2010-5#1)
their coping##2##2##(1994-12#1)(2009-7#1)
their copper##4##2##(2008-10#1)(2008-5#2)(2012-2#1)
their copy##2##2##(1997-6#1)(2009-5#1)
their core##3##2##(1996-2#1)(2008-1#1)(2009-12#1)
their correct##5##2##(2007-6#1)(2008-10#2)(2012-12#2)
their correction##4##2##(2008-4#1)(2008-9#1)(2011-2#1)(2012-1#1)
their correlation in##2##3##(2008-3#1)(2013-1#1)
their correlation with##9##3##(1990-3#1)(1991-4#1)(2006-5#1)(2007-10#1)(2007-7#1)(2008-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
their correlation##15##2##(1990-3#1)(1991-4#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
their correlations##3##2##(2007-11#1)(2007-7#1)(2008-3#1)
their corresponding linear precursors##2##4##(2006-12#2)
their corresponding mRNAs##3##3##(1992-8#1)(1994-11#1)(2009-8#1)
their corresponding##60##2##(1990-2#1)(1992-1#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-9#1)(1996-4#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-2#2)(1997-6#1)(1997-8#2)(2004-2#1)(2005-10#1)(2005-11#1)(2006-12#5)(2007-11#3)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-8#1)(2013-1#4)
their cortisol##2##2##(1996-3#1)(2006-2#1)
their cost##3##2##(1993-12#1)(1994-12#1)(2008-10#1)
their cost-effectiveness##2##2##(2006-4#1)(2011-2#1)
their costs and##2##3##(2007-4#1)(2009-9#1)
their costs##5##2##(2005-10#1)(2007-4#1)(2009-9#1)(2010-2#1)(2013-1#1)
their counterparts from##3##3##(1994-10#1)(2008-10#1)(2009-6#1)
their counterparts in other##2##4##(2007-6#1)(2008-11#1)
their counterparts in##10##3##(1994-11#1)(1995-10#1)(1996-3#1)(1997-1#1)(1997-7#1)(2007-6#1)(2008-11#2)(2008-5#1)(2008-7#1)
their counterparts with##3##3##(2008-12#1)(2012-12#1)(2012-3#1)
their counterparts##24##2##(1994-10#1)(1994-11#1)(1995-10#1)(1995-4#1)(1996-3#1)(1997-1#1)(1997-7#1)(2005-7#1)(2006-4#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-6#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
their countries##5##2##(1993-6#1)(1996-9#1)(2006-2#1)(2008-11#1)(2013-1#1)
their coupled##2##2##(2008-9#1)(2012-2#1)
their coupling to##3##3##(1991-10#1)(1996-5#1)(2006-12#1)
their coupling##4##2##(1991-10#1)(1996-5#1)(2006-12#1)(2007-11#1)
their course##8##2##(2006-7#1)(2007-2#1)(2008-11#3)(2012-12#1)(2012-2#2)
their covalent##2##2##(1994-10#1)(1994-11#1)
their coverage##4##2##(1992-2#1)(2007-4#2)(2007-7#1)
their creation##3##2##(1991-7#1)(2006-6#1)(2007-9#1)
their critical##11##2##(1995-3#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
their cross##2##2##(2006-4#1)(2007-12#1)
their crystal structures##3##3##(2007-11#1)(2010-4#1)(2010-5#1)
their cultural##5##2##(2007-11#1)(2008-12#1)(2008-4#1)(2009-9#1)(2010-8#1)
their culture##5##2##(1991-12#1)(1994-1#1)(2008-11#1)(2008-9#1)(2012-12#1)
their current applications##2##3##(1993-12#1)(2008-4#1)
their current status##2##3##(2007-12#1)(2009-9#1)
their current##35##2##(1991-2#1)(1992-1#1)(1992-2#1)(1993-12#1)(1993-2#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-4#1)(2005-6#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2009-1#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
their curricula##3##2##(1996-2#1)(2008-1#1)(2012-3#1)
their curriculum and##2##3##(2008-10#1)(2008-9#1)
their curriculum##5##2##(1994-12#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-9#1)
their curvatures##2##2##(2008-9#1)(2011-1#1)
their customers##5##2##(1992-12#1)(1994-12#1)(1997-1#1)(2007-2#1)(2008-10#1)
their customers'##3##2##(1992-1#3)
their cutaneous##2##2##(1991-8#1)(2011-1#1)
their cytokine##2##2##(1995-12#1)(1997-8#1)
their cytokines##2##2##(2008-4#1)(2013-1#1)
their cytoplasm##8##2##(1990-6#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-8#1)(2012-2#1)
their cytoplasmic##4##2##(2007-8#1)(2007-9#1)(2008-1#1)(2008-4#1)
their cytoskeleton##2##2##(1994-2#1)(1997-4#1)
their cytotoxic##11##2##(1992-11#1)(1994-3#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2012-2#2)(2013-1#1)
their cytotoxicity against##4##3##(1993-7#1)(2006-12#1)(2007-1#1)(2012-12#1)
their cytotoxicity##11##2##(1990-7#1)(1993-7#1)(2006-12#2)(2007-1#1)(2008-11#1)(2008-8#1)(2010-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
their daily activities##3##3##(2006-6#1)(2010-5#1)(2011-2#1)
their daily life##3##3##(2006-7#1)(2009-2#1)(2010-7#1)
their daily lives##7##3##(1990-5#1)(1993-3#1)(2006-5#1)(2008-2#1)(2008-9#1)(2012-2#1)(2012-3#1)
their daily practice##3##3##(1997-1#1)(2007-8#2)
their daily##36##2##(1990-5#1)(1993-3#1)(1997-1#1)(1997-3#1)(2005-9#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-3#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-11#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-1#1)(2010-10#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
their damage##2##2##(2008-7#1)(2009-4#1)
their data analysis##2##3##(2012-2#2)
their data##14##2##(1990-5#1)(1997-1#1)(2007-12#1)(2008-3#3)(2008-4#1)(2008-7#3)(2010-2#1)(2012-2#2)(2012-3#1)
their databases##2##2##(1996-12#1)(2008-8#1)
their daughters against##2##3##(2011-1#2)
their daughters##10##2##(1992-4#1)(2006-7#1)(2008-12#1)(2008-5#1)(2008-9#1)(2011-1#5)
their day-to-day##2##2##(2011-2#1)(2012-12#1)
their death by##2##3##(2008-10#1)(2011-2#1)
their death##8##2##(1995-4#1)(1995-6#1)(2008-10#2)(2010-4#1)(2011-2#2)(2012-1#1)
their decision##10##2##(1991-8#1)(1996-2#2)(2006-11#1)(2008-9#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#1)
their decision-making##3##2##(1992-2#1)(2010-10#1)(2011-1#1)
their decisions about##2##3##(1993-12#1)(2004-12#1)
their decisions##7##2##(1993-12#1)(2004-12#1)(2008-11#1)(2009-3#1)(2009-9#1)(2012-11#1)(2013-8#1)
their decomposition##2##2##(2009-10#1)(2010-3#1)
their decreased##2##2##(1993-4#1)(1997-3#1)
their deficiencies##2##2##(1996-2#1)(2008-4#1)
their deficiency##2##2##(2007-6#1)(2011-1#1)
their definition and##2##3##(1995-4#1)(2008-1#1)
their definition##3##2##(1995-4#1)(2008-1#1)(2009-5#1)
their degradation behavior##2##3##(2010-10#1)(2010-8#1)
their degradation products##5##3##(1990-7#1)(2007-8#1)(2008-10#1)(2013-1#2)
their degradation##14##2##(1990-7#1)(2007-12#1)(2007-8#2)(2008-10#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-8#1)(2012-2#1)(2013-1#2)(2013-8#2)
their degree of##14##3##(1990-11#1)(1991-5#1)(1993-9#1)(1994-8#1)(1995-3#1)(1997-3#1)(2004-12#1)(2007-1#1)(2007-12#1)(2008-4#1)(2008-9#2)(2010-12#1)(2013-1#1)
their delayed##2##2##(2006-9#1)(2013-7#1)
their demand##3##2##(2008-2#1)(2013-1#2)
their demanding##2##2##(1991-12#1)(2006-2#1)
their demands and##2##3##(2009-10#1)(2013-1#1)
their demands##5##2##(2008-6#1)(2008-7#1)(2009-10#1)(2009-2#1)(2013-1#1)
their demographic and##2##3##(2007-3#1)(2007-7#1)
their demographic characteristics##3##3##(2007-10#1)(2010-12#1)(2010-3#1)
their demographic##7##2##(1991-1#1)(2007-10#1)(2007-3#1)(2007-7#1)(2010-12#1)(2010-3#1)(2011-2#1)
their demonstrated##2##2##(1996-9#1)(2008-9#1)
their dendrites##4##2##(1994-10#1)(1995-6#1)(1997-3#1)(2008-8#1)
their density##5##2##(1992-3#1)(1992-9#1)(1993-12#1)(1995-1#1)(2008-1#1)
their dental##3##2##(2008-8#1)(2011-12#1)(2012-3#1)
their dependence on the##4##4##(1996-5#1)(2005-11#1)(2006-10#1)(2008-3#1)
their dependence on##10##3##(1990-5#1)(1991-11#1)(1995-6#1)(1996-5#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-3#3)
their dependence##11##2##(1990-5#1)(1991-11#1)(1995-6#1)(1996-5#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#3)
their deployment##2##2##(2008-10#1)(2011-2#1)
their depth##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2009-3#1)
their deregulation##2##2##(1991-9#1)(2009-4#1)
their derivatives##17##2##(1990-8#1)(1991-3#1)(1991-8#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-5#1)(2007-4#1)(2008-10#3)(2008-11#2)(2008-5#1)(2009-4#1)(2010-11#1)(2012-3#1)
their descendants##3##2##(2006-5#1)(2008-5#1)(2009-3#1)
their descriptions of##4##3##(2007-5#1)(2008-1#1)(2008-11#1)(2008-12#1)
their desensitization##2##2##(2008-4#1)(2013-1#1)
their design and##3##3##(2012-2#1)(2013-1#2)
their design to##2##3##(2004-4#1)(2010-1#1)
their design##11##2##(2004-4#1)(2006-10#1)(2006-11#1)(2006-2#1)(2009-2#1)(2010-1#2)(2011-2#1)(2012-2#1)(2013-1#2)
their desire##2##2##(1993-1#1)(2007-2#1)
their desired##2##2##(1993-2#1)(2010-5#1)
their destabilization##2##2##(1990-8#1)(1997-3#1)
their destinations##4##2##(1995-2#1)(1996-5#1)(2009-4#1)(2011-2#1)
their detection and##2##3##(2010-6#1)(2012-3#1)
their detection at##2##3##(2008-10#1)(2008-11#1)
their detection limits##3##3##(2007-1#1)(2008-10#2)
their detection rates##2##3##(2010-12#1)(2012-2#1)
their detection with##2##3##(1994-10#1)(2008-9#1)
their detection##23##2##(1994-10#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
their determination by electrothermal##2##4##(2008-10#2)
their determination by inductively coupled plasma atomic emission spectrometry##3##9##(2008-10#3)
their determination by inductively coupled##4##5##(2008-10#4)
their determination by##17##3##(2008-10#17)
their determination in##6##3##(2008-10#6)
their determination##29##2##(2006-12#1)(2008-10#26)(2009-8#1)(2013-8#1)
their developing##2##2##(2007-12#1)(2013-1#1)
their development and function##2##4##(1995-8#1)(1996-3#1)
their development and##11##3##(1992-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-6#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-4#1)(2009-3#1)(2011-2#1)
their development is##5##3##(1997-7#1)(2007-12#1)(2007-8#1)(2008-7#1)(2010-4#1)
their development were##2##3##(2008-10#1)(2008-5#1)
their development##49##2##(1992-2#1)(1992-6#1)(1992-9#1)(1994-2#1)(1994-3#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-1#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#2)(2009-8#2)(2010-12#1)(2010-3#1)(2010-4#2)(2010-7#2)(2010-9#1)(2011-11#1)(2011-2#1)(2012-1#1)(2013-1#1)
their developmental##11##2##(1991-2#1)(1994-9#1)(1995-1#1)(2006-12#1)(2006-5#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-12#1)(2012-11#1)(2012-2#1)
their diabetes##3##2##(1997-3#1)(2011-2#1)(2012-1#1)
their diagnosis and##3##3##(1992-10#1)(2007-7#1)(2010-9#1)
their diagnosis##17##2##(1990-12#1)(1992-10#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-8#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-7#1)(2010-8#1)(2010-9#1)(2012-3#2)(2013-1#2)
their diagnostic and therapeutic##3##4##(2006-12#2)(2009-2#1)
their diagnostic and##5##3##(1992-10#1)(2006-12#2)(2009-2#1)(2010-4#1)
their diagnostic##10##2##(1992-10#1)(2006-12#2)(2006-2#1)(2008-10#1)(2009-2#1)(2010-4#1)(2012-1#1)(2012-12#1)(2013-1#1)
their diameters##3##2##(2008-3#2)(2008-7#1)
their diet to##2##3##(2008-2#1)(2011-2#1)
their diet with##2##3##(2008-5#2)
their diet##22##2##(1990-6#3)(1991-11#1)(1996-1#1)(1997-1#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-1#1)
their dietary habits##2##3##(1992-8#1)(2008-1#1)
their dietary##4##2##(1992-8#1)(2008-1#1)(2008-3#1)(2010-6#1)
their diets##4##2##(1991-11#2)(2004-3#1)(2008-9#1)
their difference in##2##3##(2008-10#1)(2009-7#1)
their difference##4##2##(2008-10#2)(2008-12#1)(2009-7#1)
their differences in##3##3##(1994-3#1)(1995-1#1)(2008-10#1)
their differences##6##2##(1994-3#1)(1995-1#1)(1996-5#1)(2008-10#1)(2008-3#1)(2011-2#1)
their different##31##2##(1990-11#1)(1992-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1996-12#1)(1997-4#1)(2007-11#3)(2008-10#7)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#1)(2011-1#2)(2012-1#1)(2012-11#2)
their differential diagnosis##3##3##(2007-9#1)(2010-6#1)(2013-8#1)
their differential effects##2##3##(1995-10#1)(1995-12#1)
their differential expression##2##3##(2008-10#1)(2010-2#1)
their differential##11##2##(1991-11#1)(1993-5#1)(1995-10#1)(1995-12#1)(2007-3#1)(2007-9#1)(2008-10#1)(2010-2#1)(2010-6#1)(2010-8#1)(2013-8#1)
their differentiation and##2##3##(2008-8#1)(2012-12#1)
their differentiation into mature##2##4##(1995-1#1)(2008-8#1)
their differentiation into##6##3##(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(2008-8#1)(2012-1#1)
their differentiation potential##2##3##(2006-10#1)(2008-11#1)
their differentiation##18##2##(1992-12#1)(1993-2#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(2006-10#1)(2006-9#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-8#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-4#1)
their differing##2##2##(1993-6#1)(2006-8#1)
their diffusion##3##2##(1993-8#1)(2007-7#1)(2009-2#1)
their digestive##3##2##(2007-3#1)(2008-5#1)(2012-12#1)
their dimensions##2##2##(2008-10#2)
their direct determination without previous separation##2##6##(2008-10#2)
their direct##12##2##(1992-3#1)(1992-8#1)(1994-2#1)(2005-1#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-2#1)(2009-8#1)(2010-11#1)
their direction of##2##3##(1997-6#1)(2010-10#1)
their direction##3##2##(1997-6#1)(2008-7#1)(2010-10#1)
their directions##3##2##(1993-3#1)(2008-2#2)
their disabilities##2##2##(1993-1#1)(1994-6#1)
their disability assessed as being more than 75%##2##8##(2006-10#2)
their disability assessed##3##3##(2006-10#3)
their disability##6##2##(2006-10#4)(2010-2#1)(2011-1#1)
their disappearance##2##2##(2007-8#1)(2008-1#1)
their discharge##6##2##(1993-12#2)(1996-8#1)(2008-11#1)(2010-10#1)(2013-1#1)
their discovery##8##2##(2006-12#1)(2008-7#2)(2008-8#1)(2010-12#2)(2010-5#1)(2013-1#1)
their discrimination##4##2##(1993-9#1)(2008-10#1)(2008-2#1)(2010-2#1)
their disease and the##2##4##(2007-8#1)(2008-7#1)
their disease and##8##3##(1990-6#1)(2007-2#2)(2007-3#1)(2007-8#1)(2008-7#1)(2011-1#1)(2011-12#1)
their disease within##2##3##(2007-11#1)(2010-12#1)
their disease##44##2##(1990-1#1)(1990-6#2)(1991-2#1)(1996-12#1)(1996-7#1)(2004-11#1)(2005-11#1)(2006-10#2)(2006-11#1)(2007-11#1)(2007-2#3)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#2)(2009-10#1)(2009-2#1)(2010-11#3)(2010-12#2)(2010-3#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)
their diseases##2##2##(2008-1#1)(2009-2#1)
their disorder##4##2##(1995-1#1)(2009-6#1)(2010-2#1)(2010-9#1)
their dispersal##2##2##(2008-8#2)
their disposal in##2##3##(2008-10#1)(2009-6#1)
their disposal##6##2##(1994-3#1)(2005-11#1)(2008-10#1)(2009-4#1)(2009-6#1)(2012-12#1)
their disruption##3##2##(2008-4#1)(2008-6#1)(2009-8#1)
their dissolution##2##2##(2004-12#1)(2008-10#1)
their distal##6##2##(1996-9#2)(2008-7#2)(2011-12#1)(2012-3#1)
their distance from the##2##4##(2010-9#1)(2013-1#1)
their distance to##2##3##(2008-11#1)(2008-9#1)
their distance##6##2##(1991-5#1)(1993-9#1)(2008-11#1)(2008-9#1)(2010-9#1)(2013-1#1)
their distinct##5##2##(1993-2#1)(1996-12#1)(1997-7#1)(2008-10#1)(2012-12#1)
their distinctive##3##2##(2008-8#1)(2010-7#1)(2012-12#1)
their distribution and##3##3##(2008-10#2)(2011-2#1)
their distribution in the##4##4##(1995-11#1)(1996-12#1)(2008-10#1)(2008-5#1)
their distribution in##10##3##(1995-11#1)(1996-12#1)(2008-10#1)(2008-5#1)(2009-7#1)(2011-12#1)(2013-1#3)(2013-8#1)
their distribution is##2##3##(1995-8#1)(2008-10#1)
their distribution##30##2##(1990-5#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(2005-11#1)(2006-12#1)(2007-6#1)(2008-10#5)(2008-12#1)(2008-5#2)(2008-8#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#3)(2013-8#1)
their distributions##5##2##(1991-8#1)(1991-9#1)(1993-12#1)(1997-2#1)(2006-9#1)
their divergence##2##2##(1996-4#1)(2012-3#1)
their divergent##2##2##(2011-12#1)(2012-12#1)
their diverse##7##2##(1993-1#1)(2008-10#1)(2008-12#1)(2010-12#1)(2012-12#1)(2013-8#2)
their diversity and##2##3##(2008-11#1)(2013-7#1)
their diversity##5##2##(1996-6#1)(2008-11#1)(2008-5#1)(2010-9#1)(2013-7#1)
their docking##2##2##(1997-7#1)(2013-8#1)
their doctors##3##2##(1990-6#1)(2007-8#1)(2011-1#1)
their documentation##2##2##(2008-7#1)(2012-2#1)
their domain##3##2##(1990-10#2)(2009-10#1)
their dominance##2##2##(2007-9#1)(2011-2#1)
their dosage##3##2##(1997-2#1)(2005-11#1)(2008-10#1)
their dose of##2##3##(1995-2#1)(2007-12#1)
their downstream##4##2##(2008-4#1)(2008-8#2)(2010-10#1)
their drawbacks##2##2##(2007-8#1)(2012-2#1)
their drinking solution##2##3##(2009-5#2)
their drinking water##6##3##(1996-11#1)(2004-11#1)(2008-10#2)(2009-5#1)(2013-8#1)
their drinking##10##2##(1996-11#1)(2004-11#1)(2008-10#2)(2009-5#3)(2010-7#1)(2011-1#1)(2013-8#1)
their driving##3##2##(2012-12#3)
their drug use##2##3##(2005-10#1)(2007-2#1)
their drug##5##2##(1993-10#1)(1996-12#1)(2005-10#1)(2007-2#1)(2008-11#1)
their dry##2##2##(2008-5#1)(2010-6#1)
their dual##3##2##(2007-8#1)(2010-10#1)(2013-8#1)
their duration##6##2##(1995-6#1)(1996-3#1)(2006-11#1)(2008-2#1)(2011-2#1)(2012-11#1)
their duties and obligations##2##4##(2005-5#1)(2008-6#1)
their duties##5##2##(1995-1#1)(1996-12#1)(2005-5#1)(2008-6#1)(2012-3#1)
their dynamic##3##2##(1993-1#1)(2006-10#1)(2008-7#1)
their dynamics##3##2##(1991-7#1)(1996-12#1)(2011-3#1)
their early detection##2##3##(1996-6#1)(2013-8#1)
their early experience with##2##4##(2006-7#1)(2006-8#1)
their early##20##2##(1996-6#1)(2006-10#1)(2006-5#1)(2006-7#2)(2006-8#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
their ears##2##2##(2008-7#1)(2011-12#1)
their ease of##2##3##(1997-2#1)(2010-12#1)
their eating habits##2##3##(2008-9#1)(2010-7#1)
their eating##5##2##(1993-6#1)(2005-3#1)(2008-1#1)(2008-9#1)(2010-7#1)
their ecological and##2##3##(2008-9#1)(2012-5#1)
their ecological##6##2##(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#2)(2012-5#1)
their economic##6##2##(1991-2#1)(1994-1#2)(2006-10#1)(2008-10#1)(2013-8#1)
their ectoparasites##2##2##(2008-5#1)(2011-1#1)
their education and##2##3##(1992-12#1)(2010-8#1)
their education##7##2##(1992-12#1)(2006-6#1)(2007-1#1)(2008-11#2)(2010-8#1)(2013-1#1)
their effect in##3##3##(1993-6#1)(2007-12#1)(2010-12#1)
their effect on the growth of##2##6##(2008-10#1)(2008-5#1)
their effect on the##20##4##(1991-2#1)(1996-2#1)(1997-8#1)(2005-11#1)(2006-11#1)(2007-10#1)(2008-10#8)(2008-11#1)(2008-5#2)(2008-7#1)(2012-1#2)
their effect on##61##3##(1990-8#1)(1991-2#1)(1991-3#2)(1991-9#1)(1992-3#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-11#1)(1996-2#1)(1996-3#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#2)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-12#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
their effect through##2##3##(2008-9#1)(2009-2#1)
their effect upon##2##3##(1991-5#1)(1995-5#1)
their effect##73##2##(1990-8#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#2)(2007-12#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-12#1)(2012-1#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
their effective use##2##3##(1991-2#1)(1994-1#1)
their effective##7##2##(1991-2#1)(1994-1#1)(2004-9#1)(2008-2#1)(2008-3#1)(2008-9#1)(2013-1#1)
their effectiveness and##3##3##(2008-9#1)(2010-12#1)(2013-1#1)
their effectiveness as##3##3##(2008-1#1)(2008-11#1)(2013-1#1)
their effectiveness in the prevention and##2##6##(2005-1#1)(2007-9#1)
their effectiveness in the prevention##3##5##(2005-1#1)(2007-8#1)(2007-9#1)
their effectiveness in the##5##4##(2005-1#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-5#1)
their effectiveness in##13##3##(1990-11#1)(2005-1#1)(2006-4#1)(2007-1#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-5#2)(2008-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
their effectiveness is##3##3##(2005-11#1)(2012-12#1)(2013-8#1)
their effectiveness to##3##3##(2008-7#1)(2012-2#2)
their effectiveness##49##2##(1990-11#1)(1990-12#1)(1992-1#1)(1993-11#1)(1993-3#1)(1993-7#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-1#1)(2005-1#1)(2005-11#1)(2005-7#1)(2006-4#1)(2006-7#1)(2007-1#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-1#1)(2010-12#2)(2010-2#1)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#2)
their effector##3##2##(1990-3#1)(1996-5#1)(2012-1#1)
their effects and##3##3##(2008-1#1)(2008-10#2)
their effects are##3##3##(1994-8#1)(2006-10#1)(2008-9#1)
their effects by##5##3##(1991-2#1)(1994-11#1)(1994-4#1)(1996-5#1)(2008-4#1)
their effects in a##2##4##(2008-10#1)(2012-12#1)
their effects on LDL metabolism##2##5##(1993-6#2)
their effects on a##2##4##(1991-5#1)(2007-1#1)
their effects on embryonic development##2##5##(2010-7#2)
their effects on growth##2##4##(1993-12#1)(1994-11#1)
their effects on the cell##2##5##(2008-3#1)(2008-5#1)
their effects on the immune##2##5##(2012-2#2)
their effects on the##31##4##(1990-11#1)(1991-5#1)(1992-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-5#1)(1995-6#1)(1996-11#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-12#1)(2006-12#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-3#4)(2008-5#1)(2010-5#1)(2011-2#1)(2012-2#3)(2012-3#1)
their effects on##97##3##(1990-11#2)(1990-5#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#2)(1992-10#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-4#1)(1993-6#3)(1993-8#1)(1993-9#2)(1994-11#2)(1994-5#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-11#2)(1996-12#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#2)(2004-12#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-9#1)(2007-1#2)(2007-12#2)(2008-10#8)(2008-11#1)(2008-12#2)(2008-3#4)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#6)(2008-9#3)(2009-4#1)(2009-5#1)(2010-5#1)(2010-7#2)(2011-1#3)(2011-2#3)(2012-2#4)(2012-3#3)(2013-1#2)
their effects through##3##3##(1996-5#1)(1997-4#1)(2008-8#1)
their effects upon##2##3##(2005-9#1)(2008-3#1)
their effects via##2##3##(1990-8#1)(1994-8#1)
their effects were##3##3##(1991-4#1)(1995-3#1)(2008-11#1)
their effects##141##2##(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-9#1)(1992-10#2)(1992-3#1)(1992-5#2)(1993-12#1)(1993-4#1)(1993-6#3)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#3)(1994-4#1)(1994-5#1)(1994-8#2)(1995-3#2)(1995-5#1)(1995-6#2)(1996-11#2)(1996-12#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#2)(2004-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-9#1)(2007-1#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#14)(2008-11#2)(2008-12#2)(2008-3#5)(2008-4#4)(2008-5#3)(2008-7#1)(2008-8#7)(2008-9#4)(2009-4#1)(2009-5#1)(2010-2#1)(2010-5#2)(2010-7#3)(2011-1#3)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#3)(2013-7#1)
their efficacy and##9##3##(1990-1#1)(1990-2#1)(1993-11#1)(2006-10#1)(2008-5#1)(2011-12#1)(2012-2#1)(2013-1#2)
their efficacy for##2##3##(2008-3#1)(2010-12#1)
their efficacy in the##2##4##(1990-1#1)(2005-9#1)
their efficacy in##10##3##(1990-1#1)(2005-7#1)(2005-9#1)(2006-10#1)(2008-10#2)(2009-7#1)(2011-2#1)(2012-12#1)(2013-7#1)
their efficacy is##2##3##(2010-9#1)(2012-1#1)
their efficacy##43##2##(1990-1#2)(1990-2#1)(1990-4#1)(1991-3#1)(1993-11#2)(1994-10#1)(1994-11#1)(1996-12#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-12#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#1)(2009-7#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#1)
their efficiencies##2##2##(1994-6#1)(1996-7#1)
their efficiency in##3##3##(2007-8#1)(2008-11#1)(2008-5#1)
their efficiency to##3##3##(2008-2#1)(2008-5#1)(2013-7#1)
their efficiency##14##2##(1991-5#1)(1993-3#1)(2005-1#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#3)(2012-11#1)(2013-7#1)
their efficient##4##2##(1992-12#1)(2008-11#1)(2008-7#1)(2012-2#1)
their effort##2##2##(1990-12#1)(1993-12#1)
their efforts in##3##3##(1995-1#1)(2009-1#1)(2009-4#1)
their efforts on##3##3##(1997-1#1)(2010-5#1)(2011-1#1)
their efforts to improve##2##4##(1995-3#1)(2012-3#1)
their efforts to##16##3##(1990-10#1)(1995-3#1)(1996-3#2)(2004-9#1)(2007-4#1)(2007-9#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#2)
their efforts##31##2##(1990-10#1)(1991-8#1)(1995-1#1)(1995-3#1)(1996-3#2)(1997-1#1)(2004-9#1)(2006-11#1)(2007-11#1)(2007-4#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-1#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-3#3)(2013-8#1)
their eggs##7##2##(1991-11#1)(1992-1#1)(2004-11#1)(2007-12#1)(2008-9#1)(2013-1#2)
their electrical properties##3##3##(2007-9#1)(2010-2#1)(2012-2#1)
their electrical##7##2##(2007-9#1)(2008-10#1)(2009-3#1)(2010-2#1)(2010-4#1)(2012-2#1)(2013-8#1)
their electrocatalytic##2##2##(2008-10#2)
their electrochemical detection##2##3##(2008-10#2)
their electrochemical##6##2##(2005-7#1)(2008-10#4)(2008-8#1)
their electronic##6##2##(1990-5#1)(2007-12#3)(2007-4#1)(2008-5#1)
their electrophoretic mobility##2##3##(1996-5#1)(2008-9#1)
their electrophoretic##5##2##(1990-3#1)(1991-10#1)(1992-2#1)(1996-5#1)(2008-9#1)
their elements##2##2##(2008-2#1)(2012-2#1)
their elimination##4##2##(2005-11#1)(2008-10#1)(2008-12#1)(2008-9#1)
their elution##2##2##(1990-7#1)(1991-11#1)
their embryonic##2##2##(2007-5#1)(2010-10#1)
their emergence##2##2##(1995-1#1)(2008-9#1)
their emerging role in the##3##5##(2007-3#1)(2009-3#1)(2010-2#1)
their emerging role in##4##4##(2007-3#1)(2009-3#1)(2010-2#1)(2012-2#1)
their emerging##5##2##(2007-3#1)(2008-10#1)(2009-3#1)(2010-2#1)(2012-2#1)
their emission##3##2##(2006-5#1)(2008-10#1)(2008-9#1)
their emotions##2##2##(2008-11#1)(2008-5#1)
their employees##8##2##(1990-12#1)(1992-3#1)(1993-3#1)(1995-1#1)(1996-12#1)(2006-1#1)(2007-2#1)(2008-11#1)
their employers##4##2##(1992-12#1)(2005-7#1)(2007-2#1)(2012-12#1)
their employment##7##2##(1995-1#2)(2006-9#1)(2007-12#1)(2007-8#1)(2009-9#1)(2012-11#1)
their encoding##3##2##(1993-3#1)(2008-10#1)(2013-1#1)
their endogenous expression##2##3##(1995-1#1)(2008-4#1)
their endogenous ligands##2##3##(2008-7#1)(2009-7#1)
their endogenous##7##2##(1995-1#2)(2008-4#1)(2008-7#1)(2009-6#1)(2009-7#1)(2011-2#1)
their endoscopic removal##2##3##(2007-3#1)(2008-5#1)
their endoscopic##4##2##(2006-10#1)(2007-3#1)(2008-5#1)(2010-9#1)
their energies##2##2##(1997-1#1)(2006-5#1)
their energy##8##2##(1995-11#1)(2005-3#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-7#1)(2010-10#1)(2011-2#1)
their engagement with##2##3##(2008-11#1)(2009-4#1)
their enhanced##4##2##(1993-6#1)(1995-12#1)(2008-10#1)(2008-5#1)
their enrichment##2##2##(2008-10#1)(2008-4#1)
their enrollment decisions after##2##4##(2009-6#2)
their entire##4##2##(1992-11#1)(1997-2#1)(2008-11#1)(2008-5#1)
their entry into##2##3##(1991-8#1)(1994-10#1)
their entry##3##2##(1991-8#1)(1994-10#1)(2008-11#1)
their environment and##4##3##(1992-10#1)(1994-6#1)(2008-7#1)(2010-10#1)
their environment to##3##3##(1992-12#1)(2008-10#2)
their environment##32##2##(1992-10#1)(1992-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1996-12#2)(1996-2#1)(1997-3#1)(1997-4#2)(2007-8#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#1)(2008-7#2)(2009-3#1)(2009-6#1)(2010-10#1)(2010-8#1)(2010-9#2)(2011-2#3)(2012-12#1)(2012-2#1)
their environmental##5##2##(1990-12#1)(1992-3#1)(2008-10#2)(2008-5#1)
their environments##6##2##(1991-1#1)(1991-8#1)(1994-11#1)(2008-11#1)(2008-9#1)(2011-2#1)
their enzymatic activity##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2010-2#1)
their enzymatic##6##2##(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2010-2#1)
their epidemiological##2##2##(1996-12#1)(2012-12#1)
their epidemiology##3##2##(2007-11#1)(2009-4#1)(2010-3#1)
their epitope##2##2##(1993-1#1)(2011-2#1)
their epitopes##4##2##(1993-1#1)(1997-7#1)(2008-8#2)
their equivalent##3##2##(1995-4#1)(2008-10#1)(2008-2#1)
their essential role in##2##4##(1996-5#1)(2010-8#1)
their essential##6##2##(1996-5#1)(2008-1#1)(2008-8#1)(2010-8#1)(2011-1#1)(2012-12#1)
their estimated##2##2##(1990-3#1)(2012-2#1)
their estimates##2##2##(2006-5#1)(2008-10#1)
their estimation##2##2##(1997-7#1)(2008-10#1)
their estrogen receptor##4##3##(2008-11#4)
their estrous cycle##2##3##(1992-9#1)(2013-1#1)
their ethanol intake##2##3##(1996-10#2)
their ethanol##3##2##(1996-10#3)
their ethnic##4##2##(2004-12#1)(2006-8#1)(2007-12#1)(2010-4#1)
their ethnocultural##2##2##(2008-12#1)(2011-2#1)
their etiology##5##2##(1997-8#1)(2006-10#1)(2009-12#1)(2011-1#1)(2011-2#1)
their evaluation in vivo##2##4##(1994-9#1)(2006-6#1)
their evaluation in##5##3##(1992-9#1)(1994-9#1)(2006-12#1)(2006-6#1)(2008-5#1)
their evaluation of##4##3##(1995-2#1)(2008-11#1)(2008-7#1)(2012-12#1)
their evaluation##14##2##(1992-9#1)(1994-9#1)(1995-2#1)(2006-12#1)(2006-6#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#1)(2010-5#1)(2012-12#1)
their evaluations##2##2##(1995-2#1)(2008-2#1)
their eventual##2##2##(1991-9#1)(2009-11#1)
their everyday practice##3##3##(2007-3#1)(2007-9#1)(2010-1#1)
their everyday##6##2##(1995-6#1)(2005-7#1)(2007-3#1)(2007-9#1)(2010-1#1)(2010-11#1)
their evolution and##2##3##(2008-7#1)(2011-12#1)
their evolution is##2##3##(1992-8#1)(2010-3#1)
their evolution##10##2##(1992-8#1)(2005-11#1)(2008-1#1)(2008-7#2)(2009-2#1)(2010-3#1)(2010-5#1)(2011-12#1)(2013-8#1)
their evolutionary relationships##3##3##(1994-6#1)(2010-2#1)(2013-8#1)
their evolutionary##14##2##(1994-6#1)(1996-6#1)(2004-11#1)(2008-7#1)(2008-8#2)(2010-2#1)(2010-5#1)(2010-6#1)(2012-2#1)(2013-1#2)(2013-8#2)
their evolving##2##2##(1992-1#1)(2009-10#1)
their exact position on##2##4##(2007-6#2)
their exact role##2##3##(1996-4#1)(2008-4#1)
their exact##8##2##(1992-6#1)(1996-4#1)(2006-10#1)(2007-11#1)(2007-6#2)(2008-3#1)(2008-4#1)
their excellent##4##2##(1997-8#1)(2008-5#1)(2009-7#1)(2010-4#1)
their excess##2##2##(1994-2#1)(2010-8#1)
their excessive##3##2##(2007-7#1)(2008-3#1)(2010-12#1)
their exchange##2##2##(1997-1#1)(2008-10#1)
their existence##7##2##(1991-12#1)(1992-5#1)(1993-5#1)(1997-6#1)(1997-8#1)(2006-9#1)(2008-8#1)
their existing##8##2##(1993-2#1)(1994-1#1)(2008-11#1)(2008-5#1)(2011-3#1)(2013-1#2)(2013-8#1)
their expectations and##2##3##(2008-3#1)(2008-9#1)
their expectations##12##2##(1992-12#1)(1994-1#1)(2006-8#1)(2007-4#1)(2008-3#1)(2008-9#2)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
their expected##4##2##(1994-5#1)(2008-11#1)(2009-3#1)(2011-2#1)
their experience about##3##3##(1990-10#1)(1990-5#1)(1992-5#1)
their experience and##3##3##(1993-10#1)(1994-2#1)(2008-12#1)
their experience as##2##3##(1996-12#1)(2009-5#1)
their experience in the##3##4##(1993-10#2)(2006-2#1)
their experience in##6##3##(1990-5#1)(1991-6#1)(1993-10#2)(1993-5#1)(2006-2#1)
their experience of social##2##4##(2009-5#1)(2011-2#1)
their experience of the##3##4##(1993-9#1)(1996-9#1)(1997-6#1)
their experience of##14##3##(1990-3#1)(1990-9#1)(1991-8#1)(1992-6#1)(1993-5#1)(1993-9#1)(1996-9#2)(1997-6#1)(2007-2#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
their experience the##2##3##(1992-5#1)(1993-10#1)
their experience with the##6##4##(1990-8#1)(1993-10#1)(2006-12#1)(2007-7#1)(2008-6#1)(2012-2#1)
their experience with this##4##4##(1993-11#1)(1993-3#1)(2006-11#1)(2008-11#1)
their experience with##21##3##(1990-10#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-4#1)(1993-10#1)(1993-11#1)(1993-3#1)(1996-1#1)(2006-11#2)(2006-12#2)(2006-8#1)(2007-4#1)(2007-7#2)(2008-11#1)(2008-6#1)(2011-2#1)(2012-2#1)
their experience##60##2##(1990-10#2)(1990-3#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-5#2)(1992-6#1)(1993-10#5)(1993-11#1)(1993-3#1)(1993-5#2)(1993-9#2)(1994-2#1)(1994-8#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-9#2)(1997-6#1)(2006-11#2)(2006-12#2)(2006-2#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-4#1)(2007-7#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2009-5#3)(2009-9#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
their experiences and##2##3##(2011-1#1)(2011-2#1)
their experiences in caring for##2##5##(2010-8#1)(2011-2#1)
their experiences in the##2##4##(1995-12#1)(2009-12#1)
their experiences in##5##3##(1995-12#1)(2007-11#1)(2009-12#1)(2010-8#1)(2011-2#1)
their experiences of being##2##4##(2008-11#1)(2010-10#1)
their experiences of##5##3##(1993-1#1)(2006-4#1)(2008-11#1)(2009-5#1)(2010-10#1)
their experiences on##2##3##(1995-4#1)(2007-2#1)
their experiences with the##3##4##(2007-7#1)(2007-9#1)(2013-7#1)
their experiences with##12##3##(1995-12#1)(1996-1#1)(2007-10#1)(2007-7#2)(2007-9#2)(2008-10#1)(2008-12#1)(2009-9#1)(2011-1#1)(2013-7#1)
their experiences##40##2##(1993-1#1)(1994-1#1)(1995-12#2)(1995-4#1)(1996-1#1)(2005-7#1)(2006-3#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-5#1)(2007-7#2)(2007-9#2)(2008-10#2)(2008-11#3)(2008-12#2)(2009-12#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#3)(2013-7#1)
their experimental##4##2##(2008-10#1)(2008-3#2)(2008-7#1)
their expertise and##2##3##(2008-9#1)(2011-2#1)
their expertise##9##2##(2005-9#1)(2007-4#2)(2008-1#1)(2008-11#2)(2008-9#1)(2011-2#1)(2013-8#1)
their exposure to##8##3##(1991-12#1)(1995-3#1)(2004-9#1)(2005-11#1)(2006-5#1)(2008-2#1)(2012-12#2)
their expression in##12##3##(1991-4#1)(1992-4#1)(1992-7#1)(1993-8#1)(1994-12#1)(1995-12#1)(1996-4#1)(1997-6#1)(2007-2#1)(2008-8#1)(2010-11#1)(2011-2#1)
their expression is regulated##3##4##(2006-11#1)(2010-10#1)(2011-1#1)
their expression is##6##3##(1994-11#1)(2006-11#1)(2008-11#1)(2010-10#1)(2011-1#1)(2013-8#1)
their expression of cell##2##4##(2008-11#1)(2008-4#1)
their expression of##10##3##(1993-4#1)(1994-8#1)(1995-12#1)(2007-12#1)(2008-11#2)(2008-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
their expression patterns in##2##4##(1997-7#1)(2008-10#1)
their expression patterns##8##3##(1993-9#1)(1995-12#1)(1997-4#1)(1997-7#1)(2005-12#1)(2007-12#1)(2008-10#1)(2008-5#1)
their expression profiles##2##3##(1993-8#1)(2008-4#1)
their expression was##2##3##(1995-11#1)(2011-2#1)
their expression##62##2##(1990-12#1)(1991-4#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-4#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-3#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-12#1)(2006-10#1)(2006-11#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#1)
their expressions##2##2##(2005-11#1)(2012-12#1)
their extensive##6##2##(1993-9#1)(2007-4#1)(2008-1#1)(2008-3#1)(2011-2#1)(2012-12#1)
their external##3##2##(1993-12#1)(1995-2#1)(2007-12#1)
their extracellular domains##2##3##(1993-8#1)(1995-3#1)
their extracellular environment##2##3##(2011-1#1)(2013-8#1)
their extracellular##12##2##(1990-9#1)(1992-9#1)(1993-8#1)(1994-11#1)(1995-3#1)(1997-1#1)(2008-11#1)(2009-12#1)(2011-1#3)(2013-8#1)
their extraction##5##2##(1997-8#1)(2007-8#1)(2008-10#1)(2009-8#1)(2010-9#1)
their extreme##2##2##(2008-7#1)(2011-1#1)
their eyes and##2##3##(1995-11#1)(2007-9#1)
their eyes##8##2##(1995-11#1)(1995-8#1)(1996-1#1)(2007-1#1)(2007-4#1)(2007-9#1)(2010-10#1)(2011-1#1)
their fabrication##4##2##(2008-10#1)(2008-3#2)(2008-5#1)
their facilitation##2##2##(2008-11#1)(2010-10#1)
their facilities##2##2##(1994-3#1)(2010-1#1)
their facility##2##2##(1990-5#1)(2007-12#1)
their failure to##4##3##(1994-9#1)(1995-5#1)(1995-8#1)(2007-11#1)
their failure##6##2##(1994-9#1)(1995-5#1)(1995-8#1)(2007-11#1)(2008-11#1)(2008-8#1)
their families and the##2##4##(2008-1#1)(2012-12#1)
their families and##10##3##(1990-6#1)(1996-11#1)(2007-9#1)(2008-1#2)(2008-11#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
their families in##4##3##(1991-12#1)(1996-4#1)(2010-1#1)(2012-2#1)
their families##133##2##(1990-10#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-1#3)(1992-12#3)(1992-3#3)(1992-4#1)(1993-3#1)(1993-9#1)(1994-1#2)(1994-12#1)(1994-3#2)(1995-12#1)(1995-2#1)(1995-3#4)(1996-1#2)(1996-11#1)(1996-4#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#2)(2005-11#2)(2005-6#1)(2006-10#2)(2006-5#1)(2006-9#1)(2007-10#2)(2007-12#3)(2007-2#9)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#1)(2008-11#15)(2008-12#2)(2008-2#2)(2008-5#1)(2008-7#5)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#6)(2013-1#5)
their family and##3##3##(2008-12#1)(2011-2#1)(2012-2#1)
their family caregivers##7##3##(2007-10#1)(2007-12#1)(2011-2#5)
their family members and friends##2##5##(1996-3#2)
their family members##8##3##(1992-2#1)(1993-3#1)(1996-3#2)(2008-11#2)(2009-4#1)(2009-6#1)
their family##34##2##(1990-4#1)(1992-2#1)(1993-3#2)(1994-12#1)(1995-1#1)(1996-3#2)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#2)(2011-1#1)(2011-2#6)(2012-2#2)(2013-1#2)
their family's##2##2##(1996-1#1)(2007-2#1)
their fate##4##2##(2008-1#1)(2008-10#1)(2010-11#1)(2013-8#1)
their fatty acid##3##3##(2008-10#1)(2008-11#1)(2012-1#1)
their fatty##4##2##(2008-10#1)(2008-11#1)(2008-4#1)(2012-1#1)
their fears##2##2##(2010-9#1)(2011-2#1)
their feasibility##2##2##(1997-7#1)(2008-10#1)
their features##2##2##(2008-4#1)(2013-7#1)
their feedback##2##2##(2012-12#1)(2013-8#1)
their feeding##3##2##(2008-11#1)(2010-8#1)(2011-2#1)
their feelings about##2##3##(1992-3#1)(2008-5#1)
their feelings##7##2##(1992-3#1)(2004-3#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-5#2)
their female##5##2##(1993-5#1)(1996-3#1)(2007-6#1)(2013-1#2)
their fertility##5##2##(2006-5#1)(2007-7#1)(2012-2#1)(2013-8#2)
their field of##3##3##(2008-2#1)(2008-5#1)(2008-6#1)
their fields##3##2##(1996-2#1)(2008-10#1)(2009-11#1)
their final post-stressed vowels##2##4##(2009-11#2)
their final##16##2##(1993-2#1)(1995-11#1)(1996-3#1)(1997-1#1)(2007-8#1)(2008-11#1)(2008-9#1)(2009-11#2)(2009-4#1)(2009-9#2)(2010-12#1)(2010-6#1)(2012-11#2)
their financial##8##2##(1995-1#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-7#1)(2010-10#2)(2010-5#1)
their finding##2##2##(2007-9#1)(2010-8#1)
their findings are##2##3##(1993-12#1)(2010-12#1)
their findings to the##2##4##(2005-7#1)(2006-2#1)
their findings to##3##3##(2005-7#1)(2006-2#1)(2013-7#1)
their findings with##2##3##(1993-11#1)(2006-7#1)
their findings##12##2##(1993-11#1)(1993-12#1)(1993-3#1)(2004-10#1)(2005-7#1)(2006-2#1)(2006-7#2)(2007-9#1)(2010-12#1)(2013-7#2)
their finger##2##2##(2009-2#2)
their fingers in##2##3##(2006-3#1)(2013-8#1)
their finite##2##2##(1997-7#1)(2009-12#1)
their first HIV test##2##4##(2009-5#2)
their first child##3##3##(1991-5#1)(2004-3#1)(2006-2#1)
their first choice##2##3##(2010-4#1)(2013-1#1)
their first clinical placement##4##4##(2008-12#2)(2012-12#2)
their first clinical practice##2##4##(2007-10#2)
their first clinical##8##3##(2007-10#2)(2008-10#1)(2008-12#3)(2012-12#2)
their first encounter##2##3##(2008-11#2)
their first episode of##2##4##(1993-3#1)(2011-2#1)
their first exposure to##3##4##(1993-7#2)(2012-1#1)
their first months##2##3##(1992-1#1)(2013-1#1)
their first practice placement##3##4##(2008-11#3)
their first practice##4##3##(2008-11#3)(2008-9#1)
their first pregnancy##3##3##(2012-12#3)
their first sexual##2##3##(1992-10#1)(2007-3#1)
their first test##2##3##(2009-5#2)
their first visit##2##3##(1994-2#1)(2008-7#1)
their first year of life##5##5##(1992-7#1)(2006-10#1)(2012-2#2)(2013-1#1)
their first year of##9##4##(1992-1#1)(1992-7#1)(2006-10#1)(2007-10#1)(2011-1#2)(2012-2#2)(2013-1#1)
their first year##12##3##(1992-1#1)(1992-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-4#1)(2009-4#1)(2011-1#2)(2012-2#2)(2013-1#1)
their first##90##2##(1990-12#1)(1990-3#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#2)(1992-10#1)(1992-5#1)(1992-7#1)(1993-10#1)(1993-3#1)(1993-5#1)(1993-7#2)(1994-2#1)(1995-9#1)(1997-2#1)(1997-6#2)(2004-3#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-7#2)(2007-10#4)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#5)(2008-12#3)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-5#4)(2009-9#1)(2010-1#1)(2010-10#1)(2010-3#2)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#2)(2013-1#6)(2013-8#1)
their first-degree relatives##4##3##(2006-9#1)(2008-3#1)(2009-4#2)
their fitness for##2##3##(2006-8#1)(2008-10#1)
their fitness##4##2##(2006-8#1)(2008-1#1)(2008-10#1)(2008-8#1)
their flame atomic absorption spectrometric determinations##2##6##(2008-10#2)
their flame atomic absorption spectrometric##3##5##(2008-10#3)
their flanking##4##2##(1990-11#1)(1993-8#1)(1997-7#1)(2012-1#1)
their flexibility##3##2##(2007-4#1)(2009-9#1)(2010-5#1)
their flight##2##2##(2008-9#1)(2011-1#1)
their fluidity##2##2##(1990-12#1)(1991-9#1)
their fluorescence##5##2##(1991-7#2)(2009-12#1)(2011-2#1)(2013-8#1)
their fluorescent##3##2##(1990-5#1)(1993-11#1)(2008-10#1)
their focal##3##2##(1995-12#1)(2008-3#2)
their focus on the##2##4##(1996-1#1)(2008-8#1)
their focus##5##2##(1996-1#1)(2007-7#1)(2008-10#1)(2008-8#2)
their folding##4##2##(1993-11#1)(2008-5#1)(2008-7#1)(2008-9#1)
their food##3##2##(1993-9#1)(1996-3#1)(2013-7#1)
their forehead areas##2##3##(2005-11#2)
their foremost consideration##2##3##(2009-4#2)
their form##3##2##(2006-5#1)(2007-8#1)(2008-9#1)
their formation and##3##3##(2006-10#1)(2007-12#1)(2008-10#1)
their formation was##2##3##(1993-8#1)(2010-12#1)
their formation##21##2##(1991-11#1)(1991-3#1)(1991-9#1)(1993-8#1)(1994-12#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#1)(2009-10#1)(2010-12#1)(2010-7#1)(2012-12#1)
their former##5##2##(1993-9#1)(2009-10#1)(2012-3#1)(2013-1#2)
their fractional##2##2##(2008-2#1)(2010-3#1)
their fractionation##2##2##(1991-8#1)(2008-10#1)
their fragile##3##2##(2008-1#1)(2009-10#1)(2009-7#1)
their fragment##2##2##(2008-10#1)(2008-12#1)
their fragmentation##2##2##(2008-10#1)(2012-3#1)
their free radical##2##3##(1991-2#1)(2007-3#1)
their free##7##2##(1991-11#1)(1991-2#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-7#1)
their free-living##2##2##(2006-10#1)(2007-12#1)
their freedom##2##2##(2009-9#1)(2012-2#1)
their frequency##12##2##(1994-6#1)(1995-2#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-4#1)(2008-9#1)(2010-12#2)(2010-2#1)(2013-8#1)
their frequent##3##2##(1992-8#1)(2008-3#1)(2013-1#1)
their fresh##2##2##(1992-8#1)(2007-7#1)
their friends##6##2##(1995-1#1)(2007-1#1)(2009-7#3)(2012-1#1)
their fruit##2##2##(2010-3#1)(2010-6#1)
their full potential##4##3##(1994-3#1)(2007-1#1)(2007-10#1)(2008-12#1)
their full##13##2##(1994-3#1)(1994-6#1)(2006-10#2)(2007-1#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)
their full-term peers##3##3##(2008-11#3)
their fully##3##2##(1993-9#1)(1995-5#1)(2009-5#1)
their function and##7##3##(2007-12#1)(2007-9#1)(2008-4#1)(2008-5#2)(2010-10#1)(2010-11#1)
their function##38##2##(1990-11#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-9#1)(1995-8#1)(1996-10#1)(1996-5#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#2)(2008-8#2)(2009-10#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#2)
their functional capacity##2##3##(2006-2#1)(2013-8#1)
their functional importance##3##3##(1990-10#1)(2007-12#1)(2013-1#1)
their functional properties##2##3##(1993-12#1)(1996-4#1)
their functional significance##3##3##(1996-2#1)(2008-4#1)(2010-12#1)
their functional status is##2##4##(2008-7#1)(2008-8#1)
their functional status##5##3##(1995-3#1)(2004-10#1)(2008-7#1)(2008-8#1)(2013-8#1)
their functional##41##2##(1990-10#1)(1990-12#1)(1990-8#1)(1992-12#1)(1993-12#1)(1993-2#1)(1994-3#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(2004-10#1)(2006-10#5)(2006-2#2)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
their functionality##4##2##(2006-4#1)(2008-3#1)(2008-7#1)(2012-3#1)
their functioning##6##2##(1994-6#1)(2010-2#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-3#1)
their functions and adjustments##2##4##(2008-1#1)(2008-4#1)
their functions and##5##3##(2008-1#1)(2008-4#1)(2008-7#1)(2011-1#2)
their functions in##4##3##(2009-3#1)(2010-10#1)(2012-12#1)(2013-1#1)
their functions##20##2##(1995-4#1)(1995-8#1)(2005-1#1)(2005-11#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-10#1)(2011-1#2)(2012-12#2)(2013-1#1)
their fundamental##6##2##(2007-12#1)(2009-10#1)(2009-8#1)(2011-1#1)(2013-1#1)(2013-7#1)
their further##8##2##(1996-3#1)(2007-8#1)(2008-10#2)(2009-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
their fusion##2##2##(1991-5#1)(2008-10#1)
their future career##2##3##(1992-6#1)(2007-8#1)
their future contributions##2##3##(1993-2#2)
their future development##2##3##(2005-10#1)(2011-1#1)
their future use##2##3##(2007-6#1)(2013-7#1)
their future##18##2##(1992-6#1)(1993-2#2)(1993-3#1)(1996-2#1)(1997-4#1)(1997-6#1)(2005-10#1)(2007-6#1)(2007-8#1)(2008-3#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-7#1)
their gas##2##2##(2008-10#1)(2011-2#1)
their gastrointestinal##3##2##(2006-10#1)(2007-11#1)(2013-1#1)
their gender##3##2##(2005-10#1)(2007-4#1)(2008-2#1)
their gene expression##4##3##(2008-10#1)(2009-2#1)(2012-2#1)(2012-3#1)
their gene products##2##3##(1997-4#1)(2008-7#1)
their gene regulation##2##3##(1995-11#1)(2007-1#1)
their gene##11##2##(1995-11#1)(1997-4#1)(2007-1#1)(2008-10#1)(2008-5#3)(2008-7#1)(2009-2#1)(2012-2#1)(2012-3#1)
their general health##3##3##(1996-6#1)(2011-2#1)(2013-1#1)
their general lack of##2##4##(2007-8#1)(2008-5#1)
their general practitioner##3##3##(1992-5#1)(1994-11#1)(1997-6#1)
their general##18##2##(1991-11#1)(1992-5#2)(1994-11#1)(1995-12#1)(1996-6#1)(1997-6#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-9#1)(2011-2#1)(2013-1#1)
their generally##2##2##(1992-12#1)(2008-5#1)
their generation##4##2##(1995-4#1)(2007-12#1)(2008-10#1)(2012-11#1)
their genes##5##2##(1993-5#1)(1995-10#1)(2006-10#1)(2008-11#1)(2008-4#1)
their genetic relationship##2##3##(2008-10#1)(2008-12#1)
their genetic##19##2##(1992-10#1)(1995-11#1)(2005-8#1)(2006-5#1)(2007-5#1)(2008-10#5)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2012-2#1)(2013-1#1)
their genome##8##2##(1992-2#1)(1996-6#1)(1997-2#1)(1997-6#1)(2007-6#1)(2008-8#1)(2009-2#1)(2011-1#1)
their genomes##4##2##(2007-1#1)(2008-10#1)(2008-7#1)(2013-1#1)
their genomic DNA##3##3##(1995-8#1)(2008-10#1)(2008-7#1)
their genomic##7##2##(1995-8#1)(2006-10#1)(2008-10#2)(2008-7#1)(2010-3#1)(2013-1#1)
their genotypes##3##2##(1996-6#1)(2010-11#1)(2010-12#1)
their geographic origin##2##3##(1994-3#1)(2008-10#1)
their geographic##7##2##(1994-3#1)(2008-1#1)(2008-10#3)(2008-2#1)(2010-10#1)
their geographical origin##2##3##(2008-10#1)(2012-11#1)
their geographical##7##2##(2008-10#2)(2008-8#2)(2009-5#1)(2009-6#1)(2012-11#1)
their geometric##3##2##(2006-5#1)(2008-3#1)(2009-9#1)
their germination##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
their goals##9##2##(1991-4#1)(1994-3#1)(1996-3#2)(2007-2#1)(2007-6#1)(2008-12#1)(2008-9#2)
their good##8##2##(1995-5#2)(1995-8#1)(2008-7#2)(2010-4#2)(2013-7#1)
their governing##2##2##(1991-2#1)(2007-1#1)
their graduates##2##2##(2010-12#1)(2012-3#1)
their grafts##2##2##(2008-1#1)(2008-4#1)
their great##3##2##(1991-9#1)(2008-3#1)(2008-8#1)
their greater##9##2##(1994-9#1)(1995-10#1)(2005-11#1)(2007-7#1)(2008-2#1)(2008-5#2)(2011-1#1)(2011-2#1)
their greatest##3##2##(1996-11#1)(2006-8#1)(2008-4#1)
their gross and fine motor skills##2##6##(2006-10#2)
their gross##4##2##(1997-8#1)(2006-10#2)(2010-3#1)
their group##7##2##(1990-12#1)(1997-4#1)(2008-1#1)(2011-2#2)(2012-1#1)(2012-12#1)
their group's##3##2##(1991-3#1)(2008-5#1)(2009-8#1)
their growing##2##2##(1991-3#1)(2011-12#1)
their growth and##4##3##(1996-12#1)(1996-4#1)(2008-9#1)(2009-6#1)
their growth in##4##3##(1990-7#1)(1990-8#1)(2008-10#1)(2011-2#1)
their growth inhibitory##2##3##(2008-11#1)(2008-5#1)
their growth promoting activities##2##4##(2008-11#1)(2008-9#1)
their growth rate##3##3##(2008-11#1)(2009-10#2)
their growth response to##2##4##(1991-5#1)(1992-9#1)
their growth##44##2##(1990-4#1)(1990-7#1)(1990-8#1)(1991-5#1)(1992-3#1)(1992-9#1)(1993-4#1)(1995-6#1)(1996-12#1)(1996-4#1)(2005-8#1)(2006-10#1)(2007-6#1)(2008-10#3)(2008-11#9)(2008-12#1)(2008-3#1)(2008-5#6)(2008-7#2)(2008-9#2)(2009-10#2)(2009-6#2)(2011-1#1)(2011-2#1)(2012-2#1)
their habitats##3##2##(2008-5#1)(2008-7#1)(2013-8#1)
their hair##6##2##(1993-9#2)(2005-10#1)(2006-12#2)(2012-2#1)
their hand##7##2##(1993-5#1)(1993-7#1)(2008-6#2)(2008-9#3)
their hands##7##2##(1997-4#1)(2007-2#1)(2010-4#1)(2010-5#1)(2012-1#1)(2012-12#2)
their heads##2##2##(1995-6#1)(2012-2#1)
their health and##9##3##(1994-3#1)(1997-1#1)(1997-3#1)(2005-7#1)(2006-1#1)(2008-12#1)(2009-4#1)(2012-2#1)(2013-1#1)
their health as##3##3##(1994-6#1)(2006-7#1)(2011-2#1)
their health by##2##3##(1992-1#1)(2006-7#1)
their health care expenditures##2##4##(1994-1#1)(1995-2#1)
their health care providers##2##4##(2006-10#1)(2007-7#1)
their health care##14##3##(1994-1#1)(1994-3#1)(1995-2#1)(1997-1#1)(2004-3#1)(2006-10#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
their health status and##2##4##(1996-2#1)(2010-10#1)
their health status##9##3##(1996-2#1)(2005-10#1)(2008-9#1)(2010-10#2)(2010-9#1)(2011-2#2)(2013-1#1)
their health##78##2##(1991-6#1)(1992-1#1)(1993-1#1)(1993-6#1)(1994-1#1)(1994-3#2)(1994-6#3)(1995-2#1)(1996-2#1)(1996-9#1)(1997-1#2)(1997-3#2)(2004-3#1)(2004-9#1)(2005-10#3)(2005-7#1)(2006-1#1)(2006-10#6)(2006-7#2)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#3)(2008-2#3)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#2)(2009-6#1)(2010-10#3)(2010-3#1)(2010-4#1)(2010-9#5)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#2)
their health-related##2##2##(2008-8#1)(2012-1#1)
their healthcare providers##4##3##(2008-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
their healthcare##12##2##(2006-1#1)(2007-12#2)(2008-3#1)(2009-4#1)(2010-3#1)(2011-1#2)(2012-2#2)(2013-1#1)(2013-8#1)
their healthy##3##2##(1996-3#1)(2008-4#1)(2013-1#1)
their hearing peers##2##3##(2008-9#1)(2012-2#1)
their hearing##3##2##(2008-9#1)(2011-2#1)(2012-2#1)
their heart##2##2##(2008-3#1)(2010-11#1)
their heavy##2##2##(1997-4#1)(2008-4#1)
their hepatic##2##2##(1992-5#1)(2006-2#1)
their high affinity for##3##4##(2008-10#1)(2008-7#1)(2013-7#1)
their high affinity##4##3##(1991-9#1)(2008-10#1)(2008-7#1)(2013-7#1)
their high levels of##2##4##(2008-1#1)(2010-2#1)
their high sensitivity##3##3##(1996-6#1)(2008-10#1)(2009-7#1)
their high##57##2##(1990-12#1)(1991-12#1)(1991-9#1)(1992-1#1)(1995-10#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-6#1)(1997-8#1)(2005-11#2)(2006-10#2)(2006-3#1)(2007-11#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#4)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-9#1)(2013-1#4)(2013-7#1)(2013-8#1)
their high-affinity##2##2##(1990-2#1)(1990-3#1)
their higher##11##2##(1990-11#1)(2005-11#1)(2006-5#1)(2007-5#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-4#1)(2010-8#1)(2012-12#1)(2013-8#1)
their highest##6##2##(1991-3#1)(1992-2#1)(1995-12#1)(1996-11#1)(2010-3#1)(2013-7#1)
their highly conserved##2##3##(2008-7#1)(2013-1#1)
their highly##5##2##(1993-2#1)(1994-8#1)(1997-4#1)(2008-7#1)(2013-1#1)
their histologic##4##2##(1990-2#1)(1994-1#1)(2004-11#1)(2010-3#1)
their histopathological##2##2##(1995-5#1)(2013-1#1)
their history and##2##3##(2010-12#1)(2012-2#1)
their history of##3##3##(2005-11#1)(2007-2#1)(2012-3#1)
their history##9##2##(2005-11#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-6#1)(2009-2#1)(2010-12#1)(2012-2#1)(2012-3#1)
their home and##3##3##(2008-11#1)(2010-8#1)(2011-2#1)
their home##14##2##(1990-12#2)(2006-10#1)(2007-4#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-8#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#2)
their homes and##4##3##(2008-2#1)(2009-9#1)(2012-2#1)(2013-1#1)
their homes##19##2##(1990-12#1)(1990-8#2)(1991-12#1)(1993-3#2)(1994-4#1)(1995-1#1)(2008-2#1)(2008-9#2)(2009-10#1)(2009-9#1)(2011-2#2)(2012-2#2)(2013-1#2)
their homologies##2##2##(1992-2#1)(1993-9#1)
their homologous##3##2##(1991-2#1)(2008-10#1)(2008-9#1)
their homologs##3##2##(2008-4#2)(2010-3#1)
their homologues##3##2##(1995-8#1)(2011-2#1)(2013-1#1)
their hopes##3##2##(2007-9#1)(2008-6#1)(2008-8#1)
their hospital##9##2##(1990-12#2)(1991-12#1)(1992-1#1)(1993-2#1)(1995-2#1)(1995-6#2)(2008-7#1)
their hospitals##5##2##(1993-3#2)(1996-9#1)(2004-8#1)(2008-12#1)
their host plants##3##3##(2008-10#1)(2008-9#1)(2009-8#1)
their host##18##2##(2004-11#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-9#1)(2009-5#1)(2009-8#2)(2010-3#1)(2012-2#1)(2013-1#2)
their hosts by##2##3##(1997-1#1)(2008-8#1)
their hosts for##2##3##(1997-7#1)(2007-9#1)
their hosts##26##2##(1994-3#1)(1997-1#1)(1997-7#2)(2004-11#2)(2006-10#1)(2007-9#1)(2008-10#4)(2008-8#4)(2008-9#1)(2010-12#2)(2011-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
their hosts'##3##2##(2008-8#1)(2012-2#2)
their house##3##2##(1992-12#1)(1993-1#1)(2008-1#1)
their household##5##2##(1996-12#1)(2006-4#1)(2007-2#1)(2008-1#1)(2013-1#1)
their human##6##2##(1991-6#1)(1993-2#1)(1993-5#1)(1997-7#1)(2008-5#1)(2010-4#1)
their husbands and their newborns##2##5##(2011-1#2)
their husbands and##3##3##(2008-9#1)(2011-1#2)
their husbands from##2##3##(1994-6#1)(2011-1#1)
their husbands were##2##3##(2006-4#1)(2008-9#1)
their husbands##9##2##(1994-6#1)(2006-4#1)(2008-4#1)(2008-9#2)(2010-8#1)(2011-1#3)
their husbands'##3##2##(2008-9#3)
their hybrid##2##2##(2008-9#1)(2010-3#1)
their hydrocarbon analogs##2##3##(2005-11#1)(2009-7#1)
their hydrolysis products##2##3##(2008-10#2)
their hydrolysis##5##2##(2007-7#1)(2008-10#2)(2008-4#1)(2008-6#1)
their hydrophobic##2##2##(2005-11#1)(2008-5#1)
their hydrophobicity##2##2##(1991-4#1)(2008-10#1)
their hypertension##2##2##(2007-3#1)(2008-1#1)
their hypotheses##2##2##(2005-10#2)
their i##2##2##(1990-2#1)(1997-4#1)
their ideal##2##2##(2007-12#1)(2010-8#1)
their ideas##2##2##(2008-12#1)(2013-1#1)
their identification and##2##3##(2008-11#1)(2009-4#1)
their identification by##2##3##(2008-1#1)(2008-10#1)
their identification##14##2##(1992-11#1)(1992-6#1)(1996-5#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2009-4#1)(2009-5#1)(2011-3#1)
their identities and##3##3##(1991-4#1)(1995-6#1)(2008-9#1)
their identities##6##2##(1991-4#1)(1995-6#1)(2007-11#1)(2008-9#1)(2009-4#1)(2010-7#1)
their identity##12##2##(1990-10#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-6#1)(2010-12#1)(2011-1#1)(2012-2#1)
their illness and##3##3##(1992-12#1)(1993-3#1)(2006-8#1)
their illness##20##2##(1992-12#2)(1993-12#1)(1993-3#1)(1996-1#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-2#2)(2007-7#2)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
their immature##3##2##(2006-5#1)(2009-7#1)(2013-8#1)
their immediate environment##4##3##(1991-3#1)(1996-2#1)(2006-7#1)(2007-11#1)
their immediate##12##2##(1991-3#1)(1992-8#1)(1996-2#2)(2005-9#1)(2006-11#1)(2006-4#1)(2006-7#1)(2007-11#1)(2008-9#1)(2010-12#1)(2012-12#1)
their immune status##2##3##(2013-1#1)(2013-8#1)
their immune suppressive##2##3##(2011-2#2)
their immune##4##2##(2011-2#2)(2013-1#1)(2013-8#1)
their immunogenic##2##2##(2008-1#1)(2011-2#1)
their immunogenicity##4##2##(1990-12#1)(2005-7#1)(2008-10#1)(2010-12#1)
their immunoglobulin##2##2##(1994-3#1)(1995-2#1)
their immunohistochemical##2##2##(2004-2#1)(2007-4#1)
their immunological##2##2##(2008-7#1)(2013-1#1)
their immunosuppressive effects##2##3##(2007-2#1)(2013-8#1)
their immunosuppressive##3##2##(2006-10#1)(2007-2#1)(2013-8#1)
their impact in##2##3##(2008-7#1)(2011-2#1)
their impact is##2##3##(1996-12#1)(2007-12#1)
their impact on ozone formation##2##5##(2007-11#1)(2007-8#1)
their impact on the##14##4##(1994-5#1)(1996-12#1)(1996-3#1)(1997-4#1)(2007-8#1)(2008-10#3)(2008-7#1)(2009-11#1)(2009-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
their impact on##53##3##(1991-9#1)(1992-1#1)(1992-12#1)(1994-5#1)(1995-3#1)(1996-1#1)(1996-12#2)(1996-3#2)(1997-4#1)(2006-10#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#4)(2008-1#1)(2008-10#6)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
their impact##64##2##(1991-9#1)(1992-1#1)(1992-12#1)(1994-5#1)(1995-3#1)(1996-1#1)(1996-12#4)(1996-3#2)(1997-4#1)(2004-9#1)(2006-10#3)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#4)(2008-1#1)(2008-10#6)(2008-11#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#2)(2009-4#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
their impacts##3##2##(2008-7#1)(2010-8#1)(2011-2#1)
their impaired##3##2##(1997-1#1)(2008-5#1)(2012-1#1)
their impairment##2##2##(2008-1#1)(2012-1#1)
their implantation and##2##3##(2009-10#1)(2012-2#1)
their implantation##4##2##(2007-8#1)(2009-10#1)(2012-1#1)(2012-2#1)
their implants##3##2##(2008-8#1)(2008-9#1)(2012-2#1)
their implementation in clinical settings remains a challenge##2##8##(2012-12#2)
their implementation in##3##3##(2008-1#1)(2012-12#2)
their implementation##15##2##(1991-1#1)(1994-2#1)(1997-7#1)(2005-5#1)(2006-7#1)(2008-1#1)(2008-2#1)(2008-3#2)(2009-10#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)
their implication##4##2##(1995-8#1)(2008-2#1)(2008-4#1)(2009-6#1)
their implications for disease##2##4##(2007-2#1)(2008-10#1)
their implications for the##9##4##(1990-12#1)(1991-4#1)(1993-11#1)(1997-8#1)(2006-6#1)(2007-12#2)(2008-8#1)(2011-1#1)
their implications for##33##3##(1990-12#1)(1991-4#1)(1993-11#1)(1993-6#1)(1997-8#1)(2006-10#2)(2006-6#1)(2007-1#1)(2007-12#4)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
their implications in##5##3##(1990-6#1)(2007-11#1)(2008-7#1)(2013-1#1)(2013-8#1)
their implications to##2##3##(2007-7#1)(2008-5#1)
their implications##51##2##(1990-12#1)(1990-6#1)(1991-4#1)(1993-11#1)(1993-6#1)(1994-2#1)(1995-1#1)(1996-3#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-6#1)(2007-1#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-4#1)(2009-5#2)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
their import##2##2##(1994-6#1)(2008-8#1)
their importance as##4##3##(2006-2#1)(2008-5#1)(2008-7#2)
their importance for the##3##4##(1994-6#1)(2008-10#1)(2010-6#1)
their importance for##5##3##(1994-6#1)(2008-10#2)(2010-10#1)(2010-6#1)
their importance in cancer##2##4##(2007-10#1)(2007-3#1)
their importance in the##2##4##(2012-12#1)(2013-1#1)
their importance in these##2##4##(2008-3#1)(2010-12#1)
their importance in##14##3##(1995-11#1)(1997-4#1)(2007-10#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-12#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
their importance to##3##3##(1993-3#1)(2004-3#1)(2008-7#1)
their importance##31##2##(1993-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1997-4#1)(2004-3#1)(2006-2#1)(2007-10#1)(2007-3#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#2)(2013-1#2)
their important##4##2##(2008-2#1)(2009-2#1)(2013-7#1)(2013-8#1)
their impressive##2##2##(1997-4#1)(2006-10#1)
their improvement##2##2##(1995-2#1)(2008-7#1)
their impulse##2##2##(2008-2#1)(2009-2#1)
their in vitro and in vivo##2##6##(1991-9#1)(1994-9#1)
their in vitro growth##2##4##(2008-10#2)
their in vitro##19##3##(1991-9#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-3#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2013-1#1)
their in vivo##10##3##(1991-5#1)(1994-3#1)(2004-1#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-6#1)
their in##31##2##(1991-5#1)(1991-9#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-3#1)(2004-1#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#1)(2013-1#1)
their inability to##5##3##(1994-11#1)(2008-2#1)(2010-2#1)(2010-8#1)(2011-2#1)
their inception##3##2##(1997-3#1)(2009-9#1)(2013-1#1)
their incidence##6##2##(1990-11#1)(1991-3#1)(1992-9#1)(2008-12#1)(2008-6#1)(2013-7#1)
their inclusion in##2##3##(1992-9#1)(2007-3#1)
their inclusion##5##2##(1992-9#1)(1996-5#1)(2006-12#1)(2007-3#1)(2008-5#1)
their income##8##2##(1996-9#1)(2008-1#1)(2008-12#1)(2008-4#1)(2009-10#1)(2010-11#1)(2010-8#2)
their incorporation into##6##3##(1991-2#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-7#1)
their incorporation##7##2##(1991-2#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-7#1)
their increased participation in##2##4##(2006-8#1)(2012-12#1)
their increased##10##2##(1993-12#2)(1994-12#1)(1994-2#1)(2006-8#1)(2007-11#1)(2008-9#1)(2012-12#1)(2012-2#2)
their increases##2##2##(1993-9#1)(1994-12#1)
their increasing use##3##3##(2006-10#1)(2008-11#1)(2008-8#1)
their increasing##12##2##(1994-3#2)(1995-4#1)(2005-3#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-3#1)(2010-7#1)(2011-2#1)
their independence##3##2##(1993-3#1)(2007-6#1)(2008-12#1)
their independent##3##2##(2005-11#1)(2008-4#1)(2008-8#1)
their index##2##2##(1996-8#1)(2010-2#1)
their indications for##2##3##(2006-10#1)(2010-8#1)
their indications##9##2##(1990-3#1)(1993-2#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-8#1)(2009-5#1)(2010-8#1)
their individual needs##2##3##(1992-1#1)(2007-12#1)
their individual##18##2##(1992-1#1)(1994-5#1)(1995-3#1)(1995-6#1)(1996-12#1)(2006-10#1)(2007-12#2)(2007-9#2)(2008-10#3)(2008-11#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-9#1)
their induction##2##2##(1994-8#1)(2011-2#1)
their industry##2##2##(2008-10#1)(2008-8#1)
their infant##3##2##(2008-10#1)(2009-7#1)(2010-10#1)
their infant's##2##2##(1993-3#1)(2007-2#1)
their infants in##3##3##(2007-2#2)(2012-2#1)
their infants##16##2##(1991-11#1)(1991-2#1)(1992-12#1)(1995-1#1)(1996-8#1)(2007-2#5)(2009-11#1)(2009-9#2)(2011-1#1)(2012-2#1)(2013-1#1)
their infection##4##2##(2006-6#1)(2008-10#1)(2010-11#1)(2010-12#1)
their infectivity##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
their influence on the##9##4##(1992-1#1)(2005-8#1)(2007-11#1)(2007-6#1)(2008-10#2)(2012-12#1)(2012-2#1)(2013-8#1)
their influence on##30##3##(1992-1#1)(1994-8#1)(1996-7#1)(2005-11#1)(2005-8#1)(2006-1#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-4#1)(2008-9#1)(2009-9#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
their influence##40##2##(1992-1#1)(1994-8#1)(1996-7#1)(2005-11#1)(2005-8#1)(2006-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-4#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-9#1)(2010-5#1)(2010-6#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#2)
their influences on##3##3##(2008-1#1)(2008-8#1)(2013-1#1)
their information##5##2##(1990-9#1)(1992-11#1)(1996-9#1)(1997-3#1)(2012-2#1)
their inherent##14##2##(1994-11#1)(1994-12#1)(1995-1#1)(2005-11#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-3#1)(2012-11#1)(2012-2#1)
their inhibition by##2##3##(1997-7#1)(2006-2#1)
their inhibition of##3##3##(1991-2#1)(1993-8#1)(1997-2#1)
their inhibition##8##2##(1991-2#1)(1992-8#1)(1993-8#1)(1996-5#1)(1997-2#1)(1997-7#1)(2005-11#1)(2006-2#1)
their inhibitory activities##5##3##(1992-6#1)(1994-3#1)(1995-3#1)(2005-7#1)(2012-2#1)
their inhibitory activity##5##3##(1992-8#1)(1994-9#1)(2008-4#1)(2011-1#1)(2013-1#1)
their inhibitory effect on##2##4##(1993-4#1)(1994-5#1)
their inhibitory effect##4##3##(1993-12#1)(1993-4#1)(1994-5#1)(2006-9#1)
their inhibitory effects on the##2##5##(1990-3#1)(1991-7#1)
their inhibitory effects on##6##4##(1990-3#1)(1991-7#1)(2008-10#1)(2011-2#1)(2012-1#1)(2013-1#1)
their inhibitory effects##7##3##(1990-3#1)(1991-7#1)(1996-11#1)(2008-10#1)(2011-2#1)(2012-1#1)(2013-1#1)
their inhibitory##24##2##(1990-3#1)(1991-1#1)(1991-10#1)(1991-7#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-4#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-3#1)(1996-11#1)(2005-7#1)(2006-9#1)(2008-10#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
their initial evaluation##2##3##(2006-10#1)(2006-8#1)
their initial experience with##2##4##(2008-9#1)(2013-8#1)
their initial##32##2##(1991-12#1)(1993-12#1)(1994-2#1)(1995-1#1)(1996-1#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-11#1)(2010-8#2)(2011-11#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#2)
their injury##3##2##(1991-11#1)(2006-11#1)(2011-2#1)
their innervation##2##2##(1996-3#1)(2007-12#1)
their inputs##2##2##(1991-6#1)(1995-9#1)
their insertion##2##2##(2008-2#1)(2013-1#1)
their insolubility in##3##3##(1991-2#1)(2007-11#1)(2011-1#1)
their insolubility##4##2##(1991-2#1)(1994-9#1)(2007-11#1)(2011-1#1)
their instability##3##2##(1995-3#1)(1995-8#1)(2012-3#1)
their institution##7##2##(1992-1#1)(1995-1#1)(2005-10#1)(2006-11#1)(2006-12#1)(2006-9#1)(2007-4#1)
their institution's##2##2##(1996-1#1)(1996-2#1)
their institutions##9##2##(1990-12#1)(1991-12#1)(1994-1#1)(1994-3#1)(2006-5#1)(2009-5#1)(2010-1#2)(2010-6#1)
their instruments##2##2##(2010-3#2)
their insulin secretion##2##3##(1994-12#1)(2010-11#1)
their insulin##4##2##(1994-12#1)(1995-8#1)(2010-11#1)(2010-12#1)
their insulin-sensitizing##3##2##(2008-3#2)(2013-1#1)
their intake and##2##3##(2008-12#1)(2012-2#1)
their intake of##3##3##(1991-5#1)(2007-2#1)(2008-4#1)
their intake##6##2##(1991-5#1)(1993-12#1)(2007-2#1)(2008-12#1)(2008-4#1)(2012-2#1)
their integrated##3##2##(2007-12#1)(2009-4#1)(2011-2#1)
their integration##6##2##(1994-3#1)(2008-11#2)(2009-12#1)(2009-9#1)(2011-7#1)
their intended use##2##3##(2007-11#1)(2011-2#1)
their intended##5##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#1)
their intense##3##2##(1993-10#1)(2006-4#1)(2008-5#1)
their intensity##3##2##(2007-12#2)(2008-11#1)
their intent##2##2##(2011-2#1)(2012-12#1)
their intentions##3##2##(2009-12#2)(2011-1#1)
their interaction had##2##3##(2009-4#1)(2012-2#1)
their interaction in##2##3##(2007-11#1)(2008-8#1)
their interaction with DNA##2##4##(1995-6#1)(2005-11#1)
their interaction with DPPC##2##4##(1990-2#1)(2005-11#1)
their interaction with a##2##4##(2005-11#1)(2013-1#1)
their interaction with nuclear##2##4##(2008-10#1)(2011-2#1)
their interaction with other##2##4##(1995-2#1)(2012-3#1)
their interaction with the##7##4##(1991-6#1)(1994-9#1)(1995-2#1)(1995-3#1)(2008-2#1)(2010-12#1)(2012-1#1)
their interaction with##47##3##(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#1)(1991-1#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-9#1)(1994-2#1)(1994-9#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1997-8#1)(2005-11#3)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
their interaction##72##2##(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#1)(1991-1#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-9#2)(1995-10#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1997-8#1)(2005-11#3)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-5#3)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
their interactions is of##2##4##(1994-9#1)(2006-5#1)
their interactions with a##3##4##(1992-11#1)(2006-3#1)(2008-4#1)
their interactions with proteins##2##4##(2011-1#2)
their interactions with the##7##4##(1990-2#2)(1996-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2012-1#1)
their interactions with##25##3##(1990-12#1)(1990-2#2)(1992-11#1)(1992-5#1)(1995-10#1)(1996-12#1)(2006-3#1)(2006-5#1)(2006-9#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-9#1)(2009-3#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)
their interactions##50##2##(1990-12#1)(1990-2#2)(1992-11#1)(1992-5#1)(1994-3#1)(1994-9#1)(1995-10#1)(1996-12#1)(2006-10#2)(2006-3#1)(2006-5#2)(2006-9#1)(2007-1#2)(2007-12#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-1#1)
their interest in##3##3##(2004-3#1)(2008-2#1)(2013-8#1)
their interest##6##2##(1990-10#1)(2004-3#1)(2007-12#1)(2008-2#1)(2010-9#1)(2013-8#1)
their interesting##2##2##(2008-5#1)(2008-7#1)
their interests##5##2##(1992-3#1)(2008-11#1)(2008-6#1)(2010-2#1)(2012-2#1)
their interference##3##2##(1994-5#1)(2007-11#1)(2008-10#1)
their internal structure##2##3##(2007-8#1)(2008-6#1)
their internal##10##2##(1994-3#1)(1996-2#1)(1997-1#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-6#1)
their interpersonal##3##2##(1993-2#1)(2008-12#1)(2010-12#1)
their interpretation and##2##3##(2008-10#1)(2010-9#1)
their interpretation##15##2##(1993-3#1)(1994-6#1)(1995-5#1)(2005-7#1)(2006-10#1)(2007-4#1)(2008-10#2)(2008-8#1)(2010-1#1)(2010-2#1)(2010-9#1)(2013-1#2)(2013-8#1)
their interpretations##2##2##(2008-11#2)
their intervention##4##2##(2009-2#1)(2009-6#1)(2009-8#1)(2010-2#1)
their interventions##2##2##(2006-10#1)(2012-2#1)
their intimate##3##2##(2008-7#1)(2009-5#2)
their intracellular##7##2##(1992-4#1)(1992-7#1)(1994-6#1)(1995-3#1)(2005-12#1)(2008-8#1)(2010-5#1)
their intrinsic##11##2##(1994-6#1)(1995-12#2)(2006-2#1)(2006-5#1)(2006-7#1)(2007-11#1)(2008-10#1)(2009-3#1)(2009-8#1)(2010-10#1)
their introduction in##2##3##(2008-7#1)(2010-12#1)
their introduction to the##2##4##(1990-4#1)(2013-1#1)
their introduction to##3##3##(1990-4#1)(2008-10#1)(2013-1#1)
their introduction##11##2##(1990-4#1)(2005-7#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-7#1)(2009-4#1)(2010-12#1)(2013-1#1)
their invasion##2##2##(2008-11#2)
their invasive##2##2##(2006-6#1)(2008-9#1)
their investigation of##2##3##(1995-6#1)(2012-3#1)
their investigation##4##2##(1995-6#1)(2008-7#1)(2012-3#1)(2013-1#1)
their investment in sexual reproduction##2##5##(2012-3#2)
their involvement in##17##3##(1991-7#1)(1992-2#1)(1994-11#1)(1994-12#1)(1995-8#1)(1996-10#1)(1996-5#1)(1996-8#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-5#1)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#1)
their involvement##22##2##(1991-7#1)(1992-2#1)(1994-11#1)(1994-12#1)(1995-3#2)(1995-8#1)(1996-10#1)(1996-5#1)(1996-8#1)(2005-7#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#1)
their ion##2##2##(2008-10#1)(2008-5#1)
their ionic##4##2##(1995-4#1)(2008-10#1)(2009-3#1)(2013-1#1)
their ionized##2##2##(2008-10#2)
their iron##3##2##(2005-11#1)(2006-10#1)(2007-5#1)
their isoelectric##4##2##(1995-3#1)(2008-12#1)(2008-2#1)(2008-4#1)
their isolation and##2##3##(2006-10#1)(2008-1#1)
their isolation##7##2##(2006-10#1)(2006-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-9#1)(2011-2#1)
their job satisfaction##4##3##(1995-1#1)(1995-2#1)(2011-1#1)(2013-1#1)
their job##17##2##(1990-12#2)(1991-11#2)(1993-6#1)(1995-1#1)(1995-2#1)(1997-2#2)(2004-4#1)(2006-2#1)(2010-9#1)(2011-1#1)(2013-1#3)(2013-8#1)
their jobs##14##2##(1991-2#1)(1994-3#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-1#1)(1996-6#1)(1997-3#2)(2007-1#1)(2007-12#1)(2008-12#1)(2011-1#1)
their joint##4##2##(2008-11#1)(2008-4#1)(2008-7#1)(2012-12#1)
their journey##4##2##(2007-2#1)(2008-10#1)(2011-2#1)(2013-1#1)
their judicious##2##2##(2006-2#1)(2007-11#1)
their karyotypes##2##2##(2008-12#1)(2010-3#1)
their key##4##2##(2007-2#1)(2008-3#1)(2012-1#1)(2012-3#1)
their kind##2##2##(1990-9#1)(2012-2#1)
their kinetic properties##3##3##(1993-8#1)(1995-11#1)(1996-5#1)
their kinetic##7##2##(1993-8#1)(1995-11#1)(1996-5#1)(2004-2#1)(2008-10#2)(2008-12#1)
their kinetics of##2##3##(2004-11#1)(2005-9#1)
their kinetics##3##2##(1993-2#1)(2004-11#1)(2005-9#1)
their knowledge and skills in##2##5##(2008-11#1)(2008-7#1)
their knowledge and skills##4##4##(1990-12#1)(2008-11#1)(2008-7#1)(2013-8#1)
their knowledge and##16##3##(1990-12#1)(1993-2#1)(2005-8#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#2)(2011-3#1)(2011-7#1)(2012-12#1)(2013-8#1)
their knowledge base and##2##4##(2008-11#1)(2010-4#1)
their knowledge of the##2##4##(2005-8#1)(2006-10#1)
their knowledge of##17##3##(1994-12#1)(1996-12#1)(1996-6#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-3#2)(2007-9#1)(2008-11#1)(2008-7#1)(2010-12#2)(2010-2#1)(2011-1#1)(2013-1#2)
their knowledge##58##2##(1990-12#1)(1993-2#1)(1994-12#1)(1996-12#1)(1996-6#1)(1997-3#1)(2005-7#1)(2005-8#2)(2006-10#9)(2007-3#3)(2007-9#1)(2008-1#1)(2008-11#7)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#2)(2011-3#1)(2011-7#1)(2012-11#1)(2012-12#1)(2013-1#2)(2013-8#3)
their known##3##2##(1995-5#1)(2008-5#1)(2009-8#1)
their labor##2##2##(2007-2#1)(2008-6#1)
their lack of toxicity##2##4##(1991-12#1)(2008-10#1)
their lack of##8##3##(1991-12#1)(1991-9#1)(1996-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2013-7#1)
their large size and##2##4##(2008-4#1)(2012-3#1)
their large size##3##3##(2008-4#1)(2009-11#1)(2012-3#1)
their large##12##2##(1991-11#1)(1993-6#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)(2009-11#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
their large-scale##2##2##(2009-2#1)(2010-5#1)
their larger##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-12#1)
their larval##2##2##(2011-12#1)(2011-2#1)
their last##10##2##(1990-6#1)(1991-2#1)(1994-2#1)(1994-6#1)(1994-9#1)(2007-11#1)(2009-6#1)(2009-9#1)(2010-8#1)(2012-3#1)
their late##2##2##(2007-11#1)(2010-8#1)
their lateral##4##2##(2006-7#1)(2008-1#1)(2010-3#1)(2011-1#1)
their latest##3##2##(2007-5#1)(2007-8#1)(2009-2#1)
their learning and##3##3##(2010-3#1)(2011-1#1)(2011-2#1)
their learning in##2##3##(2012-3#1)(2013-1#1)
their learning needs##3##3##(1992-12#1)(2008-11#1)(2012-3#1)
their learning##20##2##(1991-2#1)(1992-12#1)(2008-11#7)(2008-12#3)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#2)
their left##3##2##(1997-1#1)(2008-4#1)(2013-1#1)
their legal##2##2##(1995-1#1)(2008-11#1)
their length and##2##3##(2011-12#1)(2012-2#1)
their length##9##2##(1990-6#1)(2006-4#1)(2008-5#1)(2008-9#2)(2010-4#1)(2011-12#1)(2012-2#2)
their lengths##3##2##(1995-3#1)(2011-12#1)(2013-8#1)
their lesion##2##2##(1991-1#1)(1995-11#1)
their lesser##2##2##(1995-11#1)(2008-5#1)
their level of knowledge about##2##5##(2004-10#1)(2007-9#1)
their level of resistance##2##4##(2008-10#2)
their level of##24##3##(1993-2#2)(1994-2#1)(1995-10#1)(1996-1#1)(2004-10#1)(2006-10#1)(2007-10#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-12#1)(2009-2#1)(2010-5#1)(2011-2#1)(2013-8#2)
their levels of pain and stiffness##2##6##(2006-10#2)
their levels of##10##3##(1995-2#1)(1995-6#1)(1996-12#1)(1997-2#1)(2006-1#1)(2006-10#2)(2007-12#1)(2008-10#2)
their levels##19##2##(1993-6#1)(1995-10#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-2#1)(2006-1#1)(2006-10#2)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)(2009-4#1)(2012-1#1)
their liability##2##2##(1995-2#1)(1997-5#1)
their licenses##2##2##(1996-11#1)(2006-2#1)
their life cycle##3##3##(1991-10#1)(1993-9#1)(2006-12#1)
their life cycles##2##3##(2006-8#1)(2013-7#1)
their life history##2##3##(1994-4#1)(2010-3#1)
their life in the##2##4##(1994-11#1)(2008-7#1)
their life in##3##3##(1994-11#1)(2007-1#1)(2008-7#1)
their life quality##2##3##(2007-11#1)(2008-3#1)
their life span##3##3##(2008-10#1)(2008-11#1)(2010-8#1)
their life##38##2##(1990-12#1)(1991-10#1)(1993-9#1)(1994-11#1)(1994-4#1)(1994-6#1)(2004-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-1#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-5#1)(2010-3#2)(2010-8#3)(2011-1#1)(2011-2#4)(2012-1#1)(2013-1#2)(2013-7#1)
their lifestyles##2##2##(2007-7#1)(2013-1#1)
their lifetime##12##2##(1990-6#2)(1990-8#1)(1995-1#1)(2007-12#1)(2008-8#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#1)
their lifetimes##3##2##(2008-8#1)(2008-9#2)
their ligand##2##2##(1992-11#1)(1993-8#1)
their ligands are##2##3##(1995-8#1)(2008-5#1)
their ligands##14##2##(1995-8#1)(2005-7#1)(2008-11#2)(2008-4#4)(2008-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
their likelihood of##7##3##(1992-12#1)(2004-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2010-8#1)
their likelihood##9##2##(1992-12#1)(2004-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2010-3#1)(2010-8#1)(2010-9#1)
their limitations and##4##3##(2007-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
their limitations##18##2##(2006-10#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#2)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
their limited##9##2##(1990-12#1)(1994-11#1)(1996-4#2)(1997-9#1)(2008-1#1)(2008-3#1)(2010-2#1)(2011-2#1)
their limiting membrane##2##3##(1997-4#1)(2007-12#1)
their limiting##3##2##(1997-4#1)(2007-12#1)(2007-9#1)
their limits of detection##2##4##(1996-5#1)(2010-4#1)
their limits of##3##3##(1996-5#1)(2005-8#1)(2010-4#1)
their limits##5##2##(1996-5#1)(2005-8#1)(2008-8#1)(2010-4#1)(2012-2#1)
their line##2##2##(2008-3#1)(2008-6#1)
their lineages##2##2##(2007-12#2)
their linear##8##2##(1994-6#1)(1996-6#1)(1997-3#1)(2005-12#1)(2007-6#1)(2008-11#1)(2008-7#1)(2013-8#1)
their lipid##6##2##(1990-5#1)(1991-3#1)(2008-11#1)(2008-4#1)(2009-12#1)(2010-10#1)
their liquid##2##2##(2008-10#1)(2008-5#1)
their litter##2##2##(2008-8#1)(2010-12#1)
their lives and##5##3##(1993-9#1)(1997-8#1)(2006-7#1)(2008-11#1)(2009-4#1)
their lives as##2##3##(2008-11#1)(2013-1#1)
their lives##53##2##(1990-2#1)(1992-1#1)(1993-3#1)(1993-9#1)(1994-4#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-9#1)(1997-8#2)(2004-12#1)(2004-3#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#6)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#2)(2010-12#2)(2010-3#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#1)
their living conditions##2##3##(2006-4#1)(2009-6#1)
their living environment##2##3##(2011-2#2)
their living##6##2##(1997-3#1)(2006-4#1)(2009-6#1)(2011-2#3)
their local communities##2##3##(1990-12#1)(1997-3#1)
their local##13##2##(1990-12#1)(1993-6#1)(1994-11#1)(1996-11#1)(1996-3#1)(1997-3#1)(1997-4#1)(2007-5#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)
their localization and##2##3##(2008-8#1)(2010-9#1)
their localization##5##2##(1994-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-9#1)
their location and the##2##4##(2005-2#1)(2010-6#1)
their location in the##3##4##(2008-2#1)(2008-4#1)(2008-9#1)
their location in##4##3##(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)
their location within the##2##4##(1991-2#1)(2008-12#1)
their location within##3##3##(1991-2#1)(2008-12#1)(2008-7#1)
their location##15##2##(1991-2#1)(1997-2#1)(1997-6#1)(2005-2#1)(2006-4#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-6#1)
their locations##10##2##(1990-2#1)(1997-4#1)(2007-8#1)(2008-3#1)(2009-2#1)(2009-7#1)(2010-10#1)(2010-9#1)(2013-1#2)
their locomotion##2##2##(1995-5#1)(2008-8#1)
their long term##2##3##(2008-10#1)(2012-11#1)
their long##9##2##(1993-8#1)(2008-10#1)(2008-8#1)(2009-5#2)(2011-1#2)(2012-11#1)(2012-2#1)
their long-term growth##2##3##(1992-9#1)(2012-3#1)
their long-term survival##2##3##(2007-2#1)(2008-7#1)
their long-term use##2##3##(2007-7#1)(2013-1#1)
their long-term##19##2##(1992-9#1)(1996-1#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-7#1)(2009-1#1)(2009-7#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#1)
their longest##2##2##(2008-3#1)(2011-2#1)
their longitudinal##4##2##(1996-12#1)(2008-3#1)(2010-1#1)(2013-1#1)
their low price##2##3##(1993-8#1)(2007-2#1)
their low##25##2##(1990-9#1)(1993-5#1)(1993-8#1)(1995-11#1)(1996-1#1)(2007-2#1)(2007-3#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-4#2)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#2)
their lower##6##2##(1994-11#1)(2007-11#2)(2007-5#1)(2008-12#1)(2012-12#1)
their mRNA##4##2##(1995-2#1)(1997-8#1)(2008-9#1)(2013-1#1)
their mRNAs in##2##3##(1993-2#1)(1993-9#1)
their mRNAs##8##2##(1990-7#1)(1991-10#1)(1992-5#1)(1993-2#3)(1993-9#1)(1995-2#1)
their magnetic##2##2##(1996-7#1)(2012-12#1)
their magnitudes##2##2##(1994-8#1)(2008-2#1)
their main effects##2##3##(2008-6#1)(2012-12#1)
their main##29##2##(1990-10#1)(1993-2#1)(1994-2#1)(1995-1#1)(1996-1#2)(1996-12#1)(1996-9#1)(1997-5#1)(2006-2#1)(2006-5#1)(2007-6#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-6#1)(2009-6#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
their maintenance##6##2##(1990-3#1)(1991-12#1)(2006-3#1)(2008-4#2)(2013-1#1)
their major##4##2##(2005-12#1)(2006-8#1)(2007-10#1)(2007-5#1)
their male colleagues##4##3##(1991-6#1)(1993-8#1)(1995-6#1)(1997-6#1)
their male##8##2##(1991-6#1)(1993-8#1)(1995-6#1)(1997-6#1)(2007-2#1)(2009-1#1)(2010-5#1)(2012-12#1)
their malignant##2##2##(2008-12#1)(2011-2#1)
their managed care##2##3##(1994-1#1)(2007-2#1)
their management and##4##3##(2007-3#1)(2007-8#1)(2008-2#1)(2009-3#1)
their management in##3##3##(2005-8#1)(2008-7#1)(2010-3#1)
their management is##3##3##(2007-7#1)(2008-2#1)(2009-6#1)
their management of the##2##4##(1991-2#1)(2007-8#1)
their management of##7##3##(1991-2#3)(1993-10#1)(2006-10#1)(2006-9#1)(2007-8#1)
their management##43##2##(1991-2#4)(1992-6#1)(1993-10#1)(1993-7#1)(1995-12#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-9#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#3)(2007-8#2)(2008-12#1)(2008-2#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2013-8#2)
their mandate##2##2##(2011-2#2)
their manifestation##2##2##(1995-12#1)(2008-11#1)
their manipulation##2##2##(2008-4#1)(2008-6#1)
their manufacture##5##2##(2007-11#2)(2008-10#1)(2010-12#1)(2013-1#1)
their many##4##2##(2006-10#1)(2008-5#1)(2012-12#2)
their marketing##2##2##(2008-12#2)
their markets##2##2##(2011-2#2)
their mass spectra##2##3##(2007-3#1)(2013-7#1)
their mass##5##2##(2005-11#1)(2007-3#1)(2008-2#1)(2008-7#1)(2013-7#1)
their mate##2##2##(2008-8#1)(2009-6#1)
their material##4##2##(2006-11#1)(2007-7#1)(2008-10#1)(2009-11#1)
their mates##7##2##(2006-6#1)(2006-7#2)(2008-9#2)(2012-2#1)(2012-3#1)
their matrix##3##2##(2008-10#1)(2012-2#2)
their maturation##4##2##(2006-10#1)(2008-4#1)(2013-1#1)(2013-8#1)
their mature##5##2##(1991-3#1)(1992-6#2)(1995-2#1)(2008-8#1)
their maxima in the##2##4##(1993-3#1)(2008-7#1)
their maxima##4##2##(1991-7#1)(1993-3#1)(1994-12#1)(2008-7#1)
their maximal##5##2##(1990-5#1)(1992-1#1)(2008-3#1)(2008-7#1)(2013-8#1)
their maximum##10##2##(1990-4#1)(1993-12#1)(1995-2#1)(2005-8#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)
their mean##11##2##(1991-11#1)(1994-11#1)(1997-3#1)(2006-2#1)(2006-7#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-7#2)(2013-1#1)
their meaning##2##2##(1994-6#1)(2013-8#1)
their means##3##2##(1992-4#1)(1993-6#1)(2013-7#1)
their measured##2##2##(2007-12#2)
their measurement##5##2##(1995-2#1)(1997-8#1)(2008-3#1)(2009-11#1)(2012-8#1)
their mechanical properties##5##3##(2006-12#1)(2008-5#2)(2009-7#1)(2011-1#1)
their mechanical response##2##3##(2006-11#1)(2007-4#1)
their mechanical stability in bioreactors##2##5##(2008-7#2)
their mechanical##11##2##(2006-11#1)(2006-12#1)(2007-4#1)(2008-5#2)(2008-7#2)(2009-7#2)(2011-1#1)(2012-2#1)
their mechanism of action##9##4##(1990-2#1)(1992-8#1)(1993-8#1)(2006-10#1)(2007-10#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#1)
their mechanism of##13##3##(1990-2#1)(1992-8#1)(1993-8#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
their mechanism##14##2##(1990-2#1)(1992-8#1)(1993-8#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
their mechanisms are##2##3##(2008-10#1)(2008-4#1)
their mechanisms in##2##3##(2008-5#1)(2009-2#1)
their mechanisms of action and##3##5##(2008-10#1)(2008-5#1)(2012-3#1)
their mechanisms of action are##2##5##(1995-12#1)(2008-7#1)
their mechanisms of action##13##4##(1995-12#1)(1995-5#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-5#1)(2008-7#2)(2010-2#1)(2011-1#1)(2012-3#1)(2013-1#1)
their mechanisms of##15##3##(1995-12#1)(1995-3#1)(1995-5#1)(2005-11#1)(2006-10#1)(2008-10#3)(2008-5#1)(2008-7#2)(2010-2#1)(2011-1#1)(2012-3#1)(2013-1#1)
their mechanisms##24##2##(1995-12#1)(1995-3#2)(1995-5#1)(2005-11#1)(2006-10#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-7#3)(2009-2#1)(2010-12#2)(2010-2#1)(2011-1#2)(2012-3#1)(2013-1#1)
their medial post-stressed vowels##2##4##(2009-11#2)
their median age was##2##4##(1990-10#1)(1991-2#1)
their median##3##2##(1990-10#1)(1991-2#2)
their medical condition##2##3##(2007-5#1)(2011-12#1)
their medical staff##3##3##(1991-1#1)(1994-1#1)(1994-3#1)
their medical##18##2##(1991-1#1)(1992-2#1)(1992-9#1)(1994-1#1)(1994-3#1)(1995-12#1)(1996-2#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-4#1)(2010-2#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
their medication##15##2##(1990-8#1)(1993-11#1)(2005-9#1)(2007-7#1)(2008-11#4)(2008-3#1)(2010-1#1)(2011-1#3)(2012-1#1)(2012-12#1)
their medications##3##2##(2008-11#1)(2008-8#1)(2011-1#1)
their members##4##2##(1991-2#1)(1993-1#1)(2007-4#1)(2008-11#1)
their membership##2##2##(2008-1#1)(2013-1#1)
their membrane##5##2##(1991-5#1)(1991-9#1)(1992-6#1)(2011-1#2)
their membranes##4##2##(1991-10#1)(1994-9#1)(2008-10#2)
their memory##2##2##(2008-12#1)(2008-7#1)
their menopausal##2##2##(2006-6#1)(2013-8#1)
their menstrual##2##2##(1990-12#1)(2006-4#1)
their mental health##5##3##(2008-12#1)(2008-2#1)(2010-8#1)(2011-2#1)(2012-3#1)
their mental##7##2##(2008-12#1)(2008-2#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
their mentor##3##2##(2007-9#1)(2008-11#1)(2012-3#1)
their merits and##4##3##(2008-8#1)(2009-9#1)(2010-12#1)(2013-1#1)
their merits##5##2##(2008-8#1)(2009-9#1)(2010-12#1)(2012-12#1)(2013-1#1)
their metabolic activity##2##3##(2009-8#1)(2011-1#1)
their metabolic and##2##3##(2009-7#1)(2010-12#1)
their metabolic##12##2##(1993-1#1)(1996-5#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-1#1)
their metabolism##10##2##(1990-5#1)(1992-4#1)(1994-3#1)(1996-3#1)(1996-9#1)(2006-10#1)(2007-12#1)(2010-8#1)(2012-3#2)
their metabolites are##3##3##(2008-10#1)(2008-11#2)
their metabolites were##2##3##(1996-10#1)(1997-3#1)
their metabolites##21##2##(1994-11#1)(1994-12#1)(1996-10#1)(1996-12#1)(1996-8#1)(1997-3#1)(1997-5#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-3#1)(2013-1#1)
their metal chelates have been##2##5##(2008-5#2)
their metal chelates##3##3##(2008-5#3)
their metal##16##2##(2008-10#6)(2008-5#9)(2012-1#1)
their metastatic potential##2##3##(1992-10#1)(1995-8#1)
their metastatic##3##2##(1992-10#1)(1995-8#1)(2009-3#1)
their method##3##2##(1996-12#1)(2005-11#1)(2008-10#1)
their methods of##2##3##(2007-11#1)(2012-12#1)
their methods##3##2##(1993-2#1)(2007-11#1)(2012-12#1)
their microenvironment##6##2##(1996-11#1)(1997-8#1)(2005-10#1)(2008-4#1)(2010-10#1)(2013-8#1)
their middle##2##2##(2008-7#1)(2010-12#1)
their migration into the##3##4##(1997-8#1)(2008-11#1)(2010-12#1)
their migration##7##2##(1993-4#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-8#1)
their milk production and##2##4##(2012-2#2)
their milk##6##2##(1994-5#1)(2006-9#1)(2011-1#1)(2012-2#3)
their minimum##2##2##(2008-3#1)(2008-4#1)
their mission##3##2##(1990-12#1)(1996-3#1)(2008-2#1)
their missions and##3##3##(1990-12#2)(1995-2#1)
their missions##4##2##(1990-12#3)(1995-2#1)
their mitochondrial##4##2##(1990-12#1)(1995-11#1)(2008-1#1)(2009-5#1)
their mitotic##2##2##(2007-12#2)
their mixture using##3##3##(2008-10#2)(2008-6#1)
their mixture##7##2##(2008-10#6)(2008-6#1)
their mixtures##16##2##(2004-12#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-5#3)(2008-8#1)(2010-5#1)
their mobilities in##2##3##(1991-4#1)(2008-10#1)
their mobility##3##2##(2007-11#1)(2008-11#1)(2010-1#1)
their mode of action##8##4##(1991-10#1)(1993-6#1)(1994-11#1)(2008-1#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#1)
their mode of##11##3##(1991-10#1)(1993-6#1)(1994-11#1)(2008-1#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-1#2)(2011-2#1)
their models##2##2##(1994-5#1)(2008-11#1)
their modes of##3##3##(1995-3#1)(2008-11#2)
their modest##3##2##(1991-6#1)(2008-3#1)(2009-4#1)
their modification##2##2##(2006-3#1)(2008-7#1)
their modified##2##2##(1993-9#1)(2008-5#1)
their modulation by##4##3##(1990-7#1)(1993-2#1)(2008-5#1)(2008-7#1)
their modulation##6##2##(1990-7#1)(1993-2#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#1)
their molecular masses##2##3##(1990-12#1)(1992-7#1)
their molecular mechanism##2##3##(1990-2#1)(2006-10#1)
their molecular size##3##3##(1991-7#1)(1996-8#1)(2008-7#1)
their molecular structure##3##3##(1991-2#1)(2005-11#2)
their molecular weight##6##3##(2006-8#1)(2008-2#1)(2008-4#2)(2008-5#2)
their molecular weights##2##3##(1992-7#1)(2013-1#1)
their molecular##41##2##(1990-12#1)(1990-2#1)(1991-2#1)(1991-7#1)(1992-6#2)(1992-7#2)(1992-8#1)(1993-7#1)(1995-1#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-8#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-1#2)(2012-12#2)(2013-1#2)
their monitoring in##2##3##(2008-10#2)
their monitoring##3##2##(2008-10#2)(2008-6#1)
their monomeric##4##2##(1994-11#1)(2007-8#1)(2008-10#1)(2008-5#1)
their moral##4##2##(2007-11#1)(2009-6#1)(2010-12#2)
their morbidity and mortality##2##4##(1994-2#1)(2006-10#1)
their more mature##2##3##(2009-12#1)(2010-4#1)
their more##10##2##(1994-5#1)(1995-3#1)(2008-8#1)(2009-12#1)(2010-4#1)(2012-12#1)(2013-1#4)
their morphological and##2##3##(2008-5#1)(2013-8#1)
their morphological characteristics##2##3##(1990-4#1)(2007-10#1)
their morphological##15##2##(1990-4#1)(1995-1#1)(1996-12#1)(2005-11#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
their morphologies##2##2##(2008-11#2)
their morphology and##4##3##(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)
their morphology##12##2##(1995-3#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2011-2#1)(2012-11#1)(2013-1#1)
their mortality##4##2##(2007-7#1)(2008-10#1)(2008-5#1)(2008-6#1)
their most important##5##3##(1996-1#1)(1996-3#1)(1997-7#1)(2007-12#1)(2008-4#1)
their most recent##2##3##(2009-5#1)(2012-3#1)
their most##23##2##(1991-2#1)(1991-3#1)(1994-1#1)(1996-1#1)(1996-3#1)(1997-7#1)(2006-10#2)(2006-11#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-4#2)(2008-6#2)(2008-7#1)(2009-5#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
their mother and##2##3##(1997-3#1)(2011-2#1)
their mother##8##2##(1994-2#1)(1997-3#1)(2005-11#1)(2008-10#1)(2008-8#1)(2009-5#1)(2011-2#1)(2013-1#1)
their mothers and##3##3##(1997-5#1)(2008-2#1)(2010-2#1)
their mothers##35##2##(1990-11#1)(1990-2#1)(1992-2#1)(1993-1#1)(1993-4#1)(1993-5#1)(1994-3#1)(1994-6#1)(1997-5#1)(2006-12#1)(2006-3#1)(2007-2#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2009-11#1)(2009-4#1)(2009-7#2)(2010-2#2)(2011-1#3)(2011-12#1)(2011-2#3)(2012-12#1)(2013-8#2)
their mothers' smoking##2##3##(2009-5#2)
their mothers'##5##2##(2007-2#1)(2009-5#2)(2009-7#1)(2013-1#1)
their motility##5##2##(1993-7#1)(1997-7#1)(2007-8#1)(2008-4#1)(2013-8#1)
their motivation for##3##3##(1990-6#1)(2012-1#1)(2012-2#1)
their motivations##2##2##(1993-12#2)
their motives##2##2##(1991-12#1)(2010-12#1)
their motor##3##2##(2005-6#1)(2013-1#1)(2013-7#1)
their mouths##2##2##(2008-7#1)(2010-5#1)
their movement##6##2##(1993-6#1)(2006-10#2)(2007-11#1)(2007-7#1)(2011-12#1)
their movements##3##2##(2008-5#1)(2012-1#2)
their multifunctionality##2##2##(1997-7#1)(2006-12#1)
their multiple##7##2##(1990-11#1)(1993-12#1)(2004-12#1)(2007-11#1)(2008-9#1)(2012-11#1)(2012-12#1)
their muscle##2##2##(2008-11#1)(2008-7#1)
their musculoskeletal##2##2##(2006-10#1)(2006-2#1)
their mutagenicity##2##2##(1993-3#1)(2008-5#1)
their mutual interactions##3##3##(1992-8#1)(2008-9#1)(2009-8#1)
their mutual##9##2##(1992-8#1)(1997-2#1)(2005-4#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-8#1)(2013-8#1)
their name##3##2##(2008-11#1)(2009-10#1)(2009-2#1)
their natal##2##2##(2008-8#1)(2008-9#1)
their national##2##2##(2005-5#1)(2008-10#1)
their native fluorescence##2##3##(1990-8#1)(1993-2#1)
their native states##2##3##(1995-4#1)(2012-1#1)
their native##23##2##(1990-8#1)(1993-2#1)(1995-2#1)(1995-4#2)(1995-8#2)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#2)(2008-8#4)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
their natural function##2##3##(2008-7#1)(2010-12#1)
their natural habitat##2##3##(2008-3#1)(2009-9#1)
their natural history##3##3##(2005-11#1)(2006-6#1)(2011-7#1)
their natural resources##2##3##(1992-5#1)(2006-5#1)
their natural##39##2##(1992-5#1)(1995-3#1)(1995-9#1)(1996-7#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-5#2)(2006-6#1)(2007-1#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-9#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
their naturally occurring##2##3##(1990-2#1)(2008-4#1)
their naturally##3##2##(1990-2#1)(2008-4#1)(2009-12#1)
their nature and##4##3##(1995-1#1)(1996-2#1)(2008-10#1)(2012-2#1)
their nature##7##2##(1990-7#1)(1995-1#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2012-2#1)
their necks in##3##3##(2006-11#2)(2007-1#1)
their need for##4##3##(2008-3#3)(2010-12#1)
their need to##2##3##(1992-3#1)(2013-1#1)
their need##8##2##(1992-3#1)(2008-3#3)(2010-12#1)(2010-2#1)(2011-2#1)(2013-1#1)
their needs and##5##3##(1997-3#1)(2005-7#1)(2007-6#1)(2007-7#1)(2009-9#1)
their needs are fulfilled##2##4##(2005-7#2)
their needs are##4##3##(2005-7#2)(2010-2#1)(2013-1#1)
their needs in##2##3##(1993-2#1)(2012-12#1)
their needs were met##2##4##(1991-8#1)(2005-7#1)
their needs##28##2##(1991-8#1)(1993-1#1)(1993-2#1)(1994-1#1)(1997-3#1)(2005-7#6)(2007-4#1)(2007-6#1)(2007-7#1)(2008-11#3)(2008-9#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
their negative##12##2##(1991-6#1)(1992-2#1)(1992-9#1)(1995-2#1)(1996-4#1)(2004-9#1)(2006-10#1)(2007-5#1)(2008-4#1)(2012-1#1)(2012-12#1)(2013-8#1)
their negatively charged##2##3##(1992-6#1)(2009-12#1)
their neighborhoods##2##2##(2007-9#1)(2009-9#1)
their neighboring##2##2##(1991-7#1)(1996-6#1)
their neighbors##2##2##(1990-3#1)(2008-9#1)
their neighbours##2##2##(1991-5#1)(2012-2#1)
their nervous systems##2##3##(1997-6#1)(2007-1#1)
their nest##2##2##(2008-2#1)(2008-8#1)
their nests##4##2##(1994-3#1)(2004-4#1)(2007-3#1)(2008-6#1)
their network##2##2##(1996-12#1)(1996-2#1)
their neural##2##2##(1997-6#1)(2008-5#1)
their neurological##2##2##(1997-6#1)(2007-11#1)
their neurons##2##2##(2007-12#2)
their neuroprotective##3##2##(2007-11#1)(2008-1#1)(2008-3#1)
their neutral##3##2##(1990-10#1)(2008-10#1)(2012-2#1)
their new##8##2##(1991-3#1)(1992-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-4#1)(2011-1#1)(2013-1#1)
their newborn infants##4##3##(2006-7#2)(2007-12#1)(2007-8#1)
their newborn##6##2##(2006-7#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-8#1)
their newborns##6##2##(1993-4#1)(2006-7#1)(2009-6#1)(2011-1#3)
their niches##2##2##(2008-8#1)(2012-12#1)
their non-specific##2##2##(2007-8#1)(2012-12#1)
their non-traditional family##2##3##(2005-9#2)
their nontransgenic littermates##5##3##(1992-11#1)(1992-8#3)(2007-12#1)
their normal activities##2##3##(2005-7#1)(2008-7#1)
their normal cell##2##3##(1997-1#1)(2007-1#1)
their normal counterparts##7##3##(1991-10#1)(1991-8#1)(1991-9#1)(1993-6#1)(2008-6#1)(2008-9#1)(2010-7#1)
their normal position##2##3##(1996-5#1)(2012-2#1)
their normal##39##2##(1991-10#1)(1991-8#1)(1991-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(2004-3#1)(2005-7#1)(2005-9#1)(2006-12#1)(2007-1#1)(2007-6#1)(2007-7#2)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#2)(2008-9#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#2)(2012-2#2)(2013-8#1)
their nuclear magnetic resonance##2##4##(2008-4#1)(2012-11#1)
their nuclei##5##2##(1992-3#1)(1996-3#1)(2008-3#1)(2008-8#1)(2008-9#1)
their nucleosides##2##2##(2006-10#2)
their nucleotide sequences##6##3##(1990-4#1)(1990-5#1)(1991-8#1)(1997-6#1)(1997-8#1)(2008-8#1)
their nucleotide##8##2##(1990-4#1)(1990-5#1)(1991-8#1)(1993-6#1)(1997-6#1)(1997-8#1)(2008-8#1)(2013-8#1)
their number and##3##3##(1991-3#1)(1995-12#1)(2008-10#1)
their number##15##2##(1991-3#1)(1991-8#1)(1992-5#1)(1995-12#1)(1996-9#1)(2007-2#1)(2007-9#2)(2008-10#2)(2008-9#1)(2009-2#1)(2009-5#1)(2011-2#1)(2012-2#1)
their numbers in##2##3##(1994-3#1)(2010-10#1)
their numbers##4##2##(1990-12#1)(1994-3#1)(2009-2#1)(2010-10#1)
their numerous##2##2##(2009-10#1)(2010-9#1)
their nursing actions##2##3##(2008-11#1)(2012-3#1)
their nursing practice##3##3##(2007-3#1)(2008-12#1)(2013-8#1)
their nursing role##3##3##(2011-1#1)(2013-1#2)
their nursing##11##2##(2004-10#1)(2007-3#1)(2008-11#2)(2008-12#2)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
their nutrient requirements##2##3##(2007-8#1)(2008-12#1)
their nutrient##4##2##(2004-2#1)(2007-8#1)(2008-12#1)(2012-12#1)
their nutritional##2##2##(2008-2#1)(2012-1#1)
their objections to##2##3##(1995-5#1)(2008-11#1)
their objectives##2##2##(2007-7#1)(2011-2#1)
their observations##3##2##(1994-2#1)(2008-9#1)(2009-4#1)
their obvious##2##2##(1990-9#1)(2009-12#1)
their occupational##2##2##(1991-3#1)(2009-12#1)
their occurrence and##4##3##(2008-10#1)(2008-8#1)(2012-2#1)(2013-8#1)
their occurrence in##5##3##(1994-3#1)(2006-1#1)(2007-8#1)(2009-5#1)(2011-1#1)
their occurrence##17##2##(1990-9#2)(1991-5#1)(1994-3#1)(2005-8#1)(2006-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-1#1)(2012-2#3)(2013-8#1)
their offspring##23##2##(1990-9#3)(2005-7#1)(2006-5#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-3#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
their offspring's##2##2##(2010-10#1)(2011-1#1)
their older##3##2##(2006-11#1)(2008-4#1)(2008-9#1)
their ongoing##2##2##(2008-7#1)(2013-1#1)
their online##2##2##(1993-2#1)(2008-12#1)
their onset and##2##3##(2007-7#1)(2013-1#1)
their onset##4##2##(2006-2#1)(2006-3#1)(2007-7#1)(2013-1#1)
their operating rooms##2##3##(2006-6#2)
their operating##4##2##(1990-12#1)(2006-6#2)(2008-10#1)
their operation and##2##3##(1992-11#1)(2008-2#1)
their operation##10##2##(1992-11#1)(1996-2#2)(2007-1#1)(2007-12#3)(2008-2#1)(2009-4#1)(2009-5#1)
their operational##3##2##(1991-12#1)(2010-9#1)(2013-1#1)
their operations##4##2##(1990-12#1)(1992-12#1)(1993-2#1)(1994-3#1)
their opinion about##2##3##(1990-5#1)(1992-2#1)
their opinion of##2##3##(1990-5#1)(1991-2#1)
their opinion##6##2##(1990-5#2)(1991-2#1)(1992-2#1)(2006-11#1)(2008-2#1)
their opinions on##2##3##(1992-3#1)(1994-10#1)
their opinions##8##2##(1992-3#1)(1994-10#1)(1995-5#1)(1997-8#1)(2007-2#1)(2010-2#1)(2012-3#1)(2013-8#1)
their opponents##3##2##(1994-6#2)(2008-8#1)
their opportunities for##2##3##(1995-12#1)(2012-2#1)
their opposing##2##2##(1990-5#1)(1995-3#1)
their opposite effects on##2##4##(1991-2#1)(1994-9#1)
their opposite##3##2##(1991-2#1)(1994-9#1)(1995-8#1)
their opposite-sex##2##2##(2007-12#2)
their opposition##2##2##(1992-5#1)(1995-6#1)
their optical properties##3##3##(2008-10#1)(2008-3#1)(2009-11#1)
their optical##17##2##(1997-7#1)(2005-11#1)(2007-4#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-4#1)(2011-2#1)
their optimal values##3##3##(2008-10#2)(2009-10#1)
their optimal##10##2##(1995-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-3#1)
their optimum values##3##3##(2005-4#1)(2007-11#1)(2008-10#1)
their optimum##4##2##(2005-4#1)(2007-11#1)(2008-10#1)(2009-11#1)
their options##2##2##(2007-7#1)(2012-12#1)
their oral health##2##3##(2008-9#1)(2010-7#1)
their oral##4##2##(1990-2#1)(2008-9#1)(2010-7#1)(2012-1#1)
their organic##3##2##(2008-10#2)(2010-4#1)
their organization##7##2##(1994-1#1)(1996-3#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-9#1)
their organization's##2##2##(1992-12#1)(1995-3#1)
their organizational##2##2##(1991-4#1)(1993-1#1)
their organizations to##2##3##(1995-3#1)(1997-1#1)
their organizations##11##2##(1990-12#1)(1992-2#1)(1992-9#1)(1993-2#1)(1994-1#1)(1995-3#1)(1996-3#2)(1997-1#1)(2011-2#1)(2013-1#1)
their organs##4##2##(1996-2#1)(2006-10#1)(2008-5#1)(2009-8#1)
their orientation can be##2##4##(1997-7#1)(2008-3#1)
their orientation##10##2##(1991-5#1)(1993-11#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#2)(2009-9#1)
their origin and##5##3##(1994-3#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-7#1)
their origin##23##2##(1991-9#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-3#1)(1997-5#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-12#1)
their original counterparts##2##3##(2007-12#2)
their original positions##3##3##(1992-9#1)(1996-10#1)(2007-5#1)
their original##30##2##(1990-11#2)(1992-5#1)(1992-9#1)(1994-6#1)(1996-10#1)(1997-4#1)(2007-12#5)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#2)(2009-10#1)(2009-6#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
their originally##2##2##(2005-8#1)(2006-2#1)
their origins##12##2##(1991-4#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2010-3#1)(2011-1#1)(2012-2#1)(2012-5#1)
their osteogenic##2##2##(2008-11#1)(2008-5#1)
their other##3##2##(1994-8#1)(2007-10#1)(2009-12#1)
their outcome##6##2##(2009-10#1)(2010-11#1)(2010-3#2)(2011-12#1)(2013-1#1)
their outcomes##6##2##(1996-2#1)(1996-4#1)(2007-12#1)(2007-4#1)(2008-11#1)(2011-3#1)
their outer##6##2##(1991-2#1)(1995-12#2)(2006-10#1)(2008-10#1)(2008-7#1)
their output##4##2##(1995-11#1)(1995-3#1)(2008-2#1)(2008-3#1)
their ovaries##3##2##(1994-6#1)(1995-11#1)(2008-5#1)
their overall health##2##3##(2008-7#1)(2013-8#1)
their overall stability constants##2##4##(2008-10#2)
their overall treatment##2##3##(1993-2#1)(2013-1#1)
their overall##27##2##(1991-12#1)(1991-2#1)(1993-2#1)(1996-3#1)(2004-11#1)(2007-3#1)(2007-4#1)(2007-8#2)(2008-10#4)(2008-3#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-4#1)(2011-1#3)(2012-1#1)(2012-2#2)(2012-4#1)(2013-1#1)(2013-8#1)
their overexpression##2##2##(2013-1#2)
their overlapping##2##2##(2007-8#1)(2008-2#1)
their own accord##4##3##(2004-1#1)(2006-8#1)(2008-11#1)(2011-1#1)
their own activity##2##3##(2004-4#1)(2008-7#1)
their own and their##5##4##(2007-12#1)(2010-8#1)(2012-11#1)(2012-3#2)
their own and##7##3##(2006-5#1)(2007-12#1)(2009-8#1)(2010-8#1)(2012-11#1)(2012-3#2)
their own benefit##2##3##(2007-9#1)(2012-12#1)
their own caches##2##3##(2008-8#2)
their own care##2##3##(1992-3#1)(2013-1#1)
their own controls##3##3##(1995-2#1)(2009-7#1)(2011-2#1)
their own data##3##3##(2005-12#1)(2008-7#1)(2008-9#1)
their own experience##9##3##(1991-11#1)(1993-10#1)(2004-12#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-4#1)
their own experiences##4##3##(1997-8#1)(2007-11#1)(2007-8#1)(2008-11#1)
their own facilities##2##3##(1994-1#1)(1995-1#1)
their own ganglion##2##3##(1991-3#2)
their own health and##3##4##(1996-6#1)(2005-8#1)(2006-9#1)
their own health##13##3##(1991-12#1)(1991-4#1)(1994-2#1)(1994-6#1)(1996-6#3)(2005-8#1)(2006-9#1)(2007-9#1)(2008-6#1)(2008-9#1)(2013-7#1)
their own healthcare##3##3##(2007-12#2)(2008-8#1)
their own homes##5##3##(1991-8#2)(1996-5#1)(2010-10#2)
their own initiative##3##3##(1996-9#1)(2006-8#1)(2011-12#1)
their own institution##2##3##(1994-3#1)(2009-4#1)
their own material##2##3##(1996-1#1)(2007-8#1)
their own observation##2##3##(1995-5#1)(2005-1#1)
their own or in combination with##2##6##(2004-2#1)(2008-7#1)
their own or##4##3##(2004-2#1)(2007-10#1)(2008-7#1)(2009-12#1)
their own pain##2##3##(2006-12#1)(2010-8#1)
their own personal experience##2##4##(2006-7#1)(2008-11#1)
their own personal##5##3##(1992-3#1)(2006-7#1)(2006-9#1)(2008-11#2)
their own perspective##2##3##(2008-4#1)(2011-1#1)
their own practices##3##3##(1991-6#1)(1993-3#1)(2007-5#1)
their own professional##2##3##(2008-11#2)
their own requirements##2##3##(1993-2#1)(1994-3#1)
their own research##3##3##(2007-11#2)(2008-9#1)
their own right##5##3##(1990-12#1)(1992-2#1)(2010-10#1)(2010-7#1)(2012-2#1)
their own sensitivity to the##2##5##(1996-4#1)(2008-5#1)
their own set of##2##4##(1994-3#1)(2013-8#1)
their own signal##2##3##(2008-4#1)(2008-8#1)
their own special##2##3##(2011-2#1)(2012-3#1)
their own system##2##3##(1994-9#1)(2010-12#1)
their own use##3##3##(1991-7#1)(1994-12#1)(2008-11#1)
their own values and##2##4##(2008-12#1)(2010-5#1)
their own values##4##3##(1993-2#1)(2008-12#2)(2010-5#1)
their own way##2##3##(2005-11#1)(2010-4#1)
their own weight##2##3##(2007-12#2)
their own words##5##3##(2008-4#1)(2008-6#1)(2011-2#3)
their own work##2##3##(2009-2#1)(2013-7#1)
their own##369##2##(1990-10#1)(1990-12#2)(1990-5#1)(1990-6#2)(1990-8#2)(1991-10#1)(1991-11#3)(1991-12#1)(1991-2#1)(1991-3#4)(1991-4#2)(1991-6#1)(1991-7#1)(1991-8#4)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#4)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#3)(1993-10#2)(1993-12#3)(1993-2#5)(1993-3#6)(1993-6#1)(1993-9#1)(1994-1#2)(1994-12#3)(1994-2#2)(1994-3#4)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#7)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-7#1)(1995-9#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#3)(1996-9#2)(1997-1#1)(1997-3#2)(1997-6#1)(1997-8#2)(2004-1#1)(2004-12#1)(2004-2#2)(2004-4#1)(2005-1#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-5#1)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#2)(2006-12#3)(2006-2#1)(2006-3#1)(2006-5#4)(2006-6#4)(2006-7#4)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#5)(2007-11#7)(2007-12#10)(2007-2#1)(2007-3#3)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#6)(2007-9#4)(2008-1#2)(2008-10#3)(2008-11#15)(2008-12#5)(2008-2#3)(2008-3#3)(2008-4#7)(2008-5#5)(2008-6#5)(2008-7#6)(2008-8#7)(2008-9#7)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#2)(2009-9#1)(2010-10#4)(2010-11#1)(2010-12#5)(2010-2#6)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#5)(2011-1#7)(2011-12#1)(2011-2#12)(2012-1#2)(2012-11#2)(2012-12#12)(2012-2#6)(2012-3#8)(2013-1#3)(2013-7#2)(2013-8#4)
their owners##4##2##(1995-11#1)(2008-12#2)(2013-1#1)
their oxidation##6##2##(1997-8#1)(2008-10#4)(2008-3#1)
their oxidative##2##2##(1990-3#1)(1996-5#1)
their oxygen##2##2##(2006-12#1)(2008-5#1)
their pH##2##2##(2005-4#1)(2008-5#1)
their pHi##2##2##(1994-11#1)(2008-5#1)
their pain during##2##3##(1996-12#1)(2010-4#1)
their pain relief##2##3##(1992-5#1)(2007-11#1)
their pain##16##2##(1992-5#1)(1996-12#1)(2004-10#1)(2005-9#1)(2006-12#2)(2006-8#1)(2007-11#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-4#1)(2010-6#3)(2012-2#1)
their paired##4##2##(2007-12#1)(2010-2#1)(2010-8#1)(2013-8#1)
their paracrine##2##2##(2007-9#1)(2013-1#1)
their parameters##3##2##(2008-3#2)(2008-6#1)
their parasites##3##2##(2008-1#1)(2008-8#1)(2012-3#1)
their parasitic##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
their parent##9##2##(1990-5#1)(1992-7#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-5#1)(2013-8#2)
their parental##9##2##(1993-2#1)(1995-12#1)(2007-10#1)(2008-10#3)(2008-11#1)(2009-10#1)(2010-5#1)
their parenting##3##2##(2007-10#1)(2007-8#1)(2008-12#1)
their parents also##2##3##(1990-5#1)(2008-9#1)
their parents and##4##3##(2009-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
their parents had##2##3##(2006-9#1)(2010-10#1)
their parents in##4##3##(2007-7#1)(2008-12#1)(2013-1#2)
their parents or##2##3##(2006-7#1)(2011-1#1)
their parents participated##2##3##(2006-8#1)(2013-1#1)
their parents were##4##3##(1995-2#1)(2006-4#1)(2007-7#1)(2008-3#1)
their parents##74##2##(1990-12#2)(1990-4#1)(1990-5#2)(1990-9#1)(1991-2#1)(1991-8#1)(1993-2#1)(1994-2#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#2)(1997-8#1)(2006-4#1)(2006-7#3)(2006-8#3)(2006-9#1)(2007-12#5)(2007-7#4)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-7#2)(2010-10#1)(2010-3#2)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#4)(2012-2#4)(2013-1#4)(2013-7#2)
their parents'##3##2##(1990-5#1)(2006-2#1)(2007-8#1)
their part##2##2##(1990-4#1)(2006-7#1)
their partial##3##2##(2008-10#1)(2008-8#1)(2013-8#1)
their participation in the##5##4##(1994-1#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-8#1)
their participation in##12##3##(1994-1#1)(1994-8#1)(1995-12#1)(2006-10#1)(2006-12#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-6#1)(2010-3#1)(2011-2#1)
their participation##17##2##(1992-12#1)(1994-1#1)(1994-8#1)(1995-12#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-6#2)(2010-3#1)(2011-2#1)(2012-12#1)
their particular country##2##3##(2005-12#2)
their particular##12##2##(1992-12#1)(1997-6#1)(2005-12#2)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2009-5#1)(2009-9#1)(2011-2#1)(2013-1#1)
their partition##3##2##(1990-11#1)(1996-1#1)(2008-10#1)
their partner##9##2##(1995-6#1)(2007-12#2)(2008-8#1)(2010-5#1)(2010-9#2)(2011-2#1)(2012-12#1)
their partners from##2##3##(2008-12#2)
their partners in a##2##4##(2008-9#1)(2011-2#1)
their partners in##4##3##(2007-2#1)(2008-9#1)(2011-2#1)(2012-1#1)
their partners##19##2##(1997-7#1)(2005-10#1)(2005-7#1)(2007-12#2)(2007-2#1)(2008-12#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2011-2#2)(2012-1#1)(2013-1#2)
their partners'##2##2##(1997-7#1)(2009-5#1)
their parts##2##2##(2008-9#1)(2013-1#1)
their pastoral##2##2##(1991-2#1)(2010-9#1)
their pathogenesis##7##2##(2006-10#3)(2007-11#1)(2007-8#1)(2008-4#1)(2011-2#1)
their pathogenic potential##2##3##(2008-10#1)(2011-1#1)
their pathogenic##4##2##(2006-10#1)(2007-6#1)(2008-10#1)(2011-1#1)
their pathogenicity in##2##3##(2008-10#1)(2012-3#1)
their pathogenicity on##3##3##(2008-10#3)
their pathogenicity##8##2##(2008-10#6)(2008-5#1)(2012-3#1)
their pathogens##4##2##(2008-10#2)(2009-5#1)(2013-1#1)
their pathological##5##2##(1991-12#1)(1995-3#1)(2008-6#1)(2009-2#1)(2013-8#1)
their pathophysiologic##2##2##(2007-7#1)(2008-1#1)
their pathophysiological##3##2##(1995-6#1)(2008-5#1)(2011-1#1)
their pathophysiology##5##2##(2006-10#1)(2006-11#1)(2009-12#1)(2010-12#1)(2010-6#1)
their pathotype##2##2##(2008-10#2)
their patient volume##2##3##(1994-2#1)(1997-1#1)
their patient##9##2##(1993-1#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1997-1#1)(2008-6#1)(2013-1#2)
their patients and##9##3##(1991-11#1)(1992-2#1)(1995-3#1)(1997-3#1)(2008-11#1)(2009-9#2)(2012-1#1)(2013-1#1)
their patients for##3##3##(2007-2#1)(2007-4#1)(2010-12#1)
their patients have##2##3##(2006-5#1)(2010-8#1)
their patients in the##2##4##(2006-7#1)(2007-8#1)
their patients in##6##3##(1990-2#1)(2006-7#1)(2006-8#1)(2007-8#1)(2013-1#2)
their patients is##2##3##(1990-9#1)(1993-3#1)
their patients or##2##3##(2006-7#1)(2010-2#1)
their patients to##7##3##(1997-6#1)(2006-10#3)(2007-4#1)(2010-9#1)(2011-1#1)
their patients when##2##3##(2007-3#1)(2011-2#1)
their patients with##3##3##(1995-3#1)(1997-3#1)(2007-12#1)
their patients##98##2##(1990-2#2)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-12#3)(1992-2#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-1#3)(1994-12#1)(1994-3#1)(1994-6#1)(1994-7#2)(1995-2#1)(1995-3#2)(1995-4#1)(1996-7#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-6#2)(2005-10#1)(2005-12#1)(2006-10#4)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#3)(2007-8#3)(2008-1#2)(2008-11#4)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#6)(2013-8#2)
their patients'##11##2##(1993-12#1)(1994-2#1)(1997-2#1)(2006-2#1)(2006-8#1)(2006-9#1)(2008-7#2)(2008-8#2)(2012-12#1)
their pattern of##5##3##(1991-9#1)(2007-12#1)(2008-11#1)(2009-4#1)(2012-3#1)
their pattern##6##2##(1991-9#1)(2007-12#1)(2008-11#1)(2009-4#1)(2012-2#1)(2012-3#1)
their patterns of inheritance##2##4##(1993-2#1)(2012-2#1)
their patterns of##12##3##(1993-2#1)(1994-2#1)(1996-4#1)(2007-12#1)(2008-1#1)(2008-8#1)(2009-6#1)(2010-10#1)(2012-2#2)(2013-1#2)
their patterns##14##2##(1993-2#1)(1994-2#1)(1996-4#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-2#1)(2008-8#1)(2009-6#1)(2010-10#1)(2012-2#2)(2013-1#2)
their peak experiences##2##3##(2013-8#2)
their peak##8##2##(2005-11#1)(2008-10#1)(2008-5#1)(2012-2#1)(2012-3#1)(2013-8#3)
their peaks##2##2##(1995-11#1)(2007-4#1)
their pediatric##3##2##(1996-1#1)(2010-7#1)(2012-1#1)
their peer##2##2##(2005-9#1)(2010-4#1)
their peers and##3##3##(2007-4#1)(2012-2#1)(2013-1#1)
their peers in##2##3##(2005-6#1)(2011-1#1)
their peers##22##2##(1990-5#1)(1991-8#1)(1993-1#1)(1997-1#1)(2005-6#1)(2007-4#1)(2008-10#3)(2008-11#2)(2008-9#1)(2009-7#2)(2009-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
their penetration through the##2##4##(1995-12#1)(1997-4#1)
their pension plans##2##3##(1993-3#2)
their perceived##11##2##(1996-2#1)(2008-11#3)(2010-12#1)(2010-9#2)(2011-2#1)(2012-11#1)(2012-12#1)(2013-7#1)
their perception of the##4##4##(1991-2#1)(1992-11#1)(1992-12#1)(2006-7#1)
their perception of their##2##4##(2010-12#1)(2013-7#1)
their perception of##11##3##(1991-2#1)(1992-11#1)(1992-12#1)(1993-2#1)(2006-7#1)(2007-12#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-7#1)
their perception##14##2##(1991-2#1)(1992-11#1)(1992-12#1)(1993-2#1)(2006-7#1)(2007-12#1)(2008-11#1)(2008-6#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-7#1)
their perceptions and##3##3##(1992-2#1)(2006-2#1)(2012-3#1)
their perceptions of the##10##4##(1993-1#1)(2006-7#2)(2007-10#1)(2008-5#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)
their perceptions of their##3##4##(1992-1#1)(2006-9#1)(2008-9#1)
their perceptions of##24##3##(1990-12#1)(1992-1#1)(1993-1#1)(2005-7#1)(2006-7#2)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-3#2)(2010-8#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
their perceptions##31##2##(1990-12#1)(1992-1#1)(1992-2#1)(1993-1#1)(2005-7#1)(2006-2#2)(2006-7#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#2)
their percutaneous##2##2##(2008-5#1)(2010-12#1)
their performance as##6##3##(2006-10#1)(2007-11#2)(2007-4#1)(2008-10#1)(2012-11#1)
their performance has been##2##4##(2007-11#1)(2009-6#1)
their performance has##3##3##(2007-11#1)(2008-2#1)(2009-6#1)
their performance in terms of##2##5##(2005-11#1)(2012-3#1)
their performance in the##2##4##(1993-9#1)(2008-11#1)
their performance in##13##3##(1991-2#1)(1993-1#1)(1993-9#1)(2005-11#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-8#1)(2009-1#1)(2012-2#1)(2012-3#1)
their performance of##2##3##(1992-11#1)(2008-10#1)
their performance on a##2##4##(2007-9#1)(2008-10#1)
their performance on the##3##4##(1996-2#1)(2009-3#1)(2012-3#1)
their performance on##7##3##(1996-2#1)(2007-9#1)(2008-10#1)(2008-2#1)(2009-3#1)(2012-2#1)(2012-3#1)
their performance was##4##3##(1993-12#1)(2008-3#1)(2008-7#1)(2008-8#1)
their performance with##3##3##(1997-1#1)(2005-9#1)(2008-8#1)
their performance##71##2##(1990-3#1)(1990-6#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-3#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-9#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-4#2)(2007-9#1)(2008-10#7)(2008-11#3)(2008-2#7)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#4)(2009-1#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-4#1)(2010-8#1)(2010-9#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#2)
their performances##4##2##(1996-8#1)(1997-7#1)(2008-3#1)(2012-3#1)
their periodic##2##2##(2008-2#1)(2008-3#1)
their peripheral##6##2##(1991-3#1)(1996-12#1)(1996-3#1)(2006-10#1)(2008-4#1)(2008-5#1)
their periphery##3##2##(1992-9#1)(2009-11#1)(2010-7#1)
their permeability to##2##3##(1991-8#1)(1992-6#1)
their permeability##4##2##(1991-8#1)(1992-6#1)(1997-8#1)(2007-8#1)
their persistence and##2##3##(2009-7#1)(2010-11#1)
their persistence##5##2##(1993-9#1)(2008-3#1)(2009-7#1)(2010-11#1)(2011-12#1)
their personal and professional lives##2##5##(2007-7#1)(2008-11#1)
their personal and professional##3##4##(2007-7#1)(2008-11#1)(2009-11#1)
their personal and##4##3##(2007-7#1)(2008-11#1)(2008-2#1)(2009-11#1)
their personal experience##3##3##(1990-5#1)(1990-9#1)(1991-9#1)
their personal experiences##2##3##(2008-12#1)(2010-3#1)
their personal##28##2##(1990-5#1)(1990-9#1)(1991-3#1)(1991-9#1)(1992-6#1)(1993-1#1)(1994-1#1)(1994-10#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-9#1)(2007-11#1)(2007-7#3)(2008-11#2)(2008-12#1)(2008-2#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-2#1)(2010-3#1)(2012-12#1)(2013-1#2)
their personnel##2##2##(2007-2#2)
their perspective on##4##3##(1994-1#1)(2008-2#1)(2009-4#1)(2009-9#1)
their perspective##8##2##(1994-1#1)(2007-3#1)(2008-12#1)(2008-2#1)(2009-4#1)(2009-9#1)(2011-1#1)(2011-2#1)
their pharmaceutical preparations##3##3##(2008-10#3)
their pharmaceutical##7##2##(2008-10#7)
their pharmacodynamic##2##2##(1996-12#1)(2008-5#1)
their pharmacokinetics##2##2##(2007-11#1)(2013-1#1)
their pharmacological##3##2##(2008-1#1)(2008-5#1)(2013-1#1)
their phase##3##2##(1994-3#1)(2007-12#1)(2008-12#1)
their phases##2##2##(2008-3#1)(2008-4#1)
their phenology##2##2##(2007-3#1)(2008-8#1)
their phenotype and##2##3##(2006-10#1)(2012-12#1)
their phenotype##7##2##(1995-1#1)(1996-5#1)(2006-10#1)(2008-9#1)(2012-12#2)(2013-8#1)
their phenotypic and genotypic characteristics##2##5##(2008-5#1)(2012-12#1)
their phenotypic##7##2##(1996-10#1)(2005-10#1)(2008-5#1)(2008-7#1)(2010-3#1)(2012-12#1)(2013-1#1)
their phosphorylation##3##2##(1992-8#1)(1994-9#1)(2005-8#1)
their photodegradation##3##2##(2008-10#2)(2011-1#1)
their photoluminescent properties##2##3##(2005-11#1)(2008-3#1)
their photon##2##2##(2007-11#1)(2008-2#1)
their photoproducts##2##2##(1994-9#1)(2008-10#1)
their phylogenetic##7##2##(1993-11#1)(1997-6#1)(2006-10#1)(2008-4#1)(2008-7#1)(2010-10#1)(2013-7#1)
their physical activity##2##3##(2011-1#1)(2013-1#1)
their physical and##2##3##(1990-9#1)(2012-12#1)
their physical properties were##2##4##(2008-11#1)(2008-5#1)
their physical properties##4##3##(1996-5#1)(2008-11#1)(2008-5#2)
their physical##33##2##(1990-9#1)(1991-1#1)(1996-5#1)(2005-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#11)(2009-8#2)(2010-8#3)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#3)
their physician##6##2##(1993-12#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)
their physicians for##3##3##(2006-5#1)(2007-3#1)(2008-11#1)
their physicians regarding##2##3##(2009-7#1)(2012-3#1)
their physicians##21##2##(1990-8#1)(1991-1#1)(1991-2#1)(1993-9#1)(1996-3#1)(1997-6#1)(2006-5#1)(2007-3#1)(2008-11#2)(2008-3#1)(2008-6#1)(2009-5#2)(2009-7#2)(2010-8#1)(2012-3#1)(2013-1#3)
their physico-chemical properties##8##3##(2006-1#1)(2008-10#2)(2008-5#3)(2012-1#1)(2013-1#1)
their physico-chemical##10##2##(1994-11#1)(2006-1#1)(2008-10#2)(2008-5#4)(2012-1#1)(2013-1#1)
their physicochemical parameters##2##3##(1996-5#1)(2008-10#1)
their physicochemical properties##6##3##(1996-5#1)(2004-12#1)(2005-11#1)(2008-5#2)(2010-5#1)
their physicochemical##10##2##(1996-5#2)(1996-8#1)(2004-12#1)(2005-11#1)(2008-10#1)(2008-5#2)(2010-4#1)(2010-5#1)
their physiologic##2##2##(1992-11#1)(2008-3#1)
their physiological and##2##3##(2009-9#1)(2012-3#1)
their physiological functions##2##3##(1994-9#1)(2008-4#1)
their physiological relevance##2##3##(1995-2#1)(2007-11#1)
their physiological role##2##3##(2012-12#2)
their physiological roles##3##3##(1996-2#1)(1996-5#1)(2012-12#1)
their physiological##22##2##(1990-11#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-2#1)(1996-5#1)(2007-11#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-1#1)(2009-9#1)(2010-5#1)(2011-1#1)(2012-12#3)(2012-2#1)(2012-3#1)
their place in the##3##4##(2005-8#1)(2008-11#1)(2008-3#1)
their place in##7##3##(1994-3#1)(2005-8#2)(2008-11#1)(2008-2#1)(2008-3#1)(2012-12#1)
their place of##2##3##(2008-10#1)(2010-10#1)
their place##10##2##(1994-3#1)(2005-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-5#1)(2010-10#1)(2012-12#1)
their placement##5##2##(2008-4#1)(2012-12#1)(2013-1#3)
their places of##2##3##(2010-10#1)(2013-1#1)
their plan##2##2##(2007-2#1)(2009-10#1)
their planned##2##2##(2006-10#1)(2010-2#1)
their plans##5##2##(1994-1#1)(1996-3#1)(2007-6#1)(2008-6#1)(2010-2#1)
their plant##3##2##(2008-10#1)(2008-8#1)(2009-8#1)
their plasma concentrations##2##3##(1990-12#1)(1990-4#1)
their plasma membrane##2##3##(1992-7#1)(1993-11#1)
their plasma##7##2##(1990-12#1)(1990-4#1)(1992-7#1)(1993-11#1)(1994-6#1)(1996-8#1)(2012-2#1)
their plastids##2##2##(1997-4#1)(2007-12#1)
their plausible##2##2##(2009-8#1)(2010-4#1)
their point of##2##3##(1994-12#1)(2007-10#1)
their point-spread functions##2##3##(2007-12#2)
their polarization##3##2##(2007-11#1)(2008-1#1)(2008-2#1)
their policies##3##2##(1994-3#1)(2013-1#2)
their political affiliation##2##3##(2010-12#2)
their political##3##2##(1995-9#1)(2010-12#2)
their poor prognosis##2##3##(2005-10#1)(2007-9#1)
their poor##13##2##(1992-10#1)(1994-9#1)(1996-12#1)(2005-10#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-2#1)(2013-8#1)
their poor-fitting models##2##3##(2008-4#2)
their poorer##2##2##(2007-2#1)(2009-7#1)
their population density##2##3##(2008-9#1)(2013-8#1)
their population##7##2##(2007-9#1)(2008-1#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-8#1)
their populations##5##2##(1994-3#1)(1995-3#1)(2007-5#1)(2008-10#1)(2009-7#1)
their position and##2##3##(2007-11#1)(2011-2#1)
their position in##2##3##(1994-3#1)(2013-8#1)
their position##13##2##(1994-3#1)(2007-11#1)(2007-12#2)(2008-5#1)(2009-4#2)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-8#1)
their positions##6##2##(1990-9#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-11#1)(2009-8#1)
their positive##9##2##(1995-6#1)(1996-4#1)(2006-2#1)(2008-10#2)(2008-5#1)(2011-1#2)(2013-1#1)
their possibility##2##2##(2008-10#1)(2013-1#1)
their possible clinical##2##3##(1994-6#1)(2005-8#1)
their possible effects on the##3##5##(2004-11#1)(2005-11#1)(2011-1#1)
their possible involvement in##2##4##(1997-5#1)(2006-1#1)
their possible mechanisms of action##3##5##(2009-2#1)(2013-1#2)
their possible role as##2##4##(1995-7#1)(2007-9#1)
their possible role in##5##4##(1990-3#1)(1996-12#1)(2007-6#1)(2008-5#1)(2011-2#1)
their possible role##9##3##(1990-3#1)(1995-7#1)(1996-12#1)(2007-11#1)(2007-6#1)(2007-9#1)(2008-5#1)(2010-4#1)(2011-2#1)
their possible roles in the##2##5##(1993-12#1)(2008-7#1)
their possible roles in##3##4##(1993-12#1)(2005-10#1)(2008-7#1)
their possible##66##2##(1990-3#1)(1991-4#1)(1992-6#1)(1993-1#1)(1993-12#1)(1994-6#1)(1995-3#1)(1995-7#1)(1996-12#1)(1996-4#1)(1997-5#1)(2004-11#1)(2005-10#2)(2005-11#2)(2005-6#1)(2005-8#2)(2006-1#1)(2006-10#3)(2006-2#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-8#2)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#3)
their postoperative##2##2##(1996-12#1)(2010-8#1)
their postpartum##3##2##(2006-2#1)(2007-2#1)(2012-2#1)
their potencies in##2##3##(1991-6#1)(1992-3#1)
their potencies to##2##3##(1993-12#1)(1995-11#1)
their potencies##7##2##(1991-6#1)(1992-3#1)(1992-8#1)(1993-12#1)(1995-11#1)(2008-5#1)(2009-10#1)
their potency to##2##3##(1995-11#1)(1996-6#1)
their potency##10##2##(1990-12#1)(1992-1#1)(1993-4#1)(1995-11#1)(1996-6#1)(1997-3#1)(2006-12#1)(2008-8#1)(2009-2#1)(2011-1#1)
their potential application in##3##4##(2005-7#1)(2006-7#1)(2007-1#1)
their potential application##5##3##(2005-7#2)(2006-7#1)(2007-1#1)(2012-4#1)
their potential applications in##2##4##(2009-2#1)(2009-5#1)
their potential applications##6##3##(2009-2#1)(2009-4#1)(2009-5#1)(2010-4#1)(2013-1#2)
their potential as##8##3##(1994-11#1)(1995-1#1)(2005-7#1)(2008-11#1)(2008-5#1)(2010-1#1)(2011-2#1)(2013-1#1)
their potential beneficial effects##2##4##(2006-10#1)(2007-11#1)
their potential benefits##2##3##(2005-8#1)(2010-4#1)
their potential clinical##2##3##(2008-8#1)(2012-3#1)
their potential for osteogenic##3##4##(2008-11#2)(2013-7#1)
their potential for##12##3##(2005-10#1)(2006-10#1)(2007-12#1)(2008-11#2)(2008-5#2)(2008-7#1)(2009-10#1)(2010-6#1)(2013-1#1)(2013-7#1)
their potential impact on##4##4##(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#1)
their potential in the##3##4##(2006-11#1)(2006-7#1)(2011-1#1)
their potential in##5##3##(2006-11#1)(2006-7#1)(2009-5#1)(2010-12#1)(2011-1#1)
their potential role in##7##4##(1995-10#1)(2008-1#1)(2008-10#2)(2008-7#1)(2011-2#1)(2013-8#1)
their potential therapeutic##2##3##(2008-4#1)(2013-1#1)
their potential to be##2##4##(2008-5#1)(2010-8#1)
their potential to increase##2##4##(1995-3#1)(1996-11#1)
their potential to##19##3##(1993-6#1)(1993-9#1)(1995-3#1)(1996-1#1)(1996-11#1)(2006-12#1)(2007-3#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-7#1)
their potential toxic##2##3##(2008-10#2)
their potential toxicity##2##3##(2010-10#1)(2010-12#1)
their potential use as##3##4##(2006-5#1)(2008-5#1)(2009-8#1)
their potential use for##3##4##(2008-10#1)(2008-5#1)(2009-8#1)
their potential use in the##2##5##(2006-10#1)(2007-11#1)
their potential use in##4##4##(2006-10#1)(2007-11#1)(2008-1#1)(2011-1#1)
their potential use##10##3##(2006-10#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#2)(2009-8#2)(2011-1#1)
their potential usefulness in the##2##5##(2005-4#1)(2008-5#1)
their potential usefulness##4##3##(2005-4#1)(2007-8#1)(2008-10#1)(2008-5#1)
their potential utility##2##3##(2008-1#1)(2011-1#1)
their potential value##2##3##(2007-1#1)(2013-8#1)
their potential##138##2##(1990-6#1)(1992-5#1)(1993-2#1)(1993-6#2)(1993-9#1)(1994-11#1)(1995-1#1)(1995-10#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-4#1)(2005-7#3)(2005-8#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-5#1)(2006-7#2)(2007-1#3)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#11)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#10)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#3)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#2)(2012-4#1)(2013-1#6)(2013-7#2)(2013-8#2)
their potentially##3##2##(1997-2#1)(2012-2#1)(2013-7#1)
their potentials##4##2##(2008-1#1)(2008-9#3)
their potentiating effect##2##3##(1991-7#1)(1993-4#1)
their power##2##2##(1995-8#1)(2008-4#1)
their powers##3##2##(2008-2#1)(2009-3#1)(2011-1#1)
their practical applications##2##3##(2010-12#1)(2011-2#1)
their practical use##2##3##(2005-11#1)(2008-8#1)
their practical##7##2##(2005-11#1)(2007-6#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-1#1)
their practice patterns##3##3##(1994-2#1)(2006-8#1)(2008-11#1)
their practice settings##2##3##(1996-7#1)(2008-3#1)
their practice to##3##3##(2006-10#1)(2007-9#1)(2011-1#1)
their practice##37##2##(1991-4#1)(1993-10#1)(1994-2#1)(1995-3#1)(1996-1#2)(1996-7#1)(2006-10#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#2)(2008-6#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-2#1)
their practices and##4##3##(1996-2#1)(2006-7#1)(2007-9#1)(2008-6#1)
their practices in##2##3##(2007-12#1)(2007-4#1)
their practices##24##2##(1993-12#1)(1994-12#1)(1996-2#1)(2004-9#1)(2006-7#1)(2006-8#1)(2007-12#2)(2007-4#2)(2007-8#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#4)(2011-1#1)
their precise contribution##2##3##(1996-5#1)(2005-11#1)
their precise##14##2##(1990-3#1)(1991-9#1)(1993-6#1)(1996-5#1)(2005-11#1)(2005-3#1)(2006-12#1)(2008-10#1)(2008-3#1)(2009-5#1)(2010-4#1)(2012-2#2)(2012-3#1)
their precision##2##2##(1994-8#1)(2008-8#1)
their precursor cells##2##3##(1996-1#1)(2013-8#1)
their precursor##3##2##(1996-1#1)(1996-5#1)(2013-8#1)
their precursors##7##2##(1992-8#1)(1994-12#1)(1995-3#1)(2008-10#1)(2008-12#1)(2010-10#1)(2010-12#1)
their predicted##4##2##(1992-2#1)(1993-1#1)(1993-9#1)(2008-7#1)
their predictions##3##2##(1992-1#1)(2005-6#1)(2008-9#1)
their predominant##3##2##(2008-10#1)(2008-12#1)(2008-3#1)
their preference for the##2##4##(1992-7#1)(2007-11#1)
their preference for##6##3##(1992-7#1)(2007-11#1)(2007-9#1)(2008-4#1)(2010-2#1)(2012-2#1)
their preference##9##2##(1992-7#1)(1993-6#1)(2007-11#1)(2007-6#1)(2007-9#1)(2008-11#1)(2008-4#1)(2010-2#1)(2012-2#1)
their preferences of##2##3##(2010-2#1)(2013-8#1)
their preferences##8##2##(2006-5#1)(2008-3#1)(2008-8#1)(2010-11#1)(2010-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
their preferential##3##2##(1995-8#1)(2008-4#1)(2009-12#1)
their preferred##6##2##(1995-11#1)(2007-6#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-8#1)
their pregnancies##6##2##(2007-12#1)(2007-2#1)(2007-3#1)(2010-3#1)(2011-2#1)(2013-1#1)
their pregnancy##6##2##(1990-6#1)(2006-8#1)(2007-2#1)(2009-2#1)(2013-1#1)(2013-8#1)
their preliminary##3##2##(2006-11#2)(2006-2#1)
their premature##2##2##(2011-12#1)(2011-2#1)
their preoperative##2##2##(1994-11#1)(2010-9#1)
their preparation##7##2##(1995-11#1)(2008-5#1)(2009-10#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-11#1)
their preparedness##2##2##(2007-3#1)(2012-1#1)
their prepregnancy##2##2##(2011-1#1)(2013-1#1)
their prescribed##3##2##(2007-2#1)(2008-11#1)(2010-1#1)
their prescribing##3##2##(2007-2#1)(2008-11#2)
their presence at##2##3##(2008-10#1)(2013-1#1)
their presence can##2##3##(1994-3#1)(2008-10#1)
their presence has been##2##4##(2008-10#1)(2012-2#1)
their presence in human##2##4##(1993-2#1)(2008-2#1)
their presence in##9##3##(1993-12#1)(1993-2#1)(1994-3#1)(1996-1#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-9#1)(2013-8#1)
their presence##27##2##(1991-3#1)(1992-10#1)(1993-12#1)(1993-2#1)(1994-3#2)(1994-5#1)(1995-3#1)(1996-1#2)(2005-9#1)(2007-12#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-6#1)(2012-2#1)(2013-1#2)(2013-8#1)
their present##6##2##(1990-6#1)(1993-3#1)(1995-3#1)(1997-7#1)(2006-2#1)(2010-2#1)
their presentation##5##2##(2007-11#1)(2007-9#1)(2008-9#2)(2010-12#1)
their presenting symptoms##2##3##(2006-11#1)(2006-2#1)
their presumed##3##2##(1997-3#1)(2007-12#1)(2008-12#1)
their preterm##2##2##(1992-2#1)(1994-12#1)
their prevalence##7##2##(1991-12#1)(2006-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2011-1#1)
their prevention and treatment##3##4##(2008-8#1)(2009-10#1)(2011-2#1)
their prevention and##5##3##(2006-12#1)(2008-8#1)(2009-10#1)(2009-12#1)(2011-2#1)
their prevention##9##2##(1990-8#1)(2005-10#1)(2006-12#1)(2008-1#1)(2008-8#1)(2009-10#1)(2009-12#1)(2011-2#2)
their previous##9##2##(1994-9#1)(1995-9#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)(2011-10#1)
their prey##2##2##(1995-12#1)(2008-9#1)
their primary bacterial##2##3##(2007-12#1)(2012-2#1)
their primary care##3##3##(2010-3#2)(2010-8#1)
their primary structures##2##3##(1994-5#1)(1995-3#1)
their primary treatment##2##3##(2007-11#1)(2007-6#1)
their primary##32##2##(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-6#1)(1992-8#1)(1994-5#1)(1994-8#1)(1995-2#2)(1995-3#1)(1996-2#1)(1996-6#1)(1997-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-4#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-3#2)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
their probability of##3##3##(2007-11#1)(2007-9#2)
their probability##4##2##(2007-11#1)(2007-9#2)(2008-10#1)
their probiotic##3##2##(2008-5#1)(2012-11#1)(2012-2#1)
their problem##7##2##(1990-12#1)(2007-11#1)(2009-6#3)(2013-1#2)
their problems##7##2##(1991-2#1)(1991-6#1)(1995-3#1)(1995-9#1)(2005-7#1)(2006-10#1)(2011-1#1)
their process##3##2##(2008-2#1)(2011-1#1)(2012-2#1)
their processes##10##2##(1990-12#1)(1991-3#1)(1992-6#1)(1992-8#1)(1995-5#1)(1996-9#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-7#1)
their product##4##2##(1997-4#1)(2007-12#1)(2007-7#1)(2008-11#1)
their production and##2##3##(1996-2#1)(2007-3#1)
their production as##2##3##(1991-12#1)(1997-7#1)
their production is##3##3##(1991-2#1)(2008-4#1)(2009-8#1)
their production of##2##3##(1994-11#1)(2008-4#1)
their production##23##2##(1991-12#1)(1991-2#1)(1991-3#1)(1994-11#1)(1994-9#1)(1995-5#1)(1996-2#2)(1997-7#1)(2007-3#2)(2007-9#1)(2008-10#3)(2008-11#2)(2008-4#3)(2009-8#1)(2012-2#1)(2013-1#1)
their products and services##2##4##(1994-1#1)(1994-3#1)
their products are##2##3##(2006-10#1)(2009-7#1)
their products##21##2##(1992-5#1)(1994-1#1)(1994-3#1)(1997-1#1)(1997-5#1)(2005-10#1)(2005-7#1)(2006-10#1)(2007-2#2)(2007-4#1)(2008-10#3)(2008-4#1)(2008-5#2)(2009-4#1)(2009-5#1)(2009-7#1)(2012-1#1)
their profession##10##2##(1991-3#1)(1991-4#1)(1992-1#1)(1992-2#1)(1995-2#1)(2007-2#1)(2008-3#1)(2008-7#1)(2009-4#1)(2012-2#1)
their professional development##2##3##(2008-11#1)(2013-8#1)
their professional life##2##3##(2008-2#1)(2010-9#1)
their professional lives##2##3##(2008-11#1)(2013-1#1)
their professional practice##3##3##(1997-7#1)(2008-1#1)(2013-1#1)
their professional role##2##3##(2009-7#1)(2010-10#1)
their professional##32##2##(1997-7#1)(2004-12#1)(2005-9#1)(2006-1#1)(2006-5#1)(2007-1#1)(2007-7#1)(2008-1#2)(2008-11#6)(2008-2#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-5#2)(2010-9#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
their progenies##3##2##(2007-1#1)(2008-9#1)(2013-1#1)
their progeny##9##2##(2007-12#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
their prognosis and##4##3##(1994-7#1)(1995-5#1)(2008-3#1)(2012-2#1)
their prognosis##5##2##(1994-7#1)(1995-5#1)(2008-3#1)(2012-11#1)(2012-2#1)
their prognostic value##2##3##(2009-2#1)(2012-12#1)
their prognostic##6##2##(2008-1#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-2#1)(2012-12#1)
their program##3##2##(2007-10#1)(2007-9#1)(2011-2#1)
their programme##2##2##(2007-6#1)(2008-12#1)
their programs##6##2##(1991-3#1)(1992-3#1)(1994-2#1)(1995-1#1)(2008-10#1)(2008-2#1)
their progress##2##2##(2007-2#1)(2007-8#1)
their progression to##3##3##(2008-1#1)(2010-8#1)(2013-1#1)
their project##2##2##(1991-1#2)
their projection##3##2##(1996-5#1)(2007-12#1)(2008-2#1)
their projects##2##2##(2012-2#1)(2012-3#1)
their prokaryotic##2##2##(2008-7#1)(2009-2#1)
their proliferation##6##2##(1993-12#1)(1995-10#1)(1997-2#1)(2008-5#1)(2009-3#1)(2013-8#1)
their proliferative##9##2##(1992-5#1)(1995-10#1)(1995-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-1#2)(2013-7#1)
their prolonged##2##2##(1990-11#1)(2008-10#1)
their promise##2##2##(2005-7#1)(2013-1#1)
their promoter regions##4##3##(1994-11#1)(1994-12#1)(1997-2#1)(2008-8#1)
their promoter##9##2##(1992-9#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-2#1)(1997-2#1)(2007-11#1)(2008-8#1)(2009-8#1)
their promoters##4##2##(1993-3#1)(1993-8#1)(2008-7#1)(2012-3#1)
their propagation##2##2##(1993-12#1)(2008-9#1)
their proper##7##2##(1994-9#1)(2008-1#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#2)
their properties for##2##3##(2008-3#1)(2011-12#1)
their properties##21##2##(1990-8#1)(1991-1#1)(1992-6#1)(1995-1#1)(1997-1#1)(2005-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-6#1)(2009-7#1)(2011-12#1)(2011-2#1)
their proposed##3##2##(1996-11#1)(2007-7#1)(2011-2#1)
their pros and cons##2##4##(1994-5#1)(2009-12#1)
their prospects##2##2##(1992-12#1)(2010-7#1)
their protection against##2##3##(1992-9#1)(2013-1#1)
their protection##3##2##(1992-9#1)(2013-1#2)
their protective##9##2##(1993-12#1)(1995-10#1)(1995-12#2)(2008-12#1)(2008-4#1)(2008-7#1)(2009-8#1)(2013-8#1)
their protein products##2##3##(2008-4#1)(2011-2#1)
their protein##7##2##(1992-12#1)(1992-6#1)(1994-8#1)(1997-7#1)(2008-4#1)(2008-5#1)(2011-2#1)
their proteins##4##2##(1990-12#1)(1994-8#1)(1997-6#1)(1997-8#1)
their proven##2##2##(1996-9#1)(2007-10#1)
their provider##2##2##(2006-8#1)(2011-2#1)
their providers##5##2##(1995-1#1)(2008-12#1)(2013-1#3)
their proximity to##3##3##(1996-7#1)(1997-7#1)(2012-3#1)
their proximity##4##2##(1996-7#1)(1997-7#1)(2009-12#1)(2012-3#1)
their psychiatric disabilities##2##3##(2007-8#2)
their psychiatric##5##2##(1992-2#1)(2007-8#2)(2013-1#1)(2013-8#1)
their psychological well-being##3##3##(2005-9#2)(2007-8#1)
their psychological##10##2##(2005-11#1)(2005-9#2)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-2#3)
their psychometric properties##3##3##(2007-1#1)(2010-10#1)(2010-11#1)
their psychopathology##2##2##(1997-8#1)(2008-3#1)
their psychosocial##4##2##(1991-1#1)(2009-5#1)(2010-2#1)(2013-1#1)
their public health##2##3##(2007-2#1)(2008-11#1)
their pulmonary##2##2##(2007-6#1)(2010-1#1)
their pups##2##2##(1993-2#1)(2008-11#1)
their purification in##2##3##(2007-9#1)(2008-4#1)
their purification##10##2##(1990-2#1)(1995-12#1)(2007-9#1)(2008-4#6)(2008-9#1)
their purpose##3##2##(1993-12#1)(1997-1#1)(2008-3#1)
their putative functions##2##3##(2008-11#1)(2009-12#1)
their putative##14##2##(1992-5#1)(1994-3#1)(1995-3#1)(1997-6#1)(1997-7#1)(2005-8#1)(2007-1#1)(2008-11#1)(2008-3#1)(2009-1#1)(2009-12#1)(2009-8#1)(2012-2#2)
their quality for##2##3##(1997-6#1)(2007-10#1)
their quality is##2##3##(1991-6#1)(2007-7#1)
their quality of life and##5##5##(2008-6#1)(2009-11#1)(2009-7#1)(2011-2#2)
their quality of life##20##4##(1992-4#1)(1997-1#1)(2004-10#1)(2007-11#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#6)(2012-12#1)(2013-7#1)(2013-8#1)
their quality of##23##3##(1992-4#1)(1997-1#1)(2004-10#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#6)(2012-12#1)(2013-7#1)(2013-8#2)
their quality##33##2##(1991-6#1)(1992-4#1)(1997-1#1)(1997-6#1)(2004-10#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#7)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#3)
their quantification##4##2##(2008-10#2)(2008-11#1)(2010-4#1)
their quantum##2##2##(2005-12#1)(2008-3#1)
their ramifications##2##2##(2005-8#1)(2006-10#1)
their range##3##2##(2007-3#1)(2009-4#1)(2013-1#1)
their rank order##2##3##(1990-11#1)(2009-12#1)
their rank##3##2##(1990-11#1)(1993-1#1)(2009-12#1)
their ranks##2##2##(1993-1#1)(1994-12#1)
their rapid##8##2##(1991-4#1)(1992-10#1)(1992-2#1)(1996-6#1)(2008-10#1)(2008-4#1)(2010-7#1)(2011-1#1)
their rarity##4##2##(2005-10#1)(2006-12#1)(2010-12#1)(2012-12#1)
their rate of##4##3##(1991-2#1)(1997-5#1)(2008-10#1)(2008-11#1)
their rate##7##2##(1991-2#1)(1994-12#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
their rates of##6##3##(1991-11#1)(1991-3#1)(1993-3#1)(1996-2#1)(2011-12#1)(2013-8#1)
their rather##3##2##(1996-11#1)(2007-12#1)(2010-4#1)
their rating of##2##3##(1996-2#1)(2007-12#1)
their ratio##4##2##(2005-1#1)(2007-12#1)(2008-10#1)(2010-12#1)
their reaction to##2##3##(2008-10#2)
their reaction with##10##3##(1990-5#1)(1995-6#1)(2005-9#1)(2007-11#1)(2008-10#5)(2008-5#1)
their reaction##18##2##(1990-5#1)(1994-6#1)(1995-6#1)(2005-11#1)(2005-9#1)(2007-11#2)(2007-8#1)(2008-10#7)(2008-5#1)(2013-7#1)(2013-8#1)
their reactions to##3##3##(2008-10#2)(2012-11#1)
their reactions with##5##3##(1996-2#1)(2008-10#1)(2008-11#3)
their reactions##10##2##(1996-2#1)(1996-6#1)(2008-10#4)(2008-11#3)(2012-11#1)
their reactivity with##3##3##(2007-2#1)(2008-10#1)(2010-11#1)
their reactivity##8##2##(1993-12#1)(1994-5#1)(1994-9#1)(2007-10#1)(2007-2#1)(2008-10#2)(2010-11#1)
their readiness to##2##3##(2007-2#1)(2013-1#1)
their reading##2##2##(2010-3#1)(2012-1#1)
their real##2##2##(2006-10#1)(2009-3#1)
their recent##3##2##(2008-10#2)(2010-1#1)
their recently##2##2##(2008-9#1)(2012-3#1)
their receptor##3##2##(1992-9#1)(2008-1#1)(2008-9#1)
their receptors and their##2##4##(1996-3#1)(2009-8#1)
their receptors and##4##3##(1996-3#1)(2006-10#1)(2009-8#1)(2010-9#1)
their receptors are##5##3##(2008-1#1)(2008-4#3)(2008-8#1)
their receptors in the##6##4##(1995-11#2)(1996-12#1)(2008-4#1)(2008-5#1)(2009-8#1)
their receptors in##12##3##(1995-11#2)(1996-12#1)(1997-2#1)(2007-2#1)(2008-4#1)(2008-5#3)(2009-8#1)(2010-5#1)(2013-1#1)
their receptors##44##2##(1990-11#1)(1990-7#1)(1991-12#1)(1994-10#2)(1994-12#1)(1994-8#1)(1995-1#1)(1995-11#2)(1996-12#1)(1996-3#2)(1997-2#1)(2006-10#1)(2006-12#1)(2007-2#1)(2008-1#2)(2008-11#1)(2008-4#6)(2008-5#3)(2008-8#1)(2009-12#1)(2009-8#3)(2010-10#1)(2010-5#2)(2010-9#1)(2011-2#4)(2012-12#1)(2013-1#1)
their reciprocal##5##2##(2008-12#2)(2008-5#3)
their recognition by the##2##4##(1996-12#1)(2010-12#1)
their recognition##5##2##(1995-8#1)(1996-12#1)(2008-4#1)(2010-12#1)(2012-1#1)
their recognizability##2##2##(1995-8#2)
their reconstruction##2##2##(2007-12#1)(2007-8#1)
their recovery##6##2##(2007-8#1)(2008-10#3)(2012-1#1)(2012-3#1)
their recurrence##4##2##(2007-12#1)(2008-1#1)(2009-3#1)(2013-1#1)
their redox status##2##3##(2008-10#1)(2011-1#1)
their redox##5##2##(1991-4#1)(2008-10#1)(2010-7#1)(2011-1#1)(2013-8#1)
their reducing##2##2##(2007-8#1)(2008-10#1)
their reduction potentials##2##3##(1990-5#1)(1995-5#1)
their reduction##7##2##(1990-5#1)(1993-8#1)(1995-5#1)(1995-8#1)(2007-11#1)(2008-10#2)
their reference##4##2##(2008-12#1)(2008-3#1)(2008-5#1)(2011-2#1)
their referral##2##2##(1992-9#1)(1997-3#1)
their reflectivity##2##2##(2007-11#1)(2007-12#1)
their refractive-index##2##2##(2008-2#1)(2008-3#1)
their regenerative potential##2##3##(2010-8#1)(2012-12#1)
their regenerative##5##2##(2008-7#1)(2008-9#1)(2010-8#1)(2012-12#1)(2012-7#1)
their regimens##2##2##(2010-8#2)
their regional##3##2##(2004-4#1)(2006-6#1)(2009-4#1)
their registration##3##2##(2008-2#1)(2009-3#1)(2011-1#1)
their regulated##2##2##(1992-4#1)(2009-8#1)
their regulation by##2##3##(1994-11#1)(1995-5#1)
their regulation of##5##3##(2008-10#1)(2011-1#1)(2012-12#2)(2013-7#1)
their regulation##20##2##(1992-11#1)(1992-5#1)(1993-12#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-5#1)(2006-10#1)(2008-1#1)(2008-10#4)(2008-8#1)(2011-1#1)(2011-12#1)(2012-12#2)(2012-2#1)(2013-7#1)
their regulatory##6##2##(1991-3#1)(1995-3#1)(1997-4#1)(2009-10#1)(2010-1#1)(2011-1#1)
their rehabilitation programme##2##3##(1995-9#1)(2008-9#1)
their rehabilitation##3##2##(1995-9#1)(2008-9#1)(2009-12#1)
their related##6##2##(1995-11#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2013-8#1)
their relation to##19##3##(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#1)(1993-5#1)(1994-6#1)(1995-1#1)(1995-3#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-11#1)(2009-7#1)(2011-1#1)(2012-12#2)
their relation##23##2##(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#1)(1993-5#1)(1994-6#1)(1995-1#1)(1995-3#1)(1996-10#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-11#1)(2009-7#1)(2011-1#2)(2012-12#2)(2012-2#1)(2013-1#1)
their relations with##3##3##(2005-5#1)(2010-1#1)(2010-6#1)
their relations##4##2##(2005-5#1)(2008-11#1)(2010-1#1)(2010-6#1)
their relationship and##3##3##(2007-9#1)(2009-7#1)(2012-1#1)
their relationship to health##2##4##(2008-7#1)(2013-1#1)
their relationship to other##2##4##(2008-10#1)(2012-2#1)
their relationship to##32##3##(1990-11#1)(1990-9#1)(1991-2#1)(1992-4#1)(1992-6#1)(1993-1#1)(1993-6#1)(1994-11#1)(1996-5#1)(1997-6#1)(2006-5#2)(2006-6#1)(2007-10#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-4#1)(2011-3#1)(2012-11#1)(2012-2#1)(2013-1#2)(2013-8#1)
their relationship with the##2##4##(1995-12#1)(2006-10#1)
their relationship with their##3##4##(2007-12#1)(2008-10#1)(2013-1#1)
their relationship with##21##3##(1994-8#1)(1995-12#1)(1996-3#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-4#2)(2008-10#3)(2009-12#1)(2010-4#1)(2012-2#3)(2012-9#1)(2013-1#2)(2013-7#1)
their relationship##61##2##(1990-11#1)(1990-9#1)(1991-2#1)(1992-4#1)(1992-6#1)(1993-1#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-12#1)(1996-3#1)(1996-5#1)(1997-5#1)(1997-6#1)(2006-10#1)(2006-5#2)(2006-6#1)(2006-9#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-4#3)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-12#2)(2009-7#1)(2010-4#2)(2010-7#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-2#5)(2012-9#1)(2013-1#4)(2013-7#1)(2013-8#1)
their relationships and##2##3##(2007-2#1)(2010-4#1)
their relationships to other##2##4##(2008-2#1)(2008-7#1)
their relationships to the##2##4##(1995-1#1)(2011-1#1)
their relationships to##7##3##(1995-1#1)(2008-10#1)(2008-2#1)(2008-7#2)(2009-4#1)(2011-1#1)
their relationships with##14##3##(1990-12#1)(1994-12#1)(1995-9#1)(1997-2#1)(2004-5#1)(2006-7#1)(2006-9#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
their relationships##35##2##(1990-12#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-9#1)(1997-2#1)(2004-5#1)(2006-7#1)(2006-9#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#3)(2008-8#2)(2009-4#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
their relative abundance##2##3##(1996-8#1)(2007-5#1)
their relative amounts are##2##4##(1993-1#1)(2008-4#1)
their relative contribution to##4##4##(1992-9#1)(2008-3#1)(2008-7#1)(2009-2#1)
their relative contributions to##2##4##(1997-2#1)(1997-5#1)
their relative contributions##4##3##(1997-2#1)(1997-5#1)(2012-3#1)(2013-8#1)
their relative importance##2##3##(2008-8#2)
their relative merits##2##3##(2007-8#1)(2009-4#1)
their relative orientation##2##3##(1993-9#1)(2010-2#1)
their relative strengths and weaknesses##2##5##(2007-8#1)(2008-4#1)
their relative value##2##3##(1995-8#1)(2006-10#1)
their relative##74##2##(1990-3#1)(1990-5#1)(1990-9#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-4#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-8#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(2005-8#1)(2006-10#4)(2007-10#1)(2007-12#2)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#2)(2008-8#6)(2008-9#2)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
their relatively##5##2##(1997-2#1)(2008-5#2)(2009-4#1)(2010-10#1)
their relatives or##2##3##(1997-8#1)(2006-10#1)
their relatives##16##2##(1991-6#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-8#1)(2006-1#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-6#1)(2007-7#1)(2008-11#1)(2008-2#1)(2011-2#1)(2013-8#1)
their relatives'##3##2##(2007-8#1)(2010-10#1)(2012-12#1)
their relaxation rate##2##3##(1991-8#2)
their release from the##2##4##(1990-12#1)(1996-8#1)
their release from##3##3##(1990-12#1)(1996-8#1)(2008-4#1)
their release##10##2##(1990-12#1)(1991-2#1)(1996-8#1)(2005-10#1)(2006-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)
their relevance for##3##3##(2008-7#1)(2012-12#1)(2013-1#1)
their relevance in##2##3##(2007-7#1)(2010-7#1)
their relevance to the##5##4##(2007-4#1)(2007-7#1)(2008-11#1)(2008-3#1)(2011-1#1)
their relevance to##13##3##(2007-12#1)(2007-4#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-3#2)(2008-8#2)(2008-9#1)(2011-1#2)
their relevance##21##2##(1996-1#1)(2007-12#1)(2007-4#1)(2007-7#3)(2008-1#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-7#1)(2011-1#2)(2012-12#1)(2013-1#2)
their reliability##3##2##(2008-10#1)(2008-9#1)(2011-1#1)
their remarkable##5##2##(1996-1#1)(1996-5#1)(2008-10#1)(2008-5#1)(2012-3#1)
their removal from##3##3##(1995-2#1)(1997-1#1)(2012-3#1)
their removal in##2##3##(2008-7#2)
their removal##8##2##(1990-2#1)(1995-2#1)(1997-1#1)(2007-12#1)(2008-11#1)(2008-7#2)(2012-3#1)
their renal function and##2##4##(2008-1#1)(2008-4#1)
their renal function##5##3##(2005-10#1)(2008-1#1)(2008-4#2)(2011-12#1)
their renal##6##2##(2005-10#1)(2008-1#2)(2008-4#2)(2011-12#1)
their repeated use##2##3##(1994-3#1)(2011-2#1)
their repercussions on##2##3##(2006-10#1)(2009-7#1)
their replacement##2##2##(2005-11#1)(2007-11#1)
their replacements##2##2##(1996-1#1)(1996-12#1)
their replication##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
their reported##7##2##(1990-11#1)(1991-5#1)(1996-7#1)(2008-3#1)(2011-2#1)(2013-1#2)
their reproducibility##4##2##(2008-10#2)(2008-11#1)(2008-5#1)
their reproductive age##3##3##(1997-5#1)(2009-6#1)(2012-2#1)
their reproductive##18##2##(1992-1#1)(1992-2#1)(1997-5#1)(2008-10#1)(2008-6#1)(2008-8#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#2)(2012-2#1)(2013-8#2)
their research and##2##3##(1993-2#1)(2010-8#1)
their research on##2##3##(1990-9#1)(2009-4#1)
their research##15##2##(1990-9#1)(1993-2#1)(1996-1#1)(2005-8#1)(2006-8#1)(2008-11#2)(2008-12#1)(2008-4#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-8#1)(2012-2#1)(2013-1#1)
their resistance levels##2##3##(2008-10#1)(2008-6#1)
their resistance to several##2##4##(1994-6#1)(2008-8#1)
their resistance to the##3##4##(1993-2#1)(2008-5#1)(2012-3#1)
their resistance to##13##3##(1993-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(2005-11#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#1)(2012-2#1)(2012-3#1)
their resistance##18##2##(1993-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(2005-11#1)(2007-11#1)(2008-10#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2012-2#1)(2012-3#1)
their resolution##6##2##(1991-9#1)(1993-12#1)(2006-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
their resources##4##2##(1992-3#1)(2008-10#1)(2008-3#1)(2009-8#1)
their respective biological##2##3##(2008-4#1)(2008-8#1)
their respective concentrations##2##3##(1991-8#1)(2008-10#1)
their respective controls##3##3##(1994-5#1)(1994-6#1)(2008-10#1)
their respective jobs##2##3##(1991-3#1)(2010-7#1)
their respective ligands##2##3##(1994-2#1)(1997-4#1)
their respective potential##2##3##(2006-10#2)
their respective receptors##2##3##(2007-2#1)(2008-8#1)
their respective roles##3##3##(1992-12#1)(1997-3#1)(2010-4#1)
their respective target##3##3##(1996-9#1)(2008-1#1)(2008-5#1)
their respective##144##2##(1990-11#2)(1990-5#2)(1990-7#1)(1990-8#1)(1991-2#2)(1991-3#3)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#3)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1993-12#2)(1993-3#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#1)(2004-10#1)(2005-11#2)(2005-4#1)(2006-1#1)(2006-10#4)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#19)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#7)(2008-7#8)(2008-8#3)(2008-9#1)(2009-2#1)(2009-5#1)(2009-6#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#2)(2011-4#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
their respiratory##5##2##(1992-7#1)(1995-6#1)(2004-12#1)(2008-5#1)(2012-12#1)
their response and##2##3##(1997-4#1)(2011-1#1)
their response to the##4##4##(2007-9#1)(2008-10#1)(2009-9#1)(2013-8#1)
their response to##37##3##(1990-10#1)(1990-11#1)(1990-7#1)(1990-9#1)(1992-11#1)(1992-3#1)(1992-7#1)(1992-9#2)(1993-9#1)(1994-5#1)(1995-12#1)(1996-6#1)(1997-3#1)(2005-10#1)(2005-9#1)(2006-2#1)(2007-1#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-8#1)(2008-9#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#2)(2012-9#1)(2013-1#1)(2013-8#2)
their response##47##2##(1990-10#1)(1990-11#1)(1990-7#1)(1990-9#1)(1992-11#1)(1992-3#1)(1992-7#1)(1992-9#2)(1993-2#1)(1993-9#1)(1994-5#1)(1995-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-4#1)(2005-10#1)(2005-9#1)(2006-2#1)(2006-4#1)(2007-1#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#6)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2012-9#1)(2013-1#1)(2013-8#2)
their responses to stimulation of##2##5##(1991-8#1)(1992-8#1)
their responses to the##2##4##(2008-5#1)(2013-8#1)
their responses to##18##3##(1990-7#1)(1991-8#1)(1992-8#1)(1993-9#1)(1994-3#1)(1994-9#2)(1995-11#1)(1996-9#1)(1997-7#1)(2008-10#2)(2008-5#1)(2010-5#1)(2010-8#1)(2011-12#1)(2012-2#1)(2013-8#1)
their responses were##2##3##(1997-8#1)(2008-7#1)
their responses##30##2##(1990-7#1)(1991-8#1)(1992-8#1)(1993-9#1)(1994-3#1)(1994-9#2)(1995-11#1)(1996-7#1)(1996-9#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-8#1)
their responsibilities##3##2##(2007-2#1)(2010-11#1)(2012-12#1)
their responsiveness to##8##3##(1990-7#1)(1993-2#1)(1994-5#1)(1995-12#1)(1996-11#1)(2004-11#1)(2010-8#1)(2012-12#1)
their responsiveness##9##2##(1990-7#1)(1993-2#1)(1994-5#1)(1994-9#1)(1995-12#1)(1996-11#1)(2004-11#1)(2010-8#1)(2012-12#1)
their restricted##4##2##(1992-3#1)(2010-2#1)(2010-8#1)(2012-2#1)
their restriction maps##2##3##(1990-4#1)(1992-11#1)
their restriction##4##2##(1990-4#1)(1992-11#1)(1997-4#1)(2006-10#1)
their results and to##2##4##(2006-10#1)(2013-7#1)
their results and##3##3##(2006-10#1)(2011-1#1)(2013-7#1)
their results can be##2##4##(1996-3#1)(2008-11#1)
their results in the##4##4##(2007-11#1)(2007-9#1)(2009-5#2)
their results of##2##3##(2006-3#1)(2006-8#1)
their results to##2##3##(1995-12#1)(1997-8#1)
their results##39##2##(1993-10#1)(1993-2#1)(1994-1#1)(1995-12#1)(1996-3#1)(1997-1#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-3#3)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-11#1)(2008-2#1)(2009-4#1)(2009-5#3)(2009-9#1)(2010-11#1)(2010-3#2)(2010-8#1)(2011-1#2)(2011-2#1)(2013-1#2)(2013-7#1)
their retention and##3##3##(1994-9#1)(1996-5#1)(2008-10#1)
their retention times##3##3##(2007-1#1)(2008-10#2)
their retention##15##2##(1992-7#1)(1994-9#1)(1996-5#2)(1996-8#1)(2007-1#1)(2007-8#1)(2008-10#6)(2010-2#1)(2010-8#1)
their return to##4##3##(1993-3#1)(2005-10#1)(2007-2#2)
their right hand##2##3##(1997-1#1)(2008-6#1)
their right to##5##3##(1990-12#1)(1995-2#1)(1995-9#1)(2006-8#1)(2008-1#1)
their right##11##2##(1990-12#1)(1995-2#1)(1995-9#1)(1997-1#1)(2006-8#1)(2008-1#1)(2008-6#1)(2012-12#1)(2013-1#3)
their rights and##3##3##(1996-7#1)(2005-5#1)(2012-11#1)
their rights to##2##3##(2008-11#1)(2008-9#1)
their rights##9##2##(1991-10#1)(1996-7#1)(2005-5#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-4#1)(2012-11#1)(2012-3#1)
their risk factors##3##3##(2007-3#1)(2011-2#1)(2013-8#1)
their risk for##2##3##(1996-8#1)(2010-5#1)
their risk of##8##3##(2006-10#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
their risk##20##2##(1995-9#3)(1996-8#1)(1997-8#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#1)(2013-8#1)
their risks and##2##3##(2007-2#1)(2010-8#1)
their risks##3##2##(1992-1#1)(2007-2#1)(2010-8#1)
their robustness to##4##3##(1997-5#1)(1997-7#1)(2008-2#2)
their robustness##5##2##(1997-5#1)(1997-7#1)(2008-12#1)(2008-2#2)
their role and##4##3##(1990-12#1)(2008-3#1)(2011-1#1)(2011-2#1)
their role as a##3##4##(2009-3#1)(2011-1#1)(2012-11#1)
their role as##13##3##(1993-6#1)(1995-1#1)(2005-11#1)(2005-8#2)(2007-11#1)(2007-2#1)(2008-11#1)(2009-3#1)(2010-1#1)(2011-1#2)(2012-11#1)
their role has##2##3##(1990-11#1)(2006-10#1)
their role in cellular physiology##2##5##(2008-10#1)(2008-8#1)
their role in early##2##4##(2006-9#1)(2011-2#1)
their role in health and disease##2##6##(2006-7#1)(2009-4#1)
their role in human##2##4##(2011-1#1)(2011-2#1)
their role in risk##2##4##(1993-2#1)(2012-3#1)
their role in the development of##2##6##(1994-12#1)(2009-11#1)
their role in the transmission of##2##6##(2010-1#2)
their role in the treatment of##2##6##(2007-11#1)(2007-8#1)
their role in the##20##4##(1993-11#1)(1994-12#1)(1994-3#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-11#1)(2010-1#2)(2011-1#1)(2012-12#2)(2012-2#1)
their role in##89##3##(1990-11#1)(1990-12#1)(1991-4#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-5#1)(1997-5#1)(1997-6#1)(2003-11#1)(2005-10#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-10#2)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#3)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#3)(2010-12#1)(2010-2#2)(2010-3#1)(2011-1#3)(2011-2#3)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#2)
their role to be##2##4##(2011-2#1)(2012-12#1)
their role to##4##3##(1990-12#1)(2009-3#1)(2011-2#1)(2012-12#1)
their role##127##2##(1990-10#1)(1990-11#2)(1990-12#3)(1991-4#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-5#1)(1997-5#1)(1997-6#1)(2003-11#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#4)(2006-10#4)(2006-11#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#3)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#4)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#6)(2011-2#7)(2012-11#3)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#2)
their roles and##3##3##(1995-3#1)(2006-10#1)(2011-1#1)
their roles as##3##3##(2006-1#1)(2006-10#1)(2008-5#1)
their roles in development##2##4##(2007-12#1)(2008-1#1)
their roles in junction dynamics and spermatogenesis##2##7##(2009-10#2)
their roles in##23##3##(1994-3#1)(1994-6#1)(2005-7#1)(2006-10#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-8#1)(2011-1#3)(2011-2#2)(2013-1#1)
their roles##40##2##(1993-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-3#1)(2005-7#1)(2006-1#1)(2006-10#5)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#1)(2009-8#2)(2010-6#1)(2011-1#4)(2011-2#3)(2012-12#1)(2013-1#1)
their romantic##2##2##(2009-5#1)(2009-9#1)
their root##3##2##(1992-9#2)(2009-8#1)
their roots and##2##3##(2008-10#1)(2008-12#1)
their roots##7##2##(2007-5#1)(2008-10#4)(2008-12#1)(2012-2#1)
their routine##3##2##(2007-11#1)(2008-1#1)(2010-9#1)
their rural state##2##3##(2006-5#1)(2010-5#1)
their rural##4##2##(2006-5#1)(2007-12#1)(2010-5#1)(2011-2#1)
their safe##3##2##(2007-2#1)(2008-3#1)(2009-7#1)
their safety and their##2##4##(1993-8#1)(2008-4#1)
their safety and##5##3##(1993-8#1)(2008-3#1)(2008-4#1)(2010-12#1)(2013-1#1)
their safety##15##2##(1993-8#1)(1994-3#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#2)
their salaries##2##2##(1991-3#1)(1995-3#1)
their salient##3##2##(2008-11#1)(2009-11#1)(2010-12#1)
their satisfaction and##3##3##(1994-2#1)(2007-10#1)(2011-2#1)
their satisfaction with medical care##2##5##(1996-2#1)(2008-8#1)
their satisfaction with##12##3##(1993-12#1)(1993-3#1)(1993-4#1)(1996-2#1)(2006-12#1)(2007-8#1)(2008-8#3)(2010-2#2)(2011-2#1)
their satisfaction##17##2##(1990-12#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-2#1)(1996-2#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-8#4)(2010-2#2)(2011-2#2)
their satisfactory##2##2##(1991-2#1)(2010-12#1)
their say##2##2##(1993-6#1)(1995-12#1)
their school##7##2##(2006-6#1)(2007-12#2)(2008-11#1)(2009-7#1)(2010-8#2)
their schools##2##2##(2005-12#1)(2010-2#1)
their scientific##2##2##(1992-6#1)(2009-10#1)
their scope of##2##3##(2006-5#1)(2011-1#1)
their scope##3##2##(2006-5#1)(2010-12#1)(2011-1#1)
their scores on##2##3##(2006-2#1)(2012-2#1)
their scores##4##2##(2005-10#1)(2006-2#1)(2008-9#1)(2012-2#1)
their screening##3##2##(1997-4#1)(2007-9#1)(2010-8#1)
their search##4##2##(1997-8#1)(2008-11#1)(2008-8#2)
their second decade##3##3##(2008-4#1)(2013-1#2)
their second year##2##3##(2009-4#2)
their second##15##2##(1995-3#1)(1996-7#1)(1997-2#1)(1997-5#1)(1997-8#1)(2004-11#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#1)(2009-4#2)(2013-1#2)
their secondary structures##2##3##(2006-12#1)(2009-11#1)
their secondary##7##2##(1991-6#1)(1995-8#1)(2006-12#1)(2008-4#1)(2008-9#1)(2009-11#1)(2012-2#1)
their secretion##7##2##(1990-2#1)(1990-6#2)(1990-9#1)(1994-9#1)(1995-12#1)(2004-11#1)
their secretions##3##2##(2007-12#1)(2008-5#1)(2011-12#1)
their segregating progeny##2##3##(2011-2#2)
their segregating##3##2##(2011-2#3)
their selection of##3##3##(2010-6#1)(2013-1#2)
their selective##6##2##(1990-12#1)(1994-6#1)(1996-8#1)(2007-8#1)(2008-8#1)(2012-12#1)
their selectivity##4##2##(2008-10#4)
their self##3##2##(1992-10#1)(2008-2#1)(2010-4#1)
their self-confidence and self-reliance##2##4##(2006-8#2)
their self-esteem##2##2##(2006-10#1)(2008-7#1)
their semantic networks##2##3##(1996-7#1)(2013-7#1)
their semantic##5##2##(1996-7#1)(2007-10#1)(2013-1#2)(2013-7#1)
their sensations##2##2##(2008-10#1)(2008-5#1)
their sensibility to auxin##2##4##(2008-8#2)
their sensing##2##2##(2008-10#2)
their sensitivities##2##2##(1996-9#1)(2008-10#1)
their sensitivity for##2##3##(2006-11#1)(2008-10#1)
their sensitivity to growth##3##4##(1995-10#1)(2008-11#2)
their sensitivity to inhibition by##2##5##(1995-11#1)(2007-11#1)
their sensitivity to mutation##2##4##(1994-5#1)(1997-3#1)
their sensitivity to##30##3##(1990-11#1)(1991-12#1)(1991-9#1)(1992-7#4)(1994-12#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1997-1#1)(1997-3#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#3)(2010-1#1)
their sensitivity##41##2##(1990-11#2)(1991-12#1)(1991-9#1)(1992-7#4)(1994-12#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-4#1)(1997-1#1)(1997-3#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#1)(2010-1#1)(2012-12#1)(2012-3#1)(2013-8#2)
their separate##3##2##(1990-12#1)(2006-11#1)(2008-10#1)
their separation and detection##2##4##(2008-10#2)
their separation and##3##3##(2008-10#3)
their separation from##3##3##(2008-10#2)(2008-3#1)
their separation##9##2##(1994-5#1)(2006-11#1)(2008-10#6)(2008-3#1)
their separations##2##2##(2008-10#1)(2008-2#1)
their sequence and##2##3##(1992-7#1)(2006-10#1)
their sequence similarity##3##3##(1994-9#1)(1996-6#1)(2008-6#1)
their sequence##9##2##(1992-7#1)(1994-9#1)(1995-12#2)(1996-6#1)(2006-10#1)(2008-4#1)(2008-6#1)(2012-2#1)
their sequences were##4##3##(1995-6#1)(1996-10#1)(1996-2#1)(2008-5#1)
their sequences##10##2##(1993-12#1)(1993-3#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-4#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)
their sequential##3##2##(1990-12#1)(2005-7#1)(2008-10#1)
their series##2##2##(1995-2#1)(2008-10#1)
their serological##2##2##(1994-8#1)(2007-8#1)
their serotype##3##2##(2006-8#1)(2008-6#1)(2010-4#1)
their serum##5##2##(1991-9#1)(2006-12#1)(2007-10#1)(2008-5#1)(2011-1#1)
their serum-cholesterol##4##2##(1990-6#4)
their service##5##2##(1992-1#1)(1992-12#1)(1996-2#1)(2007-4#1)(2012-3#1)
their services##9##2##(1990-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1995-3#1)(1996-1#1)(1997-2#2)(2008-11#1)
their severity##11##2##(1995-12#1)(2005-7#1)(2006-10#2)(2006-8#1)(2007-10#1)(2008-3#1)(2008-4#1)(2010-4#1)(2013-1#1)(2013-8#1)
their sex##7##2##(1995-5#1)(1996-4#1)(2004-10#1)(2006-8#1)(2008-10#1)(2008-3#1)(2009-5#1)
their sexual and reproductive##2##4##(2008-11#1)(2011-2#1)
their sexual and##3##3##(2008-11#1)(2009-7#1)(2011-2#1)
their sexual behavior##2##3##(1995-1#1)(1996-2#1)
their sexual practices##3##3##(1994-12#1)(2012-1#1)(2012-3#1)
their sexual##18##2##(1994-12#1)(1995-1#1)(1996-2#1)(2006-7#1)(2008-11#1)(2008-12#2)(2009-5#2)(2009-7#1)(2011-2#3)(2012-1#1)(2012-3#3)(2013-8#1)
their sexuality##3##2##(1990-5#1)(2007-3#1)(2009-7#1)
their shape and##2##3##(2006-6#1)(2008-3#1)
their shape##16##2##(1993-11#1)(1994-12#1)(1997-6#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-6#1)(2009-8#1)(2012-11#2)
their share of##2##3##(1990-12#1)(1995-1#1)
their share##3##2##(1990-12#1)(1995-1#1)(2007-9#1)
their shared evolutionary##2##3##(2008-8#1)(2009-4#1)
their shared##3##2##(2008-8#1)(2009-4#1)(2011-12#1)
their short##3##2##(1995-1#1)(2007-11#1)(2013-1#1)
their short-term##2##2##(2008-4#1)(2013-1#1)
their shorter##3##2##(2007-1#1)(2011-2#1)(2013-1#1)
their sibling##4##2##(2008-12#3)(2010-2#1)
their siblings##5##2##(1996-1#1)(2006-7#1)(2007-8#1)(2010-9#1)(2011-12#1)
their side effects##8##3##(2006-10#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-12#1)(2009-1#1)(2009-5#1)(2011-2#1)
their side##9##2##(2006-10#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-12#1)(2009-1#1)(2009-5#1)(2010-10#1)(2011-2#1)
their side-effects##4##2##(2006-10#2)(2006-12#1)(2013-8#1)
their sign##2##2##(1992-10#1)(2007-12#1)
their signalling##2##2##(2008-4#1)(2013-1#1)
their signatures##2##2##(2010-5#1)(2013-8#1)
their significance and##2##3##(2008-4#1)(2008-9#1)
their significance for##7##3##(1990-9#1)(1992-11#1)(1993-3#1)(2008-12#1)(2008-8#1)(2009-5#1)(2010-11#1)
their significance in##6##3##(1991-11#1)(1993-2#1)(2006-5#1)(2007-11#1)(2010-12#1)(2012-2#1)
their significance to##3##3##(2005-8#1)(2008-10#1)(2012-2#1)
their significance##23##2##(1990-10#1)(1990-9#1)(1991-11#1)(1992-11#1)(1993-2#1)(1993-3#1)(1996-4#1)(2005-8#1)(2006-5#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-12#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-12#1)(2012-2#2)
their significant and##2##3##(2008-8#1)(2012-12#1)
their significant##6##2##(2007-11#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#2)
their similar##3##2##(1990-2#1)(1991-8#1)(1991-9#1)
their similarities and differences##2##4##(2008-9#1)(2009-3#1)
their similarities##6##2##(1990-11#1)(1994-11#1)(1996-9#1)(2008-7#1)(2008-9#1)(2009-3#1)
their similarity in##2##3##(2008-4#1)(2008-8#1)
their similarity to##3##3##(1995-12#1)(1995-3#1)(2008-7#1)
their similarity##6##2##(1995-12#1)(1995-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)
their simple##3##2##(2008-10#1)(2008-7#1)(2009-10#1)
their simplicity##2##2##(2010-4#2)
their simultaneous##8##2##(1992-5#1)(1993-8#1)(2007-8#1)(2008-10#4)(2008-7#1)
their single##4##2##(1992-1#1)(2007-8#1)(2008-10#1)(2013-1#1)
their sites of action##3##4##(1990-5#1)(2008-1#1)(2008-11#1)
their situation##3##2##(1995-5#1)(2007-3#1)(2009-11#1)
their size and##7##3##(1992-3#1)(1994-9#1)(1995-3#1)(2007-3#1)(2008-10#1)(2011-2#1)(2012-2#1)
their size##26##2##(1990-6#1)(1991-6#1)(1992-3#2)(1994-9#1)(1995-3#1)(1997-6#1)(2004-9#1)(2005-11#1)(2006-12#1)(2007-12#1)(2007-3#1)(2008-10#5)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
their sizes##7##2##(1990-2#1)(1994-6#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)
their skeletal##4##2##(2006-11#1)(2008-7#1)(2010-2#1)(2013-1#1)
their skills and##2##3##(1993-1#1)(1993-3#1)
their skills for##2##3##(2008-9#1)(2010-12#1)
their skills in##4##3##(2007-6#1)(2008-12#1)(2008-9#1)(2013-7#1)
their skills##16##2##(1993-1#1)(1993-3#1)(1994-3#1)(2005-5#1)(2007-6#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#2)(2010-12#1)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
their skin##15##2##(1996-6#1)(2007-4#1)(2007-8#1)(2008-5#9)(2011-1#1)(2012-12#2)
their small size and##2##4##(2006-12#1)(2009-8#1)
their small size##11##3##(1993-4#1)(1993-8#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-7#1)(2009-5#1)(2009-8#1)(2011-1#1)
their small##14##2##(1993-4#1)(1993-6#1)(1993-8#1)(2005-11#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-5#1)(2009-8#1)(2011-1#1)
their smoking habits##4##3##(1991-11#1)(1993-10#1)(1995-6#1)(2011-2#1)
their smoking status##2##3##(2011-2#2)
their smoking##8##2##(1991-11#1)(1993-10#1)(1995-6#1)(2010-2#2)(2011-2#3)
their social and economic##2##4##(1996-4#1)(2009-7#1)
their social and##4##3##(1996-4#1)(2009-7#2)(2013-8#1)
their social context##2##3##(2008-2#1)(2008-7#1)
their social networks##2##3##(2008-7#1)(2008-9#1)
their social support##2##3##(1992-3#1)(2006-4#1)
their social##30##2##(1992-3#1)(1994-6#1)(1995-1#1)(1996-4#1)(1997-2#1)(1997-8#1)(2006-2#1)(2006-4#1)(2007-8#1)(2008-1#1)(2008-11#4)(2008-2#2)(2008-7#2)(2008-9#1)(2009-5#1)(2009-7#2)(2010-2#1)(2011-2#4)(2012-12#2)(2013-8#1)
their socio-economic##2##2##(2008-12#1)(2012-2#1)
their solubility##5##2##(1993-8#1)(2005-11#1)(2006-5#1)(2008-10#1)(2008-5#1)
their soluble##3##2##(1996-2#2)(2008-11#1)
their solution##6##2##(1991-3#1)(2006-2#1)(2007-12#1)(2008-9#1)(2010-4#1)(2010-5#1)
their solutions##5##2##(1992-4#1)(2008-10#2)(2008-9#2)
their somata##2##2##(1995-11#1)(2010-12#1)
their sorption##2##2##(2008-10#2)
their source##3##2##(2008-4#1)(2011-1#1)(2013-1#1)
their sources##4##2##(1995-3#1)(1997-1#1)(1997-3#1)(1997-6#1)
their spatial and temporal##2##4##(2006-12#1)(2008-10#1)
their spatial distribution##5##3##(2008-2#1)(2008-8#2)(2013-7#1)(2013-8#1)
their spatial##19##2##(1990-8#1)(1993-3#1)(1995-12#1)(1997-4#1)(2006-12#1)(2008-10#4)(2008-2#4)(2008-8#2)(2009-8#1)(2010-10#1)(2013-7#1)(2013-8#1)
their special##4##2##(1993-5#1)(2008-10#1)(2009-8#1)(2011-1#1)
their speciality##2##2##(2008-11#1)(2008-2#1)
their specialties##2##2##(2006-8#1)(2011-1#1)
their specialty##3##2##(2006-10#1)(2007-8#1)(2013-1#1)
their speciation##2##2##(2008-10#2)
their species##5##2##(1991-8#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-9#1)
their specific and##2##3##(1995-1#1)(2007-12#1)
their specific binding##2##3##(1991-5#1)(1997-1#1)
their specific needs##3##3##(1992-2#1)(2006-2#1)(2008-11#1)
their specific prediction model##2##4##(2013-1#2)
their specific receptors##2##3##(1990-4#1)(1997-4#1)
their specific##42##2##(1990-3#1)(1990-4#1)(1991-4#2)(1991-5#1)(1991-8#1)(1992-2#1)(1992-8#1)(1993-3#1)(1994-12#2)(1994-4#1)(1995-1#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-11#2)(2006-2#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-12#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
their specificities##2##2##(1995-3#1)(2008-11#1)
their specificity##8##2##(1991-11#1)(1992-8#1)(1997-6#1)(2006-5#1)(2008-10#2)(2008-7#1)(2012-1#1)
their spectra##3##2##(1992-3#1)(2008-10#1)(2008-3#1)
their spectral and##2##3##(1994-3#1)(2007-8#1)
their spectral characteristics##2##3##(2008-3#1)(2008-9#1)
their spectral properties##2##3##(2008-1#1)(2008-10#1)
their spectral##10##2##(1994-3#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-9#1)
their speech##5##2##(2007-7#1)(2008-4#1)(2008-9#1)(2010-2#1)(2012-2#1)
their sperm investment##2##3##(2009-6#2)
their sperm##4##2##(2009-2#1)(2009-6#3)
their spinal##4##2##(1996-5#4)
their spiritual##4##2##(2010-2#2)(2013-1#2)
their spirituality##3##2##(2007-2#1)(2013-1#2)
their splenocytes##2##2##(1991-12#1)(1997-4#1)
their sponsors##2##2##(1992-1#1)(2012-2#1)
their spontaneous##3##2##(1992-7#1)(1995-6#1)(2008-8#1)
their sport##2##2##(2008-5#1)(2009-11#1)
their spouse##4##2##(1994-6#1)(2006-5#1)(2007-12#1)(2012-11#1)
their spouses##2##2##(2008-10#1)(2012-12#1)
their spread##2##2##(2013-1#1)(2013-8#1)
their spreading##2##2##(2004-9#1)(2008-7#1)
their stabilities##4##2##(1990-12#1)(1994-3#1)(1995-2#1)(2008-5#1)
their stability and##6##3##(2004-9#2)(2008-11#1)(2008-4#1)(2012-12#1)(2012-2#1)
their stability constants##4##3##(2008-10#3)(2008-5#1)
their stability in##2##3##(1997-1#1)(2006-12#1)
their stability##21##2##(1997-1#1)(2004-9#2)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
their stabilization##2##2##(2009-7#1)(2013-1#1)
their stable##3##2##(2008-3#2)(2011-2#1)
their staff in##2##3##(1994-6#1)(1995-2#1)
their staff##7##2##(1993-2#1)(1994-6#1)(1995-2#1)(1996-1#1)(2006-8#1)(2008-7#1)(2009-11#1)
their staffing##2##2##(1996-3#1)(2011-2#1)
their stage of##3##3##(1993-11#1)(1996-2#1)(2008-4#1)
their standard errors##3##3##(1993-9#1)(1997-4#1)(2012-3#1)
their standard##7##2##(1993-9#1)(1997-3#1)(1997-4#1)(2008-10#2)(2012-3#2)
their standing in##2##3##(2006-10#1)(2009-3#1)
their state##3##2##(1990-5#1)(1996-3#1)(2007-6#1)
their stated accuracy##3##3##(2008-3#3)
their statistical significance##2##3##(2009-4#1)(2009-7#1)
their statistical##4##2##(2008-10#1)(2009-4#1)(2009-7#1)(2013-1#1)
their status as##2##3##(2007-8#1)(2008-11#1)
their status to their##2##4##(2012-12#2)
their status to##3##3##(2012-12#3)
their status##11##2##(2007-12#2)(2007-8#1)(2008-1#1)(2008-11#1)(2012-12#3)(2012-3#1)(2013-1#2)
their stay##8##2##(1992-1#1)(1995-9#1)(1997-7#1)(2007-7#1)(2008-9#1)(2013-1#2)(2013-8#1)
their stimulatory effects##2##3##(1990-12#1)(1990-5#1)
their stimulatory##8##2##(1990-12#1)(1990-2#1)(1990-5#1)(1992-4#1)(1994-8#1)(2008-11#2)(2008-8#1)
their storage##2##2##(2008-5#1)(2009-2#1)
their strain##4##2##(2007-4#1)(2008-10#1)(2008-4#1)(2013-1#1)
their strengths and weaknesses##5##4##(2006-10#1)(2008-6#1)(2008-9#1)(2011-2#1)(2013-1#1)
their strengths and##7##3##(1996-3#1)(2006-10#1)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
their strict##2##2##(2006-4#1)(2011-1#1)
their stroke protective effect##2##4##(2008-8#2)
their stroke##5##2##(2007-10#1)(2008-4#1)(2008-8#3)
their stromal##3##2##(2009-8#1)(2011-1#1)(2012-12#1)
their strong##7##2##(1995-2#1)(1995-8#2)(1997-2#1)(2007-7#1)(2008-10#1)(2009-10#1)
their structural and functional##2##4##(2006-12#1)(2008-4#1)
their structural and##4##3##(1994-5#1)(2006-12#1)(2007-11#1)(2008-4#1)
their structural diversity##2##3##(1996-6#1)(2012-11#1)
their structural features##2##3##(2005-7#1)(2009-12#1)
their structural integrity##2##3##(2006-12#1)(2013-8#1)
their structural##23##2##(1990-2#1)(1991-2#1)(1991-9#1)(1994-5#1)(1996-2#1)(1996-6#1)(2005-7#1)(2006-12#2)(2007-11#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-1#1)(2012-11#1)(2012-12#1)(2013-8#2)
their structure and function##4##4##(1995-2#1)(2008-4#1)(2009-8#1)(2011-1#1)
their structure and##8##3##(1995-2#1)(1995-8#1)(1996-12#1)(2006-5#1)(2007-11#1)(2008-4#1)(2009-8#1)(2011-1#1)
their structure##19##2##(1991-11#1)(1992-6#1)(1993-6#1)(1995-2#1)(1995-8#1)(1996-12#1)(2004-12#1)(2005-8#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#3)(2009-3#1)(2009-8#1)(2011-1#1)(2012-2#1)
their structure-activity relationships##2##3##(1997-2#1)(2007-11#1)
their structures and##2##3##(1995-3#1)(2009-5#1)
their structures are##2##3##(1997-8#1)(2008-5#1)
their structures have been##4##4##(1996-2#1)(2007-11#1)(2010-4#1)(2012-2#1)
their structures were established by##2##5##(2006-12#1)(2007-1#1)
their structures were##7##3##(2006-12#2)(2007-1#4)(2010-5#1)
their structures##29##2##(1995-11#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-7#1)(1997-8#1)(2006-12#3)(2007-1#5)(2007-11#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)
their student##2##2##(1992-6#1)(2013-8#1)
their students may##2##3##(2007-2#1)(2008-12#1)
their students##15##2##(2005-10#2)(2005-12#2)(2006-5#1)(2007-2#1)(2008-11#1)(2008-12#6)(2010-3#1)(2011-2#1)
their studies are##2##3##(2006-8#1)(2008-5#1)
their studies##10##2##(2006-12#1)(2006-8#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-2#1)(2011-1#1)
their study and##3##3##(1990-5#1)(2008-10#2)
their study##19##2##(1990-5#1)(1992-3#1)(1993-6#1)(1996-3#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-2#1)(2009-7#1)(2010-8#1)(2011-1#1)(2012-12#2)
their subcellular##3##2##(1996-4#1)(2008-4#1)(2012-12#1)
their subsequent challenge##2##3##(2008-4#1)(2011-2#1)
their subsequent reaction with##2##4##(2008-10#2)
their subsequent##28##2##(1994-12#1)(1995-1#1)(1997-5#1)(2004-11#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-12#1)(2009-3#1)(2009-5#2)(2009-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
their substitution##2##2##(1990-12#1)(2010-8#1)
their substrate specificities##2##3##(1994-3#1)(2010-3#1)
their substrate##8##2##(1994-3#2)(1994-9#1)(1996-5#1)(2005-8#1)(2007-11#1)(2010-3#1)(2010-6#1)
their substrates##5##2##(1990-12#1)(1991-2#1)(1995-3#1)(2007-12#1)(2012-2#1)
their subsystems##2##2##(2008-2#1)(2008-3#1)
their success and##2##3##(2006-2#1)(2008-10#1)
their success##10##2##(1990-10#1)(1992-1#1)(1993-1#1)(2006-2#1)(2007-4#1)(2008-10#1)(2008-11#1)(2011-3#1)(2012-1#1)(2012-3#1)
their successful##3##2##(1996-2#1)(2007-11#1)(2009-5#1)
their sucking instinct##2##3##(2007-10#2)
their suckling kids##3##3##(2012-2#3)
their sugar##2##2##(2004-11#1)(2009-8#1)
their suggestions##5##2##(1994-2#1)(2007-9#1)(2008-6#1)(2012-2#1)(2013-8#1)
their suitability and##2##3##(1990-11#1)(1993-12#1)
their suitability as##3##3##(2004-9#1)(2008-2#1)(2008-7#1)
their suitability for##5##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)
their suitability in##2##3##(1996-12#1)(2007-11#1)
their suitability to##3##3##(1994-3#1)(2006-11#1)(2011-12#1)
their suitability##16##2##(1990-11#1)(1993-12#1)(1994-3#1)(1996-12#1)(1996-2#1)(2004-9#1)(2006-11#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2011-1#1)(2011-12#1)
their sum##2##2##(1993-12#1)(2008-3#1)
their superficial##2##2##(1996-3#1)(2006-5#1)
their superior##6##2##(1995-7#1)(1997-1#1)(1997-3#1)(2006-6#1)(2011-2#1)(2012-11#1)
their support for##3##3##(2009-5#1)(2012-11#1)(2013-7#1)
their support##6##2##(2005-5#1)(2008-6#1)(2009-5#1)(2012-11#1)(2012-2#1)(2013-7#1)
their suppressive function##2##3##(1992-7#1)(2008-4#1)
their surface properties##4##3##(2005-11#2)(2006-12#1)(2008-10#1)
their surface were##2##3##(2006-2#1)(2008-10#1)
their surface##32##2##(1990-11#1)(1990-9#1)(1991-6#1)(1994-2#1)(1996-2#1)(1996-4#1)(1997-6#1)(2004-9#1)(2005-11#4)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#2)(2008-5#2)(2008-7#1)(2010-4#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
their surfaces##4##2##(1990-9#1)(2008-2#1)(2008-7#2)
their surgery##6##2##(1994-2#1)(1995-1#1)(2007-8#1)(2007-9#1)(2012-3#1)(2013-1#1)
their surgical##11##2##(1991-7#1)(1993-9#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-5#1)(2008-8#2)(2008-9#1)(2009-3#1)(2013-8#1)
their surrounding##5##2##(1991-7#1)(2008-12#1)(2008-4#1)(2009-8#1)(2011-2#1)
their surroundings##5##2##(1993-6#1)(2008-10#1)(2008-3#1)(2009-5#1)(2012-2#1)
their surveillance##2##2##(1993-5#1)(2011-3#1)
their survival and##5##3##(1993-9#1)(2008-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
their survival following##2##3##(1994-5#1)(2008-10#1)
their survival##23##2##(1993-9#1)(1994-5#1)(1995-2#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-7#1)(2013-7#1)
their susceptibility to antibiotics##2##4##(1997-4#1)(2010-4#1)
their susceptibility to the##4##4##(1990-2#1)(2008-8#1)(2008-9#2)
their susceptibility to##26##3##(1990-2#1)(1994-5#1)(1995-6#1)(1995-8#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-7#1)(2006-10#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-7#1)(2010-4#1)(2011-1#1)(2011-10#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
their susceptibility##31##2##(1990-2#1)(1994-5#1)(1995-6#1)(1995-8#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-7#1)(2006-10#2)(2007-7#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-7#2)(2010-4#1)(2011-1#1)(2011-10#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
their sustainability##3##2##(2006-4#2)(2011-2#1)
their sustained##2##2##(1997-7#1)(2008-11#1)
their swimming##4##2##(1992-6#1)(1995-6#2)(2012-3#1)
their symmetry##2##2##(1997-5#1)(2008-8#1)
their symptoms and##3##3##(2007-10#1)(2008-10#1)(2012-2#1)
their symptoms##23##2##(1990-12#1)(1990-8#1)(1992-2#1)(1992-3#1)(1993-11#1)(1997-6#1)(2004-10#2)(2004-3#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-9#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
their synaptic targets##2##3##(1991-3#1)(2007-8#1)
their synaptic##5##2##(1990-12#1)(1991-3#1)(1995-11#1)(2007-8#1)(2008-3#1)
their synergistic effect##2##3##(1992-2#1)(2006-10#1)
their synergistic##3##2##(1992-2#1)(2006-10#1)(2011-2#1)
their synthesis and##2##3##(1991-12#1)(2008-10#1)
their synthesis##14##2##(1991-12#1)(1994-9#2)(1995-4#2)(1996-9#1)(1997-7#1)(2006-12#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-3#1)
their synthesized##3##2##(1991-7#1)(2008-5#2)
their synthetic##4##2##(1992-2#1)(2008-10#1)(2008-5#1)(2009-12#1)
their systemic##4##2##(1996-12#1)(1997-1#1)(2006-10#1)(2010-12#1)
their target cells##3##3##(1990-4#1)(1995-2#1)(2009-8#1)
their target fields##3##3##(1996-3#3)
their target genes##5##3##(1994-8#1)(1996-9#1)(2008-9#1)(2011-2#1)(2012-3#1)
their target mRNAs##2##3##(2008-1#1)(2012-12#1)
their target sites##2##3##(1994-8#1)(2011-2#1)
their target##29##2##(1990-4#1)(1991-3#1)(1993-6#1)(1994-8#2)(1995-2#1)(1996-3#3)(1996-9#1)(1997-1#1)(2006-1#1)(2006-10#3)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
their targets in##2##3##(1994-2#1)(2008-1#1)
their targets##17##2##(1991-3#4)(1993-9#1)(1994-2#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-9#1)(2009-4#1)(2009-8#1)(2010-6#1)(2012-12#1)(2012-2#2)
their task to##2##3##(1991-10#1)(1995-11#1)
their taxonomic classification##2##3##(1997-4#1)(2013-1#1)
their teachers##3##2##(2008-12#3)
their teaching to##2##3##(1995-1#1)(2007-7#1)
their teaching##5##2##(1995-1#1)(2007-7#1)(2008-11#2)(2010-7#1)
their technical##2##2##(1990-11#1)(1995-1#1)
their technological##3##2##(2008-7#2)(2010-4#1)
their teeth was##2##3##(1991-6#1)(2008-9#1)
their teeth##4##2##(1991-6#1)(1995-9#1)(1997-2#1)(2008-9#1)
their temperature##3##2##(1995-5#1)(2008-2#1)(2008-3#1)
their template##3##2##(1995-1#1)(2007-8#1)(2008-10#1)
their temporal and spatial##3##4##(2006-11#1)(2008-10#1)(2011-2#1)
their temporal and##4##3##(2006-11#1)(2008-10#1)(2011-12#1)(2011-2#1)
their temporal##10##2##(1996-9#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-12#1)(2011-2#1)(2012-1#2)
their temporary##3##2##(2006-12#1)(2008-4#1)(2009-3#1)
their tendency to##3##3##(1993-4#1)(2005-11#1)(2008-10#1)
their tendency##4##2##(1993-4#1)(1994-3#1)(2005-11#1)(2008-10#1)
their terminal velocity##4##3##(2008-5#4)
their terminal##7##2##(1990-4#1)(1995-11#1)(2008-5#5)
their terminals##4##2##(1994-2#1)(1995-7#1)(2007-10#1)(2008-4#1)
their ternary chelates##2##3##(2008-10#2)
their territory##2##2##(1991-11#1)(2009-2#1)
their theoretical and##2##3##(2007-12#1)(2010-10#1)
their theoretical##9##2##(1995-7#1)(2005-11#1)(2007-10#1)(2007-12#1)(2008-3#1)(2010-10#1)(2010-2#1)(2012-2#1)(2012-3#1)
their therapeutic benefit##2##3##(2007-10#1)(2013-1#1)
their therapeutic effect##2##3##(2008-4#1)(2009-12#1)
their therapeutic efficacy##2##3##(2005-7#1)(2007-11#1)
their therapeutic implications##2##3##(2008-1#1)(2009-3#1)
their therapeutic potential##3##3##(2011-1#1)(2012-12#1)(2013-1#1)
their therapeutic use##3##3##(2011-1#1)(2012-12#1)(2013-8#1)
their therapeutic##33##2##(1990-1#1)(1990-12#1)(1995-1#1)(1995-4#1)(1997-7#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2007-10#2)(2007-11#1)(2007-6#1)(2008-1#2)(2008-11#1)(2008-4#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-7#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
their therapy##6##2##(2006-12#1)(2006-9#1)(2007-8#1)(2008-5#1)(2010-12#1)(2013-1#1)
their thermal##3##2##(1994-5#1)(2008-2#1)(2008-3#1)
their thermostability##2##2##(2005-9#1)(2011-1#1)
their thickness##4##2##(2007-11#1)(2008-2#2)(2010-2#1)
their thicknesses##4##2##(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
their thoughts and##2##3##(2009-4#1)(2009-7#1)
their thoughts##3##2##(1992-4#1)(2009-4#1)(2009-7#1)
their three##7##2##(1996-2#1)(1997-9#1)(2007-1#1)(2008-9#1)(2009-7#1)(2010-2#1)(2012-12#1)
their three-dimensional##4##2##(1991-4#1)(1993-6#1)(1994-8#1)(2006-12#1)
their threshold##2##2##(1993-12#1)(2008-10#1)
their thyroid function##2##3##(2008-7#1)(2011-1#1)
their thyroid stimulating antibody (TSAb)##2##5##(1991-12#1)(1991-5#1)
their thyroid##4##2##(1991-12#1)(1991-5#1)(2008-7#1)(2011-1#1)
their time and##3##3##(1991-12#1)(1994-1#1)(2013-8#1)
their time of##2##3##(2012-12#1)(2012-2#1)
their time##24##2##(1990-12#2)(1991-12#1)(1994-1#1)(1994-2#2)(1997-1#1)(2006-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-3#1)(2010-5#1)(2010-8#3)(2011-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
their tissue distribution##2##3##(1993-6#1)(2008-4#1)
their tissue natural inhibitors##2##4##(2007-1#2)
their tissue##7##2##(1993-6#1)(2007-1#2)(2008-4#1)(2009-10#1)(2010-12#1)(2011-2#1)
their tobacco##2##2##(2010-9#1)(2012-1#1)
their tolerance to##2##3##(2012-5#2)
their tolerance##5##2##(1991-9#1)(2008-10#1)(2008-12#1)(2012-5#2)
their tongue##2##2##(1997-4#1)(2012-1#1)
their top##2##2##(2007-1#1)(2007-7#1)
their topical##2##2##(2006-12#2)
their total##22##2##(1990-10#1)(1990-11#1)(1991-10#1)(1991-11#1)(1992-5#1)(1993-10#1)(1994-7#1)(1996-3#3)(1997-2#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-3#1)(2008-10#5)(2008-4#1)(2008-9#1)
their toxic##5##2##(1994-3#1)(2006-12#1)(2008-10#1)(2008-3#1)(2011-12#1)
their toxicity to##4##3##(1990-3#1)(2008-10#2)(2011-12#1)
their toxicity##17##2##(1990-3#1)(1995-1#1)(1995-3#1)(1997-1#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-5#1)(2009-3#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-8#1)
their toxicological##2##2##(2008-10#1)(2011-1#1)
their traditional use##2##3##(2007-11#1)(2008-6#1)
their traditional##13##2##(1990-12#1)(1991-12#1)(1992-2#1)(1996-1#2)(1997-2#1)(2005-11#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2012-3#1)
their training and##2##3##(2009-5#1)(2010-2#1)
their training##19##2##(1992-12#1)(1992-6#1)(1994-3#2)(2006-10#2)(2008-11#4)(2008-2#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
their trajectory##2##2##(2008-3#1)(2008-4#1)
their transcription##2##2##(1997-7#2)
their transcriptional##3##2##(1990-5#1)(2008-7#1)(2010-10#1)
their transcripts##4##2##(1993-2#1)(1994-2#1)(1997-2#1)(2006-10#1)
their transfection##2##2##(2008-9#1)(2010-8#1)
their transfer##4##2##(1997-8#1)(2008-10#1)(2010-5#1)(2013-1#1)
their transformation into##3##3##(1992-5#1)(2010-4#1)(2012-12#1)
their transformation##6##2##(1992-5#1)(1997-4#1)(2008-10#2)(2010-4#1)(2012-12#1)
their transfusion requirements##3##3##(2007-2#3)
their transfusion##4##2##(2006-10#1)(2007-2#3)
their transition##2##2##(1991-5#1)(2008-3#1)
their translation initiation##2##3##(1997-2#1)(2008-11#1)
their translation##5##2##(1997-2#1)(2008-11#1)(2008-9#1)(2009-8#1)(2012-12#1)
their transmission to##2##3##(1990-11#1)(2013-1#1)
their transmission##3##2##(1990-11#1)(2008-2#1)(2013-1#1)
their transport to##2##3##(1990-3#1)(2007-12#1)
their transport##10##2##(1990-11#1)(1990-3#2)(1991-5#1)(1994-9#1)(2007-12#1)(2007-8#2)(2007-9#1)(2012-2#1)
their transverse##2##2##(2007-12#1)(2008-3#1)
their treatment and##4##3##(1991-2#1)(2006-10#1)(2006-7#1)(2013-1#1)
their treatment has##2##3##(1992-5#1)(2007-8#1)
their treatment is##2##3##(2006-8#1)(2007-8#1)
their treatment regimen##2##3##(2008-3#1)(2012-3#1)
their treatment##50##2##(1990-4#1)(1991-2#1)(1992-10#1)(1992-5#2)(1993-12#1)(1994-7#1)(1995-1#1)(1995-4#1)(1997-6#1)(2005-1#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-2#2)(2006-3#1)(2006-7#2)(2006-8#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-2#1)(2009-7#2)(2009-9#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
their trip##3##2##(2007-2#2)(2011-2#1)
their true##2##2##(1995-4#1)(2006-10#1)
their trust##2##2##(1997-4#1)(2004-2#1)
their tumor##2##2##(1995-8#1)(2013-1#1)
their tumors##3##2##(2005-5#1)(2006-6#1)(2008-7#1)
their twenties##2##2##(2007-2#1)(2011-1#1)
their two##8##2##(1993-6#1)(1995-4#1)(1996-12#1)(1996-5#1)(2007-12#1)(2009-8#1)(2013-1#2)
their type##2##2##(2006-2#1)(2010-12#1)
their typical##5##2##(2004-12#1)(2007-12#1)(2009-2#1)(2012-2#2)
their ubiquitous##4##2##(2007-8#1)(2011-2#1)(2012-12#2)
their ultimate##4##2##(1991-3#1)(2007-12#1)(2008-9#1)(2011-2#1)
their undergraduate##5##2##(1993-3#1)(2007-6#4)
their underlying##11##2##(2005-8#1)(2006-10#1)(2006-2#1)(2006-4#1)(2008-1#1)(2008-8#2)(2009-11#1)(2009-4#1)(2011-1#2)
their understanding and##2##3##(1992-12#1)(2008-1#1)
their understanding of the##4##4##(1994-12#1)(1996-3#1)(2006-9#1)(2008-12#1)
their understanding of##11##3##(1994-12#1)(1996-3#1)(2006-9#1)(2007-4#1)(2008-10#1)(2008-12#5)(2012-1#1)
their understanding##15##2##(1992-12#1)(1994-12#1)(1996-3#1)(1996-9#1)(2006-9#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-12#5)(2009-12#1)(2012-1#1)
their undifferentiated state##2##3##(2012-12#1)(2013-1#1)
their undifferentiated##3##2##(2011-2#1)(2012-12#1)(2013-1#1)
their unique characteristics##2##3##(1992-1#1)(2010-8#1)
their unique combination of##3##4##(1996-1#1)(2012-2#1)(2013-1#1)
their unique properties##2##3##(1993-3#1)(2008-10#1)
their unique requirements##2##3##(2010-7#1)(2010-8#1)
their unique##32##2##(1992-1#1)(1993-3#2)(1994-2#1)(1995-5#1)(1996-1#1)(1996-3#1)(1997-6#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-1#1)(2010-10#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2012-2#1)(2013-1#2)
their unknown##2##2##(2010-12#1)(2012-2#1)
their unmodified counterparts##2##3##(2009-10#1)(2012-2#1)
their unusual##5##2##(1996-4#1)(1997-1#1)(2008-4#1)(2009-2#1)(2012-2#1)
their upper##2##2##(2006-8#1)(2007-10#1)
their uptake by##3##3##(1996-2#1)(1997-3#1)(2013-8#1)
their uptake##5##2##(1996-2#1)(1997-3#2)(2005-7#1)(2013-8#1)
their urine##3##2##(1993-12#1)(1997-3#1)(2011-2#1)
their usage in##3##3##(1990-11#1)(2008-10#2)
their usage##10##2##(1990-11#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#2)
their use also involves non-clinical care coordination##2##7##(2013-1#2)
their use and##4##3##(2007-7#1)(2008-9#2)(2010-8#1)
their use are##3##3##(1991-11#1)(2008-11#1)(2008-4#1)
their use as a##5##4##(1997-5#1)(2006-10#1)(2008-1#1)(2010-6#1)(2011-2#1)
their use as an##2##4##(1993-12#2)
their use as therapeutic##2##4##(2006-7#1)(2008-11#1)
their use as##25##3##(1992-3#1)(1993-12#2)(1996-6#1)(1997-4#1)(1997-5#1)(2006-10#3)(2006-6#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
their use by##2##3##(2007-12#1)(2013-8#1)
their use for the##3##4##(1995-3#1)(2008-4#1)(2010-2#1)
their use for##12##3##(1990-8#1)(1995-3#1)(1997-4#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2010-2#1)(2013-8#1)
their use has##2##3##(2007-4#1)(2008-1#1)
their use in a##3##4##(2012-2#1)(2013-1#2)
their use in clinical practice##4##5##(1997-7#1)(2006-10#1)(2008-6#1)(2009-12#1)
their use in improving##2##4##(1994-12#1)(2008-7#1)
their use in the treatment of##4##6##(1996-4#1)(2008-1#1)(2008-6#1)(2009-3#1)
their use in the##14##4##(1991-12#1)(1991-2#1)(1996-4#1)(2005-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-3#1)(2012-12#1)(2013-1#2)
their use in##56##3##(1991-12#2)(1991-2#1)(1992-3#1)(1994-12#1)(1996-10#1)(1996-4#1)(1997-7#1)(2004-9#2)(2005-11#1)(2005-7#1)(2005-9#2)(2006-10#5)(2006-12#1)(2007-11#3)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#6)
their use is a##2##4##(1996-7#1)(2009-8#1)
their use is limited by their##3##6##(2006-10#1)(2008-10#1)(2009-4#1)
their use is limited by##4##5##(2006-10#1)(2008-10#1)(2009-4#1)(2013-7#1)
their use is limited##5##4##(2006-10#1)(2008-10#1)(2008-5#1)(2009-4#1)(2013-7#1)
their use is##17##3##(1994-12#1)(1996-7#1)(1996-9#2)(2005-11#1)(2005-8#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-5#1)(2009-4#1)(2009-8#1)(2010-12#1)(2011-2#1)(2011-3#1)(2013-7#1)(2013-8#1)
their use of the##3##4##(2008-8#1)(2013-1#2)
their use of treatment modalities##2##5##(2005-7#2)
their use of##22##3##(1990-9#1)(1994-4#1)(1996-1#1)(1996-2#1)(1996-9#1)(2005-7#2)(2007-10#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-11#2)(2008-6#1)(2008-8#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
their use requires##2##3##(2007-12#1)(2013-7#1)
their use should##3##3##(2006-10#1)(2006-12#1)(2011-2#1)
their use to##4##3##(2007-11#1)(2008-12#1)(2008-9#1)(2012-2#1)
their use was##4##3##(1990-2#1)(1994-9#1)(2006-5#1)(2010-3#1)
their use with##2##3##(2008-6#1)(2012-2#1)
their use##226##2##(1990-2#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#1)(1992-12#1)(1992-3#2)(1992-4#1)(1993-1#1)(1993-12#3)(1994-12#2)(1994-4#2)(1994-9#1)(1995-3#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-9#3)(1997-4#2)(1997-5#1)(1997-7#1)(2004-9#3)(2005-10#1)(2005-11#2)(2005-7#3)(2005-8#1)(2005-9#2)(2006-10#12)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#9)(2007-12#2)(2007-2#3)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#3)(2008-1#3)(2008-10#6)(2008-11#12)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#8)(2008-5#8)(2008-6#5)(2008-7#4)(2008-8#4)(2008-9#4)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-8#2)(2010-1#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#19)(2013-7#3)(2013-8#4)
their useful##2##2##(2008-7#1)(2012-2#1)
their usefulness as##2##3##(1994-3#1)(2013-1#1)
their usefulness for##2##3##(1994-3#1)(2008-11#1)
their usefulness in the##2##4##(1991-6#1)(2007-1#1)
their usefulness in##10##3##(1990-3#1)(1991-6#1)(1994-3#1)(2007-1#1)(2007-10#1)(2008-10#1)(2008-11#1)(2009-4#1)(2012-12#1)(2013-1#1)
their usefulness to study##2##4##(2011-1#1)(2012-12#1)
their usefulness to##3##3##(1995-6#1)(2011-1#1)(2012-12#1)
their usefulness##24##2##(1990-3#1)(1991-6#1)(1994-3#3)(1995-6#1)(1996-11#1)(1996-3#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-5#1)(2008-10#1)(2008-11#2)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#3)(2013-8#1)
their users##2##2##(1995-3#1)(2011-2#1)
their usual##10##2##(1990-11#1)(1991-3#1)(1993-3#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#1)
their utility and##3##3##(2008-10#1)(2010-4#1)(2011-12#1)
their utility as##2##3##(2005-7#1)(2008-11#1)
their utility for studying##2##4##(1995-2#1)(2008-4#1)
their utility for##4##3##(1993-12#1)(1995-2#1)(2008-10#1)(2008-4#1)
their utility in the##2##4##(2006-10#1)(2011-2#1)
their utility in##4##3##(2006-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
their utility##19##2##(1993-12#1)(1995-2#1)(2005-7#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#2)(2009-9#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
their utilization in##2##3##(2008-10#1)(2009-5#1)
their utilization##7##2##(2007-4#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-5#1)(2011-1#2)
their validity as##5##3##(2010-8#1)(2013-1#4)
their validity##18##2##(1994-12#1)(1997-2#1)(2004-8#2)(2005-11#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#4)(2013-8#1)
their value to the##2##4##(1992-3#1)(2010-3#1)
their value to##3##3##(1992-3#1)(1995-2#1)(2010-3#1)
their value##6##2##(1992-3#1)(1995-2#1)(2005-7#1)(2006-10#1)(2008-11#1)(2010-3#1)
their values and##3##3##(1990-7#1)(1995-1#1)(2010-2#1)
their values##7##2##(1990-7#1)(1995-1#1)(1996-2#1)(2007-8#1)(2008-3#1)(2008-7#1)(2010-2#1)
their variability##5##2##(2006-12#1)(2008-12#1)(2008-7#1)(2013-1#2)
their variable##2##2##(2006-2#1)(2008-11#1)
their varied##3##2##(2005-10#1)(2008-11#1)(2008-7#1)
their varietal origin##2##3##(2008-10#2)
their various##9##2##(1994-3#1)(1994-8#1)(2008-10#1)(2008-4#3)(2009-11#1)(2011-1#1)(2013-1#1)
their vascular access##2##3##(2007-7#2)
their vascular##4##2##(2006-2#1)(2007-7#3)
their vectorial##2##2##(2008-11#1)(2012-12#1)
their vectors##3##2##(2008-1#1)(2008-10#1)(2008-8#1)
their verbal##2##2##(2008-9#1)(2011-1#1)
their vertebrate##2##2##(1991-3#1)(1992-5#1)
their vertical##2##2##(2008-3#2)
their very##7##2##(2007-10#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#1)
their veterinarian##3##2##(2007-4#2)(2010-2#1)
their viability and##4##3##(2006-10#1)(2007-1#1)(2008-10#1)(2008-7#1)
their viability##10##2##(1991-1#1)(1996-10#1)(1996-12#1)(1997-4#1)(2006-10#1)(2007-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)
their view##3##2##(1993-1#1)(2007-7#1)(2008-6#1)
their views of##3##3##(2009-9#1)(2011-1#1)(2013-1#1)
their views on##8##3##(1992-3#1)(1997-3#1)(2006-10#1)(2007-8#2)(2008-12#1)(2011-2#1)(2013-8#1)
their views##18##2##(1992-3#1)(1992-4#1)(1994-1#1)(1995-12#1)(1997-3#1)(2006-10#1)(2007-8#2)(2008-12#4)(2009-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
their villages##2##2##(1991-12#1)(2008-2#1)
their virulence##6##2##(2008-10#3)(2008-5#1)(2013-1#1)(2013-8#1)
their virus-free##2##2##(2008-10#2)
their vision and##2##3##(2008-1#1)(2010-11#1)
their vision more than##2##4##(2007-12#1)(2011-2#1)
their vision##5##2##(2007-12#1)(2008-1#1)(2010-11#1)(2011-2#2)
their visual##2##2##(2009-3#1)(2011-2#1)
their vital##2##2##(2006-10#1)(2012-12#1)
their voices##6##2##(1992-3#1)(1997-8#3)(2004-5#1)(2012-1#1)
their volatile##2##2##(2008-10#1)(2008-8#1)
their voltammetric##2##2##(2008-10#2)
their volume##2##2##(2005-11#1)(2007-12#1)
their voluntary##2##2##(1993-12#1)(1996-2#1)
their vulnerability##3##2##(2007-7#1)(2007-8#1)(2008-9#1)
their water##6##2##(2008-10#2)(2008-5#2)(2008-6#1)(2012-1#1)
their wavelength##2##2##(2008-2#1)(2008-9#1)
their way into##2##3##(2007-7#1)(2008-11#1)
their way out of##2##4##(1992-6#1)(1996-12#1)
their way to the##2##4##(1991-1#1)(2013-8#1)
their way to##5##3##(1991-1#1)(1993-6#1)(2009-10#1)(2010-4#1)(2013-8#1)
their way##17##2##(1991-1#1)(1991-4#1)(1992-1#1)(1992-6#1)(1993-6#1)(1994-12#1)(1996-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-4#1)(2010-4#1)(2011-2#1)(2012-11#2)(2013-8#1)
their ways##2##2##(2010-10#1)(2010-9#1)
their weight##9##2##(1991-10#1)(1993-2#1)(2004-3#1)(2007-12#2)(2010-11#1)(2011-2#2)(2013-1#1)
their well being##3##3##(1995-1#1)(2006-7#1)(2008-1#1)
their well##4##2##(1995-1#1)(2006-7#1)(2008-1#1)(2013-1#1)
their well-being and##2##3##(2006-8#1)(2008-6#1)
their well-being##3##2##(2006-8#1)(2008-6#1)(2010-10#1)
their wheelchairs##3##2##(2007-10#1)(2007-7#2)
their whole##2##2##(2010-1#1)(2011-1#1)
their wide##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2011-2#1)(2012-2#1)
their wider##2##2##(2007-12#1)(2010-7#1)
their widespread use##2##3##(2004-4#1)(2008-10#1)
their widespread##3##2##(2004-4#1)(2008-10#1)(2008-7#1)
their wild type##2##3##(1995-11#1)(2008-11#1)
their wild##3##2##(1995-11#1)(2008-10#1)(2008-11#1)
their wild-type counterparts##4##3##(2004-1#1)(2007-9#1)(2008-10#1)(2008-3#1)
their wild-type##6##2##(2004-1#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-8#1)
their willingness to##5##3##(1994-3#1)(2007-10#1)(2007-3#1)(2008-11#1)(2009-9#1)
their wisdom##2##2##(2007-2#1)(2011-2#1)
their withdrawal##2##2##(2005-11#1)(2008-7#1)
their wives'##2##2##(2007-12#1)(2008-9#1)
their wives/partners during labour##3##4##(2010-3#3)
their work and##3##3##(1996-1#1)(2008-7#1)(2012-12#1)
their work environment##2##3##(2008-12#1)(2009-10#1)
their work in##4##3##(2005-7#1)(2005-8#1)(2007-1#1)(2008-7#1)
their work makes##2##3##(2007-4#1)(2012-12#1)
their work performance##3##3##(1994-2#1)(2012-12#2)
their work with##2##3##(2007-10#1)(2008-4#1)
their work##62##2##(1991-12#1)(1992-2#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-6#2)(1996-1#3)(1996-7#1)(1996-9#1)(1997-1#1)(2004-10#1)(2004-9#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-6#2)(2007-1#1)(2007-10#3)(2007-2#1)(2007-4#3)(2007-8#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#5)(2008-9#1)(2009-10#1)(2009-8#1)(2010-5#1)(2010-9#1)(2011-1#2)(2012-1#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
their working##8##2##(1991-3#1)(1992-6#1)(1993-1#1)(1994-1#1)(2004-8#1)(2008-10#1)(2008-3#1)(2008-9#1)
their workload and##2##3##(2004-10#1)(2011-1#1)
their workload##5##2##(1990-10#1)(2004-10#2)(2011-1#1)(2012-12#1)
their workplace##6##2##(1991-2#1)(2008-11#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
their workplaces##2##2##(2004-9#1)(2010-5#1)
their worlds##2##2##(2008-11#1)(2009-5#1)
their writing##4##2##(2008-11#1)(2010-6#1)(2013-7#2)
their written##2##2##(2006-9#1)(2009-7#1)
their yield##2##2##(2009-7#1)(2011-10#1)
their young adult##3##3##(2007-4#3)
their young##9##2##(2007-4#3)(2007-6#1)(2008-3#2)(2008-9#1)(2010-7#1)(2012-2#1)
their younger##4##2##(1997-3#1)(2008-11#1)(2010-9#1)(2013-1#1)
their youth##2##2##(1996-12#1)(2008-9#1)
their zoonotic implications##2##3##(2012-2#2)
their##17896##1##(1990-1#8)(1990-10#29)(1990-11#54)(1990-12#99)(1990-2#40)(1990-3#36)(1990-4#29)(1990-5#54)(1990-6#41)(1990-7#25)(1990-8#28)(1990-9#36)(1991-1#33)(1991-10#27)(1991-11#45)(1991-12#60)(1991-2#81)(1991-3#67)(1991-4#43)(1991-5#33)(1991-6#30)(1991-7#26)(1991-8#44)(1991-9#45)(1992-1#62)(1992-10#20)(1992-11#32)(1992-12#71)(1992-2#53)(1992-3#61)(1992-4#19)(1992-5#48)(1992-6#66)(1992-7#33)(1992-8#44)(1992-9#38)(1993-1#46)(1993-10#19)(1993-11#36)(1993-12#86)(1993-2#81)(1993-3#78)(1993-4#21)(1993-5#25)(1993-6#63)(1993-7#17)(1993-8#37)(1993-9#57)(1994-1#37)(1994-10#17)(1994-11#63)(1994-12#80)(1994-2#72)(1994-3#107)(1994-4#9)(1994-5#35)(1994-6#74)(1994-7#7)(1994-8#51)(1994-9#68)(1995-1#108)(1995-10#19)(1995-11#58)(1995-12#85)(1995-2#85)(1995-3#112)(1995-4#27)(1995-5#48)(1995-6#68)(1995-7#11)(1995-8#53)(1995-9#19)(1996-1#70)(1996-10#18)(1996-11#38)(1996-12#86)(1996-2#82)(1996-3#94)(1996-4#35)(1996-5#71)(1996-6#44)(1996-7#27)(1996-8#37)(1996-9#47)(1997-1#72)(1997-2#76)(1997-3#69)(1997-4#73)(1997-5#28)(1997-6#63)(1997-7#65)(1997-8#59)(1997-9#3)(2003-11#1)(2004-1#3)(2004-10#19)(2004-11#25)(2004-12#23)(2004-2#10)(2004-3#13)(2004-4#11)(2004-5#2)(2004-8#4)(2004-9#28)(2005-1#11)(2005-10#55)(2005-11#132)(2005-12#18)(2005-2#1)(2005-3#5)(2005-4#11)(2005-5#13)(2005-6#6)(2005-7#69)(2005-8#58)(2005-9#29)(2006-1#19)(2006-10#300)(2006-11#48)(2006-12#138)(2006-2#72)(2006-3#26)(2006-4#40)(2006-5#78)(2006-6#51)(2006-7#84)(2006-8#82)(2006-9#42)(2007-1#77)(2007-10#111)(2007-11#248)(2007-12#381)(2007-2#176)(2007-3#77)(2007-4#96)(2007-5#42)(2007-6#56)(2007-7#132)(2007-8#219)(2007-9#116)(2008-1#232)(2008-10#1235)(2008-11#546)(2008-12#241)(2008-2#258)(2008-3#311)(2008-4#363)(2008-5#513)(2008-6#137)(2008-7#381)(2008-8#325)(2008-9#328)(2009-1#10)(2009-10#93)(2009-11#50)(2009-12#78)(2009-2#83)(2009-3#73)(2009-4#122)(2009-5#114)(2009-6#68)(2009-7#109)(2009-8#110)(2009-9#78)(2010-1#46)(2010-10#91)(2010-11#47)(2010-12#190)(2010-2#128)(2010-3#98)(2010-4#110)(2010-5#93)(2010-6#45)(2010-7#71)(2010-8#143)(2010-9#84)(2011-1#320)(2011-10#5)(2011-11#4)(2011-12#59)(2011-2#493)(2011-3#13)(2011-4#1)(2011-7#4)(2011-9#1)(2012-1#131)(2012-11#71)(2012-12#336)(2012-2#390)(2012-3#240)(2012-4#5)(2012-5#7)(2012-7#3)(2012-8#2)(2012-9#3)(2013-1#596)(2013-7#99)(2013-8#255)
theirs##3##1##(1991-9#1)(2010-11#1)(2011-3#1)
thelytokous populations from leek##2##4##(2008-10#2)
thelytokous populations##3##2##(2008-10#3)
them &quot##3##2##(2007-3#1)(2008-10#1)(2010-5#1)
them (the##3##2##(1997-4#1)(2011-1#2)
them a##14##2##(1990-12#1)(1993-12#2)(1993-9#1)(1995-1#1)(1995-6#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#2)(2012-12#2)
them about their##3##3##(2008-8#1)(2010-5#1)(2012-3#1)
them about##6##2##(1994-3#1)(1996-6#1)(2008-8#1)(2010-5#1)(2012-2#1)(2012-3#1)
them according to the##2##4##(2010-2#2)
them according to their##3##4##(2008-1#1)(2008-2#1)(2012-12#1)
them according to##8##3##(2008-1#1)(2008-2#2)(2010-2#2)(2011-1#1)(2012-12#2)
them after##3##2##(2007-4#1)(2007-9#1)(2009-6#1)
them against##6##2##(1994-3#1)(2007-11#1)(2008-10#1)(2008-5#1)(2013-1#2)
them all##2##2##(1993-2#1)(1994-8#1)
them also##10##2##(1991-12#1)(1992-2#1)(1997-2#1)(2006-6#1)(2007-11#2)(2008-4#1)(2008-7#1)(2012-1#1)(2013-1#1)
them an excellent##3##3##(1993-8#1)(2006-10#1)(2010-2#1)
them an important##3##3##(2008-5#1)(2008-9#1)(2010-12#1)
them an##15##2##(1990-9#1)(1993-8#1)(1997-1#1)(2005-12#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-2#1)
them and a##2##3##(1991-12#1)(2008-12#1)
them and how##2##3##(2005-12#1)(2011-2#1)
them and the##8##3##(1990-6#1)(1994-2#1)(1997-4#1)(2008-12#1)(2008-5#1)(2009-9#1)(2011-1#1)(2012-2#1)
them and their##3##3##(2008-11#1)(2013-1#2)
them and to##2##3##(2008-1#1)(2008-8#1)
them and##52##2##(1990-12#1)(1990-6#2)(1991-12#1)(1992-11#1)(1993-2#1)(1994-2#1)(1994-8#1)(1996-11#1)(1996-12#1)(1997-4#1)(1997-7#1)(2005-12#2)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-11#1)(2008-12#4)(2008-4#1)(2008-5#4)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-11#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
them are discussed##2##3##(1990-12#1)(2006-4#1)
them are still##2##3##(1992-10#1)(2012-2#1)
them are the##3##3##(2004-8#1)(2007-7#1)(2011-1#1)
them are##81##2##(1990-12#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-4#1)(1991-5#1)(1992-10#1)(1992-7#2)(1994-8#1)(1994-9#2)(1995-12#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-6#2)(2004-8#1)(2005-12#1)(2005-7#2)(2006-10#3)(2006-4#1)(2007-1#2)(2007-11#1)(2007-3#3)(2007-7#2)(2007-8#3)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-1#1)(2012-12#3)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#1)
them as a##10##3##(1994-11#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#2)(2010-10#1)(2012-12#1)(2013-1#2)
them as an##2##3##(2008-8#1)(2011-2#1)
them as distinct##2##3##(2004-2#1)(2008-10#1)
them as part of##3##4##(2008-11#1)(2013-1#2)
them as potential##2##3##(2005-7#1)(2009-3#1)
them as the##5##3##(1990-12#1)(1993-12#1)(1995-2#1)(2007-12#1)(2008-10#1)
them as##57##2##(1990-12#1)(1993-12#2)(1993-2#1)(1994-11#2)(1994-12#1)(1995-12#1)(1995-2#1)(1997-4#1)(2004-12#1)(2004-2#1)(2005-7#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#4)(2013-8#1)
them at risk for##2##4##(2007-4#1)(2010-12#1)
them at risk of##3##4##(2008-11#1)(2012-12#1)(2013-7#1)
them at risk##5##3##(2007-4#1)(2008-11#1)(2010-12#1)(2012-12#1)(2013-7#1)
them at the##4##3##(1996-1#1)(2008-3#1)(2008-8#2)
them at##17##2##(1992-1#1)(1993-9#1)(1996-1#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-5#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-7#1)
them attractive##5##2##(2008-10#1)(2008-7#1)(2011-2#2)(2012-12#1)
them back##2##2##(1994-9#1)(2008-8#1)
them based on##2##3##(2008-3#1)(2012-12#1)
them because of##3##3##(1993-2#1)(2008-7#1)(2012-12#1)
them become##3##2##(1990-12#1)(1994-4#1)(1997-5#1)
them being##14##2##(1990-6#1)(1993-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-1#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-5#1)(2013-1#1)(2013-7#1)
them better##2##2##(1990-8#1)(2011-2#1)
them both##2##2##(1992-1#1)(1997-2#1)
them by means of##2##4##(1994-12#1)(2008-12#1)
them by the##2##3##(1995-1#1)(2007-10#1)
them by##29##2##(1990-10#1)(1990-9#1)(1992-1#1)(1993-11#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-4#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2010-1#1)(2010-2#1)(2012-12#1)(2012-2#2)
them can be##7##3##(1990-12#1)(1992-6#1)(1996-3#1)(2006-6#1)(2008-2#1)(2008-9#1)(2013-8#1)
them can##10##2##(1990-12#1)(1991-9#1)(1992-6#1)(1996-3#1)(1997-8#1)(2006-6#1)(2008-2#1)(2008-3#1)(2008-9#1)(2013-8#1)
them consistently##2##2##(2010-1#1)(2012-12#1)
them cope##2##2##(1993-3#1)(2005-8#1)
them correctly##2##2##(1993-12#1)(2008-12#1)
them could not##2##3##(1995-8#1)(2005-10#1)
them could##8##2##(1993-5#1)(1995-8#1)(2005-10#1)(2006-8#1)(2007-11#1)(2011-1#1)(2012-11#1)(2013-1#1)
them develop##3##2##(1993-2#1)(1997-8#1)(2010-10#1)
them difficult to##5##3##(2006-8#1)(2008-10#1)(2009-6#1)(2010-9#1)(2013-7#1)
them difficult##6##2##(2006-8#1)(2007-7#1)(2008-10#1)(2009-6#1)(2010-9#1)(2013-7#1)
them directly##2##2##(2006-10#1)(2008-3#1)
them do not##2##3##(2008-2#1)(2008-9#1)
them due to##3##3##(1996-1#1)(2008-10#1)(2008-4#1)
them during the##2##3##(2006-3#1)(2011-2#1)
them during##6##2##(1993-1#1)(2006-10#1)(2006-12#1)(2006-3#1)(2009-10#1)(2011-2#1)
them early##2##2##(1995-12#1)(2007-12#1)
them easily##3##2##(2008-11#1)(2010-12#1)(2011-1#1)
them easy to##3##3##(2008-3#1)(2011-12#1)(2011-2#1)
them effectively##2##2##(1992-1#1)(2007-12#1)
them efficiently##4##2##(2008-10#1)(2012-2#1)(2013-1#2)
them either##5##2##(1992-7#1)(2008-2#1)(2008-4#1)(2009-3#1)(2013-1#1)
them excellent##2##2##(2007-12#1)(2008-6#1)
them exhibiting##2##2##(1997-6#1)(2009-6#1)
them feel##6##2##(1991-3#1)(1996-1#1)(1997-8#2)(2006-7#1)(2012-12#1)
them for the##7##3##(1992-1#1)(1994-9#1)(2007-4#1)(2008-12#1)(2008-7#1)(2010-3#1)(2010-8#1)
them for their##4##3##(2008-10#1)(2008-12#1)(2008-5#1)(2011-1#1)
them for##37##2##(1992-1#1)(1994-12#1)(1994-9#1)(1995-12#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#2)(2008-5#2)(2008-7#1)(2009-12#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#5)
them from a##2##3##(1993-12#1)(2009-5#1)
them from each other##2##4##(1991-1#1)(2008-10#1)
them from other types##2##4##(2008-2#1)(2008-9#1)
them from other##3##3##(2008-11#1)(2008-2#1)(2008-9#1)
them from the##7##3##(1994-5#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-2#1)(2009-9#1)(2013-1#1)
them from##59##2##(1991-1#1)(1992-8#1)(1993-12#2)(1993-7#1)(1994-5#1)(1995-2#1)(1996-2#1)(1997-7#2)(2004-9#1)(2005-7#1)(2006-10#1)(2006-7#2)(2006-8#1)(2007-11#1)(2007-3#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#3)(2008-4#1)(2008-5#2)(2008-9#3)(2009-5#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-11#1)(2012-12#3)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
them fully##2##2##(2007-3#1)(2008-7#1)
them get##2##2##(2009-10#1)(2012-12#1)
them good candidates for##2##4##(2008-10#1)(2010-6#1)
them has been##3##3##(2008-2#1)(2011-2#2)
them has yet##2##3##(2008-10#1)(2009-5#1)
them has##12##2##(1991-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)(2010-6#1)(2011-2#3)
them have been##7##3##(1990-3#1)(1997-8#1)(2005-7#1)(2008-3#1)(2008-8#1)(2009-10#1)(2010-1#1)
them have proven##2##3##(2006-12#1)(2008-1#1)
them have##24##2##(1990-3#1)(1990-6#1)(1996-1#1)(1996-6#1)(1997-8#1)(2005-7#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#2)(2010-1#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
them having##6##2##(1993-2#1)(2006-6#1)(2007-7#1)(2008-2#1)(2011-2#2)
them ideal for##2##3##(1992-3#1)(2010-12#1)
them ideal##5##2##(1992-3#1)(2005-5#1)(2007-5#1)(2008-7#1)(2010-12#1)
them if##5##2##(1994-3#2)(2008-1#2)(2010-9#1)
them immediately##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
them in a##21##3##(1994-3#1)(1995-1#1)(1995-12#1)(1997-6#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-1#1)(2011-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
them in an##4##3##(1995-4#1)(2008-11#1)(2009-9#1)(2012-2#1)
them in context##2##3##(2005-10#1)(2010-12#1)
them in developing##2##3##(1996-2#1)(1996-3#1)
them in order to##4##4##(1996-9#1)(2008-10#1)(2013-1#2)
them in research##2##3##(2012-11#1)(2012-2#1)
them in the context of the##3##6##(2006-2#1)(2008-12#1)(2010-7#1)
them in the context of##7##5##(1993-12#1)(2006-2#1)(2008-1#1)(2008-12#1)(2009-4#1)(2010-7#1)(2012-2#1)
them in the process##2##4##(2004-3#1)(2008-11#1)
them in the##38##3##(1990-4#1)(1991-10#2)(1991-11#1)(1991-6#1)(1993-12#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-10#1)(1997-3#1)(2004-3#1)(2005-10#1)(2005-4#1)(2005-7#1)(2006-2#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#2)(2008-6#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-6#1)(2010-7#1)(2012-2#2)
them in their##5##3##(1994-3#1)(2007-4#1)(2008-10#1)(2011-2#1)(2012-3#1)
them in##139##2##(1990-4#1)(1991-10#2)(1991-11#1)(1991-2#2)(1991-4#1)(1991-6#1)(1992-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#4)(1994-5#1)(1995-1#2)(1995-12#2)(1995-3#1)(1995-4#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2004-3#1)(2005-10#2)(2005-4#1)(2005-7#1)(2006-10#3)(2006-2#1)(2006-7#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#4)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#2)(2012-11#2)(2012-12#3)(2012-2#8)(2012-3#2)(2013-1#4)(2013-7#4)(2013-8#1)
them include##2##2##(2006-5#1)(2007-11#1)
them independently##3##2##(2007-12#1)(2008-3#1)(2013-1#1)
them individually in##2##3##(1992-3#1)(2007-10#1)
them individually##3##2##(1992-3#1)(2007-10#1)(2012-1#1)
them into a##3##3##(2012-3#1)(2013-1#2)
them into the##7##3##(1993-7#1)(1997-1#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-7#1)(2008-8#1)
them into##42##2##(1990-8#1)(1991-12#1)(1991-3#1)(1993-12#1)(1993-3#1)(1993-7#1)(1996-1#1)(1997-1#1)(2003-11#1)(2005-11#1)(2006-12#1)(2006-6#2)(2006-9#1)(2007-10#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#4)
them is based on the##2##5##(2008-10#1)(2009-3#1)
them is##28##2##(1991-6#1)(1992-3#1)(1992-9#1)(1996-11#1)(1997-5#1)(2004-11#1)(2005-10#1)(2005-11#2)(2006-6#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-9#1)(2009-2#1)(2009-3#2)(2011-2#2)(2012-2#1)(2013-1#2)
them less than##2##3##(1991-2#1)(1994-12#1)
them less##7##2##(1991-2#1)(1994-12#1)(2005-7#2)(2007-11#1)(2008-1#1)(2008-3#1)
them maintained##2##2##(1995-12#1)(2008-11#1)
them may be##4##3##(1995-8#1)(2007-12#1)(2008-1#1)(2011-1#1)
them may##9##2##(1995-8#1)(2007-12#1)(2008-1#1)(2008-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
them more susceptible to##2##4##(2007-2#1)(2008-3#1)
them more##14##2##(1994-9#1)(1995-7#1)(1996-3#1)(2005-8#1)(2007-12#1)(2007-2#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-1#1)
them most##2##2##(1994-3#1)(2007-9#1)
them needs##2##2##(1992-6#1)(2007-11#1)
them not##3##2##(2006-10#1)(2008-8#1)(2012-1#1)
them of the##4##3##(2009-5#1)(2011-2#2)(2012-3#1)
them of##7##2##(2007-11#1)(2008-10#1)(2009-5#1)(2011-2#2)(2012-3#1)(2013-8#1)
them on a##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
them on the##4##3##(1996-11#1)(1996-3#1)(2008-9#1)(2009-9#1)
them on##21##2##(1992-3#1)(1995-12#1)(1996-11#1)(1996-3#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-2#1)(2010-6#1)(2011-2#1)(2013-7#1)
them once they have##2##4##(2004-9#1)(2010-8#1)
them one##2##2##(2008-2#1)(2008-8#1)
them only##5##2##(2007-3#1)(2008-10#1)(2008-2#1)(2010-4#1)(2011-2#1)
them onto the##2##3##(2008-11#1)(2012-3#1)
them onto##3##2##(2008-11#1)(2011-1#1)(2012-3#1)
them or with##2##3##(2008-10#1)(2008-3#1)
them or##5##2##(1994-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#1)
them out##2##2##(1994-1#1)(2007-9#1)
them particularly##2##2##(2008-4#1)(2010-7#1)
them remain##4##2##(1996-7#1)(2007-12#1)(2009-8#1)(2011-2#1)
them severe##2##2##(1997-5#1)(2006-10#1)
them showed a##2##3##(2010-8#1)(2013-8#1)
them showed no##2##3##(2008-4#1)(2008-5#1)
them showed##18##2##(1991-10#1)(1992-10#1)(1992-12#1)(1993-7#1)(1995-12#1)(1995-8#1)(1996-2#1)(2007-3#1)(2008-4#1)(2008-5#3)(2008-9#1)(2010-2#1)(2010-8#1)(2011-12#1)(2013-1#1)(2013-8#1)
them stated that##2##3##(2008-1#1)(2011-2#1)
them still##2##2##(2008-11#1)(2011-2#1)
them successfully##2##2##(1991-2#1)(2008-11#1)
them such as##2##3##(2006-2#1)(2012-1#1)
them suitable for##5##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-7#1)
them suitable##6##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-7#1)
them than##3##2##(1995-1#1)(2007-12#1)(2010-9#1)
them that##4##2##(1992-8#1)(1996-11#1)(1996-2#1)(2012-3#1)
them the##22##2##(1990-10#1)(1990-5#1)(1994-3#1)(2004-5#1)(2007-12#1)(2007-2#1)(2007-7#3)(2007-9#1)(2008-10#4)(2008-2#1)(2009-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
them their##4##2##(2008-10#1)(2008-8#1)(2010-10#1)(2010-9#1)
them there##4##2##(1992-5#1)(1993-6#1)(2008-4#1)(2013-1#1)
them through the##4##3##(1992-12#1)(2008-10#1)(2008-6#1)(2008-8#1)
them through##8##2##(1992-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)
them to a##4##3##(2008-10#2)(2009-12#1)(2011-1#1)
them to achieve a##2##4##(1993-12#1)(2013-1#1)
them to achieve##4##3##(1993-12#1)(2010-3#1)(2013-1#1)(2013-8#1)
them to be able to##2##5##(2007-6#1)(2008-12#1)
them to be used##3##4##(2008-3#1)(2008-4#1)(2008-9#1)
them to be##30##3##(1990-10#1)(1990-8#1)(1991-12#2)(1991-5#1)(1992-12#1)(1996-5#1)(1997-7#1)(2006-12#1)(2007-10#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)
them to become more##2##4##(1997-3#1)(2011-1#1)
them to become##4##3##(1997-3#1)(2008-7#1)(2010-9#1)(2011-1#1)
them to better##2##3##(2009-12#1)(2010-7#1)
them to develop the##2##4##(2008-8#1)(2010-3#1)
them to develop##5##3##(1997-2#1)(2006-5#1)(2007-8#1)(2008-8#1)(2010-3#1)
them to do##2##3##(1997-3#1)(2008-9#1)
them to evaluate##2##3##(2007-12#1)(2008-1#1)
them to examine##3##3##(1993-12#1)(2007-8#1)(2008-12#1)
them to improve their##2##4##(2011-2#1)(2012-1#1)
them to influence##2##3##(2005-10#1)(2008-6#1)
them to keep##2##3##(2008-11#1)(2012-12#1)
them to make##3##3##(2007-8#1)(2008-2#2)
them to meet the##2##4##(2006-8#1)(2011-1#1)
them to obtain##4##3##(2007-4#1)(2008-2#1)(2013-1#2)
them to practice##4##3##(2005-7#2)(2013-1#2)
them to reduce the##2##4##(2007-12#1)(2009-7#1)
them to return to##2##4##(2009-10#1)(2010-3#1)
them to seek more information##2##5##(1996-1#1)(2008-12#1)
them to seek##5##3##(1996-1#1)(2004-9#1)(2008-12#1)(2013-1#2)
them to the##27##3##(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-3#1)(1994-4#1)(1997-6#1)(2005-12#1)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-7#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
them to their individual##2##4##(1992-1#1)(1995-3#1)
them to their##3##3##(1992-1#1)(1995-3#1)(2008-12#1)
them to undergo##2##3##(1994-3#1)(2009-9#1)
them to understand##2##3##(1997-3#1)(2012-1#1)
them to use##2##3##(2008-9#1)(2010-12#1)
them to work##2##3##(2005-5#1)(2012-1#1)
them to##298##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#3)(1991-1#3)(1991-11#2)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-12#4)(1993-3#2)(1993-9#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#2)(1995-3#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#2)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-12#1)(2004-4#1)(2004-9#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-5#1)(2005-7#4)(2005-8#2)(2006-10#3)(2006-12#2)(2006-2#3)(2006-5#1)(2006-7#2)(2006-8#1)(2007-10#5)(2007-11#1)(2007-12#6)(2007-2#1)(2007-3#2)(2007-4#3)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#7)(2007-9#5)(2008-1#5)(2008-10#13)(2008-11#8)(2008-12#5)(2008-2#8)(2008-3#4)(2008-4#4)(2008-5#4)(2008-6#5)(2008-7#5)(2008-8#3)(2008-9#9)(2009-10#1)(2009-12#3)(2009-2#1)(2009-6#4)(2009-7#3)(2009-8#2)(2009-9#4)(2010-1#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#6)(2011-12#2)(2011-2#8)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#8)(2012-2#4)(2012-3#3)(2013-1#20)(2013-7#1)(2013-8#1)
them two##3##2##(1992-6#1)(2008-2#1)(2011-2#1)
them under##5##2##(1991-8#1)(1996-9#1)(2008-10#1)(2008-2#1)(2010-8#1)
them until##2##2##(1991-9#1)(2009-5#1)
them up##5##2##(1991-2#1)(1995-12#2)(2007-5#1)(2010-2#1)
them useful as##2##3##(2006-7#1)(2008-10#1)
them useful##7##2##(1990-2#1)(1991-9#1)(2006-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-7#1)
them using##9##2##(1994-8#1)(2008-4#2)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#2)(2013-7#1)
them very##4##2##(1994-6#1)(2007-9#1)(2008-1#1)(2008-10#1)
them vulnerable to##2##3##(2008-4#1)(2009-5#1)
them was##23##2##(1991-10#1)(1991-3#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-3#1)(1995-6#1)(1996-10#1)(1997-4#1)(1997-5#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-4#1)(2012-12#1)(2012-3#1)
them we##3##2##(2008-1#1)(2011-2#1)(2012-12#1)
them well##4##2##(2007-2#1)(2008-10#2)(2010-12#1)
them were analyzed##2##3##(2008-10#1)(2012-2#1)
them were found to be##2##5##(2007-11#1)(2008-10#1)
them were found##4##3##(2007-11#1)(2008-10#1)(2013-7#1)(2013-8#1)
them were not##2##3##(2008-5#1)(2011-12#1)
them were stained##2##3##(2007-11#1)(2012-1#1)
them were##113##2##(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-5#1)(1993-2#1)(1993-5#1)(1993-9#1)(1995-12#1)(1995-6#1)(1995-7#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-2#2)(1997-3#2)(1997-6#1)(2004-2#1)(2006-11#2)(2006-2#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-3#1)(2007-7#8)(2007-8#3)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#3)(2009-2#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-4#2)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#3)(2013-1#9)(2013-7#2)(2013-8#2)
them when##3##2##(2006-10#1)(2008-10#2)
them while the##2##3##(2008-10#1)(2012-1#1)
them while##5##2##(1995-6#1)(2004-2#1)(2008-10#1)(2010-10#1)(2012-1#1)
them will##7##2##(1993-2#1)(2006-8#1)(2009-3#1)(2009-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
them with a##8##3##(1991-8#1)(2005-1#1)(2006-10#1)(2007-7#1)(2008-10#1)(2011-2#2)(2012-12#1)
them with high##2##3##(2010-1#1)(2010-2#1)
them with other##2##3##(2008-4#1)(2011-3#1)
them with the##22##3##(1990-4#1)(1991-9#1)(1994-9#1)(1996-12#1)(1997-1#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
them with their##2##3##(2012-12#1)(2013-1#1)
them with those##2##3##(1993-12#1)(1994-4#1)
them with##105##2##(1990-4#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-7#1)(1993-12#3)(1994-11#2)(1994-4#1)(1994-9#2)(1996-12#2)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#1)(2004-11#1)(2005-1#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-11#3)(2007-12#5)(2007-2#2)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-8#3)(2008-9#2)(2009-12#1)(2009-2#1)(2009-5#2)(2010-1#1)(2010-12#1)(2010-2#2)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#5)(2011-3#1)(2012-12#4)(2012-2#2)(2012-3#2)(2012-4#1)(2013-1#3)(2013-7#1)(2013-8#3)
them within the##3##3##(1992-12#1)(2010-2#1)(2010-6#1)
them within##6##2##(1992-12#1)(2008-10#1)(2008-12#1)(2010-2#1)(2010-6#1)(2012-12#1)
them without##3##2##(1995-5#1)(2008-8#1)(2010-8#1)
them would##3##2##(1991-11#1)(1996-12#1)(2008-7#1)
them##2852##1##(1990-1#1)(1990-10#6)(1990-11#4)(1990-12#17)(1990-2#5)(1990-3#8)(1990-4#3)(1990-5#3)(1990-6#14)(1990-7#5)(1990-8#6)(1990-9#4)(1991-1#6)(1991-10#6)(1991-11#11)(1991-12#11)(1991-2#14)(1991-3#8)(1991-4#10)(1991-5#5)(1991-6#6)(1991-7#6)(1991-8#7)(1991-9#10)(1992-1#9)(1992-10#5)(1992-11#6)(1992-12#11)(1992-2#10)(1992-3#14)(1992-4#4)(1992-5#3)(1992-6#5)(1992-7#7)(1992-8#5)(1992-9#5)(1993-1#4)(1993-10#4)(1993-11#6)(1993-12#24)(1993-2#16)(1993-3#9)(1993-4#1)(1993-5#11)(1993-6#3)(1993-7#6)(1993-8#9)(1993-9#10)(1994-1#6)(1994-11#7)(1994-12#8)(1994-2#7)(1994-3#21)(1994-4#4)(1994-5#4)(1994-6#6)(1994-7#2)(1994-8#6)(1994-9#9)(1995-1#11)(1995-10#3)(1995-11#5)(1995-12#20)(1995-2#12)(1995-3#6)(1995-4#2)(1995-5#4)(1995-6#10)(1995-7#3)(1995-8#8)(1995-9#3)(1996-1#8)(1996-10#3)(1996-11#8)(1996-12#12)(1996-2#11)(1996-3#14)(1996-4#4)(1996-5#6)(1996-6#7)(1996-7#7)(1996-8#5)(1996-9#5)(1997-1#9)(1997-2#12)(1997-3#10)(1997-4#12)(1997-5#6)(1997-6#12)(1997-7#12)(1997-8#10)(1997-9#1)(2003-11#1)(2004-10#1)(2004-11#2)(2004-12#2)(2004-2#3)(2004-3#2)(2004-4#2)(2004-5#2)(2004-8#1)(2004-9#4)(2005-1#1)(2005-10#7)(2005-11#16)(2005-12#6)(2005-3#2)(2005-4#1)(2005-5#3)(2005-6#1)(2005-7#15)(2005-8#7)(2005-9#1)(2006-1#1)(2006-10#43)(2006-11#5)(2006-12#13)(2006-2#10)(2006-3#5)(2006-4#9)(2006-5#4)(2006-6#16)(2006-7#14)(2006-8#23)(2006-9#4)(2007-1#11)(2007-10#23)(2007-11#45)(2007-12#49)(2007-2#24)(2007-3#24)(2007-4#13)(2007-5#12)(2007-6#8)(2007-7#58)(2007-8#43)(2007-9#24)(2008-1#36)(2008-10#183)(2008-11#65)(2008-12#34)(2008-2#60)(2008-3#40)(2008-4#45)(2008-5#67)(2008-6#22)(2008-7#63)(2008-8#51)(2008-9#62)(2009-1#2)(2009-10#15)(2009-11#3)(2009-12#11)(2009-2#15)(2009-3#11)(2009-4#8)(2009-5#23)(2009-6#17)(2009-7#6)(2009-8#11)(2009-9#15)(2010-1#11)(2010-10#9)(2010-11#4)(2010-12#23)(2010-2#17)(2010-3#13)(2010-4#17)(2010-5#8)(2010-6#6)(2010-7#10)(2010-8#25)(2010-9#13)(2011-1#56)(2011-12#9)(2011-2#98)(2011-3#3)(2011-7#1)(2012-1#25)(2012-11#11)(2012-12#64)(2012-2#68)(2012-3#41)(2012-4#2)(2013-1#122)(2013-7#32)(2013-8#34)
them&quot##3##1##(1996-1#1)(1997-6#1)(2006-4#1)
them)##9##1##(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-6#1)(2009-9#1)(2010-6#1)(2011-12#1)
them?##5##1##(1991-7#1)(1994-3#1)(2004-12#1)(2007-11#1)(2008-7#1)
them?]##2##1##(1990-12#1)(1990-2#1)
thematic analysis of##4##3##(2008-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
thematic analysis##15##2##(2005-12#1)(2008-11#2)(2008-12#1)(2010-6#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#3)
thematic area##2##2##(2010-10#2)
thematic areas##2##2##(2010-10#2)
thematic categories##2##2##(2009-7#1)(2012-12#1)
thematic content analysis of##2##4##(2009-10#1)(2012-11#1)
thematic content analysis was##2##4##(2008-12#1)(2008-2#1)
thematic content analysis##8##3##(2008-11#2)(2008-12#1)(2008-2#1)(2009-10#1)(2009-3#1)(2010-10#1)(2012-11#1)
thematic content##9##2##(1994-2#1)(2008-11#2)(2008-12#1)(2008-2#1)(2009-10#1)(2009-3#1)(2010-10#1)(2012-11#1)
thematic focus##2##2##(2011-2#2)
thematic maps##3##2##(2008-8#1)(2011-2#2)
thematic matrix##4##2##(2008-11#2)(2008-4#2)
thematic##56##1##(1994-2#1)(1995-11#1)(1996-3#1)(2005-12#1)(2007-2#1)(2007-3#1)(2008-11#9)(2008-12#2)(2008-2#2)(2008-4#3)(2008-5#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-10#5)(2010-6#1)(2010-9#2)(2011-1#2)(2011-2#7)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#4)
theme and##2##2##(2008-7#1)(2009-10#1)
theme for##2##2##(1996-1#1)(2010-8#1)
theme in##8##2##(1994-12#1)(2007-2#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-7#1)(2009-8#1)(2012-12#1)
theme is that the##2##4##(1996-2#1)(2007-8#1)
theme is that##3##3##(1996-2#1)(2007-8#1)(2010-8#1)
theme is the##2##3##(2006-3#1)(2008-11#1)
theme is##7##2##(1996-2#1)(2006-3#1)(2007-8#1)(2008-1#1)(2008-11#1)(2010-8#1)(2012-2#1)
theme of the meeting was the##2##6##(2005-8#1)(2008-5#1)
theme of the meeting##3##4##(2005-8#1)(2008-11#1)(2008-5#1)
theme of the##6##3##(1993-3#1)(2005-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-10#1)
theme of this##4##3##(2005-8#1)(2008-11#1)(2008-5#2)
theme of##21##2##(1993-3#1)(1995-3#1)(2004-10#1)(2005-8#2)(2005-9#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-11#3)(2008-12#2)(2008-5#3)(2009-10#1)(2009-4#1)(2011-2#1)(2012-3#1)
theme that is##2##3##(2008-6#1)(2009-10#1)
theme that##6##2##(2006-9#1)(2008-6#1)(2008-8#1)(2009-10#2)(2011-12#1)
theme to##2##2##(2008-12#1)(2009-11#1)
theme was##4##2##(2008-1#1)(2010-5#1)(2013-1#1)(2013-7#1)
theme##84##1##(1991-2#1)(1992-3#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-3#2)(1996-1#2)(1996-2#1)(1996-3#1)(2004-10#1)(2005-8#2)(2005-9#1)(2006-12#1)(2006-3#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#4)(2008-11#6)(2008-12#4)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#3)(2009-10#6)(2009-11#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#4)(2010-3#1)(2010-5#1)(2010-8#2)(2011-12#1)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)
themed##2##1##(2011-2#1)(2012-1#1)
themedium##2##1##(2008-11#2)
themes and##8##2##(2008-12#1)(2008-2#1)(2008-4#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-9#1)(2013-7#1)
themes are##10##2##(1994-8#1)(2007-12#1)(2008-11#2)(2008-7#1)(2009-10#3)(2010-10#1)(2010-2#1)
themes by##2##2##(2008-2#1)(2013-7#1)
themes emerged from the##9##4##(1994-12#1)(2007-10#1)(2008-11#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
themes emerged from##11##3##(1994-12#1)(2007-10#1)(2007-2#1)(2008-11#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
themes emerged that##2##3##(2009-9#1)(2012-12#1)
themes emerged##27##2##(1994-12#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-11#4)(2008-12#2)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#3)(2012-12#3)(2013-1#2)
themes for##3##2##(1995-3#1)(2007-9#1)(2008-1#1)
themes from the##2##3##(2008-11#1)(2013-1#1)
themes have been##2##3##(2007-8#1)(2008-1#1)
themes have##3##2##(2007-12#1)(2007-8#1)(2008-1#1)
themes identified in##2##3##(2007-2#1)(2008-11#1)
themes identified##5##2##(1993-3#1)(2007-2#1)(2008-11#3)
themes in the##4##3##(2010-7#1)(2011-2#2)(2012-2#1)
themes in##11##2##(2006-9#1)(2007-8#1)(2008-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)
themes include##2##2##(1996-2#1)(1997-1#1)
themes included##4##2##(2009-5#1)(2011-1#1)(2012-2#1)(2012-3#1)
themes of the##6##3##(1996-1#1)(2005-8#2)(2008-12#1)(2008-7#1)(2009-9#1)
themes of##14##2##(1990-12#1)(1996-1#1)(2005-8#3)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-9#1)(2010-8#1)(2010-9#1)(2013-1#1)
themes regarding##3##2##(2008-6#1)(2010-5#1)(2012-11#1)
themes related to the##2##4##(2007-2#1)(2011-2#1)
themes related to##5##3##(2007-2#1)(2007-8#1)(2010-11#1)(2011-2#1)(2013-7#1)
themes reported##2##2##(2004-12#1)(2011-1#1)
themes that are##2##3##(2008-12#1)(2008-2#1)
themes that emerge##2##3##(1996-2#1)(2007-11#1)
themes that##14##2##(1995-12#1)(1996-2#1)(2006-6#1)(2007-11#2)(2008-11#1)(2008-12#1)(2008-2#1)(2009-4#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
themes to emerge from##2##4##(2007-9#1)(2008-11#1)
themes to##8##2##(1996-1#1)(2007-9#1)(2008-11#1)(2008-12#2)(2010-11#1)(2012-12#1)(2013-7#1)
themes were identified from the##2##5##(2008-11#1)(2011-1#1)
themes were identified##11##3##(1992-2#1)(2006-10#1)(2007-2#1)(2008-11#2)(2009-6#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
themes were##20##2##(1992-2#1)(1995-3#1)(2006-10#1)(2006-9#2)(2007-10#1)(2007-11#1)(2007-2#1)(2008-11#2)(2008-5#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-8#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
themes##213##1##(1990-12#1)(1991-2#1)(1991-6#1)(1992-11#2)(1992-2#1)(1993-12#1)(1993-3#2)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-3#2)(1996-1#2)(1996-2#2)(1997-1#1)(1997-2#1)(2004-12#1)(2005-12#1)(2005-7#2)(2005-8#5)(2006-10#4)(2006-6#1)(2006-9#3)(2007-10#2)(2007-11#5)(2007-12#5)(2007-2#5)(2007-3#2)(2007-8#6)(2007-9#2)(2008-1#2)(2008-11#18)(2008-12#11)(2008-2#4)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#2)(2009-10#5)(2009-4#2)(2009-5#7)(2009-6#1)(2009-7#2)(2009-9#4)(2010-10#4)(2010-11#3)(2010-2#3)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#3)(2011-1#12)(2011-2#6)(2012-1#1)(2012-11#3)(2012-12#6)(2012-2#4)(2012-3#7)(2013-1#13)(2013-7#5)(2013-8#1)
themselves a##2##2##(1990-12#1)(2008-9#1)
themselves against##7##2##(1993-3#1)(1997-5#1)(1997-7#1)(2005-12#1)(2006-10#1)(2009-8#1)(2011-10#1)
themselves and others##3##3##(1990-12#1)(2006-9#1)(2007-7#1)
themselves and the##2##3##(1993-12#1)(2006-12#1)
themselves and their children##2##4##(2007-12#1)(2010-2#1)
themselves and their##15##3##(1991-6#1)(1992-1#1)(1992-3#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-12#2)(2009-11#1)(2009-12#1)(2010-11#1)(2010-2#1)(2012-2#1)(2012-3#1)
themselves and##38##2##(1990-12#1)(1990-8#1)(1991-6#1)(1992-1#2)(1992-3#1)(1993-12#1)(2006-12#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-6#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
themselves are not##2##3##(2006-10#1)(2008-11#1)
themselves are##14##2##(1994-3#1)(1996-9#1)(1997-9#1)(2006-10#2)(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#2)
themselves as being##2##3##(2009-12#1)(2010-2#1)
themselves as significantly more##2##4##(1992-2#1)(2007-9#1)
themselves as well as##2##4##(1994-3#1)(2008-2#1)
themselves as well##3##3##(1994-3#1)(2008-2#1)(2008-7#1)
themselves as##24##2##(1991-2#1)(1992-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-6#1)(1996-1#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
themselves at risk##2##3##(1990-3#1)(2009-12#1)
themselves at##4##2##(1990-3#1)(2007-7#1)(2008-9#1)(2009-12#1)
themselves but also##2##3##(1990-3#1)(2008-2#1)
themselves by##3##2##(2007-6#1)(2008-1#1)(2012-1#1)
themselves can##2##2##(2008-10#1)(2008-11#1)
themselves did not##2##3##(1995-10#1)(1995-6#1)
themselves during##2##2##(2008-1#1)(2012-3#1)
themselves for the##2##3##(1997-1#1)(2005-11#1)
themselves for##4##2##(1992-6#1)(1997-1#1)(2005-11#1)(2006-6#1)
themselves from the##2##3##(2007-2#1)(2009-12#1)
themselves from##8##2##(1991-3#1)(2006-7#1)(2007-2#1)(2007-7#1)(2009-12#1)(2009-5#1)(2011-2#1)(2012-2#1)
themselves had##2##2##(1996-11#1)(2006-3#1)
themselves have##3##2##(1990-12#1)(1997-7#1)(2009-8#1)
themselves in a##8##3##(1993-12#2)(1997-5#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-6#1)
themselves in order to##2##4##(2007-2#1)(2010-9#1)
themselves in the##5##3##(1992-2#1)(2008-10#1)(2008-3#1)(2013-1#1)(2013-8#1)
themselves in##28##2##(1991-11#1)(1992-2#1)(1993-12#2)(1994-12#1)(1995-5#1)(1996-4#1)(1997-5#1)(2004-12#1)(2005-4#1)(2006-3#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
themselves may be##3##3##(2008-1#1)(2010-1#1)(2012-2#1)
themselves may##7##2##(2006-10#1)(2008-1#1)(2008-4#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
themselves more##3##2##(2006-8#1)(2007-12#1)(2008-3#1)
themselves on the##2##3##(1997-1#1)(2007-4#1)
themselves on##7##2##(1992-2#1)(1994-8#2)(1997-1#1)(2007-4#1)(2008-12#2)
themselves or the##3##3##(2010-3#1)(2013-1#2)
themselves or##10##2##(1990-1#1)(1990-6#1)(1991-12#1)(2006-3#1)(2006-4#1)(2008-10#1)(2010-2#1)(2010-3#1)(2013-1#2)
themselves rather than##2##3##(2004-10#1)(2010-2#1)
themselves should be##2##3##(2005-7#1)(2007-8#1)
themselves should##4##2##(1993-1#1)(1993-5#1)(2005-7#1)(2007-8#1)
themselves the##4##2##(1992-12#1)(2006-10#1)(2006-3#1)(2008-4#1)
themselves through the##2##3##(2008-10#1)(2009-9#1)
themselves through##3##2##(2007-12#1)(2008-10#1)(2009-9#1)
themselves to a##2##3##(1991-3#1)(2008-3#1)
themselves to be overweight##2##4##(1997-7#1)(2007-7#1)
themselves to be##10##3##(1997-7#1)(2004-2#1)(2006-10#1)(2007-11#1)(2007-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)
themselves to the##3##3##(1995-9#1)(2008-1#1)(2008-11#1)
themselves to##40##2##(1991-2#1)(1991-3#1)(1992-3#1)(1992-9#1)(1994-8#1)(1995-1#1)(1995-4#1)(1995-9#1)(1996-1#1)(1997-1#1)(1997-7#1)(2004-2#1)(2006-10#2)(2006-8#2)(2007-11#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#2)(2009-7#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
themselves under##2##2##(1996-4#1)(2010-5#1)
themselves undergo##2##2##(2007-10#1)(2008-4#1)
themselves were##2##2##(2010-6#1)(2010-8#1)
themselves will##3##2##(1993-2#1)(2008-1#1)(2008-8#1)
themselves with the##3##3##(1995-2#1)(2007-8#1)(2008-10#1)
themselves with##8##2##(1995-2#1)(1996-3#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-6#1)(2010-1#1)
themselves##503##1##(1990-1#1)(1990-12#6)(1990-3#3)(1990-5#1)(1990-6#2)(1990-8#2)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#5)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#5)(1992-3#4)(1992-5#2)(1992-6#2)(1992-9#1)(1993-1#2)(1993-10#1)(1993-12#3)(1993-2#2)(1993-3#3)(1993-5#1)(1993-8#1)(1993-9#1)(1994-1#3)(1994-12#6)(1994-2#1)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#5)(1995-1#3)(1995-10#1)(1995-2#2)(1995-3#6)(1995-4#2)(1995-5#3)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#1)(1997-3#1)(1997-5#3)(1997-7#4)(1997-8#1)(1997-9#1)(2004-10#1)(2004-12#1)(2004-2#1)(2005-11#4)(2005-12#1)(2005-4#2)(2005-7#3)(2005-8#1)(2006-10#15)(2006-11#1)(2006-12#3)(2006-2#2)(2006-3#4)(2006-4#3)(2006-6#3)(2006-7#6)(2006-8#4)(2006-9#1)(2007-10#5)(2007-11#6)(2007-12#12)(2007-2#8)(2007-3#1)(2007-4#6)(2007-6#1)(2007-7#7)(2007-8#7)(2007-9#5)(2008-1#9)(2008-10#17)(2008-11#28)(2008-12#9)(2008-2#6)(2008-3#6)(2008-4#6)(2008-5#4)(2008-6#4)(2008-7#12)(2008-8#4)(2008-9#10)(2009-10#1)(2009-11#2)(2009-12#5)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#5)(2009-6#4)(2009-7#5)(2009-8#3)(2009-9#2)(2010-1#3)(2010-10#4)(2010-11#1)(2010-12#3)(2010-2#4)(2010-3#5)(2010-4#4)(2010-5#2)(2010-6#2)(2010-8#4)(2010-9#2)(2011-1#6)(2011-10#1)(2011-12#1)(2011-2#9)(2012-1#5)(2012-11#1)(2012-12#9)(2012-2#7)(2012-3#5)(2013-1#14)(2013-7#1)(2013-8#3)
then 0##2##2##(2008-3#1)(2008-7#1)
then 10##3##2##(2007-10#2)(2012-2#1)
then 100 mg##2##3##(2006-4#1)(2011-2#1)
then 100##3##2##(2006-4#1)(2008-3#1)(2011-2#1)
then 2##3##2##(1991-4#1)(2007-11#1)(2007-8#1)
then 20##2##2##(2007-7#1)(2007-9#1)
then 30##2##2##(2007-8#1)(2008-7#1)
then 40##2##2##(2007-7#1)(2007-8#1)
then South##2##2##(1992-2#1)(2007-7#1)
then a##34##2##(1990-12#1)(1990-8#1)(1992-1#1)(1992-8#1)(1995-8#1)(1996-1#1)(1997-2#1)(1997-8#1)(2004-9#1)(2005-1#1)(2005-11#1)(2005-8#1)(2006-3#2)(2007-11#1)(2007-12#1)(2007-8#3)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
then able to##5##3##(1996-4#1)(2004-12#1)(2006-5#1)(2008-10#1)(2011-2#1)
then accomplished by##2##3##(1996-5#1)(2008-10#1)
then act as a##2##4##(2008-10#1)(2008-7#1)
then activated by##2##3##(1994-9#1)(1996-12#1)
then activated##5##2##(1992-6#2)(1994-9#1)(1995-8#1)(1996-12#1)
then activation##2##2##(2008-4#1)(2008-5#1)
then added to the##3##4##(2008-11#2)(2012-12#1)
then added to##6##3##(1994-2#1)(2008-11#2)(2008-8#2)(2012-12#1)
then added##8##2##(1990-12#1)(1994-2#1)(2008-11#2)(2008-6#1)(2008-8#2)(2012-12#1)
then adjusted##2##2##(2008-10#1)(2008-2#1)
then administered to##2##3##(2010-2#1)(2013-1#1)
then administered##4##2##(1991-3#1)(1994-5#1)(2010-2#1)(2013-1#1)
then after##8##2##(1996-2#1)(2006-10#1)(2006-9#1)(2008-10#2)(2008-5#1)(2008-8#1)(2013-1#1)
then again##3##2##(2008-12#1)(2008-2#2)
then aggregate##2##2##(2008-7#1)(2008-8#1)
then allowed to##3##3##(1990-10#1)(2008-10#1)(2008-9#1)
then allowing##2##2##(2008-10#2)
then allows the##3##3##(2007-5#1)(2007-9#1)(2008-10#1)
then allows##6##2##(2006-12#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-3#1)
then also##2##2##(1994-5#1)(2008-10#1)
then an##11##2##(1991-5#1)(2007-1#1)(2007-4#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#1)
then analysed by##2##3##(2005-12#1)(2008-10#1)
then analysed##6##2##(2005-12#1)(2006-12#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#1)
then analyze the##2##3##(2008-3#1)(2013-8#1)
then analyzed by##6##3##(1994-3#1)(2008-10#2)(2008-2#1)(2008-4#1)(2012-3#1)
then analyzed in##2##3##(1991-2#1)(2007-12#1)
then analyzed to determine##2##4##(2007-11#1)(2008-6#1)
then analyzed##18##2##(1991-2#1)(1994-3#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2010-12#1)(2012-3#2)
then analyzes##2##2##(1996-12#1)(2012-3#1)
then and now##2##3##(1996-12#1)(2005-10#1)
then and##3##2##(1996-12#1)(2005-10#1)(2006-6#1)
then another##2##2##(1995-9#1)(2007-8#1)
then answered##2##2##(1993-2#2)
then appear##3##2##(1993-2#1)(2008-4#1)(2008-7#1)
then appeared##2##2##(2007-4#1)(2008-10#1)
then applied and##2##3##(2008-5#2)
then applied for##3##3##(2008-10#2)(2012-2#1)
then applied the##2##3##(2006-10#1)(2009-4#1)
then applied to a##3##4##(1992-12#1)(2008-3#1)(2008-6#1)
then applied to the##16##4##(1990-10#1)(1996-3#1)(2006-11#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#2)(2009-11#1)(2010-3#1)(2011-1#1)
then applied to##39##3##(1990-10#1)(1991-9#1)(1992-12#1)(1996-3#1)(2005-11#1)(2006-11#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-2#3)(2008-3#6)(2008-4#2)(2008-6#1)(2009-11#1)(2009-2#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-2#2)(2012-3#1)
then applied##51##2##(1990-10#1)(1991-9#1)(1992-12#1)(1996-3#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#1)(2009-11#1)(2009-2#1)(2009-4#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-7#1)
then apply##2##2##(2007-11#1)(2008-2#1)
then are##5##2##(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2012-2#1)
then asked##5##2##(1995-12#1)(1996-5#1)(1997-8#1)(2008-10#1)(2008-9#1)
then assembled with##2##3##(2008-11#1)(2008-4#1)
then assembled##3##2##(1995-6#1)(2008-11#1)(2008-4#1)
then assessed##9##2##(1997-5#1)(2006-7#1)(2008-10#3)(2008-2#1)(2008-5#1)(2013-1#2)
then associated##2##2##(2008-12#1)(2008-9#1)
then at the##2##3##(1997-6#1)(2008-8#1)
then at##9##2##(1992-8#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-2#1)(2012-12#1)(2013-1#1)
then attached to the##3##4##(2008-10#1)(2008-11#1)(2008-4#1)
then attempted to identify##2##4##(1996-3#1)(2010-8#1)
then be a##2##3##(1994-5#1)(2008-10#1)
then be applied##2##3##(2006-4#1)(2009-8#1)
then be considered##2##3##(2007-2#1)(2008-4#1)
then be extended to##2##4##(2010-10#1)(2012-3#1)
then be integrated##2##3##(2008-2#1)(2008-3#1)
then be measured##2##3##(2005-12#1)(2008-4#1)
then be obtained##2##3##(2008-10#1)(2008-2#1)
then be the##2##3##(1992-6#1)(2008-2#1)
then be used for##6##4##(1997-4#1)(2006-11#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-3#1)
then be used to##13##4##(2005-5#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-4#1)(2012-3#1)
then be used##23##3##(1996-5#1)(1997-4#1)(2005-5#1)(2006-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-8#1)(2008-9#2)(2009-3#1)(2010-11#1)(2010-4#1)(2012-1#1)(2012-3#1)
then be viewed##4##3##(1991-8#1)(1996-12#1)(2006-5#1)(2007-12#1)
then be##112##2##(1990-11#1)(1990-3#1)(1991-10#1)(1991-12#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-3#1)(1996-1#1)(1996-12#2)(1996-5#1)(1997-3#1)(1997-4#2)(2005-12#1)(2005-5#1)(2006-10#3)(2006-11#1)(2006-4#1)(2006-5#2)(2007-12#4)(2007-2#1)(2007-3#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-2#13)(2008-3#4)(2008-4#15)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#4)(2009-10#1)(2009-12#2)(2009-3#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#2)
then become##4##2##(1993-2#1)(1996-2#1)(2007-12#2)
then becomes##4##2##(1994-2#1)(2007-1#1)(2007-12#1)(2012-3#1)
then been##2##2##(1997-2#1)(2008-11#1)
then being##2##2##(1991-2#1)(2008-11#1)
then bound##2##2##(2008-4#1)(2008-5#1)
then briefly##4##2##(2007-12#1)(2008-10#1)(2008-4#1)(2010-12#1)
then by##12##2##(1992-10#1)(1992-3#1)(1995-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-6#1)(2013-1#1)
then calculated for##3##3##(2008-10#1)(2008-9#1)(2010-2#1)
then calculated##6##2##(1992-9#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-9#1)(2010-2#1)
then can be##4##3##(1990-12#1)(2007-8#2)(2008-8#1)
then can##5##2##(1990-12#1)(2007-8#2)(2008-8#1)(2010-11#1)
then carefully##2##2##(2008-11#1)(2011-2#1)
then carried out to##3##4##(1994-3#1)(2008-10#1)(2008-2#1)
then carried out##7##3##(1994-3#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-6#1)(2010-4#1)
then carried##8##2##(1994-3#1)(2005-11#1)(2008-10#2)(2008-2#1)(2008-8#1)(2009-6#1)(2010-4#1)
then cells are##3##3##(2008-8#3)
then centrifuged##3##2##(2008-11#2)(2010-7#1)
then challenged with##4##3##(2007-11#1)(2008-10#1)(2008-5#1)(2013-8#1)
then challenged##5##2##(1997-3#1)(2007-11#1)(2008-10#1)(2008-5#1)(2013-8#1)
then characterized by##5##3##(1992-6#1)(1994-9#1)(2008-10#2)(2010-12#1)
then characterized##7##2##(1992-11#1)(1992-6#1)(1994-9#1)(2008-10#2)(2009-7#1)(2010-12#1)
then check your answers at http##2##6##(2004-4#1)(2004-5#1)
then chose##2##2##(2011-2#1)(2013-1#1)
then classified by##2##3##(2008-10#1)(2008-5#1)
then classified##5##2##(2006-12#1)(2006-8#1)(2008-10#1)(2008-5#1)(2010-2#1)
then cleaved##2##2##(1994-12#1)(2008-4#1)
then cloned##3##2##(1991-6#1)(2005-11#1)(2008-8#1)
then collected##2##2##(2008-10#2)
then combined with##3##3##(1996-5#1)(2007-8#1)(2008-3#1)
then combined##10##2##(1995-8#1)(1996-5#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-9#1)(2012-1#2)
then compared our##2##3##(2006-7#1)(2009-4#1)
then compared to the##3##4##(2008-10#2)(2008-2#1)
then compared to##8##3##(1992-10#1)(1993-11#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#1)
then compared with the##10##4##(1990-10#1)(1995-6#1)(1996-11#1)(2004-10#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-2#1)
then compared with##16##3##(1990-10#1)(1995-6#1)(1996-11#1)(1997-4#1)(2004-10#1)(2006-6#1)(2007-8#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-8#1)(2012-2#2)
then compared##40##2##(1990-10#1)(1992-10#1)(1993-11#1)(1993-9#1)(1994-8#1)(1995-6#1)(1996-11#1)(1997-4#1)(2004-10#1)(2004-4#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-8#3)(2007-9#1)(2008-10#4)(2008-2#2)(2008-3#3)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-2#1)(2010-3#1)(2010-7#1)(2012-2#2)(2012-3#1)
then compensated for##2##3##(2007-12#2)
then completed a##3##3##(2009-4#1)(2010-8#2)
then completed##6##2##(1994-3#1)(2009-4#1)(2010-4#1)(2010-8#2)(2012-12#1)
then concentrated##2##2##(2004-9#1)(2008-4#1)
then conducted##5##2##(1996-4#1)(2007-12#1)(2008-5#1)(2009-4#1)(2012-1#1)
then confirmed by##3##3##(2008-8#1)(2010-12#1)(2012-12#1)
then confirmed##6##2##(2008-12#1)(2008-3#1)(2008-8#1)(2009-8#1)(2010-12#1)(2012-12#1)
then consider the##3##3##(2005-6#1)(2006-3#1)(2008-8#1)
then consider##6##2##(1992-1#1)(2005-6#1)(2006-3#1)(2006-5#1)(2008-8#1)(2011-1#1)
then considered##4##2##(1991-1#1)(2008-11#1)(2008-3#1)(2010-11#1)
then construct a##3##3##(2005-11#1)(2008-11#1)(2009-12#1)
then contribute to the##2##4##(2008-12#1)(2009-8#1)
then converted into##3##3##(2007-11#3)
then converted to a##3##4##(1990-3#1)(1992-12#1)(2008-10#1)
then converted to the corresponding##2##5##(1996-10#1)(2008-4#1)
then converted to##8##3##(1990-3#1)(1992-12#1)(1994-12#2)(1994-3#1)(1996-10#1)(2008-10#1)(2008-4#1)
then converted##11##2##(1990-3#1)(1992-12#1)(1994-12#2)(1994-3#1)(1996-10#1)(2007-11#3)(2008-10#1)(2008-4#1)
then correlate##3##2##(2006-12#1)(2013-1#2)
then correlated with##4##3##(1996-3#1)(2007-12#1)(2008-12#1)(2008-8#1)
then correlated##5##2##(1996-3#1)(2007-12#1)(2008-12#1)(2008-8#1)(2009-3#1)
then could be##2##3##(2008-10#1)(2008-3#1)
then covered##2##2##(2008-10#1)(2008-9#1)
then cultured in##2##3##(1997-5#1)(2008-10#1)
then cultured##3##2##(1996-10#1)(1997-5#1)(2008-10#1)
then decayed##2##2##(1997-2#1)(2007-1#1)
then decline##2##2##(1991-9#1)(2008-8#1)
then declined below##2##3##(1995-3#1)(2006-7#1)
then declined progressively##2##3##(2007-12#1)(2008-10#1)
then declined to##4##3##(1990-2#1)(1990-7#1)(2008-10#2)
then declined##21##2##(1990-2#2)(1990-7#1)(1991-5#1)(1991-8#1)(1994-2#1)(1995-3#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-10#10)(2009-2#1)
then declining##2##2##(1990-7#1)(1992-9#1)
then decreased in##3##3##(1991-10#1)(2008-7#2)
then decreased significantly##3##3##(2008-10#1)(2008-12#1)(2010-5#1)
then decreased to##4##3##(1994-12#1)(1995-8#1)(2006-7#1)(2011-1#1)
then decreased##25##2##(1990-3#1)(1991-10#1)(1992-5#1)(1993-11#1)(1994-12#1)(1994-5#1)(1995-3#1)(1995-8#1)(1996-4#1)(1997-3#1)(2005-11#1)(2006-7#1)(2008-10#3)(2008-12#1)(2008-7#3)(2008-8#2)(2010-5#2)(2011-1#1)(2012-1#1)
then decreasing##2##2##(1992-3#1)(1997-7#1)
then demonstrate how##2##3##(2008-10#1)(2008-11#1)
then demonstrate that##2##3##(1996-10#1)(2011-12#1)
then demonstrate##8##2##(1996-10#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-7#1)(2009-2#1)(2011-12#1)
then depends on the##2##4##(2008-3#1)(2008-8#1)
then describe a##2##3##(1997-2#1)(2008-2#1)
then describe the##4##3##(2005-5#1)(2006-10#1)(2008-3#1)(2010-12#1)
then describe##11##2##(1992-6#1)(1997-2#1)(2005-5#1)(2005-8#1)(2006-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2010-12#1)(2012-2#1)
then described##7##2##(1994-2#1)(2008-3#1)(2008-4#4)(2009-10#1)
then describes the##4##3##(1991-10#1)(1995-3#1)(2007-4#1)(2008-4#1)
then describes##8##2##(1991-10#1)(1994-1#1)(1995-3#1)(2007-4#1)(2008-2#1)(2008-4#2)(2013-1#1)
then designed##3##2##(2008-2#1)(2013-1#2)
then detected##4##2##(1993-2#1)(2008-2#1)(2008-4#1)(2010-1#1)
then determine##2##2##(2008-9#1)(2009-4#1)
then determined by##14##3##(1993-1#1)(1993-12#1)(1997-3#1)(2008-10#8)(2008-4#1)(2008-5#1)(2013-8#1)
then determined in##2##3##(2006-8#1)(2008-4#1)
then determined##26##2##(1990-6#1)(1993-1#1)(1993-12#1)(1997-3#1)(2006-8#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2012-11#1)(2013-8#1)
then develop##6##2##(1993-3#1)(1995-6#1)(1995-8#1)(2005-11#1)(2008-4#1)(2008-8#1)
then developed##11##2##(1991-10#1)(1992-3#1)(1993-9#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2010-1#1)(2010-8#1)
then died of##2##3##(1993-6#1)(2010-9#1)
then digested##3##2##(1990-7#1)(2008-10#1)(2008-8#1)
then diluted##3##2##(1990-12#1)(2008-10#1)(2008-11#1)
then direct##2##2##(2007-12#1)(2008-6#1)
then directly##7##2##(1996-8#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-3#1)
then discuss the##7##3##(2008-11#1)(2008-2#1)(2008-9#1)(2010-10#1)(2011-1#1)(2012-12#1)(2012-3#1)
then discuss##20##2##(2004-10#1)(2006-7#1)(2007-12#2)(2008-11#2)(2008-2#2)(2008-8#1)(2008-9#1)(2010-10#1)(2010-9#1)(2011-1#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-8#1)
then discussed##8##2##(1990-7#1)(1991-12#1)(2007-7#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-9#1)
then discusses the##3##3##(2007-11#1)(2008-5#1)(2008-9#1)
then discusses##6##2##(1991-11#1)(2007-11#1)(2008-1#2)(2008-5#1)(2008-9#1)
then displayed##3##2##(2008-2#1)(2008-9#1)(2010-4#1)
then divided into##3##3##(2007-8#1)(2012-12#1)(2013-1#1)
then divided##4##2##(2007-8#1)(2008-10#1)(2012-12#1)(2013-1#1)
then does##2##2##(1996-8#1)(1996-9#1)
then dried##2##2##(2008-10#1)(2008-4#1)
then each##5##2##(1991-3#1)(2006-4#1)(2007-5#1)(2008-10#1)(2008-3#1)
then eluted by##2##3##(1992-7#1)(2008-10#1)
then eluted from the##2##4##(2008-10#2)
then eluted from##3##3##(2008-10#3)
then eluted with 1 M##2##5##(2008-10#2)
then eluted with methanol##3##4##(1997-8#1)(2007-8#1)(2008-10#1)
then eluted with##7##3##(1997-8#1)(2007-8#1)(2008-10#5)
then eluted##14##2##(1990-12#1)(1992-7#1)(1997-8#1)(2007-8#1)(2008-10#10)
then employed to##3##3##(1990-12#1)(2008-8#1)(2011-2#1)
then employed##4##2##(1990-12#1)(2007-8#1)(2008-8#1)(2011-2#1)
then energetically##2##2##(1990-10#1)(1992-12#1)
then estimated##3##2##(1995-3#1)(2008-2#1)(2008-3#1)
then evaluate the##3##3##(2008-2#2)(2008-5#1)
then evaluated and##2##3##(2005-5#1)(2008-10#1)
then evaluated in##6##3##(2007-8#1)(2008-11#2)(2008-3#1)(2008-5#1)(2012-3#1)
then evaluated the##2##3##(1994-9#1)(2008-11#1)
then evaluated##19##2##(1992-1#1)(1994-9#1)(2005-5#1)(2007-8#2)(2008-10#2)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-12#1)(2012-3#2)
then examine the##2##3##(2005-10#1)(2006-3#1)
then examine##3##2##(2005-10#1)(2006-3#1)(2008-11#1)
then examined in##2##3##(1997-4#1)(1997-5#1)
then examined##19##2##(1992-2#1)(1993-3#1)(1995-3#1)(1996-8#1)(1997-4#1)(1997-5#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2012-11#1)(2012-3#1)(2013-1#1)
then examines##5##2##(2008-1#1)(2008-5#1)(2008-7#1)(2010-11#1)(2012-12#1)
then exhibited##2##2##(1996-12#1)(2008-4#1)
then exit##4##2##(2008-3#1)(2012-12#2)(2012-3#1)
then expanded to##3##3##(2008-10#1)(2008-12#1)(2008-2#1)
then explore##3##2##(2007-4#2)(2008-3#1)
then exposed to##5##3##(1991-5#1)(2005-10#1)(2008-10#1)(2009-9#1)(2012-2#1)
then expressed##2##2##(1994-2#1)(2008-4#1)
then extended to##3##3##(1991-9#1)(1997-4#1)(2008-2#1)
then extended##5##2##(1991-9#1)(1994-12#1)(1997-4#1)(2008-2#2)
then extracted and##2##3##(2007-2#1)(2008-10#1)
then extracted by##4##3##(2008-10#3)(2013-1#1)
then extracted in##2##3##(2008-10#1)(2008-5#1)
then extracted with##5##3##(1992-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2012-3#1)
then extracted##18##2##(1990-9#1)(1992-2#1)(2007-2#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-5#1)(2012-3#1)(2013-1#1)
then extrapolating##2##2##(2008-1#1)(2008-10#1)
then fell##2##2##(1991-10#1)(1993-7#1)
then find##2##2##(2007-12#1)(2010-5#1)
then fitted with a##2##4##(2008-3#1)(2009-12#1)
then fitted##3##2##(2008-3#2)(2009-12#1)
then focused##2##2##(2007-9#1)(2008-3#1)
then focuses on##4##3##(1990-12#1)(2005-8#1)(2008-6#1)(2010-12#1)
then follow##3##2##(1995-11#1)(2009-3#1)(2010-8#1)
then followed by a##2##4##(1992-12#1)(2008-11#1)
then followed by##4##3##(1992-12#1)(1994-11#1)(2008-10#1)(2008-11#1)
then followed the##2##3##(1995-11#1)(2010-1#1)
then followed##10##2##(1992-12#1)(1992-6#1)(1994-11#1)(1995-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-1#1)(2012-2#1)
then for##4##2##(2007-9#1)(2008-3#2)(2009-9#1)
then formed##3##2##(2007-12#1)(2008-10#2)
then fractionated##4##2##(1991-11#1)(1992-4#1)(1993-2#1)(1994-3#1)
then function##2##2##(1996-5#1)(2009-8#1)
then further##7##2##(1992-8#1)(2007-12#2)(2008-4#1)(2011-1#1)(2012-1#1)(2013-8#1)
then fused##2##2##(2008-11#1)(2010-5#1)
then generated##4##2##(2007-11#1)(2008-2#2)(2011-2#1)
then given##2##2##(1993-12#1)(1997-7#1)
then go##4##2##(1992-1#1)(2005-6#1)(2006-3#1)(2008-8#1)
then gradually decreased from##2##4##(1996-7#1)(2006-9#1)
then gradually decreased##6##3##(1990-7#1)(1996-7#1)(2006-9#1)(2007-3#1)(2008-11#1)(2008-7#1)
then gradually##11##2##(1990-2#1)(1990-7#1)(1992-2#1)(1992-7#1)(1994-3#1)(1996-7#1)(2006-9#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
then grouped##2##2##(1995-2#1)(2008-10#1)
then had##7##2##(1992-9#1)(2007-8#1)(2008-11#1)(2009-2#2)(2009-9#1)(2011-12#1)
then he##3##2##(1991-2#1)(2010-12#1)(2013-1#1)
then highlight##3##2##(1994-2#1)(2009-9#1)(2010-2#1)
then hydrolyzed##2##2##(2008-10#1)(2009-10#1)
then identified at##2##3##(2008-4#1)(2011-2#1)
then identified by##2##3##(2008-4#1)(2010-11#1)
then identified##9##2##(1995-6#1)(1997-7#1)(2005-11#1)(2006-9#1)(2008-4#2)(2009-6#1)(2010-11#1)(2011-2#1)
then identify##2##2##(2008-6#1)(2009-8#1)
then illustrate##3##2##(2008-11#1)(2010-4#1)(2013-1#1)
then illustrated with##2##3##(2007-12#1)(2008-1#1)
then imaged##4##2##(2006-5#1)(2007-11#1)(2008-7#1)(2012-1#1)
then immediately##2##2##(2007-7#1)(2008-10#1)
then immobilized on##2##3##(2008-10#1)(2010-4#1)
then immobilized##3##2##(2008-10#1)(2010-4#1)(2012-11#1)
then implemented##3##2##(2006-10#2)(2008-11#1)
then in a##2##3##(1997-4#1)(2008-10#1)
then in the presence of##4##5##(1990-5#1)(2005-11#1)(2008-10#2)
then in the##5##3##(1990-5#1)(2005-11#1)(2008-10#3)
then in vivo##2##3##(2007-11#1)(2008-10#1)
then in##27##2##(1990-10#1)(1990-5#1)(1993-7#1)(1994-10#1)(1994-2#1)(1995-1#1)(1997-4#1)(2005-11#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-4#1)(2008-9#1)(2011-2#3)(2012-2#3)(2013-7#1)
then incorporated in##2##3##(2008-10#1)(2013-7#1)
then incorporated into Monte Carlo##2##5##(2010-2#2)
then incorporated into a##2##4##(2007-11#1)(2007-2#1)
then incorporated into the##2##4##(1995-8#1)(2008-3#1)
then incorporated into##6##3##(1995-8#1)(2007-11#1)(2007-2#1)(2008-3#1)(2010-2#2)
then incorporated##8##2##(1995-8#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-3#1)(2010-2#2)(2013-7#1)
then increase##2##2##(2008-8#1)(2010-5#1)
then increased to##3##3##(1992-5#1)(1995-12#1)(2011-2#1)
then increased##21##2##(1991-4#1)(1992-5#1)(1992-6#1)(1995-12#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(2004-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#2)
then increases##4##2##(2007-12#1)(2008-12#1)(2008-2#1)(2011-1#1)
then incubated at 37 degrees C for##2##7##(1994-8#1)(2008-11#1)
then incubated at##3##3##(1994-8#1)(1997-7#1)(2008-11#1)
then incubated in##4##3##(1993-8#1)(1994-8#1)(1995-3#1)(2012-2#1)
then incubated with##2##3##(1992-12#1)(2008-4#1)
then incubated##12##2##(1992-12#1)(1993-8#1)(1994-8#2)(1995-3#1)(1996-4#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-3#1)(2012-2#1)
then induced##4##2##(1993-6#1)(2007-8#1)(2007-9#1)(2010-6#1)
then infected##2##2##(2006-8#1)(2008-5#1)
then inhibited##2##2##(1993-11#1)(1994-5#1)
then injected##4##2##(1995-12#1)(1996-12#1)(2008-10#1)(2010-12#1)
then inoculated with##2##3##(2008-10#1)(2011-12#1)
then inserted##3##2##(1991-12#1)(1991-5#1)(2008-8#1)
then integrated into a##2##4##(2007-10#1)(2007-4#1)
then integrated into##4##3##(2007-10#1)(2007-4#1)(2008-8#1)(2011-2#1)
then into##5##2##(2006-5#1)(2007-9#1)(2008-2#1)(2008-5#1)(2009-2#1)
then introduce##5##2##(1994-2#1)(2007-12#1)(2007-4#1)(2008-7#1)(2012-3#1)
then introduced into the##2##4##(1990-9#1)(2008-4#1)
then introduced into##3##3##(1990-9#1)(2008-4#1)(2008-8#1)
then introduced##7##2##(1990-9#1)(1995-9#1)(1996-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)
then investigate the##2##3##(2008-3#1)(2012-1#1)
then investigated##6##2##(1993-8#1)(2006-3#1)(2008-10#1)(2008-2#1)(2009-11#1)(2012-12#1)
then irradiated with##2##3##(2007-1#1)(2013-1#1)
then irradiated##5##2##(2007-1#1)(2008-3#1)(2008-4#1)(2010-7#1)(2013-1#1)
then is##10##2##(1992-7#1)(1996-11#1)(2008-10#5)(2008-2#1)(2008-8#1)(2012-2#1)
then isolated##4##2##(1992-7#1)(1994-3#1)(2007-2#1)(2008-4#1)
then it is##6##3##(1992-9#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-6#1)(2013-1#1)
then it##20##2##(1991-5#1)(1992-9#1)(2006-12#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-6#1)(2011-2#1)(2013-1#3)
then its##7##2##(1994-12#1)(1994-6#1)(1997-5#1)(2005-11#1)(2008-10#3)
then joined##2##2##(2008-8#1)(2012-3#1)
then kept on##2##3##(1992-9#1)(2011-2#1)
then kept##3##2##(1992-9#1)(1993-5#1)(2011-2#1)
then labeled with##2##3##(1997-2#1)(2008-8#1)
then lead to##2##3##(2008-3#1)(2010-2#1)
then ligated##2##2##(1993-12#1)(2008-8#1)
then little##2##2##(2008-12#1)(2012-2#1)
then loaded##4##2##(1992-1#1)(2008-10#1)(2008-4#1)(2013-1#1)
then made a##2##3##(1995-6#1)(2008-11#1)
then made##10##2##(1991-7#1)(1994-2#1)(1995-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-3#1)(2011-2#1)(2012-3#1)
then many##3##2##(2007-5#1)(2012-12#1)(2012-2#1)
then matched to##2##3##(2008-11#1)(2008-8#1)
then matched##3##2##(2008-11#1)(2008-7#1)(2008-8#1)
then measured at##2##3##(2008-10#1)(2010-5#1)
then measured the##4##3##(1992-12#1)(2008-3#1)(2008-5#2)
then measured##16##2##(1990-12#2)(1991-3#1)(1992-12#1)(1994-5#1)(1996-9#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#3)(2010-5#1)(2013-1#1)
then mediate##2##2##(1994-10#1)(1996-10#1)
then men##2##2##(1992-10#1)(2008-10#1)
then merged with##5##3##(2008-10#5)
then mixed with##5##3##(2008-10#3)(2008-4#1)(2011-3#1)
then modified##4##2##(1996-2#1)(2008-7#1)(2008-9#1)(2010-9#1)
then modulated##2##2##(1993-3#1)(2008-2#1)
then monitored spectrophotometrically##2##3##(2008-10#2)
then monitored##6##2##(1995-2#1)(2008-10#4)(2010-2#1)
then more##2##2##(1991-2#1)(2007-12#1)
then moved to the##2##4##(2008-5#1)(2008-8#1)
then moved##4##2##(1996-1#1)(2006-8#1)(2008-5#1)(2008-8#1)
then moves on to##2##4##(2008-11#1)(2008-6#1)
then new##2##2##(2008-10#1)(2012-2#1)
then obtained##4##2##(2007-8#1)(2008-11#1)(2008-5#1)(2009-4#1)
then occurs##2##2##(1992-6#1)(2008-7#1)
then on the##2##3##(1992-2#1)(2008-5#1)
then on##9##2##(1990-9#1)(1992-2#1)(1994-2#1)(2007-10#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-12#1)(2012-3#1)
then one has a##3##4##(2008-10#3)
then one##4##2##(2008-10#3)(2008-8#1)
then only##3##2##(1991-5#1)(2008-10#1)(2008-2#1)
then orchestrating a collection of analytics that identify at-risk patients##2##10##(2013-1#2)
then our##2##2##(1997-7#1)(2008-2#1)
then oxidized##3##2##(1996-5#1)(2008-10#1)(2008-11#1)
then packaged##2##2##(2008-7#1)(2010-1#1)
then participated in the##2##4##(1993-6#1)(1995-3#1)
then passed through a##3##4##(2008-10#2)(2008-11#1)
then passed through##4##3##(2008-10#3)(2008-11#1)
then passed##5##2##(2008-10#3)(2008-11#1)(2008-4#1)
then patients##2##2##(2010-4#1)(2012-2#1)
then performed by##6##3##(1993-3#1)(2007-1#1)(2007-11#1)(2008-10#2)(2013-7#1)
then performed to##6##3##(2006-11#1)(2006-7#1)(2008-11#1)(2008-4#1)(2013-1#2)
then performed with a##2##4##(1997-7#1)(2011-2#1)
then performed##22##2##(1993-3#1)(1997-7#1)(2005-11#1)(2005-12#1)(2006-11#1)(2006-7#1)(2007-1#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-4#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
then phosphorylates##2##2##(1996-5#1)(2011-2#1)
then placed in a##2##4##(1990-10#1)(2008-10#1)
then placed##6##2##(1990-10#1)(2008-10#2)(2008-11#2)(2012-2#1)
then precipitated##2##2##(1996-12#1)(2007-11#1)
then prepared##5##2##(1996-7#1)(2007-11#2)(2008-10#1)(2008-4#1)
then present a##2##3##(1993-4#1)(2008-10#1)
then present##7##2##(1993-4#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#1)(2010-2#1)
then presented with##2##3##(2007-5#1)(2009-4#1)
then presented##12##2##(2006-12#1)(2007-12#1)(2007-5#1)(2008-2#2)(2008-3#1)(2009-4#1)(2011-1#1)(2011-2#2)(2013-1#2)
then presents##3##2##(1990-5#1)(1993-12#1)(2010-8#1)
then probed with a non-antibody protein##2##6##(2008-2#1)(2008-4#1)
then probed##3##2##(2007-12#1)(2008-2#1)(2008-4#1)
then proceed to##4##3##(1992-12#1)(1995-4#1)(2007-9#1)(2008-11#1)
then produced by##2##3##(1994-2#1)(2010-5#1)
then produced##3##2##(1990-2#1)(1994-2#1)(2010-5#1)
then propose##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2010-8#1)
then proposed##5##2##(1990-7#1)(2007-8#1)(2008-2#2)(2008-3#1)
then propranolol##2##2##(1990-5#2)
then provide a##3##3##(2010-8#1)(2011-2#1)(2012-1#1)
then provide##5##2##(2007-8#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-1#1)
then provided##2##2##(2008-12#1)(2008-4#1)
then provides##4##2##(1995-8#1)(1996-5#1)(2007-4#1)(2008-11#1)
then purified by##5##3##(1994-12#1)(1994-2#1)(1994-8#1)(1996-11#1)(2006-12#1)
then purified##11##2##(1994-12#1)(1994-2#1)(1994-8#1)(1996-11#1)(2006-12#1)(2008-10#1)(2008-4#2)(2008-5#1)(2011-1#1)(2011-2#1)
then put##2##2##(1995-2#1)(1996-12#1)
then quantified##3##2##(1996-6#1)(2008-10#2)
then quantitated by##2##3##(2008-4#2)
then quantitatively##4##2##(2008-10#3)(2008-3#1)
then randomly assigned to##2##4##(2007-8#1)(2009-11#1)
then randomly##3##2##(2007-8#1)(2009-11#1)(2012-2#1)
then rapidly declined##3##3##(1994-8#1)(1996-1#1)(2008-10#1)
then rapidly##11##2##(1993-12#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-1#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)
then rated##2##2##(2008-5#1)(2009-4#1)
then re-suspended##2##2##(2008-11#1)(2008-8#1)
then reached##2##2##(2008-5#1)(2011-2#1)
then reaches a##2##3##(2008-10#1)(2008-2#1)
then reaches##4##2##(2008-10#2)(2008-2#1)(2010-10#1)
then react with##3##3##(2006-10#1)(2008-10#1)(2012-2#1)
then reacted##4##2##(2007-11#2)(2008-4#2)
then reacts with##3##3##(1996-2#1)(2007-12#1)(2008-10#1)
then reacts##4##2##(1996-2#1)(1997-7#1)(2007-12#1)(2008-10#1)
then received either##2##3##(1990-11#1)(2008-10#1)
then received##6##2##(1990-11#1)(2007-2#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)
then reconstructed by##2##3##(1992-3#1)(2008-3#1)
then reconstructed##5##2##(1992-3#1)(2008-2#1)(2008-3#3)
then recorded##2##2##(2008-10#2)
then recovered##4##2##(1991-12#1)(2007-8#1)(2008-10#1)(2008-5#1)
then reduced at##2##3##(2008-10#2)
then reduced to##4##3##(2007-7#1)(2008-10#2)(2011-1#1)
then reduced##11##2##(1995-3#1)(1995-8#1)(2007-7#1)(2008-10#4)(2008-4#1)(2008-7#1)(2011-1#2)
then removed and the##2##4##(2008-11#1)(2013-8#1)
then removed##9##2##(1990-2#1)(1990-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2013-1#2)(2013-8#1)
then repeated in##2##3##(1993-2#1)(2008-10#1)
then repeated##9##2##(1993-2#1)(1997-2#1)(2008-10#3)(2011-2#1)(2012-1#1)(2013-1#2)
then replaced##3##2##(2007-10#1)(2008-5#1)(2012-2#1)
then report##3##2##(2008-2#1)(2008-3#1)(2009-9#1)
then require##4##2##(1991-12#1)(2008-11#1)(2008-3#1)(2012-11#1)
then required to##2##3##(2008-4#1)(2008-9#1)
then required##3##2##(2008-4#1)(2008-9#1)(2011-2#1)
then resolved##3##2##(1991-4#1)(2008-4#1)(2012-2#1)
then retrieved##2##2##(2008-2#1)(2010-8#1)
then returned to normal##2##4##(1992-11#1)(1993-12#1)
then returned to the##4##4##(1992-8#1)(1994-5#1)(2008-10#1)(2008-9#1)
then returned to##9##3##(1990-10#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-5#1)(1996-4#1)(2008-10#1)(2008-9#1)
then returned##10##2##(1990-10#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-10#1)(1994-5#1)(1996-4#1)(2008-10#1)(2008-9#1)
then reversed##2##2##(2006-10#1)(2008-2#1)
then review##6##2##(2005-7#1)(2008-7#1)(2010-8#1)(2012-11#1)(2013-8#2)
then reviewed##2##2##(2008-5#1)(2013-1#1)
then reviews##3##2##(1993-12#1)(2006-10#1)(2012-12#1)
then sacrificed##6##2##(1997-4#3)(1997-7#1)(2006-8#1)(2008-10#1)
then scanned##3##2##(2007-12#1)(2008-2#1)(2010-5#1)
then scientific conferences##2##3##(2006-10#2)
then screened for##2##3##(1993-11#1)(1995-1#1)
then screened##3##2##(1993-11#1)(1995-1#1)(2008-10#1)
then segment##2##2##(2010-6#1)(2011-1#1)
then select##2##2##(1995-3#1)(2006-2#1)
then selected##4##2##(2005-10#1)(2008-2#1)(2008-8#1)(2012-2#1)
then selectively##3##2##(2008-10#1)(2010-12#1)(2011-1#1)
then sent##2##2##(2008-10#1)(2010-8#1)
then separated by##7##3##(1991-1#1)(1992-7#1)(1993-11#1)(1997-2#1)(2008-10#2)(2008-4#1)
then separated##12##2##(1990-8#1)(1991-1#1)(1992-7#1)(1993-11#1)(1995-2#1)(1997-2#1)(2007-4#1)(2008-10#3)(2008-4#1)(2008-5#1)
then sequenced##3##2##(1995-8#1)(1997-4#1)(2008-10#1)
then sequentially##4##2##(1997-2#1)(2008-10#2)(2008-7#1)
then serve as a##2##4##(1990-3#1)(2006-8#1)
then serve as##3##3##(1990-12#1)(1990-3#1)(2006-8#1)
then serve##4##2##(1990-12#1)(1990-3#1)(1997-7#1)(2006-8#1)
then served##3##2##(1995-1#1)(2007-4#1)(2008-10#1)
then shifted to##2##3##(1995-3#1)(2011-2#1)
then show how##5##3##(1993-12#1)(2005-11#1)(2008-10#1)(2008-2#1)(2011-1#1)
then show that##4##3##(2008-2#1)(2008-3#1)(2010-3#1)(2013-8#1)
then show##11##2##(1993-12#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-3#1)(2011-1#1)(2013-8#1)
then showed##3##2##(1995-1#1)(2007-2#1)(2008-7#1)
then shown to be##2##4##(2008-10#1)(2013-8#1)
then shown##4##2##(2008-10#1)(2008-3#1)(2010-2#1)(2013-8#1)
then simulated##2##2##(1993-9#1)(1995-3#1)
then slowly returned##2##3##(2006-3#1)(2007-5#1)
then slowly##4##2##(2005-12#1)(2006-3#1)(2007-5#1)(2008-11#1)
then spread to##2##3##(2008-10#1)(2011-1#1)
then spread##3##2##(2008-10#2)(2011-1#1)
then stabilized##4##2##(1994-2#1)(2008-4#3)
then stained with##3##3##(2008-11#1)(2009-6#1)(2011-2#1)
then stained##4##2##(1990-12#1)(2008-11#1)(2009-6#1)(2011-2#1)
then started##5##2##(1995-3#2)(1997-2#1)(2010-8#1)(2013-8#1)
then stored holographically in a##2##5##(2008-3#2)
then stored##4##2##(1995-8#1)(2008-10#1)(2008-3#2)
then stripped from the disk with a minimal amount of##2##10##(2008-10#2)
then stripped from the disk##3##5##(2008-10#3)
then stripped##4##2##(2008-10#3)(2008-3#1)
then studied##4##2##(1990-12#1)(1996-3#1)(2005-11#2)
then subcultured##2##2##(2012-12#1)(2013-8#1)
then subjected to a##4##4##(1995-6#1)(2008-12#1)(2008-2#1)(2009-4#1)
then subjected to##17##3##(1991-5#1)(1992-8#1)(1993-2#1)(1995-6#2)(2006-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-4#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-3#1)
then submitted to##3##3##(1990-10#1)(2008-11#1)(2008-12#1)
then subtracted from the##2##4##(2008-2#1)(2008-5#1)
then such##2##2##(1996-8#1)(2005-8#1)
then suggest##2##2##(2006-3#1)(2008-5#1)
then switched to##2##3##(1991-8#1)(2008-4#1)
then systematically##3##2##(1993-3#1)(2010-2#1)(2011-2#1)
then taken##4##2##(2007-10#1)(2008-3#1)(2008-5#1)(2012-12#1)
then test##3##2##(1992-2#1)(2008-8#1)(2013-1#1)
then tested for##2##3##(1991-9#1)(1992-2#1)
then tested on a##3##4##(1994-6#1)(2008-2#1)(2012-1#1)
then tested on##5##3##(1994-6#1)(2008-10#1)(2008-2#1)(2012-1#2)
then tested under##2##3##(2008-10#1)(2008-2#1)
then tested##18##2##(1990-10#1)(1991-9#1)(1992-2#1)(1993-12#1)(1994-6#1)(1995-2#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#2)(2008-9#1)(2010-12#1)(2012-1#2)
then that##3##2##(2009-9#1)(2013-1#2)
then the formaldehyde##2##3##(2008-10#2)
then the lower##2##3##(1995-3#1)(2008-9#1)
then the new##2##3##(2005-4#1)(2008-6#1)
then the##133##2##(1991-12#1)(1991-4#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-2#1)(1993-8#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-1#1)(1996-12#3)(1996-4#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(2004-8#1)(2005-11#2)(2005-4#2)(2006-10#3)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#4)(2008-10#18)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#10)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-3#1)(2010-1#1)(2010-2#2)(2010-4#1)(2010-5#2)(2011-1#3)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#4)
then their##4##2##(1994-11#1)(2008-12#1)(2013-1#2)
then there is no##2##4##(2007-7#1)(2011-2#1)
then there##4##2##(1991-10#1)(1992-10#1)(2007-7#1)(2011-2#1)
then thermally##2##2##(2008-10#1)(2008-5#1)
then these##4##2##(2006-11#1)(2008-11#1)(2009-2#1)(2013-1#1)
then they were concentrated##2##4##(2008-10#2)
then they were##6##3##(2008-10#2)(2008-2#1)(2008-5#2)(2012-3#1)
then they##11##2##(1990-6#1)(1997-6#1)(2008-10#4)(2008-2#1)(2008-5#2)(2011-2#1)(2012-3#1)
then this##8##2##(1993-6#1)(2006-7#1)(2007-12#1)(2008-2#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-12#1)
then titrated with##2##3##(2005-4#1)(2008-10#1)
then to a##3##3##(1997-6#1)(2007-8#1)(2008-5#1)
then to be##2##3##(2008-3#1)(2011-1#1)
then to the##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
then to##47##2##(1990-12#1)(1991-1#1)(1991-2#1)(1993-2#1)(1994-2#1)(1995-11#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-7#1)(2006-10#2)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#1)
then transfected into##2##3##(2008-11#1)(2008-4#1)
then transfected##3##2##(2008-11#1)(2008-4#1)(2008-5#1)
then transferred into##2##3##(2008-10#1)(2010-2#1)
then transferred to##9##3##(1994-5#1)(1997-2#1)(2004-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2013-1#1)
then transferred##13##2##(1994-5#1)(1996-8#1)(1997-2#1)(2004-4#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2010-2#1)(2013-1#1)
then transformed into##6##3##(2005-11#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-1#1)
then transformed to##2##3##(1996-10#1)(2005-11#1)
then transformed##10##2##(1996-10#1)(2005-11#2)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2013-1#1)
then transplanted into##3##3##(1995-11#1)(2008-11#1)(2010-2#1)
then transported##2##2##(1993-3#1)(2007-8#1)
then traverses the##2##3##(2006-10#1)(2008-2#1)
then treated with 300##2##4##(1994-3#1)(1995-11#1)
then treated with a##2##4##(2008-7#1)(2009-3#1)
then treated with ammonium##2##4##(2008-10#2)
then treated with##20##3##(1992-3#1)(1994-2#1)(1994-3#1)(1995-11#1)(2006-10#1)(2007-11#1)(2007-7#3)(2007-9#2)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-2#1)
then treated##22##2##(1992-3#1)(1994-2#1)(1994-3#1)(1995-11#1)(2006-10#1)(2007-11#2)(2007-7#3)(2007-9#2)(2008-10#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-2#1)
then try##2##2##(2008-4#1)(2008-9#1)
then turn##2##2##(1992-3#1)(2008-8#1)
then undergo##4##2##(1997-7#1)(2008-3#1)(2008-6#1)(2012-12#1)
then undergoes a conformational change##2##5##(1990-5#1)(1995-8#1)
then undergoes##9##2##(1990-5#1)(1991-12#1)(1995-10#1)(1995-8#1)(2006-5#1)(2007-3#1)(2009-10#2)(2009-7#1)
then underwent##9##2##(2006-3#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
then use a##2##3##(1994-6#1)(2008-2#1)
then use##7##2##(1994-6#1)(2007-4#1)(2008-2#2)(2008-9#1)(2013-1#2)
then used as a tool##2##5##(1997-5#1)(2009-12#1)
then used as a##4##4##(1991-2#1)(1997-5#1)(2005-11#1)(2009-12#1)
then used as the##3##4##(1997-1#1)(2009-11#1)(2011-2#1)
then used as##15##3##(1991-2#1)(1993-11#1)(1997-1#1)(1997-5#1)(1997-7#1)(2005-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2011-2#1)(2012-2#1)
then used for the##2##4##(2008-10#1)(2008-5#1)
then used for##8##3##(1992-6#1)(1995-2#1)(2008-10#2)(2008-5#1)(2010-8#1)(2011-1#1)(2013-8#1)
then used in a##3##4##(1994-3#1)(2005-11#1)(2007-11#1)
then used in the##3##4##(2008-10#2)(2008-3#1)
then used in##9##3##(1994-1#1)(1994-3#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2012-3#1)
then used the##4##3##(2007-12#1)(2007-5#1)(2008-11#1)(2013-8#1)
then used to analyze##3##4##(2008-10#2)(2008-3#1)
then used to ascertain##2##4##(1990-12#1)(2010-2#1)
then used to calculate the##2##5##(1997-7#1)(2008-10#1)
then used to calculate##4##4##(1997-7#1)(2008-10#1)(2008-2#1)(2010-2#1)
then used to demonstrate##2##4##(1990-10#1)(2012-12#1)
then used to determine the##2##5##(2006-9#1)(2010-12#1)
then used to estimate the##3##5##(1995-8#1)(2007-8#1)(2008-7#1)
then used to estimate##4##4##(1995-8#1)(2007-8#1)(2008-7#1)(2010-1#1)
then used to facilitate##2##4##(2006-7#1)(2008-6#1)
then used to identify##3##4##(1990-5#1)(2013-1#2)
then used to isolate##2##4##(1991-5#1)(2008-8#1)
then used to predict the##3##5##(2005-10#1)(2008-3#1)(2008-7#1)
then used to predict##5##4##(1995-8#1)(2005-10#1)(2008-3#1)(2008-7#1)(2009-6#1)
then used to##76##3##(1990-10#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-12#1)(1993-9#1)(1995-5#2)(1995-8#2)(1997-4#1)(1997-7#1)(2005-10#1)(2006-11#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#7)(2008-12#1)(2008-2#6)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#4)(2009-10#2)(2009-11#1)(2009-3#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#3)
then used##124##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-5#2)(1995-8#2)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(2004-11#1)(2005-10#1)(2005-11#2)(2006-11#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#6)(2007-5#1)(2007-8#1)(2008-10#11)(2008-11#2)(2008-12#2)(2008-2#6)(2008-3#6)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-3#2)(2009-6#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#3)(2013-8#2)
then uses##2##2##(1996-7#1)(2012-2#1)
then using##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
then utilize##3##2##(2008-10#1)(2009-4#1)(2009-8#1)
then validated using##2##3##(2008-10#1)(2008-8#1)
then validated##4##2##(2007-8#1)(2008-10#1)(2008-8#1)(2012-2#1)
then verified##3##2##(1995-2#1)(2008-2#2)
then viewed##4##2##(2007-11#1)(2007-12#1)(2008-4#1)(2012-1#1)
then was developed##2##3##(2008-10#1)(2008-11#1)
then was##19##2##(1993-11#1)(1996-5#1)(2005-12#1)(2006-12#1)(2007-10#1)(2007-6#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)
then we##8##2##(1997-2#1)(2006-7#1)(2007-12#1)(2007-7#1)(2008-2#2)(2012-12#1)(2013-1#1)
then weekly for##2##3##(1997-2#1)(2006-6#1)
then were##20##2##(1991-12#1)(1993-11#1)(1993-8#1)(1994-3#1)(1994-9#1)(1997-2#1)(2006-5#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-9#3)(2009-3#1)(2011-2#1)(2013-7#1)
then what##2##2##(1995-3#1)(2007-7#1)
then with a##3##3##(2007-12#1)(2008-9#1)(2009-8#1)
then with##11##2##(1997-6#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#1)(2012-1#1)
then##3200##1##(1990-10#11)(1990-11#6)(1990-12#18)(1990-2#5)(1990-3#4)(1990-4#1)(1990-5#10)(1990-6#4)(1990-7#8)(1990-8#8)(1990-9#5)(1991-1#4)(1991-10#7)(1991-11#7)(1991-12#12)(1991-2#8)(1991-3#5)(1991-4#6)(1991-5#11)(1991-6#2)(1991-7#6)(1991-8#5)(1991-9#8)(1992-1#8)(1992-10#7)(1992-11#3)(1992-12#9)(1992-2#10)(1992-3#13)(1992-4#2)(1992-5#5)(1992-6#13)(1992-7#9)(1992-8#11)(1992-9#10)(1993-1#4)(1993-10#2)(1993-11#10)(1993-12#13)(1993-2#17)(1993-3#9)(1993-4#2)(1993-5#1)(1993-6#4)(1993-7#4)(1993-8#7)(1993-9#5)(1994-1#3)(1994-10#3)(1994-11#3)(1994-12#13)(1994-2#21)(1994-3#16)(1994-5#9)(1994-6#7)(1994-8#11)(1994-9#7)(1995-1#7)(1995-10#2)(1995-11#9)(1995-12#7)(1995-2#16)(1995-3#19)(1995-4#2)(1995-5#8)(1995-6#12)(1995-7#1)(1995-8#16)(1995-9#4)(1996-1#8)(1996-10#5)(1996-11#5)(1996-12#18)(1996-2#10)(1996-3#6)(1996-4#11)(1996-5#16)(1996-6#2)(1996-7#5)(1996-8#8)(1996-9#6)(1997-1#8)(1997-2#18)(1997-3#10)(1997-4#14)(1997-5#7)(1997-6#9)(1997-7#18)(1997-8#9)(2003-11#2)(2004-1#1)(2004-10#2)(2004-11#3)(2004-12#1)(2004-3#1)(2004-4#3)(2004-5#1)(2004-8#2)(2004-9#5)(2005-1#1)(2005-10#10)(2005-11#26)(2005-12#7)(2005-4#5)(2005-5#3)(2005-6#4)(2005-7#7)(2005-8#10)(2005-9#1)(2006-10#35)(2006-11#11)(2006-12#18)(2006-2#3)(2006-3#9)(2006-4#6)(2006-5#13)(2006-6#10)(2006-7#12)(2006-8#11)(2006-9#6)(2007-1#8)(2007-10#16)(2007-11#51)(2007-12#81)(2007-2#9)(2007-3#6)(2007-4#17)(2007-5#12)(2007-6#2)(2007-7#21)(2007-8#68)(2007-9#23)(2008-1#31)(2008-10#404)(2008-11#104)(2008-12#33)(2008-2#125)(2008-3#120)(2008-4#104)(2008-5#86)(2008-6#33)(2008-7#61)(2008-8#88)(2008-9#49)(2009-10#12)(2009-11#7)(2009-12#9)(2009-2#12)(2009-3#12)(2009-4#14)(2009-5#3)(2009-6#8)(2009-7#7)(2009-8#19)(2009-9#15)(2010-1#7)(2010-10#4)(2010-11#10)(2010-12#21)(2010-2#26)(2010-3#12)(2010-4#14)(2010-5#14)(2010-6#4)(2010-7#10)(2010-8#24)(2010-9#7)(2011-1#38)(2011-12#8)(2011-2#71)(2011-3#3)(2011-7#1)(2012-1#32)(2012-11#12)(2012-12#38)(2012-2#48)(2012-3#39)(2013-1#77)(2013-7#12)(2013-8#41)
thenar flap##4##2##(2008-9#4)
thenar muscle##2##2##(2007-11#1)(2008-9#1)
thenar muscles##2##2##(2007-11#1)(2009-1#1)
thenar##11##1##(2006-3#1)(2007-11#2)(2008-5#1)(2008-9#6)(2009-1#1)
thence to##2##2##(2008-10#1)(2010-2#1)
thence##4##1##(1992-12#1)(2007-10#1)(2008-10#1)(2010-2#1)
thenoyltrifluoroacetone and##2##2##(2008-10#2)
thenoyltrifluoroacetone##3##1##(2008-10#3)
theobromae was##2##2##(2008-10#1)(2008-5#1)
theobromae##9##1##(2008-10#5)(2008-5#4)
theobromine and##3##2##(1997-8#1)(2008-10#2)
theobromine##5##1##(1997-8#2)(2008-10#3)
theological##6##1##(1994-3#1)(2005-12#1)(2008-4#1)(2009-11#2)(2013-1#1)
theology##6##1##(2006-12#1)(2008-12#1)(2009-10#3)(2013-1#1)
theophylline (1##2##2##(1994-8#1)(2008-10#1)
theophylline and##11##2##(1990-8#1)(1991-12#3)(1992-2#1)(1992-3#2)(2007-11#1)(2008-10#1)(2011-2#1)(2013-8#1)
theophylline are##4##2##(1990-8#1)(2006-10#1)(2008-10#1)(2011-2#1)
theophylline in##6##2##(1991-12#1)(1997-8#1)(2008-10#3)(2013-8#1)
theophylline pellets formulation for once-daily evening administration##3##7##(2005-10#3)
theophylline serum levels##2##3##(1991-12#1)(2005-10#1)
theophylline therapy##2##2##(2005-10#2)
theophylline to##2##2##(2007-8#2)
theophylline was##4##2##(1992-6#1)(2008-1#2)(2008-10#1)
theophylline were##4##2##(1990-9#1)(2004-12#1)(2006-1#1)(2007-2#1)
theophylline with##2##2##(1991-2#1)(1992-8#1)
theophylline##102##1##(1990-10#3)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-11#3)(1991-12#10)(1991-2#2)(1992-2#4)(1992-3#3)(1992-6#2)(1992-8#2)(1994-8#1)(1996-12#1)(1997-5#2)(1997-8#5)(2004-12#6)(2005-10#7)(2005-7#1)(2006-1#3)(2006-10#1)(2006-9#1)(2007-11#2)(2007-2#4)(2007-8#4)(2008-1#6)(2008-10#14)(2008-5#1)(2010-11#1)(2011-2#3)(2013-8#3)
theorem and the##3##3##(2007-12#1)(2008-2#2)
theorem for##3##2##(2007-12#1)(2008-3#1)(2008-9#1)
theorem of##2##2##(1993-8#1)(2007-12#1)
theorem shows that##2##3##(1995-9#2)
theorem to##3##2##(2007-12#1)(2007-9#1)(2008-3#1)
theorem we##2##2##(2008-2#1)(2013-8#1)
theorem##35##1##(1990-10#1)(1993-8#1)(1995-2#1)(1995-9#2)(1996-11#1)(2007-11#1)(2007-12#6)(2007-9#1)(2008-1#1)(2008-2#5)(2008-3#11)(2008-9#1)(2012-1#2)(2013-8#1)
theorems and##2##2##(1990-2#1)(1990-7#1)
theorems##17##1##(1990-12#1)(1990-2#1)(1990-7#2)(2008-2#5)(2008-7#1)(2010-3#6)(2012-1#1)
theoretic approach##2##2##(2008-8#1)(2010-2#1)
theoretic image restoration##2##3##(2008-2#1)(2008-3#1)
theoretic##15##1##(1991-12#1)(2005-4#1)(2008-10#1)(2008-2#4)(2008-3#1)(2008-8#2)(2009-12#1)(2010-2#1)(2011-12#1)(2013-1#2)
theoretical advances##3##2##(2008-3#1)(2008-9#1)(2009-12#1)
theoretical advantages in##2##3##(1993-1#1)(2007-5#1)
theoretical advantages of##3##3##(2008-1#1)(2008-3#1)(2010-11#1)
theoretical advantages##8##2##(1993-1#1)(1997-3#1)(2005-7#1)(2006-10#1)(2007-5#1)(2008-1#1)(2008-3#1)(2010-11#1)
theoretical alpha##2##2##(2005-4#2)
theoretical analyses and the##2##4##(2008-3#1)(2010-2#1)
theoretical analyses and##3##3##(2008-3#2)(2010-2#1)
theoretical analyses##10##2##(2005-10#1)(2008-2#2)(2008-3#6)(2010-2#1)
theoretical analysis and an experimental##2##5##(2008-2#1)(2008-3#1)
theoretical analysis and experimental results are given##2##7##(2008-3#2)
theoretical analysis and the##3##4##(2008-2#1)(2013-7#1)(2013-8#1)
theoretical analysis and##15##3##(2005-11#1)(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#4)(2009-7#1)(2010-2#1)(2013-7#1)(2013-8#1)
theoretical analysis for##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
theoretical analysis has##2##3##(2007-12#1)(2008-3#1)
theoretical analysis is presented##2##4##(2007-12#2)
theoretical analysis is##6##3##(2007-12#2)(2008-11#1)(2008-2#2)(2008-3#1)
theoretical analysis of the##11##4##(2005-11#1)(2007-11#1)(2007-9#1)(2008-2#6)(2008-3#2)
theoretical analysis of this##3##4##(1997-3#1)(2008-2#1)(2008-3#1)
theoretical analysis of##24##3##(1993-9#1)(1997-3#1)(2005-11#2)(2007-11#1)(2007-12#2)(2007-9#1)(2008-2#8)(2008-3#5)(2009-3#1)(2010-7#1)(2012-1#1)
theoretical analysis shows that##2##4##(2008-2#1)(2013-8#1)
theoretical analysis##75##2##(1993-12#1)(1993-6#1)(1993-9#1)(1997-3#1)(2005-11#3)(2006-1#1)(2007-11#4)(2007-12#8)(2007-9#2)(2008-1#1)(2008-11#1)(2008-2#23)(2008-3#20)(2009-3#1)(2009-7#1)(2010-2#1)(2010-7#1)(2012-1#1)(2013-7#1)(2013-8#2)
theoretical and clinical##9##3##(1993-3#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-11#2)(2011-1#1)(2012-3#1)
theoretical and empirical##7##3##(1993-3#1)(1996-3#1)(1996-6#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)
theoretical and experimental data##3##4##(2007-12#1)(2008-2#1)(2009-4#1)
theoretical and experimental investigation of the##3##6##(2006-7#1)(2007-12#1)(2008-3#1)
theoretical and experimental investigation of##5##5##(2006-7#1)(2007-11#1)(2007-12#1)(2008-3#2)
theoretical and experimental results obtained##2##5##(2007-12#2)
theoretical and experimental results show##2##5##(2007-12#1)(2008-3#1)
theoretical and experimental results##13##4##(2007-11#2)(2007-12#4)(2008-10#1)(2008-2#3)(2008-3#3)
theoretical and experimental studies##2##4##(2007-11#1)(2008-2#1)
theoretical and experimental study of##2##5##(1996-11#1)(2008-3#1)
theoretical and experimental study##5##4##(1996-11#1)(2005-11#1)(2008-2#1)(2008-3#2)
theoretical and experimental##41##3##(1992-1#1)(1992-5#1)(1996-11#1)(1997-2#1)(2005-11#3)(2006-7#1)(2007-11#4)(2007-12#6)(2008-10#1)(2008-2#8)(2008-3#10)(2009-2#1)(2009-4#1)(2013-1#2)
theoretical and methodological##3##3##(1994-3#1)(2008-9#1)(2009-4#1)
theoretical and practical##10##3##(1990-12#1)(1993-3#1)(1997-4#1)(2006-4#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-8#1)(2013-1#1)
theoretical and professional##2##3##(2010-10#2)
theoretical and technical##2##3##(1993-4#1)(2008-11#1)
theoretical and the experimental##2##4##(2008-3#1)(2009-12#1)
theoretical and the##3##3##(2008-3#2)(2009-12#1)
theoretical and##87##2##(1990-12#1)(1990-3#1)(1992-1#1)(1992-5#1)(1993-3#3)(1993-4#1)(1994-3#2)(1996-11#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-4#1)(2005-11#3)(2006-4#1)(2006-7#1)(2007-11#6)(2007-12#8)(2007-7#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#9)(2008-3#14)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#1)(2009-2#1)(2009-4#2)(2010-10#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
theoretical approach to##2##3##(2008-2#1)(2010-7#1)
theoretical approach was##2##3##(1997-4#1)(2010-2#1)
theoretical approach##12##2##(1995-3#1)(1997-4#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-8#1)(2010-2#1)(2010-7#1)
theoretical approaches##10##2##(1996-2#1)(2004-12#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-12#1)(2009-12#1)(2009-4#1)(2011-1#1)(2012-3#1)
theoretical arguments##2##2##(2010-2#1)(2010-3#1)
theoretical aspect##2##2##(2008-6#1)(2011-1#1)
theoretical aspects of##4##3##(2005-4#1)(2008-10#1)(2009-12#1)(2013-7#1)
theoretical aspects##9##2##(1993-6#1)(1995-5#1)(2005-4#1)(2008-10#2)(2008-9#1)(2009-12#1)(2009-3#1)(2013-7#1)
theoretical assessment of##2##3##(2008-10#2)
theoretical assessments##2##2##(2005-5#1)(2007-9#1)
theoretical assumptions##3##2##(2006-12#1)(2010-1#1)(2010-2#1)
theoretical background for the##3##4##(2008-2#2)(2009-5#1)
theoretical background##10##2##(2006-4#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-5#1)(2011-1#1)(2012-12#1)
theoretical bases and##2##3##(1991-12#1)(2008-2#1)
theoretical bases##3##2##(1991-12#1)(2008-2#1)(2008-9#1)
theoretical basis for##4##3##(1992-3#1)(2007-12#1)(2013-8#2)
theoretical basis of##5##3##(1991-2#1)(2006-12#1)(2006-9#1)(2007-11#1)(2008-1#1)
theoretical basis##16##2##(1991-2#1)(1992-3#1)(1997-3#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-8#1)(2011-12#1)(2011-2#1)(2013-7#1)(2013-8#2)
theoretical benefit##2##2##(1993-1#1)(2011-2#1)
theoretical calculation with the##2##4##(2008-2#1)(2008-3#1)
theoretical calculation##9##2##(2007-11#1)(2008-2#5)(2008-3#1)(2011-1#2)
theoretical calculations##19##2##(1991-7#1)(1993-9#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#5)(2008-6#1)(2008-7#1)(2009-3#1)(2010-2#2)(2013-1#1)
theoretical concepts of##2##3##(2006-10#1)(2008-7#1)
theoretical concepts##8##2##(1994-6#1)(1996-3#1)(1997-8#2)(2006-10#1)(2008-12#1)(2008-7#1)(2011-2#1)
theoretical consequences##2##2##(2008-8#2)
theoretical considerations##20##2##(1991-2#1)(1992-2#1)(1993-11#1)(1994-6#1)(1996-1#1)(1996-8#1)(1997-7#1)(2005-10#2)(2006-12#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2010-10#1)(2010-12#1)
theoretical context##2##2##(1995-1#1)(2008-11#1)
theoretical data and##3##3##(2008-2#2)(2008-3#1)
theoretical data for##2##3##(2008-2#1)(2009-11#1)
theoretical data##7##2##(2008-2#3)(2008-3#3)(2009-11#1)
theoretical density##2##2##(2009-2#1)(2010-5#1)
theoretical derivation##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
theoretical description of the##2##4##(2006-5#1)(2008-3#1)
theoretical description of##4##3##(2006-5#1)(2008-1#1)(2008-2#1)(2008-3#1)
theoretical description##8##2##(2006-5#1)(2008-1#2)(2008-2#2)(2008-3#3)
theoretical design##4##2##(2008-3#4)
theoretical development##5##2##(2007-4#1)(2008-12#1)(2008-2#1)(2009-12#1)(2013-8#1)
theoretical diffraction##2##2##(2007-12#1)(2008-3#1)
theoretical discussion##2##2##(2008-3#1)(2010-1#1)
theoretical efficiency of##2##3##(2007-11#1)(2007-12#1)
theoretical efficiency##4##2##(1990-7#1)(2007-11#1)(2007-12#1)(2008-3#1)
theoretical equations##2##2##(1996-11#1)(2006-10#1)
theoretical estimate of##2##3##(1996-12#1)(2007-12#1)
theoretical estimates##2##2##(2007-11#1)(2012-2#1)
theoretical expansion##2##2##(2008-3#2)
theoretical expectation##2##2##(2007-11#1)(2008-9#1)
theoretical expectations##10##2##(1995-2#1)(2006-5#1)(2007-11#1)(2008-2#3)(2008-3#2)(2008-9#1)(2011-2#1)
theoretical experimental##2##2##(2007-9#2)
theoretical explanation##3##2##(2008-10#1)(2008-3#1)(2010-3#1)
theoretical expression##3##2##(1991-7#1)(2005-11#1)(2008-3#1)
theoretical expressions for the##2##4##(2008-2#2)
theoretical expressions##5##2##(2007-11#1)(2008-2#3)(2010-2#1)
theoretical extension##2##2##(2009-5#1)(2011-1#1)
theoretical findings##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2013-8#1)
theoretical formalism is developed to##2##5##(2008-3#1)(2009-2#1)
theoretical formalism##5##2##(2007-3#1)(2008-3#3)(2009-2#1)
theoretical formulas for##2##3##(2008-2#1)(2008-3#1)
theoretical formulation##2##2##(2007-12#1)(2008-10#1)
theoretical foundation##5##2##(2004-12#1)(2008-2#2)(2008-8#1)(2010-1#1)
theoretical foundations##4##2##(1995-2#1)(2008-12#1)(2008-3#1)(2012-2#1)
theoretical framework for a##2##4##(2007-11#1)(2008-8#1)
theoretical framework for##6##3##(2007-11#1)(2007-7#1)(2008-4#1)(2008-8#2)(2009-4#1)
theoretical framework of##4##3##(2008-4#1)(2009-11#1)(2011-2#1)(2013-8#1)
theoretical framework to##5##3##(1992-3#1)(2007-3#1)(2008-1#1)(2008-7#1)(2012-3#1)
theoretical framework##34##2##(1992-3#1)(1994-3#1)(2006-4#2)(2007-11#1)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2009-4#2)(2009-6#1)(2009-9#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-8#1)
theoretical frameworks and##2##3##(2006-12#1)(2012-2#1)
theoretical frameworks of##2##3##(2009-6#1)(2013-7#1)
theoretical frameworks##8##2##(2006-12#1)(2008-12#1)(2009-6#2)(2010-9#1)(2012-2#1)(2012-3#1)(2013-7#1)
theoretical grounding##2##2##(2010-11#2)
theoretical grounds##2##2##(1997-1#1)(2008-2#1)
theoretical ideas##3##2##(1994-3#1)(1995-6#1)(2011-2#1)
theoretical implications##3##2##(1993-9#1)(2007-11#1)(2008-2#1)
theoretical interest##3##2##(1992-5#1)(2008-4#1)(2008-9#1)
theoretical interpretation##2##2##(1995-7#1)(2008-2#1)
theoretical investigation of the##4##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-9#1)
theoretical investigation of##6##3##(2007-11#1)(2007-12#3)(2008-2#1)(2008-9#1)
theoretical investigation##8##2##(1993-8#1)(1996-12#1)(2007-11#1)(2007-12#3)(2008-2#1)(2008-9#1)
theoretical investigations of##2##3##(2008-2#2)
theoretical investigations##3##2##(2008-11#1)(2008-2#2)
theoretical issues##4##2##(1991-12#1)(1993-12#1)(2008-2#1)(2008-7#1)
theoretical knowledge of holistic care into practice##2##7##(2008-11#2)
theoretical knowledge of holistic care into##3##6##(2008-11#3)
theoretical knowledge of holistic care##4##5##(2008-11#4)
theoretical knowledge of##7##3##(1997-4#1)(2005-10#1)(2008-11#4)(2010-10#1)
theoretical knowledge##13##2##(1997-4#1)(2005-10#1)(2007-4#1)(2008-1#1)(2008-11#6)(2008-5#1)(2010-10#1)(2011-2#1)
theoretical limit##6##2##(1996-8#1)(2007-12#2)(2008-2#2)(2008-4#1)
theoretical limitations##3##2##(1990-12#1)(2007-8#1)(2013-7#1)
theoretical limits##3##2##(2006-10#1)(2007-12#1)(2008-3#1)
theoretical literature##2##2##(2011-1#1)(2012-12#1)
theoretical math model##2##3##(2007-1#2)
theoretical maximum number of##2##4##(2008-10#1)(2008-2#1)
theoretical maximum##8##2##(2007-10#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#2)
theoretical method##2##2##(2008-3#1)(2011-3#1)
theoretical methods##2##2##(1992-11#1)(2009-3#1)
theoretical minimum##3##2##(1995-4#1)(2008-3#2)
theoretical model based on##3##4##(2007-11#1)(2008-10#1)(2013-8#1)
theoretical model for the##7##4##(2007-12#1)(2008-2#3)(2008-3#2)(2013-7#1)
theoretical model for##12##3##(2007-11#1)(2007-12#3)(2007-5#1)(2008-2#3)(2008-3#3)(2013-7#1)
theoretical model is##7##3##(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#1)(2013-8#1)
theoretical model of the##5##4##(1996-3#1)(2008-3#2)(2008-9#1)(2013-8#1)
theoretical model of##11##3##(1996-3#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-3#3)(2008-9#1)(2009-11#1)(2009-9#1)(2013-8#1)
theoretical model proposed##2##3##(2006-10#1)(2013-8#1)
theoretical model that##4##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)
theoretical model to##5##3##(2007-12#3)(2008-2#2)
theoretical model was developed##2##4##(2008-10#1)(2008-2#1)
theoretical model was##3##3##(2008-10#1)(2008-12#1)(2008-2#1)
theoretical model##82##2##(1990-12#1)(1994-3#1)(1996-2#1)(1996-3#1)(2005-11#1)(2006-10#3)(2006-2#1)(2006-5#1)(2007-11#6)(2007-12#10)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#14)(2008-3#18)(2008-5#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-9#1)(2010-11#1)(2010-2#1)(2011-1#1)(2013-7#1)(2013-8#6)
theoretical modeling of##2##3##(2007-12#1)(2008-3#1)
theoretical modeling##4##2##(2007-12#2)(2008-3#2)
theoretical models and##2##3##(2008-9#1)(2009-5#1)
theoretical models of##6##3##(2008-2#1)(2008-4#1)(2008-8#1)(2009-7#1)(2009-9#1)(2012-2#1)
theoretical models that##6##3##(1996-4#1)(2007-12#1)(2008-3#1)(2009-2#1)(2013-1#2)
theoretical models to##2##3##(2005-11#1)(2009-2#1)
theoretical models##35##2##(1990-12#1)(1995-6#1)(1996-4#2)(1996-8#1)(2005-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-2#2)(2009-5#2)(2009-7#1)(2009-9#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
theoretical nature of##2##3##(2007-12#1)(2008-9#1)
theoretical noise##2##2##(2008-2#1)(2008-3#1)
theoretical notions##2##2##(1992-3#1)(2008-12#1)
theoretical ones##3##2##(2008-3#2)(2012-3#1)
theoretical paper##2##2##(2005-10#1)(2008-3#1)
theoretical papers##2##2##(2010-6#1)(2011-2#1)
theoretical performance##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
theoretical perspectives##5##2##(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-7#1)
theoretical physics##2##2##(1993-4#1)(1997-6#1)
theoretical plate##5##2##(1994-9#1)(1997-1#1)(2008-10#3)
theoretical plates was##3##3##(2008-10#3)
theoretical plates##9##2##(1990-8#1)(1994-9#1)(1996-5#2)(2008-10#5)
theoretical point of view##7##4##(1996-12#1)(2004-12#1)(2008-2#3)(2008-3#1)(2008-8#1)
theoretical point of##8##3##(1993-8#1)(1996-12#1)(2004-12#1)(2008-2#3)(2008-3#1)(2008-8#1)
theoretical point##9##2##(1993-8#1)(1996-12#1)(2004-12#1)(2008-2#3)(2008-3#1)(2008-8#1)(2011-1#1)
theoretical prediction of##3##3##(1992-4#1)(2007-12#1)(2008-3#1)
theoretical prediction##20##2##(1992-4#1)(1996-11#1)(2005-11#1)(2007-11#2)(2007-12#4)(2008-2#4)(2008-3#6)(2012-3#1)
theoretical predictions and##4##3##(2007-12#2)(2008-10#1)(2008-3#1)
theoretical predictions are##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
theoretical predictions for the##3##4##(2007-12#3)
theoretical predictions for##6##3##(1991-9#1)(2007-12#4)(2008-3#1)
theoretical predictions that##2##3##(1995-2#1)(2008-3#1)
theoretical predictions##77##2##(1991-9#1)(1992-6#1)(1995-2#1)(1996-2#1)(1997-3#1)(2005-11#4)(2007-11#5)(2007-12#19)(2007-5#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#9)(2008-3#16)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-2#2)(2012-1#1)(2012-3#2)(2013-1#1)
theoretical principles of##3##3##(2007-9#1)(2008-10#1)(2008-11#1)
theoretical problems##3##2##(2006-10#1)(2008-2#1)(2008-5#1)
theoretical profiles of##2##3##(2008-2#1)(2008-3#1)
theoretical profiles##3##2##(2008-2#1)(2008-3#2)
theoretical properties of##3##3##(2009-9#1)(2010-1#1)(2012-3#1)
theoretical properties##4##2##(2009-9#1)(2010-1#1)(2011-1#1)(2012-3#1)
theoretical questions##3##2##(1996-5#1)(2010-10#1)(2010-7#1)
theoretical rationale##2##2##(2008-6#2)
theoretical reference##2##2##(2012-12#1)(2013-8#1)
theoretical relation##2##2##(2008-10#1)(2008-7#1)
theoretical relationship##2##2##(2005-11#1)(2013-1#1)
theoretical relationships##5##2##(2004-9#1)(2005-11#3)(2008-8#1)
theoretical research and##2##3##(2005-11#1)(2013-8#1)
theoretical research##5##2##(1993-3#1)(2005-11#1)(2008-8#1)(2012-3#1)(2013-8#1)
theoretical resolution is##2##3##(2008-2#1)(2008-3#1)
theoretical resolution##3##2##(2008-2#1)(2008-3#2)
theoretical result##3##2##(2007-12#1)(2008-8#1)(2010-7#1)
theoretical results are compared##2##4##(2008-2#1)(2008-8#1)
theoretical results are##6##3##(2007-12#1)(2008-2#2)(2008-8#1)(2010-12#1)(2011-2#1)
theoretical results for##2##3##(2007-11#1)(2008-3#1)
theoretical results from##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
theoretical results indicate that##2##4##(2008-2#1)(2008-8#1)
theoretical results of##4##3##(2008-11#1)(2008-2#2)(2008-3#1)
theoretical results show that the##2##5##(2005-11#1)(2008-3#1)
theoretical results##47##2##(1995-4#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#5)(2008-11#1)(2008-2#13)(2008-3#13)(2008-8#2)(2008-9#2)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#1)
theoretical risk##3##2##(1997-6#1)(2008-7#1)(2011-2#1)
theoretical role of##2##3##(2006-10#1)(2012-3#1)
theoretical sensitivity##2##2##(2008-2#1)(2008-3#1)
theoretical simulation##3##2##(2006-12#1)(2008-10#1)(2008-3#1)
theoretical simulations##4##2##(2008-10#2)(2008-3#1)(2008-7#1)
theoretical skin##2##2##(2008-5#2)
theoretical spectra##2##2##(2008-3#1)(2010-7#1)
theoretical studies have##3##3##(2008-11#1)(2008-8#1)(2013-1#1)
theoretical studies of##4##3##(1997-6#1)(2006-10#2)(2007-12#1)
theoretical studies##15##2##(1997-6#1)(2006-10#2)(2007-11#2)(2007-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#2)(2011-1#1)(2013-1#1)
theoretical study of a##2##4##(2008-2#1)(2008-3#1)
theoretical study of the##2##4##(2008-2#1)(2008-3#1)
theoretical study of##11##3##(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#2)(2008-8#1)(2010-12#1)
theoretical study##24##2##(1991-9#1)(1993-4#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#4)(2008-3#4)(2008-8#1)(2009-2#1)(2010-10#2)(2010-12#1)(2010-2#1)(2012-2#1)
theoretical tool##3##2##(1996-11#1)(2008-2#1)(2012-1#1)
theoretical tools##3##2##(2006-10#2)(2008-8#1)
theoretical treatment of the##2##4##(2008-2#1)(2008-3#1)
theoretical treatment of##4##3##(2008-2#1)(2008-3#2)(2009-8#1)
theoretical treatment##9##2##(1994-11#1)(2005-11#1)(2008-2#4)(2008-3#2)(2009-8#1)
theoretical understanding##2##2##(1996-2#1)(2008-6#1)
theoretical upper limit##2##3##(2007-12#2)
theoretical value of##4##3##(1996-2#1)(2007-11#1)(2007-12#1)(2008-3#1)
theoretical value##11##2##(1994-3#1)(1996-2#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#2)
theoretical values of##2##3##(2008-10#1)(2008-6#1)
theoretical values##17##2##(1990-6#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#2)(2008-6#1)(2008-9#3)(2012-3#1)
theoretical work on##2##3##(2010-6#1)(2011-1#1)
theoretical work##5##2##(1992-3#1)(2008-2#1)(2010-6#1)(2011-1#1)(2012-12#1)
theoretical works##2##2##(2007-12#1)(2013-7#1)
theoretical yield##5##2##(2004-8#1)(2008-5#1)(2008-6#3)
theoretical yields##2##2##(2008-5#1)(2008-6#1)
theoretical##1248##1##(1990-11#1)(1990-12#4)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#2)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#3)(1991-6#2)(1991-7#3)(1991-9#2)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-1#2)(1993-10#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#4)(1993-4#5)(1993-6#4)(1993-7#1)(1993-8#6)(1993-9#4)(1994-11#1)(1994-12#1)(1994-3#6)(1994-5#1)(1994-6#3)(1994-9#2)(1995-1#2)(1995-2#4)(1995-3#2)(1995-4#3)(1995-5#1)(1995-6#2)(1995-7#1)(1996-1#2)(1996-11#5)(1996-12#3)(1996-2#6)(1996-3#4)(1996-4#2)(1996-5#3)(1996-6#1)(1996-8#5)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#4)(1997-4#4)(1997-6#3)(1997-7#1)(1997-8#5)(2004-11#1)(2004-12#5)(2004-8#1)(2004-9#1)(2005-10#5)(2005-11#29)(2005-12#1)(2005-4#4)(2005-5#1)(2005-7#1)(2006-1#2)(2006-10#21)(2006-11#1)(2006-12#6)(2006-2#2)(2006-4#4)(2006-5#4)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#4)(2007-11#50)(2007-12#92)(2007-2#2)(2007-3#4)(2007-4#3)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#9)(2008-1#13)(2008-10#59)(2008-11#26)(2008-12#14)(2008-2#165)(2008-3#185)(2008-4#8)(2008-5#18)(2008-6#20)(2008-7#17)(2008-8#28)(2008-9#31)(2009-11#3)(2009-12#5)(2009-2#9)(2009-3#5)(2009-4#6)(2009-5#7)(2009-6#5)(2009-7#5)(2009-8#2)(2009-9#7)(2010-1#5)(2010-10#7)(2010-11#4)(2010-12#5)(2010-2#14)(2010-3#4)(2010-4#2)(2010-5#3)(2010-6#5)(2010-7#8)(2010-8#2)(2010-9#1)(2011-1#17)(2011-12#3)(2011-2#14)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#7)(2012-2#11)(2012-3#19)(2013-1#17)(2013-7#8)(2013-8#23)
theoretically analyze the##4##3##(2007-12#2)(2008-3#2)
theoretically analyze##7##2##(2007-11#1)(2007-12#4)(2008-3#2)
theoretically analyzed by##2##3##(2008-2#1)(2008-3#1)
theoretically analyzed##8##2##(2007-12#2)(2008-2#5)(2008-3#1)
theoretically and experimentally by##2##4##(2007-11#1)(2007-12#1)
theoretically and experimentally for##2##4##(2005-11#1)(2008-3#1)
theoretically and experimentally investigated##2##4##(2007-12#1)(2008-3#1)
theoretically and experimentally that the##6##5##(2007-12#2)(2008-2#3)(2008-3#1)
theoretically and experimentally that##13##4##(2007-12#4)(2008-1#1)(2008-2#4)(2008-3#4)
theoretically and experimentally the##4##4##(2007-11#1)(2008-2#1)(2008-3#2)
theoretically and experimentally##63##3##(1995-1#1)(2005-11#1)(2007-11#6)(2007-12#13)(2008-1#1)(2008-10#2)(2008-2#13)(2008-3#24)(2010-12#2)
theoretically and numerically analyzed##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
theoretically and verified experimentally##2##4##(2007-12#1)(2008-2#1)
theoretically and##75##2##(1990-7#1)(1994-6#1)(1995-1#1)(1997-6#1)(2005-11#1)(2007-11#6)(2007-12#17)(2008-1#1)(2008-10#2)(2008-2#15)(2008-3#26)(2009-9#1)(2010-12#2)
theoretically as well##2##3##(2007-11#1)(2008-2#1)
theoretically as##3##2##(2007-11#1)(2008-2#1)(2008-8#1)
theoretically be##2##2##(2008-8#1)(2013-1#1)
theoretically by use of a##2##5##(2008-1#1)(2008-2#1)
theoretically by use of##4##4##(2007-12#1)(2008-1#1)(2008-2#2)
theoretically by##12##2##(1990-7#1)(2007-12#4)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-7#1)
theoretically calculated values##3##3##(2008-3#3)
theoretically calculated##11##2##(1995-2#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#4)
theoretically derived##7##2##(2005-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-6#1)(2010-8#1)(2012-12#1)
theoretically estimated##2##2##(2008-2#1)(2008-3#1)
theoretically evaluated##2##2##(2008-3#1)(2009-10#1)
theoretically examined##3##2##(2007-9#1)(2008-2#1)(2008-3#1)
theoretically expected##8##2##(1997-3#2)(2008-10#1)(2008-2#3)(2008-3#1)(2010-8#1)
theoretically for the##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
theoretically for##6##2##(1991-9#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#1)
theoretically in##3##2##(2008-2#3)
theoretically investigated the##2##3##(2007-12#1)(2008-2#1)
theoretically investigated##6##2##(2007-11#1)(2007-12#4)(2008-2#1)
theoretically modeled##2##2##(2008-2#1)(2008-3#1)
theoretically possible##4##2##(1996-7#1)(1997-6#1)(2009-8#1)(2013-8#1)
theoretically predict##2##2##(2008-8#1)(2010-12#1)
theoretically predicted##6##2##(1990-12#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-3#1)
theoretically studied by##2##3##(2007-11#1)(2008-10#1)
theoretically studied##6##2##(1996-8#1)(2007-11#1)(2008-10#1)(2008-3#2)(2010-2#1)
theoretically that the##5##3##(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#1)
theoretically that##10##2##(1997-1#1)(1997-2#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#1)(2008-3#1)
theoretically the##5##2##(2005-11#1)(2007-12#2)(2008-10#1)(2008-8#1)
theoretically to##3##2##(2007-11#1)(2008-11#1)(2012-11#1)
theoretically##293##1##(1990-12#1)(1990-7#2)(1991-12#1)(1991-9#1)(1992-8#1)(1994-12#1)(1994-6#1)(1995-1#2)(1995-2#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-6#2)(2004-9#1)(2005-11#7)(2005-4#1)(2006-10#1)(2006-3#1)(2006-7#1)(2007-11#20)(2007-12#53)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#13)(2008-11#2)(2008-2#53)(2008-3#64)(2008-5#1)(2008-7#3)(2008-8#6)(2008-9#1)(2009-10#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#3)(2011-1#3)(2011-2#4)(2012-11#2)(2012-12#5)(2013-1#3)(2013-8#1)
theoreticians##2##1##(2008-10#1)(2010-12#1)
theories about the##2##3##(2007-8#1)(2009-4#1)
theories about##10##2##(1994-6#1)(1995-1#1)(2007-8#1)(2008-11#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-6#1)(2010-8#1)
theories and concepts##2##3##(2013-8#2)
theories and practices##2##3##(1992-2#1)(2009-8#1)
theories and the##5##3##(1992-6#1)(2008-2#2)(2010-7#1)(2011-2#1)
theories and##26##2##(1992-2#1)(1992-6#1)(1993-12#1)(1997-8#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-2#2)(2009-8#1)(2010-1#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#3)
theories are needed##2##3##(2009-8#2)
theories are##10##2##(1997-6#1)(2006-7#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-2#1)(2009-8#2)(2010-7#1)(2011-1#1)
theories as##2##2##(2008-11#1)(2010-10#1)
theories can be##2##3##(2008-6#1)(2010-6#1)
theories emphasizing the##2##3##(2007-12#2)
theories for improvement##2##3##(1994-12#2)
theories for##8##2##(1992-2#1)(1994-12#2)(2005-11#1)(2006-10#1)(2007-11#1)(2008-2#2)
theories have been proposed##4##4##(2006-5#1)(2007-11#1)(2009-12#1)(2011-1#1)
theories have been##6##3##(2006-5#1)(2007-11#1)(2008-3#2)(2009-12#1)(2011-1#1)
theories have##9##2##(2006-2#1)(2006-5#1)(2007-11#1)(2008-3#2)(2008-5#1)(2009-12#1)(2010-10#1)(2011-1#1)
theories in##5##2##(2007-12#1)(2008-12#2)(2009-8#1)(2012-3#1)
theories is##2##2##(1994-1#1)(2008-3#1)
theories may##2##2##(2007-12#1)(2008-11#1)
theories of aging##5##3##(1992-12#1)(1994-5#1)(1995-3#1)(2008-3#1)(2008-9#1)
theories of autism##3##3##(2006-2#1)(2008-11#1)(2013-1#1)
theories of prosody##2##3##(2010-9#2)
theories of the##4##3##(1990-7#1)(1997-6#1)(2006-4#1)(2006-7#1)
theories of these##3##3##(2008-3#1)(2013-1#2)
theories of##67##2##(1990-12#1)(1990-7#2)(1991-8#1)(1992-12#1)(1993-2#2)(1993-6#2)(1994-1#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-3#2)(1996-4#1)(1997-4#1)(1997-6#2)(2005-10#1)(2005-7#1)(2006-10#3)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-9#2)(2012-12#2)(2013-1#3)
theories on##5##2##(1992-3#1)(1995-6#1)(2008-9#1)(2010-4#1)(2012-12#1)
theories that##14##2##(2005-10#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-4#1)(2009-8#1)(2010-9#1)(2012-1#1)
theories to##3##2##(2008-3#1)(2010-9#1)(2013-8#1)
theories were##2##2##(2008-11#1)(2010-1#1)
theories with a##2##3##(2008-2#1)(2012-11#1)
theories##257##1##(1990-12#1)(1990-6#1)(1990-7#2)(1991-8#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-6#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#2)(1994-1#4)(1994-12#2)(1994-3#1)(1994-5#2)(1994-6#1)(1995-1#2)(1995-11#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-3#2)(1996-4#1)(1997-1#1)(1997-4#1)(1997-6#4)(1997-8#1)(2004-2#1)(2005-10#3)(2005-11#1)(2005-7#1)(2006-10#6)(2006-2#3)(2006-4#1)(2006-5#7)(2006-6#3)(2006-7#4)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#14)(2007-4#1)(2007-5#1)(2007-8#8)(2007-9#4)(2008-1#2)(2008-10#2)(2008-11#6)(2008-12#4)(2008-2#13)(2008-3#7)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#5)(2009-5#2)(2009-6#1)(2009-8#5)(2010-1#4)(2010-10#7)(2010-12#2)(2010-2#5)(2010-4#2)(2010-6#2)(2010-7#4)(2010-8#2)(2010-9#4)(2011-1#4)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#10)(2013-8#8)
theorists##8##1##(1994-3#1)(1995-3#1)(1996-2#1)(2008-12#1)(2009-10#2)(2010-5#1)(2011-12#1)
theorize##3##1##(2009-10#2)(2009-6#1)
theorized that##2##2##(1996-5#1)(2013-8#1)
theorized##6##1##(1996-5#1)(2009-10#1)(2010-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
theorizing##5##1##(2008-12#1)(2008-3#1)(2010-10#1)(2012-11#1)(2013-8#1)
theory (DFT)##12##2##(2007-9#1)(2008-11#1)(2009-3#1)(2010-5#4)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#2)
theory I##3##2##(1995-6#2)(2006-12#1)
theory about the##2##3##(2005-11#1)(2008-8#1)
theory about##4##2##(2005-11#1)(2008-8#1)(2010-1#1)(2012-12#1)
theory accurately predicts##2##3##(1996-1#1)(2006-10#1)
theory allows##2##2##(2008-1#1)(2008-10#1)
theory also##3##2##(2007-11#1)(2008-2#1)(2008-9#1)
theory and a##4##3##(1994-2#1)(2008-2#1)(2008-3#1)(2013-7#1)
theory and an experimental##2##4##(2008-2#1)(2008-3#1)
theory and an##4##3##(2008-2#1)(2008-3#1)(2008-9#1)(2012-2#1)
theory and application of##2##4##(2007-4#1)(2008-4#1)
theory and application##3##3##(1992-2#1)(2007-4#1)(2008-4#1)
theory and applications to molecular systems##2##6##(2013-1#2)
theory and applications##4##3##(2010-11#1)(2012-3#1)(2013-1#2)
theory and clinical##3##3##(1993-12#1)(1997-2#1)(2012-3#1)
theory and computation##2##3##(2008-10#1)(2010-7#1)
theory and computer##2##3##(2008-2#1)(2008-3#1)
theory and empirical##3##3##(2010-7#1)(2013-1#2)
theory and experiment##19##3##(1992-5#1)(1992-6#1)(2005-11#1)(2007-11#2)(2007-12#3)(2008-2#6)(2008-3#4)(2008-5#1)
theory and experimental results##2##4##(2007-12#1)(2008-3#1)
theory and experimental##4##3##(2007-12#1)(2008-1#1)(2008-3#2)
theory and experiments##2##3##(2008-2#1)(2013-8#1)
theory and indicate that##2##4##(2007-12#1)(2008-8#1)
theory and is##2##3##(2007-12#1)(2008-2#1)
theory and its application##2##4##(1993-2#1)(2008-11#1)
theory and its##5##3##(1993-2#1)(1994-6#1)(1997-6#1)(2005-10#1)(2008-11#1)
theory and other##3##3##(2006-10#1)(2009-6#1)(2010-6#1)
theory and practice in##2##4##(1991-6#1)(2012-3#1)
theory and practice of##3##4##(1995-1#1)(1997-3#1)(2009-2#1)
theory and practice##20##3##(1991-3#1)(1991-6#1)(1992-8#1)(1995-1#1)(1997-3#2)(2006-9#1)(2008-11#4)(2008-12#5)(2008-8#1)(2009-2#1)(2012-3#2)
theory and present##3##3##(1993-12#1)(2008-2#2)
theory and research on the##2##5##(2008-5#1)(2008-9#1)
theory and research##8##3##(1991-12#1)(1993-2#1)(2008-11#1)(2008-5#3)(2008-9#1)(2010-2#1)
theory and suggest that##2##4##(2011-2#1)(2013-1#1)
theory and the experimental results##3##5##(1990-12#1)(2008-2#2)
theory and the##16##3##(1990-12#1)(1994-2#1)(2005-4#1)(2008-2#4)(2008-3#6)(2008-5#1)(2009-6#1)(2012-3#1)
theory and##193##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-10#1)(1993-12#5)(1993-2#4)(1993-3#2)(1994-2#3)(1994-6#1)(1995-1#1)(1995-8#1)(1997-2#1)(1997-3#2)(1997-6#1)(2005-10#1)(2005-11#4)(2005-4#2)(2005-6#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-9#1)(2007-11#4)(2007-12#10)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#6)(2008-12#8)(2008-2#26)(2008-3#31)(2008-4#3)(2008-5#5)(2008-6#1)(2008-8#6)(2008-9#3)(2009-11#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#4)(2009-7#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#6)(2013-1#6)(2013-7#3)(2013-8#2)
theory applied to##2##3##(2008-2#1)(2011-12#1)
theory approach to##4##3##(2008-1#1)(2008-11#1)(2008-2#1)(2013-1#1)
theory approach##15##2##(2006-7#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2009-11#2)(2010-3#1)(2010-8#1)(2012-3#1)(2013-1#2)
theory are compared with##3##4##(2008-3#3)
theory are used##4##3##(2008-2#1)(2008-3#2)(2012-12#1)
theory are##16##2##(1996-11#1)(2007-11#1)(2008-2#1)(2008-3#7)(2008-8#1)(2009-9#1)(2010-10#1)(2011-2#2)(2012-12#1)
theory as a##2##3##(1993-9#1)(2006-7#1)
theory as an##2##3##(2006-5#1)(2008-11#1)
theory as well as##4##4##(1993-10#1)(2008-2#1)(2008-3#2)
theory as##11##2##(1990-8#1)(1993-10#1)(1993-9#1)(2005-11#1)(2006-5#1)(2006-7#1)(2008-11#1)(2008-2#2)(2008-3#2)
theory at##3##2##(1992-8#1)(2007-9#1)(2008-10#1)
theory based on##5##3##(2007-11#1)(2007-12#1)(2008-2#2)(2011-2#1)
theory based##6##2##(2007-11#1)(2007-12#1)(2008-2#2)(2011-2#1)(2013-8#1)
theory behind the##3##3##(2010-6#1)(2012-1#1)(2013-8#1)
theory behind##5##2##(2007-11#1)(2008-2#1)(2010-6#1)(2012-1#1)(2013-8#1)
theory building##4##2##(1995-3#1)(2007-9#1)(2008-5#2)
theory by considering##2##3##(1994-2#1)(2008-3#1)
theory by using##2##3##(2008-3#1)(2008-9#1)
theory by##10##2##(1994-2#1)(1996-8#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-8#1)(2008-9#1)
theory calculations##8##2##(2006-2#2)(2008-3#2)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#1)
theory can be used to##4##5##(2008-2#2)(2008-3#1)(2011-1#1)
theory can be used##5##4##(2008-2#3)(2008-3#1)(2011-1#1)
theory can be##11##3##(1994-11#1)(2007-9#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#1)(2009-9#1)(2011-1#1)
theory can explain##2##3##(2010-2#1)(2012-3#1)
theory can##14##2##(1991-8#1)(1994-11#1)(2007-9#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-2#1)(2011-1#1)(2012-3#1)
theory cannot##2##2##(2008-8#1)(2012-2#1)
theory concerning##3##2##(2007-12#1)(2010-1#1)(2012-2#1)
theory contends that##2##3##(2008-1#1)(2012-12#1)
theory could be used##2##4##(1992-6#1)(2008-10#1)
theory could be##3##3##(1992-6#1)(2008-10#1)(2010-6#1)
theory developed##8##2##(1993-2#1)(2005-11#3)(2006-4#1)(2007-10#1)(2008-3#1)(2008-8#1)
theory development##5##2##(2008-8#2)(2009-8#2)(2010-2#1)
theory emphasizes the importance of##2##5##(1995-2#1)(2009-7#1)
theory explaining the##2##3##(2007-10#1)(2012-12#1)
theory explaining##3##2##(1996-5#1)(2007-10#1)(2012-12#1)
theory explains##2##2##(2009-3#1)(2009-5#1)
theory for a new##2##4##(2008-10#1)(2008-3#1)
theory for a##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
theory for an##2##3##(2008-2#2)
theory for homogeneous##2##3##(2008-10#1)(2008-2#1)
theory for the evolution of##2##5##(2007-12#1)(2008-8#1)
theory for the##14##3##(2005-11#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-8#1)
theory for##66##2##(1991-12#1)(1992-12#1)(1992-3#1)(1994-6#2)(1995-11#1)(1995-5#1)(1996-2#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-7#1)(2007-11#2)(2007-12#6)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#11)(2008-3#18)(2008-8#3)(2008-9#1)(2009-2#1)(2010-1#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-3#1)
theory framework##2##2##(2012-12#1)(2012-3#1)
theory from##3##2##(2007-11#1)(2008-8#1)(2009-12#1)
theory gives##2##2##(2008-10#1)(2008-3#1)
theory has been##9##3##(1992-8#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-6#1)(2008-7#1)
theory has##18##2##(1992-8#1)(1997-8#1)(2005-10#1)(2006-7#2)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-2#1)
theory have##4##2##(2008-10#1)(2010-11#1)(2010-12#1)(2010-2#1)
theory in practice##3##3##(2008-12#2)(2013-8#1)
theory in the##5##3##(1990-7#1)(1994-2#1)(2007-9#1)(2008-11#1)(2009-6#1)
theory in##25##2##(1990-7#1)(1994-2#1)(1995-2#1)(1996-3#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2011-1#2)(2012-3#1)(2013-1#1)(2013-8#1)
theory indicates that the##2##4##(1991-11#1)(2008-8#1)
theory into practice##2##3##(1997-4#1)(2008-11#1)
theory involving##2##2##(1992-6#1)(1994-6#1)
theory is applied to##2##4##(2008-3#2)
theory is applied##3##3##(2008-2#1)(2008-3#2)
theory is described##2##3##(2008-3#1)(2009-10#1)
theory is developed from##2##4##(1990-8#1)(2008-3#1)
theory is developed##4##3##(1990-8#1)(2008-3#3)
theory is extended to include##2##5##(1993-3#1)(2008-3#1)
theory is extended to##3##4##(1993-3#1)(2008-2#1)(2008-3#1)
theory is illustrated##2##3##(1991-1#1)(2008-2#1)
theory is not##2##3##(1995-9#1)(2005-11#1)
theory is presented for the##2##5##(1990-8#1)(2008-10#1)
theory is presented that##2##4##(2005-11#1)(2007-12#1)
theory is presented##9##3##(1990-8#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)
theory is proposed for##2##4##(1990-5#1)(2008-2#1)
theory is proposed in##2##4##(2008-2#1)(2013-8#1)
theory is proposed##4##3##(1990-5#1)(2008-2#2)(2013-8#1)
theory is shown to##2##4##(2008-2#1)(2008-3#1)
theory is still##2##3##(2009-3#1)(2010-12#1)
theory is tested##2##3##(2008-3#1)(2010-4#1)
theory is that##2##3##(2008-2#1)(2008-8#1)
theory is used to##8##4##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)(2010-4#1)(2012-12#1)
theory is##75##2##(1990-5#1)(1990-8#3)(1991-1#2)(1991-2#1)(1991-8#1)(1993-3#1)(1995-9#1)(2005-11#2)(2006-2#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#11)(2008-3#20)(2008-5#1)(2008-8#2)(2009-10#1)(2009-3#1)(2009-6#1)(2009-9#2)(2010-12#1)(2010-4#2)(2011-1#1)(2011-12#1)(2012-12#1)(2013-8#2)
theory may##2##2##(1993-6#1)(2010-10#1)
theory method was##2##3##(2007-10#1)(2013-1#1)
theory method##5##2##(2007-10#1)(2008-11#1)(2008-3#1)(2013-1#1)(2013-8#1)
theory methods##2##2##(2010-7#1)(2013-1#1)
theory of X-ray##2##3##(2006-4#1)(2006-5#1)
theory of a##3##3##(2006-12#1)(2007-11#1)(2008-2#1)
theory of aging is##2##4##(2009-12#1)(2013-8#1)
theory of aging##9##3##(1994-6#1)(1997-6#1)(2009-12#2)(2009-5#2)(2013-8#3)
theory of beauty##2##3##(2006-12#2)
theory of behavior##2##3##(2009-9#1)(2011-2#1)
theory of diffraction##2##3##(2007-12#1)(2008-3#1)
theory of energy coding##2##4##(2008-11#2)
theory of evolution##4##3##(1991-8#1)(2009-2#2)(2012-2#1)
theory of global##2##3##(1990-8#1)(2008-4#1)
theory of image formation##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
theory of image##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
theory of knowledge##2##3##(1996-1#2)
theory of light##3##3##(2007-11#2)(2009-5#1)
theory of management##2##3##(1996-1#1)(2008-1#1)
theory of mind in##4##4##(2006-2#2)(2008-7#1)(2012-1#1)
theory of mind tasks##2##4##(2006-2#2)
theory of mind##19##3##(2006-2#9)(2006-3#1)(2008-11#2)(2008-12#2)(2008-7#1)(2009-4#1)(2012-1#2)(2013-1#1)
theory of molecular evolution##2##4##(1994-8#1)(1997-6#1)
theory of molecular##3##3##(1994-8#1)(1997-6#1)(2006-10#1)
theory of multiple##2##3##(1992-3#1)(2008-2#1)
theory of nationalism##2##3##(2011-1#2)
theory of personality##2##3##(2007-1#1)(2007-8#1)
theory of planned behaviour##2##4##(2006-9#1)(2012-1#1)
theory of planned##3##3##(2006-9#1)(2008-3#1)(2012-1#1)
theory of radiation##2##3##(2008-3#1)(2008-7#1)
theory of reasoned##2##3##(2006-9#1)(2008-3#1)
theory of schizophrenia##2##3##(1996-11#1)(2005-7#1)
theory of soliton-induced waveguides##2##4##(2007-12#2)
theory of spherical##2##3##(2008-10#1)(2008-2#1)
theory of stochastic##2##3##(2008-10#1)(2008-8#1)
theory of the double-edge technique##2##5##(2008-2#1)(2008-3#1)
theory of the double-edge##3##4##(2008-2#2)(2008-3#1)
theory of the inalienable right to life and liberty is enforced by the Thirteenth Amendment##2##15##(2011-2#2)
theory of the inalienable right to life and liberty##3##9##(2011-2#3)
theory of the speckle velocimeter##2##5##(2008-3#2)
theory of the##24##3##(1993-2#1)(1995-11#1)(1995-8#1)(2005-11#1)(2006-3#2)(2007-11#1)(2008-2#4)(2008-3#7)(2008-4#1)(2011-2#4)(2012-3#1)
theory of these##2##3##(2007-12#1)(2008-3#1)
theory of this##5##3##(1990-8#1)(2007-12#1)(2008-2#1)(2008-3#2)
theory of three-dimensional radiance measurements##2##5##(2008-2#2)
theory of##289##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#4)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#2)(1992-12#6)(1992-3#3)(1992-8#1)(1993-2#3)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-7#1)(1995-8#4)(1996-1#3)(1996-11#1)(1996-4#1)(1996-5#2)(1997-2#1)(1997-5#1)(1997-6#2)(2004-3#1)(2005-10#1)(2005-11#7)(2005-4#2)(2005-7#2)(2006-10#4)(2006-12#4)(2006-2#9)(2006-3#4)(2006-4#2)(2006-5#1)(2006-7#2)(2006-8#1)(2006-9#3)(2007-1#2)(2007-10#1)(2007-11#8)(2007-12#15)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#9)(2008-11#5)(2008-12#2)(2008-2#19)(2008-3#31)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#5)(2009-10#1)(2009-12#5)(2009-2#4)(2009-3#1)(2009-4#4)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#3)(2010-2#1)(2010-4#2)(2010-7#2)(2011-1#5)(2011-2#7)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#8)
theory often##2##2##(2008-8#1)(2008-9#1)
theory on the##4##3##(1994-6#1)(2007-9#1)(2008-3#1)(2010-7#1)
theory on##11##2##(1994-6#1)(2006-11#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-9#1)(2013-1#1)
theory or##4##2##(2006-7#1)(2008-2#1)(2009-2#1)(2009-8#1)
theory posits##2##2##(2009-7#1)(2011-12#1)
theory postulates##2##2##(1996-5#1)(2005-10#1)
theory predictions##4##2##(2005-11#1)(2008-3#1)(2008-9#1)(2012-2#1)
theory predicts that the##3##4##(1990-3#1)(2008-10#1)(2012-3#1)
theory predicts that##7##3##(1990-3#1)(1993-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-2#1)(2012-3#1)
theory predicts##11##2##(1990-3#1)(1993-3#2)(2006-7#1)(2008-10#1)(2008-2#1)(2008-7#2)(2008-8#1)(2009-2#1)(2012-3#1)
theory provides a useful framework for##2##6##(2009-12#1)(2010-2#1)
theory provides a##4##3##(1994-3#1)(2008-3#1)(2009-12#1)(2010-2#1)
theory provides##11##2##(1994-3#1)(2006-2#1)(2007-11#1)(2007-9#1)(2008-2#1)(2008-3#1)(2009-12#1)(2009-3#1)(2010-2#1)(2013-1#2)
theory regarding the##2##3##(2006-3#1)(2012-2#1)
theory relating##2##2##(1994-3#1)(2008-10#1)
theory requires##4##2##(1991-9#1)(2007-7#1)(2008-2#1)(2008-8#1)
theory reveals that##2##3##(2008-2#1)(2008-8#1)
theory reveals##3##2##(2008-2#2)(2008-8#1)
theory show that the##3##4##(2006-2#1)(2008-3#2)
theory show that##4##3##(2006-2#1)(2008-3#3)
theory show##5##2##(2006-2#1)(2008-1#1)(2008-3#3)
theory shows that##2##3##(2008-3#1)(2012-3#1)
theory since##2##2##(1993-5#1)(2005-11#1)
theory suggests that##3##3##(1995-4#1)(2008-8#1)(2011-2#1)
theory that describes##2##3##(2008-2#1)(2009-5#1)
theory that is##2##3##(2009-7#1)(2010-7#1)
theory that the##4##3##(1992-4#1)(1994-4#1)(2007-6#1)(2008-7#1)
theory that uses##2##3##(2007-12#1)(2009-5#1)
theory that##48##2##(1991-11#1)(1992-4#1)(1994-4#1)(1995-1#2)(1995-2#1)(2004-2#1)(2006-12#2)(2006-8#1)(2007-11#1)(2007-12#5)(2007-6#3)(2007-8#1)(2007-9#2)(2008-1#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#3)(2009-5#3)(2009-7#1)(2009-8#1)(2010-1#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-12#1)(2012-3#1)
theory the##3##2##(1997-1#1)(2005-10#1)(2008-2#1)
theory to account for the##2##5##(1992-8#1)(2008-8#1)
theory to compute the##2##4##(2007-12#1)(2008-2#1)
theory to describe the##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
theory to describe##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
theory to explain the##2##4##(2007-11#1)(2009-3#1)
theory to practice in##2##4##(2008-11#2)
theory to practice##12##3##(1996-2#2)(2008-11#8)(2008-12#1)(2008-6#1)
theory to show##2##3##(2007-11#1)(2008-8#1)
theory to the##7##3##(1991-6#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-2#1)(2009-3#1)
theory to##72##2##(1991-1#1)(1991-6#1)(1992-8#1)(1993-3#2)(1996-1#1)(1996-2#2)(1997-3#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-3#1)(2007-11#4)(2007-12#5)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#10)(2008-12#2)(2008-2#10)(2008-3#5)(2008-6#1)(2008-8#5)(2008-9#2)(2009-11#1)(2009-3#2)(2009-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
theory tools##2##2##(1996-3#2)
theory using the##2##3##(2007-10#1)(2008-11#1)
theory using##4##2##(1994-6#1)(2007-10#1)(2008-11#1)(2008-9#1)
theory was applied to##2##4##(2010-8#1)(2012-12#1)
theory was developed##2##3##(2008-9#1)(2010-2#1)
theory was used to model##2##5##(2008-2#2)
theory was used to##3##4##(2008-2#2)(2012-12#1)
theory was used##4##3##(2008-2#3)(2012-12#1)
theory was##16##2##(1990-5#1)(2006-11#1)(2007-12#1)(2008-11#1)(2008-2#4)(2008-9#1)(2009-2#2)(2010-2#2)(2010-8#1)(2012-12#2)
theory we##3##2##(1995-6#1)(2006-10#1)(2008-3#1)
theory were##2##2##(2008-10#1)(2010-10#1)
theory which##4##2##(1990-12#1)(1990-3#1)(1996-1#1)(1997-8#1)
theory while##2##2##(1995-1#1)(2008-1#1)
theory with a##3##3##(2008-2#1)(2008-8#1)(2009-3#1)
theory with practice##3##3##(1991-2#1)(1993-12#1)(2008-11#1)
theory with the##2##3##(2005-4#1)(2008-1#1)
theory with##20##2##(1991-2#1)(1993-12#1)(1993-5#1)(2005-11#1)(2005-4#1)(2006-6#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-2#4)(2008-8#1)(2008-9#1)(2009-3#1)(2012-12#1)(2012-2#1)
theory##1707##1##(1990-11#2)(1990-12#6)(1990-3#4)(1990-5#5)(1990-7#1)(1990-8#8)(1991-1#3)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#2)(1991-4#1)(1991-6#3)(1991-8#4)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#7)(1992-2#2)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#5)(1992-8#6)(1993-1#2)(1993-10#3)(1993-12#6)(1993-2#8)(1993-3#9)(1993-4#1)(1993-5#2)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#3)(1994-11#2)(1994-12#3)(1994-2#6)(1994-3#5)(1994-4#1)(1994-5#2)(1994-6#7)(1994-8#1)(1995-1#4)(1995-11#2)(1995-12#2)(1995-2#7)(1995-3#3)(1995-4#3)(1995-5#1)(1995-6#5)(1995-7#2)(1995-8#11)(1995-9#1)(1996-1#8)(1996-11#3)(1996-2#9)(1996-3#4)(1996-4#1)(1996-5#5)(1996-8#1)(1997-1#1)(1997-2#5)(1997-3#4)(1997-4#2)(1997-5#3)(1997-6#6)(1997-7#1)(1997-8#2)(2004-10#1)(2004-2#2)(2004-3#1)(2005-10#6)(2005-11#42)(2005-4#5)(2005-6#1)(2005-7#2)(2006-1#1)(2006-10#29)(2006-11#2)(2006-12#12)(2006-2#16)(2006-3#10)(2006-4#6)(2006-5#3)(2006-6#1)(2006-7#18)(2006-8#3)(2006-9#5)(2007-1#2)(2007-10#8)(2007-11#47)(2007-12#92)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#5)(2007-7#2)(2007-8#11)(2007-9#15)(2008-1#27)(2008-10#58)(2008-11#52)(2008-12#24)(2008-2#189)(2008-3#221)(2008-4#11)(2008-5#11)(2008-6#11)(2008-7#23)(2008-8#55)(2008-9#30)(2009-10#4)(2009-11#5)(2009-12#7)(2009-2#14)(2009-3#16)(2009-4#7)(2009-5#15)(2009-6#11)(2009-7#12)(2009-8#12)(2009-9#12)(2010-1#5)(2010-10#7)(2010-11#2)(2010-12#4)(2010-2#17)(2010-3#7)(2010-4#12)(2010-5#4)(2010-6#4)(2010-7#15)(2010-8#5)(2010-9#3)(2011-1#19)(2011-12#8)(2011-2#27)(2011-3#1)(2012-1#8)(2012-11#3)(2012-12#25)(2012-2#25)(2012-3#23)(2013-1#30)(2013-7#7)(2013-8#26)
theory&quot##2##1##(1997-2#1)(2007-6#1)
theory's##4##1##(1991-8#1)(1995-2#1)(2008-10#1)(2008-2#1)
theory)##3##1##(1996-8#1)(2010-1#1)(2013-8#1)
theory-based problem-solving approach##2##3##(2010-10#2)
theory-based##9##1##(1995-3#1)(1997-1#1)(2007-7#1)(2008-6#1)(2010-10#2)(2013-1#3)
theory-building##2##1##(2007-5#1)(2008-5#1)
theory-driven research##2##2##(2009-8#2)
theory-driven##5##1##(2008-2#1)(2009-8#2)(2011-1#2)
theory-of-mind##5##1##(2006-3#1)(2008-9#4)
theory-practice gap##8##2##(2008-11#8)
theory-practice##10##1##(2008-11#8)(2012-3#1)(2013-1#1)
theory?##3##1##(1990-8#1)(2008-8#1)(2010-1#1)
theother two carriers##2##3##(2008-11#2)
theother##3##1##(2008-11#3)
thepatient##3##1##(2009-8#1)(2013-8#2)
thepresence of##4##2##(2008-11#4)
thepresence##6##1##(2008-11#5)(2013-8#1)
theprimary cells##2##2##(2008-11#2)
theproduction of##2##2##(2008-11#2)
theranostic agents##2##2##(2012-12#2)
theranostic##4##1##(2012-11#2)(2012-12#2)
therapeutic Abs##2##2##(2010-1#2)
therapeutic aPTT##4##2##(2006-9#4)
therapeutic action of##4##3##(1994-8#1)(2008-9#1)(2012-1#2)
therapeutic action##9##2##(1992-7#1)(1994-8#1)(2007-11#1)(2007-7#1)(2008-9#1)(2011-1#2)(2012-1#2)
therapeutic actions of##3##3##(1996-1#1)(1996-10#1)(2006-4#1)
therapeutic actions##6##2##(1996-1#1)(1996-10#1)(2006-12#1)(2006-4#1)(2006-6#2)
therapeutic activated partial thromboplastin time (aPTT)##2##6##(2006-9#2)
therapeutic activity of##3##3##(1990-2#1)(2007-11#1)(2013-1#1)
therapeutic activity##7##2##(1990-2#1)(1993-9#1)(1996-3#1)(2007-11#1)(2008-1#1)(2010-2#1)(2013-1#1)
therapeutic adherence##3##2##(2008-12#1)(2008-3#2)
therapeutic administration of##3##3##(1991-12#1)(1992-2#1)(2012-1#1)
therapeutic administration##4##2##(1991-12#1)(1992-2#1)(2006-10#1)(2012-1#1)
therapeutic advances##5##2##(2006-10#2)(2006-12#1)(2006-9#2)
therapeutic advantage in##3##3##(1990-12#1)(1994-12#1)(2009-6#1)
therapeutic advantage##4##2##(1990-12#1)(1994-12#1)(2009-6#2)
therapeutic advantages##5##2##(2006-5#1)(2007-5#1)(2008-10#1)(2008-8#1)(2012-3#1)
therapeutic agent for##6##3##(1991-12#1)(1994-6#1)(1995-3#1)(2008-1#1)(2008-7#1)(2012-2#1)
therapeutic agent in##5##3##(1990-2#1)(2005-7#1)(2007-11#1)(2008-6#1)(2008-7#1)
therapeutic agent##20##2##(1990-2#1)(1991-12#1)(1992-3#1)(1994-6#1)(1995-3#1)(1996-8#1)(2005-7#1)(2007-11#2)(2008-1#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#2)(2010-10#1)(2010-12#1)(2012-2#1)(2012-3#1)
therapeutic agents against##4##3##(1994-12#1)(2008-11#1)(2008-8#1)(2010-1#1)
therapeutic agents and##3##3##(2005-8#1)(2008-6#1)(2009-11#1)
therapeutic agents are##5##3##(2006-10#1)(2008-5#1)(2009-8#1)(2010-11#1)(2010-5#1)
therapeutic agents for cancer##3##4##(1995-6#1)(2008-1#1)(2012-12#1)
therapeutic agents for the treatment of##3##6##(1994-12#1)(2005-7#1)(2009-6#1)
therapeutic agents for the##5##4##(1994-12#1)(2005-7#1)(2008-1#1)(2009-12#1)(2009-6#1)
therapeutic agents for##22##3##(1992-12#1)(1994-11#1)(1994-12#1)(1995-6#1)(2005-7#3)(2005-8#1)(2007-5#1)(2008-1#2)(2008-4#1)(2008-8#2)(2009-12#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-12#2)(2012-2#1)
therapeutic agents has##3##3##(2008-10#1)(2008-4#1)(2012-12#1)
therapeutic agents have been##2##4##(2007-12#1)(2010-5#1)
therapeutic agents have##3##3##(2007-12#1)(2008-7#1)(2010-5#1)
therapeutic agents in##4##3##(2006-7#1)(2007-11#1)(2008-1#1)(2013-8#1)
therapeutic agents on##2##3##(1996-8#1)(2008-9#1)
therapeutic agents such as##3##4##(2007-2#1)(2013-1#1)(2013-8#1)
therapeutic agents that##4##3##(2006-10#1)(2008-6#1)(2008-7#1)(2010-7#1)
therapeutic agents to the##2##4##(2007-11#1)(2011-1#1)
therapeutic agents to treat##2##4##(2008-1#1)(2008-7#1)
therapeutic agents to##8##3##(2005-7#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-11#1)(2011-1#1)
therapeutic agents will##2##3##(2006-10#1)(2009-4#1)
therapeutic agents with##3##3##(2008-5#1)(2009-2#1)(2012-12#1)
therapeutic agents##114##2##(1990-9#1)(1991-9#1)(1992-12#1)(1994-11#1)(1994-12#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-8#1)(1997-1#1)(2005-7#7)(2005-8#3)(2005-9#1)(2006-10#9)(2006-7#2)(2007-11#5)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#6)(2008-10#1)(2008-11#2)(2008-3#3)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#2)(2009-1#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#2)(2010-12#1)(2010-5#5)(2010-7#1)(2011-1#4)(2011-12#1)(2011-2#1)(2012-12#4)(2012-2#1)(2013-1#4)(2013-8#2)
therapeutic aim##2##2##(2006-8#1)(2008-4#1)
therapeutic alliance with##2##3##(2008-3#1)(2008-6#1)
therapeutic alliance##11##2##(1992-8#1)(2006-5#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#2)(2011-1#1)(2013-1#1)
therapeutic alternative for the##2##4##(2006-10#1)(2011-2#1)
therapeutic alternative in##2##3##(1992-4#1)(1995-11#1)
therapeutic alternative that##2##3##(2006-2#1)(2010-9#1)
therapeutic alternative##8##2##(1992-4#1)(1994-11#1)(1995-11#1)(2006-10#1)(2006-2#1)(2009-2#1)(2010-9#1)(2011-2#1)
therapeutic alternatives##6##2##(2005-7#1)(2006-10#1)(2007-8#1)(2010-12#1)(2012-2#1)(2013-8#1)
therapeutic and diagnostic##6##3##(1995-4#1)(2006-8#1)(2007-11#1)(2008-11#1)(2008-5#1)(2012-2#1)
therapeutic and preventive strategies##2##4##(2006-10#1)(2008-10#1)
therapeutic and preventive##5##3##(2006-10#1)(2007-8#1)(2008-10#1)(2011-1#1)(2011-2#1)
therapeutic and prognostic implications##2##4##(2007-12#1)(2010-7#1)
therapeutic and prognostic##3##3##(1993-5#1)(2007-12#1)(2010-7#1)
therapeutic and prophylactic##2##3##(2009-10#1)(2009-7#1)
therapeutic and social use##2##4##(2005-10#2)
therapeutic and##41##2##(1991-9#1)(1993-5#2)(1994-4#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-4#1)(2005-10#2)(2006-10#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-7#3)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
therapeutic angiogenesis##3##2##(2008-1#3)
therapeutic anti-tumor##2##2##(2009-12#2)
therapeutic antibodies are##2##3##(2008-11#1)(2013-8#1)
therapeutic antibodies in##2##3##(2010-11#1)(2011-1#1)
therapeutic antibodies on##2##3##(2008-11#2)
therapeutic antibodies##14##2##(2008-11#9)(2010-11#2)(2010-7#1)(2011-1#1)(2013-8#1)
therapeutic antibody development##2##3##(2008-10#1)(2011-1#1)
therapeutic antibody##5##2##(2008-10#1)(2010-11#1)(2011-1#2)(2013-8#1)
therapeutic antitumor##2##2##(2006-7#1)(2009-12#1)
therapeutic application of##3##3##(2007-10#1)(2010-3#1)(2013-1#1)
therapeutic application##12##2##(1990-11#1)(1991-1#1)(1991-2#1)(1997-1#1)(2007-10#1)(2009-10#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#2)
therapeutic applications for##6##3##(1994-5#1)(1995-3#1)(2005-7#1)(2008-4#1)(2009-12#1)(2012-12#1)
therapeutic applications in##3##3##(2006-2#1)(2013-1#2)
therapeutic applications of##9##3##(1991-11#1)(1997-8#1)(2005-9#1)(2006-12#1)(2008-1#1)(2008-3#1)(2010-5#1)(2013-1#2)
therapeutic applications##47##2##(1990-7#1)(1991-11#1)(1992-11#1)(1994-5#1)(1995-3#1)(1997-4#1)(1997-8#2)(2005-7#2)(2005-9#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-6#1)(2007-5#1)(2008-1#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#2)(2009-12#2)(2009-2#1)(2009-3#3)(2010-11#1)(2010-5#2)(2012-1#1)(2012-12#3)(2013-1#5)
therapeutic approach against##2##3##(2010-12#1)(2013-1#1)
therapeutic approach and its##2##4##(1991-12#1)(2006-12#1)
therapeutic approach and##6##3##(1990-2#1)(1991-12#1)(1992-12#1)(1996-8#1)(2006-12#1)(2008-10#1)
therapeutic approach for the##2##4##(2008-10#1)(2010-6#1)
therapeutic approach for##16##3##(1992-12#1)(1992-8#1)(1993-10#1)(2005-7#1)(2007-5#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-3#1)(2010-6#1)(2012-12#2)(2013-1#1)
therapeutic approach in##8##3##(1990-6#1)(1991-3#1)(1996-11#1)(2007-8#1)(2012-12#3)(2012-3#1)
therapeutic approach is##8##3##(1990-12#2)(1990-6#1)(1992-6#1)(1993-5#1)(2005-7#1)(2008-10#1)(2008-11#1)
therapeutic approach of##3##3##(1991-6#1)(1997-7#1)(2011-2#1)
therapeutic approach to patients##2##4##(2007-7#1)(2008-7#1)
therapeutic approach to##23##3##(1990-2#1)(1990-3#1)(1992-11#1)(1992-12#1)(1992-9#1)(1996-3#1)(1996-9#2)(2005-7#2)(2006-2#1)(2007-7#2)(2008-1#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
therapeutic approach with##2##3##(1990-12#1)(1992-4#1)
therapeutic approach##105##2##(1990-12#3)(1990-2#2)(1990-3#2)(1990-4#1)(1990-6#2)(1991-12#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#3)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-2#1)(1993-5#2)(1994-5#1)(1995-11#1)(1995-4#1)(1996-11#1)(1996-3#1)(1996-8#1)(1996-9#2)(1997-5#1)(1997-7#1)(1997-8#2)(2005-6#1)(2005-7#4)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-9#1)(2007-11#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#4)(2008-11#2)(2008-2#2)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#3)(2009-1#1)(2009-10#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#3)(2011-7#1)(2012-12#6)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
therapeutic approach]##4##2##(1991-6#1)(1997-3#1)(2008-8#1)(2009-1#1)
therapeutic approaches against##2##3##(2005-10#1)(2008-1#1)
therapeutic approaches and##2##3##(2005-7#1)(2007-11#1)
therapeutic approaches are being actively developed##2##6##(2006-10#2)
therapeutic approaches are##8##3##(2005-9#1)(2006-10#3)(2011-2#1)(2011-3#1)(2012-12#1)(2013-7#1)
therapeutic approaches for the treatment of##2##6##(1993-11#1)(2004-12#1)
therapeutic approaches for the##6##4##(1990-7#1)(1993-11#1)(2004-12#1)(2010-11#1)(2012-12#2)
therapeutic approaches for##15##3##(1990-5#1)(1990-7#1)(1991-9#1)(1993-11#1)(2004-12#1)(2005-7#1)(2007-11#2)(2008-9#1)(2009-3#1)(2009-4#1)(2010-11#1)(2012-12#3)
therapeutic approaches in the##2##4##(2010-5#1)(2012-2#1)
therapeutic approaches in##7##3##(1991-12#1)(1996-11#1)(2008-12#1)(2010-5#1)(2010-6#1)(2012-12#1)(2012-2#1)
therapeutic approaches may##2##3##(2008-11#1)(2008-6#1)
therapeutic approaches that##4##3##(2006-11#1)(2010-6#1)(2012-1#1)(2012-2#1)
therapeutic approaches to these##2##4##(2006-10#1)(2008-4#1)
therapeutic approaches to##14##3##(1995-4#1)(1996-2#1)(1997-1#1)(2006-10#1)(2008-1#3)(2008-4#1)(2008-7#1)(2010-11#2)(2010-4#1)(2012-12#1)(2013-1#1)
therapeutic approaches were##2##3##(2005-9#2)
therapeutic approaches which##2##3##(1991-7#1)(2008-5#1)
therapeutic approaches##103##2##(1990-12#2)(1990-5#2)(1990-7#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-5#1)(1993-11#1)(1995-4#1)(1996-11#1)(1996-2#1)(1997-1#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-7#2)(2005-8#3)(2005-9#3)(2006-10#8)(2006-11#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-11#6)(2008-1#6)(2008-10#2)(2008-11#4)(2008-12#1)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#2)(2009-4#1)(2010-11#3)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#7)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
therapeutic area##2##2##(1996-12#1)(2005-8#1)
therapeutic areas##3##2##(2005-8#1)(2005-9#1)(2008-12#1)
therapeutic armamentarium##7##2##(1990-1#1)(1990-12#1)(2007-4#1)(2008-7#1)(2009-11#1)(2010-11#1)(2012-12#1)
therapeutic arsenal##3##2##(1990-5#1)(2009-9#1)(2012-12#1)
therapeutic aspects and##2##3##(1990-9#1)(2007-8#1)
therapeutic aspects of##9##3##(1990-9#1)(1992-5#1)(1993-6#1)(1994-3#1)(2007-12#1)(2007-5#1)(2007-8#1)(2011-1#1)(2012-3#1)
therapeutic aspects##20##2##(1990-9#2)(1991-4#2)(1992-5#1)(1993-5#1)(1993-6#1)(1994-3#1)(1996-4#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
therapeutic avenues##4##2##(1996-11#1)(2007-6#1)(2009-3#1)(2011-2#1)
therapeutic benefit and##2##3##(2006-6#1)(2013-1#1)
therapeutic benefit in this##2##4##(2008-3#1)(2010-12#1)
therapeutic benefit in##6##3##(1995-10#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-12#1)
therapeutic benefit of the##2##4##(2007-11#1)(2008-11#1)
therapeutic benefit of##7##3##(2007-11#2)(2008-11#1)(2008-2#1)(2011-2#1)(2012-1#1)(2013-1#1)
therapeutic benefit##31##2##(1990-6#1)(1994-3#1)(1995-10#1)(1995-9#1)(1996-11#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-6#1)(2007-10#1)(2007-11#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-11#1)(2009-4#1)(2010-12#3)(2011-2#1)(2012-1#2)(2013-1#3)(2013-8#1)
therapeutic benefits of##2##3##(2005-10#1)(2008-3#1)
therapeutic benefits##12##2##(2005-10#2)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2009-11#1)(2010-3#1)(2011-1#1)(2013-1#1)
therapeutic bronchoscopy##2##2##(1992-4#1)(2006-6#1)
therapeutic capabilities will##2##3##(2006-10#1)(2007-5#1)
therapeutic capabilities##4##2##(2006-10#2)(2007-5#1)(2011-2#1)
therapeutic challenge for##5##3##(2006-12#1)(2006-9#1)(2009-4#1)(2012-2#2)
therapeutic challenge##19##2##(1993-10#1)(1995-11#1)(1997-7#1)(2005-11#1)(2006-11#1)(2006-12#1)(2006-9#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-6#1)(2009-4#1)(2010-11#1)(2010-5#2)(2012-2#2)
therapeutic challenges to the##2##4##(2007-7#1)(2009-8#1)
therapeutic challenges to##3##3##(2007-7#1)(2008-11#1)(2009-8#1)
therapeutic challenges##8##2##(2005-8#1)(2007-7#1)(2008-11#1)(2008-12#2)(2009-8#1)(2013-1#2)
therapeutic choice##7##2##(1994-6#1)(2006-10#2)(2007-6#1)(2008-1#1)(2010-8#1)(2012-12#1)
therapeutic choices##5##2##(2006-2#1)(2007-11#1)(2010-12#1)(2012-2#1)(2012-3#1)
therapeutic classes##3##2##(1996-11#1)(2008-8#1)(2011-2#1)
therapeutic cloning##6##2##(2006-8#2)(2007-1#1)(2008-11#1)(2008-6#2)
therapeutic combinations##2##2##(2007-6#1)(2010-12#1)
therapeutic communication skills as##2##4##(2008-11#2)
therapeutic communication##4##2##(2008-11#4)
therapeutic communities##2##2##(2008-6#1)(2012-2#1)
therapeutic compliance##3##2##(1993-11#3)
therapeutic compounds##5##2##(1994-5#1)(2008-11#1)(2011-1#1)(2012-12#1)(2012-2#1)
therapeutic concentration##2##2##(2007-11#1)(2008-10#1)
therapeutic concentrations##5##2##(1992-2#1)(1994-8#1)(1997-4#1)(2010-3#1)(2012-12#1)
therapeutic concepts and##2##3##(1992-6#1)(1995-11#1)
therapeutic concepts##4##2##(1992-6#1)(1993-3#1)(1995-11#1)(2012-2#1)
therapeutic consequences##5##2##(1990-11#1)(1990-12#1)(1995-4#1)(2005-11#1)(2006-6#1)
therapeutic considerations]##2##2##(1991-6#2)
therapeutic criteria##2##2##(2011-12#1)(2013-8#1)
therapeutic culture##2##2##(1990-10#2)
therapeutic decision making##4##3##(1991-12#1)(2006-10#1)(2007-10#1)(2011-2#1)
therapeutic decision of##2##3##(1993-11#1)(2011-2#1)
therapeutic decision##9##2##(1990-2#1)(1991-12#1)(1993-11#1)(2006-10#1)(2007-10#1)(2007-5#1)(2011-2#2)(2012-3#1)
therapeutic decision-making##5##2##(1992-2#1)(2007-8#1)(2008-3#1)(2009-9#1)(2012-3#1)
therapeutic decisions and##2##3##(2009-4#1)(2010-5#1)
therapeutic decisions by##2##3##(2007-7#1)(2007-8#1)
therapeutic decisions in##5##3##(2006-12#1)(2009-12#1)(2010-12#2)(2013-8#1)
therapeutic decisions##20##2##(1990-3#1)(1996-6#1)(2006-12#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-2#1)(2013-8#2)
therapeutic development##3##2##(2005-8#1)(2006-12#1)(2013-1#1)
therapeutic developments##4##2##(1991-3#1)(2005-8#1)(2007-11#1)(2008-8#1)
therapeutic devices##2##2##(2012-1#1)(2013-1#1)
therapeutic diets##2##2##(1993-3#1)(1995-2#1)
therapeutic difficulties##8##2##(1993-2#1)(2005-8#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-2#1)(2009-5#1)(2012-12#1)
therapeutic dilemma##6##2##(2006-10#2)(2007-12#1)(2008-6#1)(2010-3#1)(2010-7#1)
therapeutic dilemmas##3##2##(2006-10#1)(2008-6#1)(2011-2#1)
therapeutic dosages##3##2##(1991-9#1)(2008-5#1)(2012-12#1)
therapeutic dose of##2##3##(2006-4#1)(2008-7#1)
therapeutic dose##5##2##(1991-9#1)(2006-4#1)(2008-7#1)(2010-12#2)
therapeutic doses of##5##3##(1991-11#1)(1993-2#1)(1995-4#1)(2006-12#1)(2008-6#1)
therapeutic doses##14##2##(1991-11#2)(1992-11#1)(1993-2#1)(1995-4#1)(1997-8#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-8#1)(2008-6#1)(2008-7#1)(2008-8#2)
therapeutic drug monitoring of##3##4##(1996-11#1)(2008-6#1)(2008-8#1)
therapeutic drug monitoring##12##3##(1996-11#1)(1997-8#2)(2006-10#1)(2008-3#1)(2008-6#2)(2008-8#2)(2009-4#1)(2010-11#2)
therapeutic drug##17##2##(1993-11#1)(1996-11#1)(1997-8#3)(2005-8#1)(2006-10#1)(2008-3#1)(2008-6#3)(2008-8#2)(2009-4#1)(2010-11#2)(2012-2#1)
therapeutic drugs for##5##3##(2010-12#1)(2011-1#3)(2012-12#1)
therapeutic drugs##20##2##(1994-11#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-6#1)(2010-1#1)(2010-12#2)(2010-2#1)(2011-1#4)(2012-12#2)
therapeutic effect and##2##3##(2007-10#1)(2010-6#1)
therapeutic effect in##5##3##(1991-3#1)(2006-10#1)(2009-12#1)(2010-5#1)(2013-8#1)
therapeutic effect is##2##3##(1992-3#1)(2007-11#1)
therapeutic effect of a##2##4##(1994-9#1)(1996-3#1)
therapeutic effect of the##3##4##(2006-4#1)(2008-7#2)
therapeutic effect of##22##3##(1990-5#1)(1994-10#2)(1994-11#1)(1994-9#1)(1996-10#1)(1996-3#1)(2006-4#1)(2006-7#2)(2007-2#2)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#1)(2012-1#1)(2012-2#3)(2012-3#1)
therapeutic effect on##2##3##(1992-3#1)(2008-7#1)
therapeutic effect##45##2##(1990-2#1)(1990-5#1)(1991-2#1)(1991-3#2)(1992-3#2)(1994-10#2)(1994-11#1)(1994-3#1)(1994-9#1)(1996-10#1)(1996-3#1)(1997-4#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-6#1)(2006-7#2)(2007-10#1)(2007-11#2)(2007-2#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2012-1#1)(2012-2#3)(2012-3#2)(2013-8#1)
therapeutic effectiveness in the treatment of##2##6##(1990-3#1)(2008-1#1)
therapeutic effectiveness of##5##3##(1992-6#1)(1996-12#1)(2006-8#1)(2008-7#1)(2009-3#1)
therapeutic effectiveness##11##2##(1990-3#1)(1992-2#1)(1992-6#1)(1993-8#1)(1996-12#1)(2006-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-3#1)(2013-8#1)
therapeutic effects and##2##3##(2010-1#1)(2011-1#1)
therapeutic effects are##2##3##(2007-11#1)(2008-6#1)
therapeutic effects between##2##3##(2006-4#1)(2012-3#1)
therapeutic effects in##5##3##(1993-9#1)(2006-4#1)(2009-7#1)(2013-1#2)
therapeutic effects of the##3##4##(1991-8#1)(2006-6#1)(2013-1#1)
therapeutic effects of##19##3##(1990-7#1)(1991-8#1)(1993-12#1)(1996-1#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-12#1)(2008-4#2)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#2)(2013-1#2)
therapeutic effects on##3##3##(2010-12#1)(2013-1#2)
therapeutic effects##47##2##(1990-7#1)(1991-8#1)(1993-12#1)(1993-9#1)(1996-1#1)(1997-2#1)(2006-12#1)(2006-4#3)(2006-6#1)(2007-11#4)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#2)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#7)
therapeutic efficacy against##2##3##(2008-10#1)(2013-1#1)
therapeutic efficacy and toxicity##2##4##(1990-2#1)(2009-6#1)
therapeutic efficacy and##7##3##(1990-10#1)(1990-2#1)(1990-3#1)(1991-6#1)(2009-6#1)(2013-1#2)
therapeutic efficacy in##4##3##(2005-7#1)(2007-11#2)(2008-1#1)
therapeutic efficacy of an##2##4##(1990-5#1)(2011-2#1)
therapeutic efficacy of glucocorticoid injection##2##5##(2006-10#2)
therapeutic efficacy of the##3##4##(2006-2#1)(2007-11#1)(2012-12#1)
therapeutic efficacy of these drugs##3##5##(1991-8#1)(1994-11#1)(2005-7#1)
therapeutic efficacy of##25##3##(1990-1#1)(1990-5#1)(1991-8#1)(1991-9#1)(1994-11#1)(1995-6#1)(1996-3#1)(1997-3#1)(2005-7#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-5#1)(2009-10#2)(2009-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
therapeutic efficacy on##2##3##(1997-3#1)(2013-1#1)
therapeutic efficacy##59##2##(1990-1#1)(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-3#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-3#1)(1997-3#2)(2005-10#2)(2005-7#3)(2006-10#4)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#5)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-10#2)(2009-12#1)(2009-6#1)(2009-8#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#5)
therapeutic efficiency and##2##3##(2008-7#1)(2011-2#1)
therapeutic efficiency##3##2##(2008-3#1)(2008-7#1)(2011-2#1)
therapeutic efforts##4##2##(2006-6#1)(2007-11#1)(2008-1#1)(2013-1#1)
therapeutic elements##2##2##(2007-7#1)(2009-11#1)
therapeutic embolization##2##2##(2006-2#1)(2006-9#1)
therapeutic emplotment##2##2##(2013-1#2)
therapeutic endoscopists##3##2##(2006-10#1)(2007-5#2)
therapeutic endoscopy in##2##3##(2006-10#1)(2007-5#1)
therapeutic endoscopy##8##2##(1990-2#1)(1991-11#1)(1996-11#1)(2006-10#3)(2007-5#1)(2010-6#1)
therapeutic enhancement of##2##3##(2007-11#1)(2008-1#1)
therapeutic environments has##2##3##(2012-2#2)
therapeutic equivalence##2##2##(2007-12#1)(2008-11#1)
therapeutic exercise##3##2##(2008-12#2)(2012-1#1)
therapeutic exercises##3##2##(2008-7#1)(2010-12#1)(2012-1#1)
therapeutic failure and##2##3##(1993-11#1)(2007-8#1)
therapeutic failure##6##2##(1992-5#1)(1993-11#1)(2006-10#1)(2007-8#1)(2008-10#1)(2012-2#1)
therapeutic failures##3##2##(2009-6#1)(2010-12#1)(2013-8#1)
therapeutic field##3##2##(1990-12#1)(2008-1#1)(2008-9#1)
therapeutic for##6##2##(1994-3#1)(1997-7#1)(2007-10#1)(2010-12#2)(2012-12#1)
therapeutic gene##7##2##(2006-6#2)(2007-3#1)(2008-11#1)(2008-5#1)(2013-7#2)
therapeutic genes into##2##3##(2007-6#1)(2008-8#1)
therapeutic genes##6##2##(1993-2#1)(2005-8#1)(2007-6#1)(2008-5#1)(2008-8#1)(2010-12#1)
therapeutic goals##4##2##(1996-2#1)(2011-2#1)(2012-2#1)(2012-5#1)
therapeutic gold standard##2##3##(2008-10#2)
therapeutic group##4##2##(2008-11#3)(2011-2#1)
therapeutic guidance##2##2##(2010-2#1)(2013-1#1)
therapeutic hypothermia##6##2##(2007-10#2)(2008-3#1)(2008-8#1)(2010-12#2)
therapeutic immunization against##2##3##(2006-10#1)(2009-12#1)
therapeutic implications for the##2##4##(2008-7#1)(2011-2#1)
therapeutic implications for##5##3##(1991-7#1)(2006-6#1)(2008-11#1)(2008-7#1)(2011-2#1)
therapeutic implications in##5##3##(1997-1#1)(2006-10#1)(2006-2#1)(2008-1#1)(2012-2#1)
therapeutic implications of##8##3##(1991-9#1)(1992-6#1)(1993-10#1)(1994-7#1)(2006-2#1)(2007-8#1)(2008-3#1)(2013-7#1)
therapeutic implications##52##2##(1991-3#1)(1991-7#1)(1991-9#1)(1992-6#1)(1993-10#1)(1994-11#1)(1994-6#1)(1994-7#1)(1996-11#1)(1997-1#1)(2005-11#1)(2005-7#1)(2006-10#5)(2006-11#1)(2006-2#2)(2006-6#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#6)(2009-3#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#2)(2013-8#2)
therapeutic implications]##4##2##(1990-3#1)(1993-10#1)(2006-2#1)(2007-8#1)
therapeutic importance##4##2##(1994-12#1)(1995-12#1)(2008-4#1)(2013-1#1)
therapeutic improvements##2##2##(2010-12#1)(2011-1#1)
therapeutic in##6##2##(1992-3#1)(2007-10#1)(2007-3#1)(2010-12#1)(2012-12#1)(2012-2#1)
therapeutic index of##4##3##(1995-5#1)(2005-8#1)(2007-3#1)(2008-5#1)
therapeutic index##16##2##(1992-11#1)(1995-5#1)(1995-6#2)(1996-9#1)(1997-1#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-8#1)(2007-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-11#1)
therapeutic indications of##4##3##(1996-9#1)(2005-7#1)(2006-10#1)(2012-2#1)
therapeutic indications##10##2##(1992-4#1)(1994-6#1)(1996-9#1)(2005-7#1)(2006-10#1)(2007-5#3)(2009-3#1)(2012-2#1)
therapeutic information##2##2##(2006-2#1)(2010-8#1)
therapeutic injections##4##2##(2006-8#2)(2012-1#2)
therapeutic inroads##2##2##(2010-3#1)(2010-7#1)
therapeutic interest##4##2##(1995-3#1)(2005-8#1)(2006-6#1)(2011-2#1)
therapeutic intervention and##3##3##(2006-10#1)(2009-4#1)(2010-12#1)
therapeutic intervention as##2##3##(2007-6#1)(2012-12#1)
therapeutic intervention for##3##3##(2005-8#1)(2007-11#1)(2007-12#1)
therapeutic intervention in##6##3##(1990-7#1)(1991-12#1)(1992-11#1)(1994-8#1)(2010-3#1)(2011-2#1)
therapeutic intervention is##2##3##(1996-1#1)(2006-8#1)
therapeutic intervention may##2##3##(2008-11#1)(2011-12#1)
therapeutic intervention of##3##3##(2010-12#1)(2012-12#1)(2012-2#1)
therapeutic intervention to##4##3##(1990-6#1)(1993-5#1)(2007-11#1)(2010-3#1)
therapeutic intervention##65##2##(1990-3#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-9#1)(1992-11#1)(1993-5#1)(1994-8#1)(1995-9#1)(1996-1#1)(1996-3#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-6#1)(2005-8#3)(2006-1#1)(2006-10#2)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#7)(2007-12#2)(2007-2#1)(2007-6#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-10#1)(2009-4#2)(2010-10#1)(2010-12#3)(2010-3#2)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#4)(2012-2#1)
therapeutic interventional pain medicine##2##4##(2006-8#2)
therapeutic interventional##3##2##(2006-7#1)(2006-8#2)
therapeutic interventions are##2##3##(2006-10#1)(2008-7#1)
therapeutic interventions available##2##3##(2006-8#1)(2007-7#1)
therapeutic interventions for the treatment of##2##6##(2006-10#1)(2013-1#1)
therapeutic interventions for##5##3##(1997-4#1)(1997-8#1)(2006-10#1)(2006-12#1)(2013-1#1)
therapeutic interventions that##6##3##(2005-11#1)(2007-12#1)(2008-7#1)(2009-10#1)(2012-1#1)(2013-1#1)
therapeutic interventions to##4##3##(2009-6#1)(2010-8#1)(2011-2#1)(2012-12#1)
therapeutic interventions##60##2##(1997-4#1)(1997-8#1)(2004-11#1)(2004-12#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#7)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
therapeutic itinerary##2##2##(2008-2#1)(2009-10#1)
therapeutic jurisprudence##3##2##(2006-5#3)
therapeutic levels of##2##3##(1990-11#1)(1990-8#1)
therapeutic levels##3##2##(1990-11#1)(1990-8#1)(2008-3#1)
therapeutic lifestyle##2##2##(2008-1#1)(2010-6#1)
therapeutic management of##8##3##(1992-8#1)(1997-6#1)(2005-8#1)(2007-11#1)(2008-3#1)(2012-11#1)(2012-2#1)(2012-3#1)
therapeutic management##19##2##(1992-8#1)(1995-11#2)(1997-6#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-12#2)(2010-9#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)
therapeutic management]##2##2##(1992-4#1)(2009-5#1)
therapeutic manipulation##4##2##(2005-10#1)(2005-7#1)(2007-12#1)(2009-8#1)
therapeutic manipulations in##2##3##(2006-10#2)
therapeutic manipulations##3##2##(2006-10#2)(2007-5#1)
therapeutic means##2##2##(1994-3#1)(2007-11#1)
therapeutic measure##2##2##(1991-12#1)(2008-3#1)
therapeutic measures are##2##3##(1990-12#1)(2009-10#1)
therapeutic measures##14##2##(1990-12#1)(1990-6#1)(1991-8#1)(1992-9#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
therapeutic medical applications##2##3##(1994-2#1)(2013-7#1)
therapeutic medical##3##2##(1994-2#1)(2007-8#1)(2013-7#1)
therapeutic medicine##2##2##(2006-9#1)(2008-5#1)
therapeutic method in##2##3##(1990-3#1)(1992-10#1)
therapeutic method##7##2##(1990-3#2)(1992-10#2)(1995-5#1)(2007-5#1)(2013-1#1)
therapeutic methods##8##2##(1990-6#1)(1992-8#1)(1995-11#1)(1995-5#1)(2006-10#1)(2008-10#1)(2009-8#1)(2013-1#1)
therapeutic milieu##5##2##(1993-2#2)(2010-5#1)(2013-1#2)
therapeutic minimum effective concentration##2##4##(2004-12#2)
therapeutic misconception##3##2##(2009-6#2)(2012-2#1)
therapeutic modalities and##2##3##(1991-2#1)(1993-2#1)
therapeutic modalities are##4##3##(2007-7#2)(2008-2#1)(2009-4#1)
therapeutic modalities for the treatment of##2##6##(1994-8#1)(2011-1#1)
therapeutic modalities for##7##3##(1993-1#1)(1993-9#1)(1994-10#1)(1994-8#1)(2007-10#1)(2010-12#1)(2011-1#1)
therapeutic modalities including##2##3##(2009-3#1)(2010-7#1)
therapeutic modalities of##2##3##(2006-8#1)(2008-11#1)
therapeutic modalities such as##2##4##(1995-5#1)(2013-8#1)
therapeutic modalities that##2##3##(2006-10#1)(2012-2#1)
therapeutic modalities##38##2##(1991-2#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-9#1)(1994-10#1)(1994-8#1)(1995-5#1)(1997-6#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
therapeutic modality for the treatment of##2##6##(2007-7#1)(2007-8#1)
therapeutic modality for##9##3##(2007-7#3)(2007-8#1)(2008-1#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
therapeutic modality in##8##3##(2006-10#2)(2007-11#1)(2007-7#3)(2011-2#1)(2012-2#1)
therapeutic modality that##3##3##(2007-11#1)(2008-4#1)(2010-6#1)
therapeutic modality##27##2##(1993-2#1)(2006-10#3)(2006-6#1)(2006-9#1)(2007-11#2)(2007-7#6)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
therapeutic modulation of##2##3##(2008-2#1)(2011-2#1)
therapeutic molecules for##2##3##(2008-11#1)(2009-8#1)
therapeutic molecules##6##2##(2005-11#1)(2008-11#1)(2009-2#1)(2009-8#2)(2011-2#1)
therapeutic monitoring##2##2##(2007-11#1)(2007-12#1)
therapeutic needs of##2##3##(2008-12#1)(2012-3#1)
therapeutic needs##5##2##(1992-3#1)(1993-10#1)(2008-12#1)(2012-2#1)(2012-3#1)
therapeutic opportunities##5##2##(2005-8#1)(2006-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
therapeutic option for patients with##4##5##(2006-8#1)(2007-8#2)(2013-8#1)
therapeutic option for the treatment of##2##6##(2013-8#2)
therapeutic option for##21##3##(2006-1#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#5)(2009-9#1)(2011-2#1)(2011-3#2)(2012-2#1)(2013-1#1)(2013-8#4)
therapeutic option has##2##3##(2006-2#1)(2011-2#1)
therapeutic option in patients##3##4##(2010-12#2)(2013-1#1)
therapeutic option in##8##3##(1992-10#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-5#1)(2010-12#2)(2013-1#1)
therapeutic option to##3##3##(1996-4#1)(2006-6#1)(2010-12#1)
therapeutic option##50##2##(1992-10#1)(1996-4#1)(1997-3#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-3#1)(2007-7#2)(2007-8#8)(2008-1#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#6)(2010-5#1)(2011-2#2)(2011-3#2)(2012-2#1)(2013-1#2)(2013-8#6)
therapeutic options are##3##3##(2007-8#1)(2010-8#1)(2012-12#1)
therapeutic options available for##6##4##(2005-6#1)(2005-7#1)(2006-12#1)(2008-11#1)(2010-12#1)(2010-8#1)
therapeutic options available to##2##4##(2009-9#1)(2011-2#1)
therapeutic options available##8##3##(2005-6#1)(2005-7#1)(2006-12#1)(2008-11#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#1)
therapeutic options for the##2##4##(2008-5#1)(2010-8#1)
therapeutic options for##12##3##(2006-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
therapeutic options have##2##3##(2007-11#1)(2010-6#1)
therapeutic options in##9##3##(1993-10#1)(1994-8#1)(1997-1#1)(2006-10#1)(2006-6#1)(2008-1#1)(2009-5#1)(2009-8#1)(2011-3#1)
therapeutic options of the##2##4##(1992-12#1)(1993-5#1)
therapeutic options of##3##3##(1992-12#1)(1993-5#1)(2006-10#1)
therapeutic options such as##2##4##(1990-9#1)(2007-8#1)
therapeutic options to##2##3##(2006-10#1)(2008-3#1)
therapeutic options will##2##3##(2006-9#1)(2010-11#1)
therapeutic options##87##2##(1990-12#1)(1990-9#1)(1992-12#1)(1992-6#1)(1993-10#2)(1993-11#1)(1993-5#2)(1994-8#1)(1995-5#1)(1997-1#2)(2004-11#1)(2005-11#1)(2005-6#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#6)(2006-12#1)(2006-2#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#3)(2007-7#1)(2007-8#3)(2008-1#2)(2008-11#1)(2008-3#4)(2008-5#2)(2008-6#3)(2008-7#1)(2009-2#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-6#1)(2010-8#4)(2011-1#5)(2011-2#2)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
therapeutic options]##4##2##(1994-8#1)(2006-8#1)(2009-9#1)(2012-2#1)
therapeutic or##6##2##(1994-12#1)(2005-8#1)(2007-11#1)(2007-3#1)(2007-9#1)(2013-7#1)
therapeutic outcome##12##2##(1992-5#1)(1995-12#1)(1996-7#1)(2007-8#2)(2008-11#1)(2008-8#1)(2010-12#1)(2011-2#2)(2012-12#2)
therapeutic outcomes as##2##3##(2010-12#1)(2012-12#1)
therapeutic outcomes##11##2##(2006-10#1)(2007-11#1)(2008-3#1)(2009-3#2)(2010-10#1)(2010-12#2)(2011-1#1)(2012-12#1)(2013-8#1)
therapeutic paradigm##3##2##(2007-4#1)(2007-8#1)(2012-12#1)
therapeutic parameters##3##2##(2010-8#3)
therapeutic particularities##2##2##(2008-12#1)(2012-2#1)
therapeutic perspective##3##2##(2004-12#1)(2008-8#1)(2010-5#1)
therapeutic perspectives##3##2##(2008-7#2)(2012-12#1)
therapeutic plan##2##2##(1993-3#1)(2013-1#1)
therapeutic plasma exchange##2##3##(2011-2#2)
therapeutic plasma##3##2##(2011-2#2)(2012-12#1)
therapeutic possibilities for##3##3##(1995-5#1)(2008-10#1)(2009-9#1)
therapeutic possibilities##9##2##(1990-6#1)(1990-8#1)(1991-11#1)(1995-3#1)(1995-5#1)(2005-1#1)(2008-10#1)(2009-4#1)(2009-9#1)
therapeutic possibilities]##3##2##(1995-5#1)(2006-6#1)(2010-12#1)
therapeutic possibility##2##2##(1990-4#1)(2013-1#1)
therapeutic potential as##4##3##(1992-3#1)(1994-5#1)(2008-1#1)(2008-7#1)
therapeutic potential for treating##2##4##(2008-11#1)(2009-3#1)
therapeutic potential for##9##3##(1991-2#1)(1993-4#1)(2006-10#1)(2008-11#1)(2008-5#1)(2009-3#1)(2010-12#1)(2012-2#1)(2013-1#1)
therapeutic potential in inflammatory bowel disease##2##6##(2006-10#2)
therapeutic potential in##11##3##(1997-1#1)(2006-10#3)(2008-1#2)(2008-5#2)(2012-12#3)
therapeutic potential of##33##3##(1997-7#1)(2005-7#6)(2005-8#1)(2006-10#1)(2007-11#3)(2007-6#1)(2007-8#1)(2008-1#1)(2008-11#4)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-11#1)(2012-12#4)(2012-2#3)(2013-8#1)
therapeutic potential##82##2##(1990-6#1)(1990-9#1)(1991-2#1)(1992-3#1)(1993-11#1)(1993-4#1)(1994-5#1)(1995-12#1)(1996-4#1)(1997-1#1)(1997-7#2)(2005-11#1)(2005-7#6)(2005-8#1)(2006-10#5)(2006-12#1)(2007-11#4)(2007-6#1)(2007-8#1)(2008-1#5)(2008-11#5)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-3#2)(2009-8#2)(2010-12#3)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#9)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
therapeutic potentials##3##2##(2008-1#1)(2010-1#1)(2013-8#1)
therapeutic principle for##3##3##(1993-11#1)(1994-4#1)(2007-5#1)
therapeutic principle##4##2##(1993-11#1)(1994-4#1)(1994-6#1)(2007-5#1)
therapeutic principles##2##2##(1997-4#1)(2005-6#1)
therapeutic problem##8##2##(1992-2#1)(1993-5#2)(2006-6#1)(2007-11#1)(2007-7#1)(2008-7#1)(2013-1#1)
therapeutic problem]##2##2##(1991-8#1)(1992-6#1)
therapeutic problems associated with##2##4##(2007-8#1)(2008-7#1)
therapeutic problems##9##2##(1990-10#1)(1993-10#1)(1997-2#2)(2005-12#1)(2007-8#2)(2008-7#1)(2008-9#1)
therapeutic procedure in##2##3##(1990-3#1)(2007-5#1)
therapeutic procedure##8##2##(1990-3#1)(1991-1#1)(1994-8#1)(2007-11#1)(2007-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
therapeutic procedures and##2##3##(1993-3#1)(1993-8#1)
therapeutic procedures are##6##3##(1991-2#1)(1993-9#1)(1996-1#1)(1996-3#2)(2007-11#1)
therapeutic procedures##24##2##(1991-2#1)(1991-9#1)(1992-11#1)(1993-3#1)(1993-8#1)(1993-9#1)(1996-1#1)(1996-3#3)(2006-10#2)(2007-1#1)(2007-11#1)(2007-8#2)(2008-3#1)(2008-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-7#1)
therapeutic procedures]##2##2##(1991-11#1)(1992-3#1)
therapeutic process##3##2##(1990-5#1)(2006-11#1)(2011-2#1)
therapeutic product##3##2##(2008-10#1)(2012-12#2)
therapeutic products##10##2##(2007-11#1)(2008-10#1)(2008-11#4)(2012-12#4)
therapeutic profile##2##2##(2005-7#2)
therapeutic profiles##2##2##(2005-7#1)(2012-2#1)
therapeutic program##2##2##(1990-12#1)(2007-2#1)
therapeutic programs##2##2##(1990-1#1)(2009-7#1)
therapeutic progress##3##2##(2007-8#1)(2008-5#1)(2008-9#1)
therapeutic promise##2##2##(2006-10#1)(2010-10#1)
therapeutic properties of##2##3##(1996-9#1)(2007-1#1)
therapeutic properties##4##2##(1996-9#1)(2007-1#1)(2008-6#1)(2013-1#1)
therapeutic protein in##2##3##(2008-11#2)
therapeutic protein##11##2##(1996-8#1)(2007-6#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#1)(2012-2#2)
therapeutic proteins##13##2##(1996-1#1)(2006-12#1)(2008-10#4)(2008-11#4)(2012-2#2)(2013-8#1)
therapeutic protocol##2##2##(1995-12#1)(2013-1#1)
therapeutic protocols##3##2##(2006-10#2)(2010-9#1)
therapeutic purposes##20##2##(1990-12#1)(1994-6#1)(1994-8#1)(1995-7#1)(2005-10#1)(2006-8#2)(2006-9#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#2)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
therapeutic quantities##2##2##(2008-11#1)(2012-1#1)
therapeutic range of##3##3##(2007-11#3)
therapeutic range##17##2##(1990-5#1)(1992-2#2)(1992-3#1)(1992-8#1)(1995-2#1)(1996-10#1)(1997-5#2)(2007-11#3)(2008-10#1)(2009-4#1)(2010-12#1)(2013-1#2)
therapeutic ranges##4##2##(1991-11#1)(2007-11#1)(2013-1#2)
therapeutic ratio##6##2##(1992-3#1)(1997-1#1)(2005-8#1)(2007-11#1)(2007-4#1)(2008-10#1)
therapeutic recommendations##2##2##(2010-2#1)(2012-11#1)
therapeutic regime##2##2##(2005-10#1)(2006-10#1)
therapeutic regimen for the individual patient##2##6##(2007-7#1)(2009-9#1)
therapeutic regimen for##3##3##(2007-7#1)(2009-9#1)(2013-7#1)
therapeutic regimen in##2##3##(2009-1#1)(2011-2#1)
therapeutic regimen##16##2##(1990-6#1)(1991-9#1)(1992-8#1)(1993-2#1)(1994-9#1)(2006-12#1)(2007-7#2)(2007-9#1)(2008-7#1)(2009-1#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-7#1)
therapeutic regimens have##2##3##(2005-8#1)(2008-1#1)
therapeutic regimens on##2##3##(2010-12#1)(2012-3#1)
therapeutic regimens with##2##3##(1996-11#1)(2008-6#1)
therapeutic regimens##17##2##(1993-5#1)(1996-11#1)(2005-8#1)(2006-10#4)(2006-12#1)(2008-1#2)(2008-6#2)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-7#1)
therapeutic relationship##5##2##(2008-11#1)(2008-2#1)(2008-3#1)(2009-9#1)(2011-1#1)
therapeutic relevance##3##2##(1994-8#1)(1995-11#1)(2011-1#1)
therapeutic repair##2##2##(2009-9#2)
therapeutic research##2##2##(2008-11#1)(2008-4#1)
therapeutic resistance##5##2##(1993-1#2)(2008-7#1)(2009-3#1)(2012-12#1)
therapeutic response and##3##3##(2006-6#1)(2007-7#1)(2009-11#1)
therapeutic response in##4##3##(2006-2#1)(2007-7#1)(2012-12#2)
therapeutic response to##4##3##(1997-1#1)(2006-10#1)(2008-10#1)(2009-11#1)
therapeutic response##31##2##(1991-2#1)(1991-8#1)(1993-9#1)(1997-1#1)(2006-10#3)(2006-2#1)(2006-6#1)(2007-10#1)(2007-7#5)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-11#2)(2009-4#1)(2010-11#1)(2010-12#1)(2011-1#2)(2012-12#2)(2012-2#1)(2012-3#1)
therapeutic responses to##2##3##(2009-11#1)(2013-8#1)
therapeutic responses##4##2##(2007-3#1)(2009-11#2)(2013-8#1)
therapeutic results and##2##3##(1992-10#1)(2012-3#1)
therapeutic results##8##2##(1990-5#1)(1992-10#1)(1996-9#1)(2008-10#1)(2008-5#1)(2009-5#1)(2010-5#1)(2012-3#1)
therapeutic role for##3##3##(2006-10#2)(2013-7#1)
therapeutic role of##9##3##(1990-5#1)(1993-12#1)(1994-6#1)(1996-10#1)(2005-3#1)(2006-10#1)(2007-8#1)(2010-12#1)(2013-1#1)
therapeutic role##14##2##(1990-5#1)(1993-12#1)(1994-6#1)(1996-10#1)(2005-3#1)(2006-10#4)(2007-8#1)(2008-4#1)(2010-12#1)(2013-1#1)(2013-7#1)
therapeutic roles in##2##3##(2010-1#1)(2012-2#1)
therapeutic roles##6##2##(2008-3#1)(2010-1#1)(2010-5#1)(2011-2#2)(2012-2#1)
therapeutic scheme##3##2##(1991-3#1)(2008-8#1)(2009-1#1)
therapeutic services##3##2##(1993-2#1)(2008-11#1)(2011-2#1)
therapeutic significance##2##2##(1995-12#1)(2008-11#1)
therapeutic spectrum of##3##3##(1991-8#1)(1992-3#1)(2008-5#1)
therapeutic strategies against##2##3##(2007-11#1)(2008-4#1)
therapeutic strategies and##4##3##(2008-1#1)(2009-8#1)(2010-12#1)(2012-2#1)
therapeutic strategies are##8##3##(1992-3#1)(2006-1#1)(2006-10#1)(2008-7#1)(2008-8#2)(2010-5#1)(2012-12#1)
therapeutic strategies for atherosclerosis##3##4##(2008-4#2)(2013-1#1)
therapeutic strategies for the treatment of##3##6##(2007-5#1)(2011-2#1)(2013-1#1)
therapeutic strategies for the##5##4##(2007-5#1)(2010-2#1)(2011-2#1)(2011-9#1)(2013-1#1)
therapeutic strategies for treatment##2##4##(2004-1#1)(2012-12#1)
therapeutic strategies for##23##3##(1997-8#1)(2004-1#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#4)(2008-5#1)(2009-7#1)(2010-10#3)(2010-2#1)(2011-2#1)(2011-9#1)(2012-12#2)(2013-1#2)
therapeutic strategies have been##2##4##(2010-11#1)(2013-1#1)
therapeutic strategies have##4##3##(2007-8#1)(2010-11#1)(2010-12#1)(2013-1#1)
therapeutic strategies in the##2##4##(2006-10#1)(2008-12#1)
therapeutic strategies in##3##3##(1993-3#1)(2006-10#1)(2008-12#1)
therapeutic strategies is##2##3##(1990-6#1)(2006-1#1)
therapeutic strategies of##5##3##(1994-8#1)(2008-12#1)(2008-5#1)(2010-6#1)(2012-12#1)
therapeutic strategies targeting##3##3##(2010-4#1)(2012-12#1)(2013-1#1)
therapeutic strategies that target##2##4##(2007-8#1)(2008-7#1)
therapeutic strategies that##5##3##(2006-8#1)(2007-8#1)(2008-7#1)(2010-2#1)(2010-7#1)
therapeutic strategies to##5##3##(2007-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-5#1)
therapeutic strategies##117##2##(1990-4#1)(1990-6#1)(1991-12#1)(1991-7#1)(1992-3#1)(1993-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-11#1)(1997-8#1)(2004-1#1)(2005-11#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#2)(2006-10#7)(2006-2#4)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#4)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#6)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#3)(2010-11#1)(2010-12#4)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2011-1#2)(2011-2#4)(2011-3#1)(2011-9#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#1)
therapeutic strategy for the treatment of##3##6##(2005-7#1)(2008-7#1)(2009-3#1)
therapeutic strategy for##17##3##(2005-7#1)(2005-8#1)(2006-6#1)(2007-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-2#1)(2013-8#1)
therapeutic strategy in##3##3##(1990-4#1)(1991-5#1)(2008-7#1)
therapeutic strategy is##2##3##(1997-1#1)(2005-10#1)
therapeutic strategy of##2##3##(2008-4#1)(2012-3#1)
therapeutic strategy remains to be##2##5##(1996-9#1)(2012-2#1)
therapeutic strategy to reduce##2##4##(2010-2#1)(2011-2#1)
therapeutic strategy to##10##3##(1995-1#1)(2007-8#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-12#4)(2013-1#1)
therapeutic strategy##49##2##(1990-4#1)(1991-5#1)(1992-10#1)(1992-6#1)(1995-1#1)(1996-9#1)(1997-1#1)(2005-1#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-6#2)(2007-11#1)(2007-8#2)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-3#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#6)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
therapeutic studies##5##2##(2007-12#1)(2007-2#1)(2011-1#1)(2012-12#2)
therapeutic study##2##2##(1993-11#1)(1994-2#1)
therapeutic success##9##2##(2007-11#2)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-7#1)
therapeutic successes##2##2##(1990-3#1)(2007-9#1)
therapeutic system##2##2##(2004-12#1)(2008-3#1)
therapeutic system)##2##2##(1992-8#2)
therapeutic target for the treatment of##5##6##(2008-1#1)(2010-6#1)(2012-2#1)(2013-1#2)
therapeutic target for the##6##4##(2007-11#1)(2008-1#1)(2010-6#1)(2012-2#1)(2013-1#2)
therapeutic target for##18##3##(1997-6#1)(2004-12#1)(2007-11#1)(2007-6#1)(2008-1#3)(2008-11#1)(2010-11#1)(2010-6#1)(2011-2#3)(2012-2#2)(2013-1#3)
therapeutic target in##9##3##(2005-9#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-5#1)(2009-10#1)(2009-2#1)(2009-5#1)(2012-2#1)
therapeutic target##50##2##(1992-4#1)(1993-11#1)(1996-3#1)(1997-6#1)(2004-12#1)(2005-7#2)(2005-9#1)(2007-11#2)(2007-6#2)(2008-1#5)(2008-11#2)(2008-5#3)(2008-7#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#2)(2011-2#3)(2012-12#2)(2012-2#4)(2013-1#3)(2013-8#1)
therapeutic targeting of##4##3##(2005-8#1)(2008-1#1)(2009-3#1)(2012-12#1)
therapeutic targeting##8##2##(2005-10#1)(2005-8#1)(2006-10#1)(2008-1#1)(2009-3#1)(2009-9#1)(2012-12#2)
therapeutic targets and biomarkers##2##4##(2013-1#2)
therapeutic targets and##3##3##(2010-7#1)(2013-1#2)
therapeutic targets for the treatment of##2##6##(2008-1#1)(2011-1#1)
therapeutic targets for this##2##4##(2008-5#1)(2009-11#1)
therapeutic targets for##8##3##(2008-1#2)(2008-5#1)(2008-8#1)(2009-11#1)(2011-1#1)(2013-1#2)
therapeutic targets in a##2##4##(2005-8#1)(2010-5#1)
therapeutic targets in human##3##4##(2010-12#1)(2012-2#2)
therapeutic targets in the##2##4##(2005-9#1)(2011-2#1)
therapeutic targets in##13##3##(2005-8#1)(2005-9#1)(2007-9#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
therapeutic targets##63##2##(2005-7#2)(2005-8#5)(2005-9#1)(2006-10#4)(2007-9#1)(2008-1#4)(2008-12#1)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
therapeutic techniques##3##2##(1990-12#1)(2008-12#1)(2008-7#1)
therapeutic time##3##2##(2007-9#2)(2008-8#1)
therapeutic tool for##6##3##(1990-5#1)(1994-6#1)(2006-2#1)(2007-8#1)(2008-1#1)(2013-7#1)
therapeutic tool in##6##3##(1995-4#1)(2007-11#3)(2009-9#1)(2012-2#1)
therapeutic tool##18##2##(1990-5#1)(1994-6#1)(1995-4#2)(2006-2#1)(2006-9#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-6#1)(2008-9#1)(2009-9#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-7#1)
therapeutic tools to##2##3##(1997-3#1)(2011-2#1)
therapeutic tools##8##2##(1990-5#1)(1997-3#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-3#1)(2011-1#1)(2011-2#1)
therapeutic training##2##2##(2012-1#2)
therapeutic transgenes##2##2##(2007-12#1)(2008-11#1)
therapeutic treatment of##4##3##(2005-7#1)(2009-4#1)(2012-2#1)(2012-3#1)
therapeutic treatment##12##2##(1996-12#1)(2005-7#2)(2008-1#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-4#1)(2012-2#2)(2012-3#1)
therapeutic trials##12##2##(1991-6#1)(1993-10#1)(1993-2#1)(2006-10#2)(2006-11#1)(2006-12#1)(2007-10#1)(2008-12#1)(2008-7#1)(2010-12#1)(2011-2#1)
therapeutic usage of##2##3##(1993-3#1)(2008-1#1)
therapeutic use for##2##3##(2012-12#1)(2012-2#1)
therapeutic use in##2##3##(2005-7#1)(2008-3#1)
therapeutic use is limited##2##4##(2007-8#1)(2013-8#1)
therapeutic use is##3##3##(2007-8#1)(2012-12#1)(2013-8#1)
therapeutic use of cannabis##2##4##(2005-10#2)
therapeutic use of##23##3##(1990-11#1)(1991-5#1)(1992-9#1)(1993-12#1)(1994-5#1)(1996-11#1)(2005-10#2)(2005-7#1)(2006-10#1)(2006-12#1)(2007-11#4)(2008-7#2)(2009-9#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#2)
therapeutic use to##2##3##(2005-10#1)(2008-11#1)
therapeutic use##44##2##(1990-11#1)(1990-3#1)(1991-5#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-5#1)(1996-11#1)(2005-10#4)(2005-7#2)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#4)(2007-7#1)(2007-8#1)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-7#1)(2013-8#3)
therapeutic usefulness##4##2##(1996-2#1)(2008-11#1)(2008-5#1)(2013-1#1)
therapeutic uses for##2##3##(2006-8#1)(2008-5#1)
therapeutic uses of##4##3##(1991-2#1)(1992-6#1)(2005-7#1)(2008-1#1)
therapeutic uses##9##2##(1991-2#1)(1992-6#1)(2005-7#1)(2005-8#1)(2006-8#1)(2008-1#1)(2008-5#1)(2012-12#2)
therapeutic utility in##2##3##(2010-4#1)(2012-12#1)
therapeutic utility of##3##3##(2005-8#2)(2007-11#1)
therapeutic utility##10##2##(1997-7#1)(2005-8#2)(2007-11#1)(2008-1#1)(2008-7#1)(2010-4#1)(2012-12#1)(2013-1#1)(2013-8#1)
therapeutic vaccine##6##2##(1993-3#1)(1995-8#1)(2007-12#1)(2007-7#1)(2008-3#1)(2008-4#1)
therapeutic vaccines##3##2##(2007-12#1)(2008-4#1)(2013-8#1)
therapeutic value for##2##3##(2004-2#1)(2007-10#1)
therapeutic value in the treatment of##2##6##(1991-4#1)(1996-2#1)
therapeutic value in##5##3##(1991-4#1)(1991-9#1)(1993-11#1)(1994-11#1)(1996-2#1)
therapeutic value of cranberries in##2##5##(1997-4#2)
therapeutic value of##8##3##(1996-9#1)(1997-4#2)(2006-2#1)(2007-7#1)(2008-4#1)(2012-3#2)
therapeutic value##24##2##(1991-4#1)(1991-9#1)(1993-11#1)(1993-2#1)(1994-11#1)(1996-2#1)(1996-9#1)(1997-4#2)(2004-2#1)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-7#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-5#1)(2012-3#2)
therapeutic window of##4##3##(2007-11#1)(2008-3#1)(2010-6#1)(2010-8#1)
therapeutic window##9##2##(1997-5#1)(2007-10#1)(2007-11#2)(2008-3#1)(2008-5#1)(2010-6#1)(2010-8#1)(2012-2#1)
therapeutic work and##2##3##(2007-5#1)(2012-12#1)
therapeutic work##3##2##(1990-6#1)(2007-5#1)(2012-12#1)
therapeutic##2958##1##(1990-1#3)(1990-10#6)(1990-11#4)(1990-12#17)(1990-2#9)(1990-3#12)(1990-4#5)(1990-5#14)(1990-6#13)(1990-7#6)(1990-8#2)(1990-9#6)(1991-1#3)(1991-11#7)(1991-12#8)(1991-2#11)(1991-3#6)(1991-4#4)(1991-5#4)(1991-6#7)(1991-7#4)(1991-8#6)(1991-9#12)(1992-10#5)(1992-11#7)(1992-12#6)(1992-2#7)(1992-3#15)(1992-4#6)(1992-5#4)(1992-6#9)(1992-7#1)(1992-8#8)(1992-9#3)(1993-1#3)(1993-10#12)(1993-11#15)(1993-12#5)(1993-2#13)(1993-3#10)(1993-4#1)(1993-5#17)(1993-6#2)(1993-8#3)(1993-9#5)(1994-10#3)(1994-11#8)(1994-12#5)(1994-2#4)(1994-3#7)(1994-4#4)(1994-5#5)(1994-6#10)(1994-7#2)(1994-8#14)(1994-9#4)(1995-1#4)(1995-10#1)(1995-11#9)(1995-12#9)(1995-2#7)(1995-3#5)(1995-4#7)(1995-5#9)(1995-6#4)(1995-7#1)(1995-8#3)(1995-9#5)(1996-1#5)(1996-10#4)(1996-11#12)(1996-12#3)(1996-2#10)(1996-3#11)(1996-4#3)(1996-6#2)(1996-7#1)(1996-8#4)(1996-9#9)(1997-1#11)(1997-2#4)(1997-3#6)(1997-4#10)(1997-5#4)(1997-6#4)(1997-7#8)(1997-8#11)(2004-1#2)(2004-11#3)(2004-12#8)(2004-2#1)(2005-1#3)(2005-10#20)(2005-11#12)(2005-12#1)(2005-3#1)(2005-6#5)(2005-7#51)(2005-8#48)(2005-9#11)(2006-1#6)(2006-10#140)(2006-11#9)(2006-12#22)(2006-2#31)(2006-3#1)(2006-4#7)(2006-5#10)(2006-6#24)(2006-7#10)(2006-8#35)(2006-9#22)(2007-1#4)(2007-10#20)(2007-11#97)(2007-12#25)(2007-2#10)(2007-3#6)(2007-4#4)(2007-5#25)(2007-6#14)(2007-7#48)(2007-8#57)(2007-9#11)(2008-1#78)(2008-10#48)(2008-11#90)(2008-12#27)(2008-2#12)(2008-3#55)(2008-4#47)(2008-5#67)(2008-6#35)(2008-7#69)(2008-8#41)(2008-9#17)(2009-1#5)(2009-10#14)(2009-11#13)(2009-12#14)(2009-2#11)(2009-3#24)(2009-4#15)(2009-5#8)(2009-6#15)(2009-7#8)(2009-8#18)(2009-9#19)(2010-1#10)(2010-10#12)(2010-11#25)(2010-12#68)(2010-2#12)(2010-3#12)(2010-4#12)(2010-5#26)(2010-6#18)(2010-7#15)(2010-8#12)(2010-9#8)(2011-1#55)(2011-12#6)(2011-2#93)(2011-3#6)(2011-7#1)(2011-9#1)(2012-1#21)(2012-11#13)(2012-12#106)(2012-2#93)(2012-3#31)(2012-5#1)(2013-1#105)(2013-7#22)(2013-8#42)
therapeutical agents##2##2##(1994-11#2)
therapeutical applications##2##2##(1991-9#1)(1994-11#1)
therapeutical approach##2##2##(1994-9#1)(2012-12#1)
therapeutical approaches to##2##3##(1992-9#1)(2005-10#1)
therapeutical approaches##3##2##(1990-6#1)(1992-9#1)(2005-10#1)
therapeutical possibilities##3##2##(1990-2#1)(1995-12#1)(2012-2#1)
therapeutical potential##2##2##(1996-10#1)(2008-4#1)
therapeutical strategies##2##2##(2008-1#1)(2009-10#1)
therapeutical##40##1##(1990-2#1)(1990-5#1)(1990-6#1)(1991-9#1)(1992-10#1)(1992-9#1)(1993-10#1)(1993-9#1)(1994-11#3)(1994-6#1)(1994-9#1)(1995-12#2)(1996-10#1)(2005-10#1)(2005-11#1)(2006-12#1)(2006-6#1)(2006-8#3)(2007-11#1)(2007-7#2)(2008-1#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2012-12#1)(2012-2#1)(2012-7#1)
therapeutically effective##5##2##(1993-8#1)(1997-1#1)(2006-12#2)(2009-4#1)
therapeutically for##2##2##(2006-12#1)(2012-12#1)
therapeutically relevant##3##2##(1997-1#1)(2008-12#1)(2010-7#1)
therapeutically significant##2##2##(1991-12#1)(2008-9#1)
therapeutically to##4##2##(1992-10#1)(1996-10#1)(2008-1#1)(2008-10#1)
therapeutically useful##4##2##(1993-9#1)(1995-12#1)(1995-3#1)(2005-8#1)
therapeutically##43##1##(1990-9#2)(1991-12#1)(1992-10#1)(1993-8#1)(1993-9#1)(1994-5#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-10#1)(1997-1#2)(2005-8#1)(2006-10#3)(2006-12#3)(2006-4#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-7#1)(2012-12#1)(2013-1#2)(2013-8#1)
therapeutics and in##2##3##(2007-10#1)(2012-12#1)
therapeutics and##11##2##(2005-7#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-11#1)(2010-4#1)(2011-1#2)(2012-12#1)
therapeutics are##6##2##(1990-12#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-7#1)(2009-12#1)
therapeutics as well as##2##4##(2005-9#1)(2013-8#1)
therapeutics currently##2##2##(2005-7#1)(2009-12#1)
therapeutics for the##2##3##(2007-11#1)(2009-12#1)
therapeutics for##10##2##(2005-7#1)(2007-11#1)(2008-1#1)(2008-9#1)(2009-12#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#2)
therapeutics has##2##2##(2007-11#1)(2008-4#1)
therapeutics in the##3##3##(2005-8#1)(2008-1#1)(2011-1#1)
therapeutics in##10##2##(2005-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-1#3)
therapeutics is##4##2##(2008-10#2)(2011-1#1)(2011-3#1)
therapeutics of##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
therapeutics options##2##2##(2008-10#1)(2011-3#1)
therapeutics targeting##4##2##(2005-7#3)(2010-12#1)
therapeutics that##3##2##(1995-8#1)(2012-12#1)(2013-8#1)
therapeutics to target##2##3##(2008-8#1)(2013-1#1)
therapeutics to the##2##3##(2007-11#1)(2008-11#1)
therapeutics to##10##2##(2005-10#1)(2005-7#1)(2007-11#3)(2008-11#2)(2008-8#1)(2012-2#1)(2013-1#1)
therapeutics which##2##2##(2005-8#1)(2012-3#1)
therapeutics with##3##2##(2005-6#1)(2008-10#1)(2009-1#1)
therapeutics##205##1##(1990-12#3)(1991-9#1)(1992-12#1)(1994-5#1)(1995-8#1)(1996-5#3)(1996-7#1)(1997-1#1)(1997-4#1)(2005-10#2)(2005-11#1)(2005-6#2)(2005-7#12)(2005-8#13)(2005-9#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#15)(2007-12#1)(2007-7#1)(2008-1#11)(2008-10#14)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#6)(2008-7#4)(2008-8#4)(2008-9#1)(2009-1#1)(2009-10#2)(2009-12#5)(2009-2#3)(2009-3#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-12#5)(2010-4#4)(2010-5#2)(2010-7#1)(2011-1#13)(2011-2#8)(2011-3#2)(2012-1#1)(2012-11#2)(2012-12#14)(2012-2#6)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#5)
theraphy##4##1##(2006-4#1)(2007-11#1)(2007-8#2)
therapies against##4##2##(2008-1#2)(2008-8#1)(2009-12#1)
therapies aimed at##5##3##(1996-6#1)(2006-12#1)(2007-11#1)(2008-7#1)(2013-8#1)
therapies also##2##2##(2008-7#1)(2010-5#1)
therapies and the##6##3##(1991-2#1)(2006-10#1)(2008-1#1)(2008-4#2)(2012-2#1)
therapies and##40##2##(1991-2#1)(1997-6#1)(2005-10#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-3#1)(2006-6#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-5#1)(2009-7#1)(2010-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
therapies applied##2##2##(2006-10#1)(2008-11#1)
therapies are available##3##3##(2007-7#1)(2007-8#1)(2008-6#1)
therapies are being developed##2##4##(2006-10#1)(2008-3#1)
therapies are being##4##3##(2006-10#2)(2008-3#1)(2013-8#1)
therapies are currently##2##3##(2006-9#1)(2010-5#1)
therapies are effective##2##3##(1993-2#1)(2006-5#1)
therapies are in##2##3##(2010-12#1)(2012-2#1)
therapies are likely to##2##4##(2010-5#1)(2011-12#1)
therapies are needed##4##3##(1992-10#1)(2007-11#1)(2007-12#1)(2008-5#1)
therapies are used##2##3##(2008-11#1)(2011-1#1)
therapies are##54##2##(1990-10#1)(1990-7#1)(1991-12#1)(1991-2#2)(1992-10#1)(1993-2#1)(1996-9#1)(2004-4#1)(2005-8#2)(2006-10#3)(2006-2#1)(2006-5#1)(2006-9#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2009-7#1)(2010-10#2)(2010-12#2)(2010-5#2)(2010-6#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
therapies as they##2##3##(2010-11#1)(2013-7#1)
therapies available##2##2##(2005-10#1)(2010-9#1)
therapies based on the##2##4##(1994-9#1)(2008-11#1)
therapies based on##3##3##(1994-9#1)(1995-4#1)(2008-11#1)
therapies being##2##2##(2006-7#1)(2008-3#1)
therapies by the##2##3##(2006-5#1)(2011-1#1)
therapies by##5##2##(2006-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
therapies can be##4##3##(1993-9#1)(2006-10#1)(2012-2#1)(2013-8#1)
therapies can##9##2##(1993-9#1)(2006-10#1)(2006-12#1)(2006-4#1)(2008-6#1)(2009-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
therapies continue to be##2##4##(2008-3#1)(2013-1#1)
therapies continue to##4##3##(2006-10#2)(2008-3#1)(2013-1#1)
therapies designed to##2##3##(2007-11#1)(2009-12#1)
therapies directed at##2##3##(2006-10#1)(2009-12#1)
therapies directed##3##2##(2006-10#1)(2007-11#1)(2009-12#1)
therapies do##2##2##(2006-9#1)(2010-11#1)
therapies exist##2##2##(2007-11#1)(2013-8#1)
therapies for RA##2##3##(2006-10#1)(2009-7#1)
therapies for a number of diseases##2##6##(2007-8#1)(2008-9#1)
therapies for acute##2##3##(2006-7#2)
therapies for atherosclerosis##2##3##(2008-8#1)(2013-1#1)
therapies for both##2##3##(2005-10#1)(2007-8#1)
therapies for cancer##4##3##(2005-8#1)(2007-12#1)(2007-2#2)
therapies for cardiovascular disease##2##4##(2006-10#1)(2012-12#1)
therapies for cardiovascular##3##3##(2006-10#1)(2012-12#2)
therapies for chronic##2##3##(2012-11#1)(2012-2#1)
therapies for human##2##3##(2006-10#2)
therapies for management of##2##4##(2006-3#1)(2007-12#1)
therapies for patients with##5##4##(2006-2#1)(2008-1#1)(2010-5#1)(2010-6#1)(2012-1#1)
therapies for patients##6##3##(2006-2#1)(2006-7#1)(2008-1#1)(2010-5#1)(2010-6#1)(2012-1#1)
therapies for sepsis##2##3##(2006-10#1)(2011-2#1)
therapies for the frail elderly##2##5##(1995-1#2)
therapies for the management of##2##5##(2006-2#1)(2008-6#1)
therapies for the treatment of##8##5##(2005-7#1)(2006-10#1)(2008-4#2)(2010-11#1)(2011-12#1)(2011-2#1)(2012-3#1)
therapies for the##20##3##(1995-1#2)(2004-11#1)(2005-7#2)(2006-10#2)(2006-2#1)(2007-11#1)(2008-1#1)(2008-4#2)(2008-6#1)(2009-10#1)(2010-11#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
therapies for these##2##3##(2010-12#1)(2012-1#1)
therapies for this##2##3##(2005-8#1)(2008-7#1)
therapies for treatment##2##3##(2005-7#1)(2008-4#1)
therapies for##136##2##(1993-11#1)(1995-1#2)(1995-10#1)(1996-2#3)(1997-6#1)(1997-7#1)(2004-11#2)(2004-3#1)(2005-10#1)(2005-11#2)(2005-7#6)(2005-8#3)(2006-10#12)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-7#5)(2006-9#4)(2007-1#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-8#2)(2008-1#6)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#4)(2008-7#2)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#2)(2009-4#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#6)(2012-11#2)(2012-12#6)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)
therapies had##2##2##(1997-6#1)(2008-3#1)
therapies has##4##2##(2006-10#1)(2010-6#1)(2011-1#1)(2011-2#1)
therapies have been developed##3##4##(2007-11#1)(2008-6#1)(2008-7#1)
therapies have been used##2##4##(2006-10#1)(2010-7#1)
therapies have been##14##3##(2005-8#1)(2006-10#2)(2006-3#1)(2007-11#1)(2007-5#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-5#1)(2010-7#1)(2012-12#2)
therapies have emerged##2##3##(2006-10#1)(2009-9#1)
therapies have improved##2##3##(2010-11#1)(2012-2#1)
therapies have not##2##3##(2008-2#1)(2010-12#1)
therapies have proven##2##3##(2006-5#1)(2008-5#1)
therapies have shown##2##3##(2006-8#1)(2010-12#1)
therapies have##37##2##(2005-8#2)(2006-10#3)(2006-3#2)(2006-5#1)(2006-8#2)(2007-11#3)(2007-5#1)(2008-10#1)(2008-2#2)(2008-5#2)(2008-6#2)(2008-7#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#3)(2012-2#2)
therapies in inflammatory bowel disease##2##5##(2006-10#1)(2010-12#1)
therapies in patients with##2##4##(2011-1#1)(2012-3#1)
therapies in the management of##3##5##(2006-4#1)(2009-8#1)(2010-5#1)
therapies in the treatment of##4##5##(2009-8#1)(2010-6#1)(2011-2#1)(2012-1#1)
therapies in the##12##3##(1993-8#1)(2005-8#1)(2006-4#1)(2009-8#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)
therapies in this##6##3##(2010-7#1)(2012-2#1)(2013-8#4)
therapies in##60##2##(1990-5#1)(1992-12#1)(1993-8#1)(1995-1#1)(1995-2#1)(1996-9#1)(1997-6#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2007-1#1)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2009-10#1)(2009-11#1)(2009-8#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
therapies include##3##2##(2006-10#1)(2011-2#1)(2013-1#1)
therapies including##7##2##(2005-6#1)(2005-8#1)(2006-10#1)(2010-12#1)(2012-12#1)(2013-1#2)
therapies into##2##2##(2008-6#1)(2009-11#1)
therapies is a##3##3##(2006-12#1)(2006-5#1)(2008-3#1)
therapies is continuing##2##3##(2008-12#1)(2010-5#1)
therapies is often##2##3##(2006-5#1)(2008-7#1)
therapies is presented##2##3##(2006-5#1)(2011-2#1)
therapies is the##3##3##(2006-2#1)(2007-2#1)(2008-1#1)
therapies is##24##2##(1997-6#1)(2005-9#1)(2006-12#1)(2006-2#1)(2006-5#4)(2006-6#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)
therapies may be a##2##4##(1993-2#1)(2010-12#1)
therapies may be##7##3##(1993-2#1)(2006-10#1)(2008-4#1)(2010-12#3)(2013-8#1)
therapies may##10##2##(1993-2#1)(2006-10#1)(2008-4#1)(2010-12#4)(2013-1#1)(2013-7#1)(2013-8#1)
therapies must##2##2##(1997-5#1)(2005-7#1)
therapies need to be##2##4##(1992-8#1)(2007-11#1)
therapies of##15##2##(1991-6#1)(1995-11#2)(2005-3#1)(2006-10#1)(2006-2#1)(2007-7#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
therapies offer##3##2##(2006-7#1)(2009-8#1)(2013-1#1)
therapies on symptoms of##2##4##(2008-10#1)(2010-12#1)
therapies on the##5##3##(1993-2#1)(2006-10#1)(2007-11#1)(2007-8#1)(2009-5#1)
therapies on##13##2##(1993-2#2)(2005-3#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-7#2)(2009-5#1)(2010-12#2)
therapies remains##3##2##(2006-10#1)(2007-7#1)(2010-2#1)
therapies seem##2##2##(2006-10#1)(2008-1#1)
therapies should be##3##3##(2006-5#1)(2007-11#1)(2008-12#1)
therapies should##4##2##(2006-5#1)(2007-11#1)(2008-12#1)(2011-2#1)
therapies such as##11##3##(2005-10#1)(2005-6#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-6#1)(2013-7#1)
therapies such##12##2##(2005-10#1)(2005-6#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-6#1)(2013-7#1)
therapies targeted##2##2##(2009-12#1)(2012-12#1)
therapies targeting##4##2##(2005-7#1)(2008-4#1)(2008-5#1)(2009-12#1)
therapies that are##3##3##(2005-8#1)(2006-9#1)(2007-8#1)
therapies that can##4##3##(2008-4#1)(2010-12#1)(2012-1#1)(2012-12#1)
therapies that have##4##3##(2005-8#1)(2009-7#1)(2009-8#1)(2010-8#1)
therapies that may##2##3##(2006-10#1)(2013-7#1)
therapies that specifically##2##3##(2009-12#1)(2010-4#1)
therapies that target##2##3##(2010-12#1)(2012-2#1)
therapies that##35##2##(1995-6#1)(2005-8#2)(2006-10#1)(2006-5#1)(2006-9#2)(2007-8#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#3)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
therapies to be##2##3##(1997-6#1)(2008-1#1)
therapies to improve##3##3##(2006-10#1)(2008-3#1)(2010-3#1)
therapies to prevent##2##3##(2006-10#1)(2013-1#1)
therapies to reduce##2##3##(2006-10#1)(2011-2#1)
therapies to treat##4##3##(2008-11#1)(2008-5#1)(2009-9#1)(2012-12#1)
therapies to##25##2##(1997-3#1)(1997-6#1)(2006-10#4)(2007-9#1)(2008-1#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
therapies used to##2##3##(2008-5#1)(2008-7#1)
therapies used##4##2##(2007-11#1)(2008-5#1)(2008-7#1)(2012-11#1)
therapies using##2##2##(2008-4#1)(2013-8#1)
therapies was##2##2##(2007-7#1)(2008-3#1)
therapies were##4##2##(2006-4#1)(2006-5#1)(2007-11#1)(2008-11#1)
therapies which##2##2##(2008-11#1)(2008-5#1)
therapies will be discussed in##2##5##(2006-2#1)(2007-2#1)
therapies will be discussed##3##4##(2006-2#1)(2007-2#1)(2010-11#1)
therapies will be##5##3##(2006-2#1)(2007-2#2)(2010-11#1)(2010-12#1)
therapies will##7##2##(2006-2#1)(2007-2#2)(2008-11#1)(2009-7#1)(2010-11#1)(2010-12#1)
therapies with other##2##3##(2006-11#1)(2010-3#1)
therapies with##12##2##(2006-11#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-3#1)(2011-2#1)
therapies within##5##2##(2005-8#1)(2006-9#2)(2013-1#2)
therapies would be##3##3##(2006-7#1)(2008-7#1)(2009-6#1)
therapies would##4##2##(2006-7#1)(2007-11#1)(2008-7#1)(2009-6#1)
therapies##1063##1##(1990-10#2)(1990-3#1)(1990-5#2)(1990-6#2)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#3)(1991-6#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-11#3)(1993-12#1)(1993-2#6)(1993-3#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-6#2)(1994-9#2)(1995-1#5)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-2#3)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#14)(1997-7#1)(2004-1#2)(2004-11#4)(2004-2#1)(2004-3#1)(2004-4#2)(2005-10#6)(2005-11#7)(2005-3#2)(2005-6#5)(2005-7#19)(2005-8#31)(2005-9#3)(2006-10#74)(2006-11#6)(2006-12#13)(2006-2#13)(2006-3#4)(2006-4#4)(2006-5#20)(2006-6#3)(2006-7#9)(2006-8#4)(2006-9#13)(2007-1#2)(2007-10#7)(2007-11#32)(2007-12#6)(2007-2#8)(2007-3#1)(2007-4#3)(2007-5#2)(2007-6#2)(2007-7#8)(2007-8#10)(2007-9#6)(2008-1#30)(2008-10#10)(2008-11#31)(2008-12#7)(2008-2#7)(2008-3#25)(2008-4#17)(2008-5#23)(2008-6#26)(2008-7#28)(2008-8#16)(2008-9#3)(2009-1#3)(2009-10#6)(2009-11#4)(2009-12#10)(2009-2#2)(2009-3#5)(2009-4#7)(2009-5#3)(2009-6#6)(2009-7#13)(2009-8#12)(2009-9#5)(2010-1#1)(2010-10#7)(2010-11#9)(2010-12#37)(2010-2#3)(2010-3#5)(2010-4#5)(2010-5#16)(2010-6#6)(2010-7#5)(2010-8#5)(2010-9#3)(2011-1#19)(2011-12#5)(2011-2#32)(2011-3#1)(2012-1#11)(2012-11#5)(2012-12#51)(2012-2#25)(2012-3#11)(2013-1#47)(2013-7#9)(2013-8#25)
therapies&quot##2##1##(2009-10#1)(2010-12#1)
therapist and patient##2##3##(1993-5#1)(1994-4#1)
therapist and##6##2##(1993-5#1)(1994-4#1)(2006-1#1)(2008-2#1)(2009-6#1)(2009-9#1)
therapist for##2##2##(2008-12#1)(2012-1#1)
therapist in##3##2##(1991-7#1)(2006-7#1)(2008-12#1)
therapist who##2##2##(1993-3#1)(2006-11#1)
therapist with##3##2##(1991-2#1)(1991-4#1)(2006-7#1)
therapist##75##1##(1990-4#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-7#1)(1993-12#1)(1993-3#2)(1993-5#2)(1994-4#2)(1995-1#1)(2004-3#1)(2006-1#3)(2006-10#2)(2006-11#1)(2006-2#1)(2006-7#5)(2007-10#1)(2007-7#1)(2008-10#2)(2008-12#3)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#2)(2009-6#9)(2009-9#6)(2010-9#2)(2011-2#2)(2012-1#8)(2012-2#6)(2013-7#1)
therapist's##5##1##(1991-3#1)(2006-7#1)(2007-11#1)(2009-3#1)(2012-1#1)
therapists and members##3##3##(2007-10#3)
therapists and##7##2##(1995-12#1)(2005-2#1)(2007-10#3)(2013-8#2)
therapists are##5##2##(1992-12#1)(1992-3#2)(2007-1#1)(2010-5#1)
therapists can##2##2##(2006-10#2)
therapists have##2##2##(1992-3#1)(2008-12#1)
therapists identified##2##2##(1993-3#1)(2006-10#1)
therapists in the##3##3##(1993-12#1)(2008-6#1)(2012-2#1)
therapists in##10##2##(1992-3#1)(1993-12#2)(1993-2#1)(2006-1#1)(2006-10#1)(2006-11#1)(2008-12#1)(2008-6#1)(2012-2#1)
therapists may##3##2##(1991-2#1)(1993-5#1)(2008-4#1)
therapists to the##2##3##(1992-12#1)(2008-8#1)
therapists to##4##2##(1991-3#1)(1992-12#1)(2008-8#1)(2012-2#1)
therapists were##4##2##(1993-12#1)(1996-2#1)(2010-7#1)(2013-1#1)
therapists who work with##2##4##(1991-12#1)(2009-9#1)
therapists who##4##2##(1991-12#1)(2009-9#1)(2012-12#1)(2012-2#1)
therapists with##3##2##(1991-12#1)(1993-12#1)(2008-12#1)
therapists working##2##2##(1991-12#1)(1993-12#1)
therapists##104##1##(1990-12#1)(1991-12#3)(1991-2#2)(1991-3#2)(1992-12#3)(1992-3#5)(1993-1#2)(1993-12#6)(1993-2#1)(1993-3#1)(1993-5#4)(1993-9#1)(1994-3#1)(1995-1#1)(1995-12#4)(1996-2#3)(2005-2#1)(2006-1#2)(2006-10#5)(2006-11#2)(2006-3#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-12#6)(2008-4#4)(2008-6#1)(2008-8#2)(2009-1#1)(2009-7#1)(2009-9#1)(2010-5#2)(2010-7#2)(2010-9#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#11)(2013-1#2)(2013-8#4)
therapists' knowledge of##2##3##(2008-8#1)(2012-12#1)
therapists' knowledge##5##2##(2008-8#1)(2012-12#1)(2013-8#3)
therapists'##15##1##(1995-12#1)(1995-3#2)(2006-10#2)(2007-10#2)(2008-10#1)(2008-12#1)(2008-8#1)(2012-12#1)(2012-3#1)(2013-8#3)
therapy (0##2##2##(1991-6#1)(2013-1#1)
therapy (50##2##2##(2009-10#2)
therapy (ART) has##2##3##(2008-8#1)(2009-3#1)
therapy (ART)##18##2##(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-3#2)(2010-12#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#2)
therapy (CBT) and##2##3##(2006-9#1)(2008-6#1)
therapy (CBT)##8##2##(2006-9#1)(2007-12#2)(2008-6#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
therapy (CRT) is##2##3##(2006-9#1)(2008-10#1)
therapy (CRT)##5##2##(2006-9#1)(2008-10#1)(2010-6#1)(2012-12#1)(2012-2#1)
therapy (ECT) and##2##3##(2011-1#2)
therapy (ECT)##6##2##(1992-8#1)(1996-1#1)(1996-2#1)(2011-1#2)(2012-12#1)
therapy (HAART) in##3##3##(2009-2#1)(2010-7#1)(2012-2#1)
therapy (HAART)##24##2##(2007-11#3)(2007-7#1)(2008-11#1)(2008-3#2)(2008-5#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-2#2)(2013-8#1)
therapy (MDT)##2##2##(2007-7#1)(2012-12#1)
therapy (MT)##2##2##(2008-10#1)(2013-1#1)
therapy (P =##2##3##(2007-10#1)(2012-1#1)
therapy (P##3##2##(2007-10#1)(2008-1#1)(2012-1#1)
therapy (PDT) is##7##3##(1992-8#1)(2005-7#1)(2007-1#1)(2007-11#1)(2009-4#1)(2011-2#1)(2013-8#1)
therapy (PDT) with##2##3##(1994-1#1)(2007-8#1)
therapy (PDT)##42##2##(1990-11#1)(1990-9#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-1#1)(2005-7#1)(2006-10#1)(2006-12#2)(2007-1#1)(2007-11#1)(2007-8#3)(2008-5#10)(2008-7#1)(2008-8#1)(2009-4#5)(2010-8#1)(2011-11#1)(2011-2#1)(2012-12#2)(2012-3#3)(2013-8#2)
therapy (PT)##5##2##(2008-11#1)(2009-9#1)(2010-9#1)(2012-2#1)(2013-8#1)
therapy (RT)##5##2##(1996-3#1)(2008-6#1)(2008-7#2)(2013-1#1)
therapy (e##2##2##(1992-11#1)(2007-8#1)
therapy (group##2##2##(2007-8#2)
therapy (n =##4##3##(1990-5#1)(2008-6#2)(2012-2#1)
therapy (n##5##2##(1990-5#1)(2008-6#2)(2012-2#1)(2013-1#1)
therapy (primary##2##2##(1992-6#1)(2007-7#1)
therapy -##7##2##(2004-12#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-4#1)(2012-2#1)(2013-1#1)
therapy a##5##2##(1992-7#1)(1995-2#1)(2007-11#2)(2010-12#1)
therapy adaptation##2##2##(2010-7#2)
therapy adherence in##2##3##(2010-12#1)(2013-1#1)
therapy adherence##3##2##(2009-8#1)(2010-12#1)(2013-1#1)
therapy administered##2##2##(2007-5#1)(2007-7#1)
therapy after radical prostatectomy##3##4##(2006-9#3)
therapy after##25##2##(1992-5#1)(1995-9#1)(2006-10#3)(2006-4#1)(2006-9#3)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-12#4)(2010-7#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)
therapy against##4##2##(2007-8#1)(2008-10#1)(2013-1#1)(2013-8#1)
therapy aimed at##3##3##(2005-10#1)(2006-2#1)(2010-3#1)
therapy aiming##2##2##(2006-6#1)(2013-8#1)
therapy aims at##2##3##(2011-2#1)(2013-8#1)
therapy aims to##3##3##(1994-4#1)(2008-4#1)(2010-4#1)
therapy aims##5##2##(1994-4#1)(2008-4#1)(2010-4#1)(2011-2#1)(2013-8#1)
therapy algorithms##2##2##(2007-8#1)(2008-11#1)
therapy allowed to##2##3##(2006-2#1)(2010-11#1)
therapy allows##2##2##(2008-1#1)(2013-8#1)
therapy alone##16##2##(1990-4#1)(1991-6#1)(1995-9#1)(2004-1#1)(2006-10#1)(2006-9#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-7#2)(2010-12#1)(2010-9#2)(2012-12#1)
therapy along with##3##3##(1993-2#1)(2007-11#1)(2007-2#1)
therapy along##4##2##(1993-2#1)(2006-10#1)(2007-11#1)(2007-2#1)
therapy also##11##2##(1991-7#1)(1994-9#1)(1995-6#1)(2004-2#1)(2006-10#1)(2007-11#1)(2008-12#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-12#1)
therapy although##2##2##(2008-1#2)
therapy among patients##2##3##(2006-10#1)(2008-3#1)
therapy among##5##2##(1994-6#1)(2006-10#1)(2008-3#1)(2012-12#2)
therapy and a##6##3##(1992-12#1)(1997-4#1)(2006-10#1)(2008-3#1)(2008-8#1)(2012-2#1)
therapy and administration of##2##4##(2011-2#1)(2013-8#1)
therapy and as##2##3##(2005-11#1)(2007-11#1)
therapy and avoidance of##2##4##(2008-10#1)(2011-2#1)
therapy and cancer##2##3##(2005-8#1)(2010-6#1)
therapy and cardiovascular##2##3##(1993-11#1)(2009-4#1)
therapy and changes in##3##4##(1992-9#1)(2008-8#1)(2011-2#1)
therapy and chemotherapy##7##3##(2006-11#1)(2008-7#2)(2010-2#1)(2013-8#3)
therapy and compared##2##3##(1990-5#1)(2006-9#1)
therapy and diagnosis##3##3##(1991-2#1)(1996-11#1)(2007-8#1)
therapy and drug##3##3##(2005-7#1)(2005-8#1)(2006-8#1)
therapy and drug-eluting##2##3##(2008-11#1)(2011-2#1)
therapy and for the##2##4##(1993-8#1)(1994-12#1)
therapy and for##5##3##(1993-8#1)(1994-12#1)(2009-9#1)(2013-1#2)
therapy and gene therapy##2##4##(1996-10#1)(2012-3#1)
therapy and had##4##3##(2007-7#1)(2008-1#1)(2011-2#1)(2013-8#1)
therapy and immune##2##3##(2006-10#1)(2013-7#1)
therapy and in whom##2##4##(2007-7#1)(2010-6#1)
therapy and in##5##3##(2007-1#1)(2007-11#2)(2007-7#1)(2010-6#1)
therapy and is##2##3##(2006-5#1)(2007-8#1)
therapy and its##5##3##(1991-2#1)(1994-6#1)(1996-11#1)(2007-7#1)(2013-7#1)
therapy and magnetic field therapy##2##5##(2007-7#2)
therapy and management of##2##4##(2008-3#1)(2012-3#1)
therapy and management##4##3##(2008-3#1)(2008-5#1)(2012-2#1)(2012-3#1)
therapy and may##3##3##(2006-10#1)(2008-3#1)(2009-9#1)
therapy and mechanical ventilation##2##4##(2007-2#1)(2007-7#1)
therapy and new##2##3##(2005-7#1)(2010-5#1)
therapy and nuclear##2##3##(1994-2#1)(2011-1#1)
therapy and occupational##3##3##(2010-3#1)(2010-9#2)
therapy and other##3##3##(1993-2#2)(2007-11#1)
therapy and prediction of##2##4##(2008-12#1)(2010-5#1)
therapy and prevention of##2##4##(1991-2#1)(2008-5#1)
therapy and prevention##3##3##(1991-2#1)(2008-5#1)(2011-1#1)
therapy and prognosis##4##3##(1994-11#1)(2005-8#1)(2007-7#1)(2009-4#1)
therapy and progression of##2##4##(2008-1#1)(2008-11#1)
therapy and prompt##3##3##(2011-2#1)(2013-1#2)
therapy and prostate cancer##2##4##(2006-9#1)(2011-2#1)
therapy and provide##2##3##(2007-9#1)(2009-3#1)
therapy and rehabilitation##3##3##(1995-5#1)(2006-12#1)(2012-12#1)
therapy and relationship education##4##4##(2012-2#4)
therapy and short-term##2##3##(1994-12#1)(2004-3#1)
therapy and so##2##3##(2007-7#1)(2012-2#1)
therapy and surgery##2##3##(2006-2#1)(2008-5#1)
therapy and surgical##5##3##(2006-10#2)(2007-11#1)(2008-4#1)(2008-7#1)
therapy and the use of##2##5##(1993-1#1)(2006-8#1)
therapy and the##26##3##(1992-5#1)(1993-1#1)(1993-8#1)(1995-4#2)(2005-10#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#2)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)
therapy and their##2##3##(2007-10#1)(2008-12#1)
therapy and tissue engineering##10##4##(2006-6#1)(2008-11#1)(2008-5#3)(2012-12#4)(2012-2#1)
therapy and to assess##2##4##(2006-10#1)(2008-6#1)
therapy and to##6##3##(1996-4#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-6#1)(2012-2#1)
therapy and treatment##2##3##(1992-11#1)(2009-3#1)
therapy and use of##3##4##(1990-11#1)(2010-6#1)(2012-1#1)
therapy and vaccination##3##3##(2008-11#2)(2012-2#1)
therapy and vaccines##2##3##(2008-5#2)
therapy and volume treatment in elective##2##6##(1990-11#2)
therapy and were##4##3##(1991-10#1)(2006-7#1)(2008-10#1)(2011-2#1)
therapy and who will##2##4##(2006-5#1)(2008-3#1)
therapy and##411##2##(1990-11#3)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#6)(1991-3#1)(1992-10#3)(1992-11#2)(1992-12#2)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#3)(1994-6#2)(1994-7#3)(1995-1#1)(1995-10#1)(1995-4#4)(1995-5#1)(1995-8#1)(1996-10#1)(1996-11#3)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(2004-11#2)(2004-3#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-6#2)(2005-7#4)(2005-8#10)(2005-9#1)(2006-1#1)(2006-10#12)(2006-11#1)(2006-12#2)(2006-2#3)(2006-4#3)(2006-5#3)(2006-6#4)(2006-7#4)(2006-8#4)(2006-9#6)(2007-1#1)(2007-10#2)(2007-11#15)(2007-12#1)(2007-2#1)(2007-3#3)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#13)(2007-8#10)(2007-9#1)(2008-1#6)(2008-10#8)(2008-11#8)(2008-12#6)(2008-3#7)(2008-4#5)(2008-5#14)(2008-6#6)(2008-7#7)(2008-8#5)(2008-9#1)(2009-11#2)(2009-2#1)(2009-3#3)(2009-4#4)(2009-9#2)(2010-11#1)(2010-12#7)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#5)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#12)(2011-11#1)(2011-2#19)(2012-1#6)(2012-11#1)(2012-12#12)(2012-2#19)(2012-3#8)(2013-1#14)(2013-7#2)(2013-8#8)
therapy and/or##3##2##(2007-6#1)(2008-11#1)(2008-7#1)
therapy appears##2##2##(2007-11#1)(2013-1#1)
therapy applications##5##2##(2005-7#1)(2007-6#1)(2008-11#1)(2008-3#1)(2008-5#1)
therapy approach##6##2##(1994-5#1)(1995-2#1)(2008-7#1)(2009-4#1)(2013-1#1)(2013-8#1)
therapy approaches that##2##3##(2004-1#1)(2013-1#1)
therapy approaches##8##2##(2004-1#1)(2005-8#1)(2007-11#2)(2007-3#1)(2008-4#1)(2012-2#1)(2013-1#1)
therapy are discussed##8##3##(1991-8#1)(1992-9#1)(1993-6#2)(2004-1#1)(2008-4#1)(2008-5#1)(2008-9#1)
therapy are not##5##3##(1991-5#1)(1994-6#1)(1995-4#1)(2006-10#1)(2011-1#1)
therapy are still##2##3##(2006-10#1)(2010-12#1)
therapy are the##2##3##(1997-4#1)(2007-7#1)
therapy are to improve##2##4##(1996-3#1)(2012-1#1)
therapy are to##4##3##(1993-9#1)(1994-4#1)(1996-3#1)(2012-1#1)
therapy are##64##2##(1990-11#1)(1990-5#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-9#1)(1993-6#2)(1993-9#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-4#1)(1996-3#1)(1996-9#1)(1997-4#1)(2004-1#1)(2004-11#1)(2004-12#1)(2005-6#1)(2005-7#1)(2006-10#3)(2006-6#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)
therapy area and##2##3##(2006-5#1)(2012-2#1)
therapy as a##11##3##(1990-8#1)(1991-3#1)(1991-8#1)(1996-3#1)(2007-7#1)(2008-11#1)(2008-12#1)(2009-4#1)(2013-8#3)
therapy as an##3##3##(2006-10#1)(2008-5#1)(2008-7#1)
therapy as soon as##3##4##(2006-8#1)(2013-1#1)(2013-8#1)
therapy as the##2##3##(2009-8#1)(2013-1#1)
therapy as well as##5##4##(1990-6#1)(2007-12#1)(2008-7#1)(2012-1#1)(2012-2#1)
therapy as well##6##3##(1990-6#1)(2007-12#1)(2007-7#1)(2008-7#1)(2012-1#1)(2012-2#1)
therapy as##36##2##(1990-6#1)(1990-8#1)(1991-3#1)(1991-8#1)(1992-5#1)(1994-6#1)(1996-3#1)(1997-6#1)(2004-3#1)(2006-10#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-4#1)(2009-8#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#4)
therapy at home##2##3##(1995-2#1)(2012-2#1)
therapy at the##2##3##(2007-11#1)(2009-11#1)
therapy at##14##2##(1995-2#1)(1996-3#1)(1997-8#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-8#1)(2009-11#1)(2009-6#1)(2012-2#3)(2013-8#1)
therapy based on the##3##4##(2007-8#1)(2008-8#1)(2011-2#1)
therapy based on##12##3##(1991-12#1)(1996-10#1)(2007-8#2)(2008-7#1)(2008-8#1)(2009-6#2)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#1)
therapy based##17##2##(1991-12#1)(1996-10#1)(2007-8#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#2)(2010-12#1)(2010-3#2)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
therapy be##3##2##(1990-4#1)(1993-11#1)(2006-3#1)
therapy became available##2##3##(1996-9#1)(2006-8#1)
therapy became##4##2##(1991-6#1)(1996-9#1)(2006-8#1)(2007-12#1)
therapy because of adverse##2##4##(2008-1#1)(2012-12#1)
therapy because of its##2##4##(1994-5#1)(2011-2#1)
therapy because of the##2##4##(2005-10#1)(2005-11#1)
therapy because of##9##3##(1994-5#1)(2005-10#1)(2005-11#2)(2007-10#1)(2008-1#1)(2011-2#2)(2012-12#1)
therapy because##10##2##(1994-5#1)(2005-10#1)(2005-11#2)(2007-10#1)(2008-1#1)(2009-5#1)(2011-2#2)(2012-12#1)
therapy before##5##2##(2006-2#1)(2007-11#1)(2007-8#1)(2011-2#2)
therapy began##2##2##(2008-7#1)(2012-2#1)
therapy being the##2##3##(2010-12#1)(2013-1#1)
therapy benefit##2##2##(2005-10#1)(2006-11#1)
therapy benefits##2##2##(2008-5#1)(2013-1#1)
therapy brought##2##2##(1995-4#1)(2011-2#1)
therapy but##10##2##(1993-8#1)(1993-9#1)(1995-2#1)(2006-10#1)(2007-12#1)(2008-12#1)(2008-6#1)(2010-11#1)(2010-12#1)(2013-1#1)
therapy by the##2##3##(1995-6#1)(1996-9#1)
therapy by using##3##3##(1994-3#1)(2007-9#1)(2012-1#1)
therapy by##24##2##(1992-6#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-6#1)(1996-2#1)(1996-9#1)(2005-11#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-1#2)(2010-3#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
therapy can be applied##3##4##(1995-8#1)(2006-9#1)(2008-6#1)
therapy can be effective##2##4##(2008-1#1)(2008-8#1)
therapy can be##22##3##(1994-7#1)(1995-8#1)(1997-2#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
therapy can result in##2##4##(1996-6#1)(2006-12#1)
therapy can##43##2##(1991-12#1)(1993-10#1)(1993-9#1)(1994-7#1)(1995-8#1)(1996-6#1)(1997-2#1)(2004-11#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-9#2)(2007-11#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
therapy carry##2##2##(2006-9#1)(2012-2#1)
therapy centers##2##2##(1996-1#1)(2006-7#1)
therapy clinic##2##2##(2008-12#1)(2008-7#1)
therapy clinical trial for##4##4##(1994-5#1)(2008-5#2)(2010-10#1)
therapy clinical##5##2##(1994-5#1)(2007-3#1)(2008-5#2)(2010-10#1)
therapy combined with a##2##4##(1995-2#1)(2007-11#1)
therapy combined with##12##3##(1990-4#1)(1991-2#1)(1992-8#1)(1995-2#1)(2004-3#1)(2006-10#2)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-6#1)
therapy compared##2##2##(2008-7#1)(2012-3#1)
therapy comprising##3##2##(2004-3#1)(2007-11#1)(2010-9#1)
therapy consisting of##3##3##(1991-2#1)(2008-6#1)(2012-1#1)
therapy consists##2##2##(1994-4#1)(2007-8#1)
therapy constitutes an##3##3##(2007-4#1)(2010-12#2)
therapy continued##3##2##(1994-6#1)(2011-2#2)
therapy continues to##2##3##(2008-7#1)(2012-12#1)
therapy continues##3##2##(1993-11#1)(2008-7#1)(2012-12#1)
therapy could be##3##3##(2007-11#1)(2008-7#1)(2011-2#1)
therapy could##13##2##(1990-12#1)(2005-8#1)(2006-10#1)(2007-11#2)(2007-8#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#1)(2011-2#1)(2013-1#1)
therapy currently##2##2##(2008-5#1)(2012-2#1)
therapy decreased the##2##3##(2009-2#1)(2011-2#1)
therapy decreased##4##2##(2007-2#1)(2007-8#1)(2009-2#1)(2011-2#1)
therapy decreases##2##2##(2007-5#1)(2008-7#1)
therapy depends on the##4##4##(2007-11#1)(2008-4#1)(2008-7#1)(2013-1#1)
therapy depends on##10##3##(2006-1#1)(2007-11#2)(2008-4#1)(2008-7#1)(2009-11#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
therapy descriptions##4##2##(2013-1#4)
therapy did not differ##2##4##(1997-2#1)(2007-9#1)
therapy did not##8##3##(1997-2#1)(2005-8#1)(2006-6#1)(2007-10#1)(2007-9#1)(2008-6#1)(2011-1#1)(2013-1#1)
therapy directed against##3##3##(1993-6#1)(1995-3#1)(2005-10#1)
therapy directed at##2##3##(1996-11#1)(2007-11#1)
therapy directed##6##2##(1993-6#1)(1995-3#1)(1996-11#1)(2005-10#1)(2007-11#1)(2008-6#1)
therapy discussed##2##2##(2008-1#1)(2008-3#1)
therapy does not##7##3##(1992-12#1)(2005-8#1)(2006-3#1)(2006-9#1)(2008-11#1)(2009-6#1)(2010-10#1)
therapy due to the##2##4##(2008-10#1)(2008-5#1)
therapy due to##9##3##(1995-9#1)(2005-7#1)(2006-1#1)(2007-10#1)(2008-10#1)(2008-5#1)(2011-2#2)(2012-12#1)
therapy during##10##2##(1990-5#1)(1994-11#1)(1996-12#1)(1996-8#1)(2005-7#1)(2007-2#2)(2008-11#1)(2013-1#2)
therapy education in Brazil##2##4##(2010-7#2)
therapy education##3##2##(2010-7#3)
therapy effect of##2##3##(2010-12#1)(2012-11#1)
therapy effect##3##2##(2010-12#1)(2011-1#1)(2012-11#1)
therapy efficacy##2##2##(2008-4#1)(2012-2#1)
therapy either##2##2##(2005-8#1)(2007-9#1)
therapy enables##2##2##(2004-3#1)(2009-11#1)
therapy existed for##2##3##(2005-8#1)(2009-8#1)
therapy exists##4##2##(1990-12#1)(2007-10#1)(2007-8#1)(2008-8#1)
therapy failed##3##2##(1990-2#1)(2006-10#1)(2007-8#1)
therapy fails##6##2##(1990-9#1)(2006-10#2)(2007-8#1)(2009-3#1)(2011-2#1)
therapy failure##4##2##(2010-12#2)(2012-2#1)(2013-1#1)
therapy failures##4##2##(2008-8#1)(2011-2#2)(2012-12#1)
therapy focused##2##2##(2005-8#1)(2006-10#1)
therapy followed by##2##3##(2012-12#2)
therapy followed##3##2##(2008-6#1)(2012-12#2)
therapy following surgery##3##3##(1994-3#2)(2008-7#1)
therapy following##8##2##(1994-12#1)(1994-3#2)(1994-5#1)(1996-3#1)(2008-7#1)(2009-8#1)(2011-2#1)
therapy for Crohn's disease##3##4##(2006-10#1)(2007-12#1)(2012-2#1)
therapy for HIV##2##3##(2010-12#1)(2012-2#1)
therapy for Parkinson's disease (PD)##2##5##(2012-2#1)(2013-1#1)
therapy for Parkinson's disease##3##4##(2008-11#1)(2012-2#1)(2013-1#1)
therapy for a##10##3##(1997-4#1)(2006-9#1)(2007-3#2)(2008-10#1)(2008-6#1)(2010-12#1)(2012-2#2)(2013-8#1)
therapy for active##3##3##(2006-10#1)(2010-12#2)
therapy for acute ischemic stroke##9##5##(2006-7#1)(2007-10#2)(2007-7#2)(2007-9#1)(2008-8#1)(2013-7#2)
therapy for acute myocardial infarction##2##5##(1997-8#1)(2011-2#1)
therapy for acute renal failure##2##5##(2006-5#1)(2008-11#1)
therapy for acute##18##3##(1997-8#2)(2005-8#1)(2006-5#1)(2006-7#1)(2007-10#2)(2007-7#2)(2007-9#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-4#1)(2010-7#1)(2011-2#1)(2013-7#2)
therapy for advanced non-small cell lung cancer##2##7##(1994-12#1)(2010-8#1)
therapy for advanced##7##3##(1991-12#1)(1993-12#1)(1994-12#1)(2009-8#1)(2010-12#1)(2010-8#1)(2013-7#1)
therapy for all##2##3##(2007-7#1)(2008-3#1)
therapy for allergic##2##3##(2007-11#2)
therapy for arthritis##4##3##(2005-9#1)(2006-10#2)(2008-10#1)
therapy for asthma##2##3##(1996-2#1)(2008-3#1)
therapy for atrial fibrillation##2##4##(2006-8#1)(2007-8#1)
therapy for bone metastases##4##4##(2007-11#1)(2010-12#1)(2010-3#1)(2013-8#1)
therapy for bone##5##3##(1997-6#1)(2007-11#1)(2010-12#1)(2010-3#1)(2013-8#1)
therapy for both##4##3##(2006-9#1)(2007-12#1)(2008-1#1)(2008-11#1)
therapy for breast cancer has##2##5##(1996-6#1)(2004-2#1)
therapy for breast cancer##8##4##(1990-4#1)(1994-7#1)(1996-6#1)(2004-2#2)(2008-4#1)(2013-1#1)(2013-8#1)
therapy for cancer##4##3##(1994-5#2)(2005-10#1)(2008-5#1)
therapy for cardiovascular##2##3##(2009-8#1)(2010-6#1)
therapy for cervical cancer##3##4##(1994-7#1)(2009-5#2)
therapy for cervical##4##3##(1994-7#1)(2009-5#2)(2011-2#1)
therapy for children with##2##4##(1990-3#1)(2013-8#1)
therapy for children##6##3##(1990-3#1)(2007-7#1)(2009-10#1)(2012-2#1)(2013-8#2)
therapy for chronic HCV##2##4##(2005-8#1)(2013-1#1)
therapy for chronic hepatitis B##3##5##(2009-8#2)(2012-2#1)
therapy for chronic hepatitis C##3##5##(2009-3#1)(2011-2#1)(2012-2#1)
therapy for chronic hepatitis##6##4##(2009-3#1)(2009-8#2)(2011-2#1)(2012-2#2)
therapy for chronic myeloid leukemia##2##5##(2008-1#1)(2009-3#1)
therapy for chronic obstructive pulmonary disease##2##6##(2006-5#1)(2011-2#1)
therapy for chronic##20##3##(1993-9#1)(2005-8#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-2#1)(2008-1#1)(2009-3#2)(2009-8#2)(2010-3#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)(2013-7#1)
therapy for colorectal cancer##3##4##(2008-8#1)(2010-11#1)(2013-1#1)
therapy for colorectal##4##3##(2008-8#1)(2010-11#1)(2012-1#1)(2013-1#1)
therapy for depression##2##3##(2011-3#1)(2012-2#1)
therapy for diabetes mellitus##2##4##(1995-5#1)(2009-11#1)
therapy for diabetes##4##3##(1995-5#1)(2008-1#1)(2009-11#1)(2012-12#1)
therapy for early##4##3##(1994-12#1)(1997-7#1)(2010-12#1)(2012-2#1)
therapy for elderly##2##3##(2009-5#1)(2009-8#1)
therapy for end-stage##2##3##(2007-8#1)(2010-6#1)
therapy for esophageal cancer##2##4##(2006-10#1)(2012-2#1)
therapy for esophageal##3##3##(2006-10#1)(2008-5#1)(2012-2#1)
therapy for fistulizing##2##3##(2010-12#2)
therapy for gastric cancer##2##4##(1992-8#1)(2008-5#1)
therapy for heart failure##3##4##(2007-1#1)(2010-8#2)
therapy for hepatitis##2##3##(2008-5#1)(2009-8#1)
therapy for human immunodeficiency##2##4##(1995-1#1)(2005-7#1)
therapy for human##4##3##(1991-7#1)(1994-5#1)(1995-1#1)(2005-7#1)
therapy for hypertension##6##3##(1993-9#3)(1994-6#1)(2008-3#1)(2008-8#1)
therapy for idiopathic##2##3##(2010-6#2)
therapy for inflammatory bowel disease##2##5##(1994-6#1)(2006-10#1)
therapy for inflammatory bowel##6##4##(1994-6#1)(2006-10#1)(2008-12#2)(2012-11#2)
therapy for inflammatory##8##3##(1994-6#1)(2006-10#1)(2008-12#2)(2010-5#1)(2011-2#1)(2012-11#2)
therapy for ischaemic heart disease##2##5##(2007-8#1)(2008-7#1)
therapy for liver##3##3##(1997-5#1)(2007-11#1)(2010-12#1)
therapy for lung cancer##2##4##(2004-1#2)
therapy for malignant pleurisy##2##4##(2012-1#2)
therapy for malignant##3##3##(2008-7#1)(2012-1#2)
therapy for management of##2##4##(2008-3#1)(2011-2#1)
therapy for metastatic breast cancer##2##5##(1991-4#1)(2013-8#1)
therapy for metastatic colorectal##2##4##(1993-10#1)(2012-1#1)
therapy for metastatic renal cell carcinoma##3##6##(1991-8#1)(1993-12#1)(2008-6#1)
therapy for metastatic##9##3##(1991-4#1)(1991-8#1)(1993-10#1)(1993-12#1)(2008-6#1)(2012-1#2)(2012-12#1)(2013-8#1)
therapy for mild##2##3##(1992-6#1)(2008-10#1)
therapy for most##2##3##(2008-12#1)(2010-12#1)
therapy for multiple##3##3##(2008-5#1)(2008-6#1)(2008-7#1)
therapy for neoplastic##2##3##(1992-4#1)(1994-5#1)
therapy for neuropathic pain##2##4##(2006-7#1)(2007-12#1)
therapy for obstructive##2##3##(2007-12#1)(2008-5#1)
therapy for osteoporosis##4##3##(1991-3#1)(2008-3#1)(2008-8#1)(2013-8#1)
therapy for other##2##3##(1996-1#1)(2010-7#1)
therapy for patients who##2##4##(1997-7#1)(2013-1#1)
therapy for patients with acute##2##5##(2008-3#1)(2009-11#1)
therapy for patients with advanced##2##5##(2008-6#2)
therapy for patients with chronic##2##5##(2009-3#1)(2011-2#1)
therapy for patients with##30##4##(1997-7#1)(2005-10#1)(2006-10#3)(2006-5#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-7#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)
therapy for patients##41##3##(1993-4#1)(1995-9#1)(1997-7#2)(2004-1#1)(2005-10#1)(2006-10#3)(2006-5#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#4)(2008-7#2)(2008-8#1)(2009-11#1)(2009-3#1)(2010-12#1)(2011-1#3)(2011-2#2)(2012-12#2)(2013-1#1)
therapy for preventing##3##3##(2006-9#1)(2007-7#1)(2012-2#1)
therapy for prevention of##2##4##(2008-4#1)(2010-9#1)
therapy for prevention##3##3##(1993-11#1)(2008-4#1)(2010-9#1)
therapy for primary##4##3##(1992-12#1)(2010-12#1)(2011-1#1)(2012-2#1)
therapy for prostate cancer##5##4##(1995-4#1)(2006-9#1)(2010-10#1)(2010-9#1)(2013-8#1)
therapy for psoriasis##2##3##(2007-11#1)(2008-3#1)
therapy for pulmonary##2##3##(2008-1#1)(2013-1#1)
therapy for recurrent##6##3##(1994-1#1)(1995-12#1)(2006-10#1)(2013-1#3)
therapy for relapsing##2##3##(2005-8#1)(2007-11#1)
therapy for retroperitoneal sarcoma##2##4##(2008-6#2)
therapy for retroperitoneal##3##3##(2006-6#1)(2008-6#2)
therapy for rheumatoid arthritis##6##4##(1997-5#1)(2006-10#2)(2007-11#2)(2008-8#1)
therapy for selected##3##3##(1995-12#1)(1996-8#1)(2007-11#1)
therapy for serious##2##3##(2006-10#1)(2011-2#1)
therapy for severe##3##3##(2007-8#1)(2008-5#1)(2012-12#1)
therapy for superficial##2##3##(2004-10#1)(2008-5#1)
therapy for systemic##2##3##(1994-2#1)(2007-7#1)
therapy for the eradication of##2##5##(2007-12#1)(2007-3#1)
therapy for the management of##2##5##(2005-8#1)(2007-12#1)
therapy for the prevention of##2##5##(2006-10#1)(2006-9#1)
therapy for the primary##3##4##(2011-12#3)
therapy for the treatment of hepatocellular carcinoma##2##7##(2008-8#1)(2013-8#1)
therapy for the treatment of##16##5##(1994-7#1)(2005-7#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-7#1)(2007-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-8#1)
therapy for the##41##3##(1992-2#2)(1994-6#1)(1994-7#1)(1996-3#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-3#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#4)(2008-8#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-12#3)(2011-2#1)(2013-8#1)
therapy for these##5##3##(2006-5#1)(2007-10#1)(2007-8#1)(2008-7#1)(2012-12#1)
therapy for this##6##3##(2006-10#1)(2007-12#1)(2008-11#1)(2010-4#1)(2012-1#1)(2013-1#1)
therapy for those patients##2##4##(2010-12#1)(2011-2#1)
therapy for those##5##3##(2007-2#1)(2008-1#1)(2010-12#1)(2010-5#1)(2011-2#1)
therapy for treating##2##3##(2012-2#1)(2013-8#1)
therapy for treatment of##5##4##(2006-10#1)(2007-6#1)(2007-9#1)(2008-3#1)(2010-12#1)
therapy for treatment##7##3##(2005-7#1)(2006-10#1)(2006-9#1)(2007-6#1)(2007-9#1)(2008-3#1)(2010-12#1)
therapy for ulcerative colitis##4##4##(2007-8#1)(2012-11#1)(2013-1#2)
therapy for unresectable##2##3##(2008-6#1)(2010-12#1)
therapy for wound and scar management##2##6##(2012-3#2)
therapy for##604##2##(1990-2#1)(1990-3#1)(1990-4#2)(1991-12#2)(1991-2#4)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-6#2)(1992-8#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-8#1)(1993-9#6)(1994-1#1)(1994-10#1)(1994-12#3)(1994-2#1)(1994-5#7)(1994-6#5)(1994-7#4)(1995-1#3)(1995-12#2)(1995-2#1)(1995-4#2)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-6#2)(1996-8#1)(1997-1#2)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#3)(2004-1#4)(2004-10#1)(2004-12#1)(2004-2#2)(2005-10#4)(2005-7#7)(2005-8#5)(2005-9#2)(2006-10#36)(2006-11#4)(2006-12#3)(2006-2#4)(2006-3#2)(2006-4#2)(2006-5#5)(2006-6#1)(2006-7#5)(2006-8#2)(2006-9#14)(2007-1#2)(2007-10#9)(2007-11#18)(2007-12#11)(2007-2#5)(2007-3#3)(2007-5#3)(2007-6#2)(2007-7#10)(2007-8#13)(2007-9#3)(2008-1#6)(2008-10#5)(2008-11#9)(2008-12#4)(2008-3#11)(2008-4#5)(2008-5#19)(2008-6#18)(2008-7#14)(2008-8#12)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#3)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#5)(2009-6#1)(2009-7#1)(2009-8#7)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#27)(2010-3#3)(2010-4#3)(2010-5#4)(2010-6#6)(2010-7#3)(2010-8#6)(2010-9#2)(2011-1#7)(2011-12#4)(2011-2#26)(2011-3#3)(2012-1#10)(2012-11#3)(2012-12#13)(2012-2#21)(2012-3#3)(2013-1#24)(2013-7#6)(2013-8#16)
therapy from##3##2##(1994-6#1)(2008-12#1)(2009-6#1)
therapy given to##2##3##(2006-2#1)(2010-3#1)
therapy given##3##2##(2006-2#1)(2008-7#1)(2010-3#1)
therapy group##7##2##(2006-10#3)(2011-2#1)(2012-3#1)(2013-1#2)
therapy had been##3##3##(1997-1#1)(2006-8#1)(2007-10#1)
therapy had no##2##3##(1994-12#1)(2006-11#1)
therapy had##16##2##(1990-4#1)(1994-12#1)(1994-7#1)(1995-12#1)(1995-4#1)(1997-1#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-10#1)(2008-3#1)(2008-7#1)(2009-9#1)(2012-12#2)(2012-2#1)
therapy has a##3##3##(2008-3#1)(2010-12#1)(2013-8#1)
therapy has also##2##3##(2007-3#1)(2010-12#1)
therapy has become a##2##4##(2008-1#1)(2010-5#1)
therapy has become##5##3##(2007-10#1)(2007-6#1)(2007-7#1)(2008-1#1)(2010-5#1)
therapy has been advocated##2##4##(1996-3#1)(2009-6#1)
therapy has been demonstrated to##3##5##(2008-5#1)(2009-1#1)(2010-6#1)
therapy has been demonstrated##4##4##(2005-7#1)(2008-5#1)(2009-1#1)(2010-6#1)
therapy has been proposed to##2##5##(2008-1#1)(2012-1#1)
therapy has been reported in##2##5##(2007-2#1)(2012-12#1)
therapy has been reported##4##4##(1994-2#1)(2007-2#1)(2011-2#1)(2012-12#1)
therapy has been shown to be effective in##3##8##(2006-8#1)(2007-10#1)(2011-2#1)
therapy has been shown to##6##5##(1995-8#1)(2006-8#1)(2007-10#1)(2007-11#1)(2009-7#1)(2011-2#1)
therapy has been used as a##2##6##(2007-11#1)(2013-7#1)
therapy has been used in##5##5##(2004-1#1)(2005-10#1)(2007-11#1)(2012-11#2)
therapy has been used##8##4##(2004-1#1)(2005-10#1)(2007-11#2)(2007-8#1)(2012-11#2)(2013-7#1)
therapy has been##50##3##(1990-1#1)(1991-2#1)(1991-6#1)(1992-10#1)(1994-2#2)(1995-8#1)(1996-3#1)(1996-8#1)(1997-1#1)(2004-1#1)(2005-10#2)(2005-11#1)(2005-7#3)(2006-10#2)(2006-11#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-2#1)(2007-8#2)(2008-1#3)(2008-10#3)(2008-5#1)(2008-7#1)(2009-1#1)(2009-6#1)(2009-7#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#1)(2013-7#1)
therapy has dramatically##2##3##(2007-8#1)(2010-12#1)
therapy has emerged as##2##4##(2006-10#2)
therapy has increased##2##3##(2006-10#1)(2008-3#1)
therapy has many##2##3##(2007-1#1)(2012-2#1)
therapy has not been##4##4##(2005-7#1)(2006-10#1)(2006-6#1)(2007-11#1)
therapy has not##7##3##(1993-2#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-11#2)(2012-1#1)
therapy has shown##2##3##(2007-11#1)(2007-3#1)
therapy has significant##2##3##(2008-6#1)(2013-1#1)
therapy has the potential to##2##5##(2007-11#1)(2012-3#1)
therapy has the##4##3##(2006-10#1)(2007-11#1)(2009-4#1)(2012-3#1)
therapy has to be##2##4##(2006-1#1)(2006-2#1)
therapy has to##3##3##(2006-1#1)(2006-2#1)(2008-5#1)
therapy has##109##2##(1990-1#1)(1990-11#1)(1991-2#1)(1991-6#1)(1992-10#1)(1993-2#1)(1993-3#1)(1994-2#2)(1995-8#1)(1996-11#1)(1996-3#1)(1996-8#2)(1997-1#1)(2004-1#1)(2005-10#2)(2005-11#1)(2005-7#4)(2006-1#1)(2006-10#9)(2006-11#1)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#10)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#6)(2008-10#4)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-1#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-12#4)(2010-4#1)(2010-5#1)(2010-6#2)(2011-2#3)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#2)
therapy have been reported##3##4##(1994-6#1)(1996-6#1)(2007-5#1)
therapy have been used for##2##5##(2005-10#1)(2007-11#1)
therapy have been used##3##4##(2005-10#1)(2007-11#1)(2008-9#1)
therapy have been##14##3##(1991-6#1)(1994-6#1)(1996-6#1)(2005-10#1)(2006-10#2)(2007-11#3)(2007-5#2)(2008-9#1)(2010-8#1)(2012-1#1)
therapy have demonstrated##2##3##(1991-12#1)(2008-7#1)
therapy have resulted in##2##4##(2011-2#1)(2012-2#1)
therapy have##27##2##(1991-12#1)(1991-6#1)(1992-3#1)(1994-6#1)(1994-7#1)(1996-6#1)(2005-10#1)(2006-10#2)(2007-11#5)(2007-5#2)(2007-8#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-6#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
therapy if the##2##3##(2008-4#1)(2011-2#1)
therapy if##4##2##(2008-4#1)(2011-2#2)(2012-12#1)
therapy improved the##2##3##(2007-11#1)(2010-12#1)
therapy improved##5##2##(1996-3#1)(2004-1#1)(2006-10#1)(2007-11#1)(2010-12#1)
therapy improves the##3##3##(1993-5#1)(2006-10#1)(2008-4#1)
therapy improves##5##2##(1993-5#1)(2006-10#1)(2008-4#1)(2009-2#1)(2010-8#1)
therapy in 14##3##3##(2004-10#1)(2007-7#1)(2007-8#1)
therapy in Crohn's##2##3##(2006-10#1)(2008-5#1)
therapy in HIV##2##3##(1997-4#1)(2009-4#1)
therapy in ICU##2##3##(2006-4#1)(2011-2#1)
therapy in Parkinson's disease##2##4##(2008-7#2)
therapy in a case of##2##5##(2007-5#1)(2012-3#1)
therapy in a large##2##4##(1996-3#1)(2009-9#1)
therapy in a patient with##2##5##(2011-2#1)(2012-12#1)
therapy in a##18##3##(1993-12#1)(1994-5#1)(1994-6#1)(1996-3#1)(1997-2#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-1#1)(2009-11#1)(2009-9#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#2)
therapy in accordance with##2##4##(2008-3#1)(2011-1#1)
therapy in acute myocardial infarction]##3##5##(1991-5#1)(1994-5#1)(1994-6#1)
therapy in acute myocardial##5##4##(1991-5#1)(1994-5#1)(1994-6#1)(1996-6#1)(1997-1#1)
therapy in acute##9##3##(1991-5#1)(1994-5#1)(1994-6#1)(1996-6#1)(1997-1#1)(2007-10#1)(2007-9#1)(2010-4#1)(2010-8#1)
therapy in adult patients##2##4##(1993-9#1)(2007-3#1)
therapy in adults##4##3##(1996-11#1)(2007-11#2)(2009-7#1)
therapy in advanced##6##3##(1990-10#1)(2005-7#1)(2007-11#1)(2008-5#1)(2009-10#1)(2010-12#1)
therapy in all##2##3##(1990-3#1)(2012-3#1)
therapy in an##4##3##(1994-4#1)(2008-7#1)(2010-7#1)(2013-1#1)
therapy in breast cancer##3##4##(1993-11#1)(1996-3#1)(2007-10#1)
therapy in breast##5##3##(1992-11#1)(1993-11#1)(1996-3#1)(2007-10#1)(2013-8#1)
therapy in cancer##2##3##(1991-5#1)(2008-2#1)
therapy in cardiovascular##4##3##(1991-9#1)(2008-3#1)(2013-7#2)
therapy in children and##2##4##(1997-1#1)(2009-7#1)
therapy in children with##3##4##(2008-1#1)(2009-7#1)(2011-2#1)
therapy in children##7##3##(1997-1#1)(2008-1#1)(2008-4#1)(2009-7#2)(2011-2#1)(2013-1#1)
therapy in chronic heart failure##3##5##(1991-6#1)(2005-7#1)(2007-1#1)
therapy in chronic hepatitis B##3##5##(1994-7#1)(1995-10#1)(2005-12#1)
therapy in chronic hepatitis C##2##5##(2009-7#1)(2013-1#1)
therapy in chronic hepatitis##5##4##(1994-7#1)(1995-10#1)(2005-12#1)(2009-7#1)(2013-1#1)
therapy in chronic##17##3##(1991-6#1)(1992-11#1)(1994-7#1)(1995-10#1)(2005-10#1)(2005-12#1)(2005-7#1)(2007-1#1)(2008-1#1)(2008-4#1)(2009-3#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
therapy in clinical trials##2##4##(2006-10#1)(2013-1#1)
therapy in clinical##6##3##(2006-10#1)(2007-7#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
therapy in combination with##2##4##(2005-10#1)(2010-12#1)
therapy in conjunction with##2##4##(2007-8#1)(2008-12#1)
therapy in controlling##2##3##(1995-10#1)(1997-1#1)
therapy in coronary##2##3##(2007-8#1)(2008-8#1)
therapy in critically ill patients with##2##6##(2006-10#1)(2006-4#1)
therapy in daily practice##2##4##(1993-11#1)(2007-8#1)
therapy in daily##4##3##(1993-11#3)(2007-8#1)
therapy in diabetes##2##3##(2007-1#1)(2008-1#1)
therapy in different##2##3##(2007-11#1)(2010-12#1)
therapy in early##2##3##(2007-5#2)
therapy in elderly patients##4##4##(1996-7#1)(2005-12#1)(2008-11#1)(2013-7#1)
therapy in elderly##5##3##(1994-4#1)(1996-7#1)(2005-12#1)(2008-11#1)(2013-7#1)
therapy in five##2##3##(2006-2#1)(2008-3#1)
therapy in general practice##2##4##(1991-6#1)(1996-4#1)
therapy in general##4##3##(1991-6#1)(1996-4#1)(2008-10#1)(2012-2#1)
therapy in heart failure##2##4##(2006-9#1)(2007-1#1)
therapy in heart##4##3##(2006-10#1)(2006-9#1)(2007-1#1)(2009-10#1)
therapy in liver##2##3##(2005-10#1)(2008-3#1)
therapy in men##3##3##(2006-9#1)(2007-12#1)(2008-7#1)
therapy in metastatic colorectal cancer##2##5##(1990-2#1)(1992-12#1)
therapy in metastatic renal cell##2##5##(1992-8#1)(2011-3#1)
therapy in metastatic##5##3##(1990-2#1)(1992-12#1)(1992-8#1)(2011-2#1)(2011-3#1)
therapy in most patients##2##4##(1992-8#1)(2010-4#1)
therapy in multiple##2##3##(1991-6#1)(2012-3#1)
therapy in neurology##2##3##(1990-5#1)(2010-7#1)
therapy in oral cancer##2##4##(2013-8#2)
therapy in oral##3##3##(2007-12#1)(2013-8#2)
therapy in order to##3##4##(2006-3#1)(2011-2#1)(2012-2#1)
therapy in organ##2##3##(2007-11#2)
therapy in osteomyelitis##2##3##(2010-6#2)
therapy in our hospital##2##4##(2007-7#1)(2008-1#1)
therapy in our##5##3##(2005-10#1)(2007-3#1)(2007-7#1)(2008-1#1)(2012-2#1)
therapy in paediatric##2##3##(2008-4#1)(2013-1#1)
therapy in patients and once in control group##2##8##(2007-9#2)
therapy in patients with acute##2##5##(1995-9#1)(2008-7#1)
therapy in patients with chronic hepatitis##2##6##(2010-12#1)(2013-7#1)
therapy in patients with chronic##3##5##(1994-11#1)(2010-12#1)(2013-7#1)
therapy in patients with rheumatoid arthritis##2##6##(1992-11#1)(2012-3#1)
therapy in patients with severe##2##5##(2009-6#1)(2013-1#1)
therapy in patients with solid tumors##2##6##(2006-6#1)(2008-7#1)
therapy in patients with##51##4##(1992-11#1)(1992-2#1)(1992-4#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-9#1)(1997-1#1)(1997-7#1)(2004-2#1)(2005-10#1)(2006-1#1)(2006-6#1)(2007-11#3)(2007-2#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-3#2)(2008-7#5)(2008-8#3)(2009-6#1)(2010-12#5)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
therapy in patients##59##3##(1992-11#1)(1992-2#1)(1992-4#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-9#1)(1997-1#1)(1997-7#1)(2004-2#1)(2005-10#1)(2006-1#1)(2006-2#1)(2006-6#1)(2007-11#4)(2007-2#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#5)(2008-8#4)(2009-6#1)(2010-12#6)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
therapy in postmenopausal women##3##4##(1993-6#1)(2006-10#1)(2013-1#1)
therapy in postmenopausal##6##3##(1993-6#1)(2004-1#1)(2006-10#1)(2012-3#2)(2013-1#1)
therapy in primary##2##3##(1994-8#1)(2013-1#1)
therapy in reducing##2##3##(2006-7#1)(2007-11#1)
therapy in rheumatoid arthritis##3##4##(1992-5#1)(2006-10#1)(2007-11#1)
therapy in selected cases##2##4##(2010-12#1)(2010-8#1)
therapy in selected patients##2##4##(1994-6#1)(2011-3#1)
therapy in selected##4##3##(1994-6#1)(2010-12#1)(2010-8#1)(2011-3#1)
therapy in severe sepsis##2##4##(2011-2#1)(2013-1#1)
therapy in severe##4##3##(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
therapy in steroid##2##3##(2007-7#2)
therapy in stroke##4##3##(1995-9#1)(2008-8#3)
therapy in systemic sclerosis##2##4##(2007-7#1)(2012-12#1)
therapy in systemic##3##3##(2006-10#1)(2007-7#1)(2012-12#1)
therapy in the Netherlands##2##4##(2008-12#2)
therapy in the form of##2##5##(2004-10#1)(2008-5#1)
therapy in the future##2##4##(2007-1#1)(2013-1#1)
therapy in the intensive care##5##5##(2006-10#1)(2006-4#2)(2008-3#1)(2009-9#1)
therapy in the management of##10##5##(1994-10#1)(1996-7#2)(2006-12#1)(2007-12#1)(2007-7#1)(2008-3#1)(2010-12#2)(2011-1#1)
therapy in the prevention of##2##5##(1993-11#1)(2012-2#1)
therapy in the prevention##3##4##(1993-11#1)(2006-10#1)(2012-2#1)
therapy in the setting of##4##5##(2004-1#1)(2007-11#1)(2008-4#1)(2011-2#1)
therapy in the treatment of##18##5##(1992-5#1)(1992-6#1)(1994-4#1)(1995-9#1)(2005-7#1)(2007-10#1)(2007-11#3)(2007-8#2)(2008-10#1)(2008-3#1)(2009-4#1)(2011-3#1)(2012-12#1)(2012-2#2)
therapy in the treatment##19##4##(1992-5#1)(1992-6#1)(1994-4#1)(1995-9#1)(2005-7#1)(2007-10#1)(2007-11#3)(2007-8#2)(2008-10#1)(2008-3#1)(2009-4#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-8#1)
therapy in the use of##3##5##(2009-6#2)(2010-8#1)
therapy in the##104##3##(1990-3#1)(1991-4#1)(1991-8#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#1)(1994-10#1)(1994-2#1)(1994-4#3)(1994-6#1)(1995-5#1)(1995-9#1)(1996-7#2)(1996-8#1)(1997-2#1)(2004-1#2)(2004-10#1)(2005-7#2)(2005-8#1)(2006-10#4)(2006-12#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#6)(2007-12#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-12#2)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#1)
therapy in these patients##3##4##(2006-10#1)(2007-11#1)(2013-1#1)
therapy in these##4##3##(2006-10#2)(2007-11#1)(2013-1#1)
therapy in this age group##2##5##(1997-1#2)
therapy in this patient population##2##5##(2008-6#1)(2013-1#1)
therapy in this setting##3##4##(2006-9#1)(2011-2#1)(2013-1#1)
therapy in this##12##3##(1993-12#1)(1997-1#2)(2005-7#1)(2006-10#1)(2006-9#1)(2008-11#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#2)
therapy in treating##2##3##(2006-10#1)(2009-7#1)
therapy in type 1 diabetes##2##5##(2007-5#1)(2008-1#1)
therapy in type 1##3##4##(2007-5#1)(2008-1#2)
therapy in various##2##3##(2006-10#1)(2009-8#1)
therapy in vivo##2##3##(2011-1#1)(2012-12#1)
therapy in women##4##3##(1996-9#1)(2008-4#1)(2008-7#1)(2012-3#1)
therapy in##612##2##(1990-10#1)(1990-11#2)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#2)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#4)(1991-8#1)(1991-9#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-4#3)(1992-5#3)(1992-6#3)(1992-8#2)(1993-1#2)(1993-10#1)(1993-11#7)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#3)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-4#5)(1994-5#2)(1994-6#5)(1994-7#1)(1994-8#1)(1995-1#2)(1995-10#2)(1995-5#2)(1995-6#1)(1995-9#4)(1996-11#5)(1996-12#1)(1996-2#3)(1996-3#3)(1996-4#1)(1996-6#1)(1996-7#3)(1996-8#2)(1996-9#1)(1997-1#10)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-1#3)(2004-10#2)(2004-2#1)(2005-10#6)(2005-11#2)(2005-12#2)(2005-3#1)(2005-6#1)(2005-7#5)(2005-8#1)(2006-1#1)(2006-10#23)(2006-12#4)(2006-2#2)(2006-3#4)(2006-4#9)(2006-5#1)(2006-6#5)(2006-7#2)(2006-8#1)(2006-9#5)(2007-1#5)(2007-10#7)(2007-11#31)(2007-12#7)(2007-2#2)(2007-3#2)(2007-5#4)(2007-6#1)(2007-7#14)(2007-8#17)(2007-9#4)(2008-1#12)(2008-10#6)(2008-11#6)(2008-12#5)(2008-2#3)(2008-3#14)(2008-4#13)(2008-5#6)(2008-6#4)(2008-7#15)(2008-8#16)(2009-10#4)(2009-11#3)(2009-12#1)(2009-3#3)(2009-4#4)(2009-5#1)(2009-6#3)(2009-7#7)(2009-8#4)(2009-9#3)(2010-10#5)(2010-11#4)(2010-12#22)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#6)(2010-9#3)(2011-1#7)(2011-2#27)(2011-3#4)(2012-1#4)(2012-12#13)(2012-2#11)(2012-3#15)(2013-1#19)(2013-7#7)(2013-8#12)
therapy include the##2##3##(1993-10#1)(2008-1#1)
therapy include##7##2##(1993-10#1)(2007-11#3)(2008-1#1)(2009-2#1)(2010-2#1)
therapy included##3##2##(1994-12#1)(2008-11#1)(2011-2#1)
therapy includes##3##2##(1992-3#1)(2007-11#1)(2008-10#1)
therapy including cyclophosphamide##2##3##(1990-12#1)(1995-4#1)
therapy including##11##2##(1990-12#1)(1991-9#2)(1995-4#2)(2008-10#1)(2008-12#1)(2010-6#1)(2011-1#1)(2012-1#1)(2013-8#1)
therapy increases the##2##3##(2005-12#1)(2009-7#1)
therapy increases##4##2##(1994-2#1)(2005-12#1)(2009-7#1)(2012-3#1)
therapy induced##3##2##(1991-3#1)(2007-3#1)(2013-8#1)
therapy intervention##6##2##(2006-10#2)(2008-6#2)(2009-7#2)
therapy interventions##4##2##(2007-6#1)(2008-12#1)(2012-2#1)(2013-1#1)
therapy into clinical practice##2##4##(2008-6#1)(2012-1#1)
therapy into##5##2##(2004-3#1)(2006-10#1)(2008-12#1)(2008-6#1)(2012-1#1)
therapy involving##4##2##(1991-12#1)(1992-1#1)(2006-6#1)(2012-1#1)
therapy ion##3##2##(2007-11#3)
therapy is a promising approach##2##5##(2012-1#1)(2012-7#1)
therapy is a promising##8##4##(1991-9#1)(2006-10#1)(2006-7#1)(2008-11#1)(2008-6#1)(2010-6#1)(2012-1#1)(2012-7#1)
therapy is a safe and effective##2##6##(2006-8#1)(2007-11#1)
therapy is a safe and##3##5##(1991-6#1)(2006-8#1)(2007-11#1)
therapy is a##21##3##(1990-11#1)(1990-12#1)(1991-6#1)(1991-9#1)(1995-4#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-6#1)(2009-9#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-7#1)
therapy is also##7##3##(1996-10#1)(2004-12#1)(2007-11#1)(2008-11#1)(2010-3#1)(2012-2#1)(2013-7#1)
therapy is an effective##3##4##(2006-1#1)(2007-8#1)(2010-8#1)
therapy is an important##2##4##(2009-10#1)(2012-3#1)
therapy is an##11##3##(2006-1#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-3#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-7#1)
therapy is associated with a##4##5##(2007-11#2)(2008-7#1)(2010-12#1)
therapy is associated with##6##4##(2007-11#2)(2008-7#1)(2010-12#1)(2013-1#2)
therapy is available for##2##4##(2005-10#1)(2008-4#1)
therapy is available##6##3##(1996-3#1)(2005-10#1)(2006-10#1)(2008-3#1)(2008-4#1)(2013-1#1)
therapy is based on the##2##5##(2005-10#1)(2008-7#1)
therapy is based on##3##4##(2005-10#1)(2005-6#1)(2008-7#1)
therapy is being##2##3##(2008-3#1)(2008-5#1)
therapy is beneficial##2##3##(1997-1#1)(2006-10#1)
therapy is clearly##2##3##(1993-11#1)(2007-7#1)
therapy is commonly used##2##4##(2008-3#1)(2009-8#1)
therapy is crucial##2##3##(2007-8#1)(2009-10#1)
therapy is currently##3##3##(2007-11#2)(2008-3#1)
therapy is described##3##3##(1990-7#1)(2007-12#1)(2012-3#1)
therapy is directed##2##3##(1991-2#1)(2008-3#1)
therapy is discussed##4##3##(1996-11#1)(2006-2#1)(2009-3#1)(2013-1#1)
therapy is effective at##2##4##(2005-7#1)(2008-7#1)
therapy is effective for##3##4##(2005-3#1)(2008-3#1)(2012-12#1)
therapy is effective in the treatment of##2##7##(1993-11#1)(1994-9#1)
therapy is effective in the treatment##3##6##(1993-11#1)(1994-9#1)(2007-11#1)
therapy is effective in the##4##5##(1993-11#1)(1994-9#1)(2007-10#1)(2007-11#1)
therapy is effective in treating##2##5##(2006-2#1)(2007-11#1)
therapy is effective in##10##4##(1993-11#1)(1994-9#1)(2006-2#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-4#1)(2008-7#1)(2013-1#1)
therapy is effective##15##3##(1993-11#1)(1994-9#1)(2005-3#1)(2005-7#1)(2006-2#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#2)(2012-12#1)(2013-1#1)
therapy is emphasized##2##3##(1991-11#1)(1995-2#1)
therapy is essential##3##3##(1993-12#1)(2005-8#1)(2009-11#1)
therapy is highly effective##2##4##(2005-8#1)(2010-4#1)
therapy is important##2##3##(2007-10#1)(2007-2#1)
therapy is in##2##3##(2006-2#1)(2010-10#1)
therapy is indicated##6##3##(1996-8#1)(2007-5#1)(2008-10#2)(2011-1#1)(2011-2#1)
therapy is initiated##4##3##(2007-7#1)(2008-3#1)(2008-7#1)(2011-2#1)
therapy is likely to##2##4##(2005-7#1)(2006-10#1)
therapy is more effective##2##4##(2007-12#1)(2013-1#1)
therapy is more##5##3##(2007-11#1)(2007-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
therapy is necessary##3##3##(1990-10#1)(2006-2#1)(2007-12#1)
therapy is needed and##2##4##(2006-10#1)(2010-8#1)
therapy is not indicated for##2##5##(1994-9#1)(2010-6#1)
therapy is not indicated##3##4##(1994-9#1)(2008-3#1)(2010-6#1)
therapy is not related to##2##5##(1996-2#1)(2008-5#1)
therapy is not well##2##4##(2009-10#1)(2011-2#1)
therapy is not##12##3##(1993-9#1)(1994-9#1)(1996-2#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
therapy is now##3##3##(2004-1#1)(2006-10#1)(2013-1#1)
therapy is often##7##3##(1993-9#1)(2005-10#1)(2007-10#1)(2008-11#1)(2008-7#1)(2009-4#1)(2012-1#1)
therapy is one of the most##2##6##(2005-10#1)(2006-6#1)
therapy is planned##2##3##(2005-12#1)(2010-2#1)
therapy is recommended##4##3##(1990-2#1)(1995-9#1)(2006-10#1)(2007-11#1)
therapy is required for##2##4##(2011-2#1)(2012-1#1)
therapy is required##4##3##(2008-1#1)(2011-2#2)(2012-1#1)
therapy is reviewed##2##3##(2006-10#1)(2008-8#1)
therapy is started##2##3##(1996-2#1)(2009-7#1)
therapy is still##7##3##(1991-2#1)(2006-10#2)(2007-11#1)(2008-1#1)(2008-3#1)(2008-5#1)
therapy is the mainstay of treatment##3##6##(1993-9#1)(2010-12#1)(2010-4#1)
therapy is the mainstay of##6##5##(1993-9#1)(1997-1#1)(2006-4#1)(2010-12#1)(2010-4#1)(2012-11#1)
therapy is the use of##2##5##(2007-9#1)(2013-8#1)
therapy is the##26##3##(1990-6#1)(1991-6#1)(1993-8#1)(1993-9#1)(1997-1#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2010-12#2)(2010-4#2)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#1)
therapy is to prevent##2##4##(2008-7#1)(2013-8#1)
therapy is to##8##3##(2005-3#1)(2006-2#1)(2007-11#1)(2008-7#1)(2012-3#1)(2013-7#1)(2013-8#2)
therapy is used to##2##4##(2005-10#1)(2007-10#1)
therapy is used##5##3##(2005-10#1)(2007-10#2)(2008-6#1)(2010-8#1)
therapy is useful for the treatment of##2##7##(2005-3#1)(2007-10#1)
therapy is useful##3##3##(2005-3#1)(2007-10#1)(2007-6#1)
therapy is well tolerated and##2##5##(2007-11#1)(2008-5#1)
therapy is well##5##3##(1991-6#1)(2007-11#2)(2008-5#1)(2008-6#1)
therapy is widely used##3##4##(1996-11#1)(2013-1#1)(2013-7#1)
therapy is##300##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#2)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-6#3)(1991-9#1)(1992-11#1)(1992-5#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-2#1)(1994-6#2)(1994-9#2)(1995-2#1)(1995-4#1)(1995-9#2)(1996-10#1)(1996-11#2)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#2)(2004-1#2)(2004-12#1)(2004-2#1)(2005-10#8)(2005-11#1)(2005-12#1)(2005-3#3)(2005-6#1)(2005-7#4)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#18)(2006-11#1)(2006-2#5)(2006-4#2)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#7)(2007-11#22)(2007-12#4)(2007-2#1)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#5)(2008-10#6)(2008-11#4)(2008-12#1)(2008-3#13)(2008-4#4)(2008-5#8)(2008-6#8)(2008-7#7)(2008-8#1)(2009-10#3)(2009-11#1)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#5)(2010-6#3)(2010-8#4)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#9)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#7)(2012-3#4)(2012-7#1)(2013-1#11)(2013-7#6)(2013-8#5)
therapy it##2##2##(1991-9#1)(2007-8#1)
therapy leads to##2##3##(2008-1#1)(2008-7#1)
therapy level ionization chambers##2##4##(2007-11#2)
therapy level##3##2##(2007-11#3)
therapy mainly##2##2##(1993-3#1)(2011-2#1)
therapy management of##2##3##(2008-12#2)
therapy management##7##2##(2008-12#4)(2009-3#2)(2011-1#1)
therapy may be an effective##2##5##(2008-1#1)(2012-3#1)
therapy may be indicated for##2##5##(2005-8#1)(2008-4#1)
therapy may be used##2##4##(2007-10#1)(2008-1#1)
therapy may be##31##3##(1995-3#1)(1997-7#1)(2004-10#1)(2004-3#1)(2005-8#1)(2006-10#4)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-8#2)(2012-3#2)(2013-7#1)
therapy may cause##2##3##(1994-6#1)(2009-2#1)
therapy may have a##2##4##(2008-1#1)(2011-2#1)
therapy may have##3##3##(1997-1#1)(2008-1#1)(2011-2#1)
therapy may improve##3##3##(2006-2#1)(2009-10#1)(2011-2#1)
therapy may induce##2##3##(1990-11#1)(2006-10#1)
therapy may lead to##3##4##(1994-5#1)(2008-3#1)(2009-12#1)
therapy may offer##2##3##(2006-10#1)(2008-1#1)
therapy may provide a##2##4##(2006-10#1)(2013-7#1)
therapy may provide##3##3##(2006-10#1)(2007-11#1)(2013-7#1)
therapy may reduce##2##3##(2009-4#1)(2011-2#1)
therapy may##70##2##(1990-11#1)(1990-5#1)(1991-10#1)(1994-5#1)(1994-6#1)(1995-3#1)(1995-7#1)(1997-1#1)(1997-6#1)(1997-7#1)(2004-10#1)(2004-3#1)(2005-8#2)(2006-10#9)(2006-12#1)(2006-2#3)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-8#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#2)(2011-2#4)(2012-2#1)(2012-3#2)(2013-7#2)
therapy measures##2##2##(1996-1#2)
therapy methods##2##2##(1994-3#1)(2012-2#1)
therapy might be##7##3##(2006-10#1)(2006-2#1)(2008-11#1)(2008-4#1)(2010-3#1)(2011-1#1)(2012-3#1)
therapy might##13##2##(1993-9#1)(2006-10#2)(2006-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-11#1)(2010-3#1)(2011-1#1)(2012-3#1)
therapy modalities##5##2##(1995-5#1)(2005-7#1)(2008-7#3)
therapy monitoring##4##2##(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
therapy more##4##2##(1996-3#1)(1997-2#1)(2005-7#1)(2006-10#1)
therapy must also##2##3##(1994-6#1)(2006-2#1)
therapy must be##11##3##(1991-8#1)(1993-9#1)(1997-5#1)(2006-10#3)(2007-8#1)(2008-1#1)(2010-12#1)(2011-2#1)(2012-2#1)
therapy must##14##2##(1991-8#1)(1993-9#1)(1994-6#1)(1996-1#1)(1997-5#1)(2006-10#3)(2006-2#1)(2007-8#1)(2008-1#1)(2010-12#1)(2011-2#1)(2012-2#1)
therapy necessary##2##2##(1996-11#1)(2004-10#1)
therapy not only##2##3##(2007-11#1)(2008-7#1)
therapy of CVI##2##3##(2011-3#2)
therapy of Crohn's##2##3##(1992-12#1)(2007-11#1)
therapy of HIV##2##3##(1993-10#1)(2010-5#1)
therapy of a##2##3##(2006-8#1)(2008-7#1)
therapy of acute##11##3##(1990-12#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1994-2#2)(2007-7#2)(2008-5#1)(2013-8#1)
therapy of advanced##3##3##(1991-9#1)(1992-1#1)(2005-7#1)
therapy of arthritis##2##3##(1992-3#1)(2011-2#1)
therapy of asthma##2##3##(2005-7#1)(2010-5#1)
therapy of biliary##3##3##(1993-5#1)(2006-10#1)(2007-3#1)
therapy of bisphosphonate with CEE##2##5##(2005-3#2)
therapy of bisphosphonate with##4##4##(2005-3#4)
therapy of brain tumors##2##4##(1993-6#1)(1995-2#1)
therapy of brain##3##3##(1993-6#1)(1995-2#1)(2008-7#1)
therapy of breast cancer##8##4##(1993-11#2)(1993-2#1)(1995-2#1)(1996-11#1)(1996-4#1)(2008-3#1)(2012-3#1)
therapy of cancer and other diseases##3##6##(1994-5#3)
therapy of cancer##16##3##(1991-10#1)(1992-7#1)(1994-5#4)(1996-10#1)(2005-7#1)(2007-3#2)(2007-7#1)(2008-3#1)(2008-7#1)(2008-8#2)(2013-8#1)
therapy of choice for##3##4##(2005-11#1)(2006-10#1)(2010-5#1)
therapy of choice##8##3##(1990-12#1)(1992-9#1)(1997-1#1)(2005-11#1)(2006-10#2)(2010-5#1)(2013-1#1)
therapy of chronic pancreatitis]##3##4##(2006-6#3)
therapy of chronic##14##3##(1990-8#1)(1991-5#1)(1997-1#1)(1997-4#1)(2006-10#2)(2006-6#4)(2007-11#1)(2008-1#1)(2011-2#2)
therapy of colorectal cancer##2##4##(2009-9#1)(2010-11#1)
therapy of community-acquired##2##3##(2006-10#1)(2008-11#1)
therapy of deep##2##3##(2011-3#1)(2012-3#1)
therapy of depression##2##3##(1994-8#1)(1997-3#1)
therapy of diabetic##2##3##(1990-5#1)(1992-4#1)
therapy of genital##2##3##(2007-11#1)(2010-6#1)
therapy of head and neck cancer##2##6##(1993-4#1)(1993-9#1)
therapy of head and neck##3##5##(1990-12#1)(1993-4#1)(1993-9#1)
therapy of heart failure##2##4##(1994-7#1)(2010-6#1)
therapy of human##2##3##(1994-3#1)(2009-5#1)
therapy of hypertension##3##3##(1990-2#1)(1997-8#1)(2008-1#1)
therapy of infectious##2##3##(2007-11#1)(2010-7#1)
therapy of inflammatory bowel##4##4##(2006-10#2)(2008-12#1)(2012-11#1)
therapy of inflammatory##5##3##(2006-10#2)(2008-12#1)(2012-11#1)(2012-12#1)
therapy of leprosy##2##3##(2007-7#2)
therapy of lung##2##3##(1991-9#1)(2013-8#1)
therapy of malignant##2##3##(2007-8#1)(2010-12#1)
therapy of metastatic##2##3##(2007-11#1)(2009-11#1)
therapy of neurological diseases##2##4##(1996-1#1)(2009-8#1)
therapy of onychomycoses##2##3##(1993-4#1)(1996-1#1)
therapy of oral##2##3##(1990-2#1)(2009-12#1)
therapy of patients with chronic##2##5##(2006-7#1)(2011-1#1)
therapy of patients with##9##4##(1991-10#1)(2005-7#1)(2006-6#2)(2006-7#1)(2008-10#1)(2011-1#2)(2013-8#1)
therapy of patients##13##3##(1991-10#1)(1993-6#1)(2005-7#1)(2006-6#2)(2006-7#1)(2008-1#1)(2008-10#1)(2009-8#1)(2011-1#2)(2013-7#1)(2013-8#1)
therapy of peritoneal##2##3##(2007-12#1)(2012-3#1)
therapy of postoperative##2##3##(2006-10#2)
therapy of prostate cancer##2##4##(2008-5#1)(2011-2#1)
therapy of prostate##3##3##(1991-9#1)(2008-5#1)(2011-2#1)
therapy of resectable##2##3##(1992-12#1)(2008-3#1)
therapy of severe##2##3##(2006-8#1)(2013-7#1)
therapy of spinal##2##3##(1994-10#1)(2008-12#1)
therapy of the##17##3##(1992-2#1)(1994-5#1)(1995-8#2)(2004-2#1)(2006-6#1)(2007-11#1)(2008-1#3)(2008-12#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-1#1)
therapy of these infections##3##4##(2005-7#1)(2005-9#1)(2006-10#1)
therapy of these##10##3##(1990-6#1)(1995-2#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2007-5#1)(2008-7#1)(2010-1#1)(2012-12#1)
therapy of this disease##3##4##(2004-12#1)(2011-1#1)(2012-12#1)
therapy of this kind of##2##5##(2007-9#1)(2008-8#1)
therapy of this potentially##2##4##(2007-7#1)(2008-5#1)
therapy of this##12##3##(1990-2#1)(1991-10#1)(1991-5#1)(2004-12#1)(2007-7#2)(2007-9#1)(2008-5#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-3#1)
therapy of tumor##2##3##(1994-11#1)(2006-6#1)
therapy of tumors##4##3##(2008-5#1)(2008-7#1)(2009-2#1)(2011-2#1)
therapy of uncomplicated##2##3##(1993-1#1)(2007-2#1)
therapy of visceral leishmaniasis##2##4##(2006-10#1)(2007-12#1)
therapy of##419##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#6)(1990-8#1)(1990-9#4)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#2)(1991-9#4)(1992-1#4)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#3)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#2)(1993-1#2)(1993-10#2)(1993-11#3)(1993-2#1)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#4)(1993-8#3)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#4)(1994-5#6)(1994-6#1)(1994-7#2)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-5#2)(1995-6#1)(1995-8#4)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#2)(1996-2#1)(1996-4#3)(1996-9#1)(1997-1#4)(1997-2#1)(1997-3#1)(1997-4#4)(1997-7#1)(1997-8#1)(2004-12#1)(2004-2#1)(2004-3#1)(2005-11#3)(2005-3#4)(2005-7#7)(2005-8#2)(2005-9#2)(2006-10#23)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#11)(2006-7#2)(2006-8#3)(2007-10#1)(2007-11#14)(2007-12#2)(2007-2#2)(2007-3#3)(2007-5#3)(2007-7#11)(2007-8#4)(2007-9#2)(2008-1#12)(2008-10#6)(2008-11#3)(2008-12#3)(2008-3#4)(2008-4#2)(2008-5#11)(2008-6#2)(2008-7#12)(2008-8#7)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#4)(2009-9#2)(2010-1#2)(2010-11#5)(2010-12#5)(2010-2#1)(2010-3#1)(2010-5#5)(2010-6#2)(2010-7#4)(2010-8#2)(2011-1#7)(2011-12#1)(2011-2#14)(2011-3#7)(2012-1#3)(2012-11#2)(2012-12#5)(2012-2#2)(2012-3#6)(2013-1#4)(2013-7#4)(2013-8#8)
therapy offer##2##2##(2007-8#2)
therapy offers the##2##3##(2008-1#1)(2008-3#1)
therapy offers##6##2##(2005-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-3#1)(2012-12#1)
therapy often##4##2##(1991-6#1)(2005-11#1)(2007-11#1)(2008-10#1)
therapy on left ventricular function##2##5##(2007-6#1)(2013-7#1)
therapy on plasma##3##3##(1996-9#1)(2007-8#2)
therapy on quality of life##3##5##(1996-9#1)(2005-6#1)(2011-12#1)
therapy on serum##2##3##(1996-9#1)(2011-1#1)
therapy on survival time##2##4##(2007-11#2)
therapy on the##16##3##(1990-7#1)(1992-6#1)(1993-2#1)(2006-10#1)(2006-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-8#2)
therapy on their lives##2##4##(2007-8#2)
therapy on their##4##3##(2007-8#3)(2011-2#1)
therapy on##79##2##(1990-7#1)(1992-2#1)(1992-6#1)(1993-2#1)(1994-3#1)(1994-5#1)(1996-2#2)(1996-9#3)(1997-5#2)(2004-1#1)(2005-10#1)(2005-6#1)(2006-10#7)(2006-11#1)(2007-10#1)(2007-11#4)(2007-6#1)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#3)(2008-5#1)(2008-7#4)(2009-3#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#4)
therapy or chemotherapy##2##3##(2007-6#1)(2008-12#1)
therapy or in##2##3##(2008-1#1)(2008-7#1)
therapy or other##2##3##(2012-3#1)(2013-1#1)
therapy or the##3##3##(1991-8#1)(2009-11#1)(2011-2#1)
therapy or##52##2##(1990-11#1)(1991-8#2)(1992-3#1)(1993-3#1)(1995-12#1)(1995-5#1)(1996-4#1)(2004-12#1)(2004-3#1)(2005-8#1)(2006-10#2)(2006-5#1)(2007-10#3)(2007-11#3)(2007-12#2)(2007-5#1)(2007-6#2)(2007-7#1)(2008-1#4)(2008-12#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-11#1)(2010-12#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
therapy other than##2##3##(2008-8#1)(2010-1#1)
therapy outcome in##3##3##(2006-10#1)(2010-12#1)(2012-2#1)
therapy outcome##6##2##(2006-10#1)(2010-12#1)(2012-2#4)
therapy outcomes##2##2##(2008-4#1)(2010-10#1)
therapy over##6##2##(1993-9#1)(1996-2#1)(2007-8#1)(2008-11#1)(2013-1#2)
therapy period##2##2##(1991-6#1)(2008-12#1)
therapy planning##8##2##(1991-4#1)(2006-6#1)(2009-3#1)(2009-4#1)(2012-2#4)
therapy plus##3##2##(1994-7#2)(2009-5#1)
therapy practice##4##2##(2006-6#1)(2008-12#1)(2010-5#2)
therapy practices##3##2##(1991-12#2)(2010-9#1)
therapy predicts##2##2##(2008-9#1)(2011-2#1)
therapy presenting##2##2##(2010-7#1)(2012-1#1)
therapy prior to##5##3##(1990-12#1)(1994-9#1)(2005-7#1)(2007-1#1)(2008-6#1)
therapy procedures##3##2##(2007-7#1)(2008-4#1)(2009-8#1)
therapy products##5##2##(2008-11#2)(2012-12#1)(2013-1#2)
therapy program##7##2##(1991-2#2)(1995-3#1)(1996-3#1)(2006-8#1)(2007-7#1)(2013-1#1)
therapy programs##2##2##(1990-12#1)(2013-7#1)
therapy progress##6##2##(2012-2#6)
therapy protocol for##2##3##(2005-7#1)(2009-8#1)
therapy protocol with##2##3##(1994-5#1)(2011-2#1)
therapy protocol##9##2##(1991-3#1)(1994-5#2)(2005-7#1)(2007-11#1)(2008-7#1)(2009-8#1)(2011-2#2)
therapy protocols##8##2##(1991-12#1)(1992-8#1)(1994-5#1)(1995-3#1)(2007-2#1)(2008-1#2)(2008-11#1)
therapy proves##2##2##(1994-6#1)(2011-2#1)
therapy provides##3##2##(2005-7#1)(2009-6#1)(2013-8#1)
therapy ranged##2##2##(2007-7#1)(2012-2#1)
therapy rather than##2##3##(1996-9#1)(2012-2#1)
therapy received by##2##3##(1990-12#1)(2011-2#1)
therapy received##3##2##(1990-12#1)(1995-2#1)(2011-2#1)
therapy reduces the risk of##2##5##(1995-9#1)(2008-3#1)
therapy reduces##4##2##(1995-9#1)(2008-12#1)(2008-3#1)(2012-2#1)
therapy regarding##2##2##(1997-8#1)(2011-1#1)
therapy regimen##2##2##(2007-11#1)(2013-7#1)
therapy regimens in##2##3##(2007-11#2)
therapy regimens##7##2##(2005-11#1)(2005-7#1)(2006-8#1)(2007-11#2)(2010-12#1)(2011-2#1)
therapy relies##2##2##(2009-8#1)(2011-1#1)
therapy remain##3##2##(1997-3#1)(2008-8#2)
therapy remains an##3##3##(1997-3#1)(2006-10#1)(2006-9#1)
therapy remains##6##2##(1997-3#1)(2006-10#1)(2006-9#1)(2010-9#1)(2012-2#1)(2013-7#1)
therapy represents a promising##3##4##(2008-5#1)(2010-3#1)(2012-3#1)
therapy represents an##3##3##(1995-8#1)(2004-3#1)(2010-6#1)
therapy represents the##2##3##(1994-4#1)(2007-11#1)
therapy represents##8##2##(1994-4#1)(1995-8#1)(2004-3#1)(2007-11#1)(2008-5#1)(2010-3#1)(2010-6#1)(2012-3#1)
therapy requires further##2##3##(2010-10#1)(2012-12#1)
therapy requires##5##2##(2010-10#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
therapy research##4##2##(1996-1#1)(2006-10#1)(2008-12#1)(2011-12#1)
therapy response##5##2##(2008-4#1)(2008-7#1)(2010-12#3)
therapy resulted in rapid improvement##2##5##(1992-8#1)(2005-11#1)
therapy resulted in##5##3##(1992-8#1)(2005-11#1)(2006-10#1)(2007-7#1)(2011-12#1)
therapy resulting in##2##3##(2008-11#1)(2008-3#1)
therapy results in##6##3##(1992-12#1)(2008-6#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
therapy results##8##2##(1992-12#1)(2006-6#1)(2008-6#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-2#1)
therapy revisited##2##2##(1991-3#1)(2008-2#1)
therapy seems to be##2##4##(2008-11#1)(2008-8#1)
therapy seems##4##2##(1992-5#1)(2008-11#1)(2008-8#1)(2013-8#1)
therapy services in##2##3##(1996-3#1)(2013-7#1)
therapy services##10##2##(1996-3#1)(2007-7#1)(2013-7#7)(2013-8#1)
therapy sessions##7##2##(1992-9#1)(1995-1#1)(2006-10#1)(2010-2#1)(2013-1#3)
therapy settings##2##2##(2010-5#1)(2012-10#1)
therapy should be considered for##2##5##(2008-1#1)(2009-8#1)
therapy should be considered##5##4##(2006-10#1)(2008-1#1)(2008-6#1)(2009-8#1)(2010-12#1)
therapy should be given in##2##5##(2006-10#1)(2007-11#1)
therapy should be performed##2##4##(1993-5#1)(2012-2#1)
therapy should be##28##3##(1990-9#1)(1993-5#1)(1996-3#1)(1996-8#1)(2004-10#1)(2005-10#1)(2006-10#3)(2006-6#2)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-9#2)(2009-3#1)(2009-8#2)(2010-10#1)(2010-12#1)(2011-2#3)(2012-2#1)
therapy should start##2##3##(1990-2#1)(1993-2#1)
therapy should##37##2##(1990-2#1)(1990-9#1)(1993-2#1)(1993-5#1)(1996-3#1)(1996-6#1)(1996-8#1)(2004-10#1)(2005-10#1)(2006-10#5)(2006-6#2)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#2)(2009-3#1)(2009-8#2)(2010-10#1)(2010-12#3)(2011-2#4)(2012-2#1)
therapy showed a##2##3##(2007-11#1)(2007-7#1)
therapy showed##7##2##(1991-6#1)(2007-10#1)(2007-11#1)(2007-7#3)(2008-8#1)
therapy significantly##2##2##(2007-8#1)(2012-2#1)
therapy since##6##2##(1990-9#2)(1993-1#1)(2008-1#1)(2008-6#1)(2013-8#1)
therapy so##4##2##(2006-1#1)(2009-10#1)(2009-3#1)(2010-5#1)
therapy still##3##2##(1994-7#1)(2009-3#1)(2010-12#1)
therapy strategies for##2##3##(1994-5#1)(2005-7#1)
therapy strategies##5##2##(1994-5#1)(2005-7#2)(2006-10#1)(2008-1#1)
therapy student##2##2##(2008-7#1)(2009-7#1)
therapy students##7##2##(1995-3#2)(2009-9#1)(2011-2#2)(2013-7#2)
therapy students'##2##2##(1995-3#1)(2013-7#1)
therapy study##2##2##(2011-2#1)(2012-3#1)
therapy such as##3##3##(1990-3#1)(2008-7#1)(2009-10#1)
therapy targeting##3##2##(2006-9#1)(2008-1#1)(2013-1#1)
therapy technique##2##2##(2006-4#1)(2008-12#1)
therapy than##13##2##(1991-12#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-11#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#2)
therapy that is##2##3##(2008-10#1)(2009-11#1)
therapy that provides##2##3##(1992-8#1)(2006-2#1)
therapy that will##2##3##(2005-8#1)(2012-1#1)
therapy that##22##2##(1990-12#1)(1992-3#1)(1992-8#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#2)(2010-2#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-8#1)
therapy the only##2##3##(1994-7#1)(2007-8#1)
therapy the##11##2##(1992-5#1)(1992-6#1)(1993-5#1)(1994-7#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-7#1)(2007-8#1)(2011-2#1)(2012-12#1)
therapy there##2##2##(1991-12#1)(2011-2#1)
therapy through##3##2##(2007-8#1)(2009-9#1)(2012-10#1)
therapy to achieve##3##3##(1992-8#1)(2005-7#1)(2006-10#1)
therapy to be##5##3##(2006-10#1)(2008-11#2)(2008-5#1)(2008-6#1)
therapy to both##2##3##(1992-3#1)(2006-2#1)
therapy to help##2##3##(2008-6#1)(2009-7#1)
therapy to improve##7##3##(1994-12#1)(2006-7#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#2)
therapy to increase##2##3##(2007-11#1)(2008-3#1)
therapy to maintain##5##3##(2008-6#1)(2013-8#4)
therapy to patients##3##3##(2007-2#1)(2008-1#1)(2008-5#1)
therapy to prevent##4##3##(1991-3#1)(1996-6#1)(2008-1#1)(2010-3#1)
therapy to reduce##4##3##(1994-7#1)(2005-9#1)(2008-1#1)(2010-7#1)
therapy to the##10##3##(1991-12#1)(2007-11#1)(2008-12#1)(2008-7#1)(2009-9#1)(2010-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
therapy to treat diabetes##2##4##(2008-1#1)(2009-3#1)
therapy to treat##11##3##(1997-1#1)(1997-5#1)(2006-6#1)(2007-12#1)(2008-1#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-4#1)
therapy to##101##2##(1991-12#2)(1991-3#1)(1991-6#1)(1991-7#1)(1992-3#1)(1992-5#1)(1992-8#1)(1994-12#1)(1994-5#1)(1994-7#1)(1995-8#1)(1996-6#1)(1997-1#1)(1997-5#1)(2004-1#1)(2004-11#1)(2005-6#1)(2005-7#1)(2005-9#1)(2006-10#7)(2006-11#2)(2006-2#2)(2006-6#1)(2006-7#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#5)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#3)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-1#3)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#5)
therapy together with##2##3##(1992-8#1)(1993-2#1)
therapy training##2##2##(2008-11#1)(2012-1#1)
therapy treatment of##4##3##(1992-3#1)(2008-12#1)(2012-1#1)(2013-7#1)
therapy treatment##10##2##(1992-3#1)(1994-3#3)(2008-12#3)(2012-1#1)(2012-12#1)(2013-7#1)
therapy treatments##2##2##(2008-12#1)(2009-9#1)
therapy trial##2##2##(2007-11#2)
therapy trials in##2##3##(2006-2#1)(2008-8#1)
therapy trials with##2##3##(2007-11#1)(2012-3#1)
therapy trials##12##2##(1997-1#1)(2004-2#1)(2006-2#1)(2007-11#2)(2007-9#1)(2008-8#2)(2012-2#3)(2012-3#1)
therapy under##2##2##(2007-11#1)(2011-2#1)
therapy until##2##2##(2007-9#1)(2010-12#1)
therapy use##5##2##(2008-11#1)(2008-5#1)(2009-5#1)(2010-8#1)(2011-1#1)
therapy used to##2##3##(2008-7#1)(2013-8#1)
therapy used##4##2##(1993-4#1)(2008-4#1)(2008-7#1)(2013-8#1)
therapy using strontium 89##3##4##(2007-11#3)
therapy using the##3##3##(2007-3#2)(2011-2#1)
therapy using##35##2##(1990-10#1)(1993-11#3)(1993-7#1)(1994-2#1)(1996-10#1)(1996-11#1)(2006-10#1)(2007-10#1)(2007-11#6)(2007-12#1)(2007-3#3)(2008-5#1)(2009-2#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-8#2)
therapy versus##2##2##(2006-10#1)(2008-6#1)
therapy via##2##2##(2007-8#1)(2010-7#1)
therapy vs##3##2##(2007-8#1)(2008-8#1)(2012-1#1)
therapy was administered##3##3##(2007-7#1)(2007-8#1)(2011-2#1)
therapy was associated with##2##4##(2007-8#1)(2010-5#1)
therapy was commenced##2##3##(1990-9#1)(2007-7#1)
therapy was continued##2##3##(1990-2#1)(1997-2#1)
therapy was delivered##2##3##(1991-2#1)(2008-6#1)
therapy was discontinued##3##3##(1994-6#1)(1995-7#1)(2006-10#1)
therapy was effective in##2##4##(2006-12#1)(2007-10#1)
therapy was effective##4##3##(1994-7#1)(2006-12#1)(2007-10#1)(2011-1#1)
therapy was found##2##3##(1996-2#1)(2007-6#1)
therapy was given##3##3##(1993-7#1)(2006-10#1)(2007-10#1)
therapy was ineffective##2##3##(2006-2#1)(2007-8#1)
therapy was initiated and##3##4##(2006-4#1)(2012-3#1)(2013-8#1)
therapy was initiated##12##3##(1992-8#1)(1994-2#1)(1995-11#1)(2006-10#1)(2006-4#1)(2007-2#1)(2007-3#1)(2008-4#1)(2009-6#1)(2010-12#1)(2012-3#1)(2013-8#1)
therapy was instituted##2##3##(2007-2#1)(2007-8#1)
therapy was not##2##3##(2005-10#1)(2005-12#1)
therapy was observed##2##3##(2007-11#1)(2010-9#1)
therapy was performed##4##3##(1990-10#1)(2004-1#1)(2007-11#1)(2013-7#1)
therapy was rated##2##3##(1993-2#1)(2011-2#1)
therapy was shown##2##3##(2007-9#1)(2008-5#1)
therapy was significantly##2##3##(2007-8#1)(2008-1#1)
therapy was started in##2##4##(2007-7#1)(2013-8#1)
therapy was started##7##3##(2006-8#2)(2006-9#1)(2007-11#1)(2007-7#1)(2011-2#1)(2013-8#1)
therapy was the##3##3##(2006-10#1)(2006-2#1)(2007-3#1)
therapy was used##3##3##(2009-2#1)(2012-12#1)(2013-8#1)
therapy was##146##2##(1990-10#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-2#2)(1991-3#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-7#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-7#2)(1995-11#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-2#1)(1997-2#2)(1997-8#1)(2004-1#1)(2005-10#1)(2005-12#1)(2005-6#1)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#7)(2006-11#1)(2006-12#3)(2006-2#2)(2006-4#1)(2006-8#3)(2006-9#1)(2007-10#2)(2007-11#7)(2007-12#2)(2007-2#2)(2007-3#3)(2007-6#2)(2007-7#11)(2007-8#6)(2007-9#2)(2008-1#3)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#1)(2009-2#1)(2009-6#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#11)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#1)(2013-7#2)(2013-8#5)
therapy were administered##2##3##(1992-5#1)(2009-8#1)
therapy were associated with##2##4##(2007-7#1)(2012-2#1)
therapy were compared##2##3##(2005-10#1)(2007-7#1)
therapy were considered##2##3##(2004-3#1)(2008-11#1)
therapy were evaluated##2##3##(2006-4#1)(2013-1#1)
therapy were given##2##3##(1992-10#1)(1994-7#1)
therapy were observed in##2##4##(2007-11#1)(2007-2#1)
therapy were observed##4##3##(2007-11#1)(2007-2#1)(2007-7#1)(2008-4#1)
therapy were used as##2##4##(2007-8#1)(2013-1#1)
therapy were##50##2##(1990-12#1)(1991-12#1)(1992-10#1)(1992-11#1)(1992-5#1)(1992-6#1)(1994-7#3)(1994-8#1)(1995-10#1)(1995-9#1)(1996-1#1)(1996-3#1)(1997-1#2)(2004-3#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-11#1)(2007-2#1)(2007-7#4)(2007-8#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-8#1)(2010-10#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#2)
therapy when##6##2##(1992-1#1)(2004-3#1)(2007-6#1)(2008-11#1)(2008-3#1)(2008-4#1)
therapy where##2##2##(2005-12#1)(2007-8#1)
therapy which can##2##3##(2007-11#1)(2010-8#1)
therapy which is##2##3##(2007-11#1)(2011-1#1)
therapy which resulted in##2##4##(1995-4#1)(2008-7#1)
therapy which##12##2##(1994-3#1)(1995-12#1)(1995-4#1)(1997-2#1)(2007-11#2)(2008-6#1)(2008-7#1)(2010-7#1)(2010-8#1)(2011-1#1)(2013-8#1)
therapy who##2##2##(2008-11#1)(2010-6#1)
therapy will be##2##3##(2007-2#1)(2010-3#1)
therapy will##14##2##(1991-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-3#2)(2011-12#1)(2012-10#1)
therapy with 20 mg fluoxetine##2##5##(1997-3#2)
therapy with 3##2##3##(2007-10#1)(2012-12#1)
therapy with 600##2##3##(1996-4#1)(2007-11#1)
therapy with L-thyroxine##2##3##(2006-9#2)
therapy with a handcrafted system##3##5##(2007-8#3)
therapy with a##16##3##(1992-9#1)(1993-11#1)(2005-8#1)(2007-5#1)(2007-8#3)(2007-9#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
therapy with an##4##3##(1996-9#1)(2009-10#1)(2009-11#1)(2009-6#1)
therapy with antiplatelet##2##3##(1990-11#1)(2007-10#1)
therapy with aspirin and##2##4##(2006-10#2)
therapy with aspirin##4##3##(2006-10#2)(2007-8#1)(2011-12#1)
therapy with azithromycin##2##3##(2007-12#1)(2008-10#1)
therapy with conventional##2##3##(2008-5#1)(2010-5#1)
therapy with corticosteroids##2##3##(2007-11#1)(2007-8#1)
therapy with cyclophosphamide and##3##4##(2008-1#1)(2011-1#2)
therapy with cyclophosphamide##5##3##(1993-9#1)(2004-2#1)(2008-1#1)(2011-1#2)
therapy with diuretics##2##3##(1992-4#1)(1996-9#1)
therapy with fumaric acid##2##4##(1990-6#1)(2007-8#1)
therapy with good##2##3##(2012-12#1)(2013-1#1)
therapy with high-dose##3##3##(1991-6#1)(1994-4#1)(2011-2#1)
therapy with infliximab##2##3##(2006-10#1)(2013-8#1)
therapy with interferon##3##3##(2005-1#1)(2006-10#1)(2007-11#1)
therapy with interferon-alpha and##2##4##(2008-6#2)
therapy with interferon-alpha##3##3##(2007-11#1)(2008-6#2)
therapy with interleukin-2##2##3##(1991-10#1)(1993-8#1)
therapy with intravenous##3##3##(2007-8#1)(2008-5#1)(2013-1#1)
therapy with low-dose##5##3##(1993-12#1)(1996-9#2)(2007-10#1)(2011-2#1)
therapy with mechanical##3##3##(2005-8#1)(2008-12#1)(2013-1#1)
therapy with minimal toxicity##2##4##(1991-12#1)(2012-3#1)
therapy with or without##2##4##(2005-12#1)(2010-12#1)
therapy with oral##2##3##(1990-11#1)(1992-6#1)
therapy with proton pump##2##4##(2005-12#1)(2006-10#1)
therapy with radiation and##2##4##(2008-6#1)(2010-5#1)
therapy with radioactive##2##3##(2006-1#1)(2006-10#1)
therapy with radiolabelled##2##3##(2006-9#1)(2007-11#1)
therapy with recombinant##4##3##(1996-8#1)(2007-11#1)(2007-7#1)(2011-2#1)
therapy with regimens##2##3##(1996-9#1)(2008-1#1)
therapy with statins##2##3##(2009-4#1)(2013-8#1)
therapy with that##2##3##(1994-7#1)(2009-8#1)
therapy with the frail elderly##2##5##(1995-1#1)(1995-2#1)
therapy with the##12##3##(1990-6#1)(1991-7#1)(1995-1#1)(1995-2#1)(2005-11#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-8#1)
therapy with these##2##3##(2009-11#1)(2009-3#1)
therapy with three##2##3##(2012-12#1)(2013-1#1)
therapy with##309##2##(1990-10#1)(1990-11#2)(1990-2#2)(1990-5#4)(1990-6#2)(1990-8#4)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#4)(1991-7#1)(1991-9#2)(1992-11#2)(1992-4#2)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-8#2)(1996-9#5)(1997-1#1)(1997-2#3)(1997-3#2)(1997-7#1)(1997-8#1)(2004-2#1)(2005-1#2)(2005-10#1)(2005-11#4)(2005-12#2)(2005-7#2)(2005-8#2)(2005-9#1)(2006-1#3)(2006-10#13)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#4)(2006-8#1)(2006-9#3)(2007-10#5)(2007-11#14)(2007-12#2)(2007-3#2)(2007-5#3)(2007-6#1)(2007-7#4)(2007-8#14)(2007-9#1)(2008-1#6)(2008-10#5)(2008-12#1)(2008-3#6)(2008-4#4)(2008-5#8)(2008-6#4)(2008-7#6)(2008-8#5)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#3)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2010-11#1)(2010-12#8)(2010-5#2)(2010-8#2)(2011-1#9)(2011-12#1)(2011-2#13)(2011-3#1)(2012-1#1)(2012-12#11)(2012-2#6)(2012-3#4)(2012-4#1)(2013-1#17)(2013-8#6)
therapy within##5##2##(2007-9#1)(2008-12#1)(2010-10#1)(2012-12#1)(2012-3#1)
therapy without ABD##2##3##(2007-11#2)
therapy without##10##2##(1994-8#1)(2006-10#2)(2007-11#2)(2007-12#1)(2007-8#2)(2011-1#1)(2012-12#1)
therapy works##3##2##(1996-3#1)(2012-2#2)
therapy would be##2##3##(2011-1#1)(2011-2#1)
therapy would##3##2##(2006-2#1)(2011-1#1)(2011-2#1)
therapy##7482##1##(1990-1#2)(1990-10#16)(1990-11#27)(1990-12#23)(1990-2#17)(1990-3#9)(1990-4#11)(1990-5#19)(1990-6#26)(1990-7#6)(1990-8#13)(1990-9#16)(1991-1#2)(1991-10#11)(1991-11#5)(1991-12#31)(1991-2#37)(1991-3#14)(1991-4#12)(1991-5#9)(1991-6#29)(1991-7#7)(1991-8#18)(1991-9#18)(1992-1#11)(1992-10#13)(1992-11#17)(1992-12#15)(1992-2#17)(1992-3#13)(1992-4#13)(1992-5#19)(1992-6#24)(1992-7#5)(1992-8#27)(1992-9#12)(1993-1#14)(1993-10#10)(1993-11#34)(1993-12#24)(1993-2#28)(1993-3#8)(1993-4#9)(1993-5#10)(1993-6#14)(1993-7#5)(1993-8#21)(1993-9#37)(1994-1#2)(1994-10#3)(1994-11#8)(1994-12#20)(1994-2#17)(1994-3#36)(1994-4#12)(1994-5#43)(1994-6#37)(1994-7#30)(1994-8#13)(1994-9#10)(1995-1#12)(1995-10#15)(1995-11#9)(1995-12#13)(1995-2#22)(1995-3#17)(1995-4#19)(1995-5#18)(1995-6#14)(1995-7#3)(1995-8#15)(1995-9#20)(1996-1#13)(1996-10#10)(1996-11#28)(1996-12#7)(1996-2#17)(1996-3#37)(1996-4#20)(1996-5#1)(1996-6#17)(1996-7#6)(1996-8#16)(1996-9#29)(1997-1#35)(1997-2#25)(1997-3#15)(1997-4#18)(1997-5#10)(1997-6#7)(1997-7#14)(1997-8#21)(2004-1#23)(2004-10#7)(2004-11#10)(2004-12#7)(2004-2#12)(2004-3#17)(2004-9#1)(2005-1#3)(2005-10#50)(2005-11#35)(2005-12#13)(2005-3#10)(2005-6#17)(2005-7#75)(2005-8#61)(2005-9#14)(2006-1#15)(2006-10#381)(2006-11#26)(2006-12#42)(2006-2#55)(2006-3#10)(2006-4#31)(2006-5#26)(2006-6#54)(2006-7#27)(2006-8#48)(2006-9#73)(2007-1#26)(2007-10#89)(2007-11#329)(2007-12#69)(2007-2#42)(2007-3#35)(2007-4#12)(2007-5#31)(2007-6#32)(2007-7#172)(2007-8#170)(2007-9#42)(2008-1#164)(2008-10#98)(2008-11#111)(2008-12#70)(2008-2#18)(2008-3#135)(2008-4#88)(2008-5#164)(2008-6#118)(2008-7#200)(2008-8#109)(2008-9#28)(2009-1#5)(2009-10#27)(2009-11#48)(2009-12#21)(2009-2#26)(2009-3#40)(2009-4#34)(2009-5#25)(2009-6#29)(2009-7#26)(2009-8#59)(2009-9#31)(2010-1#16)(2010-10#31)(2010-11#31)(2010-12#171)(2010-2#23)(2010-3#42)(2010-4#31)(2010-5#40)(2010-6#49)(2010-7#32)(2010-8#38)(2010-9#30)(2011-1#104)(2011-10#1)(2011-11#2)(2011-12#30)(2011-2#323)(2011-3#21)(2011-7#1)(2012-1#87)(2012-10#7)(2012-11#23)(2012-12#147)(2012-2#229)(2012-3#113)(2012-4#2)(2012-5#2)(2012-7#2)(2013-1#234)(2013-7#69)(2013-8#153)
therapy&quot##7##1##(1990-4#1)(1990-8#1)(2006-9#2)(2009-12#1)(2011-1#1)(2013-8#1)
therapy'##2##1##(2007-11#1)(2007-8#1)
therapy) and##2##2##(1994-8#1)(1996-11#1)
therapy) have##2##2##(2007-12#1)(2012-3#1)
therapy) in patients with##2##4##(2007-8#1)(2008-7#1)
therapy) in##3##2##(2007-8#1)(2008-7#1)(2010-2#1)
therapy) of##2##2##(2007-10#1)(2007-8#1)
therapy)##30##1##(1991-10#1)(1991-9#1)(1994-8#1)(1996-11#1)(1996-12#1)(2004-3#1)(2005-6#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#3)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)
therapy-##2##1##(2008-7#2)
therapy--a##2##1##(1990-2#1)(1996-1#1)
therapy-based##2##1##(2006-10#1)(2009-4#1)
therapy-induced antibodies##2##2##(2007-11#2)
therapy-induced##10##1##(2007-11#3)(2008-1#1)(2008-7#3)(2009-10#1)(2010-11#1)(2011-2#1)
therapy-related acute myeloid leukemia##3##4##(2007-12#1)(2013-7#2)
therapy-related##12##1##(1997-8#1)(2004-2#2)(2007-12#2)(2007-3#1)(2008-6#1)(2008-7#3)(2013-7#2)
therapy-relevant##2##1##(1991-4#1)(1993-3#1)
therapy-resistant##3##1##(1997-8#1)(2011-1#2)
therapy? An##2##2##(1994-6#1)(2008-11#1)
therapy?##14##1##(1992-8#1)(1994-6#1)(1994-8#1)(1995-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-3#1)(2009-12#1)(2009-5#2)(2011-2#1)
therapy?]##4##1##(1990-9#1)(1994-3#2)(2008-12#1)
therapy]##82##1##(1990-1#1)(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-2#4)(1991-4#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-10#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-4#1)(1994-5#1)(1995-11#1)(1995-4#2)(1995-5#2)(1995-6#1)(1995-7#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#1)(2005-1#2)(2005-11#2)(2005-3#1)(2006-2#2)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-8#2)(2008-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
there a causal##2##3##(1991-3#1)(1994-3#1)
there a difference?##3##3##(1997-3#1)(2004-3#1)(2007-8#1)
there a need for##6##4##(1991-1#1)(1994-10#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-4#1)
there a need##7##3##(1991-1#1)(1991-3#1)(1994-10#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-4#1)
there a place for##3##4##(1995-1#1)(2008-11#2)
there a relationship between##5##4##(1992-2#1)(1995-12#1)(1996-8#1)(2006-8#1)(2012-2#1)
there a role for the use of##2##7##(2007-8#2)
there a role for the##3##5##(2007-11#1)(2007-8#2)
there a role for##14##4##(1994-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-8#3)(2007-9#1)(2008-10#1)(2008-12#1)(2010-3#1)(2011-12#1)(2011-2#1)
there a##90##2##(1990-10#1)(1991-1#1)(1991-12#1)(1991-3#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-10#1)(1994-3#1)(1994-8#3)(1995-1#1)(1995-12#1)(1995-3#1)(1996-8#2)(1997-3#1)(1997-5#1)(2004-3#1)(2006-10#4)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-4#2)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#6)(2008-12#2)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#2)
there also exists a##2##4##(1994-12#1)(2008-9#1)
there also##4##2##(1994-12#1)(1996-2#1)(2008-9#2)
there an association?##2##3##(2007-7#1)(2008-1#1)
there an##9##2##(1993-7#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-10#1)
there and##2##2##(2006-10#1)(2013-8#1)
there any differences in the##2##5##(1992-2#1)(2007-12#1)
there any##24##2##(1991-3#1)(1991-4#1)(1991-8#1)(1992-2#1)(1992-5#1)(1992-9#1)(1994-1#1)(1994-4#1)(1995-9#1)(1996-9#1)(2006-4#2)(2006-7#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-2#1)
there appear to be##3##4##(1992-3#1)(1992-9#1)(1994-2#1)
there appeared to be a##2##5##(1991-12#1)(2011-2#1)
there appeared to be##5##4##(1990-4#1)(1991-12#1)(2006-10#1)(2008-12#1)(2011-2#1)
there appeared##6##2##(1990-4#1)(1991-12#1)(2006-10#1)(2008-12#1)(2011-1#1)(2011-2#1)
there appears to be a##5##5##(1990-5#1)(2007-6#1)(2007-9#1)(2008-4#1)(2012-2#1)
there appears to be an##3##5##(2008-5#1)(2011-2#1)(2012-3#1)
there appears to be little##3##5##(2008-1#1)(2008-11#1)(2008-12#1)
there appears to be no##5##5##(1996-9#1)(2004-10#1)(2006-2#1)(2008-11#1)(2008-7#1)
there appears to be##20##4##(1990-5#1)(1996-9#1)(1997-1#1)(2004-10#1)(2006-2#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-7#1)
there appears##21##2##(1990-5#1)(1996-9#1)(1997-1#1)(2004-10#1)(2006-2#1)(2007-6#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-7#1)
there are (1)##2##3##(1995-7#1)(2010-1#1)
there are 12##2##3##(1992-6#1)(2013-1#1)
there are 2##2##3##(1993-7#1)(2009-5#1)
there are 20##2##3##(1990-4#1)(1993-4#1)
there are 3##4##3##(1994-2#1)(2004-9#1)(2008-11#1)(2011-1#1)
there are a few reports##2##5##(2007-12#1)(2012-1#1)
there are a few##3##4##(2007-12#1)(2012-1#1)(2013-1#1)
there are a lot of##2##5##(2006-12#1)(2008-9#1)
there are a number of other##2##6##(1995-4#1)(2010-2#1)
there are a number of potentially##2##6##(1993-11#1)(2006-10#1)
there are a number of##23##5##(1990-10#2)(1993-1#1)(1993-11#1)(1995-4#1)(1997-2#1)(2004-11#1)(2006-10#3)(2006-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-2#1)(2010-9#1)(2012-11#1)(2012-12#2)(2012-3#1)
there are a variety of##4##5##(2006-3#1)(2007-1#1)(2008-10#1)(2010-2#1)
there are a wide##2##4##(2008-4#1)(2008-5#1)
there are a##40##3##(1990-10#2)(1993-1#1)(1993-11#1)(1995-4#1)(1997-2#1)(2004-11#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-3#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2010-2#2)(2010-9#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#1)
there are about##2##3##(1991-4#1)(2010-8#1)
there are additional##2##3##(2008-9#1)(2010-5#1)
there are advantages##2##3##(1997-3#1)(2008-9#1)
there are also some##3##4##(1995-3#1)(2008-12#1)(2012-2#1)
there are also##17##3##(1995-3#1)(1995-8#1)(2006-2#2)(2007-7#1)(2008-1#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
there are always##2##3##(2007-12#1)(2008-3#1)
there are an##4##3##(1991-4#1)(1991-5#1)(2007-12#1)(2011-2#1)
there are any##4##3##(1994-7#1)(1995-4#1)(2008-10#1)(2012-2#1)
there are approximately##5##3##(1996-11#1)(1996-12#1)(2008-10#1)(2012-11#1)(2012-12#1)
there are areas##2##3##(2010-4#1)(2011-1#1)
there are at least two##11##5##(1990-8#1)(1992-5#1)(1994-3#1)(1997-2#1)(1997-6#1)(2006-10#1)(2006-11#1)(2007-6#1)(2008-2#1)(2012-2#2)
there are at least##20##4##(1990-8#1)(1992-2#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-2#1)(1993-7#1)(1994-3#1)(1996-4#1)(1997-2#1)(1997-6#1)(2006-10#1)(2006-11#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-2#2)
there are barriers to##2##4##(1995-2#1)(2012-2#1)
there are barriers##3##3##(1995-2#1)(1996-2#1)(2012-2#1)
there are both##4##3##(1991-1#1)(1993-9#1)(2008-10#1)(2008-3#1)
there are case reports of##2##5##(2006-12#1)(2007-8#1)
there are certain##5##3##(1992-1#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
there are challenges in##2##4##(2008-4#1)(2013-8#1)
there are challenges##3##3##(2008-12#1)(2008-4#1)(2013-8#1)
there are changes in the##2##5##(1990-4#1)(1991-4#1)
there are changes in##6##4##(1990-4#1)(1991-4#1)(2006-10#1)(2008-10#1)(2008-5#2)
there are clear differences in##2##5##(1993-9#1)(2009-4#1)
there are clear##6##3##(1993-9#1)(1995-1#1)(2004-11#1)(2007-12#1)(2009-4#1)(2013-8#1)
there are common##4##3##(1992-11#1)(2005-7#1)(2008-7#1)(2013-8#1)
there are concerns about##2##4##(1997-1#1)(2007-8#1)
there are concerns that##3##4##(2008-11#1)(2009-3#1)(2009-9#1)
there are concerns##6##3##(1997-1#1)(2007-8#1)(2008-11#1)(2009-3#1)(2009-5#1)(2009-9#1)
there are conflicting##3##3##(1996-8#1)(2006-10#1)(2008-5#1)
there are considerable##2##3##(2009-7#1)(2013-8#1)
there are currently no##3##4##(2007-8#1)(2010-12#1)(2011-2#1)
there are currently##8##3##(1996-1#1)(2005-6#1)(2007-4#1)(2007-8#1)(2008-7#1)(2010-12#2)(2011-2#1)
there are data##2##3##(1990-8#1)(2009-9#1)
there are differences in the##6##5##(1991-7#1)(1994-12#1)(1996-10#1)(1997-2#1)(2006-12#1)(2008-10#1)
there are differences in##10##4##(1991-7#1)(1993-2#1)(1994-12#1)(1996-10#1)(1996-5#1)(1997-2#1)(2006-12#1)(2008-10#1)(2009-3#1)(2013-1#1)
there are differences##12##3##(1991-7#1)(1993-2#1)(1994-12#1)(1996-10#1)(1996-5#1)(1997-2#1)(2005-10#1)(2006-12#1)(2008-10#1)(2009-3#1)(2010-7#1)(2013-1#1)
there are different##8##3##(1995-10#1)(1995-12#1)(1997-7#2)(2006-1#1)(2008-10#1)(2008-3#1)(2009-2#1)
there are discrepancies between##2##4##(1995-3#1)(1996-1#1)
there are distinct differences##2##4##(1994-9#1)(2011-2#1)
there are distinct##4##3##(1994-9#1)(1995-3#1)(1996-12#1)(2011-2#1)
there are drawbacks##2##3##(1995-1#1)(2008-9#1)
there are few data in##2##5##(2007-9#1)(2009-10#1)
there are few data##5##4##(1995-8#1)(2007-9#1)(2009-10#1)(2010-12#1)(2012-3#1)
there are few direct##2##4##(1992-12#1)(2012-3#1)
there are few published studies##2##5##(1996-9#1)(2008-1#1)
there are few published##3##4##(1996-9#1)(2008-1#1)(2010-12#1)
there are few reports of##2##5##(2008-3#1)(2013-7#1)
there are few reports##6##4##(2006-1#1)(2008-1#1)(2008-10#1)(2008-3#1)(2012-2#1)(2013-7#1)
there are few studies##3##4##(1996-9#1)(2011-2#1)(2012-11#1)
there are few##41##3##(1992-12#1)(1993-2#2)(1993-6#1)(1994-3#1)(1994-6#1)(1995-8#1)(1996-12#1)(1996-9#2)(1997-4#1)(2005-11#1)(2005-5#1)(2006-1#1)(2006-2#1)(2007-11#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-10#2)(2010-1#2)(2010-11#1)(2010-12#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-7#1)
there are fewer##4##3##(1990-11#1)(2007-7#1)(2007-9#1)(2012-2#1)
there are functional##3##3##(1994-2#1)(1994-3#1)(2012-3#1)
there are fundamental##2##3##(2008-9#1)(2010-8#1)
there are gaps in##3##4##(2012-2#1)(2013-1#2)
there are good##2##3##(2010-2#1)(2012-2#1)
there are health##2##3##(1996-1#1)(2008-1#1)
there are high##3##3##(1994-12#1)(2008-10#1)(2011-1#1)
there are higher##2##3##(2008-8#1)(2011-2#1)
there are important##5##3##(1991-10#1)(1995-3#1)(1995-5#1)(2010-12#1)(2011-10#1)
there are increasing##3##3##(2006-10#1)(2007-7#1)(2010-9#1)
there are indeed##3##3##(1995-2#1)(2006-12#2)
there are indications that##6##4##(1993-3#1)(1997-5#1)(2006-6#1)(2007-12#1)(2008-3#1)(2008-4#1)
there are indications##7##3##(1993-3#1)(1997-5#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-3#1)(2008-4#1)
there are insufficient data to##2##5##(2006-12#1)(2007-11#1)
there are insufficient resources to##2##5##(1997-6#1)(2012-3#1)
there are insufficient##5##3##(1997-6#1)(2006-12#1)(2007-11#1)(2008-11#1)(2012-3#1)
there are key##2##3##(1996-12#1)(2010-12#1)
there are known##2##3##(2007-11#1)(2010-12#1)
there are large numbers of##2##5##(2008-7#1)(2012-1#1)
there are large##3##3##(2008-2#1)(2008-7#1)(2012-1#1)
there are limitations depending on study species##2##7##(2012-12#2)
there are limitations to##2##4##(2009-5#1)(2009-8#1)
there are limitations##4##3##(2009-5#1)(2009-8#1)(2012-12#2)
there are limited data##3##4##(2005-6#1)(2008-8#1)(2012-2#1)
there are major##2##3##(2007-7#1)(2010-12#1)
there are many cases##2##4##(2006-2#1)(2007-4#1)
there are many challenges##2##4##(2007-7#1)(2011-1#1)
there are many clinical##2##4##(2007-1#1)(2008-10#1)
there are many different##2##4##(2008-7#1)(2008-8#1)
there are many examples##3##4##(2008-10#1)(2013-1#2)
there are many factors##4##4##(1991-12#1)(2007-8#1)(2009-1#1)(2011-2#1)
there are many methods##2##4##(2007-11#1)(2010-11#1)
there are many possible##2##4##(2008-3#1)(2009-5#1)
there are many potential##3##4##(2008-11#1)(2010-11#1)(2010-3#1)
there are many questions##2##4##(2005-10#1)(2007-4#1)
there are many similarities between the two countries##2##8##(1993-3#1)(2008-7#1)
there are many##63##3##(1991-12#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-9#1)(1996-1#1)(1997-4#1)(2005-10#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-5#1)(2010-11#2)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#4)
there are marked differences in##2##5##(1994-9#1)(2012-12#1)
there are methods##2##3##(2008-2#1)(2008-9#1)
there are more##9##3##(1990-3#1)(1996-3#1)(2008-1#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)
there are multiple##11##3##(1991-2#1)(2005-8#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-3#1)(2010-6#1)(2011-1#1)(2011-2#1)
there are new##4##3##(2005-7#1)(2006-7#1)(2007-10#1)(2008-11#1)
there are nine##2##3##(2008-5#1)(2008-8#1)
there are no absolute##2##4##(2006-12#1)(2009-4#1)
there are no available##2##4##(2012-11#1)(2012-2#1)
there are no clear##2##4##(2008-10#1)(2012-2#1)
there are no clinical##3##4##(2006-6#1)(2006-9#1)(2008-4#1)
there are no currently##2##4##(2006-7#1)(2008-1#1)
there are no data on the##2##6##(1992-6#1)(2008-6#1)
there are no data on##4##5##(1990-2#1)(1992-6#1)(2008-6#1)(2009-7#1)
there are no data##5##4##(1990-2#1)(1992-6#1)(2008-12#1)(2008-6#1)(2009-7#1)
there are no definitive##2##4##(2008-10#1)(2010-5#1)
there are no differences in##2##5##(1990-10#1)(2008-12#1)
there are no documented cases of##2##6##(1996-5#1)(1996-6#1)
there are no effective##2##4##(2008-10#1)(2010-2#1)
there are no guidelines for##2##5##(2012-3#1)(2013-1#1)
there are no guidelines##4##4##(2005-11#1)(2008-11#1)(2012-3#1)(2013-1#1)
there are no published reports##2##5##(2007-4#1)(2013-1#1)
there are no published##4##4##(1990-2#1)(2007-4#1)(2007-8#1)(2013-1#1)
there are no reports of##2##5##(1996-12#1)(2008-5#1)
there are no reports##7##4##(1996-12#1)(2006-12#1)(2007-5#1)(2008-5#1)(2010-7#1)(2012-12#1)(2013-1#1)
there are no significant differences##3##5##(2005-10#1)(2008-10#2)
there are no significant##6##4##(2005-10#1)(2008-10#2)(2008-11#1)(2010-2#1)(2010-3#1)
there are no signs of##4##5##(1993-10#1)(1994-6#1)(1994-9#1)(2008-6#1)
there are no specific##4##4##(1996-2#1)(2007-12#1)(2007-7#1)(2011-2#1)
there are no studies##4##4##(1997-2#1)(2006-8#1)(2012-12#1)(2012-2#1)
there are no##135##3##(1990-10#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-9#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-10#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-6#3)(2005-10#1)(2005-11#2)(2005-12#1)(2005-5#1)(2005-7#1)(2006-10#2)(2006-12#2)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-11#1)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#7)(2008-9#4)(2009-2#1)(2009-3#2)(2009-4#1)(2009-7#3)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#5)(2012-2#6)(2012-3#2)(2013-1#4)(2013-8#2)
there are not many##2##4##(2008-4#1)(2008-5#1)
there are not##8##3##(1990-6#2)(2007-4#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-8#1)
there are now a number of##2##6##(2007-11#1)(2011-12#1)
there are now many##2##4##(2005-8#1)(2010-11#1)
there are now##10##3##(1991-11#1)(1993-7#1)(2005-8#1)(2006-12#1)(2007-11#1)(2008-7#1)(2009-4#1)(2010-11#1)(2011-12#1)(2013-1#1)
there are numerous evidence based studies about protective role of exercise against chronic diseases such as cardio- respiratory diseases##2##19##(2013-1#2)
there are numerous##13##3##(1994-11#1)(2006-3#1)(2006-7#1)(2006-8#1)(2008-10#1)(2008-4#2)(2009-12#1)(2009-3#1)(2011-1#1)(2013-1#3)
there are occasional##2##3##(2007-11#1)(2008-10#1)
there are often##5##3##(1992-5#1)(1996-9#1)(2004-4#1)(2008-11#1)(2009-3#1)
there are only a few published##2##6##(2008-11#1)(2013-1#1)
there are only a few##7##5##(2007-12#1)(2008-11#1)(2012-2#1)(2013-1#3)(2013-7#1)
there are only few##6##4##(1996-12#1)(1997-4#1)(2007-4#1)(2008-11#1)(2009-7#1)(2011-2#1)
there are only four##3##4##(1997-8#1)(2008-10#1)(2009-5#1)
there are only isolated##2##4##(2008-10#1)(2013-8#1)
there are only limited##2##4##(2005-10#1)(2011-2#1)
there are only two##3##4##(1991-12#1)(1992-4#1)(1995-6#1)
there are only##31##3##(1991-12#1)(1992-4#1)(1993-8#1)(1995-6#1)(1996-12#1)(1997-4#1)(1997-8#1)(2005-10#1)(2007-12#2)(2007-4#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2009-5#1)(2009-7#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
there are opportunities for##2##4##(2010-5#1)(2011-12#1)
there are other##10##3##(1991-11#1)(1991-12#1)(1994-1#1)(1996-11#1)(2006-6#1)(2008-11#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
there are over##2##3##(2007-1#1)(2008-10#1)
there are overlapping##2##3##(2008-8#1)(2010-12#1)
there are patients who are##2##5##(1992-5#1)(2006-10#1)
there are patients##5##3##(1990-12#1)(1992-5#1)(2006-10#1)(2007-2#1)(2011-2#1)
there are plans to##2##4##(1991-10#1)(2007-9#1)
there are potential##2##3##(2006-10#1)(2013-1#1)
there are potentially##3##3##(2007-2#1)(2013-1#2)
there are rare##2##3##(1994-3#1)(2007-9#1)
there are reasons##2##3##(1995-2#1)(2008-5#1)
there are relatively few##3##4##(1996-2#1)(2008-11#1)(2008-6#1)
there are reports of##3##4##(2009-3#1)(2013-1#2)
there are reports##4##3##(2008-2#1)(2009-3#1)(2013-1#2)
there are serious##2##3##(1993-8#1)(2013-1#1)
there are several benefits##2##4##(2012-2#1)(2013-8#1)
there are several circumstances which require the surgical removal##2##9##(2008-4#2)
there are several clinical##2##4##(2008-5#1)(2011-1#1)
there are several early supportive treatments and interventions which are beneficial##2##11##(2013-1#2)
there are several reasons##2##4##(2008-2#1)(2012-1#1)
there are several reports##2##4##(2008-5#1)(2009-8#1)
there are several##41##3##(1993-3#1)(1995-1#1)(1996-10#1)(1996-2#1)(1996-7#1)(2004-10#1)(2004-7#1)(2005-7#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-5#2)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#1)
there are significant challenges##2##4##(2008-12#1)(2009-12#1)
there are significant changes in the##2##6##(1991-2#1)(1995-9#1)
there are significant differences between##2##5##(1992-2#1)(2008-5#1)
there are significant differences in the##2##6##(1995-2#1)(2013-1#1)
there are significant differences##7##4##(1990-8#1)(1992-2#1)(1995-2#1)(2008-5#1)(2010-12#1)(2012-2#1)(2013-1#1)
there are significant##20##3##(1990-8#1)(1991-2#1)(1992-2#1)(1994-10#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-5#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-12#1)(2008-5#1)(2009-12#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
there are significantly fewer hospitals##2##5##(1994-2#2)
there are six##3##3##(1994-2#1)(2010-1#1)(2012-11#1)
there are so many##2##4##(2008-11#1)(2011-1#1)
there are some clinical##2##4##(2006-11#1)(2008-7#1)
there are some differences in the##2##6##(2007-12#1)(2008-4#1)
there are some differences in##3##5##(2007-12#1)(2008-4#1)(2011-12#1)
there are some differences##5##4##(2007-12#1)(2008-3#1)(2008-4#1)(2011-12#1)(2012-11#1)
there are some disadvantages##3##4##(2004-9#1)(2007-8#1)(2010-8#1)
there are some##37##3##(1990-5#1)(1991-1#2)(1992-3#1)(1993-12#1)(1995-2#1)(1995-3#1)(1997-5#1)(2004-9#1)(2005-12#1)(2006-11#1)(2006-6#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-2#1)(2009-3#1)(2010-8#3)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-7#1)
there are specific##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2010-8#1)
there are still few##2##4##(2008-10#1)(2010-10#1)
there are still many##6##4##(1990-11#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-5#1)
there are still some##4##4##(2008-10#1)(2008-4#1)(2008-7#1)(2009-4#1)
there are still##23##3##(1990-11#1)(1994-11#1)(1997-7#1)(2006-2#1)(2006-6#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-4#1)(2010-10#2)(2010-5#2)(2013-1#2)
there are strong##4##3##(1997-8#1)(2005-8#1)(2007-8#1)(2010-12#1)
there are subsets##2##3##(1995-12#2)
there are substantial##2##3##(1995-6#1)(2009-10#1)
there are suggestions that##2##4##(2008-6#1)(2011-12#1)
there are three varieties of##2##5##(2007-12#1)(2008-12#1)
there are three##14##3##(1991-1#1)(1993-12#1)(1993-9#1)(1995-3#1)(1995-6#1)(1997-3#1)(2005-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-10#1)(2010-5#1)
there are times when the care##2##6##(2007-8#2)
there are times when##3##4##(2004-12#1)(2007-8#2)
there are too##2##3##(2012-3#1)(2013-8#1)
there are two &quot##2##4##(1995-3#1)(2008-5#1)
there are two different##2##4##(2008-10#2)
there are two distinct##2##4##(1995-3#1)(2005-7#1)
there are two forms of##2##5##(1994-6#1)(2008-5#1)
there are two separate##3##4##(1997-4#1)(2006-12#1)(2008-4#1)
there are two types of##4##5##(1996-12#1)(2008-3#1)(2008-5#1)(2008-7#1)
there are two types##5##4##(1993-12#1)(1996-12#1)(2008-3#1)(2008-5#1)(2008-7#1)
there are two##54##3##(1990-1#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-12#2)(1993-3#2)(1993-6#1)(1994-5#2)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#2)(1996-12#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-11#3)(2005-7#1)(2006-10#3)(2006-12#1)(2006-2#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)
there are unique##4##3##(2008-2#1)(2010-12#1)(2010-3#1)(2013-1#1)
there are various##3##3##(2007-7#1)(2008-2#1)(2008-4#1)
there are very few##5##4##(1996-12#1)(2005-7#1)(2008-5#1)(2008-8#1)(2009-9#1)
there are very##6##3##(1996-12#1)(2005-7#1)(2007-11#1)(2008-5#1)(2008-8#1)(2009-9#1)
there are##1080##2##(1990-1#1)(1990-10#3)(1990-11#3)(1990-12#2)(1990-2#4)(1990-3#3)(1990-4#3)(1990-5#1)(1990-6#2)(1990-8#4)(1990-9#1)(1991-1#4)(1991-10#2)(1991-11#4)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#3)(1992-10#1)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#3)(1992-4#3)(1992-5#4)(1992-6#2)(1992-8#5)(1992-9#2)(1993-1#1)(1993-10#2)(1993-11#1)(1993-12#7)(1993-2#4)(1993-3#6)(1993-4#5)(1993-6#3)(1993-7#3)(1993-8#4)(1993-9#5)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#7)(1994-3#6)(1994-5#5)(1994-6#3)(1994-7#1)(1994-9#4)(1995-1#6)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#9)(1995-3#8)(1995-4#2)(1995-5#2)(1995-6#4)(1995-7#2)(1995-8#4)(1995-9#2)(1996-1#4)(1996-10#2)(1996-11#2)(1996-12#10)(1996-2#4)(1996-3#7)(1996-4#1)(1996-5#3)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#5)(1997-1#1)(1997-2#5)(1997-3#2)(1997-4#4)(1997-5#7)(1997-6#5)(1997-7#7)(1997-8#5)(2004-10#1)(2004-11#2)(2004-12#1)(2004-2#1)(2004-4#2)(2004-7#1)(2004-9#2)(2005-10#6)(2005-11#7)(2005-12#2)(2005-2#1)(2005-4#2)(2005-5#2)(2005-6#4)(2005-7#7)(2005-8#5)(2005-9#1)(2006-1#2)(2006-10#18)(2006-11#2)(2006-12#11)(2006-2#8)(2006-3#3)(2006-4#1)(2006-5#3)(2006-6#5)(2006-7#6)(2006-8#3)(2006-9#5)(2007-1#4)(2007-10#1)(2007-11#19)(2007-12#21)(2007-2#6)(2007-3#4)(2007-4#8)(2007-5#3)(2007-6#2)(2007-7#10)(2007-8#16)(2007-9#5)(2008-1#14)(2008-10#52)(2008-11#33)(2008-12#11)(2008-2#18)(2008-3#26)(2008-4#25)(2008-5#29)(2008-6#8)(2008-7#32)(2008-8#21)(2008-9#20)(2009-1#1)(2009-10#7)(2009-11#1)(2009-12#3)(2009-2#5)(2009-3#10)(2009-4#5)(2009-5#9)(2009-7#5)(2009-8#6)(2009-9#4)(2010-1#4)(2010-10#2)(2010-11#5)(2010-12#15)(2010-2#5)(2010-3#3)(2010-4#3)(2010-5#10)(2010-6#4)(2010-7#2)(2010-8#8)(2010-9#3)(2011-1#12)(2011-10#1)(2011-12#5)(2011-2#30)(2011-3#1)(2012-1#5)(2012-11#6)(2012-12#20)(2012-2#26)(2012-3#16)(2012-5#1)(2013-1#37)(2013-7#3)(2013-8#14)
there be a##3##3##(2006-12#1)(2008-11#1)(2009-2#1)
there be##10##2##(1992-11#1)(1993-12#1)(1994-12#1)(1997-8#1)(2006-12#1)(2008-11#1)(2009-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
there being##7##2##(1990-5#1)(1994-12#1)(1995-12#1)(2006-10#2)(2008-10#1)(2010-12#1)
there by##2##2##(2008-10#1)(2008-4#1)
there can be no##2##4##(1992-2#1)(2008-1#1)
there can be##9##3##(1990-7#1)(1992-2#1)(1995-1#1)(2005-9#1)(2008-1#1)(2008-12#1)(2008-8#2)(2013-7#1)
there can##10##2##(1990-7#1)(1992-2#1)(1995-1#1)(2005-9#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-8#2)(2013-7#1)
there could be##6##3##(1993-7#1)(1995-7#1)(1997-6#1)(2009-12#1)(2009-3#1)(2011-2#1)
there could##7##2##(1993-7#1)(1994-6#1)(1995-7#1)(1997-6#1)(2009-12#1)(2009-3#1)(2011-2#1)
there currently is##2##3##(2007-5#1)(2011-2#1)
there currently##3##2##(2007-10#1)(2007-5#1)(2011-2#1)
there differences between##2##3##(1997-8#1)(2012-12#1)
there differences in##3##3##(2007-11#1)(2008-5#1)(2012-2#1)
there differences##5##2##(1997-8#1)(2007-11#1)(2008-5#1)(2012-12#1)(2012-2#1)
there does not appear to be a##2##7##(2007-12#1)(2008-10#1)
there evidence of##4##3##(2005-11#1)(2007-7#1)(2010-9#1)(2012-3#1)
there exist several##2##3##(2011-1#1)(2013-8#1)
there exist two##3##3##(2007-12#2)(2008-3#1)
there exist##22##2##(1990-6#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-11#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
there existed##3##2##(1990-6#1)(2008-9#1)(2011-2#1)
there exists a##20##3##(1990-12#1)(1990-5#1)(1991-11#1)(1992-2#1)(1992-8#1)(1993-3#1)(1994-10#1)(1996-8#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-5#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#2)(2013-1#2)
there exists an##7##3##(1990-12#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2011-2#2)
there exists##32##2##(1990-12#2)(1990-5#1)(1991-11#1)(1992-2#2)(1992-8#1)(1993-3#1)(1994-10#1)(1996-8#1)(1997-2#1)(2005-11#2)(2006-10#1)(2006-4#1)(2007-12#1)(2007-5#1)(2008-1#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2011-2#4)(2013-1#2)
there for a##2##3##(1991-5#1)(2007-10#1)
there for##8##2##(1991-5#1)(2007-10#1)(2007-8#1)(2008-10#1)(2010-11#2)(2012-12#1)(2013-8#1)
there had been no##3##4##(1991-5#1)(1996-1#1)(2007-7#1)
there had been##6##3##(1991-5#1)(1994-11#1)(1996-1#1)(2007-11#1)(2007-7#1)(2008-6#1)
there had##8##2##(1991-5#1)(1994-11#1)(1996-1#1)(1996-11#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-6#1)
there has been a change in the##2##7##(1995-2#1)(2005-9#1)
there has been a concerted effort to##2##7##(2006-10#1)(2009-9#1)
there has been a constant##2##5##(2008-10#1)(2011-1#1)
there has been a decrease in##2##6##(2008-11#1)(2013-1#1)
there has been a dramatic##4##5##(2006-10#1)(2006-8#1)(2007-11#1)(2008-11#1)
there has been a great deal of##2##7##(1992-9#1)(2008-10#1)
there has been a great##3##5##(1992-9#1)(2008-10#1)(2010-12#1)
there has been a growing interest in##4##7##(2006-7#1)(2006-8#1)(2008-7#1)(2010-2#1)
there has been a growing interest##5##6##(2006-7#1)(2006-8#1)(2008-1#1)(2008-7#1)(2010-2#1)
there has been a growing##8##5##(2006-10#1)(2006-7#1)(2006-8#2)(2007-12#1)(2008-1#1)(2008-7#1)(2010-2#1)
there has been a lack of##2##6##(2006-10#1)(2007-7#1)
there has been a large##2##5##(1990-11#1)(2011-1#1)
there has been a lot of synergism between them##2##9##(2013-1#2)
there has been a lot of##3##6##(2008-10#1)(2013-1#2)
there has been a proliferation of##2##6##(2008-3#1)(2010-12#1)
there has been a rapid increase in the number of##2##10##(2008-10#1)(2013-8#1)
there has been a rapid##3##5##(2008-10#1)(2013-7#1)(2013-8#1)
there has been a renewed interest in##2##7##(2008-2#1)(2009-11#1)
there has been a renewed##3##5##(1996-3#1)(2008-2#1)(2009-11#1)
there has been a resurgence in the##2##7##(2006-4#1)(2008-11#1)
there has been a resurgence##3##5##(1997-7#1)(2006-4#1)(2008-11#1)
there has been a serious##2##5##(2007-9#1)(2008-10#1)
there has been a significant increase in the##3##8##(2006-10#1)(2007-6#1)(2011-2#1)
there has been a significant increase in##4##7##(1995-1#1)(2006-10#1)(2007-6#1)(2011-2#1)
there has been a significant##8##5##(1995-1#1)(2006-10#1)(2007-11#2)(2007-6#1)(2008-1#1)(2008-7#1)(2011-2#1)
there has been a steady increase in the##3##8##(2009-7#1)(2009-9#1)(2010-9#1)
there has been a substantial increase in the##2##8##(2008-1#1)(2011-2#1)
there has been a substantial##3##5##(2008-1#1)(2008-5#1)(2011-2#1)
there has been a##88##4##(1990-11#1)(1992-8#1)(1992-9#1)(1993-11#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-7#1)(2005-11#1)(2005-9#1)(2006-10#10)(2006-4#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#5)(2008-10#5)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-12#4)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#2)(2011-4#1)(2012-12#1)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#1)
there has been an explosion of##2##6##(2005-8#1)(2008-11#1)
there has been an increase in the number of##2##9##(2006-10#1)(2010-8#1)
there has been an increase in the##6##7##(2006-10#1)(2008-6#2)(2010-8#1)(2012-2#1)(2012-3#1)
there has been an increase in##9##6##(2004-9#1)(2006-10#1)(2008-11#1)(2008-6#2)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
there has been an increase##10##5##(2004-9#1)(2006-10#1)(2008-11#1)(2008-6#2)(2010-8#1)(2012-12#1)(2012-2#2)(2012-3#1)
there has been an increased##2##5##(2012-3#2)
there has been an increasing interest in##3##7##(1992-8#1)(2008-10#1)(2012-12#1)
there has been an increasing##5##5##(1992-8#1)(1993-5#1)(2008-10#1)(2010-9#1)(2012-12#1)
there has been an##25##4##(1992-8#1)(1993-1#1)(1993-5#1)(1996-9#1)(2004-9#1)(2005-8#1)(2006-10#1)(2006-8#2)(2008-10#1)(2008-11#2)(2008-6#2)(2010-8#1)(2010-9#1)(2012-12#2)(2012-2#2)(2012-3#5)
there has been considerable activity##2##5##(1992-1#1)(1993-3#1)
there has been considerable interest in##4##6##(1991-9#1)(2006-10#2)(2009-2#1)
there has been considerable interest##5##5##(1991-9#1)(2006-10#2)(2009-1#1)(2009-2#1)
there has been considerable progress in##2##6##(2006-10#1)(2007-8#1)
there has been considerable##12##4##(1991-9#1)(1992-1#1)(1993-3#1)(2006-10#4)(2007-8#1)(2008-11#1)(2009-1#1)(2009-2#1)(2011-12#1)
there has been great##2##4##(2008-12#1)(2012-3#1)
there has been growing interest in the##3##7##(2008-11#1)(2008-7#2)
there has been growing interest in##5##6##(2007-7#1)(2008-11#1)(2008-7#2)(2010-7#1)
there has been growing##6##4##(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#2)(2010-7#1)
there has been increased##4##4##(2007-12#1)(2008-1#2)(2013-1#1)
there has been increasing interest in the##3##7##(2008-3#1)(2008-7#2)
there has been increasing interest in##4##6##(1991-2#1)(2008-3#1)(2008-7#2)
there has been increasing##8##4##(1991-2#1)(1991-4#1)(2005-5#1)(2008-3#1)(2008-4#1)(2008-7#2)(2013-1#1)
there has been interest in##2##5##(2007-2#1)(2008-9#1)
there has been limited##5##4##(2008-10#1)(2008-8#2)(2009-10#1)(2011-2#1)
there has been little discussion##2##5##(2004-10#1)(2012-1#1)
there has been little##17##4##(1991-4#1)(1991-8#1)(1992-1#1)(2004-10#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
there has been much##2##4##(2008-3#1)(2008-7#1)
there has been no effective##2##5##(2008-7#1)(2010-8#1)
there has been no recurrence##2##5##(1990-11#1)(2008-7#1)
there has been no report##2##5##(2008-11#1)(2012-3#1)
there has been no reported##3##5##(2007-11#1)(2010-6#1)(2012-12#1)
there has been no significant##2##5##(2007-7#1)(2008-7#1)
there has been no##33##4##(1990-11#1)(1990-6#1)(1990-8#1)(1992-4#1)(1994-12#1)(1995-3#1)(2005-12#1)(2006-11#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-7#4)(2008-9#1)(2009-4#1)(2010-12#1)(2010-6#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#1)
there has been none concerning the medication in its extended-release form##2##11##(2013-1#2)
there has been only one##4##5##(2006-10#1)(2007-9#1)(2008-9#1)(2010-6#1)
there has been only##5##4##(2006-10#1)(2007-9#1)(2008-9#1)(2010-6#2)
there has been rapid##2##4##(2007-7#1)(2012-12#1)
there has been recent##2##4##(1997-8#1)(2010-1#1)
there has been relatively little##2##5##(2007-7#1)(2008-5#1)
there has been remarkable##2##4##(2006-10#1)(2008-11#1)
there has been renewed interest in##2##6##(1995-6#1)(2007-11#1)
there has been renewed##3##4##(1995-6#1)(2006-10#1)(2007-11#1)
there has been significant##3##4##(2006-10#1)(2008-2#1)(2013-8#1)
there has been some##6##4##(1994-2#1)(2007-1#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-12#1)
there has been substantial##2##4##(2008-11#1)(2009-4#1)
there has been very little##3##5##(2007-6#1)(2008-10#1)(2012-2#1)
there has been very##4##4##(2007-6#1)(2008-10#1)(2012-2#2)
there has been##260##3##(1990-11#2)(1990-6#1)(1990-8#1)(1991-2#1)(1991-4#2)(1991-8#1)(1991-9#1)(1992-1#2)(1992-2#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-7#1)(1997-8#1)(2004-10#1)(2004-9#1)(2005-11#1)(2005-12#1)(2005-5#1)(2005-8#2)(2005-9#1)(2006-10#23)(2006-11#1)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#5)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#4)(2007-2#2)(2007-4#1)(2007-6#2)(2007-7#6)(2007-8#3)(2007-9#3)(2008-1#7)(2008-10#10)(2008-11#13)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#6)(2008-5#4)(2008-6#2)(2008-7#12)(2008-8#4)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-6#1)(2009-7#1)(2009-9#3)(2010-1#1)(2010-12#5)(2010-2#1)(2010-3#2)(2010-6#3)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#4)(2011-4#1)(2012-1#1)(2012-11#1)(2012-12#9)(2012-2#6)(2012-3#14)(2013-1#10)(2013-7#2)(2013-8#2)
there has not been a##2##5##(1995-6#1)(2006-10#1)
there has not been any##2##5##(2005-11#1)(2007-2#1)
there has not been##5##4##(1995-6#1)(2005-11#1)(2006-10#1)(2007-2#1)(2009-1#1)
there has not##6##3##(1990-7#1)(1995-6#1)(2005-11#1)(2006-10#1)(2007-2#1)(2009-1#1)
there has##274##2##(1990-11#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-4#2)(1991-8#1)(1991-9#1)(1992-1#2)(1992-2#1)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-7#1)(1997-8#1)(2004-10#1)(2004-9#1)(2005-11#2)(2005-12#1)(2005-5#1)(2005-8#2)(2005-9#1)(2006-10#24)(2006-11#1)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#5)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#4)(2007-2#3)(2007-4#1)(2007-6#2)(2007-7#6)(2007-8#3)(2007-9#3)(2008-1#7)(2008-10#11)(2008-11#14)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#6)(2008-5#4)(2008-6#2)(2008-7#12)(2008-8#4)(2008-9#4)(2009-1#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-6#1)(2009-7#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-12#5)(2010-2#1)(2010-3#2)(2010-6#3)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#4)(2011-4#1)(2012-1#1)(2012-11#2)(2012-12#9)(2012-2#6)(2012-3#14)(2013-1#12)(2013-7#2)(2013-8#2)
there have been a number of case reports concerning rhabdomyolysis following quetiapine poisoning##2##13##(2013-1#2)
there have been a number of##7##6##(2006-8#1)(2007-4#2)(2008-11#1)(2008-7#1)(2013-1#2)
there have been a##9##4##(2006-6#1)(2006-8#1)(2007-4#2)(2008-11#1)(2008-4#1)(2008-7#1)(2013-1#2)
there have been advances in##4##5##(1992-2#1)(2006-10#1)(2007-12#1)(2011-2#1)
there have been an##2##4##(2011-2#1)(2012-2#1)
there have been few reports##3##5##(2008-8#1)(2012-12#1)(2012-3#1)
there have been few studies of the##3##7##(1993-12#1)(2008-7#2)
there have been few studies##5##5##(1993-12#1)(1996-6#1)(2007-1#1)(2008-7#2)
there have been few##12##4##(1993-12#1)(1996-2#1)(1996-6#1)(2007-1#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#2)(2012-12#1)(2012-3#1)
there have been many##5##4##(2006-2#1)(2007-11#1)(2007-8#1)(2008-2#1)(2011-7#1)
there have been no empirical##2##5##(2008-5#1)(2008-7#1)
there have been no incidents of##2##6##(1994-2#1)(2007-8#1)
there have been no previous reports##2##6##(1995-8#1)(2008-12#1)
there have been no reports of##2##6##(1997-8#1)(2010-12#1)
there have been no reports##4##5##(1994-6#1)(1997-8#1)(2008-9#1)(2010-12#1)
there have been no significant##2##5##(2013-1#1)(2013-7#1)
there have been no studies##2##5##(2008-11#1)(2008-7#1)
there have been no##30##4##(1991-11#1)(1991-8#1)(1994-2#1)(1994-6#1)(1995-8#1)(1996-6#1)(1997-8#2)(2007-10#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2010-12#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
there have been numerous##2##4##(2008-1#1)(2012-12#1)
there have been only##4##4##(1992-2#1)(2005-6#1)(2009-8#1)(2013-1#1)
there have been questions##2##4##(2011-2#1)(2013-7#1)
there have been rapid advances in##2##6##(1994-9#1)(2007-8#1)
there have been several advances##3##5##(2006-10#2)(2006-2#1)
there have been several reports##2##5##(2010-6#1)(2012-3#1)
there have been several##5##4##(2006-10#2)(2006-2#1)(2010-6#1)(2012-3#1)
there have been significant advances in the##2##7##(1990-11#1)(2007-12#1)
there have been significant developments in the##2##7##(2013-7#1)(2013-8#1)
there have been significant developments in##3##6##(2008-11#1)(2013-7#1)(2013-8#1)
there have been significant##8##4##(1990-11#1)(2007-12#1)(2008-11#2)(2008-3#1)(2009-6#1)(2013-7#1)(2013-8#1)
there have been some reports##2##5##(1993-3#1)(1997-8#1)
there have been some##4##4##(1991-10#1)(1993-3#1)(1997-8#1)(2012-3#1)
there have been two##2##4##(2008-6#2)
there have been very few##3##5##(2008-7#3)
there have been##133##3##(1990-11#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-8#1)(1992-10#1)(1992-2#2)(1992-8#1)(1993-12#1)(1993-3#2)(1994-2#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-6#2)(1997-2#1)(1997-8#3)(2005-6#1)(2006-10#8)(2006-2#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-4#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#4)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#10)(2008-8#2)(2008-9#3)(2009-10#2)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#5)(2011-7#1)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#4)(2013-7#3)(2013-8#2)
there have##137##2##(1990-11#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-3#2)(1991-8#1)(1992-10#1)(1992-2#2)(1992-8#1)(1993-12#1)(1993-3#2)(1994-2#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-6#2)(1997-2#1)(1997-8#3)(2005-6#1)(2006-10#8)(2006-2#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-4#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#4)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#10)(2008-8#2)(2008-9#3)(2009-10#2)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#6)(2011-7#1)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#5)(2013-7#3)(2013-8#2)
there in a##2##3##(2008-5#1)(2012-3#1)
there in##5##2##(1990-11#1)(2008-5#1)(2009-10#1)(2012-2#1)(2012-3#1)
there is a brief##2##4##(2009-9#2)
there is a causal relationship##2##5##(2004-11#1)(2005-11#1)
there is a change in the##2##6##(2006-10#1)(2007-12#1)
there is a change of##2##5##(1996-1#1)(2012-2#1)
there is a change##5##4##(1996-1#1)(2006-10#1)(2007-12#1)(2010-12#1)(2012-2#1)
there is a clear need for##3##6##(2007-8#1)(2008-10#1)(2008-7#1)
there is a clear need##4##5##(2007-8#1)(2008-10#1)(2008-7#1)(2010-11#1)
there is a clear trend toward##2##6##(2006-8#1)(2010-7#1)
there is a clear##9##4##(1996-4#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-11#1)(2010-7#1)(2011-2#1)
there is a close relationship between the##2##7##(2006-12#1)(2008-8#1)
there is a close##4##4##(2006-12#1)(2006-2#1)(2008-3#1)(2008-8#1)
there is a common##2##4##(1990-11#1)(1995-1#1)
there is a complete##2##4##(1993-8#1)(1994-9#1)
there is a considerable amount of##2##6##(2005-11#1)(2010-11#1)
there is a considerable difference##2##5##(1995-5#1)(2008-3#1)
there is a considerable##9##4##(1995-5#1)(1997-5#1)(1997-8#1)(2005-11#1)(2008-10#1)(2008-3#1)(2010-11#1)(2010-9#1)(2012-11#1)
there is a constant##4##4##(2007-8#1)(2008-1#1)(2008-5#1)(2011-12#1)
there is a continuing##2##4##(1992-3#1)(2010-7#1)
there is a correlation between##4##5##(2006-2#1)(2008-10#1)(2008-5#1)(2011-2#1)
there is a correlation in the##2##6##(2006-10#1)(2006-12#1)
there is a correlation##7##4##(2006-10#1)(2006-12#1)(2006-2#1)(2008-10#1)(2008-5#1)(2011-2#2)
there is a cost##2##4##(2008-10#1)(2008-8#1)
there is a critical need for##2##6##(2005-7#1)(2007-12#1)
there is a critical##5##4##(2005-11#1)(2005-7#1)(2007-12#1)(2011-2#2)
there is a dearth of information on##2##7##(1997-3#1)(2007-3#1)
there is a dearth of information##3##6##(1997-3#1)(2006-5#1)(2007-3#1)
there is a dearth of##7##5##(1997-3#1)(2006-5#1)(2007-3#1)(2008-11#2)(2008-12#1)(2009-12#1)
there is a decrease in##4##5##(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
there is a defect in##2##5##(2006-8#1)(2013-8#1)
there is a delay in##2##5##(1996-5#1)(2006-10#1)
there is a delay##3##4##(1996-5#1)(2006-10#1)(2008-10#1)
there is a difference##5##4##(1997-2#1)(2010-10#1)(2012-2#1)(2013-1#2)
there is a direct relationship between##2##6##(2010-7#1)(2013-1#1)
there is a discussion of the##2##6##(1990-12#1)(2008-1#1)
there is a discussion of##3##5##(1990-12#1)(2008-1#1)(2008-9#1)
there is a dramatic##3##4##(1994-5#1)(2005-11#1)(2006-2#1)
there is a family##4##4##(1994-3#1)(1997-4#1)(2005-11#1)(2010-9#1)
there is a good##5##4##(1991-3#1)(1993-1#1)(1994-3#1)(2008-10#1)(2008-6#1)
there is a gradual##4##4##(1991-5#1)(1994-8#1)(1997-5#1)(2009-11#1)
there is a great deal of##3##6##(2005-7#1)(2008-10#1)(2012-3#1)
there is a great need for##2##6##(1994-9#1)(2010-9#1)
there is a great need to##2##6##(2008-10#1)(2009-11#1)
there is a great need##4##5##(1994-9#1)(2008-10#1)(2009-11#1)(2010-9#1)
there is a great##8##4##(1994-9#1)(2005-7#1)(2008-10#2)(2009-11#1)(2010-9#1)(2012-2#1)(2012-3#1)
there is a greater##3##4##(2007-3#1)(2008-9#1)(2011-2#1)
there is a group##2##4##(2007-8#1)(2012-2#1)
there is a growing body of evidence##3##7##(2005-8#1)(2006-7#1)(2012-2#1)
there is a growing body of##5##6##(2005-8#1)(2006-7#1)(2008-12#1)(2010-8#1)(2012-2#1)
there is a growing interest in##3##6##(2008-11#1)(2010-5#1)(2013-1#1)
there is a growing need for##4##6##(2008-11#1)(2008-3#1)(2009-7#1)(2012-2#1)
there is a growing need##5##5##(2008-11#1)(2008-3#1)(2009-7#1)(2010-12#1)(2012-2#1)
there is a growing trend##2##5##(1996-1#1)(2006-8#1)
there is a growing##25##4##(1996-1#1)(1996-7#1)(2005-8#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-7#1)(2010-12#1)(2010-5#2)(2010-8#1)(2012-2#2)(2013-1#1)(2013-8#1)
there is a high clinical##2##5##(2006-9#1)(2013-8#1)
there is a high degree of##2##6##(2005-8#1)(2009-11#1)
there is a high incidence of##4##6##(1992-2#1)(1997-3#1)(2008-8#1)(2011-2#1)
there is a high prevalence of##2##6##(2008-6#1)(2013-1#1)
there is a high##20##4##(1992-12#1)(1992-2#1)(1995-8#1)(1997-3#1)(2005-8#1)(2006-9#1)(2008-10#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-12#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#2)
there is a higher incidence of##2##6##(1992-2#1)(1996-3#1)
there is a higher##5##4##(1992-2#1)(1996-3#1)(2006-11#1)(2009-1#1)(2011-2#1)
there is a history of##2##5##(2006-10#1)(2010-9#1)
there is a lack of data##2##6##(2008-8#1)(2011-2#1)
there is a lack of information on##3##7##(2010-7#2)(2012-3#1)
there is a lack of information##4##6##(2010-7#2)(2012-3#1)(2013-7#1)
there is a lack of##25##5##(1994-6#1)(1996-12#1)(2005-11#1)(2006-8#1)(2007-11#1)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-11#1)(2010-7#2)(2010-9#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
there is a large##15##4##(1993-9#1)(1994-9#1)(1995-8#2)(2005-3#1)(2006-12#1)(2007-1#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
there is a limited##4##4##(2005-9#1)(2008-4#2)(2009-5#1)
there is a loss of##2##5##(1993-12#1)(2008-11#1)
there is a loss##3##4##(1993-12#1)(1996-8#1)(2008-11#1)
there is a low##3##4##(1992-6#1)(2007-2#2)
there is a major##3##4##(2005-12#1)(2007-8#1)(2008-8#1)
there is a marked##4##4##(1992-3#1)(1997-4#1)(2008-8#1)(2008-9#1)
there is a mechanism##2##4##(1991-10#1)(1997-4#1)
there is a modification of##2##5##(1991-6#1)(2007-12#1)
there is a more##2##4##(1997-4#1)(2008-9#1)
there is a need for a##4##6##(2006-10#2)(2007-2#1)(2011-2#1)
there is a need for greater##2##6##(2007-2#1)(2011-1#1)
there is a need for more##3##6##(1995-2#1)(2008-12#1)(2008-4#1)
there is a need for##37##5##(1993-12#1)(1994-7#1)(1995-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#3)(2007-10#1)(2007-2#2)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-12#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)
there is a need of##3##5##(2007-7#1)(2008-3#1)(2011-2#1)
there is a need to develop##5##6##(2007-10#1)(2008-3#1)(2008-4#1)(2012-2#2)
there is a need to focus on##2##7##(2007-12#1)(2011-2#1)
there is a need to provide##2##6##(2007-7#1)(2013-8#1)
there is a need to solidify the terminology of and measurements for CS in nursing##2##15##(2013-1#2)
there is a need to understand the##3##7##(2008-5#1)(2010-12#1)(2012-12#1)
there is a need to##39##5##(2006-10#1)(2007-10#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#2)
there is a need##81##4##(1993-12#1)(1994-7#1)(1995-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#4)(2007-10#2)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#4)(2007-8#2)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#4)(2008-9#1)(2009-12#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#4)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#8)(2013-8#2)
there is a negative##3##4##(1993-8#1)(1994-5#1)(2008-5#1)
there is a paucity of data##3##6##(2008-10#1)(2008-7#1)(2011-2#1)
there is a paucity of evidence regarding##2##7##(2008-6#1)(2010-12#1)
there is a paucity of information##2##6##(2006-7#1)(2008-1#1)
there is a paucity of##15##5##(2006-10#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#3)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
there is a paucity##16##4##(2006-10#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#3)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
there is a poor##2##4##(2005-8#1)(2010-6#1)
there is a population of##2##5##(1990-8#1)(2007-2#1)
there is a positive##3##4##(1993-12#1)(2007-6#1)(2008-4#1)
there is a possibility of##6##5##(2005-3#1)(2007-6#1)(2007-8#1)(2010-8#1)(2011-2#1)(2012-12#1)
there is a possibility##7##4##(1994-2#1)(2005-3#1)(2007-6#1)(2007-8#1)(2010-8#1)(2011-2#1)(2012-12#1)
there is a potential risk of##2##6##(2008-4#1)(2013-1#1)
there is a potential##4##4##(1991-12#1)(2008-4#1)(2008-7#1)(2013-1#1)
there is a preferential##2##4##(1997-6#1)(2008-6#1)
there is a pressing need for##3##6##(2007-11#1)(2008-12#1)(2013-1#1)
there is a pressing need##4##5##(2007-11#1)(2008-12#1)(2008-7#1)(2013-1#1)
there is a progressive##2##4##(2007-12#1)(2013-7#1)
there is a range of##3##5##(2006-11#1)(2007-12#1)(2008-1#1)
there is a rapid##3##4##(1994-7#1)(1996-10#1)(2009-11#1)
there is a real##2##4##(1995-12#1)(2008-11#1)
there is a reasonable##2##4##(1991-1#1)(1991-9#1)
there is a reduction in##2##5##(1990-8#2)
there is a relative##3##4##(2010-11#1)(2010-2#1)(2012-2#1)
there is a relatively##3##4##(1991-12#1)(1994-6#1)(2008-5#1)
there is a risk of##5##5##(1997-3#1)(2007-2#1)(2008-3#1)(2008-8#1)(2010-5#1)
there is a risk##6##4##(1997-3#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-5#1)
there is a scarcity of##2##5##(1991-11#1)(1994-3#1)
there is a serious##3##4##(1997-4#1)(2008-8#1)(2011-2#1)
there is a sharp rise in##2##6##(1992-3#1)(2010-12#1)
there is a sharp##4##4##(1992-3#1)(2004-9#1)(2009-4#1)(2010-12#1)
there is a significant decrease##2##5##(1994-2#1)(2007-9#1)
there is a significant##12##4##(1992-1#1)(1994-2#1)(1995-11#1)(2006-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-8#2)(2008-9#1)(2009-8#1)(2011-2#1)
there is a simple##3##4##(2007-12#1)(2008-6#1)(2009-11#1)
there is a single##4##4##(2006-9#1)(2008-1#1)(2008-4#1)(2008-5#1)
there is a slight##2##4##(2007-8#1)(2008-12#1)
there is a small##3##4##(1991-7#1)(2008-10#1)(2008-11#1)
there is a strong correlation between##2##6##(1997-1#1)(2011-2#1)
there is a strong need for##3##6##(2007-9#1)(2010-8#1)(2012-3#1)
there is a strong positive##2##5##(1995-12#1)(2009-4#1)
there is a strong##21##4##(1991-2#1)(1995-12#1)(1995-5#1)(1997-1#1)(1997-2#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-3#3)(2009-4#1)(2009-5#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-8#1)
there is a substantial increase##2##5##(1995-1#1)(2005-11#1)
there is a substantial##4##4##(1995-1#1)(2005-11#1)(2010-1#1)(2010-9#1)
there is a tendency to##3##5##(2008-6#1)(2010-4#1)(2013-7#1)
there is a tendency##5##4##(2007-9#1)(2008-6#1)(2010-4#1)(2011-2#1)(2013-7#1)
there is a therapeutic need for alternative knee OA treatments that directly address joint overload to fill the gap between ineffective conservative care and invasive joint-modifying surgical procedures##2##28##(2013-1#2)
there is a therapeutic##4##4##(2010-6#1)(2012-12#1)(2013-1#2)
there is a third##2##4##(1991-1#1)(2006-9#1)
there is a threshold##4##4##(2008-10#1)(2008-8#2)(2010-1#1)
there is a trade-off between the##2##6##(2008-2#1)(2008-3#1)
there is a trade-off between##7##5##(2007-11#1)(2008-2#2)(2008-3#1)(2008-9#1)(2010-2#1)(2013-1#1)
there is a transition to##2##5##(1991-2#1)(2007-9#1)
there is a transition##4##4##(1991-2#1)(2007-9#1)(2011-1#1)(2012-12#1)
there is a tremendous##2##4##(2008-1#1)(2011-2#1)
there is a variety of##3##5##(2008-3#1)(2013-1#2)
there is a very##5##4##(1993-8#1)(1995-5#1)(2008-10#1)(2008-4#1)(2008-5#1)
there is a weak##2##4##(2009-5#1)(2010-3#1)
there is a wealth of##2##5##(2007-6#1)(2009-3#1)
there is a wide##5##4##(1994-9#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-9#1)
there is a##676##3##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#4)(1990-9#2)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#2)(1991-5#2)(1991-6#3)(1991-7#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#3)(1992-6#3)(1993-1#1)(1993-11#1)(1993-12#5)(1993-2#1)(1993-6#1)(1993-8#4)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#2)(1994-7#2)(1994-8#1)(1994-9#5)(1995-1#2)(1995-11#3)(1995-12#3)(1995-2#2)(1995-5#3)(1995-6#1)(1995-8#3)(1995-9#2)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#6)(1997-4#6)(1997-5#4)(1997-6#1)(1997-7#1)(1997-8#3)(2004-11#1)(2004-12#1)(2004-9#1)(2005-11#11)(2005-12#1)(2005-3#2)(2005-7#4)(2005-8#3)(2005-9#2)(2006-10#16)(2006-11#3)(2006-12#4)(2006-2#3)(2006-5#1)(2006-7#4)(2006-8#4)(2006-9#4)(2007-1#2)(2007-10#4)(2007-11#7)(2007-12#11)(2007-2#8)(2007-3#3)(2007-5#1)(2007-6#7)(2007-7#5)(2007-8#13)(2007-9#6)(2008-1#13)(2008-10#23)(2008-11#18)(2008-12#10)(2008-2#10)(2008-3#20)(2008-4#15)(2008-5#16)(2008-6#8)(2008-7#16)(2008-8#21)(2008-9#14)(2009-1#2)(2009-10#3)(2009-11#6)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#3)(2009-5#4)(2009-7#1)(2009-8#2)(2009-9#6)(2010-1#3)(2010-10#3)(2010-11#4)(2010-12#8)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#7)(2010-6#3)(2010-7#5)(2010-8#6)(2010-9#8)(2011-1#10)(2011-12#1)(2011-2#31)(2012-1#3)(2012-11#2)(2012-12#11)(2012-2#13)(2012-3#8)(2013-1#31)(2013-7#5)(2013-8#12)
there is accumulating##2##3##(1994-12#1)(2005-8#1)
there is active##2##3##(1997-9#1)(2007-9#1)
there is already a##2##4##(2008-9#1)(2013-1#1)
there is already##3##3##(2007-11#1)(2008-9#1)(2013-1#1)
there is also a high##2##5##(2008-8#1)(2011-2#1)
there is also a need to##2##6##(1995-5#1)(2007-7#1)
there is also a##11##4##(1992-5#1)(1994-7#1)(1995-5#1)(2005-8#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-7#1)(2011-2#1)
there is also an increase in the##2##7##(1990-7#1)(2011-2#1)
there is also an##4##4##(1990-7#1)(1996-8#1)(2008-10#1)(2011-2#1)
there is also evidence##2##4##(1995-12#1)(2010-8#1)
there is also significant##2##4##(2007-12#1)(2012-11#1)
there is also some##3##4##(1990-2#1)(1991-6#1)(2008-8#1)
there is also##30##3##(1990-2#1)(1990-7#1)(1991-6#2)(1992-5#1)(1994-7#1)(1995-12#1)(1995-5#1)(1996-8#1)(2005-11#1)(2005-8#1)(2006-5#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-8#2)(2009-4#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-11#1)
there is always a##2##4##(2005-5#1)(2008-3#1)
there is always the possibility that##2##6##(2008-9#2)
there is always the##4##4##(2006-10#1)(2008-9#2)(2009-6#1)
there is always##9##3##(2005-5#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-3#1)(2008-9#2)(2009-6#1)(2010-4#1)
there is ample evidence##2##4##(2008-3#1)(2008-7#1)
there is an additional##2##4##(1991-1#1)(1995-11#1)
there is an additive##2##4##(2006-11#1)(2008-12#1)
there is an alteration##2##4##(1997-1#1)(2006-6#1)
there is an apparent##3##4##(2005-7#1)(2008-3#1)(2010-1#1)
there is an association between##2##5##(2004-12#1)(2013-1#1)
there is an association##3##4##(2004-12#1)(2011-2#1)(2013-1#1)
there is an evident##2##4##(2006-2#1)(2008-3#1)
there is an excellent##2##4##(1991-2#1)(2008-8#1)
there is an increase in the number##2##7##(1995-7#1)(2010-12#1)
there is an increase in the##5##6##(1993-6#1)(1995-7#1)(2007-8#1)(2008-11#1)(2010-12#1)
there is an increase in##7##5##(1993-6#1)(1995-12#1)(1995-7#1)(2007-8#1)(2008-11#1)(2010-12#1)(2013-8#1)
there is an increase##8##4##(1993-6#1)(1995-12#1)(1995-7#1)(2007-8#1)(2008-11#1)(2010-12#1)(2012-2#1)(2013-8#1)
there is an increased risk of##3##6##(2007-11#1)(2009-12#1)(2011-1#1)
there is an increased risk##5##5##(1996-6#1)(2007-11#1)(2007-8#1)(2009-12#1)(2011-1#1)
there is an increased##14##4##(1991-3#1)(1994-5#1)(1995-7#1)(1996-6#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2009-12#1)(2010-8#1)(2011-1#1)(2013-8#1)
there is an increasing need##2##5##(1991-4#1)(2010-2#1)
there is an increasing number of##3##6##(2006-10#2)(2006-2#1)
there is an increasing tendency for##2##6##(2005-11#1)(2008-5#1)
there is an increasing##14##4##(1991-4#1)(2005-11#1)(2006-10#4)(2006-2#1)(2006-6#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-5#1)(2009-5#1)(2010-2#1)
there is an ongoing##2##4##(2010-9#1)(2012-12#1)
there is an opportunity to##2##5##(2008-12#1)(2013-1#1)
there is an optimum##4##4##(2007-2#1)(2008-2#2)(2008-3#1)
there is an unmet##2##4##(2008-1#1)(2011-2#1)
there is an urgent need for the##2##7##(2008-10#1)(2008-5#1)
there is an urgent need for##5##6##(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)
there is an urgent need to##9##6##(2004-10#1)(2006-10#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-1#1)
there is an urgent need##14##5##(2004-10#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-1#1)
there is an urgent##16##4##(2004-10#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-1#1)(2013-7#1)
there is an##158##3##(1990-3#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-12#1)(1992-2#2)(1992-6#1)(1993-10#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-5#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-7#2)(1996-11#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-10#1)(2004-12#1)(2005-11#1)(2005-6#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#8)(2006-11#1)(2006-2#2)(2006-5#1)(2006-6#4)(2006-8#1)(2006-9#1)(2007-11#4)(2007-12#2)(2007-2#4)(2007-3#1)(2007-5#1)(2007-8#3)(2008-1#5)(2008-10#7)(2008-11#6)(2008-12#5)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#4)(2009-1#1)(2009-12#2)(2009-3#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
there is any difference##2##4##(1995-7#1)(2012-12#1)
there is any##12##3##(1995-7#1)(1996-12#1)(1997-5#1)(2006-4#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-3#1)(2008-7#1)(2012-12#1)(2012-3#1)
there is as yet##2##4##(2011-1#1)(2012-12#1)
there is as##4##3##(2007-7#1)(2009-7#1)(2011-1#1)(2012-12#1)
there is better##2##3##(2008-6#1)(2008-8#1)
there is both##2##3##(2006-9#1)(2008-10#1)
there is clear##2##3##(2008-6#1)(2010-11#1)
there is clinical##2##3##(2005-10#1)(2007-12#1)
there is compelling##2##3##(2007-8#1)(2011-2#1)
there is concern about the##2##5##(2008-7#1)(2011-12#1)
there is concern about##4##4##(2006-10#1)(2007-11#1)(2008-7#1)(2011-12#1)
there is concern that##4##4##(1994-9#1)(2007-11#1)(2008-8#1)(2012-1#1)
there is concern##8##3##(1994-9#1)(2006-10#1)(2007-11#2)(2008-7#1)(2008-8#1)(2011-12#1)(2012-1#1)
there is considerable evidence that##2##5##(2007-11#1)(2009-10#1)
there is considerable variation in the##2##6##(1991-11#1)(2011-2#1)
there is considerable variation in##3##5##(1991-11#1)(2011-2#1)(2013-1#1)
there is considerable variation##4##4##(1991-11#1)(1996-8#1)(2011-2#1)(2013-1#1)
there is considerable##19##3##(1991-11#1)(1992-6#1)(1994-12#1)(1996-8#1)(1997-5#1)(2006-12#1)(2007-11#1)(2008-10#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-2#1)(2011-2#1)(2013-1#2)
there is controversy about##2##4##(2010-11#1)(2011-2#1)
there is currently a##3##4##(2006-7#1)(2007-12#1)(2008-11#1)
there is currently no evidence that##2##6##(2007-8#1)(2007-9#1)
there is currently no##5##4##(1996-1#1)(2007-8#1)(2007-9#1)(2011-2#2)
there is currently##10##3##(1996-1#1)(2006-7#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-11#1)(2011-2#2)(2012-3#1)
there is debate##2##3##(2006-9#1)(2008-11#1)
there is diffuse##2##3##(2007-7#1)(2009-9#1)
there is direct##3##3##(2007-12#1)(2008-7#1)(2011-2#1)
there is disagreement##2##3##(1997-7#1)(2009-3#1)
there is emerging evidence##2##4##(1994-5#1)(2008-4#1)
there is emerging##3##3##(1994-5#1)(2008-4#1)(2010-10#1)
there is enough##6##3##(2005-11#1)(2006-8#1)(2007-2#1)(2008-5#1)(2008-7#1)(2009-8#1)
there is every##2##3##(1991-5#1)(2007-3#1)
there is evidence for##5##4##(2004-11#1)(2006-10#1)(2008-5#1)(2008-7#1)(2012-3#1)
there is evidence from##2##4##(1994-9#1)(2007-8#1)
there is evidence of an##3##5##(1996-5#1)(2008-11#1)(2012-3#1)
there is evidence of##10##4##(1996-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-10#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-3#1)
there is evidence suggesting that##2##5##(2008-10#1)(2009-2#1)
there is evidence that it is##2##6##(1992-4#1)(2008-4#1)
there is evidence that the##4##5##(1992-7#1)(1993-7#1)(2006-10#1)(2008-6#1)
there is evidence that##25##4##(1991-4#1)(1992-4#1)(1992-7#1)(1993-7#1)(1995-12#1)(1995-2#1)(1996-5#1)(2004-9#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#2)(2009-5#1)(2010-1#1)(2010-5#1)(2012-12#1)(2013-7#2)
there is evidence to suggest that##2##6##(2007-12#1)(2010-2#1)
there is evidence to support##3##5##(2007-12#1)(2007-8#1)(2010-3#1)
there is evidence to##6##4##(2006-10#1)(2007-12#2)(2007-8#1)(2010-2#1)(2010-3#1)
there is evidence##56##3##(1991-4#1)(1992-4#1)(1992-7#1)(1993-7#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-5#2)(2004-11#1)(2004-9#1)(2005-10#1)(2006-10#4)(2006-12#1)(2007-11#3)(2007-12#2)(2007-6#1)(2007-8#3)(2008-10#3)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#2)
there is extensive##2##3##(1995-3#1)(1996-3#1)
there is general agreement that##4##5##(1991-9#1)(1994-8#1)(2008-11#1)(2008-6#1)
there is general##5##3##(1991-9#1)(1994-8#1)(2008-11#1)(2008-6#1)(2008-8#1)
there is generally##2##3##(1995-9#1)(2008-4#1)
there is good agreement##2##4##(2008-10#1)(2008-2#1)
there is good evidence that##3##5##(2007-8#1)(2009-11#1)(2009-6#1)
there is good evidence##4##4##(2007-8#1)(2008-7#1)(2009-11#1)(2009-6#1)
there is good##8##3##(1997-8#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-11#1)(2009-6#1)
there is great##5##3##(2008-1#1)(2008-11#2)(2009-7#1)(2010-10#1)
there is greater##2##3##(1990-11#1)(2008-10#1)
there is growing evidence that##2##5##(2009-10#1)(2009-7#1)
there is growing evidence to##2##5##(2008-2#1)(2008-7#1)
there is growing evidence##6##4##(1992-2#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-7#1)
there is growing interest##2##4##(2007-10#1)(2010-12#1)
there is growing##11##3##(1992-2#1)(2005-6#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-12#1)
there is high##5##3##(2007-11#1)(2008-5#1)(2010-11#1)(2011-12#1)(2012-3#1)
there is highly##2##3##(2008-2#1)(2012-3#1)
there is hope for##2##4##(2008-12#1)(2011-2#1)
there is hope##3##3##(1990-2#1)(2008-12#1)(2011-2#1)
there is however##3##3##(1992-3#1)(2006-6#1)(2011-1#1)
there is increased##6##3##(1994-7#1)(1997-1#1)(1997-8#1)(2007-7#1)(2010-11#1)(2012-2#1)
there is increasing evidence that a##2##6##(1992-9#1)(2007-5#1)
there is increasing evidence that##8##5##(1991-7#1)(1992-9#1)(2006-8#1)(2006-9#1)(2007-5#1)(2008-1#2)(2008-7#1)
there is increasing evidence##11##4##(1991-7#1)(1992-9#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-7#1)(2008-8#1)
there is increasing interest in the##2##6##(2007-8#1)(2010-7#1)
there is increasing interest in##3##5##(2007-8#1)(2010-10#1)(2010-7#1)
there is increasing##20##3##(1991-7#1)(1992-9#1)(1993-12#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-2#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-10#1)(2010-7#1)(2012-12#1)(2012-2#1)
there is insufficient evidence to##2##5##(2008-3#1)(2011-1#1)
there is insufficient evidence##3##4##(2008-3#1)(2009-10#1)(2011-1#1)
there is insufficient information##2##4##(2005-7#2)
there is insufficient##8##3##(2005-7#2)(2008-3#1)(2009-10#2)(2011-1#2)(2013-7#1)
there is interest in##5##4##(1991-3#1)(2008-12#1)(2010-1#1)(2010-5#1)(2012-12#1)
there is lack of##4##4##(2008-5#1)(2009-9#1)(2011-10#1)(2013-7#1)
there is large##2##3##(2007-11#1)(2008-5#1)
there is less##3##3##(2005-8#1)(2006-10#1)(2008-10#1)
there is limited empirical##2##4##(2012-3#1)(2013-8#1)
there is limited information on the##3##6##(2008-8#1)(2009-9#1)(2011-2#1)
there is limited information on##5##5##(2008-8#1)(2009-3#1)(2009-9#1)(2011-2#1)(2012-1#1)
there is limited information##6##4##(2008-8#1)(2009-3#1)(2009-9#1)(2011-2#1)(2012-1#1)(2013-7#1)
there is limited understanding of##2##5##(2012-2#1)(2013-1#1)
there is limited##12##3##(1992-1#1)(2008-8#1)(2009-3#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
there is little consensus##4##4##(1995-1#1)(2008-10#1)(2008-11#1)(2013-1#1)
there is little direct##2##4##(1993-11#1)(1994-6#1)
there is little evidence that##7##5##(2006-7#1)(2007-8#1)(2008-7#1)(2010-10#1)(2011-12#1)(2012-1#1)(2013-7#1)
there is little evidence to support##2##6##(2006-7#1)(2007-8#1)
there is little evidence to##6##5##(2006-7#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-5#1)(2011-2#1)
there is little evidence##15##4##(2006-7#2)(2007-11#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-12#1)(2011-2#1)(2012-1#2)(2013-7#1)
there is little experimental evidence##2##5##(2008-10#1)(2008-8#1)
there is little information about the##2##6##(2007-1#1)(2007-7#1)
there is little information on##2##5##(2009-4#1)(2010-5#1)
there is little information##7##4##(1993-1#1)(2007-1#1)(2007-10#1)(2007-7#1)(2008-7#1)(2009-4#1)(2010-5#1)
there is little or no##3##5##(2008-8#1)(2011-2#1)(2013-8#1)
there is little##69##3##(1990-7#1)(1991-6#1)(1992-6#1)(1993-1#1)(1993-11#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-3#2)(1996-9#1)(1997-2#1)(1997-3#1)(2004-12#1)(2004-7#1)(2006-10#1)(2006-4#1)(2006-7#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#3)(2008-11#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2009-4#1)(2009-7#1)(2010-10#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#4)
there is marked##4##3##(1996-8#1)(2006-9#1)(2008-4#1)(2008-6#1)
there is migration##2##3##(2008-1#1)(2008-8#1)
there is minimal##4##3##(1992-5#1)(2006-12#1)(2007-8#1)(2009-11#1)
there is moderate##2##3##(2007-10#1)(2007-7#1)
there is more than one##2##5##(1996-3#1)(2006-12#1)
there is more than##4##4##(1994-10#1)(1996-3#1)(2006-12#1)(2008-5#1)
there is more to##4##4##(1995-1#1)(2008-4#1)(2008-7#1)(2012-3#1)
there is more##13##3##(1994-10#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-3#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-3#1)
there is much to be##2##5##(2009-12#1)(2013-1#1)
there is much##9##3##(1994-1#1)(1994-6#1)(2005-6#1)(2006-10#2)(2007-12#1)(2008-2#1)(2009-12#1)(2013-1#1)
there is need for##4##4##(2004-8#1)(2007-3#1)(2007-7#1)(2008-2#1)
there is need to##6##4##(2007-6#1)(2007-7#2)(2009-6#1)(2011-1#1)(2012-2#1)
there is need##10##3##(2004-8#1)(2007-3#1)(2007-6#1)(2007-7#3)(2008-2#1)(2009-6#1)(2011-1#1)(2012-2#1)
there is negligible concern for##2##5##(2005-7#1)(2006-12#1)
there is no &quot##2##4##(1993-8#1)(2008-10#1)
there is no a##2##4##(2008-12#1)(2011-1#1)
there is no advantage in##2##5##(1994-7#1)(2009-10#1)
there is no agreement##3##4##(2008-5#1)(2008-8#1)(2012-2#1)
there is no clear##6##4##(1996-3#1)(2006-11#1)(2007-12#1)(2007-6#1)(2008-5#1)(2013-1#1)
there is no conclusive##2##4##(1993-3#1)(1996-10#1)
there is no consensus among##2##5##(2008-1#1)(2013-1#1)
there is no consensus on##7##5##(1995-3#1)(2008-4#2)(2008-7#1)(2009-5#1)(2010-12#1)(2012-2#1)
there is no consensus regarding the##3##6##(1994-12#1)(2008-11#1)(2012-2#1)
there is no consensus regarding##5##5##(1993-12#1)(1994-12#1)(2008-11#1)(2012-2#1)(2013-8#1)
there is no consensus##19##4##(1993-12#1)(1994-12#1)(1995-3#1)(2006-2#1)(2006-5#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#1)(2009-5#1)(2009-8#1)(2010-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
there is no convincing evidence##2##5##(1992-2#1)(2007-8#1)
there is no correlation between##2##5##(1994-5#1)(2011-2#1)
there is no correlation##4##4##(1990-9#1)(1994-3#1)(1994-5#1)(2011-2#1)
there is no cure for##2##5##(2010-11#1)(2011-2#1)
there is no cure##4##4##(2010-11#2)(2011-2#2)
there is no definite##2##4##(2007-11#1)(2012-2#1)
there is no definitive##3##4##(2008-4#1)(2008-9#1)(2010-12#1)
there is no detectable TR##2##5##(1994-9#2)
there is no detectable##5##4##(1990-8#1)(1994-9#2)(1995-1#1)(1995-5#1)
there is no difference between##2##5##(1993-9#1)(1997-1#1)
there is no difference in##3##5##(2008-6#1)(2009-3#1)(2011-1#1)
there is no difference##5##4##(1993-9#1)(1997-1#1)(2008-6#1)(2009-3#1)(2011-1#1)
there is no direct evidence that##3##6##(1993-7#1)(1997-2#1)(2007-11#1)
there is no direct evidence##5##5##(1993-7#1)(1993-9#1)(1995-10#1)(1997-2#1)(2007-11#1)
there is no direct##8##4##(1993-7#1)(1993-9#1)(1995-10#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-5#1)(2009-2#1)
there is no doubt that##4##5##(2006-7#1)(2009-12#1)(2011-2#2)
there is no doubt##6##4##(2006-7#1)(2008-7#1)(2009-12#1)(2011-2#2)(2012-2#1)
there is no drug##2##4##(1991-12#1)(2005-9#1)
there is no effective therapy for##2##6##(2005-10#1)(2011-1#1)
there is no effective therapy##4##5##(2005-10#1)(2006-10#1)(2007-8#1)(2011-1#1)
there is no effective##8##4##(1990-2#1)(1995-9#1)(1996-12#1)(2005-10#1)(2006-10#1)(2007-8#1)(2011-1#1)(2012-2#1)
there is no evidence for an##2##6##(2008-11#1)(2012-3#1)
there is no evidence for##7##5##(1994-11#1)(1994-6#1)(1997-7#1)(2007-6#1)(2007-8#1)(2008-11#1)(2012-3#1)
there is no evidence of##12##5##(1990-2#1)(1993-5#1)(1994-3#1)(1995-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-7#1)(2013-1#1)(2013-8#1)
there is no evidence that it##2##6##(1997-3#1)(2006-9#1)
there is no evidence that the##2##6##(1990-12#1)(2007-8#1)
there is no evidence that they##2##6##(2010-12#1)(2012-12#1)
there is no evidence that##16##5##(1990-12#1)(1992-2#1)(1995-4#1)(1996-11#1)(1997-3#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-6#1)(2010-12#1)(2012-12#3)
there is no evidence to##3##5##(2007-11#1)(2007-8#1)(2008-10#1)
there is no evidence##42##4##(1990-12#1)(1990-2#1)(1992-2#2)(1993-5#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-11#2)(1995-4#1)(1996-11#1)(1997-3#1)(1997-7#1)(2006-5#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-6#2)(2007-8#3)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#1)
there is no free##2##4##(2007-4#1)(2008-3#1)
there is no general##3##4##(2008-7#1)(2008-8#1)(2009-12#1)
there is no genetic##2##4##(2008-5#1)(2011-2#1)
there is no increase in##2##5##(1997-1#1)(2007-8#1)
there is no indication##3##4##(1991-10#1)(1992-12#1)(1996-4#1)
there is no information available##2##5##(2008-10#1)(2013-7#1)
there is no information on##2##5##(2008-10#1)(2008-5#1)
there is no information##5##4##(2008-10#2)(2008-5#1)(2009-8#1)(2013-7#1)
there is no interference##2##4##(2004-12#1)(2008-10#1)
there is no known##4##4##(1995-6#1)(2008-3#1)(2011-1#1)(2013-1#1)
there is no loss##2##4##(2007-12#1)(2008-10#1)
there is no need for an##2##6##(2006-9#1)(2013-7#1)
there is no need for##5##5##(2006-9#1)(2007-8#1)(2008-10#1)(2008-2#1)(2013-7#1)
there is no need to##4##5##(1993-9#1)(2007-12#1)(2008-10#1)(2011-2#1)
there is no need##9##4##(1993-9#1)(2006-9#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2011-2#1)(2013-7#1)
there is no one##2##4##(1996-1#1)(2011-12#1)
there is no precise##2##4##(2008-6#1)(2011-1#1)
there is no published##4##4##(2006-10#1)(2006-8#1)(2008-5#1)(2010-12#1)
there is no relationship between##4##5##(2008-11#1)(2008-12#1)(2008-8#1)(2010-8#1)
there is no report on##2##5##(2006-12#1)(2013-8#1)
there is no report##4##4##(2006-12#1)(2010-11#1)(2012-12#1)(2013-8#1)
there is no reported##2##4##(2012-2#2)
there is no risk##2##4##(2006-10#1)(2012-2#1)
there is no sign##2##4##(1997-8#1)(2007-12#1)
there is no significant difference between the##3##7##(1992-1#1)(2008-9#1)(2012-12#1)
there is no significant difference##6##5##(1992-1#1)(2008-10#2)(2008-9#2)(2012-12#1)
there is no significant effect##2##5##(2005-11#1)(2009-5#1)
there is no significant##16##4##(1990-2#1)(1990-6#1)(1992-1#1)(1996-7#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-6#1)(2008-9#2)(2009-5#1)(2012-12#1)
there is no simple##2##4##(2008-8#1)(2009-6#1)
there is no single set of universal guidance documents that can be used to inform the preclinical development path for these therapeutics##2##22##(2012-12#2)
there is no single##6##4##(2008-6#1)(2009-4#1)(2012-11#1)(2012-12#2)(2012-2#1)
there is no specific treatment for AP##2##7##(2013-1#2)
there is no specific treatment##3##5##(2011-2#1)(2013-1#2)
there is no specific##5##4##(1990-4#1)(2006-6#1)(2011-2#1)(2013-1#2)
there is no standard method##2##5##(1997-4#1)(2013-1#1)
there is no standard##3##4##(1997-4#1)(2008-5#1)(2013-1#1)
there is no statistically significant difference in the##2##8##(2006-2#1)(2013-1#1)
there is no strong evidence that##2##6##(2007-8#1)(2008-4#1)
there is no strong##3##4##(2007-12#1)(2007-8#1)(2008-4#1)
there is no study##2##4##(2008-12#1)(2012-2#1)
there is no such##3##4##(1992-2#1)(2008-2#1)(2008-3#1)
there is no true consensus on how to treat them##2##10##(2013-1#2)
there is no universal##2##4##(2007-11#1)(2013-1#1)
there is no universally##2##4##(2006-12#1)(2008-1#1)
there is no widely accepted##2##5##(2005-11#1)(2012-3#1)
there is no##389##3##(1990-11#1)(1990-12#1)(1990-2#4)(1990-4#1)(1990-6#3)(1990-8#2)(1990-9#2)(1991-10#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#4)(1993-1#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-11#2)(1994-12#2)(1994-3#2)(1994-5#3)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#2)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#4)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-9#2)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#3)(2006-4#1)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-11#6)(2007-12#8)(2007-2#2)(2007-3#2)(2007-4#4)(2007-6#3)(2007-7#3)(2007-8#15)(2007-9#1)(2008-1#5)(2008-10#17)(2008-11#6)(2008-12#6)(2008-2#6)(2008-3#8)(2008-4#9)(2008-5#10)(2008-6#7)(2008-7#7)(2008-8#8)(2008-9#7)(2009-10#1)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#5)(2009-6#4)(2009-7#2)(2009-8#2)(2010-11#4)(2010-12#5)(2010-3#2)(2010-6#1)(2010-8#2)(2011-1#9)(2011-12#3)(2011-2#14)(2012-11#1)(2012-12#9)(2012-2#17)(2012-3#6)(2013-1#17)(2013-7#3)(2013-8#5)
there is not a##4##4##(2007-11#1)(2007-8#1)(2008-11#1)(2011-2#1)
there is not any##2##4##(2008-5#1)(2011-2#1)
there is not enough##2##4##(2007-7#1)(2008-3#1)
there is not sufficient##2##4##(2011-2#1)(2012-2#1)
there is not##15##3##(1996-12#1)(2006-11#1)(2006-5#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-8#1)(2011-2#3)(2012-2#1)
there is now evidence that the##2##6##(2010-7#1)(2012-12#1)
there is now evidence that##3##5##(2006-10#1)(2010-7#1)(2012-12#1)
there is now##12##3##(1990-2#1)(1992-5#1)(1994-12#1)(2006-10#2)(2007-4#1)(2008-3#1)(2010-1#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)
there is obvious##2##3##(1996-12#1)(2005-10#1)
there is often##3##3##(2005-9#1)(2007-7#1)(2012-1#1)
there is one##5##3##(1994-9#1)(2008-3#1)(2008-8#1)(2010-11#1)(2010-7#1)
there is only 1##2##4##(2006-12#2)
there is only one possible mode of##2##7##(2008-3#2)
there is only one report##2##5##(2008-12#1)(2013-8#1)
there is only one##7##4##(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2013-8#1)
there is only##13##3##(1995-10#1)(2006-12#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2012-12#1)(2013-1#1)(2013-8#2)
there is paucity of##4##4##(2007-6#1)(2007-7#1)(2011-2#1)(2012-2#1)
there is potential for##4##4##(1996-3#1)(2008-10#1)(2009-3#1)(2011-1#1)
there is potential##7##3##(1996-3#1)(2005-12#1)(2008-10#2)(2009-3#1)(2011-1#1)(2012-12#1)
there is presently##2##3##(1994-5#1)(2007-4#1)
there is progressive##3##3##(1993-6#1)(2006-1#1)(2008-7#1)
there is reason##2##3##(2006-10#1)(2008-12#1)
there is reduced##2##3##(1997-8#1)(2008-7#1)
there is relatively little##3##4##(2006-9#1)(2007-4#1)(2010-9#1)
there is room for##4##4##(1996-2#1)(2008-3#1)(2011-1#1)(2012-3#1)
there is scope for##2##4##(1995-2#1)(2007-10#1)
there is severe##3##3##(1995-7#1)(2007-10#1)(2007-8#1)
there is significant evidence##2##4##(1997-7#1)(2010-5#1)
there is significant##16##3##(1993-7#1)(1997-7#1)(2006-12#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#1)
there is some consensus that##2##5##(1996-3#1)(2008-7#1)
there is some evidence of##2##5##(2007-2#1)(2011-2#1)
there is some evidence that the##2##6##(1996-2#1)(2007-11#1)
there is some evidence that##7##5##(1993-1#1)(1996-2#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-2#1)(2012-2#1)
there is some evidence to suggest that##2##7##(2008-3#1)(2013-1#1)
there is some evidence##11##4##(1993-1#1)(1996-2#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-2#2)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
there is some##28##3##(1990-7#1)(1992-11#1)(1992-5#1)(1993-1#1)(1996-2#1)(1996-3#1)(2005-8#2)(2006-10#1)(2006-12#2)(2007-11#2)(2007-2#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
there is something##3##3##(1997-4#1)(2006-5#1)(2010-5#1)
there is still a large##2##5##(1991-12#1)(2011-2#1)
there is still a long way to go before##2##9##(1995-11#1)(2012-3#1)
there is still a long##3##5##(1995-11#1)(2008-4#1)(2012-3#1)
there is still a need for##5##6##(2008-10#1)(2008-4#1)(2008-5#2)(2013-1#1)
there is still a need to##2##6##(2008-10#1)(2012-12#1)
there is still a need##7##5##(2008-10#2)(2008-4#1)(2008-5#2)(2012-12#1)(2013-1#1)
there is still a##18##4##(1991-12#1)(1995-11#1)(1997-2#1)(2006-2#1)(2008-10#2)(2008-4#2)(2008-5#2)(2009-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
there is still considerable##2##4##(1995-6#1)(2009-4#1)
there is still more##2##4##(2005-7#1)(2008-5#1)
there is still much controversy##2##5##(1990-9#1)(2007-2#1)
there is still much to##2##5##(2008-10#2)
there is still much##10##4##(1990-9#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-1#1)
there is still need to##3##5##(2007-6#1)(2008-12#1)(2012-12#1)
there is still no cure##2##5##(2008-1#1)(2011-7#1)
there is still no##11##4##(2004-10#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-7#1)(2011-7#1)(2013-1#1)
there is still not##2##4##(2007-1#1)(2011-2#1)
there is still substantial##2##4##(2004-2#1)(2007-2#1)
there is still##66##3##(1990-9#1)(1991-12#1)(1993-2#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-6#1)(1995-8#1)(1997-2#1)(2004-10#1)(2004-2#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-6#2)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-1#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#2)(2011-7#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
there is strong evidence that##4##5##(2007-8#1)(2008-1#1)(2008-8#1)(2009-2#1)
there is strong evidence##7##4##(1997-2#1)(2007-8#1)(2008-1#1)(2008-8#1)(2009-2#1)(2010-12#1)(2013-1#1)
there is strong##14##3##(1997-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#3)(2009-2#1)(2009-8#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#1)
there is substantial##11##3##(1992-2#1)(1993-11#1)(1994-3#2)(1997-5#1)(2007-7#1)(2008-3#1)(2010-11#1)(2010-9#1)(2012-2#1)(2012-3#1)
there is such##2##3##(1994-9#1)(2006-10#1)
there is sufficient##3##3##(2008-1#2)(2012-3#1)
there is surprisingly little##3##4##(2007-1#1)(2008-11#1)(2009-4#1)
there is suspicion of##2##4##(2007-7#1)(2008-3#1)
there is the need to##2##5##(2006-10#1)(2008-10#1)
there is the need##5##4##(2006-10#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)
there is the possibility of##3##5##(2007-12#1)(2008-5#2)
there is the possibility that##2##5##(1995-4#1)(1996-8#1)
there is the possibility##5##4##(1995-4#1)(1996-8#1)(2007-12#1)(2008-5#2)
there is the##16##3##(1990-3#1)(1995-4#1)(1996-8#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-12#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
there is uncertainty##4##3##(1994-7#1)(2006-12#1)(2008-8#2)
there is up to##2##4##(1992-8#1)(2008-1#1)
there is value in##2##4##(2009-1#1)(2012-12#1)
there is variation##2##3##(2008-10#1)(2012-3#1)
there is very little##10##4##(1991-2#1)(1992-11#1)(2007-7#1)(2007-8#3)(2008-7#2)(2008-8#1)(2009-8#1)
there is wide##2##3##(1994-4#1)(2010-11#1)
there is##2077##2##(1990-10#1)(1990-11#5)(1990-12#2)(1990-2#10)(1990-3#4)(1990-4#2)(1990-5#1)(1990-6#3)(1990-7#5)(1990-8#8)(1990-9#5)(1991-1#4)(1991-10#3)(1991-11#3)(1991-12#7)(1991-2#6)(1991-3#6)(1991-4#3)(1991-5#4)(1991-6#8)(1991-7#5)(1991-8#1)(1991-9#3)(1992-1#3)(1992-11#4)(1992-12#7)(1992-2#10)(1992-3#6)(1992-4#1)(1992-5#5)(1992-6#6)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#4)(1993-10#2)(1993-11#4)(1993-12#8)(1993-2#4)(1993-3#3)(1993-5#1)(1993-6#4)(1993-7#4)(1993-8#5)(1993-9#4)(1994-1#2)(1994-10#1)(1994-11#4)(1994-12#7)(1994-2#3)(1994-3#8)(1994-4#1)(1994-5#8)(1994-6#6)(1994-7#6)(1994-8#5)(1994-9#13)(1995-1#8)(1995-10#3)(1995-11#10)(1995-12#8)(1995-2#6)(1995-3#3)(1995-4#3)(1995-5#6)(1995-6#4)(1995-7#4)(1995-8#5)(1995-9#4)(1996-1#4)(1996-10#2)(1996-11#2)(1996-12#7)(1996-2#6)(1996-3#15)(1996-4#3)(1996-5#3)(1996-6#2)(1996-7#2)(1996-8#6)(1996-9#7)(1997-1#9)(1997-2#6)(1997-3#8)(1997-4#9)(1997-5#10)(1997-6#4)(1997-7#6)(1997-8#14)(1997-9#1)(2004-10#2)(2004-11#2)(2004-12#4)(2004-2#1)(2004-7#1)(2004-8#1)(2004-9#3)(2005-10#6)(2005-11#21)(2005-12#5)(2005-3#2)(2005-5#1)(2005-6#3)(2005-7#10)(2005-8#9)(2005-9#6)(2006-1#3)(2006-10#56)(2006-11#6)(2006-12#17)(2006-2#10)(2006-3#2)(2006-4#5)(2006-5#8)(2006-6#7)(2006-7#9)(2006-8#11)(2006-9#13)(2007-1#6)(2007-10#9)(2007-11#37)(2007-12#34)(2007-2#22)(2007-3#11)(2007-4#8)(2007-5#5)(2007-6#17)(2007-7#32)(2007-8#55)(2007-9#11)(2008-1#43)(2008-10#81)(2008-11#49)(2008-12#29)(2008-2#30)(2008-3#51)(2008-4#39)(2008-5#47)(2008-6#28)(2008-7#53)(2008-8#65)(2008-9#31)(2009-1#6)(2009-10#9)(2009-11#9)(2009-12#9)(2009-2#8)(2009-3#8)(2009-4#11)(2009-5#13)(2009-6#8)(2009-7#8)(2009-8#8)(2009-9#11)(2010-1#8)(2010-10#9)(2010-11#17)(2010-12#20)(2010-2#8)(2010-3#5)(2010-4#4)(2010-5#15)(2010-6#6)(2010-7#12)(2010-8#13)(2010-9#13)(2011-1#36)(2011-10#1)(2011-12#10)(2011-2#76)(2011-3#1)(2011-7#1)(2012-1#10)(2012-11#6)(2012-12#37)(2012-2#50)(2012-3#33)(2013-1#67)(2013-7#18)(2013-8#34)
there isn't##2##2##(2008-4#1)(2011-2#1)
there lessons to be##2##4##(2007-7#1)(2008-12#1)
there may be a need for##2##6##(1995-1#1)(2012-3#1)
there may be a##18##4##(1990-5#1)(1991-10#1)(1991-2#1)(1992-2#1)(1993-3#1)(1993-8#1)(1994-9#1)(1995-1#1)(1996-12#1)(1996-5#1)(2004-3#1)(2006-5#1)(2006-7#1)(2008-1#1)(2008-9#1)(2012-3#1)(2013-7#1)(2013-8#1)
there may be an##4##4##(1996-1#1)(2006-10#1)(2007-7#1)(2008-7#1)
there may be associations##2##4##(1995-8#1)(2007-3#1)
there may be more than##2##5##(1995-3#1)(2012-2#1)
there may be more##3##4##(1994-3#1)(1995-3#1)(2012-2#1)
there may be no##7##4##(1991-11#1)(1996-10#1)(2005-8#1)(2008-1#1)(2008-8#1)(2011-2#1)(2012-12#1)
there may be other##3##4##(1997-1#1)(1997-7#1)(2008-2#1)
there may be some##3##4##(1993-6#1)(2008-3#1)(2012-3#1)
there may be two##4##4##(1994-9#1)(1997-4#1)(2008-10#1)(2009-11#1)
there may be##77##3##(1990-5#1)(1991-10#1)(1991-11#1)(1991-2#1)(1992-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-7#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-3#1)(2005-10#2)(2005-12#1)(2005-8#1)(2006-10#2)(2006-3#1)(2006-5#2)(2006-7#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
there may exist a##2##4##(1995-11#1)(1996-2#1)
there may exist##4##3##(1995-11#1)(1995-5#1)(1996-2#1)(2008-8#1)
there may have been##3##4##(1996-12#1)(2006-10#1)(2008-10#1)
there may not be a##3##5##(2007-9#1)(2008-8#1)(2011-1#1)
there may##90##2##(1990-5#1)(1991-10#1)(1991-11#1)(1991-2#1)(1992-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-7#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-3#1)(2005-10#2)(2005-12#1)(2005-8#2)(2006-10#3)(2006-3#1)(2006-5#2)(2006-7#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-11#1)(2009-3#1)(2010-11#1)(2010-12#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
there might be a##4##4##(1993-4#1)(1994-12#1)(2010-10#1)(2012-12#1)
there might be##11##3##(1992-4#1)(1993-4#1)(1994-11#1)(1994-12#1)(1995-6#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-10#1)(2012-12#1)(2012-2#1)
there more##2##2##(1991-1#1)(2011-12#1)
there must be a##2##4##(2007-4#1)(2012-3#1)
there must be##10##3##(1996-12#1)(1997-8#1)(2007-4#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)(2012-3#1)
there must##12##2##(1996-12#1)(1997-8#1)(2007-3#1)(2007-4#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)(2012-3#1)
there needs to be##2##4##(2009-7#1)(2013-1#1)
there no##2##2##(2010-6#1)(2012-3#1)
there occurred##3##2##(1991-11#1)(2009-6#1)(2012-3#1)
there only##2##2##(2007-9#1)(2008-10#1)
there other##2##2##(1996-1#1)(2010-12#1)
there probably##2##2##(1995-12#1)(1995-8#1)
there really##3##2##(1991-2#1)(2006-9#1)(2011-2#1)
there remain a number of##3##5##(2007-12#1)(2008-11#1)(2008-8#1)
there remain many##2##3##(2007-2#1)(2008-4#1)
there remain significant##3##3##(2007-2#1)(2008-6#2)
there remain##12##2##(2007-12#2)(2007-2#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#2)(2008-8#1)(2010-9#1)
there remains a##6##3##(2005-8#1)(2006-8#1)(2007-12#2)(2007-7#1)(2012-12#1)
there remains considerable##2##3##(2008-11#1)(2008-7#1)
there remains no##2##3##(2008-3#1)(2010-7#1)
there remains##16##2##(1992-9#1)(2005-7#1)(2005-8#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
there seems to be a lack of##2##7##(1997-8#1)(2007-1#1)
there seems to be a##10##5##(1993-3#1)(1995-4#1)(1996-1#1)(1996-12#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-1#1)(2007-12#1)(2012-1#1)
there seems to be no##3##5##(1996-2#1)(2007-2#1)(2008-10#1)
there seems to be##13##4##(1993-3#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-2#1)(2008-10#1)(2012-1#1)
there seems##14##2##(1993-3#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-2#1)(2008-10#1)(2010-7#1)(2012-1#1)
there should be a##5##4##(1992-6#1)(1995-2#1)(2007-11#1)(2008-7#1)(2012-12#1)
there should be more##2##4##(2006-10#1)(2008-1#1)
there should be##14##3##(1990-12#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-6#1)(1995-2#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2012-12#1)
there should##15##2##(1990-12#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-6#1)(1995-2#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2012-12#1)
there still exists##2##3##(1991-8#1)(2008-8#1)
there still remain many##2##4##(2008-4#1)(2012-3#1)
there still remain##3##3##(2005-1#1)(2008-4#1)(2012-3#1)
there still remains##2##3##(2006-12#1)(2012-2#1)
there still##11##2##(1991-8#1)(1996-1#1)(2005-1#1)(2006-12#1)(2007-8#1)(2008-4#1)(2008-6#1)(2008-8#1)(2011-12#1)(2012-2#1)(2012-3#1)
there such a##2##3##(1990-11#1)(2007-11#1)
there to be a##3##4##(2006-10#1)(2006-8#1)(2008-10#1)
there to be##4##3##(2006-10#1)(2006-8#1)(2008-10#1)(2008-8#1)
there to##8##2##(1992-9#1)(1996-6#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)
there was a 'post-stimulus##2##4##(1997-6#2)
there was a 12%##2##4##(2012-1#1)(2013-1#1)
there was a 3##2##4##(1997-6#1)(2013-1#1)
there was a 33%##2##4##(2008-3#1)(2013-8#1)
there was a 40%##2##4##(1991-2#1)(1996-5#1)
there was a bilateral##2##4##(1994-5#2)
there was a clear##2##4##(1991-2#1)(2012-1#1)
there was a close##3##4##(1992-11#1)(1993-1#1)(2008-5#1)
there was a concentration##2##4##(1990-11#1)(2013-1#1)
there was a concern##2##4##(2007-3#1)(2011-1#1)
there was a concomitant reduction in the##2##7##(1990-12#1)(1997-2#1)
there was a consistent##2##4##(1991-5#1)(2008-10#1)
there was a corresponding##2##4##(2007-8#1)(2008-11#1)
there was a decline in##2##5##(1990-12#1)(1992-12#1)
there was a decrease in the##2##6##(1991-8#1)(1991-9#1)
there was a decrease in##9##5##(1991-12#1)(1991-8#1)(1991-9#1)(1993-12#1)(1995-12#1)(2006-9#1)(2008-5#1)(2009-10#1)(2010-4#1)
there was a decrease of##2##5##(1990-7#1)(2008-1#1)
there was a decrease##13##4##(1990-7#1)(1991-12#1)(1991-8#1)(1991-9#1)(1993-12#1)(1995-12#1)(1997-5#1)(2006-9#1)(2008-1#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-4#1)
there was a delay in the##2##6##(2006-8#1)(2008-10#1)
there was a delay##4##4##(2006-8#1)(2008-10#1)(2012-2#1)(2012-6#1)
there was a difference in##3##5##(1990-12#1)(2007-8#1)(2011-12#1)
there was a difference##4##4##(1990-12#1)(2007-8#1)(2011-1#1)(2011-12#1)
there was a direct relationship between##2##6##(2008-10#2)
there was a dose-dependent reduction##2##5##(1992-12#1)(1995-12#1)
there was a dose-dependent##3##4##(1992-12#1)(1995-12#1)(1995-7#1)
there was a fall in##2##5##(1997-1#1)(2008-7#1)
there was a further##2##4##(1990-11#1)(1997-5#1)
there was a general##3##4##(2008-10#1)(2011-1#1)(2012-3#1)
there was a good agreement between the two##2##8##(2007-8#1)(2008-10#1)
there was a good correlation between the##2##7##(1990-7#1)(2008-5#1)
there was a good correlation between##3##6##(1990-7#1)(1996-5#1)(2008-5#1)
there was a good##5##4##(1990-7#1)(1996-5#1)(2007-8#1)(2008-10#1)(2008-5#1)
there was a graded reduction in the rate of##2##9##(2008-5#2)
there was a gradual decrease in##2##6##(1990-11#1)(2008-11#1)
there was a greater##3##4##(1995-1#1)(1997-6#1)(2008-11#1)
there was a high incidence of##2##6##(1994-12#1)(2005-12#1)
there was a high prevalence of##2##6##(2008-12#1)(2013-1#1)
there was a high probability that the##2##7##(1990-5#1)(2007-2#1)
there was a high rate of##2##6##(1992-10#1)(2008-6#1)
there was a high##9##4##(1990-5#1)(1992-10#1)(1994-12#1)(2005-12#1)(2007-2#1)(2008-12#1)(2008-5#1)(2008-6#1)(2013-1#1)
there was a higher frequency of##2##6##(2008-7#1)(2013-7#1)
there was a higher incidence of##2##6##(1990-6#1)(2008-9#1)
there was a higher##9##4##(1990-6#1)(1991-11#1)(1992-4#1)(1993-11#1)(2008-7#1)(2008-9#1)(2009-6#1)(2012-3#1)(2013-7#1)
there was a lack of##3##5##(1997-7#1)(2008-10#1)(2012-2#1)
there was a large##4##4##(1994-2#1)(2005-7#1)(2008-7#1)(2009-12#1)
there was a linear relationship between##2##6##(2007-2#1)(2008-10#1)
there was a linear##4##4##(1996-5#1)(2007-2#1)(2008-10#1)(2008-12#1)
there was a little difference in##2##6##(2008-11#1)(2013-8#1)
there was a low##4##4##(1990-2#1)(1990-7#1)(2007-10#1)(2009-4#1)
there was a marked reduction in##2##6##(1994-4#1)(2007-12#1)
there was a marked reduction##3##5##(1994-4#1)(1997-5#1)(2007-12#1)
there was a marked##7##4##(1994-4#1)(1995-7#1)(1997-1#1)(1997-5#1)(2007-12#1)(2008-11#1)(2008-6#1)
there was a mild##2##4##(1990-11#1)(2012-2#1)
there was a much greater##2##5##(1995-12#1)(2008-5#1)
there was a negative correlation between##2##6##(1993-7#1)(1997-8#1)
there was a negative correlation##4##5##(1993-7#1)(1997-8#1)(2006-3#1)(2008-10#1)
there was a permanent##2##4##(2008-11#1)(2008-9#1)
there was a poor##2##4##(2010-11#1)(2011-1#1)
there was a positive correlation between the##2##7##(1990-10#1)(2006-5#1)
there was a positive correlation of##2##6##(2006-9#1)(2008-10#1)
there was a positive correlation##5##5##(1990-10#1)(1993-12#1)(2006-5#1)(2006-9#1)(2008-10#1)
there was a positive##7##4##(1990-10#1)(1993-12#1)(1996-3#1)(2006-5#1)(2006-9#2)(2008-10#1)
there was a possible relationship between##2##6##(2004-1#1)(2008-9#1)
there was a progressive##3##4##(1992-8#1)(2006-12#1)(2010-10#1)
there was a rapid##5##4##(1993-12#1)(1993-4#1)(1993-6#1)(1995-4#1)(2006-5#1)
there was a reduction in the##2##6##(1992-10#1)(2011-1#1)
there was a reduction in##6##5##(1990-5#1)(1992-10#1)(2004-2#1)(2011-1#1)(2012-1#1)(2013-8#1)
there was a reduction of##2##5##(2008-10#1)(2013-1#1)
there was a reduction##8##4##(1990-5#1)(1992-10#1)(2004-2#1)(2008-10#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
there was a relative##2##4##(1991-9#1)(2012-12#1)
there was a sharp##3##4##(1991-3#1)(1992-8#1)(1997-1#1)
there was a shift##3##4##(1990-4#1)(1991-12#1)(2008-1#1)
there was a significant (P &lt##3##6##(2008-1#1)(2009-5#2)
there was a significant association with##2##6##(2008-12#1)(2013-1#1)
there was a significant association##3##5##(2008-12#1)(2012-12#1)(2013-1#1)
there was a significant correlation between##2##6##(2007-10#1)(2008-6#1)
there was a significant correlation##3##5##(2007-10#1)(2008-6#1)(2013-1#1)
there was a significant decrease in the##7##7##(1990-8#1)(1991-1#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-8#1)(2013-8#1)
there was a significant decrease in##13##6##(1990-8#1)(1991-1#1)(1995-1#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#2)
there was a significant decrease##16##5##(1990-4#1)(1990-8#1)(1991-1#1)(1995-1#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-8#2)(2009-5#1)(2011-2#1)(2012-2#1)(2013-8#2)
there was a significant difference between the##2##7##(2007-7#1)(2009-8#1)
there was a significant difference between##3##6##(1995-5#1)(2007-7#1)(2009-8#1)
there was a significant difference in##2##6##(2006-10#1)(2006-12#1)
there was a significant difference##6##5##(1995-5#1)(2006-10#1)(2006-12#1)(2007-7#1)(2009-8#1)(2012-12#1)
there was a significant effect##2##5##(1996-12#1)(2008-12#1)
there was a significant improvement in##4##6##(1991-2#1)(1995-6#1)(2007-12#1)(2008-10#1)
there was a significant improvement##5##5##(1991-2#1)(1995-6#1)(2006-6#1)(2007-12#1)(2008-10#1)
there was a significant increase (P &lt##3##7##(1994-7#1)(1997-5#1)(2009-5#1)
there was a significant increase in the##6##7##(1994-5#1)(1997-8#1)(2006-4#1)(2007-8#1)(2008-1#1)(2013-8#1)
there was a significant increase in##18##6##(1991-1#1)(1994-5#1)(1996-9#1)(1997-8#1)(2006-4#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
there was a significant increase of##2##6##(1995-8#1)(2012-2#1)
there was a significant increase##24##5##(1991-1#1)(1994-5#1)(1994-7#1)(1995-8#1)(1996-9#1)(1997-5#1)(1997-8#1)(2006-4#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#3)(2009-5#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
there was a significant inverse correlation between##2##7##(1995-8#1)(1997-8#1)
there was a significant linear relationship between the##2##8##(1992-4#1)(2011-2#1)
there was a significant linear##3##5##(1992-4#1)(1996-5#1)(2011-2#1)
there was a significant positive##2##5##(2007-7#1)(2008-10#1)
there was a significant reduction in the##4##7##(1993-12#1)(1996-1#1)(2007-5#1)(2008-10#1)
there was a significant reduction in##7##6##(1993-1#1)(1993-12#1)(1995-12#1)(1996-1#1)(2007-5#1)(2008-10#1)(2008-5#1)
there was a significant reduction##8##5##(1993-1#1)(1993-12#1)(1995-12#1)(1996-1#1)(1996-12#1)(2007-5#1)(2008-10#1)(2008-5#1)
there was a significant##93##4##(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-2#1)(1991-7#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-12#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#2)(1996-5#1)(1996-9#2)(1997-5#1)(1997-8#2)(2006-10#2)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#9)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#2)(2009-5#4)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#4)(2013-8#3)
there was a significantly##2##4##(1996-12#1)(2010-7#1)
there was a similar##3##4##(1994-8#1)(1995-9#1)(2008-7#1)
there was a single##3##4##(1997-4#1)(2007-8#1)(2008-9#1)
there was a slight##2##4##(2007-2#1)(2008-10#1)
there was a small but##2##5##(1992-2#1)(2008-9#1)
there was a small##5##4##(1992-2#1)(1992-7#1)(1993-2#1)(2008-9#1)(2012-1#1)
there was a statistical difference##2##5##(2006-6#1)(2007-6#1)
there was a statistical##3##4##(2006-6#1)(2007-6#1)(2008-3#1)
there was a statistically significant difference between the##2##8##(2007-6#1)(2009-8#1)
there was a statistically significant difference between##3##7##(2007-12#1)(2007-6#1)(2009-8#1)
there was a statistically significant difference in the##2##8##(1993-2#1)(2013-8#1)
there was a statistically significant difference in##3##7##(1993-2#1)(2007-11#1)(2013-8#1)
there was a statistically significant difference##6##6##(1993-2#1)(2007-11#1)(2007-12#1)(2007-6#1)(2009-8#1)(2013-8#1)
there was a statistically significant reduction in##2##7##(2007-8#2)
there was a statistically significant##14##5##(1990-7#1)(1993-10#1)(1993-2#1)(2004-1#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#2)(2009-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
there was a strong correlation between the##2##7##(1990-11#1)(1991-6#1)
there was a strong correlation between##3##6##(1990-11#1)(1990-8#1)(1991-6#1)
there was a strong correlation##6##5##(1990-11#1)(1990-8#1)(1991-6#1)(1994-8#1)(1995-12#1)(2008-10#1)
there was a strong##10##4##(1990-11#1)(1990-8#1)(1991-6#1)(1994-8#2)(1995-12#1)(1995-6#1)(2008-10#1)(2008-9#1)(2010-6#1)
there was a substantial##2##4##(1991-6#1)(1992-2#1)
there was a tendency for##3##5##(1991-2#1)(1995-7#1)(2007-12#1)
there was a tendency##6##4##(1991-2#1)(1993-3#1)(1995-7#1)(2007-12#1)(2008-11#1)(2008-3#1)
there was a time##2##4##(2006-12#1)(2009-10#1)
there was a time-dependent##2##4##(1990-11#1)(1996-12#1)
there was a trend for##2##5##(1992-11#1)(2005-10#1)
there was a trend toward##5##5##(1995-2#1)(2008-10#1)(2009-2#1)(2009-3#1)(2011-2#1)
there was a trend towards##4##5##(2005-1#1)(2008-5#1)(2008-6#1)(2009-3#1)
there was a trend##13##4##(1992-11#1)(1992-5#1)(1995-2#1)(1996-6#1)(2005-1#1)(2005-10#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-2#1)(2009-3#2)(2011-2#1)
there was a wide##4##4##(1997-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
there was a##436##3##(1990-10#1)(1990-11#7)(1990-12#5)(1990-2#2)(1990-3#1)(1990-4#3)(1990-5#4)(1990-6#1)(1990-7#5)(1990-8#2)(1990-9#2)(1991-1#2)(1991-11#2)(1991-12#3)(1991-2#4)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#2)(1992-2#3)(1992-4#3)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#6)(1993-2#2)(1993-3#3)(1993-4#1)(1993-6#1)(1993-7#2)(1993-9#2)(1994-12#1)(1994-2#2)(1994-4#1)(1994-5#3)(1994-7#1)(1994-8#4)(1995-1#2)(1995-11#1)(1995-12#5)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#4)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-3#1)(1996-5#5)(1996-6#1)(1996-7#1)(1996-9#4)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#5)(1997-6#4)(1997-7#1)(1997-8#3)(2004-1#2)(2004-2#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-4#1)(2005-7#2)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#3)(2006-8#3)(2006-9#5)(2007-10#3)(2007-11#3)(2007-12#5)(2007-2#4)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#8)(2008-1#5)(2008-10#29)(2008-11#9)(2008-12#6)(2008-3#6)(2008-4#3)(2008-5#15)(2008-6#4)(2008-7#7)(2008-8#5)(2008-9#8)(2009-10#2)(2009-12#1)(2009-2#3)(2009-3#4)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-3#2)(2010-4#2)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#11)(2011-3#1)(2012-1#6)(2012-12#6)(2012-2#11)(2012-3#5)(2012-6#1)(2013-1#12)(2013-7#1)(2013-8#9)
there was agreement##2##3##(2009-10#1)(2011-10#1)
there was also a##5##4##(1991-12#1)(1994-8#1)(1997-1#1)(1997-3#1)(2007-1#1)
there was also an##2##4##(2006-8#1)(2008-3#1)
there was also evidence##2##4##(1991-8#1)(2008-11#1)
there was also##12##3##(1990-7#2)(1991-12#1)(1991-8#1)(1994-8#1)(1997-1#1)(1997-3#1)(2006-8#1)(2007-1#1)(2007-2#1)(2008-11#1)(2008-3#1)
there was an association##2##4##(2007-5#1)(2008-10#1)
there was an effect of##2##5##(1991-3#1)(1996-5#1)
there was an excellent##2##4##(1992-2#1)(2010-11#1)
there was an improvement in##3##5##(2008-5#2)(2008-7#1)
there was an improvement##4##4##(2008-5#3)(2008-7#1)
there was an increase in the##8##6##(1992-2#1)(1994-11#1)(1996-10#1)(2007-12#1)(2008-11#1)(2008-9#1)(2010-7#1)(2013-8#1)
there was an increase in##12##5##(1992-12#1)(1992-2#1)(1994-11#1)(1996-10#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-7#1)(2011-2#1)(2013-8#1)
there was an increased##2##4##(1996-2#1)(2007-10#1)
there was an increasing##2##4##(2008-10#1)(2008-7#1)
there was an induction##2##4##(1997-8#1)(2009-8#1)
there was an overall##2##4##(2007-11#1)(2007-8#1)
there was an##64##3##(1990-2#1)(1990-9#1)(1991-3#1)(1992-12#1)(1992-2#2)(1992-4#1)(1993-10#1)(1993-9#1)(1994-11#1)(1994-8#1)(1994-9#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-8#1)(2006-8#3)(2007-10#2)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#2)(2008-10#7)(2008-11#2)(2008-5#4)(2008-7#2)(2008-9#2)(2009-3#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
there was any##5##3##(1995-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)
there was clear evidence of carcinogenic activity of##2##8##(2008-9#2)
there was clear evidence of##3##5##(2008-6#1)(2008-9#2)
there was clear evidence##4##4##(1993-3#1)(2008-6#1)(2008-9#2)
there was clearly##2##3##(2008-10#1)(2012-12#1)
there was complete##3##3##(1996-4#1)(2005-12#1)(2008-5#1)
there was considerable heterogeneity##2##4##(1993-3#1)(2008-4#1)
there was considerable variation in##2##5##(2006-8#1)(2008-10#1)
there was considerable##7##3##(1993-3#1)(2004-2#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-2#1)
there was diffuse##2##3##(1992-11#1)(2007-7#1)
there was evidence of##10##4##(1992-5#1)(1993-12#1)(1994-3#1)(1995-5#1)(2004-4#1)(2005-7#1)(2006-8#2)(2007-10#1)(2008-4#1)
there was evidence##12##3##(1992-5#1)(1993-12#1)(1994-3#1)(1995-5#1)(2004-4#1)(2005-10#1)(2005-7#1)(2006-8#2)(2007-10#1)(2008-4#1)(2013-1#1)
there was full##2##3##(2007-7#1)(2008-3#1)
there was genetic##2##3##(2007-10#1)(2008-9#1)
there was good##5##3##(1991-7#1)(1992-3#1)(2007-7#1)(2011-1#1)(2012-3#1)
there was gradual##2##3##(2008-10#1)(2011-2#1)
there was great##2##3##(1994-3#1)(2009-7#1)
there was greater##3##3##(2007-7#1)(2008-10#2)
there was highly significant improvement##2##5##(2008-5#1)(2011-2#1)
there was improvement##2##3##(2008-3#1)(2008-4#1)
there was increased##4##3##(1994-12#1)(2008-11#1)(2010-12#1)(2011-2#1)
there was insufficient##4##3##(1993-8#1)(2006-12#1)(2006-2#1)(2007-1#1)
there was less variation##2##4##(2008-10#1)(2013-1#1)
there was less##11##3##(1991-4#1)(1994-10#1)(2007-4#1)(2007-8#2)(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#2)(2013-8#1)
there was limited##2##3##(1996-8#1)(2006-8#1)
there was little difference in##2##5##(1994-8#1)(2010-8#1)
there was little difference##3##4##(1992-9#1)(1994-8#1)(2010-8#1)
there was little evidence##4##4##(1990-12#1)(2004-11#1)(2008-5#1)(2012-2#1)
there was little increase in##2##5##(1996-11#1)(2008-5#1)
there was little or no##4##5##(1994-12#1)(1997-2#1)(2007-12#1)(2008-6#1)
there was little##27##3##(1990-11#1)(1990-12#1)(1992-9#1)(1994-12#1)(1994-8#1)(1995-8#1)(1996-11#1)(1997-2#1)(2004-11#1)(2005-8#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)
there was marked##3##3##(1996-11#1)(2005-7#1)(2008-7#1)
there was minimal##4##3##(1993-12#1)(1995-3#1)(2008-11#1)(2010-6#1)
there was moderate##2##3##(1994-3#1)(2012-12#1)
there was more##3##3##(1993-6#1)(1994-9#1)(2010-5#1)
there was negative##2##3##(1993-12#1)(2008-5#1)
there was neither##2##3##(1990-10#1)(2012-2#1)
there was no association of##2##5##(2010-8#1)(2011-1#1)
there was no association with##2##5##(1991-9#1)(2008-12#1)
there was no association##5##4##(1991-9#1)(1995-11#1)(2008-12#1)(2010-8#1)(2011-1#1)
there was no change in the##10##6##(1990-5#1)(1991-2#1)(1991-6#1)(1991-8#1)(1994-12#1)(1995-12#1)(1996-12#1)(2006-10#1)(2007-11#1)(2008-3#1)
there was no change in##16##5##(1990-5#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-1#1)(1993-2#1)(1994-12#1)(1995-12#1)(1995-6#1)(1996-12#2)(2006-10#1)(2007-11#1)(2008-3#1)(2013-8#2)
there was no change##17##4##(1990-5#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-1#1)(1993-2#1)(1994-12#1)(1995-12#1)(1995-6#1)(1996-12#2)(2006-10#1)(2007-11#1)(2008-3#1)(2012-3#1)(2013-8#2)
there was no clear##5##4##(1992-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2011-1#1)
there was no conversion##2##4##(2007-8#1)(2008-10#1)
there was no correlation between the##4##6##(1996-1#1)(2012-2#3)
there was no correlation between##13##5##(1990-12#1)(1990-9#1)(1993-2#1)(1995-11#1)(1996-1#1)(1996-3#1)(1997-2#1)(2008-1#1)(2011-2#2)(2012-2#3)
there was no correlation with##2##5##(2008-6#1)(2013-1#1)
there was no correlation##18##4##(1990-12#1)(1990-9#1)(1993-2#1)(1995-11#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-2#1)(2008-1#1)(2008-5#1)(2008-6#1)(2011-2#3)(2012-2#3)(2013-1#1)
there was no corresponding increase in##2##6##(1994-3#1)(1996-2#1)
there was no detectable##2##4##(1991-10#1)(1994-11#1)
there was no difference between patients##2##6##(1993-12#1)(2006-8#1)
there was no difference between the two##3##7##(1995-2#1)(2007-8#1)(2008-5#1)
there was no difference between the##7##6##(1990-2#1)(1990-5#1)(1990-7#1)(1995-2#1)(2007-10#1)(2007-8#1)(2008-5#1)
there was no difference between##11##5##(1990-2#1)(1990-5#1)(1990-7#1)(1993-12#1)(1995-2#1)(2006-8#1)(2007-10#2)(2007-8#2)(2008-5#1)
there was no difference in the##7##6##(1990-7#1)(1992-6#1)(1993-3#1)(2008-12#1)(2008-8#1)(2009-11#1)(2013-8#1)
there was no difference in##20##5##(1990-7#1)(1991-3#1)(1992-6#1)(1993-3#1)(1994-12#1)(1996-6#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
there was no difference##33##4##(1990-2#1)(1990-5#1)(1990-7#2)(1991-3#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-2#1)(1996-6#1)(1997-3#1)(2006-8#1)(2007-10#2)(2007-8#2)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
there was no effect on the##2##6##(1995-3#1)(2008-5#1)
there was no effect on##3##5##(1995-2#1)(1995-3#1)(2008-5#1)
there was no effect##6##4##(1990-5#1)(1993-4#1)(1995-2#1)(1995-3#1)(2008-10#1)(2008-5#1)
there was no evidence for a##2##6##(2009-5#1)(2013-1#1)
there was no evidence for##7##5##(1990-3#1)(1992-12#1)(1992-9#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
there was no evidence of a significant difference in the##2##10##(1996-7#1)(2013-1#1)
there was no evidence of carcinogenic activity of##5##8##(2008-8#1)(2008-9#4)
there was no evidence of carcinogenic##6##6##(2008-8#1)(2008-9#5)
there was no evidence of##29##5##(1990-3#1)(1991-1#1)(1991-6#1)(1992-2#1)(1993-7#1)(1994-3#1)(1996-7#1)(1996-8#1)(1997-2#1)(2006-5#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#6)(2010-9#1)(2013-1#2)(2013-8#2)
there was no evidence that##3##5##(1994-5#1)(1996-3#1)(2008-9#1)
there was no evidence##41##4##(1990-3#2)(1991-1#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-7#1)(1994-3#1)(1994-5#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-2#1)(2006-5#1)(2007-6#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#7)(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#2)
there was no further##2##4##(1997-1#1)(2008-5#1)
there was no improvement##2##4##(2006-8#1)(2009-8#1)
there was no increase in##3##5##(1991-3#1)(1995-11#1)(2006-7#1)
there was no increase##4##4##(1990-7#1)(1991-3#1)(1995-11#1)(2006-7#1)
there was no indication of##2##5##(1990-5#1)(2008-10#1)
there was no interference##2##4##(2008-10#2)
there was no mortality##2##4##(1997-8#1)(2008-7#1)
there was no need to start##2##6##(1992-2#1)(2007-11#1)
there was no need to##3##5##(1992-2#1)(2006-5#1)(2007-11#1)
there was no other##2##4##(2008-7#1)(2009-9#1)
there was no recurrence of##4##5##(2006-8#1)(2007-11#2)(2008-4#1)
there was no recurrence##9##4##(2004-10#1)(2006-8#1)(2007-11#2)(2008-12#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
there was no reduction in##2##5##(2008-1#1)(2008-10#1)
there was no reduction of##2##5##(1992-12#1)(1996-12#1)
there was no reduction##4##4##(1992-12#1)(1996-12#1)(2008-1#1)(2008-10#1)
there was no relation##2##4##(1995-8#1)(2008-11#1)
there was no relationship between the##3##6##(1991-11#1)(2008-12#1)(2008-8#1)
there was no relationship between##9##5##(1991-11#1)(1994-6#1)(2005-7#1)(2006-7#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-8#1)
there was no significant change in the##2##7##(1997-1#1)(2006-10#1)
there was no significant change in##7##6##(1990-12#1)(1992-8#1)(1993-3#1)(1997-1#1)(2006-10#1)(2011-2#1)(2013-1#1)
there was no significant change##8##5##(1990-12#1)(1992-8#1)(1993-3#1)(1997-1#1)(2006-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
there was no significant correlation between##3##6##(2006-12#1)(2007-10#1)(2008-10#1)
there was no significant correlation with the##2##7##(2006-6#1)(2007-8#1)
there was no significant correlation##5##5##(2006-12#1)(2006-6#1)(2007-10#1)(2007-8#1)(2008-10#1)
there was no significant difference among##2##6##(2008-10#1)(2013-1#1)
there was no significant difference between the two groups##2##9##(1992-12#1)(2007-9#1)
there was no significant difference between the two##3##8##(1991-6#1)(1992-12#1)(2007-9#1)
there was no significant difference between the##10##7##(1991-6#1)(1992-12#1)(1996-10#1)(1997-8#1)(2005-8#1)(2007-9#2)(2008-10#1)(2008-9#1)(2011-2#1)
there was no significant difference between them##2##7##(2011-1#1)(2013-7#1)
there was no significant difference between##24##6##(1990-5#1)(1991-10#1)(1991-6#1)(1991-8#2)(1992-12#1)(1993-10#1)(1994-4#1)(1996-10#1)(1997-2#1)(1997-8#1)(2005-8#1)(2007-9#2)(2008-10#2)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#2)(2013-7#2)(2013-8#1)
there was no significant difference in the number of##2##9##(1996-6#1)(2011-2#1)
there was no significant difference in the##12##7##(1990-7#1)(1991-8#1)(1996-6#1)(2007-3#1)(2007-7#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
there was no significant difference in##33##6##(1990-7#1)(1991-10#1)(1991-8#1)(1992-9#1)(1994-2#1)(1994-3#1)(1996-6#1)(1997-8#1)(2006-11#1)(2007-11#1)(2007-3#1)(2007-7#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-5#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-3#2)(2013-1#1)
there was no significant difference of##2##6##(2007-2#1)(2011-2#1)
there was no significant difference##67##5##(1990-5#1)(1990-7#1)(1991-10#2)(1991-6#1)(1991-8#3)(1992-12#1)(1992-9#1)(1993-10#1)(1994-2#1)(1994-3#1)(1994-4#1)(1996-10#1)(1996-6#1)(1997-2#1)(1997-8#3)(2005-8#1)(2006-11#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-9#2)(2008-10#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-2#1)(2009-5#1)(2010-8#2)(2011-1#5)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
there was no significant improvement##2##5##(1993-3#1)(2005-9#1)
there was no significant increase in##3##6##(1990-3#1)(1997-6#1)(2008-2#1)
there was no significant increase##4##5##(1990-3#1)(1997-6#1)(2008-11#1)(2008-2#1)
there was no significant interaction between##2##6##(2007-12#1)(2008-10#1)
there was no significant interaction##3##5##(2007-12#1)(2008-10#2)
there was no significant loss of##2##6##(1996-12#1)(2008-11#1)
there was no significant relationship between##2##6##(2006-1#1)(2007-5#1)
there was no significant relationship##3##5##(2006-1#1)(2007-5#1)(2008-10#1)
there was no significant##108##4##(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-10#2)(1991-6#1)(1991-8#3)(1992-12#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-3#2)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1995-12#1)(1995-8#2)(1996-10#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#3)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-2#1)(2009-5#1)(2010-8#2)(2011-1#6)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#1)
there was no statistical difference between##3##6##(1996-6#1)(2008-10#1)(2013-1#1)
there was no statistical difference##4##5##(1991-5#1)(1996-6#1)(2008-10#1)(2013-1#1)
there was no statistical##5##4##(1991-5#1)(1996-6#1)(2008-10#1)(2008-11#1)(2013-1#1)
there was no statistically significant difference in the##3##8##(1993-3#1)(2006-10#1)(2008-11#1)
there was no statistically significant difference in##6##7##(1993-3#1)(1994-2#1)(1996-6#1)(2006-10#1)(2008-11#1)(2008-12#1)
there was no statistically significant difference##9##6##(1993-3#1)(1994-2#1)(1996-6#1)(2006-10#1)(2006-9#1)(2008-11#1)(2008-12#1)(2009-12#1)(2011-1#1)
there was no statistically##10##4##(1993-3#1)(1994-2#1)(1996-6#1)(2006-10#1)(2006-9#1)(2007-8#1)(2008-11#1)(2008-12#1)(2009-12#1)(2011-1#1)
there was no##416##3##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#6)(1990-7#4)(1990-9#1)(1991-1#1)(1991-10#4)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#4)(1991-8#4)(1991-9#2)(1992-1#1)(1992-12#5)(1992-2#3)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#3)(1993-10#1)(1993-12#1)(1993-2#3)(1993-3#4)(1993-4#2)(1993-7#2)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#4)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-11#3)(1995-12#2)(1995-2#4)(1995-3#1)(1995-6#1)(1995-8#3)(1996-1#1)(1996-10#1)(1996-12#4)(1996-2#3)(1996-3#5)(1996-5#1)(1996-6#4)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#1)(1997-6#2)(1997-8#5)(2004-10#1)(2005-11#1)(2005-12#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#3)(2006-6#2)(2006-7#2)(2006-8#5)(2006-9#1)(2007-10#6)(2007-11#7)(2007-12#1)(2007-2#4)(2007-3#2)(2007-5#2)(2007-6#2)(2007-7#6)(2007-8#10)(2007-9#3)(2008-1#3)(2008-10#40)(2008-11#9)(2008-12#6)(2008-2#3)(2008-3#2)(2008-4#5)(2008-5#12)(2008-6#3)(2008-7#8)(2008-8#4)(2008-9#14)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#3)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#6)(2010-9#1)(2011-1#11)(2011-2#16)(2012-1#1)(2012-12#6)(2012-2#7)(2012-3#5)(2013-1#14)(2013-7#4)(2013-8#8)
there was not a##4##4##(1990-1#1)(2008-10#1)(2008-12#1)(2008-7#1)
there was not##7##3##(1990-1#1)(2007-3#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-7#1)(2013-1#1)
there was one case of##2##5##(2006-8#2)
there was one##6##3##(1995-11#1)(2006-7#1)(2006-8#2)(2008-10#2)
there was only a##2##4##(1997-1#1)(2011-2#1)
there was only one##3##4##(1993-8#1)(1996-5#1)(1997-2#1)
there was only##9##3##(1993-8#2)(1994-8#1)(1996-5#1)(1997-1#1)(1997-2#2)(2008-10#1)(2011-2#1)
there was positive##2##3##(2008-8#1)(2011-1#1)
there was reduced##2##3##(2008-7#1)(2010-8#1)
there was significant correlation of##2##5##(2006-8#1)(2008-10#1)
there was significant pain##2##4##(2007-2#1)(2012-2#1)
there was significant##17##3##(1991-3#1)(1991-8#1)(1992-6#1)(1996-5#1)(2006-8#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-9#2)(2009-4#1)(2009-7#1)(2010-4#2)(2012-2#1)(2013-1#1)
there was some evidence of##4##5##(1991-9#1)(2007-9#1)(2008-10#1)(2010-8#1)
there was some evidence##6##4##(1991-9#1)(1992-1#1)(1994-3#1)(2007-9#1)(2008-10#1)(2010-8#1)
there was some##18##3##(1991-12#1)(1991-9#1)(1992-1#1)(1994-3#1)(1995-12#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
there was still##2##3##(2008-6#1)(2011-1#1)
there was strong evidence##2##4##(2006-8#1)(2012-12#1)
there was strong##4##3##(1997-4#1)(2006-8#1)(2012-12#1)(2012-3#1)
there was the##2##3##(1996-2#1)(2010-3#1)
there was variability##2##3##(2008-10#1)(2013-1#1)
there was very##2##3##(1994-8#1)(2008-2#1)
there was##1269##2##(1990-1#1)(1990-10#4)(1990-11#8)(1990-12#9)(1990-2#4)(1990-3#4)(1990-4#4)(1990-5#10)(1990-6#1)(1990-7#11)(1990-8#3)(1990-9#4)(1991-1#4)(1991-10#4)(1991-11#3)(1991-12#7)(1991-2#6)(1991-3#5)(1991-4#1)(1991-5#2)(1991-6#6)(1991-7#4)(1991-8#9)(1991-9#5)(1992-1#3)(1992-10#3)(1992-11#4)(1992-12#8)(1992-2#9)(1992-3#3)(1992-4#4)(1992-5#2)(1992-6#3)(1992-7#3)(1992-8#4)(1992-9#5)(1993-1#2)(1993-10#4)(1993-11#1)(1993-12#11)(1993-2#5)(1993-3#9)(1993-4#3)(1993-5#1)(1993-6#2)(1993-7#4)(1993-8#7)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#6)(1994-2#4)(1994-3#10)(1994-4#2)(1994-5#4)(1994-6#1)(1994-7#2)(1994-8#11)(1994-9#3)(1995-1#2)(1995-11#5)(1995-12#9)(1995-2#7)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#3)(1995-7#4)(1995-8#8)(1995-9#1)(1996-1#2)(1996-10#2)(1996-11#4)(1996-12#9)(1996-2#5)(1996-3#7)(1996-4#2)(1996-5#9)(1996-6#6)(1996-7#2)(1996-8#4)(1996-9#6)(1997-1#7)(1997-2#11)(1997-3#4)(1997-4#3)(1997-5#6)(1997-6#6)(1997-7#2)(1997-8#9)(2004-1#2)(2004-10#2)(2004-11#1)(2004-2#2)(2004-4#1)(2005-1#1)(2005-10#2)(2005-11#4)(2005-12#3)(2005-4#1)(2005-7#9)(2005-8#5)(2005-9#1)(2006-1#1)(2006-10#11)(2006-11#2)(2006-12#6)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#8)(2006-6#5)(2006-7#4)(2006-8#22)(2006-9#6)(2007-1#2)(2007-10#16)(2007-11#18)(2007-12#9)(2007-2#11)(2007-3#6)(2007-4#2)(2007-5#5)(2007-6#6)(2007-7#21)(2007-8#24)(2007-9#5)(2008-1#9)(2008-10#114)(2008-11#34)(2008-12#15)(2008-2#4)(2008-3#14)(2008-4#13)(2008-5#44)(2008-6#15)(2008-7#21)(2008-8#13)(2008-9#34)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#4)(2009-3#6)(2009-4#4)(2009-5#7)(2009-6#1)(2009-7#6)(2009-8#5)(2009-9#5)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#2)(2010-3#4)(2010-4#5)(2010-5#3)(2010-6#5)(2010-7#2)(2010-8#13)(2010-9#2)(2011-1#24)(2011-10#1)(2011-12#1)(2011-2#37)(2011-3#1)(2012-1#9)(2012-12#19)(2012-2#26)(2012-3#15)(2012-6#1)(2013-1#39)(2013-7#5)(2013-8#21)
there were 10##2##3##(2006-8#1)(2010-2#1)
there were 11##2##3##(2007-8#1)(2008-10#1)
there were 12##3##3##(1990-6#1)(2007-7#1)(2012-11#1)
there were 2##5##3##(1990-12#1)(1993-2#1)(2008-6#1)(2011-2#1)(2013-8#1)
there were 20##2##3##(1993-11#1)(2005-11#1)
there were 21##2##3##(2006-10#1)(2013-8#1)
there were 3##6##3##(1990-3#1)(2007-7#1)(2010-11#1)(2011-2#2)(2012-12#1)
there were 36##2##3##(2006-6#1)(2012-2#1)
there were 39##2##3##(1993-9#1)(2008-1#1)
there were 4##3##3##(2007-1#1)(2008-9#1)(2010-12#1)
there were 5##2##3##(1993-6#1)(1997-1#1)
there were 56##2##3##(2007-8#1)(2013-8#1)
there were 65##2##3##(2007-2#2)
there were 7##2##3##(1993-6#1)(2008-6#1)
there were a large number of##2##6##(1995-7#1)(2008-5#1)
there were a##8##3##(1995-7#1)(1995-8#1)(2005-8#1)(2008-5#2)(2008-9#2)(2012-12#1)
there were almost##2##3##(1994-9#1)(2007-3#1)
there were also##5##3##(1993-9#1)(1994-10#1)(1995-7#1)(2008-5#1)(2009-5#1)
there were any##3##3##(1994-12#1)(2008-11#1)(2008-9#1)
there were approximately##2##3##(1995-2#1)(2009-9#1)
there were differences in the##4##5##(1990-2#1)(1991-7#1)(1996-2#1)(2008-10#1)
there were differences in##7##4##(1990-2#1)(1991-7#1)(1996-2#1)(2008-10#1)(2013-1#2)(2013-7#1)
there were differences##8##3##(1990-2#1)(1991-7#1)(1996-2#1)(2008-10#1)(2010-3#1)(2013-1#2)(2013-7#1)
there were different##2##3##(1992-8#1)(2008-8#1)
there were eight##2##3##(1992-2#1)(1997-3#1)
there were few significant##2##4##(2004-4#1)(2012-2#1)
there were few##7##3##(1995-3#1)(2004-4#1)(2006-7#1)(2008-10#1)(2008-2#1)(2010-2#1)(2012-2#1)
there were fewer##2##3##(2008-10#2)
there were five##4##3##(1990-4#1)(1994-12#1)(2007-7#1)(2008-10#1)
there were four##6##3##(2006-10#1)(2006-12#1)(2006-7#1)(2007-11#1)(2008-10#2)
there were high##2##3##(1990-12#1)(1996-12#1)
there were increased incidences of##2##5##(2008-9#2)
there were insufficient##2##3##(1995-10#1)(2011-12#1)
there were less##2##3##(2007-11#1)(2008-10#1)
there were little##2##3##(1994-11#1)(1997-7#1)
there were many instances##2##4##(2008-10#1)(2008-7#1)
there were many##9##3##(1997-6#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-8#1)(2012-3#2)
there were mononuclear##2##3##(1997-3#1)(2008-5#1)
there were more##7##3##(2004-1#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-10#2)(2009-6#1)
there were multiple##4##3##(1995-5#1)(2005-7#1)(2008-4#1)(2008-9#1)
there were neither##2##3##(1993-7#1)(2006-12#1)
there were no cases of##4##5##(2006-5#1)(2006-8#1)(2011-2#2)
there were no clinical##2##4##(2007-2#1)(2008-7#1)
there were no deaths in##2##5##(2007-9#1)(2008-4#1)
there were no deaths##3##4##(2005-12#1)(2007-9#1)(2008-4#1)
there were no differences between the##2##6##(2008-4#1)(2013-1#1)
there were no differences between##5##5##(2008-4#1)(2010-2#1)(2011-2#1)(2013-1#2)
there were no differences in the##4##6##(1992-10#1)(2006-5#1)(2008-7#1)(2013-8#1)
there were no differences in##14##5##(1990-11#1)(1992-10#1)(1994-9#1)(1995-1#1)(1997-4#1)(2006-5#1)(2006-9#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-7#2)(2013-8#1)
there were no differences##21##4##(1990-11#1)(1992-10#1)(1994-9#1)(1995-1#1)(1997-4#1)(2006-5#1)(2006-9#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-2#1)(2011-2#1)(2013-1#2)(2013-8#1)
there were no local##2##4##(2008-6#1)(2011-12#1)
there were no major##3##4##(1996-12#1)(2005-8#1)(2010-10#1)
there were no recurrences##3##4##(1991-6#1)(1995-2#1)(1995-5#1)
there were no serious##5##4##(2005-1#1)(2005-8#1)(2007-8#1)(2008-5#1)(2012-2#1)
there were no significant changes in the##2##7##(1996-2#1)(2008-7#1)
there were no significant changes in##6##6##(1996-2#1)(1997-3#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)
there were no significant changes##7##5##(1996-2#1)(1997-3#1)(2007-12#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)
there were no significant differences among##2##6##(1994-2#1)(2012-2#1)
there were no significant differences between QMR##2##7##(2010-8#2)
there were no significant differences between the##4##7##(1990-7#1)(1995-7#1)(2008-12#1)(2013-1#1)
there were no significant differences between##9##6##(1990-7#1)(1995-7#1)(1997-2#1)(2007-11#1)(2008-12#1)(2010-8#2)(2011-2#1)(2013-1#1)
there were no significant differences found##2##6##(2007-6#1)(2008-12#1)
there were no significant differences in the##5##7##(1994-10#1)(2005-11#1)(2007-7#1)(2012-2#1)(2013-1#1)
there were no significant differences in##22##6##(1991-2#1)(1993-1#1)(1994-10#1)(1994-11#1)(1996-11#1)(1997-1#1)(2005-11#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#2)(2010-4#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
there were no significant differences##41##5##(1990-7#1)(1991-2#1)(1993-1#1)(1994-10#1)(1994-11#1)(1994-2#1)(1995-7#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-8#1)(2004-11#1)(2005-11#1)(2006-8#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#1)(2010-4#1)(2010-8#2)(2011-12#1)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
there were no significant effects##2##5##(2008-11#1)(2011-2#1)
there were no significant statistical differences##2##6##(2008-1#1)(2008-7#1)
there were no significant##60##4##(1990-7#1)(1991-2#1)(1993-1#1)(1994-10#1)(1994-11#1)(1994-2#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-11#1)(2005-11#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#2)(2010-4#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
there were no signs of##5##5##(1990-5#1)(1993-1#1)(1993-6#1)(2008-3#1)(2011-2#1)
there were no signs##6##4##(1990-5#1)(1993-1#1)(1993-6#1)(2006-8#1)(2008-3#1)(2011-2#1)
there were no statistically significant differences between transdermal and oral granisetron##2##11##(2010-12#2)
there were no statistically significant differences between##3##7##(2010-12#2)(2013-1#1)
there were no statistically significant differences##6##6##(1991-3#1)(2010-12#2)(2011-2#1)(2013-1#1)(2013-8#1)
there were no statistically significant##8##5##(1991-3#1)(2004-11#1)(2008-10#1)(2010-12#2)(2011-2#1)(2013-1#1)(2013-8#1)
there were no treatment-related##2##4##(2008-9#2)
there were no##181##3##(1990-11#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-10#1)(1993-1#2)(1993-12#1)(1993-5#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-11#3)(2005-1#1)(2005-11#1)(2005-12#2)(2005-7#1)(2005-8#4)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#3)(2006-8#3)(2006-9#1)(2007-11#2)(2007-12#4)(2007-2#2)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#9)(2007-9#4)(2008-1#3)(2008-10#9)(2008-11#2)(2008-12#4)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#4)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#13)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#4)
there were normal levels of##2##5##(2008-5#1)(2011-2#1)
there were numerous##4##3##(1992-1#1)(1995-7#1)(2007-8#1)(2013-8#1)
there were only a few##3##5##(1997-8#1)(2009-2#1)(2010-8#1)
there were only##9##3##(1993-10#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-7#1)(2009-2#1)(2009-6#1)(2010-4#1)(2010-8#1)
there were over##2##3##(1997-2#1)(2005-7#1)
there were positive##5##3##(1994-6#1)(2007-1#1)(2012-12#2)(2012-2#1)
there were problems in##2##4##(2006-6#1)(2008-12#1)
there were seven##3##3##(2008-1#2)(2008-5#1)
there were several##4##3##(2008-1#1)(2008-12#1)(2008-5#1)(2012-3#1)
there were significant correlations between##4##5##(1994-11#1)(1995-3#1)(2004-11#1)(2008-7#1)
there were significant decreases in##2##5##(1995-9#1)(1996-1#1)
there were significant difference##2##4##(2008-12#1)(2008-7#1)
there were significant differences among##4##5##(1993-2#1)(2007-3#1)(2012-3#1)(2013-8#1)
there were significant differences between the##2##6##(2008-3#1)(2009-12#1)
there were significant differences between##6##5##(2008-10#1)(2008-12#1)(2008-3#1)(2009-12#1)(2010-4#1)(2010-8#1)
there were significant differences in the##4##6##(1990-6#1)(1994-2#1)(1995-12#1)(2006-12#1)
there were significant differences in##7##5##(1990-6#1)(1994-2#1)(1995-12#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-10#1)
there were significant differences##19##4##(1990-6#1)(1993-2#1)(1994-2#1)(1995-12#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2012-3#1)(2013-8#1)
there were significant improvements in##2##5##(2008-3#1)(2008-5#1)
there were significant increases in##3##5##(1992-10#1)(2006-9#1)(2013-1#1)
there were significant interactions##2##4##(2008-10#2)
there were significant reductions in##2##5##(1997-5#1)(2010-12#1)
there were significant##47##3##(1990-6#1)(1992-10#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-8#2)(1995-12#1)(1995-3#1)(1995-9#1)(1996-1#1)(1997-5#1)(2004-11#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#2)(2009-12#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
there were significantly##2##3##(1997-5#1)(2008-9#1)
there were similarities##2##3##(1994-12#1)(1997-3#1)
there were small##4##3##(1992-9#1)(2006-9#1)(2007-9#1)(2011-2#1)
there were some differences between##2##5##(2006-7#1)(2012-12#1)
there were some differences##3##4##(2006-7#1)(2008-5#1)(2012-12#1)
there were some##9##3##(1993-5#1)(1994-12#1)(2006-7#1)(2008-5#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
there were statistically significant##5##4##(2005-1#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
there were strong##2##3##(2007-10#1)(2008-8#1)
there were three##3##3##(2004-11#1)(2008-9#1)(2010-8#1)
there were two##12##3##(1991-10#1)(1992-8#1)(1993-9#1)(1997-7#1)(2004-10#1)(2004-4#1)(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-2#1)(2013-1#1)
there were very##2##3##(1992-1#1)(2008-11#1)
there were##575##2##(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#4)(1990-6#3)(1990-7#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-2#2)(1991-3#4)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#3)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-8#3)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-5#3)(1993-6#5)(1993-7#1)(1993-8#2)(1993-9#3)(1994-10#2)(1994-11#3)(1994-12#4)(1994-2#2)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#3)(1995-10#2)(1995-12#2)(1995-2#2)(1995-3#3)(1995-5#3)(1995-7#4)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#2)(1996-12#3)(1996-2#4)(1996-3#1)(1996-7#1)(1996-9#2)(1997-1#3)(1997-2#2)(1997-3#5)(1997-4#1)(1997-5#3)(1997-6#2)(1997-7#2)(1997-8#3)(2004-1#1)(2004-10#3)(2004-11#6)(2004-2#1)(2004-4#2)(2005-1#2)(2005-10#1)(2005-11#2)(2005-12#3)(2005-6#1)(2005-7#3)(2005-8#7)(2005-9#3)(2006-10#9)(2006-11#2)(2006-12#4)(2006-5#5)(2006-6#4)(2006-7#4)(2006-8#9)(2006-9#3)(2007-1#3)(2007-10#3)(2007-11#11)(2007-12#7)(2007-2#8)(2007-3#2)(2007-5#2)(2007-6#3)(2007-7#9)(2007-8#18)(2007-9#6)(2008-1#12)(2008-10#33)(2008-11#4)(2008-12#11)(2008-2#3)(2008-3#7)(2008-4#6)(2008-5#17)(2008-6#4)(2008-7#16)(2008-8#6)(2008-9#14)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#4)(2010-3#5)(2010-4#4)(2010-6#2)(2010-7#4)(2010-8#6)(2011-1#2)(2011-12#4)(2011-2#27)(2012-1#2)(2012-11#3)(2012-12#11)(2012-2#13)(2012-3#10)(2013-1#15)(2013-7#3)(2013-8#10)
there will be a##5##4##(1994-8#1)(2008-1#1)(2008-11#1)(2008-9#1)(2010-12#1)
there will be an##2##4##(2009-9#1)(2012-2#1)
there will be no##2##4##(2008-10#1)(2011-2#1)
there will be##20##3##(1990-6#1)(1991-6#1)(1993-2#1)(1994-8#1)(2005-9#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
there will not##2##3##(1990-10#1)(1994-3#1)
there will##22##2##(1990-10#1)(1990-6#1)(1991-6#1)(1993-2#1)(1994-3#1)(1994-8#1)(2005-9#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
there would be a##5##4##(1990-8#2)(1995-2#1)(1997-8#1)(2011-2#1)
there would be no##2##4##(1992-12#1)(2008-10#1)
there would be##12##3##(1990-12#1)(1990-8#2)(1992-12#1)(1995-2#1)(1997-8#1)(2006-4#1)(2006-5#1)(2007-12#1)(2008-10#1)(2011-2#2)
there would##14##2##(1990-12#1)(1990-8#2)(1992-12#1)(1995-1#1)(1995-2#1)(1997-8#1)(2006-4#1)(2006-5#1)(2007-12#1)(2008-10#2)(2011-2#2)
there##6079##1##(1990-1#2)(1990-10#10)(1990-11#24)(1990-12#20)(1990-2#20)(1990-3#13)(1990-4#13)(1990-5#21)(1990-6#13)(1990-7#19)(1990-8#19)(1990-9#12)(1991-1#14)(1991-10#12)(1991-11#15)(1991-12#19)(1991-2#20)(1991-3#22)(1991-4#10)(1991-5#11)(1991-6#17)(1991-7#11)(1991-8#17)(1991-9#11)(1992-1#14)(1992-10#7)(1992-11#14)(1992-12#22)(1992-2#33)(1992-3#14)(1992-4#11)(1992-5#12)(1992-6#14)(1992-7#4)(1992-8#19)(1992-9#17)(1993-1#11)(1993-10#9)(1993-11#9)(1993-12#30)(1993-2#19)(1993-3#24)(1993-4#9)(1993-5#6)(1993-6#16)(1993-7#14)(1993-8#19)(1993-9#16)(1994-1#6)(1994-10#7)(1994-11#13)(1994-12#28)(1994-2#20)(1994-3#30)(1994-4#5)(1994-5#17)(1994-6#13)(1994-7#10)(1994-8#23)(1994-9#25)(1995-1#24)(1995-10#6)(1995-11#17)(1995-12#29)(1995-2#29)(1995-3#22)(1995-4#7)(1995-5#15)(1995-6#14)(1995-7#15)(1995-8#22)(1995-9#10)(1996-1#20)(1996-10#7)(1996-11#12)(1996-12#35)(1996-2#25)(1996-3#32)(1996-4#7)(1996-5#17)(1996-6#16)(1996-7#8)(1996-8#17)(1996-9#24)(1997-1#23)(1997-2#26)(1997-3#21)(1997-4#19)(1997-5#27)(1997-6#22)(1997-7#20)(1997-8#42)(1997-9#1)(2004-1#3)(2004-10#10)(2004-11#11)(2004-12#5)(2004-2#5)(2004-3#2)(2004-4#5)(2004-7#2)(2004-8#1)(2004-9#7)(2005-1#4)(2005-10#18)(2005-11#40)(2005-12#15)(2005-2#1)(2005-3#2)(2005-4#3)(2005-5#4)(2005-6#9)(2005-7#30)(2005-8#32)(2005-9#14)(2006-1#6)(2006-10#147)(2006-11#13)(2006-12#42)(2006-2#24)(2006-3#7)(2006-4#14)(2006-5#29)(2006-6#23)(2006-7#28)(2006-8#55)(2006-9#29)(2007-1#18)(2007-10#38)(2007-11#107)(2007-12#96)(2007-2#57)(2007-3#27)(2007-4#25)(2007-5#17)(2007-6#32)(2007-7#93)(2007-8#130)(2007-9#37)(2008-1#101)(2008-10#322)(2008-11#164)(2008-12#80)(2008-2#63)(2008-3#117)(2008-4#99)(2008-5#154)(2008-6#66)(2008-7#156)(2008-8#133)(2008-9#119)(2009-1#9)(2009-10#27)(2009-11#15)(2009-12#18)(2009-2#23)(2009-3#31)(2009-4#28)(2009-5#33)(2009-6#14)(2009-7#21)(2009-8#23)(2009-9#27)(2010-1#16)(2010-10#16)(2010-11#31)(2010-12#60)(2010-2#20)(2010-3#22)(2010-4#17)(2010-5#29)(2010-6#22)(2010-7#23)(2010-8#47)(2010-9#22)(2011-1#83)(2011-10#3)(2011-12#25)(2011-2#204)(2011-3#3)(2011-4#1)(2011-7#2)(2012-1#30)(2012-11#17)(2012-12#110)(2012-2#140)(2012-3#107)(2012-5#1)(2012-6#1)(2013-1#182)(2013-7#40)(2013-8#89)
there's##5##1##(1991-11#1)(1993-12#1)(1993-2#1)(2006-4#1)(2008-9#1)
there?##2##1##(1996-3#1)(2006-5#1)
thereafter and##3##2##(1996-5#1)(2006-8#1)(2007-6#1)
thereafter by##2##2##(2007-12#1)(2013-1#1)
thereafter every##2##2##(1993-2#1)(1994-2#1)
thereafter for##2##2##(2004-2#1)(2008-7#1)
thereafter in##4##2##(1990-12#1)(1994-8#1)(1995-2#1)(1995-5#1)
thereafter injected##2##2##(1993-5#1)(2008-10#1)
thereafter the##5##2##(1990-12#1)(1996-12#1)(2008-3#2)(2008-5#1)
thereafter they##2##2##(2007-11#1)(2012-12#1)
thereafter to##6##2##(1993-9#1)(1994-4#1)(2006-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
thereafter until##3##2##(1991-6#1)(1992-8#1)(2006-8#1)
thereafter with##2##2##(1993-11#1)(2012-2#1)
thereafter##171##1##(1990-11#1)(1990-12#3)(1990-3#1)(1990-4#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#5)(1993-9#2)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-4#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#5)(1995-3#3)(1995-5#3)(1995-6#2)(1995-8#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#2)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-2#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-7#2)(2006-8#4)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-6#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-3#4)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#2)(2009-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#5)(2012-2#3)(2013-1#5)(2013-8#3)
thereby a##3##2##(1996-8#1)(2007-7#1)(2008-10#1)
thereby acting as a platform for communication between peers and the wider public##3##13##(2010-12#3)
thereby acting as##5##3##(1994-9#1)(2010-12#4)
thereby adding##2##2##(1997-6#1)(2005-8#1)
thereby affecting##3##2##(1994-5#1)(2004-11#1)(2007-12#1)
thereby alleviating the need for##2##5##(2008-10#1)(2008-2#1)
thereby alleviating the##3##3##(2008-10#1)(2008-2#1)(2009-5#1)
thereby allow##2##2##(2006-10#1)(2008-7#1)
thereby allowing a##2##3##(2008-10#1)(2008-2#1)
thereby allowing##17##2##(1991-11#1)(1992-11#1)(1992-5#1)(1993-12#1)(1993-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-4#2)(2008-6#1)(2009-4#1)(2010-5#1)
thereby also##2##2##(2008-7#1)(2008-8#1)
thereby avoiding the need for##2##5##(2006-10#1)(2006-8#1)
thereby avoiding the##4##3##(2006-10#1)(2006-8#1)(2008-1#1)(2008-2#1)
thereby avoiding##5##2##(2006-10#2)(2006-8#1)(2008-1#1)(2008-2#1)
thereby be##2##2##(2007-6#1)(2012-2#1)
thereby becoming##2##2##(2010-3#1)(2012-2#1)
thereby breaking##2##2##(2008-9#1)(2012-2#1)
thereby causing the##2##3##(1997-6#1)(2011-2#1)
thereby causing##4##2##(1994-9#1)(1997-6#1)(2008-5#1)(2011-2#1)
thereby completing##2##2##(2008-10#1)(2009-6#1)
thereby confirming the##3##3##(1993-9#1)(2007-8#1)(2008-10#1)
thereby confirming##4##2##(1993-9#1)(2007-8#1)(2008-10#1)(2008-8#1)
thereby continuously##2##2##(1991-1#1)(2008-11#1)
thereby contributing to the##2##4##(1991-1#1)(2008-10#1)
thereby contributing to##6##3##(1991-1#1)(1995-8#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#1)
thereby controlling##4##2##(2008-3#1)(2008-8#1)(2009-2#1)(2010-8#1)
thereby creating a##5##3##(1993-12#1)(2007-11#1)(2008-3#1)(2012-12#1)(2012-3#1)
thereby creating##8##2##(1993-12#1)(2007-11#1)(2008-11#1)(2008-3#1)(2009-6#1)(2012-1#1)(2012-12#1)(2012-3#1)
thereby decreasing##2##2##(1992-1#1)(1993-8#1)
thereby defining##2##2##(1997-4#1)(2008-4#1)
thereby demonstrating that##3##3##(1991-12#1)(1992-11#1)(2008-10#1)
thereby demonstrating##4##2##(1990-5#1)(1991-12#1)(1992-11#1)(2008-10#1)
thereby directly##2##2##(1990-3#1)(2011-12#1)
thereby eliminating the need for##3##5##(2006-11#1)(2012-2#2)
thereby eliminating the need##4##4##(2006-11#1)(2008-2#1)(2012-2#2)
thereby eliminating the##6##3##(1991-3#1)(2006-11#1)(2007-8#1)(2008-2#1)(2012-2#2)
thereby eliminating##7##2##(1991-3#1)(2006-11#1)(2007-8#1)(2008-2#1)(2008-3#1)(2012-2#2)
thereby enabling the detection of##2##5##(2008-10#1)(2013-1#1)
thereby enabling the##4##3##(2006-12#1)(2008-10#1)(2012-12#1)(2013-1#1)
thereby enabling##6##2##(2006-12#1)(2008-10#1)(2008-5#1)(2012-11#1)(2012-12#1)(2013-1#1)
thereby enhance##2##2##(1994-2#1)(1995-8#1)
thereby enhanced##2##2##(2005-8#1)(2008-10#1)
thereby enhancing the##3##3##(1994-6#1)(2008-11#1)(2009-4#1)
thereby enhancing##12##2##(1994-6#1)(1995-11#1)(1997-5#1)(1997-7#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-4#1)(2012-2#1)(2013-1#1)
thereby ensuring##4##2##(1992-8#1)(2007-5#1)(2009-8#1)(2013-1#1)
thereby establishing that##2##3##(1993-3#1)(1997-2#1)
thereby facilitating##9##2##(1990-3#1)(1990-7#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-7#1)(2011-1#1)(2011-2#1)
thereby generating##5##2##(1992-12#1)(2005-10#1)(2008-10#1)(2008-2#1)(2012-3#1)
thereby having the potential to##2##5##(2007-4#1)(2010-2#1)
thereby help##3##2##(2008-5#1)(2010-12#1)(2011-2#1)
thereby identifying##4##2##(1990-12#1)(1995-3#1)(1997-7#1)(2012-2#1)
thereby implicating##2##2##(1994-3#1)(1995-8#1)
thereby implying##2##2##(1992-9#1)(1997-8#1)
thereby improving the##6##3##(2006-10#1)(2007-11#1)(2008-2#2)(2008-7#2)
thereby improving their quality of life##2##6##(2009-11#1)(2010-12#1)
thereby improving##17##2##(1990-12#1)(2005-12#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-7#3)(2009-11#1)(2010-12#2)(2010-2#1)(2010-9#1)(2012-1#1)(2012-12#1)
thereby increase##4##2##(1994-2#1)(1995-1#1)(2007-1#1)(2011-2#1)
thereby increasing the##3##3##(1991-9#1)(1993-12#1)(2008-7#1)
thereby increasing##16##2##(1991-11#1)(1991-9#1)(1992-4#1)(1993-12#1)(1994-8#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-4#1)(2008-7#1)(2010-4#1)(2012-2#1)(2013-8#1)
thereby indicating that##2##3##(1997-6#1)(2011-2#1)
thereby indicating##6##2##(1994-3#1)(1995-6#1)(1997-6#1)(2008-4#1)(2010-8#1)(2011-2#1)
thereby inducing##2##2##(2009-6#2)
thereby influencing##3##2##(2006-10#1)(2008-8#1)(2008-9#1)
thereby inheriting relationships among the visual entities##2##7##(2013-1#2)
thereby inhibiting##3##2##(1993-11#1)(1993-3#1)(1994-9#1)
thereby killing all distal leaves##2##5##(2008-10#2)
thereby leading to the##3##4##(2008-3#1)(2011-2#1)(2013-8#1)
thereby leading to##6##3##(1996-4#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
thereby limiting the##2##3##(2008-10#1)(2012-2#1)
thereby limiting##5##2##(1997-4#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-2#1)
thereby making the##3##3##(1997-7#1)(2006-12#1)(2013-1#1)
thereby making##6##2##(1991-10#1)(1992-12#1)(1997-7#1)(2006-12#1)(2007-2#1)(2013-1#1)
thereby maximizing##2##2##(2007-12#1)(2008-2#1)
thereby minimizing the##2##3##(1995-3#1)(2007-8#1)
thereby minimizing##3##2##(1993-2#1)(1995-3#1)(2007-8#1)
thereby mitigating##2##2##(1990-11#1)(1994-11#1)
thereby obtaining##2##2##(2008-2#1)(2012-2#1)
thereby offering##2##2##(2008-10#1)(2010-8#1)
thereby permitting the##2##3##(1992-10#1)(2006-3#1)
thereby permitting##4##2##(1990-12#1)(1990-5#1)(1992-10#1)(2006-3#1)
thereby perturbing##2##2##(2012-2#2)
thereby possibly##3##2##(1994-12#1)(1997-2#1)(2011-2#1)
thereby potentially##2##2##(2005-7#1)(2008-10#1)
thereby presenting a##2##3##(2010-2#1)(2012-12#1)
thereby preventing the##3##3##(1993-12#1)(2011-2#1)(2013-1#1)
thereby preventing their##2##3##(1995-3#1)(2013-1#1)
thereby preventing##12##2##(1993-12#1)(1995-3#2)(2006-12#1)(2007-10#1)(2008-10#1)(2008-8#1)(2009-7#1)(2011-2#1)(2013-1#3)
thereby producing##4##2##(1990-11#1)(2008-11#1)(2008-8#1)(2009-10#1)
thereby promoting##3##2##(1990-12#1)(2008-10#1)(2012-2#1)
thereby providing a##5##3##(1993-6#1)(2006-5#1)(2008-12#1)(2010-11#1)(2010-4#1)
thereby providing an##2##3##(2007-11#1)(2007-9#1)
thereby providing the basis for##2##5##(1990-10#1)(2007-12#1)
thereby providing the##5##3##(1990-10#1)(1993-3#1)(2007-12#1)(2011-2#1)(2013-8#1)
thereby providing##22##2##(1990-10#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-2#1)(1996-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-2#1)(2010-4#1)(2011-2#2)(2013-7#1)(2013-8#1)
thereby reduce##5##2##(1993-7#1)(2006-10#1)(2008-8#1)(2013-1#1)(2013-8#1)
thereby reducing the risk of##4##5##(2006-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
thereby reducing the##12##3##(1997-7#1)(2006-12#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)(2009-9#1)(2010-11#1)(2011-2#1)
thereby reducing##31##2##(1991-12#1)(1993-3#1)(1996-2#1)(1997-4#1)(1997-7#1)(2006-12#2)(2006-2#1)(2006-8#1)(2007-11#1)(2008-10#6)(2008-11#2)(2008-4#2)(2008-6#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#1)
thereby regulating##3##2##(1994-12#1)(2011-12#1)(2012-2#1)
thereby reinforcing the##2##3##(2007-5#1)(2011-12#1)
thereby resulting in##3##3##(2008-3#1)(2010-4#1)(2013-8#1)
thereby retaining##2##2##(1992-6#1)(1996-3#1)
thereby stabilizing##2##2##(2010-7#1)(2012-2#1)
thereby stimulating##2##2##(1990-12#1)(2010-2#1)
thereby suggesting that##4##3##(1993-12#1)(1997-2#1)(2006-10#1)(2012-2#1)
thereby suggesting the presence of##2##5##(1993-3#1)(1997-2#1)
thereby suggesting the##3##3##(1993-3#1)(1997-2#1)(2012-2#1)
thereby suggesting##9##2##(1993-12#2)(1993-3#1)(1997-2#2)(1997-3#1)(2006-10#1)(2012-2#2)
thereby supporting##2##2##(2007-2#1)(2010-2#1)
thereby sustaining##3##2##(1995-10#1)(1995-3#1)(2009-11#1)
thereby the##10##2##(1997-7#1)(2006-8#1)(2007-8#1)(2008-12#1)(2008-5#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
thereby verifying##3##2##(1991-8#1)(2008-10#2)
thereby would##2##2##(2007-11#1)(2008-10#1)
thereby yielding a##2##3##(1993-12#1)(2007-12#1)
thereby##618##1##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#5)(1990-3#6)(1990-5#3)(1990-7#3)(1991-1#2)(1991-10#2)(1991-11#3)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#6)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#10)(1993-2#1)(1993-3#7)(1993-6#4)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#6)(1994-2#6)(1994-3#4)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#7)(1995-5#1)(1995-6#1)(1995-8#6)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#5)(1996-4#2)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#4)(1996-9#3)(1997-2#4)(1997-3#2)(1997-4#6)(1997-5#1)(1997-6#5)(1997-7#7)(1997-8#2)(2004-11#1)(2004-4#1)(2005-10#2)(2005-12#1)(2005-3#1)(2005-7#1)(2005-8#3)(2006-10#9)(2006-11#4)(2006-12#7)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#5)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#11)(2007-12#8)(2007-2#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#7)(2007-9#2)(2008-1#6)(2008-10#37)(2008-11#12)(2008-12#3)(2008-2#25)(2008-3#14)(2008-4#12)(2008-5#14)(2008-6#4)(2008-7#13)(2008-8#17)(2008-9#5)(2009-10#5)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#5)(2009-4#3)(2009-5#3)(2009-6#6)(2009-7#1)(2009-8#4)(2009-9#3)(2010-1#2)(2010-11#5)(2010-12#11)(2010-2#9)(2010-3#1)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#6)(2011-12#4)(2011-2#17)(2012-1#3)(2012-11#2)(2012-12#9)(2012-2#27)(2012-3#5)(2013-1#16)(2013-7#1)(2013-8#6)
therefore a method##2##3##(2006-10#1)(2008-2#1)
therefore a potential##3##3##(1996-11#1)(2008-10#1)(2011-1#1)
therefore a very##2##3##(1992-7#1)(2008-1#1)
therefore a##47##2##(1990-6#1)(1990-9#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-4#1)(1995-11#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-2#2)(1997-4#2)(2006-10#2)(2006-7#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#5)(2008-5#1)(2008-6#2)(2009-2#1)(2010-10#1)(2010-12#1)(2011-1#2)(2011-2#4)(2012-11#1)(2012-2#1)(2012-3#1)
therefore acts##3##2##(1992-1#1)(1996-10#1)(2008-8#1)
therefore affect the##2##3##(2004-11#1)(2007-11#1)
therefore aims to##2##3##(2008-2#1)(2010-9#1)
therefore all##2##2##(1996-1#1)(2008-7#1)
therefore also##2##2##(2007-10#1)(2008-4#1)
therefore an##14##2##(1990-10#1)(1992-2#1)(1994-3#1)(2006-10#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-8#2)(2009-8#1)(2010-8#1)(2012-12#1)
therefore appears that##5##3##(1990-5#1)(1992-6#1)(2006-12#1)(2008-7#2)
therefore appears to be##4##4##(1990-2#1)(1992-11#1)(1992-2#1)(2009-5#1)
therefore appears to##6##3##(1990-2#1)(1992-11#1)(1992-2#1)(1992-3#1)(1995-1#1)(2009-5#1)
therefore appears##13##2##(1990-2#1)(1990-5#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-7#1)(1995-1#1)(2006-12#1)(2008-10#1)(2008-7#2)(2009-5#1)
therefore are##8##2##(1990-9#1)(1992-10#1)(2006-2#1)(2007-8#1)(2008-4#2)(2008-8#1)(2013-8#1)
therefore as##6##2##(1996-1#1)(2005-7#1)(2006-1#1)(2007-11#1)(2008-10#1)(2009-2#1)
therefore assessed##4##2##(1995-6#1)(2006-7#1)(2007-6#1)(2011-2#1)
therefore assist##2##2##(2005-8#1)(2008-11#1)
therefore attempted to##2##3##(1991-5#1)(1995-6#1)
therefore be a useful##2##4##(1990-10#1)(2008-9#1)
therefore be a##6##3##(1990-10#1)(1992-11#1)(1994-6#1)(2008-9#1)(2009-8#1)(2012-12#1)
therefore be at##2##3##(1990-5#1)(1997-3#1)
therefore be beneficial##2##3##(1990-10#1)(2013-1#1)
therefore be capable of##2##4##(2007-12#1)(2012-2#1)
therefore be considered##9##3##(1991-5#1)(1991-9#1)(1992-1#1)(1994-2#1)(2006-12#1)(2007-8#1)(2008-8#1)(2009-3#1)(2010-2#1)
therefore be of##2##3##(1990-11#1)(2008-5#1)
therefore be particularly useful##2##4##(1991-8#1)(2007-8#1)
therefore be prescribed##2##3##(1990-12#1)(2008-9#1)
therefore be regarded as##2##4##(1995-4#1)(2008-6#1)
therefore be used as an##2##5##(1994-9#1)(2008-10#1)
therefore be used as##5##4##(1991-12#1)(1991-9#1)(1994-8#1)(1994-9#1)(2008-10#1)
therefore be used to##5##4##(1992-1#1)(1994-9#1)(1995-11#1)(2007-9#1)(2008-2#1)
therefore be used##11##3##(1991-12#1)(1991-9#1)(1992-1#1)(1994-8#1)(1994-9#2)(1995-11#1)(2007-9#1)(2008-10#1)(2008-2#1)(2010-4#1)
therefore be useful in##3##4##(1990-8#1)(2008-12#1)(2008-5#1)
therefore be useful##6##3##(1990-8#1)(1995-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-7#1)
therefore be##116##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-5#1)(1990-8#2)(1991-1#1)(1991-12#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#3)(1992-1#2)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-10#2)(1995-11#1)(1995-12#1)(1995-4#1)(1995-6#1)(1996-11#1)(1996-8#1)(1997-3#2)(1997-4#1)(1997-7#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-12#3)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#3)(2012-2#3)(2013-1#1)(2013-8#1)
therefore become##4##2##(2007-12#1)(2007-6#1)(2008-6#1)(2008-7#1)
therefore been##27##2##(1990-11#1)(1990-8#1)(1994-12#1)(1994-3#1)(1994-8#1)(2005-7#1)(2006-6#1)(2006-8#1)(2007-1#1)(2008-10#2)(2008-11#8)(2008-3#1)(2008-4#1)(2008-7#2)(2010-10#1)(2011-1#1)(2012-12#1)(2012-3#1)
therefore belong to##2##3##(1993-3#1)(1996-11#1)
therefore can be considered as##3##5##(2008-5#1)(2011-2#1)(2013-7#1)
therefore can be##9##3##(1996-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-4#1)(2009-8#1)(2011-2#1)(2013-7#1)
therefore can##11##2##(1996-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-8#1)(2011-2#1)(2013-7#1)
therefore cannot be##6##3##(1994-9#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#1)(2012-2#1)
therefore cannot##7##2##(1994-9#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#1)(2012-2#2)
therefore carried out##5##3##(2005-11#1)(2006-2#1)(2007-1#1)(2010-10#1)(2011-2#1)
therefore classified##2##2##(1994-11#1)(2008-10#1)
therefore commonly##3##2##(2008-1#1)(2013-1#2)
therefore conclude that##8##3##(1990-12#1)(1992-8#1)(1993-8#1)(1994-3#1)(1994-4#1)(1996-5#1)(2012-1#1)(2013-8#1)
therefore concluded that##11##3##(1991-5#1)(1996-2#1)(1996-7#1)(1997-3#1)(2007-1#2)(2008-1#1)(2008-10#1)(2008-8#1)(2009-6#1)(2013-1#1)
therefore concluded##12##2##(1991-5#1)(1991-7#1)(1996-2#1)(1996-7#1)(1997-3#1)(2007-1#2)(2008-1#1)(2008-10#1)(2008-8#1)(2009-6#1)(2013-1#1)
therefore conducted##6##2##(1996-11#1)(2007-7#1)(2010-12#1)(2011-2#2)(2013-1#1)
therefore confer##2##2##(1994-10#1)(1995-3#1)
therefore consider##2##2##(2007-7#2)
therefore considered as##3##3##(1996-4#1)(2007-8#1)(2008-8#1)
therefore considered to be##2##4##(1990-7#1)(2008-2#1)
therefore considered to##3##3##(1990-7#1)(2008-10#1)(2008-2#1)
therefore considered##9##2##(1990-7#1)(1996-4#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-5#2)(2008-8#1)
therefore contribute to##2##3##(1994-3#1)(2009-2#1)
therefore contribute##3##2##(1994-3#1)(2009-2#1)(2009-3#1)
therefore control##3##2##(1994-8#1)(2008-8#1)(2008-9#1)
therefore could not be##2##4##(1990-3#1)(2004-2#1)
therefore could not##4##3##(1990-3#1)(1991-8#1)(2004-2#1)(2006-2#1)
therefore could##14##2##(1990-11#1)(1990-3#1)(1991-3#1)(1991-8#1)(1993-4#1)(1994-5#1)(1995-12#1)(1995-4#1)(2004-2#1)(2006-2#1)(2008-7#1)(2009-5#1)(2010-8#1)(2013-8#1)
therefore demonstrate##2##2##(1995-5#1)(1997-5#1)
therefore demonstrated##2##2##(1991-12#1)(2008-10#1)
therefore depend##2##2##(1996-12#1)(2010-7#1)
therefore developed##4##2##(1995-12#1)(1996-11#1)(2007-8#1)(2012-1#1)
therefore diagnosed##2##2##(2005-7#1)(2012-3#1)
therefore different##3##2##(1992-11#1)(2007-8#1)(2008-4#1)
therefore difficult to##2##3##(1994-3#1)(2008-3#1)
therefore does not##2##3##(2004-4#1)(2007-1#1)
therefore dramatically##3##2##(1997-1#1)(2006-10#1)(2009-3#1)
therefore essential to##2##3##(2007-4#1)(2008-1#1)
therefore essential##4##2##(2007-2#1)(2007-4#1)(2008-1#1)(2008-2#1)
therefore established##2##2##(2008-11#1)(2008-5#1)
therefore evaluated##2##2##(1990-8#1)(1993-7#1)
therefore examined the##2##3##(2007-3#1)(2012-3#1)
therefore examined##5##2##(1995-5#1)(1996-11#1)(1996-7#1)(2007-3#1)(2012-3#1)
therefore excluded from the##2##4##(2007-6#1)(2007-8#1)
therefore expected to##2##3##(2006-7#1)(2008-9#1)
therefore explored the##2##3##(1994-12#1)(2010-3#1)
therefore explored##3##2##(1994-11#1)(1994-12#1)(2010-3#1)
therefore focus##2##2##(1994-5#1)(2011-2#1)
therefore focused on##2##3##(2006-10#1)(2008-7#1)
therefore for##3##2##(1991-12#1)(2010-4#1)(2012-2#1)
therefore fundamental##2##2##(2008-7#1)(2009-8#1)
therefore given##3##2##(1991-9#1)(2006-4#1)(2008-5#1)
therefore greatly##2##2##(2006-2#1)(2008-10#1)
therefore has the##2##3##(2008-3#1)(2008-9#1)
therefore has##12##2##(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#2)(2010-12#1)(2011-7#1)(2012-1#1)(2013-1#1)
therefore have##10##2##(1990-8#1)(1993-12#1)(1994-8#1)(2007-1#1)(2007-11#1)(2008-11#1)(2008-6#1)(2010-3#1)(2011-2#2)
therefore help##2##2##(2008-5#1)(2013-1#1)
therefore in a##2##3##(1994-2#1)(2008-2#1)
therefore in##4##2##(1991-4#1)(1994-2#1)(2008-2#1)(2009-12#1)
therefore includes##2##2##(1992-6#1)(2008-4#1)
therefore increase##3##2##(1993-11#1)(2009-10#1)(2012-3#1)
therefore increasing##2##2##(2008-1#1)(2008-5#1)
therefore indicate that##4##3##(1990-11#1)(1991-7#1)(1994-3#1)(1997-4#1)
therefore indicate##5##2##(1990-11#1)(1991-7#1)(1992-5#1)(1994-3#1)(1997-4#1)
therefore initiated##2##2##(2008-7#1)(2011-2#1)
therefore interact with the##2##4##(1990-11#1)(1992-12#1)
therefore introduced##2##2##(2008-1#1)(2012-1#1)
therefore investigated in##2##3##(1991-4#1)(1994-3#1)
therefore investigated the##6##3##(1990-11#1)(1991-10#1)(1996-11#1)(1996-9#1)(2009-10#1)(2010-2#1)
therefore investigated##15##2##(1990-11#1)(1990-3#1)(1991-10#1)(1991-4#1)(1992-2#1)(1993-2#1)(1994-3#1)(1996-11#1)(1996-9#1)(2004-9#1)(2006-8#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-2#1)
therefore is a useful##2##4##(1990-5#1)(1993-3#1)
therefore is a##6##3##(1990-5#1)(1993-3#1)(1995-4#1)(2010-4#1)(2013-1#2)
therefore is##15##2##(1990-5#1)(1993-3#1)(1995-4#1)(2007-8#1)(2008-1#1)(2008-4#1)(2009-10#1)(2009-6#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#4)
therefore it can be##2##4##(1994-3#1)(2008-3#1)
therefore it is a##2##4##(2007-8#1)(2009-4#1)
therefore it is necessary to##3##5##(2008-11#1)(2011-2#1)(2013-8#1)
therefore it is##14##3##(1990-11#1)(1991-2#1)(1997-7#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-4#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-7#1)(2013-8#1)
therefore it##23##2##(1990-11#1)(1991-2#1)(1994-3#1)(1997-7#1)(2007-3#1)(2007-5#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-4#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-7#1)(2013-8#1)
therefore its value as a##2##5##(1991-12#1)(2009-8#1)
therefore its##5##2##(1991-12#1)(2007-3#1)(2009-8#2)(2012-6#1)
therefore leading to##2##3##(2005-11#1)(2011-2#1)
therefore led##2##2##(1990-3#1)(2008-5#1)
therefore likely to be##3##4##(1991-6#1)(2008-10#1)(2008-8#1)
therefore likely to##6##3##(1991-6#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#1)
therefore likely##10##2##(1991-6#1)(1992-6#1)(1993-3#1)(1995-3#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-3#1)(2011-2#1)
therefore make##2##2##(2008-2#1)(2010-6#1)
therefore makes##3##2##(2008-1#1)(2008-9#1)(2013-8#1)
therefore may##13##2##(1991-5#1)(1991-6#1)(1994-6#1)(1994-9#1)(1996-4#1)(1996-9#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
therefore measured##3##2##(1995-11#1)(1997-5#1)(2012-2#1)
therefore molecular##2##2##(1995-12#1)(2010-4#1)
therefore more likely to##2##4##(1992-3#1)(2011-3#1)
therefore more likely##3##3##(1992-3#1)(1996-12#1)(2011-3#1)
therefore more##9##2##(1992-3#1)(1995-11#1)(1996-12#1)(2007-6#1)(2008-10#2)(2008-4#1)(2011-3#1)(2012-1#1)
therefore most##2##2##(1992-9#1)(2013-1#1)
therefore must be##3##3##(1991-3#1)(1992-3#1)(1994-8#1)
therefore must##4##2##(1990-5#1)(1991-3#1)(1992-3#1)(1994-8#1)
therefore necessary for a##2##4##(1994-6#1)(2008-5#1)
therefore necessary for##3##3##(1994-6#1)(2008-5#2)
therefore necessary that##3##3##(1991-3#1)(2007-12#1)(2012-3#1)
therefore necessary to use##2##4##(1990-2#1)(1990-3#1)
therefore necessary##16##2##(1990-2#1)(1990-3#2)(1990-8#1)(1991-3#1)(1994-6#1)(1996-8#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#2)(2010-2#1)(2010-4#1)(2012-3#1)
therefore need to##3##3##(2005-11#1)(2012-12#1)(2013-1#1)
therefore needed##5##2##(1993-5#1)(1995-12#1)(1997-7#1)(2006-9#1)(2008-10#1)
therefore no##3##2##(1997-4#1)(2008-6#1)(2013-1#1)
therefore not be##2##3##(1996-3#1)(2008-10#1)
therefore not##25##2##(1990-5#1)(1991-11#1)(1992-12#1)(1993-4#1)(1993-9#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-6#1)(1997-7#2)(2006-10#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-9#2)(2009-3#1)(2009-7#1)(2010-4#1)(2010-7#1)
therefore of great importance##3##4##(2008-7#1)(2009-1#1)(2010-11#1)
therefore of great##5##3##(1996-11#1)(2008-7#1)(2009-1#1)(2010-11#1)(2011-1#1)
therefore of particular interest##2##4##(2005-9#1)(2009-7#1)
therefore of##18##2##(1990-9#1)(1996-11#1)(1996-12#1)(2005-9#1)(2006-10#1)(2006-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-1#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-11#1)(2011-1#2)(2012-1#1)(2012-2#1)
therefore offer##2##2##(2007-4#1)(2008-8#1)
therefore offers a##5##3##(1991-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2012-2#1)
therefore on##4##2##(1990-1#1)(1990-3#1)(2005-5#1)(2010-2#1)
therefore only##5##2##(1993-10#1)(1995-3#1)(2008-11#1)(2012-12#2)
therefore performed##5##2##(1994-4#1)(1997-6#1)(2006-12#1)(2007-12#1)(2008-5#1)
therefore plays a##2##3##(2006-1#1)(2009-8#1)
therefore possible to##4##3##(1993-9#1)(2007-12#1)(2008-3#2)
therefore possible##8##2##(1993-9#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#2)(2011-2#1)(2013-8#1)
therefore postulated that##2##3##(1995-2#1)(2008-10#1)
therefore predicted##3##2##(1994-5#1)(1995-12#1)(2006-12#1)
therefore present##3##2##(1995-12#1)(2008-11#1)(2013-8#1)
therefore prevent##3##2##(2007-11#1)(2011-2#1)(2012-12#1)
therefore preventing##2##2##(2009-3#1)(2010-12#1)
therefore primarily##2##2##(2005-10#1)(2008-10#1)
therefore probably##4##2##(1994-9#1)(1997-3#1)(2006-6#1)(2007-8#1)
therefore produce##3##2##(1996-9#1)(2007-9#1)(2008-2#1)
therefore produced##3##2##(1995-12#1)(1996-1#1)(2009-10#1)
therefore promote##3##2##(1992-4#1)(1994-10#1)(2012-3#1)
therefore propose that##7##3##(1992-3#1)(1992-6#1)(1995-2#2)(1995-3#1)(1995-8#1)(2012-2#1)
therefore propose##9##2##(1992-3#1)(1992-6#1)(1995-2#2)(1995-3#1)(1995-8#1)(2005-7#1)(2012-12#1)(2012-2#1)
therefore proposed##4##2##(1991-11#1)(1995-3#1)(2006-12#1)(2008-10#1)
therefore prove##2##2##(1990-11#1)(2005-7#1)
therefore provide a##6##3##(1992-8#1)(1994-3#1)(1995-2#1)(2007-11#1)(2009-5#1)(2010-4#1)
therefore provide##11##2##(1992-8#1)(1994-3#1)(1995-2#1)(2007-11#1)(2008-11#1)(2008-3#1)(2009-2#1)(2009-5#1)(2010-4#2)(2012-11#1)
therefore provides a##2##3##(2008-5#1)(2008-9#1)
therefore provides an##2##3##(1990-8#1)(2008-11#1)
therefore provides##8##2##(1990-8#1)(1994-9#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-12#1)
therefore quite##2##2##(1993-3#1)(2010-7#1)
therefore recommend##3##2##(1993-5#1)(2006-10#1)(2009-9#1)
therefore recommended##8##2##(1992-6#1)(1994-3#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-7#1)(2010-2#1)(2011-2#1)
therefore reduce##2##2##(1990-12#1)(2006-7#1)
therefore reflect a##2##3##(1991-3#1)(1992-8#1)
therefore reflects##2##2##(1996-8#1)(2007-7#1)
therefore remains##4##2##(1990-7#1)(1991-9#1)(2004-9#1)(2008-6#1)
therefore represent a##2##3##(2008-1#1)(2008-4#1)
therefore represent##5##2##(2008-1#1)(2008-10#2)(2008-4#1)(2012-12#1)
therefore represents a new##2##4##(2008-10#1)(2011-2#1)
therefore represents a##5##3##(1995-6#1)(2008-10#1)(2009-7#1)(2011-2#1)(2013-1#1)
therefore represents an##2##3##(2008-11#1)(2009-5#1)
therefore represents##7##2##(1995-6#1)(2008-10#1)(2008-11#1)(2009-5#1)(2009-7#1)(2011-2#1)(2013-1#1)
therefore require careful##2##3##(1990-12#1)(2006-2#1)
therefore require##4##2##(1990-12#1)(2006-2#1)(2007-7#1)(2008-8#1)
therefore required##6##2##(2008-10#1)(2008-2#1)(2011-2#2)(2012-2#1)(2012-3#1)
therefore requires##4##2##(1992-4#1)(2008-10#1)(2008-11#1)(2012-1#1)
therefore reviewed##2##2##(1993-3#1)(2008-6#1)
therefore seem to be##3##4##(1990-12#1)(1991-8#1)(1993-9#1)
therefore seems to##2##3##(1991-3#1)(2012-2#1)
therefore seems##4##2##(1990-8#1)(1991-3#1)(2007-11#1)(2012-2#1)
therefore serve as a##2##4##(1994-2#1)(2012-3#1)
therefore serve as##5##3##(1993-2#1)(1994-2#1)(2007-12#1)(2008-8#1)(2012-3#1)
therefore set##2##2##(2008-11#1)(2009-5#1)
therefore severely##2##2##(1997-2#1)(1997-8#1)
therefore should be a##2##4##(1991-10#1)(2007-6#1)
therefore should be##5##3##(1991-10#1)(2006-8#1)(2007-11#1)(2007-6#1)(2008-10#1)
therefore should##7##2##(1991-10#1)(2006-8#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-11#1)(2009-4#1)
therefore significant##2##2##(2008-4#1)(2008-9#1)
therefore special attention##2##3##(2006-7#1)(2008-5#1)
therefore specific##3##2##(1996-5#1)(2008-10#1)(2008-2#1)
therefore strongly##3##2##(2006-10#1)(2007-3#2)
therefore studied in##2##3##(1990-5#1)(1992-11#1)
therefore studied##6##2##(1990-5#1)(1992-11#1)(1992-8#1)(1994-8#1)(1997-4#1)(2008-10#1)
therefore suggest##9##2##(1990-12#1)(1990-5#1)(1996-12#1)(2008-11#2)(2008-5#2)(2008-9#1)(2012-12#1)
therefore suggested that##6##3##(1993-10#1)(1997-2#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-1#1)
therefore suggested##7##2##(1993-10#1)(1997-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-1#1)
therefore suitable for the##2##4##(1993-12#1)(2006-10#1)
therefore suitable for##5##3##(1993-12#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-4#1)
therefore support the##2##3##(1994-4#1)(2008-7#1)
therefore supports the##2##3##(1992-4#1)(1994-6#1)
therefore susceptible to##2##3##(1994-12#1)(2012-12#1)
therefore tested the##2##3##(2008-1#1)(2010-10#1)
therefore tested##3##2##(1997-8#1)(2008-1#1)(2010-10#1)
therefore that the##7##3##(1990-5#1)(1990-8#1)(1991-12#1)(1995-3#1)(2008-5#1)(2010-2#1)(2013-1#1)
therefore that this##2##3##(1990-9#1)(1992-3#1)
therefore that##15##2##(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-3#1)(1995-11#1)(1995-3#1)(2006-2#1)(2007-1#1)(2008-10#2)(2008-5#1)(2010-2#1)(2013-1#1)
therefore the best##2##3##(2006-6#1)(2008-12#1)
therefore the method##2##3##(2006-10#1)(2008-3#1)
therefore the present##2##3##(2007-12#1)(2008-10#1)
therefore the prosthesis##2##3##(1991-2#2)
therefore the treatment##2##3##(1992-9#1)(2012-2#1)
therefore the##53##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-10#1)(1991-2#2)(1991-3#1)(1991-4#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-5#1)(1993-6#1)(1996-2#1)(1996-5#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#4)(2008-5#2)(2008-7#2)(2008-9#1)(2010-3#1)(2010-7#1)(2011-12#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#2)
therefore their##3##2##(2008-10#1)(2008-4#1)(2008-8#1)
therefore there is##2##3##(2007-6#1)(2008-5#1)
therefore they are##2##3##(2011-2#1)(2013-7#1)
therefore they##7##2##(1993-6#1)(2007-3#1)(2008-2#1)(2008-3#1)(2011-2#2)(2013-7#1)
therefore this##4##2##(1993-9#1)(1995-8#1)(2008-4#1)(2009-8#1)
therefore to be##3##3##(1996-1#1)(1997-5#1)(2007-12#1)
therefore to describe##2##3##(2009-6#1)(2012-3#1)
therefore to the##3##3##(2005-11#1)(2007-7#1)(2013-8#1)
therefore to##19##2##(1990-5#1)(1996-1#1)(1996-11#1)(1997-5#1)(2005-11#2)(2006-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-4#1)(2012-3#2)(2013-8#1)
therefore used##6##2##(1990-9#1)(1994-6#1)(1994-9#1)(1995-11#1)(2008-6#1)(2009-6#1)
therefore utilized##2##2##(1993-7#1)(2008-5#1)
therefore very##4##2##(2005-7#1)(2008-11#1)(2008-9#1)(2013-1#1)
therefore was##5##2##(1996-6#2)(2008-1#1)(2010-12#1)(2011-2#1)
therefore we##3##2##(1990-4#1)(1993-6#1)(2008-2#1)
therefore with the##2##3##(1990-12#1)(2008-10#1)
therefore with##4##2##(1990-12#1)(2007-3#1)(2008-10#1)(2008-2#1)
therefore##1853##1##(1990-1#1)(1990-10#5)(1990-11#15)(1990-12#15)(1990-2#4)(1990-3#9)(1990-4#3)(1990-5#14)(1990-6#2)(1990-7#4)(1990-8#13)(1990-9#6)(1991-1#2)(1991-10#5)(1991-11#4)(1991-12#9)(1991-2#11)(1991-3#8)(1991-4#9)(1991-5#8)(1991-6#5)(1991-7#7)(1991-8#5)(1991-9#9)(1992-1#3)(1992-10#2)(1992-11#9)(1992-12#2)(1992-2#7)(1992-3#9)(1992-4#6)(1992-5#3)(1992-6#10)(1992-7#6)(1992-8#7)(1992-9#3)(1993-1#2)(1993-10#2)(1993-11#8)(1993-12#6)(1993-2#4)(1993-3#10)(1993-4#4)(1993-5#3)(1993-6#3)(1993-7#4)(1993-8#3)(1993-9#9)(1994-10#3)(1994-11#5)(1994-12#11)(1994-2#8)(1994-3#19)(1994-4#4)(1994-5#5)(1994-6#9)(1994-7#1)(1994-8#12)(1994-9#10)(1995-1#4)(1995-10#3)(1995-11#8)(1995-12#14)(1995-2#10)(1995-3#10)(1995-4#3)(1995-5#10)(1995-6#8)(1995-7#2)(1995-8#9)(1995-9#2)(1996-1#10)(1996-10#2)(1996-11#13)(1996-12#7)(1996-2#5)(1996-3#3)(1996-4#3)(1996-5#6)(1996-6#5)(1996-7#5)(1996-8#6)(1996-9#5)(1997-1#5)(1997-2#5)(1997-3#9)(1997-4#9)(1997-5#5)(1997-6#6)(1997-7#13)(1997-8#5)(2004-10#1)(2004-11#1)(2004-2#1)(2004-4#1)(2004-9#4)(2005-10#2)(2005-11#11)(2005-12#2)(2005-3#1)(2005-4#1)(2005-5#1)(2005-7#7)(2005-8#8)(2005-9#5)(2006-1#3)(2006-10#31)(2006-11#3)(2006-12#21)(2006-2#9)(2006-4#3)(2006-5#6)(2006-6#8)(2006-7#9)(2006-8#8)(2006-9#3)(2007-1#11)(2007-10#5)(2007-11#23)(2007-12#27)(2007-2#6)(2007-3#11)(2007-4#5)(2007-5#5)(2007-6#7)(2007-7#11)(2007-8#30)(2007-9#6)(2008-1#27)(2008-10#128)(2008-11#55)(2008-12#16)(2008-2#38)(2008-3#44)(2008-4#34)(2008-5#52)(2008-6#26)(2008-7#48)(2008-8#36)(2008-9#42)(2009-1#2)(2009-10#8)(2009-11#2)(2009-12#5)(2009-2#7)(2009-3#7)(2009-4#8)(2009-5#13)(2009-6#5)(2009-7#5)(2009-8#11)(2009-9#2)(2010-1#2)(2010-10#6)(2010-11#5)(2010-12#20)(2010-2#10)(2010-3#8)(2010-4#12)(2010-5#1)(2010-6#5)(2010-7#5)(2010-8#10)(2010-9#1)(2011-1#19)(2011-12#4)(2011-2#58)(2011-3#3)(2011-7#1)(2012-1#12)(2012-11#4)(2012-12#26)(2012-2#36)(2012-3#24)(2012-6#1)(2012-7#2)(2013-1#42)(2013-7#4)(2013-8#19)
therefrom##6##1##(1992-12#1)(1996-4#1)(2005-8#1)(2008-3#2)(2008-8#1)
therein##12##1##(1992-3#1)(1994-2#1)(1994-8#1)(1995-12#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2012-2#1)
therelative##2##1##(2008-11#2)
thereof are##2##2##(1995-2#1)(2011-1#1)
thereof for##2##2##(1994-2#1)(2008-1#1)
thereof in##2##2##(1995-6#1)(1996-2#1)
thereof were also##2##3##(2006-8#1)(2008-5#1)
thereof were##3##2##(2006-8#1)(2008-5#1)(2008-8#1)
thereof##40##1##(1990-8#1)(1991-12#2)(1992-12#1)(1992-3#1)(1994-2#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#2)(1996-5#1)(1997-7#1)(2006-12#1)(2006-8#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
thermal (85)Rb vapor##3##3##(2007-11#3)
thermal ablation of##3##3##(2008-5#1)(2010-8#1)(2012-12#1)
thermal ablation##12##2##(2006-10#1)(2006-6#2)(2007-12#1)(2007-8#1)(2008-5#3)(2009-4#1)(2009-8#1)(2010-8#1)(2012-12#1)
thermal acoustics (LITA)##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
thermal acoustics##10##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#6)
thermal analgesia and##2##3##(2013-8#2)
thermal analgesia##3##2##(2013-8#3)
thermal analyses##2##2##(2004-9#1)(2005-11#1)
thermal analysis of##3##3##(2008-10#3)
thermal analysis##22##2##(1990-3#1)(1996-2#1)(2004-9#3)(2005-11#2)(2007-11#1)(2008-10#9)(2008-2#1)(2008-5#1)(2010-4#1)(2011-2#1)(2013-7#1)
thermal analysis)##2##2##(2007-8#1)(2008-10#1)
thermal and chemical stimuli##2##4##(2009-6#2)
thermal and chemical##4##3##(2006-10#1)(2009-6#2)(2012-2#1)
thermal and mechanical##4##3##(1996-8#1)(2008-2#1)(2008-7#2)
thermal and photochemical##2##3##(1995-2#1)(2006-10#1)
thermal and photolytic##2##3##(2010-12#1)(2012-12#1)
thermal and##31##2##(1995-2#1)(1996-8#1)(2005-11#1)(2006-10#2)(2007-11#2)(2007-12#3)(2007-4#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#3)(2009-5#1)(2009-6#2)(2010-12#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
thermal annealing at##2##3##(2007-11#1)(2007-12#1)
thermal annealing on the##3##4##(2007-12#1)(2008-2#2)
thermal annealing##13##2##(2007-11#3)(2007-12#3)(2008-2#5)(2010-4#1)(2012-2#1)
thermal asymmetric interlaced PCR (TAIL-PCR) technique##2##6##(2008-10#1)(2008-8#1)
thermal behavior of a##2##4##(2005-11#1)(2008-9#1)
thermal behavior of silver##2##4##(2005-11#2)
thermal behavior of##6##3##(1994-5#1)(2005-11#3)(2008-2#1)(2008-9#1)
thermal behavior##8##2##(1994-5#1)(2005-11#3)(2007-12#1)(2008-2#1)(2008-9#1)(2010-12#1)
thermal behaviour##2##2##(2008-10#2)
thermal birefringence##2##2##(2007-11#1)(2008-3#1)
thermal blooming##2##2##(2008-2#2)
thermal boundary##3##2##(1995-6#1)(2008-3#2)
thermal burns##2##2##(2008-1#1)(2008-11#1)
thermal characteristics of Ag-HHDA##2##4##(2005-11#2)
thermal characteristics of##6##3##(2005-11#2)(2007-8#1)(2008-2#1)(2008-3#2)
thermal characteristics##8##2##(2005-11#2)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#3)
thermal characterization of##2##3##(2008-3#2)
thermal characterization##3##2##(2004-9#1)(2008-3#2)
thermal chopping##2##2##(2008-3#2)
thermal compensation##2##2##(2007-6#2)
thermal conditions##5##2##(1996-5#1)(2005-11#1)(2007-6#1)(2008-6#2)
thermal conductance##3##2##(2008-2#1)(2008-3#2)
thermal conductivities##3##2##(2008-3#3)
thermal conductivity detector##3##3##(2008-10#2)(2011-1#1)
thermal conductivity of the##2##4##(2008-2#1)(2008-3#1)
thermal conductivity of##4##3##(2008-2#1)(2008-3#3)
thermal conductivity##14##2##(1997-5#1)(2008-10#3)(2008-2#1)(2008-3#7)(2011-1#1)(2013-1#1)
thermal conductivity)##3##2##(1996-5#1)(2008-3#2)
thermal constant##2##2##(2007-6#2)
thermal constraint on activity##2##4##(2008-8#2)
thermal constraints on activity##2##4##(2008-8#2)
thermal constraints##3##2##(2008-8#3)
thermal contribution to the nonlinear refractive index of air at##2##10##(2007-12#2)
thermal control##2##2##(2008-3#2)
thermal cycling##5##2##(2008-2#1)(2008-4#1)(2011-2#2)(2013-8#1)
thermal damage##7##2##(1991-2#1)(2006-12#1)(2008-2#2)(2008-3#2)(2012-2#1)
thermal data##4##2##(2006-10#1)(2007-11#1)(2008-5#2)
thermal decay of##2##3##(1990-2#1)(2007-11#1)
thermal decay##3##2##(1990-2#1)(2007-11#1)(2007-12#1)
thermal decomposition of a##2##4##(2008-10#2)
thermal decomposition of##7##3##(1996-12#1)(2007-11#1)(2008-10#4)(2010-7#1)
thermal decomposition##19##2##(1996-12#1)(1996-8#2)(2007-11#3)(2008-10#10)(2008-6#1)(2010-4#1)(2010-7#1)
thermal deformations are##2##3##(2008-3#2)
thermal deformations of mirror##3##4##(2008-3#3)
thermal deformations of##4##3##(2008-3#4)
thermal deformations##7##2##(2008-3#7)
thermal degradation of the##2##4##(2008-10#1)(2008-3#1)
thermal degradation of##3##3##(2008-10#2)(2008-3#1)
thermal degradation products##2##3##(1991-8#1)(2013-7#1)
thermal degradation##14##2##(1990-8#4)(1991-8#1)(1997-5#1)(2008-10#2)(2008-3#2)(2010-2#1)(2012-12#1)(2013-7#2)
thermal denaturation of##9##3##(1991-2#4)(1993-8#1)(1996-11#1)(2006-10#1)(2008-4#1)(2010-4#1)
thermal denaturation studies##2##3##(2008-5#2)
thermal denaturation temperature##3##3##(1992-8#1)(1994-9#1)(2007-11#1)
thermal denaturation##31##2##(1990-5#1)(1991-2#4)(1991-5#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-8#2)(1994-3#2)(1994-9#1)(1996-11#1)(1997-2#2)(2006-10#2)(2007-11#1)(2008-4#2)(2008-5#3)(2008-9#2)(2009-12#1)(2010-4#1)
thermal dephasing##2##2##(2007-12#2)
thermal desorption and gas chromatography-mass spectrometry##2##6##(2008-3#2)
thermal desorption and gas##3##4##(2008-3#2)(2010-5#1)
thermal desorption##13##2##(2007-10#1)(2008-10#8)(2008-3#2)(2010-5#2)
thermal detector##2##2##(2007-11#1)(2008-3#1)
thermal detectors##2##2##(2008-3#2)
thermal difference between the##2##4##(1996-3#2)
thermal diffusion##5##2##(1990-8#1)(2007-12#2)(2008-3#2)
thermal diffusivity##8##2##(2008-3#7)(2013-1#1)
thermal distributions##2##2##(2007-11#2)
thermal drift##2##2##(2008-2#1)(2008-3#1)
thermal drying##2##2##(2005-11#2)
thermal effect##5##2##(1995-10#1)(2006-10#1)(2008-3#3)
thermal effects are##2##3##(1995-2#1)(2008-2#1)
thermal effects in##5##3##(2006-4#1)(2007-12#2)(2008-2#2)
thermal effects on##2##3##(2007-12#1)(2008-10#1)
thermal effects##24##2##(1995-2#1)(2006-4#1)(2007-11#1)(2007-12#7)(2008-10#1)(2008-2#5)(2008-3#5)(2011-2#2)(2013-1#1)
thermal emission and##2##3##(2008-3#2)
thermal emission from##3##3##(2007-12#1)(2008-3#2)
thermal emission##9##2##(1991-5#1)(1994-7#1)(2007-12#1)(2008-2#1)(2008-3#5)
thermal energy##8##2##(1995-7#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-3#1)(2012-6#1)
thermal environments##3##2##(2006-8#1)(2010-8#2)
thermal equilibria among##2##3##(1994-11#2)
thermal equilibrium at##2##3##(2008-3#2)
thermal equilibrium##6##2##(1995-10#1)(2007-3#1)(2008-11#1)(2008-3#2)(2012-2#1)
thermal evaporation##4##2##(2006-12#1)(2007-12#1)(2008-2#1)(2008-3#1)
thermal expansion of##2##3##(2008-1#1)(2010-4#1)
thermal expansion##11##2##(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#3)(2010-4#1)
thermal fixing of##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
thermal fixing##7##2##(2007-12#1)(2008-2#4)(2008-3#2)
thermal fluctuation##2##2##(2008-3#1)(2009-11#1)
thermal fluctuations of##2##3##(1995-7#1)(2009-11#1)
thermal fluctuations##8##2##(1993-7#1)(1995-7#1)(2005-11#1)(2006-10#1)(2008-3#3)(2009-11#1)
thermal gradient##6##2##(2006-6#1)(2007-7#1)(2008-3#3)(2011-2#1)
thermal gradients##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
thermal grating##4##2##(2007-12#4)
thermal gratings##4##2##(2007-12#1)(2008-3#3)
thermal gravimetry##2##2##(2005-11#1)(2007-11#1)
thermal heating and##2##3##(2006-12#1)(2009-2#1)
thermal hyperalgesia in##4##3##(1995-12#1)(1996-5#2)(2008-5#1)
thermal hyperalgesia was##2##3##(1996-5#1)(2008-5#1)
thermal hyperalgesia##13##2##(1995-11#1)(1995-12#5)(1996-5#4)(2008-5#2)(2008-7#1)
thermal inactivation of the##3##4##(1991-2#1)(1995-8#1)(2008-10#1)
thermal inactivation of##8##3##(1991-2#1)(1994-3#1)(1995-8#1)(2008-10#4)(2010-4#1)
thermal inactivation##14##2##(1990-7#1)(1991-2#2)(1994-3#1)(1995-2#1)(1995-8#1)(1997-4#1)(2008-10#6)(2010-4#1)
thermal induced digestion##2##3##(2008-10#2)
thermal infrared detectors##2##3##(2007-11#2)
thermal infrared##9##2##(2007-11#2)(2008-3#7)
thermal initiation##6##2##(2004-9#1)(2008-10#5)
thermal injuries##3##2##(1994-5#1)(2005-10#1)(2009-4#1)
thermal injury##11##2##(1995-1#1)(2005-10#1)(2006-12#1)(2006-7#1)(2008-9#6)(2013-1#1)
thermal ionization mass spectrometry##5##4##(1992-2#1)(1992-3#1)(1992-7#1)(2008-10#2)
thermal isomerization##2##2##(1995-1#1)(1997-4#1)
thermal lens (TL)##2##3##(2008-3#2)
thermal lens and##4##3##(2008-2#1)(2008-3#3)
thermal lens effect##2##3##(2008-2#1)(2008-3#1)
thermal lens signal##2##3##(2007-11#1)(2008-10#1)
thermal lens spectrometer##4##3##(2008-10#3)(2008-2#1)
thermal lens spectrometry (TLS)##2##4##(2008-10#2)
thermal lens spectrometry can be##2##5##(2007-11#1)(2008-10#1)
thermal lens spectrometry##9##3##(2007-11#1)(2008-10#8)
thermal lens##35##2##(2007-11#3)(2008-10#13)(2008-2#7)(2008-3#12)
thermal lensing and##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
thermal lensing effect##4##3##(2008-2#2)(2008-3#2)
thermal lensing in##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
thermal lensing##32##2##(2007-11#2)(2007-12#4)(2008-10#6)(2008-2#6)(2008-3#14)
thermal load##2##2##(2007-12#1)(2008-2#1)
thermal loading can be##2##4##(2007-12#1)(2008-3#1)
thermal loading effects in room-temperature##2##5##(2007-12#1)(2008-2#1)
thermal loading in##4##3##(2008-2#3)(2008-3#1)
thermal loading of##2##3##(2007-12#2)
thermal loading##17##2##(2007-12#7)(2008-2#7)(2008-3#3)
thermal luminescence##2##2##(2008-3#2)
thermal means##2##2##(2006-12#1)(2008-10#1)
thermal melting##3##2##(1993-8#1)(1995-2#1)(1995-6#1)
thermal method of##2##3##(2008-10#1)(2013-1#1)
thermal model##2##2##(2008-3#2)
thermal motion##4##2##(1996-2#1)(2006-10#2)(2008-3#1)
thermal noise##6##2##(1991-2#1)(2007-12#2)(2008-2#2)(2008-3#1)
thermal nonlinearities##3##2##(2007-12#2)(2008-3#1)
thermal offset##3##2##(2008-3#3)
thermal or mechanical##2##3##(2008-10#1)(2008-7#1)
thermal or##6##2##(1994-11#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-9#1)
thermal oxidation of##2##3##(2008-10#2)
thermal oxidation##3##2##(2008-10#2)(2011-1#1)
thermal pain##3##2##(2009-3#1)(2010-4#1)(2011-1#1)
thermal parameters##3##2##(2008-3#2)(2013-1#1)
thermal phase behaviour of##2##4##(1994-3#2)
thermal phase##5##2##(1994-3#2)(1996-1#1)(2007-12#1)(2008-10#1)
thermal poling##2##2##(2007-11#1)(2007-12#1)
thermal preferences##2##2##(2011-2#2)
thermal probe##2##2##(2008-2#1)(2013-8#1)
thermal probes##2##2##(1991-2#1)(2008-5#1)
thermal process##2##2##(2011-2#2)
thermal processing of##3##3##(2008-5#1)(2011-2#2)
thermal processing on##2##3##(2004-9#1)(2012-2#1)
thermal processing##10##2##(2004-9#1)(2008-2#1)(2008-5#3)(2011-2#4)(2012-2#1)
thermal profiles##2##2##(2008-3#1)(2008-5#1)
thermal properties and##3##3##(1991-7#1)(2009-3#1)(2012-12#1)
thermal properties of##3##3##(2008-3#2)(2012-12#1)
thermal properties##13##2##(1991-7#1)(2004-9#1)(2007-12#1)(2008-3#4)(2009-3#2)(2012-12#4)
thermal radiation##3##2##(2008-2#2)(2010-4#1)
thermal reaction##5##2##(2008-10#2)(2008-3#1)(2011-12#2)
thermal refractive-index coefficients of 7##2##5##(2008-2#2)
thermal requirements##3##2##(2008-6#2)(2008-8#1)
thermal resistance##7##2##(1992-5#3)(1992-9#1)(2007-12#1)(2008-12#1)(2010-6#1)
thermal response##2##2##(1990-7#1)(2007-10#1)
thermal sensitivity in##2##3##(2006-5#1)(2008-7#1)
thermal sensitivity of##2##3##(1992-6#1)(2008-8#1)
thermal sensitivity##5##2##(1992-6#1)(2006-5#1)(2008-2#1)(2008-7#1)(2008-8#1)
thermal shift##2##2##(2007-12#2)
thermal silica##5##2##(2005-11#5)
thermal silicon##2##2##(2005-11#2)
thermal springs in##2##3##(1994-3#2)
thermal springs##3##2##(1994-3#3)
thermal stabilisation##2##2##(2008-10#2)
thermal stabilities##3##2##(1995-6#1)(2008-10#1)(2011-1#1)
thermal stability and##6##3##(1994-8#1)(2005-10#1)(2008-2#1)(2011-1#1)(2012-11#2)
thermal stability of 5-fluorouracil##2##4##(2010-4#2)
thermal stability of the##9##4##(1990-12#1)(1993-6#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-5#1)(2009-3#1)(2011-2#1)
thermal stability of##27##3##(1990-12#1)(1993-6#1)(1995-2#1)(1995-8#1)(1997-6#1)(2005-11#2)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-9#2)(2010-4#2)(2011-1#1)(2011-2#1)
thermal stability than the##2##4##(1994-5#1)(2009-3#1)
thermal stability than##3##3##(1994-5#1)(2008-3#1)(2009-3#1)
thermal stability##66##2##(1990-11#1)(1990-12#1)(1991-7#1)(1993-6#1)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-2#1)(1995-8#2)(1996-2#1)(1996-7#1)(1997-6#1)(2005-10#1)(2005-11#4)(2006-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#9)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#1)(2008-9#1)(2009-3#2)(2009-9#2)(2010-3#1)(2010-4#4)(2011-1#4)(2011-2#2)(2012-11#2)(2012-2#1)
thermal stabilization of tellurium in graphite furnaces##2##7##(2008-10#2)
thermal stabilization of##4##3##(2008-10#4)
thermal stabilization##5##2##(2008-10#5)
thermal stimuli##2##2##(1997-5#1)(2009-12#1)
thermal stress was##2##3##(1992-5#1)(2006-6#1)
thermal stress##13##2##(1990-2#1)(1992-1#1)(1992-5#1)(1994-11#2)(2006-6#4)(2007-12#1)(2012-2#1)(2013-7#2)
thermal studies##3##2##(2007-11#1)(2008-10#1)(2008-6#1)
thermal therapy##2##2##(2008-5#2)
thermal time##3##2##(2008-10#3)
thermal tolerance##3##2##(2008-1#1)(2009-6#2)
thermal transients##5##2##(1996-8#2)(2007-12#2)(2008-2#1)
thermal transition##6##2##(1993-8#1)(1994-2#1)(1994-8#2)(1995-6#1)(2008-5#1)
thermal transitions at##2##3##(1996-5#1)(2012-2#1)
thermal transitions##3##2##(1996-5#2)(2012-2#1)
thermal treatment##8##2##(1993-12#1)(1996-2#1)(1996-5#1)(2005-11#1)(2007-11#1)(2008-10#1)(2009-3#2)
thermal tuning and##2##3##(2007-12#2)
thermal unfolding##5##2##(1995-3#1)(1997-2#3)(1997-7#1)
thermal##1027##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#5)(1990-8#5)(1991-1#1)(1991-11#2)(1991-2#9)(1991-5#3)(1991-6#1)(1991-7#3)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#4)(1992-6#1)(1992-7#4)(1992-8#2)(1992-9#4)(1993-11#2)(1993-12#1)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#4)(1994-11#6)(1994-2#1)(1994-3#9)(1994-5#5)(1994-7#2)(1994-8#4)(1994-9#2)(1995-1#2)(1995-10#2)(1995-11#1)(1995-12#5)(1995-2#6)(1995-3#1)(1995-6#4)(1995-7#2)(1995-8#4)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#5)(1996-3#3)(1996-5#10)(1996-6#1)(1996-7#3)(1996-8#5)(1997-2#5)(1997-4#3)(1997-5#4)(1997-6#1)(1997-7#1)(2004-3#1)(2004-9#13)(2005-10#3)(2005-11#28)(2005-4#1)(2005-7#1)(2005-8#2)(2006-10#13)(2006-12#10)(2006-2#2)(2006-4#4)(2006-5#1)(2006-6#7)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#42)(2007-12#74)(2007-3#1)(2007-4#2)(2007-6#5)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#5)(2008-10#127)(2008-11#4)(2008-12#1)(2008-2#92)(2008-3#170)(2008-4#7)(2008-5#30)(2008-6#9)(2008-7#7)(2008-8#13)(2008-9#10)(2009-10#2)(2009-11#5)(2009-12#4)(2009-2#1)(2009-3#9)(2009-4#2)(2009-5#1)(2009-6#8)(2009-7#1)(2009-8#1)(2009-9#2)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#19)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#9)(2011-12#3)(2011-2#23)(2012-1#4)(2012-11#5)(2012-12#7)(2012-2#11)(2012-6#1)(2013-1#9)(2013-7#6)(2013-8#9)
thermal-expansion coefficient##2##2##(2007-11#1)(2008-3#1)
thermal-expansion##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
thermal-induced mask##2##2##(2008-2#2)
thermal-induced##4##1##(2006-2#1)(2008-2#2)(2010-6#1)
thermal-lens Raman spectroscopy##2##3##(2007-12#2)
thermal-lens technique##2##2##(2007-12#2)
thermal-lens##11##1##(2007-12#6)(2008-10#2)(2008-3#3)
thermal-lensing##2##1##(2007-11#1)(2008-3#1)
thermal-mending##2##1##(2010-4#2)
thermalization of##2##2##(1994-5#1)(2008-2#1)
thermally activated##5##2##(2004-9#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-2#1)
thermally boosted pumping##2##3##(2008-3#2)
thermally damaged##2##2##(1994-5#1)(2008-2#1)
thermally decomposed##2##2##(1997-5#1)(2008-10#1)
thermally denatured##3##2##(1995-3#1)(2008-10#2)
thermally desorbed##4##2##(2008-10#3)(2010-5#1)
thermally driven##2##2##(1993-4#1)(2008-7#1)
thermally evaporated##4##2##(2008-2#2)(2009-12#1)(2009-2#1)
thermally excited##3##2##(2008-2#1)(2008-3#2)
thermally fixed##4##2##(2007-12#3)(2008-2#1)
thermally inactivated enzyme##3##3##(1997-4#3)
thermally inactivated##4##2##(1997-4#4)
thermally induced birefringence in##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
thermally induced birefringence##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
thermally induced phase mismatch##2##4##(2007-12#2)
thermally induced second-harmonic output depolarization##2##5##(2007-12#2)
thermally induced##29##2##(1991-9#1)(1992-6#1)(1994-5#1)(2005-11#1)(2007-12#10)(2008-10#1)(2008-2#5)(2008-3#8)(2009-2#1)
thermally overexpanded fiber##2##3##(2008-2#2)
thermally oxidized##4##2##(2008-5#1)(2009-5#3)
thermally poled fused-silica##2##3##(2007-12#2)
thermally poled##10##2##(2007-11#2)(2007-12#6)(2008-1#2)
thermally reversible##2##2##(1996-11#1)(2008-10#1)
thermally stabilized##3##2##(2005-11#1)(2007-12#1)(2008-10#1)
thermally stable up to##2##4##(2007-9#1)(2008-5#1)
thermally stable##9##2##(1992-12#1)(1996-2#1)(1997-4#1)(2005-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-5#1)(2010-4#1)
thermally stimulated##3##2##(2007-12#1)(2008-2#1)(2011-1#1)
thermally##129##1##(1990-7#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-6#1)(1993-4#1)(1994-2#1)(1994-5#2)(1995-3#1)(1996-11#1)(1996-2#2)(1997-4#5)(1997-5#1)(2004-9#1)(2005-11#3)(2006-12#1)(2006-5#1)(2006-6#1)(2007-11#4)(2007-12#26)(2007-9#1)(2008-1#2)(2008-10#16)(2008-2#17)(2008-3#17)(2008-5#2)(2008-6#1)(2008-7#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-5#4)(2010-4#2)(2010-5#1)(2011-1#2)(2012-2#1)
thermine##5##1##(2008-11#5)
thermionic emission##2##2##(1992-8#1)(2007-9#1)
thermionic##3##1##(1992-8#1)(2007-9#1)(2009-6#1)
thermistor bolometer radiometers##2##3##(2008-2#2)
thermistor bolometer##4##2##(2008-2#4)
thermistor##8##1##(1996-7#1)(2007-11#1)(2008-10#1)(2008-2#4)(2008-3#1)
thermistors##2##1##(2008-3#2)
thermo##5##1##(2008-10#2)(2008-11#1)(2011-2#1)(2013-8#1)
thermo-chemical pre-treatments##3##2##(2013-1#3)
thermo-chemical##4##1##(2013-1#4)
thermo-coagulated blood##5##2##(1996-12#5)
thermo-coagulation##2##1##(1996-12#1)(2010-12#1)
thermo-mechanical##2##1##(2004-9#1)(2013-1#1)
thermo-optic coefficient of the##2##4##(2007-11#2)
thermo-optic coefficient of##3##3##(2007-11#2)(2007-12#1)
thermo-optic effect##3##2##(2007-11#1)(2008-3#2)
thermo-optic phase shifters##2##3##(2008-2#2)
thermo-optic##16##1##(2007-11#4)(2007-12#4)(2008-2#4)(2008-3#4)
thermo-optical properties##3##2##(2008-3#3)
thermo-optical##7##1##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)
thermo-sensitive genic male-sterile##2##3##(2008-8#2)
thermo-tolerance##2##1##(2007-7#1)(2012-6#1)
thermoTRP channels##2##2##(2008-7#2)
thermoTRP##4##1##(2008-7#2)(2009-3#2)
thermoTRP's##3##1##(2009-3#3)
thermoTRPs##2##1##(2008-7#1)(2009-3#1)
thermoacidophilic archaebacterium Sulfolobus acidocaldarius##2##4##(1990-3#1)(1990-7#1)
thermoacidophilic archaebacterium Sulfolobus solfataricus##2##4##(1990-9#1)(1995-2#1)
thermoacidophilic archaebacterium Sulfolobus##4##3##(1990-3#1)(1990-7#1)(1990-9#1)(1995-2#1)
thermoacidophilic archaebacterium##5##2##(1990-12#1)(1990-3#1)(1990-7#1)(1990-9#1)(1995-2#1)
thermoacidophilic archaeon Sulfolobus##2##3##(1997-7#1)(2008-9#1)
thermoacidophilic##9##1##(1990-12#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-9#2)(1995-2#1)(1997-7#1)(2008-9#1)
thermoanalytical examination##2##2##(2004-9#1)(2008-5#1)
thermoanalytical##4##1##(2004-9#2)(2008-5#2)
thermocatenulatus##3##1##(1996-5#2)(2011-2#1)
thermocellum ATCC 27405##3##3##(2008-5#2)(2013-1#1)
thermocellum cell extracts##2##3##(2008-6#2)
thermocellum endoglucanase##3##2##(1990-3#1)(1990-4#1)(1991-7#1)
thermocellum was##2##2##(1990-4#1)(2013-1#1)
thermocellum##32##1##(1990-3#2)(1990-4#4)(1991-2#3)(1991-5#3)(1991-7#3)(1995-2#2)(2006-8#2)(2008-5#6)(2008-6#4)(2013-1#3)
thermochemical##2##1##(2008-5#1)(2013-1#1)
thermochemical/biological processing##2##2##(2008-5#2)
thermochemically##2##1##(1996-5#1)(2008-5#1)
thermochemolysis##2##1##(2013-1#2)
thermocline##5##1##(1991-11#1)(1993-2#1)(2007-5#2)(2007-9#1)
thermocoagulation of##2##2##(1993-11#1)(1996-9#1)
thermocoagulation##4##1##(1993-11#2)(1996-9#1)(2006-7#1)
thermocoagulatory lesion##2##2##(1996-9#2)
thermocoagulatory lesions##4##2##(1996-9#4)
thermocoagulatory##7##1##(1996-9#7)
thermocouple measurements##3##2##(2008-2#1)(2008-3#2)
thermocouple##13##1##(2006-5#1)(2008-10#2)(2008-2#3)(2008-3#5)(2009-11#1)(2012-12#1)
thermocouples##2##1##(2006-6#1)(2008-3#1)
thermocyclers##2##1##(2013-8#2)
thermocycling##5##1##(1997-6#1)(2008-12#1)(2011-1#1)(2013-8#2)
thermodenaturation##4##1##(1992-3#4)
thermodestruction##2##1##(1993-8#1)(2008-2#1)
thermodynamic activation parameters##4##3##(1992-3#1)(1994-8#2)(2008-10#1)
thermodynamic analogy##2##2##(1991-6#2)
thermodynamic analysis of the##5##4##(1994-9#1)(1997-2#2)(2005-11#2)
thermodynamic analysis of##9##3##(1994-9#1)(1997-1#1)(1997-2#3)(1997-4#1)(2005-11#2)(2007-12#1)
thermodynamic analysis##11##2##(1990-7#1)(1993-8#1)(1994-9#1)(1997-1#1)(1997-2#3)(1997-4#1)(2005-11#2)(2007-12#1)
thermodynamic and kinetic constants##2##4##(2008-10#2)
thermodynamic and kinetic parameters##2##4##(1993-8#1)(2008-4#1)
thermodynamic and kinetic##6##3##(1993-3#1)(1993-8#1)(2008-10#2)(2008-4#1)(2009-11#1)
thermodynamic and structural##2##3##(1996-4#1)(2011-2#1)
thermodynamic and##14##2##(1992-1#1)(1993-3#1)(1993-8#1)(1996-4#1)(1996-5#1)(2006-10#1)(2008-10#4)(2008-4#1)(2009-11#1)(2009-9#1)(2011-2#1)
thermodynamic approach##3##2##(1991-4#1)(2008-10#1)(2008-4#1)
thermodynamic binding##2##2##(1990-8#1)(1991-4#1)
thermodynamic characteristics##4##2##(1993-8#1)(2006-10#1)(2008-10#2)
thermodynamic characterization of the##2##4##(1993-11#1)(1994-11#1)
thermodynamic considerations##4##2##(1992-2#1)(2004-4#1)(2006-10#1)(2008-10#1)
thermodynamic constants of##2##3##(2008-10#2)
thermodynamic constants##4##2##(1993-3#1)(2008-10#3)
thermodynamic control##2##2##(2013-1#2)
thermodynamic coupling##2##2##(1997-4#1)(2008-3#1)
thermodynamic cycle##4##2##(1991-7#1)(1993-11#1)(1994-8#1)(1997-4#1)
thermodynamic data for##2##3##(1992-9#1)(1994-8#1)
thermodynamic data were##2##3##(1996-2#1)(2008-10#1)
thermodynamic data##16##2##(1991-6#1)(1992-9#2)(1993-3#1)(1994-8#1)(1996-2#1)(1996-4#1)(2005-11#1)(2008-10#8)
thermodynamic dissociation constant##3##3##(2008-10#3)
thermodynamic dissociation##4##2##(2008-10#4)
thermodynamic driving force##3##3##(1995-6#1)(2009-11#1)(2009-7#1)
thermodynamic driving##4##2##(1995-6#1)(2005-11#1)(2009-11#1)(2009-7#1)
thermodynamic effect##2##2##(1990-8#1)(2008-8#1)
thermodynamic effects of##2##3##(1990-8#1)(1995-5#1)
thermodynamic equilibrium##10##2##(1995-2#1)(2008-10#4)(2008-2#1)(2008-3#1)(2010-9#2)(2013-1#1)
thermodynamic experiments##2##2##(1996-2#1)(2007-11#1)
thermodynamic functions of##2##3##(1992-5#1)(2008-10#1)
thermodynamic functions##3##2##(1992-5#1)(2008-10#2)
thermodynamic information##2##2##(2007-11#1)(2008-3#1)
thermodynamic integration##2##2##(2006-10#1)(2009-5#1)
thermodynamic limit##6##2##(2008-11#1)(2008-2#2)(2008-3#3)
thermodynamic measurements##2##2##(2008-1#1)(2008-10#1)
thermodynamic methods##2##2##(1995-6#1)(2009-11#1)
thermodynamic model of inorganic arsenic##3##5##(2008-10#3)
thermodynamic model##6##2##(2005-11#1)(2008-10#5)
thermodynamic parameters and##3##3##(1994-11#1)(1996-2#1)(2008-10#1)
thermodynamic parameters associated##2##3##(1995-5#1)(2008-10#1)
thermodynamic parameters for the##3##4##(1992-3#1)(1997-2#1)(2008-10#1)
thermodynamic parameters for##7##3##(1991-7#1)(1992-3#1)(1997-2#1)(2008-10#4)
thermodynamic parameters of##7##3##(1991-4#1)(1992-3#1)(2006-10#1)(2008-10#3)(2008-6#1)
thermodynamic parameters were calculated##2##4##(2008-10#2)
thermodynamic parameters were determined##2##4##(2005-11#1)(2008-10#1)
thermodynamic parameters were##5##3##(1993-8#1)(2005-11#1)(2008-10#3)
thermodynamic parameters##49##2##(1990-7#2)(1991-4#1)(1991-7#1)(1991-8#1)(1992-3#2)(1992-9#1)(1993-8#1)(1994-11#2)(1994-8#1)(1995-5#2)(1996-2#1)(1997-1#1)(1997-2#1)(2005-11#4)(2006-10#2)(2006-12#2)(2008-10#20)(2008-4#3)(2008-6#1)
thermodynamic properties of the##5##4##(1990-7#1)(1993-3#1)(1996-11#1)(2006-10#1)(2008-10#1)
thermodynamic properties of##8##3##(1990-7#1)(1990-8#1)(1991-5#1)(1993-3#1)(1996-11#1)(1997-5#1)(2006-10#1)(2008-10#1)
thermodynamic properties##12##2##(1990-7#1)(1990-8#1)(1991-5#2)(1992-6#1)(1993-3#1)(1996-11#1)(1997-5#1)(2006-10#1)(2008-10#2)(2008-9#1)
thermodynamic quantities##11##2##(1996-11#3)(2005-11#4)(2008-10#2)(2008-9#1)(2010-2#1)
thermodynamic speciation##2##2##(2007-8#2)
thermodynamic stability and structure of##2##5##(1995-5#1)(2007-11#1)
thermodynamic stability of the##3##4##(1994-8#1)(1995-10#1)(2006-10#1)
thermodynamic stability of##11##3##(1992-3#1)(1992-4#1)(1994-8#1)(1995-10#1)(1995-8#1)(2006-10#1)(2007-10#1)(2008-10#2)(2008-9#1)(2012-2#1)
thermodynamic stability##22##2##(1990-8#1)(1992-3#1)(1992-4#1)(1994-11#1)(1994-8#1)(1995-10#1)(1995-5#1)(1995-8#1)(1996-2#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-9#2)(2010-5#1)(2012-1#1)(2012-2#2)
thermodynamic studies of##4##3##(1990-9#1)(1993-3#1)(2006-10#1)(2008-10#1)
thermodynamic studies##5##2##(1990-9#1)(1991-5#1)(1993-3#1)(2006-10#1)(2008-10#1)
thermodynamic study##3##2##(1990-8#1)(2008-10#2)
thermodynamic system##2##2##(1990-8#1)(2005-11#1)
thermodynamic theory##3##2##(1990-8#2)(1994-11#1)
thermodynamic##298##1##(1990-5#1)(1990-7#4)(1990-8#11)(1990-9#1)(1991-11#1)(1991-4#4)(1991-5#3)(1991-6#3)(1991-7#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#3)(1992-6#1)(1992-7#1)(1992-9#3)(1993-11#3)(1993-3#5)(1993-6#1)(1993-8#4)(1994-11#5)(1994-12#1)(1994-7#1)(1994-8#8)(1994-9#1)(1995-1#3)(1995-10#1)(1995-2#1)(1995-4#1)(1995-5#6)(1995-6#2)(1995-8#1)(1996-11#6)(1996-2#4)(1996-4#3)(1996-5#1)(1997-1#2)(1997-2#9)(1997-4#5)(1997-5#2)(1997-6#1)(2004-4#1)(2005-10#1)(2005-11#19)(2006-10#10)(2006-12#2)(2006-6#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#75)(2008-11#1)(2008-2#4)(2008-3#8)(2008-4#5)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#5)(2009-11#5)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-2#2)(2010-5#2)(2010-9#3)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#3)(2013-7#1)
thermodynamical##6##1##(1990-8#1)(1994-12#1)(2005-4#2)(2007-11#1)(2009-2#1)
thermodynamically and kinetically##4##3##(1997-2#1)(2008-3#2)(2010-5#1)
thermodynamically favored##4##2##(1993-11#1)(2006-10#1)(2008-7#1)(2009-10#1)
thermodynamically linked##2##2##(1991-7#1)(1993-11#1)
thermodynamically stable##3##2##(2006-4#1)(2008-9#1)(2012-2#1)
thermodynamically unstable##2##2##(2008-2#1)(2010-4#1)
thermodynamically##30##1##(1990-5#1)(1991-4#1)(1991-7#1)(1992-5#1)(1993-11#2)(1994-8#1)(1995-5#1)(1996-2#1)(1997-2#1)(2005-10#1)(2006-10#1)(2006-4#1)(2006-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-4#1)(2010-5#1)(2012-2#1)(2013-1#1)
thermodynamics and##7##2##(1992-9#2)(1997-2#1)(2005-11#2)(2009-8#1)(2011-1#1)
thermodynamics in##2##2##(1991-2#1)(2010-2#1)
thermodynamics is##2##2##(2006-10#1)(2013-8#1)
thermodynamics of the binding of ligands by##2##7##(1996-11#2)
thermodynamics of the binding##4##4##(1996-11#3)(2007-8#1)
thermodynamics of the##13##3##(1990-8#1)(1991-8#1)(1993-3#1)(1994-8#2)(1995-4#1)(1996-11#4)(2007-8#1)(2008-10#2)
thermodynamics of##27##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-4#1)(1991-8#1)(1992-5#1)(1992-9#3)(1993-3#1)(1994-8#2)(1995-4#1)(1996-11#5)(2005-11#1)(2007-8#1)(2008-10#3)(2008-8#2)(2008-9#1)(2010-7#1)
thermodynamics##59##1##(1990-12#1)(1990-5#1)(1990-8#2)(1991-2#2)(1991-4#1)(1991-7#1)(1991-8#1)(1992-5#1)(1992-9#5)(1993-12#1)(1993-3#1)(1994-8#2)(1995-11#2)(1995-4#1)(1996-11#5)(1997-2#3)(2005-11#4)(2006-10#2)(2007-8#1)(2007-9#1)(2008-10#5)(2008-3#3)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
thermoelastic##4##1##(2007-12#2)(2008-3#2)
thermoelectric materials##2##2##(1996-5#2)
thermoelectric##10##1##(1992-12#1)(1996-5#4)(2006-5#2)(2007-11#1)(2008-3#1)(2008-9#1)
thermoelectrically cooled##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
thermoformed##3##1##(2006-2#3)
thermogenesis and##2##2##(2013-1#2)
thermogenesis in brown adipose tissue##2##5##(2006-2#1)(2013-1#1)
thermogenesis in##4##2##(1997-3#1)(2006-2#1)(2013-1#2)
thermogenesis##25##1##(1990-4#2)(1992-6#1)(1994-6#1)(1995-8#1)(1997-3#1)(1997-4#1)(2004-12#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-12#6)(2012-3#1)(2013-1#5)
thermogenic nutritional supplement##4##3##(2013-8#4)
thermogenic response##2##2##(1994-2#2)
thermogenic##12##1##(1994-2#2)(1995-12#1)(1995-3#1)(2008-4#1)(2009-8#1)(2012-12#2)(2013-8#4)
thermogram##4##1##(1993-11#3)(2008-10#1)
thermograms are##2##2##(1997-7#1)(2005-11#1)
thermograms##16##1##(1990-7#2)(1993-11#6)(1997-7#4)(2005-11#2)(2011-1#1)(2011-3#1)
thermographic examination##3##2##(2007-7#3)
thermographic results##5##2##(1993-11#5)
thermographic##17##1##(1990-6#1)(1991-7#1)(1993-11#6)(2007-7#7)(2008-3#2)
thermography and##2##2##(1991-4#1)(2006-8#1)
thermography in##4##2##(1990-2#1)(1991-4#1)(1996-3#1)(2008-10#1)
thermography is a##2##3##(1991-8#1)(1993-11#1)
thermography is##3##2##(1991-8#1)(1993-11#2)
thermography##20##1##(1990-2#3)(1991-4#2)(1991-8#2)(1993-11#3)(1994-5#2)(1996-3#2)(2006-6#1)(2006-8#1)(2008-10#2)(2008-5#1)(2011-1#1)
thermogravimetric analysis (TGA) and##4##4##(2005-12#1)(2008-10#2)(2009-3#1)
thermogravimetric analysis (TGA)##8##3##(2004-9#1)(2005-12#1)(2008-10#5)(2009-3#1)
thermogravimetric analysis##15##2##(1995-11#1)(2004-9#1)(2005-12#1)(2007-10#1)(2008-10#8)(2009-3#1)(2010-4#1)(2013-7#1)
thermogravimetric and##2##2##(2004-9#1)(2008-5#1)
thermogravimetric measurements##3##2##(2007-12#1)(2008-10#2)
thermogravimetric##25##1##(1995-11#1)(1996-2#1)(2004-9#2)(2005-12#1)(2007-10#1)(2007-12#1)(2008-10#13)(2008-5#1)(2009-3#1)(2010-4#2)(2013-7#1)
thermogravimetry##5##1##(2005-11#1)(2007-11#2)(2007-8#1)(2008-10#1)
thermoinactivation##2##1##(2008-5#2)
thermolabile##10##1##(1990-8#1)(1992-12#1)(1994-12#1)(1996-6#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)
thermoluminescence (TL)##2##2##(2008-10#1)(2011-2#1)
thermoluminescence##4##1##(1996-4#1)(1997-8#1)(2008-10#1)(2011-2#1)
thermoluminescent dosimeters##3##2##(1995-9#1)(2007-10#2)
thermoluminescent##5##1##(1991-4#1)(1995-9#1)(2007-10#2)(2008-6#1)
thermolysin and##2##2##(1994-3#1)(1994-5#1)
thermolysin have been##2##3##(1994-5#2)
thermolysin##17##1##(1990-2#2)(1990-5#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-5#8)(1997-2#2)
thermolysis##5##1##(1996-5#1)(2006-12#1)(2008-10#2)(2010-5#1)
thermolytic##5##1##(2008-10#1)(2008-4#4)
thermomechanical##8##1##(1991-3#1)(2006-2#1)(2008-5#5)(2008-6#1)
thermometer is##2##2##(2008-2#2)
thermometer ranging from 20##2##4##(2008-2#2)
thermometer with##2##2##(2008-2#2)
thermometer##24##1##(1990-2#5)(1990-8#1)(2005-10#1)(2008-2#10)(2008-5#1)(2010-5#4)(2013-1#1)(2013-7#1)
thermometers##5##1##(1990-3#1)(2008-2#1)(2011-2#1)(2013-1#2)
thermometry is##2##2##(2008-3#2)
thermometry of##2##2##(2008-2#1)(2008-3#1)
thermometry techniques##2##2##(2007-11#1)(2007-12#1)
thermometry##20##1##(1992-7#1)(1992-8#1)(2007-11#2)(2007-12#4)(2008-2#8)(2008-3#4)
thermonuclear##2##1##(1997-5#1)(2007-9#1)
thermooptical##2##1##(2008-10#1)(2008-3#1)
thermophila and##2##2##(1994-12#1)(1996-9#1)
thermophila##15##1##(1990-6#1)(1991-1#1)(1991-9#1)(1994-12#3)(1995-3#2)(1996-9#1)(2008-10#1)(2008-3#3)(2012-3#2)
thermophile##6##1##(1992-11#1)(1993-11#1)(1996-5#1)(1996-7#1)(2011-12#1)(2011-2#1)
thermophiles##2##1##(2006-10#1)(2008-7#1)
thermophilic Bacillus PS3##4##3##(1994-12#2)(1996-7#2)
thermophilic Bacillus##6##2##(1994-12#2)(1994-8#1)(1996-7#2)(2013-1#1)
thermophilic and mesophilic##2##3##(1990-5#1)(2006-8#1)
thermophilic and##4##2##(1990-3#1)(1990-5#1)(2006-8#1)(2011-2#1)
thermophilic archaebacterium##5##2##(1990-12#1)(1990-3#1)(1990-5#2)(1995-2#1)
thermophilic bacterium##10##2##(1990-9#1)(1991-3#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-7#1)(2008-5#1)(2012-12#1)(2013-1#1)
thermophilic conditions##3##2##(2006-8#3)
thermophilic genus##2##2##(2011-2#2)
thermophilic##57##1##(1990-12#1)(1990-3#4)(1990-5#3)(1990-7#1)(1990-9#1)(1991-3#2)(1992-11#1)(1993-11#1)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#1)(1994-8#1)(1995-2#1)(1996-3#1)(1996-7#3)(1996-9#1)(1997-7#1)(2006-8#11)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2011-2#4)(2012-12#1)(2013-1#3)(2013-8#1)
thermophilum##4##1##(2006-5#2)(2006-8#1)(2011-2#1)
thermophilus CNRZ368##2##2##(1996-10#2)
thermophilus EF-Tu##2##2##(1995-2#2)
thermophilus HB-8##4##2##(1991-1#4)
thermophilus and L##2##3##(1996-10#2)
thermophilus and##3##2##(1996-10#3)
thermophilus##34##1##(1990-7#3)(1991-1#4)(1994-2#5)(1995-1#3)(1995-2#2)(1995-3#1)(1996-10#6)(1996-4#3)(1997-6#2)(2006-12#1)(2007-7#1)(2011-12#3)
thermoplastic##9##1##(2006-2#1)(2007-12#1)(2007-8#1)(2008-2#2)(2008-3#1)(2010-1#1)(2011-2#1)(2012-12#1)
thermoplastics##2##1##(2008-10#1)(2008-5#1)
thermoradiotherapy##2##1##(1994-4#1)(1994-7#1)
thermoreceptive##2##1##(1991-8#1)(2007-12#1)
thermoreflectance data##2##2##(2008-3#2)
thermoregulation and##2##2##(1995-8#1)(2007-10#1)
thermoregulation in##2##2##(2009-8#1)(2011-2#1)
thermoregulation##21##1##(1992-3#1)(1994-4#1)(1995-8#1)(1996-1#1)(2006-2#1)(2007-10#1)(2008-5#1)(2008-9#2)(2009-8#3)(2011-2#6)(2012-3#2)(2013-1#1)
thermoregulatory effects of##3##3##(1994-2#2)(1997-3#1)
thermoregulatory responses##2##2##(1992-3#2)
thermoregulatory system##3##2##(1996-8#1)(2006-10#2)
thermoregulatory##16##1##(1990-2#1)(1992-3#2)(1994-2#5)(1994-4#1)(1996-8#1)(1997-3#1)(1997-6#1)(2006-10#3)(2007-10#1)
thermoresistant##3##1##(1990-3#1)(1991-3#1)(1992-9#1)
thermoresponsive##2##1##(2006-12#1)(2008-10#1)
thermoreversible##5##1##(1991-6#1)(2007-11#2)(2007-12#1)(2009-12#1)
thermoseed for##2##2##(2004-9#2)
thermoseeds for##2##2##(2004-9#1)(2008-5#1)
thermosensitive TRP##2##2##(2013-1#2)
thermosensitive ion channels##2##3##(2013-1#2)
thermosensitive##19##1##(1994-10#1)(1994-11#1)(1994-12#2)(1995-8#1)(1997-2#1)(1997-4#2)(2007-12#2)(2008-5#1)(2009-10#4)(2013-1#4)
thermosensitivity of##4##2##(1994-8#1)(1995-8#1)(1997-4#1)(2008-8#1)
thermosensitivity##5##1##(1994-8#1)(1995-8#2)(1997-4#1)(2008-8#1)
thermoset##2##1##(2009-7#1)(2010-4#1)
thermosets##6##1##(2010-4#6)
thermospray flame furnace atomic absorption spectrometry##2##6##(2008-10#2)
thermospray##3##1##(1997-3#1)(2008-10#2)
thermostabilities##3##1##(1990-8#1)(1992-8#2)
thermostability and##2##2##(1993-4#1)(2012-2#1)
thermostability of proteins##3##3##(1991-5#1)(1997-4#1)(2006-10#1)
thermostability of the##2##3##(1995-2#1)(1997-6#1)
thermostability of##13##2##(1991-5#1)(1992-8#1)(1995-2#1)(1995-5#1)(1996-12#1)(1997-4#2)(1997-6#1)(2006-10#1)(2007-12#1)(2008-10#1)(2010-9#1)(2011-1#1)
thermostability##29##1##(1990-12#1)(1990-9#1)(1991-2#1)(1991-5#1)(1992-8#1)(1993-4#2)(1995-2#1)(1995-5#2)(1996-12#1)(1997-4#3)(1997-5#1)(1997-6#1)(2005-9#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-5#1)(2010-9#1)(2011-1#2)(2012-2#1)(2013-1#1)
thermostabilization##4##1##(1995-2#1)(1997-5#3)
thermostable D-hydantoinase##2##2##(2008-7#2)
thermostable DNA polymerase##2##3##(1995-8#2)
thermostable DNA##4##2##(1995-8#2)(2008-2#1)(2008-9#1)
thermostable alpha-amylase from Bacillus licheniformis##3##5##(1997-4#3)
thermostable alpha-amylase##4##2##(1997-4#3)(2008-7#1)
thermostable and##2##2##(1990-10#1)(2013-1#1)
thermostable enzyme##5##2##(1994-12#1)(1996-11#1)(1996-2#1)(2008-10#1)(2008-5#1)
thermostable ornithine 5-aminotransferase##2##3##(1996-7#2)
thermostable polymerase##2##2##(1994-11#1)(1995-8#1)
thermostable##46##1##(1990-10#1)(1991-9#3)(1993-11#2)(1993-3#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-9#1)(1995-12#1)(1995-8#3)(1996-11#1)(1996-2#1)(1996-7#5)(1997-4#3)(1997-5#1)(1997-7#1)(2004-8#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2013-1#1)
thermosulfurogenes EM1##5##2##(1991-9#5)
thermotherapy and##2##2##(2006-9#1)(2009-2#1)
thermotherapy##11##1##(2006-9#1)(2007-8#4)(2008-10#1)(2008-12#1)(2008-2#3)(2009-2#1)
thermotolerance development in##3##3##(1992-7#1)(1994-8#2)
thermotolerance development##5##2##(1992-7#2)(1994-8#3)
thermotolerance##12##1##(1992-5#1)(1992-7#4)(1994-8#3)(1995-3#1)(1995-8#2)(2011-2#1)
thermotolerant coliform##2##2##(2006-10#2)
thermotolerant##7##1##(1992-7#1)(1995-8#2)(2006-10#3)(2008-6#1)
thermotropic phase behavior of##3##4##(1990-7#1)(1993-8#1)(2006-10#1)
thermotropic phase behavior##5##3##(1990-7#2)(1993-8#1)(2006-10#1)(2008-8#1)
thermotropic phase##8##2##(1990-7#2)(1993-8#1)(2006-10#3)(2008-5#1)(2008-8#1)
thermotropic properties##2##2##(1997-7#1)(2008-10#1)
thermotropic##19##1##(1990-4#1)(1990-7#2)(1991-5#1)(1993-7#1)(1993-8#1)(1994-2#1)(1997-7#2)(2005-11#1)(2006-10#4)(2008-10#2)(2008-5#2)(2008-8#1)
thesame##2##1##(2008-11#1)(2008-2#1)
thesaurus##2##1##(1996-3#1)(2008-7#1)
these &quot##13##2##(1990-4#1)(1994-3#1)(1995-12#1)(2005-8#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#1)(2009-7#1)
these (and##2##2##(1990-12#1)(2008-7#1)
these 1##2##2##(1996-5#1)(2007-11#1)
these 10##7##2##(1993-4#1)(2005-10#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2013-1#1)
these 109##2##2##(2006-10#1)(2008-1#1)
these 11##4##2##(1991-8#1)(2008-10#1)(2008-8#1)(2010-3#1)
these 12##2##2##(1996-11#1)(2012-3#1)
these 14##4##2##(1991-7#1)(1996-4#1)(2005-10#1)(2012-2#1)
these 16 patients##2##3##(1997-8#1)(2007-7#1)
these 16##3##2##(1997-8#1)(2007-7#1)(2013-7#1)
these 17##2##2##(1992-10#1)(1996-11#1)
these 2 patients##2##3##(1993-12#1)(2007-10#1)
these 2##20##2##(1990-3#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1997-2#1)(2006-10#2)(2006-11#1)(2006-12#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-7#1)(2009-1#1)(2011-2#1)(2013-7#1)
these 21 patients##2##3##(2007-9#1)(2008-1#1)
these 21##6##2##(1990-3#1)(1992-12#1)(1997-5#1)(2007-9#2)(2008-1#1)
these 27##3##2##(1993-5#1)(1997-7#1)(2007-7#1)
these 3 compounds##3##3##(1995-6#2)(2007-1#1)
these 3##10##2##(1990-6#1)(1991-3#1)(1995-5#1)(1995-6#2)(1996-1#1)(2006-5#1)(2007-1#1)(2007-2#1)(2009-11#1)
these 3'##2##2##(2007-12#1)(2008-4#1)
these 30##3##2##(1993-9#1)(2006-10#1)(2007-8#1)
these 31 patients##2##3##(1990-2#1)(2007-9#1)
these 31##3##2##(1990-2#1)(2007-7#1)(2007-9#1)
these 4 cases##2##3##(2007-12#1)(2008-11#1)
these 4##8##2##(2007-11#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-12#1)(2012-2#1)(2013-8#1)
these 44##2##2##(2008-6#1)(2013-1#1)
these 5 patients##2##3##(1991-11#1)(1992-9#1)
these 5##4##2##(1991-11#1)(1992-9#1)(2011-2#2)
these 6##6##2##(1991-9#1)(1993-8#1)(1994-3#1)(2007-10#1)(2008-12#1)(2013-1#1)
these 61##2##2##(2008-10#1)(2012-1#1)
these 7##6##2##(1996-11#1)(2007-12#1)(2007-9#1)(2010-12#2)(2013-1#1)
these Alu##2##2##(1991-5#1)(1995-3#1)
these BI-BS-resistant isolates##2##3##(2008-10#2)
these BSC's are##2##3##(2008-2#1)(2008-3#1)
these BSC's##3##2##(2008-2#1)(2008-3#2)
these CFC replacements##2##3##(1992-3#2)
these CT antigens##2##3##(2012-2#2)
these Ca2+ binding##2##3##(1991-1#1)(1994-9#1)
these DNA lesions##2##3##(1995-5#1)(1997-1#1)
these DNA replication proteins##2##4##(1992-5#1)(2008-7#1)
these DNA##12##2##(1992-5#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-1#2)(2008-10#2)(2008-7#1)(2011-12#1)(2011-2#1)(2012-1#1)
these DNA-lipids##2##2##(2008-10#2)
these ECG##2##2##(2007-12#1)(2010-8#1)
these ER isoforms##2##3##(1996-2#2)
these GIS projects##2##3##(2008-8#2)
these GTPases##2##2##(1997-6#2)
these HPV types##2##3##(2008-11#1)(2013-1#1)
these IARVs##2##2##(2006-11#2)
these MAbs was##2##3##(1991-2#1)(1991-7#1)
these MAbs##5##2##(1991-2#1)(1991-7#2)(1993-9#1)(2008-4#1)
these MDIs##2##2##(1992-3#1)(1996-1#1)
these Medicaid##2##2##(1996-11#1)(1996-12#1)
these NPs can be##2##4##(2010-5#1)(2012-6#1)
these NPs##3##2##(2010-5#2)(2012-6#1)
these NWs##2##2##(2009-2#2)
these ORFs##7##2##(1991-9#1)(1995-12#1)(1995-9#1)(1997-3#2)(1997-4#1)(2008-10#1)
these PCR products##2##3##(2008-10#2)
these PCR##4##2##(1991-9#1)(2008-10#2)(2008-12#1)
these PKC##3##2##(1990-9#1)(1991-9#1)(1994-5#1)
these PR proteins##2##3##(2008-10#2)
these QTL##5##2##(2008-10#1)(2009-5#1)(2011-1#1)(2012-1#1)(2012-3#1)
these QTLs##2##2##(2008-10#1)(2012-11#1)
these RBCs##2##2##(1993-6#1)(1995-2#1)
these RNA##4##2##(1990-7#1)(1995-2#1)(1995-6#1)(1997-4#1)
these RNAs##5##2##(1991-2#1)(1997-3#1)(1997-4#1)(2006-12#1)(2008-10#1)
these SNPs##3##2##(2008-11#1)(2010-12#1)(2012-3#1)
these STM##2##2##(2008-7#1)(2013-7#1)
these T cells##3##3##(1994-2#1)(2008-11#1)(2013-1#1)
these a##3##2##(1995-6#1)(2008-11#1)(2013-8#1)
these abnormal##4##2##(1992-7#1)(2006-12#1)(2009-3#1)(2011-2#1)
these abnormalities in##2##3##(1995-3#1)(2007-7#1)
these abnormalities reflect##2##3##(2006-9#1)(2008-6#1)
these abnormalities##22##2##(1991-10#1)(1993-1#1)(1993-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-3#1)(1996-6#1)(2004-11#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-6#1)(2013-8#1)
these absorption##3##2##(2008-10#1)(2008-3#1)(2013-8#1)
these achievements##3##2##(2008-1#1)(2008-12#1)(2010-8#1)
these acids were##3##3##(2006-12#1)(2007-11#1)(2008-5#1)
these acids##5##2##(2006-12#1)(2007-11#1)(2007-3#1)(2008-5#1)(2011-2#1)
these acting##2##2##(2008-7#1)(2012-12#1)
these actions may##2##3##(1995-12#1)(2012-2#1)
these actions of##3##3##(1994-2#1)(2008-11#1)(2008-8#1)
these actions##18##2##(1990-12#1)(1994-11#1)(1994-2#1)(1995-12#1)(1997-2#1)(1997-5#1)(2006-11#1)(2006-12#1)(2007-1#2)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#2)(2012-12#1)(2012-2#1)(2013-7#1)
these active##2##2##(2008-10#1)(2008-5#1)
these activities and##4##3##(1994-2#1)(1996-10#1)(2007-5#1)(2011-2#1)
these activities are##3##3##(2006-10#1)(2012-1#1)(2012-12#1)
these activities were##3##3##(1990-6#1)(1993-12#1)(1994-3#1)
these activities##42##2##(1990-11#1)(1990-6#3)(1991-1#1)(1991-5#1)(1991-9#1)(1993-1#1)(1993-12#1)(1994-11#2)(1994-2#2)(1994-3#2)(1994-6#2)(1995-10#1)(1996-10#1)(1996-2#1)(1997-1#1)(1997-7#1)(2004-3#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#1)
these adaptive changes##2##3##(2005-12#1)(2013-1#1)
these additional##5##2##(1996-7#1)(2006-10#1)(2006-12#1)(2009-10#1)(2013-1#1)
these adducts##4##2##(1991-5#1)(1994-5#1)(1994-8#1)(2008-12#1)
these adolescents##3##2##(2007-2#1)(2012-12#1)(2013-1#1)
these adrenal##3##2##(2007-11#2)(2008-7#1)
these adsorbents was##2##3##(1996-8#1)(1997-8#1)
these advances in##4##3##(2005-7#1)(2010-6#1)(2011-1#2)
these advances##20##2##(2005-7#1)(2006-10#5)(2006-7#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-8#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#3)(2012-2#1)(2013-8#1)
these adverse effects##6##3##(1991-11#1)(2007-11#1)(2007-7#1)(2009-3#1)(2010-12#1)(2011-2#1)
these adverse events##4##3##(1992-11#1)(2006-9#1)(2012-12#1)(2012-2#1)
these adverse##15##2##(1991-11#1)(1992-11#1)(1996-7#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-10#2)(2009-3#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
these age groups##2##3##(2006-10#1)(2012-2#1)
these age-related changes##2##3##(1991-12#1)(1995-9#1)
these age-related##3##2##(1991-12#1)(1995-9#1)(2012-3#1)
these agents and##4##3##(1996-7#1)(2006-7#1)(2007-2#1)(2008-11#1)
these agents are##13##3##(1990-2#1)(1991-12#1)(1991-3#1)(1993-11#1)(2005-8#2)(2006-10#1)(2008-5#1)(2008-7#1)(2008-8#2)(2013-1#2)
these agents as a##2##4##(2005-7#1)(2013-7#1)
these agents at##3##3##(1992-12#1)(1993-6#1)(2008-10#1)
these agents can be##2##4##(1991-12#1)(2008-8#1)
these agents can##5##3##(1991-12#1)(2006-10#2)(2008-8#2)
these agents effectively##2##3##(1996-11#1)(2010-11#1)
these agents for##3##3##(1990-2#1)(2005-7#1)(2009-3#1)
these agents has been##2##4##(1990-2#1)(2004-11#1)
these agents has##4##3##(1990-2#1)(2004-11#1)(2007-12#1)(2011-2#1)
these agents have been##3##4##(2006-10#2)(2008-8#1)
these agents have##11##3##(1991-12#1)(2005-8#1)(2006-10#3)(2007-11#2)(2008-5#1)(2008-8#3)
these agents in combination##2##4##(1993-6#1)(2008-7#1)
these agents in the treatment of##3##6##(2006-10#1)(2006-11#1)(2006-12#1)
these agents in the##6##4##(2006-10#2)(2006-11#1)(2006-12#1)(2008-6#1)(2010-4#1)
these agents in##18##3##(1993-6#1)(1995-11#1)(2005-6#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-12#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-4#1)
these agents is##8##3##(1991-12#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-3#1)(2009-8#1)(2010-3#1)
these agents may lead to##2##5##(1991-5#1)(2005-8#1)
these agents may##4##3##(1991-5#1)(2005-7#1)(2005-8#1)(2006-12#1)
these agents must be##2##4##(2008-5#1)(2008-7#1)
these agents should be##2##4##(2005-8#1)(2007-8#1)
these agents should##3##3##(2005-8#1)(2007-8#1)(2008-11#1)
these agents that##2##3##(2006-10#1)(2007-6#1)
these agents to##5##3##(1992-3#1)(1995-1#1)(1997-5#1)(2006-8#1)(2008-3#1)
these agents was##3##3##(1996-9#1)(2005-7#1)(2007-6#1)
these agents were##5##3##(1997-4#1)(2007-8#1)(2008-11#1)(2008-2#1)(2011-2#1)
these agents##209##2##(1990-2#8)(1991-12#4)(1991-3#1)(1991-5#2)(1991-7#1)(1992-12#1)(1992-3#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-6#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#3)(1995-6#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-4#1)(1997-5#1)(2004-11#1)(2005-11#1)(2005-6#1)(2005-7#7)(2005-8#8)(2006-10#18)(2006-11#1)(2006-12#3)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#14)(2007-12#3)(2007-2#3)(2007-4#1)(2007-6#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#4)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#9)(2008-6#2)(2008-7#6)(2008-8#11)(2008-9#2)(2009-1#1)(2009-11#2)(2009-3#3)(2009-8#3)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#6)(2013-7#2)
these ages##2##2##(1993-12#1)(2008-9#1)
these aggregates##3##2##(1990-11#1)(1990-12#1)(2005-11#1)
these agonists##9##2##(1990-2#1)(1990-3#1)(1993-11#1)(1993-6#1)(1994-12#1)(1995-11#1)(1996-9#1)(2008-1#1)(2008-11#1)
these aims##5##2##(2008-11#2)(2010-8#1)(2011-2#1)(2012-2#1)
these airway##2##2##(1992-3#1)(2006-10#1)
these alcohols##2##2##(1992-6#1)(1995-2#1)
these algorithms are##2##3##(2008-2#2)
these algorithms##5##2##(2008-2#3)(2008-3#1)(2008-9#1)
these alkaloids##2##2##(2008-10#1)(2011-3#1)
these allegations##6##2##(2008-10#6)
these alleles##4##2##(2008-10#1)(2008-12#1)(2008-2#1)(2012-12#1)
these alterations can be##2##4##(1996-1#1)(2007-9#1)
these alterations in##3##3##(1996-12#1)(2008-11#1)(2008-2#1)
these alterations may be##3##4##(1995-12#1)(2010-12#1)(2013-7#1)
these alterations were##3##3##(1990-2#1)(2012-12#2)
these alterations##28##2##(1990-2#2)(1991-2#1)(1991-8#1)(1993-4#1)(1994-5#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-2#2)(2008-8#1)(2010-12#1)(2011-1#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-7#1)
these altered##3##2##(1995-2#1)(1995-5#1)(2013-1#1)
these alternate structures##2##3##(1995-1#2)
these alternate##3##2##(1995-1#2)(2008-1#1)
these alternating##2##2##(2008-3#1)(2010-4#1)
these alternative outcomes may##2##4##(2008-8#2)
these alternative##8##2##(1997-5#1)(2008-10#1)(2008-8#2)(2010-11#1)(2010-2#1)(2010-4#1)(2012-1#1)
these alternatives##2##2##(1992-3#1)(1996-6#1)
these amino acid##4##3##(1990-5#1)(1995-5#1)(1996-7#1)(1997-4#1)
these amino acids in##3##4##(1995-6#1)(2006-12#2)
these amino acids were##2##4##(2006-8#1)(2012-12#1)
these amino acids##13##3##(1991-9#1)(1994-3#2)(1995-11#1)(1995-3#1)(1995-6#1)(2006-12#2)(2006-8#1)(2008-10#2)(2010-12#1)(2012-12#1)
these amino##17##2##(1990-5#1)(1991-9#1)(1994-3#2)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-7#1)(1997-4#1)(2006-12#2)(2006-8#1)(2008-10#2)(2010-12#1)(2012-12#1)
these analogs were##3##3##(1990-4#1)(1994-9#1)(2009-2#1)
these analogs##9##2##(1990-4#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-9#2)(1996-8#1)(1997-8#1)(2009-2#1)
these analogues##4##2##(1991-5#1)(1996-5#2)(2005-11#1)
these analyses are##3##3##(1990-12#1)(1994-1#1)(2008-10#1)
these analyses in##2##3##(2006-10#1)(2010-4#1)
these analyses were##2##3##(2008-2#1)(2010-12#1)
these analyses##29##2##(1990-11#1)(1990-12#1)(1991-1#1)(1992-12#1)(1992-6#1)(1993-7#1)(1994-1#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-10#1)(1997-4#1)(1997-5#1)(2005-11#1)(2006-10#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-4#1)
these analytes##9##2##(1996-5#2)(2008-10#7)
these analytical##2##2##(2008-10#1)(2008-3#1)
these anatomical##3##2##(2007-4#1)(2008-6#1)(2011-2#1)
these and additional##2##3##(1996-2#1)(2008-4#1)
these and other drugs##2##4##(2007-11#1)(2007-7#1)
these and other issues##3##4##(1995-12#1)(2008-12#1)(2011-12#1)
these and other questions##3##4##(1992-12#1)(2008-3#1)(2012-2#1)
these and other##46##3##(1990-11#1)(1990-5#1)(1991-11#1)(1992-12#1)(1992-2#2)(1992-9#2)(1995-12#2)(1996-12#1)(1997-4#1)(1997-5#2)(1997-8#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-8#2)(2007-11#3)(2007-3#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#2)(2008-8#1)(2008-9#2)(2010-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
these and the##3##3##(2008-10#1)(2009-4#1)(2013-8#1)
these and##69##2##(1990-11#1)(1990-5#2)(1991-11#1)(1992-12#1)(1992-2#2)(1992-9#2)(1993-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-4#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-4#1)(1997-5#2)(1997-8#1)(2005-11#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-8#2)(2007-11#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#2)(2009-4#1)(2009-8#1)(2010-1#2)(2010-9#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
these angiogenic inhibitors##2##3##(2008-1#2)
these animal models##4##3##(2006-1#1)(2006-10#1)(2008-4#1)(2010-12#1)
these animal##6##2##(2006-1#1)(2006-10#1)(2007-12#1)(2008-4#1)(2010-12#1)(2012-1#1)
these animals are##3##3##(1994-5#1)(2006-1#1)(2008-5#1)
these animals showed##3##3##(1990-3#1)(2004-11#1)(2008-12#1)
these animals were##4##3##(1993-7#1)(1994-10#1)(1995-5#1)(2008-9#1)
these animals##50##2##(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#1)(1992-1#1)(1992-3#1)(1993-5#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-12#4)(1996-2#1)(1996-3#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-11#2)(2005-7#1)(2006-1#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-9#2)(2009-4#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
these anions##4##2##(1990-8#1)(1991-8#1)(2008-10#1)(2010-5#1)
these anisotropic##2##2##(2007-12#1)(2008-10#1)
these anomalies##3##2##(2007-5#1)(2007-8#1)(2010-11#1)
these antagonists on##2##3##(1991-5#1)(1991-7#1)
these antagonists##8##2##(1990-2#1)(1991-5#1)(1991-7#1)(1992-4#1)(1993-3#1)(1994-11#1)(1997-2#2)
these antibiotics##9##2##(2005-11#1)(2006-8#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2013-8#2)
these antibodies and##2##3##(1990-6#1)(2007-8#1)
these antibodies are##4##3##(1991-2#1)(1995-12#1)(2006-10#1)(2008-10#1)
these antibodies did not##2##4##(1995-11#1)(1996-11#1)
these antibodies were##2##3##(1992-8#2)
these antibodies##38##2##(1990-11#1)(1990-6#2)(1990-7#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-9#2)(1992-12#1)(1992-8#3)(1993-2#2)(1993-9#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1996-11#3)(1997-7#3)(2006-10#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)
these antiestrogen binding sites##2##4##(2008-11#2)
these antigens are##3##3##(2011-1#1)(2012-2#2)
these antigens in##3##3##(1994-7#1)(1997-7#1)(2011-2#1)
these antigens##15##2##(1994-7#1)(1997-7#2)(2007-11#1)(2008-10#1)(2008-5#1)(2009-2#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)
these antioxidants may##2##3##(2006-10#2)
these antioxidants##8##2##(1995-3#1)(2006-10#2)(2008-10#2)(2008-11#1)(2008-4#1)(2009-12#1)
these apparently##3##2##(1993-12#1)(2009-11#1)(2011-2#1)
these appear to be##2##4##(1991-2#1)(1993-4#1)
these appear to##3##3##(1991-2#1)(1993-4#1)(2009-12#1)
these appear##4##2##(1991-2#1)(1993-4#1)(2009-12#1)(2012-2#1)
these applications##13##2##(1993-6#1)(1997-7#1)(2007-8#1)(2008-1#2)(2008-11#2)(2008-2#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-7#1)(2012-2#1)
these approaches are##7##3##(2006-12#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-5#1)(2012-3#1)
these approaches have##3##3##(2004-1#1)(2010-10#1)(2012-2#1)
these approaches is##2##3##(2008-1#1)(2012-1#1)
these approaches to##3##3##(1995-5#1)(2008-11#1)(2008-7#1)
these approaches##51##2##(1993-2#1)(1995-5#1)(1997-6#1)(1997-8#1)(2004-1#1)(2005-7#1)(2006-12#1)(2006-5#2)(2006-9#2)(2007-11#2)(2008-1#2)(2008-10#3)(2008-11#4)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-9#2)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
these are also##2##3##(2008-10#1)(2008-7#1)
these are being##2##3##(2005-8#1)(2011-1#1)
these are difficult to##2##4##(2008-8#1)(2010-12#1)
these are discussed##5##3##(1993-3#1)(2006-10#1)(2006-11#1)(2008-1#1)(2012-2#1)
these are due##2##3##(1995-12#1)(2008-4#1)
these are important##3##3##(2008-10#1)(2009-12#1)(2010-10#1)
these are linked to##2##4##(2005-7#1)(2013-8#1)
these are not specific##2##4##(1991-4#1)(2005-11#1)
these are not##7##3##(1991-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2008-10#1)(2010-9#1)(2013-1#1)
these are often##2##3##(1994-9#1)(2011-2#1)
these are present##2##3##(1990-5#1)(2008-10#1)
these are the first##2##4##(2007-2#1)(2011-2#1)
these are the##9##3##(1992-4#1)(1995-2#1)(2005-3#1)(2007-2#1)(2010-11#1)(2011-2#1)(2012-2#2)(2013-8#1)
these are##140##2##(1990-10#1)(1990-12#1)(1990-5#2)(1991-3#2)(1991-4#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1993-12#1)(1993-3#1)(1994-2#2)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-4#4)(1997-7#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-3#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-11#4)(2007-12#3)(2007-2#2)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#1)(2010-10#1)(2010-11#3)(2010-12#3)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#1)(2012-2#7)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#6)
these areas and##3##3##(1991-3#1)(2008-11#1)(2010-10#1)
these areas are##3##3##(1994-1#1)(1994-9#1)(2008-8#1)
these areas in##2##3##(1996-1#1)(2010-5#1)
these areas is##4##3##(2008-8#1)(2009-12#1)(2010-7#2)
these areas of##4##3##(1997-7#1)(2006-2#1)(2008-3#1)(2009-8#1)
these areas requires##2##3##(2008-4#1)(2008-9#1)
these areas were##3##3##(1997-2#1)(2011-1#1)(2013-7#1)
these areas##78##2##(1991-3#2)(1992-1#1)(1992-10#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-2#1)(1994-8#1)(1994-9#2)(1995-3#1)(1995-7#1)(1996-1#1)(1996-10#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#1)(2005-5#1)(2006-10#3)(2006-2#2)(2006-6#3)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#3)(2011-1#2)(2011-12#2)(2011-2#2)(2013-7#1)(2013-8#1)
these arguments##2##2##(2006-11#1)(2008-3#1)
these arrangements##3##2##(1993-1#1)(1996-3#1)(1997-2#1)
these arrays##2##2##(2008-3#1)(2008-8#1)
these arrivals##2##2##(1991-3#2)
these articles##6##2##(1994-12#1)(1997-2#1)(2007-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
these artificial##2##2##(2006-8#1)(2008-3#1)
these as##8##2##(1994-12#1)(2007-10#1)(2008-12#1)(2008-5#1)(2012-12#2)(2013-1#2)
these aspects is##2##3##(2007-10#1)(2008-10#1)
these aspects of##8##3##(1993-7#1)(2006-10#1)(2007-12#2)(2008-11#1)(2008-4#1)(2008-9#1)(2012-3#1)
these aspects##19##2##(1993-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-3#2)(2013-1#1)
these assay##2##2##(1991-2#1)(2008-4#1)
these assays are not##2##4##(2008-1#1)(2008-10#1)
these assays are##6##3##(1993-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-9#1)(2011-1#1)
these assays can be##2##4##(1992-3#1)(1997-3#1)
these assays is to##2##4##(2008-4#1)(2008-9#1)
these assays is##3##3##(2008-4#1)(2008-9#2)
these assays may also be used to determine the concentration of a particular chemical##3##14##(2008-4#1)(2008-9#2)
these assays provide##3##3##(2008-4#2)(2008-9#1)
these assays##45##2##(1990-6#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-2#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2005-7#1)(2006-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#8)(2008-5#1)(2008-8#1)(2008-9#7)(2009-10#1)(2011-1#2)(2012-1#1)(2012-2#1)
these assessments##7##2##(1995-5#1)(1996-9#1)(2007-12#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
these associated##2##2##(2012-12#1)(2013-8#1)
these associations and the##2##4##(1997-3#1)(2005-8#1)
these associations are not##2##4##(2007-5#1)(2013-8#1)
these associations are##6##3##(2005-10#1)(2007-5#1)(2008-1#1)(2008-4#1)(2009-10#1)(2013-8#1)
these associations have##2##3##(2008-1#1)(2008-4#1)
these associations is##4##3##(1997-2#1)(2005-11#1)(2012-12#2)
these associations were between##2##4##(2008-10#2)
these associations were##4##3##(2008-10#2)(2012-12#1)(2013-1#1)
these associations##29##2##(1991-9#1)(1997-2#1)(1997-3#1)(2005-10#3)(2005-11#1)(2005-8#1)(2007-5#1)(2008-1#2)(2008-10#3)(2008-4#2)(2009-10#1)(2009-7#2)(2010-4#1)(2011-1#2)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#1)
these assumptions##8##2##(1995-1#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-9#1)
these astrocytes##2##2##(1993-12#1)(1994-5#1)
these astrocytic##2##2##(1993-12#1)(1994-11#1)
these attacks##4##2##(2006-7#1)(2007-12#1)(2011-2#1)(2012-2#1)
these attempts have##2##3##(1991-1#1)(2012-12#1)
these attempts##4##2##(1991-1#1)(1997-6#1)(2005-9#1)(2012-12#1)
these attitudes##7##2##(1990-11#1)(1996-2#1)(2008-3#1)(2009-1#1)(2010-10#1)(2010-2#1)(2013-1#1)
these attributes##5##2##(1992-5#1)(1994-3#1)(2008-10#1)(2008-8#1)(2009-12#1)
these atypical##2##2##(2007-11#1)(2011-1#1)
these authors##6##2##(1994-6#1)(1996-3#1)(2007-8#1)(2008-2#1)(2008-4#1)(2009-3#1)
these averages##2##2##(1996-6#1)(2008-10#1)
these axons have##2##3##(1996-9#2)
these background##2##2##(2008-2#1)(2008-3#1)
these bacteria were not##3##4##(2006-8#1)(2008-10#1)(2008-11#1)
these bacteria were##5##3##(1993-2#1)(2006-8#1)(2008-10#2)(2008-11#1)
these bacteria##32##2##(1990-6#1)(1993-2#1)(1997-2#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-8#5)(2007-12#1)(2007-6#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#2)(2011-1#1)(2011-2#1)(2013-1#1)
these bacterial##3##2##(1992-7#1)(1997-8#1)(2009-5#1)
these bands##11##2##(1993-5#1)(1995-10#1)(1995-5#1)(1996-4#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2010-11#1)
these barriers##13##2##(1994-11#1)(1996-7#1)(2006-10#1)(2007-12#1)(2008-10#1)(2009-11#1)(2010-11#2)(2011-1#1)(2013-1#4)
these base##2##2##(2008-4#2)
these basic##5##2##(1993-12#1)(1994-6#1)(2007-3#1)(2008-11#1)(2009-1#1)
these bats##3##2##(2005-12#1)(2007-3#2)
these beams##4##2##(2007-12#2)(2008-2#2)
these behavioral##5##2##(1991-5#1)(1991-6#1)(1992-10#1)(1997-2#1)(2006-10#1)
these behaviors in##2##3##(1993-6#1)(2012-3#1)
these behaviors with a tool were more consistent##2##8##(2013-1#2)
these behaviors##17##2##(1993-6#1)(1993-9#1)(1994-2#2)(1997-7#1)(2006-7#1)(2008-4#3)(2009-4#1)(2010-9#1)(2012-12#2)(2012-3#1)(2013-1#3)
these behaviours##5##2##(1991-2#1)(1994-10#1)(2007-3#1)(2008-11#1)(2009-9#1)
these being##5##2##(1995-2#1)(2005-7#1)(2007-11#1)(2011-1#1)(2011-2#1)
these beneficial effects##5##3##(2006-12#1)(2008-10#1)(2008-5#1)(2008-7#2)
these benefits are##3##3##(1991-5#1)(1997-8#1)(2008-10#1)
these benefits come at##2##4##(2008-8#1)(2009-12#1)
these benefits may be##2##4##(2006-10#1)(2006-9#1)
these benefits##18##2##(1991-5#1)(1991-8#1)(1995-1#1)(1997-8#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-1#1)(2011-1#1)
these biases##3##2##(1997-5#1)(2008-8#1)(2012-12#1)
these binding sites##4##3##(1990-3#1)(1990-5#1)(1992-9#1)(1995-8#1)
these binding##9##2##(1990-10#1)(1990-3#1)(1990-5#1)(1992-9#1)(1994-8#2)(1995-8#1)(2010-7#1)(2011-2#1)
these biochemical##4##2##(1992-6#1)(1997-1#1)(2007-9#1)(2008-5#1)
these biogeological##2##2##(1995-3#2)
these biological effects##2##3##(2008-4#1)(2012-11#1)
these biological processes##2##3##(2007-8#1)(2010-2#1)
these biological##14##2##(1991-3#1)(2005-8#1)(2006-11#1)(2006-6#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2010-2#1)(2010-6#1)(2011-2#1)(2012-11#1)
these biomarkers##4##2##(2007-5#1)(2010-2#1)(2011-1#1)(2013-1#1)
these birds##7##2##(1993-9#1)(1997-3#1)(2005-9#1)(2007-2#2)(2008-5#2)
these blocks##3##2##(2006-7#1)(2008-3#1)(2009-2#1)
these body##2##2##(2008-4#1)(2008-5#1)
these bone##2##2##(2009-3#1)(2010-6#1)
these brain areas##3##3##(1991-2#1)(1994-3#1)(2011-2#1)
these brain regions are##2##4##(2010-5#1)(2010-6#1)
these brain regions##5##3##(1992-8#1)(2006-4#1)(2008-6#1)(2010-5#1)(2010-6#1)
these brain##11##2##(1991-2#1)(1992-8#1)(1994-2#1)(1994-3#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-6#1)(2010-5#1)(2010-6#1)(2011-2#1)
these breaks##2##2##(1996-5#1)(2008-7#1)
these breast##2##2##(1992-8#1)(2011-2#1)
these cDNA clones##6##3##(1990-12#1)(1992-11#1)(1993-11#1)(1996-6#1)(2008-11#1)(2008-8#1)
these cDNAs are##2##3##(1993-6#1)(1993-8#1)
these cDNAs were##2##3##(1994-9#1)(1997-8#1)
these cDNAs##9##2##(1991-7#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-9#1)(1997-8#1)
these calculations##6##2##(2007-11#1)(2008-2#1)(2008-3#3)(2008-4#1)
these calibration##3##2##(2008-10#2)(2008-3#1)
these calls##2##2##(1992-9#1)(2007-3#1)
these cameras##2##2##(2008-6#1)(2010-4#1)
these campaigns##3##2##(2008-3#1)(2008-9#2)
these can also##2##3##(1992-4#1)(2010-11#1)
these can be used to##2##5##(1995-3#1)(2009-10#1)
these can be used##3##4##(1995-3#1)(2008-3#1)(2009-10#1)
these can be##13##3##(1995-3#1)(1996-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-10#1)(2012-2#1)(2012-3#1)
these can##23##2##(1992-4#1)(1995-12#1)(1995-3#1)(1996-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#2)(2010-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
these cancer cells##2##3##(2008-5#1)(2009-3#1)
these cancer##3##2##(1990-7#1)(2008-5#1)(2009-3#1)
these cancers have##2##3##(2008-4#1)(2010-12#1)
these cancers##9##2##(1990-8#1)(2007-11#1)(2008-11#1)(2008-4#2)(2010-12#1)(2010-8#1)(2012-1#1)(2013-1#1)
these candidate##4##2##(2008-3#1)(2008-4#1)(2008-6#1)(2010-12#1)
these candidates is selected using information from silent amino acid substitutions##2##11##(2008-4#2)
these capabilities##3##2##(2006-5#1)(2007-12#1)(2008-8#1)
these carbohydrate groups##2##3##(1993-8#2)
these carbohydrate##3##2##(1993-11#1)(1993-8#2)
these carcinogens##2##2##(1992-3#1)(1996-2#1)
these caregivers##3##2##(2005-7#1)(2007-8#1)(2008-6#1)
these carriers##3##2##(1995-5#1)(2006-8#1)(2008-11#1)
these case reports##2##3##(2008-11#1)(2011-2#1)
these case studies##3##3##(2006-1#1)(2008-10#1)(2008-11#1)
these case##7##2##(2006-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2011-2#2)
these cases and##6##3##(1992-2#1)(1992-5#1)(2008-11#1)(2010-12#1)(2012-12#1)(2013-7#1)
these cases are difficult##2##4##(2013-1#1)(2013-7#1)
these cases are##8##3##(1991-5#1)(1991-8#1)(1996-2#1)(2008-8#1)(2010-1#1)(2013-1#2)(2013-7#1)
these cases have##2##3##(2010-8#1)(2013-7#1)
these cases is##3##3##(2006-12#1)(2008-11#1)(2008-4#1)
these cases of##2##3##(1993-2#1)(2006-2#1)
these cases require##2##3##(2008-8#1)(2011-2#1)
these cases should be##2##4##(2008-10#1)(2010-8#1)
these cases should##4##3##(2007-7#1)(2008-10#1)(2009-4#1)(2010-8#1)
these cases the##13##3##(1991-5#1)(1992-2#1)(1994-5#1)(1994-9#1)(1997-6#1)(2006-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-9#1)(2012-3#1)(2013-8#1)
these cases was##4##3##(1993-1#1)(2007-10#1)(2008-4#2)
these cases were##6##3##(1996-3#1)(2006-4#1)(2009-5#1)(2011-1#1)(2011-12#1)(2012-12#1)
these cases with##2##3##(2007-10#1)(2008-6#1)
these cases##169##2##(1990-4#1)(1990-5#1)(1990-6#1)(1991-12#2)(1991-5#2)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-8#3)(1993-1#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#2)(1997-2#1)(1997-6#2)(2005-11#1)(2005-8#2)(2005-9#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2007-10#2)(2007-11#5)(2007-12#2)(2007-5#1)(2007-7#6)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#4)(2008-6#5)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-9#2)(2010-1#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#3)(2011-12#2)(2011-2#10)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#4)(2013-8#2)
these catalysts##5##2##(2004-12#1)(2009-3#2)(2013-1#2)
these categories and##3##3##(2008-11#1)(2008-12#1)(2009-3#1)
these categories of##4##3##(1995-6#1)(2005-9#1)(2008-11#1)(2010-7#1)
these categories##13##2##(1991-2#1)(1995-6#1)(2005-9#1)(2007-10#1)(2007-4#1)(2008-11#2)(2008-12#1)(2009-3#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-3#1)
these catheters##4##2##(2006-6#1)(2007-7#2)(2008-1#1)
these cations##5##2##(1990-2#1)(1990-7#1)(1991-2#1)(2008-10#1)(2012-1#1)
these causes##4##2##(2007-8#1)(2008-11#1)(2009-2#1)(2012-2#1)
these cell lines are##2##4##(1992-4#1)(2008-4#1)
these cell lines have##2##4##(1990-4#1)(2008-11#1)
these cell lines were##2##4##(1990-10#1)(1993-3#1)
these cell lines##27##3##(1990-10#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-9#2)(1994-12#1)(1994-3#1)(1994-6#1)(1995-6#1)(2003-11#1)(2008-11#2)(2008-4#3)(2010-7#1)
these cell types##13##3##(1991-9#1)(1992-4#1)(1993-4#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-10#1)(2008-4#2)(2008-7#1)(2012-2#2)
these cell##55##2##(1990-10#1)(1990-11#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-9#2)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2003-11#2)(2006-10#2)(2007-1#1)(2007-10#1)(2008-10#2)(2008-11#3)(2008-4#5)(2008-7#1)(2010-3#1)(2010-7#1)(2012-2#2)
these cells a##2##3##(2008-1#1)(2008-11#1)
these cells after##4##3##(1995-3#1)(1996-5#1)(1997-7#2)
these cells also##2##3##(1991-3#1)(1997-3#1)
these cells and to##2##4##(1994-3#1)(1994-9#1)
these cells and##12##3##(1990-12#1)(1991-12#1)(1992-7#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-9#1)(1996-12#1)(2008-10#1)(2008-4#1)(2012-1#1)(2012-2#1)
these cells are mixed##2##4##(2008-4#1)(2012-12#1)
these cells are##14##3##(1993-12#1)(2006-10#1)(2007-12#2)(2008-11#1)(2008-4#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#1)(2012-12#1)
these cells as well##2##4##(1995-3#1)(2006-10#1)
these cells as##4##3##(1995-3#1)(1996-8#1)(2006-10#1)(2008-11#1)
these cells by##7##3##(1990-11#1)(1990-7#1)(1991-3#1)(1994-11#1)(1995-8#1)(1996-7#1)(1997-2#1)
these cells can be##2##4##(2005-8#1)(2008-4#1)
these cells can##5##3##(2005-8#1)(2006-10#1)(2007-7#1)(2008-4#1)(2012-12#1)
these cells could##3##3##(2006-10#1)(2008-10#1)(2013-1#1)
these cells demonstrated##3##3##(1990-2#1)(2008-11#2)
these cells did##2##3##(1990-12#1)(2008-10#1)
these cells during##4##3##(1991-8#1)(2008-4#1)(2009-8#1)(2012-12#1)
these cells exhibit##2##3##(1991-3#1)(2008-7#1)
these cells for##3##3##(1990-7#1)(2007-5#1)(2013-1#1)
these cells from##3##3##(1995-1#1)(1996-1#1)(1996-4#1)
these cells has##2##3##(2008-11#1)(2012-1#1)
these cells have##6##3##(1992-5#1)(1994-12#1)(1995-8#1)(2008-7#1)(2008-9#2)
these cells in a##4##4##(2008-11#2)(2008-9#1)(2010-1#1)
these cells in the##7##4##(1992-9#2)(1995-2#1)(1996-12#1)(2009-5#1)(2012-12#2)
these cells in##24##3##(1991-2#1)(1991-9#1)(1992-5#1)(1992-9#2)(1993-9#1)(1995-2#2)(1996-12#1)(1996-4#1)(1997-8#1)(2008-11#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-1#1)(2012-1#2)(2012-12#2)(2012-2#2)(2013-8#1)
these cells into##5##3##(1997-4#1)(2008-3#1)(2008-9#1)(2010-12#1)(2012-1#1)
these cells is not##3##4##(1992-5#1)(1993-11#1)(1995-3#1)
these cells is##10##3##(1992-12#1)(1992-5#1)(1993-11#1)(1994-12#1)(1994-9#1)(1995-3#1)(1996-1#1)(1997-1#1)(2008-11#1)(2011-2#1)
these cells may help##2##4##(2008-4#1)(2008-9#1)
these cells may##9##3##(1990-8#1)(1996-9#1)(1997-6#1)(2005-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-12#1)
these cells produce##2##3##(1996-9#1)(2008-9#1)
these cells represents##2##3##(2008-6#1)(2008-9#1)
these cells show##2##3##(1991-1#1)(1995-2#1)
these cells showed that##2##4##(1995-6#1)(2008-7#1)
these cells showed##3##3##(1994-9#1)(1995-6#1)(2008-7#1)
these cells that##3##3##(1995-2#1)(2008-11#1)(2010-11#1)
these cells to produce##2##4##(1993-5#1)(2012-3#1)
these cells to##16##3##(1990-8#1)(1991-12#1)(1993-5#1)(1994-11#1)(1996-2#1)(1996-7#1)(1996-8#2)(2007-11#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-9#1)(2012-3#1)
these cells under##2##3##(1990-12#1)(1996-6#1)
these cells using##2##3##(1992-9#1)(2008-5#1)
these cells was also##2##4##(1991-2#1)(1995-3#1)
these cells was##17##3##(1991-12#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-9#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-11#1)(1997-8#1)(2008-5#3)(2008-8#1)
these cells were shown to##2##5##(2008-8#1)(2013-1#1)
these cells were##19##3##(1992-1#1)(1992-12#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-8#1)(1996-11#1)(1996-12#1)(2008-11#1)(2008-5#2)(2008-8#2)(2008-9#1)(2010-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
these cells with a##3##4##(1991-9#1)(1994-2#1)(2008-8#1)
these cells with##15##3##(1991-9#2)(1992-2#1)(1992-9#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-9#2)(1995-12#1)(1995-3#1)(1996-10#1)(1996-6#1)(2008-11#1)(2008-8#1)
these cells##442##2##(1990-10#2)(1990-11#3)(1990-12#6)(1990-2#7)(1990-5#2)(1990-6#3)(1990-7#4)(1990-8#5)(1990-9#2)(1991-1#1)(1991-10#2)(1991-12#8)(1991-2#4)(1991-3#4)(1991-5#6)(1991-6#2)(1991-8#5)(1991-9#4)(1992-1#3)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#4)(1992-5#3)(1992-6#4)(1992-7#1)(1992-8#1)(1992-9#9)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#4)(1993-6#4)(1993-7#1)(1993-8#2)(1993-9#2)(1994-11#6)(1994-12#7)(1994-2#4)(1994-3#5)(1994-6#3)(1994-8#4)(1994-9#7)(1995-1#4)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#11)(1995-3#9)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#7)(1996-1#3)(1996-10#2)(1996-11#4)(1996-12#4)(1996-2#1)(1996-4#2)(1996-5#4)(1996-6#3)(1996-7#2)(1996-8#4)(1996-9#4)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#6)(1997-7#6)(1997-8#4)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#6)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#8)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#7)(2008-11#28)(2008-3#1)(2008-4#11)(2008-5#12)(2008-6#3)(2008-7#14)(2008-8#10)(2008-9#12)(2009-10#1)(2009-12#2)(2009-3#3)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#3)(2010-11#1)(2010-12#7)(2010-2#1)(2010-4#1)(2010-5#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-1#8)(2012-12#10)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
these cellular processes##4##3##(1995-1#1)(1995-2#1)(2005-7#1)(2009-9#1)
these cellular proteins##2##3##(1992-12#2)
these cellular##13##2##(1990-11#1)(1992-11#1)(1992-12#2)(1993-12#2)(1995-1#1)(1995-2#1)(2005-7#1)(2009-9#1)(2010-2#1)(2011-1#1)(2012-12#1)
these centers##5##2##(1992-8#1)(1996-12#1)(1997-2#1)(2008-1#1)(2008-3#1)
these chains##3##2##(1991-5#1)(2008-10#1)(2008-4#1)
these challenges and##2##3##(2006-7#1)(2011-2#1)
these challenges using##2##3##(2006-10#1)(2009-12#1)
these challenges##35##2##(1994-12#1)(1995-1#1)(1996-2#2)(1997-1#2)(2006-10#1)(2006-2#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-4#2)(2007-5#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-6#2)(2009-10#1)(2009-12#2)(2010-10#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-8#1)
these challenging##5##2##(1996-8#1)(2006-2#1)(2008-10#1)(2010-5#1)(2011-2#1)
these changes and the##3##4##(2010-12#1)(2012-2#1)(2013-8#1)
these changes and to##2##4##(2006-8#1)(2008-1#1)
these changes and##9##3##(1991-3#1)(2006-8#1)(2008-1#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-8#1)
these changes appear to be##2##5##(1994-11#1)(2005-10#1)
these changes are##10##3##(1992-11#1)(1992-6#1)(1993-4#1)(1996-5#1)(2006-9#1)(2007-10#1)(2007-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
these changes can be##3##4##(1995-8#1)(2007-12#1)(2009-9#1)
these changes can##4##3##(1991-2#1)(1995-8#1)(2007-12#1)(2009-9#1)
these changes could be##3##4##(1995-12#1)(2007-8#1)(2008-3#1)
these changes have been##5##4##(1992-3#1)(1992-4#1)(2005-10#1)(2009-10#1)(2013-7#1)
these changes have##7##3##(1992-3#1)(1992-4#1)(1996-10#1)(2005-10#1)(2006-10#1)(2009-10#1)(2013-7#1)
these changes in the##4##4##(1990-2#1)(1992-3#1)(2007-11#1)(2007-8#1)
these changes in##17##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-9#1)(1992-3#1)(1993-9#1)(1996-5#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)
these changes is the##2##4##(1995-1#1)(2007-10#1)
these changes occur in##2##4##(2005-10#1)(2008-1#1)
these changes occurred##4##3##(1994-6#1)(2008-10#1)(2008-9#1)(2011-2#1)
these changes on##4##3##(1992-1#1)(1992-4#1)(2007-11#1)(2010-2#1)
these changes the##2##3##(1992-4#1)(2007-3#1)
these changes to##4##3##(1991-10#1)(2008-10#1)(2008-12#1)(2008-9#1)
these changes was##2##3##(1994-11#1)(2006-9#1)
these changes were associated with a##2##6##(1992-9#1)(1993-11#1)
these changes were not##3##4##(1993-6#1)(2011-1#1)(2012-1#1)
these changes were##12##3##(1990-9#1)(1992-9#1)(1993-11#1)(1993-6#1)(1996-12#1)(2007-8#1)(2008-1#1)(2008-12#1)(2011-1#2)(2011-2#1)(2012-1#1)
these changes with##2##3##(1994-3#1)(2005-11#1)
these changes##147##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#3)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#3)(1992-6#1)(1992-9#2)(1993-11#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-3#1)(1994-6#2)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-4#1)(1997-5#1)(2004-9#1)(2005-10#3)(2005-11#1)(2005-8#1)(2006-10#5)(2006-5#1)(2006-8#1)(2006-9#2)(2007-10#4)(2007-11#3)(2007-12#2)(2007-3#2)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#5)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#4)(2011-2#6)(2012-1#3)(2012-2#5)(2012-3#1)(2013-7#2)(2013-8#3)
these channel##3##2##(1995-9#1)(2008-2#1)(2013-1#1)
these channels in##2##3##(1994-11#1)(2008-8#1)
these channels##17##2##(1991-3#1)(1994-11#3)(1994-2#1)(1995-11#1)(1995-8#1)(2006-10#2)(2007-9#1)(2008-5#2)(2008-7#1)(2008-8#4)
these characteristics are##2##3##(1992-9#1)(2007-12#1)
these characteristics at##2##3##(2008-2#1)(2008-7#1)
these characteristics of##2##3##(2007-11#1)(2007-12#1)
these characteristics##30##2##(1991-12#1)(1991-3#1)(1992-6#1)(1992-9#1)(1996-10#1)(1996-2#2)(2004-4#1)(2005-4#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#1)(2012-2#1)(2013-1#1)
these characters##3##2##(2007-1#1)(2008-8#1)(2008-9#1)
these charts##3##2##(2007-12#1)(2013-1#2)
these chemical##3##2##(2008-10#1)(2008-2#1)(2009-6#1)
these chemicals in##4##3##(1993-3#1)(2008-10#2)(2009-6#1)
these chemicals##18##2##(1993-3#1)(2006-12#1)(2007-10#1)(2008-10#9)(2008-11#3)(2008-2#1)(2009-6#1)(2012-2#1)
these children and their families##3##5##(1995-3#1)(2009-7#1)(2010-3#1)
these children and##6##3##(1995-3#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-7#1)(2010-3#1)
these children are##2##3##(2008-11#1)(2010-12#1)
these children the##2##3##(1992-7#1)(2008-4#1)
these children to##3##3##(2006-1#1)(2007-1#1)(2008-9#1)
these children was##3##3##(2008-2#1)(2008-3#1)(2008-6#1)
these children were##5##3##(1990-12#1)(1993-12#1)(1996-1#1)(2007-7#1)(2012-12#1)
these children##66##2##(1990-12#1)(1990-2#1)(1992-7#1)(1993-1#2)(1993-12#1)(1993-8#1)(1994-6#1)(1995-3#1)(1996-1#1)(2005-10#2)(2005-11#1)(2005-9#1)(2006-1#1)(2006-10#3)(2006-4#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-7#3)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#3)(2008-6#1)(2008-9#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-7#2)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#3)
these chimeras##2##2##(1995-11#1)(2008-9#1)
these chiral##3##2##(2008-3#1)(2009-10#2)
these choices are##2##3##(2008-1#1)(2008-8#1)
these cholinergic##2##2##(1993-11#1)(1993-12#1)
these chromosomes##6##2##(1996-12#1)(1996-3#1)(1997-5#1)(1997-6#1)(2007-2#1)(2008-7#1)
these chronic##5##2##(1996-9#1)(2006-2#1)(2007-11#1)(2008-12#1)(2011-2#1)
these circuits##4##2##(2008-11#1)(2008-12#1)(2008-2#2)
these circumstances the##2##3##(1990-8#1)(1993-12#1)
these circumstances##22##2##(1990-8#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-8#1)(1996-3#1)(1996-9#1)(2006-10#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
these claims##3##2##(2009-2#1)(2010-9#1)(2013-8#1)
these class##2##2##(1997-4#1)(1997-8#1)
these classes##7##2##(1996-6#1)(1997-2#1)(2005-8#1)(2006-11#1)(2007-10#1)(2008-1#1)(2008-10#1)
these classifications##2##2##(2009-11#1)(2009-7#1)
these clients##4##2##(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
these clinical situations##3##3##(1996-9#1)(2007-11#1)(2008-3#1)
these clinical trials##2##3##(2008-5#1)(2010-6#1)
these clinical##20##2##(1994-11#1)(1994-12#1)(1996-9#1)(1997-2#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-9#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#2)
these clinically important drugs##2##4##(1994-11#1)(1995-2#1)
these clinically##5##2##(1994-11#1)(1995-2#1)(2009-10#1)(2009-5#1)(2010-12#1)
these clinics##3##2##(1992-1#1)(1992-2#1)(2007-2#1)
these clonal##2##2##(2008-10#1)(2008-6#1)
these clones##11##2##(1990-10#1)(1990-12#1)(1991-12#1)(1991-5#1)(1993-5#1)(1996-6#1)(1997-4#1)(1997-7#1)(1997-8#2)(2008-11#1)
these closely related##2##3##(1993-4#1)(2008-7#1)
these clusters are##3##3##(1993-11#1)(1997-8#1)(2008-10#1)
these clusters##11##2##(1993-11#1)(1995-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-4#1)(2011-1#1)
these coalitions##2##2##(1995-12#1)(2009-4#1)
these coated##3##2##(1995-2#1)(2008-10#1)(2012-11#1)
these coatings##2##2##(2008-2#1)(2008-3#1)
these codes##2##2##(1991-3#1)(2006-8#1)
these coefficients are##2##3##(1993-3#1)(2008-3#1)
these coefficients##7##2##(1993-3#1)(2007-4#1)(2008-2#4)(2008-3#1)
these coexisting##2##2##(2006-9#1)(2012-2#1)
these cognitive##3##2##(2006-3#1)(2007-2#1)(2013-8#1)
these cohorts of##2##3##(2013-1#2)
these cohorts##4##2##(2007-7#1)(2008-10#1)(2013-1#2)
these collections##5##2##(2008-10#1)(2008-7#2)(2010-12#1)(2011-12#1)
these colonies##3##2##(2008-10#2)(2009-8#1)
these columns##4##2##(1991-3#1)(1996-8#1)(1997-3#1)(2008-10#1)
these combinations##7##2##(2007-10#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-11#2)(2009-12#1)
these combined##2##2##(1996-6#1)(2008-5#1)
these comments##2##2##(1996-9#1)(2006-10#1)
these committees##2##2##(1992-2#1)(2007-4#1)
these common##11##2##(1991-5#1)(1993-12#1)(1994-11#1)(1997-8#1)(2006-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-9#1)(2012-3#1)
these communications##2##2##(2008-4#2)
these communities##8##2##(2007-7#1)(2008-10#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-9#1)(2013-1#1)(2013-7#1)
these companies##4##2##(1995-1#2)(2007-4#1)(2007-8#1)
these comparisons##10##2##(1994-8#1)(1995-1#1)(1996-1#1)(2006-4#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-2#1)
these compartments##6##2##(1996-2#1)(2006-5#1)(2008-1#1)(2008-4#2)(2009-8#1)
these competing##2##2##(2005-7#1)(2008-10#1)
these complaints##3##2##(1993-2#1)(2006-10#1)(2011-2#1)
these complex issues##2##3##(1995-6#1)(2006-2#1)
these complex patients##2##3##(2006-1#1)(2008-4#1)
these complex processes##2##3##(2008-11#1)(2009-4#1)
these complex##17##2##(1994-12#1)(1995-6#1)(2005-10#1)(2006-1#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-2#1)(2011-1#1)
these complexes are##6##3##(1992-3#1)(2008-10#2)(2008-5#2)(2009-3#1)
these complexes by##2##3##(1995-1#1)(2008-4#1)
these complexes has been##2##4##(2008-5#2)
these complexes have been determined##3##5##(1992-9#1)(2008-10#1)(2010-5#1)
these complexes have been##4##4##(1992-9#1)(1997-7#1)(2008-10#1)(2010-5#1)
these complexes in##10##3##(1992-9#1)(1996-11#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#4)
these complexes were##7##3##(1991-7#1)(1995-3#1)(1996-8#2)(2006-12#1)(2008-5#1)(2010-5#1)
these complexes with##2##3##(1995-1#1)(2008-5#1)
these complexes##64##2##(1990-7#1)(1991-7#1)(1992-3#1)(1992-5#1)(1992-9#2)(1993-8#1)(1994-8#1)(1994-9#2)(1995-1#3)(1995-11#1)(1995-3#3)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-8#2)(1997-4#1)(1997-6#1)(1997-7#2)(2006-12#1)(2007-10#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#12)(2009-3#1)(2010-2#1)(2010-5#3)(2010-7#2)(2012-12#4)
these complications as well as##2##5##(2011-2#1)(2012-12#1)
these complications##29##2##(1990-12#1)(1991-5#1)(1993-5#1)(1994-11#1)(1996-2#2)(2005-7#1)(2006-9#1)(2007-6#1)(2007-7#3)(2008-1#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
these components are##6##3##(1993-6#1)(2007-11#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)
these components can##3##3##(2008-10#1)(2010-1#1)(2012-3#1)
these components for##2##3##(2008-8#1)(2011-1#1)
these components of##2##3##(2008-10#1)(2013-1#1)
these components to##2##3##(2008-7#1)(2009-7#1)
these components##52##2##(1990-7#1)(1992-9#1)(1993-6#1)(1994-1#1)(1994-5#1)(1996-9#1)(1997-1#1)(1997-3#1)(2005-11#3)(2005-5#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-7#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#1)
these compositions##2##2##(2005-12#1)(2008-5#1)
these compounds and their##3##4##(1991-4#1)(2006-10#1)(2008-8#1)
these compounds and##15##3##(1990-7#2)(1991-4#2)(2006-10#2)(2007-10#1)(2008-10#3)(2008-4#1)(2008-8#1)(2009-8#1)(2010-11#1)(2012-1#1)
these compounds are based on##2##5##(1990-7#1)(2012-3#1)
these compounds are strongly##2##4##(2008-10#2)
these compounds are##28##3##(1990-7#1)(1991-9#1)(1992-5#1)(1992-8#1)(1996-8#1)(1997-1#1)(1997-8#1)(2004-4#1)(2005-4#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-6#1)(2007-11#2)(2008-1#1)(2008-10#6)(2008-8#1)(2010-5#1)(2012-3#1)(2013-1#2)
these compounds at##3##3##(1993-12#1)(1995-3#1)(2007-12#1)
these compounds by##3##3##(1996-8#1)(2008-10#2)
these compounds can be##3##4##(1992-8#1)(2008-10#1)(2012-2#1)
these compounds can##4##3##(1992-8#1)(2008-10#1)(2008-11#1)(2012-2#1)
these compounds did not produce##2##5##(1994-11#1)(1997-2#1)
these compounds did not##3##4##(1994-11#1)(1997-2#1)(2007-10#1)
these compounds do not##2##4##(1990-9#1)(1995-5#1)
these compounds generally##2##3##(1992-12#1)(2007-10#1)
these compounds had##3##3##(2011-2#1)(2012-11#2)
these compounds have been##4##4##(1994-9#1)(2006-9#1)(2007-11#1)(2011-1#1)
these compounds have the##2##4##(1995-3#1)(2008-4#1)
these compounds have##12##3##(1994-3#1)(1994-9#1)(1995-3#1)(1996-8#1)(1997-2#1)(2005-11#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-4#1)(2010-12#1)(2011-1#1)
these compounds in the##6##4##(1990-5#1)(2008-10#1)(2008-5#1)(2010-5#1)(2011-1#1)(2011-2#1)
these compounds in##33##3##(1990-11#1)(1990-12#1)(1990-5#1)(1992-1#1)(1992-5#1)(1992-7#1)(1993-11#1)(1994-2#1)(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#12)(2008-5#4)(2009-4#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)
these compounds is##3##3##(1991-12#1)(2008-10#2)
these compounds may##2##3##(1995-6#1)(2008-1#1)
these compounds possess a potential##2##5##(1996-8#1)(2008-10#1)
these compounds possess##4##3##(1996-8#1)(2007-11#1)(2008-10#1)(2008-5#1)
these compounds to##4##3##(1993-11#1)(1996-8#1)(2008-10#2)
these compounds was determined by##2##5##(2008-10#1)(2012-2#1)
these compounds was found to be##3##6##(1993-11#1)(1995-3#1)(2008-10#1)
these compounds was performed##3##4##(2008-4#1)(2009-6#1)(2011-1#1)
these compounds was##21##3##(1991-2#1)(1992-4#1)(1993-11#1)(1995-12#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-5#1)(2009-6#1)(2011-1#1)(2012-2#1)
these compounds were##22##3##(1990-11#1)(1990-8#1)(1991-5#1)(1992-5#1)(1993-12#1)(1993-6#1)(2006-12#2)(2007-1#1)(2007-11#4)(2008-10#3)(2008-11#1)(2009-10#1)(2009-5#1)(2010-5#1)(2011-2#2)
these compounds with##10##3##(1991-5#1)(1992-11#1)(1997-2#1)(2008-10#2)(2009-7#1)(2009-9#1)(2010-2#1)(2011-1#1)(2012-3#1)
these compounds##321##2##(1990-11#3)(1990-12#2)(1990-3#1)(1990-5#1)(1990-7#6)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#4)(1991-5#2)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#3)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#4)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#1)(1993-11#5)(1993-12#3)(1993-4#3)(1993-6#2)(1993-7#1)(1993-9#3)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#2)(1994-9#2)(1995-10#1)(1995-12#4)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-8#6)(1997-1#2)(1997-2#8)(1997-3#1)(1997-5#2)(1997-8#2)(2004-2#1)(2004-4#1)(2005-11#1)(2005-12#1)(2005-4#1)(2005-7#1)(2005-8#2)(2006-10#6)(2006-12#9)(2006-6#1)(2006-9#1)(2007-1#2)(2007-10#4)(2007-11#19)(2007-12#2)(2007-6#1)(2007-8#1)(2008-1#5)(2008-10#67)(2008-11#8)(2008-3#3)(2008-4#4)(2008-5#14)(2008-6#1)(2008-8#4)(2009-10#2)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#5)(2010-6#1)(2011-1#7)(2011-12#1)(2011-2#4)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#3)
these computational##4##2##(2008-11#1)(2008-7#1)(2009-2#1)(2012-2#1)
these concentrations##14##2##(1990-10#1)(1990-12#1)(1991-3#1)(1991-7#1)(1994-12#1)(1994-2#1)(1996-5#1)(2004-12#1)(2006-12#1)(2006-5#1)(2008-10#1)(2008-11#2)(2009-4#1)
these concepts and##5##3##(1995-5#1)(2006-10#1)(2008-2#1)(2009-3#1)(2012-12#1)
these concepts are##2##3##(2008-10#1)(2008-9#1)
these concepts in the##2##4##(2008-11#1)(2011-2#1)
these concepts to##2##3##(2008-7#1)(2012-2#1)
these concepts##22##2##(1995-5#1)(1996-1#1)(1997-1#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
these concerns are##4##3##(2008-12#2)(2008-3#1)(2008-5#1)
these concerns have##2##3##(2009-4#1)(2013-8#1)
these concerns is##3##3##(2008-11#1)(2008-12#1)(2013-1#1)
these concerns##26##2##(1994-1#1)(1994-12#1)(2006-11#1)(2007-12#2)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-9#1)(2009-4#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
these conclusions and##2##3##(1990-8#1)(2007-8#1)
these conclusions##8##2##(1990-11#1)(1990-8#1)(1993-12#1)(2007-8#2)(2008-7#1)(2008-9#1)(2009-11#1)
these concurrent##2##2##(2005-10#1)(2012-2#1)
these conditions a##3##3##(1990-3#1)(2008-10#2)
these conditions and##9##3##(1990-5#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-2#1)(2008-4#1)(2008-6#1)(2012-11#1)(2012-2#1)
these conditions are##15##3##(1991-8#1)(1992-6#1)(1997-1#1)(2005-11#1)(2006-10#3)(2006-5#1)(2007-7#2)(2008-10#1)(2008-3#1)(2008-9#1)(2010-5#1)(2013-1#1)
these conditions could##2##3##(2008-10#1)(2008-5#1)
these conditions has##2##3##(1993-4#1)(2008-8#1)
these conditions in the##3##4##(1996-6#1)(2006-9#1)(2012-2#1)
these conditions in##6##3##(1996-6#1)(2006-9#1)(2008-11#1)(2008-2#1)(2008-8#1)(2012-2#1)
these conditions is##7##3##(1994-2#1)(2005-11#1)(2006-10#1)(2009-11#2)(2011-1#1)(2012-7#1)
these conditions may##2##3##(2007-12#1)(2008-9#1)
these conditions the##9##3##(1990-12#1)(1993-3#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)
these conditions were##5##3##(1990-7#1)(1994-7#1)(2006-5#1)(2008-8#2)
these conditions will##5##3##(2006-11#1)(2006-12#1)(2007-8#1)(2008-7#1)(2009-12#1)
these conditions with##2##3##(2005-7#1)(2008-10#1)
these conditions##262##2##(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#3)(1990-5#2)(1990-6#1)(1990-7#3)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#1)(1991-3#2)(1991-5#2)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-3#4)(1993-4#3)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#3)(1995-12#2)(1995-2#2)(1995-3#2)(1995-4#2)(1995-8#1)(1995-9#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-7#2)(2005-11#5)(2005-12#1)(2005-7#1)(2006-10#10)(2006-11#3)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#3)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#7)(2007-2#3)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#35)(2008-11#6)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#8)(2008-8#5)(2008-9#5)(2009-10#1)(2009-11#3)(2009-12#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#3)(2010-6#1)(2010-9#1)(2011-1#3)(2011-12#3)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#4)(2012-3#1)(2012-7#1)(2013-1#2)(2013-7#1)(2013-8#1)
these conflicts##2##2##(2006-7#1)(2007-9#1)
these conformations##2##2##(1992-5#1)(1994-11#1)
these conidia##2##2##(2008-10#2)
these conjugates##5##2##(1990-5#1)(1994-3#1)(1996-1#1)(1997-8#1)(2008-4#1)
these connections##3##2##(1994-8#1)(2008-11#1)(2009-8#1)
these connectors##2##2##(2008-3#2)
these consequences##3##2##(2008-4#1)(2011-2#1)(2012-11#1)
these conserved##4##2##(1995-2#1)(1995-6#1)(2012-2#1)(2012-3#1)
these considerations##4##2##(1991-3#1)(1993-12#1)(2009-10#1)(2011-1#1)
these constants##5##2##(2005-11#1)(2008-10#4)
these constituents##4##2##(1993-2#1)(1995-6#1)(2007-8#1)(2008-7#1)
these constraints##4##2##(2007-11#1)(2008-3#1)(2008-7#1)(2008-9#1)
these constructs are##2##3##(1997-2#1)(2009-2#1)
these constructs have##2##3##(1991-5#1)(2008-5#1)
these constructs were##3##3##(1993-5#1)(1994-3#1)(2008-10#1)
these constructs##14##2##(1991-5#1)(1993-11#1)(1993-5#1)(1994-3#1)(1997-2#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-12#1)(2009-2#2)
these consumers##2##2##(1996-1#1)(2008-8#1)
these contact##2##2##(1992-7#1)(2009-2#1)
these contained##3##2##(1997-3#1)(2008-8#1)(2011-2#1)
these contexts##4##2##(2010-12#1)(2010-9#1)(2012-12#1)(2012-3#1)
these contrasting##3##2##(2006-10#1)(2008-11#1)(2013-8#1)
these contributions##5##2##(2008-2#2)(2008-3#1)(2009-4#1)(2010-5#1)
these control##4##2##(2005-11#1)(2008-10#2)(2013-8#1)
these controlled trials##2##3##(2006-2#1)(2007-11#1)
these controls##3##2##(1990-3#1)(1991-6#1)(2008-7#1)
these controversies?##2##2##(2008-11#2)
these conventional##5##2##(1993-4#1)(2007-11#1)(2009-9#1)(2010-9#1)(2013-1#1)
these convergent##2##2##(2007-12#1)(2008-11#1)
these correlation##2##2##(2007-11#1)(2010-2#1)
these correlations were##2##3##(2008-10#1)(2011-10#1)
these correlations##6##2##(1992-9#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2011-10#1)
these costs are##2##3##(1992-3#1)(2008-8#1)
these costs##7##2##(1990-12#1)(1992-3#1)(1995-11#1)(2006-12#1)(2007-1#1)(2008-8#1)(2011-1#1)
these could be##5##3##(2007-10#1)(2008-1#1)(2008-7#1)(2010-12#1)(2010-5#1)
these could##7##2##(1993-6#1)(1995-11#1)(2007-10#1)(2008-1#1)(2008-7#1)(2010-12#1)(2010-5#1)
these countries and##4##3##(2008-10#1)(2008-7#1)(2010-3#1)(2010-4#1)
these countries##27##2##(1991-4#1)(1992-5#1)(1993-9#1)(1994-12#1)(1996-9#1)(2005-7#1)(2005-8#3)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-10#1)(2009-3#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-8#2)
these couplers##4##2##(2007-11#1)(2008-2#3)
these courses are##2##3##(1994-12#1)(1995-1#1)
these courses were##2##3##(1992-12#1)(2013-1#1)
these courses##8##2##(1992-12#1)(1994-12#2)(1995-1#1)(2004-12#1)(2013-1#3)
these creams##2##2##(2008-5#2)
these criteria and##2##3##(2008-6#1)(2011-2#1)
these criteria are##2##3##(2008-2#1)(2013-8#1)
these criteria##29##2##(1991-9#1)(1992-6#1)(1993-8#1)(1994-5#1)(1995-2#2)(1996-12#1)(1997-8#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-5#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-2#1)(2013-1#3)(2013-8#1)
these critical##5##2##(1995-2#1)(2006-6#1)(2007-2#1)(2011-1#1)(2013-1#1)
these criticisms##4##2##(2006-5#1)(2007-11#2)(2008-5#1)
these crops##4##2##(2006-12#1)(2006-4#1)(2008-10#2)
these crystals were##2##3##(1994-9#1)(2008-4#1)
these crystals##8##2##(1992-6#1)(1992-9#1)(1994-8#1)(1994-9#1)(2007-11#1)(2008-2#2)(2008-4#1)
these cultivars##3##2##(2008-10#2)(2012-11#1)
these cultural##2##2##(1995-1#1)(2008-1#1)
these culture##4##2##(1992-1#1)(2008-1#1)(2008-10#1)(2008-9#1)
these cultured cells##2##3##(1990-7#1)(1997-4#1)
these cultures are##2##3##(1990-7#1)(2008-11#1)
these cultures were##2##3##(2008-11#2)
these cultures##21##2##(1990-2#1)(1990-7#2)(1991-5#1)(1993-9#1)(1995-12#1)(1995-9#1)(1997-4#1)(2007-12#1)(2007-5#2)(2008-11#7)(2010-2#1)(2012-2#1)(2013-1#1)
these current##2##2##(1995-12#1)(2008-5#1)
these currents##2##2##(2008-4#1)(2008-8#1)
these curricula##2##2##(2008-12#1)(2011-2#1)
these curves##4##2##(2005-11#1)(2008-10#1)(2008-2#1)(2008-5#1)
these cyclic##2##2##(1996-1#1)(2006-9#1)
these cysts##4##2##(2005-9#1)(2006-5#1)(2010-6#1)(2012-2#1)
these cytokine-secreting vaccines##2##3##(1997-4#2)
these cytokines and##3##3##(2008-8#1)(2008-9#1)(2010-9#1)
these cytokines are##4##3##(1992-8#1)(2006-10#1)(2008-3#1)(2009-11#1)
these cytokines were##2##3##(1996-12#1)(2008-1#1)
these cytokines##22##2##(1990-2#1)(1992-8#1)(1994-11#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-4#1)(2005-8#1)(2006-10#3)(2007-12#1)(2008-1#1)(2008-3#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-9#1)
these data a##2##3##(1997-8#1)(2012-12#1)
these data also##2##3##(1995-12#1)(2008-7#1)
these data and##3##3##(1995-1#1)(2007-4#1)(2012-3#1)
these data are##10##3##(1996-5#1)(1997-2#1)(2008-4#2)(2008-7#1)(2009-4#1)(2010-11#1)(2010-2#1)(2012-3#1)(2013-1#1)
these data as##3##3##(1994-6#1)(1994-8#1)(2008-10#1)
these data can be##3##4##(1991-5#1)(1993-12#1)(2008-1#1)
these data can##4##3##(1991-5#1)(1993-12#1)(2008-1#1)(2008-3#1)
these data demonstrate that##6##4##(1991-12#1)(1995-12#1)(1997-1#1)(2007-6#1)(2008-4#1)(2009-6#1)
these data demonstrate##7##3##(1991-12#1)(1995-12#1)(1997-1#1)(2007-6#1)(2008-4#1)(2009-4#1)(2009-6#1)
these data for##3##3##(2006-5#1)(2008-10#1)(2008-2#1)
these data have##4##3##(1994-8#1)(1997-4#1)(2006-11#1)(2012-3#1)
these data highlight##2##3##(2012-2#1)(2013-8#1)
these data in##3##3##(2007-12#1)(2007-4#1)(2008-2#1)
these data indicate that the##2##5##(1995-3#1)(1997-2#1)
these data indicate that##11##4##(1990-9#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-3#1)(1997-2#2)(2007-10#1)(2008-4#2)(2012-12#1)
these data indicated that##2##4##(1991-5#1)(1994-12#1)
these data into a##2##4##(2010-2#1)(2012-12#1)
these data is difficult##2##4##(1993-11#1)(2013-1#1)
these data is that##2##4##(1995-3#1)(2012-2#1)
these data is##11##3##(1990-11#1)(1993-11#2)(1995-3#1)(1995-9#1)(2007-12#1)(2008-4#1)(2012-2#1)(2013-1#3)
these data may##5##3##(1990-2#1)(2006-11#2)(2009-12#1)(2012-11#1)
these data provide evidence that##2##5##(2008-10#1)(2008-9#1)
these data provide evidence##3##4##(2008-10#1)(2008-7#1)(2008-9#1)
these data provide##6##3##(1991-7#1)(1994-8#1)(2008-10#2)(2008-7#1)(2008-9#1)
these data show that##5##4##(1990-10#1)(1992-7#1)(2007-10#1)(2008-5#1)(2008-7#1)
these data show##7##3##(1990-10#1)(1991-6#1)(1992-7#1)(2007-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
these data suggest a##2##4##(1994-3#1)(1997-2#1)
these data suggest an##2##4##(1990-8#1)(1994-3#1)
these data suggest that the##2##5##(1992-12#1)(1997-1#1)
these data suggest that##30##4##(1990-7#1)(1992-12#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-9#2)(1995-12#1)(1995-3#2)(1996-10#1)(1997-1#2)(1997-8#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-10#1)(2009-9#1)(2011-2#2)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
these data suggest##36##3##(1990-7#1)(1990-8#1)(1992-12#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-9#3)(1995-12#1)(1995-3#2)(1996-10#1)(1997-1#2)(1997-2#1)(1997-8#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-10#1)(2009-9#1)(2011-2#2)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
these data support a##2##4##(1993-11#1)(1993-12#1)
these data support##4##3##(1993-11#1)(1993-12#1)(1994-2#1)(1994-8#1)
these data the##6##3##(1990-6#1)(1990-7#1)(1992-10#1)(1997-4#1)(2008-3#1)(2012-3#1)
these data to a##2##4##(2006-4#1)(2008-5#1)
these data to demonstrate##2##4##(1994-2#1)(2008-6#1)
these data to##9##3##(1994-2#1)(1995-3#1)(1996-12#1)(2006-4#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#2)
these data using##2##3##(1997-1#1)(2010-12#1)
these data was##2##3##(2006-4#1)(2008-10#1)
these data we##6##3##(1993-2#1)(1993-8#1)(1996-6#1)(2005-11#1)(2007-11#1)(2012-2#1)
these data were##3##3##(1991-12#1)(2008-9#1)(2012-12#1)
these data will##3##3##(1992-12#1)(2008-4#1)(2010-9#1)
these data with##4##3##(1992-10#1)(1997-4#1)(2008-7#1)(2012-12#1)
these data##267##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-12#3)(1991-5#3)(1991-6#2)(1991-7#1)(1992-10#3)(1992-11#1)(1992-12#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#6)(1994-9#3)(1995-1#2)(1995-12#3)(1995-3#6)(1995-5#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#4)(1997-2#5)(1997-4#4)(1997-7#1)(1997-8#2)(2004-11#1)(2004-12#1)(2004-9#1)(2005-11#4)(2006-10#3)(2006-11#3)(2006-2#1)(2006-4#2)(2006-5#1)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#4)(2007-2#2)(2007-4#4)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#12)(2008-11#2)(2008-2#6)(2008-3#7)(2008-4#11)(2008-5#4)(2008-6#2)(2008-7#9)(2008-8#4)(2008-9#2)(2009-10#2)(2009-12#3)(2009-2#2)(2009-4#3)(2009-6#1)(2009-8#1)(2009-9#2)(2010-11#2)(2010-12#1)(2010-2#3)(2010-7#2)(2010-9#1)(2011-1#3)(2011-2#8)(2012-11#4)(2012-12#8)(2012-2#4)(2012-3#9)(2013-1#6)(2013-7#1)(2013-8#2)
these databases##7##2##(1997-1#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-10#1)(2009-3#1)
these days##6##2##(2007-9#1)(2008-1#1)(2008-12#1)(2008-5#1)(2011-1#1)(2013-1#1)
these deaths##5##2##(1990-6#1)(1992-6#1)(2010-8#1)(2011-9#1)(2012-1#1)
these decisions##7##2##(1993-2#1)(1994-3#2)(2007-2#1)(2008-5#1)(2010-3#1)(2013-7#1)
these decreases were##2##3##(2005-12#1)(2008-4#1)
these defects in##2##3##(2007-10#1)(2008-8#1)
these defects were##2##3##(1994-12#1)(2007-9#1)
these defects##11##2##(1994-12#1)(2005-11#2)(2007-10#1)(2007-12#1)(2007-9#1)(2008-8#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#1)
these defenses##3##2##(1992-3#1)(1995-8#1)(2006-7#1)
these deficiencies##2##2##(2007-2#1)(2012-12#1)
these deficits are##3##3##(1993-12#1)(1995-1#1)(2012-1#1)
these deficits##12##2##(1992-11#1)(1993-12#1)(1995-1#1)(1996-3#1)(1996-8#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-7#1)(2011-2#1)(2012-1#1)
these definitions##2##2##(1991-12#1)(2010-5#1)
these deformities##4##2##(2007-12#1)(2007-7#1)(2008-4#1)(2010-11#1)
these delayed##4##2##(1995-7#1)(2007-9#1)(2008-7#1)(2009-9#1)
these deleterious effects##2##3##(1993-11#1)(2012-12#1)
these deleterious##3##2##(1993-11#1)(2009-8#1)(2012-12#1)
these delivery##2##2##(1994-7#1)(2008-4#1)
these demands##4##2##(2005-5#1)(2007-1#1)(2008-7#1)(2010-4#1)
these demographic##3##2##(1991-8#1)(1995-1#1)(2009-4#1)
these dendrites##2##2##(1996-9#1)(2010-11#1)
these dependencies are##2##3##(1996-4#1)(2006-10#1)
these derivatives are##2##3##(1990-12#1)(2006-12#1)
these derivatives were##3##3##(1990-12#1)(1997-2#1)(2008-5#1)
these derivatives##15##2##(1990-12#2)(1991-12#1)(1991-5#1)(1992-1#1)(1992-9#1)(1994-11#1)(1996-8#1)(1997-2#2)(2006-12#2)(2008-5#1)(2012-3#1)(2013-8#1)
these designs##2##2##(2007-12#1)(2008-3#1)
these detection##2##2##(2008-10#1)(2010-8#1)
these detectors##4##2##(2007-12#1)(2008-2#3)
these determinants##2##2##(1990-11#1)(2008-10#1)
these determinations##3##2##(2008-10#2)(2008-8#1)
these devastating##3##2##(1996-6#1)(2008-5#1)(2011-2#1)
these developmental##2##2##(1991-3#1)(2006-12#1)
these developments and##4##3##(2006-10#1)(2007-2#1)(2008-7#1)(2011-1#1)
these developments##17##2##(1991-2#1)(1993-1#1)(2005-5#1)(2006-10#2)(2006-6#1)(2006-9#2)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-1#1)
these devices are##6##3##(2007-11#1)(2007-12#1)(2008-6#1)(2010-11#1)(2010-9#1)(2013-1#1)
these devices can##2##3##(2007-12#1)(2008-7#1)
these devices in##3##3##(2006-6#1)(2008-2#1)(2010-11#1)
these devices is##5##3##(1990-3#1)(2006-6#1)(2007-12#1)(2008-5#1)(2010-8#1)
these devices show##2##3##(2008-3#1)(2008-7#1)
these devices##40##2##(1990-3#1)(2005-12#1)(2006-6#2)(2007-11#2)(2007-12#4)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#4)(2009-11#1)(2009-5#1)(2010-11#2)(2010-7#2)(2010-8#1)(2010-9#2)(2011-2#3)(2013-1#2)(2013-8#1)
these diabetic patients##2##3##(2008-1#1)(2008-8#1)
these diabetic##5##2##(2008-1#2)(2008-10#1)(2008-8#1)(2012-12#1)
these diagnoses##2##2##(1990-12#1)(2012-12#1)
these diagnostic##5##2##(1990-12#1)(1992-6#1)(1993-1#1)(1996-4#1)(2007-8#1)
these dietary##4##2##(2008-11#1)(2008-5#1)(2010-1#1)(2012-12#1)
these diets##4##2##(1994-2#1)(1996-12#1)(2008-10#1)(2010-8#1)
these differences and##5##3##(1994-5#1)(2007-8#1)(2008-10#1)(2008-3#1)(2012-2#1)
these differences are due to##2##5##(2006-8#1)(2008-3#1)
these differences are not##2##4##(1995-5#1)(2011-12#1)
these differences are##10##3##(1993-3#1)(1994-1#1)(1995-5#1)(1997-1#1)(1997-7#1)(2006-5#1)(2006-8#1)(2007-11#1)(2008-3#1)(2011-12#1)
these differences can be##2##4##(2010-8#1)(2012-1#1)
these differences can##4##3##(1991-12#1)(1994-8#1)(2010-8#1)(2012-1#1)
these differences in##12##3##(1992-3#1)(1993-12#1)(1994-2#1)(2005-11#1)(2006-11#1)(2008-8#3)(2010-2#1)(2010-9#1)(2011-2#1)(2012-2#1)
these differences may be related to the##2##7##(1997-7#1)(2011-2#1)
these differences may be##3##4##(1997-7#1)(2008-10#1)(2011-2#1)
these differences may have##3##4##(1991-8#1)(1997-3#1)(2007-10#1)
these differences may##8##3##(1991-8#1)(1993-2#1)(1996-10#1)(1997-3#1)(1997-7#1)(2007-10#1)(2008-10#1)(2011-2#1)
these differences to##2##3##(2007-11#1)(2009-10#1)
these differences were no longer##2##5##(1991-6#1)(1992-7#1)
these differences were not##3##4##(2008-5#1)(2012-2#1)(2013-1#1)
these differences were##9##3##(1991-6#1)(1992-7#1)(2008-2#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
these differences##92##2##(1990-1#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#3)(1995-5#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#3)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-4#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#2)
these different manifestations##2##3##(2011-2#1)(2012-12#1)
these different methods##3##3##(1993-1#1)(2008-11#1)(2010-4#1)
these different types of##2##4##(2008-4#1)(2009-12#1)
these different##46##2##(1990-12#1)(1990-4#1)(1990-8#1)(1991-9#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-12#1)(1997-7#1)(2005-12#1)(2006-11#1)(2006-3#1)(2006-5#1)(2006-9#1)(2007-3#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#2)(2009-2#1)(2009-4#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-8#1)
these differentially expressed##2##3##(2012-3#1)(2013-8#1)
these differentiations##2##2##(2007-5#2)
these differing##2##2##(1993-2#1)(1997-3#1)
these difficult lesions##2##3##(2006-12#2)
these difficult patients##2##3##(2007-8#2)
these difficult##6##2##(2006-12#2)(2007-8#2)(2008-11#1)(2008-7#1)
these difficulties##14##2##(1994-11#1)(2005-8#3)(2007-11#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-7#2)(2009-10#1)(2011-12#1)(2011-2#1)(2012-1#1)
these dimensions##4##2##(1994-2#1)(1996-2#1)(1997-3#1)(2005-10#1)
these direct##2##2##(2008-3#1)(2008-4#1)
these disadvantages##2##2##(2006-12#1)(2012-1#1)
these disciplines##5##2##(1996-12#1)(2005-5#1)(2008-11#1)(2010-3#1)(2010-9#1)
these discrepancies##2##2##(2005-11#1)(2007-8#1)
these discussions##4##2##(2008-10#1)(2008-7#2)(2009-10#1)
these disease states##5##3##(2006-12#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-4#1)
these disease##11##2##(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#2)(2010-4#1)
these diseased##2##2##(1993-2#1)(2008-10#1)
these diseases and the##4##4##(1997-8#1)(2005-11#1)(2006-8#1)(2007-7#1)
these diseases and##11##3##(1997-8#1)(2005-11#1)(2006-8#1)(2007-7#1)(2009-4#1)(2009-9#1)(2011-1#2)(2013-1#2)(2013-8#1)
these diseases are##14##3##(1995-3#1)(1995-9#1)(2006-10#2)(2006-2#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-7#1)(2008-9#2)(2013-8#1)
these diseases as##3##3##(2006-8#1)(2008-8#1)(2013-8#1)
these diseases have been##2##4##(2010-4#1)(2012-2#1)
these diseases have##5##3##(2008-8#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
these diseases in the##3##4##(2008-1#1)(2010-6#1)(2011-2#1)
these diseases in##4##3##(2007-7#1)(2008-1#1)(2010-6#1)(2011-2#1)
these diseases is##5##3##(1994-5#1)(1996-5#1)(2009-4#1)(2013-1#2)
these diseases were##2##3##(2007-7#1)(2008-10#1)
these diseases##115##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-12#1)(1992-9#1)(1993-10#1)(1994-3#1)(1994-5#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-8#3)(2004-2#1)(2005-10#1)(2005-11#1)(2006-10#7)(2006-11#1)(2006-2#1)(2006-8#3)(2007-1#1)(2007-12#1)(2007-2#1)(2007-5#2)(2007-7#5)(2008-1#3)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-7#4)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-4#3)(2009-7#1)(2009-9#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#6)(2013-8#4)
these disorders and##3##3##(1992-1#1)(2006-10#1)(2010-9#1)
these disorders are##11##3##(1995-11#1)(1997-7#1)(2006-2#1)(2007-6#1)(2008-1#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
these disorders as##2##3##(2008-9#1)(2010-4#1)
these disorders in##4##3##(1997-3#1)(2005-7#1)(2010-5#1)(2011-2#1)
these disorders is##5##3##(1995-5#1)(2008-1#1)(2008-7#1)(2013-7#2)
these disorders still##2##3##(2005-10#1)(2008-3#1)
these disorders were##2##3##(2009-4#1)(2012-12#1)
these disorders##91##2##(1990-11#1)(1990-9#1)(1991-4#1)(1992-1#1)(1992-12#1)(1993-12#2)(1994-10#1)(1994-2#2)(1995-11#1)(1995-12#1)(1995-5#2)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#2)(2004-11#1)(2005-10#2)(2005-6#1)(2005-7#1)(2006-10#5)(2006-12#2)(2006-2#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-2#3)(2007-3#1)(2007-6#2)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#1)(2009-4#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#1)(2013-7#3)(2013-8#1)
these disparate##2##2##(2008-9#1)(2013-8#1)
these disparities##2##2##(2008-1#1)(2008-11#1)
these dissipative structures##2##3##(2007-12#1)(2012-2#1)
these dissociation##2##2##(1994-6#1)(2008-10#1)
these distinct##4##2##(1994-8#1)(2008-10#1)(2008-12#1)(2009-10#1)
these distinctions##3##2##(1990-8#1)(1993-12#1)(2006-12#1)
these distributions##3##2##(1997-6#1)(2007-10#1)(2007-5#1)
these disturbances##4##2##(2006-9#1)(2007-8#1)(2008-5#1)(2008-8#1)
these divergences##2##2##(1997-4#1)(2008-10#1)
these diverse effects##2##3##(1994-12#1)(1996-8#1)
these diverse##13##2##(1991-1#1)(1991-5#1)(1992-7#1)(1994-12#1)(1996-8#1)(1997-7#1)(2005-7#1)(2006-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-9#1)
these do not##4##3##(2007-11#1)(2008-10#1)(2013-1#2)
these doctors##4##2##(1996-3#1)(1997-8#1)(2009-4#1)(2010-11#1)
these documents##5##2##(2007-5#2)(2009-11#1)(2013-1#2)
these dogs##2##2##(2005-7#1)(2008-12#1)
these domains are##3##3##(1990-7#1)(1994-6#1)(1995-11#1)
these domains is##3##3##(1992-4#1)(1993-6#1)(2008-5#1)
these domains##17##2##(1990-7#1)(1991-5#1)(1992-4#1)(1992-7#1)(1993-3#1)(1993-6#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-5#1)(2006-2#1)(2008-12#1)(2008-5#2)(2008-7#1)
these donors##2##2##(2004-12#1)(2011-2#1)
these doses were##3##3##(2006-9#1)(2007-11#1)(2007-7#1)
these doses##12##2##(1990-6#1)(1991-3#2)(1994-11#1)(1995-12#1)(1996-9#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-7#1)
these drawbacks##6##2##(2006-10#1)(2007-6#1)(2008-7#1)(2010-5#1)(2010-6#1)(2013-1#1)
these droplets##2##2##(2006-12#1)(2008-2#1)
these drug##7##2##(1993-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2010-1#1)(2013-1#1)
these drugs and their##2##4##(1995-5#1)(2006-10#1)
these drugs and##3##3##(1995-5#1)(1996-9#1)(2006-10#1)
these drugs are not##2##4##(2005-10#1)(2012-1#1)
these drugs are##16##3##(1991-9#1)(2005-10#1)(2006-4#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-3#1)(2008-8#1)(2009-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
these drugs could##2##3##(1994-5#1)(2013-8#1)
these drugs during pregnancy##2##4##(2008-7#1)(2012-2#1)
these drugs for##3##3##(1994-5#1)(2006-9#1)(2008-2#1)
these drugs have been##4##4##(1997-2#1)(2007-11#1)(2010-5#1)(2013-7#1)
these drugs have##10##3##(1997-2#1)(2005-8#1)(2006-10#1)(2007-11#1)(2010-10#1)(2010-5#1)(2012-12#1)(2013-1#1)(2013-7#2)
these drugs in the##8##4##(1996-3#1)(2005-7#1)(2007-11#3)(2008-10#1)(2010-6#1)(2012-2#1)
these drugs in##19##3##(1991-4#1)(1991-8#1)(1996-3#1)(2005-7#1)(2006-8#1)(2007-11#4)(2008-10#2)(2008-7#1)(2010-2#1)(2010-6#3)(2011-1#1)(2012-2#1)(2013-1#1)
these drugs may be##4##4##(1991-11#1)(1992-8#1)(2007-11#1)(2008-8#1)
these drugs may##9##3##(1991-11#1)(1992-8#1)(1993-2#1)(1993-8#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-4#1)
these drugs were##2##3##(1993-11#1)(2008-10#1)
these drugs when used##2##4##(1990-3#1)(1993-9#1)
these drugs##176##2##(1990-10#1)(1990-3#1)(1990-5#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-8#2)(1991-9#2)(1992-12#1)(1992-2#1)(1992-8#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#2)(1994-4#1)(1994-5#3)(1994-6#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#2)(2005-10#1)(2005-7#1)(2005-8#2)(2006-10#7)(2006-12#3)(2006-4#2)(2006-5#1)(2006-8#1)(2006-9#3)(2007-1#1)(2007-11#14)(2007-12#1)(2007-5#1)(2007-8#3)(2008-1#4)(2008-10#13)(2008-11#4)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#3)(2008-8#7)(2009-12#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-11#3)(2010-2#1)(2010-4#1)(2010-5#3)(2010-6#3)(2011-1#3)(2011-2#3)(2012-1#4)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#4)(2013-8#2)
these during##2##2##(1995-5#1)(2006-12#1)
these dyes##8##2##(1996-12#2)(2005-11#1)(2007-8#1)(2008-10#2)(2008-9#1)(2010-2#1)
these dynamic##4##2##(1993-2#1)(1995-2#1)(2006-12#1)(2008-1#1)
these dynamics##3##2##(2007-12#1)(2010-3#1)(2011-1#1)
these dysfunctions##3##2##(1993-2#1)(2008-10#1)(2013-1#1)
these earlier##3##2##(1993-6#1)(1996-9#1)(2008-7#1)
these early##12##2##(1990-8#1)(1994-6#1)(1994-8#1)(1996-5#1)(2004-1#1)(2005-11#1)(2008-8#1)(2009-5#1)(2010-2#1)(2011-12#2)(2011-2#1)
these economic##2##2##(2008-3#1)(2009-10#1)
these effectors##3##2##(1990-9#1)(1996-2#1)(2011-2#1)
these effects and##12##3##(1997-2#1)(2006-10#1)(2006-5#1)(2007-12#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-11#1)
these effects are mediated##3##4##(1990-11#1)(1991-8#1)(1995-10#1)
these effects are not##5##4##(2007-12#2)(2008-10#1)(2008-7#1)(2010-5#1)
these effects are##28##3##(1990-10#1)(1990-11#1)(1990-7#1)(1991-7#2)(1991-8#1)(1992-1#1)(1992-11#1)(1993-3#1)(1995-10#1)(1996-4#2)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-5#1)(2012-11#1)(2012-2#1)
these effects by##2##3##(2009-4#1)(2010-4#1)
these effects can be##2##4##(2007-12#1)(2009-4#1)
these effects disappear##2##3##(1992-8#1)(2006-10#1)
these effects has##2##3##(1993-9#1)(2008-5#1)
these effects have been##3##4##(1997-5#1)(2005-11#1)(2008-10#1)
these effects have##5##3##(1997-5#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-8#1)
these effects is##5##3##(1994-8#1)(2008-2#2)(2008-3#1)(2008-5#1)
these effects may be##2##4##(2005-12#1)(2006-10#1)
these effects may##5##3##(1997-8#1)(2005-10#1)(2005-12#1)(2006-10#1)(2011-1#1)
these effects might be##3##4##(1993-12#1)(1996-5#1)(2008-3#1)
these effects might##7##3##(1991-10#1)(1993-12#1)(1996-5#1)(2008-3#1)(2008-9#1)(2012-12#1)(2013-1#1)
these effects of##11##3##(1991-2#1)(1991-5#1)(1992-6#1)(1996-10#1)(1996-5#1)(1996-8#2)(2008-10#2)(2008-6#1)(2008-8#1)
these effects on##2##3##(1991-5#1)(1992-9#1)
these effects remain##2##3##(2009-8#1)(2011-2#1)
these effects was##2##3##(1990-3#1)(1994-5#1)
these effects were##23##3##(1991-1#1)(1991-8#1)(1992-4#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1996-2#1)(1996-9#1)(1997-5#1)(2005-8#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-2#1)(2011-1#2)(2011-2#2)
these effects##185##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-2#2)(1991-5#2)(1991-7#2)(1991-8#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#3)(1993-3#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#4)(1994-5#1)(1994-6#2)(1994-8#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#4)(1996-8#2)(1996-9#2)(1997-2#1)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#1)(2005-10#2)(2005-11#3)(2005-12#1)(2005-6#1)(2005-8#1)(2006-10#5)(2006-12#2)(2006-2#2)(2006-5#1)(2007-11#3)(2007-12#10)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#8)(2008-2#2)(2008-3#9)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#9)(2008-9#4)(2009-10#1)(2009-11#2)(2009-4#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-2#1)(2010-4#2)(2010-5#1)(2011-1#3)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)
these efforts are##3##3##(2005-7#1)(2010-8#1)(2011-1#1)
these efforts have been##2##4##(2008-6#1)(2009-5#1)
these efforts have##4##3##(1995-2#1)(2006-10#1)(2008-6#1)(2009-5#1)
these efforts##20##2##(1992-3#1)(1995-2#1)(2005-7#1)(2006-10#1)(2006-7#2)(2006-9#1)(2007-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
these eight##7##2##(1997-7#1)(2004-11#1)(2008-10#2)(2008-7#1)(2009-4#1)(2011-3#1)
these electrodes in##3##3##(2008-10#3)
these electrodes##10##2##(2008-10#10)
these elements are##9##3##(1992-6#1)(1994-8#1)(1995-1#1)(1995-8#1)(1996-4#2)(2008-10#1)(2010-9#1)(2013-1#1)
these elements in##9##3##(1990-5#1)(1991-11#1)(1995-3#1)(1995-6#1)(2008-10#3)(2009-6#1)(2012-2#1)
these elements to##2##3##(2008-10#1)(2008-3#1)
these elements were##2##3##(2008-10#1)(2012-3#1)
these elements##54##2##(1990-5#1)(1990-9#1)(1991-11#1)(1991-7#1)(1992-6#1)(1993-6#1)(1994-2#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#2)(1995-6#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-4#3)(2004-4#1)(2005-4#1)(2007-11#1)(2007-12#2)(2008-10#16)(2008-3#2)(2008-7#1)(2009-6#1)(2010-5#1)(2010-9#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
these emerging##4##2##(1992-1#1)(2007-8#1)(2012-1#1)(2012-2#1)
these emissions##2##2##(2006-5#1)(2008-3#1)
these employees##4##2##(1992-12#1)(2004-9#1)(2007-7#1)(2011-2#1)
these emulsions##2##2##(2005-11#1)(2008-5#1)
these encouraging##2##2##(2006-6#1)(2013-8#1)
these endocrine organs##2##3##(1990-7#2)
these endocrine##3##2##(1990-7#2)(2013-1#1)
these endogenous##4##2##(1990-7#1)(1994-5#1)(1996-2#1)(2008-1#1)
these endothelial##2##2##(1991-12#1)(1997-2#1)
these ends##2##2##(1990-9#1)(2008-4#1)
these energies##2##2##(2007-12#1)(2012-2#1)
these engineered##2##2##(2008-11#1)(2009-5#1)
these enlarged##2##2##(2009-10#2)
these entities##11##2##(1993-1#1)(1996-3#1)(2006-10#1)(2008-3#2)(2008-4#1)(2010-7#1)(2012-12#1)(2012-2#2)(2013-8#1)
these environmental##2##2##(2008-10#1)(2009-7#1)
these environments##6##2##(1994-2#1)(1996-12#1)(2007-1#1)(2008-8#1)(2008-9#2)
these enzymatic##4##2##(1995-1#1)(1995-3#1)(2008-10#1)(2012-2#1)
these enzyme activities##2##3##(1993-11#1)(2008-5#1)
these enzyme##7##2##(1991-2#1)(1991-9#1)(1993-11#1)(1997-7#1)(2008-10#1)(2008-5#2)
these enzymes and their##2##4##(1991-2#1)(2007-8#1)
these enzymes and##5##3##(1991-2#1)(1997-3#1)(2006-10#1)(2007-8#1)(2013-8#1)
these enzymes are##8##3##(1990-9#1)(1991-5#1)(1993-7#1)(1994-11#1)(2005-8#1)(2006-8#1)(2008-4#1)(2009-8#1)
these enzymes as##2##3##(1995-3#1)(2008-6#1)
these enzymes in the##5##4##(1991-2#1)(1992-12#1)(1995-11#1)(2006-6#1)(2008-8#1)
these enzymes in##13##3##(1990-7#1)(1991-11#1)(1991-2#1)(1992-12#1)(1992-4#1)(1994-6#1)(1995-11#1)(1995-3#1)(2006-6#1)(2008-11#1)(2008-8#1)(2009-8#1)(2010-2#1)
these enzymes is##2##3##(1991-5#1)(1996-9#1)
these enzymes may##3##3##(1993-2#1)(2008-11#1)(2008-4#1)
these enzymes was##3##3##(1990-4#1)(1994-11#1)(2008-6#1)
these enzymes##95##2##(1990-1#1)(1990-12#1)(1990-3#1)(1990-4#2)(1990-7#4)(1990-8#2)(1990-9#1)(1991-11#1)(1991-2#2)(1991-5#3)(1991-7#1)(1992-11#1)(1992-12#1)(1992-4#3)(1992-5#2)(1992-8#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-7#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#3)(1995-11#2)(1995-3#2)(1995-7#1)(1996-2#1)(1996-9#1)(1997-3#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-10#7)(2008-11#3)(2008-4#5)(2008-5#3)(2008-6#2)(2008-8#1)(2009-8#4)(2010-11#1)(2010-2#1)(2011-1#2)(2012-12#2)(2013-1#1)(2013-8#1)
these epidemics are##2##3##(2008-10#1)(2012-2#1)
these epidemics##6##2##(2008-10#2)(2008-5#1)(2009-5#2)(2012-2#1)
these epigenetic##2##2##(2008-7#1)(2011-2#1)
these epithelial##2##2##(1991-12#1)(2007-12#1)
these epsps were##2##3##(1991-6#2)
these equations were##2##3##(2008-10#1)(2008-11#1)
these equations##10##2##(2005-11#1)(2006-6#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-3#3)(2011-2#1)
these equilibrium constants##2##3##(1994-9#2)
these error sources##2##3##(2008-2#1)(2008-3#1)
these error##5##2##(2006-6#1)(2008-2#1)(2008-3#2)(2008-6#1)
these errors##12##2##(1993-4#1)(2007-7#1)(2008-2#1)(2008-3#7)(2009-9#1)(2010-12#1)
these essential##5##2##(2008-10#1)(2008-6#1)(2009-5#1)(2012-2#2)
these esters##3##2##(1993-8#1)(1997-8#1)(2008-5#1)
these estimates are##2##3##(1995-6#1)(1997-3#1)
these estimates##16##2##(1993-1#2)(1993-9#1)(1995-6#1)(1996-8#1)(1997-3#1)(2006-10#1)(2006-7#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-2#1)(2011-1#1)(2013-1#2)
these estimators##2##2##(1992-6#1)(1997-7#1)
these ethical##2##2##(1995-1#1)(2008-7#1)
these etiologic agents##2##3##(2011-2#1)(2012-3#1)
these evaluations##9##2##(2006-5#3)(2006-7#1)(2007-4#1)(2009-11#1)(2013-1#3)
these events and##2##3##(2009-4#1)(2011-2#1)
these events are##5##3##(1991-1#1)(1993-8#1)(2007-8#1)(2008-10#1)(2008-9#1)
these events can##2##3##(2008-9#1)(2012-12#1)
these events is##3##3##(1991-10#1)(1997-1#1)(2013-1#1)
these events were##3##3##(1992-11#1)(1993-2#1)(2012-12#1)
these events##32##2##(1990-3#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-8#1)(1992-11#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-9#1)(1996-4#1)(1997-1#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-9#3)(2009-3#1)(2009-4#1)(2009-6#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
these evidence-based##3##2##(2008-3#1)(2012-3#2)
these ex vivo##2##3##(2008-7#2)
these examples##7##2##(1996-12#1)(1996-4#1)(2005-8#1)(2008-12#1)(2008-3#1)(2009-8#1)(2010-2#1)
these exceptional##3##2##(1990-9#1)(1996-3#2)
these exchanges##2##2##(2008-12#1)(2012-12#1)
these exhibit##2##2##(1995-2#1)(2011-1#1)
these expectations##3##2##(2007-10#1)(2008-7#1)(2012-12#1)
these experiences and##3##3##(2012-3#1)(2013-1#2)
these experiences##7##2##(1994-12#1)(2006-3#1)(2012-3#1)(2013-1#2)(2013-8#2)
these experimental conditions##9##3##(1991-1#1)(1991-12#1)(1993-2#1)(1996-5#1)(1997-2#1)(2008-10#3)(2008-5#1)
these experimental data##3##3##(2006-1#1)(2007-4#1)(2008-10#1)
these experimental results##3##3##(1991-12#1)(2008-10#1)(2008-2#1)
these experimental##25##2##(1991-1#1)(1991-12#2)(1993-2#1)(1995-4#1)(1996-5#1)(1997-2#1)(2004-9#1)(2006-1#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#5)(2008-2#1)(2008-5#2)(2008-7#1)(2010-4#1)(2012-12#1)(2013-1#1)
these experiments are discussed##2##4##(1990-11#1)(1996-3#1)
these experiments are##6##3##(1990-11#1)(1990-8#1)(1996-3#1)(2006-4#1)(2010-8#1)(2011-3#1)
these experiments demonstrate that##2##4##(1992-5#1)(1994-3#1)
these experiments demonstrate##3##3##(1992-5#1)(1994-3#1)(2007-3#1)
these experiments illustrate##2##3##(1993-11#1)(2008-3#1)
these experiments it##2##3##(1990-11#1)(2008-2#1)
these experiments suggest that##2##4##(1995-3#1)(2007-12#1)
these experiments suggest##3##3##(1992-10#1)(1995-3#1)(2007-12#1)
these experiments we##3##3##(1990-12#1)(1996-8#1)(1997-5#1)
these experiments were##3##3##(1994-10#1)(1994-3#1)(2007-4#1)
these experiments##81##2##(1990-11#2)(1990-12#1)(1990-7#1)(1990-8#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-3#3)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#3)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-6#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(2005-11#1)(2006-12#2)(2006-4#2)(2006-5#1)(2007-12#1)(2007-3#1)(2007-4#2)(2008-10#15)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-2#1)(2011-3#1)(2013-1#1)
these explanations##2##2##(2005-10#1)(2008-1#1)
these explosives##3##2##(2008-10#3)
these exposures##6##2##(1992-5#1)(2008-11#1)(2008-9#1)(2009-12#1)(2009-6#1)(2011-2#1)
these expressions##5##2##(1996-11#1)(2005-11#1)(2007-12#1)(2008-11#1)(2008-3#1)
these extended##2##2##(1992-9#1)(1993-12#1)
these external##3##2##(2007-7#1)(2008-8#2)
these extracts were##2##3##(2008-10#1)(2013-1#1)
these extracts##8##2##(1994-12#1)(1996-5#1)(2008-10#2)(2008-5#2)(2010-12#1)(2013-1#1)
these extremely low##2##3##(2004-10#1)(2012-2#1)
these extremely##4##2##(2004-10#1)(2007-8#1)(2008-1#1)(2012-2#1)
these extrinsic##2##2##(1992-9#1)(1997-7#1)
these facial##3##2##(1993-1#2)(2008-11#1)
these facilities##3##2##(1992-12#1)(2009-11#1)(2013-1#1)
these factors also##2##3##(1993-9#1)(2008-11#1)
these factors and by##2##4##(1996-7#1)(2008-11#1)
these factors and the Snail density##2##6##(2011-1#2)
these factors and the##4##4##(1994-9#1)(2007-9#1)(2011-1#2)
these factors and their##2##4##(2008-10#1)(2012-2#1)
these factors and##16##3##(1994-9#1)(1996-5#1)(1996-7#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2009-12#1)(2009-9#1)(2011-1#2)(2012-2#1)(2013-8#1)
these factors are related to##2##5##(1993-12#1)(2006-7#1)
these factors are##15##3##(1993-12#1)(1997-5#1)(2006-10#1)(2006-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2009-4#2)(2009-5#1)(2011-2#1)(2013-1#1)
these factors as##3##3##(1995-5#1)(2006-8#1)(2008-4#1)
these factors can##5##3##(2008-2#1)(2008-7#1)(2010-4#1)(2012-3#1)(2013-8#1)
these factors has##2##3##(1991-8#1)(2007-12#1)
these factors have##4##3##(2006-1#1)(2008-10#2)(2013-8#1)
these factors in##11##3##(1991-2#1)(1993-6#1)(1994-12#1)(2007-8#1)(2008-12#2)(2008-2#1)(2011-1#1)(2011-2#2)(2013-8#1)
these factors interact##2##3##(1992-5#1)(2008-11#1)
these factors is the##2##4##(2009-10#1)(2009-6#1)
these factors is##8##3##(1993-3#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-6#1)(2010-10#1)
these factors may be##2##4##(1996-6#1)(2007-6#1)
these factors may##6##3##(1993-2#1)(1996-6#1)(2005-11#1)(2007-6#1)(2008-11#1)(2010-2#1)
these factors might##2##3##(2008-1#1)(2008-10#1)
these factors should be considered in##2##6##(1997-4#1)(2008-12#1)
these factors should be considered##3##5##(1997-4#1)(2007-12#1)(2008-12#1)
these factors to##5##3##(1995-3#1)(1996-12#2)(2007-7#1)(2008-9#1)
these factors was##2##3##(2008-8#1)(2010-2#1)
these factors were##4##3##(1997-7#1)(2008-11#1)(2008-12#2)
these factors##166##2##(1990-11#1)(1990-12#2)(1990-3#1)(1991-10#2)(1991-11#2)(1991-2#1)(1991-5#2)(1991-8#3)(1992-12#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#2)(1993-9#1)(1994-12#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-4#1)(2005-8#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-5#1)(2006-7#2)(2006-8#1)(2007-10#2)(2007-12#2)(2007-6#2)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#12)(2008-11#9)(2008-12#7)(2008-2#4)(2008-3#4)(2008-4#4)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#8)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#4)
these facts##8##2##(1992-4#1)(1996-8#1)(2005-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-9#1)(2012-12#1)
these failures can be##2##4##(2004-9#1)(2007-9#1)
these families are##3##3##(1994-6#1)(2010-8#1)(2011-2#1)
these families##26##2##(1993-10#1)(1994-6#3)(1994-9#1)(1996-5#1)(1996-6#1)(1997-5#1)(1997-9#1)(2006-6#1)(2007-2#2)(2007-8#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#3)(2008-9#1)(2009-8#1)(2010-8#1)(2010-9#1)(2011-2#1)
these fascinating##2##2##(2010-9#1)(2012-12#1)
these fatty acids may be##2##5##(2006-7#2)
these fatty acids may##3##4##(1991-10#1)(2006-7#2)
these fatty acids##7##3##(1991-10#1)(1991-5#1)(2006-7#2)(2008-11#1)(2012-1#2)
these favorable##2##2##(1996-8#1)(2008-10#1)
these fears##2##2##(2011-2#1)(2012-12#1)
these features are##4##3##(2008-2#1)(2008-3#1)(2010-12#1)(2012-2#1)
these features to##3##3##(1991-12#1)(2007-12#1)(2008-11#1)
these features were##2##3##(2008-3#1)(2012-2#1)
these features##28##2##(1991-12#1)(1991-2#1)(1991-9#1)(1994-6#1)(2005-8#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-12#3)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#3)(2010-12#2)(2012-2#2)(2013-1#2)
these fibers##5##2##(2007-11#2)(2007-12#2)(2008-2#1)
these fibrils##2##2##(1993-2#1)(2008-1#1)
these fibroblasts##2##2##(1990-3#1)(1990-7#1)
these fields in##2##3##(1993-3#1)(2005-7#1)
these fields##10##2##(1993-3#1)(1995-6#1)(2005-7#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-7#1)
these figures of merit##2##4##(2008-10#1)(2008-3#1)
these figures##6##2##(1993-10#1)(1995-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-12#1)
these films is##3##3##(1990-9#1)(2008-10#1)(2010-2#1)
these films##14##2##(1990-9#1)(2005-11#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#3)(2010-2#1)
these filters are##5##3##(2007-11#1)(2008-3#4)
these filters in##2##3##(2008-2#1)(2008-7#1)
these filters##10##2##(2005-12#1)(2007-11#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#1)
these finding##2##2##(1993-12#1)(1995-6#1)
these findings and revealed##2##4##(2007-10#1)(2010-2#1)
these findings and the##3##4##(2007-7#1)(2008-11#1)(2008-4#1)
these findings and##17##3##(1992-7#1)(1993-9#1)(1994-2#1)(2006-4#1)(2007-10#1)(2007-3#1)(2007-7#1)(2008-11#2)(2008-3#1)(2008-4#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
these findings are consistent with the##3##6##(1993-6#1)(2006-2#1)(2007-7#1)
these findings are discussed##19##4##(1990-3#1)(1991-2#1)(1992-3#1)(1993-1#1)(1994-2#1)(1996-9#1)(2004-2#1)(2006-3#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-9#1)(2012-1#1)(2013-1#1)
these findings are##31##3##(1990-3#1)(1991-2#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-8#1)(1996-9#1)(2004-10#1)(2004-2#1)(2005-8#1)(2006-2#1)(2006-3#1)(2007-1#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-1#1)(2013-1#2)
these findings by##2##3##(2008-8#1)(2010-3#1)
these findings can be##3##4##(1991-3#1)(2005-8#1)(2008-11#1)
these findings could be##3##4##(1995-3#1)(2011-1#1)(2012-2#1)
these findings could direct and encourage other iPad implementations at other hospital EDs'##2##13##(2013-1#2)
these findings could##5##3##(1995-3#1)(2011-1#1)(2012-2#1)(2013-1#2)
these findings demonstrate that##2##4##(2008-5#1)(2012-2#1)
these findings demonstrate##4##3##(1990-5#1)(2008-5#1)(2012-12#1)(2012-2#1)
these findings have important implications for##2##6##(2005-7#1)(2007-3#1)
these findings have##4##3##(2005-7#1)(2007-3#1)(2010-12#1)(2012-2#1)
these findings highlight##2##3##(2011-2#1)(2013-7#1)
these findings illustrate##3##3##(2008-8#1)(2012-2#2)
these findings in a larger##2##5##(1994-10#1)(2009-4#1)
these findings in relation to the##2##6##(1990-10#1)(2008-8#1)
these findings in terms of the##2##6##(1996-3#1)(2008-10#1)
these findings in the general population##2##6##(2006-8#1)(2007-8#1)
these findings in the##6##4##(1994-5#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-8#1)
these findings in##18##3##(1990-10#1)(1994-10#1)(1994-11#1)(1994-5#1)(1996-2#1)(1996-3#1)(2006-8#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-8#1)(2009-4#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-12#1)
these findings indicate that##8##4##(1991-8#1)(1993-12#1)(1993-3#1)(1996-12#1)(1997-4#1)(2008-7#1)(2008-9#1)(2013-1#1)
these findings indicate##9##3##(1991-8#1)(1993-12#1)(1993-3#1)(1996-12#1)(1997-4#1)(2007-12#1)(2008-7#1)(2008-9#1)(2013-1#1)
these findings is that##3##4##(1995-8#1)(2007-12#1)(2013-7#1)
these findings is##9##3##(1991-10#1)(1995-8#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-8#1)(2009-7#1)(2011-1#1)(2013-7#1)
these findings it##2##3##(1993-2#1)(2009-3#1)
these findings may##2##3##(1992-7#1)(2010-12#1)
these findings might##2##3##(2008-10#1)(2013-1#1)
these findings provide##3##3##(1993-9#1)(1996-3#1)(1997-4#1)
these findings reveal##2##3##(1995-2#1)(2009-12#1)
these findings should##2##3##(2005-10#1)(2009-11#1)
these findings show that##4##4##(2008-7#2)(2008-9#1)(2012-2#1)
these findings suggest that the##6##5##(1991-2#1)(1992-6#1)(1994-6#1)(2008-11#1)(2008-8#1)(2013-7#1)
these findings suggest that##31##4##(1990-7#2)(1991-2#1)(1991-8#1)(1992-11#1)(1992-6#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-5#1)(1997-2#1)(2007-10#1)(2007-2#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-8#2)(2009-10#1)(2009-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
these findings suggest##33##3##(1990-7#2)(1991-2#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-6#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-5#1)(1997-2#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-8#2)(2009-10#1)(2009-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
these findings support##3##3##(1991-1#2)(2010-7#1)
these findings the##5##3##(1990-8#1)(2005-11#1)(2007-9#1)(2008-10#2)
these findings to other##2##4##(2007-10#1)(2009-5#1)
these findings to the##3##4##(1994-2#1)(2007-5#1)(2008-10#1)
these findings to##12##3##(1994-2#1)(1996-6#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-12#1)(2009-5#1)(2010-6#1)
these findings using##2##3##(2006-4#1)(2007-12#1)
these findings we##3##3##(1991-5#1)(2010-2#1)(2011-2#1)
these findings were##7##3##(1997-8#1)(2005-12#1)(2007-12#1)(2008-11#1)(2010-1#1)(2012-11#1)(2013-8#1)
these findings will##3##3##(2006-10#1)(2008-5#1)(2013-1#1)
these findings with those##2##4##(2005-10#1)(2006-10#1)
these findings with##5##3##(1993-7#1)(1994-7#1)(2005-10#1)(2006-10#1)(2008-10#1)
these findings##355##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-1#2)(1991-10#1)(1991-2#3)(1991-3#2)(1991-5#2)(1991-8#2)(1992-1#1)(1992-11#1)(1992-3#2)(1992-6#1)(1992-7#3)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#1)(1994-2#6)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-6#2)(1995-8#2)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#4)(1997-8#1)(2004-10#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-3#1)(2004-8#1)(2005-10#2)(2005-11#4)(2005-12#1)(2005-7#2)(2005-8#2)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-7#2)(2006-8#2)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#10)(2007-2#2)(2007-3#3)(2007-4#2)(2007-5#1)(2007-6#4)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#17)(2008-11#11)(2008-12#2)(2008-2#1)(2008-3#8)(2008-4#6)(2008-5#6)(2008-6#1)(2008-7#9)(2008-8#7)(2008-9#7)(2009-1#1)(2009-10#4)(2009-11#2)(2009-12#2)(2009-3#3)(2009-4#3)(2009-5#3)(2009-6#1)(2009-7#4)(2009-8#4)(2009-9#4)(2010-1#1)(2010-11#1)(2010-12#5)(2010-2#3)(2010-3#2)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#10)(2012-1#10)(2012-11#1)(2012-12#5)(2012-2#17)(2012-3#1)(2013-1#14)(2013-7#3)(2013-8#10)
these first##2##2##(1990-5#1)(2009-6#1)
these fish species##4##3##(1992-5#1)(1997-3#1)(2007-3#1)(2008-10#1)
these fish were##3##3##(2008-5#1)(2010-8#1)(2013-1#1)
these fish##10##2##(1992-5#1)(1997-3#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-8#3)(2013-1#1)
these fistulas are##2##3##(2006-11#1)(2009-9#1)
these five species##2##3##(2008-10#1)(2008-6#1)
these five##29##2##(1990-2#1)(1991-3#1)(1992-11#1)(1993-11#2)(1993-6#1)(1993-8#1)(1995-3#2)(1995-6#1)(1996-10#1)(1997-1#1)(1997-6#1)(1997-7#1)(2004-12#1)(2006-10#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
these flies##2##2##(2004-11#1)(2008-6#1)
these fluctuations##7##2##(1996-4#1)(2006-10#1)(2007-12#3)(2008-12#1)(2008-2#1)
these fluids##5##2##(1991-4#1)(1993-12#1)(2008-4#1)(2011-2#1)(2012-2#1)
these fluorescence changes##2##3##(1990-7#1)(1994-11#1)
these fluorescence##3##2##(1990-7#1)(1991-2#1)(1994-11#1)
these fluorophores##2##2##(2009-10#1)(2010-10#1)
these focus##2##2##(2007-7#1)(2010-3#1)
these folate##2##2##(1990-3#1)(2011-1#1)
these food##2##2##(1992-9#1)(2009-3#1)
these foods##6##2##(1992-10#1)(2008-10#2)(2011-1#2)(2012-1#1)
these forces##6##2##(1994-12#1)(1996-2#1)(2006-11#1)(2007-12#1)(2013-1#2)
these foreign##2##2##(1997-7#1)(2007-5#1)
these forms of##11##3##(1991-7#1)(1995-2#1)(1997-1#1)(1997-8#3)(2004-10#1)(2007-3#1)(2008-7#1)(2008-9#1)(2010-5#1)
these forms to##2##3##(1997-8#1)(2008-3#1)
these forms##21##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-7#1)(1992-12#1)(1995-2#1)(1997-1#1)(1997-8#4)(2004-10#1)(2006-2#1)(2007-11#1)(2007-3#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-5#1)(2012-1#1)
these formulae##3##2##(1994-2#1)(1994-4#1)(2006-10#1)
these formulas##4##2##(2005-10#1)(2008-1#1)(2008-2#1)(2008-3#1)
these formulations##6##2##(2004-12#1)(2007-11#1)(2007-8#1)(2008-5#2)(2010-5#1)
these found##2##2##(2007-11#1)(2013-1#1)
these four dimensions##2##3##(2007-10#1)(2011-2#1)
these four genes##2##3##(1995-12#1)(1996-6#1)
these four methods##2##3##(1993-10#1)(1995-2#1)
these four patients##2##3##(1994-6#1)(2008-7#1)
these four transitions seem to form a continuum rather than four distinct types##2##13##(2012-12#2)
these four##60##2##(1990-7#1)(1990-8#1)(1990-9#1)(1992-12#1)(1993-1#1)(1993-10#1)(1993-6#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-6#1)(1997-8#1)(2004-10#1)(2004-11#1)(2005-10#1)(2005-8#1)(2006-3#1)(2007-10#1)(2007-4#1)(2007-8#1)(2008-10#12)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
these fractions from##2##3##(1990-5#1)(2008-10#1)
these fractions was##2##3##(1994-3#1)(1997-2#1)
these fractions were##2##3##(1990-10#1)(2008-10#1)
these fractions##12##2##(1990-10#1)(1990-12#1)(1990-5#2)(1990-6#1)(1994-3#1)(1995-11#1)(1997-2#2)(2008-10#2)(2008-11#1)
these fractures##11##2##(1991-9#2)(1993-8#1)(2006-3#1)(2008-6#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-1#3)
these fragments to homogeneity##2##4##(1992-6#1)(1995-3#1)
these fragments to##3##3##(1992-6#1)(1993-11#1)(1995-3#1)
these fragments were##2##3##(1992-9#1)(1996-8#1)
these fragments##15##2##(1990-3#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-8#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-5#1)(1996-8#2)(2008-11#1)(2008-8#1)
these frameworks##2##2##(2010-7#1)(2012-2#1)
these from##2##2##(2008-1#1)(2008-8#1)
these functional##9##2##(1994-6#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-8#1)(2010-12#1)(2010-5#1)(2012-2#2)
these functions are##3##3##(1996-5#1)(2012-12#1)(2013-1#1)
these functions could##2##3##(1996-2#1)(2008-10#1)
these functions is##2##3##(1996-7#1)(2008-11#1)
these functions##29##2##(1990-3#1)(1991-8#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-1#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-9#1)(2009-5#1)(2012-12#2)(2013-1#1)(2013-8#1)
these fundamental##3##2##(1990-10#1)(2005-2#1)(2006-10#1)
these fungi##17##2##(1993-2#1)(1997-4#1)(2008-10#9)(2008-12#1)(2008-8#1)(2009-8#1)(2010-10#1)(2013-1#2)
these gaps##3##2##(1996-9#1)(2008-10#1)(2010-11#1)
these gaze##2##2##(2008-11#1)(2010-10#1)
these gels##3##2##(2005-10#1)(2008-8#1)(2009-9#1)
these gender##2##2##(2007-3#1)(2008-10#1)
these gene fusions##2##3##(1993-3#1)(2012-12#1)
these gene##11##2##(1990-9#1)(1993-3#1)(1993-8#1)(2006-10#1)(2008-4#1)(2008-6#1)(2012-12#3)(2012-2#1)(2013-1#1)
these genera##4##2##(2008-10#2)(2008-12#1)(2008-5#1)
these general##2##2##(1995-11#1)(2008-5#1)
these genes and##3##3##(2008-10#2)(2012-2#1)
these genes are##17##3##(1990-11#1)(1990-8#1)(1991-5#1)(1992-3#1)(1994-3#1)(1995-2#1)(1996-10#1)(2006-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#2)(2010-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
these genes as##4##3##(1990-7#1)(1991-6#1)(1993-12#1)(2006-12#1)
these genes by##2##3##(1992-6#1)(2008-2#1)
these genes can be##4##4##(1997-8#1)(2006-12#1)(2008-11#1)(2008-9#1)
these genes could be##2##4##(2007-11#1)(2008-10#1)
these genes do not contain##2##5##(1993-6#1)(2008-5#1)
these genes encode##3##3##(1991-7#1)(1995-6#1)(1995-8#1)
these genes from##2##3##(1992-11#1)(2006-10#1)
these genes have##3##3##(1992-3#1)(2006-10#1)(2008-1#1)
these genes in##15##3##(1990-4#1)(1995-12#1)(1996-12#1)(1996-6#1)(1997-6#1)(2005-11#1)(2008-10#3)(2008-11#2)(2008-4#1)(2009-10#1)(2009-8#1)(2011-2#1)
these genes is the##2##4##(2009-8#1)(2013-8#1)
these genes is##7##3##(1990-8#2)(1993-6#1)(2008-9#1)(2009-8#1)(2012-2#1)(2013-8#1)
these genes may be##2##4##(2008-10#1)(2008-9#1)
these genes may play important roles##2##6##(1992-6#1)(2008-9#1)
these genes may play##4##4##(1992-6#1)(2008-7#2)(2008-9#1)
these genes may##8##3##(1990-3#1)(1992-6#1)(2008-10#2)(2008-7#2)(2008-9#2)
these genes showed##2##3##(2006-8#1)(2007-12#1)
these genes to##3##3##(1991-5#1)(2008-10#2)
these genes was##2##3##(2005-11#1)(2012-2#1)
these genes were##11##3##(1991-7#1)(1996-8#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-8#2)(2010-4#1)(2013-8#1)
these genes with##2##3##(1992-3#1)(2006-10#1)
these genes##180##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#3)(1990-8#3)(1991-12#2)(1991-5#2)(1991-6#2)(1991-7#3)(1991-8#1)(1991-9#3)(1992-11#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#3)(1992-9#1)(1993-12#3)(1993-2#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-3#2)(1994-8#2)(1994-9#2)(1995-12#4)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#3)(2003-11#1)(2005-11#2)(2006-10#4)(2006-12#4)(2006-8#2)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#17)(2008-11#6)(2008-2#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#6)(2009-10#4)(2009-3#1)(2009-6#1)(2009-8#8)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#4)
these genetic and##2##3##(2007-8#1)(2008-10#1)
these genetic effects##2##3##(2009-7#1)(2010-4#1)
these genetic##13##2##(1997-8#1)(2005-7#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2009-7#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-9#1)(2013-1#1)
these genomic##5##2##(1997-2#1)(1997-3#1)(2008-11#1)(2008-7#2)
these genotypes##4##2##(2008-10#3)(2010-12#1)
these giant neurons##2##3##(2007-12#2)
these giant##3##2##(2007-12#2)(2008-5#1)
these girls##4##2##(2007-2#2)(2008-1#1)(2008-4#1)
these glasses##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
these glial cells##3##3##(1994-5#1)(1995-9#1)(2008-7#1)
these global##2##2##(2008-7#1)(2008-9#1)
these glycoproteins##3##2##(1990-2#1)(1992-10#1)(1995-2#1)
these goals and to##2##4##(2011-2#1)(2013-1#1)
these goals##22##2##(1991-1#1)(1993-1#1)(1993-5#1)(1993-6#1)(1996-1#1)(2004-3#1)(2005-8#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
these grafts##2##2##(2007-7#1)(2008-5#1)
these grants##2##2##(2007-7#2)
these graphs##2##2##(2006-12#1)(2011-1#1)
these gratings are##2##3##(2007-12#1)(2008-3#1)
these gratings##6##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)
these grouping##2##2##(1993-8#1)(2008-4#1)
these groupings##3##2##(1997-8#1)(2013-1#2)
these groups at##2##3##(2008-11#1)(2008-7#1)
these groups for##2##3##(1991-12#1)(2007-10#1)
these groups have##2##3##(1990-4#1)(2008-8#1)
these groups in##2##3##(1995-3#1)(1997-7#1)
these groups of##5##3##(1990-10#1)(1992-11#1)(2008-10#1)(2008-11#1)(2010-7#1)
these groups should##2##3##(2007-3#1)(2009-3#1)
these groups was##2##3##(2011-2#1)(2012-12#1)
these groups were##5##3##(1992-3#1)(2008-10#1)(2010-2#1)(2011-1#2)
these groups will##2##3##(1996-12#1)(2008-10#1)
these groups##72##2##(1990-10#1)(1990-4#1)(1990-6#1)(1991-12#4)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-5#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-12#1)(1997-7#1)(2004-10#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-7#1)(2008-10#8)(2008-11#2)(2008-12#3)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#2)(2010-2#4)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#1)(2011-3#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-7#1)
these growth factors##6##3##(1992-9#2)(2007-11#1)(2007-3#1)(2008-1#1)(2010-10#1)
these growth##11##2##(1992-9#2)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-10#1)
these guidances##2##2##(2006-8#1)(2010-11#1)
these guidelines do not##2##4##(2006-8#1)(2008-11#1)
these guidelines to##3##3##(1993-12#1)(1996-12#1)(2012-1#1)
these guidelines##24##2##(1992-12#1)(1993-12#1)(1996-12#1)(2006-12#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#3)(2008-4#1)(2009-11#1)(2010-8#1)(2011-2#1)(2012-1#1)
these guldehnes will##2##3##(2008-3#2)
these guldehnes##3##2##(2008-3#3)
these habitats##2##2##(2007-6#1)(2010-6#1)
these had a##3##3##(1991-5#1)(1992-12#1)(1995-5#1)
these had been##4##3##(1990-4#1)(2007-2#1)(2007-7#1)(2008-5#1)
these had##30##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-10#1)(1992-12#1)(1993-5#1)(1994-2#1)(1994-6#1)(1995-5#1)(1995-9#1)(1996-11#4)(1996-12#1)(2006-11#1)(2007-2#2)(2007-3#1)(2007-7#1)(2008-5#1)(2008-6#1)(2010-12#1)(2012-12#1)(2013-1#1)
these has##2##2##(1992-1#1)(1997-7#1)
these have a##4##3##(1992-5#1)(2006-12#1)(2008-7#1)(2012-12#1)
these have been##10##3##(1994-9#1)(2005-11#1)(2006-8#1)(2007-1#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-8#1)(2013-8#1)
these have##24##2##(1992-5#1)(1993-6#1)(1994-9#1)(2005-11#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-8#1)(2010-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
these health##8##2##(1990-2#1)(1995-2#1)(1996-12#1)(2008-4#2)(2010-3#1)(2010-8#1)(2011-1#1)
these helices##3##2##(1991-4#1)(1993-3#1)(1993-6#1)
these herbicides##9##2##(1994-10#1)(1996-3#1)(2006-5#2)(2008-10#5)
these heuristic algorithms##3##3##(2010-2#3)
these high risk patients##2##4##(2008-10#1)(2012-12#1)
these high##12##2##(1990-12#1)(1990-2#1)(1993-11#1)(1995-3#1)(1997-3#1)(2007-10#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-12#1)(2012-12#1)
these high-risk patients##4##3##(2006-10#1)(2006-11#1)(2007-8#2)
these high-risk##6##2##(2005-7#1)(2006-10#1)(2006-11#1)(2007-2#1)(2007-8#2)
these highly productive##2##3##(2006-6#1)(2008-10#1)
these highly purified##2##3##(1995-2#1)(2008-1#1)
these highly##15##2##(1990-11#1)(1990-7#1)(1993-1#1)(1995-2#1)(1995-3#1)(1996-2#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#3)(2010-6#1)(2011-2#1)
these histones##3##2##(1992-5#2)(2013-8#1)
these homologous##2##2##(1993-4#1)(1994-8#1)
these homologs##2##2##(1991-12#1)(2008-10#1)
these hormones are##2##3##(1992-10#1)(2006-10#1)
these hormones##15##2##(1990-10#1)(1990-3#1)(1992-10#1)(1993-12#1)(1995-11#1)(1996-12#1)(1996-4#1)(1997-5#1)(2006-10#1)(2008-1#1)(2008-2#1)(2008-4#1)(2009-12#2)(2009-4#1)
these hospitals##7##2##(1992-12#1)(1992-2#1)(1993-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
these host plants##2##3##(2008-10#1)(2009-8#1)
these host##4##2##(2006-5#1)(2007-7#1)(2008-10#1)(2009-8#1)
these hosts##6##2##(2008-10#3)(2008-3#1)(2008-8#1)(2012-2#1)
these human##6##2##(1990-5#1)(1992-8#1)(1994-5#1)(1994-8#1)(2006-10#1)(2006-8#1)
these hybrid##3##2##(1996-9#1)(2008-10#1)(2009-2#1)
these hybridomas##2##2##(1994-9#1)(2008-11#1)
these hybrids##4##2##(1997-2#1)(2005-8#1)(2008-10#1)(2010-4#1)
these hydrogels##4##2##(2008-5#1)(2009-9#1)(2013-7#2)
these hydrophobic##3##2##(1997-1#1)(2006-1#2)
these hypertensive##2##2##(1994-12#1)(2007-10#1)
these hypotheses and##2##3##(2006-11#1)(2008-9#1)
these hypotheses in##2##3##(2009-2#1)(2012-3#1)
these hypotheses##17##2##(1993-12#1)(1995-11#1)(2005-10#2)(2006-11#1)(2007-11#1)(2007-6#1)(2007-9#1)(2008-6#1)(2008-8#2)(2008-9#3)(2009-2#1)(2012-3#1)(2013-1#1)
these ideas have##2##3##(2008-7#1)(2010-12#1)
these ideas with##2##3##(1993-5#1)(2008-8#1)
these ideas##14##2##(1992-3#1)(1993-3#1)(1993-5#1)(2007-11#1)(2008-7#2)(2008-8#3)(2009-4#2)(2010-12#1)(2012-1#2)
these identified##2##2##(1996-10#1)(2006-7#1)
these illnesses##3##2##(1992-2#1)(2006-10#1)(2010-12#1)
these images is##2##3##(2007-2#1)(2010-12#1)
these images##10##2##(1997-6#1)(2007-1#1)(2007-2#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-12#1)(2012-2#1)
these imaging procedures for##2##4##(2007-11#2)
these imaging##4##2##(1991-12#1)(2007-11#2)(2013-8#1)
these immigrants##2##2##(1993-9#1)(2008-7#1)
these immortalized T cell lines##2##5##(2008-11#2)
these immunological##3##2##(2007-11#1)(2010-8#1)(2013-7#1)
these impacts##2##2##(2006-10#1)(2012-3#1)
these implants##7##2##(2006-12#1)(2007-12#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-3#1)(2011-1#1)
these important issues##2##3##(2008-6#1)(2010-7#1)
these important##16##2##(1994-1#1)(2006-10#3)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2009-7#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
these impressive##2##2##(2006-10#1)(2009-4#1)
these improved##3##2##(1993-9#1)(2008-3#1)(2011-1#1)
these improvements are##2##3##(1996-2#1)(2012-1#1)
these improvements were not##2##4##(2007-12#1)(2007-2#1)
these improvements were##3##3##(2007-12#1)(2007-2#1)(2008-7#1)
these improvements##11##2##(1991-11#1)(1992-3#1)(1996-2#1)(1996-9#1)(1997-4#1)(2007-12#1)(2007-2#1)(2008-5#1)(2008-7#1)(2010-5#1)(2012-1#1)
these in the##2##3##(2010-3#1)(2013-1#1)
these in vitro##9##3##(1990-11#1)(1992-11#1)(1994-12#1)(1994-9#1)(1995-1#1)(1996-5#1)(1997-6#1)(2008-10#1)(2008-5#1)
these in vivo and in vitro studies##2##7##(1991-9#1)(1994-8#1)
these in vivo##4##3##(1991-9#1)(1994-8#1)(2007-11#1)(2007-8#1)
these in##32##2##(1990-11#1)(1991-9#1)(1992-11#1)(1993-12#1)(1994-12#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-4#1)(1995-8#1)(1996-5#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#2)
these include the##2##3##(2007-12#1)(2008-10#1)
these include##10##2##(1991-7#1)(2005-10#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-10#1)(2010-3#1)
these included##2##2##(2007-7#1)(2009-8#1)
these increases in##2##3##(1992-7#1)(1993-3#1)
these increases##12##2##(1990-10#1)(1992-3#1)(1992-7#1)(1993-3#1)(1993-9#1)(1996-1#1)(2007-3#1)(2008-10#2)(2008-11#1)(2009-11#1)(2011-2#1)
these indicate##2##2##(1995-3#1)(1997-8#1)
these indications##7##2##(1997-2#1)(2005-8#1)(2005-9#1)(2007-11#2)(2008-3#1)(2008-5#1)
these indicators to##2##3##(1994-2#1)(2007-3#1)
these indicators##14##2##(1992-10#1)(1994-2#2)(2005-11#1)(2006-2#1)(2006-5#1)(2007-3#2)(2007-4#1)(2008-11#1)(2010-11#1)(2010-4#1)(2010-5#1)(2012-12#1)
these indices are##2##3##(2006-11#1)(2011-2#1)
these indices##10##2##(2006-11#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-2#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
these individual##6##2##(2006-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-12#1)(2012-2#1)
these individuals and##2##3##(1995-3#1)(2013-1#1)
these individuals are##3##3##(2008-10#1)(2008-12#1)(2010-11#1)
these individuals have##2##3##(1994-11#1)(2010-12#1)
these individuals in##3##3##(1995-1#1)(2008-11#1)(2011-1#1)
these individuals to##2##3##(2009-4#1)(2011-1#1)
these individuals were##2##3##(2008-11#1)(2008-5#1)
these individuals##43##2##(1991-11#1)(1991-12#2)(1992-8#1)(1994-11#1)(1995-1#1)(1995-3#2)(1996-9#1)(1997-7#1)(1997-8#1)(2005-8#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#2)(2009-7#1)(2010-11#2)(2010-12#1)(2011-1#3)(2011-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
these induced##3##2##(1995-11#1)(2008-7#1)(2009-10#1)
these inducers##2##2##(1992-5#1)(1992-7#1)
these infants##12##2##(1992-3#2)(1992-7#3)(1996-8#1)(2004-10#1)(2008-11#1)(2011-1#1)(2011-2#2)(2012-3#1)
these infected##3##2##(2007-11#1)(2007-8#1)(2008-10#1)
these infection##2##2##(2007-8#1)(2011-3#1)
these infections and##3##3##(1990-8#1)(2007-8#1)(2011-2#1)
these infections are##6##3##(2006-10#1)(2007-12#1)(2009-9#1)(2010-11#1)(2010-6#1)(2011-2#1)
these infections##40##2##(1990-8#1)(1994-3#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-8#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#4)(2008-7#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-6#2)(2010-8#1)(2011-2#4)(2012-11#2)(2013-8#3)
these inferences##2##2##(2010-12#1)(2012-7#1)
these infiltrating##2##2##(1997-3#1)(2008-11#1)
these inflammatory##4##2##(1991-7#1)(2005-10#1)(2006-4#1)(2009-10#1)
these influences##3##2##(1990-2#1)(2009-9#1)(2010-4#1)
these information##3##2##(2009-2#1)(2009-5#1)(2011-2#1)
these inhibitions##2##2##(1992-12#1)(2008-11#1)
these inhibitors and##2##3##(1991-7#1)(2007-11#1)
these inhibitors attenuated the##2##4##(1993-3#2)
these inhibitors##28##2##(1990-12#1)(1991-2#1)(1991-7#1)(1992-12#1)(1992-6#4)(1992-8#1)(1993-12#1)(1993-3#3)(1994-12#2)(1994-3#1)(1994-8#1)(1994-9#2)(1995-11#1)(1997-3#1)(2006-6#1)(2007-11#2)(2008-1#1)(2008-4#1)(2008-5#1)(2009-11#1)
these inhibitory effects##2##3##(1992-2#1)(1995-7#1)
these inhibitory##6##2##(1990-2#1)(1991-9#1)(1992-2#1)(1995-7#1)(1996-9#1)(2008-10#1)
these initial##12##2##(1994-4#1)(1995-11#1)(1995-12#1)(1997-2#1)(2006-8#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2012-1#1)(2013-1#1)
these initiatives##6##2##(1995-3#1)(1996-11#1)(1996-2#1)(2007-4#1)(2008-4#1)(2012-2#1)
these injuries are##2##3##(2006-10#1)(2013-8#1)
these injuries in##4##3##(1995-8#1)(2007-3#1)(2013-1#2)
these injuries is##3##3##(1990-6#1)(2006-10#1)(2007-4#1)
these injuries##27##2##(1990-6#1)(1991-3#1)(1991-4#1)(1992-3#2)(1994-3#2)(1995-8#2)(2006-10#2)(2006-11#2)(2006-4#1)(2006-8#1)(2007-3#1)(2007-4#2)(2007-8#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
these innovative##4##2##(1991-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
these inputs##2##2##(2008-4#1)(2012-2#1)
these insects##6##2##(2006-8#2)(2011-12#2)(2013-1#1)(2013-8#1)
these insertions##2##2##(1991-12#1)(2005-8#1)
these insights##2##2##(2010-1#1)(2011-2#1)
these instabilities##3##2##(1990-10#1)(2007-12#2)
these instances##3##2##(2006-10#1)(2007-8#1)(2008-5#1)
these institutions##3##2##(1997-1#1)(2008-5#1)(2009-7#1)
these instruments have##2##3##(2006-9#1)(2008-2#1)
these instruments##13##2##(1990-4#1)(1991-6#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)(2011-2#1)
these integer##2##2##(2008-2#2)
these integral##2##2##(2009-2#1)(2012-2#1)
these integration##2##2##(2008-10#1)(2008-12#1)
these integrin##2##2##(1991-10#1)(2010-10#1)
these interact##2##2##(1995-9#1)(2009-5#1)
these interactions are##3##3##(1990-6#1)(1994-12#1)(1994-5#1)
these interactions can##4##3##(1990-11#1)(2007-12#1)(2008-3#1)(2010-12#1)
these interactions has##2##3##(1992-12#1)(2006-10#1)
these interactions##52##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-3#1)(1995-9#1)(1996-10#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-10#2)(2007-1#1)(2007-11#2)(2007-12#3)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-12#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-8#1)
these intermediate##3##2##(2008-1#1)(2009-9#2)
these intermediates##4##2##(1992-1#1)(1994-8#1)(1995-4#1)(1997-4#1)
these internal##2##2##(1997-8#1)(2008-1#1)
these international##2##2##(2008-5#1)(2012-3#1)
these intervention strategies##2##3##(1997-2#1)(2008-7#1)
these interventions and##2##3##(2008-8#1)(2012-2#1)
these interventions are##2##3##(2006-4#1)(2011-2#1)
these interventions##21##2##(1991-9#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2011-2#1)(2012-2#4)(2013-1#4)
these into##5##2##(1991-12#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)
these intracellular events##2##3##(2008-4#1)(2009-8#1)
these intracellular##5##2##(1990-2#1)(1993-4#1)(2005-11#1)(2008-4#1)(2009-8#1)
these introns##3##2##(1993-11#1)(1993-2#1)(1996-7#1)
these investigations should##2##3##(1990-12#1)(1992-12#1)
these investigations##21##2##(1990-12#1)(1992-12#1)(1993-12#1)(1995-5#1)(1996-10#1)(1996-12#1)(1996-8#1)(1997-2#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-12#1)
these investments##2##2##(1994-2#1)(1996-1#1)
these ion##3##2##(1991-4#1)(1997-7#1)(2007-7#1)
these ionic##3##2##(1994-2#1)(1996-8#1)(2008-10#1)
these ions are##4##3##(2008-10#3)(2008-4#1)
these ions in##3##3##(2008-10#3)
these ions with##3##3##(1996-7#1)(2008-10#2)
these ions##21##2##(1994-8#1)(1996-7#2)(1997-1#1)(2008-10#16)(2008-4#1)
these is the##7##3##(1990-8#1)(1992-11#1)(1995-1#1)(1996-8#1)(2004-9#1)(2007-11#1)(2008-4#1)
these is##23##2##(1990-8#2)(1991-3#1)(1992-11#1)(1992-6#1)(1993-3#1)(1993-9#1)(1995-1#1)(1996-8#1)(1997-1#2)(2004-9#1)(2005-11#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#1)
these islands##6##2##(1990-5#1)(2007-12#1)(2008-8#2)(2008-9#2)
these isoforms##11##2##(1990-12#2)(1992-5#1)(1992-6#1)(1994-12#2)(1994-8#1)(1995-5#1)(1996-3#1)(2008-10#2)
these isolated##2##2##(1992-7#1)(1996-6#1)
these isolates in the##2##4##(2008-10#2)
these isolates in##4##3##(2008-10#3)(2008-9#1)
these isolates were##12##3##(2007-7#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-6#1)(2010-4#1)(2013-8#1)
these isolates##49##2##(1995-12#1)(2007-6#1)(2007-7#2)(2007-8#4)(2008-10#31)(2008-12#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-4#1)(2012-3#2)(2013-1#1)(2013-8#1)
these isomers##4##2##(1990-7#1)(1991-2#2)(1995-11#1)
these isozymes##3##2##(1991-1#1)(2008-5#1)(2010-2#1)
these issues and to##3##4##(2007-1#1)(2007-4#1)(2009-2#1)
these issues and##16##3##(2007-1#1)(2007-10#1)(2007-2#1)(2007-4#2)(2007-5#1)(2008-1#1)(2008-11#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-11#1)(2011-2#1)
these issues are##3##3##(1991-3#1)(1994-2#1)(2008-3#1)
these issues by##5##3##(2008-2#1)(2008-7#1)(2009-12#1)(2010-12#1)(2010-6#1)
these issues in the##2##4##(2010-12#1)(2011-2#1)
these issues in##3##3##(2007-2#1)(2010-12#1)(2011-2#1)
these issues may##3##3##(2007-4#1)(2008-1#1)(2009-5#1)
these issues should be##2##4##(1993-7#1)(2008-3#1)
these issues that##2##3##(1995-8#1)(2007-4#1)
these issues using##2##3##(2008-6#1)(2009-10#1)
these issues with##4##3##(1996-3#1)(2006-2#1)(2010-5#1)(2012-2#1)
these issues##110##2##(1990-12#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-9#1)(1993-3#1)(1993-7#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2004-10#1)(2005-10#1)(2005-11#1)(2005-8#2)(2006-10#5)(2006-12#1)(2006-2#2)(2006-4#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-4#7)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#3)(2009-9#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#2)(2012-2#4)(2013-1#2)
these items##5##2##(1996-3#1)(2006-10#1)(2008-7#2)(2011-2#1)
these joints##3##2##(2006-8#1)(2007-11#1)(2012-2#1)
these judgments##2##2##(2008-6#1)(2009-5#1)
these key##8##2##(1991-2#2)(1993-1#1)(2007-12#1)(2007-2#1)(2009-8#1)(2010-8#1)(2010-9#1)
these kinase##2##2##(2009-8#1)(2011-1#1)
these kinases##6##2##(1991-2#1)(1994-3#1)(1996-2#1)(2008-11#1)(2008-9#1)(2012-12#1)
these kinds of systems##2##4##(2010-7#1)(2012-2#1)
these kinds of##6##3##(2007-1#1)(2008-11#2)(2008-2#1)(2010-7#1)(2012-2#1)
these kinetic results##2##3##(1990-2#1)(1995-6#1)
these kinetic studies##3##3##(1992-6#1)(1992-8#1)(1994-11#1)
these kinetic##8##2##(1990-2#1)(1991-7#2)(1992-6#1)(1992-8#1)(1994-11#1)(1995-6#1)(1995-8#1)
these kinetics##2##2##(1994-11#1)(1997-7#1)
these labeled##3##2##(1994-9#1)(1995-1#1)(1997-3#1)
these lakes##2##2##(2008-5#2)
these large##10##2##(1991-11#1)(1992-12#1)(1992-2#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
these larger##3##2##(2007-11#1)(2008-4#1)(2012-2#1)
these last##9##2##(1990-5#1)(1991-10#1)(1991-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)
these lateral##3##2##(1996-1#1)(2012-12#2)
these latter##9##2##(1994-5#1)(1996-10#1)(2006-3#1)(2007-3#1)(2008-10#1)(2008-7#2)(2009-3#1)(2012-3#1)
these laws##3##2##(1994-12#1)(1996-11#1)(2006-8#1)
these layered##2##2##(2007-8#1)(2008-10#1)
these layers was##2##3##(1997-2#1)(2007-11#1)
these leader exons##2##3##(1991-4#1)(1992-9#1)
these leaves##3##2##(2008-10#2)(2013-7#1)
these lesions a##2##3##(2005-5#1)(2008-8#1)
these lesions and##5##3##(2006-10#1)(2006-2#1)(2007-10#1)(2010-7#1)(2012-2#1)
these lesions are##5##3##(1996-11#1)(2005-12#1)(2006-5#1)(2007-6#1)(2012-3#1)
these lesions as##2##3##(2005-12#1)(2011-2#1)
these lesions from##2##3##(1997-1#1)(2007-10#1)
these lesions in##2##3##(1991-5#1)(2007-12#1)
these lesions is not##2##4##(2007-8#1)(2013-8#1)
these lesions is presented##2##4##(1991-6#1)(2008-7#1)
these lesions is##11##3##(1991-6#1)(1992-4#1)(2006-10#1)(2007-8#2)(2008-7#2)(2009-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
these lesions to##3##3##(1990-6#1)(1997-1#1)(2010-5#1)
these lesions using##2##3##(1996-11#1)(2008-2#1)
these lesions##92##2##(1990-5#1)(1990-6#1)(1991-3#1)(1991-5#2)(1991-6#1)(1992-2#1)(1992-4#1)(1993-10#1)(1993-6#1)(1994-6#1)(1995-2#1)(1996-11#2)(1996-9#1)(1997-1#4)(1997-8#1)(2005-12#2)(2005-5#1)(2006-10#3)(2006-11#1)(2006-12#3)(2006-2#3)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#5)(2007-12#2)(2007-2#1)(2007-6#3)(2007-8#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#2)(2013-8#2)
these less##5##2##(2006-10#1)(2006-12#1)(2009-10#1)(2011-2#1)(2012-2#1)
these lessons will##2##3##(2004-7#1)(2008-11#1)
these levels of##3##3##(1996-11#1)(2008-10#1)(2008-11#1)
these levels were##3##3##(1992-8#1)(2008-10#2)
these levels with the##2##4##(2010-4#1)(2013-1#1)
these levels##18##2##(1990-2#1)(1990-5#1)(1991-2#1)(1992-8#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-8#1)(2010-4#1)(2012-1#1)(2013-1#1)
these libraries##5##2##(1993-1#2)(1995-7#1)(2005-7#1)(2008-5#1)
these ligand##2##2##(1994-9#1)(2010-11#1)
these ligands and their synthesized metal##2##6##(2008-5#2)
these ligands is##2##3##(1994-9#1)(2008-3#1)
these ligands##17##2##(1990-7#1)(1991-11#1)(1992-11#2)(1993-11#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-9#2)(1996-2#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#2)
these light##3##2##(1991-8#1)(1993-9#1)(2011-7#1)
these limitations and##3##3##(2008-2#1)(2008-7#1)(2009-5#1)
these limitations are overcome##2##4##(1996-11#1)(2007-4#1)
these limitations are##3##3##(1996-11#1)(2007-4#1)(2012-1#1)
these limitations by##3##3##(2007-11#1)(2009-6#1)(2010-2#1)
these limitations##35##2##(1994-12#1)(1996-11#1)(1996-4#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#2)(2009-3#1)(2009-5#2)(2009-6#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-8#1)
these limits are##3##3##(1995-9#1)(1997-4#1)(2008-3#1)
these limits##4##2##(1995-9#1)(1997-4#1)(2008-3#2)
these linear##3##2##(2008-7#2)(2010-7#1)
these lines of##4##3##(2006-10#2)(2007-7#1)(2008-5#1)
these lines was##2##3##(2008-10#2)
these lines##22##2##(1992-12#1)(1993-4#1)(1993-6#1)(1994-3#1)(1995-1#1)(1996-7#1)(2006-10#2)(2007-7#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#2)(2009-9#1)(2012-11#1)(2012-3#1)
these links##3##2##(2006-5#1)(2009-7#1)(2012-2#1)
these lipid mediators are##2##4##(2008-1#2)
these lipid##3##2##(1992-8#1)(2008-1#2)
these lipids##11##2##(1990-4#1)(1990-7#1)(1991-7#1)(1992-8#1)(1993-8#1)(1994-3#1)(1996-5#2)(2008-10#1)(2008-5#1)(2012-1#1)
these lipoproteins##3##2##(1990-8#1)(1991-2#1)(1994-6#1)
these liposomes##7##2##(1990-2#1)(1990-6#1)(1995-2#1)(1997-5#1)(2005-11#1)(2008-5#1)(2009-7#1)
these localities##2##2##(2007-10#1)(2008-8#1)
these locations##3##2##(1996-4#1)(2007-10#1)(2008-3#1)
these loci##16##2##(1991-6#1)(1992-7#1)(1993-6#1)(1994-9#2)(1995-2#1)(1995-3#1)(1996-4#1)(2008-10#4)(2008-5#1)(2009-10#1)(2013-1#1)(2013-8#1)
these long##3##2##(2009-2#1)(2011-2#1)(2012-1#1)
these loops##3##2##(1992-11#1)(1994-11#1)(1995-2#1)
these losses##2##2##(2008-10#2)
these low levels##2##3##(1995-5#1)(2008-10#1)
these low##6##2##(1991-1#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-7#1)(2011-2#1)
these lower##2##2##(1994-8#1)(2012-3#1)
these lymphocytes##2##2##(1992-1#1)(2012-2#1)
these lysates##2##2##(1990-2#1)(1997-3#1)
these lysines##3##2##(1990-12#1)(1994-11#1)(1995-8#1)
these mAbs##2##2##(1994-5#1)(1996-12#1)
these mRNA##3##2##(1992-7#1)(1996-12#1)(1997-6#1)
these mRNAs are##2##3##(1993-5#1)(1994-10#1)
these mRNAs##11##2##(1992-12#1)(1993-5#1)(1994-10#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-8#1)(1996-12#1)(2004-11#1)(2008-10#1)(2008-7#1)
these machines##2##2##(2008-2#1)(2008-3#1)
these macrophages##2##2##(1995-10#1)(2008-3#1)
these magazines##2##2##(2006-7#1)(2007-12#1)
these main##3##2##(2008-11#1)(2008-5#1)(2008-8#1)
these major##6##2##(1994-12#1)(1994-9#1)(1995-12#1)(2007-1#1)(2008-10#1)(2008-7#1)
these males##3##2##(1993-7#1)(1995-11#2)
these malignancies##6##2##(1991-9#1)(2006-6#1)(2008-4#1)(2008-7#1)(2010-9#1)(2012-12#1)
these mammals##2##2##(2008-5#1)(2008-7#1)
these mammary##2##2##(1991-2#1)(1992-9#1)
these manifestations##2##2##(2006-8#1)(2012-2#1)
these many##3##2##(1996-3#1)(2008-4#1)(2011-2#1)
these maps##2##2##(1993-9#1)(2006-12#1)
these markers in##6##3##(1991-4#1)(1994-7#1)(2006-9#1)(2008-10#1)(2008-8#1)(2012-1#1)
these markers##29##2##(1991-2#1)(1991-4#1)(1994-7#1)(1995-11#1)(1996-9#1)(2005-10#1)(2006-3#1)(2006-9#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#3)
these mass##2##2##(2007-9#1)(2009-5#1)
these masses##2##2##(2008-5#1)(2012-1#1)
these materials and##2##3##(2008-2#1)(2009-5#1)
these materials are##4##3##(1993-4#1)(2008-10#1)(2008-2#1)(2009-2#1)
these materials have##3##3##(1996-5#1)(2007-11#1)(2012-2#1)
these materials is##4##3##(2008-11#1)(2008-3#1)(2008-7#1)(2009-7#1)
these materials##63##2##(1993-4#1)(1994-3#2)(1995-3#1)(1996-5#1)(1997-6#1)(2004-9#3)(2005-11#2)(2006-12#1)(2006-7#1)(2007-11#3)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#5)(2008-3#4)(2008-5#4)(2008-7#4)(2008-8#1)(2009-11#1)(2009-12#1)(2009-2#3)(2009-5#1)(2009-7#2)(2010-10#1)(2010-12#3)(2010-7#2)(2010-8#2)(2011-2#1)(2012-11#3)(2012-2#1)(2012-3#1)(2013-7#1)
these matrices are##2##3##(2008-3#1)(2008-5#1)
these matrices##7##2##(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#2)
these matters##2##2##(1990-6#1)(1997-6#1)
these may be##9##3##(1995-8#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-3#1)(2012-12#1)
these may have##3##3##(1991-7#1)(1995-12#1)(2006-10#1)
these may##29##2##(1990-4#1)(1990-8#1)(1991-7#1)(1993-10#1)(1994-3#2)(1995-12#1)(1995-8#1)(1997-1#1)(1997-4#1)(2006-10#2)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-5#1)(2009-1#1)(2009-3#1)(2009-5#1)(2010-3#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
these means##2##2##(1996-3#1)(2004-9#1)
these measurements and##2##3##(2007-12#1)(2008-3#1)
these measurements are##2##3##(2008-2#1)(2008-7#1)
these measurements has##2##3##(2007-12#1)(2008-7#1)
these measurements to##3##3##(2008-9#1)(2009-2#1)(2013-1#1)
these measurements were##3##3##(1990-9#1)(2004-10#1)(2008-3#1)
these measurements##38##2##(1990-9#1)(1993-12#1)(1993-5#1)(1994-11#1)(1995-12#1)(1995-6#1)(1997-6#1)(2004-10#1)(2005-11#1)(2005-9#1)(2006-11#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#4)(2008-3#10)(2008-7#2)(2008-9#1)(2009-2#1)(2009-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
these measures and##3##3##(2007-7#1)(2008-9#1)(2009-5#1)
these measures are##4##3##(1992-9#1)(1995-2#1)(2007-10#1)(2009-7#1)
these measures did not##2##4##(1992-9#1)(1993-2#1)
these measures to##4##3##(1996-12#1)(2008-8#1)(2009-10#1)(2010-2#1)
these measures were##2##3##(2008-3#1)(2008-8#1)
these measures with##3##3##(1990-2#1)(2006-10#1)(2007-12#1)
these measures##41##2##(1990-2#1)(1991-12#1)(1992-11#1)(1992-9#2)(1993-1#1)(1993-2#2)(1994-3#1)(1995-2#1)(1996-11#1)(1996-12#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-12#3)(2007-3#1)(2007-7#2)(2008-3#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-2#2)(2010-4#1)(2010-8#1)(2011-2#2)(2012-1#1)(2013-7#1)
these mechanical##2##2##(2006-6#1)(2010-4#1)
these mechanisms affect##2##3##(2009-10#1)(2011-2#1)
these mechanisms and their##2##4##(2006-1#1)(2010-5#1)
these mechanisms and##4##3##(1994-12#1)(2006-1#1)(2010-5#2)
these mechanisms are##4##3##(2008-1#1)(2008-5#1)(2009-1#1)(2012-12#1)
these mechanisms have##2##3##(2008-1#1)(2009-2#1)
these mechanisms in##5##3##(2007-12#1)(2007-8#1)(2011-2#2)(2012-2#1)
these mechanisms is##3##3##(1990-2#1)(2008-2#1)(2008-7#1)
these mechanisms may##3##3##(2008-11#1)(2011-2#2)
these mechanisms of##2##3##(2009-4#1)(2010-11#1)
these mechanisms##58##2##(1990-2#1)(1993-12#1)(1993-2#1)(1993-9#2)(1994-12#1)(1996-6#2)(1996-8#1)(1997-4#1)(1997-7#1)(2006-1#1)(2006-10#4)(2006-9#1)(2007-12#2)(2007-8#3)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-5#2)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#3)
these media to##2##3##(2008-2#1)(2012-2#1)
these media##14##2##(1991-8#1)(1995-12#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-12#2)(2008-2#2)(2009-10#1)(2009-7#1)(2010-6#1)(2012-2#2)
these mediators##6##2##(1990-9#1)(1995-10#1)(2006-10#2)(2010-5#1)(2012-12#1)
these medical problems##3##3##(2006-10#2)(2006-2#1)
these medical##7##2##(1990-11#1)(2006-10#2)(2006-2#1)(2008-11#1)(2011-2#2)
these medicaments##3##2##(1997-2#2)(2011-2#1)
these medications##16##2##(2004-12#1)(2006-10#2)(2007-3#1)(2007-8#2)(2008-1#1)(2008-2#1)(2008-3#1)(2008-8#2)(2010-11#2)(2010-4#1)(2011-2#2)
these medicines##4##2##(2009-2#1)(2013-8#3)
these membrane##5##2##(1990-2#1)(1994-12#1)(2005-8#1)(2008-11#1)(2009-9#1)
these membranes also##2##3##(2005-11#1)(2008-10#1)
these membranes##13##2##(1990-7#1)(1991-11#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-7#1)(1993-4#1)(2005-11#2)(2008-10#2)(2008-5#1)(2009-8#1)
these memory processes##2##3##(1995-12#1)(2008-9#1)
these men##7##2##(1996-11#2)(2005-10#1)(2008-4#1)(2008-6#2)(2009-12#1)
these mental disorders##2##3##(2012-1#2)
these mental##4##2##(1991-8#1)(2012-1#2)(2013-8#1)
these messages##3##2##(2007-12#1)(2008-3#1)(2009-10#1)
these meta-analyses##2##2##(2007-8#1)(2012-3#1)
these metabolic disorders##2##3##(1990-2#1)(1997-4#1)
these metabolic##10##2##(1990-2#1)(1996-9#1)(1997-4#1)(2006-10#1)(2007-9#1)(2008-11#2)(2008-3#1)(2010-4#1)(2011-2#1)
these metabolites##13##2##(1991-5#1)(1994-8#2)(1996-8#1)(1997-2#1)(2006-6#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-11#1)(2012-2#1)(2013-7#1)
these metal ions are##4##4##(2008-10#4)
these metal ions in##6##4##(2008-10#6)
these metal ions is##2##4##(2008-10#2)
these metal ions were##5##4##(2008-10#5)
these metal ions with##2##4##(2008-10#2)
these metal ions##31##3##(1997-2#1)(2008-10#27)(2008-5#2)(2010-5#1)
these metal##34##2##(1997-2#1)(2008-10#27)(2008-5#3)(2010-11#1)(2010-5#2)
these metalloproteinases##2##2##(1993-6#1)(2006-9#1)
these metals were##3##3##(1997-4#1)(2008-10#2)
these metals##26##2##(1997-4#1)(2005-4#1)(2006-12#1)(2007-8#2)(2008-10#15)(2008-12#1)(2008-5#1)(2009-10#1)(2009-6#1)(2011-1#2)
these methodological##4##2##(1995-9#1)(2008-12#1)(2010-6#1)(2011-1#1)
these methodologies##2##2##(1990-8#1)(1994-12#1)
these methods and##2##3##(1993-4#1)(2006-10#1)
these methods are applied to##3##5##(1993-3#1)(2010-7#1)(2010-8#1)
these methods are outlined in a Support##2##7##(2008-2#1)(2008-4#1)
these methods are##22##3##(1992-1#1)(1993-3#1)(1995-2#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-3#1)
these methods can##4##3##(1992-2#1)(2008-10#1)(2008-8#1)(2009-5#1)
these methods could be##2##4##(2008-2#1)(2008-4#1)
these methods do not result in gross histological or histochemical changes that would adversely affect research results##2##17##(2008-4#2)
these methods do not##3##4##(2007-11#1)(2008-4#2)
these methods have been##3##4##(1996-12#1)(2008-10#1)(2012-1#1)
these methods have##5##3##(1996-12#1)(2007-12#1)(2008-10#1)(2011-2#1)(2012-1#1)
these methods in##6##3##(2007-11#1)(2008-8#1)(2009-11#1)(2010-12#2)(2013-8#1)
these methods is the##2##4##(2008-2#1)(2011-2#1)
these methods is##7##3##(1993-9#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#1)(2011-2#1)
these methods may not always##2##5##(2008-9#1)(2013-7#1)
these methods may##6##3##(1990-3#1)(2008-1#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-7#1)
these methods provide##3##3##(1991-2#1)(2009-11#1)(2011-2#1)
these methods to a number of##2##6##(2008-10#1)(2010-8#1)
these methods to a##5##4##(1997-2#1)(2008-10#1)(2010-3#1)(2010-8#1)(2012-3#1)
these methods to##20##3##(1990-6#1)(1993-9#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-8#1)(1997-2#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-3#1)(2010-8#1)(2012-3#1)
these methods using##2##3##(2012-3#2)
these methods were##3##3##(2008-10#3)
these methods##171##2##(1990-3#2)(1990-6#1)(1991-2#1)(1992-1#2)(1992-2#1)(1992-3#1)(1992-6#3)(1992-9#1)(1993-3#1)(1993-4#2)(1993-9#4)(1994-12#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(2004-9#1)(2005-11#1)(2005-7#1)(2006-10#4)(2006-2#2)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#20)(2008-11#2)(2008-2#7)(2008-3#6)(2008-4#10)(2008-5#2)(2008-7#4)(2008-8#4)(2008-9#5)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2010-10#2)(2010-12#6)(2010-2#1)(2010-3#2)(2010-6#1)(2010-7#2)(2010-8#2)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#8)(2013-1#6)(2013-7#1)(2013-8#1)
these metrics##2##2##(2012-1#1)(2012-2#1)
these miRNAs##5##2##(2008-1#1)(2009-8#1)(2010-7#1)(2013-8#2)
these mice was##5##3##(1996-9#1)(2008-10#1)(2010-12#1)(2012-12#2)
these mice were##2##3##(1994-2#1)(1996-2#1)
these mice##21##2##(1992-5#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-10#1)(1996-2#1)(1996-9#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-4#2)(2009-6#1)(2010-12#1)(2012-12#2)(2013-1#1)
these microbes##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
these microbial##3##2##(2007-6#1)(2008-1#1)(2008-11#1)
these micronutrients##2##2##(1992-9#1)(2006-12#1)
these microorganisms and##2##3##(2007-11#1)(2007-12#1)
these microorganisms##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
these microvesicles##2##2##(1990-12#1)(1997-3#1)
these might be##2##3##(1996-5#1)(2011-2#1)
these might##4##2##(1996-5#1)(2008-4#1)(2010-5#1)(2011-2#1)
these milestones##2##2##(2006-10#1)(2008-11#1)
these mines##3##2##(2008-10#3)
these minima##2##2##(2007-11#1)(2008-3#1)
these minor##2##2##(1995-6#1)(1996-9#1)
these mitochondrial##4##2##(1995-1#1)(2005-8#2)(2011-2#1)
these mitogens##3##2##(1992-4#1)(1992-7#1)(2008-4#1)
these mitosenes##2##2##(1997-7#2)
these mixtures##7##2##(1990-7#1)(1991-9#1)(1993-8#1)(1994-12#1)(2004-2#1)(2008-10#1)(2008-5#1)
these modalities##10##2##(1995-5#1)(1996-2#1)(2006-12#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-8#1)(2011-2#1)(2013-1#1)
these model systems##2##3##(1994-9#1)(2008-4#1)
these model##4##2##(1994-9#1)(1995-9#1)(2008-10#1)(2008-4#1)
these models and##5##3##(1995-6#1)(2008-2#1)(2008-4#2)(2013-1#1)
these models are##9##3##(1992-3#1)(1996-4#1)(2007-9#1)(2008-10#1)(2008-7#1)(2009-5#1)(2011-12#1)(2012-1#1)(2012-2#1)
these models for##2##3##(2007-8#1)(2008-7#1)
these models have##4##3##(1993-11#1)(2007-4#1)(2007-8#1)(2010-6#1)
these models is##2##3##(1993-9#1)(2007-4#1)
these models may##4##3##(1992-2#1)(1995-2#1)(2008-7#1)(2008-8#1)
these models to##7##3##(1997-7#1)(2007-11#1)(2007-4#1)(2008-3#1)(2008-8#1)(2010-3#1)(2012-4#1)
these models using##3##3##(2007-11#1)(2008-6#1)(2008-8#1)
these models was##4##3##(2007-9#1)(2008-10#1)(2008-5#1)(2012-2#1)
these models##88##2##(1991-5#1)(1992-2#2)(1992-3#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-9#1)(1994-10#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-10#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-1#1)(2006-10#1)(2006-7#1)(2007-11#2)(2007-12#2)(2007-4#4)(2007-8#4)(2007-9#3)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-12#1)(2012-1#1)(2012-2#5)(2012-4#1)(2013-1#1)
these modern##2##2##(2007-7#1)(2011-3#1)
these modes and##3##3##(1993-6#1)(2007-12#1)(2011-1#1)
these modes##6##2##(1993-6#1)(1994-12#1)(2007-12#3)(2011-1#1)
these modifications is the##2##4##(1994-8#1)(1996-6#1)
these modifications is##3##3##(1994-8#1)(1996-6#1)(2008-10#1)
these modifications##13##2##(1990-4#1)(1991-12#1)(1992-3#1)(1994-8#1)(1996-5#1)(1996-6#1)(1997-6#1)(2007-8#1)(2008-10#2)(2009-5#1)(2009-8#1)(2011-1#1)
these modified surfaces##3##3##(2008-10#1)(2012-11#2)
these modified##19##2##(1990-8#1)(1991-4#1)(1996-7#1)(2004-9#1)(2005-11#2)(2008-10#4)(2008-4#3)(2008-7#1)(2008-9#1)(2009-10#1)(2010-3#1)(2012-11#2)
these modifiers##2##2##(2008-10#1)(2012-12#1)
these modules##4##2##(1995-12#1)(1996-5#1)(2008-3#1)(2012-2#1)
these molecular##13##2##(1994-11#1)(1994-3#1)(2007-8#2)(2008-1#1)(2008-2#1)(2008-5#1)(2009-5#1)(2010-11#1)(2012-12#1)(2013-1#3)
these molecules and##2##3##(2007-5#1)(2009-6#1)
these molecules are##7##3##(1990-3#1)(1994-9#1)(2005-8#1)(2006-10#1)(2008-4#1)(2009-4#1)(2009-9#1)
these molecules at##2##3##(2008-10#1)(2008-4#1)
these molecules in##7##3##(1991-2#1)(2006-10#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-5#1)(2010-10#1)
these molecules may##3##3##(1991-3#1)(2008-1#1)(2008-5#1)
these molecules play##2##3##(2008-4#1)(2008-5#1)
these molecules to##2##3##(1994-2#1)(2008-10#1)
these molecules was##3##3##(1994-9#1)(2012-12#2)
these molecules were##2##3##(1996-7#1)(2012-12#1)
these molecules##67##2##(1990-3#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1993-4#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-2#2)(1995-6#1)(1996-4#1)(1996-7#1)(2005-8#1)(2006-10#3)(2006-12#2)(2007-10#1)(2007-11#2)(2007-5#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-4#7)(2008-5#5)(2009-10#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2012-12#5)(2013-1#1)(2013-8#1)
these monitors##2##2##(2004-9#1)(2006-10#1)
these monoclonal antibodies##5##3##(1990-3#1)(1992-1#1)(1992-7#1)(1993-12#1)(2007-11#1)
these monolayers were##2##3##(1992-6#1)(2007-12#1)
these monomers##2##2##(2008-3#1)(2009-12#1)
these more##5##2##(1991-3#1)(2006-11#1)(2006-5#1)(2007-8#1)(2008-7#1)
these morphological##2##2##(1997-8#1)(2008-10#1)
these mosquitoes##3##2##(2004-11#2)(2012-12#1)
these mothers##4##2##(1991-11#1)(2007-7#1)(2008-2#1)(2011-2#1)
these motifs##5##2##(1993-12#1)(1996-10#1)(2008-4#2)(2013-1#1)
these motives##2##2##(1991-12#1)(2009-8#1)
these multimorbidity aspects need to be defined rigorously in a formal language##2##12##(2013-1#2)
these multiple##9##2##(2008-2#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-7#1)(2010-9#1)(2012-3#1)(2013-1#1)
these muscles##9##2##(1990-2#1)(1994-11#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#2)(2009-1#1)(2012-12#1)
these must##2##2##(2008-7#1)(2012-11#1)
these mutant alleles##4##3##(1990-8#1)(1993-3#1)(1995-1#1)(2012-11#1)
these mutant enzymes##2##3##(1994-5#1)(1994-9#1)
these mutant strains##2##3##(2009-10#1)(2012-3#1)
these mutant##14##2##(1990-8#1)(1992-8#1)(1993-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-4#1)(1996-5#1)(1997-4#1)(2005-7#1)(2009-10#1)(2012-11#1)(2012-3#1)
these mutants have##2##3##(1993-11#1)(1995-8#1)
these mutants were##4##3##(1993-11#1)(1995-2#1)(1995-8#2)
these mutants##35##2##(1990-7#2)(1991-8#1)(1992-6#1)(1992-9#1)(1993-11#2)(1994-10#1)(1994-12#2)(1995-1#1)(1995-2#2)(1995-8#5)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#1)(2010-8#1)(2011-1#1)(2012-11#1)
these mutations are##2##3##(1993-11#1)(2013-1#1)
these mutations cause##2##3##(1990-8#1)(2006-10#1)
these mutations have##2##3##(1996-8#1)(2007-9#1)
these mutations result in##2##4##(1990-1#1)(1990-3#1)
these mutations were##4##3##(1992-11#1)(1993-3#1)(1996-8#1)(1997-3#1)
these mutations##44##2##(1990-1#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-5#1)(1992-11#1)(1993-11#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-7#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-8#1)(2006-10#1)(2007-9#1)(2008-11#2)(2008-3#1)(2008-7#3)(2009-4#1)(2009-5#1)(2012-12#1)(2012-3#1)(2013-1#2)
these nanomaterials##3##2##(2008-10#1)(2010-12#2)
these nanoparticles##17##2##(2005-11#1)(2007-8#1)(2008-7#2)(2009-2#2)(2010-1#1)(2010-6#2)(2011-2#3)(2012-11#4)(2013-1#1)
these nanostructures##3##2##(1996-5#1)(2008-7#1)(2010-4#1)
these native##2##2##(1995-3#1)(2012-1#1)
these natural##8##2##(1992-3#1)(1993-4#1)(2007-5#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-6#1)(2012-12#1)
these naturally occurring##2##3##(1992-9#1)(2013-1#1)
these need##2##2##(1994-6#1)(2008-6#1)
these needs and##3##3##(1993-3#1)(2006-12#1)(2006-5#1)
these needs are##2##3##(1994-2#1)(2010-2#1)
these needs##16##2##(1991-12#1)(1992-3#1)(1993-3#1)(1994-2#1)(2005-12#1)(2006-12#1)(2006-5#1)(2007-8#1)(2009-12#1)(2009-2#1)(2009-9#1)(2010-2#1)(2011-2#1)(2013-1#3)
these negative##4##2##(1994-12#1)(2006-9#1)(2008-8#1)(2013-1#1)
these nematodes##4##2##(1994-12#1)(2007-11#1)(2008-9#2)
these neo-epitopes##2##2##(2013-8#2)
these neoplasms is##2##3##(1991-4#1)(2010-8#1)
these neoplasms##9##2##(1990-5#2)(1991-4#1)(1991-6#1)(2007-11#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
these nerves##6##2##(1992-8#1)(1995-7#1)(1995-8#1)(2008-2#2)(2011-2#1)
these networks##11##2##(1991-6#1)(1994-12#1)(1996-3#1)(2006-6#1)(2007-12#2)(2008-2#1)(2008-7#2)(2009-4#1)(2009-9#1)
these neural system components in BD##2##6##(2010-8#2)
these neural system##3##3##(2010-8#3)
these neurochemical##3##2##(1994-2#2)(1996-8#1)
these neurological disorders##2##3##(1995-12#1)(1997-1#1)
these neurological##4##2##(1995-12#1)(1997-1#1)(2007-7#1)(2008-6#1)
these neuronal##3##2##(1991-5#1)(1996-11#1)(1996-9#1)
these neurones##4##2##(1993-9#1)(1995-12#1)(1996-1#1)(1996-5#1)
these neurons are##5##3##(1990-11#1)(1990-2#1)(1990-8#1)(2010-10#1)(2013-8#1)
these neurons were##4##3##(1993-12#2)(1996-3#1)(2009-2#1)
these neurons##47##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-3#2)(1991-8#1)(1992-3#2)(1992-7#2)(1993-12#3)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#1)(1996-9#2)(1997-5#2)(2007-12#1)(2008-11#4)(2008-4#1)(2008-7#1)(2009-10#1)(2009-2#2)(2010-10#1)(2013-8#1)
these neuropeptides##3##2##(1990-5#1)(1995-11#1)(2008-5#1)
these neurophysiological##2##2##(1995-12#1)(1997-5#1)
these neurotrophins##4##2##(1991-5#1)(1993-9#1)(1996-3#2)
these new agents##5##3##(2007-11#1)(2008-11#1)(2008-5#1)(2010-12#2)
these new compounds##3##3##(1996-8#1)(2007-11#1)(2007-9#1)
these new drugs##6##3##(2006-10#2)(2006-12#1)(2007-11#1)(2012-12#2)
these new formulations##2##3##(2007-11#1)(2008-11#1)
these new methods##4##3##(2008-10#2)(2010-1#1)(2010-6#1)
these new paradigms##2##3##(2006-10#1)(2009-12#1)
these new retroviral vectors##2##4##(1997-8#2)
these new techniques##4##3##(2006-6#1)(2007-5#1)(2009-3#1)(2012-2#1)
these new technologies##6##3##(2006-10#2)(2007-6#1)(2008-11#1)(2010-7#1)(2012-2#1)
these new therapies##3##3##(2008-12#1)(2008-5#1)(2010-12#1)
these new##110##2##(1990-12#1)(1990-5#1)(1991-1#1)(1992-7#1)(1993-2#1)(1994-3#2)(1994-8#1)(1995-1#1)(1996-12#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#2)(1997-9#1)(2004-2#1)(2005-7#1)(2006-10#8)(2006-12#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#8)(2008-12#2)(2008-2#5)(2008-3#1)(2008-5#4)(2008-6#1)(2009-1#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-1#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#1)
these newer##8##2##(1992-2#1)(2004-3#1)(2005-8#1)(2007-12#1)(2007-7#1)(2009-3#1)(2010-12#1)(2013-7#1)
these newly##7##2##(2008-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#1)(2012-12#1)
these nine##5##2##(1990-12#1)(1991-7#1)(1996-3#1)(2008-10#2)
these nitrates##2##2##(1992-6#2)
these noises##2##2##(2007-12#1)(2008-3#1)
these nominal##2##2##(1996-3#1)(2010-8#1)
these nontraditional##3##2##(1996-12#2)(2008-3#1)
these normal variants##2##3##(2010-1#2)
these normal##4##2##(1992-8#1)(2005-12#1)(2010-1#2)
these novel inclusions##3##3##(2008-10#3)
these novel proteolysis##2##3##(2012-3#2)
these novel##37##2##(1994-5#1)(1995-6#1)(1997-8#1)(2006-12#1)(2006-2#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-9#2)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#2)
these nuclear proteins are##2##4##(1992-12#1)(1994-12#1)
these nuclear receptors##2##3##(2008-4#1)(2010-7#1)
these nuclear##8##2##(1991-12#1)(1992-12#1)(1993-4#1)(1994-12#1)(2007-12#1)(2008-4#1)(2010-7#1)(2012-3#1)
these nucleases##2##2##(1990-7#1)(1993-11#1)
these nuclei##2##2##(1993-12#1)(1997-6#1)
these nucleosides##7##2##(1991-8#1)(1992-3#2)(1994-9#2)(1996-8#1)(1997-5#1)
these nucleotide##2##2##(1991-2#1)(2008-4#1)
these numbers##3##2##(2005-9#1)(2009-8#1)(2013-1#1)
these nurses##6##2##(2008-1#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-1#1)
these nutrients##5##2##(1993-9#1)(2005-10#1)(2008-1#1)(2008-11#1)(2013-1#1)
these objections##2##2##(2004-12#2)
these objectives##9##2##(1994-3#1)(1995-2#1)(1997-3#1)(2005-5#1)(2007-9#1)(2008-7#1)(2009-9#1)(2010-3#1)(2010-4#1)
these objects and##2##3##(2007-11#1)(2007-12#1)
these objects##10##2##(2007-10#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-2#1)(2008-3#2)(2010-8#1)(2013-8#1)
these obligatory##2##2##(2007-9#1)(2008-3#1)
these observations and##4##3##(1990-4#1)(1991-3#1)(1995-5#1)(2008-7#1)
these observations are##6##3##(1995-3#1)(1997-8#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-2#1)
these observations demonstrate##2##3##(1995-2#2)
these observations for the##3##4##(1996-1#1)(1996-2#1)(2008-10#1)
these observations for##6##3##(1994-6#1)(1996-1#1)(1996-2#1)(2008-10#1)(2009-9#1)(2010-9#1)
these observations is##5##3##(1990-9#1)(1991-2#1)(1992-3#1)(1995-10#1)(1997-6#1)
these observations may##2##3##(1994-2#1)(1995-11#1)
these observations reflect##2##3##(1991-7#1)(2008-7#1)
these observations reveal that sizzled##2##5##(2012-12#2)
these observations reveal that##3##4##(2008-10#1)(2012-12#2)
these observations reveal##4##3##(2008-10#1)(2012-12#2)(2013-7#1)
these observations suggest that##2##4##(1992-8#1)(2008-6#1)
these observations suggest the##2##4##(1993-7#1)(1996-5#1)
these observations suggest##4##3##(1992-8#1)(1993-7#1)(1996-5#1)(2008-6#1)
these observations to##5##3##(1990-12#1)(1990-9#1)(1994-2#1)(2008-7#1)(2011-2#1)
these observations we##3##3##(1991-6#1)(1995-3#1)(2011-2#1)
these observations##83##2##(1990-12#2)(1990-2#1)(1990-4#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-7#1)(1994-2#2)(1994-6#1)(1994-9#3)(1995-1#1)(1995-10#2)(1995-11#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-8#2)(2006-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#3)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#3)(2012-12#2)(2013-7#1)
these observed##2##2##(2008-10#1)(2012-3#1)
these obstacles##6##2##(1994-12#1)(1996-1#1)(1996-3#1)(2005-11#1)(2008-11#1)(2009-5#1)
these occupational##2##2##(2007-4#1)(2008-3#1)
these occurred##3##2##(1995-7#1)(2008-9#1)(2009-8#1)
these often##6##2##(2005-8#1)(2006-7#1)(2008-12#1)(2008-9#1)(2009-4#1)(2013-8#1)
these older##3##2##(2008-4#1)(2009-4#1)(2012-12#1)
these oligonucleotides##4##2##(1991-5#1)(1997-2#1)(2008-10#1)(2008-4#1)
these operational##4##2##(1996-3#1)(2008-8#1)(2013-1#2)
these operations##5##2##(2006-8#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-3#1)
these opportunities and##2##3##(1992-3#1)(2010-2#1)
these opportunities##5##2##(1992-3#1)(2004-10#1)(2008-3#1)(2010-2#1)(2011-12#1)
these opposite##2##2##(1990-2#1)(1995-1#1)
these optical parameters##2##3##(1990-8#1)(2007-12#1)
these optical##9##2##(1990-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#3)
these optimal##4##2##(1996-2#1)(2008-5#2)(2008-7#1)
these optimized conditions##3##3##(2008-10#2)(2008-5#1)
these optimized##4##2##(2008-10#2)(2008-5#1)(2008-6#1)
these options in##2##3##(2005-11#1)(2008-1#1)
these options##12##2##(1997-7#1)(2004-1#1)(2005-11#1)(2006-7#1)(2007-11#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-2#1)
these orchids##2##2##(1997-4#2)
these order##2##2##(2008-10#1)(2011-1#1)
these organelles##7##2##(1990-9#1)(1992-8#1)(1994-5#1)(1997-4#1)(1997-6#1)(2008-4#1)(2009-8#1)
these organisations##2##2##(2005-7#1)(2006-2#1)
these organisms are##2##3##(2008-7#1)(2008-8#1)
these organisms in##5##3##(2007-12#2)(2007-3#1)(2011-2#2)
these organisms is##5##3##(2006-8#1)(2007-7#2)(2008-9#1)(2013-7#1)
these organisms##32##2##(1990-9#1)(1991-6#1)(2006-10#3)(2006-12#1)(2006-8#2)(2007-12#2)(2007-3#1)(2007-7#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#3)(2008-8#1)(2008-9#4)(2011-2#4)(2012-2#1)(2013-7#1)
these organizational##2##2##(1992-12#1)(2007-6#1)
these organizations and##2##3##(1991-3#1)(2007-4#1)
these organizations##8##2##(1991-3#1)(1992-12#1)(1994-12#1)(1995-12#1)(1996-1#1)(1996-3#1)(2007-4#1)(2011-2#1)
these organs##17##2##(1990-11#1)(1990-3#1)(1990-8#1)(1991-5#1)(1992-7#1)(1993-8#1)(1996-12#1)(1997-3#1)(2006-10#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-1#1)
these origins##2##2##(2008-7#2)
these oscillations##4##2##(1996-7#1)(2008-1#1)(2013-8#2)
these other disorders##2##3##(2009-10#1)(2012-3#1)
these other##8##2##(1993-2#1)(1994-12#1)(1995-1#1)(2007-1#1)(2007-4#1)(2009-10#1)(2011-2#1)(2012-3#1)
these outbreaks##6##2##(1991-11#1)(1991-6#1)(1997-3#1)(1997-6#1)(2007-6#1)(2008-10#1)
these outcome##2##2##(2006-10#1)(2008-12#1)
these outcomes##8##2##(1994-12#1)(2007-12#1)(2009-11#1)(2009-12#1)(2009-7#1)(2012-3#2)(2013-1#1)
these oxidants##2##2##(1996-2#1)(2007-8#1)
these oxides##3##2##(1996-5#2)(2008-10#1)
these pH-dependent##2##2##(1992-7#1)(1995-6#1)
these pairs##2##2##(1990-9#2)
these papers are##33##3##(2007-8#33)
these papers##38##2##(2007-2#1)(2007-8#33)(2008-1#1)(2008-2#1)(2008-7#1)(2010-8#1)
these paradigms##2##2##(1996-8#1)(2008-12#1)
these parameter values##2##3##(2008-10#1)(2008-7#1)
these parameters and##7##3##(1990-12#1)(1992-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2009-9#1)(2010-12#1)
these parameters are##11##3##(1995-12#1)(2005-11#1)(2007-8#2)(2008-4#1)(2008-5#2)(2008-7#2)(2010-12#1)(2011-12#1)
these parameters but##2##3##(2004-4#1)(2006-10#1)
these parameters by##2##3##(2008-2#1)(2010-3#1)
these parameters did not change##3##5##(1992-6#1)(1995-12#1)(1996-3#1)
these parameters do not differ between strides with different transition types##2##11##(2012-12#2)
these parameters for##5##3##(1992-6#1)(2008-10#1)(2008-2#2)(2011-1#1)
these parameters have been##2##4##(1997-2#1)(2008-2#1)
these parameters have##4##3##(1997-2#1)(2007-12#1)(2008-2#1)(2010-12#1)
these parameters in the##2##4##(1990-2#1)(2012-3#1)
these parameters in##8##3##(1990-2#1)(1991-12#1)(1993-11#1)(1996-12#1)(2005-10#1)(2007-8#1)(2008-10#1)(2012-3#1)
these parameters increased with##2##4##(1997-4#1)(2008-5#1)
these parameters increased##3##3##(1997-4#1)(2008-12#1)(2008-5#1)
these parameters is##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
these parameters of##2##3##(1997-2#1)(2008-10#1)
these parameters to##5##3##(2008-2#1)(2008-3#1)(2008-7#1)(2012-1#1)(2013-8#1)
these parameters using##2##3##(2008-8#1)(2013-3#1)
these parameters was##3##3##(2005-8#1)(2011-1#1)(2013-8#1)
these parameters were##6##3##(1991-5#1)(1994-11#1)(1996-9#1)(2006-6#1)(2006-8#1)(2008-10#1)
these parameters with##2##3##(2006-8#1)(2008-3#1)
these parameters##125##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#2)(1991-12#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-11#2)(1994-11#1)(1994-3#1)(1995-11#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-4#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#3)(2007-10#1)(2007-12#3)(2007-2#2)(2007-3#1)(2007-5#1)(2007-8#5)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#10)(2008-3#9)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-3#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-3#1)(2013-8#2)
these parasites##12##2##(2006-10#2)(2007-12#2)(2007-2#1)(2007-7#1)(2008-9#1)(2009-10#1)(2012-2#1)(2013-1#1)(2013-8#2)
these parasitic##2##2##(2007-12#1)(2011-2#1)
these parents##4##2##(1993-1#1)(2008-10#1)(2008-9#2)
these participants##9##2##(2007-4#1)(2008-5#1)(2009-11#1)(2010-2#1)(2010-8#2)(2013-1#3)
these particles##11##2##(1990-5#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2010-1#2)(2010-7#1)(2013-1#1)(2013-7#1)
these particular##5##2##(1997-7#1)(2004-4#1)(2006-12#1)(2006-8#1)(2008-10#1)
these partnerships##2##2##(2009-11#1)(2012-3#1)
these parts##2##2##(1990-3#1)(1997-5#1)
these patches##2##2##(2007-12#1)(2007-9#1)
these pathogens and##2##3##(2006-10#1)(2008-10#1)
these pathogens are##3##3##(2008-10#2)(2008-9#1)
these pathogens can##2##3##(2007-12#1)(2012-12#1)
these pathogens should be##2##4##(2007-12#1)(2011-2#1)
these pathogens##32##2##(1995-5#2)(2005-8#1)(2006-10#1)(2007-12#3)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-9#1)(2009-10#1)(2009-3#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-7#1)
these pathological##3##2##(1990-10#1)(1990-6#1)(2010-4#1)
these pathologies##11##2##(1991-9#1)(2006-2#2)(2008-1#1)(2008-12#1)(2009-2#1)(2010-11#1)(2010-12#1)(2011-1#2)(2012-2#1)
these pathovars##2##2##(2008-10#2)
these paths##2##2##(2008-3#1)(2008-8#1)
these pathways are##3##3##(1996-10#1)(2006-10#1)(2007-11#1)
these pathways for the##2##4##(2009-1#1)(2011-2#1)
these pathways has##2##3##(1996-2#1)(2009-12#1)
these pathways in##2##3##(2006-10#1)(2013-7#1)
these pathways is##3##3##(1995-12#1)(2008-9#1)(2012-3#1)
these pathways##33##2##(1990-8#1)(1993-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-2#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-1#1)(2009-12#1)(2009-6#1)(2010-11#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-7#1)
these patient groups##2##3##(1993-2#1)(2009-10#1)
these patient populations##2##3##(1995-2#1)(2012-2#1)
these patient##6##2##(1993-2#1)(1995-2#1)(2006-12#1)(2008-8#1)(2009-10#1)(2012-2#1)
these patients a##3##3##(2008-6#2)(2012-3#1)
these patients also have##5##4##(2011-1#1)(2013-8#4)
these patients also##9##3##(2006-6#1)(2007-2#1)(2008-7#1)(2010-12#1)(2011-1#1)(2013-8#4)
these patients and the##2##4##(2007-10#1)(2011-2#1)
these patients and their##2##4##(1991-6#1)(2009-9#1)
these patients and they were##2##5##(1992-6#1)(2012-2#1)
these patients and they##3##4##(1992-6#1)(2007-9#1)(2012-2#1)
these patients and to##2##4##(2007-8#1)(2008-9#1)
these patients and##19##3##(1991-6#1)(1992-6#1)(2005-1#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-6#1)(2008-9#1)(2009-3#1)(2009-9#1)(2011-1#2)(2011-2#2)(2012-2#1)
these patients are discussed##2##4##(2006-9#1)(2008-8#1)
these patients are not##2##4##(2009-5#1)(2013-1#1)
these patients are often##3##4##(1991-4#1)(2006-10#1)(2008-7#1)
these patients are##28##3##(1990-6#1)(1990-9#1)(1991-4#1)(1992-10#1)(1992-8#1)(1993-7#1)(1997-8#1)(2005-8#1)(2006-10#2)(2006-9#2)(2007-11#1)(2007-3#1)(2007-6#1)(2007-9#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-5#1)(2010-8#2)(2011-1#1)(2013-1#2)
these patients as##5##3##(1992-9#1)(1996-3#1)(2006-10#1)(2008-7#1)(2012-3#1)
these patients at##5##3##(1993-3#1)(2004-4#1)(2008-7#1)(2009-6#1)(2013-1#1)
these patients can be##4##4##(1997-3#1)(2007-11#1)(2007-3#1)(2007-5#1)
these patients can##5##3##(1997-3#1)(2006-7#1)(2007-11#1)(2007-3#1)(2007-5#1)
these patients could be##2##4##(2006-10#1)(2010-12#1)
these patients could##3##3##(2006-10#1)(2010-12#1)(2012-2#1)
these patients did##2##3##(1992-12#1)(2007-9#1)
these patients do not##2##4##(2008-1#1)(2013-1#1)
these patients does not##4##4##(2007-11#1)(2007-7#1)(2012-2#1)(2013-1#1)
these patients exhibited##2##3##(1995-3#1)(2010-12#1)
these patients for##3##3##(1990-2#1)(2007-12#1)(2011-1#1)
these patients frequently##2##3##(2006-10#1)(2010-12#1)
these patients from##2##3##(2007-8#1)(2013-1#1)
these patients had##22##3##(1990-12#1)(1991-4#1)(1992-2#1)(1995-2#1)(1997-5#1)(2006-10#1)(2006-8#1)(2007-10#2)(2007-7#2)(2007-8#3)(2007-9#2)(2008-6#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-8#1)
these patients has been##4##4##(1995-8#1)(2006-10#1)(2007-1#1)(2008-7#1)
these patients has##10##3##(1991-12#1)(1993-10#1)(1995-8#1)(2006-10#1)(2007-1#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-7#2)
these patients have##8##3##(1994-3#1)(2006-10#2)(2007-1#1)(2007-12#1)(2007-7#1)(2009-3#1)(2011-1#1)
these patients in order to##2##5##(2006-1#1)(2011-11#1)
these patients in the##2##4##(2011-2#1)(2012-12#1)
these patients in##7##3##(1992-5#1)(2006-1#1)(2007-7#1)(2011-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
these patients included##2##3##(2006-10#1)(2007-7#1)
these patients is a##2##4##(2006-12#1)(2008-8#1)
these patients is##25##3##(1990-9#1)(1996-3#1)(2006-10#4)(2006-12#3)(2006-2#1)(2006-6#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-12#1)(2009-2#1)(2010-12#1)(2012-12#1)(2012-2#1)
these patients may be##3##4##(2008-1#1)(2009-9#1)(2012-12#1)
these patients may##7##3##(1996-6#1)(2008-1#1)(2008-3#1)(2009-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
these patients must##2##3##(1991-6#1)(2007-1#1)
these patients received##4##3##(1992-5#1)(1993-1#1)(2006-9#1)(2007-11#1)
these patients remain##2##3##(2007-11#1)(2011-1#1)
these patients should be##6##4##(1991-4#1)(1996-11#1)(2005-12#1)(2006-1#1)(2007-11#1)(2008-7#1)
these patients should##8##3##(1991-4#1)(1996-11#1)(2005-12#1)(2006-1#1)(2007-11#1)(2008-7#1)(2009-8#1)(2011-2#1)
these patients subsequently##3##3##(2007-2#2)(2008-9#1)
these patients the##5##3##(1990-7#1)(2006-10#1)(2007-11#1)(2007-7#2)
these patients there##2##3##(1990-6#1)(2006-8#1)
these patients to a##2##4##(2008-4#1)(2011-2#1)
these patients to the##2##4##(2008-1#1)(2008-3#1)
these patients to##7##3##(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2010-6#1)(2011-2#1)(2013-8#1)
these patients underwent##3##3##(2005-5#1)(2009-6#1)(2010-12#1)
these patients was##21##3##(1990-7#1)(1991-3#1)(1993-10#1)(1993-8#1)(1994-3#1)(2005-5#1)(2006-9#1)(2007-2#2)(2007-7#2)(2008-3#1)(2008-5#2)(2008-7#2)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
these patients were treated with##2##5##(2007-8#1)(2008-1#1)
these patients were##45##3##(1990-4#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-10#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-9#1)(1996-9#1)(1997-7#1)(2004-1#1)(2004-10#1)(2005-11#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-11#2)(2007-2#2)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#1)(2008-7#1)(2008-9#2)(2010-12#1)(2011-1#2)(2011-12#2)(2013-1#4)
these patients while##2##3##(2005-10#1)(2011-1#1)
these patients who##5##3##(1997-8#1)(2004-1#1)(2006-1#1)(2006-11#1)(2007-7#1)
these patients will need##2##4##(2006-10#1)(2013-8#1)
these patients will##9##3##(2006-10#1)(2007-10#1)(2007-8#2)(2010-11#1)(2010-2#1)(2010-3#1)(2012-1#1)(2013-8#1)
these patients with the##2##4##(2006-10#1)(2011-2#1)
these patients with##13##3##(1997-6#1)(2006-10#1)(2006-9#1)(2007-2#1)(2007-8#1)(2008-8#1)(2009-6#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)
these patients##712##2##(1990-1#1)(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#3)(1990-7#2)(1990-8#2)(1990-9#4)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#7)(1991-3#3)(1991-4#4)(1991-5#2)(1991-6#8)(1991-8#3)(1992-10#2)(1992-12#4)(1992-2#3)(1992-5#5)(1992-6#2)(1992-8#3)(1992-9#1)(1993-1#3)(1993-10#2)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#2)(1993-7#4)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#4)(1994-6#1)(1994-9#2)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#2)(1995-8#3)(1995-9#2)(1996-1#2)(1996-11#1)(1996-2#1)(1996-3#4)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#4)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#4)(2004-1#3)(2004-10#1)(2004-11#1)(2004-3#1)(2004-4#1)(2005-1#1)(2005-10#2)(2005-11#2)(2005-12#3)(2005-5#3)(2005-8#4)(2005-9#2)(2006-1#6)(2006-10#43)(2006-11#1)(2006-12#6)(2006-2#6)(2006-3#1)(2006-4#2)(2006-6#9)(2006-7#5)(2006-8#6)(2006-9#7)(2007-1#3)(2007-10#10)(2007-11#30)(2007-12#3)(2007-2#13)(2007-3#4)(2007-5#2)(2007-6#4)(2007-7#28)(2007-8#31)(2007-9#19)(2008-1#27)(2008-10#5)(2008-11#5)(2008-12#2)(2008-2#6)(2008-3#7)(2008-4#8)(2008-5#7)(2008-6#10)(2008-7#27)(2008-8#10)(2008-9#7)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#4)(2009-3#6)(2009-4#1)(2009-5#3)(2009-6#4)(2009-8#1)(2009-9#3)(2010-11#3)(2010-12#9)(2010-2#1)(2010-3#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#5)(2010-9#2)(2011-1#21)(2011-11#1)(2011-12#5)(2011-2#21)(2012-1#1)(2012-11#2)(2012-12#8)(2012-2#15)(2012-3#9)(2013-1#23)(2013-7#2)(2013-8#17)
these patients'##5##2##(1992-2#1)(2007-8#1)(2008-1#1)(2008-3#1)(2012-12#1)
these patterns in##3##3##(2008-8#1)(2013-1#2)
these patterns##26##2##(1990-7#1)(1990-9#1)(1994-2#1)(2006-9#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#2)(2008-8#4)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#1)(2013-1#5)
these peaks##9##2##(1990-5#2)(1996-9#2)(2008-10#1)(2008-3#2)(2008-9#1)(2009-6#1)
these people##13##2##(1995-11#1)(2004-8#1)(2007-1#2)(2007-11#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-2#2)(2009-7#1)(2012-12#1)(2013-8#1)
these peptide##3##2##(1991-10#1)(1996-11#1)(2008-7#1)
these peptides are##2##3##(1994-6#1)(2005-7#1)
these peptides in##3##3##(1990-10#1)(1994-8#1)(2009-6#1)
these peptides to##6##3##(1990-4#1)(1991-2#1)(1992-9#1)(1994-11#1)(1996-9#1)(2008-10#1)
these peptides were##3##3##(1990-10#1)(1991-5#1)(1994-8#1)
these peptides with##2##3##(1991-9#1)(1993-11#1)
these peptides##65##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-9#2)(1992-11#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-3#2)(1993-6#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#2)(1995-12#1)(1995-3#1)(1996-12#3)(1996-3#1)(1996-5#2)(1996-8#2)(1996-9#1)(1997-3#1)(1997-7#1)(2005-7#1)(2006-1#1)(2006-10#2)(2007-11#1)(2008-1#2)(2008-10#1)(2009-6#1)(2011-1#1)(2011-2#1)
these perceptions##2##2##(1996-3#1)(2007-11#1)
these periods##4##2##(1992-7#1)(2004-3#1)(2008-10#1)(2012-1#1)
these permanent##2##2##(1990-4#1)(2006-12#1)
these personality traits##2##3##(2004-11#1)(2006-9#1)
these persons##9##2##(1991-11#1)(1991-6#1)(1993-9#2)(1994-2#1)(1994-9#1)(2012-1#1)(2012-2#2)
these perturbations##2##2##(1992-1#1)(2008-7#1)
these pesticides##7##2##(2007-3#1)(2007-8#1)(2008-10#4)(2010-2#1)
these phages##3##2##(1994-12#2)(2007-2#1)
these phantoms##2##2##(2011-2#1)(2012-1#1)
these phase##3##2##(2007-11#1)(2008-3#2)
these phases##7##2##(1992-9#1)(1993-4#1)(1996-2#1)(2005-8#1)(2008-12#1)(2010-4#1)(2013-8#1)
these phenolic##2##2##(2008-6#1)(2011-2#1)
these phenomena and##3##3##(2007-10#1)(2008-2#1)(2013-1#1)
these phenomena are##3##3##(1992-2#1)(1996-8#1)(1997-2#1)
these phenomena can##3##3##(2005-11#1)(2008-8#1)(2009-5#1)
these phenomena have##2##3##(2008-2#1)(2009-5#1)
these phenomena in##3##3##(1995-11#1)(1997-4#1)(2007-12#1)
these phenomena is not##2##4##(2008-1#1)(2008-11#1)
these phenomena##37##2##(1991-1#1)(1991-12#1)(1991-5#1)(1992-2#1)(1993-6#1)(1995-11#1)(1996-8#1)(1997-2#1)(1997-4#1)(2005-11#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-7#3)(2008-8#1)(2009-11#1)(2009-5#2)(2009-7#1)(2010-12#1)(2010-3#1)(2013-1#1)
these phenotypes##5##2##(1994-11#1)(1995-11#1)(2008-8#1)(2011-1#1)(2013-1#1)
these phenylalanine##2##2##(1990-4#2)
these phosphoramidites##2##2##(2008-4#2)
these phosphorylation##2##2##(1995-12#1)(2008-8#1)
these physical##6##2##(1994-6#1)(2005-11#1)(2008-11#3)(2008-5#1)
these physicians##3##2##(1991-12#1)(1991-2#1)(2007-6#1)
these physiological##8##2##(1993-12#1)(1997-6#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-7#1)(2013-7#1)
these phytohormones##2##2##(2004-2#1)(2009-8#1)
these pieces##3##2##(1995-3#1)(2008-10#1)(2011-1#1)
these pigmented##2##2##(1990-5#1)(1991-7#1)
these plans##5##2##(1992-3#1)(1996-2#1)(2007-4#1)(2008-1#1)(2008-12#1)
these plant##4##2##(2004-4#1)(2006-12#1)(2008-10#1)(2009-3#1)
these plants was##2##3##(2006-12#1)(2008-10#1)
these plants were##3##3##(2008-10#3)
these plants##25##2##(1993-5#1)(2006-12#2)(2007-6#1)(2008-10#16)(2008-5#1)(2009-8#2)(2010-3#1)(2011-1#1)
these plaques##2##2##(1990-6#1)(2008-4#1)
these plasma##2##2##(1991-9#1)(2005-10#1)
these plasmids##13##2##(1990-4#1)(1990-5#1)(1991-7#3)(1991-8#1)(1991-9#2)(1994-9#1)(1995-8#1)(2008-5#2)(2008-9#1)
these plastic##2##2##(1995-4#1)(2008-2#1)
these plasticizers##2##2##(2008-10#1)(2012-2#1)
these plots##5##2##(2005-11#1)(2008-10#3)(2010-12#1)
these points of##2##3##(2009-5#1)(2012-2#1)
these points##9##2##(2007-5#1)(2008-1#2)(2008-2#1)(2008-3#1)(2009-5#1)(2011-10#1)(2012-1#1)(2012-2#1)
these policies##9##2##(1993-3#1)(1995-1#2)(1997-7#1)(2007-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)
these polymer particles##2##3##(2008-10#2)
these polymer##3##2##(2007-12#1)(2008-10#2)
these polymers##5##2##(2008-10#2)(2008-11#1)(2008-5#1)(2011-1#1)
these polymorphic##4##2##(1996-11#1)(1996-8#1)(2008-9#1)(2013-8#1)
these polymorphisms##8##2##(1993-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-12#1)(2010-2#1)(2012-12#2)
these polypeptides##4##2##(1992-4#1)(1995-6#1)(1996-5#1)(2008-11#1)
these populations and##4##3##(2007-3#1)(2008-1#1)(2008-10#1)(2012-3#1)
these populations are##5##3##(2006-2#1)(2008-10#3)(2008-8#1)
these populations was##3##3##(2008-10#2)(2013-1#1)
these populations##42##2##(1994-9#1)(1996-11#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-3#1)(2008-1#2)(2008-10#15)(2008-4#2)(2008-8#2)(2009-10#1)(2009-11#1)(2010-10#1)(2010-12#1)(2010-8#2)(2011-2#2)(2012-2#1)(2012-3#4)(2012-7#1)(2013-1#1)
these positions##6##2##(1990-3#1)(1993-10#1)(1993-8#1)(1996-7#1)(1997-4#1)(2009-10#1)
these positive##3##2##(1994-12#1)(2008-8#1)(2010-2#1)
these possibilities##6##2##(1991-1#1)(1992-12#1)(1992-3#1)(1994-5#1)(2007-11#1)(2009-8#1)
these potential complications##3##3##(1994-5#1)(2006-11#1)(2007-8#1)
these potential##11##2##(1992-3#1)(1993-11#1)(1994-5#1)(2006-11#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#1)
these potentially##6##2##(1995-12#1)(1996-6#1)(2006-10#1)(2007-9#1)(2011-2#2)
these practical##2##2##(2006-8#1)(2007-11#1)
these practices##7##2##(1991-12#1)(2006-2#1)(2008-4#2)(2008-9#1)(2010-5#1)(2012-12#1)
these precautions##4##2##(1993-2#1)(2007-7#1)(2012-11#2)
these precursor##2##2##(1994-11#1)(2008-1#1)
these precursors can##2##3##(1995-1#2)
these precursors in##2##3##(2008-12#1)(2008-5#1)
these precursors##6##2##(1992-2#1)(1995-1#2)(2008-12#1)(2008-5#1)(2013-1#1)
these predicted##2##2##(2008-7#1)(2008-8#1)
these predictions in a##2##4##(2007-4#1)(2010-2#1)
these predictions in##6##3##(1993-12#1)(2007-4#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-2#1)
these predictions##21##2##(1993-12#1)(1995-8#1)(1997-7#1)(2007-4#1)(2007-9#1)(2008-11#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#1)(2009-6#1)(2010-2#1)(2012-2#1)(2013-1#2)
these predictors##2##2##(2007-1#1)(2007-3#1)
these preferences##3##2##(2009-9#1)(2012-12#1)(2012-3#1)
these preliminary experiments##2##3##(2006-4#1)(2007-12#1)
these preliminary results##7##3##(1990-12#1)(1992-6#1)(2005-5#1)(2008-10#1)(2008-7#1)(2010-12#1)(2012-1#1)
these preliminary studies##2##3##(2010-11#1)(2011-2#1)
these preliminary##17##2##(1990-12#1)(1992-6#1)(1995-2#1)(2004-2#1)(2005-5#1)(2006-4#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
these premises##2##2##(2009-6#1)(2010-4#1)
these preparations##12##2##(1990-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1994-3#1)(2004-12#1)(2005-8#1)(2007-11#1)(2007-6#1)(2008-5#1)(2010-2#1)(2011-1#1)
these prerequisites##2##2##(2005-10#1)(2006-10#1)
these presentations##5##2##(1994-7#1)(1997-7#1)(2006-11#1)(2007-2#1)(2008-1#1)
these pretreated##2##2##(1991-12#1)(1996-9#1)
these preventable##2##2##(2006-4#1)(2011-1#1)
these previous studies##2##3##(2009-3#1)(2011-2#1)
these previous##4##2##(2008-8#1)(2009-3#1)(2009-4#1)(2011-2#1)
these previously##2##2##(2007-11#1)(2008-10#1)
these primary##3##2##(1991-2#1)(2008-11#1)(2013-7#1)
these primers##9##2##(1993-12#1)(1993-3#1)(1996-4#1)(2008-10#6)
these principal##3##2##(2008-3#1)(2010-12#1)(2012-2#1)
these principles can##2##3##(1993-3#1)(2009-9#1)
these principles##12##2##(1992-2#1)(1993-3#1)(2006-10#1)(2006-3#1)(2007-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-9#1)(2012-2#1)(2013-1#2)
these probes##9##2##(1990-2#1)(1990-3#1)(1990-4#2)(2006-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)
these problem##3##2##(1992-12#1)(2013-1#2)
these problems and##7##3##(1990-6#1)(2007-3#1)(2008-1#1)(2009-11#1)(2009-2#1)(2010-12#1)(2013-7#1)
these problems are usually##2##4##(2007-7#1)(2008-8#1)
these problems are##11##3##(1996-9#1)(2006-10#1)(2006-12#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-11#1)(2013-8#1)
these problems by##6##3##(1991-3#1)(1992-12#1)(1996-1#1)(2005-8#1)(2007-11#1)(2008-10#1)
these problems in order to##2##5##(1991-5#1)(2008-8#1)
these problems in##5##3##(1991-5#1)(2007-8#1)(2008-8#2)(2011-2#1)
these problems we##3##3##(1991-11#1)(2013-1#2)
these problems##105##2##(1990-6#1)(1991-11#1)(1991-3#2)(1991-5#1)(1992-12#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-5#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-9#1)(1996-1#2)(1996-3#2)(1996-9#1)(1997-8#1)(2004-2#1)(2005-8#3)(2006-10#3)(2006-12#2)(2006-2#1)(2006-3#2)(2006-6#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-2#2)(2007-3#2)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#1)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#4)(2013-7#2)(2013-8#1)
these procedures are described##2##4##(2006-7#1)(2007-8#1)
these procedures are##9##3##(1991-4#1)(2006-7#1)(2006-8#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-9#1)
these procedures can be##3##4##(1991-6#1)(1993-3#1)(2008-4#1)
these procedures during##2##3##(2006-10#1)(2010-8#1)
these procedures in##3##3##(2007-12#1)(2011-2#1)(2012-12#1)
these procedures is##2##3##(2008-9#1)(2011-2#1)
these procedures to##2##3##(2008-3#1)(2012-3#1)
these procedures were##3##3##(1991-8#1)(2008-8#1)(2011-1#1)
these procedures##64##2##(1990-6#1)(1991-4#1)(1991-6#1)(1991-8#2)(1992-8#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-2#2)(2006-10#6)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-2#1)(2009-3#1)(2009-5#2)(2009-9#1)(2010-8#2)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
these processes and their##2##4##(2010-10#1)(2011-2#1)
these processes and##4##3##(1990-11#1)(2010-10#1)(2010-12#1)(2011-2#1)
these processes are not##2##4##(2008-8#1)(2009-3#1)
these processes are##12##3##(1996-2#1)(2006-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-3#1)(2009-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
these processes at the molecular level##2##6##(2011-2#1)(2012-2#1)
these processes in##5##3##(1993-12#1)(1996-5#1)(2006-9#1)(2010-11#1)(2012-2#1)
these processes is the##2##4##(2006-10#1)(2011-1#1)
these processes is##9##3##(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
these processes might be##2##4##(2006-10#1)(2008-7#1)
these processes with##2##3##(2007-11#1)(2012-1#1)
these processes##106##2##(1990-11#1)(1990-12#1)(1990-4#1)(1992-1#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-8#1)(1995-12#2)(1995-8#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-5#1)(1997-6#2)(1997-8#1)(2004-4#1)(2005-5#1)(2005-8#1)(2006-10#5)(2006-3#2)(2006-5#1)(2006-9#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#5)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#3)(2009-12#2)(2009-3#2)(2009-5#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-6#2)(2011-1#3)(2011-2#4)(2012-1#4)(2012-12#2)(2012-2#4)(2013-1#6)
these product##2##2##(2008-5#1)(2009-7#1)
these products and##2##3##(2007-11#1)(2007-2#1)
these products are##6##3##(1994-8#1)(2006-12#1)(2007-11#1)(2011-12#1)(2012-2#1)(2013-1#1)
these products have##2##3##(2006-10#1)(2008-1#1)
these products to##3##3##(2008-10#1)(2008-6#1)(2012-12#1)
these products were##2##3##(1992-10#1)(2005-12#1)
these products##55##2##(1991-2#1)(1992-10#1)(1992-5#1)(1993-11#2)(1994-8#1)(1996-3#1)(1997-3#2)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#3)(2006-8#2)(2007-11#3)(2007-2#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-4#1)(2010-6#1)(2010-7#2)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)
these professionals##7##2##(1993-2#2)(2005-5#1)(2008-11#1)(2009-1#1)(2009-8#1)(2012-12#1)
these profiles were##2##3##(1996-8#1)(2012-11#1)
these profiles##8##2##(1993-3#1)(1996-8#1)(1997-8#1)(2008-10#1)(2008-3#2)(2008-7#1)(2012-11#1)
these programmes##6##2##(1991-7#1)(2005-5#1)(2008-11#1)(2008-12#1)(2010-12#1)(2012-1#1)
these programs are##3##3##(1991-4#1)(1994-2#1)(2013-1#1)
these programs at##2##3##(2009-4#1)(2013-1#1)
these programs have##3##3##(1990-12#1)(1996-12#1)(2008-9#1)
these programs is##2##3##(2008-7#1)(2008-8#1)
these programs to##2##3##(1995-1#1)(2012-2#1)
these programs##37##2##(1990-12#1)(1991-1#1)(1991-12#1)(1991-4#1)(1993-1#1)(1994-12#2)(1994-2#1)(1995-1#1)(1996-12#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-4#1)(2009-5#1)(2009-6#1)(2011-3#2)(2012-12#1)(2012-2#2)(2013-1#4)
these projections##3##2##(2006-3#1)(2008-7#1)(2009-8#1)
these projects##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
these promoters##6##2##(1994-2#1)(1995-2#1)(1997-4#2)(2006-12#1)(2008-5#1)
these properties are##7##3##(1991-5#1)(1992-8#1)(1994-8#1)(1996-2#1)(2007-12#1)(2008-10#1)(2012-2#1)
these properties in##2##3##(2008-11#1)(2008-7#1)
these properties on##2##3##(2008-5#1)(2008-7#1)
these properties was##2##3##(1996-2#1)(2008-7#1)
these properties were##2##3##(2007-4#1)(2011-2#1)
these properties##41##2##(1991-12#1)(1991-3#1)(1991-5#1)(1992-7#1)(1992-8#1)(1993-8#1)(1994-3#1)(1994-8#2)(1995-3#1)(1996-2#2)(1996-6#2)(2006-10#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#5)(2008-9#1)(2009-7#2)(2010-1#2)(2010-4#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
these proposals##2##2##(1994-11#1)(2005-8#1)
these prostheses##2##2##(1994-6#1)(2012-2#1)
these protease inhibitors##2##3##(1993-4#1)(2013-1#1)
these proteases##6##2##(1990-7#1)(1994-6#2)(1996-10#2)(2012-3#1)
these protective##3##2##(1993-12#1)(1994-6#1)(2013-1#1)
these protein##10##2##(1990-5#1)(1993-11#1)(1994-12#1)(2008-10#1)(2008-11#1)(2009-6#1)(2009-7#1)(2009-8#1)(2011-1#1)(2013-1#1)
these protein-protein interactions##2##3##(1990-10#1)(1995-1#1)
these proteins and##5##3##(1991-2#2)(1992-12#1)(2009-8#2)
these proteins are##16##3##(1990-4#1)(1992-8#1)(1993-2#1)(1994-11#1)(1994-5#2)(1994-6#1)(1997-5#1)(1997-6#1)(2007-10#1)(2008-7#1)(2008-9#1)(2009-8#2)(2011-2#1)(2012-3#1)
these proteins as the##2##4##(1990-7#2)
these proteins as##3##3##(1990-7#2)(2010-11#1)
these proteins during##3##3##(1993-5#1)(1996-3#1)(2012-12#1)
these proteins have##5##3##(1991-4#1)(1992-12#1)(1994-12#1)(1997-7#1)(2005-7#1)
these proteins in the##7##4##(1990-11#1)(1994-12#1)(1996-5#1)(2006-12#1)(2007-10#1)(2009-2#1)(2013-8#1)
these proteins in##26##3##(1990-11#1)(1991-4#1)(1993-6#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-8#3)(1996-5#1)(2006-12#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
these proteins is##7##3##(1992-8#1)(1993-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#1)(2012-2#1)
these proteins may be##3##4##(1991-6#1)(1995-5#1)(2011-2#1)
these proteins may have##2##4##(2008-1#1)(2008-7#1)
these proteins may##10##3##(1991-6#1)(1994-3#1)(1994-8#1)(1995-5#1)(1996-5#1)(2005-12#1)(2008-1#1)(2008-7#1)(2011-1#1)(2011-2#1)
these proteins showed##4##3##(1990-11#1)(1997-4#1)(2012-12#2)
these proteins was observed##2##4##(1990-9#1)(2009-10#1)
these proteins was##6##3##(1990-9#1)(1993-6#1)(1994-12#1)(1997-3#1)(1997-6#1)(2009-10#1)
these proteins were##12##3##(1990-6#1)(1991-12#1)(1991-3#1)(1992-12#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-5#1)(2006-8#1)(2013-8#2)
these proteins##189##2##(1990-1#1)(1990-10#1)(1990-11#3)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-12#4)(1991-2#3)(1991-3#1)(1991-4#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#4)(1992-4#1)(1992-5#2)(1992-7#1)(1992-8#3)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#2)(1993-6#4)(1993-8#2)(1993-9#1)(1994-10#2)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#4)(1994-5#4)(1994-6#1)(1994-8#2)(1994-9#6)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#5)(1995-3#2)(1995-5#3)(1995-6#1)(1995-8#3)(1995-9#1)(1996-12#1)(1996-3#2)(1996-5#5)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#3)(2005-11#1)(2005-12#1)(2005-7#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#3)(2009-2#1)(2009-5#4)(2009-8#4)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#2)(2011-1#2)(2011-2#4)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#6)
these protocols are##3##3##(2008-2#1)(2008-4#2)
these protocols can be used in##2##6##(2007-10#1)(2008-4#1)
these protocols can be used##3##5##(2007-10#1)(2008-4#2)
these protocols can be##4##4##(2007-10#1)(2008-4#3)
these protocols##17##2##(1994-3#1)(2005-11#1)(2007-10#1)(2008-1#1)(2008-2#2)(2008-4#8)(2008-9#3)
these protozoa##2##2##(2006-10#1)(2007-12#1)
these proved to be##3##4##(1991-8#1)(1995-3#1)(2007-8#1)
these providers##3##2##(1997-1#1)(1997-2#2)
these publications##4##2##(2006-10#1)(2008-1#1)(2010-8#1)(2011-2#1)
these pulmonary##2##2##(2007-8#1)(2008-6#1)
these pulses##3##2##(2007-12#2)(2008-3#1)
these purified##4##2##(1990-7#1)(1994-6#2)(2008-4#1)
these purposes##13##2##(1992-10#1)(1993-12#2)(2007-5#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-9#1)(2009-11#1)(2010-11#1)(2011-2#1)(2012-12#1)
these putative##7##2##(1990-7#1)(1993-3#1)(1995-2#1)(2007-11#1)(2008-10#2)(2008-11#1)
these quality##3##2##(2008-5#1)(2012-2#1)(2013-1#1)
these quantitative traits##2##3##(2008-10#1)(2008-12#1)
these quantitative##5##2##(1994-12#1)(1996-11#1)(2008-10#1)(2008-12#1)(2008-2#1)
these quantities##3##2##(1990-8#1)(2008-3#2)
these questions and##2##3##(2008-12#1)(2008-8#1)
these questions are##3##3##(1996-1#1)(2006-10#1)(2008-8#1)
these questions by##3##3##(2009-2#2)(2009-4#1)
these questions in a##2##4##(2005-7#1)(2013-8#1)
these questions is##2##3##(1991-11#1)(2005-10#1)
these questions will##2##3##(2012-3#1)(2013-7#1)
these questions##39##2##(1991-11#1)(1991-3#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-8#1)(2005-10#2)(2005-7#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-7#4)(2008-8#2)(2009-1#1)(2009-2#2)(2009-4#1)(2010-5#1)(2010-7#1)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
these radicals are##2##3##(1997-4#1)(2007-3#1)
these radicals##3##2##(1997-4#1)(2007-3#1)(2013-8#1)
these ranges##3##2##(1997-2#1)(2008-10#1)(2008-6#1)
these rapid##4##2##(1995-8#1)(2008-1#1)(2008-9#1)(2010-8#1)
these rare cases##2##3##(1992-6#1)(2007-8#1)
these rare variants##2##3##(2012-3#2)
these rare##15##2##(1992-6#1)(1993-11#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2009-10#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)
these rat##3##2##(1991-12#1)(1992-12#1)(1993-5#1)
these rates##10##2##(2007-12#1)(2007-2#2)(2007-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#2)(2012-12#1)
these rather##2##2##(2008-7#1)(2011-2#1)
these ratings##2##2##(1991-3#1)(1995-12#1)
these ratios##4##2##(1992-7#1)(1995-1#1)(2007-8#1)(2008-5#1)
these rats were##2##3##(1993-12#1)(1993-2#1)
these rats##8##2##(1991-6#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-11#1)(1994-8#1)(1996-4#1)(2008-4#1)
these reaction##2##2##(1996-5#1)(2008-11#1)
these reactions are##6##3##(1990-12#1)(1992-2#1)(1993-6#1)(2008-4#1)(2008-5#1)(2010-8#1)
these reactions can##2##3##(1992-2#1)(2008-10#1)
these reactions has##2##3##(1996-2#1)(2008-10#1)
these reactions in##3##3##(1996-12#1)(2008-10#2)
these reactions is##4##3##(1990-12#1)(1994-9#1)(2008-11#1)(2008-7#1)
these reactions may##2##3##(1990-3#1)(2008-3#1)
these reactions were##2##3##(1995-6#1)(2007-5#1)
these reactions##29##2##(1990-12#2)(1990-3#1)(1991-10#1)(1992-2#2)(1993-4#1)(1993-6#1)(1994-9#1)(1995-6#1)(1996-12#1)(1996-2#1)(2006-3#1)(2007-5#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-6#1)(2010-8#2)
these reagents were##2##3##(1990-12#1)(2007-8#1)
these reagents##12##2##(1990-10#1)(1990-12#1)(1992-11#1)(1995-5#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-9#1)(2012-2#1)
these reasons##32##2##(1991-2#1)(1993-9#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-8#3)(2009-12#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
these recent developments##2##3##(1991-11#1)(2010-7#1)
these recent findings##2##3##(2006-1#1)(2011-1#1)
these recent##8##2##(1991-11#1)(2006-1#1)(2006-10#1)(2007-6#1)(2008-2#1)(2008-3#1)(2010-7#1)(2011-1#1)
these receptor subtypes##2##3##(1990-3#1)(1995-3#1)
these receptor##5##2##(1990-3#1)(1991-8#1)(1995-3#1)(1996-2#1)(2006-10#1)
these receptors and are##2##4##(2008-1#1)(2009-12#1)
these receptors and signaling##2##4##(2008-5#1)(2009-8#1)
these receptors and##7##3##(1993-2#1)(1996-2#1)(2008-1#1)(2008-5#1)(2009-12#1)(2009-8#1)(2011-2#1)
these receptors are##7##3##(1993-2#1)(1994-11#1)(1995-7#1)(1996-10#1)(2008-4#1)(2008-7#1)(2012-1#1)
these receptors could be##2##4##(1997-5#1)(2008-7#1)
these receptors in the##2##4##(1993-6#1)(2008-10#1)
these receptors in##9##3##(1993-6#1)(1993-9#1)(1994-11#1)(1994-8#1)(1996-5#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-11#1)
these receptors is##2##3##(1996-12#1)(2008-4#1)
these receptors may##6##3##(1992-1#1)(1995-12#2)(1997-5#1)(2008-4#1)(2008-5#1)
these receptors was##2##3##(1995-12#1)(2008-10#1)
these receptors##81##2##(1990-3#1)(1991-12#2)(1991-5#2)(1991-6#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-2#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#5)(1995-3#1)(1995-5#2)(1995-7#1)(1996-1#1)(1996-10#2)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-5#2)(1997-6#1)(2005-10#1)(2006-10#2)(2006-3#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#10)(2008-5#3)(2008-7#3)(2008-8#2)(2009-12#2)(2009-3#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
these recombinant viruses##2##3##(2008-10#2)
these recombinant##8##2##(1990-10#1)(2005-11#1)(2006-8#1)(2007-11#1)(2008-10#2)(2012-3#2)
these recommendations should##2##3##(2008-1#1)(2008-12#1)
these recommendations##14##2##(1994-2#1)(1996-2#1)(2004-12#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#2)(2010-11#1)(2010-8#1)
these reconstructions##3##2##(1995-8#1)(2008-2#1)(2008-6#1)
these records##5##2##(1991-3#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-8#1)
these recurrent##2##2##(2008-3#1)(2009-9#1)
these reefs##6##2##(1991-6#1)(2007-3#2)(2007-5#2)(2008-5#1)
these reference materials##2##3##(2008-10#2)
these reference##4##2##(2008-10#3)(2008-2#1)
these reflexes##2##2##(1992-12#1)(1993-12#1)
these reforms##2##2##(1993-2#1)(2012-3#1)
these regional##2##2##(2007-12#1)(2008-12#1)
these regions are required##2##4##(1993-6#1)(2010-5#1)
these regions are##7##3##(1993-11#1)(1993-6#1)(1995-6#1)(2007-12#1)(2008-3#1)(2010-2#1)(2010-5#1)
these regions is##2##3##(1995-12#1)(2008-10#1)
these regions may##3##3##(1991-12#1)(1993-8#1)(2010-8#1)
these regions of the##2##4##(1992-11#1)(2008-10#1)
these regions of##4##3##(1992-11#1)(1994-10#1)(1994-8#1)(2008-10#1)
these regions to##2##3##(1991-8#1)(2008-2#1)
these regions##60##2##(1991-10#2)(1991-12#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-9#3)(1993-11#1)(1993-6#1)(1993-8#2)(1994-10#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#2)(1996-4#1)(1997-4#1)(1997-5#1)(1997-6#2)(2006-12#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-2#1)(2010-5#3)(2010-6#1)(2010-8#2)(2011-1#3)(2012-1#1)(2012-2#1)
these regulations##2##2##(1993-3#1)(1994-1#1)
these regulatory elements in##2##4##(1993-12#2)
these regulatory elements##3##3##(1992-7#1)(1993-12#2)
these regulatory##8##2##(1991-11#1)(1992-7#1)(1993-12#2)(1994-12#1)(1994-6#1)(2008-11#1)(2011-2#1)
these related##2##2##(1991-3#1)(2006-5#1)
these relations##4##2##(2008-3#3)(2009-12#1)
these relationships are##4##3##(2008-10#1)(2008-3#1)(2012-1#1)(2012-2#1)
these relationships differ##2##3##(1990-11#1)(2008-8#1)
these relationships over##2##3##(1993-12#1)(2006-10#1)
these relationships were not##2##4##(1991-9#1)(2009-4#1)
these relationships were##5##3##(1991-9#1)(1993-12#1)(2009-4#1)(2010-1#1)(2013-7#1)
these relationships##43##2##(1990-11#1)(1991-12#1)(1991-9#1)(1992-10#1)(1993-12#3)(1996-2#1)(2006-10#1)(2006-3#1)(2006-4#1)(2007-1#1)(2007-12#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#3)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
these repeats##8##2##(1992-1#1)(1992-10#1)(1992-3#1)(1993-9#2)(2007-6#1)(2008-10#1)(2008-7#1)
these repetitive elements in##2##4##(2008-4#1)(2008-7#1)
these reported##3##2##(2009-5#1)(2009-8#1)(2011-2#1)
these reports to##3##3##(1991-1#1)(2009-4#1)(2013-1#1)
these reports##17##2##(1991-1#1)(1991-3#1)(1994-3#1)(2005-7#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-11#1)(2009-11#1)(2009-4#1)(2010-3#1)(2010-6#1)(2011-2#3)(2013-1#1)(2013-8#1)
these represent##4##2##(1991-2#1)(2005-8#1)(2008-5#1)(2009-10#1)
these requirements are##2##3##(2008-3#1)(2008-5#1)
these requirements is##2##3##(2008-7#1)(2009-1#1)
these requirements##23##2##(1991-12#1)(1992-12#1)(2005-11#2)(2006-11#1)(2007-11#1)(2007-5#1)(2007-6#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#1)(2009-1#1)(2013-1#3)(2013-7#1)
these research##5##2##(2008-10#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-3#1)
these residues are##6##3##(1990-7#1)(1994-3#1)(1995-5#1)(1996-9#2)(1997-2#1)
these residues by##2##3##(1996-5#1)(1996-9#1)
these residues in the##6##4##(1990-5#1)(1992-9#1)(1993-8#1)(1994-11#1)(1995-5#1)(1996-5#1)
these residues in##7##3##(1990-5#1)(1992-9#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-5#1)(1996-5#1)
these residues to##3##3##(1993-4#1)(1996-11#1)(1997-2#1)
these residues##41##2##(1990-10#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-4#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-11#2)(1995-12#1)(1995-5#3)(1996-11#1)(1996-5#4)(1996-8#2)(1996-9#3)(1997-2#2)(1997-3#1)(2008-4#1)(2012-12#1)
these resistance##2##2##(2008-10#2)
these resistances##2##2##(2004-12#1)(2008-10#1)
these resistant##5##2##(1995-11#1)(1997-4#1)(2008-10#2)(2011-12#1)
these resonances##4##2##(2007-11#2)(2007-8#1)(2008-3#1)
these resources##9##2##(1992-5#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#1)(2013-7#1)
these respective##3##2##(1990-6#1)(2006-9#1)(2008-10#1)
these respiratory##2##2##(2006-10#1)(2008-7#1)
these response##3##2##(1997-5#1)(2008-11#1)(2010-2#1)
these responses and##2##3##(1991-8#1)(2008-7#1)
these responses can##2##3##(1994-9#1)(1995-11#1)
these responses to##2##3##(1992-10#1)(1992-11#1)
these responses##33##2##(1990-5#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-3#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#3)(2007-12#1)(2007-4#1)(2008-10#4)(2008-4#4)(2008-7#3)(2008-9#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-11#1)
these results also##2##3##(1996-12#1)(2009-9#1)
these results and the##5##4##(1990-2#1)(1990-9#1)(1992-6#1)(2008-10#1)(2008-2#1)
these results and those##2##4##(2007-11#1)(2008-2#1)
these results and##15##3##(1990-2#1)(1990-9#1)(1992-6#2)(1993-8#1)(1995-3#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#2)(2009-8#1)
these results are consistent with previous##2##6##(1992-9#1)(2008-10#1)
these results are consistent with##6##5##(1990-3#1)(1991-12#1)(1992-9#2)(1995-10#1)(2008-10#1)
these results are described##2##4##(2008-2#1)(2008-4#1)
these results are discussed in##2##5##(1992-9#1)(2013-7#1)
these results are discussed##10##4##(1991-12#1)(1992-9#1)(1994-2#1)(1994-9#1)(2004-2#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-7#1)
these results are in agreement with##2##6##(1991-11#1)(1996-9#1)
these results are in##3##4##(1991-11#1)(1996-9#1)(1997-6#1)
these results are the first##2##5##(2007-12#1)(2010-11#1)
these results are##28##3##(1990-3#1)(1991-11#1)(1991-12#2)(1991-5#1)(1992-9#3)(1994-2#1)(1994-9#1)(1995-10#1)(1996-9#1)(1997-6#1)(2004-2#1)(2006-7#1)(2006-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#2)(2008-9#1)(2010-11#1)(2012-1#1)(2013-7#1)
these results by##3##3##(1994-9#1)(2008-2#1)(2010-2#1)
these results confirm##3##3##(1994-10#2)(2008-10#1)
these results confirmed that##2##4##(2008-12#1)(2008-5#1)
these results could be##2##4##(1990-7#1)(2012-12#1)
these results could##3##3##(1990-7#1)(2011-2#1)(2012-12#1)
these results demonstrate that a##2##5##(1994-9#1)(2007-11#1)
these results demonstrate that exposure to##2##6##(2008-10#2)
these results demonstrate that the##3##5##(1991-4#1)(1994-3#1)(1995-12#1)
these results demonstrate that##10##4##(1991-4#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-12#1)(2007-11#1)(2008-10#2)(2009-10#1)
these results demonstrate the presence##2##5##(1993-6#1)(1995-5#1)
these results demonstrate the##5##4##(1993-6#1)(1995-5#1)(2007-11#1)(2008-11#1)(2009-2#1)
these results demonstrate##20##3##(1991-4#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-12#1)(1995-5#1)(1996-9#1)(2007-11#2)(2008-10#2)(2008-11#2)(2008-5#2)(2008-7#1)(2009-10#1)(2009-2#1)
these results demonstrated that##2##4##(2011-2#1)(2013-1#1)
these results establish##2##3##(1992-11#1)(2009-6#1)
these results have been##2##4##(2006-5#1)(2007-9#1)
these results have##5##3##(2006-10#1)(2006-5#1)(2007-9#1)(2010-4#1)(2013-8#1)
these results highlight the##2##4##(2010-8#1)(2011-2#1)
these results illustrate##2##3##(2007-8#1)(2008-10#1)
these results implicate##3##3##(1993-11#1)(1993-12#1)(2009-4#1)
these results imply that the##2##5##(1990-10#1)(2009-8#1)
these results imply that##3##4##(1990-10#1)(2008-4#1)(2009-8#1)
these results in other populations##2##5##(2012-2#1)(2013-1#1)
these results in the##3##4##(2008-10#1)(2008-7#1)(2008-8#1)
these results in##10##3##(2006-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#2)
these results indicate a##2##4##(2006-12#1)(2008-3#1)
these results indicate that the major##2##6##(1991-8#1)(1995-5#1)
these results indicate that the##10##5##(1991-6#1)(1991-8#1)(1992-12#1)(1994-8#1)(1995-5#1)(1997-7#1)(2008-10#3)(2013-1#1)
these results indicate that##41##4##(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-12#1)(1993-11#2)(1993-12#1)(1993-6#1)(1993-9#1)(1994-6#1)(1994-8#2)(1995-2#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-5#1)(1997-7#1)(2006-7#1)(2008-10#6)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
these results indicate the##2##4##(2008-10#1)(2012-1#1)
these results indicate##49##3##(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-12#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-6#2)(1993-9#1)(1994-6#1)(1994-8#2)(1995-2#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-5#1)(1997-7#1)(2006-12#1)(2006-7#1)(2007-8#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
these results is that##3##4##(2005-11#1)(2006-9#1)(2007-6#1)
these results is##9##3##(1993-8#1)(1995-2#1)(2005-11#1)(2006-9#1)(2007-12#1)(2007-6#1)(2008-3#1)(2010-3#1)(2011-2#1)
these results may##5##3##(1991-5#1)(2006-8#1)(2007-2#1)(2008-7#1)(2012-2#1)
these results need to be##3##5##(2007-9#1)(2009-7#1)(2010-8#1)
these results need##4##3##(2007-9#1)(2008-1#1)(2009-7#1)(2010-8#1)
these results point##2##3##(1992-5#1)(2005-11#1)
these results provide a better##2##5##(1997-2#1)(2008-7#1)
these results provide direct evidence that##2##6##(1993-12#1)(1994-8#1)
these results provide evidence that##2##5##(1993-9#1)(2008-8#1)
these results provide##17##3##(1991-2#1)(1991-7#1)(1992-3#2)(1993-12#1)(1993-9#1)(1994-8#1)(1995-7#1)(1997-2#1)(1997-8#1)(2006-4#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-6#1)(2010-8#2)
these results represent the first demonstration##2##6##(2007-12#1)(2008-8#1)
these results reveal##2##3##(1992-5#1)(1992-8#1)
these results show that the##2##5##(2008-4#1)(2008-5#1)
these results show that##10##4##(1991-4#1)(1993-8#1)(1994-9#1)(2008-4#3)(2008-5#1)(2008-7#1)(2009-7#1)(2012-2#1)
these results show##11##3##(1991-4#1)(1993-8#1)(1994-9#1)(2007-12#1)(2008-4#3)(2008-5#1)(2008-7#1)(2009-7#1)(2012-2#1)
these results strongly suggest that the##2##6##(1995-6#1)(1997-6#1)
these results strongly suggest that##3##5##(1995-6#1)(1996-12#1)(1997-6#1)
these results strongly suggest##4##4##(1995-6#1)(1996-12#1)(1997-6#1)(2010-11#1)
these results strongly##6##3##(1990-5#1)(1995-6#1)(1996-12#1)(1997-6#1)(2010-11#1)(2013-1#1)
these results suggest a##3##4##(1993-11#1)(2006-7#1)(2012-2#1)
these results suggest an##3##4##(1993-6#1)(1995-1#1)(2008-3#1)
these results suggest that TGF-beta##2##5##(1995-3#1)(1995-6#1)
these results suggest that a##3##5##(1993-6#1)(1996-3#1)(2009-10#1)
these results suggest that caffeine abstinence may be beneficial for patients with type 2 diabetes##2##15##(2012-12#2)
these results suggest that the##14##5##(1990-12#1)(1991-1#1)(1993-6#1)(1994-12#1)(1996-2#1)(1997-5#1)(1997-7#1)(2007-10#1)(2007-3#1)(2008-11#1)(2008-5#1)(2009-8#1)(2010-2#1)(2012-3#1)
these results suggest that##74##4##(1990-12#3)(1990-2#2)(1990-4#1)(1991-1#1)(1991-12#1)(1993-11#2)(1993-12#1)(1993-6#2)(1993-9#1)(1994-12#2)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#3)(2003-11#1)(2005-9#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-11#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-8#1)(2009-9#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
these results suggest the presence of##2##6##(1993-11#1)(2010-2#1)
these results suggest the##4##4##(1990-12#1)(1993-11#1)(1994-5#1)(2010-2#1)
these results suggest##87##3##(1990-12#4)(1990-2#2)(1990-4#1)(1991-1#1)(1991-12#1)(1992-3#1)(1993-11#4)(1993-12#1)(1993-6#3)(1993-9#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#3)(2003-11#1)(2005-9#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-2#2)(2010-5#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
these results suggested that the##2##5##(1994-12#1)(2007-2#1)
these results suggested that##5##4##(1994-12#1)(1996-5#1)(2007-2#1)(2008-9#1)(2011-1#1)
these results support a model##2##5##(1994-9#2)
these results support a##3##4##(1994-9#2)(2009-8#1)
these results support the feasibility of conducting automated illustration##2##9##(2013-1#2)
these results support the hypothesis that##3##6##(1992-2#1)(1992-8#1)(2009-8#1)
these results support the##8##4##(1990-11#1)(1990-8#1)(1992-2#1)(1992-8#1)(1995-12#1)(2009-8#1)(2013-1#2)
these results support##12##3##(1990-11#1)(1990-8#1)(1992-2#1)(1992-8#1)(1994-10#1)(1994-9#2)(1995-12#1)(2009-8#2)(2013-1#2)
these results the##6##3##(1996-3#1)(1997-8#1)(2008-12#1)(2008-3#1)(2008-5#2)
these results to a##2##4##(1990-5#1)(2008-9#1)
these results to the##4##4##(1991-12#1)(2007-11#1)(2008-3#2)
these results to##18##3##(1990-5#1)(1990-7#1)(1991-12#1)(1994-3#1)(1995-10#1)(1995-3#1)(2007-11#2)(2007-4#1)(2008-10#2)(2008-11#1)(2008-3#4)(2008-9#1)(2013-7#1)
these results was##2##3##(2010-1#1)(2012-12#1)
these results we are##2##4##(2008-10#1)(2010-9#1)
these results we conclude that the##2##6##(1995-4#1)(2008-10#1)
these results we conclude that##5##5##(1991-9#1)(1995-4#1)(1995-6#1)(1996-7#1)(2008-10#1)
these results we propose##2##4##(1991-10#1)(1992-6#1)
these results we##12##3##(1991-10#1)(1991-9#1)(1992-6#1)(1995-4#2)(1995-6#1)(1996-7#1)(2008-10#2)(2008-5#1)(2010-9#1)(2013-1#1)
these results were not##2##4##(2008-11#1)(2010-8#1)
these results were##10##3##(1991-12#1)(1992-3#1)(1997-4#1)(2005-10#1)(2007-12#1)(2008-11#2)(2008-8#1)(2010-8#1)(2012-12#1)
these results will##2##3##(2008-10#1)(2012-3#1)
these results with a##3##4##(1993-2#1)(1993-8#1)(2006-10#1)
these results with those##2##4##(1995-2#1)(2006-8#1)
these results with##14##3##(1993-12#1)(1993-2#1)(1993-8#1)(1995-2#1)(1996-8#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-1#1)
these results##615##2##(1990-10#1)(1990-11#1)(1990-12#6)(1990-2#4)(1990-3#3)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#3)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#6)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#9)(1992-5#2)(1992-6#4)(1992-7#1)(1992-8#4)(1992-9#3)(1993-1#1)(1993-11#9)(1993-12#7)(1993-2#2)(1993-3#2)(1993-4#1)(1993-6#6)(1993-8#6)(1993-9#4)(1994-1#2)(1994-10#3)(1994-11#1)(1994-12#5)(1994-2#5)(1994-3#2)(1994-5#3)(1994-6#2)(1994-7#2)(1994-8#7)(1994-9#11)(1995-1#2)(1995-10#3)(1995-12#3)(1995-2#5)(1995-3#6)(1995-4#4)(1995-5#3)(1995-6#4)(1995-7#2)(1995-8#3)(1996-1#1)(1996-10#1)(1996-12#4)(1996-2#3)(1996-3#3)(1996-5#6)(1996-7#1)(1996-8#4)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#6)(1997-8#4)(2003-11#2)(2004-2#1)(2004-9#1)(2005-10#2)(2005-11#3)(2005-8#2)(2005-9#1)(2006-1#2)(2006-10#7)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#2)(2006-7#4)(2006-8#4)(2006-9#3)(2007-10#2)(2007-11#7)(2007-12#14)(2007-2#4)(2007-3#1)(2007-4#2)(2007-6#2)(2007-7#1)(2007-8#6)(2007-9#2)(2008-1#2)(2008-10#57)(2008-11#16)(2008-12#4)(2008-2#11)(2008-3#15)(2008-4#8)(2008-5#20)(2008-6#3)(2008-7#10)(2008-8#10)(2008-9#8)(2009-10#5)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#3)(2009-8#5)(2009-9#3)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#7)(2010-9#1)(2011-1#3)(2011-2#12)(2012-1#2)(2012-12#10)(2012-2#10)(2012-3#5)(2012-9#1)(2013-1#14)(2013-7#3)(2013-8#6)
these rice##4##2##(1996-8#1)(2008-10#1)(2009-10#1)(2012-1#1)
these rights and##2##3##(2005-7#1)(2012-3#1)
these rights##3##2##(2005-7#2)(2012-3#1)
these risk factors are##2##4##(2009-4#1)(2011-1#1)
these risk factors##16##3##(2005-10#1)(2005-11#1)(2005-8#1)(2007-10#1)(2008-1#2)(2008-4#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-6#1)(2011-1#3)(2011-2#1)
these risk##17##2##(2005-10#1)(2005-11#1)(2005-8#1)(2007-10#1)(2008-1#2)(2008-4#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-6#1)(2011-1#3)(2011-2#1)(2012-2#1)
these risks may be##2##4##(2008-11#1)(2008-7#1)
these risks##8##2##(1993-3#1)(1993-9#1)(2008-11#1)(2008-3#2)(2008-7#2)(2010-3#1)
these roles##12##2##(1994-1#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-7#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
these roots##2##2##(2008-10#1)(2009-8#1)
these round cells##2##3##(1996-5#2)
these routes of##2##3##(2008-5#1)(2012-12#1)
these routes##4##2##(2008-5#1)(2009-11#1)(2011-2#1)(2012-12#1)
these routine##2##2##(2008-9#1)(2010-8#1)
these rules##4##2##(1991-11#1)(1993-12#1)(1993-3#1)(2006-10#1)
these rural##2##2##(2007-2#1)(2013-1#1)
these same cells##2##3##(1994-12#1)(1996-5#1)
these same conditions##2##3##(1994-3#1)(2008-11#1)
these same##48##2##(1990-5#1)(1991-4#1)(1991-5#1)(1992-12#1)(1992-2#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-3#2)(1995-7#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-2#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#2)(2009-5#1)(2009-9#1)
these sample sizes and##2##4##(1992-2#1)(1993-1#1)
these sample##3##2##(1992-2#1)(1993-1#1)(2007-8#1)
these samples by##2##3##(2008-10#2)
these samples is##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
these samples was##8##3##(1990-1#1)(2008-10#5)(2008-7#1)(2011-1#1)
these samples were##5##3##(2007-1#1)(2007-8#1)(2008-10#3)
these samples with##2##3##(2008-10#1)(2008-5#1)
these samples##49##2##(1990-1#1)(1991-12#1)(1991-6#1)(1991-7#1)(1994-11#1)(1994-8#1)(1995-1#1)(1996-3#1)(2007-1#1)(2007-7#1)(2007-8#2)(2008-10#21)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-4#2)(2011-1#2)(2012-3#1)(2013-1#1)(2013-8#3)
these sampling##2##2##(2007-2#1)(2008-10#1)
these sarcomas##2##2##(1994-6#1)(2008-6#1)
these scales##2##2##(2008-11#1)(2008-2#1)
these scans##3##2##(2008-10#2)(2008-3#1)
these scenarios##3##2##(2007-7#1)(2008-2#1)(2008-5#1)
these scientists##2##2##(2006-7#1)(2008-9#1)
these screening##3##2##(2005-7#1)(2007-2#1)(2007-4#1)
these screens##2##2##(2007-12#1)(2008-7#1)
these seaweeds##3##2##(2008-11#3)
these second##2##2##(1993-5#1)(1996-7#1)
these second-generation##4##2##(1991-12#1)(2006-2#1)(2009-3#1)(2012-12#1)
these secreted##2##2##(1994-6#1)(2011-1#1)
these seem to##2##3##(2007-11#1)(2008-5#1)
these seemingly##3##2##(1993-12#1)(1996-11#1)(2008-11#1)
these segments##4##2##(2006-12#1)(2012-12#3)
these selected patients##2##3##(2007-12#1)(2013-8#1)
these selected##3##2##(2007-12#1)(2008-10#1)(2013-8#1)
these selection##4##2##(1996-4#1)(2008-11#1)(2012-12#1)(2013-8#1)
these selective##2##2##(2010-8#1)(2013-7#1)
these sensilla##3##2##(2008-8#1)(2010-11#2)
these sensitive##4##2##(1992-8#1)(1994-11#1)(2006-10#1)(2008-4#1)
these sensors##11##2##(2007-8#1)(2008-10#7)(2008-7#1)(2010-4#1)(2012-1#1)
these sensory##4##2##(1994-10#1)(1994-5#1)(1995-12#1)(2007-12#1)
these sequence##3##2##(1994-11#1)(1995-3#1)(2008-8#1)
these sequences are##4##3##(1991-3#1)(1996-12#1)(2008-7#1)(2008-9#1)
these sequences can be##2##4##(1990-5#1)(1991-1#1)
these sequences can##4##3##(1990-5#1)(1991-1#2)(1997-4#1)
these sequences to##4##3##(1991-1#1)(1991-12#1)(2008-10#2)
these sequences were##4##3##(1994-9#1)(2008-10#1)(2008-7#1)(2010-10#1)
these sequences##37##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-1#3)(1991-12#1)(1991-3#2)(1991-7#2)(1993-6#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-4#1)(1996-12#2)(1996-4#2)(1997-4#1)(1997-5#1)(2008-10#6)(2008-7#3)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#1)(2012-2#1)
these sera##5##2##(1991-9#1)(1992-12#1)(1995-2#1)(1996-4#1)(2007-12#1)
these series##2##2##(2005-7#1)(2005-8#1)
these serum##2##2##(2006-4#1)(2008-5#1)
these services and##2##3##(2007-8#1)(2008-9#1)
these services are##2##3##(1991-12#1)(1992-12#1)
these services as##2##3##(2005-5#1)(2012-3#1)
these services in##3##3##(1994-1#2)(1997-1#1)
these services##36##2##(1990-12#1)(1991-12#2)(1992-12#1)(1992-3#1)(1993-2#1)(1994-1#3)(1995-2#2)(1997-1#1)(1997-8#1)(2005-5#1)(2006-8#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-2#2)(2008-9#1)(2010-3#1)(2010-8#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
these sets##3##2##(1992-12#1)(2008-3#1)(2010-9#1)
these settings##14##2##(1991-1#1)(1996-12#1)(1996-2#1)(2005-8#1)(2006-10#2)(2007-1#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-8#1)(2012-2#1)
these seven##12##2##(1991-12#1)(2005-9#1)(2006-9#1)(2007-10#1)(2007-8#1)(2008-10#5)(2008-5#1)(2009-5#1)
these severe##2##2##(2007-10#1)(2007-11#1)
these sex differences##2##3##(1997-3#1)(2012-11#1)
these sex##3##2##(1997-3#1)(2008-10#1)(2012-11#1)
these sexual##3##2##(1995-6#1)(2008-1#1)(2008-5#1)
these shifts##2##2##(1990-10#1)(1996-5#1)
these short-term##2##2##(1995-11#1)(2008-10#1)
these shortcomings##5##2##(2007-12#2)(2008-10#1)(2008-3#1)(2012-12#1)
these should be##2##3##(2009-4#1)(2010-1#1)
these should##3##2##(2005-8#1)(2009-4#1)(2010-1#1)
these show##3##2##(1994-9#1)(2008-3#1)(2010-8#1)
these showed##4##2##(1993-5#1)(2007-7#1)(2012-12#1)(2013-8#1)
these side chains##2##3##(1992-9#1)(1994-3#1)
these side effects##4##3##(1991-6#1)(2004-3#1)(2007-7#1)(2011-2#1)
these side##6##2##(1991-6#1)(1992-9#1)(1994-3#1)(2004-3#1)(2007-7#1)(2011-2#1)
these signal##2##2##(2008-9#1)(2011-3#1)
these signaling pathways are##2##4##(2006-10#1)(2008-4#1)
these signaling pathways##3##3##(2006-10#1)(2008-4#1)(2008-9#1)
these signaling##7##2##(2006-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-4#1)(2009-9#1)(2013-8#1)
these signalling##2##2##(1996-2#1)(2009-3#1)
these signals are##3##3##(1996-1#1)(2008-2#1)(2010-8#1)
these signals##26##2##(1991-7#1)(1994-12#1)(1994-9#1)(1995-12#1)(1996-1#1)(2006-9#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-1#1)(2012-3#1)
these signatures##3##2##(2009-6#1)(2011-12#1)(2013-1#1)
these significant##3##2##(1991-3#1)(2008-3#1)(2010-4#1)
these signs are##3##3##(1990-5#1)(1993-2#1)(2007-7#1)
these signs##7##2##(1990-5#1)(1993-2#1)(2006-12#2)(2007-7#1)(2008-1#1)(2010-8#1)
these similarities##2##2##(1992-11#1)(2008-7#1)
these simple##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
these simulations with##2##3##(1993-11#1)(2008-2#1)
these simulations##9##2##(1993-11#2)(2006-2#1)(2006-5#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-3#1)
these sites and##3##3##(1991-1#1)(1991-7#1)(2012-12#1)
these sites are##6##3##(1994-12#1)(1994-8#1)(1994-9#1)(1996-7#1)(2004-12#1)(2007-7#1)
these sites for##3##3##(1990-5#1)(1990-7#1)(1996-3#1)
these sites in##3##3##(1991-7#1)(1996-4#1)(1997-5#1)
these sites is##4##3##(1990-5#1)(1991-3#1)(1992-12#1)(1993-6#1)
these sites were##4##3##(1991-12#1)(1993-3#1)(1994-9#1)(1997-8#1)
these sites##65##2##(1990-3#2)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-7#2)(1992-12#1)(1992-3#2)(1992-6#2)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-8#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-5#3)(1997-7#1)(1997-8#3)(2004-12#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#2)(2012-12#1)(2012-2#3)(2013-7#1)
these situations##6##2##(1992-6#1)(1994-6#1)(2006-2#1)(2010-4#1)(2011-1#1)(2012-3#1)
these six##12##2##(1990-5#2)(1991-11#1)(1991-3#1)(1993-12#1)(1994-6#1)(1996-6#1)(1996-8#1)(2006-8#1)(2008-12#1)(2010-4#1)(2011-3#1)
these skills##2##2##(2008-9#1)(2009-4#1)
these sleep##3##2##(2004-11#1)(2008-7#1)(2008-8#1)
these slides##2##2##(2008-11#1)(2008-5#1)
these small##8##2##(1992-11#1)(1996-10#1)(1996-8#1)(2007-8#1)(2008-2#1)(2008-5#1)(2010-8#1)(2013-8#1)
these smaller##2##2##(1990-8#1)(2006-4#1)
these social##2##2##(1992-3#1)(1993-3#1)
these socially##2##2##(2007-5#1)(2012-12#1)
these societies##3##2##(1992-1#1)(2008-10#1)(2009-12#1)
these soft##2##2##(2008-12#1)(2010-2#1)
these soils##6##2##(1992-3#1)(2006-3#2)(2008-10#2)(2013-7#1)
these soluble##2##2##(1995-2#1)(2008-4#1)
these solutions are##3##3##(2008-2#1)(2008-3#1)(2008-8#1)
these solutions##12##2##(1996-9#1)(1997-4#1)(2008-10#4)(2008-12#1)(2008-2#3)(2008-3#1)(2008-8#1)
these solvents can be##2##4##(2008-10#2)
these solvents##10##2##(1995-2#1)(2006-10#2)(2008-10#6)(2008-3#1)
these sorbents##2##2##(1996-8#2)
these sources are used##2##4##(1995-12#1)(2008-10#1)
these sources of##2##3##(1992-6#1)(2008-1#1)
these sources##12##2##(1992-6#1)(1995-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-2#1)(2010-9#1)(2011-2#1)(2012-2#1)
these spatial##2##2##(2007-9#1)(2013-7#1)
these special##3##2##(2008-12#1)(2008-2#1)(2012-2#1)
these specializations##2##2##(1996-4#1)(2007-12#1)
these specialized##2##2##(1997-6#1)(2008-1#1)
these species and##7##3##(2006-10#1)(2008-10#3)(2008-5#2)(2010-12#1)
these species are##13##3##(2004-4#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-5#1)(2011-2#1)
these species as##3##3##(2004-4#1)(2008-10#1)(2011-12#1)
these species have##2##3##(2006-8#1)(2008-10#1)
these species in the##4##4##(1997-5#1)(2008-10#1)(2008-5#2)
these species in##6##3##(1997-5#1)(2008-10#2)(2008-5#2)(2010-8#1)
these species is##5##3##(1997-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-8#1)
these species show##2##3##(2008-10#1)(2011-2#1)
these species using##2##3##(1997-1#1)(2008-10#1)
these species were##2##3##(1996-5#1)(2011-2#1)
these species##97##2##(1991-8#1)(1991-9#2)(1993-12#1)(1993-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-5#1)(1996-6#2)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#2)(2004-11#1)(2004-4#2)(2006-10#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-12#4)(2007-3#5)(2007-5#1)(2008-10#22)(2008-11#3)(2008-5#8)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#3)(2009-2#1)(2009-5#1)(2010-12#1)(2010-3#3)(2010-8#3)(2011-12#1)(2011-2#4)(2012-2#1)(2013-1#1)
these specific##20##2##(1990-11#1)(1990-12#1)(1993-3#1)(1994-2#2)(1994-3#1)(1994-6#1)(1996-5#1)(1996-6#1)(2005-10#1)(2006-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#3)(2009-5#1)(2010-8#1)(2012-12#1)
these specimens##5##2##(1994-12#1)(1997-1#1)(2006-10#1)(2007-2#1)(2012-2#1)
these spectra##5##2##(1995-3#1)(2008-10#2)(2008-2#1)(2010-2#1)
these spectral##4##2##(1994-6#1)(1995-5#1)(2008-3#1)(2010-11#1)
these spontaneous##2##2##(1994-11#1)(2012-2#1)
these stages##8##2##(1992-1#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2011-3#1)(2013-8#1)
these standard##2##2##(2008-12#1)(2010-12#1)
these standards and##3##3##(2007-12#1)(2008-1#1)(2013-1#1)
these standards##7##2##(1993-12#1)(2007-12#1)(2008-1#1)(2008-2#1)(2011-2#1)(2013-1#2)
these states##10##2##(1991-6#1)(1991-8#1)(1996-11#1)(2006-11#1)(2007-11#1)(2007-9#1)(2008-2#1)(2008-8#1)(2012-1#1)(2012-2#1)
these statistical results##2##3##(1996-12#1)(2008-7#1)
these statistical##5##2##(1996-12#1)(2007-12#1)(2008-7#1)(2009-5#1)(2012-2#1)
these statistics##5##2##(1995-3#1)(1997-1#1)(2006-7#1)(2008-10#1)(2008-2#1)
these steps and##2##3##(2008-4#1)(2008-9#1)
these steps are##2##3##(1994-8#1)(2008-3#1)
these steps##10##2##(1992-6#1)(1994-12#1)(1994-8#1)(2007-10#1)(2007-4#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-2#1)
these steroids##11##2##(1990-11#1)(1990-2#2)(1991-6#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#2)(2008-9#1)(2012-3#1)
these sterols##2##2##(1997-2#1)(2008-10#1)
these stimulatory effects##3##3##(1990-2#2)(1995-3#1)
these stimuli are##2##3##(1992-10#1)(1995-12#1)
these stimuli##10##2##(1990-12#1)(1991-7#1)(1992-10#1)(1992-9#1)(1995-12#1)(1996-1#1)(1996-8#1)(2008-10#1)(2010-2#1)(2012-7#1)
these stores##2##2##(1997-7#1)(2008-7#1)
these strains are##4##3##(1993-9#1)(2008-10#1)(2008-8#1)(2012-3#1)
these strains has been##2##4##(2005-11#1)(2008-10#1)
these strains of##2##3##(2007-11#1)(2008-4#1)
these strains was##7##3##(1993-3#1)(1996-9#1)(2006-11#1)(2008-10#3)(2008-4#1)
these strains were##7##3##(1993-5#1)(1996-5#1)(2008-10#3)(2008-5#2)
these strains##53##2##(1990-3#1)(1993-12#1)(1993-3#1)(1993-5#2)(1993-9#1)(1994-2#1)(1994-5#1)(1995-8#1)(1996-5#1)(1996-9#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-9#1)(2007-11#1)(2008-10#17)(2008-4#5)(2008-5#3)(2008-8#2)(2009-6#1)(2010-9#1)(2012-3#3)(2013-8#3)
these strategies are discussed##2##4##(1995-8#1)(2008-5#1)
these strategies are##3##3##(1995-8#1)(2008-11#1)(2008-5#1)
these strategies will##2##3##(2007-11#1)(2011-3#1)
these strategies##27##2##(1991-6#1)(1992-2#1)(1995-8#1)(1996-2#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-2#1)(2010-7#1)(2011-1#4)(2011-2#1)(2011-3#1)(2012-12#2)(2012-3#1)(2013-8#1)
these stress##2##2##(1996-9#1)(2009-5#1)
these stresses##3##2##(2006-11#1)(2008-7#1)(2008-8#1)
these structural and functional##2##4##(1995-6#1)(2008-1#1)
these structural features##2##3##(1991-10#1)(1996-12#1)
these structural##8##2##(1991-10#1)(1992-8#1)(1995-6#1)(1996-12#1)(2006-11#1)(2008-1#1)(2010-2#2)
these structures and##3##3##(1993-2#1)(2007-8#1)(2008-1#1)
these structures are##3##3##(2007-11#1)(2007-12#1)(2008-7#1)
these structures as##2##3##(1993-7#1)(2007-12#1)
these structures can##2##3##(2007-12#1)(2009-5#1)
these structures in##6##3##(1993-5#1)(1993-7#1)(2006-8#1)(2009-12#1)(2011-2#1)(2012-2#1)
these structures may be##2##4##(1992-1#1)(2007-4#1)
these structures may##4##3##(1991-1#1)(1992-1#1)(1992-12#1)(2007-4#1)
these structures was##2##3##(1996-6#1)(2009-2#1)
these structures##53##2##(1990-12#1)(1990-2#1)(1991-1#2)(1991-11#2)(1991-2#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-7#2)(1994-9#1)(1996-6#1)(1997-4#1)(1997-5#1)(2005-11#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-12#6)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-2#2)(2009-5#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-2#2)(2013-7#1)(2013-8#1)
these students##11##2##(1993-3#1)(2008-10#1)(2008-11#4)(2008-8#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
these studies a##2##3##(2008-10#1)(2011-2#1)
these studies also##3##3##(1995-10#1)(2005-7#1)(2011-1#1)
these studies and##6##3##(2005-7#1)(2006-10#1)(2008-10#2)(2008-11#1)(2011-1#1)
these studies are consistent with the##2##6##(1997-1#1)(2007-8#1)
these studies are presented##2##4##(2006-9#1)(2008-3#1)
these studies are##18##3##(1991-9#1)(1993-4#1)(1994-11#1)(1995-4#1)(1997-1#1)(2006-9#1)(2007-5#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
these studies can be used##2##5##(2008-10#1)(2011-2#1)
these studies demonstrate that##5##4##(1995-2#1)(1997-6#1)(2007-11#1)(2008-10#2)
these studies demonstrate##6##3##(1995-2#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-7#1)
these studies demonstrated that##3##4##(1991-3#1)(1997-4#1)(2013-8#1)
these studies demonstrated##4##3##(1991-3#1)(1997-4#1)(2008-10#1)(2013-8#1)
these studies did not##2##4##(2005-7#1)(2009-2#1)
these studies failed to##2##4##(1990-11#1)(2009-11#1)
these studies have been##4##4##(2008-5#1)(2008-7#1)(2010-6#1)(2011-1#1)
these studies have provided##2##4##(2010-9#1)(2012-2#1)
these studies have##16##3##(1991-2#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-6#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
these studies in##7##3##(1995-3#1)(1995-9#1)(2006-10#1)(2006-12#1)(2006-9#1)(2008-9#1)(2010-12#1)
these studies indicate that##6##4##(1991-9#1)(1997-8#1)(2005-7#1)(2006-12#1)(2008-10#1)(2008-4#1)
these studies indicate##7##3##(1991-9#1)(1997-8#1)(2005-7#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-4#1)
these studies indicated that##2##4##(1992-7#1)(2008-9#1)
these studies is that##3##4##(1990-7#1)(1997-2#1)(2008-7#1)
these studies is##8##3##(1990-7#1)(1997-2#1)(2005-11#1)(2005-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#1)
these studies provide##7##3##(1991-9#1)(1992-11#1)(2008-10#1)(2008-5#2)(2010-11#1)(2010-4#1)
these studies revealed##3##3##(2008-10#1)(2008-7#1)(2013-8#1)
these studies show##2##3##(1992-3#1)(1996-10#1)
these studies showed##2##3##(1995-9#1)(2011-2#1)
these studies suggest that##11##4##(1990-2#1)(1992-3#1)(1993-3#1)(1994-3#1)(2007-11#1)(2008-10#2)(2008-2#1)(2009-6#1)(2010-12#1)(2010-5#1)
these studies support the##2##4##(2007-8#1)(2008-5#1)
these studies support##4##3##(1994-2#1)(2007-8#1)(2008-3#1)(2008-5#1)
these studies the##3##3##(1990-10#1)(1994-2#1)(2008-10#1)
these studies to include##2##4##(1996-9#1)(2011-2#1)
these studies to##6##3##(1996-9#1)(2006-5#1)(2006-8#1)(2009-6#1)(2010-9#1)(2011-2#1)
these studies were##6##3##(1990-10#1)(2006-11#1)(2008-5#1)(2009-11#1)(2012-12#2)
these studies will##2##3##(2009-3#1)(2012-12#1)
these studies with##3##3##(1990-12#1)(2006-8#1)(2008-3#1)
these studies##276##2##(1990-10#2)(1990-11#3)(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#4)(1992-10#2)(1992-11#4)(1992-12#1)(1992-3#4)(1992-5#2)(1992-7#1)(1992-8#1)(1993-11#2)(1993-3#3)(1993-4#1)(1993-7#1)(1994-10#1)(1994-11#3)(1994-2#2)(1994-3#2)(1994-5#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-7#1)(1995-9#2)(1996-10#2)(1996-11#1)(1996-2#2)(1996-5#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-1#1)(2004-11#1)(2004-9#1)(2005-11#2)(2005-7#5)(2005-8#1)(2006-10#4)(2006-11#2)(2006-12#4)(2006-2#3)(2006-3#1)(2006-5#2)(2006-6#1)(2006-8#3)(2006-9#3)(2007-11#7)(2007-12#2)(2007-4#1)(2007-5#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#26)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#8)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#9)(2008-8#6)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-6#3)(2009-8#4)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#9)(2012-1#4)(2012-12#8)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#4)
these study##2##2##(2007-2#1)(2008-4#1)
these subgroups##3##2##(1996-3#1)(2007-8#1)(2010-12#1)
these subjects were##2##3##(2008-3#1)(2013-8#1)
these subjects##29##2##(1991-10#1)(1991-11#1)(1994-3#1)(1995-4#1)(1995-5#1)(1996-5#2)(2005-10#1)(2006-10#1)(2007-1#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#1)(2010-7#1)(2012-2#3)(2013-8#1)
these sublines##6##2##(1991-1#1)(1991-7#1)(1993-9#1)(1997-4#1)(2008-11#2)
these subsets##2##2##(1995-12#1)(2007-10#1)
these substances and the##2##4##(2007-1#1)(2008-7#1)
these substances and##3##3##(2006-12#1)(2007-1#1)(2008-7#1)
these substances in the##2##4##(1991-11#1)(1997-7#1)
these substances in##4##3##(1991-11#1)(1997-7#1)(2005-10#1)(2008-10#1)
these substances##39##2##(1990-12#1)(1990-3#1)(1990-4#1)(1991-10#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-6#1)(1994-3#1)(1994-8#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-3#1)(1997-7#1)(2005-10#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#3)(2008-10#2)(2008-4#1)(2008-5#2)(2008-7#2)(2009-7#1)(2010-12#1)(2010-6#1)(2012-12#1)(2012-2#1)
these substitutions##7##2##(1990-8#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-8#1)(1997-3#1)(2008-10#1)
these substrates are##3##3##(1990-11#1)(1994-11#1)(1996-5#1)
these substrates were##2##3##(1991-9#1)(2012-2#1)
these substrates##26##2##(1990-11#1)(1991-1#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-3#2)(1994-11#1)(1994-8#1)(1995-1#1)(1995-3#1)(1996-5#2)(1997-3#1)(1997-7#1)(2006-5#1)(2006-8#1)(2007-12#1)(2008-11#3)(2008-3#1)(2008-6#1)(2012-2#1)
these subtypes##2##2##(1992-7#1)(1996-8#1)
these subunits##6##2##(1992-2#2)(1993-11#1)(1993-6#1)(1995-12#1)(2009-9#1)
these sugar chains##2##3##(1993-11#1)(2012-11#1)
these sugars##2##2##(1991-4#1)(1993-11#1)
these suggest##2##2##(1997-7#1)(2008-5#1)
these superantigens##2##2##(2007-7#2)
these supplements##3##2##(2008-5#1)(2009-5#2)
these supporting##2##2##(1995-12#1)(2008-1#1)
these surfaces##11##2##(1997-4#1)(2007-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2010-4#1)(2011-2#1)(2012-11#1)(2013-1#1)
these surveys##4##2##(2007-2#1)(2010-12#1)(2012-12#1)(2013-8#1)
these symptoms are##3##3##(1991-12#1)(2008-11#2)
these symptoms in##4##3##(2007-11#1)(2008-10#1)(2008-6#1)(2011-2#1)
these symptoms to##2##3##(2006-2#1)(2010-12#1)
these symptoms##41##2##(1991-12#1)(1991-8#1)(1992-4#1)(1995-11#1)(1995-7#1)(1996-4#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-3#2)(2006-6#3)(2006-8#1)(2006-9#2)(2007-11#4)(2007-12#2)(2007-8#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2009-12#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-2#1)
these synapses##3##2##(1991-6#2)(1997-3#1)
these syndromes are##2##3##(2008-1#1)(2012-2#1)
these syndromes is##3##3##(1995-12#1)(2008-3#1)(2010-7#1)
these syndromes##22##2##(1992-8#1)(1995-12#1)(1996-11#1)(1996-6#1)(1997-5#1)(2005-7#1)(2006-10#1)(2007-1#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-12#2)(2010-11#1)(2010-12#1)(2010-7#1)(2012-2#5)
these synthetic##9##2##(1991-9#1)(1993-3#1)(1993-8#1)(1994-9#1)(1997-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2013-7#1)
these systems and##6##3##(1996-1#1)(2004-9#1)(2010-10#1)(2011-1#1)(2012-2#1)(2012-3#1)
these systems are##9##3##(1990-5#1)(1991-6#1)(1994-12#1)(2005-7#1)(2006-6#1)(2007-8#1)(2008-3#1)(2008-7#1)(2011-2#1)
these systems as##2##3##(2006-10#1)(2008-10#1)
these systems has##2##3##(2008-11#1)(2010-4#1)
these systems have been##3##4##(2005-11#1)(2009-9#1)(2010-11#1)
these systems have##6##3##(1997-7#1)(2005-11#1)(2008-11#1)(2008-4#1)(2009-9#1)(2010-11#1)
these systems in##6##3##(1994-1#1)(1997-1#1)(2008-11#1)(2008-3#2)(2008-8#1)
these systems is##9##3##(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-2#2)(2011-7#1)(2012-1#1)
these systems must be##2##4##(1994-3#1)(1997-3#1)
these systems should be##2##4##(1997-6#1)(2007-7#1)
these systems should##3##3##(1997-6#1)(2007-7#1)(2008-10#1)
these systems to##4##3##(1991-6#1)(2004-4#1)(2008-3#1)(2009-12#1)
these systems will##2##3##(1993-3#1)(1997-3#1)
these systems##115##2##(1990-12#3)(1990-2#1)(1990-5#1)(1991-6#2)(1993-3#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-7#1)(1997-1#1)(1997-3#5)(1997-6#1)(1997-7#1)(2004-4#1)(2004-9#1)(2005-11#3)(2005-5#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#4)(2006-12#2)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#6)(2008-11#5)(2008-2#5)(2008-3#11)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#2)(2009-12#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-2#2)(2010-4#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-2#3)(2012-3#5)
these target##3##2##(1994-3#1)(2008-4#2)
these targeted agents##2##3##(2009-11#1)(2010-10#1)
these targeted##4##2##(2009-11#1)(2010-10#1)(2010-2#1)(2013-1#1)
these targets##7##2##(1991-3#1)(2008-1#2)(2008-7#1)(2009-12#3)
these tasks and##2##3##(2006-6#1)(2012-12#1)
these tasks##15##2##(1992-9#1)(1994-2#1)(2006-4#4)(2006-6#1)(2008-11#2)(2010-5#1)(2010-8#1)(2012-12#1)(2013-1#2)(2013-7#1)
these taxa##6##2##(2007-12#1)(2008-10#1)(2010-3#4)
these teams##6##2##(1994-2#1)(2008-11#1)(2008-2#2)(2010-5#1)(2011-1#1)
these technical##3##2##(2007-11#1)(2007-5#1)(2008-4#1)
these techniques are##13##3##(1990-5#1)(1991-3#1)(1991-9#1)(1992-2#1)(2004-2#1)(2006-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2010-6#1)
these techniques can be##3##4##(2008-4#1)(2008-7#1)(2008-9#1)
these techniques can##4##3##(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)
these techniques have been##2##4##(2010-8#1)(2010-9#1)
these techniques have##4##3##(2006-10#1)(2010-8#1)(2010-9#2)
these techniques in the##6##4##(2005-8#1)(2006-10#1)(2007-9#1)(2008-11#2)(2012-2#1)
these techniques in##11##3##(2005-8#1)(2006-10#4)(2007-12#1)(2007-9#1)(2008-11#2)(2012-2#1)(2012-3#1)
these techniques is##8##3##(1994-11#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-11#1)(2010-11#1)(2012-2#1)
these techniques may##4##3##(2006-10#1)(2006-3#1)(2006-9#1)(2008-6#1)
these techniques on##2##3##(1990-4#1)(2008-6#1)
these techniques should##2##3##(1996-12#1)(2006-12#1)
these techniques to##7##3##(1995-8#1)(2006-7#1)(2007-12#1)(2008-3#2)(2008-8#1)(2010-9#1)
these techniques was##2##3##(2006-10#1)(2008-7#1)
these techniques##104##2##(1990-4#1)(1990-5#1)(1991-10#1)(1991-3#2)(1991-9#1)(1992-2#1)(1993-6#1)(1994-11#1)(1995-8#1)(1996-12#1)(1997-3#1)(2004-2#2)(2005-11#1)(2005-8#1)(2006-10#8)(2006-11#1)(2006-12#3)(2006-3#1)(2006-5#2)(2006-7#2)(2006-9#1)(2007-1#1)(2007-12#3)(2007-4#1)(2007-6#3)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-3#6)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-6#1)(2010-8#1)(2010-9#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
these technologies for##2##3##(2008-11#2)
these technologies##14##2##(2006-10#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-7#1)(2009-2#1)(2009-3#1)(2010-1#1)(2010-7#1)
these teeth##3##2##(2007-12#1)(2008-7#1)(2010-3#1)
these templates##2##2##(2008-2#1)(2010-6#1)
these terms and##2##3##(1995-1#1)(2008-2#1)
these terms##15##2##(1995-1#1)(2006-6#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-5#3)(2011-2#3)(2012-2#1)(2013-1#2)
these test properties##2##3##(2008-4#2)
these test##8##2##(1997-3#1)(1997-4#1)(2006-5#1)(2006-8#1)(2008-10#1)(2008-4#2)(2013-8#1)
these tests and##3##3##(1993-1#1)(2007-11#1)(2012-2#1)
these tests are not##2##4##(2005-10#1)(2010-3#1)
these tests are##3##3##(2005-10#1)(2008-10#1)(2010-3#1)
these tests in##3##3##(1990-12#1)(1996-9#1)(2006-10#1)
these tests is##3##3##(2006-11#1)(2008-12#1)(2008-2#1)
these tests##52##2##(1990-12#1)(1991-6#1)(1993-1#1)(1993-12#1)(1995-2#2)(1996-9#1)(1997-2#1)(2005-10#1)(2005-9#1)(2006-10#3)(2006-11#7)(2006-2#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-4#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-12#3)(2008-2#2)(2008-4#1)(2008-5#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-3#1)(2011-2#3)(2012-2#1)
these the##4##2##(1994-8#1)(1995-5#1)(1995-8#1)(2008-7#1)
these themes are probably##2##4##(2009-10#2)
these themes##6##2##(2006-10#1)(2009-10#3)(2010-2#1)(2010-8#1)
these theoretical predictions##2##3##(1997-3#1)(2012-1#1)
these theoretical##5##2##(1997-3#1)(2008-2#1)(2010-3#1)(2012-1#1)(2012-3#1)
these theories##7##2##(2007-12#1)(2007-8#1)(2008-2#1)(2010-1#1)(2010-10#1)(2010-7#2)
these therapeutic##9##2##(2006-2#1)(2006-9#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2013-1#1)(2013-8#1)
these therapeutics##3##2##(1990-12#1)(2012-12#2)
these therapies are##2##3##(2006-9#1)(2008-11#1)
these therapies have##2##3##(2006-10#1)(2008-6#1)
these therapies##22##2##(1990-9#1)(2004-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-5#1)(2006-9#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
these there##3##2##(1990-10#1)(1996-8#1)(2005-12#1)
these thermal##2##2##(2004-9#1)(2005-11#1)
these threats##2##2##(2008-5#1)(2011-12#1)
these three aspects##4##3##(1994-12#1)(1994-3#1)(1995-5#1)(2012-3#1)
these three conditions##2##3##(2008-11#1)(2013-1#1)
these three countries##2##3##(2008-7#1)(2010-12#1)
these three events##2##3##(1995-3#2)
these three forms tend to##2##5##(2011-2#2)
these three genes in##2##4##(1995-3#1)(1997-2#1)
these three genes##3##3##(1993-11#1)(1995-3#1)(1997-2#1)
these three groups##4##3##(2004-1#1)(2008-10#2)(2012-1#1)
these three hosts##3##3##(2008-10#3)
these three ions##2##3##(2008-10#2)
these three lineages##2##3##(2008-10#2)
these three methods##3##3##(2011-12#1)(2012-3#2)
these three parameters##4##3##(2008-1#1)(2008-10#1)(2008-2#1)(2013-8#1)
these three proteins##2##3##(1990-10#1)(1994-8#1)
these three species##7##3##(1992-7#1)(2004-11#1)(2007-5#1)(2008-10#1)(2008-4#1)(2011-12#2)
these three##163##2##(1990-10#1)(1990-11#1)(1990-12#1)(1991-1#1)(1991-2#1)(1991-4#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-7#2)(1992-8#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#4)(1995-5#2)(1995-8#1)(1996-1#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#2)(2004-1#1)(2004-11#1)(2005-11#2)(2005-12#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#30)(2008-11#5)(2008-12#1)(2008-2#5)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#3)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-8#2)(2011-1#2)(2011-12#3)(2011-2#3)(2012-1#2)(2012-2#4)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#3)
these thresholds##2##2##(2008-4#2)
these time points##2##3##(2012-12#1)(2013-8#1)
these time##6##2##(1996-7#1)(2007-2#1)(2007-8#1)(2012-12#1)(2013-8#2)
these times##5##2##(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2011-3#1)
these tiny##2##2##(1993-5#1)(2008-12#1)
these tissues and##2##3##(1996-3#1)(2013-1#1)
these tissues were##4##3##(1991-2#1)(1994-11#2)(1997-5#1)
these tissues##44##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-2#1)(1992-9#1)(1993-7#1)(1994-11#3)(1994-3#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-5#1)(1997-6#1)(2006-9#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#3)(2009-7#1)(2010-2#1)(2012-12#2)(2012-2#2)(2013-1#2)
these to the##2##3##(2007-2#1)(2008-1#1)
these to##14##2##(1994-1#2)(1996-1#1)(1997-4#2)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-12#2)(2013-7#1)(2013-8#1)
these tools and##2##3##(2008-3#1)(2011-1#1)
these tools are##4##3##(1997-8#1)(2010-2#1)(2013-1#2)
these tools##20##2##(1997-1#1)(1997-8#1)(2006-5#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#3)(2008-9#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)
these topics##6##2##(2005-9#1)(2006-4#1)(2009-7#1)(2012-3#1)(2013-1#2)
these toxic compounds##2##3##(2007-10#1)(2008-8#1)
these toxic##5##2##(2007-10#1)(2007-11#1)(2008-6#1)(2008-8#1)(2011-12#1)
these toxicities##2##2##(2008-7#1)(2012-12#1)
these toxins are##2##3##(2007-11#1)(2008-10#1)
these toxins##3##2##(2007-11#1)(2008-10#1)(2008-5#1)
these trace elements##2##3##(2008-10#1)(2008-12#1)
these traditional##2##2##(2008-1#1)(2012-12#1)
these traits is##2##3##(2012-3#2)
these traits##15##2##(1994-3#1)(2007-12#1)(2008-10#2)(2008-8#2)(2008-9#2)(2009-4#1)(2010-8#1)(2012-3#3)(2013-1#2)
these trajectories##4##2##(1997-3#1)(2008-7#1)(2009-9#1)(2012-1#1)
these transcription factors are##3##4##(2010-7#1)(2012-3#1)(2013-1#1)
these transcription factors##8##3##(1993-12#1)(1995-12#1)(1996-11#1)(2008-9#1)(2010-7#1)(2012-3#2)(2013-1#1)
these transcription##9##2##(1993-12#1)(1995-12#1)(1996-11#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-3#2)(2013-1#1)
these transcriptional##3##2##(2008-7#1)(2012-12#2)
these transcripts##5##2##(1990-8#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-8#1)
these transducers##2##2##(2008-10#1)(2009-5#1)
these transfected##2##2##(2008-11#1)(2008-8#1)
these transformants##2##2##(1990-4#1)(2008-10#1)
these transformations##3##2##(1995-2#1)(2008-2#1)(2011-1#1)
these transformed##2##2##(1995-2#2)
these transgenic lines##3##3##(1996-3#1)(2006-12#1)(2008-10#1)
these transgenic##7##2##(1996-3#1)(1997-7#1)(2006-12#1)(2008-10#3)(2010-8#1)
these transient##2##2##(2007-11#1)(2008-11#1)
these transition##2##2##(1997-7#2)
these transitions were##2##3##(1994-8#1)(2007-12#1)
these transitions##10##2##(1994-8#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-11#1)(2009-12#1)(2009-5#1)(2012-2#1)(2013-8#1)
these transport##3##2##(1990-12#1)(1991-9#1)(2011-2#1)
these treatment approaches##2##3##(2007-11#1)(2013-1#1)
these treatment##6##2##(2007-11#1)(2008-4#1)(2010-12#1)(2010-8#2)(2013-1#1)
these treatments and##2##3##(1993-7#1)(2007-12#1)
these treatments for##2##3##(2005-4#1)(2008-5#1)
these treatments##31##2##(1990-5#1)(1992-1#1)(1993-7#1)(1996-12#1)(1996-5#1)(2005-4#1)(2005-6#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-5#3)(2008-8#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-1#2)(2010-12#1)(2011-12#1)(2012-12#2)
these trees##3##2##(2008-10#2)(2012-6#1)
these trends##4##2##(1997-2#1)(2006-9#1)(2007-4#1)(2008-8#1)
these trials are##3##3##(1996-11#1)(2005-11#1)(2008-5#1)
these trials have##2##3##(2005-10#1)(2005-11#1)
these trials is##2##3##(2005-8#1)(2007-3#1)
these trials must##2##3##(1995-9#1)(1997-4#1)
these trials suggest that##2##4##(2008-11#1)(2008-5#1)
these trials will##3##3##(1991-12#1)(2007-1#1)(2007-4#1)
these trials##30##2##(1991-12#1)(1995-2#1)(1995-9#1)(1996-11#1)(1997-4#1)(2005-10#1)(2005-11#2)(2005-8#2)(2006-10#1)(2007-1#1)(2007-11#2)(2007-3#1)(2007-4#1)(2007-9#1)(2008-11#1)(2008-5#2)(2008-6#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#1)
these tsp##2##2##(1991-8#1)(1993-9#1)
these tumor cells##3##3##(1991-7#1)(1991-9#1)(1992-9#1)
these tumor##7##2##(1990-12#1)(1991-7#1)(1991-9#1)(1992-9#1)(2006-10#1)(2008-8#1)(2010-2#1)
these tumors and##7##3##(1992-5#1)(1993-6#1)(2006-12#1)(2007-12#2)(2012-12#1)(2013-8#1)
these tumors are##5##3##(1996-10#1)(2005-5#1)(2006-12#1)(2008-7#1)(2012-12#1)
these tumors as##2##3##(2006-10#1)(2009-5#1)
these tumors can##3##3##(1991-10#1)(2006-5#1)(2010-11#1)
these tumors with##2##3##(2011-2#1)(2012-12#1)
these tumors##64##2##(1990-10#1)(1991-1#1)(1991-10#1)(1991-8#1)(1991-9#1)(1992-5#1)(1992-8#1)(1993-10#1)(1993-6#1)(1995-2#1)(1996-10#1)(1997-1#1)(2005-10#1)(2005-5#2)(2006-1#1)(2006-10#3)(2006-12#5)(2006-5#2)(2007-12#3)(2007-2#1)(2007-6#2)(2007-7#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#2)(2010-9#3)(2011-2#6)(2012-12#5)(2012-3#1)(2013-1#3)(2013-8#1)
these tumours##11##2##(1993-11#1)(1997-3#1)(2004-2#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
these two NOSs likely rely on the downstream soluble guanylyl cyclase/cGMP/protein kinase G signaling pathway to regulate the structural components at the tight junctions and adherens junctions in the testes##2##30##(2009-10#2)
these two activities##2##3##(1990-7#1)(2012-12#1)
these two agents##6##3##(1993-4#1)(1994-6#1)(2006-10#1)(2008-10#1)(2008-8#1)(2009-6#1)
these two algorithms##2##3##(2008-2#1)(2008-3#1)
these two approaches are##2##4##(2007-3#1)(2008-9#1)
these two approaches##9##3##(2007-10#1)(2007-3#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-9#1)(2009-12#1)(2013-1#1)
these two approximations##2##3##(2008-2#2)
these two aspects of##2##4##(1993-12#1)(2008-11#1)
these two aspects##3##3##(1993-12#1)(1996-5#1)(2008-11#1)
these two assays##3##3##(1994-12#1)(2004-9#1)(2008-10#1)
these two cases##4##3##(1997-1#1)(2009-10#1)(2010-2#1)(2010-4#1)
these two cell lines##4##4##(1990-10#1)(1990-5#1)(1992-11#1)(1995-5#1)
these two cell types##4##4##(1990-5#1)(1992-9#1)(1997-4#1)(2012-12#1)
these two cell##8##3##(1990-10#1)(1990-5#2)(1992-11#1)(1992-9#1)(1995-5#1)(1997-4#1)(2012-12#1)
these two channels##2##3##(2008-2#1)(2008-8#1)
these two classes of##2##4##(2007-6#1)(2012-2#1)
these two closely related##2##4##(1991-11#1)(2008-7#1)
these two competing##3##3##(1991-3#1)(2005-11#1)(2012-3#1)
these two complexes##5##3##(1992-3#1)(1997-7#1)(2008-3#1)(2008-5#1)(2012-12#1)
these two components##5##3##(1994-12#1)(1996-9#1)(2008-3#2)(2012-12#1)
these two compounds in##2##4##(1996-6#1)(2011-3#1)
these two compounds##5##3##(1991-9#2)(1996-6#1)(2008-5#1)(2011-3#1)
these two conditions##8##3##(1992-11#2)(2007-10#1)(2007-4#1)(2007-8#1)(2008-9#1)(2010-4#1)(2012-3#1)
these two different##5##3##(1996-7#1)(2006-10#1)(2006-6#2)(2011-2#1)
these two dimeric impurities##2##4##(2010-2#2)
these two disciplines##2##3##(1996-1#1)(2008-11#1)
these two diseases##6##3##(1991-10#1)(2006-10#1)(2008-10#1)(2012-12#1)(2012-3#2)
these two disorders##6##3##(2005-10#1)(2006-10#1)(2007-2#1)(2009-7#1)(2012-2#1)(2012-3#1)
these two distinct##7##3##(1992-4#1)(2005-8#1)(2006-2#1)(2008-7#2)(2010-3#1)(2013-1#1)
these two domains##2##3##(1995-3#1)(1996-5#1)
these two drugs##6##3##(1990-5#1)(1991-9#1)(1993-4#1)(1993-8#1)(1995-12#1)(1996-1#1)
these two dummies in##2##4##(2006-11#2)
these two effects##4##3##(1996-9#1)(1997-4#1)(2007-12#1)(2008-2#1)
these two elements##3##3##(1994-6#1)(2005-10#1)(2008-11#1)
these two entities##3##3##(2004-11#1)(2006-12#1)(2008-6#1)
these two enzymes##6##3##(1990-6#1)(1994-3#1)(1994-8#2)(1995-10#1)(2005-11#1)
these two events##2##3##(2011-2#2)
these two expression##2##3##(1995-12#1)(1995-5#1)
these two extremes##3##3##(1994-9#1)(2008-2#1)(2008-7#1)
these two factors##13##3##(1990-10#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-4#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-6#1)(2009-6#1)(2010-5#1)(2011-2#1)
these two families of##2##4##(1993-12#1)(1994-5#1)
these two families##3##3##(1990-3#1)(1993-12#1)(1994-5#1)
these two forms of##4##4##(1992-12#1)(1996-8#1)(1997-2#1)(2008-7#1)
these two forms were##2##4##(1994-11#1)(2009-7#1)
these two forms##8##3##(1992-12#1)(1994-11#1)(1996-8#1)(1997-2#1)(1997-7#1)(2007-7#1)(2008-7#1)(2009-7#1)
these two fractions are##2##4##(1990-12#1)(1991-2#1)
these two functions in##2##4##(2008-10#1)(2008-11#1)
these two functions##5##3##(1991-12#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
these two fungi##2##3##(2006-3#1)(2008-10#1)
these two genera##4##3##(2008-10#4)
these two genes##10##3##(1990-9#1)(1991-5#1)(1991-9#1)(1993-12#1)(1994-11#1)(1996-7#1)(2008-1#1)(2008-4#1)(2010-3#1)(2012-3#1)
these two genotypes##2##3##(2006-2#1)(2007-8#1)
these two groups were##5##4##(1990-2#1)(1992-11#1)(2007-7#1)(2007-9#1)(2008-10#1)
these two groups##20##3##(1990-2#1)(1991-12#1)(1991-3#1)(1992-11#2)(1992-12#1)(1993-7#1)(1996-12#1)(2006-9#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#1)
these two herbs##3##3##(1992-2#3)
these two hormones##3##3##(2006-10#1)(2008-6#1)(2011-2#1)
these two hypotheses##3##3##(1994-2#1)(2008-2#1)(2009-8#1)
these two important##3##3##(1991-12#1)(1995-1#1)(2013-1#1)
these two isoforms##2##3##(1994-3#1)(1995-2#1)
these two isolates##4##3##(1991-8#1)(2008-10#2)(2012-2#1)
these two issues##2##3##(2008-10#1)(2010-7#1)
these two lesions##3##3##(2006-12#1)(2013-1#2)
these two lines##2##3##(1997-8#1)(2008-10#1)
these two loci##3##3##(1994-8#1)(1997-5#1)(2008-4#1)
these two loops##3##3##(1992-11#1)(1996-7#2)
these two materials in##2##4##(1990-11#1)(2008-5#1)
these two materials##3##3##(1990-11#1)(2008-3#1)(2008-5#1)
these two measures##3##3##(2008-9#2)(2012-2#1)
these two methods were##2##4##(1996-8#1)(2011-1#1)
these two methods##15##3##(1995-9#1)(1996-12#1)(1996-5#1)(1996-8#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-6#1)(2009-3#1)(2011-1#1)
these two models##3##3##(1992-5#1)(1996-3#1)(2008-3#1)
these two molecules##5##3##(1993-11#1)(1995-3#1)(2008-7#1)(2010-10#1)(2011-1#1)
these two mutations##2##3##(1991-1#1)(2012-12#1)
these two new##2##3##(1996-2#1)(2008-5#1)
these two opposing##2##3##(1995-9#1)(1996-12#1)
these two organisms##2##3##(1991-3#1)(2006-10#1)
these two parameters##15##3##(1990-12#1)(1992-11#1)(1992-6#1)(1994-5#1)(2005-11#2)(2007-10#1)(2007-2#2)(2008-10#2)(2008-3#2)(2008-7#1)(2012-2#1)
these two pathogens##2##3##(2008-10#1)(2008-7#1)
these two pathways##4##3##(1996-5#1)(2008-4#1)(2010-3#1)(2011-2#1)
these two patients with##2##4##(2006-10#1)(2008-8#1)
these two patients##5##3##(2006-1#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-8#1)
these two peptides##4##3##(1990-5#1)(1992-9#1)(1994-11#1)(1996-11#1)
these two phenomena##6##3##(1995-5#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-11#1)
these two populations of##3##4##(1995-11#1)(2007-5#1)(2008-11#1)
these two populations##12##3##(1994-6#1)(1995-11#1)(2007-12#2)(2007-5#1)(2008-10#2)(2008-11#2)(2008-5#2)(2009-9#1)
these two procedures##4##3##(2006-3#1)(2007-11#1)(2009-12#2)
these two processes##8##3##(1991-6#1)(1992-8#1)(1995-2#1)(2006-12#1)(2007-3#1)(2009-2#1)(2009-8#1)(2011-2#1)
these two promoters##2##3##(1994-8#1)(2006-12#1)
these two proteins were##4##4##(1995-2#1)(2005-11#2)(2008-5#1)
these two proteins##20##3##(1990-7#1)(1990-8#1)(1991-2#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-7#1)(1997-4#1)(1997-7#1)(2005-11#2)(2008-5#1)
these two reactions##2##3##(1993-12#1)(2008-10#1)
these two receptor##2##3##(1994-11#1)(2008-7#1)
these two receptors##4##3##(1992-1#1)(1994-3#1)(2006-10#1)(2012-2#1)
these two regions##6##3##(1992-1#1)(1993-11#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-7#1)
these two residues##3##3##(1990-12#1)(1990-5#1)(1996-5#1)
these two risk##3##3##(2011-2#1)(2013-1#2)
these two sets of##3##4##(1992-6#1)(1992-7#1)(2008-10#1)
these two sets##4##3##(1992-6#1)(1992-7#1)(1995-3#1)(2008-10#1)
these two signaling##2##3##(2009-6#1)(2012-12#1)
these two single##2##3##(1995-3#1)(2011-1#1)
these two sites##8##3##(1993-9#1)(1994-9#1)(1996-6#1)(1997-2#1)(1997-6#1)(2007-6#1)(2008-5#2)
these two situations##2##3##(2005-12#1)(2006-1#1)
these two species were##2##4##(1994-3#1)(2006-5#1)
these two species##19##3##(1990-9#1)(1992-12#1)(1994-12#1)(1994-3#2)(1995-8#2)(1996-12#1)(1997-2#1)(2006-11#1)(2006-5#2)(2007-1#1)(2008-10#2)(2008-5#1)(2011-2#2)(2012-11#1)
these two strains##2##3##(2008-10#1)(2008-7#1)
these two structurally##2##3##(1992-12#1)(1996-5#1)
these two subgroups##2##3##(1990-8#1)(1997-7#1)
these two substances##3##3##(1990-12#1)(1996-1#1)(2006-10#1)
these two substrates##2##3##(1994-5#1)(1997-8#1)
these two syndromes##2##3##(1995-5#1)(2009-12#1)
these two systems##4##3##(1991-3#1)(2008-10#1)(2008-11#1)(2009-9#1)
these two techniques are##3##4##(2007-12#1)(2008-1#1)(2008-2#1)
these two techniques##7##3##(1992-2#1)(1992-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2011-1#1)
these two tissues##4##3##(1993-7#1)(1996-7#1)(2010-12#1)(2012-12#1)
these two treatments##5##3##(2004-10#1)(2006-9#1)(2007-11#1)(2012-2#1)(2013-1#1)
these two types of##17##4##(1990-7#1)(1992-8#1)(1993-12#2)(1995-2#1)(1996-10#1)(2005-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-10#1)(2010-2#1)(2011-2#2)(2012-3#1)
these two types##19##3##(1990-7#1)(1992-8#1)(1993-12#2)(1995-2#1)(1996-10#1)(2005-8#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-10#1)(2010-2#1)(2011-2#2)(2012-3#1)
these two variables##6##3##(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2013-8#1)
these two viruses##4##3##(2006-10#1)(2007-6#1)(2008-10#2)
these two wheat##2##3##(2008-12#2)
these two##763##2##(1990-10#2)(1990-11#3)(1990-12#5)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#7)(1990-6#1)(1990-7#5)(1990-8#3)(1990-9#2)(1991-1#2)(1991-10#2)(1991-11#3)(1991-12#6)(1991-2#3)(1991-3#4)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#3)(1991-9#8)(1992-1#2)(1992-10#1)(1992-11#7)(1992-12#6)(1992-2#6)(1992-3#1)(1992-4#3)(1992-5#3)(1992-6#4)(1992-7#2)(1992-8#5)(1992-9#3)(1993-11#4)(1993-12#10)(1993-2#2)(1993-3#1)(1993-4#3)(1993-7#3)(1993-8#1)(1993-9#2)(1994-11#7)(1994-12#6)(1994-2#1)(1994-3#6)(1994-5#4)(1994-6#5)(1994-8#6)(1994-9#6)(1995-1#2)(1995-10#2)(1995-11#2)(1995-12#2)(1995-2#7)(1995-3#6)(1995-5#5)(1995-8#3)(1995-9#3)(1996-1#7)(1996-10#1)(1996-11#2)(1996-12#5)(1996-2#1)(1996-3#3)(1996-4#4)(1996-5#8)(1996-6#3)(1996-7#6)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#7)(1997-4#4)(1997-5#2)(1997-6#4)(1997-7#7)(1997-8#3)(1997-9#1)(2003-11#1)(2004-10#1)(2004-11#1)(2004-3#1)(2004-9#1)(2005-10#3)(2005-11#11)(2005-12#1)(2005-8#3)(2005-9#1)(2006-1#3)(2006-10#11)(2006-11#3)(2006-12#7)(2006-2#2)(2006-3#3)(2006-4#1)(2006-5#3)(2006-6#3)(2006-7#1)(2006-9#2)(2007-1#5)(2007-10#4)(2007-11#3)(2007-12#15)(2007-2#7)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#4)(2007-7#3)(2007-8#9)(2007-9#2)(2008-1#7)(2008-10#72)(2008-11#17)(2008-12#3)(2008-2#20)(2008-3#23)(2008-4#12)(2008-5#23)(2008-6#7)(2008-7#19)(2008-8#10)(2008-9#10)(2009-10#7)(2009-12#8)(2009-2#1)(2009-3#2)(2009-4#3)(2009-6#3)(2009-7#2)(2009-8#3)(2009-9#3)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#6)(2010-3#4)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#17)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#11)(2012-2#15)(2012-3#10)(2013-1#15)(2013-8#3)
these type of##3##3##(1991-3#1)(1996-6#1)(2008-10#1)
these type##4##2##(1991-3#1)(1996-6#1)(2008-10#2)
these types of data##3##4##(1997-8#1)(2008-1#2)
these types of fractures##2##4##(2013-8#2)
these types of studies##2##4##(2010-4#1)(2010-9#1)
these types of##36##3##(1990-12#1)(1991-1#1)(1991-11#1)(1991-3#1)(1992-2#1)(1993-2#1)(1996-6#1)(1997-8#1)(2005-11#1)(2006-11#1)(2006-5#1)(2007-12#4)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2010-4#3)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#2)(2013-8#2)
these types##39##2##(1990-12#1)(1991-1#1)(1991-11#1)(1991-3#1)(1992-2#1)(1993-2#1)(1996-6#1)(1997-8#1)(2005-11#1)(2006-11#1)(2006-5#1)(2007-12#4)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2010-4#3)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-11#1)(2013-1#2)(2013-8#2)
these tyrosine##3##2##(1992-9#2)(1995-2#1)
these tyrosines##2##2##(1993-9#1)(1995-1#1)
these ulcers##3##2##(2005-12#1)(2013-1#2)
these uncertain##2##2##(1994-5#1)(2009-2#1)
these uncertainties##4##2##(2005-7#1)(2006-10#1)(2008-10#1)(2009-11#1)
these underwent##2##2##(1991-6#1)(2012-2#1)
these undesirable##2##2##(1995-1#1)(2008-4#1)
these unexpected##2##2##(1996-5#1)(1996-7#1)
these unique##11##2##(1992-8#1)(1997-2#1)(2006-10#2)(2006-3#1)(2007-11#1)(2008-10#1)(2008-6#1)(2010-11#1)(2010-2#1)(2012-2#1)
these units are##2##3##(1992-11#1)(1995-5#1)
these units##10##2##(1991-6#2)(1992-11#1)(1994-9#1)(1995-5#1)(1995-9#1)(2005-5#1)(2007-8#1)(2008-10#1)(2013-1#1)
these unusual##6##2##(1990-11#1)(1990-7#1)(1991-8#1)(1996-5#1)(2007-8#1)(2012-2#1)
these use##3##2##(2008-4#1)(2013-1#2)
these useful##2##2##(1994-11#1)(2009-9#1)
these uses has##2##3##(2007-2#1)(2012-3#1)
these uses##3##2##(1991-5#1)(2007-2#1)(2012-3#1)
these vaccines##4##2##(2007-8#1)(2008-11#1)(2008-3#1)(2011-2#1)
these vacuoles##2##2##(2007-12#1)(2008-11#1)
these valuable##2##2##(1995-1#1)(2011-2#1)
these values are in##2##4##(1995-10#1)(2008-3#1)
these values are##7##3##(1995-10#1)(1997-2#1)(2006-11#1)(2008-10#3)(2008-3#1)
these values in##2##3##(1997-8#1)(2009-4#1)
these values increased##2##3##(1991-6#1)(2008-5#1)
these values to##2##3##(1997-1#1)(2007-12#1)
these values were similar##2##4##(1996-12#1)(2008-7#1)
these values were##8##3##(1990-11#1)(1990-12#1)(1992-12#1)(1995-5#1)(1996-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
these values with##3##3##(1995-8#1)(2008-10#1)(2008-3#1)
these values##55##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-6#1)(1993-12#1)(1994-5#1)(1995-10#2)(1995-2#1)(1995-5#1)(1995-7#1)(1995-8#2)(1996-12#1)(1997-1#1)(1997-2#1)(1997-8#2)(2005-11#1)(2006-1#2)(2006-11#1)(2006-4#1)(2007-1#1)(2007-12#1)(2007-3#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#2)(2009-4#2)(2013-1#1)
these variables and##4##3##(2004-12#1)(2008-10#2)(2008-8#1)
these variables are##4##3##(1992-6#1)(2008-10#1)(2008-4#1)(2010-2#1)
these variables in##6##3##(1991-6#1)(1994-8#1)(1996-12#1)(2006-12#1)(2006-6#1)(2007-2#1)
these variables to##2##3##(2008-4#1)(2012-2#1)
these variables were##5##3##(1993-8#1)(1996-3#1)(2008-10#1)(2013-1#1)(2013-8#1)
these variables will##2##3##(1993-1#1)(2008-5#1)
these variables with##2##3##(1993-2#1)(2007-12#1)
these variables##62##2##(1991-4#1)(1991-6#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-2#2)(1993-8#1)(1994-6#1)(1994-8#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-5#1)(2004-10#1)(2004-12#1)(2004-3#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-12#4)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-2#1)(2008-4#2)(2008-5#3)(2008-8#3)(2009-8#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#3)
these variants##12##2##(1990-6#1)(1992-9#1)(1993-6#1)(1995-6#2)(1996-3#1)(1997-7#1)(2007-7#1)(2009-3#1)(2010-2#1)(2012-3#1)(2013-1#1)
these variations are##4##3##(1997-2#1)(2007-10#1)(2007-7#1)(2008-8#1)
these variations in##2##3##(2008-7#1)(2011-2#1)
these variations##13##2##(1993-1#1)(1997-2#1)(2007-10#1)(2007-7#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#1)
these varieties##3##2##(2008-12#1)(2009-10#2)
these various components##2##3##(1993-6#1)(2009-10#1)
these various##25##2##(1990-9#1)(1992-1#1)(1992-6#1)(1993-6#1)(1994-9#1)(1997-5#1)(2005-8#1)(2006-10#2)(2006-6#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
these vascular##2##2##(2008-4#1)(2013-7#1)
these vectors have##2##3##(1990-3#1)(1990-5#1)
these vectors##16##2##(1990-3#1)(1990-5#1)(1991-7#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-5#1)(1995-7#1)(1996-10#1)(1997-4#2)(2007-6#1)(2008-10#1)(2008-2#1)(2013-1#2)
these very high risk patients##2##5##(2008-1#2)
these very##8##2##(1997-2#1)(2006-10#1)(2007-9#1)(2008-1#2)(2008-5#1)(2009-11#1)(2009-6#1)
these vesicles##5##2##(1991-2#1)(1997-4#1)(2007-10#1)(2009-2#1)(2013-7#1)
these views##3##2##(1990-12#1)(1990-5#1)(2008-5#1)
these viral##2##2##(1995-2#1)(2008-9#1)
these virulence factors##2##3##(2010-12#2)
these virulence##3##2##(2010-12#2)(2011-1#1)
these viruses in##3##3##(2006-10#1)(2008-10#1)(2012-2#1)
these viruses##24##2##(1995-2#1)(1995-6#1)(1997-6#1)(2005-9#1)(2006-10#1)(2007-11#2)(2007-6#1)(2008-10#11)(2008-11#1)(2009-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
these volatiles in##2##3##(1990-11#2)
these volatiles##4##2##(1990-11#2)(2008-10#2)
these volumes##2##2##(2008-10#1)(2008-2#1)
these vulnerable##2##2##(2008-12#1)(2009-5#1)
these was##11##2##(1990-12#1)(1991-8#1)(1992-9#1)(2004-2#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-12#2)(2013-8#1)
these water##4##2##(1995-5#1)(2004-8#1)(2005-11#1)(2008-5#1)
these waters##2##2##(2008-3#1)(2009-6#1)
these waveguides had high##2##4##(2008-2#2)
these waveguides##6##2##(2007-12#2)(2008-2#4)
these wavelengths##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
these waves##4##2##(1991-3#1)(2007-12#1)(2008-3#2)
these ways##4##2##(1990-2#1)(1996-4#1)(2008-10#1)(2008-7#1)
these were applied to##2##4##(2008-10#1)(2011-2#1)
these were associated##2##3##(1990-6#1)(1997-7#1)
these were confirmed##2##3##(2005-7#1)(2008-10#1)
these were considered##2##3##(1996-9#1)(2012-2#1)
these were found to have##2##5##(2007-9#1)(2008-10#1)
these were found to##5##4##(1995-12#1)(1997-2#1)(2007-9#1)(2008-10#2)
these were found##6##3##(1995-12#1)(1997-2#1)(2007-9#1)(2008-10#2)(2008-5#1)
these were further##3##3##(2004-4#1)(2008-10#1)(2008-7#1)
these were in##2##3##(1994-3#1)(1997-2#1)
these were not##5##3##(2008-10#3)(2009-12#1)(2010-3#1)
these were obtained from##2##4##(2005-9#1)(2012-12#1)
these were only##2##3##(1992-12#1)(2013-8#1)
these were the##3##3##(1993-6#1)(2008-10#1)(2010-11#1)
these were used##2##3##(2009-12#1)(2012-2#1)
these were##121##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-2#3)(1991-4#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-7#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#3)(1996-3#2)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#2)(2004-10#1)(2004-4#1)(2005-11#1)(2005-7#3)(2005-8#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-12#2)(2009-4#2)(2009-5#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#5)(2013-7#1)(2013-8#1)
these will be##7##3##(1992-11#1)(2006-10#1)(2007-11#1)(2008-11#3)(2012-2#1)
these will##13##2##(1992-11#1)(1992-2#1)(2004-9#1)(2006-10#1)(2007-11#2)(2008-11#3)(2009-1#1)(2009-5#1)(2012-2#2)
these wines##2##2##(2008-10#2)
these with a##4##3##(1992-5#1)(1995-8#1)(2007-6#1)(2007-9#1)
these with the##2##3##(1992-12#1)(2008-3#1)
these with##12##2##(1992-12#1)(1992-5#1)(1995-8#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-3#2)(2008-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
these women in##2##3##(1997-7#1)(2012-3#1)
these women may##2##3##(2007-2#1)(2011-2#1)
these women were##2##3##(1994-12#1)(2011-2#1)
these women##40##2##(1990-12#1)(1990-3#1)(1991-8#1)(1991-9#1)(1994-12#2)(1994-2#2)(1995-1#1)(1995-5#1)(1996-12#1)(1997-7#1)(2004-1#1)(2006-10#1)(2006-8#1)(2007-2#2)(2008-1#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-3#1)(2009-9#2)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
these women's##2##2##(2007-2#1)(2011-2#1)
these workers##6##2##(1991-12#1)(1997-2#1)(2008-4#1)(2008-6#1)(2009-12#2)
these working##2##2##(1994-12#1)(2008-10#1)
these works##4##2##(2007-2#1)(2007-5#1)(2010-11#1)(2013-7#1)
these would##3##2##(1991-6#1)(1995-5#1)(2012-3#1)
these wounds##2##2##(2007-12#1)(2008-10#1)
these xanthones##2##2##(2006-12#1)(2009-3#1)
these years##13##2##(1990-6#1)(1991-8#1)(1992-5#1)(1997-3#1)(2007-4#1)(2007-6#1)(2008-10#1)(2009-2#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
these yeasts in##2##3##(2004-8#1)(2013-1#1)
these yeasts##7##2##(1997-4#1)(2004-8#1)(2007-9#1)(2008-5#2)(2013-1#2)
these young patients##2##3##(2006-10#1)(2010-7#1)
these young##9##2##(1996-2#1)(2006-1#1)(2006-10#1)(2007-2#1)(2007-3#2)(2009-5#1)(2010-7#1)(2011-1#1)
these youth are very likely to use text messaging##2##9##(2013-1#2)
these youth##6##2##(2008-11#1)(2010-7#1)(2012-12#1)(2013-1#2)(2013-8#1)
these##20718##1##(1990-1#8)(1990-10#46)(1990-11#67)(1990-12#119)(1990-2#83)(1990-3#61)(1990-4#42)(1990-5#89)(1990-6#49)(1990-7#86)(1990-8#66)(1990-9#51)(1991-1#48)(1991-10#41)(1991-11#42)(1991-12#117)(1991-2#94)(1991-3#84)(1991-4#42)(1991-5#89)(1991-6#63)(1991-7#55)(1991-8#68)(1991-9#84)(1992-1#46)(1992-10#29)(1992-11#60)(1992-12#89)(1992-2#57)(1992-3#102)(1992-4#36)(1992-5#55)(1992-6#82)(1992-7#53)(1992-8#77)(1992-9#86)(1993-1#41)(1993-10#11)(1993-11#91)(1993-12#124)(1993-2#67)(1993-3#81)(1993-4#43)(1993-5#36)(1993-6#79)(1993-7#30)(1993-8#60)(1993-9#74)(1994-1#20)(1994-10#23)(1994-11#95)(1994-12#136)(1994-2#106)(1994-3#110)(1994-4#4)(1994-5#61)(1994-6#83)(1994-7#13)(1994-8#113)(1994-9#124)(1995-1#83)(1995-10#34)(1995-11#77)(1995-12#113)(1995-2#140)(1995-3#122)(1995-4#19)(1995-5#86)(1995-6#66)(1995-7#23)(1995-8#88)(1995-9#34)(1996-1#57)(1996-10#51)(1996-11#58)(1996-12#99)(1996-2#82)(1996-3#77)(1996-4#52)(1996-5#116)(1996-6#51)(1996-7#43)(1996-8#78)(1996-9#79)(1997-1#71)(1997-2#124)(1997-3#80)(1997-4#114)(1997-5#57)(1997-6#64)(1997-7#106)(1997-8#90)(1997-9#3)(2003-11#6)(2004-1#9)(2004-10#15)(2004-11#25)(2004-12#20)(2004-2#16)(2004-3#12)(2004-4#14)(2004-7#1)(2004-8#5)(2004-9#22)(2005-1#2)(2005-10#71)(2005-11#140)(2005-12#34)(2005-2#1)(2005-3#1)(2005-4#9)(2005-5#20)(2005-6#4)(2005-7#67)(2005-8#100)(2005-9#28)(2006-1#36)(2006-10#454)(2006-11#70)(2006-12#180)(2006-2#71)(2006-3#41)(2006-4#43)(2006-5#73)(2006-6#66)(2006-7#56)(2006-8#116)(2006-9#70)(2007-1#60)(2007-10#116)(2007-11#364)(2007-12#372)(2007-2#124)(2007-3#75)(2007-4#87)(2007-5#69)(2007-6#70)(2007-7#170)(2007-8#279)(2007-9#102)(2008-1#268)(2008-10#1669)(2008-11#518)(2008-12#143)(2008-2#369)(2008-3#494)(2008-4#408)(2008-5#496)(2008-6#162)(2008-7#512)(2008-8#369)(2008-9#298)(2009-1#17)(2009-10#126)(2009-11#57)(2009-12#101)(2009-2#75)(2009-3#88)(2009-4#105)(2009-5#104)(2009-6#60)(2009-7#65)(2009-8#122)(2009-9#86)(2010-1#37)(2010-10#52)(2010-11#81)(2010-12#178)(2010-2#119)(2010-3#79)(2010-4#90)(2010-5#97)(2010-6#56)(2010-7#74)(2010-8#115)(2010-9#70)(2011-1#251)(2011-10#3)(2011-11#1)(2011-12#53)(2011-2#480)(2011-3#20)(2011-7#4)(2011-9#1)(2012-1#135)(2012-11#54)(2012-12#303)(2012-2#386)(2012-3#219)(2012-4#1)(2012-6#2)(2012-7#4)(2012-8#1)(2012-9#1)(2013-1#466)(2013-3#1)(2013-7#98)(2013-8#260)
thesecretion##2##1##(2008-11#2)
theses and##2##2##(2008-9#1)(2011-2#1)
theses##15##1##(1991-6#1)(1992-3#2)(1997-1#1)(2007-2#1)(2007-8#2)(2008-2#2)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
thesis abstracts##2##2##(2008-1#2)
thesis and##2##2##(2011-2#1)(2013-1#1)
thesis for##3##2##(1991-10#1)(2008-8#2)
thesis is that##2##3##(2008-1#1)(2009-2#1)
thesis is##4##2##(2006-7#1)(2008-1#1)(2008-3#1)(2009-2#1)
thesis of##3##2##(1994-11#1)(2006-7#1)(2011-2#1)
thesis that the##4##3##(1991-1#1)(1996-12#1)(1996-5#1)(2010-2#1)
thesis that##8##2##(1991-1#1)(1996-12#1)(1996-5#1)(2007-12#1)(2008-11#1)(2009-4#1)(2010-2#1)(2012-2#1)
thesis##39##1##(1991-1#1)(1991-10#1)(1991-12#1)(1994-11#1)(1996-12#1)(1996-5#1)(2006-7#5)(2007-12#1)(2007-5#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-2#2)(2009-4#1)(2010-2#2)(2011-1#2)(2011-2#3)(2012-2#4)(2013-1#1)(2013-8#1)
thestandard##2##1##(2008-11#1)(2008-2#1)
theta &lt##3##2##(2008-2#2)(2008-3#1)
theta 0##4##2##(1995-5#4)
theta = 0##3##3##(1997-5#1)(2008-10#1)(2008-3#1)
theta =##4##2##(1992-5#1)(1997-5#1)(2008-10#1)(2008-3#1)
theta and##3##2##(1995-3#1)(2005-11#1)(2008-2#1)
theta burst stimulation##2##3##(1997-7#1)(2010-7#1)
theta in##2##2##(1996-3#1)(2008-11#1)
theta microscopy##3##2##(2007-12#3)
theta of##5##2##(1997-5#4)(2008-10#1)
theta parameter of the beta-binomial distribution##3##6##(2008-10#3)
theta parameter of the beta-binomial##4##5##(2008-10#4)
theta phase coding##4##3##(2008-11#4)
theta phase precession in##3##4##(2008-11#3)
theta phase precession##7##3##(2008-11#7)
theta phase##13##2##(2008-11#13)
theta rhythm in the##3##4##(1993-9#2)(1997-8#1)
theta rhythm in##5##3##(1993-9#3)(1997-8#1)(2008-11#1)
theta rhythm##9##2##(1993-12#1)(1993-9#3)(1997-8#1)(2008-11#4)
theta synchronization##2##2##(2012-1#2)
theta##112##1##(1991-12#4)(1992-5#1)(1993-12#1)(1993-9#5)(1994-12#1)(1994-9#1)(1995-3#2)(1995-5#4)(1996-12#1)(1996-2#1)(1996-3#6)(1996-7#1)(1997-5#5)(1997-7#1)(1997-8#1)(2005-11#6)(2006-10#1)(2007-12#7)(2008-10#14)(2008-11#22)(2008-2#3)(2008-3#8)(2008-4#1)(2008-8#2)(2010-2#1)(2010-7#1)(2010-9#3)(2012-1#3)(2012-2#1)(2013-8#4)
theta(0)##4##1##(2008-2#4)
theta(i) = 30##2##3##(2008-2#2)
theta(i)##6##1##(2005-11#1)(2008-2#3)(2008-3#2)
theta(m) for##2##2##(2008-3#2)
theta(m)##3##1##(2008-3#3)
theta)##2##1##(2008-10#1)(2008-3#1)
theta-values##4##1##(2009-8#4)
thetaiotaomicron##8##1##(1997-2#2)(2006-8#6)
they accepted##2##2##(1991-8#1)(2007-8#1)
they account for##2##3##(2006-5#1)(2010-12#1)
they accounted for##2##3##(2007-3#1)(2008-5#1)
they accumulate##2##2##(2008-10#1)(2008-11#1)
they achieve##3##2##(1991-12#1)(1992-3#1)(2007-12#1)
they acquire##3##2##(1990-11#1)(1992-12#1)(1996-9#1)
they act as##5##3##(1992-2#1)(1992-9#1)(2007-6#1)(2008-10#1)(2008-2#1)
they act in##3##3##(1996-12#1)(2008-8#1)(2009-8#1)
they act on##2##3##(1994-9#1)(2009-6#1)
they act##19##2##(1992-2#1)(1992-9#1)(1993-8#1)(1994-9#2)(1996-1#1)(1996-12#1)(1997-1#1)(2006-10#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#1)
they activate##3##2##(2010-1#1)(2011-1#1)(2012-1#1)
they actually##3##2##(1994-3#1)(1996-3#1)(2008-5#1)
they address##2##2##(2006-5#1)(2007-12#1)
they administered##2##2##(1993-1#1)(2006-11#1)
they adopt##3##2##(1992-9#1)(1995-3#1)(2006-7#1)
they affect the##3##3##(1991-3#1)(2005-8#1)(2013-7#1)
they affect##13##2##(1991-3#1)(1992-9#1)(1996-1#1)(1996-3#1)(2004-12#1)(2005-8#1)(2006-11#1)(2007-8#1)(2008-10#1)(2010-3#1)(2012-3#1)(2013-7#2)
they affected##2##2##(1992-5#1)(2010-8#1)
they again##2##2##(2008-12#1)(2008-5#1)
they aggregate##2##2##(1995-8#1)(2008-10#1)
they agree with the##2##4##(2008-10#1)(2008-2#1)
they agree with##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
they agreed##2##2##(2009-6#1)(2010-3#1)
they aim to##2##3##(2008-6#1)(2011-2#1)
they all have##4##3##(2005-11#1)(2008-10#1)(2008-12#1)(2010-12#1)
they all##22##2##(1991-2#1)(1991-7#1)(1992-11#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-7#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-7#1)(2006-8#1)(2008-10#3)(2008-12#1)(2010-12#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-8#1)
they allow for##3##3##(1994-7#1)(2008-4#1)(2011-2#1)
they allow the##3##3##(2007-11#1)(2008-1#1)(2008-5#1)
they allow to##3##3##(1990-1#1)(2008-10#2)
they allow##16##2##(1990-1#1)(1992-3#1)(1994-7#1)(1996-2#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-4#2)(2008-5#1)(2009-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
they also cause##2##3##(2006-10#1)(2008-12#1)
they also consider##2##3##(2006-2#1)(2008-2#1)
they also have##4##3##(1993-7#1)(2009-4#1)(2011-2#1)(2012-11#1)
they also imply that##2##4##(1995-1#1)(2013-1#1)
they also indicated##2##3##(2007-7#1)(2012-2#1)
they also offer##3##3##(2008-11#1)(2008-7#2)
they also reported##2##3##(2010-10#1)(2013-1#1)
they also show##4##3##(1994-5#1)(1994-8#1)(2009-2#1)(2012-1#1)
they also##69##2##(1990-3#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1992-11#1)(1993-10#1)(1993-7#2)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#1)(2004-11#1)(2006-10#2)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2009-10#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#3)
they always##2##2##(2012-1#1)(2012-2#1)
they analyze##4##2##(1990-6#1)(1993-3#1)(2006-5#1)(2008-12#1)
they and the##2##3##(1996-2#1)(2007-12#1)
they and##7##2##(1994-3#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-9#1)(2010-5#1)(2011-2#1)
they anticipate##2##2##(2010-12#1)(2013-8#1)
they anticipated##3##2##(2007-5#2)(2008-9#1)
they apparently##2##2##(1992-6#1)(2008-10#1)
they appear as##2##3##(1991-5#1)(2007-12#1)
they appear to be##5##4##(1991-7#1)(2006-10#2)(2006-3#1)(2011-2#1)
they appear to##14##3##(1990-7#1)(1991-7#1)(1994-12#1)(2006-10#2)(2006-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-12#2)
they appear##21##2##(1990-7#1)(1991-5#1)(1991-7#1)(1994-12#1)(1995-12#1)(2006-10#2)(2006-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-12#2)
they appeared to be##2##4##(1990-4#1)(1997-8#1)
they appeared to##6##3##(1990-4#1)(1993-1#1)(1997-2#1)(1997-8#1)(2008-11#1)(2010-2#1)
they appeared##9##2##(1990-4#1)(1993-1#1)(1996-8#1)(1997-2#1)(1997-8#1)(2008-11#1)(2010-2#1)(2010-8#1)(2013-1#1)
they applied to the##2##4##(2008-10#1)(2012-1#1)
they applied to##3##3##(1995-2#1)(2008-10#1)(2012-1#1)
they applied##4##2##(1995-2#1)(2008-10#1)(2012-1#1)(2013-1#1)
they apply to the##2##4##(1991-4#1)(2006-10#1)
they apply to##8##3##(1991-4#1)(1992-2#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-6#1)(2010-7#1)
they approach##2##2##(1991-4#1)(2011-2#1)
they are a##11##3##(2007-3#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#3)(2011-2#2)(2012-3#1)
they are able to##9##4##(1993-3#1)(2006-10#1)(2007-2#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-2#1)
they are admitted to##2##4##(1997-3#1)(2008-3#1)
they are affected##3##3##(1995-5#1)(2008-10#1)(2008-2#1)
they are all##4##3##(1994-6#1)(1996-10#1)(2010-11#1)(2012-2#1)
they are allowed to##2##4##(1992-6#1)(2010-12#1)
they are also called anticholinesterase agents##2##6##(2013-1#2)
they are also##18##3##(1991-2#1)(1994-6#1)(1995-11#1)(1997-8#1)(2006-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-2#1)(2013-1#3)
they are among the##2##4##(1995-8#1)(2007-9#1)
they are an##3##3##(1994-9#1)(2007-7#1)(2008-10#1)
they are applicable##2##3##(2007-7#1)(2008-2#1)
they are applied to##2##4##(2008-3#1)(2011-2#1)
they are applied##4##3##(1991-8#1)(2008-10#1)(2008-3#1)(2011-2#1)
they are as##2##3##(2007-11#1)(2008-1#1)
they are assigned##2##3##(1995-10#1)(2008-12#1)
they are associated with a##2##5##(2006-10#1)(2011-2#1)
they are associated with the##2##5##(2007-12#1)(2008-7#1)
they are associated with##12##4##(1991-11#1)(1992-4#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-12#1)(2011-2#1)
they are asymptomatic##2##3##(1996-8#1)(2007-12#1)
they are at a##2##4##(2008-3#1)(2012-12#1)
they are at##5##3##(1993-9#1)(2008-3#1)(2010-12#1)(2011-3#1)(2012-12#1)
they are attached##2##3##(1991-7#1)(2009-6#1)
they are attempting##2##3##(1997-6#1)(2007-5#1)
they are based on the##2##5##(2007-12#1)(2007-2#1)
they are based on##4##4##(2007-12#1)(2007-2#1)(2007-3#1)(2008-5#1)
they are based##7##3##(2006-11#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-5#1)(2008-8#1)
they are better##2##3##(2009-6#1)(2010-7#1)
they are both##3##3##(1994-12#1)(2003-11#1)(2008-6#1)
they are called##4##3##(1990-11#1)(1997-3#1)(2007-12#1)(2008-10#1)
they are capable of##3##4##(1990-2#1)(2007-11#1)(2008-4#1)
they are carrying##2##3##(2007-5#1)(2012-12#1)
they are characterized as &quot##2##5##(2013-1#2)
they are characterized by##5##4##(2007-8#1)(2007-9#1)(2008-10#1)(2009-1#1)(2011-1#1)
they are characterized##7##3##(2007-8#1)(2007-9#1)(2008-10#1)(2009-1#1)(2011-1#1)(2013-1#2)
they are clinically asymptomatic##2##4##(2012-3#2)
they are close##2##3##(1991-5#1)(1991-8#1)
they are colonized by##2##4##(2013-1#1)(2013-8#1)
they are commonly##2##3##(2007-4#1)(2010-8#1)
they are compared with##2##4##(2005-11#1)(2006-12#1)
they are concentrated##2##3##(2006-5#1)(2008-5#1)
they are concerned##2##3##(1996-2#1)(2007-4#1)
they are considered##6##3##(1993-8#1)(2008-2#1)(2009-4#1)(2011-1#1)(2013-8#2)
they are consistent with##4##4##(1991-5#1)(1997-1#1)(2008-11#1)(2009-5#1)
they are costly##2##3##(2005-7#1)(2008-7#1)
they are created##2##3##(2006-3#1)(2009-11#1)
they are critical##2##3##(1995-1#1)(2005-7#1)
they are currently##2##3##(1993-11#1)(2007-8#1)
they are deemed##2##3##(1993-5#1)(2009-4#1)
they are derived from##2##4##(1997-2#1)(2007-9#1)
they are derived##3##3##(1993-9#1)(1997-2#1)(2007-9#1)
they are designated as##2##4##(1995-11#1)(1996-10#1)
they are designed to##3##4##(1990-3#1)(2008-7#1)(2011-2#1)
they are designed##7##3##(1990-3#1)(1996-3#1)(2006-10#1)(2008-7#1)(2008-9#1)(2010-2#1)(2011-2#1)
they are different##3##3##(1991-9#1)(2005-11#1)(2010-5#1)
they are differentiated from##2##4##(2008-4#1)(2010-12#1)
they are difficult to##4##4##(2008-2#1)(2008-4#1)(2012-2#2)
they are distinctly different##2##4##(1990-11#1)(1994-12#1)
they are divided in##2##4##(1991-4#1)(2008-9#1)
they are easily##3##3##(1991-1#1)(2008-10#1)(2008-4#1)
they are effective##5##3##(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-4#1)
they are either##4##3##(1990-1#1)(2006-10#1)(2007-7#1)(2008-4#1)
they are expected to be##3##5##(1993-6#1)(2008-3#1)(2008-4#1)
they are expected to##4##4##(1993-6#1)(2005-8#1)(2008-3#1)(2008-4#1)
they are exposed to##5##4##(2004-4#1)(2008-10#1)(2009-12#1)(2011-12#1)(2012-12#1)
they are expressed##3##3##(1993-6#1)(2008-4#1)(2008-5#1)
they are extremely##2##3##(2008-3#1)(2008-6#1)
they are fairly##3##3##(2008-4#1)(2010-11#1)(2011-1#1)
they are far from being fully utilized in the protein science community##2##12##(2008-2#1)(2008-4#1)
they are far from being##3##5##(2008-2#1)(2008-4#1)(2009-5#1)
they are far from##5##4##(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)
they are feasible##2##3##(2013-1#1)(2013-8#1)
they are fed##2##3##(1992-3#1)(1996-12#1)
they are for##2##3##(2007-9#1)(2008-10#1)
they are formed##2##3##(2007-12#2)
they are found##8##3##(1991-5#1)(1993-9#1)(1994-3#1)(1995-11#1)(2007-2#1)(2008-2#1)(2008-5#2)
they are free##2##3##(1992-3#1)(2005-11#1)
they are frequently##2##3##(2006-10#1)(2011-12#1)
they are gaining##2##3##(1993-1#1)(2006-10#1)
they are generally##4##3##(1996-2#1)(2007-5#1)(2007-8#1)(2008-10#1)
they are good##3##3##(2006-10#1)(2013-1#2)
they are handled##2##3##(2008-10#1)(2008-2#1)
they are highly##4##3##(1993-3#1)(2007-3#1)(2010-6#1)(2011-12#1)
they are homologous to##2##4##(2008-10#2)
they are homologous##3##3##(1996-2#1)(2008-10#2)
they are identical##2##3##(1991-3#1)(1992-9#1)
they are ill##2##3##(1994-9#1)(2012-2#1)
they are important for##2##4##(1991-8#1)(2006-11#1)
they are important##4##3##(1991-8#1)(2006-11#1)(2008-8#1)(2012-2#1)
they are in a##3##4##(1994-3#1)(2006-5#1)(2008-7#1)
they are in the##3##4##(1997-1#1)(2008-8#1)(2011-2#1)
they are in##14##3##(1994-3#1)(1997-1#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-6#1)(2010-10#1)(2011-2#1)(2013-7#1)
they are inaccessible to##2##4##(1993-6#1)(1995-1#1)
they are incorporated into##3##4##(2008-10#1)(2008-12#1)(2008-4#1)
they are increasingly##2##3##(1993-2#1)(2009-5#1)
they are indeed##3##3##(1991-10#1)(2008-10#1)(2011-2#1)
they are influenced##2##3##(2012-2#1)(2013-1#1)
they are introduced##4##3##(1995-5#1)(2008-7#1)(2008-8#2)
they are involved in the##3##5##(1997-3#1)(2011-2#1)(2013-7#1)
they are involved##4##3##(1997-3#1)(2008-7#1)(2011-2#1)(2013-7#1)
they are known##2##3##(1991-5#1)(2005-11#1)
they are less##7##3##(1994-5#1)(1997-8#1)(2004-2#1)(2006-9#1)(2007-12#2)(2011-2#1)
they are likely to be##4##5##(1992-6#1)(1996-11#1)(2008-10#1)(2008-4#1)
they are likely to##6##4##(1992-6#1)(1996-11#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-3#1)
they are likely##7##3##(1992-6#1)(1995-12#1)(1996-11#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-3#1)
they are limited##3##3##(2009-7#1)(2011-2#1)(2013-8#1)
they are made available##2##4##(1995-5#1)(2007-7#1)
they are made##4##3##(1991-6#1)(1995-5#1)(1996-6#1)(2007-7#1)
they are mainly##2##3##(1994-6#1)(2011-2#1)
they are mediated by##2##4##(1991-1#1)(2011-2#1)
they are mild##2##3##(2007-9#1)(2013-1#1)
they are more effective in##2##5##(1994-5#1)(2013-1#1)
they are more effective##3##4##(1994-5#1)(2010-11#1)(2013-1#1)
they are more##15##3##(1992-10#2)(1994-5#1)(1997-8#1)(2005-9#1)(2006-11#1)(2006-9#1)(2007-12#1)(2007-2#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-12#1)(2013-1#1)
they are morphologically##2##3##(2008-11#1)(2010-3#1)
they are most commonly##2##4##(1991-7#1)(2013-8#1)
they are most##9##3##(1991-7#1)(1994-10#1)(1994-9#1)(1995-8#1)(2006-10#1)(2008-8#2)(2009-8#1)(2013-8#1)
they are much more##2##4##(1990-11#1)(2009-12#1)
they are much##3##3##(1990-11#1)(2008-2#1)(2009-12#1)
they are nearly##2##3##(1990-12#1)(2007-12#1)
they are not a##3##4##(2008-7#1)(2012-3#1)(2013-1#1)
they are not able to##2##5##(2005-4#1)(2013-1#1)
they are not as##4##4##(1997-2#1)(2006-5#1)(2007-10#1)(2012-3#1)
they are not likely to##2##5##(2004-11#1)(2011-1#1)
they are not sufficient##2##4##(2007-10#1)(2008-4#1)
they are not##61##3##(1990-5#1)(1990-7#1)(1991-12#2)(1991-5#1)(1991-7#1)(1992-12#1)(1993-7#1)(1994-3#1)(1994-4#1)(1994-6#1)(1996-11#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#3)(2008-7#2)(2008-8#1)(2009-11#1)(2009-6#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#4)(2011-7#1)(2012-11#1)(2012-12#2)(2012-3#3)(2013-1#3)(2013-8#2)
they are now being##2##4##(2009-5#1)(2013-8#1)
they are now##8##3##(1997-1#1)(2005-11#1)(2006-4#1)(2007-4#1)(2008-5#1)(2009-5#1)(2010-12#1)(2013-8#1)
they are of particular interest##2##5##(2007-12#1)(2008-11#1)
they are of##4##3##(1996-9#1)(2007-12#1)(2008-11#1)(2008-7#1)
they are often limited and do not have good coverage for narrative clinical text##2##14##(2013-1#2)
they are often##12##3##(2006-5#1)(2006-9#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-6#1)(2011-7#1)(2012-12#1)(2012-3#1)(2013-1#3)
they are only##2##3##(2006-6#1)(2008-10#1)
they are organized##2##3##(1990-4#1)(1992-9#1)
they are potent##2##3##(1993-11#1)(2008-8#1)
they are potentially##4##3##(1992-8#1)(2006-7#1)(2006-9#1)(2008-5#1)
they are present in##2##4##(2007-2#1)(2008-11#1)
they are present##4##3##(2006-12#1)(2007-12#1)(2007-2#1)(2008-11#1)
they are presented##3##3##(1992-2#1)(2007-8#1)(2008-3#1)
they are probably the##2##4##(1995-12#1)(2008-5#1)
they are probably##4##3##(1994-11#1)(1995-12#1)(2008-5#2)
they are properly##2##3##(1995-12#1)(1996-3#1)
they are quite##3##3##(1993-12#1)(2008-10#1)(2010-12#1)
they are rarely##3##3##(2005-12#1)(2007-4#1)(2007-7#1)
they are regarded as##2##4##(2012-2#2)
they are regulated in##2##4##(1997-2#1)(2011-2#1)
they are regulated##4##3##(1994-11#1)(1997-2#1)(2009-8#1)(2011-2#1)
they are relatively##3##3##(2007-3#1)(2008-10#1)(2012-2#1)
they are required##3##3##(1992-9#1)(2007-8#1)(2008-12#1)
they are responsible for##2##4##(1995-1#1)(2007-11#1)
they are responsible##3##3##(1995-1#1)(1996-12#1)(2007-11#1)
they are routinely used##2##4##(2008-12#1)(2008-9#1)
they are safe and##2##4##(2008-1#1)(2011-2#1)
they are safe##3##3##(2008-1#1)(2008-7#1)(2011-2#1)
they are seeking##2##3##(1994-2#1)(2007-2#1)
they are separated##5##3##(2005-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)
they are shifted##2##3##(1995-8#1)(2009-4#1)
they are shown to##2##4##(2004-12#1)(2008-2#1)
they are significantly##3##3##(1993-5#1)(2006-5#1)(2006-6#1)
they are similar##3##3##(1994-6#1)(1995-8#1)(2008-7#1)
they are slightly more##2##4##(2008-5#1)(2013-8#1)
they are stable##3##3##(1991-10#1)(1995-8#1)(2008-2#1)
they are still##5##3##(1990-4#1)(1996-8#1)(2006-2#1)(2008-1#1)(2008-8#1)
they are sufficient##2##3##(1993-12#1)(2008-9#1)
they are suitable##2##3##(2008-10#1)(2009-11#1)
they are susceptible##2##3##(2005-9#1)(2008-10#1)
they are taken up##2##4##(1994-6#1)(2008-9#1)
they are taken##3##3##(1994-6#1)(2008-9#1)(2011-3#1)
they are taking##2##3##(2007-7#1)(2008-8#1)
they are the##17##3##(1991-2#1)(1996-2#1)(2006-10#1)(2006-12#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-2#1)(2012-1#1)
they are time-consuming and##2##4##(1995-1#1)(2012-2#1)
they are time-consuming##3##3##(1993-2#1)(1995-1#1)(2012-2#1)
they are to be##7##4##(1996-11#1)(1996-3#1)(2007-11#1)(2007-9#1)(2008-1#1)(2012-2#2)
they are to##25##3##(1992-11#1)(1992-3#1)(1994-2#3)(1994-9#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-3#2)(1997-3#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-9#1)(2008-1#2)(2008-12#2)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#2)
they are transmitted##2##3##(2008-1#1)(2008-2#1)
they are transported##2##3##(2007-8#1)(2013-1#1)
they are trying to##3##4##(1997-4#1)(2010-2#1)(2011-1#1)
they are typically##3##3##(2007-2#1)(2008-7#1)(2011-2#1)
they are unable to##8##4##(1995-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2013-1#3)
they are unaffected by##2##4##(1991-8#1)(2007-8#1)
they are uncertain##2##3##(1993-11#1)(2011-2#1)
they are uncommon##2##3##(1993-9#1)(2006-7#1)
they are under##3##3##(1995-2#1)(1996-2#1)(2010-8#1)
they are underutilized##2##3##(2006-10#1)(2008-11#1)
they are unlikely to##2##4##(1997-7#1)(2006-10#1)
they are used as##3##4##(1994-6#1)(2010-3#1)(2013-7#1)
they are used for##3##4##(1991-12#1)(1992-9#1)(2008-8#1)
they are used in##6##4##(2007-1#1)(2007-11#1)(2008-3#1)(2008-7#1)(2010-12#1)(2013-8#1)
they are used##17##3##(1991-12#1)(1992-9#1)(1994-6#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-3#1)(2010-5#1)(2013-7#1)(2013-8#1)
they are useful##3##3##(2008-11#1)(2010-11#1)(2010-4#1)
they are usually##7##3##(2006-10#1)(2007-2#1)(2007-8#1)(2009-2#1)(2010-12#1)(2012-3#1)(2013-1#1)
they are very similar##2##4##(2007-11#1)(2008-8#1)
they are very useful##2##4##(2008-8#1)(2008-9#1)
they are very##10##3##(2007-11#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-3#1)(2012-1#1)(2012-11#1)
they are widely##2##3##(2005-11#1)(2013-7#1)
they are with##2##3##(2007-12#1)(2007-7#1)
they are##1063##2##(1990-1#2)(1990-10#1)(1990-11#4)(1990-12#4)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#1)(1991-1#3)(1991-10#3)(1991-11#2)(1991-12#4)(1991-2#5)(1991-3#2)(1991-4#1)(1991-5#6)(1991-6#3)(1991-7#6)(1991-8#5)(1991-9#1)(1992-10#3)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#9)(1992-4#1)(1992-6#2)(1992-8#2)(1992-9#4)(1993-1#3)(1993-11#5)(1993-12#3)(1993-2#3)(1993-3#4)(1993-4#1)(1993-5#3)(1993-6#5)(1993-7#1)(1993-8#1)(1993-9#4)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#5)(1994-3#7)(1994-4#2)(1994-5#3)(1994-6#7)(1994-9#5)(1995-1#8)(1995-10#2)(1995-11#5)(1995-12#5)(1995-2#3)(1995-3#4)(1995-5#6)(1995-6#4)(1995-7#1)(1995-8#9)(1996-1#2)(1996-10#3)(1996-11#4)(1996-12#7)(1996-2#7)(1996-3#6)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#5)(1997-2#6)(1997-3#6)(1997-4#3)(1997-6#3)(1997-7#3)(1997-8#5)(2003-11#1)(2004-10#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-4#1)(2005-10#3)(2005-11#12)(2005-12#2)(2005-4#1)(2005-5#1)(2005-7#2)(2005-8#2)(2005-9#3)(2006-10#27)(2006-11#4)(2006-12#7)(2006-2#5)(2006-3#4)(2006-4#2)(2006-5#5)(2006-6#2)(2006-7#7)(2006-8#5)(2006-9#5)(2007-1#1)(2007-10#7)(2007-11#16)(2007-12#32)(2007-2#16)(2007-3#5)(2007-4#6)(2007-5#6)(2007-6#3)(2007-7#11)(2007-8#13)(2007-9#18)(2008-1#15)(2008-10#51)(2008-11#19)(2008-12#10)(2008-2#30)(2008-3#20)(2008-4#31)(2008-5#20)(2008-6#10)(2008-7#26)(2008-8#28)(2008-9#14)(2009-1#1)(2009-10#2)(2009-11#4)(2009-12#5)(2009-2#2)(2009-3#3)(2009-4#8)(2009-5#7)(2009-6#7)(2009-7#1)(2009-8#9)(2009-9#3)(2010-10#2)(2010-11#7)(2010-12#14)(2010-2#7)(2010-3#5)(2010-4#3)(2010-5#6)(2010-6#1)(2010-7#7)(2010-8#4)(2010-9#2)(2011-1#13)(2011-12#4)(2011-2#31)(2011-3#2)(2011-7#2)(2012-1#3)(2012-11#5)(2012-12#13)(2012-2#18)(2012-3#16)(2013-1#33)(2013-7#8)(2013-8#15)
they aren't##2##2##(1994-2#1)(2007-4#1)
they argue##3##2##(1993-1#1)(2007-9#1)(2008-1#1)
they arise from the##2##4##(2005-8#1)(2006-5#1)
they arise from##5##3##(1996-12#1)(2005-8#1)(2006-5#1)(2006-9#1)(2012-2#1)
they arise##9##2##(1996-12#1)(2005-8#1)(2006-5#1)(2006-9#1)(2007-12#1)(2008-11#1)(2008-9#1)(2012-1#1)(2012-2#1)
they ask##2##2##(2005-9#1)(2007-8#1)
they associated##2##2##(2005-8#1)(2009-5#1)
they attach to##2##3##(2008-11#2)
they attained##3##2##(1994-7#1)(1997-5#1)(2007-3#1)
they attribute##2##2##(2006-5#1)(2012-1#1)
they avoid##2##2##(2007-11#2)
they avoided##2##2##(2008-12#2)
they be##13##2##(1991-12#1)(1992-1#1)(1992-5#1)(1993-5#1)(1996-12#1)(2006-10#2)(2008-9#1)(2009-8#1)(2010-11#1)(2010-5#1)(2012-12#1)(2013-1#1)
they became##7##2##(1990-2#1)(1992-7#1)(1994-6#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-11#1)
they become more##2##3##(2004-9#1)(2008-3#1)
they become symptomatic##3##3##(2007-10#1)(2007-8#1)(2008-10#1)
they become##25##2##(1990-5#1)(1992-5#1)(1992-6#1)(1994-6#1)(2004-9#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#2)(2008-9#1)(2010-4#1)(2012-2#1)
they begin##2##2##(1992-3#1)(2006-11#1)
they believe the##2##3##(1990-2#1)(2005-9#1)
they believe##6##2##(1990-2#1)(1993-1#1)(1995-1#1)(2005-9#1)(2008-2#1)(2012-3#1)
they believed that the##2##4##(2006-9#1)(2012-2#1)
they believed##5##2##(1996-11#1)(2006-9#1)(2009-4#1)(2012-2#1)(2013-1#1)
they belong to a##2##4##(2008-4#1)(2008-8#1)
they belong to##4##3##(2006-12#1)(2008-11#1)(2008-4#1)(2008-8#1)
they belong##8##2##(2006-12#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-3#1)
they belonged to##2##3##(1992-11#1)(2008-10#1)
they bind to##3##3##(1992-12#1)(1997-4#1)(2008-11#1)
they bind##8##2##(1991-9#1)(1992-12#1)(1996-10#1)(1997-4#1)(2007-12#1)(2008-11#1)(2008-4#1)(2010-11#1)
they both##5##2##(2005-11#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
they bound##2##2##(1994-9#1)(1996-10#1)
they bring##4##2##(1996-2#1)(1996-3#1)(1997-8#1)(2009-5#1)
they buy##2##2##(2010-4#1)(2012-2#1)
they calculated##2##2##(1993-2#1)(1996-6#1)
they called##3##2##(1993-6#1)(1997-6#1)(2009-2#1)
they can act as##2##4##(2010-7#1)(2012-2#1)
they can affect##2##3##(1991-7#1)(2007-12#1)
they can also be##3##4##(2007-8#1)(2008-10#1)(2008-4#1)
they can also contribute to the development of##2##8##(2008-4#1)(2013-8#1)
they can also##9##3##(1993-11#1)(2005-11#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-4#2)(2012-2#1)(2013-8#1)
they can be applied##2##4##(2005-11#1)(2008-4#1)
they can be combined##2##4##(2007-12#1)(2008-2#1)
they can be considered##2##4##(2005-11#1)(2006-6#1)
they can be diagnosed##2##4##(1997-3#1)(2006-8#1)
they can be divided into two##2##6##(2008-9#1)(2010-2#1)
they can be located##2##4##(2007-12#1)(2008-2#1)
they can be of great value in##2##7##(2009-8#1)(2013-8#1)
they can be used as##2##5##(1996-2#1)(2009-7#1)
they can be used for##3##5##(1992-8#1)(2008-9#1)(2009-3#1)
they can be used in##2##5##(1994-12#1)(2013-1#1)
they can be used to investigate##2##6##(1990-7#1)(2012-3#1)
they can be used to##4##5##(1990-12#1)(1990-7#1)(2008-3#1)(2012-3#1)
they can be used with##2##5##(2006-10#1)(2011-1#1)
they can be used##15##4##(1990-12#1)(1990-7#1)(1992-8#1)(1994-12#1)(1995-6#1)(1996-2#1)(2006-10#1)(2006-5#1)(2008-3#1)(2008-9#1)(2009-3#1)(2009-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
they can be##103##3##(1990-11#1)(1990-12#3)(1990-7#1)(1991-12#1)(1991-3#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-6#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(2004-4#1)(2004-9#1)(2005-11#3)(2006-10#2)(2006-12#2)(2006-5#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#8)(2008-3#4)(2008-4#6)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#5)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#2)
they can become##2##3##(2007-2#1)(2012-2#1)
they can bind##2##3##(1992-12#1)(1996-10#1)
they can cause##5##3##(1990-3#1)(1990-6#1)(2008-8#1)(2009-2#1)(2013-1#1)
they can contribute to##2##4##(2009-5#1)(2013-8#1)
they can control##2##3##(1991-7#1)(2008-4#1)
they can easily be##4##4##(1994-3#1)(2008-10#1)(2008-2#1)(2012-12#1)
they can easily##6##3##(1994-3#1)(2007-7#1)(2008-10#1)(2008-2#1)(2011-1#1)(2012-12#1)
they can expect##3##3##(2007-2#1)(2009-9#1)(2013-1#1)
they can form##2##3##(2007-11#1)(2008-4#1)
they can help##2##3##(2008-2#1)(2008-5#1)
they can influence the##2##4##(1996-3#1)(2008-7#1)
they can lead to##5##4##(2006-12#1)(2007-12#1)(2007-8#1)(2008-7#1)(2013-8#1)
they can no longer##2##4##(1997-5#1)(2009-10#1)
they can provide##3##3##(2006-12#1)(2008-10#1)(2013-1#1)
they can reach##2##3##(2008-5#1)(2011-2#1)
they can replace##2##3##(1992-2#1)(2008-7#1)
they can take##2##3##(1995-2#1)(2011-1#1)
they can then##2##3##(1997-8#1)(2008-10#1)
they can undergo##2##3##(1994-11#1)(2008-8#1)
they can work##2##3##(1994-1#1)(2011-1#1)
they can##247##2##(1990-11#1)(1990-12#3)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-3#2)(1991-7#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-4#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-12#1)(2004-3#1)(2004-4#1)(2004-9#2)(2005-11#5)(2005-12#1)(2006-10#3)(2006-12#5)(2006-2#3)(2006-4#1)(2006-5#2)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#2)(2007-11#3)(2007-12#4)(2007-2#4)(2007-4#1)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#14)(2008-11#5)(2008-12#3)(2008-2#10)(2008-3#6)(2008-4#12)(2008-5#4)(2008-7#9)(2008-8#4)(2008-9#9)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#7)(2012-1#3)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#6)(2013-8#5)
they cannot be##2##3##(1992-3#1)(2008-2#1)
they cannot##9##2##(1992-3#1)(1993-4#1)(1994-12#1)(1997-5#1)(2006-2#1)(2007-11#1)(2008-2#1)(2010-12#1)(2010-4#1)
they care##2##2##(1991-2#1)(2007-12#1)
they carry a##2##3##(2005-8#1)(2008-10#1)
they carry##6##2##(1996-2#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2012-3#1)
they cause a##2##3##(1994-8#1)(2012-12#1)
they cause and##2##3##(2006-10#1)(2006-3#1)
they cause##17##2##(1990-9#1)(1994-8#1)(1997-7#1)(2006-10#2)(2006-3#1)(2008-1#1)(2008-10#5)(2008-5#1)(2008-8#1)(2011-2#2)(2012-12#1)
they ceased##2##2##(2005-7#1)(2010-8#1)
they change##3##2##(2007-9#1)(2008-2#1)(2011-12#1)
they choose##4##2##(1991-3#1)(2007-2#1)(2012-1#1)(2013-8#1)
they chose their##2##3##(2006-7#1)(2010-2#1)
they chose to##2##3##(2008-7#1)(2009-6#1)
they chose##5##2##(2006-7#1)(2008-7#1)(2009-6#1)(2010-2#1)(2010-8#1)
they clearly##2##2##(2008-12#1)(2013-8#1)
they come##3##2##(1996-2#1)(1997-5#1)(2010-9#1)
they compete##2##2##(2008-10#1)(2009-3#1)
they completed##3##2##(2006-7#1)(2007-12#1)(2008-12#1)
they comprise a##2##3##(1993-2#1)(1997-6#1)
they comprise##3##2##(1993-2#1)(1997-6#1)(2009-2#1)
they compromise##3##2##(2008-2#1)(2013-1#2)
they connect##3##2##(1991-3#1)(2008-8#1)(2009-7#1)
they consent to##2##3##(1992-3#1)(2007-11#1)
they consider to be important##2##5##(1996-1#1)(2011-2#1)
they consider##12##2##(1992-10#1)(1993-10#1)(1993-6#1)(1996-1#1)(2007-8#1)(2008-11#1)(2008-8#1)(2009-6#1)(2011-2#4)
they considered##5##2##(2006-12#1)(2007-7#1)(2008-11#1)(2009-6#1)(2013-1#1)
they consist of##2##3##(1990-7#1)(1997-2#1)
they constitute a##2##3##(1996-8#1)(2008-12#1)
they constitute##4##2##(1996-8#1)(2006-10#1)(2008-12#1)(2008-3#1)
they construct##2##2##(2008-12#1)(2009-7#1)
they consumed##4##2##(1992-8#1)(2010-8#1)(2012-12#1)(2012-2#1)
they contain a##4##3##(2006-2#1)(2008-3#1)(2009-3#1)(2013-1#1)
they contain different##2##3##(1992-7#1)(2013-1#1)
they contain##18##2##(1991-5#1)(1992-7#1)(1996-10#1)(1996-4#1)(1997-1#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-3#1)(2010-8#1)(2013-1#3)
they contained##7##2##(1990-11#1)(1991-10#1)(1991-3#1)(1997-2#1)(2008-10#1)(2008-5#2)
they continue to##6##3##(1991-11#1)(2004-9#1)(2008-10#1)(2012-3#1)(2013-1#2)
they continued##2##2##(1994-6#1)(2008-4#1)
they contribute to the##3##4##(2006-2#1)(2008-10#1)(2012-1#1)
they contribute to##6##3##(2006-2#1)(2006-6#1)(2008-10#1)(2010-11#1)(2012-1#1)(2012-12#1)
they contribute##8##2##(1996-3#1)(2006-2#1)(2006-6#1)(2008-10#1)(2009-5#1)(2010-11#1)(2012-1#1)(2012-12#1)
they correspond to##2##3##(1995-5#1)(2010-3#1)
they could be used##2##4##(2008-10#1)(2010-8#1)
they could be##20##3##(1995-2#1)(1996-9#1)(1997-6#1)(2006-2#1)(2007-3#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#2)(2008-9#1)(2009-12#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
they could not be##4##4##(1992-6#1)(1992-8#1)(1995-6#1)(1996-6#1)
they could not##7##3##(1992-6#1)(1992-8#1)(1995-6#1)(1996-10#1)(1996-6#1)(2010-8#1)(2013-8#1)
they could potentially##2##3##(2008-10#1)(2009-7#1)
they could still##2##3##(1996-2#1)(2009-4#1)
they could##63##2##(1990-2#1)(1991-9#1)(1992-10#1)(1992-4#1)(1992-6#1)(1992-8#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-6#1)(2005-11#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-3#1)(2007-9#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-12#1)(2009-4#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#5)(2012-2#1)(2013-1#3)(2013-8#2)
they covered##3##2##(1994-8#1)(2008-5#1)(2013-8#1)
they create##3##2##(1994-12#1)(1997-1#1)(2011-2#1)
they created##3##2##(1996-9#1)(2008-5#1)(2011-2#1)
they cross the##2##3##(1996-4#1)(2008-10#1)
they deal with##2##3##(2007-11#1)(2008-3#1)
they decrease##2##2##(1993-12#1)(2008-4#1)
they decreased##2##2##(1991-6#1)(1997-6#1)
they deemed##2##2##(2008-1#1)(2008-5#1)
they delay the##2##3##(2008-1#1)(2010-12#1)
they delay##3##2##(2008-1#2)(2010-12#1)
they demonstrate a##2##3##(1993-1#1)(2008-7#1)
they demonstrate that##4##3##(1992-7#1)(1994-3#1)(2008-7#1)(2008-9#1)
they demonstrate##10##2##(1990-3#1)(1992-7#1)(1993-1#1)(1994-3#1)(2005-8#1)(2008-3#1)(2008-7#2)(2008-9#1)(2012-12#1)
they depend##2##2##(1993-6#1)(2008-2#1)
they derive##2##2##(2006-6#1)(2008-2#1)
they describe the##3##3##(1991-3#1)(2008-2#1)(2012-12#1)
they describe##9##2##(1990-5#1)(1991-3#1)(1993-9#1)(1995-1#1)(2006-11#1)(2006-7#1)(2006-8#1)(2008-2#1)(2012-12#1)
they deserve##2##2##(1994-12#1)(2010-11#1)
they detect##2##2##(2008-4#1)(2012-2#1)
they develop##13##2##(1990-7#1)(1993-1#1)(1994-3#1)(1995-11#1)(1995-3#1)(1996-1#1)(2005-9#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-8#1)(2012-2#1)
they developed##4##2##(1993-10#1)(1993-12#2)(1993-7#1)
they did in##2##3##(1993-12#1)(2008-10#1)
they did not change##2##4##(2008-10#1)(2012-12#1)
they did not have to##2##5##(2006-7#1)(2009-10#1)
they did not have##4##4##(1994-3#1)(2006-7#1)(2009-10#1)(2012-12#1)
they did not impair##2##4##(1992-9#1)(2009-12#1)
they did not know##3##4##(1996-2#1)(2010-8#1)(2012-12#1)
they did not receive##2##4##(2009-10#1)(2011-12#1)
they did not##44##3##(1991-1#1)(1991-6#1)(1991-7#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-7#1)(1995-11#2)(1996-2#1)(1996-8#1)(2004-12#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-3#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-10#2)(2009-12#1)(2009-4#1)(2010-4#1)(2010-8#1)(2011-12#1)(2012-12#5)(2013-1#1)(2013-8#1)
they did##57##2##(1991-1#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-7#1)(1995-11#2)(1995-6#1)(1996-2#1)(1996-8#1)(2004-12#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-3#1)(2007-5#2)(2007-8#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#2)(2009-12#1)(2009-4#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-12#1)(2012-12#5)(2012-2#1)(2013-1#1)(2013-8#1)
they didn't##2##2##(1993-12#1)(1996-2#1)
they die##2##2##(1993-8#1)(2008-7#1)
they differ from##3##3##(1990-10#1)(1997-6#1)(2008-4#1)
they differ in the##2##4##(1990-6#1)(2010-3#1)
they differ in their##2##4##(1991-9#1)(2006-8#1)
they differ in##10##3##(1990-6#1)(1991-5#1)(1991-9#1)(1997-4#1)(2006-10#1)(2006-8#1)(2008-10#2)(2010-3#1)(2010-8#1)
they differ##20##2##(1990-10#1)(1990-6#1)(1991-5#1)(1991-9#1)(1993-5#1)(1996-5#1)(1997-4#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-12#1)
they differed in their##2##4##(1996-7#1)(2010-8#1)
they differed in##3##3##(1992-7#1)(1996-7#1)(2010-8#1)
they differed##5##2##(1992-7#1)(1996-7#1)(2005-8#1)(2008-10#1)(2010-8#1)
they differentiate##2##2##(2006-10#1)(2008-11#1)
they directly##2##2##(1994-3#1)(2005-11#1)
they discuss the##3##3##(1997-3#1)(2007-8#1)(2010-8#1)
they discuss##6##2##(1993-12#1)(1997-3#1)(2006-10#2)(2007-8#1)(2010-8#1)
they display a##2##3##(1995-8#1)(2009-9#1)
they display##9##2##(1993-12#1)(1994-8#1)(1995-8#1)(1996-9#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-3#1)(2010-6#1)
they displayed a##2##3##(2008-11#1)(2008-4#1)
they displayed##4##2##(1993-6#1)(2008-11#1)(2008-4#1)(2012-12#1)
they distinguished##2##2##(1992-12#1)(2008-6#1)
they diverge##2##2##(1990-3#1)(1990-5#1)
they divide##2##2##(1995-11#1)(2009-4#1)
they do in##5##3##(1991-11#1)(1992-7#1)(1993-12#1)(1994-9#1)(1995-1#1)
they do it##2##3##(2008-6#1)(2009-8#1)
they do not act##2##4##(1993-8#1)(2010-10#1)
they do not appear to##2##5##(1996-11#1)(2007-9#1)
they do not bind##2##4##(1995-5#1)(2008-10#1)
they do not completely##2##4##(2006-10#1)(2010-4#1)
they do not depend on##2##5##(1993-12#1)(1995-11#1)
they do not explicitly##2##4##(1993-3#1)(2011-2#1)
they do not form##2##4##(1996-9#1)(2008-10#1)
they do not give##2##4##(2008-10#1)(2012-3#1)
they do not have##5##4##(2006-10#2)(2008-5#1)(2012-12#2)
they do not need##2##4##(2008-1#1)(2008-5#1)
they do not provide##4##4##(1992-3#1)(1997-4#1)(2007-7#1)(2008-10#1)
they do not reach##2##4##(2005-8#1)(2008-10#1)
they do not require##4##4##(2006-3#1)(2007-12#2)(2008-4#1)
they do not##104##3##(1990-3#1)(1991-4#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-6#2)(1996-9#1)(1997-1#2)(1997-4#1)(1997-6#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-4#1)(2011-1#3)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#6)
they do so##2##3##(1992-11#1)(2008-2#1)
they do to##3##3##(1990-7#1)(2005-7#1)(2008-11#1)
they do##141##2##(1990-2#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-7#2)(1992-8#2)(1992-9#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-2#2)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-6#2)(1996-9#1)(1997-1#2)(1997-4#1)(1997-6#2)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#6)(2006-12#1)(2006-3#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-4#1)(2011-1#3)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#6)
they don't##4##2##(1991-2#1)(1992-10#1)(2006-9#1)(2007-9#1)
they effectively##2##2##(2008-3#1)(2013-8#1)
they either##6##2##(1995-5#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2013-1#1)
they elicit##3##2##(1994-11#1)(2008-11#1)(2008-4#1)
they emerge##5##2##(2008-1#1)(2008-10#1)(2008-6#1)(2009-5#1)(2010-7#1)
they emphasize the##3##3##(1992-5#1)(1995-5#1)(1996-6#1)
they emphasize##4##2##(1992-5#1)(1995-5#1)(1996-6#1)(2010-12#1)
they enable the##2##3##(2007-11#1)(2008-10#1)
they enable##5##2##(2007-11#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
they encode##3##2##(1993-11#1)(1993-12#1)(2006-10#1)
they encounter##11##2##(1991-11#1)(1996-1#1)(2006-11#1)(2006-5#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-8#1)(2012-2#1)(2013-8#1)
they encountered##5##2##(1991-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
they engage in##2##3##(2008-12#1)(2008-6#1)
they engage##3##2##(2007-10#1)(2008-12#1)(2008-6#1)
they enhance##4##2##(1993-4#1)(1995-6#1)(1996-11#1)(2011-2#1)
they enjoy##2##2##(1997-1#1)(2004-10#1)
they enter##3##2##(1990-12#1)(1995-8#1)(2009-4#1)
they establish##3##2##(2008-1#1)(2008-11#1)(2008-2#1)
they evaluate##2##2##(1993-3#1)(2009-6#1)
they eventually##2##2##(1993-7#1)(2005-10#1)
they ever##2##2##(2006-7#1)(2012-3#1)
they evolve##6##2##(2007-6#1)(2008-11#1)(2008-2#1)(2009-10#1)(2010-12#1)(2010-3#1)
they evolved##2##2##(2006-12#1)(2008-8#1)
they exert##9##2##(1990-11#1)(2008-11#1)(2008-4#1)(2010-10#1)(2011-2#1)(2013-1#2)(2013-8#2)
they exhibit a##6##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2012-2#1)(2013-1#1)
they exhibit##21##2##(1996-5#1)(2006-10#1)(2007-11#3)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#1)(2008-6#1)(2009-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
they exhibited a##2##3##(1991-6#1)(2012-2#1)
they exhibited##7##2##(1991-2#1)(1991-6#1)(1995-12#1)(1995-2#1)(2008-10#1)(2008-7#1)(2012-2#1)
they exist in##2##3##(1995-4#1)(2010-6#1)
they exist##5##2##(1995-4#1)(2010-11#1)(2010-3#1)(2010-6#1)(2012-3#1)
they expect##2##2##(2005-10#1)(2007-10#1)
they expected##3##2##(2005-10#1)(2008-11#1)(2012-1#1)
they experience##7##2##(1994-11#1)(2005-7#1)(2006-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-5#1)
they experienced##11##2##(2008-11#1)(2008-6#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-3#2)(2010-4#1)(2011-12#1)(2011-2#1)(2012-2#1)
they explain##2##2##(1990-3#1)(1994-8#1)
they explore##3##2##(1993-12#1)(2006-5#1)(2008-12#1)
they explored##2##2##(2007-4#1)(2008-10#1)
they express##3##2##(1994-11#1)(2007-12#1)(2008-7#1)
they expressed##3##2##(1995-11#1)(1995-6#1)(2006-10#1)
they face in##2##3##(2007-7#1)(2008-12#1)
they face##11##2##(1994-2#1)(2006-5#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-4#1)(2009-7#1)(2011-1#2)(2012-3#1)
they faced##2##2##(2008-7#1)(2013-8#1)
they facilitate##4##2##(1994-11#1)(1995-8#1)(1997-2#1)(2010-9#1)
they fail to##9##3##(1990-8#1)(1993-9#1)(1994-9#1)(1995-2#1)(1995-5#1)(1997-5#1)(2008-10#1)(2008-6#1)(2008-7#1)
they failed to##3##3##(1995-8#1)(1996-5#1)(2006-7#1)
they failed##5##2##(1995-8#1)(1996-5#1)(2006-7#1)(2007-8#1)(2010-8#1)
they fall##3##2##(1990-5#1)(1993-3#1)(2008-11#1)
they feel##7##2##(2007-2#1)(2008-3#1)(2009-12#1)(2011-2#2)(2012-1#1)(2012-3#1)
they fell##2##2##(2007-6#1)(2008-5#1)
they felt more##2##3##(2008-11#1)(2009-12#1)
they felt they had##2##4##(2007-9#1)(2008-1#1)
they felt##8##2##(1991-3#1)(1994-3#1)(1996-3#1)(2007-9#1)(2008-1#1)(2008-11#2)(2009-12#1)
they fill##2##2##(2008-8#1)(2012-2#1)
they find a##4##3##(1992-1#1)(1994-12#1)(2009-3#1)(2012-2#1)
they find in##2##3##(2007-8#1)(2010-12#1)
they find that##4##3##(1992-2#2)(1994-3#1)(2008-5#1)
they find##11##2##(1992-1#1)(1992-2#2)(1994-12#1)(1994-3#1)(1997-5#1)(2007-8#1)(2008-5#1)(2009-3#1)(2010-12#1)(2012-2#1)
they first##4##2##(1993-7#1)(2005-7#1)(2009-3#1)(2010-3#1)
they fit into##3##3##(1992-12#1)(1993-3#1)(2008-12#1)
they focus on##2##3##(1994-3#1)(2009-4#1)
they focus##4##2##(1994-3#1)(2009-4#2)(2010-7#1)
they followed##2##2##(1994-3#1)(2008-12#1)
they form a##2##3##(1994-3#1)(2008-10#1)
they form##17##2##(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-8#1)(1997-1#1)(2004-11#1)(2005-11#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-3#1)(2009-5#1)(2012-1#1)(2012-12#1)
they formed a##2##3##(2008-11#1)(2008-7#1)
they formed##5##2##(1990-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-7#1)
they found##9##2##(1990-3#1)(1996-4#1)(2005-1#1)(2005-11#1)(2005-7#1)(2007-4#1)(2008-12#1)(2011-2#1)(2012-12#1)
they frequently##4##2##(2005-10#1)(2007-12#1)(2007-6#1)(2009-5#1)
they fulfill##3##2##(1992-8#1)(2009-4#1)(2012-12#1)
they fully##3##2##(2008-10#1)(2008-2#1)(2008-7#1)
they function in##3##3##(2007-1#1)(2007-12#1)(2008-6#1)
they function##9##2##(1990-12#1)(1993-12#1)(2007-1#1)(2007-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-9#1)
they gain##3##2##(1991-7#1)(1997-5#1)(2006-9#1)
they gained##3##2##(2008-11#1)(2011-1#1)(2012-12#1)
they gave##2##2##(2006-8#1)(2008-5#1)
they generate the##2##3##(1994-6#1)(2008-1#1)
they generate##6##2##(1994-6#1)(1995-2#1)(1996-2#1)(2008-1#1)(2008-4#1)(2008-9#1)
they get##4##2##(2006-6#1)(2008-8#1)(2009-10#1)(2011-1#1)
they give rise to##2##4##(1994-3#1)(1995-2#1)
they give##3##2##(1994-3#1)(1994-8#1)(1995-2#1)
they go##3##2##(2010-5#1)(2011-2#1)(2012-1#1)
they grew##2##2##(1994-7#1)(1995-2#1)
they grow##4##2##(2008-6#1)(2008-8#1)(2010-12#1)(2010-2#1)
they had a clinical##2##4##(1994-3#1)(2007-9#1)
they had a higher##2##4##(1992-5#1)(2010-10#1)
they had a##12##3##(1992-5#1)(1994-3#1)(1994-4#1)(2006-10#1)(2007-9#1)(2008-4#2)(2009-3#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-2#1)
they had acquired##2##3##(2008-11#1)(2011-2#1)
they had become##2##3##(2006-8#1)(2008-11#1)
they had been##15##3##(1990-7#1)(1992-2#1)(1995-5#1)(1995-9#1)(1996-12#1)(1997-7#1)(2007-2#2)(2007-8#1)(2007-9#2)(2008-5#1)(2011-12#1)(2012-3#2)
they had contacted##2##3##(2006-8#1)(2011-12#1)
they had ever##2##3##(2008-12#1)(2012-3#1)
they had experienced##5##3##(1991-4#1)(2007-4#1)(2007-8#1)(2010-2#1)(2012-1#1)
they had in##2##3##(2010-1#1)(2012-3#1)
they had learned##3##3##(1992-6#1)(2004-10#1)(2008-1#1)
they had no##3##3##(2007-7#1)(2008-10#1)(2012-1#1)
they had not been##4##4##(1995-5#1)(2006-8#1)(2011-2#1)(2013-1#1)
they had not##7##3##(1995-5#1)(1996-6#1)(2006-8#1)(2008-8#1)(2010-3#1)(2011-2#1)(2013-1#1)
they had previously##3##3##(2008-12#1)(2010-2#1)(2010-4#1)
they had received##9##3##(1990-5#1)(1994-2#1)(1995-6#1)(1997-2#1)(2006-7#1)(2007-7#1)(2011-1#1)(2013-1#2)
they had similar##2##3##(1992-5#1)(2008-11#1)
they had the##2##3##(1996-7#1)(2006-7#1)
they had to##5##3##(1994-3#1)(1995-9#1)(2006-8#1)(2010-3#1)(2012-12#1)
they had used##2##3##(2007-2#1)(2012-12#1)
they had##159##2##(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-2#1)(1992-5#3)(1992-6#1)(1992-7#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-2#2)(1994-3#2)(1994-4#1)(1994-6#1)(1995-1#1)(1995-5#3)(1995-6#2)(1995-9#3)(1996-12#1)(1996-2#2)(1996-3#4)(1996-6#1)(1996-7#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#1)(2004-10#1)(2005-10#2)(2006-10#2)(2006-2#1)(2006-5#1)(2006-7#2)(2006-8#5)(2006-9#1)(2007-10#4)(2007-12#2)(2007-2#5)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#4)(2008-1#4)(2008-10#1)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#2)(2008-8#4)(2009-10#1)(2009-11#1)(2009-3#1)(2009-6#4)(2010-1#1)(2010-10#1)(2010-2#2)(2010-3#3)(2010-4#1)(2010-7#1)(2011-1#2)(2011-12#3)(2011-2#7)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#6)(2013-1#4)(2013-7#1)(2013-8#1)
they handle##2##2##(2008-8#1)(2012-3#1)
they have a greater##3##4##(1990-12#1)(1996-9#1)(2008-10#1)
they have a high##2##4##(2012-2#1)(2013-1#1)
they have a physiological##2##4##(1996-4#1)(2012-12#1)
they have a strong##2##4##(2012-2#1)(2013-8#1)
they have a tendency to##2##5##(2006-9#1)(2008-1#1)
they have a##35##3##(1990-12#1)(1990-8#1)(1991-12#1)(1993-6#1)(1995-2#1)(1996-4#1)(1996-9#1)(1997-2#1)(2005-9#1)(2006-7#1)(2006-9#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#2)(2008-7#1)(2009-6#1)(2010-11#2)(2010-4#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
they have adopted##2##3##(2006-5#1)(2010-12#1)
they have also##3##3##(2008-1#1)(2008-10#1)(2009-5#1)
they have an##10##3##(1994-12#1)(1997-2#1)(2007-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-4#1)(2011-2#1)(2012-3#1)
they have become##7##3##(1997-6#1)(2005-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2010-2#1)(2010-5#1)
they have been implicated in##2##5##(2007-6#1)(2012-2#1)
they have been reported##2##4##(2012-11#1)(2012-2#1)
they have been shown to##4##5##(1994-11#1)(2006-8#1)(2008-5#1)(2008-8#1)
they have been simultaneously determined##2##5##(2007-8#1)(2008-10#1)
they have been successfully##2##4##(2011-2#1)(2012-12#1)
they have been used##2##4##(1996-12#1)(2012-2#1)
they have been##47##3##(1990-11#1)(1990-12#1)(1990-9#1)(1991-12#1)(1994-11#1)(1994-6#1)(1996-11#1)(1996-12#1)(1997-2#2)(1997-3#1)(1997-5#1)(2005-7#1)(2005-8#1)(2006-8#4)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-7#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#2)
they have carried out##2##4##(1993-3#1)(1996-2#1)
they have developed##3##3##(1996-2#1)(2007-4#1)(2008-2#1)
they have different##5##3##(1990-11#1)(1991-1#1)(1996-2#1)(2007-11#1)(2008-7#1)
they have evolved##2##3##(2008-8#1)(2008-9#1)
they have experienced##2##3##(2007-6#1)(2008-2#1)
they have failed to##2##4##(2007-11#1)(2012-2#1)
they have fundamentally some problems in different features##2##8##(2013-1#2)
they have gained##4##3##(1994-2#1)(2007-4#1)(2008-10#1)(2011-2#1)
they have great##2##3##(1997-8#1)(2007-3#1)
they have had no##2##4##(2005-7#1)(2006-12#1)
they have had##3##3##(2005-7#1)(2006-12#1)(2008-5#1)
they have higher##2##3##(1990-7#1)(2008-9#1)
they have learned##3##3##(1996-1#1)(2006-8#1)(2010-9#1)
they have limitations##2##3##(2011-2#1)(2013-7#1)
they have lost##2##3##(1993-2#1)(2010-7#1)
they have made##2##3##(1994-12#1)(2007-8#1)
they have more##2##3##(1995-4#1)(2008-7#1)
they have never##2##3##(1991-12#1)(2013-1#1)
they have no effect on the##2##6##(2008-3#1)(2008-5#1)
they have no effect on##3##5##(1994-5#1)(2008-3#1)(2008-5#1)
they have no##9##3##(1991-5#1)(1994-5#1)(1997-5#1)(2007-11#1)(2007-9#1)(2008-1#2)(2008-3#1)(2008-5#1)
they have not been##7##4##(1997-3#1)(1997-4#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-3#1)(2012-12#1)
they have not yet##3##4##(2008-5#2)(2013-8#1)
they have not##13##3##(1990-3#1)(1995-1#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-3#1)(2008-5#2)(2012-12#1)(2013-8#1)
they have now##2##3##(2008-5#1)(2011-2#1)
they have potential##2##3##(2006-12#1)(2008-7#1)
they have presented hypersensitivity reactions##2##5##(2008-8#1)(2011-1#1)
they have received##4##3##(1994-12#1)(2008-2#1)(2010-4#1)(2012-12#1)
they have shown##3##3##(2005-7#1)(2008-1#1)(2013-8#1)
they have taken##2##3##(2007-4#1)(2008-7#1)
they have the potential to##3##5##(2005-12#1)(2009-3#1)(2010-5#1)
they have the potential##4##4##(2005-12#1)(2008-4#1)(2009-3#1)(2010-5#1)
they have the same##3##4##(1992-7#1)(1994-12#1)(2008-5#1)
they have the##13##3##(1992-1#1)(1992-7#1)(1994-12#1)(2004-9#1)(2005-12#1)(2005-8#1)(2007-8#1)(2008-4#1)(2008-5#1)(2009-3#1)(2010-5#1)(2011-2#1)(2013-8#1)
they have their##2##3##(2006-10#1)(2009-8#1)
they have to be replaced##2##5##(1996-11#1)(2008-10#1)
they have to be##5##4##(1996-11#1)(2008-10#1)(2008-3#1)(2012-2#1)(2012-3#1)
they have to##13##3##(1993-9#1)(1996-11#1)(1997-6#1)(2006-6#1)(2008-10#2)(2008-2#2)(2008-3#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
they have undergone##3##3##(2006-8#1)(2010-8#1)(2011-2#1)
they have##321##2##(1990-11#3)(1990-12#2)(1990-3#3)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#5)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-7#1)(1996-1#1)(1996-11#3)(1996-12#1)(1996-2#3)(1996-4#1)(1996-8#1)(1996-9#1)(1997-2#6)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-8#3)(2004-9#1)(2005-10#1)(2005-12#1)(2005-7#6)(2005-8#2)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#4)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#4)(2006-8#7)(2006-9#2)(2007-11#3)(2007-12#6)(2007-2#2)(2007-3#1)(2007-4#4)(2007-6#5)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#11)(2008-10#12)(2008-11#10)(2008-2#10)(2008-3#4)(2008-4#4)(2008-5#12)(2008-6#1)(2008-7#8)(2008-8#8)(2008-9#4)(2009-11#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-10#1)(2010-11#2)(2010-12#8)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#3)(2011-2#11)(2012-1#2)(2012-11#2)(2012-12#7)(2012-2#10)(2012-3#2)(2013-1#7)(2013-7#5)(2013-8#5)
they hear##2##2##(1991-1#1)(2008-2#1)
they held##2##2##(2008-12#1)(2010-3#1)
they help##4##2##(1995-3#1)(2007-6#1)(2008-11#1)(2008-9#1)
they highlight the##2##3##(1990-5#1)(1995-11#1)
they highlight##3##2##(1990-5#1)(1995-11#1)(2006-11#1)
they hold great promise for##2##5##(2005-8#1)(2008-11#1)
they hold##5##2##(2005-8#1)(2008-11#1)(2008-7#1)(2012-12#1)(2012-2#1)
they hope to##2##3##(1991-1#1)(1992-12#1)
they hope##3##2##(1991-1#1)(1992-12#1)(2007-3#1)
they house##2##2##(2007-12#2)
they hybridize##2##2##(1997-1#1)(2008-10#1)
they identified##3##2##(2007-10#1)(2007-12#1)(2008-7#1)
they illustrate the##2##3##(1991-4#1)(2006-7#1)
they illustrate##3##2##(1990-5#1)(1991-4#1)(2006-7#1)
they impact the role of##2##5##(2008-1#1)(2012-1#1)
they impact the##3##3##(2008-1#1)(2008-3#1)(2012-1#1)
they impact##7##2##(2006-2#1)(2008-1#2)(2008-3#2)(2008-5#1)(2012-1#1)
they imply##3##2##(1990-12#1)(1992-3#1)(2008-9#1)
they improve##5##2##(2004-3#1)(2006-1#1)(2006-10#1)(2008-4#1)(2011-2#1)
they improved##2##2##(1993-3#1)(2008-5#1)
they include##5##2##(1991-2#1)(1997-3#1)(2006-2#1)(2008-11#2)
they included##4##2##(1991-11#1)(2004-10#1)(2008-1#1)(2008-5#1)
they increase the##3##3##(1990-12#1)(1991-2#1)(2008-10#1)
they increase##9##2##(1990-12#1)(1990-8#1)(1991-2#1)(1992-4#1)(2005-11#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
they increased##7##2##(1991-12#1)(1993-11#1)(1993-9#1)(1995-3#1)(1997-1#1)(2005-1#1)(2009-12#1)
they indicate that##5##3##(1991-11#1)(1991-9#1)(1992-3#1)(1995-12#1)(2013-1#1)
they indicate##7##2##(1990-4#1)(1991-11#1)(1991-9#1)(1992-3#1)(1994-2#1)(1995-12#1)(2013-1#1)
they indicated##3##2##(1994-12#1)(1995-1#1)(2008-11#1)
they induce##10##2##(1990-2#1)(1992-8#1)(1994-6#1)(1995-5#1)(2008-10#3)(2009-6#1)(2010-10#1)(2013-8#1)
they induced##3##2##(2006-7#1)(2008-10#1)(2009-4#1)
they infect##2##2##(2008-10#1)(2008-11#1)
they influence the##3##3##(1997-2#1)(2008-5#1)(2008-6#1)
they influence##6##2##(1997-2#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-8#1)(2013-1#1)
they ingest##2##2##(1995-12#1)(2007-2#1)
they inhabit##2##2##(2007-12#1)(2011-2#1)
they inhibit the##4##3##(1991-5#1)(1994-11#1)(1995-8#1)(2006-10#1)
they inhibit##7##2##(1991-5#1)(1994-11#1)(1995-8#1)(1997-1#1)(2006-10#2)(2008-1#1)
they inhibited the##2##3##(1990-8#1)(1997-1#1)
they inhibited##5##2##(1990-8#1)(1991-11#1)(1995-3#1)(1997-1#1)(2008-10#1)
they initially##2##2##(1994-8#1)(1995-11#1)
they intended to##2##3##(1991-3#1)(2009-10#1)
they interact with##7##3##(1994-2#1)(2008-4#1)(2008-8#1)(2009-10#1)(2010-9#1)(2011-2#2)
they interact##16##2##(1994-2#1)(2008-2#1)(2008-4#3)(2008-8#2)(2009-10#2)(2009-4#1)(2010-5#1)(2010-9#1)(2011-2#3)(2012-3#1)
they intervene##2##2##(2008-12#1)(2008-2#1)
they involve##3##2##(1996-8#1)(2008-3#1)(2012-1#1)
they judged##3##2##(1995-5#1)(2007-7#1)(2008-10#1)
they kill##2##2##(2007-8#1)(2008-8#1)
they knew##2##2##(2007-2#2)
they know##2##2##(1991-12#1)(2008-5#1)
they lack the##5##3##(1991-3#1)(1991-4#1)(2008-7#1)(2012-12#1)(2012-2#1)
they lack##12##2##(1991-3#1)(1991-4#1)(1996-6#1)(2006-10#1)(2006-11#1)(2007-6#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2012-12#1)(2012-2#1)
they lacked the##2##3##(2008-10#1)(2008-8#1)
they lacked##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2011-1#1)
they later##4##2##(1994-5#1)(2006-4#1)(2007-10#1)(2008-11#1)
they lay##3##2##(2007-11#1)(2008-12#1)(2008-8#1)
they leach from supply pipes into drinking water and##2##9##(2008-10#2)
they lead to##3##3##(2007-11#1)(2008-2#1)(2010-7#1)
they leave##2##2##(1993-3#1)(2011-2#1)
they liked the##2##3##(1992-3#1)(2008-11#1)
they liked##3##2##(1992-3#1)(2008-11#1)(2012-2#1)
they listened to##2##3##(1997-7#1)(2009-2#1)
they live in a##2##4##(2005-9#1)(2007-3#1)
they live in##3##3##(2005-9#1)(2007-3#1)(2008-11#1)
they live##6##2##(2005-9#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-2#1)(2012-3#1)
they lived##2##2##(2008-7#1)(2013-1#1)
they looked##3##2##(2007-12#2)(2008-1#1)
they lost##3##2##(1990-2#1)(1992-2#1)(1994-12#1)
they made the##2##3##(2008-1#1)(2009-6#1)
they made##8##2##(1995-12#1)(1997-3#1)(2008-1#1)(2008-9#2)(2009-6#1)(2010-9#1)(2012-3#1)
they maintain##3##2##(2008-5#1)(2009-8#1)(2012-2#1)
they make##10##2##(1991-2#1)(1993-1#1)(1995-2#1)(1996-12#1)(1997-1#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-9#1)(2012-11#1)
they matched##2##2##(2007-1#1)(2010-8#1)
they may also be##3##4##(2008-4#2)(2010-5#1)
they may also serve as a transformative model for emerging EMR/EHR requirements##2##12##(2010-8#2)
they may also##8##3##(1995-5#1)(2008-2#1)(2008-4#2)(2008-5#1)(2010-5#1)(2010-8#2)
they may appear as##2##4##(1990-5#1)(2011-12#1)
they may be associated with##2##5##(1995-11#1)(2009-5#1)
they may be related to##2##5##(2008-6#1)(2008-7#1)
they may be the##3##4##(2006-10#1)(2008-9#1)(2010-12#1)
they may be##42##3##(1990-3#1)(1990-7#1)(1991-3#1)(1992-1#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-11#2)(1996-3#1)(2004-9#1)(2005-11#1)(2005-2#1)(2005-7#1)(2006-10#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#2)(2010-12#1)(2010-3#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
they may become symptomatic##2##4##(2008-10#1)(2010-12#1)
they may become##3##3##(2008-10#1)(2010-12#1)(2011-2#1)
they may benefit##3##3##(2007-12#2)(2010-3#1)
they may cause##4##3##(2007-1#1)(2008-8#1)(2011-1#1)(2012-12#1)
they may constitute##2##3##(1991-12#1)(2008-10#1)
they may continue to##3##4##(2007-12#1)(2010-12#1)(2013-1#1)
they may contribute to##2##4##(2006-10#1)(2008-2#1)
they may correspond to##2##4##(1997-6#1)(2013-8#1)
they may eventually##2##3##(2006-1#1)(2006-3#1)
they may explain##3##3##(1995-12#1)(1997-5#1)(2010-7#1)
they may function##3##3##(1991-10#1)(1994-12#1)(2012-12#1)
they may have a##2##4##(2008-4#1)(2009-8#1)
they may have##13##3##(1991-2#1)(1992-2#1)(1993-3#1)(2006-10#1)(2007-12#1)(2007-9#2)(2008-4#2)(2008-5#1)(2008-9#1)(2009-8#1)(2010-12#1)
they may increase##2##3##(2008-7#2)
they may lead to##2##4##(2007-6#1)(2007-7#1)
they may not be##5##4##(1993-3#1)(2006-10#1)(2008-4#1)(2011-2#1)(2012-3#1)
they may play a role in the##3##7##(1990-2#1)(1992-6#1)(1996-5#1)
they may play a role in##4##6##(1990-2#1)(1992-6#1)(1996-5#1)(2008-10#1)
they may play a##5##4##(1990-2#1)(1992-6#1)(1996-5#1)(2008-10#1)(2008-11#1)
they may play##7##3##(1990-2#1)(1992-6#1)(1996-5#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)
they may present##2##3##(2007-8#1)(2011-1#1)
they may provide an##2##4##(2007-10#1)(2012-3#1)
they may provide##5##3##(1995-6#1)(2007-10#1)(2008-3#1)(2008-5#1)(2012-3#1)
they may reduce the##2##4##(1996-12#1)(2008-9#1)
they may represent##3##3##(1996-3#1)(2008-7#1)(2012-2#1)
they may result in##2##4##(1995-11#1)(2006-10#1)
they may result##3##3##(1995-11#1)(2006-10#1)(2008-7#1)
they may serve as##2##4##(2008-8#1)(2013-7#1)
they may##181##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#2)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-3#3)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#2)(2004-9#1)(2005-11#1)(2005-12#1)(2005-2#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#11)(2006-3#1)(2007-1#3)(2007-10#2)(2007-11#3)(2007-12#5)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#4)(2008-4#7)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#4)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-8#1)(2009-9#1)(2010-12#4)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#6)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#2)
they measure##2##2##(2005-9#1)(2010-2#1)
they mediate the##2##3##(1995-10#1)(2008-1#1)
they mediate##5##2##(1995-10#1)(1995-12#1)(2008-1#1)(2009-3#1)(2013-1#1)
they meet##4##2##(1990-4#1)(2007-2#2)(2008-11#1)
they met specific##2##3##(2011-11#1)(2012-1#1)
they met##4##2##(2007-12#1)(2010-10#1)(2011-11#1)(2012-1#1)
they might also##3##3##(2007-11#1)(2008-10#1)(2008-4#1)
they might be##14##3##(1990-6#1)(1994-3#1)(1996-2#1)(2005-8#1)(2007-12#3)(2007-8#1)(2008-5#1)(2009-11#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-2#1)
they might form##2##3##(2006-10#1)(2009-8#1)
they might not##2##3##(1996-3#1)(2008-10#1)
they might##40##2##(1990-12#1)(1990-6#2)(1993-12#1)(1993-4#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-5#1)(1996-2#1)(1996-3#2)(1997-2#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-2#2)(2006-6#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-8#3)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#1)
they migrate##3##2##(2007-11#1)(2007-12#1)(2008-4#1)
they modify the##2##3##(1994-1#1)(2008-3#1)
they modify##3##2##(1994-1#1)(1994-9#1)(2008-3#1)
they more often##3##3##(1990-2#1)(1996-12#1)(2006-8#1)
they mostly##2##2##(2011-2#1)(2012-3#1)
they must adopt standards and enforce requirements that are at least as effective as federal requirements##3##16##(1993-12#1)(1993-2#1)(1993-3#1)
they must also##2##3##(1992-3#1)(2012-12#1)
they must be of##2##4##(1994-2#1)(2012-2#1)
they must be##13##3##(1994-2#1)(1996-10#1)(1997-5#1)(2006-10#2)(2006-2#1)(2008-2#1)(2008-3#2)(2008-6#1)(2009-3#1)(2012-2#2)
they must use##2##3##(1994-1#1)(1994-3#1)
they must##34##2##(1991-7#1)(1992-3#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1996-10#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-5#1)(2006-10#2)(2006-2#1)(2006-7#2)(2007-2#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2009-3#1)(2012-12#2)(2012-2#2)(2013-1#1)
they need to be##4##4##(1996-1#1)(1996-3#1)(2006-5#1)(2011-2#1)
they need to know##2##4##(1994-12#1)(2007-4#1)
they need to##15##3##(1994-1#1)(1994-12#1)(1995-2#1)(1996-1#1)(1996-3#1)(2006-5#1)(2007-1#1)(2007-4#1)(2008-11#1)(2008-9#1)(2010-5#1)(2011-2#3)(2012-12#1)
they need##24##2##(1990-4#1)(1994-1#1)(1994-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-4#1)(2006-5#1)(2007-1#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-11#2)(2008-2#1)(2008-9#1)(2010-5#1)(2011-2#4)(2012-12#2)
they needed more help##2##4##(1994-1#1)(1997-2#1)
they needed more##3##3##(1992-10#1)(1994-1#1)(1997-2#1)
they needed to##2##3##(2009-4#1)(2012-2#1)
they needed##8##2##(1992-10#1)(1994-1#1)(1997-2#1)(1997-6#1)(2007-10#1)(2009-4#1)(2009-9#1)(2012-2#1)
they never##4##2##(1993-1#1)(1997-5#1)(2008-8#1)(2012-12#1)
they nonetheless##2##2##(1994-10#1)(2013-8#1)
they normally##2##2##(1997-3#1)(2012-1#1)
they not only##2##3##(1993-3#1)(2008-7#1)
they not##3##2##(1993-3#1)(2008-2#1)(2008-7#1)
they now##2##2##(1994-3#1)(1996-3#1)
they occupy##2##2##(2007-12#1)(2007-5#1)
they occur in the##2##4##(1994-12#1)(1996-5#1)
they occur in##5##3##(1992-6#1)(1994-12#1)(1996-5#1)(2009-7#1)(2010-8#1)
they occur##17##2##(1990-9#1)(1992-6#1)(1994-12#1)(1996-4#1)(1996-5#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-8#1)(2010-9#1)(2012-3#1)(2013-1#2)
they occurred##5##2##(2006-10#1)(2007-8#1)(2009-4#1)(2011-1#1)(2011-2#1)
they offer a##7##3##(1991-1#1)(1991-12#1)(2008-10#1)(2008-7#1)(2009-2#1)(2010-7#1)(2012-2#1)
they offer the##4##3##(2006-11#1)(2007-1#1)(2008-8#1)(2009-4#1)
they offer valuable##2##3##(2008-8#1)(2012-2#1)
they offer##22##2##(1991-1#1)(1991-12#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-1#1)(2006-11#1)(2007-1#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-8#3)(2009-2#1)(2009-4#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#2)
they offered##2##2##(1996-1#1)(2010-3#1)
they often are##2##3##(1993-2#1)(2012-2#1)
they often do##2##3##(2008-3#1)(2009-6#1)
they often lead to##2##4##(2005-10#1)(2007-11#1)
they often##16##2##(1993-2#1)(1996-9#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
they only##6##2##(2008-5#1)(2009-9#1)(2013-1#4)
they operate##2##2##(2007-12#1)(2008-9#1)
they or##2##2##(2006-3#1)(2012-1#1)
they originate from##3##3##(1992-3#1)(1997-1#1)(2008-6#1)
they originate##5##2##(1992-3#1)(1996-7#1)(1997-1#1)(2008-6#1)(2008-7#1)
they originated##5##2##(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-7#1)
they otherwise would##2##3##(1992-4#1)(2010-2#1)
they ought to##2##3##(1992-12#1)(2008-7#1)
they overlap with the##2##4##(2008-7#1)(2010-8#1)
they overlap##5##2##(2006-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-8#1)
they participate in the##2##4##(2010-2#1)(2011-2#1)
they participate in##5##3##(1992-8#1)(1995-8#1)(2010-2#1)(2011-2#1)(2012-1#1)
they participate##6##2##(1992-8#1)(1993-1#1)(1995-8#1)(2010-2#1)(2011-2#1)(2012-1#1)
they participated in##5##3##(2006-8#1)(2007-12#1)(2010-11#1)(2011-1#1)(2011-2#1)
they pass through##2##3##(2007-9#1)(2008-2#1)
they pass##3##2##(2007-9#1)(2008-2#1)(2009-2#1)
they passed##2##2##(1992-8#1)(2008-10#1)
they perceive managed care organizations as certifying them less often for all treatment modalities except##2##15##(2005-7#2)
they perceive managed care organizations as certifying them to practice##2##10##(2005-7#2)
they perceive managed care organizations as certifying them##4##8##(2005-7#4)
they perceive##10##2##(2005-7#4)(2008-10#1)(2008-11#1)(2010-11#1)(2012-3#3)
they perceived as##4##3##(2008-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
they perceived##9##2##(1992-2#1)(1994-12#1)(2008-11#1)(2010-7#1)(2011-2#2)(2012-3#2)(2013-8#1)
they perform##3##2##(2008-11#1)(2008-7#1)(2012-2#1)
they performed##7##2##(1991-2#1)(1996-2#1)(2005-2#1)(2007-11#1)(2008-5#1)(2010-3#1)(2012-3#1)
they persist##3##2##(1995-12#1)(2006-8#1)(2012-2#1)
they phosphorylate##2##2##(1996-11#1)(2008-8#1)
they place##3##2##(2008-9#1)(2010-8#1)(2012-3#1)
they plan and##2##3##(2008-1#1)(2011-2#1)
they play a role in##2##5##(2008-7#1)(2012-2#1)
they play a##8##3##(1991-9#1)(1992-9#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-2#1)(2012-2#1)
they play an important role in the##4##7##(1994-12#1)(2007-9#1)(2008-1#1)(2011-2#1)
they play an important role in##7##6##(1991-3#1)(1994-12#1)(2006-8#1)(2007-9#1)(2008-1#1)(2009-10#1)(2011-2#1)
they play an##9##3##(1991-3#1)(1994-12#1)(2006-8#1)(2007-6#1)(2007-9#1)(2008-1#1)(2009-10#1)(2010-11#1)(2011-2#1)
they play in the##3##4##(1996-2#1)(2006-6#1)(2012-12#1)
they play in##6##3##(1990-12#1)(1995-2#1)(1996-2#1)(2005-11#1)(2006-6#1)(2012-12#1)
they play##29##2##(1990-12#1)(1991-3#1)(1991-9#1)(1992-9#1)(1994-12#1)(1995-2#1)(1996-2#1)(2005-11#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
they point to##2##3##(2012-1#1)(2013-1#1)
they point##3##2##(1990-2#1)(2012-1#1)(2013-1#1)
they possess a##3##3##(1991-6#1)(1996-2#1)(2010-5#1)
they possess the##2##3##(1990-2#1)(2010-8#1)
they possess##11##2##(1990-2#1)(1991-6#1)(1996-2#1)(1996-8#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-7#2)(2010-5#1)(2010-8#1)
they possessed##2##2##(2007-12#1)(2008-7#1)
they practice##3##2##(1994-1#1)(2007-7#1)(2008-11#1)
they practiced##2##2##(1992-4#1)(2005-7#1)
they preferentially##2##2##(2008-10#1)(2012-12#1)
they preferred##4##2##(2008-8#1)(2009-9#2)(2013-1#1)
they present a##5##3##(2006-5#1)(2006-9#1)(2007-5#1)(2007-7#1)(2013-8#1)
they present with##2##3##(2007-2#1)(2010-2#1)
they present##18##2##(1991-5#1)(2004-9#1)(2005-6#1)(2005-9#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-1#1)(2010-2#1)(2011-2#1)(2013-8#1)
they presented a##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
they presented##9##2##(1990-4#1)(1992-5#1)(2008-10#1)(2008-5#1)(2012-3#1)(2013-1#3)(2013-7#1)
they prevent##3##2##(1994-11#1)(2007-11#1)(2010-12#1)
they produce a##3##3##(1996-4#1)(2008-4#1)(2012-12#1)
they produce significant##2##3##(1996-10#1)(2008-1#1)
they produce##13##2##(1990-11#1)(1990-4#1)(1996-10#1)(1996-4#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
they produced##4##2##(1992-11#1)(1993-8#1)(2008-10#1)(2008-5#1)
they promote##2##2##(1991-2#1)(2012-12#1)
they propagate##2##2##(2007-12#1)(2008-2#1)
they proposed##2##2##(1993-6#1)(2013-1#1)
they protect##2##2##(2007-6#1)(2008-5#1)
they proved##2##2##(2005-1#1)(2008-10#1)
they provide a##5##3##(1991-12#1)(2006-10#1)(2006-7#1)(2008-10#1)(2010-9#1)
they provide an##3##3##(1990-3#1)(2006-10#1)(2008-3#1)
they provide different approaches for multitasking##2##6##(2013-1#2)
they provide excellent##2##3##(2007-8#1)(2012-3#1)
they provide information##2##3##(1997-1#1)(2008-9#1)
they provide new##2##3##(2008-1#1)(2008-4#1)
they provide the foundation for##2##5##(2008-5#1)(2008-9#1)
they provide the##6##3##(1996-10#1)(2007-7#1)(2008-5#1)(2008-9#1)(2010-9#2)
they provide##44##2##(1990-3#1)(1990-4#1)(1991-12#1)(1992-2#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-2#1)(1997-1#2)(2006-10#3)(2006-2#2)(2006-7#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#4)(2009-8#1)(2010-12#1)(2010-9#3)(2011-2#2)(2012-3#1)(2013-1#2)
they provided for##2##3##(1990-12#1)(2009-2#1)
they provided##4##2##(1990-12#1)(2007-10#1)(2008-11#1)(2009-2#1)
they pursue##2##2##(1991-2#1)(1995-1#1)
they put##3##2##(1996-11#1)(2009-6#1)(2009-9#1)
they raise##2##2##(1995-5#1)(2010-11#1)
they rarely##4##2##(1994-1#1)(1996-9#1)(2007-11#2)
they rated the##2##3##(2008-10#1)(2010-2#1)
they reach##5##2##(1996-6#1)(2006-10#1)(2007-3#1)(2011-2#1)(2012-2#1)
they reached##5##2##(1991-9#1)(1992-11#1)(2008-10#1)(2008-11#1)(2010-4#1)
they react with##2##3##(2008-10#2)
they react##3##2##(2008-10#2)(2009-6#1)
they reacted to##2##3##(2008-5#2)
they reacted##3##2##(1992-2#1)(2008-5#2)
they read##3##2##(2007-9#1)(2013-1#1)(2013-8#1)
they realize##2##2##(1997-1#1)(2008-3#1)
they really##3##2##(2007-8#1)(2008-5#1)(2013-8#1)
they receive and##2##3##(2007-9#1)(2009-5#1)
they receive at##2##3##(1992-3#1)(1995-2#1)
they receive from##2##3##(2011-1#1)(2012-2#1)
they receive##13##2##(1992-3#1)(1995-2#1)(1995-6#1)(2006-2#1)(2007-12#1)(2007-9#1)(2008-12#2)(2009-5#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-1#1)
they received a##2##3##(1993-10#1)(2008-10#1)
they received##17##2##(1993-10#1)(1993-6#1)(1994-7#1)(1995-6#1)(1996-8#1)(2006-2#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-7#1)(2011-1#1)(2012-1#1)(2013-1#2)
they recognize##3##2##(1995-10#1)(1995-2#1)(1995-6#1)
they recommend##3##2##(1991-7#1)(2008-9#1)(2011-2#1)
they recovered##2##2##(1990-5#1)(2008-10#1)
they reduce the##3##3##(1996-6#1)(2006-10#1)(2008-9#1)
they reduce##10##2##(1991-8#1)(1993-8#1)(1994-11#1)(1996-6#1)(1997-6#1)(2004-3#1)(2006-10#1)(2008-7#1)(2008-8#1)(2008-9#1)
they reduced##5##2##(1992-5#1)(2008-10#2)(2008-5#1)(2012-2#1)
they reflect the##5##3##(2006-2#1)(2006-8#1)(2007-3#1)(2008-11#1)(2010-8#1)
they reflect##6##2##(1996-4#1)(2006-2#1)(2006-8#1)(2007-3#1)(2008-11#1)(2010-8#1)
they regulate the##2##3##(2008-10#1)(2008-5#1)
they regulate##5##2##(1990-11#1)(2007-12#2)(2008-10#1)(2008-5#1)
they relate to the##6##4##(1991-2#1)(1997-2#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-1#1)
they relate to##21##3##(1991-2#1)(1993-3#1)(1996-7#1)(1997-2#1)(2005-7#2)(2006-10#1)(2006-5#1)(2007-11#1)(2007-4#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-8#1)(2011-1#1)(2012-1#1)(2013-8#1)
they relate##22##2##(1991-2#1)(1993-3#1)(1996-7#1)(1997-2#1)(2005-7#2)(2006-10#1)(2006-5#1)(2007-11#1)(2007-4#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-8#1)(2010-2#1)(2011-1#1)(2012-1#1)(2013-8#1)
they related?##5##2##(2006-10#2)(2008-11#1)(2011-12#1)(2013-1#1)
they release##4##2##(1992-2#1)(2008-4#1)(2012-11#2)
they remain##11##2##(1994-12#1)(1995-9#1)(1997-4#1)(2006-10#1)(2007-10#1)(2008-1#2)(2008-2#2)(2008-5#1)(2012-11#1)
they remained in the##2##4##(1993-3#1)(2008-9#1)
they remained##3##2##(1993-3#1)(2008-5#1)(2008-9#1)
they report##2##2##(1991-3#1)(2007-7#1)
they reported##3##2##(2006-6#1)(2009-5#1)(2013-1#1)
they represent a##7##3##(1993-6#1)(1995-1#2)(1995-2#1)(2007-10#1)(2008-12#1)(2013-1#1)
they represent the##3##3##(1992-6#1)(2004-4#1)(2011-1#1)
they represent##22##2##(1992-6#1)(1993-12#1)(1993-6#1)(1995-1#2)(1995-2#1)(2004-4#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)
they represented##3##2##(2011-1#1)(2011-2#1)(2013-7#1)
they require a##2##3##(1995-12#1)(2008-1#1)
they require##19##2##(1994-3#1)(1995-12#1)(1996-2#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
they required##2##2##(1996-11#1)(2010-12#1)
they resemble##3##2##(1990-5#1)(2007-12#1)(2008-2#1)
they resembled##2##2##(2008-5#1)(2012-2#1)
they reside##3##2##(2008-3#1)(2008-4#1)(2010-11#1)
they respond to##5##3##(1994-5#1)(2006-12#1)(2008-6#1)(2008-8#1)(2010-10#1)
they respond##9##2##(1994-5#2)(2004-12#1)(2006-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#1)(2013-7#1)
they responded##2##2##(1992-7#1)(1996-1#1)
they result in##2##3##(2008-10#1)(2008-2#1)
they reveal a##3##3##(1995-12#1)(1995-9#1)(2008-7#1)
they reveal##8##2##(1991-12#1)(1995-12#1)(1995-9#1)(2008-10#1)(2008-7#1)(2009-5#1)(2012-3#1)(2013-8#1)
they revealed##2##2##(2007-3#1)(2009-9#1)
they review the##2##3##(2006-5#1)(2006-8#1)
they run##3##2##(1992-5#1)(2006-8#1)(2010-12#1)
they say##2##2##(1992-8#1)(2007-9#1)
they secrete##3##2##(2008-7#2)(2012-12#1)
they see##6##2##(1991-12#1)(1992-11#1)(2006-10#1)(2006-12#1)(2010-4#1)(2012-3#1)
they seek##3##2##(2006-3#1)(2007-4#1)(2010-7#1)
they seem to be##4##4##(1995-11#1)(2005-10#1)(2007-9#1)(2008-12#1)
they seem to##6##3##(1991-4#1)(1995-11#1)(2005-10#1)(2007-9#1)(2008-12#1)(2012-5#1)
they seemed to##2##3##(2010-10#1)(2011-1#1)
they serve as a##2##4##(1996-1#1)(2006-6#1)
they serve as##6##3##(1991-2#1)(1996-1#1)(2006-6#1)(2007-12#1)(2008-4#1)(2012-12#1)
they serve##26##2##(1991-12#1)(1991-2#2)(1991-3#1)(1992-2#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-1#1)(1997-3#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-11#1)(2011-12#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)
they share similar##2##3##(1995-2#1)(2008-1#1)
they share the##2##3##(1994-9#1)(2008-4#1)
they share##19##2##(1991-8#1)(1994-9#1)(1995-2#1)(1997-4#2)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-4#2)(2008-7#1)(2011-2#1)(2012-12#2)
they shared##4##2##(1996-11#1)(2008-10#2)(2010-11#1)
they shifted##2##2##(2008-10#1)(2009-2#1)
they should always##2##3##(2007-2#1)(2010-12#1)
they should be able to##3##5##(1992-3#1)(2010-9#1)(2011-2#1)
they should be carefully implemented with periodic post-implementation analysis and refinement##2##11##(2013-1#2)
they should be interpreted as representing situations##2##7##(2013-1#2)
they should be interpreted##3##4##(1997-1#1)(2013-1#2)
they should be used##2##4##(2008-11#1)(2011-2#1)
they should be##29##3##(1992-3#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-1#1)(2004-3#1)(2005-9#1)(2006-3#1)(2006-5#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-2#4)(2013-1#4)
they should not be##3##4##(2006-8#1)(2008-8#1)(2012-2#1)
they should not##6##3##(1993-2#1)(2006-8#1)(2007-11#1)(2008-4#1)(2008-8#1)(2012-2#1)
they should##53##2##(1992-12#1)(1992-3#1)(1993-2#2)(1994-11#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-9#1)(1997-1#1)(2004-3#1)(2005-9#1)(2006-3#1)(2006-5#1)(2006-7#3)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-6#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-2#4)(2012-11#1)(2012-2#2)(2013-1#4)
they show a##2##3##(2005-11#1)(2010-5#1)
they show an##2##3##(1995-12#1)(2008-3#1)
they show##16##2##(1991-1#1)(1991-5#1)(1995-12#2)(1997-4#1)(2005-11#1)(2005-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-9#1)(2010-5#1)(2010-6#1)(2012-2#1)(2013-1#1)
they showed a##8##3##(1992-10#1)(1993-3#1)(1993-8#1)(1994-8#1)(2006-11#1)(2007-2#1)(2008-11#1)(2008-8#1)
they showed different##2##3##(2008-10#2)
they showed greater##2##3##(2010-2#1)(2012-12#1)
they showed no##3##3##(1991-3#1)(1995-8#1)(1996-8#1)
they showed the##2##3##(2008-11#1)(2011-2#1)
they showed to##2##3##(2008-11#1)(2008-3#1)
they showed##31##2##(1990-11#1)(1991-3#1)(1991-4#1)(1992-10#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-6#1)(2006-11#1)(2007-2#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-8#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
they significantly##3##2##(1997-1#1)(2008-1#1)(2008-8#1)
they simply##3##2##(1992-10#1)(1994-8#1)(2008-5#1)
they soon##2##2##(1992-3#1)(1996-9#1)
they sought##2##2##(2007-2#1)(2009-5#1)
they spare##2##2##(2008-11#1)(2008-8#1)
they specifically##2##2##(1997-1#1)(2012-2#1)
they spend##2##2##(1992-12#1)(2013-8#1)
they spent##2##2##(2007-2#1)(2009-9#1)
they start##4##2##(2007-7#1)(2009-12#1)(2010-5#1)(2011-12#1)
they started##3##2##(2008-8#1)(2010-2#1)(2011-1#1)
they still##12##2##(1990-11#1)(1992-2#1)(1993-12#1)(1994-1#1)(1995-6#1)(1995-9#1)(2004-9#1)(2008-10#2)(2009-6#1)(2011-2#1)(2012-3#1)
they stop##2##2##(1996-8#1)(2011-2#1)
they stress the##2##3##(1990-7#1)(1992-5#1)
they subsequently##2##2##(1997-3#1)(2010-8#1)
they successfully##2##2##(1992-3#1)(2011-2#1)
they suffer##2##2##(2008-2#1)(2009-6#1)
they suffered from##2##3##(1995-2#1)(2005-10#1)
they suffered##3##2##(1991-11#1)(1995-2#1)(2005-10#1)
they suggest that##13##3##(1990-1#1)(1991-12#1)(1991-5#1)(1992-9#1)(1993-10#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-2#1)(2006-3#1)(2008-11#1)(2008-4#1)
they suggest##16##2##(1990-1#1)(1991-12#1)(1991-5#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-2#1)(2006-3#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)
they summarize the##2##3##(2006-10#1)(2010-2#1)
they support the##3##3##(1991-2#1)(2010-5#1)(2012-2#1)
they support##6##2##(1991-2#1)(2010-2#1)(2010-5#1)(2012-2#1)(2013-1#2)
they survived##2##2##(2006-8#1)(2008-8#1)
they switch##2##2##(1992-3#1)(2006-10#1)
they take##4##2##(1995-9#1)(1996-11#1)(2008-1#1)(2013-1#1)
they target##5##2##(1991-11#1)(2006-10#1)(2008-1#1)(2009-8#1)(2012-3#1)
they tend to##7##3##(1994-4#1)(1995-12#1)(2005-11#1)(2006-10#1)(2008-11#1)(2008-5#1)(2013-8#1)
they tend##8##2##(1994-4#1)(1995-12#1)(2005-11#1)(2006-10#1)(2008-11#1)(2008-5#1)(2011-3#1)(2013-8#1)
they tended to have##2##4##(2007-2#1)(2012-1#1)
they tended to##5##3##(2005-10#1)(2007-2#1)(2008-11#1)(2010-3#1)(2012-1#1)
they themselves##4##2##(1991-12#1)(1993-1#1)(2006-3#1)(2012-2#1)
they think##3##2##(1994-2#1)(2007-12#1)(2013-1#1)
they thought##5##2##(1997-4#1)(2007-12#2)(2007-7#1)(2010-4#1)
they told##2##2##(1995-6#1)(2009-10#1)
they too are##2##3##(1991-7#1)(2007-8#1)
they too have##2##3##(2006-10#1)(2009-7#1)
they too##6##2##(1991-7#1)(2006-10#1)(2007-8#1)(2008-3#1)(2008-4#1)(2009-7#1)
they took##6##2##(2005-11#1)(2006-4#1)(2008-5#1)(2009-5#1)(2011-2#1)(2013-1#1)
they trigger##3##2##(2008-4#1)(2011-2#1)(2012-3#1)
they try to##2##3##(1991-12#1)(2010-5#1)
they try##3##2##(1991-12#1)(2008-9#1)(2010-5#1)
they typically##2##2##(2008-4#1)(2012-3#1)
they undergo##11##2##(1991-3#1)(1992-3#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-4#1)(2010-3#1)(2010-4#1)(2010-7#1)(2012-1#1)
they underline the##2##3##(1991-10#1)(1991-6#1)
they underline##3##2##(1991-10#1)(1991-6#1)(1993-6#1)
they understood##2##2##(1993-12#1)(2008-11#1)
they underwent##7##2##(1994-11#1)(1995-10#1)(1995-4#1)(2007-8#1)(2008-6#1)(2010-7#1)(2013-1#1)
they use to##3##3##(2008-5#1)(2009-12#1)(2011-2#1)
they use##20##2##(1991-1#1)(1993-12#1)(1997-3#2)(2004-10#1)(2006-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#1)
they used to##2##3##(2007-3#1)(2010-2#1)
they used##15##2##(1990-12#1)(1992-8#1)(1993-2#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-2#2)(2010-3#1)(2011-1#1)
they usually present##2##3##(2011-1#1)(2012-2#1)
they usually##9##2##(2007-8#1)(2008-10#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
they varied##3##2##(2008-11#1)(2012-3#1)(2013-1#1)
they vary##2##2##(2006-10#1)(2008-3#1)
they viewed##3##2##(2008-11#1)(2008-12#1)(2012-2#1)
they want##7##2##(1994-12#1)(1996-8#1)(1997-2#1)(2009-4#1)(2009-6#1)(2010-9#1)(2012-3#1)
they wanted to##2##3##(2011-2#1)(2013-1#1)
they wanted##3##2##(2009-5#1)(2011-2#1)(2013-1#1)
they were &quot##3##3##(1994-1#1)(2008-7#2)
they were 0##2##3##(2005-11#1)(2007-6#1)
they were HIV-positive##2##3##(1995-6#1)(1997-5#1)
they were able to##3##4##(1993-5#1)(2008-9#1)(2012-1#1)
they were able##4##3##(1993-5#1)(2008-11#1)(2008-9#1)(2012-1#1)
they were active##2##3##(1994-8#1)(1997-3#1)
they were all##3##3##(1992-3#1)(2008-10#1)(2008-8#1)
they were allowed to##2##4##(1993-4#1)(2008-10#1)
they were also##8##3##(1995-2#1)(1995-6#1)(2005-9#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
they were applied to##2##4##(2006-10#1)(2011-2#1)
they were applied##3##3##(2006-10#1)(2009-10#1)(2011-2#1)
they were asked to##2##4##(2010-2#1)(2013-8#1)
they were asked##3##3##(2010-2#1)(2013-1#1)(2013-8#1)
they were at##3##3##(2007-10#1)(2007-3#1)(2010-8#1)
they were aware of##2##4##(2006-10#1)(2011-1#1)
they were being##2##3##(2007-10#1)(2009-3#1)
they were both##2##3##(1994-12#1)(2008-10#1)
they were characterized by##2##4##(2007-11#1)(2008-12#1)
they were classified as##2##4##(1992-6#1)(1993-8#1)
they were comfortable##2##3##(2007-9#1)(2008-11#1)
they were completely##2##3##(2009-4#1)(2009-8#1)
they were concentrated##3##3##(1993-12#1)(2008-10#2)
they were conducted##2##3##(2006-10#1)(2006-2#1)
they were considered to be##2##5##(1994-6#1)(2007-12#1)
they were considered to##3##4##(1994-6#1)(2007-12#1)(2008-7#1)
they were considered##5##3##(1994-6#1)(1996-2#1)(2007-12#1)(2008-7#1)(2013-7#1)
they were constructed from data##2##5##(1993-12#2)
they were contaminated##2##3##(2008-11#2)
they were derived##6##3##(1997-1#1)(2008-10#3)(2008-4#1)(2008-7#1)
they were detected##2##3##(1994-5#1)(1996-12#1)
they were developed##3##3##(2005-5#1)(2006-10#1)(2009-12#1)
they were discharged##3##3##(2007-10#1)(2007-2#1)(2012-12#1)
they were distributed##2##3##(1997-3#1)(2007-6#1)
they were employed##2##3##(2008-10#1)(2008-11#1)
they were expected##2##3##(1995-1#1)(2008-10#1)
they were exposed to##8##4##(1990-2#1)(1990-5#1)(1996-9#1)(2008-10#1)(2008-5#1)(2009-6#2)(2011-12#1)
they were expressed##3##3##(1991-9#1)(1997-6#2)
they were extracted##2##3##(2008-10#1)(2013-7#1)
they were fed##3##3##(2004-11#1)(2008-11#1)(2008-5#1)
they were for##2##3##(1995-6#1)(2011-2#1)
they were found in 16 terms (out of 251) in the collection of inflammation terms##2##15##(2013-1#2)
they were found in##4##4##(2007-3#1)(2013-1#3)
they were found to be##3##5##(2005-11#1)(2008-5#1)(2010-7#1)
they were found to##4##4##(2005-11#1)(2008-5#1)(2008-7#1)(2010-7#1)
they were found##10##3##(1993-11#1)(2005-11#1)(2007-3#1)(2007-5#1)(2008-5#1)(2008-7#1)(2010-7#1)(2013-1#3)
they were further##2##3##(2008-10#1)(2008-5#1)
they were generated##3##3##(1991-12#1)(2008-11#1)(2013-8#1)
they were given a##2##4##(1996-5#1)(2009-4#1)
they were given##3##3##(1996-5#1)(2009-10#1)(2009-4#1)
they were highly correlated##2##4##(2006-6#1)(2008-1#1)
they were highly##4##3##(2006-6#1)(2008-1#1)(2008-10#1)(2013-8#1)
they were identical to##2##4##(2008-10#2)
they were in a##3##4##(2006-10#1)(2008-5#2)
they were in the##3##4##(2008-10#1)(2012-12#1)(2012-3#1)
they were in##16##3##(1990-5#2)(1995-6#1)(2006-10#1)(2007-3#1)(2008-10#1)(2008-4#1)(2008-5#2)(2009-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)
they were increased##2##3##(1996-11#1)(2007-10#1)
they were inoculated with##3##4##(2005-9#1)(2006-8#1)(2008-10#1)
they were inoculated##4##3##(2005-9#1)(2006-8#1)(2008-10#2)
they were isolated from##2##4##(2008-10#1)(2008-5#1)
they were isolated##4##3##(2008-10#3)(2008-5#1)
they were kept##2##3##(1996-6#1)(2008-10#1)
they were killed##2##3##(1997-3#1)(2006-9#1)
they were less##3##3##(2008-3#1)(2010-12#1)(2013-8#1)
they were likely to##2##4##(2008-2#1)(2010-9#1)
they were located##3##3##(1990-4#1)(1995-10#1)(2006-10#1)
they were managing##2##3##(1994-1#2)
they were more##4##3##(2006-8#1)(2008-10#1)(2009-5#1)(2013-1#1)
they were negative for##2##4##(1992-6#1)(2012-1#1)
they were no##2##3##(2008-10#1)(2011-1#1)
they were not##30##3##(1990-6#1)(1991-2#1)(1991-9#1)(1993-10#1)(1993-2#1)(1995-1#1)(1997-1#1)(1997-6#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#3)(2013-8#1)
they were of##3##3##(1991-2#1)(2005-11#1)(2008-10#1)
they were often##3##3##(2010-12#1)(2011-2#1)(2013-1#1)
they were only##3##3##(1992-5#1)(2006-2#1)(2008-12#1)
they were originally##2##3##(2007-4#1)(2008-10#1)
they were partially##2##3##(1997-4#1)(2011-2#1)
they were performing##2##3##(1994-3#1)(2008-11#1)
they were physically##2##3##(1991-11#1)(2008-9#1)
they were placed on##2##4##(1994-6#1)(2007-7#1)
they were placed##4##3##(1994-6#1)(2007-7#1)(2008-10#1)(2008-5#1)
they were properly##2##3##(2004-7#1)(2012-2#1)
they were related##2##3##(1993-12#1)(2007-12#1)
they were required to##2##4##(1994-3#1)(2010-2#1)
they were satisfied with the##2##5##(2008-9#1)(2012-3#1)
they were satisfied with##5##4##(1990-2#1)(2007-10#1)(2007-2#1)(2008-9#1)(2012-3#1)
they were separated##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
they were significantly higher##2##4##(1995-4#1)(2008-7#1)
they were significantly more##2##4##(2004-12#1)(2007-1#1)
they were significantly##6##3##(1995-12#1)(1995-4#1)(2004-12#1)(2007-1#1)(2007-8#1)(2008-7#1)
they were slower##2##3##(1993-6#1)(2007-12#1)
they were still##3##3##(1994-5#1)(2006-8#1)(2012-1#1)
they were subjected to a##2##5##(2012-12#1)(2013-8#1)
they were subjected to##3##4##(2010-3#1)(2012-12#1)(2013-8#1)
they were subjected##4##3##(2010-3#1)(2012-12#1)(2013-8#2)
they were taking##2##3##(1993-9#1)(2008-11#1)
they were tested for their##2##5##(1993-6#1)(2008-10#1)
they were tested for##3##4##(1993-2#1)(1993-6#1)(2008-10#1)
they were tested##5##3##(1993-2#1)(1993-6#1)(1994-2#1)(2008-10#1)(2008-5#1)
they were the same##2##4##(1996-2#1)(2006-3#1)
they were the##7##3##(1995-12#1)(1996-2#1)(2006-3#1)(2008-12#1)(2008-7#1)(2009-11#1)(2011-2#1)
they were then##4##3##(1993-12#1)(2004-12#1)(2008-1#1)(2008-7#1)
they were to##3##3##(1997-6#1)(2008-9#1)(2013-1#1)
they were trained##2##3##(1994-3#1)(2008-9#1)
they were treated##2##3##(1997-3#1)(1997-4#1)
they were unable to##2##4##(1991-4#1)(2008-7#1)
they were under##3##3##(1995-5#1)(2008-7#1)(2013-8#1)
they were used for##2##4##(2008-10#2)
they were used in the##2##5##(2008-10#1)(2011-2#1)
they were used in##4##4##(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
they were used to##3##4##(1993-8#1)(2008-10#1)(2011-2#1)
they were used##12##3##(1993-6#1)(1993-8#1)(2008-10#5)(2008-11#1)(2011-2#2)(2013-8#2)
they were well##3##3##(1990-7#1)(1991-4#1)(2007-11#1)
they were##596##2##(1990-10#3)(1990-2#3)(1990-3#2)(1990-4#3)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#3)(1991-3#3)(1991-4#3)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#3)(1992-11#1)(1992-12#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#8)(1993-2#2)(1993-4#1)(1993-5#2)(1993-6#5)(1993-8#4)(1993-9#2)(1994-1#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#3)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#4)(1995-10#1)(1995-12#3)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#4)(1995-8#1)(1996-11#2)(1996-12#3)(1996-2#3)(1996-3#1)(1996-4#3)(1996-5#4)(1996-6#1)(1996-7#1)(1996-9#4)(1997-1#3)(1997-2#2)(1997-3#6)(1997-4#4)(1997-5#2)(1997-6#4)(1997-8#5)(2004-11#3)(2004-12#2)(2004-2#2)(2004-7#1)(2005-11#5)(2005-12#1)(2005-4#1)(2005-5#2)(2005-9#2)(2006-10#9)(2006-2#4)(2006-3#1)(2006-5#4)(2006-6#1)(2006-8#4)(2006-9#3)(2007-1#3)(2007-10#7)(2007-11#6)(2007-12#5)(2007-2#8)(2007-3#7)(2007-4#1)(2007-5#4)(2007-6#2)(2007-7#8)(2007-8#5)(2007-9#2)(2008-1#5)(2008-10#73)(2008-11#16)(2008-12#4)(2008-2#3)(2008-3#5)(2008-4#6)(2008-5#19)(2008-6#5)(2008-7#18)(2008-8#8)(2008-9#6)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#5)(2009-5#3)(2009-6#2)(2009-8#4)(2010-1#2)(2010-11#1)(2010-12#6)(2010-2#2)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#7)(2011-12#1)(2011-2#20)(2011-7#1)(2012-1#4)(2012-11#2)(2012-12#8)(2012-2#8)(2012-3#9)(2013-1#22)(2013-7#3)(2013-8#20)
they will be##17##3##(1991-12#1)(1992-2#1)(1992-5#2)(1996-3#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-3#1)(2006-6#1)(2007-3#1)(2008-10#1)(2008-11#1)(2010-2#1)(2013-8#1)
they will have##3##3##(1994-2#1)(2008-10#2)
they will need to##3##4##(1994-12#1)(2005-10#1)(2010-2#1)
they will serve##2##3##(1996-3#1)(2009-11#1)
they will##58##2##(1990-12#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-5#2)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#2)(1996-12#2)(1996-2#1)(1996-3#3)(1996-8#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-3#1)(2005-10#1)(2006-10#1)(2006-5#1)(2006-6#2)(2006-7#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-6#1)(2010-2#3)(2010-3#1)(2011-12#1)(2013-8#1)
they wish to##2##3##(2006-12#1)(2006-7#1)
they wish##5##2##(1995-6#1)(2006-12#1)(2006-7#1)(2008-12#1)(2012-3#1)
they won't##2##2##(2004-9#1)(2007-9#1)
they work with##3##3##(1993-1#1)(2009-6#1)(2011-1#1)
they work##15##2##(1993-1#1)(1995-1#1)(1995-3#1)(1996-3#1)(2005-8#1)(2005-9#1)(2007-4#1)(2008-11#1)(2009-6#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)
they work?##4##2##(1994-3#1)(1997-3#1)(2007-1#1)(2013-7#1)
they would be##8##3##(1994-1#1)(1994-9#1)(2006-10#1)(2007-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2012-12#1)
they would choose to##3##4##(2007-3#1)(2010-4#2)
they would consent to##2##4##(1993-8#1)(2008-11#1)
they would do##2##3##(2007-12#1)(2010-2#1)
they would like to##3##4##(1991-2#1)(2010-10#1)(2011-1#1)
they would like##5##3##(1991-2#1)(2006-6#1)(2010-10#1)(2011-1#1)(2011-12#1)
they would make##4##3##(2005-4#1)(2007-3#1)(2010-4#2)
they would not##3##3##(1992-2#1)(2007-11#1)(2008-1#1)
they would otherwise##2##3##(1997-1#1)(2008-8#1)
they would prescribe morphine##2##4##(2007-2#2)
they would prescribe##3##3##(1993-2#1)(2007-2#2)
they would recommend##2##3##(1996-12#1)(2012-12#1)
they would still##2##3##(1996-2#1)(2012-11#1)
they would undergo##2##3##(1993-5#1)(2013-1#1)
they would##66##2##(1990-6#2)(1991-2#2)(1991-8#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#3)(1994-1#1)(1994-9#1)(1995-12#2)(1996-12#1)(1996-2#1)(1997-1#1)(2005-4#2)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-2#4)(2007-3#2)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-10#1)(2010-2#3)(2010-4#4)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#4)(2012-2#1)(2013-1#2)(2013-7#1)
they##5749##1##(1990-1#4)(1990-10#6)(1990-11#15)(1990-12#20)(1990-2#15)(1990-3#17)(1990-4#12)(1990-5#18)(1990-6#15)(1990-7#13)(1990-8#6)(1990-9#7)(1991-1#15)(1991-10#10)(1991-11#19)(1991-12#27)(1991-2#32)(1991-3#27)(1991-4#14)(1991-5#16)(1991-6#11)(1991-7#16)(1991-8#13)(1991-9#11)(1992-1#6)(1992-10#10)(1992-11#13)(1992-12#18)(1992-2#22)(1992-3#36)(1992-4#10)(1992-5#14)(1992-6#14)(1992-7#13)(1992-8#19)(1992-9#14)(1993-1#15)(1993-10#6)(1993-11#10)(1993-12#36)(1993-2#23)(1993-3#26)(1993-4#7)(1993-5#8)(1993-6#27)(1993-7#6)(1993-8#18)(1993-9#14)(1994-1#13)(1994-10#2)(1994-11#20)(1994-12#32)(1994-2#22)(1994-3#40)(1994-4#4)(1994-5#16)(1994-6#20)(1994-7#6)(1994-8#17)(1994-9#16)(1995-1#32)(1995-10#7)(1995-11#22)(1995-12#31)(1995-2#37)(1995-3#18)(1995-4#5)(1995-5#30)(1995-6#27)(1995-7#3)(1995-8#22)(1995-9#11)(1996-1#25)(1996-10#11)(1996-11#18)(1996-12#27)(1996-2#36)(1996-3#33)(1996-4#11)(1996-5#13)(1996-6#13)(1996-7#9)(1996-8#14)(1996-9#18)(1997-1#33)(1997-2#33)(1997-3#31)(1997-4#20)(1997-5#16)(1997-6#24)(1997-7#10)(1997-8#19)(2003-11#1)(2004-1#1)(2004-10#5)(2004-11#7)(2004-12#7)(2004-2#3)(2004-3#6)(2004-4#3)(2004-7#1)(2004-9#10)(2005-1#4)(2005-10#19)(2005-11#41)(2005-12#7)(2005-2#2)(2005-4#4)(2005-5#3)(2005-6#2)(2005-7#25)(2005-8#21)(2005-9#16)(2006-1#2)(2006-10#124)(2006-11#18)(2006-12#30)(2006-2#33)(2006-3#15)(2006-4#5)(2006-5#35)(2006-6#22)(2006-7#41)(2006-8#43)(2006-9#19)(2007-1#16)(2007-10#36)(2007-11#71)(2007-12#118)(2007-2#65)(2007-3#30)(2007-4#30)(2007-5#20)(2007-6#25)(2007-7#48)(2007-8#70)(2007-9#60)(2008-1#81)(2008-10#318)(2008-11#158)(2008-12#64)(2008-2#117)(2008-3#77)(2008-4#120)(2008-5#138)(2008-6#52)(2008-7#131)(2008-8#109)(2008-9#79)(2009-1#3)(2009-10#25)(2009-11#16)(2009-12#20)(2009-2#18)(2009-3#19)(2009-4#43)(2009-5#35)(2009-6#33)(2009-7#14)(2009-8#32)(2009-9#18)(2010-1#9)(2010-10#16)(2010-11#28)(2010-12#54)(2010-2#44)(2010-3#37)(2010-4#26)(2010-5#22)(2010-6#8)(2010-7#32)(2010-8#42)(2010-9#20)(2011-1#68)(2011-11#1)(2011-12#25)(2011-2#170)(2011-3#4)(2011-7#4)(2012-1#51)(2012-11#18)(2012-12#105)(2012-2#108)(2012-3#84)(2012-5#1)(2013-1#165)(2013-7#28)(2013-8#84)
they're##8##1##(1992-11#1)(1992-9#2)(2007-8#1)(2007-9#1)(2010-9#1)(2013-1#1)(2013-8#1)
they've##3##1##(2007-9#2)(2010-12#1)
they?##6##1##(2006-5#1)(2006-7#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-4#1)
thia FA with the sulfur atom##2##6##(2007-8#2)
thia FA##5##2##(2007-8#5)
thia fatty acids are##2##4##(1995-3#2)
thia fatty acids##3##3##(1995-3#3)
thia fatty##4##2##(1995-3#4)
thia##10##1##(1995-3#4)(2007-8#5)(2008-10#1)
thiabendazole and fuberidazole##2##3##(2008-10#2)
thiabendazole in water samples##2##4##(2007-8#1)(2008-10#1)
thiabendazole in water##3##3##(2007-8#1)(2008-10#2)
thiabendazole in##4##2##(2007-8#2)(2008-10#2)
thiabendazole##20##1##(1993-8#1)(2007-8#6)(2008-10#11)(2008-4#2)
thiacetazone##4##1##(1992-2#1)(1995-5#2)(2005-9#1)
thiacrown ether##2##2##(2008-10#2)
thiadiazole and##2##2##(1992-10#1)(2007-11#1)
thiadiazole##6##1##(1992-10#1)(2007-11#5)
thiadiazoles and##2##2##(2007-11#2)
thiadiazoles##3##1##(2007-11#3)
thiamazole##3##1##(1994-3#3)
thiamethoxam##2##1##(2011-2#2)
thiamin and##2##2##(1990-2#1)(2010-4#1)
thiamin diphosphate##4##2##(1990-7#1)(1995-10#2)(2010-4#1)
thiamin phosphate esters##3##3##(2010-4#3)
thiamin tetraphosphate##2##2##(2010-4#2)
thiamin transport##3##2##(1990-2#3)
thiamin triphosphate##2##2##(2010-4#2)
thiamin##28##1##(1990-2#5)(1990-7#1)(1995-10#2)(1995-6#3)(2005-10#2)(2008-10#1)(2010-4#13)(2010-9#1)
thiamine (vitamin B1)##2##3##(2006-10#1)(2008-1#1)
thiamine and thiamine##2##3##(1995-1#2)
thiamine and##9##2##(1995-1#4)(1997-5#1)(2008-1#2)(2012-4#2)
thiamine deficiency in##2##3##(2008-1#2)
thiamine deficiency##10##2##(1990-11#1)(1991-9#1)(1995-1#1)(1997-7#1)(2006-10#1)(2006-4#1)(2008-1#4)
thiamine deficient##3##2##(1990-11#1)(2006-4#2)
thiamine diphosphate##3##2##(1995-1#3)
thiamine disulfide##2##2##(1994-11#2)
thiamine may##2##2##(2006-4#1)(2007-7#1)
thiamine pyrophosphate##2##2##(1990-11#1)(2007-11#1)
thiamine transport##2##2##(1996-9#1)(2009-7#1)
thiamine triphosphatase##2##2##(1991-5#2)
thiamine triphosphate##2##2##(1990-9#1)(1991-5#1)
thiamine uptake##2##2##(1996-9#1)(2006-10#1)
thiamine##96##1##(1990-11#4)(1990-9#5)(1991-5#4)(1991-9#2)(1994-11#2)(1995-1#14)(1996-9#2)(1997-5#3)(1997-7#1)(2006-10#4)(2006-4#10)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#13)(2008-10#24)(2008-7#1)(2009-7#2)(2012-4#2)
thiamine-responsive MSUD##2##2##(1991-1#2)
thiamine-responsive##4##1##(1991-1#3)(2009-7#1)
thiamine[Symbol##2##1##(2008-11#2)
thiazide diuretic alone)##2##3##(2009-9#2)
thiazide diuretic##4##2##(2009-9#4)
thiazide diuretics and##2##3##(1992-11#1)(1994-12#1)
thiazide diuretics##6##2##(1992-11#1)(1994-12#1)(1996-9#2)(2009-4#1)(2009-9#1)
thiazide##17##1##(1992-11#1)(1994-12#1)(1995-6#1)(1996-9#4)(2008-10#1)(2008-5#1)(2009-4#3)(2009-9#5)
thiazides in##3##2##(1993-8#1)(1995-6#1)(2009-4#1)
thiazides to##2##2##(1995-6#2)
thiazides##12##1##(1993-8#5)(1995-6#3)(2005-1#1)(2008-7#1)(2009-4#2)
thiazole##6##1##(1995-3#1)(1996-2#1)(2006-6#1)(2008-10#1)(2008-3#1)(2008-5#1)
thiazolidine derivatives##4##2##(1995-3#3)(2008-10#1)
thiazolidine##7##1##(1995-3#5)(1996-9#1)(2008-10#1)
thiazolidinediones (TZDs)##4##2##(2008-1#2)(2008-3#1)(2010-10#1)
thiazolidinediones and##3##2##(1997-4#1)(2008-3#1)(2008-7#1)
thiazolidinediones##18##1##(1997-4#2)(2007-9#1)(2008-1#5)(2008-10#1)(2008-3#5)(2008-5#1)(2008-7#1)(2010-10#1)(2013-1#1)
thiazoline##3##1##(1992-6#1)(1994-8#1)(2008-3#1)
thibetanus ussuricus##3##2##(2009-5#3)
thibetanus##4##1##(2009-5#4)
thick CsI)##2##2##(2011-1#2)
thick and##10##2##(1991-9#1)(1997-6#1)(2005-11#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-6#1)(2012-1#1)
thick ascending limb cells##2##4##(1993-3#2)
thick ascending limb of##4##4##(1991-1#2)(1995-2#1)(2007-7#1)
thick ascending limb##6##3##(1991-1#2)(1993-3#2)(1995-2#1)(2007-7#1)
thick ascending##8##2##(1990-2#1)(1991-1#2)(1993-3#2)(1993-7#1)(1995-2#1)(2007-7#1)
thick birefringent##2##2##(2007-12#1)(2008-3#1)
thick collagenous capsule##2##3##(2011-2#2)
thick filament loss##2##3##(2008-7#2)
thick filament##3##2##(1996-11#1)(2008-7#2)
thick filaments##4##2##(1992-9#1)(1997-4#3)
thick film semiconductor sensor##2##4##(2008-10#2)
thick film##6##2##(2008-10#4)(2008-12#1)(2008-3#1)
thick films##4##2##(2006-2#1)(2007-2#1)(2007-9#1)(2008-3#1)
thick gratings with##2##3##(2008-2#2)
thick insulating coatings##2##3##(2008-10#2)
thick layer of##4##3##(2007-12#2)(2009-12#1)(2011-1#1)
thick layer##5##2##(2006-4#1)(2007-12#2)(2009-12#1)(2011-1#1)
thick layers of##2##3##(2008-3#1)(2008-7#1)
thick layers##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
thick medium##2##2##(2007-12#1)(2008-3#1)
thick nasal discharge##2##3##(2011-2#2)
thick nonlinear##3##2##(2007-11#1)(2007-12#2)
thick polymer films##2##3##(2008-10#2)
thick polymer##3##2##(2008-10#3)
thick scattering##4##2##(2008-3#4)
thick sections were##2##3##(2004-9#1)(2012-3#1)
thick sections##3##2##(1994-4#1)(2004-9#1)(2012-3#1)
thick skin##2##2##(2005-11#1)(2010-8#1)
thick soft##2##2##(2008-6#2)
thick turbid##2##2##(2008-2#1)(2008-3#1)
thick uniaxial##2##2##(2008-3#2)
thick walled##2##2##(2012-12#1)(2012-2#1)
thick were##2##2##(1995-6#1)(2008-1#1)
thick with a##2##3##(1995-11#1)(2008-3#1)
thick with##3##2##(1995-11#1)(2008-2#1)(2008-3#1)
thick##235##1##(1990-2#1)(1991-1#2)(1991-12#1)(1991-8#1)(1991-9#1)(1992-6#1)(1992-9#2)(1993-12#1)(1993-3#2)(1993-7#1)(1993-9#1)(1994-2#1)(1994-4#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#1)(2004-11#1)(2004-2#1)(2004-9#1)(2005-11#5)(2006-10#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#7)(2007-12#26)(2007-2#2)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#18)(2008-11#2)(2008-12#4)(2008-2#39)(2008-3#30)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#5)(2008-9#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-5#4)(2009-6#1)(2009-9#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
thick)##8##1##(2008-10#2)(2008-2#1)(2008-3#1)(2009-7#2)(2010-1#1)(2010-9#1)
thick-film carbon##4##2##(2008-10#4)
thick-film semiconductor sensor##2##3##(2008-10#2)
thick-film##6##1##(2008-10#6)
thick-walled##6##1##(2007-12#1)(2008-10#1)(2010-3#1)(2013-1#2)(2013-7#1)
thicken##2##1##(2008-5#1)(2008-8#1)
thickened and##3##2##(2005-7#1)(2007-8#1)(2008-5#1)
thickened cell walls##2##3##(1996-4#1)(2008-5#1)
thickened wall##2##2##(2008-5#1)(2010-12#1)
thickened with##2##2##(2008-10#1)(2008-5#1)
thickened##39##1##(1990-3#1)(1991-11#1)(1991-3#1)(1991-8#1)(1996-4#1)(1997-2#1)(2005-11#1)(2005-7#2)(2006-10#3)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#2)(2008-10#3)(2008-4#1)(2008-5#10)(2008-7#1)(2009-3#1)(2010-10#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-2#1)
thickening agent##2##2##(1996-4#1)(2008-5#1)
thickening and##17##2##(1990-9#1)(1995-12#2)(1996-10#1)(1996-12#1)(2005-10#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-4#1)(2010-10#1)(2012-1#1)(2012-12#2)(2013-1#1)
thickening in the##2##3##(2009-8#1)(2013-7#1)
thickening of dura matter##2##4##(2012-2#2)
thickening of the bowel wall##2##5##(1992-5#1)(2012-2#1)
thickening of the glomerular basement membrane##2##6##(2007-8#1)(2008-1#1)
thickening of the wall of the##2##6##(2006-4#1)(2008-7#1)
thickening of the##24##3##(1992-12#2)(1992-5#1)(1996-3#2)(1997-5#1)(1997-6#1)(2006-10#3)(2006-4#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-5#3)(2008-6#1)(2008-7#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#1)
thickening of##37##2##(1990-9#1)(1992-12#2)(1992-5#1)(1996-3#2)(1997-5#1)(1997-6#1)(2005-3#1)(2006-10#4)(2006-4#1)(2006-6#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#3)
thickening was##3##2##(2005-12#1)(2008-10#1)(2011-2#1)
thickening##100##1##(1990-9#2)(1991-12#3)(1991-8#1)(1992-12#2)(1992-5#2)(1994-8#1)(1995-12#5)(1995-8#1)(1996-10#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-7#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-3#1)(2006-10#7)(2006-2#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-4#2)(2007-7#6)(2007-8#2)(2008-1#4)(2008-10#7)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-10#2)(2010-12#2)(2010-9#2)(2011-1#2)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#4)(2013-1#1)(2013-7#1)
thickenings##2##1##(1997-1#1)(2008-10#1)
thickens##3##1##(2007-12#2)(2008-4#1)
thicker and##4##2##(2007-11#1)(2007-4#1)(2008-10#1)(2010-12#1)
thicker lenses were##2##3##(2005-11#2)
thicker than 4 mm or with##2##6##(1990-6#1)(2008-8#1)
thicker than in##2##3##(1992-7#1)(2005-1#1)
thicker than the##4##3##(2005-11#1)(2007-12#1)(2008-3#2)
thicker than##15##2##(1990-6#1)(1992-7#1)(1992-9#1)(1993-4#1)(1997-3#1)(2005-1#1)(2005-11#1)(2005-7#1)(2007-12#1)(2008-2#1)(2008-3#4)(2008-8#1)
thicker##50##1##(1990-6#1)(1991-2#1)(1991-3#1)(1992-7#2)(1992-9#1)(1993-4#1)(1995-6#1)(1996-5#1)(1997-3#1)(2004-9#1)(2005-1#2)(2005-11#4)(2005-7#1)(2006-2#1)(2006-6#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#6)(2008-5#3)(2008-8#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-3#1)
thickest##3##1##(2008-8#1)(2009-3#1)(2009-5#1)
thickness (CIMT)##3##2##(2012-1#1)(2012-3#1)(2013-8#1)
thickness (ET)##2##2##(1994-9#1)(1996-2#1)
thickness (IMT) in##2##3##(2008-3#1)(2011-2#1)
thickness (IMT) of##3##3##(2007-10#1)(2008-1#1)(2011-1#1)
thickness (IMT)##8##2##(2007-10#2)(2008-1#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
thickness (P##2##2##(2008-5#1)(2010-2#1)
thickness (r = -0##3##4##(1995-8#1)(2012-2#2)
thickness (r =##4##3##(1995-8#2)(2012-2#2)
thickness 0##5##2##(2007-12#1)(2008-10#1)(2009-8#3)
thickness 2##2##2##(2009-8#2)
thickness after##2##2##(2008-4#1)(2012-2#1)
thickness and by##2##3##(2006-10#1)(2008-5#1)
thickness and group refractive index##3##5##(2008-3#3)
thickness and length##2##3##(2008-5#1)(2010-10#1)
thickness and optical constants##2##4##(2008-3#2)
thickness and optical##3##3##(2008-3#3)
thickness and plaque##3##3##(2008-3#1)(2009-1#1)(2013-7#1)
thickness and refractive index##2##4##(2008-10#1)(2008-3#1)
thickness and the##14##3##(1991-7#1)(1994-3#1)(2004-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#7)(2011-1#1)
thickness and volume##3##3##(2007-11#2)(2013-1#1)
thickness and##88##2##(1991-7#1)(1994-3#1)(1995-3#1)(1995-5#1)(2004-12#1)(2004-9#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-11#8)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#3)(2008-3#21)(2008-4#1)(2008-5#9)(2008-7#1)(2008-9#1)(2009-1#1)(2009-2#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#2)(2011-1#2)(2011-2#4)(2011-7#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
thickness are##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
thickness as##2##2##(2008-3#2)
thickness at##7##2##(1990-4#1)(2008-2#2)(2008-3#2)(2012-2#1)(2013-1#1)
thickness but with##2##3##(2008-3#1)(2009-7#1)
thickness but##3##2##(1993-11#1)(2008-3#1)(2009-7#1)
thickness by##8##2##(1990-4#2)(1992-3#1)(1992-4#1)(2008-2#1)(2008-3#1)(2009-7#1)(2010-5#1)
thickness can be##2##3##(2005-11#1)(2007-12#1)
thickness can##3##2##(2005-11#1)(2006-4#1)(2007-12#1)
thickness change##3##2##(2008-2#3)
thickness control##2##2##(2008-3#2)
thickness d##3##2##(2007-11#1)(2008-3#2)
thickness dependence of##2##3##(2008-2#1)(2008-3#1)
thickness distribution of##3##3##(1994-12#1)(2007-12#2)
thickness distribution##6##2##(1994-12#1)(2007-12#2)(2008-3#1)(2008-7#1)(2013-1#1)
thickness due to the##2##4##(1992-7#1)(2012-2#1)
thickness fluctuations in##2##3##(2008-3#2)
thickness for an optimum##2##4##(2005-11#2)
thickness for##14##2##(1995-3#1)(2005-11#3)(2008-10#2)(2008-12#1)(2008-2#4)(2008-3#2)(2010-12#1)
thickness from##3##2##(2008-2#2)(2011-1#1)
thickness improved##2##2##(2007-8#1)(2011-2#1)
thickness in a##2##3##(2008-2#1)(2010-2#1)
thickness in patients##2##3##(2008-7#1)(2013-1#1)
thickness in##22##2##(1997-4#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-2#2)(2012-12#1)(2013-1#6)(2013-8#1)
thickness increased##6##2##(2004-9#1)(2007-4#1)(2008-10#1)(2008-5#2)(2009-10#1)
thickness increases##2##2##(2008-3#1)(2008-5#1)
thickness is a##3##3##(2008-10#1)(2008-5#1)(2009-12#1)
thickness is determined##2##3##(2008-3#1)(2009-5#1)
thickness is significantly greater##2##4##(2008-2#1)(2013-1#1)
thickness is##18##2##(2007-11#1)(2008-10#1)(2008-2#5)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#1)(2009-12#1)(2009-5#1)(2013-1#1)
thickness larger than##2##3##(2008-2#1)(2008-3#1)
thickness measurement##5##2##(2007-12#1)(2008-2#1)(2008-3#1)(2009-1#1)(2013-7#1)
thickness measurements in##3##3##(2005-10#2)(2011-2#1)
thickness measurements##6##2##(2005-10#3)(2008-3#1)(2011-2#1)(2012-12#1)
thickness modulation##3##2##(2008-2#3)
thickness obtained by##2##3##(2006-5#1)(2009-4#1)
thickness of 1##6##3##(2005-11#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-5#1)
thickness of 2##4##3##(2007-12#1)(2008-2#2)(2012-12#1)
thickness of 3 mm##2##4##(1993-2#1)(1997-8#1)
thickness of 3##4##3##(1993-2#1)(1997-8#1)(2007-11#1)(2009-2#1)
thickness of 4##3##3##(1990-6#1)(2013-1#2)
thickness of 5##2##3##(2007-12#1)(2008-5#1)
thickness of a##4##3##(2006-10#1)(2007-4#1)(2008-3#2)
thickness of approximately##4##3##(2007-12#1)(2008-2#1)(2009-5#1)(2010-7#1)
thickness of each##2##3##(2008-3#1)(2013-1#1)
thickness of hydrogel contact lenses##2##5##(2005-11#2)
thickness of metal##2##3##(2007-12#1)(2008-10#1)
thickness of the GaAs crystal##3##5##(2008-2#3)
thickness of the adsorbed##2##4##(2008-10#1)(2008-5#1)
thickness of the film##4##4##(2008-10#1)(2008-2#1)(2008-3#2)
thickness of the first##5##4##(2008-2#4)(2011-2#1)
thickness of the membrane##3##4##(2006-10#2)(2008-10#1)
thickness of the secondary perimysium##2##5##(2010-2#2)
thickness of the unstirred layer in the##5##7##(1991-5#5)
thickness of the unstirred##6##4##(1991-5#6)
thickness of the##118##3##(1990-12#1)(1990-2#1)(1991-5#7)(1992-6#1)(1993-8#1)(1994-3#1)(1995-6#1)(1996-5#1)(1996-7#1)(2005-1#1)(2005-11#4)(2006-10#2)(2006-12#1)(2006-6#1)(2007-11#6)(2007-12#6)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#8)(2008-11#3)(2008-2#18)(2008-3#18)(2008-5#5)(2008-7#3)(2008-8#2)(2008-9#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-9#2)(2010-2#2)(2010-8#2)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#4)(2013-8#2)
thickness of thin films##2##4##(2008-2#2)
thickness of thin##3##3##(2008-2#3)
thickness of this##2##3##(2009-7#1)(2013-7#1)
thickness of##218##2##(1990-12#1)(1990-2#1)(1990-4#4)(1990-6#2)(1991-5#7)(1992-4#1)(1992-6#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-3#1)(1995-6#2)(1996-11#1)(1996-5#2)(1996-7#1)(1997-8#1)(2005-1#1)(2005-11#8)(2006-10#5)(2006-12#1)(2006-6#2)(2007-11#10)(2007-12#15)(2007-3#1)(2007-4#2)(2007-5#1)(2007-8#2)(2007-9#3)(2008-10#19)(2008-11#3)(2008-12#1)(2008-2#29)(2008-3#27)(2008-5#8)(2008-7#4)(2008-8#2)(2008-9#2)(2009-2#3)(2009-3#3)(2009-5#2)(2009-7#2)(2009-9#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-7#1)(2010-8#2)(2011-2#4)(2012-11#1)(2012-12#3)(2012-2#4)(2013-1#5)(2013-7#1)(2013-8#4)
thickness on the##3##3##(2008-10#2)(2010-4#1)
thickness on##8##2##(1990-4#1)(2007-9#1)(2008-10#4)(2008-2#1)(2010-4#1)
thickness or##7##2##(1991-9#1)(1992-5#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-3#2)
thickness over##4##2##(2006-5#1)(2008-3#3)
thickness produces##2##2##(2007-12#1)(2008-3#1)
thickness profile##4##2##(2006-2#1)(2007-11#3)
thickness resection device (FTRD)##2##4##(2006-6#2)
thickness resection##4##2##(2006-6#3)(2007-8#1)
thickness should##2##2##(2008-3#1)(2008-9#1)
thickness skin##8##2##(1992-11#1)(2013-1#6)(2013-8#1)
thickness than##2##2##(2008-10#1)(2008-3#1)
thickness that is##2##3##(2007-11#1)(2008-3#1)
thickness that##7##2##(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#3)(2009-7#1)
thickness to##5##2##(2007-12#1)(2008-3#3)(2013-1#1)
thickness values##4##2##(2006-5#1)(2007-11#1)(2007-12#1)(2013-1#1)
thickness variations##4##2##(2007-11#1)(2007-4#2)(2008-5#1)
thickness varied##2##2##(2004-9#1)(2008-10#1)
thickness varies##2##2##(2007-12#1)(2008-3#1)
thickness was compared##2##3##(2007-8#1)(2013-1#1)
thickness was found to be##3##5##(2005-11#1)(2008-10#2)
thickness was found to##4##4##(2005-11#1)(2008-10#3)
thickness was measured by##2##4##(1990-6#1)(2013-1#1)
thickness was measured using##2##4##(2007-12#1)(2010-1#1)
thickness was measured##5##3##(1990-6#1)(1996-2#1)(2007-12#1)(2010-1#1)(2013-1#1)
thickness was##26##2##(1990-4#1)(1990-6#1)(1992-4#1)(1995-3#1)(1996-2#1)(2005-11#2)(2007-12#2)(2007-8#2)(2008-10#6)(2008-2#1)(2008-3#1)(2010-1#1)(2010-2#1)(2011-2#2)(2013-1#2)(2013-8#1)
thickness were evaluated##2##3##(1990-4#1)(2008-4#1)
thickness were##11##2##(1990-4#2)(1992-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2012-12#1)
thickness with##3##2##(2008-2#2)(2008-3#1)
thickness##875##1##(1990-12#1)(1990-2#1)(1990-4#11)(1990-6#3)(1990-8#1)(1991-5#7)(1991-7#2)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-4#4)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-3#5)(1995-5#1)(1995-6#2)(1995-8#2)(1996-11#1)(1996-2#3)(1996-5#2)(1996-7#1)(1997-3#1)(1997-4#1)(1997-8#2)(2004-12#2)(2004-9#4)(2005-1#1)(2005-10#4)(2005-11#27)(2006-10#9)(2006-12#5)(2006-2#2)(2006-4#3)(2006-5#7)(2006-6#8)(2007-1#1)(2007-10#5)(2007-11#45)(2007-12#44)(2007-2#1)(2007-3#1)(2007-4#7)(2007-5#2)(2007-7#1)(2007-8#9)(2007-9#12)(2008-1#4)(2008-10#66)(2008-11#12)(2008-12#5)(2008-2#107)(2008-3#136)(2008-4#5)(2008-5#40)(2008-6#1)(2008-7#10)(2008-8#6)(2008-9#9)(2009-1#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#6)(2009-3#3)(2009-4#3)(2009-5#5)(2009-6#4)(2009-7#7)(2009-8#6)(2009-9#4)(2010-1#3)(2010-10#3)(2010-12#8)(2010-2#14)(2010-3#1)(2010-4#8)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#20)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#8)(2012-2#22)(2012-3#3)(2013-1#32)(2013-7#5)(2013-8#14)
thickness) of##2##2##(2008-2#1)(2008-3#1)
thickness)##9##1##(1993-12#1)(1996-1#1)(2005-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-4#1)(2011-2#1)
thickness-modulated designs##4##2##(2008-2#1)(2008-3#3)
thickness-modulated##5##1##(2008-2#1)(2008-3#4)
thickness-profile measurement##2##2##(2007-11#1)(2008-3#1)
thickness]##3##1##(2012-3#1)(2013-1#2)
thicknesses (0##3##2##(2007-12#1)(2008-5#1)(2012-2#1)
thicknesses and##5##2##(2005-11#1)(2008-2#2)(2008-3#2)
thicknesses are##5##2##(2008-10#1)(2008-2#3)(2008-3#1)
thicknesses as##3##2##(2008-2#1)(2008-3#1)(2009-7#1)
thicknesses of the##6##3##(2005-11#1)(2007-4#1)(2008-2#2)(2008-3#2)
thicknesses of##21##2##(2005-11#3)(2007-12#2)(2007-4#1)(2008-10#1)(2008-12#1)(2008-2#4)(2008-3#9)
thicknesses were##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
thicknesses##80##1##(1996-5#1)(2005-11#5)(2006-8#1)(2007-12#4)(2007-2#1)(2007-4#2)(2008-10#4)(2008-12#2)(2008-2#23)(2008-3#22)(2008-5#6)(2009-10#2)(2009-2#2)(2009-6#1)(2009-7#1)(2012-2#2)(2013-8#1)
thief##2##1##(1995-3#1)(2009-4#1)
thienyl and##2##2##(2008-5#2)
thienyl##3##1##(1993-4#1)(2008-5#2)
thigh circumference##3##2##(2007-7#2)(2008-5#1)
thigh in##5##2##(2006-1#1)(2007-11#1)(2009-3#1)(2012-12#1)(2013-8#1)
thigh mass##2##2##(1992-2#1)(1994-10#1)
thigh muscle##3##2##(1996-12#1)(2007-8#1)(2008-12#1)
thigh muscles##4##2##(2008-5#1)(2008-6#1)(2010-12#2)
thigh of##2##2##(2009-2#1)(2009-5#1)
thigh or##2##2##(1997-3#1)(2009-5#1)
thigh pain##4##2##(2007-11#1)(2012-3#1)(2013-1#1)(2013-7#1)
thigh were##2##2##(1994-10#1)(2008-9#1)
thigh##96##1##(1990-2#1)(1991-3#2)(1991-6#1)(1992-2#1)(1993-9#2)(1994-10#3)(1996-12#1)(1997-3#1)(2006-1#2)(2006-11#3)(2006-6#1)(2006-7#4)(2007-10#1)(2007-11#10)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#2)(2007-7#7)(2007-8#1)(2008-1#1)(2008-12#5)(2008-5#7)(2008-6#9)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-7#1)(2010-11#1)(2010-12#2)(2010-8#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
thighs and buttocks##2##3##(2008-5#2)
thighs and##8##2##(1992-12#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-5#2)(2010-6#1)(2013-7#1)
thighs##14##1##(1992-12#1)(2006-10#1)(2006-8#3)(2007-10#1)(2007-12#1)(2008-5#3)(2008-6#1)(2009-9#1)(2010-6#1)(2013-7#1)
thigmotaxia##3##1##(1993-12#3)
thigmotaxis##4##1##(1994-3#4)
thiirane##2##1##(1996-5#2)
thimerosal and##2##2##(2007-12#1)(2008-5#1)
thimerosal##7##1##(1995-5#1)(1997-2#2)(2007-12#1)(2008-10#2)(2008-5#1)
thimidine##2##1##(1992-8#1)(2008-8#1)
thin (&lt##2##2##(2008-1#1)(2009-4#1)
thin PDMS membrane##3##3##(2008-11#3)
thin aluminum film##2##3##(2007-12#1)(2008-3#1)
thin aluminum##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
thin and medium-thick clouds##2##4##(2008-2#2)
thin and medium-thick##3##3##(2008-2#3)
thin and the##2##3##(1995-7#1)(2007-11#1)
thin and thick##2##3##(2007-12#1)(2008-10#1)
thin and##20##2##(1995-7#1)(1997-6#1)(2006-3#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#3)(2008-5#6)(2008-7#1)(2009-6#1)(2013-1#1)
thin aplanatic achromatic doublets##2##4##(2008-3#2)
thin basal##2##2##(2007-12#1)(2008-7#1)
thin body##2##2##(2007-12#2)
thin cirrus clouds##4##3##(2008-3#4)
thin clouds##5##2##(2008-2#3)(2008-3#2)
thin coatings##2##2##(2008-5#2)
thin collimation##4##2##(2006-4#3)(2008-7#1)
thin coronary sections were obtained##2##5##(2012-3#2)
thin coronary sections##3##3##(2012-3#3)
thin cortical##2##2##(2012-3#1)(2013-8#1)
thin crystal##3##2##(2007-11#1)(2008-1#1)(2008-2#1)
thin crystals##2##2##(2008-2#2)
thin deformable##2##2##(2005-11#1)(2008-2#1)
thin dielectric##2##2##(2007-12#1)(2008-2#1)
thin diffractive elements##2##3##(2008-3#2)
thin disk##3##2##(2007-11#1)(2007-12#2)
thin ferroelectric films##2##3##(2007-12#2)
thin fibres##2##2##(1997-2#2)
thin fibrous cap##3##3##(2007-10#1)(2008-10#1)(2012-2#1)
thin fibrous##4##2##(2004-9#1)(2007-10#1)(2008-10#1)(2012-2#1)
thin filament##13##2##(1990-12#1)(1994-11#1)(1994-9#1)(1995-6#1)(1996-5#4)(1997-7#1)(2008-2#2)(2008-6#1)(2010-5#1)
thin filaments##7##2##(1991-5#1)(1995-2#2)(1997-4#2)(1997-7#1)(2008-7#1)
thin film as##2##3##(2006-12#1)(2007-11#1)
thin film can be##2##4##(2008-1#1)(2008-2#1)
thin film coated##3##3##(2008-10#1)(2008-3#2)
thin film electrode##6##3##(2008-10#5)(2008-12#1)
thin film electrodes##5##3##(2008-10#5)
thin film is##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
thin film morphology##2##3##(2010-4#2)
thin film of##10##3##(2007-11#1)(2008-10#7)(2008-3#1)(2008-5#1)
thin film on a##2##4##(2007-12#1)(2008-2#1)
thin film on the##2##4##(2007-8#1)(2008-2#1)
thin film on##5##3##(2007-12#1)(2007-8#1)(2008-2#2)(2012-3#1)
thin film upon##2##3##(2008-3#2)
thin film was##5##3##(2005-11#2)(2007-2#1)(2008-10#2)
thin film were##2##3##(2007-11#1)(2007-8#1)
thin film with##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2010-7#1)
thin film##108##2##(2004-9#1)(2005-11#3)(2006-12#2)(2006-2#1)(2006-5#2)(2007-11#11)(2007-12#5)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#33)(2008-12#1)(2008-2#14)(2008-3#13)(2008-4#2)(2008-5#1)(2008-7#1)(2009-4#2)(2009-6#1)(2009-7#1)(2010-4#2)(2010-7#2)(2012-11#2)(2012-3#1)(2013-7#1)
thin films and bulk##2##4##(2007-11#1)(2008-3#1)
thin films and##10##3##(2007-11#2)(2007-12#1)(2008-2#4)(2008-3#3)
thin films are##3##3##(2008-2#1)(2008-3#1)(2010-4#1)
thin films as##2##3##(2007-8#1)(2008-2#1)
thin films at##2##3##(2007-12#1)(2008-3#1)
thin films by use of##3##5##(2007-12#1)(2008-2#2)
thin films can##2##3##(2008-2#1)(2008-3#1)
thin films constructed of nanowires of small organic molecules##2##9##(2009-11#2)
thin films containing##2##3##(2006-2#1)(2007-11#1)
thin films deposited on##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
thin films deposited##5##3##(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
thin films for##3##3##(2008-3#2)(2009-2#1)
thin films from##4##3##(2008-2#2)(2008-3#1)(2009-2#1)
thin films grown by##2##4##(2007-11#1)(2007-12#1)
thin films grown##3##3##(2007-11#1)(2007-12#1)(2008-1#1)
thin films has been##2##4##(2008-10#1)(2008-3#1)
thin films has##3##3##(2008-10#1)(2008-3#1)(2009-2#1)
thin films have been##2##4##(2005-11#1)(2011-2#1)
thin films have##3##3##(2005-11#1)(2007-12#1)(2011-2#1)
thin films in the##3##4##(2008-2#2)(2008-3#1)
thin films in##4##3##(2008-2#3)(2008-3#1)
thin films is presented##2##4##(2008-3#1)(2010-4#1)
thin films is##5##3##(2007-12#1)(2008-3#3)(2010-4#1)
thin films of ion-beam-deposited SiC##2##5##(2008-3#2)
thin films of##16##3##(1996-8#1)(1997-1#3)(2006-12#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#4)(2008-3#2)(2010-2#1)
thin films on##5##3##(2005-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
thin films prepared by##3##4##(2008-10#1)(2008-3#1)(2010-1#1)
thin films prepared##4##3##(2008-10#1)(2008-3#1)(2010-1#2)
thin films that are##2##4##(2007-12#1)(2007-9#1)
thin films that##4##3##(2007-12#1)(2007-9#1)(2008-3#1)(2009-12#1)
thin films using##5##3##(2006-12#1)(2006-5#1)(2008-10#1)(2008-2#1)(2010-4#1)
thin films was##4##3##(2005-11#1)(2007-11#1)(2008-10#1)(2010-1#1)
thin films were deposited by reactive##2##6##(2008-2#1)(2008-3#1)
thin films were##10##3##(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-1#2)(2010-12#1)(2012-2#1)
thin films with a##2##4##(2007-12#1)(2007-8#1)
thin films with##8##3##(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#4)(2013-8#1)
thin films##193##2##(1990-8#1)(1991-3#1)(1992-8#1)(1993-8#1)(1995-5#2)(1996-8#1)(1997-1#3)(2005-11#5)(2005-4#1)(2006-12#7)(2006-2#1)(2006-5#1)(2007-11#8)(2007-12#19)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#16)(2008-2#41)(2008-3#48)(2009-11#2)(2009-12#1)(2009-2#4)(2009-4#1)(2010-1#6)(2010-12#1)(2010-2#1)(2010-4#6)(2010-7#1)(2011-2#1)(2012-2#4)(2013-8#1)
thin foil mirrors##2##3##(2008-3#2)
thin foil##3##2##(2008-1#1)(2008-3#2)
thin glass films##2##3##(2008-2#2)
thin glass##3##2##(2008-2#2)(2008-3#1)
thin glass-ceramic rod##2##3##(2008-10#2)
thin gold films##2##3##(2008-10#1)(2008-3#1)
thin gold##4##2##(2008-1#1)(2008-10#1)(2008-3#2)
thin gratings with##2##3##(2008-2#2)
thin high-index##2##2##(2008-3#2)
thin horizontal##2##2##(1991-4#1)(2007-12#1)
thin ideal for women##2##4##(2007-12#2)
thin ideal##6##2##(2006-7#1)(2007-12#5)
thin layer chromatogram##2##3##(2008-12#1)(2013-1#1)
thin layer chromatographic method##3##4##(2008-10#1)(2010-2#2)
thin layer chromatography (TLC)##4##4##(2006-12#1)(2008-10#1)(2008-2#1)(2010-9#1)
thin layer chromatography and the##2##5##(2008-10#1)(2008-11#1)
thin layer chromatography and##5##4##(2008-10#2)(2008-11#1)(2012-1#1)(2012-2#1)
thin layer chromatography##26##3##(1992-3#1)(1994-9#1)(1997-3#1)(2005-10#1)(2006-12#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2009-7#2)(2009-8#1)(2010-5#4)(2010-9#1)(2012-1#1)(2012-2#2)
thin layer of silica##2##4##(2008-3#2)
thin layer of##4##3##(2008-10#1)(2008-3#2)(2008-4#1)
thin layer on the##2##4##(2008-10#1)(2008-6#1)
thin layer on##3##3##(2008-10#1)(2008-5#1)(2008-6#1)
thin layer##48##2##(1992-3#1)(1992-9#1)(1994-11#1)(1994-9#1)(1997-3#1)(2005-10#1)(2006-12#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#1)(2009-7#2)(2009-8#1)(2010-2#2)(2010-5#4)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
thin layers of##5##3##(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
thin layers##13##2##(1996-3#1)(2006-12#2)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-2#1)(2008-3#3)
thin lipid##2##2##(1992-6#1)(2008-11#1)
thin liquid films##5##3##(1992-5#1)(2005-11#1)(2008-10#1)(2008-3#2)
thin liquid##8##2##(1992-5#1)(2005-11#2)(2008-10#2)(2008-3#2)(2009-6#1)
thin liquid-crystal##2##2##(2007-12#1)(2008-2#1)
thin membrane##3##2##(1994-2#1)(2007-12#1)(2008-10#1)
thin mercury film electrode##2##4##(2008-10#2)
thin mercury film electrodes is demonstrated##2##6##(2008-10#2)
thin mercury film electrodes##4##4##(2008-10#4)
thin mercury film##6##3##(2008-10#6)
thin mercury##7##2##(2008-10#6)(2008-3#1)
thin metal film of finite width##3##6##(2007-12#3)
thin metal film##8##3##(2007-12#5)(2008-3#1)(2009-11#1)(2009-7#1)
thin metal##12##2##(2006-3#1)(2007-12#5)(2008-1#1)(2008-3#2)(2009-11#1)(2009-7#1)(2010-7#1)
thin metallic wires##3##3##(2008-3#3)
thin metallic##4##2##(2008-3#4)
thin models##4##2##(2007-12#4)
thin optical##3##2##(2006-6#2)(2008-3#1)
thin or##2##2##(2008-2#1)(2012-3#1)
thin organic##2##2##(1997-4#1)(2007-12#1)
thin oxide##2##2##(2008-10#1)(2009-11#1)
thin planar##2##2##(2007-11#1)(2007-12#1)
thin plastic foils##2##3##(1997-6#1)(2008-1#1)
thin plate##4##2##(2008-2#2)(2008-3#2)
thin platinum##2##2##(2009-11#2)
thin polymer film##4##3##(2007-12#3)(2010-2#1)
thin polymer films##6##3##(1990-8#1)(2006-12#1)(2006-5#3)(2008-10#1)
thin polymer##12##2##(1990-8#1)(2006-12#1)(2006-5#3)(2007-12#3)(2008-10#1)(2008-2#1)(2010-2#1)(2013-7#1)
thin polymeric##2##2##(1994-2#1)(2008-10#1)
thin porous##5##2##(2005-11#3)(2008-2#1)(2011-1#1)
thin sample##3##2##(2007-12#2)(2008-3#1)
thin section##2##2##(2005-8#1)(2009-4#1)
thin sections of##3##3##(2007-12#1)(2008-10#1)(2008-4#1)
thin sections##9##2##(2005-12#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-9#1)(2012-3#1)
thin surface##2##2##(2006-12#1)(2007-12#1)
thin targets##2##2##(2007-8#1)(2008-3#1)
thin tissue sections##3##3##(2008-3#1)(2010-11#2)
thin transparent plate##2##3##(2008-2#2)
thin wall##3##2##(2008-5#1)(2012-2#1)(2013-8#1)
thin walls##3##2##(2007-11#1)(2008-2#1)(2008-5#1)
thin words##3##2##(2007-12#3)
thin##828##1##(1990-12#1)(1990-4#1)(1990-7#1)(1990-8#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-5#1)(1994-9#2)(1995-12#1)(1995-2#2)(1995-5#3)(1995-6#2)(1995-7#1)(1996-3#1)(1996-5#6)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#4)(1997-6#3)(1997-7#3)(2004-2#1)(2004-9#4)(2005-1#1)(2005-10#1)(2005-11#26)(2005-12#2)(2005-4#1)(2005-8#1)(2006-10#1)(2006-12#16)(2006-2#3)(2006-3#2)(2006-4#3)(2006-5#6)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#28)(2007-12#95)(2007-2#1)(2007-3#2)(2007-5#2)(2007-8#12)(2007-9#3)(2008-1#11)(2008-10#98)(2008-11#14)(2008-12#5)(2008-2#106)(2008-3#131)(2008-4#6)(2008-5#29)(2008-6#4)(2008-7#14)(2008-8#1)(2008-9#3)(2009-11#8)(2009-12#2)(2009-2#4)(2009-3#1)(2009-4#6)(2009-6#3)(2009-7#6)(2009-8#2)(2009-9#1)(2010-1#6)(2010-11#2)(2010-12#2)(2010-2#5)(2010-4#9)(2010-5#5)(2010-6#1)(2010-7#4)(2010-8#1)(2010-9#2)(2011-1#8)(2011-12#3)(2011-2#5)(2012-1#3)(2012-11#3)(2012-2#12)(2012-3#7)(2013-1#5)(2013-7#3)(2013-8#5)
thin-and-beautiful##3##1##(2007-12#3)
thin-element##2##1##(2008-2#1)(2008-3#1)
thin-film OWG##2##2##(2008-10#2)
thin-film coatings##3##2##(2008-2#1)(2008-3#2)
thin-film deposition and##2##3##(2008-2#1)(2008-7#1)
thin-film deposition##7##2##(2008-2#2)(2008-3#3)(2008-7#1)(2010-5#1)
thin-film glass plates##2##3##(2007-11#2)
thin-film heaters for##2##3##(2007-12#1)(2008-3#1)
thin-film heaters##3##2##(2007-12#1)(2008-3#2)
thin-film interference effects##2##3##(2008-3#2)
thin-film interference##6##2##(2008-2#1)(2008-3#4)(2008-5#1)
thin-film layer##2##2##(2008-2#1)(2008-3#1)
thin-film layers##5##2##(2008-2#1)(2008-3#4)
thin-film material##2##2##(2008-2#1)(2008-3#1)
thin-film materials##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
thin-film optical##3##2##(2008-2#2)(2008-3#1)
thin-film planar waveguide (PWG) evanescently coupled by a##2##8##(2008-2#1)(2008-3#1)
thin-film planar waveguide##3##3##(2008-2#1)(2008-3#2)
thin-film polarizing beam splitter##2##4##(2008-3#2)
thin-film resistive heaters##2##3##(2007-12#1)(2008-3#1)
thin-film stacks##2##2##(2008-3#2)
thin-film structure##3##2##(2006-5#1)(2008-2#1)(2008-3#1)
thin-film transistors##2##2##(2008-2#1)(2008-7#1)
thin-film##111##1##(1990-8#1)(1991-3#1)(2005-11#1)(2006-12#4)(2006-5#1)(2007-11#7)(2007-12#9)(2008-1#1)(2008-10#8)(2008-2#28)(2008-3#42)(2008-5#1)(2008-7#4)(2009-2#1)(2010-4#1)(2010-5#1)
thin-films##2##1##(2008-10#2)
thin-layer chromatographic method of##2##4##(2005-12#1)(2008-10#1)
thin-layer chromatographic##6##2##(1990-5#1)(1991-8#1)(1993-2#1)(2005-12#1)(2007-8#1)(2008-10#1)
thin-layer chromatography (TLC)##6##3##(1992-11#1)(1994-3#1)(1996-2#1)(2008-10#1)(2008-4#2)
thin-layer chromatography and##6##3##(1990-1#1)(1992-1#1)(1993-9#1)(1996-2#1)(1997-3#1)(2007-12#1)
thin-layer chromatography for##2##3##(1990-11#1)(1993-9#1)
thin-layer chromatography showed that##2##4##(2007-2#1)(2008-4#1)
thin-layer chromatography showed##3##3##(2007-2#2)(2008-4#1)
thin-layer chromatography##44##2##(1990-1#1)(1990-11#2)(1990-12#1)(1990-3#1)(1990-9#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-9#1)(1993-2#3)(1993-9#2)(1994-12#1)(1994-3#1)(1996-2#2)(1996-5#1)(1996-6#1)(1997-3#1)(2004-12#1)(2006-3#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-10#4)(2008-4#3)(2008-5#2)(2008-6#1)(2008-9#1)(2009-6#1)(2012-1#1)(2012-2#1)(2013-1#2)
thin-layer chromatography-densitometric##2##2##(2012-3#2)
thin-layer radial flow##2##3##(2008-10#2)
thin-layer##75##1##(1990-1#1)(1990-11#2)(1990-12#1)(1990-3#2)(1990-5#1)(1990-9#1)(1991-3#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-9#1)(1993-2#4)(1993-9#2)(1994-12#1)(1994-3#1)(1996-11#1)(1996-2#2)(1996-5#1)(1996-6#1)(1997-3#2)(2004-12#1)(2005-12#2)(2006-3#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-8#2)(2008-10#15)(2008-12#1)(2008-2#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#2)
thin-layered dual-band electrochemical cell##2##4##(2008-10#2)
thin-lens##2##1##(2008-3#2)
thin-section electron microscopy##2##3##(2008-10#1)(2008-11#1)
thin-section electron##3##2##(2006-8#1)(2008-10#1)(2008-11#1)
thin-section##7##1##(1997-8#1)(2005-8#1)(2006-8#2)(2008-10#1)(2008-11#1)(2012-2#1)
thin-sectioned##2##1##(2008-9#2)
thin-wall##2##1##(2008-11#1)(2010-8#1)
thin-walled##6##1##(2006-2#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-7#1)(2009-3#1)
thing in##2##2##(2004-5#1)(2012-1#1)
thing is##2##2##(2007-8#1)(2007-9#1)
thing that##3##2##(2007-2#1)(2008-5#1)(2009-2#1)
thing to##2##2##(1995-12#1)(2007-4#1)
thing##17##1##(1992-2#1)(1993-5#1)(1995-12#1)(1996-11#1)(2004-5#1)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-5#1)(2009-11#1)(2009-2#1)(2012-1#1)
things and##2##2##(1996-3#2)
things as##6##2##(1995-1#1)(2006-8#1)(2007-11#2)(2012-2#1)(2012-3#1)
things better##2##2##(1994-1#1)(2011-2#1)
things go##2##2##(1994-3#1)(2012-2#1)
things in##7##2##(1991-11#1)(2005-7#1)(2007-11#1)(2012-2#1)(2012-3#2)(2013-8#1)
things that are##2##3##(2008-7#1)(2011-1#1)
things that##6##2##(1996-1#1)(2005-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)
things to come##3##3##(1991-8#1)(2008-7#1)(2009-5#1)
things to consider##2##3##(1995-1#1)(1995-2#1)
things to##8##2##(1991-8#1)(1995-1#1)(1995-2#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-5#1)(2013-8#1)
things##80##1##(1990-2#1)(1991-10#1)(1991-11#2)(1991-2#1)(1991-3#2)(1991-8#1)(1992-12#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-4#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-2#2)(1996-1#2)(1996-3#4)(1996-6#2)(1997-8#1)(2004-10#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#4)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#4)(2009-10#1)(2009-5#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#5)(2012-3#3)(2013-8#2)
things'##3##1##(1990-10#1)(2006-10#1)(2007-8#1)
think about their##3##3##(2007-12#1)(2008-6#1)(2013-8#1)
think about##19##2##(2004-12#1)(2006-2#1)(2007-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-5#2)(2009-8#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#1)
think differently##2##2##(1990-8#1)(2012-3#1)
think is##2##2##(2004-12#1)(2012-3#1)
think it##4##2##(2006-5#1)(2010-4#1)(2010-9#2)
think of the##3##3##(2007-5#1)(2008-12#1)(2013-8#1)
think of##10##2##(1991-1#1)(1995-6#1)(1996-11#1)(2004-10#1)(2006-10#1)(2007-5#1)(2008-12#1)(2008-4#1)(2008-5#1)(2013-8#1)
think tank##2##2##(1994-1#1)(2008-6#1)
think that in the##2##4##(2008-8#1)(2011-2#1)
think that it is##2##4##(2008-5#1)(2012-2#1)
think that the##8##3##(1990-11#1)(1995-6#1)(2006-10#1)(2007-7#1)(2008-5#1)(2010-12#1)(2011-2#1)(2013-7#1)
think that this##3##3##(1992-5#1)(2006-11#1)(2006-6#1)
think that##28##2##(1990-11#1)(1991-9#1)(1992-5#1)(1995-6#1)(1997-3#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-5#2)(2008-8#1)(2009-6#1)(2010-12#1)(2011-2#3)(2012-11#1)(2012-2#1)(2012-3#1)(2013-7#1)
think the##2##2##(2007-12#1)(2011-2#1)
think they may have found##2##5##(2007-9#2)
think to##3##2##(1990-5#1)(2004-12#2)
think##123##1##(1990-11#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-9#1)(1992-5#1)(1993-2#2)(1993-5#1)(1994-1#1)(1994-2#1)(1995-3#1)(1995-6#2)(1996-11#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-3#1)(1997-8#1)(2004-10#1)(2004-12#7)(2005-12#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-3#2)(2006-4#4)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#4)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#2)(2009-5#2)(2009-6#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#2)(2010-9#2)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#6)(2013-1#3)(2013-7#2)(2013-8#4)
think?##5##1##(2005-10#1)(2008-11#1)(2008-8#1)(2012-2#1)(2013-1#1)
thinker##3##1##(1991-3#1)(2007-5#1)(2012-12#1)
thinkers##2##1##(1993-3#1)(1995-1#1)
thinking about the##5##3##(2006-10#1)(2006-5#1)(2007-10#1)(2008-8#1)(2010-8#1)
thinking about##23##2##(1992-1#1)(2006-10#1)(2006-5#2)(2007-10#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-2#2)(2008-6#3)(2008-8#2)(2009-8#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-8#1)
thinking and clinical##2##3##(1992-3#1)(2006-8#1)
thinking and the##2##3##(1994-2#1)(2008-8#1)
thinking and##23##2##(1992-3#1)(1994-2#1)(1995-1#1)(1996-1#2)(2005-12#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-5#1)(2008-11#2)(2008-12#1)(2008-8#1)(2010-8#2)(2012-12#4)(2012-2#2)(2012-3#1)
thinking by##2##2##(2005-12#1)(2013-1#1)
thinking in the##4##3##(1991-2#1)(2007-3#1)(2007-7#1)(2008-12#1)
thinking in##12##2##(1991-2#1)(1995-5#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-12#4)(2008-2#1)(2010-8#1)
thinking into##2##2##(1991-12#1)(2008-8#1)
thinking is a##2##3##(2008-12#1)(2013-1#1)
thinking is##5##2##(2005-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2013-1#1)
thinking may##3##2##(2008-12#1)(2008-8#1)(2009-7#1)
thinking of##8##2##(1996-3#1)(2004-3#1)(2007-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-1#1)
thinking on##5##2##(1994-1#1)(1995-1#1)(2008-7#1)(2009-8#1)(2013-1#1)
thinking related to##2##3##(2007-12#1)(2013-1#1)
thinking that##4##2##(2007-12#1)(2010-11#1)(2012-1#1)(2012-12#1)
thinking to##4##2##(1994-12#1)(2007-11#2)(2008-10#1)
thinking toward##3##2##(2008-1#1)(2012-12#2)
thinking within##2##2##(2008-12#1)(2010-11#1)
thinking##200##1##(1991-12#1)(1991-2#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#2)(1994-2#3)(1994-6#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-1#3)(1996-10#1)(1996-3#1)(1997-3#1)(2004-3#2)(2005-10#1)(2005-12#8)(2006-1#1)(2006-10#2)(2006-12#1)(2006-3#2)(2006-5#5)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-3#3)(2007-4#1)(2007-5#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#26)(2008-12#17)(2008-2#5)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#5)(2008-9#1)(2009-10#2)(2009-12#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-11#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#9)(2010-9#2)(2011-1#5)(2011-2#3)(2012-1#6)(2012-12#7)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
thinking'##2##1##(1990-10#1)(2012-1#1)
thinking) and##2##2##(1990-3#1)(2007-11#1)
thinks##5##1##(1994-1#1)(1997-3#1)(2008-11#1)(2008-2#1)(2010-12#1)
thinned skull##2##2##(2011-1#2)
thinned##10##1##(1997-3#1)(2006-10#2)(2006-12#1)(2007-7#1)(2008-2#1)(2008-3#1)(2011-1#2)(2011-2#1)
thinner and##2##2##(1997-3#1)(2007-12#1)
thinner layer##2##2##(2005-11#1)(2010-4#1)
thinner than those of##2##4##(1991-12#1)(2011-1#1)
thinner than those##3##3##(1991-12#1)(2005-11#1)(2011-1#1)
thinner than##10##2##(1991-12#1)(2005-11#1)(2007-12#3)(2008-5#1)(2009-3#1)(2010-8#1)(2011-1#1)(2011-3#1)
thinner women##2##2##(2007-12#1)(2013-1#1)
thinner##38##1##(1991-12#1)(1992-4#2)(1994-9#1)(1997-3#1)(2005-11#3)(2006-7#1)(2007-12#7)(2007-4#1)(2008-10#1)(2008-3#2)(2008-5#3)(2008-8#1)(2008-9#1)(2009-3#2)(2009-6#2)(2010-4#1)(2010-8#2)(2011-1#1)(2011-3#2)(2012-12#1)(2013-1#2)
thinness and##6##2##(2006-6#3)(2007-12#3)
thinness in##2##2##(2006-7#1)(2007-12#1)
thinness##25##1##(1991-12#1)(2006-6#3)(2006-7#6)(2007-12#14)(2008-3#1)
thinnest##6##1##(2007-12#3)(2008-5#1)(2009-7#1)(2011-1#1)
thinning and##7##2##(1994-5#1)(2008-10#1)(2008-5#1)(2009-3#1)(2009-7#1)(2011-2#1)(2013-8#1)
thinning by##2##2##(1996-2#2)
thinning of the cornea##2##4##(2005-11#1)(2008-5#1)
thinning of the##11##3##(1997-3#1)(2005-11#1)(2006-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#1)(2009-6#1)(2012-1#1)(2012-2#2)
thinning of##17##2##(1995-12#1)(1997-3#1)(2005-11#1)(2006-10#1)(2007-7#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#2)(2009-6#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)
thinning the##2##2##(2008-3#2)
thinning##47##1##(1994-5#1)(1995-12#1)(1996-1#1)(1996-2#2)(1997-3#1)(2005-11#1)(2006-10#1)(2007-3#1)(2007-7#1)(2008-10#3)(2008-3#3)(2008-5#10)(2008-6#1)(2008-9#1)(2009-2#3)(2009-3#1)(2009-6#1)(2009-7#4)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
thio-ceramide 3##2##2##(2006-12#2)
thioTEPA or cisplatin##2##3##(1991-7#2)
thioacetate 11##2##2##(1996-5#2)
thioacetate##3##1##(1995-11#1)(1996-5#2)
thioacetyl styrene##2##2##(2008-12#2)
thioacyl-enzyme##2##1##(1991-4#2)
thioamide##6##1##(1996-8#2)(2008-10#3)(2011-2#1)
thiobarbituric acid (TBA)##3##3##(2007-3#1)(2008-5#1)(2008-9#1)
thiobarbituric acid assay##2##3##(1990-4#1)(1991-7#1)
thiobarbituric acid method##3##3##(1990-8#1)(1992-11#1)(2007-2#1)
thiobarbituric acid reactants##2##3##(1995-1#1)(1997-2#1)
thiobarbituric acid reactive material##2##4##(1995-1#2)
thiobarbituric acid reactive substance (TBARS)##2##5##(1994-6#1)(2012-2#1)
thiobarbituric acid reactive substance##3##4##(1994-6#1)(1995-12#1)(2012-2#1)
thiobarbituric acid reactive substances (TBARS) in##2##6##(1993-2#1)(1995-3#1)
thiobarbituric acid reactive substances (TBARS)##14##5##(1993-2#1)(1995-1#1)(1995-3#2)(1995-6#1)(1997-8#1)(2004-12#1)(2007-9#1)(2008-10#2)(2011-2#3)(2013-8#1)
thiobarbituric acid reactive substances in##3##5##(1992-3#1)(1992-8#1)(2008-10#1)
thiobarbituric acid reactive substances##22##4##(1992-3#2)(1992-8#1)(1993-2#1)(1995-1#1)(1995-3#2)(1995-6#1)(1997-8#1)(2004-12#1)(2005-8#1)(2007-9#1)(2008-10#3)(2008-4#1)(2011-2#4)(2012-2#1)(2013-8#1)
thiobarbituric acid reactive##28##3##(1992-3#2)(1992-8#1)(1993-2#1)(1994-6#1)(1995-1#3)(1995-12#1)(1995-3#2)(1995-6#1)(1997-8#1)(2004-12#1)(2005-8#1)(2007-9#1)(2008-10#3)(2008-4#1)(2010-5#1)(2011-2#4)(2012-2#2)(2013-8#1)
thiobarbituric acid##43##2##(1990-4#1)(1990-8#1)(1991-2#1)(1991-7#1)(1992-11#1)(1992-3#2)(1992-8#1)(1993-2#1)(1994-3#1)(1994-6#1)(1995-1#4)(1995-12#1)(1995-3#2)(1995-6#1)(1997-2#1)(1997-8#1)(2004-12#1)(2005-8#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-5#1)(2011-2#4)(2012-2#2)(2013-8#1)
thiobarbituric acid-reactive substance##2##3##(1991-7#1)(2012-5#1)
thiobarbituric acid-reactive substances (TBARS)##2##4##(1996-3#1)(2010-4#1)
thiobarbituric acid-reactive substances in the##2##5##(1991-7#1)(1995-12#1)
thiobarbituric acid-reactive substances##10##3##(1991-7#1)(1994-3#1)(1995-12#4)(1996-3#1)(2004-11#1)(2010-4#2)
thiobarbituric acid-reactive##12##2##(1991-7#2)(1994-3#1)(1995-12#4)(1996-3#1)(2004-11#1)(2010-4#2)(2012-5#1)
thiobarbituric##55##1##(1990-4#1)(1990-8#1)(1991-2#1)(1991-7#3)(1992-11#1)(1992-3#2)(1992-8#1)(1993-2#1)(1994-3#2)(1994-6#1)(1995-1#4)(1995-12#5)(1995-3#2)(1995-6#1)(1996-3#1)(1997-2#1)(1997-8#1)(2004-11#1)(2004-12#1)(2005-8#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-4#2)(2010-5#1)(2011-2#4)(2012-2#2)(2012-5#1)(2013-8#1)
thiocarbohydrazide##2##1##(2008-10#2)
thiocarbonohydrazide (PSTH) immobilized on an anion-exchange resin##2##7##(2008-10#2)
thiocarbonohydrazide and##2##2##(2008-10#2)
thiocarbonohydrazide##5##1##(2008-10#5)
thiocholine##2##1##(1991-8#1)(2008-10#1)
thiochrome##3##1##(2008-10#3)
thiocolchicine##3##1##(1993-6#1)(2006-12#1)(2007-8#1)
thioctic acid##4##2##(2008-10#3)(2008-5#1)
thiocyanate and##5##2##(1990-12#1)(1996-2#1)(2007-10#1)(2008-10#2)
thiocyanate at##2##2##(1990-12#1)(2006-8#1)
thiocyanate complex##3##2##(2008-10#3)
thiocyanate complexes##3##2##(2008-10#3)
thiocyanate concentration##3##2##(2008-10#3)
thiocyanate in##6##2##(2008-10#6)
thiocyanate insulin##2##2##(1995-11#2)
thiocyanate ion##4##2##(1995-11#1)(2008-10#3)
thiocyanate ions##4##2##(2008-10#4)
thiocyanate media##3##2##(2007-8#1)(2008-10#2)
thiocyanate solution##5##2##(2008-10#5)
thiocyanate which##2##2##(2008-10#2)
thiocyanate with##3##2##(2008-10#3)
thiocyanate##87##1##(1990-12#2)(1991-12#1)(1992-9#1)(1993-2#1)(1995-11#5)(1996-2#1)(1996-5#1)(2005-11#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-8#3)(2008-10#59)(2008-12#2)(2008-4#1)(2008-5#1)(2009-11#1)
thiocyanate-selective##3##1##(2008-10#3)
thiocyanates##5##1##(2007-11#3)(2008-10#2)
thiocyanato-complexes formed##3##2##(2008-10#3)
thiocyanato-complexes##6##1##(2008-10#6)
thiodicarb##3##1##(2005-3#3)
thioester binding##3##2##(1994-2#3)
thioester of##3##2##(1990-5#2)(1990-7#1)
thioester##19##1##(1990-2#2)(1990-5#2)(1990-7#1)(1991-2#3)(1994-2#3)(1994-3#3)(1994-8#2)(1997-7#1)(2005-8#1)(2012-2#1)
thioesterase##4##1##(1996-4#2)(2009-11#2)
thioesters were##2##2##(1992-1#1)(1994-8#1)
thioesters##9##1##(1990-2#1)(1990-5#1)(1991-2#2)(1992-1#1)(1994-8#1)(2010-6#1)(2012-2#2)
thioether methyltransferase##3##2##(1994-8#3)
thioether##15##1##(1992-5#1)(1994-11#1)(1994-8#6)(2008-4#2)(2008-5#1)(2009-11#1)(2010-5#1)(2013-1#2)
thioether-bridged cyclic peptides##2##3##(1992-5#2)
thioethers##5##1##(1992-5#1)(1994-8#1)(2008-11#2)(2010-5#1)
thioflavin S##2##2##(1992-1#1)(1995-8#1)
thiogallate##2##1##(2007-12#2)
thioglycolate##3##1##(2008-4#1)(2008-5#2)
thioglycolic acid (TGA)##4##3##(1992-8#1)(2009-6#1)(2012-12#1)(2013-7#1)
thioglycolic acid##11##2##(1992-8#1)(2008-10#3)(2008-5#1)(2009-6#2)(2012-12#2)(2012-3#1)(2013-7#1)
thioglycollate medium##2##2##(1997-2#1)(2006-10#1)
thioglycollate##6##1##(1990-9#1)(1994-8#1)(1994-9#2)(1997-2#1)(2006-10#1)
thioglycollic acid##2##2##(1996-2#1)(2008-10#1)
thioglycosides##3##1##(2008-12#2)(2009-12#1)
thioguanine##3##1##(1991-4#1)(1994-11#1)(2008-8#1)
thiohemiacetal##3##1##(1991-5#3)
thiol and##6##2##(1993-2#1)(1995-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-4#1)
thiol cathepsins##2##2##(2008-10#2)
thiol compounds and##4##3##(1990-10#1)(1996-2#1)(1997-8#2)
thiol compounds##13##2##(1990-10#2)(1990-12#1)(1990-8#1)(1991-9#1)(1992-8#1)(1996-2#1)(1997-8#2)(2008-10#4)
thiol content##3##2##(1990-7#1)(2006-12#1)(2008-7#1)
thiol derivatives##6##2##(1996-11#3)(2008-10#3)
thiol ester##2##2##(1994-11#1)(1994-3#1)
thiol form##2##2##(1996-7#1)(2009-8#1)
thiol functionalities##3##2##(2008-10#1)(2008-3#1)(2008-4#1)
thiol group with##2##3##(1994-8#1)(2008-10#1)
thiol group##5##2##(1990-11#1)(1994-8#1)(1995-6#1)(2008-10#1)(2010-11#1)
thiol groups and disulfides##2##4##(1993-3#2)
thiol groups and##4##3##(1993-3#2)(1997-2#1)(2007-8#1)
thiol groups in##4##3##(1994-3#1)(1997-8#1)(2008-1#1)(2008-5#1)
thiol groups of##3##3##(1995-8#1)(2008-10#1)(2011-2#1)
thiol groups to##2##3##(2008-10#1)(2008-4#1)
thiol groups were##2##3##(1990-12#1)(2008-10#1)
thiol groups##38##2##(1990-12#2)(1990-2#1)(1991-12#1)(1991-4#2)(1991-9#2)(1992-3#1)(1993-12#1)(1993-3#2)(1993-4#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-8#1)(1997-2#1)(1997-8#1)(2005-11#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-4#2)(2008-5#2)(2009-12#1)(2009-9#1)(2010-11#1)(2011-2#1)
thiol methyltransferase##3##2##(1994-8#3)
thiol monolayer on##2##3##(2005-11#1)(2008-10#1)
thiol oxidation at 60 degrees C##2##6##(2008-5#2)
thiol oxidation at##3##3##(2008-5#3)
thiol oxidation##7##2##(1994-6#1)(2008-5#6)
thiol protease##6##2##(1992-4#1)(1993-2#1)(1996-3#1)(1996-8#3)
thiol self-assembled monolayers##2##3##(2005-11#1)(2008-10#1)
thiol to##2##2##(1995-5#1)(2008-2#1)
thiol##168##1##(1990-10#2)(1990-11#1)(1990-12#5)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-4#2)(1991-8#1)(1991-9#8)(1992-11#3)(1992-12#1)(1992-3#4)(1992-4#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-3#3)(1993-4#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#8)(1994-9#1)(1995-1#2)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#2)(1996-11#4)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#3)(1997-1#1)(1997-2#5)(1997-8#4)(2005-11#5)(2006-12#2)(2006-2#1)(2007-11#2)(2007-8#1)(2008-1#2)(2008-10#31)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#11)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#3)(2009-8#1)(2009-9#2)(2010-11#3)(2010-2#1)(2010-4#2)(2011-2#1)(2012-12#1)(2013-1#2)
thiol(s)##2##1##(1994-3#1)(1994-6#1)
thiol-##2##1##(2008-11#1)(2009-4#1)
thiol-activated##3##1##(1991-3#1)(1992-2#1)(1996-12#1)
thiol-containing agents##3##2##(1991-9#3)
thiol-containing compound##2##2##(2007-8#1)(2008-10#1)
thiol-containing drugs##2##2##(2008-10#2)
thiol-containing##9##1##(1991-9#3)(2007-8#1)(2008-10#4)(2008-4#1)
thiol-dependent##3##1##(1991-12#1)(1992-9#1)(2013-1#1)
thiol-derivatized##3##1##(1996-11#2)(2007-8#1)
thiol-disulfide exchange##3##2##(1992-12#1)(1992-6#1)(1993-6#1)
thiol-ene chemistry##3##2##(2010-12#3)
thiol-ene##5##1##(2008-7#2)(2010-12#3)
thiol-ene/thiol-epoxy hybrid networks##2##3##(2008-3#2)
thiol-ene/thiol-epoxy hybrid##3##2##(2008-3#3)
thiol-functionalized mesoporous sorbent##3##3##(2008-10#3)
thiol-functionalized poly(styrene-co-acrylic acid)##2##3##(2007-8#2)
thiol-functionalized##6##1##(2007-8#2)(2008-10#3)(2009-9#1)
thiol-reactive##2##1##(2008-6#1)(2013-7#1)
thiol-specific antioxidant protein##2##3##(1994-2#2)
thiol-specific antioxidant##3##2##(1994-2#3)
thiol-terminated silica##2##2##(2005-12#2)
thiol-terminated##4##1##(2005-12#3)(2009-9#1)
thiol-thione##2##1##(2007-11#2)
thiolactic acid##2##2##(2008-10#2)
thiolactone##3##1##(1994-11#3)
thiolase is##2##2##(1991-12#1)(1992-7#1)
thiolase##13##1##(1991-12#4)(1992-7#4)(1994-6#1)(1997-7#2)(2008-8#2)
thiolate complexes##2##2##(2008-5#2)
thiolate is##2##2##(2008-5#2)
thiolate##12##1##(1990-5#1)(1993-11#1)(1995-5#1)(1996-8#1)(2005-11#1)(2008-10#1)(2008-3#1)(2008-5#5)
thiolate-ligated heme##2##2##(2009-9#2)
thiolated gold##2##2##(2007-8#2)
thiolated##6##1##(2007-8#2)(2008-10#3)(2009-4#1)
thiolates##8##1##(1994-11#1)(2008-10#2)(2008-3#2)(2008-5#3)
thiolic##4##1##(1995-6#1)(2008-10#3)
thiols amperometric##2##2##(2008-10#2)
thiols and##7##2##(1991-9#1)(1993-3#1)(1994-11#1)(1997-8#2)(2008-10#2)
thiols associated with##2##3##(1993-12#2)
thiols by##2##2##(1991-9#1)(2005-11#1)
thiols in the##2##3##(1995-5#1)(1996-7#1)
thiols in##7##2##(1991-9#1)(1995-5#1)(1996-7#1)(1997-2#1)(1997-8#1)(2008-10#2)
thiols is##3##2##(1991-9#1)(1994-12#1)(2008-3#1)
thiols oxidation##2##2##(2008-10#2)
thiols to the corresponding disulfides##2##5##(2007-11#2)
thiols to##6##2##(1994-5#1)(1995-5#1)(2006-12#1)(2007-10#1)(2007-11#2)
thiols were##2##2##(1992-11#1)(2008-10#1)
thiols with##3##2##(1990-8#1)(2008-7#1)(2010-8#1)
thiols##101##1##(1990-12#2)(1990-3#1)(1990-6#1)(1990-8#2)(1991-3#2)(1991-9#9)(1992-11#6)(1992-12#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#2)(1994-5#1)(1995-5#2)(1995-6#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-8#4)(2005-11#2)(2006-11#1)(2006-12#5)(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#22)(2008-11#2)(2008-3#4)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#3)(2010-11#3)(2010-4#1)(2010-8#3)
thioltransferase##3##1##(1991-10#3)
thiomalate or##2##2##(1993-12#1)(2008-5#1)
thiomalate##7##1##(1993-12#1)(1994-5#2)(1995-3#2)(2008-5#2)
thion analogues##2##2##(1992-11#2)
thione##3##1##(2004-7#1)(2008-5#1)(2010-11#1)
thionin##3##1##(1997-6#1)(2008-10#1)(2008-4#1)
thionine##2##1##(2008-10#2)
thiono##2##1##(2008-10#1)(2008-4#1)
thionyl chloride##3##2##(2007-11#2)(2010-3#1)
thiopental sodium##3##2##(1992-7#1)(1996-10#1)(2011-2#1)
thiopental##13##1##(1990-12#3)(1992-7#1)(1996-10#1)(1997-6#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-7#1)
thiopentone##9##1##(1996-6#6)(2008-10#1)(2010-7#1)(2012-2#1)
thioperamide##12##1##(1992-5#3)(1993-11#3)(1993-3#5)(1995-12#1)
thiophanate-methy1##5##1##(2008-10#5)
thiophanate-methyl##7##1##(2008-10#7)
thiophene analogue of##2##3##(1997-1#2)
thiophene rings##2##2##(2010-2#1)(2010-4#1)
thiophene##13##1##(1992-10#1)(1997-1#2)(1997-2#1)(2007-10#1)(2008-10#2)(2008-4#1)(2009-3#3)(2010-2#1)(2010-4#1)
thiophene-1##2##1##(2008-5#2)
thiophenes##3##1##(1993-4#1)(2007-11#2)
thiophosphate##2##1##(2008-4#1)(2012-2#1)
thiophosphonoacetate##2##1##(2008-4#2)
thiophosphorus insecticides##2##2##(2008-10#2)
thiophosphorylation##2##1##(1995-5#1)(1997-6#1)
thiopurine drugs##4##2##(1994-11#1)(2008-8#3)
thiopurine methyltransferase##3##2##(1994-11#1)(2007-11#1)(2013-1#1)
thiopurine##14##1##(1994-11#2)(2006-10#1)(2007-11#2)(2008-8#4)(2010-12#3)(2012-11#1)(2013-1#1)
thiopurines##5##1##(1994-11#1)(2008-12#1)(2008-5#1)(2010-12#1)(2013-1#1)
thioredoxin and##5##2##(1991-2#2)(1991-7#1)(1993-11#1)(2008-4#1)
thioredoxin by##3##2##(1991-2#1)(1991-7#1)(2009-10#1)
thioredoxin does not affect the unfolded state##2##7##(1993-11#2)
thioredoxin f##2##2##(1990-12#2)
thioredoxin fusion proteins##3##3##(2008-4#3)
thioredoxin fusion##4##2##(2008-4#4)
thioredoxin gene is##2##3##(1992-2#2)
thioredoxin gene##3##2##(1992-2#2)(2008-7#1)
thioredoxin genes##3##2##(1994-9#1)(2009-10#2)
thioredoxin h##3##2##(2013-7#3)
thioredoxin in##2##2##(1991-2#1)(2009-10#1)
thioredoxin is##2##2##(1991-7#1)(1994-9#1)
thioredoxin m##3##2##(1990-12#3)
thioredoxin mutant##3##2##(1994-9#3)
thioredoxin reductase activity##2##3##(2009-9#2)
thioredoxin reductase##16##2##(1990-12#2)(1991-2#3)(1992-4#2)(1995-6#2)(2008-10#1)(2009-10#1)(2009-9#2)(2010-11#1)(2012-2#1)(2013-7#1)
thioredoxin reductases##3##2##(2009-10#1)(2009-9#2)
thioredoxin stability##4##2##(1991-7#4)
thioredoxin##95##1##(1990-12#9)(1991-2#9)(1991-4#7)(1991-7#14)(1992-12#1)(1992-2#3)(1992-4#2)(1993-11#3)(1993-4#1)(1993-9#1)(1994-9#7)(1995-6#2)(1996-2#2)(2008-10#1)(2008-4#6)(2008-7#1)(2009-10#12)(2009-9#5)(2010-11#1)(2010-3#1)(2010-4#1)(2012-2#2)(2013-7#4)
thioredoxin-2##2##1##(2012-2#2)
thioredoxin-like##2##1##(1993-9#1)(1997-6#1)
thioredoxins f and m##3##4##(1995-6#3)
thioredoxins##12##1##(1990-12#2)(1992-2#1)(1995-6#3)(2009-10#6)
thioridazine and##2##2##(1990-5#1)(2008-3#1)
thioridazine##7##1##(1990-5#1)(2008-10#2)(2008-3#1)(2008-7#2)(2010-8#1)
thiorphan##5##1##(1994-2#1)(1995-1#1)(1996-2#2)(1997-4#1)
thiosemicarbazide##4##1##(2007-10#1)(2007-11#2)(2008-10#1)
thiosemicarbazone##16##1##(1990-7#1)(1995-5#1)(2007-11#1)(2008-10#10)(2008-5#3)
thiosemicarbazones##5##1##(1990-7#1)(2007-11#2)(2008-5#2)
thiosulfate and##4##2##(2006-8#1)(2008-10#3)
thiosulfate as##3##2##(1997-1#2)(2011-2#1)
thiosulfate in##2##2##(1993-3#1)(2008-10#1)
thiosulfate or sulfite##3##3##(1993-3#3)
thiosulfate or##6##2##(1993-3#3)(2006-8#2)(2011-2#1)
thiosulfate to##2##2##(2006-8#1)(2010-4#1)
thiosulfate##39##1##(1990-4#6)(1992-12#1)(1993-3#4)(1997-1#2)(1997-6#1)(1997-7#1)(2006-5#1)(2006-8#6)(2007-8#2)(2008-10#9)(2008-5#2)(2008-6#1)(2010-4#1)(2011-2#2)
thiosulfinates##2##1##(2008-10#2)
thiosulphate in the##2##3##(2008-10#2)
thiosulphate##5##1##(2008-10#5)
thiotaurine##2##1##(2008-5#2)
thiotrophic##2##1##(2009-8#2)
thiourea and##6##2##(2007-11#2)(2007-9#1)(2008-10#3)
thiourea for##2##2##(2008-10#2)
thiourea from the##2##3##(2008-10#2)
thiourea in##2##2##(2005-4#1)(2008-10#1)
thiourea##46##1##(1993-8#1)(1995-12#1)(1995-2#1)(1996-8#1)(2005-4#6)(2007-11#4)(2007-9#2)(2008-10#25)(2009-3#1)(2011-2#3)(2013-1#1)
thiourea)##2##1##(2008-10#2)
thioureas and their##2##3##(2008-5#2)
thioureas##3##1##(2007-11#1)(2008-5#2)
thioureides##4##1##(2009-6#1)(2011-1#3)
thioxanthones##4##1##(2012-3#4)
thioxanthonic derivatives##2##2##(2012-3#2)
thiram##10##1##(2008-10#10)
third ORF##5##2##(1990-9#1)(1996-6#1)(1997-2#1)(2008-10#2)
third PA##2##2##(1990-11#2)
third a##2##2##(2004-2#1)(2008-8#1)
third alternate protocol##3##3##(2008-2#1)(2008-4#2)
third and fourth##20##3##(1990-4#1)(1990-8#1)(1991-2#1)(1997-2#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-9#1)(2011-1#1)(2011-2#2)
third and in the##2##4##(2006-2#1)(2011-2#1)
third and lateral##3##3##(2006-5#3)
third and##36##2##(1990-4#1)(1990-8#2)(1991-2#1)(1993-8#1)(1996-1#1)(1997-2#2)(2005-10#1)(2006-1#1)(2006-2#1)(2006-5#3)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-9#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)
third approach##5##2##(1993-4#1)(2005-11#1)(2008-3#1)(2008-4#2)
third arm##3##2##(2006-6#1)(2013-1#2)
third beam##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
third case was##3##3##(1995-9#1)(2007-7#1)(2008-8#1)
third case##16##2##(1991-12#1)(1995-9#1)(2006-12#1)(2007-10#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-2#1)(2011-2#1)(2013-1#1)
third cases##2##2##(2007-11#1)(2008-8#1)
third category##2##2##(2011-1#1)(2013-1#1)
third child##2##2##(1995-1#1)(1996-1#1)
third chromosome in##2##3##(1996-5#1)(2007-11#1)
third chromosome##4##2##(1992-12#1)(1993-5#1)(1996-5#1)(2007-11#1)
third class##4##2##(1990-3#1)(2008-11#1)(2010-6#1)(2012-11#1)
third clone##2##2##(1990-5#1)(1993-9#1)
third cluster##2##2##(2007-12#1)(2011-1#1)
third component of the##3##4##(1995-3#1)(2008-10#1)(2009-11#1)
third component of##5##3##(1992-12#1)(1992-7#1)(1995-3#1)(2008-10#1)(2009-11#1)
third component##9##2##(1991-8#1)(1992-12#1)(1992-7#1)(1994-5#1)(1995-3#1)(2008-10#2)(2009-11#1)(2010-4#1)
third consisted of##2##3##(1990-3#1)(2011-1#1)
third day##12##2##(1990-10#1)(1990-11#1)(1992-5#1)(1993-12#1)(1995-3#1)(1995-8#1)(1997-2#1)(2005-8#1)(2007-3#1)(2007-9#1)(2011-12#1)(2012-1#1)
third degree##8##2##(1996-5#1)(2005-7#1)(2006-6#1)(2006-7#1)(2007-11#1)(2008-1#1)(2009-4#1)(2011-2#1)
third derivative spectrophotometry##3##3##(2008-10#2)(2012-11#1)
third derivative##5##2##(2008-10#3)(2012-11#2)
third describes##2##2##(2006-10#1)(2012-12#1)
third dimension##4##2##(1991-11#1)(2007-12#1)(2011-1#1)(2012-12#1)
third domain##3##2##(1991-8#1)(1997-4#1)(2009-7#1)
third dose##6##2##(1991-5#1)(1995-3#2)(2004-12#1)(2007-2#2)
third edition##2##2##(2007-2#1)(2010-5#1)
third enzyme##2##2##(1993-12#1)(1997-7#1)
third experiment##7##2##(1996-6#1)(2006-5#1)(2007-6#1)(2008-10#3)(2009-4#1)
third family##2##2##(1990-3#1)(2007-8#1)
third gene##3##2##(1990-11#1)(1993-3#1)(2005-12#1)
third generation aromatase inhibitors##2##4##(2004-2#1)(2008-5#1)
third generation cephalosporins##4##3##(2007-7#4)
third generation##22##2##(1990-3#1)(1993-2#1)(1995-9#1)(1996-11#3)(2004-2#1)(2005-8#1)(2006-11#1)(2007-7#6)(2008-10#2)(2008-5#3)(2009-3#1)(2012-2#1)
third grade students##2##3##(2007-3#1)(2008-12#1)
third grade##9##2##(2006-3#1)(2007-3#1)(2007-9#1)(2008-12#3)(2009-9#1)(2010-3#1)(2012-3#1)
third group was##3##3##(1996-9#1)(2009-5#1)(2010-4#1)
third group##30##2##(1991-10#1)(1994-6#1)(1995-5#1)(1996-1#1)(1996-9#1)(2006-5#2)(2006-7#1)(2007-1#1)(2007-11#1)(2008-10#3)(2008-4#1)(2008-5#2)(2009-5#2)(2010-12#2)(2010-3#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-3#2)(2013-1#1)
third had##5##2##(1990-9#1)(1993-5#1)(1994-5#1)(2006-10#1)(2007-10#1)
third harmonic generation##4##3##(2013-1#4)
third harmonic of a##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
third harmonic of##5##3##(2007-11#2)(2007-12#2)(2008-3#1)
third harmonic##13##2##(2007-11#3)(2007-12#3)(2008-1#1)(2008-3#2)(2013-1#4)
third harmonics##2##2##(2007-12#2)
third has##2##2##(1993-3#1)(1995-8#1)
third in a series of##2##5##(2008-4#1)(2008-5#1)
third in a series##4##4##(1993-12#1)(1994-3#1)(2008-4#1)(2008-5#1)
third in a##6##3##(1993-12#1)(1994-3#1)(2005-7#1)(2006-10#1)(2008-4#1)(2008-5#1)
third in##7##2##(1993-12#1)(1994-3#1)(1997-5#1)(2005-7#1)(2006-10#1)(2008-4#1)(2008-5#1)
third instar larvae and##2##4##(1993-5#1)(1994-3#1)
third instar larvae of##3##4##(2009-8#1)(2013-1#2)
third instar larvae##6##3##(1993-5#1)(1994-3#1)(1996-5#1)(2009-8#1)(2013-1#2)
third instar##9##2##(1993-5#1)(1994-3#1)(1996-5#1)(2005-11#1)(2007-12#1)(2009-8#1)(2012-12#1)(2013-1#2)
third is##12##2##(1991-11#1)(1996-4#1)(1997-1#1)(1997-7#1)(2007-3#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-12#1)(2012-2#1)(2012-3#2)
third largest polII subunit##2##4##(1997-1#2)
third largest##3##2##(1997-1#3)
third left##2##2##(2006-9#1)(2007-12#1)
third level##2##2##(2008-11#1)(2008-6#1)
third line hormonotherapy##3##3##(1993-1#3)
third line therapies##2##3##(1993-1#2)
third line therapy##2##3##(1992-6#2)
third line##8##2##(1992-2#1)(1992-6#2)(1993-1#5)
third location##2##2##(2008-5#1)(2008-8#1)
third major genotype##2##3##(1994-3#2)
third major##3##2##(1994-3#2)(2012-2#1)
third member of the##5##4##(1990-7#1)(1991-5#1)(1992-11#1)(1993-12#1)(2008-2#1)
third member of##6##3##(1990-7#1)(1991-5#1)(1992-11#1)(1993-12#1)(1994-12#1)(2008-2#1)
third method is##3##3##(1995-2#1)(2008-2#1)(2008-8#1)
third method##9##2##(1992-2#1)(1995-2#1)(2008-10#4)(2008-2#1)(2008-8#1)(2010-4#1)
third millennium##5##2##(2006-10#2)(2008-10#2)(2012-9#1)
third model##3##2##(2006-3#2)(2008-4#1)
third molar and the##2##4##(2007-12#1)(2013-8#1)
third molar and##4##3##(2007-12#1)(2010-2#1)(2013-1#1)(2013-8#1)
third molar in##3##3##(2013-1#2)(2013-8#1)
third molar removal##9##3##(2007-12#9)
third molar surgery##6##3##(2007-12#6)
third molar to##2##3##(2007-12#1)(2010-2#1)
third molar##36##2##(2007-12#24)(2010-2#2)(2011-2#1)(2012-12#2)(2013-1#3)(2013-8#4)
third molars is##6##3##(2007-12#6)
third molars position##2##3##(2013-8#2)
third molars##16##2##(1993-1#1)(2007-12#10)(2013-8#5)
third molars)##3##2##(2011-1#3)
third month for two years##2##5##(1997-8#2)
third month##8##2##(1996-6#1)(1997-8#2)(2006-9#1)(2007-11#1)(2007-8#1)(2011-1#1)(2012-2#1)
third most common##9##3##(1991-6#1)(1992-5#1)(2007-4#1)(2008-5#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#1)
third most##16##2##(1991-6#1)(1992-5#1)(2006-4#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-11#2)(2010-2#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
third mutant##2##2##(1996-10#1)(2012-11#1)
third occipital condyle##3##3##(2013-1#3)
third of all##10##3##(1991-10#2)(1996-3#1)(1997-5#1)(2005-10#1)(2007-12#1)(2007-4#1)(2008-12#1)(2008-8#1)(2011-1#1)
third of our##3##3##(2007-10#1)(2007-8#1)(2008-8#1)
third of patients with##3##4##(1993-11#1)(2009-11#1)(2012-1#1)
third of patients##8##3##(1993-11#1)(2007-8#1)(2008-5#1)(2009-11#1)(2009-4#1)(2011-2#1)(2012-1#1)(2013-1#1)
third of that##2##3##(1990-5#1)(1993-6#1)
third of the cases##3##4##(1990-3#1)(2007-12#1)(2012-12#1)
third of the esophagus##2##4##(2007-2#1)(2008-5#1)
third of the face##3##4##(2007-12#1)(2010-11#1)(2012-12#1)
third of the patients##3##4##(2004-1#1)(2006-8#1)(2008-7#1)
third of the tibia could be##2##6##(2009-9#2)
third of the tibia##3##4##(2009-9#3)
third of the##69##3##(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-4#1)(1991-7#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-10#1)(1993-2#1)(1994-2#1)(1995-3#1)(1995-9#1)(1997-3#1)(1997-4#2)(1997-6#1)(2004-1#1)(2005-11#1)(2006-12#1)(2006-2#2)(2006-8#4)(2007-12#4)(2007-2#2)(2007-5#1)(2007-7#2)(2008-1#2)(2008-10#5)(2008-5#2)(2008-7#1)(2008-8#2)(2009-2#2)(2009-3#1)(2009-9#3)(2010-11#2)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#2)(2012-12#2)(2012-3#1)(2013-7#2)
third of them##4##3##(2007-3#1)(2007-7#1)(2009-3#1)(2011-2#1)
third of these##3##3##(2008-3#1)(2011-2#1)(2013-1#1)
third of##134##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-2#1)(1991-4#1)(1991-7#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-2#2)(1994-3#1)(1995-3#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(2004-1#1)(2005-10#1)(2005-11#2)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#3)(2006-7#1)(2006-8#5)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#5)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#2)(2008-1#3)(2008-10#7)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#1)(2009-11#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-9#3)(2010-11#4)(2010-8#2)(2011-1#3)(2011-11#1)(2011-12#2)(2011-2#5)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#2)
third one is##2##3##(1990-7#1)(2010-2#1)
third one##8##2##(1990-7#1)(1991-8#1)(1992-10#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-2#1)
third or##5##2##(1991-4#1)(2005-7#1)(2006-5#1)(2007-7#1)(2010-6#1)
third order##3##2##(2007-11#1)(2008-2#1)(2009-7#1)
third part of this##2##4##(1994-6#1)(2006-12#1)
third part of##6##3##(1994-6#1)(2006-12#1)(2008-10#1)(2008-7#1)(2011-1#1)(2013-8#1)
third part##12##2##(1994-6#1)(2006-12#1)(2008-10#1)(2008-4#2)(2008-7#2)(2009-8#1)(2011-1#1)(2012-2#1)(2013-8#2)
third parties##9##2##(1991-1#1)(1992-1#1)(1992-3#1)(1994-3#1)(1994-5#1)(2006-8#1)(2007-4#1)(2013-1#2)
third party payers##2##3##(1992-1#1)(1996-12#1)
third party payors##2##3##(1991-1#1)(1992-12#1)
third party personal data##3##4##(2007-1#3)
third party##18##2##(1991-1#1)(1992-1#1)(1992-12#1)(1995-2#1)(1996-12#1)(2007-1#5)(2007-12#1)(2008-10#1)(2008-4#1)(2009-6#2)(2010-6#1)(2011-2#1)(2012-12#1)
third patient presented##2##3##(2008-1#1)(2008-7#1)
third patient##15##2##(1991-3#1)(1992-1#1)(1996-9#1)(1997-6#1)(2004-1#1)(2008-1#1)(2008-3#2)(2008-7#2)(2009-1#1)(2009-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
third phase##6##2##(1993-12#1)(2005-12#1)(2007-12#1)(2008-10#2)(2008-8#1)
third population##4##2##(1995-1#1)(2006-10#1)(2007-5#1)(2008-10#1)
third position of##4##3##(1990-12#1)(1993-11#1)(1993-7#1)(1997-4#1)
third position##5##2##(1990-12#1)(1993-11#1)(1993-7#1)(1997-4#1)(2008-11#1)
third protocol is##2##3##(2008-4#2)
third protocol##3##2##(2008-4#2)(2008-9#1)
third quartile##3##2##(2007-10#1)(2008-3#1)(2011-2#1)
third region##2##2##(1992-7#1)(1995-5#1)
third set of##3##3##(1990-10#1)(1993-12#1)(2007-4#1)
third set##4##2##(1990-10#1)(1990-12#1)(1993-12#1)(2007-4#1)
third showed##2##2##(1997-4#1)(2008-1#1)
third signal##2##2##(1993-4#1)(2007-11#1)
third stage of labour##3##4##(1992-1#3)
third stage of##4##3##(1992-1#3)(2005-11#1)
third stage##12##2##(1990-3#1)(1992-1#4)(1992-8#1)(2005-11#2)(2008-12#1)(2009-5#1)(2013-1#2)
third step##5##2##(1995-1#1)(1995-5#1)(2007-10#1)(2009-8#1)(2011-1#1)
third strand##10##2##(1992-9#1)(1993-3#2)(1994-12#1)(1995-3#4)(2006-10#1)(2008-9#1)
third study conducted in##2##4##(2007-2#2)
third study##11##2##(1992-8#1)(1994-2#1)(2006-10#1)(2007-2#2)(2008-10#1)(2009-10#1)(2009-9#1)(2010-3#1)(2011-2#1)(2013-1#1)
third support protocols##2##3##(2008-4#2)
third system##2##2##(1990-5#1)(1993-6#1)
third the##4##2##(1994-9#1)(2008-2#1)(2008-7#1)(2011-2#1)
third thoracic##4##2##(1991-3#2)(2007-12#1)(2013-1#1)
third to##9##2##(1991-4#1)(1992-6#1)(1997-7#1)(2005-10#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-6#1)
third traits##2##2##(1997-4#2)
third transmembrane domain##4##3##(1991-10#1)(1993-8#1)(1996-5#1)(2008-4#1)
third transmembrane##7##2##(1991-10#1)(1993-8#1)(1994-9#1)(1996-5#1)(1997-2#2)(2008-4#1)
third treatment##3##2##(1996-12#1)(2006-12#1)(2008-12#1)
third trimester of pregnancy##11##4##(1990-12#1)(1991-12#2)(1992-10#1)(1992-2#2)(1992-4#1)(2007-2#1)(2008-12#2)(2011-2#1)
third trimester of##12##3##(1990-12#1)(1991-12#2)(1992-10#1)(1992-2#2)(1992-4#1)(2007-2#1)(2008-12#2)(2010-6#1)(2011-2#1)
third trimester##37##2##(1990-12#2)(1990-6#1)(1990-9#1)(1991-12#2)(1992-10#1)(1992-2#2)(1992-4#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-10#1)(1995-8#1)(1996-4#1)(1997-8#1)(2004-10#1)(2007-12#1)(2007-2#3)(2007-7#1)(2008-1#1)(2008-12#2)(2009-11#1)(2009-7#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#4)
third type of##4##3##(1991-1#2)(1994-9#1)(2010-12#1)
third type##9##2##(1991-1#2)(1994-8#1)(1994-9#1)(1997-3#1)(2008-2#1)(2008-4#1)(2010-12#1)(2011-2#1)
third variables##6##2##(1997-4#3)(2012-1#3)
third ventricle (AV3V)##2##3##(1991-8#1)(1992-7#1)
third ventricle##30##2##(1990-7#1)(1991-8#2)(1992-7#2)(1993-12#1)(1993-4#1)(1996-2#1)(1996-3#1)(1996-7#2)(1997-5#1)(1997-8#2)(2006-5#4)(2006-8#2)(2007-1#1)(2008-7#5)(2012-1#3)(2012-12#1)
third ventricular tumors##2##3##(2006-8#2)
third ventricular##5##2##(2006-8#3)(2011-1#2)
third ventriculostomies##2##2##(2006-5#2)
third ventriculostomy is considered to be##2##6##(2006-5#2)
third ventriculostomy is##4##3##(2006-5#4)
third ventriculostomy was##2##3##(2006-5#2)
third ventriculostomy##21##2##(2006-5#18)(2006-8#1)(2008-2#1)(2011-2#1)
third was a##2##3##(2006-6#1)(2009-2#1)
third was##4##2##(1991-2#1)(2006-6#1)(2008-6#1)(2009-2#1)
third wave##2##2##(1991-12#1)(2012-3#1)
third wave&quot##2##2##(1995-2#1)(2011-1#1)
third were##4##2##(1991-12#1)(1997-6#1)(2008-10#1)(2012-3#1)
third world countries##2##3##(1991-5#1)(2006-8#1)
third world##7##2##(1990-12#1)(1991-4#1)(1991-5#1)(1995-6#1)(2006-8#1)(2008-10#1)(2011-2#1)
third year of##4##3##(1992-12#1)(2008-10#1)(2008-3#1)(2012-1#1)
third year student nurses##2##4##(2008-11#2)
third year##14##2##(1990-5#1)(1992-12#2)(2007-8#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#1)(2012-1#1)
third zinc##5##2##(1991-2#1)(1994-10#2)(1994-12#1)(1995-5#1)
third##1286##1##(1990-10#4)(1990-11#5)(1990-12#8)(1990-2#1)(1990-3#8)(1990-4#1)(1990-5#6)(1990-6#1)(1990-7#6)(1990-8#10)(1990-9#4)(1991-1#5)(1991-10#4)(1991-11#2)(1991-12#9)(1991-2#7)(1991-3#6)(1991-4#6)(1991-5#6)(1991-6#1)(1991-7#2)(1991-8#8)(1991-9#2)(1992-1#8)(1992-10#3)(1992-11#3)(1992-12#5)(1992-2#6)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#4)(1992-7#4)(1992-8#5)(1992-9#4)(1993-1#7)(1993-10#3)(1993-11#3)(1993-12#15)(1993-2#3)(1993-3#7)(1993-4#5)(1993-5#5)(1993-6#5)(1993-7#1)(1993-8#5)(1993-9#4)(1994-10#2)(1994-12#6)(1994-2#5)(1994-3#10)(1994-5#4)(1994-6#4)(1994-8#1)(1994-9#4)(1995-1#3)(1995-10#1)(1995-11#1)(1995-2#5)(1995-3#18)(1995-4#1)(1995-5#10)(1995-6#4)(1995-8#4)(1995-9#4)(1996-1#4)(1996-10#1)(1996-11#4)(1996-12#4)(1996-2#1)(1996-3#6)(1996-4#2)(1996-5#6)(1996-6#4)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#5)(1997-2#10)(1997-3#4)(1997-4#17)(1997-5#4)(1997-6#7)(1997-7#6)(1997-8#10)(2004-1#2)(2004-10#1)(2004-12#2)(2004-2#2)(2004-3#1)(2004-4#1)(2005-10#5)(2005-11#6)(2005-12#2)(2005-5#1)(2005-6#1)(2005-7#4)(2005-8#5)(2006-1#2)(2006-10#12)(2006-11#1)(2006-12#8)(2006-2#6)(2006-3#3)(2006-4#2)(2006-5#35)(2006-6#4)(2006-7#9)(2006-8#15)(2006-9#5)(2007-1#11)(2007-10#7)(2007-11#18)(2007-12#72)(2007-2#13)(2007-3#7)(2007-4#5)(2007-5#4)(2007-6#4)(2007-7#21)(2007-8#10)(2007-9#7)(2008-1#11)(2008-10#78)(2008-11#14)(2008-12#18)(2008-2#22)(2008-3#21)(2008-4#26)(2008-5#26)(2008-6#6)(2008-7#20)(2008-8#18)(2008-9#7)(2009-1#2)(2009-10#2)(2009-11#3)(2009-2#4)(2009-3#4)(2009-4#5)(2009-5#5)(2009-6#2)(2009-7#6)(2009-8#4)(2009-9#7)(2010-10#4)(2010-11#7)(2010-12#8)(2010-2#7)(2010-3#4)(2010-4#4)(2010-5#3)(2010-6#7)(2010-7#1)(2010-8#4)(2011-1#26)(2011-11#1)(2011-12#5)(2011-2#36)(2012-1#12)(2012-11#7)(2012-12#16)(2012-2#12)(2012-3#12)(2012-5#1)(2012-9#1)(2013-1#49)(2013-7#5)(2013-8#17)
third- and##5##2##(2005-8#1)(2007-11#2)(2007-12#1)(2008-3#1)
third-##8##1##(2005-8#1)(2007-11#2)(2007-12#2)(2008-3#3)
third-degree##2##1##(1997-5#1)(2012-12#1)
third-generation PTH assays##2##3##(2007-8#2)
third-generation PTH##3##2##(2007-8#3)
third-generation cephalosporins##3##2##(2006-8#1)(2007-9#2)
third-generation synchrotron radiation##2##3##(2006-4#1)(2006-5#1)
third-generation synchrotron##3##2##(2006-4#1)(2006-5#1)(2008-2#1)
third-generation##27##1##(1991-3#1)(2006-4#4)(2006-5#4)(2006-8#1)(2007-12#1)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#3)(2013-1#1)
third-harmonic generation (THG) microscopy##2##4##(2008-3#2)
third-harmonic generation (THG) of##2##4##(2007-12#1)(2008-3#1)
third-harmonic generation (THG)##6##3##(2007-11#2)(2007-12#1)(2008-3#3)
third-harmonic generation from##2##3##(2007-12#1)(2008-1#1)
third-harmonic generation in a periodically poled##2##6##(2007-12#2)
third-harmonic generation in##4##3##(2007-11#2)(2007-12#2)
third-harmonic generation of CO(2) laser##2##5##(2007-12#2)
third-harmonic generation##29##2##(2007-11#5)(2007-12#15)(2008-1#4)(2008-3#4)(2013-1#1)
third-harmonic##36##1##(2007-11#6)(2007-12#18)(2008-1#4)(2008-3#7)(2013-1#1)
third-harmonic-generation##3##1##(2007-11#2)(2007-12#1)
third-instar##3##1##(1991-12#1)(2008-10#1)(2011-12#1)
third-level##4##1##(1990-11#1)(1994-5#1)(2009-9#1)(2012-12#1)
third-line##9##1##(1997-3#1)(2007-2#2)(2007-6#1)(2008-7#2)(2010-12#2)(2011-2#1)
third-order aberration theory##2##3##(2008-3#2)
third-order aberrations##2##2##(2008-3#2)
third-order design##2##2##(2008-2#2)
third-order dispersion of the##2##4##(2007-11#1)(2008-1#1)
third-order dispersion##8##2##(2007-11#3)(2007-12#2)(2008-1#1)(2008-2#2)
third-order grating coupler##2##3##(2008-3#2)
third-order molecular##2##2##(2007-12#2)
third-order nonlinear absorption##2##3##(2007-11#2)
third-order nonlinear optical response of Au nanocrystals embedded in##2##9##(2007-11#2)
third-order nonlinear optical response##3##4##(2007-11#2)(2007-12#1)
third-order nonlinear optical susceptibilities##3##4##(2007-12#3)
third-order nonlinear optical susceptibility##3##4##(2007-11#2)(2007-12#1)
third-order nonlinear optical##11##3##(2007-11#5)(2007-12#5)(2008-3#1)
third-order nonlinear susceptibility##2##3##(2007-12#2)
third-order nonlinear##18##2##(2007-11#7)(2007-12#10)(2008-3#1)
third-order optical nonlinearities##2##3##(2008-10#2)
third-order optical nonlinearity##2##3##(2007-11#1)(2007-12#1)
third-order optical##5##2##(2007-11#1)(2007-12#2)(2008-10#2)
third-order processes##4##2##(2007-11#2)(2007-12#1)(2008-1#1)
third-order susceptibilities##3##2##(2007-12#3)
third-order susceptibility##2##2##(2007-12#1)(2010-7#1)
third-order##74##1##(1993-8#1)(1995-8#1)(1996-5#1)(2007-11#14)(2007-12#30)(2008-1#2)(2008-10#2)(2008-2#5)(2008-3#15)(2008-7#1)(2010-7#1)(2012-12#1)
third-party payer##4##2##(2006-12#3)(2007-4#1)
third-party payers for##2##3##(1994-12#1)(2005-10#1)
third-party payers##7##2##(1994-12#1)(1994-2#1)(1995-1#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-4#1)
third-party reimbursement for##2##3##(1997-1#2)
third-party##22##1##(1991-3#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#2)(1997-1#2)(2005-10#1)(2006-10#1)(2006-12#3)(2006-8#1)(2007-11#1)(2007-4#3)(2008-7#1)(2008-9#1)(2012-12#1)
third-stage larvae##3##2##(1991-10#1)(1991-3#1)(2007-3#1)
third-stage##4##1##(1991-10#1)(1991-3#1)(1992-12#1)(2007-3#1)
third-trimester##4##1##(1990-8#1)(1996-12#1)(2004-11#1)(2008-9#1)
third-year medical##3##2##(2006-10#1)(2008-7#1)(2010-8#1)
third-year orchard block##2##3##(2008-10#2)
third-year orchard##3##2##(2008-10#3)
third-year##8##1##(1994-3#1)(2006-10#1)(2008-10#3)(2008-7#1)(2010-8#1)(2013-1#1)
thirdly##9##1##(1995-5#1)(1997-6#1)(2008-11#2)(2008-12#1)(2008-5#1)(2009-2#1)(2010-4#1)(2012-12#1)
thirds of the##17##3##(1992-3#1)(1995-11#1)(1995-9#2)(1996-6#1)(1997-6#1)(2004-12#1)(2005-10#1)(2006-10#2)(2006-8#1)(2007-2#1)(2008-10#1)(2008-11#1)(2009-4#1)(2012-12#2)
thirds of##31##2##(1991-11#1)(1992-3#1)(1993-8#1)(1995-11#1)(1995-2#1)(1995-9#2)(1996-6#1)(1997-6#1)(2004-12#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-8#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
thirds##40##1##(1991-11#1)(1991-3#1)(1992-3#1)(1993-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-9#2)(1996-6#1)(1997-6#1)(2004-12#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-8#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#1)
thirst and satiety##3##3##(2009-12#3)
thirst and##4##2##(2006-10#1)(2009-12#3)
thirst##12##1##(1990-8#1)(2006-10#1)(2009-12#3)(2009-6#1)(2010-2#4)(2012-1#1)(2013-1#1)
thirsty##5##1##(1990-8#1)(2008-4#2)(2010-2#2)
thirteen cases##2##2##(2008-10#1)(2012-2#1)
thirteen patients##4##2##(1996-2#1)(1997-3#1)(2006-4#1)(2007-8#1)
thirteen##50##1##(1991-10#1)(1992-6#2)(1992-7#1)(1994-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-8#2)(2006-10#2)(2006-11#1)(2006-4#1)(2006-6#1)(2007-10#2)(2007-2#2)(2007-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
thirties##2##1##(1994-3#1)(2009-12#1)
thirtieth##2##1##(2010-8#1)(2013-1#1)
thirty cases##3##2##(2006-7#1)(2013-8#2)
thirty minutes##2##2##(1991-12#2)
thirty patients##4##2##(2006-8#1)(2007-7#2)(2007-8#1)
thirty positive##2##2##(1992-11#2)
thirty six##2##2##(1997-2#1)(2007-3#1)
thirty two##4##2##(2007-2#1)(2007-5#1)(2008-6#1)(2012-2#1)
thirty years ago##3##3##(1995-11#1)(2006-9#1)(2007-5#1)
thirty years and##2##3##(2006-8#1)(2010-12#1)
thirty years##12##2##(1995-11#1)(1996-3#1)(2006-5#1)(2006-8#4)(2006-9#1)(2007-5#1)(2008-9#1)(2010-12#1)(2013-1#1)
thirty##66##1##(1991-10#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-11#2)(1992-12#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-3#1)(1997-2#1)(2006-5#1)(2006-7#1)(2006-8#5)(2006-9#1)(2007-10#2)(2007-2#2)(2007-3#1)(2007-5#3)(2007-7#5)(2007-8#2)(2008-11#1)(2008-12#6)(2008-4#2)(2008-5#3)(2008-6#1)(2008-9#1)(2009-4#2)(2009-7#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
thirty-eight##3##1##(2006-10#1)(2008-10#1)(2011-2#1)
thirty-five##7##1##(1992-1#1)(1993-9#1)(1996-2#1)(2004-10#1)(2004-12#1)(2007-11#1)(2012-2#1)
thirty-four clinical samples##2##3##(2013-8#2)
thirty-four##3##1##(2005-5#1)(2013-8#2)
thirty-nine patients with##2##3##(2007-8#1)(2011-2#1)
thirty-nine##4##1##(1992-12#1)(2005-2#1)(2007-8#1)(2011-2#1)
thirty-seven##3##1##(1992-11#1)(1996-11#1)(2007-8#1)
thirty-six##4##1##(2007-10#1)(2007-7#1)(2008-10#1)(2009-10#1)
thirty-three##5##1##(1993-1#1)(1994-2#1)(2008-10#1)(2008-12#1)(2011-2#1)
thirty-two##6##1##(1990-6#1)(1992-2#1)(1997-6#1)(2007-2#1)(2008-11#1)(2012-2#1)
this &quot##41##2##(1990-3#1)(1990-8#2)(1991-8#1)(1992-12#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-2#3)(1994-8#2)(1995-5#1)(1996-2#1)(1996-9#1)(1997-3#1)(2005-10#1)(2006-7#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2010-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
this 10-year##2##2##(1992-5#1)(2013-1#1)
this 4##2##2##(1997-1#1)(2008-7#1)
this 5##2##2##(2008-12#1)(2008-8#1)
this 5-year##2##2##(2008-1#1)(2010-3#1)
this A2 population##2##3##(2008-10#2)
this ATPase##5##2##(1991-3#1)(1991-9#1)(1996-11#1)(1996-9#1)(1997-6#1)
this Act##2##2##(1996-12#1)(2006-12#1)
this CRE##2##2##(2013-1#2)
this Ca2+ influx##2##3##(1996-8#1)(1996-9#1)
this Ca2+##5##2##(1992-8#1)(1993-9#1)(1996-8#1)(1996-9#1)(2009-3#1)
this DNA fragment##6##3##(1990-1#1)(1991-9#1)(2007-9#1)(2008-10#1)(2008-8#2)
this DNA is##3##3##(1990-2#1)(1994-12#1)(2008-4#1)
this DNA was##2##3##(1990-5#1)(2008-10#1)
this DNA##24##2##(1990-1#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-5#1)(1991-7#1)(1991-9#1)(1993-8#1)(1994-11#1)(1994-12#2)(1995-3#1)(1997-4#1)(2007-9#1)(2008-10#2)(2008-4#3)(2008-5#1)(2008-8#2)(2012-1#1)(2012-3#1)
this E box##2##3##(1995-3#2)
this ECL sensor##2##3##(2007-8#2)
this ELISA##4##2##(1992-7#1)(2007-2#1)(2008-11#2)
this ER##3##2##(1996-5#1)(2008-5#1)(2013-1#1)
this EcoRI##2##2##(1991-5#1)(1996-9#1)
this H-bond##2##2##(2006-12#1)(2008-8#1)
this HMO##2##2##(1994-12#1)(2007-2#1)
this IC##2##2##(2013-7#2)
this IGFBP may##2##3##(1991-4#2)
this IGFBP##3##2##(1991-4#3)
this IgG##2##2##(1991-11#1)(1991-9#1)
this Institution##2##2##(2008-9#2)
this Letter##2##2##(2007-11#1)(2007-12#1)
this MAb##2##2##(1990-2#1)(1992-12#1)
this MRI##2##2##(2008-7#2)
this N-glycosylation##2##2##(2013-1#2)
this NSCC##2##2##(1990-11#2)
this NTS site##4##3##(1993-7#4)
this O##2##2##(1991-3#1)(1996-2#1)
this O2##2##2##(2007-8#2)
this ORF is##2##3##(1993-9#1)(1996-8#1)
this ORF##5##2##(1990-4#1)(1993-9#1)(1995-4#1)(1996-8#2)
this PCR assay##2##3##(2008-10#2)
this PCR##4##2##(1994-12#1)(2007-8#1)(2008-10#2)
this PDGFalphaR promoter##2##3##(1996-5#2)
this Perspective##11##2##(2007-8#1)(2007-9#8)(2010-12#1)(2010-6#1)
this QTL##4##2##(2008-10#4)
this RNA##6##2##(1990-5#1)(1991-9#1)(1992-8#1)(1996-8#1)(1996-9#1)(2008-10#1)
this Special Issue##3##3##(2009-4#2)(2011-12#1)
this State##2##2##(2008-9#2)
this ToLCV is##2##3##(2008-10#2)
this X-ray##2##2##(2006-4#1)(2006-5#1)
this a##11##2##(1996-11#1)(2004-7#1)(2005-11#1)(2006-11#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)
this aberrant expression of##2##4##(1993-9#1)(1995-12#1)
this ability is##2##3##(2006-6#1)(2008-10#1)
this ability##19##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-1#1)(1995-10#1)(1995-2#1)(1995-5#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-3#1)(2009-4#2)(2012-1#1)
this abnormal##9##2##(1991-1#1)(1991-9#1)(1992-1#1)(2006-9#1)(2008-3#1)(2008-5#1)(2008-7#2)(2012-1#1)
this abnormality##7##2##(1994-2#1)(1995-1#1)(2007-3#1)(2007-9#1)(2008-7#1)(2010-8#1)(2012-12#1)
this accelerated##2##2##(2007-2#1)(2011-1#1)
this accident##2##2##(1995-11#1)(2007-4#1)
this account##3##2##(2007-12#2)(2011-12#1)
this accumulation##2##2##(2008-10#1)(2009-12#1)
this accuracy##4##2##(2005-11#1)(2008-2#2)(2008-3#1)
this acid##4##2##(1997-4#1)(2008-10#3)
this act##3##2##(2007-10#1)(2007-2#1)(2008-8#1)
this action is not##3##4##(1992-8#1)(1994-10#1)(2008-2#1)
this action is##6##3##(1991-10#1)(1991-4#1)(1992-8#1)(1994-10#1)(2008-2#1)(2012-3#1)
this action of##6##3##(1990-5#1)(1992-6#1)(1993-2#1)(1995-12#2)(1995-7#1)
this action was not##3##4##(1990-8#1)(1995-2#1)(1996-12#1)
this action was##5##3##(1990-8#1)(1993-3#1)(1994-2#1)(1995-2#1)(1996-12#1)
this action##26##2##(1990-5#1)(1990-8#1)(1991-10#1)(1991-4#1)(1991-5#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-10#1)(1994-2#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-7#1)(1996-10#1)(1996-12#2)(2006-5#1)(2008-2#1)(2008-5#1)(2008-6#1)(2012-3#1)
this activation is##3##3##(1990-9#1)(2008-5#1)(2012-12#1)
this activation pattern##2##3##(1996-12#1)(1997-2#1)
this activation##17##2##(1990-5#1)(1990-9#1)(1991-12#1)(1992-7#1)(1993-12#2)(1994-2#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-2#1)(2008-5#1)(2010-10#1)(2012-12#1)(2012-2#1)(2013-8#1)
this active site##2##3##(1994-8#1)(1997-7#1)
this active##7##2##(1991-7#1)(1992-1#1)(1994-8#1)(1997-7#1)(2007-12#1)(2008-5#1)(2008-6#1)
this activity by##3##3##(1991-2#1)(1993-3#1)(2008-10#1)
this activity has##2##3##(1994-8#1)(2008-7#1)
this activity in##4##3##(1992-3#1)(1996-3#1)(1997-4#1)(2012-3#1)
this activity is##8##3##(1992-10#1)(1992-7#1)(1994-9#1)(1995-1#1)(1995-5#1)(1996-5#1)(2005-8#1)(2008-4#1)
this activity was##11##3##(1990-10#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-9#1)(1995-6#1)(1996-10#1)(1997-2#1)(1997-8#1)(2008-10#1)(2010-8#1)
this activity##62##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#1)(1991-2#2)(1991-9#1)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-7#2)(1992-9#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-1#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-5#1)(1995-6#2)(1996-10#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-8#1)(2004-12#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-8#1)(2007-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#2)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
this acute##5##2##(1994-12#1)(2007-3#1)(2007-8#1)(2012-2#1)(2013-1#1)
this adaptive response##2##3##(2008-5#1)(2011-1#1)
this adaptive##4##2##(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)
this added##2##2##(1992-3#1)(1997-8#1)
this addendum##18##2##(2008-8#1)(2009-8#14)(2010-12#2)(2013-1#1)
this additional##5##2##(1994-8#1)(1997-6#1)(2007-8#1)(2008-2#1)(2012-1#1)
this adduct##2##2##(1990-11#1)(1996-7#1)
this adhesion##3##2##(1993-6#1)(1996-3#1)(2008-10#1)
this adjunct therapy##3##3##(2009-7#3)
this advantage in##2##3##(1996-7#1)(2008-5#1)
this advantage##7##2##(1996-7#2)(2005-7#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-8#1)
this adverse effect##2##3##(1996-4#1)(2007-12#1)
this adverse##4##2##(1995-5#1)(1996-4#1)(2007-12#1)(2007-8#1)
this affects##3##2##(1991-3#1)(2007-3#1)(2013-1#1)
this age category##2##3##(2008-5#1)(2011-1#1)
this age group##32##3##(1990-1#1)(1991-8#1)(1992-11#1)(1993-12#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-8#1)(1997-1#4)(1997-4#1)(2004-1#1)(2005-11#1)(2006-10#2)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-11#1)(2011-2#2)(2012-2#1)
this age is##2##3##(1990-7#1)(2008-7#1)
this age##64##2##(1990-1#1)(1990-7#1)(1991-4#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-9#1)(1993-11#1)(1993-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#2)(1995-2#1)(1996-8#1)(1997-1#4)(1997-4#1)(1997-5#1)(2004-1#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-4#2)(2009-5#1)(2009-7#1)(2010-3#3)(2010-4#1)(2010-8#1)(2011-1#1)(2011-11#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)
this age-related##2##2##(1995-9#1)(1996-3#1)
this agent and##2##3##(2005-11#1)(2012-2#1)
this agent in the##2##4##(1991-9#1)(2009-9#1)
this agent in##6##3##(1990-6#1)(1991-9#1)(1995-12#1)(2006-10#1)(2007-10#1)(2009-9#1)
this agent is##6##3##(1993-2#1)(1995-8#1)(2005-7#1)(2007-11#2)(2008-7#1)
this agent may##2##3##(1996-6#1)(2008-4#1)
this agent was##3##3##(1990-10#1)(1992-11#1)(2009-2#1)
this agent##55##2##(1990-10#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-11#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-10#1)(1996-6#1)(1997-2#1)(2005-11#1)(2005-7#3)(2005-8#1)(2006-1#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#3)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#5)(2009-2#1)(2009-9#1)(2010-12#2)(2010-8#1)(2012-1#1)(2012-2#1)(2013-8#1)
this aggregation##4##2##(1995-5#1)(1997-6#1)(2006-2#1)(2007-12#1)
this aggressive approach##3##3##(2006-6#1)(2007-8#1)(2010-3#1)
this aggressive disease##2##3##(2012-12#2)
this aggressive##9##2##(2006-6#1)(2007-11#1)(2007-8#1)(2008-12#1)(2010-3#1)(2012-1#1)(2012-12#3)
this agreement is##2##3##(2008-2#1)(2008-3#1)
this agreement##4##2##(2005-7#1)(2008-2#1)(2008-3#1)(2008-8#1)
this aim##14##2##(1991-2#1)(1996-7#1)(2007-10#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-8#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)
this alanine##2##2##(1991-4#1)(1996-5#1)
this algorithm are##2##3##(2008-2#2)
this algorithm is##6##3##(2008-2#4)(2008-3#2)
this algorithm##29##2##(2006-10#1)(2006-12#1)(2007-11#2)(2008-2#16)(2008-3#6)(2010-12#1)(2011-1#1)(2013-8#1)
this allele##7##2##(1995-12#1)(1995-8#1)(1997-2#1)(2007-2#1)(2010-12#1)(2011-1#1)(2013-1#1)
this allows a##2##3##(2008-3#1)(2008-7#1)
this allows for##2##3##(2008-10#1)(2008-3#1)
this allows the##2##3##(1996-2#1)(2008-5#1)
this allows##9##2##(1996-2#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)
this alone##4##2##(1990-6#1)(2012-12#3)
this alpha##4##2##(1990-12#1)(1992-2#1)(1994-2#1)(1995-11#1)
this alpha-helix##2##2##(1991-2#1)(1994-9#1)
this already##5##2##(1994-2#1)(2006-9#1)(2008-5#1)(2011-1#1)(2012-2#1)
this also applies to##2##4##(1996-2#1)(2010-3#1)
this also occurs##2##3##(1995-8#1)(2008-7#1)
this also##11##2##(1992-6#1)(1995-8#1)(1996-2#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-3#2)(2011-2#1)
this alteration in##2##3##(2008-2#1)(2008-6#1)
this alteration may##2##3##(2006-8#1)(2007-8#1)
this alteration##6##2##(1997-1#1)(2006-8#1)(2007-8#1)(2008-2#1)(2008-6#1)(2013-1#1)
this altered##3##2##(1991-8#1)(1995-1#1)(2008-10#1)
this alternative##8##2##(1992-1#1)(1993-8#1)(1993-9#1)(2006-7#1)(2007-12#1)(2008-5#1)(2010-7#1)(2012-1#1)
this altitude##2##2##(2007-7#1)(2008-8#1)
this amino acid sequence##2##4##(1992-8#1)(1995-3#1)
this amino acid was##2##4##(1995-8#1)(1997-7#1)
this amino acid##11##3##(1992-6#3)(1992-8#2)(1995-3#1)(1995-8#1)(1997-7#1)(2007-6#1)(2008-3#1)(2010-8#1)
this amino##12##2##(1992-6#3)(1992-8#2)(1994-12#1)(1995-3#1)(1995-8#1)(1997-7#1)(2007-6#1)(2008-3#1)(2010-8#1)
this amount##2##2##(1996-11#1)(2010-4#1)
this amplification procedure##2##3##(1990-4#1)(1992-8#1)
this amplification##3##2##(1990-4#1)(1992-8#1)(2007-7#1)
this amplifier##2##2##(2007-12#1)(2008-2#1)
this an##11##2##(1994-5#1)(1995-9#1)(1996-11#1)(2007-10#1)(2007-4#1)(2007-5#1)(2008-12#1)(2008-7#1)(2009-4#1)(2010-5#1)(2012-12#1)
this analog##3##2##(1992-12#1)(1992-6#1)(2008-3#1)
this analogue##4##2##(1990-6#1)(1990-7#1)(1991-7#2)
this analysis are##2##3##(2007-10#1)(2008-1#1)
this analysis can##2##3##(1995-3#1)(2006-10#1)
this analysis has##3##3##(1992-6#1)(2008-2#1)(2009-5#1)
this analysis in##2##3##(1990-11#1)(2007-8#1)
this analysis is the##2##4##(1996-7#1)(2012-2#1)
this analysis is##9##3##(1994-11#1)(1995-12#1)(1996-7#1)(2008-12#1)(2008-3#1)(2008-7#2)(2010-11#1)(2012-2#1)
this analysis of the##5##4##(1992-2#1)(2007-10#1)(2012-3#2)(2013-1#1)
this analysis of##7##3##(1992-2#1)(2006-7#1)(2007-10#1)(2010-2#1)(2012-3#2)(2013-1#1)
this analysis to the##2##4##(1992-3#1)(1997-8#1)
this analysis to##6##3##(1992-3#1)(1996-7#1)(1997-8#1)(2008-10#1)(2008-2#1)(2009-12#1)
this analysis was##2##3##(1995-8#1)(2005-11#1)
this analysis were##6##3##(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2013-7#1)
this analysis##105##2##(1990-11#1)(1990-12#1)(1990-4#2)(1991-12#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-6#1)(1992-7#1)(1992-9#1)(1994-11#2)(1994-3#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-1#1)(1996-7#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-11#2)(2006-10#2)(2006-5#1)(2006-7#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#2)(2009-5#1)(2010-11#2)(2010-12#1)(2010-2#3)(2010-5#1)(2010-9#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#3)
this analytical method##2##3##(2008-10#2)
this analytical procedure##3##3##(2007-1#1)(2008-10#2)
this analytical technique##2##3##(2008-10#2)
this analytical##12##2##(1991-5#1)(1993-2#1)(2007-1#1)(2008-10#8)(2010-5#1)
this anatomical##2##2##(2005-8#1)(2013-1#1)
this anatomy##2##2##(2007-8#1)(2010-8#1)
this ancient##4##2##(2008-4#1)(2008-9#1)(2009-8#1)(2012-12#1)
this and other studies##3##4##(1995-11#1)(2005-11#1)(2008-9#1)
this and other##26##3##(1991-4#1)(1993-1#1)(1993-6#1)(1995-1#1)(1995-11#1)(1995-3#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-8#2)(2008-9#2)(2010-12#1)(2012-2#1)(2013-1#1)
this and previous studies##2##4##(1997-2#1)(2010-6#1)
this and previous##3##3##(1997-2#1)(1997-4#1)(2010-6#1)
this and similar##5##3##(2008-3#1)(2008-6#1)(2010-10#1)(2011-1#1)(2011-2#1)
this and the##5##3##(1990-9#1)(1994-2#1)(2007-4#1)(2008-9#1)(2011-2#1)
this and to##2##3##(1993-12#1)(2010-4#1)
this and##52##2##(1990-8#1)(1990-9#1)(1991-3#1)(1991-4#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-5#2)(2007-11#2)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-6#1)(2008-8#2)(2008-9#4)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
this angle##8##2##(1994-3#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-2#1)(2008-3#1)(2008-7#1)
this animal model##6##3##(1992-12#1)(1996-12#1)(1996-7#1)(2008-4#1)(2010-12#1)(2011-2#1)
this animal##13##2##(1992-12#1)(1992-2#1)(1996-12#1)(1996-7#1)(1997-4#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-3#1)
this anion##2##2##(2008-10#1)(2010-4#1)
this anisotropy##2##2##(1993-11#1)(1996-7#1)
this anomaly##8##2##(1991-8#1)(1991-9#1)(1993-9#1)(2008-11#2)(2008-7#1)(2013-1#1)(2013-2#1)
this antagonism##2##2##(2008-10#1)(2012-3#1)
this antagonist##2##2##(1992-6#1)(1997-7#1)
this antagonistic##2##2##(1996-12#1)(1997-8#1)
this antibiotic##3##2##(1990-2#1)(1991-3#1)(2010-5#1)
this antibody also##2##3##(1997-3#1)(2008-6#1)
this antibody in##2##3##(1995-11#1)(1997-3#1)
this antibody##31##2##(1990-10#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-3#2)(1991-4#1)(1992-3#1)(1993-12#1)(1994-10#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-8#2)(1996-5#1)(1997-3#2)(1997-4#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-6#2)(2009-4#1)(2013-1#2)
this antigen is##2##3##(1991-9#1)(2008-4#1)
this antigen##17##2##(1991-11#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-4#2)(1995-5#2)(2006-10#1)(2007-2#1)(2007-6#1)(2008-11#2)(2008-4#1)(2008-8#1)(2010-12#1)(2011-2#1)
this antimicrobial##4##2##(1990-9#1)(2006-8#1)(2010-11#2)
this antiserum##2##2##(1990-3#1)(1991-1#1)
this apparatus##6##2##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
this apparent discrepancy##2##3##(1991-6#1)(1997-6#1)
this apparent paradox##2##3##(1994-11#1)(2006-4#1)
this apparent##18##2##(1991-6#1)(1994-11#2)(1995-10#1)(1997-6#1)(2004-1#1)(2006-4#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-6#1)(2009-4#1)(2009-6#1)(2009-9#1)(2012-12#2)
this apparently##7##2##(1991-11#1)(1992-5#1)(1993-9#1)(1996-5#1)(1997-1#1)(2008-10#2)
this appears to be due to##2##6##(1996-12#1)(1996-8#1)
this appears to be##5##4##(1991-5#1)(1996-12#1)(1996-8#1)(2005-10#1)(2008-6#1)
this appendix##8##2##(2008-4#6)(2008-9#2)
this application are##4##3##(1996-5#1)(2007-3#1)(2008-10#1)(2009-11#1)
this application##23##2##(1992-2#1)(1994-2#1)(1996-5#1)(1997-3#1)(2006-6#1)(2007-3#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#1)(2009-11#1)(2010-2#1)(2010-6#1)(2011-1#2)(2013-8#1)
this applies to##3##3##(2006-4#1)(2006-8#1)(2008-8#1)
this approach allows##2##3##(2008-3#1)(2010-6#1)
this approach an##3##3##(2008-10#2)(2008-7#1)
this approach and##8##3##(1997-1#1)(1997-7#1)(2007-12#1)(2007-9#1)(2008-2#2)(2008-4#1)(2013-8#1)
this approach are also##2##4##(2008-12#1)(2008-2#1)
this approach are##15##3##(1993-2#1)(1994-3#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)
this approach by##3##3##(2007-12#1)(2008-7#1)(2012-3#1)
this approach can be##8##4##(1993-7#1)(1993-9#1)(1996-4#1)(1997-1#1)(2008-11#1)(2011-2#1)(2012-1#1)(2012-3#1)
this approach can##17##3##(1993-7#1)(1993-9#1)(1995-6#1)(1996-4#1)(1997-1#1)(2006-3#1)(2008-11#1)(2008-2#3)(2008-6#1)(2008-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
this approach could lead to more accurate and efficient radiology reporting##2##11##(2013-1#2)
this approach could##3##3##(2008-8#1)(2013-1#2)
this approach does not##4##4##(2008-2#1)(2008-5#1)(2008-9#1)(2012-11#1)
this approach for the##2##4##(1994-5#1)(2009-10#1)
this approach for##9##3##(1992-9#1)(1994-5#1)(1994-6#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-10#1)(2009-2#1)(2010-8#1)
this approach has been##6##4##(2007-5#1)(2012-2#1)(2012-3#1)(2013-1#3)
this approach has##17##3##(1991-2#1)(1997-7#1)(2005-7#1)(2006-8#1)(2007-12#1)(2007-5#2)(2007-6#1)(2007-8#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#4)
this approach in the##3##4##(2008-10#1)(2008-5#1)(2012-11#1)
this approach in##10##3##(2006-6#1)(2006-9#1)(2007-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-3#1)
this approach include##3##3##(1992-4#1)(2004-2#1)(2005-8#1)
this approach is frequently##2##4##(1992-3#1)(2006-10#1)
this approach is less##2##4##(2008-8#1)(2011-2#1)
this approach is limited##3##4##(2008-3#1)(2012-3#2)
this approach is more##2##4##(2008-2#1)(2008-8#1)
this approach is not very##2##5##(2007-6#1)(2008-10#1)
this approach is not##5##4##(1993-11#1)(2007-6#1)(2008-10#1)(2008-5#1)(2010-8#1)
this approach is that the##4##5##(2008-4#1)(2008-9#1)(2011-2#1)(2012-1#1)
this approach is that##11##4##(2008-10#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-2#1)(2010-7#1)(2011-2#1)(2012-1#2)
this approach is the##2##4##(2008-10#1)(2008-11#1)
this approach is to##4##4##(1997-2#1)(2010-2#1)(2010-4#1)(2012-3#1)
this approach is##55##3##(1990-5#1)(1992-11#1)(1992-3#2)(1992-9#1)(1993-11#1)(1995-5#1)(1996-6#1)(1997-2#1)(2006-10#2)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-2#3)(2012-1#3)(2012-2#1)(2012-3#4)
this approach may be##4##4##(1993-2#1)(2011-1#1)(2012-1#1)(2012-3#1)
this approach may not##3##4##(1997-4#1)(2006-12#1)(2012-2#1)
this approach may##8##3##(1993-2#1)(1997-3#1)(1997-4#1)(2006-12#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)
this approach need to be##3##5##(2008-3#1)(2008-5#1)(2008-9#1)
this approach of##3##3##(2007-7#1)(2008-3#1)(2011-2#1)
this approach offers a##3##4##(1997-4#1)(2013-1#2)
this approach on##2##3##(1990-2#1)(2008-7#1)
this approach provides a##2##4##(2008-1#1)(2008-10#1)
this approach the##2##3##(2008-12#1)(2008-2#1)
this approach to identify##2##4##(1992-2#1)(2012-2#1)
this approach to learning##2##4##(2008-11#2)
this approach to predict##2##4##(1993-11#1)(2008-2#1)
this approach to study##2##4##(2008-4#1)(2009-12#1)
this approach to the##5##4##(1993-11#1)(2008-3#1)(2008-7#1)(2009-12#1)(2012-3#1)
this approach to##28##3##(1992-2#1)(1993-11#3)(1996-12#1)(2005-12#1)(2005-7#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-12#2)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-8#1)
this approach uses##2##3##(2005-12#1)(2008-2#1)
this approach was##8##3##(1996-12#1)(2006-12#1)(2008-10#4)(2009-8#1)(2013-1#1)
this approach we##10##3##(1990-11#1)(1992-11#1)(1996-5#1)(2007-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2013-1#1)
this approach were##2##3##(1997-6#1)(2008-10#1)
this approach will ultimately##2##4##(2009-6#1)(2010-12#1)
this approach will##7##3##(2007-10#1)(2007-11#1)(2008-7#2)(2009-6#1)(2010-12#1)(2011-2#1)
this approach with a##2##4##(2007-11#1)(2008-8#1)
this approach with##8##3##(1996-8#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-6#1)(2008-8#1)(2010-9#1)
this approach yields##4##3##(2005-8#1)(2007-12#1)(2008-3#2)
this approach##378##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-8#1)(1992-9#2)(1993-11#5)(1993-12#1)(1993-2#2)(1993-7#1)(1993-9#3)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#4)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#3)(1997-6#1)(1997-7#2)(2004-2#1)(2005-11#1)(2005-12#2)(2005-6#1)(2005-7#3)(2005-8#2)(2006-10#3)(2006-12#4)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#6)(2007-12#14)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#23)(2008-11#9)(2008-12#2)(2008-2#28)(2008-3#17)(2008-4#11)(2008-5#10)(2008-6#6)(2008-7#15)(2008-8#6)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#4)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#12)(2012-1#8)(2012-11#3)(2012-12#1)(2012-2#18)(2012-3#13)(2013-1#11)(2013-8#3)
this approximation the##2##3##(2008-3#2)
this approximation##7##2##(2007-12#1)(2008-3#5)(2013-1#1)
this architecture##2##2##(2008-2#1)(2009-11#1)
this are discussed in##2##4##(1991-4#1)(2008-5#1)
this are discussed##7##3##(1991-4#1)(1994-8#1)(2006-4#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)
this are##16##2##(1991-4#1)(1994-8#1)(2006-10#1)(2006-4#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#1)
this area and##11##3##(1990-5#1)(1994-2#1)(1995-3#1)(1996-5#1)(2005-8#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-3#1)(2009-9#1)(2013-8#1)
this area as##2##3##(2008-1#1)(2008-9#1)
this area but##2##3##(1997-6#1)(2008-11#1)
this area for##2##3##(2008-10#1)(2008-12#1)
this area in##6##3##(1993-8#1)(1995-2#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-7#1)
this area is##18##3##(1991-7#1)(1994-1#1)(2005-7#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#2)(2009-7#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-9#1)
this area may be##3##4##(1992-12#1)(2008-10#1)(2012-12#1)
this area may have##2##4##(2007-12#1)(2011-2#1)
this area may##6##3##(1992-12#1)(2007-12#1)(2008-10#1)(2010-11#1)(2011-2#1)(2012-12#1)
this area of health##2##4##(1993-8#1)(2013-1#1)
this area of influence was somewhat elliptical##2##7##(2008-10#2)
this area of research and##2##5##(2007-1#1)(2007-7#1)
this area of research##8##4##(1997-8#1)(2006-10#2)(2007-1#1)(2007-7#1)(2008-10#1)(2008-2#1)(2010-7#1)
this area of study##2##4##(1990-12#1)(2012-2#1)
this area of##30##3##(1990-12#1)(1993-8#1)(1995-6#1)(1997-5#1)(1997-8#2)(2005-8#1)(2006-10#2)(2006-4#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-5#1)(2010-7#1)(2011-11#1)(2012-1#1)(2012-2#2)(2013-1#1)
this area requires##3##3##(2006-11#1)(2010-5#1)(2012-12#1)
this area the##5##3##(1991-12#1)(2007-5#1)(2008-5#2)(2011-2#1)
this area to##4##3##(2008-10#1)(2009-3#1)(2012-3#1)(2013-1#1)
this area was##2##3##(1994-2#1)(2007-12#1)
this area we##2##3##(2006-6#1)(2011-2#1)
this area with##3##3##(1994-8#1)(2005-7#1)(2008-4#1)
this area##278##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-5#2)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-8#2)(1994-1#2)(1994-11#1)(1994-2#4)(1994-3#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-8#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-12#1)(2005-7#3)(2005-8#6)(2006-1#1)(2006-10#9)(2006-11#1)(2006-12#1)(2006-2#2)(2006-3#2)(2006-4#2)(2006-5#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-2#3)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#3)(2007-9#1)(2008-1#7)(2008-10#16)(2008-11#13)(2008-12#7)(2008-2#7)(2008-3#1)(2008-4#3)(2008-5#8)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#7)(2009-10#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-10#2)(2010-11#4)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#3)(2011-11#1)(2011-2#8)(2011-9#1)(2012-1#5)(2012-12#11)(2012-2#5)(2012-3#1)(2012-9#1)(2013-1#8)(2013-7#2)(2013-8#5)
this argument##6##2##(2005-11#1)(2008-1#1)(2008-5#1)(2008-8#1)(2009-11#1)(2012-11#1)
this arrangement##11##2##(1990-4#3)(1996-1#1)(1996-2#1)(2006-12#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-12#1)
this array##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
this arrhythmia##9##2##(1996-4#2)(2006-10#1)(2006-8#1)(2007-8#1)(2007-9#2)(2010-12#1)(2011-2#1)
this article I##6##3##(1992-2#1)(2007-12#1)(2008-7#1)(2009-6#1)(2010-3#1)(2012-2#1)
this article a survey##2##4##(1995-12#1)(1996-12#1)
this article a##5##3##(1995-12#1)(1996-12#1)(2007-11#1)(2008-11#1)(2013-8#1)
this article addresses the##2##4##(2006-5#1)(2008-9#1)
this article addresses##3##3##(1994-12#1)(2006-5#1)(2008-9#1)
this article aims to##2##4##(2009-8#1)(2012-12#1)
this article also##5##3##(1995-12#1)(2006-5#1)(2006-9#1)(2010-9#1)(2013-8#1)
this article an attempt has been made to##2##8##(2006-1#1)(2008-4#1)
this article an##4##3##(2006-1#1)(2008-1#1)(2008-11#1)(2008-4#1)
this article and##8##3##(1992-1#2)(1992-2#1)(2005-9#1)(2006-8#1)(2008-2#1)(2008-7#1)(2012-12#1)
this article are##14##3##(1990-12#1)(1991-2#1)(1992-1#1)(1994-2#1)(1996-1#1)(2006-10#1)(2006-9#1)(2007-2#1)(2008-3#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
this article can be##5##4##(1990-12#1)(2008-7#3)(2008-9#1)
this article can##6##3##(1990-12#1)(2006-5#1)(2008-7#3)(2008-9#1)
this article considers##4##3##(2006-4#1)(2009-7#1)(2010-2#1)(2011-2#1)
this article demonstrates##2##3##(2007-8#1)(2008-3#1)
this article describe##2##3##(2007-11#1)(2012-11#1)
this article describes the##2##4##(2011-2#1)(2012-3#1)
this article describes##4##3##(1990-10#1)(1992-12#1)(2011-2#1)(2012-3#1)
this article discusses how##2##4##(2007-8#1)(2013-1#1)
this article discusses the##3##4##(1992-1#1)(2006-10#1)(2008-7#1)
this article discusses##8##3##(1992-1#1)(1993-3#2)(2006-10#1)(2007-8#1)(2008-7#1)(2010-7#1)(2013-1#1)
this article evaluates##2##3##(2007-12#1)(2008-2#1)
this article examines the##3##4##(1995-3#1)(2007-12#1)(2008-11#1)
this article examines##8##3##(1993-1#1)(1995-1#1)(1995-3#1)(2006-8#1)(2007-12#1)(2008-11#1)(2012-12#1)(2012-2#1)
this article explores the##3##4##(1996-12#1)(2006-4#1)(2008-11#1)
this article explores##4##3##(1996-12#1)(2006-4#1)(2008-11#1)(2008-2#1)
this article focuses on the##3##5##(1992-12#1)(1993-2#1)(2011-2#1)
this article focuses on##4##4##(1992-12#1)(1993-2#1)(2010-11#1)(2011-2#1)
this article focuses##5##3##(1992-12#1)(1993-2#1)(2007-1#1)(2010-11#1)(2011-2#1)
this article has##3##3##(1990-12#1)(1994-1#1)(2007-1#1)
this article highlights##2##3##(2006-5#1)(2010-2#1)
this article include##3##3##(1996-2#1)(1997-1#1)(2010-7#1)
this article includes##2##3##(1991-1#1)(2008-12#1)
this article is a##2##4##(1992-9#1)(2008-10#1)
this article is an##10##4##(1992-1#1)(2008-11#6)(2008-4#1)(2008-7#1)(2012-3#1)
this article is on##4##4##(2006-10#1)(2008-10#1)(2008-12#1)(2010-2#1)
this article is that##2##4##(2007-8#1)(2008-7#1)
this article is to##162##4##(1993-1#1)(1993-12#1)(1994-1#2)(1994-11#2)(1994-3#2)(1994-4#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-2#3)(1997-3#1)(1997-8#1)(2004-12#1)(2005-10#3)(2005-11#2)(2005-7#2)(2005-8#1)(2006-10#3)(2006-8#1)(2006-9#2)(2007-1#3)(2007-11#10)(2007-12#9)(2007-2#2)(2007-4#1)(2007-5#2)(2007-7#9)(2007-8#3)(2008-1#4)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-4#2)(2009-5#3)(2009-7#1)(2009-9#4)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#3)(2012-11#2)(2012-12#3)(2012-2#10)(2012-3#4)(2013-1#9)(2013-7#1)(2013-8#3)
this article is##191##3##(1992-1#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-1#2)(1994-11#2)(1994-3#2)(1994-4#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-2#4)(1997-3#1)(1997-8#1)(2004-12#1)(2004-2#1)(2005-10#3)(2005-11#2)(2005-7#2)(2005-8#1)(2006-10#5)(2006-8#1)(2006-9#2)(2007-1#3)(2007-11#10)(2007-12#9)(2007-2#2)(2007-4#1)(2007-5#2)(2007-7#9)(2007-8#4)(2008-1#4)(2008-10#6)(2008-11#9)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-4#2)(2009-5#3)(2009-7#1)(2009-9#4)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#3)(2012-11#2)(2012-12#4)(2012-2#11)(2012-3#5)(2013-1#9)(2013-7#1)(2013-8#3)
this article offers##2##3##(2006-12#1)(2007-4#1)
this article outlines##2##3##(1996-1#1)(2012-2#1)
this article presents the##3##4##(1996-1#1)(1996-2#1)(2013-1#1)
this article presents##5##3##(1996-1#1)(1996-2#1)(2006-5#1)(2008-5#1)(2013-1#1)
this article proposes##3##3##(1993-1#1)(2008-2#1)(2012-3#1)
this article provides##4##3##(1990-12#1)(1994-1#1)(2008-7#1)(2012-2#1)
this article represents##2##3##(1997-3#1)(2009-3#1)
this article reviews##3##3##(2006-10#1)(2008-4#1)(2008-7#1)
this article sets out##2##4##(2007-3#1)(2012-12#1)
this article suggests that the##2##5##(1994-2#1)(2011-2#1)
this article suggests##4##3##(1991-3#1)(1994-1#1)(1994-2#1)(2011-2#1)
this article summarizes##2##3##(1997-1#1)(2008-1#1)
this article the author##5##4##(2006-5#1)(2006-7#1)(2007-11#1)(2007-6#1)(2007-8#1)
this article the##27##3##(1990-12#1)(1990-3#2)(1992-3#1)(1993-1#1)(1996-3#1)(2005-2#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#2)(2007-10#2)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#2)(2009-10#1)(2011-2#1)(2012-3#1)
this article to##3##3##(2007-11#1)(2007-8#1)(2008-10#1)
this article was##26##3##(1991-2#1)(1992-3#1)(1993-12#1)(1993-6#2)(1996-11#1)(1997-8#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-10#2)(2010-11#1)(2010-3#1)(2011-1#2)(2011-2#1)(2011-7#1)(2012-2#2)
this article we demonstrate##3##4##(2008-11#1)(2008-7#1)(2008-8#1)
this article we##89##3##(1990-9#1)(1991-12#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-5#1)(1993-5#1)(1994-1#1)(1995-4#1)(1995-6#1)(1995-7#1)(1996-4#1)(1996-9#1)(1997-6#2)(2004-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-12#1)(2006-4#2)(2006-7#2)(2006-8#2)(2006-9#2)(2007-10#1)(2007-11#4)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#2)(2008-7#9)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#6)(2013-8#1)
this article were##2##3##(1993-12#1)(2010-9#1)
this article will address##2##4##(1996-1#1)(2008-1#1)
this article will focus on the##2##6##(1995-12#1)(2008-5#1)
this article will review##2##4##(1996-1#1)(2010-9#1)
this article will##18##3##(1990-12#1)(1992-4#1)(1994-1#1)(1995-12#1)(1996-1#2)(2005-7#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#2)(2010-11#1)(2010-9#1)(2011-2#2)(2013-1#2)
this article with##3##3##(1997-2#1)(2005-7#1)(2010-10#1)
this article##1139##2##(1990-10#1)(1990-11#1)(1990-12#13)(1990-3#2)(1990-9#1)(1991-1#9)(1991-12#6)(1991-2#9)(1991-3#9)(1991-9#1)(1992-1#13)(1992-11#1)(1992-12#9)(1992-2#12)(1992-3#6)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#6)(1993-11#1)(1993-12#8)(1993-2#6)(1993-3#8)(1993-5#1)(1993-6#3)(1994-1#13)(1994-11#3)(1994-12#2)(1994-2#5)(1994-3#6)(1994-4#1)(1995-1#7)(1995-12#7)(1995-2#4)(1995-3#7)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-1#8)(1996-11#1)(1996-12#2)(1996-2#12)(1996-3#6)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#2)(1997-6#3)(1997-8#2)(2004-10#2)(2004-12#2)(2004-2#1)(2005-10#5)(2005-11#6)(2005-2#1)(2005-4#1)(2005-7#11)(2005-8#7)(2005-9#1)(2006-1#3)(2006-10#30)(2006-11#3)(2006-12#7)(2006-2#3)(2006-3#5)(2006-4#7)(2006-5#8)(2006-6#1)(2006-7#8)(2006-8#8)(2006-9#10)(2007-1#7)(2007-10#7)(2007-11#26)(2007-12#21)(2007-2#11)(2007-3#1)(2007-4#9)(2007-5#6)(2007-6#4)(2007-7#18)(2007-8#21)(2007-9#2)(2008-1#24)(2008-10#30)(2008-11#46)(2008-12#11)(2008-2#12)(2008-3#10)(2008-4#14)(2008-5#18)(2008-6#7)(2008-7#43)(2008-8#24)(2008-9#17)(2009-1#3)(2009-10#4)(2009-11#5)(2009-12#3)(2009-2#2)(2009-3#5)(2009-4#8)(2009-5#7)(2009-6#5)(2009-7#6)(2009-8#6)(2009-9#10)(2010-1#4)(2010-10#4)(2010-11#8)(2010-12#18)(2010-2#8)(2010-3#5)(2010-4#3)(2010-5#6)(2010-6#3)(2010-7#12)(2010-8#9)(2010-9#11)(2011-1#25)(2011-12#6)(2011-2#42)(2011-3#1)(2011-7#1)(2012-1#7)(2012-11#10)(2012-12#25)(2012-2#45)(2012-3#21)(2013-1#28)(2013-7#3)(2013-8#13)
this as a##10##3##(1995-11#1)(2004-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-3#2)
this as an##2##3##(2007-4#1)(2008-3#1)
this as##20##2##(1990-3#1)(1995-11#1)(1995-6#1)(2004-11#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-3#2)(2013-1#1)
this aspect of the##2##4##(2007-11#1)(2012-2#1)
this aspect of their##2##4##(2007-2#1)(2008-9#1)
this aspect of##12##3##(1994-3#1)(1995-5#1)(2005-10#1)(2007-11#1)(2007-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)
this aspect##21##2##(1993-2#1)(1994-3#1)(1995-5#1)(2005-10#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-6#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-8#1)
this assay can be##2##4##(2010-2#1)(2011-1#1)
this assay for##3##3##(1997-2#1)(2007-2#1)(2008-10#1)
this assay has been##2##4##(1993-2#1)(1995-2#1)
this assay has##4##3##(1993-2#1)(1993-4#1)(1995-2#1)(1996-12#1)
this assay is 0##2##4##(2008-10#1)(2008-11#1)
this assay is##8##3##(1990-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2012-12#2)(2012-2#1)
this assay system##6##3##(1990-3#1)(1991-2#2)(1994-10#1)(2008-11#2)
this assay to##2##3##(1992-12#1)(2008-6#1)
this assay was##5##3##(1993-12#1)(1995-11#1)(1996-5#1)(1996-9#1)(2013-1#1)
this assay were##5##3##(1990-7#1)(1991-10#1)(1992-4#1)(1996-1#1)(2008-10#1)
this assay##82##2##(1990-11#1)(1990-12#4)(1990-3#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#3)(1991-8#1)(1991-9#3)(1992-12#1)(1992-4#1)(1992-7#2)(1992-8#1)(1993-12#1)(1993-2#3)(1993-4#1)(1994-10#2)(1994-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-5#3)(1996-9#2)(1997-2#1)(1997-4#1)(2007-2#2)(2008-10#11)(2008-11#5)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#1)(2010-2#1)(2011-1#1)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#1)
this assemblage##2##2##(2011-1#1)(2012-2#1)
this assertion##6##2##(1996-5#1)(2006-10#1)(2006-7#1)(2006-9#1)(2008-9#1)(2011-2#1)
this assessment of##2##3##(2008-10#1)(2011-12#1)
this assessment##8##2##(1995-1#1)(2007-6#1)(2008-10#2)(2008-11#1)(2010-4#1)(2011-12#1)(2011-3#1)
this assignment##4##2##(1993-6#1)(1997-6#1)(2008-3#1)(2013-1#1)
this assistance##3##2##(1991-1#1)(2006-10#1)(2012-1#1)
this association are##4##3##(1991-12#1)(2007-5#1)(2010-9#1)(2011-12#1)
this association could##2##3##(1993-12#1)(2007-7#1)
this association is explained by##2##5##(2009-7#1)(2013-1#1)
this association is##7##3##(1991-5#1)(1997-1#1)(2005-10#1)(2009-10#1)(2009-7#1)(2010-2#1)(2013-1#1)
this association was not statistically significant##2##6##(2012-12#2)
this association was not##3##4##(2012-12#2)(2013-7#1)
this association was##4##3##(2008-12#1)(2012-12#2)(2013-7#1)
this association##52##2##(1990-12#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-7#1)(1993-10#1)(1993-12#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-8#3)(1997-1#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-10#2)(2007-5#1)(2007-7#3)(2008-1#2)(2008-10#3)(2008-12#1)(2008-7#1)(2008-9#4)(2009-10#2)(2009-4#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-9#1)(2011-12#1)(2012-12#3)(2013-1#3)(2013-7#1)
this assumption and##3##3##(2008-3#1)(2008-8#1)(2012-3#1)
this assumption by##3##3##(1996-7#1)(2006-3#1)(2009-11#1)
this assumption is##7##3##(1993-5#1)(1993-7#1)(1994-11#1)(2007-9#1)(2008-2#1)(2011-2#1)(2012-3#1)
this assumption##41##2##(1990-10#1)(1990-8#2)(1993-5#1)(1993-7#1)(1994-11#1)(1995-2#1)(1995-5#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-6#1)(1997-8#2)(2004-11#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-3#1)(2007-1#1)(2007-9#2)(2008-10#1)(2008-2#3)(2008-3#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#3)
this asymmetric##4##2##(1993-8#1)(1997-3#1)(2007-12#1)(2009-2#1)
this asymmetry##4##2##(1992-7#1)(1994-2#1)(1997-3#1)(2007-10#1)
this atherogenic##2##2##(1995-3#1)(2009-11#1)
this attack##2##2##(1991-3#1)(1993-12#1)
this attenuation##2##2##(1991-2#1)(2008-9#1)
this auditory##2##2##(1991-6#1)(1996-2#1)
this augmented##2##2##(1991-12#1)(2007-11#1)
this author##2##2##(1992-1#1)(2004-10#1)
this autoimmune##2##2##(2008-1#1)(2008-4#1)
this average eigenvector##2##3##(2008-2#2)
this axis##4##2##(2006-11#1)(2008-2#1)(2008-5#1)(2012-2#1)
this background##7##2##(1991-6#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-3#2)(2013-8#1)
this bacterial##8##2##(1995-2#1)(2006-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)
this bacterium in##3##3##(2008-9#1)(2013-1#1)(2013-8#1)
this bacterium is##2##3##(1995-6#2)
this bacterium was##4##3##(1990-9#1)(2006-8#1)(2008-10#1)(2011-2#1)
this bacterium##20##2##(1990-2#1)(1990-9#1)(1993-8#2)(1995-6#2)(2006-10#1)(2006-8#1)(2007-1#1)(2008-10#5)(2008-9#2)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
this balance can##2##3##(2006-10#1)(2007-11#1)
this balance is##2##3##(2007-2#1)(2008-10#1)
this balance##8##2##(1992-6#1)(2006-10#2)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-8#1)
this band was##4##3##(1995-11#2)(1995-9#1)(1996-5#1)
this band##6##2##(1995-11#2)(1995-3#1)(1995-9#1)(1996-5#1)(2006-10#1)
this barrier##8##2##(1992-12#1)(1997-4#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-5#1)(2012-12#2)
this basal##2##2##(1991-6#1)(2008-7#1)
this base##2##2##(2005-4#1)(2006-8#1)
this baseline##2##2##(1991-12#1)(2011-2#1)
this basic##10##2##(1993-8#1)(1995-8#1)(1997-2#1)(2008-1#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-8#1)(2010-9#1)(2013-8#1)
this basis##24##2##(1990-11#1)(1992-3#1)(1993-4#1)(1993-7#1)(1994-2#1)(1995-6#2)(1997-8#1)(2006-10#1)(2007-1#1)(2007-5#1)(2008-10#3)(2008-2#2)(2008-4#1)(2008-8#1)(2009-4#1)(2010-12#2)(2011-2#1)(2012-1#1)(2013-1#1)
this batch##2##2##(2008-6#1)(2013-8#1)
this be##4##2##(2007-12#1)(2009-10#1)(2012-12#2)
this beam##2##2##(2008-3#1)(2008-9#1)
this beamline##4##2##(2006-4#3)(2006-5#1)
this behavior is##2##3##(2006-10#1)(2009-5#1)
this behavior##29##2##(1991-7#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-12#1)(1994-9#1)(1996-12#1)(2005-11#2)(2006-10#2)(2006-12#1)(2007-10#1)(2007-12#4)(2007-5#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-5#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
this behavioral##7##2##(1991-12#1)(1991-2#1)(1991-3#1)(1993-12#1)(1993-5#1)(2006-9#1)(2011-12#1)
this behaviour is##3##3##(1991-1#1)(2009-5#1)(2009-9#1)
this behaviour##14##2##(1991-1#1)(1991-11#1)(1992-1#1)(1993-12#1)(1996-3#1)(2006-4#1)(2007-9#1)(2008-10#1)(2008-11#2)(2009-5#1)(2009-9#1)(2010-2#1)(2010-8#1)
this behavioural##2##2##(1993-11#1)(1995-12#1)
this being most##2##3##(2006-8#1)(2008-2#1)
this being the##5##3##(1992-12#1)(1992-9#1)(1997-3#1)(2008-5#1)(2009-7#1)
this being##10##2##(1990-4#1)(1992-12#1)(1992-9#1)(1996-12#1)(1997-3#1)(2006-8#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-7#1)
this belief##4##2##(2006-2#1)(2008-10#1)(2010-8#1)(2013-1#1)
this beneficial effect##2##3##(1995-3#1)(2008-10#1)
this beneficial##4##2##(1995-3#1)(2004-11#1)(2008-10#2)
this benefit is##3##3##(2008-1#1)(2008-10#1)(2011-1#1)
this benefit##11##2##(1991-8#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
this benign##3##2##(1991-8#1)(2006-10#1)(2006-9#1)
this beta##2##2##(1994-11#2)
this bias##5##2##(1994-2#1)(1996-8#1)(2006-7#1)(2009-10#1)(2009-12#1)
this binding is##4##3##(1994-12#1)(1994-8#1)(1995-2#1)(2008-10#1)
this binding site##2##3##(1990-4#1)(1991-4#1)
this binding was##4##3##(1990-6#1)(1991-12#1)(1995-2#1)(1996-12#1)
this binding##30##2##(1990-1#1)(1990-12#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-3#1)(1991-4#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#1)(1996-12#1)(1997-4#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-10#1)
this bioactive##2##2##(1994-8#1)(2008-5#1)
this bioassay##3##2##(2008-10#1)(2008-12#1)(2008-9#1)
this biochemical##3##2##(1990-8#1)(1992-12#1)(2011-2#1)
this biocontrol agent##2##3##(2008-10#2)
this biocontrol##3##2##(2008-10#3)
this biological control agent##2##4##(2008-10#2)
this biological control##3##3##(2008-10#3)
this biological##10##2##(1994-8#1)(2008-10#4)(2008-7#1)(2008-8#1)(2009-4#1)(2012-2#2)
this biomechanical##2##2##(2009-3#1)(2012-2#1)
this biosensor##2##2##(2008-10#2)
this birefringence##2##2##(2008-2#1)(2008-3#1)
this black##2##2##(2006-8#1)(2010-6#1)
this blend##3##2##(2008-11#2)(2009-8#1)
this blocking group is##2##4##(1991-10#1)(1991-9#1)
this blocking##3##2##(1991-10#1)(1991-9#1)(1994-6#1)
this blood##2##2##(2010-8#1)(2013-1#1)
this body of##3##3##(2007-10#1)(2010-2#1)(2012-2#1)
this body##5##2##(1991-3#1)(2007-10#1)(2010-2#1)(2012-1#1)(2012-2#1)
this bond##4##2##(1990-5#1)(1991-5#1)(1995-10#1)(1996-4#1)
this bone##3##2##(1991-11#1)(1995-2#1)(2005-7#1)
this book##5##2##(2007-5#1)(2008-1#1)(2008-10#2)(2008-2#1)
this bovine##2##2##(1996-10#1)(1997-2#1)
this brain area##2##3##(1995-2#1)(1995-7#1)
this brain region##5##3##(1996-3#1)(1997-6#1)(2007-12#1)(2009-10#1)(2013-1#1)
this brain##8##2##(1995-2#1)(1995-7#1)(1996-3#1)(1997-6#1)(2007-12#1)(2008-6#1)(2009-10#1)(2013-1#1)
this branch of medicine##2##4##(2007-8#1)(2012-2#1)
this branch##3##2##(2007-11#1)(2007-8#1)(2012-2#1)
this brief report##2##3##(1997-8#1)(2010-11#1)
this brief review##9##3##(1992-2#1)(2005-10#1)(2006-10#1)(2006-11#1)(2008-5#1)(2008-7#2)(2009-3#1)(2010-2#1)
this brief##17##2##(1992-2#1)(1996-11#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-8#1)(2007-5#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-3#1)(2010-11#1)(2010-2#1)(2013-1#1)
this broad##3##2##(1997-8#1)(2006-12#1)(2008-12#1)
this buffer##2##2##(2007-12#1)(2013-1#1)
this bundle##2##2##(2007-10#1)(2008-3#1)
this burden##5##2##(2006-1#1)(2008-2#1)(2008-6#1)(2010-12#1)(2011-2#1)
this burgeoning##2##2##(2007-4#1)(2010-2#1)
this business##2##2##(2008-12#1)(2013-1#1)
this by##19##2##(1993-12#1)(1996-5#1)(1996-8#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-2#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2012-2#1)(2013-1#4)
this by-product##2##2##(2007-6#1)(2010-4#1)
this cDNA is##2##3##(1993-11#1)(2005-11#1)
this cDNA was##2##3##(1990-12#1)(1991-5#1)
this cDNA##21##2##(1990-12#5)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-8#1)(1993-11#2)(1994-12#1)(1994-2#1)(1994-8#1)(1997-7#1)(2005-11#2)(2008-6#1)(2008-8#1)
this calibration method##2##3##(2008-2#1)(2010-3#1)
this calibration technique##2##3##(2008-10#2)
this calibration##7##2##(2008-10#4)(2008-2#1)(2008-3#1)(2010-3#1)
this campaign##4##2##(1995-3#1)(2006-10#1)(2006-2#1)(2007-2#1)
this can be a##3##4##(2006-5#1)(2006-6#1)(2009-4#1)
this can be accomplished by##2##5##(1990-11#1)(2007-12#1)
this can be accomplished##3##4##(1990-11#1)(2007-12#2)
this can be achieved##4##4##(1993-9#1)(2007-8#1)(2010-5#1)(2012-12#1)
this can be done##2##4##(2006-2#1)(2010-10#1)
this can be explained##2##4##(1992-6#1)(2008-2#1)
this can be used##2##4##(2008-8#1)(2010-5#1)
this can be##35##3##(1990-11#1)(1991-3#1)(1992-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-8#1)(2005-8#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-12#2)(2007-8#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2010-10#1)(2010-5#2)(2012-12#1)(2012-2#1)
this can have##2##3##(1991-11#1)(2012-2#1)
this can occur in##2##4##(1990-11#1)(2008-7#1)
this can occur##3##3##(1990-11#1)(1993-4#1)(2008-7#1)
this can only be##2##4##(1993-12#1)(2007-7#1)
this can##53##2##(1990-11#2)(1991-11#1)(1991-3#1)(1992-6#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-3#1)(1996-11#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-8#1)(2005-11#1)(2005-2#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-2#3)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#2)(2010-10#1)(2010-5#2)(2011-2#1)(2012-12#1)(2012-2#2)
this cancer and##3##3##(2009-4#1)(2011-2#1)(2013-8#1)
this cancer##16##2##(1990-5#1)(1992-5#1)(2006-12#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-5#1)(2009-4#1)(2010-12#2)(2011-1#1)(2011-2#3)(2012-2#1)(2013-8#1)
this candid##2##2##(1992-1#1)(2008-11#1)
this capability##3##2##(2009-5#1)(2012-2#1)(2013-1#1)
this capacity##8##2##(1993-11#1)(1993-5#1)(2007-3#1)(2008-11#1)(2009-5#1)(2010-12#1)(2010-2#1)(2013-8#1)
this carbon##2##2##(2006-10#1)(2009-6#1)
this care##4##2##(2007-4#1)(2008-12#1)(2008-9#1)(2012-11#1)
this carrier##3##2##(1992-3#1)(1995-6#1)(2008-10#1)
this cascade##3##2##(2007-12#1)(2008-5#1)(2012-12#1)
this case a##2##3##(2008-2#2)
this case an##2##3##(1997-7#1)(2008-3#1)
this case and the##2##4##(1993-5#1)(2008-4#1)
this case and##6##3##(1993-5#1)(1996-3#1)(2008-4#1)(2009-12#1)(2009-3#1)(2012-12#1)
this case are described##2##4##(2006-8#1)(2008-5#1)
this case are presented##2##4##(2008-10#1)(2011-2#1)
this case are##4##3##(2006-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
this case as##6##3##(2008-7#1)(2009-3#1)(2010-6#2)(2013-1#2)
this case because the##2##4##(2006-6#1)(2010-12#1)
this case because##7##3##(2006-6#1)(2007-4#1)(2007-8#1)(2008-12#1)(2008-8#1)(2010-12#1)(2012-2#1)
this case could##2##3##(2007-9#1)(2008-2#1)
this case highlights the importance of##2##6##(2011-1#1)(2012-12#1)
this case highlights the##4##4##(2006-4#1)(2008-7#1)(2011-1#1)(2012-12#1)
this case illustrates##2##3##(2006-10#1)(2006-4#1)
this case interesting##2##3##(2012-2#1)(2013-7#1)
this case is that##6##4##(1997-4#1)(2006-7#1)(2008-1#1)(2008-6#1)(2010-6#1)(2012-2#1)
this case is the first##2##5##(2006-10#2)
this case is the##3##4##(2006-10#2)(2007-7#1)
this case is to##2##4##(2007-7#1)(2008-2#1)
this case is##18##3##(1992-10#1)(1996-11#1)(1997-4#1)(2005-10#1)(2006-10#2)(2006-7#1)(2007-7#2)(2008-1#1)(2008-2#1)(2008-6#1)(2008-7#2)(2010-12#1)(2010-6#1)(2012-2#1)(2013-7#1)
this case of##7##3##(1996-12#1)(2005-12#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-2#1)(2013-8#1)
this case only##2##3##(2008-2#1)(2013-1#1)
this case report and review of the literature##2##8##(1992-2#1)(2008-1#1)
this case report suggests##2##4##(2012-12#1)(2012-2#1)
this case report was##2##4##(2010-6#1)(2013-8#1)
this case report we##8##4##(2006-10#1)(2007-10#1)(2007-8#1)(2008-4#1)(2008-6#1)(2010-12#1)(2012-12#1)(2012-2#1)
this case report##47##3##(1990-2#1)(1992-2#1)(1996-8#1)(1997-3#1)(2005-12#2)(2006-10#3)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#3)(2008-4#2)(2008-6#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#3)(2013-8#2)
this case represents a##3##4##(2008-7#1)(2011-2#1)(2012-1#1)
this case represents##4##3##(2008-7#1)(2009-7#1)(2011-2#1)(2012-1#1)
this case review##2##3##(2006-9#2)
this case series##6##3##(2007-8#1)(2008-12#1)(2010-2#1)(2012-12#1)(2013-1#2)
this case study##15##3##(1991-1#1)(1992-3#1)(1992-6#1)(1993-1#2)(1994-1#2)(1996-1#1)(2006-8#1)(2010-5#1)(2012-12#4)(2013-7#1)
this case suggests that##4##4##(1990-6#1)(2010-12#1)(2010-6#1)(2012-11#1)
this case the##29##3##(1990-11#1)(1990-6#1)(1992-10#1)(1992-12#1)(1992-6#1)(1994-11#1)(1995-12#1)(1995-2#1)(1996-7#1)(2005-1#1)(2005-11#1)(2006-6#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#6)(2008-5#1)(2010-12#1)(2013-8#1)
this case to##4##3##(2007-8#1)(2010-12#1)(2010-6#1)(2012-3#1)
this case was##8##3##(1991-4#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#2)
this case we##3##3##(1994-11#1)(2008-3#1)(2013-1#1)
this case with a brief review of the##2##8##(2009-5#1)(2010-12#1)
this case with a##3##4##(2009-5#1)(2010-12#1)(2012-1#1)
this case with##5##3##(1992-3#1)(2007-8#1)(2009-5#1)(2010-12#1)(2012-1#1)
this case##404##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#3)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#2)(1991-4#2)(1991-6#1)(1991-7#1)(1992-10#3)(1992-11#1)(1992-12#6)(1992-2#1)(1992-3#3)(1992-6#3)(1993-1#2)(1993-10#1)(1993-12#1)(1993-5#1)(1993-7#1)(1994-1#2)(1994-11#2)(1994-2#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#3)(1996-3#1)(1996-4#2)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#1)(2004-3#1)(2004-7#1)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#3)(2005-12#4)(2006-1#2)(2006-10#17)(2006-2#2)(2006-4#4)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#3)(2006-9#4)(2007-10#2)(2007-11#5)(2007-12#3)(2007-2#3)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#7)(2007-8#10)(2007-9#2)(2008-1#4)(2008-10#25)(2008-11#7)(2008-12#7)(2008-2#14)(2008-3#12)(2008-4#5)(2008-5#7)(2008-6#7)(2008-7#15)(2008-8#7)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#4)(2009-4#1)(2009-5#3)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#11)(2010-2#3)(2010-4#3)(2010-5#1)(2010-6#7)(2010-7#2)(2010-9#3)(2011-1#3)(2011-12#3)(2011-2#11)(2012-1#4)(2012-11#3)(2012-12#15)(2012-2#9)(2012-3#4)(2013-1#17)(2013-7#7)(2013-8#6)
this case)##5##2##(2008-10#2)(2008-7#1)(2009-2#1)(2010-11#1)
this case-control study##2##3##(1991-8#1)(2011-2#1)
this category of patients##2##4##(1991-3#1)(1991-8#1)
this category of##5##3##(1991-3#1)(1991-8#1)(1997-8#1)(2005-10#1)(2008-6#1)
this category##10##2##(1991-3#1)(1991-8#1)(1996-6#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#1)(2008-2#1)(2008-6#1)(2012-1#1)
this cation##3##2##(1995-10#1)(2008-10#2)
this cause##3##2##(2011-1#1)(2011-2#1)(2013-1#1)
this causes##2##2##(2008-10#1)(2008-11#1)
this cavity##5##2##(1994-3#1)(2006-10#1)(2007-12#1)(2008-3#2)
this ceiling##2##2##(2008-11#1)(2013-7#1)
this cell has##2##3##(1993-7#2)
this cell line and##2##4##(1997-6#1)(2008-11#1)
this cell line for##2##4##(1992-9#1)(1994-8#1)
this cell line is##3##4##(1990-5#1)(1993-9#1)(1994-8#1)
this cell line was##3##4##(1997-5#1)(2008-11#2)
this cell line##38##3##(1990-2#1)(1990-5#3)(1990-7#1)(1991-1#1)(1991-12#1)(1991-7#1)(1992-8#1)(1992-9#3)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-5#1)(1994-8#3)(1995-1#1)(1995-10#2)(1995-3#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-11#6)(2008-4#1)
this cell population##2##3##(1997-1#1)(2011-2#1)
this cell type##4##3##(1996-8#1)(1997-1#1)(2006-5#1)(2008-5#1)
this cell##62##2##(1990-2#1)(1990-4#1)(1990-5#3)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-8#1)(1992-9#3)(1993-12#2)(1993-2#1)(1993-4#1)(1993-6#2)(1993-7#2)(1993-9#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#3)(1995-1#1)(1995-10#2)(1995-3#1)(1996-12#1)(1996-8#2)(1997-1#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-5#1)(2008-10#1)(2008-11#8)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#2)
this cellular##5##2##(1995-2#2)(2008-11#1)(2008-7#1)(2011-2#1)
this center##4##2##(1994-8#1)(2007-8#1)(2008-1#2)
this central##4##2##(2008-7#1)(2008-8#1)(2010-1#1)(2011-2#1)
this century##13##2##(1990-3#1)(1995-8#1)(1995-9#1)(1996-11#1)(1997-5#1)(2006-10#2)(2007-2#1)(2007-8#2)(2008-11#1)(2010-9#1)(2013-8#1)
this challenge and##2##3##(1993-12#1)(2006-10#1)
this challenge in##3##3##(1994-12#1)(2013-1#2)
this challenge is##2##3##(2008-7#1)(2009-8#1)
this challenge##22##2##(1993-12#1)(1993-2#1)(1994-12#2)(1997-1#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#2)
this challenging problem##2##3##(2010-8#1)(2011-2#1)
this challenging##11##2##(2006-10#2)(2006-5#1)(2009-4#1)(2010-12#1)(2010-8#2)(2011-2#2)(2012-12#1)(2013-1#1)
this change and##2##3##(1996-12#2)
this change in##7##3##(1990-11#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-3#1)
this change is##3##3##(2007-4#1)(2008-10#1)(2011-3#1)
this change was##5##3##(1992-2#1)(1993-9#1)(1996-9#1)(1997-8#1)(2013-7#1)
this change##41##2##(1990-11#1)(1990-5#1)(1991-11#1)(1991-7#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-9#1)(1994-1#1)(1995-3#1)(1996-12#2)(1996-2#1)(1996-9#1)(1997-8#2)(2004-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-4#1)(2007-6#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-7#1)(2008-8#1)(2009-6#2)(2010-3#1)(2010-7#1)(2011-3#1)(2013-1#1)(2013-7#1)
this changing##2##2##(2008-11#1)(2013-8#1)
this channel in##2##3##(1996-2#1)(2009-12#1)
this channel was##2##3##(1996-10#1)(1997-5#1)
this channel with##2##3##(1993-9#1)(2007-12#1)
this channel##19##2##(1990-10#1)(1990-11#2)(1991-5#1)(1991-9#1)(1992-11#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-10#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-3#1)(1997-5#1)(2006-12#1)(2007-12#1)(2009-12#1)(2009-8#1)
this chapter##32##2##(2007-12#3)(2007-8#1)(2008-4#8)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2011-1#1)(2012-12#1)(2013-1#2)
this character##4##2##(1991-2#1)(2008-11#2)(2008-8#1)
this characteristic##4##2##(1993-3#1)(1995-11#1)(2007-7#1)(2008-2#1)
this chart##4##2##(1992-7#1)(1995-9#2)(2008-9#1)
this checkpoint##3##2##(1994-3#1)(2008-8#1)(2013-1#1)
this chemical##7##2##(1993-2#1)(1993-7#1)(1996-9#1)(2004-11#1)(2008-10#2)(2008-11#1)
this chemically##2##2##(1994-9#1)(2008-10#1)
this chemistry##3##2##(2008-4#1)(2009-3#1)(2012-12#1)
this chemoattractant##2##2##(1992-4#1)(1994-6#1)
this child is##2##3##(1996-3#1)(2008-9#1)
this child##4##2##(1996-3#1)(2008-9#1)(2009-7#1)(2011-2#1)
this chimera##3##2##(1991-8#1)(1996-4#1)(1997-3#1)
this chimeric##3##2##(1991-10#1)(1994-9#1)(1997-4#1)
this chromatographic##4##2##(1996-2#1)(2008-10#2)(2008-5#1)
this chromosomal##3##2##(1997-2#1)(2008-7#1)(2009-10#1)
this chromosome##8##2##(1995-12#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-7#1)
this chronic disease##2##3##(2008-11#1)(2013-8#1)
this chronic##8##2##(1992-2#1)(1993-8#1)(2004-12#1)(2006-10#1)(2007-12#1)(2008-11#1)(2009-11#1)(2013-8#1)
this circuit##3##2##(2007-12#1)(2008-2#2)
this circulation##2##2##(1996-1#2)
this circumstance##2##2##(1994-8#1)(2006-12#1)
this clade##2##2##(2012-3#1)(2013-7#1)
this claim##4##2##(2008-10#1)(2008-8#1)(2009-2#2)
this class are##2##3##(2006-10#1)(2008-10#1)
this class of agents##6##4##(2005-7#1)(2005-9#1)(2006-10#1)(2006-12#1)(2008-7#1)(2010-12#1)
this class of compounds##5##4##(1993-8#2)(1996-8#1)(2008-1#1)(2008-10#1)
this class of drugs##8##4##(1993-2#1)(2006-10#1)(2006-5#1)(2008-1#1)(2008-11#1)(2008-3#2)(2011-2#1)
this class of inhibitors##2##4##(2005-7#1)(2013-1#1)
this class of models##2##4##(1995-5#1)(2007-10#1)
this class of proteins##4##4##(1991-4#1)(1993-9#1)(1994-12#1)(2008-11#1)
this class of receptors##2##4##(1993-2#1)(1997-2#1)
this class of##56##3##(1990-7#2)(1991-12#1)(1991-4#1)(1991-6#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-8#2)(1993-9#1)(1994-12#1)(1995-5#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-10#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-2#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
this class##73##2##(1990-7#2)(1991-11#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-4#1)(1993-8#2)(1993-9#1)(1994-12#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-7#4)(2005-8#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-2#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)
this classical##2##2##(2008-5#1)(2010-4#1)
this classification system##2##3##(1990-11#1)(2006-3#1)
this classification##9##2##(1990-11#1)(1992-3#1)(1992-7#1)(1997-8#1)(2005-5#1)(2006-3#1)(2007-8#1)(2008-8#1)(2009-11#1)
this classifier##2##2##(2010-3#1)(2010-5#1)
this cleavage is##2##3##(1991-10#1)(2008-8#1)
this cleavage##7##2##(1991-10#1)(1991-9#1)(1994-8#1)(1995-5#1)(2004-12#1)(2008-5#1)(2008-8#1)
this client group##3##3##(1997-7#1)(2008-11#1)(2008-7#1)
this clientele##2##2##(2008-2#1)(2011-2#1)
this clinic##4##2##(2007-3#1)(2008-2#2)(2009-10#1)
this clinical dilemma##2##3##(2008-9#1)(2011-2#1)
this clinical entity##3##3##(2004-1#1)(2006-6#1)(2008-2#1)
this clinical picture##3##3##(1991-4#1)(1993-2#1)(1993-8#1)
this clinical study##3##3##(2006-12#1)(2008-5#1)(2010-8#1)
this clinical syndrome##3##3##(1995-2#1)(2010-7#1)(2013-1#1)
this clinical##35##2##(1990-3#1)(1991-4#1)(1993-2#1)(1993-8#1)(1995-2#1)(2004-1#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-11#1)(2007-8#1)(2007-9#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-8#1)(2010-11#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#2)
this clone is##2##3##(1993-6#2)
this clone was##3##3##(1993-11#1)(1995-2#1)(2008-8#1)
this clone##20##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-3#2)(1991-6#1)(1991-9#2)(1992-3#1)(1993-11#1)(1993-6#4)(1994-8#2)(1995-2#2)(2008-10#1)(2008-8#1)
this cluster##7##2##(1991-3#1)(1992-12#1)(1993-5#1)(1994-3#1)(2008-12#1)(2012-2#1)(2013-1#1)
this coastal##2##2##(2008-5#1)(2011-1#1)
this coating##2##2##(2008-2#1)(2011-12#1)
this code##2##2##(1992-11#1)(1992-2#1)
this coding##2##2##(2005-8#1)(2009-3#1)
this codon##2##2##(1990-12#1)(1990-3#1)
this cognitive##2##2##(1997-8#1)(2007-5#1)
this cohort of##3##3##(2007-12#1)(2010-6#1)(2013-1#1)
this cohort to##2##3##(1991-7#1)(2012-3#1)
this cohort were##2##3##(2007-8#1)(2010-6#1)
this cohort##17##2##(1991-7#1)(1994-12#1)(1994-5#1)(1997-8#1)(2007-12#1)(2007-8#2)(2008-2#1)(2008-9#1)(2009-8#1)(2010-6#2)(2012-3#1)(2013-1#3)(2013-7#1)
this coincided with the##2##4##(2006-4#1)(2013-1#1)
this collaboration##2##2##(1991-2#1)(1996-3#1)
this collection##5##2##(2007-11#1)(2008-10#2)(2008-5#1)(2012-12#1)
this column##42##2##(2007-2#29)(2007-8#1)(2008-10#2)(2008-6#2)(2008-9#3)(2009-9#2)(2010-9#2)(2011-2#1)
this combination has##2##3##(1995-5#1)(2010-12#1)
this combination is##8##3##(1992-11#1)(2004-12#1)(2005-7#1)(2008-7#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#1)
this combination of##4##3##(1991-12#1)(1997-3#1)(2006-10#1)(2010-4#1)
this combination##32##2##(1991-12#1)(1992-11#1)(1994-11#1)(1995-5#1)(1995-6#1)(1997-3#1)(1997-6#1)(1997-7#1)(2004-12#1)(2005-7#1)(2006-10#4)(2006-4#1)(2007-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-12#2)(2010-4#1)(2011-2#2)(2012-12#1)(2013-1#3)(2013-7#1)
this combined pattern##2##3##(1995-6#1)(2012-3#1)
this combined treatment##2##3##(2006-2#1)(2007-11#1)
this combined##15##2##(1991-3#1)(1993-3#1)(1993-5#1)(1995-6#1)(1996-5#1)(1996-7#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-3#1)(2013-1#1)
this commentary##12##2##(2008-11#1)(2008-12#1)(2008-4#1)(2009-5#2)(2010-2#2)(2010-8#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#1)
this commercial##2##2##(2008-10#1)(2008-5#1)
this commercially##2##2##(2008-5#2)
this commissure##2##2##(2007-12#2)
this common and##5##3##(1991-8#1)(1997-8#1)(2006-10#1)(2008-6#1)(2012-12#1)
this common condition##2##3##(2006-10#1)(2010-5#1)
this common motif##2##3##(1990-9#1)(2007-12#1)
this common##19##2##(1990-9#1)(1991-8#1)(1993-12#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#2)(2007-10#1)(2007-12#1)(2008-11#1)(2008-6#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-5#1)(2012-12#1)(2013-8#1)
this commonly##3##2##(1990-12#1)(2006-10#1)(2006-12#1)
this communication##24##2##(1990-2#1)(1990-9#1)(1991-5#1)(1991-6#1)(1992-2#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(1996-3#1)(1997-2#1)(2005-7#1)(2006-1#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2012-8#1)
this community##7##2##(1993-9#1)(1996-3#1)(2008-11#2)(2011-2#2)(2012-2#1)
this compact##2##2##(2007-12#1)(2008-3#1)
this comparative##4##2##(1993-12#1)(1997-7#1)(2008-7#1)(2011-2#1)
this comparison##8##2##(1993-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-8#1)(2012-12#1)
this compartment##3##2##(1997-6#1)(1997-7#1)(2010-11#1)
this compensatory##2##2##(2010-11#1)(2010-7#1)
this competition##2##2##(2008-8#1)(2008-9#1)
this compilation##2##2##(2007-3#1)(2008-5#1)
this complete##2##2##(1992-1#1)(1996-8#1)
this complex and##8##3##(1995-6#1)(2006-2#1)(2006-6#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)
this complex disease##2##3##(1993-7#1)(2007-10#1)
this complex disorder##4##3##(2006-10#1)(2008-7#2)(2009-7#1)
this complex has been##2##4##(1994-5#1)(1995-1#1)
this complex interplay##2##3##(2007-9#1)(2011-1#1)
this complex is##5##3##(1994-8#1)(1995-11#1)(2008-10#2)(2008-5#1)
this complex process##2##3##(2006-10#1)(2008-1#1)
this complex set of##2##4##(1992-5#1)(2005-5#1)
this complex was##3##3##(1990-7#1)(1995-3#1)(2008-3#1)
this complex##88##2##(1990-5#1)(1990-7#2)(1991-2#1)(1991-5#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-7#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#4)(1996-1#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-5#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#7)(2008-8#1)(2008-9#4)(2009-10#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
this complexity##10##2##(2008-4#1)(2008-5#1)(2009-3#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
this complicated disease##2##3##(2011-2#1)(2012-12#1)
this complicated##5##2##(2006-6#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
this complication are discussed##2##4##(2008-5#1)(2009-9#1)
this complication has##2##3##(1997-3#1)(2008-7#1)
this complication in the##3##4##(1990-6#1)(2013-1#2)
this complication in##5##3##(1990-6#1)(2007-7#1)(2008-1#1)(2013-1#2)
this complication is##5##3##(1991-3#1)(2006-10#1)(2007-11#1)(2013-1#2)
this complication##55##2##(1990-6#2)(1991-3#1)(1991-8#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-6#1)(1995-9#1)(1997-3#1)(2004-11#1)(2005-12#2)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-3#1)(2007-7#2)(2007-8#6)(2008-1#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#1)(2009-2#1)(2009-4#1)(2009-9#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#6)
this component of##2##3##(1996-2#1)(2008-5#1)
this component was##3##3##(1990-7#1)(1992-11#1)(1996-2#1)
this component##13##2##(1990-7#1)(1991-2#1)(1992-11#1)(1994-12#1)(1996-2#2)(1996-7#1)(1997-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-9#1)
this composite material##2##3##(2007-11#1)(2007-12#1)
this composite polymer##2##3##(2008-10#2)
this composite##6##2##(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)
this composition##2##2##(2004-9#1)(2007-12#1)
this compound as##3##3##(1991-2#1)(1992-7#1)(2009-6#1)
this compound could##3##3##(1991-2#1)(1991-5#1)(2008-5#1)
this compound for##3##3##(1990-4#1)(2005-7#1)(2006-12#1)
this compound had##2##3##(1991-12#1)(2008-10#1)
this compound has been##2##4##(2006-12#1)(2008-10#1)
this compound has##4##3##(1996-2#1)(2006-12#1)(2007-11#1)(2008-10#1)
this compound in the##3##4##(1990-5#1)(1990-8#1)(2010-5#1)
this compound in##11##3##(1990-11#1)(1990-5#1)(1990-8#1)(1993-2#1)(1997-5#1)(2005-8#1)(2008-10#2)(2009-8#1)(2010-5#1)(2011-2#1)
this compound is##5##3##(1990-7#2)(1992-11#1)(1993-11#1)(2005-8#1)
this compound may##5##3##(1993-9#1)(1995-2#1)(1996-8#1)(2005-3#1)(2006-12#1)
this compound to##3##3##(1993-1#1)(2005-12#1)(2013-1#1)
this compound was##8##3##(1991-6#1)(1991-8#1)(1997-1#1)(2004-2#1)(2006-8#1)(2008-10#2)(2012-2#1)
this compound##100##2##(1990-11#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#3)(1992-11#2)(1992-7#1)(1993-1#1)(1993-11#1)(1993-2#3)(1993-3#1)(1993-4#3)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-7#2)(1996-12#1)(1996-2#3)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#2)(1997-5#1)(1997-7#2)(2004-2#1)(2005-12#1)(2005-3#1)(2005-7#1)(2005-8#3)(2006-12#4)(2006-8#1)(2007-11#3)(2007-8#1)(2008-10#14)(2008-3#2)(2008-5#2)(2009-6#1)(2009-8#2)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#3)(2013-1#1)
this comprehensive review##3##3##(2008-8#1)(2010-2#1)(2010-8#1)
this comprehensive##8##2##(1992-3#1)(1995-1#1)(2008-3#1)(2008-8#1)(2010-2#1)(2010-8#2)(2013-1#1)
this concentration of##3##3##(1992-8#1)(1993-3#1)(2008-10#1)
this concentration range##4##3##(1992-3#1)(1994-12#1)(2008-10#2)
this concentration##18##2##(1992-12#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-3#1)(1993-7#1)(1994-12#1)(2008-10#7)(2008-5#1)(2008-6#1)(2008-8#1)(2011-1#1)
this concept and##2##3##(2010-12#1)(2012-2#1)
this concept has##2##3##(1992-1#1)(1992-12#1)
this concept in a##2##4##(1993-9#1)(1995-2#1)
this concept in##5##3##(1993-9#1)(1995-2#1)(2008-11#1)(2009-5#1)(2011-1#1)
this concept is##7##3##(1992-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-8#1)
this concept##41##2##(1992-1#1)(1992-12#2)(1993-4#1)(1993-9#1)(1995-12#1)(1995-2#1)(2004-4#1)(2005-6#1)(2006-10#4)(2006-5#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#2)
this conceptual##5##2##(2006-3#1)(2007-5#1)(2008-11#1)(2008-7#1)(2013-1#1)
this concern##5##2##(1993-3#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#1)
this conclusion is##2##3##(1994-12#1)(2012-3#1)
this conclusion##10##2##(1990-3#1)(1991-11#1)(1991-2#1)(1994-12#1)(1994-7#1)(1996-5#1)(1996-6#1)(2007-9#1)(2008-9#1)(2012-3#1)
this condition and##10##3##(1991-6#1)(2006-9#1)(2008-3#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#2)(2013-1#1)(2013-8#1)
this condition are##2##3##(1993-1#1)(2013-8#1)
this condition can be##2##4##(2007-9#1)(2008-10#1)
this condition can##3##3##(2007-9#1)(2008-10#1)(2008-11#1)
this condition from##2##3##(2008-11#1)(2011-1#1)
this condition has##2##3##(1997-1#1)(2012-1#1)
this condition have been##2##4##(2007-11#1)(2007-7#1)
this condition in a##4##4##(2006-10#1)(2006-2#1)(2007-7#2)
this condition in their##2##4##(2006-10#1)(2008-1#1)
this condition in##13##3##(1996-11#1)(2006-10#2)(2006-2#1)(2006-4#1)(2007-7#2)(2008-1#1)(2008-5#1)(2008-6#1)(2010-11#1)(2012-12#1)(2013-1#1)
this condition is##27##3##(2005-9#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-4#1)(2009-11#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-12#4)(2012-2#2)(2013-1#2)(2013-8#2)
this condition may be##2##4##(2012-2#1)(2013-1#1)
this condition may##4##3##(2008-10#1)(2010-12#1)(2012-2#1)(2013-1#1)
this condition should be##3##4##(2008-10#1)(2008-11#1)(2008-4#1)
this condition should not##2##4##(2006-10#1)(2008-12#1)
this condition should##5##3##(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)
this condition will##2##3##(2007-11#1)(2013-1#1)
this condition##217##2##(1990-11#1)(1990-12#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-7#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-9#2)(1997-1#3)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-10#1)(2004-11#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#10)(2006-11#1)(2006-12#2)(2006-2#4)(2006-4#1)(2006-5#3)(2006-8#2)(2006-9#5)(2007-10#2)(2007-11#9)(2007-12#1)(2007-6#2)(2007-7#5)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#8)(2008-11#7)(2008-12#6)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#2)(2010-5#4)(2010-7#1)(2011-1#6)(2011-2#8)(2012-1#3)(2012-12#8)(2012-2#6)(2012-3#2)(2013-1#12)(2013-8#8)
this conditions##2##2##(1990-3#1)(1996-5#1)
this conductance are##2##3##(1990-7#1)(1996-2#1)
this conductance##3##2##(1990-7#1)(1995-2#1)(1996-2#1)
this conference was##3##3##(2005-8#2)(2011-1#1)
this conference##8##2##(1997-8#1)(2005-6#1)(2005-8#2)(2008-5#1)(2009-5#1)(2010-4#1)(2011-1#1)
this configuration by##2##3##(1995-3#1)(2007-12#1)
this configuration is##3##3##(2008-2#1)(2008-3#1)(2013-8#1)
this configuration##20##2##(1995-11#1)(1995-3#1)(2007-11#2)(2007-12#6)(2008-2#3)(2008-3#5)(2013-1#1)(2013-8#1)
this confirmed##2##2##(2006-5#1)(2011-2#1)
this confirms##2##2##(1991-3#1)(2006-10#1)
this conflict is##2##3##(1995-5#1)(2008-8#1)
this conflict##4##2##(1995-5#1)(2008-8#3)
this conformational change##2##3##(1990-2#1)(1994-11#1)
this conformational##5##2##(1990-12#1)(1990-2#1)(1992-7#1)(1994-11#1)(2012-3#1)
this congenital##3##2##(1996-9#1)(2008-7#1)(2008-9#1)
this congress##3##2##(2005-8#1)(2008-5#2)
this conjugate##2##2##(1996-1#1)(2005-7#1)
this connection##10##2##(1990-8#1)(1991-8#1)(1992-2#1)(1993-5#1)(1996-8#1)(2006-2#3)(2012-1#1)(2012-3#1)
this consensus##6##2##(1992-1#1)(2007-12#1)(2008-8#1)(2009-10#1)(2009-6#1)(2013-1#1)
this conserved sequence##3##3##(1992-3#1)(1994-8#1)(1997-1#1)
this conserved##8##2##(1992-3#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-2#1)(1997-1#1)(2008-4#1)(2012-12#1)
this constant##3##2##(1991-7#1)(1994-5#1)(2012-3#1)
this constraint##4##2##(1997-2#1)(2006-3#1)(2012-1#1)(2012-2#1)
this construct##12##2##(1991-7#1)(1995-2#2)(1995-3#1)(1997-8#1)(2007-12#2)(2010-6#2)(2012-1#1)(2012-2#1)(2013-1#1)
this contact##2##2##(2007-1#1)(2009-4#1)
this contamination##2##2##(2006-8#1)(2008-10#1)
this content##6##2##(1996-1#1)(1997-2#1)(2008-12#1)(2008-2#1)(2013-1#2)
this context of##2##3##(1995-12#1)(2013-1#1)
this context that the##2##4##(1993-12#1)(2009-10#1)
this context##119##2##(1990-12#1)(1993-10#1)(1993-12#1)(1993-5#1)(1994-11#1)(1994-3#1)(1994-6#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-5#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#2)(2007-10#3)(2007-11#1)(2007-12#2)(2007-5#3)(2007-8#3)(2008-1#3)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#4)(2008-5#3)(2008-7#4)(2008-8#1)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#6)(2010-12#3)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#6)(2012-12#6)(2012-2#6)(2012-3#2)(2012-7#1)(2013-1#8)(2013-7#1)(2013-8#1)
this continuing##9##2##(2006-10#8)(2008-7#1)
this continuum##3##2##(1991-12#1)(2010-8#1)(2011-2#1)
this contrast##3##2##(2008-6#1)(2011-1#1)(2013-1#1)
this contributes to##4##3##(1994-11#1)(1996-2#1)(2007-7#1)(2009-3#1)
this contribution##17##2##(2006-10#1)(2006-6#1)(2006-7#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2010-2#1)(2010-8#1)(2011-2#2)
this control##6##2##(1990-6#1)(1994-5#2)(1996-11#1)(2007-8#1)(2008-11#1)
this controversial##4##2##(2007-10#1)(2008-5#1)(2009-12#1)(2013-1#1)
this controversy and##4##3##(1991-5#1)(1996-8#1)(2007-4#1)(2008-1#1)
this controversy##10##2##(1991-5#1)(1995-5#1)(1996-8#2)(2007-4#1)(2008-1#1)(2008-8#1)(2008-9#1)(2009-12#1)(2012-1#1)
this conventional##3##2##(2006-2#1)(2007-9#1)(2008-2#1)
this conversion##7##2##(1992-8#1)(2005-10#2)(2005-12#1)(2007-11#1)(2009-12#1)(2010-9#1)
this core##7##2##(1991-7#1)(2006-12#2)(2008-10#2)(2008-2#1)(2012-2#1)
this correction##2##2##(2006-10#1)(2011-2#1)
this correlates with##2##3##(1995-12#1)(2010-8#1)
this correlation between##2##3##(1990-8#1)(2008-12#1)
this correlation is##3##3##(1992-6#1)(1995-6#1)(2010-5#1)
this correlation was##3##3##(1990-10#1)(1997-5#1)(2009-12#1)
this correlation##19##2##(1990-10#1)(1990-8#1)(1991-6#1)(1992-6#1)(1995-6#1)(1997-5#1)(2006-12#1)(2007-9#1)(2008-10#2)(2008-12#2)(2008-3#2)(2008-5#1)(2009-12#1)(2010-5#2)(2013-8#1)
this corresponded to##2##3##(2008-10#2)
this corresponds to a##2##4##(1991-9#1)(1996-3#1)
this cortical##2##2##(1997-7#1)(2008-11#1)
this cost##4##2##(1991-1#1)(1991-12#1)(1994-2#1)(2008-9#1)
this could be a##2##4##(1993-1#1)(2013-1#1)
this could be considered##2##4##(2005-8#1)(2012-12#1)
this could be##19##3##(1993-1#1)(1993-7#1)(1994-11#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-2#1)(2004-9#1)(2005-8#2)(2006-10#1)(2006-3#1)(2009-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)
this could contribute to##2##4##(1995-1#1)(2009-5#1)
this could have##2##3##(2006-10#1)(2008-7#1)
this could not be##2##4##(1990-12#1)(2010-8#1)
this could reflect the##2##4##(1992-4#1)(2005-8#1)
this could##33##2##(1990-12#1)(1992-4#1)(1993-1#1)(1993-7#1)(1994-1#1)(1994-11#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-2#1)(2004-9#1)(2005-8#3)(2006-10#2)(2006-3#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
this country has##2##3##(1995-12#1)(2007-9#1)
this country##46##2##(1990-3#1)(1991-1#1)(1991-8#1)(1992-12#1)(1992-5#1)(1993-3#2)(1994-12#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-5#2)(1996-11#1)(1996-3#1)(1996-7#1)(1997-8#2)(2004-11#1)(2007-12#3)(2007-3#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-8#4)(2009-12#1)(2009-2#1)(2010-10#1)(2010-6#1)(2012-12#1)(2012-3#1)
this country's##2##2##(1993-12#1)(2005-7#1)
this coupling is##2##3##(1995-12#1)(2005-11#1)
this coupling##5##2##(1991-7#1)(1995-12#1)(2005-11#1)(2007-11#1)(2008-10#1)
this course##3##2##(2008-1#1)(2008-11#1)(2008-9#1)
this crisis##2##2##(2008-10#1)(2009-5#1)
this criterion##6##2##(1991-6#1)(1995-2#1)(2008-3#1)(2008-5#1)(2010-4#1)(2011-2#1)
this critical period##2##3##(2007-11#1)(2008-10#1)
this critical##21##2##(1994-11#1)(2004-9#2)(2005-11#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#1)(2012-11#2)
this crop##5##2##(2008-10#2)(2010-10#2)(2012-11#1)
this cross##9##2##(1994-12#1)(2007-12#1)(2008-10#4)(2008-4#1)(2009-11#1)(2013-8#1)
this cross-section##2##2##(1993-9#1)(2008-9#1)
this cross-sectional study was##4##4##(2007-2#1)(2008-10#1)(2010-2#1)(2012-12#1)
this cross-sectional study##16##3##(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
this cross-sectional##22##2##(2005-10#1)(2006-7#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#2)(2010-2#1)(2010-4#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)
this cross-talk##3##2##(2008-9#1)(2009-6#1)(2010-7#1)
this crucial##3##2##(1995-6#1)(2008-10#1)(2009-4#1)
this crystal are##2##3##(2007-12#1)(2008-2#1)
this crystal##6##2##(1991-5#2)(1991-7#1)(2007-12#1)(2008-2#1)(2009-2#1)
this culture system##2##3##(2006-3#1)(2009-4#1)
this culture##4##2##(1995-1#1)(2006-3#1)(2008-12#1)(2009-4#1)
this current##11##2##(1991-9#1)(1996-2#1)(1996-7#1)(1997-8#1)(2004-9#1)(2006-8#1)(2008-10#1)(2008-12#1)(2010-3#1)(2012-12#1)(2013-1#1)
this curriculum##2##2##(2004-3#1)(2008-11#1)
this cycle##7##2##(1996-2#1)(2006-2#1)(2008-3#1)(2008-9#2)(2012-1#1)(2013-1#1)
this cysteine##3##2##(1992-3#1)(1992-8#1)(1994-9#1)
this cytochrome##3##2##(1990-11#1)(1994-3#1)(2010-2#1)
this cytokine may##2##3##(1994-9#1)(2006-10#1)
this cytokine##22##2##(1992-11#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-6#1)(1994-10#1)(1994-2#1)(1994-9#1)(1995-2#2)(1996-10#2)(1996-4#1)(1996-7#1)(2006-10#1)(2006-2#1)(2006-3#1)(2008-10#1)(2008-4#1)(2009-9#1)(2010-12#1)
this cytotoxic##2##2##(1991-9#1)(1996-12#1)
this damage##6##2##(1993-2#1)(1993-4#1)(2008-5#1)(2009-3#1)(2010-2#1)(2011-2#1)
this dangerous##4##2##(1994-3#1)(1995-5#1)(2006-12#1)(2007-10#1)
this data and##3##3##(1997-4#1)(2007-2#1)(2012-1#1)
this data is##5##3##(1992-12#1)(1997-1#1)(2008-10#1)(2008-7#1)(2010-5#1)
this data set is##2##4##(2007-4#1)(2012-3#1)
this data set##4##3##(2007-4#1)(2012-3#3)
this data was##3##3##(1996-1#1)(2007-4#1)(2007-8#1)
this data##48##2##(1991-12#1)(1991-2#1)(1991-4#1)(1992-12#1)(1993-2#1)(1996-1#1)(1996-10#1)(1997-1#1)(1997-4#1)(2006-1#1)(2007-2#1)(2007-4#3)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-4#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#4)(2013-1#6)
this database##12##2##(1990-3#1)(1994-8#1)(1995-6#1)(1996-3#1)(2007-6#1)(2008-10#1)(2010-2#1)(2010-5#2)(2011-1#1)(2012-11#1)(2013-8#1)
this date##2##2##(1990-6#1)(2008-10#1)
this day##4##2##(1991-1#1)(2006-9#1)(2010-12#1)(2010-8#1)
this deadly disease##2##3##(2006-10#1)(2012-2#1)
this debate##6##2##(1993-3#1)(2006-10#1)(2007-8#1)(2008-7#1)(2010-11#1)(2012-2#1)
this debilitating disease##3##3##(2006-1#1)(2008-9#1)(2009-3#1)
this debilitating##6##2##(2006-1#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-11#1)
this debt##2##2##(1994-2#2)
this decade##6##2##(1990-1#1)(1996-1#1)(2005-7#1)(2007-8#1)(2008-5#1)(2009-3#1)
this decapeptide sequence##2##3##(1992-11#2)
this decapeptide##3##2##(1992-11#2)(1995-8#1)
this decision##10##2##(1991-12#1)(1992-2#1)(1993-3#1)(1994-3#1)(1997-1#1)(2005-8#1)(2008-1#1)(2008-12#1)(2008-6#1)(2011-12#1)
this decline in##2##3##(1995-12#1)(2013-1#1)
this decline was##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
this decline##13##2##(1990-5#1)(1995-12#1)(2004-11#1)(2008-10#1)(2008-11#2)(2008-7#2)(2008-9#1)(2011-2#3)(2013-1#1)
this decrease in##5##3##(1993-3#1)(2005-12#1)(2008-10#1)(2009-6#1)(2010-4#1)
this decrease is##5##3##(1995-3#1)(1997-5#1)(2005-12#1)(2007-6#1)(2007-9#1)
this decrease was##6##3##(1992-12#1)(1993-4#1)(1993-9#1)(1995-5#2)(1996-6#1)
this decrease##24##2##(1992-12#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-5#1)(1995-3#1)(1995-5#2)(1996-6#1)(1997-2#1)(1997-5#2)(2004-12#1)(2005-12#2)(2006-9#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-6#1)(2010-4#1)
this defect##9##2##(1990-2#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-4#1)(1997-7#1)(2007-9#1)(2008-1#2)
this defence##2##2##(1994-8#1)(2005-11#1)
this defense##3##2##(2004-2#1)(2007-12#1)(2010-3#1)
this deficiency##6##2##(1990-4#1)(2007-4#1)(2007-8#1)(2009-1#1)(2012-12#1)(2013-8#1)
this deficit in##2##3##(2006-3#1)(2012-11#1)
this deficit##7##2##(1994-3#2)(2006-3#1)(2008-9#2)(2012-11#1)(2013-1#1)
this definition##5##2##(1993-1#1)(1996-6#1)(2008-3#2)(2013-1#1)
this deformation##2##2##(2005-10#1)(2007-9#1)
this deformity##3##2##(1990-9#1)(2006-3#1)(2007-11#1)
this degenerative##2##2##(2007-11#1)(2013-1#1)
this degradation##4##2##(1995-1#1)(2006-12#1)(2008-10#2)
this degree of##3##3##(1993-5#1)(2006-10#1)(2008-5#1)
this degree##4##2##(1993-5#1)(2006-10#1)(2008-5#1)(2013-8#1)
this deletion##5##2##(1991-10#2)(1991-9#1)(1993-12#1)(2012-12#1)
this dementia##2##2##(2008-9#2)
this demonstrates##3##2##(1995-8#1)(2007-8#1)(2008-1#1)
this demonstration##3##2##(2007-11#1)(2008-1#1)(2008-3#1)
this density##3##2##(1992-1#1)(1995-10#1)(2008-10#1)
this department##4##2##(1990-12#1)(1991-12#1)(2007-12#1)(2010-3#1)
this dependence##8##2##(1990-3#1)(2007-11#1)(2008-2#2)(2008-3#3)(2009-8#1)
this derivative##6##2##(1992-9#1)(1993-4#1)(1994-8#1)(1997-2#1)(2007-12#1)(2008-10#1)
this description##3##2##(2006-7#1)(2007-4#1)(2008-2#1)
this descriptive study##5##3##(2007-2#1)(2008-6#1)(2012-12#1)(2013-1#2)
this descriptive##9##2##(2006-9#1)(2007-2#2)(2008-6#1)(2010-4#1)(2010-5#1)(2012-12#1)(2013-1#2)
this desensitization##2##2##(1992-3#2)
this design##23##2##(1992-9#1)(1993-9#1)(1994-2#1)(2006-11#1)(2007-12#2)(2008-10#1)(2008-2#5)(2008-3#4)(2009-10#2)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2013-1#1)
this detection scheme##2##3##(2006-11#1)(2008-10#1)
this detection system##2##3##(2008-10#2)
this detection##7##2##(1995-8#1)(2006-11#1)(2008-10#5)
this detector##5##2##(2008-10#3)(2008-3#1)(2008-9#1)
this detergent##3##2##(1992-3#1)(1992-6#1)(2012-2#1)
this determinant##2##2##(1991-9#1)(1995-2#1)
this determination##5##2##(1990-7#1)(1991-11#1)(2008-10#3)
this devastating disease process##2##4##(2008-11#2)
this devastating disease##5##3##(2008-10#1)(2008-11#2)(2008-7#1)(2009-9#1)
this devastating illness##2##3##(2008-7#1)(2009-8#1)
this devastating##10##2##(2006-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#2)(2009-8#1)(2009-9#1)(2010-3#1)
this developed##2##2##(2010-3#1)(2013-7#1)
this development has##2##3##(2006-11#1)(2008-3#1)
this development is##3##3##(1992-5#1)(2008-10#1)(2008-7#1)
this development process##2##3##(1994-11#1)(2010-2#1)
this development##13##2##(1992-5#1)(1994-11#1)(2006-11#1)(2006-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-2#1)(2012-1#1)(2012-12#1)
this developmental##5##2##(1991-9#1)(1996-3#2)(2009-8#1)(2011-2#1)
this device and##2##3##(2008-2#1)(2013-8#1)
this device can##4##3##(1996-9#1)(2007-12#1)(2008-10#1)(2012-11#1)
this device has##3##3##(2008-11#1)(2008-2#1)(2008-8#1)
this device in##5##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)
this device is##4##3##(1994-6#1)(2007-12#2)(2008-1#1)
this device to##3##3##(2008-2#1)(2009-2#1)(2012-1#1)
this device##46##2##(1994-6#1)(1996-9#1)(2005-11#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#7)(2008-3#7)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-1#3)(2012-11#1)(2013-8#1)
this diagnosis earlier##2##3##(1997-8#1)(2010-10#1)
this diagnosis in##5##3##(1992-4#1)(1993-8#1)(1997-8#1)(2007-3#1)(2008-8#1)
this diagnosis to##2##3##(2008-9#1)(2013-1#1)
this diagnosis was##2##3##(1990-9#1)(2006-12#1)
this diagnosis##36##2##(1990-12#1)(1990-9#1)(1991-12#1)(1991-9#2)(1992-11#1)(1992-4#1)(1993-10#2)(1993-8#1)(1997-6#1)(1997-8#2)(2006-10#1)(2006-12#1)(2006-4#1)(2006-7#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#6)
this diagnostic procedure##2##3##(1993-10#1)(2008-1#1)
this diagnostic##9##2##(1990-6#1)(1990-9#1)(1993-10#2)(2006-4#1)(2006-7#1)(2008-1#1)(2011-1#1)(2012-3#1)
this dichotomy##3##2##(1991-11#1)(2008-8#1)(2009-8#1)
this did not appear to##2##5##(2008-11#1)(2008-9#1)
this did not reach statistical significance##4##6##(1995-6#1)(2007-9#1)(2008-6#1)(2008-7#1)
this did not##18##3##(1990-10#1)(1995-6#1)(1996-12#1)(2004-10#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)
this diet##6##2##(1991-2#1)(1995-3#1)(2007-5#1)(2008-2#1)(2008-3#1)(2013-1#1)
this difference can##2##3##(1992-11#1)(2012-3#1)
this difference disappeared##3##3##(2005-12#1)(2007-5#1)(2013-1#1)
this difference in##5##3##(1994-3#1)(1994-6#1)(2008-10#1)(2008-3#1)(2009-12#1)
this difference is due to##2##5##(1991-7#1)(2008-8#1)
this difference is##10##3##(1991-7#1)(1993-4#1)(1994-11#1)(1996-7#1)(2006-8#1)(2008-2#1)(2008-8#1)(2009-5#1)(2010-3#1)(2011-2#1)
this difference to##2##3##(2007-12#1)(2008-10#1)
this difference was not significant##5##5##(1990-6#1)(2006-2#1)(2008-10#1)(2010-9#1)(2012-12#1)
this difference was not statistically significant (P&gt##2##7##(2009-3#2)
this difference was not statistically significant##7##6##(1991-6#1)(1992-12#1)(2006-12#1)(2009-3#2)(2010-2#2)
this difference was not##15##4##(1990-6#1)(1991-6#1)(1992-12#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-5#1)(2008-10#1)(2009-3#2)(2010-12#1)(2010-2#2)(2010-9#1)(2012-12#1)
this difference was significant##2##4##(2009-3#2)
this difference was statistically significant##2##5##(2008-8#1)(2009-3#1)
this difference was statistically##3##4##(2008-8#2)(2009-3#1)
this difference was##24##3##(1990-6#1)(1991-6#1)(1992-12#1)(1993-2#1)(1995-3#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-5#1)(2008-10#1)(2008-8#3)(2009-3#5)(2010-12#1)(2010-2#2)(2010-9#1)(2012-12#1)(2012-2#1)
this difference##64##2##(1990-6#1)(1991-11#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-3#1)(1993-2#1)(1993-4#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-6#1)(1996-7#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-8#1)(2007-12#2)(2007-5#2)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#5)(2009-12#1)(2009-3#5)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
this differential##7##2##(1992-10#1)(1994-10#1)(1994-2#1)(1997-7#1)(2008-3#1)(2008-4#1)(2012-8#1)
this differentiation##2##2##(1992-3#1)(1995-9#1)
this difficult##8##2##(1990-8#1)(1997-5#1)(2004-3#1)(2006-10#1)(2007-11#1)(2008-4#1)(2008-5#1)(2008-8#1)
this difficulty##8##2##(2007-11#1)(2009-11#1)(2009-3#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#2)
this direct##5##2##(1990-10#1)(1994-9#1)(1995-1#2)(2007-11#1)
this direction##13##2##(1993-7#1)(1997-6#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-3#2)(2009-4#1)(2010-3#1)(2012-2#3)(2012-3#1)
this disabling and##2##3##(2008-2#1)(2011-2#1)
this disabling##3##2##(2006-10#1)(2008-2#1)(2011-2#1)
this disaster on##3##3##(2008-2#3)
this disaster##5##2##(2008-2#5)
this disc##2##2##(2008-3#1)(2013-1#1)
this discharge##2##2##(2007-12#1)(2008-10#1)
this discipline in##2##3##(1991-6#1)(2007-8#1)
this discipline##6##2##(1991-6#1)(1994-12#1)(2007-8#1)(2008-2#2)(2013-8#1)
this discordance is##2##3##(1995-8#1)(2010-12#1)
this discordance##4##2##(1995-8#1)(2010-12#1)(2012-3#2)
this discovery##2##2##(1990-5#1)(1992-5#1)
this discrepancy are##2##3##(2005-11#1)(2006-8#1)
this discrepancy##9##2##(1991-10#1)(1993-3#1)(1994-3#1)(1995-11#1)(1996-5#1)(2005-11#1)(2006-8#1)(2012-2#1)(2013-1#1)
this discrimination##2##2##(1994-4#1)(2010-4#1)
this discussion##16##2##(1992-2#1)(1994-2#1)(1994-3#1)(1996-12#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-7#1)
this disease also##3##3##(2005-8#1)(2010-4#1)(2013-1#1)
this disease and can be##2##5##(2008-10#1)(2013-7#1)
this disease and##19##3##(1993-3#1)(1996-6#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2009-8#1)(2010-12#1)(2010-5#1)(2012-3#1)(2013-7#1)(2013-8#1)
this disease are##13##3##(1990-12#1)(1990-6#1)(1992-2#1)(1992-6#1)(1993-8#1)(1997-8#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2012-1#1)
this disease but##2##3##(2004-8#1)(2012-2#1)
this disease by##4##3##(1995-3#1)(2006-10#1)(2007-8#1)(2011-2#1)
this disease entity##3##3##(1991-2#1)(2006-10#1)(2009-7#1)
this disease from##2##3##(2005-10#1)(2007-10#1)
this disease has been##5##4##(2005-8#1)(2007-2#1)(2008-1#1)(2008-5#1)(2012-11#1)
this disease has##11##3##(1991-9#1)(1996-6#1)(2005-8#1)(2007-2#1)(2008-1#1)(2008-5#1)(2009-6#1)(2010-11#1)(2010-5#1)(2010-6#1)(2012-11#1)
this disease in the##7##4##(2006-10#2)(2007-3#1)(2007-8#2)(2008-10#1)(2010-7#1)
this disease in##13##3##(1994-7#1)(2005-11#1)(2006-10#2)(2006-8#1)(2007-3#1)(2007-8#3)(2008-10#1)(2010-7#1)(2012-3#1)(2013-8#1)
this disease is##20##3##(1991-6#1)(1991-9#1)(1994-4#1)(1994-6#1)(1994-8#1)(1996-6#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-8#1)(2007-11#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-2#1)(2011-3#1)(2013-8#1)
this disease may##4##3##(1993-11#1)(1996-12#1)(2007-2#1)(2010-6#1)
this disease model##2##3##(2007-11#1)(2008-7#1)
this disease process##7##3##(1995-9#1)(1996-9#2)(2005-11#1)(2006-2#1)(2008-7#1)(2013-1#1)
this disease remains##2##3##(1995-5#1)(2010-2#1)
this disease still##2##3##(1995-1#1)(2011-2#1)
this disease to##3##3##(2006-11#1)(2008-10#1)(2010-6#1)
this disease was##5##3##(2005-8#1)(2008-10#3)(2010-12#1)
this disease with##3##3##(1996-3#1)(2009-3#1)(2011-1#1)
this disease##325##2##(1990-12#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-2#2)(1992-5#1)(1992-6#1)(1993-11#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-3#2)(1995-5#1)(1995-8#1)(1995-9#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-6#4)(1996-9#2)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#4)(2004-11#1)(2004-12#1)(2004-8#1)(2005-1#1)(2005-10#4)(2005-11#3)(2005-8#7)(2006-10#15)(2006-11#4)(2006-12#2)(2006-2#4)(2006-4#1)(2006-5#1)(2006-8#3)(2006-9#1)(2007-10#2)(2007-11#8)(2007-12#1)(2007-2#4)(2007-3#4)(2007-5#2)(2007-6#2)(2007-7#6)(2007-8#8)(2007-9#1)(2008-1#8)(2008-10#35)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#9)(2008-6#6)(2008-7#9)(2008-8#5)(2009-10#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#6)(2009-6#2)(2009-7#3)(2009-8#5)(2010-11#1)(2010-12#8)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#5)(2010-6#3)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#9)(2011-3#1)(2011-7#1)(2012-1#2)(2012-11#2)(2012-12#6)(2012-2#6)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#5)
this disinfecting treatment leads to the formation of halogenated by-products##2##10##(2008-10#2)
this disorder and##3##3##(2006-10#1)(2007-11#1)(2008-7#1)
this disorder are##3##3##(1997-2#1)(1997-3#1)(2008-7#1)
this disorder has been##2##4##(2006-8#1)(2007-6#1)
this disorder has##4##3##(2006-8#1)(2007-6#1)(2007-7#1)(2011-1#1)
this disorder in children##2##4##(2006-10#1)(2007-7#1)
this disorder in##6##3##(2006-10#1)(2007-7#1)(2010-11#1)(2010-12#2)(2011-2#1)
this disorder is##12##3##(2006-4#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-9#1)(2011-2#2)(2012-1#1)
this disorder should##2##3##(2006-10#1)(2011-2#1)
this disorder##99##2##(1990-3#1)(1991-12#1)(1992-3#1)(1992-5#1)(1993-11#2)(1993-5#1)(1994-5#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(2004-10#1)(2005-11#1)(2006-10#4)(2006-12#2)(2006-4#3)(2006-5#1)(2006-8#3)(2006-9#2)(2007-10#1)(2007-11#2)(2007-4#1)(2007-6#1)(2007-7#3)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#3)(2008-7#7)(2008-8#3)(2009-10#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-9#3)(2010-11#2)(2010-12#3)(2011-1#1)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
this disparity##2##2##(2007-9#1)(2010-5#1)
this display##2##2##(1996-7#1)(2008-2#1)
this disruption##3##2##(1992-10#1)(1996-8#1)(2007-1#1)
this dissemination##2##2##(1991-12#1)(2012-12#1)
this dissociation##5##2##(1994-3#1)(1994-8#1)(1995-8#1)(2004-9#1)(2008-4#1)
this distance##5##2##(1996-6#1)(2007-10#1)(2007-12#1)(2007-4#1)(2013-1#1)
this distinction and##2##3##(2008-3#1)(2010-2#1)
this distinction is##2##3##(2008-11#1)(2009-8#1)
this distinction##10##2##(1997-8#1)(2006-12#1)(2008-1#1)(2008-11#3)(2008-3#2)(2009-8#1)(2010-2#1)
this distribution##11##2##(1997-4#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-10#1)(2012-3#1)
this disturbance##2##2##(2008-12#1)(2008-5#1)
this divalent cation##2##3##(1990-2#1)(2009-8#1)
this diverse##4##2##(2006-10#1)(2008-10#1)(2009-5#1)(2013-8#1)
this diversity##4##2##(1992-2#1)(2008-7#1)(2013-1#2)
this document is##5##3##(2008-3#1)(2008-7#1)(2009-6#1)(2010-5#1)(2012-3#1)
this document##9##2##(1993-11#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-6#1)(2010-5#2)(2012-3#1)
this does not necessarily##2##4##(1992-5#1)(1995-6#1)
this does not seem to be##2##6##(1997-8#1)(2007-9#1)
this does not seem to##3##5##(1990-8#1)(1997-8#1)(2007-9#1)
this does not##11##3##(1990-8#1)(1992-5#1)(1994-8#1)(1995-6#1)(1996-8#1)(1997-8#1)(2007-2#1)(2007-9#1)(2008-2#1)(2008-5#1)(2011-2#1)
this dogma##3##2##(2006-10#1)(2007-5#1)(2008-12#1)
this domain of##2##3##(1991-6#1)(2008-2#1)
this domain##30##2##(1990-11#1)(1991-10#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-3#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-5#2)(1997-4#1)(1997-5#1)(2006-10#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-1#1)(2013-1#1)
this donor site##2##3##(2008-7#1)(2011-2#1)
this dosage##2##2##(1992-4#1)(2007-11#1)
this dose of##3##3##(1992-3#1)(1994-8#1)(1995-3#1)
this dose##20##2##(1990-6#1)(1992-12#1)(1992-3#1)(1993-9#1)(1994-8#1)(1995-3#1)(1996-1#1)(1997-8#1)(2005-7#1)(2006-10#1)(2008-4#1)(2008-6#2)(2008-7#1)(2009-6#1)(2010-2#1)(2010-8#1)(2010-9#1)(2013-1#2)
this double##3##2##(2008-10#1)(2010-7#1)(2012-2#1)
this downward##2##2##(2008-10#1)(2012-12#1)
this dramatic##2##2##(1997-2#1)(2008-10#1)
this drawback can be##2##4##(2008-2#1)(2008-3#1)
this drawback##8##2##(1997-7#1)(2008-10#2)(2008-2#2)(2008-3#1)(2009-10#1)(2013-7#1)
this drop##2##2##(1990-5#1)(1992-8#1)
this drug and##2##3##(1995-7#1)(2010-12#1)
this drug has been##2##4##(2005-7#1)(2013-1#1)
this drug has##5##3##(1990-10#1)(1997-5#1)(2005-7#1)(2013-1#1)(2013-8#1)
this drug in patients with##2##5##(2007-11#1)(2008-1#1)
this drug in patients##3##4##(2007-11#1)(2008-1#1)(2008-10#1)
this drug in the##5##4##(1991-12#1)(2006-4#1)(2007-7#1)(2008-6#1)(2011-1#1)
this drug in##20##3##(1991-12#1)(1996-4#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#2)(2010-12#2)(2011-1#1)(2011-2#1)(2013-7#1)
this drug is useful in the##2##6##(2005-7#1)(2007-11#1)
this drug is##9##3##(1995-1#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-5#1)(2010-2#1)(2012-12#2)
this drug was##3##3##(1991-7#1)(2008-5#1)(2012-3#1)
this drug##82##2##(1990-10#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-7#1)(1993-12#1)(1993-4#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#2)(1996-9#1)(1997-2#3)(1997-4#1)(1997-5#1)(2005-7#5)(2005-9#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-3#1)(2007-7#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-5#4)(2008-6#2)(2008-8#2)(2008-9#1)(2009-12#1)(2010-12#6)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
this dsRNA##5##2##(2008-10#5)
this dual-image mode for gated##2##5##(2008-3#2)
this dummy##3##2##(2007-4#3)
this during##3##2##(2007-8#1)(2007-9#1)(2012-2#1)
this dye##4##2##(1992-8#1)(1994-12#1)(2008-9#1)(2013-1#1)
this dynamic##3##2##(2008-5#1)(2008-8#1)(2009-12#1)
this dysfunction##2##2##(2007-8#1)(2011-2#1)
this earlier##2##2##(2008-2#1)(2008-8#1)
this early stage##3##3##(1991-2#1)(1993-4#1)(2008-5#1)
this early##9##2##(1990-5#1)(1991-2#1)(1993-4#1)(2005-8#1)(2008-5#1)(2009-2#1)(2011-12#1)(2012-12#1)(2012-2#1)
this easily##3##2##(1990-6#1)(2007-3#1)(2007-4#1)
this ecological##2##2##(2006-12#1)(2008-10#1)
this ecosystem##5##2##(2008-5#1)(2011-2#2)(2013-8#2)
this edge##2##2##(2008-2#1)(2008-3#1)
this editing##2##2##(1993-9#1)(1995-5#1)
this edition of##2##3##(2006-2#1)(2009-9#1)
this editorial##5##2##(2010-12#3)(2010-5#1)(2011-1#1)
this educational##3##2##(1990-4#1)(2006-7#1)(2008-11#1)
this effect and##4##3##(1996-2#1)(1997-4#1)(2007-12#1)(2008-2#1)
this effect appeared##2##3##(2008-5#1)(2009-8#1)
this effect are##3##3##(2007-12#1)(2010-12#1)(2012-12#1)
this effect at##3##3##(1990-3#1)(2006-9#1)(2008-7#1)
this effect being associated##2##4##(1994-2#1)(2005-11#1)
this effect being more marked##2##5##(1992-1#1)(2005-11#1)
this effect being##5##3##(1992-1#1)(1993-4#1)(1994-2#1)(2005-11#2)
this effect can be##6##4##(1994-9#1)(2007-8#1)(2008-2#1)(2008-3#3)
this effect could be##2##4##(2007-12#1)(2013-8#1)
this effect could##3##3##(1994-8#1)(2007-12#1)(2013-8#1)
this effect does not involve##2##5##(1990-10#1)(1997-4#1)
this effect for##4##3##(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)
this effect has been##2##4##(1994-9#1)(2006-5#1)
this effect has##3##3##(1994-9#1)(1995-8#1)(2006-5#1)
this effect in a##2##4##(2007-12#1)(2013-8#1)
this effect in##7##3##(1990-2#1)(1990-6#1)(1991-1#1)(1993-5#1)(2007-12#1)(2008-9#1)(2013-8#1)
this effect is dependent on##3##5##(1992-8#1)(1997-2#1)(2008-5#1)
this effect is due to##4##5##(1991-9#1)(1995-7#1)(2005-11#1)(2009-10#1)
this effect is mediated by##4##5##(1991-6#1)(1993-3#1)(1993-4#1)(1993-9#1)
this effect is mediated via##2##5##(1993-6#1)(2008-8#1)
this effect is mediated##7##4##(1991-6#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-2#1)(2008-8#1)
this effect is more##2##4##(1993-2#1)(2007-2#1)
this effect is not mediated by##2##6##(1995-10#1)(1997-8#1)
this effect is not##6##4##(1992-9#1)(1995-10#1)(1997-8#1)(2008-10#1)(2008-3#1)(2012-3#1)
this effect is that##2##4##(1997-1#1)(1997-2#1)
this effect is##50##3##(1990-11#1)(1990-2#1)(1990-9#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-2#1)(1995-10#1)(1995-7#2)(1997-1#2)(1997-2#2)(1997-8#1)(2005-11#1)(2006-11#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-8#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2012-3#1)
this effect may be mediated##2##5##(1994-8#1)(2008-5#1)
this effect may be through##2##5##(2010-2#2)
this effect may be##8##4##(1991-9#1)(1994-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-2#2)(2013-1#1)
this effect may##13##3##(1991-9#1)(1994-8#1)(1996-2#1)(1996-9#1)(1997-7#1)(2004-11#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-2#2)(2013-1#1)
this effect might##2##3##(1991-2#1)(2008-7#1)
this effect occurred##2##3##(2008-10#1)(2010-4#1)
this effect of BDM##2##4##(1996-9#2)
this effect of guanosine##2##4##(2008-4#2)
this effect of##17##3##(1990-12#1)(1991-1#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-7#1)(1994-6#1)(1995-12#1)(1996-9#2)(1997-7#1)(1997-8#1)(2008-4#2)(2008-8#1)(2008-9#1)(2011-12#1)
this effect on the##3##4##(1994-2#1)(2007-12#1)(2008-1#1)
this effect on##7##3##(1993-6#1)(1994-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)
this effect relative to##2##4##(1992-12#1)(2010-12#1)
this effect seems to##2##4##(1994-2#1)(2007-8#1)
this effect to##6##3##(1992-8#1)(1993-2#1)(2006-3#1)(2007-12#2)(2008-5#1)
this effect was also##2##4##(1990-5#1)(2013-1#1)
this effect was blocked by##3##5##(1991-3#2)(1991-5#1)
this effect was blocked##4##4##(1991-3#2)(1991-5#1)(2008-9#1)
this effect was due to##3##5##(1993-11#1)(2008-9#1)(2011-2#1)
this effect was not observed in##3##6##(1995-5#1)(2010-10#2)
this effect was not##9##4##(1995-5#1)(1996-6#1)(1997-7#1)(2008-10#1)(2008-12#1)(2009-2#1)(2010-10#2)(2012-2#1)
this effect was reversed##4##4##(1990-5#1)(1995-12#1)(1996-1#1)(2009-11#1)
this effect was stronger##2##4##(2008-10#1)(2012-2#1)
this effect was##55##3##(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-8#1)(1991-12#1)(1991-3#2)(1991-5#1)(1993-11#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-7#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-5#1)(1997-7#1)(2004-12#1)(2007-1#1)(2007-11#2)(2007-2#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-9#3)(2009-11#1)(2009-2#1)(2010-10#2)(2011-2#2)(2012-2#3)(2013-1#1)(2013-8#2)
this effect we##2##3##(1997-4#1)(2008-3#1)
this effect will##2##3##(1997-6#1)(2010-5#1)
this effect##301##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-5#3)(1991-6#1)(1991-9#2)(1992-1#2)(1992-11#3)(1992-12#2)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#4)(1993-12#4)(1993-2#3)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#5)(1994-3#3)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#1)(1995-10#2)(1995-12#5)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#1)(1995-7#3)(1995-8#2)(1996-1#3)(1996-12#1)(1996-2#3)(1996-5#2)(1996-6#1)(1996-9#4)(1997-1#3)(1997-2#3)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#2)(2004-11#1)(2004-12#1)(2005-11#3)(2006-10#1)(2006-11#1)(2006-3#2)(2006-5#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#10)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#20)(2008-11#5)(2008-12#2)(2008-2#13)(2008-3#14)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#8)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#3)(2010-1#1)(2010-10#2)(2010-12#4)(2010-2#2)(2010-4#2)(2010-5#5)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#4)
this effective##4##2##(1995-4#1)(1996-6#1)(2008-3#1)(2008-5#1)
this effort##13##2##(1990-6#1)(1992-1#1)(1995-3#1)(1997-4#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-4#1)(2010-12#1)(2011-2#1)(2013-1#1)
this elderly##3##2##(2006-7#1)(2007-10#1)(2011-1#1)
this electrode and##2##3##(2008-10#2)
this electrode is##3##3##(2008-10#3)
this electrode##21##2##(2007-8#2)(2008-10#19)
this element in the##3##4##(1990-8#1)(1995-1#1)(2008-10#1)
this element in##6##3##(1990-8#1)(1994-6#1)(1995-1#1)(2008-10#3)
this element is##5##3##(1996-3#1)(2008-1#1)(2008-10#2)(2013-1#1)
this element was##2##3##(1990-10#1)(1995-6#1)
this element##27##2##(1990-10#1)(1990-3#1)(1990-8#1)(1992-2#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-3#1)(2008-1#1)(2008-10#13)(2009-9#1)(2010-12#1)(2013-1#1)
this elevation##4##2##(1997-1#1)(2007-7#1)(2008-10#2)
this embryonic##2##2##(2008-11#1)(2013-1#1)
this emergent##2##2##(2010-4#1)(2013-8#1)
this emerging##8##2##(1992-2#1)(2004-11#1)(2007-4#1)(2008-1#1)(2008-10#1)(2010-7#1)(2012-1#1)(2012-2#1)
this empirical study##2##3##(2008-2#1)(2009-7#1)
this empirical##3##2##(2007-2#1)(2008-2#1)(2009-7#1)
this emulsion##2##2##(2008-11#1)(2008-5#1)
this enables##3##2##(2007-2#1)(2008-6#1)(2009-8#1)
this end##90##2##(1991-3#1)(1991-6#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-9#2)(1995-1#2)(1996-2#1)(1996-7#1)(1996-8#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#2)(2007-5#1)(2008-1#2)(2008-10#11)(2008-11#1)(2008-12#3)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#4)(2012-3#3)(2013-1#4)(2013-8#2)
this endeavor##5##2##(1995-1#1)(2008-2#1)(2009-1#1)(2011-1#1)(2012-12#1)
this endogenous##2##2##(1997-5#1)(2007-11#1)
this energy range##2##3##(2007-11#1)(2008-2#1)
this energy##3##2##(1995-12#1)(2007-11#1)(2008-2#1)
this enhanced activity##2##3##(1997-2#1)(2011-1#1)
this enhanced##7##2##(1993-3#1)(1993-7#1)(1995-1#1)(1995-5#1)(1997-2#1)(2007-11#1)(2011-1#1)
this enhancement was##3##3##(1994-9#1)(1996-12#1)(2008-11#1)
this enhancement##10##2##(1990-12#1)(1992-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-7#1)
this enhancer##4##2##(1995-3#1)(1996-11#1)(1996-4#2)
this enormous##3##2##(1997-3#1)(2011-2#1)(2013-8#1)
this entails##2##2##(2005-11#1)(2008-8#1)
this entire##2##2##(2008-3#1)(2012-12#1)
this entity in##3##3##(2007-8#1)(2009-3#1)(2012-3#1)
this entity##35##2##(1990-10#1)(1992-3#1)(1992-6#1)(1993-8#1)(1993-9#1)(1995-11#1)(1996-3#1)(2005-7#1)(2005-8#1)(2006-11#1)(2006-8#2)(2006-9#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#1)(2009-3#2)(2009-5#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
this environment##10##2##(1991-11#1)(1991-7#1)(1993-2#1)(1994-2#1)(2007-8#1)(2008-2#1)(2008-8#2)(2008-9#1)(2009-6#1)
this environmental##4##2##(1993-7#1)(1996-3#1)(2008-10#1)(2009-5#1)
this enzymatic activity##3##3##(1995-12#1)(1995-7#1)(2011-1#1)
this enzymatic##7##2##(1990-11#1)(1990-4#1)(1990-5#1)(1995-12#1)(1995-7#1)(2011-1#2)
this enzyme activity was##2##4##(1990-3#1)(1994-2#1)
this enzyme activity##9##3##(1990-3#1)(1994-2#2)(2008-10#1)(2008-3#1)(2008-6#2)(2008-8#1)(2013-1#1)
this enzyme and the##2##4##(1992-8#1)(2008-10#1)
this enzyme and##8##3##(1990-4#1)(1991-10#1)(1991-12#1)(1992-12#1)(1992-8#1)(2008-10#1)(2008-5#1)(2010-10#1)
this enzyme can##4##3##(1992-12#1)(1995-8#1)(2008-7#1)(2009-8#1)
this enzyme could##3##3##(1992-11#1)(1994-12#1)(1997-8#1)
this enzyme from##3##3##(1992-1#1)(1996-8#1)(1997-7#1)
this enzyme has##3##3##(1992-4#1)(1993-8#1)(1994-11#1)
this enzyme in the presence of##2##6##(1990-7#1)(1997-4#1)
this enzyme in the##6##4##(1990-7#2)(1994-6#1)(1995-8#1)(1997-4#1)(1997-7#1)
this enzyme in##21##3##(1990-7#2)(1991-10#1)(1991-2#1)(1991-5#2)(1993-11#1)(1994-6#1)(1994-8#2)(1995-3#2)(1995-8#1)(1996-10#1)(1996-5#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-5#1)(2009-8#1)(2011-3#1)
this enzyme is a##2##4##(1990-11#1)(2008-1#1)
this enzyme is not##3##4##(1992-10#1)(1995-6#1)(2012-6#1)
this enzyme is##15##3##(1990-11#1)(1991-9#1)(1992-10#1)(1992-9#1)(1994-11#1)(1994-9#1)(1995-6#1)(1996-6#2)(2008-1#1)(2008-4#2)(2008-5#1)(2008-7#1)(2012-6#1)
this enzyme may##3##3##(1994-9#1)(1997-2#1)(1997-4#1)
this enzyme might##2##3##(1990-12#1)(1995-1#1)
this enzyme plays##2##3##(1991-5#1)(1992-6#1)
this enzyme to##6##3##(1990-9#1)(1991-6#1)(1993-5#1)(1994-8#2)(2008-10#1)
this enzyme was found##2##4##(1994-6#1)(2008-7#1)
this enzyme was##17##3##(1990-12#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-6#1)(1994-6#2)(1995-4#1)(1997-7#1)(2004-11#1)(2005-11#1)(2008-6#1)(2008-7#1)
this enzyme were##2##3##(1996-8#1)(2006-6#1)
this enzyme with##2##3##(1990-12#1)(1997-7#1)
this enzyme##184##2##(1990-11#2)(1990-12#6)(1990-3#4)(1990-4#2)(1990-5#3)(1990-7#2)(1990-8#1)(1990-9#3)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#3)(1991-5#7)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#4)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#4)(1992-2#2)(1992-4#1)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#2)(1993-11#2)(1993-4#2)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#4)(1994-12#2)(1994-2#3)(1994-3#3)(1994-5#2)(1994-6#3)(1994-8#7)(1994-9#5)(1995-1#4)(1995-2#1)(1995-3#3)(1995-4#1)(1995-6#2)(1995-8#6)(1996-10#2)(1996-5#1)(1996-6#3)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#4)(1997-7#6)(1997-8#2)(2004-11#2)(2005-11#1)(2006-6#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-2#2)(2011-3#1)(2012-2#1)(2012-6#1)(2013-1#1)
this enzyme's##3##2##(1990-5#1)(1994-3#1)(2004-8#1)
this epidemic##8##2##(1994-7#1)(1997-3#1)(2005-10#1)(2007-7#1)(2008-1#1)(2008-5#1)(2009-4#1)(2011-2#1)
this episode##2##2##(2006-10#1)(2008-3#1)
this epitope##2##2##(1991-7#1)(1994-11#1)
this epoxide##2##2##(1990-6#2)
this equation is##5##3##(2005-11#1)(2007-12#1)(2007-2#1)(2008-2#1)(2008-3#1)
this equation##14##2##(1994-9#1)(1995-2#1)(2005-11#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)
this equilibrium##7##2##(1992-12#1)(1992-9#1)(2005-1#1)(2008-1#1)(2008-5#1)(2009-9#1)(2012-12#1)
this equivalent##2##2##(2007-12#1)(2008-3#1)
this era of##3##3##(1995-2#1)(1997-3#1)(2008-6#1)
this era##4##2##(1994-3#1)(1995-2#1)(1997-3#1)(2008-6#1)
this error is##2##3##(2008-3#2)
this error##8##2##(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2011-2#1)(2013-1#2)
this essay is##3##3##(2005-12#1)(2008-5#1)(2013-1#1)
this essay##21##2##(1995-1#1)(2005-12#1)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#4)(2008-12#1)(2008-5#1)(2009-10#1)(2009-2#1)(2009-6#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
this essential##3##2##(1991-2#1)(1996-2#1)(2006-4#1)
this estimate##4##2##(1991-9#1)(1995-6#1)(2008-9#1)(2010-1#1)
this estimation##2##2##(2007-4#1)(2010-5#1)
this ethnic##2##2##(2007-12#1)(2008-1#1)
this evaluation##21##2##(1992-12#1)(2005-7#2)(2006-12#1)(2006-8#1)(2007-10#1)(2007-4#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
this event is##6##3##(1991-5#1)(1993-11#1)(1994-10#1)(1994-9#1)(2007-12#1)(2010-12#1)
this event occurred##2##3##(1993-12#1)(2008-10#1)
this event##25##2##(1991-5#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-4#1)(1994-10#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1997-1#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2009-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
this evidence and##2##3##(2008-3#1)(2009-5#1)
this evidence##8##2##(2005-11#1)(2006-10#1)(2007-8#1)(2008-12#1)(2008-3#1)(2009-10#1)(2009-5#1)(2010-4#1)
this evolution##3##2##(2007-12#1)(2008-12#1)(2008-2#1)
this evolutionary##3##2##(1995-8#1)(2008-8#1)(2008-9#1)
this evolving##2##2##(2008-12#1)(2013-8#1)
this examination##9##2##(1992-12#1)(1992-5#1)(1994-2#1)(1996-12#1)(2007-5#1)(2008-10#1)(2012-12#2)(2013-8#1)
this example##7##2##(2006-7#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)
this excess##4##2##(1990-10#1)(1991-11#1)(1991-12#1)(1992-8#1)
this exchange is##2##3##(1994-8#1)(2006-4#1)
this exchange##4##2##(1990-11#1)(1994-8#1)(1995-2#1)(2006-4#1)
this exciting##9##2##(1991-3#1)(2005-7#1)(2007-10#1)(2008-11#1)(2008-7#1)(2011-1#2)(2012-2#1)(2013-1#1)
this exercise##7##2##(1993-2#1)(2005-10#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-7#1)
this existing##2##2##(2008-10#1)(2013-7#1)
this exon##2##2##(1994-9#1)(1997-7#1)
this expanding##3##2##(2006-10#1)(2008-7#1)(2009-5#1)
this expansion##5##2##(1991-11#1)(1991-3#1)(1992-1#1)(2008-3#1)(2009-8#1)
this expectation##2##2##(2008-7#1)(2009-8#1)
this expensive##4##2##(1993-7#1)(1994-12#1)(2007-7#1)(2011-2#1)
this experience is not##2##4##(1995-7#1)(2008-9#1)
this experience suggests that##2##4##(1993-3#1)(2007-10#1)
this experience was##2##3##(2008-12#1)(2008-5#1)
this experience##22##2##(1990-12#1)(1993-3#2)(1994-3#2)(1995-7#1)(1996-11#1)(2005-11#1)(2007-10#1)(2007-2#1)(2008-11#4)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#2)(2012-1#1)(2012-2#1)(2012-3#1)
this experiment is that##2##4##(1995-3#1)(2008-3#1)
this experiment is##4##3##(1995-3#1)(2008-2#1)(2008-3#2)
this experiment revealed that##2##4##(1993-12#1)(2011-2#1)
this experiment was##8##3##(1993-12#2)(1994-2#1)(1997-2#1)(2007-9#1)(2008-12#1)(2009-4#1)(2012-12#1)
this experiment##58##2##(1990-10#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-12#3)(1994-2#1)(1994-6#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-2#1)(2005-11#1)(2006-5#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-4#3)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-2#4)(2008-3#6)(2008-8#1)(2009-4#3)(2010-10#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)
this experimental design##5##3##(1996-8#1)(2008-10#1)(2008-7#1)(2009-2#1)(2013-1#1)
this experimental model of##2##4##(1994-2#1)(2008-4#1)
this experimental model##9##3##(1991-10#1)(1992-4#1)(1993-2#1)(1994-2#1)(1994-8#1)(2007-8#1)(2008-4#1)(2008-7#1)(2010-12#1)
this experimental study##2##3##(2008-5#1)(2013-7#1)
this experimental##26##2##(1991-10#1)(1992-4#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-8#1)(1996-8#1)(1997-8#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
this explains##2##2##(1995-2#1)(2005-11#1)
this explanation and##2##3##(1997-1#1)(2008-3#1)
this explanation##3##2##(1997-1#1)(2008-3#1)(2010-10#1)
this exploratory research##2##3##(1992-2#1)(2008-2#1)
this exploratory study##5##3##(2008-10#1)(2009-10#1)(2010-6#1)(2011-2#1)(2013-8#1)
this exploratory##10##2##(1992-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-10#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-1#1)(2013-8#1)
this exposure##2##2##(2008-12#1)(2010-11#1)
this expression is##2##3##(1995-12#1)(2010-1#1)
this expression##12##2##(1991-5#1)(1994-2#1)(1995-12#1)(1996-10#1)(1996-2#1)(1996-9#1)(1997-4#1)(2006-9#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-1#1)
this extended##3##2##(1991-1#1)(1997-5#1)(2008-7#1)
this extension##4##2##(1991-5#1)(1992-5#1)(2008-3#2)
this extensive##3##2##(1990-8#1)(1991-12#1)(2012-3#1)
this extra##6##2##(1993-2#1)(1995-4#1)(2008-11#1)(2008-9#1)(2009-7#1)(2011-2#1)
this extract was##2##3##(2005-11#1)(2008-5#1)
this extract##10##2##(2005-11#1)(2008-10#1)(2008-11#1)(2008-5#3)(2009-5#1)(2009-6#1)(2010-12#1)(2013-8#1)
this extraction##3##2##(2008-10#1)(2013-1#2)
this extremely##2##2##(2008-2#1)(2013-1#1)
this facilitates##2##2##(2008-12#1)(2009-8#1)
this facilitation##2##2##(1997-5#1)(2008-6#1)
this facility##2##2##(1991-3#1)(2007-4#1)
this fact is##2##3##(1992-5#1)(2012-1#1)
this fact##25##2##(1992-5#1)(1994-11#1)(1997-5#1)(2005-1#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-3#1)(2010-1#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
this factor also##2##3##(1994-6#2)
this factor and the##2##4##(1990-2#1)(1994-12#1)
this factor and##3##3##(1990-2#1)(1994-12#1)(2008-3#1)
this factor can##2##3##(1990-11#1)(1993-6#1)
this factor has##2##3##(1992-12#1)(2009-3#1)
this factor in##6##3##(1990-2#3)(1991-8#1)(1994-8#1)(2012-1#1)
this factor may##2##3##(1994-12#1)(2009-3#1)
this factor was##2##3##(2007-12#1)(2008-10#1)
this factor##48##2##(1990-10#1)(1990-11#1)(1990-2#6)(1990-6#2)(1991-3#3)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-6#2)(1994-12#2)(1994-6#3)(1994-8#1)(1995-10#1)(1995-12#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2009-3#4)(2012-1#1)(2012-12#1)
this fails##2##2##(2006-10#1)(2013-1#1)
this failure are##2##3##(2004-10#1)(2009-10#1)
this failure remain unclear##2##4##(2008-10#1)(2008-9#1)
this failure##8##2##(1996-2#1)(2004-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-10#1)(2010-11#1)
this family and##4##3##(1991-2#1)(1991-8#1)(2007-1#1)(2012-12#1)
this family has##3##3##(1991-10#1)(1994-10#1)(2008-7#1)
this family include##3##3##(1990-8#1)(1992-5#1)(1994-3#1)
this family into##2##3##(2008-6#1)(2010-1#1)
this family is##4##3##(1991-7#1)(1996-3#1)(1997-3#1)(2008-10#1)
this family of compounds##2##4##(2008-6#1)(2010-5#1)
this family of enzymes##2##4##(1990-5#1)(2008-4#1)
this family of proteins##5##4##(1990-5#1)(1996-10#1)(1996-9#1)(2010-10#1)(2010-2#1)
this family of##29##3##(1990-4#1)(1990-5#2)(1992-5#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-9#1)(2005-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-9#2)(2010-10#1)(2010-2#2)(2010-3#1)(2010-5#1)
this family##108##2##(1990-12#2)(1990-4#1)(1990-5#4)(1990-8#1)(1991-10#1)(1991-11#2)(1991-2#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-5#2)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#4)(1994-8#2)(1994-9#1)(1995-1#1)(1995-3#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#2)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-7#1)(2005-8#1)(2006-10#2)(2007-1#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#5)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
this fascinating##6##2##(2006-10#1)(2006-9#1)(2007-11#1)(2008-8#1)(2008-9#1)(2012-1#1)
this fatal complication##2##3##(2012-2#1)(2013-1#1)
this fatal disease##2##3##(1993-2#1)(2012-2#1)
this fatal##4##2##(1993-2#1)(2012-2#2)(2013-1#1)
this fatty acid##3##3##(1991-1#1)(1993-8#1)(1993-9#1)
this feature by##2##3##(2006-12#1)(2008-3#1)
this feature is##3##3##(1991-4#1)(2008-6#1)(2011-2#1)
this feature to##2##3##(1994-12#1)(2007-8#1)
this feature##19##2##(1991-4#1)(1994-12#1)(1996-5#1)(1996-9#1)(1997-2#1)(2004-9#1)(2006-12#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-6#2)(2009-5#1)(2010-5#1)(2011-2#2)
this feedback##2##2##(2005-9#1)(2007-11#1)
this fermentation##2##2##(2008-11#1)(2008-6#1)
this fiber##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-5#1)
this field are the##2##4##(2008-2#1)(2010-8#1)
this field are##8##3##(2007-11#1)(2007-5#1)(2008-11#1)(2008-2#2)(2010-8#1)(2011-1#1)(2013-1#1)
this field has##5##3##(2007-11#2)(2009-9#1)(2010-8#1)(2011-2#1)
this field is in##2##4##(2007-2#1)(2008-8#1)
this field is presented##2##4##(1997-7#1)(2008-11#1)
this field is##14##3##(1992-9#1)(1996-9#1)(1997-7#1)(2006-10#2)(2007-2#1)(2008-1#1)(2008-11#1)(2008-8#1)(2010-11#1)(2010-12#1)(2010-7#1)(2012-12#1)(2012-3#1)
this field of research##4##4##(2006-10#1)(2008-1#2)(2010-11#1)
this field of##10##3##(1995-11#1)(1995-5#1)(2006-10#2)(2006-11#1)(2006-8#1)(2008-1#2)(2008-10#1)(2010-11#1)
this field study##2##3##(2008-10#1)(2013-1#1)
this field##157##2##(1990-3#1)(1990-9#1)(1991-4#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-6#1)(1995-11#1)(1995-5#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#2)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-12#1)(2005-4#1)(2005-8#3)(2005-9#1)(2006-10#11)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-11#4)(2007-12#1)(2007-2#3)(2007-5#2)(2007-6#1)(2007-8#1)(2008-1#7)(2008-10#11)(2008-11#3)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#4)(2009-6#2)(2009-7#1)(2009-9#2)(2010-11#5)(2010-12#2)(2010-2#3)(2010-5#1)(2010-7#4)(2010-8#3)(2011-1#4)(2011-2#1)(2011-7#1)(2012-11#2)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#3)
this figure is##2##3##(2008-4#1)(2009-4#1)
this figure of merit##2##4##(2007-11#1)(2007-12#1)
this figure was##2##3##(1990-6#1)(1992-2#1)
this figure##11##2##(1990-6#1)(1992-2#1)(1995-3#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-4#1)(2008-5#1)(2009-4#1)(2012-3#1)
this film##3##2##(2007-11#1)(2008-1#1)(2008-10#1)
this final##4##2##(1996-3#1)(2006-10#1)(2008-10#1)(2013-1#1)
this finding and##2##3##(1991-10#1)(1993-6#1)
this finding are discussed##2##4##(2008-6#1)(2008-9#1)
this finding in two##2##4##(1992-8#1)(2009-4#1)
this finding in##6##3##(1992-8#1)(1995-11#1)(2008-12#1)(2009-4#1)(2009-6#1)(2012-2#1)
this finding is that##3##4##(1992-2#1)(1995-12#1)(1995-9#1)
this finding is##9##3##(1990-11#1)(1992-2#1)(1995-12#1)(1995-9#1)(2007-11#2)(2008-1#1)(2010-12#1)(2010-4#1)
this finding may be##2##4##(2008-3#1)(2012-3#1)
this finding may##6##3##(1990-2#1)(1991-3#1)(2008-11#1)(2008-3#1)(2011-1#1)(2012-3#1)
this finding might##2##3##(1990-2#1)(1993-6#1)
this finding suggests##2##3##(1994-9#1)(1995-1#1)
this finding to the##2##4##(2008-5#1)(2009-5#1)
this finding to##5##3##(1993-5#1)(2004-9#1)(2008-5#1)(2009-5#1)(2010-4#1)
this finding we##2##3##(1991-3#1)(2008-11#1)
this finding with##2##3##(2012-11#1)(2012-12#1)
this finding##71##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-4#1)(1990-6#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#2)(1991-9#1)(1992-2#2)(1992-7#1)(1992-8#1)(1993-4#1)(1993-5#2)(1993-6#3)(1993-9#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-9#1)(1997-1#1)(2004-9#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#2)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-12#1)(2010-4#3)(2011-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
this first part of##3##4##(1990-12#1)(1992-12#1)(2010-12#1)
this first part##4##3##(1990-12#1)(1992-12#1)(2010-12#2)
this first stage##2##3##(2008-6#1)(2010-8#1)
this first##21##2##(1990-12#1)(1991-12#1)(1992-12#1)(1995-1#1)(1995-9#1)(1996-4#1)(2007-1#1)(2007-11#1)(2007-9#1)(2008-2#1)(2008-6#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#2)
this fish##6##2##(1990-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-12#1)(2012-3#1)
this fishery is##2##3##(2007-5#1)(2008-5#1)
this fishery##4##2##(2007-5#3)(2008-5#1)
this flap##5##2##(2007-12#5)
this flow is##2##3##(2011-2#2)
this flow##7##2##(1990-12#2)(2007-12#1)(2007-8#1)(2008-10#1)(2011-2#2)
this fluid##3##2##(1990-5#1)(1991-8#1)(2005-11#1)
this fluorescent##2##2##(1991-5#1)(1992-12#1)
this focus##2##2##(2008-9#1)(2010-9#1)
this follow-up##4##2##(2005-9#1)(2006-10#2)(2008-11#1)
this for##3##2##(2005-12#1)(2008-8#1)(2011-2#1)
this force##2##2##(2007-8#1)(2012-1#1)
this form is##4##3##(1990-5#1)(1992-11#1)(1995-3#1)(1995-8#1)
this form of cell death##2##5##(2008-1#1)(2008-7#1)
this form of set##2##4##(2013-7#2)
this form of the##2##4##(1994-11#1)(1995-5#1)
this form of therapy##3##4##(1991-12#2)(2007-11#1)
this form of treatment##3##4##(1993-6#1)(1996-12#1)(2008-3#1)
this form of##46##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-12#2)(1991-3#1)(1993-6#1)(1994-11#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-11#1)(2005-11#1)(2006-1#1)(2006-11#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-11#1)(2009-2#1)(2009-4#1)(2011-2#1)(2012-2#2)(2013-7#2)
this form was##2##3##(1990-12#1)(1995-11#1)
this form##62##2##(1990-12#2)(1990-2#1)(1990-5#2)(1990-9#1)(1991-12#2)(1991-3#1)(1991-9#1)(1992-11#1)(1993-6#1)(1994-11#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#2)(1995-5#2)(1995-8#2)(1996-12#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-11#1)(2005-11#1)(2006-1#1)(2006-11#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-11#1)(2009-2#2)(2009-4#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-7#2)
this formidable##2##2##(1996-6#1)(2007-7#1)
this formula##6##2##(2006-10#1)(2008-2#1)(2008-3#2)(2008-5#2)
this formulation of##2##3##(2007-11#1)(2008-3#1)
this formulation##6##2##(2006-7#1)(2007-11#1)(2007-4#1)(2008-3#1)(2010-12#1)(2012-12#1)
this fossil##3##2##(1995-6#1)(2013-1#2)
this foundation##2##2##(1993-12#1)(2007-12#1)
this fraction##16##2##(1990-7#1)(1991-7#1)(1992-1#1)(1992-3#1)(1993-12#1)(1995-7#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-6#1)(2006-12#1)(2008-12#2)(2008-9#1)(2011-2#1)(2013-7#1)
this fracture##4##2##(1991-9#1)(2008-7#1)(2009-1#1)(2013-1#1)
this fragment as probe##2##4##(1990-12#1)(2008-8#1)
this fragment as##3##3##(1990-12#1)(2008-8#2)
this fragment contains##2##3##(1990-11#1)(1991-9#1)
this fragment was##3##3##(1990-5#1)(1995-3#1)(2008-8#1)
this fragment##23##2##(1990-11#1)(1990-12#1)(1990-3#2)(1990-5#2)(1990-9#2)(1991-9#1)(1992-4#1)(1993-11#1)(1995-3#1)(1995-4#2)(1996-8#1)(1997-3#1)(2006-5#1)(2008-10#1)(2008-12#1)(2008-8#3)(2012-12#1)
this frame##2##2##(2008-10#1)(2008-2#1)
this framework is##2##3##(2006-4#1)(2008-8#1)
this framework of##2##3##(1996-2#1)(2011-2#1)
this framework##29##2##(1990-6#1)(1991-2#1)(1993-4#1)(1995-4#1)(1996-2#1)(1997-8#2)(2005-10#1)(2006-4#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-6#1)(2011-2#2)(2012-1#2)(2012-3#1)(2013-1#6)
this free##2##2##(1993-9#1)(2008-12#1)
this frequency##2##2##(2007-12#1)(2008-2#1)
this frequently##2##2##(2005-12#1)(2007-7#1)
this from##2##2##(2006-6#1)(2007-8#1)
this function is##2##3##(2007-1#1)(2008-6#1)
this function with##2##3##(1994-2#1)(2007-1#1)
this function##21##2##(1990-3#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-3#1)(1997-4#1)(2006-6#1)(2007-1#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#3)(2009-10#1)(2009-8#1)(2010-3#1)(2012-1#1)
this functional axis##2##3##(2012-2#2)
this functional group is##2##4##(1996-9#1)(2008-4#1)
this functional group##4##3##(1996-9#1)(2008-10#2)(2008-4#1)
this functional##17##2##(1990-12#1)(1993-2#1)(1996-9#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2010-10#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
this functionally##2##2##(1992-6#1)(2008-9#1)
this fundamental##4##2##(1995-5#1)(2010-10#1)(2011-2#1)(2012-2#1)
this fungal##4##2##(2008-10#4)
this fungus in##3##3##(2007-7#1)(2008-10#2)
this fungus##26##2##(2005-11#1)(2007-2#1)(2007-7#1)(2008-10#19)(2008-5#1)(2008-8#1)(2009-9#1)(2011-1#1)
this further##5##2##(1991-6#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)
this fusion##2##2##(1992-3#1)(2006-3#1)
this gap in knowledge##2##4##(2010-2#1)(2012-11#1)
this gap in##4##3##(2010-2#1)(2010-4#1)(2012-11#1)(2012-3#1)
this gap is##2##3##(2006-10#1)(2008-11#1)
this gap##15##2##(2006-10#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-9#1)(2012-11#1)(2012-3#1)(2013-1#2)(2013-8#1)
this gas##3##2##(1990-5#1)(2005-12#1)(2011-1#1)
this gel##2##2##(2008-10#1)(2008-4#1)
this gene and##4##3##(1990-12#1)(1992-3#1)(1994-12#1)(1997-2#1)
this gene can##3##3##(1992-10#1)(1995-1#1)(2011-1#1)
this gene encodes a##2##4##(1994-2#1)(2008-9#1)
this gene family##6##3##(1991-9#1)(1992-3#1)(1994-8#1)(1996-3#1)(2008-7#1)(2012-12#1)
this gene has been##2##4##(1993-6#1)(1995-6#1)
this gene has##3##3##(1993-6#1)(1995-6#1)(1997-5#1)
this gene in B##2##4##(1990-9#1)(2006-5#1)
this gene in the##3##4##(1991-5#1)(2008-10#1)(2008-8#1)
this gene in##19##3##(1990-8#1)(1990-9#1)(1991-1#1)(1991-5#1)(1991-7#1)(1992-4#1)(1993-11#1)(1994-5#1)(1994-8#1)(1997-7#2)(2006-5#1)(2008-10#2)(2008-7#1)(2008-8#1)(2012-1#1)(2012-2#1)(2013-1#1)
this gene is composed of##2##5##(1991-6#1)(1997-4#1)
this gene is##18##3##(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-6#1)(1996-10#1)(1996-7#1)(1997-4#1)(2006-12#1)(2008-10#1)
this gene may##3##3##(1990-8#1)(1993-8#1)(2008-2#1)
this gene under##2##3##(1992-12#1)(1993-5#1)
this gene was##12##3##(1990-9#1)(1993-11#1)(1994-6#1)(2006-8#1)(2008-10#2)(2008-12#1)(2008-8#4)(2011-1#1)
this gene were##2##3##(1993-2#1)(1995-11#1)
this gene which##2##3##(1990-3#1)(2009-6#1)
this gene with the##2##4##(1997-3#1)(2010-12#1)
this gene with##5##3##(1993-6#1)(1995-11#1)(1997-3#1)(2008-10#1)(2010-12#1)
this gene##151##2##(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#2)(1990-8#3)(1990-9#4)(1991-1#2)(1991-11#1)(1991-12#2)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#2)(1992-3#2)(1992-4#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#3)(1993-12#1)(1993-2#3)(1993-3#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#5)(1995-8#1)(1996-1#1)(1996-10#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-7#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#4)(2006-12#1)(2006-5#1)(2006-8#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#2)(2009-10#1)(2009-6#1)(2009-8#1)(2010-12#2)(2011-1#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
this general##6##2##(2004-2#1)(2008-1#1)(2008-3#2)(2010-12#1)(2012-3#1)
this generic##2##2##(2008-5#1)(2008-6#1)
this genetic variation##2##3##(2008-10#1)(2010-4#1)
this genetic##12##2##(1990-7#1)(1992-9#1)(1996-12#2)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-4#1)(2011-2#1)(2013-1#1)
this genome##3##2##(1995-8#1)(1997-4#1)(2010-12#1)
this genomic sequence##2##3##(2008-8#2)
this genomic##5##2##(1997-4#1)(2008-8#3)(2013-8#1)
this genotype was##2##3##(1994-3#1)(2008-4#1)
this genotype##9##2##(1994-3#1)(1996-11#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-4#2)(2012-2#1)
this genus##19##2##(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-5#2)(2008-9#3)(2010-10#2)(2013-1#2)(2013-7#2)
this geographical area##2##3##(2007-5#1)(2008-7#1)
this geographically##2##2##(2006-7#1)(2013-7#1)
this geometry##3##2##(2008-2#1)(2008-3#2)
this gives the##2##3##(2008-11#1)(2008-3#1)
this gives##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
this gland##3##2##(1993-8#1)(2007-1#1)(2012-12#1)
this global##4##2##(1991-9#1)(2008-10#1)(2008-9#1)(2010-8#1)
this glycine##2##2##(1991-11#1)(1994-3#1)
this glycosylation##2##2##(1992-6#1)(1995-5#1)
this glycosyltransferase##2##2##(1991-7#1)(1994-5#1)
this goal a##2##3##(2006-10#1)(2007-5#1)
this goal and##2##3##(2011-2#1)(2012-1#1)
this goal by##2##3##(2008-2#1)(2008-9#1)
this goal is##5##3##(1995-3#1)(1996-1#1)(2006-10#1)(2008-7#1)(2010-6#1)
this goal was##2##3##(2008-8#1)(2010-3#1)
this goal##59##2##(1990-12#1)(1992-12#1)(1994-10#1)(1994-11#3)(1994-2#1)(1994-6#1)(1995-1#1)(1995-3#1)(1996-1#2)(1997-3#1)(2005-12#1)(2006-10#4)(2006-12#1)(2006-6#1)(2007-2#2)(2007-4#2)(2007-5#1)(2007-7#1)(2008-1#2)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2010-2#2)(2010-3#3)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#1)
this good##3##2##(2006-7#1)(2008-10#2)
this gradient##4##2##(1990-11#1)(2008-10#1)(2008-2#1)(2010-3#1)
this grating##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
this group and##5##3##(1993-4#1)(2005-10#1)(2005-8#1)(2008-11#1)(2008-6#1)
this group are##4##3##(1993-10#1)(2007-12#1)(2008-10#1)(2008-12#1)
this group can be##3##4##(1993-8#1)(2010-12#1)(2011-2#1)
this group had##6##3##(1991-3#1)(2007-8#1)(2008-11#1)(2009-3#2)(2012-3#1)
this group has##2##3##(2006-8#1)(2008-9#1)
this group is##6##3##(1990-3#1)(1991-11#1)(2004-2#1)(2007-3#1)(2008-5#1)(2009-5#1)
this group may##2##3##(2008-2#1)(2008-5#1)
this group of children##3##4##(1992-1#1)(2008-9#1)(2012-2#1)
this group of diseases##4##4##(1994-6#1)(1996-2#1)(2008-8#1)(2013-7#1)
this group of disorders##2##4##(1993-9#1)(2007-2#1)
this group of patients is##2##5##(2007-8#1)(2008-6#1)
this group of patients##43##4##(1990-2#2)(1990-3#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-4#1)(1995-4#1)(1996-1#1)(1996-9#1)(2005-12#1)(2006-10#4)(2006-2#1)(2006-5#1)(2006-6#2)(2006-9#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#1)(2010-8#1)(2011-1#1)(2011-3#1)(2012-2#1)
this group of plants##2##4##(2008-11#1)(2013-7#1)
this group of##99##3##(1990-2#2)(1990-3#1)(1991-10#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-6#1)(1995-3#1)(1995-4#2)(1996-1#1)(1996-2#1)(1996-9#1)(1997-5#1)(2004-2#1)(2005-12#1)(2006-10#7)(2006-11#1)(2006-2#1)(2006-5#1)(2006-6#2)(2006-9#1)(2007-11#3)(2007-12#1)(2007-2#4)(2007-3#4)(2007-7#1)(2007-8#3)(2008-1#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#4)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#2)(2010-3#1)(2010-5#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#3)(2013-7#2)
this group the##2##3##(1992-12#1)(1992-6#1)
this group was##10##3##(1990-9#1)(1991-9#1)(1994-5#1)(1995-2#1)(2006-7#1)(2008-1#1)(2008-6#1)(2008-9#1)(2011-2#1)(2013-1#1)
this group were##5##3##(1995-12#1)(2007-12#1)(2007-2#1)(2008-12#1)(2008-5#1)
this group with the##2##4##(1990-12#1)(1992-12#1)
this group with##3##3##(1990-12#1)(1992-12#1)(2007-9#1)
this group##278##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#3)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#3)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#2)(1995-6#1)(1996-1#4)(1996-11#2)(1996-12#1)(1996-2#2)(1996-6#1)(1996-9#1)(1997-5#2)(1997-8#1)(2004-11#1)(2004-12#1)(2004-2#3)(2004-9#1)(2005-1#1)(2005-10#1)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#10)(2006-11#1)(2006-2#1)(2006-5#4)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#5)(2007-12#5)(2007-2#7)(2007-3#5)(2007-6#2)(2007-7#2)(2007-8#9)(2007-9#3)(2008-1#3)(2008-10#7)(2008-11#5)(2008-12#10)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#9)(2008-6#7)(2008-7#2)(2008-8#5)(2008-9#9)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#2)(2009-5#4)(2009-8#2)(2010-12#1)(2010-3#1)(2010-5#3)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#6)(2013-7#8)(2013-8#3)
this grouping was##2##3##(2008-10#2)
this grouping##7##2##(1992-10#1)(1997-4#1)(2008-10#3)(2009-4#1)(2010-12#1)
this growing movement##2##3##(2008-3#2)
this growing##5##2##(2005-11#1)(2006-12#1)(2008-3#2)(2010-6#1)
this growth factor##7##3##(1990-5#1)(1990-7#1)(1990-9#1)(1992-3#1)(1996-11#1)(1997-7#1)(2007-11#1)
this growth##16##2##(1990-3#1)(1990-5#2)(1990-7#1)(1990-9#1)(1992-3#1)(1996-11#1)(1997-7#1)(2005-11#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-12#1)
this guide##2##2##(1997-3#2)
this habit##3##2##(1991-5#1)(2008-10#2)
this habitat##4##2##(2007-3#1)(2008-5#1)(2012-12#1)(2013-1#1)
this had no##3##3##(1991-7#1)(2008-1#1)(2008-3#1)
this had##6##2##(1990-3#1)(1991-7#1)(2008-1#1)(2008-3#1)(2009-6#1)(2010-12#1)
this happens##5##2##(1991-3#1)(1995-8#1)(2007-8#1)(2010-7#1)(2012-2#1)
this has been a##2##4##(2008-11#1)(2012-12#1)
this has been##14##3##(1994-11#1)(1994-2#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-7#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-1#1)(2012-12#1)(2013-1#1)
this has had##2##3##(2006-10#2)
this has led to the development of##2##7##(2006-6#1)(2007-11#1)
this has led to##8##4##(1997-7#1)(2005-8#1)(2006-6#1)(2007-11#1)(2008-2#1)(2009-7#1)(2011-2#1)(2012-2#1)
this has meant##2##3##(2005-8#1)(2008-10#1)
this has never been##2##4##(1991-4#1)(1997-8#1)
this has never##3##3##(1991-4#1)(1997-8#1)(2012-1#1)
this has not been##4##4##(1993-2#1)(2010-2#1)(2010-5#1)(2013-8#1)
this has not##5##3##(1993-2#1)(2008-12#1)(2010-2#1)(2010-5#1)(2013-8#1)
this has resulted##2##3##(2006-10#1)(2007-11#1)
this has##59##2##(1990-4#1)(1990-9#1)(1991-4#1)(1993-2#1)(1993-5#1)(1994-11#1)(1994-2#1)(1995-2#1)(1997-7#1)(1997-8#2)(2005-8#3)(2006-10#4)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-5#2)(2010-7#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
this have been##2##3##(1993-9#1)(2006-12#1)
this have##4##2##(1991-6#1)(1993-9#1)(2006-12#1)(2007-11#1)
this health##4##2##(2008-10#1)(2008-4#1)(2010-12#1)(2011-1#1)
this helminth##2##2##(1996-10#1)(2011-2#1)
this herbal##2##2##(2008-1#1)(2012-2#1)
this heterogeneity##3##2##(1990-12#1)(2008-8#1)(2008-9#1)
this heterogeneous##4##2##(2008-3#1)(2008-6#1)(2010-7#2)
this heterologous##2##2##(1991-4#1)(1995-7#1)
this hidden##2##2##(2007-12#1)(2008-3#1)
this high level##3##3##(1991-7#1)(2004-9#1)(2013-1#1)
this high risk group##4##4##(1995-4#1)(2008-3#1)(2009-2#1)(2012-3#1)
this high risk##5##3##(1995-4#1)(2007-11#1)(2008-3#1)(2009-2#1)(2012-3#1)
this high##23##2##(1991-1#1)(1991-6#1)(1991-7#1)(1991-9#2)(1995-4#1)(1997-7#1)(2004-9#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-2#2)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
this high-risk group##3##3##(2005-7#1)(2007-8#1)(2007-9#1)
this high-risk population##3##3##(2006-10#1)(2010-3#1)(2013-1#1)
this high-risk##7##2##(2005-7#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-4#1)(2010-3#1)(2013-1#1)
this higher##2##2##(2007-8#1)(2009-10#1)
this highly##23##2##(1991-1#1)(1992-1#1)(1992-3#1)(1995-7#1)(2006-10#2)(2006-6#1)(2007-1#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#3)
this hippocampal##2##2##(1993-2#1)(1996-7#1)
this historical##3##2##(2011-2#1)(2013-8#2)
this hole##2##2##(1995-6#1)(2007-8#1)
this hologram##2##2##(2008-3#2)
this homography##2##2##(2008-6#2)
this homology##2##2##(1993-12#1)(1994-3#1)
this hormone is##2##3##(2008-10#1)(2013-8#1)
this hormone##10##2##(1991-6#1)(1993-6#1)(1995-10#1)(1995-12#1)(1997-4#1)(2005-10#1)(2008-1#1)(2008-10#1)(2008-4#1)(2013-8#1)
this hospital##12##2##(1990-11#1)(1990-3#1)(1995-3#2)(2007-2#1)(2008-8#2)(2009-10#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)
this hospital-based##2##2##(2007-7#1)(2007-9#1)
this host##9##2##(2004-11#1)(2008-10#5)(2009-2#2)(2010-3#1)
this huge##3##2##(2008-8#1)(2009-7#1)(2013-8#1)
this human protein##2##3##(1995-8#1)(2008-10#1)
this human##10##2##(1992-10#1)(1993-4#3)(1994-11#1)(1995-3#1)(1995-8#1)(1997-4#1)(2007-1#1)(2008-10#1)
this hybrid##4##2##(1990-3#1)(1994-2#2)(1994-9#1)
this hydrogen##2##2##(1990-8#1)(1992-3#1)
this hydrolysis##2##2##(1994-12#1)(2008-5#1)
this hydrophobic##3##2##(1992-11#1)(1992-3#1)(2006-1#1)
this hypothesis and##4##3##(1997-3#1)(2005-6#1)(2006-10#1)(2008-7#1)
this hypothesis by examining##2##4##(1996-4#1)(2009-7#1)
this hypothesis by##11##3##(1993-6#1)(1994-3#1)(1995-12#1)(1996-4#1)(1996-8#1)(2005-10#1)(2008-2#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-7#1)
this hypothesis for##3##3##(1995-5#1)(2008-10#1)(2012-11#1)
this hypothesis in##5##3##(1990-8#1)(1996-3#1)(2006-7#1)(2008-5#1)(2009-7#1)
this hypothesis is##6##3##(1990-11#1)(2008-1#1)(2008-8#1)(2010-7#1)(2012-12#1)(2012-3#1)
this hypothesis the##2##3##(1992-8#1)(2010-1#1)
this hypothesis using##4##3##(1994-10#1)(2007-11#1)(2009-8#1)(2011-2#1)
this hypothesis was##3##3##(1996-4#1)(2008-10#1)(2013-1#1)
this hypothesis##138##2##(1990-11#2)(1990-3#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-12#2)(1993-6#2)(1994-10#1)(1994-11#3)(1994-2#1)(1994-3#3)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#3)(1996-10#1)(1996-3#1)(1996-4#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-6#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-1#3)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#5)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-4#3)(2009-6#1)(2009-7#2)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#1)
this idea by##3##3##(1994-6#1)(2007-9#1)(2012-2#1)
this idea is##2##3##(1995-6#1)(2011-2#1)
this idea we##2##3##(2007-10#1)(2007-11#1)
this idea##22##2##(1993-2#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-3#1)(2004-8#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-9#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
this ideal##3##2##(2008-2#1)(2008-3#1)(2013-1#1)
this identification was##2##3##(1992-2#1)(2010-4#1)
this identification##5##2##(1992-2#1)(2006-8#1)(2008-10#1)(2008-12#1)(2010-4#1)
this illness is##2##3##(1993-5#1)(2012-12#1)
this illness##12##2##(1990-9#1)(1992-2#1)(1993-3#1)(1993-5#1)(2007-10#1)(2007-2#1)(2008-6#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
this illusion##2##2##(2012-11#1)(2012-2#1)
this imaging modality##2##3##(2010-8#1)(2013-1#1)
this imaging technique has##2##4##(2006-9#1)(2008-3#1)
this imaging technique##4##3##(2006-9#1)(2008-2#1)(2008-3#1)(2013-1#1)
this imaging##7##2##(2006-9#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-8#1)(2013-1#2)
this imbalance##5##2##(1996-9#1)(2007-1#1)(2008-1#1)(2010-12#1)(2013-8#1)
this immune response##3##3##(1992-1#1)(1996-11#1)(2007-12#1)
this immune##4##2##(1992-1#1)(1996-11#1)(2007-12#1)(2012-2#1)
this immunosuppressive effect##3##3##(1996-12#1)(2008-3#1)(2008-4#1)
this impact##2##2##(1992-2#1)(2007-7#1)
this impairment was##2##3##(1991-2#1)(2013-1#1)
this impairment##9##2##(1991-2#2)(1995-2#1)(1995-5#1)(2006-8#1)(2008-11#1)(2008-7#1)(2009-2#1)(2013-1#1)
this implantation##2##2##(1993-2#1)(2012-3#1)
this implementation process##2##3##(1996-1#1)(2008-9#1)
this implementation##4##2##(1996-1#1)(2008-2#2)(2008-9#1)
this implies a##2##3##(2009-10#1)(2010-11#1)
this implies an##2##3##(1993-9#1)(2007-7#1)
this implies that##2##3##(2010-12#1)(2010-3#1)
this implies##6##2##(1993-9#1)(2007-7#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-3#1)
this importance##3##2##(2007-5#1)(2009-4#1)(2013-1#1)
this important class of##3##4##(1997-4#1)(2006-12#1)(2007-9#1)
this important condition##2##3##(2006-10#1)(2007-7#1)
this important field of##3##4##(2008-1#1)(2008-11#1)(2008-2#1)
this important field##4##3##(2008-1#1)(2008-11#1)(2008-2#1)(2013-1#1)
this important human##2##3##(1991-8#1)(1997-4#1)
this important patient##2##3##(2008-11#1)(2009-11#1)
this important public health problem##2##5##(1992-5#1)(2012-12#1)
this important topic##2##3##(2006-10#1)(2008-3#1)
this important##67##2##(1991-7#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-5#1)(1994-12#1)(1994-2#1)(1994-3#4)(1995-2#1)(1997-4#2)(2005-10#1)(2005-11#1)(2005-8#2)(2006-10#5)(2006-11#2)(2006-12#1)(2006-2#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#2)(2011-2#3)(2012-12#2)(2013-1#1)
this impression##3##2##(2004-10#1)(2008-11#1)(2008-8#1)
this improved##4##2##(1990-2#1)(1993-4#1)(2008-2#1)(2008-3#1)
this improvement is##4##3##(2006-10#1)(2008-10#1)(2008-3#1)(2012-3#1)
this improvement the##2##3##(2007-12#1)(2008-3#1)
this improvement##11##2##(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-2#1)(2012-3#1)
this impurity##3##2##(2007-6#2)(2008-10#1)
this in mind##11##3##(1990-11#1)(2004-3#1)(2007-12#1)(2007-3#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2012-2#1)
this in order to##2##4##(2008-10#1)(2008-12#1)
this in situ##2##3##(1997-3#1)(2008-5#1)
this in terms of the##2##5##(1997-3#1)(2008-8#1)
this in the##8##3##(2007-8#1)(2008-7#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
this in turn##7##3##(1990-12#1)(1997-6#1)(2005-5#1)(2008-12#2)(2009-2#1)(2010-4#1)
this in vitro model##3##4##(1996-3#1)(2008-10#1)(2008-5#1)
this in vitro system##2##4##(1994-8#1)(2008-11#1)
this in vitro##17##3##(1994-12#1)(1994-8#1)(1995-12#1)(1996-3#1)(2006-8#2)(2008-10#2)(2008-11#3)(2008-5#3)(2009-9#1)(2011-2#1)(2013-1#1)
this in vivo##7##3##(1995-2#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-12#1)(2012-12#1)
this in##63##2##(1990-11#1)(1990-12#1)(1993-11#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-3#2)(1997-6#1)(2004-3#1)(2005-5#1)(2006-10#1)(2006-8#2)(2007-12#1)(2007-3#1)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#4)(2008-12#4)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-9#1)(2010-12#1)(2010-4#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
this incision##2##2##(2007-5#1)(2007-8#1)
this include##2##2##(2008-11#1)(2011-1#1)
this included##2##2##(2008-10#1)(2012-1#1)
this includes##4##2##(1993-10#1)(2007-11#1)(2008-3#1)(2012-2#1)
this inclusion##2##2##(2007-11#1)(2009-8#1)
this incompatibility##2##2##(2005-10#1)(2012-2#1)
this inconsistency##2##2##(2008-3#1)(2008-5#1)
this increase in expenditures was reduced to 21##2##8##(2013-1#2)
this increase in the##2##4##(2007-8#1)(2008-7#1)
this increase in##14##3##(1990-10#1)(1991-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(2006-10#2)(2006-8#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-7#1)(2013-1#2)
this increase is due to##2##5##(2005-11#1)(2005-7#1)
this increase is##10##3##(1991-3#1)(1992-12#1)(1993-8#1)(2005-11#1)(2005-7#1)(2007-11#1)(2008-11#2)(2011-1#1)(2012-2#1)
this increase was not##2##4##(2009-12#1)(2012-2#1)
this increase was##13##3##(1990-11#1)(1991-2#1)(1991-6#1)(1995-12#1)(1995-5#1)(1996-5#1)(2007-8#1)(2008-12#1)(2008-4#1)(2009-12#1)(2010-8#1)(2012-1#1)(2012-2#1)
this increase##53##2##(1990-10#1)(1990-11#1)(1990-8#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-12#2)(1995-5#1)(1996-5#1)(1997-2#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-8#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#3)
this increased expression##2##3##(1991-3#1)(1994-2#1)
this increased use##2##3##(2006-10#1)(2012-12#1)
this increased##29##2##(1990-12#1)(1990-2#1)(1991-3#1)(1991-8#1)(1992-2#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1997-5#1)(2005-10#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-9#1)(2011-2#1)(2012-1#1)(2012-12#1)
this increases##2##2##(2005-3#1)(2008-8#1)
this increasingly complex##2##3##(2009-12#1)(2011-2#1)
this increasingly##5##2##(2006-10#1)(2006-4#1)(2008-4#1)(2009-12#1)(2011-2#1)
this increment of##2##3##(1994-9#1)(1995-3#1)
this index with##2##3##(2007-11#1)(2008-7#1)
this index##11##2##(1991-11#1)(1991-6#1)(1992-4#1)(1993-9#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-6#2)(2008-7#2)
this indicates that##3##3##(2006-6#1)(2008-6#1)(2010-2#1)
this indicates the##2##3##(2008-3#1)(2009-4#1)
this indicates##6##2##(2006-6#1)(2008-3#1)(2008-6#1)(2009-2#1)(2009-4#1)(2010-2#1)
this indication##21##2##(1992-5#1)(1994-2#1)(2005-1#1)(2005-6#1)(2005-7#2)(2005-8#2)(2005-9#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#2)(2010-12#1)(2011-2#1)
this indicator##2##2##(2013-1#2)
this indirect##3##2##(2008-10#1)(2008-7#1)(2009-8#1)
this individual##6##2##(1990-11#1)(1990-12#1)(1991-3#1)(1992-9#1)(1997-1#1)(2007-12#1)
this induced##4##2##(1991-3#1)(1995-1#1)(2007-12#1)(2008-11#1)
this induction of##3##3##(1994-11#1)(2010-10#1)(2012-12#1)
this induction was##2##3##(1994-12#2)
this induction##9##2##(1992-12#1)(1994-11#1)(1994-12#3)(1995-12#1)(2004-1#1)(2010-10#1)(2012-12#1)
this industry##5##2##(2006-10#1)(2008-11#2)(2008-6#1)(2010-4#1)
this infant##3##2##(1993-7#1)(1996-3#1)(1997-3#1)
this infection can##2##3##(2006-10#1)(2010-12#1)
this infection has##2##3##(2006-2#1)(2010-12#1)
this infection is##2##3##(2007-3#1)(2010-9#1)
this infection##25##2##(1996-3#1)(2006-10#3)(2006-2#1)(2007-12#3)(2007-2#2)(2007-3#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-2#2)(2010-12#2)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
this infectious disease##2##3##(2006-10#1)(2013-1#1)
this infectious##5##2##(1995-5#1)(2006-10#1)(2008-12#1)(2011-1#1)(2013-1#1)
this inflammation##2##2##(2006-10#1)(2009-2#1)
this influence##4##2##(1994-10#2)(2010-7#1)(2012-1#1)
this influences##2##2##(2006-2#1)(2008-1#1)
this information and##3##3##(1992-12#1)(1995-8#1)(2008-7#1)
this information can be##2##4##(1996-3#1)(1997-3#1)
this information can##5##3##(1996-1#1)(1996-3#1)(1997-3#1)(2008-6#1)(2011-2#1)
this information has##3##3##(1995-12#1)(1995-3#1)(2008-5#1)
this information in##8##3##(1991-11#1)(1996-2#1)(1997-8#1)(2007-10#1)(2008-11#1)(2008-7#1)(2013-1#2)
this information is critical for##2##5##(2008-10#1)(2008-9#1)
this information is##11##3##(1994-6#1)(1996-8#1)(2006-12#1)(2007-12#2)(2008-10#1)(2008-7#1)(2008-9#1)(2010-5#1)(2010-9#1)(2011-2#1)
this information may##2##3##(2011-2#1)(2012-2#1)
this information to##12##3##(1995-5#1)(1996-6#1)(1997-7#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#2)(2013-1#2)
this information was##2##3##(1992-11#1)(2007-12#1)
this information will##3##3##(2008-12#1)(2008-4#1)(2012-2#1)
this information with##3##3##(1997-4#1)(2007-8#1)(2013-1#1)
this information##90##2##(1991-11#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1993-12#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#3)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-12#4)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#6)(2008-9#2)(2009-12#1)(2009-8#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#3)(2013-1#10)(2013-7#1)
this infrastructure##4##2##(1993-9#1)(1997-3#1)(2013-1#2)
this infrequent##5##2##(1990-12#1)(1992-6#1)(2009-1#1)(2009-7#1)(2012-3#1)
this infusion##2##2##(1991-3#1)(1995-10#1)
this inhibition by##3##3##(1990-7#1)(1995-8#1)(2008-11#1)
this inhibition is##5##3##(1993-8#1)(1994-11#1)(1994-3#1)(1997-3#1)(2011-1#1)
this inhibition of##3##3##(1993-8#1)(1995-11#1)(2008-5#1)
this inhibition was##8##3##(1991-3#1)(1991-5#1)(1992-11#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-8#1)(1996-9#1)
this inhibition##34##2##(1990-2#1)(1990-7#2)(1990-8#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-11#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-8#2)(1994-11#2)(1994-3#2)(1994-8#3)(1995-11#2)(1995-8#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-6#2)(2006-3#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)
this inhibitor##8##2##(1992-8#1)(1992-9#2)(1994-10#1)(1994-2#1)(1995-12#1)(2008-8#1)(2010-2#1)
this inhibitory action##3##3##(1990-3#1)(1992-6#1)(2008-10#1)
this inhibitory effect of##3##4##(1990-5#1)(1995-11#1)(1995-5#1)
this inhibitory effect##7##3##(1990-5#1)(1990-7#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-2#1)(1997-1#1)
this inhibitory##14##2##(1990-3#1)(1990-5#1)(1990-7#1)(1992-6#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-4#1)(2008-10#2)(2008-7#1)
this initial interaction##2##3##(1995-6#1)(2013-1#1)
this initial##11##2##(1992-12#1)(1995-6#1)(1997-5#1)(2005-7#1)(2006-12#1)(2007-4#1)(2007-7#1)(2008-4#2)(2009-9#1)(2013-1#1)
this initiative and the##2##4##(1991-12#1)(2009-11#1)
this initiative##13##2##(1991-12#1)(2004-10#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-3#1)(2012-2#1)(2013-8#1)
this injection##2##2##(1994-9#1)(2008-10#1)
this injury pattern##3##3##(2009-3#2)(2013-1#1)
this injury##12##2##(2006-2#1)(2006-5#1)(2007-4#1)(2009-3#3)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
this innovative##3##2##(2008-11#1)(2008-12#1)(2008-5#1)
this insect##9##2##(1991-2#1)(2007-12#2)(2008-6#1)(2008-7#2)(2011-10#1)(2011-12#2)
this insertion##2##2##(1994-3#1)(2009-7#1)
this insight##2##2##(2009-9#1)(2012-11#1)
this installment of##2##3##(2007-2#1)(2007-4#1)
this instance##2##2##(1993-11#1)(2008-10#1)
this institution##7##2##(1991-9#1)(2007-7#1)(2008-6#1)(2008-8#3)(2012-2#1)
this instruction##2##2##(1991-12#1)(2008-12#1)
this instrument in##3##3##(1990-4#1)(2007-11#1)(2012-2#1)
this instrument to##2##3##(2008-11#1)(2011-1#1)
this instrument was##3##3##(2008-2#1)(2008-4#1)(2013-8#1)
this instrument##26##2##(1990-4#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#1)(2009-12#1)(2010-11#1)(2011-1#1)(2012-2#1)(2013-8#2)
this instrumentation##2##2##(2006-11#1)(2007-7#1)
this insulin##2##2##(2009-6#1)(2010-12#1)
this integration##2##2##(2008-8#1)(2008-9#1)
this integrative##4##2##(1994-2#1)(2008-9#1)(2011-1#1)(2013-1#1)
this integrin##3##2##(2012-12#3)
this intensive##3##2##(2004-3#1)(2007-11#1)(2008-5#1)
this inter-organ##2##2##(2010-11#2)
this interaction are##2##3##(2005-7#1)(2009-12#1)
this interaction by##2##3##(1997-1#1)(1997-2#1)
this interaction in##6##3##(1996-10#1)(1996-8#1)(2008-9#1)(2009-8#1)(2012-1#1)(2012-2#1)
this interaction is not##3##4##(1997-4#1)(1997-6#1)(2009-8#1)
this interaction is##11##3##(1994-6#1)(1994-9#3)(1995-3#1)(1997-4#1)(1997-6#1)(2006-12#1)(2008-10#2)(2009-8#1)
this interaction was##2##3##(1995-2#1)(2010-1#1)
this interaction##52##2##(1990-2#1)(1990-4#1)(1990-8#3)(1991-11#1)(1991-6#1)(1993-5#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-2#2)(1995-3#1)(1995-6#2)(1995-7#1)(1996-10#1)(1996-8#4)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#2)(2005-7#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-6#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-8#2)(2010-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
this interdependence##2##2##(2009-8#2)
this interesting case##2##3##(2008-6#1)(2008-9#1)
this interesting phenomenon##2##3##(2006-10#1)(2008-3#1)
this interesting##6##2##(1993-8#1)(2006-10#1)(2007-7#1)(2008-3#1)(2008-6#1)(2008-9#1)
this interface##2##2##(2007-12#1)(2008-2#1)
this interference##3##2##(2006-12#1)(2008-10#1)(2010-6#1)
this interferometer##6##2##(2007-12#2)(2008-2#2)(2008-3#2)
this intermediate##9##2##(1991-7#1)(1994-8#1)(1996-8#1)(1997-4#1)(2006-3#1)(2007-6#1)(2010-5#1)(2010-6#1)(2013-8#1)
this internalization##2##2##(1990-11#1)(1994-10#1)
this international project##2##3##(2008-4#1)(2010-3#1)
this international##4##2##(2008-4#1)(2010-3#1)(2011-10#1)(2011-2#1)
this interpretation is##2##3##(2005-7#1)(2006-10#1)
this interpretation##11##2##(1990-7#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-8#1)(2005-7#1)(2006-10#1)(2006-3#1)(2008-11#1)(2009-10#1)(2013-7#1)
this interval##7##2##(1991-2#1)(1992-2#1)(2007-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2011-1#1)
this intervention has##2##3##(1993-4#1)(1997-5#1)
this intervention study##2##3##(2006-9#1)(2008-11#1)
this intervention##20##2##(1990-9#1)(1993-4#1)(1995-1#3)(1997-2#1)(1997-5#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-3#2)(2008-4#2)(2010-4#1)(2010-7#1)(2012-12#1)(2012-3#1)
this interview##7##2##(2006-5#1)(2007-9#1)(2008-11#3)(2010-6#1)(2010-8#1)
this into account##2##3##(1991-3#1)(2011-2#1)
this into consideration##4##3##(2005-9#1)(2009-9#1)(2012-2#1)(2013-7#1)
this into##9##2##(1991-3#1)(2005-11#1)(2005-9#1)(2007-8#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-7#1)
this intriguing##3##2##(2008-1#1)(2009-9#1)(2010-12#1)
this intrinsic##2##2##(2006-10#1)(2008-2#1)
this intron##3##2##(1991-12#1)(1993-8#1)(1995-8#1)
this invasive procedure##2##3##(2007-7#1)(2010-8#1)
this inverse##2##2##(2006-10#1)(2007-8#1)
this inversion##3##2##(2008-3#3)
this invertebrate##2##2##(2008-10#1)(2013-1#1)
this investigation to determine##2##4##(1991-10#1)(2008-11#1)
this investigation to##3##3##(1991-10#1)(2008-10#1)(2008-11#1)
this investigation was to assess the##2##6##(1991-12#1)(2007-2#1)
this investigation was to##18##4##(1990-4#1)(1991-12#1)(1991-3#1)(1994-2#1)(1995-11#1)(1996-5#1)(1996-9#1)(2004-12#1)(2005-5#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-7#1)(2009-3#1)(2011-1#1)(2013-8#1)
this investigation was##21##3##(1990-4#1)(1991-12#1)(1991-3#1)(1994-2#1)(1995-11#1)(1996-5#1)(1996-9#1)(2004-12#1)(2005-5#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
this investigation##87##2##(1990-3#1)(1990-4#1)(1990-6#1)(1991-10#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-8#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-6#1)(2004-12#2)(2004-9#1)(2005-5#1)(2006-10#1)(2006-11#2)(2006-6#1)(2007-12#3)(2007-2#3)(2007-8#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
this involvement##5##2##(1993-3#1)(2006-10#1)(2007-12#2)(2008-4#1)
this involves##2##2##(1997-8#1)(2008-4#1)
this ion##6##2##(1994-8#1)(1996-7#1)(2006-4#1)(2008-10#3)
this iron##2##2##(1992-2#1)(1992-8#1)
this is a new##2##4##(1995-8#1)(2008-8#1)
this is a very##2##4##(1990-8#1)(2008-5#1)
this is a##53##3##(1990-11#1)(1990-8#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-2#1)(1993-7#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-4#1)(1995-6#1)(1995-8#1)(1997-8#1)(2005-12#1)(2005-7#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-1#1)(2009-6#1)(2009-8#1)(2010-2#1)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
this is accompanied by##2##4##(2006-6#1)(2007-8#1)
this is accomplished##5##3##(2007-2#1)(2008-1#1)(2008-2#1)(2008-4#2)
this is achieved##4##3##(1996-12#1)(2008-9#1)(2010-4#1)(2012-1#1)
this is also true of##3##5##(1991-5#1)(1991-9#1)(1993-9#1)
this is also true##5##4##(1991-5#1)(1991-9#1)(1993-9#1)(1997-5#1)(2006-10#1)
this is also##10##3##(1991-5#1)(1991-9#1)(1993-9#1)(1995-6#1)(1997-5#1)(2006-10#1)(2008-11#1)(2008-2#2)(2010-7#1)
this is an excellent##2##4##(2007-6#1)(2012-12#1)
this is an important##3##4##(1993-1#1)(1997-8#1)(2008-10#1)
this is an original##2##4##(2009-2#1)(2011-2#1)
this is an##15##3##(1991-12#1)(1993-1#1)(1997-8#1)(2007-6#1)(2008-1#2)(2008-10#2)(2008-5#1)(2008-9#1)(2009-2#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
this is applied to##2##4##(1995-8#1)(1997-8#1)
this is associated with##3##4##(1990-12#1)(1994-8#1)(1997-1#1)
this is associated##4##3##(1990-12#1)(1994-8#1)(1997-1#1)(2012-12#1)
this is based##2##3##(1996-8#1)(2008-1#1)
this is believed to be an##2##6##(2007-12#1)(2010-12#1)
this is clearly##2##3##(1996-10#1)(2008-11#1)
this is considered##2##3##(1991-9#1)(2011-2#1)
this is consistent with the##2##5##(1992-11#1)(2007-12#1)
this is consistent with##4##4##(1992-11#1)(2007-12#1)(2013-7#1)(2013-8#1)
this is consistent##5##3##(1992-11#1)(2007-12#1)(2012-12#1)(2013-7#1)(2013-8#1)
this is described##2##3##(2007-7#1)(2008-4#1)
this is done##4##3##(1996-1#1)(2008-2#1)(2012-12#1)(2013-1#1)
this is due to the##7##5##(1992-6#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
this is due to##12##4##(1992-6#1)(1997-6#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
this is due##15##3##(1990-8#1)(1992-6#1)(1997-6#1)(2006-10#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-2#1)(2012-3#2)(2013-1#1)
this is especially##3##3##(2008-2#1)(2009-4#1)(2011-3#1)
this is exactly##2##3##(2007-4#1)(2008-9#1)
this is found as a single transcript of 1##2##9##(1996-6#2)
this is in##2##3##(1994-6#1)(2008-5#1)
this is indeed##4##3##(1990-11#1)(1993-11#1)(1994-2#1)(2010-6#1)
this is known as the##2##5##(2008-2#2)
this is largely##2##3##(1996-8#1)(2012-2#1)
this is likely to##2##4##(2008-7#1)(2011-2#1)
this is linked to##2##4##(2006-9#1)(2011-2#1)
this is most##2##3##(1992-4#1)(1993-10#1)
this is no longer##2##4##(2009-5#1)(2010-9#1)
this is not a##5##4##(1994-2#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-3#1)
this is not always possible##3##5##(2008-5#1)(2011-2#1)(2012-11#1)
this is not an##3##4##(2007-12#1)(2008-1#1)(2008-11#1)
this is not because##3##4##(2007-10#1)(2007-12#2)
this is not only##2##4##(2010-12#1)(2011-2#1)
this is not the case for##2##6##(2008-1#1)(2012-2#1)
this is not the case##4##5##(2008-1#1)(2008-3#1)(2010-3#1)(2012-2#1)
this is not the##7##4##(1993-7#1)(1995-8#1)(2008-1#1)(2008-3#1)(2010-3#1)(2012-12#1)(2012-2#1)
this is not##40##3##(1993-7#1)(1994-2#1)(1995-4#1)(1995-8#1)(1997-8#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-8#1)
this is now##4##3##(1997-4#1)(2010-12#1)(2013-1#2)
this is often##3##3##(1995-1#1)(2005-11#1)(2007-5#1)
this is one of the##3##5##(1997-6#1)(2010-12#1)(2012-1#1)
this is one##4##3##(1997-6#1)(2010-12#1)(2012-1#1)(2013-8#1)
this is only the second##4##5##(2006-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
this is only##6##3##(1993-12#1)(1996-4#1)(2006-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
this is possible##2##3##(2007-12#1)(2008-5#1)
this is probably the first case##2##6##(2007-7#1)(2013-8#1)
this is probably##3##3##(2007-7#1)(2008-5#1)(2013-8#1)
this is so##4##3##(1991-2#1)(1996-3#1)(1997-1#1)(2005-10#1)
this is taken##2##3##(2007-12#1)(2008-10#1)
this is that##9##3##(2006-6#1)(2007-6#1)(2008-12#1)(2008-2#2)(2009-8#1)(2010-12#1)(2011-2#1)(2012-3#1)
this is the case of##2##5##(2008-10#1)(2008-8#1)
this is the case##13##4##(1992-7#1)(1995-5#1)(1995-9#1)(1997-5#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-12#1)(2013-1#2)
this is the first case of##12##6##(1991-12#1)(1997-8#1)(2007-12#1)(2007-7#2)(2007-8#1)(2010-3#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
this is the first case report of a##2##8##(2008-3#1)(2013-1#1)
this is the first case report of##3##7##(2008-3#1)(2009-4#1)(2013-1#1)
this is the first case report##4##6##(2008-3#1)(2009-4#1)(2012-3#1)(2013-1#1)
this is the first case##20##5##(1991-12#1)(1997-8#1)(2006-4#1)(2007-12#1)(2007-7#3)(2007-8#2)(2008-3#1)(2008-4#1)(2009-4#1)(2010-3#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
this is the first demonstration of an##3##7##(2007-12#1)(2008-10#1)(2013-1#1)
this is the first demonstration of the##2##7##(1994-8#1)(2008-1#1)
this is the first demonstration of##12##6##(1994-8#1)(1997-8#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2013-1#1)
this is the first demonstration##13##5##(1991-11#1)(1994-8#1)(1997-8#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2013-1#1)
this is the first description of##3##6##(2007-8#1)(2008-10#2)
this is the first experimental evidence of a subsecond##2##9##(2007-11#1)(2007-12#1)
this is the first instance of a##2##7##(1990-10#1)(2008-12#1)
this is the first published report##2##6##(2006-8#1)(2008-10#1)
this is the first published##3##5##(1990-12#1)(2006-8#1)(2008-10#1)
this is the first report concerning the##2##7##(1995-11#1)(2008-5#1)
this is the first report concerning##3##6##(1995-11#1)(2008-5#1)(2011-1#1)
this is the first report describing the##2##7##(1997-4#1)(2008-10#1)
this is the first report describing##3##6##(1994-12#1)(1997-4#1)(2008-10#1)
this is the first report in##2##6##(2009-3#1)(2013-8#1)
this is the first report of a simultaneous occurrence of##2##10##(1992-2#1)(1994-10#1)
this is the first report of a##12##7##(1992-2#1)(1992-9#1)(1994-10#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-12#2)
this is the first report of an improvement in severe symptoms of diabetic neuropathy with correction of vitamin D deficiency in a single patient##2##24##(2013-1#2)
this is the first report of an##7##7##(1991-9#1)(2006-12#1)(2007-8#1)(2008-3#1)(2013-1#2)(2013-8#1)
this is the first report of successful##2##7##(2006-10#1)(2008-10#1)
this is the first report of such a##2##8##(1995-1#1)(2011-1#1)
this is the first report of such##3##7##(1995-1#1)(2007-10#1)(2011-1#1)
this is the first report of the##6##7##(1993-9#1)(2008-10#3)(2008-2#1)(2013-1#1)
this is the first report of##52##6##(1991-9#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-9#1)(1994-10#1)(1994-9#1)(1995-1#1)(1995-5#1)(2005-10#1)(2006-10#3)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#3)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-8#1)(2011-1#1)(2012-12#3)(2012-3#2)(2013-1#3)(2013-8#3)
this is the first report on the##6##7##(1993-11#1)(2008-10#3)(2008-12#1)(2008-9#1)
this is the first report on##10##6##(1993-11#1)(1994-3#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-9#1)(2012-12#1)
this is the first report to##2##6##(1992-6#1)(2009-12#1)
this is the first report##75##5##(1991-9#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-5#1)(1997-4#1)(2005-10#1)(2006-10#3)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#3)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-12#4)(2012-3#2)(2013-1#3)(2013-8#4)
this is the first reported case in##2##7##(1991-9#1)(2012-2#1)
this is the first reported case of a##2##8##(2007-12#1)(2008-5#1)
this is the first reported case of##15##7##(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-11#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)
this is the first reported case##19##6##(1991-9#1)(2006-10#2)(2007-10#1)(2007-12#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-2#1)
this is the first reported##20##5##(1991-9#1)(2006-10#2)(2007-10#1)(2007-12#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-2#1)
this is the first study illustrating a framework and an approach for executing phenotyping criteria modeled in QDM using the Drools business rules management system##2##25##(2013-1#2)
this is the first study to##2##6##(2007-1#1)(2008-10#1)
this is the first study##8##5##(2007-1#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
this is the first such report##2##6##(1992-2#1)(2010-4#1)
this is the first time such a##2##7##(2006-10#1)(2013-8#1)
this is the first time that a##2##7##(1994-9#1)(2007-12#1)
this is the first time that##6##6##(1992-11#1)(1994-9#1)(2007-12#1)(2007-8#1)(2012-2#1)(2013-1#1)
this is the first time##15##5##(1992-11#1)(1994-9#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
this is the first##185##4##(1990-10#1)(1990-12#1)(1991-11#1)(1991-12#1)(1991-9#2)(1992-11#1)(1992-2#2)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-5#1)(1997-3#1)(1997-4#2)(1997-8#2)(2005-10#1)(2006-10#6)(2006-12#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#11)(2007-7#5)(2007-8#8)(2007-9#1)(2008-1#3)(2008-10#27)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#2)(2008-8#3)(2008-9#5)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-11#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#6)(2012-2#5)(2012-3#5)(2013-1#10)(2013-7#1)(2013-8#7)
this is the fourth case of##2##6##(1993-6#1)(2007-7#1)
this is the highest##4##4##(2007-12#2)(2007-7#1)(2008-3#1)
this is the most common##2##5##(2007-7#1)(2012-2#1)
this is the most##6##4##(2007-7#1)(2008-10#2)(2008-4#1)(2008-8#1)(2012-2#1)
this is the need to##2##5##(1996-8#1)(2008-11#1)
this is the only##6##4##(1992-10#1)(2007-8#1)(2008-2#1)(2008-4#1)(2010-7#1)(2011-2#1)
this is the second##4##4##(2006-10#1)(2011-2#1)(2013-1#2)
this is the seventh##2##4##(2010-12#1)(2012-2#1)
this is the youngest##2##4##(1995-4#1)(2010-9#1)
this is the##252##3##(1990-10#1)(1990-12#1)(1991-11#1)(1991-12#1)(1991-9#3)(1992-10#1)(1992-11#1)(1992-2#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-4#1)(1995-5#2)(1995-9#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-8#4)(2005-10#1)(2005-8#1)(2006-10#7)(2006-12#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#13)(2007-4#1)(2007-7#8)(2007-8#9)(2007-9#1)(2008-1#4)(2008-10#31)(2008-11#3)(2008-12#2)(2008-2#7)(2008-3#7)(2008-4#7)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#6)(2008-9#6)(2009-1#1)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#7)(2012-1#1)(2012-12#6)(2012-2#7)(2012-3#5)(2013-1#15)(2013-7#1)(2013-8#7)
this is true##5##3##(1992-6#1)(1995-11#1)(1996-4#1)(2006-9#1)(2008-12#1)
this is usually##3##3##(1997-4#1)(2007-4#1)(2008-1#1)
this is widely##2##3##(2007-6#1)(2009-3#1)
this is##601##2##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#5)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#2)(1992-6#4)(1992-7#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#3)(1993-6#4)(1993-7#3)(1993-9#3)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#2)(1994-6#3)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#2)(1995-2#1)(1995-3#1)(1995-4#3)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#2)(1996-10#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#4)(1996-6#2)(1996-8#3)(1997-1#3)(1997-3#1)(1997-4#4)(1997-5#2)(1997-6#3)(1997-8#8)(2004-10#1)(2004-4#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#17)(2006-11#1)(2006-12#1)(2006-2#2)(2006-4#2)(2006-6#6)(2006-7#1)(2006-8#4)(2006-9#3)(2007-1#1)(2007-10#3)(2007-11#8)(2007-12#23)(2007-2#1)(2007-4#4)(2007-5#2)(2007-6#3)(2007-7#12)(2007-8#12)(2007-9#3)(2008-1#14)(2008-10#48)(2008-11#11)(2008-12#5)(2008-2#21)(2008-3#12)(2008-4#11)(2008-5#14)(2008-6#2)(2008-7#6)(2008-8#14)(2008-9#14)(2009-1#3)(2009-10#1)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#4)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#5)(2010-10#2)(2010-11#2)(2010-12#7)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#4)(2011-1#9)(2011-2#21)(2011-3#2)(2012-1#4)(2012-11#3)(2012-12#14)(2012-2#15)(2012-3#12)(2013-1#23)(2013-7#3)(2013-8#13)
this isoenzyme##2##2##(2006-10#2)
this isoform##5##2##(1994-12#1)(1996-5#2)(1997-4#1)(2011-2#1)
this isolate is##2##3##(2007-2#1)(2008-10#1)
this isolate##7##2##(2007-2#1)(2008-10#3)(2008-7#1)(2012-2#2)
this isolated##4##2##(2007-8#1)(2010-3#1)(2013-1#2)
this isomerization reaction##2##3##(1992-6#2)
this isotype##2##2##(1994-12#1)(2008-4#1)
this issue and also##2##4##(2006-12#1)(2011-2#1)
this issue and##6##3##(2006-12#1)(2007-10#1)(2008-2#1)(2011-2#2)(2012-2#1)
this issue by assessing##2##4##(2008-7#1)(2009-4#1)
this issue by using##2##4##(1995-3#1)(2007-12#1)
this issue by##9##3##(1993-7#1)(1995-3#1)(1996-1#1)(1997-3#1)(2007-12#1)(2008-7#1)(2009-4#1)(2009-8#1)(2012-3#1)
this issue in a##2##4##(1997-8#1)(2007-12#1)
this issue in##7##3##(1997-8#1)(2004-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-9#1)
this issue of Molecular Ecology##2##5##(2013-1#2)
this issue of Science##3##4##(2007-8#1)(2007-9#2)
this issue of##24##3##(1994-12#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#2)(2006-11#1)(2007-2#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-11#1)(2013-1#2)(2013-7#5)
this issue using##3##3##(2007-7#1)(2008-9#1)(2012-1#1)
this issue we##3##3##(1997-2#1)(2006-4#1)(2006-6#1)
this issue when##2##3##(2008-11#1)(2009-4#1)
this issue##167##2##(1990-11#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-1#2)(1993-6#2)(1993-7#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#3)(1996-2#1)(1996-3#1)(1996-8#1)(1997-2#2)(1997-3#4)(1997-8#1)(2004-12#2)(2004-2#1)(2005-10#2)(2006-10#6)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#4)(2007-9#4)(2008-1#2)(2008-10#3)(2008-11#13)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#6)(2012-1#3)(2012-12#8)(2012-2#2)(2012-3#4)(2013-1#8)(2013-7#6)(2013-8#4)
this issue's##2##2##(2008-6#1)(2010-9#1)
this issue)##6##2##(2007-12#1)(2008-5#1)(2009-9#1)(2010-2#1)(2010-5#1)(2012-2#1)
this it is##2##3##(1991-7#1)(2008-6#1)
this it was##2##3##(1996-5#1)(2008-10#1)
this it##6##2##(1991-7#1)(1995-6#1)(1996-5#1)(2008-10#1)(2008-6#1)(2008-7#1)
this item##2##2##(2008-8#1)(2008-9#1)
this joint##6##2##(2006-10#1)(2006-8#1)(2007-12#1)(2007-7#2)(2010-4#1)
this journal##20##2##(1990-3#2)(1991-4#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-6#1)(1995-9#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-7#1)(2009-10#1)(2010-2#1)(2013-1#1)
this juncture##4##2##(2005-8#1)(2007-11#1)(2007-7#1)(2012-2#1)
this key##4##2##(1994-3#1)(1996-3#1)(2010-11#2)
this kinase##12##2##(1990-7#1)(1991-1#2)(1991-12#1)(1992-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-6#1)(1996-5#1)(2010-11#1)
this kind of device##2##4##(2007-12#1)(2007-8#1)
this kind of patients##2##4##(2007-10#1)(2013-7#1)
this kind of sample##2##4##(2008-10#2)
this kind of surgery##2##4##(1991-3#1)(2007-11#1)
this kind of surgical##2##4##(1990-4#1)(1992-6#1)
this kind of treatment##8##4##(1993-3#1)(1995-4#1)(2006-6#1)(2007-7#1)(2007-8#2)(2008-12#1)(2008-4#1)
this kind of##83##3##(1990-10#1)(1990-12#1)(1990-4#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-10#2)(1992-6#1)(1992-8#1)(1993-3#3)(1994-12#1)(1995-4#2)(1996-12#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-5#1)(2005-4#1)(2006-10#1)(2006-5#1)(2006-6#2)(2007-10#2)(2007-11#2)(2007-12#5)(2007-7#4)(2007-8#4)(2007-9#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#2)(2008-8#2)(2009-12#1)(2009-2#1)(2009-4#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2013-7#1)
this kind##103##2##(1990-10#1)(1990-12#1)(1990-4#1)(1990-6#1)(1991-2#2)(1991-3#1)(1991-9#1)(1992-10#2)(1992-6#1)(1992-8#1)(1993-3#3)(1993-9#1)(1994-12#2)(1995-4#2)(1995-5#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-5#1)(2005-11#1)(2005-4#1)(2006-10#2)(2006-5#1)(2006-6#2)(2007-10#2)(2007-11#3)(2007-12#6)(2007-7#4)(2007-8#5)(2007-9#1)(2008-10#14)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#2)(2008-7#1)(2008-8#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-1#1)(2013-7#1)
this kindred##3##2##(1993-6#1)(1995-1#1)(2006-10#1)
this kinetic##3##2##(1990-5#1)(2005-11#1)(2013-8#1)
this knowledge as##2##3##(2009-6#1)(2011-2#1)
this knowledge base##3##3##(2005-7#1)(2010-5#1)(2011-2#1)
this knowledge for##2##3##(1995-5#1)(2013-7#1)
this knowledge has##2##3##(2011-2#1)(2012-2#1)
this knowledge in a##2##4##(1990-6#1)(2007-12#1)
this knowledge in##3##3##(1990-6#1)(2007-12#1)(2008-12#1)
this knowledge is##2##3##(2013-1#1)(2013-8#1)
this knowledge may##3##3##(2006-1#1)(2013-1#2)
this knowledge to the##2##4##(2008-4#1)(2009-5#1)
this knowledge to##5##3##(2008-12#1)(2008-4#1)(2008-9#1)(2009-5#1)(2011-2#1)
this knowledge##44##2##(1990-10#1)(1990-6#1)(1991-2#1)(1992-5#1)(1993-10#1)(1995-5#1)(1996-1#1)(1997-6#1)(2005-10#1)(2005-7#1)(2006-1#1)(2006-11#1)(2006-12#1)(2007-12#2)(2008-11#1)(2008-12#2)(2008-2#3)(2008-4#2)(2008-7#2)(2008-9#2)(2009-5#1)(2009-6#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-2#4)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#1)
this labeling##2##2##(1990-12#1)(1993-7#1)
this laboratory demonstrated that##2##4##(1995-12#1)(1996-4#1)
this laboratory demonstrated##3##3##(1995-12#1)(1996-4#1)(2008-10#1)
this laboratory have##2##3##(1997-8#1)(2005-10#1)
this laboratory##29##2##(1990-11#2)(1990-2#1)(1991-3#1)(1991-4#1)(1992-7#1)(1992-8#1)(1993-11#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-4#1)(1996-8#1)(1997-8#1)(2004-9#1)(2005-10#2)(2006-9#1)(2008-10#3)(2008-6#1)(2008-7#1)(2011-2#1)(2012-1#1)
this lack of data##2##4##(2007-7#1)(2008-7#1)
this lack of information##2##4##(2010-5#1)(2013-7#1)
this lack of##8##3##(1990-12#1)(1994-2#1)(2006-7#1)(2007-7#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-7#1)
this lack##9##2##(1990-12#1)(1994-2#1)(2006-7#1)(2007-7#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-7#1)(2013-8#1)
this laparoscopic##2##2##(1994-2#1)(1996-2#1)
this large and##2##3##(2010-2#1)(2012-12#1)
this large##18##2##(1992-1#1)(1995-10#1)(1996-9#1)(2005-9#1)(2006-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-2#1)(2011-2#3)(2012-12#1)(2012-2#1)
this largely##3##2##(1991-11#1)(2008-8#1)(2010-10#1)
this larger##2##2##(2006-4#1)(2006-7#1)
this laser source##2##3##(2007-11#1)(2007-12#1)
this laser system##3##3##(2008-2#3)
this laser##24##2##(2007-11#4)(2007-12#6)(2008-1#1)(2008-2#8)(2008-3#4)(2009-5#1)
this last##12##2##(1991-7#1)(1994-2#1)(1994-3#1)(1997-3#1)(2008-10#4)(2008-5#2)(2012-2#1)(2013-8#1)
this late##2##2##(2008-12#1)(2008-7#1)
this later##2##2##(1992-11#1)(2013-8#1)
this latter effect##2##3##(1990-2#1)(1994-9#1)
this latter group were##2##4##(1992-5#1)(2005-10#1)
this latter group##9##3##(1992-5#2)(1993-8#1)(1995-1#1)(1995-8#1)(2005-10#1)(2007-8#1)(2008-10#1)(2008-7#1)
this latter method##2##3##(1992-8#1)(2008-4#1)
this latter##35##2##(1990-2#1)(1990-8#1)(1992-3#1)(1992-5#2)(1992-8#2)(1993-5#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-8#1)(1997-4#1)(2004-11#1)(2005-10#1)(2005-8#1)(2006-8#1)(2007-8#2)(2008-10#4)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-5#1)
this law##2##2##(1993-1#1)(2009-2#1)
this lawsuit##2##2##(1993-12#1)(2007-4#1)
this layer##4##2##(2007-12#1)(2007-9#1)(2009-7#1)(2012-2#1)
this leads to##8##3##(1991-2#1)(2004-11#1)(2006-4#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
this leads##10##2##(1991-2#1)(1997-6#1)(2004-11#1)(2006-4#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#1)
this learning##5##2##(1991-5#1)(1996-9#1)(2007-5#1)(2008-11#1)(2010-5#1)
this lectin##5##2##(1990-11#1)(1990-7#1)(1993-3#1)(1995-3#1)(2009-7#1)
this led to##5##3##(1993-6#1)(2006-4#1)(2008-3#1)(2008-7#1)(2008-9#1)
this length##4##2##(1995-1#1)(2007-12#1)(2008-3#1)(2008-5#1)
this lesion as##2##3##(2010-6#1)(2013-8#1)
this lesion is##5##3##(1991-6#2)(2006-2#1)(2010-12#1)(2010-5#1)
this lesion may require surgical intervention and removal##2##8##(2013-1#2)
this lesion may##3##3##(2012-3#1)(2013-1#2)
this lesion##32##2##(1990-9#1)(1991-6#2)(1994-8#1)(1995-5#1)(1995-9#1)(1996-3#1)(2006-2#1)(2007-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#5)
this letter##6##2##(2008-10#2)(2008-2#1)(2008-3#1)(2009-5#1)(2012-2#1)
this level of##8##3##(1991-9#1)(1994-9#1)(1996-1#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-1#1)
this level##33##2##(1991-9#1)(1992-5#1)(1992-7#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-6#1)(1996-1#2)(2004-1#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-8#4)(2006-9#1)(2007-11#1)(2007-2#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#2)(2010-1#1)(2011-1#2)(2013-1#2)
this library##8##2##(1990-11#1)(1992-8#1)(1997-8#1)(2008-2#1)(2008-4#1)(2008-8#1)(2011-1#1)(2013-1#1)
this lidar##2##2##(2008-3#2)
this life##3##2##(2007-2#1)(2012-12#1)(2013-1#1)
this life-threatening condition##2##3##(2006-10#1)(2012-2#1)
this life-threatening##6##2##(2005-8#1)(2006-10#2)(2011-2#1)(2012-2#1)(2013-1#1)
this ligament##2##2##(2007-1#2)
this ligand##12##2##(1990-9#1)(1991-5#1)(1992-9#1)(1994-2#1)(1994-9#1)(1996-11#1)(2006-6#1)(2008-10#2)(2008-5#1)(2010-5#2)
this light##8##2##(1993-8#1)(2008-2#1)(2008-4#1)(2010-12#1)(2010-5#1)(2011-1#2)(2012-11#1)
this likely##2##2##(2006-10#1)(2012-2#1)
this limb##2##2##(1993-9#1)(2007-12#1)
this limit##5##2##(2006-4#2)(2008-3#1)(2012-12#2)
this limitation by##4##3##(2008-12#1)(2008-2#2)(2008-3#1)
this limitation##24##2##(1991-9#1)(1994-2#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-7#2)(2008-9#2)(2009-10#1)(2010-11#1)(2010-7#1)(2012-2#1)(2013-1#2)(2013-7#1)
this limited##5##2##(1994-10#1)(2008-5#1)(2008-6#1)(2013-1#1)(2013-7#1)
this line of##3##3##(2012-2#1)(2013-1#2)
this line was##2##3##(2006-12#1)(2008-10#1)
this line##12##2##(1991-5#1)(1994-8#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2012-2#1)(2013-1#2)
this linear relationship##2##3##(2005-11#1)(2008-2#1)
this linear##4##2##(2005-11#1)(2007-11#1)(2007-12#1)(2008-2#1)
this link was##2##3##(1993-9#1)(2008-4#1)
this link##5##2##(1993-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)
this linkage##4##2##(1990-2#1)(2006-10#1)(2010-2#1)(2013-8#1)
this lipid##9##2##(1990-4#2)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-8#1)(2007-8#1)(2008-10#1)
this list##2##2##(1996-3#1)(2008-10#1)
this literature review##6##3##(2006-10#1)(2007-2#2)(2008-5#1)(2009-5#1)(2012-12#1)
this literature##22##2##(1992-12#1)(1993-1#1)(1995-3#1)(1996-8#1)(2006-10#1)(2006-11#1)(2007-2#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#2)(2009-7#1)(2012-12#1)(2012-2#1)(2013-1#2)
this liver##2##2##(1992-3#1)(2005-8#1)
this local study##2##3##(2006-10#1)(2008-10#1)
this local##8##2##(1991-10#1)(2006-10#1)(2008-10#1)(2008-2#1)(2009-8#1)(2010-11#1)(2012-2#1)(2012-7#1)
this localization##5##2##(1994-12#1)(1997-6#1)(2009-4#1)(2011-2#1)(2012-2#1)
this localized##2##2##(2008-2#1)(2010-10#1)
this locally##2##2##(1990-5#1)(2007-8#1)
this location is##3##3##(1994-12#1)(2008-5#1)(2012-12#1)
this location##15##2##(1994-12#1)(1995-1#1)(1996-9#1)(2005-5#1)(2005-9#1)(2006-10#1)(2008-10#3)(2008-5#1)(2009-3#1)(2009-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
this locking##2##2##(2006-7#1)(2008-3#1)
this locus in##2##3##(1993-3#1)(2008-5#1)
this locus is##3##3##(1993-11#1)(1994-8#1)(2010-12#1)
this locus##22##2##(1991-5#1)(1991-7#1)(1993-10#1)(1993-11#1)(1993-3#2)(1994-8#1)(1995-11#1)(1995-2#1)(1996-10#1)(1996-12#1)(1997-3#1)(1997-7#1)(2008-10#4)(2008-12#1)(2008-5#2)(2010-12#1)(2012-11#1)
this long##6##2##(1992-3#1)(1996-1#1)(2008-1#1)(2008-8#1)(2011-1#1)(2011-2#1)
this longitudinal##6##2##(1995-12#1)(2007-2#1)(2009-12#1)(2010-1#1)(2011-2#1)(2012-3#1)
this loop##8##2##(1991-7#1)(1992-11#1)(1995-2#1)(1996-5#1)(2008-8#1)(2009-10#1)(2009-6#1)(2012-3#1)
this loss of##6##3##(1990-5#2)(1992-12#1)(1995-12#1)(2007-5#1)(2008-4#1)
this loss##11##2##(1990-5#2)(1990-8#1)(1992-12#1)(1995-12#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-2#1)(2008-3#1)(2008-4#1)
this low##8##2##(1992-11#1)(1994-7#1)(1994-8#1)(1995-6#1)(2008-10#3)(2011-2#1)
this lower##4##2##(1993-8#1)(2007-4#1)(2008-7#1)(2010-1#1)
this luciferase##2##2##(1990-10#1)(1990-7#1)
this lymphoma##3##2##(2006-10#1)(2008-7#2)
this mRNA##6##2##(1991-10#1)(1992-12#1)(1992-6#1)(1994-10#1)(1994-11#1)(1994-9#1)
this magnitude##7##2##(1990-9#1)(1993-12#1)(1993-9#1)(1996-2#1)(2007-12#1)(2008-10#1)(2013-1#1)
this major side effect##2##4##(2006-10#1)(2008-3#1)
this major##12##2##(1990-11#1)(1994-8#1)(2005-10#1)(2006-10#2)(2006-2#2)(2008-10#1)(2008-11#2)(2008-3#1)(2009-6#1)
this makes it##4##3##(2006-10#2)(2008-4#2)
this makes##8##2##(2006-10#2)(2007-8#1)(2008-4#2)(2008-6#1)(2010-8#1)(2011-1#1)
this male##2##2##(2008-11#1)(2008-3#1)
this malformation##5##2##(2008-10#1)(2008-7#1)(2009-5#2)(2012-3#1)
this malignancy##10##2##(2004-1#1)(2007-4#1)(2009-11#2)(2009-5#1)(2010-11#1)(2011-2#2)(2012-2#1)(2012-3#1)
this management##5##2##(1991-3#1)(2011-2#1)(2013-1#1)(2013-7#2)
this manifestation##2##2##(2006-2#1)(2012-2#1)
this manipulation##2##2##(1993-11#1)(1993-3#1)
this manner##25##2##(1990-12#1)(1990-8#1)(1991-3#1)(1994-12#1)(1994-9#1)(1997-7#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-4#1)(2008-7#1)(2009-11#1)(2009-9#1)(2010-11#1)(2011-1#2)(2012-1#2)
this manual##17##2##(2008-4#10)(2008-9#5)(2009-6#1)(2010-12#1)
this manuscript we review the##2##5##(2011-12#1)(2012-3#1)
this manuscript we review##3##4##(2008-7#1)(2011-12#1)(2012-3#1)
this manuscript we##6##3##(2008-7#2)(2009-12#1)(2010-2#1)(2011-12#1)(2012-3#1)
this manuscript##31##2##(2006-7#1)(2006-8#2)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#3)(2008-8#1)(2009-1#1)(2009-12#1)(2009-3#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
this map##2##2##(1997-8#1)(2008-5#1)
this marine##3##2##(2007-5#1)(2009-10#1)(2011-2#1)
this marker and##2##3##(2007-2#1)(2012-1#1)
this marker##11##2##(1990-2#1)(1991-9#1)(1992-9#2)(2007-2#1)(2008-10#3)(2011-1#1)(2011-12#1)(2012-1#1)
this market##4##2##(1995-3#1)(1997-3#1)(2010-1#1)(2010-4#1)
this mass##2##2##(2008-6#1)(2009-7#1)
this material has been##2##4##(1990-9#1)(2008-8#1)
this material is##5##3##(1991-12#1)(1996-5#1)(2005-11#1)(2007-8#1)(2008-10#1)
this material was##3##3##(1992-6#1)(2008-10#1)(2008-3#1)
this material were##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
this material##39##2##(1990-9#2)(1991-12#1)(1991-7#1)(1992-6#1)(1992-8#1)(1993-1#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-3#1)(2005-11#1)(2005-4#1)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#4)(2008-8#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
this matrix##11##2##(1990-9#1)(1993-4#1)(2006-1#1)(2007-12#3)(2008-10#4)(2008-3#1)
this matter##16##2##(1991-8#1)(1993-8#1)(1997-8#1)(2005-4#1)(2006-10#1)(2007-1#1)(2007-5#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-9#2)(2010-2#1)(2011-1#1)(2011-2#1)
this maximum##3##2##(2008-2#1)(2008-8#1)(2012-11#1)
this may affect##2##3##(1997-3#1)(2008-5#1)
this may also lead to##2##5##(2008-10#1)(2008-7#1)
this may also##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2010-8#1)
this may be a disadvantage in patients##2##7##(1992-3#1)(2008-5#1)
this may be a##7##4##(1992-3#1)(1994-11#1)(1995-6#1)(1997-5#1)(2008-5#1)(2008-6#1)(2008-8#1)
this may be an##3##4##(2007-4#1)(2010-2#1)(2013-1#1)
this may be difficult##2##4##(1992-3#1)(2011-1#1)
this may be due to the##2##6##(1992-7#1)(1993-2#1)
this may be due to##7##5##(1992-7#1)(1993-12#1)(1993-2#1)(2005-8#1)(2008-7#1)(2009-10#1)(2011-2#1)
this may be due##8##4##(1992-7#1)(1993-12#1)(1993-2#1)(2005-8#1)(2006-5#1)(2008-7#1)(2009-10#1)(2011-2#1)
this may be explained by##2##5##(2007-2#1)(2008-1#1)
this may be explained##3##4##(2005-11#1)(2007-2#1)(2008-1#1)
this may be regulated by##2##5##(1994-8#1)(1995-11#1)
this may be responsible##2##4##(2008-10#1)(2008-4#1)
this may be the##3##4##(1991-12#1)(1995-6#1)(2011-1#1)
this may be##59##3##(1990-5#1)(1991-12#1)(1991-2#1)(1992-2#1)(1992-3#4)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#2)(1996-12#1)(1997-5#1)(2005-11#2)(2005-8#1)(2006-12#2)(2006-5#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-4#2)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#1)(2013-1#3)
this may cause##12##3##(2008-10#1)(2008-11#5)(2008-4#1)(2008-6#1)(2008-8#1)(2012-11#3)
this may contribute to the##2##5##(1994-2#1)(2009-4#1)
this may explain why the##2##5##(1994-12#1)(2008-10#1)
this may explain why##3##4##(1994-12#1)(2008-10#1)(2008-8#1)
this may have been due to##2##6##(1996-11#1)(2009-5#1)
this may have been##3##4##(1990-6#1)(1996-11#1)(2009-5#1)
this may have on##2##4##(2008-8#1)(2012-2#1)
this may have##10##3##(1990-6#1)(1996-11#1)(1997-5#1)(2005-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-5#1)(2012-2#1)(2013-7#1)
this may indicate##2##3##(1996-6#1)(2008-7#1)
this may lead to##7##4##(2008-10#2)(2008-8#1)(2009-6#1)(2009-8#1)(2010-7#1)(2013-1#1)
this may not be the##2##5##(2006-11#1)(2009-9#1)
this may not be##3##4##(1994-8#1)(2006-11#1)(2009-9#1)
this may not##4##3##(1994-8#1)(2006-11#1)(2008-7#1)(2009-9#1)
this may reflect a##2##4##(1996-12#1)(2006-10#1)
this may reflect##3##3##(1996-12#1)(2006-10#1)(2008-11#1)
this may represent a##2##4##(2011-2#1)(2012-12#1)
this may represent##3##3##(1995-11#1)(2011-2#1)(2012-12#1)
this may result in##4##4##(1996-4#1)(2007-3#1)(2008-10#1)(2008-11#1)
this may result##5##3##(1991-4#1)(1996-4#1)(2007-3#1)(2008-10#1)(2008-11#1)
this may##149##2##(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#4)(1992-7#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-11#2)(1995-12#1)(1995-3#1)(1995-6#2)(1996-11#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-6#1)(1997-3#1)(1997-5#2)(1997-8#1)(2005-10#3)(2005-11#2)(2005-12#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#8)(2008-12#2)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#7)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-11#4)(2012-12#2)(2012-2#2)(2013-1#5)(2013-7#1)
this mean##4##2##(2007-11#1)(2008-10#1)(2012-3#1)(2013-7#1)
this means that##3##3##(1993-6#1)(2005-10#1)(2013-8#1)
this means##7##2##(1990-2#1)(1993-6#1)(2005-10#1)(2007-12#1)(2007-7#1)(2012-2#1)(2013-8#1)
this measure of##3##3##(1995-5#1)(2008-2#1)(2010-6#1)
this measure##11##2##(1991-10#1)(1995-5#1)(1997-5#2)(1997-7#1)(2007-12#1)(2008-2#2)(2008-3#1)(2010-12#1)(2010-6#1)
this measurement technique##2##3##(2007-12#1)(2008-2#1)
this measurement##6##2##(1995-1#1)(1997-6#1)(2007-12#1)(2008-2#1)(2008-9#2)
this mechanism and##3##3##(1994-8#1)(1995-11#1)(2010-3#1)
this mechanism are##3##3##(1995-8#1)(2005-11#1)(2011-2#1)
this mechanism can be##2##4##(2007-12#1)(2008-9#1)
this mechanism is##5##3##(1992-8#1)(2007-3#1)(2008-2#1)(2008-5#1)(2009-3#1)
this mechanism may be##2##4##(1991-12#1)(1992-11#1)
this mechanism may##6##3##(1991-12#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-2#1)(1994-8#1)
this mechanism of##4##3##(1997-6#1)(2006-7#1)(2008-11#1)(2009-3#1)
this mechanism remains unclear##2##4##(2008-8#2)
this mechanism##52##2##(1990-12#1)(1990-3#1)(1991-12#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-2#1)(1994-6#2)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-5#1)(1997-6#1)(1997-8#1)(2005-11#2)(2006-7#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-3#2)(2009-7#1)(2009-8#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-1#1)
this media##2##2##(2008-10#2)
this medical##4##2##(1992-10#1)(2006-7#1)(2010-7#1)(2013-8#1)
this medication##4##2##(1996-8#1)(2008-5#1)(2008-7#1)(2010-5#1)
this medium was##2##3##(2008-10#2)
this medium##12##2##(1991-1#1)(1991-3#1)(1996-11#1)(1997-6#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)
this meeting is##2##3##(2005-8#1)(2007-11#1)
this meeting was the##2##4##(2005-9#1)(2008-5#1)
this meeting was##7##3##(2005-9#1)(2008-5#4)(2008-8#1)(2011-1#1)
this meeting##35##2##(1997-8#1)(2004-12#1)(2005-7#1)(2005-8#6)(2005-9#5)(2007-11#1)(2008-2#1)(2008-5#13)(2008-8#1)(2009-4#2)(2010-11#1)(2011-1#1)(2011-2#1)
this membrane##14##2##(1990-11#1)(1990-8#1)(1991-1#2)(1992-1#1)(1993-3#1)(1994-9#1)(1997-1#1)(2007-9#1)(2008-10#5)
this memory##2##2##(1990-11#1)(1994-2#1)
this meta-analysis##4##2##(1995-8#1)(2007-9#1)(2009-8#1)(2012-3#1)
this metabolic pathway##6##3##(1994-12#1)(1994-8#1)(2008-11#1)(2010-12#1)(2011-2#1)(2012-2#1)
this metabolic##11##2##(1992-2#1)(1994-12#1)(1994-8#1)(1995-9#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
this metabolism##4##2##(1992-10#1)(2008-11#1)(2008-7#1)(2010-2#1)
this metabolite##6##2##(1991-1#1)(1991-8#1)(1991-9#1)(1993-2#1)(2006-10#2)
this metal##11##2##(1993-4#1)(1994-8#1)(1996-12#1)(1997-1#1)(2007-12#1)(2008-10#4)(2008-5#2)
this metastatic##2##2##(1992-8#2)
this method a##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
this method allows##4##3##(1991-12#1)(2008-2#1)(2008-4#1)(2010-12#1)
this method and the results##2##5##(2008-10#2)
this method and the##6##4##(1992-4#1)(1997-4#1)(2005-4#1)(2007-11#1)(2008-10#2)
this method and##14##3##(1990-3#1)(1992-4#1)(1995-8#1)(1997-4#1)(2005-4#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)
this method are presented##2##4##(2007-12#1)(2008-3#1)
this method are shown##2##4##(1992-4#1)(2008-2#1)
this method are##23##3##(1991-11#1)(1992-4#1)(1994-6#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-9#1)(2010-3#1)
this method as a##2##4##(2007-10#1)(2008-10#1)
this method as##3##3##(2007-10#1)(2008-10#1)(2008-2#1)
this method by##5##3##(2007-12#2)(2008-3#2)(2008-7#1)
this method can be applied to determine##2##7##(1994-9#1)(2008-10#1)
this method can be applied to##5##6##(1994-9#1)(2008-10#2)(2008-3#1)(2011-2#1)
this method can be used in##2##6##(2006-6#1)(2008-3#1)
this method can be used##5##5##(2006-6#1)(2007-12#1)(2007-7#1)(2008-3#2)
this method can be##18##4##(1992-5#1)(1994-9#1)(1996-12#1)(2005-11#1)(2006-6#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#3)(2011-2#1)(2012-2#1)
this method can provide##2##4##(2007-11#1)(2008-1#1)
this method can##27##3##(1992-5#1)(1994-9#1)(1996-12#1)(2005-11#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-3#3)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
this method could be##2##4##(1991-2#1)(2007-8#1)
this method could##7##3##(1991-2#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-1#1)
this method does not provide a##2##6##(1996-3#1)(2008-5#1)
this method does not##5##4##(1996-3#1)(2008-10#2)(2008-4#1)(2008-5#1)
this method due to##2##4##(1997-2#1)(2008-10#1)
this method failed##2##3##(1993-10#1)(2006-12#1)
this method for the##7##4##(1994-5#1)(1997-1#1)(2008-10#3)(2008-12#1)(2012-3#1)
this method for##21##3##(1992-4#1)(1993-12#1)(1994-5#1)(1995-8#1)(1996-4#1)(1996-8#1)(1997-1#1)(2006-7#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
this method from##4##3##(1990-12#1)(1997-2#1)(2007-8#1)(2008-2#1)
this method gives##2##3##(2006-10#1)(2008-4#1)
this method has been##2##4##(2008-11#1)(2008-2#1)
this method has##11##3##(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-9#1)(2012-2#1)(2013-8#1)
this method have##3##3##(2007-1#1)(2012-12#1)(2012-3#1)
this method in a##2##4##(2008-2#1)(2008-3#1)
this method in the##5##4##(2006-10#1)(2007-11#1)(2008-3#1)(2010-12#2)
this method in##16##3##(1990-4#1)(1994-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2010-12#2)
this method is 0##2##4##(2008-10#2)
this method is a##4##4##(1990-12#1)(2007-12#1)(2007-7#1)(2008-3#1)
this method is discussed##2##4##(1993-10#1)(2008-3#1)
this method is not sensitive##2##5##(2011-2#1)(2013-8#1)
this method is not##4##4##(2008-10#1)(2011-2#1)(2013-8#2)
this method is remarkably##2##4##(2005-11#1)(2010-5#1)
this method is that##9##4##(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2011-2#1)(2012-3#1)
this method is the##4##4##(1996-3#1)(2005-1#1)(2007-7#2)
this method is##77##3##(1990-12#1)(1990-8#1)(1993-10#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-4#1)(2005-1#1)(2005-11#1)(2005-4#1)(2007-10#1)(2007-11#6)(2007-12#5)(2007-7#3)(2007-8#1)(2007-9#1)(2008-10#17)(2008-11#2)(2008-2#5)(2008-3#9)(2008-4#3)(2009-2#1)(2010-11#1)(2010-3#1)(2010-5#2)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
this method it is##2##4##(1992-1#1)(2008-3#1)
this method it##3##3##(1992-1#1)(1995-1#1)(2008-3#1)
this method may be used##2##5##(2007-7#1)(2010-7#1)
this method may be##4##4##(1991-12#1)(1992-5#1)(2007-7#1)(2010-7#1)
this method may provide##2##4##(1997-1#1)(2012-2#1)
this method may##9##3##(1991-12#1)(1992-5#1)(1997-1#1)(2006-6#1)(2007-7#1)(2007-9#1)(2010-7#1)(2012-2#1)(2012-3#1)
this method might be##2##4##(2008-10#1)(2008-11#1)
this method might##5##3##(1990-9#1)(2007-10#1)(2008-10#2)(2008-11#1)
this method of##15##3##(1992-4#1)(1995-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
this method provides##4##3##(2007-2#1)(2008-2#1)(2008-3#1)(2008-7#1)
this method reduces the##2##4##(1991-2#1)(2008-10#1)
this method requires##5##3##(1990-11#1)(1991-7#1)(2008-1#1)(2008-10#1)(2008-3#1)
this method should be##2##4##(1996-9#1)(2007-11#1)
this method should##4##3##(1996-9#1)(2004-11#1)(2007-11#1)(2007-12#1)
this method show##2##3##(2006-12#1)(2008-5#1)
this method showed good##2##4##(2008-10#2)
this method shows##2##3##(2005-4#1)(2008-10#1)
this method the cells##2##4##(2008-10#1)(2010-5#1)
this method the##19##3##(1991-5#1)(1995-2#1)(2005-11#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#7)(2009-2#1)(2010-5#1)
this method to a##2##4##(2008-2#1)(2009-5#1)
this method to an##2##4##(2008-3#1)(2011-1#1)
this method to the##5##4##(2007-12#1)(2008-10#2)(2008-2#1)(2012-3#1)
this method to##37##3##(1990-3#1)(1994-9#1)(1995-5#1)(1997-2#1)(1997-3#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-2#5)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#2)(2009-5#1)(2010-6#1)(2011-1#2)(2012-12#2)(2012-2#1)(2012-3#2)
this method using##2##3##(1995-8#1)(2007-8#1)
this method was 5##2##4##(2007-8#1)(2010-5#1)
this method was##38##3##(1990-2#1)(1990-4#1)(1990-9#1)(1991-5#1)(1993-2#2)(1995-2#2)(1996-6#1)(2005-4#3)(2006-6#1)(2006-8#1)(2007-8#1)(2008-10#17)(2008-11#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-1#1)(2010-5#1)
this method we were able to##2##6##(1992-7#1)(2008-5#1)
this method we##7##3##(1990-12#1)(1992-7#1)(2007-11#1)(2007-8#1)(2008-3#2)(2008-5#1)
this method were better than those obtained##2##7##(2008-10#2)
this method were compared with##4##5##(2007-10#1)(2008-10#3)
this method were compared##5##4##(2007-10#1)(2007-7#1)(2008-10#3)
this method were in good agreement with the##2##8##(2008-10#2)
this method were in good agreement with##4##7##(2008-10#4)
this method were in##6##4##(2008-10#4)(2008-5#1)(2013-8#1)
this method were##19##3##(1990-2#1)(1990-8#1)(2007-10#1)(2007-7#1)(2008-10#11)(2008-4#1)(2008-5#2)(2013-8#1)
this method will##5##3##(2007-11#1)(2008-11#2)(2008-4#1)(2011-2#1)
this method with the##2##4##(2007-12#1)(2009-3#1)
this method with##9##3##(1992-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2009-3#1)(2012-12#1)
this method would##2##3##(2008-8#1)(2012-12#1)
this method##670##2##(1990-11#1)(1990-12#5)(1990-2#4)(1990-3#3)(1990-4#4)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#5)(1990-9#3)(1991-11#3)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#4)(1991-7#1)(1992-1#1)(1992-2#2)(1992-4#4)(1992-5#2)(1992-7#1)(1992-8#1)(1993-1#1)(1993-10#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-5#2)(1993-8#2)(1993-9#1)(1994-11#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#2)(1995-2#6)(1995-3#1)(1995-5#1)(1995-8#4)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-4#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#5)(1997-3#4)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#1)(2004-11#1)(2005-1#1)(2005-11#6)(2005-12#1)(2005-4#10)(2005-8#1)(2006-10#2)(2006-12#2)(2006-5#1)(2006-6#4)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#4)(2007-11#20)(2007-12#23)(2007-2#2)(2007-5#3)(2007-7#8)(2007-8#14)(2007-9#3)(2008-1#10)(2008-10#152)(2008-11#22)(2008-12#4)(2008-2#49)(2008-3#57)(2008-4#17)(2008-5#7)(2008-6#6)(2008-7#7)(2008-8#7)(2008-9#5)(2009-10#1)(2009-12#1)(2009-2#4)(2009-3#1)(2009-5#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#10)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#4)(2011-2#7)(2012-1#1)(2012-12#14)(2012-2#8)(2012-3#9)(2013-1#2)(2013-7#2)(2013-8#6)
this methodology in##2##3##(1992-3#1)(2009-8#1)
this methodology is##7##3##(1992-11#1)(1992-12#1)(2005-5#1)(2006-12#1)(2008-2#1)(2012-12#2)
this methodology to a##2##4##(1997-2#1)(2008-10#1)
this methodology to the preparation of##2##6##(2007-11#2)
this methodology to the##3##4##(2007-11#2)(2010-7#1)
this methodology to##10##3##(1993-5#1)(1997-2#1)(2007-11#2)(2008-10#1)(2008-2#1)(2009-11#1)(2009-12#1)(2010-7#1)(2012-2#1)
this methodology##46##2##(1992-11#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-5#1)(1993-9#1)(1996-12#1)(1997-2#1)(1997-8#1)(2005-5#1)(2006-12#1)(2006-5#2)(2007-11#2)(2007-4#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-2#3)(2008-4#3)(2008-9#2)(2009-11#2)(2009-12#1)(2009-8#1)(2010-7#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
this metric##2##2##(2008-6#1)(2010-5#1)
this microchip##2##2##(2008-10#2)
this microcrystalline##2##2##(2008-10#1)(2010-12#1)
this microenvironment is##2##3##(1994-9#1)(2008-3#1)
this microenvironment##3##2##(1994-9#1)(2008-3#1)(2012-3#1)
this microfluidic device##3##3##(2008-11#3)
this microorganism##7##2##(2006-10#1)(2007-12#1)(2009-3#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
this might be a##2##4##(1994-2#1)(2007-5#1)
this might be the##2##4##(1995-8#1)(2008-6#1)
this might be##5##3##(1994-2#1)(1995-8#1)(1997-2#1)(2007-5#1)(2008-6#1)
this might explain##3##3##(2007-11#1)(2008-10#1)(2008-8#1)
this might lead to##2##4##(1991-6#1)(2013-1#1)
this might##15##2##(1991-6#1)(1994-2#1)(1995-8#1)(1996-10#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#1)(2012-1#1)(2013-1#1)(2013-8#1)
this mild##2##2##(1996-5#1)(1997-5#1)
this mini-review##10##2##(2007-1#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-2#1)(2010-7#1)(2012-3#1)
this minimal##2##2##(1997-6#1)(2007-8#1)
this minimally invasive##5##3##(1991-6#1)(2006-12#1)(2006-6#1)(2007-12#1)(2011-2#1)
this minimum##3##2##(1992-9#1)(1997-3#1)(2008-3#1)
this mirror##2##2##(2008-2#2)
this mismatch##2##2##(1996-1#1)(2006-5#1)
this missing##4##2##(2007-8#1)(2008-8#1)(2010-5#1)(2012-3#1)
this mitochondrial##2##2##(1994-11#1)(1996-9#1)
this mixture was##2##3##(1997-3#1)(2009-3#1)
this mixture##8##2##(1996-8#1)(1997-3#1)(1997-7#1)(2008-10#3)(2009-3#1)(2010-11#1)
this modality in##2##3##(2005-2#1)(2006-10#1)
this modality is##2##3##(2007-7#1)(2008-1#1)
this modality##14##2##(1997-1#1)(2004-1#1)(2005-2#1)(2005-5#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-7#1)(2010-12#1)(2010-7#1)(2010-9#1)
this mode of##15##3##(1990-4#1)(1991-12#1)(1994-6#1)(1996-2#1)(1996-7#1)(1996-8#1)(2005-5#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-9#1)(2012-11#1)(2012-3#1)
this mode##19##2##(1990-4#1)(1991-12#1)(1994-6#1)(1995-1#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(2005-5#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#1)(2010-9#1)(2012-11#1)(2012-3#1)
this model and##6##3##(1993-2#1)(2007-12#3)(2009-10#1)(2013-1#1)
this model are##6##3##(1993-2#1)(2007-9#1)(2008-2#1)(2008-3#2)(2008-4#1)
this model for the##2##4##(1991-6#1)(2009-5#1)
this model for##4##3##(1991-6#1)(1993-11#1)(2007-9#1)(2009-5#1)
this model has##3##3##(2008-12#1)(2009-7#1)(2012-2#1)
this model have##2##3##(1990-7#1)(1992-11#1)
this model in##3##3##(1996-7#1)(2007-12#1)(2010-10#1)
this model is that##2##4##(1995-1#1)(2008-10#1)
this model is##21##3##(1995-1#1)(1995-4#1)(1996-4#1)(1997-1#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-2#2)(2011-1#1)(2011-3#1)(2012-12#1)
this model may##2##3##(1991-2#1)(2008-2#1)
this model of autoimmune disease##2##5##(1996-10#1)(2008-10#1)
this model of##8##3##(1996-10#1)(2005-5#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-5#1)(2012-2#1)
this model only##2##3##(2006-10#1)(2008-10#1)
this model provides##3##3##(2006-10#1)(2008-12#1)(2008-2#1)
this model study##2##3##(2008-10#1)(2008-3#1)
this model system##8##3##(1990-4#1)(1993-2#1)(2005-11#2)(2008-11#1)(2008-4#1)(2008-9#1)(2010-1#1)
this model the##8##3##(1991-6#1)(1991-9#1)(1993-12#1)(1995-8#1)(2008-2#1)(2008-3#3)
this model to the##2##4##(2008-2#1)(2011-2#1)
this model to##13##3##(1993-9#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#2)(2008-9#1)(2010-12#1)(2011-2#1)
this model was used##2##4##(2008-5#1)(2012-3#1)
this model was##6##3##(1995-12#1)(2008-10#1)(2008-5#1)(2009-3#1)(2012-2#1)(2012-3#1)
this model we##2##3##(1991-10#1)(2008-9#1)
this model were##3##3##(2007-4#1)(2008-10#1)(2008-5#1)
this model will be##2##4##(1997-3#1)(2007-4#1)
this model with##3##3##(2008-3#2)(2010-10#1)
this model##236##2##(1990-4#1)(1990-5#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-4#1)(1992-7#1)(1992-9#3)(1993-11#1)(1993-12#4)(1993-2#3)(1993-6#1)(1993-9#1)(1994-2#1)(1994-8#4)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-4#3)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#2)(1996-2#1)(1996-3#1)(1996-4#3)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(2004-11#1)(2005-11#4)(2005-5#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-12#2)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#6)(2007-4#4)(2007-8#1)(2007-9#4)(2008-1#1)(2008-10#15)(2008-11#9)(2008-12#5)(2008-2#13)(2008-3#15)(2008-4#5)(2008-5#11)(2008-7#4)(2008-8#6)(2008-9#6)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#3)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#2)
this modeling framework##2##3##(2009-12#1)(2010-9#1)
this modeling##5##2##(1990-7#1)(2006-3#1)(2008-8#1)(2009-12#1)(2010-9#1)
this modern##2##2##(2008-4#1)(2008-5#1)
this modification in##3##3##(1997-4#1)(2008-11#1)(2009-2#1)
this modification is##2##3##(1994-12#1)(2008-3#1)
this modification##15##2##(1991-1#1)(1991-2#1)(1994-12#1)(1994-8#1)(1995-5#1)(1997-4#1)(1997-8#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2009-2#1)
this modified electrode were##2##4##(2008-10#2)
this modified electrode##5##3##(2008-10#5)
this modified enzyme##2##3##(1990-11#1)(1990-7#1)
this modified method##3##3##(1994-12#1)(1995-1#1)(2008-10#1)
this modified##22##2##(1990-11#1)(1990-12#1)(1990-7#1)(1993-6#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-10#1)(1995-8#1)(1997-4#1)(2006-3#1)(2007-11#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#1)
this modulation is##3##3##(2008-3#1)(2012-1#1)(2013-8#1)
this modulation##5##2##(2007-11#1)(2008-2#1)(2008-3#1)(2012-1#1)(2013-8#1)
this modulatory##2##2##(1993-12#1)(1993-3#1)
this module##5##2##(1996-6#1)(2008-11#2)(2008-12#1)(2012-12#1)
this molecular##10##2##(1992-3#1)(1994-11#1)(1994-3#1)(1995-5#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-8#1)(2009-8#1)
this molecule as##2##3##(1993-9#1)(1996-2#1)
this molecule has been##2##4##(1993-2#1)(1993-6#1)
this molecule has##4##3##(1993-2#1)(1993-3#1)(1993-6#1)(2007-2#1)
this molecule in the##2##4##(1990-2#1)(2006-8#1)
this molecule is##2##3##(1996-2#1)(1996-9#1)
this molecule##39##2##(1990-2#1)(1990-4#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-2#2)(1996-9#3)(1997-2#1)(1997-8#1)(2004-12#1)(2005-7#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-12#3)
this moment##7##2##(1996-9#1)(2005-10#1)(2008-5#2)(2008-7#1)(2010-10#1)(2013-1#1)
this monoclonal antibody##3##3##(1990-5#1)(1990-9#1)(2010-12#1)
this month##4##2##(2007-8#2)(2007-9#1)(2011-2#1)
this morbid condition##2##3##(1997-8#2)
this more##3##2##(1990-11#1)(2008-10#1)(2008-5#1)
this morphological change is##2##4##(2005-11#1)(2010-4#1)
this morphological##3##2##(2005-11#1)(2007-12#1)(2010-4#1)
this morphology##4##2##(1991-11#1)(2010-10#1)(2013-1#2)
this mortality##2##2##(2007-8#1)(2007-9#1)
this mosquito##2##2##(2008-5#1)(2008-7#1)
this most##5##2##(1993-3#1)(2006-12#1)(2008-6#1)(2009-9#1)(2013-1#1)
this motif is##2##3##(1992-4#1)(1996-5#1)
this motif##12##2##(1991-7#1)(1992-4#2)(1994-12#1)(1994-2#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-6#1)(2009-7#1)
this mouse model##6##3##(1997-4#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
this mouse##9##2##(1991-1#1)(1991-3#1)(1995-1#1)(1997-4#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
this movement##3##2##(1996-1#1)(2006-7#1)(2007-12#1)
this mtDNA##2##2##(2005-8#1)(2010-12#1)
this mucin##3##2##(1992-11#3)
this mucosal##2##2##(1993-11#1)(2007-2#1)
this multidisciplinary##3##2##(2008-5#1)(2008-8#1)(2009-9#1)
this multifaceted##4##2##(2005-10#1)(2008-1#1)(2008-8#1)(2011-1#1)
this multivariate regression##2##3##(2008-10#2)
this multivariate##3##2##(1992-12#1)(2008-10#2)
this murine model of##2##4##(2008-6#1)(2012-11#1)
this murine model##3##3##(1994-3#1)(2008-6#1)(2012-11#1)
this murine##4##2##(1992-8#1)(1994-3#1)(2008-6#1)(2012-11#1)
this muscle##5##2##(1991-3#1)(1993-9#1)(2005-1#1)(2009-5#1)(2010-2#1)
this must be##4##3##(1990-3#1)(1996-9#1)(2007-8#1)(2008-5#1)
this mutant by##2##3##(1994-10#1)(2010-12#1)
this mutant is##2##3##(1990-9#1)(1997-2#1)
this mutant receptor##2##3##(1993-12#1)(1997-6#1)
this mutant##30##2##(1990-3#1)(1990-5#2)(1990-9#1)(1991-2#2)(1991-4#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-6#1)(1994-10#3)(1994-11#1)(1995-1#2)(1995-11#1)(1996-5#2)(1997-2#1)(1997-6#1)(1997-7#3)(2008-4#1)(2009-10#1)(2010-12#1)(2013-8#1)
this mutation among##2##3##(1993-4#1)(2006-8#1)
this mutation in##3##3##(1996-5#1)(2008-2#2)
this mutation is##7##3##(1991-12#1)(1991-9#1)(1992-3#1)(1995-12#1)(1997-2#1)(2006-8#1)(2013-8#1)
this mutation may##2##3##(1990-12#1)(1993-4#1)
this mutation was##2##3##(1990-11#1)(1991-8#1)
this mutation##43##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-2#1)(1992-3#1)(1993-4#3)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-9#1)(1996-5#1)(1997-2#1)(2005-1#2)(2006-8#3)(2008-10#1)(2008-12#1)(2008-2#3)(2008-5#1)(2008-7#1)(2013-8#4)
this mycotoxin##2##2##(2008-10#1)(2011-2#1)
this mystery##2##2##(2007-8#1)(2011-2#1)
this nanocomposite##2##2##(2008-4#1)(2013-7#1)
this narrow##2##2##(2006-9#1)(2008-1#1)
this national##3##2##(1990-10#1)(2008-1#1)(2011-1#1)
this native peptide##2##3##(1990-7#1)(2011-2#1)
this native##3##2##(1990-7#1)(2008-10#1)(2011-2#1)
this natural##4##2##(1991-8#1)(1994-12#1)(2009-8#1)(2012-2#1)
this naturalistic##4##2##(1993-12#1)(2006-7#1)(2007-11#1)(2009-11#1)
this need by##2##3##(1992-3#1)(2012-12#1)
this need##21##2##(1992-3#1)(1997-2#1)(1997-3#1)(2005-11#1)(2005-8#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#2)(2012-1#2)(2012-12#1)(2013-1#2)
this needs to be##2##4##(2006-10#1)(2013-8#1)
this needs##3##2##(2006-10#1)(2008-5#1)(2013-8#1)
this negative##2##2##(1993-6#1)(2008-4#1)
this nematode##2##2##(1990-5#1)(2008-10#1)
this neoplasm is##2##3##(2006-10#1)(2007-4#1)
this neoplasm##15##2##(1991-4#1)(1992-2#2)(1992-4#1)(1992-5#1)(1993-10#1)(1994-2#1)(2006-10#3)(2007-2#1)(2007-4#1)(2008-5#1)(2008-9#1)(2009-5#1)
this net##2##2##(2011-1#2)
this network##7##2##(1992-9#1)(2005-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-4#1)(2012-12#1)
this neural##4##2##(1994-11#1)(2008-8#1)(2010-11#1)(2010-8#1)
this neuron##3##2##(1993-2#1)(1993-9#1)(2007-12#1)
this neuronal##6##2##(1991-1#1)(1993-5#1)(1994-11#1)(1994-3#1)(1996-3#1)(2010-9#1)
this neuropeptide##6##2##(1990-10#1)(1991-1#1)(1996-5#2)(1997-5#1)(1997-8#1)
this neurotrophic##2##2##(1994-10#1)(1997-6#1)
this neurotrophin is##2##3##(1996-3#1)(2009-8#1)
this neutral##2##2##(1996-2#1)(2008-10#1)
this new agent##2##3##(2005-7#1)(2012-3#1)
this new algorithm##4##3##(2008-2#1)(2008-3#3)
this new approach##7##3##(1993-4#1)(2005-11#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-7#1)(2012-3#1)
this new century##3##3##(2008-1#2)(2013-1#1)
this new class of drugs##2##5##(2008-5#1)(2008-8#1)
this new class of##4##4##(2006-12#1)(2007-12#1)(2008-5#1)(2008-8#1)
this new class##5##3##(2005-7#1)(2006-12#1)(2007-12#1)(2008-5#1)(2008-8#1)
this new concept of##2##4##(2007-9#1)(2009-5#1)
this new concept##3##3##(2007-9#1)(2009-5#1)(2009-7#1)
this new detector##2##3##(2008-10#2)
this new development##2##3##(1997-4#1)(2008-3#1)
this new family of##2##4##(1995-6#1)(1996-9#1)
this new family##3##3##(1995-6#1)(1996-9#1)(2007-8#1)
this new gene##2##3##(2008-10#2)
this new instrument##4##3##(1996-8#1)(2004-3#1)(2006-6#1)(2008-1#1)
this new instrumental##2##3##(2007-12#1)(2008-10#1)
this new method is##4##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
this new method was##3##4##(1991-8#1)(2009-9#1)(2010-5#1)
this new method##24##3##(1991-8#1)(1994-6#1)(1996-11#1)(1997-7#1)(2004-11#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#4)(2008-3#2)(2009-2#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-12#1)(2013-8#1)
this new model will##2##4##(1992-1#1)(1996-12#1)
this new model##6##3##(1992-1#1)(1995-1#1)(1996-12#1)(2007-12#1)(2007-4#1)(2008-2#1)
this new modified##3##3##(2007-7#1)(2008-10#1)(2008-3#1)
this new option##2##3##(2008-5#1)(2012-1#1)
this new recording##2##3##(2008-3#2)
this new role##3##3##(2007-4#1)(2008-4#1)(2008-7#1)
this new science##2##3##(2007-7#1)(2008-11#1)
this new sensor##2##3##(2008-10#2)
this new species##2##3##(2008-10#2)
this new strategy##2##3##(2008-10#1)(2010-10#1)
this new system##5##3##(1993-7#1)(2006-6#1)(2008-10#1)(2008-5#2)
this new technique##11##3##(1990-3#1)(1990-9#1)(1991-12#1)(2007-11#2)(2008-10#1)(2008-3#4)(2013-1#1)
this new technology##10##3##(1997-5#1)(2004-10#1)(2005-7#1)(2007-11#1)(2007-5#1)(2008-11#1)(2010-7#1)(2011-2#1)(2011-7#1)(2012-1#1)
this new territory##2##3##(1994-2#1)(2008-11#1)
this new therapeutic##3##3##(1994-5#1)(1997-1#1)(2005-8#1)
this new tool##2##3##(2006-6#1)(2006-8#1)
this new type of##5##4##(1996-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)
this new version##2##3##(2008-1#1)(2008-10#1)
this new##266##2##(1990-11#1)(1990-3#3)(1990-7#1)(1990-9#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-7#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#2)(1993-1#1)(1993-10#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-7#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#2)(1995-1#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-10#2)(1996-11#3)(1996-12#3)(1996-2#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-1#1)(2004-10#1)(2004-11#2)(2004-3#1)(2005-11#1)(2005-7#5)(2005-8#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-6#3)(2006-8#1)(2007-11#6)(2007-12#13)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#6)(2008-10#30)(2008-11#7)(2008-12#3)(2008-2#14)(2008-3#19)(2008-4#2)(2008-5#8)(2008-7#3)(2008-8#6)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#5)(2011-7#2)(2012-1#8)(2012-2#6)(2012-3#2)(2013-1#5)(2013-8#2)
this newly developed cylindrical encoder##2##5##(2008-3#2)
this newly developed method##8##4##(2007-8#1)(2008-10#7)
this newly developed##13##3##(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-3#3)
this newly discovered##2##3##(1994-12#1)(2008-10#1)
this newly identified gene (or allele)##2##6##(2008-10#2)
this newly identified##3##3##(2008-10#2)(2008-7#1)
this newly##22##2##(1993-4#1)(1994-12#1)(1996-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#11)(2008-3#4)(2008-7#1)
this noble##3##2##(2007-6#1)(2008-1#1)(2010-1#1)
this noise##4##2##(2007-11#1)(2009-4#1)(2010-8#1)(2012-2#1)
this nonlinear##5##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-7#1)
this nonlinearity##2##2##(2007-11#1)(2008-3#1)
this normal##5##2##(1993-3#1)(2008-2#1)(2008-3#2)(2011-1#1)
this notion##9##2##(1992-3#1)(1993-3#1)(1995-8#1)(1996-4#1)(2008-4#1)(2009-4#1)(2010-5#1)(2011-2#1)(2012-2#1)
this novel approach##6##3##(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-1#1)
this novel compound##2##3##(1993-3#1)(2012-2#1)
this novel concept##2##3##(2007-12#1)(2007-9#1)
this novel procedure##2##3##(2007-12#1)(2012-2#1)
this novel protein##2##3##(1994-6#1)(1995-3#1)
this novel technique##4##3##(1997-4#1)(2007-12#1)(2008-10#1)(2008-3#1)
this novel##73##2##(1990-12#1)(1990-2#1)(1991-11#1)(1991-5#1)(1992-12#1)(1993-3#1)(1993-8#1)(1994-6#2)(1994-9#1)(1995-3#2)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#2)(1997-4#2)(1997-7#1)(2005-11#2)(2005-8#2)(2006-12#1)(2006-8#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#5)(2008-9#2)(2010-9#2)(2011-1#3)(2012-1#1)(2012-11#2)(2012-2#2)(2013-8#1)
this nucleotide##3##2##(1990-12#1)(1993-6#1)(1995-3#1)
this nucleus##4##2##(1990-4#1)(1995-12#1)(1997-6#1)(1997-8#1)
this number is##2##3##(2011-2#1)(2012-2#1)
this number of##2##3##(2007-11#1)(2009-10#1)
this number will##2##3##(1990-12#1)(1994-6#1)
this number##10##2##(1990-12#1)(1994-6#1)(2007-11#1)(2007-9#1)(2009-10#1)(2009-5#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#1)
this numerical##2##2##(2007-11#1)(2008-3#1)
this nutritional##2##2##(1991-2#1)(1997-8#1)
this objective is##3##3##(1993-2#1)(2008-3#1)(2010-12#1)
this objective##10##2##(1993-2#1)(1997-3#1)(2006-10#2)(2008-10#1)(2008-3#1)(2008-5#2)(2010-12#1)(2011-2#1)
this obligation##2##2##(2005-11#1)(2011-2#1)
this observation and##2##3##(1994-2#1)(2008-8#1)
this observation are##3##3##(1991-6#1)(2006-5#1)(2008-3#1)
this observation can be##2##4##(1996-9#1)(2006-7#1)
this observation is discussed##3##4##(1993-6#1)(1995-12#1)(2007-6#1)
this observation is##6##3##(1991-9#1)(1992-9#1)(1993-6#1)(1995-12#1)(2007-4#1)(2007-6#1)
this observation we##2##3##(1991-10#1)(2012-3#1)
this observation##48##2##(1990-12#1)(1990-2#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-9#1)(1993-6#1)(1993-7#1)(1994-2#1)(1994-7#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-9#1)(2005-8#1)(2006-12#1)(2006-4#2)(2006-5#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
this observed##3##2##(1991-5#1)(2010-7#1)(2011-12#1)
this obstacle##2##2##(2008-4#1)(2008-6#1)
this occurred in##2##3##(2006-5#1)(2011-2#1)
this occurred##4##2##(1990-5#1)(1995-12#1)(2006-5#1)(2011-2#1)
this occurs in##3##3##(2008-1#2)(2012-2#1)
this occurs is##4##3##(1996-8#1)(2007-11#1)(2008-7#1)(2013-8#1)
this occurs##23##2##(1990-5#1)(1992-9#1)(1993-7#1)(1994-3#1)(1996-8#1)(1997-4#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
this oil##4##2##(2008-12#1)(2008-3#1)(2008-5#1)(2010-5#1)
this old##2##2##(1990-4#1)(2008-10#1)
this older##2##2##(2006-7#1)(2008-7#1)
this on the##2##3##(1994-2#1)(2008-10#1)
this on##3##2##(1994-2#1)(2008-10#1)(2008-3#1)
this once##2##2##(2010-12#1)(2012-12#1)
this oncogene##2##2##(1994-10#1)(2008-8#1)
this one is##2##3##(2007-8#1)(2013-1#1)
this one##9##2##(2007-8#1)(2008-10#1)(2008-5#1)(2009-9#1)(2010-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
this only##2##2##(2006-8#1)(2007-1#1)
this open##4##2##(1990-4#1)(2007-7#1)(2008-6#1)(2013-1#1)
this open-label##2##2##(2004-12#1)(2008-7#1)
this operation in the##2##4##(2006-10#1)(2007-8#1)
this operation in##3##3##(2006-10#1)(2007-11#1)(2007-8#1)
this operation##19##2##(1990-6#1)(1990-9#1)(1991-5#1)(1994-3#1)(2006-10#2)(2006-4#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#3)(2009-12#1)(2009-2#1)
this opinion##2##2##(1996-1#1)(2012-2#1)
this opportunity##7##2##(1992-1#1)(1993-12#1)(1993-2#1)(1995-12#1)(2008-6#1)(2012-1#1)(2012-2#1)
this optical biosensor##2##3##(2008-10#2)
this optical##6##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2010-4#1)
this optically##2##2##(2006-4#1)(2008-1#1)
this optimal##2##2##(2008-5#1)(2008-8#1)
this optimization problem##2##3##(1992-12#1)(2012-1#1)
this optimization##5##2##(1992-12#1)(1996-8#1)(2008-12#1)(2008-2#1)(2012-1#1)
this optimized##3##2##(2008-10#1)(2008-11#1)(2011-1#1)
this optimum##5##2##(2007-2#1)(2008-10#2)(2008-3#1)(2008-8#1)
this option to##2##3##(1995-12#1)(2007-12#1)
this option##9##2##(1992-2#1)(1993-11#1)(1995-12#1)(2005-5#1)(2007-12#1)(2007-7#1)(2008-10#1)(2011-2#1)(2012-2#1)
this or any other##2##4##(1996-4#1)(2010-10#1)
this or any##3##3##(1993-7#1)(1996-4#1)(2010-10#1)
this or##5##2##(1993-7#1)(1996-1#1)(1996-4#1)(2010-10#1)(2011-12#1)
this order##8##2##(1990-4#1)(1993-7#1)(1995-11#1)(1996-11#1)(1997-8#1)(2006-10#1)(2007-11#1)(2008-10#1)
this organ##9##2##(1991-4#1)(1996-12#1)(2007-12#3)(2008-10#2)(2008-5#1)(2009-2#1)
this organelle##10##2##(1996-9#1)(2007-8#2)(2007-9#2)(2008-11#3)(2008-9#1)(2009-5#1)
this organism are##4##3##(2005-8#1)(2007-12#1)(2008-10#1)(2010-4#1)
this organism from##2##3##(2008-5#1)(2009-2#1)
this organism have##2##3##(2005-8#1)(2009-9#1)
this organism in##3##3##(1996-8#1)(2006-10#1)(2011-2#1)
this organism is##6##3##(1997-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-9#1)
this organism##70##2##(1990-6#1)(1990-9#1)(1991-11#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1993-11#1)(1993-2#1)(1995-5#1)(1996-10#1)(1996-8#1)(1997-1#2)(1997-7#1)(2005-12#1)(2005-8#2)(2006-10#5)(2006-8#1)(2007-11#1)(2007-12#5)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-5#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-9#2)(2010-4#1)(2011-1#1)(2011-2#19)(2012-12#2)(2012-3#1)
this organism's##3##2##(2008-3#1)(2008-7#1)(2012-2#1)
this organization##5##2##(1991-2#1)(2007-12#1)(2008-11#1)(2009-10#1)(2011-1#1)
this orientation##2##2##(1993-12#1)(1995-1#1)
this oscillation##2##2##(2008-10#1)(2009-5#1)
this out##2##2##(1991-5#1)(2005-8#1)
this outbreak##4##2##(1995-4#1)(1996-3#1)(2007-7#1)(2008-1#1)
this outcome is##2##3##(1992-2#1)(2013-1#1)
this outcome##7##2##(1992-2#1)(1994-2#1)(2007-11#1)(2007-3#1)(2008-12#1)(2008-8#1)(2013-1#1)
this overview discusses##2##3##(2008-4#2)
this overview##13##2##(2007-4#1)(2008-1#1)(2008-11#1)(2008-4#6)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
this overwhelming##2##2##(2009-6#1)(2011-2#1)
this oxidase##2##2##(1990-11#1)(1990-3#1)
this oxidation##4##2##(1990-3#1)(1992-6#1)(1995-12#1)(2007-11#1)
this oxidative stress##2##3##(2006-8#2)
this oxidative##3##2##(2006-8#2)(2008-5#1)
this oxygen##3##2##(1992-11#1)(1994-12#1)(1994-5#1)
this pH dependence##2##3##(1990-12#1)(1996-7#1)
this pH the##2##3##(1994-3#1)(2008-11#1)
this pH##10##2##(1990-12#1)(1991-4#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-5#1)(1996-7#1)(2008-10#1)(2008-11#1)(2008-5#1)
this pain##6##2##(1995-2#2)(2007-11#1)(2007-2#1)(2009-12#1)(2012-2#1)
this painful##3##2##(2006-8#1)(2008-12#1)(2009-2#1)
this pair##2##2##(1993-3#1)(2008-3#1)
this panel##3##2##(1991-2#1)(2008-5#1)(2012-12#1)
this paper I##14##3##(1994-5#1)(1995-12#1)(1995-9#1)(1997-8#1)(2004-7#1)(2005-10#1)(2008-7#1)(2009-2#1)(2009-9#1)(2012-11#1)(2012-2#1)(2013-1#3)
this paper a##20##3##(1990-11#1)(1992-1#1)(1992-9#1)(1994-12#1)(1996-8#1)(2006-10#1)(2007-9#2)(2008-10#7)(2008-11#2)(2012-1#1)(2013-1#2)
this paper addresses##2##3##(2006-5#1)(2009-11#1)
this paper aims##2##3##(2008-11#1)(2008-2#1)
this paper also##4##3##(1993-3#1)(1995-9#1)(2008-2#1)(2008-9#1)
this paper analyzed the##4##4##(2013-8#4)
this paper are##23##3##(1992-9#2)(1994-6#1)(1996-12#1)(1997-2#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-9#1)(2010-3#1)(2011-1#1)(2013-7#1)(2013-8#1)
this paper argues that##2##4##(2008-12#1)(2013-1#1)
this paper as##12##3##(2008-12#1)(2008-2#1)(2011-2#9)(2013-8#1)
this paper assesses the##2##4##(2009-7#1)(2013-8#1)
this paper assesses##3##3##(2008-7#1)(2009-7#1)(2013-8#1)
this paper attempts to##2##4##(2006-3#1)(2010-9#1)
this paper can##2##3##(2012-1#1)(2013-8#1)
this paper compares the##2##4##(1997-4#1)(2013-8#1)
this paper deals with the##3##5##(1992-11#1)(1993-12#1)(2008-3#1)
this paper demonstrates the##2##4##(2008-12#1)(2012-12#1)
this paper demonstrates##3##3##(1997-8#1)(2008-12#1)(2012-12#1)
this paper describes##7##3##(1996-12#1)(1996-3#2)(2007-4#1)(2008-12#1)(2008-9#1)(2013-7#1)
this paper discusses the##2##4##(1993-6#1)(2012-3#1)
this paper discusses##3##3##(1991-12#1)(1993-6#1)(2012-3#1)
this paper documents the development and evaluation of a deterministic binary variant of RI##2##14##(2013-1#2)
this paper examines the##5##4##(2008-10#1)(2008-11#1)(2011-2#2)(2012-3#1)
this paper examines##8##3##(2007-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-2#1)(2011-2#2)(2012-3#1)
this paper explores the##2##4##(2008-9#1)(2011-2#1)
this paper explores##4##3##(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)
this paper has been##2##4##(2007-10#1)(2012-3#1)
this paper has##4##3##(2007-10#1)(2008-10#1)(2012-3#1)(2013-1#1)
this paper have##2##3##(2007-12#1)(2008-11#1)
this paper introduces##2##3##(2008-2#1)(2012-3#1)
this paper investigates##2##3##(2008-10#1)(2008-11#1)
this paper is an##5##4##(2006-10#1)(2007-11#1)(2008-2#1)(2012-2#1)(2012-3#1)
this paper is that##3##4##(1994-11#1)(2008-11#2)
this paper is the##6##4##(2006-6#1)(2007-9#1)(2008-10#2)(2010-10#1)(2010-12#1)
this paper is to##127##4##(1991-4#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-5#1)(1995-6#1)(1995-8#1)(1996-3#1)(1997-1#1)(1997-5#1)(1997-6#1)(2004-10#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-2#5)(2006-5#1)(2006-6#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#6)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#9)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#5)(2009-2#1)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#3)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#4)(2012-3#3)(2013-1#9)(2013-8#1)
this paper is##157##3##(1990-8#1)(1991-4#1)(1992-1#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-5#1)(1994-1#1)(1994-11#1)(1995-6#1)(1995-8#1)(1996-3#1)(1997-1#1)(1997-5#1)(1997-6#1)(2004-10#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-2#5)(2006-3#1)(2006-5#1)(2006-6#3)(2006-8#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-3#2)(2007-4#2)(2007-6#1)(2007-7#6)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#11)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#5)(2009-11#1)(2009-2#1)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#7)(2012-1#3)(2012-11#1)(2012-12#6)(2012-2#5)(2012-3#4)(2013-1#9)(2013-8#2)
this paper offers##3##3##(1997-2#1)(2008-10#1)(2008-9#1)
this paper presents a##3##4##(2008-2#1)(2010-1#1)(2010-8#1)
this paper presents##6##3##(2007-7#1)(2008-2#2)(2008-9#1)(2010-1#1)(2010-8#1)
this paper proposes a new##2##5##(2008-2#1)(2008-6#1)
this paper proposes a##4##4##(2008-2#2)(2008-6#1)(2012-2#1)
this paper proposes##6##3##(2008-2#2)(2008-6#1)(2010-2#1)(2010-9#1)(2012-2#1)
this paper provide##2##3##(2004-11#1)(2008-6#1)
this paper provides a##2##4##(2006-12#1)(2008-8#1)
this paper provides##3##3##(2006-12#1)(2008-8#1)(2009-4#1)
this paper quantitatively##2##3##(2005-11#1)(2013-8#1)
this paper reviews##4##3##(2008-4#1)(2008-5#1)(2009-10#1)(2011-2#1)
this paper shows how##3##4##(2006-7#1)(2007-7#1)(2008-7#1)
this paper shows##4##3##(1994-6#1)(2006-7#1)(2007-7#1)(2008-7#1)
this paper studied the effects of##3##6##(2013-8#3)
this paper studied the##9##4##(2013-8#9)
this paper studied their##2##4##(2013-8#2)
this paper studied##11##3##(2013-8#11)
this paper suggests##2##3##(1993-3#1)(1994-2#1)
this paper the results of a##2##6##(1995-10#1)(2009-8#1)
this paper the##42##3##(1990-3#1)(1990-7#1)(1992-4#1)(1992-9#2)(1993-3#1)(1993-5#1)(1995-1#1)(1995-10#1)(1995-4#1)(1996-3#1)(2005-11#3)(2005-4#2)(2006-11#1)(2006-2#2)(2006-5#2)(2006-6#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-7#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-3#1)(2012-2#1)(2013-1#1)
this paper to##7##3##(1994-5#1)(1995-12#1)(2005-4#1)(2006-12#1)(2007-10#1)(2008-10#1)(2008-2#1)
this paper was to determine##3##5##(1991-9#1)(2011-2#1)(2013-1#1)
this paper was to##25##4##(1991-9#2)(1992-2#1)(1992-6#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-5#3)(2009-8#2)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#3)
this paper was##31##3##(1991-9#2)(1992-2#1)(1992-6#1)(1994-9#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#3)(2009-8#2)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)
this paper we describe##22##4##(1990-12#1)(1990-8#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-12#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)
this paper we present a##9##5##(1992-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-8#1)(2012-12#1)(2013-1#2)
this paper we present##29##4##(1992-2#1)(1992-8#2)(1992-9#1)(1993-5#1)(1994-11#1)(1995-8#1)(1997-3#1)(2004-9#1)(2005-11#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2013-1#3)(2013-8#1)
this paper we##196##3##(1990-11#1)(1990-12#1)(1990-8#2)(1991-11#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-5#3)(1993-6#3)(1993-9#2)(1994-11#3)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-2#2)(1995-4#2)(1995-8#4)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#1)(2004-1#1)(2004-9#1)(2005-11#3)(2005-2#1)(2005-8#2)(2006-10#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-3#2)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#8)(2008-11#5)(2008-12#2)(2008-2#5)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-5#2)(2010-8#1)(2011-1#6)(2011-12#3)(2011-2#2)(2012-1#4)(2012-11#1)(2012-12#3)(2012-2#8)(2012-3#5)(2013-1#20)(2013-8#6)
this paper will##4##3##(1991-5#1)(2008-11#1)(2008-12#2)
this paper with the##2##4##(2005-4#1)(2009-3#1)
this paper with##4##3##(2005-4#1)(2007-11#1)(2007-8#1)(2009-3#1)
this paper##1531##2##(1990-1#1)(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#3)(1990-8#6)(1991-1#1)(1991-11#2)(1991-12#4)(1991-2#1)(1991-3#2)(1991-4#3)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#4)(1992-11#2)(1992-12#2)(1992-2#4)(1992-3#5)(1992-4#1)(1992-6#3)(1992-8#3)(1992-9#8)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#4)(1993-5#6)(1993-6#9)(1993-8#2)(1993-9#3)(1994-1#1)(1994-11#4)(1994-12#4)(1994-2#5)(1994-3#1)(1994-5#3)(1994-6#4)(1994-8#4)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#1)(1995-4#3)(1995-6#3)(1995-7#1)(1995-8#6)(1995-9#6)(1996-1#3)(1996-11#4)(1996-12#9)(1996-2#4)(1996-3#7)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#3)(1997-2#6)(1997-3#2)(1997-4#6)(1997-5#1)(1997-6#7)(1997-7#7)(1997-8#9)(2004-1#1)(2004-10#1)(2004-11#1)(2004-7#1)(2004-9#1)(2005-10#3)(2005-11#13)(2005-2#2)(2005-3#1)(2005-4#32)(2005-6#1)(2005-8#2)(2005-9#1)(2006-1#2)(2006-10#14)(2006-11#6)(2006-12#6)(2006-2#10)(2006-3#5)(2006-4#2)(2006-5#13)(2006-6#11)(2006-7#2)(2006-8#3)(2006-9#3)(2007-1#2)(2007-10#11)(2007-11#20)(2007-12#17)(2007-2#8)(2007-3#9)(2007-4#8)(2007-5#8)(2007-6#4)(2007-7#20)(2007-8#10)(2007-9#5)(2008-1#16)(2008-10#187)(2008-11#53)(2008-12#24)(2008-2#85)(2008-3#18)(2008-4#7)(2008-5#25)(2008-6#30)(2008-7#19)(2008-8#8)(2008-9#19)(2009-10#12)(2009-11#5)(2009-12#5)(2009-2#10)(2009-3#8)(2009-4#12)(2009-5#2)(2009-6#8)(2009-7#10)(2009-8#5)(2009-9#14)(2010-1#4)(2010-10#6)(2010-11#7)(2010-12#11)(2010-2#11)(2010-3#7)(2010-4#8)(2010-5#10)(2010-6#6)(2010-7#5)(2010-8#21)(2010-9#7)(2011-1#26)(2011-12#7)(2011-2#43)(2011-3#3)(2012-1#33)(2012-11#4)(2012-12#19)(2012-2#37)(2012-3#27)(2013-1#97)(2013-7#11)(2013-8#43)
this paper)##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
this paradigm##12##2##(1992-3#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-3#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2012-3#1)(2013-8#1)
this paradoxical##2##2##(1990-5#1)(1991-9#1)
this parallel##3##2##(1990-8#1)(2007-9#1)(2009-6#1)
this parameter are##2##3##(1995-6#1)(2008-3#1)
this parameter in the##2##4##(1996-12#1)(2008-7#1)
this parameter in##3##3##(1996-12#1)(2008-7#1)(2009-1#1)
this parameter was##3##3##(1990-12#1)(1997-2#1)(2010-4#1)
this parameter##24##2##(1990-12#1)(1992-11#1)(1995-6#1)(1996-12#1)(1997-2#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#2)(2009-1#1)(2009-10#1)(2009-2#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)
this parasite##8##2##(1994-8#1)(1996-8#1)(2007-12#1)(2007-2#2)(2008-10#1)(2009-5#1)(2010-4#1)
this park##2##2##(2007-5#1)(2008-5#1)
this part of the country##3##5##(2007-7#2)(2010-9#1)
this part of the world##2##5##(2008-1#1)(2013-1#1)
this part of the##11##4##(1994-11#1)(1996-12#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#1)(2010-9#1)(2013-1#2)
this part of##15##3##(1993-5#1)(1994-11#1)(1996-12#1)(1996-7#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#1)(2010-4#1)(2010-9#1)(2013-1#2)
this part##18##2##(1990-11#1)(1993-5#1)(1994-11#1)(1996-12#1)(1996-7#1)(2006-10#1)(2007-12#2)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#1)(2010-4#1)(2010-9#1)(2012-3#1)(2013-1#2)
this partial##3##2##(1995-5#1)(1997-2#1)(2008-10#1)
this participation##2##2##(1997-1#1)(2013-1#1)
this particle##2##2##(1994-8#1)(2004-11#1)
this particular case##3##3##(1992-4#1)(2008-5#2)
this particular group of##4##4##(1990-8#1)(1996-2#1)(2006-10#1)(2008-11#1)
this particular group##6##3##(1990-8#1)(1994-4#1)(1996-2#1)(2006-10#1)(2008-11#1)(2012-11#1)
this particular method##2##3##(2008-11#1)(2012-2#1)
this particular type of##5##4##(1990-11#1)(2008-2#1)(2008-3#1)(2009-1#1)(2010-1#1)
this particular##59##2##(1990-11#1)(1990-12#1)(1990-8#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-11#1)(1994-4#1)(1995-1#1)(1995-5#1)(1995-7#1)(1996-1#1)(1996-2#1)(1996-8#1)(1997-7#2)(2005-7#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-1#1)(2009-4#1)(2010-1#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#2)(2012-7#1)(2013-1#1)
this particulate##2##2##(1995-5#1)(2008-3#1)
this partnership##2##2##(2008-12#1)(2008-2#1)
this past year##6##3##(2006-10#6)
this past##7##2##(2006-10#6)(2007-8#1)
this path##3##2##(1990-10#1)(2008-2#1)(2011-1#1)
this pathogen can##2##3##(2008-10#2)
this pathogen have##3##3##(2008-10#3)
this pathogen in##5##3##(2008-10#3)(2008-9#1)(2012-2#1)
this pathogen into##2##3##(2008-10#1)(2011-2#1)
this pathogen is##2##3##(2007-7#1)(2008-10#1)
this pathogen was##2##3##(2010-10#1)(2012-3#1)
this pathogen##40##2##(2007-5#1)(2007-7#1)(2008-10#29)(2008-9#2)(2009-8#2)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
this pathogenic##2##2##(2008-10#2)
this pathology and##2##3##(1990-10#1)(2006-2#1)
this pathology##34##2##(1990-10#1)(1990-12#1)(1990-5#2)(1990-6#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-8#1)(1993-10#1)(1993-6#1)(1993-9#1)(2006-2#2)(2007-2#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-3#2)(2013-1#3)
this pathovar##4##2##(2008-10#4)
this pathway for##2##3##(2010-3#1)(2011-1#1)
this pathway include##2##3##(2008-10#1)(2008-8#1)
this pathway is##3##3##(1995-6#1)(2007-12#1)(2010-12#1)
this pathway may##5##3##(1994-12#1)(1995-1#1)(1995-12#1)(1995-2#1)(2011-2#1)
this pathway to##2##3##(2008-7#1)(2010-4#1)
this pathway##50##2##(1993-3#1)(1994-11#1)(1994-12#2)(1994-8#3)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-12#1)(1996-5#1)(1996-7#1)(1996-8#1)(2005-11#2)(2005-7#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
this patient as a##3##4##(2010-10#1)(2013-1#2)
this patient as##4##3##(2010-10#1)(2013-1#3)
this patient cannot be##3##4##(1997-3#1)(2007-2#1)(2012-2#1)
this patient for three##2##4##(2008-1#1)(2010-12#1)
this patient for##3##3##(1997-2#1)(2008-1#1)(2010-12#1)
this patient group##8##3##(1996-3#1)(2007-11#1)(2008-7#1)(2010-4#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
this patient had##2##3##(1990-3#1)(2007-8#1)
this patient have##4##3##(1992-5#1)(1996-2#1)(2005-1#1)(2012-2#1)
this patient is##6##3##(1991-1#1)(2007-2#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-3#1)
this patient population##40##3##(1992-4#1)(1992-5#1)(1996-6#1)(2004-11#1)(2005-7#1)(2006-10#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#4)(2009-6#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
this patient presented##2##3##(2008-6#1)(2011-2#1)
this patient subset##2##3##(2010-12#2)
this patient was##5##3##(1992-2#1)(1996-12#1)(2006-7#1)(2007-9#1)(2008-5#1)
this patient with##6##3##(2007-7#1)(2007-8#1)(2009-4#1)(2011-2#2)(2013-8#1)
this patient##142##2##(1990-1#1)(1990-3#1)(1991-1#1)(1991-3#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-5#2)(1993-1#1)(1993-6#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-3#1)(2004-11#1)(2004-3#2)(2005-1#1)(2005-7#1)(2006-10#12)(2006-12#1)(2006-4#1)(2006-6#1)(2006-7#2)(2006-9#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#8)(2008-8#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-6#2)(2009-8#1)(2010-10#1)(2010-12#5)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#3)(2013-1#9)(2013-2#1)(2013-8#3)
this patient's operative course was confounded by the need to extubate through the submental tunnel##2##15##(2013-1#2)
this patient's symptoms##3##3##(2006-10#1)(2007-9#1)(2010-3#1)
this patient's##16##2##(1992-3#1)(1994-3#1)(1995-9#1)(1997-6#1)(2006-10#2)(2006-4#1)(2007-10#1)(2007-5#1)(2007-9#1)(2009-5#1)(2010-2#1)(2010-3#1)(2011-12#1)(2013-1#2)
this pattern is a##3##4##(1996-4#1)(2008-7#1)(2012-2#1)
this pattern is##6##3##(1990-3#1)(1994-3#1)(1996-4#1)(2008-7#1)(2012-2#1)(2012-3#1)
this pattern of EHR usage indicates that the system as designed may not provide effective cognitive support##2##17##(2013-1#2)
this pattern of expression##2##4##(1991-5#1)(1996-7#1)
this pattern of##7##3##(1991-5#1)(1994-9#1)(1996-4#1)(1996-7#1)(1997-7#1)(2013-1#2)
this pattern was##2##3##(1993-7#1)(2008-10#1)
this pattern##30##2##(1990-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1993-2#1)(1993-7#1)(1994-3#1)(1994-9#1)(1996-4#2)(1996-7#1)(1996-8#1)(1997-7#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-7#1)(2008-9#2)(2009-2#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
this peak by##2##3##(2008-10#2)
this peak was##2##3##(1992-1#1)(1992-3#1)
this peak##7##2##(1992-1#2)(1992-12#1)(1992-3#1)(2008-10#3)
this peculiar##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
this pediatric##2##2##(2010-3#1)(2011-2#1)
this pedigree##2##2##(1992-5#1)(2010-4#1)
this peptide and##2##3##(1992-6#1)(1992-7#1)
this peptide as##2##3##(1994-2#1)(2010-10#1)
this peptide fragment##3##3##(1991-7#1)(1992-6#1)(2008-10#1)
this peptide in##5##3##(1990-12#1)(1992-11#1)(1995-5#1)(1996-5#1)(2008-10#1)
this peptide is##2##3##(1994-12#1)(2008-10#1)
this peptide was identified as##2##5##(1990-12#1)(1992-9#1)
this peptide was##6##3##(1990-12#1)(1992-9#1)(1997-3#2)(1997-8#1)(2008-10#1)
this peptide##51##2##(1990-12#2)(1990-2#1)(1990-7#3)(1991-1#1)(1991-2#4)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-5#2)(1997-3#2)(1997-8#2)(2006-12#1)(2008-10#4)(2008-3#1)(2008-5#2)(2010-10#1)(2012-1#1)(2012-12#1)
this percentage was##4##3##(1990-5#1)(1993-4#1)(2009-2#1)(2012-2#1)
this percentage##12##2##(1990-2#1)(1990-5#1)(1992-2#1)(1992-6#1)(1993-4#1)(1993-9#1)(1995-5#1)(2006-3#1)(2008-4#1)(2009-2#1)(2012-2#1)(2013-8#1)
this perception##5##2##(1991-2#1)(1996-6#1)(2007-12#1)(2012-3#1)(2013-1#1)
this performance##5##2##(1993-1#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)
this period and##3##3##(1990-11#1)(2008-11#1)(2012-3#1)
this period in##2##3##(2009-2#1)(2012-2#1)
this period of##8##3##(1993-2#1)(1993-5#1)(1994-3#1)(1995-3#2)(2008-3#2)(2012-12#1)
this period showed##2##3##(2008-11#1)(2008-7#1)
this period the##3##3##(2007-11#1)(2008-5#1)(2008-8#1)
this period##113##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-5#2)(1990-6#1)(1990-9#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-5#1)(1993-7#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-3#4)(1995-8#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#1)(2004-2#1)(2005-1#1)(2006-10#5)(2006-4#2)(2006-8#1)(2007-11#3)(2007-2#2)(2007-3#2)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#5)(2008-7#5)(2008-8#4)(2008-9#2)(2009-1#1)(2009-2#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#8)(2011-9#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
this persistence effect##2##3##(2008-4#2)
this perspective##14##2##(1992-3#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-10#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)
this phase II study##3##4##(2008-10#1)(2008-6#2)
this phase II##5##3##(2008-10#1)(2008-6#3)(2012-2#1)
this phase of the##2##4##(1992-4#1)(2009-10#1)
this phase of##4##3##(1992-4#1)(1996-4#1)(2005-9#1)(2009-10#1)
this phase##31##2##(1991-2#1)(1991-3#2)(1992-4#1)(1996-4#1)(2004-1#1)(2005-8#1)(2005-9#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-10#3)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2009-10#1)(2010-12#1)(2012-2#1)
this phenolic substance##2##3##(2008-5#2)
this phenomena##2##2##(2007-11#1)(2008-10#1)
this phenomenological study##2##3##(2007-10#1)(2007-2#1)
this phenomenon and##2##3##(1995-5#1)(2006-7#1)
this phenomenon are discussed##3##4##(1997-4#1)(1997-6#1)(2006-10#1)
this phenomenon are##6##3##(1992-1#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-11#1)(2011-12#1)
this phenomenon as##2##3##(2008-10#1)(2012-2#1)
this phenomenon has been##2##4##(2008-10#1)(2008-8#1)
this phenomenon has##3##3##(2008-10#2)(2008-8#1)
this phenomenon have##3##3##(1992-3#1)(1993-9#1)(2012-12#1)
this phenomenon in detail##2##4##(1993-11#1)(2013-8#1)
this phenomenon in the general##2##5##(2008-12#1)(2008-2#1)
this phenomenon in the##3##4##(1997-8#1)(2008-12#1)(2008-2#1)
this phenomenon in##9##3##(1993-11#1)(1995-11#1)(1997-8#1)(2008-12#1)(2008-2#1)(2008-7#1)(2013-1#2)(2013-8#1)
this phenomenon is explained##2##4##(1990-5#1)(2007-12#1)
this phenomenon is unknown##2##4##(1992-9#1)(2008-7#1)
this phenomenon is##17##3##(1990-2#1)(1990-5#1)(1992-8#1)(1992-9#1)(1997-7#1)(2006-5#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-12#1)(2011-2#1)
this phenomenon may be##2##4##(1991-6#1)(2008-7#1)
this phenomenon may##5##3##(1991-6#1)(1992-12#1)(1992-2#1)(1997-5#1)(2008-7#1)
this phenomenon of##2##3##(1994-8#1)(2009-8#1)
this phenomenon remains to be##2##5##(2008-7#1)(2012-3#1)
this phenomenon remains##3##3##(2008-12#1)(2008-7#1)(2012-3#1)
this phenomenon to##2##3##(1990-12#1)(2008-1#1)
this phenomenon was##7##3##(1990-5#2)(1992-5#1)(1997-7#1)(2005-11#1)(2008-10#1)(2008-9#1)
this phenomenon were##2##3##(1990-2#1)(2008-3#1)
this phenomenon which##2##3##(2007-8#1)(2009-8#1)
this phenomenon##147##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#4)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#2)(2005-11#1)(2005-4#1)(2005-8#1)(2006-10#4)(2006-5#2)(2006-7#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-4#1)(2007-8#1)(2008-1#3)(2008-10#7)(2008-11#4)(2008-12#3)(2008-2#6)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#5)(2008-8#4)(2008-9#2)(2009-10#1)(2009-4#4)(2009-5#2)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#3)
this phenotype is##3##3##(1995-8#1)(2012-3#2)
this phenotype##12##2##(1994-11#1)(1995-8#1)(1996-5#1)(1997-1#1)(2006-12#1)(2007-2#2)(2008-8#1)(2010-12#1)(2012-3#3)
this phenotypic plasticity##3##3##(2008-9#1)(2012-12#2)
this phenotypic##6##2##(1995-2#1)(1996-5#1)(2008-9#1)(2012-12#2)(2012-3#1)
this phospholipid##3##2##(1994-10#1)(1996-4#1)(2008-7#1)
this phosphorylation is##2##3##(1995-6#1)(2005-8#1)
this phosphorylation was##3##3##(1992-9#2)(1995-6#1)
this phosphorylation##8##2##(1992-9#2)(1994-9#1)(1995-6#2)(1996-8#2)(2005-8#1)
this photo##2##2##(1996-6#1)(2008-5#1)
this photograding##2##2##(2008-5#2)
this photoreceptor##2##2##(1995-8#2)
this phylum##4##2##(2008-10#1)(2008-7#1)(2013-8#2)
this physical##3##2##(1996-4#1)(2007-11#1)(2008-1#1)
this physiologically##2##2##(1990-12#1)(2008-4#1)
this pictorial review##4##3##(2010-12#1)(2012-2#3)
this pictorial##8##2##(1997-8#1)(2010-12#1)(2012-2#6)
this picture##5##2##(1991-8#1)(1992-1#1)(2007-11#1)(2007-7#1)(2007-8#1)
this pilot randomized##2##3##(2011-2#1)(2013-1#1)
this pilot study suggest##3##4##(2006-9#1)(2008-7#1)(2010-8#1)
this pilot study was##18##4##(1992-8#1)(1995-3#1)(1996-3#1)(2007-2#2)(2008-11#1)(2008-12#4)(2008-3#1)(2010-9#1)(2011-2#2)(2012-1#2)(2013-1#2)
this pilot study##45##3##(1992-8#1)(1993-1#1)(1995-3#1)(1996-3#2)(2006-10#1)(2006-11#1)(2006-7#1)(2006-9#1)(2007-2#4)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#5)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#3)(2009-1#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#2)(2011-2#2)(2012-1#2)(2012-12#1)(2013-1#3)
this pilot trial##2##3##(2008-7#2)
this pilot##53##2##(1992-8#1)(1993-1#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-3#2)(2006-10#2)(2006-11#1)(2006-7#1)(2006-9#1)(2007-2#4)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#5)(2008-3#2)(2008-6#1)(2008-7#4)(2008-9#3)(2009-1#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#2)(2011-2#3)(2012-1#2)(2012-12#2)(2013-1#4)
this plane##3##2##(1997-2#1)(2004-7#1)(2008-3#1)
this plant for##2##3##(2010-7#1)(2011-3#1)
this plant species##2##3##(1992-2#1)(2009-12#1)
this plant were tested##2##4##(2007-1#1)(2007-6#1)
this plant##40##2##(1990-7#1)(1991-8#1)(1992-2#2)(1994-11#1)(1994-6#1)(2004-2#1)(2006-12#2)(2007-1#3)(2007-3#1)(2007-6#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-10#1)(2011-2#1)(2011-3#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-7#1)
this plasma##2##2##(2007-12#1)(2007-8#1)
this plasmid at##2##3##(1995-1#1)(1997-3#1)
this plasmid to##3##3##(1991-9#1)(1993-12#1)(1993-5#1)
this plasmid was##2##3##(1993-12#1)(2008-10#1)
this plasmid##16##2##(1990-4#2)(1991-9#1)(1993-12#4)(1993-5#1)(1993-9#1)(1995-1#1)(1996-2#1)(1997-3#2)(2008-10#2)(2008-4#1)
this platform##5##2##(1995-12#1)(2008-10#1)(2008-11#2)(2012-11#1)
this point by##2##3##(1995-11#1)(1996-4#1)
this point in time##3##4##(2008-4#1)(2011-1#1)(2011-2#1)
this point in##6##3##(1991-6#1)(1994-3#1)(2008-2#1)(2008-4#1)(2011-1#1)(2011-2#1)
this point is##3##3##(2008-10#1)(2008-4#1)(2010-6#1)
this point it##2##3##(1992-2#1)(1994-2#1)
this point mutation##2##3##(1990-8#1)(1993-11#1)
this point of view##4##4##(2008-10#1)(2008-4#1)(2009-9#1)(2010-3#1)
this point##48##2##(1990-8#1)(1991-6#1)(1992-2#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-6#2)(1995-11#1)(1995-9#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-4#2)(2004-9#1)(2006-10#2)(2006-4#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-2#2)(2008-3#1)(2008-4#3)(2008-6#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#1)
this polarimeter##3##2##(2008-2#2)(2008-3#1)
this policy##13##2##(1992-1#1)(1997-3#1)(2004-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-7#1)(2009-2#2)(2011-12#1)(2011-2#1)(2013-1#1)
this polymer##5##2##(1996-5#1)(2008-12#1)(2008-5#1)(2009-12#1)(2011-1#1)
this polymorphism in##3##3##(1993-9#1)(1995-12#1)(2006-6#1)
this polymorphism##13##2##(1993-7#1)(1993-9#1)(1994-11#1)(1995-12#1)(1995-9#1)(1996-4#1)(2006-6#2)(2006-9#1)(2008-12#2)(2008-2#1)(2008-6#1)
this polypeptide##4##2##(1991-7#1)(1993-8#1)(2006-8#1)(2008-4#1)
this pool##2##2##(1991-8#1)(2008-8#1)
this popular##3##2##(2008-4#1)(2008-7#1)(2012-11#1)
this population and##10##3##(1993-12#1)(2006-1#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-11#1)(2010-2#2)
this population are##4##3##(1996-12#1)(2006-10#1)(2008-12#1)(2009-11#1)
this population have##3##3##(1994-6#1)(2008-11#1)(2009-4#1)
this population in##3##3##(2006-2#1)(2008-3#1)(2012-12#1)
this population is##14##3##(1994-2#1)(1994-6#1)(2008-10#2)(2008-7#1)(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#1)
this population may##4##3##(2008-10#1)(2011-2#2)(2012-2#1)
this population of##4##3##(1990-10#1)(1995-11#1)(2008-10#1)(2013-8#1)
this population was##5##3##(1991-6#1)(1992-8#1)(2008-10#2)(2008-7#1)
this population were##2##3##(2011-2#2)
this population who##2##3##(2008-3#1)(2013-1#1)
this population##195##2##(1990-10#1)(1990-2#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-6#2)(1992-6#1)(1992-8#1)(1993-12#2)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#3)(1994-7#1)(1995-10#1)(1995-11#2)(1995-2#2)(1996-1#2)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(2004-12#1)(2004-4#1)(2004-9#1)(2005-10#3)(2005-6#1)(2006-1#2)(2006-10#7)(2006-11#1)(2006-12#1)(2006-2#2)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-10#15)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#5)(2009-11#5)(2009-12#1)(2009-4#2)(2009-5#3)(2009-9#1)(2010-10#2)(2010-12#2)(2010-2#3)(2010-8#4)(2010-9#2)(2011-1#3)(2011-12#2)(2011-2#12)(2012-1#2)(2012-11#1)(2012-12#13)(2012-2#4)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#1)
this population-based##2##2##(1990-12#1)(2006-10#1)
this portion of the##2##4##(1997-4#1)(2007-2#1)
this portion##4##2##(1997-4#1)(1997-8#1)(2007-2#1)(2008-4#1)
this position and##2##3##(1996-5#1)(2008-8#1)
this position by##2##3##(1993-3#1)(1997-2#1)
this position in##3##3##(1995-2#1)(1996-6#1)(1997-3#1)
this position may##2##3##(1996-12#1)(2008-4#1)
this position##43##2##(1990-12#1)(1990-8#1)(1991-2#1)(1992-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-2#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-2#6)(2007-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-8#3)(2009-8#1)(2013-8#1)
this positive##4##2##(1995-9#1)(2008-11#1)(2011-12#1)(2012-1#1)
this possibility by##3##3##(1990-5#1)(1990-6#1)(2009-4#1)
this possibility further##4##3##(1990-5#1)(1995-1#1)(2006-10#1)(2008-9#1)
this possibility in##2##3##(2010-10#1)(2011-2#1)
this possibility using##2##3##(1990-12#1)(1996-12#1)
this possibility##34##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-6#1)(1991-2#1)(1992-2#1)(1992-6#1)(1993-6#1)(1994-12#1)(1994-3#2)(1995-1#2)(1995-2#1)(1996-12#1)(1996-3#1)(2006-10#1)(2007-12#1)(2007-5#1)(2008-2#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
this possible##6##2##(1990-11#1)(2007-10#1)(2008-12#2)(2012-3#1)(2012-5#1)
this potent##2##2##(2004-12#1)(2006-5#1)
this potential is##2##3##(2007-11#1)(2009-3#1)
this potential##24##2##(1991-11#1)(1991-9#1)(1995-2#1)(1995-6#1)(1996-8#1)(2006-10#2)(2006-9#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-3#1)(2011-2#1)(2012-1#1)(2012-11#2)(2013-1#1)
this potentially fatal##6##3##(1991-8#1)(2006-10#1)(2007-4#1)(2007-8#1)(2009-9#1)(2012-3#1)
this potentially lethal##4##3##(1995-8#1)(2008-5#1)(2009-10#1)(2010-3#1)
this potentially##18##2##(1991-12#1)(1991-8#1)(1992-12#1)(1995-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-12#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-3#1)
this potentiation was##2##3##(1993-6#1)(2009-5#1)
this potentiation##4##2##(1991-6#1)(1993-6#1)(1995-3#1)(2009-5#1)
this powerful##4##2##(1996-10#1)(1996-2#1)(2011-1#2)
this practice of##2##3##(1990-2#1)(2006-1#1)
this practice##21##2##(1990-2#2)(1990-4#1)(1991-11#1)(1991-6#1)(1992-1#1)(1993-3#1)(2004-10#1)(2006-1#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-5#1)(2009-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
this precursor is##3##3##(1991-2#1)(1991-3#1)(1994-2#1)
this precursor##7##2##(1990-7#1)(1991-1#1)(1991-2#2)(1991-3#1)(1994-2#1)(1997-7#1)
this predicted##2##2##(1991-1#1)(1992-4#1)
this prediction by measuring the##2##5##(1994-9#1)(2008-8#1)
this prediction by##4##3##(1994-9#1)(2008-8#2)(2009-2#1)
this prediction##20##2##(1990-12#1)(1990-5#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-5#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#3)(2008-9#1)(2009-2#1)(2009-3#1)(2010-5#1)(2013-1#1)(2013-8#1)
this preference is##2##3##(1992-3#1)(2008-11#1)
this preference##5##2##(1992-3#1)(1992-7#1)(2004-12#1)(2008-11#1)(2009-1#1)
this pregnancy##3##2##(1996-12#1)(2007-2#1)(2008-1#1)
this preliminary investigation##5##3##(1995-2#1)(2008-12#1)(2008-9#2)(2011-2#1)
this preliminary study##8##3##(1992-7#1)(1993-12#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-7#1)(2013-1#1)
this preliminary##20##2##(1992-7#1)(1993-12#1)(1995-2#1)(1996-5#1)(1997-6#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#2)(2008-7#1)(2008-9#2)(2010-12#1)(2011-2#1)(2013-1#1)
this preparation have##2##3##(1990-2#1)(2008-7#1)
this preparation in##2##3##(1990-12#1)(2012-1#1)
this preparation was##2##3##(2006-12#1)(2012-1#1)
this preparation##16##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-5#2)(1993-11#1)(1996-7#1)(1997-8#1)(2006-12#1)(2008-11#2)(2008-4#1)(2008-7#1)(2012-1#2)
this present study##6##3##(2004-12#2)(2008-10#2)(2011-12#1)(2013-8#1)
this present##10##2##(1996-8#1)(2004-12#2)(2008-10#2)(2008-8#1)(2010-10#1)(2010-5#1)(2011-12#1)(2013-8#1)
this presentation may##2##3##(2007-4#1)(2013-7#1)
this presentation##14##2##(2007-2#1)(2007-4#2)(2007-8#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
this presents a challenge not only for intended signal receivers##2##10##(2012-12#2)
this presents##4##2##(1995-4#1)(2008-11#1)(2012-12#2)
this preservative##2##2##(1990-11#1)(2008-5#1)
this pressure##2##2##(1993-12#1)(2006-8#1)
this presynaptic inhibition##2##3##(1995-11#2)
this prevalence##2##2##(2006-7#1)(2007-2#1)
this prevention##2##2##(2010-12#1)(2011-2#1)
this previous##5##2##(1992-12#1)(1995-1#1)(1997-6#1)(2007-12#1)(2008-8#1)
this previously unknown##2##3##(2008-3#1)(2010-4#1)
this previously##5##2##(1994-3#1)(2006-10#1)(2007-12#1)(2008-3#1)(2010-4#1)
this primary##4##2##(1996-12#1)(2006-10#1)(2007-1#1)(2011-1#1)
this primitive##2##2##(1992-2#1)(1994-8#1)
this principle is##2##3##(1995-3#1)(2012-2#1)
this principle##14##2##(1995-3#1)(2005-7#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-4#1)(2012-2#2)
this probability##2##2##(1991-12#1)(2008-10#1)
this probe was##2##3##(2007-7#1)(2012-1#1)
this probe##6##2##(1990-11#1)(1996-11#1)(2007-7#1)(2008-10#2)(2012-1#1)
this problem and improve##3##4##(2007-2#1)(2013-1#2)
this problem and to##2##4##(2008-10#1)(2008-8#1)
this problem and##14##3##(1995-7#1)(1996-7#1)(2005-10#1)(2005-7#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#3)
this problem are##3##3##(1994-6#1)(2007-11#1)(2008-1#1)
this problem at the community level##2##6##(1992-1#1)(2007-3#1)
this problem because##2##3##(2007-9#1)(2008-5#1)
this problem by##9##3##(1991-9#1)(1994-3#1)(2006-10#1)(2007-12#2)(2008-10#1)(2010-10#1)(2011-2#1)(2013-1#1)
this problem can be##3##4##(1996-5#1)(1997-4#1)(2008-1#1)
this problem for##2##3##(2007-5#1)(2008-8#1)
this problem has##3##3##(1995-5#1)(2007-11#1)(2013-8#1)
this problem have included##2##4##(2008-3#1)(2008-6#1)
this problem have##4##3##(2007-6#1)(2008-3#1)(2008-6#1)(2010-1#1)
this problem in##5##3##(1992-9#1)(2007-11#1)(2007-8#1)(2009-10#1)(2011-1#1)
this problem is presented##2##4##(1996-12#1)(2008-2#1)
this problem is to##5##4##(1993-12#1)(1996-9#1)(2008-7#2)(2011-1#1)
this problem is##14##3##(1991-5#1)(1993-12#1)(1993-9#1)(1996-12#1)(1996-9#1)(2007-4#1)(2008-10#1)(2008-2#3)(2008-7#2)(2010-11#1)(2011-1#1)
this problem may##2##3##(2006-10#1)(2011-2#1)
this problem of##2##3##(1994-9#1)(2013-8#1)
this problem the##3##3##(2007-7#1)(2009-4#1)(2011-2#1)
this problem through##2##3##(1997-8#1)(2008-2#1)
this problem using##3##3##(1990-9#1)(2008-8#1)(2012-12#1)
this problem was##2##3##(1990-11#1)(2008-10#1)
this problem##192##2##(1990-11#1)(1990-9#2)(1991-1#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#4)(1994-6#2)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#3)(1997-7#1)(1997-8#3)(2004-4#1)(2005-1#1)(2005-10#1)(2005-7#1)(2006-10#5)(2006-11#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#10)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#7)(2008-8#5)(2008-9#1)(2009-10#2)(2009-3#2)(2009-4#2)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-9#2)(2011-1#3)(2011-2#9)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#12)(2013-8#4)
this procedure and##2##3##(1997-2#1)(2013-1#1)
this procedure are##8##3##(1990-9#1)(1991-7#1)(1994-9#1)(2005-10#1)(2006-7#1)(2007-11#1)(2008-11#1)(2013-8#1)
this procedure as##2##3##(1990-9#1)(2007-8#1)
this procedure can be##2##4##(2007-7#1)(2008-5#1)
this procedure can##4##3##(1991-12#1)(2007-7#1)(2007-8#1)(2008-5#1)
this procedure for the##2##4##(2008-10#2)
this procedure for##6##3##(2006-8#1)(2008-10#3)(2008-2#1)(2009-10#1)
this procedure has been##2##4##(2005-4#1)(2006-11#1)
this procedure has##6##3##(1990-12#1)(2005-4#1)(2006-11#1)(2006-8#1)(2008-10#1)(2009-5#1)
this procedure in##6##3##(1990-8#1)(1991-9#1)(1993-9#1)(2007-8#2)(2008-12#1)
this procedure is safe##2##4##(2007-1#1)(2010-6#1)
this procedure is##25##3##(2006-11#1)(2006-3#2)(2006-8#1)(2007-1#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#2)(2008-9#1)(2009-2#1)(2009-3#1)(2010-6#1)(2012-12#1)(2013-1#1)
this procedure may##3##3##(2006-12#1)(2006-8#1)(2009-8#1)
this procedure offers##2##3##(1996-7#1)(2008-10#1)
this procedure over##2##3##(2004-2#1)(2006-5#1)
this procedure requires##2##3##(2008-11#1)(2009-11#1)
this procedure should be##2##4##(2008-9#1)(2013-8#1)
this procedure should##4##3##(2006-10#1)(2008-11#1)(2008-9#1)(2013-8#1)
this procedure the##2##3##(1995-8#1)(2008-3#1)
this procedure to be##2##4##(2007-12#1)(2008-4#1)
this procedure to the##2##4##(1991-8#1)(1997-2#1)
this procedure to##7##3##(1991-8#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-4#1)(2011-2#1)
this procedure was##3##3##(2008-10#1)(2012-12#1)(2013-8#1)
this procedure were##2##3##(2008-10#2)
this procedure with##2##3##(1996-12#1)(2008-6#1)
this procedure##184##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-8#1)(1990-9#3)(1991-11#1)(1991-12#1)(1991-7#1)(1991-8#1)(1991-9#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-12#2)(1994-3#2)(1994-9#1)(1995-10#1)(1995-8#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-2#4)(1997-4#1)(1997-6#1)(1997-8#1)(2004-2#1)(2005-10#1)(2005-4#2)(2005-5#1)(2006-10#3)(2006-11#2)(2006-12#1)(2006-3#4)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#5)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#6)(2007-8#11)(2007-9#3)(2008-1#1)(2008-10#24)(2008-11#12)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#8)(2008-5#3)(2008-6#4)(2008-7#1)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-5#2)(2009-8#1)(2010-1#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-6#3)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
this process a##2##3##(2007-12#1)(2008-5#1)
this process allows##2##3##(2005-7#1)(2008-10#1)
this process and##7##3##(1994-2#1)(1994-3#1)(1996-7#1)(2006-8#1)(2008-2#1)(2010-3#1)(2012-1#1)
this process are##8##3##(1990-5#1)(1996-9#1)(2004-9#1)(2006-10#1)(2007-12#1)(2007-8#1)(2009-8#1)(2012-12#1)
this process by##2##3##(1991-6#1)(2008-2#1)
this process can be##4##4##(1994-8#1)(2007-11#1)(2007-12#1)(2010-4#1)
this process can lead to##2##5##(2010-8#1)(2012-3#1)
this process can##8##3##(1992-3#1)(1994-8#1)(1994-9#1)(2007-11#1)(2007-12#1)(2010-4#1)(2010-8#1)(2012-3#1)
this process for##3##3##(2008-1#1)(2009-2#1)(2012-3#1)
this process has been##5##4##(1990-8#1)(2008-1#1)(2009-8#1)(2011-2#1)(2012-12#1)
this process has not been##4##5##(1993-4#1)(1995-8#1)(2008-11#1)(2011-12#1)
this process has##11##3##(1990-8#1)(1993-3#1)(1993-4#1)(1995-8#1)(2008-1#2)(2008-11#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-12#1)
this process have been##3##4##(2005-8#1)(2008-9#1)(2009-8#1)
this process have##5##3##(1995-2#1)(2005-8#1)(2006-12#1)(2008-9#1)(2009-8#1)
this process in the##3##4##(2007-11#1)(2012-12#1)(2013-1#1)
this process in##14##3##(1990-6#1)(2006-8#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#1)
this process include##2##3##(2006-10#1)(2006-9#1)
this process involves the##2##4##(1990-12#1)(2006-10#1)
this process is that##3##4##(1993-12#1)(2005-11#1)(2010-1#1)
this process is the##4##4##(1995-7#1)(2005-10#1)(2007-4#1)(2012-12#1)
this process is to##2##4##(2010-5#1)(2012-3#1)
this process is##31##3##(1990-6#1)(1991-1#1)(1991-3#1)(1992-4#2)(1993-12#1)(1994-11#1)(1994-6#1)(1995-7#1)(1997-7#1)(2005-10#1)(2005-11#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-1#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#1)
this process may be##3##4##(1992-3#1)(1995-8#1)(2008-11#1)
this process may##7##3##(1991-2#1)(1992-3#1)(1995-8#1)(2007-7#1)(2008-11#1)(2008-5#1)(2010-12#1)
this process of##4##3##(1991-6#1)(1992-7#1)(1993-3#1)(1995-6#1)
this process requires##3##3##(2007-12#1)(2008-1#1)(2008-4#1)
this process to be##3##4##(1990-7#1)(2007-11#1)(2008-2#1)
this process to##5##3##(1990-7#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)
this process was##4##3##(1996-8#1)(2005-11#1)(2006-4#1)(2008-11#1)
this process were##5##3##(1991-3#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-8#1)
this process with##2##3##(2008-1#1)(2008-7#1)
this process would##2##3##(2007-11#1)(2008-7#1)
this process##290##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-2#1)(1991-3#2)(1991-6#3)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-4#6)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#5)(1995-1#1)(1995-12#2)(1995-2#3)(1995-5#1)(1995-6#1)(1995-7#3)(1995-8#3)(1996-1#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#3)(1996-8#2)(1996-9#2)(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#5)(2006-12#2)(2006-4#1)(2006-5#2)(2006-8#4)(2006-9#1)(2007-1#1)(2007-11#9)(2007-12#12)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#7)(2008-10#9)(2008-11#6)(2008-2#8)(2008-3#5)(2008-4#5)(2008-5#9)(2008-6#3)(2008-7#8)(2008-8#2)(2008-9#5)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-7#2)(2009-8#7)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#8)(2012-1#1)(2012-12#6)(2012-2#1)(2012-3#4)(2013-1#7)(2013-8#1)
this processes##2##2##(1991-6#1)(2013-7#1)
this product##9##2##(1996-6#1)(2005-9#1)(2007-11#1)(2008-10#3)(2008-5#2)(2010-8#1)
this production##5##2##(1990-7#1)(1994-9#1)(1996-5#1)(1997-2#1)(2008-11#1)
this profession##3##2##(1990-2#1)(1994-12#1)(2007-11#1)
this professional paper##9##3##(1993-1#1)(1993-3#1)(1994-3#2)(1997-1#4)(2007-2#1)
this program has##2##3##(1995-12#1)(1996-2#1)
this program is##3##3##(1993-1#1)(2008-11#1)(2011-2#1)
this program##28##2##(1990-12#1)(1993-1#1)(1993-3#1)(1995-12#1)(1996-12#1)(1996-2#2)(1997-1#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-3#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)
this programme##13##2##(1990-11#1)(2004-2#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-4#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-7#3)
this progress will##2##3##(2006-2#1)(2007-8#1)
this progress##11##2##(1990-11#1)(2006-11#1)(2006-2#1)(2006-4#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2010-5#1)(2011-1#1)
this progression##2##2##(2006-10#1)(2008-1#1)
this proinflammatory##2##2##(2007-11#1)(2012-12#1)
this project are##4##3##(2005-10#1)(2008-12#1)(2008-7#1)(2008-8#1)
this project as##2##3##(2007-3#1)(2013-8#1)
this project was conducted##2##4##(1996-2#1)(2008-11#1)
this project was##19##3##(1991-9#1)(1994-3#1)(1995-3#2)(1995-6#1)(1996-2#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
this project##46##2##(1991-9#1)(1992-12#1)(1994-3#1)(1995-3#4)(1995-6#1)(1996-2#1)(1997-4#1)(2005-10#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-4#2)(2007-9#1)(2008-1#2)(2008-11#2)(2008-12#4)(2008-2#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-4#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
this projection##3##2##(1991-3#1)(1996-1#1)(1996-9#1)
this proliferation##2##2##(1995-2#1)(2008-11#1)
this prolonged##2##2##(1994-8#1)(2008-6#1)
this promise##2##2##(2008-11#1)(2010-10#1)
this promising##4##2##(2005-7#1)(2008-5#1)(2012-1#1)(2013-8#1)
this promoter contains##2##3##(1995-6#1)(1996-5#1)
this promoter element##2##3##(1993-6#1)(1995-6#1)
this promoter##15##2##(1990-11#1)(1992-12#1)(1993-12#1)(1993-6#1)(1993-7#1)(1993-9#1)(1995-6#2)(1996-10#1)(1996-5#1)(1996-6#1)(1997-4#1)(2006-12#1)(2007-11#1)(2008-10#1)
this property may##2##3##(1996-8#1)(2008-5#1)
this property##21##2##(1991-11#1)(1992-3#1)(1994-6#2)(1996-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-3#1)
this proportion##5##2##(1990-6#1)(1994-12#1)(2006-8#1)(2009-2#1)(2012-3#1)
this proposal is##2##3##(1991-4#1)(1996-3#1)
this proposal##16##2##(1991-2#1)(1991-4#2)(1991-7#1)(1993-3#1)(1994-12#1)(1995-8#1)(1996-3#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-1#1)(2009-4#1)(2013-8#1)
this proposed method##2##3##(2008-10#2)
this proposed technique##2##3##(2008-10#2)
this proposed##16##2##(1991-7#1)(1996-1#1)(2006-3#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-5#1)(2009-9#1)(2012-3#1)
this proposition##5##2##(1994-8#1)(2007-11#2)(2012-12#2)
this prospect##2##2##(1991-11#1)(2006-10#1)
this prospective cohort study##3##4##(2008-12#1)(2008-3#1)(2010-5#1)
this prospective randomized##2##3##(2008-8#1)(2011-2#1)
this prospective study##16##3##(1992-11#1)(1997-3#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-6#2)(2007-7#1)(2007-9#1)(2008-1#3)(2008-12#1)(2010-5#1)(2012-3#1)(2013-1#1)
this prospective##33##2##(1992-11#1)(1997-3#3)(2006-8#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-6#2)(2007-7#1)(2007-9#2)(2008-1#3)(2008-10#1)(2008-12#2)(2008-3#1)(2008-8#1)(2010-5#2)(2010-8#1)(2011-2#6)(2012-12#1)(2012-3#1)(2013-1#1)
this protection is##3##3##(1994-10#1)(2007-7#1)(2008-5#1)
this protection was##4##3##(1992-5#1)(1995-12#1)(1996-9#1)(2008-10#1)
this protection##14##2##(1992-5#1)(1994-10#1)(1994-12#1)(1995-12#1)(1996-1#1)(1996-9#1)(1997-7#1)(2005-10#1)(2007-7#1)(2008-10#2)(2008-5#1)(2011-12#1)(2011-2#1)
this protective effect##2##3##(1995-12#1)(2008-7#1)
this protective##3##2##(1995-12#1)(2008-7#1)(2010-5#1)
this protein also##2##3##(1994-6#1)(1997-6#1)
this protein and##10##3##(1990-3#1)(1991-5#1)(1993-12#2)(1994-11#1)(1994-6#1)(1995-2#1)(1997-4#1)(1997-6#2)
this protein as a##2##4##(1990-7#1)(1993-1#1)
this protein as##3##3##(1990-7#1)(1993-1#1)(1996-4#1)
this protein contains##2##3##(1994-12#1)(1995-6#1)
this protein could##4##3##(1994-5#1)(1994-6#1)(2010-2#1)(2012-12#1)
this protein has##4##3##(1991-5#1)(1994-11#1)(1994-3#1)(1997-7#1)
this protein have been##2##4##(1992-11#1)(1994-9#1)
this protein in##13##3##(1990-5#1)(1992-11#1)(1992-12#1)(1993-1#1)(1993-11#1)(1993-9#1)(1994-8#1)(1995-1#1)(1997-2#1)(2008-10#1)(2010-12#1)(2012-2#2)
this protein is##25##3##(1990-2#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-9#2)(1992-12#1)(1992-4#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-11#4)(1994-3#1)(1994-7#1)(1994-9#2)(1996-9#1)(2008-4#1)(2008-8#1)(2012-12#1)(2012-2#1)
this protein showed##2##3##(1990-4#1)(1994-8#1)
this protein to##7##3##(1990-11#1)(1990-5#1)(1992-12#1)(1992-8#1)(1993-6#1)(1994-12#1)(2008-10#1)
this protein was also##2##4##(1993-6#1)(1996-12#1)
this protein was##10##3##(1991-1#1)(1992-11#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)
this protein were##2##3##(1991-2#1)(1994-12#1)
this protein##182##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#5)(1990-6#1)(1990-7#3)(1990-8#1)(1991-1#2)(1991-11#2)(1991-12#1)(1991-2#3)(1991-5#3)(1991-6#1)(1991-9#3)(1992-11#5)(1992-12#4)(1992-2#1)(1992-4#3)(1992-6#1)(1992-7#5)(1992-8#3)(1993-1#3)(1993-11#1)(1993-12#7)(1993-3#1)(1993-4#3)(1993-6#4)(1993-8#2)(1993-9#1)(1994-11#8)(1994-12#4)(1994-3#4)(1994-5#2)(1994-6#4)(1994-7#1)(1994-8#4)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#3)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#3)(1996-5#1)(1996-9#2)(1997-2#2)(1997-4#3)(1997-6#4)(1997-7#1)(2004-12#1)(2005-8#1)(2006-12#1)(2007-1#1)(2007-10#1)(2008-10#6)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#1)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#3)
this protein(s)##3##2##(1993-2#1)(1994-12#2)
this proteolytic pathway##3##3##(1992-12#1)(1994-11#1)(1994-9#1)
this proteolytic##9##2##(1992-12#1)(1994-11#1)(1994-9#1)(1995-1#1)(2005-8#1)(2006-12#1)(2006-9#1)(2008-5#1)(2010-4#1)
this protocol can be##2##4##(2008-4#1)(2008-9#1)
this protocol is##4##3##(2008-2#2)(2008-4#1)(2008-9#1)
this protocol##33##2##(1990-6#1)(1992-8#1)(1993-11#1)(1994-10#1)(1995-2#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-11#9)(2008-2#3)(2008-3#1)(2008-4#8)(2008-5#1)(2008-9#3)
this proton##2##2##(1993-12#1)(1996-7#1)
this prototype##2##2##(2008-10#1)(2008-2#1)
this provides the##3##3##(1990-8#1)(2008-2#1)(2010-11#1)
this provides##5##2##(1990-8#1)(1990-9#1)(1996-10#1)(2008-2#1)(2010-11#1)
this pseudogene##4##2##(1993-2#1)(1993-6#2)(1994-11#1)
this public health issue##2##4##(1996-1#1)(2007-1#1)
this public health##3##3##(1996-1#1)(2007-1#1)(2009-5#1)
this publication##8##2##(1997-3#1)(2007-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-1#1)(2013-1#1)
this pulse##2##2##(2007-12#1)(2012-11#1)
this pump##3##2##(1997-5#1)(2007-12#1)(2008-2#1)
this purified##2##2##(1990-11#1)(1990-12#1)
this purpose a##4##3##(1991-3#1)(1997-1#1)(2008-10#1)(2008-3#1)
this purpose an##3##3##(1991-5#1)(2006-2#1)(2010-8#1)
this purpose is##4##3##(2004-12#1)(2008-2#1)(2010-6#1)(2013-1#1)
this purpose the##8##3##(1991-1#1)(2005-11#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-4#1)(2012-12#1)
this purpose we##10##3##(1995-10#1)(1996-11#1)(1996-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)(2013-1#2)
this purpose##218##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-3#1)(1993-12#2)(1993-5#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#2)(1995-4#1)(1995-5#1)(1995-6#1)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-6#1)(1997-8#1)(2004-10#1)(2004-12#1)(2005-11#2)(2005-9#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-11#5)(2007-12#1)(2007-7#1)(2007-8#3)(2008-1#6)(2008-10#40)(2008-11#6)(2008-12#1)(2008-2#5)(2008-3#11)(2008-4#7)(2008-5#12)(2008-7#8)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#3)(2009-7#1)(2010-11#1)(2010-5#2)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#9)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#3)(2012-9#1)(2013-1#9)(2013-8#2)
this putative##6##2##(1990-11#1)(1994-9#1)(1995-5#1)(1997-5#1)(1997-6#1)(2009-10#1)
this qualification##2##2##(2008-11#1)(2011-2#1)
this qualitative study##12##3##(2007-10#1)(2008-11#1)(2008-12#1)(2009-7#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#4)
this qualitative##17##2##(2005-10#1)(2007-10#1)(2008-11#1)(2008-12#1)(2009-7#1)(2009-9#1)(2010-10#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#4)
this quantitative approach##2##3##(2008-10#2)
this quantitative##4##2##(1991-11#1)(2007-9#1)(2008-10#2)
this quantity is enough to fertilize all the eggs produced by a female during its reproductive life##2##17##(2012-12#2)
this quantity is##3##3##(1995-5#1)(2012-12#2)
this quantity##9##2##(1995-5#1)(1996-7#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2012-12#2)
this question by##2##3##(2008-8#1)(2012-2#1)
this question in##3##3##(2005-7#1)(2010-10#1)(2012-12#1)
this question is##3##3##(2007-9#1)(2009-2#1)(2011-12#1)
this question we##3##3##(1994-11#1)(2009-6#1)(2013-8#1)
this question##62##2##(1990-12#1)(1991-12#1)(1991-6#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-4#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-5#1)(2004-3#1)(2005-10#1)(2005-7#1)(2006-3#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-6#3)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
this radical generation##2##3##(1994-9#2)
this radical##4##2##(1991-9#1)(1994-9#2)(2008-10#1)
this raises##3##2##(1991-6#1)(1997-4#1)(2013-8#1)
this randomised##2##2##(2010-7#1)(2013-1#1)
this randomized controlled trial##2##4##(2011-2#1)(2012-2#1)
this randomized controlled##3##3##(2009-12#1)(2011-2#1)(2012-2#1)
this randomized##12##2##(1997-1#1)(2006-7#1)(2007-8#2)(2008-3#1)(2008-5#1)(2009-12#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-8#1)
this range of##7##3##(1990-10#1)(1991-11#1)(1992-8#2)(1996-12#1)(2008-5#2)
this range to##2##3##(2008-2#1)(2008-3#1)
this range##29##2##(1990-10#1)(1991-11#1)(1991-8#1)(1992-8#3)(1996-12#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#6)(2008-5#2)(2008-9#1)(2012-1#1)(2013-1#2)
this rapid##2##2##(2009-9#1)(2013-1#1)
this rapidly expanding field##2##4##(1994-3#1)(2007-11#1)
this rapidly##6##2##(1994-3#1)(2006-6#1)(2007-11#1)(2010-5#1)(2013-1#2)
this rare anomaly##2##3##(2008-12#1)(2009-9#1)
this rare association##3##3##(2007-7#1)(2009-5#1)(2010-8#1)
this rare but##2##3##(2009-4#1)(2012-2#1)
this rare case##4##3##(1991-2#1)(2007-7#1)(2008-12#1)(2008-7#1)
this rare cause of##2##4##(1996-3#1)(2007-8#1)
this rare clinical entity##2##4##(2007-7#1)(2008-5#1)
this rare condition##4##3##(2004-10#1)(2006-10#1)(2008-10#1)(2012-3#1)
this rare congenital anomaly##2##4##(2008-4#1)(2008-9#1)
this rare disease##14##3##(1990-10#1)(1990-9#1)(1992-10#1)(1996-7#1)(2005-11#1)(2007-7#1)(2007-9#1)(2010-3#2)(2011-2#1)(2012-2#1)(2013-1#3)
this rare entity##5##3##(2005-10#1)(2007-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
this rare form##2##3##(1991-4#1)(1991-6#1)
this rare fracture##2##3##(2006-12#1)(2012-12#1)
this rare injury##2##3##(2008-12#1)(2012-2#1)
this rare lesion##5##3##(1993-12#1)(2006-10#1)(2006-12#1)(2012-12#1)(2013-1#1)
this rare mutation##2##3##(2008-2#1)(2011-1#1)
this rare pathology##3##3##(1992-6#1)(2007-8#1)(2009-2#1)
this rare syndrome##3##3##(2005-8#1)(2006-10#1)(2008-11#1)
this rare tumor##7##3##(1991-6#1)(2005-12#1)(2010-3#1)(2011-2#1)(2012-2#3)
this rare##97##2##(1990-10#1)(1990-12#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#2)(1992-10#1)(1992-6#1)(1993-12#2)(1993-8#1)(1994-2#1)(1996-3#1)(1996-7#1)(2004-10#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-5#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-12#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#5)(2007-8#4)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-2#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#3)(2010-8#2)(2011-1#2)(2011-2#3)(2012-12#4)(2012-2#8)(2012-3#2)(2013-1#4)(2013-8#1)
this rat model##3##3##(1995-2#1)(2008-4#1)(2012-2#1)
this rat strain##2##3##(1994-11#1)(2008-4#1)
this rat##6##2##(1994-11#1)(1995-2#1)(2008-4#2)(2008-5#1)(2012-2#1)
this rate is##3##3##(2007-2#1)(2007-4#1)(2008-8#1)
this rate of##2##3##(1992-5#1)(2008-6#1)
this rate was##4##3##(1992-6#1)(2007-2#1)(2010-3#1)(2011-1#1)
this rate##14##2##(1992-5#1)(1992-6#1)(1993-9#1)(1995-1#1)(2007-2#2)(2007-4#1)(2008-2#1)(2008-6#1)(2008-8#2)(2010-3#1)(2011-1#1)(2012-3#1)
this ratio can be##2##4##(2008-2#1)(2008-3#1)
this ratio was##2##3##(1993-8#1)(2012-2#1)
this ratio##13##2##(1990-8#1)(1992-12#1)(1992-7#1)(1993-8#1)(1994-5#1)(1995-12#1)(1997-2#1)(2005-11#2)(2008-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
this rationale##2##2##(1994-8#1)(2008-5#1)
this reaction are##3##3##(1990-1#1)(1992-6#1)(2009-10#1)
this reaction as##2##3##(1992-6#1)(2008-10#1)
this reaction by##3##3##(1997-4#1)(2007-11#1)(2008-10#1)
this reaction for the##3##4##(2007-11#1)(2008-4#2)
this reaction is##6##3##(1991-6#1)(1992-6#1)(1996-5#1)(2008-10#1)(2012-12#1)(2013-8#1)
this reaction system##3##3##(2006-10#1)(2008-10#1)(2013-1#1)
this reaction was##3##3##(1992-5#1)(1992-7#1)(1995-6#1)
this reaction##63##2##(1990-1#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-9#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-8#1)(2004-8#1)(2005-12#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#15)(2008-4#3)(2008-5#2)(2008-7#2)(2009-10#2)(2010-5#2)(2012-12#1)(2013-1#1)(2013-8#1)
this reactive oxygen##2##3##(2008-11#1)(2009-10#1)
this reagent was##2##3##(2008-10#1)(2012-2#1)
this reagent##10##2##(1995-11#1)(1996-5#1)(2008-10#5)(2008-4#2)(2012-2#1)
this realignment##2##2##(1991-3#1)(1993-3#1)
this reality##9##2##(2006-6#1)(2006-9#1)(2008-2#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-2#2)
this rearrangement##4##2##(1990-2#1)(1993-5#1)(1995-3#1)(1995-8#1)
this reason a##2##3##(1992-1#1)(2008-3#1)
this reason the##5##3##(1992-10#1)(1993-10#1)(2005-1#1)(2007-11#1)(2010-4#1)
this reason we##8##3##(1992-2#1)(1992-5#1)(1995-2#1)(1997-6#1)(2007-12#1)(2008-1#1)(2009-3#1)(2010-5#1)
this reason##94##2##(1991-11#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#2)(1992-10#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-6#1)(1995-12#1)(1995-2#1)(1995-4#1)(1996-1#1)(1996-3#1)(1997-3#1)(1997-6#1)(2004-11#1)(2005-1#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-5#1)(2006-6#1)(2007-1#2)(2007-11#5)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#2)(2007-6#2)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-3#1)(2009-5#2)(2010-12#4)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#2)(2011-7#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
this recent##2##2##(2008-10#1)(2008-6#1)
this receptor by##3##3##(1990-7#2)(1991-3#1)
this receptor in##5##3##(1990-11#1)(1991-2#1)(1994-12#1)(2007-12#1)(2008-5#1)
this receptor is a##2##4##(1995-11#1)(2007-8#1)
this receptor is##10##3##(1990-12#1)(1990-6#1)(1995-11#1)(1996-5#1)(1997-6#1)(2007-10#1)(2007-8#1)(2008-5#2)(2010-12#1)
this receptor subtype##2##3##(1994-3#1)(2008-4#1)
this receptor to##3##3##(1994-5#1)(1996-8#1)(2009-4#1)
this receptor with##2##3##(1995-10#1)(2008-8#1)
this receptor##67##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-6#1)(1990-7#3)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#4)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-12#3)(1994-3#1)(1994-5#3)(1994-8#3)(1995-1#1)(1995-10#2)(1995-11#3)(1995-12#1)(1995-3#2)(1995-6#1)(1996-11#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-9#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-4#3)(2008-5#3)(2008-8#1)(2009-4#2)(2010-12#1)(2012-2#1)
this reciprocal relationship##2##3##(2005-12#1)(2009-7#1)
this reciprocal##3##2##(2005-12#1)(2009-7#1)(2010-3#1)
this recognition##4##2##(1995-2#1)(2008-11#1)(2009-8#1)(2010-5#1)
this recombinant##5##2##(1991-7#1)(1995-11#1)(2008-11#1)(2008-6#1)(2010-11#1)
this recombination##2##2##(1996-10#1)(2009-2#1)
this recommendation##5##2##(1996-12#1)(2008-11#1)(2010-5#1)(2011-2#1)(2012-12#1)
this reconstituted##3##2##(1992-8#1)(1993-12#1)(1994-8#1)
this reconstitution##2##2##(1991-7#1)(2008-4#1)
this reconstruction##3##2##(2007-12#1)(2008-3#1)(2008-6#1)
this redox##3##2##(1995-6#1)(1997-6#1)(2008-10#1)
this reduced model##2##3##(2008-6#2)
this reduced##3##2##(2007-11#1)(2008-6#2)
this reduction in##2##3##(2007-12#1)(2008-11#1)
this reduction is##2##3##(1995-5#1)(2007-12#1)
this reduction was##2##3##(1991-6#1)(1995-9#1)
this reduction##21##2##(1990-2#1)(1991-6#1)(1992-12#1)(1993-11#1)(1993-12#1)(1995-5#1)(1995-9#1)(1997-4#1)(1997-5#1)(2005-10#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2012-2#1)
this reef##2##2##(2007-3#1)(2008-5#1)
this reflection##4##2##(2008-11#1)(2008-3#1)(2012-12#1)(2013-1#1)
this reflects##5##2##(1990-12#1)(1993-2#1)(1995-5#1)(2008-7#1)(2009-2#1)
this regard##69##2##(1990-4#1)(1990-5#2)(1991-12#1)(1991-6#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-5#1)(1996-10#1)(1996-9#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-7#2)(2006-10#1)(2006-4#2)(2006-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
this regime##7##2##(1992-8#1)(2007-11#2)(2007-12#2)(2008-2#1)(2008-6#1)
this regimen is##2##3##(1996-12#1)(2007-12#1)
this regimen##13##2##(1990-12#1)(1991-10#1)(1991-12#1)(1992-8#1)(1996-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2010-4#1)(2012-2#1)(2013-1#2)
this region and also##2##4##(1996-3#1)(2008-7#1)
this region and##6##3##(1996-3#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-7#1)(2013-7#1)
this region by##4##3##(1990-7#1)(1991-12#1)(1993-8#1)(2012-3#1)
this region contributes to##2##4##(1995-10#1)(1997-2#1)
this region has##5##3##(1993-6#1)(1994-8#1)(2007-9#1)(2012-12#2)
this region in the##3##4##(1994-6#1)(1996-7#1)(2008-10#1)
this region in##11##3##(1990-6#1)(1991-12#1)(1994-2#1)(1994-6#1)(1996-1#1)(1996-3#1)(1996-7#1)(1997-5#1)(2008-10#1)(2008-11#1)(2009-4#1)
this region is not##2##4##(1990-4#1)(1996-7#1)
this region is##22##3##(1990-12#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-6#1)(1991-8#1)(1993-11#2)(1993-12#1)(1994-9#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-7#1)(2005-10#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2012-12#2)
this region of chromosome##2##4##(1997-5#1)(2008-10#1)
this region of the##11##4##(1991-6#1)(1993-2#1)(1993-3#1)(1994-5#1)(1994-9#1)(1995-10#1)(1996-3#1)(1997-4#1)(1997-8#1)(2008-10#1)(2010-5#1)
this region of##20##3##(1990-9#1)(1991-6#1)(1993-2#1)(1993-3#1)(1994-5#2)(1994-9#1)(1995-10#1)(1995-6#1)(1996-3#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-8#1)(2008-10#2)(2008-5#1)(2010-5#1)(2012-12#1)
this region there##2##3##(1990-11#1)(2008-7#1)
this region to##4##3##(1995-3#1)(1997-3#1)(2006-12#2)
this region using##2##3##(1991-5#1)(1991-9#1)
this region was##5##3##(1990-12#1)(1991-12#1)(1995-12#1)(1995-3#1)(2008-9#1)
this region were##6##3##(1994-11#1)(1994-9#1)(2005-8#1)(2008-1#1)(2008-12#1)(2013-8#1)
this region##240##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#2)(1991-5#3)(1991-6#2)(1991-7#2)(1991-8#4)(1991-9#2)(1992-10#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#4)(1993-4#1)(1993-6#2)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#2)(1994-5#5)(1994-6#2)(1994-8#1)(1994-9#3)(1995-10#2)(1995-11#1)(1995-12#1)(1995-3#3)(1995-5#1)(1995-6#4)(1995-8#3)(1996-1#2)(1996-11#2)(1996-12#1)(1996-3#5)(1996-5#3)(1996-6#2)(1996-7#3)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#7)(1997-4#5)(1997-5#8)(1997-7#2)(1997-8#2)(2005-10#1)(2005-11#1)(2005-8#1)(2006-12#4)(2006-3#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#2)(2007-5#4)(2007-7#3)(2007-9#2)(2008-1#1)(2008-10#12)(2008-11#6)(2008-12#3)(2008-2#1)(2008-5#4)(2008-7#6)(2008-8#4)(2008-9#2)(2009-10#1)(2009-4#1)(2010-12#2)(2010-5#1)(2010-7#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#3)(2013-8#4)
this regular##4##2##(1990-12#1)(1991-2#1)(1992-2#1)(2009-8#1)
this regulation is dependent##2##4##(2008-8#2)
this regulation is##5##3##(1993-5#1)(1996-2#1)(2008-8#2)(2009-8#1)
this regulation##13##2##(1991-5#1)(1993-12#1)(1993-5#1)(1994-2#1)(1995-11#1)(1995-3#1)(1996-11#1)(1996-2#2)(2008-8#2)(2009-8#2)
this regulatory event##2##3##(1991-2#1)(1991-3#1)
this regulatory##15##2##(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-12#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-4#1)(1997-9#1)(2007-12#1)(2008-11#1)(2008-8#1)(2010-12#1)(2011-1#1)
this relates to the##2##4##(2008-1#1)(2008-2#1)
this relates to##3##3##(2006-10#1)(2008-1#1)(2008-2#1)
this relation is##2##3##(2008-5#1)(2009-6#1)
this relation was##2##3##(1996-8#1)(2011-2#1)
this relation##6##2##(1996-8#1)(2008-12#1)(2008-5#1)(2009-6#1)(2011-2#1)(2013-8#1)
this relationship and##3##3##(1995-6#1)(2006-7#1)(2007-4#1)
this relationship are##5##3##(1995-1#1)(1995-3#1)(2008-10#1)(2008-2#1)(2012-1#1)
this relationship between##4##3##(1994-10#1)(1994-5#1)(2010-2#1)(2013-1#1)
this relationship has##3##3##(1994-2#1)(2008-5#1)(2010-10#1)
this relationship in##4##3##(1993-9#1)(1994-5#1)(2006-8#1)(2012-2#1)
this relationship is not##3##4##(2006-10#1)(2007-8#1)(2009-5#1)
this relationship is##7##3##(1990-3#1)(2005-10#1)(2006-10#1)(2007-8#1)(2008-4#1)(2008-8#1)(2009-5#1)
this relationship to##2##3##(2010-3#1)(2011-1#1)
this relationship was mediated by##3##5##(2007-12#1)(2010-10#1)(2012-1#1)
this relationship was##7##3##(1993-12#1)(2007-12#1)(2008-10#1)(2010-10#1)(2010-9#1)(2012-1#1)(2013-8#1)
this relationship##65##2##(1990-11#2)(1990-3#1)(1993-12#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-5#3)(1995-1#1)(1995-3#1)(1995-6#1)(1996-2#1)(2005-10#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#3)(2007-6#1)(2007-8#1)(2008-10#5)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2010-10#2)(2010-2#1)(2010-3#2)(2010-9#1)(2011-1#1)(2012-1#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#1)
this relative##2##2##(1990-12#1)(2012-1#1)
this relatively new##3##3##(2008-8#1)(2011-1#1)(2013-8#1)
this relatively rare##2##3##(1992-5#1)(2006-11#1)
this relatively small##2##3##(1997-2#1)(2008-10#1)
this relatively##11##2##(1992-5#1)(1996-6#1)(1997-2#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-12#1)(2011-1#1)(2013-7#1)(2013-8#1)
this release##5##2##(1990-7#1)(1992-6#2)(1996-8#1)(1996-9#1)
this remains a##2##3##(2008-11#1)(2012-2#1)
this remains##9##2##(1993-9#1)(1995-12#1)(2005-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-11#1)(2011-12#1)(2012-2#1)
this remarkable##7##2##(1990-2#1)(1992-3#1)(1993-12#1)(1995-8#1)(2008-7#1)(2009-2#1)(2012-2#1)
this report a method##2##4##(1992-8#1)(2008-10#1)
this report a##4##3##(1992-12#1)(1992-8#1)(2008-10#1)(2011-1#1)
this report an##2##3##(2008-10#2)
this report are##6##3##(1991-12#1)(1993-11#1)(2008-10#1)(2011-12#1)(2011-2#1)(2012-3#1)
this report is a##3##4##(2011-2#1)(2012-2#2)
this report is that##2##4##(2008-11#1)(2011-2#1)
this report is##25##3##(1992-12#1)(2004-1#1)(2006-10#1)(2007-10#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-2#1)(2010-5#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)
this report of##2##3##(2005-12#1)(2006-4#1)
this report reviews##2##3##(1991-2#1)(2011-10#1)
this report the##8##3##(1994-11#1)(1995-8#1)(2006-5#2)(2008-5#1)(2009-10#1)(2009-5#1)(2013-1#1)
this report was##12##3##(1993-3#1)(2004-9#1)(2006-2#1)(2007-2#2)(2007-3#2)(2008-5#1)(2008-6#1)(2009-4#1)(2011-1#1)(2011-2#1)
this report we describe##18##4##(1990-8#1)(1991-7#1)(1992-11#2)(1994-3#3)(1995-3#1)(1997-3#1)(1997-9#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-2#1)(2007-7#1)(2009-10#1)(2012-3#2)
this report we present##6##4##(1991-7#1)(2008-4#1)(2008-7#2)(2008-9#1)(2012-2#1)
this report we##58##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-3#1)(1991-4#1)(1991-7#2)(1992-11#2)(1992-2#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-8#1)(1994-3#4)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#2)(1996-10#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-7#1)(1997-9#1)(2005-7#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-2#1)(2011-1#1)(2012-2#1)(2012-3#4)
this report will##2##3##(2008-7#1)(2008-9#1)
this report##325##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#3)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#2)(1993-11#3)(1993-12#2)(1993-3#2)(1993-5#1)(1993-6#3)(1993-8#3)(1994-11#1)(1994-12#1)(1994-3#4)(1994-5#1)(1994-8#3)(1994-9#2)(1995-1#4)(1995-10#1)(1995-12#1)(1995-2#4)(1995-3#4)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#3)(1997-8#1)(1997-9#1)(2004-1#2)(2004-9#1)(2005-10#1)(2005-12#2)(2005-3#1)(2005-4#1)(2005-7#1)(2005-8#4)(2005-9#1)(2006-10#6)(2006-12#2)(2006-2#1)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#3)(2006-9#3)(2007-1#2)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#4)(2007-3#5)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#3)(2007-9#4)(2008-1#3)(2008-10#14)(2008-11#8)(2008-12#3)(2008-3#1)(2008-4#6)(2008-5#7)(2008-6#2)(2008-7#9)(2008-8#3)(2008-9#5)(2009-10#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#4)(2010-4#2)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#11)(2011-10#1)(2011-12#1)(2011-2#10)(2012-1#2)(2012-12#5)(2012-2#7)(2012-3#10)(2013-1#4)(2013-7#3)(2013-8#3)
this representation##2##2##(2006-4#1)(2008-11#1)
this represents a##2##3##(2008-6#1)(2010-9#1)
this represents one of the most##2##6##(2008-10#1)(2008-5#1)
this represents the##2##3##(2008-10#1)(2010-5#1)
this represents##7##2##(2007-10#1)(2008-10#2)(2008-5#1)(2008-6#1)(2010-5#1)(2010-9#1)
this repression##2##2##(1992-1#1)(2008-3#1)
this requirement##11##2##(1996-4#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2009-10#1)(2009-8#1)(2013-1#1)
this requires a##3##3##(2006-4#1)(2007-7#1)(2008-8#1)
this requires further##2##3##(1993-11#1)(2006-4#1)
this requires##11##2##(1993-11#1)(1993-12#1)(2006-4#2)(2007-5#1)(2007-7#2)(2008-11#1)(2008-7#1)(2008-8#1)(2011-1#1)
this research a##3##3##(1990-4#1)(2008-12#1)(2008-7#1)
this research and##2##3##(2006-11#1)(2013-1#1)
this research are##2##3##(2007-4#1)(2009-6#1)
this research has##5##3##(2006-2#1)(2008-10#1)(2008-3#1)(2011-1#1)(2012-12#1)
this research in the##2##4##(2006-2#1)(2009-5#1)
this research in##3##3##(2006-2#1)(2009-5#1)(2010-11#1)
this research is##18##3##(1994-3#1)(1994-8#1)(1995-6#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-6#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)
this research might##2##3##(2007-12#1)(2010-4#1)
this research project##3##3##(2006-6#1)(2008-1#1)(2010-10#1)
this research to##2##3##(2008-1#1)(2008-8#1)
this research was to evaluate the##4##6##(2007-2#2)(2008-10#1)(2013-7#1)
this research was to evaluate##6##5##(2006-5#1)(2007-2#2)(2008-10#1)(2011-2#1)(2013-7#1)
this research was to##35##4##(1990-9#1)(1993-6#1)(1994-3#1)(2006-11#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-7#1)(2008-10#5)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2010-4#2)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
this research was##43##3##(1990-9#1)(1993-6#1)(1994-3#2)(2006-11#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#3)(2007-7#1)(2008-10#6)(2008-12#2)(2008-3#2)(2008-5#3)(2008-7#1)(2010-4#2)(2010-5#1)(2011-1#4)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
this research were##10##3##(1990-10#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2010-3#1)
this research##163##2##(1990-10#1)(1990-3#1)(1990-4#1)(1990-9#1)(1991-2#1)(1992-1#1)(1992-7#1)(1993-6#1)(1994-3#3)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-1#1)(1997-3#1)(2004-11#1)(2004-3#1)(2005-11#1)(2006-11#2)(2006-2#3)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-10#2)(2007-11#6)(2007-12#5)(2007-2#5)(2007-4#1)(2007-5#1)(2007-7#2)(2008-1#5)(2008-10#18)(2008-11#4)(2008-12#13)(2008-2#5)(2008-3#7)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#2)(2010-8#1)(2011-1#8)(2011-2#6)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#4)(2013-1#3)(2013-7#1)
this residue in##3##3##(1995-2#2)(1996-2#1)
this residue is##4##3##(1992-8#1)(1993-8#1)(1994-5#1)(2009-3#1)
this residue to alanine##2##4##(1995-5#1)(1995-6#1)
this residue to##6##3##(1992-7#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-5#1)(1995-6#1)
this residue##28##2##(1990-12#1)(1990-2#1)(1990-8#2)(1991-3#1)(1991-9#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-5#2)(1995-11#1)(1995-2#4)(1995-5#2)(1995-6#1)(1996-2#1)(2005-11#1)(2006-12#1)(2009-3#1)
this resin##2##2##(2008-10#1)(2008-7#1)
this resistance can be##2##4##(2008-10#1)(2009-9#1)
this resistance is##2##3##(2008-10#1)(2011-2#1)
this resistance to##2##3##(2008-10#2)
this resistance was##2##3##(2008-10#2)
this resistance##21##2##(1995-7#2)(2005-11#1)(2005-7#1)(2006-11#1)(2008-10#9)(2008-11#1)(2008-2#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
this resolution##3##2##(2007-12#1)(2008-3#1)(2012-12#1)
this resonator type##2##3##(2007-11#1)(2008-3#1)
this resource##9##2##(1991-2#1)(2007-3#1)(2007-5#1)(2008-7#2)(2011-2#1)(2013-1#3)
this respect##64##2##(1990-12#1)(1990-4#1)(1991-6#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-12#2)(1995-5#1)(1996-9#1)(1997-4#1)(1997-8#1)(2004-4#1)(2005-11#2)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#1)(2009-5#1)(2009-6#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2011-7#1)(2012-12#2)(2012-2#3)(2013-1#2)
this response element##2##3##(1992-9#2)
this response in##2##3##(1993-6#1)(2010-12#1)
this response is not##2##4##(1991-5#1)(1992-8#1)
this response is##6##3##(1991-5#1)(1992-8#1)(1993-4#1)(2006-4#1)(2011-2#1)(2013-8#1)
this response was##8##3##(1991-7#1)(1991-9#1)(1993-12#1)(1994-3#1)(1995-3#1)(1997-2#1)(2008-8#1)(2010-8#1)
this response##54##2##(1990-7#1)(1991-11#1)(1991-3#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-12#3)(1993-4#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-3#3)(1996-10#1)(1996-2#2)(1997-2#3)(2005-8#1)(2006-10#1)(2006-4#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
this restriction##3##2##(1993-7#1)(1994-8#1)(2008-3#1)
this result and##5##3##(1990-11#1)(1995-9#1)(1996-5#1)(2006-4#1)(2008-9#1)
this result can be##2##4##(1993-6#1)(2007-12#1)
this result in the##3##4##(1991-3#1)(1992-3#1)(2008-9#1)
this result is##4##3##(1996-5#1)(2008-10#1)(2008-9#1)(2010-7#1)
this result may##2##3##(1993-3#1)(2012-2#1)
this result suggests that##4##4##(1991-1#1)(1991-2#1)(1991-5#1)(1994-8#1)
this result suggests##5##3##(1991-1#2)(1991-2#1)(1991-5#1)(1994-8#1)
this result we##2##3##(1996-9#1)(2007-12#1)
this result with##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2010-8#1)
this result##65##2##(1990-11#1)(1990-8#1)(1991-1#2)(1991-2#2)(1991-3#1)(1991-5#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-4#1)(1996-5#3)(1996-9#1)(1997-7#1)(2006-4#1)(2007-11#2)(2007-12#6)(2007-2#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-8#3)(2008-9#5)(2009-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
this resulted in the##4##4##(1990-12#1)(1992-6#1)(1993-10#1)(2008-9#1)
this resulted in##8##3##(1990-12#1)(1992-6#1)(1993-10#1)(2008-11#2)(2008-7#1)(2008-9#1)(2013-1#1)
this results in a##5##4##(1992-3#1)(1992-5#1)(2004-9#1)(2008-10#2)
this results in the##5##4##(2006-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2012-12#1)
this results in##16##3##(1992-3#1)(1992-5#1)(1996-7#1)(2004-9#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2012-12#1)
this results##18##2##(1992-3#1)(1992-5#1)(1996-7#1)(2004-9#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-2#1)(2010-4#1)(2012-12#1)
this retrospective analysis##6##3##(1993-7#1)(1996-11#1)(2006-11#1)(2008-1#1)(2011-1#1)(2011-2#1)
this retrospective cohort##2##3##(2008-8#1)(2012-2#1)
this retrospective review##2##3##(2006-10#1)(2011-2#1)
this retrospective study##41##3##(1992-12#1)(1996-11#1)(1997-2#1)(2006-10#3)(2006-6#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#4)(2007-8#6)(2008-1#2)(2008-3#1)(2008-6#1)(2009-4#1)(2009-5#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
this retrospective##55##2##(1992-12#1)(1993-7#1)(1996-11#2)(1997-2#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#4)(2007-8#6)(2008-1#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-4#1)(2011-1#4)(2011-12#1)(2011-2#6)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
this review aims to##3##4##(2011-1#1)(2011-12#1)(2012-2#1)
this review also##2##3##(2009-10#1)(2010-10#1)
this review are to##5##4##(1990-11#1)(2007-8#1)(2008-10#1)(2008-8#1)(2012-2#1)
this review are##16##3##(1990-11#1)(2005-10#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-5#1)(2012-2#2)
this review article we##3##4##(2008-11#1)(2008-5#1)(2012-3#1)
this review article##28##3##(2006-12#1)(2006-9#4)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
this review covers the##2##4##(2006-10#1)(2008-5#1)
this review describes the##3##4##(2007-11#1)(2008-8#1)(2010-4#1)
this review discusses##3##3##(2006-11#1)(2008-1#1)(2011-12#1)
this review examines##2##3##(2008-3#1)(2012-2#1)
this review focuses on recent progress in##2##7##(1990-6#1)(2009-3#1)
this review focuses on##3##4##(1990-6#1)(2009-3#1)(2012-12#1)
this review focuses##5##3##(1990-6#1)(1997-2#1)(2009-3#1)(2010-5#1)(2012-12#1)
this review is not##3##4##(2007-10#1)(2007-11#1)(2010-7#1)
this review is that##3##4##(2007-11#1)(2008-8#1)(2008-9#1)
this review is##96##3##(1993-12#1)(1996-9#1)(1997-6#1)(2004-4#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#4)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#7)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#3)(2011-3#2)(2012-11#1)(2012-12#4)(2012-2#7)(2012-3#1)(2013-1#7)(2013-8#1)
this review it##2##3##(1993-12#1)(2013-1#1)
this review of##6##3##(1990-1#1)(2006-10#2)(2008-1#2)(2008-12#1)
this review presents the scientific background##2##6##(2012-12#2)
this review summarizes##2##3##(2006-10#1)(2008-5#1)
this review to##6##3##(2005-10#1)(2005-7#1)(2007-7#1)(2010-5#1)(2012-12#1)(2013-1#1)
this review was to##10##4##(1996-6#1)(2007-12#1)(2008-5#1)(2009-11#1)(2010-2#1)(2010-6#1)(2011-2#1)(2013-1#3)
this review was##12##3##(1996-6#1)(2007-12#1)(2008-5#1)(2009-11#1)(2010-2#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#3)
this review we provide an overview of##2##7##(2012-12#1)(2012-2#1)
this review we provide##3##4##(2011-2#1)(2012-12#1)(2012-2#1)
this review we will##16##4##(2005-10#1)(2005-7#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-3#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-2#1)(2011-1#1)(2012-1#2)
this review we##91##3##(1996-8#1)(2005-10#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-2#2)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#7)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#2)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-1#4)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#5)(2013-8#4)
this review were##2##3##(2008-1#1)(2009-1#1)
this review will attempt to##2##5##(2006-10#1)(2008-5#1)
this review will focus##2##4##(2008-10#1)(2008-9#1)
this review will##16##3##(2005-10#1)(2006-10#1)(2008-10#3)(2008-2#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-8#1)
this review##779##2##(1990-1#1)(1990-11#1)(1990-3#1)(1990-4#1)(1990-6#1)(1991-4#1)(1992-5#1)(1992-6#1)(1993-12#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-5#2)(1995-6#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(2004-11#1)(2004-2#2)(2004-4#2)(2005-10#6)(2005-11#5)(2005-4#1)(2005-7#6)(2005-9#3)(2006-1#2)(2006-10#47)(2006-11#6)(2006-12#8)(2006-2#5)(2006-4#1)(2006-6#3)(2006-7#2)(2006-8#5)(2006-9#7)(2007-1#3)(2007-10#3)(2007-11#15)(2007-12#9)(2007-2#3)(2007-3#1)(2007-4#2)(2007-5#3)(2007-7#6)(2007-8#5)(2007-9#2)(2008-1#34)(2008-10#31)(2008-11#25)(2008-12#7)(2008-2#3)(2008-3#25)(2008-4#16)(2008-5#19)(2008-6#7)(2008-7#34)(2008-8#18)(2008-9#5)(2009-1#2)(2009-10#10)(2009-11#3)(2009-12#3)(2009-2#1)(2009-3#7)(2009-4#5)(2009-5#10)(2009-6#3)(2009-7#6)(2009-8#6)(2009-9#5)(2010-1#2)(2010-10#7)(2010-11#11)(2010-12#17)(2010-2#7)(2010-3#1)(2010-4#5)(2010-5#12)(2010-6#6)(2010-7#11)(2010-8#2)(2010-9#3)(2011-1#33)(2011-12#4)(2011-2#29)(2011-3#4)(2012-1#15)(2012-11#7)(2012-12#24)(2012-2#35)(2012-3#13)(2013-1#32)(2013-7#2)(2013-8#20)
this revision##2##2##(2006-10#1)(2009-10#1)
this revolutionary##2##2##(2008-8#1)(2013-8#1)
this right##2##2##(1991-6#1)(2008-9#1)
this ring system##2##3##(1996-8#1)(2012-11#1)
this rise##2##2##(1997-8#1)(2010-12#1)
this rising##2##2##(2007-4#1)(2009-5#1)
this risk analysis##2##3##(1997-4#1)(2012-2#1)
this risk group##2##3##(1992-9#1)(2007-11#1)
this risk is##4##3##(2006-10#1)(2006-9#1)(2008-10#1)(2011-2#1)
this risk##30##2##(1992-9#1)(1994-12#1)(1994-2#1)(1996-7#1)(1997-4#1)(2006-10#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-11#2)(2010-9#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#1)
this role is##4##3##(1992-9#1)(1993-3#1)(1997-7#1)(2012-2#1)
this role may be##2##4##(1991-10#1)(2008-10#1)
this role##21##2##(1991-10#1)(1992-2#1)(1992-9#1)(1993-3#2)(1994-8#1)(1996-8#1)(1997-6#1)(1997-7#1)(2005-8#1)(2006-10#1)(2007-12#2)(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-8#1)(2010-2#1)(2012-2#1)
this route##9##2##(1990-11#1)(1993-11#1)(1994-9#1)(1995-12#1)(2008-10#1)(2008-3#1)(2011-2#2)(2012-12#1)
this rule have##2##3##(2007-8#1)(2012-2#1)
this rule is##2##3##(1996-5#1)(2006-8#1)
this rule##8##2##(1992-1#1)(1996-5#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-5#1)(2012-2#1)
this rules##2##2##(1991-5#1)(2007-9#1)
this ruling##2##2##(1994-2#1)(1997-5#1)
this rust##2##2##(2008-10#2)
this salt##3##2##(1990-12#1)(1990-2#1)(2008-10#1)
this same group##2##3##(2008-6#1)(2013-8#1)
this same time##2##3##(1990-12#1)(1995-3#1)
this same##22##2##(1990-11#1)(1990-12#1)(1992-12#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-5#1)(1996-6#1)(2007-8#1)(2008-10#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-12#1)(2011-2#1)(2013-7#1)(2013-8#1)
this sample of##6##3##(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
this sample was##4##3##(1994-12#1)(1997-2#1)(2009-7#1)(2012-12#1)
this sample##31##2##(1991-1#1)(1992-12#1)(1994-12#1)(1997-2#1)(2006-12#1)(2007-12#2)(2007-2#2)(2008-10#5)(2008-7#3)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
this sampling##2##2##(2008-10#2)
this satellite##2##2##(1996-9#1)(2008-10#1)
this scale##6##2##(1995-7#1)(2007-12#1)(2008-10#1)(2008-6#1)(2011-1#1)(2012-12#1)
this scanner##2##2##(1992-11#1)(2008-3#1)
this scattering##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
this scenario##11##2##(2006-10#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2012-1#1)(2012-12#1)(2012-2#2)
this scenery##2##2##(2006-8#1)(2013-1#1)
this schedule of##2##3##(1990-2#1)(2008-8#1)
this schedule##7##2##(1990-2#1)(1990-8#1)(1991-6#1)(1995-8#1)(1997-1#1)(2008-6#1)(2008-8#1)
this scheme are##4##3##(1995-2#1)(2007-12#2)(2008-2#1)
this scheme to##3##3##(2007-12#1)(2008-11#1)(2008-2#1)
this scheme##34##2##(1994-12#1)(1995-2#1)(2007-11#2)(2007-12#8)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#8)(2008-3#2)(2008-5#1)(2008-7#1)(2009-7#1)(2013-1#4)
this science##5##2##(2010-2#1)(2012-12#1)(2013-1#3)
this scientific evidence##2##3##(2008-5#1)(2008-6#1)
this scope##3##2##(1996-9#1)(2007-5#1)(2008-5#1)
this scourge##2##2##(1995-2#1)(2008-1#1)
this screening##4##2##(1991-3#1)(2005-11#1)(2007-11#1)(2008-6#1)
this search##4##2##(2008-9#1)(2010-8#1)(2011-2#2)
this season##4##2##(1992-1#1)(1997-1#1)(2004-11#1)(2008-5#1)
this second##16##2##(1991-5#1)(1991-6#1)(1992-1#1)(1992-5#1)(1994-1#1)(1994-3#2)(2007-11#1)(2007-12#1)(2008-3#1)(2008-5#2)(2010-8#1)(2011-1#1)(2012-2#1)(2013-7#1)
this secondary##5##2##(1993-11#1)(1995-1#1)(2005-11#1)(2007-1#1)(2008-10#1)
this secretory##3##2##(1990-7#1)(1994-12#1)(1997-1#1)
this section##8##2##(1993-3#1)(2006-10#1)(2006-12#1)(2008-2#1)(2008-4#2)(2012-2#2)
this sector##4##2##(1991-12#1)(2008-2#1)(2008-5#1)(2009-3#1)
this seemingly##3##2##(2004-9#1)(2010-2#1)(2011-1#1)
this seems to be the##2##5##(1994-9#1)(1996-7#1)
this segment of the##3##4##(1991-7#1)(2007-11#1)(2008-9#1)
this segment##13##2##(1991-7#1)(1994-3#1)(1995-3#1)(1996-11#2)(1996-4#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-9#1)(2009-10#2)(2011-2#1)
this select##2##2##(2007-1#1)(2011-2#1)
this selection##5##2##(2005-7#1)(2007-6#1)(2008-11#1)(2008-7#1)(2008-8#1)
this selective##8##2##(1990-4#1)(1991-11#1)(1994-2#1)(1995-6#1)(1996-5#2)(2008-2#1)(2012-2#1)
this selectivity##2##2##(1997-1#1)(2008-11#1)
this seminar##2##2##(2005-8#1)(2010-1#1)
this sense##11##2##(1995-10#1)(2006-3#2)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2012-11#1)
this sensing##2##2##(2008-10#2)
this sensitive##4##2##(1990-7#1)(2007-4#1)(2007-7#1)(2008-12#1)
this sensitivity##6##2##(1992-6#1)(1996-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
this sensor can be##2##4##(2008-10#2)
this sensor can##3##3##(2008-10#2)(2008-2#1)
this sensor system##2##3##(2008-10#2)
this sensor was##2##3##(2008-10#1)(2008-7#1)
this sensor were##2##3##(2008-10#2)
this sensor##20##2##(2007-11#1)(2008-10#12)(2008-2#4)(2008-3#2)(2008-7#1)
this sensory##4##2##(1996-10#1)(2009-12#2)(2011-2#1)
this separate##2##2##(1993-3#1)(2005-8#1)
this separation##5##2##(1990-12#1)(1991-8#1)(2008-10#2)(2011-2#1)
this sequence at##2##3##(1991-10#1)(1995-8#1)
this sequence for##2##3##(1997-9#1)(2007-12#1)
this sequence has##3##3##(1991-12#1)(1996-12#1)(1997-3#1)
this sequence have##2##3##(1991-11#1)(1992-10#1)
this sequence in##3##3##(1991-3#1)(1996-4#1)(2011-2#1)
this sequence is##6##3##(1991-11#1)(1991-12#1)(1993-8#1)(1994-3#1)(1995-6#1)(2008-8#1)
this sequence show##2##3##(1992-6#1)(1997-4#1)
this sequence was##4##3##(1990-2#1)(1996-4#1)(2009-8#1)(2010-10#1)
this sequence##62##2##(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-11#3)(1991-12#3)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-3#3)(1995-6#1)(1995-8#2)(1996-12#3)(1996-4#2)(1997-3#1)(1997-4#3)(1997-9#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-10#3)(2008-8#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-10#1)(2011-2#1)
this series of compounds##3##4##(1991-4#1)(1992-8#1)(2008-3#1)
this series of events##2##4##(1997-1#1)(2005-12#1)
this series of##21##3##(1990-2#1)(1990-7#1)(1991-4#1)(1992-4#1)(1992-8#1)(1995-8#1)(1996-10#1)(1996-8#1)(1997-1#1)(1997-4#1)(2005-12#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-5#2)(2010-12#1)(2010-2#1)(2012-3#1)(2013-8#1)
this series was##6##3##(1990-5#1)(1996-11#1)(2007-9#1)(2012-12#1)(2012-2#1)(2012-3#1)
this series will##4##3##(2005-10#1)(2006-10#2)(2009-4#1)
this series##87##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-4#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-4#1)(1994-12#1)(1994-7#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-3#4)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-4#1)(1997-7#1)(2005-10#1)(2005-12#1)(2006-10#7)(2006-5#2)(2006-8#3)(2006-9#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#3)(2009-10#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#4)(2012-3#2)(2013-8#2)
this series)##2##2##(2004-10#1)(2006-10#1)
this serious complication##3##3##(1996-2#1)(2007-7#1)(2013-1#1)
this serious problem##2##3##(1995-5#1)(2011-2#1)
this serious##12##2##(1993-8#1)(1995-5#1)(1996-2#1)(2007-11#1)(2007-7#1)(2010-12#1)(2011-2#2)(2012-11#1)(2013-1#3)
this serotype##2##2##(2008-5#1)(2013-8#1)
this service and##2##3##(1995-1#1)(1995-3#1)
this service##7##2##(1990-8#1)(1993-12#1)(1995-1#1)(1995-3#1)(2007-2#1)(2007-8#1)(2008-5#1)
this session was##2##3##(2005-8#2)
this session##4##2##(2005-7#1)(2005-8#2)(2008-12#1)
this set of##10##3##(1992-2#1)(1997-5#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-1#1)(2011-2#1)(2013-7#2)
this set would cover 98% of the reportable condition volume##2##10##(2013-1#2)
this set##17##2##(1992-2#1)(1993-3#2)(1995-3#1)(1997-5#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-1#1)(2011-2#1)(2013-1#2)(2013-7#2)
this setting we##3##3##(1990-8#1)(2005-7#1)(2013-8#1)
this setting##75##2##(1990-8#1)(1992-11#1)(1995-1#1)(1995-2#1)(1995-5#1)(1997-2#2)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#2)(2006-9#3)(2007-11#2)(2007-12#2)(2007-4#1)(2007-8#4)(2007-9#3)(2008-1#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-11#1)(2009-3#2)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#2)(2013-8#5)
this setup##8##2##(2006-10#1)(2007-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)
this severe##6##2##(1990-6#1)(2005-8#1)(2006-10#2)(2012-12#1)(2013-8#1)
this sex##2##2##(2008-11#1)(2008-7#1)
this sexual dimorphism##2##3##(2006-10#1)(2012-11#1)
this sexual##3##2##(2006-10#1)(2009-5#1)(2012-11#1)
this shift in##3##3##(1993-6#1)(2008-7#1)(2012-2#1)
this shift##15##2##(1992-12#1)(1993-6#1)(1994-9#1)(1996-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#2)
this short article##4##3##(1997-4#1)(2008-7#1)(2008-9#1)(2011-12#1)
this short period##3##3##(1992-6#1)(1994-10#1)(2010-8#1)
this short review##10##3##(1990-5#1)(2005-8#1)(2007-10#1)(2007-5#1)(2008-7#4)(2012-11#1)(2012-2#1)
this short##27##2##(1990-5#1)(1992-6#1)(1993-12#1)(1994-10#1)(1994-12#1)(1995-1#1)(1995-9#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-7#5)(2008-9#1)(2010-8#1)(2011-12#2)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
this shorter##2##2##(1996-5#1)(2010-12#1)
this should be##8##3##(1997-4#1)(2005-9#1)(2006-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-11#1)
this should##12##2##(1992-2#1)(1997-4#1)(2005-9#1)(2006-6#1)(2006-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-11#1)
this showed##2##2##(1990-3#1)(1992-10#1)
this shows that##2##3##(1990-5#1)(1994-8#1)
this shows##3##2##(1990-5#1)(1994-8#1)(1995-9#1)
this side effect##2##3##(2008-11#1)(2008-7#1)
this side##3##2##(1992-1#1)(2008-11#1)(2008-7#1)
this signal is##2##3##(1990-6#1)(1996-4#1)
this signal##11##2##(1990-6#1)(1992-11#1)(1996-4#1)(1997-5#1)(1997-7#1)(2008-3#2)(2009-8#1)(2009-9#1)(2011-2#1)(2012-3#1)
this signaling##5##2##(1997-4#1)(2009-6#1)(2010-4#1)(2010-5#1)(2011-1#1)
this silent##2##2##(2006-1#1)(2007-7#1)
this simple and##2##3##(1995-7#1)(2008-3#1)
this simple method##2##3##(2007-11#1)(2012-12#1)
this simple##23##2##(1990-8#1)(1991-4#1)(1993-12#1)(1995-7#1)(1997-1#1)(2005-1#1)(2007-11#4)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#1)(2010-3#1)(2012-12#1)
this simplified##2##2##(2005-11#1)(2008-11#1)
this simulation##3##2##(1991-4#1)(2008-2#2)
this single case##3##3##(1993-11#1)(2007-7#1)(2013-1#1)
this single##14##2##(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1996-12#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-2#2)(2009-8#2)(2011-2#1)(2013-1#1)
this single-blind##2##2##(1990-3#1)(2012-2#1)
this single-group##2##2##(2007-2#1)(2010-7#1)
this single-subject##2##2##(2009-12#1)(2011-2#1)
this site did not##2##4##(1994-10#1)(2008-4#1)
this site has been##2##4##(1995-2#1)(2013-8#1)
this site in##3##3##(1991-1#1)(1996-3#1)(1997-4#1)
this site is not##2##4##(1995-3#1)(2012-2#1)
this site is##5##3##(1990-5#1)(1992-3#1)(1992-5#1)(1995-3#1)(2012-2#1)
this site may be##3##4##(1991-1#1)(1996-8#1)(1997-3#1)
this site may##5##3##(1991-1#1)(1991-12#1)(1996-8#1)(1997-3#1)(2010-11#1)
this site was##2##3##(1992-1#1)(2011-2#1)
this site were##2##3##(2008-3#1)(2008-5#1)
this site##51##2##(1990-11#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-3#2)(1994-10#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#4)(1996-11#1)(1996-3#1)(1996-5#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#3)(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-8#1)
this situation a##2##3##(1990-8#1)(2008-11#1)
this situation is##6##3##(1993-2#1)(2004-9#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-7#1)
this situation##45##2##(1990-12#1)(1990-8#1)(1991-4#1)(1991-7#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-2#1)(1994-3#1)(1995-6#1)(1997-4#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-10#2)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2009-11#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
this size##5##2##(1991-8#1)(1996-7#1)(2005-11#1)(2008-3#1)(2012-12#1)
this skin##3##2##(2008-5#2)(2011-2#1)
this small series##4##3##(1993-3#1)(1996-9#1)(2007-1#1)(2007-12#1)
this small study##4##3##(1990-1#1)(2007-10#1)(2008-11#2)
this small##18##2##(1990-1#1)(1993-3#1)(1996-12#2)(1996-9#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-11#3)(2010-10#1)(2010-5#1)(2012-12#1)(2012-3#1)
this so##2##2##(1996-8#1)(2012-2#1)
this social##3##2##(2008-11#1)(2008-9#1)(2011-12#1)
this software##2##2##(1992-10#1)(1995-6#1)
this solution with##2##3##(2008-10#1)(2008-2#1)
this solution##14##2##(1994-6#1)(2006-10#1)(2007-12#1)(2008-10#7)(2008-2#3)(2008-9#1)
this solvent##4##2##(1993-2#1)(2007-8#1)(2008-5#1)(2008-7#1)
this somatic##2##2##(1990-11#1)(2008-8#1)
this sort of##2##3##(1992-3#1)(2012-3#1)
this sort##5##2##(1992-3#1)(1995-3#1)(1996-12#1)(2008-3#1)(2012-3#1)
this source is##2##3##(2007-11#1)(2008-3#1)
this source of##2##3##(1995-12#1)(2008-3#1)
this source##16##2##(1993-9#1)(1994-9#1)(1995-12#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-2#5)(2008-3#3)
this space##5##2##(1991-2#1)(2007-12#1)(2007-8#1)(2008-3#2)
this spatial##3##2##(1994-6#1)(2008-10#1)(2011-12#1)
this special case##2##3##(2008-1#1)(2013-1#1)
this special field##2##3##(1990-7#1)(1991-4#1)
this special issue of##3##4##(1994-3#1)(2009-8#1)(2011-1#1)
this special issue##9##3##(1990-12#1)(1994-3#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-1#1)
this special population##3##3##(1996-3#1)(2008-6#1)(2013-1#1)
this special##29##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-4#2)(1991-6#1)(1992-6#1)(1994-3#1)(1996-3#1)(1997-1#1)(2008-1#1)(2008-12#1)(2008-2#2)(2008-6#1)(2008-8#2)(2009-8#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#3)
this specialized##2##2##(2008-10#1)(2008-11#1)
this species and##6##3##(1993-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2010-8#1)
this species are##6##3##(1994-8#1)(2008-5#1)(2008-8#2)(2009-5#1)(2013-1#1)
this species difference##2##3##(1996-5#1)(1997-7#1)
this species exhibits##2##3##(2008-9#1)(2013-7#1)
this species for##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
this species from O##3##4##(2007-3#3)
this species has a##4##4##(1992-10#1)(2007-5#1)(2008-8#1)(2010-8#1)
this species has been##2##4##(2004-11#1)(2012-2#1)
this species has##10##3##(1992-10#1)(2004-11#1)(2007-5#2)(2008-5#1)(2008-8#1)(2010-3#1)(2010-8#1)(2012-2#1)(2013-8#1)
this species in##9##3##(1996-4#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2013-7#1)
this species is not##2##4##(1996-1#1)(2008-5#1)
this species is##15##3##(1994-5#1)(1996-1#1)(2004-11#1)(2007-3#1)(2008-10#1)(2008-12#3)(2008-5#2)(2008-8#1)(2009-8#1)(2010-12#1)(2010-6#1)(2012-6#1)
this species may##3##3##(1992-8#1)(2008-6#1)(2013-8#1)
this species of fish##2##4##(2010-8#1)(2012-3#1)
this species of##4##3##(2007-1#1)(2007-7#1)(2010-8#1)(2012-3#1)
this species was##2##3##(2007-6#1)(2012-12#1)
this species##160##2##(1990-11#1)(1991-11#1)(1991-12#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-6#1)(1997-7#1)(2004-11#3)(2004-4#1)(2005-10#1)(2006-12#2)(2006-8#1)(2007-1#2)(2007-12#2)(2007-2#1)(2007-3#9)(2007-5#5)(2007-6#1)(2007-7#2)(2008-10#18)(2008-11#2)(2008-12#7)(2008-4#1)(2008-5#24)(2008-6#4)(2008-7#2)(2008-8#10)(2008-9#2)(2009-5#1)(2009-8#3)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-6#1)(2010-8#4)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2012-6#1)(2013-1#2)(2013-7#5)(2013-8#3)
this species'##2##2##(2009-8#1)(2010-8#1)
this specific group##3##3##(2006-8#1)(2007-12#1)(2008-7#1)
this specific population##3##3##(2006-10#1)(2013-1#2)
this specific##32##2##(1990-6#1)(1992-12#1)(1992-7#1)(1993-3#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-8#1)(1996-5#1)(1996-6#1)(2006-10#1)(2006-6#2)(2006-8#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-10#1)(2011-2#3)(2012-5#1)(2013-1#4)
this specificity##2##2##(1996-11#1)(2010-5#1)
this specimen##2##2##(1997-1#1)(2010-8#1)
this spectral range##2##3##(2008-3#2)
this spectral region##8##3##(1991-5#1)(2007-12#1)(2008-2#2)(2008-3#4)
this spectral##11##2##(1991-5#1)(2007-12#1)(2008-2#3)(2008-3#6)
this spectrum##5##2##(1992-11#1)(1994-5#1)(2007-12#1)(2008-3#1)(2008-4#1)
this sport##2##2##(2007-3#2)
this spread##2##2##(1992-9#1)(1994-7#1)
this spring##2##2##(2007-1#1)(2012-1#1)
this stable##2##2##(2008-11#1)(2009-7#1)
this stage is##3##3##(1990-8#1)(2007-8#1)(2010-12#1)
this stage of development##2##4##(1996-3#1)(2008-10#1)
this stage of##3##3##(1996-3#1)(2008-1#1)(2008-10#1)
this stage##34##2##(1990-8#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-8#1)(1996-3#1)(1996-8#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-6#1)(2006-8#1)(2007-12#3)(2007-8#4)(2008-1#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2012-1#1)(2013-1#1)
this staining reaction can be used to identify monocytes/macrophages in cell preparations##2##12##(2008-4#1)(2008-9#1)
this staining##5##2##(2006-3#2)(2008-4#1)(2008-9#1)(2012-12#1)
this standard##8##2##(1990-11#1)(1992-9#1)(2006-4#1)(2007-4#1)(2008-10#2)(2008-11#1)(2010-5#1)
this standardization##2##2##(1992-4#1)(2012-3#1)
this standardized##2##2##(2006-12#1)(2012-2#1)
this state is##3##3##(1995-3#1)(2008-3#1)(2008-4#1)
this state of##2##3##(1991-5#1)(1996-10#1)
this state##10##2##(1991-5#1)(1995-3#1)(1996-10#1)(1996-3#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-9#1)
this statement##4##2##(1992-5#1)(2006-12#1)(2008-7#1)(2009-6#1)
this statistical method##3##3##(2013-1#2)(2013-8#1)
this statistical##6##2##(2007-12#1)(2008-9#1)(2013-1#3)(2013-8#1)
this step is##2##3##(1993-8#1)(2012-3#1)
this step##7##2##(1991-7#1)(1993-8#1)(1995-2#1)(2008-10#1)(2008-3#1)(2009-6#1)(2012-3#1)
this steroid##6##2##(1990-10#1)(1994-11#1)(1994-8#1)(2008-4#1)(2008-5#1)(2012-3#1)
this stimulation##7##2##(1990-11#1)(1991-12#1)(1991-9#1)(1993-12#1)(1995-2#1)(1995-8#1)(2011-1#1)
this stimulatory action##2##3##(1990-2#1)(1991-3#1)
this stimulatory effect##2##3##(1995-7#1)(2010-10#1)
this stimulatory##4##2##(1990-2#1)(1991-3#1)(1995-7#1)(2010-10#1)
this storage##2##2##(1990-4#1)(1991-4#1)
this strain showed##2##3##(2008-12#1)(2012-2#1)
this strain to##2##3##(1992-5#1)(1994-7#1)
this strain was##4##3##(2008-10#1)(2012-2#3)
this strain##36##2##(1991-7#1)(1992-12#1)(1992-5#1)(1992-7#1)(1993-3#1)(1994-7#1)(1995-12#1)(1995-6#1)(1996-1#1)(2005-11#4)(2006-3#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#9)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#6)
this strategy and##2##3##(2008-6#1)(2008-9#1)
this strategy as a standard of##2##6##(2007-11#1)(2007-8#1)
this strategy can##2##3##(2007-5#1)(2009-12#1)
this strategy has been successful in##2##6##(1997-2#1)(2011-2#1)
this strategy has##3##3##(1997-2#1)(2006-10#1)(2011-2#1)
this strategy is##7##3##(2007-11#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-7#1)(2012-12#1)
this strategy to obtain##2##4##(1993-12#1)(2007-8#1)
this strategy to##4##3##(1993-12#1)(1994-5#1)(2007-8#1)(2008-8#1)
this strategy##46##2##(1993-12#1)(1994-5#1)(1994-6#1)(1996-2#1)(1997-1#1)(1997-2#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#3)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-11#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
this stress response##3##3##(1992-12#1)(1994-3#1)(2006-10#1)
this stress##10##2##(1992-12#2)(1994-3#1)(1995-12#1)(2006-10#2)(2006-12#1)(2008-11#1)(2011-1#1)(2011-2#1)
this striking##2##2##(1994-3#1)(2009-5#1)
this strong##3##2##(1992-3#1)(2008-10#1)(2012-11#1)
this strongly suggests##2##3##(1996-7#1)(2005-10#1)
this strongly##4##2##(1996-7#1)(2005-10#1)(2008-7#1)(2010-10#1)
this structural modification##2##3##(1996-1#1)(2012-3#1)
this structural##9##2##(1992-12#1)(1992-6#1)(1993-8#1)(1996-1#1)(1996-8#1)(2008-8#1)(2010-4#1)(2010-6#1)(2012-3#1)
this structure and##2##3##(1991-11#1)(1991-6#1)
this structure can be##2##4##(2006-3#1)(2008-10#1)
this structure in##2##3##(1992-4#1)(2007-12#1)
this structure is##5##3##(1991-9#1)(1994-9#1)(1995-8#1)(2007-12#1)(2012-1#1)
this structure##36##2##(1991-11#1)(1991-2#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-5#1)(1995-8#2)(2006-3#1)(2007-11#3)(2007-12#5)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2012-1#1)(2012-12#2)
this study a total of##3##5##(1991-9#1)(2008-10#1)(2011-2#1)
this study a##14##3##(1991-9#1)(1993-12#1)(1993-2#1)(1994-8#1)(2007-3#1)(2008-10#4)(2008-3#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-2#1)
this study addresses the##2##4##(2007-11#1)(2008-12#1)
this study aimed to investigate##2##5##(2010-8#1)(2013-1#1)
this study aimed to##4##4##(2009-11#1)(2010-8#1)(2011-1#1)(2013-1#1)
this study aims to##3##4##(2008-4#1)(2008-8#1)(2011-12#1)
this study allows##2##3##(2008-7#1)(2010-6#1)
this study also##9##3##(1991-12#1)(1991-6#1)(1995-11#1)(1996-5#1)(1997-2#1)(2006-8#1)(2008-10#1)(2010-11#1)(2013-8#1)
this study and the##4##4##(1990-6#1)(2008-10#1)(2008-5#1)(2009-2#1)
this study and##23##3##(1990-6#1)(1990-8#1)(1991-2#1)(1994-6#1)(1997-8#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-6#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#2)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
this study are consistent with##3##5##(2006-9#1)(2007-12#1)(2008-11#1)
this study are discussed##4##4##(1993-1#1)(1993-7#1)(2007-11#1)(2008-3#1)
this study are similar##2##4##(2006-8#1)(2007-2#1)
this study are the##3##4##(1993-3#1)(2008-10#1)(2011-2#1)
this study are##52##3##(1990-10#1)(1990-3#1)(1992-8#1)(1993-1#1)(1993-3#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-3#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(2004-11#1)(2005-11#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-9#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)
this study as##2##3##(2006-8#1)(2008-10#1)
this study at##3##3##(1991-2#1)(2007-7#2)
this study because##4##3##(1994-12#1)(2008-1#2)(2013-1#1)
this study by##3##3##(1990-12#1)(2007-2#1)(2007-8#1)
this study can be used##5##5##(2005-8#1)(2008-12#1)(2008-2#1)(2012-2#1)(2013-1#1)
this study can be##7##4##(1995-9#1)(2005-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2012-2#1)(2013-1#1)
this study can##12##3##(1995-9#1)(2005-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2009-7#1)(2010-12#1)(2010-4#1)(2012-2#1)(2013-1#2)
this study clearly##4##3##(1994-12#1)(2008-10#2)(2008-11#1)
this study confirm that##3##4##(1990-12#1)(2006-8#1)(2007-1#1)
this study confirmed##2##3##(2010-3#1)(2012-12#1)
this study confirms##2##3##(2008-6#1)(2012-11#1)
this study consisted of##3##4##(1990-8#1)(2008-11#1)(2011-2#1)
this study contribute to the##2##5##(2008-5#1)(2012-3#1)
this study contributes to##2##4##(2008-10#1)(2012-12#1)
this study could be##7##4##(2005-10#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2013-1#1)(2013-8#1)
this study could help##2##4##(2008-7#1)(2013-1#1)
this study could##11##3##(2005-10#1)(2006-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#1)(2013-1#2)(2013-8#1)
this study demonstrate that##11##4##(1992-11#1)(1994-3#1)(1994-6#1)(2005-10#1)(2005-12#1)(2008-10#3)(2008-5#1)(2008-6#1)(2012-11#1)
this study demonstrate the##6##4##(1993-9#1)(1997-3#1)(2006-12#1)(2010-12#1)(2013-1#2)
this study demonstrate##18##3##(1992-11#1)(1993-9#1)(1994-3#1)(1994-6#1)(1997-3#1)(2005-10#1)(2005-12#1)(2006-12#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)(2012-11#1)(2013-1#2)
this study demonstrated that the##4##5##(1994-11#1)(2007-10#1)(2008-7#1)(2013-8#1)
this study demonstrated that##9##4##(1992-9#1)(1994-11#1)(2007-10#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-3#1)(2013-8#1)
this study demonstrated##12##3##(1992-9#1)(1994-11#1)(1997-1#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-3#1)(2013-1#1)(2013-8#1)
this study demonstrates that##2##4##(2007-5#1)(2008-11#1)
this study demonstrates the##3##4##(2009-12#1)(2009-5#1)(2009-9#1)
this study demonstrates##6##3##(2007-5#1)(2008-11#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-9#1)
this study did not##3##4##(1996-5#1)(2008-12#1)(2013-1#1)
this study do not##3##4##(2007-8#1)(2008-5#1)(2008-7#1)
this study enabled us to##2##5##(2008-10#2)
this study evaluated the##2##4##(1995-12#1)(1997-6#1)
this study examined the##5##4##(1991-9#1)(2006-11#1)(2009-9#1)(2010-2#1)(2012-2#1)
this study examined##10##3##(1991-9#1)(2006-11#1)(2007-10#1)(2008-6#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-2#1)(2012-2#1)
this study examines the prevalence##2##5##(2007-12#1)(2008-2#1)
this study examines the##5##4##(1994-2#1)(2007-12#1)(2008-2#1)(2009-5#1)(2011-2#1)
this study examines##7##3##(1994-2#1)(2007-12#1)(2008-12#1)(2008-2#1)(2009-5#1)(2011-2#1)(2013-7#1)
this study explores##3##3##(1992-6#1)(2008-1#1)(2010-10#1)
this study for##7##3##(1993-1#1)(1997-2#1)(2006-5#1)(2007-6#1)(2008-10#2)(2010-8#1)
this study found##2##3##(2004-3#1)(2012-12#1)
this study further##2##3##(2005-11#1)(2007-2#1)
this study had##4##3##(1990-6#1)(1992-2#1)(2013-8#2)
this study has been##4##4##(1991-10#1)(2008-5#2)(2013-8#1)
this study has found##2##4##(1997-2#1)(2008-8#1)
this study has##16##3##(1991-10#1)(1997-2#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-8#1)(2009-7#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
this study have been##2##4##(1991-1#1)(2008-10#1)
this study have##13##3##(1991-1#1)(1996-9#1)(2004-9#1)(2007-9#1)(2008-10#4)(2008-6#1)(2009-8#1)(2010-4#1)(2011-2#2)
this study helps##2##3##(1997-2#1)(2013-1#1)
this study implies##2##3##(2005-11#1)(2007-12#1)
this study in the##2##4##(2008-5#1)(2010-8#1)
this study in##7##3##(1991-2#1)(1995-3#1)(2007-2#1)(2008-5#1)(2010-8#1)(2011-12#1)(2011-2#1)
this study include##6##3##(2007-4#1)(2008-5#1)(2008-8#2)(2013-1#2)
this study included##2##3##(2009-4#1)(2010-4#1)
this study includes##2##3##(1997-8#1)(2007-4#1)
this study indicate that the##4##5##(1996-3#1)(1996-4#1)(2006-6#1)(2009-7#1)
this study indicate that##38##4##(1990-4#1)(1990-5#1)(1990-6#1)(1991-11#1)(1992-5#1)(1992-8#1)(1993-4#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-8#1)(2005-8#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-5#1)(2007-7#1)(2008-10#3)(2008-6#2)(2009-2#1)(2009-7#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#2)(2013-8#2)
this study indicate the##3##4##(2007-8#1)(2008-11#1)(2008-12#1)
this study indicate##43##3##(1990-4#1)(1990-5#1)(1990-6#1)(1991-11#1)(1992-5#1)(1992-8#1)(1993-4#2)(1994-8#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-8#1)(2005-8#1)(2006-1#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-6#2)(2009-2#1)(2009-7#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#2)(2013-8#2)
this study indicated that##10##4##(1993-12#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2009-4#1)(2010-5#1)(2011-12#1)
this study indicated##12##3##(1993-12#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2009-4#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#1)
this study indicates that##4##4##(1992-4#1)(2008-6#1)(2009-2#1)(2010-8#1)
this study indicates##6##3##(1991-7#1)(1992-4#1)(2008-10#1)(2008-6#1)(2009-2#1)(2010-8#1)
this study investigated##4##3##(2008-11#1)(2008-7#1)(2010-8#1)(2012-1#1)
this study is a##4##4##(2007-9#1)(2009-7#1)(2010-5#1)(2013-1#1)
this study is an##4##4##(1997-3#1)(2008-11#1)(2008-2#1)(2011-2#1)
this study is that##5##4##(1995-11#1)(1997-8#1)(2008-3#1)(2010-12#1)(2013-1#1)
this study is the##9##4##(1994-6#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-2#1)
this study is to demonstrate##3##5##(2007-7#2)(2008-3#1)
this study is to##183##4##(1991-12#1)(1991-4#1)(1992-10#2)(1992-12#1)(1992-2#1)(1993-12#1)(1993-7#1)(1994-2#1)(1995-12#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-8#1)(2004-2#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#3)(2007-3#1)(2007-4#4)(2007-6#1)(2007-7#8)(2007-8#12)(2007-9#2)(2008-1#6)(2008-10#8)(2008-11#3)(2008-12#3)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#7)(2008-9#5)(2009-10#1)(2009-2#2)(2009-5#1)(2009-6#2)(2009-7#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#3)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#18)(2011-3#1)(2012-1#6)(2012-12#5)(2012-2#6)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#8)
this study is##232##3##(1991-12#1)(1991-4#1)(1992-10#2)(1992-12#1)(1992-2#1)(1992-7#1)(1993-12#1)(1993-7#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-8#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-2#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#4)(2007-6#1)(2007-7#8)(2007-8#13)(2007-9#3)(2008-1#6)(2008-10#12)(2008-11#4)(2008-12#6)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#7)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-5#1)(2009-6#2)(2009-7#3)(2010-10#2)(2010-12#3)(2010-2#2)(2010-3#2)(2010-5#4)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#20)(2011-3#1)(2012-1#6)(2012-12#6)(2012-2#7)(2012-3#4)(2013-1#11)(2013-7#1)(2013-8#8)
this study it is##2##4##(2008-11#1)(2008-2#1)
this study it was##5##4##(1994-11#1)(1996-12#1)(2006-5#1)(2008-5#1)(2011-12#1)
this study it##7##3##(1994-11#1)(1996-12#1)(2006-5#1)(2008-11#1)(2008-2#1)(2008-5#1)(2011-12#1)
this study may be useful for##2##6##(2008-10#1)(2008-2#1)
this study may be useful##4##5##(1996-2#1)(2007-4#1)(2008-10#1)(2008-2#1)
this study may be##6##4##(1996-2#1)(2007-4#1)(2008-10#1)(2008-2#1)(2012-1#1)(2013-1#1)
this study may##14##3##(1990-2#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-3#1)(2005-4#1)(2007-4#1)(2008-10#2)(2008-12#1)(2008-2#1)(2010-12#1)(2012-1#1)(2013-1#1)
this study no##2##3##(1992-12#1)(2007-2#1)
this study of##12##3##(1990-4#1)(1992-3#1)(1994-10#1)(1995-6#2)(1996-1#1)(1996-8#1)(1997-1#1)(2006-10#1)(2008-7#1)(2009-6#1)(2009-9#1)
this study on##5##3##(1996-6#1)(2004-9#1)(2007-2#1)(2008-4#1)(2013-1#1)
this study presents##3##3##(1997-3#1)(2007-7#1)(2013-8#1)
this study provide the first##2##5##(2011-2#1)(2012-12#1)
this study provide##13##3##(1991-8#1)(1993-2#1)(2006-11#1)(2007-2#2)(2007-4#1)(2008-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
this study provided##2##3##(2008-7#1)(2009-11#1)
this study provides evidence for##2##5##(1990-7#1)(1995-12#1)
this study provides evidence##3##4##(1990-7#1)(1995-12#1)(2008-10#1)
this study provides further##3##4##(1994-8#1)(2006-12#1)(2008-7#1)
this study provides quantitative##2##4##(1997-7#1)(2008-10#1)
this study provides##16##3##(1990-7#1)(1994-8#1)(1995-12#1)(1997-7#1)(2006-12#1)(2007-1#1)(2008-10#3)(2008-7#1)(2009-11#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
this study reported##3##3##(2007-2#1)(2008-3#1)(2008-8#1)
this study represent##3##3##(2006-8#1)(2008-1#1)(2008-10#1)
this study represents##2##3##(2009-7#1)(2011-2#1)
this study reveal##3##3##(2009-10#1)(2009-9#1)(2010-8#1)
this study revealed that the##2##5##(2008-8#1)(2009-7#1)
this study revealed that##8##4##(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-7#1)
this study revealed##9##3##(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-7#1)
this study should be useful##2##5##(2008-10#1)(2010-4#1)
this study should be##7##4##(1995-5#1)(1996-8#1)(2006-2#1)(2006-8#1)(2008-10#1)(2010-4#1)(2013-8#1)
this study should##10##3##(1995-5#1)(1996-12#1)(1996-8#1)(2006-12#1)(2006-2#1)(2006-8#1)(2008-10#2)(2010-4#1)(2013-8#1)
this study show a##2##4##(2006-12#1)(2011-2#1)
this study show that the##6##5##(2006-8#1)(2007-10#2)(2008-10#1)(2010-8#1)(2013-1#1)
this study show that##20##4##(1990-12#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-2#1)(2008-10#2)(2008-7#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
this study show##25##3##(1990-12#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-8#2)(2006-9#1)(2007-10#2)(2007-2#1)(2008-10#2)(2008-7#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#4)
this study showed a##2##4##(1997-4#1)(2007-2#1)
this study showed that the##6##5##(1997-2#1)(2006-10#1)(2007-10#1)(2008-12#1)(2008-7#1)(2011-12#1)
this study showed that##24##4##(1995-7#1)(1997-2#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#3)(2008-7#1)(2010-8#1)(2011-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
this study showed##37##3##(1995-7#1)(1997-2#1)(1997-4#1)(2006-1#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#5)(2007-7#1)(2007-8#1)(2008-10#4)(2008-12#5)(2008-7#1)(2008-8#1)(2009-4#1)(2010-8#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
this study shows that the##2##5##(1995-6#1)(2008-5#1)
this study shows that##6##4##(1995-6#1)(2004-1#1)(2006-8#1)(2008-12#1)(2008-5#1)(2013-1#1)
this study shows##8##3##(1995-6#1)(2004-1#1)(2006-8#1)(2007-3#1)(2008-12#1)(2008-5#1)(2008-7#1)(2013-1#1)
this study sought to##5##4##(1992-11#1)(2007-11#1)(2008-11#1)(2009-7#1)(2011-2#1)
this study suggest that the##9##5##(1990-2#1)(1992-6#1)(1994-2#1)(2004-11#1)(2008-6#2)(2009-7#1)(2011-2#1)(2013-1#1)
this study suggest that this##2##5##(1996-1#1)(2008-3#1)
this study suggest that##49##4##(1990-2#1)(1991-3#1)(1992-12#1)(1992-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-3#2)(1995-8#1)(1996-1#1)(1997-2#1)(2004-11#1)(2006-12#1)(2006-9#1)(2007-10#3)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#4)
this study suggest##54##3##(1990-2#1)(1991-3#2)(1992-12#1)(1992-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-3#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-6#1)(1997-2#1)(2004-11#1)(2006-12#1)(2006-9#1)(2007-10#4)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#4)
this study suggested that the##2##5##(2007-3#1)(2008-6#1)
this study suggested that##6##4##(1992-2#1)(1995-4#1)(2006-12#1)(2007-3#1)(2008-6#1)(2011-3#1)
this study suggested##8##3##(1992-2#1)(1995-4#1)(2006-12#1)(2006-8#1)(2007-3#1)(2008-6#1)(2009-5#1)(2011-3#1)
this study suggests that the##3##5##(2007-1#1)(2008-8#1)(2011-2#1)
this study suggests that##10##4##(1995-5#1)(2007-1#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
this study suggests##11##3##(1995-5#1)(2006-10#1)(2007-1#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
this study support the hypothesis that##2##6##(2008-10#1)(2008-5#1)
this study support the##7##4##(2006-12#1)(2008-10#2)(2008-5#1)(2010-2#1)(2012-1#1)(2012-12#1)
this study support##11##3##(1991-9#1)(2004-9#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-5#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-12#1)
this study supports the##2##4##(1990-5#1)(2009-4#1)
this study supports##3##3##(1990-5#1)(1992-8#1)(2009-4#1)
this study that##9##3##(1991-9#1)(1992-10#1)(1996-2#1)(2007-10#1)(2008-10#1)(2008-9#1)(2010-6#1)(2012-2#2)
this study the effects of##4##5##(1991-1#1)(1996-8#1)(2008-1#1)(2010-5#1)
this study the##50##3##(1990-5#1)(1991-1#1)(1991-4#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-8#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-8#1)(1996-8#1)(1997-4#1)(1997-7#1)(2004-9#1)(2005-11#2)(2006-10#1)(2006-2#1)(2006-6#1)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-9#1)(2010-5#1)(2011-3#1)(2012-2#3)(2012-3#1)
this study therefore##2##3##(1994-3#1)(2008-2#1)
this study to assess##2##4##(2006-12#1)(2012-2#1)
this study to determine the prevalence##2##6##(2007-7#1)(2008-1#1)
this study to determine the##3##5##(2007-7#2)(2008-1#1)
this study to determine##6##4##(2007-10#1)(2007-7#2)(2008-1#1)(2008-10#2)
this study to document##2##4##(2007-4#1)(2008-7#1)
this study to evaluate the efficacy##2##6##(1990-2#1)(2011-2#1)
this study to evaluate the##6##5##(1990-2#1)(2007-7#2)(2008-1#1)(2009-10#1)(2011-2#1)
this study to evaluate##8##4##(1990-2#2)(2007-7#2)(2008-1#2)(2009-10#1)(2011-2#1)
this study to examine the##2##5##(2005-11#1)(2010-8#1)
this study to identify##4##4##(1990-11#1)(2008-12#1)(2010-11#1)(2012-12#1)
this study to##40##3##(1990-11#1)(1990-2#2)(1995-12#1)(1996-12#1)(1996-2#2)(2005-11#1)(2006-12#2)(2007-10#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2009-10#2)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)
this study underscore the##2##4##(2010-1#1)(2010-3#1)
this study was both to##2##5##(1997-6#1)(2011-1#1)
this study was carried out to##2##6##(1990-2#1)(2007-2#1)
this study was conducted to determine if##2##7##(1995-3#1)(2008-10#1)
this study was conducted to##4##5##(1995-3#1)(2008-10#1)(2010-5#1)(2011-1#1)
this study was conducted##6##4##(1995-3#1)(2008-10#2)(2010-5#1)(2011-1#2)
this study was designed to investigate the effects of##2##9##(2006-11#1)(2006-12#1)
this study was designed##3##4##(2006-11#1)(2006-12#1)(2008-12#1)
this study was done to assess the##2##7##(2008-4#1)(2013-8#1)
this study was done to##5##5##(2008-4#1)(2008-5#1)(2010-7#1)(2011-1#1)(2013-8#1)
this study was obtained##2##4##(2006-2#1)(2008-12#1)
this study was performed##3##4##(2007-2#1)(2009-5#1)(2011-2#1)
this study was planned to##3##5##(2012-3#1)(2013-1#1)(2013-8#1)
this study was that##5##4##(2006-9#1)(2008-10#1)(2009-7#1)(2011-1#1)(2013-1#1)
this study was the##9##4##(1992-8#1)(1993-4#1)(1994-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#1)(2013-1#1)
this study was to analyze the##15##6##(2006-11#1)(2006-5#1)(2007-3#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-3#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-3#1)
this study was to analyze##21##5##(2005-5#1)(2006-11#1)(2006-5#1)(2007-3#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-3#1)(2009-4#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-3#2)(2013-1#1)
this study was to evaluate and compare the##2##8##(2007-11#1)(2013-8#1)
this study was to evaluate the##117##6##(1990-11#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-11#1)(1996-1#1)(1996-2#1)(1997-6#1)(1997-8#2)(2004-1#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#8)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#8)(2008-3#2)(2008-4#1)(2008-5#7)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#5)(2010-6#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#11)(2013-8#2)
this study was to evaluate##169##5##(1990-11#1)(1991-5#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-8#4)(2004-1#1)(2005-10#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#7)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#10)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#9)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#11)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#5)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#8)(2012-1#2)(2012-12#2)(2012-2#10)(2012-3#1)(2013-1#13)(2013-8#7)
this study was to examine the##49##6##(1991-12#1)(1992-6#1)(1995-1#1)(1995-10#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-3#1)(1997-7#1)(2004-1#1)(2005-11#1)(2006-7#1)(2006-8#2)(2007-1#2)(2007-10#2)(2007-7#1)(2007-8#1)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-7#2)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#2)
this study was to examine##67##5##(1991-12#1)(1992-2#1)(1992-6#1)(1995-1#1)(1995-10#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-1#1)(2005-11#1)(2006-7#3)(2006-8#2)(2007-1#2)(2007-10#2)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#2)(2009-7#3)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-11#1)(2012-12#1)(2013-1#2)(2013-8#2)
this study was to investigate the##100##6##(1990-8#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-3#1)(1994-12#1)(1995-3#1)(1996-10#1)(1996-3#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-7#1)(2007-10#3)(2007-2#2)(2007-3#1)(2007-4#2)(2007-6#1)(2007-8#6)(2008-1#1)(2008-10#7)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#4)(2011-11#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#4)(2013-1#8)(2013-7#1)(2013-8#1)
this study was to investigate##139##5##(1990-8#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-9#1)(1996-10#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-7#1)(1997-8#2)(2005-11#1)(2005-8#1)(2006-1#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#3)(2007-10#4)(2007-2#3)(2007-3#1)(2007-4#2)(2007-6#2)(2007-8#6)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#2)(2011-1#5)(2011-11#1)(2011-12#2)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#10)(2013-7#3)(2013-8#1)
this study was to obtain##6##5##(1993-1#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-10#1)
this study was to##1133##4##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-10#3)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#4)(1992-6#1)(1992-7#1)(1992-8#3)(1993-1#1)(1993-11#1)(1993-12#7)(1993-2#1)(1993-3#3)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#2)(1994-8#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#1)(1996-12#6)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#2)(1996-9#4)(1997-1#1)(1997-2#2)(1997-3#3)(1997-6#2)(1997-7#3)(1997-8#13)(2004-1#3)(2004-10#1)(2004-11#1)(2004-12#1)(2004-3#1)(2004-9#4)(2005-10#5)(2005-11#2)(2005-12#2)(2005-4#1)(2005-5#1)(2005-8#3)(2006-1#3)(2006-10#17)(2006-11#10)(2006-12#5)(2006-2#7)(2006-3#1)(2006-4#1)(2006-5#9)(2006-6#2)(2006-7#8)(2006-8#24)(2006-9#4)(2007-1#8)(2007-10#25)(2007-11#17)(2007-12#5)(2007-2#30)(2007-3#11)(2007-4#10)(2007-5#2)(2007-6#7)(2007-7#20)(2007-8#45)(2007-9#11)(2008-1#4)(2008-10#44)(2008-11#20)(2008-12#30)(2008-2#4)(2008-3#14)(2008-4#13)(2008-5#52)(2008-6#21)(2008-7#26)(2008-8#16)(2008-9#25)(2009-1#1)(2009-10#2)(2009-11#4)(2009-12#2)(2009-2#8)(2009-3#4)(2009-4#7)(2009-5#11)(2009-6#2)(2009-7#8)(2009-8#6)(2009-9#4)(2010-1#2)(2010-10#6)(2010-11#2)(2010-12#13)(2010-2#6)(2010-3#10)(2010-4#13)(2010-5#3)(2010-6#5)(2010-7#6)(2010-8#9)(2010-9#9)(2011-1#24)(2011-11#1)(2011-12#6)(2011-2#61)(2011-7#1)(2012-1#19)(2012-11#4)(2012-12#20)(2012-2#30)(2012-3#15)(2012-4#1)(2012-7#1)(2013-1#54)(2013-3#1)(2013-7#11)(2013-8#33)
this study was unable to identify strong predictors of major cardiac pathology##2##12##(2013-1#2)
this study was undertaken to##2##5##(2009-12#1)(2013-1#1)
this study was##1227##3##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#1)(1990-8#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-10#3)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#4)(1992-6#1)(1992-7#1)(1992-8#4)(1993-1#1)(1993-11#1)(1993-12#8)(1993-2#1)(1993-3#4)(1993-4#2)(1993-8#2)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#5)(1994-3#1)(1994-4#1)(1994-5#2)(1994-8#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#5)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#1)(1996-12#6)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#2)(1996-9#4)(1997-1#1)(1997-2#2)(1997-3#4)(1997-6#3)(1997-7#3)(1997-8#13)(2004-1#4)(2004-10#1)(2004-11#1)(2004-12#1)(2004-3#1)(2004-8#1)(2004-9#4)(2005-10#5)(2005-11#2)(2005-12#2)(2005-4#1)(2005-5#1)(2005-8#3)(2006-1#3)(2006-10#18)(2006-11#11)(2006-12#6)(2006-2#8)(2006-3#1)(2006-4#1)(2006-5#9)(2006-6#3)(2006-7#8)(2006-8#25)(2006-9#6)(2007-1#8)(2007-10#25)(2007-11#18)(2007-12#6)(2007-2#33)(2007-3#11)(2007-4#11)(2007-5#2)(2007-6#10)(2007-7#26)(2007-8#48)(2007-9#11)(2008-1#5)(2008-10#49)(2008-11#21)(2008-12#32)(2008-2#4)(2008-3#14)(2008-4#14)(2008-5#55)(2008-6#22)(2008-7#28)(2008-8#16)(2008-9#25)(2009-1#1)(2009-10#2)(2009-11#4)(2009-12#3)(2009-2#8)(2009-3#4)(2009-4#7)(2009-5#12)(2009-6#3)(2009-7#9)(2009-8#6)(2009-9#4)(2010-1#2)(2010-10#6)(2010-11#2)(2010-12#14)(2010-2#6)(2010-3#10)(2010-4#14)(2010-5#5)(2010-6#5)(2010-7#7)(2010-8#10)(2010-9#10)(2011-1#29)(2011-11#1)(2011-12#7)(2011-2#68)(2011-7#1)(2012-1#19)(2012-11#4)(2012-12#20)(2012-2#30)(2012-3#16)(2012-4#1)(2012-7#1)(2013-1#61)(2013-3#1)(2013-7#11)(2013-8#35)
this study we conclude that##3##5##(1990-9#1)(1994-5#1)(1996-6#1)
this study we found##3##4##(2011-1#1)(2013-1#2)
this study we have found##2##5##(2008-11#1)(2012-2#1)
this study we have##34##4##(1990-10#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-10#1)(1992-12#1)(1994-11#1)(1994-12#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-3#1)(2005-12#1)(2006-4#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#2)(2009-4#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#2)
this study we investigated##20##4##(1991-2#1)(1993-3#1)(1994-2#1)(1994-5#1)(1995-10#1)(1995-5#1)(1996-5#1)(1996-8#1)(2006-5#1)(2007-1#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-6#1)(2011-2#2)(2012-7#1)(2013-8#1)
this study we performed##3##4##(2012-3#2)(2013-1#1)
this study we report##10##4##(1990-2#1)(1991-3#1)(1992-11#1)(2007-3#1)(2008-2#1)(2008-6#1)(2009-5#1)(2011-1#1)(2011-12#1)(2012-2#1)
this study we show that##14##5##(1990-10#1)(1990-5#1)(1992-8#1)(1993-8#2)(1994-11#1)(1994-3#1)(1994-9#1)(1995-9#1)(1996-4#2)(1997-2#1)(1997-7#1)(2012-2#1)
this study we##211##3##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-2#2)(1991-3#4)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-7#1)(1992-8#4)(1993-11#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#2)(1995-10#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#4)(1996-4#3)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#2)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-2#1)(2005-12#2)(2006-10#1)(2006-4#1)(2006-5#2)(2006-6#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#4)(2007-8#4)(2008-10#4)(2008-11#6)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#9)(2012-12#5)(2012-2#6)(2012-3#4)(2012-5#1)(2012-7#1)(2013-1#9)(2013-7#3)(2013-8#1)
this study were compared with##2##5##(2008-11#1)(2008-5#1)
this study were obtained##3##4##(1990-10#1)(2007-3#1)(2012-2#1)
this study were the##2##4##(1995-11#1)(2007-5#1)
this study were to assess the##3##6##(2007-2#1)(2011-2#1)(2012-12#1)
this study were to assess##4##5##(2007-2#1)(2007-7#1)(2011-2#1)(2012-12#1)
this study were to determine the##10##6##(1996-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2011-12#1)(2011-2#1)(2012-11#1)
this study were to determine##15##5##(1996-1#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
this study were to##73##4##(1995-10#1)(1996-1#1)(2006-10#2)(2006-8#2)(2007-10#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#3)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#10)(2013-7#1)(2013-8#1)
this study were##133##3##(1990-10#2)(1990-8#1)(1991-10#1)(1991-2#1)(1993-12#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-7#1)(1996-1#1)(1997-2#1)(1997-8#2)(2006-10#2)(2006-12#1)(2006-4#2)(2006-8#2)(2007-10#5)(2007-11#1)(2007-12#1)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#7)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#1)(2008-8#3)(2009-10#1)(2009-2#2)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#11)(2013-7#1)(2013-8#1)
this study whether##2##3##(2008-7#1)(2009-8#1)
this study will be helpful##2##5##(2007-8#1)(2008-5#1)
this study will be##4##4##(2007-8#1)(2008-5#1)(2010-11#1)(2012-1#1)
this study will facilitate##2##4##(2008-10#2)
this study will help##2##4##(2008-10#1)(2010-1#1)
this study will##15##3##(1993-3#1)(2007-1#1)(2007-8#2)(2008-10#4)(2008-5#3)(2010-1#1)(2010-11#1)(2012-1#1)(2012-2#1)
this study with a##3##4##(2005-11#1)(2006-7#1)(2007-12#1)
this study with##7##3##(2005-11#1)(2006-7#1)(2007-12#1)(2008-11#1)(2008-12#1)(2009-5#1)(2009-7#1)
this study would##2##3##(1997-3#1)(2009-10#1)
this study yielded##2##3##(1994-12#1)(2011-2#1)
this study##4155##2##(1990-10#7)(1990-11#7)(1990-12#11)(1990-2#8)(1990-3#3)(1990-4#3)(1990-5#6)(1990-6#5)(1990-7#6)(1990-8#9)(1990-9#3)(1991-1#5)(1991-10#6)(1991-11#6)(1991-12#15)(1991-2#12)(1991-3#8)(1991-4#6)(1991-5#7)(1991-6#6)(1991-7#4)(1991-8#5)(1991-9#7)(1992-1#1)(1992-10#10)(1992-11#7)(1992-12#11)(1992-2#9)(1992-3#7)(1992-4#3)(1992-5#3)(1992-6#5)(1992-7#5)(1992-8#14)(1992-9#4)(1993-1#4)(1993-11#6)(1993-12#18)(1993-2#6)(1993-3#16)(1993-4#7)(1993-5#2)(1993-6#8)(1993-7#2)(1993-8#10)(1993-9#12)(1994-1#1)(1994-10#1)(1994-11#11)(1994-12#19)(1994-2#18)(1994-3#12)(1994-4#1)(1994-5#7)(1994-6#8)(1994-8#17)(1994-9#4)(1995-1#13)(1995-10#10)(1995-11#8)(1995-12#14)(1995-2#20)(1995-3#15)(1995-4#4)(1995-5#9)(1995-6#16)(1995-7#4)(1995-8#6)(1995-9#4)(1996-1#13)(1996-10#2)(1996-11#7)(1996-12#24)(1996-2#13)(1996-3#10)(1996-4#11)(1996-5#14)(1996-6#8)(1996-7#3)(1996-8#14)(1996-9#10)(1997-1#9)(1997-2#20)(1997-3#17)(1997-4#12)(1997-5#3)(1997-6#14)(1997-7#14)(1997-8#33)(2004-1#5)(2004-10#2)(2004-11#7)(2004-12#2)(2004-2#2)(2004-3#2)(2004-8#1)(2004-9#8)(2005-10#10)(2005-11#23)(2005-12#9)(2005-4#2)(2005-5#2)(2005-8#10)(2005-9#1)(2006-1#5)(2006-10#37)(2006-11#27)(2006-12#34)(2006-2#13)(2006-3#1)(2006-4#5)(2006-5#19)(2006-6#10)(2006-7#16)(2006-8#51)(2006-9#14)(2007-1#26)(2007-10#61)(2007-11#34)(2007-12#32)(2007-2#87)(2007-3#23)(2007-4#29)(2007-5#11)(2007-6#20)(2007-7#74)(2007-8#98)(2007-9#23)(2008-1#33)(2008-10#352)(2008-11#102)(2008-12#102)(2008-2#25)(2008-3#53)(2008-4#42)(2008-5#148)(2008-6#60)(2008-7#83)(2008-8#52)(2008-9#53)(2009-1#1)(2009-10#17)(2009-11#16)(2009-12#8)(2009-2#22)(2009-3#13)(2009-4#25)(2009-5#37)(2009-6#12)(2009-7#31)(2009-8#11)(2009-9#14)(2010-1#9)(2010-10#14)(2010-11#9)(2010-12#46)(2010-2#23)(2010-3#25)(2010-4#32)(2010-5#20)(2010-6#13)(2010-7#21)(2010-8#51)(2010-9#16)(2011-1#76)(2011-10#1)(2011-11#1)(2011-12#26)(2011-2#178)(2011-3#4)(2011-7#1)(2012-1#46)(2012-11#25)(2012-12#68)(2012-2#104)(2012-3#64)(2012-4#1)(2012-5#2)(2012-6#1)(2012-7#3)(2013-1#198)(2013-3#1)(2013-7#36)(2013-8#94)
this study's findings##2##3##(2006-5#1)(2012-3#1)
this study's##5##2##(2006-5#1)(2007-10#1)(2010-10#1)(2012-3#1)(2013-1#1)
this study)##5##2##(1991-3#1)(1995-4#1)(2005-11#1)(2008-5#1)(2013-1#1)
this subfamily##2##2##(1994-5#1)(1997-4#1)
this subgroup of##3##3##(2007-1#1)(2007-7#1)(2008-6#1)
this subgroup##8##2##(1992-11#1)(2007-1#1)(2007-7#1)(2007-9#1)(2008-6#2)(2009-9#1)(2012-3#1)
this subject is##4##3##(1993-10#1)(2009-6#1)(2010-11#1)(2013-8#1)
this subject##38##2##(1991-10#1)(1992-1#1)(1992-12#1)(1993-10#1)(1993-3#1)(1994-9#1)(1996-8#1)(2006-10#1)(2006-2#3)(2006-9#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-11#1)(2011-12#1)(2011-2#1)(2013-8#1)
this subpopulation of##3##3##(1991-12#1)(1995-11#1)(2006-7#1)
this subpopulation##5##2##(1991-12#1)(1993-5#1)(1995-11#1)(2006-7#1)(2008-12#1)
this subset is##2##3##(2008-9#1)(2010-8#1)
this subset of patients##2##4##(2008-12#1)(2010-12#1)
this subset of##4##3##(1995-8#1)(1996-12#1)(2008-12#1)(2010-12#1)
this subset were##2##3##(2007-12#1)(2008-9#1)
this subset##11##2##(1995-2#1)(1995-8#1)(1996-12#1)(1996-8#1)(2007-12#1)(2008-12#1)(2008-9#2)(2010-12#1)(2010-8#1)(2012-12#1)
this subsite##2##2##(1993-6#1)(1996-7#1)
this subspecialty##2##2##(2008-2#1)(2013-1#1)
this substance##10##2##(1990-7#1)(2006-3#1)(2007-7#1)(2008-11#3)(2008-3#1)(2009-6#1)(2010-5#1)(2013-8#1)
this substantially##2##2##(1992-1#1)(2007-7#1)
this substituent##2##2##(1991-4#1)(1995-3#1)
this substituted##2##2##(2009-3#1)(2010-11#1)
this substitution##4##2##(1994-9#1)(1996-9#1)(1997-5#1)(2007-8#1)
this substrate was##2##3##(2004-4#1)(2008-10#1)
this substrate##12##2##(1991-12#1)(1992-11#1)(1994-5#1)(1995-7#1)(1996-12#1)(1996-9#1)(2004-4#1)(2007-8#1)(2008-10#3)(2008-11#1)
this subtype of##4##3##(1991-5#1)(1993-8#1)(2006-10#1)(2013-8#1)
this subtype##6##2##(1991-5#1)(1993-8#1)(1997-2#2)(2006-10#1)(2013-8#1)
this subunit from##2##3##(1993-12#1)(2009-7#1)
this subunit##11##2##(1992-1#1)(1992-11#3)(1993-12#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-8#1)(2009-7#1)(2012-2#1)
this success has##2##3##(2007-4#1)(2010-10#1)
this success##5##2##(1991-5#1)(2007-4#1)(2008-10#1)(2009-5#1)(2010-10#1)
this successful##2##2##(2007-12#1)(2008-11#1)
this sugar##2##2##(1990-2#1)(1995-11#1)
this suggested##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
this suggestion##2##2##(1995-12#1)(2006-1#1)
this suggests a##2##3##(1994-5#1)(2008-11#1)
this suggests that both##2##4##(1990-10#1)(1991-3#1)
this suggests that##16##3##(1990-10#1)(1990-11#1)(1990-7#1)(1991-3#1)(1992-3#1)(1993-11#1)(1994-11#1)(1995-11#1)(1997-8#1)(1997-9#1)(2007-12#2)(2008-5#1)(2008-9#1)(2009-11#1)(2009-5#1)
this suggests##21##2##(1990-10#1)(1990-11#1)(1990-4#1)(1990-7#1)(1991-3#1)(1992-3#1)(1992-7#1)(1993-11#1)(1994-11#1)(1994-5#1)(1995-11#1)(1997-8#2)(1997-9#1)(2007-12#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-5#1)
this summary##4##2##(1992-6#1)(1997-2#1)(2006-10#1)(2006-8#1)
this summer##2##2##(2007-9#1)(2008-7#1)
this superfamily##4##2##(1995-2#1)(1996-8#1)(2006-10#1)(2011-1#1)
this supplement##6##2##(1994-2#1)(1996-9#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-5#1)
this support##4##2##(1990-8#1)(1994-2#1)(2007-11#1)(2008-5#1)
this suppression is##2##3##(1997-6#1)(2007-11#1)
this suppression##5##2##(1997-6#1)(2006-7#1)(2007-11#1)(2008-10#1)(2013-1#1)
this suppressive response was##2##4##(1991-12#2)
this suppressive##3##2##(1991-12#2)(2011-2#1)
this surface##5##2##(1994-12#1)(2008-10#1)(2008-2#1)(2012-1#1)(2012-11#1)
this surgery##7##2##(1993-7#1)(2005-10#1)(2007-8#2)(2011-2#1)(2012-12#1)(2012-2#1)
this surgical protocol##2##3##(2008-5#1)(2013-1#1)
this surgical##11##2##(1996-12#1)(2006-5#1)(2007-7#1)(2007-8#2)(2008-5#1)(2011-1#2)(2013-1#2)(2013-8#1)
this survey are##3##3##(1996-3#1)(2006-4#1)(2008-3#1)
this survey is##2##3##(2008-11#1)(2008-9#1)
this survey to##2##3##(2007-8#1)(2013-1#1)
this survey##50##2##(1990-1#1)(1990-12#1)(1990-3#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-6#2)(1993-2#1)(1993-5#1)(1994-2#1)(1995-1#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-3#1)(2005-10#1)(2005-8#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2010-11#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#1)
this susceptibility##2##2##(1993-6#1)(1996-8#1)
this suspension##2##2##(2004-9#1)(2008-10#1)
this suspicion##3##2##(1992-8#1)(1995-5#1)(2013-1#1)
this sweeping##2##2##(1991-12#1)(2007-8#1)
this switch##8##2##(1992-12#1)(1995-12#1)(1996-5#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
this sympatho-excitation##2##2##(2005-10#2)
this symposium##9##2##(1992-3#1)(1995-12#1)(2005-7#2)(2005-8#1)(2005-9#1)(2008-10#1)(2008-5#1)(2009-9#1)
this symptom##2##2##(2007-11#1)(2008-4#1)
this symptomatic comorbidity##2##3##(2008-2#2)
this symptomatic##3##2##(2008-2#3)
this synapse##2##2##(2006-10#1)(2008-6#1)
this syndrome and##5##3##(2006-4#1)(2007-10#1)(2008-7#1)(2011-12#1)(2012-12#1)
this syndrome are##3##3##(1991-5#1)(2006-7#1)(2013-1#1)
this syndrome can##2##3##(2008-12#1)(2008-9#1)
this syndrome have##2##3##(1992-11#1)(1997-6#1)
this syndrome in##2##3##(2008-1#1)(2008-12#1)
this syndrome is##11##3##(1997-1#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-7#1)(2008-12#2)(2008-3#1)(2008-9#1)(2012-12#1)
this syndrome##79##2##(1990-10#1)(1991-4#1)(1991-5#2)(1992-11#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-12#2)(1996-3#2)(1997-1#2)(1997-3#1)(1997-6#1)(2005-10#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#8)(2006-2#1)(2006-4#2)(2006-6#1)(2006-7#2)(2006-9#1)(2007-10#2)(2007-11#1)(2007-3#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#2)(2008-12#4)(2008-3#4)(2008-5#1)(2008-7#4)(2008-9#2)(2011-12#2)(2011-2#2)(2012-12#4)(2012-2#2)(2013-1#5)
this synergistic##3##2##(1993-9#1)(2008-10#1)(2008-4#1)
this synergy##3##2##(1993-8#1)(1995-3#1)(1997-2#1)
this synthesis##3##2##(1991-8#1)(2007-12#1)(2011-1#1)
this synthetic##8##2##(1992-2#1)(1994-3#2)(1995-2#1)(2006-12#1)(2008-10#1)(2009-12#1)(2012-2#1)
this system allowed the##2##4##(2008-10#2)
this system and##4##3##(1993-11#1)(2007-11#1)(2007-12#1)(2011-1#1)
this system are##11##3##(1990-11#1)(2005-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)
this system can be##2##4##(1995-2#1)(2008-2#1)
this system can##5##3##(1995-2#1)(2008-10#1)(2008-2#2)(2010-8#1)
this system could be##2##4##(1990-4#1)(2006-2#1)
this system could##3##3##(1990-4#1)(2006-2#1)(2007-12#1)
this system for the##2##4##(1997-4#1)(2006-6#1)
this system for##11##3##(1994-12#1)(1997-3#1)(1997-4#1)(2006-5#1)(2006-6#2)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#1)
this system has been##2##4##(2008-2#1)(2008-9#1)
this system has##4##3##(2005-11#1)(2008-2#1)(2008-9#1)(2009-11#1)
this system in the##5##4##(1993-12#1)(1994-12#1)(2008-5#1)(2011-12#2)
this system in##10##3##(1993-12#1)(1994-12#1)(1997-3#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)(2011-12#2)
this system include##3##3##(1997-4#1)(2004-1#1)(2011-2#1)
this system is##31##3##(1992-3#1)(1994-6#1)(1995-12#1)(1996-4#1)(1997-3#1)(2004-2#1)(2006-10#2)(2006-8#2)(2007-12#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#6)(2008-6#1)(2008-7#1)(2009-8#1)(2013-1#1)
this system of##3##3##(1992-9#1)(1993-2#1)(2010-2#1)
this system provided##2##3##(1995-12#1)(2008-10#1)
this system provides the##2##4##(2007-12#1)(2008-1#1)
this system provides##3##3##(2007-12#2)(2008-1#1)
this system to be##2##4##(2008-2#1)(2010-5#1)
this system to##8##3##(1993-12#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-2#1)(2010-5#1)
this system was##9##3##(1991-2#1)(1991-9#1)(1997-8#2)(2008-10#3)(2008-12#1)(2008-3#1)
this system we##3##3##(1994-11#1)(2008-11#1)(2008-8#1)
this system were##5##3##(2008-10#3)(2008-11#1)(2008-5#1)
this system with##2##3##(1991-9#1)(2008-2#1)
this system##284##2##(1990-11#2)(1990-4#3)(1990-5#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-10#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-4#1)(1993-7#1)(1994-10#2)(1994-11#1)(1994-12#5)(1994-6#2)(1994-8#1)(1994-9#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#3)(1996-6#1)(1996-9#1)(1997-2#3)(1997-3#4)(1997-4#4)(1997-8#4)(2004-1#1)(2004-11#1)(2004-2#1)(2005-11#4)(2005-4#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#2)(2007-10#2)(2007-11#5)(2007-12#18)(2007-5#2)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#42)(2008-11#17)(2008-12#1)(2008-2#20)(2008-3#16)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#7)(2008-9#4)(2009-11#1)(2009-2#3)(2009-6#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#3)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#1)(2012-1#1)(2012-10#1)(2012-3#3)(2013-1#2)(2013-8#4)
this system's##2##2##(2008-2#1)(2013-1#1)
this systematic review##9##3##(2005-8#1)(2006-8#2)(2008-10#1)(2008-6#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
this systematic##11##2##(2005-8#1)(2006-8#2)(2008-10#2)(2008-6#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
this systemic##3##2##(2004-1#1)(2009-10#1)(2013-7#1)
this tRNA##2##2##(1992-2#1)(1995-6#1)
this target##8##2##(1991-7#1)(1992-12#2)(2008-2#1)(2008-9#1)(2010-8#1)(2012-12#1)(2012-2#1)
this task by##2##3##(2008-7#2)
this task is##2##3##(2006-7#1)(2008-10#1)
this task was##2##3##(1994-3#1)(2009-10#1)
this task##46##2##(1990-10#1)(1991-2#1)(1992-9#1)(1993-3#2)(1993-6#1)(1994-2#1)(1994-3#3)(1995-1#1)(1995-11#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-8#1)(1997-8#2)(2005-10#1)(2006-2#1)(2006-6#2)(2006-7#1)(2007-2#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-10#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
this taxon##2##2##(2007-12#1)(2013-7#1)
this teaching strategy##2##3##(2006-5#1)(2008-11#1)
this teaching##3##2##(2006-5#1)(2008-11#1)(2009-2#1)
this technical problem##2##3##(1997-8#1)(2007-7#1)
this technical##5##2##(1997-8#1)(2006-11#1)(2007-7#1)(2008-9#1)(2012-2#1)
this technique a##5##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-8#1)
this technique allows##3##3##(2007-11#1)(2012-12#2)
this technique and the##4##4##(1993-12#1)(2008-8#1)(2009-5#1)(2013-7#1)
this technique and##13##3##(1993-12#1)(1995-1#1)(1997-1#1)(2006-12#1)(2007-12#1)(2008-11#2)(2008-7#3)(2008-8#1)(2009-5#1)(2013-7#1)
this technique are compared with##2##5##(2007-12#1)(2008-3#1)
this technique are##12##3##(1991-3#1)(1993-10#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-2#2)(2008-3#2)
this technique as a##6##4##(1994-5#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)
this technique as##7##3##(1994-5#1)(2005-9#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)
this technique by##4##3##(1990-12#1)(2007-12#1)(2008-3#2)
this technique can be applied to##2##6##(1996-8#1)(2012-2#1)
this technique can be successfully applied to##2##7##(1990-4#1)(2008-3#1)
this technique can be##7##4##(1990-4#1)(1996-8#1)(2006-3#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
this technique can##14##3##(1990-4#1)(1996-8#1)(2006-3#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2009-2#1)(2011-2#1)(2012-2#1)(2013-8#1)
this technique could be##2##4##(1996-12#1)(2013-7#1)
this technique could##6##3##(1996-12#1)(2008-3#1)(2008-5#1)(2012-2#1)(2013-7#2)
this technique for the##2##4##(2007-12#1)(2008-10#1)
this technique for##17##3##(1991-2#1)(2005-7#1)(2007-12#3)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#2)(2012-2#1)(2013-1#1)
this technique had##2##3##(1993-12#1)(2011-12#1)
this technique has become##2##4##(2007-2#1)(2008-3#1)
this technique has been used##2##5##(1991-11#1)(2007-7#1)
this technique has been##6##4##(1991-11#1)(2006-7#1)(2007-1#1)(2007-7#2)(2008-10#1)
this technique has improved##2##4##(2008-7#1)(2011-2#1)
this technique has##17##3##(1991-11#1)(1994-11#1)(2006-3#1)(2006-7#1)(2007-1#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2011-2#1)(2012-2#1)
this technique have##4##3##(2006-2#1)(2007-1#1)(2007-12#1)(2008-6#1)
this technique in the##5##4##(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
this technique in##22##3##(1993-10#1)(1993-11#1)(1997-6#1)(2006-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
this technique is also##3##4##(2004-2#1)(2008-10#2)
this technique is based on the##2##6##(2007-12#1)(2008-11#1)
this technique is limited##2##4##(2007-12#1)(2008-3#1)
this technique is to##2##4##(1995-4#1)(2008-1#1)
this technique is useful##2##4##(2006-3#1)(2008-3#1)
this technique is##44##3##(1990-9#1)(1991-7#1)(1991-9#1)(1995-4#1)(1996-8#1)(1997-7#1)(2004-2#1)(2005-11#1)(2006-3#1)(2006-8#1)(2007-11#2)(2007-12#5)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#4)(2008-3#5)(2008-6#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)
this technique it is possible to##2##6##(2007-12#1)(2008-3#1)
this technique it##3##3##(1996-12#1)(2007-12#1)(2008-3#1)
this technique on##4##3##(1990-6#1)(2006-3#1)(2008-11#1)(2008-2#1)
this technique particularly##2##3##(1991-5#1)(2008-3#1)
this technique permits##2##3##(2008-2#2)
this technique should be##2##4##(1990-10#1)(2007-12#1)
this technique should##3##3##(1990-10#1)(2007-12#1)(2008-10#1)
this technique showed##2##3##(2007-10#1)(2008-10#1)
this technique the sample is##2##5##(2007-11#1)(2007-12#1)
this technique the##7##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-9#1)(2010-7#1)(2012-2#1)
this technique to a##3##4##(2007-8#1)(2008-2#1)(2008-3#1)
this technique to analyze##2##4##(2008-10#1)(2008-4#1)
this technique to imaging##2##4##(2007-12#1)(2012-2#1)
this technique to measure the##4##5##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
this technique to the##4##4##(1995-2#1)(2007-8#1)(2008-3#1)(2011-1#1)
this technique to##43##3##(1991-8#1)(1991-9#1)(1993-3#1)(1995-2#1)(1996-8#1)(1997-6#2)(2007-11#1)(2007-12#9)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#5)(2008-4#3)(2008-8#1)(2009-9#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-8#1)
this technique was##4##3##(2006-5#1)(2007-11#1)(2007-8#1)(2008-11#1)
this technique we have##2##4##(1991-1#1)(2008-2#1)
this technique we##6##3##(1991-1#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#1)
this technique were##3##3##(1996-2#1)(2007-8#1)(2008-10#1)
this technique will be##3##4##(1992-3#1)(2007-11#1)(2007-12#1)
this technique will##5##3##(1992-3#1)(2007-11#1)(2007-12#1)(2008-2#1)(2012-2#1)
this technique with a##2##4##(2008-3#1)(2008-5#1)
this technique with the##2##4##(2007-11#1)(2008-3#1)
this technique with##9##3##(1993-8#1)(2007-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2012-2#1)
this technique##441##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-10#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-8#2)(1994-11#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-2#1)(1995-4#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-8#3)(1997-1#1)(1997-3#1)(1997-6#3)(1997-7#1)(2004-2#1)(2005-11#1)(2005-7#3)(2005-9#1)(2006-10#7)(2006-12#3)(2006-2#2)(2006-3#6)(2006-5#3)(2006-6#3)(2006-7#1)(2006-8#4)(2007-1#4)(2007-10#1)(2007-11#21)(2007-12#49)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#5)(2007-8#12)(2007-9#1)(2008-1#7)(2008-10#38)(2008-11#11)(2008-12#2)(2008-2#44)(2008-3#41)(2008-4#7)(2008-5#7)(2008-6#2)(2008-7#11)(2008-8#6)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#2)(2009-7#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#4)(2011-1#2)(2011-12#2)(2011-2#9)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#12)(2012-3#1)(2013-1#7)(2013-7#3)(2013-8#5)
this technology and to##2##4##(2008-4#1)(2010-5#1)
this technology and##4##3##(2008-4#1)(2010-5#1)(2011-2#1)(2012-12#1)
this technology can##2##3##(2006-7#1)(2013-1#1)
this technology in##10##3##(1991-11#1)(1996-1#1)(2006-10#1)(2007-3#1)(2008-10#1)(2008-11#1)(2009-6#1)(2012-3#1)(2013-1#2)
this technology is the##2##4##(2008-11#1)(2008-7#1)
this technology is##6##3##(2006-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#1)
this technology to##6##3##(1996-2#1)(2008-10#1)(2008-4#1)(2008-5#2)(2013-8#1)
this technology were##2##3##(2008-10#1)(2008-6#1)
this technology will##4##3##(1990-12#1)(1995-7#1)(2008-10#2)
this technology##73##2##(1990-12#1)(1991-11#1)(1992-12#1)(1993-12#2)(1995-5#1)(1995-7#1)(1996-1#1)(1996-2#1)(1996-5#1)(2006-10#2)(2006-11#1)(2006-6#3)(2006-7#1)(2007-11#2)(2007-12#2)(2007-3#2)(2007-4#2)(2008-10#9)(2008-11#4)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#4)(2008-9#1)(2009-3#1)(2009-6#2)(2010-5#1)(2010-8#4)(2011-1#1)(2011-2#2)(2011-7#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#5)(2013-8#1)
this telescope##2##2##(2008-2#2)
this temperature range##2##3##(1990-3#1)(2005-11#1)
this temperature##8##2##(1990-11#1)(1990-3#1)(1990-5#1)(1995-11#1)(2005-11#1)(2008-3#1)(2008-7#1)(2012-2#1)
this tendency##7##2##(1991-11#1)(1992-1#1)(2007-10#1)(2008-11#1)(2009-7#1)(2011-1#2)
this term##13##2##(1992-5#1)(1996-7#1)(2008-1#1)(2009-2#1)(2010-12#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#4)
this terminology##2##2##(1993-7#1)(2012-12#1)
this territory##2##2##(1996-3#1)(2011-2#1)
this test is##3##3##(1997-2#1)(2006-10#1)(2013-1#1)
this test the##2##3##(1994-3#1)(2008-5#1)
this test was##3##3##(2006-10#1)(2007-7#1)(2011-2#1)
this test##45##2##(1990-3#1)(1991-11#1)(1992-11#2)(1992-2#1)(1992-7#1)(1993-11#1)(1994-3#1)(1997-2#1)(1997-3#1)(2006-10#2)(2006-8#1)(2007-11#3)(2007-2#1)(2007-4#2)(2007-7#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2011-1#1)(2011-2#2)(2012-3#3)(2013-1#1)
this testing##3##2##(1996-5#1)(1996-6#1)(2007-4#1)
this text##3##2##(2007-12#1)(2008-1#1)(2008-7#1)
this the##16##2##(1992-12#1)(1992-4#1)(1994-5#1)(1997-4#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-10#1)(2009-7#1)(2010-12#1)(2013-1#2)
this theme##4##2##(1992-3#1)(2008-11#1)(2008-8#1)(2011-2#1)
this theoretical framework##2##3##(1994-3#1)(2008-1#1)
this theoretical study##2##3##(2010-10#1)(2012-2#1)
this theoretical##9##2##(1993-1#1)(1994-3#1)(2005-4#1)(2008-1#1)(2008-2#2)(2008-8#1)(2010-10#1)(2012-2#1)
this theory and##2##3##(1993-2#1)(2013-1#1)
this theory are##2##3##(2008-3#1)(2011-2#1)
this theory##27##2##(1993-2#1)(1994-3#1)(1995-4#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-1#1)(2010-10#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#1)
this therapeutic approach##6##3##(1991-12#1)(1992-12#1)(1992-4#1)(2008-10#1)(2008-5#1)(2012-12#1)
this therapeutic method##4##3##(1992-10#2)(1995-5#1)(2013-1#1)
this therapeutic##15##2##(1991-12#1)(1992-10#2)(1992-12#1)(1992-4#1)(1995-4#1)(1995-5#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
this therapy are##2##3##(2006-10#1)(2011-2#1)
this therapy in the##3##4##(1996-8#1)(2008-3#1)(2013-1#1)
this therapy in##6##3##(1996-8#1)(2006-10#1)(2007-11#1)(2008-3#1)(2010-12#1)(2013-1#1)
this therapy is##4##3##(1991-6#1)(2008-1#1)(2012-12#1)(2013-8#1)
this therapy may##4##3##(1991-10#1)(2006-8#1)(2007-11#1)(2012-2#1)
this therapy##41##2##(1990-9#1)(1991-10#1)(1991-12#1)(1991-6#1)(1993-11#1)(1995-9#1)(1996-8#1)(2005-1#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-6#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-6#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#3)
this there is##2##3##(2007-8#1)(2013-8#1)
this thermal##2##2##(1994-3#1)(2007-10#1)
this thesis##2##2##(1991-12#1)(2009-2#1)
this thickness##2##2##(2008-2#2)
this third##6##2##(1990-11#1)(1991-1#1)(1992-11#1)(1992-2#1)(2008-4#1)(2012-2#1)
this thought##2##2##(2010-8#1)(2012-12#1)
this threat##2##2##(2007-2#1)(2012-12#1)
this three-part##2##2##(1995-2#1)(2008-7#1)
this threshold##8##2##(1991-11#1)(1997-3#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-3#1)
this tick##2##2##(2004-11#1)(2011-1#1)
this time about##2##3##(1990-10#1)(2012-12#1)
this time and that##3##4##(1993-4#1)(1993-7#1)(2011-12#1)
this time and##5##3##(1993-4#1)(1993-7#1)(2008-10#1)(2011-12#1)(2012-2#1)
this time in##3##3##(1995-11#1)(2008-6#1)(2011-2#1)
this time of##2##3##(2004-11#1)(2006-12#1)
this time period##7##3##(1994-12#1)(2004-4#1)(2007-5#1)(2008-6#2)(2008-9#1)(2011-12#1)
this time point##4##3##(2008-5#1)(2009-8#1)(2010-8#1)(2012-1#1)
this time showed##2##3##(1992-5#1)(1996-9#1)
this time the##6##3##(1995-8#1)(2004-11#1)(2007-1#1)(2008-11#1)(2008-2#1)(2013-1#1)
this time was##2##3##(1990-2#1)(1995-3#1)
this time##120##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-5#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-11#2)(1995-3#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-3#1)(1997-5#1)(2004-11#3)(2004-2#1)(2004-3#1)(2004-4#1)(2005-6#2)(2005-7#4)(2006-10#1)(2006-12#2)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-5#3)(2007-8#2)(2007-9#4)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-1#1)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-3#1)(2010-8#1)(2011-12#2)(2011-2#1)(2011-4#1)(2012-1#1)(2012-12#4)(2012-2#3)(2013-1#2)(2013-8#1)
this tissue##22##2##(1990-11#2)(1990-12#1)(1990-5#2)(1990-8#1)(1991-10#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-3#1)(1994-6#1)(1995-10#1)(1995-12#1)(1996-12#1)(1997-5#1)(2007-11#1)(2008-7#1)(2013-1#2)(2013-8#1)
this tissue-specific##3##2##(1994-12#1)(1995-3#1)(2009-8#1)
this to be a##2##4##(2007-5#1)(2011-2#1)
this to be achieved##2##4##(1992-9#1)(2008-11#1)
this to be the##4##4##(2006-7#1)(2007-12#1)(2008-9#1)(2012-2#1)
this to be##14##3##(1992-9#1)(2006-12#1)(2006-7#1)(2007-12#1)(2007-4#1)(2007-5#2)(2008-11#2)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-2#1)
this to happen##2##3##(2006-10#1)(2007-8#1)
this to the change in##2##5##(2008-4#1)(2009-12#1)
this to the##6##3##(1994-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-12#1)
this to##39##2##(1992-9#1)(1994-12#1)(1994-2#1)(1994-9#1)(2005-5#1)(2006-10#1)(2006-12#1)(2006-7#2)(2007-12#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-12#2)(2009-2#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
this tolerance##4##2##(1992-2#1)(1993-12#1)(1994-3#1)(2006-11#1)
this tool can##2##3##(2009-3#1)(2011-12#1)
this tool may##2##3##(1993-12#1)(2010-12#1)
this tool to##3##3##(2008-7#1)(2012-7#1)(2013-8#1)
this tool##19##2##(1993-12#2)(1993-5#1)(1995-2#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-7#1)(2013-1#1)(2013-8#1)
this topic and##3##3##(2008-10#1)(2008-4#1)(2011-1#1)
this topic in##4##3##(1993-5#1)(1994-7#1)(2006-8#1)(2007-4#1)
this topic is##7##3##(1992-4#1)(2007-6#1)(2008-10#1)(2008-8#1)(2011-12#1)(2011-2#1)(2012-1#1)
this topic##65##2##(1990-11#1)(1992-10#1)(1992-4#1)(1993-5#1)(1993-6#1)(1994-7#1)(1997-1#1)(2004-10#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#7)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#3)(2009-8#2)(2010-12#2)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#6)(2013-7#1)(2013-8#1)
this total##2##2##(1990-5#1)(2008-10#1)
this toxic##5##2##(1991-4#1)(1992-8#1)(2008-10#2)(2013-1#1)
this toxicity is##2##3##(1995-1#1)(2010-5#1)
this toxicity##9##2##(1990-3#1)(1991-12#1)(1992-3#1)(1995-1#1)(1995-10#1)(2008-10#2)(2010-5#1)(2011-2#1)
this toxin is##3##3##(1995-8#1)(2008-10#1)(2012-12#1)
this toxin##8##2##(1993-3#1)(1995-1#2)(1995-8#1)(1997-4#1)(2008-10#2)(2012-12#1)
this trace##3##2##(2008-12#1)(2008-5#1)(2012-2#1)
this trade-off##4##2##(2008-8#4)
this traditional##6##2##(1995-2#2)(2006-10#1)(2007-11#1)(2008-10#1)(2009-7#1)
this trainer##2##2##(2007-8#2)
this training##7##2##(1991-8#1)(2004-12#2)(2007-5#1)(2010-8#1)(2011-2#1)(2012-2#1)
this trait##5##2##(1997-7#1)(2005-7#1)(2008-10#1)(2008-8#1)(2008-9#1)
this trajectory##2##2##(2011-7#1)(2013-1#1)
this transcript##3##2##(1991-10#1)(1991-9#1)(1992-8#1)
this transcription factor in##2##4##(1990-5#1)(1995-1#1)
this transcription factor may##2##4##(1991-1#1)(1994-8#1)
this transcription factor##7##3##(1990-5#1)(1991-1#1)(1994-8#1)(1995-1#1)(1995-2#1)(2009-8#2)
this transcriptional##3##2##(1992-12#1)(1994-11#1)(2008-7#1)
this transfer##4##2##(1994-11#1)(1995-11#1)(2008-2#1)(2012-12#1)
this transformation##5##2##(1996-11#1)(2007-11#1)(2008-12#1)(2009-5#1)(2012-1#1)
this transgenic##3##2##(1990-11#1)(1994-12#1)(2008-10#1)
this transient##2##2##(1992-6#1)(2008-3#1)
this transition##13##2##(1994-12#1)(1994-2#1)(1996-12#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-5#1)(2010-8#1)(2011-2#1)
this translation##2##2##(1993-11#1)(2009-10#1)
this translational##3##2##(1992-12#1)(1992-3#1)(2012-3#1)
this transmission##3##2##(2007-12#1)(2007-2#1)(2013-1#1)
this transport system##2##3##(1990-11#1)(1992-6#1)
this transport##5##2##(1990-11#1)(1992-6#1)(1997-1#1)(1997-7#1)(2008-6#1)
this transporter##5##2##(1991-3#1)(1994-10#1)(1995-6#1)(1995-8#1)(1996-5#1)
this treatable##2##2##(2006-10#1)(2009-9#1)
this treatment and##2##3##(2008-10#1)(2012-12#1)
this treatment are##5##3##(1997-5#1)(2005-6#1)(2006-10#1)(2008-8#1)(2011-1#1)
this treatment has##4##3##(1990-12#1)(1997-5#1)(2006-6#1)(2007-8#1)
this treatment is not##2##4##(1993-5#1)(2013-1#1)
this treatment is##7##3##(1991-9#1)(1993-3#1)(1993-5#1)(1993-6#1)(2007-11#1)(2010-10#1)(2013-1#1)
this treatment may##2##3##(2010-12#1)(2012-2#1)
this treatment modality for##2##4##(1997-1#1)(2007-7#1)
this treatment modality##8##3##(1990-4#2)(1992-10#1)(1994-3#1)(1997-1#1)(2006-10#1)(2007-7#1)(2011-1#1)
this treatment option##5##3##(1994-3#1)(2004-3#1)(2007-9#1)(2008-1#1)(2008-6#1)
this treatment regimen##3##3##(1995-3#1)(2007-11#1)(2007-8#1)
this treatment the##2##3##(1994-3#1)(2006-10#1)
this treatment was##2##3##(2007-11#1)(2008-1#1)
this treatment with##2##3##(1995-2#1)(2008-9#1)
this treatment##108##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-4#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-4#1)(1993-3#1)(1993-5#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#4)(1994-3#3)(1994-5#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-5#1)(1997-1#1)(1997-5#2)(1997-8#1)(2004-3#1)(2005-6#1)(2005-7#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#2)(2006-7#1)(2006-9#2)(2007-11#4)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2010-10#2)(2010-12#2)(2010-4#1)(2010-5#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#3)
this treatment's##2##2##(1996-10#1)(2012-3#1)
this trend is likely to continue##2##6##(2007-7#1)(2012-12#1)
this trend is##5##3##(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2012-12#1)
this trend was not##2##4##(2008-12#1)(2012-2#1)
this trend was##4##3##(1992-10#1)(2008-12#1)(2012-2#1)(2012-3#1)
this trend will##2##3##(2007-7#1)(2011-2#1)
this trend##31##2##(1991-6#1)(1992-10#1)(1994-7#1)(1995-11#1)(1996-5#1)(1997-5#1)(2006-4#1)(2007-12#2)(2007-7#3)(2008-1#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#1)
this trial##24##2##(1991-9#1)(1994-12#1)(1994-7#1)(1995-4#1)(1996-3#1)(2004-1#1)(2005-8#3)(2006-2#1)(2007-7#3)(2007-9#1)(2008-1#1)(2008-11#1)(2008-7#3)(2009-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
this tripeptide##2##2##(1992-10#1)(2011-1#1)
this triple##2##2##(1990-12#1)(2011-2#1)
this tumor and##5##3##(1997-6#1)(2007-8#1)(2013-1#2)(2013-7#1)
this tumor are##2##3##(1990-10#1)(2013-1#1)
this tumor in the##3##4##(2008-10#1)(2008-9#1)(2013-7#1)
this tumor in##5##3##(1991-10#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-7#1)
this tumor is##2##3##(2009-1#1)(2010-12#1)
this tumor system may##2##4##(1993-7#1)(2006-10#1)
this tumor type##3##3##(1997-7#1)(2006-8#2)
this tumor was##3##3##(2010-11#1)(2012-1#1)(2013-7#1)
this tumor##53##2##(1990-10#1)(1990-4#1)(1990-9#1)(1991-10#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-6#1)(1992-9#2)(1993-7#1)(1996-3#1)(1996-9#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-2#1)(2006-8#2)(2007-2#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#2)(2008-9#1)(2009-1#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-7#3)
this tumour is##3##3##(2011-2#1)(2013-7#1)(2013-8#1)
this tumour##16##2##(1990-6#1)(1992-5#1)(1993-10#1)(2008-5#2)(2010-3#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-7#2)(2013-8#1)
this tutorial##5##2##(1993-12#1)(1993-3#1)(1994-12#1)(2012-12#2)
this two##4##2##(2006-12#1)(2008-6#1)(2011-2#1)(2012-12#1)
this type is##4##3##(1990-5#1)(1997-3#1)(2008-10#1)(2011-2#1)
this type of activity##2##4##(2008-11#1)(2008-8#1)
this type of alkaloid##2##4##(2011-3#2)
this type of analysis is##2##5##(2008-9#2)
this type of assessment##2##4##(2008-11#1)(2008-9#1)
this type of device##2##4##(1994-11#1)(2008-4#1)
this type of education##2##4##(2008-11#1)(2008-12#1)
this type of event##2##4##(1993-3#1)(2012-2#1)
this type of fiber##2##4##(2007-12#2)
this type of health##2##4##(1992-2#1)(1994-1#1)
this type of infection##3##4##(2005-8#1)(2009-2#1)(2009-3#1)
this type of information##2##4##(2007-6#1)(2008-10#1)
this type of injury##2##4##(2007-11#1)(2013-1#1)
this type of laser##3##4##(2007-12#1)(2008-2#1)(2010-1#1)
this type of lesions##2##4##(2006-2#1)(2008-8#1)
this type of patients##3##4##(1993-10#1)(2011-2#1)(2013-1#1)
this type of planning##2##4##(1993-3#1)(1994-1#1)
this type of program##4##4##(1993-2#1)(2007-2#1)(2012-11#2)
this type of reagent##2##4##(2008-10#2)
this type of research##6##4##(1993-11#1)(1994-7#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-4#1)
this type of study##4##4##(1997-7#1)(2008-10#1)(2008-7#1)(2010-6#1)
this type of surgery##2##4##(2004-2#1)(2010-6#1)
this type of treatment##5##4##(1991-11#1)(1992-3#1)(1993-2#1)(2004-4#1)(2007-11#1)
this type of tumor##3##4##(1990-2#1)(2008-9#1)(2011-2#1)
this type of tumour##3##4##(1993-3#1)(2009-2#1)(2010-12#1)
this type of##213##3##(1990-2#1)(1990-4#3)(1990-8#1)(1991-11#2)(1991-4#1)(1991-5#1)(1991-7#1)(1992-2#3)(1992-3#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#2)(1993-3#3)(1993-8#1)(1994-1#3)(1994-11#2)(1994-3#1)(1994-6#2)(1994-7#1)(1994-8#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-3#2)(1996-4#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#2)(1997-8#2)(2004-2#1)(2004-4#2)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-2#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#3)(2007-7#2)(2008-1#2)(2008-10#15)(2008-11#7)(2008-12#4)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#4)(2008-7#7)(2008-8#4)(2008-9#9)(2009-1#2)(2009-11#1)(2009-2#2)(2009-3#2)(2009-4#2)(2009-6#2)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#10)(2011-3#2)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#5)
this type##249##2##(1990-2#1)(1990-4#3)(1990-5#1)(1990-8#1)(1991-11#3)(1991-4#2)(1991-5#1)(1991-7#1)(1992-1#1)(1992-2#3)(1992-3#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#2)(1993-3#3)(1993-8#1)(1994-1#3)(1994-11#2)(1994-3#2)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#3)(1995-1#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-3#2)(1996-4#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#3)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-2#1)(2004-4#2)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-2#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#4)(2007-12#9)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#3)(2007-7#2)(2008-1#2)(2008-10#16)(2008-11#8)(2008-12#4)(2008-2#4)(2008-3#12)(2008-4#3)(2008-5#5)(2008-7#7)(2008-8#4)(2008-9#9)(2009-1#2)(2009-11#1)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#3)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#11)(2011-3#2)(2012-1#1)(2012-11#3)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#5)
this typical##2##2##(2005-8#1)(2007-2#1)
this typically##2##2##(2008-12#1)(2008-7#1)
this tyrosine kinase##4##3##(1991-5#1)(1995-8#1)(2009-3#1)(2012-2#1)
this tyrosine##5##2##(1991-5#1)(1991-9#1)(1995-8#1)(2009-3#1)(2012-2#1)
this ubiquitous##2##2##(1995-5#1)(2007-4#1)
this ultrafast##3##2##(2006-6#2)(2007-12#1)
this uncommon condition##3##3##(2005-9#1)(2007-8#1)(2013-7#1)
this uncommon disease##4##3##(1993-5#1)(2007-2#1)(2008-12#1)(2008-7#1)
this uncommon##20##2##(1993-5#1)(2005-9#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-7#1)
this understanding##5##2##(1994-6#1)(2008-10#1)(2008-12#2)(2012-1#1)
this undertaking##2##2##(1995-12#1)(2012-2#1)
this undesirable##2##2##(1991-3#1)(2009-5#1)
this unfolding##2##2##(1994-8#1)(1995-5#1)
this unique combination##2##3##(2008-3#1)(2012-3#1)
this unique population##2##3##(2013-1#2)
this unique##30##2##(1991-3#1)(1991-5#1)(1991-7#2)(1993-11#1)(1994-10#1)(1994-9#1)(1995-8#1)(1996-2#1)(1997-9#1)(2005-7#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-9#1)(2010-7#1)(2012-3#1)(2013-1#2)
this unit addresses##2##3##(2008-2#1)(2008-4#1)
this unit also##2##3##(2008-2#1)(2008-4#1)
this unit are protocols for##2##5##(2008-4#2)
this unit are##16##3##(2008-2#1)(2008-4#10)(2008-9#3)(2010-7#1)(2012-3#1)
this unit describes an##3##4##(2008-4#3)
this unit describes preparation of##3##5##(2008-4#3)
this unit describes the##5##4##(2008-1#1)(2008-2#3)(2008-4#1)
this unit describes##18##3##(2008-1#2)(2008-2#4)(2008-4#11)(2008-9#1)
this unit discusses the##4##4##(2008-4#3)(2008-9#1)
this unit discusses##5##3##(2008-4#4)(2008-9#1)
this unit includes##2##3##(2008-4#2)
this unit is a##2##4##(2008-2#1)(2008-9#1)
this unit is##32##3##(2008-1#1)(2008-2#1)(2008-4#20)(2008-9#9)(2010-8#1)
this unit presents##2##3##(2008-4#2)
this unit should be##2##4##(2008-1#1)(2008-9#1)
this unit##297##2##(1990-11#1)(1994-11#1)(2008-1#15)(2008-2#31)(2008-4#193)(2008-9#53)(2010-7#1)(2010-8#1)(2012-3#1)
this unusual case##2##3##(2005-11#1)(2010-3#1)
this unusual presentation##2##3##(2008-6#1)(2013-1#1)
this unusual##34##2##(1990-4#1)(1991-2#1)(1993-11#1)(1995-8#1)(1996-2#2)(1997-6#1)(2005-11#1)(2006-10#2)(2006-12#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-4#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
this upper##2##2##(2007-12#1)(2007-5#1)
this upstream##2##2##(1994-2#1)(1997-4#1)
this uptake##2##2##(1995-6#1)(1997-2#1)
this urgent##2##2##(2006-10#1)(2008-3#1)
this use##4##2##(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)
this useful##2##2##(1995-2#1)(2006-8#1)
this using##2##2##(2008-8#1)(2010-5#1)
this usually##2##2##(1997-6#1)(2006-10#1)
this vaccine##5##2##(2006-10#2)(2007-11#1)(2008-8#1)(2012-3#1)
this validation##2##2##(1996-7#1)(2008-10#1)
this valuable##2##2##(1993-1#1)(2008-10#1)
this value and the##2##4##(1991-5#1)(1997-2#1)
this value and##3##3##(1991-5#1)(1997-2#1)(2008-3#1)
this value is##5##3##(1996-5#1)(1996-7#1)(2008-1#1)(2008-3#1)(2013-1#1)
this value was##6##3##(1990-7#1)(1997-8#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-12#1)
this value##22##2##(1990-12#1)(1990-7#1)(1991-5#1)(1992-12#1)(1992-9#1)(1995-6#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-8#1)(2006-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2009-4#1)(2013-1#1)
this valve is##2##3##(2006-8#2)
this valve##3##2##(1991-3#1)(2006-8#2)
this variability##8##2##(1993-12#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-4#1)(2012-2#1)(2012-3#1)
this variable and##2##3##(1994-6#1)(2011-2#1)
this variable region##2##3##(1995-1#1)(2008-10#1)
this variable##9##2##(1994-6#1)(1995-1#1)(2007-12#1)(2008-10#4)(2008-8#1)(2011-2#1)
this variance##2##2##(1996-7#1)(2010-12#1)
this variant was##2##3##(1994-11#1)(2010-12#1)
this variant##10##2##(1991-12#1)(1994-11#1)(1994-2#1)(1996-3#1)(1996-4#1)(2008-9#1)(2009-12#1)(2010-12#1)(2011-1#1)(2012-3#1)
this variation and##2##3##(2008-10#1)(2008-2#1)
this variation can##3##3##(1993-3#1)(2006-1#1)(2008-8#1)
this variation in##4##3##(1991-12#1)(2008-10#1)(2008-7#1)(2009-5#1)
this variation is##2##3##(1992-5#1)(2006-1#1)
this variation##27##2##(1991-12#1)(1992-5#1)(1993-3#1)(1995-3#1)(1995-5#1)(1997-3#1)(2004-10#1)(2005-11#1)(2006-1#2)(2008-10#7)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-8#1)(2011-3#1)(2012-2#1)
this variety of##2##3##(1996-3#1)(2010-2#1)
this variety##6##2##(1993-2#1)(1995-11#1)(1996-3#1)(2008-5#2)(2010-2#1)
this vascular##2##2##(1990-4#1)(1997-2#1)
this vector in##2##3##(1995-8#1)(2008-5#1)
this vector system##4##3##(1990-3#1)(1996-12#1)(1997-2#1)(1997-4#1)
this vector was##3##3##(1993-6#1)(1996-11#1)(2008-8#1)
this vector##20##2##(1990-3#1)(1991-7#2)(1991-9#1)(1993-6#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-4#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#3)
this versatile##2##2##(2008-11#1)(2010-2#1)
this very important##2##3##(2010-12#1)(2011-2#1)
this very rare##3##3##(2007-8#1)(2008-6#1)(2008-9#1)
this very unusual##2##3##(1992-10#1)(2008-1#1)
this very##23##2##(1992-10#1)(1992-11#1)(1992-7#1)(1993-7#1)(1995-12#1)(1995-3#1)(1996-9#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-12#1)(2011-2#1)(2012-12#1)
this vessel##3##2##(1995-12#1)(2012-12#2)
this video is##2##3##(2008-11#2)
this video protocol##5##3##(2008-10#1)(2008-11#4)
this video##21##2##(2008-10#1)(2008-11#19)(2008-8#1)
this view##17##2##(1990-4#1)(1991-6#1)(1995-2#1)(1995-7#1)(1996-8#1)(1997-4#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2012-11#1)(2012-3#1)
this viewpoint##2##2##(1994-3#1)(2008-6#1)
this viral##6##2##(1992-9#1)(1995-2#1)(1997-3#1)(2005-8#1)(2008-1#1)(2013-8#1)
this virus as a##3##4##(2008-10#1)(2011-2#1)(2013-8#1)
this virus is##4##3##(1995-7#1)(2007-12#1)(2008-10#1)(2008-12#1)
this virus may be##2##4##(2008-10#1)(2008-11#1)
this virus was##2##3##(2008-10#2)
this virus##36##2##(1991-3#1)(1992-6#2)(1993-8#1)(1995-7#1)(2004-11#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#2)
this vital##5##2##(1993-1#1)(1995-12#1)(2006-8#1)(2008-11#1)(2012-1#1)
this vitamin##6##2##(1990-3#1)(2005-8#1)(2007-7#2)(2010-6#1)(2012-3#1)
this void##2##2##(1991-2#1)(2012-12#1)
this volatile##2##2##(1994-3#1)(1997-3#1)
this voltammetric method##3##3##(2008-10#3)
this voltammetric peak##2##3##(2008-10#2)
this voltammetric##5##2##(2008-10#5)
this volume##12##2##(1990-3#1)(1992-6#1)(1994-6#1)(1997-8#2)(2008-11#2)(2008-2#4)(2008-3#1)
this vulnerable group of patients##2##5##(2011-1#1)(2013-1#1)
this vulnerable population##6##3##(2008-12#1)(2009-5#1)(2009-9#2)(2011-1#1)(2013-1#1)
this vulnerable##11##2##(2007-1#1)(2007-12#1)(2008-12#1)(2009-5#1)(2009-9#2)(2010-7#1)(2011-1#2)(2013-1#2)
this was a##12##3##(1993-12#1)(1993-5#1)(2006-3#1)(2006-9#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
this was accompanied by a##4##5##(1991-1#1)(1992-9#1)(1994-8#1)(2008-11#1)
this was accompanied by##5##4##(1991-1#1)(1992-9#1)(1994-8#1)(2008-11#1)(2009-6#1)
this was an##5##3##(1993-12#1)(2007-12#1)(2009-2#1)(2009-4#1)(2010-8#1)
this was associated with##8##4##(1993-12#1)(1994-8#1)(1996-3#1)(2007-8#1)(2008-11#1)(2008-7#1)(2011-1#1)(2013-1#1)
this was compared##2##3##(1991-11#1)(2012-12#1)
this was confirmed by an##2##5##(2008-5#1)(2008-7#1)
this was confirmed by##4##4##(1994-11#1)(2007-11#1)(2008-5#1)(2008-7#1)
this was confirmed##7##3##(1994-11#1)(1995-2#1)(2007-1#1)(2007-11#1)(2008-5#1)(2008-7#1)(2010-11#1)
this was demonstrated##2##3##(1992-10#1)(2007-8#1)
this was due to##6##4##(1990-8#1)(1995-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2012-2#1)
this was followed by##2##4##(2008-6#1)(2008-8#1)
this was followed##3##3##(1993-1#1)(2008-6#1)(2008-8#1)
this was not observed##4##4##(2005-11#1)(2008-6#1)(2009-4#1)(2012-1#1)
this was not statistically significant##3##5##(1990-6#1)(1996-12#1)(2012-12#1)
this was not the case for the##2##7##(2006-7#1)(2008-11#1)
this was not the case##6##5##(1991-5#1)(1993-5#1)(1994-5#1)(2006-7#1)(2008-11#1)(2008-6#1)
this was not##36##3##(1990-6#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-7#1)(1993-12#2)(1993-5#1)(1994-2#1)(1994-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-4#1)(2005-11#1)(2006-12#1)(2006-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#3)(2008-7#1)(2009-4#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
this was only significant##2##4##(1996-3#1)(2008-11#1)
this was only##4##3##(1996-3#1)(2008-10#1)(2008-11#1)(2008-5#1)
this was prevented by##2##4##(2006-9#1)(2008-5#1)
this was significant##2##3##(2004-1#1)(2011-1#1)
this was significantly##2##3##(1990-4#1)(2009-10#1)
this was statistically##3##3##(2007-2#1)(2008-6#1)(2010-4#1)
this was tested##2##3##(1995-1#1)(2008-12#1)
this was the case##2##4##(1993-1#1)(1996-12#1)
this was the##9##3##(1992-2#1)(1993-1#1)(1993-8#1)(1996-12#1)(2007-7#1)(2008-12#1)(2008-6#1)(2011-2#2)
this was true##3##3##(1996-5#1)(2006-4#1)(2012-2#1)
this was##190##2##(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#6)(1993-5#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-8#1)(2004-1#1)(2005-11#1)(2005-2#1)(2005-8#1)(2006-10#2)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#3)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#3)(2007-3#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#16)(2008-11#8)(2008-12#5)(2008-3#1)(2008-5#3)(2008-6#6)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#5)(2012-2#3)(2013-1#7)(2013-7#2)(2013-8#1)
this water##3##2##(2008-7#1)(2011-2#1)(2012-12#1)
this water-soluble##3##2##(1990-4#1)(1994-5#1)(2008-10#1)
this wavelength range##5##3##(2006-4#1)(2007-11#2)(2008-3#2)
this wavelength##15##2##(2006-4#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#3)(2013-1#1)
this way a##5##3##(1990-9#1)(1992-6#1)(2008-2#2)(2008-8#1)
this way being considered##2##4##(2013-8#2)
this way can##2##3##(1992-8#1)(2008-11#1)
this way for##3##3##(2008-10#1)(2008-2#1)(2012-10#1)
this way it##2##3##(2007-7#1)(2008-3#1)
this way of working##2##4##(2006-2#1)(2013-1#1)
this way of##3##3##(2006-2#1)(2008-8#1)(2013-1#1)
this way the##15##3##(1990-8#1)(1995-1#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-8#1)(2010-4#1)(2013-1#2)
this way##157##2##(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#2)(1991-8#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-1#3)(1995-2#1)(1995-8#2)(1996-1#1)(1996-11#1)(1997-2#3)(1997-6#1)(1997-8#1)(2005-11#1)(2005-4#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-11#5)(2007-12#7)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#20)(2008-11#8)(2008-12#1)(2008-2#12)(2008-3#9)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#3)(2009-10#1)(2009-3#1)(2009-6#2)(2009-8#2)(2009-9#1)(2010-11#2)(2010-4#2)(2012-1#1)(2012-10#1)(2013-1#7)(2013-8#5)
this we found##2##3##(1996-2#1)(1996-5#1)
this we have##3##3##(1997-1#1)(2008-7#1)(2008-9#1)
this we show that##2##4##(1991-4#1)(2008-2#1)
this we##19##2##(1991-4#1)(1993-12#1)(1996-2#2)(1996-5#1)(1997-1#1)(2005-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-11#1)(2012-2#1)
this week##2##2##(2007-9#2)
this were##3##2##(1996-5#1)(2008-7#1)(2009-5#1)
this widely available##2##3##(2009-6#1)(2010-5#1)
this widely used##2##3##(1991-12#1)(2007-8#1)
this widely##6##2##(1991-12#1)(2006-12#1)(2007-8#1)(2009-5#1)(2009-6#1)(2010-5#1)
this will allow##2##3##(2008-10#1)(2008-5#1)
this will be a##3##4##(1997-2#1)(2005-11#1)(2008-11#1)
this will be achieved##2##4##(2007-10#1)(2008-5#1)
this will be the##2##4##(2006-12#1)(2008-12#1)
this will be##9##3##(1997-2#1)(2005-11#1)(2006-12#1)(2007-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)
this will help##3##3##(2007-7#1)(2008-7#1)(2011-2#1)
this will increase##3##3##(2007-11#1)(2008-3#1)(2012-10#1)
this will lead to##2##4##(2007-6#1)(2011-2#1)
this will provide##2##3##(1995-2#1)(2007-2#1)
this will##43##2##(1992-3#1)(1993-9#1)(1995-2#2)(1997-2#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#2)(2008-10#1)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2010-4#2)(2010-8#1)(2011-12#1)(2011-2#2)(2012-10#1)(2012-12#1)(2013-8#1)
this with a##5##3##(2006-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-7#1)
this with the##4##3##(2006-3#1)(2006-8#1)(2008-12#1)(2008-5#1)
this with##15##2##(2005-10#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-10#1)(2010-7#1)(2012-2#2)
this work a##10##3##(2007-8#1)(2008-10#6)(2008-5#1)(2011-2#1)(2012-2#1)
this work and##5##3##(1996-11#1)(2005-11#1)(2008-10#1)(2008-3#1)(2010-6#1)
this work demonstrates##2##3##(2010-5#1)(2013-7#1)
this work focuses on##2##4##(1995-12#1)(2008-10#1)
this work for##6##3##(1990-8#1)(1995-5#1)(2008-10#4)
this work has been##2##4##(2006-10#1)(2013-1#1)
this work has##9##3##(1995-12#1)(2006-10#3)(2008-10#1)(2008-11#1)(2009-3#1)(2012-3#1)(2013-1#1)
this work have##3##3##(2005-11#1)(2007-4#1)(2008-5#1)
this work in order to##2##5##(2004-9#1)(2008-10#1)
this work in##5##3##(2004-9#1)(2007-8#1)(2008-10#2)(2010-11#1)
this work is the##7##4##(2007-4#1)(2008-10#3)(2008-4#1)(2008-5#1)(2012-1#1)
this work is##56##3##(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1993-10#1)(1996-8#1)(2004-2#1)(2005-10#1)(2006-2#2)(2007-11#3)(2007-4#1)(2007-7#1)(2008-10#9)(2008-2#2)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#2)(2009-3#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-2#3)(2011-2#2)(2012-1#1)(2012-2#4)(2013-1#2)(2013-7#1)
this work presents##3##3##(2008-12#1)(2009-12#1)(2010-12#1)
this work showed that##2##4##(2006-10#1)(2011-1#1)
this work shows that##2##4##(2008-10#1)(2008-5#1)
this work shows##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
this work the##14##3##(1990-1#1)(1990-3#1)(1993-8#1)(2005-8#1)(2006-10#1)(2006-2#1)(2008-10#4)(2008-5#2)(2008-7#1)(2013-1#1)
this work was to study##13##5##(2006-6#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-7#2)
this work was to##74##4##(1991-11#1)(1993-11#1)(1993-12#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-10#2)(2005-11#1)(2006-10#2)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#13)(2008-6#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-4#4)(2010-5#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#3)(2013-8#2)
this work was##84##3##(1991-11#1)(1993-11#1)(1993-12#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-10#2)(2005-11#2)(2005-9#1)(2006-10#2)(2006-6#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#14)(2008-6#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#3)(2010-4#4)(2010-5#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#3)(2013-8#2)
this work we have studied##4##5##(1990-5#1)(1991-4#1)(2008-11#1)(2012-2#1)
this work we have##8##4##(1990-5#1)(1991-4#1)(1991-5#1)(1992-8#1)(1996-12#1)(2005-10#1)(2008-11#1)(2012-2#1)
this work we##59##3##(1990-5#2)(1991-12#1)(1991-4#1)(1991-5#2)(1991-6#1)(1992-8#1)(1993-4#1)(1994-9#1)(1995-3#1)(1996-12#1)(1997-2#2)(2004-12#1)(2005-10#2)(2005-11#1)(2006-10#2)(2007-10#1)(2007-5#2)(2008-10#8)(2008-11#6)(2008-5#1)(2008-6#1)(2009-3#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
this work were##8##3##(1994-6#1)(2007-10#1)(2007-2#1)(2008-10#3)(2008-5#1)(2010-4#1)
this work##662##2##(1990-1#1)(1990-3#2)(1990-5#3)(1990-7#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#4)(1991-6#1)(1992-11#1)(1992-12#3)(1992-4#2)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-4#1)(1993-8#2)(1994-12#1)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-8#2)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#1)(2004-12#2)(2004-2#1)(2004-4#1)(2004-9#2)(2005-10#9)(2005-11#15)(2005-8#1)(2005-9#1)(2006-10#13)(2006-12#5)(2006-2#4)(2006-6#1)(2006-8#1)(2007-1#3)(2007-10#6)(2007-11#13)(2007-12#4)(2007-2#3)(2007-3#2)(2007-4#5)(2007-5#6)(2007-7#1)(2007-8#15)(2008-1#2)(2008-10#177)(2008-11#17)(2008-12#5)(2008-2#7)(2008-3#3)(2008-4#3)(2008-5#45)(2008-6#10)(2008-7#9)(2008-8#4)(2008-9#3)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#4)(2009-5#4)(2009-6#3)(2009-7#4)(2009-8#3)(2009-9#2)(2010-1#2)(2010-10#4)(2010-11#6)(2010-12#8)(2010-2#7)(2010-4#10)(2010-5#4)(2010-6#1)(2010-7#5)(2010-8#6)(2011-1#6)(2011-12#3)(2011-2#12)(2011-3#3)(2012-1#8)(2012-11#2)(2012-12#3)(2012-2#15)(2012-3#4)(2013-1#31)(2013-7#10)(2013-8#6)
this workforce##3##2##(2010-11#1)(2011-1#1)(2013-1#1)
this workshop##4##2##(2008-11#1)(2008-5#2)(2011-2#1)
this world##3##2##(1996-3#1)(2008-10#1)(2013-1#1)
this worsening##2##2##(2007-8#1)(2013-1#1)
this would be##3##3##(1994-5#1)(2008-10#1)(2008-7#1)
this would indicate that##2##4##(1990-2#1)(2008-5#1)
this would indicate##3##3##(1990-2#1)(2008-10#1)(2008-5#1)
this would produce##2##3##(1990-5#1)(1992-8#1)
this would##21##2##(1990-2#1)(1990-5#1)(1992-8#1)(1993-1#1)(1994-2#1)(1994-5#1)(1995-3#1)(1997-1#1)(2005-7#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
this writing##2##2##(1991-10#1)(2007-4#1)
this year that##2##3##(1991-4#1)(2007-9#1)
this year##21##2##(1991-4#2)(1993-5#1)(1996-2#1)(1996-3#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-8#1)(2007-9#3)(2008-4#3)(2008-5#2)(2008-7#3)(2009-11#1)
this year's##13##2##(1991-2#1)(1995-3#1)(2005-6#2)(2005-8#1)(2005-9#1)(2006-10#2)(2007-9#1)(2008-7#2)(2009-6#1)(2010-11#1)
this year]##2##2##(1990-10#1)(1993-11#1)
this yeast##5##2##(1992-12#1)(1994-9#1)(1996-12#1)(2008-7#1)(2009-12#1)
this young##6##2##(1997-3#1)(2008-3#1)(2008-7#1)(2011-2#2)(2013-1#1)
this zone is##2##3##(2012-12#1)(2013-7#1)
this zone##11##2##(1990-2#1)(1991-1#1)(1992-12#1)(1997-4#1)(2007-3#1)(2007-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
this zoonosis##2##2##(2012-12#1)(2013-1#1)
this##35693##1##(1990-1#13)(1990-10#58)(1990-11#133)(1990-12#166)(1990-2#108)(1990-3#90)(1990-4#79)(1990-5#127)(1990-6#69)(1990-7#90)(1990-8#102)(1990-9#80)(1991-1#78)(1991-10#55)(1991-11#97)(1991-12#135)(1991-2#141)(1991-3#121)(1991-4#73)(1991-5#129)(1991-6#101)(1991-7#95)(1991-8#83)(1991-9#127)(1992-1#83)(1992-10#54)(1992-11#96)(1992-12#160)(1992-2#119)(1992-3#126)(1992-4#68)(1992-5#74)(1992-6#115)(1992-7#65)(1992-8#112)(1992-9#95)(1993-1#57)(1993-10#27)(1993-11#109)(1993-12#185)(1993-2#101)(1993-3#140)(1993-4#63)(1993-5#61)(1993-6#125)(1993-7#57)(1993-8#92)(1993-9#99)(1994-1#32)(1994-10#38)(1994-11#133)(1994-12#176)(1994-2#160)(1994-3#180)(1994-4#7)(1994-5#91)(1994-6#122)(1994-7#19)(1994-8#177)(1994-9#143)(1995-1#139)(1995-10#43)(1995-11#103)(1995-12#142)(1995-2#190)(1995-3#171)(1995-4#42)(1995-5#119)(1995-6#136)(1995-7#40)(1995-8#143)(1995-9#45)(1996-1#109)(1996-10#49)(1996-11#79)(1996-12#158)(1996-2#141)(1996-3#129)(1996-4#79)(1996-5#135)(1996-6#71)(1996-7#69)(1996-8#128)(1996-9#97)(1997-1#131)(1997-2#164)(1997-3#133)(1997-4#158)(1997-5#80)(1997-6#116)(1997-7#126)(1997-8#177)(1997-9#5)(2004-1#22)(2004-10#21)(2004-11#47)(2004-12#37)(2004-2#26)(2004-3#15)(2004-4#15)(2004-7#7)(2004-8#6)(2004-9#36)(2005-1#16)(2005-10#112)(2005-11#199)(2005-12#47)(2005-2#6)(2005-3#4)(2005-4#61)(2005-5#20)(2005-6#12)(2005-7#109)(2005-8#152)(2005-9#42)(2006-1#38)(2006-10#675)(2006-11#100)(2006-12#217)(2006-2#122)(2006-3#68)(2006-4#95)(2006-5#129)(2006-6#132)(2006-7#113)(2006-8#221)(2006-9#116)(2007-1#112)(2007-10#221)(2007-11#559)(2007-12#738)(2007-2#311)(2007-3#126)(2007-4#161)(2007-5#150)(2007-6#94)(2007-7#365)(2007-8#542)(2007-9#199)(2008-1#461)(2008-10#2771)(2008-11#964)(2008-12#469)(2008-2#914)(2008-3#872)(2008-4#691)(2008-5#906)(2008-6#375)(2008-7#791)(2008-8#579)(2008-9#534)(2009-1#30)(2009-10#165)(2009-11#96)(2009-12#103)(2009-2#140)(2009-3#149)(2009-4#180)(2009-5#190)(2009-6#118)(2009-7#140)(2009-8#192)(2009-9#138)(2010-1#61)(2010-10#121)(2010-11#131)(2010-12#357)(2010-2#191)(2010-3#132)(2010-4#162)(2010-5#205)(2010-6#93)(2010-7#146)(2010-8#230)(2010-9#108)(2011-1#485)(2011-10#5)(2011-11#3)(2011-12#126)(2011-2#967)(2011-3#36)(2011-4#1)(2011-7#10)(2011-9#2)(2012-1#304)(2012-10#3)(2012-11#125)(2012-12#572)(2012-2#741)(2012-3#426)(2012-4#1)(2012-5#4)(2012-6#4)(2012-7#7)(2012-8#2)(2012-9#2)(2013-1#1092)(2013-2#2)(2013-3#1)(2013-7#210)(2013-8#483)
thistle##6##1##(2005-8#1)(2008-10#3)(2008-5#1)(2011-2#1)
thiyl and##2##2##(1992-11#1)(1994-9#1)
thiyl##3##1##(1992-11#1)(1994-12#1)(1994-9#1)
thomasi##5##1##(2007-12#5)
thoracal##3##1##(1997-4#1)(2005-12#1)(2013-8#1)
thoracentesis##3##1##(2011-2#1)(2012-12#2)
thoracic CT scanning##2##3##(1991-3#2)
thoracic CT##5##2##(1991-3#2)(1997-8#1)(2007-10#1)(2007-6#1)
thoracic air##2##2##(2008-5#2)
thoracic airsacculitis##2##2##(2010-4#2)
thoracic and abdominal##6##3##(1996-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-3#1)
thoracic and cardiovascular surgery##8##4##(2007-8#7)(2010-8#1)
thoracic and lumbar spine##3##4##(2006-11#1)(2007-4#1)(2010-10#1)
thoracic and lumbar##7##3##(2006-11#1)(2006-8#1)(2007-4#1)(2008-12#1)(2008-7#2)(2010-10#1)
thoracic and##32##2##(1991-6#1)(1995-6#1)(1996-12#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-4#1)(2007-7#1)(2007-8#8)(2008-12#1)(2008-7#2)(2010-10#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-3#1)
thoracic anesthesia##2##2##(2006-10#2)
thoracic aneurysm##3##2##(2007-8#1)(2011-2#1)(2013-7#1)
thoracic aorta and abdominal aorta) in##2##6##(1997-8#2)
thoracic aorta and##5##3##(1991-11#1)(1996-10#1)(1997-8#2)(2013-3#1)
thoracic aorta dissection##2##3##(2013-8#2)
thoracic aorta in##2##3##(1992-9#1)(2009-8#1)
thoracic aorta of##2##3##(1997-5#1)(2009-7#1)
thoracic aorta surgery##2##3##(2007-8#2)
thoracic aorta to femoral artery bypass##3##6##(2007-8#3)
thoracic aorta to##6##3##(2007-8#3)(2008-7#2)(2010-12#1)
thoracic aorta without##2##3##(2007-8#1)(2011-1#1)
thoracic aorta##52##2##(1990-2#1)(1990-6#1)(1991-11#1)(1992-6#1)(1992-9#1)(1995-11#1)(1996-10#1)(1997-5#1)(1997-8#4)(2007-2#1)(2007-8#16)(2007-9#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-7#1)(2009-8#3)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-3#1)(2013-7#2)(2013-8#2)
thoracic aorta) was##2##3##(2007-8#1)(2010-8#1)
thoracic aorta)##3##2##(1997-8#1)(2007-8#1)(2010-8#1)
thoracic aorta]##2##2##(1993-10#1)(2008-10#1)
thoracic aortic aneurysm##2##3##(2008-11#1)(2009-4#1)
thoracic aortic dissection##3##3##(2007-1#1)(2007-8#2)
thoracic aortic surgery##4##3##(2007-8#1)(2007-9#1)(2010-8#2)
thoracic aortic surgery]##2##3##(2010-8#2)
thoracic aortic##22##2##(1995-12#1)(2005-9#1)(2006-10#1)(2007-1#1)(2007-10#2)(2007-8#6)(2007-9#1)(2008-11#1)(2009-12#1)(2009-4#1)(2010-12#2)(2010-8#4)
thoracic aortitis##4##2##(2010-2#4)
thoracic approach##2##2##(2006-8#1)(2007-8#1)
thoracic artery (ITA)##3##3##(2007-8#3)
thoracic artery##18##2##(2006-10#1)(2006-6#1)(2007-8#14)(2009-3#1)(2011-2#1)
thoracic cage##6##2##(2005-11#1)(2006-11#2)(2008-6#1)(2012-2#1)(2013-1#1)
thoracic cavity##11##2##(2004-2#1)(2006-12#1)(2007-2#1)(2007-8#1)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
thoracic chaetigers##2##2##(2008-5#2)
thoracic computed tomography (CT)##2##4##(2008-7#1)(2012-2#1)
thoracic cord##2##2##(1995-12#1)(2008-7#1)
thoracic curve##2##2##(2007-7#1)(2008-8#1)
thoracic deflections##2##2##(2006-11#2)
thoracic deformity##2##2##(2009-3#1)(2012-12#1)
thoracic disc disease##10##3##(2006-7#10)
thoracic disc herniation##5##3##(2006-3#1)(2006-7#4)
thoracic disc herniations##5##3##(2006-7#5)
thoracic disc surgery##2##3##(2006-7#2)
thoracic disc##26##2##(2006-3#1)(2006-7#25)
thoracic discectomies##2##2##(2006-8#2)
thoracic discectomy may be##2##4##(2006-7#2)
thoracic discectomy##9##2##(2006-3#1)(2006-7#5)(2007-1#3)
thoracic discs##3##2##(2006-7#3)
thoracic diseases##4##2##(2004-2#1)(2010-8#3)
thoracic dissecting aneurysm##2##3##(2007-8#2)
thoracic drainage##6##2##(1992-2#1)(2007-8#1)(2010-8#4)
thoracic duct and##2##3##(2011-2#1)(2012-3#1)
thoracic duct##10##2##(1992-11#2)(1992-9#1)(2006-8#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#2)
thoracic emergencies##3##2##(2012-2#3)
thoracic endovascular##2##2##(2013-1#1)(2013-7#1)
thoracic epidural anaesthesia##3##3##(2006-10#2)(2007-8#1)
thoracic epidural analgesia##2##3##(2007-8#1)(2007-9#1)
thoracic epidural anesthesia##4##3##(2006-10#1)(2007-12#1)(2008-10#1)(2010-2#1)
thoracic epidural neurolysis after##2##4##(2012-2#2)
thoracic epidural##11##2##(2006-10#3)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#1)(2010-2#1)(2012-2#2)
thoracic esophagus##2##2##(2008-5#2)
thoracic ganglia of##2##3##(1991-3#1)(2008-10#1)
thoracic ganglion runs##2##3##(1991-3#2)
thoracic ganglion##6##2##(1991-3#3)(1993-9#1)(2013-8#2)
thoracic impacts##2##2##(2007-4#2)
thoracic injuries in##3##3##(1991-4#1)(2006-11#1)(2007-1#1)
thoracic injuries##12##2##(1991-4#2)(1992-2#2)(2006-11#1)(2007-1#1)(2007-4#1)(2007-8#2)(2008-1#1)(2010-9#1)(2012-12#1)
thoracic injuries]##2##2##(1991-4#1)(1992-2#1)
thoracic injury criteria##4##3##(2006-11#2)(2007-4#1)(2012-12#1)
thoracic injury is##2##3##(2007-8#2)
thoracic injury potential##2##3##(2007-1#2)
thoracic injury risk for##3##4##(2006-11#1)(2007-4#2)
thoracic injury risk##5##3##(2006-11#1)(2007-4#4)
thoracic injury##21##2##(2006-11#7)(2007-1#2)(2007-4#5)(2007-8#2)(2012-12#4)(2013-1#1)
thoracic irradiation##7##2##(1993-9#1)(1995-4#1)(2004-1#3)(2012-12#2)
thoracic kidney##4##2##(2011-2#2)(2012-2#2)
thoracic kyphoscoliosis##2##2##(1991-3#1)(2008-8#1)
thoracic kyphosis##11##2##(2006-10#1)(2007-11#4)(2007-7#6)
thoracic level##4##2##(1990-4#1)(1996-11#1)(2006-7#1)(2007-7#1)
thoracic lordoscoliosis##3##2##(2009-3#3)
thoracic lordosis##2##2##(2006-10#1)(2007-11#1)
thoracic lymphomas##2##2##(2006-6#2)
thoracic or abdominal##3##3##(1990-5#1)(2006-12#1)(2012-2#1)
thoracic outlet syndrome##2##3##(2008-9#1)(2011-3#1)
thoracic pain##10##2##(1996-12#1)(1997-5#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-8#4)(2007-8#1)
thoracic patients##2##2##(1991-7#1)(1994-6#1)
thoracic pedicle screw##2##3##(2006-6#1)(2009-3#1)
thoracic pedicle##4##2##(2006-6#1)(2008-12#1)(2009-3#1)(2012-12#1)
thoracic practice##2##2##(2007-8#1)(2011-2#1)
thoracic radiation therapy##2##3##(2008-10#1)(2008-6#1)
thoracic radiation##3##2##(2008-10#2)(2008-6#1)
thoracic radiographs##2##2##(2012-2#2)
thoracic region and##2##3##(2007-7#1)(2012-3#1)
thoracic region##6##2##(1996-3#1)(2007-7#2)(2008-11#1)(2010-10#1)(2012-3#1)
thoracic sclerites##4##2##(2007-12#1)(2013-1#3)
thoracic scoliosis##14##2##(1996-1#1)(2006-10#1)(2007-11#1)(2007-7#4)(2007-8#3)(2009-3#4)
thoracic segment##3##2##(1997-8#1)(2007-7#1)(2007-8#1)
thoracic segments##5##2##(1997-8#1)(2007-12#2)(2008-2#1)(2012-1#1)
thoracic spinal canal##2##3##(2006-7#2)
thoracic spinal cord##7##3##(1990-7#1)(1991-6#1)(1993-12#2)(1996-1#1)(2008-12#1)(2008-7#1)
thoracic spinal##17##2##(1990-7#1)(1991-6#1)(1993-12#2)(1993-9#1)(1996-1#1)(2006-7#2)(2006-8#1)(2008-12#3)(2008-7#1)(2011-12#2)(2012-12#1)(2013-1#1)
thoracic spine and the##2##4##(2007-8#1)(2008-8#1)
thoracic spine and##3##3##(2006-10#1)(2007-8#1)(2008-8#1)
thoracic spine fractures##2##3##(2007-11#1)(2009-8#1)
thoracic spine is##2##3##(2006-3#1)(2006-7#1)
thoracic spine thrust manipulation and##2##5##(2008-12#2)
thoracic spine with##2##3##(2009-3#1)(2012-12#1)
thoracic spine##42##2##(1997-4#1)(2006-10#2)(2006-11#2)(2006-3#1)(2006-7#3)(2006-8#1)(2007-1#2)(2007-11#10)(2007-4#2)(2007-7#3)(2007-8#1)(2008-12#6)(2008-3#1)(2008-8#2)(2009-3#1)(2009-8#2)(2012-12#2)
thoracic stiffness##3##2##(2008-9#3)
thoracic surgeon##2##2##(2007-8#1)(2009-3#1)
thoracic surgeons##8##2##(2005-8#1)(2007-8#5)(2012-1#1)(2013-7#1)
thoracic surgery for##4##3##(1990-10#1)(2007-12#1)(2012-12#1)(2013-7#1)
thoracic surgery in the##2##4##(2007-8#1)(2012-12#1)
thoracic surgery in##7##3##(1990-10#1)(1990-12#1)(1991-2#1)(2006-10#1)(2007-8#1)(2010-2#1)(2012-12#1)
thoracic surgery was written according to a structured protocol##4##9##(2007-8#4)
thoracic surgery##64##2##(1990-10#2)(1990-12#1)(1991-2#2)(2004-1#2)(2004-2#1)(2006-10#6)(2007-1#1)(2007-12#1)(2007-8#17)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-2#3)(2010-8#6)(2011-2#1)(2012-1#1)(2012-12#8)(2012-2#2)(2012-3#1)(2013-7#4)
thoracic surgical procedures##6##3##(2006-10#1)(2007-8#3)(2010-8#2)
thoracic surgical##10##2##(1993-12#2)(2006-10#1)(2007-8#3)(2008-5#1)(2010-8#2)(2013-1#1)
thoracic sympathectomy in the treatment of##2##6##(2011-2#1)(2012-12#1)
thoracic sympathectomy##14##2##(1993-7#1)(2007-8#4)(2011-2#8)(2012-12#1)
thoracic sympathetic##2##2##(1991-5#1)(2006-12#1)
thoracic to##2##2##(2007-12#1)(2011-2#1)
thoracic tolerance##2##2##(2006-11#2)
thoracic trauma##7##2##(1992-2#1)(2006-4#1)(2007-11#1)(2007-3#1)(2012-2#2)(2013-1#1)
thoracic venous##2##2##(2009-9#1)(2011-2#1)
thoracic vertebra##4##2##(2007-12#1)(2007-4#2)(2008-6#1)
thoracic vertebrae##6##2##(1993-3#1)(2006-11#1)(2007-11#1)(2007-4#1)(2010-12#1)(2011-2#1)
thoracic vertebral##2##2##(2007-4#1)(2011-2#1)
thoracic wall##9##2##(1991-5#1)(1992-6#1)(1997-4#1)(2007-8#2)(2008-6#1)(2011-2#1)(2012-2#2)
thoracic wounds##2##2##(1990-2#1)(2012-2#1)
thoracic##737##1##(1990-10#3)(1990-11#3)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#9)(1991-4#3)(1991-5#4)(1991-6#2)(1991-7#1)(1992-10#1)(1992-11#2)(1992-2#6)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#2)(1993-12#4)(1993-3#1)(1993-5#1)(1993-7#1)(1993-9#4)(1994-3#2)(1994-6#1)(1995-11#1)(1995-12#4)(1995-3#1)(1995-4#1)(1995-6#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-3#1)(1997-4#2)(1997-5#2)(1997-6#2)(1997-8#13)(2004-1#5)(2004-2#3)(2005-11#1)(2005-12#1)(2005-2#1)(2005-8#1)(2005-9#1)(2006-10#28)(2006-11#22)(2006-12#5)(2006-2#1)(2006-3#3)(2006-4#2)(2006-6#5)(2006-7#43)(2006-8#14)(2007-1#13)(2007-10#4)(2007-11#21)(2007-12#8)(2007-2#4)(2007-3#1)(2007-4#18)(2007-6#4)(2007-7#22)(2007-8#111)(2007-9#5)(2008-1#2)(2008-10#10)(2008-11#2)(2008-12#14)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#10)(2008-6#6)(2008-7#11)(2008-8#5)(2008-9#5)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#13)(2009-4#1)(2009-7#1)(2009-8#5)(2009-9#2)(2010-10#2)(2010-12#5)(2010-2#8)(2010-4#2)(2010-5#1)(2010-8#28)(2010-9#2)(2011-1#1)(2011-12#2)(2011-2#30)(2011-3#1)(2012-1#7)(2012-12#27)(2012-2#30)(2012-3#7)(2013-1#18)(2013-3#4)(2013-7#11)(2013-8#5)
thoracic)##3##1##(2007-4#1)(2007-6#1)(2013-1#1)
thoracic/thoracolumbar level##4##2##(2012-3#4)
thoracic/thoracolumbar##6##1##(2012-3#6)
thoracis et lumborum##3##3##(2010-4#3)
thoracis##10##1##(2007-2#1)(2007-8#3)(2010-4#6)
thoraco-abdominal##9##1##(2006-10#2)(2007-8#1)(2012-12#6)
thoraco-lumbar region##2##2##(2007-7#2)
thoraco-lumbar scoliosis by##2##3##(2007-7#2)
thoraco-lumbar scoliosis##5##2##(2007-7#5)
thoraco-lumbar##14##1##(2007-11#3)(2007-7#11)
thoracoabdominal aneurysm##2##2##(2005-10#1)(2007-8#1)
thoracoabdominal aorta##2##2##(2007-8#1)(2010-8#1)
thoracoabdominal aortic##4##2##(2005-10#1)(2007-8#1)(2008-12#1)(2012-12#1)
thoracoabdominal trauma##2##2##(2008-3#1)(2009-4#1)
thoracoabdominal type##2##2##(2007-8#2)
thoracoabdominal##17##1##(1991-8#1)(2005-10#2)(2007-8#6)(2008-12#1)(2008-3#1)(2008-9#1)(2009-4#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)
thoracocentesis##2##1##(2007-8#1)(2008-1#1)
thoracolumbar and lumbar scoliosis##2##4##(2008-8#2)
thoracolumbar and lumbar##4##3##(2008-8#4)
thoracolumbar burst fractures##5##3##(2006-8#4)(2011-2#1)
thoracolumbar burst##7##2##(2006-8#5)(2010-1#1)(2011-2#1)
thoracolumbar junction##3##2##(2006-10#1)(2010-8#1)(2012-2#1)
thoracolumbar or lumbar##2##3##(2007-7#2)
thoracolumbar spine##11##2##(2006-8#7)(2008-7#1)(2008-8#1)(2012-12#1)(2012-3#1)
thoracolumbar tumors##2##2##(2006-2#1)(2013-7#1)
thoracolumbar##45##1##(1995-11#1)(1997-6#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#19)(2007-5#1)(2007-7#2)(2008-7#1)(2008-8#5)(2009-3#2)(2010-1#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
thoracolumbosacral##2##1##(2012-3#2)
thoracoports##2##1##(2006-6#2)
thoracoscope and##4##2##(2007-8#2)(2012-12#2)
thoracoscope has been##2##3##(2008-5#1)(2012-12#1)
thoracoscope##10##1##(1990-12#1)(2007-8#3)(2008-5#1)(2010-8#1)(2012-12#4)
thoracoscopic and abdominal open surgery##2##5##(2011-2#2)
thoracoscopic and##3##2##(2008-7#1)(2011-2#2)
thoracoscopic approach##2##2##(2006-8#2)
thoracoscopic decortication##2##2##(2012-2#2)
thoracoscopic drainage##2##2##(2007-8#1)(2012-2#1)
thoracoscopic esophagectomy for esophageal##2##4##(2010-8#1)(2013-7#1)
thoracoscopic esophagectomy##3##2##(2010-8#2)(2013-7#1)
thoracoscopic internal mammary artery##2##4##(2007-8#2)
thoracoscopic lung biopsy##2##3##(2006-10#1)(2010-11#1)
thoracoscopic lung##3##2##(2006-10#1)(2010-11#1)(2010-8#1)
thoracoscopic procedures##3##2##(2006-10#1)(2006-7#1)(2007-1#1)
thoracoscopic resection##5##2##(2007-8#5)
thoracoscopic surgery is##2##3##(2006-10#1)(2010-8#1)
thoracoscopic surgery##21##2##(2006-10#4)(2006-7#1)(2007-5#2)(2007-8#6)(2008-1#1)(2008-4#1)(2010-8#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
thoracoscopic surgical##2##2##(2007-8#2)
thoracoscopic sympathectomy##4##2##(2007-1#1)(2007-8#3)
thoracoscopic technique##2##2##(2006-7#1)(2006-8#1)
thoracoscopic techniques##4##2##(2006-7#1)(2006-8#3)
thoracoscopic thymectomy##5##2##(2007-8#2)(2010-8#1)(2012-12#2)
thoracoscopic##92##1##(1997-4#1)(2006-10#7)(2006-7#5)(2006-8#8)(2007-1#3)(2007-5#2)(2007-8#35)(2008-1#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-11#1)(2010-8#8)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#3)(2013-7#2)
thoracoscopically##2##1##(2006-6#1)(2007-8#1)
thoracoscopy as a##2##3##(1990-12#1)(2007-8#1)
thoracoscopy procedures##2##2##(2006-10#1)(2012-12#1)
thoracoscopy was performed##2##3##(2007-8#1)(2008-6#1)
thoracoscopy was##4##2##(2007-8#1)(2008-5#1)(2008-6#1)(2010-8#1)
thoracoscopy##29##1##(1990-12#2)(1991-3#1)(2004-2#1)(2006-10#3)(2006-7#3)(2007-8#5)(2008-5#3)(2008-6#1)(2010-2#1)(2010-8#2)(2012-12#4)(2013-1#2)(2013-8#1)
thoracostomy was##2##2##(2007-7#1)(2007-8#1)
thoracostomy##15##1##(2006-10#1)(2007-3#1)(2007-7#5)(2007-8#5)(2008-1#1)(2008-10#1)(2012-2#1)
thoracotomic##2##1##(2007-8#1)(2008-5#1)
thoracotomies##3##1##(2004-1#1)(2007-2#1)(2011-3#1)
thoracotomy and laminectomy##2##3##(2007-8#2)
thoracotomy and##21##2##(1990-8#1)(1993-3#1)(2005-2#1)(2007-5#1)(2007-6#1)(2007-8#9)(2008-1#1)(2008-6#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#1)
thoracotomy for##2##2##(2007-8#2)
thoracotomy has##2##2##(2007-8#2)
thoracotomy in##6##2##(1990-10#1)(1990-12#1)(2006-7#1)(2007-8#2)(2013-1#1)
thoracotomy is##2##2##(2007-8#2)
thoracotomy to##2##2##(2007-8#2)
thoracotomy was performed##2##3##(1995-6#1)(2013-7#1)
thoracotomy was##4##2##(1995-6#1)(2007-8#1)(2013-1#1)(2013-7#1)
thoracotomy with##4##2##(1993-10#1)(2007-8#2)(2012-11#1)
thoracotomy without##2##2##(2007-8#2)
thoracotomy##107##1##(1990-10#2)(1990-12#2)(1990-8#1)(1991-6#1)(1992-8#1)(1993-10#1)(1993-3#1)(1995-6#1)(1997-4#1)(1997-6#1)(2004-1#1)(2005-2#1)(2006-10#3)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#49)(2007-9#1)(2008-1#4)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#4)
thoracotomy)##2##1##(1990-12#1)(2007-8#1)
thorax and pelvis##2##3##(2006-11#1)(2007-4#1)
thorax and##8##2##(2006-11#3)(2006-2#1)(2007-12#1)(2007-4#1)(2010-4#1)(2012-2#1)
thorax have##2##2##(1997-8#1)(2012-2#1)
thorax of the trace##2##4##(2013-1#2)
thorax of the##4##3##(1992-6#1)(2008-6#1)(2013-1#2)
thorax or##2##2##(1993-10#1)(2006-11#1)
thorax showed##2##2##(2007-8#1)(2012-2#1)
thorax##83##1##(1990-5#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-6#1)(1992-6#1)(1993-10#1)(1993-3#2)(1996-1#1)(1996-12#1)(1996-3#2)(1997-4#1)(1997-8#2)(2006-11#15)(2006-2#1)(2007-1#2)(2007-12#3)(2007-2#1)(2007-4#8)(2007-8#5)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#4)(2012-1#2)(2012-12#2)(2012-2#5)(2013-1#3)
thoraxes##2##1##(2005-8#1)(2007-4#1)
thorium and uranium##2##3##(2008-10#2)
thorium and##6##2##(2008-10#6)
thorium content##2##2##(2008-10#2)
thorium##28##1##(2008-10#25)(2010-5#1)(2013-1#2)
thorium(IV) and uranium(VI)##3##3##(2008-10#3)
thorium(IV) in##2##2##(2008-10#2)
thorium(IV)##10##1##(2008-10#10)
thorn##2##1##(2008-9#1)(2012-12#1)
thorn-like##2##1##(1994-3#2)
thornei and##2##2##(2008-10#2)
thornei##5##1##(2008-10#5)
thorny##6##1##(1990-12#1)(1994-10#1)(2007-10#1)(2009-4#1)(2010-12#1)(2010-8#1)
thoron and their progeny in some dwellings of northern##2##9##(2008-1#2)
thoron and##3##2##(2008-1#3)
thoron concentration##3##2##(2008-1#3)
thoron##7##1##(2008-1#7)
thorough analysis of##4##3##(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)
thorough analysis##5##2##(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
thorough and detailed##2##3##(1993-12#1)(2007-2#1)
thorough and##7##2##(1993-12#1)(1993-3#1)(2007-12#1)(2007-2#1)(2008-8#1)(2011-1#1)(2012-12#1)
thorough assessment##2##2##(1994-2#1)(2008-3#1)
thorough characterization of the##2##4##(2008-4#2)
thorough characterization of##4##3##(2005-11#1)(2008-2#1)(2008-4#2)
thorough clinical examination##2##3##(2009-6#1)(2012-2#1)
thorough clinical##5##2##(1996-2#1)(2007-2#1)(2007-7#1)(2009-6#1)(2012-2#1)
thorough debridement##3##2##(2005-12#1)(2012-2#1)(2013-8#1)
thorough discussion##4##2##(2008-4#1)(2010-11#1)(2010-5#1)(2010-8#1)
thorough documentation of##2##3##(1991-12#1)(2008-5#1)
thorough evaluation of patients##2##4##(1991-2#1)(2008-7#1)
thorough evaluation of##3##3##(1991-2#1)(2006-3#1)(2008-7#1)
thorough evaluation##5##2##(1991-2#1)(1992-5#1)(2006-3#1)(2008-7#1)(2011-2#1)
thorough examination and provides##3##4##(1990-4#1)(2006-11#1)(2006-12#1)
thorough examination of the##3##4##(2006-10#1)(2006-5#1)(2008-4#1)
thorough examination of##6##3##(1997-8#1)(2006-10#1)(2006-5#1)(2007-7#2)(2008-4#1)
thorough examination##10##2##(1990-4#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2007-7#2)(2008-4#1)(2013-8#1)
thorough investigation of the##3##4##(2010-2#1)(2013-1#2)
thorough investigation of##6##3##(2006-10#1)(2008-10#1)(2010-2#1)(2012-2#1)(2013-1#2)
thorough investigation##13##2##(1990-3#1)(1996-3#1)(2006-1#1)(2006-10#1)(2006-11#1)(2008-10#1)(2008-7#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#3)
thorough investigations##3##2##(2007-10#1)(2008-2#1)(2013-1#1)
thorough knowledge of##3##3##(2006-10#1)(2006-8#1)(2009-3#1)
thorough knowledge##4##2##(2006-10#1)(2006-2#1)(2006-8#1)(2009-3#1)
thorough overview of##2##3##(2006-11#1)(2008-10#1)
thorough physical examination##6##3##(1991-12#1)(2006-10#1)(2007-8#1)(2010-2#1)(2010-4#1)(2010-5#1)
thorough planning##2##2##(2007-4#1)(2007-8#1)
thorough preoperative evaluation##2##3##(1996-2#1)(2010-12#1)
thorough preoperative##4##2##(1990-9#1)(1996-2#1)(2010-12#1)(2012-12#1)
thorough review of the literature##2##5##(1993-1#1)(2008-6#1)
thorough review of the##6##4##(1993-1#1)(2005-5#1)(2006-5#1)(2008-1#1)(2008-4#1)(2008-6#1)
thorough review##7##2##(1993-1#1)(1993-12#1)(2005-5#1)(2006-5#1)(2008-1#1)(2008-4#1)(2008-6#1)
thorough search for##2##3##(1994-5#1)(2008-7#1)
thorough surgical##2##2##(2007-7#1)(2011-2#1)
thorough understanding of the##11##4##(1995-12#1)(2005-7#1)(2006-12#1)(2007-12#2)(2007-9#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-4#1)(2011-2#1)
thorough understanding of##28##3##(1993-1#1)(1995-12#1)(1995-3#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-3#1)(2009-5#1)(2010-4#2)(2010-8#1)(2011-2#1)(2012-12#1)
thorough use##2##2##(1993-8#1)(2006-9#1)
thorough##197##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-1#2)(1993-12#2)(1993-3#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#2)(1996-2#2)(1996-3#3)(1997-3#2)(1997-8#1)(2005-11#2)(2005-12#1)(2005-5#2)(2005-7#1)(2006-1#1)(2006-10#6)(2006-11#3)(2006-12#5)(2006-2#2)(2006-3#1)(2006-5#3)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#5)(2007-4#2)(2007-7#8)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#9)(2008-5#5)(2008-6#1)(2008-7#9)(2008-8#7)(2008-9#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#3)(2011-1#2)(2011-2#4)(2012-12#4)(2012-2#4)(2012-3#5)(2013-1#5)(2013-8#2)
thoroughbred##6##1##(1993-1#2)(1993-10#1)(1994-7#2)(1996-9#1)
thoroughly characterized##7##2##(1991-12#1)(1996-7#1)(2006-12#1)(2007-8#1)(2013-1#3)
thoroughly compared##3##2##(2008-2#1)(2011-2#1)(2012-2#1)
thoroughly discussed##3##2##(2008-10#1)(2008-2#1)(2013-1#1)
thoroughly investigated##10##2##(2005-7#1)(2006-10#1)(2007-11#1)(2008-10#4)(2010-4#1)(2011-1#1)(2013-1#1)
thoroughly removed##2##2##(1993-2#1)(2008-6#1)
thoroughly reviewed##3##2##(1997-4#1)(2005-8#1)(2006-11#1)
thoroughly studied##9##2##(1990-5#1)(2006-8#1)(2007-11#1)(2008-2#1)(2008-3#1)(2012-12#1)(2012-2#1)(2013-8#2)
thoroughly tested##2##2##(2008-10#1)(2011-1#1)
thoroughly validated##2##2##(1996-1#1)(2011-1#1)
thoroughly##94##1##(1990-4#1)(1990-5#1)(1991-1#1)(1991-12#1)(1993-11#1)(1993-2#1)(1994-12#1)(1995-1#1)(1996-1#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-4#1)(2004-9#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-8#4)(2007-11#2)(2007-12#2)(2007-8#3)(2007-9#1)(2008-10#11)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-7#2)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#5)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#8)(2013-8#3)
thoroughness of##2##2##(1990-6#1)(2008-8#1)
thoroughness##7##1##(1990-4#1)(1990-6#1)(1995-12#1)(1996-1#1)(1996-9#1)(1997-3#1)(2008-8#1)
those &lt##3##2##(1994-9#1)(2006-5#1)(2007-7#1)
those 20##2##2##(2006-10#1)(2008-7#1)
those 60##2##2##(2005-10#1)(2007-12#1)
those 8 patients##2##3##(2007-3#1)(2007-9#1)
those aa##2##2##(1990-10#1)(1990-9#1)
those above##2##2##(2006-10#1)(2008-10#1)
those achieved by the##3##4##(1993-6#1)(2008-10#1)(2008-12#1)
those achieved by##9##3##(1993-6#1)(1997-8#1)(2007-6#1)(2008-10#5)(2008-12#1)
those achieved for##2##3##(1993-3#1)(2008-8#1)
those achieved in##4##3##(1991-2#1)(2007-12#1)(2007-7#2)
those achieved using##4##3##(1991-3#1)(2007-8#1)(2008-10#2)
those achieved with##7##3##(1991-3#1)(2007-12#1)(2007-7#2)(2008-10#3)
those achieved##26##2##(1991-2#1)(1991-3#2)(1993-3#1)(1993-6#1)(1997-8#1)(2007-12#2)(2007-6#1)(2007-7#4)(2007-8#1)(2008-10#10)(2008-12#1)(2008-8#1)
those activated##3##2##(1990-2#1)(1996-1#1)(1997-5#1)
those activities##3##2##(1994-2#1)(2009-8#1)(2011-2#1)
those administered##2##2##(1990-3#1)(2008-9#1)
those admitted##3##2##(2006-7#1)(2012-2#2)
those adolescents with##2##3##(2011-1#1)(2012-12#1)
those affected by the##3##4##(2010-5#1)(2011-1#1)(2012-2#1)
those affected by##4##3##(2010-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
those affected##11##2##(1993-2#1)(1995-1#1)(1997-1#1)(2008-1#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
those affecting##3##2##(1994-12#1)(2006-2#1)(2008-10#1)
those afflicted##2##2##(1991-5#1)(2006-6#1)
those afforded by the##2##4##(2007-11#1)(2008-10#1)
those afforded by##3##3##(2007-11#1)(2008-10#1)(2013-8#1)
those after##4##2##(2007-11#1)(2007-8#1)(2008-5#1)(2008-8#1)
those against##2##2##(1993-8#1)(1993-9#1)
those aged 65##2##3##(1990-12#2)
those aged between##2##3##(1992-10#1)(2010-3#1)
those aged less than##2##4##(1990-5#1)(1993-2#1)
those aged##20##2##(1990-12#2)(1990-3#1)(1990-5#1)(1990-9#1)(1991-12#1)(1992-10#1)(1992-5#1)(1993-10#1)(1993-11#1)(1993-2#1)(1994-5#1)(1995-4#1)(2006-2#1)(2006-8#1)(2008-4#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
those agents that##2##3##(1990-2#1)(2008-5#1)
those agents##4##2##(1990-2#1)(2006-5#1)(2007-11#1)(2008-5#1)
those aimed at##2##3##(2009-12#1)(2010-11#1)
those allocated##2##2##(2007-10#1)(2013-8#1)
those already described##2##3##(1994-10#1)(1997-6#1)
those already##9##2##(1990-11#1)(1992-2#1)(1994-10#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-2#1)(2008-4#1)(2009-8#1)
those animals that##2##3##(2008-5#2)
those animals##4##2##(1992-9#1)(2008-3#1)(2008-5#2)
those antibodies##2##2##(1991-7#1)(2008-4#1)
those applications##2##2##(2006-6#1)(2008-3#1)
those approaches##2##2##(2008-10#1)(2009-5#1)
those appropriate to##2##3##(2008-2#2)
those are##10##2##(1992-7#1)(2006-10#2)(2007-7#1)(2008-1#1)(2008-10#1)(2011-2#3)(2012-3#1)
those areas of##2##3##(1997-3#1)(2005-9#1)
those areas##8##2##(1994-6#1)(1997-3#1)(2005-7#1)(2005-9#1)(2010-2#1)(2012-11#2)(2013-1#1)
those arising from##4##3##(1990-4#1)(1995-11#1)(2007-8#1)(2010-5#1)
those arising##5##2##(1990-4#1)(1994-3#1)(1995-11#1)(2007-8#1)(2010-5#1)
those aspects of the##2##4##(2008-11#1)(2008-9#1)
those aspects##4##2##(1991-12#1)(2008-11#1)(2008-9#1)(2011-1#1)
those assigned to##3##3##(2008-6#1)(2008-7#1)(2009-2#1)
those associated with the##6##4##(1992-12#1)(2005-12#1)(2006-11#1)(2007-9#1)(2008-10#1)(2008-2#1)
those associated with##24##3##(1992-12#1)(1992-7#1)(1993-7#1)(1994-10#1)(1994-8#1)(1996-3#1)(2005-11#1)(2005-12#2)(2006-10#1)(2006-11#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-7#2)(2009-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)
those associated##25##2##(1992-12#1)(1992-7#1)(1992-9#1)(1993-7#1)(1994-10#1)(1994-8#1)(1996-3#1)(2005-11#1)(2005-12#2)(2006-10#1)(2006-11#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-7#2)(2009-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)
those at a##2##3##(1994-3#1)(2008-11#1)
those at high risk##2##4##(2006-10#1)(2008-7#1)
those at high##4##3##(2006-10#1)(2008-7#1)(2009-3#1)(2012-12#1)
those at highest risk##2##4##(2007-2#1)(2009-11#1)
those at pH##2##3##(2006-8#1)(2009-3#1)
those at risk for##4##4##(2008-1#2)(2008-3#1)(2010-12#1)
those at risk##8##3##(1994-12#1)(2008-1#2)(2008-3#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-3#1)
those at the highest risk##2##5##(1996-6#1)(2006-10#1)
those at the##14##3##(1993-2#1)(1993-7#1)(1994-12#1)(1996-6#1)(2004-3#1)(2006-10#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#1)(2012-2#1)(2013-8#1)
those at##56##2##(1991-10#1)(1992-11#1)(1992-12#1)(1993-2#1)(1993-7#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-9#1)(1996-6#1)(1997-7#1)(2004-3#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-1#4)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#2)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#3)
those attending##4##2##(1993-2#1)(1995-12#1)(2008-10#1)(2008-9#1)
those attitudes##2##2##(2007-7#1)(2008-12#1)
those attributable to##2##3##(1994-12#1)(1997-5#1)
those available##3##2##(2007-5#1)(2008-10#1)(2008-11#1)
those based on the##4##4##(1997-4#1)(2007-11#1)(2008-5#1)(2013-8#1)
those based on##21##3##(1992-1#1)(1995-6#1)(1997-3#1)(1997-4#1)(2007-11#2)(2008-10#6)(2008-2#1)(2008-5#4)(2008-7#1)(2009-10#1)(2013-1#1)(2013-8#1)
those before the##2##3##(2007-5#1)(2008-10#1)
those before##6##2##(2007-5#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-10#1)(2012-2#1)
those behaviors##2##2##(2009-7#1)(2011-1#1)
those being##3##2##(2008-3#1)(2010-12#1)(2010-5#1)
those belonging to the##3##4##(1993-3#1)(2010-12#1)(2010-2#1)
those belonging to##4##3##(1993-3#1)(1996-12#1)(2010-12#1)(2010-2#1)
those between##9##2##(1994-3#1)(1995-6#1)(2006-10#1)(2007-5#1)(2008-9#1)(2009-10#3)(2012-12#1)
those born at##2##3##(2006-6#1)(2008-11#1)
those born in the##4##4##(1992-2#1)(1994-5#1)(2005-10#1)(2007-2#1)
those born##11##2##(1992-2#1)(1994-4#1)(1994-5#1)(1995-5#1)(2005-10#2)(2006-6#1)(2007-2#1)(2008-11#1)(2008-4#1)(2011-1#1)
those bound##2##2##(1992-11#1)(1994-12#1)
those broadly##2##2##(1990-9#1)(2008-10#1)
those by the##5##3##(2005-4#1)(2008-10#4)
those by##15##2##(1990-8#1)(1992-4#1)(1997-2#1)(2005-3#1)(2005-4#1)(2008-10#8)(2010-5#1)(2012-1#1)
those calculated from the##3##4##(1990-8#1)(1995-6#1)(2008-2#1)
those calculated from##5##3##(1990-8#1)(1995-6#1)(2005-11#1)(2008-2#1)(2008-5#1)
those calculated using##2##3##(1992-12#1)(2008-8#1)
those calculated with##3##3##(1990-12#1)(2008-2#2)
those calculated##16##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-9#1)(1992-12#1)(1995-6#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-2#3)(2008-5#1)(2008-8#1)(2012-12#2)
those cases in which##6##4##(1991-11#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-8#1)
those cases of##2##3##(2006-10#1)(2006-11#1)
those cases that##2##3##(2007-6#1)(2009-4#1)
those cases with##4##3##(1990-3#1)(1992-10#1)(1995-11#1)(2006-12#1)
those cases##28##2##(1990-3#1)(1991-11#1)(1992-10#2)(1992-12#2)(1993-10#1)(1994-9#1)(1995-11#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-4#1)(2010-12#1)
those caused by the##2##4##(2008-7#1)(2012-2#1)
those caused by##21##3##(1990-11#1)(1991-9#1)(1995-5#1)(1996-12#1)(2005-7#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-3#1)(2008-5#2)(2008-7#1)(2009-9#1)(2012-2#1)
those causing##2##2##(1992-1#1)(2006-10#1)
those cells treated with##2##4##(1990-4#1)(2008-9#1)
those cells##16##2##(1990-4#1)(1991-12#1)(1991-3#1)(1992-7#1)(1994-3#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-9#2)(2010-12#1)(2012-2#1)
those cellular##2##2##(2005-11#1)(2012-12#1)
those challenges##4##2##(1990-12#1)(2008-4#1)(2010-6#1)(2012-1#1)
those changes##9##2##(1993-1#1)(1993-12#1)(2007-11#1)(2007-9#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-1#1)
those characteristics##6##2##(1991-3#1)(2006-12#1)(2008-4#1)(2008-7#1)(2010-4#1)(2013-7#1)
those characterized by##2##3##(1990-2#1)(2013-1#1)
those characters that##2##3##(2007-12#1)(2007-3#1)
those charged with##2##3##(1993-5#1)(2008-12#1)
those chemicals are##2##3##(2010-5#2)
those chemicals##3##2##(2008-11#1)(2010-5#2)
those children##6##2##(1993-3#1)(2005-11#1)(2007-7#1)(2008-8#1)(2010-11#1)(2010-4#1)
those circumstances##2##2##(2008-10#1)(2012-2#1)
those clinical##3##2##(2006-10#1)(2007-11#1)(2011-2#1)
those clones##3##2##(1992-8#1)(2008-11#1)(2010-1#1)
those closer to the##2##4##(1992-1#1)(2013-7#1)
those collected in##4##3##(2006-4#1)(2008-2#1)(2008-3#1)(2008-5#1)
those collected##11##2##(1992-8#1)(2006-4#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2009-4#1)(2012-3#1)
those coming from##2##3##(1992-3#1)(2008-10#1)
those common##2##2##(2008-10#1)(2008-7#1)
those commonly used##2##3##(1995-12#1)(2006-7#1)
those commonly##5##2##(1990-9#1)(1995-12#1)(2006-10#1)(2006-7#1)(2007-7#1)
those communities##4##2##(1996-2#1)(2008-10#1)(2013-1#2)
those complexes that##2##3##(1990-2#2)
those composed of##3##3##(2007-4#1)(2008-1#1)(2009-3#1)
those compounds##6##2##(1995-12#1)(1996-3#1)(1997-4#1)(2004-9#1)(2005-7#1)(2008-10#1)
those computed by##4##3##(1993-6#1)(2008-3#3)
those concerning##5##2##(1992-12#1)(2004-11#1)(2008-5#1)(2008-7#2)
those conditions where##2##3##(1993-8#1)(2005-10#1)
those conditions##7##2##(1993-8#1)(2005-10#1)(2007-11#1)(2008-10#2)(2008-5#1)(2011-2#1)
those conidia##2##2##(2008-10#1)(2008-5#1)
those considered##4##2##(1990-5#1)(2005-7#1)(2009-1#1)(2009-2#1)
those consisting##2##2##(2007-12#1)(2008-5#1)
those constructed##2##2##(2007-12#1)(2008-8#1)
those consuming##2##2##(1991-7#1)(2012-2#1)
those containing the##4##3##(1994-9#1)(1995-12#1)(1995-3#1)(2010-4#1)
those containing##23##2##(1990-12#1)(1990-2#1)(1992-2#1)(1994-9#2)(1995-12#1)(1995-3#1)(1996-3#1)(1996-5#2)(2006-10#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-5#1)(2008-9#1)(2010-4#2)(2012-1#1)
those corresponding to##3##3##(2005-11#1)(2008-10#1)(2008-3#1)
those costs##2##2##(1995-6#1)(2007-4#1)
those covered##2##2##(1996-2#1)(2008-5#1)
those cultured in##2##3##(2008-11#2)
those cultured##3##2##(2008-11#2)(2009-9#1)
those currently used##2##3##(1994-1#1)(2008-2#1)
those currently##7##2##(1994-1#1)(1994-3#1)(2006-4#1)(2008-10#2)(2008-11#1)(2008-2#1)
those data##7##2##(1992-5#1)(1997-6#1)(2007-11#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-12#1)
those deduced from##3##3##(1990-4#1)(1990-8#1)(1994-2#1)
those defined##3##2##(2008-2#1)(2008-3#2)
those delivered by##2##3##(2004-10#1)(2007-12#1)
those delivered##3##2##(2004-10#2)(2007-12#1)
those demonstrated##2##2##(1991-8#1)(2006-3#1)
those deposited in##2##3##(1996-8#1)(2011-1#1)
those derived from the##3##4##(2006-5#1)(2008-10#1)(2012-12#1)
those derived from##16##3##(1992-12#1)(1992-5#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-8#1)(2006-5#1)(2006-7#1)(2008-10#3)(2008-2#1)(2008-3#1)(2010-7#1)(2012-12#2)
those derived##17##2##(1992-12#1)(1992-5#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-8#1)(2006-5#1)(2006-7#1)(2007-10#1)(2008-10#3)(2008-2#1)(2008-3#1)(2010-7#1)(2012-12#2)
those described for the other##2##5##(2008-5#2)
those described for the##4##4##(1994-11#1)(2008-5#2)(2011-2#1)
those described for##7##3##(1993-6#1)(1994-11#1)(2008-4#2)(2008-5#2)(2011-2#1)
those described in the literature##3##5##(1995-11#1)(2008-6#1)(2013-7#1)
those described in the##5##4##(1995-11#1)(2008-10#1)(2008-6#1)(2012-3#1)(2013-7#1)
those described in##12##3##(1992-12#1)(1995-11#1)(1997-1#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-6#1)(2011-2#1)(2012-3#1)(2013-7#1)
those described previously##2##3##(1991-8#1)(1991-9#1)
those described##28##2##(1990-5#1)(1990-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-11#1)(1997-1#1)(2006-10#1)(2007-2#1)(2008-10#4)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2011-2#2)(2012-3#1)(2013-7#1)
those detected in##5##3##(1995-12#2)(1997-5#1)(2008-10#2)
those detected##6##2##(1995-12#2)(1997-5#1)(2008-10#2)(2008-7#1)
those determined by the##3##4##(2008-10#2)(2011-2#1)
those determined by##9##3##(1990-4#1)(2008-10#4)(2008-3#2)(2011-1#1)(2011-2#1)
those determined in the##2##4##(1992-6#1)(2008-10#1)
those determined using##3##3##(2008-10#3)
those determined##21##2##(1990-4#1)(1990-9#1)(1992-6#1)(1992-9#2)(1993-9#1)(1994-8#1)(1996-2#1)(2008-10#9)(2008-3#2)(2011-1#1)(2011-2#1)
those developed##2##2##(2006-6#1)(2008-10#1)
those developing##4##2##(1992-12#1)(2007-2#1)(2007-8#1)(2009-12#1)
those diagnosed with##6##3##(2007-8#1)(2008-7#1)(2011-2#4)
those diagnosed##10##2##(2004-2#1)(2006-12#1)(2007-8#1)(2008-7#1)(2011-2#6)
those differences##3##2##(1991-9#1)(1994-12#1)(2008-10#1)
those discharged##4##2##(1995-3#2)(2007-9#1)(2008-10#1)
those diseases##6##2##(1996-8#1)(1997-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-4#1)
those drugs##4##2##(1994-5#1)(2006-10#1)(2007-8#1)(2011-1#1)
those due to the##3##4##(1992-1#1)(2006-10#1)(2008-10#1)
those due to##10##3##(1990-10#1)(1992-1#1)(1996-5#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#1)
those during##3##2##(1994-11#1)(2008-10#1)(2010-12#1)
those effects##6##2##(1994-8#1)(2007-7#1)(2008-2#1)(2011-2#2)(2013-7#1)
those efforts##2##2##(2006-6#1)(2008-1#1)
those elements##3##2##(1993-11#1)(2008-10#2)
those elicited by infection with the##2##6##(2008-5#2)
those elicited by the##2##4##(1995-5#1)(2008-10#1)
those elicited by##8##3##(1995-5#1)(1997-3#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-12#2)
those elicited##9##2##(1990-9#1)(1995-5#1)(1997-3#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-12#2)
those employed in##2##3##(1991-8#1)(1993-6#1)
those employed##5##2##(1991-8#1)(1993-3#1)(1993-6#1)(2008-2#1)(2008-8#1)
those encoded by the##3##4##(1990-12#1)(1996-3#1)(2008-9#1)
those encoded by##4##3##(1990-12#1)(1996-3#1)(1997-2#1)(2008-9#1)
those encoding the##2##3##(2008-10#1)(2008-11#1)
those encoding##6##2##(1994-3#1)(1996-12#1)(1996-3#1)(2005-8#1)(2008-10#1)(2008-11#1)
those encountered in##4##3##(2006-6#1)(2010-10#1)(2012-2#2)
those engaged with##2##3##(2008-9#1)(2012-1#1)
those engaged##3##2##(2006-6#1)(2008-9#1)(2012-1#1)
those entities##2##2##(1991-3#1)(1991-8#1)
those enzymes##2##2##(1992-7#1)(2010-10#1)
those established##3##2##(1995-5#1)(1997-5#1)(2008-4#1)
those estimated by##2##3##(2008-10#1)(2008-2#1)
those estimated##6##2##(2005-11#1)(2008-10#3)(2008-2#1)(2011-1#1)
those evaluated##3##2##(1997-7#1)(2006-8#2)
those evoked by##3##3##(1990-9#1)(1992-11#1)(2012-12#1)
those evoked##4##2##(1990-9#1)(1992-11#1)(1996-5#1)(2012-12#1)
those examined##2##2##(2007-11#1)(2008-10#1)
those expected for##3##3##(2008-3#1)(2008-4#1)(2008-8#1)
those expected from##2##3##(1996-12#1)(2010-5#1)
those expected if##2##3##(1996-4#1)(2008-9#1)
those expected##11##2##(1991-8#1)(1996-10#1)(1996-12#1)(1996-4#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#2)(2010-5#1)
those expenses##2##2##(1991-9#1)(1992-12#1)
those experiencing##4##2##(2006-1#1)(2007-11#1)(2008-6#1)(2012-2#1)
those experiments##2##2##(1990-3#1)(1994-11#1)
those exposed to##13##3##(1992-7#1)(1995-12#1)(1995-3#1)(1996-10#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)(2009-6#1)(2011-2#3)
those exposed##19##2##(1992-7#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#2)(2009-12#1)(2009-6#1)(2011-2#5)
those expressed##2##2##(1992-10#1)(2008-9#1)
those expressing the##3##3##(2006-11#1)(2008-10#1)(2012-12#1)
those expressing##6##2##(2005-8#1)(2006-11#1)(2008-10#1)(2008-9#1)(2009-4#1)(2012-12#1)
those extracted from##2##3##(1995-10#1)(2012-8#1)
those extracted##3##2##(1995-10#1)(2008-10#1)(2012-8#1)
those factors that##3##3##(1996-8#1)(2008-11#1)(2011-1#1)
those factors##12##2##(1992-3#1)(1996-8#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-12#2)(2008-11#1)(2011-1#1)(2011-2#1)
those families##2##2##(2009-10#1)(2012-3#1)
those features##2##2##(2008-5#1)(2009-11#1)
those fed a##2##3##(2008-11#2)
those fed daily##2##3##(2005-7#1)(2012-12#1)
those fed on##4##3##(2004-11#2)(2007-5#2)
those fed the##4##3##(2007-8#1)(2010-2#2)(2012-2#1)
those fed with##4##3##(1990-5#1)(2006-12#1)(2008-6#1)(2009-9#1)
those fed##24##2##(1990-5#1)(1990-7#1)(2004-11#2)(2005-7#1)(2006-12#1)(2007-5#2)(2007-8#4)(2008-11#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-4#1)(2009-9#1)(2010-2#2)(2012-12#1)(2012-2#1)
those findings##4##2##(2007-12#1)(2008-6#1)(2009-4#1)(2009-5#1)
those flanking the##2##3##(1991-6#1)(1994-5#1)
those focused on##2##3##(2007-11#1)(2012-1#1)
those focusing on##2##3##(2008-1#1)(2012-12#1)
those following##4##2##(1993-7#1)(2008-10#1)(2008-12#1)(2008-7#1)
those for a##3##3##(1997-3#1)(2006-6#1)(2007-12#1)
those for adults##2##3##(2008-1#1)(2008-9#1)
those for patients##2##3##(1996-9#1)(2007-9#1)
those for the reference method##2##5##(2008-10#2)
those for the tetrabutylammonium salts##2##5##(1995-5#2)
those for the##29##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-8#1)(1993-8#1)(1995-10#1)(1995-5#2)(1995-6#1)(1996-11#1)(1996-2#2)(1997-6#1)(1997-8#1)(2005-11#1)(2006-3#1)(2007-3#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2010-4#1)(2010-8#1)(2012-3#1)(2013-1#1)
those for traditional##2##3##(2006-6#1)(2011-1#1)
those for which##2##3##(2008-3#1)(2008-4#1)
those for##130##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-5#2)(1995-6#4)(1995-7#1)(1996-11#1)(1996-2#2)(1996-5#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-3#2)(1997-6#3)(1997-7#2)(1997-8#1)(2004-2#1)(2004-4#1)(2005-10#1)(2005-11#4)(2005-7#2)(2005-9#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-6#2)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#4)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2010-3#2)(2010-4#3)(2010-6#1)(2010-8#2)(2011-1#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
those formed by##6##3##(1992-6#1)(1994-2#1)(1996-4#1)(2008-10#1)(2008-2#1)(2012-2#1)
those formed##11##2##(1992-6#1)(1994-12#1)(1994-2#1)(1996-4#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-11#1)(2012-2#2)
those forms##2##2##(1990-7#1)(1996-2#1)
those found by##7##3##(2008-10#7)
those found in other##6##4##(2004-4#1)(2006-8#1)(2007-12#1)(2008-11#1)(2010-12#1)(2012-1#1)
those found in the##10##4##(1991-9#1)(1993-12#1)(1994-9#1)(1996-10#1)(1996-11#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-7#2)
those found in their##2##4##(1995-3#1)(2006-12#1)
those found in##46##3##(1990-2#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-9#2)(1995-3#2)(1995-8#2)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#1)(1997-5#1)(2004-4#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-9#1)(2010-10#1)(2010-12#2)(2010-4#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
those found on crabgrass##2##4##(2008-10#2)
those found on##6##3##(2008-10#5)(2008-5#1)
those found to##2##3##(1994-2#1)(2007-2#1)
those found with##2##3##(2008-3#1)(2008-5#1)
those found##75##2##(1990-2#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-3#2)(1995-8#2)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-5#1)(1997-6#1)(2004-4#2)(2005-11#2)(2006-12#1)(2006-8#1)(2007-12#2)(2007-2#2)(2007-4#1)(2007-7#1)(2008-10#17)(2008-11#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#2)(2008-9#2)(2010-10#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
those from a##11##3##(1992-9#1)(2007-4#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-7#1)(2011-2#1)(2012-3#1)
those from control##3##3##(1990-4#2)(1991-12#1)
those from conventional##5##3##(2007-11#1)(2008-10#3)(2008-11#1)
those from healthy##2##3##(1990-12#1)(1996-1#1)
those from mice##2##3##(2008-11#2)
those from normal##2##3##(1992-11#1)(1993-8#1)
those from other Streptomyces species##2##5##(1993-9#2)
those from other regions##2##4##(2008-10#1)(2012-11#1)
those from other##11##3##(1993-9#2)(1994-8#1)(1995-4#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-6#1)(2012-11#1)
those from public##2##3##(2008-12#1)(2013-7#1)
those from the##39##3##(1990-7#2)(1992-6#1)(1993-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-3#1)(1996-4#1)(1997-8#1)(2004-11#1)(2006-12#1)(2006-8#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-3#1)(2010-11#1)(2010-5#2)(2011-1#1)(2011-12#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
those from##175##2##(1990-12#1)(1990-2#3)(1990-4#2)(1990-5#1)(1990-6#2)(1990-7#3)(1991-1#1)(1991-12#1)(1991-4#1)(1991-5#2)(1991-6#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-5#2)(1993-8#1)(1993-9#4)(1994-3#1)(1994-8#2)(1995-11#1)(1995-12#3)(1995-4#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-4#3)(1996-7#1)(1997-5#1)(1997-8#1)(2004-11#1)(2005-11#2)(2005-8#1)(2006-12#1)(2006-5#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#3)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-10#33)(2008-11#7)(2008-12#4)(2008-2#6)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#1)
those functional##2##2##(1994-6#1)(2009-5#1)
those functions##2##2##(1996-2#1)(2011-2#1)
those generally##4##2##(1991-3#1)(1993-12#1)(1994-7#1)(2008-5#1)
those generated by##3##3##(1995-8#1)(2008-10#1)(2013-1#1)
those generated in##2##3##(2008-2#1)(2010-2#1)
those generated##7##2##(1995-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-2#1)(2013-1#1)
those genes##10##2##(1994-5#1)(2007-11#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-7#1)(2012-3#1)
those given by the##4##4##(1994-9#1)(2008-10#2)(2008-3#1)
those given by##11##3##(1994-9#1)(2006-2#1)(2008-10#5)(2008-2#1)(2008-3#3)
those given##19##2##(1990-5#1)(1992-7#1)(1994-9#1)(1995-5#1)(1996-6#1)(2004-3#1)(2006-10#1)(2006-2#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-7#1)
those going to##2##3##(1995-3#1)(2006-12#1)
those groups that##3##3##(1993-12#1)(1994-1#2)
those groups##13##2##(1993-12#2)(1994-1#2)(1996-11#1)(1996-12#1)(1997-6#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-7#1)(2012-1#1)(2012-11#1)
those grown in the##2##4##(2008-10#2)
those grown in##6##3##(1991-3#1)(1996-12#1)(2008-10#3)(2009-12#1)
those grown on##2##3##(1991-3#1)(1993-6#1)
those grown under##2##3##(2007-12#1)(2008-11#1)
those grown##12##2##(1991-3#2)(1993-6#1)(1994-12#1)(1996-12#1)(2007-12#1)(2008-10#4)(2008-11#1)(2009-12#1)
those harboring##2##2##(1997-6#1)(2006-7#1)
those having a##5##3##(1992-1#1)(2007-8#1)(2008-7#1)(2010-4#1)(2013-1#1)
those having##33##2##(1990-5#1)(1992-1#2)(1993-9#1)(1995-3#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#2)(2009-2#1)(2009-5#1)(2009-6#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#2)
those heterozygous##2##2##(1995-9#1)(2008-12#1)
those holding##4##2##(1993-2#1)(2006-2#1)(2009-4#1)(2010-8#1)
those hospitalized##2##2##(1996-5#1)(2008-1#1)
those identified as##2##3##(2008-10#1)(2012-3#1)
those identified by the##2##4##(1994-2#1)(2012-12#1)
those identified in##2##3##(1991-12#1)(1991-2#1)
those identified##8##2##(1991-12#1)(1991-2#1)(1992-12#1)(1994-2#1)(2008-10#1)(2010-4#1)(2012-12#1)(2012-3#1)
those implanted##3##2##(2005-10#1)(2008-9#2)
those implemented##2##2##(2006-10#1)(2013-1#1)
those imposed by the##3##4##(2011-2#1)(2012-2#2)
those imposed by##4##3##(1994-3#1)(2011-2#1)(2012-2#2)
those in FFS##2##3##(2010-11#2)
those in Group 1##2##4##(2007-2#1)(2011-2#1)
those in Group 2##2##4##(2011-1#1)(2011-2#1)
those in Group I##2##4##(1992-11#1)(2013-1#1)
those in Group##6##3##(1992-11#1)(2007-2#1)(2011-1#1)(2011-2#2)(2013-1#1)
those in a##7##3##(1991-2#1)(1995-8#1)(1996-12#1)(2006-10#1)(2008-10#1)(2008-9#1)(2013-8#1)
those in brain##2##3##(1994-3#1)(2010-8#1)
those in control rats##3##4##(1995-11#1)(1995-3#1)(2007-10#1)
those in control##7##3##(1995-11#1)(1995-3#1)(2007-10#2)(2009-8#1)(2012-12#1)(2013-1#1)
those in controls##5##3##(1994-10#1)(1995-6#1)(1997-1#1)(2006-9#1)(2008-11#1)
those in developing countries##3##4##(2005-10#1)(2006-4#1)(2012-12#1)
those in group##3##3##(1996-3#1)(2007-9#1)(2010-7#1)
those in healthy##3##3##(1995-2#1)(2005-10#1)(2008-4#1)
those in human##3##3##(1992-6#1)(2008-1#1)(2012-12#1)
those in need##2##3##(2006-10#1)(2010-5#1)
those in normal tissues##2##4##(1997-7#1)(2008-4#1)
those in normal##4##3##(1997-7#1)(2005-4#1)(2008-4#1)(2013-8#1)
those in other##9##3##(1990-5#1)(1993-3#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2011-1#1)
those in our##2##3##(1994-11#1)(1997-3#1)
those in patients##2##3##(1991-7#1)(2007-3#1)
those in peripheral arterial blood##3##5##(1996-3#3)
those in plasma##6##3##(1992-7#1)(1994-11#2)(1995-7#2)(2010-8#1)
those in previous studies##2##4##(2005-11#1)(2010-5#1)
those in the Middle East##2##5##(2007-7#1)(2008-9#1)
those in the control group##10##5##(2007-11#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-8#3)
those in the control subjects##2##5##(2011-2#1)(2013-8#1)
those in the control##20##4##(1996-3#1)(1997-1#2)(1997-5#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-9#3)(2011-1#1)(2011-2#2)(2013-8#5)
those in the cortex##2##4##(1993-4#1)(1995-5#1)
those in the field##2##4##(2005-9#1)(2008-9#1)
those in the group of##2##5##(2008-7#1)(2013-1#1)
those in the group##3##4##(1994-12#1)(2008-7#1)(2013-1#1)
those in the literature##4##4##(1991-8#1)(1997-8#1)(2008-2#1)(2011-2#1)
those in the low##2##4##(1997-8#1)(2008-4#1)
those in the non-violent group##3##5##(1997-8#3)
those in the other##4##4##(1991-11#1)(2007-1#1)(2007-2#1)(2007-7#1)
those in the right##3##4##(1990-3#1)(1996-3#1)(1997-1#1)
those in the##162##3##(1990-2#3)(1990-3#1)(1990-5#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-10#2)(1994-12#1)(1994-3#2)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#2)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-7#2)(1996-9#2)(1997-1#3)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#7)(2004-11#1)(2004-4#1)(2005-10#1)(2005-12#1)(2005-9#1)(2006-12#1)(2006-3#1)(2006-4#2)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#10)(2009-3#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#1)(2013-7#1)(2013-8#11)
those in their care##2##4##(2010-10#1)(2011-2#1)
those in which the##3##4##(2008-10#1)(2008-2#1)(2008-8#1)
those in which##15##3##(1991-10#1)(1991-3#1)(1992-10#1)(1996-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-8#2)(2008-9#1)(2009-3#1)(2010-12#2)(2013-1#1)
those in whom it##2##4##(1994-4#1)(2008-7#1)
those in whom the##2##4##(2010-12#1)(2012-2#1)
those in whom##6##3##(1994-4#1)(1997-5#1)(2008-11#1)(2008-7#1)(2010-12#1)(2012-2#1)
those in##443##2##(1990-1#1)(1990-10#1)(1990-12#2)(1990-2#5)(1990-3#2)(1990-5#2)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#3)(1991-3#4)(1991-4#1)(1991-5#2)(1991-7#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-10#3)(1994-11#4)(1994-12#2)(1994-2#3)(1994-3#4)(1994-4#1)(1994-5#3)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#4)(1995-12#4)(1995-2#2)(1995-3#3)(1995-5#2)(1995-6#5)(1995-7#2)(1995-8#5)(1996-1#3)(1996-10#2)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#8)(1996-4#1)(1996-5#1)(1996-6#4)(1996-7#2)(1996-9#2)(1997-1#5)(1997-2#3)(1997-3#5)(1997-4#2)(1997-5#5)(1997-6#1)(1997-7#3)(1997-8#7)(2004-11#1)(2004-4#2)(2005-10#3)(2005-11#1)(2005-12#3)(2005-3#1)(2005-4#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#3)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#4)(2007-11#2)(2007-12#2)(2007-2#6)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#2)(2007-8#6)(2007-9#5)(2008-1#3)(2008-10#35)(2008-11#8)(2008-12#5)(2008-2#4)(2008-3#8)(2008-4#5)(2008-5#7)(2008-6#1)(2008-7#12)(2008-8#7)(2008-9#14)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#2)(2010-5#2)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#14)(2012-1#1)(2012-12#8)(2012-2#7)(2012-3#4)(2012-5#1)(2013-1#9)(2013-7#1)(2013-8#17)
those included##2##2##(2008-10#1)(2013-1#1)
those incubated in##2##3##(1991-10#1)(2006-5#1)
those incubated##5##2##(1991-10#1)(1992-4#1)(2006-5#1)(2008-5#2)
those indicating##2##2##(1992-4#1)(2010-1#1)
those individuals who are##2##4##(2004-11#1)(2011-1#1)
those individuals who##6##3##(1996-12#1)(2004-11#1)(2006-10#1)(2006-2#1)(2007-7#1)(2011-1#1)
those individuals with the##2##4##(2006-8#1)(2010-12#1)
those individuals with##4##3##(2006-7#1)(2006-8#1)(2008-3#1)(2010-12#1)
those individuals##17##2##(1992-7#1)(1996-12#1)(2004-11#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-7#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-12#1)(2010-2#1)(2011-1#1)
those induced by MHT##2##4##(2011-2#2)
those induced by the##4##4##(1992-3#1)(2008-10#1)(2008-5#1)(2008-8#1)
those induced by##30##3##(1990-12#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-3#2)(1995-5#2)(1996-12#1)(1997-6#1)(2005-11#1)(2007-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#2)(2013-1#1)
those induced##31##2##(1990-12#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-3#2)(1995-5#2)(1996-10#1)(1996-12#1)(1997-6#1)(2005-11#1)(2007-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#2)(2013-1#1)
those infected by the##2##4##(2008-10#1)(2012-12#1)
those infected by##3##3##(2008-10#2)(2012-12#1)
those infected with the##2##4##(1993-1#1)(1996-2#1)
those infected with##4##3##(1993-1#1)(1996-2#1)(2009-8#1)(2011-2#1)
those infected##12##2##(1993-1#1)(1996-2#1)(2006-10#1)(2007-7#1)(2008-10#2)(2009-5#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
those infections##3##2##(2006-6#1)(2008-7#1)(2011-2#1)
those injured##3##2##(1990-12#1)(1995-3#1)(2013-1#1)
those inoculated##2##2##(2008-10#1)(2009-8#1)
those institutions##2##2##(2007-4#1)(2009-10#1)
those interested in##7##3##(1990-3#1)(1991-3#1)(1994-2#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-9#1)
those investigators##2##2##(2008-2#1)(2008-4#1)
those involved in the process##2##5##(2005-5#2)
those involved in the##7##4##(2005-5#2)(2005-8#1)(2008-11#1)(2009-10#1)(2011-1#1)(2012-3#1)
those involved in##22##3##(1991-7#1)(1995-8#1)(1996-5#1)(2005-11#1)(2005-5#2)(2005-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#1)
those involved##30##2##(1991-7#1)(1994-1#1)(1995-8#1)(1996-5#1)(1996-8#1)(1996-9#1)(2004-7#1)(2005-11#1)(2005-5#2)(2005-8#2)(2005-9#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-8#1)
those involving the##4##3##(1991-5#1)(2008-10#1)(2008-8#1)(2012-2#1)
those involving##20##2##(1991-12#1)(1991-5#1)(2006-10#2)(2007-9#1)(2008-10#5)(2008-11#2)(2008-7#1)(2008-8#1)(2009-4#1)(2010-2#1)(2011-2#1)(2012-2#2)(2012-3#1)
those isolated from##3##3##(1992-11#1)(1994-3#1)(2007-1#1)
those isolated##5##2##(1992-11#1)(1992-9#1)(1994-3#1)(1996-6#1)(2007-1#1)
those isolates##2##2##(2008-9#1)(2012-2#1)
those issues##5##2##(1992-1#1)(2006-11#1)(2007-4#1)(2007-7#1)(2012-2#1)
those items##2##2##(2008-4#1)(2009-5#1)
those leading##2##2##(1991-4#1)(2012-12#1)
those lesions that##2##3##(2008-7#1)(2012-2#1)
those lesions##4##2##(2007-10#1)(2008-7#1)(2008-8#1)(2012-2#1)
those less##2##2##(2007-12#1)(2008-3#1)
those levels##2##2##(2006-4#1)(2013-1#1)
those likely to##3##3##(2008-3#1)(2008-5#1)(2011-2#1)
those lines##3##2##(2008-10#2)(2010-3#1)
those linked to##2##3##(2007-10#1)(2012-9#1)
those living in##7##3##(2006-10#1)(2006-8#1)(2008-10#2)(2009-9#1)(2011-2#1)(2013-1#1)
those living with##5##3##(1997-3#1)(1997-8#1)(2010-2#1)(2013-1#2)
those living##16##2##(1997-3#1)(1997-8#1)(2006-10#1)(2006-12#2)(2006-8#1)(2008-10#2)(2008-3#1)(2008-6#1)(2009-9#1)(2010-2#1)(2011-2#1)(2013-1#3)
those located in the##3##4##(2007-7#1)(2012-2#2)
those located##4##2##(2007-7#1)(2008-6#1)(2012-2#2)
those low on##2##3##(2007-12#1)(2010-2#1)
those low##3##2##(2007-12#1)(2010-2#2)
those made by##2##3##(2008-10#1)(2008-3#1)
those made on##2##3##(1996-5#1)(2008-8#1)
those made##6##2##(1996-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-4#1)
those maintained##2##2##(1992-6#1)(1994-8#1)
those managing##2##2##(1994-1#1)(2008-11#1)
those materials##2##2##(2007-8#1)(2008-2#1)
those measured experimentally##2##3##(2007-4#1)(2008-10#1)
those measured for##4##3##(1990-8#1)(1995-1#1)(2006-8#1)(2007-5#1)
those measured in##8##3##(1991-6#1)(1992-4#1)(1994-8#1)(1995-12#1)(1996-12#1)(2004-4#1)(2006-9#1)(2008-2#1)
those measured on a##2##4##(2005-11#1)(2008-10#1)
those measured##18##2##(1990-11#1)(1990-8#1)(1991-6#1)(1992-4#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-12#1)(2004-4#1)(2005-11#1)(2006-8#1)(2006-9#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#1)
those mediated by type I AMPA receptors were##2##8##(1996-2#2)
those mediated by##4##3##(1993-9#1)(1996-2#2)(2011-2#1)
those medical conditions##2##3##(2010-1#1)(2011-2#1)
those medical##5##2##(1991-3#1)(1995-12#1)(2008-1#1)(2010-1#1)(2011-2#1)
those mentioned##2##2##(2007-7#1)(2010-2#1)
those met with##2##3##(1994-2#1)(2007-8#1)
those methods##7##2##(1994-3#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-4#1)(2010-10#1)(2012-3#1)
those mice##5##2##(1993-3#1)(1995-12#1)(1996-12#1)(2008-8#1)(2013-1#1)
those minerals##2##2##(1990-12#1)(2005-11#1)
those modified##2##2##(2008-10#2)
those most at risk##2##4##(1994-6#1)(2010-12#1)
those most##6##2##(1992-5#1)(1994-6#1)(2006-7#1)(2007-4#1)(2010-12#1)(2012-2#1)
those mothers##2##2##(2007-2#1)(2008-8#1)
those muscles##2##2##(2006-11#1)(2010-3#1)
those near the##2##3##(1990-12#1)(1995-3#1)
those near##4##2##(1990-12#1)(1994-11#1)(1995-3#1)(1995-4#1)
those necessary to##2##3##(1992-4#1)(1995-2#1)
those necessary##3##2##(1992-4#1)(1995-2#1)(2010-12#1)
those needing##4##2##(1994-1#1)(2007-4#1)(2008-12#1)(2011-2#1)
those needs##6##2##(1994-1#1)(2006-1#1)(2007-4#1)(2007-7#1)(2009-9#1)(2011-1#1)
those normally used##2##3##(2008-3#1)(2010-1#1)
those normally##3##2##(1994-9#1)(2008-3#1)(2010-1#1)
those not on##2##3##(2006-8#1)(2012-1#1)
those not practising##2##3##(1993-1#1)(2013-1#1)
those not receiving##2##3##(2008-3#1)(2011-2#1)
those not registered##2##3##(1994-9#1)(2008-6#1)
those not##30##2##(1990-6#1)(1992-12#1)(1993-1#3)(1994-2#1)(1994-9#1)(1995-4#1)(1995-5#1)(1997-3#1)(2004-11#1)(2006-10#1)(2006-8#2)(2007-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#2)(2009-12#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)
those now##2##2##(1992-2#1)(1992-6#1)
those observations##4##2##(2004-2#1)(2007-11#1)(2008-12#1)(2008-7#1)
those observed after##3##3##(1995-5#1)(1997-2#1)(2008-5#1)
those observed between##2##3##(1997-4#1)(2011-2#1)
those observed during##4##3##(1992-3#1)(1994-11#1)(1994-3#1)(2013-7#1)
those observed for other##2##4##(1993-9#1)(1995-8#1)
those observed for the##2##4##(1996-11#1)(2008-3#1)
those observed for##14##3##(1993-3#1)(1993-9#1)(1995-8#1)(1996-11#1)(2006-10#1)(2007-10#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#1)(2009-11#1)(2009-2#1)
those observed in a##2##4##(1993-11#1)(2011-12#1)
those observed in control##2##4##(1994-6#1)(2010-4#1)
those observed in human##2##4##(2008-4#1)(2011-2#1)
those observed in the##14##4##(1990-7#1)(1992-4#1)(1996-10#1)(1996-2#1)(1996-8#1)(1997-8#1)(2006-11#1)(2006-4#1)(2008-10#4)(2008-11#1)(2008-2#1)
those observed in##57##3##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#1)(1992-4#1)(1993-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#2)(1995-5#1)(1995-6#1)(1996-10#2)(1996-2#1)(1996-8#1)(1997-7#2)(1997-8#2)(2004-4#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-4#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-12#2)(2011-2#2)(2012-2#1)(2013-1#1)
those observed using##2##3##(1994-3#1)(1995-10#1)
those observed with##8##3##(1990-2#1)(1992-12#1)(1992-3#1)(2005-7#1)(2008-10#2)(2012-1#1)(2012-3#1)
those observed##103##2##(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#1)(1992-12#2)(1992-3#2)(1992-4#1)(1993-11#2)(1993-3#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1995-10#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-10#2)(1996-11#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#3)(1997-8#2)(2004-4#1)(2005-11#2)(2005-7#1)(2006-1#1)(2006-10#4)(2006-11#2)(2006-4#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#4)(2008-9#1)(2009-11#1)(2009-2#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
those obtained after##3##3##(1996-11#1)(2007-8#1)(2008-10#1)
those obtained at the##2##4##(2008-10#2)
those obtained at##6##3##(2007-11#1)(2008-10#3)(2008-2#1)(2008-5#1)
those obtained by HPLC method##2##5##(2008-10#2)
those obtained by HPLC##6##4##(2008-10#6)
those obtained by ICP-AES##4##4##(2008-10#4)
those obtained by a conventional##4##5##(2008-10#3)(2008-5#1)
those obtained by a##18##4##(1996-1#1)(1997-2#1)(2007-10#1)(2007-8#1)(2008-10#11)(2008-2#1)(2008-5#2)
those obtained by conventional##8##4##(2006-2#1)(2007-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2012-3#1)
those obtained by gas chromatography##2##5##(2008-10#2)
those obtained by high performance liquid chromatography (HPLC)##3##8##(2008-10#3)
those obtained by inductively coupled plasma##2##6##(2008-10#2)
those obtained by means of##5##5##(2008-10#4)(2008-2#1)
those obtained by other authors using##2##6##(2008-7#2)
those obtained by other##5##4##(2008-10#2)(2008-5#1)(2008-7#2)
those obtained by the conventional##3##5##(2008-10#3)
those obtained by the reference##3##5##(2008-10#3)
those obtained by the standard##3##5##(2008-10#3)
those obtained by the traditional##3##5##(2005-4#1)(2008-10#1)(2008-11#1)
those obtained by the##45##4##(1990-8#1)(1993-1#1)(1997-7#1)(2005-4#1)(2008-10#37)(2008-11#2)(2008-2#1)(2012-2#1)
those obtained by using a##2##5##(2008-10#2)
those obtained by using the##3##5##(2008-10#2)(2010-4#1)
those obtained by using##6##4##(2008-10#5)(2010-4#1)
those obtained by##168##3##(1990-10#1)(1990-8#1)(1991-8#1)(1992-1#1)(1992-3#1)(1993-1#1)(1994-11#1)(1994-12#1)(1996-1#1)(1996-7#1)(1997-2#1)(1997-7#2)(2005-11#1)(2005-4#2)(2006-2#1)(2007-1#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-10#116)(2008-11#3)(2008-2#7)(2008-3#7)(2008-5#5)(2008-7#3)(2009-12#1)(2009-4#1)(2010-2#1)(2010-4#1)(2012-2#1)(2012-3#1)
those obtained following##2##3##(2005-9#1)(2008-3#1)
those obtained for the##6##4##(1993-12#1)(1993-2#1)(1993-8#1)(2008-10#2)(2012-12#1)
those obtained for##13##3##(1993-12#1)(1993-2#1)(1993-8#1)(1995-5#1)(2005-11#1)(2007-11#1)(2008-10#4)(2009-2#1)(2009-3#1)(2012-12#1)
those obtained from a##5##4##(1994-11#1)(2008-10#2)(2013-1#2)
those obtained from the##4##4##(2006-5#1)(2008-1#1)(2008-10#2)
those obtained from##38##3##(1990-12#1)(1992-12#1)(1994-11#1)(1995-10#1)(1995-8#1)(1996-4#1)(1996-6#1)(2005-11#2)(2006-5#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-8#1)(2012-3#1)(2013-1#3)
those obtained in a##6##4##(1994-4#1)(2006-10#1)(2008-10#1)(2008-11#2)(2013-1#1)
those obtained in our##2##4##(1994-2#1)(2008-3#1)
those obtained in the absence of##2##6##(2005-11#1)(2008-10#1)
those obtained in the##10##4##(1990-4#1)(1995-12#1)(1995-7#1)(2005-11#1)(2008-10#3)(2008-3#1)(2008-5#2)
those obtained in vivo##2##4##(1990-8#1)(1993-9#1)
those obtained in##42##3##(1990-4#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-2#1)(1992-6#1)(1992-7#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-4#1)(1995-12#1)(1995-7#1)(1996-5#1)(1996-9#1)(1997-8#2)(2005-11#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-3#3)(2008-5#2)(2009-2#1)(2013-1#1)
those obtained on the##2##4##(2008-10#1)(2008-3#1)
those obtained on##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2009-11#1)
those obtained previously##4##3##(1992-3#1)(1993-11#1)(2006-12#1)(2008-10#1)
those obtained using a##10##4##(1990-8#1)(1992-2#1)(2006-5#1)(2008-10#6)(2012-2#1)
those obtained using the##9##4##(1993-1#1)(1997-2#1)(2008-10#6)(2008-5#1)
those obtained using##36##3##(1990-8#1)(1992-2#1)(1992-8#1)(1993-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-2#1)(2006-5#1)(2007-8#1)(2008-10#22)(2008-5#1)(2008-7#1)(2009-5#1)(2012-2#1)
those obtained with a##12##4##(1992-8#1)(1993-4#1)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#1)
those obtained with conventional##3##4##(1996-8#1)(2006-6#1)(2008-10#1)
those obtained with other##2##4##(2007-11#1)(2008-10#1)
those obtained with the microscopic method##2##6##(2008-10#2)
those obtained with the standard##3##5##(2008-10#2)(2009-3#1)
those obtained with the##18##4##(1994-3#1)(2004-8#1)(2008-10#12)(2008-11#1)(2008-2#1)(2009-3#1)(2012-12#1)
those obtained with##74##3##(1990-7#1)(1992-6#1)(1992-8#1)(1993-4#1)(1994-3#1)(1994-9#1)(1996-8#1)(1997-4#1)(1997-7#1)(2004-8#1)(2006-3#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#37)(2008-11#1)(2008-2#5)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-3#1)(2010-1#1)(2011-2#1)(2012-12#1)
those obtained without##3##3##(2007-12#1)(2008-10#1)(2010-2#1)
those obtained##405##2##(1990-10#1)(1990-12#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#2)(1992-7#1)(1992-8#2)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-4#2)(1997-7#4)(1997-8#2)(2004-8#1)(2005-11#5)(2005-4#2)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#3)(2006-6#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#4)(2007-3#1)(2007-5#1)(2007-8#4)(2008-1#2)(2008-10#210)(2008-11#7)(2008-2#15)(2008-3#17)(2008-5#14)(2008-6#2)(2008-7#6)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#2)(2010-4#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#4)
those occurring during##3##3##(2008-10#2)(2009-12#1)
those occurring in the##2##4##(1997-6#1)(2006-7#1)
those occurring##7##2##(1992-10#1)(1997-6#1)(2006-7#1)(2008-10#2)(2009-12#1)(2012-12#1)
those of ALDH3m##2##3##(1992-8#2)
those of Cu##2##3##(1995-3#1)(2008-10#1)
those of F##2##3##(2008-10#2)
those of H##2##3##(1997-6#1)(2008-8#1)
those of HRP##2##3##(1991-9#1)(2008-10#1)
those of L##3##3##(1993-3#1)(2007-12#1)(2008-10#1)
those of LEA rats##2##4##(1993-12#2)
those of P##3##3##(2008-10#2)(2008-5#1)
those of PAH##2##3##(2008-11#2)
those of PT523 and##2##4##(1997-1#2)
those of Ras(1-171)##2##3##(1997-7#2)
those of T##3##3##(1992-8#1)(2004-11#1)(2011-2#1)
those of TSWV and INSV##2##5##(2008-10#2)
those of WKY##2##3##(1990-3#1)(1997-6#1)
those of WT##2##3##(2008-9#1)(2013-8#1)
those of a commercial##2##4##(1994-8#1)(2008-5#1)
those of a control group##3##5##(1990-6#1)(1997-8#1)(2004-10#1)
those of a control##6##4##(1990-12#1)(1990-6#1)(1997-8#1)(2004-10#1)(2008-10#1)(2011-2#1)
those of a##49##3##(1990-12#2)(1990-6#1)(1991-2#1)(1991-3#1)(1992-3#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-7#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-10#1)(2005-7#1)(2006-3#1)(2007-12#3)(2007-9#1)(2008-1#1)(2008-10#11)(2008-2#2)(2008-3#1)(2008-5#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
those of adult##3##3##(1993-3#1)(1994-9#1)(1997-7#1)
those of age-matched##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
those of all##4##3##(2006-11#1)(2008-10#1)(2008-4#1)(2009-6#1)
those of an##10##3##(1991-7#1)(1993-1#1)(2006-6#1)(2007-1#1)(2007-12#1)(2008-10#4)(2008-6#1)
those of another##5##3##(1994-10#1)(1995-10#1)(2008-10#2)(2011-2#1)
those of any other##3##4##(1991-5#1)(1996-7#1)(2008-10#1)
those of any##5##3##(1991-5#2)(1996-7#1)(2008-10#1)(2012-2#1)
those of authentic##2##3##(2008-10#2)
those of bilateral##2##3##(2007-8#1)(2007-9#1)
those of bone##2##3##(2007-11#1)(2009-7#1)
those of both##3##3##(1991-3#1)(1993-9#1)(2007-6#1)
those of bovine##3##3##(1993-11#1)(1993-8#1)(1994-8#1)
those of carrageenan##2##3##(2008-7#2)
those of cells##3##3##(1996-1#1)(1997-1#1)(2008-5#1)
those of children##2##3##(1996-12#1)(2011-1#1)
those of classical##2##3##(1997-4#1)(2006-10#1)
those of clinical##2##3##(1993-9#1)(2007-9#1)
those of commercial##2##3##(2008-10#1)(2010-4#1)
those of control mice##3##4##(1991-6#1)(1992-4#1)(1995-12#1)
those of control subjects##5##4##(1990-4#1)(1993-5#1)(1995-1#1)(2007-10#1)(2007-11#1)
those of control##19##3##(1990-4#1)(1991-6#1)(1992-4#1)(1993-1#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-3#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2013-8#1)
those of controls##10##3##(1991-10#1)(1991-6#1)(1995-11#1)(1996-1#2)(1996-11#1)(1996-3#1)(2007-9#1)(2008-7#1)(2008-9#1)
those of conventional##14##3##(1992-10#1)(1992-3#1)(2006-2#1)(2007-12#3)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-6#1)(2010-4#1)
those of cytochrome##2##3##(1991-2#1)(1995-5#1)
those of earlier##2##3##(1996-7#1)(2007-12#1)
those of either##2##3##(2007-11#1)(2008-2#1)
those of endogenous##2##3##(1990-8#1)(2008-10#1)
those of existing##2##3##(2007-12#1)(2008-2#1)
those of films##2##3##(2008-12#1)(2008-3#1)
those of glutathione reductase##2##4##(1992-1#2)
those of group II##3##4##(2008-10#3)
those of group##4##3##(2008-10#4)
those of healthy controls##2##4##(2009-8#1)(2013-8#1)
those of healthy##7##3##(1991-5#1)(1995-11#1)(2008-10#2)(2009-8#1)(2011-12#1)(2013-8#1)
those of high##2##3##(2007-7#1)(2008-10#1)
those of higher##2##3##(2005-12#1)(2006-10#1)
those of his##2##3##(1991-3#1)(1997-1#1)
those of human##12##3##(1991-10#1)(1991-3#1)(1991-8#1)(1992-6#1)(1993-12#1)(1993-5#1)(1994-12#1)(1994-5#1)(1994-8#1)(1997-5#1)(2007-4#1)(2008-10#1)
those of insulin##3##3##(1993-6#1)(1995-10#1)(2009-8#1)
those of its##5##3##(1995-11#1)(1997-6#1)(2008-10#1)(2008-2#1)(2013-8#1)
those of known##3##3##(1996-7#1)(2008-10#2)
those of larval##2##3##(1991-5#2)
those of lathosterol##2##3##(1992-6#2)
those of liver##2##3##(1992-7#1)(1995-4#1)
those of low##2##3##(1993-4#1)(2009-6#1)
those of males##3##3##(2008-5#2)(2009-4#1)
those of mammalian##5##3##(1992-12#1)(1993-6#1)(1997-4#2)(1997-7#1)
those of mice##2##3##(1992-7#1)(2012-2#1)
those of mitochondrial##3##3##(1992-7#1)(2005-8#1)(2008-11#1)
those of monolingual##3##3##(2009-10#3)
those of morphine were##2##4##(1995-11#2)
those of mouse##2##3##(1993-6#1)(1994-9#1)
those of native##6##3##(1991-9#1)(1993-8#1)(1993-9#1)(2008-5#1)(2008-8#1)(2009-10#1)
those of natural##5##3##(1994-3#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-7#1)
those of normal controls##2##4##(1996-12#1)(2009-9#1)
those of normal or##2##4##(1993-9#1)(1995-11#1)
those of normal tissues##2##4##(1994-2#1)(2008-5#1)
those of normal##18##3##(1990-2#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(2006-5#1)(2008-3#1)(2008-5#2)(2009-9#1)(2010-11#1)
those of other authors##2##4##(2007-3#1)(2008-5#1)
those of other fungal##3##4##(1997-2#2)(2008-10#1)
those of other known##2##4##(1990-2#1)(1997-6#1)
those of other species##2##4##(2004-4#1)(2011-2#1)
those of other tospoviruses##3##4##(2008-10#3)
those of other##72##3##(1990-11#1)(1990-2#1)(1990-3#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-9#1)(1993-11#1)(1994-5#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-1#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-6#1)(2004-4#1)(2004-9#1)(2005-12#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#3)(2008-7#1)(2008-8#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2013-1#1)
those of others are##2##4##(1996-3#1)(2009-9#1)
those of others##3##3##(1996-3#1)(2009-9#1)(2012-2#1)
those of our##2##3##(2007-3#1)(2007-7#1)
those of patients with##5##4##(1991-5#2)(1997-1#1)(2006-8#1)(2010-6#1)
those of patients##10##3##(1991-5#2)(1997-1#1)(2004-1#1)(2004-11#1)(2006-8#1)(2007-10#1)(2007-8#1)(2007-9#1)(2010-6#1)
those of pattern##2##3##(2008-5#2)
those of pig##2##3##(1990-12#2)
those of previous studies##4##4##(1990-8#1)(2007-7#1)(2008-10#1)(2011-2#1)
those of previous##10##3##(1990-8#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-8#2)(2011-1#1)(2011-2#1)
those of previously reported##2##4##(2007-11#1)(2008-5#1)
those of previously##6##3##(1993-11#1)(1996-10#1)(1996-7#1)(2005-7#1)(2007-11#1)(2008-5#1)
those of primary##2##3##(2008-5#1)(2013-8#1)
those of protein##4##3##(1990-12#1)(1992-6#1)(1996-4#1)(2006-4#1)
those of pure##2##3##(1996-6#1)(2011-2#1)
those of rat##4##3##(1990-11#1)(1991-12#1)(1991-5#1)(1994-3#1)
those of recent##4##3##(1997-6#1)(2006-10#1)(2007-11#1)(2008-7#1)
those of scales in##2##4##(2007-9#1)(2013-1#1)
those of serum##2##3##(1992-8#1)(2007-8#1)
those of similar##3##3##(1990-12#1)(1991-7#1)(1992-9#1)
those of some##2##3##(1994-3#1)(2008-2#1)
those of spheres##2##3##(2008-2#1)(2008-3#1)
those of tadpoles##2##3##(1991-5#2)
those of the &quot##2##4##(1991-4#2)
those of the 15-##2##4##(1994-3#2)
those of the 25 degrees C-grown##3##6##(2008-5#3)
those of the PMHSs##2##4##(2006-11#2)
those of the authors##2##4##(2008-6#1)(2012-12#1)
those of the bovine##2##4##(1990-7#1)(1996-6#1)
those of the breast##2##4##(2006-2#1)(2012-2#1)
those of the central##2##4##(1991-11#1)(1991-7#1)
those of the control group##8##5##(1994-3#1)(2008-10#1)(2008-9#4)(2013-8#2)
those of the control groups##5##5##(2008-9#5)
those of the control##20##4##(1993-9#1)(1994-11#1)(1994-3#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#9)(2012-2#1)(2013-8#2)
those of the controls throughout##2##5##(2008-8#1)(2008-9#1)
those of the controls##15##4##(1992-9#1)(1997-8#1)(2006-1#1)(2008-10#1)(2008-5#1)(2008-8#3)(2008-9#6)(2012-12#1)
those of the conventional##5##4##(1992-12#1)(2005-9#1)(2008-10#2)(2010-4#1)
those of the corresponding##10##4##(1991-2#1)(1992-3#1)(1993-8#1)(1994-11#1)(1995-11#1)(1997-2#1)(2006-9#1)(2008-10#1)(2008-3#1)(2009-3#1)
those of the enzyme##2##4##(1996-7#2)
those of the first##2##4##(2008-3#1)(2010-8#1)
those of the general population##2##5##(2006-10#1)(2011-2#1)
those of the general##3##4##(1997-2#1)(2006-10#1)(2011-2#1)
those of the head##2##4##(2007-12#1)(2012-12#1)
those of the human##4##4##(1991-6#1)(1993-9#1)(1997-7#1)(2008-3#1)
those of the latter##3##4##(2008-2#1)(2008-5#1)(2008-8#1)
those of the mammalian##2##4##(1991-2#1)(2005-9#1)
those of the more##3##4##(2008-11#1)(2008-3#1)(2008-8#1)
those of the native enzyme##2##5##(1995-12#1)(2008-5#1)
those of the native protein##2##5##(1993-6#1)(1994-8#1)
those of the native##7##4##(1992-3#1)(1993-6#1)(1994-8#1)(1995-10#1)(1995-12#1)(1997-2#1)(2008-5#1)
those of the new##2##4##(2004-9#1)(2007-1#1)
those of the normal controls##4##5##(2008-10#2)(2008-7#2)
those of the normal##6##4##(1993-9#1)(2007-6#1)(2008-10#2)(2008-7#2)
those of the other##12##4##(1992-3#1)(1993-6#1)(1993-7#1)(1995-3#1)(1997-2#1)(1997-5#1)(2006-5#1)(2008-10#2)(2008-3#1)(2008-9#1)(2010-4#1)
those of the paraventricular nucleus##2##5##(1996-9#2)
those of the parent##3##4##(1995-7#1)(1996-4#1)(2008-10#1)
those of the parental##5##4##(1991-1#1)(1991-12#1)(1995-3#1)(2008-5#1)(2013-1#1)
those of the preceding##2##4##(1993-5#1)(2008-10#1)
those of the respective##4##4##(1995-3#1)(1995-5#2)(2007-11#1)
those of the same##2##4##(1995-5#1)(2008-5#1)
those of the standard##5##4##(2006-12#2)(2007-8#1)(2008-12#1)(2010-11#1)
those of the vehicle control##4##5##(2008-9#4)
those of the vehicle controls throughout the study##3##8##(2008-9#3)
those of the vehicle controls##29##5##(2008-9#29)
those of the vehicle##33##4##(2008-9#33)
those of the wild type##3##5##(1991-2#1)(1997-8#1)(2013-8#1)
those of the wild-type enzyme##4##5##(1990-10#1)(1992-9#1)(1995-2#1)(1995-5#1)
those of the wild-type protein##4##5##(1990-5#1)(1992-3#1)(1994-9#1)(1997-5#1)
those of the wild-type##19##4##(1990-10#1)(1990-5#1)(1992-3#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-9#1)(1995-10#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-7#1)(1997-5#1)(2006-12#1)(2006-9#1)(2008-10#3)
those of the young##3##4##(1995-6#1)(1995-8#1)(2005-1#1)
those of the##457##3##(1990-1#1)(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#8)(1990-7#2)(1991-1#2)(1991-10#1)(1991-11#3)(1991-12#4)(1991-2#7)(1991-3#2)(1991-4#3)(1991-5#1)(1991-6#2)(1991-7#3)(1991-9#1)(1992-1#3)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#4)(1992-4#1)(1992-7#1)(1992-8#2)(1992-9#3)(1993-11#2)(1993-12#1)(1993-2#2)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#3)(1993-9#4)(1994-11#5)(1994-12#4)(1994-3#4)(1994-5#1)(1994-8#4)(1994-9#2)(1995-1#2)(1995-10#2)(1995-11#5)(1995-12#1)(1995-2#3)(1995-3#5)(1995-5#5)(1995-6#3)(1995-7#1)(1995-8#3)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#4)(1996-4#1)(1996-6#2)(1996-7#4)(1996-8#1)(1996-9#2)(1997-2#6)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#5)(1997-7#5)(1997-8#3)(2004-11#2)(2004-9#2)(2005-1#1)(2005-10#1)(2005-11#9)(2005-4#1)(2005-9#2)(2006-1#1)(2006-10#3)(2006-11#5)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#2)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#8)(2007-3#3)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#40)(2008-11#3)(2008-12#2)(2008-2#7)(2008-3#16)(2008-4#5)(2008-5#16)(2008-6#3)(2008-7#10)(2008-8#9)(2008-9#49)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#6)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#3)(2013-1#3)(2013-7#3)(2013-8#8)
those of their##9##3##(1990-7#1)(1992-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-5#1)(2010-8#1)(2012-3#1)
those of tospoviruses##2##3##(2008-10#2)
those of total##2##3##(1993-3#1)(2004-4#1)
those of two##5##3##(1997-4#1)(2008-10#1)(2008-4#1)(2009-4#1)(2013-1#1)
those of type 2 cytokines##2##5##(2005-10#2)
those of type##3##3##(2005-10#2)(2008-1#1)
those of wild type##3##4##(1991-4#1)(1991-7#1)(1991-8#1)
those of wild-type recombinant##2##4##(1994-11#1)(1995-5#1)
those of wild-type##11##3##(1992-1#1)(1992-6#1)(1993-11#1)(1994-11#3)(1995-2#1)(1995-5#1)(2008-10#1)(2008-8#2)
those of young##6##3##(1990-5#1)(1990-7#1)(1992-12#1)(1995-6#1)(2004-11#1)(2006-7#1)
those of younger##5##3##(1990-3#1)(2006-11#1)(2008-11#1)(2009-4#1)(2010-4#1)
those of##1585##2##(1990-1#2)(1990-10#4)(1990-11#6)(1990-12#13)(1990-2#6)(1990-3#10)(1990-4#5)(1990-5#16)(1990-6#4)(1990-7#10)(1990-8#4)(1990-9#2)(1991-1#3)(1991-10#4)(1991-11#3)(1991-12#9)(1991-2#16)(1991-3#13)(1991-4#9)(1991-5#15)(1991-6#6)(1991-7#8)(1991-8#7)(1991-9#9)(1992-1#8)(1992-10#1)(1992-11#11)(1992-12#11)(1992-2#4)(1992-3#10)(1992-4#5)(1992-6#11)(1992-7#7)(1992-8#12)(1992-9#7)(1993-1#3)(1993-11#11)(1993-12#6)(1993-2#5)(1993-3#4)(1993-4#3)(1993-5#4)(1993-6#8)(1993-7#5)(1993-8#6)(1993-9#14)(1994-1#1)(1994-10#2)(1994-11#11)(1994-12#17)(1994-2#4)(1994-3#10)(1994-4#1)(1994-5#6)(1994-6#4)(1994-7#2)(1994-8#15)(1994-9#6)(1995-1#8)(1995-10#4)(1995-11#12)(1995-12#4)(1995-2#11)(1995-3#11)(1995-4#2)(1995-5#14)(1995-6#9)(1995-7#4)(1995-8#11)(1995-9#2)(1996-1#6)(1996-10#2)(1996-11#2)(1996-12#6)(1996-2#6)(1996-3#4)(1996-4#2)(1996-5#5)(1996-6#7)(1996-7#14)(1996-8#2)(1996-9#3)(1997-1#8)(1997-2#17)(1997-3#4)(1997-4#11)(1997-5#5)(1997-6#17)(1997-7#16)(1997-8#11)(2004-1#1)(2004-10#1)(2004-11#5)(2004-12#2)(2004-3#1)(2004-4#3)(2004-9#4)(2005-1#1)(2005-10#4)(2005-11#17)(2005-12#2)(2005-4#5)(2005-7#2)(2005-8#3)(2005-9#2)(2006-1#1)(2006-10#12)(2006-11#8)(2006-12#11)(2006-2#3)(2006-3#6)(2006-4#3)(2006-5#3)(2006-6#3)(2006-7#2)(2006-8#5)(2006-9#2)(2007-1#2)(2007-10#9)(2007-11#21)(2007-12#40)(2007-2#2)(2007-3#7)(2007-4#7)(2007-5#3)(2007-6#2)(2007-7#4)(2007-8#12)(2007-9#11)(2008-1#6)(2008-10#180)(2008-11#17)(2008-12#9)(2008-2#27)(2008-3#43)(2008-4#12)(2008-5#49)(2008-6#9)(2008-7#29)(2008-8#26)(2008-9#59)(2009-10#7)(2009-11#1)(2009-12#3)(2009-2#4)(2009-3#6)(2009-4#7)(2009-5#4)(2009-6#6)(2009-7#6)(2009-8#8)(2009-9#4)(2010-10#2)(2010-11#4)(2010-12#7)(2010-2#6)(2010-3#2)(2010-4#15)(2010-5#3)(2010-6#2)(2010-7#4)(2010-8#6)(2011-1#16)(2011-12#2)(2011-2#25)(2011-3#1)(2012-1#6)(2012-11#1)(2012-12#7)(2012-2#13)(2012-3#6)(2013-1#16)(2013-7#8)(2013-8#20)
those older than##5##3##(2006-5#1)(2007-12#2)(2010-9#1)(2013-8#1)
those older##6##2##(2006-5#1)(2007-12#2)(2010-9#1)(2011-1#1)(2013-8#1)
those on drugs##2##3##(2008-5#1)(2008-7#1)
those on placebo##4##3##(1991-3#1)(2008-5#2)(2008-6#1)
those on the##12##3##(1991-2#1)(1993-11#1)(1996-6#1)(1997-1#1)(2006-12#1)(2006-4#1)(2008-11#1)(2008-5#2)(2008-9#1)(2011-2#2)
those on##46##2##(1991-2#1)(1991-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-6#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-8#1)(2004-9#2)(2006-10#1)(2006-12#1)(2006-4#1)(2007-2#1)(2007-3#1)(2008-10#4)(2008-11#3)(2008-3#2)(2008-5#5)(2008-6#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-2#2)(2012-1#1)
those only##3##2##(1997-5#1)(2008-3#1)(2010-1#1)
those organisms##2##2##(2006-10#1)(2012-2#1)
those originally##6##2##(2006-10#1)(2006-4#1)(2008-2#1)(2008-4#3)
those originating from##3##3##(1990-8#1)(1996-6#1)(2010-12#1)
those originating##5##2##(1990-8#1)(1996-6#1)(2008-10#1)(2008-6#1)(2010-12#1)
those oscillations##2##2##(2013-8#2)
those outlined##2##2##(2007-11#1)(2008-9#1)
those over 60 years##2##4##(1991-10#1)(2008-2#1)
those over the age of##2##5##(2007-2#1)(2009-4#1)
those over##8##2##(1990-12#1)(1991-10#1)(1992-10#1)(1993-6#1)(1996-5#1)(2007-2#1)(2008-2#1)(2009-4#1)
those papers##3##2##(2008-7#1)(2011-2#1)(2012-3#1)
those parameters##6##2##(1995-2#1)(2006-10#1)(2008-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
those participants who##2##3##(2007-12#1)(2008-3#1)
those participants with##2##3##(2010-2#1)(2011-1#1)
those participants##7##2##(2006-6#1)(2007-12#1)(2008-3#1)(2010-2#1)(2011-1#1)(2012-1#1)(2013-7#1)
those pathogens##2##2##(2010-9#1)(2012-1#1)
those pathways##3##2##(2007-12#1)(2010-4#1)(2012-3#1)
those patients at##2##3##(2011-2#1)(2013-1#1)
those patients receiving##2##3##(2006-10#1)(2008-6#1)
those patients requiring##2##3##(2007-7#1)(2007-8#1)
those patients that##3##3##(2012-1#3)
those patients treated with##2##4##(2008-3#1)(2010-5#1)
those patients who are##7##4##(1996-5#1)(2004-10#1)(2005-12#1)(2006-12#2)(2006-9#1)(2010-12#1)
those patients who did not##2##5##(2007-10#1)(2011-2#1)
those patients who had##3##4##(1991-2#1)(2007-7#1)(2008-6#1)
those patients who have##2##4##(2004-1#1)(2006-1#1)
those patients who were##2##4##(1994-6#1)(2012-12#1)
those patients who##29##3##(1991-2#1)(1992-10#1)(1994-6#1)(1996-5#1)(1997-8#1)(2004-1#1)(2004-10#1)(2005-12#1)(2006-1#1)(2006-10#1)(2006-12#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
those patients with a##5##4##(1993-11#1)(2006-1#1)(2007-10#1)(2007-11#1)(2013-7#1)
those patients with##19##3##(1993-11#1)(1995-3#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-6#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-1#2)(2011-2#1)(2013-7#1)(2013-8#1)
those patients##101##2##(1990-12#1)(1991-1#1)(1991-2#1)(1992-10#1)(1993-11#1)(1994-6#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-8#1)(2004-1#1)(2004-10#1)(2005-1#1)(2005-11#1)(2005-12#1)(2005-7#2)(2005-8#1)(2006-1#2)(2006-10#6)(2006-12#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#3)(2007-7#3)(2007-8#9)(2007-9#1)(2008-1#3)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#7)(2012-1#4)(2012-12#3)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#5)
those payers##2##2##(1992-1#1)(1994-12#1)
those people##2##2##(2008-7#1)(2013-1#1)
those peptides##3##2##(1991-3#1)(1994-3#1)(2010-12#1)
those performed##2##2##(1991-6#1)(1997-4#1)
those performing##4##2##(2008-10#2)(2008-4#2)
those persons who##2##3##(2008-10#1)(2012-12#1)
those persons##3##2##(2007-10#1)(2008-10#1)(2012-12#1)
those pertaining to##2##3##(2008-2#2)
those pharmacies##3##2##(1995-1#1)(2008-10#2)
those planning to##2##3##(1993-1#1)(2007-2#1)
those planning##7##2##(1993-1#1)(1995-1#1)(2006-8#1)(2007-2#1)(2012-2#1)(2013-1#2)
those plants##2##2##(2008-10#1)(2008-5#1)
those policies##3##2##(2007-6#1)(2008-12#1)(2012-3#1)
those policy##2##2##(1995-1#1)(2013-7#1)
those positive for##4##3##(1991-9#3)(2009-11#1)
those positive##5##2##(1990-11#1)(1991-9#3)(2009-11#1)
those predicted by the##3##4##(2005-11#1)(2008-3#1)(2008-8#1)
those predicted by##10##3##(2005-11#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-3#1)(2008-8#2)
those predicted for##2##3##(1991-7#1)(2013-1#1)
those predicted from##2##3##(1995-2#1)(2006-5#1)
those predicted##19##2##(1991-7#1)(1991-8#1)(1994-8#1)(1995-2#1)(2005-11#2)(2006-5#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#2)(2013-1#1)
those preferring eager strategies##3##4##(2009-9#3)
those preferring vigilant strategies##2##4##(2009-9#2)
those preferring##5##2##(2009-9#5)
those pregnant women##2##3##(1991-12#1)(2011-1#1)
those preparations##2##2##(1995-3#1)(2004-12#1)
those prepared##4##2##(2008-10#2)(2008-11#1)(2010-4#1)
those prescribed##2##2##(2007-10#1)(2008-3#1)
those present in the##2##4##(2008-11#1)(2008-7#1)
those present in##7##3##(1991-9#1)(1993-11#1)(2004-2#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
those present##9##2##(1991-5#1)(1991-9#1)(1993-11#1)(2004-2#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-11#1)
those presented##2##2##(1997-7#1)(2008-8#1)
those presenting to the emergency department with##2##7##(2008-3#1)(2011-2#1)
those presenting to the emergency department##3##6##(2007-10#1)(2008-3#1)(2011-2#1)
those presenting with acute##2##4##(2008-7#2)
those presenting with##4##3##(2008-1#2)(2008-7#2)
those presenting##14##2##(1995-3#1)(2007-10#2)(2007-7#1)(2008-1#2)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#2)(2011-2#2)
those previous##2##2##(2007-11#1)(2008-5#1)
those previously described in##3##4##(1990-4#1)(2011-2#1)(2012-3#1)
those previously described##6##3##(1990-4#1)(1991-6#1)(1992-2#1)(1995-3#1)(2011-2#1)(2012-3#1)
those previously established##2##3##(1996-1#1)(2007-4#1)
those previously identified##2##3##(1995-6#1)(1996-8#1)
those previously obtained in##2##4##(2008-10#1)(2010-6#1)
those previously obtained##5##3##(1990-2#1)(2006-10#1)(2008-10#2)(2010-6#1)
those previously published##4##3##(2004-9#1)(2005-11#1)(2006-5#1)(2008-6#1)
those previously reported for##6##4##(1990-2#1)(1991-4#1)(1995-5#1)(1996-2#1)(2007-1#1)(2012-1#1)
those previously reported in##3##4##(1994-11#1)(2008-10#1)(2008-9#1)
those previously reported##17##3##(1990-2#1)(1991-4#1)(1991-9#1)(1993-2#1)(1994-11#2)(1994-12#1)(1995-5#1)(1996-2#1)(1996-4#1)(2006-10#1)(2007-1#1)(2008-10#3)(2008-9#1)(2012-1#1)
those previously##47##2##(1990-2#2)(1990-4#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-5#1)(1993-2#1)(1994-11#2)(1994-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-8#1)(2004-9#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-5#1)(2007-1#1)(2007-4#1)(2008-10#7)(2008-5#1)(2008-6#1)(2008-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
those problems##9##2##(1997-1#1)(2006-11#1)(2006-6#1)(2008-2#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
those procedures##3##2##(2006-11#1)(2007-2#1)(2008-3#1)
those processes that##2##3##(1992-7#1)(2005-11#1)
those processes##3##2##(1992-7#1)(1996-4#1)(2005-11#1)
those produced by the##4##4##(2006-12#1)(2007-11#1)(2008-2#2)
those produced by##18##3##(1990-10#2)(1992-8#1)(1996-9#1)(1997-7#1)(1997-8#1)(2004-2#1)(2006-12#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)
those produced in##4##3##(1994-9#1)(2008-10#3)
those produced on##2##3##(2008-10#2)
those produced##26##2##(1990-10#2)(1992-8#1)(1994-9#1)(1996-8#1)(1996-9#1)(1997-7#1)(1997-8#1)(2004-2#1)(2004-9#1)(2006-12#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)
those programs##3##2##(1994-3#1)(2008-12#1)(2013-8#1)
those prone to##3##3##(2009-12#1)(2010-12#1)(2012-2#1)
those properties##2##2##(2011-1#1)(2012-2#1)
those proposed by the##3##4##(2008-2#1)(2012-1#1)(2013-1#1)
those proposed##4##2##(2008-12#1)(2008-2#1)(2012-1#1)(2013-1#1)
those proteins with##2##3##(2008-4#1)(2008-7#1)
those proteins##8##2##(1990-7#1)(1992-6#1)(1993-5#1)(1995-7#1)(2007-2#1)(2008-4#1)(2008-7#1)(2009-12#1)
those protons coupled to the labeled##2##6##(1992-3#2)
those provided by the##7##4##(2008-10#5)(2008-4#2)
those provided by##11##3##(2008-10#7)(2008-3#1)(2008-4#2)(2010-5#1)
those providing##5##2##(2005-10#1)(2007-2#1)(2008-12#1)(2010-10#1)(2013-8#1)
those publications##2##2##(1995-8#1)(2010-7#1)
those published##3##2##(1990-6#1)(1991-6#1)(2007-3#1)
those receiving disability pension##2##4##(2006-8#2)
those receiving disability##4##3##(2006-10#2)(2006-8#2)
those receiving##33##2##(1991-4#2)(1993-9#1)(1994-12#1)(1994-2#1)(1995-4#1)(2004-1#1)(2005-7#1)(2006-1#1)(2006-10#4)(2006-8#3)(2007-11#5)(2007-12#1)(2007-2#2)(2007-4#1)(2007-6#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#3)
those recently reported##2##3##(1993-3#1)(1995-12#1)
those recently##5##2##(1991-11#1)(1993-3#1)(1995-12#1)(1996-12#1)(2008-2#1)
those receptors##5##2##(1991-6#2)(2007-9#1)(2008-4#2)
those recorded in##3##3##(1992-7#1)(1994-6#1)(2010-8#1)
those recorded##9##2##(1990-6#1)(1992-7#1)(1994-6#1)(1994-8#1)(1997-3#1)(1997-5#1)(2008-10#2)(2010-8#1)
those referred##3##2##(1994-12#1)(2007-12#1)(2011-1#1)
those regarding the##2##3##(1991-7#1)(2006-9#1)
those regarding##5##2##(1991-7#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-1#1)
those regions of the##2##4##(1991-6#1)(1995-6#1)
those regions that##2##3##(1994-2#1)(2010-4#1)
those regions##10##2##(1991-6#1)(1991-9#1)(1994-2#1)(1995-6#1)(1996-3#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-1#1)
those registered##3##2##(2006-8#1)(2008-6#1)(2010-4#1)
those regulated by##2##3##(1997-2#1)(2009-6#1)
those regulated##3##2##(1993-5#1)(1997-2#1)(2009-6#1)
those regulating##3##2##(1996-2#1)(2007-7#1)(2008-6#1)
those related to the##11##4##(1992-11#1)(2004-2#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-7#1)(2012-1#1)(2013-7#1)
those related to##27##3##(1991-6#1)(1992-11#1)(1995-12#2)(1995-6#1)(2004-11#1)(2004-2#2)(2005-8#1)(2006-10#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#2)(2009-12#1)(2010-2#2)(2010-5#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
those related##28##2##(1991-6#1)(1992-11#1)(1995-12#2)(1995-6#1)(2004-11#1)(2004-2#2)(2005-8#1)(2006-10#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#3)(2008-8#2)(2009-12#1)(2010-2#2)(2010-5#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
those relationships##3##2##(1990-12#1)(1997-1#2)
those released##3##2##(2008-11#2)(2008-4#1)
those reported after##2##3##(2007-10#1)(2013-1#1)
those reported by##8##3##(1992-1#1)(1994-5#1)(1996-7#1)(2007-7#1)(2007-8#1)(2008-10#3)
those reported for other##3##4##(1991-8#1)(1993-11#1)(2008-5#1)
those reported for the##6##4##(1993-4#1)(1994-2#1)(1995-11#1)(2008-10#2)(2008-3#1)
those reported for##20##3##(1990-12#1)(1990-2#1)(1990-3#1)(1991-6#1)(1991-8#1)(1993-11#1)(1993-4#1)(1993-8#1)(1994-2#1)(1995-11#1)(1995-7#1)(1997-4#1)(2005-11#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-6#1)
those reported from other##4##4##(2007-7#1)(2008-1#1)(2010-4#1)(2010-6#1)
those reported from##6##3##(1991-8#1)(2006-5#1)(2007-7#1)(2008-1#1)(2010-4#1)(2010-6#1)
those reported in literature##2##4##(2008-10#2)
those reported in other##3##4##(1991-3#1)(2007-12#1)(2007-3#1)
those reported in previous##2##4##(2008-10#1)(2012-1#1)
those reported in the literature##9##5##(1993-12#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-8#1)
those reported in##24##3##(1991-2#1)(1991-3#1)(1993-12#1)(1995-12#1)(1997-2#2)(2004-11#1)(2006-10#1)(2006-11#1)(2007-12#2)(2007-2#1)(2007-3#2)(2008-10#5)(2008-11#1)(2008-8#1)(2010-9#1)(2012-1#1)(2012-2#1)
those reported previously for##3##4##(1990-3#1)(1996-2#1)(2008-5#1)
those reported previously##11##3##(1990-3#1)(1993-9#1)(1996-2#1)(1996-4#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)
those reported recently##2##3##(2007-11#1)(2008-10#1)
those reported##81##2##(1990-12#1)(1990-2#1)(1990-3#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-10#1)(1993-11#1)(1993-12#1)(1993-4#2)(1993-8#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-7#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-2#2)(1997-4#1)(1997-7#1)(2004-11#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-3#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-4#1)(2010-6#1)(2010-9#1)(2012-1#1)(2012-2#1)(2013-1#2)
those reporting a##2##3##(2008-12#1)(2011-1#1)
those reporting##6##2##(1991-7#2)(2008-12#1)(2008-5#1)(2010-8#1)(2011-1#1)
those required for a##2##4##(1990-7#1)(2013-1#1)
those required for##6##3##(1990-7#1)(1994-3#1)(1995-3#1)(2007-11#1)(2009-8#1)(2013-1#1)
those required to inhibit##2##4##(1990-7#1)(1995-2#1)
those required to##7##3##(1990-7#1)(1992-11#1)(1994-5#1)(1995-2#1)(1997-7#1)(2006-12#1)(2008-10#1)
those required##17##2##(1990-7#2)(1991-2#1)(1992-11#1)(1992-6#1)(1994-3#2)(1994-5#1)(1995-2#1)(1995-3#1)(1997-7#1)(2006-12#1)(2007-11#1)(2008-10#1)(2009-8#1)(2011-2#1)(2013-1#1)
those requiring##2##2##(2006-12#1)(2013-1#1)
those residents##2##2##(2008-11#1)(2011-2#1)
those residing in##3##3##(1994-3#1)(2007-2#1)(2009-4#1)
those residues that##2##3##(1990-7#1)(2008-4#1)
those residues##6##2##(1990-7#1)(1997-8#3)(2008-4#1)(2012-2#1)
those resistant to##2##3##(1991-4#1)(2006-10#1)
those resources##4##2##(2008-7#2)(2010-9#1)(2011-2#1)
those respondents##2##2##(2009-11#1)(2009-4#1)
those responsible for##3##3##(1991-1#1)(1991-12#1)(2006-6#1)
those resulting from withdrawal##2##4##(2006-8#2)
those resulting from##7##3##(2006-8#4)(2008-10#1)(2008-7#1)(2012-3#1)
those resulting##9##2##(2006-8#4)(2008-10#2)(2008-7#1)(2012-3#2)
those results is##2##3##(2006-7#1)(2010-3#1)
those results##6##2##(2006-10#1)(2006-7#1)(2008-10#1)(2008-3#2)(2010-3#1)
those rules##2##2##(1991-2#1)(1996-11#1)
those same##5##2##(1990-2#1)(1991-3#1)(1996-9#1)(1997-3#1)(2012-1#1)
those sampled##2##2##(1994-3#1)(2006-10#1)
those samples that were##2##4##(2008-10#1)(2008-3#1)
those samples that##4##3##(2008-10#3)(2008-3#1)
those samples##8##2##(2006-3#1)(2007-12#1)(2008-10#5)(2008-3#1)
those searching for##2##3##(2008-10#1)(2008-5#1)
those sections##2##2##(1995-6#1)(2007-8#1)
those seeking##5##2##(1992-1#1)(1995-12#1)(2008-1#1)(2011-2#1)(2012-11#1)
those seen during##2##3##(1991-12#1)(1992-12#1)
those seen for##3##3##(1992-7#1)(1993-8#1)(2009-4#1)
those seen in other##2##4##(1992-2#1)(1992-9#1)
those seen in the##7##4##(1994-5#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-7#1)(2012-2#1)(2012-3#1)
those seen in##28##3##(1990-12#1)(1991-12#1)(1992-2#1)(1992-9#1)(1993-11#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-7#1)(1996-12#1)(1997-2#1)(1997-8#1)(2005-10#1)(2007-12#2)(2007-4#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-4#1)(2011-1#1)(2012-12#3)(2012-2#1)(2012-3#1)
those seen with##9##3##(1997-5#1)(2006-10#1)(2007-11#2)(2008-5#2)(2008-7#1)(2011-2#1)(2012-3#1)
those seen##49##2##(1990-12#1)(1991-12#2)(1991-6#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-5#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-7#1)(1996-12#1)(1997-2#1)(1997-5#1)(1997-8#1)(2005-10#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-4#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#3)(2009-12#1)(2009-4#2)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#2)
those segments##2##2##(1992-2#1)(1995-12#1)
those sent by their TD peers##2##6##(2012-3#2)
those services##4##2##(1990-12#1)(1992-3#1)(1993-12#1)(1997-2#1)
those showing##5##2##(1992-4#1)(1992-7#1)(2007-8#1)(2008-7#1)(2009-8#1)
those shown by##2##3##(2007-9#1)(2012-1#1)
those shown in##2##3##(1997-4#1)(2012-2#1)
those shown##5##2##(1995-3#1)(1997-4#1)(2007-9#1)(2012-1#1)(2012-2#1)
those sites##3##2##(1990-3#1)(2008-12#1)(2008-5#1)
those situations##3##2##(1993-1#1)(2006-10#1)(2008-7#1)
those slides##2##2##(2007-5#2)
those species of##2##3##(1997-4#1)(2008-3#1)
those species##9##2##(1997-4#1)(2007-3#1)(2007-5#1)(2008-10#3)(2008-3#1)(2008-8#1)(2010-4#1)
those specific for##2##3##(1991-4#1)(2008-4#1)
those specific##3##2##(1991-4#1)(2008-1#1)(2008-4#1)
those specimens##4##2##(2008-5#1)(2009-4#1)(2009-7#1)(2013-8#1)
those standards##2##2##(2007-4#1)(2013-1#1)
those states##2##2##(2006-6#1)(2007-11#1)
those staying &gt##2##3##(2013-1#2)
those stimuli that act &quot##2##5##(1997-1#2)
those stored at##3##3##(2007-7#1)(2008-10#1)(2012-2#1)
those strains##2##2##(2006-10#1)(2007-11#1)
those students##3##2##(2006-5#1)(2007-1#2)
those studied in##2##3##(2007-12#1)(2011-2#1)
those studies that##3##3##(2006-2#3)
those studies##12##2##(1993-11#1)(1996-1#1)(1996-12#2)(2006-2#4)(2008-2#1)(2008-4#1)(2008-6#1)(2009-4#1)
those subjects who##2##3##(1992-3#1)(2007-5#1)
those subjects with##5##3##(1991-5#2)(1996-8#1)(1997-2#1)(2007-10#1)
those subjects##12##2##(1991-5#2)(1992-3#1)(1993-7#1)(1995-4#1)(1996-8#1)(1997-2#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-5#1)(2008-12#1)
those substances##2##2##(1990-2#1)(1992-4#1)
those suffering from##4##3##(1992-11#1)(1996-8#1)(2008-7#1)(2013-1#1)
those suffering##5##2##(1992-11#1)(1996-8#1)(2007-10#1)(2008-7#1)(2013-1#1)
those suggested##2##2##(1991-9#1)(2012-2#1)
those surveyed##4##2##(1995-12#1)(1997-3#1)(2008-1#1)(2012-2#1)
those systems##6##2##(2006-10#1)(2006-5#1)(2008-2#1)(2012-2#1)(2013-1#2)
those taken at the end of R-5 or##2##8##(1997-4#2)
those taken by##3##3##(2007-10#2)(2010-7#1)
those taken##8##2##(1991-11#1)(1993-12#1)(1997-4#2)(2007-10#2)(2008-10#1)(2010-7#1)
those targeting##3##2##(2007-11#1)(2008-10#1)(2009-12#1)
those targets##2##2##(1991-3#1)(2007-7#1)
those teams##2##2##(1995-2#1)(2011-1#1)
those techniques that##2##3##(2008-7#1)(2010-12#1)
those tested##4##2##(1990-5#1)(1994-12#1)(1997-2#1)(2008-10#1)
those that appear##2##3##(2009-3#1)(2011-2#1)
those that applied##2##3##(2008-10#2)
those that are currently##2##4##(2007-11#1)(2008-2#1)
those that are not##2##4##(1992-12#1)(2008-11#1)
those that are##36##3##(1992-12#1)(1992-3#1)(1994-11#2)(1994-2#1)(1994-8#1)(1996-12#1)(1996-3#1)(1997-3#1)(2005-8#2)(2006-12#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#3)(2008-11#2)(2008-2#3)(2008-4#3)(2008-7#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
those that arise##3##3##(1997-2#1)(2008-1#1)(2012-2#1)
those that bind only##2##4##(1997-3#2)
those that can be##4##4##(1991-11#1)(1993-3#1)(2008-2#1)(2008-7#1)
those that can##7##3##(1991-11#1)(1993-3#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)
those that contain##2##3##(2007-12#2)
those that did not##4##4##(2007-10#1)(2007-11#1)(2007-12#1)(2011-2#1)
those that did##6##3##(2007-10#1)(2007-11#1)(2007-12#1)(2008-5#2)(2011-2#1)
those that do not##3##4##(1994-2#1)(1997-3#1)(2008-12#1)
those that do##4##3##(1994-2#1)(1997-3#1)(2007-11#1)(2008-12#1)
those that had been##3##4##(2008-7#1)(2008-8#1)(2010-4#1)
those that had##7##3##(1995-1#1)(2006-7#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-1#1)(2013-1#1)
those that have##8##3##(1993-12#1)(1993-3#1)(1996-1#1)(1996-2#1)(2008-10#2)(2009-10#1)(2009-3#1)
those that may##4##3##(1993-11#1)(2006-1#1)(2006-10#1)(2007-8#1)
those that mediate##2##3##(1991-8#1)(2008-9#1)
those that occur at##2##4##(1995-8#1)(2008-11#1)
those that occur##5##3##(1995-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-7#1)
those that produced##2##3##(2008-10#1)(2009-2#1)
those that received##2##3##(1995-5#1)(2008-10#1)
those that rely##3##3##(2008-8#1)(2011-1#1)(2012-12#1)
those that reported##2##3##(2007-2#1)(2007-8#1)
those that represent##3##3##(2007-2#1)(2009-11#1)(2010-10#1)
those that require##2##3##(2008-4#1)(2010-9#1)
those that respond##2##3##(2012-2#2)
those that result in##2##4##(2006-9#1)(2008-11#1)
those that survive##2##3##(1991-11#1)(2008-8#1)
those that use##2##3##(2008-3#1)(2008-9#1)
those that were not##3##4##(2006-8#1)(2008-7#1)(2008-9#1)
those that were##19##3##(1992-6#1)(1995-9#1)(1996-5#1)(1997-6#1)(2004-10#1)(2006-10#1)(2006-11#2)(2006-8#1)(2008-10#3)(2008-2#2)(2008-7#1)(2008-9#1)(2012-12#3)
those that would##2##3##(1993-3#1)(2008-9#1)
those that##202##2##(1990-2#1)(1991-11#2)(1991-5#3)(1991-8#1)(1992-12#2)(1992-3#1)(1992-6#1)(1993-11#3)(1993-12#1)(1993-3#5)(1994-11#2)(1994-12#2)(1994-2#3)(1994-7#1)(1994-8#2)(1995-1#2)(1995-5#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#2)(1997-2#1)(1997-3#4)(1997-4#1)(1997-6#1)(2004-10#1)(2005-8#2)(2006-1#1)(2006-10#4)(2006-11#2)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#5)(2007-2#3)(2007-3#1)(2007-8#4)(2008-1#4)(2008-10#16)(2008-11#5)(2008-12#3)(2008-2#14)(2008-3#3)(2008-4#4)(2008-5#3)(2008-7#5)(2008-8#4)(2008-9#8)(2009-10#2)(2009-11#2)(2009-2#1)(2009-3#4)(2009-4#2)(2009-5#1)(2009-7#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-12#8)(2012-2#5)(2012-3#1)(2013-1#2)(2013-7#1)
those three populations##2##3##(2008-10#1)(2011-1#1)
those three##6##2##(1995-2#1)(2007-2#1)(2008-10#1)(2008-3#1)(2009-4#1)(2011-1#1)
those times##2##2##(2009-2#1)(2011-2#1)
those tissues##2##2##(2005-8#1)(2008-2#1)
those to##7##2##(1996-5#1)(1997-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-1#1)
those traditionally##3##2##(2008-2#1)(2008-9#1)(2012-12#1)
those travelling##2##2##(2007-2#2)
those treated by##5##3##(1992-9#1)(2004-1#2)(2007-2#1)(2008-1#1)
those treated for##4##3##(2008-3#1)(2008-6#1)(2012-12#1)(2013-1#1)
those treated in##2##3##(1992-5#1)(2009-6#1)
those treated with primary PCI##2##5##(2008-3#2)
those treated with surgery##2##4##(1995-5#1)(2007-8#1)
those treated with##33##3##(1991-11#1)(1991-3#1)(1991-7#2)(1993-11#1)(1993-2#2)(1993-3#1)(1995-12#1)(1995-5#1)(1996-1#1)(1997-8#1)(2004-12#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#1)(2008-6#2)(2010-12#1)(2010-6#1)(2011-2#3)(2012-12#1)(2013-1#1)
those treated##49##2##(1990-10#1)(1991-11#1)(1991-3#1)(1991-7#2)(1992-5#1)(1992-9#1)(1993-11#1)(1993-2#2)(1993-3#1)(1995-12#1)(1995-5#1)(1996-1#1)(1997-4#1)(1997-8#1)(2004-1#2)(2004-12#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-5#2)(2008-6#4)(2009-6#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-12#2)(2013-1#2)
those treatment##2##2##(2012-2#1)(2013-1#1)
those treatments##2##2##(1993-9#1)(2008-12#1)
those triggered##2##2##(1993-9#1)(1996-11#1)
those two##7##2##(1993-12#1)(1995-1#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-5#1)(2013-8#1)
those typical of##2##3##(1996-12#1)(2010-8#1)
those typical##3##2##(1996-12#1)(2006-6#1)(2010-8#1)
those typically##2##2##(2007-12#1)(2009-10#1)
those under 50##3##3##(2006-2#3)
those under##13##2##(1991-12#1)(1991-7#1)(1992-2#1)(1993-2#1)(2006-10#1)(2006-2#3)(2008-10#1)(2011-2#1)(2012-12#2)(2012-2#1)
those undergoing##5##2##(1991-3#1)(1995-1#1)(2006-2#1)(2008-7#2)
those undertaking##2##2##(2005-7#1)(2008-11#1)
those used for##8##3##(1990-11#1)(1992-7#1)(1994-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2011-2#1)
those used in a##3##4##(2007-12#1)(2008-3#1)(2008-7#1)
those used in conventional##2##4##(2006-5#1)(2007-12#1)
those used in the##5##4##(1993-2#1)(1995-6#1)(2008-11#1)(2009-3#1)(2010-3#1)
those used in##24##3##(1993-2#1)(1995-6#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-11#2)(2007-12#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-4#1)(2010-3#1)(2011-2#1)(2012-2#1)
those used to##3##3##(1990-2#1)(1994-8#1)(2009-4#1)
those used##37##2##(1990-11#1)(1990-2#1)(1992-7#1)(1993-2#1)(1994-11#1)(1994-8#1)(1995-6#1)(2006-10#2)(2006-11#1)(2006-5#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-4#2)(2010-3#1)(2011-2#2)(2012-2#1)
those using other##3##3##(1997-3#1)(2010-4#1)(2011-2#1)
those using the##3##3##(1993-2#1)(2007-11#1)(2010-6#1)
those using##23##2##(1992-1#1)(1993-2#1)(1997-3#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-4#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-6#1)(2009-2#1)(2009-7#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)
those values##6##2##(1992-9#1)(1993-12#1)(2006-7#1)(2008-2#1)(2009-3#2)
those variables##3##2##(1992-6#1)(1993-1#1)(2008-8#1)
those video sequences containing##2##4##(2008-2#2)
those wavelengths##2##2##(1997-5#1)(2008-3#1)
those we##3##2##(2006-8#1)(2007-2#1)(2008-8#1)
those were##8##2##(2007-9#1)(2008-10#2)(2008-12#1)(2010-8#2)(2011-2#1)(2012-2#1)
those when##3##2##(1994-8#1)(2006-3#1)(2008-9#1)
those where##9##2##(1990-4#1)(1990-9#1)(1992-6#1)(1994-3#1)(1994-6#1)(2007-1#1)(2008-9#1)(2009-7#1)(2010-5#1)
those which are##9##3##(2005-11#1)(2005-7#1)(2008-1#2)(2008-10#2)(2008-5#1)(2010-12#1)(2013-8#1)
those which had been##2##4##(1992-2#1)(1992-9#1)
those which had##4##3##(1992-2#1)(1992-9#1)(1994-6#1)(2013-8#1)
those which were##3##3##(1991-3#1)(1997-2#1)(2008-5#1)
those which##36##2##(1990-4#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-2#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-6#1)(1996-10#1)(1996-12#1)(1997-2#1)(2005-11#3)(2005-7#1)(2006-10#1)(2007-4#1)(2008-1#2)(2008-10#3)(2008-4#1)(2008-5#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-8#2)
those who are at##2##4##(2006-10#2)
those who are concerned##4##4##(1993-11#1)(2007-4#1)(2007-6#1)(2011-2#1)
those who are dying##2##4##(1993-12#1)(2007-12#1)
those who are infected##2##4##(2004-9#1)(2012-3#1)
those who are most##2##4##(2006-10#1)(2007-7#1)
those who are not##4##4##(1995-12#1)(1996-11#1)(2006-12#1)(2008-11#1)
those who are##43##3##(1990-12#1)(1991-2#1)(1991-4#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-1#1)(1995-12#1)(1996-11#1)(2004-9#1)(2006-10#5)(2006-12#1)(2006-8#2)(2007-12#1)(2007-4#2)(2007-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2011-1#2)(2011-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
those who attended training##2##4##(2013-8#2)
those who attended##4##3##(2007-10#1)(2009-5#1)(2013-8#2)
those who became##2##3##(2006-10#1)(2006-11#1)
those who can be##2##4##(2008-3#1)(2011-1#1)
those who can##4##3##(1991-4#1)(1996-2#1)(2008-3#1)(2011-1#1)
those who cannot##3##3##(1994-2#1)(2007-3#1)(2007-6#1)
those who care for them##2##5##(1992-3#1)(2008-7#1)
those who continued##2##3##(1991-3#1)(2008-11#1)
those who could##2##3##(1992-12#1)(2007-7#1)
those who develop##5##3##(2007-9#1)(2008-3#1)(2008-6#1)(2010-5#1)(2013-7#1)
those who did not have##4##5##(1996-12#1)(2008-7#1)(2012-12#1)(2012-3#1)
those who did not receive##2##5##(1990-6#1)(2007-7#1)
those who did not##31##4##(1990-11#1)(1990-6#1)(1991-8#2)(1993-3#1)(1996-12#1)(2004-12#1)(2004-3#1)(2006-9#2)(2007-10#2)(2007-12#2)(2007-2#2)(2007-7#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#2)(2009-4#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
those who did##34##3##(1990-11#1)(1990-6#1)(1991-8#2)(1992-5#1)(1993-3#2)(1993-7#1)(1996-12#1)(2004-12#1)(2004-3#1)(2006-9#2)(2007-10#2)(2007-12#2)(2007-2#2)(2007-7#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#2)(2009-4#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
those who died##2##3##(1990-9#1)(2007-8#1)
those who discontinued treatment##2##4##(2011-2#2)
those who do not##8##4##(1994-4#1)(2005-10#1)(2006-5#1)(2007-10#1)(2008-4#1)(2009-10#1)(2009-12#1)(2011-2#1)
those who do##10##3##(1994-3#1)(1994-4#1)(2005-10#1)(2006-5#1)(2007-10#1)(2008-12#1)(2008-4#1)(2009-10#1)(2009-12#1)(2011-2#1)
those who engaged in##2##4##(2009-10#1)(2013-1#1)
those who experience##2##3##(1993-10#1)(2013-1#1)
those who experienced##3##3##(1992-1#1)(2011-1#1)(2012-11#1)
those who grew up##2##4##(2011-12#2)
those who had a##2##4##(2008-3#1)(2013-7#1)
those who had been##5##4##(1997-5#1)(2007-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
those who had had##2##4##(1990-12#1)(2013-1#1)
those who had lower##2##4##(2004-11#1)(2009-4#1)
those who had no##2##4##(2008-11#1)(2012-3#1)
those who had not##12##4##(1993-1#1)(1993-3#1)(1995-2#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-4#2)(2008-9#1)(2012-12#2)(2012-3#1)
those who had undergone##2##4##(2013-1#1)(2013-8#1)
those who had##61##3##(1990-10#1)(1990-12#1)(1990-4#1)(1990-6#1)(1991-12#1)(1991-7#1)(1993-1#1)(1993-2#1)(1993-3#2)(1995-2#1)(1995-9#1)(1996-1#1)(1996-12#1)(1997-5#1)(2004-11#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#2)(2007-7#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-4#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-12#5)(2012-2#2)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#1)
those who have a##3##4##(1993-12#1)(2006-10#1)(2009-12#1)
those who have been##3##4##(1995-6#1)(2008-11#1)(2010-2#1)
those who have experienced##2##4##(2004-3#1)(2012-11#1)
those who have had##2##4##(2006-10#1)(2007-9#1)
those who have##23##3##(1993-12#1)(1994-4#1)(1995-6#1)(2004-3#1)(2004-9#1)(2006-10#4)(2006-5#1)(2006-9#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-2#1)(2012-11#1)(2013-1#1)
those who initiated PT on##2##5##(2012-2#2)
those who left##2##3##(1994-3#1)(2011-2#1)
those who made##2##3##(1992-1#1)(2009-10#1)
those who may##3##3##(2007-4#1)(2012-1#1)(2013-8#1)
those who need to##2##4##(1993-2#1)(2008-3#1)
those who need##4##3##(1991-3#1)(1993-2#1)(1995-1#1)(2008-3#1)
those who never##4##3##(1990-8#1)(1996-1#1)(2009-5#2)
those who presented with##3##4##(1994-12#1)(2005-8#1)(2007-9#1)
those who receive##3##3##(2008-2#1)(2010-2#1)(2010-4#1)
those who received them##2##4##(1990-6#1)(1993-3#1)
those who received##12##3##(1990-6#2)(1991-4#1)(1993-3#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-6#2)(2010-8#1)(2011-2#1)(2013-8#1)
those who reported##3##3##(1993-1#1)(1994-1#1)(2013-8#1)
those who responded##2##3##(2006-8#1)(2007-9#1)
those who started##2##3##(2007-2#1)(2013-8#1)
those who suffer from##3##4##(2005-3#1)(2006-7#1)(2008-8#1)
those who suffer##4##3##(2005-3#1)(2006-7#1)(2008-3#1)(2008-8#1)
those who survived##2##3##(1995-9#1)(2011-3#1)
those who take##2##3##(1995-1#1)(2008-11#1)
those who underwent##3##3##(2006-8#1)(2007-8#1)(2008-6#1)
those who went##2##3##(1995-3#1)(2008-1#1)
those who were not##8##4##(1991-8#1)(1992-2#1)(2007-2#2)(2007-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
those who were transfused##2##4##(2012-2#2)
those who were##44##3##(1990-2#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-2#2)(1993-1#1)(1993-3#1)(1997-8#1)(2006-10#1)(2006-7#2)(2007-2#2)(2007-5#1)(2007-6#1)(2008-1#1)(2008-6#1)(2008-7#3)(2008-8#3)(2009-10#1)(2009-2#2)(2010-10#1)(2010-2#2)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#4)(2013-1#2)(2013-8#2)
those who wish to##3##4##(1991-12#1)(1991-5#1)(2012-3#1)
those who wish##4##3##(1991-12#1)(1991-5#1)(2009-10#1)(2012-3#1)
those who work with##2##4##(2006-3#1)(2011-2#1)
those who work##5##3##(1996-12#1)(2006-3#1)(2010-10#1)(2011-2#1)(2013-1#1)
those who would##3##3##(1991-7#2)(2006-10#1)
those who##438##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-4#1)(1990-6#5)(1990-8#1)(1990-9#3)(1991-12#3)(1991-2#1)(1991-3#3)(1991-4#3)(1991-5#1)(1991-7#4)(1991-8#3)(1991-9#3)(1992-1#2)(1992-10#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-5#1)(1993-1#3)(1993-10#1)(1993-11#1)(1993-12#6)(1993-2#2)(1993-3#8)(1993-7#2)(1994-1#4)(1994-12#1)(1994-2#2)(1994-3#4)(1994-4#2)(1994-8#1)(1995-1#3)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#2)(1996-1#2)(1996-11#2)(1996-12#4)(1996-2#1)(1996-3#1)(1997-4#1)(1997-5#1)(1997-8#2)(2004-10#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-3#2)(2004-4#1)(2004-9#2)(2005-10#1)(2005-3#1)(2005-8#2)(2006-10#24)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#2)(2006-7#3)(2006-8#6)(2006-9#3)(2007-10#6)(2007-11#4)(2007-12#8)(2007-2#9)(2007-3#3)(2007-4#4)(2007-5#1)(2007-6#3)(2007-7#6)(2007-8#6)(2007-9#5)(2008-1#6)(2008-10#3)(2008-11#12)(2008-12#2)(2008-2#3)(2008-3#8)(2008-4#5)(2008-5#3)(2008-6#6)(2008-7#6)(2008-8#8)(2008-9#2)(2009-10#7)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#7)(2009-6#1)(2009-7#4)(2009-8#1)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#6)(2010-2#6)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#4)(2011-1#7)(2011-12#5)(2011-2#17)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#9)(2012-2#9)(2012-3#13)(2013-1#19)(2013-7#3)(2013-8#11)
those whose##17##2##(1992-3#1)(1995-5#1)(2006-10#1)(2006-2#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-8#1)
those wishing to##3##3##(2008-11#1)(2008-4#1)(2012-12#1)
those with &lt##3##3##(2010-3#1)(2011-1#1)(2012-2#1)
those with 1##2##3##(2008-10#1)(2008-11#1)
those with LBP##3##3##(2004-10#1)(2012-12#1)(2012-2#1)
those with Parkinson's disease##2##4##(1994-4#1)(2012-12#1)
those with a history of##4##5##(2007-11#1)(2008-10#1)(2012-2#1)(2013-1#1)
those with a low##2##4##(1992-9#1)(2007-11#1)
those with a normal##2##4##(2008-10#1)(2008-5#1)
those with a positive##2##4##(2008-9#1)(2010-8#1)
those with a tectal tumor##2##5##(2006-5#2)
those with a##51##3##(1990-9#2)(1991-12#1)(1991-5#1)(1992-1#1)(1992-9#1)(1993-11#1)(1993-2#1)(1995-9#1)(1996-12#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-5#2)(2007-11#2)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
those with active##2##3##(2009-10#1)(2010-1#1)
those with acute##2##3##(1992-6#1)(2005-6#1)
those with advanced##2##3##(2006-10#1)(2008-3#1)
those with an active##2##4##(1997-8#1)(2013-7#1)
those with an##18##3##(1991-8#1)(1992-7#1)(1997-8#1)(2006-4#1)(2006-7#2)(2007-1#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-4#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
those with and without##4##4##(2008-3#1)(2010-12#1)(2013-1#1)(2013-8#1)
those with atherosclerotic##2##3##(2007-10#1)(2013-8#1)
those with better##3##3##(1995-10#2)(2011-1#1)
those with bilateral##2##3##(1995-12#1)(2007-10#1)
those with both##4##3##(1997-2#1)(2006-2#1)(2007-2#1)(2009-7#1)
those with cancer##4##3##(2004-2#2)(2007-2#1)(2007-4#1)
those with cardiac##2##3##(2007-11#1)(2008-3#1)
those with chronic##4##3##(2008-1#1)(2008-3#1)(2009-2#1)(2012-3#1)
those with collateral flow##2##4##(1997-8#2)
those with combined##3##3##(2009-5#1)(2012-1#1)(2012-2#1)
those with conventional##3##3##(2006-8#1)(2007-11#1)(2010-3#1)
those with darker skin##2##4##(2006-12#1)(2010-8#1)
those with darker##3##3##(2006-12#1)(2010-8#2)
those with delayed##2##3##(2007-8#1)(2010-12#1)
those with diabetes##3##3##(1996-9#1)(2007-7#1)(2011-2#1)
those with early##2##3##(2009-8#1)(2011-2#1)
those with eating##4##3##(2006-7#3)(2007-12#1)
those with effect##2##3##(2008-7#1)(2012-3#1)
those with elevated##4##3##(2006-10#1)(2006-6#1)(2008-7#1)(2011-2#1)
those with expertise##2##3##(2008-8#1)(2011-2#1)
those with extremely##2##3##(1992-3#1)(2006-10#1)
those with familial##2##3##(1993-9#1)(1997-2#1)
those with family##2##3##(2008-7#1)(2010-11#1)
those with good##2##3##(1996-9#1)(2008-5#1)
those with high##6##3##(1990-8#1)(1995-6#1)(2004-11#1)(2005-10#1)(2008-12#1)(2012-2#1)
those with higher##12##3##(1991-1#1)(1995-10#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-4#1)(2012-3#1)(2013-1#1)
those with hypertension##2##3##(2008-8#1)(2013-1#1)
those with incomplete##2##3##(2011-1#1)(2013-1#1)
those with increased##2##3##(2011-1#1)(2012-2#1)
those with known##4##3##(2008-11#1)(2010-12#1)(2011-1#1)(2013-8#1)
those with lesions##2##3##(1991-2#1)(1996-9#1)
those with less than##3##4##(1993-9#1)(2008-8#1)(2012-12#1)
those with less##5##3##(1993-9#1)(2007-1#1)(2008-8#1)(2012-12#1)(2012-3#1)
those with limited##2##3##(2007-7#1)(2008-2#1)
those with low##10##3##(1991-2#1)(1994-8#1)(2006-10#1)(2006-2#1)(2007-3#1)(2007-7#1)(2008-1#1)(2009-2#1)(2011-1#1)(2012-2#1)
those with lower levels##2##4##(1994-2#1)(2011-2#1)
those with lower##7##3##(1994-2#1)(1997-8#1)(2006-10#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
those with malignant##2##3##(2007-3#1)(2008-3#1)
those with more##3##3##(1994-11#1)(2004-1#1)(2008-10#1)
those with multiple##3##3##(1991-2#2)(2008-5#1)
those with no##17##3##(1991-2#1)(1993-1#1)(1993-5#1)(1994-2#1)(1995-12#1)(1995-4#1)(2004-2#1)(2006-1#1)(2007-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-1#1)(2013-8#1)
those with noncystic##2##3##(2007-12#2)
those with normal##12##3##(1990-2#2)(1990-6#1)(1991-12#1)(2005-9#1)(2006-10#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-3#1)(2012-3#1)
those with only##4##3##(1992-8#1)(1993-2#1)(2008-7#1)(2012-2#1)
those with or without##2##4##(2007-2#1)(2007-7#1)
those with other##2##3##(2007-3#1)(2010-10#1)
those with partial##2##3##(2006-10#1)(2008-7#1)
those with penetrating##2##3##(2006-10#2)
those with physical illnesses##2##4##(2009-4#1)(2010-12#1)
those with positive##2##3##(1993-3#1)(2012-2#1)
those with pre-existing##2##3##(2007-11#1)(2007-2#1)
those with primary##3##3##(2008-6#2)(2013-1#1)
those with progressive##2##3##(1992-12#1)(2009-2#1)
those with psychotic symptoms##2##4##(2007-6#1)(2009-7#1)
those with relatively##2##3##(2006-10#1)(2008-3#1)
those with renal##2##3##(2007-11#1)(2008-6#1)
those with serious##2##3##(2006-6#1)(2011-2#1)
those with severe##4##3##(2007-11#1)(2008-7#1)(2010-5#1)(2012-12#1)
those with significant##2##3##(1993-12#1)(2008-7#1)
those with some##2##3##(1992-8#1)(2009-9#1)
those with sporadic AD##2##4##(1994-8#1)(1997-5#1)
those with stable##2##3##(1990-2#1)(1994-8#1)
those with strong##3##3##(1993-12#2)(1996-2#1)
those with systemic##2##3##(2006-10#1)(2007-11#1)
those with the##29##3##(1990-8#1)(1992-8#1)(1993-10#2)(1994-11#1)(1995-10#1)(1995-2#1)(1995-4#1)(2004-11#1)(2004-2#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-5#1)(2007-9#2)(2008-10#5)(2008-2#1)(2008-3#1)(2008-8#2)(2012-2#2)
those with thyroid disorders had significantly greater average annual total healthcare expenditures ($15##2##13##(2013-1#2)
those with twin##2##3##(2008-3#2)
those with underlying##2##3##(2005-8#1)(2011-1#1)
those with various##3##3##(2008-3#1)(2008-7#1)(2012-2#1)
those with very low##2##4##(2008-7#1)(2011-1#1)
those with very##3##3##(2008-7#1)(2010-11#1)(2011-1#1)
those with##602##2##(1990-12#1)(1990-2#4)(1990-3#1)(1990-4#1)(1990-6#3)(1990-8#2)(1990-9#3)(1991-1#1)(1991-10#1)(1991-12#4)(1991-2#5)(1991-4#1)(1991-5#1)(1991-7#4)(1991-8#1)(1991-9#1)(1992-1#4)(1992-10#2)(1992-11#1)(1992-12#2)(1992-3#5)(1992-5#1)(1992-6#2)(1992-7#4)(1992-8#4)(1992-9#1)(1993-1#1)(1993-10#2)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#3)(1993-5#2)(1993-8#1)(1993-9#4)(1994-11#3)(1994-12#1)(1994-2#4)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-10#4)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#6)(1995-4#2)(1995-6#1)(1995-9#2)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#2)(1996-4#1)(1996-8#1)(1996-9#5)(1997-1#1)(1997-2#3)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#5)(2004-1#3)(2004-10#3)(2004-11#2)(2004-12#1)(2004-2#4)(2004-3#1)(2004-9#1)(2005-1#1)(2005-10#5)(2005-11#1)(2005-6#1)(2005-8#5)(2005-9#2)(2006-1#1)(2006-10#23)(2006-11#3)(2006-12#1)(2006-2#5)(2006-4#2)(2006-5#3)(2006-6#2)(2006-7#5)(2006-8#5)(2007-1#4)(2007-10#10)(2007-11#21)(2007-12#6)(2007-2#7)(2007-3#7)(2007-4#3)(2007-5#3)(2007-6#2)(2007-7#6)(2007-8#7)(2007-9#5)(2008-1#12)(2008-10#18)(2008-11#9)(2008-12#4)(2008-2#4)(2008-3#17)(2008-4#6)(2008-5#7)(2008-6#5)(2008-7#26)(2008-8#8)(2008-9#4)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#5)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#2)(2009-7#4)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#5)(2010-12#11)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#5)(2011-1#14)(2011-12#1)(2011-2#25)(2012-1#3)(2012-12#10)(2012-2#27)(2012-3#7)(2013-1#15)(2013-7#2)(2013-8#9)
those within the##3##3##(1990-10#1)(2008-1#1)(2010-8#1)
those within##4##2##(1990-10#1)(2008-1#1)(2008-9#1)(2010-8#1)
those without CoM##2##3##(2008-8#2)
those without a significant##2##4##(2008-7#2)
those without a##7##3##(1996-8#1)(2007-1#1)(2007-10#1)(2008-7#2)(2008-9#1)(2013-8#1)
those without previous##2##3##(1996-12#1)(2013-8#1)
those without stroke##3##3##(2007-10#3)
those without such##3##3##(1990-8#1)(2008-3#1)(2008-7#1)
those without the##6##3##(1992-11#1)(2007-4#1)(2008-3#2)(2008-5#1)(2010-4#1)
those without thyroid disorders##4##4##(2013-1#4)
those without##99##2##(1990-2#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-11#2)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-7#1)(1995-10#1)(1995-6#2)(1996-12#1)(1996-2#2)(1996-8#1)(1997-1#2)(1997-3#1)(1997-8#1)(2004-2#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#8)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#3)(2009-11#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-4#2)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#9)(2013-8#5)
those women who##3##3##(1990-6#1)(2006-8#2)
those women##5##2##(1990-6#2)(2006-4#1)(2006-8#2)
those working in##5##3##(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-8#1)
those working##6##2##(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
those written by##2##3##(2008-4#1)(2010-12#1)
those young##2##2##(2006-6#1)(2007-1#1)
those##7534##1##(1990-1#3)(1990-10#15)(1990-11#15)(1990-12#45)(1990-2#38)(1990-3#23)(1990-4#19)(1990-5#32)(1990-6#23)(1990-7#24)(1990-8#23)(1990-9#18)(1991-1#10)(1991-10#12)(1991-11#15)(1991-12#36)(1991-2#39)(1991-3#42)(1991-4#22)(1991-5#33)(1991-6#24)(1991-7#30)(1991-8#24)(1991-9#31)(1992-1#30)(1992-10#16)(1992-11#23)(1992-12#37)(1992-2#23)(1992-3#36)(1992-4#16)(1992-5#11)(1992-6#30)(1992-7#29)(1992-8#25)(1992-9#22)(1993-1#21)(1993-10#6)(1993-11#31)(1993-12#35)(1993-2#27)(1993-3#37)(1993-4#10)(1993-5#12)(1993-6#16)(1993-7#13)(1993-8#16)(1993-9#46)(1994-1#14)(1994-10#7)(1994-11#33)(1994-12#42)(1994-2#33)(1994-3#47)(1994-4#7)(1994-5#20)(1994-6#20)(1994-7#5)(1994-8#37)(1994-9#25)(1995-1#24)(1995-10#15)(1995-11#27)(1995-12#43)(1995-2#25)(1995-3#42)(1995-4#10)(1995-5#42)(1995-6#38)(1995-7#11)(1995-8#25)(1995-9#10)(1996-1#24)(1996-10#14)(1996-11#20)(1996-12#42)(1996-2#38)(1996-3#27)(1996-4#18)(1996-5#24)(1996-6#19)(1996-7#22)(1996-8#19)(1996-9#19)(1997-1#29)(1997-2#41)(1997-3#36)(1997-4#36)(1997-5#28)(1997-6#35)(1997-7#35)(1997-8#46)(2004-1#8)(2004-10#9)(2004-11#17)(2004-12#9)(2004-2#14)(2004-3#6)(2004-4#12)(2004-7#1)(2004-8#1)(2004-9#14)(2005-1#3)(2005-10#24)(2005-11#59)(2005-12#9)(2005-3#4)(2005-4#10)(2005-5#2)(2005-6#1)(2005-7#19)(2005-8#27)(2005-9#10)(2006-1#12)(2006-10#157)(2006-11#28)(2006-12#44)(2006-2#36)(2006-3#16)(2006-4#19)(2006-5#31)(2006-6#32)(2006-7#26)(2006-8#55)(2006-9#13)(2007-1#23)(2007-10#64)(2007-11#120)(2007-12#125)(2007-2#56)(2007-3#34)(2007-4#42)(2007-5#24)(2007-6#21)(2007-7#60)(2007-8#84)(2007-9#49)(2008-1#79)(2008-10#840)(2008-11#124)(2008-12#59)(2008-2#142)(2008-3#186)(2008-4#92)(2008-5#196)(2008-6#57)(2008-7#176)(2008-8#106)(2008-9#135)(2009-1#1)(2009-10#33)(2009-11#13)(2009-12#23)(2009-2#25)(2009-3#34)(2009-4#39)(2009-5#32)(2009-6#19)(2009-7#28)(2009-8#30)(2009-9#21)(2010-1#14)(2010-10#18)(2010-11#18)(2010-12#64)(2010-2#37)(2010-3#21)(2010-4#50)(2010-5#25)(2010-6#14)(2010-7#15)(2010-8#40)(2010-9#9)(2011-1#92)(2011-11#1)(2011-12#17)(2011-2#199)(2011-3#2)(2012-1#38)(2012-11#11)(2012-12#105)(2012-2#127)(2012-3#80)(2012-5#1)(2012-7#1)(2012-8#1)(2012-9#1)(2013-1#145)(2013-7#31)(2013-8#99)
though a number of##2##4##(1997-4#1)(2008-12#1)
though a##19##2##(1991-8#1)(1992-6#1)(1994-3#1)(1996-5#1)(1997-4#1)(2005-11#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-3#1)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
though all##4##2##(1993-7#1)(1997-8#1)(2007-11#1)(2008-10#1)
though an##3##2##(2008-2#1)(2008-7#1)(2013-8#1)
though associated with##2##3##(2007-7#1)(2007-8#1)
though at a##2##3##(1993-6#1)(2013-1#1)
though at##5##2##(1993-6#1)(1996-9#1)(2009-4#1)(2012-1#1)(2013-1#1)
though each##3##2##(1995-11#1)(2007-4#1)(2011-1#1)
though further research is##2##4##(2009-1#1)(2011-1#1)
though further##3##2##(2009-1#1)(2011-1#1)(2012-12#1)
though in the##2##3##(2007-5#1)(2008-6#1)
though in##7##2##(1993-3#1)(1994-2#1)(1996-11#1)(2007-5#1)(2008-10#1)(2008-6#1)(2011-1#1)
though it has lower##2##4##(2008-9#1)(2012-12#1)
though it has##4##3##(2006-8#1)(2008-11#1)(2008-9#1)(2012-12#1)
though it is not##2##4##(2008-11#1)(2010-9#1)
though it is possible that##2##5##(1991-6#1)(2011-2#1)
though it is##15##3##(1991-11#1)(1991-6#1)(1995-1#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-8#1)
though it seems##2##3##(2008-1#1)(2012-11#1)
though it was not##2##4##(2006-8#1)(2008-10#1)
though it was##5##3##(1990-12#1)(1991-1#1)(1992-6#1)(2006-8#1)(2008-10#1)
though it##48##2##(1990-12#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-4#1)(1992-6#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-11#1)(1996-9#1)(2005-10#1)(2006-12#1)(2006-2#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-8#1)(2013-8#2)
though its##8##2##(1990-12#2)(2006-2#1)(2007-12#1)(2008-1#1)(2008-5#1)(2009-6#1)(2012-12#1)
though less##6##2##(1991-1#1)(2006-7#1)(2006-8#1)(2008-10#1)(2012-1#1)(2012-3#1)
though many studies##2##3##(1992-9#1)(2008-3#1)
though many##9##2##(1992-9#1)(1995-1#1)(1996-3#1)(2005-11#1)(2006-10#1)(2008-2#1)(2008-3#1)(2011-1#1)(2012-2#1)
though modestly##2##2##(1992-3#1)(2010-5#1)
though more##6##2##(1993-1#1)(1994-3#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
though most##8##2##(1994-4#1)(2006-8#1)(2007-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-2#1)
though no##5##2##(1992-7#1)(1997-4#1)(2007-11#2)(2007-9#1)
though not significant##2##3##(2008-10#1)(2008-6#1)
though not statistically significant##3##4##(1992-3#1)(2008-10#1)(2010-3#1)
though not sufficient##2##3##(1992-7#1)(2006-5#1)
though not##24##2##(1990-12#2)(1991-12#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#1)(1994-12#1)(1995-2#1)(1996-5#1)(1997-7#1)(2005-8#1)(2006-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-8#1)(2010-3#1)(2011-1#1)(2012-1#1)(2013-8#1)
though often##4##2##(2006-10#1)(2007-4#1)(2009-8#1)(2012-2#1)
though one##3##2##(2008-12#1)(2008-4#1)(2010-4#1)
though only##6##2##(1992-10#1)(2008-10#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-2#1)
though present##2##2##(1994-9#1)(1996-12#1)
though rare##8##2##(1993-10#1)(2007-7#1)(2007-8#1)(2008-4#1)(2009-9#1)(2010-9#1)(2011-2#2)
though results##3##2##(1991-4#1)(1997-1#1)(2009-5#1)
though several##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
though similar##2##2##(2010-4#1)(2011-2#1)
though some##8##2##(2006-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2009-6#1)(2010-8#1)(2012-12#1)(2013-7#1)
though still##2##2##(2008-4#1)(2011-1#1)
though such##2##2##(1995-6#1)(2013-1#1)
though that##2##2##(2006-12#1)(2007-11#1)
though the intensity##2##3##(1993-7#1)(2008-3#1)
though the new##2##3##(1992-5#1)(2005-8#1)
though the number of patients##2##5##(2006-8#1)(2007-8#1)
though the number of##3##4##(1995-6#1)(2006-8#1)(2007-8#1)
though the total##2##3##(2008-11#1)(2012-12#1)
though the two##6##3##(2005-11#1)(2007-7#1)(2009-4#1)(2013-1#2)(2013-8#1)
though the##125##2##(1990-12#1)(1990-4#1)(1991-10#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-4#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#3)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2004-12#1)(2004-4#1)(2004-8#1)(2005-11#2)(2005-8#2)(2006-10#2)(2006-2#1)(2006-5#2)(2006-8#2)(2006-9#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#3)(2008-10#11)(2008-11#3)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-12#5)(2012-2#4)(2013-1#5)(2013-8#2)
though their##4##2##(1994-8#1)(2007-8#1)(2008-10#1)(2009-10#1)
though there are##2##3##(1991-1#1)(2012-12#1)
though there is some evidence that##2##6##(1993-1#1)(2007-2#1)
though there is##7##3##(1993-1#1)(1997-1#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-1#1)(2013-8#1)
though there was a##2##4##(2008-5#1)(2009-5#1)
though there was##4##3##(1994-3#1)(2006-12#1)(2008-5#1)(2009-5#1)
though there were##2##3##(2004-4#1)(2013-8#1)
though there##16##2##(1991-1#1)(1993-1#1)(1994-3#1)(1997-1#1)(2004-4#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-1#2)(2008-5#1)(2009-5#1)(2012-12#1)(2013-8#2)
though these##9##2##(1991-12#1)(1991-3#1)(2006-8#1)(2007-11#1)(2009-4#1)(2009-7#1)(2010-7#1)(2012-12#1)(2012-2#1)
though they are##4##3##(1993-7#1)(1995-8#1)(2006-11#1)(2006-9#1)
though they may##3##3##(1993-3#1)(2008-8#1)(2010-7#1)
though they were##5##3##(1993-5#1)(1996-12#1)(2007-10#1)(2008-10#1)(2009-4#1)
though they##22##2##(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-7#1)(1995-8#1)(1996-12#1)(1997-6#1)(2006-11#1)(2006-9#1)(2007-10#2)(2007-4#1)(2008-10#2)(2008-8#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-7#1)(2012-1#2)
though this may##2##3##(2005-8#1)(2007-6#1)
though this##18##2##(1993-3#1)(1996-2#1)(1996-8#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-7#1)(2007-10#1)(2007-6#2)(2007-9#1)(2008-10#1)(2009-11#1)(2010-11#1)(2010-8#2)(2012-2#1)
though to a##2##3##(2008-10#1)(2013-1#1)
though to be##3##3##(1992-5#1)(1994-5#1)(1996-6#1)
though to reflect##2##3##(1994-3#1)(1996-6#1)
though to##9##2##(1992-5#1)(1993-8#1)(1994-3#1)(1994-5#1)(1996-6#2)(1997-4#1)(2008-10#1)(2013-1#1)
though unlikely##2##2##(1994-11#1)(2011-2#1)
though very high overall##2##4##(2013-1#2)
though very##3##2##(2010-1#1)(2013-1#2)
though we##4##2##(1994-3#1)(1997-7#1)(2006-7#1)(2008-8#1)
though with##4##2##(1990-3#1)(1996-9#1)(2008-5#1)(2012-2#1)
though##662##1##(1990-10#1)(1990-11#1)(1990-12#7)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-1#4)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-4#2)(1992-5#3)(1992-6#3)(1992-7#3)(1992-8#1)(1992-9#4)(1993-1#2)(1993-10#1)(1993-12#3)(1993-2#1)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#3)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#2)(1994-2#3)(1994-3#7)(1994-4#2)(1994-5#2)(1994-8#2)(1994-9#3)(1995-1#3)(1995-10#1)(1995-11#2)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#4)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#5)(1996-12#5)(1996-2#3)(1996-3#3)(1996-4#2)(1996-5#3)(1996-6#3)(1996-7#1)(1996-8#2)(1996-9#3)(1997-1#4)(1997-2#4)(1997-3#2)(1997-4#7)(1997-5#2)(1997-6#1)(1997-7#5)(1997-8#4)(2004-1#1)(2004-11#1)(2004-12#2)(2004-4#2)(2004-8#1)(2004-9#1)(2005-10#1)(2005-11#7)(2005-7#1)(2005-8#4)(2006-1#1)(2006-10#10)(2006-11#1)(2006-12#4)(2006-2#4)(2006-5#4)(2006-7#4)(2006-8#17)(2006-9#2)(2007-1#3)(2007-10#6)(2007-11#14)(2007-12#7)(2007-2#2)(2007-3#1)(2007-4#6)(2007-5#3)(2007-6#4)(2007-7#7)(2007-8#13)(2007-9#3)(2008-1#14)(2008-10#50)(2008-11#11)(2008-12#6)(2008-2#8)(2008-3#11)(2008-4#8)(2008-5#12)(2008-6#4)(2008-7#10)(2008-8#10)(2008-9#7)(2009-1#1)(2009-10#1)(2009-11#2)(2009-3#2)(2009-4#5)(2009-5#8)(2009-6#5)(2009-7#2)(2009-8#5)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#2)(2010-2#4)(2010-3#2)(2010-4#4)(2010-5#3)(2010-7#2)(2010-8#6)(2010-9#4)(2011-1#10)(2011-12#1)(2011-2#26)(2011-3#1)(2012-1#6)(2012-11#1)(2012-12#14)(2012-2#21)(2012-3#1)(2012-8#1)(2013-1#19)(2013-7#5)(2013-8#12)
thought about##6##2##(2006-6#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-10#1)
thought and its##2##3##(2009-12#1)(2013-8#1)
thought and that##2##3##(1997-4#1)(2008-11#1)
thought and the##2##3##(2008-8#1)(2012-2#1)
thought and##20##2##(1993-3#1)(1995-12#1)(1995-3#1)(1996-3#1)(1997-3#1)(1997-4#1)(2005-7#1)(2006-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#2)
thought as##4##2##(2010-8#1)(2012-2#1)(2012-3#2)
thought could##2##2##(2007-7#1)(2012-2#1)
thought disorder in##3##3##(1997-2#1)(2006-3#1)(2010-2#1)
thought disorder##11##2##(1997-2#3)(1997-8#1)(2005-7#1)(2006-3#2)(2007-5#1)(2008-11#1)(2010-2#2)
thought experiments##2##2##(1992-3#1)(2008-8#1)
thought for##2##2##(1996-12#1)(2013-1#1)
thought in##7##2##(1994-8#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-7#1)(2009-5#1)
thought initially to##2##3##(1992-9#1)(2008-5#1)
thought intrusion##2##2##(2012-3#2)
thought is##2##2##(1995-1#1)(2008-3#1)
thought it was##2##3##(2006-5#1)(2007-12#1)
thought it##6##2##(2006-5#1)(2007-12#1)(2010-9#1)(2011-1#1)(2012-3#2)
thought not to##4##3##(2006-12#1)(2007-11#1)(2007-8#1)(2011-12#1)
thought of as being##2##4##(2007-8#1)(2012-11#1)
thought of as##12##3##(1996-3#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-4#1)(2007-8#1)(2008-10#2)(2008-5#1)(2010-8#1)(2012-11#1)(2013-1#1)
thought of in##2##3##(2008-6#1)(2010-5#1)
thought of##18##2##(1996-3#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-4#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2009-10#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-11#1)(2013-1#1)
thought on##2##2##(2006-12#1)(2011-3#1)
thought out##2##2##(2007-6#1)(2008-5#1)
thought process##2##2##(2012-12#2)
thought processes##6##2##(2007-12#1)(2007-3#1)(2011-2#1)(2012-12#2)(2013-8#1)
thought suppression and cognitive##2##4##(2009-11#2)
thought suppression and##3##3##(2009-11#2)(2012-3#1)
thought suppression##9##2##(2009-11#5)(2012-3#4)
thought that a##6##3##(1996-5#1)(2006-12#1)(2007-5#1)(2008-5#1)(2008-6#1)(2010-12#1)
thought that an##2##3##(1991-9#1)(2013-7#1)
thought that differentiation##2##3##(2007-9#1)(2008-11#1)
thought that it##2##3##(1992-8#1)(2006-2#1)
thought that the##11##3##(1990-2#1)(1990-3#1)(1993-9#1)(1994-9#1)(1996-3#1)(1997-2#1)(2007-12#1)(2008-3#1)(2010-3#1)(2011-2#1)(2013-8#1)
thought that##48##2##(1990-2#2)(1990-3#1)(1990-6#1)(1990-7#1)(1991-9#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-9#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-2#1)(2004-12#1)(2005-7#1)(2006-12#1)(2006-2#3)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#3)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#2)(2013-8#1)
thought the##9##2##(1996-1#1)(2006-10#1)(2006-8#3)(2007-9#1)(2008-9#1)(2012-1#1)(2013-1#1)
thought their##2##2##(2007-12#1)(2008-9#1)
thought they were##3##3##(2008-10#1)(2009-3#1)(2011-2#1)
thought they##5##2##(2006-10#1)(2007-12#1)(2008-10#1)(2009-3#1)(2011-2#1)
thought to act as an##2##5##(1990-7#1)(2008-4#1)
thought to act as##6##4##(1990-7#1)(1996-12#1)(1997-6#1)(2008-12#1)(2008-4#1)(2012-2#1)
thought to act##9##3##(1990-7#1)(1993-9#1)(1996-12#1)(1997-3#1)(1997-6#1)(2005-9#1)(2008-12#1)(2008-4#1)(2012-2#1)
thought to affect##2##3##(1995-12#1)(2008-8#1)
thought to arise from the##2##5##(2012-3#1)(2013-7#1)
thought to arise from##4##4##(2007-6#1)(2007-7#1)(2012-3#1)(2013-7#1)
thought to arise##5##3##(2007-6#1)(2007-7#1)(2012-3#1)(2013-1#1)(2013-7#1)
thought to be &quot##2##4##(2006-10#1)(2007-12#1)
thought to be a##36##4##(1991-3#1)(1992-1#1)(1992-11#1)(1992-8#1)(1993-4#1)(1993-9#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-3#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-5#1)(2006-10#2)(2006-2#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-6#4)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2011-1#1)
thought to be also##2##4##(1996-2#1)(2008-11#1)
thought to be an important##6##5##(1996-11#1)(2005-10#1)(2005-8#1)(2007-2#1)(2007-4#1)(2012-3#1)
thought to be an##19##4##(1991-7#2)(1992-1#1)(1993-3#2)(1994-12#1)(1996-11#1)(2004-11#1)(2005-10#1)(2005-8#1)(2006-7#1)(2007-2#1)(2007-4#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
thought to be associated with##5##5##(1994-11#1)(2004-12#1)(2006-8#1)(2008-11#1)(2008-5#1)
thought to be caused by##7##5##(1990-11#1)(1993-2#1)(2006-8#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-9#1)
thought to be derived from##2##5##(1991-9#1)(2008-6#1)
thought to be due to##10##5##(1990-6#1)(1991-5#1)(1992-12#1)(1996-12#1)(1996-2#1)(2005-8#1)(2006-10#1)(2008-11#1)(2011-1#1)(2012-2#1)
thought to be due##11##4##(1990-6#1)(1991-5#1)(1992-12#1)(1996-12#1)(1996-2#1)(2005-8#1)(2006-10#1)(2008-11#1)(2008-8#1)(2011-1#1)(2012-2#1)
thought to be essential for##3##5##(1990-5#1)(1995-8#1)(2008-9#1)
thought to be essential to##2##5##(1996-9#1)(2004-10#1)
thought to be essential##5##4##(1990-5#1)(1995-8#1)(1996-9#1)(2004-10#1)(2008-9#1)
thought to be important for the##2##6##(1996-5#1)(1996-9#1)
thought to be important for##4##5##(1996-5#1)(1996-9#1)(1997-4#1)(2008-7#1)
thought to be important in##4##5##(1993-5#1)(1996-6#1)(2004-4#1)(2008-8#1)
thought to be important##11##4##(1990-11#1)(1993-5#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-4#1)(2004-4#1)(2007-11#1)(2008-7#1)(2008-8#2)
thought to be initiated by##4##5##(1990-11#1)(2008-11#1)(2008-4#2)
thought to be involved in the##6##6##(1993-9#1)(1994-6#1)(1995-5#1)(1996-11#1)(2008-10#1)(2008-8#1)
thought to be involved in##14##5##(1993-9#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-4#1)(1997-6#1)(2008-10#2)(2008-7#1)(2008-8#1)(2013-8#1)
thought to be involved##18##4##(1993-9#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-4#1)(1997-6#1)(2008-10#2)(2008-7#2)(2008-8#1)(2009-10#1)(2013-8#2)
thought to be mediated by the##2##6##(1990-6#1)(1995-6#1)
thought to be mediated by##3##5##(1990-6#1)(1991-5#1)(1995-6#1)
thought to be mediated through##2##5##(1995-3#1)(2008-4#1)
thought to be mediated##6##4##(1990-6#1)(1991-5#1)(1995-3#1)(1995-6#1)(2008-4#1)(2008-8#1)
thought to be necessary##2##4##(2008-11#1)(2010-8#1)
thought to be of importance##3##5##(2006-6#1)(2011-2#2)
thought to be of##5##4##(2006-11#1)(2006-6#1)(2011-2#2)(2013-1#1)
thought to be one of the##4##6##(1993-2#1)(2007-9#1)(2010-5#1)(2011-1#1)
thought to be related to##6##5##(1990-5#1)(1997-8#1)(2006-9#1)(2007-11#1)(2009-1#1)(2013-7#1)
thought to be relatively##2##4##(2008-10#1)(2010-7#1)
thought to be representative##2##4##(1991-3#1)(2007-4#1)
thought to be responsible for activation of##2##7##(1990-5#1)(1997-4#1)
thought to be responsible for the##4##6##(1991-2#1)(1995-1#1)(2006-12#2)
thought to be responsible for these##2##6##(2006-3#1)(2007-11#1)
thought to be responsible for##10##5##(1990-5#1)(1991-2#1)(1994-11#1)(1995-1#1)(1997-4#1)(2006-12#2)(2006-3#1)(2007-11#1)(2008-10#1)
thought to be secondary to##3##5##(1991-9#1)(2008-1#1)(2010-5#1)
thought to be the cause of the##2##7##(1997-2#1)(2008-7#1)
thought to be the cause of##6##6##(1990-11#1)(1996-8#1)(1997-1#1)(1997-2#1)(2008-4#1)(2008-7#1)
thought to be the major##4##5##(1996-10#1)(2005-3#1)(2008-7#1)(2010-12#1)
thought to be the only##3##5##(1993-4#1)(1994-9#1)(2010-12#1)
thought to be the##25##4##(1990-11#1)(1991-8#1)(1993-4#1)(1993-6#1)(1994-4#1)(1994-9#1)(1995-12#1)(1996-10#1)(1996-11#1)(1996-8#1)(1997-1#1)(1997-2#1)(2005-3#1)(2006-10#1)(2007-10#1)(2007-3#1)(2008-11#1)(2008-4#2)(2008-7#2)(2010-12#2)(2010-6#1)(2012-12#1)
thought to be useful for##2##5##(2008-11#1)(2008-6#1)
thought to be useful##3##4##(1993-1#1)(2008-11#1)(2008-6#1)
thought to be##292##3##(1990-10#1)(1990-11#4)(1990-5#4)(1990-6#2)(1990-9#1)(1991-10#1)(1991-2#2)(1991-3#3)(1991-5#3)(1991-7#2)(1991-8#1)(1991-9#3)(1992-1#2)(1992-11#1)(1992-12#5)(1992-8#1)(1993-1#1)(1993-2#2)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-11#2)(1994-12#4)(1994-2#1)(1994-4#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#3)(1995-12#2)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#1)(1995-8#3)(1996-1#2)(1996-10#1)(1996-11#5)(1996-12#2)(1996-2#3)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#1)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2004-10#1)(2004-11#1)(2004-12#1)(2004-4#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-3#1)(2005-5#1)(2005-8#2)(2006-1#1)(2006-10#7)(2006-11#1)(2006-12#2)(2006-2#3)(2006-3#1)(2006-6#3)(2006-7#2)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-2#3)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#4)(2008-1#2)(2008-10#12)(2008-11#10)(2008-3#5)(2008-4#6)(2008-5#8)(2008-6#6)(2008-7#9)(2008-8#6)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-12#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-11#1)(2011-2#7)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#4)
thought to belong to##2##4##(1992-3#1)(2008-9#1)
thought to constitute the##3##4##(1997-6#1)(2007-12#1)(2008-10#1)
thought to contain##2##3##(1995-11#1)(2008-5#1)
thought to contribute to the##2##5##(2008-10#1)(2008-5#1)
thought to contribute to##10##4##(1994-9#1)(1995-11#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#2)(2012-2#1)
thought to exist##4##3##(1990-8#1)(1995-8#1)(2008-10#1)(2008-8#1)
thought to function##2##3##(2008-9#1)(2009-3#1)
thought to have a beneficial effect on##2##7##(1995-9#1)(2012-3#1)
thought to have a##6##4##(1992-2#1)(1995-9#1)(1997-1#1)(2006-6#2)(2012-3#1)
thought to have been##4##4##(1992-3#1)(1996-12#1)(2006-2#1)(2008-9#1)
thought to have##31##3##(1992-2#1)(1992-3#1)(1993-8#1)(1993-9#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-1#1)(2004-10#1)(2006-10#2)(2006-2#1)(2006-6#3)(2007-2#1)(2007-8#1)(2008-4#2)(2008-9#1)(2009-6#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#1)
thought to improve##2##3##(2011-1#1)(2013-1#1)
thought to induce##2##3##(2006-10#1)(2008-11#1)
thought to influence the##3##4##(2007-12#1)(2008-12#1)(2008-8#1)
thought to influence##4##3##(2007-12#1)(2008-12#1)(2008-8#1)(2010-6#1)
thought to interact with##2##4##(1991-5#1)(1995-2#1)
thought to interact##3##3##(1991-5#1)(1995-2#1)(1996-1#1)
thought to involve the red nucleus##2##6##(1992-11#2)
thought to involve the##4##4##(1992-11#2)(1996-8#1)(2009-8#1)
thought to involve##13##3##(1991-12#1)(1992-11#2)(1996-8#1)(1997-5#1)(2006-9#1)(2008-5#1)(2008-9#1)(2009-1#1)(2009-8#1)(2012-11#1)(2012-12#1)(2013-8#1)
thought to mediate##5##3##(1991-8#1)(1993-12#1)(1995-2#1)(1997-4#1)(2008-6#1)
thought to modify##2##3##(1995-2#2)
thought to occur##8##3##(1994-3#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-2#1)
thought to play a critical role in##2##7##(1995-11#1)(2011-2#1)
thought to play a role in the##2##7##(1991-9#1)(1997-2#1)
thought to play a role in##5##6##(1991-9#1)(1993-3#1)(1995-12#1)(1997-2#1)(1997-4#1)
thought to play a##18##4##(1991-9#1)(1992-4#1)(1992-8#1)(1993-3#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)
thought to play an important role in many diseases##2##9##(1997-3#1)(2008-5#1)
thought to play an important role in##10##7##(1993-9#1)(1995-8#1)(1996-10#1)(1997-3#1)(1997-8#1)(2008-4#1)(2008-5#1)(2009-4#1)(2010-11#2)
thought to play important roles in##3##6##(2009-2#1)(2010-11#1)(2011-2#1)
thought to play important##4##4##(2009-2#1)(2010-11#1)(2011-2#1)(2013-1#1)
thought to play##32##3##(1991-9#1)(1992-4#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-10#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-4#1)(2010-11#3)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
thought to promote##2##3##(2012-12#1)(2012-3#1)
thought to reflect the##4##4##(1997-1#1)(2008-2#1)(2009-9#1)(2011-2#1)
thought to reflect##6##3##(1996-9#1)(1997-1#1)(2008-2#1)(2009-9#1)(2010-2#1)(2011-2#1)
thought to regulate##3##3##(1990-3#1)(2007-12#1)(2007-8#1)
thought to represent a##4##4##(1993-8#1)(2006-10#1)(2007-10#1)(2011-2#1)
thought to represent the##5##4##(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-1#1)
thought to represent##12##3##(1993-8#1)(1996-4#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
thought to require##2##3##(1990-3#1)(2009-9#1)
thought to result from the##4##5##(2007-12#1)(2008-9#1)(2009-3#1)(2010-12#1)
thought to result from##10##4##(1995-6#1)(1996-9#1)(2007-12#1)(2007-7#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-8#1)(2011-2#1)
thought to result##11##3##(1995-6#1)(1996-9#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-8#1)(2011-2#1)
thought to underlie##5##3##(2005-8#1)(2007-11#1)(2008-11#1)(2009-8#1)(2013-8#1)
thought to work##2##3##(2008-5#1)(2013-1#1)
thought to##549##2##(1990-10#1)(1990-11#4)(1990-12#1)(1990-3#2)(1990-5#6)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#3)(1991-5#5)(1991-7#2)(1991-8#2)(1991-9#5)(1992-1#2)(1992-11#5)(1992-12#5)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#3)(1993-3#5)(1993-4#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#6)(1994-11#3)(1994-12#6)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#2)(1994-8#1)(1994-9#7)(1995-1#3)(1995-10#1)(1995-11#3)(1995-12#6)(1995-2#5)(1995-3#5)(1995-5#1)(1995-6#4)(1995-7#1)(1995-8#5)(1995-9#1)(1996-1#3)(1996-10#2)(1996-11#5)(1996-12#4)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#3)(1996-6#2)(1996-8#3)(1996-9#4)(1997-1#5)(1997-2#2)(1997-3#2)(1997-4#6)(1997-5#2)(1997-6#4)(1997-7#2)(1997-8#5)(2004-10#2)(2004-11#1)(2004-12#1)(2004-4#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-3#1)(2005-5#1)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#13)(2006-11#2)(2006-12#2)(2006-2#5)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#6)(2006-7#3)(2006-8#3)(2006-9#3)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#11)(2007-2#4)(2007-3#1)(2007-4#2)(2007-6#3)(2007-7#5)(2007-8#6)(2007-9#4)(2008-1#2)(2008-10#20)(2008-11#15)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#12)(2008-5#19)(2008-6#10)(2008-7#14)(2008-8#14)(2008-9#9)(2009-1#2)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#7)(2009-9#2)(2010-11#3)(2010-12#6)(2010-2#3)(2010-4#1)(2010-5#2)(2010-6#4)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#5)(2011-11#1)(2011-12#1)(2011-2#16)(2012-1#1)(2012-11#2)(2012-12#9)(2012-2#13)(2012-3#6)(2013-1#11)(2013-7#3)(2013-8#7)
thought was##4##2##(1994-2#1)(2008-7#1)(2010-5#1)(2010-8#1)
thought were##3##2##(2007-9#1)(2008-12#1)(2010-4#1)
thought##813##1##(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#2)(1990-3#3)(1990-5#7)(1990-6#3)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#3)(1991-3#3)(1991-5#5)(1991-7#3)(1991-8#3)(1991-9#6)(1992-1#2)(1992-11#5)(1992-12#5)(1992-2#1)(1992-3#4)(1992-4#2)(1992-6#1)(1992-8#4)(1992-9#2)(1993-1#1)(1993-12#1)(1993-2#3)(1993-3#7)(1993-4#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#7)(1994-11#3)(1994-12#6)(1994-2#2)(1994-3#2)(1994-4#2)(1994-6#2)(1994-8#2)(1994-9#8)(1995-1#4)(1995-10#1)(1995-11#4)(1995-12#7)(1995-2#6)(1995-3#6)(1995-5#1)(1995-6#5)(1995-7#1)(1995-8#5)(1995-9#1)(1996-1#4)(1996-10#2)(1996-11#6)(1996-12#5)(1996-2#4)(1996-3#4)(1996-4#2)(1996-5#5)(1996-6#2)(1996-8#3)(1996-9#4)(1997-1#5)(1997-2#7)(1997-3#3)(1997-4#8)(1997-5#2)(1997-6#5)(1997-7#4)(1997-8#6)(2004-10#2)(2004-11#1)(2004-12#2)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-12#2)(2005-3#1)(2005-5#1)(2005-7#3)(2005-8#4)(2005-9#1)(2006-1#2)(2006-10#22)(2006-11#2)(2006-12#5)(2006-2#8)(2006-3#3)(2006-4#2)(2006-5#2)(2006-6#7)(2006-7#3)(2006-8#7)(2006-9#4)(2007-1#1)(2007-10#3)(2007-11#8)(2007-12#19)(2007-2#4)(2007-3#2)(2007-4#2)(2007-5#3)(2007-6#4)(2007-7#11)(2007-8#11)(2007-9#10)(2008-1#2)(2008-10#26)(2008-11#24)(2008-12#3)(2008-2#7)(2008-3#9)(2008-4#14)(2008-5#25)(2008-6#16)(2008-7#17)(2008-8#17)(2008-9#12)(2009-1#2)(2009-10#2)(2009-11#5)(2009-12#3)(2009-2#2)(2009-3#4)(2009-4#5)(2009-5#4)(2009-6#3)(2009-8#8)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#9)(2010-2#7)(2010-3#2)(2010-4#2)(2010-5#4)(2010-6#5)(2010-7#3)(2010-8#6)(2010-9#3)(2011-1#6)(2011-11#1)(2011-12#3)(2011-2#22)(2011-3#1)(2012-1#4)(2012-11#3)(2012-12#16)(2012-2#18)(2012-3#20)(2013-1#16)(2013-7#5)(2013-8#16)
thought]##2##1##(1990-5#1)(2008-4#1)
thoughtful##11##1##(1992-2#1)(2004-10#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-9#1)(2011-2#1)(2012-2#1)
thoughtfully##3##1##(1992-3#1)(2011-2#2)
thoughts about##11##2##(1991-12#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-2#1)(2009-10#1)(2009-7#1)(2010-10#2)(2010-11#1)(2011-2#1)
thoughts and behaviors##4##3##(2008-11#2)(2009-9#1)(2012-12#1)
thoughts and feelings about physical activity and##2##7##(2009-6#2)
thoughts and feelings##4##3##(2009-6#2)(2012-12#1)(2013-1#1)
thoughts and##15##2##(1993-8#1)(2004-12#1)(2008-11#2)(2009-4#1)(2009-6#2)(2009-7#2)(2009-9#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
thoughts of death (p &lt##2##5##(2008-6#2)
thoughts of death##3##3##(2008-6#3)
thoughts of##6##2##(2008-6#3)(2010-2#1)(2010-9#1)(2012-12#1)
thoughts on how##2##3##(1997-3#1)(2010-11#1)
thoughts on the##4##3##(1995-1#1)(2006-10#1)(2008-10#1)(2011-1#1)
thoughts on##14##2##(1992-4#1)(1993-2#1)(1995-1#1)(1997-3#1)(2005-7#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-11#1)(2011-1#1)(2013-1#2)
thoughts or##2##2##(1996-9#1)(2011-1#1)
thoughts that##2##2##(2008-7#1)(2013-1#1)
thoughts to##2##2##(1995-12#1)(2008-9#1)
thoughts##77##1##(1991-12#1)(1992-4#1)(1993-2#2)(1993-8#1)(1994-3#1)(1995-1#2)(1995-12#1)(1996-9#1)(1997-3#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-3#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-6#5)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#3)(2009-9#2)(2010-10#2)(2010-11#2)(2010-2#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#2)
thousand and##8##2##(1990-12#1)(1991-9#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-3#1)(2008-5#1)(2012-3#1)
thousand cells##3##2##(2007-12#1)(2008-9#1)(2011-1#1)
thousand four hundred##2##3##(2007-7#1)(2011-2#1)
thousand in##7##2##(2009-4#1)(2012-3#2)(2013-7#4)
thousand patients##4##2##(1990-1#1)(1994-2#1)(2007-3#1)(2013-8#1)
thousand to##2##2##(2008-2#1)(2009-4#1)
thousand two hundred and##2##4##(2007-2#1)(2013-1#1)
thousand years##2##2##(1992-1#1)(2007-11#1)
thousand##100##1##(1990-1#1)(1990-12#2)(1990-4#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-2#2)(1995-11#1)(1995-6#2)(1995-7#1)(1996-10#1)(1996-2#1)(1997-6#1)(2004-12#2)(2006-10#3)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#2)(2007-5#1)(2007-7#3)(2007-8#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#6)(2008-8#1)(2008-9#1)(2009-4#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-9#2)(2011-1#3)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#3)(2013-7#4)(2013-8#1)
thousands of copies per cell##2##5##(1991-2#1)(2007-11#1)
thousands of genes in##2##4##(2008-7#1)(2011-3#1)
thousands of genes simultaneously##3##4##(2008-10#1)(2008-7#1)(2010-2#1)
thousands of genes##9##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#3)(2010-2#1)(2011-3#1)
thousands of kilometers##2##3##(2007-12#1)(2008-10#1)
thousands of new##3##3##(1994-6#1)(1995-10#1)(2008-11#1)
thousands of patients##3##3##(1992-6#1)(2008-10#1)(2011-2#1)
thousands of people##4##3##(2006-11#1)(2008-10#1)(2008-7#1)(2008-8#1)
thousands of women##3##3##(1994-12#1)(2008-10#1)(2010-8#1)
thousands of years##11##3##(1991-9#1)(1996-11#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-9#1)(2009-1#1)(2009-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
thousands of##99##2##(1990-6#1)(1990-9#1)(1991-2#2)(1991-9#1)(1992-11#1)(1992-6#1)(1993-3#2)(1994-12#1)(1994-6#1)(1995-10#1)(1995-8#1)(1996-11#1)(1996-12#2)(2005-11#1)(2005-8#1)(2005-9#1)(2006-11#1)(2006-2#1)(2007-11#2)(2007-12#4)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#3)(2008-10#7)(2008-11#3)(2008-2#4)(2008-3#2)(2008-4#8)(2008-6#1)(2008-7#9)(2008-8#2)(2008-9#2)(2009-1#1)(2009-12#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#5)(2013-1#2)
thousands##105##1##(1990-6#1)(1990-9#1)(1991-2#2)(1991-9#1)(1992-11#1)(1992-6#1)(1993-3#2)(1994-12#1)(1994-6#1)(1995-10#1)(1995-8#1)(1996-11#1)(1996-12#2)(2005-11#1)(2005-8#1)(2005-9#1)(2006-11#1)(2006-2#1)(2006-5#1)(2007-11#2)(2007-12#4)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#3)(2008-10#7)(2008-11#3)(2008-2#4)(2008-3#2)(2008-4#8)(2008-6#1)(2008-7#10)(2008-8#2)(2008-9#2)(2009-1#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#2)
thousands)##2##1##(2006-10#1)(2006-5#1)
thread of##2##2##(2007-11#1)(2007-7#1)
thread running##2##2##(2006-4#1)(2009-2#1)
thread##22##1##(1990-4#1)(1997-5#1)(2006-3#1)(2006-4#1)(2007-11#2)(2007-12#2)(2007-7#4)(2007-9#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-8#1)(2012-12#1)(2012-3#1)
threaded##8##1##(2006-8#2)(2007-8#3)(2009-2#1)(2012-12#1)(2012-3#1)
threadfin Eleutheronema tetradactylum##2##3##(2010-8#2)
threading process##2##2##(2008-5#2)
threading##7##1##(1996-9#1)(2006-12#2)(2007-11#1)(2008-5#3)
threads in the##2##3##(2007-12#1)(2009-8#1)
threads were##2##2##(1995-7#1)(1996-11#1)
threads##16##1##(1990-7#1)(1991-2#1)(1992-3#1)(1993-12#1)(1995-7#1)(1996-11#1)(2004-9#1)(2007-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-8#1)(2011-1#1)(2011-12#1)(2012-3#1)
threat agents##2##2##(2009-2#2)
threat and##4##2##(1991-4#1)(2008-5#1)(2009-10#1)(2012-1#1)
threat appraisals##2##2##(2012-1#2)
threat because of the##2##4##(1995-11#1)(2008-11#1)
threat combined with exposure to thin##2##6##(2007-12#2)
threat for##3##2##(2008-1#1)(2008-12#1)(2012-12#1)
threat from##5##2##(1994-6#1)(2005-8#1)(2008-10#1)(2008-8#2)
threat in the##5##3##(2005-7#1)(2008-4#1)(2009-10#1)(2011-2#1)(2013-8#1)
threat in##11##2##(2005-7#1)(2007-12#1)(2007-8#1)(2008-4#1)(2009-10#1)(2011-1#2)(2011-2#3)(2013-8#1)
threat is##3##2##(1991-12#1)(2007-2#1)(2011-1#1)
threat of##38##2##(1991-12#1)(1991-3#1)(1991-4#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-5#1)(2004-10#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-5#1)(2006-6#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)
threat on the##2##3##(2009-12#1)(2012-2#1)
threat on##3##2##(2009-12#1)(2012-2#1)(2013-7#1)
threat or##2##2##(2006-8#1)(2008-7#1)
threat posed by the##2##4##(2007-8#1)(2009-9#1)
threat posed by##5##3##(2007-11#1)(2007-8#1)(2008-10#1)(2009-9#1)(2010-9#1)
threat processing##2##2##(2012-2#2)
threat stimuli##4##2##(1991-10#1)(2008-4#1)(2009-4#2)
threat that##3##2##(2004-7#1)(2007-9#1)(2008-10#1)
threat to global##2##3##(2006-5#1)(2011-2#1)
threat to health##5##3##(1995-9#1)(1997-5#1)(2008-3#1)(2009-5#1)(2013-8#1)
threat to human health##2##4##(2007-9#1)(2010-9#1)
threat to human##4##3##(1997-5#1)(2007-9#1)(2010-9#1)(2011-3#1)
threat to lettuce##2##3##(2008-10#2)
threat to public health##6##4##(1995-9#1)(2006-2#1)(2007-2#1)(2008-1#1)(2010-4#1)(2013-1#1)
threat to the local people##2##5##(2008-7#2)
threat to the local##3##4##(1996-8#1)(2008-7#2)
threat to the##18##3##(1991-4#1)(1992-1#1)(1994-1#1)(1996-3#1)(1996-8#1)(1997-3#1)(2005-8#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-7#2)(2009-5#1)(2011-2#2)(2012-2#1)(2013-8#1)
threat to##67##2##(1990-2#1)(1990-6#1)(1991-4#1)(1992-1#1)(1993-6#1)(1994-1#1)(1994-3#1)(1995-9#2)(1996-11#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-5#2)(2005-11#1)(2005-12#1)(2005-8#2)(2006-10#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-2#3)(2007-6#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-5#2)(2010-1#1)(2010-4#1)(2010-9#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
threat was##4##2##(1996-12#1)(2010-1#1)(2011-1#1)(2012-2#1)
threat##224##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-6#2)(1991-10#1)(1991-12#2)(1991-3#1)(1991-4#5)(1992-1#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-7#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-5#3)(2004-10#1)(2004-7#2)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#4)(2006-10#4)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#5)(2007-2#5)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#4)(2008-1#4)(2008-10#24)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#9)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#3)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-8#1)(2009-9#3)(2010-1#2)(2010-10#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#7)(2011-12#5)(2011-2#12)(2011-3#1)(2012-1#4)(2012-12#7)(2012-2#8)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
threat-related and##3##2##(2008-2#3)
threat-related information##3##2##(2007-4#1)(2008-2#1)(2012-2#1)
threat-related##7##1##(2007-4#1)(2008-2#4)(2012-2#2)
threaten the##10##2##(1992-12#1)(1993-4#1)(1993-7#1)(1995-6#1)(1996-2#1)(2007-2#1)(2007-6#1)(2008-11#1)(2010-8#1)(2012-12#1)
threaten their##2##2##(2011-1#1)(2011-2#1)
threaten to##4##2##(1994-12#1)(1996-8#1)(2008-3#1)(2008-7#1)
threaten##30##1##(1990-12#1)(1992-12#1)(1993-11#1)(1993-4#1)(1993-7#1)(1994-12#1)(1994-4#1)(1995-6#1)(1996-2#1)(1996-8#1)(2004-1#1)(2007-2#1)(2007-4#2)(2007-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-8#1)
threatened and##2##2##(1996-12#1)(2012-1#1)
threatened by the##3##3##(2008-10#2)(2013-1#1)
threatened by##9##2##(1995-2#1)(2008-10#2)(2009-8#1)(2010-4#1)(2011-1#1)(2012-11#2)(2013-1#1)
threatened or##3##2##(2007-2#1)(2008-3#1)(2011-2#1)
threatened preterm delivery##2##3##(1992-2#1)(2011-2#1)
threatened species and##3##3##(2005-7#1)(2009-4#1)(2012-1#1)
threatened species##5##2##(2005-7#1)(2009-4#1)(2012-1#1)(2013-1#1)(2013-7#1)
threatened the##4##2##(2008-10#1)(2008-4#1)(2010-1#1)(2013-1#1)
threatened to##2##2##(1996-12#1)(1997-2#1)
threatened##52##1##(1990-12#1)(1990-2#1)(1991-9#1)(1992-2#1)(1993-12#1)(1993-5#3)(1993-6#1)(1994-3#1)(1995-2#1)(1996-12#2)(1996-6#1)(1997-2#1)(1997-3#1)(2005-7#1)(2006-8#1)(2007-2#1)(2007-6#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-4#2)(2009-8#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#2)
threatening and##2##2##(1995-12#1)(2009-9#1)
threatening bacterial##2##2##(2007-2#1)(2007-7#1)
threatening cardiac##2##2##(2006-7#1)(2012-2#1)
threatening complications may occur##2##4##(2009-4#1)(2012-3#1)
threatening complications##10##2##(1992-12#1)(2006-4#1)(2007-2#1)(2007-8#1)(2008-5#1)(2008-8#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-3#1)
threatening conditions##2##2##(2008-6#1)(2013-1#1)
threatening disease##3##2##(2007-2#1)(2007-8#1)(2011-1#1)
threatening experiences##2##2##(1996-10#2)
threatening the##4##2##(1992-12#1)(2007-4#1)(2009-12#1)(2011-2#1)
threatening their##3##2##(1991-4#1)(2008-2#1)(2008-3#1)
threatening##100##1##(1990-5#1)(1991-4#1)(1992-11#1)(1992-12#2)(1992-8#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-10#3)(1996-2#1)(1996-5#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-4#3)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#4)(2007-4#3)(2007-5#1)(2007-7#3)(2007-8#4)(2007-9#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#6)(2008-5#4)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#4)(2009-9#1)(2010-10#1)(2010-2#1)(2010-7#2)(2011-1#2)(2011-12#1)(2011-2#8)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#1)
threatening)##2##1##(2008-2#1)(2013-1#1)
threatens the##12##2##(1994-11#1)(1997-2#1)(1997-7#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-3#1)
threatens to##4##2##(2007-8#1)(2007-9#1)(2008-4#1)(2010-9#1)
threatens##25##1##(1991-6#1)(1992-10#1)(1994-11#1)(1995-3#1)(1997-2#1)(1997-7#1)(2005-1#1)(2006-10#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2009-3#1)(2010-9#1)(2011-3#1)(2013-7#1)
threats and opportunities##2##3##(1991-1#1)(2007-4#1)
threats and##5##2##(1991-1#1)(2007-4#1)(2011-1#3)
threats from##2##2##(2008-10#2)
threats in the##2##3##(2008-10#1)(2010-12#1)
threats of##4##2##(2008-10#2)(2011-1#1)(2011-2#1)
threats or##2##2##(1991-2#1)(1993-1#1)
threats posed by##2##3##(2007-2#1)(2010-2#1)
threats to hospital##2##3##(1997-2#1)(2008-11#1)
threats to the##3##3##(2007-2#1)(2008-10#1)(2011-2#1)
threats to##25##2##(1991-3#1)(1992-12#1)(1992-5#1)(1997-2#1)(1997-3#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-12#1)(2010-2#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#4)(2013-1#1)(2013-7#1)
threats##69##1##(1991-1#2)(1991-2#1)(1991-3#1)(1992-12#1)(1992-5#1)(1993-1#1)(1996-12#1)(1997-2#1)(1997-3#1)(2005-11#2)(2006-7#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#6)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#2)(2011-1#6)(2011-12#2)(2011-2#4)(2012-1#2)(2012-2#4)(2013-1#1)(2013-7#1)(2013-8#1)
three &quot##6##2##(1991-10#1)(1991-2#1)(1991-3#1)(1994-3#1)(1995-10#1)(1996-1#1)
three (16%)##2##2##(2010-7#1)(2013-1#1)
three (2##2##2##(2008-1#1)(2012-2#1)
three (3##3##2##(2007-8#1)(2008-1#2)
three (4##2##2##(2012-2#1)(2013-8#1)
three (5%)##3##2##(2008-1#2)(2008-3#1)
three (two##2##2##(1995-5#1)(2008-1#1)
three 2-min exposures to##2##4##(1994-3#2)
three Army##2##2##(2012-2#2)
three B##5##2##(1993-11#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-6#1)
three BDV proteins##2##3##(1995-1#2)
three C##2##2##(2006-8#1)(2008-5#1)
three Canadian##2##2##(2007-12#1)(2010-8#1)
three Candida##2##2##(1991-3#1)(2008-5#1)
three Ceratitis##2##2##(2007-6#2)
three Chinese##2##2##(2008-10#1)(2008-12#1)
three DNA##8##2##(1992-5#1)(1993-3#1)(1996-6#1)(2008-10#2)(2008-7#2)(2008-8#1)
three E##2##2##(1997-7#1)(2011-2#1)
three ELISAs##2##2##(2008-5#2)
three European oak species (Quercus robur##2##6##(2012-5#1)(2012-7#1)
three European##5##2##(1990-6#1)(2007-1#2)(2012-5#1)(2012-7#1)
three F(2)##2##2##(2008-10#2)
three Finnish patients##2##3##(1991-7#2)
three Finnish##3##2##(1991-7#3)
three French##2##2##(2008-10#2)
three Fusarium species##2##3##(2008-10#2)
three H2A variants##2##3##(1996-4#1)(1997-1#1)
three HPs##2##2##(1996-4#2)
three MAP##2##2##(2006-10#1)(2007-11#1)
three MEKA-like proteins##2##3##(1993-3#2)
three Mexican##2##2##(2007-3#1)(2009-2#1)
three Montana physicians who##2##4##(1995-9#2)
three ORFs of##2##3##(1997-1#1)(1997-3#1)
three PCR##2##2##(2008-10#1)(2011-2#1)
three PP1 isoforms##2##3##(1996-2#2)
three Pediatric##2##2##(2006-8#2)
three QTL##2##2##(2008-10#1)(2012-3#1)
three QTLs for##2##3##(2008-8#1)(2008-9#1)
three RAPD markers##2##3##(2008-10#1)(2008-5#1)
three S##2##2##(1996-7#1)(2008-10#1)
three SH3 domains##4##3##(1995-3#1)(1996-8#1)(1997-4#2)
three T-flask tests##2##3##(2008-11#2)
three V lambda##2##3##(1996-11#2)
three aa##3##2##(1990-11#1)(1991-12#1)(1991-9#1)
three abamectin resistance-correlated oligonucleotides##2##4##(2011-2#2)
three acidic##2##2##(1990-10#1)(1991-6#1)
three active##6##2##(1994-2#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-3#1)
three activities##3##2##(1991-1#1)(1992-12#1)(1997-3#1)
three additional##13##2##(1991-4#1)(1991-8#1)(1993-3#1)(1994-8#1)(1995-12#1)(1997-1#1)(2006-11#1)(2007-12#1)(2008-10#4)(2012-2#1)
three adjacent##2##2##(2007-3#1)(2008-2#1)
three adsorbed##2##2##(2005-11#1)(2008-10#1)
three adult##3##2##(1992-8#1)(1997-6#1)(2008-11#1)
three affected##3##2##(1997-7#1)(2011-2#1)(2012-1#1)
three after##4##2##(1995-3#1)(1997-8#2)(2012-3#1)
three age groups##11##3##(1994-11#1)(2004-2#1)(2007-1#1)(2008-7#2)(2009-4#1)(2010-12#3)(2012-12#2)
three agents##10##2##(1990-11#1)(1994-5#1)(1995-11#1)(2008-10#6)(2008-7#1)
three ages##2##2##(1996-2#1)(2008-10#1)
three agonists##4##2##(1990-3#1)(1995-11#2)(2008-8#1)
three algorithms##2##2##(2008-9#1)(2012-3#1)
three allogeneic##2##2##(2012-12#2)
three alpha-helices##3##2##(1994-9#1)(1997-2#1)(1997-5#1)
three alternating##2##2##(2008-3#1)(2012-2#1)
three alternative##6##2##(1992-12#1)(1994-12#1)(2006-10#1)(2007-6#1)(2009-3#1)(2012-2#1)
three amino acid residues of##2##5##(2008-11#1)(2008-8#1)
three amino acid residues##5##4##(1993-11#1)(1996-5#1)(2008-11#1)(2008-8#2)
three amino acid substitutions##2##4##(1991-7#1)(1992-3#1)
three amino acid##10##3##(1991-7#1)(1992-3#1)(1993-11#1)(1995-8#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)
three amino acids##5##3##(1990-4#1)(1991-9#1)(1994-12#1)(1994-9#1)(1996-5#1)
three amino##15##2##(1990-4#1)(1991-7#1)(1991-9#1)(1992-3#1)(1993-11#1)(1994-12#1)(1994-9#1)(1995-8#1)(1996-5#2)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)
three amphiphilic forms##2##3##(1990-5#2)
three analogs##2##2##(1991-7#1)(1994-12#1)
three analogues##3##2##(1992-6#1)(1994-9#1)(2013-1#1)
three analyses##2##2##(2008-10#1)(2008-2#1)
three analytes##17##2##(1996-6#3)(2008-10#13)(2010-5#1)
three anatomic##2##2##(2010-11#1)(2011-2#1)
three and a half months##2##5##(1990-6#1)(2008-9#1)
three and a half##4##4##(1990-6#1)(1996-6#1)(2008-4#1)(2008-9#1)
three and five year##2##4##(2008-1#2)
three and five##4##3##(2008-1#2)(2008-9#1)(2009-8#1)
three and four years##2##4##(2007-11#1)(2008-5#1)
three and four##9##3##(1990-8#2)(1991-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-5#1)(2013-1#1)(2013-8#1)
three and six days##2##4##(1993-8#1)(2008-5#1)
three and six months after the##2##6##(2007-11#1)(2011-2#1)
three and six months after##3##5##(1993-3#1)(2007-11#1)(2011-2#1)
three and six##7##3##(1993-3#1)(1993-8#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-5#1)(2011-2#1)
three and two##6##3##(1991-1#1)(2006-6#1)(2007-7#1)(2008-10#2)(2008-3#1)
three and##46##2##(1990-6#1)(1990-8#2)(1991-1#1)(1991-8#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-4#1)(1996-1#1)(1996-6#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#3)(2009-8#1)(2010-11#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#1)
three angular##2##2##(2006-11#1)(2012-3#1)
three animals##4##2##(1993-4#1)(2007-2#1)(2007-8#1)(2011-2#1)
three antagonists were##2##3##(1990-11#2)
three antagonists##4##2##(1990-11#2)(1994-2#1)(1996-12#1)
three anthropometric##3##2##(2007-1#1)(2010-6#2)
three antibiotics##3##2##(2008-10#1)(2008-5#1)(2010-8#1)
three antibodies##8##2##(1990-12#1)(1994-9#1)(1995-10#1)(1995-12#1)(1996-12#1)(2007-12#2)(2007-8#1)
three antigens##4##2##(1991-6#1)(1995-8#1)(2008-5#1)(2013-8#1)
three antioxidant##2##2##(1992-7#1)(2013-8#1)
three applications##4##2##(2006-4#1)(2007-5#1)(2007-7#2)
three approaches to##4##3##(1994-9#1)(2007-10#1)(2008-10#1)(2010-2#1)
three approaches##12##2##(1994-9#1)(2004-2#1)(2007-10#1)(2008-10#3)(2008-12#1)(2008-6#2)(2010-2#1)(2010-3#1)(2012-2#1)
three approximations##2##2##(2006-10#1)(2008-2#1)
three are##12##2##(1993-11#1)(1995-1#1)(1995-2#1)(2006-7#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#2)(2009-12#1)(2012-3#1)
three areas in the##2##4##(2008-10#1)(2008-12#1)
three areas of##3##3##(1995-10#1)(2005-7#1)(2011-1#1)
three areas##19##2##(1990-12#1)(1992-2#1)(1993-12#1)(1995-10#1)(1997-6#1)(1997-8#1)(2005-7#1)(2006-10#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-9#1)(2010-12#1)(2011-1#1)(2013-1#1)
three arsenic species in##2##4##(2008-10#2)
three arsenic species##3##3##(2008-10#3)
three articles on##2##3##(1991-4#1)(2012-12#1)
three articles##6##2##(1991-4#1)(1996-12#1)(1996-3#1)(2007-8#1)(2011-2#1)(2012-12#1)
three as##4##2##(2006-12#1)(2006-8#1)(2008-1#1)(2010-4#1)
three aspects of##5##3##(2007-12#1)(2010-4#1)(2012-3#2)(2013-1#1)
three aspects to##2##3##(1995-5#1)(2008-11#1)
three aspects##11##2##(1994-12#1)(1994-3#1)(1995-5#1)(1996-1#1)(2007-12#1)(2008-11#1)(2010-4#1)(2011-12#1)(2012-3#2)(2013-1#1)
three assay systems##2##3##(1994-6#1)(2007-12#1)
three assay##3##2##(1994-6#1)(2007-12#1)(2008-6#1)
three assessment methods##2##3##(2008-10#2)
three assessment##3##2##(2007-8#1)(2008-10#2)
three attributes##2##2##(1994-5#1)(2013-1#1)
three autosomal##2##2##(1996-4#1)(2012-3#1)
three auxiliary cells##3##3##(2007-12#2)(2008-7#1)
three available##2##2##(1992-6#1)(2008-5#1)
three avirulence##2##2##(2008-10#2)
three axes##3##2##(2006-5#1)(2007-12#1)(2008-3#1)
three bacterial species##2##3##(2006-8#1)(2008-10#1)
three bacterial##4##2##(2006-8#1)(2008-10#1)(2008-8#1)(2011-1#1)
three bands##4##2##(1990-7#1)(1991-12#1)(1997-1#1)(2008-10#1)
three bases##2##2##(1995-8#1)(1997-2#1)
three basic matrices##3##3##(2007-11#1)(2007-12#2)
three basic methods##2##3##(1994-9#2)
three basic residues##2##3##(1994-9#1)(2008-7#1)
three basic##22##2##(1991-6#1)(1992-4#1)(1994-9#3)(1995-4#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-2#2)(2010-4#1)(2012-2#1)(2013-1#2)
three batches##3##2##(2008-11#2)(2013-1#1)
three bays##2##2##(2008-10#2)
three beams##3##2##(2007-12#1)(2008-3#2)
three beta##6##2##(1990-2#1)(1992-8#1)(1995-4#1)(1997-4#1)(2008-11#1)(2010-12#1)
three billion##2##2##(1995-5#1)(2008-5#1)
three binding sites##3##3##(1990-5#1)(1993-4#1)(1994-6#1)
three biosensors##2##2##(2008-10#2)
three blocks##3##2##(2006-12#1)(2008-2#1)(2009-5#1)
three bond coupling constants##2##4##(1992-4#2)
three bones##3##2##(2006-11#1)(2007-4#1)(2008-9#1)
three brain regions##2##3##(1996-10#1)(1996-3#1)
three breast cancer cell lines##2##5##(2010-2#2)
three broad##7##2##(1991-2#1)(1991-3#1)(1997-1#1)(2006-10#1)(2006-12#1)(2011-1#1)(2011-2#1)
three but##2##2##(1992-8#1)(1996-9#1)
three by##3##2##(1992-2#1)(1993-8#1)(2011-2#1)
three cDNAs were##3##3##(1992-8#2)(1993-2#1)
three case reports of##2##4##(2009-2#1)(2010-3#1)
three case reports##3##3##(2008-4#1)(2009-2#1)(2010-3#1)
three case studies of##2##4##(1991-1#1)(2007-7#1)
three case studies##7##3##(1991-1#1)(1991-12#1)(1996-1#1)(2007-7#1)(2010-12#1)(2010-5#1)(2012-1#1)
three case study organizations##2##4##(1996-1#2)
three case##12##2##(1991-1#1)(1991-12#1)(1996-1#3)(2007-7#1)(2008-4#1)(2009-2#1)(2010-12#1)(2010-3#1)(2010-5#1)(2012-1#1)
three cases and##4##3##(2006-12#1)(2007-8#1)(2008-4#1)(2009-5#1)
three cases demonstrated##2##3##(2010-7#1)(2013-1#1)
three cases of patients with##2##5##(2011-1#1)(2011-12#1)
three cases of##35##3##(1991-11#1)(1991-4#1)(1993-10#1)(1993-9#1)(1996-3#1)(1997-5#1)(1997-6#1)(1997-8#2)(2006-10#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-3#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#2)(2009-9#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#4)
three cases the##2##3##(1991-12#1)(1992-11#1)
three cases were##3##3##(1992-12#1)(2007-8#1)(2008-6#1)
three cases where##2##3##(1995-11#1)(2010-7#1)
three cases with##4##3##(1990-12#1)(1994-12#1)(2007-2#1)(2007-7#1)
three cases##139##2##(1990-10#1)(1990-12#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-4#1)(1993-10#2)(1993-11#2)(1993-9#1)(1994-12#1)(1995-11#2)(1996-12#2)(1996-3#1)(1997-1#1)(1997-3#4)(1997-5#1)(1997-6#1)(1997-8#2)(2004-4#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#2)(2006-4#3)(2006-6#1)(2006-7#1)(2006-8#2)(2007-12#4)(2007-2#5)(2007-3#4)(2007-4#3)(2007-7#4)(2007-8#7)(2008-1#2)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#7)(2008-7#4)(2008-8#4)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-7#3)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#7)(2013-8#2)
three catalytic##2##2##(1994-8#1)(1997-4#1)
three categories of##9##3##(1991-3#1)(1995-2#1)(2005-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)
three categories to##2##3##(2007-7#1)(2008-7#1)
three categories##37##2##(1991-3#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(2005-2#1)(2005-7#1)(2006-11#1)(2007-4#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-11#1)(2009-4#1)(2010-12#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)
three cations##4##2##(1995-8#1)(2008-10#3)
three cell lines##12##3##(1990-2#1)(1990-3#1)(1992-3#1)(1993-11#1)(1995-5#1)(1995-6#2)(1997-1#1)(2008-11#2)(2008-5#1)(2012-2#1)
three cell populations##2##3##(1996-11#1)(2008-7#1)
three cell types##5##3##(1990-12#1)(1991-2#1)(2004-11#1)(2006-7#1)(2012-2#1)
three cell##20##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-2#1)(1992-3#1)(1993-11#1)(1995-5#1)(1995-6#2)(1995-7#1)(1996-11#1)(1997-1#1)(2004-11#1)(2006-7#1)(2008-11#2)(2008-5#1)(2008-7#1)(2012-2#2)
three cells##2##2##(1992-9#1)(2008-10#1)
three centers##2##2##(2008-4#1)(2008-5#1)
three cephalosporin antibiotics##2##3##(2008-10#2)
three certified reference materials##2##4##(2008-10#2)
three channel##2##2##(1994-9#1)(2013-1#1)
three channels##5##2##(2008-10#3)(2008-2#1)(2008-8#1)
three characteristic##2##2##(2005-4#1)(2008-10#1)
three chemical##3##2##(2005-7#1)(2008-10#1)(2008-5#1)
three children were diagnosed##2##4##(2006-10#1)(2007-2#1)
three children with##5##3##(1991-6#1)(1993-5#1)(2006-12#1)(2007-12#1)(2011-2#1)
three children##14##2##(1991-12#1)(1991-6#2)(1993-5#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-12#3)(2007-2#1)(2007-7#1)(2011-2#1)
three chronic##2##2##(2007-7#1)(2008-6#1)
three cities##3##2##(2008-10#1)(2009-6#1)(2012-2#1)
three clades##4##2##(2008-10#3)(2009-6#1)
three classes of##15##3##(1991-11#1)(1992-9#1)(1994-9#1)(1995-2#2)(1995-8#1)(1996-10#1)(1997-2#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-4#1)
three classes##23##2##(1991-11#1)(1992-9#1)(1994-9#1)(1995-2#2)(1995-8#1)(1996-10#1)(1996-8#1)(1997-2#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-4#1)(2010-8#2)(2010-9#1)(2013-7#1)
three clinical trials that##3##4##(1996-8#1)(2007-12#1)(2008-6#1)
three clinical trials##7##3##(1996-8#2)(2007-12#1)(2008-6#1)(2008-8#1)(2012-3#2)
three clinical##14##2##(1995-4#1)(1996-8#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-11#1)(2011-1#1)(2012-3#2)(2013-8#1)
three clonal lineages##5##3##(2008-10#3)(2009-2#2)
three clones##6##2##(1990-1#1)(1991-4#1)(1994-11#1)(1996-11#1)(1997-7#1)(2006-8#1)
three close-in sites##2##3##(2004-4#2)
three closely related##3##3##(1990-12#1)(2008-1#1)(2009-5#1)
three closely##4##2##(1990-12#1)(2005-10#1)(2008-1#1)(2009-5#1)
three clusters##7##2##(1994-9#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-6#1)(2012-2#1)(2013-1#1)
three cognate##2##2##(1992-2#1)(2008-8#1)
three cognitive vulnerabilities##2##3##(2012-1#2)
three colorants##3##2##(2008-10#3)
three column##3##2##(1990-11#2)(1997-5#1)
three combinations##2##2##(2008-10#1)(2013-1#1)
three commercial##13##2##(1992-2#1)(1996-12#1)(2008-10#8)(2008-3#1)(2008-5#1)(2012-3#1)
three commercially available monoclonal antibodies##2##5##(1992-8#1)(2008-5#1)
three commercially available##6##3##(1991-3#1)(1992-8#1)(2006-6#1)(2007-4#1)(2008-5#1)(2013-8#1)
three commercially important species##2##4##(2013-7#2)
three commercially##8##2##(1991-3#1)(1992-8#1)(2006-6#1)(2007-4#1)(2008-5#1)(2013-7#2)(2013-8#1)
three common types of##2##4##(1994-8#1)(2007-9#1)
three common##15##2##(1994-8#1)(1995-1#1)(1997-4#1)(2006-8#1)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2009-9#1)(2011-2#3)(2012-1#1)
three commonly used##2##3##(1993-6#1)(1996-5#1)
three commonly##4##2##(1992-1#1)(1993-6#1)(1996-5#1)(2011-1#1)
three community hospitals##2##3##(2007-1#1)(2011-2#1)
three community##3##2##(2007-1#1)(2011-2#1)(2012-2#1)
three compartments##2##2##(2008-4#1)(2012-2#1)
three compatible hosts##2##3##(2008-10#2)
three competing##2##2##(2006-2#1)(2006-3#1)
three complementary##3##2##(2005-11#1)(2006-7#1)(2008-4#1)
three complexes##4##2##(1991-4#1)(1994-11#2)(2009-4#1)
three component##6##2##(1996-6#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-3#1)
three components of the##5##4##(1992-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-8#1)
three components of##9##3##(1990-7#1)(1992-6#1)(1994-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-6#1)
three components##24##2##(1990-7#1)(1992-12#1)(1992-6#1)(1993-10#1)(1994-3#1)(1994-6#1)(2005-4#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2010-5#1)(2010-6#1)(2012-12#1)(2012-3#1)(2013-1#1)
three compound##2##2##(1995-2#1)(1997-5#1)
three compounds were##3##3##(1990-10#1)(1995-2#1)(2011-1#1)
three compounds##26##2##(1990-10#1)(1990-8#2)(1992-11#2)(1992-7#1)(1993-2#1)(1995-2#1)(1996-3#1)(1997-5#1)(2007-1#2)(2007-5#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#2)(2010-5#2)(2011-1#1)(2011-2#1)(2012-12#1)
three concentration levels of##2##4##(2008-10#2)
three concentration levels##6##3##(1995-3#1)(2007-8#1)(2008-10#3)(2011-3#1)
three concepts##3##2##(2008-11#1)(2008-2#1)(2012-3#1)
three conceptual##3##2##(1993-12#1)(1995-8#1)(2008-9#1)
three conclusions##3##2##(1994-12#1)(1995-8#1)(1997-4#1)
three concurrent##2##2##(1993-12#1)(2008-5#1)
three conditions##17##2##(1993-6#1)(1995-5#1)(1997-1#1)(2006-7#1)(2007-4#1)(2008-11#5)(2011-2#1)(2012-1#3)(2012-2#1)(2013-1#1)(2013-8#1)
three configurations##3##2##(2008-10#2)(2008-2#1)
three consecutive days and##2##4##(1995-3#1)(2010-12#1)
three consecutive days##7##3##(1992-3#1)(1992-6#2)(1995-3#1)(2008-1#2)(2010-12#1)
three consecutive years##3##3##(2007-3#1)(2008-10#1)(2008-5#1)
three consecutive##28##2##(1991-3#1)(1992-3#1)(1992-6#2)(1994-4#1)(1994-5#1)(1995-3#1)(1996-1#1)(1997-8#1)(2007-12#1)(2007-3#2)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)
three consensus##3##2##(1991-1#1)(1991-6#1)(1994-8#1)
three conserved domains##2##3##(1993-6#1)(1994-12#1)
three conserved regions##2##3##(1994-12#1)(1995-6#1)
three conserved##8##2##(1993-6#1)(1994-12#2)(1995-6#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-7#1)
three constituent##2##2##(1991-2#1)(2008-3#1)
three constructs##3##2##(1995-1#1)(1996-7#1)(2008-10#1)
three contained##2##2##(1993-4#1)(2012-12#1)
three containers##2##2##(2006-5#2)
three continents##3##2##(2005-10#1)(2008-10#1)(2012-3#1)
three continuous##4##2##(1992-6#1)(1995-6#1)(2012-3#2)
three control##5##2##(1991-6#1)(1994-12#1)(2004-4#1)(2008-5#1)(2010-4#1)
three controlled clinical##2##3##(1991-6#1)(2012-2#1)
three conventional##2##2##(2008-3#1)(2013-8#1)
three copies of the##3##4##(1994-11#1)(1994-12#1)(2008-10#1)
three copies of##7##3##(1991-10#1)(1994-11#1)(1994-12#1)(1996-10#1)(2008-10#2)(2009-7#1)
three core functions##3##3##(1996-3#2)(1997-2#1)
three corresponding##2##2##(1990-8#1)(1994-4#1)
three cortical##3##2##(1992-8#1)(1993-2#1)(2007-2#1)
three counties##5##2##(2007-7#3)(2013-1#2)
three countries in##2##3##(2010-12#1)(2011-1#1)
three countries##12##2##(1994-5#1)(1996-3#1)(2008-10#1)(2008-7#2)(2009-3#1)(2009-7#1)(2010-12#3)(2011-1#1)(2012-3#1)
three courses of##2##3##(1992-8#1)(1996-12#1)
three courses##3##2##(1991-6#1)(1992-8#1)(1996-12#1)
three cowpea cultivars##2##3##(2008-12#2)
three cows##3##2##(1997-4#2)(2011-2#1)
three criteria##8##2##(1992-11#1)(1995-2#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-3#1)(2012-2#1)
three critical##2##2##(1990-12#1)(1994-2#1)
three crop##2##2##(2007-1#1)(2008-10#1)
three cropping seasons##2##3##(2007-6#1)(2008-10#1)
three cryptic species##2##3##(2008-10#1)(2013-7#1)
three cultivars##7##2##(2007-1#1)(2008-10#4)(2008-12#1)(2012-2#1)
three culture##3##2##(2008-11#1)(2013-1#1)(2013-7#1)
three cycles of##4##3##(1991-10#1)(1991-7#1)(2007-8#1)(2012-3#1)
three cycles##6##2##(1991-10#1)(1991-7#1)(1992-2#1)(2007-8#1)(2012-3#1)(2013-8#1)
three cytosolic##2##2##(1993-8#1)(1996-2#1)
three daily##2##2##(2008-7#1)(2013-1#1)
three dairy##2##2##(1992-2#1)(2012-12#1)
three data sets##2##3##(1994-11#1)(2008-10#1)
three data##3##2##(1994-11#1)(2008-10#1)(2008-3#1)
three databases##2##2##(1994-3#2)
three days after##7##3##(1990-12#1)(2007-12#1)(2008-4#1)(2008-5#2)(2013-1#2)
three days of##9##3##(1993-1#1)(2007-12#2)(2008-5#1)(2008-7#1)(2010-4#1)(2012-12#1)(2012-2#2)
three days##46##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#1)(1991-5#1)(1991-9#1)(1993-1#1)(1993-7#1)(1994-2#1)(2004-9#2)(2006-6#1)(2007-12#4)(2007-2#1)(2007-5#1)(2007-7#1)(2008-12#1)(2008-4#1)(2008-5#5)(2008-7#1)(2009-5#1)(2009-9#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#3)
three deaths##4##2##(2004-11#1)(2005-7#1)(2007-8#1)(2012-12#1)
three decades ago##4##3##(2008-1#1)(2008-2#1)(2011-1#1)(2012-12#1)
three decades have##3##3##(2006-4#1)(2007-3#1)(2012-2#1)
three decades of research##2##4##(2007-12#1)(2010-5#1)
three decades of##4##3##(2005-11#1)(2007-12#1)(2008-3#1)(2010-5#1)
three decades##52##2##(1991-12#1)(1992-12#1)(1992-3#1)(1994-7#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-3#1)(2005-11#2)(2006-10#2)(2006-4#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-1#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#3)(2009-5#2)(2009-9#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#3)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-8#1)
three defined##4##2##(1993-4#1)(1995-1#2)(1995-5#1)
three definitions of##2##3##(1997-5#1)(2008-2#1)
three degrees of freedom##3##4##(1993-9#1)(2007-12#1)(2012-1#1)
three degrees of##4##3##(1993-9#1)(2007-12#1)(2008-10#1)(2012-1#1)
three dental##3##2##(1996-6#1)(2012-2#1)(2013-1#1)
three dependent variables##2##3##(1995-12#2)
three derivatives##2##2##(1991-2#1)(2007-12#1)
three detection##2##2##(2008-10#1)(2008-3#1)
three developed##2##2##(2008-6#1)(2008-9#1)
three diagnostic groups##2##3##(1996-1#1)(2006-7#1)
three diagnostic##4##2##(1996-1#1)(2006-7#1)(2008-4#1)(2012-2#1)
three dialysis sessions##2##3##(2007-7#2)
three died##3##2##(1993-5#1)(2007-8#1)(2008-7#1)
three dietary##2##2##(1994-2#1)(1997-4#1)
three differences##3##2##(1990-8#1)(1993-6#1)(2008-10#1)
three different academic##2##3##(2008-11#1)(2009-5#1)
three different age groups##2##4##(1992-12#1)(1997-5#1)
three different approaches##3##3##(1995-12#1)(2007-8#1)(2008-4#1)
three different aspects##3##3##(2007-6#1)(2008-4#1)(2012-2#1)
three different assays##2##3##(1997-6#1)(2008-10#1)
three different average##2##3##(2007-1#1)(2008-2#1)
three different batches##2##3##(2008-11#2)
three different biological##2##3##(2007-5#1)(2012-3#1)
three different cell##2##3##(2007-11#1)(2010-4#1)
three different classes##2##3##(1994-8#1)(2008-10#1)
three different compositions##2##3##(1990-11#1)(2008-10#1)
three different conditions##3##3##(1997-1#1)(1997-3#1)(2012-1#1)
three different densities##2##3##(2008-11#1)(2008-9#1)
three different directions##2##3##(2008-3#1)(2012-1#1)
three different environments##4##3##(1995-11#1)(2008-10#1)(2008-5#1)(2008-6#1)
three different experiments##2##3##(2008-10#1)(2008-5#1)
three different forms of##4##4##(1991-11#1)(1993-6#1)(2008-10#1)(2009-2#1)
three different forms##5##3##(1991-11#1)(1993-6#1)(2007-12#1)(2008-10#1)(2009-2#1)
three different groups of##3##4##(1997-2#1)(2008-4#1)(2008-7#1)
three different groups##5##3##(1997-2#1)(2008-10#2)(2008-4#1)(2008-7#1)
three different habitats##2##3##(2007-3#1)(2008-8#1)
three different hosts##3##3##(2008-10#3)
three different human##2##3##(1990-6#1)(2008-3#1)
three different ion##2##3##(2008-3#2)
three different kinds of##3##4##(2008-10#1)(2008-2#1)(2008-5#1)
three different levels of##3##4##(2008-2#1)(2008-4#1)(2012-11#1)
three different media##4##3##(2005-11#2)(2008-11#2)
three different methods of##3##4##(1996-3#1)(1997-2#1)(2009-8#1)
three different methods##10##3##(1995-1#2)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(2008-10#3)(2009-8#1)
three different modalities##3##3##(2007-7#2)(2012-1#1)
three different phases##2##3##(2011-2#1)(2012-2#1)
three different polymers##4##3##(2006-2#1)(2008-5#1)(2012-2#2)
three different positions##3##3##(1996-7#1)(2007-12#1)(2012-2#1)
three different production##2##3##(2008-11#1)(2012-2#1)
three different promoters##2##3##(1990-11#1)(2008-7#1)
three different regions of##3##4##(2007-12#2)(2009-5#1)
three different regions##4##3##(1991-7#1)(2007-12#2)(2009-5#1)
three different signals##2##3##(2008-10#1)(2008-3#1)
three different sites in##3##4##(2008-10#2)(2008-8#1)
three different sites##4##3##(2008-10#2)(2008-6#1)(2008-8#1)
three different species of##3##4##(1992-4#1)(2008-10#1)(2010-11#1)
three different steps##2##3##(1997-4#1)(2010-2#1)
three different strains of##3##4##(1996-5#1)(2008-5#1)(2011-1#1)
three different structural##2##3##(1993-2#1)(1994-9#1)
three different subunits##3##3##(1990-12#1)(1993-9#1)(1997-7#1)
three different techniques for##2##4##(2007-8#1)(2008-2#1)
three different types of##9##4##(1991-11#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-9#1)(2010-8#1)(2012-12#1)
three different wavelengths##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
three different ways##3##3##(1995-6#1)(2006-11#1)(2008-10#1)
three different##385##2##(1990-11#2)(1990-12#3)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-6#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-4#2)(1993-6#2)(1993-9#2)(1994-3#3)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#4)(1996-6#1)(1996-7#2)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#1)(2004-9#1)(2005-11#7)(2006-10#4)(2006-11#4)(2006-12#4)(2006-2#1)(2006-7#1)(2006-8#1)(2007-1#4)(2007-10#1)(2007-11#3)(2007-12#10)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#9)(2008-10#65)(2008-11#15)(2008-12#5)(2008-2#16)(2008-3#16)(2008-4#6)(2008-5#19)(2008-6#6)(2008-7#7)(2008-8#3)(2008-9#3)(2009-11#1)(2009-2#2)(2009-4#1)(2009-5#3)(2009-8#2)(2010-11#1)(2010-12#5)(2010-2#5)(2010-3#4)(2010-4#4)(2010-5#1)(2010-6#1)(2010-8#4)(2011-1#5)(2011-2#4)(2012-1#4)(2012-11#2)(2012-12#2)(2012-2#9)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#5)
three differently##3##2##(1997-4#1)(2008-10#1)(2008-5#1)
three diffraction orders##2##3##(2007-12#2)
three diketopiperazines##2##2##(2008-10#2)
three dimensional (3D)##3##3##(2006-6#1)(2010-12#1)(2012-11#1)
three dimensional imaging##4##3##(1994-9#1)(1997-6#1)(2010-7#2)
three dimensional structure of##3##4##(1994-9#1)(2008-4#1)(2013-1#1)
three dimensional structure##5##3##(1990-7#1)(1994-9#1)(2008-4#1)(2012-1#1)(2013-1#1)
three dimensional transesophageal echocardiography##3##4##(2010-7#2)(2012-3#1)
three dimensional##39##2##(1990-7#1)(1994-9#2)(1995-12#1)(1995-8#1)(1997-6#2)(2006-12#2)(2006-5#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-7#5)(2011-2#1)(2012-1#2)(2012-11#2)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
three dimensionally##4##2##(2007-12#1)(2008-3#2)(2009-5#1)
three dimensions of##5##3##(1991-11#1)(2007-12#1)(2008-10#1)(2010-1#1)(2012-12#1)
three dimensions with##2##3##(2009-2#1)(2012-12#1)
three dimensions##39##2##(1991-11#1)(1991-4#1)(1994-3#2)(1995-1#1)(2005-11#1)(2006-4#1)(2007-11#2)(2007-12#6)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#7)(2008-7#1)(2009-2#1)(2010-1#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
three diode laser bars##2##4##(2007-12#1)(2008-2#1)
three diode##4##2##(2007-12#2)(2008-2#2)
three directions##4##2##(1996-2#2)(2008-6#1)(2012-12#1)
three discrete##3##2##(1997-2#1)(2008-5#1)(2009-1#1)
three disorders##3##2##(2008-11#1)(2012-2#2)
three distant##2##2##(1991-4#1)(2008-10#1)
three distinct clades##3##3##(2008-10#2)(2009-8#1)
three distinct clonal##2##3##(1996-10#1)(2009-2#1)
three distinct clusters were##2##4##(2008-10#2)
three distinct clusters##4##3##(1996-11#1)(2008-10#3)
three distinct components##2##3##(1994-5#1)(2009-9#1)
three distinct domains##2##3##(1995-4#1)(1997-4#1)
three distinct groups of##2##4##(1996-2#1)(2009-4#1)
three distinct groups##4##3##(1996-2#1)(2008-10#1)(2009-4#1)(2011-2#1)
three distinct peaks##2##3##(1994-3#1)(2008-10#1)
three distinct regions##2##3##(1992-7#1)(2008-10#1)
three distinct size##2##3##(2008-10#1)(2008-12#1)
three distinct subgroups##3##3##(1996-10#1)(2008-10#2)
three distinct subtypes##2##3##(1993-11#1)(2008-1#1)
three distinct##92##2##(1990-12#1)(1990-3#1)(1991-2#1)(1991-4#1)(1992-10#1)(1992-12#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#3)(1996-10#3)(1996-11#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-4#1)(2006-12#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#19)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#2)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#2)(2010-10#3)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-7#1)
three distinctive##4##2##(1997-2#1)(2008-12#1)(2010-8#1)(2013-8#1)
three disulfide bonds##5##3##(1990-7#1)(1992-11#1)(1994-2#1)(1995-2#1)(1995-3#1)
three disulfide##7##2##(1990-7#1)(1992-11#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-3#1)(2008-8#1)
three divalent##2##2##(2005-11#1)(2008-10#1)
three diverse##2##2##(1995-8#1)(2008-12#1)
three doctors##2##2##(1995-6#1)(2007-8#1)
three domains of life##2##4##(2010-11#1)(2011-12#1)
three domains of the##2##4##(1997-7#1)(2007-7#1)
three domains of##4##3##(1997-7#1)(2007-7#1)(2010-11#1)(2011-12#1)
three domains##15##2##(1992-4#1)(1993-3#1)(1994-9#1)(1997-5#1)(1997-7#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-11#1)(2011-12#1)
three dominant##2##2##(1995-6#1)(2006-8#1)
three dopaminergic##2##2##(1996-5#2)
three doses of E##2##4##(1994-7#2)
three doses of##12##3##(1992-9#1)(1994-7#2)(1995-12#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-8#1)(2007-2#2)(2011-2#1)(2013-1#1)
three doses##21##2##(1992-9#1)(1994-7#2)(1995-12#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-8#1)(2004-12#1)(2005-11#1)(2005-8#2)(2007-2#3)(2008-7#1)(2011-2#1)(2013-1#3)(2013-8#1)
three dots##3##2##(1996-8#1)(2008-10#2)
three drug##2##2##(2008-1#1)(2008-10#1)
three drugs inhibited##3##3##(1994-3#2)(2007-5#1)
three drugs##14##2##(1993-5#1)(1994-3#2)(1996-6#1)(2005-8#1)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
three dummies##4##2##(2006-11#4)
three dyes##7##2##(2008-10#5)(2008-3#1)(2008-5#1)
three each##2##2##(1996-9#1)(2008-9#1)
three edible mushrooms##2##3##(2006-12#2)
three effects##2##2##(2008-3#1)(2008-5#1)
three electrodes##2##2##(2008-10#2)
three elements are##2##3##(1997-5#1)(2008-10#1)
three elements of##2##3##(1993-1#1)(2008-4#1)
three elements##9##2##(1993-1#1)(1997-5#3)(2008-10#3)(2008-3#1)(2008-4#1)
three embryonic germ layers##2##4##(2008-9#2)
three endoglycanases##2##2##(2005-12#2)
three entities##2##2##(1993-5#1)(2009-2#1)
three environmental##2##2##(1993-9#1)(2008-10#1)
three environments##3##2##(1997-7#1)(2008-10#2)
three enzymatic activities##2##3##(1996-5#1)(1997-6#1)
three enzymatic##3##2##(1996-5#1)(1997-6#1)(2008-10#1)
three enzyme##2##2##(2008-10#2)
three enzymes was##2##3##(1992-5#1)(2009-10#1)
three enzymes##15##2##(1992-5#2)(1997-4#1)(1997-7#2)(2006-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)
three episodes##2##2##(1996-7#1)(2010-7#1)
three equal groups##2##3##(2008-12#1)(2013-8#1)
three equally##2##2##(2007-11#1)(2008-3#1)
three essential##7##2##(1991-2#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-8#1)(2010-2#1)(2012-2#1)
three ethnic groups##3##3##(2011-2#3)
three ethnic##4##2##(2011-1#1)(2011-2#3)
three events##4##2##(1995-3#2)(1996-8#1)(2008-10#1)
three evidence-based postoperative pain assessment practices##2##6##(2010-11#2)
three examples of##6##3##(1994-1#1)(1994-9#1)(2007-11#1)(2007-12#1)(2008-10#2)
three examples##9##2##(1994-1#1)(1994-9#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
three exchanges##2##2##(2007-12#2)
three existing##4##2##(2008-2#1)(2012-3#1)(2013-1#2)
three exons and two introns##3##5##(1990-8#1)(1991-2#1)(1992-8#1)
three exons and##4##3##(1990-8#1)(1991-2#1)(1992-8#1)(1995-1#1)
three exons of the##2##4##(1992-10#1)(1994-8#1)
three exons of##3##3##(1992-1#1)(1992-10#1)(1994-8#1)
three exons##11##2##(1990-7#1)(1990-8#1)(1991-2#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-8#2)(1993-2#1)(1994-8#1)(1995-1#1)
three expansion methods##4##3##(2013-1#4)
three experimental groups##8##3##(1996-2#1)(1997-2#1)(1997-6#2)(2007-1#1)(2008-12#1)(2011-1#1)(2011-2#1)
three experimental##13##2##(1991-6#1)(1996-2#1)(1997-2#1)(1997-6#2)(2005-11#1)(2007-1#1)(2008-10#1)(2008-12#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
three experiments using##2##3##(2008-11#1)(2008-2#1)
three experiments##18##2##(1993-2#1)(1996-6#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-5#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-2#1)(2011-1#1)(2012-2#2)
three exponential##2##2##(1996-4#1)(2006-10#1)
three extracellular##2##2##(1991-1#1)(1994-9#1)
three extracts##2##2##(2008-5#2)
three factors were##3##3##(1990-6#1)(1995-8#1)(1997-8#1)
three factors##15##2##(1990-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-8#2)(2009-7#1)(2010-12#1)(2011-11#1)
three families of##5##3##(1994-3#1)(2008-7#1)(2010-12#1)(2011-12#1)(2013-7#1)
three families were##2##3##(1992-1#1)(2008-10#1)
three families##12##2##(1991-6#1)(1992-1#1)(1994-3#1)(1995-1#1)(1996-6#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-12#1)(2013-7#1)
three fatal cases##2##3##(1997-5#1)(2013-8#1)
three features##2##2##(1993-12#1)(2008-2#1)
three females##4##2##(2007-7#1)(2008-1#2)(2008-10#1)
three field##5##2##(2007-6#1)(2008-10#3)(2013-8#1)
three fields##4##2##(2007-8#1)(2008-10#2)(2012-1#1)
three fitness##2##2##(2008-3#1)(2008-9#1)
three flavonoids##3##2##(2007-1#1)(2008-10#2)
three fluoroquinolones##2##2##(2008-10#2)
three focus groups##3##3##(2008-11#1)(2009-9#1)(2012-3#1)
three fold##6##2##(1990-10#1)(1990-3#1)(1991-10#1)(1994-12#1)(1994-3#1)(2006-7#1)
three follow-up##2##2##(1993-12#1)(2012-3#1)
three for P450 2C12##2##4##(1993-6#2)
three for##5##2##(1993-6#2)(2007-9#1)(2008-9#2)
three forms of##8##3##(1991-10#1)(1991-8#1)(1993-2#1)(1994-9#1)(2007-1#1)(2008-10#1)(2010-8#1)(2011-2#1)
three forms##15##2##(1990-12#1)(1991-10#1)(1991-2#1)(1991-8#2)(1992-8#1)(1993-2#1)(1994-9#1)(1995-5#1)(2007-1#1)(2008-10#1)(2010-8#1)(2011-2#3)
three formulations were tested for in vitro drug release pattern##2##10##(2010-3#2)
three formulations##4##2##(2008-10#1)(2008-5#1)(2010-3#2)
three fourths of##2##3##(1991-2#1)(2010-12#1)
three fourths##3##2##(1991-2#1)(2010-12#1)(2011-2#1)
three fractions##7##2##(1991-5#1)(1992-12#1)(1993-8#1)(1995-6#1)(1996-5#1)(2008-10#1)(2012-12#1)
three fragments##2##2##(1990-3#1)(1995-12#1)
three frequency##2##2##(1991-10#1)(1991-4#1)
three from the##2##3##(2008-5#1)(2008-9#1)
three from##4##2##(1994-3#1)(1997-4#1)(2008-5#1)(2008-9#1)
three functional domains##2##3##(1995-3#1)(1997-1#1)
three functional##13##2##(1991-12#1)(1992-5#1)(1994-12#1)(1995-2#1)(1995-3#1)(1997-1#1)(1997-7#1)(2007-12#3)(2007-3#1)(2008-4#1)(2009-6#1)
three functionally##2##2##(1992-4#1)(1995-5#1)
three functions##4##2##(1995-12#1)(2007-4#1)(2008-7#1)(2010-6#1)
three fundamental##2##2##(2007-10#1)(2008-10#1)
three fungal##2##2##(2007-7#1)(2008-10#1)
three fungi##2##2##(2010-12#1)(2010-7#1)
three fungicides##3##2##(2008-10#3)
three further##3##2##(1992-4#1)(2008-11#1)(2011-2#1)
three fusion##2##2##(2008-5#1)(2008-8#1)
three gene products##2##3##(1995-3#1)(1996-10#1)
three gene##4##2##(1995-3#1)(1996-10#1)(1996-5#1)(2008-11#1)
three genera##6##2##(1995-2#1)(1996-6#2)(1997-4#1)(2008-10#1)(2010-7#1)
three general##4##2##(1993-4#1)(2008-4#1)(2011-2#1)(2013-8#1)
three generations of##4##3##(1993-3#1)(2005-7#1)(2006-11#1)(2011-1#1)
three generations##8##2##(1991-8#1)(1993-3#1)(2004-4#1)(2005-7#1)(2006-11#1)(2007-7#1)(2011-1#1)(2012-12#1)
three generic##2##2##(1992-3#1)(2007-12#1)
three genes are##2##3##(1990-12#1)(1990-7#1)
three genes encoding##2##3##(1996-10#1)(1997-4#1)
three genes in the##3##4##(1996-5#1)(1997-2#2)
three genes in##4##3##(1995-3#1)(1996-5#1)(1997-2#2)
three genes that##2##3##(1990-12#1)(2008-10#1)
three genes were##3##3##(1994-5#1)(1996-5#1)(2010-5#1)
three genes##30##2##(1990-12#2)(1990-5#1)(1990-7#1)(1993-11#1)(1994-12#2)(1994-5#2)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-10#2)(1996-5#3)(1997-2#2)(1997-3#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-5#1)(2009-12#1)(2010-5#1)(2011-2#1)
three genetic##4##2##(1995-3#1)(2008-10#3)
three genetically distinct##2##3##(2008-10#2)
three genetically##5##2##(1995-7#1)(2008-10#3)(2013-1#1)
three genomes##2##2##(2008-5#1)(2008-9#1)
three genotypes##4##2##(1995-11#1)(1997-7#1)(2008-12#1)(2013-8#1)
three genotypic##3##2##(2008-10#3)
three geographic##2##2##(2008-10#2)
three geographical##2##2##(2008-10#2)
three geographically##2##2##(1994-4#1)(2008-10#1)
three germ layers##4##3##(1997-8#1)(2012-12#3)
three germ##5##2##(1997-8#1)(2006-5#1)(2012-12#3)
three goals of##2##3##(1996-1#2)
three goals##4##2##(1995-12#1)(1996-1#2)(2008-9#1)
three grade levels##2##3##(2012-12#1)(2013-8#1)
three grades##2##2##(1990-12#1)(2010-7#1)
three gratings##2##2##(2008-2#1)(2008-3#1)
three great##2##2##(1991-12#1)(1997-6#1)
three groups (P &lt##2##4##(1996-12#1)(2012-1#1)
three groups according to the##8##5##(1996-6#1)(2007-6#1)(2008-10#2)(2008-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
three groups according to##12##4##(1991-4#1)(1996-6#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-12#1)(2010-10#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)
three groups according##13##3##(1991-4#1)(1996-6#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-12#1)(2010-10#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#2)
three groups at##2##3##(2007-12#1)(2013-1#1)
three groups did not differ##2##5##(2009-9#1)(2010-7#1)
three groups in##8##3##(1994-12#1)(1997-6#1)(2006-9#1)(2008-1#1)(2008-9#1)(2009-10#1)(2009-11#1)(2012-2#1)
three groups of healthy##2##4##(1990-10#1)(1994-1#1)
three groups of patients in##2##5##(2007-8#1)(2010-7#1)
three groups of patients##6##4##(1990-1#1)(2007-8#1)(2010-7#2)(2011-2#1)(2013-1#1)
three groups of rats##2##4##(2009-5#1)(2011-1#1)
three groups of##38##3##(1990-1#1)(1990-10#1)(1991-10#1)(1991-12#1)(1993-1#1)(1994-1#1)(1995-12#1)(1996-9#1)(2006-3#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#4)(2010-7#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)
three groups on##4##3##(1990-4#1)(2008-1#1)(2008-10#1)(2013-8#1)
three groups showed##2##3##(2008-7#1)(2010-3#1)
three groups to##2##3##(1991-1#1)(2007-2#1)
three groups was##6##3##(1991-9#1)(2004-1#1)(2008-9#2)(2012-2#2)
three groups were##7##3##(1993-1#1)(1995-2#1)(1995-5#1)(2007-8#1)(2008-10#2)(2012-5#1)
three groups##213##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-4#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-9#1)(1993-1#2)(1993-2#1)(1993-4#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#3)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#1)(2004-1#1)(2004-12#1)(2005-4#1)(2005-7#3)(2006-10#1)(2006-3#1)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#1)(2006-9#2)(2007-1#1)(2007-11#1)(2007-12#3)(2007-2#4)(2007-3#1)(2007-6#3)(2007-7#2)(2007-8#5)(2008-1#3)(2008-10#25)(2008-12#4)(2008-4#5)(2008-5#6)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#7)(2009-10#5)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#4)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#2)(2010-4#4)(2010-7#3)(2011-1#9)(2011-12#4)(2011-2#6)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#8)(2012-3#1)(2012-5#3)(2013-1#6)(2013-7#1)(2013-8#8)
three growth##4##2##(1991-1#1)(1993-11#1)(2008-12#1)(2012-12#1)
three guilds##2##2##(2008-8#2)
three habitats##2##2##(2008-10#2)
three had##18##2##(1991-12#1)(1992-3#1)(1993-5#1)(1997-5#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-3#1)(2007-7#1)(2007-8#3)(2008-6#2)(2008-8#2)(2010-5#1)(2012-12#1)
three haptens##2##2##(2008-10#2)
three have##3##2##(2008-10#1)(2008-9#1)(2010-7#1)
three health##2##2##(2006-10#1)(2013-7#1)
three healthy subjects##2##3##(1990-11#1)(2012-1#1)
three healthy##4##2##(1990-11#1)(1996-12#1)(2006-8#1)(2012-1#1)
three helices##2##2##(1991-4#1)(1997-2#1)
three herbicides##2##2##(2008-10#2)
three heterologous##2##2##(1997-4#1)(2008-10#1)
three hierarchical##2##2##(1997-4#1)(1997-5#1)
three high##3##2##(2006-12#1)(2007-3#1)(2009-8#1)
three highly conserved##2##3##(1995-2#1)(1997-2#1)
three highly##6##2##(1995-2#1)(1997-2#1)(2008-10#2)(2008-3#2)
three histidines are##2##3##(1993-6#1)(1994-10#1)
three histidines##3##2##(1993-6#1)(1994-10#2)
three homogeneous##2##2##(2007-12#1)(2008-10#1)
three homozygous##2##2##(1993-6#1)(2007-7#1)
three hospitals in##4##3##(2008-10#1)(2008-9#1)(2009-5#1)(2012-3#1)
three hospitals##7##2##(1995-2#1)(2008-10#1)(2008-9#2)(2009-5#1)(2012-3#1)(2013-1#1)
three host##3##2##(2008-10#2)(2010-4#1)
three hosts##4##2##(2008-10#4)
three hours after##2##3##(2009-6#1)(2013-1#1)
three hours of##5##3##(1990-7#1)(1993-12#1)(1997-2#1)(2008-11#1)(2011-1#1)
three hours##22##2##(1990-7#1)(1991-12#1)(1992-8#2)(1993-12#2)(1996-11#1)(1996-6#1)(1997-2#1)(2006-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2009-6#1)(2010-4#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
three household##2##2##(2008-10#1)(2011-1#1)
three human alpha##2##3##(1994-6#2)
three human tissues##2##3##(1990-6#1)(2008-3#1)
three human tumor cell lines##2##5##(1992-11#1)(2008-5#1)
three human##25##2##(1990-6#1)(1991-6#1)(1992-11#1)(1992-8#2)(1993-12#1)(1994-11#1)(1994-6#4)(1995-5#1)(2006-12#1)(2007-1#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2010-4#1)
three hundred##3##2##(1994-2#1)(2011-2#1)(2013-8#1)
three hybridization##2##2##(1994-3#1)(2008-10#1)
three i##2##2##(2007-2#1)(2007-8#1)
three identical##3##2##(1994-11#1)(2008-10#1)(2008-5#1)
three ilarviruses##2##2##(2008-10#2)
three illustrative cases##2##3##(2006-7#1)(2007-7#1)
three images##2##2##(2008-2#1)(2008-6#1)
three immunologically##2##2##(1991-10#1)(1991-2#1)
three important##11##2##(1992-11#1)(2005-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2009-5#1)(2011-1#1)(2012-1#1)
three in the##2##3##(1994-12#1)(2008-10#1)
three in vitro##2##3##(2004-12#1)(2007-11#1)
three in##19##2##(1991-12#1)(1991-8#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-8#1)(1996-6#1)(2004-12#1)(2006-1#1)(2007-11#1)(2007-5#1)(2008-10#3)(2011-2#3)(2012-3#1)
three incoherent feed-forward##2##3##(2008-11#2)
three independent analysis of a##2##5##(2008-10#2)
three independent data##3##3##(2008-10#2)(2008-8#1)
three independent genes##2##3##(1995-5#1)(2008-11#1)
three independent samples of##2##4##(2007-12#1)(2009-4#1)
three independent variables##4##3##(1997-7#1)(2007-10#1)(2007-12#2)
three independent##43##2##(1991-12#1)(1991-2#1)(1993-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-7#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-6#2)(2008-10#9)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#3)(2009-12#1)(2009-2#1)(2009-4#2)(2009-8#1)(2012-1#1)
three indexes##3##2##(1990-9#1)(2012-2#2)
three indices##5##2##(1995-8#1)(2007-6#1)(2008-5#2)(2009-8#1)
three individual##3##2##(1996-9#1)(2007-10#1)(2012-3#1)
three individuals tossed a ball##2##5##(2008-11#2)
three individuals##4##2##(2008-11#2)(2008-8#1)(2012-12#1)
three inhibitors##2##2##(1992-11#1)(2010-12#1)
three injections##2##2##(2006-8#1)(2007-11#1)
three instances##2##2##(1992-1#2)
three institutions##2##2##(2009-8#1)(2012-1#1)
three intermediate##2##2##(2008-10#1)(2012-3#1)
three internal##5##2##(1992-1#1)(1993-6#1)(1994-9#1)(1995-8#1)(2010-4#1)
three international##2##2##(2006-9#1)(2008-10#1)
three interrelated##3##2##(1992-12#1)(2010-8#1)(2013-1#1)
three intervention components##3##3##(2006-10#2)(2011-2#1)
three introns and encodes a##2##5##(1993-6#1)(1996-10#1)
three introns and##3##3##(1993-6#1)(1994-11#1)(1996-10#1)
three introns of##3##3##(1993-3#1)(1994-12#1)(1995-8#1)
three introns##15##2##(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#2)(1995-8#3)(1996-10#1)(1997-2#1)(2010-5#1)
three islands##2##2##(2008-10#2)
three isoflavone aglycones##2##3##(2008-10#2)
three isoforms of pIGFBP-3##2##4##(1991-12#2)
three isoforms of the##2##4##(1995-2#1)(1996-2#1)
three isoforms of##7##3##(1991-12#2)(1995-2#1)(1995-8#1)(1996-2#1)(2008-1#1)(2008-10#1)
three isoforms##9##2##(1991-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(2008-1#1)(2008-10#1)(2010-12#1)
three isolated##3##2##(1990-6#1)(1996-6#2)
three isolates of T##2##4##(2008-10#2)
three isolates of nucleopolyhedrovirus of Helicoverpa armigera##2##7##(2008-12#2)
three isolates of##8##3##(2008-10#4)(2008-12#2)(2008-6#1)(2013-1#1)
three isolates were##4##3##(1997-4#1)(2007-12#1)(2008-10#1)(2008-5#1)
three isolates##26##2##(1997-4#1)(2006-10#1)(2007-12#1)(2008-10#17)(2008-12#2)(2008-5#1)(2008-6#1)(2011-1#1)(2013-1#1)
three isolation trials##2##3##(2007-7#2)
three issues##5##2##(1993-12#1)(2007-8#1)(2008-1#1)(2008-9#1)(2009-4#1)
three items##2##2##(1991-5#1)(2008-5#1)
three key elements##2##3##(2005-5#1)(2008-11#1)
three key##15##2##(1991-2#1)(1995-2#1)(2005-5#1)(2006-12#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-4#1)(2008-10#1)(2008-11#1)(2009-7#1)(2010-7#1)(2011-3#1)(2013-8#1)
three kinases##3##2##(1995-8#1)(2008-4#1)(2012-12#1)
three kinds of media##2##4##(2008-10#2)
three kinds of##19##3##(1991-4#1)(1992-8#1)(1994-12#1)(1994-2#1)(2005-4#2)(2007-10#1)(2008-10#7)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)(2012-3#1)
three kinds##20##2##(1991-4#1)(1992-8#1)(1994-12#1)(1994-2#1)(2005-4#2)(2007-10#1)(2008-10#7)(2008-5#1)(2008-7#1)(2008-9#2)(2010-2#1)(2012-3#1)
three kingdoms##2##2##(1990-12#1)(2009-10#1)
three known##14##2##(1991-9#1)(1993-4#1)(1994-12#1)(1995-5#1)(2005-11#1)(2006-12#3)(2007-1#3)(2007-11#1)(2008-5#1)(2009-7#1)
three labeled##2##2##(1990-11#1)(2008-10#1)
three laboratory##3##2##(2004-11#1)(2006-7#1)(2010-12#1)
three lakes##2##2##(2008-8#1)(2010-8#1)
three lamins##3##2##(1992-5#2)(1995-5#1)
three large##9##2##(1991-5#1)(1994-9#1)(1995-12#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-7#1)(2009-10#1)(2011-2#1)
three laser##4##2##(2008-2#2)(2008-3#2)
three latent##2##2##(2007-12#1)(2008-10#1)
three layer##3##2##(2008-10#2)(2009-5#1)
three layers of nodes was trained##4##6##(2008-10#4)
three layers of##6##3##(1994-2#1)(2008-10#4)(2010-8#1)
three layers##15##2##(1994-2#1)(2007-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2010-12#1)(2010-8#3)(2013-1#1)
three leafhopper species##2##3##(2008-10#2)
three lesions##3##2##(2008-11#1)(2008-6#2)
three levels of the health##2##5##(1994-12#1)(2008-1#1)
three levels of##17##3##(1994-12#1)(1997-3#1)(2007-12#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2012-12#2)
three levels##24##2##(1994-12#1)(1997-3#1)(1997-7#1)(2004-11#1)(2007-12#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-12#3)(2013-8#1)
three ligands##6##2##(1990-7#1)(1995-11#1)(1996-2#1)(1997-4#2)(2008-10#1)
three light##4##2##(1991-8#1)(2008-10#1)(2008-8#1)(2011-2#1)
three lineages##4##2##(2008-10#2)(2009-2#2)
three linear##3##2##(2006-11#1)(2008-10#1)(2008-3#1)
three lines of evidence##2##4##(1991-3#1)(2008-7#1)
three lines##5##2##(1991-3#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
three lipids##2##2##(1995-1#1)(2005-11#1)
three lipophilic##2##2##(1996-11#1)(2008-10#1)
three lipoproteins##2##2##(1991-2#1)(1993-5#1)
three local##3##2##(1992-1#1)(2004-2#1)(2006-8#1)
three localities##2##2##(1992-4#1)(2013-8#1)
three locations##5##2##(2006-9#1)(2008-10#3)(2008-3#1)
three loci##5##2##(1996-12#1)(2008-10#4)
three logs##2##2##(1996-2#1)(1997-1#1)
three long##2##2##(1994-9#1)(1997-5#1)
three longitudinal##2##2##(2008-3#2)
three low##2##2##(2007-1#1)(2008-5#1)
three low-copy##2##2##(2008-10#1)(2013-1#1)
three lysine residues##2##3##(1991-4#1)(1997-7#1)
three lysines##2##2##(1992-9#1)(2010-5#1)
three mRNA##2##2##(1993-3#1)(2008-5#1)
three mRNAs##2##2##(1995-5#1)(1997-6#1)
three main areas##2##3##(2008-11#1)(2012-3#1)
three main categories##3##3##(2005-8#1)(2006-10#1)(2008-11#1)
three main components##4##3##(2009-9#1)(2012-3#1)(2013-1#2)
three main coronary##2##3##(2007-8#1)(2010-12#1)
three main findings##2##3##(1992-1#1)(2008-2#1)
three main groups##3##3##(2006-12#1)(2008-10#1)(2010-8#1)
three main implications##2##3##(2007-7#1)(2009-2#1)
three main types##2##3##(1997-4#1)(2007-12#1)
three main##68##2##(1992-1#1)(1994-5#1)(1994-8#1)(1995-4#1)(1996-1#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#3)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#3)(2012-9#1)(2013-1#2)
three major bands##2##3##(1993-11#1)(1996-8#1)
three major categories##3##3##(2008-12#1)(2012-11#2)
three major classes of##5##4##(1990-8#1)(1995-11#2)(2006-2#1)(2008-4#1)
three major classes##6##3##(1990-8#1)(1994-2#1)(1995-11#2)(2006-2#1)(2008-4#1)
three major components##2##3##(1994-5#1)(2008-10#1)
three major groups##3##3##(1995-11#1)(2006-6#1)(2010-3#1)
three major lineages##2##3##(2008-6#1)(2010-6#1)
three major lines of##2##4##(2010-1#1)(2013-8#1)
three major loci##2##3##(2008-10#1)(2009-4#1)
three major metabolites##2##3##(1990-8#1)(2008-7#1)
three major risk factors##2##4##(1997-8#2)
three major steps##2##3##(2008-4#1)(2011-12#1)
three major transcription##2##3##(1991-11#1)(1992-5#1)
three major##94##2##(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-7#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-8#2)(1994-2#2)(1994-5#1)(1995-11#3)(1996-1#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-8#3)(2005-12#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-12#2)(2008-2#2)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#2)(2009-10#1)(2009-4#2)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
three males and##3##3##(1992-9#1)(2008-1#1)(2011-12#1)
three males##6##2##(1992-9#1)(2004-11#1)(2007-3#1)(2008-1#1)(2010-8#1)(2011-12#1)
three mammalian##2##2##(2009-3#1)(2013-8#1)
three marine##3##2##(1990-7#1)(2008-2#1)(2011-2#1)
three markers##10##2##(1991-2#4)(1992-1#2)(1995-12#1)(1997-8#1)(2007-11#1)(2008-11#1)
three masses##2##2##(2007-2#1)(2008-7#1)
three may##2##2##(2007-3#1)(2012-12#1)
three meals##3##2##(2008-2#1)(2008-4#1)(2013-7#1)
three measurement##4##2##(1995-9#1)(2005-10#1)(2010-10#1)(2010-7#1)
three measurements of##2##3##(2006-7#1)(2008-1#1)
three measurements##6##2##(2006-7#1)(2008-1#3)(2008-10#1)(2012-12#1)
three measures of durability##2##4##(2008-10#2)
three measures of##4##3##(2007-12#1)(2008-10#2)(2008-4#1)
three measures##9##2##(1995-12#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-4#1)(2010-11#1)(2013-1#2)
three mechanisms##5##2##(1996-6#1)(2005-9#1)(2007-11#1)(2008-10#1)(2013-7#1)
three media##4##2##(2005-11#1)(2008-10#3)
three medical##2##2##(2006-10#1)(2013-7#1)
three medications##3##2##(1997-3#1)(2010-11#1)(2011-1#1)
three meiotic mutants##2##3##(2008-5#2)
three member##2##2##(2008-7#1)(2008-8#1)
three members of the##5##4##(1994-12#1)(1996-12#1)(1997-5#1)(2009-6#1)(2013-1#1)
three members of##7##3##(1993-12#1)(1994-12#1)(1996-12#2)(1997-5#1)(2009-6#1)(2013-1#1)
three members##9##2##(1993-12#2)(1994-12#1)(1994-5#1)(1996-12#2)(1997-5#1)(2009-6#1)(2013-1#1)
three membrane##3##2##(1990-11#1)(1994-12#1)(2009-7#1)
three membrane-spanning##2##2##(1994-3#1)(1997-7#1)
three men##5##2##(1991-11#1)(1994-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
three metal ions##4##3##(2008-10#2)(2008-3#1)(2009-4#1)
three metals##6##2##(1996-3#1)(2008-10#5)
three methods for the##5##4##(1990-12#1)(1994-12#1)(2008-1#1)(2010-4#1)(2013-8#1)
three methods for##10##3##(1990-12#1)(1994-12#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-4#1)(2013-8#1)
three methods of##8##3##(1997-8#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-4#1)(2010-6#1)(2013-7#1)
three methods to estimate##2##4##(1993-1#1)(1995-1#1)
three methods to##3##3##(1993-1#1)(1995-1#1)(2012-3#1)
three methods were compared with##2##5##(1994-12#1)(1996-5#1)
three methods were##6##3##(1993-2#1)(1994-12#1)(1996-5#2)(2008-10#1)(2011-1#1)
three methods##68##2##(1990-12#1)(1991-3#2)(1991-8#1)(1992-2#2)(1993-1#2)(1993-2#3)(1993-5#2)(1994-12#2)(1994-9#1)(1995-1#2)(1996-5#2)(1997-8#2)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#9)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-1#2)(2012-2#1)(2012-3#6)(2013-1#2)(2013-7#1)(2013-8#2)
three methylxanthines##2##2##(2008-10#2)
three metrics##2##2##(2008-2#2)
three micronutrients##2##2##(2007-11#2)
three million##4##2##(2004-9#1)(2007-7#1)(2012-12#1)(2013-8#1)
three minor##5##2##(1992-2#1)(1997-4#1)(2007-12#1)(2008-11#1)(2009-10#1)
three minority populations##2##3##(2011-1#2)
three model##6##2##(2008-11#2)(2012-12#4)
three models for##2##3##(1996-7#1)(2012-3#1)
three models of##2##3##(2007-10#1)(2008-4#1)
three models##13##2##(1990-5#1)(1996-7#2)(2007-10#1)(2007-9#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-12#1)(2012-1#1)(2012-2#1)(2012-3#1)
three modes of##3##3##(2006-5#1)(2008-3#1)(2013-1#1)
three modes##6##2##(1992-3#1)(2006-5#1)(2008-3#2)(2012-2#1)(2013-1#1)
three modules##2##2##(1993-12#1)(2008-7#1)
three molecular##4##2##(1990-8#1)(1994-8#1)(2008-10#2)
three molecules is##2##3##(1990-4#1)(2006-4#1)
three molecules##4##2##(1990-4#1)(1992-4#2)(2006-4#1)
three moles of##3##3##(2006-8#2)(2008-10#1)
three monoclonal antibodies##5##3##(1991-2#1)(1992-8#1)(2007-12#1)(2008-10#1)(2008-9#1)
three monoclonal##6##2##(1990-5#1)(1991-2#1)(1992-8#1)(2007-12#1)(2008-10#1)(2008-9#1)
three monomers##3##2##(1994-8#1)(1995-6#1)(2010-4#1)
three month period##2##3##(1990-6#1)(1991-4#1)
three month##8##2##(1990-2#1)(1990-3#1)(1990-6#1)(1991-4#1)(2004-7#1)(2005-1#1)(2006-8#1)(2008-5#1)
three months after surgery##3##4##(1993-3#1)(2006-2#1)(2007-7#1)
three months after the##3##4##(1990-5#1)(2006-8#1)(2007-1#1)
three months after##10##3##(1990-5#1)(1991-11#1)(1992-9#1)(1993-3#1)(1996-3#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-7#1)(2008-1#1)
three months and one year##2##5##(1991-11#1)(2007-2#1)
three months and##17##3##(1990-12#1)(1990-6#1)(1991-11#1)(1992-8#1)(1993-3#1)(1993-6#1)(2006-7#1)(2007-11#1)(2007-2#2)(2008-11#2)(2008-12#1)(2008-2#1)(2009-6#1)(2013-1#2)
three months during##2##3##(2008-1#1)(2012-3#1)
three months for##2##3##(2007-11#1)(2011-1#1)
three months from##2##3##(2010-2#1)(2013-1#1)
three months in##2##3##(1996-8#1)(2008-12#1)
three months later for##2##4##(2007-8#1)(2012-2#1)
three months later##6##3##(1992-6#1)(2006-6#1)(2006-9#1)(2007-8#1)(2010-3#1)(2012-2#1)
three months of age##5##4##(1992-1#1)(1996-8#1)(2008-11#1)(2008-7#1)(2012-2#1)
three months of orthodontic treatment##2##5##(2012-12#2)
three months of treatment##2##4##(2010-8#2)
three months of##25##3##(1990-4#1)(1991-8#1)(1992-1#1)(1992-11#1)(1993-10#1)(1993-7#1)(1996-8#1)(2007-2#1)(2007-7#2)(2008-11#1)(2008-7#1)(2009-7#1)(2010-8#2)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#5)
three months prior to##2##4##(1997-8#1)(2013-8#1)
three months the##2##3##(2006-7#1)(2008-10#1)
three months were##5##3##(1991-4#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-6#1)
three months##141##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#2)(1990-6#1)(1991-11#5)(1991-12#1)(1991-3#1)(1991-4#2)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-3#3)(1993-6#1)(1993-7#1)(1994-2#1)(1995-11#1)(1996-3#3)(1996-8#3)(1997-8#1)(2004-2#1)(2005-1#1)(2006-10#2)(2006-2#2)(2006-4#1)(2006-6#1)(2006-7#4)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#5)(2007-6#1)(2007-7#6)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#15)(2013-8#2)
three months'##3##2##(1990-9#1)(1992-9#1)(2008-11#1)
three more##7##2##(1991-3#1)(1991-8#1)(1994-12#1)(1994-2#1)(1995-11#1)(2008-2#1)(2008-4#1)
three morphological types##2##3##(1996-6#1)(2008-12#1)
three morphological##4##2##(1996-6#1)(2008-12#1)(2008-7#1)(2009-4#1)
three most common##4##3##(1997-6#1)(2007-2#1)(2011-2#1)(2013-1#1)
three most important##4##3##(2007-8#1)(2008-3#1)(2008-4#1)(2012-12#1)
three most##19##2##(1990-12#1)(1990-4#1)(1997-6#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2010-6#1)(2011-2#2)(2012-12#1)(2013-1#1)
three mouse##3##2##(1994-12#1)(1996-10#1)(2008-11#1)
three multicenter studies##2##3##(2006-10#2)
three murine##2##2##(1992-4#1)(2008-4#1)
three mutant antibodies##2##3##(1992-8#2)
three mutant##5##2##(1990-3#1)(1992-8#2)(1993-3#1)(1994-8#1)
three mutants was##2##3##(2008-10#2)
three mutants##9##2##(1993-11#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-6#1)(1997-4#1)(2008-10#2)(2008-9#1)
three mutations##3##2##(1991-9#1)(1992-11#1)(1993-12#1)
three natural##3##2##(1995-2#1)(2008-10#2)
three nebulizers##3##2##(1996-12#3)
three needed##2##2##(1991-8#1)(2006-8#1)
three negative##4##2##(1995-5#1)(1996-8#1)(2006-6#2)
three neurotrophic factors##2##3##(2013-1#2)
three neurotrophins##2##2##(1996-3#2)
three new##30##2##(1990-12#1)(1991-2#1)(1991-4#1)(1993-11#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-8#1)(1997-3#1)(1997-8#1)(2005-12#1)(2006-10#2)(2006-12#2)(2007-1#3)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#5)(2008-2#1)(2010-5#1)(2012-2#1)(2013-1#1)
three nights##2##2##(2008-3#2)
three normal##3##2##(1990-2#1)(2007-2#1)(2010-12#1)
three novel neuropeptides##2##3##(1997-7#2)
three novel##18##2##(1991-4#1)(1991-9#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-5#1)(1997-7#2)(2008-1#1)(2008-10#1)(2009-8#1)(2010-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)
three nuclear##4##2##(1991-9#1)(1993-11#1)(1993-3#1)(2007-12#1)
three nucleoside##3##2##(2005-7#1)(2012-12#2)
three nucleotide##2##2##(1996-4#1)(2008-7#1)
three nucleotides and##2##3##(1990-3#1)(1990-7#1)
three nucleotides##4##2##(1990-3#1)(1990-7#1)(1992-9#1)(1995-8#1)
three numerical##2##2##(1992-6#1)(2008-2#1)
three oak species##2##3##(2012-6#1)(2012-9#1)
three objectives##6##2##(1993-12#1)(1995-12#1)(1996-1#1)(2008-9#2)(2009-12#1)
three occasions##5##2##(1993-1#1)(1994-12#1)(2007-12#1)(2007-8#1)(2013-1#1)
three of eight##2##3##(1990-5#1)(2006-7#1)
three of five##4##3##(1991-10#1)(2006-7#1)(2008-10#2)
three of four##10##3##(1991-12#1)(1992-11#1)(1993-8#1)(2008-10#4)(2011-2#2)(2013-1#1)
three of six##6##3##(1997-4#2)(2008-10#2)(2008-3#1)(2008-8#1)
three of the five##4##4##(1997-1#1)(2006-3#1)(2008-10#1)(2008-9#1)
three of the four##15##4##(1990-8#1)(1991-2#1)(1992-11#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-12#1)(2007-2#1)(2008-10#2)(2008-5#1)(2008-9#1)(2011-1#1)(2012-11#1)
three of the isoforms##2##4##(1994-9#2)
three of the most##3##4##(1997-7#1)(2007-4#1)(2010-6#1)
three of the patients##3##4##(1995-11#1)(2006-10#1)(2008-10#1)
three of the six patients##2##5##(1992-2#1)(1995-1#1)
three of the six##6##4##(1991-6#1)(1992-2#1)(1994-12#1)(1995-1#1)(1997-6#1)(2008-5#1)
three of the##78##3##(1990-10#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-6#2)(1991-7#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#3)(1994-5#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-4#1)(1996-12#2)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2006-10#3)(2006-12#2)(2006-3#1)(2006-8#2)(2006-9#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#2)(2009-4#1)(2010-6#1)(2011-1#2)(2012-11#1)(2012-3#2)(2013-1#1)
three of them had##2##4##(2008-7#1)(2009-2#1)
three of them were##3##4##(1990-7#1)(1996-7#1)(2007-1#1)
three of them##21##3##(1990-7#1)(1991-12#1)(1991-5#1)(1992-3#1)(1992-7#1)(1993-8#1)(1996-10#1)(1996-7#1)(1997-9#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-3#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-2#1)(2011-2#1)(2013-1#1)
three of these events##2##4##(1992-11#1)(2008-10#1)
three of these##22##3##(1991-12#1)(1991-5#1)(1992-11#1)(1992-7#1)(1993-6#1)(1996-7#1)(1996-8#1)(1997-7#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#1)(2008-9#1)(2010-5#2)(2011-2#1)(2012-1#1)
three of which are in##2##5##(2008-5#1)(2012-12#1)
three of which are##7##4##(1992-3#1)(1993-5#1)(1995-12#1)(2006-11#1)(2008-5#1)(2010-2#1)(2012-12#1)
three of which had##2##4##(2007-3#1)(2008-10#1)
three of which were##4##4##(2008-10#3)(2008-7#1)
three of which##18##3##(1992-3#1)(1993-5#1)(1995-12#1)(1995-4#1)(1996-5#1)(2006-11#1)(2007-3#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-7#1)(2012-12#1)
three of whom had##2##4##(1991-11#1)(2008-9#1)
three of whom##3##3##(1991-11#1)(2008-9#2)
three of##174##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-5#2)(1991-6#2)(1991-7#1)(1992-10#1)(1992-11#3)(1992-2#1)(1992-3#3)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#2)(1994-12#3)(1994-3#1)(1994-5#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#2)(1995-4#2)(1996-10#1)(1996-12#2)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#1)(1997-9#2)(2006-10#3)(2006-11#2)(2006-12#2)(2006-3#1)(2006-6#1)(2006-7#3)(2006-8#2)(2006-9#2)(2007-1#1)(2007-12#2)(2007-2#1)(2007-3#3)(2007-4#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#24)(2008-11#3)(2008-3#3)(2008-4#2)(2008-5#5)(2008-7#4)(2008-8#2)(2008-9#5)(2009-11#1)(2009-2#1)(2009-4#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#3)
three offer##2##2##(2006-7#1)(2008-8#1)
three on##8##2##(1992-10#1)(1997-8#1)(2006-12#1)(2008-1#2)(2008-10#1)(2011-2#2)
three open reading frames (ORFs)##4##5##(1993-12#1)(1993-9#1)(1997-2#1)(2008-10#1)
three open reading frames##7##4##(1993-12#1)(1993-9#1)(1995-3#1)(1997-1#1)(1997-2#1)(2008-10#2)
three open-ended##2##2##(2008-12#1)(2012-12#1)
three operationalizations of burnout phase##2##5##(1997-1#2)
three operationalizations##3##2##(1997-1#3)
three operators##2##2##(1991-8#1)(2007-5#1)
three opioid##2##2##(1996-12#2)
three optical parameters that##2##4##(2008-3#2)
three optical parameters##3##3##(2008-3#3)
three optical##4##2##(2008-3#3)(2013-8#1)
three options##4##2##(1995-1#1)(1997-4#2)(2008-10#1)
three or five##3##3##(1991-3#1)(2008-10#2)
three or four##12##3##(1990-12#1)(1993-12#1)(1993-5#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-7#1)
three or less##2##3##(2011-11#1)(2011-2#1)
three or more children##3##4##(1997-2#2)(2010-8#1)
three or more of##2##4##(2006-10#1)(2008-10#1)
three or more##26##3##(1995-4#1)(1997-2#3)(2005-11#1)(2006-10#1)(2007-12#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#1)(2009-5#2)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#2)
three or##48##2##(1990-12#1)(1991-3#1)(1992-10#1)(1993-12#1)(1993-5#1)(1995-12#1)(1995-4#1)(1996-12#1)(1997-2#4)(2005-11#1)(2006-10#1)(2007-12#2)(2007-7#2)(2008-10#5)(2008-11#2)(2008-3#4)(2008-5#3)(2009-5#2)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-11#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
three orchards##2##2##(2008-10#2)
three orders in the magnitude##2##5##(2008-10#1)(2008-11#1)
three orders of magnitude and the##3##6##(2008-10#3)
three orders of magnitude##20##4##(1991-5#1)(1996-5#2)(2006-4#1)(2008-10#14)(2008-7#1)(2012-3#1)
three orders of##24##3##(1991-5#1)(1995-7#1)(1996-5#2)(2006-4#1)(2007-11#1)(2007-5#1)(2008-10#14)(2008-3#1)(2008-7#1)(2012-3#1)
three orders##27##2##(1991-5#1)(1995-7#1)(1996-5#2)(2006-4#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#15)(2008-11#1)(2008-3#1)(2008-7#1)(2012-3#1)
three organ##2##2##(2008-8#2)
three organizations##2##2##(1996-1#2)
three organs##2##2##(2008-7#1)(2008-9#1)
three orthogonal##4##2##(1997-7#1)(2008-2#1)(2008-3#1)(2009-7#1)
three other##33##2##(1990-12#2)(1990-3#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-12#1)(1997-6#1)(2005-8#1)(2006-12#1)(2006-4#1)(2008-10#6)(2008-11#1)(2008-7#1)(2010-4#1)(2011-2#1)
three others##2##2##(1991-8#1)(1996-12#1)
three out of five##3##4##(1996-12#1)(1996-5#1)(2008-11#1)
three out of four##4##4##(1991-10#1)(1991-2#1)(1992-7#1)(1996-9#1)
three out of seven##2##4##(2008-5#1)(2012-2#1)
three out of the##4##4##(1994-3#1)(1997-3#1)(2008-10#1)(2008-9#1)
three out of##16##3##(1991-10#1)(1991-2#1)(1992-7#1)(1993-8#1)(1994-3#1)(1994-8#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-3#1)(2004-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#1)
three outpatient##2##2##(1994-12#1)(2012-1#1)
three oxysterols##2##2##(1993-6#2)
three pH values##2##3##(2008-10#1)(2008-5#1)
three pHs##2##2##(1991-1#1)(2008-10#1)
three pairs of##8##3##(1991-1#1)(1995-2#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-7#1)(2013-8#1)
three pairs##10##2##(1991-1#1)(1994-5#1)(1995-2#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-7#1)(2013-8#1)
three parallel##6##2##(1994-5#1)(1995-3#1)(2005-7#1)(2008-10#1)(2008-2#1)(2008-7#1)
three parameter##3##2##(2007-1#1)(2008-10#1)(2008-2#1)
three parameters in##2##3##(2007-9#1)(2008-10#1)
three parameters##19##2##(1991-10#1)(2005-11#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-2#3)(2008-3#2)(2008-9#1)(2009-4#1)(2012-12#1)(2013-8#2)
three parametric##2##2##(1997-7#1)(2007-9#1)
three partial##3##2##(2006-4#1)(2008-6#1)(2012-1#1)
three parts##6##2##(1995-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2011-12#1)(2012-2#1)
three passages##2##2##(2006-10#1)(2008-5#1)
three passes##2##2##(2008-10#1)(2008-7#1)
three pathogen##2##2##(2007-12#1)(2008-10#1)
three pathogenic##2##2##(2008-10#1)(2008-11#1)
three pathotypes of##2##3##(2008-10#2)
three pathovars of##2##3##(2008-10#2)
three pathways##3##2##(1990-12#1)(1991-2#1)(2009-5#1)
three patients and##6##3##(1991-8#1)(2006-5#1)(2007-3#1)(2007-7#1)(2008-11#1)(2008-6#1)
three patients died##2##3##(1997-4#1)(2006-11#1)
three patients during##2##3##(2006-7#1)(2010-7#1)
three patients had a##2##4##(1990-9#1)(1992-2#1)
three patients had##8##3##(1990-9#1)(1992-2#1)(1996-9#1)(2006-4#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-3#1)
three patients in##4##3##(1996-9#1)(2006-10#1)(2011-2#1)(2013-8#1)
three patients presented with##3##4##(2006-8#1)(2007-8#1)(2008-7#1)
three patients underwent##3##3##(1993-5#1)(1994-3#1)(2007-8#1)
three patients were treated with##2##5##(2008-6#1)(2011-2#1)
three patients were##12##3##(1991-11#1)(1991-8#1)(1995-2#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-12#1)(2008-6#1)(2010-4#1)(2011-2#2)
three patients who##8##3##(1990-7#1)(1992-3#1)(1997-6#1)(2006-3#1)(2006-8#1)(2008-11#2)(2013-1#1)
three patients with primary##2##4##(1994-5#1)(2012-2#1)
three patients with##40##3##(1990-6#1)(1990-8#3)(1991-3#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-5#1)(1995-12#1)(1996-3#1)(1996-6#1)(1996-9#2)(2005-10#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-7#1)(2007-12#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-3#1)(2008-6#2)(2008-7#1)(2010-10#1)(2011-2#1)(2012-1#2)(2012-2#3)(2013-1#2)
three patients##173##2##(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#2)(1991-11#3)(1991-12#1)(1991-3#1)(1991-8#4)(1992-10#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#3)(1993-3#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-7#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-6#2)(1996-9#4)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#1)(2004-1#1)(2004-10#1)(2004-2#1)(2005-10#1)(2005-11#1)(2006-10#5)(2006-11#3)(2006-12#4)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#4)(2006-7#3)(2006-8#4)(2007-1#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-7#5)(2007-8#10)(2007-9#3)(2008-1#3)(2008-11#3)(2008-12#1)(2008-3#3)(2008-5#2)(2008-6#8)(2008-7#5)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#10)(2012-1#3)(2012-2#4)(2013-1#5)(2013-8#3)
three patients)##2##2##(2007-8#1)(2007-9#1)
three patterns##3##2##(1993-5#1)(2008-10#1)(2010-4#1)
three peaks of##2##3##(1997-7#2)
three peaks##5##2##(1991-2#1)(1994-8#1)(1997-7#2)(2008-10#1)
three pediatric patients with##3##4##(2006-10#1)(2011-1#1)(2013-8#1)
three people##2##2##(2006-8#1)(2008-10#1)
three peptide##3##2##(1991-5#1)(1992-7#1)(2008-4#1)
three peptides were##2##3##(1997-4#1)(2012-1#1)
three peptides##10##2##(1992-12#2)(1992-2#3)(1996-12#1)(1997-4#1)(2008-6#1)(2012-1#2)
three percent of##7##3##(2006-10#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2010-7#1)(2013-1#1)
three percent##9##2##(2006-10#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-12#1)(2010-7#1)(2013-1#1)
three periods##9##2##(1995-4#2)(2006-10#1)(2008-10#1)(2008-2#1)(2010-8#1)(2011-2#1)(2013-8#2)
three periplasmic##2##2##(1994-9#1)(1996-11#1)
three persons##2##2##(1991-2#1)(1994-11#1)
three perspectives##2##2##(2009-12#2)
three pesticides##4##2##(2008-10#4)
three pharmaceutical##2##2##(2008-10#2)
three phase fluidized bed reactor##2##5##(2008-7#2)
three phase maps##2##3##(2008-3#2)
three phase##6##2##(2008-3#3)(2008-7#2)(2009-11#1)
three phases in##2##3##(1992-6#1)(2009-7#1)
three phases of the##3##4##(2008-11#1)(2010-4#1)(2013-8#1)
three phases of##6##3##(1991-3#1)(1993-12#1)(2007-12#1)(2008-11#1)(2010-4#1)(2013-8#1)
three phases##23##2##(1990-7#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-6#1)(1993-12#1)(1993-3#1)(1997-6#1)(2006-12#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-7#1)(2010-4#2)(2010-8#1)(2013-1#1)(2013-8#2)
three phenomena##2##2##(1996-3#1)(1997-6#1)
three physical parameters##2##3##(2008-12#1)(2008-7#1)
three planes##2##2##(2008-6#1)(2008-9#1)
three plant species##4##3##(2004-4#1)(2008-10#2)(2013-8#1)
three plant##6##2##(2004-4#1)(2008-10#3)(2011-2#1)(2013-8#1)
three plants##2##2##(2008-10#1)(2008-9#1)
three plays##2##2##(1993-3#2)
three plowing##2##2##(2008-12#2)
three point mutations##2##3##(1996-11#1)(2010-2#1)
three point##5##2##(1996-11#1)(2006-10#1)(2008-5#1)(2010-2#1)(2013-8#1)
three points##5##2##(1990-10#1)(2005-4#1)(2007-12#1)(2008-7#1)(2009-9#1)
three policy##2##2##(2010-8#1)(2012-12#1)
three polymers##4##2##(2006-10#2)(2008-10#1)(2010-2#1)
three polymorphisms##3##2##(1991-6#1)(1996-5#1)(2012-1#1)
three polypeptide chains##2##3##(1992-8#1)(1995-6#1)
three polypeptide##3##2##(1992-8#1)(1995-6#1)(1997-4#1)
three polypeptides##6##2##(1990-4#1)(1991-10#2)(1993-11#1)(1995-3#1)(1996-5#1)
three populations of##6##3##(1990-10#1)(1995-1#1)(1995-2#1)(2005-11#1)(2010-8#1)(2011-12#1)
three populations##18##2##(1990-10#1)(1995-1#1)(1995-2#1)(1997-3#1)(2005-11#1)(2007-3#1)(2008-10#4)(2009-7#1)(2010-8#2)(2011-1#1)(2011-12#1)(2012-7#2)(2013-8#1)
three portions##4##2##(1991-3#1)(1994-4#1)(2011-1#1)(2012-2#1)
three ports##2##2##(2007-7#1)(2007-8#1)
three positions##5##2##(1993-6#1)(1996-6#1)(1996-9#1)(2007-4#1)(2008-7#1)
three positive and##3##3##(1997-2#1)(2006-6#2)
three positively charged residues##4##4##(1992-11#2)(1997-8#2)
three possible combinations of##2##4##(1990-3#1)(1996-4#1)
three possible##10##2##(1990-3#1)(1991-3#1)(1993-8#1)(1993-9#1)(1996-4#1)(2007-2#1)(2008-10#2)(2008-8#1)(2011-1#1)
three potato cultivars##2##3##(2008-10#2)
three potato##3##2##(2008-10#3)
three potential##8##2##(1990-5#1)(1991-12#1)(1996-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-7#1)
three preterm##2##2##(2009-12#1)(2010-5#1)
three previously sequenced##2##3##(1996-6#1)(2008-10#1)
three previously##5##2##(1992-2#1)(1996-6#1)(2008-10#1)(2008-7#1)(2012-1#1)
three primary##9##2##(1992-2#1)(1994-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2009-11#1)(2010-5#1)
three primer##2##2##(2008-10#1)(2008-5#1)
three primers##4##2##(2008-10#1)(2010-4#2)(2013-8#1)
three principal types of junctions are found namely anchoring junctions##2##10##(2009-10#2)
three principal##6##2##(1997-7#1)(2007-12#1)(2008-3#2)(2009-10#2)
three principles##3##2##(2006-6#1)(2006-7#1)(2008-4#1)
three problems##2##2##(1996-12#1)(2010-8#1)
three procedures for##2##3##(1992-2#1)(2008-4#1)
three procedures##5##2##(1992-2#1)(2006-11#1)(2008-4#3)
three processes##4##2##(2007-7#1)(2008-11#1)(2008-2#2)
three products##3##2##(1990-7#1)(1996-3#1)(2008-5#1)
three prognostic##2##2##(2008-6#1)(2013-8#1)
three proinflammatory##2##2##(1994-8#1)(2011-2#1)
three prominent##2##2##(1996-3#1)(2008-10#1)
three promising formulations##2##3##(2010-3#2)
three promising##4##2##(2005-6#1)(2010-3#2)(2012-5#1)
three proteases##2##2##(2008-10#1)(2008-11#1)
three protected##2##2##(1994-9#1)(2013-7#1)
three protein kinases##2##3##(2009-8#1)(2011-1#1)
three protein##8##2##(1990-9#1)(1991-6#1)(1994-6#1)(1995-10#1)(1995-2#1)(1996-5#1)(2009-8#1)(2011-1#1)
three proteins share##2##3##(1991-5#1)(1995-5#1)
three proteins were##2##3##(1993-2#1)(2010-12#1)
three proteins##23##2##(1990-10#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-2#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-4#1)(2005-11#1)(2008-1#3)(2008-10#1)(2010-12#1)(2012-2#1)
three protocols for##3##3##(2008-4#3)
three protocols##5##2##(2008-4#4)(2012-1#1)
three provinces##2##2##(2007-1#1)(2008-8#1)
three putative##7##2##(1991-4#1)(1992-11#2)(1992-5#1)(1994-12#1)(1997-1#1)(2010-4#1)
three quantitative phenotypes##2##3##(2012-3#2)
three quantitative##5##2##(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#2)
three quarters of##3##3##(2007-2#1)(2010-6#1)(2012-2#1)
three quarters##5##2##(1997-8#1)(2006-8#1)(2007-2#1)(2010-6#1)(2012-2#1)
three questionnaires##2##2##(2006-8#1)(2007-10#1)
three questions##7##2##(1996-1#1)(1997-3#2)(2007-2#1)(2007-7#1)(2008-8#1)(2012-2#1)
three races##5##2##(2008-10#3)(2009-12#1)(2011-2#1)
three random##2##2##(2008-1#1)(2012-2#1)
three randomised##2##2##(1996-8#1)(1997-4#1)
three randomized controlled trials and##2##5##(2012-12#2)
three randomized controlled trials##4##4##(2009-4#1)(2012-12#3)
three randomized##8##2##(2008-1#1)(2008-2#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-12#3)
three raters##3##2##(2006-10#1)(2013-1#2)
three reaction##2##2##(2008-10#1)(2008-3#1)
three reactions##2##2##(1997-4#1)(2011-1#1)
three reactive dyes##2##3##(2008-1#2)
three reactive##3##2##(1992-9#1)(2008-1#2)
three reading frames##3##3##(1990-10#1)(1994-12#1)(1997-9#1)
three real samples##3##3##(2008-10#3)
three real##5##2##(2008-10#4)(2008-6#1)
three received##3##2##(2007-2#1)(2007-7#1)(2007-8#1)
three recent studies##3##3##(1992-6#1)(2006-10#1)(2007-2#1)
three recently described##2##3##(1992-11#1)(1994-12#1)
three recently##3##2##(1992-11#1)(1994-12#1)(2007-8#1)
three receptor##3##2##(1994-6#1)(2007-11#1)(2012-12#1)
three recordings##2##2##(1990-8#2)
three red##2##2##(2008-10#1)(2008-2#1)
three reference##3##2##(2006-8#1)(2008-10#1)(2008-3#1)
three regions and##2##3##(1992-7#1)(2008-10#1)
three regions of homology##2##4##(1990-7#1)(1993-6#1)
three regions of the##3##4##(1994-12#1)(1995-7#1)(1997-2#1)
three regions of##12##3##(1990-5#1)(1990-7#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-7#1)(1997-2#1)(2007-12#1)(2008-10#1)(2011-2#2)(2012-2#1)
three regions##35##2##(1990-5#1)(1990-7#1)(1991-6#2)(1991-7#2)(1992-7#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-7#2)(1995-8#1)(1996-3#1)(1997-2#1)(2007-12#1)(2007-3#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-9#2)(2009-4#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#2)
three regulatory##2##2##(1990-8#1)(2006-8#1)
three related proteins##2##3##(1993-11#1)(1994-2#1)
three related##11##2##(1990-12#1)(1991-7#1)(1993-11#1)(1994-2#1)(1995-6#1)(2005-7#1)(2007-11#1)(2008-10#3)(2008-7#1)
three relative##2##2##(2008-2#1)(2011-2#1)
three remaining##6##2##(1992-11#1)(1992-5#1)(1993-2#1)(1994-9#1)(2007-12#1)(2008-10#1)
three replicate##5##2##(2006-11#1)(2006-12#1)(2008-10#1)(2010-2#1)(2013-7#1)
three replicates##5##2##(2008-10#5)
three replications##5##2##(2008-10#2)(2008-12#2)(2010-4#1)
three reports##2##2##(1991-2#1)(2007-7#1)
three representative##9##2##(1990-9#1)(1994-9#1)(1996-5#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-3#2)(2013-1#1)
three research##3##2##(2007-2#1)(2007-5#1)(2010-3#1)
three residues in the##2##4##(1996-6#1)(2013-1#1)
three residues in##3##3##(1994-3#1)(1996-6#1)(2013-1#1)
three residues of the##2##4##(1990-11#1)(1995-11#1)
three residues##8##2##(1990-11#1)(1990-8#1)(1992-11#1)(1994-3#1)(1995-11#1)(1996-6#1)(1996-8#1)(2013-1#1)
three resistance##2##2##(2008-10#1)(2008-8#1)
three resistant##2##2##(1996-5#1)(2008-10#1)
three resources##4##2##(2008-8#1)(2011-2#3)
three restriction enzymes##2##3##(2006-5#1)(2008-10#1)
three restriction fragment length polymorphism (RFLP) markers##2##7##(1995-6#1)(2008-9#1)
three restriction fragment length polymorphism (RFLP)##3##6##(1995-6#1)(2008-10#1)(2008-9#1)
three restriction##5##2##(1995-6#1)(2006-5#1)(2008-10#2)(2008-9#1)
three risk factors##2##3##(1991-2#1)(2007-12#1)
three risk##3##2##(1991-2#1)(2007-12#1)(2010-11#1)
three root-knot nematode species##2##4##(2008-10#1)(2009-3#1)
three rounds of screening##2##4##(2005-11#2)
three rounds of##5##3##(1991-3#1)(2005-11#2)(2008-10#1)(2009-6#1)
three rounds##7##2##(1991-3#1)(1997-7#1)(2005-11#2)(2008-10#2)(2009-6#1)
three routes to##2##3##(1997-7#1)(2008-8#1)
three rows of##2##3##(2008-10#1)(2008-5#1)
three rural communities##3##3##(2007-7#1)(2008-4#1)(2011-2#1)
three rural##4##2##(2007-7#1)(2008-4#1)(2010-6#1)(2011-2#1)
three samples##8##2##(1992-6#1)(1994-6#1)(2007-8#1)(2008-10#3)(2008-2#1)(2013-8#1)
three sampling campaigns##2##3##(2008-7#2)
three sampling sites##3##3##(2007-2#1)(2008-5#1)(2013-7#1)
three sampling##5##2##(2007-2#1)(2008-5#1)(2008-7#2)(2013-7#1)
three scales of##2##3##(2008-10#2)
three scales##7##2##(2008-10#3)(2010-8#1)(2011-1#2)(2013-7#1)
three scenarios##3##2##(2006-11#1)(2008-8#1)(2012-2#1)
three scores##2##2##(2013-8#2)
three seasons##4##2##(1994-3#1)(2008-10#1)(2008-5#1)(2011-2#1)
three sections##5##2##(1991-2#1)(2006-10#1)(2007-7#1)(2008-10#1)(2011-2#1)
three segments##7##2##(1991-5#1)(1994-12#1)(2004-11#1)(2007-12#2)(2008-3#1)(2013-8#1)
three selected##6##2##(1990-7#1)(1993-11#1)(1996-6#1)(2007-6#1)(2008-10#1)(2009-8#1)
three selective##4##2##(1993-11#1)(2007-8#1)(2008-12#1)(2010-2#1)
three separate electron flow pathways through##2##6##(1995-6#2)
three separate times##2##3##(2007-12#1)(2007-2#1)
three separate##32##2##(1991-3#2)(1993-5#1)(1993-7#1)(1995-4#1)(1995-6#3)(1996-2#1)(1997-3#1)(2006-3#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#3)(2009-10#1)(2009-8#1)(2011-1#2)(2012-2#1)(2013-1#3)
three sequential##6##2##(1994-5#1)(1996-5#1)(2006-9#1)(2008-10#1)(2008-2#1)(2009-11#1)
three sera positive for IgG alone##2##6##(2007-8#2)
three sera##3##2##(2007-8#3)
three serial##2##2##(1996-5#1)(2011-1#1)
three series of##2##3##(1997-7#1)(2008-5#1)
three series##3##2##(1997-7#1)(2008-5#1)(2009-9#1)
three sessions a week##2##4##(2007-9#1)(2008-4#1)
three sessions of##2##3##(1994-6#1)(2012-3#1)
three sessions##8##2##(1994-6#1)(1995-8#1)(2007-9#1)(2008-4#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
three sets of##12##3##(1994-8#1)(1995-2#1)(2004-12#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-7#2)(2010-2#1)(2010-5#1)
three sets##13##2##(1994-8#1)(1995-2#1)(2004-12#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-7#2)(2010-2#1)(2010-5#1)
three sexual##3##2##(2006-7#1)(2008-5#1)(2013-1#1)
three shampoos##2##2##(2008-5#2)
three short##8##2##(1991-3#1)(1993-2#1)(1993-3#1)(1996-9#1)(1997-4#1)(1997-6#1)(2010-11#1)(2012-12#1)
three shoulder##2##2##(2007-1#1)(2008-12#1)
three showed##4##2##(1991-3#1)(2013-1#3)
three showing##2##2##(2008-5#1)(2013-8#1)
three signals##3##2##(1997-3#2)(2007-11#1)
three significant##2##2##(2007-12#2)
three simple##2##2##(2007-8#1)(2008-9#1)
three single##3##2##(2008-9#1)(2009-4#1)(2013-1#1)
three sites in the##2##4##(1993-7#1)(2008-5#1)
three sites in##4##3##(1993-7#1)(1995-1#1)(2007-5#1)(2008-5#1)
three sites of##2##3##(2007-9#1)(2008-5#1)
three sites##21##2##(1990-7#1)(1992-3#1)(1993-7#1)(1994-1#1)(1995-1#1)(1995-6#1)(1996-7#1)(1997-5#1)(2004-2#1)(2004-4#1)(2007-5#2)(2007-9#1)(2008-10#2)(2008-5#2)(2010-4#1)(2010-5#1)(2012-3#1)(2013-7#1)
three size##3##2##(1992-6#1)(2007-5#1)(2008-5#1)
three sizes##2##2##(2007-12#1)(2013-7#1)
three small##2##2##(1995-3#1)(2008-3#1)
three soils##6##2##(2008-10#6)
three solenoid valves##2##3##(2008-10#2)
three sources of##2##3##(2009-9#1)(2012-3#1)
three sources##6##2##(1997-6#1)(2008-10#3)(2009-9#1)(2012-3#1)
three spatial dimensions##4##3##(2007-11#1)(2008-3#2)(2009-10#1)
three spatial##5##2##(2007-11#1)(2008-1#1)(2008-3#2)(2009-10#1)
three species and##2##3##(2008-10#1)(2008-7#1)
three species are##2##3##(1995-11#1)(2006-8#1)
three species have##2##3##(2007-12#1)(2007-5#1)
three species in##2##3##(2011-2#1)(2012-8#1)
three species of##24##3##(1992-8#1)(1993-9#1)(1995-11#1)(1996-1#1)(1997-4#1)(2007-12#2)(2007-2#1)(2007-3#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-9#1)(2010-2#2)(2010-8#1)(2013-1#2)(2013-8#1)
three species the##2##3##(1995-11#1)(2007-3#1)
three species were##9##3##(1994-2#1)(1997-2#1)(2004-4#1)(2007-3#1)(2008-10#2)(2011-3#1)(2012-8#1)(2013-7#1)
three species##79##2##(1990-5#1)(1992-1#1)(1992-7#1)(1992-8#2)(1993-2#1)(1993-9#1)(1994-2#1)(1995-11#5)(1996-1#1)(1997-2#1)(1997-4#1)(2004-11#1)(2004-4#4)(2006-8#1)(2007-1#1)(2007-12#5)(2007-2#1)(2007-3#4)(2007-5#2)(2007-8#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-2#1)(2010-2#3)(2010-8#2)(2011-12#2)(2011-2#2)(2011-3#5)(2012-8#2)(2012-9#1)(2013-1#2)(2013-7#1)(2013-8#1)
three specific##6##2##(1995-10#1)(2007-12#1)(2008-2#1)(2009-10#1)(2009-3#1)(2013-7#1)
three spectroscopic##2##2##(2008-10#2)
three spherical mirrors##2##3##(2008-3#2)
three stage##3##2##(1995-2#1)(2008-9#1)(2012-1#1)
three stages of##2##3##(2011-2#1)(2012-12#1)
three stages##20##2##(1996-3#1)(1996-6#1)(1997-8#1)(2005-11#1)(2006-8#1)(2007-10#1)(2008-10#1)(2008-4#4)(2008-6#1)(2009-5#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#2)
three standard reference materials##2##4##(2008-10#2)
three standard##9##2##(2007-12#1)(2008-10#6)(2008-7#1)(2012-2#1)
three stations##3##2##(1993-9#1)(2007-5#1)(2011-2#1)
three statistical##2##2##(1997-3#1)(2009-4#1)
three step process##2##3##(1991-3#1)(2008-1#1)
three step##3##2##(1991-3#1)(2008-1#1)(2008-10#1)
three steps from##6##3##(1993-12#1)(2006-12#1)(2008-10#1)(2008-4#1)(2010-6#1)(2012-3#1)
three steps of##2##3##(1996-12#1)(2007-8#1)
three steps##25##2##(1990-12#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-9#1)(1996-12#1)(1996-4#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#1)(2010-6#1)(2010-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
three strains of the##3##4##(2008-10#2)(2008-11#1)
three strains of##15##3##(1990-3#1)(1994-2#1)(1994-5#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-8#1)(2012-11#1)
three strains were##4##3##(2004-11#1)(2008-10#2)(2008-7#1)
three strains##32##2##(1990-3#1)(1993-9#1)(1994-2#3)(1994-5#1)(1995-6#1)(1997-6#1)(2004-11#1)(2006-8#3)(2007-12#1)(2008-10#11)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-11#1)(2012-12#1)
three strands of##2##3##(1994-8#1)(1995-3#1)
three strategies##3##2##(2006-7#1)(2008-10#1)(2008-8#1)
three structural domains##2##3##(1992-11#1)(1994-8#1)
three structural##3##2##(1992-11#1)(1994-8#1)(1994-9#1)
three structurally##4##2##(1992-8#1)(1995-5#1)(1997-3#1)(2008-5#1)
three structures##4##2##(1992-9#1)(1995-11#1)(2008-4#1)(2013-7#1)
three studied parameters##2##3##(2008-10#1)(2009-9#1)
three studied##7##2##(2005-11#1)(2008-10#5)(2009-9#1)
three studies that##2##3##(2007-2#1)(2013-8#1)
three studies##18##2##(1990-12#1)(2006-10#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-2#1)(2010-10#1)(2010-7#1)(2011-2#2)(2012-11#1)(2013-1#2)(2013-8#1)
three subfamilies##3##2##(1992-8#1)(1995-3#1)(1997-1#1)
three subgroups of##2##3##(2005-12#1)(2007-12#1)
three subgroups##9##2##(1995-12#1)(2005-12#1)(2006-11#2)(2007-12#2)(2008-5#1)(2008-7#1)(2013-8#1)
three subject groups##2##3##(1991-8#1)(1992-4#1)
three subjects##12##2##(1994-6#1)(1996-8#1)(1997-1#1)(2007-4#2)(2007-7#1)(2008-7#2)(2008-9#1)(2009-3#1)(2012-1#2)
three subpopulations##3##2##(1995-12#1)(2008-10#1)(2008-7#1)
three subscales##2##2##(2007-12#2)
three substances##2##2##(1991-8#1)(2008-11#1)
three substrates##9##2##(1990-10#1)(1990-3#1)(1990-5#1)(1994-5#1)(1996-4#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-8#1)
three subtypes of##2##3##(1993-12#1)(2013-8#1)
three subtypes##8##2##(1992-7#1)(1993-12#1)(1994-10#2)(1994-12#1)(2007-12#1)(2010-12#1)(2013-8#1)
three subunit##2##2##(1993-9#1)(1994-9#1)
three subunits of##3##3##(1994-12#1)(1996-9#1)(2009-2#1)
three subunits##10##2##(1992-11#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-3#1)(1996-9#1)(1997-4#1)(2008-9#1)(2009-2#1)
three successive years##3##3##(2008-10#3)
three successive##15##2##(1994-2#1)(1996-12#2)(2007-10#1)(2007-2#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-2#2)
three such##6##2##(1992-1#1)(1994-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2012-2#1)
three support##2##2##(2008-4#1)(2010-10#1)
three surface treatment methods##2##4##(2009-8#2)
three surface##4##2##(1995-8#1)(2009-2#1)(2009-8#2)
three surfaces##3##2##(2004-9#1)(2008-2#1)(2013-1#1)
three surgeons##3##2##(2007-5#1)(2007-8#1)(2008-6#1)
three surveys were##2##3##(2012-3#1)(2013-8#1)
three surveys##9##2##(1990-4#1)(1991-9#1)(2006-4#1)(2007-7#1)(2008-5#1)(2012-2#2)(2012-3#1)(2013-8#1)
three susceptible##2##2##(2008-10#2)
three synthetic peptides##2##3##(1990-12#1)(1992-12#1)
three systems##3##2##(1992-1#1)(2008-10#1)(2010-12#1)
three tRNA genes##2##3##(1995-6#2)
three tachykinin##3##2##(1991-5#1)(1993-11#1)(1993-12#1)
three tandem##2##2##(1995-3#1)(2008-7#1)
three tasks was##2##3##(1993-12#1)(1993-3#1)
three tasks##5##2##(1993-12#1)(1993-3#2)(1996-7#1)(2009-8#1)
three teaching hospitals##2##3##(2010-3#2)
three techniques for##2##3##(1992-8#1)(2009-4#1)
three techniques##7##2##(1992-1#1)(1992-8#1)(2008-10#2)(2008-4#1)(2009-4#1)(2010-12#1)
three technologies##2##2##(2006-6#1)(2012-2#1)
three temperature##3##2##(2007-6#1)(2008-7#1)(2012-2#1)
three test emulsions##3##3##(2008-5#3)
three test##7##2##(1996-8#1)(2007-4#1)(2008-5#4)(2010-5#1)
three tested##4##2##(2008-10#2)(2008-6#1)(2013-1#1)
three testing ages##2##3##(2006-5#2)
three testing##3##2##(2006-5#2)(2007-1#1)
three tests##10##2##(1992-10#1)(1993-5#1)(1995-4#1)(1996-3#1)(1996-9#3)(2007-4#1)(2008-10#1)(2008-12#1)
three that are##2##3##(1996-10#1)(2006-12#1)
three themes##6##2##(1996-1#1)(2008-11#1)(2009-5#1)(2010-11#1)(2012-3#1)(2013-1#1)
three theories##3##2##(2007-9#2)(2008-2#1)
three tiers of##2##3##(2008-11#1)(2010-2#1)
three tiers##3##2##(2007-9#1)(2008-11#1)(2010-2#1)
three time##3##2##(2006-7#1)(2008-11#1)(2012-1#1)
three times a day for##2##5##(2005-10#1)(2012-12#1)
three times a day##7##4##(2005-10#1)(2008-8#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
three times a week for##5##5##(1991-3#1)(1996-6#1)(1997-5#1)(2008-5#1)(2010-4#1)
three times a week##8##4##(1991-3#1)(1992-2#1)(1996-10#1)(1996-6#1)(1997-5#1)(2007-8#1)(2008-5#1)(2010-4#1)
three times a year##3##4##(2006-8#1)(2008-10#1)(2013-8#1)
three times a##18##3##(1991-3#1)(1992-2#1)(1996-10#1)(1996-6#1)(1997-5#1)(2005-10#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-4#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
three times and averaged##2##4##(2006-7#2)
three times and##3##3##(2006-7#2)(2007-7#1)
three times as large##2##4##(1994-4#1)(1997-1#1)
three times as many##2##4##(1991-2#1)(1995-1#1)
three times as##8##3##(1990-2#1)(1991-2#1)(1994-4#1)(1994-8#1)(1995-1#1)(1995-2#1)(1997-1#1)(2006-10#1)
three times at##2##3##(2008-10#1)(2010-5#1)
three times before##3##3##(1996-5#1)(2008-10#1)(2010-4#1)
three times daily and##2##4##(1997-1#1)(2007-11#1)
three times daily##9##3##(1990-10#1)(1991-12#1)(1992-2#1)(1995-12#1)(1997-1#2)(2007-11#1)(2008-3#1)(2012-12#1)
three times during the##7##4##(1992-7#1)(1994-3#1)(1996-5#1)(2008-10#3)(2008-12#1)
three times each##2##3##(1997-7#1)(2008-10#1)
three times faster than that##2##5##(1992-12#1)(2008-2#1)
three times greater than##5##4##(1990-9#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-2#1)
three times greater##8##3##(1990-9#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-2#2)(2010-8#1)
three times higher in##2##4##(1996-1#1)(2008-6#1)
three times higher than the##2##5##(1991-9#1)(2008-5#1)
three times higher than those##2##5##(1993-3#1)(1993-7#1)
three times higher than##6##4##(1991-9#1)(1993-3#1)(1993-7#1)(2008-2#2)(2008-5#1)
three times higher##13##3##(1991-9#1)(1993-3#1)(1993-7#1)(1995-12#1)(1995-4#1)(1996-1#1)(2006-10#1)(2006-3#1)(2008-2#2)(2008-5#1)(2008-6#1)(2010-4#1)
three times in a##2##4##(2008-9#1)(2010-3#1)
three times in##5##3##(1994-2#1)(1997-2#1)(2007-3#1)(2008-9#1)(2010-3#1)
three times larger than##2##4##(2007-12#1)(2008-10#1)
three times larger##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
three times less##2##3##(1995-12#1)(1995-6#1)
three times longer than##2##4##(2008-11#1)(2010-8#1)
three times lower than that found##2##6##(1990-9#1)(1995-1#1)
three times lower than##3##4##(1990-9#1)(1995-1#1)(2008-10#1)
three times lower##4##3##(1990-9#1)(1992-9#1)(1995-1#1)(2008-10#1)
three times more common##2##4##(1990-2#1)(2009-4#1)
three times more often than##2##5##(1994-12#1)(1996-3#1)
three times more##10##3##(1990-2#1)(1991-12#1)(1991-2#1)(1994-12#1)(1996-3#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-4#1)
three times per day##4##4##(1991-3#1)(2008-7#1)(2010-6#1)(2011-11#1)
three times per week during##2##5##(2007-7#1)(2012-12#1)
three times per week for##7##5##(1990-4#2)(1996-9#1)(2005-1#1)(2007-7#1)(2008-10#1)(2012-1#1)
three times per week##17##4##(1990-4#2)(1996-9#1)(2005-1#2)(2006-6#1)(2007-2#1)(2007-7#3)(2008-1#1)(2008-10#1)(2010-10#1)(2011-11#1)(2012-1#1)(2012-12#1)(2013-7#1)
three times per##22##3##(1990-4#2)(1991-3#1)(1996-9#1)(2005-1#2)(2006-6#1)(2007-2#1)(2007-7#3)(2008-1#1)(2008-10#1)(2008-7#1)(2010-10#1)(2010-6#1)(2011-11#2)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
three times standard deviation of the blank##2##7##(2008-10#2)
three times the standard deviation of the blank##7##8##(2008-10#7)
three times the standard deviation of the##11##7##(2008-10#11)
three times the standard deviation of##14##6##(2008-10#14)
three times the standard deviation##15##5##(2008-10#15)
three times the##24##3##(1992-2#1)(1992-3#1)(1993-4#1)(2005-7#1)(2006-9#1)(2008-1#1)(2008-10#15)(2008-2#2)(2008-8#1)
three times to##3##3##(1994-8#1)(2007-7#1)(2008-10#1)
three times weekly##4##3##(2006-10#1)(2007-11#1)(2007-7#1)(2008-2#1)
three times##201##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-4#2)(1990-8#1)(1990-9#2)(1991-12#2)(1991-2#3)(1991-3#2)(1991-9#2)(1992-12#1)(1992-2#3)(1992-3#1)(1992-7#1)(1992-9#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-8#2)(1995-1#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#3)(1997-2#4)(1997-5#1)(1997-7#1)(2005-1#2)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-3#1)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#2)(2006-9#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#6)(2007-8#1)(2008-1#2)(2008-10#37)(2008-11#3)(2008-12#2)(2008-2#11)(2008-3#2)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-4#2)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#3)(2011-11#2)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#2)
three tissues at##2##3##(1991-3#1)(2008-3#1)
three tissues##10##2##(1990-11#1)(1990-4#2)(1991-3#1)(1996-10#1)(2008-3#2)(2009-12#1)(2013-1#2)
three to 11##2##3##(2006-10#1)(2013-8#1)
three to eight##2##3##(2008-5#1)(2008-7#1)
three to five times##2##4##(2008-10#2)
three to five years##2##4##(1994-9#1)(1995-9#1)
three to five##12##3##(1991-4#1)(1992-5#1)(1994-9#2)(1995-9#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-5#1)(2009-8#1)
three to four times##3##4##(1995-9#1)(2006-9#1)(2008-5#1)
three to four##18##3##(1991-8#1)(1992-10#1)(1992-9#2)(1995-3#1)(1995-6#1)(1995-9#1)(1997-3#1)(2006-10#1)(2006-9#1)(2007-12#1)(2008-10#4)(2008-5#1)(2009-8#1)(2013-1#1)
three to seven##2##3##(1995-2#1)(2009-12#1)
three to six months##2##4##(1993-6#1)(2011-1#1)
three to six##8##3##(1992-6#1)(1992-8#1)(1993-6#1)(1993-8#1)(2008-1#2)(2011-1#2)
three to##53##2##(1990-2#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-6#1)(1993-8#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#2)(1997-3#2)(2006-10#3)(2006-9#1)(2007-12#2)(2008-1#4)(2008-10#7)(2008-2#2)(2008-5#4)(2008-7#1)(2009-12#1)(2009-8#2)(2011-1#2)(2013-1#1)(2013-8#2)
three tomato##4##2##(2008-10#4)
three toxins##2##2##(1994-3#1)(2006-8#1)
three traditional##2##2##(2004-3#1)(2010-12#1)
three traits##5##2##(2008-10#2)(2008-12#1)(2008-8#1)(2011-12#1)
three transcription factors##3##3##(1994-11#1)(2008-11#1)(2013-8#1)
three transcripts##2##2##(1994-5#1)(2009-4#1)
three transient and##2##3##(1991-10#1)(1992-12#1)
three transient##3##2##(1991-10#1)(1992-12#1)(1995-9#1)
three transport modes##2##3##(1990-3#1)(1991-4#1)
three treatment classes##2##3##(2008-10#2)
three treatment groups##3##3##(1990-11#1)(1997-3#1)(2013-1#1)
three treatment settings##2##3##(2009-7#2)
three treatment##13##2##(1990-11#1)(1997-3#1)(2004-11#1)(2007-5#1)(2008-10#2)(2008-7#1)(2009-7#3)(2010-11#1)(2010-6#1)(2013-1#1)
three treatments were##2##3##(2008-10#2)
three treatments##7##2##(1991-1#1)(2007-7#1)(2008-10#2)(2008-5#1)(2012-2#1)(2013-7#1)
three trials on##2##3##(2008-10#1)(2008-12#1)
three trials##13##2##(1991-1#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-12#3)(2010-8#1)(2012-11#1)
three tribes##2##2##(2013-7#2)
three tumor##2##2##(1990-12#1)(2008-11#1)
three types of experiments##2##4##(1996-11#1)(2009-11#1)
three types of friends##2##4##(2009-7#2)
three types of kenkey##2##4##(1997-4#2)
three types of minimax optimal designs##2##6##(2009-9#2)
three types of receptors##2##4##(1993-12#1)(1995-11#1)
three types of##97##3##(1990-6#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-4#1)(1992-7#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-5#1)(1995-11#2)(1995-3#1)(1995-6#1)(1996-11#2)(1996-2#4)(1996-8#1)(1997-4#2)(2005-11#1)(2006-10#2)(2007-1#2)(2007-12#3)(2008-1#1)(2008-10#9)(2008-11#5)(2008-2#6)(2008-3#3)(2008-4#3)(2008-5#6)(2008-7#3)(2008-8#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-7#3)(2009-8#1)(2009-9#2)(2010-12#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
three types##110##2##(1990-6#1)(1990-8#2)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-4#1)(1992-7#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-5#1)(1995-11#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-11#3)(1996-2#4)(1996-6#1)(1996-8#1)(1997-4#2)(2005-11#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-1#2)(2007-12#3)(2008-1#1)(2008-10#10)(2008-11#5)(2008-2#6)(2008-3#3)(2008-4#3)(2008-5#6)(2008-7#5)(2008-8#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-7#3)(2009-8#1)(2009-9#2)(2010-12#2)(2011-1#2)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#2)
three typical##3##2##(1991-4#1)(2008-10#1)(2009-4#1)
three tyrosine residues##3##3##(1993-9#1)(1996-5#1)(2008-4#1)
three tyrosine##4##2##(1990-12#1)(1993-9#1)(1996-5#1)(2008-4#1)
three underwent##2##2##(2007-11#2)
three unique##2##2##(2011-2#1)(2013-1#1)
three units##2##2##(1991-2#2)
three unrelated##3##2##(1991-12#1)(2008-10#2)
three unusual cases##2##3##(2005-8#1)(2008-8#1)
three unusual##3##2##(2005-8#1)(2008-8#1)(2012-2#1)
three urban##3##2##(2008-7#1)(2013-1#2)
three vaccinations##5##2##(1990-2#1)(1992-8#2)(2007-2#1)(2008-4#1)
three variable##2##2##(2005-11#1)(2008-10#1)
three variables##6##2##(1990-8#1)(1995-1#1)(2008-12#1)(2008-7#1)(2009-4#1)(2011-2#1)
three variant##3##2##(1995-8#1)(1996-5#1)(1996-7#1)
three varieties of##4##3##(2007-12#1)(2008-12#1)(2008-3#1)(2008-9#1)
three varieties##6##2##(2007-12#1)(2008-12#3)(2008-3#1)(2008-9#1)
three very##3##2##(1992-2#1)(2007-3#1)(2012-1#1)
three vessel disease and##2##4##(1994-11#1)(2007-8#1)
three vessel##3##2##(1994-11#1)(2007-8#2)
three veterinary##2##2##(2008-10#1)(2010-4#1)
three victims##2##2##(1995-3#1)(1996-11#1)
three villages in##2##3##(2006-10#1)(2008-10#1)
three villages##3##2##(2006-10#1)(2008-10#2)
three viruses##5##2##(2008-10#4)(2008-5#1)
three visualization methods##2##3##(1990-12#2)
three was##6##2##(1990-6#1)(2007-1#1)(2008-10#4)
three wavelength##2##2##(2007-11#1)(2008-3#1)
three wavelengths##9##2##(2006-4#1)(2007-11#2)(2008-2#4)(2008-3#2)
three waves##2##2##(2010-10#1)(2011-2#1)
three ways##7##2##(1992-1#1)(1996-4#1)(2007-6#1)(2008-10#1)(2010-2#1)(2011-1#1)(2012-1#1)
three week##7##2##(1991-5#1)(1992-6#2)(1994-6#1)(2008-5#1)(2012-1#1)(2012-12#1)
three weekly##2##2##(2008-12#1)(2008-6#1)
three weeks after the##2##4##(1995-11#1)(1995-2#1)
three weeks after##7##3##(1991-6#1)(1994-3#1)(1995-11#1)(1995-2#1)(2007-11#1)(2008-9#1)(2010-12#1)
three weeks in##2##3##(2005-7#1)(2007-12#1)
three weeks later##2##3##(2007-8#1)(2008-7#1)
three weeks of the##2##4##(2008-5#1)(2008-9#1)
three weeks of##9##3##(1995-1#1)(2006-4#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-9#1)(2009-3#1)(2010-4#1)
three weeks##55##2##(1990-10#1)(1990-9#1)(1991-3#2)(1991-6#2)(1994-10#1)(1994-3#1)(1994-6#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-6#1)(2005-11#1)(2005-3#1)(2005-7#1)(2006-4#1)(2006-6#1)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#4)(2008-7#2)(2008-9#3)(2009-3#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-11#2)(2012-12#1)(2013-8#1)
three well-known##6##2##(1990-7#1)(2006-12#1)(2008-2#3)(2009-8#1)
three were PCL-only knees##2##4##(2007-1#2)
three were found to##2##4##(1993-6#1)(2008-10#1)
three were located in the##2##5##(1996-1#1)(2011-1#1)
three were not##2##3##(1994-2#1)(1995-4#1)
three were of grade##2##4##(2013-8#2)
three were##29##2##(1990-3#1)(1993-6#1)(1994-2#1)(1995-4#1)(1996-1#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-8#1)(2005-10#1)(2006-12#1)(2006-3#1)(2007-1#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-5#1)(2011-1#1)(2013-1#1)(2013-8#3)
three wheat##3##2##(2008-10#2)(2008-12#1)
three widely##4##2##(2006-7#1)(2008-10#1)(2013-1#2)
three wire twists##2##3##(2007-8#2)
three with##13##2##(1991-7#1)(1992-5#1)(1992-6#1)(1995-5#1)(2007-3#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2012-2#1)
three women##5##2##(2006-12#1)(2006-8#1)(2007-2#1)(2011-2#2)
three workshops##2##2##(2008-12#2)
three year old##3##3##(2007-7#1)(2007-8#1)(2009-7#1)
three year##15##2##(1991-4#1)(1991-6#1)(1993-9#1)(2005-12#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-5#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-3#1)
three years after##4##3##(1995-9#1)(2007-8#1)(2008-1#1)(2010-9#1)
three years and##2##3##(1993-3#1)(2007-7#1)
three years as##2##3##(1995-1#1)(2007-7#1)
three years at##2##3##(2007-11#1)(2007-3#1)
three years earlier##3##3##(1991-6#1)(2006-10#2)
three years in the##2##4##(2005-4#1)(2010-8#1)
three years in##5##3##(1990-8#1)(1991-6#1)(2005-10#1)(2005-4#1)(2010-8#1)
three years later##4##3##(1991-6#2)(2006-10#1)(2008-8#1)
three years of age##6##4##(2007-7#1)(2008-11#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
three years of follow-up##2##4##(1995-5#1)(2008-11#1)
three years of##17##3##(1990-8#1)(1991-4#1)(1993-10#1)(1995-1#2)(1995-5#1)(2006-8#1)(2007-7#1)(2008-11#2)(2008-3#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-7#1)
three years old##3##3##(1994-2#1)(2009-11#1)(2012-2#1)
three years was##4##3##(2007-11#1)(2007-8#2)(2008-1#1)
three years##106##2##(1990-12#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-4#1)(1991-6#4)(1991-9#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-10#1)(1993-3#3)(1993-9#1)(1994-11#1)(1994-2#1)(1994-4#1)(1994-6#2)(1995-1#3)(1995-5#2)(1995-6#1)(1995-9#1)(1996-9#1)(2005-10#1)(2005-4#1)(2006-10#4)(2006-8#4)(2007-11#2)(2007-3#1)(2007-7#7)(2007-8#5)(2008-1#5)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-4#2)(2009-5#2)(2009-6#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-8#2)(2010-9#2)(2011-1#3)(2011-2#3)(2012-2#5)(2012-3#5)(2013-7#1)
three zinc##2##2##(1995-11#1)(1995-3#1)
three zones of##3##3##(1993-7#1)(1997-8#1)(2006-12#1)
three zones##8##2##(1993-7#1)(1997-8#1)(2006-12#1)(2007-12#1)(2007-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
three##8173##1##(1990-1#2)(1990-10#17)(1990-11#21)(1990-12#47)(1990-2#17)(1990-3#26)(1990-4#17)(1990-5#26)(1990-6#16)(1990-7#31)(1990-8#32)(1990-9#14)(1991-1#17)(1991-10#18)(1991-11#21)(1991-12#36)(1991-2#46)(1991-3#30)(1991-4#28)(1991-5#20)(1991-6#31)(1991-7#25)(1991-8#29)(1991-9#25)(1992-1#24)(1992-10#10)(1992-11#32)(1992-12#27)(1992-2#33)(1992-3#22)(1992-4#18)(1992-5#20)(1992-6#24)(1992-7#20)(1992-8#45)(1992-9#21)(1993-1#11)(1993-10#6)(1993-11#34)(1993-12#33)(1993-2#27)(1993-3#36)(1993-4#12)(1993-5#18)(1993-6#29)(1993-7#11)(1993-8#18)(1993-9#25)(1994-1#6)(1994-10#6)(1994-11#21)(1994-12#54)(1994-2#26)(1994-3#52)(1994-4#10)(1994-5#27)(1994-6#28)(1994-7#6)(1994-8#29)(1994-9#52)(1995-1#34)(1995-10#12)(1995-11#30)(1995-12#39)(1995-2#41)(1995-3#40)(1995-4#15)(1995-5#31)(1995-6#41)(1995-7#16)(1995-8#46)(1995-9#10)(1996-1#27)(1996-10#19)(1996-11#24)(1996-12#40)(1996-2#38)(1996-3#36)(1996-4#13)(1996-5#47)(1996-6#44)(1996-7#28)(1996-8#32)(1996-9#28)(1997-1#36)(1997-2#42)(1997-3#38)(1997-4#55)(1997-5#30)(1997-6#33)(1997-7#39)(1997-8#38)(1997-9#4)(2004-1#3)(2004-10#2)(2004-11#16)(2004-12#7)(2004-2#10)(2004-3#1)(2004-4#14)(2004-7#1)(2004-8#1)(2004-9#6)(2005-1#7)(2005-10#15)(2005-11#50)(2005-12#8)(2005-2#1)(2005-3#1)(2005-4#9)(2005-5#2)(2005-6#2)(2005-7#16)(2005-8#11)(2005-9#4)(2006-1#2)(2006-10#78)(2006-11#33)(2006-12#56)(2006-2#9)(2006-3#12)(2006-4#20)(2006-5#23)(2006-6#33)(2006-7#40)(2006-8#62)(2006-9#11)(2007-1#60)(2007-10#21)(2007-11#72)(2007-12#199)(2007-2#66)(2007-3#40)(2007-4#30)(2007-5#28)(2007-6#22)(2007-7#99)(2007-8#130)(2007-9#32)(2008-1#98)(2008-10#1082)(2008-11#160)(2008-12#95)(2008-2#164)(2008-3#176)(2008-4#104)(2008-5#237)(2008-6#79)(2008-7#148)(2008-8#101)(2008-9#121)(2009-1#3)(2009-10#24)(2009-11#14)(2009-12#20)(2009-2#23)(2009-3#18)(2009-4#35)(2009-5#30)(2009-6#16)(2009-7#25)(2009-8#26)(2009-9#20)(2010-1#5)(2010-10#19)(2010-11#24)(2010-12#61)(2010-2#44)(2010-3#25)(2010-4#56)(2010-5#31)(2010-6#20)(2010-7#29)(2010-8#56)(2010-9#9)(2011-1#105)(2011-11#4)(2011-12#26)(2011-2#182)(2011-3#11)(2012-1#62)(2012-11#21)(2012-12#89)(2012-2#137)(2012-3#93)(2012-5#5)(2012-6#2)(2012-7#3)(2012-8#2)(2012-9#3)(2013-1#189)(2013-7#40)(2013-8#125)
three)##7##1##(1990-2#1)(1990-4#1)(1994-6#1)(2007-12#2)(2007-8#1)(2012-12#1)
three- and##6##2##(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2013-8#1)
three- or##2##2##(1995-11#1)(2006-5#1)
three- to fourfold##3##3##(1992-11#1)(1997-3#1)(2009-4#1)
three- to##7##2##(1991-8#1)(1992-11#1)(1993-2#1)(1997-3#1)(2007-12#1)(2009-4#1)(2010-4#1)
three-##21##1##(1991-8#1)(1992-11#1)(1993-2#1)(1995-11#1)(1997-3#2)(2006-10#1)(2006-5#1)(2007-11#2)(2007-12#2)(2007-4#2)(2007-7#1)(2008-10#2)(2008-9#1)(2009-4#1)(2010-4#1)(2013-8#1)
three-armed infant with spinal dysraphism##2##5##(2013-1#2)
three-aspherical-mirror imaging##2##2##(2008-3#2)
three-aspherical-mirror##3##1##(2008-3#3)
three-base linkers##2##2##(2008-5#2)
three-base##3##1##(2008-10#1)(2008-5#2)
three-beam##5##1##(2006-5#2)(2008-2#2)(2008-3#1)
three-body##2##1##(1993-3#1)(2006-8#1)
three-by-three-tree quadrats##2##2##(2008-10#2)
three-category oddball task##2##3##(2009-11#2)
three-category##3##1##(2007-7#1)(2009-11#2)
three-cavity##2##1##(2008-3#2)
three-center hydrogen bonds##2##3##(1991-10#2)
three-center##3##1##(1991-10#2)(2007-9#1)
three-channel##3##1##(1995-3#1)(2008-10#1)(2008-3#1)
three-color flow cytometry##2##3##(2008-4#2)
three-color##9##1##(2008-2#3)(2008-4#4)(2008-9#2)
three-component condensation##2##2##(2007-11#2)
three-component coupling##2##2##(2011-2#1)(2012-3#1)
three-component##18##1##(1995-10#1)(1996-7#1)(2007-11#3)(2008-10#4)(2008-2#4)(2011-1#1)(2011-2#2)(2012-3#2)
three-day conference##2##2##(1997-8#1)(2005-9#1)
three-day##13##1##(1991-2#1)(1993-1#1)(1993-7#1)(1997-8#1)(2005-9#1)(2007-2#4)(2008-8#1)(2009-11#1)(2011-2#2)
three-dimensional (3-D) display##2##3##(2007-11#1)(2007-12#1)
three-dimensional (3-D) image##2##3##(2008-2#2)
three-dimensional (3-D) object recognition##2##4##(2008-3#2)
three-dimensional (3-D) sensing##2##3##(2008-3#2)
three-dimensional (3-D)##55##2##(2006-5#3)(2007-11#3)(2007-12#4)(2008-11#1)(2008-2#17)(2008-3#19)(2008-4#1)(2008-8#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
three-dimensional (3D) NMR##2##3##(1993-6#1)(2006-12#1)
three-dimensional (3D) imaging##3##3##(2007-11#1)(2007-12#1)(2007-8#1)
three-dimensional (3D) objects##2##3##(2007-12#1)(2008-3#1)
three-dimensional (3D) structure of##3##4##(2008-8#2)(2012-2#1)
three-dimensional (3D) structure##4##3##(2008-7#1)(2008-8#2)(2012-2#1)
three-dimensional (3D)##55##2##(1993-6#1)(1997-8#1)(2006-11#1)(2006-12#2)(2007-11#2)(2007-12#8)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#9)(2008-7#1)(2008-8#2)(2009-11#2)(2009-2#1)(2010-10#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#2)(2011-7#1)(2012-2#4)(2012-3#1)(2012-4#1)(2013-1#1)
three-dimensional CT angiography##2##3##(2008-7#2)
three-dimensional CT##4##2##(1995-2#1)(2007-1#1)(2008-7#2)
three-dimensional MR angiography##3##3##(2007-8#2)(2013-1#1)
three-dimensional Monte Carlo##2##3##(2008-3#2)
three-dimensional X-ray##3##2##(2010-2#3)
three-dimensional aggregate##2##2##(2008-10#1)(2008-11#1)
three-dimensional analysis of##2##3##(2007-1#1)(2012-2#1)
three-dimensional analysis##3##2##(2007-1#1)(2009-3#1)(2012-2#1)
three-dimensional anisotropic scatterers##2##3##(2007-12#2)
three-dimensional arrangement of##2##3##(1995-6#1)(2008-7#1)
three-dimensional arrangements##2##2##(1990-8#1)(2006-12#1)
three-dimensional bit density of##2##4##(2007-12#2)
three-dimensional bit##5##2##(2007-12#5)
three-dimensional bright and long-lasting phosphorescence in a##2##7##(2008-3#2)
three-dimensional capillary morphogenesis in a microfluidic platform##2##7##(2010-11#2)
three-dimensional cell##2##2##(2008-11#1)(2010-11#1)
three-dimensional complex##2##2##(2007-12#1)(2008-2#1)
three-dimensional compound parabolic##2##3##(2008-3#2)
three-dimensional computed tomography##3##3##(1995-2#1)(2007-8#1)(2010-8#1)
three-dimensional computer##2##2##(2009-2#1)(2012-2#1)
three-dimensional conformal radiotherapy##2##3##(1995-8#1)(2013-1#1)
three-dimensional conformal##3##2##(1995-8#1)(2006-2#1)(2013-1#1)
three-dimensional coordinate##2##2##(2008-4#1)(2010-3#1)
three-dimensional correction of##3##3##(2007-11#1)(2007-8#2)
three-dimensional cultures##2##2##(2008-11#1)(2012-4#1)
three-dimensional deformation field##2##3##(2008-3#2)
three-dimensional density##2##2##(2006-4#1)(2008-4#1)
three-dimensional diffused##2##2##(2008-2#1)(2008-3#1)
three-dimensional display##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
three-dimensional echocardiography##5##2##(2007-8#3)(2008-4#1)(2009-10#1)
three-dimensional electrospun##3##2##(2010-9#3)
three-dimensional eye movements##2##3##(1991-5#2)
three-dimensional finite element##7##3##(2007-4#2)(2009-7#1)(2011-2#1)(2012-1#1)(2013-8#2)
three-dimensional finite-element##2##2##(2005-10#1)(2008-2#1)
three-dimensional flow##3##2##(1996-12#1)(2008-2#1)(2008-6#1)
three-dimensional fluorescence lifetime imaging microscope that##2##6##(2007-12#2)
three-dimensional fluorescence##4##2##(2007-11#1)(2007-12#2)(2008-10#1)
three-dimensional growth and##3##3##(2008-10#1)(2008-11#2)
three-dimensional hematopoietic##2##2##(2008-11#2)
three-dimensional image reconstruction##3##3##(1990-5#1)(2006-12#1)(2011-2#1)
three-dimensional image##6##2##(1990-5#1)(2006-12#1)(2008-2#2)(2008-5#1)(2011-2#1)
three-dimensional images of##2##3##(2007-11#1)(2007-12#1)
three-dimensional images##12##2##(2007-11#6)(2007-12#3)(2008-2#1)(2008-3#2)
three-dimensional imaging and##3##3##(2007-11#1)(2007-12#2)
three-dimensional imaging of##4##3##(1993-11#1)(2006-6#1)(2008-3#2)
three-dimensional imaging with##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
three-dimensional imaging##24##2##(1993-11#1)(2006-6#1)(2007-11#5)(2007-12#4)(2007-8#1)(2008-10#1)(2008-2#4)(2008-3#5)(2008-9#1)(2012-2#1)
three-dimensional incoherent##2##2##(2007-12#1)(2008-2#1)
three-dimensional information##6##2##(2007-12#1)(2007-3#1)(2008-2#2)(2008-3#2)
three-dimensional integral imaging##3##3##(2007-11#3)
three-dimensional keys##2##2##(2007-12#2)
three-dimensional light##2##2##(2007-12#1)(2008-10#1)
three-dimensional location of##2##3##(2008-3#2)
three-dimensional magnetic resonance##3##3##(2006-10#2)(2008-9#1)
three-dimensional mapping##2##2##(2008-2#1)(2008-3#1)
three-dimensional measurements##2##2##(2008-2#2)
three-dimensional model of the##3##4##(1991-6#1)(1993-3#1)(2007-1#1)
three-dimensional model of##5##3##(1991-6#1)(1993-3#1)(2007-1#1)(2008-3#1)(2012-2#1)
three-dimensional model##10##2##(1991-6#1)(1993-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(2007-1#1)(2007-5#1)(2008-3#1)(2008-5#1)(2012-2#1)
three-dimensional models##3##2##(1992-9#1)(1993-2#1)(2008-11#1)
three-dimensional movement##2##2##(2007-5#1)(2007-8#1)
three-dimensional network of nanofibers##2##4##(2008-5#2)
three-dimensional network##7##2##(2005-11#1)(2007-11#1)(2008-5#2)(2008-7#1)(2012-2#2)
three-dimensional numerical##3##2##(1993-4#1)(2007-12#1)(2008-3#1)
three-dimensional object coordinates##2##3##(2008-2#2)
three-dimensional object recognition with##2##4##(2008-3#2)
three-dimensional object recognition##9##3##(1992-9#1)(2007-11#2)(2007-12#2)(2008-3#4)
three-dimensional object##20##2##(1992-9#2)(2007-11#3)(2007-12#4)(2008-2#3)(2008-3#8)
three-dimensional objects##7##2##(1996-2#1)(1997-8#1)(2007-12#2)(2008-2#1)(2008-3#2)
three-dimensional observation of##2##3##(2007-11#1)(2013-8#1)
three-dimensional optical data-storage density in a two-photon bleaching polymer##2##9##(2008-2#2)
three-dimensional optical interconnects##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
three-dimensional optical##12##2##(2007-11#1)(2007-12#4)(2008-2#4)(2008-3#3)
three-dimensional pattern of##2##3##(2007-12#1)(2009-10#1)
three-dimensional phase##2##2##(2008-3#2)
three-dimensional photonic crystals##3##3##(2007-11#3)
three-dimensional photonic##5##2##(2007-11#3)(2007-12#1)(2012-2#1)
three-dimensional point-spread function##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
three-dimensional profile##3##2##(2007-11#1)(2008-3#2)
three-dimensional profilometry by##2##3##(2007-12#1)(2008-3#1)
three-dimensional profilometry##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
three-dimensional protein##4##2##(1990-11#1)(1994-2#1)(1995-2#1)(2008-4#1)
three-dimensional quantitative structure-activity relationship##2##4##(1997-2#1)(2009-3#1)
three-dimensional quantitative##3##2##(1997-2#1)(2009-3#1)(2011-3#1)
three-dimensional ray tracing##2##3##(2007-12#1)(2008-2#1)
three-dimensional reconstruction and##2##3##(2007-12#1)(2011-7#1)
three-dimensional reconstruction of##4##3##(2007-12#1)(2007-8#1)(2008-3#1)(2012-2#1)
three-dimensional reconstruction##14##2##(2006-10#1)(2007-12#3)(2007-8#3)(2008-2#1)(2008-3#1)(2008-4#2)(2010-5#1)(2011-7#1)(2012-2#1)
three-dimensional reconstructions are##2##3##(2007-11#1)(2007-7#1)
three-dimensional reconstructions of the##2##4##(2007-12#1)(2010-9#1)
three-dimensional reconstructions of##5##3##(1996-11#1)(1997-6#1)(2007-12#1)(2008-11#1)(2010-9#1)
three-dimensional reconstructions##10##2##(1995-8#1)(1996-11#2)(1997-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-11#1)(2010-9#2)
three-dimensional reflectivity distributions in scattering media##2##6##(2007-12#2)
three-dimensional refractive-index##3##2##(2007-11#3)
three-dimensional resolution##2##2##(2007-12#1)(2008-3#1)
three-dimensional shape measurement of##2##4##(2008-3#2)
three-dimensional shape measurement##4##3##(2008-3#4)
three-dimensional shape##16##2##(1991-1#4)(1994-4#3)(2008-2#1)(2008-3#6)(2008-8#1)(2013-8#1)
three-dimensional shapes##3##2##(2008-1#1)(2008-3#1)(2008-7#1)
three-dimensional solution structure of the##4##5##(1994-11#1)(1994-12#1)(1995-1#1)(1996-7#1)
three-dimensional solution structure of##5##4##(1994-11#1)(1994-12#1)(1994-5#1)(1995-1#1)(1996-7#1)
three-dimensional space##8##2##(1994-3#1)(1997-2#1)(2008-2#2)(2008-3#4)
three-dimensional spatial##5##2##(2006-10#1)(2007-11#1)(2007-12#2)(2008-3#1)
three-dimensional stereotactic##2##2##(2004-1#1)(2007-1#1)
three-dimensional structural##4##2##(1994-11#1)(2008-8#1)(2012-12#2)
three-dimensional structure and##4##3##(1991-8#1)(2008-4#1)(2008-7#1)(2008-8#1)
three-dimensional structure in##2##3##(1996-7#1)(2009-10#1)
three-dimensional structure of the##21##4##(1990-10#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-6#1)(1993-3#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-5#1)(2006-10#1)(2008-7#1)(2011-1#1)
three-dimensional structure of##46##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-4#2)(1991-6#1)(1992-12#1)(1993-11#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-2#2)(1995-4#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#3)(1997-5#1)(1997-6#1)(2006-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
three-dimensional structure with##2##3##(1992-11#1)(1994-11#1)
three-dimensional structure##75##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-4#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1993-11#2)(1993-3#2)(1993-6#3)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-11#1)(1996-7#4)(1997-1#1)(1997-2#1)(1997-4#3)(1997-5#2)(1997-6#1)(1997-8#1)(2006-10#1)(2008-4#5)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
three-dimensional structures of##7##3##(1994-11#1)(1994-3#1)(1995-2#1)(1996-7#1)(1997-4#1)(2007-11#1)(2008-9#1)
three-dimensional structures##16##2##(1990-9#1)(1991-4#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-2#1)(1996-7#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-12#1)
three-dimensional surface##5##2##(2008-3#4)(2008-5#1)
three-dimensional system##3##2##(2007-12#1)(2007-8#1)(2008-2#1)
three-dimensional systems##2##2##(2008-2#1)(2008-3#1)
three-dimensional temperature##3##2##(2008-3#3)
three-dimensional topography##2##2##(2008-2#2)
three-dimensional treatment planning##2##3##(1995-9#1)(2004-1#1)
three-dimensional ultrasonography##5##2##(2011-1#1)(2013-1#4)
three-dimensional ultrasound##3##2##(2009-6#2)(2011-1#1)
three-dimensional vector##3##2##(2008-3#2)(2008-6#1)
three-dimensional view##2##2##(2007-11#1)(2007-8#1)
three-dimensional virtual##2##2##(2007-7#1)(2008-7#1)
three-dimensional volume##4##2##(2008-3#2)(2012-12#2)
three-dimensional##822##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#4)(1991-1#5)(1991-11#2)(1991-12#1)(1991-4#3)(1991-5#6)(1991-6#2)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-9#6)(1993-11#3)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#7)(1993-8#1)(1994-11#5)(1994-12#1)(1994-2#1)(1994-3#4)(1994-4#3)(1994-5#1)(1994-8#6)(1994-9#2)(1995-1#3)(1995-10#2)(1995-11#3)(1995-12#1)(1995-2#7)(1995-3#1)(1995-4#2)(1995-6#5)(1995-7#1)(1995-8#6)(1995-9#1)(1996-11#3)(1996-12#1)(1996-2#4)(1996-5#1)(1996-7#7)(1996-8#1)(1997-1#2)(1997-2#3)(1997-4#4)(1997-5#2)(1997-6#3)(1997-8#3)(2004-1#2)(2005-10#1)(2005-11#2)(2005-7#2)(2006-10#8)(2006-11#4)(2006-12#7)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#1)(2006-8#1)(2007-1#4)(2007-11#51)(2007-12#90)(2007-3#2)(2007-4#4)(2007-5#2)(2007-7#4)(2007-8#21)(2007-9#1)(2008-1#3)(2008-10#13)(2008-11#16)(2008-2#95)(2008-3#150)(2008-4#14)(2008-5#9)(2008-6#5)(2008-7#14)(2008-8#9)(2008-9#4)(2009-10#4)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#1)(2009-6#2)(2009-7#1)(2010-10#2)(2010-11#3)(2010-12#2)(2010-2#3)(2010-3#1)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#7)(2011-1#7)(2011-2#17)(2011-3#1)(2011-7#2)(2012-1#2)(2012-11#1)(2012-12#7)(2012-2#19)(2012-3#4)(2012-4#2)(2013-1#15)(2013-7#1)(2013-8#7)
three-dimensionally##3##1##(2007-11#1)(2007-12#1)(2008-10#1)
three-disulfide##2##1##(1994-8#2)
three-drug combination##2##2##(1994-11#1)(1996-11#1)
three-drug regimen##2##2##(1996-11#1)(2010-3#1)
three-drug##5##1##(1994-11#1)(1996-11#2)(2007-3#1)(2010-3#1)
three-electrode cell##3##2##(2008-10#3)
three-electrode system##3##2##(2008-10#3)
three-electrode##8##1##(1992-2#1)(2008-10#6)(2009-9#1)
three-element##3##1##(2006-5#1)(2007-12#1)(2008-2#1)
three-flat test##2##2##(2008-2#1)(2008-3#1)
three-fold cross-validation)##2##2##(2013-1#2)
three-fold higher##7##2##(1993-7#1)(1997-5#1)(2007-8#1)(2008-10#1)(2008-7#1)(2012-11#2)
three-fold increase##5##2##(1993-11#1)(1993-12#1)(1994-10#1)(2008-7#1)(2010-8#1)
three-fold##33##1##(1990-8#1)(1993-11#1)(1993-12#1)(1993-7#1)(1994-10#1)(1995-6#1)(1996-3#1)(1996-4#1)(1996-5#2)(1997-5#1)(1997-8#2)(2006-8#1)(2007-5#1)(2007-8#2)(2008-10#2)(2008-4#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#1)(2013-1#2)
three-fourths of the##4##3##(1994-1#1)(1995-1#1)(1997-2#1)(1997-5#1)
three-generation##6##1##(1996-6#2)(2008-10#3)(2009-12#1)
three-helix##3##1##(2008-7#2)(2012-12#1)
three-hole chromatomembrane cell##2##3##(2008-10#2)
three-hole##3##1##(2008-10#3)
three-hospital##2##1##(1994-3#1)(2007-9#1)
three-judge appellate panel##2##3##(1996-11#1)(1996-6#1)
three-judge panel##5##2##(1995-12#1)(1995-6#1)(1996-11#1)(1997-5#2)
three-judge##7##1##(1995-12#1)(1995-6#1)(1996-11#2)(1996-6#1)(1997-5#2)
three-layer feed-forward##2##2##(2008-10#1)(2008-2#1)
three-layer##10##1##(1990-12#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2011-2#1)
three-layered##6##1##(2007-12#2)(2008-10#3)(2008-12#1)
three-level atomic##2##2##(2007-11#2)
three-level##22##1##(1992-1#1)(1993-5#1)(1994-3#1)(2007-11#5)(2007-12#5)(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-2#1)(2010-4#1)(2011-2#1)(2013-1#2)
three-line EPR spectrum of##2##4##(1993-9#1)(1994-5#1)
three-line manifold##2##2##(2008-10#2)
three-line##7##1##(1993-9#2)(1994-5#1)(1995-2#1)(2008-10#2)(2008-2#1)
three-material##2##1##(2007-11#1)(2012-2#1)
three-mirror cavity##2##2##(2008-3#2)
three-mirror configuration##2##2##(2007-11#1)(2007-12#1)
three-mirror##9##1##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#5)
three-mode binding##2##2##(1991-2#2)
three-month period##7##2##(1990-5#1)(1991-6#1)(1993-7#1)(2012-11#1)(2013-1#3)
three-month##18##1##(1990-5#1)(1991-12#1)(1991-6#2)(1993-11#1)(1993-7#1)(1994-6#1)(1997-4#1)(2007-7#1)(2008-5#1)(2010-12#1)(2010-8#1)(2012-11#1)(2012-3#1)(2013-1#4)
three-nuclei##3##1##(2008-3#3)
three-nucleotide##2##1##(1996-7#1)(2006-12#1)
three-panel##5##1##(1993-12#1)(1993-3#1)(1996-12#2)(2006-10#1)
three-parameter logistic##2##2##(2008-10#2)
three-parameter##5##1##(1992-1#1)(2008-10#2)(2008-6#1)(2013-8#1)
three-part##11##1##(1994-12#1)(1995-1#1)(1995-2#2)(2005-7#1)(2007-8#2)(2008-7#1)(2011-1#2)(2012-12#1)
three-peak-wavelength##4##1##(2008-2#4)
three-period crossover designs##2##3##(1994-5#2)
three-period##4##1##(1994-5#4)
three-phase contact line##2##3##(2005-11#2)
three-phase##13##1##(1990-2#1)(2005-11#3)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2013-1#1)
three-photon absorption##3##2##(2007-11#1)(2008-1#1)(2009-4#1)
three-photon##7##1##(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#3)(2009-4#1)
three-photon-absorption autocorrelation##2##2##(2007-12#2)
three-plane##5##1##(2007-11#3)(2007-8#2)
three-point bending##4##2##(2007-1#1)(2008-12#2)(2010-10#1)
three-point##10##1##(1993-3#1)(2007-1#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-12#2)(2008-8#1)(2010-10#1)
three-port##3##1##(2007-11#2)(2007-12#1)
three-pronged##2##1##(2008-4#1)(2010-12#1)
three-quarters of the##4##3##(1996-3#1)(1996-6#1)(2011-2#1)(2013-1#1)
three-quarters of##8##2##(1992-3#1)(1996-3#1)(1996-6#1)(2005-8#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
three-quarters##10##1##(1992-3#1)(1996-3#1)(1996-6#1)(2005-8#2)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
three-site##2##1##(1990-5#1)(2013-1#1)
three-spined stickleback Gasterosteus aculeatus from two U##2##7##(2010-8#2)
three-spined stickleback Gasterosteus aculeatus from##5##5##(2010-8#5)
three-spined stickleback Gasterosteus aculeatus sneaking##2##5##(2010-8#2)
three-spined stickleback Gasterosteus aculeatus##18##4##(2010-8#18)
three-spined sticklebacks Gasterosteus aculeatus##10##4##(2010-8#10)
three-spined sticklebacks##11##2##(2008-9#1)(2010-8#10)
three-spined##29##1##(2008-9#1)(2010-8#28)
three-stage model of##2##3##(1993-11#1)(2008-6#1)
three-stage##18##1##(1990-9#1)(1991-6#1)(1993-11#1)(1994-2#1)(1995-2#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-6#2)
three-state##6##1##(1992-2#1)(1993-8#1)(1997-2#1)(2006-10#1)(2008-3#2)
three-step method##2##2##(2006-5#1)(2013-8#1)
three-step procedure##3##2##(1996-12#2)(1997-2#1)
three-step process##3##2##(1994-12#1)(2008-10#1)(2011-2#1)
three-step sequential extraction procedure for the fractionation of##2##8##(2008-10#2)
three-step sequential extraction procedure##4##4##(2008-10#4)
three-step sequential extraction##5##3##(2008-10#5)
three-step##38##1##(1994-12#1)(1994-8#1)(1996-12#2)(1996-8#1)(1997-2#4)(2005-4#1)(2006-11#1)(2006-5#3)(2007-2#1)(2008-10#7)(2008-2#2)(2008-3#1)(2008-8#1)(2009-8#3)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
three-stranded antiparallel beta-sheet##4##3##(1994-12#1)(1994-8#1)(1997-4#1)(1997-5#1)
three-stranded coiled-coil##2##2##(1995-4#1)(1995-6#1)
three-stranded##11##1##(1994-12#1)(1994-8#1)(1995-1#1)(1995-4#2)(1995-6#2)(1997-4#1)(1997-5#1)(1997-9#2)
three-terminal molecular##2##2##(2009-11#2)
three-terminal##5##1##(2008-3#2)(2008-7#1)(2009-11#2)
three-tiered##2##1##(2007-11#1)(2010-2#1)
three-vessel coronary artery##2##3##(2007-8#2)
three-vessel coronary disease##2##3##(2007-8#2)
three-vessel coronary##4##2##(2007-8#4)
three-vessel disease##2##2##(1997-6#1)(2007-8#1)
three-vessel##6##1##(1997-6#1)(2007-8#5)
three-wave lateral shearing interferometer##2##4##(2007-11#1)(2007-12#1)
three-wave mixing interaction##2##3##(2007-12#2)
three-wave mixing##7##2##(2007-11#1)(2007-12#6)
three-wave parametric##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
three-wave##19##1##(1995-11#1)(2006-3#1)(2007-11#3)(2007-12#13)(2008-2#1)
three-wavelength Raman-lidar observations##2##3##(2008-3#2)
three-wavelength##11##1##(1997-6#1)(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#4)
three-way ANOVA##2##2##(2010-2#1)(2013-1#1)
three-way data##10##2##(2008-10#7)(2008-3#1)(2011-1#2)
three-way interaction##3##2##(2008-10#1)(2009-5#1)(2010-2#1)
three-way junction in##2##3##(1996-8#2)
three-way junction##5##2##(1996-8#5)
three-way partial least squares##2##4##(2008-10#2)
three-way solenoid valve##2##3##(2007-8#1)(2008-10#1)
three-way solenoid valves##7##3##(2007-10#1)(2008-10#6)
three-way solenoid##9##2##(2007-10#1)(2007-8#1)(2008-10#7)
three-way##49##1##(1996-8#5)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#32)(2008-3#1)(2009-4#1)(2009-5#1)(2010-2#2)(2011-1#2)(2013-1#1)
three-week##5##1##(2004-2#1)(2008-2#1)(2009-6#1)(2011-3#1)(2013-8#1)
three-year educational programme##2##3##(2008-11#2)
three-year educational##3##2##(2008-11#3)
three-year period##11##2##(1993-3#1)(1997-1#1)(1997-3#1)(2007-1#1)(2007-7#1)(2011-2#1)(2012-2#1)(2013-1#4)
three-year study##2##2##(2007-3#1)(2008-11#1)
three-year##37##1##(1990-12#1)(1990-8#2)(1992-3#1)(1993-3#1)(1994-3#1)(1995-12#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(2006-5#1)(2007-1#1)(2007-3#3)(2007-4#1)(2007-7#1)(2008-11#6)(2008-12#2)(2010-2#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#4)
three-year-old##4##1##(2006-10#1)(2006-11#1)(2007-4#1)(2011-11#1)
threefold higher##5##2##(2006-12#2)(2008-10#1)(2008-2#1)(2008-5#1)
threefold increase compared##2##3##(1990-8#1)(2008-10#1)
threefold increase in##6##3##(1994-8#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)
threefold increase##9##2##(1990-8#1)(1994-8#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)
threefold increased##2##2##(2006-12#1)(2010-4#1)
threefold more##2##2##(1994-9#1)(2008-2#1)
threefold to##2##2##(2007-11#1)(2008-5#1)
threefold##51##1##(1990-8#1)(1991-2#1)(1992-11#2)(1993-12#1)(1993-9#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-8#1)(1997-7#1)(2004-11#1)(2006-10#1)(2006-12#5)(2007-11#1)(2007-12#3)(2007-6#1)(2008-10#7)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
three months##2##1##(2012-2#2)
threonine 143 mutant##2##3##(1994-11#2)
threonine and tyrosine residues##3##4##(1990-11#1)(1994-11#1)(1995-3#1)
threonine and tyrosine##4##3##(1990-11#1)(1994-11#1)(1995-3#2)
threonine and##10##2##(1990-11#1)(1993-8#1)(1994-11#1)(1995-1#1)(1995-3#2)(1997-2#1)(1997-5#1)(2006-8#1)(2008-5#1)
threonine at##4##2##(1993-8#1)(1995-1#1)(1996-5#1)(2008-11#1)
threonine in##3##2##(1994-3#2)(2008-11#1)
threonine or methionine in##2##4##(2008-11#2)
threonine phosphorylation of##2##3##(1990-11#1)(1997-6#1)
threonine phosphorylation##3##2##(1990-11#1)(1994-9#1)(1997-6#1)
threonine residue##7##2##(1990-5#1)(1991-12#1)(1991-3#1)(1991-5#1)(1993-11#1)(1993-6#1)(2008-8#1)
threonine residues in the##2##4##(1991-12#1)(1991-3#1)
threonine residues in##3##3##(1991-12#1)(1991-3#1)(2006-9#1)
threonine residues##19##2##(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-7#2)(1993-3#1)(1994-8#2)(1994-9#3)(1995-10#1)(2006-9#1)(2008-11#1)(2008-4#1)(2008-8#1)
threonine was##2##2##(1991-10#1)(2006-8#1)
threonine##100##1##(1990-10#1)(1990-11#2)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-8#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#2)(1993-11#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#2)(1994-11#4)(1994-12#1)(1994-3#2)(1994-8#2)(1994-9#7)(1995-1#2)(1995-10#1)(1995-3#3)(1995-8#1)(1996-2#1)(1996-4#1)(1996-5#2)(1997-2#3)(1997-5#1)(1997-6#1)(1997-8#7)(2006-10#1)(2006-7#1)(2006-8#5)(2006-9#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-4#3)(2008-5#3)(2008-8#2)(2011-2#2)(2013-7#1)
threonine)##2##1##(1991-1#1)(1991-10#1)
threonine-23##2##1##(1993-6#2)
threonine-rich##2##1##(1993-3#1)(1993-8#1)
threonines##2##1##(1990-10#1)(1992-6#1)
threshold (&lt##2##2##(2007-11#1)(2008-2#1)
threshold (LNT) model for##2##4##(2008-7#1)(2013-1#1)
threshold (LNT) model##3##3##(2008-7#2)(2013-1#1)
threshold (LNT)##4##2##(2008-7#3)(2013-1#1)
threshold and the##5##3##(1990-7#1)(2005-11#1)(2007-12#1)(2008-11#1)(2008-8#1)
threshold and##27##2##(1990-7#2)(1992-3#1)(1994-10#1)(1994-3#1)(1995-12#1)(1996-2#1)(1997-1#1)(1997-5#1)(2005-11#1)(2006-8#1)(2007-12#3)(2007-6#1)(2008-1#1)(2008-11#1)(2008-2#4)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2013-8#1)
threshold are##4##2##(2007-12#2)(2008-3#1)(2008-7#1)
threshold as a##2##3##(2007-11#1)(2008-3#1)
threshold as low as##3##4##(2007-12#2)(2008-1#1)
threshold as##10##2##(2007-11#1)(2007-12#3)(2008-1#1)(2008-3#1)(2008-8#3)(2010-11#1)
threshold at##8##2##(1990-6#1)(1995-8#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
threshold behavior##2##2##(2007-11#2)
threshold below which##3##3##(1996-6#1)(2005-10#2)
threshold between the##2##3##(2008-10#1)(2009-12#1)
threshold by##2##2##(2003-11#1)(2007-12#1)
threshold can be##2##3##(2007-11#1)(2008-8#1)
threshold concentration of##8##3##(1990-11#1)(1993-12#1)(1994-2#1)(1995-11#1)(1997-4#1)(2008-10#1)(2008-5#1)(2008-8#1)
threshold concentration##15##2##(1990-11#2)(1990-8#1)(1992-9#1)(1993-12#3)(1994-2#1)(1994-9#1)(1995-11#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-8#1)
threshold concentrations##4##2##(1993-12#2)(2008-10#2)
threshold conditions##2##2##(2008-10#1)(2008-8#1)
threshold could be##2##3##(1996-7#1)(2008-10#1)
threshold criteria##2##2##(2008-2#1)(2008-3#1)
threshold current##7##2##(1993-12#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
threshold density##2##2##(2008-10#1)(2008-8#1)
threshold dissociation energies (E(o))##2##4##(2006-1#1)(2006-4#1)
threshold dissociation energies##4##3##(2006-1#1)(2006-3#1)(2006-4#2)
threshold dissociation energy##2##3##(2006-4#2)
threshold dissociation##6##2##(2006-1#1)(2006-3#1)(2006-4#4)
threshold dose for##2##3##(1990-10#1)(2008-7#1)
threshold dose##7##2##(1990-10#2)(2008-10#2)(2008-4#1)(2008-7#1)(2012-12#1)
threshold effect##7##2##(2008-10#1)(2008-3#2)(2008-8#2)(2010-1#2)
threshold effects##3##2##(2007-9#1)(2008-7#1)(2008-9#1)
threshold element##2##2##(2008-1#1)(2008-2#1)
threshold energy##4##2##(2007-12#2)(2008-3#2)
threshold exists##2##2##(2007-11#1)(2008-11#1)
threshold fluences##2##2##(2008-3#1)(2013-1#1)
threshold for activation of##2##4##(1990-10#1)(1994-9#1)
threshold for electrical##2##3##(1991-5#1)(1993-12#1)
threshold for induction of##5##4##(1990-4#1)(1994-2#1)(1995-2#1)(1997-1#2)
threshold for the##10##3##(1990-8#1)(1992-8#1)(1994-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#3)(2012-3#1)
threshold for##76##2##(1990-10#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-5#1)(1992-8#2)(1993-12#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-6#2)(2005-11#1)(2006-11#1)(2006-2#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-4#1)(2008-1#4)(2008-10#6)(2008-2#1)(2008-3#7)(2008-4#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-4#2)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-8#1)
threshold in a##2##3##(2008-8#1)(2013-8#1)
threshold in the##4##3##(1996-1#1)(2008-10#1)(2008-3#1)(2011-1#1)
threshold in##20##2##(1995-2#1)(1996-1#2)(1996-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-8#2)(2010-12#1)(2011-1#1)(2012-1#2)(2013-8#1)
threshold is also##2##3##(1994-6#1)(2008-8#1)
threshold is found##2##3##(1996-11#1)(2008-1#1)
threshold is the same##2##4##(2008-8#1)(2009-9#1)
threshold is##27##2##(1994-6#1)(1996-11#1)(1996-6#1)(2005-11#1)(2007-11#2)(2007-12#5)(2007-4#1)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#2)(2008-8#3)(2008-9#1)(2009-5#1)(2009-9#1)
threshold level of##5##3##(1997-8#1)(2007-11#1)(2008-2#1)(2009-2#1)(2011-1#1)
threshold level##13##2##(1997-8#1)(2004-4#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-2#1)(2009-2#1)(2010-10#1)(2011-1#2)
threshold levels##4##2##(1994-5#1)(2008-10#2)(2008-9#1)
threshold light##2##2##(2007-12#1)(2011-1#1)
threshold limit values##2##3##(1991-12#1)(1991-4#1)
threshold limit##3##2##(1991-12#1)(1991-4#1)(2008-10#1)
threshold logic##3##2##(2008-2#3)
threshold measurements##2##2##(1990-11#1)(1993-12#1)
threshold might##2##2##(1991-10#1)(1991-11#1)
threshold migration rate##2##3##(2008-8#2)
threshold of 0##3##3##(2008-1#1)(2008-10#1)(2008-2#1)
threshold of 20##2##3##(2007-11#1)(2007-12#1)
threshold of 25##2##3##(2007-12#1)(2010-4#1)
threshold of 3##2##3##(2007-11#1)(2007-6#1)
threshold of a##3##3##(2007-12#2)(2008-7#1)
threshold of the##8##3##(2006-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-12#1)(2011-2#1)(2013-7#1)
threshold of##77##2##(1990-10#1)(1990-4#1)(1990-7#2)(1992-7#1)(1996-5#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-4#2)(2006-5#3)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#4)(2007-12#9)(2007-4#2)(2007-6#1)(2008-1#4)(2008-10#10)(2008-2#4)(2008-3#7)(2008-4#1)(2008-7#2)(2009-11#1)(2010-12#1)(2010-4#3)(2011-2#3)(2012-2#1)(2012-3#1)(2012-9#1)(2013-1#1)(2013-7#1)
threshold or##4##2##(2006-10#1)(2008-10#1)(2008-3#1)(2011-2#1)
threshold over##2##2##(2007-12#1)(2008-3#1)
threshold power of##4##3##(2007-12#2)(2008-2#2)
threshold power##7##2##(2007-12#4)(2008-2#3)
threshold pump power##5##3##(2007-12#3)(2008-2#2)
threshold pump##10##2##(2007-12#5)(2008-2#3)(2008-3#2)
threshold queries##2##2##(2010-2#2)
threshold temperature##4##2##(2007-10#1)(2008-3#1)(2008-6#1)(2010-4#1)
threshold temperatures##3##2##(2005-8#1)(2007-10#1)(2008-12#1)
threshold the##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
threshold to be##2##3##(2007-12#1)(2008-10#1)
threshold to##19##2##(1992-9#1)(1996-12#1)(1996-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-3#2)(2008-7#1)(2009-12#2)(2010-4#1)(2012-1#1)
threshold value of##5##3##(1990-12#1)(1997-7#1)(2005-11#1)(2008-10#1)(2010-9#1)
threshold value##18##2##(1990-12#1)(1992-6#1)(1996-8#3)(1997-7#1)(2005-11#2)(2006-6#1)(2008-10#6)(2008-2#1)(2009-8#1)(2010-9#1)
threshold values are##2##3##(2008-10#1)(2013-8#1)
threshold values##10##2##(1992-6#1)(1997-1#1)(1997-2#1)(2008-10#4)(2008-2#1)(2013-8#2)
threshold varies##2##2##(2008-1#1)(2008-8#1)
threshold voltage##4##2##(2006-5#1)(2008-7#1)(2009-3#1)(2009-5#1)
threshold volume##2##2##(1994-4#2)
threshold was##20##2##(1993-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(2007-11#1)(2007-12#4)(2007-4#1)(2008-10#5)(2008-3#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#1)
threshold when##2##2##(2008-10#1)(2008-3#1)
threshold with##3##2##(1994-10#1)(2007-12#1)(2008-10#1)
threshold within 24 hours##2##4##(2006-9#2)
threshold within##3##2##(2006-9#2)(2008-10#1)
threshold##825##1##(1990-10#4)(1990-11#5)(1990-12#1)(1990-3#1)(1990-4#4)(1990-5#1)(1990-6#2)(1990-7#7)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#5)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#3)(1992-7#3)(1992-8#4)(1992-9#3)(1993-11#1)(1993-12#11)(1993-2#1)(1993-3#2)(1993-9#4)(1994-10#3)(1994-2#3)(1994-3#1)(1994-4#2)(1994-5#3)(1994-6#3)(1994-9#2)(1995-1#3)(1995-11#2)(1995-12#2)(1995-2#3)(1995-8#4)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#4)(1996-4#1)(1996-5#4)(1996-6#3)(1996-7#1)(1996-8#5)(1996-9#2)(1997-1#4)(1997-2#3)(1997-3#4)(1997-4#1)(1997-5#5)(1997-6#3)(1997-7#1)(1997-8#3)(2003-11#1)(2004-4#1)(2005-1#4)(2005-10#2)(2005-11#7)(2005-8#1)(2006-1#1)(2006-10#6)(2006-11#2)(2006-2#1)(2006-3#1)(2006-4#8)(2006-5#5)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#5)(2007-1#2)(2007-10#5)(2007-11#32)(2007-12#81)(2007-4#7)(2007-6#4)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#21)(2008-10#88)(2008-11#7)(2008-12#3)(2008-2#54)(2008-3#71)(2008-4#12)(2008-5#4)(2008-6#4)(2008-7#30)(2008-8#31)(2008-9#17)(2009-10#2)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#6)(2009-7#1)(2009-8#5)(2009-9#4)(2010-1#3)(2010-10#3)(2010-11#1)(2010-12#9)(2010-2#3)(2010-4#11)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#11)(2011-2#11)(2012-1#8)(2012-12#7)(2012-2#9)(2012-3#5)(2012-9#1)(2013-1#11)(2013-7#1)(2013-8#10)
threshold&quot##5##1##(1990-3#1)(1991-11#3)(1995-8#1)
threshold'##2##1##(1993-2#1)(2007-11#1)
threshold)##7##1##(1996-5#1)(2007-12#1)(2008-2#1)(2008-7#1)(2009-4#1)(2012-1#1)(2012-11#1)
threshold-decomposition##2##1##(2008-2#1)(2008-3#1)
threshold-like##2##1##(2008-7#2)
thresholded##2##1##(2007-12#2)
thresholding algorithms##2##2##(2007-11#1)(2007-12#1)
thresholding and##3##2##(2008-2#2)(2012-1#1)
thresholding is##2##2##(2008-2#1)(2008-3#1)
thresholding of##3##2##(2008-2#3)
thresholding technique##5##2##(2007-11#1)(2008-2#2)(2009-10#1)(2011-1#1)
thresholding##34##1##(2007-11#3)(2007-12#3)(2007-6#1)(2008-2#15)(2008-3#5)(2009-10#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-1#1)(2012-1#1)
thresholds and the##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
thresholds and their##2##3##(2007-12#1)(2012-3#1)
thresholds and##18##2##(1991-5#1)(1993-12#1)(1993-2#1)(1995-2#1)(1997-3#1)(2007-12#3)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-2#1)(2012-2#1)(2012-3#1)
thresholds are not##2##3##(2006-12#1)(2008-2#1)
thresholds are##9##2##(2006-12#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-2#3)
thresholds as low as##3##4##(2007-11#1)(2007-12#2)
thresholds at##2##2##(1996-9#1)(2007-4#1)
thresholds by##2##2##(1993-1#1)(2008-2#1)
thresholds for both##2##3##(1995-11#1)(2008-8#1)
thresholds for primary EL ERs in the##2##7##(1993-9#2)
thresholds for the##5##3##(1996-1#1)(2005-4#1)(2006-11#1)(2007-12#1)(2007-8#1)
thresholds for##30##2##(1990-2#1)(1991-5#2)(1993-9#3)(1995-11#1)(1995-12#1)(1996-1#1)(1996-3#1)(1996-6#1)(2005-4#1)(2006-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2012-1#1)(2012-3#1)
thresholds from##3##2##(1994-2#1)(2007-4#1)(2008-2#1)
thresholds in the##3##3##(1996-1#1)(2006-12#1)(2012-2#1)
thresholds in##14##2##(1996-1#1)(1997-2#1)(2006-12#2)(2007-10#1)(2007-12#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-8#1)
thresholds of the##2##3##(2008-3#1)(2012-2#1)
thresholds of##20##2##(2006-10#2)(2006-8#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-9#2)(2009-9#1)(2010-4#1)(2012-12#2)(2012-2#1)
thresholds that##3##2##(2007-12#1)(2008-3#1)(2008-4#1)
thresholds to##9##2##(1991-11#1)(1992-11#2)(1993-1#3)(1995-6#1)(1996-9#1)(2008-10#1)
thresholds was##2##2##(1993-12#1)(1997-3#1)
thresholds were measured##2##3##(1993-5#1)(1996-12#1)
thresholds were##8##2##(1992-11#1)(1993-12#1)(1993-5#1)(1996-12#1)(1996-9#1)(2007-9#1)(2008-2#1)(2011-2#1)
thresholds with##2##2##(2005-4#1)(2008-3#1)
thresholds##213##1##(1990-2#1)(1990-4#1)(1990-7#1)(1991-11#1)(1991-5#6)(1992-11#4)(1993-1#4)(1993-12#5)(1993-2#3)(1993-5#2)(1993-9#3)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#3)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#3)(1997-2#1)(1997-3#8)(1997-5#3)(2005-10#1)(2005-4#2)(2006-10#4)(2006-11#1)(2006-12#3)(2006-8#2)(2007-10#2)(2007-11#2)(2007-12#11)(2007-4#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-2#9)(2008-3#16)(2008-4#11)(2008-7#9)(2008-8#6)(2008-9#11)(2009-10#2)(2009-2#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#2)(2011-1#2)(2011-2#6)(2012-1#3)(2012-12#5)(2012-2#9)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#1)
thresholds)##3##1##(1992-4#1)(2006-9#1)(2008-9#1)
thrice weekly##2##2##(1990-5#1)(1990-7#1)
thrice##11##1##(1990-5#1)(1990-7#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
thrice-weekly regimen##2##2##(2013-1#2)
thrice-weekly##4##1##(2007-12#1)(2013-1#3)
thrifty genes##2##2##(2008-1#2)
thrifty genes&quot##2##2##(2008-1#2)
thrifty##5##1##(1993-2#1)(2008-1#4)
thrip##3##1##(2006-12#1)(2007-3#2)
thrips (Frankliniella occidentalis)##3##3##(2006-12#1)(2008-10#1)(2009-8#1)
thrips produced on##2##3##(2008-10#2)
thrips resistance##2##2##(2008-10#2)
thrips species##4##2##(2008-10#4)
thrips that##2##2##(2008-10#2)
thrips were##3##2##(2008-10#3)
thrips##49##1##(2006-12#3)(2007-12#1)(2008-10#40)(2009-8#3)(2011-2#2)
thrive in the##4##3##(1996-1#1)(1997-1#1)(2007-4#1)(2007-9#1)
thrive in##7##2##(1996-1#1)(1997-1#1)(2007-4#1)(2007-9#1)(2012-1#1)(2012-2#2)
thrive with##2##2##(2007-3#1)(2008-9#1)
thrive##34##1##(1992-3#1)(1993-1#1)(1994-12#1)(1994-3#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-2#2)(2007-3#2)(2007-4#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)
thriving in##2##2##(1994-12#1)(2005-12#1)
thriving##6##1##(1994-12#1)(2005-11#1)(2005-12#1)(2006-9#1)(2008-7#1)(2012-2#1)
throat and respiratory##2##3##(1996-8#1)(2007-11#1)
throat and##8##2##(1992-6#1)(1996-8#1)(2005-1#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2012-12#1)
throat of##2##2##(2006-10#2)
throat pack##3##2##(2008-2#1)(2012-12#2)
throat pain and##2##3##(2008-11#1)(2012-12#1)
throat pain##4##2##(2008-11#1)(2012-12#3)
throat specialists##5##2##(1990-12#1)(1993-2#4)
throat swab##2##2##(1994-4#1)(2010-4#1)
throat swabs were collected from##2##5##(2013-8#2)
throat##55##1##(1990-12#1)(1990-8#2)(1992-4#2)(1992-6#1)(1993-2#4)(1993-9#1)(1994-4#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-8#1)(1996-9#1)(2005-1#1)(2005-11#1)(2006-10#6)(2006-6#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#3)(2009-2#1)(2009-6#1)(2010-12#2)(2010-4#1)(2011-1#1)(2012-12#6)(2012-2#2)(2013-7#1)(2013-8#3)
thrombasthenia##4##1##(1997-7#1)(2006-6#2)(2009-5#1)
thrombectomy and##3##2##(2007-8#1)(2008-1#1)(2011-2#1)
thrombectomy in##3##2##(1997-8#1)(2007-8#1)(2011-2#1)
thrombectomy of the##3##3##(2007-8#1)(2011-2#2)
thrombectomy of##5##2##(2007-7#2)(2007-8#1)(2011-2#2)
thrombectomy with##3##2##(1991-9#1)(1996-6#1)(2013-8#1)
thrombectomy##25##1##(1991-9#1)(1996-6#1)(1997-8#1)(2007-7#4)(2007-8#3)(2008-1#2)(2010-7#1)(2011-2#9)(2013-7#1)(2013-8#2)
thrombelastographic##2##1##(1997-4#2)
thrombendarterectomy##6##1##(1990-7#1)(1992-3#1)(1992-8#1)(2011-2#3)
thrombi and##3##2##(1990-12#2)(2008-5#1)
thrombi in the culprit##2##4##(2008-5#2)
thrombi in the##4##3##(2005-12#1)(2008-1#1)(2008-5#2)
thrombi in##12##2##(1995-6#1)(1997-3#1)(2005-12#1)(2008-1#1)(2008-5#7)(2010-10#1)
thrombi or##3##2##(1990-12#1)(2008-7#1)(2011-1#1)
thrombi than the others##3##4##(2008-5#3)
thrombi than##4##2##(1990-12#1)(2008-5#3)
thrombi were found in##2##4##(1995-6#1)(1997-1#1)
thrombi were more frequently observed than##2##6##(2008-5#2)
thrombi were##7##2##(1995-6#1)(1997-1#2)(2007-8#1)(2008-5#2)(2013-8#1)
thrombi##65##1##(1990-12#9)(1991-9#1)(1995-6#3)(1995-8#1)(1997-1#3)(1997-3#1)(2005-12#1)(2006-10#2)(2007-10#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#18)(2008-7#1)(2008-8#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-6#2)(2011-1#1)(2012-1#2)(2012-12#1)(2012-3#2)(2013-8#2)
thrombin action##2##2##(2004-11#2)
thrombin activation##3##2##(1996-2#2)(2007-7#1)
thrombin activity##3##2##(1990-11#1)(2007-11#1)(2012-1#1)
thrombin amidolytic activity##2##3##(1991-6#1)(1993-11#1)
thrombin and FXa##2##3##(2005-7#2)
thrombin and collagen##2##3##(1996-5#1)(2007-10#1)
thrombin and factor Xa##2##4##(1994-11#2)
thrombin and hirudin##2##3##(1990-11#1)(2007-10#1)
thrombin and the##3##3##(1994-12#2)(1996-7#1)
thrombin and##25##2##(1990-11#1)(1990-5#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-6#1)(1994-11#2)(1994-12#3)(1994-6#1)(1995-3#1)(1996-5#2)(1996-7#1)(1997-7#1)(2005-7#4)(2007-10#2)(2009-3#1)
thrombin as##2##2##(1990-7#1)(1996-7#1)
thrombin binding to##2##3##(1994-11#1)(1994-12#1)
thrombin binding##3##2##(1994-11#1)(1994-12#1)(2009-12#1)
thrombin by##2##2##(1994-12#1)(1994-3#1)
thrombin cleavage sites were##3##4##(1992-5#1)(1997-4#1)(2005-11#1)
thrombin cleavage sites##4##3##(1992-5#1)(1997-4#2)(2005-11#1)
thrombin cleavage##8##2##(1991-6#1)(1992-5#1)(1993-4#1)(1995-3#1)(1997-4#3)(2005-11#1)
thrombin concentration##2##2##(1990-5#1)(2009-4#1)
thrombin crystals##2##2##(1997-1#2)
thrombin exosite##2##2##(1994-12#2)
thrombin formation in##2##3##(1994-5#1)(2012-1#1)
thrombin formation##3##2##(1994-5#2)(2012-1#1)
thrombin generation by the##2##4##(1994-5#1)(2013-7#1)
thrombin generation in##2##3##(1990-11#1)(1991-7#1)
thrombin generation##17##2##(1990-11#5)(1991-7#1)(1994-5#1)(2005-10#5)(2005-8#1)(2007-11#1)(2007-9#1)(2011-12#1)(2013-7#1)
thrombin in the absence##2##4##(1995-5#1)(2008-4#1)
thrombin in the##4##3##(1994-12#1)(1995-5#1)(2008-4#1)(2009-4#1)
thrombin in##8##2##(1992-8#1)(1994-12#1)(1995-5#2)(1996-12#1)(1997-2#1)(2008-4#1)(2009-4#1)
thrombin increased the##2##3##(1992-11#1)(1994-12#1)
thrombin increased##3##2##(1992-11#1)(1994-12#1)(2009-12#1)
thrombin induced changes of cytosolic free calcium##2##7##(1991-6#2)
thrombin induced changes##3##3##(1991-6#3)
thrombin inhibition by##5##3##(1994-12#5)
thrombin inhibition##11##2##(1990-7#1)(1994-11#1)(1994-12#5)(1995-5#1)(2009-3#3)
thrombin inhibitor which##2##3##(2005-7#1)(2007-11#1)
thrombin inhibitor##23##2##(1990-11#4)(1990-12#2)(1991-9#2)(1994-5#1)(1995-5#1)(2005-7#4)(2006-10#1)(2007-10#2)(2007-11#1)(2008-5#1)(2009-8#1)(2012-12#1)(2013-1#2)
thrombin inhibitors and##2##3##(2013-1#2)
thrombin inhibitors##9##2##(1992-9#1)(1993-12#2)(2005-7#1)(2007-11#2)(2008-1#1)(2013-1#2)
thrombin injection##9##2##(2007-10#4)(2008-7#3)(2010-12#2)
thrombin interaction with##2##3##(1994-11#1)(1995-5#1)
thrombin is##2##2##(1991-9#1)(1994-8#1)
thrombin may be##2##3##(1992-6#1)(1997-4#1)
thrombin may##3##2##(1992-6#1)(1995-5#1)(1997-4#1)
thrombin on##3##2##(1991-9#1)(1995-3#1)(1996-8#1)
thrombin or##6##2##(1991-12#1)(1991-7#1)(1993-6#1)(1994-8#1)(1997-7#1)(2005-7#1)
thrombin receptor activation##2##3##(1992-4#1)(1994-8#1)
thrombin receptor agonist##2##3##(1994-3#1)(1996-8#1)
thrombin receptor expression##5##3##(1995-3#1)(1997-5#4)
thrombin receptor gene##2##3##(1996-8#1)(1997-5#1)
thrombin receptor mRNA and protein##2##5##(1995-3#1)(1997-5#1)
thrombin receptor mRNA##3##3##(1995-3#1)(1997-5#2)
thrombin receptor##36##2##(1991-9#2)(1992-4#1)(1994-3#4)(1994-8#3)(1995-3#6)(1996-8#8)(1997-5#8)(1997-7#3)(2005-7#1)
thrombin receptor-activating##2##2##(1996-8#2)
thrombin receptors##4##2##(1991-9#1)(1992-4#1)(1994-8#1)(1996-8#1)
thrombin stimulates##2##2##(1993-8#1)(1997-7#1)
thrombin stimulation##7##2##(1990-8#1)(1992-12#1)(1993-8#1)(1994-12#1)(1996-5#1)(1997-7#1)(2007-10#1)
thrombin time##6##2##(1994-12#1)(1994-4#2)(2004-11#2)(2008-1#1)
thrombin to activate factors VIII##2##5##(1990-11#1)(2005-10#1)
thrombin to##3##2##(1990-11#1)(2005-10#1)(2010-12#1)
thrombin was also inhibited by##2##5##(1992-8#2)
thrombin was##3##2##(1992-8#2)(2007-8#1)
thrombin##374##1##(1990-11#17)(1990-12#3)(1990-5#6)(1990-7#7)(1990-8#1)(1991-10#1)(1991-12#1)(1991-4#2)(1991-6#11)(1991-7#3)(1991-9#15)(1992-11#1)(1992-12#4)(1992-2#2)(1992-4#6)(1992-5#1)(1992-6#7)(1992-8#4)(1992-9#2)(1993-11#2)(1993-12#2)(1993-3#8)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#2)(1994-11#5)(1994-12#24)(1994-3#5)(1994-4#2)(1994-5#5)(1994-6#1)(1994-8#8)(1995-11#2)(1995-3#14)(1995-5#14)(1995-6#1)(1996-12#2)(1996-2#2)(1996-5#5)(1996-7#3)(1996-8#26)(1997-1#9)(1997-2#3)(1997-4#9)(1997-5#8)(1997-6#1)(1997-7#9)(2004-11#6)(2005-10#9)(2005-11#1)(2005-7#12)(2005-8#1)(2006-10#1)(2006-6#1)(2007-10#12)(2007-11#7)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-12#3)(2009-3#8)(2009-4#6)(2009-8#2)(2010-12#3)(2010-5#1)(2011-12#1)(2012-1#6)(2012-12#1)(2013-1#5)(2013-7#1)(2013-8#1)
thrombin)##2##1##(1991-8#1)(2009-4#1)
thrombin-activated platelets##4##2##(1992-11#1)(1995-1#1)(2005-10#2)
thrombin-activated##7##1##(1991-10#1)(1992-11#1)(1995-1#2)(2005-10#3)
thrombin-antithrombin III complex##2##3##(1991-3#1)(1991-8#1)
thrombin-antithrombin##3##1##(1991-3#2)(1991-8#1)
thrombin-cleaved##2##1##(1997-4#1)(2012-2#1)
thrombin-cut scu-PA##5##2##(1990-11#5)
thrombin-induced aggregation of human platelets##2##5##(1992-8#1)(2012-1#1)
thrombin-induced aggregation##3##2##(1992-8#1)(1995-3#1)(2012-1#1)
thrombin-induced mitogenesis and##2##3##(1996-8#2)
thrombin-induced platelet aggregation##2##3##(1990-10#1)(1991-10#1)
thrombin-induced##16##1##(1990-10#1)(1991-10#1)(1991-9#1)(1992-8#1)(1995-11#1)(1995-3#2)(1996-2#2)(1996-8#5)(2007-10#1)(2012-1#1)
thrombin-like##5##1##(1992-4#1)(1994-12#1)(1994-9#1)(2008-5#2)
thrombin-mediated fibrinogen activation##2##3##(1990-11#2)
thrombin-mediated##5##1##(1990-11#4)(2005-7#1)
thrombin-stimulated platelets##4##2##(1990-12#1)(1993-8#2)(1994-12#1)
thrombin-stimulated##10##1##(1990-12#1)(1990-5#1)(1992-8#2)(1993-8#3)(1994-12#1)(1995-11#1)(2008-8#1)
thrombin-treated MG-63 cells##2##3##(1993-8#2)
thrombin-treated##4##1##(1993-3#1)(1993-8#2)(2009-12#1)
thrombin/antithrombin##2##1##(2010-3#1)(2010-4#1)
thrombins##2##1##(1994-12#1)(2012-1#1)
thrombo-embolic##6##1##(1990-8#1)(1997-6#2)(2007-3#1)(2008-12#1)(2008-7#1)
thrombo-embolism##2##1##(2007-8#1)(2008-8#1)
thromboangiitis obliterans##2##2##(1996-8#1)(2006-10#1)
thromboangiitis##3##1##(1990-8#1)(1996-8#1)(2006-10#1)
thrombocyte P-selectin expression##2##3##(2007-10#2)
thrombocyte activation##4##2##(2007-10#4)
thrombocyte concentrates with##2##3##(1996-1#2)
thrombocyte concentrates##5##2##(1996-1#5)
thrombocyte count##3##2##(1990-2#1)(1995-3#1)(2007-2#1)
thrombocyte##20##1##(1990-2#1)(1991-11#1)(1995-3#2)(1996-1#7)(1997-6#1)(2007-10#7)(2007-2#1)
thrombocytes##17##1##(1990-2#2)(1996-1#2)(2007-10#1)(2007-9#6)(2008-7#1)(2013-1#5)
thrombocythemia##4##1##(2008-4#1)(2011-2#2)(2012-12#1)
thrombocytopaenia and##2##2##(2006-4#1)(2008-7#1)
thrombocytopaenia##6##1##(2006-4#1)(2007-10#2)(2008-7#1)(2008-8#1)(2013-8#1)
thrombocytopenia (HIT) is a serious complication of heparin##2##8##(2007-12#1)(2013-1#1)
thrombocytopenia (HIT) is a serious##3##5##(2007-12#1)(2008-10#1)(2013-1#1)
thrombocytopenia (HIT) is##5##3##(2006-12#1)(2007-12#1)(2008-10#1)(2010-3#1)(2013-1#1)
thrombocytopenia (HIT)##11##2##(1997-2#1)(2006-12#1)(2007-11#3)(2007-12#1)(2008-10#1)(2009-8#1)(2010-3#1)(2013-1#2)
thrombocytopenia and an##2##3##(2007-8#1)(2013-1#1)
thrombocytopenia and##22##2##(1990-9#1)(1991-11#1)(1994-4#1)(1995-4#2)(1996-2#1)(1997-1#1)(1997-5#1)(2005-10#1)(2006-12#1)(2007-12#2)(2007-2#1)(2007-8#2)(2008-10#1)(2009-9#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#1)
thrombocytopenia are##2##2##(1991-4#1)(2006-12#1)
thrombocytopenia associated with##2##3##(1990-10#1)(2006-2#1)
thrombocytopenia can##3##2##(2007-11#1)(2007-9#1)(2008-3#1)
thrombocytopenia due to##2##3##(1992-10#1)(2007-3#1)
thrombocytopenia during##2##2##(1990-10#1)(2007-8#1)
thrombocytopenia in##10##2##(1990-12#1)(1991-10#1)(1996-11#1)(2006-10#2)(2006-9#1)(2007-9#1)(2008-11#1)(2008-8#1)(2011-12#1)
thrombocytopenia is##5##2##(1997-2#1)(2005-7#1)(2007-11#1)(2008-11#1)(2011-12#1)
thrombocytopenia purpura##4##2##(1996-4#1)(2006-10#1)(2006-9#1)(2007-12#1)
thrombocytopenia that##2##2##(2006-10#1)(2010-5#1)
thrombocytopenia type II##3##3##(2007-11#1)(2007-8#1)(2013-1#1)
thrombocytopenia with##5##2##(1991-3#1)(1996-2#1)(1997-6#1)(2007-11#1)(2011-12#1)
thrombocytopenia##164##1##(1990-10#2)(1990-12#1)(1990-6#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-6#2)(1992-10#5)(1992-2#1)(1993-11#1)(1993-6#2)(1994-3#1)(1994-4#1)(1995-3#1)(1995-4#3)(1996-11#1)(1996-2#3)(1996-4#1)(1997-1#1)(1997-2#4)(1997-5#1)(1997-6#1)(1997-7#1)(2004-1#1)(2005-10#1)(2005-7#1)(2006-10#8)(2006-12#5)(2006-2#2)(2006-6#1)(2006-8#1)(2006-9#2)(2007-11#16)(2007-12#9)(2007-2#4)(2007-3#1)(2007-6#5)(2007-8#6)(2007-9#5)(2008-1#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#9)(2009-8#3)(2009-9#2)(2010-3#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-12#4)(2011-2#5)(2012-12#3)(2012-2#4)(2013-1#6)(2013-7#1)
thrombocytopenia]##3##1##(1990-9#1)(2006-12#2)
thrombocytopenias##2##1##(1992-10#1)(1993-6#1)
thrombocytopenic purpura (TTP)##3##3##(1991-3#1)(2006-10#1)(2007-12#1)
thrombocytopenic purpura and##3##3##(2007-7#1)(2008-4#1)(2012-2#1)
thrombocytopenic purpura##28##2##(1990-12#1)(1990-6#1)(1991-3#2)(1991-6#3)(1992-5#1)(1995-3#2)(1997-8#2)(2005-6#1)(2006-10#2)(2006-4#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-4#1)(2009-7#1)(2010-6#2)(2012-2#2)(2012-3#2)
thrombocytopenic##34##1##(1990-12#1)(1990-6#1)(1991-11#1)(1991-3#2)(1991-4#1)(1991-6#3)(1992-5#1)(1995-3#2)(1997-8#2)(2005-6#2)(2005-7#1)(2006-10#2)(2006-4#1)(2006-6#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-4#1)(2008-8#1)(2009-7#1)(2010-6#2)(2012-2#2)(2012-3#2)
thrombocytosis and##3##2##(2007-9#1)(2010-12#1)(2011-2#1)
thrombocytosis##20##1##(1990-11#1)(1990-12#5)(1997-7#3)(2005-10#1)(2006-6#1)(2007-9#3)(2008-9#2)(2010-12#2)(2011-2#2)
thromboelastography##6##1##(2007-8#3)(2012-11#1)(2012-2#1)(2013-1#1)
thromboembolic complications##17##2##(1990-12#1)(1990-9#1)(1991-7#1)(1996-4#2)(1997-5#1)(1997-6#1)(2007-11#1)(2007-8#4)(2009-4#1)(2012-1#1)(2013-1#3)
thromboembolic disease (TED)##2##3##(1990-11#1)(2008-1#1)
thromboembolic disease and##3##3##(2008-5#1)(2010-10#2)
thromboembolic disease in##4##3##(1996-3#1)(1996-4#1)(1996-9#1)(2010-2#1)
thromboembolic disease##18##2##(1990-11#1)(1996-3#1)(1996-4#1)(1996-9#1)(2005-1#1)(2006-2#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-5#1)(2009-8#1)(2010-10#2)(2010-2#2)(2012-2#2)
thromboembolic diseases##3##2##(1992-9#1)(2008-5#1)(2010-3#1)
thromboembolic disorders##4##2##(2005-7#4)
thromboembolic event##5##2##(2007-8#1)(2008-7#1)(2009-4#1)(2010-6#1)(2013-8#1)
thromboembolic events after##2##3##(2007-8#1)(2012-3#1)
thromboembolic events##13##2##(1994-3#1)(1996-4#1)(1997-1#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-7#1)(2009-4#1)(2012-3#1)(2013-1#3)
thromboembolic occlusion##2##2##(2007-9#1)(2008-4#1)
thromboembolic pulmonary hypertension (CTEPH) is##3##5##(2010-6#3)
thromboembolic pulmonary hypertension (CTEPH)##7##4##(2010-6#7)
thromboembolic pulmonary hypertension##12##3##(2009-10#1)(2010-10#1)(2010-6#7)(2013-1#2)(2013-7#1)
thromboembolic pulmonary hypertension]##8##3##(2010-6#8)
thromboembolic pulmonary##21##2##(2009-10#1)(2010-10#2)(2010-6#15)(2013-1#2)(2013-7#1)
thromboembolic risk##6##2##(2007-9#1)(2008-7#3)(2010-7#1)(2013-8#1)
thromboembolic##107##1##(1990-11#1)(1990-12#1)(1990-9#1)(1991-3#1)(1991-7#1)(1992-9#1)(1994-3#1)(1995-4#2)(1996-3#1)(1996-4#4)(1996-9#1)(1997-1#1)(1997-5#2)(1997-6#1)(2005-1#1)(2005-12#2)(2005-7#4)(2006-10#1)(2006-11#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#9)(2007-9#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#3)(2008-7#7)(2008-8#2)(2009-10#1)(2009-4#3)(2009-8#1)(2010-10#5)(2010-2#2)(2010-3#1)(2010-6#16)(2010-7#1)(2010-8#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#2)
thromboembolism (VTE)##11##2##(2006-2#1)(2007-10#2)(2007-12#1)(2007-2#2)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
thromboembolism (p = 0##2##4##(2008-5#2)
thromboembolism after##4##2##(2007-10#1)(2007-8#1)(2013-1#2)
thromboembolism and##8##2##(1990-9#1)(1996-11#1)(2007-8#1)(2008-3#1)(2008-7#2)(2010-12#1)(2013-7#1)
thromboembolism but##2##2##(2007-8#1)(2011-2#1)
thromboembolism guidebook##2##2##(2008-3#2)
thromboembolism have been reported##2##4##(1990-11#1)(2006-10#1)
thromboembolism have been##3##3##(1990-11#2)(2006-10#1)
thromboembolism in patients with##2##4##(2006-8#1)(2008-7#1)
thromboembolism in##15##2##(1993-5#2)(2005-11#1)(2006-2#2)(2006-8#3)(2007-8#2)(2008-12#2)(2008-7#1)(2010-11#2)
thromboembolism prophylaxis##3##2##(2011-2#1)(2012-12#1)(2012-2#1)
thromboembolism within##2##2##(2008-3#1)(2009-4#1)
thromboembolism##118##1##(1990-11#2)(1990-12#2)(1990-9#1)(1991-8#1)(1993-5#5)(1994-3#1)(1995-9#1)(1996-11#3)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#4)(2005-1#1)(2005-10#2)(2005-11#1)(2005-7#1)(2006-10#5)(2006-11#1)(2006-2#3)(2006-4#1)(2006-8#4)(2007-10#8)(2007-12#2)(2007-2#3)(2007-8#9)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#6)(2009-4#1)(2010-11#3)(2010-12#6)(2010-2#2)(2010-3#1)(2010-6#3)(2010-7#1)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#1)
thromboendarterectomy##3##1##(2010-6#3)
thrombogenesis##7##1##(2006-6#3)(2007-1#1)(2007-8#1)(2009-1#1)(2013-1#1)
thrombogenic potential##2##2##(1990-11#1)(2008-8#1)
thrombogenic##13##1##(1990-11#1)(1990-12#1)(1993-6#1)(1994-5#1)(1996-9#2)(2007-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-4#2)
thrombogenicity##5##1##(1990-11#1)(2004-9#1)(2007-10#1)(2007-7#1)(2010-4#1)
thrombolitic##3##1##(2007-7#1)(2008-10#2)
thrombolysis and##4##2##(1990-11#1)(1997-8#1)(2007-10#1)(2007-7#1)
thrombolysis by##2##2##(1990-11#1)(1994-3#1)
thrombolysis for acute ischemic stroke##4##5##(2007-10#4)
thrombolysis for acute##6##3##(1997-8#1)(2007-10#4)(2007-9#1)
thrombolysis for##11##2##(1997-8#1)(2007-10#6)(2007-9#2)(2008-8#1)(2012-12#1)
thrombolysis has been##4##3##(2007-10#3)(2013-7#1)
thrombolysis has##5##2##(1994-3#1)(2007-10#3)(2013-7#1)
thrombolysis in a##2##3##(1990-12#1)(2009-6#1)
thrombolysis in acute myocardial##2##4##(1990-12#1)(2006-10#1)
thrombolysis in acute##4##3##(1990-12#1)(2006-10#1)(2007-10#1)(2009-11#1)
thrombolysis in myocardial infarction##2##4##(2007-11#2)
thrombolysis in##12##2##(1990-12#2)(1996-6#1)(2006-10#1)(2007-10#2)(2007-11#2)(2007-9#1)(2008-8#1)(2009-11#1)(2009-6#1)
thrombolysis is an effective##2##4##(2007-9#2)
thrombolysis is##8##2##(1990-12#1)(1994-11#1)(1996-6#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-9#2)
thrombolysis of##6##2##(1993-2#1)(1997-3#1)(1997-8#1)(2007-10#1)(2007-8#1)(2013-8#1)
thrombolysis to##2##2##(2007-10#1)(2008-3#1)
thrombolysis with recombinant tissue plasminogen activator##3##6##(2007-7#1)(2009-11#1)(2013-7#1)
thrombolysis with reflow##2##3##(1990-11#2)
thrombolysis with##8##2##(1990-11#2)(1992-7#1)(2007-10#1)(2007-11#1)(2007-7#1)(2009-11#1)(2013-7#1)
thrombolysis##115##1##(1990-11#7)(1990-12#4)(1990-3#4)(1991-3#1)(1992-2#1)(1992-7#1)(1993-10#1)(1993-2#2)(1994-11#2)(1994-3#3)(1996-6#5)(1996-9#1)(1997-3#1)(1997-8#10)(2005-7#1)(2006-10#3)(2007-10#23)(2007-11#7)(2007-7#3)(2007-8#1)(2007-9#12)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#5)(2009-11#2)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#2)(2013-8#3)
thrombolysis'##2##1##(2008-11#2)
thrombolysis-eligible##3##1##(2008-3#2)(2009-11#1)
thrombolysis]##3##1##(1992-5#1)(1994-11#1)(1994-4#1)
thrombolytic activity##2##2##(2007-11#1)(2008-8#1)
thrombolytic agent for##2##3##(2008-7#1)(2012-2#1)
thrombolytic agent##7##2##(1990-11#1)(1997-8#2)(2008-7#3)(2012-2#1)
thrombolytic agents are##2##3##(1994-11#1)(2008-7#1)
thrombolytic agents in patients with acute##2##6##(1993-10#1)(2006-10#1)
thrombolytic agents in##7##3##(1990-12#1)(1993-10#1)(2006-10#1)(2007-10#1)(2007-7#1)(2007-9#1)(2011-1#1)
thrombolytic agents##12##2##(1990-12#1)(1990-5#1)(1993-10#1)(1994-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-7#2)(2011-1#1)
thrombolytic and##4##2##(2007-9#2)(2008-3#2)
thrombolytic drugs##2##2##(2006-10#1)(2007-11#1)
thrombolytic or##2##2##(2006-9#1)(2007-10#1)
thrombolytic therapy for acute ischemic stroke##3##6##(2007-10#1)(2007-9#1)(2013-7#1)
thrombolytic therapy for acute##4##4##(1997-8#1)(2007-10#1)(2007-9#1)(2013-7#1)
thrombolytic therapy for patients with##4##5##(2008-11#3)(2009-11#1)
thrombolytic therapy for##13##3##(1997-8#1)(2007-10#1)(2007-9#2)(2008-11#3)(2008-3#1)(2008-4#2)(2008-7#1)(2009-11#1)(2013-7#1)
thrombolytic therapy in acute myocardial infarction##2##6##(1996-6#1)(1997-1#1)
thrombolytic therapy in acute myocardial##3##5##(1994-6#1)(1996-6#1)(1997-1#1)
thrombolytic therapy in acute##5##4##(1994-6#1)(1996-6#1)(1997-1#1)(2007-9#1)(2010-8#1)
thrombolytic therapy in patients with##3##5##(1995-9#1)(2007-11#2)
thrombolytic therapy in##10##3##(1994-5#1)(1994-6#1)(1995-9#1)(1996-6#1)(1997-1#1)(2007-11#2)(2007-9#1)(2008-8#1)(2010-8#1)
thrombolytic therapy is##3##3##(2007-11#1)(2008-3#1)(2013-7#1)
thrombolytic therapy or primary##2##4##(2007-5#1)(2008-3#1)
thrombolytic therapy was##5##3##(1994-5#1)(1995-9#1)(1997-8#1)(2006-8#1)(2007-8#1)
thrombolytic therapy with##2##3##(1990-10#1)(2007-9#1)
thrombolytic therapy##60##2##(1990-10#2)(1990-11#1)(1990-6#1)(1992-5#1)(1993-9#1)(1994-5#3)(1994-6#1)(1995-3#1)(1995-6#1)(1995-9#3)(1996-6#1)(1997-1#1)(1997-3#1)(1997-8#3)(2006-8#1)(2007-10#3)(2007-11#4)(2007-5#1)(2007-8#1)(2007-9#7)(2008-11#4)(2008-3#4)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-11#1)(2010-8#2)(2012-2#1)(2013-7#3)
thrombolytic treatment##11##2##(1990-12#1)(1990-3#1)(1990-6#2)(1994-4#1)(2005-8#1)(2007-10#2)(2007-9#2)(2008-3#1)
thrombolytic##117##1##(1990-10#2)(1990-11#2)(1990-12#3)(1990-3#1)(1990-5#1)(1990-6#3)(1992-5#1)(1993-10#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-4#1)(1994-5#3)(1994-6#1)(1994-9#1)(1995-3#1)(1995-6#1)(1995-9#3)(1996-6#1)(1997-1#1)(1997-3#1)(1997-8#6)(2005-8#2)(2006-10#2)(2006-8#1)(2006-9#1)(2007-10#7)(2007-11#11)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#14)(2008-11#4)(2008-3#11)(2008-4#2)(2008-6#1)(2008-7#7)(2008-8#4)(2009-11#1)(2010-8#2)(2011-1#1)(2012-2#2)(2013-7#4)
thrombolytics is##3##2##(2006-7#1)(2007-11#1)(2008-2#1)
thrombolytics were##3##2##(2005-8#1)(2007-9#1)(2008-8#1)
thrombolytics##16##1##(1997-3#1)(2005-7#1)(2005-8#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-9#3)(2008-2#2)(2008-3#1)(2008-8#1)
thrombomodulin##13##1##(1990-5#4)(1994-3#2)(1995-1#2)(1995-5#1)(1997-2#1)(2007-10#2)(2008-9#1)
thrombophilia##6##1##(1992-3#1)(2010-12#3)(2010-3#1)(2013-7#1)
thrombophlebitis and pulmonary##2##3##(2006-4#1)(2009-4#1)
thrombophlebitis and##3##2##(2006-4#1)(2009-4#1)(2013-8#1)
thrombophlebitis of the##2##3##(1991-9#1)(2008-9#1)
thrombophlebitis##11##1##(1991-9#1)(1995-1#1)(2006-10#1)(2006-4#1)(2008-9#1)(2009-4#3)(2010-2#1)(2013-1#1)(2013-8#1)
thromboplastin##29##1##(1990-11#3)(1990-12#6)(1991-2#1)(1994-4#2)(1994-9#1)(1996-4#1)(1996-5#1)(2004-11#2)(2006-9#2)(2007-10#3)(2007-11#2)(2008-10#1)(2008-7#1)(2008-9#2)(2012-1#1)
thrombopoiesis##3##1##(2006-6#2)(2007-11#1)
thrombopoietin (TPO)##2##2##(1997-4#1)(2008-4#1)
thrombopoietin##9##1##(1997-4#3)(2008-4#1)(2008-5#1)(2008-8#3)(2012-12#1)
thromboprophylactic##3##1##(2006-10#2)(2007-10#1)
thromboprophylaxis in##3##2##(1997-5#1)(2013-1#2)
thromboprophylaxis##8##1##(1997-5#1)(2005-1#1)(2010-11#1)(2013-1#3)(2013-8#2)
thrombose##2##1##(2012-2#2)
thrombosed AVF##3##2##(2007-7#3)
thrombosed polytetrafluoroethylene (PTFE)##3##3##(2007-7#3)
thrombosed##25##1##(1995-11#1)(1996-3#1)(1997-3#2)(1997-8#1)(2006-12#1)(2007-7#13)(2007-8#1)(2007-9#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)
thromboses in the leg##2##4##(1990-6#1)(1996-4#1)
thromboses in the##3##3##(1990-6#1)(1996-4#1)(2011-2#1)
thromboses in##6##2##(1990-6#1)(1996-4#1)(2007-11#1)(2007-7#2)(2011-2#1)
thromboses of the##2##3##(2005-1#1)(2008-1#1)
thromboses of##4##2##(2005-1#1)(2007-7#1)(2008-1#1)(2011-2#1)
thromboses were##3##2##(1990-6#2)(2010-1#1)
thromboses##29##1##(1990-6#4)(1991-3#1)(1996-4#1)(1997-5#1)(2005-1#1)(2005-9#1)(2006-10#2)(2006-5#2)(2007-11#3)(2007-7#3)(2007-8#1)(2008-1#2)(2010-1#1)(2010-12#1)(2010-2#1)(2011-2#3)(2012-3#1)
thrombosis (6%##2##2##(2006-10#1)(2007-7#1)
thrombosis (DVT) in##3##3##(2006-2#1)(2007-2#1)(2013-8#1)
thrombosis (DVT)##16##2##(1990-12#2)(1993-5#1)(1993-7#1)(1997-8#1)(2005-7#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
thrombosis after hip##2##3##(1990-12#1)(1997-5#1)
thrombosis after##13##2##(1990-12#2)(1990-6#1)(1997-5#1)(2007-10#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#2)(2010-8#1)(2011-2#1)
thrombosis and acute##2##3##(2006-10#1)(2012-2#1)
thrombosis and are##2##3##(1997-8#1)(2006-5#1)
thrombosis and occlusion##2##3##(2008-10#1)(2013-7#1)
thrombosis and pulmonary##7##3##(1997-2#1)(2005-1#1)(2008-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
thrombosis and septic##2##3##(2006-2#1)(2006-4#1)
thrombosis and stroke##2##3##(1990-3#1)(2005-9#1)
thrombosis and the##5##3##(1992-4#1)(1997-5#1)(2009-1#1)(2011-2#1)(2013-1#1)
thrombosis and##54##2##(1990-3#1)(1992-12#1)(1992-4#1)(1993-5#1)(1993-9#1)(1996-2#2)(1997-2#1)(1997-5#1)(1997-8#1)(2004-10#1)(2005-1#1)(2005-7#1)(2005-9#1)(2006-10#3)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2007-10#1)(2007-7#5)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#2)(2008-5#2)(2008-6#1)(2009-1#1)(2009-11#1)(2009-8#1)(2010-12#2)(2011-2#3)(2011-3#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
thrombosis as##2##2##(2005-7#1)(2008-1#1)
thrombosis associated with##3##3##(2007-8#1)(2007-9#1)(2008-12#1)
thrombosis at##2##2##(1993-5#1)(2006-10#1)
thrombosis by##2##2##(1991-11#1)(2012-11#1)
thrombosis complicating##2##2##(1997-2#1)(2011-2#1)
thrombosis during the##2##3##(1997-5#1)(2007-10#1)
thrombosis following coronary##2##3##(2007-11#1)(2010-12#1)
thrombosis following##7##2##(1990-12#1)(1990-9#1)(1995-9#1)(2007-11#1)(2007-2#1)(2008-4#1)(2010-12#1)
thrombosis from##2##2##(1995-9#1)(2008-7#1)
thrombosis has##2##2##(2006-10#1)(2011-1#1)
thrombosis in 1##2##3##(2007-7#2)
thrombosis in a##10##3##(2004-10#1)(2007-10#1)(2007-8#1)(2008-7#1)(2009-1#1)(2009-3#1)(2010-12#1)(2013-1#2)(2013-8#1)
thrombosis in children##2##3##(2005-10#1)(2013-8#1)
thrombosis in patients with##2##4##(2006-10#2)
thrombosis in patients##3##3##(2006-10#2)(2007-11#1)
thrombosis in the leg##2##4##(1992-3#1)(1996-4#1)
thrombosis in the past##2##4##(1993-5#1)(2006-6#1)
thrombosis in the##14##3##(1992-10#1)(1992-3#1)(1993-5#1)(1996-4#1)(1997-5#1)(2006-10#2)(2006-6#2)(2008-1#1)(2011-2#3)(2013-8#1)
thrombosis in vivo##2##3##(2006-6#1)(2008-9#1)
thrombosis in##57##2##(1990-12#1)(1990-8#1)(1992-10#2)(1992-3#1)(1992-9#1)(1993-5#1)(1996-4#1)(1996-6#1)(1997-5#2)(2004-10#1)(2005-10#1)(2005-7#1)(2006-10#5)(2006-12#1)(2006-6#3)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#2)(2008-7#1)(2008-9#3)(2009-1#1)(2009-3#1)(2010-11#2)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
thrombosis is a##2##3##(2007-8#1)(2013-8#1)
thrombosis is an##2##3##(2007-8#1)(2011-1#1)
thrombosis is not##2##3##(2007-7#1)(2007-9#1)
thrombosis is the##2##3##(2007-7#1)(2010-12#1)
thrombosis is##20##2##(1990-4#1)(1990-8#1)(1992-9#1)(1996-2#1)(2007-3#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-4#1)(2008-7#2)(2010-12#1)(2011-1#2)(2012-3#1)(2013-1#1)(2013-8#1)
thrombosis may be##2##3##(2007-7#1)(2010-6#1)
thrombosis may##5##2##(1996-9#1)(2006-10#1)(2007-7#1)(2008-7#1)(2010-6#1)
thrombosis model##2##2##(1990-11#1)(1994-3#1)
thrombosis occurred##2##2##(2007-7#2)
thrombosis occurring##2##2##(2008-11#1)(2012-3#1)
thrombosis occurs in##2##3##(1996-2#1)(2008-4#1)
thrombosis of a major trunk (MCA##2##6##(1997-3#2)
thrombosis of an##2##3##(1994-6#1)(2007-3#1)
thrombosis of the##17##3##(1990-10#2)(1991-11#1)(1993-2#1)(1994-11#1)(1996-4#1)(1996-6#1)(1997-6#1)(2006-12#1)(2007-7#3)(2008-5#1)(2008-7#2)(2010-12#1)(2011-1#1)
thrombosis of##27##2##(1990-10#2)(1991-11#1)(1993-2#1)(1994-11#1)(1994-6#1)(1996-4#1)(1996-6#2)(1997-3#2)(1997-6#2)(2006-12#1)(2007-3#1)(2007-7#3)(2007-8#1)(2008-5#1)(2008-7#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)
thrombosis on##2##2##(2008-11#1)(2008-4#1)
thrombosis or##3##2##(2007-12#1)(2007-7#1)(2007-8#1)
thrombosis rates in the##2##4##(2006-5#1)(2007-7#1)
thrombosis related to##3##3##(1994-3#1)(2006-6#1)(2010-6#1)
thrombosis related##4##2##(1994-3#1)(2006-6#1)(2007-2#1)(2010-6#1)
thrombosis secondary to##2##3##(2007-9#1)(2012-12#1)
thrombosis that##3##2##(2006-10#1)(2007-10#1)(2007-2#1)
thrombosis was##7##2##(1990-12#2)(1992-3#1)(2006-10#1)(2006-2#1)(2008-8#1)(2010-5#1)
thrombosis were##2##2##(2007-11#1)(2008-8#1)
thrombosis with regional anesthesia##2##4##(1990-12#2)
thrombosis with##14##2##(1990-12#4)(1992-3#1)(1995-5#1)(1996-4#1)(1997-8#1)(2007-7#1)(2007-9#2)(2008-10#1)(2008-8#1)(2013-8#1)
thrombosis##519##1##(1990-10#4)(1990-11#4)(1990-12#14)(1990-2#1)(1990-3#2)(1990-4#1)(1990-6#3)(1990-8#3)(1990-9#2)(1991-11#2)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#3)(1992-12#2)(1992-2#1)(1992-3#7)(1992-4#1)(1992-7#1)(1992-9#2)(1993-10#1)(1993-2#1)(1993-5#8)(1993-6#2)(1993-7#2)(1993-8#2)(1993-9#3)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-4#1)(1994-6#2)(1994-7#1)(1994-9#1)(1995-4#1)(1995-5#1)(1995-9#3)(1996-10#1)(1996-2#5)(1996-4#3)(1996-6#4)(1996-8#1)(1996-9#1)(1997-2#4)(1997-3#5)(1997-5#9)(1997-6#4)(1997-8#4)(2004-10#4)(2005-1#1)(2005-10#5)(2005-11#5)(2005-12#1)(2005-7#10)(2005-8#1)(2005-9#2)(2006-10#25)(2006-12#2)(2006-2#4)(2006-3#1)(2006-4#2)(2006-5#4)(2006-6#7)(2006-8#1)(2007-10#19)(2007-11#9)(2007-12#4)(2007-2#5)(2007-3#4)(2007-5#1)(2007-7#36)(2007-8#17)(2007-9#17)(2008-1#5)(2008-10#3)(2008-11#6)(2008-12#6)(2008-3#9)(2008-4#6)(2008-5#6)(2008-6#3)(2008-7#24)(2008-8#8)(2008-9#4)(2009-1#3)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#11)(2010-2#2)(2010-5#3)(2010-6#3)(2010-8#2)(2011-1#8)(2011-2#22)(2011-3#1)(2012-11#2)(2012-12#5)(2012-2#6)(2012-3#6)(2013-1#12)(2013-7#5)(2013-8#12)
thrombosis)##3##1##(1991-6#1)(2006-2#1)(2008-4#1)
thrombosis]##10##1##(1990-10#1)(1991-3#1)(1991-4#1)(1992-2#1)(1992-3#1)(1992-7#1)(1995-4#1)(1996-2#1)(1997-1#1)(2008-12#1)
thrombospondin (TSP)##5##2##(1991-6#1)(1993-4#1)(1993-6#1)(1993-9#1)(2008-1#1)
thrombospondin 1 with protein disulfide isomerase and reduced glutathione##2##9##(1996-7#2)
thrombospondin 1##24##2##(1994-5#6)(1995-3#2)(1996-7#16)
thrombospondin##41##1##(1990-7#2)(1990-9#1)(1991-2#1)(1991-6#1)(1993-4#1)(1993-6#2)(1993-9#2)(1994-5#6)(1995-3#2)(1996-7#16)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2009-3#1)(2009-7#1)
thrombospondin-1##2##1##(1993-4#1)(2008-1#1)
thrombosuction##2##1##(2010-12#2)
thrombotic and ischaemic stroke##2##4##(2005-7#2)
thrombotic and##4##2##(2005-7#2)(2007-7#1)(2011-2#1)
thrombotic complications following##2##3##(2011-12#2)
thrombotic complications##13##2##(1995-1#1)(2005-7#1)(2006-7#1)(2007-11#1)(2007-7#1)(2007-8#4)(2008-5#1)(2011-12#2)(2011-2#1)
thrombotic diseases##2##2##(2008-5#2)
thrombotic disorders##7##2##(1991-7#1)(1991-9#1)(1995-5#1)(2004-10#1)(2005-12#1)(2005-8#1)(2007-11#1)
thrombotic endocarditis##4##2##(1996-11#4)
thrombotic event##5##2##(1990-11#1)(2006-10#1)(2010-5#1)(2010-6#1)(2012-12#1)
thrombotic events in##2##3##(2008-4#1)(2013-8#1)
thrombotic events##7##2##(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2013-8#1)
thrombotic microangiopathy##6##2##(2005-11#1)(2006-10#1)(2007-7#1)(2008-1#1)(2010-4#1)(2013-8#1)
thrombotic occlusion of the##2##4##(2007-9#1)(2011-1#1)
thrombotic occlusion of##3##3##(1991-6#1)(2007-9#1)(2011-1#1)
thrombotic occlusion##7##2##(1990-12#1)(1991-6#1)(1996-2#1)(2006-4#1)(2007-9#1)(2011-1#1)(2013-1#1)
thrombotic occlusions##3##2##(2011-2#3)
thrombotic process##2##2##(2012-3#1)(2013-1#1)
thrombotic response##2##2##(2006-6#1)(2008-4#1)
thrombotic risk##7##2##(2005-11#1)(2007-12#3)(2008-12#1)(2010-11#1)(2010-3#1)
thrombotic thrombocytopenia purpura##2##3##(2006-9#1)(2007-12#1)
thrombotic thrombocytopenic purpura and##2##4##(2007-7#1)(2008-4#1)
thrombotic thrombocytopenic purpura##9##3##(1990-6#1)(1991-3#1)(1991-6#1)(1995-3#2)(2006-4#1)(2007-7#1)(2008-4#1)(2009-7#1)
thrombotic thrombocytopenic##10##2##(1990-6#1)(1991-3#1)(1991-6#1)(1995-3#2)(2006-4#1)(2007-7#1)(2008-4#1)(2008-8#1)(2009-7#1)
thrombotic vegetation##2##2##(2006-6#2)
thrombotic##113##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1991-3#1)(1991-6#2)(1991-7#1)(1991-9#1)(1995-1#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-11#4)(1996-2#1)(1997-1#1)(2004-10#1)(2005-11#2)(2005-12#1)(2005-7#4)(2005-8#1)(2006-10#4)(2006-4#3)(2006-6#3)(2006-7#2)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#8)(2007-7#5)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#6)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#3)(2011-1#1)(2011-12#2)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
thromboxane (TX)##2##2##(1992-12#1)(1992-8#1)
thromboxane A(2)##2##2##(1997-7#1)(2008-1#1)
thromboxane A2 (TXA2)##2##3##(1990-12#1)(1995-3#1)
thromboxane A2 and##2##3##(1992-1#2)
thromboxane A2 in##3##3##(1990-11#1)(1990-12#1)(1993-11#1)
thromboxane A2 mimetic##4##3##(1990-11#1)(1993-11#1)(1996-10#1)(2008-8#1)
thromboxane A2 receptor agonist##2##4##(1993-11#2)
thromboxane A2 receptor##5##3##(1990-11#1)(1992-9#1)(1993-11#2)(1993-4#1)
thromboxane A2##26##2##(1990-11#3)(1990-12#3)(1990-3#2)(1990-8#1)(1991-5#1)(1992-1#4)(1992-9#2)(1993-11#6)(1993-4#1)(1995-3#1)(1996-10#1)(2008-8#1)
thromboxane A2/prostaglandin H2##2##3##(1993-4#1)(1995-3#1)
thromboxane B2 (TxB2)##2##3##(1995-12#1)(1995-3#1)
thromboxane B2 and##2##3##(1991-8#1)(1995-12#1)
thromboxane B2 concentration##2##3##(1990-12#2)
thromboxane B2##19##2##(1990-12#5)(1990-3#1)(1991-8#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-3#1)(1996-12#1)(1996-2#1)(2008-5#1)
thromboxane in##2##2##(1990-12#1)(1994-6#1)
thromboxane production##3##2##(1993-2#2)(2010-12#1)
thromboxane receptor blocking##2##3##(1990-11#2)
thromboxane receptor##4##2##(1990-11#2)(1990-5#1)(2007-8#1)
thromboxane synthase##6##2##(1991-5#3)(1994-5#2)(1994-8#1)
thromboxane##84##1##(1990-11#5)(1990-12#9)(1990-3#3)(1990-5#2)(1990-6#1)(1990-8#1)(1991-2#1)(1991-5#4)(1991-8#1)(1992-1#4)(1992-12#1)(1992-8#1)(1992-9#2)(1993-11#7)(1993-2#3)(1993-3#2)(1993-4#2)(1993-8#1)(1994-11#1)(1994-5#3)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#3)(1996-10#1)(1996-12#4)(1996-2#1)(1997-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-5#2)(2008-8#2)(2010-12#2)
thromboxanes##3##1##(1990-3#1)(2006-6#1)(2008-4#1)
thrombus and##7##2##(2007-7#1)(2007-8#3)(2008-5#1)(2008-8#1)(2011-2#1)
thrombus aspiration##2##2##(2009-5#2)
thrombus formation and##3##3##(1996-8#1)(2005-11#1)(2012-2#1)
thrombus formation at##2##3##(2006-6#2)
thrombus formation in##3##3##(1990-12#1)(2006-6#1)(2007-11#1)
thrombus formation on##2##3##(2005-12#1)(2008-11#1)
thrombus formation##30##2##(1990-12#2)(1991-9#1)(1993-10#1)(1994-10#1)(1995-3#1)(1995-6#1)(1996-8#1)(1997-1#1)(2005-11#1)(2005-12#1)(2006-6#8)(2007-10#1)(2007-11#1)(2007-8#4)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
thrombus in the left##2##4##(2007-9#1)(2013-7#1)
thrombus in the##9##3##(2007-8#1)(2007-9#1)(2011-2#4)(2012-1#1)(2012-2#1)(2013-7#1)
thrombus in##15##2##(1993-10#1)(1997-1#1)(2007-8#1)(2007-9#1)(2008-7#1)(2008-9#1)(2011-2#6)(2012-1#1)(2012-2#1)(2013-7#1)
thrombus is##5##2##(1997-1#2)(2008-6#2)(2012-2#1)
thrombus of the##2##3##(2006-4#1)(2006-7#1)
thrombus of##3##2##(2006-4#1)(2006-7#1)(2010-6#1)
thrombus or##2##2##(2008-7#1)(2010-12#1)
thrombus was##8##2##(1990-8#2)(1997-1#1)(2005-1#1)(2011-2#1)(2013-1#3)
thrombus were##2##2##(1997-1#1)(2008-7#1)
thrombus##127##1##(1990-11#1)(1990-12#2)(1990-8#4)(1991-9#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#4)(1994-10#1)(1995-3#1)(1995-6#1)(1996-8#1)(1997-1#9)(1997-5#1)(1997-6#1)(2005-1#1)(2005-11#1)(2005-12#1)(2006-4#1)(2006-6#8)(2006-7#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#13)(2007-9#3)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#3)(2010-10#1)(2010-12#5)(2010-6#1)(2011-1#1)(2011-2#14)(2012-1#1)(2012-2#7)(2013-1#6)(2013-7#2)(2013-8#1)
through &quot##5##2##(2006-7#1)(2007-7#1)(2007-8#1)(2008-8#1)(2013-7#1)
through 1##2##2##(2004-3#1)(2010-7#1)
through 10##2##2##(1995-1#1)(2008-3#1)
through 12##2##2##(2009-7#1)(2013-1#1)
through 14##2##2##(1991-6#1)(1994-3#1)
through 16##2##2##(2007-12#1)(2009-7#1)
through 1984##4##2##(1990-6#1)(1991-3#1)(1991-4#1)(1993-3#1)
through 1986##9##2##(1990-12#4)(1991-12#2)(1991-2#1)(1991-3#1)(2006-7#1)
through 1987 for##2##3##(1991-12#1)(1993-12#1)
through 1987##5##2##(1990-12#1)(1991-12#1)(1993-1#1)(1993-12#2)
through 1988##12##2##(1990-5#1)(1991-2#2)(1991-3#2)(1991-9#1)(1992-1#1)(1992-5#1)(1992-7#1)(1993-3#1)(1996-3#1)(2006-8#1)
through 1989##6##2##(1991-6#2)(1992-12#2)(1993-6#1)(1994-2#1)
through 1990##3##2##(1991-8#1)(1996-6#1)(2006-2#1)
through 1991##2##2##(1996-1#1)(1997-2#1)
through 1992##2##2##(1993-11#1)(1993-8#1)
through 1993##3##2##(1994-2#1)(1996-9#1)(1997-2#1)
through 1996##8##2##(1997-4#1)(2008-1#1)(2008-10#5)(2008-9#1)
through 1997##2##2##(2004-11#1)(2008-8#1)
through 2##4##2##(1992-6#1)(2007-9#1)(2008-3#1)(2009-8#1)
through 2001##3##2##(2007-10#1)(2008-10#2)
through 2002##3##2##(2007-5#1)(2007-6#1)(2009-11#1)
through 2003##5##2##(2007-1#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
through 2004##3##2##(2007-8#1)(2008-4#1)(2008-8#1)
through 2008##2##2##(2012-2#1)(2013-7#1)
through 2009##2##2##(2010-12#1)(2012-2#1)
through 21##2##2##(1996-3#1)(2010-8#1)
through 30##2##2##(2009-7#1)(2013-7#1)
through 31 December##2##3##(2008-6#1)(2011-2#1)
through 50##2##2##(1997-6#1)(2012-2#1)
through 6##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
through 7##2##2##(2008-7#1)(2009-7#1)
through 8##3##2##(1990-3#1)(1993-9#1)(2007-8#1)
through A##2##2##(1992-8#1)(2008-11#1)
through April##6##2##(1992-6#1)(2004-11#1)(2008-1#1)(2008-10#1)(2011-1#1)(2013-1#1)
through August 1994##2##3##(1994-9#2)
through August##8##2##(1990-8#1)(1992-2#1)(1994-9#2)(2004-11#1)(2008-10#2)(2008-8#1)
through BABO##2##2##(2008-9#2)
through Bragg##2##2##(2007-12#1)(2013-7#1)
through Ca2+ channels##3##3##(1993-12#2)(1993-7#1)
through Caco-2##2##2##(2007-11#1)(2007-8#1)
through Complex I##2##3##(1995-6#2)
through Congress##3##2##(1996-11#1)(1996-5#1)(2007-9#1)
through Cys##2##2##(1994-8#1)(1995-8#1)
through D)##2##2##(2008-10#1)(2012-2#1)
through DNA##2##2##(2007-3#1)(2008-10#1)
through December 1991##2##3##(1992-2#1)(1992-5#1)
through December 1996##2##3##(1997-1#1)(1997-6#1)
through December 31##5##3##(1993-6#1)(2007-8#1)(2009-2#1)(2009-5#1)(2012-2#1)
through December##19##2##(1990-6#1)(1992-2#1)(1992-5#2)(1993-6#1)(1994-9#1)(1997-1#1)(1997-6#1)(2005-7#1)(2006-10#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2009-2#1)(2009-5#1)(2012-2#1)(2012-3#1)
through EP1 receptors##2##3##(1997-8#2)
through EP1##3##2##(1997-8#3)
through EST##2##2##(2008-7#1)(2008-9#1)
through February##5##2##(1992-8#1)(1996-3#1)(2004-11#1)(2008-9#1)(2009-9#1)
through Fourier##2##2##(2008-2#1)(2013-8#1)
through G##2##2##(2006-10#1)(2008-7#1)
through G1##3##2##(1997-8#1)(2007-12#1)(2007-8#1)
through Gene##2##2##(2008-4#1)(2010-7#1)
through Gi##2##2##(1994-5#2)
through Internet##3##2##(2013-7#1)(2013-8#2)
through January 18##2##3##(1992-1#1)(1997-1#1)
through January##6##2##(1992-1#2)(1997-1#2)(2008-5#1)(2012-12#1)
through July##5##2##(2007-3#1)(2008-10#2)(2009-2#1)(2010-9#1)
through June##5##2##(1995-1#1)(1996-2#1)(2006-6#1)(2007-10#1)(2008-3#1)
through L-type##2##2##(1991-8#1)(1996-2#1)
through March##3##2##(1991-5#1)(2006-12#1)(2008-7#1)
through May 2000##2##3##(2005-10#1)(2008-5#1)
through May##6##2##(1992-1#1)(2004-11#1)(2005-10#1)(2008-12#1)(2008-5#2)
through N-methyl-D-aspartate##2##2##(1996-12#1)(1997-7#1)
through NADPH##2##2##(2009-8#1)(2010-12#1)
through NMDA receptors##2##3##(1996-9#1)(1997-6#1)
through NMDA##4##2##(1996-9#1)(1997-6#1)(1997-7#1)(2009-12#1)
through November##4##2##(1991-11#1)(2004-11#1)(2007-3#1)(2008-3#1)
through N→S##2##2##(2012-2#2)
through October##7##2##(1993-6#1)(2004-11#1)(2007-5#2)(2008-10#1)(2012-12#1)(2013-1#1)
through P2 purinoceptors##2##3##(2008-4#2)
through P4'##2##2##(1993-6#1)(1994-5#1)
through PKC##2##2##(1990-9#1)(1995-7#1)
through RNA##2##2##(1992-1#1)(1994-6#1)
through September##5##2##(1991-3#1)(2004-11#1)(2007-7#1)(2011-2#1)(2013-1#1)
through X-ray##3##2##(2008-10#2)(2013-8#1)
through a &quot##2##3##(1994-5#1)(2011-2#1)
through a 0##9##3##(1997-8#1)(2006-5#1)(2008-10#2)(2008-12#2)(2008-5#2)(2010-9#1)
through a 2##2##3##(2008-2#1)(2008-4#1)
through a 4##2##3##(2007-12#1)(2008-2#1)
through a DNA##3##3##(1990-5#1)(1994-12#1)(2012-2#1)
through a Fabry-Perot##2##3##(2008-2#2)
through a PTFE membrane into an acceptor stream##2##8##(2008-10#2)
through a bleaching medium##2##4##(2007-11#2)
through a brief##2##3##(2008-7#1)(2009-8#1)
through a carrier-mediated mechanism##2##4##(1994-8#1)(2006-10#1)
through a case study of the##2##6##(2008-7#1)(2011-2#1)
through a case study of##3##5##(2008-3#1)(2008-7#1)(2011-2#1)
through a case study##5##4##(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#1)
through a case##6##3##(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
through a case-control study##2##4##(2011-1#1)(2011-2#1)
through a catheter##3##3##(1993-10#1)(1995-7#1)(2008-10#1)
through a cell##4##3##(2007-12#2)(2008-10#1)(2012-12#1)
through a central##5##3##(1991-5#1)(2006-10#1)(2006-2#1)(2011-2#1)(2013-1#1)
through a change in##2##4##(2005-11#1)(2011-12#1)
through a collaborative##2##3##(1994-3#1)(2008-10#1)
through a combination of##14##4##(1994-3#1)(1996-11#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2011-12#1)(2013-8#1)
through a combined##5##3##(2007-8#1)(2009-3#1)(2010-12#1)(2010-6#1)(2012-2#1)
through a common##5##3##(1991-8#1)(1997-1#1)(2006-10#1)(2008-2#1)(2008-6#1)
through a comparison with##3##4##(2008-10#1)(2013-1#2)
through a complete##2##3##(2007-12#1)(2007-8#1)
through a complex##2##3##(2008-6#1)(2010-11#1)
through a comprehensive##2##3##(2011-1#1)(2011-2#1)
through a conserved##2##3##(1997-4#2)
through a continuous##2##3##(1993-3#1)(2008-10#1)
through a conventional##2##3##(2005-11#1)(2008-2#1)
through a convergent strategy##2##4##(2006-12#1)(2010-2#1)
through a critical##3##3##(2008-11#1)(2009-9#1)(2010-2#1)
through a cyclic##3##3##(1997-8#2)(2007-12#1)
through a decrease##2##3##(1997-5#1)(2011-2#1)
through a defect##4##3##(1991-9#1)(2009-6#1)(2011-2#2)
through a detailed##3##3##(2008-10#1)(2008-2#1)(2011-7#1)
through a dialysis##2##3##(1996-11#1)(1997-2#1)
through a different lens##2##4##(2005-9#2)
through a different##3##3##(2005-9#2)(2009-12#1)
through a direct effect on##2##5##(1995-6#1)(2008-8#1)
through a direct##6##3##(1990-12#1)(1995-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-2#1)
through a distorting medium##2##4##(2007-12#1)(2008-3#1)
through a dual biochemical and molecular-genetics approach##2##7##(1996-7#2)
through a few##2##3##(2007-12#1)(2008-2#1)
through a fiber with##2##4##(2008-3#2)
through a fiber##3##3##(2008-3#3)
through a film##2##3##(2007-11#1)(2008-11#1)
through a formal##2##3##(1994-12#2)
through a given##2##3##(2008-3#2)
through a glass##3##3##(2008-10#2)(2008-7#1)
through a highly scattering##2##4##(2007-12#1)(2008-2#1)
through a highly##5##3##(1991-5#1)(1993-11#1)(2007-12#1)(2008-11#1)(2008-2#1)
through a home-made##2##3##(2008-10#2)
through a large number of##2##5##(2006-10#1)(2012-12#1)
through a large##3##3##(2006-10#1)(2008-10#1)(2012-12#1)
through a layer##2##3##(2008-10#1)(2008-2#1)
through a left posterolateral thoracotomy##2##5##(2007-8#2)
through a left##3##3##(2007-8#2)(2011-2#1)
through a lesion of their spinal pathway##2##7##(1996-5#2)
through a linear polarizing filter##2##5##(2008-2#1)(2008-3#1)
through a linear##3##3##(2008-2#2)(2008-3#1)
through a liquid membrane##3##4##(2008-10#3)
through a liquid##4##3##(2007-12#1)(2008-10#3)
through a long##2##3##(2008-10#1)(2008-7#1)
through a longitudinal##2##3##(2009-5#1)(2013-1#1)
through a low##2##3##(2010-10#1)(2010-2#1)
through a mechanism involving##4##4##(1991-5#1)(1991-6#1)(1995-1#1)(2012-12#1)
through a mechanism other than##2##5##(2008-6#1)(2008-9#1)
through a mechanism that is##2##5##(1995-10#1)(2008-2#1)
through a mechanism that##3##4##(1994-2#1)(1995-10#1)(2008-2#1)
through a mechanism##15##3##(1991-2#1)(1991-5#1)(1991-6#1)(1994-2#1)(1995-1#1)(1995-10#1)(1996-5#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-1#1)(2012-12#1)
through a median sternotomy##2##4##(2007-8#1)(2013-1#1)
through a medium##7##3##(2007-11#1)(2007-12#5)(2008-3#1)
through a membrane##4##3##(1996-1#1)(2007-8#1)(2008-10#2)
through a microscope objective##2##4##(2007-12#2)
through a minimum##2##3##(1992-11#1)(2005-11#1)
through a model of##2##4##(2008-3#1)(2008-7#1)
through a modification of the##2##5##(2008-10#1)(2013-1#1)
through a modification##4##3##(2008-10#2)(2008-3#1)(2013-1#1)
through a multidisciplinary##2##3##(1996-11#1)(2008-10#1)
through a national##4##3##(1993-12#1)(1995-12#1)(2008-11#1)(2009-4#1)
through a network of##3##4##(2007-12#1)(2008-7#1)(2012-3#1)
through a noninvasive##2##3##(2007-3#1)(2012-2#1)
through a novel mechanism##2##4##(2012-3#1)(2013-8#1)
through a novel##10##3##(1993-5#1)(1997-2#1)(2008-10#1)(2008-4#1)(2009-11#1)(2012-3#1)(2013-1#3)(2013-8#1)
through a number of##3##4##(2008-2#2)(2010-5#1)
through a one-step procedure##2##4##(1995-2#1)(2008-10#1)
through a one-step##3##3##(1995-2#1)(2008-10#1)(2008-4#1)
through a p53-independent pathway##2##4##(1995-6#1)(1997-4#1)
through a percutaneous##3##3##(2008-5#2)(2012-2#1)
through a phase mask##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
through a positive##2##3##(2005-11#1)(2010-12#1)
through a post-transcriptional mechanism##2##4##(1992-1#2)
through a posterior##2##3##(2008-9#1)(2012-12#1)
through a posterolateral thoracotomy##2##4##(2007-12#1)(2010-12#1)
through a posterolateral##3##3##(2007-12#1)(2010-12#1)(2010-3#1)
through a previously implanted cannula##2##5##(1993-12#1)(1994-6#1)
through a probe##2##3##(1994-8#1)(2013-1#1)
through a process that##3##4##(1994-2#1)(2008-10#2)
through a process##5##3##(1994-2#1)(2008-10#2)(2011-2#1)(2012-2#1)
through a public##2##3##(2005-10#1)(2007-7#1)
through a questionnaire##4##3##(1990-10#1)(1991-4#1)(1996-1#1)(2008-9#1)
through a range of##4##4##(2007-12#2)(2008-11#1)(2008-12#1)
through a reaction coil to a##2##6##(2008-10#2)
through a reaction coil##3##4##(2008-10#3)
through a receptor##4##3##(1991-5#1)(1993-8#2)(1995-2#1)
through a reduction of##2##4##(2008-3#1)(2011-2#1)
through a regularized##2##3##(2007-12#1)(2008-2#1)
through a retrospective##5##3##(1990-8#1)(1995-12#1)(2007-2#1)(2010-7#1)(2011-2#1)
through a sample##2##3##(2007-11#1)(2008-10#1)
through a scattering medium##5##4##(2007-12#2)(2008-2#2)(2008-3#1)
through a scattering##6##3##(2007-12#2)(2008-2#3)(2008-3#1)
through a scavenging##2##3##(1992-2#1)(2010-8#1)
through a selective##2##3##(1994-12#1)(2008-7#1)
through a sequence of##2##4##(2008-5#1)(2012-12#1)
through a sequence##3##3##(1996-4#1)(2008-5#1)(2012-12#1)
through a series of##21##4##(1990-7#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-6#1)(1996-3#1)(1996-8#1)(1997-2#1)(2005-11#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-7#1)(2009-9#2)(2012-2#1)(2013-1#1)
through a set of##7##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)(2011-3#1)(2012-1#1)
through a short##3##3##(1990-2#1)(2007-8#1)(2008-3#1)
through a silicone##2##3##(1994-11#1)(2008-7#1)
through a similar##3##3##(1990-12#1)(1991-2#1)(2008-10#1)
through a simple example##2##4##(2007-12#1)(2013-8#1)
through a simple##9##3##(1996-6#1)(2006-12#1)(2007-12#2)(2007-8#1)(2008-3#1)(2010-4#1)(2011-2#1)(2013-8#1)
through a simulation study##2##4##(1993-6#1)(2012-2#1)
through a single##11##3##(1994-12#1)(1996-7#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-11#1)
through a single-mode fiber##2##4##(2007-11#1)(2008-3#1)
through a single-mode optical fiber##4##5##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
through a single-mode##6##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)
through a small incision##4##4##(1996-8#1)(2006-3#2)(2006-6#1)
through a small##11##3##(1990-2#1)(1991-12#1)(1996-8#1)(2006-3#3)(2006-6#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
through a specific##6##3##(1990-12#1)(1994-8#1)(1995-11#1)(1996-8#1)(1997-4#1)(2012-3#1)
through a standardized##2##3##(2008-7#1)(2011-2#1)
through a stratified##3##3##(1996-8#1)(2008-3#2)
through a suboccipital##2##3##(2004-12#2)
through a subwavelength aperture##2##4##(2007-12#1)(2008-7#1)
through a successful##2##3##(2007-4#1)(2008-11#1)
through a sucrose gradient##2##4##(1991-1#1)(1994-9#1)
through a supported liquid membrane##2##5##(2008-10#1)(2012-1#1)
through a survey of 46 domain experts##2##7##(2013-1#2)
through a survey##4##3##(2011-2#1)(2012-3#1)(2013-1#2)
through a systematic##2##3##(2009-4#1)(2013-8#1)
through a tank##2##3##(2008-2#1)(2008-6#1)
through a thick##3##3##(2007-12#3)
through a turbid medium##2##4##(2007-11#1)(2008-2#1)
through a turbid##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
through a variety of mechanisms##3##5##(2007-5#1)(2008-3#1)(2011-2#1)
through a variety of##12##4##(1994-12#1)(1994-5#1)(2007-5#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
through a vesicle protein in a manner independent of Rab3A##2##10##(1994-12#2)
through a video assisted mini-thoracotomy in##2##6##(2013-1#2)
through a volar approach##2##4##(2008-9#2)
through a weak##2##3##(1995-12#1)(1997-8#1)
through a web##3##3##(2008-10#1)(2008-7#2)
through a working##2##3##(2008-10#2)
through a##956##2##(1990-10#1)(1990-11#3)(1990-12#5)(1990-2#5)(1990-3#3)(1990-5#3)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#5)(1991-6#2)(1991-7#2)(1991-8#3)(1991-9#2)(1992-1#4)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#2)(1993-10#2)(1993-11#3)(1993-12#3)(1993-3#4)(1993-4#1)(1993-5#3)(1993-6#1)(1993-8#2)(1993-9#3)(1994-11#3)(1994-12#15)(1994-2#3)(1994-3#3)(1994-5#2)(1994-6#2)(1994-7#2)(1994-8#6)(1994-9#3)(1995-1#3)(1995-10#2)(1995-11#3)(1995-12#4)(1995-2#7)(1995-3#1)(1995-5#1)(1995-6#6)(1995-7#2)(1995-8#3)(1995-9#2)(1996-1#4)(1996-11#4)(1996-12#1)(1996-2#3)(1996-3#6)(1996-4#1)(1996-5#5)(1996-6#6)(1996-7#5)(1996-8#7)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#5)(1997-5#2)(1997-6#5)(1997-7#3)(1997-8#7)(2004-12#2)(2005-10#3)(2005-11#14)(2005-5#1)(2005-7#1)(2005-9#5)(2006-10#7)(2006-12#8)(2006-2#3)(2006-3#3)(2006-5#3)(2006-6#3)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#28)(2007-12#65)(2007-2#2)(2007-3#3)(2007-4#2)(2007-5#3)(2007-7#5)(2007-8#20)(2007-9#1)(2008-1#9)(2008-10#94)(2008-11#20)(2008-12#12)(2008-2#53)(2008-3#44)(2008-4#13)(2008-5#15)(2008-6#10)(2008-7#31)(2008-8#7)(2008-9#16)(2009-1#1)(2009-10#2)(2009-11#4)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#6)(2009-6#2)(2009-7#3)(2009-8#6)(2009-9#3)(2010-10#2)(2010-11#3)(2010-12#10)(2010-2#7)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#4)(2010-7#3)(2010-8#5)(2010-9#2)(2011-1#13)(2011-12#2)(2011-2#29)(2011-3#2)(2011-7#1)(2011-9#1)(2012-1#7)(2012-11#2)(2012-12#15)(2012-2#16)(2012-3#9)(2013-1#23)(2013-7#4)(2013-8#7)
through activation of the##10##4##(1993-4#1)(1995-3#1)(1996-12#2)(1997-4#1)(2003-11#1)(2008-1#1)(2009-3#1)(2013-1#1)(2013-8#1)
through activation of##25##3##(1993-4#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-12#2)(1997-4#1)(2003-11#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#2)(2009-3#1)(2010-12#3)(2011-2#1)(2013-1#2)(2013-8#1)
through activities##2##2##(2009-5#1)(2013-1#1)
through adaptations##2##2##(2005-10#1)(2010-4#1)
through additional##2##2##(1991-4#1)(2008-10#1)
through adenosine##3##2##(2006-1#1)(2008-10#1)(2009-6#1)
through adjacent##2##2##(1996-5#2)
through adolescence##4##2##(1995-3#1)(1997-7#1)(2008-11#1)(2011-12#1)
through adult##3##2##(1990-7#1)(1996-4#1)(2009-2#1)
through adulthood##2##2##(1996-4#1)(2011-2#1)
through advances in##3##3##(2006-10#1)(2010-11#1)(2010-5#1)
through affecting##2##2##(2008-8#1)(2009-11#1)
through affinity chromatography##2##3##(1994-8#1)(2008-9#1)
through age##2##2##(2009-9#1)(2010-4#1)
through air##2##2##(2007-12#1)(2008-10#1)
through all##3##2##(1990-5#1)(2006-4#1)(2010-2#1)
through alterations in##2##3##(2008-3#2)
through altered##2##2##(1995-2#1)(2013-7#1)
through alternative splicing of a##2##5##(1993-11#1)(1993-5#1)
through alternative splicing##4##3##(1992-1#1)(1993-11#1)(1993-5#1)(1994-5#1)
through alternative##7##2##(1992-1#1)(1993-11#1)(1993-5#1)(1994-5#1)(1996-10#1)(1996-8#1)(2008-12#1)
through amino##2##2##(1993-12#1)(2010-5#1)
through an adapted##2##3##(2007-11#1)(2013-1#1)
through an analysis of##4##4##(2007-12#1)(2008-12#1)(2009-4#1)(2009-5#1)
through an anterior##3##3##(2008-4#1)(2009-3#1)(2013-7#1)
through an appreciation of##2##4##(2008-4#1)(2008-9#1)
through an autocrine##2##3##(1995-6#1)(2009-11#1)
through an effect on the##2##5##(1994-11#1)(2006-9#1)
through an effect on##4##4##(1994-11#1)(1994-5#1)(1996-11#1)(2006-9#1)
through an effective##3##3##(1995-2#1)(2007-12#1)(2008-10#1)
through an electrochemical##2##3##(2008-10#2)
through an endoscope##2##3##(1997-5#1)(2008-3#1)
through an example##2##3##(2008-4#1)(2010-6#1)
through an excised##2##3##(1991-5#1)(2008-10#1)
through an experimental##2##3##(2008-3#2)
through an immunoallergic##2##3##(1992-2#1)(1997-2#1)
through an incision##4##3##(2012-12#4)
through an increase in##6##4##(1990-11#1)(1995-11#1)(1997-1#1)(2006-8#1)(2008-4#1)(2010-12#1)
through an increase##7##3##(1990-11#1)(1995-11#1)(1997-1#1)(2006-8#1)(2008-4#1)(2008-5#1)(2010-12#1)
through an increased##2##3##(1991-9#1)(1994-5#1)
through an independent##2##3##(1993-3#1)(2008-10#1)
through an infinite##2##3##(2007-11#1)(2008-2#1)
through an inhibition of##2##4##(1990-7#1)(1996-4#1)
through an innovative##2##3##(2012-3#1)(2013-7#1)
through an interaction with##4##4##(1991-9#1)(1992-6#1)(1995-11#1)(2006-9#1)
through an interaction##6##3##(1991-9#1)(1992-6#1)(1995-11#1)(1995-2#1)(1997-8#1)(2006-9#1)
through an interdisciplinary##2##3##(2008-1#1)(2009-4#1)
through an interface##3##3##(2007-12#2)(2008-3#1)
through an intermediate##2##3##(1994-3#1)(1994-8#1)
through an internal##3##3##(1990-5#1)(2007-7#1)(2008-6#1)
through an inverse-modeling##2##3##(2008-2#1)(2008-3#1)
through an optical fiber##3##4##(2007-12#1)(2008-3#2)
through an optical##9##3##(2007-12#4)(2008-2#2)(2008-3#2)(2008-5#1)
through an understanding of the##2##5##(2007-8#1)(2008-1#1)
through an unknown##2##3##(2010-12#1)(2012-12#1)
through an##215##2##(1990-11#3)(1990-5#1)(1990-7#1)(1990-8#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-2#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-4#3)(1997-1#1)(1997-2#1)(1997-5#2)(1997-8#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#2)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#18)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#6)(2007-9#2)(2008-1#4)(2008-10#25)(2008-11#3)(2008-12#2)(2008-2#10)(2008-3#13)(2008-4#8)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#3)(2009-11#2)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#2)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#9)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#2)
through analysis of##8##3##(1994-12#1)(2008-3#1)(2008-5#1)(2009-10#1)(2011-1#1)(2012-3#2)(2013-1#1)
through animal studies##2##3##(2011-2#1)(2012-2#1)
through animal##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
through anion##2##2##(2008-10#1)(2008-4#1)
through another##3##2##(1996-8#1)(1997-5#1)(2007-12#1)
through antenatal##2##2##(2007-11#1)(2011-1#1)
through anthesis##2##2##(2008-10#2)
through antisense##2##2##(2006-12#1)(2011-1#1)
through aphid##2##2##(2004-2#1)(2008-10#1)
through apoptosis##4##2##(1993-9#1)(1997-3#1)(2003-11#1)(2005-8#1)
through application of##5##3##(2006-12#1)(2007-8#1)(2008-10#1)(2012-11#2)
through application##6##2##(2006-12#1)(2007-8#1)(2008-10#1)(2012-11#2)(2012-3#1)
through appropriate##7##2##(1995-3#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2011-2#1)
through areas of##2##3##(2008-9#1)(2009-10#1)
through artificial selection##2##3##(2011-12#2)
through artificial##5##2##(1994-3#1)(2008-10#1)(2011-12#2)(2011-2#1)
through assessment of##2##3##(2008-4#1)(2012-12#1)
through association with##2##3##(1994-9#1)(2008-11#1)
through at least two##2##4##(1994-9#1)(2008-11#1)
through at least##3##3##(1993-2#1)(1994-9#1)(2008-11#1)
through atmospheric turbulence##4##3##(2008-2#1)(2008-3#3)
through atmospheric##5##2##(2008-2#2)(2008-3#3)
through axons##2##2##(1990-5#1)(2008-1#1)
through basic##2##2##(2006-7#1)(2011-1#1)
through behavioral##2##2##(2008-3#1)(2013-8#1)
through behavioural testing##2##3##(2008-9#2)
through better##5##2##(1995-3#1)(2006-10#1)(2008-1#1)(2009-11#1)(2013-8#1)
through bilateral##2##2##(1990-5#1)(2013-1#1)
through binding of##2##3##(1995-3#1)(2008-11#1)
through binding to the##4##4##(1995-2#2)(1996-5#1)(2008-9#1)
through binding to##7##3##(1994-5#1)(1994-6#1)(1995-2#2)(1996-5#1)(2008-11#1)(2008-9#1)
through binding##14##2##(1990-11#1)(1994-5#1)(1994-6#1)(1995-2#2)(1995-3#1)(1996-5#2)(1997-4#1)(2006-10#1)(2008-11#2)(2008-9#2)
through biochemical##2##2##(2006-10#1)(2008-2#1)
through biological##4##2##(1996-5#1)(2007-12#1)(2007-3#1)(2008-3#1)
through biomolecular##2##2##(2008-7#2)
through biotechnological##2##2##(2008-5#2)
through blockade of##2##3##(1997-1#1)(2008-7#1)
through blood transfusion##3##3##(2007-7#1)(2012-2#2)
through blood##5##2##(2007-7#1)(2012-2#4)
through both the##5##3##(1996-12#1)(1997-8#1)(2006-8#1)(2008-10#1)(2009-7#1)
through both##31##2##(1990-12#1)(1990-2#1)(1991-11#1)(1991-3#1)(1994-10#1)(1995-10#1)(1995-11#1)(1995-6#1)(1996-12#1)(1997-8#1)(2004-9#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-9#1)(2009-11#2)(2009-4#1)(2009-6#1)(2009-7#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-2#1)
through brain##3##2##(1993-7#2)(1995-11#1)
through breast milk##4##3##(2011-1#1)(2012-2#2)(2013-1#1)
through bulk potting mix##2##4##(2008-10#2)
through bulk##5##2##(2007-12#1)(2008-10#3)(2008-3#1)
through by##2##2##(1991-1#1)(2012-1#1)
through caecal microflora of rats##2##5##(1993-8#2)
through calcium##2##2##(1992-7#1)(2008-5#1)
through calculation##2##2##(1992-4#1)(2008-5#1)
through careful##3##2##(1991-3#1)(1993-12#1)(1993-8#1)
through case##4##2##(2005-10#1)(2008-10#1)(2010-4#1)(2012-12#1)
through cell division##2##3##(1994-5#1)(2009-2#1)
through cell##16##2##(1994-5#1)(2006-7#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#1)(2009-2#1)(2010-12#1)(2011-1#1)(2011-3#1)(2012-12#1)
through cellular##2##2##(1995-8#1)(2012-12#1)
through central##3##2##(1991-2#1)(2007-7#1)(2008-11#1)
through changes in the##3##4##(2008-1#1)(2008-10#1)(2008-3#1)
through changes in##10##3##(1994-10#1)(1995-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2010-8#1)(2011-2#1)
through changes##11##2##(1994-10#1)(1995-3#1)(2004-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2010-8#1)(2011-2#1)
through changing##3##2##(2006-12#1)(2006-8#1)(2010-5#1)
through channels##2##2##(1997-1#1)(2005-11#1)
through charge##2##2##(1994-5#1)(2008-10#1)
through chemical modification##2##3##(2008-4#1)(2009-2#1)
through chemical##6##2##(1991-11#1)(1991-2#1)(2008-10#2)(2008-4#1)(2009-2#1)
through childhood and adolescence##2##4##(2009-4#1)(2012-1#1)
through chimneys##3##2##(2008-9#3)
through choice of##2##3##(2008-12#1)(2008-3#1)
through chromosome##2##2##(1997-7#1)(2008-8#1)
through chronic##2##2##(1993-2#1)(2008-10#1)
through cirrus clouds##3##3##(2008-3#3)
through classical##2##2##(2008-2#1)(2008-3#1)
through clinical trials##2##3##(2005-7#1)(2008-10#1)
through clinical##7##2##(1994-3#1)(2005-7#1)(2006-11#1)(2008-10#1)(2008-12#1)(2013-1#2)
through close##3##2##(1994-6#1)(2008-4#1)(2009-4#1)
through clouds##2##2##(2008-2#1)(2008-3#1)
through cluster##2##2##(2006-7#1)(2008-10#1)
through coherent##2##2##(2008-2#1)(2008-3#1)
through collaboration##3##2##(2007-5#1)(2008-5#1)(2010-2#1)
through combinations##2##2##(2006-11#1)(2007-4#1)
through combinatorial##2##2##(1997-4#1)(2008-4#1)
through common##3##2##(2008-1#1)(2008-5#1)(2012-3#1)
through community##5##2##(1996-3#1)(2008-11#1)(2008-2#1)(2010-2#1)(2012-3#1)
through community-based##4##2##(1995-1#1)(2007-8#1)(2008-10#1)(2008-7#1)
through comparison of##2##3##(2008-10#1)(2008-5#1)
through comparison with##6##3##(1994-12#1)(1996-12#1)(2008-10#1)(2008-2#1)(2009-5#1)(2011-2#1)
through comparison##8##2##(1994-12#1)(1996-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-5#1)(2011-2#1)
through comparisons with##2##3##(2008-3#1)(2013-7#1)
through comparisons##4##2##(2008-3#1)(2011-3#1)(2013-1#1)(2013-7#1)
through competition for##2##3##(1996-5#1)(2009-4#1)
through competition##3##2##(1993-2#1)(1996-5#1)(2009-4#1)
through competitive exclusion##2##3##(2008-10#2)
through competitive##6##2##(1991-1#1)(1993-3#1)(2008-10#2)(2008-7#1)(2008-8#1)
through completely##2##2##(2008-8#1)(2010-2#1)
through complex terrain##2##3##(2007-12#2)
through complex##8##2##(1990-3#1)(1994-6#1)(1995-6#1)(2007-12#2)(2008-10#1)(2010-6#1)(2011-2#1)
through complexation##2##2##(1993-6#1)(2007-8#1)
through composite##2##2##(2010-2#2)
through compound parabolic##2##3##(2007-12#1)(2013-8#1)
through comprehensive##2##2##(2010-12#1)(2013-7#1)
through compression isotherms##2##3##(1991-3#1)(2008-10#1)
through compression##3##2##(1991-3#1)(2008-10#1)(2008-6#1)
through computational methods##2##3##(2008-7#1)(2010-7#1)
through computer simulation##2##3##(2008-2#2)
through computer simulations##2##3##(2008-3#1)(2008-7#1)
through computer##5##2##(2006-12#1)(2008-2#2)(2008-3#1)(2008-7#1)
through computerized##2##2##(1997-2#1)(2012-2#1)
through concentration##2##2##(1997-8#1)(2008-9#1)
through concerted##2##2##(2006-10#1)(2008-7#1)
through consensus##2##2##(1995-12#1)(2013-1#1)
through contact with##2##3##(2008-5#1)(2013-7#1)
through contaminated##3##2##(2007-7#1)(2008-10#1)(2012-2#1)
through continuous##6##2##(1992-8#1)(1993-1#1)(2007-10#1)(2008-2#1)(2010-8#1)(2012-7#1)
through control of##4##3##(1990-9#1)(1996-1#1)(1997-1#1)(2013-8#1)
through convenience##2##2##(2011-2#1)(2013-8#1)
through conventional##6##2##(2006-11#1)(2006-12#1)(2007-12#1)(2008-4#1)(2012-2#1)(2012-3#1)
through cooperation between the##2##4##(1994-4#1)(1995-6#1)
through correlation of##2##3##(2008-11#2)
through correspondence##2##2##(2006-11#1)(2010-5#1)
through creation of##3##3##(2007-12#1)(2007-7#1)(2013-1#1)
through creative##2##2##(1994-6#1)(2008-2#1)
through critical##3##2##(2007-11#1)(2008-11#1)(2010-10#1)
through crop##2##2##(2008-10#1)(2008-7#1)
through cross-phase modulation##2##3##(2007-11#2)
through cultural##3##2##(1991-11#1)(2008-4#1)(2011-2#1)
through cyclic voltammetry##2##3##(2008-10#2)
through cyclic##3##2##(2008-10#2)(2011-1#1)
through data##5##2##(1994-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
through day##3##2##(1991-2#1)(1995-5#1)(1996-12#1)
through deconvolution##2##2##(1997-3#1)(2008-3#1)
through decreased##2##2##(1991-11#1)(2008-5#1)
through decyl)##2##2##(1994-9#2)
through defects##3##2##(2006-12#2)(2012-1#1)
through deletion##2##2##(1997-4#1)(2008-4#1)
through delivery##2##2##(2007-12#1)(2009-9#1)
through dental##2##2##(2010-2#1)(2011-1#1)
through detailed##3##2##(2006-11#1)(2006-12#1)(2007-12#1)
through detection of##2##3##(1990-5#1)(2009-4#1)
through development of##2##3##(2008-8#1)(2009-4#1)
through development##4##2##(1995-3#1)(2008-11#1)(2008-8#1)(2009-4#1)
through dialysis##3##2##(1995-3#1)(2006-1#1)(2007-7#1)
through differences in##3##3##(1994-3#1)(1995-5#1)(1996-5#1)
through different mechanisms##8##3##(1995-2#1)(1995-8#1)(2007-12#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-2#2)
through different receptors##2##3##(1991-5#1)(1994-10#1)
through different##30##2##(1991-11#1)(1991-5#1)(1993-9#1)(1994-10#1)(1995-10#1)(1995-2#1)(1995-8#1)(1997-2#1)(1997-7#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)
through differential##4##2##(1993-4#1)(1994-8#1)(2008-2#1)(2008-4#1)
through direct interactions with##3##4##(1997-4#2)(2008-8#1)
through direct interviews##2##3##(2012-12#1)(2013-1#1)
through direct##27##2##(1990-2#1)(1994-10#1)(1995-6#1)(1996-1#1)(1997-2#1)(1997-4#2)(2006-10#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-9#1)(2011-2#2)(2012-12#1)(2013-1#1)
through directly##2##2##(1996-3#1)(2008-10#1)
through discrete##2##2##(2006-10#1)(2010-10#1)
through disease##2##2##(2008-10#1)(2012-2#1)
through dispersion##2##2##(1991-8#1)(2008-3#1)
through disruption of##2##3##(2008-10#1)(2009-8#1)
through dissolution##2##2##(2007-1#1)(2011-1#1)
through distinct##2##2##(1991-1#1)(1995-3#1)
through disulfide and##2##3##(1994-8#1)(2005-11#1)
through disulfide##3##2##(1994-8#1)(1997-6#1)(2005-11#1)
through document##2##2##(2008-11#1)(2009-4#1)
through down-regulation of##6##3##(1993-6#1)(2007-10#1)(2011-2#1)(2012-12#2)(2013-1#1)
through downregulation of the##2##4##(2010-2#1)(2013-1#1)
through downregulation of##3##3##(1997-1#1)(2010-2#1)(2013-1#1)
through drinking water##11##3##(1994-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
through drip irrigation systems##4##4##(2008-10#4)
through drug##2##2##(1993-4#1)(2008-5#1)
through dual##3##2##(2007-8#2)(2009-8#1)
through each##9##2##(1992-5#1)(1996-4#1)(2008-1#1)(2008-3#1)(2009-7#1)(2011-1#1)(2011-2#2)(2013-7#1)
through early April##2##3##(1992-6#2)
through early##11##2##(1992-6#2)(1994-9#1)(2006-3#1)(2007-7#1)(2009-6#1)(2010-10#1)(2010-11#1)(2012-12#2)(2013-1#1)
through education and##3##3##(2008-3#1)(2008-8#1)(2013-8#1)
through education##8##2##(1991-1#1)(1995-3#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-8#1)(2011-2#1)(2013-8#1)
through educational##5##2##(1996-3#1)(2008-11#2)(2008-2#1)(2013-1#1)
through effective##6##2##(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-10#1)(2012-12#1)
through efficient##3##2##(2007-3#1)(2008-11#1)(2012-1#1)
through eight##2##2##(2006-10#1)(2008-10#1)
through either##7##2##(1993-8#1)(2008-2#3)(2008-4#1)(2008-8#1)(2010-8#1)
through electro-optic##2##2##(2007-11#1)(2007-12#1)
through electroabsorption spectroscopy##2##3##(2007-12#2)
through electronic and##3##3##(1991-2#1)(2007-11#1)(2011-2#1)
through electronic##4##2##(1991-2#1)(2007-11#1)(2008-2#1)(2011-2#1)
through electrophoretic##2##2##(1996-12#1)(2005-11#1)
through electrostatic##5##2##(1992-2#1)(2005-11#1)(2008-3#1)(2008-5#1)(2010-9#1)
through elevated##2##2##(1997-6#1)(2013-1#1)
through elevation of the##2##4##(1992-3#1)(1997-3#1)
through endocrine##3##2##(2005-9#1)(2006-11#1)(2010-3#1)
through endogenous channels##2##3##(1994-9#2)
through endogenous##3##2##(1994-3#1)(1994-9#2)
through endoscopic##2##2##(2006-6#1)(2013-8#1)
through endothelial cell monolayers##2##4##(2008-10#2)
through endothelial##3##2##(2008-10#3)
through energy##2##2##(2004-9#1)(2007-2#1)
through enhanced##3##2##(1997-6#1)(2008-10#1)(2010-11#1)
through enhancement of##2##3##(2008-11#1)(2010-10#1)
through environmental##3##2##(2005-8#1)(2008-8#1)(2011-12#1)
through enzyme##2##2##(1991-12#1)(2008-5#1)
through establishing##2##2##(2007-8#1)(2008-1#1)
through ether-type polyurethane membrane##2##4##(2008-10#2)
through evaluation##3##2##(2005-12#1)(2007-2#1)(2008-10#1)
through evaporation##2##2##(1992-3#1)(2006-11#1)
through every##2##2##(2008-11#1)(2010-8#1)
through evolution##5##2##(1994-3#1)(2008-10#1)(2009-5#1)(2010-2#1)(2011-2#1)
through examining##3##2##(2008-11#1)(2008-12#1)(2011-1#1)
through excised##2##2##(2004-12#1)(2009-4#1)
through experimental##3##2##(2008-3#1)(2008-5#1)(2012-2#1)
through experiments##3##2##(1996-7#1)(2008-2#1)(2012-2#1)
through expert##4##2##(2008-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
through exposure to##2##3##(2008-12#1)(2008-5#1)
through expression of##5##3##(1991-3#1)(1996-7#1)(2007-5#1)(2013-1#2)
through extensive##5##2##(2005-7#1)(2008-10#1)(2008-2#1)(2011-1#1)(2011-2#1)
through extracellular##2##2##(2012-12#2)
through face-to-face##2##2##(2009-9#1)(2010-10#1)
through facilitating##2##2##(1995-7#1)(2013-1#1)
through family##3##2##(2005-11#1)(2010-7#1)(2013-8#1)
through fiber##2##2##(2007-11#1)(2007-2#1)
through field##2##2##(2008-10#1)(2008-11#1)
through fifth##2##2##(2009-9#1)(2012-2#1)
through filters##2##2##(1990-3#1)(2008-11#1)
through fine needle aspiration##2##4##(1993-10#1)(2013-8#1)
through five##2##2##(1992-6#1)(2008-10#1)
through flexible##3##2##(2007-12#1)(2010-12#1)(2012-3#1)
through flow##2##2##(2006-6#1)(2008-10#1)
through focus groups##2##3##(1994-12#1)(2007-10#1)
through focus##6##2##(1992-12#1)(1994-12#1)(2006-11#1)(2007-10#1)(2007-11#1)(2012-1#1)
through food##2##2##(1995-8#1)(2008-9#1)
through formation of##2##3##(2008-10#1)(2008-5#1)
through four##11##2##(1994-3#1)(1996-3#1)(2006-11#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-11#1)(2012-1#1)(2012-3#1)
through fracture##3##2##(2008-10#1)(2008-6#1)(2009-3#1)
through full sib-pair mating##2##4##(2012-3#2)
through functional##2##2##(2008-5#1)(2008-9#1)
through fused silica##2##3##(2007-11#1)(2008-3#1)
through fused##3##2##(2007-11#1)(2008-3#1)(2010-10#1)
through gene duplication##3##3##(1996-8#1)(2006-4#1)(2009-5#1)
through gene##7##2##(1991-11#1)(1996-8#1)(2006-12#1)(2006-4#1)(2007-7#1)(2008-4#1)(2009-5#1)
through general##2##2##(2006-8#1)(2007-12#1)
through generations##2##2##(2008-5#1)(2010-12#1)
through genetic manipulation of##2##4##(1994-11#1)(2010-2#1)
through genetic##11##2##(1994-11#1)(1997-8#1)(2006-10#1)(2008-10#5)(2008-2#1)(2010-2#1)(2011-2#1)
through genomic in situ hybridization##2##5##(2008-5#1)(2013-8#1)
through genomic##3##2##(2008-11#1)(2008-5#1)(2013-8#1)
through global##2##2##(1996-12#1)(2012-3#1)
through greater##2##2##(2008-6#1)(2009-6#1)
through group##3##2##(2007-7#1)(2009-3#1)(2012-12#1)
through growth##3##2##(2005-11#1)(2006-12#1)(2013-8#1)
through health care##2##3##(1991-3#1)(1995-2#1)
through health##5##2##(1991-3#1)(1994-1#1)(1995-2#2)(2012-1#1)
through high##2##2##(1993-12#1)(1994-11#1)
through highly scattering media##3##4##(2007-12#1)(2008-3#2)
through highly scattering##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
through highly##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
through his##4##2##(1996-11#1)(2008-10#1)(2008-4#1)(2008-7#1)
through history and##2##3##(2006-12#1)(2011-2#1)
through history##4##2##(2006-10#1)(2006-12#2)(2011-2#1)
through homogeneous##2##2##(2008-3#1)(2010-12#1)
through homologous recombination##3##3##(1997-2#1)(2008-8#1)(2012-2#1)
through homologous##4##2##(1997-2#1)(2008-8#1)(2011-2#1)(2012-2#1)
through human tissue##2##3##(2007-11#1)(2008-3#1)
through human##12##2##(1993-10#1)(2004-12#2)(2007-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-2#1)(2010-5#1)(2012-12#2)(2012-2#1)
through hydrogen bonding##4##3##(1991-4#1)(1994-9#1)(2008-10#1)(2013-7#1)
through hydrogen##6##2##(1991-4#1)(1994-9#1)(1995-10#1)(2005-11#1)(2008-10#1)(2013-7#1)
through hydrolysis##2##2##(1997-2#1)(2008-5#1)
through identification of the##2##4##(2008-3#1)(2009-8#1)
through imaging##2##2##(2008-3#1)(2009-10#1)
through immunization##3##2##(1994-3#1)(2006-10#2)
through improved##5##2##(1993-12#1)(1995-2#1)(2004-12#1)(2006-5#1)(2007-12#1)
through in situ##4##3##(2004-4#1)(2007-12#1)(2010-8#1)(2012-1#1)
through in the##2##3##(2008-3#1)(2009-10#1)
through in vitro##5##3##(1994-9#1)(2006-8#1)(2008-4#1)(2009-12#1)(2009-9#1)
through in vivo##2##3##(2009-7#1)(2012-12#1)
through in##14##2##(1994-9#1)(2004-4#1)(2006-8#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-8#1)(2012-1#1)(2012-12#1)
through in-person##2##2##(1994-2#1)(2009-7#1)
through inactivation of the##2##4##(1994-12#1)(2009-9#1)
through inadequate##2##2##(1991-6#1)(2007-2#1)
through incorporation into##2##3##(1996-5#1)(2008-10#1)
through incorporation of##2##3##(1992-2#1)(2008-11#1)
through incorporation##4##2##(1992-2#1)(1996-5#1)(2008-10#1)(2008-11#1)
through increased##13##2##(1990-10#1)(1992-4#1)(1993-12#1)(1996-10#1)(1996-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2011-1#1)(2012-3#1)
through increasing the##4##3##(1991-5#1)(1994-12#1)(2008-11#1)(2010-2#1)
through increasing##6##2##(1991-5#1)(1994-12#1)(2008-11#1)(2008-8#1)(2009-4#1)(2010-2#1)
through indirect##4##2##(1994-10#1)(2008-8#1)(2010-2#2)
through individual##2##2##(1994-3#1)(2008-10#1)
through induced##2##2##(1991-3#1)(2008-10#1)
through inducing##2##2##(1994-12#1)(2012-3#1)
through induction of##5##3##(1993-8#1)(1994-11#1)(1995-1#1)(2008-10#1)(2009-4#1)
through induction##6##2##(1993-8#1)(1994-11#1)(1995-1#1)(1997-1#1)(2008-10#1)(2009-4#1)
through inflammatory##2##2##(2008-1#1)(2008-3#1)
through information##3##2##(1992-5#1)(1993-2#1)(2007-12#1)
through informed consent##2##3##(1992-3#1)(2008-9#1)
through inhalation##2##2##(1996-8#1)(2007-7#1)
through inhibition of##15##3##(1990-3#1)(1994-11#1)(1994-5#1)(1995-5#1)(1997-4#1)(2005-3#1)(2005-9#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-10#1)(2011-1#1)(2013-1#2)(2013-8#1)
through inhibition##18##2##(1990-3#1)(1992-6#1)(1994-11#1)(1994-5#1)(1995-5#1)(1997-4#1)(2005-3#1)(2005-9#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-10#1)(2011-1#1)(2011-12#1)(2013-1#2)(2013-8#1)
through institutional##2##2##(2010-8#1)(2011-2#1)
through intact egg in early##2##5##(2013-1#2)
through intact skin##2##3##(2008-1#1)(2008-5#1)
through intact##6##2##(2008-1#1)(2008-5#2)(2008-9#1)(2013-1#2)
through integrated##4##2##(1996-3#1)(2008-10#2)(2008-9#1)
through integrating##2##2##(2011-2#1)(2012-2#1)
through integrins##3##2##(1991-5#2)(2010-11#1)
through intense##2##2##(2008-10#1)(2008-8#1)
through intensive##2##2##(1994-12#1)(2005-7#1)
through interaction with the##7##4##(1991-9#1)(1994-12#1)(1996-2#1)(2006-12#1)(2007-11#1)(2008-8#1)(2012-12#1)
through interaction with##14##3##(1991-3#1)(1991-9#1)(1993-6#1)(1994-11#1)(1994-12#1)(1996-2#1)(1997-2#1)(2005-12#1)(2006-12#1)(2007-11#1)(2008-4#1)(2008-8#1)(2009-2#1)(2012-12#1)
through interactions with the##3##4##(1995-6#1)(1997-6#1)(2010-12#1)
through interactions with##6##3##(1995-6#1)(1997-6#1)(2006-10#1)(2008-5#1)(2010-12#1)(2011-1#1)
through interactions##7##2##(1991-2#1)(1995-6#1)(1997-6#1)(2006-10#1)(2008-5#1)(2010-12#1)(2011-1#1)
through international##3##2##(2008-10#1)(2008-11#1)(2009-9#1)
through interviews and##2##3##(2006-10#1)(2007-7#1)
through interviews with##3##3##(2008-11#1)(2008-9#1)(2011-2#1)
through interviews##11##2##(2006-10#1)(2006-12#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-9#2)(2011-1#2)(2011-2#2)
through into##2##2##(2008-7#1)(2011-2#1)
through intracellular##2##2##(1993-3#1)(1997-2#1)
through intramolecular##2##2##(1992-6#1)(1996-5#1)
through inversion##2##2##(1997-7#1)(2006-7#1)
through ion##2##2##(2008-4#1)(2010-6#1)
through it##9##2##(1992-11#1)(1996-5#1)(2006-10#1)(2006-12#1)(2006-9#1)(2008-10#1)(2008-4#1)(2011-2#1)(2013-8#1)
through its ability to##5##4##(1991-8#1)(2008-3#1)(2008-5#1)(2010-7#1)(2012-12#1)
through its action##2##3##(1996-1#1)(2006-10#1)
through its binding to##3##4##(1991-9#1)(1997-6#1)(2010-2#1)
through its effects on##3##4##(1994-6#1)(2008-12#1)(2012-3#1)
through its influence on##2##4##(1994-12#1)(2008-11#1)
through its interaction with##2##4##(1997-4#1)(2011-1#1)
through its##80##2##(1990-12#1)(1991-5#3)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#2)(1996-1#1)(1996-5#1)(1996-8#2)(1997-4#3)(1997-6#1)(1997-7#3)(2006-10#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#1)(2009-2#1)(2009-9#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)
through joint efforts of##2##4##(1992-4#1)(2007-7#1)
through joint##5##2##(1992-4#1)(1996-5#1)(2007-7#1)(2013-1#2)
through large##3##2##(2007-11#2)(2011-2#1)
through large-core microstructured fibers##2##4##(2007-11#2)
through large-core optical fibers##2##4##(2008-3#2)
through large-core##4##2##(2007-11#2)(2008-3#2)
through larger##2##2##(2005-11#1)(2007-9#1)
through late##3##2##(1997-7#1)(2009-7#1)(2010-4#1)
through learning##2##2##(1993-6#1)(2012-3#1)
through left##2##2##(2007-9#1)(2008-1#1)
through legislative##2##2##(1994-1#1)(2006-2#1)
through life##2##2##(2006-2#1)(2011-2#1)
through limited##3##2##(2007-8#3)
through linear##2##2##(2007-11#1)(2011-1#1)
through linkage##2##2##(2008-10#1)(2008-7#1)
through lipid##3##2##(1992-6#1)(1993-11#1)(1994-6#1)
through literature review##2##3##(1990-8#1)(1997-8#1)
through local##2##2##(1997-3#1)(2008-5#1)
through logistic regression##2##3##(1993-9#1)(2011-2#1)
through logistic##3##2##(1993-9#1)(2011-2#1)(2013-8#1)
through long##2##2##(2008-2#1)(2012-3#1)
through long-term##2##2##(2008-5#1)(2012-2#1)
through loss of##2##3##(1996-5#1)(2012-3#1)
through loss##3##2##(1996-5#1)(2011-2#1)(2012-3#1)
through low##3##2##(1990-11#1)(1992-7#1)(1994-12#1)
through lower##3##2##(1991-12#1)(1997-1#1)(2012-1#1)
through male##3##2##(1997-7#1)(2008-8#2)
through managed##2##2##(1995-1#1)(1997-3#1)
through manual##3##2##(2004-12#1)(2008-8#1)(2012-1#1)
through many##7##2##(2008-10#2)(2008-12#1)(2008-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
through mapping##2##2##(2006-12#1)(2008-8#1)
through market##2##2##(1994-2#1)(1995-1#1)
through materials##3##2##(2007-12#1)(2008-3#1)(2010-7#1)
through maternal##2##2##(2007-2#1)(2008-7#1)
through measurement of the##2##4##(2008-3#1)(2012-12#1)
through measurement of##5##3##(2008-10#1)(2008-3#2)(2009-5#1)(2012-12#1)
through measurements of##5##3##(1993-6#1)(2007-12#1)(2008-10#1)(2008-6#1)(2010-8#1)
through measuring the##2##3##(1995-3#1)(2008-10#1)
through measuring##3##2##(1995-3#1)(2008-10#1)(2008-5#1)
through mechanical##3##2##(2008-11#1)(2009-5#1)(2012-3#1)
through mechanisms of##3##3##(1995-12#1)(1995-6#1)(2008-9#1)
through mechanisms such as##2##4##(1997-2#1)(2008-11#1)
through mechanisms that##5##3##(1996-5#1)(2008-11#1)(2008-6#1)(2009-8#1)(2013-1#1)
through mechanisms##13##2##(1994-5#1)(1995-12#1)(1995-6#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-9#1)(2009-8#1)(2013-1#1)
through median sternotomy##3##3##(2007-8#3)
through medical##3##2##(1991-3#1)(1996-7#1)(2012-2#1)
through membrane##4##2##(2008-1#1)(2008-10#3)
through membranes##2##2##(1990-5#1)(1992-3#1)
through mental##2##2##(2008-6#1)(2012-2#1)
through metabolic##7##2##(1991-6#1)(1994-12#1)(2008-11#1)(2009-5#1)(2009-6#1)(2012-2#1)(2013-7#1)
through metaphase##2##2##(1991-5#1)(1994-8#1)
through minimally invasive##2##3##(2008-9#1)(2013-1#1)
through minimizing##2##2##(2008-2#1)(2010-12#1)
through mitochondrial##2##2##(1994-6#1)(1994-8#1)
through mitosis##2##2##(1995-2#1)(2009-8#1)
through modeling##2##2##(2008-2#1)(2008-9#1)
through modification of the##3##4##(2007-8#1)(2008-10#1)(2010-2#1)
through modification of##7##3##(1993-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-2#1)(2013-1#2)
through modulating the##2##3##(1994-11#1)(2013-8#1)
through modulating##3##2##(1994-11#1)(1994-12#1)(2013-8#1)
through modulation of the##3##4##(2007-12#1)(2008-8#1)(2013-8#1)
through modulation of##8##3##(1992-6#2)(2007-12#1)(2008-1#1)(2008-8#2)(2012-3#1)(2013-8#1)
through modulation##9##2##(1992-6#2)(1992-7#1)(2007-12#1)(2008-1#1)(2008-8#2)(2012-3#1)(2013-8#1)
through molecular##10##2##(1991-5#1)(1994-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2012-2#1)
through molecules##2##2##(2008-7#1)(2010-12#1)
through monitoring##3##2##(2008-10#2)(2013-8#1)
through more appropriate##2##3##(1996-3#1)(2012-3#1)
through more than##2##3##(2008-5#1)(2010-1#1)
through more##6##2##(1993-2#1)(1996-3#1)(2008-11#1)(2008-5#1)(2010-1#1)(2012-3#1)
through most of the##2##4##(1991-11#1)(2004-3#1)
through most of##3##3##(1991-11#1)(2004-3#1)(2013-8#1)
through most##6##2##(1991-11#1)(1991-8#1)(1992-5#1)(2004-3#1)(2008-8#1)(2013-8#1)
through mouth and##3##3##(2008-11#1)(2011-2#1)(2012-12#1)
through movement##2##2##(2008-2#2)
through much of the##3##4##(1996-5#1)(2008-10#2)
through multiple logistic regression##2##4##(1993-9#1)(2007-10#1)
through multiple signaling pathways##3##4##(1993-4#1)(1995-12#1)(2009-8#1)
through multiple##19##2##(1992-3#1)(1993-4#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-2#1)(2007-10#1)(2007-12#2)(2007-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)(2009-8#1)(2010-10#1)(2011-1#1)(2012-12#1)(2012-2#1)
through multivariate##3##2##(1990-3#1)(2008-10#1)(2009-4#1)
through muscarinic##3##2##(1992-6#3)
through mutation##2##2##(1997-3#1)(2008-4#1)
through naso-gastric tube##2##3##(1991-9#1)(2011-1#1)
through national##4##2##(2005-5#1)(2006-12#1)(2008-3#1)(2013-7#1)
through nationally##2##2##(2005-5#1)(2011-2#1)
through natural##3##2##(1997-2#1)(2008-11#1)(2012-12#1)
through new##3##2##(1991-1#1)(2007-8#1)(2010-4#1)
through nine##3##2##(1990-11#1)(1995-11#1)(2007-12#1)
through nitric oxide##2##3##(1996-11#1)(2008-1#1)
through non-NMDA glutamate receptors##2##4##(2010-10#2)
through non-NMDA glutamate##3##3##(1991-3#1)(2010-10#2)
through non-NMDA##4##2##(1991-3#2)(2010-10#2)
through noncovalent##2##2##(2008-7#1)(2010-4#1)
through novel##2##2##(2008-10#1)(2008-8#1)
through nuclear##4##2##(1994-6#1)(2008-11#1)(2011-2#2)
through numerical simulations##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
through numerical##5##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
through numerous##2##2##(1996-9#1)(2011-1#1)
through nutritional##2##2##(2008-8#1)(2012-2#1)
through observation##3##2##(1991-1#1)(2007-12#1)(2012-3#1)
through octadecyl silica membrane disks modified with##2##7##(2008-10#2)
through of##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
through one of##2##3##(1990-5#1)(1997-6#1)
through one##4##2##(1990-5#1)(1997-6#1)(2008-10#1)(2008-8#1)
through ongoing##2##2##(2008-11#1)(2008-8#1)
through ontogeny##3##2##(2010-8#3)
through operant##2##2##(2007-2#1)(2008-8#1)
through operational##2##2##(1996-3#1)(2012-3#1)
through optical and##2##3##(2007-11#1)(2012-12#1)
through optical fibers##5##3##(2007-11#1)(2007-12#1)(2008-2#3)
through optical##9##2##(2007-11#3)(2007-12#1)(2008-2#3)(2008-5#1)(2012-12#1)
through optically thick##2##3##(2008-2#1)(2008-3#1)
through or##2##2##(2007-12#1)(2008-3#1)
through oral##2##2##(2008-11#1)(2008-7#1)
through orange to red (very##2##5##(2012-2#2)
through other##3##2##(1997-2#1)(2008-10#1)(2010-6#1)
through our##8##2##(1993-1#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-7#1)(2012-12#1)
through out the##2##3##(2007-7#1)(2008-10#1)
through oxidative stress##2##3##(2008-10#1)(2010-7#1)
through pH##2##2##(2008-10#1)(2008-9#1)
through paracrine##4##2##(2010-9#1)(2011-2#1)(2012-7#1)(2013-1#1)
through parallel##3##2##(1997-6#1)(2007-12#1)(2010-10#1)
through parasite##2##2##(2006-10#1)(2008-8#1)
through parental##3##2##(2010-2#3)
through participation##2##2##(1992-6#1)(2008-12#1)
through partnership working##2##3##(2008-11#2)
through passive neutral membranes##2##4##(2008-10#2)
through passive##4##2##(1994-3#1)(2008-10#2)(2012-12#1)
through paternal##2##2##(1995-11#1)(2008-7#1)
through patient##2##2##(1996-3#1)(2008-7#1)
through pediatric##2##2##(2010-9#1)(2012-3#1)
through periodic##3##2##(1991-12#1)(2007-12#1)(2008-10#1)
through personal interviews##2##3##(2008-12#1)(2008-2#1)
through personal##4##2##(1994-1#1)(2008-12#1)(2008-2#1)(2010-5#1)
through pharmacological##2##2##(2006-10#1)(2009-4#1)
through phosphorylation by##5##3##(1993-6#1)(1994-12#1)(1995-2#1)(1997-1#1)(2005-8#1)
through phosphorylation of##4##3##(1997-7#1)(2005-11#1)(2008-11#1)(2011-1#1)
through phosphorylation##12##2##(1991-3#1)(1992-11#1)(1993-6#1)(1994-12#1)(1995-2#1)(1997-1#1)(1997-7#1)(2005-11#1)(2005-8#1)(2008-11#1)(2011-1#1)(2011-2#1)
through photorefractive##2##2##(2007-11#1)(2007-12#1)
through physical##5##2##(2004-3#1)(2007-6#1)(2008-5#1)(2010-12#1)(2013-1#1)
through plaque##2##2##(2013-8#2)
through plasmodesmata##2##2##(1997-3#1)(2009-8#1)
through platelet##2##2##(1994-12#1)(2008-9#1)
through point mutations##2##3##(2008-8#1)(2010-8#1)
through pollen##4##2##(2008-10#1)(2008-8#2)(2010-10#1)
through pores in##3##3##(1997-6#1)(2008-2#1)(2008-4#1)
through pores##5##2##(1997-6#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)
through port##2##2##(2007-11#1)(2011-2#1)
through practice##2##2##(1991-1#1)(2012-1#1)
through predictive##2##2##(2010-3#1)(2012-2#1)
through pregnancy##3##2##(2012-12#1)(2012-2#1)(2012-3#1)
through primary##3##2##(1991-8#1)(2008-7#1)(2010-8#1)
through production of##4##3##(1997-7#1)(2007-12#1)(2007-2#1)(2012-7#1)
through professional##3##2##(1994-12#1)(1996-1#1)(2013-8#1)
through promoter##2##2##(1993-12#1)(2008-4#1)
through promoting##2##2##(1994-10#1)(2008-5#1)
through promotion of##2##3##(1992-8#1)(2013-1#1)
through proper##4##2##(2007-11#1)(2008-1#1)(2008-2#1)(2013-1#1)
through protein kinase##2##3##(1990-9#1)(2011-12#1)
through protein##7##2##(1990-9#1)(1992-11#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#2)
through protein-protein interactions##5##3##(1993-9#1)(1994-3#1)(1996-11#1)(2008-4#1)(2008-8#1)
through protein-protein##7##2##(1993-9#1)(1994-3#1)(1996-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-3#1)
through public health##4##3##(1997-7#1)(2005-7#1)(2007-3#1)(2008-8#1)
through public##6##2##(1997-7#1)(2005-7#1)(2007-3#1)(2008-8#1)(2013-1#2)
through pyruvate carboxylase##3##3##(1990-2#1)(1991-3#1)(1991-8#1)
through pyruvate##4##2##(1990-2#2)(1991-3#1)(1991-8#1)
through quality##2##2##(1993-12#1)(1995-12#1)
through quantitative##3##2##(1991-12#1)(1995-2#1)(2008-10#1)
through questionnaires and##2##3##(2008-11#1)(2010-8#1)
through questionnaires##4##2##(2008-11#1)(2010-8#1)(2011-2#1)(2012-12#1)
through rabbit skin##2##3##(2004-12#1)(2008-5#1)
through rapid##2##2##(2006-10#1)(2008-8#1)
through reaction of##2##3##(2008-11#1)(2009-4#1)
through recent##5##2##(1997-4#1)(2005-8#1)(2006-5#1)(2008-7#1)(2009-10#1)
through receptors##2##2##(2007-12#1)(2012-3#1)
through recombination##2##2##(2008-10#1)(2011-2#1)
through recruitment##2##2##(2009-3#1)(2010-8#1)
through reduced##3##2##(2008-5#1)(2008-9#1)(2009-5#1)
through reducing##2##2##(2005-11#1)(2010-11#1)
through reduction of##2##3##(2010-12#1)(2013-1#1)
through reduction##6##2##(1993-4#1)(2007-6#1)(2008-3#1)(2010-12#1)(2011-2#1)(2013-1#1)
through reflection##2##2##(2008-11#2)
through reflective##2##2##(2008-11#2)
through regional##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
through regulating the##2##3##(2011-3#1)(2013-7#1)
through regulation of the##2##4##(1996-8#1)(2010-4#1)
through regulation of##5##3##(1995-2#1)(1996-8#1)(2010-11#1)(2010-4#1)(2013-1#1)
through regulation##7##2##(1991-3#1)(1995-2#1)(1996-8#1)(2010-11#1)(2010-4#1)(2011-2#1)(2013-1#1)
through regulatory##2##2##(2007-12#1)(2013-1#1)
through removal##2##2##(2008-4#1)(2009-7#1)
through research##8##2##(1992-1#1)(2006-12#1)(2008-1#1)(2008-12#1)(2008-4#1)(2012-12#1)(2013-8#2)
through response surface##2##3##(2008-10#1)(2008-5#1)
through restructuring##2##2##(1995-1#1)(2008-6#1)
through retrospective##3##2##(1996-6#1)(2006-10#1)(2012-3#1)
through reverse##2##2##(2008-10#1)(2008-4#1)
through reviewing##2##2##(2007-9#1)(2012-3#1)
through right##4##2##(2012-1#1)(2013-1#2)(2013-7#1)
through rigid bronchoscopy##2##3##(2007-8#1)(2013-1#1)
through scanning electron microscopy##2##4##(2006-10#1)(2008-5#1)
through scattering media by##2##4##(2007-12#1)(2008-2#1)
through scattering media with##2##4##(2007-12#2)
through scattering media##13##3##(2007-12#6)(2008-1#1)(2008-2#5)(2008-3#1)
through scattering##14##2##(2007-11#1)(2007-12#6)(2008-1#1)(2008-2#5)(2008-3#1)
through scattering-absorbing media##2##3##(2008-2#2)
through screening##3##2##(2009-4#1)(2010-7#1)(2013-1#1)
through seed##5##2##(2005-10#1)(2008-10#3)(2008-8#1)
through selected##2##2##(2008-10#1)(2008-9#1)
through selection in##2##3##(2008-8#2)
through selection##4##2##(1995-5#1)(2006-12#1)(2008-8#2)
through selective##9##2##(1993-6#1)(1995-11#1)(2006-10#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-8#2)
through self-association##2##2##(1993-6#1)(1996-5#1)
through semi-structured##4##2##(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
through separate##4##2##(2007-8#2)(2008-3#1)(2009-9#1)
through sequence##2##2##(1997-2#1)(2009-8#1)
through sequencing##2##2##(2009-12#1)(2011-2#1)
through seven passages##2##3##(2012-12#2)
through seven##3##2##(2007-8#1)(2012-12#2)
through several pathways##2##3##(1996-10#1)(2008-1#1)
through several##13##2##(1994-3#1)(1995-5#1)(1996-10#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-4#1)(2010-7#1)(2010-9#1)(2011-1#2)
through sexual contact##3##3##(1993-6#1)(2006-10#1)(2009-10#1)
through sexual intercourse##3##3##(1997-5#2)(1997-7#1)
through sexual##10##2##(1993-6#1)(1997-5#2)(1997-7#1)(2006-10#1)(2006-7#1)(2008-10#1)(2008-8#1)(2009-10#1)(2013-8#1)
through shared##4##2##(2008-1#1)(2008-8#2)(2008-9#1)
through signal##2##2##(1992-2#1)(2013-7#1)
through signaling##3##2##(2008-11#1)(2008-5#1)(2012-2#1)
through simple##3##2##(2007-11#1)(2008-3#1)(2011-2#1)
through simulation studies##3##3##(2008-2#1)(2008-3#1)(2012-3#1)
through simulation##8##2##(1994-6#1)(2006-6#1)(2008-2#1)(2008-3#1)(2010-4#1)(2012-3#3)
through simulations##2##2##(2008-2#1)(2012-3#1)
through site-directed mutagenesis##3##3##(1990-7#1)(1991-10#1)(1991-2#1)
through skin##6##2##(1990-12#1)(1991-9#1)(1994-3#1)(1994-9#1)(2008-5#1)(2009-2#1)
through small##6##2##(1991-8#1)(1994-12#1)(2007-11#1)(2008-12#1)(2008-7#1)(2009-10#1)
through social##4##2##(1994-2#1)(2008-11#1)(2009-10#1)(2012-11#1)
through software##2##2##(1996-3#1)(2008-10#1)
through soil##3##2##(2008-10#3)
through some##7##2##(1994-5#1)(1997-6#1)(2008-12#1)(2008-2#3)(2009-9#1)
through space and time##2##4##(2010-5#1)(2013-1#1)
through specific receptors##3##3##(1991-12#1)(1996-5#1)(2007-9#1)
through specific##13##2##(1990-5#1)(1991-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1995-6#1)(1995-8#1)(1996-5#1)(2006-2#1)(2007-9#1)(2008-1#1)(2008-8#1)(2011-1#1)
through spectral##2##2##(2007-12#1)(2010-5#1)
through spontaneous##3##2##(1993-12#1)(1994-8#1)(1995-12#1)
through stacking##2##2##(2007-8#1)(2008-10#1)
through stem##3##2##(2008-10#1)(2012-12#2)
through stimulated##2##2##(2007-12#2)
through stimulation of##6##3##(1993-11#1)(1996-12#1)(1996-5#1)(2006-1#1)(2006-10#1)(2008-10#1)
through stimulation##7##2##(1993-11#1)(1996-12#1)(1996-5#1)(2006-1#1)(2006-10#1)(2008-10#1)(2008-8#1)
through stomata##3##2##(2008-10#3)
through stomatal##2##2##(2008-10#1)(2009-8#1)
through storage period##2##3##(2012-2#2)
through storage##3##2##(2012-2#3)
through strategic##3##2##(1994-3#1)(2009-9#1)(2012-3#1)
through structural changes##2##3##(1997-4#1)(2008-5#1)
through structured##3##2##(1995-1#1)(2012-3#1)(2013-7#1)
through studies of##3##3##(1997-4#1)(2008-10#2)
through studies##5##2##(1997-4#1)(2004-12#1)(2008-10#2)(2013-1#1)
through such##5##2##(1995-1#2)(1995-3#1)(1997-2#1)(1997-7#1)
through sucrose##2##2##(1990-12#1)(2008-4#1)
through sugar##2##2##(2005-11#1)(2009-8#1)
through supplementation##2##2##(2007-11#1)(2008-5#1)
through suppression of##8##3##(1990-11#1)(1993-6#1)(1994-11#2)(2008-10#1)(2011-2#2)(2012-2#1)
through surface##2##2##(1992-1#1)(2005-12#1)
through surgery##2##2##(2008-4#2)
through surgical##2##2##(1992-9#1)(2010-6#1)
through surveillance and##2##3##(2005-5#1)(2010-12#1)
through synchronous##2##2##(1996-5#1)(2007-12#1)
through synthesis##2##2##(1992-9#1)(2008-4#1)
through system##2##2##(1990-12#1)(1997-5#1)
through systematic##3##2##(2008-11#1)(2010-2#1)(2011-2#1)
through systemic##7##2##(1991-11#1)(1994-8#1)(2006-6#1)(2008-10#1)(2009-3#1)(2011-2#2)
through targeting CD44v3##2##3##(2013-8#2)
through targeting##5##2##(2007-11#1)(2008-11#1)(2009-11#1)(2013-8#2)
through team##4##2##(1997-3#1)(2008-6#3)
through tests##2##2##(1993-5#1)(2013-1#1)
through the ASA##2##3##(1997-6#2)
through the CD4 molecule##2##4##(1994-8#2)
through the Golgi complex##2##4##(1992-11#1)(1995-1#1)
through the Golgi is##2##4##(2009-2#2)
through the Golgi##7##3##(1990-6#1)(1992-11#1)(1995-1#1)(2009-2#4)
through the Institute##2##3##(2007-12#1)(2008-1#1)
through the Internet##9##3##(1995-1#1)(1997-1#1)(2007-2#2)(2008-10#1)(2008-2#1)(2008-4#1)(2010-8#2)
through the Lucent Technologies-Advanced Research Projects##2##6##(2008-2#1)(2008-3#1)
through the National Institutes of##2##5##(1997-5#1)(2008-1#1)
through the National##4##3##(1997-5#1)(2008-1#1)(2008-3#1)(2008-4#1)
through the Shc SH2 domain##2##5##(1997-7#2)
through the aberrant##2##3##(2007-12#1)(2008-7#1)
through the action of the##2##5##(1990-5#1)(1995-1#1)
through the action of##9##4##(1990-5#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-1#1)(2008-11#1)(2008-3#1)(2010-5#1)(2010-9#1)
through the action##10##3##(1990-5#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-1#1)(1996-2#1)(2008-11#1)(2008-3#1)(2010-5#1)(2010-9#1)
through the activation of a##3##5##(1992-8#1)(1993-8#1)(1995-6#1)
through the activation of##17##4##(1990-9#1)(1992-8#1)(1993-3#1)(1993-8#1)(1995-5#1)(1995-6#1)(1996-9#1)(2007-11#1)(2008-3#2)(2008-4#2)(2008-7#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-3#1)
through the activity of##2##4##(2009-3#1)(2012-3#1)
through the addition of##4##4##(1991-10#1)(1994-9#1)(2008-10#1)(2009-9#1)
through the air##3##3##(1995-9#1)(2006-6#1)(2010-4#1)
through the alternative##2##3##(1991-7#1)(1994-11#1)
through the analysis of the##4##5##(1992-9#1)(2009-7#1)(2011-2#1)(2013-8#1)
through the analysis of##11##4##(1992-9#1)(1996-3#1)(2007-8#2)(2008-10#3)(2008-5#1)(2009-7#1)(2011-2#1)(2013-8#1)
through the analysis##12##3##(1992-9#1)(1996-3#1)(2007-8#2)(2008-10#3)(2008-5#1)(2009-7#1)(2010-7#1)(2011-2#1)(2013-8#1)
through the annulus##2##3##(2006-8#1)(2011-2#1)
through the anterior##3##3##(1992-7#1)(1997-6#1)(2007-7#1)
through the anus##4##3##(2007-2#1)(2008-4#1)(2013-1#2)
through the apical##2##3##(2008-10#1)(2008-8#1)
through the application of##12##4##(1992-12#1)(1995-4#1)(2006-10#1)(2006-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-1#1)
through the aqueous phase##3##4##(1990-2#1)(1992-3#1)(1993-3#1)
through the assay##2##3##(1993-12#1)(2008-10#1)
through the atmosphere##5##3##(2007-12#1)(2008-2#3)(2008-3#1)
through the authors'##2##3##(2008-11#1)(2009-11#1)
through the basal##2##3##(1997-6#1)(2008-7#1)
through the beam##3##3##(2008-2#1)(2008-3#2)
through the binding of##2##4##(1995-1#1)(1995-11#1)
through the biological and##2##4##(2008-12#1)(2008-3#1)
through the blood-brain barrier and##2##5##(1993-12#1)(2012-1#1)
through the blood-brain barrier##5##4##(1993-12#1)(1995-12#2)(2012-1#2)
through the body##3##3##(2007-12#1)(2008-7#1)(2012-2#1)
through the cardiac##2##3##(2006-12#1)(2007-8#1)
through the cartridge##2##3##(2008-10#2)
through the cell cycle##10##4##(1990-8#1)(1991-8#1)(1992-8#2)(1993-11#1)(1993-8#1)(1994-5#1)(1996-1#1)(2008-11#1)(2008-9#1)
through the cell membranes##2##4##(1995-12#1)(1997-2#1)
through the cell##17##3##(1990-8#1)(1991-8#1)(1992-8#2)(1993-11#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-1#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-9#1)
through the center of the##2##5##(1994-8#1)(2008-3#1)
through the central##3##3##(1992-3#1)(1996-9#1)(2007-12#1)
through the channel##3##3##(2006-10#1)(2007-8#1)(2009-11#1)
through the classical##2##3##(1994-11#1)(2008-8#1)
through the clinical##2##3##(2009-6#1)(2013-8#1)
through the column##8##3##(1990-12#1)(2008-10#5)(2008-4#1)(2008-9#1)
through the combination of##6##4##(2005-11#1)(2008-10#3)(2008-11#1)(2008-3#1)
through the combined use of CT##2##6##(2013-1#2)
through the combined use of##4##5##(2006-12#1)(2007-12#1)(2013-1#2)
through the combined##7##3##(1993-2#1)(2006-12#1)(2007-12#1)(2008-2#1)(2010-7#1)(2013-1#2)
through the composite##2##3##(2010-2#2)
through the concentration##2##3##(2008-5#1)(2008-9#1)
through the concept of a##2##5##(2008-2#1)(2008-3#1)
through the controlled##2##3##(2007-12#1)(2012-2#1)
through the corpus callosum##3##4##(1996-1#1)(1997-2#1)(2013-1#1)
through the course of##2##4##(1997-6#1)(2008-10#1)
through the creation of a##2##5##(2010-9#1)(2011-2#1)
through the cuticle and##2##4##(2008-10#2)
through the cuticle##4##3##(2007-12#2)(2008-10#2)
through the decreasing##2##3##(2008-5#1)(2010-2#1)
through the degeneration of##2##4##(2010-5#1)(2010-7#1)
through the degradation of##2##4##(1996-5#1)(2012-3#1)
through the deployment of##3##4##(2007-5#1)(2008-10#2)
through the design and synthesis of##2##6##(1994-12#1)(2010-12#1)
through the design of##2##4##(2008-10#1)(2012-12#1)
through the design##4##3##(1994-12#1)(2008-10#1)(2010-12#1)(2012-12#1)
through the detector##4##3##(2007-8#1)(2008-10#2)(2008-3#1)
through the determination of the##3##5##(2008-10#3)
through the determination of##7##4##(2008-10#6)(2011-1#1)
through the development and##2##4##(2008-11#1)(2011-12#1)
through the development of a##3##5##(1993-12#1)(2008-10#1)(2012-2#1)
through the development of##15##4##(1993-12#1)(1997-3#1)(1997-8#1)(2004-12#1)(2005-12#1)(2005-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-5#1)(2012-2#1)
through the development##18##3##(1993-12#1)(1997-3#1)(1997-8#1)(2004-12#1)(2005-12#1)(2005-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-12#1)(2012-2#1)
through the device##6##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)
through the dialysis membrane##2##4##(1992-3#1)(1994-10#1)
through the dialysis##4##3##(1992-3#2)(1993-7#1)(1994-10#1)
through the diaphragm into the##2##5##(1991-8#1)(2008-5#1)
through the different##3##3##(1994-6#1)(2008-1#1)(2008-7#1)
through the digestive##2##3##(2008-10#1)(2013-1#1)
through the direct measurement of the optical phase change##2##9##(2007-12#2)
through the direct##4##3##(2007-12#2)(2008-10#1)(2012-12#1)
through the display##2##3##(2008-2#1)(2008-4#1)
through the dynamic##2##3##(2008-2#2)
through the early##2##3##(1990-11#1)(2007-4#1)
through the effects of##2##4##(1992-3#1)(2008-8#1)
through the electro-optic effect##4##4##(2007-11#1)(2007-12#1)(2008-3#2)
through the elimination##2##3##(2010-9#1)(2013-1#1)
through the emergency##3##3##(1995-9#1)(2007-10#1)(2008-3#1)
through the end of##2##4##(2008-2#1)(2008-7#1)
through the endoplasmic reticulum##3##4##(1994-11#1)(1994-9#1)(2008-10#1)
through the engagement of##2##4##(2009-9#1)(2013-1#1)
through the entire thickness of the##2##6##(1992-6#1)(2008-8#1)
through the entire##10##3##(1992-4#1)(1992-6#1)(1996-6#1)(1997-8#1)(2006-10#1)(2007-9#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-2#1)
through the epidermal##3##3##(2007-8#1)(2008-10#2)
through the epidermis##2##3##(2008-10#2)
through the expression of##2##4##(2008-10#1)(2011-1#1)
through the extracellular matrix##2##4##(1996-3#2)
through the eyes of##3##4##(2006-8#1)(2008-1#1)(2011-2#1)
through the eyes##4##3##(2006-8#1)(2008-1#1)(2009-10#1)(2011-2#1)
through the fiber##5##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
through the first##6##3##(1992-5#1)(1994-12#1)(2006-6#1)(2006-8#1)(2008-10#1)(2010-5#1)
through the flexible endoscope##2##4##(2006-6#1)(2008-5#1)
through the flood water##2##4##(2008-10#2)
through the flow cell##3##4##(2008-10#3)
through the flow##5##3##(2008-10#4)(2008-2#1)
through the focus##2##3##(2007-12#1)(2008-3#1)
through the following##3##3##(1994-8#1)(2008-10#1)(2008-7#1)
through the food chain##3##4##(1995-11#1)(2008-10#1)(2013-8#1)
through the foramen##2##3##(2006-5#1)(2006-9#1)
through the formation of a##8##5##(1990-10#1)(1990-11#1)(1994-8#1)(2005-11#1)(2007-11#1)(2008-10#2)(2008-4#1)
through the formation of##23##4##(1990-10#1)(1990-11#1)(1994-8#1)(1995-10#1)(1996-5#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-4#1)(2009-11#1)(2009-12#1)(2010-5#1)(2010-8#1)
through the frontal##2##3##(2007-12#1)(2012-8#1)
through the gastrointestinal tract##2##4##(2007-11#1)(2011-2#1)
through the gastrointestinal##4##3##(2007-11#1)(2007-5#1)(2008-4#1)(2011-2#1)
through the generation of##2##4##(2009-5#1)(2011-2#1)
through the gut##2##3##(2006-10#1)(2008-10#1)
through the hole##2##3##(2007-8#1)(2008-2#1)
through the human##2##3##(2006-1#1)(2008-5#1)
through the hydrophobic##2##3##(1993-11#1)(2009-8#1)
through the identification of##2##4##(1992-2#1)(2012-2#1)
through the implementation of a##2##5##(2008-11#1)(2010-9#1)
through the implementation of##5##4##(1997-7#1)(2008-10#1)(2008-11#2)(2010-9#1)
through the improvement of##2##4##(2010-12#1)(2013-1#1)
through the inclusion of##2##4##(2008-10#1)(2010-1#1)
through the increase of##3##4##(1994-2#1)(2005-3#1)(2008-12#1)
through the induction of apoptosis##3##5##(2009-12#1)(2009-4#1)(2012-12#1)
through the induction of##7##4##(1995-2#1)(2007-11#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-5#1)(2012-12#1)
through the inhibition of##8##4##(1993-11#1)(1993-8#1)(2008-11#2)(2009-12#1)(2009-9#1)(2011-1#1)(2011-2#1)
through the interaction between##2##4##(2007-11#1)(2012-3#1)
through the interaction of##3##4##(1990-3#1)(1995-6#1)(2008-10#1)
through the interaction##6##3##(1990-2#1)(1990-3#1)(1995-6#1)(2007-11#1)(2008-10#1)(2012-3#1)
through the intermediate##2##3##(1993-12#1)(1995-11#1)
through the internet##2##3##(2007-5#1)(2008-3#1)
through the interpretation of##2##4##(1995-12#1)(2007-12#1)
through the interpretation##3##3##(1995-12#1)(2007-12#1)(2010-9#1)
through the intestinal##4##3##(1993-9#1)(2006-12#1)(2006-2#1)(2009-2#1)
through the introduction of##2##4##(2008-10#2)
through the lateral##3##3##(1996-9#1)(2009-8#1)(2013-7#1)
through the left##4##3##(1991-12#1)(1996-9#1)(2007-9#1)(2008-12#1)
through the lens of##5##4##(2006-5#1)(2008-7#1)(2009-4#1)(2012-11#1)(2012-12#1)
through the lens##6##3##(2006-5#1)(2008-3#1)(2008-7#1)(2009-4#1)(2012-11#1)(2012-12#1)
through the limited##2##3##(2006-12#1)(2008-11#1)
through the lipid##2##3##(1990-11#1)(1996-1#1)
through the liquid membrane##2##4##(2008-10#2)
through the liquid##3##3##(2008-10#2)(2010-8#1)
through the looking glass##3##4##(1990-9#1)(2006-12#1)(2006-8#1)
through the loss of##4##4##(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)
through the main##2##3##(2007-11#1)(2007-12#1)
through the mass##3##3##(1993-3#1)(2007-12#1)(2008-3#1)
through the maze of##2##4##(1995-1#1)(2007-2#1)
through the measurement of##4##4##(1990-11#1)(1990-8#1)(2008-5#1)(2010-9#1)
through the measurement##5##3##(1990-11#1)(1990-8#1)(2008-2#1)(2008-5#1)(2010-9#1)
through the mediation of##2##4##(1990-12#1)(2009-3#1)
through the medium of##3##4##(1991-11#1)(2005-12#1)(2007-10#1)
through the medium##4##3##(1991-11#1)(2005-12#1)(2007-10#1)(2007-12#1)
through the membrane and##2##4##(1995-6#1)(1996-11#1)
through the membrane##15##3##(1991-5#1)(1991-9#1)(1993-8#1)(1994-2#1)(1995-6#1)(1996-1#1)(1996-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2009-10#1)(2010-4#1)
through the membranes##2##3##(2008-6#2)
through the metabolism of microorganisms##2##5##(2008-5#2)
through the metal##2##3##(2006-4#1)(2008-2#1)
through the microcolumn##2##3##(2008-10#2)
through the microdialysis probe##3##4##(1996-9#1)(1997-2#1)(2008-10#1)
through the midcollicular line and microinjected with IC##2##8##(1992-11#2)
through the midcollicular line##3##4##(1992-11#3)
through the minor##2##3##(2007-5#1)(2008-3#1)
through the modification of##2##4##(1997-2#1)(2007-11#1)
through the modification##3##3##(1997-2#1)(2007-11#1)(2008-5#1)
through the nanopore##2##3##(2008-7#2)
through the network##2##3##(2006-7#1)(2008-2#1)
through the nose##3##3##(1993-2#1)(2005-11#1)(2006-10#1)
through the object##3##3##(2008-2#1)(2008-3#1)(2012-1#1)
through the open##2##3##(1991-4#1)(2008-7#1)
through the opposite##2##3##(2007-12#1)(2008-3#1)
through the optical##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
through the outer membrane##3##4##(1993-9#1)(1997-2#1)(1997-4#1)
through the ovarian stroma##2##4##(2008-12#2)
through the ovarian##3##3##(2008-12#3)
through the pages of##2##4##(2008-4#1)(2011-2#1)
through the parallel##2##3##(1991-11#1)(2008-10#1)
through the participation of##2##4##(1990-5#1)(2007-4#1)
through the patch pipette##2##4##(1995-12#1)(2009-12#1)
through the peritoneal membrane##3##4##(2008-10#3)
through the peritoneal##4##3##(2008-1#1)(2008-10#3)
through the phloem to##2##4##(2009-8#1)(2012-2#1)
through the plant##2##3##(2008-10#2)
through the plasma membrane and cell wall##2##7##(1997-6#1)(2009-8#1)
through the plasma membrane of##2##5##(1994-3#1)(2009-8#1)
through the plasma membrane##6##4##(1991-12#1)(1994-3#1)(1994-9#1)(1997-6#1)(2009-8#2)
through the plasma##7##3##(1991-12#1)(1994-3#1)(1994-9#1)(1997-6#1)(2009-8#2)(2010-10#1)
through the pleckstrin homology domain##2##5##(1994-11#1)(1994-12#1)
through the political##2##3##(2009-4#1)(2010-8#1)
through the population##4##3##(2008-8#1)(2009-6#1)(2012-3#1)(2013-8#1)
through the pore##2##3##(2008-9#1)(2012-2#1)
through the pores##2##3##(2007-12#1)(2010-2#1)
through the practice of##2##4##(1996-2#1)(2008-10#1)
through the presence##2##3##(2008-9#1)(2013-7#1)
through the process of##5##4##(2008-11#2)(2008-9#1)(2012-2#2)
through the process##7##3##(2004-12#1)(2008-11#3)(2008-9#1)(2012-2#2)
through the production of##8##4##(1991-10#1)(1994-3#1)(1997-5#1)(2008-1#1)(2008-10#2)(2012-12#1)(2012-3#1)
through the progressive##2##3##(1994-2#1)(2012-2#1)
through the promotion of##4##4##(2007-8#1)(2008-10#1)(2010-6#1)(2013-1#1)
through the proposed##2##3##(2005-11#1)(2010-5#1)
through the protection##2##3##(2007-8#1)(2008-7#1)
through the protein##2##3##(1994-5#1)(2008-1#1)
through the provision of##3##4##(1997-2#1)(2010-10#1)(2011-1#1)
through the reaction between##2##4##(2010-4#1)(2011-2#1)
through the reaction of##2##4##(2008-10#1)(2013-8#1)
through the reaction##6##3##(2007-11#1)(2008-10#2)(2010-4#1)(2011-2#1)(2013-8#1)
through the recording##2##3##(1992-7#1)(2008-11#1)
through the reduction of##4##4##(1995-6#1)(2006-3#1)(2008-12#1)(2010-12#1)
through the regulation of##6##4##(1994-11#1)(2007-12#1)(2008-7#1)(2010-12#1)(2012-7#1)(2013-1#1)
through the release of##7##4##(1990-5#1)(1990-9#1)(1994-10#1)(2007-11#1)(2007-12#1)(2008-12#1)(2009-3#1)
through the respiratory##2##3##(1997-8#1)(2010-12#1)
through the right##3##3##(1996-9#1)(2008-11#2)
through the root##2##3##(2008-10#2)
through the rotation of##2##4##(1993-3#1)(2008-8#1)
through the same fiber##2##4##(2007-11#1)(2008-3#1)
through the same##12##3##(1990-10#1)(1995-12#1)(1997-2#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-5#1)(2008-3#2)(2010-10#1)(2012-12#1)(2013-1#1)
through the sample##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
through the scalp##2##3##(2010-5#1)(2010-7#1)
through the second kringle domain##2##5##(1991-11#1)(1996-5#1)
through the second##4##3##(1991-11#1)(1994-12#1)(1996-5#1)(2007-12#1)
through the secretory pathway##3##4##(1997-1#1)(2008-1#1)(2008-4#1)
through the sensing##2##3##(2008-10#1)(2009-5#1)
through the series##4##3##(1990-12#1)(1992-9#2)(1997-7#1)
through the shell-bulk interface##2##4##(1995-8#2)
through the short##2##3##(1997-3#1)(2011-1#1)
through the skin and##3##4##(2008-10#1)(2008-5#1)(2009-3#1)
through the skin was##2##4##(1996-5#1)(2008-5#1)
through the skin##11##3##(1994-6#1)(1996-5#1)(2008-10#2)(2008-3#1)(2008-5#2)(2009-11#1)(2009-3#1)(2012-12#1)(2012-2#1)
through the so-called##4##3##(2005-11#1)(2007-12#1)(2008-4#1)(2010-2#1)
through the soil and##2##4##(2008-10#2)
through the somatic##2##3##(1991-8#1)(2012-12#1)
through the specific##4##3##(2008-10#1)(2009-3#1)(2009-7#1)(2010-4#1)
through the standard##2##3##(2008-10#1)(2008-9#1)
through the stem##3##3##(2008-10#3)
through the stoichiometric##2##3##(2008-10#1)(2008-7#1)
through the strong##2##3##(2008-10#2)
through the study of##5##4##(2006-10#1)(2006-5#1)(2008-10#1)(2008-7#1)(2011-1#1)
through the stylar canal and##2##5##(2008-10#2)
through the stylar canal##3##4##(2008-10#3)
through the substrate##2##3##(2007-12#1)(2008-3#1)
through the suppression of cell death##2##6##(1996-10#1)(2008-6#1)
through the suppression of##4##4##(1992-11#1)(1996-10#1)(2008-3#1)(2008-6#1)
through the surface##3##3##(2008-10#1)(2008-3#2)
through the sympathetic##2##3##(2006-12#1)(2009-10#1)
through the system##8##3##(1990-8#1)(1996-8#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-6#1)(2012-2#1)
through the test section##4##4##(2008-2#1)(2008-3#3)
through the test##5##3##(2008-1#1)(2008-2#1)(2008-3#3)
through the time##3##3##(1996-3#1)(2013-1#2)
through the tip of##2##4##(2008-4#1)(2010-8#1)
through the tip##3##3##(2008-2#1)(2008-4#1)(2010-8#1)
through the tracheal##2##3##(1997-1#1)(2009-6#1)
through the transverse##2##3##(2007-5#1)(2012-1#1)
through the turbulent atmosphere##3##4##(2007-12#1)(2008-2#2)
through the turbulent##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
through the two##4##3##(1993-6#1)(2008-10#2)(2008-3#1)
through the ultrasonic##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
through the use of a##18##5##(1995-3#1)(1995-6#1)(1996-2#1)(2006-10#1)(2006-3#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-4#3)(2009-12#1)(2009-7#1)(2011-1#1)(2013-8#1)
through the use of an##4##5##(1996-1#1)(2008-10#1)(2010-12#1)(2012-2#1)
through the use of appropriate##3##5##(2008-11#1)(2008-3#1)(2008-6#1)
through the use of the##4##5##(1996-3#1)(1997-5#1)(2008-3#1)(2008-6#1)
through the use of##104##4##(1990-11#1)(1991-12#2)(1991-7#1)(1991-8#1)(1991-9#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-6#1)(1995-3#3)(1995-6#1)(1996-1#1)(1996-2#2)(1996-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-3#1)(2006-4#1)(2007-11#3)(2007-12#3)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#4)(2008-4#10)(2008-5#3)(2008-6#2)(2008-7#3)(2008-9#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-8#2)
through the use##105##3##(1990-11#1)(1991-12#2)(1991-7#1)(1991-8#1)(1991-9#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-6#1)(1995-3#3)(1995-6#1)(1996-1#1)(1996-2#2)(1996-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-3#1)(2006-4#1)(2007-11#3)(2007-12#3)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#4)(2008-4#10)(2008-5#3)(2008-6#2)(2008-7#3)(2008-9#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-8#2)
through the usual##2##3##(1991-7#1)(2007-4#1)
through the vagina##2##3##(2007-4#1)(2011-1#1)
through the variation of the##2##5##(2007-8#1)(2008-10#1)
through the various##2##3##(2010-7#1)(2013-7#1)
through the ventral##2##3##(1990-11#1)(1992-10#1)
through the water##2##3##(1993-11#1)(2008-1#1)
through the waveguide##2##3##(2008-3#2)
through the whole##4##3##(1994-9#1)(2007-12#1)(2007-8#1)(2008-3#1)
through the year 2000##3##4##(1991-9#1)(1992-3#1)(1995-6#1)
through the year##6##3##(1991-9#1)(1992-3#1)(1995-6#1)(1996-2#1)(2007-3#1)(2008-9#1)
through the years##2##3##(2007-4#1)(2007-8#1)
through the##1784##2##(1990-10#2)(1990-11#11)(1990-12#6)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#3)(1990-7#2)(1990-8#3)(1990-9#4)(1991-1#1)(1991-10#2)(1991-11#4)(1991-12#9)(1991-2#2)(1991-3#5)(1991-4#2)(1991-5#3)(1991-6#6)(1991-7#5)(1991-8#5)(1991-9#6)(1992-1#1)(1992-10#3)(1992-11#8)(1992-12#3)(1992-2#2)(1992-3#7)(1992-4#3)(1992-5#3)(1992-6#6)(1992-7#3)(1992-8#4)(1992-9#7)(1993-11#6)(1993-12#7)(1993-2#4)(1993-3#9)(1993-4#1)(1993-5#1)(1993-6#4)(1993-7#1)(1993-8#5)(1993-9#7)(1994-1#1)(1994-10#2)(1994-11#9)(1994-12#10)(1994-2#8)(1994-3#8)(1994-4#1)(1994-5#5)(1994-6#8)(1994-8#10)(1994-9#9)(1995-1#11)(1995-10#4)(1995-11#8)(1995-12#17)(1995-2#5)(1995-3#11)(1995-4#1)(1995-5#1)(1995-6#9)(1995-7#1)(1995-8#2)(1995-9#5)(1996-1#7)(1996-10#3)(1996-11#2)(1996-12#2)(1996-2#8)(1996-3#10)(1996-4#1)(1996-5#12)(1996-6#4)(1996-7#1)(1996-8#4)(1996-9#10)(1997-1#7)(1997-2#11)(1997-3#5)(1997-4#5)(1997-5#9)(1997-6#14)(1997-7#12)(1997-8#9)(2004-10#1)(2004-11#1)(2004-12#2)(2004-8#1)(2004-9#1)(2005-1#1)(2005-10#3)(2005-11#10)(2005-12#3)(2005-3#2)(2005-4#1)(2005-5#2)(2005-8#3)(2006-1#2)(2006-10#18)(2006-11#2)(2006-12#15)(2006-2#2)(2006-3#5)(2006-4#3)(2006-5#3)(2006-6#8)(2006-7#4)(2006-8#9)(2006-9#6)(2007-10#4)(2007-11#34)(2007-12#67)(2007-2#8)(2007-3#2)(2007-4#8)(2007-5#11)(2007-6#1)(2007-7#5)(2007-8#27)(2007-9#14)(2008-1#19)(2008-10#209)(2008-11#49)(2008-12#21)(2008-2#54)(2008-3#82)(2008-4#41)(2008-5#43)(2008-6#16)(2008-7#47)(2008-8#24)(2008-9#29)(2009-10#7)(2009-11#6)(2009-12#11)(2009-2#12)(2009-3#10)(2009-4#12)(2009-5#4)(2009-6#9)(2009-7#7)(2009-8#12)(2009-9#5)(2010-1#3)(2010-10#7)(2010-11#3)(2010-12#11)(2010-2#12)(2010-3#4)(2010-4#7)(2010-5#11)(2010-6#1)(2010-7#12)(2010-8#15)(2010-9#7)(2011-1#19)(2011-12#1)(2011-2#38)(2011-3#2)(2012-1#8)(2012-11#2)(2012-12#33)(2012-2#26)(2012-3#15)(2012-7#1)(2012-8#1)(2013-1#33)(2013-7#11)(2013-8#17)
through their ability to##4##4##(1994-5#1)(1994-8#1)(1996-1#1)(2011-2#1)
through their effect on##2##4##(2008-10#2)
through their effects on##3##4##(2006-9#1)(2008-10#1)(2008-8#1)
through their interaction with##2##4##(2008-5#1)(2010-10#1)
through their own##2##3##(2004-4#1)(2009-2#1)
through their respective##2##3##(2005-4#1)(2008-8#1)
through their roots showed##2##4##(2008-10#2)
through their roots##3##3##(2008-10#3)
through their unique##2##3##(1996-1#1)(2008-3#1)
through their use##2##3##(2007-6#1)(2008-5#1)
through their##87##2##(1990-11#1)(1990-2#1)(1990-3#1)(1991-7#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-7#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-1#2)(1996-2#2)(1996-3#1)(1997-1#1)(2004-4#1)(2005-11#1)(2005-4#1)(2006-1#1)(2006-10#3)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-3#2)(2007-6#1)(2008-10#10)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#9)(2008-8#4)(2009-2#1)(2009-4#2)(2010-10#1)(2010-6#1)(2010-8#2)(2011-2#3)(2012-12#4)(2013-1#2)
through them##3##2##(2007-12#1)(2008-11#1)(2008-3#1)
through these points##2##3##(2009-5#1)(2012-1#1)
through these receptors##3##3##(2007-11#1)(2008-1#1)(2008-4#1)
through these##22##2##(1997-4#1)(1997-7#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-4#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-6#1)(2011-1#1)(2012-1#1)(2013-8#1)
through thin##4##2##(1992-6#1)(1997-6#1)(2007-11#1)(2008-3#1)
through third##2##2##(2007-3#1)(2007-9#1)
through this method##2##3##(2008-10#1)(2008-7#1)
through this process##2##3##(1994-2#1)(2008-1#1)
through this##33##2##(1991-9#1)(1992-12#1)(1992-8#2)(1994-2#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-12#1)(1997-1#1)(2004-3#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-10#1)(2012-12#1)(2013-1#1)
through those##3##2##(1997-4#2)(2008-1#1)
through three consecutive##2##3##(2007-8#1)(2008-10#1)
through three major##2##3##(2008-10#1)(2010-12#1)
through three times##2##3##(1997-2#1)(2008-8#1)
through three##15##2##(1992-2#1)(1995-12#1)(1996-1#1)(1997-2#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-8#1)(2009-8#1)(2009-9#1)(2010-12#1)(2012-3#1)
through time##11##2##(2008-10#5)(2008-11#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-12#1)
through time)##2##2##(1992-9#1)(2008-10#1)
through tissue##4##2##(1991-2#1)(2007-12#2)(2013-1#1)
through tissues for##2##3##(2007-11#2)
through to its##2##3##(1995-3#1)(2013-1#1)
through to the##4##3##(2006-7#1)(2008-1#1)(2008-5#1)(2010-11#1)
through to##20##2##(1991-7#1)(1993-11#1)(1995-3#1)(2005-5#1)(2006-10#1)(2006-12#1)(2006-7#1)(2008-1#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#1)(2010-11#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
through topical##2##2##(1992-2#1)(1997-8#1)
through total quality management##2##4##(1994-1#1)(1996-2#1)
through total##3##2##(1994-1#1)(1996-2#1)(2008-2#1)
through training and##2##3##(2008-9#1)(2009-5#1)
through training##4##2##(2007-2#1)(2007-5#1)(2008-9#1)(2009-5#1)
through transfusion##2##2##(2011-2#2)
through transportation networks##2##3##(2013-8#2)
through treatment##2##2##(2007-11#1)(2010-6#1)
through tunnels##2##2##(2009-10#2)
through turbid media##8##3##(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#1)
through turbid##10##2##(2007-11#1)(2007-12#3)(2008-2#4)(2008-3#2)
through two##25##2##(1990-8#1)(1992-8#1)(1993-12#1)(1993-3#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-4#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-12#3)(2008-10#2)(2008-3#1)(2008-7#2)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-7#1)(2013-8#1)
through two-photon##2##2##(2007-12#2)
through type##2##2##(1995-6#1)(2008-9#1)
through typeII##2##2##(2008-1#2)
through tyrosine phosphorylation##3##3##(1990-11#1)(1992-3#1)(1997-7#1)
through tyrosine##4##2##(1990-11#1)(1992-3#1)(1997-4#1)(1997-7#1)
through ultrasound##2##2##(2012-3#1)(2013-1#1)
through unprotected sexual intercourse##2##4##(1997-7#1)(2007-2#1)
through urine##2##2##(1994-6#1)(2011-2#1)
through use of a##2##4##(1994-9#1)(2008-3#1)
through use of an##3##4##(2008-3#1)(2013-1#2)
through use of the##2##4##(2007-12#1)(2008-10#1)
through use of##13##3##(1991-10#1)(1994-9#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2013-1#5)
through vaccination##3##2##(1994-3#1)(2007-8#1)(2013-1#1)
through vapour phase##2##3##(2007-8#1)(2008-10#1)
through variation of the##2##4##(2008-1#1)(2008-10#1)
through variation of##4##3##(2007-12#2)(2008-1#1)(2008-10#1)
through various##13##2##(1996-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-1#1)(2010-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
through vascular##3##2##(2008-6#1)(2009-4#1)(2011-1#1)
through vertical##2##2##(2008-2#1)(2008-3#1)
through videoconferencing##2##2##(2008-11#2)
through vigorous##2##2##(2007-11#1)(2008-7#1)
through visualization##2##2##(2008-3#1)(2008-7#1)
through voltage-dependent##3##2##(1990-12#1)(1993-3#1)(1994-11#1)
through volume and limit of detection##3##6##(2008-10#3)
through volume##4##2##(2008-10#4)
through voluntary##3##2##(1994-12#1)(1995-1#1)(2008-10#1)
through water##4##2##(2008-10#2)(2008-8#1)(2011-2#1)
through wave-front coding##2##3##(2008-2#1)(2008-3#1)
through weak##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
through which a##3##3##(2011-2#1)(2012-1#1)(2012-2#1)
through which all##3##3##(1990-4#1)(2008-4#2)
through which it##3##3##(2005-7#2)(2008-10#1)
through which pyruvate##2##3##(1993-12#1)(2013-8#1)
through which the##17##3##(1992-8#1)(1993-11#1)(1993-12#1)(1996-4#1)(1996-5#1)(1997-6#1)(2005-11#1)(2006-2#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-6#1)(2010-4#1)(2012-2#1)
through which these##3##3##(1995-10#1)(1996-12#1)(2007-12#1)
through which they##3##3##(2006-8#1)(2007-12#1)(2008-4#1)
through which to##3##3##(2008-11#1)(2009-2#1)(2009-7#1)
through which we##2##3##(2007-9#1)(2008-1#1)
through which##84##2##(1990-4#1)(1990-8#1)(1991-3#1)(1992-3#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#1)(1994-5#1)(1995-10#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-6#1)(2005-11#1)(2005-7#2)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#4)(2008-4#4)(2008-5#4)(2008-6#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-1#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
through with##2##2##(2010-2#1)(2011-2#1)
through workplace connections##2##3##(2010-2#2)
through wounds##2##2##(2008-10#2)
through written##2##2##(2009-9#1)(2013-7#1)
through x-ray##2##2##(2008-2#1)(2010-4#1)
through yeast##2##2##(1991-9#1)(2008-8#1)
through zero##2##2##(2008-2#2)
through##7261##1##(1990-10#5)(1990-11#29)(1990-12#32)(1990-2#18)(1990-3#18)(1990-4#5)(1990-5#17)(1990-6#6)(1990-7#11)(1990-8#11)(1990-9#9)(1991-1#12)(1991-10#7)(1991-11#16)(1991-12#25)(1991-2#20)(1991-3#31)(1991-4#10)(1991-5#23)(1991-6#16)(1991-7#13)(1991-8#18)(1991-9#23)(1992-1#18)(1992-10#5)(1992-11#19)(1992-12#16)(1992-2#15)(1992-3#22)(1992-4#8)(1992-5#13)(1992-6#27)(1992-7#11)(1992-8#23)(1992-9#14)(1993-1#9)(1993-10#6)(1993-11#21)(1993-12#33)(1993-2#15)(1993-3#29)(1993-4#8)(1993-5#9)(1993-6#27)(1993-7#7)(1993-8#18)(1993-9#19)(1994-1#10)(1994-10#9)(1994-11#35)(1994-12#55)(1994-2#30)(1994-3#45)(1994-4#3)(1994-5#28)(1994-6#26)(1994-7#3)(1994-8#37)(1994-9#34)(1995-1#36)(1995-10#12)(1995-11#24)(1995-12#40)(1995-2#32)(1995-3#35)(1995-4#2)(1995-5#10)(1995-6#35)(1995-7#10)(1995-8#13)(1995-9#8)(1996-1#27)(1996-10#9)(1996-11#19)(1996-12#27)(1996-2#25)(1996-3#34)(1996-4#16)(1996-5#54)(1996-6#13)(1996-7#11)(1996-8#25)(1996-9#13)(1997-1#28)(1997-2#41)(1997-3#21)(1997-4#37)(1997-5#20)(1997-6#38)(1997-7#38)(1997-8#31)(2003-11#2)(2004-10#1)(2004-11#11)(2004-12#13)(2004-2#2)(2004-3#5)(2004-4#4)(2004-8#1)(2004-9#4)(2005-1#1)(2005-10#17)(2005-11#55)(2005-12#14)(2005-3#3)(2005-4#2)(2005-5#7)(2005-7#11)(2005-8#13)(2005-9#8)(2006-1#8)(2006-10#85)(2006-11#15)(2006-12#54)(2006-2#15)(2006-3#14)(2006-4#7)(2006-5#14)(2006-6#25)(2006-7#18)(2006-8#25)(2006-9#14)(2007-1#13)(2007-10#24)(2007-11#142)(2007-12#306)(2007-2#31)(2007-3#24)(2007-4#23)(2007-5#25)(2007-6#11)(2007-7#41)(2007-8#110)(2007-9#35)(2008-1#91)(2008-10#678)(2008-11#181)(2008-12#75)(2008-2#241)(2008-3#270)(2008-4#143)(2008-5#185)(2008-6#61)(2008-7#160)(2008-8#133)(2008-9#121)(2009-1#2)(2009-10#34)(2009-11#24)(2009-12#22)(2009-2#34)(2009-3#34)(2009-4#45)(2009-5#34)(2009-6#22)(2009-7#33)(2009-8#40)(2009-9#34)(2010-1#11)(2010-10#32)(2010-11#23)(2010-12#55)(2010-2#60)(2010-3#11)(2010-4#29)(2010-5#34)(2010-6#16)(2010-7#32)(2010-8#51)(2010-9#21)(2011-1#86)(2011-10#1)(2011-12#14)(2011-2#182)(2011-3#10)(2011-7#2)(2011-8#1)(2011-9#1)(2012-1#53)(2012-10#3)(2012-11#15)(2012-12#146)(2012-2#124)(2012-3#92)(2012-7#4)(2012-8#1)(2013-1#199)(2013-7#46)(2013-8#90)
through&quot##2##1##(2006-12#1)(2006-9#1)
through-bond##5##1##(2005-8#1)(2006-10#1)(2007-11#1)(2008-9#1)(2010-12#1)
through-focus##2##1##(2007-5#1)(2008-2#1)
through-put of##2##2##(2008-10#2)
through-space##5##1##(1992-5#1)(2007-11#1)(2008-10#1)(2008-9#1)(2010-12#1)
through-thickness##5##1##(2008-7#1)(2009-7#4)
throughout 12##2##2##(2007-2#1)(2011-2#1)
throughout Africa##2##2##(2008-10#1)(2012-2#1)
throughout Australia and New Zealand##2##5##(2007-10#1)(2008-5#1)
throughout California##3##2##(2008-10#1)(2009-4#1)(2011-1#1)
throughout Europe##2##2##(2008-10#1)(2008-7#1)
throughout Florida##2##2##(2007-2#1)(2008-10#1)
throughout Germany##2##2##(2006-10#1)(2006-6#1)
throughout India##3##2##(2008-1#1)(2008-10#1)(2011-2#1)
throughout Japan##2##2##(2012-11#1)(2013-8#1)
throughout North America##2##3##(2007-10#1)(2008-11#1)
throughout North##3##2##(2007-10#2)(2008-11#1)
throughout Ontario##2##2##(1994-1#1)(2007-12#1)
throughout Russia##2##2##(1997-1#1)(2008-12#1)
throughout Southeast Asia##2##3##(2008-10#1)(2008-8#1)
throughout a year##2##3##(1995-5#1)(2008-5#1)
throughout a##22##2##(1990-10#1)(1991-3#1)(1992-8#1)(1995-5#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-11#1)(2011-1#1)(2012-2#2)(2013-8#1)
throughout adult life##4##3##(2007-10#1)(2008-7#1)(2010-11#1)(2010-3#1)
throughout all the stages of##2##5##(1992-1#1)(2013-1#1)
throughout all the##3##3##(1992-1#1)(2008-9#1)(2013-1#1)
throughout all##11##2##(1991-2#1)(1992-1#1)(1992-3#1)(1992-8#1)(1995-11#1)(1997-2#1)(2007-4#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#1)
throughout an individual's lifetime##2##4##(2006-12#1)(2012-2#1)
throughout an##6##2##(1993-12#1)(2006-12#1)(2008-10#1)(2008-5#1)(2010-10#1)(2012-2#1)
throughout and##2##2##(1995-6#1)(2008-12#1)
throughout both studies##3##3##(2008-9#3)
throughout both##6##2##(1991-12#1)(1997-7#1)(2008-10#1)(2008-9#3)
throughout by##3##2##(1992-11#1)(2006-10#1)(2008-3#1)
throughout childhood##3##2##(2008-4#1)(2009-8#1)(2013-8#1)
throughout development##10##2##(1993-2#1)(1994-10#1)(1996-5#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-12#1)
throughout different##2##2##(2011-2#1)(2012-2#1)
throughout each##5##2##(1996-4#1)(2007-9#1)(2008-10#1)(2013-8#2)
throughout early##2##2##(1996-8#1)(2008-4#1)
throughout embryogenesis##3##2##(1994-9#1)(1996-7#1)(2007-12#1)
throughout embryonic development##2##3##(1993-5#1)(1994-12#1)
throughout evolution and##2##3##(1993-12#1)(1994-5#1)
throughout evolution##10##2##(1993-12#2)(1994-5#1)(2005-10#2)(2007-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
throughout follow-up##2##2##(1991-3#1)(1995-2#1)
throughout gestation##3##2##(1996-10#2)(1996-4#1)
throughout her##2##2##(1994-12#1)(2009-11#1)
throughout his life##3##3##(1996-3#2)(2008-1#1)
throughout his##5##2##(1992-3#1)(1996-3#2)(2007-11#1)(2008-1#1)
throughout history##3##2##(2005-4#1)(2007-12#1)(2010-9#1)
throughout is that##2##3##(2008-2#1)(2009-9#1)
throughout its##7##2##(1990-11#1)(1992-9#1)(2007-3#1)(2008-10#1)(2008-2#1)(2011-1#1)(2012-2#1)
throughout life as##2##3##(1997-5#1)(2013-8#1)
throughout life##15##2##(1995-7#1)(1996-3#2)(1996-4#1)(1997-5#1)(2006-1#1)(2006-6#1)(2007-9#2)(2010-11#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
throughout most of the##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
throughout most of##5##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#2)
throughout much of the##5##4##(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-9#1)
throughout much of##7##3##(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-5#1)(2010-9#1)(2011-2#1)
throughout normal##2##2##(1990-7#1)(1992-12#1)
throughout our##3##2##(2008-5#2)(2011-2#1)
throughout pregnancy##6##2##(1992-1#1)(1993-11#2)(1994-3#1)(1996-11#1)(2009-5#1)
throughout spermatogenesis##3##2##(2006-5#2)(2008-5#1)
throughout the 24-hour##2##3##(1992-8#1)(2008-3#1)
throughout the 5##2##3##(1990-5#1)(2010-4#1)
throughout the CNS##2##3##(1993-7#1)(2007-12#1)
throughout the Caribbean##2##3##(1996-6#1)(2009-7#1)
throughout the European Union##2##4##(2011-2#1)(2013-8#1)
throughout the Indian##2##3##(2004-4#1)(2008-8#1)
throughout the PSD##2##3##(2008-4#2)
throughout the SNOM##2##3##(2008-3#2)
throughout the United States and##4##5##(2007-12#1)(2008-10#2)(2008-4#1)
throughout the United States##10##4##(1995-12#1)(1996-12#1)(2007-12#1)(2008-10#4)(2008-4#1)(2012-12#1)(2013-1#1)
throughout the United##12##3##(1995-12#1)(1996-12#1)(2007-12#1)(2008-10#4)(2008-4#1)(2008-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
throughout the animal kingdom##3##4##(1990-8#1)(2007-12#1)(2009-8#1)
throughout the body##10##3##(1990-3#1)(1995-5#1)(1996-1#1)(1997-1#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-12#1)(2009-6#1)(2009-9#1)
throughout the brain in##2##4##(1990-7#1)(2007-12#1)
throughout the brain of##2##4##(1997-3#1)(2012-1#1)
throughout the brain##10##3##(1990-7#1)(1993-12#2)(1995-12#1)(1997-3#2)(1997-4#1)(2005-7#1)(2007-12#1)(2012-1#1)
throughout the cardiac cycle##2##4##(2006-5#1)(2008-10#1)
throughout the case##2##3##(2009-9#1)(2011-2#1)
throughout the cell cycle##6##4##(1991-5#1)(1992-6#1)(1995-2#1)(1996-5#1)(2009-2#1)(2010-4#1)
throughout the cell##9##3##(1991-5#1)(1992-6#1)(1995-2#1)(1996-5#1)(1997-6#1)(2008-1#1)(2009-2#1)(2009-8#1)(2010-4#1)
throughout the continuum of care##2##5##(1994-12#1)(1997-2#1)
throughout the cortex of##2##4##(1992-9#1)(1996-5#1)
throughout the cortex##3##3##(1992-9#1)(1996-5#1)(2007-9#1)
throughout the country##9##3##(1995-1#1)(1996-1#1)(1997-1#1)(2004-2#1)(2006-12#1)(2008-11#2)(2013-1#2)
throughout the course and##2##4##(2008-11#2)
throughout the course of the experiment##2##6##(2004-11#1)(2008-7#1)
throughout the course of the study##2##6##(2008-7#1)(2013-1#1)
throughout the course of the##9##5##(1990-4#1)(1992-6#1)(1993-9#1)(1995-3#1)(2004-11#1)(2008-11#1)(2008-7#2)(2013-1#1)
throughout the course of treatment##2##5##(1995-9#1)(2013-7#1)
throughout the course of##13##4##(1990-4#1)(1992-6#1)(1993-3#1)(1993-9#1)(1995-3#1)(1995-9#1)(2004-11#1)(2007-12#1)(2008-11#1)(2008-7#2)(2013-1#1)(2013-7#1)
throughout the course##16##3##(1990-4#1)(1992-6#1)(1993-3#1)(1993-9#1)(1995-3#1)(1995-9#1)(2004-11#1)(2007-12#1)(2008-11#4)(2008-7#2)(2013-1#1)(2013-7#1)
throughout the culture period and##2##5##(1991-1#1)(2008-11#1)
throughout the culture period##4##4##(1991-1#1)(1993-3#1)(2008-11#2)
throughout the culture##5##3##(1991-1#1)(1993-3#1)(2008-11#3)
throughout the cytoplasm##4##3##(1994-10#1)(1996-9#1)(2008-11#1)(2013-1#1)
throughout the day and night##2##5##(1990-12#1)(2008-3#1)
throughout the day##10##3##(1990-12#1)(1991-2#1)(1994-6#1)(2006-12#1)(2007-7#1)(2008-3#1)(2008-5#2)(2010-1#2)
throughout the duration of the##2##5##(1996-2#1)(2009-4#1)
throughout the duration of##4##4##(1991-6#1)(1996-2#1)(2008-8#1)(2009-4#1)
throughout the embryo##2##3##(1995-3#1)(2008-8#1)
throughout the entire course of##2##5##(1995-11#1)(2006-2#1)
throughout the entire extent of the##2##6##(1991-9#1)(1995-11#1)
throughout the entire##24##3##(1991-9#1)(1992-12#1)(1993-3#1)(1995-11#2)(1996-12#2)(1997-5#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-5#1)(2007-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2010-3#1)(2010-9#1)(2012-1#2)
throughout the evolution of the##2##5##(1990-12#1)(2006-12#1)
throughout the experiment and##4##4##(1992-9#1)(2008-10#1)(2012-2#2)
throughout the experiment##13##3##(1992-9#1)(2004-9#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-12#1)(2010-5#1)(2012-2#2)(2013-1#2)
throughout the experimental##2##3##(1990-11#1)(1996-10#1)
throughout the first##2##3##(1996-5#1)(2008-11#1)
throughout the follow-up period##3##4##(1995-2#3)
throughout the following##3##3##(2005-10#1)(2007-11#1)(2009-4#1)
throughout the gastrointestinal tract##2##4##(1995-11#1)(1997-1#1)
throughout the genome##8##3##(2007-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-8#1)(2012-2#1)(2013-1#1)
throughout the grazing period##2##4##(1996-12#2)
throughout the grazing season##2##4##(1996-12#1)(2012-2#1)
throughout the grazing##4##3##(1996-12#3)(2012-2#1)
throughout the growing season in##2##5##(2008-10#2)
throughout the growing season##8##4##(2008-10#7)(2011-1#1)
throughout the health care##2##4##(1994-3#1)(2008-7#1)
throughout the history of##3##4##(2006-4#1)(2008-1#1)(2008-11#1)
throughout the hypothalamus##2##3##(1991-11#1)(1993-2#1)
throughout the infusion##2##3##(1992-10#1)(2007-10#1)
throughout the irradiation##2##3##(2010-5#2)
throughout the last##3##3##(2006-10#1)(2007-2#1)(2011-12#1)
throughout the length of the##2##5##(1996-3#1)(2008-7#1)
throughout the life cycle##2##4##(2007-4#1)(2008-10#1)
throughout the life of the##2##5##(2008-7#1)(2009-8#1)
throughout the life##7##3##(1991-6#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-11#1)
throughout the lifespan##2##3##(2007-2#1)(2008-7#1)
throughout the lungs##2##3##(2008-3#1)(2012-2#1)
throughout the male##2##3##(2008-7#1)(2013-8#1)
throughout the mammary gland in response to S##2##8##(2011-2#2)
throughout the menstrual cycle##2##4##(2006-10#1)(2006-3#1)
throughout the molecule##2##3##(1997-2#1)(2006-10#1)
throughout the nation##2##3##(1995-3#1)(2008-3#1)
throughout the nervous system##2##4##(1992-9#1)(2008-4#1)
throughout the observation period of##2##5##(1991-2#1)(2007-8#1)
throughout the observation period##5##4##(1990-8#1)(1991-2#1)(1994-5#1)(2007-1#1)(2007-8#1)
throughout the organization##9##3##(1992-12#1)(1994-1#2)(1995-1#1)(1995-3#2)(1996-1#1)(1996-3#1)(1997-1#1)
throughout the period of##3##4##(1992-3#1)(1993-7#1)(2009-6#1)
throughout the period##8##3##(1991-12#1)(1992-3#1)(1993-7#1)(1997-6#1)(2008-5#2)(2009-6#1)(2011-2#1)
throughout the periods##2##3##(1990-3#1)(2012-1#1)
throughout the plant##3##3##(2008-10#3)
throughout the plot##2##3##(2008-10#2)
throughout the procedure##3##3##(1992-1#1)(2010-7#2)
throughout the project##2##3##(2006-1#1)(2008-10#1)
throughout the province##3##3##(1992-10#1)(1993-9#1)(2007-2#1)
throughout the purification##2##3##(1992-11#1)(2007-8#1)
throughout the range of the##2##5##(2008-3#1)(2009-10#1)
throughout the range of##3##4##(2008-3#1)(2009-10#1)(2012-3#1)
throughout the range##4##3##(2005-10#1)(2008-3#1)(2009-10#1)(2012-3#1)
throughout the region##3##3##(2007-5#1)(2009-2#1)(2011-2#1)
throughout the research##3##3##(2010-8#1)(2012-12#1)(2013-1#1)
throughout the review##2##3##(1995-5#1)(2009-2#1)
throughout the same##2##3##(2008-10#1)(2008-7#1)
throughout the sampling period##2##4##(2008-5#2)
throughout the season##2##3##(2007-12#1)(2008-10#1)
throughout the seed##2##3##(2006-12#2)
throughout the series##2##3##(2007-2#1)(2008-7#1)
throughout the soil profile##2##4##(2008-10#2)
throughout the state##2##3##(2007-2#1)(2008-9#1)
throughout the study and##2##4##(2008-12#1)(2008-9#1)
throughout the study in the##2##5##(1996-6#1)(2008-7#1)
throughout the study period##13##4##(1991-8#1)(2006-12#1)(2007-3#1)(2007-5#1)(2007-9#2)(2008-10#3)(2008-8#1)(2010-8#1)(2013-1#1)(2013-7#1)
throughout the study##33##3##(1991-8#1)(1993-12#1)(1996-6#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#4)(2008-9#5)(2009-5#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
throughout the system##4##3##(1992-1#1)(1994-1#1)(1994-11#1)(2008-6#1)
throughout the test period##2##4##(1997-5#1)(2008-10#1)
throughout the three##2##3##(1993-7#1)(2013-8#1)
throughout the time period##2##4##(2008-9#1)(2010-11#1)
throughout the treatment##3##3##(2008-10#1)(2011-1#2)
throughout the tropical##2##3##(2007-5#1)(2010-5#1)
throughout the whole##6##3##(1992-12#1)(1996-3#1)(2007-12#1)(2008-10#1)(2009-11#1)(2010-2#1)
throughout the world and##7##4##(2006-10#1)(2007-11#2)(2008-10#1)(2009-6#1)(2009-9#1)(2013-8#1)
throughout the world are##2##4##(2009-10#1)(2010-12#1)
throughout the world have##2##4##(2006-8#1)(2008-7#1)
throughout the world in##3##4##(2008-1#1)(2008-8#1)(2008-9#1)
throughout the world##66##3##(1990-11#1)(1991-7#1)(1994-3#1)(1994-9#1)(1996-1#2)(2005-6#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-2#3)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#9)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#2)(2009-6#3)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#4)(2011-1#2)(2011-2#4)(2012-12#1)(2012-3#2)(2013-8#1)
throughout the year and##2##4##(1994-7#1)(2008-10#1)
throughout the year with##3##4##(2008-10#3)
throughout the year##26##3##(1991-12#1)(1993-9#1)(1994-7#1)(1995-1#1)(2004-2#3)(2007-10#1)(2007-3#1)(2007-5#1)(2008-10#6)(2008-3#1)(2008-5#3)(2008-6#1)(2009-4#1)(2011-1#1)(2013-7#1)(2013-8#2)
throughout the##700##2##(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-5#5)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#3)(1992-10#3)(1992-11#2)(1992-12#4)(1992-3#1)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#4)(1993-12#7)(1993-2#1)(1993-3#3)(1993-6#2)(1993-7#3)(1993-8#2)(1993-9#3)(1994-1#3)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#8)(1994-3#3)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#5)(1995-10#1)(1995-11#6)(1995-12#5)(1995-2#4)(1995-3#7)(1995-5#2)(1995-8#2)(1995-9#1)(1996-1#6)(1996-10#1)(1996-11#1)(1996-12#8)(1996-2#3)(1996-3#5)(1996-5#4)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#5)(1997-2#3)(1997-3#5)(1997-4#2)(1997-5#3)(1997-6#3)(1997-7#2)(2004-11#1)(2004-2#7)(2004-4#1)(2004-9#2)(2005-10#7)(2005-11#4)(2005-12#1)(2005-5#1)(2005-6#1)(2005-7#2)(2005-8#2)(2006-1#3)(2006-10#8)(2006-11#2)(2006-12#7)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-1#2)(2007-10#3)(2007-11#9)(2007-12#16)(2007-2#10)(2007-3#4)(2007-4#5)(2007-5#7)(2007-6#2)(2007-7#4)(2007-8#6)(2007-9#7)(2008-1#7)(2008-10#77)(2008-11#17)(2008-12#5)(2008-2#10)(2008-3#17)(2008-4#8)(2008-5#15)(2008-6#5)(2008-7#23)(2008-8#15)(2008-9#11)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#4)(2009-5#2)(2009-6#7)(2009-7#1)(2009-8#7)(2009-9#4)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#5)(2010-6#2)(2010-7#3)(2010-8#8)(2010-9#2)(2011-1#9)(2011-12#2)(2011-2#18)(2012-1#6)(2012-11#2)(2012-12#4)(2012-2#8)(2012-3#6)(2012-7#1)(2013-1#12)(2013-7#4)(2013-8#13)
throughout their life cycle##2##4##(1991-10#1)(1993-9#1)
throughout their lives##2##3##(1993-9#1)(2012-3#1)
throughout their##16##2##(1991-10#1)(1991-9#1)(1993-9#2)(2006-5#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-9#1)(2010-12#1)(2012-3#1)(2013-8#1)
throughout this paper##2##3##(1992-12#1)(2008-11#1)
throughout this##7##2##(1991-5#1)(1992-12#1)(1995-2#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-10#1)
throughout three##2##2##(1995-5#1)(2010-12#1)
throughout treatment and##2##3##(2008-10#1)(2012-1#1)
throughout treatment##4##2##(2008-10#1)(2008-6#1)(2009-7#1)(2012-1#1)
throughout with##2##2##(2006-10#1)(2011-2#1)
throughout##1045##1##(1990-10#1)(1990-11#4)(1990-12#4)(1990-2#1)(1990-3#4)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#5)(1991-2#3)(1991-3#2)(1991-5#6)(1991-6#4)(1991-7#2)(1991-8#2)(1991-9#4)(1992-1#5)(1992-10#3)(1992-11#3)(1992-12#6)(1992-3#3)(1992-5#2)(1992-6#3)(1992-8#5)(1992-9#7)(1993-11#3)(1993-12#11)(1993-2#2)(1993-3#3)(1993-5#1)(1993-6#3)(1993-7#3)(1993-8#2)(1993-9#5)(1994-1#4)(1994-10#2)(1994-11#1)(1994-12#4)(1994-2#11)(1994-3#4)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#4)(1995-1#5)(1995-10#2)(1995-11#7)(1995-12#5)(1995-2#7)(1995-3#8)(1995-5#4)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#7)(1996-10#3)(1996-11#2)(1996-12#8)(1996-2#3)(1996-3#9)(1996-4#5)(1996-5#7)(1996-6#3)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#6)(1997-2#6)(1997-3#6)(1997-4#3)(1997-5#4)(1997-6#5)(1997-7#3)(2004-10#1)(2004-11#1)(2004-2#7)(2004-4#1)(2004-9#2)(2005-10#9)(2005-11#4)(2005-12#1)(2005-4#1)(2005-5#1)(2005-6#1)(2005-7#2)(2005-8#3)(2006-1#4)(2006-10#14)(2006-11#3)(2006-12#9)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#5)(2006-6#3)(2006-7#1)(2006-8#1)(2007-1#4)(2007-10#8)(2007-11#11)(2007-12#28)(2007-2#21)(2007-3#5)(2007-4#6)(2007-5#7)(2007-6#2)(2007-7#5)(2007-8#9)(2007-9#11)(2008-1#9)(2008-10#112)(2008-11#22)(2008-12#11)(2008-2#16)(2008-3#22)(2008-4#14)(2008-5#27)(2008-6#8)(2008-7#30)(2008-8#21)(2008-9#21)(2009-10#3)(2009-11#3)(2009-12#2)(2009-2#5)(2009-3#3)(2009-4#7)(2009-5#4)(2009-6#7)(2009-7#2)(2009-8#11)(2009-9#6)(2010-1#3)(2010-10#5)(2010-11#6)(2010-12#8)(2010-2#1)(2010-3#3)(2010-4#6)(2010-5#6)(2010-6#2)(2010-7#3)(2010-8#8)(2010-9#6)(2011-1#14)(2011-12#3)(2011-2#31)(2012-1#8)(2012-11#3)(2012-12#6)(2012-2#18)(2012-3#7)(2012-7#1)(2013-1#14)(2013-7#6)(2013-8#23)
throughput analysis of the##2##4##(2008-10#2)
throughput analysis of##3##3##(2008-10#2)(2008-4#1)
throughput and##18##2##(1995-1#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-4#1)(2011-1#1)(2012-2#1)
throughput for the##2##3##(2008-10#2)
throughput is##10##2##(1994-3#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-5#1)
throughput of 10h(-1)##3##3##(2008-10#3)
throughput of 20 samples##2##4##(2008-10#2)
throughput of 20##4##3##(2008-10#4)
throughput of 25h(-1)##2##3##(2008-10#2)
throughput of 40##4##3##(2008-10#4)
throughput of 50##2##3##(2008-10#2)
throughput of 60##2##3##(2008-10#2)
throughput of 7##2##3##(2008-10#2)
throughput of samples##2##3##(2007-1#1)(2008-10#1)
throughput of the##11##3##(2005-4#1)(2006-12#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-4#1)
throughput of this##2##3##(2008-1#1)(2008-10#1)
throughput of up to##2##4##(2008-10#2)
throughput of##78##2##(1990-12#1)(2005-4#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-10#52)(2008-11#1)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#2)(2010-2#1)
throughput rate##4##2##(2008-10#4)
throughput screening##18##2##(1993-11#1)(2005-8#1)(2007-11#1)(2007-8#1)(2008-10#8)(2009-6#2)(2010-12#2)(2011-2#1)(2012-11#1)
throughput technologies##2##2##(2008-11#1)(2012-3#1)
throughput up to##2##3##(2008-10#2)
throughput was 20##2##3##(2008-10#2)
throughput was##17##2##(2007-9#1)(2008-10#16)
throughput with##2##2##(2008-2#1)(2008-3#1)
throughput##278##1##(1990-1#1)(1990-11#1)(1990-12#1)(1992-11#1)(1993-11#1)(1994-3#1)(1995-1#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-6#1)(2005-12#1)(2005-4#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-6#1)(2007-8#6)(2007-9#2)(2008-1#3)(2008-10#141)(2008-11#6)(2008-2#21)(2008-3#13)(2008-4#9)(2008-5#4)(2008-6#2)(2008-7#5)(2008-9#2)(2009-3#1)(2009-4#2)(2009-6#3)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#6)(2010-2#1)(2010-4#1)(2011-1#4)(2011-2#4)(2012-11#1)(2012-2#2)(2012-3#3)(2013-1#4)
throughputs of##2##2##(2008-10#1)(2008-3#1)
throughputs##8##1##(2008-10#3)(2008-3#3)(2008-7#2)
throw a##2##2##(2008-4#1)(2013-8#1)
throw caution##2##2##(2006-10#1)(2008-11#1)
throw light on##4##3##(1992-8#1)(1996-8#1)(2008-1#1)(2010-3#1)
throw##14##1##(1992-8#1)(1996-8#1)(1997-3#2)(2006-10#2)(2007-10#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-3#1)(2013-8#1)
throwaways##5##1##(2006-8#5)
thrower's elbow##3##2##(2008-8#3)
throwing athletes##2##2##(2006-10#1)(2007-10#1)
throwing money##2##2##(2008-7#2)
throwing power##2##2##(2005-11#2)
throwing##12##1##(2005-11#2)(2006-10#1)(2007-10#2)(2007-12#1)(2007-9#1)(2008-7#2)(2008-8#2)(2009-1#1)
thrown into##2##2##(2006-10#1)(2013-1#1)
thrown##7##1##(1991-4#1)(2006-10#1)(2008-11#1)(2008-4#1)(2009-10#1)(2011-2#1)(2013-1#1)
throws##3##1##(2008-8#1)(2011-2#1)(2013-7#1)
thrush (Turdus chrysolaus)##2##3##(1997-4#2)
thrush##8##1##(1997-4#2)(2007-2#1)(2007-3#2)(2008-9#2)(2010-5#1)
thrust manipulation and##3##3##(2008-12#3)
thrust manipulation##6##2##(2007-11#1)(2008-12#5)
thrust of##3##2##(1994-9#1)(2008-4#1)(2009-3#1)
thrust production##2##2##(2009-9#2)
thrust to the##2##3##(1994-1#1)(2007-11#1)
thrust to##3##2##(1994-1#1)(2007-11#1)(2009-9#1)
thrust##32##1##(1992-6#1)(1994-1#1)(1994-9#1)(1997-3#1)(1997-7#1)(2005-7#2)(2006-10#1)(2007-11#2)(2007-4#2)(2007-7#1)(2008-12#6)(2008-2#1)(2008-4#1)(2009-3#1)(2009-9#5)(2010-8#2)(2011-1#1)(2012-2#1)(2013-1#1)
thrusts##2##1##(2010-2#1)(2011-1#1)
thuiswonende##3##1##(2012-12#3)
thulium laser##3##2##(2008-2#1)(2008-3#2)
thulium##4##1##(2008-2#2)(2008-3#2)
thulium-doped fiber amplifier (TDFA)##2##4##(2007-12#2)
thulium-doped fiber amplifier##3##3##(2007-12#3)
thulium-doped fiber##5##2##(2007-12#3)(2008-3#2)
thulium-doped fluorozirconate fiber##2##3##(2007-12#2)
thulium-doped##10##1##(2007-11#1)(2007-12#5)(2008-2#1)(2008-3#3)
thumb and little finger##3##4##(1997-8#3)
thumb and##7##2##(1996-2#1)(1996-3#1)(1997-8#3)(2007-7#1)(2012-3#1)
thumb carpometacarpal##2##2##(2006-3#1)(2008-9#1)
thumb domain##2##2##(1997-1#1)(2011-1#1)
thumb hypoplasia##3##2##(1996-3#1)(2008-9#2)
thumb metacarpal##3##2##(2006-3#1)(2008-9#1)(2009-3#1)
thumb metacarpophalangeal joint##2##3##(2006-3#1)(2008-9#1)
thumb metacarpophalangeal##3##2##(2006-3#2)(2008-9#1)
thumb reconstruction##3##2##(2006-3#1)(2006-6#1)(2008-9#1)
thumb spica##2##2##(2008-9#2)
thumb with##5##2##(2006-3#1)(2007-11#1)(2007-7#1)(2008-3#1)(2010-6#1)
thumb##97##1##(1990-8#1)(1992-9#1)(1995-12#1)(1996-11#1)(1996-2#2)(1996-3#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-8#4)(2006-10#2)(2006-3#23)(2006-4#1)(2006-5#1)(2006-6#2)(2007-11#2)(2007-7#7)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#3)(2008-9#19)(2009-10#2)(2009-3#1)(2009-5#2)(2010-6#4)(2010-7#2)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)
thumbs down to##2##3##(1993-6#1)(1995-8#1)
thumbs down##3##2##(1992-6#1)(1993-6#1)(1995-8#1)
thumbs##9##1##(1992-6#1)(1993-6#1)(1995-8#1)(1996-3#1)(2005-12#1)(2006-3#1)(2008-12#1)(2010-12#1)(2012-3#1)
thummi##5##1##(1991-5#5)
thunderclap##2##1##(2010-12#2)
thuringiensis delta endotoxin##3##3##(1991-12#3)
thuringiensis subsp##8##2##(1993-12#2)(1994-3#1)(2004-11#2)(2013-1#3)
thuringiensis var##7##2##(1990-7#5)(2008-11#1)(2011-12#1)
thuringiensis##57##1##(1990-3#1)(1990-7#5)(1990-9#1)(1991-12#3)(1993-12#2)(1993-8#1)(1994-2#2)(1994-3#2)(1994-6#2)(1995-2#2)(1995-6#1)(1997-6#2)(2004-11#3)(2005-11#4)(2007-11#1)(2007-12#1)(2007-6#3)(2008-10#4)(2008-11#1)(2008-5#4)(2008-9#1)(2010-10#1)(2011-12#2)(2011-2#4)(2013-1#4)
thus 3##2##2##(1994-12#1)(2008-1#1)
thus a very##2##3##(2008-10#1)(2008-2#1)
thus a##32##2##(1990-12#1)(1990-6#1)(1991-5#1)(1992-3#1)(1994-10#1)(1996-12#1)(1996-6#1)(1997-3#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#2)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
thus able to##3##3##(2008-2#2)(2011-2#1)
thus accounting for the##2##4##(2008-2#1)(2008-8#1)
thus accounting for##3##3##(1991-4#1)(2008-2#1)(2008-8#1)
thus achieving a##2##3##(2005-4#1)(2008-10#1)
thus achieving##4##2##(1996-1#1)(2005-4#1)(2006-2#1)(2008-10#1)
thus acting as##4##3##(2007-11#1)(2007-6#1)(2008-5#1)(2010-12#1)
thus acts as##2##3##(2007-12#1)(2010-2#1)
thus acts##3##2##(1994-12#1)(2007-12#1)(2010-2#1)
thus adding##3##2##(1990-8#1)(1996-1#1)(2013-7#1)
thus affect##2##2##(2007-11#1)(2008-6#1)
thus affecting the##2##3##(2008-1#1)(2012-2#1)
thus affecting##4##2##(2008-1#1)(2008-5#1)(2012-2#1)(2013-7#1)
thus affording##3##2##(2007-11#1)(2008-10#1)(2010-8#1)
thus aiding##2##2##(2008-11#1)(2010-12#1)
thus aimed##2##2##(2012-12#2)
thus allow##3##2##(1996-11#1)(2008-3#1)(2009-5#1)
thus allowing a##3##3##(1994-3#1)(2009-10#1)(2010-4#1)
thus allowing for the##2##4##(1996-10#1)(2007-8#1)
thus allowing for##3##3##(1996-10#1)(2006-6#1)(2007-8#1)
thus allowing the##5##3##(2006-10#1)(2007-11#1)(2007-9#1)(2008-2#1)(2008-8#1)
thus allowing us to##2##4##(1991-2#1)(2008-3#1)
thus allowing##31##2##(1990-11#1)(1991-2#1)(1991-9#1)(1993-10#1)(1993-12#1)(1993-2#1)(1994-3#1)(1996-10#1)(1996-12#1)(1996-5#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-4#1)
thus allows##2##2##(2008-10#1)(2009-8#1)
thus also##8##2##(1990-3#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-5#2)(2010-5#1)
thus alter##3##2##(1990-3#1)(1995-3#1)(2008-11#1)
thus always##2##2##(1994-12#1)(1996-2#1)
thus ameliorate##2##2##(1992-8#1)(2013-1#1)
thus an##9##2##(1991-2#1)(1992-1#1)(1995-9#1)(1996-5#1)(1997-3#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-1#1)
thus apparently##2##2##(2008-10#1)(2010-2#1)
thus appear to be##4##4##(1991-3#1)(1992-6#1)(1994-11#1)(2009-8#1)
thus appear to offer##2##4##(2008-1#1)(2008-10#1)
thus appear to##12##3##(1990-3#1)(1991-3#1)(1992-6#1)(1992-7#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2009-8#1)
thus appear##13##2##(1990-3#1)(1991-3#1)(1992-6#1)(1992-7#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2009-8#1)
thus appeared to##2##3##(1992-1#1)(2008-5#1)
thus appeared##3##2##(1992-1#1)(1995-8#1)(2008-5#1)
thus appears that##5##3##(1990-4#1)(1990-7#1)(1991-7#1)(1996-3#1)(2008-7#1)
thus appears to be a##2##5##(1994-12#1)(1995-1#1)
thus appears to be##6##4##(1990-12#1)(1993-9#1)(1994-12#1)(1995-1#1)(1995-3#1)(2012-2#1)
thus appears to##9##3##(1990-12#1)(1990-5#1)(1993-12#1)(1993-9#1)(1994-12#1)(1995-1#1)(1995-3#1)(2010-2#1)(2012-2#1)
thus appears##16##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-7#1)(1993-12#1)(1993-9#1)(1994-12#1)(1995-1#1)(1995-3#1)(1996-3#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-2#1)
thus are##9##2##(1990-12#1)(1991-6#1)(1995-10#1)(1995-8#1)(2006-12#1)(2008-4#1)(2009-5#1)(2010-4#1)(2012-12#1)
thus as##2##2##(2006-4#1)(2013-1#1)
thus assuring##2##2##(2008-10#1)(2008-5#1)
thus at##3##2##(1992-10#1)(1993-9#1)(1997-7#1)
thus attained##2##2##(2007-8#1)(2008-10#1)
thus avoided##4##2##(2006-9#1)(2008-10#3)
thus avoiding the necessity of##2##5##(2008-3#2)
thus avoiding the need##2##4##(1991-11#1)(2007-8#1)
thus avoiding the use of##3##5##(1996-9#1)(2008-10#1)(2008-2#1)
thus avoiding the##11##3##(1991-11#1)(1996-9#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#2)(2010-8#1)(2012-12#1)
thus avoiding##22##2##(1991-11#1)(1991-8#1)(1992-9#1)(1996-9#1)(2005-12#1)(2007-12#3)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#2)(2008-8#1)(2010-8#1)(2012-12#2)
thus be a##4##3##(1990-7#1)(1994-11#1)(2008-3#1)(2008-4#1)
thus be capable of##2##4##(1990-7#1)(2006-8#1)
thus be considered as##2##4##(1993-2#1)(1997-3#1)
thus be suitable for##2##4##(2007-12#1)(2008-1#1)
thus be used for##2##4##(2008-10#2)
thus be used in##2##4##(1991-3#1)(2008-10#1)
thus be used##6##3##(1991-3#1)(2008-10#3)(2008-11#1)(2008-5#1)
thus be##57##2##(1990-10#1)(1990-2#1)(1990-6#1)(1990-7#2)(1991-2#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-7#1)(1993-12#2)(1993-2#1)(1994-11#1)(1994-6#2)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-2#2)(1997-3#1)(2005-4#1)(2005-8#1)(2006-6#2)(2006-8#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#2)
thus become##3##2##(2006-6#1)(2007-6#1)(2008-10#1)
thus been##7##2##(1990-2#1)(1995-6#1)(2005-8#1)(2006-1#1)(2008-1#1)(2008-2#1)(2009-5#1)
thus being the##2##3##(2008-5#1)(2012-3#1)
thus being##8##2##(1997-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
thus believe that the##2##4##(1997-8#1)(2007-12#1)
thus both##3##2##(1992-7#1)(2008-11#1)(2008-2#1)
thus building a##2##3##(2008-10#1)(2008-2#1)
thus bypassing##2##2##(1995-8#1)(2008-5#1)
thus can be used to##3##5##(2008-2#1)(2010-2#1)(2012-3#1)
thus can be used##6##4##(2008-11#2)(2008-2#1)(2009-6#1)(2010-2#1)(2012-3#1)
thus can be##11##3##(1997-3#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-2#1)(2012-3#1)
thus can##17##2##(1993-2#1)(1997-3#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-7#1)
thus cannot##4##2##(1995-3#1)(1996-1#1)(2007-12#1)(2008-4#1)
thus causing##7##2##(2005-12#1)(2007-4#1)(2008-11#1)(2008-3#2)(2008-4#1)(2010-2#1)
thus closely##2##2##(1992-1#1)(2008-10#1)
thus concluded that##5##3##(1991-7#1)(1994-2#1)(1994-9#1)(1995-3#1)(2009-8#1)
thus concluded##6##2##(1991-7#1)(1994-2#1)(1994-9#1)(1995-3#1)(2007-10#1)(2009-8#1)
thus confirm the##2##3##(1991-8#1)(1997-6#1)
thus confirming that##2##3##(1994-5#1)(2012-2#1)
thus confirming the##7##3##(1990-7#1)(1992-6#2)(1994-6#2)(1996-11#1)(2013-1#1)
thus confirming##12##2##(1990-7#1)(1992-6#2)(1994-5#1)(1994-6#2)(1996-11#1)(2007-7#1)(2008-10#1)(2012-2#1)(2012-6#1)(2013-1#1)
thus considered to be##2##4##(1994-3#1)(2006-10#1)
thus considered to##4##3##(1994-3#1)(2006-10#1)(2008-11#1)(2010-3#1)
thus constitute##3##2##(1990-11#1)(1996-10#1)(2009-10#1)
thus constitutes the##2##3##(2007-12#1)(2012-2#1)
thus constitutes##5##2##(2007-12#2)(2009-6#1)(2012-2#2)
thus constructed##2##2##(2008-11#1)(2008-8#1)
thus contribute to##5##3##(1992-2#1)(2007-5#1)(2008-10#1)(2008-5#1)(2013-1#1)
thus contributing to the##2##4##(2009-6#1)(2012-12#1)
thus contributing to##7##3##(1990-8#1)(1992-2#1)(2008-10#1)(2009-6#1)(2012-12#2)(2013-1#1)
thus could##12##2##(1994-12#1)(1995-1#1)(2005-12#1)(2006-4#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-6#1)(2010-3#1)(2013-1#1)(2013-8#1)
thus created##4##2##(1995-6#1)(2006-3#1)(2007-12#1)(2011-1#1)
thus creating a##4##3##(1991-6#1)(2007-7#1)(2008-10#1)(2008-2#1)
thus creating the##2##3##(1990-5#1)(2011-1#1)
thus creating##6##2##(1990-5#1)(1991-6#1)(2007-7#1)(2008-10#1)(2008-2#1)(2011-1#1)
thus decreasing the##6##3##(1995-10#1)(1995-5#1)(2006-8#1)(2008-10#1)(2008-3#1)(2013-1#1)
thus decreasing##10##2##(1995-10#1)(1995-5#1)(2006-6#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-12#1)(2013-1#2)
thus defining the##3##3##(2009-10#1)(2011-1#2)
thus defining##4##2##(2008-10#1)(2009-10#1)(2011-1#2)
thus delaying##2##2##(2006-10#1)(2007-7#1)
thus demonstrate##3##2##(1990-12#1)(1992-4#1)(2008-2#1)
thus demonstrated##4##2##(1994-3#1)(2005-4#1)(2008-10#1)(2008-11#1)
thus demonstrates that##2##3##(1997-8#1)(2008-12#1)
thus demonstrates##3##2##(1997-8#1)(2008-12#1)(2012-2#1)
thus demonstrating that##3##3##(1990-5#1)(1993-9#1)(1996-3#1)
thus demonstrating the potential##2##4##(2004-9#1)(2011-2#1)
thus demonstrating the##10##3##(2004-9#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-12#1)(2011-1#1)(2011-2#1)
thus demonstrating##16##2##(1990-5#1)(1993-9#1)(1994-3#1)(1996-3#1)(2004-9#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
thus determined##6##2##(1991-2#1)(1993-11#1)(1994-5#1)(2008-10#3)
thus developed##4##2##(1992-7#1)(2006-8#1)(2008-10#1)(2012-2#1)
thus differed##2##2##(1992-8#1)(2008-7#1)
thus do not##2##3##(2008-11#1)(2012-3#1)
thus eliciting##2##2##(1996-1#1)(2013-8#1)
thus eliminating the##4##3##(1992-2#1)(2007-11#1)(2008-10#1)(2010-1#1)
thus eliminating##6##2##(1992-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-1#1)
thus enabling a##2##3##(2006-6#1)(2013-8#1)
thus enabling the##5##3##(2006-11#1)(2008-10#1)(2009-2#1)(2010-4#1)(2010-6#1)
thus enabling##14##2##(2006-11#1)(2006-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-4#1)(2010-6#1)(2012-1#1)(2012-12#1)(2013-8#1)
thus enhance##2##2##(1995-10#1)(2008-2#1)
thus enhances##2##2##(2007-12#1)(2012-3#1)
thus enhancing the##2##3##(2005-11#1)(2008-2#1)
thus enhancing##4##2##(2005-11#1)(2007-12#2)(2008-2#1)
thus ensuring##5##2##(2008-12#1)(2008-3#2)(2010-7#1)(2012-3#1)
thus established##2##2##(2008-10#1)(2008-11#1)
thus establishing##2##2##(2007-12#1)(2008-10#1)
thus examined##3##2##(1995-2#1)(2008-4#1)(2008-7#1)
thus excluding##3##2##(1992-1#1)(1996-11#1)(2005-8#1)
thus exerting##2##2##(2006-12#1)(2013-1#1)
thus expected##2##2##(2005-11#1)(2008-2#1)
thus explaining##3##2##(1992-8#1)(1993-6#1)(2009-2#1)
thus exposing the##2##3##(2007-1#1)(2007-12#1)
thus extend the##2##3##(2007-12#2)
thus extend##3##2##(2007-12#2)(2011-3#1)
thus extended to##2##3##(2008-2#1)(2008-7#1)
thus extending the##3##3##(1996-12#1)(2007-11#1)(2007-12#1)
thus extending##4##2##(1996-12#1)(2007-11#1)(2007-12#1)(2013-8#1)
thus facilitate the##2##3##(1994-6#1)(2009-4#1)
thus facilitate##4##2##(1994-6#1)(1996-6#1)(2009-4#1)(2013-1#1)
thus facilitating the##4##3##(2008-10#2)(2008-3#1)(2008-7#1)
thus facilitating use of standard data mining algorithms##2##8##(2013-1#2)
thus facilitating##13##2##(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
thus far been##3##3##(1994-9#1)(1995-5#1)(2007-7#1)
thus far described##2##3##(1997-1#1)(2006-11#1)
thus far for##2##3##(2005-11#1)(2010-2#1)
thus far in the##3##4##(2007-1#1)(2008-10#1)(2011-2#1)
thus far in##6##3##(2007-1#1)(2008-10#2)(2009-8#1)(2011-1#1)(2011-2#1)
thus far is##2##3##(1994-5#1)(2004-12#1)
thus far reported in the literature##2##6##(2008-2#1)(2008-3#1)
thus far reported##5##3##(1993-6#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
thus far##69##2##(1990-2#1)(1991-12#3)(1993-11#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-9#1)(1997-1#3)(1997-5#2)(2004-12#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-11#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-9#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#2)
thus favoring##2##2##(2004-11#1)(2006-5#1)
thus finding##2##2##(2007-11#1)(2007-12#1)
thus for the##3##3##(1990-7#1)(1997-2#1)(2008-5#1)
thus for##4##2##(1990-7#1)(1997-2#1)(2008-5#1)(2010-8#1)
thus formed is##4##3##(2007-11#2)(2007-7#1)(2008-7#1)
thus formed##10##2##(1990-9#1)(1991-10#1)(2007-11#2)(2007-7#1)(2008-10#3)(2008-7#1)(2010-5#1)
thus forming##6##2##(1994-5#1)(2007-12#2)(2008-5#1)(2009-8#1)(2010-4#1)
thus found##2##2##(1994-12#1)(2008-2#1)
thus further##2##2##(2005-7#1)(2013-7#1)
thus generally##2##2##(2008-10#1)(2008-4#1)
thus generated##8##2##(1992-11#1)(1995-12#1)(1996-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-6#1)(2010-2#1)
thus give##3##2##(1996-12#1)(2007-12#1)(2008-7#1)
thus giving a##2##3##(2008-3#1)(2008-5#1)
thus giving rise to##4##4##(1991-9#1)(1992-2#1)(2008-1#1)(2009-1#1)
thus giving##9##2##(1991-9#1)(1992-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2009-1#1)
thus greatly##3##2##(2005-7#1)(2008-10#1)(2008-3#1)
thus harbors##2##2##(2009-5#1)(2009-8#1)
thus has a##3##3##(1990-3#1)(2008-3#1)(2012-2#1)
thus has##6##2##(1990-3#1)(1993-11#1)(2008-10#1)(2008-3#1)(2010-5#1)(2012-2#1)
thus have been##2##3##(1993-8#1)(1994-12#1)
thus have##10##2##(1991-12#1)(1993-11#1)(1993-8#1)(1994-12#1)(1996-5#1)(2007-9#1)(2008-2#1)(2008-7#1)(2008-8#1)(2013-1#1)
thus having##2##2##(2007-11#1)(2008-5#1)
thus help##3##2##(2008-3#1)(2012-3#1)(2013-1#1)
thus helping##3##2##(2007-9#1)(2008-5#1)(2012-2#1)
thus highlighting##2##2##(2012-12#1)(2013-8#1)
thus identified##7##2##(1992-12#1)(1995-4#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-2#1)
thus identifying##5##2##(1994-8#1)(1995-9#1)(1996-4#1)(2008-4#1)(2011-3#1)
thus illustrate##2##2##(2012-2#2)
thus illustrating the##2##3##(1997-2#1)(2008-10#1)
thus impairing their##2##3##(2008-10#1)(2010-2#1)
thus implicating##3##2##(2007-9#1)(2010-10#1)(2012-2#1)
thus implying##3##2##(1990-5#1)(2008-11#1)(2008-8#1)
thus improved##4##2##(2008-2#1)(2008-4#1)(2009-4#1)(2011-2#1)
thus improving the##5##3##(2007-8#1)(2008-10#1)(2008-2#1)(2011-2#1)(2012-2#1)
thus improving##14##2##(1994-6#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#2)
thus in##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
thus increasing its##2##3##(1995-9#1)(2012-12#1)
thus increasing the risk##2##4##(2009-3#1)(2010-3#1)
thus increasing the##13##3##(1993-2#1)(1995-1#1)(1996-2#1)(1997-1#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-3#1)(2010-3#1)(2012-12#1)
thus increasing##20##2##(1992-3#1)(1993-2#1)(1994-8#1)(1995-1#1)(1995-9#1)(1996-2#1)(1997-1#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-3#1)(2010-3#1)(2012-12#3)
thus indicate that##8##3##(1990-3#1)(1990-5#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-11#1)(1997-8#1)(2008-10#1)
thus indicate##12##2##(1990-3#1)(1990-5#1)(1994-2#1)(1994-6#1)(1995-2#2)(1995-6#1)(1996-11#1)(1996-5#1)(1997-8#1)(2008-10#1)(2008-4#1)
thus indicates that##2##3##(1993-7#1)(1994-8#1)
thus indicating a##6##3##(1991-12#1)(1992-12#1)(1994-9#1)(1995-11#1)(1997-2#1)(2008-10#1)
thus indicating that the##2##4##(1990-10#1)(2006-8#1)
thus indicating that these##2##4##(1990-2#1)(1995-5#1)
thus indicating that##10##3##(1990-10#2)(1990-2#1)(1991-5#1)(1992-8#1)(1993-11#1)(1995-3#1)(1995-5#1)(2006-8#1)(2008-4#1)
thus indicating the existence of a##2##6##(2008-5#1)(2008-8#1)
thus indicating the possibility of using mild conditions for sample preparation instead of intensive treatments inherent with the digestion##2##19##(2008-10#2)
thus indicating the possibility of using##3##6##(2008-10#3)
thus indicating the##8##3##(1990-8#1)(1994-6#1)(2008-10#4)(2008-5#1)(2008-8#1)
thus indicating##29##2##(1990-10#2)(1990-2#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-8#1)(1993-11#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-8#1)(1997-2#1)(2006-8#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-10#1)(2010-6#1)(2011-12#1)
thus inducing the##2##3##(2007-2#2)
thus inducing##3##2##(1993-11#1)(2007-2#2)
thus inhibit##2##2##(2005-7#1)(2011-3#1)
thus inhibiting##2##2##(2007-11#1)(2009-8#1)
thus inhibits##3##2##(1993-9#1)(1995-2#1)(2007-11#1)
thus interfering with##2##3##(1990-12#1)(2009-10#1)
thus involved##2##2##(1994-8#1)(1995-12#1)
thus is##12##2##(1992-4#1)(1993-11#1)(1995-1#1)(1995-8#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-3#1)(2011-2#1)(2012-3#1)
thus it does not##2##4##(2008-3#1)(2012-12#1)
thus it is##4##3##(2006-11#1)(2008-11#1)(2008-4#1)(2009-5#1)
thus it##19##2##(1994-8#1)(2006-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#1)
thus its##9##2##(1990-6#1)(1991-5#1)(1997-5#1)(1997-7#1)(2006-5#1)(2007-11#1)(2007-5#1)(2008-10#1)(2013-8#1)
thus justifying##2##2##(2008-4#1)(2008-6#1)
thus keeping##2##2##(1991-6#1)(2008-3#1)
thus lead to##4##3##(1992-12#1)(2007-8#1)(2008-6#1)(2011-10#1)
thus leading to a##6##4##(1991-5#1)(1993-9#1)(2005-11#1)(2006-5#1)(2008-6#1)(2011-2#1)
thus leading to##13##3##(1991-5#1)(1992-8#1)(1993-9#1)(2005-11#1)(2006-5#1)(2008-2#2)(2008-4#1)(2008-6#1)(2009-1#1)(2010-12#1)(2011-2#2)
thus leading##16##2##(1991-5#1)(1992-8#1)(1993-9#1)(1997-7#1)(2005-11#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-6#1)(2009-1#1)(2010-12#1)(2011-2#2)
thus leaving##2##2##(2008-2#1)(2012-2#1)
thus likely to have##2##4##(1995-5#1)(2008-8#1)
thus likely to##3##3##(1995-5#1)(2008-8#1)(2009-9#1)
thus likely##10##2##(1990-7#1)(1994-12#1)(1995-5#1)(1997-5#1)(2006-10#1)(2008-10#1)(2008-8#2)(2009-9#1)(2011-2#1)
thus limit##2##2##(2007-12#1)(2008-2#1)
thus limiting the##3##3##(1994-2#1)(1997-2#1)(2006-6#1)
thus limiting##6##2##(1994-2#1)(1997-1#1)(1997-2#1)(2006-6#1)(2007-12#1)(2012-12#1)
thus lowering##2##2##(2008-10#1)(2008-11#1)
thus made##3##2##(2007-8#1)(2011-1#1)(2012-2#1)
thus maintaining their##2##3##(1992-12#1)(2007-12#1)
thus makes it possible to##2##5##(1992-6#1)(2007-8#1)
thus making it possible to##2##5##(1997-2#1)(2013-7#1)
thus making it##9##3##(1994-10#1)(1997-2#1)(2005-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-2#1)(2013-7#1)
thus making the##7##3##(2006-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-3#1)(2013-8#1)
thus making them##3##3##(2008-10#1)(2008-2#1)(2010-2#1)
thus making use of##2##4##(2008-10#1)(2008-2#1)
thus making##32##2##(1991-8#1)(1994-10#1)(1997-2#1)(1997-4#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-8#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#4)(2008-4#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-2#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
thus many##2##2##(1991-6#1)(2008-11#1)
thus may be##11##3##(1991-3#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2011-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
thus may play a##3##4##(1990-7#1)(1996-10#1)(2012-2#1)
thus may##29##2##(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#2)(1995-11#2)(1995-3#2)(1995-9#1)(1996-10#1)(1996-2#2)(2005-12#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-1#1)(2011-11#1)(2012-12#1)(2012-2#2)(2012-3#1)
thus metabolism##2##2##(2006-7#1)(2008-11#1)
thus minimizing the##2##3##(2008-10#1)(2008-4#1)
thus minimizing##4##2##(2008-10#2)(2008-4#1)(2011-9#1)
thus modifying the##4##3##(1994-11#1)(2007-12#1)(2008-3#1)(2008-5#1)
thus more likely to##2##4##(2007-4#1)(2008-8#1)
thus more##6##2##(1991-11#1)(1992-3#1)(2005-10#1)(2007-12#1)(2007-4#1)(2008-8#1)
thus necessary##3##2##(2005-11#1)(2008-5#1)(2012-2#1)
thus needs to be##2##4##(1997-8#1)(2008-10#1)
thus no##3##2##(1991-11#1)(2005-4#1)(2007-8#1)
thus not only##2##3##(1990-2#1)(1997-7#1)
thus not##11##2##(1990-2#1)(1991-11#1)(1992-5#1)(1994-11#1)(1997-5#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)
thus obtained are##2##3##(2008-10#1)(2011-1#1)
thus obtained from##2##3##(2005-11#1)(2007-11#1)
thus obtained is##2##3##(2007-11#1)(2008-10#1)
thus obtained was##2##3##(1991-5#1)(2008-10#1)
thus obtained were##2##3##(1996-10#1)(2008-5#1)
thus obtained##21##2##(1990-3#1)(1991-5#1)(1995-11#1)(1996-10#1)(1996-5#2)(2005-11#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-9#1)(2008-10#5)(2008-5#1)(2011-1#1)
thus of##5##2##(1992-6#1)(2008-3#1)(2008-6#1)(2010-9#1)(2011-2#1)
thus offer##3##2##(2007-12#1)(2008-8#1)(2009-10#1)
thus offering a##3##3##(2007-12#1)(2008-9#1)(2011-2#1)
thus offering the##2##3##(2008-5#1)(2009-3#1)
thus offering##7##2##(1994-9#1)(2007-12#1)(2008-5#2)(2008-9#1)(2009-3#1)(2011-2#1)
thus offers##2##2##(1996-1#1)(2010-3#1)
thus on##2##2##(2009-8#1)(2011-1#1)
thus opening a##2##3##(2007-6#1)(2009-3#1)
thus opening##3##2##(2007-6#1)(2009-3#1)(2012-12#1)
thus optimizing the##2##3##(1991-7#1)(2013-8#1)
thus overcoming the##2##3##(1993-3#1)(2008-10#1)
thus overcoming##6##2##(1993-3#1)(1994-6#1)(2008-10#2)(2008-3#1)(2008-4#1)
thus participate in the##2##4##(1990-7#1)(2011-2#1)
thus participate in##3##3##(1990-7#1)(1991-10#1)(2011-2#1)
thus paving the way for the##2##6##(2007-10#1)(2007-2#1)
thus paving the way for##3##5##(2007-10#1)(2007-2#1)(2010-12#1)
thus permits##2##2##(1993-7#1)(2007-12#1)
thus permitting the##2##3##(2007-12#1)(2008-2#1)
thus permitting##13##2##(1993-12#1)(2006-12#1)(2007-12#2)(2007-4#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-7#1)
thus play a##2##3##(1994-5#1)(1997-6#1)
thus play an important role in##2##6##(1992-8#1)(2008-9#1)
thus play##5##2##(1992-8#1)(1994-5#1)(1997-6#1)(1997-7#1)(2008-9#1)
thus playing a##3##3##(2009-9#1)(2011-2#1)(2013-1#1)
thus plays##2##2##(2010-9#1)(2012-12#1)
thus posing a##2##3##(1990-10#1)(1994-1#1)
thus posing##4##2##(1990-10#1)(1994-1#1)(2008-12#1)(2012-3#1)
thus possible to##5##3##(1990-2#1)(1990-8#1)(2006-10#1)(2008-10#1)(2008-11#1)
thus possible##6##2##(1990-2#1)(1990-8#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)
thus potentially##5##2##(1997-7#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-3#1)
thus precluding##2##2##(2008-4#1)(2010-12#1)
thus present##3##2##(1991-8#1)(1992-3#1)(2007-8#1)
thus presented##2##2##(2006-12#1)(2008-2#1)
thus presents##2##2##(2008-10#1)(2009-6#1)
thus prevent##2##2##(1997-8#1)(2007-11#1)
thus preventing the##5##3##(1991-12#1)(1995-3#1)(1997-5#1)(2008-10#1)(2010-8#1)
thus preventing##11##2##(1991-12#1)(1991-2#1)(1991-4#1)(1995-3#1)(1997-5#1)(1997-6#1)(2007-11#1)(2008-10#1)(2010-8#1)(2011-2#1)(2012-2#1)
thus produced##5##2##(1991-12#1)(1994-7#1)(1997-2#1)(2008-3#2)
thus producing a##3##3##(2005-10#1)(2006-8#1)(2008-3#1)
thus producing##5##2##(2005-10#1)(2006-8#1)(2008-3#2)(2008-5#1)
thus promoting##4##2##(2006-3#1)(2008-1#1)(2008-8#1)(2010-7#1)
thus proposed##3##2##(2008-8#1)(2011-2#1)(2013-1#1)
thus provide a##6##3##(1991-8#1)(2007-12#1)(2007-9#1)(2008-5#1)(2009-3#1)(2013-1#1)
thus provide an##2##3##(1991-7#1)(2007-12#1)
thus provide the##3##3##(1995-8#1)(2008-4#2)
thus provide##19##2##(1990-7#1)(1991-7#1)(1991-8#1)(1995-8#1)(2007-12#2)(2007-9#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-12#1)(2010-3#1)(2011-1#1)(2013-1#1)
thus provided##3##2##(2008-10#1)(2008-8#1)(2010-7#1)
thus provides a powerful##2##4##(1991-12#1)(2007-12#1)
thus provides a##7##3##(1991-11#1)(1991-12#1)(1995-6#1)(1996-8#2)(2007-12#1)(2008-10#1)
thus provides##13##2##(1991-11#1)(1991-12#1)(1994-5#1)(1995-1#1)(1995-6#1)(1996-8#2)(1997-1#1)(1997-6#1)(2007-12#1)(2008-10#1)(2009-6#1)(2012-2#1)
thus providing a much##2##4##(1995-3#1)(2005-12#1)
thus providing a##14##3##(1995-1#1)(1995-2#1)(1995-3#1)(2005-12#1)(2006-12#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#2)(2010-10#1)(2012-12#1)
thus providing accurate##2##3##(2006-5#1)(2008-10#1)
thus providing an explanation for##2##5##(1992-1#1)(1996-7#1)
thus providing an##3##3##(1992-1#1)(1996-7#1)(2008-2#1)
thus providing evidence for a##2##5##(1994-9#2)
thus providing evidence for the##2##5##(1991-5#1)(1992-12#1)
thus providing evidence for##4##4##(1991-5#1)(1992-12#1)(1994-9#2)
thus providing evidence that##3##4##(2008-10#2)(2008-11#1)
thus providing evidence##7##3##(1991-5#1)(1992-12#1)(1994-9#2)(2008-10#2)(2008-11#1)
thus providing the##3##3##(1995-2#1)(2004-9#1)(2008-10#1)
thus providing##44##2##(1991-5#1)(1992-1#1)(1992-12#1)(1992-8#1)(1994-9#2)(1995-1#1)(1995-2#2)(1995-3#2)(1996-7#1)(1997-5#1)(2004-9#1)(2005-12#1)(2006-12#2)(2006-5#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-10#1)(2011-1#1)(2012-12#2)(2012-2#1)
thus proving the stability-indicating##2##4##(2012-12#2)
thus proving the##4##3##(2007-5#1)(2012-12#2)(2013-7#1)
thus proving##6##2##(2007-5#1)(2008-10#1)(2012-12#3)(2013-7#1)
thus raising the##2##3##(1994-8#1)(1995-11#1)
thus raising##3##2##(1994-8#1)(1995-11#1)(2010-8#1)
thus realized##2##2##(2008-10#2)
thus recommended##2##2##(1991-4#1)(2008-10#1)
thus reduce##5##2##(1996-3#1)(2003-11#1)(2006-10#1)(2008-5#1)(2013-1#1)
thus reducing the need for##3##5##(2007-11#1)(2007-7#1)(2008-3#1)
thus reducing the##9##3##(1990-6#1)(2007-11#1)(2007-7#2)(2008-10#2)(2008-2#1)(2008-3#1)(2009-8#1)
thus reducing##12##2##(1990-6#1)(2007-11#1)(2007-7#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-2#1)
thus reflects##4##2##(1992-3#1)(1996-6#1)(2009-7#1)(2013-1#1)
thus regulate##3##2##(1990-7#1)(1990-8#1)(2009-8#1)
thus regulating##2##2##(1990-9#1)(2012-2#1)
thus releasing the##2##3##(1994-11#1)(2008-4#1)
thus removing##2##2##(2008-2#1)(2010-5#1)
thus rendering the##2##3##(2008-10#1)(2008-7#1)
thus rendering##4##2##(1991-4#1)(2008-10#1)(2008-11#1)(2008-7#1)
thus represent a##3##3##(1990-4#1)(2008-10#1)(2008-11#1)
thus represent the##2##3##(1992-9#1)(1995-2#1)
thus represent##7##2##(1990-4#1)(1992-9#1)(1995-11#1)(1995-2#1)(2006-1#1)(2008-10#1)(2008-11#1)
thus representing a##2##3##(2008-5#1)(2008-8#1)
thus representing##3##2##(1996-5#1)(2008-5#1)(2008-8#1)
thus represents a##5##3##(1990-4#1)(1993-8#1)(1995-3#1)(2007-12#1)(2007-9#1)
thus represents an##2##3##(1994-11#1)(2007-11#1)
thus represents the##2##3##(1990-5#1)(1996-9#1)
thus represents##10##2##(1990-4#1)(1990-5#1)(1993-8#1)(1994-11#1)(1995-3#1)(1996-9#1)(2007-11#1)(2007-12#1)(2007-9#1)(2009-4#1)
thus requires##2##2##(1994-8#1)(2012-12#1)
thus requiring an##2##3##(2008-10#2)
thus restoring##3##2##(1993-8#1)(2008-7#1)(2012-12#1)
thus restricting##2##2##(2010-4#1)(2013-1#1)
thus resulting in a##2##4##(1993-3#1)(2008-2#1)
thus resulting in the##2##4##(2005-11#1)(2010-4#1)
thus resulting in##7##3##(1993-11#1)(1993-3#1)(2005-11#1)(2007-6#1)(2008-2#1)(2008-3#1)(2010-4#1)
thus resulting##8##2##(1993-11#1)(1993-3#1)(2005-11#1)(2007-6#1)(2007-8#1)(2008-2#1)(2008-3#1)(2010-4#1)
thus revealing##3##2##(1994-3#1)(2010-4#1)(2013-1#1)
thus saving time##2##3##(2007-7#1)(2012-2#1)
thus saving##4##2##(2007-7#1)(2008-7#1)(2008-8#1)(2012-2#1)
thus seem##2##2##(1990-9#1)(2008-12#1)
thus seems to##2##3##(1992-2#1)(1995-11#1)
thus seems##3##2##(1992-2#1)(1995-11#1)(1996-3#1)
thus separate the##2##3##(1994-3#1)(2011-2#1)
thus serve as a##2##4##(2010-2#1)(2012-1#1)
thus serve as##4##3##(1992-6#1)(2008-11#1)(2010-2#1)(2012-1#1)
thus serves as a##2##4##(1991-1#1)(1996-5#1)
thus showed that##2##3##(1994-9#1)(2008-11#1)
thus showed##5##2##(1992-11#1)(1994-9#1)(1996-6#1)(2008-11#1)(2012-1#1)
thus showing that##5##3##(1994-10#1)(1995-2#1)(2007-12#1)(2008-2#1)(2011-2#1)
thus showing the##3##3##(1990-3#1)(2008-10#1)(2011-2#1)
thus showing##12##2##(1990-3#1)(1991-7#1)(1992-11#1)(1993-8#1)(1994-10#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-2#2)(2011-2#2)
thus stabilizing##2##2##(2008-1#1)(2008-5#1)
thus stimulating##2##2##(1990-11#1)(2008-4#1)
thus strongly##3##2##(1993-7#1)(1994-8#1)(2008-3#1)
thus subjecting##2##2##(1992-3#1)(2013-1#1)
thus substantially##2##2##(2008-7#1)(2011-1#1)
thus suggest that##5##3##(1991-8#1)(1996-10#1)(1997-8#1)(2011-2#1)(2012-11#1)
thus suggest##6##2##(1991-8#1)(1996-10#1)(1997-8#1)(2011-2#1)(2012-11#1)(2013-8#1)
thus suggested that the##3##4##(1995-3#2)(2007-7#1)
thus suggested##5##2##(1991-8#1)(1994-9#1)(1995-3#2)(2007-7#1)
thus suggesting a##3##3##(1995-12#1)(1996-9#1)(2007-7#1)
thus suggesting an##3##3##(1992-8#1)(2007-3#1)(2012-3#1)
thus suggesting that a##2##4##(1994-6#1)(1995-12#1)
thus suggesting that the##11##4##(1990-11#1)(1990-8#1)(1990-9#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-7#1)(1996-8#1)(2008-3#1)(2008-7#1)(2011-12#1)
thus suggesting that##24##3##(1990-11#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-9#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-8#2)(1996-3#1)(1996-7#1)(1996-8#1)(1997-6#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-12#1)(2012-2#1)
thus suggesting the##2##3##(2008-7#1)(2011-2#1)
thus suggesting##34##2##(1990-11#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-9#1)(1992-8#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#3)(1995-2#1)(1995-8#2)(1996-12#1)(1996-3#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-6#1)(2005-12#1)(2007-3#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
thus suggests that##2##3##(1995-11#1)(1996-7#1)
thus support the##5##3##(1992-11#1)(1992-9#1)(2006-8#1)(2008-4#1)(2009-4#1)
thus supporting the##5##3##(1996-8#1)(2006-3#1)(2007-7#1)(2010-8#1)(2011-2#1)
thus suppressing the##2##3##(2008-10#1)(2008-3#1)
thus that the##2##3##(2007-11#1)(2008-10#1)
thus the detection##2##3##(2008-10#1)(2008-3#1)
thus the need for##2##4##(2010-12#1)(2013-8#1)
thus the##70##2##(1990-2#1)(1991-3#1)(1992-1#1)(1992-10#2)(1992-5#1)(1992-7#1)(1993-8#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-4#1)(1997-3#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#1)(2008-6#1)(2008-8#2)(2010-12#4)(2010-2#2)(2010-6#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#5)(2013-8#3)
thus there is##2##3##(1994-5#1)(2008-10#1)
thus they are##2##3##(1995-12#1)(2008-8#1)
thus they##7##2##(1995-12#1)(2007-11#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
thus this##2##2##(2008-8#1)(2013-1#1)
thus to the##3##3##(1992-8#1)(1995-6#1)(1996-12#1)
thus to##21##2##(1990-10#1)(1992-8#1)(1993-5#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-7#1)(1997-5#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-4#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
thus unlikely##2##2##(1994-9#1)(2008-8#1)
thus used##2##2##(1996-10#1)(2010-1#1)
thus validate##2##2##(1990-10#1)(2011-1#1)
thus warranting##2##2##(2007-7#1)(2009-11#1)
thus was##3##2##(1995-2#1)(2008-10#1)(2008-11#1)
thus well##2##2##(2008-3#1)(2008-4#1)
thus yielding##4##2##(1995-3#1)(2007-12#1)(2008-2#1)(2008-6#1)
thus yields##2##2##(2007-12#1)(2008-7#1)
thus##2260##1##(1990-10#9)(1990-11#11)(1990-12#10)(1990-2#12)(1990-3#11)(1990-4#5)(1990-5#6)(1990-6#7)(1990-7#10)(1990-8#10)(1990-9#5)(1991-1#3)(1991-10#4)(1991-11#7)(1991-12#13)(1991-2#10)(1991-3#5)(1991-4#6)(1991-5#9)(1991-6#6)(1991-7#6)(1991-8#11)(1991-9#3)(1992-1#7)(1992-10#4)(1992-11#6)(1992-12#9)(1992-2#7)(1992-3#12)(1992-4#4)(1992-5#4)(1992-6#9)(1992-7#6)(1992-8#9)(1992-9#5)(1993-10#2)(1993-11#12)(1993-12#6)(1993-2#4)(1993-3#4)(1993-4#2)(1993-5#2)(1993-6#4)(1993-7#3)(1993-8#6)(1993-9#6)(1994-1#1)(1994-10#4)(1994-11#8)(1994-12#11)(1994-2#10)(1994-3#12)(1994-4#1)(1994-5#11)(1994-6#15)(1994-7#1)(1994-8#12)(1994-9#15)(1995-1#10)(1995-10#4)(1995-11#10)(1995-12#12)(1995-2#15)(1995-3#18)(1995-4#2)(1995-5#5)(1995-6#7)(1995-7#2)(1995-8#15)(1995-9#6)(1996-1#7)(1996-10#8)(1996-11#7)(1996-12#16)(1996-2#7)(1996-3#6)(1996-4#5)(1996-5#13)(1996-6#4)(1996-7#5)(1996-8#5)(1996-9#6)(1997-1#12)(1997-2#16)(1997-3#7)(1997-4#16)(1997-5#12)(1997-6#13)(1997-7#8)(1997-8#8)(2003-11#1)(2004-11#2)(2004-12#2)(2004-9#2)(2005-10#6)(2005-11#11)(2005-12#8)(2005-3#1)(2005-4#4)(2005-7#5)(2005-8#8)(2005-9#5)(2006-1#2)(2006-10#26)(2006-11#4)(2006-12#15)(2006-2#6)(2006-3#3)(2006-4#4)(2006-5#11)(2006-6#14)(2006-7#3)(2006-8#8)(2006-9#6)(2007-1#5)(2007-10#8)(2007-11#42)(2007-12#75)(2007-2#6)(2007-3#2)(2007-4#9)(2007-5#11)(2007-6#6)(2007-7#20)(2007-8#24)(2007-9#12)(2008-1#26)(2008-10#193)(2008-11#55)(2008-12#17)(2008-2#73)(2008-3#74)(2008-4#43)(2008-5#53)(2008-6#22)(2008-7#43)(2008-8#54)(2008-9#23)(2009-1#2)(2009-10#7)(2009-11#4)(2009-12#9)(2009-2#9)(2009-3#7)(2009-4#9)(2009-5#9)(2009-6#13)(2009-7#2)(2009-8#22)(2009-9#5)(2010-1#3)(2010-10#8)(2010-11#1)(2010-12#30)(2010-2#18)(2010-3#10)(2010-4#12)(2010-5#8)(2010-6#4)(2010-7#7)(2010-8#14)(2010-9#5)(2011-1#25)(2011-10#1)(2011-11#1)(2011-12#5)(2011-2#40)(2011-3#5)(2011-9#1)(2012-1#11)(2012-11#4)(2012-12#40)(2012-2#51)(2012-3#21)(2012-4#1)(2012-6#1)(2013-1#49)(2013-7#9)(2013-8#24)
thwart##3##1##(1994-4#1)(2008-7#1)(2011-2#1)
thylakoid bioassay##3##2##(2008-11#3)
thylakoid lipids##2##2##(1994-10#2)
thylakoid lumen##2##2##(1992-6#1)(1994-12#1)
thylakoid membrane protein##3##3##(2008-8#3)
thylakoid membrane##11##2##(1991-3#1)(1992-3#1)(1992-4#1)(1992-6#2)(1993-6#1)(1994-12#1)(2005-10#1)(2008-8#3)
thylakoid membranes and##2##3##(1994-12#2)
thylakoid membranes of##2##3##(1990-5#1)(1991-12#1)
thylakoid membranes was##2##3##(1997-4#2)
thylakoid membranes##14##2##(1990-5#1)(1991-1#1)(1991-12#1)(1994-11#1)(1994-12#2)(1995-8#2)(1997-4#4)(2009-10#2)
thylakoid redox##2##2##(2009-10#2)
thylakoid##48##1##(1990-5#1)(1991-1#1)(1991-12#2)(1991-3#1)(1992-3#1)(1992-4#2)(1992-6#6)(1993-6#2)(1994-10#2)(1994-11#1)(1994-12#7)(1995-8#2)(1997-4#4)(2005-10#1)(2007-3#1)(2008-10#2)(2008-11#3)(2008-8#4)(2009-10#5)
thylakoid-like features##2##2##(1997-6#2)
thylakoid-like##3##1##(1997-6#3)
thylakoids and##2##2##(1997-6#2)
thylakoids##13##1##(1991-12#3)(1992-3#1)(1992-6#1)(1993-6#1)(1997-6#4)(2008-11#1)(2009-10#1)(2009-7#1)
thyme (Thymus##2##2##(2007-1#1)(2008-10#1)
thyme in##2##2##(2007-1#1)(2010-3#1)
thyme##6##1##(2007-1#2)(2008-10#1)(2010-3#1)(2012-12#1)(2012-2#1)
thymectomy and##3##2##(1997-5#1)(2006-10#1)(2008-5#1)
thymectomy in myasthenia gravis##2##4##(2007-9#1)(2012-2#1)
thymectomy in##4##2##(1994-9#1)(2007-8#1)(2007-9#1)(2012-2#1)
thymectomy was performed##2##3##(2006-10#2)
thymectomy was the most##2##4##(2012-12#2)
thymectomy was##4##2##(2006-10#2)(2012-12#2)
thymectomy with the##2##3##(2007-8#2)
thymectomy##40##1##(1994-9#1)(1997-5#1)(1997-7#1)(2006-1#1)(2006-10#4)(2007-8#17)(2007-9#3)(2008-4#3)(2008-5#1)(2010-8#1)(2012-12#5)(2012-2#2)
thymi##3##1##(1995-12#1)(2008-10#1)(2008-4#1)
thymic T-cell lymphoblastic lymphoma##2##4##(2007-8#2)
thymic T-cell##3##2##(2007-8#2)(2008-10#1)
thymic and splenic##2##3##(1991-6#1)(2008-10#1)
thymic atrophy##4##2##(2008-10#4)
thymic carcinomas##7##2##(2008-7#7)
thymic cellularity##2##2##(2007-3#1)(2008-10#1)
thymic cyst##6##2##(2007-8#4)(2013-1#2)
thymic dendritic cells##4##3##(2008-8#4)
thymic epithelial cells##7##3##(1992-12#2)(2008-4#4)(2012-12#1)
thymic epithelial##10##2##(1992-12#2)(2007-8#2)(2008-4#4)(2008-8#1)(2012-12#1)
thymic epithelium is sufficient to induce##2##6##(1997-4#2)
thymic epithelium##3##2##(1997-4#3)
thymic function##3##2##(1991-12#1)(1993-12#1)(2010-10#1)
thymic hormones##2##2##(1992-12#2)
thymic involution##7##2##(1991-11#1)(1993-12#1)(2008-10#1)(2008-7#1)(2013-7#3)
thymic lobes##3##2##(2008-4#3)
thymic lymphocytes##2##2##(2006-10#1)(2008-7#1)
thymic lymphomas in C57BL/6 mice##2##5##(1991-7#1)(2008-7#1)
thymic lymphosarcoma cells##3##3##(1992-8#3)
thymic lymphosarcoma##6##2##(1992-8#4)(1995-11#2)
thymic medulla##3##2##(1995-1#1)(2008-8#2)
thymic microenvironment##5##2##(1992-12#2)(1992-5#1)(1995-6#1)(2005-10#1)
thymic selection##2##2##(1994-6#1)(1997-7#1)
thymic stroma##3##2##(1991-8#1)(1992-12#2)
thymic stromal cells##4##3##(1992-12#1)(2008-5#2)(2008-8#1)
thymic stromal##5##2##(1992-12#1)(2008-5#2)(2008-8#1)(2012-2#1)
thymic tissue##6##2##(2007-7#1)(2007-8#5)
thymic##136##1##(1991-11#2)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#4)(1991-8#2)(1992-12#13)(1992-2#1)(1992-5#1)(1992-8#4)(1993-12#2)(1994-6#1)(1995-1#1)(1995-11#2)(1995-5#1)(1995-6#1)(1997-3#3)(1997-4#4)(1997-7#1)(1997-9#1)(2005-10#1)(2006-10#1)(2007-3#1)(2007-7#1)(2007-8#18)(2008-10#11)(2008-4#7)(2008-5#2)(2008-7#12)(2008-8#11)(2008-9#1)(2009-5#2)(2010-10#1)(2010-2#2)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#6)
thymidine analog##3##2##(2008-4#3)
thymidine analogue##6##2##(1993-11#1)(1995-6#2)(1996-5#1)(2008-4#1)(2013-1#1)
thymidine and adenosine##2##3##(1997-5#2)
thymidine and##6##2##(1991-2#1)(1997-5#2)(2006-3#1)(2008-11#1)(2008-4#1)
thymidine by##2##2##(1990-3#1)(1997-8#1)
thymidine in##2##2##(1993-12#2)
thymidine incorporation and##3##3##(1990-12#1)(1990-8#1)(1991-10#1)
thymidine incorporation by##2##3##(1991-10#1)(1992-7#1)
thymidine incorporation in##2##3##(1991-12#1)(1992-7#1)
thymidine incorporation into##2##3##(1992-8#1)(1994-3#1)
thymidine incorporation was##2##3##(1990-10#1)(1991-9#1)
thymidine incorporation with##2##3##(1991-10#1)(1991-9#1)
thymidine incorporation##23##2##(1990-10#2)(1990-12#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#6)(1991-12#1)(1991-9#2)(1992-3#1)(1992-7#2)(1992-8#1)(1993-11#1)(1994-3#2)(2007-1#1)
thymidine into##4##2##(1991-10#1)(1991-5#2)(1992-8#1)
thymidine kinase (TK) promoter##2##4##(1992-11#1)(1992-12#1)
thymidine kinase (TK)##6##3##(1992-11#1)(1992-12#1)(1994-5#1)(1994-8#1)(1996-5#1)(1997-7#1)
thymidine kinase (tk) promoter##2##4##(1993-8#1)(1997-7#1)
thymidine kinase 1##3##3##(1991-4#1)(2011-2#2)
thymidine kinase activity##2##3##(1992-8#1)(1996-10#1)
thymidine kinase gene##4##3##(1991-7#1)(1994-12#1)(2007-11#1)(2009-4#1)
thymidine kinase promoter##5##3##(1992-11#1)(1993-8#1)(1994-9#1)(1995-1#1)(1995-3#1)
thymidine kinase##40##2##(1991-4#3)(1991-7#1)(1992-11#2)(1992-12#1)(1992-4#2)(1992-8#2)(1993-8#2)(1994-12#2)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#5)(1996-10#1)(1996-5#1)(1997-7#2)(1997-8#4)(2005-6#1)(2007-11#1)(2007-3#1)(2008-5#1)(2009-4#1)(2011-2#2)
thymidine kinases##4##2##(1995-3#4)
thymidine phosphorylase##5##2##(2008-12#1)(2008-7#3)(2012-1#1)
thymidine synthesis##2##2##(1990-9#1)(2008-1#1)
thymidine uptake in##2##3##(1992-9#1)(2008-10#1)
thymidine uptake##4##2##(1992-9#1)(1994-3#1)(2008-10#1)(2008-5#1)
thymidine was##2##2##(1991-5#1)(1997-8#1)
thymidine were##2##2##(2008-11#1)(2011-1#1)
thymidine##143##1##(1990-10#2)(1990-12#1)(1990-3#2)(1990-6#1)(1990-8#1)(1990-9#2)(1991-10#8)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#3)(1991-5#6)(1991-7#1)(1991-9#3)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#2)(1992-7#2)(1992-8#4)(1992-9#1)(1993-11#2)(1993-12#8)(1993-3#1)(1993-8#2)(1994-10#1)(1994-12#2)(1994-3#3)(1994-4#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-3#12)(1995-6#3)(1996-10#1)(1996-11#1)(1996-5#2)(1997-5#2)(1997-7#2)(1997-8#9)(2005-11#1)(2005-6#1)(2006-12#1)(2006-3#2)(2007-1#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#7)(2008-5#3)(2008-7#3)(2008-9#2)(2009-4#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2013-1#1)
thymidine)##2##1##(2008-11#1)(2008-2#1)
thymidylate synthase (TS)##7##3##(1990-7#2)(1992-12#1)(1994-8#1)(1994-9#1)(1995-6#1)(1997-2#1)
thymidylate synthase and thymidine kinase##4##5##(1997-8#4)
thymidylate synthase gene##3##3##(1992-5#3)
thymidylate synthase inhibitor##3##3##(1994-8#2)(1995-7#1)
thymidylate synthase##35##2##(1990-7#5)(1992-12#2)(1992-5#5)(1993-11#4)(1993-9#1)(1994-8#3)(1994-9#2)(1995-6#1)(1995-7#2)(1997-1#1)(1997-2#2)(1997-8#4)(2005-7#1)(2008-5#1)(2009-9#1)
thymidylate synthases##3##2##(1993-9#3)
thymidylate##42##1##(1990-7#5)(1992-12#2)(1992-5#5)(1993-11#4)(1993-9#4)(1994-8#3)(1994-9#2)(1995-3#2)(1995-6#1)(1995-7#2)(1997-1#1)(1997-2#2)(1997-8#4)(2005-7#1)(2008-5#1)(2009-9#1)(2011-2#1)(2012-2#1)
thymine and cytosine##2##3##(1996-4#1)(2008-10#1)
thymine and##7##2##(1992-2#1)(1992-3#1)(1993-3#1)(1996-4#1)(1996-5#1)(2007-8#1)(2008-10#1)
thymine at##2##2##(1993-3#1)(2008-3#1)
thymine dimer repair-enhancing##2##3##(2008-11#2)
thymine hydroperoxide##2##2##(1997-6#2)
thymine methyl##3##2##(1992-6#2)(1993-11#1)
thymine radical anion was##2##4##(2006-10#2)
thymine radical anion##7##3##(2006-10#7)
thymine residue of##2##3##(1992-8#1)(2005-11#1)
thymine residues##2##2##(1991-7#1)(1994-9#1)
thymine to##2##2##(1991-12#1)(1994-7#1)
thymine was also##2##3##(1991-5#1)(2008-10#1)
thymine##58##1##(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-2#1)(1992-3#4)(1992-5#1)(1992-6#5)(1992-8#1)(1993-11#1)(1993-3#2)(1994-12#2)(1994-7#4)(1994-9#2)(1996-4#2)(1996-5#2)(1997-6#2)(1997-8#1)(2005-11#1)(2006-10#10)(2007-8#2)(2008-10#2)(2008-11#3)(2008-3#1)(2010-7#1)(2011-1#1)(2012-2#2)
thymines##5##1##(1992-3#1)(1993-11#3)(1995-3#1)
thymocyte and##2##2##(2007-3#2)
thymocyte apoptosis##6##2##(1993-7#2)(1995-8#1)(1997-6#1)(2008-10#2)
thymocyte death##2##2##(1992-9#1)(1997-6#1)
thymocyte development and##2##3##(2007-3#1)(2008-8#1)
thymocyte development##8##2##(1991-12#1)(2005-10#1)(2007-3#1)(2008-10#2)(2008-8#1)(2010-2#2)
thymocyte differentiation##2##2##(1995-6#1)(1995-8#1)
thymocyte maturation##2##2##(1990-8#1)(1995-6#1)
thymocyte proliferation##6##2##(1991-10#1)(1991-12#1)(1996-11#1)(1997-6#1)(2008-10#2)
thymocyte subpopulation##2##2##(1993-7#1)(2008-10#1)
thymocyte subpopulations##2##2##(2008-10#2)
thymocyte subsets##3##2##(1995-8#2)(2008-10#1)
thymocyte##49##1##(1990-5#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-12#3)(1992-12#1)(1992-9#1)(1993-7#4)(1995-6#3)(1995-8#4)(1996-11#1)(1997-6#3)(2005-10#1)(2007-3#4)(2008-10#15)(2008-8#1)(2010-2#2)(2012-2#1)
thymocytes and peripheral##2##3##(1994-3#1)(1994-9#1)
thymocytes and##10##2##(1991-10#1)(1991-12#1)(1992-8#2)(1994-3#1)(1994-9#1)(1997-7#1)(2008-5#1)(2008-9#1)(2013-7#1)
thymocytes are##2##2##(1994-6#1)(2008-10#1)
thymocytes by##4##2##(1990-5#1)(1993-7#1)(1995-8#1)(2008-8#1)
thymocytes die##2##2##(1991-11#1)(1997-6#1)
thymocytes exposed to##2##3##(1991-12#1)(1995-5#1)
thymocytes from##10##2##(1990-9#1)(1991-11#1)(1991-12#2)(1992-12#1)(1992-9#1)(1995-5#1)(1995-8#1)(2008-10#2)
thymocytes in vitro##2##3##(1997-3#1)(2008-8#1)
thymocytes in##4##2##(1997-3#1)(1997-6#1)(2008-10#1)(2008-8#1)
thymocytes may##2##2##(1994-6#1)(2008-8#1)
thymocytes that recognize self with##2##5##(1991-12#2)
thymocytes that##3##2##(1991-12#3)
thymocytes to##6##2##(1991-12#2)(1994-2#1)(1995-2#1)(1995-8#1)(2008-10#1)
thymocytes was##4##2##(1990-8#1)(1993-7#1)(2008-5#1)(2008-9#1)
thymocytes were##4##2##(1994-12#1)(2008-10#1)(2008-5#1)(2008-8#1)
thymocytes with##2##2##(1991-12#1)(1992-5#1)
thymocytes##133##1##(1990-12#2)(1990-5#5)(1990-8#3)(1990-9#3)(1991-10#1)(1991-11#6)(1991-12#11)(1991-3#2)(1992-1#1)(1992-12#2)(1992-5#1)(1992-8#5)(1992-9#1)(1993-4#2)(1993-7#3)(1994-12#6)(1994-2#1)(1994-3#3)(1994-6#3)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-5#2)(1995-6#2)(1995-8#7)(1997-3#3)(1997-6#7)(1997-7#3)(2005-10#3)(2007-3#1)(2008-10#8)(2008-4#1)(2008-5#8)(2008-8#13)(2008-9#5)(2012-12#2)(2013-7#1)
thymol and carvacrol in honey##2##5##(2008-10#2)
thymol and carvacrol##3##3##(2008-10#3)
thymol and##5##2##(1997-2#1)(2007-1#1)(2008-10#3)
thymol blue and##2##3##(2008-10#2)
thymol blue##8##2##(2008-10#8)
thymol##25##1##(1997-2#2)(2007-1#3)(2008-10#13)(2008-12#2)(2010-4#2)(2012-12#2)(2012-2#1)
thymoma alone##2##2##(1991-9#2)
thymoma and##3##2##(2007-8#2)(2013-1#1)
thymoma arising##2##2##(2007-8#2)
thymoma is##2##2##(2007-2#1)(2007-8#1)
thymoma on CT##2##3##(2007-8#2)
thymoma on##3##2##(2007-2#1)(2007-8#2)
thymoma##44##1##(1990-6#1)(1991-4#2)(1991-5#1)(1991-9#5)(1992-7#1)(1994-12#2)(1994-2#1)(1997-2#1)(2007-2#3)(2007-8#18)(2008-12#1)(2008-7#2)(2009-4#1)(2012-12#2)(2013-1#3)
thymoma'##2##1##(2008-7#2)
thymoma-derived##2##1##(1990-5#1)(1996-5#1)
thymomas with##3##2##(2007-8#2)(2008-12#1)
thymomas##17##1##(1991-4#1)(2006-6#1)(2007-8#7)(2008-12#1)(2008-7#6)(2012-12#1)
thymopentin treatment##2##2##(1990-2#1)(1991-3#1)
thymopentin##9##1##(1990-2#2)(1991-3#6)(2004-12#1)
thymopoiesis##5##1##(2005-10#2)(2008-4#3)
thymosin##5##1##(1992-12#3)(2004-12#2)
thymostimulin in patients with##2##4##(1991-5#1)(1992-5#1)
thymostimulin##6##1##(1990-2#2)(1991-5#3)(1992-5#1)
thymulin##3##1##(1992-12#1)(2013-7#2)
thymus DNA by##4##3##(1993-4#1)(1995-2#1)(2008-5#1)(2008-8#1)
thymus DNA##62##2##(1990-2#5)(1990-7#2)(1990-8#1)(1991-4#1)(1992-1#2)(1992-2#1)(1992-7#1)(1993-2#2)(1993-3#2)(1993-4#1)(1994-11#2)(1994-2#1)(1995-1#2)(1995-11#1)(1995-2#2)(1995-6#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-10#17)(2008-3#2)(2008-4#1)(2008-5#9)(2008-8#1)(2009-3#1)
thymus Hsc70 protein##2##3##(1995-6#2)
thymus after##3##2##(2008-10#2)(2013-8#1)
thymus and liver##4##3##(2008-10#1)(2008-11#1)(2008-4#2)
thymus and spleen weights##2##4##(2008-10#2)
thymus and spleen were##2##4##(1993-3#1)(2010-7#1)
thymus and spleen##8##3##(1993-3#1)(1995-12#2)(1996-10#1)(2008-10#3)(2010-7#1)
thymus and##28##2##(1990-5#1)(1990-6#1)(1991-12#1)(1992-8#1)(1993-12#1)(1993-3#2)(1995-12#2)(1996-10#1)(1996-4#1)(1997-9#2)(2008-10#6)(2008-11#2)(2008-4#3)(2008-5#2)(2010-7#1)(2012-1#1)
thymus are##3##2##(1995-8#1)(2010-2#1)(2013-1#1)
thymus atrophy##4##2##(2008-10#1)(2008-5#2)(2013-8#1)
thymus by##4##2##(1996-8#1)(1997-4#1)(2008-10#1)(2010-10#1)
thymus cells##4##2##(1990-3#1)(1992-8#1)(1994-2#1)(2008-10#1)
thymus in##4##2##(1992-12#1)(1997-7#1)(2008-5#1)(2008-9#1)
thymus involution##3##2##(2008-10#2)(2013-7#1)
thymus lymphocytes##3##2##(1994-3#3)
thymus of mice##2##3##(1990-5#1)(1991-12#1)
thymus of the##3##3##(2008-4#2)(2013-1#1)
thymus of##10##2##(1990-5#1)(1991-12#1)(1991-3#1)(1992-5#1)(1994-5#1)(1997-7#1)(2008-4#2)(2013-1#2)
thymus or##4##2##(1996-10#1)(2008-11#1)(2008-4#2)
thymus organ##2##2##(2008-4#2)
thymus regeneration##2##2##(1992-12#1)(1995-12#1)
thymus through##2##2##(2008-10#1)(2009-9#1)
thymus tissue##3##2##(2008-4#2)(2011-2#1)
thymus weight##4##2##(1996-4#1)(2008-10#2)(2012-1#1)
thymus weights of##2##3##(2008-9#2)
thymus weights##4##2##(2008-10#1)(2008-9#2)(2013-8#1)
thymus##271##1##(1990-11#5)(1990-12#2)(1990-2#7)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#3)(1990-8#3)(1990-9#2)(1991-11#3)(1991-12#4)(1991-3#1)(1991-4#2)(1991-6#1)(1991-8#2)(1992-1#2)(1992-11#1)(1992-12#7)(1992-2#1)(1992-3#1)(1992-5#2)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#4)(1993-4#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#3)(1994-8#1)(1995-1#3)(1995-11#2)(1995-12#5)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#6)(1995-8#1)(1996-10#2)(1996-3#1)(1996-4#3)(1996-5#2)(1996-7#1)(1996-8#3)(1997-2#3)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#3)(1997-9#3)(2005-10#2)(2006-1#1)(2006-10#1)(2007-11#1)(2007-3#1)(2007-5#1)(2008-10#43)(2008-11#4)(2008-3#2)(2008-4#16)(2008-5#21)(2008-7#3)(2008-8#4)(2008-9#5)(2009-2#1)(2009-3#1)(2009-9#3)(2010-10#2)(2010-2#3)(2010-7#1)(2011-2#3)(2012-1#4)(2012-2#1)(2013-1#11)(2013-7#3)(2013-8#3)
thymus)##2##1##(1996-7#1)(1997-3#1)
thymus-dependent##3##1##(1994-6#1)(1995-2#1)(1996-4#1)
thymuses##3##1##(2008-10#2)(2008-5#1)
thyrocytes and C cells##3##4##(2012-3#3)
thyrocytes in primary##2##3##(1990-12#1)(1996-9#1)
thyrocytes to##2##2##(2012-3#2)
thyrocytes##13##1##(1990-12#1)(1991-8#1)(1996-9#4)(2012-3#6)(2013-8#1)
thyroglobulin (Tg)##3##2##(2008-4#1)(2013-1#2)
thyroglobulin secreted##2##2##(1992-12#2)
thyroglobulin##36##1##(1990-10#1)(1990-11#1)(1990-5#1)(1991-12#1)(1991-5#3)(1991-7#3)(1991-9#2)(1992-12#4)(1992-2#1)(1992-4#1)(1992-8#2)(1993-3#2)(1994-11#1)(1994-3#1)(1995-12#1)(1995-3#1)(2006-1#1)(2006-9#1)(2008-4#2)(2009-2#3)(2009-7#1)(2013-1#2)
thyrohyoid membrane##2##2##(2012-2#2)
thyroid FNA##2##2##(2013-8#2)
thyroid adenoma##5##2##(2006-10#2)(2012-1#3)
thyroid adenomas##2##2##(1991-7#1)(2008-4#1)
thyroid and colon##2##3##(2011-2#2)
thyroid and parathyroid##6##3##(2006-6#3)(2009-4#1)(2010-12#1)(2013-1#1)
thyroid and the##2##3##(2007-8#1)(2009-3#1)
thyroid and##19##2##(1991-9#1)(1992-4#2)(1995-5#1)(2006-6#3)(2006-9#1)(2007-8#2)(2008-4#1)(2008-5#1)(2009-3#1)(2009-4#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
thyroid antibodies##3##2##(1991-8#1)(1996-11#1)(2007-8#1)
thyroid antigens##3##2##(1991-8#1)(1994-11#2)
thyroid autoantibodies##3##2##(1990-5#1)(1991-8#1)(2008-7#1)
thyroid autoimmunity and##3##3##(2006-10#1)(2008-7#2)
thyroid autoimmunity in##3##3##(2006-1#1)(2007-2#1)(2008-7#1)
thyroid autoimmunity##9##2##(2006-1#2)(2006-10#1)(2006-11#1)(2006-9#1)(2007-2#1)(2008-7#3)
thyroid cancer and the##2##4##(2008-5#1)(2013-1#1)
thyroid cancer and##5##3##(1991-5#1)(2008-3#1)(2008-5#2)(2013-1#1)
thyroid cancer cell##3##3##(1992-8#1)(1993-9#1)(2008-4#1)
thyroid cancer cells##4##3##(1993-9#2)(2013-1#1)(2013-8#1)
thyroid cancer has##3##3##(1995-5#1)(2006-9#1)(2013-8#1)
thyroid cancer in a##2##4##(2008-12#1)(2012-12#1)
thyroid cancer in##4##3##(2006-10#1)(2008-12#1)(2012-12#1)(2013-8#1)
thyroid cancer is##2##3##(1990-6#1)(2008-4#1)
thyroid cancer with##2##3##(2011-1#2)
thyroid cancer##68##2##(1990-10#1)(1990-3#2)(1990-6#1)(1991-10#2)(1991-5#3)(1992-8#4)(1993-9#3)(1995-5#3)(1996-5#1)(2006-10#1)(2006-11#1)(2006-9#4)(2007-11#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#5)(2008-5#2)(2010-12#1)(2011-1#2)(2011-2#2)(2012-1#3)(2012-12#6)(2012-2#3)(2013-1#7)(2013-8#6)
thyroid cancer]##2##2##(1993-10#1)(2013-1#1)
thyroid cancers##6##2##(1992-8#1)(2008-4#3)(2012-12#1)(2013-1#1)
thyroid carcinoma (MTC)##2##3##(1991-2#1)(2008-7#1)
thyroid carcinoma and##5##3##(2008-5#1)(2008-7#1)(2013-1#2)(2013-8#1)
thyroid carcinoma cell line##4##4##(1990-4#2)(1993-3#2)
thyroid carcinoma cells##4##3##(1992-6#2)(1993-3#1)(1993-8#1)
thyroid carcinoma in a##4##4##(1990-6#2)(2012-2#1)(2013-1#1)
thyroid carcinoma in children and adolescents##2##6##(2006-1#1)(2012-3#1)
thyroid carcinoma in children and##3##5##(2006-1#1)(2012-3#2)
thyroid carcinoma in##9##3##(1990-6#2)(2006-1#1)(2011-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
thyroid carcinoma were treated##2##4##(1990-10#1)(2013-1#1)
thyroid carcinoma with tracheal invasion##2##5##(2008-5#2)
thyroid carcinoma with##4##3##(2008-5#2)(2012-3#1)(2013-1#1)
thyroid carcinoma##86##2##(1990-10#2)(1990-3#3)(1990-4#3)(1990-6#3)(1990-8#3)(1991-2#2)(1992-5#2)(1992-6#2)(1993-10#2)(1993-3#3)(1993-8#1)(1994-4#1)(2006-1#3)(2007-11#2)(2007-12#2)(2008-1#4)(2008-10#1)(2008-12#1)(2008-5#6)(2008-7#2)(2009-12#3)(2009-2#2)(2009-5#2)(2011-1#1)(2011-12#3)(2012-2#2)(2012-3#9)(2013-1#14)(2013-8#2)
thyroid carcinoma]##4##2##(2005-10#1)(2008-10#1)(2008-7#1)(2013-8#1)
thyroid carcinomas##8##2##(1991-7#1)(1992-6#1)(1993-10#1)(1993-3#1)(2006-1#1)(2007-3#1)(2008-5#1)(2013-1#1)
thyroid cartilage##5##2##(2008-2#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-7#1)
thyroid cell##4##2##(1992-2#1)(1992-8#3)
thyroid cells##20##2##(1990-11#2)(1991-12#1)(1991-5#3)(1991-9#1)(1992-2#3)(1992-8#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-9#2)(2006-9#1)
thyroid colloid##2##2##(1996-6#1)(2008-7#1)
thyroid deficiency##3##2##(2013-1#3)
thyroid disease is##3##3##(2008-6#1)(2010-6#1)(2013-1#1)
thyroid disease##20##2##(1990-4#1)(1990-6#1)(1991-8#1)(1993-5#2)(1996-12#1)(2006-1#1)(2006-9#3)(2007-11#1)(2007-5#1)(2008-6#2)(2009-2#1)(2010-11#1)(2010-6#1)(2011-1#2)(2013-1#1)
thyroid diseases##5##2##(2006-12#1)(2008-6#1)(2013-1#3)
thyroid disorders and##2##3##(2006-9#1)(2007-11#1)
thyroid disorders is##2##3##(2006-4#1)(2008-6#1)
thyroid disorders were associated with greater healthcare expenditures##2##8##(2013-1#2)
thyroid disorders##23##2##(2006-10#1)(2006-11#1)(2006-4#1)(2006-9#1)(2007-11#1)(2008-4#1)(2008-6#2)(2011-1#1)(2013-1#14)
thyroid doses##3##2##(1993-9#3)
thyroid dysfunction in##2##3##(2008-4#1)(2008-7#1)
thyroid dysfunction was##3##3##(1991-8#1)(1992-2#1)(2008-7#1)
thyroid dysfunction##21##2##(1991-8#3)(1992-2#1)(2004-1#1)(2006-11#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-4#2)(2008-6#4)(2008-7#2)(2011-1#1)(2012-12#1)(2013-1#2)
thyroid epithelium##3##2##(2005-1#1)(2009-2#2)
thyroid follicular##2##2##(2008-7#1)(2009-8#1)
thyroid function and##5##3##(1991-8#1)(1994-11#1)(2006-11#2)(2012-2#1)
thyroid function during##2##3##(2006-9#1)(2012-2#1)
thyroid function in##8##3##(2006-11#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2013-1#2)
thyroid function test##3##3##(2008-4#1)(2011-1#1)(2012-2#1)
thyroid function tests##9##3##(2006-10#5)(2007-9#1)(2008-4#1)(2008-7#1)(2011-1#1)
thyroid function##50##2##(1991-8#2)(1992-2#1)(1994-11#1)(1994-6#1)(2006-10#5)(2006-11#6)(2006-9#1)(2007-9#2)(2008-11#1)(2008-4#6)(2008-5#2)(2008-6#3)(2008-7#7)(2011-1#2)(2012-12#1)(2012-2#3)(2013-1#6)
thyroid function]##2##2##(1993-4#1)(2013-8#1)
thyroid gland and##4##3##(1996-3#1)(2008-9#1)(2011-2#1)(2012-1#1)
thyroid gland in##3##3##(2008-12#1)(2008-7#1)(2012-1#1)
thyroid gland of##2##3##(2008-11#1)(2012-1#1)
thyroid gland##84##2##(1990-3#1)(1990-4#3)(1990-5#3)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#1)(1992-1#2)(1992-2#1)(1992-4#1)(1993-3#4)(1993-4#4)(1993-5#3)(1993-9#1)(1994-6#1)(1996-3#2)(1997-2#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-2#4)(2006-6#2)(2007-10#3)(2007-3#1)(2008-11#1)(2008-12#3)(2008-6#1)(2008-7#2)(2008-9#4)(2009-2#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#2)(2011-1#3)(2011-2#1)(2012-1#8)(2012-12#3)(2012-2#1)(2013-1#6)
thyroid glands of##3##3##(1990-2#1)(1990-5#1)(1995-12#1)
thyroid glands##4##2##(1990-2#1)(1990-5#1)(1995-12#1)(2011-2#1)
thyroid growth##2##2##(1991-12#1)(1991-7#1)
thyroid homeostasis##6##2##(2013-1#6)
thyroid hormone 3##2##3##(1990-12#1)(1992-12#1)
thyroid hormone and TSH levels##2##5##(2008-4#2)
thyroid hormone and retinoic acid##2##5##(1994-11#1)(1994-9#1)
thyroid hormone and##5##3##(1994-11#1)(1994-9#2)(2008-4#2)
thyroid hormone as##2##3##(1996-5#1)(2009-5#1)
thyroid hormone binding##4##3##(1991-8#2)(1992-11#2)
thyroid hormone concentrations##2##3##(1990-3#1)(2012-1#1)
thyroid hormone in##5##3##(1992-5#2)(1994-11#1)(2007-1#1)(2009-12#1)
thyroid hormone induced##2##3##(1990-8#1)(1997-3#1)
thyroid hormone levels in##3##4##(2006-11#1)(2008-7#1)(2009-12#1)
thyroid hormone levels were##2##4##(1997-3#1)(2006-9#1)
thyroid hormone levels##10##3##(1991-10#1)(1995-10#1)(1997-3#1)(2006-11#1)(2006-9#1)(2008-4#1)(2008-7#3)(2009-12#1)
thyroid hormone nuclear receptor##2##4##(1991-2#1)(1995-7#1)
thyroid hormone receptor beta##3##4##(1991-7#1)(1997-7#1)(2008-7#1)
thyroid hormone receptor##23##3##(1990-8#2)(1991-2#2)(1991-7#2)(1993-10#1)(1993-3#1)(1993-8#2)(1994-11#3)(1994-9#3)(1995-8#1)(1996-5#1)(1997-7#2)(2008-4#1)(2008-7#1)(2013-1#1)
thyroid hormone receptors##5##3##(1991-5#1)(1993-3#1)(1994-3#1)(1994-9#1)(1996-4#1)
thyroid hormone replacement##4##3##(2008-5#1)(2011-1#2)(2012-2#1)
thyroid hormone resistance##3##3##(1991-7#3)
thyroid hormone response element##2##4##(1990-8#1)(1993-8#1)
thyroid hormone were##2##3##(1993-3#1)(1994-9#1)
thyroid hormone withdrawal##3##3##(2006-9#1)(2013-1#2)
thyroid hormone##125##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-8#5)(1991-10#1)(1991-2#4)(1991-5#1)(1991-7#5)(1991-8#2)(1991-9#1)(1992-11#6)(1992-12#1)(1992-4#1)(1992-5#3)(1993-10#1)(1993-3#7)(1993-8#3)(1993-9#1)(1994-11#7)(1994-12#1)(1994-3#1)(1994-9#9)(1995-10#3)(1995-12#1)(1995-2#2)(1995-6#1)(1995-7#1)(1995-8#4)(1996-4#1)(1996-5#3)(1997-3#3)(1997-7#4)(2006-11#1)(2006-9#2)(2007-1#3)(2008-1#1)(2008-10#1)(2008-4#4)(2008-5#1)(2008-7#7)(2009-12#2)(2009-5#3)(2011-1#2)(2012-1#3)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#1)
thyroid hormones and prostaglandin E2##2##5##(2011-2#2)
thyroid hormones and##6##3##(1995-8#1)(1997-3#1)(2011-2#2)(2012-2#2)
thyroid hormones for##2##3##(2007-1#1)(2010-9#1)
thyroid hormones in##4##3##(1994-12#1)(2007-7#1)(2012-1#1)(2012-2#1)
thyroid hormones to##3##3##(1991-9#1)(2008-5#1)(2012-1#1)
thyroid hormones were##3##3##(1990-3#1)(1992-2#1)(2012-2#1)
thyroid hormones##44##2##(1990-3#2)(1990-8#2)(1991-10#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-7#2)(1995-8#1)(1997-3#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-7#1)(2007-9#2)(2008-5#1)(2008-6#1)(2008-7#3)(2010-9#1)(2011-2#3)(2012-1#4)(2012-2#4)(2013-8#2)
thyroid hyperplasia##3##2##(2008-4#1)(2012-12#2)
thyroid hypoplasia##2##2##(2008-4#1)(2010-11#1)
thyroid in the##2##3##(2009-10#1)(2011-1#1)
thyroid in##8##2##(1992-2#2)(1994-11#1)(2008-6#1)(2009-10#1)(2009-3#1)(2011-1#1)(2011-2#1)
thyroid is##6##2##(2006-9#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-3#1)
thyroid lobe##2##2##(2009-7#1)(2009-9#1)
thyroid lobectomy##4##2##(2012-12#4)
thyroid lobes were##2##3##(1991-12#2)
thyroid lobes##8##2##(1991-12#4)(1991-7#2)(2009-9#1)(2012-3#1)
thyroid malignancy##2##2##(2006-9#1)(2011-12#1)
thyroid mass##6##2##(1992-10#1)(2006-9#1)(2008-12#2)(2009-3#1)(2011-1#1)
thyroid microsomal##2##2##(1991-3#1)(1992-1#1)
thyroid morphology##2##2##(2008-7#2)
thyroid nodule##12##2##(1992-9#1)(1994-5#1)(2006-1#1)(2006-10#1)(2006-11#1)(2008-12#1)(2009-9#1)(2011-1#1)(2011-12#3)(2011-2#1)
thyroid nodules with##2##3##(2013-1#1)(2013-7#1)
thyroid nodules##17##2##(1990-6#1)(1997-2#1)(2006-7#1)(2007-11#1)(2011-1#4)(2011-12#4)(2012-3#3)(2013-1#1)(2013-7#1)
thyroid parenchyma##2##2##(2008-12#1)(2008-7#1)
thyroid pathologies##2##2##(1992-10#2)
thyroid pathology##4##2##(2006-11#1)(2013-1#3)
thyroid peroxidase##5##2##(1991-8#3)(1992-12#1)(2011-1#1)
thyroid receptor##2##2##(1994-3#1)(2010-3#1)
thyroid remnant ablation##4##3##(2013-1#4)
thyroid remnant##6##2##(2006-1#1)(2008-5#1)(2013-1#4)
thyroid response##3##2##(1991-7#1)(1994-11#1)(1994-12#1)
thyroid screening##2##2##(1992-2#1)(2013-1#1)
thyroid secretion##2##2##(1991-10#2)
thyroid slices##4##2##(1994-11#2)(1994-6#2)
thyroid state##3##2##(2007-8#2)(2009-12#1)
thyroid status##6##2##(1992-11#1)(1995-7#2)(2008-5#1)(2008-6#1)(2008-7#1)
thyroid stimulating activities##3##3##(1991-12#1)(1991-9#2)
thyroid stimulating antibodies##3##3##(1990-9#1)(1991-8#1)(1991-9#1)
thyroid stimulating antibody (TSAb)##3##4##(1991-12#1)(1991-5#1)(1991-7#1)
thyroid stimulating antibody##4##3##(1991-12#1)(1991-5#1)(1991-7#2)
thyroid stimulating autoantibodies##2##3##(1992-12#2)
thyroid stimulating hormone (TSH)##7##4##(1990-8#1)(1994-9#1)(1995-5#1)(2007-9#1)(2008-6#1)(2010-7#1)(2011-12#1)
thyroid stimulating hormone##9##3##(1990-8#1)(1994-9#1)(1995-5#1)(2007-9#1)(2008-1#1)(2008-6#1)(2008-7#1)(2010-7#1)(2011-12#1)
thyroid stimulating##25##2##(1990-8#1)(1990-9#1)(1991-12#2)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#6)(1992-12#2)(1994-9#1)(1995-12#1)(1995-5#1)(2007-9#1)(2008-1#1)(2008-6#1)(2008-7#1)(2010-7#1)(2011-12#1)
thyroid stimulation blocking##2##3##(1991-5#1)(1991-8#1)
thyroid storm##3##2##(2012-12#3)
thyroid surgery in##2##3##(2006-12#1)(2013-1#1)
thyroid surgery##6##2##(1990-4#1)(2005-8#1)(2006-12#1)(2009-3#1)(2011-2#1)(2013-1#1)
thyroid tissue specimens from patients with##2##6##(2012-1#2)
thyroid tissue##13##2##(1991-8#1)(1992-5#2)(1992-8#1)(1994-11#1)(1996-9#1)(2007-8#2)(2008-11#1)(2008-12#1)(2009-2#1)(2012-1#2)
thyroid tissues##2##2##(1990-7#1)(1991-7#1)
thyroid tumor##3##2##(1992-2#1)(1994-12#1)(2009-5#1)
thyroid tumors##6##2##(1990-2#1)(1990-3#1)(2006-9#1)(2008-7#1)(2009-12#1)(2012-1#1)
thyroid tumours##2##2##(1994-11#2)
thyroid was##4##2##(1990-2#1)(1990-7#1)(1991-10#1)(2006-2#1)
thyroid##983##1##(1990-10#4)(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#10)(1990-4#8)(1990-5#6)(1990-6#11)(1990-7#3)(1990-8#13)(1990-9#2)(1991-10#8)(1991-12#8)(1991-2#7)(1991-3#1)(1991-5#14)(1991-6#1)(1991-7#14)(1991-8#20)(1991-9#15)(1992-1#3)(1992-10#4)(1992-11#7)(1992-12#4)(1992-2#12)(1992-4#4)(1992-5#7)(1992-6#4)(1992-8#15)(1992-9#1)(1993-1#1)(1993-10#5)(1993-12#2)(1993-2#1)(1993-3#16)(1993-4#7)(1993-5#5)(1993-8#6)(1993-9#10)(1994-10#1)(1994-11#20)(1994-12#5)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#7)(1994-8#1)(1994-9#16)(1995-10#4)(1995-12#7)(1995-2#2)(1995-5#6)(1995-6#1)(1995-7#5)(1995-8#5)(1995-9#1)(1996-11#4)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#1)(1996-9#1)(1997-2#3)(1997-3#4)(1997-7#4)(1997-8#1)(2004-1#1)(2005-1#1)(2005-10#1)(2005-12#1)(2005-8#3)(2005-9#1)(2006-1#9)(2006-10#18)(2006-11#15)(2006-12#4)(2006-2#5)(2006-4#2)(2006-6#8)(2006-7#1)(2006-9#20)(2007-1#5)(2007-10#5)(2007-11#8)(2007-12#2)(2007-2#1)(2007-3#4)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#12)(2007-9#6)(2008-1#10)(2008-10#9)(2008-11#4)(2008-12#13)(2008-2#1)(2008-3#1)(2008-4#28)(2008-5#16)(2008-6#19)(2008-7#39)(2008-8#2)(2008-9#4)(2009-10#5)(2009-12#7)(2009-2#8)(2009-3#6)(2009-4#1)(2009-5#7)(2009-7#5)(2009-8#1)(2009-9#3)(2010-10#1)(2010-11#4)(2010-12#6)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#22)(2011-12#14)(2011-2#20)(2012-1#28)(2012-12#27)(2012-2#18)(2012-3#18)(2013-1#91)(2013-7#4)(2013-8#22)
thyroid-stimulating hormone (TSH)##2##3##(1996-2#1)(2012-3#1)
thyroid-stimulating hormone##6##2##(1991-10#1)(1996-2#1)(2007-1#1)(2007-5#1)(2008-4#1)(2012-3#1)
thyroid/steroid receptor superfamily##2##3##(1994-12#2)
thyroidal##4##1##(1991-5#2)(1994-9#1)(2006-9#1)
thyroidectomies##2##1##(2010-11#1)(2013-8#1)
thyroidectomized##4##1##(1991-9#1)(1995-12#1)(2008-7#2)
thyroidectomy and##4##2##(1992-2#1)(1992-5#1)(2006-10#1)(2013-1#1)
thyroidectomy for##2##2##(2006-10#1)(2007-12#1)
thyroidectomy is the##3##3##(1990-9#1)(1993-6#1)(2011-2#1)
thyroidectomy is##6##2##(1990-9#1)(1993-6#1)(2011-2#2)(2012-12#2)
thyroidectomy##45##1##(1990-2#1)(1990-9#4)(1992-10#1)(1992-2#1)(1992-5#2)(1993-6#2)(2006-10#3)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-11#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-12#8)(2013-1#5)(2013-7#1)
thyroiditis and##9##2##(1990-6#1)(1991-8#1)(1995-12#1)(2006-1#1)(2007-5#2)(2008-12#1)(2008-4#1)(2009-3#1)
thyroiditis in the##2##3##(1995-12#1)(2008-4#1)
thyroiditis in##3##2##(1995-12#2)(2008-4#1)
thyroiditis is a##2##3##(2008-12#1)(2013-7#1)
thyroiditis is##5##2##(1990-5#1)(1991-4#1)(1994-11#1)(2008-12#1)(2013-7#1)
thyroiditis with##3##2##(1991-8#1)(1992-4#1)(2008-6#1)
thyroiditis##53##1##(1990-5#2)(1990-6#3)(1991-12#1)(1991-4#1)(1991-8#3)(1992-4#1)(1992-7#1)(1994-11#3)(1995-12#4)(1995-3#1)(1996-12#1)(1996-9#2)(2006-1#2)(2006-10#1)(2006-9#2)(2007-5#2)(2007-7#2)(2008-12#5)(2008-4#4)(2008-6#2)(2008-8#1)(2009-3#1)(2009-9#1)(2010-10#1)(2011-2#1)(2013-1#2)(2013-7#3)
thyroiditis]##5##1##(1990-6#1)(1991-11#1)(1991-4#1)(2013-1#1)(2013-7#1)
thyroids and##2##2##(1992-5#1)(1994-11#1)
thyroids of fasted##2##3##(2008-7#2)
thyroids of##4##2##(2008-7#3)(2013-8#1)
thyroids##11##1##(1992-5#1)(1994-11#1)(1995-12#1)(1996-11#3)(2008-7#3)(2012-1#1)(2013-8#1)
thyroliberin on structural state of##2##5##(2008-4#2)
thyroliberin##3##1##(2008-4#3)
thyromedins##2##1##(1991-7#2)
thyronine##3##1##(1991-5#1)(1992-11#1)(2007-9#1)
thyropathic women with##2##3##(2013-1#2)
thyropathic women##3##2##(2013-1#3)
thyroperoxidase##3##1##(1990-7#2)(1995-12#1)
thyrostatic-induced##2##1##(1994-3#2)
thyrotoxic periodic paralysis##2##3##(2007-5#2)
thyrotoxicosis and##3##2##(2006-10#1)(2007-2#1)(2011-2#1)
thyrotoxicosis associated with##2##3##(2008-4#1)(2008-7#1)
thyrotoxicosis##16##1##(2005-1#1)(2005-8#1)(2006-10#1)(2006-4#3)(2007-2#1)(2007-5#1)(2008-4#1)(2008-7#3)(2011-2#3)(2012-12#1)
thyrotrophin##2##1##(2006-10#2)
thyrotropic##3##1##(1992-2#1)(1994-6#1)(2006-6#1)
thyrotropin (TSH) receptor##7##3##(1990-8#1)(1991-5#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-7#1)
thyrotropin (TSH)##15##2##(1990-8#1)(1991-12#1)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-7#1)(1993-12#1)(2006-11#1)(2009-5#1)(2011-1#1)(2013-1#2)
thyrotropin and##3##2##(1990-9#1)(1994-11#1)(1994-6#1)
thyrotropin as##2##2##(1992-2#1)(1994-11#1)
thyrotropin receptor (TSH-R)##2##3##(1991-12#1)(1991-9#1)
thyrotropin receptor (TSHR)##3##3##(1991-8#1)(1994-3#1)(1995-12#1)
thyrotropin receptor (TSHr)##3##3##(1994-11#2)(2008-4#1)
thyrotropin receptor cDNA##4##3##(1990-11#1)(1990-9#1)(1992-2#2)
thyrotropin receptor mRNA##2##3##(1992-2#2)
thyrotropin receptor##29##2##(1990-11#3)(1990-8#1)(1990-9#2)(1991-12#2)(1991-5#1)(1991-8#2)(1991-9#2)(1992-2#4)(1994-11#6)(1994-3#2)(1995-12#2)(1996-5#1)(2008-4#1)
thyrotropin releasing hormone (TRH) and##2##5##(1992-7#1)(2007-7#1)
thyrotropin releasing hormone (TRH)##6##4##(1992-6#1)(1992-7#1)(1992-8#1)(1995-5#1)(2006-1#1)(2007-7#1)
thyrotropin releasing hormone##7##3##(1992-6#1)(1992-7#1)(1992-8#2)(1995-5#1)(2006-1#1)(2007-7#1)
thyrotropin stimulates##2##2##(1993-12#1)(1994-11#1)
thyrotropin##86##1##(1990-11#4)(1990-8#2)(1990-9#7)(1991-10#1)(1991-12#6)(1991-5#2)(1991-7#2)(1991-8#3)(1991-9#3)(1992-10#1)(1992-12#1)(1992-2#7)(1992-6#1)(1992-7#3)(1992-8#2)(1993-12#2)(1993-8#1)(1994-11#11)(1994-3#2)(1994-6#3)(1994-9#1)(1995-12#3)(1995-5#1)(1996-5#1)(2006-1#1)(2006-11#1)(2006-9#3)(2007-7#1)(2008-4#1)(2009-5#1)(2011-1#1)(2012-12#1)(2013-1#6)
thyrotropin-releasing hormone (TRH) analog##2##4##(1996-9#1)(2005-8#1)
thyrotropin-releasing hormone (TRH)##9##3##(1990-5#1)(1991-2#1)(1992-2#1)(1994-3#1)(1994-9#1)(1996-11#1)(1996-9#1)(2005-8#1)(2008-4#1)
thyrotropin-releasing hormone and##2##3##(1992-2#1)(1996-11#1)
thyrotropin-releasing hormone receptor##4##3##(1993-8#2)(1995-5#2)
thyrotropin-releasing hormone##24##2##(1990-5#1)(1991-10#1)(1991-2#1)(1992-2#2)(1992-3#1)(1992-8#1)(1993-11#1)(1993-8#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-5#2)(1996-11#2)(1996-9#2)(2005-8#1)(2008-4#1)(2013-7#1)
thyroxin##7##1##(1990-10#1)(1992-8#1)(2006-1#2)(2008-1#1)(2012-3#1)(2013-1#1)
thyroxine (T(4))##3##2##(2009-12#1)(2010-8#1)(2012-1#1)
thyroxine (T4) and triiodothyronine (T3)##2##5##(1991-12#1)(2008-7#1)
thyroxine (T4) using##2##3##(1991-3#1)(1996-1#1)
thyroxine (T4)##12##2##(1991-10#1)(1991-12#1)(1991-3#1)(1992-12#1)(1994-12#1)(1996-1#1)(1997-8#1)(2006-9#1)(2008-6#2)(2008-7#1)(2010-7#1)
thyroxine and a##2##3##(2007-8#1)(2013-8#1)
thyroxine and##4##2##(2007-1#1)(2007-8#1)(2008-11#1)(2013-8#1)
thyroxine binding globulin (TBG)##2##4##(1990-2#2)
thyroxine binding globulin##3##3##(1990-2#2)(1995-12#1)
thyroxine binding##4##2##(1990-2#2)(1991-3#1)(1995-12#1)
thyroxine levels##2##2##(1992-11#1)(1996-3#1)
thyroxine transport##2##2##(1993-12#2)
thyroxine##59##1##(1990-2#2)(1990-5#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-3#3)(1991-5#4)(1991-9#1)(1992-11#1)(1992-12#1)(1993-12#5)(1994-12#2)(1995-12#1)(1996-1#2)(1996-3#1)(1997-5#1)(1997-8#1)(2006-11#2)(2006-9#4)(2007-1#3)(2007-5#1)(2007-8#3)(2008-11#2)(2008-6#2)(2008-7#3)(2009-12#1)(2009-2#1)(2010-12#1)(2010-7#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-8#3)
thyroxine-binding globulin##4##2##(1990-2#1)(1994-12#3)
thyroxine-treated rats##9##2##(1995-12#9)
thérapeutique##5##1##(2011-2#2)(2012-2#1)(2013-1#2)
thérapeutiques##3##1##(2009-4#1)(2011-2#1)(2012-2#1)
ti qualitative software##2##3##(2013-1#2)
ti##4##1##(2008-2#1)(2008-3#1)(2013-1#2)
tiadenol##3##1##(1990-2#3)
tianeptine##5##1##(1991-5#5)
tiapride##3##1##(1997-3#1)(2008-10#2)
tiazofurin##4##1##(1990-10#1)(1993-8#2)(1995-3#1)
tibia -##2##2##(2007-11#2)
tibia after##3##2##(2009-3#1)(2009-9#2)
tibia and femur##3##3##(2007-11#1)(2007-4#2)
tibia and fibula##3##3##(2007-7#1)(2008-12#1)(2008-8#1)
tibia and##13##2##(2007-1#1)(2007-11#1)(2007-4#3)(2007-7#1)(2007-8#1)(2008-12#1)(2008-8#1)(2009-3#1)(2010-12#2)(2012-1#1)
tibia fracture##4##2##(2007-11#2)(2007-4#1)(2012-12#1)
tibia in##3##2##(2008-12#1)(2009-3#1)(2012-2#1)
tibia of##3##2##(2008-7#1)(2009-3#1)(2009-7#1)
tibia simulating##2##2##(1993-11#2)
tibia using##2##2##(2007-11#1)(2007-4#1)
tibia was##3##2##(2008-4#1)(2012-1#1)(2013-1#1)
tibia were##2##2##(2012-1#1)(2012-12#1)
tibia with##2##2##(2007-8#1)(2008-6#1)
tibia##131##1##(1992-11#3)(1992-3#1)(1993-11#2)(1993-8#1)(2006-10#3)(2006-11#3)(2006-6#2)(2007-1#8)(2007-11#16)(2007-12#2)(2007-4#8)(2007-5#1)(2007-7#2)(2007-8#8)(2008-1#1)(2008-12#3)(2008-4#3)(2008-5#2)(2008-6#11)(2008-7#2)(2008-8#5)(2008-9#1)(2009-3#11)(2009-7#1)(2009-9#6)(2010-11#2)(2010-12#4)(2010-3#2)(2011-2#3)(2012-1#3)(2012-12#2)(2012-2#4)(2013-1#3)(2013-8#2)
tibiae and##2##2##(2007-7#1)(2012-2#1)
tibiae##8##1##(2007-7#1)(2007-8#1)(2008-11#1)(2008-5#2)(2012-12#2)(2012-2#1)
tibial and##3##2##(2007-1#1)(2007-5#1)(2011-2#1)
tibial arteries##4##2##(1990-11#1)(1990-6#1)(1991-3#1)(2008-8#1)
tibial artery##12##2##(1991-6#1)(1991-8#1)(2008-12#1)(2008-8#3)(2009-3#2)(2013-1#4)
tibial bone##3##2##(2008-12#1)(2009-7#1)(2011-2#1)
tibial component##5##2##(1991-12#1)(2007-8#1)(2009-3#1)(2009-4#1)(2011-2#1)
tibial defect following##2##3##(2008-6#2)
tibial diaphyseal##2##2##(2007-11#2)
tibial diaphysis##2##2##(2005-12#1)(2008-4#1)
tibial drawer##2##2##(2007-1#2)
tibial dyschondroplasia##3##2##(1991-9#1)(1997-3#2)
tibial fracture with##2##3##(2008-12#1)(2009-3#1)
tibial fracture##4##2##(2008-12#1)(2008-7#1)(2009-3#1)(2009-9#1)
tibial fractures complicated by##2##4##(2007-8#2)
tibial fractures##7##2##(2007-8#3)(2008-4#1)(2009-3#1)(2009-9#2)
tibial nail##3##2##(1995-3#1)(2009-3#2)
tibial nerve at the ankle##2##5##(1991-4#1)(2012-2#1)
tibial nerve##12##2##(1991-4#1)(2007-7#6)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)
tibial nerves##3##2##(2007-7#2)(2007-8#1)
tibial osteotomy##16##2##(1990-6#1)(2005-7#1)(2008-8#10)(2011-2#2)(2013-1#2)
tibial plateau fractures##5##3##(2009-4#1)(2010-3#1)(2013-1#3)
tibial plateau in##2##3##(2006-11#1)(2007-4#1)
tibial plateau leveling osteotomy##2##4##(2012-3#2)
tibial plateau##14##2##(2005-7#2)(2006-11#1)(2007-4#2)(2008-10#1)(2009-4#1)(2010-3#1)(2012-3#2)(2013-1#4)
tibial segments##3##2##(2007-8#3)
tibial shaft fracture with##2##4##(1995-3#1)(2008-12#1)
tibial shaft fracture##4##3##(1995-3#1)(2008-12#1)(2009-3#2)
tibial shaft fractures##4##3##(2009-9#2)(2012-2#2)
tibial shaft##14##2##(1995-3#1)(2007-8#1)(2008-12#1)(2009-3#2)(2009-9#4)(2010-11#2)(2012-2#2)(2013-8#1)
tibial slope##3##2##(2008-8#3)
tibial tendon insufficiency##2##3##(2008-8#2)
tibial tendon##4##2##(1990-9#2)(2008-8#2)
tibial translation in##2##3##(2006-3#1)(2008-12#1)
tibial translation##8##2##(2006-3#1)(2008-12#2)(2009-9#2)(2012-3#3)
tibial tubercle##5##2##(2008-8#1)(2008-9#2)(2012-12#1)(2012-2#1)
tibial##200##1##(1990-11#1)(1990-6#4)(1990-9#2)(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#2)(1994-2#1)(1995-3#3)(1996-6#1)(1997-3#3)(2005-10#1)(2005-12#1)(2005-7#6)(2006-11#1)(2006-3#1)(2007-1#12)(2007-11#4)(2007-12#1)(2007-2#1)(2007-4#4)(2007-5#2)(2007-7#8)(2007-8#10)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#8)(2008-4#2)(2008-6#4)(2008-7#1)(2008-8#25)(2008-9#2)(2009-10#1)(2009-3#15)(2009-4#2)(2009-7#1)(2009-8#1)(2009-9#10)(2010-11#3)(2010-12#1)(2010-3#4)(2010-5#2)(2011-2#8)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#5)(2013-1#15)(2013-7#1)(2013-8#1)
tibial-femoral##3##1##(2007-4#3)
tibialis anterior (TA) and extensor digitorum longus (EDL)##2##8##(1990-4#1)(1991-6#1)
tibialis anterior muscle of##3##4##(1995-12#1)(2012-1#2)
tibialis anterior muscle##5##3##(1995-12#1)(2006-10#1)(2012-1#3)
tibialis anterior##12##2##(1990-4#1)(1991-6#1)(1993-11#1)(1995-12#1)(2006-10#1)(2008-6#1)(2012-1#3)(2012-3#2)(2013-8#1)
tibialis group##2##2##(2008-5#2)
tibialis muscles of conscious##2##4##(1993-2#1)(1995-2#1)
tibialis##25##1##(1990-4#1)(1991-6#1)(1993-11#1)(1993-2#1)(1995-12#1)(1995-2#1)(1996-6#2)(2006-10#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-3#3)(2012-1#4)(2012-12#1)(2012-3#2)(2013-7#1)(2013-8#1)
tibias##5##1##(1992-11#1)(2006-9#1)(2007-11#1)(2009-3#1)(2010-2#1)
tibiocalcaneal fusion##3##2##(2009-3#3)
tibiofemoral malalignment##4##2##(2008-8#4)
tibiofemoral##5##1##(2008-8#4)(2013-1#1)
tibiofibular##3##1##(2006-12#2)(2011-2#1)
tibiotarsal##3##1##(1993-11#1)(1996-8#1)(2010-3#1)
tibiotarsus and##2##2##(1997-3#1)(2004-4#1)
tibiotarsus##4##1##(1997-3#2)(2004-4#1)(2005-9#1)
tibolone##3##1##(2008-10#3)
tic disorder##4##2##(1996-2#2)(1996-8#1)(2011-2#1)
tic##7##1##(1996-2#2)(1996-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2011-2#1)
ticarcillin##5##1##(2006-8#2)(2007-2#2)(2008-7#1)
ticarcillin-clavulanate##3##1##(2006-8#3)
ticarcillin-clavulanic acid##2##2##(2006-8#2)
tick (Acari##2##2##(1996-12#1)(2004-11#1)
tick abundance##2##2##(2004-11#2)
tick and##2##2##(1997-7#1)(2013-8#1)
tick attachment##4##2##(2004-11#2)(2006-10#2)
tick eggs##3##2##(2010-10#3)
tick habitat suitability##2##3##(2008-8#2)
tick populations##3##2##(1994-3#2)(2004-11#1)
tick species were collected from dogs##2##6##(2011-1#2)
tick species##12##2##(2004-11#4)(2008-8#2)(2010-2#1)(2011-1#4)(2013-8#1)
tick vector##2##2##(1994-6#1)(2008-8#1)
tick##81##1##(1992-1#1)(1993-8#1)(1994-3#5)(1994-6#1)(1996-11#2)(1996-12#5)(1996-8#1)(1997-7#2)(2004-11#15)(2005-7#1)(2006-10#3)(2007-2#1)(2008-10#1)(2008-12#3)(2008-4#1)(2008-8#12)(2008-9#1)(2010-1#3)(2010-10#6)(2010-2#2)(2010-9#1)(2011-1#7)(2012-3#1)(2013-1#1)(2013-8#4)
tick-borne disease##3##2##(2004-11#1)(2008-10#1)(2010-1#1)
tick-borne diseases##3##2##(2010-1#2)(2013-8#1)
tick-borne encephalitis##5##2##(2006-10#1)(2007-2#1)(2008-8#2)(2011-1#1)
tick-borne pathogen##3##2##(2013-8#3)
tick-borne rickettsial##2##2##(2010-9#2)
tick-borne##20##1##(1993-9#1)(2004-11#1)(2006-10#1)(2007-2#2)(2008-10#1)(2008-11#1)(2008-8#2)(2010-1#3)(2010-2#1)(2010-9#2)(2011-1#1)(2013-8#4)
tickborne infections##5##2##(2006-10#5)
tickborne##7##1##(1997-7#2)(2006-10#5)
ticket for##2##2##(1993-12#1)(2007-8#1)
ticket##5##1##(1993-12#1)(1994-6#1)(2007-8#1)(2013-1#2)
ticketing##5##1##(2013-8#5)
tickets##8##1##(1992-2#1)(1993-12#2)(2013-1#5)
ticking##4##1##(1997-1#1)(2007-12#1)(2008-1#1)(2012-12#1)
ticks and fleas##2##3##(2012-12#2)
ticks and their##2##3##(1994-3#1)(1997-7#1)
ticks and##10##2##(1991-11#1)(1994-3#1)(1997-7#1)(2005-7#1)(2006-10#1)(2012-12#3)(2013-1#2)
ticks collected##4##2##(2004-11#2)(2011-1#1)(2012-12#1)
ticks in##2##2##(2008-8#1)(2012-12#1)
ticks of the##2##3##(2010-2#1)(2011-2#1)
ticks of##4##2##(2004-11#1)(2010-2#1)(2011-2#1)(2013-1#1)
ticks on##6##2##(1996-12#2)(2007-2#1)(2008-8#2)(2011-1#1)
ticks were collected##2##3##(2004-11#2)
ticks were##9##2##(1997-4#1)(2004-11#6)(2008-5#1)(2010-1#1)
ticks##72##1##(1991-11#1)(1994-3#2)(1995-5#1)(1996-11#2)(1996-12#4)(1997-4#3)(1997-7#1)(2004-11#14)(2005-7#1)(2006-10#4)(2007-2#3)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#4)(2010-1#6)(2010-10#1)(2010-2#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-12#7)(2012-2#1)(2013-1#4)(2013-8#2)
ticlopidine and##4##2##(1991-3#1)(2006-10#1)(2007-10#1)(2007-9#1)
ticlopidine##21##1##(1991-3#5)(1991-4#2)(1996-11#1)(1996-3#1)(2005-7#1)(2006-10#2)(2006-2#2)(2007-10#4)(2007-9#2)(2008-3#1)
ticlopidine-induced##2##1##(1991-3#1)(2006-10#1)
tics and##2##2##(2006-12#1)(2011-2#1)
tics or tourettism##2##3##(2008-7#2)
tics##14##1##(1996-2#1)(1996-5#3)(2006-12#2)(2007-6#1)(2008-4#2)(2008-7#3)(2011-2#1)(2013-1#1)
tidal breathing##3##2##(1997-4#1)(2013-1#2)
tidal cycles##4##2##(2007-5#3)(2010-8#1)
tidal flats##2##2##(2007-5#1)(2008-5#1)
tidal flows##2##2##(2007-5#1)(2013-1#1)
tidal transport##3##2##(2007-5#3)
tidal volume (TV)##2##3##(2012-2#1)(2013-1#1)
tidal volume and##3##3##(2007-9#1)(2009-3#1)(2013-1#1)
tidal volume limitation##2##3##(2006-10#2)
tidal volume##17##2##(1996-2#2)(1996-5#1)(1997-3#2)(2006-10#2)(2006-9#1)(2007-9#1)(2008-7#2)(2009-3#1)(2009-6#1)(2012-2#1)(2013-1#2)(2013-7#1)
tidal volume)##2##2##(1991-12#1)(2013-7#1)
tidal volumes##4##2##(1997-3#1)(2005-11#1)(2006-10#1)(2006-4#1)
tidal##53##1##(1991-12#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-3#4)(1997-4#1)(2005-11#1)(2006-10#3)(2006-4#1)(2006-6#1)(2006-9#2)(2007-5#8)(2007-9#1)(2008-5#3)(2008-7#2)(2009-3#1)(2009-6#1)(2010-6#1)(2010-8#5)(2012-2#2)(2013-1#8)(2013-7#3)
tide of suicide in##2##4##(2009-5#2)
tide of##4##2##(1991-1#1)(2008-10#1)(2009-5#2)
tide##13##1##(1991-1#1)(2007-11#1)(2007-3#3)(2007-5#4)(2008-10#1)(2008-3#1)(2009-5#2)
tides and##3##2##(1992-7#1)(2007-5#1)(2013-1#1)
tides is##2##2##(2006-6#1)(2007-9#1)
tides##12##1##(1992-7#2)(2006-6#1)(2007-3#1)(2007-5#2)(2007-9#2)(2012-11#1)(2012-2#1)(2013-1#2)
tie between##2##2##(1990-7#1)(2007-5#1)
tie##24##1##(1990-4#1)(1990-7#1)(1991-12#1)(1993-12#1)(1995-1#2)(1996-2#1)(2006-6#3)(2007-5#1)(2007-9#1)(2008-2#1)(2009-6#1)(2011-1#3)(2011-2#5)(2012-12#2)
tie-down sutures##2##2##(2012-2#2)
tied to a##3##3##(1996-5#1)(2008-4#1)(2011-1#1)
tied to the##8##3##(1991-3#1)(2006-2#1)(2007-11#1)(2008-3#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-2#1)
tied to##25##2##(1990-11#1)(1990-8#1)(1991-3#1)(1992-3#1)(1992-9#1)(1995-8#1)(1996-5#1)(2006-2#2)(2007-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)
tied##35##1##(1990-11#1)(1990-8#1)(1991-3#1)(1992-3#1)(1992-9#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-5#1)(1997-7#1)(2006-10#1)(2006-11#3)(2006-2#2)(2007-11#1)(2007-7#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)
tier of##4##2##(2009-2#1)(2010-2#1)(2011-1#1)(2013-8#1)
tier##13##1##(1990-12#1)(1990-3#4)(2007-7#1)(2008-10#1)(2009-2#2)(2010-2#1)(2011-1#2)(2013-8#1)
tiered approach##2##2##(2008-5#2)
tiered##5##1##(1996-2#1)(2008-3#1)(2008-5#2)(2009-2#1)
tiers of##4##2##(2008-1#1)(2008-11#1)(2008-2#1)(2010-2#1)
tiers##5##1##(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2010-2#1)
ties the##2##2##(2008-3#1)(2008-6#1)
ties to nonresident fathers##2##4##(2008-2#2)
ties to##7##2##(2007-9#1)(2008-2#6)
ties with##7##2##(1990-4#1)(1992-3#1)(1995-1#1)(1995-2#1)(2005-8#1)(2008-5#1)(2011-2#1)
ties##39##1##(1990-4#1)(1992-3#1)(1993-6#2)(1994-2#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-1#1)(2005-8#1)(2006-1#1)(2007-9#1)(2008-2#6)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#8)(2012-12#1)(2013-1#2)(2013-8#1)
tiger##4##1##(1995-11#1)(2005-7#1)(2008-4#1)(2011-1#1)
tigers (Panthera tigris)##3##3##(1996-12#1)(2009-4#2)
tigers##14##1##(1996-12#1)(2007-8#1)(2009-4#12)
tight and##7##2##(1990-7#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-10#1)(2009-2#1)
tight association between##2##3##(1994-3#1)(2009-2#1)
tight association##5##2##(1990-2#1)(1994-3#1)(1997-6#1)(2009-2#1)(2012-2#1)
tight binding of the##2##4##(1995-1#1)(2012-2#1)
tight binding of##3##3##(1995-1#1)(1997-1#1)(2012-2#1)
tight binding to##2##3##(1995-10#1)(1996-8#1)
tight binding##12##2##(1992-11#1)(1992-6#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-6#1)(1996-8#1)(1997-1#1)(2005-8#1)(2010-7#1)(2012-2#1)
tight blood pressure control##2##4##(2005-10#1)(2013-8#1)
tight blood-brain barrier##2##3##(1995-2#1)(2006-7#1)
tight clusters separate from clusters formed by##2##7##(2008-10#2)
tight clusters##3##2##(2008-10#2)(2008-11#1)
tight control of the##2##4##(2006-10#1)(2008-2#1)
tight control of##5##3##(1995-4#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-2#1)
tight control##9##2##(1995-4#1)(1996-4#1)(2006-10#2)(2008-1#1)(2008-11#1)(2008-2#1)(2009-8#1)(2012-2#1)
tight correlation##3##2##(1995-1#1)(2008-3#1)(2012-1#1)
tight coupling##2##2##(1990-8#1)(1996-8#1)
tight fiscal constraint##2##3##(1990-12#1)(1993-1#1)
tight fixation##2##2##(2007-8#1)(2013-8#1)
tight glycemic control##3##3##(2009-11#2)(2010-12#1)
tight interaction of##2##3##(1996-5#1)(2008-8#1)
tight junction (TJ)##2##3##(2012-2#2)
tight junction disruption during##2##4##(2011-2#2)
tight junction disruption##3##3##(2011-2#3)
tight junction##10##2##(2006-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2010-12#1)(2011-2#3)(2012-2#2)
tight junctions and##3##3##(2008-11#1)(2009-10#2)
tight junctions at##2##3##(1995-1#1)(2006-10#1)
tight junctions##12##2##(1995-1#1)(2006-10#1)(2008-11#1)(2008-7#1)(2009-10#4)(2011-2#3)(2012-2#1)
tight linkage##2##2##(1990-7#1)(2008-10#1)
tight regulation and##2##3##(2007-6#1)(2013-8#1)
tight regulation of##2##3##(2009-8#1)(2010-12#1)
tight regulation##4##2##(2007-6#1)(2009-8#1)(2010-12#1)(2013-8#1)
tight turn as the##2##4##(1990-11#2)
tight##152##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-7#3)(1990-8#1)(1992-11#1)(1992-3#1)(1992-6#2)(1993-1#1)(1993-11#2)(1993-4#1)(1993-6#1)(1994-3#1)(1994-8#2)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-6#2)(1995-8#1)(1996-4#2)(1996-5#4)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#2)(2005-10#4)(2005-11#1)(2005-8#1)(2006-10#4)(2006-12#3)(2006-6#1)(2006-7#1)(2007-11#3)(2007-12#5)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#6)(2009-11#2)(2009-2#3)(2009-3#2)(2009-5#1)(2009-8#2)(2010-10#1)(2010-12#4)(2010-4#1)(2010-5#1)(2010-7#1)(2011-10#1)(2011-2#6)(2012-1#1)(2012-2#8)(2012-3#1)(2013-8#4)
tight-binding inhibition##2##2##(1992-8#1)(1993-8#1)
tight-binding inhibitor of the human##2##5##(1993-11#1)(1995-5#1)
tight-binding inhibitor of##5##3##(1993-11#1)(1993-4#1)(1995-1#1)(1995-5#1)(2005-7#1)
tight-binding inhibitor##6##2##(1993-11#1)(1993-4#1)(1995-1#1)(1995-5#1)(2005-7#1)(2010-4#1)
tight-binding method##6##2##(2007-11#1)(2007-12#1)(2008-10#1)(2009-6#1)(2012-12#2)
tight-binding##22##1##(1991-5#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-4#1)(1993-8#1)(1995-1#2)(1995-5#1)(1996-4#1)(2005-7#1)(2007-11#2)(2007-12#1)(2008-10#3)(2009-6#1)(2010-4#1)(2010-7#1)(2012-12#2)
tight-junctional permeability##2##2##(1997-1#1)(2008-11#1)
tight-junctional##4##1##(1997-1#2)(2008-11#2)
tightened##4##1##(1991-2#1)(2006-2#1)(2007-9#1)(2008-2#1)
tightening of the##2##3##(2007-8#1)(2009-6#1)
tightening of##3##2##(1995-1#1)(2007-8#1)(2009-6#1)
tightening##6##1##(1993-3#1)(1995-1#1)(2007-12#1)(2007-8#1)(2009-6#2)
tighter binding for##2##3##(1995-2#1)(1997-1#1)
tighter binding##4##2##(1992-12#1)(1995-2#1)(1997-1#1)(2011-1#1)
tighter than that of##2##4##(1991-9#1)(1995-11#1)
tighter than that##3##3##(1991-9#1)(1995-11#1)(1995-8#1)
tighter than##5##2##(1990-5#1)(1991-9#1)(1995-11#1)(1995-8#1)(2008-5#1)
tighter##17##1##(1990-5#1)(1991-7#1)(1991-9#1)(1992-12#1)(1993-7#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-8#1)(1997-1#1)(2007-9#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-1#1)(2013-1#1)
tightly adherent##2##2##(2009-2#1)(2009-5#1)
tightly and##4##2##(1994-11#1)(1994-6#1)(1995-2#1)(2008-2#1)
tightly associated to##2##3##(1992-6#1)(1994-12#1)
tightly associated with the##3##4##(1991-1#1)(1992-3#1)(2012-2#1)
tightly associated with##10##3##(1991-1#1)(1992-12#1)(1992-3#1)(1994-12#1)(1994-6#1)(1997-4#1)(2008-10#1)(2008-7#1)(2009-3#1)(2012-2#1)
tightly associated##15##2##(1991-1#1)(1992-12#1)(1992-3#1)(1992-6#3)(1994-12#2)(1994-6#1)(1994-8#1)(1997-4#1)(2008-10#1)(2008-7#1)(2009-3#1)(2012-2#1)
tightly bound metal##2##3##(1991-3#1)(1992-3#1)
tightly bound to the##3##4##(1990-5#1)(1994-8#1)(1995-10#1)
tightly bound to##6##3##(1990-5#2)(1991-1#1)(1994-8#1)(1995-10#1)(1995-6#1)
tightly bound water##2##3##(1995-11#1)(2007-3#1)
tightly bound##31##2##(1990-10#1)(1990-4#1)(1990-5#3)(1991-1#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-11#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#1)(1995-2#1)(1995-6#2)(1996-5#1)(1997-4#2)(2005-11#1)(2007-3#1)(2007-8#1)
tightly control the##2##3##(2009-8#1)(2013-1#1)
tightly control##4##2##(1996-1#1)(2008-11#1)(2009-8#1)(2013-1#1)
tightly controlled by##5##3##(1993-8#1)(2007-8#1)(2010-11#1)(2012-2#2)
tightly controlled##8##2##(1993-8#1)(1996-5#2)(2005-11#1)(2007-8#1)(2010-11#1)(2012-2#2)
tightly coupled to##6##3##(1994-11#1)(1997-1#1)(1997-4#1)(2008-11#1)(2008-8#1)(2012-3#1)
tightly coupled##7##2##(1994-11#1)(1995-6#1)(1997-1#1)(1997-4#1)(2008-11#1)(2008-8#1)(2012-3#1)
tightly focused##6##2##(2007-12#1)(2008-1#1)(2008-3#3)(2009-5#1)
tightly linked to the##9##4##(1995-6#1)(1996-3#1)(2006-12#2)(2008-10#2)(2011-12#1)(2013-7#1)(2013-8#1)
tightly linked to##15##3##(1995-2#1)(1995-6#1)(1996-3#1)(2006-12#2)(2008-10#6)(2011-12#1)(2011-2#1)(2013-7#1)(2013-8#1)
tightly linked##20##2##(1994-3#1)(1995-2#1)(1995-6#1)(1996-3#1)(1997-3#1)(2006-12#2)(2008-10#9)(2011-12#1)(2011-2#1)(2013-7#1)(2013-8#1)
tightly on the##2##3##(1996-10#1)(2009-3#1)
tightly packed##14##2##(1991-6#1)(1993-7#1)(1994-5#1)(1994-9#1)(2007-12#3)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-3#1)
tightly regulated by phosphorylation and dephosphorylation##2##6##(1991-9#1)(1995-3#1)
tightly regulated by##10##3##(1991-9#1)(1994-6#1)(1995-10#1)(1995-3#1)(1996-4#1)(2004-12#1)(2008-9#1)(2009-8#1)(2010-2#1)(2013-1#1)
tightly regulated in##2##3##(2005-10#1)(2009-8#1)
tightly regulated##29##2##(1990-4#1)(1991-9#1)(1994-12#2)(1994-6#1)(1995-1#1)(1995-10#2)(1995-2#1)(1995-3#1)(1996-4#1)(1997-4#1)(2004-12#1)(2005-10#1)(2005-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#2)(2010-2#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#1)
tightly regulates##2##2##(1992-7#1)(1997-4#1)
tightly than##9##2##(1991-4#1)(1992-12#1)(1994-5#1)(1994-9#1)(1995-10#2)(1995-11#1)(1996-5#1)(1996-6#1)
tightly to the##5##3##(1992-12#1)(1992-3#1)(1992-6#1)(1994-12#1)(2008-10#1)
tightly to##14##2##(1990-11#1)(1990-7#1)(1991-5#1)(1992-12#1)(1992-3#2)(1992-6#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-10#1)(1995-3#1)(2008-10#1)(2008-9#1)
tightly with##3##2##(1992-3#1)(2007-8#1)(2008-5#1)
tightly##218##1##(1990-10#1)(1990-11#1)(1990-4#2)(1990-5#3)(1990-7#2)(1991-1#2)(1991-12#1)(1991-3#1)(1991-4#3)(1991-5#4)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-3#6)(1992-4#1)(1992-5#1)(1992-6#8)(1992-7#1)(1993-11#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#4)(1994-12#5)(1994-3#1)(1994-5#3)(1994-6#3)(1994-8#2)(1994-9#4)(1995-1#4)(1995-10#6)(1995-11#2)(1995-2#5)(1995-3#2)(1995-6#4)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-4#2)(1996-5#4)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#6)(1997-6#2)(2004-12#1)(2005-10#1)(2005-11#4)(2006-12#2)(2006-6#1)(2007-11#2)(2007-12#5)(2007-3#1)(2007-7#1)(2007-8#4)(2008-1#3)(2008-10#14)(2008-11#3)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#7)(2009-2#1)(2009-3#4)(2009-5#2)(2009-6#2)(2009-8#3)(2010-11#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#8)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
tightness in##2##2##(1995-8#1)(2012-2#1)
tightness of the##3##3##(2006-10#1)(2007-7#1)(2008-10#1)
tightness of##4##2##(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#1)
tightness##12##1##(1995-8#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2010-9#1)(2012-2#1)(2013-7#1)
tightrope between##2##2##(2007-10#1)(2007-9#1)
tigress was##2##2##(2011-1#2)
tigress##5##1##(2011-1#5)
tijdens een multidisciplinair overleg##2##4##(2012-12#2)
til##2##1##(1991-10#1)(1992-8#1)
tilapia (Oreochromis mossambicus)##2##3##(1996-7#1)(2008-5#1)
tilapia (Oreochromis niloticus) and##2##4##(2007-3#2)
tilapia (Oreochromis niloticus)##3##3##(2007-3#2)(2013-7#1)
tilapia (Oreochromis##5##2##(1996-7#1)(2007-3#2)(2008-5#1)(2013-7#1)
tilapia Oreochromis aureus##2##3##(2008-5#2)
tilapia Oreochromis##4##2##(2008-5#2)(2010-8#2)
tilapia population##2##2##(2008-5#2)
tilapia##32##1##(1993-3#3)(1994-11#2)(1996-7#4)(1997-3#1)(2007-3#4)(2008-12#4)(2008-5#9)(2010-8#2)(2013-7#3)
tile boundaries##3##2##(2008-2#3)
tile##4##1##(2005-8#1)(2008-2#3)
tiled regression##4##2##(2012-3#4)
tiled##5##1##(2008-2#1)(2012-3#4)
tiles deployed##2##2##(2007-5#2)
tiles##11##1##(1994-6#1)(2005-7#1)(2007-5#4)(2008-10#2)(2008-2#3)
tilidine-naloxone##3##1##(1995-9#3)
tiling path##5##2##(2008-5#1)(2008-7#2)(2012-3#2)
tiling##11##1##(1997-2#1)(2007-12#1)(2008-5#1)(2008-6#1)(2008-7#3)(2011-1#1)(2012-2#1)(2012-3#2)
till 7##2##2##(2009-2#2)
till date##7##2##(1991-5#1)(2007-7#3)(2008-6#1)(2010-2#1)(2013-8#1)
till delivery##2##2##(2012-12#1)(2012-3#1)
till now##8##2##(2007-11#2)(2009-6#1)(2010-1#1)(2011-1#2)(2011-12#1)(2011-2#1)
till the adult##2##3##(1990-7#1)(2008-10#1)
till the disease progression##2##4##(2013-8#2)
till the end of##4##4##(1996-3#1)(2007-7#1)(2007-8#1)(2008-10#1)
till the last##3##3##(2008-10#1)(2011-1#1)(2013-1#1)
till the##24##2##(1990-7#1)(1991-2#1)(1994-6#1)(1996-3#1)(1996-6#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-7#2)(2009-2#2)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#2)
till their##2##2##(2009-6#1)(2009-8#1)
till they##2##2##(2007-1#1)(2011-12#1)
till today##2##2##(2011-3#1)(2013-1#1)
till##89##1##(1990-7#1)(1991-2#1)(1991-5#1)(1994-6#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-6#1)(1997-7#1)(2004-9#1)(2007-1#1)(2007-11#5)(2007-4#1)(2007-7#8)(2007-8#3)(2008-1#4)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#2)(2008-7#3)(2008-8#2)(2009-10#1)(2009-2#7)(2009-6#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#6)(2011-12#2)(2011-2#4)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#4)
tillage after##2##2##(2008-10#1)(2009-3#1)
tillage and soil texture##3##4##(2008-10#3)
tillage and##14##2##(2008-10#9)(2008-12#1)(2013-8#4)
tillage had##2##2##(2008-10#1)(2008-12#1)
tillage in##4##2##(2008-10#2)(2011-12#1)(2013-8#1)
tillage information##3##2##(2008-10#3)
tillage mode##2##2##(2013-8#2)
tillage modes##3##2##(2013-8#3)
tillage on##3##2##(2008-10#3)
tillage practices##6##2##(2008-10#6)
tillage system##3##2##(2008-10#2)(2008-12#1)
tillage systems##6##2##(2008-10#6)
tillage than in##2##3##(2008-10#2)
tillage treatment##3##2##(2008-10#3)
tillage treatments##6##2##(2008-10#6)
tillage was##6##2##(2008-10#2)(2008-12#2)(2009-3#1)(2013-8#1)
tillage x texture interaction##2##4##(2008-10#2)
tillage##110##1##(2008-10#75)(2008-12#14)(2009-3#3)(2011-12#3)(2013-8#15)
tilled fields##3##2##(2008-10#3)
tilled##11##1##(2008-10#10)(2009-3#1)
tiller elongation##2##2##(2008-10#2)
tiller##5##1##(2008-10#4)(2008-9#1)
tillering##9##1##(2008-10#5)(2008-12#3)(2008-9#1)
tillers##5##1##(2006-9#1)(2008-10#2)(2008-9#2)
tilmicosin##9##1##(2006-5#1)(2008-5#8)
tilt and the##3##3##(2008-2#2)(2008-3#1)
tilt and##13##2##(1995-12#1)(2007-11#2)(2007-12#2)(2008-2#7)(2008-3#1)
tilt angle of##5##3##(2008-12#1)(2008-2#2)(2008-3#2)
tilt angle##14##2##(1994-11#1)(2007-11#1)(2007-12#1)(2008-12#2)(2008-2#5)(2008-3#4)
tilt angles##6##2##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#3)
tilt compensation##2##2##(2008-2#1)(2008-3#1)
tilt components##4##2##(2007-12#1)(2008-2#3)
tilt correction##2##2##(2008-2#2)
tilt errors##3##2##(2008-2#2)(2008-3#1)
tilt estimation##2##2##(2008-2#1)(2008-3#1)
tilt for Polaris##2##3##(2007-12#2)
tilt for##3##2##(2007-12#2)(2008-3#1)
tilt from a laser guide star##2##6##(2007-12#1)(2008-3#1)
tilt from##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
tilt in##2##2##(2007-11#1)(2008-9#1)
tilt is##3##2##(2008-2#2)(2008-3#1)
tilt of 32##2##3##(1991-2#1)(2007-12#1)
tilt of the##9##3##(1994-5#1)(2005-11#1)(2008-2#4)(2008-3#2)(2008-6#1)
tilt of##15##2##(1991-2#1)(1992-1#1)(1994-5#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-2#6)(2008-3#2)(2008-6#1)
tilt on the##3##3##(2007-11#2)(2008-2#1)
tilt on##5##2##(1993-1#1)(2007-11#2)(2008-2#2)
tilt position##3##2##(1993-1#2)(2006-10#1)
tilt produces##2##2##(2008-2#2)
tilt sensing error##2##3##(2008-3#2)
tilt the##2##2##(2008-2#1)(2012-1#1)
tilt towards the##2##3##(1991-2#2)
tilt with a##2##3##(2007-12#1)(2008-3#1)
tilt with##3##2##(2005-11#1)(2007-12#1)(2008-3#1)
tilt##156##1##(1990-10#1)(1991-2#3)(1992-1#1)(1993-1#5)(1994-11#2)(1994-5#1)(1995-12#1)(1995-6#1)(1997-1#3)(2005-11#2)(2006-10#1)(2006-12#1)(2006-9#2)(2007-11#11)(2007-12#12)(2007-5#1)(2008-1#1)(2008-12#2)(2008-2#58)(2008-3#35)(2008-6#1)(2008-7#1)(2008-9#2)(2010-7#1)(2012-1#1)(2012-2#5)(2013-7#1)
tilt-mirror##2##1##(2008-2#2)
tilt-shift error##2##2##(2008-3#2)
tilt-shift##4##1##(2008-3#4)
tilted fiber gratings##2##3##(2008-3#2)
tilted fiber##3##2##(2008-3#3)
tilted implants##2##2##(2011-7#2)
tilted mirror##2##2##(2007-11#2)
tilted optical fiber##2##3##(2007-12#1)(2008-2#1)
tilted optical##3##2##(2007-12#1)(2008-2#2)
tilted planar waveguide gratings##2##4##(2008-3#2)
tilted to##2##2##(2007-11#1)(2008-3#1)
tilted with respect to the##5##5##(1996-2#1)(2008-2#2)(2008-3#2)
tilted##70##1##(1992-2#1)(1993-6#1)(1995-6#1)(1996-2#2)(2004-3#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#3)(2007-12#10)(2008-2#21)(2008-3#19)(2008-5#1)(2010-2#1)(2011-7#3)(2012-2#1)(2013-1#1)(2013-8#1)
tilted-columnar biaxial##2##2##(2008-3#2)
tilted-columnar##3##1##(2008-3#3)
tilting angle##4##2##(2008-2#4)
tilting is##2##2##(1996-2#2)
tilting the##4##2##(2007-11#1)(2008-1#1)(2008-3#2)
tilting##25##1##(1995-12#1)(1996-2#2)(2006-5#2)(2007-11#2)(2007-12#3)(2008-1#1)(2008-2#6)(2008-3#3)(2010-8#1)(2011-12#1)(2011-2#2)(2011-7#1)
tilting-disc##3##1##(2007-8#3)
tilts of##2##2##(2008-2#1)(2008-3#1)
tilts##4##1##(1997-2#1)(2008-2#2)(2008-3#1)
timber and##2##2##(2011-2#1)(2013-7#1)
timber value##2##2##(2008-10#1)(2008-9#1)
timber##12##1##(2006-5#2)(2008-10#2)(2008-9#3)(2011-2#2)(2013-7#2)(2013-8#1)
timbre as##2##2##(1997-7#2)
timbre##10##1##(1997-7#6)(2013-1#2)(2013-8#2)
time &gt##2##2##(2007-10#1)(2008-10#1)
time &lt##6##2##(1991-6#1)(2007-8#1)(2008-10#3)(2008-3#1)
time (&gt##2##2##(2008-10#1)(2008-7#1)
time (&lt##5##2##(1993-2#1)(2008-10#4)
time (0##6##2##(1997-8#1)(2008-11#1)(2008-12#1)(2010-3#1)(2011-12#2)
time (1##2##2##(2008-10#1)(2008-2#1)
time (10 min)##2##3##(2008-10#1)(2008-11#1)
time (10##3##2##(2008-10#2)(2008-11#1)
time (15##2##2##(1995-11#1)(2008-10#1)
time (2##3##2##(1996-7#1)(2008-10#1)(2011-2#1)
time (20 min)##2##3##(1996-2#1)(2007-8#1)
time (3##2##2##(1992-2#1)(2007-10#1)
time (4##2##2##(1993-8#1)(2008-10#1)
time (5##3##2##(2008-10#3)
time (5-15 min)##2##3##(2006-8#1)(2008-10#1)
time (6##2##2##(1996-2#1)(2008-10#1)
time (MTT)##2##2##(2007-10#1)(2012-3#1)
time (P &lt##2##3##(2010-2#1)(2010-3#1)
time (P##3##2##(1990-3#1)(2010-2#1)(2010-3#1)
time (P=0##5##2##(2007-8#2)(2013-1#3)
time (RT) paradigm##2##3##(1993-2#1)(2010-2#1)
time (RT)##9##2##(1993-2#1)(1996-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-2#1)(2011-2#1)(2013-7#1)
time (T1/2)##2##2##(1995-7#1)(1996-1#1)
time (about##2##2##(1993-1#1)(2008-10#1)
time (an##2##2##(2008-3#1)(2008-8#1)
time (and##3##2##(1994-3#1)(2009-2#1)(2011-12#1)
time (approximately##5##2##(1992-4#1)(2008-3#1)(2010-2#1)(2010-3#2)
time (e##2##2##(2008-8#1)(2008-9#1)
time (from##4##2##(1990-12#1)(2007-9#1)(2008-10#1)(2012-1#1)
time (i##4##2##(1991-11#1)(2008-10#2)(2008-4#1)
time (in##2##2##(2008-3#1)(2008-5#1)
time (p &lt##3##3##(1996-12#1)(2013-1#2)
time (p = 0##2##4##(1997-7#1)(2007-8#1)
time (p less than 0##6##5##(1990-2#1)(1991-12#1)(2008-1#4)
time (p##11##2##(1990-2#1)(1991-12#1)(1996-12#1)(1997-7#1)(2007-8#1)(2008-1#4)(2013-1#2)
time (p&lt##2##2##(2006-8#1)(2010-2#1)
time (p=0##2##2##(2008-5#1)(2010-7#1)
time (t(1/2))##3##2##(2008-10#3)
time (tau##5##2##(1992-9#1)(1993-6#1)(1995-6#2)(1996-7#1)
time (time##3##2##(2008-1#1)(2008-5#1)(2010-8#1)
time -##2##2##(2008-11#1)(2009-9#1)
time 0##3##2##(1990-12#1)(2008-5#1)(2009-7#1)
time 1##7##2##(2006-9#1)(2008-11#1)(2011-2#3)(2013-8#2)
time 2##8##2##(1992-9#1)(2006-9#1)(2011-2#4)(2013-8#2)
time 3##6##2##(2008-11#3)(2011-2#3)
time Markov process##3##3##(1993-6#1)(1995-9#1)(2007-12#1)
time PCR##10##2##(2008-11#1)(2008-8#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2013-1#3)
time RT-PCR##2##2##(2008-6#1)(2010-4#1)
time T##3##2##(2008-7#2)(2008-9#1)
time T(2)##2##2##(2008-1#1)(2012-2#1)
time a##30##2##(1990-6#1)(1992-3#1)(1993-3#1)(1993-7#1)(1994-4#1)(1994-9#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#2)(2010-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
time about##3##2##(1990-10#1)(1990-2#1)(2012-12#1)
time above the##2##3##(2005-11#1)(2006-10#1)
time above##3##2##(2005-11#1)(2006-10#1)(2012-12#1)
time according to##5##3##(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2013-1#1)
time across the##3##3##(1995-3#1)(2008-10#2)
time across##5##2##(1995-3#1)(2006-4#1)(2008-10#2)(2009-9#1)
time activities##2##2##(2005-10#1)(2009-7#1)
time affected##2##2##(2005-11#1)(2010-4#1)
time after a##2##3##(1996-7#1)(2008-3#1)
time after addition of##4##4##(1991-5#1)(2007-8#1)(2008-10#2)
time after drug##2##3##(2003-11#1)(2013-1#1)
time after inoculation##4##3##(2008-10#3)(2008-5#1)
time after planting##2##3##(2008-10#2)
time after sample##2##3##(2008-10#1)(2011-2#1)
time after surgery##4##3##(1990-12#1)(2007-11#1)(2007-12#1)(2007-7#1)
time after the onset of##3##5##(1991-10#1)(2007-9#1)(2008-7#1)
time after the##10##3##(1991-10#1)(1995-7#1)(1996-6#1)(1997-2#1)(1997-4#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-7#1)(2011-2#1)
time after##60##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-5#1)(1992-3#1)(1992-9#1)(1993-8#1)(1994-10#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-7#1)(1996-11#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(2003-11#1)(2006-5#1)(2007-11#4)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#11)(2008-3#3)(2008-5#1)(2008-7#1)(2010-12#1)(2011-12#1)(2011-2#3)(2012-3#2)(2013-1#2)
time algorithm for##2##3##(2006-10#2)
time allocated##3##2##(1990-2#1)(2008-5#1)(2012-1#1)
time allocation##2##2##(2008-5#1)(2008-8#1)
time allowed##2##2##(2006-11#1)(2012-10#1)
time along##2##2##(1996-4#1)(2011-1#1)
time also##3##2##(2005-11#1)(2008-5#1)(2009-2#1)
time among##3##2##(1994-6#1)(2008-8#1)(2010-3#1)
time an##5##2##(1996-12#1)(1996-8#1)(2007-8#1)(2008-5#1)(2010-3#1)
time analysis##2##2##(2008-10#2)
time and a decrease in the##2##6##(1997-1#1)(2008-10#1)
time and a##8##3##(1996-8#1)(1997-1#1)(2006-7#1)(2008-10#2)(2008-11#1)(2009-7#1)(2010-4#1)
time and accuracy##3##3##(2008-3#1)(2009-2#1)(2010-8#1)
time and an##2##3##(2007-12#1)(2008-10#1)
time and applied##2##3##(2008-10#2)
time and as##2##3##(1995-3#1)(2008-10#1)
time and between groups##2##4##(2007-2#2)
time and between##3##3##(2007-2#2)(2009-5#1)
time and body size##2##4##(2011-12#2)
time and by##4##3##(1992-9#1)(1996-11#1)(2006-8#1)(2007-8#1)
time and can##4##3##(2008-10#3)(2009-3#1)
time and concentration dependence of##2##5##(1990-3#1)(2008-10#1)
time and concentration dependent##5##4##(1990-11#1)(1990-9#1)(1991-4#1)(1991-6#1)(2006-12#1)
time and concentration##8##3##(1990-11#1)(1990-3#1)(1990-9#1)(1991-4#1)(1991-6#1)(2006-12#1)(2007-8#1)(2008-10#1)
time and cost of##3##4##(2008-10#1)(2013-1#2)
time and cost##6##3##(2008-10#2)(2009-8#1)(2013-1#3)
time and costs##3##3##(1990-12#1)(2008-10#2)
time and dose dependent##4##4##(1990-3#1)(1994-3#1)(1994-9#1)(1995-12#1)
time and dose##5##3##(1990-3#1)(1991-1#1)(1994-3#1)(1994-9#1)(1995-12#1)
time and dose-dependent##6##3##(1990-12#1)(1994-11#1)(1996-11#2)(1997-8#1)(2007-2#1)
time and effort##10##3##(1994-3#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2013-1#4)
time and energy##2##3##(1992-3#1)(2008-8#1)
time and expense##2##3##(2008-11#1)(2008-2#1)
time and financial##2##3##(2013-1#2)
time and flow rate##2##4##(2008-10#2)
time and flow##3##3##(2008-10#3)
time and frequency of##2##4##(1996-12#1)(2009-9#1)
time and frequency##6##3##(1996-12#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-3#1)(2009-9#1)
time and from##2##3##(2008-10#2)
time and good##2##3##(2008-10#2)
time and had##3##3##(1995-9#1)(1997-3#1)(2010-4#1)
time and high##3##3##(2006-10#1)(2007-8#1)(2008-10#1)
time and hospital stay##2##4##(2006-10#1)(2013-1#1)
time and improve##2##3##(2006-6#1)(2008-10#1)
time and in the##4##4##(1996-3#1)(1997-4#1)(2008-1#1)(2008-11#1)
time and in##10##3##(1991-11#2)(1996-3#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2010-8#1)
time and initial##3##3##(2007-10#1)(2008-10#2)
time and is##2##3##(2005-8#1)(2009-4#1)
time and labor##3##3##(2008-10#2)(2008-11#1)
time and low##2##3##(2008-10#1)(2009-7#1)
time and magnitude##2##3##(1996-4#1)(2008-3#1)
time and mass##2##3##(2008-10#1)(2008-5#1)
time and may be##2##4##(1991-5#1)(2008-9#1)
time and money##7##3##(1992-10#1)(1995-2#1)(1997-2#1)(2008-4#2)(2008-5#1)(2010-2#1)
time and no##2##3##(2007-8#1)(2008-10#1)
time and number of##3##4##(2008-10#2)(2010-8#1)
time and pH##2##3##(2007-8#1)(2008-10#1)
time and peak width##2##4##(1997-5#1)(2008-10#1)
time and peak##5##3##(1997-5#1)(2008-10#4)
time and physical##2##3##(2008-10#1)(2013-1#1)
time and place##3##3##(1992-11#1)(1993-4#1)(2011-1#1)
time and potential##5##3##(2008-10#5)
time and power##2##3##(2008-10#1)(2008-3#1)
time and rate of##2##4##(2008-10#1)(2009-6#1)
time and reached##2##3##(1993-8#1)(2008-10#1)
time and resource constraints##2##4##(2006-1#1)(2008-11#1)
time and resources and##2##4##(2010-9#1)(2012-2#1)
time and resources##8##3##(1996-11#1)(2008-11#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
time and sample##3##3##(1990-1#1)(2007-8#1)(2008-10#1)
time and sensitivity##2##3##(2008-10#1)(2009-4#1)
time and social support##2##4##(2007-10#1)(2013-1#1)
time and social##3##3##(2007-10#1)(2008-10#1)(2013-1#1)
time and solvent##4##3##(2008-10#4)
time and space##14##3##(1996-4#1)(1997-6#1)(2007-12#3)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2010-11#1)(2013-1#1)
time and spectral##3##3##(2006-10#2)(2007-12#1)
time and staff##2##3##(1992-3#1)(2008-11#1)
time and temperature on##2##4##(1997-8#1)(2004-9#1)
time and temperature were##2##4##(2008-10#2)
time and temperature##10##3##(1997-8#2)(2004-9#1)(2008-10#5)(2008-11#1)(2008-5#1)
time and that##5##3##(1993-4#1)(1993-7#1)(2007-4#1)(2008-11#1)(2011-12#1)
time and the frequency##3##4##(1996-12#1)(2007-12#1)(2008-2#1)
time and the##40##3##(1991-5#1)(1992-12#1)(1992-2#1)(1994-11#1)(1995-3#1)(1996-12#1)(1996-5#1)(2004-9#1)(2006-10#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#9)(2008-11#1)(2008-2#4)(2008-3#1)(2008-5#2)(2008-7#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
time and their##3##3##(2008-10#1)(2010-2#1)(2012-3#1)
time and then##2##3##(2008-10#1)(2008-4#1)
time and thereby##2##3##(2008-5#1)(2010-2#1)
time and those##2##3##(1992-12#1)(1997-3#1)
time and to##7##3##(1995-3#1)(1996-8#1)(2006-5#1)(2007-8#1)(2008-12#1)(2008-4#1)(2012-12#1)
time and was##2##3##(1992-6#1)(2008-10#1)
time and were##2##3##(1992-11#1)(2010-8#1)
time and with the##2##4##(1996-9#1)(2008-3#1)
time and with##10##3##(1990-12#1)(1996-8#1)(1996-9#1)(2006-10#1)(2006-12#1)(2008-11#1)(2008-3#2)(2011-1#2)
time and##542##2##(1990-1#1)(1990-11#2)(1990-12#5)(1990-2#1)(1990-3#2)(1990-5#1)(1990-9#3)(1991-1#2)(1991-11#2)(1991-12#1)(1991-4#1)(1991-5#2)(1991-6#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#4)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-4#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-1#2)(1994-11#2)(1994-12#2)(1994-3#4)(1994-5#1)(1994-6#4)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-11#6)(1996-12#4)(1996-3#2)(1996-4#3)(1996-5#3)(1996-8#3)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#4)(2004-11#1)(2004-9#4)(2005-4#2)(2005-8#2)(2006-1#1)(2006-10#11)(2006-12#3)(2006-2#2)(2006-3#1)(2006-5#1)(2006-6#4)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#4)(2007-11#3)(2007-12#11)(2007-2#3)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#4)(2007-8#16)(2007-9#1)(2008-1#6)(2008-10#130)(2008-11#18)(2008-12#1)(2008-2#13)(2008-3#12)(2008-4#7)(2008-5#12)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#5)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-2#4)(2010-4#6)(2010-5#2)(2010-8#6)(2010-9#5)(2011-1#9)(2011-12#5)(2011-2#10)(2012-1#3)(2012-10#1)(2012-12#10)(2012-2#7)(2012-3#3)(2012-7#1)(2013-1#20)(2013-7#3)(2013-8#5)
time and/or##3##2##(1994-3#1)(2008-2#1)(2010-2#1)
time approximately##3##2##(2008-10#2)(2010-1#1)
time are the##2##3##(2007-2#1)(2008-8#1)
time are##28##2##(1990-12#1)(1991-11#1)(1991-2#1)(1992-1#1)(1994-8#1)(2004-9#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#2)(2008-10#5)(2008-3#2)(2008-8#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
time array detection##2##3##(1992-1#2)
time as a function of##3##5##(1996-2#1)(1997-4#1)(2007-12#1)
time as a##11##3##(1996-2#1)(1997-4#1)(2007-12#3)(2007-7#1)(2007-9#1)(2008-10#2)(2008-7#1)(2011-2#1)
time as the##15##3##(1991-3#1)(1993-12#1)(1995-6#1)(1996-3#1)(1997-8#1)(2006-12#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-8#1)(2009-5#1)(2012-3#1)
time as they##2##3##(1991-8#1)(2008-12#1)
time as well as the##3##5##(1992-6#1)(1994-12#1)(2004-11#1)
time as well as##8##4##(1990-5#1)(1992-6#1)(1994-12#1)(1994-8#1)(2004-11#1)(2008-10#1)(2008-5#1)(2010-9#1)
time as##65##2##(1990-2#1)(1990-5#1)(1991-3#1)(1991-8#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-4#1)(1997-8#1)(2004-11#1)(2004-2#1)(2005-11#1)(2006-12#3)(2006-5#1)(2006-8#1)(2007-1#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#3)(2008-7#2)(2008-8#1)(2009-11#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-3#1)(2012-8#1)
time associated##2##2##(2008-7#1)(2013-1#1)
time associating with##2##3##(2009-9#2)
time at a##3##3##(1996-1#1)(2008-10#1)(2012-3#1)
time at high temperatures##2##4##(1997-8#1)(2008-8#1)
time at risk##2##3##(2009-7#2)
time at the##3##3##(2006-10#1)(2006-9#1)(2009-9#1)
time at which##7##3##(1996-12#1)(1996-3#1)(2008-10#2)(2008-7#1)(2008-8#1)(2012-1#1)
time at##45##2##(1990-4#1)(1990-5#1)(1990-7#1)(1991-2#1)(1992-8#1)(1994-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-8#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-7#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)
time available for##3##3##(1996-12#1)(2007-4#1)(2012-12#1)
time available in##2##3##(2008-8#1)(2010-2#1)
time available to escape##2##4##(1996-12#2)
time available##8##2##(1996-12#3)(2007-4#1)(2008-8#2)(2010-2#1)(2012-12#1)
time average##3##2##(2007-12#1)(2008-3#2)
time averaged##2##2##(2006-10#1)(2006-6#1)
time averaging##3##2##(2008-3#3)
time away from##3##3##(2007-1#1)(2010-2#1)(2010-9#1)
time axis##3##2##(1995-9#1)(2008-8#1)(2011-1#1)
time based on##5##3##(2007-9#1)(2008-7#1)(2013-1#3)
time based solenoid injector##2##4##(2007-10#2)
time based##8##2##(1994-5#1)(2007-10#2)(2007-9#1)(2008-7#1)(2013-1#3)
time because of##4##3##(1992-9#1)(2008-1#1)(2008-10#1)(2009-11#1)
time because##7##2##(1992-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-11#1)(2012-3#1)
time before the onset of##2##5##(1990-3#1)(1990-8#1)
time before the##4##3##(1990-3#1)(1990-8#1)(2008-6#2)
time before##14##2##(1990-3#1)(1990-8#1)(1994-3#1)(1996-3#1)(1997-8#1)(2006-2#2)(2008-3#1)(2008-5#2)(2008-6#2)(2009-9#1)(2010-12#1)
time being##5##2##(1990-12#2)(1996-8#1)(2008-10#1)(2013-7#1)
time between 5 and##2##4##(2008-10#2)
time between implants##2##3##(2012-2#2)
time between onset of##3##4##(2004-10#1)(2007-2#1)(2007-8#1)
time between the two##3##4##(2007-12#1)(2009-7#1)(2013-8#1)
time between the##10##3##(1993-9#1)(2007-12#2)(2008-10#2)(2008-11#1)(2009-7#1)(2012-1#1)(2012-12#1)(2013-8#1)
time between trauma and##2##4##(2008-4#1)(2008-5#1)
time between##46##2##(1993-9#1)(1995-6#1)(1996-7#1)(1996-8#1)(1997-7#1)(2004-10#1)(2005-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-12#4)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-7#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-8#2)
time bomb##2##2##(2007-1#1)(2012-12#1)
time but##14##2##(1992-1#1)(1996-12#1)(2004-2#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-6#1)(2012-2#1)
time by 3 orders of magnitude from##2##7##(2008-2#1)(2008-3#1)
time by a##9##3##(1992-12#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-3#3)(2009-11#1)(2012-2#1)
time by an##2##3##(2008-10#1)(2008-3#1)
time by approximately##2##3##(2008-10#1)(2008-2#1)
time by measuring##2##3##(1993-5#1)(2006-7#1)
time by use of##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
time by using##3##3##(2004-3#1)(2008-10#1)(2011-1#1)
time by##55##2##(1990-12#1)(1991-11#1)(1991-4#1)(1991-8#1)(1992-12#1)(1993-11#1)(1993-5#1)(1994-12#1)(1995-5#1)(1995-8#1)(1996-4#1)(1996-5#1)(1996-6#2)(1997-3#1)(1997-7#1)(2004-3#1)(2006-12#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#10)(2008-11#2)(2008-2#4)(2008-3#7)(2008-5#1)(2008-8#1)(2009-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
time can be##8##3##(1997-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)
time can##13##2##(1990-11#1)(1996-1#1)(1997-8#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-9#1)
time causing##2##2##(2006-10#1)(2008-5#1)
time cells##2##2##(2008-11#1)(2008-8#1)
time coding##2##2##(1996-9#2)
time communicating##2##2##(2007-9#1)(2013-8#1)
time compared to##2##3##(2007-10#1)(2008-10#1)
time compared with the##3##4##(2008-3#1)(2010-1#1)(2010-12#1)
time compared with##6##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-1#1)(2010-12#1)
time compared##8##2##(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-1#1)(2010-12#1)
time conditions##2##2##(2007-11#1)(2008-5#1)
time constant (tau##2##3##(1991-2#1)(1993-2#1)
time constant for##3##3##(2006-7#1)(2007-12#1)(2010-2#1)
time constant is##3##3##(2008-3#2)(2008-7#1)
time constant of##11##3##(1994-9#1)(1995-1#1)(1995-5#1)(1996-10#1)(1996-5#1)(1997-7#1)(2006-5#1)(2007-12#1)(2007-9#1)(2008-10#1)(2013-8#1)
time constant tau##2##3##(1992-9#1)(2008-3#1)
time constant##36##2##(1991-2#1)(1992-6#1)(1992-9#1)(1993-2#3)(1994-5#1)(1994-9#1)(1995-1#1)(1995-5#1)(1996-10#1)(1996-5#1)(1996-7#1)(1997-7#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#5)(2008-7#4)(2010-2#1)(2011-2#1)(2013-8#1)
time constants associated with##3##4##(2008-11#1)(2008-2#2)
time constants for##3##3##(1994-11#1)(2007-12#1)(2008-2#1)
time constants of##2##3##(1997-2#1)(2008-2#1)
time constants##22##2##(1994-11#1)(1995-12#1)(1997-2#1)(1997-3#2)(2006-5#1)(2006-7#2)(2007-12#3)(2008-10#2)(2008-11#2)(2008-2#4)(2008-3#2)(2008-8#1)
time constraints of##4##3##(2006-9#1)(2007-10#1)(2008-12#1)(2010-8#1)
time constraints##11##2##(1991-12#1)(2005-12#1)(2006-9#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-8#2)(2010-11#1)(2010-8#1)(2012-12#1)
time construction of##2##3##(2007-8#1)(2008-2#1)
time consuming and costly##4##4##(2013-1#4)
time consuming and expensive##2##4##(2011-2#1)(2013-1#1)
time consuming and##22##3##(1990-12#1)(1991-12#1)(2006-5#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#1)(2010-10#1)(2011-1#1)(2011-2#3)(2013-1#5)(2013-8#1)
time consuming but##2##3##(1993-8#1)(2008-5#1)
time consuming##67##2##(1990-12#1)(1990-2#1)(1991-12#1)(1993-8#1)(1994-1#1)(1994-3#1)(1995-7#1)(1997-4#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-4#2)(2007-5#2)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#5)(2013-8#2)
time consumption##2##2##(2008-10#2)
time control##2##2##(2008-10#1)(2008-3#1)
time correlation##2##2##(2007-11#1)(2008-3#1)
time corresponding to the##2##4##(1990-8#1)(2008-10#1)
time corresponding to##4##3##(1990-8#1)(1995-2#1)(1996-7#1)(2008-10#1)
time cost##2##2##(2008-6#1)(2008-9#1)
time costs##2##2##(2007-7#1)(2012-12#1)
time could be##3##3##(2006-9#1)(2007-12#1)(2008-11#1)
time could##6##2##(2006-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2012-2#1)
time course and##10##3##(1990-2#1)(1993-7#1)(1994-9#1)(1996-3#1)(2006-8#1)(2008-11#1)(2008-9#1)(2010-3#1)(2011-1#1)(2013-1#1)
time course for lung cancer onset##2##6##(2009-12#2)
time course for##10##3##(1993-6#1)(1994-9#1)(1995-2#1)(1995-6#1)(1997-6#1)(2006-12#1)(2007-9#1)(2008-6#1)(2009-12#2)
time course of attentional allocation##2##5##(2010-3#2)
time course of cell physiology##2##5##(2008-11#2)
time course of changes in##3##5##(1991-1#1)(1997-3#1)(2009-11#1)
time course of changes##4##4##(1991-1#1)(1997-3#1)(2009-11#1)(2013-1#1)
time course of release of##2##5##(2004-12#1)(2007-9#1)
time course of the##18##4##(1991-11#1)(1991-4#1)(1991-6#1)(1991-9#1)(1995-11#1)(1996-1#2)(1996-7#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-8#2)
time course of##84##3##(1990-5#3)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-8#3)(1992-9#2)(1993-11#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-3#3)(1997-4#1)(1997-7#1)(2004-12#1)(2007-1#1)(2007-11#1)(2007-9#2)(2008-1#2)(2008-10#4)(2008-11#4)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#3)(2009-12#1)(2009-8#1)(2010-11#1)(2010-3#3)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#2)(2013-1#3)(2013-8#2)
time course studies##2##3##(1995-12#1)(2008-11#1)
time course study##5##3##(1991-1#1)(1992-4#1)(1994-2#1)(2007-10#1)(2007-2#1)
time course to that of##2##5##(1995-2#1)(2008-10#1)
time course to that##3##4##(1995-2#1)(2008-10#1)(2013-1#1)
time course to##4##3##(1995-2#1)(2007-10#1)(2008-10#1)(2013-1#1)
time course was##4##3##(1990-10#1)(1990-8#1)(1991-3#1)(1997-7#1)
time course##148##2##(1990-10#1)(1990-2#1)(1990-5#3)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-4#1)(1992-8#3)(1992-9#2)(1993-11#1)(1993-2#2)(1993-6#1)(1993-7#3)(1993-8#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1996-1#4)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#2)(1996-8#1)(1997-3#4)(1997-4#2)(1997-6#2)(1997-7#2)(2004-12#1)(2005-11#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#8)(2008-11#7)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-11#3)(2009-12#3)(2009-8#2)(2010-11#1)(2010-3#4)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#2)(2013-1#7)(2013-8#2)
time courses of##11##3##(1990-10#1)(1992-11#1)(1993-11#1)(1994-12#1)(1994-2#1)(1995-6#1)(1996-11#1)(2008-10#3)(2008-7#1)
time courses were##4##3##(1991-10#1)(1995-11#2)(2008-10#1)
time courses##22##2##(1990-10#1)(1991-10#1)(1991-2#1)(1992-11#1)(1993-11#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-11#2)(1995-6#1)(1996-11#1)(1997-1#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#1)
time cues##2##2##(1996-9#2)
time curve (AUC)##3##3##(1990-5#1)(2008-6#1)(2008-7#1)
time curve##11##2##(1990-5#1)(1991-12#1)(1996-11#1)(1996-3#1)(2004-12#1)(2005-11#1)(2005-7#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)
time curves##4##2##(2005-11#1)(2008-10#1)(2008-11#1)(2010-5#1)
time data from##2##3##(1997-4#1)(2008-8#1)
time data in##2##3##(1996-2#1)(1997-4#1)
time data##12##2##(1993-4#1)(1996-12#1)(1996-2#1)(1997-4#5)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)
time decreased##2##2##(2008-10#1)(2010-8#1)
time decreases##4##2##(1990-7#1)(1997-2#1)(2008-8#2)
time delay (TTD)##2##3##(2007-12#1)(2008-3#1)
time delay and integration##2##4##(2008-1#2)
time delay and##5##3##(2008-1#2)(2008-10#1)(2008-2#1)(2013-8#1)
time delay between the##3##4##(2006-10#1)(2008-2#1)(2008-3#1)
time delay between##6##3##(2006-10#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
time delay of a##2##4##(2007-11#1)(2008-2#1)
time delay of##7##3##(1993-6#2)(2006-6#1)(2007-11#2)(2007-12#1)(2008-2#1)
time delay##35##2##(1993-6#2)(1996-6#1)(2006-10#1)(2006-6#1)(2007-11#3)(2007-12#4)(2008-1#4)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#6)(2009-9#2)(2010-10#1)(2011-1#1)(2013-8#1)
time delays are##3##3##(2008-2#1)(2008-3#2)
time delays between##2##3##(2004-9#1)(2006-11#1)
time delays with##3##3##(2007-11#1)(2008-3#1)(2010-12#1)
time delays##19##2##(1997-2#1)(2004-9#1)(2006-10#2)(2006-11#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-2#4)(2008-3#4)(2010-12#2)(2010-9#1)
time demonstrate the##2##3##(1997-6#1)(2007-7#1)
time depended on the##2##4##(2005-11#1)(2007-11#1)
time dependence of the##8##4##(1993-8#1)(2005-11#1)(2007-12#2)(2007-2#1)(2008-2#2)(2009-9#1)
time dependence of##11##3##(1993-8#1)(1994-7#1)(2005-11#1)(2006-10#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-2#2)(2009-9#1)
time dependence##16##2##(1993-8#1)(1994-7#1)(1994-8#1)(2005-11#2)(2006-10#1)(2007-12#2)(2007-2#1)(2008-10#2)(2008-2#3)(2009-9#1)(2011-2#1)
time dependency##5##2##(1991-2#1)(1992-3#1)(1995-6#1)(2008-10#2)
time dependent and##4##3##(2008-10#3)(2008-7#1)
time dependent covariate##2##3##(1992-2#2)
time dependent covariates##3##3##(1992-2#3)
time dependent loss##2##3##(1991-12#1)(2004-11#1)
time dependent manner##2##3##(1991-8#1)(1992-3#1)
time dependent##36##2##(1990-11#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-2#5)(1992-3#2)(1994-11#1)(1994-8#1)(1995-10#1)(1996-1#1)(1996-11#1)(1997-8#1)(2004-11#1)(2005-11#1)(2006-12#1)(2007-2#1)(2007-4#2)(2008-10#3)(2008-7#1)(2009-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
time detection##3##2##(2008-10#1)(2008-2#2)
time did not affect##2##4##(2008-12#1)(2008-7#1)
time did not##7##3##(1990-11#1)(2007-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-4#1)
time did##8##2##(1990-11#1)(2007-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-4#1)
time difference between##5##3##(1991-3#1)(1994-3#1)(2008-10#1)(2008-2#1)(2012-2#1)
time difference##8##2##(1990-8#1)(1991-3#1)(1994-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#1)(2012-2#1)
time differences in##2##3##(2008-5#1)(2009-5#1)
time dimension##2##2##(1995-11#1)(2008-4#1)
time discrimination##3##2##(2008-10#1)(2012-2#2)
time dispersion and nonparaxiality##4##4##(2008-1#4)
time dispersion##7##2##(2008-1#5)(2008-2#2)
time displacement##3##2##(2007-11#2)(2007-12#1)
time distribution of##2##3##(2006-4#1)(2008-7#1)
time distribution##6##2##(2006-4#1)(2007-10#1)(2008-10#1)(2008-7#1)(2010-12#2)
time distributions##4##2##(1996-2#2)(2010-8#2)
time division multiple access (TDMA)##2##5##(2008-2#2)
time domain by##3##3##(2008-2#1)(2008-3#1)(2010-8#1)
time domain##18##2##(1994-5#1)(2007-11#1)(2007-12#5)(2008-10#1)(2008-2#4)(2008-3#2)(2008-9#1)(2009-10#1)(2010-8#1)(2013-7#1)
time domains##5##2##(2007-11#1)(2007-8#1)(2007-9#1)(2008-2#2)
time dramatically##2##2##(2008-3#2)
time due to##4##3##(2006-10#1)(2007-7#1)(2008-10#1)(2009-8#1)
time duration of &lt##2##4##(2008-10#2)
time duration of##5##3##(1992-8#1)(1995-6#1)(2008-10#3)
time duration##9##2##(1992-8#1)(1995-3#1)(1995-6#1)(2006-10#1)(2007-11#1)(2008-10#3)(2012-11#1)
time during the##10##3##(1997-1#1)(2006-12#1)(2006-6#1)(2006-8#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-6#1)(2013-1#2)
time during which##3##3##(2007-9#1)(2008-10#1)(2009-12#1)
time during##29##2##(1995-5#1)(1996-3#1)(1997-1#1)(2005-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-7#1)
time effect##3##2##(1996-6#1)(2010-4#1)(2013-8#1)
time effects##4##2##(1994-2#1)(1996-8#1)(2006-12#1)(2007-6#1)
time elapsed between the##2##4##(2008-11#1)(2013-1#1)
time elapsed between##4##3##(1996-3#1)(2006-2#1)(2008-11#1)(2013-1#1)
time elapsed since the##3##4##(1990-3#1)(2007-3#1)(2012-2#1)
time elapsed since##5##3##(1990-3#1)(2007-3#1)(2008-2#1)(2009-9#1)(2012-2#1)
time elapsed##16##2##(1990-3#1)(1992-12#3)(1995-6#1)(1996-3#1)(2006-2#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
time endpoints##2##2##(2004-1#1)(2010-8#1)
time enhanced##2##2##(1992-12#1)(2010-4#1)
time evolution of the##5##4##(1995-11#1)(2005-11#1)(2007-12#1)(2008-1#1)(2013-8#1)
time evolution of##7##3##(1995-11#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2010-4#1)(2013-8#1)
time evolution##9##2##(1995-11#1)(2005-11#2)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2010-4#1)(2013-8#1)
time experimental##2##2##(1996-9#1)(2005-11#1)
time factor in##3##3##(1991-10#1)(2008-10#2)
time factor##4##2##(1991-10#1)(1994-11#1)(2008-10#2)
time factors##2##2##(2007-10#1)(2011-1#1)
time following diagnosis##2##3##(1997-3#1)(2008-6#1)
time following##6##2##(1994-2#1)(1995-5#1)(1997-3#1)(2006-7#1)(2008-6#1)(2011-12#1)
time for DNA##3##3##(1993-6#1)(1995-8#1)(1996-7#1)
time for a change##2##4##(1991-1#1)(2006-4#1)
time for a paradigm##2##4##(2008-3#1)(2012-2#1)
time for a##15##3##(1991-1#1)(1991-6#1)(1995-12#1)(2006-4#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-12#1)(2011-12#1)(2012-2#1)
time for an##2##3##(1996-8#1)(2008-3#1)
time for analysis##2##3##(2008-10#2)
time for each##3##3##(2008-10#1)(2013-1#2)
time for germination##2##3##(2008-10#1)(2008-12#1)
time for health##2##3##(2007-2#1)(2008-1#1)
time for its##2##3##(2008-10#1)(2008-8#1)
time for new##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
time for one sample was##2##5##(1996-7#1)(2008-10#1)
time for one sample##3##4##(1991-8#1)(1996-7#1)(2008-10#1)
time for one##5##3##(1991-8#1)(1996-7#1)(2008-10#3)
time for patients##4##3##(1991-11#1)(1997-4#1)(2006-10#1)(2010-8#1)
time for permanent##2##3##(2008-9#1)(2012-11#1)
time for research##2##3##(2005-8#1)(2009-4#1)
time for the first##2##4##(2008-3#1)(2012-12#1)
time for the##28##3##(1991-11#1)(1992-4#1)(1995-3#1)(1997-4#2)(1997-7#1)(2004-9#2)(2005-11#1)(2006-6#1)(2007-5#1)(2007-8#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-7#1)
time for these##3##3##(1993-6#1)(2008-11#1)(2012-12#1)
time for this##3##3##(2006-12#1)(2008-10#2)
time for##208##2##(1990-12#1)(1990-8#2)(1991-1#1)(1991-11#4)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-4#1)(1993-6#2)(1994-1#1)(1994-3#1)(1994-7#1)(1995-1#2)(1995-12#2)(1995-3#4)(1995-8#2)(1995-9#1)(1996-12#1)(1996-3#2)(1996-7#2)(1996-8#1)(1997-4#4)(1997-7#1)(2004-3#1)(2004-9#2)(2005-11#1)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-12#3)(2006-4#1)(2006-6#2)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#4)(2007-12#3)(2007-2#3)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#33)(2008-11#4)(2008-12#4)(2008-2#4)(2008-3#5)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-12#2)(2010-4#1)(2010-5#3)(2010-8#3)(2010-9#4)(2011-12#1)(2011-2#9)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#4)
time frame for##2##3##(1996-1#1)(2008-3#1)
time frame of##2##3##(2010-2#1)(2013-1#1)
time frame on##2##3##(2006-1#1)(2008-11#1)
time frame##23##2##(1992-3#1)(1993-3#1)(1996-1#1)(2005-5#1)(2006-1#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2010-1#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
time frames for##2##3##(1993-1#1)(1997-3#1)
time frames##8##2##(1993-1#1)(1997-3#1)(2007-12#1)(2008-11#2)(2010-11#1)(2012-2#1)(2012-3#1)
time from 30 to##2##4##(2007-8#1)(2008-10#1)
time from a##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
time from diagnosis##2##3##(1990-10#1)(2012-12#1)
time from hatching to 90% reaching the##2##7##(2011-12#2)
time from onset of symptoms to##3##6##(1990-4#1)(2008-3#1)(2013-1#1)
time from onset of##5##4##(1990-4#1)(1995-9#1)(2008-3#1)(2008-5#1)(2013-1#1)
time from presentation to##2##4##(2008-6#1)(2011-12#1)
time from renal failure to##2##5##(1995-12#2)
time from the##16##3##(1992-4#1)(1997-6#2)(2006-12#2)(2007-1#2)(2007-11#1)(2007-9#1)(2008-2#1)(2010-2#1)(2010-3#1)(2011-2#1)(2013-1#3)
time from##86##2##(1990-10#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-2#1)(1992-11#1)(1992-4#1)(1993-5#1)(1994-5#1)(1994-7#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-9#2)(1996-11#1)(1997-6#4)(2006-12#2)(2006-5#1)(2007-1#2)(2007-10#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-5#1)(2011-12#3)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#9)(2013-8#1)
time function##4##2##(2008-3#3)(2008-5#1)
time gate##2##2##(2007-11#1)(2007-12#1)
time gating##8##2##(2007-11#1)(2007-12#3)(2008-2#4)
time greater##2##2##(2008-3#1)(2008-9#1)
time greatly##3##2##(1997-2#1)(2008-8#1)(2013-7#1)
time grew##2##2##(2007-3#1)(2010-2#1)
time had##4##2##(2007-12#1)(2008-10#1)(2008-8#1)(2013-7#1)
time has a##2##3##(1995-12#1)(2008-10#1)
time has been##3##3##(2008-10#1)(2008-2#1)(2012-1#1)
time has come to##4##4##(1996-3#1)(2004-2#1)(2007-12#1)(2007-4#1)
time has elapsed##2##3##(2007-5#1)(2010-12#1)
time has##25##2##(1990-12#1)(1990-4#1)(1991-2#1)(1991-4#1)(1995-12#1)(1996-12#1)(1996-3#1)(2004-2#1)(2005-9#1)(2006-7#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2008-10#4)(2008-2#2)(2008-8#1)(2009-4#1)(2010-12#1)(2012-1#1)
time have been##3##3##(2008-10#3)
time have##4##2##(2007-12#1)(2008-10#3)
time he##2##2##(2007-6#1)(2011-2#1)
time high##2##2##(2011-2#1)(2012-2#1)
time histories##5##2##(2007-4#5)
time history and##3##3##(2007-4#1)(2008-3#2)
time history##4##2##(2007-4#2)(2008-3#2)
time horizon##9##2##(2006-2#1)(2008-11#4)(2008-9#2)(2009-8#1)(2010-2#1)
time horizons##2##2##(2008-1#1)(2013-1#1)
time how##2##2##(1993-6#1)(1996-12#1)
time images of##2##3##(2007-8#1)(2012-2#1)
time imaging##3##2##(1995-2#1)(2008-11#1)(2008-7#1)
time in 1989##2##3##(1990-6#1)(1992-2#1)
time in Europe##2##3##(2008-10#1)(2012-3#1)
time in India##2##3##(2013-1#1)(2013-8#1)
time in a##9##3##(1990-5#1)(1996-4#1)(2006-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-4#1)(2012-3#1)
time in academic activities##2##4##(2009-7#2)
time in all##2##3##(2011-11#1)(2013-8#1)
time in an##3##3##(2007-12#1)(2009-4#1)(2009-9#1)
time in bed##2##3##(1993-2#1)(2013-1#1)
time in both##4##3##(2008-9#1)(2009-11#1)(2010-2#1)(2012-1#1)
time in comparison to##2##4##(2008-10#1)(2008-12#1)
time in culture##4##3##(1990-7#1)(1996-1#1)(1996-5#1)(1997-6#1)
time in four##2##3##(2006-4#1)(2008-10#1)
time in group##2##3##(1994-2#1)(2007-9#1)
time in life##2##3##(1996-12#1)(2007-12#1)
time in living##3##3##(2006-11#1)(2007-12#1)(2008-4#1)
time in medical##2##3##(2008-5#1)(2011-2#1)
time in mice##2##3##(1996-4#1)(2008-12#1)
time in most##2##3##(2007-10#1)(2010-12#1)
time in patients with##5##4##(1990-11#2)(2007-8#1)(2008-7#2)
time in rats##2##3##(2010-12#1)(2013-1#1)
time in relation to##3##4##(2008-10#1)(2013-1#2)
time in several##2##3##(1997-3#1)(2008-10#1)
time in the United States##2##5##(2008-10#1)(2010-12#1)
time in the absence of##2##5##(1994-3#1)(1997-4#1)
time in the future##2##4##(1992-3#1)(1992-6#1)
time in the presence of##4##5##(1997-2#1)(2008-10#1)(2008-6#1)(2013-1#1)
time in the##75##3##(1990-11#1)(1990-12#1)(1990-5#2)(1992-1#1)(1992-10#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-4#1)(1994-3#1)(1995-10#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-2#3)(1997-4#1)(2005-8#1)(2005-9#1)(2006-12#1)(2006-6#1)(2007-1#2)(2007-11#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#6)(2013-8#1)
time in this##6##3##(2007-11#1)(2008-10#1)(2008-2#1)(2009-9#1)(2011-2#1)(2013-1#1)
time in vivo and##2##4##(1996-3#1)(2012-11#1)
time in vivo##4##3##(1996-3#1)(2006-10#1)(2012-1#1)(2012-11#1)
time in which the##2##4##(2008-11#1)(2008-4#1)
time in which##6##3##(1991-12#1)(1994-9#1)(2007-2#1)(2008-11#1)(2008-4#1)(2009-2#1)
time in##298##2##(1990-11#5)(1990-12#2)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-5#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-3#2)(1996-4#3)(1996-5#3)(1996-7#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(2005-10#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#2)(2006-11#2)(2006-12#2)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#2)(2006-7#1)(2007-1#3)(2007-10#2)(2007-11#5)(2007-12#7)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#4)(2007-9#3)(2008-1#2)(2008-10#23)(2008-11#7)(2008-12#6)(2008-2#5)(2008-3#6)(2008-4#5)(2008-5#5)(2008-6#3)(2008-7#11)(2008-8#5)(2008-9#7)(2009-10#2)(2009-11#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#7)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-11#1)(2011-2#5)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#5)(2013-1#12)(2013-7#1)(2013-8#5)
time increased##6##2##(2005-11#2)(2007-10#1)(2008-9#1)(2009-7#1)(2010-2#1)
time increases##2##2##(1991-3#1)(2009-3#1)
time increasing##2##2##(2008-10#1)(2013-8#1)
time independent of the##3##4##(2005-11#1)(2008-2#1)(2008-3#1)
time independent##4##2##(1994-3#1)(2005-11#1)(2008-2#1)(2008-3#1)
time induced by##4##3##(1995-12#1)(1996-4#1)(1996-6#1)(2010-9#1)
time induced##5##2##(1992-1#1)(1995-12#1)(1996-4#1)(1996-6#1)(2010-9#1)
time information##3##2##(2012-3#1)(2013-1#2)
time integral##2##2##(1994-6#1)(2012-12#1)
time intensive##2##2##(2008-10#1)(2010-11#1)
time interactions were##2##3##(2013-1#2)
time interval between the HV##2##5##(2009-10#2)
time interval between the##9##4##(2006-10#2)(2007-11#1)(2007-12#1)(2008-9#1)(2009-10#2)(2010-7#1)(2011-2#1)
time interval between##23##3##(1996-1#1)(1997-8#1)(2006-10#6)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#3)(2009-10#2)(2009-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-7#1)
time interval from##7##3##(1994-3#1)(2007-8#1)(2008-3#1)(2008-9#1)(2012-12#1)(2013-1#2)
time interval less than 2##2##5##(1996-12#2)
time interval of##4##3##(1991-12#1)(1994-3#1)(1996-7#1)(2012-2#1)
time interval##58##2##(1990-10#1)(1990-3#1)(1991-12#1)(1994-3#3)(1996-1#1)(1996-12#2)(1996-7#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-10#6)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#4)(2008-7#1)(2008-9#5)(2009-10#2)(2009-12#1)(2009-7#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)
time intervals (0##2##3##(2007-6#1)(2010-2#1)
time intervals after##6##3##(1997-5#1)(2008-10#3)(2008-5#2)
time intervals and##4##3##(1995-5#1)(2006-10#1)(2008-10#1)(2010-4#1)
time intervals before and after##2##5##(2008-12#1)(2012-2#1)
time intervals between##7##3##(1997-6#2)(2007-12#1)(2008-3#1)(2010-8#1)(2011-1#1)(2013-7#1)
time intervals following##2##3##(1991-8#1)(2011-2#1)
time intervals over##3##3##(2007-9#1)(2008-11#1)(2008-5#1)
time intervals##65##2##(1990-6#1)(1991-8#1)(1992-12#1)(1992-8#1)(1994-3#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-12#1)(1997-5#1)(1997-6#2)(2004-11#1)(2006-10#1)(2006-2#1)(2007-12#4)(2007-2#2)(2007-5#1)(2007-6#2)(2007-9#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#5)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
time into##6##2##(1994-3#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)
time is 3##2##3##(2008-10#2)
time is a##4##3##(1997-4#1)(2006-5#1)(2008-11#1)(2013-8#1)
time is demonstrated##2##3##(2007-12#1)(2009-3#1)
time is given##2##3##(2006-12#1)(2008-10#1)
time is less than##3##4##(1991-4#1)(2008-2#1)(2008-3#1)
time is observed##2##3##(2006-12#1)(2008-10#1)
time is often##2##3##(1992-12#1)(2008-8#1)
time is required to##3##4##(2004-9#1)(2007-8#1)(2011-2#1)
time is shortened##2##3##(2006-8#1)(2008-3#1)
time is strongly##2##3##(2007-12#1)(2008-2#1)
time is##87##2##(1990-11#1)(1991-11#2)(1991-4#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-9#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-4#1)(1996-3#1)(1997-4#1)(1997-5#1)(2004-9#1)(2006-12#2)(2006-5#2)(2006-6#1)(2006-8#2)(2007-11#3)(2007-12#6)(2007-7#1)(2007-8#2)(2008-10#15)(2008-11#4)(2008-2#5)(2008-3#6)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#6)(2013-8#1)
time it has##2##3##(1997-2#1)(2008-9#1)
time it is##3##3##(1990-12#1)(1990-3#1)(2008-2#1)
time it takes for##2##4##(2006-10#1)(2008-3#1)
time it takes##5##3##(1993-3#1)(2006-10#1)(2008-3#1)(2010-5#1)(2010-9#1)
time it was##7##3##(1991-2#1)(1993-6#2)(1994-3#1)(2006-6#1)(2008-7#1)(2012-12#1)
time it##21##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#1)(1991-2#1)(1991-8#1)(1993-3#1)(1993-6#2)(1994-3#1)(1997-2#1)(2006-10#1)(2006-6#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-5#1)(2010-9#1)(2012-12#2)
time lag between##3##3##(2006-5#1)(2008-5#1)(2008-8#1)
time lag##8##2##(1996-2#1)(1997-3#1)(2006-5#1)(2008-10#2)(2008-5#1)(2008-8#1)(2011-2#1)
time lags##2##2##(2008-8#2)
time lapse of##2##3##(1990-12#1)(2008-10#1)
time lapse##8##2##(1990-12#2)(1994-3#1)(1995-4#1)(2007-10#1)(2008-10#2)(2009-6#1)
time less than##3##3##(2007-3#1)(2007-8#1)(2012-1#1)
time limit##2##2##(2007-12#1)(2010-12#1)
time limited##2##2##(2006-9#1)(2011-1#1)
time limits##5##2##(2007-11#1)(2007-12#2)(2008-10#1)(2013-8#1)
time line for##2##3##(2008-4#1)(2009-5#1)
time line of##2##3##(2008-11#1)(2013-1#1)
time line##4##2##(2008-11#1)(2008-4#1)(2009-5#1)(2013-1#1)
time lines##2##2##(2007-4#1)(2008-10#1)
time locking##2##2##(2008-10#2)
time longer##3##2##(1992-9#1)(2012-3#1)(2013-1#1)
time lost##3##2##(1992-5#1)(2007-7#1)(2010-3#1)
time management effectiveness##3##3##(1992-2#3)
time management##6##2##(1992-2#4)(2008-1#1)(2011-2#1)
time markers##2##2##(2008-10#1)(2012-12#1)
time may be##6##3##(1990-6#1)(1994-9#1)(2008-1#1)(2008-2#1)(2008-9#1)(2013-1#1)
time may##11##2##(1990-6#1)(1994-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-8#1)(2008-9#1)(2013-1#2)
time measurement##3##2##(1994-5#1)(2008-10#1)(2008-2#1)
time measurements##3##2##(1990-2#1)(1996-5#1)(2008-5#1)
time microscope##2##2##(2007-12#2)
time model was##2##3##(2006-1#1)(2008-10#1)
time model##4##2##(2006-1#1)(2008-10#3)
time necessary for the##5##4##(2008-10#3)(2008-2#1)(2008-4#1)
time necessary for##8##3##(2006-3#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2010-4#1)
time necessary to##4##3##(2008-10#3)(2013-1#1)
time necessary##12##2##(2006-3#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-5#1)(2010-4#1)(2013-1#1)
time needed for##9##3##(1991-3#1)(1993-9#1)(1995-3#1)(2008-10#2)(2008-3#2)(2010-2#1)(2012-3#1)
time needed to##5##3##(1993-9#1)(1997-2#1)(2007-7#1)(2007-8#1)(2012-2#1)
time needed##14##2##(1991-3#1)(1993-9#2)(1995-3#1)(1997-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#2)(2010-2#1)(2012-2#1)(2012-3#1)
time no##2##2##(1996-6#1)(2008-5#1)
time observed##2##2##(1993-8#1)(2008-10#1)
time obtained##2##2##(2007-9#1)(2008-10#1)
time of &lt##9##3##(2007-11#1)(2008-1#1)(2008-10#7)
time of 0##4##3##(1990-7#1)(2007-12#1)(2008-2#1)(2009-2#1)
time of 1##8##3##(1991-7#1)(2005-11#1)(2008-10#4)(2008-5#1)(2010-4#1)
time of 10 min##5##4##(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)
time of 10 s##2##4##(2008-10#1)(2008-2#1)
time of 10##9##3##(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2013-1#1)
time of 100 ms##2##4##(2008-3#2)
time of 100##3##3##(2005-8#1)(2008-3#2)
time of 10min##3##3##(2008-10#3)
time of 10s##2##3##(2008-10#2)
time of 12##6##3##(1990-12#1)(1991-3#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-3#1)
time of 120 s##6##4##(2008-10#6)
time of 15 min##2##4##(2007-8#1)(2008-10#1)
time of 15##6##3##(2007-8#1)(2008-10#2)(2008-9#1)(2013-8#2)
time of 2##2##3##(1997-3#1)(2008-10#1)
time of 20 min##2##4##(1996-2#1)(2011-2#1)
time of 20 s##3##4##(2008-10#2)(2008-3#1)
time of 20##7##3##(1996-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#1)
time of 22##3##3##(2007-8#1)(2008-11#1)(2011-2#1)
time of 23##2##3##(1996-5#1)(2010-4#1)
time of 24##2##3##(1990-8#1)(2008-7#1)
time of 2min##2##3##(2008-10#2)
time of 3 min##2##4##(2008-10#2)
time of 3##11##3##(1990-12#1)(2007-12#1)(2008-10#6)(2008-8#1)(2011-2#1)(2012-12#1)
time of 30 min##3##4##(1991-5#1)(2008-10#2)
time of 30 s##2##4##(2007-12#1)(2008-10#1)
time of 30##7##3##(1991-5#1)(2007-12#2)(2008-10#3)(2012-1#1)
time of 30min##2##3##(2008-10#1)(2012-2#1)
time of 30s and##2##4##(2008-10#2)
time of 4 h##2##4##(1996-2#1)(2008-10#1)
time of 4##6##3##(1996-2#1)(2005-11#1)(2008-10#3)(2010-12#1)
time of 40 months##2##4##(1990-5#1)(1990-9#1)
time of 40##3##3##(1990-5#1)(1990-9#1)(2008-3#1)
time of 45 min##2##4##(1992-2#1)(2008-10#1)
time of 5 min##5##4##(2008-10#5)
time of 5##9##3##(1992-2#1)(2006-12#1)(2007-8#1)(2008-10#5)(2008-11#1)
time of 51##2##3##(2008-10#1)(2012-12#1)
time of 60 min##2##4##(2008-6#1)(2010-2#1)
time of 60 s##4##4##(2008-10#3)(2008-3#1)
time of 60##6##3##(2008-10#3)(2008-3#1)(2008-6#1)(2010-2#1)
time of 7##2##3##(1991-10#1)(2008-3#1)
time of 7min##2##3##(2008-10#2)
time of 8##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
time of 9##3##3##(2008-10#1)(2008-7#1)(2010-3#1)
time of X##2##3##(2008-10#2)
time of a##10##3##(1996-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2010-2#1)(2012-12#1)(2012-2#1)
time of about 1##2##4##(1995-6#1)(2008-10#1)
time of about 10##3##4##(1992-2#1)(2008-10#2)
time of about##12##3##(1992-2#1)(1995-6#1)(2006-6#1)(2007-9#1)(2008-10#7)(2008-11#1)
time of administration##5##3##(1993-3#1)(1993-5#1)(1995-2#1)(2006-2#1)(2008-5#1)
time of admission##11##3##(1991-8#1)(1992-3#1)(1997-8#1)(2005-1#1)(2006-10#1)(2007-7#1)(2007-9#1)(2011-2#1)(2012-2#3)
time of an##3##3##(2007-12#1)(2008-3#1)(2008-8#1)
time of analysis and##2##4##(2008-10#2)
time of analysis of##2##4##(1997-3#1)(2008-10#1)
time of analysis##8##3##(1997-3#1)(2008-10#6)(2008-8#1)
time of approximately##8##3##(1991-9#1)(1996-6#1)(2008-10#4)(2008-2#1)(2010-2#1)
time of arrival##4##3##(2010-3#1)(2012-12#2)(2013-1#1)
time of both##3##3##(2005-11#1)(2007-11#1)(2011-2#1)
time of bursts##2##3##(1994-3#1)(1996-2#1)
time of contact##5##3##(2008-10#4)(2008-11#1)
time of culture##2##3##(1996-1#1)(1997-4#1)
time of day and##3##4##(1996-3#1)(2005-9#1)(2007-12#1)
time of day in##2##4##(1995-1#1)(2007-3#1)
time of day on##2##4##(1992-3#1)(1993-12#1)
time of day preference were##2##5##(2007-12#2)
time of day preference##4##4##(2007-12#4)
time of day##22##3##(1992-11#1)(1992-3#1)(1993-12#1)(1995-1#1)(1996-3#1)(2004-11#1)(2005-9#1)(2007-12#6)(2007-3#2)(2008-10#1)(2008-5#1)(2008-8#1)(2009-8#2)(2010-7#1)(2012-5#1)
time of death had##2##4##(1993-12#1)(2006-11#1)
time of death##10##3##(1993-1#1)(1993-12#1)(1993-5#1)(1994-11#1)(1997-2#1)(1997-3#1)(2006-11#1)(2011-2#2)(2013-1#1)
time of diagnosis##37##3##(1990-10#2)(1992-3#1)(1992-5#1)(1993-1#1)(1993-5#1)(1994-10#1)(1994-12#1)(1994-7#1)(1996-3#1)(1997-1#1)(1997-5#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-4#1)(2008-6#2)(2008-7#2)(2010-12#2)(2010-3#1)(2011-2#6)(2012-12#1)(2013-7#1)
time of disease##3##3##(2008-10#2)(2012-12#1)
time of drug use##2##4##(1993-10#1)(2007-8#1)
time of drug##3##3##(1993-10#1)(2007-8#1)(2008-3#1)
time of each##2##3##(2006-10#1)(2008-7#1)
time of examination##5##3##(1991-12#1)(1992-1#1)(1992-11#1)(1997-8#1)(2006-8#1)
time of exposure to##4##4##(1995-5#1)(1996-12#1)(2008-10#1)(2009-10#1)
time of exposure##7##3##(1995-5#1)(1996-12#1)(2007-12#1)(2008-10#1)(2009-10#1)(2012-2#1)(2012-4#1)
time of extraction and##2##4##(1996-7#1)(2008-10#1)
time of extraction##4##3##(1996-7#1)(2007-12#1)(2007-8#1)(2008-10#1)
time of flight mass spectrometry##7##5##(2008-10#4)(2008-11#2)(2012-12#1)
time of flight mass##8##4##(2008-10#4)(2008-11#2)(2012-12#2)
time of flight##14##3##(2007-12#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-12#2)
time of follow-up was##3##4##(2008-4#1)(2009-3#1)(2013-1#1)
time of follow-up##8##3##(1997-2#1)(2007-11#2)(2007-7#1)(2008-4#1)(2009-3#1)(2009-4#1)(2013-1#1)
time of growth##2##3##(1997-4#1)(2006-5#1)
time of hospitalization##5##3##(2005-1#1)(2007-7#1)(2007-8#1)(2008-10#1)(2013-1#1)
time of immobilization##3##3##(2005-11#2)(2008-10#1)
time of improvement##2##3##(2005-8#2)
time of incubation##5##3##(1990-12#1)(1991-5#1)(1992-12#1)(1994-8#1)(2007-2#1)
time of infection##6##3##(1995-1#1)(2008-10#4)(2008-11#1)
time of initial diagnosis##2##4##(2007-11#1)(2008-11#1)
time of initial##10##3##(1992-2#1)(2007-11#1)(2008-11#1)(2008-5#3)(2008-6#2)(2008-8#1)(2012-3#1)
time of injury was##2##4##(2006-11#1)(2006-5#1)
time of injury##7##3##(1993-2#1)(2006-11#1)(2006-5#1)(2008-9#2)(2009-6#1)(2011-2#1)
time of inoculation##4##3##(2008-10#4)
time of its##3##3##(2007-7#1)(2008-3#1)(2012-11#1)
time of lengthening##2##3##(2007-8#2)
time of less than##8##4##(1996-12#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-4#1)(2013-1#1)
time of local##3##3##(1993-4#1)(2008-10#2)
time of marriage##2##3##(2009-4#2)
time of maximum##3##3##(1995-1#1)(2008-11#1)(2010-2#1)
time of mice##2##3##(1992-3#1)(1996-2#1)
time of occurrence of##2##4##(1996-3#1)(2009-6#1)
time of only##2##3##(2008-3#1)(2010-12#1)
time of onset and##2##4##(2008-10#1)(2008-4#1)
time of onset of##5##4##(1990-5#1)(1992-12#1)(1997-3#1)(2008-5#1)(2010-12#1)
time of onset##8##3##(1990-5#1)(1992-12#1)(1997-3#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-12#1)
time of operation##3##3##(1993-1#1)(1994-9#1)(2006-9#1)
time of our##3##3##(2008-3#1)(2011-2#1)(2013-1#1)
time of patients##6##3##(2004-1#1)(2007-11#4)(2008-7#1)
time of phase##2##3##(2008-10#2)
time of plenty##2##3##(2006-1#1)(2008-1#1)
time of presentation##15##3##(1995-10#1)(1997-8#1)(2005-8#2)(2006-10#3)(2007-7#2)(2008-8#1)(2009-6#2)(2010-12#1)(2011-12#1)(2012-3#1)
time of purchase##2##3##(1992-12#1)(2013-1#1)
time of referral##2##3##(2008-1#1)(2008-11#1)
time of reperfusion##3##3##(1990-3#1)(1996-9#2)
time of return to##2##4##(2007-1#1)(2008-4#1)
time of return##4##3##(2007-1#1)(2008-4#3)
time of sampling##6##3##(1991-5#1)(1992-12#1)(2006-4#1)(2008-10#2)(2008-5#1)
time of storage##3##3##(1990-1#1)(1994-12#1)(2008-10#1)
time of study##3##3##(2007-2#1)(2010-11#1)(2011-2#1)
time of surgery##14##3##(1990-8#1)(1991-3#1)(1993-11#1)(1996-5#1)(2004-10#1)(2005-10#1)(2006-3#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-7#1)(2011-2#2)
time of survival##3##3##(2007-11#1)(2007-9#1)(2011-2#1)
time of testing##4##3##(1992-7#1)(2008-9#2)(2009-11#1)
time of the biosensor##2##4##(2008-10#2)
time of the day##3##4##(1994-6#2)(2010-12#1)
time of the first##6##4##(1995-12#1)(1995-9#1)(1996-3#1)(2006-12#1)(2008-10#1)(2013-1#1)
time of the gas##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
time of the initial##2##4##(2006-8#1)(2012-12#1)
time of the order##2##4##(1990-12#1)(2007-11#1)
time of the proposed##3##4##(2008-10#2)(2012-2#1)
time of the pulmonary artery##2##5##(2013-7#2)
time of the sample##2##4##(2008-10#1)(2010-12#1)
time of the system##3##4##(2007-12#1)(2008-2#1)(2012-2#1)
time of the two##2##4##(1992-10#1)(2007-6#1)
time of the year##4##4##(2005-7#1)(2007-3#1)(2008-3#1)(2008-5#1)
time of the##192##3##(1990-12#1)(1990-3#2)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#1)(1992-10#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-5#1)(1994-6#3)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-5#1)(1995-9#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-7#2)(1996-9#1)(1997-5#3)(1997-7#2)(2004-11#1)(2005-10#1)(2005-11#4)(2005-12#2)(2005-3#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#3)(2007-1#1)(2007-11#9)(2007-12#8)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#31)(2008-11#6)(2008-2#4)(2008-3#8)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2010-12#3)(2010-3#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#6)(2012-3#1)(2012-5#1)(2013-1#7)(2013-7#2)(2013-8#3)
time of their##15##3##(1992-8#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-2#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-10#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-1#1)(2012-3#1)(2013-8#1)
time of these##2##3##(2007-9#1)(2008-2#1)
time of this##5##3##(1991-12#1)(1991-3#1)(2006-7#1)(2007-12#1)(2007-3#1)
time of transplantation##8##3##(2006-10#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-9#1)(2010-12#1)(2012-12#1)(2012-7#1)
time of treatment##6##3##(1995-11#1)(2006-11#1)(2006-8#1)(2007-3#1)(2007-8#1)(2008-2#1)
time of two##4##3##(2006-6#1)(2010-4#1)(2013-1#2)
time of weaning##3##3##(1992-11#1)(1996-2#1)(1997-3#1)
time of year##2##3##(2008-10#1)(2010-3#1)
time of##1198##2##(1990-1#1)(1990-10#3)(1990-11#3)(1990-12#6)(1990-3#4)(1990-4#1)(1990-5#4)(1990-6#2)(1990-7#2)(1990-8#6)(1990-9#2)(1991-10#3)(1991-11#1)(1991-12#7)(1991-2#2)(1991-3#5)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#3)(1991-8#2)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#6)(1992-2#5)(1992-3#9)(1992-5#3)(1992-7#3)(1992-8#3)(1992-9#3)(1993-1#4)(1993-10#2)(1993-11#3)(1993-12#5)(1993-2#3)(1993-3#3)(1993-4#1)(1993-5#4)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#3)(1994-2#7)(1994-3#3)(1994-4#1)(1994-5#3)(1994-6#6)(1994-7#2)(1994-8#2)(1994-9#3)(1995-1#8)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#3)(1995-4#2)(1995-5#3)(1995-6#3)(1995-8#1)(1995-9#4)(1996-1#4)(1996-12#6)(1996-2#5)(1996-3#7)(1996-4#2)(1996-5#6)(1996-6#3)(1996-7#6)(1996-8#2)(1996-9#9)(1997-1#3)(1997-2#5)(1997-3#8)(1997-4#4)(1997-5#4)(1997-7#2)(1997-8#3)(2004-1#1)(2004-10#2)(2004-11#4)(2004-12#1)(2005-1#2)(2005-10#3)(2005-11#12)(2005-12#2)(2005-3#1)(2005-4#1)(2005-7#1)(2005-8#6)(2005-9#2)(2006-1#1)(2006-10#15)(2006-11#5)(2006-12#11)(2006-2#4)(2006-3#3)(2006-4#6)(2006-5#11)(2006-6#6)(2006-7#1)(2006-8#6)(2006-9#4)(2007-1#4)(2007-10#6)(2007-11#33)(2007-12#47)(2007-2#4)(2007-3#7)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#16)(2007-8#29)(2007-9#8)(2008-1#15)(2008-10#232)(2008-11#27)(2008-12#3)(2008-2#13)(2008-3#33)(2008-4#18)(2008-5#22)(2008-6#12)(2008-7#18)(2008-8#20)(2008-9#11)(2009-1#1)(2009-10#4)(2009-11#2)(2009-2#7)(2009-3#2)(2009-4#8)(2009-6#6)(2009-8#5)(2010-1#1)(2010-11#1)(2010-12#12)(2010-2#9)(2010-3#7)(2010-4#6)(2010-5#1)(2010-6#2)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#4)(2011-11#1)(2011-12#3)(2011-2#31)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#21)(2012-2#19)(2012-3#11)(2012-4#1)(2012-5#2)(2012-7#1)(2013-1#28)(2013-7#5)(2013-8#13)
time off cardioplegia##2##3##(1996-9#2)
time off work##3##3##(1992-2#1)(1992-3#1)(2008-5#1)
time off##7##2##(1992-2#2)(1992-3#1)(1996-9#2)(1997-8#1)(2008-5#1)
time on a##2##3##(2007-9#1)(2008-3#1)
time on dialysis##3##3##(1991-6#1)(2007-8#1)(2010-5#1)
time on the determination of##2##5##(2008-10#2)
time on the extraction##2##4##(2008-10#1)(2011-1#1)
time on the##30##3##(1991-7#1)(1995-12#1)(1996-2#1)(1996-6#1)(2004-9#1)(2005-11#1)(2006-12#2)(2007-8#1)(2008-10#7)(2008-12#1)(2008-3#3)(2008-5#4)(2008-8#2)(2011-1#1)(2011-2#1)(2013-8#2)
time on##77##2##(1990-7#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-7#1)(1993-1#2)(1994-2#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(2004-9#1)(2005-11#2)(2006-10#1)(2006-12#2)(2006-8#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#10)(2008-12#1)(2008-3#4)(2008-5#9)(2008-8#2)(2009-2#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#4)
time only##2##2##(2007-11#1)(2008-6#1)
time or the##2##3##(2007-12#1)(2008-10#1)
time or##31##2##(1990-10#1)(1991-11#1)(1991-3#1)(1993-11#1)(1993-9#1)(1995-2#1)(1996-1#1)(1996-12#1)(1997-8#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-7#1)
time out of the##2##4##(2008-3#1)(2008-8#1)
time out of##3##3##(2007-7#1)(2008-3#1)(2008-8#1)
time over a##2##3##(2006-4#1)(2008-2#1)
time over the##3##3##(1991-12#1)(1994-3#1)(2010-11#1)
time over which##2##3##(1995-6#1)(2010-8#1)
time over##7##2##(1991-12#1)(1994-3#1)(1995-6#1)(2006-4#1)(2008-2#1)(2010-11#1)(2010-8#1)
time parameters##2##2##(2008-2#1)(2013-1#1)
time passes##2##2##(2007-9#1)(2008-11#1)
time patients##3##2##(1990-11#1)(1995-8#1)(2013-7#1)
time per day##4##3##(1993-3#3)(2008-7#1)
time per sample was##2##4##(1990-6#1)(2008-10#1)
time per sample##4##3##(1990-6#1)(2008-10#3)
time per##15##2##(1990-6#1)(1993-3#3)(2005-4#1)(2006-8#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#1)
time perception##4##2##(2006-2#1)(2009-7#1)(2011-2#1)(2012-2#1)
time performance##3##2##(1994-2#1)(2006-12#1)(2012-1#1)
time period and##3##3##(2006-8#1)(2007-1#1)(2011-1#1)
time period for##3##3##(1995-5#1)(2006-9#1)(2011-1#1)
time period from##3##3##(2006-8#1)(2007-11#1)(2010-4#1)
time period in##2##3##(2007-10#1)(2008-9#1)
time period is##2##3##(2008-2#1)(2008-9#1)
time period of##13##3##(1993-8#1)(1994-3#1)(1995-5#1)(2006-5#2)(2006-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-4#1)(2011-2#1)
time period required##2##3##(2008-10#1)(2012-1#1)
time period that##2##3##(2008-11#1)(2008-4#1)
time period##103##2##(1990-4#1)(1990-8#2)(1991-10#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-8#1)(1991-9#1)(1993-11#1)(1993-4#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-5#2)(1996-12#1)(1996-3#1)(1996-5#1)(2004-3#1)(2004-4#2)(2005-10#1)(2006-10#1)(2006-2#1)(2006-5#2)(2006-6#1)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#2)(2007-8#5)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-9#7)(2009-2#4)(2009-4#1)(2009-7#1)(2010-11#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
time periods after##3##3##(2007-2#1)(2007-8#1)(2008-10#1)
time periods and##3##3##(2011-2#1)(2012-2#1)(2013-8#1)
time periods in##3##3##(1995-3#1)(2007-6#1)(2012-3#1)
time periods is##2##3##(1995-6#1)(2008-10#1)
time periods##43##2##(1990-10#1)(1991-11#1)(1992-9#1)(1993-7#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-9#1)(1997-1#1)(2004-9#1)(2006-8#1)(2007-2#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-2#1)(2010-11#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
time physical activity##3##3##(2005-10#1)(2009-3#1)(2010-5#1)
time point at which##3##4##(2008-11#1)(2008-7#1)(2009-1#1)
time point for##4##3##(1994-8#1)(1997-3#2)(2010-5#1)
time point of##3##3##(1997-2#2)(2012-2#1)
time point##45##2##(1991-11#1)(1993-11#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-9#1)(1997-2#3)(1997-3#2)(2006-3#1)(2007-10#2)(2007-8#2)(2008-1#1)(2008-11#2)(2008-2#1)(2008-5#3)(2008-7#1)(2009-1#1)(2009-10#1)(2009-8#1)(2010-1#1)(2010-3#2)(2010-5#3)(2010-8#1)(2011-10#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#2)
time points after##3##3##(2010-2#1)(2011-3#1)(2012-1#1)
time points and##6##3##(2008-7#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-4#1)
time points between##2##3##(2006-9#1)(2007-8#1)
time points during the##3##4##(2006-3#1)(2011-2#1)(2012-1#1)
time points during##5##3##(2006-3#1)(2006-5#1)(2010-2#1)(2011-2#1)(2012-1#1)
time points for##2##3##(2011-2#1)(2012-1#1)
time points from##4##3##(1995-2#1)(2008-11#1)(2008-4#1)(2012-1#1)
time points in##4##3##(1990-7#1)(1996-12#1)(2010-1#1)(2013-7#1)
time points of##4##3##(1991-11#1)(2008-7#1)(2009-10#1)(2013-1#1)
time points over##4##3##(1991-9#1)(2008-7#1)(2009-4#1)(2010-12#1)
time points to the##2##4##(1990-5#1)(2010-5#1)
time points were##5##3##(1995-2#1)(2008-11#1)(2013-1#2)(2013-8#1)
time points##101##2##(1990-5#1)(1990-7#1)(1991-11#1)(1991-9#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-11#1)(1994-11#1)(1995-11#1)(1995-2#2)(1996-1#1)(1996-12#1)(1996-9#1)(1997-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-12#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#6)(2008-7#3)(2008-8#2)(2009-10#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-1#3)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#2)(2010-9#1)(2011-12#1)(2011-2#9)(2011-3#1)(2012-1#6)(2012-12#3)(2012-2#1)(2012-3#2)(2012-4#2)(2013-1#5)(2013-7#2)(2013-8#1)
time pressure##2##2##(1997-5#1)(2011-1#1)
time pressures##4##2##(2006-5#1)(2007-4#1)(2007-8#1)(2010-12#1)
time prior to##3##3##(1990-2#1)(1994-9#1)(2012-1#1)
time profile of##2##3##(2006-1#1)(2007-12#1)
time profile##6##2##(2006-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2010-11#2)
time profiles##2##2##(2008-5#1)(2012-2#1)
time provides##2##2##(2008-5#1)(2011-2#1)
time range and##2##3##(1997-6#1)(2006-2#1)
time range of##3##3##(1995-1#1)(1997-3#1)(2008-5#1)
time range##13##2##(1991-2#1)(1993-7#1)(1993-8#1)(1995-1#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-2#1)(2007-1#1)(2008-5#1)
time ranged from##6##3##(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-9#1)(2012-12#1)
time ranged##7##2##(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-9#1)(2012-12#1)(2012-2#1)
time ratio##4##2##(1990-11#2)(2007-11#1)(2008-3#1)
time recommended##2##2##(1992-3#1)(2007-9#1)
time recorded##2##2##(2006-12#1)(2011-2#1)
time reduced from##2##3##(2008-5#1)(2008-9#1)
time reduction##3##2##(1990-3#1)(2009-6#1)(2013-7#1)
time related##2##2##(1993-12#1)(2010-8#1)
time relationships between plasma Hp##2##5##(1995-7#2)
time relaxation##3##2##(2007-1#1)(2007-4#1)(2008-3#1)
time release##2##2##(2008-5#2)
time remains##2##2##(2007-7#1)(2011-1#1)
time required for complete##2##4##(2008-7#1)(2010-7#1)
time required for data##2##4##(2007-12#1)(2008-3#1)
time required for the analysis of##2##6##(2008-10#2)
time required for the analysis##3##5##(2008-10#3)
time required for the##12##4##(1997-3#1)(2008-10#8)(2008-3#1)(2008-5#1)(2008-7#1)
time required for##45##3##(1996-12#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#20)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2009-10#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#1)
time required to exchange##2##4##(2011-2#2)
time required to gather##2##4##(2011-2#2)
time required to induce##2##4##(2006-10#1)(2011-12#1)
time required to reach the##3##5##(1996-5#1)(2008-10#1)(2013-8#1)
time required to reach##4##4##(1996-5#1)(2008-10#1)(2009-9#1)(2013-8#1)
time required to##31##3##(1993-12#2)(1995-1#1)(1995-12#1)(1996-5#1)(1997-4#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2008-10#7)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-9#1)(2011-12#1)(2011-2#4)(2013-8#1)
time required##84##2##(1993-12#2)(1994-5#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-9#1)(2005-11#1)(2005-4#1)(2005-5#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#28)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-6#4)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-2#2)(2013-1#1)(2013-8#1)
time requirements##4##2##(1990-12#1)(2007-11#1)(2008-9#1)(2009-3#1)
time resolution and##3##3##(2006-5#1)(2008-3#2)
time resolution is##4##3##(2008-2#1)(2008-3#3)
time resolution of the polarization##2##5##(2007-11#1)(2007-12#1)
time resolution of##11##3##(1992-6#1)(1996-7#1)(2006-4#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#4)
time resolution##34##2##(1992-6#1)(1993-2#1)(1996-7#1)(2006-12#2)(2006-4#2)(2006-5#2)(2007-11#3)(2007-12#5)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#12)(2008-7#1)
time resolved##8##2##(1991-3#1)(1994-5#1)(1997-6#1)(2008-10#3)(2008-7#1)(2009-6#1)
time resources##4##2##(2010-3#1)(2012-2#3)
time response##4##2##(1991-1#1)(2007-12#1)(2008-3#2)
time resting##2##2##(1994-8#1)(2008-5#1)
time resulted in##3##3##(1992-5#1)(2008-11#1)(2008-7#1)
time results##4##2##(1990-12#1)(1997-7#2)(2008-10#1)
time revealed a##2##3##(2005-7#1)(2008-11#1)
time revealed##4##2##(2005-11#1)(2005-7#1)(2008-11#1)(2009-1#1)
time reversal of the##2##4##(2007-12#2)
time reversal of##3##3##(2007-12#3)
time reversal##4##2##(2007-12#4)
time saving##3##2##(2007-7#1)(2007-8#1)(2008-10#1)
time savings##7##2##(1994-12#1)(1994-2#1)(1997-8#3)(2007-7#1)(2010-2#1)
time scale and is##2##4##(1994-9#1)(1995-1#1)
time scale and##4##3##(1994-9#1)(1995-1#1)(1996-2#1)(2007-6#1)
time scale as##2##3##(1995-8#1)(1996-7#1)
time scale is##3##3##(1994-4#1)(2007-12#1)(2007-6#1)
time scale of several hours##2##5##(1993-3#1)(2011-2#1)
time scale of##18##3##(1990-10#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-8#1)(1996-6#1)(1997-2#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-4#1)(2011-2#1)
time scale to the##2##4##(2005-11#1)(2012-2#1)
time scale##77##2##(1990-10#2)(1990-2#3)(1990-5#2)(1990-8#2)(1991-2#1)(1991-3#1)(1991-7#1)(1992-6#1)(1992-9#3)(1993-3#1)(1994-11#1)(1994-12#1)(1994-4#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#4)(1995-10#1)(1995-2#1)(1995-3#1)(1995-8#3)(1996-2#1)(1996-4#1)(1996-6#1)(1996-7#2)(1997-2#1)(1997-7#1)(2005-11#3)(2006-1#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-6#2)(2007-11#2)(2007-12#6)(2007-3#1)(2007-6#3)(2008-10#1)(2008-11#3)(2008-2#2)(2008-4#1)(2009-4#2)(2010-2#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)
time scales for##3##3##(2005-11#1)(2007-6#1)(2008-3#1)
time scales of a few to 30 years##2##8##(1996-4#2)
time scales of##9##3##(1996-4#2)(2007-9#1)(2008-2#1)(2008-3#3)(2009-2#1)(2012-2#1)
time scales##42##2##(1990-3#1)(1990-8#1)(1994-4#2)(1994-9#1)(1995-1#2)(1995-2#1)(1995-5#1)(1996-4#2)(2005-11#1)(2007-12#4)(2007-6#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#5)(2008-4#1)(2009-2#1)(2009-7#2)(2009-8#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
time schedule##3##2##(1993-11#1)(2008-12#1)(2008-6#1)
time separation##6##2##(2007-12#2)(2008-2#1)(2008-3#3)
time series analysis##7##3##(1997-2#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
time series data##6##3##(1992-2#1)(1993-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-2#1)
time series is##2##3##(2008-3#1)(2010-1#1)
time series methods##2##3##(2010-7#1)(2010-8#1)
time series model##2##3##(1994-8#1)(2011-2#1)
time series of glucose readings from##2##6##(2009-9#2)
time series of##22##3##(1992-9#1)(1996-3#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-8#1)(2009-9#5)(2010-1#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
time series##80##2##(1991-10#1)(1992-2#1)(1992-9#1)(1993-3#1)(1994-8#2)(1996-2#1)(1996-3#1)(1997-2#1)(2006-12#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-2#7)(2008-3#5)(2008-7#1)(2008-8#5)(2008-9#2)(2009-10#2)(2009-2#1)(2009-5#1)(2009-8#4)(2009-9#7)(2010-1#3)(2010-12#2)(2010-2#2)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-2#3)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#3)
time shift##2##2##(2008-7#1)(2011-1#1)
time shifts##2##2##(2008-10#1)(2011-1#1)
time should be##2##3##(2006-8#1)(2013-8#1)
time show##2##2##(1996-10#1)(2012-12#1)
time showed no##2##3##(1996-9#1)(2009-7#1)
time showed##6##2##(1992-5#1)(1996-9#2)(2007-8#2)(2009-7#1)
time significant##3##2##(1992-12#1)(1992-6#1)(1993-7#1)
time significantly##4##2##(1992-7#1)(1997-5#1)(2008-3#1)(2011-3#1)
time since diagnosis##4##3##(1993-9#1)(1996-2#1)(2008-9#1)(2013-1#1)
time since last coitus##3##4##(2012-11#3)
time since last##4##3##(2008-10#1)(2012-11#3)
time since stroke##2##3##(2013-8#2)
time since the##5##3##(1991-11#1)(1996-7#1)(2008-10#2)(2008-9#1)
time since##26##2##(1990-9#1)(1991-11#1)(1991-12#1)(1993-9#1)(1996-2#1)(1996-7#1)(2006-1#1)(2007-2#1)(2008-10#3)(2008-7#1)(2008-9#3)(2010-11#1)(2010-12#1)(2012-11#4)(2013-1#1)(2013-7#1)(2013-8#3)
time so that##2##3##(2008-11#1)(2008-2#1)
time span of##3##3##(1997-4#1)(2008-10#1)(2013-8#1)
time span##8##2##(1994-3#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-11#1)(2009-7#1)(2013-8#1)
time spans##2##2##(1992-12#1)(2008-3#1)
time spent by##2##3##(1995-4#1)(2008-2#1)
time spent in a##4##4##(2008-8#3)(2009-7#1)
time spent in the##5##4##(1992-8#1)(1993-2#1)(1995-5#1)(2011-2#2)
time spent in##21##3##(1992-8#1)(1993-2#1)(1995-5#1)(1996-1#1)(1996-10#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-8#3)(2009-10#1)(2009-7#1)(2011-2#4)(2013-1#2)
time spent on open arms##2##5##(1993-9#2)
time spent on the##2##4##(2008-10#1)(2008-5#1)
time spent on##13##3##(1993-12#1)(1993-9#2)(1995-11#2)(1996-1#1)(2007-7#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#3)
time spent receiving glucocorticoids##2##4##(2006-10#2)
time spent##57##2##(1992-8#1)(1993-12#1)(1993-2#1)(1993-9#2)(1995-11#2)(1995-4#1)(1995-5#1)(1996-1#2)(1996-10#1)(1996-2#1)(1997-4#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#4)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#5)(2009-10#1)(2009-4#1)(2009-7#1)(2010-8#1)(2011-2#6)(2012-1#1)(2012-2#4)(2013-1#7)
time stability##2##2##(2004-9#1)(2008-10#1)
time step##7##2##(2008-10#2)(2008-3#1)(2008-6#1)(2008-9#1)(2012-12#1)(2012-2#1)
time structure of##2##3##(2006-4#1)(2008-11#1)
time structure##5##2##(1994-5#1)(2006-4#2)(2008-11#2)
time structured##3##2##(2012-12#3)
time studies##2##2##(1994-11#1)(1995-1#1)
time study##2##2##(1993-9#1)(1995-9#1)
time such##3##2##(2006-10#1)(2008-6#1)(2013-8#1)
time suffer##2##2##(2008-1#1)(2008-3#1)
time survival##2##2##(1992-5#1)(2013-8#1)
time t##5##2##(1995-12#1)(1996-1#1)(1997-4#1)(2008-10#1)(2010-8#1)
time taken for the##5##4##(1993-2#1)(1996-2#1)(2008-10#1)(2013-1#2)
time taken for##13##3##(1990-10#1)(1992-12#1)(1993-2#1)(1996-2#1)(2007-2#1)(2007-5#1)(2008-10#2)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
time taken to complete##2##4##(1991-2#1)(2013-1#1)
time taken to##4##3##(1990-11#1)(1991-2#1)(2007-7#1)(2013-1#1)
time taken##20##2##(1990-10#1)(1990-11#1)(1991-2#1)(1992-12#1)(1993-2#1)(1996-2#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#3)
time tau##5##2##(1991-9#1)(1992-11#1)(1994-9#1)(1996-7#1)(2007-12#1)
time tests##2##2##(2007-7#1)(2011-1#1)
time than does##2##3##(1992-12#1)(2008-3#1)
time than the##7##3##(1993-3#1)(2006-8#1)(2008-10#2)(2008-3#1)(2012-12#1)(2013-8#1)
time than those##2##3##(2008-12#1)(2008-3#1)
time than##25##2##(1990-5#1)(1991-6#1)(1992-12#1)(1993-3#1)(1994-12#1)(1995-9#1)(1997-5#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-8#1)(2012-12#1)(2013-7#1)(2013-8#1)
time that in##2##3##(1991-7#1)(1992-7#1)
time that is##2##3##(2007-12#1)(2008-3#1)
time that the##20##3##(1991-8#1)(1992-11#2)(1995-6#1)(1996-6#1)(1997-1#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
time that these##2##3##(2009-5#1)(2010-3#1)
time that##113##2##(1990-3#2)(1990-4#2)(1990-7#1)(1990-9#2)(1991-11#1)(1991-3#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-7#1)(1992-8#1)(1994-4#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#3)(2005-10#1)(2005-11#1)(2005-7#2)(2006-12#1)(2006-3#1)(2006-5#2)(2006-7#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#2)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
time the##108##2##(1990-10#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-6#2)(1995-8#1)(1996-1#2)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-8#1)(2004-11#1)(2005-1#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-8#2)(2007-1#1)(2007-11#4)(2007-12#2)(2007-7#2)(2007-8#2)(2007-9#2)(2008-10#6)(2008-11#3)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-12#2)(2010-3#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
time their##5##2##(1990-10#1)(2007-12#1)(2007-8#1)(2010-10#1)(2013-1#1)
time there has been a##3##5##(1990-11#1)(1997-1#1)(2006-8#1)
time there was##3##3##(1990-10#1)(1990-11#1)(2012-12#1)
time there##9##2##(1990-10#1)(1990-11#2)(1997-1#1)(1997-4#1)(2004-10#1)(2006-10#1)(2006-8#1)(2012-12#1)
time these##3##2##(2008-6#1)(2008-7#1)(2012-2#1)
time they had##3##3##(1996-2#1)(2010-3#1)(2012-12#1)
time they##12##2##(1991-9#1)(1995-12#1)(1996-2#1)(2005-1#1)(2007-8#1)(2007-9#1)(2008-11#1)(2009-10#1)(2010-12#1)(2010-3#1)(2012-12#1)(2013-1#1)
time thought##2##2##(1991-9#1)(2006-10#1)
time through##3##2##(1995-2#1)(2008-7#1)(2012-12#1)
time to AT##2##3##(2013-1#2)
time to a##4##3##(1991-1#1)(1995-12#1)(1995-9#1)(2008-10#1)
time to abscission##2##3##(2008-10#2)
time to achieve a target weight##2##6##(2013-1#2)
time to achieve a##3##4##(2008-10#1)(2013-1#2)
time to achieve##5##3##(2008-10#1)(2008-5#1)(2012-2#1)(2013-1#2)
time to apply##2##3##(2007-11#1)(2011-2#1)
time to be a##4##4##(1991-11#1)(2009-7#1)(2012-2#1)(2013-1#1)
time to be##12##3##(1991-11#1)(1991-3#1)(1994-12#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-9#1)(2009-7#1)(2012-2#1)(2013-1#1)
time to begin##3##3##(1993-2#2)(2007-4#1)
time to bring the##2##4##(2008-10#1)(2008-11#1)
time to change##3##3##(2005-12#1)(2009-12#1)(2012-12#1)
time to complete the##3##4##(1993-2#1)(2011-1#1)(2012-1#1)
time to complete##7##3##(1992-10#1)(1993-2#1)(2007-11#1)(2011-1#1)(2011-2#2)(2012-1#1)
time to consider their##2##4##(2008-8#1)(2012-12#1)
time to death##2##3##(1996-7#1)(2008-9#1)
time to determine the##2##4##(2008-10#2)
time to determine##3##3##(2008-1#1)(2008-10#2)
time to develop##5##3##(2005-9#1)(2008-10#1)(2008-7#1)(2009-10#1)(2010-9#1)
time to development##2##3##(1995-12#1)(2013-1#1)
time to diagnosis##3##3##(2011-2#2)(2013-8#1)
time to discharge##2##3##(2006-10#1)(2010-4#1)
time to disease progression##6##4##(1997-8#1)(2007-11#2)(2008-10#1)(2008-5#1)(2008-6#1)
time to disease##7##3##(1997-8#1)(2007-11#2)(2008-10#2)(2008-5#1)(2008-6#1)
time to distant##2##3##(2008-5#1)(2008-6#1)
time to do##3##3##(1995-6#1)(2006-10#1)(2013-8#1)
time to evaluate##2##3##(1991-9#1)(2013-1#1)
time to event analysis##2##4##(2007-11#1)(2011-2#1)
time to event data##2##4##(1995-9#1)(1997-8#1)
time to event##4##3##(1995-9#1)(1997-8#1)(2007-11#1)(2011-2#1)
time to exhaustion##5##3##(2008-5#1)(2013-8#4)
time to extinction of##3##4##(2008-9#3)
time to extinction##7##3##(2007-9#1)(2008-8#1)(2008-9#5)
time to failure##6##3##(1997-7#1)(2004-1#1)(2007-8#3)(2009-10#1)
time to first rejection##2##4##(1995-2#1)(2007-8#1)
time to first##6##3##(1995-2#1)(1997-4#1)(2007-8#1)(2008-2#1)(2008-6#1)(2008-8#1)
time to growth##2##3##(2011-2#2)
time to inflection point (t(ip))##2##5##(2008-10#2)
time to initial symptoms##2##4##(2008-10#2)
time to learn new##2##4##(1993-12#1)(1996-3#1)
time to learn##3##3##(1993-12#1)(1994-3#1)(1996-3#1)
time to less than##2##4##(1997-3#1)(2011-12#1)
time to local##2##3##(2008-6#1)(2010-3#1)
time to look at##2##4##(1993-2#1)(2012-3#1)
time to maximum##2##3##(2007-2#1)(2012-3#1)
time to move##2##3##(1995-1#1)(2007-11#1)
time to one##2##3##(2012-12#1)(2012-3#1)
time to onset of convulsions##3##5##(1993-11#1)(1993-12#2)
time to onset of##9##4##(1993-11#2)(1993-12#2)(2005-8#1)(2007-11#1)(2008-1#1)(2012-3#1)(2013-1#1)
time to onset##10##3##(1993-11#2)(1993-12#2)(2004-3#1)(2005-8#1)(2007-11#1)(2008-1#1)(2012-3#1)(2013-1#1)
time to peak##6##3##(1992-11#1)(1992-4#1)(1993-11#1)(1997-7#1)(2008-7#1)(2012-12#1)
time to perform##3##3##(1994-3#1)(1996-1#1)(2007-4#1)
time to positivity##2##3##(2007-7#2)
time to produce##3##3##(1991-5#1)(2008-1#1)(2008-4#1)
time to progression (TTP)##3##4##(2004-1#1)(2006-12#1)(2008-10#1)
time to progression was 6##4##5##(1990-10#1)(1991-2#1)(2010-12#2)
time to progression was##10##4##(1990-10#1)(1990-2#1)(1991-10#1)(1991-2#1)(1993-1#1)(2008-10#1)(2010-12#2)(2012-1#1)(2013-1#1)
time to progression##17##3##(1990-10#1)(1990-2#1)(1991-10#1)(1991-2#1)(1993-1#1)(2004-1#1)(2006-12#2)(2008-10#2)(2008-12#1)(2008-3#1)(2010-12#2)(2012-1#2)(2013-1#1)
time to provide##3##3##(1993-2#1)(2008-12#1)(2012-2#1)
time to reach C(max)##2##4##(2008-12#1)(2010-12#1)
time to reach a##2##4##(2007-10#1)(2008-8#1)
time to reach##11##3##(1992-12#1)(2004-12#1)(2007-10#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)
time to reaction##2##3##(2011-2#2)
time to receive care##2##4##(2012-12#2)
time to receive##4##3##(2007-10#1)(2012-12#3)
time to recovery##2##3##(2008-8#2)
time to recurrence##4##3##(2006-10#1)(2007-11#1)(2008-5#1)(2013-1#1)
time to redefine##2##3##(1995-2#1)(2009-10#1)
time to reduce##2##3##(2007-7#1)(2013-1#1)
time to relapse##4##3##(2004-1#2)(2008-6#1)(2008-8#1)
time to response was##2##4##(1995-1#1)(2006-12#1)
time to response##3##3##(1995-1#2)(2006-12#1)
time to return##2##3##(1993-2#1)(2012-12#1)
time to say##2##3##(2006-10#1)(2008-12#1)
time to step##2##3##(1993-1#1)(2011-2#1)
time to stop##2##3##(1995-6#1)(2008-2#1)
time to the first##2##4##(2008-4#1)(2011-12#1)
time to the##38##3##(1995-2#1)(1996-3#1)(1996-4#1)(1997-4#1)(2005-8#1)(2007-11#2)(2007-12#15)(2007-6#1)(2007-8#1)(2008-10#1)(2008-2#5)(2008-3#2)(2008-4#2)(2008-5#1)(2010-3#1)(2011-12#1)(2012-3#1)
time to time##8##3##(1997-7#1)(2007-7#1)(2008-10#1)(2008-5#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-2#1)
time to treat##2##3##(1996-3#1)(2007-8#1)
time to treatment failure##3##4##(2006-6#2)(2008-5#1)
time to treatment##8##3##(2006-6#2)(2007-9#1)(2008-10#1)(2008-3#3)(2008-5#1)
time to tumor##2##3##(2006-12#1)(2007-12#1)
time to two consecutive visits with EDSS greater than three##2##10##(2008-12#2)
time to union was##3##4##(2009-10#1)(2013-8#2)
time to widespread adoption##2##4##(2012-12#2)
time to##511##2##(1990-10#1)(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#4)(1991-3#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-1#2)(1993-11#3)(1993-12#4)(1993-2#6)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#3)(1995-1#3)(1995-12#3)(1995-2#4)(1995-3#2)(1995-6#3)(1995-8#2)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#6)(1996-4#2)(1996-5#1)(1996-7#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-7#3)(1997-8#3)(2004-1#4)(2004-10#1)(2004-12#1)(2004-3#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-8#2)(2005-9#2)(2006-10#9)(2006-12#4)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#2)(2007-10#4)(2007-11#24)(2007-12#43)(2007-2#2)(2007-3#2)(2007-4#3)(2007-5#1)(2007-6#2)(2007-7#8)(2007-8#15)(2007-9#4)(2008-1#6)(2008-10#34)(2008-11#5)(2008-12#10)(2008-2#18)(2008-3#28)(2008-4#4)(2008-5#16)(2008-6#5)(2008-7#7)(2008-8#14)(2008-9#10)(2009-10#5)(2009-11#1)(2009-12#1)(2009-4#3)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#3)(2010-4#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#5)(2011-12#4)(2011-2#18)(2011-7#1)(2012-1#4)(2012-12#13)(2012-2#5)(2012-3#11)(2012-8#1)(2013-1#21)(2013-8#12)
time travel is##2##3##(2013-8#2)
time travel##7##2##(2007-2#1)(2013-8#6)
time trend##4##2##(1990-12#1)(1995-5#1)(2006-6#1)(2008-11#1)
time trends in##2##3##(1993-12#1)(2012-1#1)
time trends##3##2##(1993-12#1)(1997-7#1)(2012-1#1)
time under##2##2##(2007-9#1)(2008-9#1)
time until##10##2##(1990-4#1)(1993-3#1)(1997-6#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-2#1)
time up to##6##3##(1992-12#1)(1997-3#1)(2004-9#1)(2008-10#1)(2008-11#1)(2008-6#1)
time up##7##2##(1991-10#1)(1992-12#1)(1997-3#1)(2004-9#1)(2008-10#1)(2008-11#1)(2008-6#1)
time use##5##2##(2009-10#2)(2013-1#3)
time used for##2##3##(1992-3#1)(2008-10#1)
time used to##3##3##(1991-8#1)(2007-5#1)(2008-10#1)
time used##8##2##(1991-8#1)(1992-3#1)(1993-11#1)(2007-11#1)(2007-5#1)(2008-10#2)(2011-2#1)
time using a##3##3##(1995-9#1)(2008-10#2)
time using the##2##3##(2009-4#1)(2013-7#1)
time using##18##2##(1995-12#1)(1995-9#1)(1997-6#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)(2009-4#1)(2010-4#2)(2011-2#2)(2013-1#1)(2013-7#1)
time values##3##2##(2005-12#1)(2008-3#1)(2010-2#1)
time variables##2##2##(1996-7#1)(2008-7#1)
time variation of##4##3##(2008-2#1)(2008-3#1)(2011-2#1)(2012-2#1)
time variation##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-2#1)
time varying##5##2##(1997-7#1)(2008-11#1)(2008-3#1)(2010-8#1)(2012-12#1)
time versus##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
time was &lt##2##3##(2008-10#2)
time was 10##4##3##(1990-2#1)(2011-1#1)(2011-2#1)(2012-3#1)
time was 15 minutes##2##4##(1991-1#1)(1994-9#1)
time was 15##3##3##(1991-1#1)(1994-9#1)(2008-6#1)
time was 2##2##3##(2011-2#2)
time was 3##3##3##(1991-2#1)(2006-10#1)(2008-10#1)
time was 4##4##3##(2006-10#1)(2008-10#1)(2008-6#1)(2010-5#1)
time was 5##5##3##(1990-11#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-12#1)
time was 50 minutes##2##4##(1994-2#1)(1995-9#1)
time was 50##3##3##(1994-2#1)(1995-9#1)(2008-10#1)
time was 6 min##2##4##(1996-1#1)(2008-10#1)
time was 6##5##3##(1996-1#1)(2007-11#1)(2008-10#1)(2012-12#1)(2013-8#1)
time was 7##3##3##(1991-2#1)(1994-8#1)(2004-9#1)
time was 8##2##3##(1992-2#1)(2006-12#1)
time was about##3##3##(1996-7#1)(2007-8#1)(2008-10#1)
time was achieved##3##3##(2008-10#1)(2008-3#2)
time was also##2##3##(2009-4#1)(2013-1#1)
time was analyzed##2##3##(2005-11#1)(2013-8#1)
time was calculated##2##3##(2008-10#1)(2008-6#1)
time was determined##2##3##(2006-8#1)(2007-11#1)
time was developed##2##3##(2008-10#1)(2008-3#1)
time was discussed##2##3##(2008-10#1)(2013-8#1)
time was examined##3##3##(1993-7#1)(1996-4#1)(2008-11#1)
time was found to be##4##5##(2005-11#1)(2007-2#1)(2008-10#1)(2010-12#1)
time was found##6##3##(1997-6#1)(2005-11#2)(2007-2#1)(2008-10#1)(2010-12#1)
time was less than##6##4##(1994-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2012-3#1)
time was less##7##3##(1994-5#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#2)(2012-3#1)
time was longer in##3##4##(1996-1#1)(2013-8#2)
time was longer##4##3##(1996-1#1)(2011-1#1)(2013-8#2)
time was lower than##2##4##(2008-10#2)
time was much more##2##4##(1990-2#1)(2011-2#1)
time was much##5##3##(1990-2#1)(2008-10#1)(2008-2#1)(2011-1#1)(2011-2#1)
time was not##3##3##(1990-10#1)(2007-12#1)(2008-1#1)
time was observed in##2##4##(2007-11#1)(2008-10#1)
time was observed##7##3##(1990-12#1)(1990-4#1)(2005-11#1)(2007-11#2)(2008-10#1)(2010-4#1)
time was prolonged in##2##4##(2007-11#1)(2009-2#1)
time was prolonged##3##3##(2007-11#1)(2008-11#1)(2009-2#1)
time was reduced##5##3##(2008-1#1)(2008-10#3)(2009-7#1)
time was significantly longer in the##2##6##(2007-2#1)(2007-8#1)
time was significantly longer##4##4##(2006-8#1)(2007-2#1)(2007-8#1)(2010-8#1)
time was significantly shortened##2##4##(1990-11#1)(2008-5#1)
time was significantly shorter##2##4##(2007-9#1)(2010-8#1)
time was significantly##10##3##(1990-11#1)(2006-8#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-5#1)(2010-8#2)(2012-2#1)
time was spent##2##3##(2010-8#1)(2011-1#1)
time was the most##2##4##(2009-4#1)(2012-12#1)
time was the##3##3##(2009-4#1)(2012-12#1)(2013-1#1)
time was used by##3##4##(2007-7#3)
time was used to##2##4##(2005-11#1)(2008-10#1)
time was used##7##3##(1997-2#1)(2005-11#1)(2007-7#3)(2008-10#1)(2008-12#1)
time was##211##2##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#2)(1990-4#2)(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#2)(1992-10#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-2#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#2)(1995-9#2)(1996-1#2)(1996-2#1)(1996-4#2)(1996-7#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-9#2)(2005-11#6)(2006-10#3)(2006-12#3)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#3)(2007-11#8)(2007-12#1)(2007-2#3)(2007-3#1)(2007-5#1)(2007-7#5)(2007-8#10)(2007-9#3)(2008-1#4)(2008-10#38)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#5)(2011-2#7)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#3)(2013-1#9)(2013-8#6)
time we##7##2##(2006-12#1)(2007-8#1)(2008-5#2)(2011-2#1)(2012-12#1)(2013-1#1)
time were applied##2##3##(2007-11#1)(2008-5#1)
time were comparable##2##3##(2008-10#2)
time were determined##3##3##(2007-9#1)(2008-12#1)(2008-2#1)
time were evaluated and##2##4##(2008-10#2)
time were evaluated##3##3##(2008-10#2)(2011-12#1)
time were examined in a##2##5##(2006-9#1)(2008-10#1)
time were examined##3##3##(2006-9#1)(2007-7#1)(2008-10#1)
time were investigated##4##3##(2008-10#4)
time were measured##2##3##(1997-4#1)(2004-11#1)
time were more##2##3##(2010-11#1)(2012-2#1)
time were observed##2##3##(2007-5#1)(2013-1#1)
time were obtained##2##3##(1995-3#1)(2008-10#1)
time were optimised##2##3##(2008-10#2)
time were optimized##4##3##(2008-10#4)
time were statistically##3##3##(1992-2#1)(1996-2#1)(2013-8#1)
time were studied##2##3##(2008-10#2)
time were##63##2##(1990-12#1)(1992-2#1)(1993-12#1)(1994-3#1)(1995-3#1)(1995-9#1)(1996-2#1)(1997-4#1)(2004-11#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#21)(2008-11#2)(2008-12#3)(2008-2#1)(2008-5#3)(2008-9#1)(2009-8#2)(2010-11#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
time when compared with the##2##5##(1996-10#1)(2012-2#1)
time when compared with##3##4##(1991-5#1)(1996-10#1)(2012-2#1)
time when the patient arrived until he/she got an ED bed (&gt##2##12##(2013-1#2)
time when the##15##3##(1992-7#1)(1993-4#1)(1997-2#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#1)(2013-1#2)
time when##68##2##(1991-5#1)(1991-7#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-12#2)(1996-4#1)(1997-2#1)(2004-11#1)(2005-11#2)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#15)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#2)(2008-9#3)(2009-10#1)(2009-2#2)(2009-4#2)(2010-1#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
time where##2##2##(2006-9#1)(2011-2#1)
time which##5##2##(1993-8#1)(1996-9#1)(1997-5#1)(2008-9#1)(2010-4#1)
time while##7##2##(1997-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2012-12#2)(2012-2#1)
time will be##2##3##(2006-6#1)(2007-1#1)
time window and##2##3##(1997-8#1)(2008-3#1)
time window for##2##3##(2007-10#1)(2008-8#1)
time window of the##2##4##(2008-3#1)(2012-7#1)
time window of##3##3##(2008-3#2)(2012-7#1)
time window##23##2##(1993-7#2)(1997-1#1)(1997-8#1)(2006-11#1)(2007-10#3)(2007-9#1)(2008-10#2)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2012-12#2)(2012-2#1)(2012-7#1)
time windows##3##2##(2007-9#1)(2008-3#1)(2011-1#1)
time with a##4##3##(1995-11#1)(2007-12#1)(2010-12#1)(2012-1#1)
time with and##2##3##(2009-9#1)(2010-2#1)
time with elimination of##2##4##(1990-5#1)(2006-10#1)
time with no##2##3##(1993-7#1)(2007-12#1)
time with the##11##3##(1994-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-9#1)
time with##61##2##(1990-10#1)(1990-2#1)(1990-5#1)(1992-12#1)(1992-3#1)(1993-7#1)(1994-2#2)(1995-11#1)(1995-3#1)(1996-9#1)(1997-6#1)(2005-11#2)(2006-10#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#9)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2009-2#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-3#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-8#1)
time within the##3##3##(2007-12#1)(2008-7#1)(2013-8#1)
time within##7##2##(2007-12#1)(2008-10#2)(2008-7#1)(2010-12#1)(2012-12#1)(2013-8#1)
time without##4##2##(2007-11#1)(2008-1#1)(2008-10#1)(2009-11#1)
time x##2##2##(1992-2#2)
time zero##4##2##(2006-3#1)(2007-1#1)(2008-8#1)(2010-4#1)
time##9594##1##(1990-1#3)(1990-10#25)(1990-11#40)(1990-12#51)(1990-2#30)(1990-3#20)(1990-4#14)(1990-5#30)(1990-6#13)(1990-7#11)(1990-8#28)(1990-9#18)(1991-1#13)(1991-10#14)(1991-11#35)(1991-12#27)(1991-2#36)(1991-3#29)(1991-4#12)(1991-5#14)(1991-6#20)(1991-7#10)(1991-8#22)(1991-9#16)(1992-1#19)(1992-10#10)(1992-11#21)(1992-12#35)(1992-2#39)(1992-3#41)(1992-4#9)(1992-5#13)(1992-6#14)(1992-7#8)(1992-8#28)(1992-9#24)(1993-1#15)(1993-10#4)(1993-11#20)(1993-12#31)(1993-2#27)(1993-3#22)(1993-4#10)(1993-5#10)(1993-6#19)(1993-7#19)(1993-8#15)(1993-9#26)(1994-1#8)(1994-10#4)(1994-11#21)(1994-12#25)(1994-2#35)(1994-3#47)(1994-4#13)(1994-5#21)(1994-6#28)(1994-7#8)(1994-8#22)(1994-9#23)(1995-1#38)(1995-10#6)(1995-11#26)(1995-12#49)(1995-2#28)(1995-3#32)(1995-4#7)(1995-5#25)(1995-6#33)(1995-7#8)(1995-8#15)(1995-9#27)(1996-1#35)(1996-10#5)(1996-11#19)(1996-12#49)(1996-2#36)(1996-3#45)(1996-4#28)(1996-5#34)(1996-6#22)(1996-7#30)(1996-8#14)(1996-9#36)(1997-1#20)(1997-2#41)(1997-3#45)(1997-4#47)(1997-5#19)(1997-6#28)(1997-7#25)(1997-8#37)(2003-11#2)(2004-1#7)(2004-10#6)(2004-11#27)(2004-12#8)(2004-2#4)(2004-3#7)(2004-4#3)(2004-9#21)(2005-1#5)(2005-10#15)(2005-11#88)(2005-12#9)(2005-3#2)(2005-4#9)(2005-5#4)(2005-6#2)(2005-7#16)(2005-8#21)(2005-9#10)(2006-1#10)(2006-10#102)(2006-11#11)(2006-12#71)(2006-2#25)(2006-3#17)(2006-4#30)(2006-5#49)(2006-6#46)(2006-7#22)(2006-8#51)(2006-9#23)(2007-1#30)(2007-10#70)(2007-11#185)(2007-12#297)(2007-2#43)(2007-3#26)(2007-4#50)(2007-5#34)(2007-6#19)(2007-7#104)(2007-8#206)(2007-9#79)(2008-1#115)(2008-10#1355)(2008-11#231)(2008-12#87)(2008-2#235)(2008-3#325)(2008-4#98)(2008-5#240)(2008-6#83)(2008-7#158)(2008-8#182)(2008-9#136)(2009-1#5)(2009-10#42)(2009-11#25)(2009-12#16)(2009-2#40)(2009-3#28)(2009-4#48)(2009-5#24)(2009-6#33)(2009-7#41)(2009-8#47)(2009-9#40)(2010-1#22)(2010-10#18)(2010-11#22)(2010-12#82)(2010-2#67)(2010-3#52)(2010-4#52)(2010-5#38)(2010-6#17)(2010-7#33)(2010-8#69)(2010-9#26)(2011-1#105)(2011-10#1)(2011-11#2)(2011-12#43)(2011-2#256)(2011-3#13)(2011-4#1)(2011-7#3)(2012-1#61)(2012-10#2)(2012-11#15)(2012-12#149)(2012-2#184)(2012-3#93)(2012-4#3)(2012-5#2)(2012-6#1)(2012-7#4)(2012-8#4)(2013-1#293)(2013-7#43)(2013-8#144)
time&quot##12##1##(1994-6#1)(2007-12#2)(2008-1#1)(2008-5#1)(2008-8#1)(2011-2#3)(2012-12#3)
time'##6##1##(1992-7#2)(1994-2#1)(1995-3#1)(1996-10#1)(2008-10#1)
time) and##7##2##(2008-10#4)(2008-2#1)(2011-1#1)(2012-1#1)
time) are optimized##2##3##(2008-10#2)
time) for##2##2##(2008-2#1)(2008-3#1)
time) of##4##2##(1995-12#1)(2008-10#1)(2008-2#1)(2012-1#1)
time) showed##2##2##(2008-10#1)(2008-7#1)
time) was##2##2##(2008-10#1)(2008-11#1)
time) were investigated##2##3##(2008-10#2)
time) were recorded##2##3##(2008-10#1)(2009-3#1)
time) were##7##2##(1996-11#1)(2008-10#5)(2009-3#1)
time)##71##1##(1990-7#1)(1992-3#1)(1992-7#1)(1992-9#1)(1995-12#2)(1995-2#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-10#23)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-12#1)(2012-1#3)(2012-8#1)(2013-1#2)
time- and concentration-dependent##19##3##(1991-5#1)(1991-9#1)(1992-11#2)(1992-6#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-5#1)(1996-9#1)(1997-1#2)(1997-4#1)(2005-8#1)(2008-9#1)
time- and dose-dependent increase in##2##5##(1990-4#1)(1996-5#1)
time- and dose-dependent increase##4##4##(1990-4#1)(1992-6#1)(1994-9#1)(1996-5#1)
time- and dose-dependent##22##3##(1990-4#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-5#1)(1991-6#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-5#1)(2008-4#1)(2010-1#1)
time- and frequency-domain##2##3##(2007-12#1)(2008-2#1)
time- and space-resolved##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
time- and temperature-dependent##5##3##(1990-11#1)(1991-3#1)(1994-3#1)(1994-6#1)(2007-8#1)
time- and voltage-dependent##3##3##(1993-2#1)(1993-3#2)
time- and##64##2##(1990-11#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-11#2)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-4#1)(1996-5#1)(1996-9#2)(1997-1#2)(1997-4#1)(2005-8#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-9#1)(2010-1#1)
time-##68##1##(1990-11#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-11#2)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-4#1)(1996-5#1)(1996-9#2)(1997-1#3)(1997-4#1)(2005-8#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-2#3)(2008-3#6)(2008-4#2)(2008-9#1)(2010-1#1)
time-activity##5##1##(2008-5#1)(2008-8#3)(2012-2#1)
time-averaged Strehl ratio##2##3##(2008-2#1)(2008-3#1)
time-averaged TV holography##2##3##(2008-2#2)
time-averaged##17##1##(1992-1#1)(1993-11#1)(2007-10#1)(2007-12#3)(2008-2#4)(2008-3#3)(2008-8#2)(2009-9#1)(2012-3#1)
time-bandwidth product compared with##2##4##(2007-12#1)(2008-1#1)
time-bandwidth product##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
time-bandwidth##4##1##(2007-12#2)(2008-1#1)(2008-3#1)
time-based flow injection (FI) method for on-line preconcentration and determination of##2##11##(2008-10#2)
time-based flow injection (FI)##3##4##(2008-10#3)
time-based flow##5##2##(2008-10#5)
time-based technique##2##2##(2008-10#2)
time-based##19##1##(1991-8#1)(2007-8#1)(2008-10#15)(2008-5#1)(2013-7#1)
time-by-covariate interactions in##2##3##(1994-5#2)
time-by-covariate interactions##3##2##(1994-5#3)
time-by-covariate##4##1##(1994-5#4)
time-constrained##3##1##(2012-12#1)(2013-1#2)
time-consuming and do not##2##4##(2008-10#1)(2012-2#1)
time-consuming and tedious##2##3##(2008-10#1)(2008-2#1)
time-consuming and##24##2##(1993-11#1)(1995-1#1)(1995-2#1)(2004-10#1)(2005-11#1)(2006-10#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-12#1)(2012-12#1)(2012-2#1)
time-consuming for##2##2##(2011-2#1)(2012-3#1)
time-consuming or##2##2##(2008-8#1)(2013-1#1)
time-consuming procedure##3##2##(2006-10#1)(2008-4#2)
time-consuming process##3##2##(2007-6#1)(2008-4#1)(2009-8#1)
time-consuming task##3##2##(2008-5#1)(2013-1#2)
time-consuming to##3##2##(2005-10#1)(2010-8#1)(2011-1#1)
time-consuming##107##1##(1990-12#1)(1991-12#1)(1992-6#1)(1993-10#1)(1993-11#1)(1993-2#2)(1993-7#1)(1993-9#2)(1994-1#1)(1994-12#1)(1994-6#1)(1995-1#2)(1995-2#2)(1995-6#1)(2004-10#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-6#3)(2007-12#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#22)(2008-11#3)(2008-2#5)(2008-3#2)(2008-4#4)(2008-5#5)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-8#1)(2010-11#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#4)(2012-2#1)(2012-3#3)(2012-8#1)(2013-1#5)(2013-7#1)
time-correlated single photon counting (TCSPC)##3##5##(2006-10#1)(2007-11#1)(2011-1#1)
time-correlated single-photon counting##3##3##(2008-3#3)
time-correlated##11##1##(1991-7#1)(2006-10#1)(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#3)(2011-1#1)
time-correlation##2##1##(2006-4#2)
time-course and##3##2##(1993-6#1)(2007-2#1)(2008-5#1)
time-course experiments##2##2##(1995-2#1)(2008-7#1)
time-course gene expression data##2##4##(2010-1#1)(2010-10#1)
time-course of the##4##3##(1994-11#1)(1995-12#1)(1997-6#1)(2008-8#1)
time-course of##19##2##(1990-6#1)(1991-5#3)(1992-11#1)(1992-4#1)(1994-11#1)(1995-12#2)(1995-5#1)(1996-5#1)(1997-6#2)(1997-8#1)(2005-8#1)(2008-8#1)(2010-2#1)(2012-3#1)(2013-8#1)
time-course##45##1##(1990-3#1)(1990-5#1)(1990-6#1)(1991-5#3)(1992-11#1)(1992-4#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-6#2)(1997-8#1)(2005-8#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2010-1#1)(2010-10#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
time-courses of the##2##3##(1991-7#1)(1995-1#1)
time-courses of##3##2##(1991-7#1)(1995-1#1)(2008-7#1)
time-courses##4##1##(1991-4#1)(1991-7#1)(1995-1#1)(2008-7#1)
time-delay and##2##2##(2008-2#1)(2008-3#1)
time-delay units##2##2##(2008-2#2)
time-delay##7##1##(2008-10#1)(2008-2#5)(2008-3#1)
time-delayed##8##1##(2007-11#2)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#1)
time-dependence of##3##2##(1993-2#1)(1995-2#1)(2008-7#1)
time-dependence##7##1##(1992-12#1)(1993-2#1)(1995-2#1)(2005-8#1)(2008-7#1)(2012-11#2)
time-dependency of##2##2##(1996-7#1)(2008-7#1)
time-dependency##7##1##(1996-7#1)(1997-1#1)(2008-7#5)
time-dependent (TD)##2##2##(2010-5#1)(2012-1#1)
time-dependent and was##2##3##(1990-11#1)(1994-10#1)
time-dependent and##11##2##(1990-11#1)(1991-1#1)(1991-10#1)(1992-3#1)(1994-10#1)(1995-1#1)(1995-10#1)(1996-6#1)(2007-3#1)(2008-11#1)(2009-2#1)
time-dependent anisotropy##4##2##(1997-1#2)(1997-3#2)
time-dependent changes in the##3##4##(1992-2#1)(1992-4#1)(2010-11#1)
time-dependent changes##4##2##(1992-2#1)(1992-4#1)(2008-3#1)(2010-11#1)
time-dependent concentrations##2##2##(2008-2#1)(2009-9#1)
time-dependent covariate##4##2##(1992-9#1)(1996-12#2)(1997-3#1)
time-dependent covariates##4##2##(1993-11#1)(1996-12#1)(2007-6#1)(2010-8#1)
time-dependent decrease in##3##3##(1993-9#1)(1995-3#1)(2011-2#1)
time-dependent decrease##7##2##(1990-5#1)(1993-9#1)(1994-8#1)(1995-3#1)(1995-5#1)(2006-5#1)(2011-2#1)
time-dependent disappearance of the##2##4##(1990-11#1)(2008-10#1)
time-dependent disease risk##2##3##(1996-7#2)
time-dependent effect##2##2##(2008-7#1)(2011-2#1)
time-dependent elimination of##2##3##(2008-5#2)
time-dependent elimination##5##2##(2008-5#5)
time-dependent factors##3##2##(2007-9#1)(2008-10#2)
time-dependent inactivation##2##2##(1991-5#1)(1991-9#1)
time-dependent inhibition of##4##3##(1993-6#1)(1993-8#1)(1995-7#1)(1996-5#1)
time-dependent inhibitors of##2##3##(1994-11#1)(1995-6#1)
time-dependent irreversible inhibitors of##2##4##(1991-4#1)(1994-11#1)
time-dependent irreversible##3##2##(1991-4#1)(1994-11#2)
time-dependent loss of##3##3##(1992-11#1)(1996-12#1)(2005-8#1)
time-dependent manner##45##2##(1990-10#1)(1990-11#1)(1990-7#1)(1991-1#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1994-12#2)(1994-3#1)(1994-8#2)(1994-9#2)(1995-2#1)(1995-5#1)(1995-7#1)(1996-2#2)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-12#1)(2008-10#1)(2008-11#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#2)(2010-5#1)(2011-2#1)(2012-12#2)
time-dependent mutation##2##2##(1995-8#2)
time-dependent photon##2##2##(2008-2#1)(2008-3#1)
time-dependent response of##3##3##(1997-7#1)(2008-10#1)(2012-2#1)
time-dependent response##4##2##(1997-7#1)(2008-10#1)(2010-2#1)(2012-2#1)
time-dependent signal##2##2##(2008-2#2)
time-dependent##239##1##(1990-10#1)(1990-11#3)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-2#1)(1991-4#2)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#4)(1994-8#4)(1994-9#2)(1995-1#2)(1995-10#4)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#1)(1995-5#3)(1995-6#2)(1995-7#2)(1995-8#2)(1995-9#1)(1996-10#1)(1996-12#6)(1996-2#2)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#3)(1997-1#2)(1997-2#2)(1997-3#5)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-11#4)(2007-12#5)(2007-3#2)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#9)(2008-11#9)(2008-2#14)(2008-3#9)(2008-4#2)(2008-5#10)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#4)(2009-10#1)(2009-2#1)(2009-6#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-5#2)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
time-dependently##5##1##(1990-3#1)(1995-7#1)(1996-10#1)(2007-12#1)(2012-2#1)
time-derivative weights##2##2##(2008-2#2)
time-derivative##4##1##(2008-2#4)
time-differential sensor##2##2##(2008-2#2)
time-differential##3##1##(2008-2#3)
time-division demultiplexing and spatial pulse routing##2##6##(2007-11#2)
time-division demultiplexing##3##2##(2007-11#3)
time-division multiplexed##5##2##(2007-11#3)(2008-3#2)
time-division multiplexing##6##2##(2007-11#4)(2008-2#1)(2008-3#1)
time-division##15##1##(2007-11#10)(2007-12#1)(2008-2#1)(2008-3#3)
time-division-multiplexed and##2##2##(2008-2#2)
time-division-multiplexed##8##1##(2008-2#5)(2008-3#3)
time-domain (FDTD) method##3##3##(2006-2#1)(2007-11#1)(2008-3#1)
time-domain (FDTD)##7##2##(2006-2#1)(2007-11#1)(2008-3#5)
time-domain and##3##2##(2006-7#1)(2011-7#1)(2013-1#1)
time-domain calculations##4##2##(2007-11#1)(2007-12#2)(2009-12#1)
time-domain demodulation technique##3##3##(2007-11#1)(2007-12#2)
time-domain demodulation##4##2##(2007-11#1)(2007-12#3)
time-domain method##13##2##(2007-11#2)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#4)(2013-8#2)
time-domain optical##8##2##(2007-12#4)(2008-1#1)(2008-2#1)(2008-3#2)
time-domain reflectometry##9##2##(2007-12#1)(2008-2#4)(2008-3#3)(2011-1#1)
time-domain simulation##2##2##(2007-11#2)
time-domain spectral##2##2##(2007-12#1)(2008-3#1)
time-domain spectroscopy (THz-TDS)##2##3##(2012-2#1)(2013-8#1)
time-domain spectroscopy##10##2##(2007-12#4)(2008-2#1)(2008-3#1)(2010-5#2)(2012-2#1)(2013-8#1)
time-domain##110##1##(2005-10#1)(2006-2#1)(2006-7#1)(2007-11#13)(2007-12#26)(2008-1#4)(2008-2#18)(2008-3#30)(2009-12#1)(2009-4#1)(2010-4#1)(2010-5#2)(2011-1#2)(2011-7#3)(2012-2#1)(2013-1#1)(2013-8#4)
time-effect##2##1##(1992-4#1)(1994-5#1)
time-efficient##4##1##(1995-1#1)(2008-2#1)(2010-9#2)
time-evolving##2##1##(2008-2#2)
time-expanded##2##1##(2007-7#2)
time-frequency analysis##2##2##(2008-1#1)(2012-1#1)
time-frequency domain##2##2##(2008-10#1)(2010-8#1)
time-frequency signal analysis##2##3##(2007-12#2)
time-frequency signal##3##2##(2007-12#2)(2008-3#1)
time-frequency##14##1##(2007-12#4)(2008-1#1)(2008-10#2)(2008-3#3)(2010-8#3)(2012-1#1)
time-gated##8##1##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#2)(2010-5#1)
time-gating##6##1##(2007-12#3)(2008-2#2)(2008-3#1)
time-independent##2##1##(2008-3#1)(2012-2#1)
time-integrative##2##1##(2008-3#2)
time-interval##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
time-invariant##4##1##(2008-3#2)(2009-12#1)(2009-8#1)
time-keeping##4##1##(2005-8#1)(2010-8#2)(2011-1#1)
time-kill assessments##2##2##(2006-8#2)
time-kill##9##1##(2006-12#1)(2006-8#5)(2008-5#2)(2012-2#1)
time-lag##2##1##(2007-6#1)(2013-8#1)
time-lapse analysis##2##2##(2008-1#1)(2008-11#1)
time-lapse differential interference##2##3##(1996-9#1)(2009-8#1)
time-lapse imaging##2##2##(2008-1#1)(2010-10#1)
time-lapse microscopy##7##2##(2008-11#4)(2008-8#1)(2008-9#1)(2012-12#1)
time-lapse studies##4##2##(1995-9#2)(2008-11#1)(2008-9#1)
time-lapse##26##1##(1990-12#1)(1994-8#1)(1995-11#1)(1995-9#2)(1996-9#1)(2005-7#1)(2008-1#2)(2008-11#7)(2008-8#1)(2008-9#3)(2009-12#1)(2009-8#1)(2010-10#1)(2012-12#3)
time-lens##2##1##(2007-12#2)
time-locked subsampling##2##2##(2007-3#2)
time-of-fight##2##1##(2008-7#1)(2012-3#1)
time-of-flight (TOF) and##2##3##(2008-10#2)
time-of-flight (TOF) mass spectrometry##2##4##(1995-7#1)(1997-2#1)
time-of-flight (TOF)##9##2##(1995-7#1)(1997-2#1)(2007-12#1)(2008-10#4)(2008-7#1)(2009-5#1)
time-of-flight mass spectrometer##7##3##(1992-1#2)(2008-10#2)(2008-2#1)(2008-3#1)(2009-12#1)
time-of-flight mass spectrometry (GC x GC-IDTOFMS)##2##6##(2008-10#2)
time-of-flight mass spectrometry (GC x##3##5##(2008-10#3)
time-of-flight mass spectrometry detection##2##4##(2008-10#2)
time-of-flight mass spectrometry##24##3##(1995-4#1)(1996-5#1)(2004-9#1)(2008-10#13)(2008-11#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-7#2)(2013-8#1)
time-of-flight mass##35##2##(1992-1#2)(1995-4#1)(1996-5#1)(2004-9#1)(2008-10#16)(2008-11#1)(2008-2#1)(2008-3#1)(2009-12#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-7#2)(2013-8#3)
time-of-flight secondary ion mass spectrometry##2##5##(1997-1#2)
time-of-flight secondary ion mass##3##4##(1997-1#2)(2005-11#1)
time-of-flight technique##2##2##(2007-12#1)(2007-9#1)
time-of-flight##64##1##(1992-1#2)(1995-4#1)(1995-7#1)(1996-2#1)(1996-5#1)(1997-1#2)(1997-2#1)(2004-9#1)(2005-11#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#24)(2008-11#2)(2008-2#4)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-4#2)(2010-7#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-7#2)(2013-8#3)
time-ordered narrative reports##4##3##(2013-1#4)
time-point##3##1##(2012-3#2)(2013-1#1)
time-points##6##1##(1995-5#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
time-range##2##1##(2008-3#2)
time-related changes in##2##3##(1995-12#1)(1996-10#1)
time-related changes##3##2##(1995-12#1)(1996-10#1)(2007-12#1)
time-related##11##1##(1991-7#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-10#1)(2006-11#1)(2006-6#4)(2007-12#1)
time-resolution##4##1##(2008-10#2)(2008-3#1)(2011-1#1)
time-resolved Fourier transform##3##3##(1997-4#1)(2008-3#2)
time-resolved Shpol'skii spectrometry##4##3##(2008-10#4)
time-resolved and##2##2##(1992-2#1)(2007-11#1)
time-resolved backscattering##2##2##(2007-11#1)(2007-12#1)
time-resolved direct imaging##2##3##(2007-12#2)
time-resolved emission spectra##2##3##(1997-1#2)
time-resolved emission##6##2##(1996-11#1)(1997-1#3)(2006-10#2)
time-resolved fluorescence anisotropy##2##3##(1990-2#1)(2006-10#1)
time-resolved fluorescence measurements##3##3##(1996-11#1)(2007-12#1)(2009-2#1)
time-resolved fluorescence quenching##2##3##(2005-11#2)
time-resolved fluorescence spectra##2##3##(2008-10#1)(2008-8#1)
time-resolved fluorescence spectroscopy##6##3##(1990-3#1)(1993-8#1)(2006-10#1)(2008-10#1)(2008-3#1)(2010-5#1)
time-resolved fluorescence##28##2##(1990-2#2)(1990-3#1)(1991-10#1)(1991-7#2)(1993-8#1)(1995-2#1)(1996-11#1)(1997-2#1)(2005-11#2)(2006-10#3)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-2#1)(2010-5#1)(2011-1#1)
time-resolved fluoroimmunoassay for##2##3##(1990-8#1)(2008-10#1)
time-resolved fluoroimmunoassay of##3##3##(2008-10#3)
time-resolved fluoroimmunoassay##11##2##(1990-8#1)(2007-8#2)(2008-10#8)
time-resolved imaging##6##2##(2007-12#2)(2008-1#1)(2008-3#2)(2009-4#1)
time-resolved infrared##2##2##(1992-6#1)(2008-1#1)
time-resolved laser-induced incandescence##2##3##(2008-2#2)
time-resolved laser-induced##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
time-resolved luminescence##2##2##(2005-11#1)(2008-10#1)
time-resolved measurements of the##4##4##(2007-12#2)(2008-2#1)(2008-3#1)
time-resolved measurements of##9##3##(1992-7#1)(2007-12#6)(2008-2#1)(2008-3#1)
time-resolved measurements##16##2##(1992-7#1)(1993-3#1)(2007-12#7)(2008-10#1)(2008-2#3)(2008-3#3)
time-resolved method##3##2##(2008-2#2)(2011-1#1)
time-resolved optical tomography##3##3##(2007-11#1)(2008-3#2)
time-resolved optical##8##2##(1991-7#1)(1995-8#1)(2007-11#1)(2007-12#1)(2008-3#2)(2009-9#1)(2011-1#1)
time-resolved phosphorescence##2##2##(1991-7#2)
time-resolved photoacoustic technique##2##3##(2008-3#2)
time-resolved photoacoustic##3##2##(1990-8#1)(2008-3#2)
time-resolved predamage##2##2##(2007-12#1)(2008-3#1)
time-resolved pump-probe##2##2##(2007-12#1)(2008-3#1)
time-resolved reflectance spectroscopy##3##3##(2007-12#1)(2008-3#2)
time-resolved reflectance##13##2##(2007-12#3)(2008-2#6)(2008-3#4)
time-resolved resonance Raman##3##3##(1995-1#2)(2006-6#1)
time-resolved resonance energy transfer measurements##2##5##(1994-8#2)
time-resolved resonance energy transfer##3##4##(1994-8#3)
time-resolved resonance##7##2##(1994-8#3)(1995-1#2)(2006-6#1)(2007-12#1)
time-resolved signals##2##2##(2008-3#2)
time-resolved small angle##2##3##(2008-11#1)(2008-5#1)
time-resolved spectroscopic experiments##3##3##(2006-10#1)(2007-12#1)(2009-3#1)
time-resolved spectroscopic##5##2##(2006-10#2)(2007-12#1)(2008-2#1)(2009-3#1)
time-resolved spectroscopy##9##2##(1992-2#1)(1994-11#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2009-3#1)
time-resolved terahertz spectroscopy##2##3##(2007-12#2)
time-resolved transillumination##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
time-resolved transmission##3##2##(2007-11#1)(2008-3#2)
time-resolved transmittance measurements##2##3##(2008-3#2)
time-resolved transmittance##5##2##(2008-2#1)(2008-3#4)
time-resolved trasmittance##2##2##(2008-3#2)
time-resolved x-ray diffraction##2##3##(2007-11#2)
time-resolved##232##1##(1990-2#2)(1990-3#1)(1990-8#3)(1990-9#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-7#5)(1992-1#2)(1992-2#2)(1992-6#3)(1992-7#1)(1993-3#3)(1993-8#1)(1994-11#3)(1994-8#3)(1995-1#2)(1995-2#2)(1995-8#1)(1996-11#3)(1997-1#3)(1997-2#1)(1997-4#1)(1997-6#1)(2005-11#3)(2006-10#7)(2006-12#2)(2006-4#2)(2006-5#3)(2006-6#1)(2007-1#1)(2007-11#11)(2007-12#35)(2007-4#1)(2007-8#3)(2008-1#2)(2008-10#28)(2008-11#3)(2008-2#27)(2008-3#37)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-5#1)(2011-1#4)(2012-2#1)
time-response##4##1##(1994-9#1)(2004-4#1)(2008-3#1)(2008-7#1)
time-saving##6##1##(1990-11#2)(1992-7#1)(1994-8#1)(1996-7#1)(2008-10#1)
time-scale##8##1##(1997-5#2)(2006-7#2)(2008-11#1)(2008-5#1)(2010-8#1)(2012-2#1)
time-scales are##2##2##(1997-8#1)(2008-10#1)
time-scales##4##1##(1997-8#1)(2008-10#1)(2008-11#1)(2010-10#1)
time-sensitive##2##1##(2008-12#1)(2008-3#1)
time-series analyses##3##2##(1992-12#1)(1995-12#1)(2010-3#1)
time-series analysis##4##2##(1994-11#1)(1995-12#2)(2007-10#1)
time-series measurements##3##2##(2008-2#1)(2008-3#2)
time-series##22##1##(1992-12#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-12#3)(1997-1#1)(2007-10#1)(2008-2#2)(2008-3#4)(2008-9#1)(2009-11#2)(2009-9#1)(2010-3#1)(2011-2#2)
time-space##4##1##(1996-4#1)(2007-11#1)(2008-3#1)(2008-5#1)
time-stamp##2##1##(2007-10#1)(2012-2#1)
time-steered##2##1##(2008-2#2)
time-temperature##2##1##(1995-3#1)(2011-2#1)
time-tested##4##1##(2007-12#1)(2008-9#2)(2009-4#1)
time-to-event data##2##2##(1997-4#1)(2007-9#1)
time-to-event##5##1##(1996-2#1)(1997-4#1)(2007-9#1)(2012-2#1)(2012-3#1)
time-to-peak values##3##2##(2008-4#3)
time-varying data##3##2##(2008-3#2)(2008-6#1)
time-varying magnetic fields##4##3##(1992-3#3)(2006-10#1)
time-varying magnetic##5##2##(1992-3#3)(2006-10#1)(2006-5#1)
time-varying phase##2##2##(2007-11#1)(2008-3#1)
time-varying##32##1##(1992-3#4)(2006-10#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-2#6)(2008-3#9)(2008-6#2)(2008-7#2)(2009-12#2)(2009-2#1)(2010-1#1)(2011-2#1)
time-weighted##2##1##(1993-1#1)(2008-5#1)
time-window##2##1##(1994-8#1)(2008-8#1)
time/date of order##2##3##(2013-1#2)
time?##15##1##(1992-2#1)(1993-5#1)(1994-2#1)(2003-11#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-12#1)(2008-9#2)(2009-4#1)(2009-6#1)(2010-12#1)(2010-5#1)(2013-8#1)
time?]##4##1##(1991-11#1)(1992-11#1)(1994-6#1)(2008-4#1)
time]##11##1##(1990-8#1)(1991-9#1)(1992-9#1)(1993-11#1)(1993-8#1)(1996-1#2)(1996-3#1)(2010-11#1)(2012-1#1)(2013-1#1)
timecourse of activation within##2##4##(2008-11#2)
timecourse of activation##3##3##(2008-11#3)
timecourse of##9##2##(1993-8#2)(2008-11#7)
timecourse##12##1##(1993-8#2)(2008-11#10)
timed up and go test##2##5##(2006-10#1)(2010-3#1)
timed up and##3##3##(2006-10#1)(2010-3#1)(2012-12#1)
timed##26##1##(1990-11#1)(1990-5#1)(1990-9#1)(1992-8#1)(1993-4#1)(1993-9#1)(1995-2#1)(1995-5#1)(1997-8#1)(2006-10#2)(2007-12#2)(2007-2#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-10#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
timeframe of##2##2##(2008-8#1)(2009-3#1)
timeframe##4##1##(2008-8#1)(2009-10#1)(2009-3#1)(2012-1#1)
timeframes for##2##2##(1996-2#1)(2008-4#1)
timeless##2##1##(2007-4#1)(2008-1#1)
timeline for##3##2##(2008-9#1)(2012-12#1)(2013-1#1)
timeline of##3##2##(2010-12#1)(2011-1#1)(2012-12#1)
timeline##11##1##(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-12#2)(2013-1#1)
timelines##2##1##(2006-2#1)(2011-2#1)
timeliness and##4##2##(1990-4#1)(1995-3#1)(2013-1#2)
timeliness could be substantially improved when using HL7 connections##2##9##(2013-1#2)
timeliness of##12##2##(1990-11#1)(2007-10#1)(2007-4#1)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-2#4)(2012-3#1)
timeliness##28##1##(1990-11#1)(1990-4#2)(1994-2#1)(1995-12#1)(1995-3#2)(2007-10#1)(2007-4#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#5)(2012-3#1)(2013-1#4)
timely and accurate##3##3##(1992-12#1)(1995-12#1)(2008-10#1)
timely and appropriate##2##3##(2007-4#1)(2013-1#1)
timely and efficient##2##3##(2008-10#1)(2008-9#1)
timely and##15##2##(1992-12#1)(1995-12#1)(1997-3#1)(2006-9#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-9#1)(2010-12#1)(2011-1#2)(2012-12#1)(2013-1#1)
timely detection of##3##3##(2008-7#1)(2010-12#1)(2011-2#1)
timely detection##4##2##(2007-11#1)(2008-7#1)(2010-12#1)(2011-2#1)
timely diagnosis and##3##3##(2005-10#1)(2006-10#1)(2013-7#1)
timely diagnosis##10##2##(1991-12#1)(2005-10#1)(2006-10#1)(2008-12#1)(2008-3#1)(2009-11#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-7#1)
timely fashion##12##2##(1994-2#1)(1995-12#1)(1996-7#1)(2006-6#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#1)(2010-11#2)(2010-3#1)(2010-9#1)
timely health##3##2##(2007-12#1)(2008-5#1)(2013-1#1)
timely identification##2##2##(2008-10#1)(2011-2#1)
timely information on##2##3##(1996-1#1)(1997-3#1)
timely information##7##2##(1995-3#1)(1996-1#1)(1997-3#1)(2008-11#1)(2010-11#1)(2012-2#2)
timely intervention##5##2##(1997-2#1)(1997-7#1)(2006-12#1)(2008-2#1)(2012-2#1)
timely manner##16##2##(1993-1#1)(1994-12#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#5)
timely recognition of the##2##4##(2008-7#1)(2011-1#1)
timely referral to a##2##4##(2010-12#1)(2010-9#1)
timely referral to##4##3##(2008-7#1)(2008-8#1)(2010-12#1)(2010-9#1)
timely referrals##2##2##(2006-3#1)(2013-8#1)
timely source##2##2##(1997-3#1)(2011-2#1)
timely to##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
timely treatment##7##2##(2007-2#1)(2007-9#1)(2009-4#1)(2012-12#1)(2012-3#2)(2013-1#1)
timely use of##2##3##(2008-11#1)(2008-7#1)
timely##190##1##(1991-12#1)(1991-4#1)(1991-6#1)(1992-12#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#3)(1995-3#2)(1996-1#2)(1996-2#2)(1996-7#1)(1997-2#2)(1997-3#5)(1997-7#1)(2005-10#3)(2005-8#1)(2006-1#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-11#5)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#8)(2008-12#2)(2008-2#2)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#2)(2009-11#1)(2009-2#1)(2009-4#2)(2010-1#1)(2010-11#4)(2010-12#8)(2010-3#2)(2010-4#2)(2010-5#2)(2010-9#4)(2011-1#5)(2011-12#3)(2011-2#10)(2012-12#10)(2012-2#4)(2012-3#3)(2013-1#15)(2013-7#1)(2013-8#1)
timepoint##3##1##(1995-11#1)(1996-3#1)(2008-10#1)
timepoints##5##1##(1997-8#1)(2008-5#1)(2008-9#2)(2012-2#1)
timer##4##1##(2008-10#2)(2009-1#1)(2010-12#1)
times (&lt##3##2##(1997-6#1)(2008-10#2)
times (0##2##2##(1991-7#1)(1997-4#1)
times (15##2##2##(1993-6#1)(2013-1#1)
times (3##2##2##(1996-11#1)(2008-10#1)
times (95% CI##2##3##(2006-4#2)
times (95%##3##2##(2006-4#2)(2007-7#1)
times (RTs)##2##2##(1996-6#1)(2009-8#1)
times (T##2##2##(2004-11#2)
times (p&lt##2##2##(2012-1#1)(2013-1#1)
times (versus##2##2##(2008-10#2)
times 1##2##2##(1992-6#1)(2008-11#1)
times a day for 3##2##5##(1996-2#1)(2005-10#1)
times a day for##4##4##(1990-9#1)(1996-2#1)(2005-10#1)(2012-12#1)
times a day##17##3##(1990-9#1)(1993-10#1)(1994-2#1)(1996-2#1)(2005-10#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-8#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
times a day)##2##3##(1992-11#1)(2011-1#1)
times a week for 6##2##5##(2008-5#1)(2009-1#1)
times a week for##10##4##(1990-3#1)(1991-3#1)(1995-9#1)(1996-6#1)(1997-5#1)(2007-11#1)(2008-5#2)(2009-1#1)(2010-4#1)
times a week##21##3##(1990-3#1)(1990-8#1)(1991-3#1)(1992-2#1)(1995-9#1)(1996-10#1)(1996-6#3)(1997-5#1)(2007-11#2)(2007-8#1)(2008-5#2)(2009-1#1)(2009-6#2)(2009-8#1)(2010-4#1)(2013-1#1)
times a week)##2##3##(1994-6#1)(1996-6#1)
times a year##7##3##(1997-3#1)(1997-4#1)(2006-4#2)(2006-8#1)(2008-10#1)(2013-8#1)
times a##53##2##(1990-3#1)(1990-8#1)(1990-9#1)(1991-3#1)(1992-11#1)(1992-2#1)(1993-10#1)(1993-2#1)(1994-2#1)(1994-6#1)(1995-9#1)(1996-10#1)(1996-2#1)(1996-6#4)(1997-3#1)(1997-4#1)(1997-5#1)(2005-10#1)(2006-4#2)(2006-8#1)(2007-10#1)(2007-11#3)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-1#1)(2009-6#2)(2009-8#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#2)
times above##3##2##(2007-12#1)(2008-3#2)
times after inoculation##2##3##(2008-10#2)
times after##22##2##(1991-6#1)(1994-1#1)(1994-5#1)(1994-7#1)(1997-3#2)(1997-8#1)(2003-11#1)(2006-4#1)(2007-4#1)(2008-10#5)(2008-11#1)(2008-12#1)(2010-7#1)(2011-2#1)(2012-1#2)(2012-2#1)
times and a##2##3##(1992-1#1)(1996-2#1)
times and an increase in##2##5##(2008-10#1)(2011-1#1)
times and has##2##3##(2008-10#1)(2010-9#1)
times and higher##2##3##(2008-12#1)(2012-2#1)
times and improved##2##3##(1990-12#1)(2013-1#1)
times and in##2##3##(2008-5#1)(2012-2#1)
times and peak areas##3##4##(2007-8#1)(2008-10#2)
times and peak##4##3##(2007-8#1)(2008-10#3)
times and smaller##2##3##(2008-7#1)(2010-12#1)
times and that##2##3##(2008-8#1)(2008-9#1)
times and the##10##3##(2005-12#1)(2006-2#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-3#1)(2010-12#1)(2013-1#1)
times and was##2##3##(2005-11#1)(2013-8#1)
times and##104##2##(1990-11#1)(1990-12#1)(1992-1#1)(1992-9#1)(1993-10#2)(1993-11#1)(1993-12#1)(1993-3#1)(1994-3#2)(1996-2#1)(1996-4#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#1)(2004-9#3)(2005-11#1)(2005-12#1)(2006-2#2)(2006-7#2)(2006-8#1)(2007-1#2)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#4)(2008-10#16)(2008-11#3)(2008-12#3)(2008-2#2)(2008-5#6)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#2)(2010-11#2)(2010-12#3)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
times are##20##2##(1992-6#1)(1993-2#1)(1995-2#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-6#1)(2010-8#1)
times as fast##2##3##(1994-9#1)(2008-3#1)
times as frequent as in##2##5##(1992-12#1)(1997-3#1)
times as great##2##3##(2008-1#1)(2013-8#1)
times as high as##2##4##(2007-8#1)(2008-2#1)
times as high##3##3##(1990-2#1)(2007-8#1)(2008-2#1)
times as large as##2##4##(1994-12#1)(1997-1#1)
times as large##4##3##(1994-12#1)(1994-4#1)(1997-1#2)
times as likely to##4##4##(1995-2#2)(2013-1#2)
times as many##7##3##(1990-4#1)(1991-2#1)(1992-5#1)(1992-9#1)(1995-1#1)(1995-5#1)(2010-8#1)
times as much as##2##4##(1994-9#1)(2007-12#1)
times as much##4##3##(1994-9#1)(2005-9#1)(2007-12#1)(2008-10#1)
times as well##2##3##(1990-11#1)(2010-6#1)
times as##41##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-9#1)(1994-12#1)(1994-4#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-2#2)(1995-5#1)(1997-1#2)(1997-3#1)(2005-9#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-9#1)(2010-4#1)(2010-6#1)(2010-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
times at 37 degrees C##2##5##(1995-1#1)(2008-11#1)
times at a##2##3##(2007-10#1)(2011-2#1)
times at different electrodes##2##4##(2008-10#1)(2010-5#1)
times at different##3##3##(2008-10#1)(2010-5#2)
times at the##3##3##(2007-11#1)(2010-5#1)(2013-1#1)
times at which##5##3##(1990-2#1)(1994-6#1)(1995-8#2)(2008-7#1)
times at##27##2##(1990-2#1)(1990-6#1)(1992-11#1)(1993-6#1)(1994-6#1)(1995-1#1)(1995-8#2)(1996-1#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-5#3)(2011-2#1)(2013-1#1)(2013-8#1)
times because of##2##3##(1995-4#1)(2008-1#1)
times before##8##2##(1994-7#1)(1994-8#1)(1996-5#1)(2008-10#1)(2008-3#1)(2010-3#1)(2010-4#1)(2010-8#1)
times below##2##2##(2008-10#1)(2010-9#1)
times better for##2##3##(2008-10#1)(2008-2#1)
times better than that##2##4##(2007-12#1)(2008-2#1)
times better than##5##3##(1990-6#1)(2007-12#2)(2008-2#1)(2010-5#1)
times better##9##2##(1990-6#1)(1996-6#1)(2007-12#2)(2008-10#2)(2008-2#2)(2010-5#1)
times between##13##2##(1991-7#1)(1994-4#1)(1994-9#1)(1995-9#1)(1997-6#1)(1997-8#1)(2007-2#1)(2008-10#2)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#1)
times by the same##2##4##(2008-10#1)(2013-1#1)
times by the##4##3##(1995-11#1)(2008-1#1)(2008-10#1)(2013-1#1)
times by##9##2##(1990-9#1)(1995-1#1)(1995-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2010-8#1)(2013-1#1)
times calculated##2##2##(1996-11#1)(1997-1#1)
times can be##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
times centered##2##2##(2009-4#2)
times compared to##2##3##(2010-12#2)
times compared with##4##3##(1995-1#1)(2004-11#1)(2007-11#1)(2007-12#1)
times compared##6##2##(1995-1#1)(2004-11#1)(2007-11#1)(2007-12#1)(2010-12#2)
times contacted by staff##2##4##(2012-3#2)
times daily and##3##3##(1997-1#1)(2007-11#1)(2008-12#1)
times daily for##2##3##(1995-12#1)(2007-11#1)
times daily to##2##3##(1992-8#1)(2007-7#1)
times daily was##2##3##(1997-1#1)(2007-11#1)
times daily##18##2##(1990-10#1)(1991-12#1)(1992-2#1)(1992-8#1)(1995-12#1)(1997-1#2)(2007-11#5)(2007-7#1)(2008-12#1)(2008-3#3)(2012-12#1)
times daily)##5##2##(1991-9#1)(1993-12#1)(1995-3#2)(1997-6#1)
times diffraction limited##2##3##(2007-12#2)
times diluted##2##2##(2007-8#1)(2008-10#1)
times due to##5##3##(1990-9#1)(1992-6#1)(1994-4#2)(2009-4#1)
times due##6##2##(1990-9#1)(1992-6#1)(1994-4#2)(2005-11#1)(2009-4#1)
times during a period of##2##5##(2007-2#1)(2008-10#1)
times during a##4##3##(1995-11#1)(2007-2#2)(2008-10#1)
times during development##3##3##(1993-9#1)(1997-6#1)(2012-3#1)
times during the last##2##4##(1991-4#1)(1994-3#1)
times during the season##2##4##(2008-10#1)(2008-8#1)
times during the##16##3##(1991-4#1)(1991-5#1)(1991-8#1)(1992-7#1)(1994-3#1)(1995-8#1)(1996-5#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-8#1)(2010-8#1)(2012-12#1)
times during##35##2##(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-12#2)(1994-3#2)(1995-11#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-6#1)(2007-10#1)(2007-2#2)(2008-10#7)(2008-12#1)(2008-2#1)(2008-8#1)(2010-7#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-3#1)
times each year##2##3##(2008-10#2)
times each##8##2##(1997-7#1)(2005-8#2)(2006-10#1)(2008-10#3)(2008-5#1)
times even on##2##3##(2007-9#1)(2008-3#1)
times even##4##2##(2007-11#1)(2007-9#1)(2008-3#1)(2008-9#1)
times faster at##2##3##(1992-7#1)(2008-5#1)
times faster in##2##3##(2006-10#2)
times faster than a##2##4##(2007-11#1)(2008-3#1)
times faster than between two##2##5##(2008-11#2)
times faster than that of the##2##6##(1995-3#1)(2008-2#1)
times faster than that##3##4##(1992-12#1)(1995-3#1)(2008-2#1)
times faster than the##7##4##(1994-11#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
times faster than##24##3##(1991-2#1)(1992-12#1)(1994-1#1)(1994-11#1)(1995-3#1)(1996-2#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#4)(2008-6#1)(2008-8#1)(2009-6#1)
times faster##32##2##(1991-2#1)(1992-12#1)(1992-7#1)(1994-1#1)(1994-11#1)(1995-3#1)(1996-2#1)(2006-10#2)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#5)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#1)(2012-3#2)
times following##3##2##(1990-10#1)(1995-11#1)(2008-10#1)
times for Mn2+##2##3##(1995-6#2)
times for a##3##3##(1991-8#1)(2008-3#1)(2012-2#1)
times for each##3##3##(2009-8#1)(2010-6#1)(2013-1#1)
times for patients##3##3##(2006-2#1)(2007-4#1)(2013-8#1)
times for the formation of##2##5##(2008-10#2)
times for the##10##3##(1991-3#1)(1995-11#2)(1997-7#1)(2007-11#1)(2008-10#3)(2008-6#1)(2012-1#1)
times for##74##2##(1990-2#1)(1990-6#1)(1990-9#1)(1991-3#1)(1991-8#1)(1994-4#1)(1995-11#2)(1995-4#2)(1995-6#3)(1995-8#2)(1996-2#1)(1996-8#2)(1996-9#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-6#4)(2008-9#1)(2009-3#2)(2009-8#1)(2009-9#1)(2010-6#2)(2010-7#1)(2011-2#1)(2012-1#2)(2012-2#2)(2013-1#1)(2013-8#1)
times from the##3##3##(2007-12#1)(2008-5#1)(2008-8#1)
times from##11##2##(2007-12#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2009-9#1)(2011-2#1)(2013-1#1)
times given##2##2##(2005-5#1)(2012-2#1)
times greater at##2##3##(1992-8#1)(2008-10#1)
times greater for##5##3##(2007-11#1)(2008-10#1)(2008-2#1)(2009-5#1)(2013-8#1)
times greater in##2##3##(2008-10#2)
times greater prevalence##2##3##(2008-1#1)(2010-8#1)
times greater than that of the##6##6##(1991-4#1)(1997-1#1)(2008-10#1)(2008-3#2)(2010-2#1)
times greater than that of##9##5##(1991-1#1)(1991-4#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-3#2)(2010-2#1)
times greater than that##12##4##(1991-1#1)(1991-4#1)(1997-1#1)(1997-2#1)(1997-8#1)(2004-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2009-6#1)(2010-2#1)
times greater than the##7##4##(1991-2#1)(1995-10#1)(1995-2#1)(1996-2#1)(2008-10#1)(2008-2#1)(2011-1#1)
times greater than those of the##2##6##(2008-5#2)
times greater than those of##4##5##(2007-12#1)(2008-5#3)
times greater than those##5##4##(1993-1#1)(2007-12#1)(2008-5#3)
times greater than##39##3##(1990-7#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-4#1)(1992-3#1)(1993-1#1)(1994-12#1)(1995-10#1)(1995-2#1)(1996-2#1)(1997-1#2)(1997-2#1)(1997-8#1)(2004-11#1)(2004-4#1)(2007-12#3)(2008-10#5)(2008-2#3)(2008-3#4)(2008-5#3)(2009-6#1)(2010-2#1)(2011-1#2)
times greater##63##2##(1990-7#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-4#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-3#1)(1994-12#1)(1995-10#1)(1995-2#1)(1996-2#1)(1996-4#1)(1997-1#2)(1997-2#1)(1997-8#1)(2004-11#1)(2004-4#2)(2007-10#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#4)(2008-3#4)(2008-5#3)(2009-5#1)(2009-6#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-3#2)(2013-8#1)
times have##5##2##(1992-9#1)(1997-7#1)(2006-6#1)(2008-10#1)(2008-5#1)
times higher among##4##3##(1995-12#2)(2012-3#1)(2013-1#1)
times higher compared with##2##4##(2008-8#1)(2011-2#1)
times higher compared##3##3##(2008-8#1)(2009-6#1)(2011-2#1)
times higher death rate from##2##5##(1993-1#2)
times higher death rate##3##4##(1993-1#3)
times higher for##8##3##(1990-5#1)(1992-4#1)(1993-7#2)(2006-10#1)(2008-10#1)(2008-2#1)(2013-7#1)
times higher in##16##3##(1990-11#1)(1990-3#1)(1993-2#1)(1994-2#1)(1994-5#1)(1995-8#1)(1996-1#1)(1996-5#1)(2007-1#1)(2008-10#1)(2008-3#1)(2008-6#2)(2010-2#1)(2013-1#1)(2013-8#1)
times higher than expected##2##4##(1990-12#1)(2008-12#1)
times higher than for##2##4##(1991-2#1)(1992-5#1)
times higher than has been reported##2##6##(1992-2#1)(2010-2#1)
times higher than in##10##4##(1991-5#1)(1992-5#1)(1992-8#1)(1993-9#1)(2006-10#1)(2007-11#1)(2007-7#1)(2009-5#1)(2012-1#1)(2012-3#1)
times higher than that for##2##5##(2008-2#1)(2008-3#1)
times higher than that in the##4##6##(1990-10#1)(1996-10#1)(2007-12#1)(2009-2#1)
times higher than that in##5##5##(1990-10#1)(1996-10#1)(2007-12#1)(2009-2#1)(2010-2#1)
times higher than that of the conventional##2##7##(2008-5#1)(2013-8#1)
times higher than that of the culture under 5% CO(2) supply##2##11##(2008-11#2)
times higher than that of the##9##6##(2007-11#1)(2008-11#2)(2008-5#3)(2008-6#1)(2011-3#1)(2013-8#1)
times higher than that of##22##5##(1991-2#1)(1991-7#1)(1992-1#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#1)(2010-9#1)(2011-3#1)(2013-8#1)
times higher than that##34##4##(1990-10#1)(1991-2#1)(1991-7#1)(1992-1#1)(1995-12#1)(1996-10#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#1)(2009-2#1)(2010-2#1)(2010-9#1)(2011-3#1)(2013-8#1)
times higher than the control##2##5##(1992-2#1)(2013-8#1)
times higher than the rates##3##5##(1992-5#1)(1996-4#1)(2005-8#1)
times higher than the##23##4##(1990-10#1)(1991-9#1)(1992-2#1)(1992-5#1)(1994-6#1)(1996-4#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-5#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#3)(2012-3#1)(2013-8#1)
times higher than those from##2##5##(2008-11#2)
times higher than those in##2##5##(1995-8#1)(2008-11#1)
times higher than those of the##2##6##(1993-8#1)(1994-11#1)
times higher than those of##5##5##(1993-3#1)(1993-8#1)(1994-11#1)(1997-8#1)(2004-4#1)
times higher than those##11##4##(1993-3#1)(1993-7#1)(1993-8#1)(1994-11#1)(1995-8#1)(1997-8#1)(2004-4#1)(2008-11#3)(2009-2#1)
times higher than##100##3##(1990-10#2)(1990-12#2)(1991-2#2)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-2#2)(1992-5#3)(1992-6#1)(1992-8#1)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-4#1)(1995-8#1)(1996-10#1)(1996-4#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#2)(2009-5#1)(2010-12#1)(2010-2#3)(2010-9#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-3#2)(2013-8#3)
times higher with an African##2##5##(1993-6#2)
times higher with##4##3##(1993-6#2)(2008-10#1)(2008-6#1)
times higher##173##2##(1990-10#3)(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-2#2)(1992-4#1)(1992-5#3)(1992-6#1)(1992-8#1)(1993-1#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-7#3)(1993-8#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#2)(1995-11#1)(1995-12#4)(1995-4#2)(1995-8#3)(1996-1#1)(1996-10#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-5#1)(2007-1#2)(2007-11#2)(2007-12#6)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#7)(2008-12#2)(2008-2#6)(2008-3#6)(2008-4#1)(2008-5#9)(2008-6#5)(2008-7#3)(2008-8#3)(2008-9#1)(2009-2#2)(2009-5#2)(2009-6#1)(2010-12#1)(2010-2#4)(2010-4#1)(2010-9#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#5)
times improvement##2##2##(2008-10#1)(2008-2#1)
times in a single##2##4##(1992-9#1)(2010-3#1)
times in a##6##3##(1992-9#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-9#1)(2010-3#1)
times in acute##2##3##(2008-3#1)(2011-1#1)
times in each##2##3##(1994-2#1)(2008-10#1)
times in our##2##3##(2007-2#1)(2011-2#1)
times in patients##2##3##(2008-3#1)(2008-8#1)
times in the past##2##4##(1992-12#1)(2008-12#1)
times in the range##2##4##(1994-11#1)(2008-3#1)
times in the##25##3##(1991-3#1)(1992-12#1)(1993-10#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-3#1)(1995-8#1)(1997-4#1)(2006-2#1)(2007-12#1)(2007-3#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-3#1)(2010-1#1)(2010-4#1)(2010-5#1)(2012-1#2)(2012-3#1)(2013-7#1)(2013-8#1)
times in total)##2##3##(1997-8#1)(2008-10#1)
times in##78##2##(1990-11#1)(1990-5#1)(1991-3#1)(1992-12#1)(1992-9#1)(1993-10#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-3#1)(1995-8#2)(1996-5#1)(1997-2#1)(1997-4#2)(1997-8#1)(2004-1#1)(2005-11#1)(2006-2#1)(2006-9#2)(2007-11#3)(2007-12#3)(2007-2#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-3#1)(2010-1#1)(2010-12#4)(2010-3#1)(2010-4#2)(2010-5#1)(2011-1#4)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
times increase in the##2##4##(2008-3#1)(2008-8#1)
times increase in##3##3##(2008-11#1)(2008-3#1)(2008-8#1)
times increase##5##2##(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)
times increased level of##2##4##(1992-6#2)
times indicate##2##2##(1997-7#1)(2008-5#1)
times intoxicated were##3##3##(2005-10#3)
times intoxicated##5##2##(2005-10#5)
times is##3##2##(1997-7#1)(2007-11#1)(2007-12#1)
times its##3##2##(1996-5#1)(2011-12#1)(2012-1#1)
times larger than that of##6##5##(1994-8#1)(1996-7#1)(2007-12#2)(2008-10#1)(2008-2#1)
times larger than that##9##4##(1994-8#1)(1996-7#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#1)
times larger than the##7##4##(1995-5#1)(1997-6#1)(2006-12#1)(2007-12#1)(2008-2#1)(2008-3#2)
times larger than those##3##4##(2007-12#1)(2008-10#1)(2008-8#1)
times larger than##22##3##(1994-8#1)(1995-5#1)(1996-7#1)(1997-6#1)(2006-11#1)(2006-12#1)(2007-12#6)(2008-10#3)(2008-2#2)(2008-3#3)(2008-8#1)(2009-5#1)
times larger##28##2##(1993-10#2)(1994-8#1)(1995-5#1)(1996-7#1)(1997-6#1)(2006-11#1)(2006-12#1)(2007-12#8)(2008-10#4)(2008-2#3)(2008-3#3)(2008-8#1)(2009-5#1)
times lead to##3##3##(2010-7#1)(2010-8#1)(2013-8#1)
times less in##2##3##(1995-12#1)(2009-2#1)
times less potent in##2##4##(1995-12#1)(1995-6#1)
times less potent than the##2##5##(1992-2#1)(1994-9#1)
times less potent than##4##4##(1991-3#1)(1992-2#1)(1994-9#2)
times less potent##6##3##(1991-3#1)(1992-2#1)(1994-9#2)(1995-12#1)(1995-6#1)
times less than##5##3##(1995-12#1)(1996-2#1)(2007-12#1)(2008-4#1)(2009-6#1)
times less##27##2##(1990-5#1)(1990-8#1)(1991-3#1)(1992-2#1)(1994-9#2)(1995-12#3)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-4#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-4#1)(2009-2#2)(2009-6#1)(2011-2#1)
times longer than##5##3##(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-8#1)
times longer##10##2##(1993-1#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2010-8#1)
times lower in##2##3##(1993-12#1)(2008-7#1)
times lower than in##2##4##(1990-10#1)(2008-7#1)
times lower than that found in##3##6##(1990-9#1)(1991-10#1)(1991-2#1)
times lower than that found##4##5##(1990-9#1)(1991-10#1)(1991-2#1)(1995-1#1)
times lower than that in##2##5##(1995-8#1)(2008-10#1)
times lower than that of the##2##6##(1995-2#1)(2008-10#1)
times lower than that of##4##5##(1992-8#1)(1992-9#1)(1995-2#1)(2008-10#1)
times lower than that##12##4##(1990-9#1)(1991-10#1)(1991-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1995-1#1)(1995-2#1)(1995-8#1)(2008-10#2)(2011-2#1)
times lower than the##7##4##(1990-11#1)(1990-8#1)(1992-7#1)(2007-11#1)(2008-10#2)(2008-5#1)
times lower than those obtained##2##5##(1990-10#1)(2008-11#1)
times lower than those of##5##5##(1990-6#1)(1991-3#1)(2008-10#1)(2008-11#1)(2010-4#1)
times lower than those##8##4##(1990-10#1)(1990-6#1)(1991-3#1)(2008-10#2)(2008-11#2)(2010-4#1)
times lower than##32##3##(1990-10#2)(1990-11#1)(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1995-1#1)(1995-2#1)(1995-8#1)(2007-11#1)(2008-10#7)(2008-11#3)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#1)
times lower##42##2##(1990-1#1)(1990-10#2)(1990-11#2)(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-3#1)(1992-7#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-4#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-8#1)(2007-11#1)(2008-10#8)(2008-11#3)(2008-5#1)(2008-7#2)(2009-2#1)(2010-4#1)(2011-2#1)
times measured##2##2##(2007-1#1)(2008-1#1)
times measurements)##2##2##(2008-10#2)
times meter##2##2##(2008-2#1)(2008-3#1)
times more PKC##2##3##(1994-5#2)
times more active##2##3##(1990-4#1)(1992-9#1)
times more common in##4##4##(1990-2#1)(1992-2#1)(2005-7#1)(2007-9#1)
times more common##6##3##(1990-2#1)(1992-2#1)(2005-7#1)(2007-9#1)(2008-1#1)(2009-4#1)
times more dead##2##3##(2008-10#2)
times more effective than##3##4##(1990-10#1)(1992-3#2)
times more effective##4##3##(1990-10#1)(1992-3#2)(1997-7#1)
times more efficient than##2##4##(1990-5#1)(2008-8#1)
times more frequent in##2##4##(1993-12#1)(2011-12#1)
times more frequent##6##3##(1990-4#1)(1990-8#1)(1992-12#1)(1993-12#1)(1997-3#1)(2011-12#1)
times more frequently than##2##4##(2008-5#1)(2009-2#1)
times more in##2##3##(1992-7#1)(2008-10#1)
times more likely than##4##4##(1992-5#1)(2007-9#1)(2010-12#1)(2012-3#1)
times more likely to be##2##5##(2008-11#1)(2008-8#1)
times more likely to have##6##5##(1991-12#1)(1995-1#1)(2007-6#1)(2007-7#1)(2008-9#1)(2011-2#1)
times more likely to intend to resume tobacco##2##8##(2007-12#2)
times more likely to report having four or more risk factors##2##11##(2009-5#2)
times more likely to report##4##5##(2007-2#1)(2009-5#2)(2011-1#1)
times more likely to##25##4##(1991-12#1)(1994-7#1)(1995-1#2)(1996-5#1)(2007-1#1)(2007-12#2)(2007-2#2)(2007-6#1)(2007-7#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-5#2)(2011-1#1)(2011-2#5)(2012-12#1)(2013-8#1)
times more likely##29##3##(1991-12#1)(1992-5#1)(1994-7#1)(1995-1#2)(1996-5#1)(2007-1#1)(2007-12#2)(2007-2#2)(2007-6#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-5#2)(2010-12#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-8#1)
times more often than##4##4##(1994-12#1)(1996-3#1)(2008-3#1)(2010-2#1)
times more potent for the##2##5##(1991-2#2)
times more potent than that##2##5##(1993-11#1)(1995-11#1)
times more potent than the##2##5##(1992-4#1)(1994-5#1)
times more potent than##8##4##(1991-2#1)(1992-12#1)(1992-4#1)(1993-11#1)(1994-5#1)(1995-11#1)(1995-6#1)(2007-11#1)
times more potent##14##3##(1991-2#3)(1992-12#1)(1992-4#1)(1993-11#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#1)(2007-11#1)(2008-7#1)
times more sensitive than conventional##2##5##(1992-8#1)(2008-4#1)
times more sensitive than the##4##5##(1993-12#1)(2008-10#3)
times more sensitive than##10##4##(1990-12#1)(1992-8#2)(1993-12#1)(2008-10#5)(2008-4#1)
times more sensitive##12##3##(1990-12#1)(1991-9#1)(1992-8#2)(1993-12#1)(2007-8#1)(2008-10#5)(2008-4#1)
times more than the##2##4##(2008-8#1)(2013-1#1)
times more than##6##3##(1991-2#1)(1992-6#1)(2008-7#1)(2008-8#1)(2013-1#2)
times more##133##2##(1990-10#2)(1990-12#1)(1990-2#1)(1990-4#2)(1990-5#1)(1990-8#2)(1991-12#2)(1991-2#4)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-12#2)(1994-5#3)(1994-6#1)(1994-7#1)(1994-9#2)(1995-1#4)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#3)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#4)(2005-11#1)(2005-7#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#10)(2008-11#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-2#2)(2009-4#1)(2009-5#2)(2009-6#1)(2010-12#1)(2010-2#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
times nominal##3##2##(2007-12#3)
times normal##4##2##(1995-2#1)(1997-4#1)(2007-9#1)(2008-1#1)
times of 1##3##3##(1992-7#1)(2004-9#1)(2008-10#1)
times of 2##4##3##(1992-2#1)(1992-8#1)(2008-10#1)(2008-3#1)
times of 30 and##3##4##(2008-10#3)
times of 30##4##3##(1996-5#1)(2008-10#3)
times of 4##2##3##(2008-10#1)(2008-2#1)
times of acute academic##2##4##(2012-1#2)
times of ambulances to##3##4##(2010-3#3)
times of ambulances##4##3##(2010-3#4)
times of crisis##3##3##(2007-2#1)(2008-12#1)(2011-2#1)
times of exposure##3##3##(1990-5#1)(2005-12#1)(2008-6#1)
times of first##2##3##(1995-8#2)
times of flight##4##3##(2008-2#3)(2008-3#1)
times of incubation##2##3##(1991-7#1)(1993-4#1)
times of observation##2##3##(1996-3#1)(2008-2#1)
times of tarabine PFS and adriblastina were##2##7##(2008-10#2)
times of that of##2##4##(2008-3#1)(2008-9#1)
times of that##5##3##(2008-11#2)(2008-3#1)(2008-8#1)(2008-9#1)
times of the year##3##4##(1991-12#1)(2008-5#1)(2011-2#1)
times of the##30##3##(1991-12#1)(1991-5#1)(1991-7#1)(1994-3#2)(1995-7#1)(1996-5#1)(1997-8#1)(2004-11#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#2)
times of##163##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-7#2)(1991-9#1)(1992-2#1)(1992-6#1)(1992-7#3)(1992-8#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#2)(1994-12#1)(1994-3#3)(1995-12#1)(1995-7#1)(1995-8#4)(1996-12#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#1)(2004-11#2)(2004-9#2)(2005-11#1)(2005-12#1)(2005-6#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#4)(2007-12#2)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#24)(2008-11#8)(2008-12#3)(2008-2#9)(2008-3#3)(2008-5#4)(2008-6#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#2)(2010-1#2)(2010-2#2)(2010-3#6)(2010-8#3)(2011-1#3)(2011-2#5)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-7#1)(2013-1#3)(2013-8#4)
times on test items##2##4##(2009-12#2)
times on##9##2##(1992-6#1)(2005-10#1)(2006-2#1)(2008-10#2)(2008-2#1)(2009-12#2)(2010-4#1)
times or more##4##3##(2006-5#2)(2008-10#1)(2011-2#1)
times or##6##2##(1991-8#1)(2006-5#2)(2006-7#1)(2008-10#1)(2011-2#1)
times over the##4##3##(1997-6#1)(2008-10#2)(2009-12#1)
times over##7##2##(1997-6#1)(2007-7#2)(2008-10#2)(2008-12#1)(2009-12#1)
times owing to##2##3##(2005-8#1)(2008-10#1)
times per day for##2##4##(1992-3#1)(2008-5#1)
times per day##11##3##(1991-3#1)(1992-3#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-11#1)(2010-6#2)(2011-11#1)(2013-1#1)
times per week for 2 h per day##2##8##(2008-10#2)
times per week for##11##4##(1990-4#2)(1994-6#1)(1996-9#1)(2005-1#1)(2007-7#1)(2008-10#2)(2012-1#1)(2013-1#1)(2013-8#1)
times per week##29##3##(1990-4#2)(1994-6#1)(1996-9#1)(2005-1#2)(2006-10#1)(2006-3#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-7#4)(2008-1#1)(2008-10#2)(2009-12#1)(2010-10#1)(2011-1#1)(2011-11#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#2)(2013-8#1)
times per year had a relative risk of##2##8##(1993-9#2)
times per year##6##3##(1993-9#2)(2005-8#1)(2005-9#1)(2006-6#1)(2011-2#1)
times per##52##2##(1990-4#2)(1991-3#1)(1992-3#1)(1993-9#2)(1994-6#1)(1996-9#1)(2005-1#2)(2005-8#1)(2005-9#1)(2006-10#1)(2006-3#1)(2006-6#2)(2007-11#1)(2007-2#1)(2007-7#4)(2007-8#3)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-7#2)(2009-11#1)(2009-12#1)(2010-10#1)(2010-6#2)(2011-1#1)(2011-11#2)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#4)(2013-7#2)(2013-8#1)
times quicker than##2##3##(2008-3#1)(2009-2#1)
times quicker##3##2##(2008-3#1)(2009-2#2)
times range##2##2##(2008-10#1)(2008-6#1)
times ranging from 1 to##2##5##(1994-12#1)(2008-10#1)
times ranging from##4##3##(1992-12#1)(1994-12#1)(2007-12#1)(2008-10#1)
times ranging##5##2##(1992-12#1)(1994-12#1)(2007-12#1)(2008-10#2)
times relative to##2##3##(2008-10#1)(2012-12#1)
times reported by Mills##2##4##(2008-10#2)
times reported##3##2##(2008-10#3)
times required for infection##2##4##(2008-10#2)
times required for##3##3##(2008-10#2)(2008-3#1)
times required to##2##3##(2008-10#1)(2011-2#1)
times required##5##2##(2008-10#3)(2008-3#1)(2011-2#1)
times resulted in##2##3##(1992-8#1)(2008-10#1)
times risk (AOR##3##3##(2009-10#3)
times shorter than those##2##4##(2007-12#1)(2008-10#1)
times since##2##2##(2008-9#1)(2011-12#1)
times slower than that of##2##5##(1996-6#1)(2007-11#1)
times slower than the##3##4##(1992-6#1)(1994-12#1)(2008-10#1)
times slower than##5##3##(1992-6#1)(1994-12#1)(1996-6#1)(2007-11#1)(2008-10#1)
times slower##6##2##(1992-6#1)(1994-12#1)(1995-8#1)(1996-6#1)(2007-11#1)(2008-10#1)
times smaller than that for##2##5##(2008-3#1)(2012-2#1)
times smaller than that of##2##5##(2008-10#1)(2008-2#1)
times smaller than that##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
times smaller than the##3##4##(2008-1#1)(2008-7#1)(2009-5#1)
times smaller than##8##3##(1994-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-5#1)(2012-2#1)
times smaller##10##2##(1990-3#1)(1994-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-5#1)(2012-2#1)
times stronger than that of##2##5##(1996-2#1)(2008-8#1)
times stronger than the##3##4##(1990-4#1)(2008-2#1)(2012-2#1)
times stronger than##7##3##(1990-4#1)(1996-2#1)(2008-11#2)(2008-2#1)(2008-8#1)(2012-2#1)
times stronger##8##2##(1990-4#1)(1996-2#1)(2008-11#2)(2008-2#1)(2008-8#1)(2009-7#1)(2012-2#1)
times taken to##2##3##(2008-5#1)(2011-2#1)
times taken##3##2##(2008-5#1)(2009-2#1)(2011-2#1)
times than other##2##3##(2007-12#1)(2012-3#1)
times than##11##2##(1995-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-6#1)(2010-8#1)(2012-3#3)(2013-1#1)
times that are##2##3##(1991-12#1)(1997-7#1)
times that in the medium containing only FCS##2##8##(2008-11#2)
times that in the##3##4##(2008-11#3)
times that in##5##3##(1995-1#1)(1996-3#1)(2008-11#3)
times that of a##3##4##(2008-2#1)(2008-3#2)
times that of chromium(VI)##2##4##(2008-10#2)
times that of control##2##4##(1990-4#1)(1993-3#1)
times that of the##10##4##(1991-9#1)(1992-3#1)(1994-5#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2012-3#1)
times that of##29##3##(1990-4#1)(1991-9#2)(1992-3#2)(1993-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2012-3#1)
times that##49##2##(1990-4#1)(1990-5#1)(1991-12#1)(1991-8#1)(1991-9#2)(1992-3#3)(1993-3#1)(1994-11#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#1)(1996-3#2)(1997-7#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-2#3)(2008-3#4)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-11#1)(2012-3#1)
times the average##3##3##(1993-4#2)(2008-10#1)
times the basal##2##3##(1997-4#1)(2007-9#1)
times the concentration##2##3##(1993-5#1)(1997-5#1)
times the control##5##3##(1993-2#1)(2008-10#1)(2010-3#2)(2012-2#1)
times the diffraction##2##3##(2007-12#1)(2008-2#1)
times the free-space Planck density##2##5##(2007-12#2)
times the level of##2##4##(1996-2#1)(2009-4#1)
times the level##3##3##(1992-3#1)(1996-2#1)(2009-4#1)
times the maximum##2##3##(2008-2#2)
times the mean##2##3##(2005-7#1)(2008-3#1)
times the normal value##2##4##(1992-9#1)(2008-6#1)
times the normal##5##3##(1990-11#1)(1991-9#1)(1992-9#1)(2007-12#1)(2008-6#1)
times the preadministration value along with a##2##7##(1996-10#2)
times the root-mean-square##2##3##(2008-10#1)(2008-8#1)
times the standard deviation of the reagent blank) is##2##9##(2008-10#2)
times the standard deviation of the##12##6##(2008-10#12)
times the standard deviation of##15##5##(2008-10#15)
times the standard deviation##16##4##(2008-10#16)
times the total##2##3##(2007-12#1)(2013-1#1)
times the upper limit of normal##2##6##(1991-7#1)(1995-4#1)
times the upper limit of##3##5##(1991-7#2)(1995-4#1)
times the##118##2##(1990-11#1)(1990-6#1)(1990-9#1)(1991-10#2)(1991-5#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-4#2)(1993-5#1)(1993-6#1)(1993-7#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-4#1)(1996-10#2)(1996-2#1)(1997-4#1)(1997-5#1)(2005-11#2)(2005-7#1)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#10)(2007-6#1)(2007-9#1)(2008-1#2)(2008-10#25)(2008-11#1)(2008-2#12)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-3#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
times they##6##2##(1996-2#1)(1997-1#1)(1997-7#1)(2011-2#1)(2012-12#2)
times those##4##2##(1990-5#1)(2008-6#1)(2008-8#1)(2013-1#1)
times threshold##2##2##(2008-3#2)
times through##2##2##(2008-10#2)
times throughout the##5##3##(1992-1#1)(2005-11#1)(2008-5#1)(2010-3#1)(2012-3#1)
times to reach##2##3##(1990-12#1)(2012-12#1)
times to that##2##3##(2007-11#1)(2008-10#1)
times to the##2##3##(1996-4#1)(2007-12#1)
times to##36##2##(1990-12#3)(1990-5#1)(1991-3#1)(1992-2#1)(1994-5#1)(1994-8#1)(1996-4#1)(1996-7#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#2)(2010-3#2)(2012-1#2)(2012-12#2)(2013-8#1)
times under##6##2##(1996-1#1)(1996-6#1)(2008-8#1)(2010-6#1)(2011-12#1)(2011-2#1)
times until##3##2##(1990-11#1)(2006-6#1)(2010-7#1)
times using a##2##3##(1997-6#1)(2007-12#1)
times using##6##2##(1992-2#1)(1995-10#1)(1995-4#1)(1997-6#1)(2007-12#1)(2008-2#1)
times usual##2##2##(2012-2#2)
times was##8##2##(2005-12#2)(2006-5#1)(2007-12#1)(2008-10#2)(2009-3#1)(2010-3#1)
times weekly for##5##3##(2007-11#3)(2008-2#1)(2011-2#1)
times weekly##13##2##(2006-10#1)(2007-11#7)(2007-7#1)(2008-2#1)(2008-7#1)(2010-8#1)(2011-2#1)
times were 2##3##3##(2005-11#1)(2008-5#2)
times were determined##2##3##(2008-2#1)(2010-2#1)
times were established##2##3##(2008-10#1)(2012-12#1)
times were required##2##3##(1990-11#1)(2013-1#1)
times were##45##2##(1990-11#1)(1991-12#1)(1991-4#1)(1991-5#1)(1993-6#1)(1995-10#1)(1995-8#1)(1995-9#1)(1997-2#1)(2004-9#1)(2005-11#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-8#2)(2008-10#10)(2008-11#2)(2008-2#2)(2008-5#4)(2008-7#1)(2010-2#2)(2010-3#1)(2010-8#1)(2012-12#2)(2013-1#1)
times when##14##2##(1991-11#1)(1995-12#1)(1995-7#1)(1996-9#1)(2004-12#1)(2006-5#1)(2007-8#2)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)(2010-2#1)
times where##2##2##(2009-6#1)(2011-1#1)
times which are##2##3##(1994-3#1)(2010-3#1)
times which##5##2##(1994-3#1)(1995-3#1)(2005-11#1)(2010-3#1)(2012-3#1)
times while##4##2##(2008-1#1)(2010-2#2)(2011-2#1)
times with a##3##3##(1990-3#1)(2008-10#1)(2008-3#1)
times with different##2##3##(1993-8#1)(2008-3#1)
times with the##6##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-3#1)(2013-1#1)
times with##28##2##(1990-12#1)(1990-3#1)(1992-3#1)(1993-6#1)(1993-8#1)(1995-8#2)(1996-6#1)(2007-11#2)(2007-12#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-7#1)(2009-3#1)(2010-2#1)(2013-1#1)
times within a##5##3##(1997-8#1)(2007-10#1)(2012-12#2)(2013-8#1)
times within##12##2##(1990-7#1)(1997-8#1)(2007-10#1)(2008-11#1)(2008-2#1)(2010-12#1)(2010-3#1)(2010-5#1)(2012-12#2)(2012-2#1)(2013-8#1)
times without##5##2##(2006-12#1)(2007-8#1)(2008-10#2)(2010-7#1)
times##2479##1##(1990-1#1)(1990-10#13)(1990-11#16)(1990-12#14)(1990-2#7)(1990-3#10)(1990-4#7)(1990-5#10)(1990-6#8)(1990-7#4)(1990-8#8)(1990-9#7)(1991-1#2)(1991-10#3)(1991-11#3)(1991-12#7)(1991-2#15)(1991-3#9)(1991-4#7)(1991-5#7)(1991-6#5)(1991-7#9)(1991-8#6)(1991-9#7)(1992-1#6)(1992-10#1)(1992-11#3)(1992-12#11)(1992-2#13)(1992-3#13)(1992-4#2)(1992-5#6)(1992-6#16)(1992-7#9)(1992-8#9)(1992-9#18)(1993-1#8)(1993-10#7)(1993-11#3)(1993-12#10)(1993-2#10)(1993-3#7)(1993-4#5)(1993-5#2)(1993-6#12)(1993-7#6)(1993-8#4)(1993-9#9)(1994-1#2)(1994-11#5)(1994-12#13)(1994-2#7)(1994-3#14)(1994-4#6)(1994-5#10)(1994-6#10)(1994-7#3)(1994-8#8)(1994-9#11)(1995-1#11)(1995-10#4)(1995-11#11)(1995-12#14)(1995-2#7)(1995-3#12)(1995-4#9)(1995-5#3)(1995-6#6)(1995-7#2)(1995-8#21)(1995-9#3)(1996-1#4)(1996-10#5)(1996-11#3)(1996-12#8)(1996-2#12)(1996-3#7)(1996-4#4)(1996-5#9)(1996-6#13)(1996-7#5)(1996-8#4)(1996-9#6)(1997-1#9)(1997-2#13)(1997-3#9)(1997-4#17)(1997-5#8)(1997-6#8)(1997-7#15)(1997-8#9)(2003-11#1)(2004-1#2)(2004-11#7)(2004-12#1)(2004-2#1)(2004-4#3)(2004-5#1)(2004-9#7)(2005-1#2)(2005-10#9)(2005-11#18)(2005-12#5)(2005-5#1)(2005-6#1)(2005-7#2)(2005-8#7)(2005-9#2)(2006-10#19)(2006-11#2)(2006-12#17)(2006-2#8)(2006-3#2)(2006-4#6)(2006-5#8)(2006-6#10)(2006-7#5)(2006-8#15)(2006-9#4)(2007-1#10)(2007-10#9)(2007-11#60)(2007-12#81)(2007-2#13)(2007-3#7)(2007-4#3)(2007-5#3)(2007-6#2)(2007-7#20)(2007-8#36)(2007-9#9)(2008-1#23)(2008-10#332)(2008-11#73)(2008-12#23)(2008-2#76)(2008-3#87)(2008-4#14)(2008-5#61)(2008-6#21)(2008-7#35)(2008-8#34)(2008-9#27)(2009-1#1)(2009-10#4)(2009-11#2)(2009-12#6)(2009-2#15)(2009-3#13)(2009-4#8)(2009-5#9)(2009-6#10)(2009-7#3)(2009-8#8)(2009-9#7)(2010-1#3)(2010-10#2)(2010-11#4)(2010-12#18)(2010-2#20)(2010-3#23)(2010-4#14)(2010-5#8)(2010-6#10)(2010-7#10)(2010-8#19)(2010-9#4)(2011-1#34)(2011-11#2)(2011-12#7)(2011-2#45)(2011-3#5)(2012-1#20)(2012-11#2)(2012-12#30)(2012-2#31)(2012-3#25)(2012-7#2)(2013-1#52)(2013-7#7)(2013-8#36)
times) and##2##2##(1990-10#1)(2009-2#1)
times) than##2##2##(1997-8#1)(2008-9#1)
times)##20##1##(1990-10#1)(1992-7#1)(1993-3#1)(1995-10#1)(1997-8#1)(2008-10#4)(2008-4#2)(2008-5#1)(2008-9#2)(2009-2#4)(2010-6#1)(2010-7#1)
times/day##2##1##(1993-3#1)(2006-12#1)
times/week##4##1##(1997-8#1)(2007-7#2)(2009-3#1)
times/week)##2##1##(2011-2#1)(2012-1#1)
times?##3##1##(1992-1#1)(2007-11#1)(2011-2#1)
times]##3##1##(1992-3#1)(1993-3#1)(2010-9#1)
timesaving##2##1##(2006-4#1)(2010-4#1)
timescale of##6##2##(1990-8#1)(1996-3#1)(2006-10#1)(2006-3#1)(2010-12#1)(2012-2#1)
timescale##25##1##(1990-8#1)(1991-4#1)(1992-7#1)(1995-11#1)(1995-3#1)(1996-3#1)(2006-10#5)(2006-3#1)(2006-4#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-7#1)(2012-2#3)(2013-1#2)
timescales of##3##2##(1997-5#1)(2006-12#1)(2008-8#1)
timescales##15##1##(1997-5#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-7#1)(2008-8#3)(2008-9#5)(2013-1#2)
timespan of##2##2##(1991-12#1)(2008-5#1)
timespan##3##1##(1991-12#1)(2008-5#1)(2010-3#1)
timetable##3##1##(2007-7#1)(2011-2#1)(2012-3#1)
timetables##5##1##(1991-11#1)(2008-11#3)(2011-2#1)
timing and initial dosage##2##4##(2008-7#2)
timing and intensity of##2##4##(2008-12#1)(2009-9#1)
timing and the##2##3##(2008-3#1)(2013-8#1)
timing and type of##3##4##(2007-7#1)(2009-11#1)(2009-12#1)
timing and##49##2##(1992-3#1)(1993-2#1)(1994-5#1)(1995-8#1)(1997-4#1)(1997-8#1)(2006-10#3)(2006-2#1)(2006-5#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#3)(2008-5#1)(2008-7#6)(2008-8#2)(2009-10#4)(2009-11#1)(2009-12#1)(2009-7#1)(2009-9#2)(2010-8#2)(2011-12#1)(2012-2#2)(2013-8#1)
timing are##2##2##(1996-3#1)(2009-7#1)
timing error##3##2##(2007-12#3)
timing errors for##2##3##(2010-10#2)
timing errors##3##2##(2009-3#1)(2010-10#2)
timing for implantation##2##3##(2007-8#1)(2010-12#1)
timing for##12##2##(1993-6#1)(2006-4#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-12#1)(2013-1#1)
timing in the##2##3##(2006-4#1)(2010-4#1)
timing in##3##2##(2006-4#1)(2009-11#1)(2010-4#1)
timing information can be##2##4##(2008-1#2)
timing information##5##2##(2008-1#5)
timing is##2##2##(2006-6#1)(2008-7#1)
timing jitter between two independent##2##5##(2007-11#2)
timing jitter between##3##3##(2007-11#2)(2007-12#1)
timing jitter for##2##3##(2007-11#1)(2007-12#1)
timing jitter in a##2##4##(2007-11#1)(2007-12#1)
timing jitter in dispersion-managed##2##4##(2007-12#2)
timing jitter in##6##3##(2007-11#2)(2007-12#4)
timing jitter is##7##3##(2007-11#3)(2007-12#2)(2008-1#1)(2008-3#1)
timing jitter of##7##3##(2007-11#3)(2007-12#2)(2008-1#1)(2008-3#1)
timing jitter that##2##3##(2007-12#1)(2008-1#1)
timing jitter##42##2##(2007-11#15)(2007-12#20)(2008-1#3)(2008-3#4)
timing jitters##2##2##(2007-12#1)(2008-3#1)
timing of diagnosis and##2##4##(1991-11#1)(2010-12#1)
timing of drug##2##3##(1996-4#1)(2007-9#1)
timing of egg##2##3##(2012-12#2)
timing of liver transplantation##2##4##(2006-2#1)(2007-11#1)
timing of secondary-response gene expression##2##5##(1997-4#2)
timing of such an##2##4##(1997-5#1)(2008-11#1)
timing of surgery##5##3##(2007-12#1)(2009-10#1)(2009-5#1)(2010-8#1)(2013-1#1)
timing of the##29##3##(1992-3#1)(1993-12#1)(1994-10#1)(1994-8#1)(1995-12#1)(1995-3#1)(1997-2#1)(1997-6#2)(2005-8#1)(2006-12#2)(2006-9#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-2#1)(2010-8#1)(2011-2#1)
timing of their##5##3##(1994-4#1)(1994-7#1)(1995-5#1)(1995-9#1)(2009-3#1)
timing of those##2##3##(1993-12#1)(2010-3#1)
timing of##193##2##(1990-12#1)(1991-10#1)(1991-11#2)(1991-3#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1994-10#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-6#1)(1994-7#1)(1994-8#2)(1995-11#2)(1995-12#2)(1995-3#1)(1995-5#2)(1995-9#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-2#3)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#1)(2004-1#1)(2005-11#1)(2005-8#2)(2006-10#7)(2006-12#3)(2006-2#1)(2006-6#2)(2006-9#2)(2007-11#2)(2007-12#6)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#3)(2008-10#21)(2008-11#10)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#3)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#3)(2009-6#1)(2009-9#1)(2010-10#3)(2010-12#3)(2010-2#3)(2010-3#1)(2010-6#3)(2010-7#1)(2010-8#4)(2011-1#2)(2011-2#2)(2012-12#8)(2012-2#2)(2012-3#3)(2012-6#1)(2013-1#8)(2013-8#4)
timing on##3##2##(2006-11#2)(2008-10#1)
timing resolution##3##2##(2008-10#2)(2008-2#1)
timing shift##5##2##(2007-11#2)(2007-12#3)
timing shifts in##2##3##(2007-11#1)(2007-12#1)
timing shifts##4##2##(2007-11#2)(2007-12#2)
timing system##2##2##(2006-1#1)(2008-10#1)
timing through##2##2##(2007-11#1)(2008-6#1)
timing to##4##2##(1995-11#1)(1997-3#1)(2009-5#1)(2011-2#1)
timing were##4##2##(1994-2#1)(1997-8#1)(2012-2#2)
timing##416##1##(1990-12#1)(1990-4#1)(1990-5#1)(1991-10#1)(1991-11#2)(1991-3#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#2)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#1)(1994-10#1)(1994-2#3)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#2)(1995-11#3)(1995-12#5)(1995-3#1)(1995-5#2)(1995-8#1)(1995-9#1)(1996-11#3)(1996-3#2)(1996-4#1)(1996-7#1)(1997-2#3)(1997-3#2)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2004-1#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#11)(2006-11#2)(2006-12#3)(2006-2#2)(2006-4#4)(2006-5#1)(2006-6#3)(2006-8#2)(2006-9#2)(2007-11#27)(2007-12#41)(2007-2#1)(2007-5#1)(2007-7#4)(2007-8#5)(2007-9#4)(2008-1#14)(2008-10#30)(2008-11#14)(2008-12#2)(2008-2#7)(2008-3#12)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#15)(2008-8#5)(2008-9#4)(2009-10#10)(2009-11#2)(2009-12#4)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#4)(2009-6#3)(2009-7#4)(2009-8#2)(2009-9#3)(2010-10#6)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#7)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#3)(2012-12#8)(2012-2#7)(2012-3#4)(2012-6#1)(2013-1#13)(2013-7#1)(2013-8#5)
timings##2##1##(2008-10#2)
timolol##16##1##(1990-11#2)(1990-9#1)(1997-5#2)(2008-3#2)(2009-8#8)(2011-2#1)
timopheevii subsp##7##2##(2008-10#7)
timothy grass pollen##2##3##(1994-2#1)(2012-2#1)
timothy grass profilin##2##3##(1994-2#2)
timothy grass##7##2##(1994-2#5)(2008-6#1)(2012-2#1)
tin (ll) etiopurpurin dichloride##2##4##(1992-1#2)
tin and nickel##3##3##(2008-10#3)
tin and organotin##2##3##(2005-4#2)
tin and titanium##2##3##(2008-10#2)
tin and##10##2##(2005-4#3)(2008-10#6)(2008-12#1)
tin compounds##2##2##(1993-4#1)(2008-10#1)
tin determination##2##2##(2008-10#2)
tin dioxide##2##2##(2006-12#1)(2008-10#1)
tin in marine materials##2##4##(2008-10#2)
tin in some##2##3##(2005-4#1)(2008-10#1)
tin in##14##2##(2005-4#2)(2007-8#1)(2008-10#11)
tin is##3##2##(2008-10#3)
tin oxide films##3##3##(2008-2#2)(2008-3#1)
tin oxide thin films##2##4##(2008-10#2)
tin oxide thin##3##3##(2008-10#3)
tin oxide with high##2##4##(2008-10#2)
tin oxide##32##2##(2007-12#2)(2007-8#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-7#1)
tin protoporphyrin##2##2##(1995-2#2)
tin slag samples##2##3##(2008-10#2)
tin##124##1##(1992-1#2)(1993-4#1)(1995-2#2)(1995-3#1)(1997-3#1)(2004-4#1)(2005-4#11)(2006-12#1)(2007-11#1)(2007-12#5)(2007-8#11)(2007-9#1)(2008-10#61)(2008-11#2)(2008-12#3)(2008-2#5)(2008-3#6)(2009-11#1)(2009-12#2)(2009-3#1)(2010-11#2)(2010-5#1)(2010-6#1)(2010-7#1)
tin(II) complexes##2##2##(2008-5#2)
tin(II)##9##1##(2005-4#1)(2008-10#6)(2008-5#2)
tin(II)-strong phosphoric##2##2##(2008-10#2)
tin(IV)##7##1##(1996-4#1)(2007-11#1)(2008-10#5)
tin-fluorophosphate##2##1##(2007-12#2)
tinca##2##1##(2008-5#2)
tinctorius L##2##2##(2008-12#1)(2012-12#1)
tinctorius##4##1##(2008-11#2)(2008-12#1)(2012-12#1)
tincture##2##1##(2008-10#1)(2012-12#1)
tinctures##5##1##(2007-8#3)(2008-10#2)
tinea capitis in##3##3##(2008-5#2)(2010-11#1)
tinea capitis##8##2##(2007-7#1)(2008-5#5)(2010-11#2)
tinea corporis gladiatorum##2##3##(2012-3#2)
tinea corporis##10##2##(2006-3#1)(2007-7#3)(2008-5#2)(2012-11#2)(2012-3#2)
tinea cruris and corporis##2##4##(2007-7#2)
tinea cruris and##3##3##(2007-7#3)
tinea cruris##5##2##(2007-7#4)(2008-5#1)
tinea faciei##2##2##(2007-7#1)(2008-5#1)
tinea pedis##2##2##(2006-12#1)(2007-7#1)
tinea unguium of the toenails##3##5##(2008-5#3)
tinea unguium##5##2##(2008-5#5)
tinea versicolor##6##2##(2007-7#2)(2007-8#2)(2011-2#2)
tinea##48##1##(2005-11#1)(2006-12#1)(2006-3#1)(2007-7#16)(2007-8#2)(2008-5#18)(2010-11#2)(2011-2#2)(2012-11#2)(2012-3#3)
tinge##2##1##(1990-7#1)(2007-7#1)
tinged##2##1##(2012-2#1)(2013-8#1)
tingling and##2##2##(2007-8#1)(2012-2#1)
tingling##9##1##(1992-4#1)(1995-12#1)(2006-10#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-3#1)(2010-6#1)(2012-2#1)
tinidazole##7##1##(1996-2#5)(2006-6#2)
tinkering##2##1##(1997-2#1)(1997-6#1)
tinman##2##1##(1995-6#2)
tinned fish consumption##3##3##(2008-1#3)
tinned fish##5##2##(2008-1#5)
tinned##6##1##(2008-1#6)
tinnitus and sudden##2##3##(1995-6#2)
tinnitus and##12##2##(1994-9#1)(1995-6#2)(1996-6#1)(2006-12#1)(2007-8#2)(2008-7#1)(2010-12#2)(2010-3#1)(2012-3#1)
tinnitus is##4##2##(2008-4#3)(2010-3#1)
tinnitus patients##3##2##(1996-6#1)(2010-3#1)(2012-12#1)
tinnitus that##2##2##(2007-9#1)(2010-7#1)
tinnitus was##2##2##(2007-9#1)(2010-7#1)
tinnitus##69##1##(1994-9#1)(1995-6#5)(1996-6#5)(2006-11#1)(2006-12#4)(2007-8#5)(2007-9#8)(2008-4#5)(2008-7#3)(2008-9#2)(2010-12#6)(2010-3#10)(2010-7#7)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
tinplate##3##1##(2005-4#3)
tiny defects##2##2##(2008-3#2)
tiny infants##3##2##(1991-9#2)(1993-5#1)
tiny##38##1##(1991-9#2)(1993-12#1)(1993-5#1)(1993-6#1)(1994-9#1)(1996-8#1)(2005-11#1)(2005-4#1)(2006-10#1)(2007-12#1)(2007-7#2)(2007-9#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
tion##3##1##(2006-5#1)(2007-4#1)(2013-8#1)
tiopronin and##2##2##(1994-5#1)(2007-11#1)
tiopronin##5##1##(1994-5#4)(2007-11#1)
tiotropium##4##1##(1997-1#1)(2010-5#3)
tip and a##2##3##(2007-12#1)(2008-3#1)
tip and sample##2##3##(1994-9#1)(2008-3#1)
tip and the##4##3##(1996-5#1)(2007-7#1)(2008-10#1)(2010-12#1)
tip and##21##2##(1994-9#1)(1996-5#1)(1997-3#1)(2005-10#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-12#1)(2010-12#1)
tip blight disease##2##3##(2008-10#2)
tip by##4##2##(2006-12#1)(2007-7#1)(2008-10#2)
tip cell##5##2##(2007-12#3)(2008-5#1)(2012-12#1)
tip cells##3##2##(2008-5#1)(2009-10#1)(2013-8#1)
tip configuration##2##2##(2007-11#2)
tip diameter##2##2##(2008-3#1)(2011-2#1)
tip for##2##2##(2008-3#2)
tip growth##3##2##(2008-10#2)(2009-8#1)
tip in a##2##3##(2007-12#1)(2008-10#1)
tip in the##3##3##(2007-7#2)(2011-2#1)
tip in##8##2##(1992-1#1)(2007-12#2)(2007-7#2)(2008-10#1)(2008-3#1)(2011-2#1)
tip is##12##2##(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2012-2#1)
tip location##2##2##(2007-7#1)(2008-7#1)
tip necrosis and##2##3##(1995-3#1)(2008-10#1)
tip necrosis##5##2##(1995-3#1)(2008-10#4)
tip of a fiber optic##2##5##(2007-8#1)(2008-10#1)
tip of a##18##3##(1990-9#1)(2005-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2012-2#1)
tip of an##4##3##(2006-2#1)(2007-12#2)(2008-10#1)
tip of the internal##2##4##(1991-5#1)(2008-10#1)
tip of the##60##3##(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#1)(1993-5#1)(1994-12#2)(1994-2#1)(1995-3#1)(1996-7#1)(1997-5#1)(1997-6#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#9)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#3)(2008-10#9)(2008-4#1)(2008-5#5)(2009-2#2)(2009-4#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#2)(2012-12#1)
tip of##92##2##(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#1)(1993-12#1)(1993-5#1)(1994-12#2)(1994-2#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-7#1)(1997-5#1)(1997-6#1)(2005-11#1)(2006-2#1)(2006-6#1)(2006-7#2)(2006-9#1)(2007-11#1)(2007-12#12)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#4)(2008-1#1)(2008-10#20)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-7#1)(2009-2#2)(2009-4#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)
tip position##4##2##(2006-5#1)(2006-8#1)(2007-7#1)(2009-4#1)
tip relative to blade##2##4##(2009-12#2)
tip shapes by##2##3##(2008-10#2)
tip size##3##2##(2008-2#1)(2010-2#1)(2011-2#1)
tip that##2##2##(2008-3#1)(2008-7#1)
tip to##5##2##(1997-4#1)(2006-11#1)(2006-6#1)(2008-10#1)(2009-7#1)
tip using a##2##3##(2008-11#1)(2012-3#1)
tip was##7##2##(1996-5#1)(2006-6#1)(2006-8#2)(2008-2#1)(2009-6#1)(2009-7#1)
tip were##2##2##(2008-10#1)(2008-8#1)
tip with##6##2##(2007-12#1)(2008-10#1)(2008-2#2)(2010-8#1)(2013-1#1)
tip##355##1##(1990-10#1)(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#2)(1992-12#1)(1993-12#1)(1993-5#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-6#1)(1995-8#1)(1996-3#1)(1996-5#2)(1996-7#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#4)(2005-10#1)(2005-11#3)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#13)(2006-7#6)(2006-8#9)(2006-9#2)(2007-1#1)(2007-11#6)(2007-12#27)(2007-3#1)(2007-5#2)(2007-7#19)(2007-8#5)(2008-1#2)(2008-10#56)(2008-11#7)(2008-12#4)(2008-2#17)(2008-3#15)(2008-4#4)(2008-5#19)(2008-6#1)(2008-7#14)(2008-8#4)(2008-9#3)(2009-10#1)(2009-12#3)(2009-2#3)(2009-4#3)(2009-6#1)(2009-7#4)(2009-8#2)(2009-9#3)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#7)(2011-1#3)(2011-2#5)(2012-1#2)(2012-12#8)(2012-2#5)(2012-3#3)(2013-1#1)(2013-8#2)
tip)##3##1##(2008-6#1)(2008-9#1)(2012-3#1)
tip-sample distance##3##2##(2007-12#2)(2008-2#1)
tip-sample##6##1##(2007-12#3)(2008-2#1)(2008-3#1)(2012-2#1)
tip-tilt##5##1##(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)
tip-to-surface##2##1##(2008-5#2)
tipA promoter##2##2##(1990-9#2)
tipburn##3##1##(2008-10#3)
tipifarnib##5##1##(2009-8#5)
tipped##6##1##(1993-2#1)(2005-7#1)(2006-10#1)(2008-2#1)(2008-3#1)(2012-3#1)
tipping the##2##2##(2012-11#1)(2012-2#1)
tipping##6##1##(2007-6#1)(2008-10#1)(2012-11#1)(2012-2#3)
tipranavir##4##1##(2007-1#1)(2008-5#3)
tips and the##2##3##(1997-8#1)(2008-10#1)
tips and##9##2##(1994-3#1)(1994-9#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-12#1)(2013-8#1)
tips are##5##2##(1995-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)
tips for the##2##3##(2005-12#1)(2012-2#1)
tips for##23##2##(1993-12#2)(1994-3#1)(1995-12#1)(1995-2#1)(2005-12#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
tips from##2##2##(2008-8#1)(2013-8#1)
tips in##2##2##(2007-12#1)(2009-9#1)
tips of the##7##3##(1991-12#1)(1994-7#1)(2006-6#1)(2008-5#1)(2008-7#3)
tips of##22##2##(1991-12#1)(1994-2#1)(1994-7#1)(1997-4#1)(1997-6#1)(2006-6#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-6#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-6#1)
tips on how##2##3##(1994-1#1)(1995-2#1)
tips on##4##2##(1991-12#1)(1994-1#1)(1995-2#1)(2007-11#1)
tips or##2##2##(2012-3#1)(2013-8#1)
tips that##2##2##(2008-7#1)(2010-9#1)
tips to##5##2##(1992-1#1)(2007-12#2)(2008-10#1)(2013-8#1)
tips under##2##2##(2007-7#1)(2012-3#1)
tips was##2##2##(2008-5#1)(2008-8#1)
tips were##5##2##(2007-1#1)(2007-8#1)(2008-10#1)(2008-9#1)(2013-8#1)
tips##146##1##(1991-12#2)(1991-8#1)(1992-1#3)(1993-12#2)(1994-1#1)(1994-2#1)(1994-3#2)(1994-7#1)(1994-9#1)(1995-12#1)(1995-2#5)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-12#1)(2006-10#5)(2006-12#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#10)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-10#20)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#3)(2009-10#2)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-3#3)(2010-4#3)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#8)
tipulae##6##1##(2007-12#6)
tirapazamine##7##1##(1997-4#2)(2008-8#5)
tired##2##1##(1997-7#1)(2007-12#1)
tiredness and##5##2##(1992-12#1)(1992-9#1)(1995-5#1)(2013-7#1)(2013-8#1)
tiredness##11##1##(1991-8#1)(1992-12#1)(1992-9#1)(1995-5#1)(1997-6#1)(2004-10#1)(2006-10#1)(2009-7#1)(2012-12#1)(2013-7#1)(2013-8#1)
tires##3##1##(2004-11#1)(2008-10#2)
tirilazad##7##1##(2007-9#7)
tirofiban and##2##2##(2005-7#1)(2008-3#1)
tirofiban##10##1##(2005-7#1)(2006-12#5)(2007-8#2)(2008-3#1)(2012-12#1)
tiron##2##1##(2006-3#1)(2008-10#1)
tirotropin releasing hormone##3##3##(1991-3#3)
tissu##2##1##(2007-8#1)(2008-11#1)
tissue (MALT)##11##2##(1991-6#1)(1996-9#1)(1997-1#1)(2005-8#1)(2006-11#1)(2006-2#1)(2008-1#1)(2009-8#2)(2010-5#1)(2013-1#1)
tissue (NIST SRM##2##3##(2008-10#2)
tissue (P##2##2##(2007-8#1)(2008-8#1)
tissue ACE##2##2##(1993-12#1)(2008-1#1)
tissue ATP##2##2##(1993-2#2)
tissue DNA##4##2##(1996-12#1)(2008-4#1)(2008-5#1)(2011-2#1)
tissue Doppler and##2##3##(2009-10#2)
tissue Doppler echocardiography##2##3##(2005-1#1)(2009-10#1)
tissue Doppler##6##2##(2005-1#1)(2009-10#3)(2010-5#1)(2011-2#1)
tissue IGF-I##2##2##(1995-10#2)
tissue PMNs in both##2##4##(1995-1#2)
tissue PMNs in human and rabbit##2##6##(1995-1#2)
tissue PMNs in##4##3##(1995-1#4)
tissue PMNs##8##2##(1995-1#8)
tissue RNA##2##2##(1994-12#1)(1996-12#1)
tissue V content and##3##4##(2011-2#3)
tissue V content##4##3##(2011-2#4)
tissue V##5##2##(1993-12#1)(2011-2#4)
tissue ablation is##2##3##(2008-3#2)
tissue ablation##4##2##(1993-1#1)(2006-6#1)(2008-3#2)
tissue abnormalities##4##2##(1997-8#1)(2010-6#1)(2011-1#1)(2011-2#1)
tissue absorption##3##2##(2007-12#1)(2008-2#2)
tissue accumulation##4##2##(1991-9#1)(1992-3#1)(2012-2#1)(2013-7#1)
tissue acidification##2##2##(2008-10#2)
tissue adhesive##2##2##(2004-7#1)(2007-3#1)
tissue adhesives in##4##3##(2007-8#1)(2009-2#3)
tissue adhesives##8##2##(2004-9#1)(2007-8#1)(2009-2#6)
tissue adjacent to the##3##4##(1990-9#1)(1997-3#1)(2008-10#1)
tissue affected by##2##3##(1993-2#1)(1995-12#1)
tissue affected##3##2##(1993-2#1)(1994-2#1)(1995-12#1)
tissue after treatment##2##3##(1992-8#1)(2012-1#1)
tissue after##14##2##(1992-8#1)(1994-11#1)(1994-3#1)(1995-7#1)(1997-3#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-12#1)(2009-10#1)(2009-3#1)(2010-2#1)(2012-1#1)(2013-1#1)
tissue against##3##2##(2006-10#1)(2008-6#1)(2008-8#1)
tissue allotransplantation##3##2##(2008-9#1)(2011-2#1)(2013-7#1)
tissue along the##2##3##(2009-7#1)(2010-12#1)
tissue also##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
tissue an##2##2##(2008-3#1)(2012-3#1)
tissue analyses##2##2##(1996-12#1)(2008-5#1)
tissue analysis##3##2##(2008-2#2)(2011-12#1)
tissue and 1##2##3##(1996-12#1)(2011-1#1)
tissue and a##4##3##(1994-3#1)(2007-4#1)(2008-6#1)(2013-1#1)
tissue and an##2##3##(2007-12#1)(2009-11#1)
tissue and are associated with##2##5##(2010-12#1)(2011-1#1)
tissue and are##4##3##(2007-12#1)(2010-11#1)(2010-12#1)(2011-1#1)
tissue and arterial saturation##2##4##(2007-12#2)
tissue and blood vessels##2##4##(2007-1#1)(2008-7#1)
tissue and blood##4##3##(1991-3#1)(2007-1#1)(2008-7#1)(2010-12#1)
tissue and bone##7##3##(2007-11#1)(2008-11#1)(2008-7#1)(2010-6#1)(2013-1#2)(2013-8#1)
tissue and cell##4##3##(1991-12#1)(1997-3#1)(2007-8#1)(2008-4#1)
tissue and cells##2##3##(2008-9#2)
tissue and in##6##3##(1990-2#1)(1991-9#1)(1995-9#1)(2006-9#1)(2008-1#2)
tissue and is##3##3##(1991-11#1)(1996-2#1)(2007-7#1)
tissue and its##6##3##(1990-9#1)(2007-8#1)(2008-1#1)(2008-4#1)(2011-1#1)(2013-1#1)
tissue and muscle##3##3##(1995-3#2)(2006-10#1)
tissue and muscles##3##3##(1990-10#1)(2013-1#2)
tissue and on##2##3##(1991-7#1)(2008-11#1)
tissue and organ##7##3##(2006-10#1)(2007-2#1)(2008-5#3)(2010-2#1)(2010-9#1)
tissue and organs##3##3##(2008-5#1)(2008-8#1)(2012-2#1)
tissue and other##3##3##(1994-3#1)(2006-10#1)(2012-2#1)
tissue and peripheral blood##2##4##(2007-12#1)(2008-4#1)
tissue and plasma##2##3##(1994-11#1)(1997-2#1)
tissue and possibly##3##3##(1990-8#1)(1993-11#1)(2008-5#1)
tissue and serum##5##3##(1996-6#1)(2005-8#1)(2008-8#2)(2010-12#1)
tissue and that changes in##2##5##(1995-7#1)(2008-10#1)
tissue and that##5##3##(1994-2#1)(1995-7#1)(2006-9#1)(2008-10#1)(2013-7#1)
tissue and the##13##3##(1990-9#1)(1995-6#1)(1997-4#1)(2006-11#1)(2007-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-2#2)(2013-1#2)(2013-7#1)
tissue and was##2##3##(1992-7#1)(2013-8#1)
tissue and whole##2##3##(2008-10#1)(2008-3#1)
tissue and##259##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#2)(1990-7#2)(1990-8#3)(1990-9#3)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1995-2#3)(1995-3#4)(1995-6#2)(1995-7#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-6#1)(1996-7#1)(1997-2#2)(1997-3#3)(1997-4#2)(1997-6#2)(1997-8#1)(2005-10#2)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#8)(2006-11#1)(2006-12#4)(2006-2#1)(2006-6#2)(2006-8#2)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#11)(2007-2#1)(2007-3#1)(2007-4#3)(2007-6#1)(2007-7#1)(2007-8#7)(2008-1#9)(2008-10#17)(2008-11#3)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#7)(2008-5#9)(2008-6#4)(2008-7#6)(2008-8#6)(2008-9#6)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#8)(2012-3#1)(2013-1#9)(2013-7#4)(2013-8#3)
tissue and/or##4##2##(2008-10#1)(2008-4#1)(2009-6#1)(2012-12#1)
tissue appears to##2##3##(1994-6#1)(2007-12#1)
tissue architecture and##2##3##(2008-1#1)(2009-5#1)
tissue architecture##9##2##(2006-11#1)(2008-1#1)(2008-2#3)(2008-5#1)(2009-5#2)(2010-9#1)
tissue are a##2##3##(2012-12#1)(2012-2#1)
tissue are##21##2##(1997-4#1)(1997-5#1)(2004-9#1)(2006-11#1)(2007-11#2)(2007-4#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2009-10#1)(2012-12#1)(2012-2#1)(2013-7#1)
tissue around the##4##3##(2006-10#1)(2008-5#1)(2009-6#1)(2013-1#1)
tissue around##6##2##(2006-10#1)(2008-5#2)(2009-6#1)(2010-4#1)(2013-1#1)
tissue as a##10##3##(1990-11#1)(1990-6#1)(2008-10#3)(2008-3#1)(2009-2#1)(2009-7#1)(2011-1#1)(2013-1#1)
tissue as the##3##3##(1992-12#1)(2008-10#1)(2008-2#1)
tissue as well as##5##4##(1992-7#1)(1994-6#1)(1997-7#1)(2008-4#1)(2008-5#1)
tissue as##29##2##(1990-11#1)(1990-6#1)(1991-12#1)(1992-12#1)(1992-7#1)(1994-6#2)(1996-12#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-2#1)(2009-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
tissue association##2##2##(1990-4#2)
tissue at the##6##3##(1992-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-1#1)(2012-12#1)
tissue at##16##2##(1992-12#1)(1996-12#1)(2007-12#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-9#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
tissue atrophy##2##2##(1997-3#1)(2013-8#1)
tissue augmentation##7##2##(2005-11#3)(2006-12#1)(2007-7#2)(2010-11#1)
tissue autofluorescence##6##2##(2008-3#1)(2011-1#3)(2012-12#2)
tissue available##2##2##(2007-12#1)(2013-1#1)
tissue balance##5##2##(2007-5#2)(2007-7#1)(2013-1#2)
tissue barriers##2##2##(2008-11#1)(2013-8#1)
tissue based on##5##3##(2007-12#1)(2008-10#1)(2009-10#1)(2009-5#1)(2012-2#1)
tissue based##7##2##(2007-12#1)(2008-10#3)(2009-10#1)(2009-5#1)(2012-2#1)
tissue because##2##2##(2008-2#1)(2009-8#1)
tissue before##5##2##(1994-5#1)(1995-12#1)(2008-1#1)(2008-2#1)(2011-2#1)
tissue behavior##3##2##(2008-9#2)(2010-9#1)
tissue being##2##2##(1996-9#1)(2008-7#1)
tissue beneath the##4##3##(2007-11#2)(2012-12#2)
tissue biochemistry##2##2##(2010-12#1)(2012-12#1)
tissue biopsies##4##2##(2006-8#1)(2008-1#1)(2008-7#1)(2010-12#1)
tissue biopsy##6##2##(2007-2#1)(2007-8#1)(2008-1#1)(2009-3#1)(2010-6#1)(2012-1#1)
tissue block radiography##3##3##(1997-8#3)
tissue block##7##2##(1997-8#3)(2011-2#3)(2013-1#1)
tissue blocks##4##2##(1997-8#1)(2004-2#1)(2006-2#1)(2009-8#1)
tissue blood flow is##2##4##(2011-12#2)
tissue blood flow##4##3##(2007-8#2)(2011-12#2)
tissue blood##5##2##(2007-8#2)(2008-7#1)(2011-12#2)
tissue blot##4##2##(2008-10#3)(2008-7#1)
tissue but not##2##3##(2008-12#1)(2010-4#1)
tissue but##6##2##(2007-11#1)(2007-3#1)(2008-12#1)(2008-8#1)(2010-4#1)(2010-8#1)
tissue by inhibiting##2##3##(1990-2#1)(2008-10#1)
tissue by the##5##3##(1990-3#1)(1996-3#1)(2008-10#1)(2009-3#1)(2012-2#1)
tissue by use of##3##4##(2007-12#2)(2008-3#1)
tissue by using##2##3##(2008-10#1)(2011-1#1)
tissue by##44##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-11#1)(1992-12#1)(1992-5#1)(1994-8#1)(1996-3#2)(1997-6#1)(2005-12#1)(2007-12#4)(2008-10#13)(2008-2#1)(2008-3#2)(2008-4#2)(2008-9#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2011-1#1)(2012-2#2)(2013-7#1)
tissue cGMP levels##3##3##(1990-12#3)
tissue cGMP##4##2##(1990-12#4)
tissue calcium content##2##3##(1992-3#1)(2008-10#1)
tissue calcium ions began to increase##2##6##(1992-3#2)
tissue calcium##5##2##(1992-3#3)(1993-4#1)(2008-10#1)
tissue can be##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
tissue can##9##2##(1992-4#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2011-12#1)(2011-2#1)
tissue cannot##2##2##(2007-11#1)(2011-2#1)
tissue caused by##2##3##(2008-10#1)(2008-2#1)
tissue causing##3##2##(2006-6#1)(2012-3#1)(2013-1#1)
tissue cells##10##2##(1990-11#1)(1990-7#1)(1996-2#1)(2007-11#1)(2007-8#2)(2008-2#1)(2008-5#1)(2009-3#1)(2010-12#1)
tissue changes in##2##3##(2008-12#1)(2008-8#1)
tissue changes##5##2##(2007-11#1)(2008-12#1)(2008-8#1)(2011-2#1)(2013-8#1)
tissue characterisation##2##2##(2012-2#2)
tissue characterization##6##2##(2007-12#1)(2009-5#1)(2010-11#1)(2011-1#3)
tissue classification##2##2##(1991-12#1)(2006-10#1)
tissue collagenase##2##2##(1994-3#2)
tissue collapse was##2##3##(2008-10#2)
tissue colonization##2##2##(2008-10#2)
tissue compared to##5##3##(1992-6#1)(1996-7#1)(2008-10#1)(2010-12#1)(2012-1#1)
tissue compared with##2##3##(1990-4#1)(2007-12#1)
tissue compared##7##2##(1990-4#1)(1992-6#1)(1996-7#1)(2007-12#1)(2008-10#1)(2010-12#1)(2012-1#1)
tissue compartments##2##2##(2008-3#1)(2011-1#1)
tissue compatibility##3##2##(2012-3#3)
tissue components##5##2##(2007-9#1)(2008-10#1)(2008-3#1)(2012-3#2)
tissue compression##3##2##(2006-7#2)(2010-8#1)
tissue concentration of##2##3##(1992-6#1)(2007-1#1)
tissue concentration##4##2##(1992-6#1)(1996-12#1)(2007-1#2)
tissue concentrations and##2##3##(1991-8#1)(2008-8#1)
tissue concentrations of##6##3##(1992-1#1)(1994-3#1)(1994-5#1)(1997-2#1)(2005-11#1)(2011-2#1)
tissue concentrations##14##2##(1991-8#1)(1992-1#2)(1994-3#1)(1994-5#1)(1997-2#1)(2005-11#1)(2008-8#1)(2011-2#5)(2012-2#1)
tissue constituents##2##2##(2007-12#2)
tissue constructs##5##2##(2009-9#1)(2010-10#1)(2010-9#1)(2012-11#1)(2013-1#1)
tissue containing##6##2##(1994-3#1)(2007-10#1)(2008-2#2)(2008-5#1)(2010-6#1)
tissue contains##3##2##(2008-11#1)(2008-3#1)(2010-4#1)
tissue content of##3##3##(1994-3#1)(1997-7#1)(2013-7#1)
tissue content##8##2##(1991-10#1)(1994-3#1)(1996-12#2)(1997-7#2)(2012-12#1)(2013-7#1)
tissue context##3##2##(1997-4#1)(2008-7#2)
tissue contrast and##4##3##(2008-1#1)(2008-8#1)(2009-10#1)(2012-12#1)
tissue contrast##10##2##(2006-9#1)(2007-4#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-8#1)(2009-10#1)(2010-12#1)(2012-12#1)
tissue contribute to the##2##4##(2006-6#1)(2011-2#1)
tissue could##4##2##(1992-3#1)(1996-12#1)(1997-3#1)(2010-8#1)
tissue coverage##8##2##(2008-2#3)(2008-6#1)(2009-5#1)(2011-2#1)(2013-8#2)
tissue cryopreservation##4##2##(2009-5#1)(2009-6#3)
tissue culture and in##2##4##(2006-11#1)(2009-2#1)
tissue culture and##7##3##(1992-2#1)(1993-11#1)(1994-6#1)(1997-3#1)(2006-11#1)(2008-5#1)(2009-2#1)
tissue culture cells##12##3##(1991-9#1)(1995-3#1)(1996-9#1)(2008-2#1)(2008-4#3)(2008-8#1)(2008-9#3)(2011-2#1)
tissue culture dishes##3##3##(1992-7#1)(2008-11#1)(2012-12#1)
tissue culture infectious dose##3##4##(2008-4#3)
tissue culture infectious##4##3##(2008-4#3)(2008-5#1)
tissue culture media##2##3##(2008-10#1)(2008-9#1)
tissue culture medium and##4##4##(1992-8#1)(2007-11#1)(2008-4#1)(2008-7#1)
tissue culture medium##9##3##(1992-8#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2010-10#1)
tissue culture model##3##3##(1995-6#1)(2006-11#1)(2007-12#1)
tissue culture of##2##3##(1991-2#1)(2008-11#1)
tissue culture plate##3##3##(1992-8#1)(1994-6#1)(2008-11#1)
tissue culture plates##2##3##(2008-10#1)(2008-11#1)
tissue culture polystyrene##5##3##(2004-9#1)(2005-11#1)(2012-11#2)(2012-5#1)
tissue culture system for##2##4##(2006-10#1)(2008-11#1)
tissue culture system##5##3##(2006-10#2)(2008-11#2)(2008-9#1)
tissue culture vaccines##2##3##(2007-11#2)
tissue culture##126##2##(1991-1#1)(1991-2#2)(1991-3#1)(1991-9#2)(1992-2#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-9#1)(1994-6#2)(1995-3#3)(1995-5#2)(1995-6#1)(1995-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#3)(2004-9#1)(2005-11#1)(2006-10#3)(2006-11#2)(2006-4#1)(2006-5#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#7)(2008-11#23)(2008-12#1)(2008-2#2)(2008-4#14)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#9)(2009-2#1)(2010-10#1)(2010-12#1)(2011-2#4)(2011-3#1)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-8#1)
tissue cultures for##2##3##(2007-11#1)(2012-3#1)
tissue cultures of##2##3##(1991-9#1)(2007-1#1)
tissue cultures##14##2##(1990-2#1)(1991-9#1)(2006-12#1)(2007-1#3)(2007-11#2)(2008-11#3)(2012-3#1)(2013-1#2)
tissue cysts and##2##3##(2008-4#2)
tissue cysts##3##2##(2007-12#1)(2008-4#2)
tissue cytosols##6##2##(1995-11#3)(1997-2#3)
tissue damage and##5##3##(2006-10#1)(2007-11#1)(2007-12#1)(2012-12#1)(2013-8#1)
tissue damage caused by##2##4##(1995-12#1)(2007-7#1)
tissue damage following##2##3##(1994-12#1)(2010-3#1)
tissue damage in##7##3##(1994-5#1)(1996-2#1)(1997-8#1)(2006-10#2)(2009-4#1)(2011-2#1)
tissue damage is##5##3##(1990-5#1)(2008-7#1)(2010-4#1)(2011-1#1)(2013-1#1)
tissue damage was##3##3##(2010-9#1)(2013-1#2)
tissue damage when##2##3##(1994-5#1)(2008-10#1)
tissue damage##69##2##(1990-12#1)(1990-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1994-11#1)(1994-12#1)(1994-5#3)(1995-12#1)(1996-2#1)(1997-1#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-10#4)(2006-2#1)(2007-10#1)(2007-11#6)(2007-12#2)(2007-7#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-9#3)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#3)
tissue damages##3##2##(2008-10#1)(2009-6#1)(2012-11#1)
tissue decreased##3##2##(2007-9#1)(2008-5#1)(2010-12#1)
tissue defect##10##2##(2007-8#1)(2008-1#2)(2008-12#1)(2008-9#2)(2010-9#2)(2011-2#1)(2012-12#1)
tissue defects in the##2##4##(2007-11#1)(2010-6#1)
tissue defects of the##4##4##(2008-3#1)(2010-9#1)(2011-2#2)
tissue defects of##5##3##(2006-3#1)(2008-3#1)(2010-9#1)(2011-2#2)
tissue defects##12##2##(2006-3#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-9#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-12#2)
tissue deformation##2##2##(1996-12#1)(2006-11#1)
tissue degeneration##2##2##(1996-7#1)(2010-2#1)
tissue degradation##4##2##(1990-11#1)(1990-9#2)(1994-11#1)
tissue density##7##2##(2006-4#2)(2007-8#1)(2009-7#1)(2010-8#3)
tissue depends##2##2##(1997-6#1)(2008-3#1)
tissue depth##3##2##(1996-5#3)
tissue derived from##3##3##(1997-4#1)(2007-12#1)(2012-2#1)
tissue derived##4##2##(1997-4#1)(2007-12#1)(2011-1#1)(2012-2#1)
tissue destruction and##5##3##(1996-9#1)(1997-2#1)(2006-9#1)(2011-2#1)(2013-7#1)
tissue destruction##16##2##(1990-11#1)(1991-1#1)(1992-12#1)(1996-9#1)(1997-2#1)(2006-9#1)(2007-11#1)(2008-4#2)(2008-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)
tissue development in##2##3##(2008-5#1)(2012-2#1)
tissue development##10##2##(1990-4#1)(1993-6#1)(2008-5#1)(2009-12#1)(2010-10#1)(2011-2#2)(2012-2#3)
tissue diagnosis##14##2##(1992-6#1)(1995-1#1)(1995-3#1)(2006-10#3)(2007-6#1)(2007-8#1)(2008-1#1)(2008-3#1)(2010-11#1)(2010-5#1)(2010-7#1)(2012-2#1)
tissue differentiation##5##2##(2007-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-3#1)
tissue directly##2##2##(1997-4#1)(2011-2#1)
tissue discs##2##2##(2008-10#2)
tissue disease##25##2##(1991-11#1)(1992-2#3)(1995-11#2)(1996-3#1)(1997-4#1)(2006-10#11)(2007-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
tissue diseases##16##2##(1990-4#1)(1991-9#1)(1993-10#2)(1995-5#2)(2005-7#1)(2006-10#2)(2007-11#1)(2008-8#1)(2012-1#1)(2012-2#2)(2013-1#2)
tissue disorder with##3##3##(1992-10#1)(1996-3#1)(2008-4#1)
tissue disorder##10##2##(1992-10#1)(1996-3#1)(2006-10#2)(2007-7#1)(2007-8#1)(2008-4#1)(2008-5#1)(2010-6#1)(2011-2#1)
tissue disorders##10##2##(1992-1#1)(2007-8#2)(2007-9#2)(2010-3#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)
tissue displacement##3##2##(2007-9#1)(2009-7#1)(2010-8#1)
tissue dissection##3##2##(2006-3#1)(2011-2#1)(2012-2#1)
tissue distribution and##5##3##(1990-5#1)(1994-3#1)(1995-12#1)(1995-8#1)(2008-4#1)
tissue distribution in##4##3##(1991-1#1)(1991-2#1)(1995-3#1)(1997-2#1)
tissue distribution of GEM 91##2##5##(1995-3#2)
tissue distribution of expression##2##4##(1994-9#1)(1997-7#1)
tissue distribution of##21##3##(1990-2#2)(1991-2#1)(1991-9#1)(1992-5#1)(1992-9#1)(1993-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#3)(1995-6#1)(1995-8#1)(1996-2#1)(1997-6#1)(1997-7#1)(2008-12#1)(2008-4#1)
tissue distribution studies##2##3##(1992-5#1)(1993-4#1)
tissue distribution##52##2##(1990-2#2)(1990-5#1)(1991-1#1)(1991-2#2)(1991-6#1)(1991-9#1)(1992-5#2)(1992-9#1)(1993-11#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-3#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#5)(1995-6#3)(1995-8#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#2)(2006-12#1)(2006-6#1)(2008-12#1)(2008-4#5)(2008-7#1)(2010-5#2)(2012-12#1)
tissue distributions##3##2##(1991-9#1)(1994-8#1)(2012-12#1)
tissue donation##3##2##(1990-12#1)(1994-7#1)(2010-6#1)
tissue due to##2##3##(1992-3#1)(2008-10#1)
tissue during##12##2##(1990-11#1)(1991-2#1)(1994-12#1)(1995-10#1)(2006-11#1)(2006-5#1)(2008-10#1)(2008-5#1)(2009-11#1)(2010-3#1)(2011-12#1)(2012-11#1)
tissue effects##4##2##(1990-5#2)(2011-2#1)(2013-7#1)
tissue elements##5##2##(1990-9#1)(2008-2#1)(2008-7#1)(2010-6#1)(2011-1#1)
tissue engineered cartilage##2##3##(2007-11#1)(2010-8#1)
tissue engineered materials##2##3##(2006-5#1)(2007-8#1)
tissue engineered products##2##3##(2008-5#1)(2012-3#1)
tissue engineered##8##2##(2006-5#2)(2007-11#1)(2007-8#1)(2008-5#2)(2010-8#1)(2012-3#1)
tissue engineering and cell##2##4##(2011-3#1)(2013-1#1)
tissue engineering and regeneration##3##4##(2008-5#1)(2010-10#1)(2013-1#1)
tissue engineering and regenerative medicine applications##2##6##(2012-5#1)(2012-6#1)
tissue engineering and regenerative medicine##8##5##(2008-5#2)(2009-7#1)(2010-10#2)(2012-5#2)(2012-6#1)
tissue engineering and regenerative##9##4##(2008-5#2)(2009-7#1)(2010-10#2)(2012-12#1)(2012-5#2)(2012-6#1)
tissue engineering and##19##3##(2006-6#2)(2007-9#1)(2008-5#3)(2009-7#1)(2010-10#3)(2011-3#2)(2012-11#1)(2012-12#1)(2012-5#2)(2012-6#1)(2013-1#2)
tissue engineering applications##11##3##(2006-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-10#2)(2010-4#1)(2010-8#2)(2012-11#2)
tissue engineering approach##3##3##(2012-12#2)(2013-7#1)
tissue engineering approaches##2##3##(2008-5#1)(2013-1#1)
tissue engineering are##5##3##(2006-6#3)(2012-11#2)
tissue engineering as a##2##4##(2012-12#1)(2012-3#1)
tissue engineering as##4##3##(2010-9#1)(2012-12#1)(2012-3#2)
tissue engineering for##2##3##(2006-9#1)(2012-12#1)
tissue engineering in the##4##4##(2007-11#1)(2008-5#2)(2012-12#1)
tissue engineering in##7##3##(2007-11#1)(2008-11#1)(2008-5#2)(2009-7#1)(2012-12#1)(2013-7#1)
tissue engineering is##7##3##(2006-6#1)(2007-11#1)(2009-9#2)(2010-10#1)(2010-2#1)(2012-12#1)
tissue engineering methods##2##3##(2007-11#1)(2010-8#1)
tissue engineering of##4##3##(2006-6#1)(2007-11#1)(2008-5#1)(2012-2#1)
tissue engineering scaffold##2##3##(2009-11#2)
tissue engineering scaffolds##5##3##(2008-5#1)(2010-10#1)(2012-1#1)(2012-11#2)
tissue engineering studies##2##3##(2012-2#1)(2013-1#1)
tissue engineering techniques##3##3##(2008-5#2)(2010-2#1)
tissue engineering using##4##3##(2007-12#1)(2007-8#1)(2008-5#1)(2012-2#1)
tissue engineering##178##2##(2006-2#1)(2006-5#2)(2006-6#13)(2006-7#1)(2006-9#2)(2007-11#7)(2007-12#2)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#1)(2008-11#10)(2008-5#30)(2009-11#3)(2009-12#2)(2009-4#3)(2009-5#1)(2009-7#9)(2009-9#2)(2010-1#3)(2010-10#9)(2010-2#3)(2010-4#3)(2010-8#3)(2010-9#4)(2011-2#2)(2011-3#2)(2012-1#1)(2012-11#13)(2012-12#12)(2012-2#8)(2012-3#2)(2012-5#3)(2012-6#1)(2012-8#2)(2013-1#7)(2013-7#2)
tissue environment in##2##3##(1995-11#1)(2010-10#1)
tissue environment##5##2##(1995-11#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-1#1)
tissue examined##2##2##(1994-2#1)(2008-10#1)
tissue expander##2##2##(1993-11#1)(2011-2#1)
tissue expansion##3##2##(2006-3#1)(2008-5#1)(2011-2#1)
tissue explants##3##2##(1993-11#1)(1996-11#1)(2012-2#1)
tissue expressed##2##2##(1992-3#1)(1995-3#1)
tissue expressing##2##2##(1994-12#1)(1996-8#1)
tissue expression and##4##3##(1992-3#1)(1997-4#1)(2009-4#1)(2011-1#1)
tissue expression of##3##3##(1991-9#1)(1997-8#1)(2008-1#1)
tissue expression##8##2##(1991-9#1)(1992-3#1)(1997-4#2)(1997-8#1)(2008-1#1)(2009-4#1)(2011-1#1)
tissue extracellular##3##2##(2008-4#1)(2009-2#1)(2012-1#1)
tissue extract##2##2##(1990-4#1)(2010-3#1)
tissue extraction and##2##3##(1995-1#1)(1997-7#1)
tissue extraction##3##2##(1993-2#1)(1995-1#1)(1997-7#1)
tissue extracts##24##2##(1990-11#2)(1990-5#1)(1990-6#2)(1991-10#1)(1991-8#1)(1992-8#1)(1993-8#1)(1994-8#1)(1995-5#1)(1996-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#1)(2007-8#1)(2008-10#5)(2008-11#1)(2012-1#1)
tissue factor (TF)##6##3##(1994-11#1)(1994-9#1)(1995-6#1)(1995-8#2)(2005-10#1)
tissue factor and##3##3##(1991-12#1)(1994-9#1)(2010-3#1)
tissue factor binding##2##3##(1994-11#1)(1995-6#1)
tissue factor pathway inhibitor##3##4##(1992-10#1)(1995-8#2)
tissue factor##27##2##(1991-12#5)(1992-10#1)(1993-3#2)(1994-11#4)(1994-9#2)(1995-6#2)(1995-8#5)(2005-10#1)(2005-12#1)(2007-2#1)(2008-10#1)(2008-7#1)(2010-3#1)
tissue fibrosis##3##2##(1996-11#1)(2008-9#2)
tissue flaps##4##2##(2007-12#2)(2007-7#1)(2008-9#1)
tissue fluid collected with a percutaneous device##3##7##(2004-9#3)
tissue fluid##10##2##(1990-2#1)(2004-9#9)
tissue fluorescence##4##2##(2008-3#2)(2011-1#2)
tissue followed by##2##3##(2008-10#1)(2008-4#1)
tissue for diagnosis##2##3##(1992-12#1)(2006-6#1)
tissue for the##10##3##(1996-2#1)(1996-6#1)(2005-11#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-11#1)(2009-4#1)(2009-8#1)
tissue for##35##2##(1991-2#2)(1992-12#2)(1994-3#1)(1994-6#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#2)(2011-1#1)(2012-8#1)
tissue formation and##5##3##(2006-6#1)(2006-9#1)(2007-8#1)(2008-5#1)(2009-12#1)
tissue formation##17##2##(2004-9#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-5#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-2#1)(2010-9#1)(2012-1#1)(2012-12#1)
tissue formed in##2##3##(2007-2#1)(2008-11#1)
tissue formed##3##2##(2007-2#1)(2008-11#1)(2010-8#1)
tissue fractions##2##2##(1995-7#1)(2006-10#1)
tissue fragments##3##2##(2008-5#1)(2011-12#1)(2012-3#1)
tissue from a##4##3##(1994-11#1)(1996-5#1)(2008-3#1)(2009-4#1)
tissue from patients with##2##4##(1994-8#1)(2009-9#1)
tissue from patients##4##3##(1991-5#2)(1994-8#1)(2009-9#1)
tissue from the##10##3##(1990-5#1)(1992-6#1)(1996-9#1)(2007-8#1)(2008-10#2)(2008-7#1)(2009-7#1)(2010-2#1)(2011-2#1)
tissue from three##2##3##(1991-8#1)(2009-6#1)
tissue from which##3##3##(1992-9#2)(2008-11#1)
tissue from young##3##3##(1993-7#1)(1994-2#1)(2010-12#1)
tissue from##54##2##(1990-5#1)(1991-2#1)(1991-5#3)(1991-8#1)(1991-9#1)(1992-10#2)(1992-3#1)(1992-6#1)(1992-9#2)(1993-7#1)(1994-11#2)(1994-2#1)(1994-8#1)(1995-3#1)(1995-9#1)(1996-5#1)(1996-9#1)(1997-7#1)(2005-8#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-2#3)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
tissue function##4##2##(1995-6#1)(2008-5#1)(2008-7#1)(2012-2#1)
tissue gas##2##2##(1994-10#1)(2006-4#1)
tissue glue##3##2##(2007-7#1)(2009-2#2)
tissue glycation)##2##2##(1996-5#2)
tissue glycolysis##2##2##(1993-4#2)
tissue graft##8##2##(2005-5#1)(2010-4#2)(2012-3#2)(2013-1#3)
tissue grafts##5##2##(1996-8#1)(2006-8#1)(2010-10#1)(2013-1#2)
tissue growth factor (CTGF)##3##4##(2012-1#1)(2012-2#1)(2013-1#1)
tissue growth factor in##2##4##(2012-12#1)(2013-8#1)
tissue growth factor##8##3##(2009-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
tissue growth in##2##3##(2007-8#1)(2008-9#1)
tissue growth##15##2##(1994-9#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
tissue handling##3##2##(2007-12#1)(2009-5#2)
tissue has been##4##3##(2006-8#1)(2007-8#1)(2008-5#1)(2010-8#1)
tissue has##8##2##(2006-7#1)(2006-8#1)(2007-8#1)(2008-4#1)(2008-5#2)(2010-8#1)(2010-9#1)
tissue have been##3##3##(1994-8#1)(2006-2#1)(2011-1#1)
tissue have##9##2##(1994-8#1)(1995-8#1)(2006-2#1)(2008-5#1)(2009-7#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-1#1)
tissue healing##7##2##(1992-6#1)(2005-10#1)(2007-11#1)(2008-6#1)(2009-8#2)(2011-12#1)
tissue heating##2##2##(1994-3#1)(2007-11#1)
tissue heterogeneity##4##2##(1995-4#1)(2007-12#1)(2008-4#1)(2013-1#1)
tissue homeostasis and##4##3##(2007-10#1)(2008-5#1)(2008-7#1)(2011-1#1)
tissue homeostasis##10##2##(2007-10#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#2)
tissue homogenate and gelatin##2##4##(2008-10#2)
tissue homogenate##19##2##(1997-8#3)(2007-6#1)(2008-10#9)(2008-11#1)(2008-5#2)(2010-8#2)(2012-3#1)
tissue homogenates of##2##3##(1992-3#1)(1997-8#1)
tissue homogenates were##2##3##(1993-11#1)(1994-3#1)
tissue homogenates##20##2##(1990-2#1)(1992-3#1)(1993-11#1)(1993-9#1)(1994-2#1)(1994-3#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-7#1)(1997-8#2)(2008-4#5)(2010-8#1)
tissue hormones and appetite and body weight regulators##2##8##(2013-8#2)
tissue hormones##5##2##(2007-11#1)(2012-3#1)(2013-8#3)
tissue hyperplasia##2##2##(2009-3#1)(2010-6#1)
tissue hypoxia##4##2##(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
tissue imaging##6##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-4#1)(2013-1#1)
tissue imbalance##2##2##(2012-12#1)(2013-1#1)
tissue immediately##2##2##(1990-4#1)(2007-8#1)
tissue improved##2##2##(1991-5#1)(2008-5#1)
tissue in a##4##3##(1991-3#1)(1994-11#1)(1995-9#1)(2008-10#1)
tissue in both##2##3##(2007-8#1)(2008-10#1)
tissue in patients with##4##4##(1991-12#1)(1995-12#1)(2010-2#1)(2013-1#1)
tissue in response to##2##4##(2008-1#1)(2008-7#1)
tissue in rheumatoid arthritis##3##4##(2006-10#1)(2007-11#2)
tissue in the absence of##3##5##(1996-12#1)(2008-10#1)(2008-6#1)
tissue in the distal##2##4##(2008-5#1)(2009-7#1)
tissue in the human##2##4##(2009-7#1)(2013-1#1)
tissue in the region##2##4##(2006-6#1)(2007-7#1)
tissue in the##36##3##(1990-3#1)(1992-1#1)(1995-11#1)(1996-12#2)(1997-2#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-7#2)(2010-6#1)(2012-2#1)(2013-1#1)
tissue in vivo##8##3##(1995-12#1)(2007-11#1)(2008-3#3)(2009-8#1)(2011-1#2)
tissue in which the##2##4##(1996-5#1)(2008-10#1)
tissue in##113##2##(1990-11#1)(1990-3#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-5#1)(1994-10#1)(1994-11#1)(1995-11#2)(1995-12#2)(1995-5#1)(1995-9#1)(1996-12#3)(1996-4#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-4#1)(2006-10#2)(2006-11#2)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#4)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#5)(2008-6#4)(2008-7#3)(2008-8#1)(2008-9#2)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#2)(2010-12#2)(2010-2#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#1)
tissue included##3##2##(2008-10#2)(2010-10#1)
tissue including##3##2##(1990-7#1)(1992-12#1)(2008-4#1)
tissue indicated##2##2##(2008-10#1)(2008-7#1)
tissue indicating##2##2##(2009-4#1)(2011-2#1)
tissue induced##2##2##(2007-8#1)(2008-11#1)
tissue infections##25##2##(1995-5#1)(2005-7#2)(2006-10#2)(2006-4#2)(2007-12#2)(2008-10#2)(2008-3#2)(2009-2#1)(2009-3#2)(2009-4#3)(2010-11#1)(2010-12#1)(2013-1#4)
tissue infiltration##2##2##(2005-7#1)(2012-3#1)
tissue inflammation and##6##3##(1991-3#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#2)
tissue inflammation##13##2##(1991-3#1)(1997-2#1)(2005-11#1)(2008-12#2)(2010-5#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#3)(2013-1#1)
tissue inhibitor of metalloproteinase##6##4##(1990-8#2)(2008-5#1)(2008-9#1)(2010-1#1)(2012-1#1)
tissue inhibitor of metalloproteinase-1 mRNA##2##5##(2006-9#2)
tissue inhibitor of metalloproteinase-1##7##4##(2006-9#4)(2007-11#1)(2008-5#1)(2008-9#1)
tissue inhibitor of metalloproteinases##7##4##(1990-12#1)(1990-7#2)(1994-5#1)(1996-1#1)(1997-4#1)(2006-9#1)
tissue inhibitor of metalloproteinases-1 (TIMP-1)##2##5##(1994-8#1)(2009-4#1)
tissue inhibitor of metalloproteinases-1 in##3##5##(1994-8#1)(2010-12#2)
tissue inhibitor of metalloproteinases-1##6##4##(1994-5#1)(1994-8#2)(2009-4#1)(2010-12#2)
tissue inhibitor of metalloproteinases-2 (TIMP-2)##2##5##(1992-2#1)(1994-5#1)
tissue inhibitor of metalloproteinases-2##4##4##(1992-2#2)(1994-5#1)(2013-1#1)
tissue inhibitor of##36##3##(1990-12#1)(1990-7#2)(1990-8#2)(1992-2#2)(1994-5#3)(1994-8#2)(1996-1#1)(1997-4#3)(2006-9#5)(2007-11#1)(2008-5#2)(2008-9#2)(2009-4#1)(2010-1#2)(2010-12#2)(2010-6#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
tissue inhibitor##38##2##(1990-12#1)(1990-7#2)(1990-8#2)(1992-2#2)(1994-5#3)(1994-8#2)(1996-1#1)(1997-4#3)(2005-10#1)(2006-9#5)(2007-11#1)(2008-5#2)(2008-9#2)(2009-4#1)(2010-1#2)(2010-12#3)(2010-6#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
tissue inhibitor-2##2##2##(2010-12#2)
tissue inhibitors of metalloproteinases##4##4##(1992-9#2)(1996-1#1)(2009-4#1)
tissue inhibitors of##6##3##(1992-9#2)(1996-1#1)(2009-4#1)(2011-2#1)(2013-1#1)
tissue inhibitors##7##2##(1992-9#2)(1996-1#1)(2009-10#1)(2009-4#1)(2011-2#1)(2013-1#1)
tissue injuries##5##2##(1990-12#1)(1994-2#1)(2007-4#1)(2008-11#1)(2009-5#1)
tissue injury and##4##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)
tissue injury during##2##3##(1994-2#1)(1997-2#1)
tissue injury in##2##3##(1991-9#1)(2006-10#1)
tissue injury##40##2##(1990-2#2)(1991-9#1)(1992-11#1)(1993-12#1)(1993-4#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-2#3)(1996-7#1)(1997-1#1)(1997-2#1)(2006-10#2)(2006-11#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-3#2)(2011-2#2)(2012-12#1)(2013-1#1)
tissue integrity and##2##3##(2006-1#1)(2012-12#1)
tissue integrity##7##2##(2006-1#1)(2008-4#1)(2009-10#1)(2009-8#1)(2012-12#3)
tissue interaction##2##2##(2007-12#1)(2008-8#1)
tissue interactions##4##2##(2007-11#1)(2008-3#1)(2008-6#2)
tissue interfaces##2##2##(2008-7#2)
tissue into the##5##3##(1991-5#1)(1994-5#1)(1995-7#1)(2012-2#1)(2013-8#1)
tissue into##7##2##(1991-5#1)(1993-12#1)(1994-5#1)(1995-7#1)(2008-10#1)(2012-2#1)(2013-8#1)
tissue invasion##4##2##(2005-8#1)(2007-2#2)(2013-8#1)
tissue involvement in##2##3##(2008-8#1)(2008-9#1)
tissue involvement##3##2##(2008-8#1)(2008-9#1)(2010-9#1)
tissue is a##2##3##(2006-8#1)(2007-8#1)
tissue is an important##3##4##(1994-11#1)(2008-1#1)(2008-11#1)
tissue is an##4##3##(1994-11#1)(2006-1#1)(2008-1#1)(2008-11#1)
tissue is considered##3##3##(2006-6#1)(2008-3#1)(2013-8#1)
tissue is described##2##3##(2008-12#1)(2008-4#1)
tissue is discussed##2##3##(2007-12#1)(2008-3#1)
tissue is essential##2##3##(2008-1#1)(2008-9#1)
tissue is relatively##2##3##(1992-2#1)(2007-8#1)
tissue is removed##3##3##(1991-9#1)(2008-4#2)
tissue is required##2##3##(2004-2#1)(2012-2#1)
tissue is the##4##3##(2006-10#1)(2007-11#1)(2010-2#1)(2012-2#1)
tissue is very##4##3##(2007-3#1)(2008-1#1)(2008-10#1)(2008-3#1)
tissue is##75##2##(1990-12#1)(1991-12#1)(1991-9#2)(1992-2#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-12#1)(1996-8#1)(1997-1#1)(2004-2#1)(2004-9#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-4#1)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#8)(2008-4#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2012-10#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
tissue ischemia##3##2##(1990-12#1)(1990-7#1)(2008-7#1)
tissue layer##3##2##(2008-2#1)(2008-7#1)(2011-1#1)
tissue layers in##2##3##(2008-7#1)(2011-1#1)
tissue layers##14##2##(1993-11#1)(2004-9#1)(2008-3#4)(2008-7#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#2)(2013-1#2)
tissue lesion in##2##3##(2008-7#1)(2010-12#1)
tissue lesions are##2##3##(2012-2#1)(2013-1#1)
tissue lesions##14##2##(1992-11#1)(1994-5#1)(1995-3#1)(2007-11#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-6#1)(2011-12#1)(2012-2#3)(2013-1#2)
tissue level##10##2##(1992-1#1)(1994-11#1)(1996-3#1)(2006-11#3)(2007-12#1)(2008-7#1)(2010-9#1)(2013-1#1)
tissue levels of##15##3##(1990-2#1)(1990-7#2)(1991-2#1)(1994-12#1)(1995-11#1)(1997-1#1)(1997-2#2)(2005-11#1)(2006-9#1)(2008-3#1)(2008-4#1)(2010-5#1)(2012-12#1)
tissue levels##22##2##(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#2)(1991-2#1)(1992-3#1)(1994-12#1)(1995-11#1)(1995-12#1)(1997-1#1)(1997-2#2)(2005-11#1)(2006-9#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-5#1)(2012-12#1)
tissue loss##9##2##(1995-8#1)(2007-3#1)(2008-6#3)(2011-2#4)
tissue lysates##2##2##(1996-12#1)(2008-1#1)
tissue macrophages and##2##3##(2008-4#1)(2012-12#1)
tissue macrophages##7##2##(1990-4#1)(1992-7#1)(2004-9#1)(2008-4#1)(2012-11#1)(2012-12#2)
tissue markers##2##2##(1995-8#1)(2008-9#1)
tissue mass with##2##3##(2011-12#1)(2012-12#1)
tissue mass##16##2##(1993-10#1)(1995-8#1)(2008-12#1)(2008-4#1)(2009-3#1)(2009-9#1)(2011-1#2)(2011-12#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
tissue masses##3##2##(2007-12#1)(2007-8#1)(2013-1#1)
tissue mast##2##2##(1990-5#1)(2008-4#1)
tissue material for##2##3##(2008-1#1)(2008-9#1)
tissue material##3##2##(2008-1#1)(2008-9#1)(2013-8#1)
tissue matrices##2##2##(1997-3#1)(2011-2#1)
tissue matrix##4##2##(1990-2#1)(1991-8#1)(1992-4#1)(2012-2#1)
tissue may be##5##3##(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
tissue may##9##2##(2007-11#1)(2007-9#1)(2008-12#1)(2008-7#2)(2008-8#1)(2011-2#1)(2013-8#2)
tissue measurements##2##2##(2008-3#1)(2011-1#1)
tissue metabolism##4##2##(1994-11#1)(2008-7#1)(2012-12#2)
tissue microarray##4##2##(2008-10#1)(2008-11#1)(2008-4#1)(2013-1#1)
tissue microarrays##3##2##(2008-4#1)(2009-4#1)(2011-2#1)
tissue microenvironment##3##2##(1990-5#1)(2007-10#1)(2011-2#1)
tissue microstructure##3##2##(2007-12#1)(2010-4#1)(2012-2#1)
tissue mineral##3##2##(1991-12#1)(1993-7#1)(2007-2#1)
tissue mineralization##2##2##(2008-11#2)
tissue model##5##2##(1992-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-9#1)
tissue models##6##2##(2008-3#1)(2008-7#2)(2010-9#1)(2011-1#1)(2012-12#1)
tissue molecular##2##2##(2008-7#1)(2009-12#1)
tissue morphogenesis##3##2##(1993-4#1)(2006-6#1)(2007-12#1)
tissue morphology and##4##3##(2008-3#1)(2008-5#1)(2011-1#1)(2011-12#1)
tissue morphology##6##2##(2007-11#1)(2008-3#1)(2008-5#1)(2011-1#2)(2011-12#1)
tissue motion##4##2##(2008-10#1)(2008-3#1)(2009-7#1)(2010-6#1)
tissue naevus##2##2##(2007-7#2)
tissue necrosis and##2##3##(1996-5#1)(2008-6#1)
tissue necrosis##12##2##(1996-10#1)(1996-5#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#3)(2008-6#2)
tissue needed##2##2##(2007-11#1)(2011-2#1)
tissue needs##2##2##(1997-1#1)(2008-1#1)
tissue nitrogen##3##2##(2008-10#3)
tissue non-specific##2##2##(1990-6#1)(2009-11#1)
tissue nuclear##2##2##(1994-9#1)(2010-12#1)
tissue obtained at##2##3##(1993-3#1)(2007-8#1)
tissue obtained from##4##3##(1993-3#1)(1996-4#1)(2011-1#1)(2012-2#1)
tissue obtained##9##2##(1992-12#1)(1993-3#2)(1996-4#1)(2007-12#1)(2007-8#1)(2011-1#1)(2012-2#1)(2013-7#1)
tissue of a##4##3##(1991-10#1)(1992-8#1)(1996-2#1)(2012-2#1)
tissue of both##2##3##(1990-7#1)(1997-4#1)
tissue of bulgy##4##3##(2012-12#4)
tissue of interest##2##3##(2009-11#1)(2012-2#1)
tissue of patients with##3##4##(1990-10#1)(1993-11#1)(2007-11#1)
tissue of the##27##3##(1990-2#1)(1991-2#1)(1991-3#1)(1994-9#1)(1996-4#1)(1996-6#1)(1997-3#1)(2006-9#1)(2007-12#3)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#2)(2011-2#2)(2012-12#1)(2013-7#1)
tissue of transgenic tomato##2##4##(2008-10#2)
tissue of transgenic##4##3##(1994-12#1)(2008-10#2)(2008-9#1)
tissue of##111##2##(1990-10#1)(1990-2#1)(1990-7#2)(1991-10#1)(1991-2#1)(1991-3#1)(1992-2#2)(1992-4#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-9#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-4#2)(1996-6#1)(1996-7#1)(1997-3#1)(1997-4#2)(1997-6#1)(2004-11#1)(2004-9#1)(2006-12#1)(2006-6#1)(2006-9#2)(2007-11#1)(2007-12#3)(2007-3#1)(2007-7#1)(2007-8#3)(2008-10#16)(2008-11#3)(2008-12#1)(2008-4#3)(2008-5#5)(2008-7#6)(2008-8#5)(2008-9#1)(2009-11#1)(2009-9#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)
tissue on the basis##2##4##(1990-10#1)(2012-12#1)
tissue on the##3##3##(1990-10#1)(2009-4#1)(2012-12#1)
tissue on##8##2##(1990-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-4#1)(2012-12#2)
tissue only##2##2##(1990-11#1)(1994-8#1)
tissue optical properties from##3##4##(2008-2#1)(2008-3#1)(2011-1#1)
tissue optical properties in##2##4##(2008-2#1)(2008-3#1)
tissue optical properties##15##3##(1997-6#1)(2007-12#1)(2008-2#5)(2008-3#6)(2011-1#2)
tissue optical##19##2##(1997-6#2)(2007-12#1)(2008-2#5)(2008-3#7)(2011-1#4)
tissue or as##2##3##(1995-11#1)(2006-3#1)
tissue or cell type##2##4##(1996-8#1)(2008-7#1)
tissue or cells##2##3##(1991-12#1)(2013-8#1)
tissue or organ and##2##4##(1994-11#1)(2012-2#1)
tissue or organ##7##3##(1994-11#1)(2007-3#1)(2008-5#1)(2008-9#1)(2012-12#2)(2012-2#1)
tissue or##31##2##(1991-12#2)(1994-11#1)(1995-11#1)(1996-8#1)(2005-10#1)(2006-3#1)(2006-5#1)(2007-3#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-9#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#2)
tissue organic base##3##3##(2006-6#3)
tissue organization and##3##3##(2007-12#1)(2008-5#1)(2009-5#1)
tissue organization##6##2##(2007-12#1)(2008-5#1)(2009-10#1)(2009-5#1)(2012-12#1)(2013-1#1)
tissue origin##5##2##(1992-4#1)(1994-9#3)(2007-11#1)
tissue overgrowth##2##2##(2008-9#2)
tissue oximeter based on##2##4##(2008-3#2)
tissue oxygen pressure##2##3##(2006-10#2)
tissue oxygen##7##2##(1996-3#2)(2006-10#3)(2006-7#1)(2009-11#1)
tissue oxygenation##9##2##(1993-4#1)(2006-10#4)(2007-8#1)(2009-5#1)(2011-1#1)(2011-2#1)
tissue pH and ATP##2##4##(1990-4#1)(1992-3#1)
tissue pH##3##2##(1990-4#1)(1992-3#1)(2008-10#1)
tissue pathologies##3##2##(1994-5#1)(2008-8#1)(2012-2#1)
tissue pathology##5##2##(1996-10#1)(2007-12#3)(2010-12#1)
tissue penetration##6##2##(1991-12#2)(1997-8#1)(2008-5#1)(2010-10#1)(2010-12#1)
tissue perfusion during##2##3##(2007-7#2)
tissue perfusion##16##2##(1993-2#1)(2006-10#3)(2006-2#1)(2007-10#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-7#1)(2011-2#2)(2013-1#2)
tissue phantom for a##2##4##(2008-3#2)
tissue phantom##5##2##(2008-3#4)(2011-1#1)
tissue phantoms and in##2##4##(2007-11#1)(2011-1#1)
tissue phantoms and##3##3##(2007-11#1)(2007-12#1)(2011-1#1)
tissue phantoms containing##4##3##(2007-12#2)(2008-2#1)(2011-1#1)
tissue phantoms that##2##3##(2007-12#1)(2008-2#1)
tissue phantoms##16##2##(2007-11#2)(2007-12#7)(2007-5#1)(2008-2#2)(2008-3#2)(2011-1#2)
tissue pharmacokinetics##2##2##(2008-8#1)(2011-1#1)
tissue pieces were##2##3##(1995-7#1)(2011-1#1)
tissue pieces##3##2##(1995-7#1)(2008-9#1)(2011-1#1)
tissue plasminogen activator (TPA)##2##4##(2007-9#1)(2008-8#1)
tissue plasminogen activator (rt-PA)##4##4##(2007-10#2)(2007-9#1)(2008-7#1)
tissue plasminogen activator (t-PA##2##4##(1990-12#1)(2007-9#1)
tissue plasminogen activator (t-PA) for acute ischemic stroke##2##8##(2007-10#1)(2007-9#1)
tissue plasminogen activator (t-PA) in##2##5##(1990-11#1)(2007-9#1)
tissue plasminogen activator (t-PA)##11##4##(1990-11#2)(1990-5#1)(1992-2#1)(1996-8#1)(2007-10#2)(2007-9#3)(2010-12#1)
tissue plasminogen activator (tPA)##2##4##(1990-9#1)(2007-7#1)
tissue plasminogen activator for##4##4##(2006-12#1)(2007-5#1)(2007-9#1)(2008-7#1)
tissue plasminogen activator in##3##4##(1990-11#1)(2007-9#1)(2008-7#1)
tissue plasminogen activator is##2##4##(2007-10#1)(2013-7#1)
tissue plasminogen activator with##2##4##(2007-11#1)(2010-8#1)
tissue plasminogen activator##66##3##(1990-11#4)(1990-12#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-9#2)(1992-12#2)(1992-2#1)(1992-7#1)(1993-2#1)(1994-5#1)(1996-8#1)(1997-2#3)(2005-10#1)(2006-12#1)(2007-10#8)(2007-11#2)(2007-5#1)(2007-7#2)(2007-9#13)(2008-11#1)(2008-7#6)(2008-8#2)(2009-11#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2013-7#2)(2013-8#1)
tissue plasminogen##67##2##(1990-11#4)(1990-12#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-9#2)(1992-12#2)(1992-2#1)(1992-7#1)(1993-2#1)(1994-5#1)(1996-8#1)(1997-2#3)(2005-10#1)(2006-12#1)(2007-10#8)(2007-11#2)(2007-5#1)(2007-7#2)(2007-9#13)(2008-11#2)(2008-7#6)(2008-8#2)(2009-11#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2013-7#2)(2013-8#1)
tissue polypeptide antigen (TPA)##3##4##(1990-10#2)(1990-8#1)
tissue polypeptide antigen##4##3##(1990-10#2)(1990-8#2)
tissue portion##2##2##(2012-12#1)(2013-1#1)
tissue preparation##2##2##(2008-4#2)
tissue preparations gave##2##3##(1993-4#2)
tissue preparations##11##2##(1990-2#1)(1990-5#1)(1990-7#1)(1993-1#1)(1993-4#3)(1994-3#1)(1994-9#1)(1995-7#1)(1996-12#1)
tissue preservation and##2##3##(2008-10#1)(2008-2#1)
tissue preservation in##2##3##(2008-10#1)(2012-2#1)
tissue preservation is##2##3##(1996-3#1)(2008-5#1)
tissue preservation##6##2##(1996-3#1)(2008-10#2)(2008-2#1)(2008-5#1)(2012-2#1)
tissue prior to##2##3##(1995-7#1)(2008-4#1)
tissue procedures##2##2##(2006-4#1)(2007-7#1)
tissue processing##2##2##(1997-7#1)(2008-2#1)
tissue procurement##2##2##(2010-9#2)
tissue produces##2##2##(2007-11#1)(2010-2#1)
tissue production##2##2##(2007-11#1)(2008-1#1)
tissue proliferation##3##2##(1992-9#1)(2007-8#1)(2010-2#1)
tissue properties##6##2##(2006-11#3)(2007-5#2)(2011-1#1)
tissue protective mechanisms##2##3##(2008-4#2)
tissue protective##4##2##(2008-4#2)(2012-12#1)(2013-1#1)
tissue protein biomarkers##2##3##(2010-9#2)
tissue protein##5##2##(2010-9#3)(2013-1#2)
tissue proteins by##2##3##(1991-3#1)(1995-8#1)
tissue proteins##6##2##(1991-3#1)(1994-5#1)(1995-6#1)(1995-8#2)(2008-5#1)
tissue provides##2##2##(2006-12#1)(2012-3#1)
tissue rather than##2##3##(1990-2#1)(2010-12#1)
tissue reaction to the##2##4##(2004-9#1)(2013-1#1)
tissue reaction to##3##3##(2004-9#1)(2013-1#2)
tissue reaction##10##2##(2004-9#2)(2007-7#1)(2012-12#1)(2013-1#6)
tissue reactions##4##2##(2004-9#2)(2009-12#1)(2013-1#1)
tissue reconstruction##7##2##(2007-8#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-8#1)
tissue recovery##2##2##(2008-5#1)(2008-7#1)
tissue regeneration and##7##3##(1993-2#1)(2007-8#1)(2009-4#1)(2010-3#1)(2012-12#1)(2012-3#2)
tissue regeneration following##3##3##(2008-10#1)(2009-4#1)(2012-12#1)
tissue regeneration##46##2##(1990-9#1)(1993-2#1)(1996-4#1)(1997-3#1)(2006-5#1)(2006-6#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-5#5)(2009-12#2)(2009-2#1)(2009-4#3)(2009-5#1)(2010-10#4)(2010-3#1)(2012-1#1)(2012-11#2)(2012-12#7)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#1)
tissue regions##3##2##(2009-8#1)(2011-1#1)(2011-2#1)
tissue regression##2##2##(2007-3#1)(2009-8#1)
tissue remained##4##2##(1990-5#1)(2007-9#1)(2008-10#2)
tissue remains##2##2##(1991-2#1)(2010-9#1)
tissue remodeling and fibrosis##2##4##(2012-12#2)
tissue remodeling and##3##3##(2012-12#2)(2012-2#1)
tissue remodeling##11##2##(1995-10#1)(1997-2#1)(2006-10#2)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)
tissue remodelling and##2##3##(2008-11#1)(2012-3#1)
tissue remodelling##6##2##(1990-9#1)(1991-10#1)(2005-7#1)(2008-11#1)(2009-5#1)(2012-3#1)
tissue removed from##2##3##(1992-7#2)
tissue removed##4##2##(1992-7#2)(2006-9#1)(2011-2#1)
tissue renewal##2##2##(2011-1#2)
tissue repair and regeneration##2##4##(2008-1#1)(2012-12#1)
tissue repair and##3##3##(2008-1#1)(2012-12#1)(2013-1#1)
tissue repair in##2##3##(1997-3#1)(2008-8#1)
tissue repair response##2##3##(1997-3#2)
tissue repair was##2##3##(1993-2#1)(1997-3#1)
tissue repair##34##2##(1993-2#2)(1996-11#1)(1997-3#10)(2006-10#1)(2006-6#1)(2008-1#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-9#1)(2012-12#4)(2012-2#1)(2013-1#4)
tissue replacement##2##2##(2008-5#1)(2012-12#1)
tissue research##2##2##(1992-7#1)(1996-2#1)
tissue resident effector memory CD8+##2##5##(2013-8#2)
tissue resident##3##2##(2013-8#3)
tissue resolution##2##2##(2009-6#1)(2010-12#1)
tissue respectively##2##2##(1991-8#1)(2008-12#1)
tissue response to##3##3##(1995-9#1)(2008-9#1)(2013-8#1)
tissue response##9##2##(1995-9#1)(2004-9#2)(2006-11#2)(2007-4#1)(2008-4#1)(2008-9#1)(2013-8#1)
tissue responses##2##2##(2007-10#1)(2010-4#1)
tissue responsiveness##2##2##(2006-10#1)(2010-10#1)
tissue resulting##2##2##(2008-8#1)(2009-4#1)
tissue revealed the presence of##2##5##(1996-5#1)(2010-12#1)
tissue revealed##4##2##(1994-6#1)(1996-2#1)(1996-5#1)(2010-12#1)
tissue sample and##2##3##(2008-5#1)(2010-12#1)
tissue sample with##2##3##(1990-10#1)(1996-12#1)
tissue sample##16##2##(1990-10#1)(1991-5#1)(1991-8#1)(1996-12#1)(2006-5#1)(2006-6#2)(2007-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-12#1)(2013-1#1)
tissue samples and##2##3##(2007-11#1)(2012-3#1)
tissue samples from##10##3##(1992-4#1)(1995-12#1)(1995-5#1)(2007-2#1)(2008-6#1)(2009-4#1)(2011-2#2)(2013-1#1)(2013-8#1)
tissue samples obtained##3##3##(1990-5#1)(1996-6#1)(1996-9#1)
tissue samples of##8##3##(1996-12#1)(2007-2#1)(2007-8#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-12#1)(2011-2#1)
tissue samples on##2##3##(2008-10#1)(2012-3#1)
tissue samples to##2##3##(2006-5#1)(2008-3#1)
tissue samples using##2##3##(1990-9#1)(2008-10#1)
tissue samples were obtained from##2##5##(1994-9#1)(2007-8#1)
tissue samples were obtained##3##4##(1994-9#1)(2007-8#1)(2011-2#1)
tissue samples were##8##3##(1994-9#1)(2004-1#1)(2007-8#1)(2010-1#1)(2011-1#1)(2011-2#2)(2012-2#1)
tissue samples##81##2##(1990-5#1)(1990-9#1)(1991-8#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-10#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-12#2)(1996-4#1)(1996-6#2)(1996-9#1)(1997-3#1)(2004-1#1)(2005-8#1)(2006-10#3)(2006-5#1)(2007-11#1)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#2)(2010-1#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#6)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
tissue sarcoma of the hand or foot##2##7##(2008-6#2)
tissue sarcoma of the##9##4##(1992-12#1)(2008-6#8)
tissue sarcoma of##11##3##(1992-12#1)(2008-6#9)(2012-12#1)
tissue sarcoma##60##2##(1990-10#2)(1992-12#1)(1994-7#1)(1995-4#1)(2006-6#1)(2007-2#1)(2008-6#46)(2008-7#1)(2009-3#1)(2010-3#1)(2012-12#4)
tissue sarcomas (STS)##4##3##(2008-6#2)(2012-12#2)
tissue sarcomas are rare##2##4##(2008-6#2)
tissue sarcomas are##7##3##(2008-6#6)(2009-3#1)
tissue sarcomas of the##5##4##(1993-9#1)(2007-4#1)(2008-6#1)(2008-7#1)(2013-7#1)
tissue sarcomas##65##2##(1992-12#3)(1993-9#1)(2006-6#4)(2007-2#1)(2007-4#1)(2008-6#47)(2008-7#1)(2009-3#2)(2011-2#1)(2012-12#3)(2013-7#1)
tissue scaffolds##2##2##(2009-7#1)(2010-9#1)
tissue scattering##2##2##(2007-12#1)(2008-2#1)
tissue section using##3##3##(2004-1#1)(2008-11#2)
tissue section##7##2##(1996-12#2)(2004-1#1)(2008-11#4)
tissue sections and##2##3##(2009-5#1)(2010-11#1)
tissue sections for##2##3##(2008-2#1)(2008-4#1)
tissue sections from##3##3##(1993-11#1)(1993-7#1)(1994-7#1)
tissue sections of##10##3##(1993-9#1)(1994-2#1)(1995-10#1)(1996-3#1)(2008-4#2)(2010-11#1)(2010-3#1)(2010-7#1)(2012-2#1)
tissue sections to##3##3##(1993-11#1)(1994-9#1)(2008-4#1)
tissue sections using##2##3##(1991-5#1)(2008-6#1)
tissue sections##45##2##(1990-2#1)(1990-7#1)(1991-5#1)(1993-11#2)(1993-7#1)(1993-9#1)(1994-2#1)(1994-7#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-9#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#9)(2008-5#2)(2008-6#1)(2009-5#1)(2010-11#2)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
tissue selected##2##2##(2008-10#1)(2011-2#1)
tissue selectivity##3##2##(1997-5#2)(2008-4#1)
tissue selenium##3##2##(1993-12#3)
tissue should be##2##3##(2012-10#1)(2013-8#1)
tissue showed that the##2##4##(1994-3#1)(2008-10#1)
tissue showed that##3##3##(1994-3#1)(2008-10#1)(2008-8#1)
tissue showed##13##2##(1991-8#1)(1994-3#1)(1996-12#1)(1997-6#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2011-2#1)
tissue showing##2##2##(1992-1#1)(1996-5#1)
tissue shows##3##2##(2005-10#1)(2006-9#1)(2008-7#1)
tissue site##3##2##(1991-3#1)(1997-7#1)(2009-9#1)
tissue sites##4##2##(1991-10#1)(2005-7#2)(2008-3#1)
tissue size##2##2##(1992-3#1)(2008-1#1)
tissue slices##10##2##(1991-11#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-3#1)(2008-8#1)(2011-1#1)(2011-3#2)
tissue slides##2##2##(2008-4#1)(2009-4#1)
tissue source##4##2##(1991-8#1)(2004-11#1)(2008-1#1)(2008-11#1)
tissue sources (e##3##3##(2008-4#3)
tissue sources##9##2##(1991-4#1)(1995-8#1)(2008-1#1)(2008-4#4)(2009-9#1)(2012-12#1)
tissue sparing##4##2##(1994-12#1)(2006-12#1)(2008-3#1)(2009-4#1)
tissue specific expression of the##2##5##(1991-12#1)(1993-9#1)
tissue specific expression of##5##4##(1991-12#1)(1992-12#1)(1993-9#1)(1994-11#1)(2008-11#1)
tissue specific expression##8##3##(1991-12#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-9#1)(1994-11#1)(2008-11#1)(2008-8#1)
tissue specific##29##2##(1990-12#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-11#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-8#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-3#1)
tissue specificity of##7##3##(1992-12#1)(1993-6#1)(1995-8#1)(1997-2#2)(2006-10#1)(2008-9#1)
tissue specificity##15##2##(1991-5#1)(1991-9#1)(1992-12#1)(1993-6#1)(1995-8#2)(1997-2#3)(2006-10#1)(2006-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-10#1)
tissue specimen##2##2##(1992-8#1)(2008-5#1)
tissue specimens was##2##3##(1994-6#1)(1994-9#1)
tissue specimens were used for##2##5##(2008-8#2)
tissue specimens were##3##3##(2008-8#2)(2011-2#1)
tissue specimens##25##2##(1991-2#1)(1991-7#2)(1992-7#1)(1992-8#1)(1994-2#1)(1994-6#1)(1994-9#1)(2004-1#1)(2006-4#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)(2011-2#2)(2012-1#2)(2012-12#1)(2013-8#1)
tissue stability##3##2##(2008-4#2)(2010-9#1)
tissue stiffness##2##2##(2009-6#1)(2009-7#1)
tissue strain##2##2##(2006-11#1)(2010-8#1)
tissue stress##2##2##(1995-2#1)(2008-4#1)
tissue structure and composition##3##4##(2007-11#1)(2008-3#1)(2012-2#1)
tissue structure and##4##3##(2007-11#2)(2008-3#1)(2012-2#1)
tissue structure##14##2##(2006-9#1)(2007-11#5)(2007-8#2)(2008-2#1)(2008-3#2)(2008-4#1)(2009-12#1)(2012-2#1)
tissue structures##13##2##(1992-5#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-10#1)(2010-9#2)(2012-11#2)
tissue substrate##2##2##(2007-11#1)(2008-5#1)
tissue such as##2##3##(2006-10#1)(2008-9#1)
tissue suggests a##2##3##(1995-8#1)(2008-10#1)
tissue suggests##3##2##(1995-8#1)(2008-10#1)(2013-8#1)
tissue support##2##2##(2008-7#1)(2012-3#1)
tissue surface##15##2##(2008-2#4)(2008-3#5)(2009-11#1)(2011-1#2)(2013-1#3)
tissue surrounding a##2##3##(2008-5#1)(2013-1#1)
tissue surrounding##4##2##(2006-12#1)(2008-5#1)(2013-1#1)(2013-8#1)
tissue survival##2##2##(2008-7#1)(2008-9#1)
tissue susceptibility to##3##3##(2008-10#2)(2008-8#1)
tissue swelling##3##2##(2007-11#1)(2008-5#1)(2013-1#1)
tissue than in##4##3##(1997-4#1)(2006-9#1)(2008-10#1)(2009-11#1)
tissue than the##3##3##(1991-8#1)(1995-12#1)(2013-1#1)
tissue than##10##2##(1991-8#1)(1995-12#1)(1997-4#1)(2006-9#1)(2008-10#3)(2008-2#1)(2009-11#1)(2013-1#1)
tissue that developed##2##3##(2008-10#1)(2008-6#1)
tissue that has been##4##4##(2006-8#1)(2008-4#2)(2011-1#1)
tissue that is##2##3##(2008-5#1)(2008-7#1)
tissue that##24##2##(2006-11#1)(2006-5#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-6#1)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
tissue therapy##2##2##(2004-3#1)(2013-1#1)
tissue thickness##7##2##(1996-5#1)(2008-3#4)(2008-5#2)
tissue through the##2##3##(2009-12#1)(2009-6#1)
tissue to be##4##3##(1996-12#1)(2007-9#1)(2008-11#1)(2011-2#1)
tissue to the liver##2##4##(1991-7#1)(2008-6#1)
tissue to the##6##3##(1991-7#1)(2005-1#1)(2008-3#2)(2008-6#1)(2011-2#1)
tissue to##37##2##(1990-2#1)(1990-5#1)(1991-7#1)(1991-9#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-5#1)(1994-6#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(2004-9#2)(2005-1#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)
tissue toxicity##3##2##(1993-1#1)(2007-11#1)(2008-2#1)
tissue transfer technique##2##3##(2007-12#1)(2011-12#1)
tissue transfer##9##2##(2006-12#2)(2006-3#1)(2007-12#1)(2008-4#1)(2011-12#1)(2011-2#2)(2012-12#1)
tissue transglutaminase (TGase)##2##3##(1990-7#1)(2008-1#1)
tissue transglutaminase gene##4##3##(1991-2#1)(1997-4#3)
tissue transglutaminase##14##2##(1990-12#2)(1990-7#1)(1991-2#2)(1992-8#1)(1994-9#1)(1997-4#3)(2006-10#2)(2008-1#1)(2008-9#1)
tissue transplantation##2##2##(1990-6#1)(2008-1#1)
tissue transport##2##2##(1992-11#1)(2008-6#1)
tissue trauma and##2##3##(2006-12#1)(2008-12#1)
tissue trauma##5##2##(2006-12#1)(2007-8#1)(2008-12#1)(2009-11#1)(2009-4#1)
tissue tropism and##2##3##(2008-5#1)(2010-7#1)
tissue tropisms##3##2##(2008-10#1)(2008-5#2)
tissue tumors##8##2##(1994-10#1)(1994-6#1)(2007-8#1)(2011-1#1)(2011-2#3)(2012-12#1)
tissue tumours of##3##3##(2007-10#1)(2008-12#1)(2008-6#1)
tissue tumours##12##2##(2007-10#1)(2008-12#1)(2008-6#6)(2008-7#1)(2012-2#3)
tissue type plasminogen activator##4##4##(1994-3#1)(1995-3#1)(1996-9#1)(2008-11#1)
tissue type##12##2##(1994-3#1)(1995-2#1)(1995-3#1)(1996-9#1)(2006-5#1)(2006-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2011-1#1)
tissue types##18##2##(1991-11#3)(1992-5#1)(1993-2#1)(1993-6#1)(1994-12#1)(1996-12#1)(2005-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-4#1)(2011-1#2)
tissue under the##2##3##(2006-11#1)(2011-1#1)
tissue under##11##2##(1990-10#1)(1994-12#1)(2006-11#2)(2007-11#1)(2008-10#1)(2008-2#2)(2008-7#1)(2009-7#1)(2011-1#1)
tissue undergoes##2##2##(2009-7#1)(2012-12#1)
tissue undergoing##2##2##(1991-8#1)(1992-4#1)
tissue until##2##2##(2008-10#1)(2013-1#1)
tissue uptake of##3##3##(1990-4#1)(1993-11#1)(1994-5#1)
tissue uptake##6##2##(1990-4#1)(1990-9#1)(1992-9#1)(1993-11#1)(1993-4#1)(1994-5#1)
tissue using a##6##3##(1990-2#1)(2006-6#2)(2008-10#2)(2011-1#1)
tissue using both conventional##2##4##(2008-9#2)
tissue using the##3##3##(2007-8#1)(2010-3#1)(2011-1#1)
tissue using##25##2##(1990-2#1)(1991-8#1)(1997-8#1)(2006-10#1)(2006-6#2)(2007-8#2)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-3#1)(2011-1#5)(2012-2#1)
tissue vaporized##2##2##(1991-2#2)
tissue versus##3##2##(1995-1#2)(2007-8#1)
tissue via##4##2##(1994-6#1)(2007-12#2)(2008-5#1)
tissue viability and##2##3##(1993-4#1)(2011-2#1)
tissue viability##7##2##(1993-4#1)(1994-5#1)(1997-6#3)(2007-7#1)(2011-2#1)
tissue volume##2##2##(1997-8#1)(2007-9#1)
tissue volumes##2##2##(2011-1#1)(2012-2#1)
tissue was also examined##2##4##(1992-3#1)(1997-2#1)
tissue was also##5##3##(1992-3#1)(1997-2#1)(2007-11#1)(2008-10#1)(2013-1#1)
tissue was associated with##2##4##(2008-10#2)
tissue was dissociated into##2##4##(1994-3#1)(2008-11#1)
tissue was examined##3##3##(2010-2#1)(2011-2#1)(2013-1#1)
tissue was found to be##2##5##(2003-11#1)(2008-3#1)
tissue was found to##3##4##(2003-11#1)(2008-3#1)(2008-4#1)
tissue was found##5##3##(2003-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-8#1)
tissue was measured##6##3##(1991-3#1)(2007-10#1)(2007-9#1)(2008-3#1)(2012-2#1)(2013-1#1)
tissue was much##2##3##(1993-11#1)(2008-9#1)
tissue was observed in##2##4##(2008-4#1)(2012-1#1)
tissue was observed##4##3##(1994-9#1)(2008-4#1)(2010-12#1)(2012-1#1)
tissue was performed##2##3##(2007-6#1)(2009-2#1)
tissue was present##2##3##(2006-12#1)(2008-1#1)
tissue was removed and##2##4##(1997-2#1)(2012-11#1)
tissue was removed##4##3##(1997-2#1)(2008-11#1)(2012-11#1)(2012-3#1)
tissue was studied##4##3##(2007-1#1)(2008-10#1)(2008-3#1)(2011-2#1)
tissue was##99##2##(1990-9#3)(1991-3#2)(1991-9#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-4#1)(1995-9#1)(1996-3#1)(1997-2#2)(2003-11#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#3)(2008-1#1)(2008-10#12)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#2)(2008-6#2)(2008-7#1)(2008-9#3)(2009-2#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#1)
tissue water content##3##3##(2008-10#1)(2011-1#1)(2012-12#1)
tissue water##8##2##(1996-5#1)(1997-5#1)(2008-10#2)(2008-2#1)(2008-7#1)(2011-1#1)(2012-12#1)
tissue weight##5##2##(1993-4#1)(1995-5#1)(1997-7#1)(2008-10#2)
tissue were developed##2##3##(2008-10#2)
tissue were evaluated##2##3##(1994-6#1)(2008-5#1)
tissue were measured to##2##4##(2008-10#1)(2010-4#1)
tissue were measured##3##3##(2008-10#1)(2008-3#1)(2010-4#1)
tissue were observed##2##3##(2007-1#1)(2012-1#1)
tissue were performed##2##3##(1994-5#1)(2006-6#1)
tissue were##40##2##(1990-2#1)(1990-5#1)(1991-8#1)(1992-9#1)(1993-4#1)(1993-8#1)(1994-5#1)(1994-6#1)(1996-5#1)(1996-7#1)(2004-4#1)(2005-12#2)(2006-11#2)(2006-6#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-10#9)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-2#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
tissue when##4##2##(2006-2#1)(2006-5#1)(2008-10#1)(2009-6#1)
tissue where the##2##3##(2007-10#1)(2010-11#1)
tissue where they##4##3##(2008-1#1)(2008-3#1)(2008-4#1)(2012-1#1)
tissue where##7##2##(1994-12#1)(2007-10#1)(2008-1#1)(2008-3#1)(2008-4#1)(2010-11#1)(2012-1#1)
tissue which##2##2##(1994-3#1)(2009-8#1)
tissue whose##2##2##(2007-11#1)(2012-12#1)
tissue with a##3##3##(2007-12#1)(2008-11#1)(2008-9#1)
tissue with high spatial##2##4##(2007-12#1)(2008-10#1)
tissue with high##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
tissue with the##4##3##(2005-10#1)(2008-10#2)(2010-3#1)
tissue with##39##2##(1991-8#1)(1993-12#2)(1995-3#1)(1997-6#1)(2005-10#1)(2006-4#1)(2007-12#4)(2007-5#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-1#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-11#2)(2013-1#1)(2013-7#1)
tissue within the##5##3##(2005-8#1)(2006-12#1)(2008-10#1)(2009-12#1)(2010-5#1)
tissue within##6##2##(2005-8#1)(2006-12#1)(2008-10#1)(2009-12#1)(2009-5#1)(2010-5#1)
tissue without the##2##3##(2007-11#1)(2008-10#1)
tissue without##8##2##(1997-5#1)(2007-11#1)(2008-10#3)(2009-4#1)(2013-1#1)(2013-8#1)
tissue yielded##3##2##(1996-12#1)(2007-7#1)(2008-2#1)
tissue##5615##1##(1990-10#15)(1990-11#28)(1990-12#21)(1990-2#28)(1990-3#6)(1990-4#13)(1990-5#25)(1990-6#7)(1990-7#20)(1990-8#9)(1990-9#20)(1991-1#3)(1991-10#14)(1991-11#11)(1991-12#24)(1991-2#31)(1991-3#14)(1991-4#6)(1991-5#14)(1991-6#4)(1991-7#6)(1991-8#22)(1991-9#23)(1992-1#10)(1992-10#6)(1992-11#9)(1992-12#26)(1992-2#21)(1992-3#24)(1992-4#11)(1992-5#12)(1992-6#16)(1992-7#16)(1992-8#16)(1992-9#17)(1993-1#6)(1993-10#7)(1993-11#28)(1993-12#19)(1993-2#14)(1993-3#13)(1993-4#22)(1993-5#3)(1993-6#7)(1993-7#4)(1993-8#4)(1993-9#12)(1994-10#8)(1994-11#30)(1994-12#22)(1994-2#17)(1994-3#31)(1994-5#27)(1994-6#23)(1994-7#3)(1994-8#13)(1994-9#20)(1995-1#15)(1995-10#6)(1995-11#18)(1995-12#17)(1995-2#17)(1995-3#30)(1995-4#6)(1995-5#15)(1995-6#18)(1995-7#14)(1995-8#20)(1995-9#10)(1996-1#2)(1996-10#6)(1996-11#10)(1996-12#38)(1996-2#10)(1996-3#16)(1996-4#11)(1996-5#20)(1996-6#7)(1996-7#10)(1996-8#11)(1996-9#9)(1997-1#9)(1997-2#28)(1997-3#30)(1997-4#30)(1997-5#12)(1997-6#21)(1997-7#16)(1997-8#26)(2003-11#1)(2004-1#5)(2004-11#5)(2004-12#1)(2004-2#4)(2004-3#1)(2004-4#4)(2004-7#1)(2004-9#32)(2005-1#2)(2005-10#14)(2005-11#14)(2005-12#8)(2005-3#1)(2005-4#1)(2005-5#1)(2005-7#18)(2005-8#10)(2006-1#3)(2006-10#93)(2006-11#36)(2006-12#32)(2006-2#13)(2006-3#8)(2006-4#16)(2006-5#18)(2006-6#72)(2006-7#10)(2006-8#14)(2006-9#35)(2007-1#20)(2007-10#24)(2007-11#133)(2007-12#121)(2007-2#22)(2007-3#17)(2007-4#17)(2007-5#19)(2007-6#8)(2007-7#42)(2007-8#101)(2007-9#45)(2008-1#84)(2008-10#356)(2008-11#121)(2008-12#37)(2008-2#106)(2008-3#163)(2008-4#145)(2008-5#169)(2008-6#146)(2008-7#105)(2008-8#57)(2008-9#96)(2009-1#1)(2009-10#21)(2009-11#27)(2009-12#18)(2009-2#28)(2009-3#39)(2009-4#50)(2009-5#31)(2009-6#25)(2009-7#32)(2009-8#26)(2009-9#23)(2010-1#10)(2010-10#28)(2010-11#21)(2010-12#58)(2010-2#33)(2010-3#22)(2010-4#24)(2010-5#10)(2010-6#23)(2010-7#10)(2010-8#33)(2010-9#44)(2011-1#122)(2011-12#21)(2011-2#144)(2011-3#5)(2012-1#48)(2012-10#2)(2012-11#35)(2012-12#142)(2012-2#120)(2012-3#55)(2012-5#4)(2012-6#1)(2012-8#6)(2013-1#163)(2013-7#35)(2013-8#59)
tissue's##4##1##(2007-3#1)(2007-7#2)(2009-7#1)
tissue) and##3##2##(1995-12#1)(2006-7#1)(2013-1#1)
tissue) from##2##2##(2008-3#1)(2013-1#1)
tissue) in##2##2##(1990-4#1)(1996-11#1)
tissue) were##2##2##(1995-5#1)(2010-12#1)
tissue)##24##1##(1990-10#1)(1990-4#1)(1991-7#1)(1992-8#1)(1994-2#2)(1994-6#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-12#2)(2004-9#1)(2006-7#1)(2008-12#1)(2008-3#2)(2008-5#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-7#1)
tissue- and cell-specific##4##3##(1992-9#1)(1994-5#1)(2007-12#2)
tissue- and##6##2##(1991-9#1)(1992-9#1)(1994-5#1)(1995-2#1)(2007-12#2)
tissue- or##2##2##(1992-9#1)(2008-9#1)
tissue-##12##1##(1991-9#1)(1992-9#2)(1994-5#1)(1995-2#1)(2007-12#3)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
tissue-based##2##1##(2008-4#1)(2013-1#1)
tissue-culture flasks##2##2##(1991-9#1)(2013-8#1)
tissue-culture polystyrene##2##2##(2008-11#2)
tissue-culture##7##1##(1991-6#1)(1991-9#1)(1992-9#1)(2008-11#2)(2010-3#1)(2013-8#1)
tissue-dependent manner##2##2##(1992-11#1)(2012-2#1)
tissue-dependent##4##1##(1992-11#1)(1993-2#1)(2008-10#1)(2012-2#1)
tissue-derived stem cells##3##3##(2009-2#1)(2010-11#1)(2012-12#1)
tissue-derived stem##4##2##(2009-2#1)(2010-11#2)(2012-12#1)
tissue-derived##5##1##(2008-11#1)(2009-2#1)(2010-11#2)(2012-12#1)
tissue-engineered bone##2##2##(2008-5#2)
tissue-engineered##16##1##(2005-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-6#1)(2009-9#1)(2010-3#2)(2010-5#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-8#1)
tissue-engineering##5##1##(2007-8#1)(2008-1#1)(2008-11#1)(2010-8#1)(2013-8#1)
tissue-equivalent phantom##2##2##(2008-3#1)(2011-2#1)
tissue-equivalent##4##1##(1993-9#1)(2008-3#2)(2011-2#1)
tissue-isolated##2##1##(2013-7#2)
tissue-level##2##1##(2009-12#1)(2013-1#1)
tissue-like##8##1##(2008-11#1)(2008-7#1)(2009-12#1)(2010-12#4)(2012-12#1)
tissue-plasminogen activator (tPA)##2##3##(1990-11#1)(2010-3#1)
tissue-plasminogen activator##3##2##(1990-11#2)(2010-3#1)
tissue-restricted##2##1##(1995-3#1)(2008-6#1)
tissue-selective##4##1##(1991-2#1)(1996-8#1)(2008-4#1)(2012-12#1)
tissue-simulating dosimeters##2##2##(2008-2#2)
tissue-simulating phantoms##5##2##(2008-2#2)(2008-3#2)(2011-1#1)
tissue-simulating turbid media##4##3##(2008-2#3)(2008-3#1)
tissue-simulating##14##1##(2008-2#10)(2008-3#3)(2011-1#1)
tissue-specific and developmentally##2##3##(1993-6#1)(1995-11#1)
tissue-specific and##10##2##(1990-11#1)(1990-7#1)(1993-12#1)(1993-6#2)(1993-8#1)(1994-12#2)(1995-11#1)(2006-12#1)
tissue-specific antigens##2##2##(1997-4#1)(2007-11#1)
tissue-specific expression in##2##3##(1992-5#1)(1994-3#1)
tissue-specific expression of the##3##4##(1990-11#1)(1990-8#1)(1997-4#1)
tissue-specific expression of##11##3##(1990-11#2)(1990-8#1)(1992-1#1)(1993-8#1)(1996-7#1)(1997-4#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)
tissue-specific expression patterns##2##3##(2009-8#1)(2010-7#1)
tissue-specific expression##20##2##(1990-11#2)(1990-8#1)(1991-4#1)(1992-1#1)(1992-5#1)(1993-8#1)(1994-12#1)(1994-3#2)(1995-3#1)(1996-4#1)(1996-7#1)(1997-4#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-7#1)
tissue-specific gene expression##2##3##(1991-5#1)(2008-7#1)
tissue-specific gene##4##2##(1991-5#1)(2006-12#1)(2008-7#1)(2012-7#1)
tissue-specific genes##6##2##(1992-5#1)(1993-8#2)(1996-10#1)(1997-4#1)(2008-11#1)
tissue-specific manner to yield##2##4##(1991-6#1)(2008-4#1)
tissue-specific manner to##3##3##(1991-6#1)(1991-9#1)(2008-4#1)
tissue-specific manner##12##2##(1990-12#1)(1991-12#1)(1991-6#1)(1991-9#1)(1994-2#1)(1994-8#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-4#1)(2011-2#1)
tissue-specific promoter##2##2##(1995-1#1)(1997-6#1)
tissue-specific regulatory##3##2##(1991-11#1)(1993-12#1)(2013-7#1)
tissue-specific splicing##2##2##(1991-6#1)(1992-6#1)
tissue-specific transcriptional##3##2##(1991-8#1)(1993-12#1)(1995-3#1)
tissue-specific variations of##2##3##(1995-1#1)(1996-10#1)
tissue-specific variations##3##2##(1991-5#1)(1995-1#1)(1996-10#1)
tissue-specific##127##1##(1990-11#4)(1990-12#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-5#2)(1992-6#3)(1992-9#1)(1993-12#3)(1993-3#1)(1993-6#2)(1993-8#4)(1994-12#4)(1994-2#3)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#4)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#3)(1995-6#2)(1995-8#2)(1995-9#1)(1996-10#3)(1996-2#1)(1996-4#3)(1996-7#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#1)(2006-12#4)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#4)(2008-9#2)(2009-8#2)(2010-10#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-7#1)(2013-1#1)(2013-7#1)(2013-8#1)
tissue-specificity##3##1##(1990-4#1)(1996-10#1)(2008-8#1)
tissue-to-plasma##2##1##(1994-11#2)
tissue-type mast cells##2##3##(1992-3#2)
tissue-type plasminogen activator (t-PA)##8##4##(1990-11#3)(1990-12#1)(1991-1#1)(1995-3#1)(1995-5#1)(1995-8#1)
tissue-type plasminogen activator (tPA)##3##4##(1992-12#1)(2008-5#1)(2008-8#1)
tissue-type plasminogen activator in##2##4##(1990-11#1)(1992-10#1)
tissue-type plasminogen activator##22##3##(1990-11#5)(1990-12#1)(1991-1#1)(1991-3#1)(1992-10#1)(1992-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1997-1#1)(2006-7#1)(2008-11#1)(2008-5#2)(2008-8#1)(2013-7#1)
tissue-type plasminogen##25##2##(1990-11#5)(1990-12#1)(1991-1#1)(1991-3#1)(1992-10#1)(1992-12#1)(1992-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#2)(1997-1#1)(2006-7#1)(2008-11#1)(2008-5#2)(2008-8#1)(2013-7#1)
tissue-type##32##1##(1990-11#5)(1990-12#1)(1991-1#2)(1991-11#1)(1991-3#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1994-3#1)(1994-6#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#2)(1997-1#1)(2006-7#1)(2008-11#1)(2008-5#2)(2008-8#1)(2013-7#1)
tissue/cell##3##1##(1997-4#1)(2008-7#1)(2010-4#1)
tissue?##3##1##(1990-8#1)(2009-10#1)(2009-5#1)
tissue]##7##1##(2005-10#2)(2005-4#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
tissuelike media##2##2##(2007-11#2)
tissuelike phantoms##4##2##(2007-12#1)(2008-3#3)
tissuelike scattering##3##2##(2008-3#3)
tissuelike turbid media##4##3##(2008-2#2)(2008-3#2)
tissuelike##18##1##(2007-11#2)(2007-12#1)(2008-2#4)(2008-3#11)
tissues (e##2##2##(1992-3#1)(2008-5#1)
tissues (liver##4##2##(1990-11#1)(1990-6#1)(1994-12#1)(2008-10#1)
tissues (n =##2##3##(2008-4#2)
tissues (renal##2##2##(2010-12#2)
tissues adjacent to##3##3##(2008-10#2)(2009-4#1)
tissues after the##2##3##(2008-10#1)(2013-1#1)
tissues after##13##2##(1990-4#1)(1992-9#1)(1995-12#1)(1996-12#1)(1997-4#1)(2004-9#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)
tissues against##3##2##(1994-11#1)(1994-5#1)(2008-7#1)
tissues and a##3##3##(1991-5#1)(2006-2#1)(2012-12#1)
tissues and are##3##3##(1997-7#1)(2008-4#1)(2008-9#1)
tissues and biological##3##3##(1992-1#1)(2008-12#1)(2012-11#1)
tissues and body fluids##2##4##(2005-8#1)(2008-4#1)
tissues and by##2##3##(1994-4#1)(2008-10#1)
tissues and cell lines and##2##5##(1994-6#1)(2007-10#1)
tissues and cell lines##7##4##(1992-1#1)(1993-8#1)(1994-6#1)(1995-10#1)(2007-10#1)(2008-8#1)(2008-9#1)
tissues and cells##9##3##(1990-6#1)(1992-9#1)(1994-9#1)(1996-4#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2013-8#1)
tissues and cultures##2##3##(2008-10#1)(2010-10#1)
tissues and fibroblasts from##2##4##(1994-10#2)
tissues and fluids is##2##4##(2007-8#2)
tissues and fluids##4##3##(2007-8#4)
tissues and for##2##3##(2008-11#1)(2013-1#1)
tissues and in the##4##4##(1993-12#1)(2008-11#1)(2009-4#1)(2011-2#1)
tissues and in##8##3##(1993-12#1)(1993-3#1)(1995-3#1)(1997-4#1)(2006-12#1)(2008-11#1)(2009-4#1)(2011-2#1)
tissues and is##7##3##(1992-5#1)(1993-3#1)(1995-6#1)(1996-3#1)(2006-10#1)(2008-10#1)(2010-12#1)
tissues and on##2##3##(2007-12#1)(2008-10#1)
tissues and organs of##2##4##(1996-3#1)(2008-7#1)
tissues and organs##19##3##(1996-3#1)(1996-6#1)(1997-5#1)(2006-11#1)(2006-7#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-12#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
tissues and other##2##3##(2008-3#1)(2008-4#1)
tissues and particularly##2##3##(1993-3#1)(1993-9#1)
tissues and the##12##3##(1995-3#1)(1996-10#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-10#1)(2010-4#1)(2010-8#1)(2013-1#2)
tissues and their##4##3##(2005-7#1)(2007-7#1)(2008-2#1)(2008-9#1)
tissues and to##3##3##(1996-10#1)(1997-3#1)(2008-9#1)
tissues and tumor##2##3##(1994-9#1)(2008-8#1)
tissues and##222##2##(1990-11#1)(1990-5#1)(1990-6#2)(1991-12#1)(1991-5#3)(1991-7#2)(1992-1#2)(1992-11#1)(1992-5#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#5)(1993-8#2)(1993-9#1)(1994-10#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-10#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-3#4)(1996-4#1)(1996-6#1)(1997-2#1)(1997-3#3)(1997-4#3)(1997-5#2)(1997-7#2)(2005-10#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#3)(2006-11#2)(2006-12#2)(2006-2#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-4#1)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#3)(2008-10#17)(2008-11#6)(2008-12#2)(2008-2#4)(2008-3#5)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#8)(2009-10#1)(2009-2#1)(2009-4#5)(2009-5#1)(2009-8#2)(2010-10#4)(2010-12#6)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#4)(2012-3#2)(2013-1#10)(2013-8#4)
tissues are damaged##2##3##(1995-12#1)(2012-12#1)
tissues are##33##2##(1993-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-9#1)(2005-7#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2009-12#1)(2009-7#1)(2009-8#2)(2010-8#2)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
tissues around the##2##3##(2009-4#1)(2013-8#1)
tissues as a##2##3##(1990-8#1)(1991-6#1)
tissues as well as##7##4##(1992-12#1)(1995-5#1)(1997-1#1)(2006-4#1)(2008-11#1)(2008-2#2)
tissues as well##8##3##(1992-12#1)(1995-5#1)(1997-1#1)(2006-4#1)(2008-11#1)(2008-2#2)(2008-9#1)
tissues as##23##2##(1990-8#1)(1991-2#1)(1991-6#1)(1992-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
tissues at all##2##3##(2008-10#1)(2010-9#1)
tissues at different##2##3##(2006-7#1)(2008-8#1)
tissues at the##8##3##(2008-10#1)(2008-11#1)(2008-2#2)(2011-2#1)(2012-11#2)(2012-2#1)
tissues at very low##2##4##(1991-5#1)(2008-7#1)
tissues at##24##2##(1990-8#1)(1991-11#1)(1991-3#1)(1991-5#1)(1994-12#1)(2006-7#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-9#1)(2011-2#1)(2012-11#2)(2012-2#1)(2012-3#1)
tissues based on##4##3##(2007-12#1)(2008-11#1)(2011-1#1)(2012-12#1)
tissues based##5##2##(2007-12#1)(2008-11#1)(2010-12#1)(2011-1#1)(2012-12#1)
tissues but##7##2##(1990-2#1)(1994-12#1)(2006-12#1)(2008-10#1)(2008-9#2)(2013-7#1)
tissues by Northern blot analysis##2##5##(1993-2#1)(1995-6#1)
tissues by Northern blot##3##4##(1990-11#1)(1993-2#1)(1995-6#1)
tissues by flow cytometry##2##4##(2008-11#1)(2008-9#1)
tissues by high-performance liquid chromatography##2##5##(2008-10#1)(2009-8#1)
tissues by the##2##3##(1992-11#1)(2008-10#1)
tissues by use of##2##4##(2008-1#1)(2008-3#1)
tissues by##36##2##(1990-11#1)(1990-5#1)(1990-9#1)(1991-5#1)(1991-9#2)(1992-11#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-7#1)(2006-7#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-3#2)(2008-4#1)(2008-9#1)(2009-8#1)(2010-4#1)(2012-12#1)
tissues can be achieved by##2##5##(2008-3#1)(2012-12#1)
tissues can be used##2##4##(2005-12#1)(2010-10#1)
tissues can be##11##3##(1994-5#1)(2005-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2010-10#1)(2012-12#1)(2013-8#1)
tissues can##16##2##(1990-8#1)(1994-5#1)(2005-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#2)(2009-10#1)(2010-10#1)(2012-12#1)(2013-8#1)
tissues collected from the##2##4##(2006-9#1)(2013-7#1)
tissues collected from##3##3##(2006-9#1)(2008-10#1)(2013-7#1)
tissues collected##4##2##(2006-9#1)(2008-10#2)(2013-7#1)
tissues compared to##2##3##(2008-1#1)(2013-1#1)
tissues compared with##3##3##(1996-3#1)(2010-12#1)(2013-1#1)
tissues compared##5##2##(1996-3#1)(2008-1#1)(2010-12#1)(2013-1#2)
tissues contain##2##2##(1990-2#1)(2008-7#1)
tissues contained##4##2##(1990-12#1)(1995-11#1)(2011-2#2)
tissues containing##5##2##(1990-10#1)(2008-10#2)(2008-11#1)(2008-3#1)
tissues could be##3##3##(2006-11#1)(2008-5#1)(2008-8#1)
tissues could##5##2##(1993-5#1)(2006-11#1)(2008-5#1)(2008-7#1)(2008-8#1)
tissues demonstrated the##2##3##(2007-12#1)(2012-3#1)
tissues demonstrated##3##2##(1993-3#1)(2007-12#1)(2012-3#1)
tissues depends##2##2##(2008-8#1)(2011-2#1)
tissues derived from all three##2##5##(1997-8#1)(2008-10#1)
tissues derived from##4##3##(1994-2#1)(1997-8#1)(2008-10#1)(2008-9#1)
tissues did not##2##3##(2008-10#1)(2012-1#1)
tissues during development##6##3##(1993-2#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-5#1)(2012-12#1)
tissues during the##3##3##(1992-7#1)(1994-5#1)(2012-1#1)
tissues during##17##2##(1990-5#1)(1992-7#1)(1993-2#1)(1994-5#1)(1995-1#1)(2004-3#1)(2006-11#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-5#1)(2012-1#1)(2012-12#1)(2012-2#1)
tissues examined##21##2##(1991-12#1)(1991-5#1)(1992-1#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-7#1)(1994-11#1)(1994-6#1)(1995-10#1)(1996-7#1)(1997-1#1)(1997-4#2)(2008-10#3)(2008-12#1)(2008-5#1)(2008-9#1)(2009-5#1)
tissues except the##2##3##(1995-2#1)(1996-3#1)
tissues except##6##2##(1992-11#1)(1992-9#1)(1995-2#1)(1996-3#1)(2010-5#1)(2011-2#1)
tissues expressing##2##2##(1990-11#1)(1991-10#1)
tissues for the##3##3##(1990-11#1)(2007-11#1)(2008-10#1)
tissues for transplantation##2##3##(2007-1#1)(2009-3#1)
tissues for##23##2##(1990-11#1)(1994-11#1)(1995-8#1)(2005-12#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#2)
tissues from all##2##3##(1990-5#1)(2008-10#1)
tissues from the##6##3##(1992-9#1)(1994-11#1)(2007-2#1)(2008-10#1)(2008-6#1)(2010-2#1)
tissues from##43##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1991-12#1)(1991-7#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-11#2)(1995-6#2)(1996-9#2)(1997-3#1)(2004-12#1)(2007-2#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#1)(2009-5#1)(2010-12#1)(2010-2#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
tissues had##2##2##(1991-8#1)(2008-10#1)
tissues has been##5##3##(1990-6#1)(1996-4#1)(2006-1#1)(2007-6#1)(2009-10#1)
tissues has##7##2##(1990-6#1)(1996-4#1)(2006-1#1)(2007-6#1)(2008-1#1)(2009-10#2)
tissues have been##3##3##(2008-2#1)(2008-5#1)(2010-12#1)
tissues have##10##2##(1990-11#1)(1991-2#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-12#1)(2010-2#1)(2010-4#1)(2012-1#1)(2012-12#1)
tissues in a##3##3##(1994-10#1)(1994-12#1)(2007-10#1)
tissues in both##2##3##(2008-10#1)(2013-1#1)
tissues in the human##2##4##(2008-7#1)(2011-2#1)
tissues in the##20##3##(1990-12#1)(1992-5#1)(1994-12#1)(2006-11#1)(2007-1#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
tissues in vivo##5##3##(1991-12#1)(1994-12#1)(1997-8#1)(2008-2#1)(2008-3#1)
tissues in which the##2##4##(1990-8#1)(2012-3#1)
tissues in which##3##3##(1990-8#1)(1991-5#1)(2012-3#1)
tissues in##72##2##(1990-10#1)(1990-12#1)(1990-8#1)(1991-12#1)(1991-5#2)(1992-2#1)(1992-5#1)(1994-10#2)(1994-12#3)(1994-3#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
tissues including muscle##2##3##(1990-12#1)(1990-9#1)
tissues including the bone##2##4##(2005-7#1)(2013-8#1)
tissues including the testis##2##4##(1995-8#1)(2012-2#1)
tissues including the##10##3##(1994-3#1)(1995-8#1)(2005-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-8#1)
tissues including##19##2##(1990-12#1)(1990-9#1)(1994-12#1)(1994-3#1)(1995-8#1)(1996-5#1)(1996-9#1)(2005-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
tissues indicated that##2##3##(1994-12#1)(2008-5#1)
tissues indicated##5##2##(1990-11#1)(1994-12#1)(2008-5#1)(2008-7#1)(2008-9#1)
tissues indicates that##3##3##(1995-1#1)(1995-6#1)(2010-12#1)
tissues infected with##2##3##(2008-10#2)
tissues inside the##2##3##(2007-11#1)(2011-1#1)
tissues into##5##2##(1997-5#1)(2008-2#1)(2008-4#1)(2012-11#2)
tissues involved in##4##3##(1992-11#1)(1993-6#1)(1995-10#1)(2007-11#1)
tissues involved##6##2##(1990-3#1)(1992-11#1)(1993-6#1)(1995-10#1)(2007-11#1)(2010-6#1)
tissues is a##3##3##(1996-10#1)(2007-8#1)(2010-5#1)
tissues is also##2##3##(1991-7#1)(1996-2#1)
tissues is described##2##3##(2008-1#1)(2008-10#1)
tissues is discussed##2##3##(2007-12#1)(2008-10#1)
tissues is frequently##2##3##(2010-6#1)(2013-8#1)
tissues is the##2##3##(1994-5#1)(2011-1#1)
tissues is##36##2##(1990-2#2)(1991-2#1)(1991-7#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-8#1)(1996-10#1)(1996-2#1)(2004-12#1)(2005-10#1)(2005-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2009-5#1)(2009-8#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2013-8#1)
tissues it is##3##3##(1992-12#1)(2008-4#1)(2008-8#1)
tissues it##4##2##(1992-12#1)(2008-10#1)(2008-4#1)(2008-8#1)
tissues like##4##2##(1991-2#1)(1992-3#1)(2008-4#1)(2009-7#1)
tissues may be##6##3##(1990-8#1)(1994-6#1)(2008-10#1)(2008-12#1)(2009-10#1)(2013-1#1)
tissues may##12##2##(1990-12#1)(1990-8#1)(1992-9#1)(1994-6#1)(1995-10#1)(2006-1#1)(2008-10#2)(2008-12#1)(2009-10#1)(2012-12#1)(2013-1#1)
tissues mediating mating##2##3##(2010-8#2)
tissues might##2##2##(1996-3#1)(2008-5#1)
tissues near##2##2##(1990-8#1)(2008-10#1)
tissues obtained##3##2##(1990-11#1)(1995-3#1)(2005-9#1)
tissues of Astacus##2##3##(2008-12#2)
tissues of a##4##3##(1990-4#1)(1995-1#2)(2008-7#1)
tissues of both##2##3##(1992-3#1)(2006-8#1)
tissues of embryos##2##3##(1992-9#1)(2009-7#1)
tissues of five##2##3##(1994-2#1)(2008-10#1)
tissues of healthy##2##3##(1994-11#1)(2007-12#1)
tissues of human##3##3##(1991-5#1)(1997-5#1)(2005-11#1)
tissues of mice##2##3##(1995-3#1)(2011-1#1)
tissues of patients##2##3##(1993-7#1)(2012-1#1)
tissues of rat##5##3##(1992-3#1)(1992-6#1)(2008-4#3)
tissues of snails##2##3##(2008-12#2)
tissues of the face##2##4##(2007-7#1)(2010-11#1)
tissues of the infected##2##4##(2008-10#1)(2008-9#1)
tissues of the lower##3##4##(2006-9#1)(2008-6#1)(2013-7#1)
tissues of the rat##2##4##(1994-12#1)(1997-4#1)
tissues of the##50##3##(1990-5#1)(1992-10#1)(1992-8#1)(1993-4#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-6#1)(1996-2#2)(1996-3#2)(1997-2#2)(1997-4#2)(2006-10#2)(2006-9#1)(2007-11#2)(2007-4#1)(2007-7#1)(2008-10#4)(2008-12#4)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-6#1)(2010-9#1)(2012-12#2)(2013-7#1)(2013-8#1)
tissues of these##2##3##(1994-2#1)(2006-10#1)
tissues of transgenic##2##3##(1993-12#1)(2008-11#1)
tissues of various##2##3##(1991-6#1)(2007-8#1)
tissues of young##2##3##(1990-5#1)(2007-7#1)
tissues of##171##2##(1990-10#2)(1990-11#3)(1990-4#1)(1990-5#3)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-3#3)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#2)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#3)(1995-10#1)(1995-2#2)(1995-3#2)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-8#1)(1997-2#6)(1997-4#2)(1997-5#2)(1997-6#3)(1997-8#1)(2004-11#1)(2005-11#2)(2006-10#3)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-12#12)(2008-2#1)(2008-3#1)(2008-4#10)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
tissues on the##3##3##(1992-1#1)(1993-9#1)(2009-6#1)
tissues on##6##2##(1992-1#1)(1993-12#1)(1993-9#1)(2007-1#1)(2009-6#1)(2011-1#1)
tissues or organs as well as##2##6##(2007-4#1)(2008-5#1)
tissues or organs##8##3##(2007-4#1)(2008-11#1)(2008-3#1)(2008-5#2)(2009-12#1)(2010-8#1)(2010-9#1)
tissues or the##2##3##(1996-3#1)(2008-4#1)
tissues or##27##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-3#1)(1996-3#1)(2006-4#1)(2007-1#1)(2007-12#1)(2007-4#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#1)(2009-12#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-8#1)
tissues other than##3##3##(1996-10#1)(2007-1#1)(2008-10#1)
tissues outside##2##2##(1991-9#1)(2006-8#1)
tissues revealed a##2##3##(1994-9#1)(2012-2#1)
tissues revealed that the##5##4##(1992-11#1)(1992-9#1)(1994-10#1)(1994-3#1)(1996-2#1)
tissues revealed that##6##3##(1992-11#1)(1992-12#1)(1992-9#1)(1994-10#1)(1994-3#1)(1996-2#1)
tissues revealed the presence of##2##5##(1997-6#1)(2008-10#1)
tissues revealed##13##2##(1992-11#1)(1992-12#1)(1992-9#1)(1994-10#1)(1994-3#1)(1994-9#1)(1995-5#1)(1996-2#1)(1997-5#1)(1997-6#1)(2008-10#2)(2012-2#1)
tissues screened##3##2##(2013-8#3)
tissues should be##2##3##(2005-12#1)(2008-5#1)
tissues should##3##2##(2005-12#1)(2008-5#1)(2008-7#1)
tissues show##2##2##(1993-3#1)(2008-4#1)
tissues showed that the##2##4##(1994-3#1)(1994-9#1)
tissues showed##10##2##(1991-12#1)(1991-8#1)(1993-5#1)(1994-3#1)(1994-9#1)(1995-5#1)(1997-1#1)(2008-10#2)(2008-9#1)
tissues shows##2##2##(2008-7#1)(2008-9#1)
tissues similar##2##2##(1995-11#1)(1997-8#1)
tissues studied##10##2##(1990-11#2)(1990-3#1)(1990-4#1)(1994-10#1)(1994-3#1)(1995-10#1)(1996-5#1)(2008-5#1)(2009-3#1)
tissues subjected to##2##3##(2006-6#1)(2012-1#1)
tissues such as brain##2##4##(1994-5#1)(2008-6#1)
tissues such as liver##2##4##(1990-11#1)(2008-4#1)
tissues such as##23##3##(1990-11#1)(1994-5#1)(1995-5#1)(1996-2#1)(1997-6#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-1#1)
tissues suggests that##3##3##(1990-8#1)(1991-5#1)(2010-10#1)
tissues suggests##4##2##(1990-8#1)(1991-5#1)(2009-4#1)(2010-10#1)
tissues surrounding the##4##3##(1991-5#1)(2008-10#1)(2008-12#1)(2008-5#1)
tissues surrounding##5##2##(1991-5#1)(2008-10#2)(2008-12#1)(2008-5#1)
tissues taken from##2##3##(1997-2#1)(2008-4#1)
tissues tested##14##2##(1990-5#1)(1991-2#1)(1992-3#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-5#1)(1995-8#1)(1997-4#2)(1997-8#1)(2009-12#1)
tissues than##7##2##(1992-9#2)(2008-10#1)(2008-12#1)(2008-4#1)(2010-12#1)(2012-3#1)
tissues that are##5##3##(2005-7#1)(2008-3#2)(2008-7#1)(2010-9#1)
tissues that have##3##3##(2008-7#1)(2008-9#1)(2012-2#1)
tissues that##21##2##(1991-9#1)(1992-9#1)(1994-9#1)(1997-7#1)(2005-7#1)(2007-11#1)(2008-12#1)(2008-3#3)(2008-4#3)(2008-7#3)(2008-9#1)(2010-2#1)(2010-9#1)(2011-1#1)(2012-2#1)
tissues there##2##2##(1992-10#1)(2010-2#1)
tissues through##2##2##(2006-6#1)(2012-1#1)
tissues to biomaterials##3##3##(2004-9#3)
tissues to##25##2##(1993-12#1)(1994-11#2)(1994-8#1)(1994-9#1)(1995-6#3)(1995-8#1)(1997-2#1)(2004-9#3)(2006-11#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-9#1)(2011-1#1)(2012-2#2)(2013-1#1)
tissues under##4##2##(2010-6#1)(2012-2#1)(2013-1#2)
tissues using a##6##3##(1991-5#1)(1991-9#1)(1994-11#1)(1996-10#1)(2013-1#1)(2013-7#1)
tissues using the##3##3##(1990-7#1)(1997-7#1)(2006-6#1)
tissues using##23##2##(1990-11#1)(1990-7#1)(1991-5#1)(1991-9#1)(1993-4#1)(1994-11#1)(1996-10#1)(1997-3#1)(1997-7#1)(2006-6#1)(2007-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-7#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)
tissues via##2##2##(2011-2#1)(2012-12#1)
tissues was found##2##3##(1990-2#1)(2008-8#1)
tissues was observed##2##3##(1992-9#1)(2008-5#1)
tissues was performed##2##3##(2008-3#1)(2008-9#1)
tissues was##27##2##(1990-2#1)(1990-4#1)(1990-5#1)(1992-9#1)(1993-11#1)(1994-5#1)(1995-10#1)(1995-8#1)(1996-3#1)(1997-6#2)(2004-11#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-1#1)(2013-1#1)
tissues were also##4##3##(1990-11#1)(2004-9#1)(2009-12#1)(2013-8#1)
tissues were assessed for##2##4##(1996-3#1)(2007-8#1)
tissues were available from##2##4##(1997-7#1)(2008-5#1)
tissues were collected##4##3##(1993-9#1)(1995-2#1)(2013-1#2)
tissues were determined##2##3##(2008-3#1)(2008-4#1)
tissues were examined##7##3##(1990-3#1)(1990-6#1)(1990-8#1)(1993-9#1)(1997-2#1)(2008-6#1)(2008-7#1)
tissues were found##2##3##(1992-9#1)(2009-10#1)
tissues were less##2##3##(1994-11#1)(2008-10#1)
tissues were measured##2##3##(1994-6#1)(2010-5#1)
tissues were obtained from##3##4##(2007-3#1)(2008-5#1)(2011-1#1)
tissues were obtained##4##3##(2007-3#1)(2008-2#1)(2008-5#1)(2011-1#1)
tissues were sampled##2##3##(2008-12#1)(2009-12#1)
tissues were studied for##2##4##(1991-2#1)(2008-10#1)
tissues were studied##4##3##(1991-2#1)(2008-10#1)(2008-4#1)(2008-5#1)
tissues were successfully##2##3##(2008-3#1)(2008-7#1)
tissues were##76##2##(1990-11#2)(1990-3#2)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-8#1)(1992-9#1)(1993-4#1)(1993-9#2)(1994-11#2)(1994-2#1)(1994-6#2)(1995-12#1)(1995-2#1)(1996-3#1)(1997-2#2)(1997-5#1)(1997-7#2)(2004-9#2)(2006-12#1)(2006-7#1)(2007-12#1)(2007-3#2)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#2)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
tissues when##5##2##(2007-6#1)(2008-5#1)(2010-12#2)(2013-1#1)
tissues where the##2##3##(2008-1#1)(2008-4#1)
tissues where##7##2##(1991-12#1)(1991-9#1)(1994-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2012-2#1)
tissues which are##3##3##(1992-4#1)(2013-1#2)
tissues which##9##2##(1991-5#1)(1992-4#1)(1994-12#1)(1995-3#1)(2008-10#1)(2010-2#1)(2010-8#1)(2013-1#2)
tissues with a##5##3##(1997-4#1)(2004-1#1)(2008-11#1)(2008-7#1)(2010-8#1)
tissues with higher strong reactivity rate##2##6##(2013-1#2)
tissues with no##2##3##(1991-12#1)(1991-7#1)
tissues with the##4##3##(1990-12#1)(1993-2#1)(1994-5#1)(2007-11#1)
tissues with##35##2##(1990-12#1)(1991-12#1)(1991-7#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-3#1)(1994-5#1)(1995-6#1)(1997-4#2)(1997-7#1)(2004-1#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
tissues within the##4##3##(2006-12#1)(2007-8#1)(2008-4#1)(2008-7#1)
tissues within##7##2##(2006-12#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-8#1)
tissues without##2##2##(2008-3#1)(2010-6#1)
tissues would##4##2##(1997-8#1)(2006-6#1)(2007-11#1)(2013-1#1)
tissues##2531##1##(1990-10#5)(1990-11#28)(1990-12#16)(1990-2#13)(1990-3#13)(1990-4#10)(1990-5#22)(1990-6#5)(1990-7#5)(1990-8#14)(1990-9#7)(1991-1#2)(1991-10#3)(1991-11#5)(1991-12#19)(1991-2#13)(1991-3#6)(1991-5#23)(1991-6#11)(1991-7#9)(1991-8#8)(1991-9#16)(1992-1#6)(1992-10#3)(1992-11#11)(1992-12#7)(1992-2#6)(1992-3#8)(1992-4#5)(1992-5#6)(1992-6#7)(1992-7#3)(1992-8#8)(1992-9#28)(1993-1#1)(1993-10#1)(1993-11#10)(1993-12#12)(1993-2#9)(1993-3#15)(1993-4#5)(1993-5#8)(1993-6#5)(1993-7#4)(1993-8#6)(1993-9#10)(1994-10#8)(1994-11#26)(1994-12#21)(1994-2#19)(1994-3#23)(1994-4#1)(1994-5#16)(1994-6#9)(1994-7#1)(1994-8#13)(1994-9#15)(1995-1#12)(1995-10#15)(1995-11#6)(1995-12#22)(1995-2#12)(1995-3#13)(1995-5#17)(1995-6#15)(1995-7#1)(1995-8#12)(1995-9#2)(1996-10#15)(1996-11#7)(1996-12#10)(1996-2#9)(1996-3#20)(1996-4#8)(1996-5#5)(1996-6#3)(1996-7#3)(1996-8#4)(1996-9#5)(1997-1#8)(1997-2#33)(1997-3#9)(1997-4#21)(1997-5#10)(1997-6#15)(1997-7#19)(1997-8#12)(1997-9#1)(2004-1#1)(2004-11#4)(2004-12#2)(2004-2#1)(2004-3#1)(2004-9#9)(2005-10#6)(2005-11#3)(2005-12#4)(2005-7#10)(2005-8#5)(2005-9#1)(2006-1#4)(2006-10#13)(2006-11#12)(2006-12#9)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#16)(2006-7#7)(2006-8#8)(2006-9#4)(2007-1#7)(2007-10#2)(2007-11#39)(2007-12#32)(2007-2#7)(2007-3#4)(2007-4#8)(2007-5#5)(2007-6#8)(2007-7#11)(2007-8#23)(2007-9#5)(2008-1#44)(2008-10#237)(2008-11#49)(2008-12#30)(2008-2#32)(2008-3#57)(2008-4#87)(2008-5#61)(2008-6#17)(2008-7#63)(2008-8#28)(2008-9#60)(2009-10#14)(2009-12#8)(2009-2#5)(2009-3#4)(2009-4#15)(2009-5#10)(2009-6#7)(2009-7#7)(2009-8#20)(2009-9#6)(2010-1#2)(2010-10#14)(2010-11#6)(2010-12#30)(2010-2#18)(2010-3#14)(2010-4#11)(2010-5#7)(2010-6#6)(2010-7#4)(2010-8#21)(2010-9#17)(2011-1#39)(2011-10#1)(2011-2#44)(2011-3#1)(2012-1#11)(2012-11#12)(2012-12#49)(2012-2#35)(2012-3#21)(2013-1#62)(2013-7#9)(2013-8#25)
tissues)##8##1##(1993-3#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2012-12#3)
tissues/cells##2##1##(1996-2#1)(2008-5#1)
tissues/secretions and##2##2##(2012-12#2)
tissues]##5##1##(1992-5#1)(1993-1#1)(2005-10#1)(2005-9#1)(2009-2#1)
tissular##6##1##(1990-5#1)(1992-12#1)(2008-10#1)(2008-11#2)(2010-12#1)
tit (Parus##2##2##(1994-3#1)(2004-4#1)
tit Parus##5##2##(1994-3#2)(2008-9#3)
tit##13##1##(1994-3#3)(2004-4#1)(2008-5#1)(2008-8#3)(2008-9#5)
titanate##14##1##(1990-4#1)(2007-12#3)(2008-2#9)(2009-11#1)
titania incorporation##3##2##(2005-11#3)
titania particles##2##2##(2005-11#2)
titania thin films##2##3##(2006-12#1)(2008-2#1)
titania##23##1##(2005-11#10)(2006-12#2)(2007-11#3)(2008-10#3)(2008-2#3)(2010-4#2)
titania/silica##4##1##(2005-11#4)
titanium (Ti)##3##2##(2008-5#1)(2009-7#1)(2010-4#1)
titanium alloy##4##2##(2004-9#3)(2008-10#1)
titanium alloys##4##2##(2004-9#2)(2009-7#1)(2010-8#1)
titanium and tin##2##3##(2008-10#2)
titanium and##5##2##(2008-10#2)(2008-11#1)(2009-7#1)(2010-12#1)
titanium atoms##2##2##(2008-8#1)(2010-4#1)
titanium bearing##3##2##(2008-10#3)
titanium by##2##2##(2008-10#1)(2008-5#1)
titanium cage##2##2##(2006-8#1)(2007-8#1)
titanium carbide##3##2##(2008-10#1)(2008-2#2)
titanium dental##2##2##(2009-7#2)
titanium determination##2##2##(2008-10#2)
titanium dioxide (TiO(2))##4##3##(2008-10#1)(2008-5#2)(2009-11#1)
titanium dioxide by##2##3##(2008-10#2)
titanium dioxide##33##2##(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#14)(2008-5#4)(2009-11#2)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#1)
titanium fiber mesh##2##3##(2004-9#2)
titanium fibermesh##2##2##(2008-11#2)
titanium films##2##2##(2008-5#1)(2012-2#1)
titanium fixtures##2##2##(1991-1#2)
titanium foil##3##2##(2009-11#3)
titanium had##2##2##(2004-9#1)(2009-3#1)
titanium implant##4##2##(2004-9#1)(2013-1#3)
titanium implants##6##2##(2004-9#4)(2012-11#2)
titanium in a##2##3##(2008-4#1)(2011-12#1)
titanium in##5##2##(2008-10#3)(2008-4#1)(2011-12#1)
titanium isopropoxide##2##2##(2005-11#1)(2008-10#1)
titanium mesh##11##2##(2006-8#4)(2007-8#2)(2008-7#2)(2011-2#3)
titanium metal backing##2##3##(2008-5#2)
titanium metal##3##2##(2008-5#3)
titanium miniplates##2##2##(2008-7#2)
titanium oxide films##5##3##(2008-2#3)(2008-8#2)
titanium oxide##21##2##(1992-7#2)(2005-11#1)(2008-10#2)(2008-2#6)(2008-3#2)(2008-8#5)(2010-4#3)
titanium plates##2##2##(2006-3#1)(2007-11#1)
titanium screws##3##2##(2004-9#1)(2007-5#1)(2008-6#1)
titanium substrate##2##2##(2008-11#1)(2009-11#1)
titanium substrates##5##2##(2007-11#1)(2008-5#3)(2009-9#1)
titanium surface##3##2##(2013-1#2)(2013-8#1)
titanium threaded##2##2##(2006-8#2)
titanium trichloride##4##2##(2008-10#4)
titanium was##2##2##(2008-10#1)(2008-5#1)
titanium##226##1##(1991-1#2)(1992-7#2)(1994-3#1)(1997-3#1)(2004-9#18)(2005-11#3)(2005-12#1)(2006-12#1)(2006-3#2)(2006-6#1)(2006-8#11)(2007-11#7)(2007-12#4)(2007-5#2)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#50)(2008-11#6)(2008-2#9)(2008-3#3)(2008-4#1)(2008-5#18)(2008-6#5)(2008-7#7)(2008-8#6)(2009-11#6)(2009-3#3)(2009-7#7)(2009-9#1)(2010-12#1)(2010-4#5)(2010-5#1)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#6)(2012-11#2)(2012-12#2)(2012-2#5)(2013-1#9)(2013-8#5)
titanium(III)##2##1##(1994-3#1)(2010-5#1)
titanium(IV) from##2##2##(2008-10#2)
titanium(IV) has##2##2##(2008-10#2)
titanium(IV)##11##1##(2005-11#2)(2008-10#6)(2008-3#1)(2008-8#1)(2010-4#1)
titanium-sapphire pump##2##2##(2008-1#2)
titans##2##1##(1992-11#1)(1993-2#1)
titanyl##13##1##(2006-4#2)(2007-11#2)(2007-12#4)(2008-10#2)(2008-3#3)
titer against ND##2##3##(2008-12#2)
titer against##3##2##(2008-12#3)
titer and PFC##2##3##(2008-11#2)
titer and##8##2##(1992-9#1)(1995-11#1)(2008-10#2)(2008-11#4)
titer at##3##2##(1991-5#1)(2013-8#2)
titer by##2##2##(1997-1#1)(2013-8#1)
titer could##2##2##(2008-10#1)(2008-11#1)
titer exceeding##3##2##(2008-10#2)(2012-2#1)
titer for##2##2##(2008-9#1)(2012-3#1)
titer in the##5##3##(2006-8#1)(2007-10#1)(2008-4#2)(2012-2#1)
titer in##10##2##(1992-9#1)(2006-8#1)(2007-10#1)(2007-2#2)(2008-10#1)(2008-4#3)(2012-2#1)
titer of virus##2##3##(2005-11#1)(2008-10#1)
titer of##27##2##(1990-8#1)(1992-12#1)(1992-9#2)(1993-10#1)(1993-9#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(2005-11#2)(2005-12#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-4#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#1)(2013-8#1)
titer was determined##2##3##(2008-10#1)(2013-8#1)
titer was##15##2##(2006-10#1)(2006-6#1)(2007-11#1)(2007-2#2)(2008-10#1)(2008-11#3)(2010-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
titer##142##1##(1990-11#1)(1990-4#1)(1990-8#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#2)(1992-9#5)(1993-1#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#1)(1995-3#1)(1995-5#1)(1996-6#1)(1997-1#2)(1997-8#1)(2005-11#4)(2005-12#1)(2006-10#3)(2006-6#1)(2006-8#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#9)(2007-7#1)(2008-10#12)(2008-11#25)(2008-12#5)(2008-2#2)(2008-4#6)(2008-8#2)(2008-9#2)(2010-1#1)(2010-12#3)(2012-1#1)(2012-2#7)(2012-3#6)(2013-1#4)(2013-8#6)
titer) and##2##2##(2008-10#1)(2011-3#1)
titer)##3##1##(2005-11#1)(2008-10#1)(2011-3#1)
titered##3##1##(1992-7#1)(2008-9#2)
titering##4##1##(2008-2#1)(2008-4#2)(2008-9#1)
titers against the##3##3##(1991-9#1)(1992-8#1)(2012-3#1)
titers against##7##2##(1991-9#1)(1992-8#1)(1997-7#2)(2008-12#1)(2008-4#1)(2012-3#1)
titers and##6##2##(1991-12#1)(1995-12#1)(1997-4#1)(2007-6#1)(2008-12#1)(2013-1#1)
titers are##3##2##(1995-5#1)(2007-10#1)(2013-8#1)
titers by##5##2##(1992-1#1)(2008-10#1)(2008-11#2)(2013-8#1)
titers during##3##2##(2006-10#1)(2007-12#1)(2008-10#1)
titers following vaccination##2##3##(1995-12#1)(2012-12#1)
titers for canine parvovirus type-2##2##5##(2012-3#2)
titers for##4##2##(1991-9#1)(2010-5#1)(2012-3#2)
titers have##2##2##(1997-7#1)(2008-8#1)
titers in the##6##3##(1992-8#1)(2008-11#1)(2008-6#1)(2010-12#1)(2011-2#1)(2013-8#1)
titers in##18##2##(1991-7#1)(1991-9#1)(1992-8#1)(2006-10#2)(2007-10#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-8#1)
titers of &gt##2##3##(1994-8#1)(2013-1#1)
titers of antibodies to##2##4##(1992-8#1)(2009-12#1)
titers of antibodies##4##3##(1992-8#1)(1995-1#1)(2009-12#1)(2012-3#1)
titers of##25##2##(1991-9#1)(1992-8#1)(1994-8#1)(1995-1#1)(1995-11#1)(1996-11#1)(1996-6#1)(2006-10#2)(2006-4#1)(2007-8#1)(2008-11#3)(2008-4#3)(2008-9#2)(2009-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
titers to the##2##3##(2008-11#1)(2012-2#1)
titers was##2##2##(1995-12#1)(2007-12#1)
titers were higher##3##3##(2006-10#1)(2011-2#2)
titers were obtained##3##3##(2008-11#1)(2008-5#2)
titers were##18##2##(1992-5#1)(1995-11#1)(2006-10#2)(2007-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#4)(2011-2#2)(2013-1#1)(2013-8#1)
titers with##2##2##(1990-7#1)(1992-8#1)
titers##145##1##(1990-12#2)(1990-4#1)(1990-7#1)(1991-12#2)(1991-7#1)(1991-9#5)(1992-1#1)(1992-5#2)(1992-8#4)(1994-12#2)(1994-8#2)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-5#1)(1996-11#1)(1996-6#1)(1997-4#1)(1997-7#5)(2006-10#10)(2006-4#1)(2007-10#5)(2007-12#2)(2007-2#5)(2007-6#1)(2007-8#1)(2008-10#12)(2008-11#16)(2008-12#4)(2008-4#8)(2008-5#5)(2008-6#1)(2008-8#2)(2008-9#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#4)(2013-8#6)
title compound##14##2##(1992-9#1)(1996-7#1)(2004-7#3)(2007-10#1)(2007-11#4)(2008-10#2)(2008-11#1)(2013-1#1)
title compounds were##3##3##(2007-11#2)(2010-12#1)
title compounds##17##2##(1994-3#1)(1997-4#1)(2006-10#1)(2007-11#3)(2008-10#1)(2008-3#1)(2008-5#2)(2009-7#1)(2010-12#1)(2011-1#3)(2011-3#1)(2012-3#1)
title##70##1##(1991-12#2)(1992-3#1)(1992-9#1)(1993-1#1)(1993-2#3)(1994-3#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-5#1)(1996-7#1)(1997-4#1)(2004-7#3)(2006-10#1)(2007-1#1)(2007-10#2)(2007-11#7)(2007-4#1)(2007-5#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#8)(2008-7#1)(2008-8#1)(2009-7#1)(2010-11#2)(2010-12#3)(2010-8#1)(2011-1#4)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#4)
titled &quot##3##2##(2007-7#1)(2008-12#1)(2013-8#1)
titled##6##1##(2006-8#1)(2007-7#1)(2008-12#1)(2008-2#1)(2009-10#1)(2013-8#1)
titles and abstracts##3##3##(2011-2#2)(2013-8#1)
titles and##5##2##(2005-7#1)(2008-11#1)(2011-2#2)(2013-8#1)
titles##13##1##(1993-2#1)(1995-9#1)(1996-12#1)(2005-7#1)(2008-11#2)(2008-7#1)(2011-2#4)(2013-7#1)(2013-8#1)
titrant and##3##2##(2008-10#3)
titrant are##2##2##(2008-10#2)
titrant concentration##3##2##(2008-10#3)
titrant containing a lipophilic##2##4##(2008-10#2)
titrant flow##2##2##(2008-10#2)
titrant is##3##2##(2008-10#3)
titrant to##2##2##(2008-10#2)
titrant##47##1##(2004-9#1)(2008-10#44)(2008-11#2)
titrants##5##1##(1992-6#1)(2004-9#1)(2008-10#3)
titratable acidity##4##2##(2008-5#2)(2011-2#1)(2013-1#1)
titratable residues in##2##3##(2008-4#2)
titratable##11##1##(1991-12#1)(2005-8#1)(2006-10#1)(2008-4#3)(2008-5#2)(2009-11#1)(2011-2#1)(2013-1#1)
titrate dose##2##2##(2005-10#1)(2010-8#1)
titrate##10##1##(1991-12#1)(1991-4#1)(1992-6#1)(2005-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-11#2)(2010-8#1)
titrated bases##2##2##(2008-10#2)
titrated by##2##2##(1997-2#1)(2007-2#1)
titrated delay values##2##3##(2011-2#2)
titrated in##2##2##(2008-10#1)(2010-7#1)
titrated intravenous##2##2##(2007-3#1)(2007-7#1)
titrated potentiometrically with##3##3##(2007-11#2)(2008-10#1)
titrated to a##2##3##(2006-12#2)
titrated to##5##2##(1996-7#1)(2006-12#2)(2010-4#1)(2012-3#1)
titrated with##14##2##(1990-7#1)(1991-2#1)(1991-8#1)(1992-6#1)(1994-5#1)(1995-2#1)(1996-12#1)(2005-4#1)(2008-10#3)(2008-5#1)(2009-12#1)(2010-2#1)
titrated##50##1##(1990-7#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-5#2)(1995-2#1)(1996-12#1)(1996-7#1)(1997-2#2)(2005-4#1)(2006-12#2)(2006-8#1)(2007-11#3)(2007-2#2)(2007-3#1)(2007-7#1)(2008-10#14)(2008-5#1)(2008-7#2)(2009-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-3#1)(2013-8#1)
titrates##2##1##(1991-5#1)(1994-5#1)
titrating##10##1##(1991-4#1)(1992-12#1)(1995-10#1)(2008-10#3)(2008-4#4)
titration and the##2##3##(2008-10#2)
titration and##20##2##(1990-2#1)(1991-7#2)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#13)(2011-1#1)
titration as well##2##3##(2008-10#2)
titration at##3##2##(2005-11#1)(2008-10#2)
titration behavior##2##2##(2005-11#1)(2008-4#1)
titration calorimetry##13##2##(1992-10#1)(1993-3#2)(1994-5#1)(1997-2#3)(2006-10#1)(2008-1#2)(2008-10#1)(2010-7#2)
titration cell##3##2##(2008-10#3)
titration curve##9##2##(1992-12#1)(1992-7#1)(1992-8#1)(1997-2#1)(2008-10#3)(2008-4#1)(2011-12#1)
titration curves for##2##3##(1997-2#1)(2008-4#1)
titration curves were obtained##2##4##(2008-10#2)
titration curves##13##2##(1990-11#1)(1991-4#1)(1991-8#1)(1994-8#1)(1997-2#1)(2005-11#1)(2007-8#1)(2008-10#4)(2008-4#2)
titration data##10##2##(1995-2#1)(2005-11#1)(2008-10#7)(2008-5#1)
titration end-point##3##2##(2008-10#3)
titration experiments##2##2##(1990-5#1)(2008-4#1)
titration for the determination of##2##5##(2008-10#2)
titration for##5##2##(2008-10#4)(2011-2#1)
titration has been##4##3##(2008-10#4)
titration in the##3##3##(1991-1#1)(2007-8#1)(2008-10#1)
titration in##9##2##(1991-1#1)(1993-11#1)(2007-8#1)(2008-10#3)(2008-5#1)(2012-2#1)(2013-8#1)
titration is described##2##3##(2008-10#2)
titration is##11##2##(1991-7#1)(2007-8#2)(2008-10#8)
titration method and##2##3##(2005-4#1)(2008-10#1)
titration method for determination of##2##5##(2008-10#2)
titration method for##4##3##(2008-10#4)
titration method is##2##3##(2008-10#2)
titration method was##2##3##(2007-2#1)(2008-10#1)
titration method##24##2##(1995-2#1)(2005-4#1)(2007-1#1)(2007-2#1)(2008-10#19)(2012-12#1)
titration methods##2##2##(2006-6#2)
titration of copper##2##3##(2008-10#2)
titration of some##2##3##(2008-10#2)
titration of the##8##3##(1992-3#1)(1992-7#1)(1996-11#1)(1997-2#1)(2008-10#4)
titration of thiocyanate##2##3##(2008-10#2)
titration of virus##2##3##(2008-11#1)(2008-9#1)
titration of weak acids in##2##5##(2008-10#2)
titration of weak acids##3##4##(2008-10#3)
titration of##84##2##(1990-11#1)(1990-5#1)(1991-4#1)(1991-7#2)(1991-9#1)(1992-3#1)(1992-7#1)(1993-1#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-10#56)(2008-11#2)(2008-4#3)(2008-8#1)(2008-9#2)(2009-8#1)(2013-1#2)
titration procedure##2##2##(2008-10#1)(2011-1#1)
titration protocol##3##2##(2007-2#1)(2007-6#1)(2008-4#1)
titration protocols##3##2##(2008-10#2)(2008-9#1)
titration rate##2##2##(2008-10#2)
titration scores##2##2##(1994-3#2)
titration system for the determination of##2##6##(2008-10#2)
titration system##5##2##(2008-10#5)
titration technique##3##2##(1997-2#1)(2006-10#1)(2008-10#1)
titration time##2##2##(2008-10#2)
titration to##5##2##(1991-7#1)(2005-11#1)(2008-10#2)(2008-7#1)
titration using an##2##3##(2008-10#2)
titration using##5##2##(2008-10#4)(2012-2#1)
titration was applied to##2##4##(2005-11#1)(2007-8#1)
titration was used##2##3##(2008-10#2)
titration was##9##2##(2005-11#1)(2007-8#1)(2008-10#6)(2008-7#1)
titration were##4##2##(2008-10#4)
titration with a##2##3##(2008-10#1)(2011-2#1)
titration with##18##2##(1995-5#1)(1996-11#2)(2006-1#1)(2008-10#10)(2008-3#1)(2008-7#2)(2011-2#1)
titration##385##1##(1990-11#2)(1990-2#1)(1990-5#2)(1990-9#1)(1991-1#1)(1991-2#2)(1991-4#3)(1991-7#7)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-6#5)(1992-7#3)(1992-8#1)(1993-1#1)(1993-11#1)(1993-3#3)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#3)(1995-5#1)(1996-11#3)(1996-12#1)(1996-7#1)(1997-2#7)(1997-3#1)(1997-7#2)(2005-11#13)(2005-4#1)(2006-1#1)(2006-10#2)(2006-12#2)(2006-4#2)(2006-6#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#8)(2007-6#2)(2007-8#9)(2008-1#2)(2008-10#229)(2008-11#2)(2008-3#1)(2008-4#11)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#3)(2009-3#2)(2009-8#1)(2010-7#2)(2011-1#3)(2011-12#3)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
titration)##4##1##(2008-10#4)
titration-reagent##2##1##(2008-10#2)
titrations and the##2##3##(2008-10#2)
titrations and##5##2##(2008-10#4)(2008-3#1)
titrations are##2##2##(2008-10#2)
titrations in 0##2##3##(1996-2#2)
titrations in the##3##3##(2007-8#1)(2008-10#1)(2008-3#1)
titrations in##10##2##(1996-2#2)(2005-11#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-5#1)
titrations is##2##2##(2008-10#2)
titrations made in##2##3##(2008-10#2)
titrations of calcium##2##3##(2008-10#2)
titrations of non-growing cells##2##4##(1991-11#2)
titrations of phenothiazine derivatives in aqueous micellar##2##7##(2008-10#2)
titrations of the##2##3##(1994-12#1)(1995-10#1)
titrations of##28##2##(1991-11#2)(1994-11#2)(1994-12#1)(1994-8#3)(1995-1#1)(1995-10#1)(1995-2#2)(1995-8#1)(1996-12#1)(1996-5#1)(2007-11#1)(2008-10#11)(2010-5#1)
titrations the pH##2##3##(2008-10#2)
titrations were##5##2##(2008-10#5)
titrations with a##2##3##(2008-10#2)
titrations with##8##2##(1990-8#1)(1992-7#1)(2008-10#6)
titrations##105##1##(1990-2#2)(1990-8#1)(1991-11#2)(1991-5#1)(1992-7#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#3)(1995-1#2)(1995-10#1)(1995-2#2)(1995-8#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-7#1)(1997-3#1)(2005-11#3)(2007-10#1)(2007-11#2)(2007-2#1)(2007-8#3)(2008-10#60)(2008-3#4)(2008-5#2)(2010-5#2)(2011-1#1)
titre &gt##3##2##(2005-8#1)(2007-7#2)
titre in the##5##3##(1993-3#1)(2007-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
titre of &gt##2##3##(2005-9#1)(2007-7#1)
titre of LDL-IC##2##3##(1995-6#2)
titre of##10##2##(1993-9#1)(1995-6#2)(1996-12#1)(1997-7#1)(2005-9#1)(2006-1#1)(2007-7#1)(2008-8#1)(2009-9#1)
titre to##4##2##(1991-5#1)(1992-1#2)(2008-5#1)
titre was##5##2##(1993-3#1)(1997-6#2)(2006-2#1)(2007-12#1)
titre##60##1##(1991-5#1)(1992-1#3)(1992-10#4)(1993-12#1)(1993-3#2)(1993-9#1)(1995-12#1)(1995-4#1)(1995-6#3)(1996-12#1)(1997-6#2)(1997-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-7#4)(2007-8#1)(2008-11#10)(2008-4#1)(2008-5#2)(2008-8#2)(2009-4#1)(2009-9#1)(2011-1#1)(2012-2#2)(2012-3#1)
titres after##3##2##(2008-5#3)
titres greater than or equal to 1##2##7##(1990-2#2)
titres greater than or equal to##3##6##(1990-2#2)(1991-8#1)
titres greater than##4##3##(1990-2#2)(1991-8#1)(1992-8#1)
titres in trachea##2##3##(1997-6#2)
titres in##8##2##(1997-3#1)(1997-6#2)(2005-9#2)(2007-2#1)(2007-6#1)(2007-7#1)
titres of anti-MDA-LDL autoantibodies##2##4##(1995-6#2)
titres of virus##2##3##(2008-5#1)(2012-12#1)
titres of##14##2##(1994-12#1)(1995-6#2)(1996-12#1)(2006-2#1)(2007-11#3)(2008-5#2)(2008-7#3)(2012-12#1)
titres to##3##2##(1994-4#1)(2006-2#1)(2008-5#1)
titres were obtained##2##3##(2008-5#2)
titres were##4##2##(1997-6#1)(2008-5#3)
titres##74##1##(1990-2#2)(1991-11#1)(1991-12#1)(1991-8#1)(1992-8#2)(1994-12#1)(1994-4#1)(1994-6#1)(1994-8#1)(1995-6#2)(1996-12#2)(1997-2#1)(1997-3#1)(1997-6#7)(2005-9#2)(2006-2#2)(2007-11#5)(2007-2#1)(2007-3#1)(2007-6#2)(2007-7#2)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#21)(2008-7#4)(2009-6#2)(2011-2#1)(2012-12#1)(2013-8#1)
titrimetric method##5##2##(2008-10#5)
titrimetric methods##3##2##(2006-1#1)(2008-10#2)
titrimetric##16##1##(2006-1#1)(2008-10#15)
titrimetry##4##1##(2008-10#2)(2008-5#1)(2010-5#1)
tits (Parus##3##2##(2004-4#1)(2008-5#2)
tits Parus##2##2##(2008-8#2)
tits were##3##2##(2008-5#3)
tits##28##1##(1994-3#6)(2004-4#1)(2008-5#15)(2008-8#6)
tizanidine##5##1##(2006-10#1)(2006-8#3)(2010-12#1)
tk promoter##3##2##(1996-4#3)
tk##4##1##(1994-3#1)(1996-4#3)
tlc##2##1##(1991-3#2)
tm homozygous##2##2##(2013-8#2)
tm values##2##2##(1996-4#1)(2007-11#1)
tm##5##1##(1996-4#1)(2007-11#2)(2013-8#2)
tmRNA##3##1##(2006-11#3)
tmax##3##1##(1995-2#2)(2012-3#1)
tmol/L at##2##2##(2008-1#2)
tmol/L##3##1##(2008-1#3)
tn and##2##2##(1996-2#2)
tn##4##1##(1996-2#4)
tna##3##1##(1993-11#3)
tnrRPE-CM##2##1##(1996-5#2)
to $1##3##2##(1992-2#1)(1993-3#1)(2008-6#1)
to $12##2##2##(1992-1#1)(1994-2#1)
to $2##4##2##(1994-1#1)(1994-3#1)(2008-10#1)(2008-6#1)
to $25##2##2##(1991-6#1)(1996-5#1)
to $8##2##2##(2007-12#1)(2008-11#1)
to &gt##40##2##(1993-11#1)(1993-12#1)(1993-4#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-6#1)(1997-2#1)(1997-3#3)(2004-11#1)(2006-8#1)(2007-11#1)(2008-10#10)(2008-11#2)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-3#1)
to &lt##44##2##(1993-9#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#1)(1997-7#1)(2005-8#1)(2006-5#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#10)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-8#1)(2011-1#4)(2012-2#1)(2012-3#2)(2013-1#4)
to &quot##114##2##(1990-5#1)(1990-9#1)(1991-2#1)(1991-3#2)(1991-7#1)(1992-12#1)(1993-2#2)(1993-3#1)(1993-5#2)(1994-1#1)(1994-6#3)(1994-7#1)(1994-8#1)(1995-6#2)(1996-3#3)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-6#1)(2004-3#1)(2004-7#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-2#5)(2007-4#3)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#3)(2008-12#4)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#5)(2009-4#1)(2009-5#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-8#2)(2011-2#6)(2012-11#2)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#5)
to (0##2##2##(1997-8#1)(2007-12#1)
to (1)##21##2##(1993-12#1)(1994-12#1)(1996-7#2)(2006-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2013-1#4)
to (3##2##2##(1992-11#1)(1992-6#1)
to (30##2##2##(2011-1#1)(2012-3#1)
to (4)##2##2##(2008-9#1)(2013-1#1)
to (a)##15##2##(1990-7#1)(1992-3#1)(1993-6#1)(1997-2#1)(2006-10#1)(2007-7#1)(2008-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-8#1)
to (alpha beta)2##2##3##(1990-7#2)
to (i) a##2##3##(2008-10#1)(2008-3#1)
to (i) distinguish##2##3##(2008-10#2)
to (i) identify##2##3##(2008-10#2)
to (i)##21##2##(1990-9#1)(1995-2#1)(1997-7#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
to (sup14)CO(inf2)##2##2##(2006-3#2)
to +##2##2##(1993-12#1)(1994-2#1)
to +/-##2##2##(1992-11#2)
to +/-0##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
to +0##4##2##(1994-4#1)(2008-10#3)
to +2##4##2##(1992-7#1)(2007-8#1)(2008-10#2)
to +3##2##2##(2006-2#1)(2011-1#1)
to +32##2##2##(1995-1#2)
to +41##2##2##(1996-11#2)
to +421##2##2##(1991-9#2)
to +50##2##2##(1996-7#1)(2007-12#1)
to +80 degrees##2##3##(2008-3#2)
to +91 bp of the gamma-GCSh gene##2##7##(1997-7#2)
to +91 bp##6##3##(1997-7#6)
to -##3##2##(1997-8#1)(2007-8#2)
to -0##24##2##(1997-8#1)(2006-9#1)(2007-12#1)(2007-8#3)(2008-10#7)(2008-2#1)(2008-5#1)(2009-4#1)(2010-4#3)(2013-1#3)(2013-8#2)
to -1##4##2##(2008-10#1)(2010-9#1)(2013-8#2)
to -10##2##2##(1994-11#1)(2012-1#1)
to -100 is essential for##2##5##(1995-6#2)
to -100##3##2##(1995-6#3)
to -102##3##2##(1990-11#1)(1991-12#2)
to -11##2##2##(1995-8#1)(2011-12#1)
to -120##3##2##(1992-8#1)(1994-9#1)(2008-2#1)
to -146##2##2##(1991-5#1)(1992-12#1)
to -15 mmHg##2##3##(1991-3#2)
to -15##4##2##(1991-3#2)(1995-2#1)(2009-5#1)
to -2##7##2##(1992-7#1)(2008-10#1)(2012-12#1)(2013-8#4)
to -20 degrees C##3##4##(1994-11#2)(1995-2#1)
to -20##4##2##(1994-11#2)(1995-2#1)(2008-10#1)
to -22##4##2##(1992-12#1)(1993-3#1)(1993-8#1)(1997-7#1)
to -25##2##2##(1991-6#1)(2007-8#1)
to -29##2##2##(2011-12#1)(2011-2#1)
to -4##4##2##(1995-2#1)(2006-9#1)(2008-10#2)
to -45##3##2##(1990-7#1)(1996-10#2)
to -5##8##2##(1993-2#1)(1995-2#1)(1996-11#2)(2004-9#1)(2011-1#1)(2012-1#1)(2013-8#1)
to -55##3##2##(1991-5#1)(1996-10#1)(1996-9#1)
to -6##2##2##(2007-10#1)(2013-8#1)
to -60 degrees C##2##4##(2008-3#2)
to -60##4##2##(1991-5#1)(1995-6#1)(2008-3#2)
to -66##3##2##(1997-2#1)(1997-7#1)(2005-11#1)
to -78##2##2##(1993-6#2)
to -8##4##2##(2006-8#2)(2011-12#2)
to -9578##2##2##(1995-3#2)
to 0 and##3##3##(2007-8#1)(2008-10#1)(2008-8#1)
to 0 degrees##5##3##(2007-12#1)(2007-8#1)(2008-10#1)(2009-3#1)(2009-9#1)
to 0 for##2##3##(2007-11#1)(2008-10#1)
to 0##663##2##(1990-10#2)(1990-11#7)(1990-12#1)(1990-3#4)(1990-4#2)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#1)(1991-1#2)(1991-10#3)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-7#3)(1991-8#1)(1991-9#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#4)(1992-7#1)(1992-9#1)(1993-1#2)(1993-12#4)(1993-6#4)(1993-8#3)(1993-9#3)(1994-10#3)(1994-11#1)(1994-3#3)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-2#3)(1995-4#2)(1995-5#1)(1995-7#1)(1996-11#2)(1996-12#8)(1996-2#1)(1996-3#2)(1996-5#3)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-11#1)(2004-2#2)(2004-4#2)(2004-8#1)(2004-9#1)(2005-1#1)(2005-11#7)(2005-12#6)(2005-4#1)(2005-8#1)(2006-1#2)(2006-10#4)(2006-11#1)(2006-12#6)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#2)(2006-7#1)(2006-8#4)(2007-1#7)(2007-11#5)(2007-12#16)(2007-2#1)(2007-3#1)(2007-5#6)(2007-7#2)(2007-8#16)(2007-9#2)(2008-1#9)(2008-10#177)(2008-11#13)(2008-12#5)(2008-2#12)(2008-3#26)(2008-4#1)(2008-5#21)(2008-6#3)(2008-7#4)(2008-8#10)(2008-9#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#1)(2010-4#8)(2010-5#3)(2010-6#4)(2010-8#3)(2010-9#1)(2011-1#8)(2011-12#6)(2011-2#12)(2012-1#6)(2012-11#2)(2012-12#11)(2012-2#11)(2012-3#7)(2013-1#28)(2013-7#1)(2013-8#14)
to 0%##4##2##(1990-2#1)(1993-5#1)(2008-10#1)(2008-2#1)
to 06##2##2##(2008-10#1)(2012-12#1)
to 0600##2##2##(1992-11#1)(2008-10#1)
to 1 GHz##2##3##(1997-6#1)(2007-12#1)
to 1 January##2##3##(1996-1#2)
to 1 M##5##3##(1991-10#1)(1994-11#1)(1995-2#1)(1997-2#1)(1997-7#1)
to 1 MHz##3##3##(2007-12#1)(2008-3#1)(2009-11#1)
to 1 W##2##3##(2007-11#1)(2008-2#1)
to 1 and##3##3##(1993-4#1)(1996-2#1)(1996-6#1)
to 1 g##2##3##(2008-10#1)(2008-11#1)
to 1 h##2##3##(2005-8#1)(2008-4#1)
to 1 in##6##3##(1990-9#2)(1991-6#1)(2006-9#1)(2008-10#1)(2008-3#1)
to 1 mM of##2##4##(1992-12#1)(2010-12#1)
to 1 mM##14##3##(1991-10#1)(1991-8#1)(1992-12#2)(1992-6#1)(1993-3#1)(1994-12#1)(1995-3#2)(1996-12#1)(2008-10#3)(2010-12#1)
to 1 mM)##3##3##(1992-3#1)(1994-3#1)(2005-11#1)
to 1 mg l(-1)##2##4##(2008-10#2)
to 1 mg##4##3##(1994-6#1)(1995-8#1)(2008-10#2)
to 1 microM##12##3##(1990-2#2)(1992-3#1)(1992-5#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-6#1)(1994-8#1)(1996-10#1)(1996-5#1)(1997-5#1)
to 1 ml of##2##4##(2008-10#1)(2008-12#1)
to 1 ml##5##3##(1992-2#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-12#1)
to 1 mm##4##3##(2006-12#1)(2008-10#1)(2008-7#1)(2009-8#1)
to 1 mol of##5##4##(1990-2#1)(1991-1#1)(1994-8#1)(1995-8#1)(2008-6#1)
to 1 mol##6##3##(1990-2#1)(1991-1#1)(1994-8#1)(1995-8#1)(2008-6#1)(2010-4#1)
to 1 month##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
to 1 mug##2##3##(2008-10#2)
to 1 of 2##3##4##(1993-4#1)(2006-10#1)(2011-1#1)
to 1 of##6##3##(1993-4#1)(1995-10#1)(2006-10#1)(2007-10#1)(2011-1#1)(2013-8#1)
to 1 or##3##3##(2004-12#1)(2004-3#1)(2011-2#1)
to 1 week after##2##4##(1993-1#1)(2007-10#1)
to 1 week##5##3##(1993-1#2)(1996-10#1)(1996-3#1)(2007-10#1)
to 1 x 10(-4) M##2##5##(1992-8#1)(2007-8#1)
to 1 x##9##3##(1990-10#1)(1992-8#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#1)(2009-3#1)
to 1 year of age##2##5##(1996-3#1)(2010-4#1)
to 1 year##6##3##(1990-12#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-4#1)
to 1 year)##3##3##(1991-8#1)(1997-4#1)(2007-9#1)
to 1##766##2##(1990-10#1)(1990-11#4)(1990-12#2)(1990-2#10)(1990-3#2)(1990-4#3)(1990-5#4)(1990-6#2)(1990-7#4)(1990-8#1)(1990-9#2)(1991-1#3)(1991-10#4)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-4#3)(1991-5#2)(1991-6#2)(1991-7#9)(1991-8#4)(1991-9#4)(1992-1#2)(1992-11#3)(1992-12#3)(1992-2#4)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#2)(1992-8#3)(1992-9#5)(1993-1#3)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#4)(1993-4#2)(1993-7#2)(1993-8#5)(1993-9#9)(1994-10#1)(1994-11#6)(1994-12#1)(1994-3#7)(1994-5#1)(1994-6#4)(1994-8#5)(1994-9#3)(1995-1#5)(1995-10#3)(1995-11#4)(1995-12#1)(1995-2#1)(1995-3#4)(1995-5#3)(1995-6#1)(1995-8#7)(1995-9#1)(1996-1#2)(1996-10#2)(1996-11#2)(1996-12#2)(1996-2#4)(1996-3#3)(1996-4#1)(1996-5#3)(1996-6#2)(1996-7#2)(1997-1#2)(1997-2#5)(1997-3#1)(1997-4#4)(1997-5#4)(1997-6#4)(1997-7#4)(2004-12#2)(2004-2#1)(2004-3#1)(2004-4#2)(2004-9#1)(2005-1#2)(2005-10#2)(2005-11#8)(2005-4#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#4)(2006-12#6)(2006-3#1)(2006-4#2)(2006-5#2)(2006-7#3)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#6)(2007-11#19)(2007-12#23)(2007-2#1)(2007-5#2)(2007-7#5)(2007-8#19)(2007-9#3)(2008-1#5)(2008-10#190)(2008-11#17)(2008-12#5)(2008-2#12)(2008-3#12)(2008-4#6)(2008-5#14)(2008-6#4)(2008-7#9)(2008-8#10)(2008-9#5)(2009-11#3)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#1)(2009-6#2)(2009-7#2)(2009-8#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#3)(2010-4#4)(2010-5#1)(2010-7#1)(2010-8#5)(2011-1#7)(2011-12#1)(2011-2#13)(2012-1#1)(2012-11#2)(2012-12#8)(2012-2#8)(2012-3#8)(2012-5#1)(2013-1#8)(2013-7#2)(2013-8#11)
to 1% of##2##3##(2008-2#1)(2009-4#1)
to 1%##16##2##(1991-8#1)(1995-8#1)(2006-10#1)(2007-5#1)(2007-7#2)(2008-10#5)(2008-2#1)(2009-10#1)(2009-4#1)(2011-1#1)(2012-3#1)
to 1)##10##2##(1992-5#1)(1995-11#1)(2006-12#1)(2006-5#2)(2008-7#1)(2009-2#1)(2011-1#1)(2011-2#2)
to 1-2##3##2##(1992-9#1)(1994-3#1)(2013-8#1)
to 1-5##2##2##(1996-11#1)(2008-5#1)
to 1/100##2##2##(1997-4#1)(2008-10#1)
to 1/20##2##2##(2007-7#1)(2008-5#1)
to 1/6##2##2##(1995-11#1)(2007-12#1)
to 10 000##2##3##(2004-9#1)(2011-1#1)
to 10 and##5##3##(2007-12#1)(2008-10#2)(2008-5#1)(2013-1#1)
to 10 days after inoculation##2##5##(2008-10#2)
to 10 days after##5##4##(1991-3#1)(2007-12#2)(2008-10#2)
to 10 days of##2##4##(2008-5#1)(2009-2#1)
to 10 days##18##3##(1991-3#1)(1992-12#1)(1995-5#1)(1996-12#1)(2004-9#1)(2005-11#1)(2007-10#1)(2007-12#2)(2008-10#2)(2008-5#1)(2008-8#1)(2009-2#1)(2009-7#1)(2010-8#1)(2012-12#2)
to 10 degrees C##2##4##(1997-7#1)(2008-11#1)
to 10 degrees##3##3##(1995-10#1)(1997-7#1)(2008-11#1)
to 10 in##3##3##(2007-11#1)(2007-3#1)(2008-10#1)
to 10 m##2##3##(2008-10#1)(2011-2#1)
to 10 mM##11##3##(1990-8#2)(1993-3#1)(1994-2#1)(1995-11#1)(1995-3#1)(1996-4#1)(1997-8#1)(2005-11#1)(2007-8#1)(2008-10#1)
to 10 mg daily##2##4##(1990-11#1)(1992-5#1)
to 10 mg##8##3##(1990-11#1)(1992-5#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#1)
to 10 mg/kg##2##3##(1991-5#1)(1995-1#1)
to 10 microM##10##3##(1991-11#1)(1991-3#1)(1991-5#1)(1994-2#1)(1994-5#1)(1995-11#1)(1996-5#1)(1997-4#2)(2005-8#1)
to 10 microM)##3##3##(1990-2#1)(2008-8#2)
to 10 microg##2##3##(2007-8#1)(2008-10#1)
to 10 microm##3##3##(2007-12#1)(2010-8#2)
to 10 min##4##3##(1997-1#2)(2007-8#1)(2008-10#1)
to 10 minutes##2##3##(1992-1#1)(2011-1#1)
to 10 ml of##2##4##(2008-10#1)(2008-11#1)
to 10 mm in diameter)##2##5##(2008-10#2)
to 10 mm in##4##4##(1990-2#2)(2008-10#2)
to 10 mm##7##3##(1990-2#2)(2006-2#1)(2006-3#1)(2008-10#2)(2008-2#1)
to 10 months##3##3##(1991-8#1)(2008-10#1)(2009-7#1)
to 10 muM##4##3##(2008-10#3)(2008-7#1)
to 10 mug##3##3##(2008-10#2)(2008-11#1)
to 10 mum##3##3##(2007-12#2)(2008-2#1)
to 10 nM##6##3##(1990-8#1)(1992-3#1)(1992-6#1)(1993-9#2)(1994-8#1)
to 10 ng/ml##2##3##(1990-12#1)(2009-2#1)
to 10 percent of the##2##5##(1992-3#1)(1995-6#1)
to 10 times higher than##2##5##(2006-10#1)(2013-8#1)
to 10 times higher##4##4##(1995-11#1)(2006-10#1)(2007-12#1)(2013-8#1)
to 10 times more##2##4##(1994-5#1)(1995-6#1)
to 10 times##6##3##(1994-5#1)(1995-11#1)(1995-6#1)(2006-10#1)(2007-12#1)(2013-8#1)
to 10 to##2##3##(2007-11#1)(2012-3#1)
to 10 weeks##2##3##(1992-7#1)(2008-5#1)
to 10 x##2##3##(1996-2#1)(2007-1#1)
to 10 years##16##3##(1990-10#1)(1991-4#1)(1996-5#1)(2005-12#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#3)(2008-10#2)(2010-2#1)(2011-2#1)(2012-12#1)
to 10##296##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#5)(1990-8#5)(1991-10#2)(1991-11#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#3)(1991-8#1)(1991-9#2)(1992-1#2)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#3)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#1)(1993-9#3)(1994-12#2)(1994-2#5)(1994-5#3)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#1)(1995-3#2)(1995-5#2)(1995-6#2)(1995-7#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#2)(1996-8#2)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-7#1)(1997-8#3)(2004-12#1)(2004-9#2)(2005-10#1)(2005-11#3)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#4)(2006-2#1)(2006-3#1)(2006-6#2)(2006-7#1)(2007-1#1)(2007-10#4)(2007-11#7)(2007-12#8)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#9)(2007-9#2)(2008-10#60)(2008-11#11)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#3)(2009-11#1)(2009-2#3)(2009-7#2)(2009-8#1)(2010-2#1)(2010-5#1)(2010-8#4)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-12#5)(2012-3#2)(2013-1#4)(2013-8#3)
to 10% and##3##3##(1996-5#1)(2008-3#1)(2011-1#1)
to 10% are##2##3##(2008-3#1)(2013-1#1)
to 10% of all##4##4##(1991-2#1)(1993-11#1)(2008-4#1)(2009-1#1)
to 10% of patients##3##4##(1991-9#1)(2007-12#1)(2009-12#1)
to 10% of the original##2##5##(2008-6#1)(2010-8#1)
to 10% of the##7##4##(1990-2#1)(1992-9#1)(2007-12#1)(2008-3#2)(2008-6#1)(2010-8#1)
to 10% of##19##3##(1990-2#1)(1991-2#1)(1991-9#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-6#1)(1996-12#1)(2007-12#2)(2008-10#1)(2008-3#2)(2008-4#1)(2008-6#1)(2009-1#1)(2009-12#1)(2009-4#1)(2010-8#1)
to 10% with##2##3##(2006-4#1)(2008-10#1)
to 10%##53##2##(1990-2#1)(1990-6#1)(1991-2#1)(1991-9#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1996-12#1)(1996-5#2)(2004-11#1)(2004-9#1)(2006-11#1)(2006-4#2)(2006-6#1)(2007-11#3)(2007-12#3)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-3#7)(2008-4#1)(2008-6#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-4#1)(2010-1#1)(2010-8#2)(2011-1#1)(2013-1#1)
to 10%)##3##2##(2008-10#3)
to 10(-1) M##2##3##(2008-10#2)
to 10(-1)##4##2##(2008-10#4)
to 10(-1)M##2##2##(2008-10#2)
to 10(-12)##3##2##(1990-4#1)(1997-4#1)(2007-8#1)
to 10(-14)##2##2##(1997-4#1)(2008-11#1)
to 10(-2) M##3##3##(1995-5#1)(2008-10#2)
to 10(-2)moll(-1) for##2##3##(2008-10#2)
to 10(-3) M##2##3##(2008-10#1)(2008-5#1)
to 10(-3)##4##2##(1990-5#1)(2008-10#1)(2008-2#1)(2008-5#1)
to 10(-4) mol/L##3##3##(2007-9#3)
to 10(-4)##5##2##(1996-10#1)(2007-9#3)(2008-10#1)
to 10(-5) M##4##3##(1996-8#1)(1997-4#1)(2008-10#2)
to 10(-5)##6##2##(1991-9#1)(1996-8#1)(1997-4#1)(2008-10#2)(2011-2#1)
to 10(-6) M##6##3##(1992-3#1)(1994-9#3)(1995-12#1)(2008-4#1)
to 10(-6)##10##2##(1990-5#1)(1992-3#1)(1994-9#3)(1995-1#1)(1995-12#1)(1997-4#1)(2008-2#1)(2008-4#1)
to 10(-7) M##7##3##(1991-5#1)(1994-3#1)(1996-10#1)(2006-12#2)(2008-10#2)
to 10(-7) M)##3##3##(1993-9#1)(1997-4#2)
to 10(-7)##11##2##(1990-2#1)(1991-5#1)(1993-9#1)(1994-3#1)(1996-10#1)(1997-4#2)(2006-12#2)(2008-10#2)
to 10(-8)##2##2##(1997-4#1)(2009-6#1)
to 10(-9) M)##4##3##(1991-2#3)(1997-4#1)
to 10(-9)##5##2##(1991-2#3)(1993-9#1)(1997-4#1)
to 10(-9)M##2##2##(2008-10#1)(2012-1#1)
to 10(10)##3##2##(1991-11#1)(1994-3#1)(2008-4#1)
to 10(12)##2##2##(1994-12#1)(1996-7#1)
to 10(3) times##2##3##(2008-3#1)(2008-4#1)
to 10(3)##7##2##(1990-2#1)(1993-12#1)(1994-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2013-8#1)
to 10(4)##4##2##(1995-9#1)(2008-10#2)(2008-5#1)
to 10(5) cgs##2##3##(2008-10#2)
to 10(5)##9##2##(1992-12#1)(1995-8#1)(2008-10#5)(2008-11#1)(2008-2#1)
to 10(6)##8##2##(1992-12#1)(1995-2#1)(2008-10#5)(2008-3#1)
to 10(7) CFU##2##3##(2008-10#2)
to 10(7)##4##2##(2008-10#4)
to 10(9)##2##2##(2008-1#1)(2008-10#1)
to 10)##2##2##(2008-8#2)
to 10-##2##2##(1991-12#1)(2008-10#1)
to 10-day intervals##3##3##(2008-10#3)
to 10-day##4##2##(2008-1#1)(2008-10#3)
to 10-fold enhanced##2##3##(1994-8#1)(2005-8#1)
to 10-fold higher in##2##4##(1991-3#1)(2012-2#1)
to 10-fold##10##2##(1990-8#1)(1991-3#1)(1994-6#1)(1994-8#1)(1996-12#1)(1997-6#1)(2005-8#1)(2007-11#1)(2009-10#1)(2012-2#1)
to 10-year-old##2##2##(2006-10#1)(2011-1#1)
to 100 GHz##2##3##(2007-11#1)(2008-3#1)
to 100 and##3##3##(1997-3#1)(2008-10#2)
to 100 days##4##3##(1995-2#2)(1996-4#1)(2010-2#1)
to 100 degrees C##6##4##(1997-2#1)(2006-8#1)(2007-12#2)(2008-2#1)(2013-8#1)
to 100 degrees##7##3##(1997-2#1)(2006-8#1)(2007-12#2)(2008-2#2)(2013-8#1)
to 100 kHz##3##3##(2007-11#1)(2008-3#1)(2008-5#1)
to 100 mM##4##3##(1992-7#1)(1994-8#1)(1997-1#1)(2008-10#1)
to 100 mg##5##3##(2008-10#1)(2008-12#1)(2008-5#1)(2011-1#1)(2013-8#1)
to 100 microM of##2##4##(1992-12#1)(1996-4#1)
to 100 microM##15##3##(1990-10#1)(1992-12#1)(1992-6#1)(1993-7#1)(1994-10#2)(1994-2#1)(1994-8#1)(1995-5#1)(1996-4#1)(2005-8#2)(2006-12#1)(2008-10#1)(2008-8#1)
to 100 microM)##2##3##(1991-5#1)(1992-9#1)
to 100 microg/L##2##3##(2012-12#2)
to 100 microg/ml)##3##3##(2010-12#2)(2010-8#1)
to 100 micrograms/ml##4##3##(1990-6#1)(1991-2#1)(1996-4#1)(1996-6#1)
to 100 muM##3##3##(2008-10#3)
to 100 mug l(-1)##3##4##(2008-10#3)
to 100 mug##6##3##(2008-10#6)
to 100 nM##6##3##(1994-12#1)(1995-11#1)(1995-6#1)(1997-8#1)(2006-12#1)(2008-11#1)
to 100 ng/ml##2##3##(1991-10#1)(1993-7#1)
to 100 ng/ml)##3##3##(1991-9#1)(2008-6#2)
to 100 nm##3##3##(2007-11#1)(2007-2#1)(2010-4#1)
to 100 ps##2##3##(1996-7#2)
to 100 times##4##3##(1993-5#1)(2007-11#1)(2008-10#1)(2011-12#1)
to 100 x##2##3##(1993-12#1)(2006-5#1)
to 100##185##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#4)(1990-6#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-7#2)(1994-10#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-4#4)(1996-6#3)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#1)(2005-12#1)(2005-8#2)(2006-12#2)(2006-5#1)(2006-8#3)(2007-10#1)(2007-11#5)(2007-12#5)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#35)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#5)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#2)(2009-2#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#3)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#3)
to 100% and##6##3##(2004-10#1)(2005-10#1)(2007-8#1)(2008-10#1)(2009-7#1)(2011-2#1)
to 100% at##2##3##(2004-10#1)(2008-10#1)
to 100% for##10##3##(1997-3#2)(2007-3#1)(2008-10#5)(2008-5#1)(2011-2#1)
to 100% nucleotide##2##3##(2008-10#1)(2008-5#1)
to 100% of the##3##4##(1993-8#1)(2008-10#1)(2008-5#1)
to 100% of##12##3##(1990-8#1)(1993-8#1)(1994-2#1)(2007-12#1)(2008-10#4)(2008-5#2)(2008-9#1)(2013-8#1)
to 100% on##2##3##(2008-10#1)(2008-5#1)
to 100% oxygen at 4##2##5##(1993-12#2)
to 100% oxygen##3##3##(1993-12#2)(1997-6#1)
to 100% relative##2##3##(2005-11#1)(2008-10#1)
to 100% were##2##3##(2008-10#2)
to 100% with##2##3##(2008-10#2)
to 100%##105##2##(1990-11#1)(1990-5#2)(1990-8#1)(1991-2#1)(1991-4#1)(1992-4#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-2#1)(1994-3#2)(1995-2#1)(1995-5#1)(1995-8#3)(1997-2#2)(1997-3#4)(1997-6#1)(1997-8#1)(2004-10#2)(2005-10#1)(2005-11#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#37)(2008-11#1)(2008-3#1)(2008-5#9)(2008-8#1)(2008-9#2)(2009-7#2)(2010-12#1)(2010-5#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-8#3)
to 100%) and##2##3##(2006-11#1)(2010-10#1)
to 100%)##11##2##(2006-11#1)(2006-5#2)(2008-10#5)(2010-10#1)(2010-11#1)(2010-6#1)
to 100)##3##2##(2008-10#1)(2010-12#1)(2010-8#1)
to 100-fold##3##2##(1991-2#1)(2005-11#1)(2007-8#1)
to 1000 Hz##2##3##(2007-12#1)(2007-4#1)
to 1000 and##2##3##(1991-2#1)(2008-10#1)
to 1000 degrees C##2##4##(1996-8#1)(2004-9#1)
to 1000 m##2##3##(2008-2#1)(2008-3#1)
to 1000 microM of##2##4##(1994-11#1)(1994-6#1)
to 1000 ng##2##3##(2007-8#1)(2010-2#1)
to 1000 ng/ml##2##3##(1990-12#1)(2012-12#1)
to 1000 nm##4##3##(2007-12#2)(2008-3#2)
to 1000 ppm##2##3##(2008-10#2)
to 1000 times##2##3##(1997-5#1)(2008-12#1)
to 1000##46##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-7#1)(1993-2#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-7#1)(1996-8#1)(1997-5#1)(2004-9#1)(2006-12#1)(2007-12#5)(2007-4#1)(2007-8#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#2)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)
to 1000-fold##3##2##(1990-8#1)(1995-10#1)(1996-11#1)
to 101##11##2##(2007-8#1)(2008-10#8)(2010-4#1)(2012-12#1)
to 101% and##3##3##(1997-3#1)(2008-10#2)
to 101%##6##2##(1997-3#1)(2008-10#5)
to 102##9##2##(1990-3#1)(1993-2#1)(2008-10#6)(2011-1#1)
to 102% for##3##3##(2008-10#3)
to 102%##8##2##(1997-3#1)(2008-10#7)
to 103##8##2##(1992-11#1)(1996-5#1)(1997-4#1)(2005-12#1)(2007-8#1)(2008-10#2)(2011-2#1)
to 103% and##2##3##(2007-8#1)(2008-10#1)
to 103% for Sb(V)##2##4##(2008-10#2)
to 103% for##4##3##(2008-10#4)
to 103%##13##2##(1993-1#1)(2007-8#1)(2008-10#10)(2011-1#1)
to 104##7##2##(1997-5#1)(2008-1#1)(2008-10#3)(2010-5#1)(2011-1#1)
to 104%##10##2##(1993-2#1)(2008-10#8)(2009-3#1)
to 105##7##2##(1990-2#1)(1990-7#1)(1996-7#1)(2008-10#2)(2009-3#1)(2012-1#1)
to 105% for##2##3##(2008-10#2)
to 105%##7##2##(1990-6#1)(1997-7#1)(2007-8#1)(2008-10#4)
to 1050##2##2##(1994-11#1)(2007-11#1)
to 106##11##2##(1997-6#1)(1997-8#1)(2005-4#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
to 106% and##2##3##(2008-10#1)(2011-1#1)
to 106% for##3##3##(2008-10#3)
to 106%##5##2##(2008-10#4)(2011-1#1)
to 1060 nm##2##3##(2007-11#1)(2013-1#1)
to 1064 nm##3##3##(2007-11#2)(2008-3#1)
to 107##2##2##(2006-5#1)(2008-10#1)
to 107%##3##2##(2008-10#2)(2011-1#1)
to 108##10##2##(1990-6#1)(1994-8#1)(1995-3#1)(2006-9#1)(2007-7#1)(2008-10#4)(2008-7#1)
to 109##2##2##(1995-3#1)(2006-12#1)
to 109% of##2##3##(2004-2#1)(2008-5#1)
to 109%##3##2##(2004-2#1)(2008-10#1)(2008-5#1)
to 10s##2##2##(2008-11#1)(2013-7#1)
to 11 +/-##3##3##(1990-5#1)(1990-9#1)(1995-12#1)
to 11 and##4##3##(2008-10#2)(2008-6#1)(2011-2#1)
to 11 days##3##3##(2007-1#1)(2008-10#1)(2008-5#1)
to 11 degrees C##2##4##(2008-10#2)
to 11 degrees##3##3##(2008-10#3)
to 11 months##2##3##(1993-7#1)(2008-12#1)
to 11 years##6##3##(1996-6#1)(1997-1#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-9#1)
to 11##83##2##(1990-2#2)(1990-5#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-2#1)(1992-5#1)(1993-11#1)(1993-4#1)(1993-7#1)(1994-9#1)(1995-12#2)(1995-8#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-4#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-3#1)(2007-1#2)(2007-10#1)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-10#20)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#4)(2008-6#1)(2008-9#1)(2009-12#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-3#2)(2013-7#2)(2013-8#2)
to 11% of##2##3##(2007-11#1)(2008-1#1)
to 11%##6##2##(1991-2#1)(2005-11#1)(2007-11#1)(2008-1#1)(2008-10#2)
to 11-12##2##2##(1993-11#1)(2006-8#1)
to 11-fold##3##2##(1992-12#1)(1993-4#1)(1995-11#1)
to 11-year-old children##2##3##(2008-5#1)(2010-8#1)
to 11-year-old##3##2##(1996-1#1)(2008-5#1)(2010-8#1)
to 110 degrees C##3##4##(1992-8#1)(2008-10#1)(2010-2#1)
to 110 degrees##4##3##(1992-8#1)(2008-10#1)(2010-2#1)(2012-2#1)
to 110##14##2##(1992-12#1)(1992-8#1)(1993-2#1)(1993-7#1)(1997-7#1)(2007-8#1)(2008-10#4)(2010-2#1)(2012-2#2)(2013-1#1)
to 110%##7##2##(2005-10#2)(2008-10#5)
to 1100##3##2##(1993-4#1)(2008-11#2)
to 111##3##2##(1997-2#2)(2012-12#1)
to 112##4##2##(1991-1#1)(1991-9#1)(2008-10#2)
to 112%##3##2##(2008-10#3)
to 113##4##2##(1994-7#1)(2008-10#1)(2011-1#1)(2012-12#1)
to 114##2##2##(1994-9#1)(2009-2#1)
to 115##2##2##(2007-11#1)(2008-6#1)
to 116##2##2##(1992-7#1)(2008-5#1)
to 117##6##2##(1997-8#1)(2007-11#1)(2008-1#2)(2008-11#1)(2009-4#1)
to 117% for##2##3##(2008-10#2)
to 117%##3##2##(1990-7#1)(2008-10#2)
to 119##2##2##(2008-5#1)(2012-12#1)
to 12 days##6##3##(1994-2#1)(1995-7#2)(2007-3#1)(2008-10#1)(2008-5#1)
to 12 days)##2##3##(2005-5#1)(2011-2#1)
to 12 h after##2##4##(2008-10#2)
to 12 h##3##3##(2008-10#3)
to 12 km##3##3##(2008-2#2)(2008-3#1)
to 12 mg##3##3##(2006-8#1)(2008-10#2)
to 12 microM##3##3##(1995-7#2)(1996-6#1)
to 12 months after##3##4##(2006-10#1)(2009-10#1)(2012-12#1)
to 12 months of age##3##5##(1994-5#1)(2007-8#1)(2007-9#1)
to 12 months##17##3##(1994-5#1)(2004-3#1)(2006-10#1)(2006-11#2)(2007-10#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2009-10#1)(2009-11#1)(2011-1#2)(2012-12#1)
to 12 weeks after##2##4##(2007-11#1)(2008-10#1)
to 12 weeks of##4##4##(1992-1#1)(1993-12#1)(1993-7#1)(2013-1#1)
to 12 weeks##13##3##(1990-2#1)(1992-1#1)(1993-12#3)(1993-7#1)(1994-9#1)(1997-5#1)(2006-8#1)(2007-11#2)(2008-10#1)(2013-1#1)
to 12 years##9##3##(1992-1#2)(1993-1#1)(2009-9#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
to 12 years)##4##3##(1990-2#1)(2006-5#1)(2012-1#1)(2012-2#1)
to 12##154##2##(1990-11#2)(1990-2#3)(1990-3#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-8#1)(1992-1#3)(1992-12#1)(1992-3#2)(1993-1#1)(1993-12#3)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-7#4)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-6#1)(2004-3#1)(2005-1#1)(2005-10#1)(2005-11#2)(2005-5#1)(2006-10#2)(2006-11#2)(2006-5#1)(2006-8#2)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#5)(2007-3#1)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#28)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#7)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#3)(2013-8#2)
to 12% in##3##3##(2008-5#1)(2011-12#1)(2012-3#1)
to 12% of the##2##4##(2006-12#1)(2007-7#1)
to 12% of##3##3##(2006-12#1)(2007-11#1)(2007-7#1)
to 12%##11##2##(1996-5#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-3#1)(2008-5#1)(2010-7#1)(2011-12#1)(2012-3#1)
to 12-fold##2##2##(1995-3#1)(2007-12#1)
to 12-year-old children##2##3##(1992-1#1)(2010-6#1)
to 12-year-old##5##2##(1992-1#1)(2006-4#1)(2010-6#1)(2012-12#2)
to 120 cm in##2##4##(2008-10#2)
to 120 cm##4##3##(2008-10#4)
to 120 degrees C##3##4##(1995-8#1)(2008-10#1)(2008-3#1)
to 120 h##3##3##(2007-6#1)(2008-8#1)(2013-8#1)
to 120 min##2##3##(1996-9#1)(2013-8#1)
to 120 months)##2##3##(2005-5#1)(2013-1#1)
to 120##36##2##(1990-7#1)(1992-7#1)(1993-1#1)(1995-8#1)(1996-9#2)(2005-12#1)(2005-5#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#10)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2013-1#1)(2013-8#2)
to 120% at the##2##4##(2008-10#1)(2013-8#1)
to 120%##7##2##(2008-10#6)(2013-8#1)
to 1200##6##2##(1997-4#1)(2007-11#1)(2008-10#2)(2008-7#1)(2011-2#1)
to 121##4##2##(2008-2#2)(2008-5#1)(2010-2#1)
to 121%##2##2##(2008-10#2)
to 122##4##2##(1995-1#1)(2005-1#1)(2009-6#1)(2012-12#1)
to 124##5##2##(1990-11#1)(1991-3#1)(1997-2#1)(2008-3#1)(2011-2#1)
to 125##10##2##(1993-4#1)(1995-5#1)(1997-1#1)(1997-4#1)(2007-1#1)(2008-11#1)(2008-2#2)(2008-9#1)(2010-7#1)
to 126##3##2##(1990-11#1)(2006-12#1)(2008-8#1)
to 128 +/-##2##3##(1995-3#1)(2008-5#1)
to 128##7##2##(1990-4#1)(1995-3#1)(2005-12#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-5#1)
to 129##2##2##(1997-6#1)(2008-3#1)
to 13 months##2##3##(1992-5#1)(2012-3#1)
to 13 patients##2##3##(1991-10#1)(2006-7#1)
to 13 years##7##3##(1995-3#1)(2006-10#2)(2007-2#1)(2007-7#1)(2009-9#1)(2010-9#1)
to 13##58##2##(1990-5#1)(1991-10#1)(1992-12#1)(1992-5#1)(1993-10#1)(1993-6#1)(1994-11#2)(1994-6#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-6#1)(1997-8#1)(2006-10#2)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#1)(2009-2#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
to 13% of##3##3##(1990-10#1)(1990-9#1)(2006-10#1)
to 13%##6##2##(1990-10#1)(1990-9#1)(1997-3#1)(2006-10#1)(2007-3#1)(2008-10#1)
to 13-fold##3##2##(1995-11#1)(1996-5#1)(2013-1#1)
to 130##6##2##(1990-10#1)(1993-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)
to 1300 nm##3##3##(2007-12#1)(2011-1#2)
to 1300##6##2##(1991-5#1)(2007-12#1)(2008-10#1)(2009-3#1)(2011-1#2)
to 131##3##2##(1990-11#1)(1996-3#1)(2008-5#1)
to 132##3##2##(1991-1#1)(2008-1#1)(2011-2#1)
to 133##4##2##(1991-6#1)(2008-1#1)(2008-11#1)(2008-8#1)
to 135##4##2##(1993-8#1)(1997-2#1)(2006-10#1)(2008-2#1)
to 136##2##2##(1995-6#1)(1997-2#1)
to 137##2##2##(2007-7#1)(2012-3#1)
to 138##3##2##(1994-9#1)(2007-11#1)(2012-12#1)
to 139##2##2##(2008-4#1)(2013-7#1)
to 14 days after##3##4##(2008-10#1)(2008-4#2)
to 14 days of##2##4##(1991-11#1)(2008-10#1)
to 14 days##11##3##(1991-11#1)(1991-9#2)(1992-5#1)(2008-10#4)(2008-4#2)(2009-12#1)
to 14 healthy##2##3##(1992-5#1)(2011-2#1)
to 14 mm)##2##3##(2007-8#1)(2012-1#1)
to 14 months##4##3##(1990-6#1)(2006-6#1)(2006-8#1)(2007-2#1)
to 14 weeks##4##3##(1991-10#1)(1997-6#1)(2008-10#1)(2011-1#1)
to 14 years of age##3##5##(2007-1#1)(2012-12#1)(2013-1#1)
to 14 years##16##3##(1991-2#1)(2006-6#1)(2007-1#1)(2007-7#1)(2007-8#3)(2009-3#3)(2010-8#1)(2012-12#1)(2013-1#4)
to 14##97##2##(1990-12#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-2#1)(1991-7#1)(1991-9#3)(1992-5#2)(1993-6#1)(1994-9#2)(1995-11#1)(1997-2#1)(1997-6#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#3)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#13)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-3#3)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#8)
to 14%##8##2##(1993-10#1)(1997-2#1)(1997-8#1)(2006-2#1)(2007-8#1)(2009-2#1)(2013-1#1)(2013-8#1)
to 14)##2##2##(1993-3#1)(1994-9#1)
to 14-fold increase in##2##4##(1990-2#1)(1997-7#1)
to 140##7##2##(2006-6#1)(2007-10#1)(2008-10#1)(2008-8#1)(2010-8#1)(2012-2#1)(2013-1#1)
to 1400##5##2##(1995-2#2)(2008-10#2)(2008-3#1)
to 143##2##2##(2008-11#1)(2008-2#1)
to 144##3##2##(1991-8#1)(2008-10#2)
to 145##2##2##(2009-2#1)(2013-1#1)
to 146##3##2##(2007-1#1)(2008-2#1)(2012-3#1)
to 147##2##2##(1993-12#1)(2008-3#1)
to 149 +/-##2##3##(1990-5#1)(1994-6#1)
to 149##5##2##(1990-5#1)(1994-6#1)(2006-12#1)(2008-3#1)(2013-1#1)
to 15 and##5##3##(1990-6#1)(1992-8#1)(2007-3#1)(2010-8#1)(2012-1#1)
to 15 cm##2##3##(2008-5#1)(2013-8#1)
to 15 day##2##3##(2008-10#1)(2011-2#1)
to 15 days##7##3##(1995-4#1)(2007-6#1)(2008-10#1)(2008-5#3)(2008-9#1)
to 15 degrees C##4##4##(2006-5#1)(2007-9#1)(2008-10#2)
to 15 degrees##5##3##(2006-5#1)(2007-9#1)(2008-10#3)
to 15 mM##2##3##(1990-5#1)(2008-7#1)
to 15 mg##5##3##(1992-8#1)(2005-8#1)(2007-8#1)(2008-10#2)
to 15 min##5##3##(1990-12#1)(1991-8#1)(1994-10#1)(1994-3#1)(2012-3#1)
to 15 minutes##2##3##(2007-7#1)(2008-10#1)
to 15 ml##2##3##(2006-12#1)(2008-10#1)
to 15 mug##2##3##(2008-10#2)
to 15 percent of the##2##5##(1992-3#1)(2011-2#1)
to 15 percent of##3##4##(1992-3#1)(1995-12#1)(2011-2#1)
to 15 percent##5##3##(1991-6#1)(1992-3#1)(1995-12#1)(1997-1#1)(2011-2#1)
to 15 years of##2##4##(2009-7#1)(2011-2#1)
to 15 years##16##3##(1991-2#1)(1997-6#1)(2005-8#1)(2006-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2009-7#1)(2011-2#2)(2013-8#1)
to 15 years)##2##3##(1997-1#1)(2013-1#1)
to 15##135##2##(1990-12#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-6#1)(1991-8#2)(1992-3#1)(1992-7#1)(1992-8#2)(1993-2#1)(1993-4#1)(1994-10#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1995-12#1)(1995-4#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-8#3)(2006-10#2)(2006-12#2)(2006-5#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#24)(2008-11#2)(2008-3#1)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#2)(2010-1#1)(2010-12#3)(2010-8#2)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
to 15% for##2##3##(2008-10#1)(2012-2#1)
to 15% in##2##3##(2009-9#1)(2013-8#1)
to 15% of patients##2##4##(1991-8#1)(2007-9#1)
to 15% of the##2##4##(1992-2#1)(2010-5#1)
to 15% of##9##3##(1991-4#1)(1991-8#1)(1992-2#1)(1995-8#1)(2007-12#1)(2007-9#1)(2010-5#1)(2010-7#1)(2012-2#1)
to 15%##25##2##(1991-4#1)(1991-5#1)(1991-8#1)(1992-2#1)(1993-9#1)(1994-12#1)(1995-8#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#4)(2009-9#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#1)
to 15-20##2##2##(1995-10#1)(2009-12#1)
to 15-fold by##2##3##(1993-6#1)(1997-3#1)
to 15-fold##7##2##(1993-6#2)(1995-8#2)(1996-7#1)(1997-3#1)(2008-10#1)
to 15-year-old##2##2##(2012-12#2)
to 150 cm##2##3##(2006-7#1)(2006-9#1)
to 150 microm##2##3##(2005-11#1)(2009-6#1)
to 150 mum##2##3##(2005-12#1)(2008-11#1)
to 150##42##2##(1991-5#2)(1991-9#1)(1993-1#1)(1995-2#1)(1996-3#1)(1996-5#1)(1997-8#1)(2005-11#1)(2005-12#1)(2006-11#1)(2006-4#1)(2006-7#1)(2006-9#1)(2007-10#2)(2007-12#4)(2007-3#2)(2007-4#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#1)
to 1500 ng/ml##2##3##(1992-7#2)
to 1500##11##2##(1991-4#2)(1991-5#1)(1992-7#2)(2008-3#2)(2008-6#1)(2008-8#1)(2009-7#1)(2013-8#1)
to 152##5##2##(1996-2#1)(2007-4#2)(2008-10#1)(2011-2#1)
to 154##2##2##(1990-3#1)(2007-4#1)
to 155##2##2##(2008-3#1)(2008-9#1)
to 158##3##2##(1991-6#1)(2008-2#1)(2012-2#1)
to 15g/kg in restructured dry-cured hams##2##6##(2010-4#2)
to 16 days##3##3##(2005-9#1)(2008-10#2)
to 16 h after##2##4##(1992-6#1)(2006-5#1)
to 16 h of##2##4##(2008-10#1)(2008-11#1)
to 16 h##5##3##(1992-6#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-11#1)
to 16 percent##2##3##(1991-12#1)(1993-3#1)
to 16 weeks after the##2##5##(2008-10#1)(2010-2#1)
to 16 weeks after##3##4##(2008-10#2)(2010-2#1)
to 16 years of age##3##5##(2008-9#1)(2009-10#1)(2013-1#1)
to 16 years of##4##4##(1995-10#1)(2008-9#1)(2009-10#1)(2013-1#1)
to 16 years##14##3##(1991-2#1)(1995-10#1)(2005-9#2)(2006-8#1)(2007-8#1)(2008-3#2)(2008-9#1)(2009-10#1)(2009-4#1)(2010-5#1)(2011-11#1)(2013-1#1)
to 16##85##2##(1990-12#2)(1990-8#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-6#2)(1993-12#1)(1993-3#1)(1993-5#1)(1994-12#1)(1995-10#1)(1995-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-11#1)(2005-9#3)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#2)(2010-2#2)(2010-5#1)(2011-11#1)(2011-2#1)(2012-1#2)(2012-2#2)(2013-1#4)(2013-8#2)
to 16%##8##2##(1990-6#1)(1993-9#1)(1997-3#1)(1997-8#1)(2004-11#1)(2006-4#1)(2008-12#1)(2008-8#1)
to 16) gave a##2##4##(2008-10#1)(2012-2#1)
to 16)##3##2##(1993-3#1)(2008-10#1)(2012-2#1)
to 16-fold##2##2##(1994-11#1)(2008-11#1)
to 160 degrees C##2##4##(2005-12#1)(2011-1#1)
to 160 degrees##3##3##(2005-12#1)(2008-3#1)(2011-1#1)
to 160##12##2##(2004-12#1)(2005-12#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2011-1#1)
to 1600##3##2##(2007-12#2)(2008-10#1)
to 162 +/-##2##3##(1992-7#1)(2005-1#1)
to 162##5##2##(1992-7#1)(1997-8#1)(2005-1#1)(2007-7#1)(2012-2#1)
to 1620 nm##2##3##(2007-12#1)(2008-2#1)
to 167##2##2##(1990-11#1)(2008-7#1)
to 168##5##2##(1992-8#2)(1993-12#1)(2009-5#1)(2012-12#1)
to 169##2##2##(1993-2#1)(2008-7#1)
to 16q12##2##2##(1997-2#2)
to 17 beta-estradiol in##2##4##(1993-9#1)(1996-10#1)
to 17 beta-estradiol##3##3##(1993-9#1)(1996-10#2)
to 17 days##2##3##(1992-8#1)(2008-10#1)
to 17 patients##2##3##(1994-1#1)(2013-1#1)
to 17 years old##2##4##(2008-9#1)(2012-12#1)
to 17 years##10##3##(1991-8#1)(1995-2#1)(2005-10#1)(2006-4#1)(2007-7#1)(2008-9#1)(2009-7#1)(2012-12#2)(2012-3#1)
to 17##50##2##(1990-5#2)(1991-2#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-4#1)(1993-9#1)(1994-1#1)(1994-8#1)(1995-2#2)(1996-10#2)(1997-2#1)(2005-10#1)(2006-4#1)(2007-4#1)(2007-7#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
to 17%##6##2##(1991-11#1)(1993-3#1)(1995-1#1)(2006-10#1)(2010-6#1)(2013-1#1)
to 17-fold##3##2##(1990-10#1)(1994-2#1)(1994-9#1)
to 170 degrees##2##3##(2007-11#1)(2008-2#1)
to 170##12##2##(1991-3#1)(1994-9#1)(1996-3#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-12#1)(2012-2#1)
to 171 m##2##3##(2008-10#2)
to 171##3##2##(1997-7#1)(2008-10#2)
to 175##5##2##(1994-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#1)
to 18 A in##2##4##(1990-7#1)(1995-6#1)
to 18 days##6##3##(2005-11#1)(2008-10#3)(2008-11#1)(2008-5#1)
to 18 degrees C but not at##2##7##(2008-10#2)
to 18 degrees C##5##4##(2008-10#5)
to 18 h##3##3##(1995-11#1)(2008-10#2)
to 18 in the##2##4##(2007-12#1)(2010-2#1)
to 18 mm##3##3##(2011-1#2)(2012-2#1)
to 18 months##7##3##(1991-12#1)(1995-9#1)(2006-5#1)(2007-2#1)(2008-5#1)(2011-2#1)(2013-1#1)
to 18 years of##2##4##(2008-9#1)(2011-2#1)
to 18 years old)##2##4##(2008-9#1)(2012-3#1)
to 18 years##7##3##(2005-12#1)(2007-8#1)(2008-9#2)(2009-7#1)(2011-2#1)(2012-3#1)
to 18##97##2##(1990-12#1)(1990-7#2)(1990-9#1)(1991-12#1)(1991-5#1)(1991-9#2)(1992-3#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-11#3)(1993-3#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-11#2)(1996-7#1)(1997-4#1)(2005-11#1)(2005-12#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#19)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#2)(2009-7#2)(2010-12#2)(2010-2#2)(2010-9#1)(2011-1#3)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
to 18% of the##2##4##(1990-7#1)(2008-10#1)
to 18% of##5##3##(1990-7#1)(1997-4#1)(2006-3#1)(2007-11#1)(2008-10#1)
to 18%##10##2##(1990-7#1)(1997-4#1)(1997-8#1)(2006-3#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-6#1)(2009-9#1)(2011-2#1)
to 18)##2##2##(2010-4#1)(2011-1#1)
to 18-hydroxycorticosterone or aldosterone##2##4##(1994-2#1)(1995-10#1)
to 180 days##2##3##(1990-12#1)(2008-10#1)
to 180 degrees##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
to 180 min##2##3##(1993-7#1)(1994-9#1)
to 180##18##2##(1990-12#1)(1991-8#1)(1993-3#1)(1993-7#1)(1994-2#1)(1994-9#1)(1995-5#1)(2007-12#4)(2008-10#2)(2008-2#2)(2008-3#1)(2009-2#1)(2013-1#1)
to 1800 degrees C##2##4##(2008-2#2)
to 1800 nm##2##3##(2008-1#1)(2008-3#1)
to 1800##7##2##(2007-3#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)
to 183##3##2##(2006-1#1)(2007-8#1)(2008-10#1)
to 185##2##2##(2008-6#1)(2008-9#1)
to 188##2##2##(1995-12#1)(2012-12#1)
to 19 days##2##3##(2007-8#1)(2008-12#1)
to 19 m/s##2##3##(1993-3#2)
to 19 years##6##3##(1990-5#1)(1992-8#1)(2008-1#2)(2008-11#1)(2011-1#1)
to 19 years)##2##3##(2008-11#1)(2011-1#1)
to 19##46##2##(1990-5#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-8#2)(1993-3#2)(1994-2#1)(1995-2#1)(1997-8#1)(2006-5#1)(2007-5#1)(2007-8#2)(2008-1#3)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#2)(2008-5#1)(2008-8#3)(2009-11#1)(2009-2#1)(2009-5#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
to 19% of##3##3##(1990-12#1)(2011-2#1)(2013-1#1)
to 19%##8##2##(1990-12#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2011-2#1)(2013-1#1)
to 19-year-old##2##2##(2005-10#1)(2011-1#1)
to 190##3##2##(1992-12#1)(2006-9#1)(2008-10#1)
to 192##5##2##(2007-10#1)(2008-2#1)(2008-6#2)(2012-2#1)
to 1920##2##2##(2008-10#1)(2011-1#1)
to 1925##2##2##(2008-8#1)(2011-2#1)
to 1930##2##2##(1991-12#1)(1992-6#1)
to 1941##2##2##(2008-8#2)
to 195##3##2##(2008-3#1)(2010-4#1)(2010-6#1)
to 1950##5##2##(1993-1#1)(1997-1#1)(1997-3#1)(2008-2#1)(2008-8#1)
to 1970##2##2##(2008-7#1)(2009-2#1)
to 1972##2##2##(2008-11#1)(2009-7#1)
to 1979##3##2##(2007-6#1)(2008-8#1)(2009-7#1)
to 1980##5##2##(1992-5#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-10#1)
to 1981##2##2##(1991-9#1)(1994-1#1)
to 1983##2##2##(2006-7#1)(2007-8#1)
to 1984##6##2##(1990-10#1)(1990-4#2)(1990-6#1)(1991-5#1)(1993-5#1)
to 1985##4##2##(1990-2#1)(1992-10#1)(1992-9#1)(1994-7#1)
to 1986##3##2##(1991-2#1)(2007-11#1)(2008-10#1)
to 1987##9##2##(1991-10#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-1#2)(1992-5#1)(1994-2#1)(1995-9#1)
to 1988 were##2##3##(1990-3#1)(1993-12#1)
to 1988##13##2##(1990-12#3)(1990-3#1)(1990-4#1)(1990-5#2)(1991-4#1)(1991-5#1)(1991-8#1)(1992-1#1)(1993-12#1)(1993-6#1)
to 1989 to##3##3##(1996-1#1)(2006-8#1)(2008-10#1)
to 1989##30##2##(1990-8#1)(1991-12#1)(1991-5#1)(1991-8#2)(1991-9#3)(1992-10#1)(1992-11#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-3#2)(1996-1#1)(1996-3#1)(1996-9#1)(1997-8#1)(2006-10#1)(2006-8#2)(2007-8#1)(2008-10#2)
to 1990 and##2##3##(2008-10#1)(2008-4#1)
to 1990 were##2##3##(1991-5#1)(1993-5#1)
to 1990##20##2##(1990-8#1)(1991-12#3)(1991-5#1)(1992-1#1)(1992-5#1)(1993-3#2)(1993-5#1)(1993-8#1)(1994-2#2)(1995-2#1)(1996-4#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)
to 1991##15##2##(1992-2#1)(1993-2#1)(1993-5#1)(1993-9#3)(1994-3#1)(1995-9#1)(2008-10#3)(2008-5#2)(2008-6#1)(2012-12#1)
to 1992##16##2##(1992-6#1)(1993-12#2)(1993-6#1)(1995-2#1)(1995-3#3)(1996-1#2)(1996-3#1)(1996-5#1)(2005-10#1)(2007-9#1)(2008-10#2)
to 1993 were##2##3##(1994-8#1)(2007-3#1)
to 1993##17##2##(1994-11#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-3#2)(1996-3#1)(1996-6#3)(1997-1#1)(2004-12#1)(2006-2#1)(2007-3#1)(2008-10#1)(2008-5#1)(2011-2#1)
to 1994##17##2##(1995-11#1)(1995-12#1)(1996-3#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-6#1)(2006-10#1)(2007-2#1)(2008-10#4)(2008-3#1)(2008-7#1)(2009-4#1)
to 1995 and##2##3##(2008-10#2)
to 1995##23##2##(1996-4#1)(1997-2#1)(1997-3#3)(1997-6#1)(1997-8#1)(2005-10#1)(2005-7#1)(2005-8#1)(2005-9#1)(2007-3#1)(2007-8#1)(2008-10#8)(2008-6#1)(2011-2#1)
to 1995)##3##2##(1996-6#1)(1997-3#1)(2008-10#1)
to 1996 and##4##3##(2006-10#1)(2008-10#1)(2008-2#1)(2011-1#1)
to 1996##37##2##(1994-1#1)(1996-11#3)(1996-9#1)(1997-5#1)(1997-6#3)(2005-10#1)(2005-9#1)(2006-10#2)(2006-6#1)(2007-2#2)(2008-10#14)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2011-1#1)
to 1997 were##2##3##(2008-10#2)
to 1997##28##2##(2006-12#1)(2006-8#1)(2007-12#1)(2007-2#3)(2007-3#1)(2008-1#1)(2008-10#17)(2008-2#1)(2008-4#1)(2008-5#1)
to 1998 were##3##3##(2006-11#1)(2008-9#1)(2011-2#1)
to 1998##38##2##(2005-8#1)(2006-10#3)(2006-11#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-12#6)(2007-3#1)(2007-6#1)(2008-1#2)(2008-10#12)(2008-11#1)(2008-4#1)(2008-9#2)(2011-1#2)(2011-2#1)
to 1998)##2##2##(2008-10#2)
to 1999 and##3##3##(2008-10#3)
to 1999 on##2##3##(2006-2#1)(2008-10#1)
to 1999 were##3##3##(2008-10#2)(2008-9#1)
to 1999##33##2##(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#16)(2008-5#1)(2008-6#1)(2008-9#3)(2009-3#1)(2012-2#1)(2013-1#1)
to 1H##2##2##(1997-5#1)(2005-11#1)
to 1h##3##2##(2007-8#1)(2008-10#1)(2010-4#1)
to 1st##2##2##(1990-12#1)(2010-2#1)
to 1x10(-1)moldm(-3) and -58##2##4##(2008-10#2)
to 1x10(-1)moldm(-3) and##5##3##(2008-10#5)
to 1x10(-2) M##3##3##(2008-10#3)
to 1x10(-2)##4##2##(2008-10#4)
to 1x10(-3)##2##2##(2008-10#2)
to 1x10(-3)M with slopes of##2##5##(2008-10#2)
to 1x10(-5) g ml(-1) for##2##5##(2008-10#2)
to 1x10(-5)##7##2##(2008-10#7)
to 1x10(-6)molL(-1)##2##2##(2008-10#2)
to 2 ATA oxygen##2##4##(1993-12#2)
to 2 M##3##3##(1993-6#1)(2005-11#1)(2008-10#1)
to 2 and##5##3##(1992-10#1)(1993-10#1)(2007-11#1)(2008-10#1)(2008-3#1)
to 2 cm##4##3##(1997-6#1)(2008-10#1)(2009-8#1)(2010-12#1)
to 2 days##7##3##(1995-7#1)(2006-3#1)(2007-9#2)(2008-10#1)(2008-5#1)(2011-12#1)
to 2 groups##2##3##(2007-2#1)(2007-9#1)
to 2 h after##2##4##(1991-2#1)(2008-10#1)
to 2 h##9##3##(1991-2#1)(1994-9#1)(2008-10#3)(2008-4#1)(2010-12#1)(2011-12#1)(2013-1#1)
to 2 hours##6##3##(1993-8#1)(1994-3#2)(2006-2#1)(2007-8#1)(2012-12#1)
to 2 kN##2##3##(2006-11#1)(2007-1#1)
to 2 mM##2##3##(1990-12#1)(1994-9#1)
to 2 mg l(-1)##2##4##(2008-10#2)
to 2 microm##2##3##(2005-11#1)(2007-11#1)
to 2 months after##3##4##(1996-12#1)(2007-10#1)(2008-2#1)
to 2 months##10##3##(1996-1#1)(1996-12#2)(2005-7#1)(2007-10#1)(2008-10#1)(2008-2#1)(2009-8#1)(2012-12#1)(2012-3#1)
to 2 mum##3##3##(1993-2#1)(2007-11#1)(2008-2#1)
to 2 pi##2##3##(1995-9#1)(1996-2#1)
to 2 weeks before##2##4##(1990-12#2)
to 2 weeks##7##3##(1990-12#2)(1991-6#1)(1992-7#1)(2008-10#2)(2013-1#1)
to 2 x CO(2)-air##2##4##(2004-4#2)
to 2 x##11##3##(1990-5#1)(1993-12#1)(1994-12#1)(2004-4#4)(2005-4#1)(2007-8#1)(2008-10#1)(2008-11#1)
to 2 years##9##3##(2006-6#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-8#1)
to 2##462##2##(1990-11#2)(1990-12#6)(1990-2#1)(1990-3#1)(1990-5#4)(1990-7#1)(1990-8#4)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#5)(1991-3#2)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#4)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#4)(1992-8#1)(1992-9#5)(1993-10#1)(1993-12#3)(1993-2#2)(1993-3#7)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-3#5)(1994-8#2)(1994-9#6)(1995-1#4)(1995-10#2)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#2)(1995-8#1)(1995-9#5)(1996-1#1)(1996-12#3)(1996-2#5)(1996-4#1)(1996-5#5)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#3)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#3)(2004-11#1)(2004-2#1)(2004-4#4)(2004-9#1)(2005-10#1)(2005-11#4)(2005-4#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-11#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#7)(2007-12#17)(2007-2#4)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#15)(2007-9#5)(2008-1#7)(2008-10#90)(2008-11#6)(2008-12#2)(2008-2#14)(2008-3#12)(2008-4#1)(2008-5#10)(2008-7#7)(2008-8#6)(2008-9#2)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#4)(2011-1#6)(2011-12#2)(2011-2#4)(2012-12#9)(2012-2#4)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#7)
to 2% of##4##3##(1995-2#1)(2005-8#1)(2006-9#1)(2013-1#1)
to 2%##17##2##(1993-8#1)(1995-12#1)(1995-2#1)(2004-9#1)(2005-8#1)(2006-9#2)(2007-12#1)(2007-2#1)(2008-10#4)(2008-5#1)(2009-3#1)(2012-12#1)(2013-1#1)
to 2%)##2##2##(1994-2#1)(2005-11#1)
to 2-4##2##2##(2008-4#1)(2010-12#1)
to 2-5A-dependent##2##2##(1990-2#2)
to 2-NLP-3##2##2##(1995-6#2)
to 2-cm##2##2##(2008-10#1)(2008-5#1)
to 2-fold##6##2##(1990-3#1)(1990-4#1)(1991-8#1)(1992-11#1)(1992-3#1)(1994-2#1)
to 2-phosphoenolpyruvate##2##2##(1990-5#2)
to 2-year##3##2##(1995-1#1)(2007-8#1)(2008-9#1)
to 20 A##2##3##(1990-12#1)(1992-12#1)
to 20 and##2##3##(2008-10#1)(2008-3#1)
to 20 cm##2##3##(1996-9#1)(1997-8#1)
to 20 days##7##3##(1991-8#2)(1995-5#1)(2008-1#1)(2008-10#2)(2011-2#1)
to 20 degrees C##4##4##(1997-7#1)(2007-8#1)(2008-10#2)
to 20 degrees C)##2##4##(2008-10#2)
to 20 degrees##8##3##(1997-7#1)(2007-7#1)(2007-8#1)(2008-10#4)(2013-1#1)
to 20 h in##2##4##(1994-8#1)(1996-9#1)
to 20 h##4##3##(1994-8#1)(1996-9#1)(2008-11#2)
to 20 mM##2##3##(1991-12#1)(2011-2#1)
to 20 mg per##2##4##(1991-2#1)(2008-5#1)
to 20 mg##4##3##(1991-2#1)(2007-8#1)(2008-10#1)(2008-5#1)
to 20 microM##2##3##(2008-10#1)(2009-3#1)
to 20 min##5##3##(1993-4#1)(2006-10#1)(2007-2#1)(2007-8#2)
to 20 minutes##2##3##(2008-10#1)(2013-8#1)
to 20 mm##4##3##(1992-1#1)(2008-11#1)(2008-2#1)(2009-8#1)
to 20 mol %##3##4##(2006-10#3)
to 20 muM##2##3##(2008-10#1)(2008-11#1)
to 20 ps##2##3##(1992-9#1)(2007-11#1)
to 20 samples##2##3##(2008-10#2)
to 20 times##2##3##(2008-10#1)(2008-6#1)
to 20 weeks##5##3##(1993-12#1)(1996-6#1)(2008-9#1)(2011-2#2)
to 20 years##6##3##(1991-12#1)(1993-11#1)(1993-2#1)(1996-5#1)(2006-10#1)(2007-8#1)
to 20##156##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#2)(1991-8#2)(1992-1#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2004-2#1)(2004-4#1)(2004-9#1)(2006-10#6)(2006-11#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#7)(2008-1#1)(2008-10#25)(2008-11#6)(2008-2#5)(2008-3#4)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#2)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-1#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
to 20% after##2##3##(1990-6#1)(2010-8#1)
to 20% between##2##3##(1994-4#1)(2008-2#1)
to 20% for##2##3##(2008-3#1)(2010-4#1)
to 20% in##2##3##(2007-11#1)(2008-10#1)
to 20% of all##2##4##(2009-6#1)(2013-1#1)
to 20% of patients##3##4##(2006-10#1)(2007-11#2)
to 20% of##18##3##(1990-8#1)(1997-7#1)(2006-10#1)(2007-11#3)(2007-7#3)(2008-11#1)(2008-6#1)(2008-7#2)(2009-12#1)(2009-6#1)(2011-1#2)(2013-1#1)
to 20%##55##2##(1990-6#1)(1990-8#1)(1994-10#1)(1994-4#1)(1995-10#1)(1997-3#1)(1997-7#2)(2005-11#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#4)(2007-2#1)(2007-5#1)(2007-7#3)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2013-1#2)
to 20%)##4##2##(1992-9#1)(2007-4#1)(2008-10#1)(2010-1#1)
to 20)##2##2##(1993-3#1)(2008-10#1)
to 20-30%##2##2##(1994-5#1)(2008-12#1)
to 20-fold higher##2##3##(1990-4#1)(1995-8#1)
to 20-fold##8##2##(1990-4#1)(1991-9#1)(1992-4#1)(1992-9#1)(1995-8#2)(1997-4#1)(2008-10#1)
to 20/100 in##2##3##(2010-9#1)(2011-1#1)
to 20/100##3##2##(2010-10#1)(2010-9#1)(2011-1#1)
to 20/20##2##2##(2009-8#1)(2010-9#1)
to 200 degrees C##3##4##(2007-11#1)(2007-12#2)
to 200 g##2##3##(2007-1#1)(2007-4#1)
to 200 kDa##2##3##(1993-12#1)(1996-12#1)
to 200 mg L(-1)##2##4##(2010-5#2)
to 200 mg##3##3##(2004-4#1)(2010-5#2)
to 200 micrograms##2##3##(1991-3#1)(1996-2#1)
to 200 nM##2##3##(1990-2#1)(2006-12#1)
to 200 ng/ml##2##3##(1993-2#1)(1996-8#1)
to 200##66##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-3#1)(1991-8#1)(1992-10#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-2#2)(1995-10#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-6#1)(2004-4#1)(2005-8#1)(2006-12#2)(2006-2#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-5#2)(2011-1#1)(2011-2#3)(2012-1#1)(2013-7#1)(2013-8#1)
to 200% of##2##3##(2008-1#1)(2013-8#1)
to 200%##6##2##(1996-2#1)(2007-8#1)(2008-1#2)(2008-5#1)(2013-8#1)
to 200)##2##2##(2005-9#1)(2008-3#1)
to 200-fold##4##2##(1994-8#1)(1997-8#1)(2008-10#1)(2008-5#1)
to 2000 and##3##3##(2006-8#1)(2007-12#1)(2008-10#1)
to 2000 mg##2##3##(2008-10#1)(2008-5#1)
to 2000 ng##2##3##(1997-8#1)(2008-10#1)
to 2000 were##2##3##(2008-10#2)
to 2000##55##2##(1990-8#1)(1995-2#1)(1996-8#1)(1997-8#2)(2005-10#2)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-8#2)(2007-11#3)(2007-12#1)(2007-6#2)(2007-7#1)(2008-1#2)(2008-10#19)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-7#1)(2010-12#1)(2011-1#1)(2013-1#1)
to 2000)##2##2##(2008-10#1)(2008-4#1)
to 2001 period##2##3##(2007-12#1)(2008-9#1)
to 2001##32##2##(2005-10#1)(2006-10#1)(2006-12#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-5#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#6)(2008-2#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#1)
to 2002##23##2##(2005-9#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-7#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#4)(2008-10#1)(2008-11#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)
to 2003 in##2##3##(2009-11#1)(2010-11#1)
to 2003##31##2##(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#3)(2007-8#7)(2007-9#1)(2008-10#7)(2008-11#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-1#1)
to 2003)##3##2##(2007-8#1)(2008-10#2)
to 2004 in##2##3##(2008-1#1)(2011-1#1)
to 2004 was##2##3##(2008-3#1)(2008-7#1)
to 2004##27##2##(2005-3#1)(2007-12#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)
to 2004)##4##2##(2008-10#4)
to 2005 for##2##3##(2008-10#1)(2008-8#1)
to 2005 in##2##3##(2010-8#1)(2011-2#1)
to 2005 was##2##3##(2007-12#1)(2011-2#1)
to 2005##31##2##(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-12#3)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-8#3)(2011-12#1)(2011-2#5)(2012-12#1)(2013-8#1)
to 2006 in##2##3##(2009-3#1)(2012-12#1)
to 2006##14##2##(2007-8#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
to 2006)##2##2##(2008-11#1)(2011-2#1)
to 2007 were##3##3##(2009-5#1)(2011-2#2)
to 2007##30##2##(2008-7#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-9#2)(2011-1#1)(2011-2#12)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
to 2007)##3##2##(2010-9#1)(2011-2#2)
to 2008 in##2##3##(2011-2#2)
to 2008##26##2##(2009-2#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-4#1)(2011-1#2)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-7#2)(2013-8#2)
to 2008]##3##2##(2010-1#1)(2011-1#1)(2011-12#1)
to 2009 showed that##2##4##(2011-12#1)(2012-3#1)
to 2009 were##2##3##(2010-12#1)(2011-12#1)
to 2009##26##2##(2007-4#1)(2010-12#1)(2011-1#2)(2011-12#3)(2011-2#4)(2011-9#2)(2012-12#3)(2012-2#4)(2012-3#5)(2013-1#1)
to 2009)##2##2##(2012-2#1)(2012-5#1)
to 2009]##2##2##(2012-2#1)(2012-3#1)
to 200muM##3##2##(2008-10#3)
to 201##2##2##(2008-10#1)(2010-8#1)
to 2010 and##2##3##(2013-1#2)
to 2010 showed that##2##4##(2012-3#2)
to 2010 were##2##3##(2012-3#2)
to 2010##22##2##(2011-7#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#5)
to 2010]##4##2##(2012-3#2)(2013-1#1)(2013-8#1)
to 2011##8##2##(2010-5#2)(2012-12#2)(2013-1#2)(2013-8#2)
to 2011]##3##2##(2012-3#1)(2013-1#1)(2013-7#1)
to 2012##3##2##(2013-1#2)(2013-8#1)
to 202##2##2##(1997-3#1)(2008-10#1)
to 203##2##2##(1994-9#1)(1995-7#1)
to 206##4##2##(1996-3#1)(1997-3#1)(1997-4#1)(2005-11#1)
to 208##2##2##(1991-9#1)(2008-4#1)
to 21 after##2##3##(1993-11#1)(2008-10#1)
to 21 days old)##2##4##(2008-10#1)(2010-4#1)
to 21 days##11##3##(1990-7#1)(1994-12#1)(1996-7#1)(2006-5#1)(2007-10#1)(2007-3#1)(2008-10#3)(2008-4#1)(2010-4#1)
to 21 degrees C##3##4##(2008-10#2)(2008-5#1)
to 21 dfs##2##3##(2008-10#2)
to 21 years##2##3##(1991-12#1)(2007-12#1)
to 21##53##2##(1990-7#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-10#1)(1993-11#1)(1994-11#1)(1994-12#1)(1996-10#1)(1996-6#1)(1996-7#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#11)(2008-4#1)(2008-5#3)(2008-7#1)(2009-5#1)(2010-4#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#4)(2013-7#3)
to 21%##6##2##(1993-11#1)(1994-3#1)(1995-5#1)(2007-5#1)(2008-10#1)(2011-1#1)
to 21-day##2##2##(2008-10#2)
to 21-hydroxylase##5##2##(1990-12#1)(1992-8#1)(2006-1#1)(2008-1#1)(2010-2#1)
to 210 +/-##2##3##(2008-10#2)
to 210##5##2##(1991-3#1)(2008-10#3)(2008-2#1)
to 210Pb##2##2##(1996-3#2)
to 214##4##2##(1994-9#3)(2007-12#1)
to 217##2##2##(1996-3#1)(2007-10#1)
to 22 days##2##3##(2008-10#1)(2010-8#1)
to 22 degrees C##5##4##(2008-10#4)(2008-11#1)
to 22 months##2##3##(1993-11#1)(2009-9#1)
to 22 years##2##3##(2006-5#1)(2007-7#1)
to 22##40##2##(1990-3#1)(1990-9#1)(1991-8#2)(1991-9#1)(1992-2#1)(1993-11#1)(1993-4#1)(1994-3#1)(1995-6#1)(1996-10#1)(1996-2#1)(2005-1#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-5#3)(2008-7#1)(2009-9#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-12#2)
to 22% in the##2##4##(2007-7#1)(2008-11#1)
to 22% of##3##3##(1996-9#1)(2004-3#1)(2008-10#1)
to 22%##9##2##(1996-9#1)(1997-8#1)(2004-3#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)
to 22+/-1##2##2##(2007-9#1)(2008-10#1)
to 220##4##2##(1991-7#1)(1995-3#1)(2006-9#1)(2010-4#1)
to 222##2##2##(1996-2#1)(2008-3#1)
to 225##5##2##(2006-12#1)(2006-8#1)(2007-8#1)(2008-10#1)(2012-2#1)
to 23 degrees C##2##4##(2008-10#1)(2008-5#1)
to 23##26##2##(1990-8#1)(1991-8#1)(1992-3#1)(1993-4#1)(1994-6#1)(1997-2#1)(2005-11#1)(2006-11#1)(2006-12#2)(2006-2#1)(2007-11#1)(2008-10#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#2)(2009-7#1)(2010-5#1)(2011-12#1)(2013-8#1)
to 23%##6##2##(1991-9#1)(1995-8#1)(1996-3#1)(2007-10#1)(2010-6#1)(2013-8#1)
to 230##5##2##(1997-6#1)(2007-12#1)(2008-10#2)(2008-2#1)
to 2300##2##2##(2008-10#1)(2010-8#1)
to 232##2##2##(1994-11#1)(1996-2#1)
to 239##2##2##(2004-10#1)(2006-12#1)
to 24 degrees C##3##4##(2008-10#2)(2008-5#1)
to 24 h after##2##4##(1995-5#1)(2008-10#1)
to 24 h and##2##4##(1997-1#1)(2008-10#1)
to 24 h at##2##4##(2005-12#1)(2008-10#1)
to 24 h of##2##4##(2008-10#2)
to 24 h##19##3##(1993-5#1)(1995-5#1)(1997-1#2)(2004-9#2)(2005-12#1)(2005-8#1)(2006-10#1)(2008-10#8)(2008-7#1)(2011-2#1)
to 24 h)##2##3##(2008-10#1)(2009-3#1)
to 24 hours of##2##4##(2011-1#2)
to 24 hours##9##3##(1993-11#1)(2006-8#1)(2007-10#3)(2007-9#1)(2008-7#1)(2011-1#2)
to 24 months##7##3##(1990-4#1)(1995-1#1)(1995-12#1)(2006-11#1)(2006-8#1)(2008-11#1)(2012-3#1)
to 24 weeks##3##3##(1996-4#1)(2008-10#1)(2010-4#1)
to 24 years##4##3##(1994-11#1)(2006-11#1)(2007-7#1)(2011-1#1)
to 24##91##2##(1990-4#1)(1991-1#1)(1993-11#1)(1993-5#1)(1994-11#1)(1994-6#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-4#1)(1996-5#1)(1997-1#2)(2004-9#3)(2005-12#1)(2005-8#1)(2006-10#1)(2006-11#2)(2006-6#1)(2006-8#2)(2007-10#3)(2007-12#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
to 24% of the##2##4##(1990-2#1)(2008-10#1)
to 24% of##4##3##(1990-2#1)(1994-3#1)(1996-1#1)(2008-10#1)
to 24%##8##2##(1990-2#1)(1994-3#1)(1996-1#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)
to 24-h##5##2##(1995-11#1)(2006-5#1)(2008-10#2)(2011-2#1)
to 24-hour##2##2##(1990-11#1)(1991-12#1)
to 240##7##2##(1990-11#1)(1992-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-3#1)
to 2400##2##2##(2008-10#1)(2008-2#1)
to 241##3##2##(2007-9#1)(2008-10#1)(2010-6#1)
to 25 days of##3##4##(2007-6#1)(2008-10#2)
to 25 days##4##3##(2007-6#1)(2008-10#2)(2008-7#1)
to 25 degrees C and##2##5##(2008-10#2)
to 25 degrees C for##2##5##(2008-10#2)
to 25 degrees C##16##4##(1992-2#1)(2008-10#15)
to 25 degrees C)##3##4##(1996-11#1)(2008-10#1)(2012-2#1)
to 25 degrees##19##3##(1992-2#1)(1996-11#1)(2008-10#16)(2012-2#1)
to 25 in##2##3##(2008-10#1)(2009-8#1)
to 25 mm##2##3##(2007-2#1)(2010-8#1)
to 25 months##2##3##(1991-8#1)(1997-5#1)
to 25 mug##2##3##(2008-10#1)(2008-11#1)
to 25 nm##2##3##(2007-11#1)(2008-2#1)
to 25 or 50##2##4##(1996-12#1)(2008-10#1)
to 25 or##3##3##(1996-12#1)(2008-10#1)(2012-2#1)
to 25##85##2##(1990-2#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-2#1)(1993-1#1)(1993-4#1)(1993-8#1)(1994-5#1)(1995-3#1)(1995-4#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-5#1)(1997-8#1)(2006-4#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#2)(2007-9#1)(2008-10#28)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-1#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#2)
to 25% and##2##3##(2005-10#1)(2008-9#1)
to 25% of patients##2##4##(1993-11#1)(2010-10#1)
to 25% of the##2##4##(2006-12#1)(2008-10#1)
to 25% of##8##3##(1993-11#1)(1994-10#1)(1997-1#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-10#1)
to 25% strain##2##3##(2010-4#2)
to 25%##28##2##(1993-11#1)(1994-10#2)(1995-12#1)(1997-1#2)(1997-5#1)(2004-11#1)(2005-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-4#2)(2010-7#1)(2010-9#1)(2013-1#2)
to 250 degrees C##4##4##(2005-12#1)(2008-10#1)(2010-2#2)
to 250 mg##2##3##(1996-3#1)(2006-2#1)
to 250 ppm##2##3##(1997-8#1)(2008-10#1)
to 250##27##2##(1990-2#1)(1990-4#2)(1990-6#1)(1992-6#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-8#1)(2004-9#1)(2005-12#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-10#5)(2008-4#1)(2008-5#1)(2010-2#2)(2011-1#2)
to 2500 nm##3##3##(2008-2#2)(2008-3#1)
to 2500##5##2##(2008-10#1)(2008-2#3)(2008-3#1)
to 256##2##2##(2006-8#1)(2007-7#1)
to 25nM##2##2##(2008-10#2)
to 25th##2##2##(1991-2#1)(2006-11#1)
to 26 degrees C##4##4##(1993-12#1)(2008-10#3)
to 26##36##2##(1990-4#1)(1991-4#1)(1992-7#1)(1993-12#1)(1994-12#1)(1996-3#2)(1996-7#1)(1997-2#1)(1997-6#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2009-10#1)(2010-2#2)(2010-8#1)(2012-2#1)
to 26% among##2##3##(1997-4#1)(2013-1#1)
to 26% of##4##3##(1996-1#1)(2007-12#1)(2013-1#1)(2013-8#1)
to 26%##16##2##(1990-11#1)(1990-12#1)(1994-12#2)(1996-1#1)(1996-8#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#2)(2013-1#2)(2013-8#2)
to 260##2##2##(1992-12#1)(2007-8#1)
to 262##2##2##(1991-1#1)(2005-12#1)
to 27 days##2##3##(2008-10#2)
to 27 years##3##3##(2006-7#1)(2007-11#1)(2009-3#1)
to 27##32##2##(1992-1#2)(1993-12#2)(1994-10#1)(1994-9#1)(1996-5#1)(1997-3#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-1#1)(2012-3#1)
to 27%##8##2##(1993-10#1)(1996-7#1)(2006-10#2)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)
to 275##2##2##(2005-8#1)(2010-4#1)
to 28 days##6##3##(2004-10#1)(2007-10#3)(2010-11#1)(2013-1#1)
to 28 degrees C for##2##5##(2008-10#2)
to 28 degrees C##7##4##(2008-10#6)(2011-2#1)
to 28 kDa##2##3##(1991-9#1)(1993-2#1)
to 28 months##2##3##(1993-8#1)(2011-2#1)
to 28 years##2##3##(1991-8#1)(2013-1#1)
to 28##54##2##(1990-5#1)(1990-9#3)(1991-4#1)(1991-8#1)(1991-9#1)(1992-1#1)(1993-2#1)(1993-8#1)(1994-9#1)(1996-6#1)(1997-1#1)(1997-3#1)(2004-10#1)(2006-5#1)(2007-10#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#10)(2008-2#1)(2008-3#2)(2008-4#1)(2009-12#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#2)(2013-1#5)(2013-8#1)
to 28% and##2##3##(1993-10#1)(1994-12#1)
to 28% of the##2##4##(2008-10#1)(2008-11#1)
to 28% of##4##3##(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)
to 28%##13##2##(1992-8#1)(1993-10#2)(1993-9#1)(1994-12#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-3#1)
to 280##6##2##(2007-12#2)(2008-10#1)(2008-2#3)
to 280-nm light##3##3##(1995-5#3)
to 280-nm##4##2##(1995-5#4)
to 286##2##2##(1994-9#1)(2007-8#1)
to 288##2##2##(2009-12#1)(2013-1#1)
to 29 in##2##3##(1993-6#1)(1997-4#1)
to 29 mgxl(-1)##2##3##(2008-5#2)
to 29 years##3##3##(1991-7#1)(1993-3#1)(2008-11#1)
to 29##21##2##(1991-1#1)(1991-7#1)(1992-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1996-1#1)(1997-3#1)(1997-4#1)(2004-9#1)(2006-2#1)(2007-1#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-5#1)(2011-2#1)(2012-2#1)
to 29%##7##2##(2006-11#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-3#1)
to 290##3##2##(2005-1#1)(2008-2#1)(2012-2#1)
to 295##2##2##(1992-2#1)(2008-10#1)
to 2D##3##2##(2010-12#1)(2011-1#1)(2012-1#1)
to 2mugL(-1)##2##2##(2008-10#2)
to 2x10(-3) M for##3##4##(2008-10#3)
to 3 and##3##3##(2008-10#2)(2008-6#1)
to 3 days after##2##4##(1993-3#1)(2008-10#1)
to 3 days in##3##4##(2007-10#2)(2008-10#1)
to 3 days##13##3##(1991-6#1)(1993-3#1)(2007-10#2)(2008-10#6)(2008-11#1)(2008-7#2)
to 3 embryos were either##2##5##(2006-5#2)
to 3 fold##2##3##(1993-2#1)(1993-9#1)
to 3 groups##2##3##(2011-2#1)(2013-1#1)
to 3 h##5##3##(1992-7#1)(1993-4#1)(2007-8#1)(2008-5#1)(2012-2#1)
to 3 hours##3##3##(1995-8#1)(2006-9#1)(2012-3#1)
to 3 mM##2##3##(2008-10#1)(2011-2#1)
to 3 microm##3##3##(2008-3#1)(2010-8#2)
to 3 min##3##3##(1996-1#1)(2008-7#1)(2009-7#1)
to 3 mm##4##3##(1997-5#1)(2007-7#1)(2008-5#1)(2012-3#1)
to 3 months in##2##4##(1992-11#1)(2009-2#1)
to 3 months##9##3##(1991-3#1)(1991-8#1)(1992-11#1)(1995-9#1)(2007-2#1)(2008-10#1)(2009-2#1)(2010-12#1)(2013-8#1)
to 3 orders of magnitude lower than##2##7##(1991-7#1)(2008-3#1)
to 3 orders of magnitude##5##5##(1991-7#1)(1995-11#1)(1996-7#1)(2008-2#1)(2008-3#1)
to 3 times##4##3##(1997-7#1)(2005-10#1)(2007-1#1)(2010-4#1)
to 3 to 4##2##4##(2008-5#1)(2013-7#1)
to 3 weeks of##2##4##(1997-6#1)(2007-12#1)
to 3 weeks##9##3##(1991-2#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2009-5#1)(2012-12#1)
to 3 x 10(7)##2##4##(2008-10#1)(2008-11#1)
to 3 x##7##3##(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#1)(2008-10#2)(2008-11#1)
to 3 years of##3##4##(1991-8#1)(1996-3#1)(2010-4#1)
to 3 years##12##3##(1991-8#2)(1996-3#1)(1997-8#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-8#2)(2007-9#1)(2010-4#1)(2013-1#1)
to 3 years)##2##3##(1990-8#1)(2008-10#1)
to 3##340##2##(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#3)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#4)(1992-11#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#7)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#3)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#2)(2006-5#2)(2006-7#2)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#4)(2007-11#7)(2007-12#11)(2007-2#5)(2007-3#1)(2007-5#3)(2007-6#1)(2007-7#5)(2007-8#11)(2007-9#1)(2008-10#61)(2008-11#8)(2008-12#2)(2008-2#5)(2008-3#8)(2008-4#1)(2008-5#13)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#2)(2009-5#2)(2009-7#3)(2010-12#1)(2010-2#1)(2010-4#4)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#10)(2013-7#3)(2013-8#5)
to 3% in##3##3##(2008-9#1)(2009-9#1)(2011-12#1)
to 3% of control##2##4##(1994-8#1)(1994-9#1)
to 3% of the##2##4##(1990-7#1)(1991-10#1)
to 3% of##9##3##(1990-7#1)(1991-10#1)(1992-5#1)(1994-8#1)(1994-9#1)(2006-5#1)(2008-9#2)(2010-3#1)
to 3%##22##2##(1990-7#1)(1991-10#1)(1992-5#1)(1994-8#1)(1994-9#2)(1995-2#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#3)(2009-9#1)(2010-3#1)(2011-12#1)(2011-2#1)
to 3%)##2##2##(1990-4#1)(2008-10#1)
to 3' end of##2##4##(1992-1#1)(1993-6#1)
to 3' end##5##3##(1992-1#1)(1993-6#1)(2008-10#1)(2008-8#2)
to 3'##13##2##(1990-12#1)(1991-8#1)(1992-1#1)(1993-6#1)(1993-8#1)(1993-9#1)(1996-4#1)(1997-4#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-8#2)
to 3)##3##2##(1990-12#1)(1992-4#1)(2008-10#1)
to 3+##2##2##(1995-2#1)(2010-8#1)
to 3-4##3##2##(1991-3#1)(1992-7#1)(2008-5#1)
to 3-8##2##2##(2007-12#1)(2008-5#1)
to 3-D##2##2##(2008-11#1)(2013-1#1)
to 3-fold##11##2##(1990-12#1)(1990-4#1)(1991-7#1)(1993-6#1)(1994-11#1)(1995-1#1)(1995-2#1)(1996-5#1)(1996-8#1)(1997-3#1)(2008-11#1)
to 3-fold)##2##2##(1994-5#1)(1995-11#1)
to 3-pentadecylcatechol##2##2##(2008-10#2)
to 30 and##2##3##(1990-3#1)(2007-2#1)
to 30 days##9##3##(1990-12#1)(1991-9#1)(1995-11#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-8#1)
to 30 degrees C and##2##5##(2008-10#2)
to 30 degrees C##12##4##(1996-11#1)(1997-7#1)(2008-10#9)(2008-5#1)
to 30 degrees##15##3##(1996-11#1)(1997-7#1)(2007-8#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-5#1)
to 30 fs##2##3##(2007-12#2)
to 30 km##2##3##(2008-2#1)(2008-3#1)
to 30 mM##3##3##(1995-2#1)(1997-1#1)(2007-11#1)
to 30 mg##4##3##(2006-10#1)(2008-10#3)
to 30 microM##2##3##(1992-1#1)(1992-8#1)
to 30 min##14##3##(1990-12#1)(1992-3#1)(1993-11#1)(1995-12#2)(1996-12#1)(1996-5#1)(1997-8#2)(2007-8#1)(2008-10#3)(2013-1#1)
to 30 min)##3##3##(1990-8#1)(2012-3#2)
to 30 minutes##2##3##(2012-1#1)(2012-12#1)
to 30 months##5##3##(1995-9#1)(2006-1#1)(2007-7#1)(2010-12#1)(2011-1#1)
to 30 mug l(-1)##2##4##(2008-10#2)
to 30 mul##2##3##(2008-10#2)
to 30 mum##2##3##(2007-5#1)(2008-2#1)
to 30 nm##4##3##(2006-12#2)(2008-10#1)(2009-5#1)
to 30 s##2##3##(2008-10#1)(2008-7#1)
to 30 seconds##3##3##(1991-5#1)(2006-6#1)(2009-8#1)
to 30 times higher##2##4##(1993-8#1)(1995-8#1)
to 30 times##4##3##(1993-8#1)(1995-8#1)(2006-12#1)(2008-1#1)
to 30 years##10##3##(1990-4#1)(1996-4#2)(1997-8#1)(2005-8#1)(2006-6#1)(2007-11#1)(2010-8#1)(2011-12#1)(2012-12#1)
to 30##178##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#2)(1990-8#2)(1991-2#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#2)(1995-9#1)(1996-11#4)(1996-12#1)(1996-3#1)(1996-4#2)(1996-5#2)(1996-9#1)(1997-1#3)(1997-4#1)(1997-7#1)(1997-8#4)(2005-11#1)(2005-8#2)(2006-1#1)(2006-10#4)(2006-12#3)(2006-6#3)(2007-11#3)(2007-12#7)(2007-2#1)(2007-5#2)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#41)(2008-11#1)(2008-2#9)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#4)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-8#2)(2011-1#3)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
to 30% in##4##3##(1996-12#1)(2008-10#2)(2008-8#1)
to 30% of patients with##2##5##(2008-6#1)(2012-2#1)
to 30% of patients##4##4##(2006-9#1)(2007-8#1)(2008-6#1)(2012-2#1)
to 30% of the patients##2##5##(1990-4#1)(2012-12#1)
to 30% of the##9##4##(1990-4#1)(1991-5#1)(1994-6#1)(2007-12#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
to 30% of##24##3##(1990-4#1)(1991-5#1)(1993-2#1)(1994-6#1)(2005-9#1)(2006-10#1)(2006-9#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
to 30%##51##2##(1990-4#1)(1991-5#1)(1991-8#1)(1993-10#1)(1993-2#1)(1993-9#1)(1994-6#1)(1996-12#1)(2004-11#1)(2005-1#1)(2005-9#2)(2006-10#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-11#1)(2011-1#3)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)
to 30%)##2##2##(1990-5#1)(2007-11#1)
to 30)##2##2##(2007-2#1)(2013-8#1)
to 30-fold##3##2##(1990-11#1)(1990-5#1)(1993-5#1)
to 30-fold)##2##2##(1993-8#1)(2006-9#1)
to 300 degrees C##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)
to 300 degrees##5##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2011-1#1)
to 300 mM##2##3##(1992-9#1)(2008-4#1)
to 300 mg##2##3##(1992-11#1)(2005-7#1)
to 300 mg/day##2##3##(1995-10#2)
to 300 nM##3##3##(1994-11#1)(1996-5#1)(2008-8#1)
to 300 nm##3##3##(1992-2#1)(2007-12#1)(2010-1#1)
to 300##31##2##(1990-12#1)(1992-11#1)(1992-2#1)(1992-9#1)(1994-11#1)(1994-5#1)(1995-10#2)(1995-8#1)(1996-12#1)(1996-5#1)(1996-8#1)(2005-11#1)(2005-7#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2010-1#1)(2011-1#1)
to 300-fold##2##2##(1994-11#1)(2013-1#1)
to 302##2##2##(2006-12#1)(2008-10#1)
to 31 December##2##3##(2004-10#1)(2013-8#1)
to 31 July##2##3##(2004-10#1)(2008-10#1)
to 31 degrees C##2##4##(2008-10#1)(2008-11#1)
to 31##26##2##(1990-12#1)(1992-6#1)(1994-3#1)(1996-12#1)(1997-6#1)(1997-8#1)(2004-10#2)(2006-12#1)(2007-4#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-12#2)(2011-2#1)(2013-1#2)(2013-8#1)
to 31% in##3##3##(1991-5#1)(2009-5#1)(2013-1#1)
to 31%##7##2##(1991-5#1)(1993-10#1)(1993-3#1)(2007-12#1)(2009-5#1)(2013-1#1)(2013-8#1)
to 310##2##2##(2008-10#1)(2008-3#1)
to 312##2##2##(1992-12#1)(2008-10#1)
to 31st##4##2##(2006-7#2)(2009-10#1)(2012-2#1)
to 32 degrees C##10##4##(1991-2#1)(1991-7#1)(1997-7#1)(2008-10#5)(2008-11#2)
to 32 kDa##2##3##(1995-5#1)(2008-5#1)
to 32 mm##2##3##(2008-3#1)(2010-8#1)
to 32 months##2##3##(1993-11#1)(2005-10#1)
to 32 samples##2##3##(2008-10#2)
to 32##48##2##(1991-2#1)(1991-7#1)(1991-8#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-5#1)(1995-11#1)(1995-5#1)(1995-6#1)(1997-7#1)(2005-10#1)(2005-8#2)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#1)(2010-8#1)(2011-12#1)(2012-1#1)(2012-2#1)
to 32% of##2##3##(1997-8#1)(2008-10#1)
to 32%##9##2##(1996-1#1)(1997-8#1)(2006-8#2)(2008-10#5)
to 320##3##2##(1990-3#1)(2008-10#1)(2012-2#1)
to 3200##2##2##(1991-12#1)(1991-2#1)
to 321##2##2##(2008-8#1)(2010-6#1)
to 325##4##2##(2007-3#1)(2007-6#1)(2008-3#1)(2008-5#1)
to 327##2##2##(1990-4#1)(2011-11#1)
to 328##2##2##(2005-1#1)(2008-5#1)
to 33##18##2##(1990-4#1)(1991-3#1)(1994-11#1)(1996-2#1)(1997-1#1)(2007-2#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2011-2#3)(2012-3#1)(2013-8#1)
to 33% of the##2##4##(1992-4#1)(2008-10#1)
to 33% of##3##3##(1992-4#1)(2008-10#1)(2010-12#1)
to 33%##8##2##(1992-4#1)(1997-5#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-12#1)(2010-4#1)
to 330##3##2##(1990-3#1)(2005-8#1)(2008-10#1)
to 334 AA##2##3##(2008-8#2)
to 34 months##2##3##(1993-11#1)(2007-3#1)
to 34##27##2##(1991-8#1)(1992-9#2)(1993-11#1)(1994-12#1)(1994-6#1)(1994-9#1)(1997-1#1)(1997-8#1)(2006-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2010-2#1)(2011-1#1)(2011-12#1)(2012-12#1)(2013-1#1)
to 34% in##2##3##(1995-5#1)(2007-3#1)
to 34%##6##2##(1995-5#1)(2007-3#1)(2007-7#1)(2008-10#1)(2009-3#1)(2010-8#1)
to 340##2##2##(1996-12#1)(2008-10#1)
to 346##2##2##(1991-10#1)(2008-10#1)
to 35 and##2##3##(1995-10#1)(2012-2#1)
to 35 degrees C##7##4##(1994-2#2)(2007-6#1)(2008-10#4)
to 35 degrees C)##2##4##(2008-10#2)
to 35 degrees##9##3##(1994-2#2)(2007-6#1)(2008-10#6)
to 35 m##2##3##(2007-3#1)(2007-5#1)
to 35##52##2##(1991-3#1)(1992-1#1)(1992-7#1)(1993-8#1)(1994-12#1)(1994-2#2)(1995-10#2)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#1)(2005-1#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-12#3)(2007-3#2)(2007-5#1)(2007-6#2)(2007-8#2)(2008-10#11)(2008-4#1)(2008-5#3)(2009-3#1)(2010-10#1)(2011-1#1)(2012-2#3)(2013-1#4)
to 35% in the##2##4##(2006-6#1)(2012-2#1)
to 35% of##3##3##(1990-5#1)(2005-10#1)(2008-10#1)
to 35%##13##2##(1990-5#1)(1996-5#2)(2005-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2008-10#4)(2009-7#1)(2012-2#1)
to 350##12##2##(1990-2#1)(2007-12#4)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#2)(2012-2#1)
to 36 degrees##2##3##(1994-3#1)(2006-4#1)
to 36 h after##2##4##(1990-12#1)(2008-11#1)
to 36 h##3##3##(1990-12#1)(2008-10#1)(2008-11#1)
to 36 m##2##3##(2006-5#1)(2009-11#1)
to 36 mg##2##3##(2008-10#1)(2008-2#1)
to 36 months##2##3##(1990-6#1)(2011-2#1)
to 36##36##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-10#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-6#1)(2004-9#1)(2005-10#1)(2006-12#1)(2006-4#1)(2006-5#2)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-5#1)(2008-8#1)(2009-11#1)(2010-10#1)(2010-8#1)(2011-2#3)(2013-1#1)
to 36%##7##2##(2006-10#1)(2008-10#3)(2008-7#1)(2010-12#1)(2011-1#1)
to 360 degrees##2##3##(2007-12#1)(2008-5#1)
to 360##7##2##(1995-5#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-5#1)(2013-8#1)
to 365##2##2##(1990-12#1)(1995-6#1)
to 366 mOsmol kg-1##3##4##(2008-11#3)
to 366 mOsmol##4##3##(2008-11#4)
to 366##6##2##(1992-10#1)(2008-11#4)(2008-7#1)
to 37 degrees C##13##4##(1993-11#1)(1993-9#2)(1994-11#1)(1994-12#2)(1996-12#1)(2008-10#3)(2008-11#2)(2008-4#1)
to 37 degrees C)##2##4##(1990-2#1)(2008-10#1)
to 37 degrees##15##3##(1990-2#1)(1993-11#1)(1993-9#2)(1994-11#1)(1994-12#2)(1996-12#1)(2008-10#4)(2008-11#2)(2008-4#1)
to 37 weeks' gestation##2##4##(1994-4#1)(2011-2#1)
to 37##41##2##(1990-2#1)(1991-8#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-4#1)(1996-12#1)(1996-2#1)(1997-6#1)(2007-1#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-7#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
to 37% of##2##3##(1991-6#1)(2008-4#1)
to 37%##7##2##(1991-11#1)(1991-6#1)(2006-8#1)(2008-11#1)(2008-4#1)(2009-6#1)(2013-8#1)
to 3700##2##2##(1991-12#1)(2007-11#1)
to 38 degrees C##4##4##(1990-11#1)(1990-2#1)(2008-5#1)(2009-6#1)
to 38##29##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-5#1)(1992-1#1)(1993-11#1)(1993-12#1)(1996-2#1)(2006-2#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-6#1)(2009-7#1)(2011-1#1)(2012-3#1)(2013-8#3)
to 38% for##2##3##(1997-2#1)(2007-7#1)
to 38% in##2##3##(2008-10#1)(2013-1#1)
to 38% of the##2##4##(1994-8#1)(2008-10#1)
to 38%##8##2##(1994-8#1)(1997-2#1)(2007-7#1)(2008-10#3)(2008-4#1)(2013-1#1)
to 380##3##2##(1997-4#2)(2008-10#1)
to 382##3##2##(1997-3#1)(2008-7#1)(2011-2#1)
to 39 degrees##2##3##(2007-12#1)(2008-10#1)
to 39##27##2##(1991-6#1)(1991-9#1)(1992-9#1)(1993-12#1)(1994-4#1)(1994-6#1)(1994-9#1)(2006-6#1)(2007-12#4)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-5#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
to 39%##6##2##(1991-3#1)(1997-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-10#1)
to 390##3##2##(1994-3#1)(2012-12#1)(2013-1#1)
to 391##3##2##(1996-5#1)(2007-4#1)(2010-1#1)
to 395##2##2##(1990-8#1)(1992-7#1)
to 3D##7##2##(2005-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-11#1)(2013-1#1)(2013-7#1)
to 4 and##2##3##(2007-7#1)(2008-10#1)
to 4 are##2##3##(2010-7#1)(2012-2#1)
to 4 days after##3##4##(1993-9#1)(2008-10#1)(2009-3#1)
to 4 days##13##3##(1990-12#1)(1993-9#1)(1995-9#1)(1997-4#1)(2006-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2009-3#1)(2011-12#1)
to 4 degrees C for##2##5##(1990-12#1)(1991-10#1)
to 4 degrees C##3##4##(1990-12#1)(1991-10#1)(1996-10#1)
to 4 fold##2##3##(1991-1#1)(1992-4#1)
to 4 groups##5##3##(1996-9#1)(2008-12#1)(2012-2#2)(2013-1#1)
to 4 h##4##3##(1993-3#1)(1994-8#1)(1997-2#1)(2006-5#1)
to 4 hours after##2##4##(1992-5#1)(1993-7#1)
to 4 hours##5##3##(1992-5#1)(1993-7#1)(2004-11#1)(2007-7#2)
to 4 in##2##3##(1996-2#1)(2007-11#1)
to 4 kN##3##3##(2006-11#1)(2007-1#1)(2007-4#1)
to 4 mm##3##3##(1996-6#1)(2008-7#1)(2009-2#1)
to 4 months after##4##4##(2008-1#1)(2010-5#1)(2013-1#2)
to 4 months of##2##4##(1991-1#1)(2008-8#1)
to 4 months##10##3##(1991-1#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-5#1)(2013-1#2)
to 4 patients##2##3##(1993-9#1)(2009-8#1)
to 4 times per##2##4##(1993-9#1)(2006-10#1)
to 4 times##4##3##(1990-5#1)(1992-3#1)(1993-9#1)(2006-10#1)
to 4 weeks after##2##4##(1996-3#1)(2008-10#1)
to 4 weeks of##3##4##(1991-6#1)(2006-12#1)(2008-5#1)
to 4 weeks##16##3##(1991-6#1)(1995-6#1)(1995-9#1)(1996-3#1)(2006-12#1)(2006-4#1)(2008-10#7)(2008-11#1)(2008-5#1)(2010-9#1)
to 4 were##2##3##(2008-4#1)(2008-7#1)
to 4 with##2##3##(2007-8#1)(2013-1#1)
to 4 years after##2##4##(1995-9#1)(2008-9#1)
to 4 years##13##3##(1991-3#1)(1995-9#1)(1996-11#1)(2007-11#2)(2007-9#1)(2008-10#1)(2008-9#2)(2009-12#1)(2011-2#1)(2013-1#1)(2013-7#1)
to 4##291##2##(1990-12#3)(1990-4#2)(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#3)(1991-10#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#2)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#3)(1992-7#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#3)(1994-3#1)(1994-5#1)(1994-8#2)(1995-12#4)(1995-5#2)(1995-6#2)(1995-9#3)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#2)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-11#2)(2004-4#1)(2005-10#1)(2005-11#3)(2005-9#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#3)(2007-11#9)(2007-12#4)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#9)(2007-8#7)(2007-9#3)(2008-1#3)(2008-10#46)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#8)(2008-6#3)(2008-7#7)(2008-8#1)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-8#1)(2010-12#2)(2010-2#2)(2010-4#4)(2010-5#1)(2010-7#3)(2010-9#1)(2011-1#1)(2011-11#1)(2011-12#3)(2011-2#11)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#12)(2013-7#1)(2013-8#2)
to 4% and##2##3##(2008-3#1)(2008-9#1)
to 4% of all##3##4##(2009-8#1)(2010-12#1)(2010-5#1)
to 4% of##6##3##(1990-2#1)(2008-6#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#1)
to 4%##17##2##(1990-2#1)(1990-6#1)(1996-12#1)(1997-6#1)(2006-5#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-3#1)
to 4)##4##2##(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
to 4-aminopyridine##2##2##(1993-2#1)(1996-5#1)
to 4-fold greater##2##3##(1991-9#1)(1992-9#1)
to 4-fold##10##2##(1990-10#1)(1990-8#1)(1991-9#1)(1992-9#1)(1994-3#1)(1995-5#1)(1997-4#2)(2005-7#1)(2007-6#1)
to 4-fold)##2##2##(1993-1#1)(1993-11#1)
to 4-week##2##2##(2008-5#1)(2012-12#1)
to 4-year-old##2##2##(1992-1#1)(2012-12#1)
to 40 GHz##2##3##(2007-11#1)(2007-12#1)
to 40 days##4##3##(1996-3#1)(2007-3#1)(2008-10#2)
to 40 degrees C##7##4##(1990-9#1)(1994-12#1)(1995-1#1)(2005-11#1)(2008-10#1)(2009-6#1)(2011-2#1)
to 40 degrees C)##2##4##(1992-5#1)(2007-12#1)
to 40 degrees##9##3##(1990-9#1)(1992-5#1)(1994-12#1)(1995-1#1)(2005-11#1)(2007-12#1)(2008-10#1)(2009-6#1)(2011-2#1)
to 40 mM [K+]o##2##4##(1993-4#2)
to 40 mg daily##2##4##(1994-3#1)(2008-1#1)
to 40 microM paraoxon##2##4##(1996-12#2)
to 40 microM##3##3##(1994-2#1)(1996-12#2)
to 40 nm##3##3##(2008-1#1)(2008-2#1)(2009-7#1)
to 40 percent##4##3##(1995-1#1)(2007-11#1)(2008-11#1)(2008-3#1)
to 40 times##2##3##(2008-10#1)(2009-6#1)
to 40 weeks##2##3##(2007-11#1)(2013-1#1)
to 40 weeks' gestation##2##4##(1994-4#2)
to 40 years##8##3##(2006-2#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-12#1)
to 40##98##2##(1990-2#2)(1990-9#1)(1991-11#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-4#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#2)(1994-6#1)(1995-1#2)(1995-10#1)(1995-12#1)(1995-8#1)(1996-10#1)(1996-12#2)(1996-3#1)(1997-2#2)(1997-7#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-11#3)(2007-12#3)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#16)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-6#2)(2009-7#1)(2009-9#3)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
to 40% and##2##3##(1996-12#1)(2010-12#1)
to 40% in##6##3##(1995-1#1)(2006-8#1)(2008-10#2)(2008-2#1)(2011-12#1)
to 40% of patients##6##4##(2004-11#1)(2007-11#2)(2007-9#1)(2008-8#1)(2012-12#1)
to 40% of the##6##4##(1990-2#1)(1990-4#1)(2004-9#1)(2007-12#1)(2008-7#2)
to 40% of##20##3##(1990-10#1)(1990-2#1)(1990-4#1)(1995-10#1)(1996-1#1)(2004-11#1)(2004-9#1)(2007-11#2)(2007-12#2)(2007-9#1)(2008-7#2)(2008-8#2)(2009-5#1)(2009-8#1)(2010-12#1)(2012-12#1)
to 40%##55##2##(1990-10#1)(1990-2#1)(1990-4#2)(1991-11#1)(1991-7#1)(1992-12#1)(1992-3#1)(1994-2#1)(1995-1#2)(1995-10#1)(1996-1#1)(1996-12#1)(2004-11#1)(2004-9#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#3)(2008-7#3)(2008-8#2)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-9#1)(2011-12#1)(2012-12#2)(2013-1#1)(2013-8#1)
to 40-fold##2##2##(1991-4#1)(2008-10#1)
to 400 ng##2##3##(1990-8#1)(2008-10#1)
to 400 nm##3##3##(2008-10#2)(2008-5#1)
to 400 nm)##3##3##(2006-3#2)(2008-10#1)
to 400##30##2##(1990-3#1)(1990-8#1)(1991-6#1)(1992-8#1)(1994-3#1)(1995-6#1)(1996-8#1)(2005-8#1)(2006-12#1)(2006-3#2)(2006-4#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-5#1)(2010-6#1)(2012-2#1)
to 400% above basal##2##4##(1991-2#1)(2004-11#1)
to 4000##5##2##(1995-2#1)(2005-12#1)(2006-5#1)(2010-2#1)(2013-1#1)
to 40S subunits##3##3##(1997-2#3)
to 40S##4##2##(1997-2#3)(2006-11#1)
to 41 days##2##3##(1995-1#1)(1996-8#1)
to 41 degrees##2##3##(1991-1#1)(2006-5#1)
to 41##18##2##(1991-1#1)(1992-12#1)(1993-3#1)(1995-1#1)(1995-8#1)(1996-8#1)(1997-1#1)(2005-12#1)(2006-5#1)(2008-1#2)(2008-10#3)(2011-1#2)(2011-2#1)(2012-3#1)
to 41%##7##2##(1995-2#1)(1996-7#1)(2006-7#1)(2006-8#1)(2008-10#2)(2009-12#1)
to 410##2##2##(2008-10#1)(2009-11#1)
to 42 additional##2##3##(2008-10#1)(2008-5#1)
to 42 days##2##3##(1991-12#1)(2012-2#1)
to 42 degrees C##3##4##(1990-3#1)(1993-4#1)(2008-10#1)
to 42 degrees C)##2##4##(1994-4#1)(2008-10#1)
to 42 degrees##5##3##(1990-3#1)(1993-4#1)(1994-4#1)(2008-10#2)
to 42##30##2##(1990-3#2)(1991-12#1)(1991-9#1)(1992-7#1)(1993-3#1)(1993-4#1)(1994-4#1)(1994-9#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-5#2)(2010-8#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
to 42% of the##2##4##(2007-2#1)(2008-10#1)
to 42% of##3##3##(1990-10#1)(2007-2#1)(2008-10#1)
to 42%##9##2##(1990-10#1)(1997-7#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#2)(2011-2#1)
to 43 degrees C##2##4##(1995-12#1)(2007-12#1)
to 43##15##2##(1991-10#1)(1991-3#1)(1991-8#1)(1994-8#1)(1995-12#1)(2007-12#2)(2007-6#1)(2007-9#2)(2008-1#1)(2008-3#1)(2008-6#2)(2012-3#1)
to 43%##6##2##(1993-12#1)(1994-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-8#1)
to 430##2##2##(1991-4#1)(1994-8#1)
to 44##10##2##(1995-3#1)(1995-5#1)(2006-11#1)(2006-6#1)(2007-11#1)(2008-10#4)(2013-1#1)
to 44%##6##2##(1992-10#1)(1996-1#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-10#1)
to 440##4##2##(1991-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
to 45 degrees C##4##4##(2005-11#1)(2008-10#2)(2008-6#1)
to 45 ng/mL##2##3##(2010-7#2)
to 45 nm in diameter##2##5##(1994-3#1)(2008-10#1)
to 45 years and##2##4##(2007-2#1)(2012-2#1)
to 45 years##5##3##(1991-5#1)(1997-4#1)(2007-2#1)(2012-2#1)(2013-1#1)
to 45##47##2##(1990-12#1)(1991-5#1)(1993-11#1)(1994-3#1)(1996-11#1)(1996-9#1)(1997-1#1)(1997-4#1)(2005-11#1)(2005-7#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-2#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2010-7#2)(2010-8#1)(2011-12#1)(2011-2#4)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
to 45% of patients##2##4##(2007-11#1)(2012-3#1)
to 45% of the##4##4##(2006-12#1)(2006-7#1)(2006-8#1)(2013-8#1)
to 45% of##8##3##(1990-11#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-11#1)(2008-4#1)(2012-3#1)(2013-8#1)
to 45%##20##2##(1990-11#1)(1991-7#1)(2006-12#1)(2006-7#1)(2006-8#6)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)(2012-3#2)(2013-8#1)
to 45%)##3##2##(1990-2#1)(2007-8#1)(2008-10#1)
to 450 nm##2##3##(2008-10#1)(2008-3#1)
to 450##8##2##(2005-4#1)(2007-6#1)(2008-10#3)(2008-2#1)(2008-3#1)(2012-12#1)
to 46 microns##2##3##(1991-5#1)(1994-12#1)
to 46 ng/ml of##2##4##(1996-5#2)
to 46 patients##2##3##(2007-11#1)(2007-8#1)
to 46##20##2##(1991-5#1)(1992-2#1)(1994-12#1)(1994-8#1)(1996-5#2)(1997-2#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)
to 46%##5##2##(1990-11#1)(1994-5#1)(2004-12#1)(2007-8#1)(2008-10#1)
to 460##2##2##(1992-2#1)(1993-8#1)
to 461##2##2##(2007-4#1)(2008-7#1)
to 47 months##2##3##(1992-10#1)(1993-8#1)
to 47##15##2##(1992-10#1)(1992-5#1)(1993-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-12#1)(2006-5#1)(2007-10#1)(2007-7#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
to 47% in the##2##4##(1997-5#1)(2004-2#1)
to 47% of##3##3##(1992-6#1)(1993-8#1)(2013-8#1)
to 47%##8##2##(1992-6#1)(1993-8#1)(1997-5#1)(2004-2#1)(2008-10#1)(2012-12#1)(2012-3#1)(2013-8#1)
to 48 degrees C##4##4##(1990-11#1)(1995-8#1)(2008-3#1)(2011-2#1)
to 48 degrees##5##3##(1990-11#1)(1995-8#1)(2008-10#1)(2008-3#1)(2011-2#1)
to 48 h after##2##4##(2008-10#2)
to 48 h and##2##4##(2008-10#2)
to 48 h of##2##4##(2008-10#2)
to 48 h##12##3##(1997-8#1)(2005-11#1)(2008-10#10)
to 48 h)##2##3##(1997-7#1)(2008-10#1)
to 48 hours##6##3##(1992-4#1)(1993-12#1)(1993-9#1)(1994-6#1)(2008-11#1)(2010-12#1)
to 48 hr##3##3##(1994-11#2)(2008-1#1)
to 48 months##3##3##(2006-12#1)(2007-11#2)
to 48 weeks of##3##4##(1991-7#2)(2009-11#1)
to 48 weeks##4##3##(1991-7#2)(2009-11#1)(2009-6#1)
to 48##56##2##(1990-11#1)(1991-5#1)(1991-7#2)(1992-4#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-9#1)(1994-11#2)(1994-6#1)(1995-8#1)(1996-5#2)(1997-7#1)(1997-8#1)(2005-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-11#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-9#1)(2009-11#1)(2009-6#1)(2010-12#1)(2011-2#1)(2013-1#1)
to 48% of##2##3##(1997-8#1)(2007-11#1)
to 48%##5##2##(1997-8#1)(2007-11#1)(2008-10#1)(2013-1#1)(2013-7#1)
to 48-fold##2##2##(1995-11#2)
to 480##3##2##(2007-8#1)(2008-10#1)(2008-5#1)
to 482##3##2##(1997-4#1)(2008-11#1)(2008-3#1)
to 49 years##3##3##(1995-9#1)(2010-3#1)(2011-2#1)
to 49##12##2##(1992-9#1)(1994-8#1)(1995-1#1)(1995-9#1)(2007-9#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#2)(2012-8#1)
to 49% of the##3##4##(1995-2#1)(1996-6#1)(2008-10#1)
to 49%##12##2##(1993-4#1)(1995-2#2)(1996-6#1)(1997-6#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-12#1)(2012-12#1)
to 495 nm##2##3##(2008-10#1)(2008-3#1)
to 495##3##2##(2008-10#1)(2008-3#1)(2012-12#1)
to 5 +/-##2##3##(1990-8#1)(1996-6#1)
to 5 and##5##3##(1991-10#1)(1994-9#1)(2005-11#1)(2008-10#1)(2012-12#1)
to 5 cm##6##3##(1992-5#1)(2007-8#1)(2010-12#1)(2013-1#2)(2013-8#1)
to 5 days of##2##4##(2007-6#1)(2011-2#1)
to 5 days##10##3##(1991-5#1)(1995-9#1)(1997-8#1)(2007-10#1)(2007-6#1)(2008-10#3)(2009-2#1)(2011-2#1)
to 5 degrees C##5##4##(2005-4#1)(2006-12#1)(2008-10#1)(2011-2#2)
to 5 degrees##6##3##(2005-4#1)(2006-12#1)(2007-7#1)(2008-10#1)(2011-2#2)
to 5 h##2##3##(1994-2#1)(2008-10#1)
to 5 km##2##3##(2008-2#1)(2008-3#1)
to 5 mW##2##3##(2007-12#2)
to 5 mg##3##3##(1993-11#1)(2008-3#1)(2012-12#1)
to 5 microM##3##3##(1995-6#2)(1995-7#1)
to 5 microM)##2##3##(1991-5#1)(2005-8#1)
to 5 min##5##3##(1994-8#1)(1996-1#1)(1997-1#2)(1997-7#1)
to 5 ml##2##3##(2008-10#2)
to 5 mm in diameter##3##5##(2006-5#2)(2008-10#1)
to 5 mm##5##3##(2006-5#2)(2007-11#1)(2008-10#1)(2008-3#1)
to 5 months##5##3##(1995-2#1)(2008-10#1)(2010-8#1)(2013-1#2)
to 5 mum##2##3##(2008-1#1)(2008-2#1)
to 5 ng/ml##2##3##(1990-12#1)(2008-10#1)
to 5 nm##2##3##(2008-10#1)(2008-7#1)
to 5 or##2##3##(1996-2#1)(2007-8#1)
to 5 weeks##7##3##(1993-12#1)(1994-2#1)(2008-10#4)(2011-2#1)
to 5 x 10(-5)##2##4##(1995-6#1)(2008-10#1)
to 5 x##8##3##(1990-2#1)(1995-6#1)(2004-9#1)(2007-12#1)(2008-10#3)(2008-3#1)
to 5 years after##5##4##(2004-11#1)(2007-8#1)(2007-9#3)
to 5 years of##2##4##(1996-3#1)(2007-11#1)
to 5 years postoperatively##2##4##(2012-12#1)(2013-1#1)
to 5 years##25##3##(1991-2#1)(1992-2#1)(1996-3#1)(2004-1#1)(2004-11#2)(2006-4#1)(2007-11#3)(2007-5#1)(2007-8#1)(2007-9#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-9#1)(2012-12#4)(2013-1#1)
to 5##333##2##(1990-10#2)(1990-11#4)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-10#2)(1991-2#1)(1991-5#2)(1991-6#2)(1991-8#5)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#4)(1992-9#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-2#3)(1994-5#1)(1994-8#1)(1994-9#3)(1995-2#1)(1995-3#3)(1995-6#3)(1995-7#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#3)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-7#3)(1997-8#3)(2004-1#1)(2004-11#4)(2004-9#1)(2005-10#1)(2005-11#2)(2005-4#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-12#2)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#8)(2007-2#1)(2007-3#1)(2007-5#4)(2007-6#1)(2007-7#4)(2007-8#8)(2007-9#4)(2008-1#2)(2008-10#79)(2008-11#5)(2008-12#4)(2008-2#6)(2008-3#8)(2008-4#4)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-6#3)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#2)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#5)(2012-1#1)(2012-11#2)(2012-12#7)(2012-2#3)(2012-3#3)(2013-1#8)(2013-7#2)(2013-8#4)
to 5% of the##2##4##(2008-10#2)
to 5% of##9##3##(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2011-1#1)
to 5%##27##2##(1991-2#1)(1992-7#1)(1994-6#1)(1996-1#1)(1997-3#1)(2006-10#1)(2007-10#2)(2007-8#3)(2008-1#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#2)(2009-12#1)(2009-9#1)(2010-4#1)(2011-1#1)
to 5%)##4##2##(1995-3#1)(2008-10#1)(2008-6#1)(2012-3#1)
to 5'##3##2##(1991-5#1)(1996-5#2)
to 5)##4##2##(1991-5#1)(2007-7#1)(2009-5#1)(2010-6#1)
to 5-HT##13##2##(1992-7#1)(1992-9#1)(1993-11#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-5#2)(2008-2#1)(2008-4#1)
to 5-HT1A##5##2##(1996-8#4)(2008-5#1)
to 5-ethynyluracil##3##2##(1994-3#3)
to 5-fluorocytosine##3##2##(1992-5#2)(2006-10#1)
to 5-fluorouracil##4##2##(1990-12#1)(1993-1#1)(2005-9#1)(2011-2#1)
to 5-fold##8##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-10#1)(1993-9#1)(1994-6#1)(1997-4#1)(2010-1#1)
to 5-fold)##2##2##(1991-9#1)(1994-5#1)
to 5-methyltryptophan##3##2##(1994-6#3)
to 5-year-old##3##2##(2004-4#1)(2006-11#1)(2012-1#1)
to 50 %##3##3##(2008-2#1)(2011-1#2)
to 50 Hz##2##3##(2007-11#1)(2008-2#1)
to 50 and##3##3##(2008-10#2)(2008-5#1)
to 50 days##2##3##(2008-10#2)
to 50 degrees C and##2##5##(1990-2#1)(2008-10#1)
to 50 degrees C for##2##5##(2008-10#1)(2008-7#1)
to 50 degrees C##11##4##(1990-2#1)(1991-5#1)(1994-11#1)(2008-10#4)(2008-3#1)(2008-6#2)(2008-7#1)
to 50 degrees##12##3##(1990-2#1)(1991-5#1)(1994-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#1)
to 50 mM##2##3##(1994-2#1)(2010-5#1)
to 50 mg##6##3##(1990-11#1)(1993-7#1)(1997-7#1)(2005-7#1)(2008-5#2)
to 50 mg/ml##2##3##(2008-2#1)(2008-4#1)
to 50 microM##5##3##(1990-2#1)(1991-1#1)(1994-10#1)(1995-3#1)(1996-6#1)
to 50 microM)##3##3##(1991-2#1)(1993-12#1)(1995-1#1)
to 50 micrograms##2##3##(1995-2#1)(1997-3#1)
to 50 micrograms/ml##2##3##(1991-3#1)(1993-2#1)
to 50 muM##5##3##(2008-10#4)(2008-5#1)
to 50 nM##4##3##(1990-2#1)(1995-6#1)(1997-8#1)(2008-10#1)
to 50 ng##3##3##(1994-6#1)(2008-10#1)(2009-6#1)
to 50 ng/ml EGF##3##4##(2006-5#3)
to 50 patients##2##3##(1991-6#1)(2007-9#1)
to 50 percent##2##3##(1991-12#1)(2009-9#1)
to 50 times##2##3##(2005-11#1)(2008-10#1)
to 50 years##5##3##(1993-5#2)(2007-8#1)(2008-12#1)(2009-2#1)
to 50##132##2##(1990-11#1)(1990-2#4)(1990-3#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-5#2)(1993-7#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#2)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-3#2)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-11#3)(2005-7#1)(2006-11#1)(2006-5#4)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#2)(2007-8#2)(2007-9#1)(2008-10#27)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#7)(2008-4#1)(2008-5#6)(2008-6#4)(2008-7#3)(2009-10#1)(2009-2#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-3#1)
to 50% at##2##3##(1990-2#1)(2011-12#1)
to 50% for##2##3##(2007-4#1)(2008-2#1)
to 50% improvement##2##3##(2006-12#2)
to 50% in##4##3##(2008-10#1)(2008-5#1)(2012-12#1)(2012-3#1)
to 50% of patients with##4##5##(1997-7#1)(2009-2#1)(2010-5#1)(2012-2#1)
to 50% of patients##10##4##(1991-10#1)(1997-7#1)(2005-8#1)(2006-11#1)(2007-11#1)(2008-1#1)(2009-2#1)(2010-5#1)(2011-2#1)(2012-2#1)
to 50% of plants##2##4##(2008-10#2)
to 50% of the patients##2##5##(2006-12#1)(2006-8#1)
to 50% of the##7##4##(1991-12#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-4#1)(2008-10#1)
to 50% of##36##3##(1991-10#1)(1991-12#1)(1993-5#1)(1993-6#1)(1995-6#1)(1997-7#1)(2005-8#1)(2006-11#1)(2006-12#1)(2006-3#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-4#1)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-12#1)(2009-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#3)
to 50%##79##2##(1990-2#1)(1990-3#1)(1991-10#1)(1991-12#1)(1991-4#1)(1993-12#1)(1993-3#1)(1993-5#2)(1993-6#1)(1993-9#1)(1994-12#1)(1995-3#1)(1995-6#2)(1997-7#1)(2005-10#1)(2005-8#1)(2006-11#1)(2006-12#4)(2006-3#2)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-4#2)(2007-9#1)(2008-1#3)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#2)(2008-7#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#2)(2013-8#4)
to 50-80%##2##2##(2005-12#1)(2008-11#1)
to 50-fold##4##2##(1990-11#1)(1990-5#1)(1992-5#1)(1993-3#1)
to 50-fold)##2##2##(1994-8#1)(1996-1#1)
to 500 mg##4##3##(2007-8#1)(2008-10#2)(2008-11#1)
to 500 microM##2##3##(1994-11#1)(1995-11#1)
to 500 ng/ml##3##3##(1996-8#1)(1997-3#2)
to 500 nm##4##3##(2008-10#1)(2008-2#2)(2012-12#1)
to 500 ppm##7##3##(1990-3#1)(1990-5#4)(1990-8#1)(2006-9#1)
to 500##53##2##(1990-2#2)(1990-3#1)(1990-5#4)(1990-8#1)(1993-2#1)(1994-11#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(2006-4#1)(2006-7#1)(2006-9#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#1)(2011-2#1)(2012-12#1)
to 5000##3##2##(1996-8#1)(2007-11#1)(2008-4#1)
to 500mg##2##2##(1995-3#1)(2008-3#1)
to 500ngml(-1) of##2##3##(2008-10#2)
to 500ngml(-1)##3##2##(2008-10#3)
to 501##2##2##(1993-2#1)(2011-2#1)
to 50K##2##2##(2012-1#2)
to 51##7##2##(1990-12#1)(1990-5#1)(1990-9#1)(1994-8#1)(2005-12#1)(2007-1#1)(2007-11#1)
to 51% of the##2##4##(2006-8#1)(2008-10#1)
to 51%##3##2##(1994-6#1)(2006-8#1)(2008-10#1)
to 511##2##2##(1996-11#1)(2012-12#1)
to 52##8##2##(1990-10#1)(1993-3#1)(1997-5#1)(2005-12#1)(2006-8#1)(2008-10#2)(2008-5#1)
to 52% for##2##3##(2008-3#1)(2010-6#1)
to 52% in##2##3##(2006-7#1)(2006-8#1)
to 52% of##2##3##(1990-2#1)(2008-3#1)
to 52%##11##2##(1990-2#1)(1993-8#1)(1996-12#1)(2006-10#1)(2006-7#1)(2006-8#1)(2008-10#1)(2008-3#2)(2010-6#1)(2012-1#1)
to 525##2##2##(2007-12#1)(2007-4#1)
to 53##8##2##(1990-12#1)(1995-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-12#1)
to 53% of##2##3##(1990-4#1)(2008-10#1)
to 53%##9##2##(1990-4#1)(1991-10#1)(1994-1#1)(2008-10#4)(2010-3#1)(2011-1#1)
to 530##3##2##(2007-12#1)(2008-10#1)(2013-8#1)
to 54 years##3##3##(1995-9#1)(2007-2#1)(2008-4#1)
to 54##21##2##(1991-7#1)(1992-7#1)(1995-3#1)(1995-9#1)(1996-3#1)(1996-4#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
to 54%##7##2##(1992-10#1)(2006-8#2)(2007-11#1)(2007-12#1)(2008-8#1)(2010-8#1)
to 540##2##2##(2008-10#1)(2010-2#1)
to 55 degrees C##3##4##(2008-10#3)
to 55 degrees##6##3##(2006-8#1)(2007-8#1)(2008-10#3)(2008-9#1)
to 55 h##2##3##(2006-5#1)(2008-10#1)
to 55 years##4##3##(1991-5#2)(2007-7#1)(2007-8#1)
to 55##25##2##(1991-5#2)(1994-11#1)(2006-5#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#4)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-2#1)(2011-2#1)(2012-12#1)
to 55%##3##2##(1990-8#1)(1993-6#1)(2008-10#1)
to 55%)##2##2##(2008-10#1)(2011-2#1)
to 55-75%##2##2##(2010-10#1)(2010-3#1)
to 550##7##2##(1993-1#1)(2008-10#2)(2008-3#2)(2012-1#1)(2012-12#1)
to 56 +/-##2##3##(1992-7#1)(1994-3#1)
to 56##18##2##(1992-7#1)(1994-3#1)(1996-7#1)(2005-1#1)(2005-12#1)(2006-2#1)(2007-8#2)(2008-10#4)(2008-9#1)(2010-12#1)(2012-1#1)(2012-3#1)(2013-1#2)
to 56% of##3##3##(1994-6#1)(2007-8#1)(2008-10#1)
to 56%##9##2##(1994-6#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-8#1)(2008-10#3)(2013-1#1)
to 567 nm##2##3##(2007-12#2)
to 567##3##2##(1994-9#1)(2007-12#2)
to 57 years##3##3##(1991-4#1)(2008-1#1)(2008-12#1)
to 57##12##2##(1990-12#1)(1991-10#1)(1991-4#1)(1996-3#1)(1997-2#1)(2008-1#3)(2008-12#1)(2008-8#1)(2009-7#1)(2013-8#1)
to 57%##8##2##(1990-9#1)(1992-6#1)(1993-6#1)(1994-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2012-12#1)
to 570##3##2##(2007-12#1)(2008-10#1)(2011-2#1)
to 575##2##2##(1991-10#1)(2008-11#1)
to 58##9##2##(1995-3#1)(1996-1#1)(1997-2#1)(2005-8#1)(2006-12#1)(2008-11#1)(2009-2#1)(2009-8#1)(2013-1#1)
to 58%##3##2##(2006-8#1)(2007-2#1)(2007-9#1)
to 58-60##2##2##(2007-6#1)(2013-1#1)
to 580##2##2##(1991-4#1)(1995-8#1)
to 584##2##2##(2008-3#2)
to 587##2##2##(1996-3#1)(2009-2#1)
to 59 months of age##3##5##(1991-2#2)(2007-11#1)
to 59 years of age##2##5##(2005-10#1)(2007-4#1)
to 59 years##9##3##(1990-6#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
to 59##15##2##(1990-6#1)(1991-2#2)(2005-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-6#1)(2011-2#2)(2013-1#1)(2013-8#1)
to 59% for##2##3##(1995-9#1)(2006-10#1)
to 59%##3##2##(1995-9#1)(2006-10#1)(2009-2#1)
to 590 nm for##2##4##(2008-2#2)
to 5S rRNA##2##3##(1997-7#2)
to 6 and##3##3##(2005-12#1)(2008-3#1)(2010-8#1)
to 6 days after##2##4##(2008-10#1)(2010-8#1)
to 6 days##11##3##(1994-9#1)(2008-10#3)(2008-11#5)(2009-6#1)(2010-8#1)
to 6 h after##3##4##(1994-10#1)(1995-4#1)(2008-5#1)
to 6 h##9##3##(1992-7#1)(1994-10#1)(1995-4#1)(1997-3#1)(2006-8#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-5#1)
to 6 hours after##3##4##(2007-9#3)
to 6 hours##8##3##(1991-5#1)(2007-10#1)(2007-11#1)(2007-9#3)(2008-6#1)(2012-12#1)
to 6 in##2##3##(2008-10#1)(2011-2#1)
to 6 mg##2##3##(2007-8#1)(2008-11#1)
to 6 months after##3##4##(1992-8#1)(2007-8#1)(2010-12#1)
to 6 months of##3##4##(2007-10#1)(2008-10#1)(2010-6#1)
to 6 months##27##3##(1990-12#1)(1991-6#1)(1991-7#1)(1992-8#2)(1994-7#3)(2007-10#1)(2007-11#2)(2007-8#4)(2008-10#2)(2008-9#1)(2009-11#1)(2009-2#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
to 6 per##2##3##(1992-10#1)(2005-8#1)
to 6 weeks after##2##4##(1996-8#1)(2008-10#1)
to 6 weeks of##2##4##(2008-10#1)(2008-9#1)
to 6 weeks postbloom##3##4##(2008-10#3)
to 6 weeks##22##3##(1992-8#1)(1996-5#1)(1996-6#1)(1996-8#1)(2005-10#1)(2007-11#2)(2007-7#2)(2008-10#8)(2008-5#2)(2008-9#1)(2013-1#2)
to 6 wk##2##3##(2007-8#1)(2009-3#1)
to 6 x##3##3##(1990-12#1)(1994-12#1)(2008-10#1)
to 6 years (mean##2##4##(2007-9#1)(2013-1#1)
to 6 years##12##3##(1992-10#1)(1996-12#1)(2005-10#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-7#1)(2008-9#1)(2011-12#2)(2012-12#1)(2013-1#1)
to 6##266##2##(1990-10#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-7#2)(1992-8#4)(1993-10#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-5#1)(1994-7#3)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#2)(2005-10#3)(2005-11#2)(2005-12#1)(2005-8#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#4)(2007-11#8)(2007-12#6)(2007-2#3)(2007-3#1)(2007-4#3)(2007-6#2)(2007-7#4)(2007-8#8)(2007-9#4)(2008-10#45)(2008-11#7)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#11)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-6#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#6)(2011-12#3)(2011-2#6)(2012-1#3)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#8)(2013-7#2)
to 6% and##2##3##(1994-10#1)(2008-10#1)
to 6% in##2##3##(1993-10#1)(2013-7#1)
to 6% of the##2##4##(1990-3#1)(2008-10#1)
to 6% of##5##3##(1990-3#1)(2006-9#1)(2008-1#1)(2008-10#1)(2010-5#1)
to 6%##12##2##(1990-3#1)(1993-10#1)(1994-10#1)(2006-9#1)(2007-10#1)(2008-1#1)(2008-10#2)(2010-5#1)(2010-9#1)(2012-3#1)(2013-7#1)
to 6)##5##2##(1990-11#1)(1995-3#1)(2008-10#1)(2008-6#1)(2011-2#1)
to 6-8##4##2##(1994-2#1)(1995-5#1)(2007-12#1)(2008-5#1)
to 6-fold higher in##2##4##(1991-3#1)(1997-4#1)
to 6-fold##6##2##(1991-3#1)(1992-7#1)(1994-8#1)(1995-8#1)(1997-4#1)(2011-2#1)
to 6-thioguanosine##2##2##(1990-2#2)
to 60 days of age##2##5##(1993-9#1)(2006-5#1)
to 60 days##7##3##(1993-11#1)(1993-9#1)(1995-11#1)(1997-5#1)(2006-5#1)(2008-9#1)(2013-1#1)
to 60 degrees C and##3##5##(2008-10#2)(2008-3#1)
to 60 degrees C##8##4##(2008-10#4)(2008-3#1)(2008-5#1)(2008-6#2)
to 60 degrees##13##3##(2004-9#2)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-9#1)
to 60 mV##2##3##(1990-2#1)(2008-10#1)
to 60 min after##2##4##(1995-11#1)(2008-10#1)
to 60 min##6##3##(1990-1#1)(1993-7#1)(1995-11#1)(2004-8#1)(2008-10#1)(2008-3#1)
to 60 minutes twice daily##2##5##(2007-10#2)
to 60 minutes##3##3##(1996-9#1)(2007-10#2)
to 60 months##3##3##(2008-12#2)(2008-6#1)
to 60 to##3##3##(1993-1#1)(1995-8#1)(2007-11#1)
to 60 years of age##2##5##(1992-4#1)(2008-8#1)
to 60 years##10##3##(1990-3#1)(1992-4#1)(1997-4#1)(2006-11#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-8#1)(2010-7#1)(2013-1#1)
to 60##94##2##(1990-1#1)(1990-2#1)(1990-3#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-12#1)(1992-4#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-3#1)(1995-11#2)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#1)(2004-8#1)(2004-9#2)(2006-11#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#19)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#3)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
to 60% after##2##3##(1990-5#1)(2010-12#1)
to 60% and##2##3##(2007-11#1)(2008-10#1)
to 60% compared with##2##4##(2008-10#1)(2011-1#1)
to 60% identity with##2##4##(1990-11#1)(2008-10#1)
to 60% of adult##2##4##(2007-11#1)(2012-12#1)
to 60% of control##2##4##(1993-2#1)(2008-11#1)
to 60% of the##10##4##(1990-5#1)(1990-6#1)(1994-2#1)(1996-6#1)(1997-2#1)(2006-8#1)(2007-5#1)(2008-10#1)(2008-8#1)(2009-10#1)
to 60% of##19##3##(1990-5#1)(1990-6#1)(1991-10#1)(1993-2#1)(1994-2#1)(1995-10#1)(1996-6#1)(1997-2#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-12#1)
to 60%##48##2##(1990-11#1)(1990-5#2)(1990-6#2)(1991-10#1)(1992-12#1)(1993-2#1)(1994-2#1)(1995-10#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-7#1)(2006-10#1)(2006-8#2)(2007-11#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#7)(2008-11#2)(2008-3#3)(2008-5#1)(2008-6#2)(2008-8#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
to 60-70% of##2##3##(1990-7#1)(1992-5#1)
to 60-70%##5##2##(1990-7#1)(1991-10#1)(1992-5#1)(1995-8#1)(1996-1#1)
to 600 mg##2##3##(2008-10#1)(2008-9#1)
to 600 nm##4##3##(1991-10#1)(1994-5#1)(2007-12#1)(2008-10#1)
to 600 s##2##3##(1991-2#1)(1996-7#1)
to 600##25##2##(1991-10#1)(1991-2#1)(1993-8#1)(1994-11#2)(1994-5#1)(1995-3#1)(1996-7#1)(2004-1#1)(2005-11#1)(2005-12#1)(2006-4#1)(2007-12#2)(2008-10#6)(2008-3#2)(2008-5#1)(2008-9#1)(2010-2#1)
to 6000##4##2##(2008-3#3)(2010-5#1)
to 61 days##2##3##(1993-5#1)(2008-10#1)
to 61##15##2##(1990-3#1)(1992-1#1)(1992-11#1)(1993-5#1)(1996-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-9#1)(2011-11#1)(2011-2#2)(2013-1#1)
to 61%##4##2##(1995-11#1)(2008-2#1)(2009-4#1)(2013-8#1)
to 62 and##2##3##(1996-6#1)(2012-2#1)
to 62 months##2##3##(1992-5#1)(2011-1#1)
to 62##18##2##(1991-4#2)(1992-5#1)(1993-3#1)(1993-6#1)(1995-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(2006-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-6#1)(2011-1#1)(2012-2#2)(2013-8#1)
to 62% in##2##3##(1993-1#1)(1993-11#1)
to 62% of##2##3##(1992-12#1)(1996-10#1)
to 62%##7##2##(1992-12#1)(1993-1#1)(1993-11#2)(1996-10#1)(2007-12#1)(2008-4#1)
to 625##2##2##(2006-7#1)(2011-1#1)
to 63##14##2##(1991-7#1)(1995-5#1)(1996-9#1)(2005-9#1)(2006-8#1)(2007-7#1)(2007-9#1)(2008-10#4)(2009-2#1)(2011-2#1)(2012-3#1)
to 63%##4##2##(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#1)
to 64 years##3##3##(1990-12#2)(1994-6#1)
to 64 yr##2##3##(2007-8#1)(2008-7#1)
to 64##21##2##(1990-12#2)(1992-12#1)(1994-6#1)(1996-5#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
to 64% of the##3##4##(2008-10#1)(2009-7#1)(2012-1#1)
to 64%##6##2##(1993-3#1)(2006-8#1)(2008-10#1)(2008-7#1)(2009-7#1)(2012-1#1)
to 65 +/-##2##3##(1994-8#1)(1995-12#1)
to 65 deg##2##3##(2008-3#2)
to 65 years##8##3##(1992-5#1)(1992-6#1)(2007-8#1)(2008-1#1)(2009-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
to 65##34##2##(1990-10#1)(1990-5#1)(1991-11#2)(1991-5#1)(1992-5#1)(1992-6#1)(1994-8#1)(1995-12#1)(2006-6#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#4)(2008-5#1)(2009-12#1)(2010-7#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#2)
to 65% in##2##3##(2009-4#1)(2013-8#1)
to 65% of the##2##4##(1994-5#1)(1997-7#1)
to 65% of##6##3##(1993-11#1)(1994-5#1)(1996-1#1)(1997-7#1)(2008-10#1)(2008-8#1)
to 65%##18##2##(1990-3#1)(1990-9#1)(1993-11#1)(1993-12#1)(1994-5#2)(1995-3#1)(1996-1#1)(1997-7#1)(2007-7#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-4#1)(2011-1#1)(2012-2#1)(2013-8#1)
to 65)##2##2##(2011-2#2)
to 650##3##2##(2008-10#2)(2008-2#1)
to 66##13##2##(1990-6#1)(1992-2#1)(1993-9#1)(1996-1#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#5)(2010-12#1)
to 66% in##2##3##(2004-11#1)(2008-11#1)
to 66%##8##2##(2004-11#1)(2006-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2009-3#1)
to 67##9##2##(1990-4#1)(1992-3#1)(1996-9#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-10#2)(2010-4#1)
to 67% for##3##3##(1995-3#1)(2006-8#1)(2008-11#1)
to 67%##6##2##(1995-3#1)(2006-3#1)(2006-8#1)(2008-10#1)(2008-11#1)(2012-3#1)
to 67%)##3##2##(1994-8#1)(2008-10#2)
to 68 years)##2##3##(2006-4#1)(2008-3#1)
to 68##15##2##(1991-2#1)(1991-7#1)(1996-7#1)(1997-5#1)(2006-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-2#1)(2012-3#1)
to 68% of##2##3##(2007-11#1)(2008-5#1)
to 68%##6##2##(2007-11#1)(2007-7#1)(2008-10#1)(2008-5#1)(2013-1#1)(2013-8#1)
to 68%)##2##2##(2007-11#1)(2008-10#1)
to 689##2##2##(2006-9#1)(2007-1#1)
to 69 years (mean age##2##5##(2007-11#1)(2007-7#1)
to 69 years of age##2##5##(1990-4#1)(2005-10#1)
to 69 years##9##3##(1990-4#1)(1996-2#1)(2005-10#1)(2007-11#2)(2007-7#1)(2012-11#1)(2012-12#2)
to 69##19##2##(1990-4#1)(1990-8#1)(1991-4#1)(1993-12#1)(1996-2#1)(2005-10#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-2#1)(2011-2#1)(2012-11#1)(2012-12#2)(2013-8#1)
to 69% of the##2##4##(2006-10#1)(2008-5#1)
to 69% of##3##3##(2006-10#1)(2007-10#1)(2008-5#1)
to 69%##7##2##(1996-12#1)(2006-10#1)(2006-7#1)(2007-10#2)(2008-10#1)(2008-5#1)
to 6th##2##2##(2010-5#1)(2011-2#1)
to 7 days after##4##4##(1990-1#1)(2008-10#1)(2010-4#1)(2013-8#1)
to 7 days in##3##4##(2007-10#2)(2008-5#1)
to 7 days##16##3##(1990-1#1)(1997-4#2)(1997-5#1)(2006-12#1)(2006-9#1)(2007-10#2)(2008-10#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-4#1)(2013-8#2)
to 7 fold increase in##2##5##(1990-11#1)(1991-10#1)
to 7 h##2##3##(1992-8#1)(2005-11#1)
to 7 months##2##3##(1991-4#1)(2008-10#1)
to 7 weeks##6##3##(1997-6#1)(2005-9#1)(2008-10#3)(2013-1#1)
to 7 years##4##3##(1996-11#1)(1996-5#1)(2007-7#1)(2007-9#1)
to 7##170##2##(1990-1#1)(1990-11#2)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-2#1)(1991-4#1)(1991-9#2)(1992-10#2)(1992-6#2)(1992-8#2)(1992-9#1)(1993-3#3)(1993-9#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#2)(1995-12#1)(1995-3#1)(1995-4#1)(1995-8#1)(1995-9#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#3)(1996-7#1)(1997-2#1)(1997-4#5)(1997-5#2)(1997-6#1)(1997-7#4)(2005-1#1)(2005-11#2)(2005-9#1)(2006-10#3)(2006-12#1)(2006-8#2)(2006-9#1)(2007-10#3)(2007-11#4)(2007-12#4)(2007-2#3)(2007-4#3)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#33)(2008-11#1)(2008-3#2)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#2)(2009-5#1)(2010-1#1)(2010-4#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#4)(2013-1#5)(2013-7#1)(2013-8#3)
to 7% at##2##3##(1992-7#1)(2008-3#1)
to 7% of##4##3##(2007-11#1)(2008-10#1)(2008-8#1)(2010-1#1)
to 7%##13##2##(1992-7#1)(1994-5#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-1#1)(2010-4#1)(2012-12#1)
to 7-10##2##2##(2007-8#1)(2013-1#1)
to 7-fold##5##2##(1991-3#1)(1993-5#1)(2006-10#1)(2008-10#1)(2008-11#1)
to 70 degrees C##4##4##(1995-11#1)(2008-10#2)(2008-3#1)
to 70 degrees C)##2##4##(1991-9#1)(2006-8#1)
to 70 degrees##10##3##(1991-9#1)(1995-11#1)(2006-3#1)(2006-8#1)(2007-7#2)(2008-10#2)(2008-3#1)(2008-6#1)
to 70 percent##2##3##(1994-3#1)(1995-3#1)
to 70 years of age##2##5##(2007-7#1)(2008-1#1)
to 70 years##5##3##(2006-6#1)(2007-7#1)(2007-8#2)(2008-1#1)
to 70##36##2##(1990-6#1)(1991-4#2)(1991-9#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-11#1)(2005-10#1)(2005-8#1)(2006-12#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)
to 70% in##2##3##(1991-4#1)(2008-10#1)
to 70% of patients##4##4##(2007-11#2)(2008-7#2)
to 70% of the##5##4##(1995-10#1)(2007-7#2)(2008-10#2)
to 70% of##17##3##(1995-10#1)(1996-1#1)(2005-7#1)(2007-11#3)(2007-7#2)(2008-1#1)(2008-10#2)(2008-7#2)(2012-12#1)(2013-8#3)
to 70%##37##2##(1991-4#1)(1992-2#1)(1995-10#1)(1996-1#2)(1997-2#1)(2005-7#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-8#2)(2007-11#4)(2007-7#2)(2008-1#1)(2008-10#6)(2008-3#1)(2008-6#2)(2008-7#2)(2010-4#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-8#3)
to 70%)##2##2##(2008-10#1)(2010-4#1)
to 70)##2##2##(1990-3#1)(2008-1#1)
to 700 K##2##3##(2008-10#2)
to 700 nm##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
to 700 nm)##2##3##(2006-3#1)(2011-1#1)
to 700##16##2##(1995-2#1)(2004-4#1)(2006-12#1)(2006-3#1)(2006-4#1)(2007-12#2)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2010-4#1)(2011-1#1)
to 7000##2##2##(1997-5#1)(2008-3#1)
to 71##10##2##(1990-5#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-7#1)(2009-3#1)(2010-12#1)(2011-1#1)(2012-3#1)
to 71% at##2##3##(2004-3#1)(2006-8#1)
to 71%##5##2##(1996-5#1)(2004-3#1)(2006-8#1)(2008-10#1)(2011-1#1)
to 710##2##2##(2007-12#1)(2010-2#1)
to 72 h after##6##4##(2008-10#4)(2008-5#1)(2010-11#1)
to 72 h##10##3##(1990-5#1)(2008-10#5)(2008-5#1)(2010-11#1)(2011-2#1)(2012-1#1)
to 72 hours after##2##4##(1993-11#1)(2007-9#1)
to 72 hours##7##3##(1990-6#1)(1992-2#1)(1993-11#1)(1994-11#1)(1996-2#1)(2007-9#1)(2008-11#1)
to 72 years##2##3##(2007-1#1)(2007-7#1)
to 72##35##2##(1990-5#1)(1990-6#1)(1990-7#1)(1992-2#2)(1993-11#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-2#1)(2005-10#1)(2006-5#1)(2007-1#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-1#1)
to 72%##7##2##(1996-12#1)(2005-7#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)
to 73 years##3##3##(1992-3#1)(2007-2#1)(2013-8#1)
to 73##13##2##(1991-7#1)(1992-2#1)(1992-3#1)(1995-3#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-3#2)(2012-3#2)(2013-8#1)
to 73% in##2##3##(1991-2#1)(2008-10#1)
to 73% of##2##3##(1994-6#1)(2008-10#1)
to 73%##8##2##(1991-2#1)(1994-6#1)(2008-10#4)(2011-2#1)(2012-3#1)
to 730##2##2##(2008-10#1)(2008-3#1)
to 735##2##2##(2004-10#1)(2013-1#1)
to 74 +/-##2##3##(1990-5#1)(1994-8#1)
to 74 years##2##3##(1991-9#1)(2008-7#1)
to 74##18##2##(1990-5#1)(1991-2#2)(1991-9#1)(1993-9#1)(1994-6#1)(1994-8#1)(2004-1#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-7#2)(2010-12#1)(2010-7#1)
to 74%##5##2##(1994-12#1)(1996-9#1)(2008-10#2)(2011-2#1)
to 75 degrees C##2##4##(2008-3#1)(2008-6#1)
to 75 microM##2##3##(1993-6#2)
to 75 mm##2##3##(2007-12#1)(2008-5#1)
to 75 percent in##2##4##(1990-8#1)(1996-9#1)
to 75 years old##3##4##(2008-3#2)(2013-1#1)
to 75 years##8##3##(1994-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-3#2)(2013-1#1)
to 75##37##2##(1990-8#1)(1991-6#1)(1992-6#1)(1993-6#2)(1994-2#1)(1994-7#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-7#1)(2005-8#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-3#3)(2008-5#1)(2008-6#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
to 75% in##2##3##(2005-8#1)(2013-1#1)
to 75% of##4##3##(2008-10#1)(2010-12#1)(2012-1#1)(2013-1#1)
to 75%##17##2##(1993-1#1)(2005-8#2)(2006-8#1)(2007-11#2)(2008-10#4)(2008-12#1)(2010-1#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-1#2)
to 75%)##4##2##(1991-8#1)(2006-10#1)(2008-10#1)(2013-8#1)
to 750 ppm##4##3##(2005-11#4)
to 750##6##2##(2005-11#4)(2008-10#1)(2008-3#1)
to 76 years##3##3##(2006-11#1)(2007-10#1)(2008-9#1)
to 76##13##2##(1991-11#1)(1993-6#1)(1995-9#1)(1996-3#1)(2006-11#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-2#1)
to 76% of##2##3##(2007-11#1)(2008-7#1)
to 76%##7##2##(1993-11#2)(1997-1#1)(2007-11#1)(2008-10#1)(2008-7#1)(2011-2#1)
to 77 K##3##3##(2007-12#1)(2010-2#2)
to 77 years (mean##2##4##(2006-11#1)(2007-7#1)
to 77 years##4##3##(1990-2#1)(2006-11#1)(2007-7#1)(2008-2#1)
to 77##13##2##(1990-2#1)(1995-11#1)(2006-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2010-2#2)(2012-12#1)(2013-1#1)
to 77% in##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
to 77% of##2##3##(2008-10#1)(2008-5#1)
to 77%##9##2##(2008-10#3)(2008-4#1)(2008-5#1)(2009-4#1)(2010-10#1)(2011-2#1)(2013-1#1)
to 78##8##2##(1990-2#1)(1991-12#1)(1992-9#1)(2007-12#1)(2008-10#3)(2011-1#1)
to 78% of##2##3##(2007-11#1)(2013-8#1)
to 78%##10##2##(1991-2#1)(1994-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2012-3#1)(2013-8#1)
to 78)##2##2##(2006-12#1)(2008-8#1)
to 79 years##6##3##(1992-2#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2013-1#1)
to 79 years)##3##3##(1995-9#1)(2006-10#1)(2013-1#1)
to 79 yr##2##3##(2008-7#2)
to 79##19##2##(1990-10#2)(1992-2#2)(1995-9#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2011-1#1)(2013-1#2)(2013-7#1)
to 79% of##2##3##(1990-2#1)(2007-11#1)
to 79%##6##2##(1990-2#1)(1993-1#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#1)
to 7alpha##3##2##(1996-5#3)
to 7th##4##2##(2006-11#2)(2007-5#1)(2013-7#1)
to 8 MPa##2##3##(2005-11#1)(2010-4#1)
to 8 and##2##3##(2006-5#1)(2008-10#1)
to 8 cm##2##3##(2006-6#1)(2006-8#1)
to 8 days after inoculation##2##5##(2008-10#2)
to 8 days##6##3##(1995-7#1)(1997-3#1)(2008-10#3)(2008-7#1)
to 8 h##4##3##(1992-10#1)(1992-8#1)(1995-11#1)(2008-10#1)
to 8 hours##2##3##(1994-9#1)(2010-12#1)
to 8 hrs##2##3##(1993-8#1)(2009-10#1)
to 8 mM##2##3##(1993-8#1)(1994-11#1)
to 8 mW##2##3##(2007-12#1)(2008-1#1)
to 8 mm##2##3##(2008-10#1)(2011-2#1)
to 8 times the##2##4##(1990-11#1)(1991-10#1)
to 8 times##3##3##(1990-11#1)(1991-10#1)(1997-4#1)
to 8 weeks of##6##4##(1991-3#1)(1991-7#1)(1992-11#1)(2008-10#1)(2009-3#1)(2011-2#1)
to 8 weeks##17##3##(1990-4#1)(1991-3#1)(1991-7#1)(1992-11#1)(1995-6#1)(1997-3#1)(2007-9#1)(2008-10#5)(2008-5#1)(2009-11#1)(2009-3#1)(2009-5#1)(2011-2#1)
to 8 years##12##3##(2007-2#1)(2007-7#2)(2007-8#2)(2008-5#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-3#1)(2012-1#1)(2012-12#1)
to 8##187##2##(1990-1#1)(1990-11#4)(1990-4#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-10#1)(1992-11#2)(1992-6#2)(1992-8#1)(1993-11#1)(1993-7#1)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-4#2)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-4#2)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-8#2)(2004-9#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#3)(2007-12#6)(2007-2#3)(2007-3#3)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#39)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#4)(2008-6#1)(2008-7#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#2)(2011-2#8)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)
to 8% of the##3##4##(1990-11#1)(2008-6#1)(2010-5#1)
to 8% of##4##3##(1990-11#1)(2008-6#1)(2010-5#1)(2013-8#1)
to 8%##14##2##(1990-11#1)(1991-2#1)(1991-5#1)(1993-11#1)(2005-9#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-5#1)(2013-8#1)
to 8-##2##2##(1990-5#1)(2007-2#1)
to 8-10##2##2##(1991-3#1)(2007-9#1)
to 8-OH-DPAT##4##2##(1994-11#1)(1996-10#2)(1997-7#1)
to 8-fold##2##2##(1991-4#1)(1997-4#1)
to 80 degrees C for##3##5##(2008-10#2)(2008-11#1)
to 80 degrees C##6##4##(1996-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-6#1)
to 80 degrees##9##3##(1996-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2010-12#1)(2010-6#1)
to 80 mV##2##3##(1991-2#1)(1995-3#1)
to 80 min##5##3##(1993-4#1)(1997-1#1)(2008-11#1)(2008-3#1)(2012-12#1)
to 80 ps##2##3##(2007-12#1)(2008-1#1)
to 80 times higher##2##4##(1992-4#1)(2008-10#1)
to 80 times##3##3##(1992-4#1)(2007-9#1)(2008-10#1)
to 80 years (mean##4##4##(2005-8#1)(2006-6#1)(2007-7#1)(2008-1#1)
to 80 years##11##3##(1996-7#1)(2005-8#1)(2006-1#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#1)(2013-7#1)(2013-8#1)
to 80##55##2##(1990-12#1)(1991-10#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-8#1)(1993-4#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-2#1)(2005-8#1)(2006-1#1)(2006-3#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#4)(2008-5#1)(2008-9#2)(2009-2#1)(2010-12#1)(2010-6#1)(2012-12#2)(2013-7#1)(2013-8#1)
to 80% in##4##3##(1991-6#1)(2006-7#1)(2008-7#1)(2012-12#1)
to 80% of patients##4##4##(2005-8#1)(2007-9#1)(2010-3#1)(2010-4#1)
to 80% of the##10##4##(1990-7#1)(1994-3#1)(1994-8#1)(1997-6#1)(2006-8#1)(2008-10#1)(2008-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
to 80% of##26##3##(1990-7#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-4#1)(1994-8#1)(1997-6#1)(2005-8#2)(2006-10#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2012-12#1)(2013-1#3)(2013-8#1)
to 80%##56##2##(1990-7#1)(1991-6#1)(1992-3#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#3)(1994-4#1)(1994-8#1)(1995-8#1)(1996-10#1)(1996-5#1)(1997-6#1)(2005-8#2)(2006-10#3)(2006-7#1)(2006-8#3)(2007-11#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2012-12#3)(2013-1#3)(2013-8#3)
to 80%)##5##2##(2005-11#1)(2005-12#1)(2008-10#3)
to 800 ng/spot for##2##4##(2010-2#1)(2012-2#1)
to 800 nm##4##3##(2008-2#3)(2008-3#1)
to 800##21##2##(1990-12#1)(1991-3#1)(1991-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#5)(2008-3#2)(2008-7#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
to 8000##3##2##(1994-6#1)(2008-3#1)(2012-11#1)
to 800muM##2##2##(2008-10#2)
to 81 years##2##3##(2007-7#1)(2011-2#1)
to 81##11##2##(1997-8#1)(2006-12#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-9#1)(2011-12#1)(2011-2#1)(2013-1#1)
to 81% of##2##3##(2007-11#1)(2010-6#1)
to 81%##9##2##(1996-5#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-6#1)(2010-6#1)(2011-2#1)(2012-2#1)
to 82 years##2##3##(1990-6#1)(2011-2#1)
to 82##11##2##(1990-6#1)(1995-3#1)(2006-10#1)(2008-10#1)(2008-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
to 82%##6##2##(1991-8#1)(2004-2#1)(2007-11#1)(2007-8#1)(2012-12#1)(2013-8#1)
to 83 per##2##3##(1990-12#1)(2013-8#1)
to 83 years##2##3##(1996-9#1)(2008-7#1)
to 83##10##2##(1990-12#1)(1996-9#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-3#2)(2013-8#1)
to 83% of##2##3##(2004-12#1)(2008-10#1)
to 83%##8##2##(1995-2#1)(1996-12#1)(2004-12#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-10#1)(2009-4#1)
to 84 years (mean##2##4##(2007-7#1)(2013-1#1)
to 84 years##5##3##(1990-12#1)(2007-7#1)(2008-4#1)(2011-2#1)(2013-1#1)
to 84##17##2##(1990-11#1)(1990-12#1)(1991-2#1)(1996-12#1)(2007-5#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-8#1)(2011-12#1)(2011-2#2)(2013-1#1)
to 84% of##2##3##(2004-3#1)(2006-10#1)
to 84%##9##2##(1992-6#1)(1994-11#1)(2004-3#1)(2006-10#1)(2007-12#1)(2008-10#3)(2013-8#1)
to 840##2##2##(2007-2#1)(2008-2#1)
to 85##14##2##(1992-10#1)(1993-2#1)(1996-7#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
to 85% for##2##3##(2007-4#1)(2008-10#1)
to 85% in the##2##4##(1994-5#1)(2006-8#1)
to 85% in##4##3##(1994-5#1)(2006-8#1)(2009-8#1)(2010-5#1)
to 85% of##6##3##(1995-8#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-5#1)(2012-12#1)
to 85% relative humidity##3##4##(2008-10#1)(2008-2#2)
to 85%##30##2##(1990-10#1)(1994-5#1)(1995-4#1)(1995-8#2)(2004-11#1)(2006-8#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-5#4)(2008-8#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
to 85%)##2##2##(2008-3#1)(2012-3#1)
to 850 nm##2##3##(2007-12#1)(2008-2#1)
to 850##5##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2012-2#1)
to 86##5##2##(1990-5#1)(2007-11#1)(2007-8#1)(2008-7#1)(2010-7#1)
to 86% of##2##3##(2007-11#1)(2007-8#1)
to 86%##9##2##(1993-2#1)(2007-11#2)(2007-8#1)(2008-10#4)(2008-3#1)
to 860##3##2##(1997-1#1)(2009-7#1)(2011-7#1)
to 865 nm##3##3##(2008-2#3)
to 865##4##2##(1991-9#1)(2008-2#3)
to 87 years old##2##4##(1992-7#1)(2006-6#1)
to 87 years##4##3##(1992-7#1)(1997-3#1)(1997-8#1)(2006-6#1)
to 87##12##2##(1990-3#1)(1992-7#1)(1997-3#1)(1997-8#1)(2006-5#1)(2006-6#1)(2008-10#1)(2008-5#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
to 87%##4##2##(2004-10#1)(2007-8#1)(2008-10#1)(2009-7#1)
to 88 years##2##3##(2006-4#1)(2008-7#1)
to 88##5##2##(1996-12#1)(1996-5#1)(2006-4#1)(2008-7#1)(2010-4#1)
to 88%##4##2##(1991-9#1)(1995-4#1)(2008-10#1)(2012-1#1)
to 880##2##2##(2007-11#1)(2007-12#1)
to 89##12##2##(1990-8#1)(1991-11#1)(1995-10#1)(1997-5#1)(1997-7#1)(2006-4#1)(2007-11#1)(2008-10#2)(2008-6#1)(2011-1#1)(2012-3#1)
to 89%##8##2##(1990-5#1)(1992-2#1)(2007-11#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-3#1)
to 8th##4##2##(1990-10#1)(2006-11#1)(2008-1#1)(2010-4#1)
to 8x10(-5) M##2##3##(2008-10#2)
to 9 days##4##3##(1994-4#1)(1995-11#1)(2008-10#2)
to 9 months##6##3##(1995-2#1)(2007-6#1)(2007-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
to 9 x##2##3##(1996-2#1)(2010-6#1)
to 9 years##5##3##(2006-2#1)(2007-8#1)(2008-12#1)(2008-4#1)(2012-1#1)
to 9##113##2##(1990-2#1)(1990-3#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-2#1)(1992-8#2)(1992-9#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-4#1)(1994-5#1)(1995-11#2)(1995-2#1)(1995-3#1)(1996-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-4#1)(2005-8#1)(2006-2#1)(2006-3#1)(2006-5#2)(2006-8#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-5#1)(2007-6#3)(2007-8#6)(2007-9#2)(2008-10#25)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#2)(2009-9#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#1)
to 9% of##4##3##(1997-2#1)(2007-11#1)(2010-6#1)(2011-2#1)
to 9%##8##2##(1991-7#1)(1993-12#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-6#1)(2011-2#1)
to 9)##2##2##(1991-8#1)(1993-3#1)
to 9-H and 9-CHO##2##4##(2008-9#2)
to 90 days##4##3##(1990-12#1)(1994-6#1)(1997-4#1)(2008-10#1)
to 90 degrees C##3##4##(1990-2#1)(1992-9#1)(2008-10#1)
to 90 degrees##8##3##(1990-2#1)(1992-9#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#1)
to 90 h##2##3##(1994-12#1)(2008-10#1)
to 90 min##5##3##(1994-2#1)(2006-10#1)(2008-11#1)(2008-4#1)(2013-8#1)
to 90 nM##2##3##(1990-2#2)
to 90 ppm##2##3##(1996-11#1)(2007-1#1)
to 90 years##3##3##(1997-6#1)(2006-8#1)(2008-1#1)
to 90##66##2##(1990-12#1)(1990-2#3)(1991-3#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-5#1)(1994-12#1)(1994-2#2)(1994-6#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-11#1)(1997-4#1)(1997-6#1)(2005-11#2)(2005-12#1)(2005-8#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2009-7#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
to 90% for the##3##4##(2007-12#1)(2013-1#2)
to 90% for##5##3##(2007-11#1)(2007-12#1)(2012-3#1)(2013-1#2)
to 90% of patients##4##4##(2004-11#1)(2006-3#1)(2008-6#1)(2012-2#1)
to 90% of the##8##4##(1990-9#1)(1992-5#1)(1994-6#1)(2005-11#1)(2008-10#3)(2008-11#1)
to 90% of##20##3##(1990-9#1)(1992-5#1)(1994-6#1)(2004-11#1)(2005-11#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2012-2#1)
to 90% with##2##3##(1991-5#1)(1993-6#1)
to 90%##58##2##(1990-10#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-5#1)(1991-9#1)(1992-5#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-3#1)(1997-8#1)(2004-11#1)(2005-11#2)(2006-3#1)(2006-8#3)(2007-11#2)(2007-12#2)(2007-5#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-9#1)(2009-3#1)(2011-12#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
to 90%)##2##2##(1991-10#1)(2011-12#1)
to 900 nm##2##3##(2007-12#1)(2008-3#1)
to 900##10##2##(1995-12#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-6#1)
to 91##10##2##(1996-12#1)(2005-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)(2012-3#1)(2013-1#2)
to 91%##4##2##(2007-4#1)(2008-10#1)(2008-6#1)(2010-5#1)
to 91%)##2##2##(2008-10#1)(2012-3#1)
to 92 years##3##3##(1992-4#1)(1994-6#1)(2007-7#1)
to 92##15##2##(1991-11#1)(1992-4#1)(1993-8#1)(1994-6#1)(1996-3#1)(1997-8#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-7#1)(2013-7#1)
to 92% of the##5##4##(1995-11#1)(1995-8#2)(1996-6#1)(2008-11#1)
to 92% of##6##3##(1995-11#1)(1995-8#2)(1996-6#1)(2007-10#1)(2008-11#1)
to 92%##14##2##(1992-3#1)(1992-5#1)(1995-11#1)(1995-8#2)(1996-6#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-6#1)(2013-8#1)
to 93##11##2##(1993-1#1)(1994-2#1)(1996-3#1)(2007-10#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2010-11#1)
to 93% for##2##3##(2007-11#1)(2008-10#1)
to 93% in##2##3##(2008-10#1)(2012-1#1)
to 93% of the##2##4##(1992-6#1)(1994-11#1)
to 93% of##3##3##(1992-6#1)(1994-11#1)(2008-10#1)
to 93%##17##2##(1991-10#1)(1992-6#1)(1994-11#1)(1994-8#1)(1996-12#1)(2006-10#1)(2007-11#1)(2008-10#4)(2009-7#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-8#1)
to 94 years##2##3##(2008-10#1)(2011-2#1)
to 94##13##2##(1992-6#1)(2005-12#1)(2007-10#1)(2008-10#4)(2009-9#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-3#1)
to 94%##8##2##(1990-11#1)(2007-3#1)(2008-10#4)(2008-12#1)(2013-8#1)
to 95 percent##2##3##(1992-12#1)(1995-3#1)
to 95##15##2##(1991-5#1)(1992-12#1)(1994-3#1)(1995-10#1)(1995-3#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)
to 95% and##3##3##(2008-10#2)(2010-5#1)
to 95% of the##2##4##(1991-12#1)(2008-3#1)
to 95% of##8##3##(1991-12#1)(1993-1#1)(1994-9#1)(1997-8#1)(2005-8#1)(2008-3#1)(2008-8#1)(2011-2#1)
to 95% oxygen##2##3##(2008-3#2)
to 95%##22##2##(1990-10#1)(1991-12#1)(1991-5#1)(1993-1#1)(1994-3#1)(1994-9#1)(1996-4#1)(1997-8#1)(2005-8#1)(2008-10#4)(2008-3#3)(2008-8#1)(2009-8#1)(2010-5#1)(2011-2#1)(2013-7#1)(2013-8#1)
to 95%)##2##2##(1994-12#1)(2008-10#1)
to 950##3##2##(2007-7#1)(2008-4#1)(2010-4#1)
to 96 h##10##3##(1991-2#1)(1994-3#1)(1997-3#1)(2004-12#1)(2008-10#5)(2008-12#1)
to 96##21##2##(1991-2#1)(1991-5#1)(1991-9#1)(1992-10#1)(1993-8#1)(1994-3#1)(1997-3#1)(2004-12#1)(2005-7#1)(2008-10#9)(2008-12#1)(2011-2#1)(2012-2#1)
to 96% for##2##3##(2007-8#1)(2008-10#1)
to 96% in##2##3##(2007-1#1)(2008-10#1)
to 96%##9##2##(1992-6#1)(1994-5#1)(2007-1#1)(2007-8#1)(2008-10#4)(2011-1#1)
to 96-well##2##2##(2008-10#1)(2011-12#1)
to 960##3##2##(1997-6#1)(2008-10#1)(2008-2#1)
to 97 years##2##3##(1993-12#1)(1995-6#1)
to 97##12##2##(1993-12#1)(1995-6#1)(2006-4#1)(2008-10#4)(2011-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
to 97% in##2##3##(2008-10#2)
to 97%##10##2##(1992-5#1)(1993-9#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-9#1)(2010-4#1)(2013-8#1)
to 98##26##2##(1992-11#2)(1995-6#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-6#1)(2008-8#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
to 98% nucleotide identities and##2##5##(2008-10#2)
to 98% of##3##3##(2008-10#2)(2008-7#1)
to 98%##17##2##(1995-3#1)(1996-5#1)(2008-10#11)(2008-6#1)(2008-7#2)(2010-5#1)
to 98%)##3##2##(1996-4#1)(2007-2#1)(2008-10#1)
to 988##3##2##(1992-9#1)(2012-1#1)(2012-3#1)
to 99##24##2##(1991-1#1)(1991-2#1)(1992-6#1)(1994-12#1)(1997-1#1)(1997-8#1)(2005-12#2)(2008-10#11)(2008-12#1)(2011-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
to 99% for##3##3##(2008-10#3)
to 99% of the##2##4##(2008-10#2)
to 99% of##4##3##(2008-10#4)
to 99%##17##2##(1990-10#1)(2005-10#1)(2007-10#2)(2007-4#1)(2008-10#10)(2009-6#1)(2010-2#1)
to 99%)##4##2##(2007-2#1)(2008-10#2)(2012-3#1)
to 990##2##2##(1997-7#1)(2006-10#1)
to 9p23-24 and 4q12##2##4##(1994-9#2)
to =##4##2##(1990-2#2)(2008-5#2)
to ?0##2##2##(2008-2#1)(2008-3#1)
to A beta##10##3##(1991-9#1)(1994-10#1)(1994-11#2)(1994-2#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)
to A##46##2##(1990-11#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-7#1)(1991-9#2)(1992-8#1)(1994-10#1)(1994-11#2)(1994-2#1)(1995-10#2)(1995-12#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1997-4#2)(1997-6#1)(2007-1#4)(2007-4#1)(2008-10#13)(2008-4#1)(2008-8#1)(2011-2#1)(2012-12#1)
to A)##2##2##(1993-3#1)(1997-3#1)
to A506##2##2##(2008-10#2)
to AA##5##2##(1991-8#1)(1992-12#1)(1995-7#1)(2008-10#1)(2008-4#1)
to AAA##2##2##(2006-1#1)(2013-1#1)
to ABA##2##2##(2009-8#2)
to ACE inhibitor therapy##2##4##(2006-10#1)(2007-11#1)
to ACE inhibitors and##2##4##(1996-9#2)
to ACE inhibitors##3##3##(1996-9#2)(2005-7#1)
to ACE##7##2##(1990-2#1)(1996-9#2)(2005-7#1)(2006-10#2)(2007-11#1)
to ACPC##3##2##(1996-12#3)
to ACT##2##2##(1994-12#2)
to ACTH##5##2##(1991-10#1)(1993-11#1)(1995-10#2)(1996-11#1)
to ACh##4##2##(2009-12#1)(2010-8#2)(2012-3#1)
to AChE##3##2##(1992-12#1)(1994-5#2)
to AChR##2##2##(2008-4#2)
to AD pathogenesis##3##3##(1993-11#1)(1996-9#1)(2009-11#1)
to AD pathology##2##3##(1995-10#1)(1997-5#1)
to AD##9##2##(1993-11#1)(1995-10#1)(1995-4#1)(1996-9#1)(1997-5#1)(2007-9#1)(2008-7#1)(2009-10#1)(2009-11#1)
to ADA##2##2##(1996-11#1)(2012-2#1)
to ADHD##2##2##(2005-10#1)(2013-1#1)
to ADP and##2##3##(1991-7#1)(1991-8#1)
to ADP or isoproterenol##3##4##(2007-9#3)
to ADP##13##2##(1990-11#2)(1991-7#1)(1991-8#1)(1996-4#1)(1996-7#1)(2007-9#3)(2008-4#1)(2008-7#1)(2013-1#2)
to ADR##3##2##(1990-2#1)(1992-11#1)(2008-11#1)
to AF##2##2##(2011-2#1)(2013-1#1)
to AFP##2##2##(1993-1#1)(2008-8#1)
to AG-6##2##2##(2008-10#2)
to AH##2##2##(1993-8#1)(2009-7#1)
to AI##2##2##(2008-5#1)(2013-1#1)
to AI-2##3##2##(2008-9#3)
to AIDS in##2##3##(1994-9#1)(2011-1#1)
to AIDS information in##2##4##(1996-6#1)(1997-6#1)
to AIDS##32##2##(1990-11#1)(1990-3#1)(1991-6#1)(1992-12#1)(1992-2#1)(1993-11#2)(1993-12#2)(1993-3#1)(1994-12#1)(1994-9#1)(1995-9#1)(1996-11#2)(1996-6#1)(1997-3#2)(1997-6#2)(2005-2#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-11#1)(2008-12#1)(2009-7#1)(2010-8#2)(2011-1#1)(2012-2#2)
to ALA-PDT##2##2##(2012-12#2)
to ALL-1##2##2##(1997-7#2)
to AM##2##2##(1992-2#1)(2008-2#1)
to AMP##3##2##(2008-4#2)(2009-2#1)
to AMPA/kainate receptor-mediated injury##2##4##(1995-5#2)
to ANA and cross-tolerance to delta##2##6##(1995-10#2)
to ANA##3##2##(1995-10#3)
to ANF##4##2##(1990-7#4)
to ANG II##3##3##(1991-8#2)(1994-11#1)
to ANN##2##2##(2008-10#2)
to ANP##3##2##(1990-12#1)(1991-8#1)(1992-3#1)
to AP##2##2##(2007-12#1)(2008-10#1)
to AP-1##2##2##(1991-10#1)(1994-8#1)
to AP-2##2##2##(1992-8#1)(1996-7#1)
to APACHE II##2##3##(2012-2#1)(2013-1#1)
to APCs of patients##2##4##(1996-4#2)
to APMV-1##4##2##(2008-5#4)
to ART##9##2##(2007-7#1)(2009-12#1)(2009-3#1)(2009-4#1)(2012-12#3)(2012-3#1)(2013-1#1)
to AS##3##2##(1994-11#1)(2013-8#2)
to ASA##4##2##(2008-10#1)(2010-7#1)(2011-12#2)
to ASD##2##2##(2009-4#1)(2011-2#1)
to AT##3##2##(1993-3#1)(2013-1#2)
to AT(1) receptor##2##3##(2008-9#2)
to AT-rich DNA##2##3##(1994-12#1)(1995-10#1)
to AT-rich##3##2##(1994-12#1)(1995-10#1)(2008-7#1)
to AT1##3##2##(1991-9#1)(1992-5#1)(1994-9#1)
to AT2##3##2##(1991-12#1)(1991-9#1)(1995-12#1)
to ATP binding##4##3##(1990-3#1)(1995-2#2)(2008-10#1)
to ATP##27##2##(1990-3#2)(1990-5#2)(1990-7#1)(1991-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#4)(1995-2#2)(1995-6#2)(1997-8#1)(2006-1#2)(2008-10#1)(2008-4#3)(2008-5#1)(2008-7#1)
to ATPase##2##2##(1994-11#1)(2010-12#1)
to AV##2##2##(1992-5#1)(2007-7#1)
to AZT##3##2##(1993-9#1)(1995-9#1)(2006-11#1)
to Absorption##2##2##(2008-3#2)
to AcNPV##2##2##(1997-3#1)(1997-4#1)
to Achieve##2##2##(2004-3#1)(2011-1#1)
to Actinobacillus actinomycetemcomitans##2##3##(2006-8#2)
to Action##2##2##(2007-2#1)(2009-4#1)
to Adolescence##2##2##(2010-9#1)(2011-1#1)
to Adult##2##2##(2009-11#1)(2011-2#1)
to Aflatoxin Contamination by Aspergillus flavus##2##6##(2008-10#2)
to Aflatoxin##3##2##(2008-10#3)
to Africa##3##2##(2007-2#2)(2008-10#1)
to African American##2##3##(2009-5#1)(2011-2#1)
to African##6##2##(2006-7#1)(2007-10#1)(2008-10#1)(2009-5#2)(2011-2#1)
to African-American hair##3##3##(2008-5#3)
to African-American##4##2##(2008-11#1)(2008-5#3)
to African-Americans##2##2##(2006-5#1)(2010-6#1)
to Ag##3##2##(1991-5#1)(2010-4#1)(2013-1#1)
to AhR ligands##3##3##(2008-10#2)(2009-3#1)
to Al exposure##2##3##(1996-8#2)
to Al toxicity##2##3##(1996-8#2)
to Al##14##2##(1996-8#8)(2008-10#3)(2013-8#3)
to Ala##12##2##(1991-10#1)(1991-4#1)(1992-3#1)(1992-9#2)(1994-11#2)(1995-2#1)(1995-6#1)(1995-8#2)(1996-8#1)
to Albritton##2##2##(2008-8#2)
to Alternaria alternata##2##3##(2008-10#2)
to Alternaria##4##2##(2007-3#1)(2008-10#3)
to Alzheimer's disease##8##3##(1992-12#1)(1995-6#1)(1996-8#2)(2004-11#1)(2005-8#1)(2008-7#1)(2013-8#1)
to Alzheimer's##9##2##(1992-12#1)(1995-6#1)(1996-8#3)(2004-11#1)(2005-8#1)(2008-7#1)(2013-8#1)
to America##3##2##(1993-6#1)(2004-12#1)(2008-11#1)
to American Indian##3##3##(1991-3#1)(2007-2#2)
to American##8##2##(1991-3#1)(1994-3#1)(1997-6#1)(2007-2#2)(2007-4#1)(2008-5#2)
to An##4##2##(2007-12#2)(2008-11#1)(2012-12#1)
to Anaplasma marginale##2##3##(1996-12#2)
to Anderson##2##2##(1996-5#1)(2007-12#1)
to Ang##3##2##(1996-4#2)(2009-10#1)
to AngII##2##2##(1990-12#2)
to Annex##3##2##(2006-6#1)(2007-7#1)(2008-11#1)
to Anopheles##2##2##(2005-8#1)(2007-2#1)
to Aphanomyces root rot##4##4##(2008-10#4)
to Aphanomyces##5##2##(2008-10#5)
to Apple##2##2##(2008-10#2)
to April 1998##2##3##(2007-3#1)(2008-6#1)
to April 2006##3##3##(2008-10#1)(2008-7#1)(2010-5#1)
to April 2008##3##3##(2009-8#1)(2011-2#2)
to April 2008)##2##3##(2013-8#2)
to April 2009##2##3##(2011-1#1)(2012-12#1)
to April##28##2##(1990-3#1)(1991-2#1)(1993-10#1)(1994-6#1)(1996-6#1)(2007-10#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-6#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#2)
to Arabidopsis##4##2##(2006-12#1)(2012-2#2)(2012-3#1)
to Arg at position##2##4##(1992-8#1)(2008-10#1)
to Arg substitution##2##3##(1991-6#1)(1992-8#1)
to Arg##6##2##(1991-6#1)(1991-9#1)(1992-8#2)(1997-1#1)(2008-10#1)
to Article##2##2##(1990-2#1)(1992-4#1)
to As##4##2##(2005-4#1)(2008-10#3)
to As(III)##5##2##(2008-10#5)
to As(V)##4##2##(2008-10#4)
to Asn##5##2##(1992-10#1)(1995-2#1)(1995-5#1)(2008-8#1)(2009-3#1)
to Asp##5##2##(1993-3#1)(1995-11#4)
to Asp)##2##2##(1994-8#1)(2008-4#1)
to Aspergillus flavus##5##3##(2006-9#1)(2008-10#4)
to Aspergillus spp##3##3##(1997-3#1)(2008-3#2)
to Aspergillus##14##2##(1993-8#1)(1997-3#1)(2006-9#1)(2008-1#1)(2008-10#8)(2008-3#2)
to Assess the##5##3##(1992-3#1)(1994-12#1)(2008-10#1)(2012-12#2)
to Assess##12##2##(1990-4#1)(1992-3#1)(1994-12#1)(2008-10#4)(2009-9#1)(2012-12#2)(2013-1#2)
to August 1997##2##3##(2006-10#1)(2007-7#1)
to August 2001##2##3##(2007-5#1)(2008-5#1)
to August 2002##2##3##(2005-8#1)(2008-3#1)
to August 2004##2##3##(2007-8#1)(2012-1#1)
to August 2007##2##3##(2011-2#1)(2012-2#1)
to August 2009##2##3##(2011-2#1)(2012-12#1)
to August 2011)##5##3##(2013-8#5)
to August##31##2##(1991-12#1)(1993-8#1)(1995-12#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-5#2)(2007-7#2)(2007-8#1)(2008-2#1)(2008-3#3)(2008-5#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#6)
to August)##3##2##(2006-5#2)(2008-10#1)
to Australia##5##2##(2007-2#3)(2008-10#1)(2011-2#1)
to Avahan##2##2##(2012-3#2)
to Avoid##2##2##(2007-9#1)(2011-2#1)
to Aβ toxicity##2##3##(2013-1#2)
to Aβ##3##2##(2013-1#3)
to B cell##2##3##(1995-2#1)(1995-5#1)
to B##35##2##(1990-9#1)(1991-11#2)(1994-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(2004-11#3)(2006-10#2)(2006-5#1)(2007-12#2)(2007-6#2)(2007-7#1)(2008-10#10)(2008-6#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)
to B-MYB##3##2##(2011-2#3)
to B2##2##2##(1991-7#1)(2008-11#1)
to BCR-ABL##2##2##(2011-2#1)(2012-12#1)
to BG##3##2##(1994-11#2)(2009-11#1)
to BGYMV-MX##2##2##(2008-10#2)
to BHA##2##2##(1992-9#1)(2008-12#1)
to BMI##5##2##(1991-11#1)(2007-8#1)(2008-3#1)(2011-1#1)(2013-8#1)
to BMP-2##2##2##(1996-5#2)
to BPH##2##2##(1992-8#1)(2008-6#1)
to BPMV##2##2##(2008-10#2)
to BSA and##3##3##(1991-5#1)(2008-10#2)
to BSA at##2##3##(1993-2#1)(2008-10#1)
to BSA##10##2##(1991-5#1)(1992-8#1)(1993-2#1)(2008-10#6)(2008-3#1)
to BTH##2##2##(2008-10#2)
to BYDV##5##2##(2008-10#3)(2008-8#2)
to BZD use##2##3##(1991-12#1)(2008-2#1)
to B[a]P##2##2##(1993-9#2)
to Ba(2+)##2##2##(2008-10#1)(2008-8#1)
to Ba2+##2##2##(1992-5#1)(1993-3#1)
to Bacillus thuringiensis##3##3##(1994-3#1)(2007-6#1)(2011-2#1)
to Bacillus##5##2##(1994-3#1)(2007-6#1)(2008-10#1)(2011-2#2)
to Bacterial Wilt Caused by Ralstonia solanacearum##3##7##(2008-10#3)
to Bacterial##5##2##(2008-10#5)
to Bangladesh##2##2##(1992-10#1)(2009-11#1)
to Basic##4##2##(2007-9#2)(2008-4#1)(2008-9#1)
to Bayesian##3##2##(1994-4#1)(2008-2#1)(2010-2#1)
to Be##3##2##(2007-9#1)(2012-1#1)(2012-3#1)
to Be?##2##2##(2009-3#1)(2012-3#1)
to Bean common mosaic necrosis virus##2##6##(2008-10#2)
to Bean common mosaic##3##4##(2008-10#3)
to Bean##4##2##(2008-10#4)
to Beet curly top virus##2##5##(2008-10#2)
to Beet##3##2##(2008-10#3)
to Bergen##3##2##(1990-6#1)(1992-6#2)
to Berlin##2##2##(1995-1#1)(2007-2#1)
to Biological##4##2##(2008-10#1)(2008-7#3)
to Bipolaris##2##2##(2008-10#2)
to Borrelia burgdorferi##3##3##(1990-2#1)(1991-11#1)(2011-2#1)
to Botrytis cinerea in##2##4##(2008-10#2)
to Botrytis cinerea##4##3##(2008-10#4)
to Botrytis##5##2##(2008-10#5)
to Bragg##2##2##(2007-11#1)(2008-2#1)
to Brassica##2##2##(2008-10#2)
to Brazil##4##2##(2006-5#1)(2008-2#1)(2008-5#1)(2011-2#1)
to Brazilian and##2##3##(1991-6#1)(2008-11#1)
to Breast##3##2##(2009-1#1)(2009-3#1)(2013-1#1)
to Brucella##2##2##(2009-3#1)(2013-8#1)
to Bs##2##2##(1994-12#2)
to Bt##2##2##(2011-2#2)
to Build##2##2##(2008-7#1)(2009-4#1)
to C and##2##3##(1993-3#1)(2008-10#1)
to C kappa##2##3##(1992-7#2)
to C##60##2##(1990-4#2)(1990-5#1)(1991-3#1)(1991-9#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-3#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-7#1)(2006-10#4)(2006-8#1)(2007-10#2)(2007-12#5)(2007-3#1)(2007-7#1)(2008-10#18)(2008-12#4)(2008-5#3)(2008-7#1)(2011-1#2)(2011-2#1)(2013-1#2)
to C(10)(+)##2##2##(1993-2#2)
to C(60)##2##2##(2007-12#1)(2008-8#1)
to C-5##3##2##(1991-4#2)(1996-10#1)
to C-6##3##2##(1994-12#1)(1996-10#1)(2008-10#1)
to C-reactive protein##2##3##(2007-8#2)
to C-type lectins##2##3##(1993-3#1)(1996-2#1)
to C2##5##2##(1995-5#1)(2009-5#1)(2012-3#3)
to C3##3##2##(1997-4#1)(2005-7#1)(2008-10#1)
to C4##3##2##(1990-12#1)(2008-10#1)(2008-2#1)
to C5##2##2##(1992-4#1)(1995-10#1)
to C57BL/6J##2##2##(1992-11#1)(1992-5#1)
to C5a##2##2##(1991-10#1)(1994-6#1)
to C923##2##2##(2008-10#2)
to CA-CRC##2##2##(2011-2#2)
to CA1 neurons##2##3##(1994-10#1)(1995-12#1)
to CA1##4##2##(1991-6#2)(1994-10#1)(1995-12#1)
to CA15-3##2##2##(1991-10#1)(1994-12#1)
to CAA##3##2##(1994-8#2)(2006-10#1)
to CAAs##2##2##(2008-10#2)
to CAG##2##2##(2006-10#1)(2008-1#1)
to CAPs##2##2##(2005-10#2)
to CAV in##3##3##(2008-5#3)
to CAV##7##2##(2008-5#7)
to CBA/j alloantigens##2##3##(1991-12#2)
to CBA/j##3##2##(1991-12#3)
to CBP##3##2##(1995-3#3)
to CBT##3##2##(2009-11#2)(2011-2#1)
to CC##4##2##(1991-8#1)(2008-11#3)
to CCA##2##2##(2008-4#2)
to CCCP##3##2##(1991-8#2)(2005-8#1)
to CCSV NP##2##3##(2008-10#2)
to CCSV##3##2##(2008-10#3)
to CD##4##2##(1997-8#1)(2006-8#1)(2013-8#2)
to CD127##3##2##(2013-1#3)
to CD34##3##2##(1997-2#1)(2012-12#1)(2013-8#1)
to CD4(+)##2##2##(2006-10#1)(2006-11#1)
to CD40##4##2##(1996-10#2)(2008-10#1)(2012-2#1)
to CDAD##2##2##(2006-8#2)
to CDB3##2##2##(1991-1#2)
to CDC##7##2##(1991-11#1)(1991-8#1)(1992-5#1)(1992-6#2)(1997-2#1)(2013-1#1)
to CDC28##2##2##(1991-5#1)(1995-4#1)
to CDDP##4##2##(1993-9#2)(2008-4#1)(2013-1#1)
to CDS##2##2##(2008-3#1)(2013-1#1)
to CDV##4##2##(2007-2#1)(2008-12#3)
to CEA and NCA##2##4##(1990-2#1)(1992-7#1)
to CEA##3##2##(1990-2#1)(1992-7#1)(2008-5#1)
to CENU therapy##2##3##(2006-12#2)
to CENU##3##2##(2006-12#3)
to CEO##2##2##(1995-2#1)(2008-1#1)
to CF##2##2##(1992-10#2)
to CFA in##2##3##(1992-8#2)
to CFA##4##2##(1992-8#2)(2012-2#2)
to CGRP##4##2##(1991-2#1)(1992-6#2)(1995-8#1)
to CHD or##2##3##(1990-3#2)
to CHD##3##2##(1990-3#2)(2005-10#1)
to CHL in##2##3##(1997-3#2)
to CHL##6##2##(1997-3#6)
to CHO cells##2##3##(2010-12#2)
to CHO##3##2##(1996-5#1)(2010-12#2)
to CHV2-NB58##2##2##(2008-10#2)
to CI##4##2##(1997-2#1)(2008-10#1)(2008-9#1)(2011-2#1)
to CII##2##2##(1996-4#1)(2008-4#1)
to CK-MM3##2##2##(1991-2#2)
to CMV##11##2##(1991-12#3)(1992-6#2)(1994-11#1)(2008-10#2)(2009-2#1)(2010-12#1)(2011-12#1)
to CNP##2##2##(1994-11#1)(2005-7#1)
to CNS injury##3##3##(1995-7#1)(1997-3#1)(2007-11#1)
to CNS##6##2##(1990-9#1)(1991-12#1)(1995-7#1)(1997-3#1)(2007-11#1)(2011-2#1)
to CO##7##2##(1990-5#1)(1992-2#1)(1994-5#1)(1996-2#1)(2006-12#1)(2008-10#2)
to CO(2) and##2##3##(2008-10#1)(2012-12#1)
to CO(2)##9##2##(2004-4#1)(2005-12#2)(2007-12#1)(2008-10#3)(2011-2#1)(2012-12#1)
to CO2 and##3##3##(1994-10#1)(1994-12#1)(1997-8#1)
to CO2##10##2##(1994-10#1)(1994-11#1)(1994-12#1)(1995-8#1)(1996-12#1)(1997-5#1)(1997-8#1)(2007-12#1)(2007-9#1)(2008-6#1)
to COPD##5##2##(1991-10#1)(2006-9#1)(2008-1#1)(2010-5#1)(2012-12#1)
to CORT##2##2##(1994-11#2)
to COX-1##2##2##(2008-7#1)(2011-1#1)
to COX-2 selective and non-selective NSAIDs##2##6##(2011-2#2)
to COX-2 selective##3##3##(2007-8#1)(2011-2#2)
to COX-2##4##2##(2007-8#1)(2008-5#1)(2011-2#2)
to CP##2##2##(1994-6#1)(1995-3#1)
to CPB##2##2##(2007-8#1)(2007-9#1)
to CPT##2##2##(1994-8#2)
to CQI##2##2##(1993-2#1)(1994-3#1)
to CRC screening##4##3##(2013-1#4)
to CRC##5##2##(2008-7#1)(2013-1#4)
to CRCoV##2##2##(2012-2#2)
to CREB##3##2##(1997-2#2)(2008-11#1)
to CRF##5##2##(1993-7#1)(1994-2#1)(1995-1#1)(1995-12#2)
to CRH##5##2##(1992-6#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-5#1)
to CSF##3##2##(1997-5#1)(2007-10#1)(2007-9#1)
to CT##11##2##(1990-12#1)(1995-3#1)(1996-12#1)(2004-1#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-7#2)(2012-12#2)
to CTB##2##2##(1997-4#2)
to CTEPH##2##2##(2010-6#2)
to CTGF##2##2##(2012-12#2)
to CVD risk##2##3##(1995-8#1)(2012-2#1)
to CVD##3##2##(1995-8#1)(2010-5#1)(2012-2#1)
to CY##2##2##(1994-5#1)(1995-12#1)
to CZE##2##2##(1996-5#2)
to Ca(2+) and##2##3##(2008-10#1)(2008-11#1)
to Ca(2+)##7##2##(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2012-2#1)
to Ca2+ entry##2##3##(1994-8#1)(1995-11#1)
to Ca2+ influx##2##3##(1993-9#1)(2008-8#1)
to Ca2+##30##2##(1990-11#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-11#2)(1995-3#1)(1995-6#1)(1996-2#2)(1997-5#1)(2006-12#1)(2008-8#2)
to CaCl(2)##3##2##(2008-5#1)(2009-5#1)(2013-1#1)
to Caco-2 cells##2##3##(2006-8#2)
to Caenorhabditis elegans##2##3##(1993-4#1)(2007-12#1)
to California##7##2##(1991-5#2)(2008-10#2)(2008-8#1)(2011-2#1)(2012-1#1)
to Canada##2##2##(1994-2#1)(2006-10#1)
to Canadian##6##2##(1993-12#1)(1994-1#1)(1995-3#1)(2010-4#1)(2010-9#1)(2011-2#1)
to Cancer##5##2##(1996-4#1)(2008-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
to Candida albicans##5##3##(1996-7#1)(2005-11#1)(2008-5#1)(2009-7#1)(2012-12#1)
to Candida##9##2##(1996-7#1)(2005-11#1)(2006-7#1)(2007-8#1)(2008-5#2)(2009-7#1)(2012-12#2)
to Cardiac##2##2##(2011-2#1)(2012-3#1)
to Care##6##2##(2008-10#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
to Cartesian##2##2##(2007-9#1)(2008-2#1)
to Cd##6##2##(1990-5#1)(1997-2#2)(1997-4#1)(2008-7#1)(2008-9#1)
to Central##4##2##(1992-2#1)(2008-1#1)(2008-10#1)(2013-7#1)
to Cercospora##2##2##(2008-10#1)(2012-3#1)
to Cereal yellow dwarf virus##2##5##(2008-10#2)
to Change##3##2##(2007-12#1)(2012-1#1)(2012-12#1)
to Chiari##2##2##(2006-5#1)(2006-9#1)
to Children##2##2##(1992-3#1)(2007-2#1)
to Children's Medical Center##2##4##(2007-2#2)
to Children's##5##2##(1995-12#1)(2007-2#2)(2008-10#1)(2013-8#1)
to Chile##2##2##(2007-1#1)(2013-1#1)
to China##4##2##(2006-12#2)(2008-3#1)(2012-2#1)
to Chinese hamster ovary##2##4##(1991-12#1)(1991-9#1)
to Chinese##8##2##(1991-12#1)(1991-9#1)(1997-4#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
to Chlamydia##3##2##(1990-2#1)(2006-10#1)(2013-8#1)
to Cl(-)##2##2##(2008-10#1)(2008-3#1)
to Cl-##2##2##(1990-11#1)(1994-6#1)
to Class II##2##3##(1991-2#1)(2008-11#1)
to Class##3##2##(1991-2#1)(1996-3#1)(2008-11#1)
to Clearfil™ Protect Bond##2##4##(2013-7#2)
to Clinic##3##2##(1995-6#1)(1997-1#1)(2008-10#1)
to Clinical##4##2##(2012-1#1)(2013-1#3)
to Clostridium##7##2##(1994-8#1)(2006-8#2)(2007-12#1)(2007-8#1)(2011-2#2)
to Clover yellow vein virus##2##5##(2008-10#2)
to Co##4##2##(1994-6#4)
to Co(II)##2##2##(1992-9#1)(2008-10#1)
to CoQ10##2##2##(1991-5#1)(2013-1#1)
to Colletotrichum gloeosporioides##2##3##(2008-10#2)
to Colletotrichum truncatum##2##3##(2008-10#2)
to Colletotrichum##6##2##(2008-10#6)
to Colonization by##2##3##(2008-10#2)
to Compare##3##2##(2008-10#1)(2009-5#1)(2010-2#1)
to Complex##2##2##(1991-1#1)(2010-6#1)
to Con A##3##3##(1991-12#2)(1992-9#1)
to Congress on##2##3##(1991-1#1)(1993-3#1)
to Congress##10##2##(1990-8#1)(1991-1#2)(1993-3#1)(1994-1#1)(1994-3#1)(1995-1#1)(1996-2#1)(1997-2#1)(2007-4#1)
to Control##4##2##(1994-2#1)(2008-10#1)(2011-2#1)(2012-2#1)
to Costa Rica##4##3##(2007-3#1)(2008-5#3)
to Costa##7##2##(2007-3#1)(2008-5#5)(2011-2#1)
to Cp1##2##2##(2008-10#2)
to Cp2##2##2##(2008-10#2)
to Cr(III)##6##2##(1990-7#1)(2008-10#3)(2011-2#1)(2013-1#1)
to Cr(VI) and##2##3##(2008-10#1)(2010-4#1)
to Cr(VI) by##2##3##(2008-10#2)
to Cr(VI)##9##2##(2008-10#8)(2010-4#1)
to Cr1##3##2##(2008-10#3)
to Cr2##4##2##(2008-10#4)
to Crohn disease##2##3##(2006-10#1)(2009-12#1)
to Crohn's disease##5##3##(1996-2#1)(2007-11#2)(2007-12#1)(2010-12#1)
to Cronartium quercuum f##2##4##(2008-10#2)
to Cronartium##5##2##(2008-10#5)
to Cry1Ac and##2##3##(2011-2#2)
to Cryphonectria hypovirus##3##3##(2008-10#3)
to Ct-DNA research##3##3##(2013-1#3)
to Cu##4##2##(2004-4#1)(2005-11#1)(2013-8#2)
to Cu(2+)##2##2##(2008-10#1)(2008-12#1)
to Cu(II)##7##2##(1992-8#1)(1994-2#1)(2008-10#5)
to Cuba##2##2##(1996-11#1)(2007-12#1)
to Cucumber##2##2##(2008-10#2)
to Culex##2##2##(1995-8#1)(2008-6#1)
to Cys##3##2##(1991-1#1)(1991-4#1)(2008-10#1)
to D##7##2##(1990-9#1)(1991-8#1)(2008-10#1)(2009-8#1)(2012-2#1)(2013-7#1)(2013-8#1)
to D-amphetamine##6##2##(1993-4#1)(1993-6#2)(1996-8#3)
to DA and MAP##2##4##(1996-10#2)
to DA##4##2##(1990-10#1)(1996-10#2)(2008-10#1)
to DBA/1 mice##2##3##(2008-11#2)
to DCA##2##2##(2008-10#2)
to DDT and##2##3##(2007-3#1)(2013-1#1)
to DDT##5##2##(1992-12#1)(2007-3#1)(2010-2#1)(2012-2#1)(2013-1#1)
to DEP extracts##2##3##(2008-10#2)
to DEP##3##2##(2008-10#3)
to DEPC##2##2##(1991-9#2)
to DES##5##2##(2008-10#5)
to DEX##3##2##(1995-12#2)(2012-3#1)
to DFO##4##2##(1992-1#1)(1992-11#1)(1996-8#2)
to DHD##2##2##(1994-3#2)
to DIBOA##2##2##(2008-10#2)
to DMI##3##2##(1995-7#1)(1996-3#1)(2008-10#1)
to DMMP vapor##2##3##(2007-8#2)
to DNA and inhibits##2##4##(1995-1#1)(2008-5#1)
to DNA and transfer RNA##2##5##(1992-3#2)
to DNA and##17##3##(1991-4#1)(1992-12#1)(1992-3#3)(1993-7#1)(1994-12#1)(1994-8#2)(1995-1#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-5#1)
to DNA binding##3##3##(1994-12#1)(1995-3#1)(2008-8#1)
to DNA by##3##3##(1994-11#1)(1995-6#1)(1997-1#1)
to DNA damage##20##3##(1991-4#1)(1992-4#1)(1994-2#1)(1995-2#3)(1995-5#1)(1995-8#1)(1996-10#1)(1997-4#2)(2008-8#3)(2009-5#1)(2011-2#3)(2013-1#2)
to DNA damaging agents##2##4##(1994-5#1)(2006-8#1)
to DNA fragmentation##2##3##(1991-3#1)(2008-9#1)
to DNA from##2##3##(1991-9#1)(2008-10#1)
to DNA in Sencar mouse epidermis##2##6##(1992-4#2)
to DNA in##8##3##(1990-11#1)(1992-4#2)(1992-8#1)(1994-8#1)(1995-3#1)(2008-8#2)
to DNA is characterized by##2##5##(1991-4#1)(1994-11#1)
to DNA is##3##3##(1991-10#1)(1991-4#1)(1994-11#1)
to DNA molecules##2##3##(1991-4#1)(1995-10#1)
to DNA of##3##3##(1993-9#1)(1994-11#1)(1997-4#1)
to DNA recognition##2##3##(1995-8#1)(1997-1#1)
to DNA repair##2##3##(1990-9#1)(2005-11#1)
to DNA replication##2##3##(1990-9#1)(1991-5#1)
to DNA sequencing##2##3##(1990-5#1)(1996-4#1)
to DNA synthesis and##3##4##(1991-12#1)(1991-7#1)(1996-7#1)
to DNA synthesis##8##3##(1991-12#2)(1991-7#1)(1996-7#1)(1997-7#1)(2008-11#1)(2010-12#1)(2012-2#1)
to DNA was unaffected##2##4##(1992-2#1)(1996-7#1)
to DNA was##7##3##(1992-2#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-1#1)(1996-7#1)(1997-8#1)
to DNA##213##2##(1990-11#4)(1990-12#2)(1990-2#4)(1990-5#2)(1990-8#2)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#7)(1991-5#2)(1991-7#2)(1991-8#4)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#3)(1992-4#4)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-3#5)(1993-7#1)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#4)(1994-12#5)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#5)(1994-9#3)(1995-1#4)(1995-10#1)(1995-2#8)(1995-3#4)(1995-5#2)(1995-6#3)(1995-8#4)(1996-10#2)(1996-11#2)(1996-2#2)(1996-4#2)(1996-5#3)(1996-6#1)(1996-7#5)(1997-1#4)(1997-2#2)(1997-4#8)(1997-6#1)(1997-7#2)(1997-8#1)(2003-11#1)(2005-11#1)(2005-6#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#6)(2008-8#10)(2008-9#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)
to DNA-damaging agents in##2##4##(1992-12#1)(1997-4#1)
to DNA-damaging agents##7##3##(1992-12#3)(1995-8#3)(1997-4#1)
to DNCB##3##2##(1995-12#1)(2008-10#1)(2011-2#1)
to DNR##2##2##(1992-3#1)(1996-3#1)
to DNase I##2##3##(1990-5#1)(1997-6#1)
to DP IV##2##3##(1993-8#2)
to DP##3##2##(1993-8#2)(2008-7#1)
to DR3##2##2##(1995-11#1)(2012-2#1)
to DRE##2##2##(1993-11#1)(2006-12#1)
to DT##2##2##(1993-3#1)(2008-3#1)
to DXA##2##2##(2010-12#1)(2013-8#1)
to Day##3##2##(2006-5#1)(2012-12#2)
to Dec##4##2##(2007-7#1)(2011-1#2)(2012-2#1)
to December 1988##2##3##(1990-9#1)(1991-2#1)
to December 1989##3##3##(1991-6#1)(1992-5#1)(1992-6#1)
to December 1990##4##3##(1992-6#1)(1993-5#1)(1994-1#1)(1995-3#1)
to December 1993##3##3##(1994-11#1)(1995-10#1)(2007-3#1)
to December 1994##2##3##(1996-2#1)(2007-10#1)
to December 1995##3##3##(2006-12#1)(2007-3#1)(2008-4#1)
to December 1997##2##3##(2005-9#1)(2008-2#1)
to December 1998##5##3##(2005-12#1)(2006-4#1)(2007-3#1)(2007-8#1)(2008-5#1)
to December 1999##3##3##(2007-7#1)(2007-8#2)
to December 2000 were##2##4##(2007-7#1)(2010-8#1)
to December 2000##9##3##(2005-7#1)(2005-8#1)(2006-12#1)(2006-2#1)(2007-3#1)(2007-7#3)(2010-8#1)
to December 2001##3##3##(2006-1#1)(2006-2#1)(2007-3#1)
to December 2002##4##3##(2005-8#1)(2006-8#1)(2007-11#1)(2007-8#1)
to December 2003##2##3##(2006-12#1)(2008-8#1)
to December 2004##5##3##(2007-7#1)(2008-3#1)(2008-9#1)(2010-6#1)(2011-2#1)
to December 2005##5##3##(2008-4#2)(2008-8#1)(2009-9#1)(2010-3#1)
to December 2006##4##3##(2008-4#1)(2011-1#1)(2011-2#2)
to December 2007##5##3##(2010-7#1)(2010-8#1)(2011-1#1)(2013-7#1)(2013-8#1)
to December 2008##4##3##(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
to December 2009##3##3##(2011-1#1)(2013-1#1)(2013-8#1)
to December 2010##4##3##(2011-7#1)(2013-1#3)
to December 31##10##3##(1993-9#1)(2006-10#1)(2007-7#1)(2007-8#1)(2009-5#1)(2012-2#1)(2013-1#3)(2013-7#1)
to December##97##2##(1990-8#1)(1990-9#1)(1991-2#1)(1991-6#1)(1992-5#1)(1992-6#2)(1993-5#1)(1993-9#1)(1994-1#1)(1994-11#1)(1995-10#1)(1995-3#2)(1996-2#1)(2005-12#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#1)(2006-12#3)(2006-2#2)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-3#7)(2007-5#1)(2007-7#7)(2007-8#5)(2008-1#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#2)(2008-8#2)(2008-9#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#4)(2011-7#1)(2012-2#1)(2013-1#9)(2013-7#3)(2013-8#2)
to Define##2##2##(2008-11#1)(2010-5#1)
to Delta(7)-PGA(1) methyl ester##2##4##(2008-11#2)
to Detect and Quantify##2##4##(2008-10#2)
to Detect##3##2##(2008-10#2)(2008-12#1)
to Determine the##2##3##(2009-7#1)(2010-2#1)
to Determine##3##2##(2006-4#1)(2009-7#1)(2010-2#1)
to Develop##2##2##(2008-10#1)(2010-2#1)
to Didymella rabiei##2##3##(2008-10#2)
to Different##5##2##(2008-10#2)(2010-12#1)(2010-2#1)(2010-9#1)
to Disease##2##2##(2008-10#1)(2012-1#1)
to DnOP##2##2##(2005-7#2)
to Doppler-broadened##3##2##(2008-2#3)
to Doppler-free##2##2##(2008-3#2)
to Dr##7##2##(1990-2#1)(1994-9#1)(1995-12#1)(1995-5#1)(2006-12#1)(2008-2#1)(2008-7#1)
to Drosophila head membranes##2##4##(1992-9#2)
to Drosophila##5##2##(1992-9#2)(1995-10#1)(1997-7#1)(2009-4#1)
to Drs##2##2##(1994-4#1)(2013-1#1)
to Drugs##3##2##(1992-2#1)(1993-8#1)(2006-12#1)
to DuP##2##2##(1991-5#1)(2005-7#1)
to Dual##2##2##(2007-7#1)(2008-12#1)
to Dy3+##2##2##(1990-11#2)
to E and##2##3##(1995-10#1)(2006-10#1)
to E##45##2##(1990-12#1)(1991-4#1)(1991-7#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-7#3)(1997-6#1)(2006-10#1)(2006-12#1)(2007-3#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-2#1)(2011-1#1)(2011-2#2)(2013-1#1)
to E-cadherin##3##2##(1993-9#2)(2010-12#1)
to E-selectin##2##2##(1992-11#1)(1995-1#1)
to E1 and E3##2##4##(2008-10#2)
to E1 and##3##3##(2008-10#2)(2008-11#1)
to E1##4##2##(1990-3#1)(2008-10#2)(2008-11#1)
to E1A##2##2##(1994-2#1)(1997-4#1)
to E2##6##2##(1990-11#5)(2008-10#1)
to E2F##2##2##(1996-4#1)(2012-2#1)
to E2F-1##3##2##(1993-6#1)(2012-12#2)
to EAE##3##2##(1991-12#2)(2011-2#1)
to EBP and##2##3##(2008-11#1)(2011-12#1)
to EBP##3##2##(2006-12#1)(2008-11#1)(2011-12#1)
to EBV infection##2##3##(1995-2#1)(2008-5#1)
to EBV##6##2##(1994-8#1)(1995-2#1)(2007-2#2)(2008-5#1)(2011-12#1)
to EC##5##2##(1990-2#2)(1994-9#1)(2013-8#2)
to ECII##3##2##(2008-11#3)
to ECM##3##2##(1994-12#1)(1994-2#2)
to EDTA is##2##3##(2006-10#2)
to EDTA##7##2##(1990-3#1)(1991-1#1)(1993-3#1)(2006-10#3)(2013-1#1)
to EEG##2##2##(1996-1#1)(2010-9#1)
to EF-Tu##3##2##(1995-2#2)(1995-5#1)
to EGF receptor##2##3##(1991-2#1)(2006-10#1)
to EGF##15##2##(1990-3#1)(1991-12#3)(1991-2#1)(1992-8#1)(1994-6#3)(1995-2#1)(1996-8#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-5#1)
to EGFR##3##2##(1990-9#2)(2008-5#1)
to EGIR##2##2##(2008-3#1)(2009-6#1)
to EGTA##2##2##(1994-2#1)(2008-8#1)
to EHR##3##2##(2007-12#1)(2013-1#2)
to ELF##2##2##(1991-1#1)(2006-10#1)
to EMF##2##2##(2006-10#1)(2011-2#1)
to EMG##2##2##(1993-9#1)(2011-2#1)
to EMR##3##2##(2008-6#2)(2012-12#1)
to EP##2##2##(2005-11#1)(2008-10#1)
to EPR##2##2##(1996-2#1)(2010-4#1)
to EPS##3##2##(1994-7#1)(2011-2#2)
to ERK1/2##2##2##(2008-4#1)(2012-3#1)
to ESRD##8##2##(1995-1#1)(1996-2#1)(2007-7#2)(2007-8#2)(2008-1#2)
to ET or##2##3##(1992-5#1)(1996-2#1)
to ET##5##2##(1990-2#1)(1992-5#1)(1994-9#1)(1996-2#1)(2008-7#1)
to ET-1 by a##2##4##(1990-10#1)(1990-9#1)
to ET-1 in##2##3##(1991-1#1)(1996-2#1)
to ET-1##22##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-1#2)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-9#1)(1994-12#3)(1994-5#1)(1995-1#3)(1996-2#1)(1997-7#1)(2009-11#2)
to ETAAS##3##2##(2008-10#3)
to Earth##2##2##(2008-3#2)
to Eastern##2##2##(1990-6#1)(2012-3#1)
to Endo H##2##3##(1990-2#1)(1992-3#1)
to England##2##2##(2010-1#1)(2011-1#1)
to English##3##2##(2011-2#3)
to Enhance##2##2##(2009-12#1)(2010-8#1)
to Enneking##2##2##(2007-11#2)
to Enrofloxacin##2##2##(2005-11#1)(2008-12#1)
to Enteric##2##2##(2012-1#1)(2012-12#1)
to Epstein-Barr virus##3##3##(2005-8#1)(2009-1#1)(2011-1#1)
to Ery+##3##2##(1990-5#3)
to Escherichia coli##7##3##(1990-10#1)(1993-11#1)(1994-12#1)(1994-5#1)(1995-1#1)(1996-12#1)(1996-6#1)
to Escherichia##8##2##(1990-10#1)(1993-11#1)(1994-12#1)(1994-5#1)(1995-1#1)(1996-12#1)(1996-6#1)(2006-10#1)
to Estimate the##2##3##(2008-10#1)(2009-10#1)
to Estimate##3##2##(2008-10#1)(2009-10#1)(2010-6#1)
to Eu(2+)##4##2##(2007-12#4)
to Eubacterium##2##2##(2006-8#2)
to Europe##7##2##(1990-4#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-8#2)
to Europe's##2##2##(2007-9#2)
to European##12##2##(1996-9#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-6#1)(2008-9#1)(2010-10#1)(2010-12#1)(2011-2#1)
to Examine the##3##3##(2011-2#1)(2012-12#1)(2012-2#1)
to Examine##4##2##(2008-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
to Exserohilum##3##2##(2007-7#1)(2008-10#2)
to Extract##2##2##(2009-12#1)(2010-5#1)
to F##21##2##(1994-7#1)(1995-6#1)(1997-8#1)(2008-10#17)(2008-4#1)
to F-actin##6##2##(1990-9#1)(1994-12#1)(1994-9#2)(1997-6#2)
to F-ddI##2##2##(1995-3#2)
to F1-ATPase##3##2##(1992-6#1)(1994-9#2)
to FAAS##2##2##(2005-4#1)(2008-10#1)
to FC##2##2##(2009-9#1)(2010-4#1)
to FDH-N##2##2##(1992-6#2)
to FGFR##3##2##(1994-8#2)(2009-7#1)
to FHB was##2##3##(2008-10#2)
to FHB##10##2##(2008-10#8)(2011-10#2)
to FIA##4##2##(2008-10#4)
to FISH##3##2##(2008-4#1)(2008-9#2)
to FLO1##3##2##(1995-4#2)(1995-6#1)
to FM##2##2##(2005-9#1)(2009-7#1)
to FPGA##2##2##(2008-12#1)(2008-2#1)
to FR1064##2##2##(2008-10#2)
to FSH in##2##3##(1996-8#1)(2012-12#1)
to FSH##7##2##(1996-8#5)(2007-11#1)(2012-12#1)
to FSWs##2##2##(2012-3#2)
to FTase inhibitors##2##3##(2005-7#2)
to FTase##3##2##(2005-7#2)(2008-5#1)
to Fabry-Perot##2##2##(2007-12#1)(2008-2#1)
to Facilitate##2##2##(2011-2#1)(2013-1#1)
to Fc receptors##2##3##(1990-12#1)(1993-4#1)
to Fc##4##2##(1990-12#1)(1991-5#1)(1993-4#1)(1994-9#1)
to Fe oxides##2##3##(2008-10#2)
to Fe##3##2##(1996-2#1)(2008-10#2)
to Fe(II) by##2##3##(2008-10#2)
to Fe(II)##11##2##(1995-6#1)(1996-2#1)(2008-10#9)
to Fe(III)##8##2##(2006-8#2)(2008-10#6)
to Fe2+##3##2##(1995-12#1)(2004-9#1)(2010-5#1)
to February 1989##2##3##(1991-2#1)(1991-4#1)
to February 1992##2##3##(2008-2#1)(2008-5#1)
to February 2000 in##2##4##(2008-5#2)
to February 2001##2##3##(2007-7#1)(2010-8#1)
to February 2002##3##3##(2006-2#1)(2007-7#1)(2008-1#1)
to February 2004##3##3##(2007-5#1)(2008-5#1)(2010-8#1)
to February 2009##3##3##(2011-2#2)(2012-3#1)
to February##32##2##(1990-12#1)(1991-2#1)(1991-4#1)(1994-12#1)(1997-4#1)(1997-8#1)(2006-2#1)(2007-2#1)(2007-5#3)(2007-7#2)(2007-8#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-5#5)(2008-7#2)(2010-11#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-7#1)
to Fieldwork Performance scores##2##4##(2013-7#2)
to Florida##2##2##(2008-10#1)(2011-2#1)
to Fourier##2##2##(2007-3#1)(2008-10#1)
to French##3##2##(2008-7#2)(2011-2#1)
to Friday##3##2##(2012-2#1)(2013-1#2)
to FucT-IV##2##2##(1992-8#2)
to Functional##2##2##(2007-9#1)(2008-7#1)
to Fusarium graminearum##3##3##(2008-10#3)
to Fusarium head blight##3##4##(2008-10#3)
to Fusarium oxysporum##2##3##(2008-10#2)
to Fusarium wilt##8##3##(2008-10#8)
to Fusarium##19##2##(2007-6#1)(2008-10#18)
to Fz bone-conducted vibration##2##4##(2011-1#2)
to Fz##3##2##(2011-1#2)(2011-2#1)
to G protein-coupled receptors##3##4##(1991-3#1)(1991-5#1)(1992-12#1)
to G transversion##3##3##(1990-5#1)(1990-6#1)(1996-6#1)
to G##23##2##(1990-12#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#1)(1995-8#1)(1996-6#1)(2005-11#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-6#1)(2011-1#1)(2012-12#2)
to G-actin##2##2##(1993-9#1)(2008-1#1)
to G-proteins##4##2##(1992-6#1)(1995-3#1)(1996-5#2)
to G1##2##2##(1990-10#1)(2009-9#1)
to G418##4##2##(1993-5#1)(1994-5#1)(1995-2#1)(2008-11#1)
to GA##2##2##(2007-8#1)(2008-5#1)
to GABA##6##2##(1994-2#2)(1995-5#1)(1995-6#1)(1995-7#2)
to GABA-ergic neurons##2##3##(1990-5#2)
to GABAA and##2##3##(1991-9#1)(1995-5#1)
to GABAA receptors was##2##4##(1993-12#1)(1994-12#1)
to GABAA receptors##3##3##(1991-9#1)(1993-12#1)(1994-12#1)
to GABAA##7##2##(1991-9#2)(1993-12#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-5#1)
to GATATC sequences##3##3##(1995-8#3)
to GC##6##2##(1996-12#1)(2006-9#1)(2008-10#2)(2008-12#1)(2010-10#1)
to GC-MS analysis##2##3##(1993-12#1)(2005-12#1)
to GC-MS##4##2##(1993-12#1)(2005-12#1)(2008-10#2)
to GC/MS##2##2##(2008-10#2)
to GCC##3##2##(2006-9#1)(2009-12#2)
to GDP##4##2##(1994-12#1)(1995-5#1)(1997-6#1)(2008-1#1)
to GERD##2##2##(2006-2#1)(2010-12#1)
to GFAP-expressing astrocytes##3##3##(2006-10#3)
to GFP##2##2##(1997-6#1)(2008-2#1)
to GH treatment##2##3##(2008-3#1)(2008-4#1)
to GH##14##2##(1993-3#1)(1994-2#1)(1994-9#1)(1995-10#1)(1995-3#1)(1996-8#1)(2006-9#1)(2008-3#3)(2008-4#2)(2010-8#2)
to GHRH##2##2##(1994-3#1)(1994-9#1)
to GHRH+GHRP-6##4##2##(2006-9#4)
to GI##2##2##(1994-11#1)(2013-8#1)
to GIP##2##2##(1994-12#1)(1997-4#1)
to GLAD##3##2##(2011-2#3)
to GM##4##2##(2006-10#1)(2011-2#1)(2013-7#2)
to GM-CSF and##2##3##(1991-6#1)(1992-8#1)
to GM-CSF##5##2##(1991-6#1)(1992-3#1)(1992-8#1)(1995-2#1)(1996-5#1)
to GM1##2##2##(1990-4#1)(2012-3#1)
to GPIb does not##2##4##(1993-3#2)
to GPS1##2##2##(1991-8#2)
to GPs##3##2##(1996-12#1)(1997-1#1)(2007-2#1)
to GRH##2##2##(1992-6#2)
to GSNO##2##2##(1994-5#1)(1997-4#1)
to GTP##8##2##(1991-2#1)(1991-9#1)(1994-12#3)(1995-6#1)(2008-3#1)(2008-4#1)
to GalCer##2##2##(1994-9#2)
to Gemcitabine##2##2##(2013-1#2)
to GenBank##2##2##(1991-8#1)(2008-7#1)
to Genetic Analysis Workshop 17##3##5##(2012-3#3)
to Gerbils##2##2##(2010-11#2)
to German##2##2##(2007-9#1)(2008-2#1)
to Germany##4##2##(2006-6#1)(2008-10#1)(2008-4#1)(2008-6#1)
to Gi##3##2##(1996-5#3)
to Gln##4##2##(1992-3#1)(1992-9#1)(1994-9#1)(2006-10#1)
to Glu##3##2##(1991-8#1)(1995-11#1)(1996-5#1)
to Gly and beta-Ala##2##4##(1995-5#2)
to Gly##3##2##(1992-6#1)(1995-5#2)
to GnRH##7##2##(1993-3#1)(1994-6#1)(1995-10#2)(1995-9#1)(2006-10#1)(2006-5#1)
to Gram##4##2##(2006-8#1)(2007-7#2)(2010-11#1)
to Gram-positive##2##2##(2005-8#1)(2006-8#1)
to Grapevine berry inner necrosis virus##2##6##(2008-10#2)
to Grapevine##3##2##(2008-10#3)
to Graves'##2##2##(1991-8#1)(2012-3#1)
to Grb2 SH2##2##3##(2006-12#2)
to Greece##2##2##(2008-11#1)(2011-2#1)
to GroEL##6##2##(1991-7#1)(1995-4#1)(1995-8#2)(1997-4#2)
to Group 1##5##3##(2007-2#2)(2008-10#1)(2011-2#2)
to Group 2##2##3##(2007-2#1)(2008-10#1)
to Group##11##2##(1995-12#1)(2007-2#3)(2008-10#2)(2010-4#1)(2010-7#1)(2011-2#2)(2013-7#1)
to Growth##2##2##(2006-1#1)(2010-2#1)
to Gs##6##2##(1992-3#1)(1994-6#1)(1995-8#1)(1996-5#3)
to Guignardia bidwellii##2##3##(2008-10#2)
to H antigen##2##3##(1996-3#2)
to H##19##2##(1996-12#1)(1996-3#2)(1996-8#1)(2006-12#2)(2006-2#3)(2006-8#1)(2008-10#2)(2008-5#2)(2009-11#1)(2009-3#2)(2010-5#1)(2011-10#1)
to H(2)O(2)##5##2##(2008-10#2)(2008-2#1)(2008-4#1)(2012-2#1)
to H+##2##2##(1997-7#2)
to H-kininogen with##2##3##(1996-5#2)
to H-kininogen##3##2##(1996-5#3)
to H/R##2##2##(2011-12#2)
to H1N1##2##2##(2012-12#2)
to H2O2##12##2##(1990-3#1)(1994-10#1)(1995-8#1)(1996-5#1)(1997-1#2)(1997-6#3)(2007-8#2)(2010-5#1)
to HA and##2##3##(1993-3#1)(2012-3#1)
to HA##4##2##(1991-10#1)(1993-3#1)(2009-7#1)(2012-3#1)
to HAART##2##2##(2009-2#1)(2009-7#1)
to HBO##4##2##(1993-12#4)
to HBV##7##2##(1991-3#1)(2006-2#1)(2008-10#1)(2009-10#1)(2009-8#1)(2012-12#2)
to HCA##2##2##(1993-3#1)(2013-1#1)
to HCC##3##2##(1991-9#1)(2011-2#1)(2013-1#1)
to HCV##8##2##(1995-10#1)(2006-2#1)(2007-2#2)(2012-2#3)(2013-8#1)
to HCl##3##2##(2008-10#1)(2009-10#2)
to HDL##4##2##(1990-12#1)(1993-11#1)(2011-12#1)(2012-2#1)
to HEL##3##2##(1994-8#1)(1995-2#1)(1996-7#1)
to HER-2/neu##2##2##(1993-11#1)(1993-9#1)
to HG##5##2##(2008-10#1)(2008-7#3)(2012-12#1)
to HGF##2##2##(1991-10#1)(1991-11#1)
to HIPAA##2##2##(2006-10#1)(2006-8#1)
to HIV and##6##3##(1993-1#3)(1996-11#1)(2007-11#1)(2012-3#1)
to HIV by##2##3##(1990-8#1)(2010-12#1)
to HIV care##3##3##(2012-12#3)
to HIV infection##14##3##(1994-6#1)(1996-5#1)(1997-7#1)(2005-10#1)(2006-7#1)(2007-3#1)(2007-7#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-8#1)
to HIV prevention interventions##2##4##(2012-3#2)
to HIV prevention##8##3##(1994-6#1)(2009-3#1)(2009-7#1)(2010-8#1)(2012-3#4)
to HIV treatment##2##3##(2010-12#1)(2011-1#1)
to HIV##61##2##(1990-6#1)(1990-8#1)(1991-11#1)(1991-5#1)(1993-1#3)(1993-7#1)(1994-6#2)(1996-11#4)(1996-12#1)(1996-5#3)(1996-6#1)(1997-5#2)(1997-7#1)(2005-10#1)(2005-6#1)(2006-5#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#3)(2008-12#1)(2008-5#2)(2008-7#2)(2009-3#1)(2009-5#1)(2009-7#2)(2010-1#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#5)(2012-3#5)(2013-8#1)
to HIV-1##13##2##(1990-9#1)(1991-4#1)(1991-6#1)(1992-11#1)(1993-3#2)(1994-11#1)(1994-6#1)(2005-9#1)(2007-11#1)(2009-4#1)(2013-1#2)
to HIV-infected##8##2##(1992-8#1)(1993-1#1)(1996-8#1)(2004-9#2)(2006-6#1)(2007-11#1)(2012-2#1)
to HIV/AIDS##19##2##(1994-4#1)(1995-2#1)(1997-6#2)(2007-12#1)(2007-7#9)(2010-12#1)(2010-8#1)(2012-12#2)(2012-3#1)
to HLA DR##2##3##(1992-12#1)(1997-3#1)
to HLA##7##2##(1991-11#1)(1992-12#1)(1997-3#1)(2007-12#1)(2007-6#1)(2008-4#2)
to HLA-DR##2##2##(1991-2#1)(1991-7#1)
to HMOs##2##2##(1993-3#1)(1995-12#1)
to HNG##2##2##(2012-12#2)
to HOMC##2##2##(1990-11#2)
to HPAIV H5N1##2##3##(2009-7#2)
to HPLC and##2##3##(1993-6#1)(2008-10#1)
to HPLC for##2##3##(1996-6#1)(2011-1#1)
to HPLC##18##2##(1990-8#1)(1991-3#2)(1993-6#1)(1996-5#3)(1996-6#1)(2008-10#9)(2011-1#1)
to HPV##6##2##(1991-2#1)(2007-11#1)(2010-7#2)(2011-2#2)
to HS##2##2##(1991-9#1)(1996-2#1)
to HSA##6##2##(1996-11#1)(2006-12#1)(2007-8#2)(2008-3#1)(2008-7#1)
to HSOs##2##2##(1990-12#2)
to HSV-2##2##2##(1991-9#1)(2007-11#1)
to HU##3##2##(1995-2#2)(2012-3#1)
to Hartmann's procedure##2##3##(2010-8#1)(2011-11#1)
to Hashimoto's##4##2##(1992-7#1)(2011-2#2)(2013-1#1)
to Hawaii##3##2##(1992-2#1)(2007-5#1)(2008-10#1)
to HeLa cells##2##3##(1993-12#1)(1996-2#1)
to HeLa##3##2##(1993-12#1)(1996-2#1)(2010-3#1)
to Health Care##2##3##(1996-3#1)(2008-11#1)
to Health##8##2##(1996-3#1)(2006-10#1)(2008-10#1)(2008-11#3)(2008-5#1)(2012-2#1)
to Helicobacter pylori and##2##4##(1997-1#1)(2006-11#1)
to Helicobacter pylori##6##3##(1997-1#1)(2005-7#1)(2006-11#1)(2006-6#1)(2007-7#1)(2011-2#1)
to Helicobacter##7##2##(1997-1#1)(2005-7#1)(2006-11#1)(2006-6#1)(2007-7#1)(2008-9#1)(2011-2#1)
to Help##3##2##(2007-9#1)(2010-8#2)
to Hg##2##2##(1990-5#1)(2008-10#1)
to Hg(0)##2##2##(2008-10#2)
to Hg(II)##3##2##(2006-12#1)(2008-10#2)
to Hib##3##2##(2006-8#2)(2008-4#1)
to His##2##2##(1991-10#1)(1994-8#1)
to Hispanic##2##2##(2007-12#1)(2008-9#1)
to Hmong##2##2##(2008-12#2)
to Homo sapiens##2##3##(2006-10#1)(2008-1#1)
to Honduras##2##2##(2007-3#1)(2008-1#1)
to Hong Kong##2##3##(1991-10#2)
to Hoogsteen##2##2##(1993-11#2)
to Hospital##2##2##(2008-12#1)(2013-8#1)
to Hotelling's T2 test##2##4##(2012-3#2)
to Human Health##2##3##(2009-4#1)(2012-2#1)
to Human##8##2##(2005-7#2)(2006-12#1)(2009-4#1)(2010-12#1)(2012-2#1)(2013-1#2)
to Hurricane Katrina##2##3##(2007-10#1)(2009-1#1)
to Hurricane##3##2##(2007-10#1)(2009-1#1)(2012-3#1)
to I##6##2##(1991-4#1)(1992-12#1)(2007-11#1)(2008-5#1)(2008-6#2)
to IB-49##3##2##(2008-10#3)
to IBD##3##2##(2006-10#1)(2008-5#2)
to IBV infection##2##3##(1997-6#1)(2008-5#1)
to IBV##6##2##(1997-3#1)(1997-6#2)(2008-5#3)
to IC##2##2##(1993-2#1)(2008-10#1)
to IC-17 was conferred by a single dominant gene##2##9##(2008-10#2)
to IC-17 was##3##3##(2008-10#3)
to IC-17##4##2##(2008-10#4)
to ICAM-1##5##2##(1991-5#1)(1995-2#1)(1995-6#1)(1996-2#1)(2007-11#1)
to ICD-10 and##5##3##(2012-12#1)(2013-1#4)
to ICD-10##8##2##(2006-10#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#4)
to ICD-10-CM##6##2##(2013-1#6)
to ICH##3##2##(2007-10#1)(2008-10#1)(2008-8#1)
to ICI##2##2##(1994-6#1)(1994-8#1)
to ICP-MS##5##2##(2007-8#2)(2008-10#2)(2010-11#1)
to ICU##9##2##(2007-12#1)(2007-8#4)(2007-9#1)(2009-5#1)(2010-12#1)(2012-3#1)
to ICs and##2##3##(2008-8#2)
to ICs##4##2##(2008-8#4)
to IDC##2##2##(2005-10#2)
to IFN##5##2##(1994-8#1)(1995-5#1)(2008-11#2)(2009-8#1)
to IGF-I##13##2##(1991-5#2)(1992-7#2)(1993-6#2)(1994-8#1)(1996-11#2)(1997-1#1)(2006-6#1)(2008-11#2)
to IHDA##2##2##(1992-10#2)
to II##7##2##(1990-5#1)(1991-10#1)(2005-5#1)(2007-9#1)(2008-5#1)(2011-2#2)
to IIA##2##2##(1995-1#1)(2008-3#1)
to III##4##2##(2006-10#1)(2006-8#2)(2008-10#1)
to IL-1 beta-induced anorexia##2##4##(1996-12#2)
to IL-1##7##2##(1990-5#1)(1994-12#1)(1994-2#1)(1996-12#2)(2007-12#1)(2009-9#1)
to IL-10##2##2##(1996-4#1)(2007-11#1)
to IL-12##4##2##(1996-10#3)(2008-11#1)
to IL-13##2##2##(2008-8#2)
to IL-2 and##3##3##(1995-2#1)(1996-9#1)(2008-4#1)
to IL-2##8##2##(1991-10#1)(1992-5#1)(1993-8#1)(1995-2#1)(1996-10#1)(1996-9#1)(2008-4#2)
to IL-3##2##2##(1990-12#1)(2008-4#1)
to IL-4##2##2##(1992-8#1)(2008-4#1)
to IL-6##5##2##(1994-2#1)(1995-12#1)(1996-5#3)
to IL-8##4##2##(1990-5#2)(1994-11#1)(1995-10#1)
to IP##3##2##(1992-7#1)(2008-7#2)
to IP3##5##2##(1990-12#1)(1991-10#1)(1992-1#1)(1995-3#1)(2008-8#1)
to IPO323##2##2##(2008-10#2)
to IPR##3##2##(1995-6#3)
to IPSB##2##2##(1996-1#2)
to IR interference##2##3##(2011-2#2)
to IR##9##2##(2007-11#2)(2007-12#1)(2008-3#1)(2010-12#2)(2011-2#3)
to IREs##2##2##(1995-2#1)(1995-6#1)
to IRP##2##2##(1995-2#2)
to IS##3##2##(1993-12#1)(2012-3#1)(2012-5#1)
to IT##3##2##(2007-9#1)(2008-7#1)(2009-9#1)
to IV with##2##3##(1994-5#1)(2008-5#1)
to IV##5##2##(1990-4#1)(1993-6#1)(1994-5#1)(1995-12#1)(2008-5#1)
to IVF##2##2##(1994-12#1)(2008-11#1)
to Identify##6##2##(2006-9#1)(2008-10#1)(2009-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
to IgE##2##2##(2007-6#1)(2009-9#1)
to IgG##7##2##(1991-11#1)(1992-3#1)(1994-2#1)(1995-2#1)(1996-3#1)(2008-10#1)(2013-1#1)
to IgG-Fc##2##2##(2013-1#2)
to IgG1##2##2##(1994-12#1)(2010-12#1)
to Ile)##2##2##(1992-8#1)(1995-6#1)
to Improve the##2##3##(2010-12#1)(2013-1#1)
to Improve##11##2##(2008-11#1)(2008-2#1)(2009-4#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-11#2)(2012-2#1)(2013-1#1)
to India##2##2##(2008-7#1)(2011-1#1)
to Indian##3##2##(2008-5#1)(2011-1#1)(2011-12#1)
to Indigenous##2##2##(2009-4#1)(2013-1#1)
to Infection##2##2##(2008-10#2)
to International##4##2##(1994-3#1)(2007-2#1)(2008-3#1)(2011-2#1)
to Italian##5##2##(1996-12#1)(2006-8#2)(2011-1#1)(2013-1#1)
to Its##2##2##(2007-9#1)(2008-5#1)
to JNK##2##2##(1995-6#2)
to JP-8##5##2##(2008-4#2)(2008-8#3)
to January 1##2##3##(2008-10#1)(2013-1#1)
to January 2008##2##3##(2011-11#1)(2011-2#1)
to January 2009##4##3##(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
to January 2010##2##3##(2012-12#1)(2013-7#1)
to January##27##2##(1991-8#1)(1992-6#1)(1994-9#1)(2007-10#1)(2007-7#3)(2007-8#1)(2008-10#2)(2008-5#2)(2008-7#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-11#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
to Japanese##6##2##(1996-5#1)(2008-10#1)(2008-12#1)(2009-1#1)(2012-1#1)(2012-12#1)
to Join the##2##3##(2007-8#1)(2011-2#1)
to July 1996##2##3##(2007-2#1)(2008-5#1)
to July 2000##3##3##(2007-7#1)(2008-3#2)
to July 2002##2##3##(2007-8#1)(2008-10#1)
to July 2008##2##3##(2009-8#1)(2013-1#1)
to July 2009##2##3##(2011-3#1)(2012-12#1)
to July##33##2##(1990-2#1)(1991-2#1)(1994-7#1)(2006-10#1)(2007-2#1)(2007-3#1)(2007-5#3)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-6#2)(2013-1#2)
to June 1997##4##3##(2007-11#1)(2007-3#1)(2008-2#1)(2008-3#1)
to June 1999##3##3##(2007-2#2)(2008-5#1)
to June 2001##2##3##(2007-7#1)(2008-6#1)
to June 2002##2##3##(2006-10#1)(2007-2#1)
to June 2003##2##3##(2007-11#1)(2007-4#1)
to June 2004##3##3##(2007-7#1)(2008-3#1)(2009-3#1)
to June 2005##4##3##(2007-8#1)(2008-11#1)(2008-12#1)(2008-8#1)
to June 2007##3##3##(2011-2#2)(2013-7#1)
to June##44##2##(1991-2#1)(1993-12#1)(1994-3#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-7#2)(2013-8#2)
to K##4##2##(1991-7#1)(2009-2#1)(2010-7#2)
to K+ and##2##3##(1990-3#1)(1993-9#1)
to K+##8##2##(1990-11#1)(1990-3#1)(1991-5#1)(1993-2#1)(1993-9#1)(1994-9#1)(2008-4#1)(2008-8#1)
to KB cell line##2##4##(2008-12#2)
to KCl##7##2##(1993-3#2)(1995-12#3)(2008-10#1)(2008-8#1)
to KFSH&amp##3##2##(2007-3#3)
to KLH in the dog##2##5##(2008-10#2)
to KLH##11##2##(2008-10#9)(2008-11#1)(2008-9#1)
to Kaposi sarcoma##2##3##(2010-12#1)(2012-12#1)
to Kell##2##2##(2007-2#1)(2013-1#1)
to Ki##3##2##(1995-1#1)(2008-10#2)
to King##2##2##(2007-3#1)(2007-7#1)
to Kir4##2##2##(2008-8#2)
to Kupffer cells##3##3##(1992-11#2)(2005-7#1)
to Kv1##2##2##(1996-2#1)(1997-4#1)
to L##6##2##(1991-7#1)(2005-8#1)(2005-9#1)(2006-8#1)(2008-10#1)(2010-8#1)
to L-citrulline##5##2##(1991-12#1)(1991-6#3)(1995-11#1)
to L-glutamate##5##2##(1991-9#1)(1996-5#2)(1997-2#2)
to L-lactate##2##2##(1991-1#1)(2007-8#1)
to L-type##2##2##(1994-3#1)(2008-8#1)
to L3##2##2##(1992-9#1)(2008-8#1)
to L35##2##2##(1997-1#2)
to LAD##2##2##(2007-8#2)
to LAK cells##3##3##(1993-11#3)
to LAK##4##2##(1992-2#1)(1993-11#3)
to LD##3##2##(1993-3#1)(2007-5#1)(2008-7#1)
to LDL oxidation during copper-catalyzed oxidative modification and its##2##9##(1991-12#2)
to LDL oxidation during copper-catalyzed oxidative modification##3##7##(1991-12#3)
to LDL receptors##3##3##(1990-4#3)
to LDL##13##2##(1990-4#4)(1991-12#3)(1991-2#2)(1993-4#1)(1994-9#1)(1996-5#1)(2011-12#1)
to LH##2##2##(1993-8#1)(1994-6#1)
to LPL##2##2##(1991-12#1)(1994-2#1)
to LPS##14##2##(1990-11#1)(1993-6#1)(1995-12#1)(1995-2#1)(2003-11#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-8#1)(2008-9#1)(2009-12#1)
to LSD##3##2##(2008-10#3)
to LT##3##2##(1994-2#1)(2011-3#1)(2013-8#1)
to LV##2##2##(1992-8#1)(2009-4#1)
to LY214352##2##2##(1996-7#2)
to Latin##2##2##(1993-6#1)(1997-7#1)
to Latino##2##2##(1997-5#1)(2012-2#1)
to Leaf##3##2##(2008-10#3)
to Lee##3##2##(1993-3#1)(2008-4#2)
to Leishmania major infection##2##4##(2006-10#2)
to Leishmania##5##2##(2006-10#2)(2007-2#1)(2007-3#2)
to Leptosphaeria maculans##6##3##(2008-10#6)
to Leptospira##6##2##(2005-7#2)(2007-8#3)(2011-2#1)
to Leu##5##2##(1991-10#1)(1992-9#1)(1994-11#1)(1995-8#1)(2008-8#1)
to Leu-261)##2##2##(1995-3#2)
to Leydig cells##2##3##(1996-5#2)
to Listeria##3##2##(1994-8#1)(2011-12#1)(2012-2#1)
to London##2##2##(2009-2#1)(2011-1#1)
to Lyme##3##2##(1991-11#1)(1993-3#1)(2007-12#1)
to Lys##4##2##(1990-11#1)(1992-8#1)(1993-12#1)(2008-10#1)
to Lys)##2##2##(1993-4#1)(1996-2#1)
to Lysenkoism##2##2##(2009-2#2)
to M##51##2##(1990-5#1)(1991-9#1)(1992-12#2)(1993-3#1)(2005-7#1)(2007-12#2)(2007-2#1)(2008-10#22)(2008-4#1)(2008-6#2)(2008-7#2)(2008-9#2)(2010-6#1)(2011-10#2)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#2)(2013-7#1)
to M1##3##2##(1990-11#1)(1991-5#1)(2011-2#1)
to MA##3##2##(1990-8#1)(1997-8#2)
to MAGI/CCR5 cells##2##3##(2006-4#2)
to MALDI##2##2##(2007-8#1)(2009-12#1)
to MAP kinase##2##3##(1993-8#1)(1995-3#1)
to MBT##2##2##(2008-10#2)
to MCI##2##2##(2008-5#2)
to MDT##2##2##(2007-7#1)(2009-5#1)
to MG##4##2##(1997-6#1)(2008-5#1)(2013-8#2)
to MHC class II proteins##2##5##(2008-4#2)
to MHC class II##4##4##(1994-11#1)(1996-4#1)(2008-4#2)
to MHC class##5##3##(1994-11#1)(1996-4#1)(2008-11#1)(2008-4#2)
to MHC molecules##2##3##(1995-5#1)(2008-4#1)
to MHC##8##2##(1994-11#1)(1995-5#1)(1996-4#1)(2008-11#1)(2008-4#4)
to MIBG##2##2##(1997-7#2)
to MMV##2##2##(2008-10#2)
to MP##2##2##(1993-9#2)
to MPTP##2##2##(1990-7#2)
to MRI fields##2##3##(1992-3#2)
to MRI##6##2##(1990-5#1)(1992-3#2)(2007-10#1)(2012-2#1)(2013-1#1)
to MRSA##2##2##(2007-8#1)(2011-2#1)
to MS##9##2##(1995-12#1)(1996-5#1)(2005-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-11#1)(2010-12#1)
to MStV##4##2##(2008-10#4)
to MT##7##2##(1993-12#1)(1994-3#1)(1997-2#1)(2008-10#4)
to MTBE##2##2##(2008-12#2)
to MTCT##2##2##(2013-1#2)
to MTX##4##2##(1994-3#1)(1995-7#3)
to Magnaporthe grisea##3##3##(2008-10#3)
to Magnaporthe##4##2##(2008-10#3)(2013-8#1)
to Magoh##2##2##(2012-2#2)
to Major##2##2##(1994-11#1)(2008-10#1)
to Malaria##2##2##(2007-2#1)(2008-12#1)
to Malassezia##2##2##(2007-9#1)(2008-5#1)
to Maori##3##2##(1991-2#1)(2008-1#2)
to March 1999##2##3##(2007-7#1)(2008-5#1)
to March 2001##4##3##(2005-6#1)(2006-1#1)(2007-3#1)(2008-12#1)
to March 2002##2##3##(2007-8#1)(2008-1#1)
to March 2003##4##3##(2007-8#1)(2008-1#1)(2008-12#1)(2008-9#1)
to March 2004##2##3##(2011-1#1)(2013-7#1)
to March 2005##2##3##(2007-7#1)(2010-12#1)
to March 2009##2##3##(2011-1#1)(2011-2#1)
to March 2010##3##3##(2011-2#2)(2013-7#1)
to March##39##2##(1992-8#1)(1993-12#1)(1993-8#1)(1996-5#1)(1996-6#1)(2005-6#1)(2006-1#1)(2006-12#1)(2007-3#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-12#3)(2008-2#1)(2008-5#4)(2008-9#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-3#1)(2013-7#2)(2013-8#3)
to March)##2##2##(2007-3#1)(2008-10#1)
to Marek's disease##2##3##(2013-8#2)
to Marfan syndrome##2##3##(2008-4#1)(2012-3#1)
to Mars##2##2##(2007-9#1)(2012-3#1)
to Martha##2##2##(2006-5#1)(2007-9#1)
to May 1995##2##3##(1996-9#1)(2006-8#1)
to May 2004##3##3##(2007-2#1)(2007-5#1)(2008-8#1)
to May 2006##2##3##(2008-11#1)(2012-2#1)
to May##30##2##(1990-10#1)(1992-6#1)(1996-9#1)(2004-11#1)(2006-8#1)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-6#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-7#3)
to Mb##2##2##(1991-7#2)
to MeOH##2##2##(2008-10#2)
to Measure##2##2##(2007-2#1)(2008-3#1)
to Medicaid##9##2##(1991-3#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-9#2)(1996-1#2)
to Medicare and Medicaid beneficiaries##2##5##(1991-3#1)(1996-2#1)
to Medicare beneficiaries##8##3##(1991-2#1)(1991-3#3)(1992-2#1)(1994-12#1)(1995-12#1)(2010-2#1)
to Medicare##22##2##(1991-2#1)(1991-3#6)(1992-2#2)(1994-1#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-1#2)(1997-3#1)(2006-7#1)(2006-8#1)(2008-11#1)(2010-2#1)
to Medicare's##2##2##(1991-1#1)(1997-2#1)
to Melampsora larici-populina##5##3##(2008-10#5)
to Melampsora medusae##2##3##(2008-10#2)
to Melampsora##7##2##(2008-10#7)
to Member Countries##2##3##(2005-5#2)
to Mexican##3##2##(2008-12#1)(2008-5#1)(2010-2#1)
to Mexico##3##2##(2005-10#1)(2007-3#1)(2008-5#1)
to Mg2+##7##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-2#1)(1994-5#1)(1995-1#1)(1996-7#1)
to Ministry of Health##2##4##(2008-10#1)(2011-12#1)
to Ministry of##3##3##(2008-10#1)(2011-12#1)(2012-12#1)
to Mn(2+)##3##2##(2008-10#1)(2008-7#1)(2011-1#1)
to Modern Healthcare's##2##3##(1991-4#1)(1992-9#1)
to Monitor##3##2##(2008-10#1)(2008-4#1)(2010-7#1)
to Mr##3##2##(1990-3#1)(1991-8#1)(1994-12#1)
to Mycobacterium tuberculosis##4##3##(1993-10#1)(1996-10#1)(1996-11#1)(2010-5#1)
to Mycobacterium##14##2##(1991-11#1)(1993-10#1)(1994-7#1)(1996-10#1)(1996-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-4#1)(2010-5#1)(2010-9#2)(2011-11#1)
to Mycoplasma##3##2##(1992-5#1)(1993-2#1)(2008-5#1)
to Mycosphaerella graminicola in##2##4##(2008-10#1)(2011-10#1)
to Mycosphaerella graminicola##4##3##(2008-10#3)(2011-10#1)
to Mycosphaerella##5##2##(2008-10#4)(2011-10#1)
to Müller##2##2##(1993-8#1)(2008-7#1)
to N##6##2##(1995-3#1)(2006-8#1)(2008-10#3)(2010-10#1)
to N-ethylmaleimide (NEM)##2##3##(1995-10#1)(1996-9#1)
to N-ethylmaleimide##3##2##(1990-7#1)(1995-10#1)(1996-9#1)
to N-methyl-D##2##2##(1993-2#2)
to N-methyl-D-aspartate##4##2##(1990-7#1)(1990-8#1)(1992-8#1)(1995-6#1)
to N-methyl-N'-nitro-N-nitrosoguanidine##3##2##(1991-7#1)(1992-3#1)(1995-9#1)
to N-terminal amino acid##2##4##(1993-3#1)(1994-5#1)
to N-terminal##3##2##(1993-3#1)(1994-5#1)(1995-10#1)
to N-type##3##2##(1994-3#2)(1997-5#1)
to N1-acetylspermidine##2##2##(1995-2#2)
to N2O##4##2##(1992-3#1)(1992-8#1)(1993-1#1)(1997-7#1)
to NA##3##2##(2008-10#1)(2008-8#2)
to NAD+##2##2##(1990-8#1)(1997-8#1)
to NADH was##2##3##(1993-12#1)(2008-10#1)
to NADH##6##2##(1990-3#1)(1991-8#1)(1992-6#1)(1993-12#1)(2007-11#1)(2008-10#1)
to NADPH##3##2##(1991-2#2)(2012-2#1)
to NASA's##2##2##(2007-9#2)
to NC##2##2##(1994-2#1)(2010-2#1)
to NCDs##4##2##(2012-12#2)(2013-8#2)
to NDV##2##2##(2005-9#1)(2008-5#1)
to NE##2##2##(2008-3#1)(2008-4#1)
to NEM##2##2##(1995-8#2)
to NF-kappa B##3##3##(1991-7#1)(1992-12#1)(1995-3#1)
to NGF and##2##3##(1995-3#1)(1996-5#1)
to NGF or to LNGFR##2##5##(1994-3#2)
to NGF##20##2##(1991-12#1)(1991-7#2)(1994-2#2)(1994-3#3)(1995-12#1)(1995-3#1)(1996-1#1)(1996-5#4)(1997-2#1)(1997-5#1)(1997-6#2)(2008-11#1)
to NH##3##2##(2006-7#2)(2008-2#1)
to NH(3)##2##2##(2008-10#2)
to NH4+##2##2##(1997-1#1)(2008-8#1)
to NH4Cl##2##2##(1992-6#2)
to NI##3##2##(2004-10#1)(2013-1#2)
to NK cell##2##3##(1996-10#1)(2013-1#1)
to NL-3 K##3##3##(2008-10#3)
to NMDA in##3##3##(1992-8#1)(1995-6#1)(1996-5#1)
to NMDA##18##2##(1991-2#1)(1991-6#1)(1992-1#1)(1992-6#1)(1992-7#3)(1992-8#2)(1993-2#1)(1994-10#1)(1995-12#1)(1995-6#2)(1996-5#3)(2008-7#1)
to NO by##2##3##(1992-6#2)
to NO in##2##3##(1997-2#1)(1997-7#1)
to NO##13##2##(1992-3#1)(1992-6#2)(1993-6#1)(1994-5#1)(1996-2#1)(1997-2#2)(1997-7#1)(2006-2#1)(2008-10#2)(2008-7#1)
to NO+ causes##2##3##(2008-5#2)
to NO2##3##2##(1992-9#2)(1993-9#1)
to NP##2##2##(1994-3#1)(2009-9#1)
to NPR-C##3##2##(1995-3#3)
to NPR-GC##5##2##(1995-3#5)
to NPY##2##2##(1995-12#1)(2008-1#1)
to NUV and H2O2##2##4##(1990-5#2)
to Na(+)##2##2##(2008-8#1)(2010-5#1)
to Na+##2##2##(1991-2#1)(1991-8#1)
to NaCl 7##2##3##(1996-9#2)
to NaCl and##4##3##(1990-9#1)(1996-8#1)(2009-10#1)(2013-1#1)
to NaCl##8##2##(1990-9#1)(1996-8#1)(1996-9#2)(2008-10#2)(2009-10#1)(2013-1#1)
to Nafion-coated##2##2##(2008-10#2)
to National Institute of##2##4##(2008-3#1)(2008-7#1)
to National##3##2##(2008-3#1)(2008-7#1)(2011-9#1)
to Nd##2##2##(2008-2#1)(2008-3#1)
to Neer's##2##2##(1993-8#1)(2007-8#1)
to NeutrAvidin##3##2##(2008-10#3)
to New York##2##3##(1996-5#1)(2009-5#1)
to New Zealand##5##3##(2007-12#1)(2007-2#1)(2008-8#3)
to New##13##2##(1996-5#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-8#3)(2009-12#1)(2009-5#1)(2012-1#1)(2012-11#1)
to Newcastle disease##2##3##(1997-6#1)(2008-5#1)
to Ni(2+)##2##2##(2013-1#2)
to Ni3S2##2##2##(1994-5#1)(1995-3#1)
to North America in the##2##5##(2006-7#1)(2008-8#1)
to North America##6##3##(1992-9#1)(2006-7#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-2#1)
to North##8##2##(1992-9#1)(2006-7#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-2#1)(2011-2#1)
to Northern##4##2##(1992-2#1)(2007-2#1)(2008-7#2)
to Norway##3##2##(1993-9#1)(1997-6#1)(2008-10#1)
to Norwegian##7##2##(1990-8#1)(1991-2#1)(1993-2#1)(1995-5#1)(1997-8#3)
to November 1997##2##3##(2006-4#1)(2007-3#1)
to November 1999 in##2##4##(2005-8#1)(2007-7#1)
to November 1999##3##3##(2005-8#1)(2007-7#1)(2008-10#1)
to November 2000##2##3##(2007-2#1)(2007-7#1)
to November##26##2##(1992-10#1)(1993-5#1)(1996-12#1)(1996-3#1)(2005-10#1)(2005-8#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#2)(2008-10#1)(2008-2#2)(2008-5#2)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
to Nursing##4##2##(2011-2#1)(2012-12#1)(2013-1#2)
to O##3##2##(1996-3#1)(1996-7#2)
to O(2)##4##2##(2006-8#1)(2008-10#1)(2008-3#1)(2010-5#1)
to O(3)##3##2##(2008-3#1)(2008-5#2)
to O-3 of##2##3##(1991-9#1)(1995-11#1)
to OA##2##2##(1992-3#1)(1994-11#1)
to OCD##3##2##(1997-4#1)(2007-6#1)(2009-4#1)
to OH##3##2##(2007-11#1)(2008-3#2)
to OKT3##2##2##(2007-11#2)
to ONOO(-)##2##2##(2008-7#2)
to OP pesticides##3##3##(1997-3#1)(2010-5#2)
to OP##6##2##(1997-3#1)(2009-6#1)(2010-5#2)(2013-8#2)
to OTA is##2##3##(2009-3#1)(2011-2#1)
to OVA##4##2##(2005-10#2)(2008-11#1)(2009-9#1)
to OXY##2##2##(2008-4#2)
to October 1999##3##3##(2005-10#1)(2005-12#1)(2008-10#1)
to October 2003##2##3##(2008-10#1)(2008-12#1)
to October 2006##2##3##(2008-7#1)(2013-7#1)
to October 2011##5##3##(2012-12#3)(2013-1#1)(2013-8#1)
to October 2012)##3##3##(2013-8#3)
to October##32##2##(1991-12#1)(1991-6#1)(1993-5#1)(1996-1#1)(2005-10#1)(2005-12#1)(2007-11#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#3)(2013-1#2)(2013-7#1)(2013-8#5)
to October)##2##2##(2008-12#1)(2012-2#1)
to Ohio##2##2##(1992-9#1)(1993-8#1)
to Open##2##2##(2007-11#1)(2012-2#1)
to Other##2##2##(2008-10#2)
to Overcome##3##2##(2007-9#1)(2010-2#1)(2011-12#1)
to P##67##2##(1991-5#1)(1993-11#1)(1993-2#1)(1995-10#1)(2006-8#1)(2007-8#1)(2008-10#45)(2008-4#1)(2008-5#3)(2008-8#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
to P-glycoprotein##3##2##(1990-12#1)(1997-1#1)(2008-11#1)
to P1##2##2##(1994-5#2)
to P2##3##2##(2005-4#1)(2008-4#2)
to P450 2C3v##2##3##(1994-9#2)
to P450##4##2##(1994-6#1)(1994-9#2)(1995-1#1)
to PACAP##3##2##(1990-11#2)(1995-11#1)
to PACAP38##3##2##(1990-7#1)(1994-10#2)
to PAEC##3##2##(2008-8#3)
to PAH##2##2##(1995-1#2)
to PAI-1##2##2##(1990-9#1)(1996-5#1)
to PAP##2##2##(1997-6#2)
to PBL##2##2##(1995-12#1)(2011-1#1)
to PC##2##2##(1992-9#1)(2013-1#1)
to PC12 cells##3##3##(1993-6#1)(2008-11#1)(2008-4#1)
to PCD##3##2##(1991-12#1)(2009-10#1)(2011-1#1)
to PCL##3##2##(2010-12#2)(2010-4#1)
to PCNA##2##2##(1994-8#1)(2008-4#1)
to PCR amplification of##2##4##(2007-8#1)(2008-10#1)
to PCR amplification##3##3##(1996-12#1)(2007-8#1)(2008-10#1)
to PCR##8##2##(1996-12#1)(1996-8#1)(2007-8#1)(2008-10#3)(2012-2#1)(2013-1#1)
to PD##7##2##(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-7#2)
to PDE alpha beta##2##4##(1992-6#2)
to PDE##3##2##(1992-6#2)(2007-10#1)
to PDGF receptor##2##3##(1996-6#2)
to PDGF##3##2##(1991-7#1)(1996-6#2)
to PDT##3##2##(2008-5#1)(2010-10#1)(2012-3#1)
to PE##2##2##(2008-1#1)(2010-6#1)
to PEG molecular weight##2##4##(2004-12#2)
to PEG##4##2##(2004-12#3)(2008-7#1)
to PEP##2##2##(1995-5#2)
to PET##2##2##(1995-8#1)(2012-12#1)
to PG##2##2##(1996-7#1)(1997-1#1)
to PGP##2##2##(1994-8#1)(2008-3#1)
to PHA##3##2##(1990-10#1)(2007-2#1)(2011-2#1)
to PHC##2##2##(2010-11#2)
to PI 3-kinase##2##3##(1992-10#1)(1994-3#1)
to PI##3##2##(1992-10#1)(1994-3#1)(2008-9#1)
to PILO##2##2##(1997-5#2)
to PIP(3)##2##2##(2008-11#2)
to PIP2##7##2##(1990-3#1)(1992-12#4)(1993-8#1)(2008-8#1)
to PKC activation##2##3##(1994-2#1)(1997-7#1)
to PKC##5##2##(1990-12#1)(1994-2#1)(1994-6#1)(1996-9#1)(1997-7#1)
to PLS##2##2##(2008-10#1)(2010-4#1)
to PM10##3##2##(2010-9#3)
to PMA##4##2##(1990-5#1)(1993-6#1)(1994-8#1)(1997-1#1)
to PMD##3##2##(2007-12#2)(2008-3#1)
to POAG##2##2##(2011-12#2)
to PP1##3##2##(1990-12#2)(2012-12#1)
to PPARalpha and PPARgamma##2##4##(1997-4#1)(2008-1#1)
to PPARalpha and##3##3##(1997-4#1)(2008-1#1)(2008-5#1)
to PPARgamma##4##2##(1997-4#1)(2008-5#3)
to PPD##5##2##(2006-12#1)(2006-8#1)(2007-2#1)(2008-5#1)(2012-3#1)
to PPI##2##2##(2013-1#2)
to PR##2##2##(1991-3#1)(2013-1#1)
to PRLR##2##2##(1997-6#2)
to PS##4##2##(2004-9#1)(2008-5#1)(2009-2#1)(2011-1#1)
to PSA##3##2##(2008-12#1)(2009-6#1)(2012-12#1)
to PSII##2##2##(1994-8#1)(2008-8#1)
to PSV subgroup##2##3##(2008-10#2)
to PSV##3##2##(2008-10#3)
to PSV-W##2##2##(2008-10#2)
to PT##2##2##(1995-5#1)(2010-7#1)
to PTCA##2##2##(2006-8#1)(2007-8#1)
to PTH##4##2##(1990-11#2)(1997-7#1)(2012-3#1)
to PTSD##3##2##(2005-10#1)(2008-6#1)(2011-1#1)
to PTZ##3##2##(1991-11#3)
to PUVA##3##2##(1994-5#2)(2007-7#1)
to PUVASOL##2##2##(2007-7#1)(2007-8#1)
to PVC plates##3##3##(1992-7#3)
to PVC ratio##2##3##(2008-10#2)
to PVC##6##2##(1992-7#3)(2008-10#3)
to PVY##2##2##(2008-10#2)
to Paget's disease##2##3##(2008-6#1)(2010-3#1)
to Pakistan##3##2##(1992-10#1)(2008-12#1)(2012-2#1)
to Parkinson's##2##2##(2008-11#1)(2008-7#1)
to Part II##2##3##(1994-10#1)(2009-2#1)
to Part##5##2##(1994-10#4)(2009-2#1)
to Patients With##2##3##(2008-5#1)(2008-6#1)
to Patients##3##2##(2008-12#1)(2008-5#1)(2008-6#1)
to Pb##2##2##(1993-7#1)(2011-1#1)
to Pb(2+) in##2##3##(2008-10#2)
to Pb(2+)##3##2##(2008-10#3)
to Pb(II)##5##2##(2005-11#4)(2008-10#1)
to Pb2+ and Cu2+##2##4##(2008-7#2)
to PbB##2##2##(1992-4#1)(1996-3#1)
to Pd(2 +)##2##3##(2008-10#2)
to Penicillin##2##2##(2005-11#1)(2011-2#1)
to Penicillium##2##2##(2007-7#1)(2008-10#1)
to Pepper##2##2##(2008-10#2)
to Phe##2##2##(1992-9#1)(1996-5#1)
to Philippine##2##2##(2008-10#2)
to Physical##4##2##(2006-10#1)(2010-3#1)(2011-2#1)(2012-3#1)
to Phytophthora root rot##2##4##(2008-10#2)
to Phytophthora##7##2##(2008-10#6)(2012-11#1)
to Plasmodium falciparum##2##3##(2008-11#1)(2012-12#1)
to Plasmodium##3##2##(2008-11#1)(2008-4#1)(2012-12#1)
to Pluto##2##2##(2007-9#2)
to Polish##2##2##(2012-12#1)(2012-3#1)
to Porphyrio##2##2##(1997-4#2)
to Postharvest##2##2##(2008-10#2)
to Powdery Mildew##2##3##(2008-10#2)
to Predict##8##2##(2007-11#1)(2009-11#1)(2012-1#1)(2012-12#1)(2013-1#3)(2013-8#1)
to Prevent##2##2##(2007-2#1)(2008-1#1)
to Produce##5##2##(2007-9#1)(2008-10#2)(2009-10#1)(2009-4#1)
to Prof##2##2##(2007-8#1)(2008-10#1)
to Professor##5##2##(1990-8#1)(2008-10#1)(2008-5#2)(2012-3#1)
to Progress##6##2##(2009-4#6)
to Prosopis juliflora##3##3##(2007-2#3)
to Prosopis##4##2##(2007-2#4)
to Protect##3##2##(2007-9#1)(2008-10#2)
to Pseudomonas exotoxin##2##3##(1991-10#1)(1997-7#1)
to Pseudomonas syringae pv##2##4##(2008-10#1)(2009-6#1)
to Pseudomonas syringae##3##3##(2008-10#2)(2009-6#1)
to Pseudomonas##13##2##(1991-10#1)(1997-7#1)(2007-12#2)(2008-10#4)(2009-6#1)(2010-11#1)(2010-2#1)(2010-9#1)(2013-1#1)
to Ptr ToxA in##2##4##(2008-10#2)
to Ptr ToxA##8##3##(2008-10#8)
to Ptr ToxB##2##3##(2008-10#2)
to Ptr##11##2##(2008-10#11)
to Puccinia hordei and##2##4##(2008-10#2)
to Puccinia hordei##3##3##(2008-10#3)
to Puccinia sorghi##2##3##(2008-10#2)
to Puccinia##7##2##(2008-10#7)
to Put##2##2##(1990-8#1)(2011-2#1)
to Pyrenophora tritici-repentis Race##2##4##(2008-10#2)
to Pythium##4##2##(2008-10#4)
to QA##3##2##(1991-1#1)(1992-12#1)(1993-3#1)
to Quantify##3##2##(2008-10#3)
to R##17##2##(1994-12#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-5#3)
to R1881##2##2##(1990-11#2)
to RA and##2##3##(1995-10#1)(2012-3#1)
to RA##13##2##(1992-1#1)(1994-8#4)(1995-10#1)(1997-7#1)(2006-12#1)(2008-1#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-3#1)
to RC##2##2##(2008-10#1)(2011-1#1)
to RD##2##2##(1993-9#1)(2010-12#1)
to RH##4##2##(2008-10#3)(2008-2#1)
to RIA##2##2##(1992-7#1)(2008-7#1)
to RNA and##2##3##(2006-12#1)(2010-1#1)
to RNA from##3##3##(1991-9#1)(1994-11#1)(2008-10#1)
to RNA silencing##2##3##(2008-10#2)
to RNA##21##2##(1990-11#1)(1991-4#1)(1991-9#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-8#1)(1997-3#2)(2006-12#2)(2008-10#3)(2008-4#2)(2009-3#1)(2010-1#1)(2013-1#1)
to RNase A##3##3##(1992-11#2)(1994-8#1)
to RNase##8##2##(1990-5#1)(1990-7#1)(1991-4#1)(1992-11#2)(1994-8#1)(1996-5#1)(2009-3#1)
to ROS membranes##2##3##(1990-2#2)
to ROS##4##2##(1990-2#2)(1994-6#1)(2011-1#1)
to RP-HPLC##2##2##(1996-5#1)(2008-10#1)
to RT##3##2##(2009-11#1)(2013-1#2)
to RT1##2##2##(1995-2#1)(2009-9#1)
to RTSV##2##2##(2008-10#2)
to RU##2##2##(1993-7#1)(1993-9#1)
to Radiation##2##2##(1995-2#1)(2008-6#1)
to Ras##3##2##(1995-1#1)(1995-3#1)(1996-8#1)
to Reduce the##3##3##(1996-3#1)(2010-1#1)(2010-7#1)
to Reduce##6##2##(1996-3#1)(2008-4#1)(2010-1#1)(2010-7#1)(2012-3#1)(2013-1#1)
to Regulate##3##2##(2008-10#1)(2012-12#2)
to Resistance##3##2##(2008-10#3)
to Rh and Ir##2##4##(2010-5#2)
to Rh##4##2##(1992-12#1)(2009-10#1)(2010-5#2)
to Rhizoctonia root rot##2##4##(2008-10#2)
to Rhizoctonia##4##2##(2008-10#4)
to Riboflavin Binding Protein##2##4##(2009-4#2)
to Rio##3##2##(1992-5#1)(2007-5#1)(2013-7#1)
to Ro##2##2##(1991-8#1)(2006-10#1)
to Rpc1##2##2##(2008-10#2)
to Rwanda##2##2##(1994-9#1)(2008-3#1)
to S phase##4##3##(1994-2#1)(1994-5#1)(1995-2#1)(1996-7#1)
to S transition##4##3##(1994-12#1)(1995-3#1)(1996-2#1)(2008-11#1)
to S##59##2##(1990-11#2)(1990-9#2)(1992-9#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-2#1)(1996-7#1)(1997-7#2)(2005-8#1)(2005-9#8)(2006-10#1)(2006-9#1)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#2)(2009-12#1)(2009-3#1)(2010-5#1)(2011-2#3)(2012-3#1)
to S-1##5##2##(2006-8#1)(2008-1#4)
to S-naproxen##4##2##(1994-3#4)
to S1##5##2##(1993-3#1)(1994-5#1)(1995-6#1)(1997-4#1)(1997-6#1)
to SA##6##2##(1993-6#1)(2008-10#4)(2009-8#1)
to SACI##2##2##(2008-11#2)
to SAH##3##2##(2007-10#1)(2008-7#1)(2012-2#1)
to SAM##3##2##(1996-9#2)(2011-2#1)
to SC##3##2##(1991-6#1)(2008-5#2)
to SCMV##2##2##(2008-10#2)
to SDS##3##2##(2005-11#3)
to SDS-PAGE##8##2##(1992-7#1)(1992-8#1)(1994-3#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)
to SEM##2##2##(2008-11#1)(2013-1#1)
to SFE##2##2##(2008-10#2)
to SH##2##2##(1994-9#1)(2008-5#1)
to SHC##2##2##(1995-3#2)
to SHR##3##2##(2006-8#2)(2011-1#1)
to SI##2##2##(1994-10#1)(2012-2#1)
to SLE##3##2##(2007-8#1)(2010-12#2)
to SLea##3##2##(1991-12#3)
to SLex##2##2##(1991-12#2)
to SMV##2##2##(2008-10#2)
to SNAP-25##3##2##(1995-12#2)(1996-9#1)
to SNP##3##2##(2009-7#1)(2012-3#1)(2013-1#1)
to SO##2##2##(1992-5#1)(1996-9#1)
to SOD1 mutations##2##3##(1996-10#2)
to SP##6##2##(1991-8#1)(1993-12#1)(1995-12#1)(1997-3#1)(1997-4#1)(2008-11#1)
to SRBC##8##2##(1991-12#4)(2004-12#1)(2005-9#1)(2008-10#2)
to SRBCs##3##2##(1993-12#2)(2008-6#1)
to SRH##3##2##(2011-2#2)(2012-3#1)
to SRP RNA is##3##4##(1992-6#2)(1996-5#1)
to SRP##4##2##(1992-6#2)(1996-5#1)(2012-3#1)
to SS##5##2##(2004-9#1)(2008-6#2)(2012-1#1)(2013-8#1)
to SSRI##2##2##(2008-6#1)(2009-6#1)
to ST##2##2##(2006-6#1)(2010-12#1)
to STAT1##2##2##(1996-5#2)
to STB in##3##3##(2008-10#3)
to STB##10##2##(2008-10#10)
to STDs##2##2##(1996-12#1)(2011-2#1)
to Saccharomyces cerevisiae##4##3##(1993-4#1)(1993-9#1)(1996-6#1)(2008-2#1)
to Saha and##2##3##(2008-8#1)(2008-9#1)
to Salmonella infection##2##3##(2011-2#1)(2012-2#1)
to Salmonella typhimurium##4##3##(1993-4#1)(2008-10#1)(2009-5#2)
to Salmonella##18##2##(1990-3#1)(1993-4#1)(1996-2#1)(2005-7#1)(2006-10#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-4#1)(2009-5#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)
to Sb(3+)##2##2##(2008-10#2)
to Sb(III)##4##2##(2008-10#4)
to SbDV##7##2##(2008-10#2)(2012-11#5)
to Schistosoma##3##2##(1996-12#2)(2006-10#1)
to Schwann cells##3##3##(1991-9#2)(1995-2#1)
to Schwann##4##2##(1991-9#2)(1995-2#1)(2008-7#1)
to Sclerotinia sclerotiorum##3##3##(2008-10#3)
to Sclerotinia trifoliorum##7##3##(2008-10#7)
to Sclerotinia##10##2##(2008-10#10)
to Sclerotium rolfsii in##3##4##(2008-10#3)
to Sclerotium rolfsii##6##3##(2008-10#6)
to Se##4##2##(2008-10#1)(2008-11#1)(2010-5#1)(2012-2#1)
to Se(IV)##9##2##(2008-10#9)
to Sepharose 4B##2##3##(1993-12#1)(2011-2#1)
to Sepharose##12##2##(1990-3#2)(1991-8#1)(1992-12#1)(1993-12#1)(2008-1#1)(2008-4#5)(2011-2#1)
to September 1995##2##3##(2007-3#1)(2008-4#1)
to September 2009##2##3##(2012-2#1)(2013-8#1)
to September in##2##3##(1996-12#1)(2008-12#1)
to September##25##2##(1993-10#1)(1994-3#1)(1996-12#1)(1997-6#1)(2006-8#1)(2007-3#3)(2007-5#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2009-2#1)(2011-1#1)(2012-2#3)(2013-7#1)(2013-8#3)
to Septoria tritici blotch##4##4##(2008-10#4)
to Septoria tritici##5##3##(2008-10#5)
to Septoria##9##2##(2008-10#9)
to Ser##6##2##(1991-2#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1997-7#1)
to Sertoli cells##2##3##(1993-2#1)(2006-5#1)
to Shack-Hartmann##2##2##(2007-11#1)(2008-3#1)
to SilicoSec##2##2##(2008-12#2)
to Sitisi##2##2##(2008-1#2)
to SnTox1##2##2##(2008-10#2)
to Somali refugee women##2##4##(2007-9#2)
to Sorghum##2##2##(2008-10#2)
to South America##2##3##(2009-2#1)(2013-8#1)
to South##7##2##(2005-9#1)(2008-10#1)(2009-2#1)(2010-1#1)(2011-2#1)(2013-8#2)
to Southern##4##2##(1994-11#1)(1997-7#1)(2007-8#1)(2008-10#1)
to Soybean##2##2##(2008-10#1)(2012-11#1)
to SpA##2##2##(1992-7#1)(2013-1#1)
to Spain##2##2##(1993-8#1)(2009-10#1)
to Spodoptera frugiperda 21##2##4##(2008-11#2)
to Sprague-Dawley (SD) rats##2##4##(1993-3#1)(1996-12#1)
to Staphylococcus aureus##6##3##(2005-9#1)(2006-10#1)(2006-8#1)(2007-8#2)(2008-12#1)
to State##2##2##(1991-10#1)(1997-1#1)
to States##2##2##(1991-2#1)(1994-3#1)
to Stewart's##3##2##(2008-10#3)
to Streptococcus##3##2##(1990-8#1)(2007-7#1)(2013-8#1)
to Streptomyces##2##2##(1993-11#1)(2012-2#1)
to Study##4##2##(2008-10#2)(2009-10#1)(2009-7#1)
to Substance##2##2##(2010-2#1)(2013-1#1)
to Success##2##2##(2007-9#1)(2009-4#1)
to Sunnaas Rehabilitation Hospital##2##4##(1991-4#1)(1995-9#1)
to Support##6##2##(2010-8#1)(2012-1#1)(2013-1#4)
to T and B##2##4##(1997-3#1)(2012-1#1)
to T and##3##3##(1997-3#1)(2008-10#1)(2012-1#1)
to T cell##8##3##(1991-12#1)(1994-12#2)(1996-8#1)(2007-12#1)(2008-1#1)(2008-9#1)(2012-3#1)
to T cells##10##3##(1991-11#1)(1991-12#1)(1996-10#2)(1996-7#1)(2006-6#1)(2008-4#3)(2008-9#1)
to T lymphocytes##3##3##(1991-1#1)(1992-12#1)(2005-12#1)
to T##51##2##(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#3)(1992-1#1)(1992-12#1)(1993-3#1)(1994-12#2)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-10#2)(1996-2#1)(1996-6#3)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-12#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-12#2)(2008-4#3)(2008-5#1)(2008-9#2)(2011-1#1)(2011-12#1)(2012-1#1)(2012-3#1)
to T-cell##4##2##(1994-3#1)(1995-6#1)(2009-9#1)(2010-7#1)
to T-toxin##2##2##(2008-10#2)
to T1##5##2##(1991-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2009-3#1)
to T1D##2##2##(2010-5#1)(2013-8#1)
to T2##4##2##(2006-9#1)(2008-12#1)(2009-3#1)(2012-12#1)
to T2D##2##2##(2009-3#1)(2012-12#1)
to T2DM##2##2##(2008-1#1)(2011-1#1)
to T3##4##2##(1994-12#1)(1996-5#1)(2007-8#1)(2008-10#1)
to T4##5##2##(1991-9#1)(1994-9#1)(2007-2#1)(2007-8#2)
to T60 for##2##3##(2013-8#2)
to TA##2##2##(1997-8#1)(2008-3#1)
to TAM##2##2##(1993-7#1)(1995-1#1)
to TB##4##2##(1995-9#1)(1996-3#1)(2013-1#1)(2013-7#1)
to TCA##2##2##(1994-11#1)(2007-8#1)
to TCDD##3##2##(1992-11#1)(2008-10#2)
to TCE##3##2##(2007-4#1)(2008-10#2)
to TCR##4##2##(1992-5#1)(2007-7#1)(2008-11#1)(2008-4#1)
to TD##4##2##(1997-3#1)(2007-8#1)(2010-12#1)(2012-1#1)
to TF##4##2##(1991-3#1)(1994-11#1)(1995-6#1)(2008-5#1)
to TGF beta##3##3##(1992-8#2)(1995-12#1)
to TGF-beta 1 in##2##4##(1992-3#1)(1994-8#1)
to TGF-beta 1##4##3##(1990-5#1)(1990-8#1)(1992-3#1)(1994-8#1)
to TGF-beta##8##2##(1990-5#1)(1990-8#1)(1992-3#1)(1994-8#1)(1995-2#1)(1995-3#3)
to TGF-beta1##2##2##(1996-5#2)
to THA##3##2##(1992-3#3)
to THC##2##2##(1991-10#1)(1997-8#1)
to THP##2##2##(1996-12#1)(2009-7#1)
to TI arcuate neurones##2##4##(1992-8#2)
to TKI##2##2##(2010-4#1)(2012-1#1)
to TMA##3##2##(1997-2#1)(2008-10#2)
to TMAO##2##2##(1997-7#1)(2008-10#1)
to TMV##2##2##(2008-10#2)
to TNA##2##2##(2006-12#2)
to TNDR selection##2##3##(2008-10#2)
to TNF alpha##4##3##(1994-6#1)(1995-2#2)(1995-3#1)
to TNF cytotoxicity##4##3##(1990-9#1)(1992-7#2)(1995-3#1)
to TNF in##3##3##(1992-9#1)(1997-7#1)(2011-2#1)
to TNF##18##2##(1990-9#2)(1992-7#2)(1992-9#1)(1993-12#1)(1994-10#1)(1994-2#1)(1994-6#1)(1995-2#2)(1995-3#2)(1997-7#1)(2006-6#2)(2011-2#2)
to TNF-alpha##2##2##(1995-3#1)(2008-11#1)
to TNM classification##2##3##(1990-10#1)(2011-2#1)
to TPA in##2##3##(1991-8#1)(1993-7#1)
to TPA##14##2##(1990-10#1)(1990-4#1)(1991-7#2)(1991-8#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-6#1)(1994-9#1)(1995-5#1)(1995-7#1)(1996-5#1)
to TPO1 and##2##3##(1995-12#2)
to TQM##2##2##(1996-2#1)(2009-6#1)
to TRAIL##3##2##(2009-9#2)(2012-2#1)
to TRAIL-induced apoptosis##2##3##(2009-9#2)
to TRH was##2##3##(1994-2#1)(2008-5#1)
to TRH##8##2##(1991-10#1)(1991-6#1)(1993-2#1)(1994-2#1)(1996-11#2)(2005-8#1)(2008-5#1)
to TS##4##2##(1992-12#1)(1996-5#2)(2009-3#1)
to TSH##5##2##(1990-12#1)(1991-8#1)(1992-12#1)(1993-3#1)(2008-4#1)
to TSP##2##2##(1991-6#1)(1993-6#1)
to TSWV infection##2##3##(2008-10#2)
to TSWV##5##2##(2008-10#5)
to TT##3##2##(1994-5#1)(2006-2#1)(2010-12#1)
to TXA2##2##2##(1990-12#2)
to TYLCV##4##2##(2008-10#4)
to TYP children around##2##4##(2009-10#2)
to TZM##2##2##(2012-12#2)
to Takayasu's arteritis##2##3##(1997-8#2)
to Tamm-Horsfall protein in patients##2##5##(1996-12#2)
to Tamm-Horsfall protein##4##3##(1996-12#4)
to Tapesia yallundae##2##3##(2008-10#2)
to Tb3+##3##2##(1995-5#2)(2005-4#1)
to Tehran##4##2##(2007-2#2)(2008-12#1)(2011-2#1)
to Test##3##2##(2008-10#1)(2012-12#2)
to Texas##2##2##(2009-6#1)(2012-1#1)
to Th##2##2##(1991-12#1)(2008-5#1)
to Th1##3##2##(2007-11#1)(2007-9#1)(2011-1#1)
to Th2##5##2##(2008-10#1)(2008-11#1)(2008-9#2)(2011-1#1)
to Thailand##2##2##(1997-4#1)(2012-2#1)
to Thatcher##2##2##(2008-10#2)
to The##5##2##(1993-11#1)(2006-5#1)(2008-9#1)(2012-12#1)(2013-7#1)
to Therapy##2##2##(1993-11#1)(2008-11#1)
to Thr##3##2##(1993-3#1)(1994-8#1)(2008-8#1)
to Ti##3##2##(2004-9#1)(2005-11#1)(2013-8#1)
to Tilletia##2##2##(2008-10#2)
to Time##2##2##(2008-10#1)(2008-12#1)
to TnC##2##2##(1995-5#2)
to Tomato bushy stunt virus (TBSV)##2##6##(2008-10#2)
to Tomato yellow leaf curl virus (TYLCV)##3##7##(2008-10#3)
to Tomato##7##2##(2008-10#7)
to Total##3##2##(1995-1#1)(2013-1#2)
to Treat##2##2##(2004-3#1)(2013-1#1)
to Treatment##4##2##(2007-11#1)(2008-5#1)(2009-9#2)
to Triton##2##2##(1990-7#1)(2011-1#1)
to Trp##4##2##(1993-11#1)(1993-4#1)(1993-9#1)(1994-9#1)
to Two##2##2##(2008-10#2)
to Type 1 diabetes##2##4##(2008-1#1)(2010-9#1)
to Type##3##2##(1990-9#1)(2008-1#1)(2010-9#1)
to Tyr##4##2##(1990-10#1)(1994-11#1)(1996-11#1)(2008-10#1)
to U##10##2##(1991-4#1)(1993-12#1)(1993-3#1)(1993-6#1)(1996-3#1)(2005-10#1)(2006-4#1)(2008-10#1)(2009-6#1)(2011-2#1)
to U-II##2##2##(2009-11#2)
to UK from##2##3##(2007-2#1)(2011-1#1)
to UK##5##2##(2005-8#2)(2007-2#1)(2011-1#1)(2012-12#1)
to UPLC##2##2##(2008-10#1)(2011-1#1)
to US and European##2##4##(2005-7#1)(2009-2#1)
to US##6##2##(1993-5#1)(1997-2#1)(2005-7#1)(2005-8#1)(2008-8#1)(2009-2#1)
to USEPA##2##2##(2008-10#2)
to UV irradiation##2##3##(1992-2#1)(2007-8#1)
to UV light##14##3##(1991-7#1)(1992-2#1)(1994-6#2)(1997-2#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#2)(2012-1#2)
to UV radiation##9##3##(1993-3#2)(1996-11#1)(1997-4#1)(2008-1#1)(2008-2#1)(2008-5#2)(2010-12#1)
to UV##36##2##(1991-3#1)(1991-7#1)(1992-2#3)(1993-3#2)(1993-8#1)(1994-6#2)(1995-8#1)(1996-11#1)(1997-2#1)(1997-3#1)(1997-4#1)(2004-4#1)(2007-12#2)(2007-8#3)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#5)(2010-12#1)(2011-2#1)(2012-1#2)
to UV-C treatment##2##3##(2008-10#1)(2009-10#1)
to UV-C##5##2##(1995-12#1)(2008-10#1)(2008-12#1)(2009-10#2)
to UVA radiation##2##3##(1994-3#1)(2009-6#1)
to UVA##4##2##(1994-3#1)(2007-7#1)(2008-5#1)(2009-6#1)
to UVB damage##2##3##(2008-5#2)
to UVB radiation##3##3##(1996-6#1)(2008-5#1)(2011-2#1)
to UVB##9##2##(1996-6#1)(2007-7#1)(2008-5#6)(2011-2#1)
to Uncover##2##2##(2008-10#1)(2008-11#1)
to Understand##2##2##(2008-4#1)(2008-7#1)
to United##2##2##(1992-1#1)(1993-6#1)
to University##2##2##(2005-6#1)(2008-12#1)
to Use##2##2##(1996-9#1)(2007-2#1)
to V##16##2##(2006-12#1)(2008-10#11)(2008-5#2)(2009-8#1)(2011-2#1)
to V3##4##2##(1994-9#2)(1995-5#1)(2006-9#1)
to V8##2##2##(2005-11#1)(2008-10#1)
to VCG##4##2##(2008-10#4)
to VCR##2##2##(1992-11#1)(2012-2#1)
to VEGF##3##2##(1995-3#1)(2010-12#2)
to VI##6##2##(1990-5#1)(1993-8#1)(1994-2#2)(1994-5#1)(1996-7#1)
to VIP##6##2##(1990-11#1)(1994-8#1)(1995-11#3)(1995-6#1)
to VLDL was##2##3##(1993-11#1)(1993-6#1)
to VLDL##7##2##(1990-8#1)(1993-11#2)(1993-6#3)(1996-4#1)
to VN##2##2##(1991-6#1)(2008-5#1)
to VO(2+)##2##2##(2008-10#1)(2008-3#1)
to VOCs##5##2##(1992-4#2)(2007-10#1)(2008-10#2)
to VPA##2##2##(2008-7#1)(2011-1#1)
to VSMC##2##2##(1991-12#1)(2008-8#1)
to VTA via##2##3##(2009-2#2)
to VZV##3##2##(2007-2#1)(2008-5#2)
to Val##3##2##(1992-2#1)(1992-8#1)(1994-11#1)
to Verticillium wilt##3##3##(2008-10#3)
to Verticillium##5##2##(2008-10#5)
to Vibrio cholerae##2##3##(2005-11#1)(2008-1#1)
to Vibrio fluvialis##2##3##(2007-10#1)(2009-12#1)
to Vibrio##5##2##(2005-11#1)(2006-8#1)(2007-10#1)(2008-1#1)(2009-12#1)
to Vickers##2##2##(2008-12#1)(2009-7#1)
to Vitamin##2##2##(2005-7#1)(2008-10#1)
to W##4##2##(2007-2#1)(2008-10#3)
to WHO and##2##3##(1996-11#1)(2006-4#1)
to WHO##10##2##(1990-10#1)(1991-9#1)(1996-11#1)(2006-10#1)(2006-4#1)(2007-2#1)(2007-8#2)(2011-2#1)(2013-8#1)
to WNV##2##2##(2010-8#1)(2013-8#1)
to WSMoV##2##2##(2008-10#2)
to WT##5##2##(2008-8#2)(2010-2#1)(2012-3#1)(2013-1#1)
to Walking-in-Place##2##2##(2012-2#2)
to Water##2##2##(2008-10#2)
to Watermelon mosaic virus##2##4##(2008-10#2)
to Watermelon silver mottle virus##2##5##(2008-10#2)
to Watermelon##4##2##(2008-10#4)
to Western##6##2##(1992-4#1)(1994-5#1)(2007-2#1)(2007-7#1)(2009-6#1)(2012-2#1)
to Wheat##2##2##(2008-10#2)
to White##5##2##(2004-12#1)(2008-11#1)(2009-9#1)(2011-2#2)
to William##2##2##(1996-6#1)(2012-2#1)
to Work##2##2##(2007-9#1)(2009-12#1)
to World Health Organization (WHO)##4##5##(2008-10#1)(2010-10#1)(2011-12#1)(2012-12#1)
to World Health##5##3##(2005-10#1)(2008-10#1)(2010-10#1)(2011-12#1)(2012-12#1)
to World##6##2##(2005-10#1)(2008-10#1)(2010-10#1)(2011-12#1)(2012-12#1)(2012-2#1)
to X##11##2##(1993-6#1)(1996-6#1)(2006-3#1)(2007-12#1)(2008-10#7)
to X-ray##6##2##(1991-7#1)(2005-11#1)(2008-10#1)(2008-5#1)(2010-8#1)(2012-12#1)
to X-rays##2##2##(1993-4#1)(2013-1#1)
to XRE1##2##2##(1997-2#2)
to Xa21 and##2##3##(2008-10#2)
to Xa21##6##2##(2008-10#6)
to Xanthomonas campestris pv##4##4##(2008-10#4)
to Xanthomonas##5##2##(2008-10#5)
to Xp22##2##2##(1992-10#1)(1996-3#1)
to Xq28##2##2##(1993-6#1)(2012-3#1)
to Y##2##2##(1996-7#1)(1997-2#1)
to Y-branch##2##2##(2008-3#2)
to ZP##3##2##(2013-1#3)
to Zn##2##2##(2008-2#1)(2008-5#1)
to [(TPP)Ru(NO)(py)](+)##2##2##(1996-2#2)
to [D-Arg2]hGRF(1-29)NH2##2##2##(1990-2#2)
to a &quot##15##3##(1991-2#1)(1991-7#1)(1993-9#1)(1994-12#1)(1995-3#1)(1997-8#1)(2006-9#1)(2007-10#1)(2007-4#2)(2008-10#1)(2008-11#1)(2008-4#1)(2010-7#1)(2011-2#1)
to a 0##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2013-8#1)
to a 1##9##3##(1990-5#1)(1992-6#1)(1993-7#1)(1993-9#1)(1994-9#1)(1995-3#1)(1997-4#1)(2008-10#1)(2011-2#1)
to a 1%##3##3##(2008-3#2)(2009-10#1)
to a 10##4##3##(1996-2#1)(1997-5#1)(2006-12#1)(2008-10#1)
to a 10%##3##3##(1997-3#1)(2004-11#1)(2008-10#1)
to a 100##3##3##(1994-5#1)(1994-6#1)(2009-8#1)
to a 12##3##3##(1991-7#1)(2007-6#1)(2011-12#1)
to a 15##3##3##(1994-2#1)(2008-10#1)(2008-11#1)
to a 2 x##2##4##(1996-12#1)(2008-3#1)
to a 2##8##3##(1994-9#1)(1995-6#1)(1996-12#1)(2007-11#1)(2008-11#1)(2008-3#2)(2013-7#1)
to a 20##2##3##(1997-2#1)(2008-11#1)
to a 20%##2##3##(1996-3#1)(2011-2#1)
to a 200-fold##2##3##(1992-6#1)(1992-9#1)
to a 3##5##3##(1990-9#1)(1995-6#1)(2008-10#2)(2010-3#1)
to a 3-fold##2##3##(1991-12#1)(1995-8#1)
to a 30%##2##3##(2008-6#1)(2010-6#1)
to a 38##2##3##(1997-2#1)(2007-11#1)
to a 4##2##3##(2008-3#1)(2009-10#1)
to a 5##5##3##(1991-9#1)(1993-3#1)(1996-1#1)(2008-10#1)(2010-5#1)
to a 500##2##3##(1994-12#1)(2012-2#1)
to a 500-fold##2##3##(2008-1#1)(2008-2#1)
to a 6##5##3##(1990-12#2)(1990-9#1)(2006-8#2)
to a 6-fold##2##3##(1995-11#1)(1995-2#1)
to a 60##2##3##(1992-11#1)(1996-12#1)
to a CAT##2##3##(1994-3#1)(1997-7#1)
to a DNA##3##3##(1990-8#1)(1992-8#1)(2008-2#1)
to a Gaussian-like##2##3##(2008-2#1)(2011-1#1)
to a German##2##3##(2008-12#1)(2010-4#1)
to a Gly##2##3##(1994-12#1)(1997-3#1)
to a Pyrenophora##2##3##(2008-10#2)
to a T cell##2##4##(1990-12#1)(1993-4#1)
to a T##3##3##(1990-12#1)(1993-4#1)(2009-9#1)
to a TATA box##3##4##(1990-6#1)(1991-12#2)
to a TATA##4##3##(1990-6#1)(1991-12#2)(1992-2#1)
to a Ti##2##3##(2004-9#1)(2007-11#1)
to a UK regional infectious diseases unit##2##7##(2007-2#2)
to a Unix system##2##4##(2008-4#2)
to a bacterial##2##3##(2005-8#1)(2009-8#1)
to a basal level##2##4##(1992-9#1)(1993-11#1)
to a basic##4##3##(1991-2#1)(2008-10#2)(2009-8#1)
to a belief##2##3##(1996-12#1)(2009-6#1)
to a better prognosis##2##4##(1993-1#1)(2006-2#1)
to a better understanding of how##2##6##(2006-10#1)(2008-7#1)
to a better understanding of the##13##6##(1990-12#1)(1993-12#1)(1997-3#1)(2005-7#1)(2005-8#1)(2007-8#1)(2008-10#3)(2008-5#2)(2009-12#1)(2010-3#1)
to a better understanding of##24##5##(1990-12#1)(1991-7#1)(1993-12#1)(1997-3#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-12#1)(2010-3#1)(2011-1#1)
to a better understanding##25##4##(1990-12#1)(1991-7#1)(1993-12#1)(1997-3#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-12#1)(2010-3#1)(2011-1#1)
to a better##41##3##(1990-12#1)(1991-7#1)(1993-1#1)(1993-12#1)(1993-2#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-7#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#2)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-3#1)(2011-1#1)(2011-2#2)
to a bilayer##2##3##(2005-11#1)(2010-4#1)
to a biological##6##3##(1996-6#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-1#1)
to a bioreactor##2##3##(2004-8#1)(2008-11#1)
to a biotinylated##3##3##(2008-10#2)(2009-12#1)
to a black##2##3##(1993-5#1)(2007-11#1)
to a blind##2##3##(1990-5#1)(1992-11#1)
to a block##3##3##(1991-11#1)(2006-6#1)(2012-12#1)
to a blood##2##3##(1997-7#1)(2008-9#1)
to a body##3##3##(2008-11#1)(2009-8#1)(2011-12#1)
to a brain##2##3##(1992-1#1)(2009-11#1)
to a brief##3##3##(1991-5#1)(1997-8#1)(2008-1#1)
to a broad range of##14##5##(2005-5#1)(2006-4#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-8#1)(2010-9#1)(2011-1#1)(2011-2#2)
to a broad range##15##4##(2005-4#1)(2005-5#1)(2006-4#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-8#1)(2010-9#1)(2011-1#1)(2011-2#2)
to a broad spectrum of##4##5##(2006-10#1)(2006-5#1)(2008-10#1)(2008-11#1)
to a broad##23##3##(2005-4#1)(2005-5#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#4)(2008-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)
to a broader population##2##4##(2007-11#1)(2008-11#1)
to a broader##3##3##(1992-7#1)(2007-11#1)(2008-11#1)
to a buffer##2##3##(1996-9#1)(2008-10#1)
to a calibration##2##3##(2008-10#1)(2008-3#1)
to a candidate##2##3##(1992-3#1)(1995-2#1)
to a capillary##2##3##(1997-2#1)(2008-10#1)
to a carbohydrate##2##3##(1992-9#1)(2010-1#1)
to a carbon##2##3##(1994-5#1)(1995-8#1)
to a carboxylic##2##3##(1995-5#1)(2008-10#1)
to a carrier##6##3##(1992-8#1)(1995-5#1)(1997-3#1)(2008-2#1)(2008-4#2)
to a case##3##3##(1995-5#1)(2008-9#1)(2011-1#1)
to a catalytic##3##3##(1991-6#1)(1994-12#1)(1996-5#1)
to a cell##4##3##(1994-8#1)(2008-11#2)(2009-5#1)
to a center##3##3##(1997-3#1)(2007-7#1)(2012-11#1)
to a central##10##3##(1991-3#1)(1994-2#1)(1996-8#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-5#1)
to a centre##2##3##(1993-5#1)(2007-4#1)
to a certain degree##3##4##(1990-11#1)(1991-3#1)(2008-12#1)
to a certain extent by##2##5##(2008-3#1)(2011-1#1)
to a certain extent##14##4##(1994-11#1)(1996-6#1)(2007-7#2)(2007-9#1)(2008-3#1)(2008-8#1)(2009-9#2)(2011-1#2)(2012-11#1)(2012-12#1)(2013-8#1)
to a certain type##2##4##(1994-2#1)(2012-12#1)
to a certain##34##3##(1990-11#1)(1991-3#1)(1994-11#1)(1994-2#1)(1996-5#1)(1996-6#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-7#2)(2007-9#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-6#1)(2009-9#2)(2010-9#1)(2011-1#2)(2012-11#1)(2012-12#2)(2012-2#1)(2013-8#1)
to a certified reference##2##4##(2008-10#2)
to a chain##2##3##(1995-2#1)(1997-7#1)
to a change in the##10##5##(1990-8#2)(1992-3#1)(1993-8#1)(1995-9#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2012-12#1)
to a change in##21##4##(1990-11#1)(1990-8#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-8#1)(1995-9#1)(2005-11#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-8#1)(2009-6#1)(2011-2#2)(2012-12#1)
to a change of the##3##5##(2008-10#1)(2008-11#1)(2008-2#1)
to a change##25##3##(1990-11#1)(1990-8#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-8#1)(1995-9#1)(2005-11#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#2)(2012-12#1)
to a changing environment##2##4##(1996-3#1)(2008-7#1)
to a changing##4##3##(1992-11#1)(1996-3#1)(2007-12#1)(2008-7#1)
to a charge of##2##4##(1991-9#1)(2009-12#1)
to a chemical##6##3##(2006-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2013-1#1)
to a child with##2##4##(2007-3#1)(2010-9#1)
to a chiral##2##3##(1992-5#1)(1996-5#1)
to a chiropractic clinic##3##4##(2007-11#1)(2007-6#2)
to a chromosomal##2##3##(1995-3#1)(2008-6#1)
to a chronic disease##2##4##(2009-4#1)(2010-7#1)
to a chronic##10##3##(1994-5#1)(2007-8#2)(2008-12#1)(2009-4#1)(2010-12#1)(2010-7#1)(2010-8#1)(2013-1#2)
to a circumscribed area##2##4##(1990-4#1)(1994-8#1)
to a class of##6##4##(1993-3#1)(1993-4#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-2#1)
to a class##9##3##(1993-3#1)(1993-4#1)(1994-11#1)(1995-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-2#1)
to a classical##2##3##(1990-10#1)(1995-4#1)
to a clear##6##3##(1995-1#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-6#1)(2010-2#1)
to a clinical population of##2##5##(2010-2#1)(2011-12#1)
to a clinical##10##3##(1990-10#1)(1990-12#1)(1992-12#1)(1995-3#1)(2006-12#1)(2008-7#1)(2010-2#1)(2011-12#1)(2012-2#1)(2012-3#1)
to a clinically##2##3##(2007-7#1)(2012-3#1)
to a close##3##3##(1992-7#1)(1995-3#1)(2008-5#1)
to a closed##2##3##(1996-3#1)(2008-10#1)
to a cluster of##3##4##(1990-7#1)(2005-6#1)(2008-10#1)
to a coherent##2##3##(2007-12#1)(2009-5#1)
to a cold environment##2##4##(1992-6#1)(2006-10#1)
to a cold##3##3##(1992-6#1)(2006-10#1)(2007-8#1)
to a collection of##2##4##(2008-6#1)(2009-5#1)
to a colourless##2##3##(1993-12#1)(2008-10#1)
to a combination of a##3##5##(1995-11#1)(2008-10#1)(2008-11#1)
to a combination of##24##4##(1991-7#1)(1994-11#1)(1995-11#1)(1995-9#2)(2005-11#1)(2005-12#1)(2005-9#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2010-1#1)(2010-2#1)(2013-1#1)
to a combination##25##3##(1991-7#1)(1994-11#1)(1995-11#1)(1995-9#2)(2005-11#1)(2005-12#1)(2005-9#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2010-1#1)(2010-2#1)(2013-1#1)
to a combined##3##3##(1995-8#1)(1997-6#1)(2008-1#1)
to a comment##2##3##(2007-12#1)(2010-6#1)
to a commercial##3##3##(1990-3#1)(2008-10#1)(2009-11#1)
to a common##24##3##(1991-4#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#2)(1995-7#1)(1997-8#1)(2005-10#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#2)
to a commonly used##2##4##(2007-8#1)(2011-2#1)
to a community##4##3##(2007-2#1)(2010-5#1)(2012-1#2)
to a community-based##2##3##(1993-12#1)(2010-9#1)
to a comparable##2##3##(1990-10#1)(2008-6#1)
to a compensatory increase in##2##5##(1995-1#1)(2006-10#1)
to a compensatory##5##3##(1993-9#1)(1995-1#1)(2006-10#1)(2008-3#1)(2009-3#1)
to a complete##15##3##(1990-10#1)(1990-11#1)(1991-2#1)(1991-6#1)(1991-7#1)(1997-4#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)
to a complex##8##3##(1990-12#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-8#1)(2008-10#1)(2009-3#1)(2012-3#1)
to a comprehensive##5##3##(1994-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-11#1)
to a computer##4##3##(1993-6#1)(2007-12#1)(2008-10#1)(2008-7#1)
to a concentration of 3##3##5##(1990-5#1)(2008-11#1)(2011-1#1)
to a concentration of##14##4##(1990-5#1)(1991-5#1)(2006-3#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#1)
to a concentration##23##3##(1990-10#2)(1990-5#1)(1991-5#1)(1991-6#1)(1994-5#1)(1997-5#1)(2006-3#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-7#2)(2011-1#1)(2011-2#1)
to a concentration-dependent increase in##2##5##(1990-4#1)(2008-10#1)
to a concentration-dependent##3##3##(1990-4#2)(2008-10#1)
to a conclusion##3##3##(2007-10#1)(2012-1#1)(2013-8#1)
to a condition##7##3##(1993-10#1)(1996-2#1)(2008-2#1)(2008-4#1)(2008-8#1)(2013-1#2)
to a congenital##2##3##(1995-1#1)(1997-3#1)
to a consensus##4##3##(1993-3#1)(1994-12#1)(1996-11#1)(1996-4#1)
to a conservative strategy##2##4##(2007-8#1)(2008-3#1)
to a conservative##5##3##(1996-2#1)(2007-8#3)(2008-3#1)
to a conserved##2##3##(1992-12#1)(2011-2#1)
to a considerable extent##2##4##(1990-5#1)(1990-8#1)
to a considerable##9##3##(1990-5#1)(1990-8#1)(1991-5#1)(1996-1#1)(1996-10#1)(2005-8#1)(2006-10#1)(2008-2#1)(2010-3#1)
to a constant##3##3##(1991-9#1)(2006-7#1)(2009-7#1)
to a continuous##3##3##(2008-10#1)(2008-2#1)(2010-2#1)
to a control group of##3##5##(2007-8#1)(2012-3#1)(2013-8#1)
to a control group##16##4##(1990-5#1)(1993-7#1)(1996-10#1)(2005-8#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-6#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
to a control or normative sample##2##6##(2008-4#2)
to a control##24##3##(1990-5#1)(1992-12#1)(1993-7#1)(1996-10#1)(1996-12#2)(2005-8#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
to a controlled##3##3##(1996-1#1)(2008-10#2)
to a conventional##15##3##(1991-6#1)(1995-3#1)(1996-2#1)(1996-8#1)(2006-4#1)(2007-12#1)(2007-2#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-7#1)
to a converging##2##3##(2008-2#2)
to a core##2##3##(1996-11#1)(2008-3#1)
to a correlation between##3##4##(2008-10#1)(2008-7#1)(2009-10#1)
to a corresponding##6##3##(1997-7#1)(2008-5#1)(2009-10#1)(2011-2#3)
to a course of##2##4##(2011-2#1)(2012-11#1)
to a course##3##3##(2010-3#1)(2011-2#1)(2012-11#1)
to a critical care##2##4##(2008-3#1)(2012-2#1)
to a critical##9##3##(1990-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-1#1)(2012-12#2)(2012-2#2)
to a crystallographic R-factor of##6##5##(1992-4#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-8#1)(1997-4#1)
to a crystallographic##7##3##(1991-4#1)(1992-4#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-8#1)(1997-4#1)
to a culture of##3##4##(1990-11#1)(2011-2#2)
to a culture##5##3##(1990-11#1)(1996-7#1)(2007-11#1)(2011-2#2)
to a cyclic##2##3##(2007-12#1)(2009-4#1)
to a cysteine##2##3##(1990-12#1)(2008-4#1)
to a cytokine##2##3##(1996-10#1)(2010-7#1)
to a cytoplasmic##2##3##(1994-5#1)(1996-10#1)
to a data set of##2##5##(1997-2#2)
to a data set##5##4##(1994-8#1)(1997-2#2)(1997-4#1)(2008-10#1)
to a data##8##3##(1994-8#1)(1997-2#2)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
to a dataset##2##3##(2010-8#1)(2013-8#1)
to a decline in the number of##2##7##(1990-12#1)(1992-12#1)
to a decline in the##3##5##(1990-12#1)(1992-12#1)(2004-4#1)
to a decline in##4##4##(1990-12#1)(1992-12#1)(2004-4#1)(2008-7#1)
to a decline##5##3##(1990-12#1)(1992-12#1)(2004-4#1)(2008-7#1)(2012-2#1)
to a decrease in insulin##2##5##(1992-8#1)(1994-3#1)
to a decrease in protein##2##5##(1996-5#1)(2011-2#1)
to a decrease in the percentage of##2##7##(1991-5#1)(2006-2#1)
to a decrease in the##26##5##(1990-5#1)(1991-5#2)(1992-8#1)(1993-11#1)(1993-4#1)(1993-8#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-5#1)(1997-2#1)(2005-11#2)(2006-2#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#2)(2009-2#1)(2010-4#1)(2013-1#1)
to a decrease in##57##4##(1990-5#2)(1990-6#1)(1990-7#1)(1991-5#2)(1992-8#2)(1993-11#1)(1993-4#2)(1993-8#1)(1994-11#1)(1994-3#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-7#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-3#1)(2005-11#2)(2005-7#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2009-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
to a decrease of the##5##5##(1993-12#1)(1995-5#1)(1997-1#1)(2009-8#1)(2010-5#1)
to a decrease of##13##4##(1990-8#1)(1993-12#1)(1995-5#1)(1996-1#1)(1997-1#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-5#1)(2013-7#1)
to a decrease##71##3##(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-5#2)(1992-8#2)(1993-11#1)(1993-12#1)(1993-4#2)(1993-8#1)(1994-11#1)(1994-3#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-11#2)(2005-7#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#3)(2013-7#2)(2013-8#1)
to a decreased##10##3##(1990-11#1)(1990-7#1)(1990-8#1)(1994-5#1)(1995-12#1)(1996-5#1)(2008-10#1)(2008-11#1)(2010-2#1)(2013-1#1)
to a deeper##2##3##(1997-1#1)(2008-3#1)
to a defect in##4##4##(1997-6#1)(2007-7#1)(2008-5#1)(2008-9#1)
to a defect##6##3##(1997-6#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-9#1)(2013-1#1)
to a defective##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
to a deficiency in the##3##5##(1993-3#1)(2013-1#2)
to a deficiency in##8##4##(1993-3#1)(1994-11#1)(2013-1#6)
to a deficiency of##6##4##(1990-8#1)(1995-1#1)(1997-1#1)(2007-11#1)(2009-5#1)(2011-2#1)
to a deficiency##14##3##(1990-8#1)(1993-3#1)(1994-11#1)(1995-1#1)(1997-1#1)(2007-11#1)(2009-5#1)(2011-2#1)(2013-1#6)
to a defined##4##3##(1990-8#1)(2006-12#1)(2008-10#2)
to a definition of the##2##5##(1996-9#1)(2008-10#1)
to a degree comparable to##2##5##(1995-3#1)(2008-9#1)
to a degree##4##3##(1995-3#1)(2007-7#1)(2008-3#1)(2008-9#1)
to a delay in the##3##5##(2006-10#1)(2006-5#1)(2010-7#1)
to a delay in##8##4##(2006-10#1)(2006-5#1)(2007-10#1)(2007-6#1)(2008-3#1)(2009-12#1)(2009-5#1)(2010-7#1)
to a delay of##2##4##(1991-3#1)(2007-12#1)
to a delay##10##3##(1991-3#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-3#1)(2009-12#1)(2009-5#1)(2010-7#1)
to a delayed##2##3##(1997-3#1)(2010-4#1)
to a deletion##2##3##(1993-12#1)(2009-5#1)
to a dense##2##3##(2005-8#1)(2011-1#1)
to a density of##3##4##(1994-8#1)(2008-11#1)(2012-11#1)
to a density##4##3##(1994-8#1)(2007-3#1)(2008-11#1)(2012-11#1)
to a depletion of##2##4##(1996-8#1)(2007-10#1)
to a depth of##5##4##(2006-10#1)(2007-12#1)(2008-10#2)(2013-7#1)
to a desired##8##3##(2007-11#2)(2007-5#1)(2008-2#3)(2008-3#1)(2012-2#1)
to a detailed study##2##4##(1991-12#1)(2008-2#1)
to a detailed##6##3##(1991-12#1)(2006-4#1)(2006-8#2)(2008-2#1)(2008-9#1)
to a detection limit of##2##5##(1990-12#1)(2007-12#1)
to a detection limit##3##4##(1990-12#1)(2007-12#1)(2008-2#1)
to a detector##3##3##(2008-10#1)(2008-2#1)(2012-1#1)
to a developmental##2##3##(1991-5#1)(2009-8#1)
to a diagnosis of##5##4##(2009-3#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#1)
to a diagnosis##6##3##(1990-3#1)(2009-3#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#1)
to a diagnostic##4##3##(1995-4#1)(2005-8#1)(2006-10#1)(2006-8#1)
to a diameter of##7##4##(1990-8#1)(1991-2#1)(2007-11#1)(2007-12#1)(2008-3#1)(2010-12#1)(2012-12#1)
to a difference between the##2##5##(1991-7#1)(2008-3#1)
to a difference between##4##4##(1991-7#1)(1995-10#1)(2008-3#1)(2010-2#1)
to a difference in the##3##5##(1992-7#1)(2006-8#1)(2007-12#1)
to a difference in##6##4##(1992-7#1)(1994-5#1)(1995-6#1)(2006-8#1)(2007-12#1)(2008-10#1)
to a difference##11##3##(1991-7#1)(1992-7#1)(1994-5#1)(1995-10#1)(1995-6#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-2#1)(2012-12#1)
to a different degree##2##4##(1994-10#1)(2007-1#1)
to a different extent##2##4##(1994-2#1)(2008-10#1)
to a different stimulus##2##4##(1994-3#1)(1995-11#1)
to a different##26##3##(1991-2#1)(1992-2#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-9#1)(1996-5#1)(1996-6#1)(2007-1#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
to a differential##4##3##(1992-11#1)(1995-5#1)(1997-4#1)(2008-7#1)
to a direct action##2##4##(1991-6#1)(1992-6#1)
to a direct##12##3##(1990-5#2)(1991-3#1)(1991-6#1)(1992-6#1)(1996-9#1)(2005-8#1)(2008-10#3)(2008-11#1)(2009-7#1)
to a discipline##2##3##(2008-10#1)(2013-8#1)
to a discourse##2##3##(2008-11#1)(2013-8#1)
to a discrete##3##3##(1994-10#1)(1996-1#1)(2008-10#1)
to a discussion of##3##4##(2005-10#1)(2005-8#1)(2008-1#1)
to a disease##5##3##(1997-5#1)(2008-10#2)(2008-4#1)(2011-2#1)
to a disruption of##2##4##(1996-2#1)(2008-5#1)
to a distance of##2##4##(1993-4#1)(2008-10#1)
to a distinct##8##3##(1990-5#1)(1994-9#1)(1997-4#1)(1997-7#1)(2008-10#2)(2008-7#1)(2011-1#1)
to a distribution##3##3##(2007-8#1)(2008-3#1)(2009-11#1)
to a disturbance of##2##4##(1994-3#1)(2007-10#1)
to a disulfide##2##3##(1992-12#1)(1992-7#1)
to a diverse array of##2##5##(2011-9#1)(2012-2#1)
to a diverse##7##3##(1990-4#1)(1997-3#1)(2007-12#1)(2008-6#1)(2009-6#1)(2011-9#1)(2012-2#1)
to a doctor##3##3##(1997-2#1)(2009-5#2)
to a dopamine##2##3##(1997-5#2)
to a dose of##3##4##(1997-3#1)(2008-6#1)(2009-11#1)
to a dose##4##3##(1997-3#1)(2008-10#1)(2008-6#1)(2009-11#1)
to a double##5##3##(1991-6#1)(1993-8#1)(1994-9#1)(2005-11#1)(2006-10#1)
to a down-regulation of##2##4##(1990-4#1)(1994-5#1)
to a dramatic##7##3##(1990-5#1)(1994-6#1)(1995-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(2006-4#1)
to a drastic##3##3##(1992-8#1)(1994-12#1)(2008-5#1)
to a duration of##2##4##(2007-12#1)(2008-2#1)
to a dynamic##4##3##(2008-10#1)(2008-3#1)(2008-4#1)(2012-2#1)
to a factor of##7##4##(1990-11#1)(1992-3#1)(1995-12#1)(2007-11#1)(2008-3#1)(2008-7#1)(2011-1#1)
to a factor##8##3##(1990-11#1)(1992-3#1)(1995-12#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#1)
to a failure in##2##4##(1995-2#1)(2012-12#1)
to a failure of##2##4##(1990-7#1)(1995-5#1)
to a failure to##3##4##(1994-11#1)(1994-12#1)(2008-5#1)
to a failure##8##3##(1990-7#1)(1992-10#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-5#1)(2008-5#1)(2012-12#1)
to a false##3##3##(2004-1#1)(2008-11#1)(2008-2#1)
to a family history of##2##5##(2007-7#1)(2011-2#1)
to a family of##16##4##(1991-9#1)(1992-5#1)(1993-2#1)(1993-3#1)(1994-12#1)(1996-5#1)(1996-9#1)(2005-7#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-10#1)(2010-5#1)
to a family##19##3##(1991-9#1)(1992-5#1)(1993-2#1)(1993-3#1)(1994-12#1)(1996-5#1)(1996-9#1)(2005-7#1)(2007-12#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-10#1)(2010-3#1)(2010-5#1)(2011-2#1)
to a far##2##3##(1991-1#1)(1993-7#1)
to a fast##3##3##(1991-5#1)(2007-12#1)(2008-10#1)
to a faster##2##3##(2006-10#1)(2013-8#1)
to a favorable##4##3##(1994-5#1)(1995-5#1)(2007-10#1)(2011-1#1)
to a feminist##2##3##(2007-12#2)
to a few hours##2##4##(2010-12#1)(2010-8#1)
to a few minutes##2##4##(1996-12#1)(2008-10#1)
to a few percent of the##2##6##(1991-8#1)(1997-4#1)
to a few percent of##3##5##(1991-8#1)(1992-9#1)(1997-4#1)
to a few percent##5##4##(1991-8#1)(1992-9#1)(1997-4#1)(2008-2#1)(2008-3#1)
to a few##27##3##(1990-4#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-9#1)(1993-10#1)(1993-3#1)(1994-6#1)(1995-5#1)(1996-12#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-2#3)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-8#1)(2013-1#1)
to a fiber##3##3##(2007-11#1)(2007-12#1)(2011-1#1)
to a final R##3##4##(1992-3#1)(1997-7#2)
to a final concentration of##2##5##(1990-12#1)(2008-11#1)
to a final##11##3##(1990-12#1)(1992-12#2)(1992-3#1)(1995-1#1)(1997-7#2)(2006-6#1)(2008-11#1)(2008-5#1)(2008-7#1)
to a finite##4##3##(1991-4#1)(1996-4#1)(1997-3#1)(2005-11#1)
to a first##2##3##(2006-5#1)(2007-12#1)
to a first-order##3##3##(1990-2#1)(1990-9#1)(1992-6#1)
to a fixed amount of##2##5##(1991-5#2)
to a fixed##10##3##(1991-5#2)(1991-6#1)(1994-2#1)(2007-12#1)(2009-12#1)(2010-1#1)(2012-1#1)(2013-1#2)
to a flame##4##3##(2008-10#4)
to a flattop beam##2##4##(2008-3#2)
to a flow cell##2##4##(2008-10#2)
to a flow injection##2##4##(2008-10#2)
to a flow##9##3##(2008-10#7)(2008-3#1)(2008-4#1)
to a flow-cell##2##3##(2008-10#2)
to a flow-injection##3##3##(2008-10#3)
to a fluorescent##2##3##(2008-10#1)(2008-4#1)
to a focal##3##3##(2008-1#1)(2008-3#1)(2008-8#1)
to a focus on##2##4##(2006-10#1)(2013-1#1)
to a focused##3##3##(2007-12#1)(2013-1#2)
to a food##2##3##(2006-12#1)(2011-2#1)
to a form of##6##4##(1991-9#1)(1993-11#1)(1997-8#1)(2006-2#1)(2006-8#1)(2011-2#1)
to a form that##4##4##(1991-12#1)(1991-5#1)(1992-12#1)(1992-8#1)
to a form##11##3##(1990-2#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-11#1)(1997-8#1)(2006-2#1)(2006-8#1)(2011-2#1)
to a four##2##3##(1990-4#1)(1994-12#1)
to a fraction collector##3##4##(2006-8#1)(2007-8#2)
to a fraction of##3##4##(1995-5#1)(2008-8#1)(2010-4#1)
to a fraction##7##3##(1992-1#1)(1995-5#1)(2006-8#1)(2007-8#2)(2008-8#1)(2010-4#1)
to a fractionated##2##3##(1992-1#1)(2008-12#1)
to a free##3##3##(1991-2#1)(2012-12#2)
to a frequency##6##3##(2007-11#1)(2007-12#1)(2007-3#1)(2008-2#1)(2008-8#1)(2010-2#1)
to a friend##2##3##(1996-12#1)(2006-8#1)
to a full##7##3##(1992-8#1)(1997-3#1)(2005-7#1)(2008-8#1)(2009-1#1)(2012-2#1)(2013-8#1)
to a fully##2##3##(1995-6#1)(2005-11#1)
to a functional role##2##4##(1997-6#1)(2012-3#1)
to a functional##11##3##(1992-8#1)(1994-9#1)(1996-1#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-7#1)(2008-5#1)(2012-3#1)(2013-1#1)
to a fundamental##2##3##(2007-11#1)(2007-12#1)
to a further##8##3##(1993-11#1)(1994-11#1)(1995-1#1)(1996-4#1)(1996-9#1)(1997-1#1)(2007-2#1)(2010-3#1)
to a fusion protein##2##4##(1993-12#1)(1996-3#1)
to a fusion##3##3##(1993-12#1)(1996-3#1)(2010-12#1)
to a future##5##3##(1994-6#1)(2008-10#1)(2008-3#1)(2010-2#1)(2012-2#1)
to a gas##2##3##(2008-10#2)
to a gel##2##3##(1991-2#1)(2011-2#1)
to a gelatin##3##3##(1996-5#2)(2011-2#1)
to a gene##8##3##(1993-3#1)(1994-3#1)(1995-1#1)(1995-11#1)(1996-6#1)(2007-12#1)(2008-5#1)(2008-7#1)
to a general##12##3##(1991-7#1)(1995-10#1)(2004-12#1)(2006-10#2)(2007-12#1)(2007-2#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-1#2)
to a generalized##5##3##(1994-2#1)(2008-2#1)(2008-3#1)(2010-6#1)(2012-12#1)
to a genetic##7##3##(1993-6#1)(1995-10#1)(1997-4#1)(2008-10#2)(2008-8#1)(2010-7#1)
to a genetically##3##3##(1990-2#1)(1991-6#1)(1995-11#1)
to a genus##2##3##(2008-5#1)(2011-2#1)
to a geometrical##2##3##(2005-11#1)(2009-2#1)
to a geriatric##2##3##(1990-3#1)(1992-12#1)
to a given##24##3##(1990-11#1)(1991-5#1)(1994-11#1)(1995-12#1)(2005-11#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-9#3)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
to a glass substrate##2##4##(2008-10#1)(2008-3#1)
to a glass##5##3##(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2010-4#1)
to a global##2##3##(1994-8#1)(1997-7#1)
to a glutamine##2##3##(1995-5#1)(2008-5#1)
to a gluten-free diet##2##4##(2006-10#1)(2011-2#1)
to a good approximation##2##4##(2007-12#1)(2008-2#1)
to a good##8##3##(1991-1#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)
to a graded##2##3##(2006-6#1)(2008-4#1)
to a gradual##2##3##(2008-2#1)(2011-2#1)
to a great extent by##2##5##(1996-6#1)(2011-12#1)
to a great extent##17##4##(1990-12#2)(1992-3#1)(1992-8#1)(1994-9#1)(1995-8#1)(1996-5#2)(1996-6#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#3)(2011-12#1)
to a great##21##3##(1990-12#2)(1992-3#1)(1992-8#1)(1994-9#1)(1995-8#1)(1996-4#1)(1996-5#2)(1996-6#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-6#3)(2010-12#1)(2011-12#1)
to a greater degree by##3##5##(1990-7#1)(1994-6#1)(2011-12#1)
to a greater degree than the##2##6##(1995-11#1)(2008-4#1)
to a greater degree than##4##5##(1991-6#1)(1995-11#1)(2008-10#1)(2008-4#1)
to a greater degree##12##4##(1990-7#1)(1991-6#1)(1992-3#1)(1993-11#1)(1993-5#1)(1994-6#1)(1995-11#1)(2008-10#1)(2008-4#2)(2009-6#1)(2011-12#1)
to a greater extent by##2##5##(1991-4#1)(1993-3#1)
to a greater extent in##5##5##(1990-3#1)(1991-10#1)(1991-5#1)(1992-9#1)(2008-7#1)
to a greater extent than other##2##6##(1990-9#1)(1992-8#1)
to a greater extent than the##4##6##(1995-10#1)(1995-12#1)(2005-11#1)(2010-2#1)
to a greater extent than##16##5##(1990-9#1)(1991-12#1)(1991-7#1)(1992-8#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1997-7#1)(2005-11#1)(2006-8#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-6#1)
to a greater extent##32##4##(1990-3#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#1)(1997-7#1)(2005-11#1)(2006-8#1)(2007-2#1)(2008-7#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-6#1)(2012-1#1)(2013-1#1)
to a greater frequency of##2##5##(2008-5#1)(2010-11#1)
to a greater or lesser extent##3##6##(2005-9#1)(2007-11#1)(2007-12#1)
to a greater understanding of the##3##6##(2008-11#1)(2008-6#1)(2010-2#1)
to a greater understanding of##7##5##(2008-11#1)(2008-6#1)(2008-7#1)(2010-2#1)(2010-6#1)(2012-2#2)
to a greater variety of##2##5##(1996-2#1)(2008-10#1)
to a greater##68##3##(1990-3#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-5#1)(1996-2#1)(1997-7#1)(2005-11#1)(2005-9#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-6#2)(2011-12#1)(2012-1#1)(2012-2#3)(2013-1#1)
to a greenhouse##2##3##(2008-10#2)
to a group of##25##4##(1990-7#1)(1992-5#1)(1994-2#1)(1995-5#2)(1996-9#1)(1997-5#1)(2006-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
to a group##32##3##(1990-7#1)(1992-5#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-5#2)(1996-9#1)(1997-5#1)(2006-11#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#1)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
to a growing body of##4##5##(2006-7#1)(2006-9#1)(2012-1#1)(2013-8#1)
to a growing##11##3##(1990-12#1)(1996-4#1)(2006-7#1)(2006-9#1)(2008-10#1)(2008-11#2)(2010-3#1)(2010-4#1)(2012-1#1)(2013-8#1)
to a half of##2##4##(2013-1#2)
to a halt##2##3##(1995-8#1)(2008-7#1)
to a health care##3##4##(1994-12#1)(1996-11#1)(2010-4#1)
to a health##6##3##(1994-12#1)(1994-9#1)(1996-11#1)(2009-4#1)(2010-4#1)(2013-1#1)
to a healthier##2##3##(2008-6#1)(2012-11#1)
to a healthy##5##3##(2006-7#1)(2011-2#3)(2013-1#1)
to a heat##2##3##(1991-9#1)(1997-7#1)
to a heterogeneous##2##3##(2006-6#1)(2008-3#1)
to a heterologous promoter##2##4##(1997-3#2)
to a heterologous##5##3##(1991-5#1)(1996-5#1)(1996-9#1)(1997-3#2)
to a high degree of##5##5##(2008-10#1)(2008-3#2)(2008-5#1)(2010-7#1)
to a high degree##8##4##(1995-2#1)(1997-6#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2010-7#1)
to a high dose##2##4##(1993-9#1)(2008-7#1)
to a high level of##3##5##(1997-4#1)(2008-10#1)(2012-2#1)
to a high level##7##4##(1995-11#1)(1997-4#1)(2008-10#2)(2008-11#1)(2012-2#1)(2013-1#1)
to a high mortality rate##2##5##(2010-12#1)(2011-2#1)
to a high of##3##4##(1991-12#1)(1996-9#1)(2013-8#1)
to a high rate of##4##5##(1991-9#1)(2008-6#1)(2010-11#1)(2011-2#1)
to a high##50##3##(1990-9#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-8#1)(2007-12#2)(2007-7#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-2#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
to a high-finesse##2##3##(2007-12#2)
to a higher concentration##2##4##(1990-7#1)(2008-10#1)
to a higher degree##3##4##(1991-6#1)(2008-3#1)(2012-11#1)
to a higher level of##2##5##(1993-5#1)(2008-3#1)
to a higher level##4##4##(1993-5#1)(2008-10#1)(2008-12#1)(2008-3#1)
to a higher power##2##4##(2008-12#1)(2012-3#1)
to a higher risk of##2##5##(2006-10#1)(2011-2#1)
to a higher##46##3##(1990-7#1)(1991-11#1)(1991-6#1)(1992-2#2)(1993-5#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-9#1)(1997-2#1)(1997-4#1)(2004-11#1)(2005-11#1)(2006-10#2)(2007-4#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-3#6)(2008-7#1)(2009-11#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-3#2)(2013-1#1)(2013-7#1)
to a higher-order##2##3##(2008-1#1)(2009-4#1)
to a highly conserved##5##4##(1990-2#1)(1991-4#1)(1992-11#1)(1992-4#1)(1995-2#1)
to a highly sensitive##2##4##(2008-10#1)(2008-2#1)
to a highly##11##3##(1990-2#1)(1991-4#1)(1992-11#1)(1992-4#1)(1995-2#1)(1997-2#1)(2008-10#2)(2008-2#1)(2008-3#2)
to a history##2##3##(2005-12#1)(2010-1#1)
to a hollow##2##3##(2007-8#1)(2008-11#1)
to a homogeneous##5##3##(1993-7#1)(1994-11#1)(1996-7#1)(2007-12#1)(2008-7#1)
to a homologous##2##3##(2007-3#1)(2013-8#1)
to a horizontal##2##3##(2008-2#1)(2008-3#1)
to a hospital with##2##4##(2006-4#2)
to a hospital##10##3##(1993-12#1)(1994-11#1)(1995-11#1)(1995-3#1)(1996-12#1)(1997-2#1)(2006-4#2)(2008-11#1)(2010-2#1)
to a host##5##3##(2008-10#2)(2008-2#1)(2008-8#1)(2010-10#1)
to a human##9##3##(1991-10#1)(1992-5#1)(1993-5#1)(1994-2#2)(1997-7#2)(2008-3#1)(2009-2#1)
to a hydraulic##2##3##(2008-2#1)(2008-3#1)
to a hydrogen##2##3##(1991-4#1)(2008-10#1)
to a hydrophobic##4##3##(1990-2#1)(1990-5#2)(2010-1#1)
to a hypoplastic##4##3##(2009-1#1)(2012-2#1)(2013-1#2)
to a hypothetical##3##3##(1995-4#1)(2008-3#1)(2012-2#1)
to a hypotonic challenge##2##4##(1990-2#2)
to a hypotonic##5##3##(1990-2#4)(1992-8#1)
to a key##2##3##(1992-11#1)(2009-8#1)
to a kinetic##4##3##(1991-3#1)(1997-1#1)(2005-11#1)(2007-1#1)
to a known##11##3##(1990-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#1)(2008-10#2)(2008-3#1)(2008-9#1)(2011-1#1)
to a lack of information##2##5##(2008-6#1)(2012-2#1)
to a lack of##22##4##(1995-12#1)(1995-9#1)(1996-8#2)(2006-11#1)(2007-4#1)(2008-1#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
to a large degree##3##4##(2007-11#1)(2008-10#1)(2008-9#1)
to a large extent on##2##5##(1990-3#1)(1992-3#1)
to a large extent##20##4##(1990-3#1)(1991-4#1)(1991-5#1)(1992-3#1)(1992-6#1)(1993-5#1)(1993-9#1)(1994-4#1)(1994-5#1)(1995-8#1)(1996-8#1)(2005-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2011-2#1)(2012-3#1)
to a large family of##2##5##(2005-9#1)(2010-12#1)
to a large group of##2##5##(2007-7#1)(2008-10#1)
to a large increase in##3##5##(1994-12#1)(1996-7#1)(2008-10#1)
to a large number of##11##5##(1994-5#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-4#1)
to a large percentage of the##3##6##(2012-12#1)(2013-1#2)
to a large##84##3##(1990-12#1)(1990-3#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-3#1)(1992-6#2)(1992-7#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-5#2)(1995-1#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-7#2)(1996-8#1)(1997-6#1)(2005-10#1)(2005-9#1)(2006-2#1)(2007-11#5)(2007-12#3)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#10)(2008-11#4)(2008-2#2)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-4#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
to a large-scale##3##3##(2010-5#1)(2012-3#2)
to a larger extent than##3##5##(2005-11#1)(2009-8#1)(2011-2#1)
to a larger extent##5##4##(1993-3#1)(2005-11#1)(2008-10#1)(2009-8#1)(2011-2#1)
to a larger##12##3##(1993-3#1)(1993-6#1)(1996-1#1)(2005-11#1)(2007-11#1)(2008-10#3)(2008-7#2)(2009-8#1)(2011-2#1)
to a laser diode##2##4##(2007-12#1)(2008-3#1)
to a later##3##3##(1992-6#1)(1996-9#1)(2008-7#1)
to a lateral##3##3##(2007-4#2)(2008-3#1)
to a learning##2##3##(1992-9#1)(2008-2#1)
to a lesion of##2##4##(1993-12#1)(1995-3#1)
to a less extent##2##4##(1994-6#1)(2006-8#1)
to a less invasive test##2##5##(2013-1#2)
to a less invasive##3##4##(2006-10#1)(2013-1#2)
to a less##10##3##(1994-5#1)(1994-6#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-5#1)(2010-3#1)(2011-2#1)(2013-1#2)
to a lesser degree in##3##5##(1991-12#1)(1997-3#1)(2013-8#1)
to a lesser degree##26##4##(1990-4#1)(1990-7#1)(1991-12#1)(1991-4#1)(1992-3#2)(1993-7#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
to a lesser extend##2##4##(1996-11#1)(1996-5#1)
to a lesser extent Ca2+ (2-20 mM)##2##7##(1990-3#2)
to a lesser extent in the##6##6##(1990-11#1)(1990-2#1)(1990-5#1)(1991-11#1)(1997-2#1)(1997-9#1)
to a lesser extent in##9##5##(1990-11#1)(1990-2#1)(1990-5#1)(1991-11#1)(1994-12#1)(1995-12#1)(1997-2#1)(1997-9#1)(2008-7#1)
to a lesser extent than the##3##6##(1992-2#1)(1996-5#1)(2008-10#1)
to a lesser extent than##11##5##(1991-12#2)(1992-2#1)(1992-4#1)(1992-8#1)(1995-10#1)(1995-12#1)(1995-8#1)(1996-5#1)(2008-10#1)(2012-2#1)
to a lesser extent the##3##5##(1994-12#1)(2008-3#1)(2011-1#1)
to a lesser extent##139##4##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#4)(1990-4#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#2)(1993-11#2)(1993-12#1)(1993-7#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#3)(1995-12#3)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#2)(1997-8#3)(1997-9#1)(2004-2#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#17)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)
to a lesser##169##3##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#4)(1990-4#2)(1990-5#2)(1990-7#2)(1990-9#1)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#2)(1993-11#3)(1993-12#1)(1993-7#2)(1993-8#1)(1994-12#2)(1994-2#2)(1994-6#2)(1994-8#4)(1994-9#2)(1995-1#1)(1995-10#3)(1995-12#3)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#5)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#3)(1997-9#1)(2004-2#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#19)(2008-11#3)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
to a lethal##4##3##(1995-5#1)(1997-4#1)(2007-3#1)(2008-12#1)
to a level 1##2##4##(1990-4#1)(1993-2#1)
to a level below the##2##5##(2008-7#2)
to a level comparable##2##4##(2006-10#1)(2012-3#1)
to a level of##4##4##(1990-3#1)(2007-7#1)(2008-11#1)(2009-6#1)
to a level similar to that##2##6##(2006-12#1)(2008-10#1)
to a level that##2##4##(1993-7#1)(1997-2#1)
to a level which was##2##5##(1995-5#1)(1997-2#1)
to a level##26##3##(1990-3#1)(1990-4#1)(1991-6#1)(1993-12#1)(1993-2#1)(1993-7#1)(1995-2#1)(1995-5#1)(1997-2#3)(1997-3#1)(1997-4#1)(2006-10#1)(2006-12#2)(2007-7#1)(2008-10#3)(2008-11#2)(2008-7#2)(2009-6#1)(2012-3#1)
to a light##3##3##(1994-2#1)(2007-11#1)(2012-12#1)
to a limited extent##5##4##(1995-3#1)(1997-6#1)(2006-6#1)(2007-11#1)(2013-7#1)
to a limited number of##4##5##(1995-2#1)(2007-11#1)(2007-12#1)(2008-2#1)
to a limited set of##3##5##(1997-8#1)(2008-1#1)(2013-8#1)
to a limited##16##3##(1995-2#1)(1995-3#1)(1997-6#1)(1997-8#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
to a line with##2##4##(2008-2#2)
to a line##6##3##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)
to a linear increase##2##4##(2008-11#1)(2012-2#1)
to a linear##9##3##(1994-9#1)(1996-2#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2012-2#1)
to a lipid##2##3##(1992-9#1)(1994-11#1)
to a liquid##3##3##(2007-8#1)(2008-10#1)(2008-7#1)
to a liquid-crystal##2##3##(2008-2#1)(2008-3#1)
to a local##10##3##(1993-1#2)(1995-9#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2013-8#1)
to a long##9##3##(1990-12#1)(1996-4#1)(1997-7#1)(2006-10#1)(2006-7#1)(2008-11#1)(2010-6#1)(2010-8#1)(2011-1#1)
to a long-term##3##3##(1992-1#1)(2006-2#1)(2007-4#1)
to a longer##5##3##(1994-8#1)(2006-8#2)(2008-7#1)(2012-1#1)
to a loss of##12##4##(1990-5#1)(1992-12#3)(1994-3#1)(1995-10#1)(2006-9#1)(2008-11#2)(2008-2#1)(2008-3#1)(2013-8#1)
to a loss##13##3##(1990-5#1)(1992-12#3)(1994-3#1)(1995-10#1)(2006-9#1)(2007-7#1)(2008-11#2)(2008-2#1)(2008-3#1)(2013-8#1)
to a low level##7##4##(1990-11#1)(1991-7#1)(1995-11#1)(1997-6#1)(2008-10#1)(2008-7#1)(2008-9#1)
to a low molecular weight##2##5##(1997-2#1)(2006-12#1)
to a low of##3##4##(1990-3#1)(2008-5#1)(2013-8#1)
to a low##29##3##(1990-11#1)(1990-3#2)(1991-7#1)(1992-3#1)(1995-11#1)(1995-2#1)(1996-5#1)(1997-2#1)(1997-6#1)(2004-11#1)(2006-10#1)(2006-12#1)(2007-9#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#1)
to a lower extent##3##4##(1993-5#1)(2005-11#1)(2011-2#1)
to a lower level in##2##5##(1990-3#1)(2008-7#1)
to a lower level of##2##5##(1997-2#1)(2013-1#1)
to a lower level##4##4##(1990-3#1)(1997-2#1)(2008-7#1)(2013-1#1)
to a lower temperature##2##4##(1995-8#1)(2008-7#1)
to a lower##31##3##(1990-3#1)(1991-2#1)(1991-4#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-3#1)(1994-9#1)(1995-8#1)(1997-2#1)(2004-11#1)(2005-11#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-6#1)(2008-7#3)(2009-9#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#2)
to a luciferase reporter##3##4##(1995-6#1)(1995-8#1)(1997-6#1)
to a macromolecule##2##3##(1995-8#1)(1997-2#1)
to a magnetic field##4##4##(1990-5#1)(1992-7#1)(2008-2#1)(2010-9#1)
to a magnetic resonance imaging##2##5##(2006-12#1)(2007-3#1)
to a magnetic##7##3##(1990-5#1)(1992-7#1)(2006-12#1)(2007-3#1)(2008-2#1)(2010-9#1)(2012-12#1)
to a magnification##2##3##(2008-3#1)(2008-9#1)
to a major gene##3##4##(2008-10#2)(2008-8#1)
to a major quantitative trait locus##2##6##(2008-10#2)
to a major##17##3##(1991-5#1)(1991-6#1)(1993-9#1)(2004-12#1)(2004-7#1)(2005-7#1)(2007-2#1)(2008-10#4)(2008-5#2)(2008-8#1)(2009-12#1)(2010-5#1)(2012-12#1)
to a man##2##3##(2007-9#1)(2009-5#1)
to a managed care##2##4##(1996-12#1)(1996-2#1)
to a marked decrease in##3##5##(2006-6#1)(2007-7#1)(2008-5#1)
to a marked decrease##4##4##(1993-4#1)(2006-6#1)(2007-7#1)(2008-5#1)
to a marked increase in##3##5##(1995-2#1)(2007-9#1)(2010-10#1)
to a marked increase##4##4##(1995-2#1)(2006-9#1)(2007-9#1)(2010-10#1)
to a marked reduction in##2##5##(1995-3#1)(2006-5#1)
to a marked reduction##3##4##(1994-8#1)(1995-3#1)(2006-5#1)
to a marked##17##3##(1993-4#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-8#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-5#1)(2010-10#1)(2010-4#1)
to a markedly##3##3##(1990-12#1)(1993-11#1)(2010-6#1)
to a mass spectrometer##3##4##(2008-10#2)(2008-4#1)
to a mass##6##3##(2008-10#3)(2008-4#1)(2008-6#1)(2012-2#1)
to a massive##3##3##(2008-2#1)(2008-7#1)(2009-6#1)
to a matched##3##3##(1992-6#1)(2007-9#1)(2010-11#1)
to a mathematical##2##3##(1995-11#1)(2008-11#1)
to a mature##3##3##(1992-12#1)(1993-3#1)(2006-10#1)
to a maximal##2##3##(1993-11#1)(2013-1#1)
to a maximum at##4##4##(1993-3#1)(1993-7#1)(1994-5#1)(2006-5#1)
to a maximum level##2##4##(1992-11#1)(1995-3#1)
to a maximum of 2##3##5##(1994-5#1)(2008-10#1)(2008-5#1)
to a maximum of about##3##5##(1991-11#1)(1995-1#1)(2009-9#1)
to a maximum of##19##4##(1990-3#1)(1991-11#1)(1993-2#1)(1994-5#2)(1995-1#1)(2006-2#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-8#1)(2009-9#2)
to a maximum value of##2##5##(2008-2#1)(2008-5#1)
to a maximum##39##3##(1990-3#1)(1991-11#1)(1992-11#1)(1993-2#2)(1993-3#1)(1993-7#1)(1994-5#3)(1995-1#1)(1995-3#1)(2005-11#1)(2006-2#1)(2006-5#2)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#3)(2008-4#1)(2008-5#2)(2008-6#1)(2009-11#1)(2009-8#1)(2009-9#2)
to a mean of##6##4##(1990-11#1)(1991-2#1)(1996-1#1)(2006-12#1)(2013-1#2)
to a mean##10##3##(1990-11#1)(1991-2#1)(1991-9#1)(1995-12#1)(1996-1#1)(1997-3#1)(2006-12#1)(2008-10#1)(2013-1#2)
to a measurable##2##3##(1995-12#1)(2007-11#1)
to a measure of##2##4##(1991-8#1)(2012-12#1)
to a mechanism involving##2##4##(1990-2#1)(1992-6#1)
to a mechanism##4##3##(1990-2#1)(1992-6#1)(2010-5#1)(2012-1#1)
to a medial##3##3##(1996-2#1)(2006-12#1)(2007-12#1)
to a median of##3##4##(1990-2#2)(1997-3#1)
to a medical service##2##4##(2007-2#1)(2008-3#1)
to a medical##13##3##(1990-4#1)(1990-5#1)(1996-12#1)(2007-2#1)(2007-9#1)(2008-3#1)(2008-7#1)(2009-3#1)(2012-2#3)(2013-1#2)
to a membrane##14##3##(1991-5#1)(1991-9#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#5)(2013-1#1)
to a mental health##2##4##(1996-4#1)(2004-12#1)
to a mental##4##3##(1996-4#1)(2004-12#1)(2009-12#1)(2009-5#1)
to a mercury##2##3##(1990-5#1)(1993-4#1)
to a metastatic##3##3##(1991-2#2)(2008-1#1)
to a mild##3##3##(2007-2#2)(2008-4#1)
to a milder##2##3##(2006-5#1)(2013-1#1)
to a miniature##2##3##(2008-1#1)(2012-12#1)
to a minimal##3##3##(1994-3#1)(2009-7#1)(2012-12#1)
to a minimum of##2##4##(2007-9#1)(2008-2#1)
to a minimum##21##3##(1990-11#1)(1992-12#1)(1992-8#1)(1995-4#1)(1996-8#1)(1997-6#1)(2007-11#2)(2007-5#2)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-12#2)
to a minor extent##2##4##(1990-3#1)(1990-5#1)
to a minor##3##3##(1990-3#1)(1990-5#1)(1997-3#1)
to a mismatch##2##3##(2007-12#1)(2009-5#1)
to a mitochondrial##3##3##(1992-2#1)(1992-7#1)(2008-8#1)
to a mixed meal##2##4##(1994-12#1)(2012-3#1)
to a mixed##6##3##(1994-12#1)(1997-6#1)(2007-8#1)(2008-2#1)(2010-2#1)(2012-3#1)
to a mixture of##15##4##(1990-5#1)(1990-7#1)(1991-3#1)(1991-7#1)(1992-3#1)(1992-4#1)(1995-3#1)(1996-2#1)(2004-11#1)(2008-1#1)(2008-10#3)(2009-6#1)(2013-1#1)
to a mixture##16##3##(1990-5#1)(1990-7#1)(1991-3#1)(1991-7#1)(1992-3#1)(1992-4#1)(1995-3#1)(1996-2#1)(2004-11#1)(2008-1#1)(2008-10#3)(2008-12#1)(2009-6#1)(2013-1#1)
to a mobile##2##3##(2008-2#1)(2010-11#1)
to a model for##2##4##(1992-3#1)(1993-8#1)
to a model of##4##4##(1990-8#1)(2006-10#3)
to a model that##2##4##(1994-11#1)(1997-1#1)
to a model##15##3##(1990-8#1)(1992-3#1)(1993-8#1)(1994-11#2)(1995-3#1)(1995-8#1)(1997-1#1)(2006-10#3)(2007-12#1)(2008-10#2)(2008-3#1)
to a moderate degree##2##4##(2008-5#1)(2013-7#1)
to a moderate##4##3##(2007-12#1)(2008-5#1)(2012-1#1)(2013-7#1)
to a modern##2##3##(2007-3#1)(2008-8#1)
to a modification of the##2##5##(1996-5#1)(2008-5#1)
to a modification##3##3##(1995-9#1)(1996-5#1)(2008-5#1)
to a modified##8##3##(1992-9#1)(1993-11#1)(1996-12#1)(2007-3#1)(2008-2#1)(2008-6#2)(2009-4#1)
to a modulated##2##3##(2008-3#1)(2008-5#1)
to a molar ratio of##2##5##(1990-5#1)(1992-12#1)
to a molar##3##3##(1990-5#1)(1992-12#1)(2011-2#1)
to a molecular##6##3##(1992-3#1)(1995-2#1)(1996-5#1)(1996-8#1)(2006-10#1)(2007-6#1)
to a molecule##4##3##(2008-2#1)(2008-4#2)(2010-7#1)
to a monoclonal##5##3##(1991-2#1)(1993-4#1)(1993-8#1)(1997-7#1)(2008-5#1)
to a monolayer##2##3##(2005-11#1)(2008-10#1)
to a more accurate##4##4##(1990-3#1)(2006-4#1)(2007-5#1)(2008-8#1)
to a more advanced stage##2##5##(1995-2#1)(2007-11#1)
to a more aggressive##2##4##(2013-1#2)
to a more complex##2##4##(1995-3#1)(2006-10#1)
to a more conventional##2##4##(1994-2#1)(2008-2#1)
to a more individualized##2##4##(2008-11#1)(2010-12#1)
to a more realistic##2##4##(1995-11#1)(2006-12#1)
to a more severe##3##4##(1991-8#1)(1992-8#1)(2007-11#1)
to a more than##2##4##(1991-9#1)(1992-3#1)
to a more##66##3##(1990-3#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-2#3)(1994-3#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-8#2)(1997-1#1)(2005-11#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
to a mouth##2##3##(2008-11#1)(2010-12#1)
to a much greater##2##4##(1991-7#1)(1993-8#1)
to a much higher degree in##2##6##(1995-2#1)(2012-12#1)
to a much lesser extent##2##5##(1990-11#1)(2008-11#1)
to a much shorter##2##4##(2005-11#1)(2007-12#1)
to a much##12##3##(1990-11#1)(1991-7#1)(1993-8#1)(1995-2#1)(2005-11#2)(2007-11#1)(2007-12#1)(2008-11#2)(2008-2#1)(2012-12#1)
to a multidisciplinary##3##3##(1992-5#1)(2006-8#1)(2011-2#1)
to a multimode##5##3##(2007-11#1)(2008-2#1)(2008-3#2)(2012-2#1)
to a multiple##3##3##(1996-10#1)(2006-8#1)(2008-6#1)
to a multitude of##2##4##(2006-10#1)(2007-7#1)
to a multivariate##2##3##(1997-4#1)(2008-2#1)
to a mutant##4##3##(1990-2#1)(1992-7#1)(1995-1#1)(2009-11#1)
to a mutation in##6##4##(1994-8#1)(1995-1#1)(2008-10#2)(2008-9#1)(2010-12#1)
to a mutation##8##3##(1994-8#1)(1995-1#1)(1996-9#1)(2008-10#3)(2008-9#1)(2010-12#1)
to a nadir of##2##4##(1991-8#1)(2007-12#1)
to a narrow##6##3##(1997-1#1)(2008-2#2)(2008-3#1)(2008-5#1)(2010-4#1)
to a national health##2##4##(1993-12#1)(2008-7#1)
to a national##7##3##(1992-12#2)(1993-12#1)(2005-12#1)(2007-12#1)(2008-7#1)(2011-1#1)
to a nearby##3##3##(1995-1#1)(1997-4#1)(2009-5#1)
to a nearly##2##3##(2008-10#1)(2008-8#1)
to a need##2##3##(1996-3#1)(2007-11#1)
to a negative##5##3##(1990-8#1)(1991-8#1)(1992-11#1)(2007-12#1)(2008-8#1)
to a negligible##3##3##(2008-3#2)(2009-10#1)
to a network of##2##4##(1990-12#1)(1995-1#1)
to a network##3##3##(1990-12#1)(1995-1#1)(2008-7#1)
to a neutral##3##3##(1996-2#1)(1996-7#1)(2008-7#1)
to a new and##2##4##(2008-11#2)
to a new category of##2##5##(1995-6#1)(2008-2#1)
to a new class of##7##5##(1992-9#1)(1996-5#1)(1997-2#1)(2005-11#1)(2007-11#1)(2008-3#1)(2008-4#1)
to a new concept##3##4##(2008-10#1)(2008-2#1)(2012-2#1)
to a new family##2##4##(2007-11#1)(2013-8#1)
to a new generation of##2##5##(2006-10#1)(2010-9#1)
to a new level of##3##5##(1994-2#1)(1997-3#1)(2008-4#1)
to a new level##4##4##(1994-2#1)(1997-3#1)(2008-4#1)(2008-7#1)
to a new paradigm for##2##5##(2008-3#1)(2012-11#1)
to a new steady-state level within approximately 1##2##8##(1997-2#2)
to a new steady-state##3##4##(1990-2#1)(1997-2#2)
to a new type of##2##5##(1991-12#1)(2008-3#1)
to a new##87##3##(1990-2#1)(1990-8#1)(1991-12#1)(1991-4#1)(1992-1#1)(1992-12#1)(1992-9#2)(1993-2#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-7#1)(1994-8#1)(1995-6#1)(1996-1#1)(1996-5#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-12#1)(2005-5#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#4)(2007-12#1)(2007-5#1)(2007-8#3)(2007-9#3)(2008-10#6)(2008-11#5)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#5)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
to a newly##5##3##(1995-5#1)(2005-11#1)(2008-10#1)(2010-8#1)(2011-1#1)
to a nitrocellulose##3##3##(1993-8#1)(2006-8#1)(2008-4#1)
to a non##4##3##(1991-11#1)(1992-4#1)(2006-12#1)(2013-8#1)
to a non-specific##3##3##(1992-11#1)(2008-10#1)(2008-6#1)
to a nonlinear##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
to a nonuniform##2##3##(2008-2#1)(2008-3#1)
to a normal level##3##4##(1991-5#1)(2007-8#1)(2009-8#1)
to a normal##6##3##(1991-5#1)(1992-5#1)(1994-8#1)(2007-8#1)(2009-7#1)(2009-8#1)
to a normalized##3##3##(2007-12#1)(2008-3#1)(2008-6#1)
to a novel class of##2##5##(1991-4#1)(2010-11#1)
to a novel environment##2##4##(1994-2#1)(2004-11#1)
to a novel mechanism##2##4##(1994-7#1)(2011-1#1)
to a novel receptor##2##4##(1992-4#1)(2008-4#1)
to a novel stimulus##2##4##(1996-2#1)(2008-5#1)
to a novel##28##3##(1990-11#1)(1990-4#1)(1991-4#1)(1992-4#1)(1994-12#1)(1994-2#2)(1994-7#1)(1996-2#1)(1996-6#1)(1997-4#2)(1997-7#1)(2004-11#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-2#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)
to a noxious##3##3##(1993-9#1)(1996-5#1)(2008-6#1)
to a nuclear##2##3##(1997-7#1)(2008-7#1)
to a number of conditions##2##5##(2008-10#1)(2008-3#1)
to a number of different stimuli##2##6##(1990-12#1)(1992-1#1)
to a number of different##5##5##(1990-12#1)(1992-1#1)(1994-2#1)(1996-7#1)(2006-10#1)
to a number of factors##5##5##(2007-11#1)(2008-10#1)(2008-7#1)(2012-12#2)
to a number of other##2##5##(1992-12#1)(2008-7#1)
to a number of the##2##5##(2008-2#1)(2010-8#1)
to a number of##70##4##(1990-12#2)(1990-4#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-12#1)(1994-11#1)(1994-2#1)(1994-6#1)(1996-3#1)(1996-5#1)(1996-7#2)(2005-8#2)(2006-10#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-3#1)(2007-8#1)(2007-9#2)(2008-10#10)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#8)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-8#2)
to a number##71##3##(1990-12#2)(1990-4#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-12#1)(1994-11#1)(1994-2#1)(1994-6#1)(1996-3#1)(1996-5#1)(1996-7#2)(2005-8#2)(2006-10#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-3#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#8)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-8#2)
to a nursing home##5##4##(1993-10#1)(1994-2#1)(2006-2#1)(2007-9#1)(2010-10#1)
to a one##2##3##(1993-12#1)(2008-11#1)
to a one-dimensional##2##3##(1997-7#1)(2008-2#1)
to a pH of 7##3##5##(1990-3#1)(1993-3#1)(2008-6#1)
to a pH of##4##4##(1990-3#1)(1993-3#1)(2008-6#1)(2013-7#1)
to a pair of##5##4##(1995-8#1)(2008-11#1)(2008-2#2)(2008-3#1)
to a panel of##4##4##(1992-11#1)(1992-8#1)(1992-9#1)(2008-4#1)
to a parallel##4##3##(1991-5#1)(2008-3#1)(2008-5#1)(2013-1#1)
to a part in##2##4##(2008-3#2)
to a part##3##3##(1990-9#1)(2008-3#2)
to a partial##10##3##(1993-9#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-8#1)(2007-4#1)(2008-9#1)(2011-1#1)
to a partially##3##3##(1993-11#1)(1994-8#1)(1996-5#1)
to a particular region##2##4##(2010-12#1)(2012-12#1)
to a particular##39##3##(1991-11#1)(1991-9#1)(1992-9#1)(1993-12#1)(1994-11#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(2006-10#2)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#5)(2008-8#2)(2008-9#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
to a past##2##3##(1992-1#1)(2008-11#1)
to a pathogen##2##3##(2008-10#1)(2012-1#1)
to a pathological##2##3##(1995-3#1)(2013-1#1)
to a patient with##9##4##(2006-8#1)(2007-9#1)(2008-11#3)(2009-5#1)(2010-12#1)(2012-3#1)(2013-1#1)
to a patient##13##3##(1990-4#1)(1993-2#1)(2006-8#1)(2007-9#1)(2008-11#3)(2009-5#1)(2010-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
to a patient's##6##3##(2008-5#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#2)
to a pattern of##3##4##(1993-6#1)(2004-2#1)(2008-2#1)
to a peak intensity##2##4##(2007-12#2)
to a peak of 1##2##5##(2012-12#2)
to a peak of##4##4##(2007-1#1)(2007-12#1)(2012-12#2)
to a peak##13##3##(1994-2#1)(1997-3#1)(2004-11#1)(2007-1#1)(2007-11#2)(2007-12#4)(2008-7#1)(2012-12#2)
to a pediatric##4##3##(2006-10#1)(2008-7#1)(2010-11#1)(2011-2#1)
to a peptide comprising residues##2##5##(1991-7#2)
to a peptide##6##3##(1990-5#1)(1991-7#3)(1995-6#1)(2008-5#1)
to a perceived##2##3##(2006-12#1)(2008-12#1)
to a permanent##2##3##(2007-7#1)(2008-5#1)
to a person##4##3##(2007-12#1)(2008-2#1)(2010-8#1)(2011-2#1)
to a personal computer##4##4##(1997-2#1)(2008-10#1)(2008-3#1)(2010-8#1)
to a personal##6##3##(1991-9#1)(1997-2#1)(2006-10#1)(2008-10#1)(2008-3#1)(2010-8#1)
to a phase change of##2##5##(2007-11#1)(2008-10#1)
to a phase##4##3##(2007-11#1)(2007-12#2)(2008-10#1)
to a photomultiplier tube##2##4##(2008-10#1)(2010-9#1)
to a phylogenetically##2##3##(2008-10#1)(2011-2#1)
to a physical##3##3##(1996-5#1)(1997-2#1)(2008-12#1)
to a physician##2##3##(1995-12#1)(2006-12#1)
to a physiologic##2##3##(1994-11#1)(2006-9#1)
to a physiological##2##3##(1992-3#1)(1993-5#1)
to a piezoelectric transducer##2##4##(2007-12#2)
to a plan##2##3##(2007-2#1)(2011-2#1)
to a plasma##4##3##(1990-6#1)(2008-11#1)(2012-2#2)
to a plastic##2##3##(1990-10#1)(1990-12#1)
to a plateau##5##3##(1991-2#1)(1994-2#1)(1997-6#1)(2008-10#1)(2008-9#1)
to a plug flow##2##4##(2007-10#1)(2008-7#1)
to a point where##4##4##(1994-10#1)(1996-3#1)(2008-1#1)(2010-3#1)
to a point##8##3##(1990-12#1)(1994-10#1)(1995-5#1)(1996-3#1)(2006-10#1)(2008-1#1)(2008-3#1)(2010-3#1)
to a polar##2##3##(1995-2#1)(2008-3#1)
to a polymeric##3##3##(2008-10#1)(2008-5#1)(2010-7#1)
to a polypeptide of Mr##2##5##(1990-1#1)(1990-5#1)
to a polypeptide of##3##4##(1990-1#1)(1990-5#1)(1995-6#1)
to a polypeptide##6##3##(1990-1#1)(1990-5#1)(1990-9#1)(1994-11#1)(1995-6#1)(2008-5#1)
to a polysaccharide vaccine##2##4##(2010-12#2)
to a poor clinical course##2##5##(2009-3#2)
to a poor##5##3##(1991-12#1)(1996-8#1)(2008-10#1)(2009-3#2)
to a population of##3##4##(1995-2#1)(2008-10#1)(2011-2#1)
to a population##6##3##(1995-2#1)(2008-10#2)(2008-7#1)(2010-2#1)(2011-2#1)
to a portion of a##2##5##(1991-6#1)(1995-12#1)
to a portion of##4##4##(1990-5#1)(1991-6#1)(1993-3#1)(1995-12#1)
to a position##4##3##(1991-11#1)(1994-12#1)(1994-8#1)(2008-5#1)
to a positive##9##3##(1992-4#1)(1997-6#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-5#1)(2010-2#1)(2010-3#1)(2011-1#1)
to a possible##8##3##(1990-8#1)(1991-2#1)(1993-2#1)(2007-7#1)(2010-12#1)(2010-3#1)(2011-12#1)(2011-2#1)
to a potential##4##3##(2006-12#1)(2007-11#1)(2009-6#1)(2012-2#1)
to a power##4##3##(2006-7#1)(2008-7#3)
to a powerful##2##3##(2007-4#1)(2008-8#1)
to a practical##4##3##(1997-7#1)(2008-2#1)(2012-2#1)(2012-3#1)
to a precise##3##3##(1991-11#1)(1993-9#1)(1994-9#1)
to a predator##4##3##(2008-6#1)(2008-8#2)(2010-8#1)
to a predefined##2##3##(1993-1#1)(2012-12#1)
to a predetermined##2##3##(1993-12#1)(2012-2#1)
to a preferred##2##3##(2008-5#1)(2009-10#1)
to a preformed##2##3##(1996-4#1)(2008-10#1)
to a premature##2##3##(1995-8#1)(2012-12#1)
to a prescribed##2##3##(2008-3#1)(2008-7#1)
to a previous report that##2##5##(1994-3#1)(1996-6#1)
to a previous report##6##4##(1990-4#1)(1991-3#1)(1991-5#1)(1994-3#1)(1994-5#1)(1996-6#1)
to a previous study##3##4##(2006-5#1)(2008-10#1)(2010-5#1)
to a previous##14##3##(1990-4#1)(1991-3#1)(1991-5#1)(1994-3#1)(1994-5#1)(1996-6#1)(2006-5#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-3#1)(2010-5#1)(2012-3#1)
to a previously described##5##4##(1990-12#1)(1991-11#1)(1991-5#1)(1992-3#1)(1995-1#1)
to a previously proposed##2##4##(2008-10#1)(2008-3#1)
to a previously published##2##4##(1992-6#1)(2010-2#1)
to a previously reported##2##4##(1993-8#1)(2007-8#1)
to a previously##21##3##(1990-12#1)(1990-6#1)(1991-11#1)(1991-5#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-6#2)(1993-8#1)(1994-3#1)(1995-1#1)(1996-5#1)(2007-8#2)(2008-10#2)(2008-3#1)(2010-2#1)(2011-2#1)(2013-8#1)
to a primary##6##3##(1993-10#1)(2008-10#1)(2008-2#1)(2013-1#1)(2013-8#2)
to a prior##2##3##(2006-8#1)(2008-7#1)
to a priori##3##3##(2008-4#1)(2008-5#1)(2013-1#1)
to a private##2##3##(1995-3#1)(2007-7#1)
to a product##3##3##(1996-8#1)(2008-5#1)(2012-12#1)
to a progressive##6##3##(2005-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)
to a projected##2##3##(1996-1#1)(2007-11#1)
to a prolonged##6##3##(2006-2#1)(2007-5#1)(2008-10#1)(2008-9#1)(2010-10#1)(2012-2#1)
to a promoter is##3##4##(1996-4#3)
to a promoter##6##3##(1995-8#1)(1996-4#4)(1996-5#1)
to a promoterless##2##3##(1993-6#1)(2008-10#1)
to a pronounced decrease in##2##5##(1995-12#1)(2009-2#1)
to a pronounced increase in##2##5##(1997-7#1)(2007-8#1)
to a pronounced##4##3##(1995-12#1)(1997-7#1)(2007-8#1)(2009-2#1)
to a proper##3##3##(1996-11#1)(2006-10#1)(2008-3#1)
to a proposed##2##3##(2008-3#1)(2008-6#1)
to a protein of##6##4##(1991-5#1)(1991-7#1)(1995-8#1)(1996-10#1)(2008-1#1)(2012-2#1)
to a protein that##2##4##(1992-3#1)(1993-12#1)
to a protein##24##3##(1990-10#1)(1990-7#1)(1991-5#1)(1991-7#1)(1992-2#1)(1992-3#1)(1993-12#1)(1994-2#1)(1994-9#1)(1995-2#2)(1995-5#2)(1995-8#1)(1996-10#2)(1997-7#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-2#1)
to a psychiatric##3##3##(2009-7#1)(2011-2#1)(2012-12#1)
to a public##3##3##(2010-6#1)(2012-11#2)
to a published##2##3##(1996-3#1)(2012-3#1)
to a putative DNA##2##4##(2012-2#2)
to a putative##8##3##(1992-8#1)(1994-8#1)(1996-6#1)(1997-1#1)(1997-3#1)(2008-7#1)(2012-2#2)
to a pyrethroid##2##3##(1997-5#2)
to a quantitative##2##3##(2008-3#2)
to a quarter of the##2##5##(2007-11#1)(2012-1#1)
to a quarter of##3##4##(2006-1#1)(2007-11#1)(2012-1#1)
to a questionnaire##7##3##(1990-6#1)(1996-1#1)(2007-2#1)(2007-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
to a radical##3##3##(1990-3#1)(2004-2#1)(2006-6#1)
to a random sample of##6##5##(1991-3#1)(2006-10#1)(2006-8#1)(2009-4#1)(2011-1#1)(2013-8#1)
to a random##9##3##(1991-12#1)(1991-3#1)(1991-6#1)(2006-10#1)(2006-8#1)(2008-2#1)(2009-4#1)(2011-1#1)(2013-8#1)
to a randomized sample of##2##5##(1993-2#1)(1995-12#1)
to a randomized##4##3##(1993-2#1)(1995-12#1)(1997-4#1)(2004-12#1)
to a range of##27##4##(1990-12#1)(1992-6#1)(1995-3#1)(1997-4#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-4#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-4#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)
to a range##28##3##(1990-12#1)(1992-6#1)(1995-3#1)(1997-4#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-4#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)
to a rapid accumulation##2##4##(2007-11#1)(2007-9#1)
to a rapid and##4##4##(1990-12#1)(1997-1#1)(2008-6#1)(2010-6#1)
to a rapid##17##3##(1990-12#2)(1990-8#1)(1991-7#1)(1996-1#1)(1996-11#1)(1996-4#1)(1996-9#1)(1997-1#1)(2006-6#1)(2007-11#1)(2007-9#2)(2008-11#1)(2008-6#1)(2008-8#1)(2010-6#1)
to a rapidly##3##3##(1994-12#1)(2010-12#1)(2013-8#1)
to a rare##3##3##(2008-11#1)(2008-12#1)(2012-12#1)
to a rat##5##3##(1991-3#1)(1991-9#1)(1993-2#1)(1993-7#1)(1996-7#1)
to a rather##2##3##(1996-5#1)(2007-12#1)
to a rational##2##3##(2008-10#1)(2013-1#1)
to a reaction##2##3##(2010-2#1)(2013-1#1)
to a reactive##2##3##(2008-10#1)(2008-7#1)
to a reader's##2##3##(2007-2#2)
to a real##3##3##(1993-9#1)(2008-10#1)(2008-8#1)
to a reasonable##3##3##(1990-8#1)(1992-2#1)(2008-2#1)
to a reasonably##2##3##(1991-6#1)(2007-6#1)
to a recent report##2##4##(1990-9#1)(2012-2#1)
to a recent##10##3##(1990-6#1)(1990-9#1)(1995-5#1)(2007-8#1)(2008-10#1)(2009-12#1)(2010-1#1)(2010-12#1)(2012-2#1)(2013-1#1)
to a recently described##2##4##(1991-7#1)(2013-1#1)
to a recently##4##3##(1991-7#1)(1992-8#1)(2012-1#1)(2013-1#1)
to a receptor##2##3##(1994-5#1)(1997-4#1)
to a recipient strain##2##4##(2008-10#2)
to a recipient##3##3##(1995-5#1)(2008-10#2)
to a recombinant##2##3##(1997-4#1)(2005-7#1)
to a recorded##2##3##(2008-5#1)(2011-2#1)
to a reduced risk of##3##5##(2006-10#2)(2013-1#1)
to a reduced##18##3##(1992-8#1)(1995-12#2)(1996-1#1)(1997-1#2)(2006-10#2)(2007-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
to a reduction in the##16##5##(1991-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-5#1)(2005-12#1)(2008-10#2)(2008-11#1)(2008-3#3)(2012-12#1)(2013-8#2)
to a reduction in##41##4##(1990-11#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-7#1)(1996-9#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#6)(2008-4#1)(2008-7#1)(2009-11#1)(2009-4#1)(2009-6#1)(2010-12#1)(2012-12#1)(2013-8#2)
to a reduction of the##4##5##(1994-9#1)(2004-4#1)(2007-7#1)(2008-10#1)
to a reduction of##16##4##(1991-2#1)(1993-4#1)(1994-6#1)(1994-9#1)(1996-3#1)(2004-4#1)(2005-6#1)(2006-6#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-12#2)(2010-4#1)
to a reduction##59##3##(1990-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-2#1)(1993-12#1)(1993-4#1)(1994-12#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-9#1)(2004-4#1)(2005-10#1)(2005-12#1)(2005-6#1)(2006-10#1)(2006-2#1)(2006-6#2)(2007-12#1)(2007-7#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-4#1)(2009-6#1)(2010-12#3)(2010-4#1)(2012-12#1)(2013-8#2)
to a reference cavity with a finesse##2##7##(2007-12#2)
to a reference material##2##4##(1996-9#1)(2008-10#1)
to a reference##11##3##(1996-9#1)(2006-7#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-10#1)(2009-9#1)
to a referral hospital in##2##5##(2007-7#1)(2012-12#1)
to a referral##4##3##(1994-6#1)(2007-7#1)(2012-12#1)(2012-2#1)
to a regime##2##3##(2007-11#1)(2008-12#1)
to a region of chromosome##2##5##(1993-12#1)(1994-11#1)
to a region of the##4##5##(1990-11#1)(1995-6#1)(1996-3#1)(1996-7#1)
to a region of##10##4##(1990-11#1)(1990-5#1)(1993-12#1)(1993-2#1)(1994-11#1)(1995-3#1)(1995-6#1)(1996-3#1)(1996-7#1)(2012-2#1)
to a region##16##3##(1990-11#1)(1990-5#1)(1991-12#2)(1991-8#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-3#1)(1996-7#1)(2008-10#1)(2008-4#1)(2012-2#1)
to a regional hospital##3##4##(1995-5#2)(2007-3#1)
to a regional##5##3##(1995-5#2)(2007-3#2)(2011-2#1)
to a regular##2##3##(2008-3#1)(2008-6#1)
to a regulatory##2##3##(1991-10#1)(1996-4#1)
to a rehabilitation##3##3##(2007-7#1)(2007-9#1)(2008-7#1)
to a related##4##3##(2008-10#1)(2011-2#1)(2013-1#2)
to a relative##4##3##(1990-11#1)(2008-10#1)(2009-5#1)(2010-5#1)
to a relatively##6##3##(1990-3#1)(1992-6#1)(1993-6#1)(2007-12#1)(2008-2#1)(2008-9#1)
to a release of##2##4##(1991-12#1)(1993-9#1)
to a release##3##3##(1991-12#1)(1993-9#1)(1995-8#1)
to a remarkable##3##3##(2006-12#1)(2007-12#1)(2011-2#1)
to a remote##3##3##(2007-12#1)(2008-8#1)(2008-9#1)
to a renal##3##3##(1996-12#1)(2006-8#1)(2010-4#1)
to a renewed interest in##3##5##(2006-10#1)(2011-2#2)
to a report##3##3##(1992-9#1)(2007-9#2)
to a reported##2##3##(1990-2#1)(2011-1#1)
to a reporter gene##4##4##(1992-3#1)(1992-5#1)(1996-5#1)(1997-4#1)
to a reporter##5##3##(1992-3#1)(1992-5#1)(1993-6#1)(1996-5#1)(1997-4#1)
to a requirement for##3##4##(1991-12#1)(1994-11#1)(2008-7#1)
to a residual##3##3##(1990-7#1)(1991-4#1)(1994-2#1)
to a resolution of##4##4##(1994-9#1)(1997-1#1)(1997-6#1)(2010-10#1)
to a resolution##5##3##(1992-9#1)(1994-9#1)(1997-1#1)(1997-6#1)(2010-10#1)
to a response##5##3##(2008-10#2)(2008-4#1)(2008-5#1)(2012-2#1)
to a restricted##3##3##(1994-2#1)(2008-1#1)(2008-3#1)
to a retained##2##3##(2008-12#1)(2012-2#1)
to a retroperitoneal##3##3##(2006-6#1)(2008-1#1)(2011-2#1)
to a reverse##4##3##(1991-8#1)(1997-6#1)(2006-12#1)(2008-9#1)
to a reversed##2##3##(2008-3#1)(2012-1#1)
to a review of##2##4##(2008-10#1)(2008-11#1)
to a review##3##3##(1991-6#1)(2008-10#1)(2008-11#1)
to a revised##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
to a rich##2##3##(1993-12#1)(2008-7#1)
to a richer##2##3##(1997-5#1)(2008-7#1)
to a rigid substrate##2##4##(2007-8#1)(2008-10#1)
to a rigid##3##3##(2007-8#1)(2008-10#1)(2008-4#1)
to a rigorous##2##3##(2006-12#1)(2007-4#1)
to a rise in##4##4##(1994-12#1)(1994-6#1)(2011-2#1)(2013-8#1)
to a river##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
to a role for##6##4##(1991-9#1)(1992-7#1)(1995-8#1)(2008-7#1)(2009-8#1)(2012-1#1)
to a role of##2##4##(2006-10#1)(2008-4#1)
to a role##8##3##(1991-9#1)(1992-7#1)(1995-8#1)(2006-10#1)(2008-4#1)(2008-7#1)(2009-8#1)(2012-1#1)
to a routine##2##3##(1990-2#1)(2004-10#1)
to a rupture of the##2##5##(1992-2#1)(2010-3#1)
to a ruptured##2##3##(2008-7#1)(2013-8#1)
to a safe##2##3##(2006-1#1)(2007-2#1)
to a safer and more##2##5##(1997-4#1)(2006-6#1)
to a safer##3##3##(1997-4#1)(2006-6#1)(2008-11#1)
to a salt##2##3##(2008-3#1)(2008-5#1)
to a sample of##8##4##(1992-4#1)(1994-2#1)(1994-9#1)(1996-2#1)(2008-10#1)(2008-11#1)(2010-5#1)(2010-9#1)
to a sample##17##3##(1992-4#1)(1992-8#1)(1993-11#1)(1994-2#1)(1994-9#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-9#1)(2010-5#1)(2010-9#1)
to a scattering##3##3##(2007-12#1)(2008-3#1)(2011-1#1)
to a scientific##4##3##(2006-10#1)(2009-10#1)(2009-5#1)(2012-2#1)
to a screening##2##3##(1991-6#1)(2008-5#1)
to a second tone##2##4##(1996-5#2)
to a second##19##3##(1990-10#1)(1990-11#1)(1992-3#1)(1992-7#1)(1993-9#1)(1996-5#2)(1997-3#1)(2006-10#2)(2007-6#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
to a second-order##2##3##(2008-2#1)(2013-7#1)
to a secondary##7##3##(1991-6#1)(1995-6#1)(2008-2#1)(2008-3#2)(2008-6#2)
to a segment of##2##4##(1991-6#1)(1994-3#1)
to a selection of##3##4##(1990-12#1)(2005-7#1)(2008-9#1)
to a selective##3##3##(1993-2#1)(2008-10#1)(2008-4#1)
to a sensitive##2##3##(2008-10#2)
to a separate##2##3##(2008-10#1)(2008-7#1)
to a separation##2##3##(2008-10#1)(2008-3#1)
to a sequence of##4##4##(1990-11#1)(1995-6#1)(1995-8#1)(1996-2#1)
to a sequence##11##3##(1990-11#1)(1992-8#1)(1993-6#1)(1995-10#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-7#1)(2008-10#2)(2008-7#1)
to a series of (S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-methoxybenzamides##2##5##(2008-10#2)
to a series of##18##4##(1990-2#1)(1991-5#1)(1991-9#1)(1995-10#1)(1995-5#1)(1996-3#1)(2004-4#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-4#1)(2008-6#1)(2010-2#1)(2013-1#2)
to a series##19##3##(1990-2#1)(1991-5#1)(1991-9#1)(1995-10#1)(1995-5#1)(1996-3#1)(2004-4#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-4#1)(2008-6#1)(2010-11#1)(2010-2#1)(2013-1#2)
to a serine##3##3##(1995-2#2)(2008-10#1)
to a service##2##3##(1991-12#2)
to a set of##22##4##(1992-12#1)(1995-6#1)(2006-10#1)(2006-12#2)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#4)(2008-8#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-8#2)
to a set point##2##4##(2008-6#2)
to a set##24##3##(1992-12#1)(1995-6#1)(2006-10#1)(2006-12#2)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#4)(2008-6#2)(2008-8#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-8#2)
to a severe form of##2##5##(2011-1#1)(2013-1#1)
to a severe##8##3##(1997-6#1)(2008-2#1)(2011-1#2)(2012-2#1)(2013-1#3)
to a shallow##3##3##(2011-2#2)(2013-8#1)
to a sharp##6##3##(1992-11#1)(1993-3#1)(1993-6#1)(2007-12#1)(2009-6#1)(2012-2#1)
to a shear stress##3##4##(2008-11#2)(2010-1#1)
to a shear##4##3##(2008-11#3)(2010-1#1)
to a shearing interferometer##2##4##(2008-3#2)
to a shift in the##4##5##(1990-7#1)(1993-12#1)(2008-10#1)(2008-2#1)
to a shift in##5##4##(1990-7#1)(1993-12#1)(2006-10#1)(2008-10#1)(2008-2#1)
to a shift to##2##4##(1994-5#1)(2008-5#1)
to a shift##10##3##(1990-7#1)(1993-12#1)(1994-5#1)(1997-8#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-3#1)
to a short but##2##4##(2007-2#1)(2008-7#1)
to a short##6##3##(2007-2#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#1)
to a short-lived##2##3##(1992-4#1)(2007-12#1)
to a short-term##2##3##(1995-12#1)(2007-12#1)
to a shortened##3##3##(1990-10#1)(2007-2#1)(2010-2#1)
to a signal##5##3##(1992-8#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-8#1)
to a significant and##2##4##(2010-7#1)(2013-1#1)
to a significant decrease in the##2##6##(1994-6#1)(2008-11#1)
to a significant decrease in##5##5##(1994-6#1)(2008-10#1)(2008-11#2)(2009-11#1)
to a significant degree##3##4##(2008-11#1)(2008-4#1)(2012-3#1)
to a significant enhancement##2##4##(1997-2#1)(2007-12#1)
to a significant extent by##2##5##(1990-4#1)(2008-7#1)
to a significant extent##9##4##(1990-4#1)(1991-6#1)(1994-11#1)(1995-1#1)(1996-7#1)(2008-4#1)(2008-6#1)(2008-7#1)(2011-2#1)
to a significant improvement of the##2##6##(2008-10#1)(2008-3#1)
to a significant improvement of##4##5##(1996-12#1)(2005-1#1)(2008-10#1)(2008-3#1)
to a significant improvement##6##4##(1996-12#1)(2005-1#1)(2006-10#1)(2008-10#1)(2008-3#1)(2013-1#1)
to a significant increase in the##2##6##(1991-4#1)(2007-11#1)
to a significant increase in##7##5##(1990-4#1)(1991-4#1)(1993-12#1)(2007-11#1)(2007-8#1)(2012-1#1)(2013-8#1)
to a significant increase##8##4##(1990-4#1)(1991-4#1)(1993-12#1)(2007-11#1)(2007-8#1)(2008-11#1)(2012-1#1)(2013-8#1)
to a significant reduction in the##4##6##(2006-5#1)(2008-3#1)(2010-7#1)(2011-1#1)
to a significant reduction in##8##5##(2006-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-7#1)(2011-1#1)(2011-10#1)
to a significant reduction of##5##5##(1996-11#1)(2008-10#1)(2008-2#1)(2008-6#1)(2011-2#1)
to a significant reduction##13##4##(1996-11#1)(2006-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-7#1)(2011-1#1)(2011-10#1)(2011-2#1)
to a significant##64##3##(1990-4#2)(1991-4#1)(1991-5#1)(1991-6#1)(1993-12#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-6#1)(1995-1#1)(1996-11#1)(1996-12#2)(1996-7#1)(1997-2#1)(2005-1#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-6#2)(2008-7#2)(2009-11#1)(2009-4#1)(2010-7#2)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-3#1)(2013-1#3)(2013-8#2)
to a significantly greater extent##3##5##(1991-7#1)(1991-8#1)(1997-9#1)
to a significantly greater##4##4##(1991-7#1)(1991-8#1)(1997-9#1)(2007-12#1)
to a significantly higher##2##4##(2008-5#2)
to a significantly##12##3##(1991-5#1)(1991-7#1)(1991-8#1)(1992-6#1)(1994-6#1)(1995-2#1)(1997-9#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-5#2)
to a silica##4##3##(1993-12#1)(1996-8#1)(2007-12#1)(2008-5#1)
to a similar degree as##2##5##(2008-7#1)(2012-12#1)
to a similar degree##7##4##(1995-8#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-12#1)
to a similar extent in##4##5##(1994-6#1)(1994-9#1)(1997-4#1)(2013-8#1)
to a similar extent##13##4##(1990-11#1)(1990-5#1)(1990-8#1)(1991-1#1)(1992-5#1)(1993-6#1)(1994-6#1)(1994-9#1)(1995-11#1)(1997-4#1)(1997-8#1)(2006-8#1)(2013-8#1)
to a similar##32##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#1)(1992-5#1)(1993-6#1)(1993-9#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-8#1)(2006-8#2)(2007-11#1)(2008-10#3)(2008-11#1)(2008-7#2)(2009-12#1)(2010-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
to a simple##15##3##(1990-7#1)(1991-3#1)(1992-6#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2011-2#1)
to a simpler##2##3##(2008-3#1)(2011-1#1)
to a simplified##2##3##(1992-8#1)(2012-2#1)
to a simulated##4##3##(2009-7#1)(2012-3#2)(2013-1#1)
to a single acute##2##4##(1993-12#1)(2007-10#1)
to a single band##2##4##(1992-7#1)(1993-2#1)
to a single class of##4##5##(1990-7#1)(1993-3#1)(1995-5#1)(1996-5#1)
to a single family##2##4##(2007-7#1)(2012-12#1)
to a single gene##3##4##(1990-12#1)(2006-1#1)(2008-8#1)
to a single host##2##4##(2007-7#1)(2011-2#1)
to a single image##2##4##(2007-11#1)(2008-2#1)
to a single mRNA##2##4##(1990-11#1)(1992-8#1)
to a single session of##2##5##(2008-7#1)(2013-7#1)
to a single##103##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#3)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-3#4)(1995-5#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-7#2)(1996-8#1)(1997-3#1)(2004-1#1)(2005-5#1)(2006-1#1)(2006-10#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-6#1)(2007-7#2)(2008-10#13)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-4#1)(2009-9#1)(2010-12#1)(2011-10#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
to a single-mode fiber##2##4##(2008-2#1)(2008-3#1)
to a single-mode##4##3##(2008-2#2)(2008-3#2)
to a single-stranded##3##3##(1990-10#1)(1997-7#1)(2008-1#1)
to a sinusoidal##2##3##(2008-2#1)(2009-4#1)
to a site##4##3##(1990-8#1)(2008-10#1)(2008-4#1)(2008-5#1)
to a situation##2##3##(2007-9#1)(2008-9#1)
to a size##3##3##(1996-10#1)(2008-3#2)
to a slight##3##3##(2005-11#1)(2008-10#1)(2010-9#1)
to a slightly lesser##2##4##(1990-5#1)(2010-3#1)
to a slightly##4##3##(1990-5#1)(1996-5#1)(2008-4#1)(2010-3#1)
to a slow##4##3##(1991-12#1)(1997-7#1)(2008-3#1)(2008-7#1)
to a slower##2##3##(1993-12#1)(2007-12#1)
to a slowing##2##3##(1991-12#1)(2006-2#1)
to a slowly##3##3##(1990-5#1)(1997-6#1)(2010-9#1)
to a small amount of##2##5##(2008-2#1)(2010-12#1)
to a small area of##2##5##(1991-8#1)(2008-5#1)
to a small area##4##4##(1991-8#1)(2008-10#2)(2008-5#1)
to a small extent by##2##5##(1991-9#1)(1996-1#1)
to a small extent##4##4##(1991-9#1)(1995-3#1)(1996-1#1)(2007-1#1)
to a small increase in the##2##6##(1992-8#1)(1997-7#1)
to a small molecule target##2##5##(2008-4#2)
to a small number of##2##5##(2008-10#1)(2008-8#1)
to a small##43##3##(1990-5#1)(1990-6#1)(1990-8#1)(1991-8#1)(1991-9#1)(1992-5#1)(1992-8#1)(1993-3#1)(1995-3#1)(1996-1#1)(1996-10#1)(1997-4#1)(1997-7#1)(2005-11#2)(2006-12#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-12#3)(2007-7#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
to a smaller extent##4##4##(1993-7#1)(1995-11#1)(2008-10#1)(2009-3#1)
to a smaller##7##3##(1993-6#1)(1993-7#1)(1995-11#1)(2008-10#1)(2008-9#1)(2009-3#1)(2012-2#1)
to a sodium atom##2##4##(1996-2#2)
to a solid support##5##4##(1991-7#1)(1993-12#1)(2008-4#3)
to a solid##12##3##(1991-10#1)(1991-7#1)(1992-11#1)(1993-12#1)(2005-11#1)(2008-2#1)(2008-3#1)(2008-4#4)(2013-1#1)
to a solid-phase##5##3##(1995-1#1)(2007-11#1)(2008-2#1)(2008-4#2)
to a soluble form of##2##5##(1994-5#1)(1995-1#1)
to a soluble##3##3##(1991-2#1)(1994-5#1)(1995-1#1)
to a solution of##5##4##(1991-6#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-1#1)
to a solution##8##3##(1991-6#1)(1994-12#1)(2006-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-2#1)
to a source of##3##4##(2008-5#1)(2008-7#1)(2009-3#1)
to a source##4##3##(1996-4#1)(2008-5#1)(2008-7#1)(2009-3#1)
to a spatial##2##3##(1995-12#1)(2008-7#1)
to a special##3##3##(1992-6#1)(1996-8#1)(2008-2#1)
to a specialist##8##3##(1995-3#1)(2006-12#1)(2008-1#1)(2008-11#1)(2009-11#1)(2010-2#1)(2013-8#2)
to a specialized##2##3##(2006-10#1)(2011-2#1)
to a species with##2##4##(1995-5#1)(1996-8#1)
to a species##5##3##(1992-10#1)(1995-5#1)(1996-8#1)(2008-10#2)
to a specific DNA##2##4##(1993-3#1)(1995-8#1)
to a specific activity of##2##5##(1990-12#1)(1996-4#1)
to a specific degree##2##4##(1990-12#1)(2005-11#1)
to a specific receptor##3##4##(2004-12#1)(2005-7#1)(2006-12#1)
to a specific region##2##4##(1993-9#1)(2011-2#1)
to a specific target##2##4##(2008-7#1)(2008-9#1)
to a specific##68##3##(1990-12#2)(1990-5#1)(1990-7#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-4#1)(1997-1#2)(1997-4#1)(1997-7#1)(2004-12#1)(2005-11#1)(2005-7#1)(2006-12#1)(2006-4#1)(2007-5#1)(2007-6#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#6)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-2#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#3)
to a spherical##3##3##(2005-11#1)(2007-12#1)(2008-3#1)
to a spontaneous##2##3##(1992-5#1)(2007-8#1)
to a square##2##3##(2007-12#1)(2008-5#1)
to a stable##11##3##(1990-11#1)(1991-9#1)(1993-8#1)(1994-5#1)(1995-5#1)(1997-5#1)(2006-12#1)(2007-12#2)(2008-6#1)(2008-8#1)
to a stage##3##3##(2006-5#1)(2008-7#1)(2009-10#1)
to a standard curve##2##4##(1990-4#1)(2008-2#1)
to a standard##26##3##(1990-12#1)(1990-4#1)(1992-8#1)(1996-8#1)(2004-9#1)(2005-6#1)(2006-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#2)(2009-10#1)(2010-1#1)(2010-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
to a standardized##6##3##(1990-12#1)(2005-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
to a state of##7##4##(1994-3#1)(1995-7#1)(2005-9#1)(2006-10#2)(2008-3#1)(2011-2#1)
to a state##10##3##(1994-3#1)(1994-9#1)(1995-2#1)(1995-7#1)(1996-6#1)(2005-9#1)(2006-10#2)(2008-3#1)(2011-2#1)
to a statistically##3##3##(1991-5#1)(2013-1#2)
to a steady##4##3##(1992-9#1)(1993-12#1)(2005-11#1)(2010-3#1)
to a steady-state##2##3##(1995-6#1)(2009-5#1)
to a stimulation##2##3##(2008-5#2)
to a stimulus##4##3##(1994-6#1)(2008-11#1)(2010-5#1)(2013-1#1)
to a stochastic##2##3##(2008-10#1)(2010-10#1)
to a straight line##3##4##(1995-8#2)(2008-10#1)
to a stray##2##3##(1994-2#1)(2007-4#1)
to a stream##2##3##(2008-10#1)(2011-2#1)
to a strong##13##3##(1990-10#1)(1990-11#2)(1993-2#1)(1997-3#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2009-5#1)(2011-1#1)(2011-12#1)
to a stronger##2##3##(2007-8#1)(2012-3#1)
to a structure##3##3##(1993-8#1)(1997-5#1)(2008-6#1)
to a structured##63##3##(2007-8#61)(2008-4#2)
to a study group##2##4##(1993-7#1)(2007-11#1)
to a study of the##4##5##(1996-8#1)(1997-1#1)(2007-11#1)(2009-5#1)
to a study of##6##4##(1993-3#1)(1996-8#1)(1997-1#1)(1997-8#1)(2007-11#1)(2009-5#1)
to a study on##2##4##(2008-11#1)(2008-2#1)
to a study##11##3##(1992-7#1)(1993-3#1)(1993-7#1)(1996-8#1)(1997-1#1)(1997-8#1)(2007-11#2)(2008-11#1)(2008-2#1)(2009-5#1)
to a sub-population of##2##4##(1992-10#1)(1992-8#1)
to a subclass of##2##4##(2006-10#1)(2008-3#1)
to a subcutaneous##2##3##(2006-6#1)(2008-3#1)
to a subpopulation of##3##4##(1994-2#1)(2012-12#2)
to a subsequent##3##3##(1991-9#1)(1995-5#1)(1997-8#1)
to a subset of patients##2##5##(1997-8#1)(2008-7#1)
to a subset of the##2##5##(1991-5#1)(1997-8#1)
to a subset of##5##4##(1991-5#1)(1997-8#2)(2008-7#1)(2009-3#1)
to a substantial##12##3##(1990-8#1)(1992-2#1)(1992-6#1)(1993-6#2)(1994-6#1)(1996-6#1)(2006-10#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-2#1)
to a substrate##7##3##(1992-11#1)(1994-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)
to a subtelomeric##2##3##(1996-4#2)
to a successful##10##3##(1991-12#1)(1995-11#1)(1996-1#1)(2006-3#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-9#1)(2009-9#1)(2010-12#1)
to a sudden##3##3##(1995-6#1)(2006-12#1)(2008-11#1)
to a suitable##4##3##(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)
to a sum of##3##4##(1991-8#1)(1997-1#1)(2006-10#1)
to a suppression##2##3##(1993-12#1)(2011-1#1)
to a surface and##2##4##(2006-11#1)(2008-9#1)
to a surface plasmon##2##4##(2008-10#1)(2008-3#1)
to a surface##12##3##(1994-8#1)(2006-11#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2013-8#1)
to a surgical##4##3##(1993-10#1)(1996-6#1)(2007-7#1)(2007-8#1)
to a surprisingly##2##3##(1990-6#1)(2008-10#1)
to a survey of##2##4##(1996-7#1)(2009-4#1)
to a survey##4##3##(1994-1#1)(1996-7#1)(2008-10#1)(2009-4#1)
to a survival##2##3##(1997-2#1)(2008-5#1)
to a suspension of##6##4##(1990-11#1)(1996-5#1)(1997-3#1)(2005-9#1)(2006-12#1)(2008-10#1)
to a sustained##3##3##(1994-6#1)(2005-8#1)(2006-9#1)
to a symptomatic##2##3##(1994-7#1)(2012-3#1)
to a syndrome##2##3##(2005-10#1)(2009-10#1)
to a synthetic peptide corresponding to the Ca(2+)-binding region##2##9##(1992-12#2)
to a synthetic peptide corresponding to##3##6##(1992-12#2)(1995-10#1)
to a synthetic peptide##7##4##(1991-7#1)(1992-12#2)(1993-3#1)(1995-10#1)(1997-8#1)(2004-2#1)
to a synthetic##12##3##(1990-3#1)(1990-6#1)(1991-7#1)(1992-12#2)(1993-3#1)(1995-10#1)(1995-8#1)(1997-8#1)(2004-2#1)(2008-10#1)(2008-7#1)
to a system of##4##4##(2005-10#2)(2007-11#1)(2008-10#1)
to a system that##2##4##(1990-10#1)(2008-6#1)
to a system##12##3##(1990-10#1)(1991-10#1)(2005-10#2)(2007-11#1)(2008-10#3)(2008-11#1)(2008-6#1)(2013-1#2)
to a systematic##3##3##(2005-11#1)(2009-8#1)(2010-4#1)
to a target on##2##4##(1993-3#1)(2008-2#1)
to a target##9##3##(1992-9#1)(1993-3#1)(1997-1#1)(2008-2#2)(2008-3#1)(2008-7#1)(2012-1#2)
to a temperature##6##3##(2007-11#1)(2007-12#2)(2008-10#2)(2008-5#1)
to a temporal##4##3##(2007-12#1)(2008-1#1)(2010-12#1)(2011-1#1)
to a terminal##3##3##(1996-9#1)(2007-3#1)(2008-11#1)
to a ternary##2##3##(1991-2#1)(1995-3#1)
to a tertiary care hospital##2##5##(1997-3#1)(2008-3#1)
to a tertiary care##4##4##(1997-3#1)(2006-10#1)(2008-3#1)(2012-2#1)
to a tertiary##8##3##(1997-3#1)(2006-10#1)(2007-11#1)(2008-3#1)(2010-12#1)(2012-2#3)
to a test##2##3##(2008-10#1)(2011-2#1)
to a theoretical expression##2##4##(1991-7#1)(2005-11#1)
to a theoretical model##4##4##(2008-2#1)(2008-3#1)(2008-5#1)(2013-8#1)
to a theoretical##8##3##(1991-7#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2013-8#1)
to a thicker##2##3##(2006-2#1)(2010-10#1)
to a thickness of##2##4##(1995-6#1)(2008-2#1)
to a thin##2##3##(2005-11#1)(2008-1#1)
to a third##2##3##(1990-5#1)(2008-10#1)
to a thorough##3##3##(1995-3#1)(1996-12#1)(2008-8#1)
to a three-dimensional##3##3##(1995-8#1)(2005-11#1)(2007-12#1)
to a threefold increase in the##2##6##(2008-10#1)(2008-4#1)
to a threshold##2##3##(2008-8#1)(2009-8#1)
to a thrombotic##2##3##(1990-11#1)(2013-8#1)
to a time##6##3##(1990-8#1)(2007-11#1)(2007-12#1)(2008-5#1)(2010-1#1)(2010-12#1)
to a time-dependent##4##3##(1993-6#1)(1994-3#1)(1995-1#1)(1996-5#1)
to a titanium##2##3##(2004-9#1)(2008-11#1)
to a toluene##2##3##(1995-10#1)(2006-4#1)
to a total dose of##3##5##(1991-2#1)(1993-7#1)(2008-6#1)
to a total of##8##4##(1990-11#1)(1990-9#1)(1997-2#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-6#1)(2012-2#1)
to a total##14##3##(1990-11#1)(1990-9#1)(1991-2#1)(1992-10#1)(1993-7#1)(1997-2#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-6#2)(2009-11#1)(2012-2#1)
to a toxicant##2##3##(2008-9#2)
to a traditional##2##3##(2008-10#1)(2009-3#1)
to a transcription##2##3##(1996-7#1)(2008-6#1)
to a transient##7##3##(1991-3#1)(1991-4#1)(1997-1#1)(1997-7#1)(2006-11#1)(2008-10#1)(2008-2#1)
to a translocation##2##3##(1992-3#1)(2008-10#1)
to a trauma##2##3##(2007-12#1)(2009-7#1)
to a treatment##5##3##(1997-7#1)(2006-1#1)(2006-5#1)(2006-8#1)(2011-1#1)
to a trial##2##3##(1996-2#1)(2008-6#1)
to a turbostratic##2##3##(1993-4#2)
to a two-chain##2##3##(1992-12#2)
to a two-dimensional##2##3##(2008-2#1)(2008-3#1)
to a two-step##2##3##(2005-11#1)(2008-11#1)
to a twofold##2##3##(2008-2#1)(2010-10#1)
to a typical##9##3##(2007-12#2)(2007-3#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#1)
to a tyrosine residue##2##4##(1992-1#1)(1993-11#1)
to a ubiquitous##2##3##(1994-8#1)(2008-10#1)
to a uniform##2##3##(1993-3#1)(2008-10#1)
to a unique##9##3##(1991-11#1)(1992-3#1)(1994-11#1)(1994-3#1)(1995-10#1)(1996-5#1)(2008-2#1)(2008-4#1)(2012-2#1)
to a university##2##3##(2007-3#1)(2008-11#1)
to a useful##2##3##(1993-4#1)(2008-7#1)
to a value of##4##4##(1991-1#1)(1992-8#1)(1994-9#1)(2008-2#1)
to a value##10##3##(1991-1#1)(1992-3#1)(1992-8#1)(1994-9#1)(2007-12#3)(2008-2#1)(2008-3#1)(2009-5#1)
to a variable##3##3##(1993-6#1)(1997-3#1)(2012-2#1)
to a variation in##2##4##(2007-12#2)
to a variation##3##3##(2007-12#2)(2008-3#1)
to a variety of environmental##3##5##(1993-4#1)(2008-3#1)(2012-2#1)
to a variety of other##3##5##(1992-2#1)(2008-4#1)(2008-9#1)
to a variety of physiological and##3##6##(2005-8#1)(2008-2#1)(2008-4#1)
to a variety of stimuli##2##5##(1992-11#1)(2008-4#1)
to a variety of##92##4##(1990-8#2)(1992-11#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-8#1)(1996-12#1)(1996-9#1)(1997-7#1)(2004-3#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-2#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#5)(2008-2#3)(2008-3#2)(2008-4#5)(2008-5#3)(2008-7#5)(2008-8#3)(2008-9#4)(2009-2#1)(2009-5#1)(2009-9#2)(2010-11#1)(2010-4#2)(2010-6#2)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#2)
to a varying##2##3##(1994-8#1)(2008-7#1)
to a vast##2##3##(2006-10#1)(2012-1#1)
to a venous##2##3##(1992-7#1)(2006-6#1)
to a very different##2##4##(2007-9#1)(2010-10#1)
to a very high##2##4##(1992-8#1)(2007-10#1)
to a very low##2##4##(1992-11#1)(2013-8#1)
to a very small extent##2##5##(2006-12#1)(2008-10#1)
to a very stable##2##4##(2008-10#2)
to a very##16##3##(1990-4#1)(1992-11#1)(1992-8#1)(1994-2#1)(1997-1#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-9#1)(2008-10#5)(2010-10#1)(2013-8#1)
to a vicious cycle of##2##5##(1994-2#1)(2012-12#1)
to a visual##5##3##(1995-12#1)(1996-2#1)(2008-10#2)(2012-12#1)
to a warm##4##3##(1995-12#1)(2005-7#1)(2012-4#1)(2012-6#1)
to a wave##2##3##(2008-2#1)(2008-3#1)
to a waveguide##2##3##(2007-12#2)
to a wavelength of##2##4##(2008-2#2)
to a wavelength##3##3##(2007-11#1)(2008-2#2)
to a weak##4##3##(1993-7#1)(1994-11#1)(1997-7#1)(2007-5#1)
to a weaker##2##3##(1996-4#1)(2005-11#1)
to a well##2##3##(2008-10#1)(2011-1#1)
to a well-defined##2##3##(1990-9#1)(2008-3#1)
to a well-established##2##3##(1996-11#1)(2008-2#1)
to a wheelchair##2##3##(1993-9#1)(2012-1#1)
to a wide array of##3##5##(1994-3#1)(2008-10#1)(2009-8#1)
to a wide range of##23##5##(1990-2#1)(1991-2#1)(1992-11#1)(1994-6#1)(1995-8#1)(1997-3#1)(2005-7#1)(2007-10#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-7#2)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)
to a wide spectrum of##3##5##(2008-6#1)(2008-7#1)(2011-2#1)
to a wide variety of other##2##6##(2008-10#1)(2011-3#1)
to a wide variety of##18##5##(1995-2#1)(1995-3#1)(1997-2#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2009-4#1)(2010-4#1)(2011-3#1)(2012-3#1)
to a wide##55##3##(1990-2#1)(1991-12#1)(1991-2#1)(1992-11#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#5)(2008-8#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#1)(2012-3#1)
to a wider audience##2##4##(2008-5#1)(2008-7#1)
to a wider##6##3##(1996-9#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-8#1)
to a wild-type##2##3##(2007-12#1)(2007-9#1)
to a woman##2##3##(1991-12#1)(1993-11#1)
to a word##2##3##(2008-2#1)(2008-4#1)
to a working##2##3##(2008-10#1)(2008-2#1)
to a worse long-term##2##4##(2006-6#1)(2007-10#1)
to a worse##3##3##(2006-6#1)(2007-10#1)(2012-12#1)
to a wound##2##3##(2007-5#1)(2008-11#1)
to a written##2##3##(2006-8#1)(2007-4#1)
to a young##2##3##(1996-3#1)(2008-2#1)
to a##6782##2##(1990-1#1)(1990-10#19)(1990-11#38)(1990-12#43)(1990-2#28)(1990-3#26)(1990-4#22)(1990-5#46)(1990-6#12)(1990-7#22)(1990-8#32)(1990-9#13)(1991-1#7)(1991-10#9)(1991-11#16)(1991-12#40)(1991-2#31)(1991-3#25)(1991-4#18)(1991-5#38)(1991-6#36)(1991-7#29)(1991-8#22)(1991-9#30)(1992-1#16)(1992-10#6)(1992-11#26)(1992-12#31)(1992-2#14)(1992-3#29)(1992-4#11)(1992-5#14)(1992-6#26)(1992-7#17)(1992-8#43)(1992-9#23)(1993-1#6)(1993-10#6)(1993-11#24)(1993-12#45)(1993-2#23)(1993-3#36)(1993-4#16)(1993-5#11)(1993-6#26)(1993-7#16)(1993-8#22)(1993-9#23)(1994-1#4)(1994-10#3)(1994-11#32)(1994-12#32)(1994-2#47)(1994-3#36)(1994-4#1)(1994-5#29)(1994-6#36)(1994-7#5)(1994-8#37)(1994-9#39)(1995-1#32)(1995-10#21)(1995-11#23)(1995-12#35)(1995-2#43)(1995-3#49)(1995-4#5)(1995-5#38)(1995-6#26)(1995-7#5)(1995-8#44)(1995-9#12)(1996-1#23)(1996-10#12)(1996-11#16)(1996-12#31)(1996-2#31)(1996-3#20)(1996-4#20)(1996-5#52)(1996-6#20)(1996-7#21)(1996-8#24)(1996-9#26)(1997-1#31)(1997-2#42)(1997-3#40)(1997-4#42)(1997-5#14)(1997-6#33)(1997-7#44)(1997-8#24)(1997-9#2)(2004-1#2)(2004-10#3)(2004-11#7)(2004-12#6)(2004-2#6)(2004-3#2)(2004-4#3)(2004-7#1)(2004-8#1)(2004-9#8)(2005-1#1)(2005-10#13)(2005-11#59)(2005-12#6)(2005-4#2)(2005-5#3)(2005-6#3)(2005-7#17)(2005-8#21)(2005-9#6)(2006-1#5)(2006-10#100)(2006-11#12)(2006-12#54)(2006-2#26)(2006-3#4)(2006-4#13)(2006-5#23)(2006-6#21)(2006-7#14)(2006-8#44)(2006-9#11)(2007-1#12)(2007-10#24)(2007-11#106)(2007-12#215)(2007-2#31)(2007-3#21)(2007-4#22)(2007-5#20)(2007-6#16)(2007-7#44)(2007-8#140)(2007-9#40)(2008-1#53)(2008-10#584)(2008-11#172)(2008-12#38)(2008-2#212)(2008-3#242)(2008-4#129)(2008-5#141)(2008-6#75)(2008-7#172)(2008-8#78)(2008-9#71)(2009-1#4)(2009-10#24)(2009-11#25)(2009-12#14)(2009-2#9)(2009-3#25)(2009-4#28)(2009-5#29)(2009-6#19)(2009-7#17)(2009-8#22)(2009-9#21)(2010-1#13)(2010-10#17)(2010-11#20)(2010-12#47)(2010-2#38)(2010-3#23)(2010-4#26)(2010-5#25)(2010-6#15)(2010-7#22)(2010-8#19)(2010-9#19)(2011-1#67)(2011-10#2)(2011-12#15)(2011-2#141)(2011-3#2)(2011-9#1)(2012-1#46)(2012-11#16)(2012-12#88)(2012-2#106)(2012-3#57)(2012-4#1)(2012-6#1)(2013-1#153)(2013-7#19)(2013-8#76)
to a)##2##2##(2007-12#1)(2008-7#1)
to abandon the##7##3##(1991-6#1)(2006-5#1)(2007-11#1)(2007-4#1)(2008-3#1)(2008-4#1)(2009-4#1)
to abandon their##2##3##(1996-6#1)(2008-9#1)
to abandon##17##2##(1991-6#1)(1993-1#1)(1993-9#1)(1996-2#1)(1996-6#1)(1997-8#1)(2004-2#1)(2006-5#1)(2007-11#2)(2007-2#1)(2007-4#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-4#1)
to abandonment of##2##3##(1992-5#1)(2012-3#1)
to abdominal hysterectomy##2##3##(1995-3#1)(2013-1#1)
to abdominal##14##2##(1992-6#1)(1993-12#1)(1993-3#1)(1995-3#1)(2007-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-7#1)(2010-12#1)(2010-8#2)(2011-12#1)(2013-1#1)
to aberrant splicing##2##3##(1990-12#1)(1996-4#1)
to aberrant##6##2##(1990-12#1)(1990-6#1)(1995-9#1)(1996-4#1)(2009-12#1)(2012-12#1)
to abiotic and##2##3##(2009-6#2)
to abiotic stress##3##3##(2008-7#1)(2009-8#2)
to abiotic stresses##2##3##(2009-8#2)
to abiotic##7##2##(2008-7#1)(2009-6#2)(2009-8#4)
to ablate the##2##3##(2007-12#1)(2007-8#1)
to ablate##7##2##(1991-2#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-5#1)(2013-1#2)
to ablation##2##2##(1993-9#1)(2010-12#1)
to abnormal##18##2##(1992-6#1)(1994-9#1)(1995-11#1)(1996-6#1)(1996-8#1)(1997-7#2)(2006-10#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
to abnormalities in##4##3##(1992-10#1)(2005-10#1)(2008-1#1)(2013-1#1)
to abnormalities of##2##3##(2006-3#1)(2008-5#1)
to abnormalities##6##2##(1992-10#1)(2005-10#1)(2006-3#1)(2008-1#1)(2008-5#1)(2013-1#1)
to abolish the##3##3##(1990-11#1)(1991-10#1)(1992-7#1)
to abolish##11##2##(1990-11#1)(1991-10#1)(1992-7#1)(1994-10#1)(1995-12#1)(1995-6#1)(1996-7#1)(1997-5#1)(2006-10#1)(2007-8#2)
to abortion##8##2##(1990-8#1)(1992-6#1)(1993-3#1)(1995-9#1)(1996-8#1)(2006-4#1)(2012-11#1)(2013-1#1)
to abortions##2##2##(1991-10#1)(1996-6#1)
to about 0##5##3##(1990-11#1)(1990-7#1)(2008-10#3)
to about 1%##2##3##(1990-11#1)(2012-11#1)
to about 10%##2##3##(1991-7#1)(2007-7#1)
to about 100##2##3##(1994-6#1)(1995-11#1)
to about 2##7##3##(1990-4#1)(1992-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-12#1)(2011-2#1)
to about 20##3##3##(1997-4#1)(2008-10#2)
to about 3##2##3##(1992-3#1)(1996-10#1)
to about 3%##2##3##(2006-12#1)(2007-3#1)
to about 4##6##3##(1996-10#2)(1996-6#1)(1997-4#1)(2008-10#1)(2012-12#1)
to about 40% of##2##4##(2005-11#1)(2010-8#1)
to about 40%##4##3##(1994-8#2)(2005-11#1)(2010-8#1)
to about 5##3##3##(1991-3#1)(1995-5#1)(2008-7#1)
to about 50##2##3##(1990-11#1)(1992-12#1)
to about 50% of##2##4##(1994-5#1)(1997-4#1)
to about 500##2##3##(1996-1#1)(2005-11#1)
to about 80% of the##2##5##(1991-6#1)(1992-3#1)
to about 80%##3##3##(1991-6#1)(1992-3#1)(2011-2#1)
to about half##3##3##(1994-11#1)(1995-8#1)(2013-8#1)
to about one##3##3##(2008-10#1)(2008-6#1)(2008-7#1)
to about the##2##3##(1994-8#1)(2008-10#1)
to about##108##2##(1990-10#1)(1990-11#3)(1990-4#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-10#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-11#3)(1994-11#1)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#4)(1996-12#2)(1996-4#2)(1996-6#2)(1996-9#2)(1997-1#2)(1997-4#3)(1997-6#1)(2004-9#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#15)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#2)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-12#2)(2011-2#2)(2011-7#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
to above the##2##3##(2007-8#1)(2012-1#1)
to above##6##2##(2005-11#1)(2007-8#1)(2007-9#1)(2010-4#1)(2011-1#1)(2012-1#1)
to abrogate##4##2##(1992-12#1)(1992-7#1)(2008-11#1)(2008-8#1)
to abscess formation##2##3##(2006-10#1)(2012-2#1)
to abscission##3##2##(2008-10#3)
to absence of##2##3##(2011-2#1)(2012-2#1)
to absent##3##2##(2008-10#1)(2008-6#1)(2008-8#1)
to absolute##7##2##(1995-12#1)(1996-4#1)(2007-11#1)(2007-12#1)(2008-2#2)(2010-8#1)
to absorb##11##2##(1992-9#1)(1993-12#1)(1996-12#1)(1997-1#1)(2006-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#2)
to absorbed##4##2##(2007-11#1)(2008-1#1)(2008-2#1)(2012-2#1)
to absorption and emission##2##4##(2008-10#1)(2008-3#1)
to absorption and##3##3##(2008-10#1)(2008-3#1)(2012-12#1)
to absorption of##3##3##(2007-11#1)(2008-3#2)
to absorption##15##2##(2006-12#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#4)(2012-12#1)
to abstain from##2##3##(2004-11#1)(2008-12#1)
to abstain##3##2##(2004-11#1)(2005-10#1)(2008-12#1)
to abstract##4##2##(1992-1#1)(2006-3#1)(2008-7#1)(2011-1#1)
to abundant##2##2##(1992-6#1)(2009-8#1)
to abuse of##2##3##(1996-2#1)(1997-2#1)
to abuse##5##2##(1993-12#1)(1995-5#1)(1996-2#1)(1997-2#1)(2007-6#1)
to academic achievement##2##3##(2009-7#1)(2010-1#1)
to academic knowledge##2##3##(1996-3#1)(2011-2#1)
to academic##11##2##(1996-3#1)(2004-3#1)(2007-4#1)(2007-8#1)(2009-7#1)(2010-1#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)
to accelerate bone healing##2##4##(2008-5#2)
to accelerate recovery##2##3##(1995-2#1)(2006-10#1)
to accelerate the##16##3##(1994-2#1)(1995-2#1)(2006-10#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-5#1)(2012-3#1)
to accelerate##40##2##(1992-8#1)(1993-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#2)(1996-5#1)(1997-2#1)(1997-4#1)(2005-8#1)(2006-10#2)(2007-8#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-5#1)(2010-6#1)(2012-2#1)(2012-3#2)
to accelerated##9##2##(1992-8#1)(1994-6#1)(1997-2#1)(2006-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#1)
to accept a##3##3##(2007-9#1)(2008-8#1)(2012-2#1)
to accept it##2##3##(2006-8#1)(2012-2#1)
to accept or##2##3##(1993-11#1)(2008-3#1)
to accept the reality of##2##5##(1994-12#1)(2006-4#1)
to accept the##10##3##(1992-3#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-11#1)(1996-6#1)(1997-8#1)(2006-4#1)(2006-8#1)(2008-11#1)
to accept##43##2##(1992-3#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-8#1)(2006-4#1)(2006-5#1)(2006-8#2)(2007-10#3)(2007-12#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#3)(2009-5#1)(2011-1#1)(2011-9#1)(2012-12#2)(2012-2#2)(2012-3#1)
to acceptable levels##2##3##(2008-5#1)(2010-9#1)
to acceptable##4##2##(1991-11#1)(2008-12#1)(2008-5#1)(2010-9#1)
to acceptance##5##2##(2006-5#1)(2012-12#2)(2013-1#1)(2013-8#1)
to accepted##9##2##(1991-11#1)(1994-3#2)(1997-4#1)(2006-5#1)(2007-11#1)(2008-12#1)(2008-7#1)(2009-5#1)
to acceptor##3##2##(1994-5#1)(2008-10#1)(2009-10#1)
to access a##2##3##(1996-4#1)(2010-4#1)
to access and utilise##2##4##(2008-11#1)(2008-4#1)
to access and##8##3##(1996-2#1)(2007-2#1)(2008-11#2)(2008-4#1)(2008-7#2)(2010-8#1)
to access health care services##2##5##(2010-1#2)
to access health services##2##4##(2008-11#1)(2012-3#1)
to access health##4##3##(2008-11#1)(2010-1#2)(2012-3#1)
to access site##2##3##(2007-7#1)(2011-2#1)
to access the##19##3##(1993-2#1)(2006-5#1)(2006-8#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#2)(2009-10#1)(2010-5#1)(2011-1#1)(2012-11#1)(2012-3#1)(2013-1#2)
to access those resources##2##4##(2008-7#1)(2010-9#1)
to access to##6##3##(1996-3#1)(2007-10#1)(2007-4#1)(2008-1#1)(2008-9#1)(2013-1#1)
to access##91##2##(1993-11#1)(1993-2#1)(1995-12#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-8#1)(2005-7#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#5)(2008-11#5)(2008-12#4)(2008-2#3)(2008-3#3)(2008-4#3)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#2)(2009-4#1)(2009-7#1)(2010-1#3)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#5)(2012-11#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
to accessibility of##2##3##(1992-2#1)(1992-8#1)
to accessibility##4##2##(1992-2#1)(1992-8#1)(2007-8#1)(2010-8#1)
to accessing##3##2##(2010-7#1)(2010-8#1)(2012-2#1)
to acclimate to##3##3##(2009-8#1)(2012-5#1)(2013-1#1)
to accommodate a##8##3##(1996-9#1)(2005-11#1)(2007-8#1)(2008-11#3)(2008-2#1)(2012-3#1)
to accommodate an##3##3##(1996-5#1)(1997-5#1)(2006-3#1)
to accommodate both##4##3##(1992-2#2)(1997-2#1)(2010-2#1)
to accommodate the##13##3##(1991-4#1)(1994-3#2)(2007-12#2)(2007-8#1)(2010-10#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-2#2)(2013-8#1)
to accommodate them##2##3##(2006-12#1)(2007-12#1)
to accommodate these##3##3##(1992-1#1)(2008-10#1)(2008-6#1)
to accommodate this##2##3##(1994-3#1)(2010-10#1)
to accommodate to##2##3##(2004-12#1)(2008-4#1)
to accommodate##74##2##(1991-4#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-3#1)(1994-1#1)(1994-3#3)(1994-4#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-6#1)(2004-12#1)(2005-11#1)(2006-12#1)(2006-3#1)(2006-5#3)(2007-11#1)(2007-12#4)(2007-8#3)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#5)(2008-4#2)(2008-6#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#4)(2012-3#1)(2013-7#1)(2013-8#1)
to accommodation##2##2##(2010-9#2)
to accompany this##2##3##(2009-3#1)(2009-5#1)
to accompany##13##2##(1992-10#1)(1992-11#1)(1992-12#1)(2005-11#1)(2008-2#1)(2008-3#1)(2009-3#1)(2009-5#1)(2011-12#2)(2011-2#1)(2012-11#1)(2012-2#1)
to accompanying##2##2##(2007-8#1)(2008-12#1)
to accomplish a##3##3##(2008-9#1)(2010-2#2)
to accomplish the##12##3##(1995-12#1)(2006-8#1)(2006-9#1)(2007-3#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-6#1)(2009-12#1)(2011-1#1)(2013-1#1)
to accomplish this##13##3##(1992-3#1)(1994-2#1)(1996-12#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#2)(2012-2#1)(2013-1#1)
to accomplish##59##2##(1991-1#1)(1992-1#1)(1992-3#1)(1994-2#1)(1995-1#1)(1995-12#2)(1996-12#1)(1996-2#1)(1996-9#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-12#2)(2009-2#2)(2010-2#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2012-2#2)(2013-1#4)(2013-7#2)(2013-8#1)
to account for a##4##4##(1997-7#1)(2007-5#1)(2008-2#1)(2009-4#1)
to account for changes in##2##5##(2008-10#2)
to account for differences in##3##5##(1991-3#1)(2008-2#1)(2012-2#1)
to account for it##2##4##(1991-2#1)(2006-11#1)
to account for most##2##4##(1995-6#1)(2008-10#1)
to account for multiple##2##4##(2008-3#2)
to account for the apparent##2##5##(2008-10#1)(2009-4#1)
to account for the complex##2##5##(2007-12#1)(2010-7#1)
to account for the effects of##3##6##(2007-5#1)(2008-10#2)
to account for the high##2##5##(1995-1#1)(2006-7#1)
to account for the large##2##5##(1991-7#1)(2007-5#1)
to account for the observed rate##2##6##(1992-9#1)(1997-4#1)
to account for the observed##4##5##(1992-9#1)(1997-4#1)(2005-11#1)(2006-3#1)
to account for the##65##4##(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-6#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-4#2)(2005-11#4)(2006-10#1)(2006-11#1)(2006-3#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-5#2)(2007-8#1)(2008-10#5)(2008-2#3)(2008-3#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-7#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#2)
to account for these##3##4##(2007-10#1)(2008-5#1)(2010-2#1)
to account for this##6##4##(1991-2#1)(1992-2#1)(1994-11#1)(1996-8#2)(1997-3#1)
to account for varying##3##4##(2008-10#1)(2010-11#1)(2013-1#1)
to account for##149##3##(1990-8#3)(1990-9#1)(1991-12#1)(1991-2#4)(1991-3#2)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#1)(1992-9#2)(1993-12#1)(1993-6#2)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#3)(1996-5#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(2004-2#1)(2005-11#5)(2006-10#2)(2006-11#2)(2006-3#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-5#3)(2007-8#1)(2007-9#2)(2008-10#12)(2008-11#1)(2008-2#6)(2008-3#12)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#3)(2009-3#1)(2009-4#3)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-12#3)(2012-2#1)(2012-3#5)(2013-1#1)
to account##155##2##(1990-8#3)(1990-9#1)(1991-12#1)(1991-2#4)(1991-3#2)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#1)(1992-9#2)(1993-12#1)(1993-6#2)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#2)(1996-12#3)(1996-5#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(2004-2#1)(2005-11#6)(2006-10#2)(2006-11#2)(2006-3#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-5#3)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#12)(2008-11#1)(2008-2#7)(2008-3#13)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#3)(2009-3#1)(2009-4#3)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-12#3)(2012-2#1)(2012-3#5)(2013-1#1)
to accountability##2##2##(1997-3#1)(2011-2#1)
to accounts##2##2##(1994-2#1)(2011-1#1)
to accredit##2##2##(1994-12#1)(2008-11#1)
to accrue##3##2##(1992-12#1)(2006-10#1)(2010-3#1)
to accumulate in the cell##2##5##(1991-10#1)(2011-2#1)
to accumulate in the food chain##2##6##(2008-10#2)
to accumulate in the##8##4##(1991-10#1)(1992-8#1)(1996-7#1)(2008-10#2)(2008-4#1)(2010-2#1)(2011-2#1)
to accumulate in##17##3##(1991-1#1)(1991-10#1)(1992-7#1)(1992-8#1)(1993-6#1)(1994-3#1)(1996-7#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)(2009-3#1)(2010-2#1)(2011-2#1)(2013-8#1)
to accumulate the##3##3##(1990-1#1)(1994-5#1)(2008-10#1)
to accumulate##59##2##(1990-1#1)(1990-2#1)(1991-1#1)(1991-10#1)(1991-6#1)(1991-8#1)(1992-7#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#2)(1997-2#1)(1997-4#1)(2005-11#1)(2006-10#4)(2006-12#2)(2007-1#1)(2007-12#2)(2008-10#12)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#2)(2009-3#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-8#2)
to accumulated##4##2##(1995-3#1)(2007-9#1)(2009-2#1)(2011-2#1)
to accumulation of##14##3##(1991-3#1)(1992-4#1)(1994-8#1)(1995-10#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
to accumulation##16##2##(1991-3#1)(1992-4#1)(1993-9#1)(1994-8#1)(1995-10#1)(2006-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
to accuracy and##2##3##(2008-10#1)(2009-1#1)
to accuracy##7##2##(1996-3#1)(2008-10#3)(2008-3#1)(2008-7#1)(2009-1#1)
to accurate##6##2##(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-8#1)
to accurately and efficiently##2##4##(2008-5#1)(2009-3#1)
to accurately and##4##3##(2008-5#1)(2009-3#1)(2013-1#2)
to accurately assess the##4##4##(2008-7#1)(2009-11#1)(2011-2#2)
to accurately assess##8##3##(1996-7#1)(2008-7#1)(2009-11#1)(2010-2#1)(2011-2#2)(2013-1#2)
to accurately define##2##3##(1994-6#1)(2007-8#1)
to accurately describe##2##3##(2008-5#1)(2009-6#1)
to accurately determine##6##3##(1994-3#1)(1996-9#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-8#1)
to accurately estimate##2##3##(2011-1#1)(2012-1#1)
to accurately evaluate the##2##4##(1991-12#1)(2008-10#1)
to accurately identify##5##3##(2008-10#1)(2008-3#1)(2009-7#1)(2010-3#1)(2012-2#1)
to accurately measure##2##3##(2007-12#1)(2008-10#1)
to accurately predict the##6##4##(1996-4#1)(2005-11#1)(2007-4#1)(2008-10#1)(2008-2#1)(2013-1#1)
to accurately predict##9##3##(1992-3#1)(1996-4#1)(2005-11#2)(2007-4#1)(2008-10#1)(2008-2#1)(2008-7#1)(2013-1#1)
to accurately quantify##3##3##(2012-12#2)(2013-8#1)
to accurately reproduce the##2##4##(1993-11#1)(2010-2#1)
to accurately##66##2##(1991-12#1)(1992-3#1)(1993-11#1)(1994-3#1)(1994-6#1)(1995-5#1)(1996-4#1)(1996-7#1)(1996-9#1)(2005-11#2)(2006-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#5)(2013-8#3)
to acesulfame potassium##5##3##(2008-9#5)
to acetaldehyde##5##2##(1993-12#1)(1994-5#1)(2008-10#1)(2009-8#1)(2010-2#1)
to acetate and carbon dioxide##2##5##(2006-8#2)
to acetate and propionate##2##4##(2006-8#2)
to acetate and##8##3##(1992-4#1)(2006-8#6)(2008-6#1)
to acetate##16##2##(1992-4#1)(1994-10#1)(2005-12#1)(2006-8#10)(2008-6#1)(2009-10#1)(2010-5#1)
to acetazolamide##2##2##(2006-8#1)(2007-9#1)
to acetic acid##5##3##(1992-11#1)(2009-8#1)(2011-2#1)(2012-2#2)
to acetoin##3##2##(2013-1#3)
to acetone##2##2##(2008-10#1)(2009-12#1)
to acetyl-CoA##3##2##(1992-7#1)(1995-6#1)(2013-1#1)
to acetylated forms of ganglioside GD3##2##6##(1992-9#2)
to acetylcholine (ACh)##2##3##(2009-12#1)(2010-8#1)
to acetylcholine was##3##3##(1992-1#1)(1994-7#1)(2013-8#1)
to acetylcholine##14##2##(1990-4#1)(1991-8#1)(1992-1#1)(1994-7#2)(1996-12#2)(2008-4#2)(2009-12#1)(2009-5#1)(2010-8#1)(2012-2#1)(2013-8#1)
to acetylcholinesterase##2##2##(1997-7#1)(2008-9#1)
to acetylsalicylic acid]##2##3##(1994-9#1)(1996-2#1)
to achieve a better##2##4##(2007-4#1)(2013-8#1)
to achieve a certain level of##2##6##(2006-6#1)(2008-1#1)
to achieve a complete##3##4##(2005-9#1)(2008-6#1)(2009-3#1)
to achieve a desirable##2##4##(2010-2#1)(2010-8#1)
to achieve a fast##2##4##(2007-12#1)(2008-10#1)
to achieve a further##2##4##(1992-3#1)(1994-3#1)
to achieve a good##4##4##(1993-12#1)(2008-10#1)(2008-5#1)(2010-7#1)
to achieve a high##7##4##(1995-6#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#1)
to achieve a maximum##2##4##(2008-10#1)(2008-3#1)
to achieve a more##3##4##(1991-9#1)(1996-1#1)(2013-8#1)
to achieve a satisfactory##2##4##(2007-8#1)(2013-7#1)
to achieve a suitable##2##4##(2011-2#2)
to achieve a target##4##4##(1991-12#1)(2007-8#1)(2013-1#2)
to achieve a therapeutic##2##4##(1992-3#1)(2010-6#1)
to achieve a uniform##2##4##(2008-2#1)(2008-3#1)
to achieve a##106##3##(1991-12#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-9#1)(1993-12#2)(1993-3#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-4#1)(1997-2#1)(2005-10#1)(2005-9#1)(2006-12#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-11#4)(2007-12#5)(2007-4#2)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#7)(2008-11#5)(2008-2#6)(2008-3#8)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#2)
to achieve accurate##5##3##(1994-2#1)(2006-6#1)(2008-2#1)(2008-4#1)(2008-5#1)
to achieve adequate##7##3##(2005-3#1)(2006-12#1)(2007-9#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#1)
to achieve all##4##3##(1994-2#1)(2008-11#1)(2009-11#1)(2012-2#1)
to achieve an improvement in##2##5##(1991-8#1)(2011-1#1)
to achieve an optimal##4##4##(1991-8#1)(2008-2#2)(2013-1#1)
to achieve an optimum##2##4##(2006-8#1)(2008-10#1)
to achieve an##26##3##(1990-12#1)(1991-8#2)(1996-5#1)(1997-1#1)(1997-3#1)(2006-12#1)(2006-8#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#1)(2008-5#1)(2011-1#2)(2012-3#1)(2013-1#1)
to achieve and maintain##2##4##(2008-10#1)(2010-12#1)
to achieve and##5##3##(2007-8#1)(2008-10#1)(2008-11#2)(2010-12#1)
to achieve appropriate##2##3##(2008-10#1)(2013-1#1)
to achieve best##3##3##(1995-5#1)(2008-3#1)(2011-1#1)
to achieve better results##2##4##(2008-5#1)(2011-2#1)
to achieve better##11##3##(1997-8#1)(2006-10#1)(2008-2#1)(2008-5#1)(2009-10#1)(2010-12#1)(2010-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
to achieve clinical##4##3##(1992-6#1)(2007-11#1)(2008-1#1)(2009-4#1)
to achieve complete##10##3##(1992-10#1)(2005-9#1)(2006-10#1)(2006-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-9#1)(2011-2#1)
to achieve consistent##2##3##(1995-3#1)(2005-5#1)
to achieve control of##2##4##(2008-10#1)(2008-8#1)
to achieve cure##3##3##(2006-10#1)(2008-2#1)(2008-6#1)
to achieve desirable##3##3##(2009-6#1)(2013-1#2)
to achieve desired##4##3##(1995-8#1)(2008-1#1)(2008-10#1)(2012-1#1)
to achieve different##2##3##(2008-10#1)(2008-3#1)
to achieve early detection of##2##5##(2008-10#1)(2009-4#1)
to achieve early##3##3##(2007-11#1)(2008-10#1)(2009-4#1)
to achieve effective##3##3##(2005-7#1)(2007-11#1)(2011-2#1)
to achieve efficient##4##3##(2007-8#1)(2009-12#1)(2012-12#1)(2013-8#1)
to achieve excellent##2##3##(2008-3#1)(2008-9#1)
to achieve full##3##3##(1992-12#1)(2007-10#1)(2008-10#1)
to achieve functional##4##3##(2011-2#2)(2012-2#1)(2012-3#1)
to achieve further##2##3##(1992-3#1)(2012-12#1)
to achieve fusion##3##3##(2006-10#1)(2006-8#1)(2008-4#1)
to achieve good surgical##2##4##(1991-5#1)(2007-11#1)
to achieve good##5##3##(1991-5#1)(2005-11#1)(2007-11#2)(2011-1#1)
to achieve greater##5##3##(1993-1#1)(1994-1#1)(2007-12#1)(2008-11#1)(2008-3#1)
to achieve hemostasis##2##3##(2010-3#1)(2013-8#1)
to achieve high resolution##2##4##(2008-10#1)(2008-3#1)
to achieve high sensitivity##2##4##(2008-10#1)(2008-3#1)
to achieve high##16##3##(1990-12#1)(2006-6#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-11#1)
to achieve high-quality##2##3##(2008-11#1)(2013-1#1)
to achieve homogeneous##2##3##(2007-12#1)(2008-3#1)
to achieve improved##4##3##(1996-2#1)(1997-7#1)(2008-3#1)(2013-1#1)
to achieve in order to##2##5##(2008-11#1)(2013-1#1)
to achieve in##6##3##(1995-5#1)(2006-6#1)(2008-1#1)(2008-11#1)(2013-1#2)
to achieve its goal##2##4##(2007-12#1)(2007-4#1)
to achieve its goals##3##4##(1990-12#1)(1996-3#1)(2007-11#1)
to achieve its##8##3##(1990-12#1)(1991-12#1)(1994-10#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-4#1)(2011-1#1)
to achieve large##3##3##(2005-10#1)(2008-3#2)
to achieve low##3##3##(1996-8#1)(2007-8#1)(2008-2#1)
to achieve lower##2##3##(2008-10#1)(2012-2#1)
to achieve maximal##4##3##(1995-8#1)(2007-12#1)(2008-2#1)(2009-3#1)
to achieve maximum##9##3##(1993-8#1)(1997-1#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-7#1)(2008-9#1)
to achieve meaningful##2##3##(1993-3#1)(2007-6#1)
to achieve more##2##3##(1992-3#1)(2010-11#1)
to achieve new##2##3##(2004-3#1)(2008-1#1)
to achieve optimal##6##3##(1990-12#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
to achieve optimum##5##3##(1992-2#1)(1997-3#1)(2006-6#2)(2009-2#1)
to achieve patient##2##3##(1996-2#1)(2012-2#1)
to achieve quality##2##3##(1991-3#1)(1996-2#1)
to achieve rapid##3##3##(2008-11#1)(2010-2#1)(2012-12#1)
to achieve recanalization##2##3##(2008-12#1)(2013-7#1)
to achieve remission##2##3##(2011-2#1)(2013-8#1)
to achieve safe##2##3##(2010-12#1)(2011-2#1)
to achieve satisfactory results##2##4##(2010-12#2)
to achieve satisfactory##3##3##(2008-7#1)(2010-12#2)
to achieve selective##3##3##(1995-12#1)(2008-7#1)(2010-1#1)
to achieve similar##2##3##(1992-6#1)(2010-2#1)
to achieve some##2##3##(2007-12#1)(2010-12#1)
to achieve specificity##2##3##(1994-12#1)(2006-6#1)
to achieve stable##3##3##(2007-12#1)(2007-6#1)(2008-7#1)
to achieve steady-state##2##3##(1991-8#1)(2008-12#1)
to achieve successful##4##3##(2008-9#2)(2011-2#1)(2013-1#1)
to achieve superior##3##3##(2006-10#1)(2010-1#1)(2011-2#1)
to achieve superresolution##2##3##(2007-12#1)(2008-3#1)
to achieve sustained##2##3##(2010-3#1)(2013-8#1)
to achieve target##5##3##(2008-1#1)(2008-3#1)(2008-8#1)(2011-12#1)(2013-1#1)
to achieve the best##8##4##(1990-3#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-4#1)(2013-8#1)
to achieve the characteristics of##2##5##(2006-1#1)(2008-3#1)
to achieve the desired##5##4##(2007-12#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-8#1)
to achieve the goal of##3##5##(1995-4#1)(2008-11#1)(2008-3#1)
to achieve the goals of##2##5##(2008-7#1)(2013-7#1)
to achieve the goals##3##4##(2008-11#1)(2008-7#1)(2013-7#1)
to achieve the intended goals##2##5##(2008-7#1)(2010-11#1)
to achieve the maximum##2##4##(2005-11#1)(2008-2#1)
to achieve the most##3##4##(1995-5#1)(2009-8#1)(2013-8#1)
to achieve the necessary##4##4##(1994-12#1)(2008-11#1)(2013-1#2)
to achieve the objectives of##2##5##(1996-12#1)(2011-2#1)
to achieve the optimum##2##4##(2007-12#1)(2012-2#1)
to achieve the quantitative##2##4##(2008-10#2)
to achieve the required##3##4##(1995-1#1)(2007-12#1)(2008-1#1)
to achieve the same##7##4##(1996-2#1)(2006-10#1)(2007-12#2)(2008-5#1)(2008-9#1)(2011-2#1)
to achieve the##91##3##(1990-11#1)(1990-3#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-12#2)(1995-1#1)(1995-4#1)(1995-5#1)(1996-12#1)(1996-2#1)(2005-11#1)(2005-5#1)(2005-9#1)(2006-1#1)(2006-10#2)(2007-11#2)(2007-12#6)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#8)(2008-11#3)(2008-2#7)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-10#1)(2009-3#2)(2009-7#1)(2009-8#2)(2010-11#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#5)(2012-1#3)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#3)
to achieve their##10##3##(1990-12#1)(1994-12#1)(2006-10#1)(2006-6#1)(2007-2#1)(2009-5#1)(2010-3#2)(2011-2#2)
to achieve these goals##3##4##(2006-5#1)(2007-1#1)(2011-2#1)
to achieve these##5##3##(1993-12#1)(2006-5#1)(2007-1#1)(2008-11#1)(2011-2#1)
to achieve this aim##2##4##(1996-7#1)(2012-3#1)
to achieve this goal##10##4##(2006-12#1)(2007-4#1)(2008-12#1)(2008-5#2)(2008-6#1)(2009-10#2)(2010-6#1)(2012-3#1)
to achieve this##28##3##(1990-11#1)(1991-3#2)(1994-9#1)(1996-11#1)(1996-7#1)(1997-3#1)(1997-8#2)(2006-12#1)(2007-11#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2009-10#2)(2010-10#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2012-3#2)
to achieve two##2##3##(1992-2#1)(2009-12#1)
to achieve union of the##2##5##(2007-7#1)(2008-4#1)
to achieve very good##2##4##(2007-11#1)(2007-7#1)
to achieve very##4##3##(2007-11#1)(2007-7#1)(2008-10#1)(2008-4#1)
to achieve your##2##3##(1996-1#1)(2012-1#1)
to achieve##721##2##(1990-11#2)(1990-12#7)(1990-2#1)(1990-3#2)(1990-8#1)(1991-12#3)(1991-2#1)(1991-3#3)(1991-5#2)(1991-6#1)(1991-8#3)(1991-9#1)(1992-10#2)(1992-12#2)(1992-2#5)(1992-3#5)(1992-4#2)(1992-6#3)(1992-8#1)(1992-9#2)(1993-1#2)(1993-12#5)(1993-3#2)(1993-6#2)(1993-8#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#6)(1994-2#2)(1994-3#1)(1994-4#1)(1994-5#2)(1994-8#2)(1994-9#2)(1995-1#2)(1995-12#3)(1995-2#2)(1995-3#3)(1995-4#1)(1995-5#4)(1995-6#1)(1995-8#3)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#6)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#3)(2004-3#1)(2004-4#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-3#1)(2005-5#2)(2005-7#4)(2005-8#1)(2005-9#5)(2006-1#1)(2006-10#11)(2006-12#6)(2006-3#1)(2006-5#3)(2006-6#9)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#3)(2007-11#26)(2007-12#31)(2007-2#1)(2007-4#6)(2007-5#3)(2007-6#2)(2007-7#7)(2007-8#14)(2007-9#3)(2008-1#14)(2008-10#44)(2008-11#28)(2008-12#8)(2008-2#39)(2008-3#41)(2008-4#11)(2008-5#12)(2008-6#6)(2008-7#16)(2008-8#10)(2008-9#7)(2009-10#5)(2009-11#2)(2009-12#4)(2009-2#1)(2009-3#6)(2009-4#4)(2009-5#1)(2009-6#3)(2009-7#3)(2009-8#4)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#10)(2010-2#4)(2010-3#7)(2010-4#3)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#17)(2011-12#3)(2011-2#30)(2012-1#5)(2012-11#1)(2012-12#6)(2012-2#9)(2012-3#13)(2013-1#27)(2013-7#3)(2013-8#13)
to achievement of##2##3##(2008-12#1)(2010-5#1)
to achieving a##4##3##(1991-12#1)(1996-3#1)(2008-3#1)(2012-1#1)
to achieving optimal##2##3##(2008-1#1)(2010-8#1)
to achieving the##2##3##(1996-3#1)(2005-5#1)
to achieving##21##2##(1991-12#1)(1994-12#1)(1994-2#1)(1996-1#1)(1996-3#2)(2005-5#1)(2006-3#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)
to acid and##5##3##(2007-3#1)(2007-8#1)(2008-10#2)(2012-12#1)
to acid hydrolysis##3##3##(1992-12#1)(2008-10#1)(2012-12#1)
to acid phosphatase##2##3##(1993-4#1)(2012-1#1)
to acid##20##2##(1990-2#1)(1992-12#1)(1992-6#1)(1993-4#1)(1994-11#1)(1996-12#1)(1996-9#1)(2007-3#1)(2007-8#1)(2008-10#5)(2008-8#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#2)
to acid-base##3##2##(2008-10#3)
to acidic conditions##2##3##(1995-8#1)(2013-7#1)
to acidic phospholipid vesicles##2##4##(1994-11#2)
to acidic##14##2##(1990-7#1)(1992-4#1)(1993-3#1)(1994-11#2)(1995-8#1)(2008-10#4)(2009-11#1)(2010-12#1)(2012-9#1)(2013-7#1)
to acidify the##2##3##(1992-6#1)(2011-1#1)
to acknowledge and##2##3##(1995-11#1)(2011-2#1)
to acknowledge the##3##3##(2006-7#1)(2008-12#1)(2012-3#1)
to acknowledge##17##2##(1993-2#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-11#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2009-2#1)(2011-2#1)(2012-3#1)
to acne##4##2##(2006-12#1)(2007-1#1)(2008-5#2)
to acoustic stimuli##2##3##(1996-2#1)(2008-4#1)
to acoustic##4##2##(1996-2#1)(2006-11#1)(2008-2#1)(2008-4#1)
to acquire a##15##3##(1992-12#1)(1992-9#1)(1994-3#1)(1995-5#1)(2005-4#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-11#1)(2012-3#1)
to acquire an##3##3##(2007-7#1)(2009-9#1)(2010-2#1)
to acquire and##4##3##(1994-3#1)(2008-10#1)(2008-4#1)(2012-3#1)
to acquire images of##2##4##(2008-11#1)(2008-5#1)
to acquire images##3##3##(2006-5#1)(2008-11#1)(2008-5#1)
to acquire information##3##3##(2006-2#1)(2008-2#1)(2008-7#1)
to acquire new##3##3##(1990-12#1)(2007-2#1)(2008-11#1)
to acquire quantitative##3##3##(2008-1#1)(2008-10#1)(2011-1#1)
to acquire such##4##3##(2006-6#1)(2007-12#1)(2008-3#1)(2008-7#1)
to acquire the##8##3##(1990-9#1)(1992-11#1)(1994-6#1)(2007-1#1)(2008-10#3)(2008-4#1)
to acquire##80##2##(1990-12#1)(1990-9#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-6#2)(1994-3#2)(1994-6#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-4#1)(1997-1#1)(2005-4#1)(2005-9#1)(2006-2#1)(2006-5#1)(2006-6#2)(2007-1#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#5)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#1)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#2)
to acquired##6##2##(1990-6#1)(1995-2#1)(2006-4#1)(2007-8#2)(2008-7#1)
to acrinathrin##2##2##(2011-2#2)
to acrylamide##2##2##(1992-6#1)(1994-9#1)
to acrylic acid##2##3##(2008-6#2)
to acrylic##3##2##(2008-6#2)(2011-1#1)
to act as a scaffold##2##5##(2012-2#1)(2012-8#1)
to act as a##28##4##(1990-7#1)(1990-8#1)(1990-9#1)(1991-7#1)(1991-9#1)(1992-7#1)(1993-3#1)(1994-10#1)(1994-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-4#1)(2005-7#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-7#1)(2009-8#1)(2010-7#1)(2011-1#1)(2012-2#1)(2012-8#1)(2013-1#1)
to act as an inhibitor of##2##6##(2008-1#1)(2010-2#1)
to act as an##11##4##(1990-7#1)(1994-12#1)(1995-3#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-2#1)(2010-8#1)
to act as inhibitors##2##4##(1990-11#1)(1991-11#1)
to act as substrates for the##2##6##(1991-5#1)(1994-5#1)
to act as substrates for##4##5##(1991-5#1)(1994-5#1)(1995-3#1)(2008-4#1)
to act as the##4##4##(1990-9#1)(1993-6#1)(1994-3#1)(2008-11#1)
to act as transcription##2##4##(1997-6#1)(2008-10#1)
to act as##81##3##(1990-11#1)(1990-2#1)(1990-7#2)(1990-8#2)(1990-9#2)(1991-11#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-7#1)(1993-3#2)(1993-4#1)(1993-6#1)(1994-10#2)(1994-12#2)(1994-3#1)(1994-5#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-10#1)(1996-12#2)(1996-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-7#1)(2006-1#1)(2006-3#1)(2007-11#4)(2007-12#3)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-2#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2012-2#1)(2012-8#1)(2013-1#1)(2013-8#2)
to act at the##3##4##(1990-5#1)(1991-9#1)(1997-3#1)
to act at##6##3##(1990-5#1)(1991-9#1)(1993-9#1)(1994-3#1)(1995-3#1)(1997-3#1)
to act by##2##3##(1997-4#1)(2008-4#1)
to act differently##2##3##(2008-10#1)(2010-12#1)
to act directly##4##3##(1991-5#1)(1991-8#1)(1994-6#1)(2008-11#1)
to act in a##2##4##(1992-1#1)(1997-8#1)
to act in##7##3##(1992-1#1)(1993-1#1)(1995-3#1)(1997-8#1)(2008-10#1)(2008-8#1)(2011-2#1)
to act like a##2##4##(2007-8#1)(2008-10#1)
to act like##3##3##(2007-8#1)(2008-10#1)(2008-3#1)
to act on the##6##4##(1991-2#1)(1993-9#1)(1994-6#1)(1996-8#1)(2007-11#1)(2012-1#1)
to act on##15##3##(1990-12#1)(1990-7#1)(1991-2#1)(1992-12#1)(1993-9#1)(1994-6#2)(1994-9#1)(1996-8#1)(1997-8#1)(2004-12#1)(2007-11#1)(2008-6#1)(2012-1#1)(2012-11#1)
to act primarily##2##3##(2005-10#1)(2008-2#1)
to act synergistically with##2##4##(1993-2#1)(2008-10#1)
to act through a##2##4##(2005-9#1)(2008-3#1)
to act through##6##3##(1991-12#1)(1994-12#1)(1995-11#1)(2005-9#1)(2008-3#1)(2010-9#1)
to act upon##3##3##(1993-12#1)(1997-8#1)(2010-12#1)
to act with##2##3##(1991-11#1)(2010-7#1)
to act##162##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#1)(1990-7#3)(1990-8#2)(1990-9#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-9#2)(1994-10#2)(1994-12#3)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#3)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#3)(2004-12#1)(2004-9#1)(2005-10#1)(2005-12#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-3#2)(2006-7#3)(2007-11#5)(2007-12#4)(2007-3#1)(2007-5#2)(2007-8#2)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-2#2)(2012-8#1)(2013-1#1)(2013-8#3)
to actin and##2##3##(1990-9#1)(1995-2#1)
to actin filament##2##3##(1991-5#1)(2008-11#1)
to actin filaments and##2##4##(1993-8#1)(2009-10#1)
to actin filaments##5##3##(1993-8#1)(1993-9#1)(1997-7#1)(2009-10#1)(2010-12#1)
to actin in##2##3##(1990-12#1)(1994-5#1)
to actin is##4##3##(1993-8#3)(1994-9#1)
to actin was##3##3##(1993-8#1)(1995-5#1)(1997-7#1)
to actin##32##2##(1990-12#2)(1990-9#1)(1991-5#1)(1992-4#1)(1992-5#1)(1993-8#7)(1993-9#1)(1994-12#1)(1994-5#4)(1994-9#2)(1995-2#1)(1995-5#1)(1996-11#1)(1997-7#2)(2008-11#1)(2008-6#1)(2009-10#1)(2010-12#2)(2011-2#1)
to acting##4##2##(1993-11#1)(2007-11#2)(2007-8#1)
to action##17##2##(1991-2#1)(1991-6#1)(1992-2#1)(1993-12#2)(1996-1#1)(1997-2#1)(2008-1#1)(2009-1#1)(2009-4#1)(2009-5#2)(2009-6#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-7#1)
to actions##2##2##(2008-7#1)(2012-2#1)
to activate C'##2##3##(2005-9#2)
to activate Fyn##2##3##(2010-2#2)
to activate Ras##2##3##(1994-12#1)(1996-8#1)
to activate a##8##3##(1991-8#1)(1993-3#1)(1996-2#1)(1996-3#1)(1996-5#1)(2007-9#1)(2009-8#2)
to activate amygdala neurons##2##4##(1997-7#2)
to activate an##2##3##(1993-11#1)(2008-10#1)
to activate and##5##3##(1996-3#1)(1996-8#1)(1997-3#1)(2008-4#1)(2009-3#1)
to activate human##2##3##(2008-10#1)(2013-1#1)
to activate peripheral##2##3##(1993-4#1)(1997-1#1)
to activate protein kinase A (PKA)##2##6##(2010-11#1)(2011-12#1)
to activate protein kinase##3##4##(1991-9#1)(2010-11#1)(2011-12#1)
to activate the enzyme##2##4##(1990-8#1)(1992-6#1)
to activate the receptor##2##4##(1992-4#1)(1995-3#1)
to activate the transcription of##3##5##(1990-8#1)(1997-1#1)(2012-1#1)
to activate the transcription##4##4##(1990-8#1)(1995-6#1)(1997-1#1)(2012-1#1)
to activate the##36##3##(1990-11#1)(1990-5#1)(1990-8#3)(1991-5#1)(1991-8#1)(1992-12#1)(1992-4#1)(1992-6#2)(1993-3#1)(1993-9#2)(1994-10#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-4#1)(1997-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#1)(2009-6#1)(2010-6#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
to activate transcription from##2##4##(1994-8#1)(1997-2#1)
to activate transcription##9##3##(1990-8#1)(1991-8#1)(1994-8#2)(1995-2#1)(1995-3#1)(1997-2#1)(1997-6#1)(2010-8#1)
to activate two##2##3##(1995-10#1)(2007-12#1)
to activate##147##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#2)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#2)(1991-5#2)(1991-7#1)(1991-8#5)(1991-9#1)(1992-11#1)(1992-12#2)(1992-4#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#4)(1994-5#1)(1994-8#3)(1995-1#2)(1995-10#1)(1995-12#2)(1995-2#2)(1995-3#5)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#3)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#1)(1997-6#1)(1997-7#3)(2005-10#1)(2005-9#2)(2006-10#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#4)(2008-7#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-6#2)(2009-8#2)(2010-11#1)(2010-2#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#2)
to activated monocytes##2##3##(1993-9#1)(2012-2#1)
to activated platelets##2##3##(1991-10#1)(2008-5#1)
to activated protein C##2##4##(1992-12#1)(1997-3#1)
to activated rhodopsin##3##3##(1994-9#2)(1997-7#1)
to activated##23##2##(1990-12#1)(1990-3#1)(1991-10#2)(1991-2#1)(1992-12#1)(1993-8#1)(1993-9#1)(1994-9#2)(1995-12#1)(1995-3#1)(1995-4#1)(1996-10#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#1)(2008-4#1)(2008-5#1)(2012-2#1)
to activating##3##2##(1990-2#1)(2007-11#1)(2009-8#1)
to activation by##4##3##(1990-3#2)(1996-12#1)(2006-3#1)
to activation of the##10##4##(1991-8#1)(1992-12#1)(1992-6#1)(1994-10#1)(1997-6#1)(2008-11#2)(2008-4#2)(2008-8#1)
to activation of##37##3##(1990-5#1)(1991-11#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-6#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#2)(1994-9#1)(1996-10#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-8#2)(2010-12#1)(2010-3#1)(2010-4#1)(2012-3#1)(2013-7#1)
to activation with##3##3##(1993-6#2)(2009-9#1)
to activation##47##2##(1990-3#2)(1990-5#1)(1991-11#1)(1991-6#1)(1991-8#2)(1992-12#1)(1992-6#1)(1993-3#1)(1993-6#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#2)(1994-9#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2012-3#1)(2013-7#1)
to active##29##2##(1992-11#1)(1992-7#1)(1993-11#1)(1994-11#2)(1994-12#1)(1994-6#1)(1996-11#1)(1996-5#1)(1997-2#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-6#1)(2007-8#2)(2008-10#2)(2008-11#2)(2009-11#1)(2009-8#2)(2010-12#2)(2010-5#1)(2010-7#1)(2012-2#1)
to actively participate in##3##4##(2011-2#2)(2012-12#1)
to actively##24##2##(1995-3#1)(1997-1#1)(2006-10#3)(2006-9#1)(2007-11#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-12#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-1#3)(2012-12#1)(2012-3#1)
to activin A##6##3##(1992-6#3)(1994-9#3)
to activin##8##2##(1991-8#1)(1992-4#1)(1992-6#3)(1994-9#3)
to activities##3##2##(1997-6#1)(2009-3#1)(2013-7#1)
to activity of##2##3##(1992-3#1)(2009-8#1)
to activity##15##2##(1992-3#2)(1993-6#1)(2006-10#2)(2006-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2009-3#3)(2009-8#1)(2013-1#2)
to actors##2##2##(2009-9#1)(2013-7#1)
to actual##7##2##(1992-12#1)(1995-12#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2011-2#1)
to actually##7##2##(1995-12#1)(2004-11#1)(2007-12#2)(2008-10#1)(2008-9#1)(2011-1#1)
to actuate##3##2##(2006-12#2)(2008-11#1)
to acuity##2##2##(1996-1#1)(2011-2#1)
to acupuncture##3##2##(1993-3#1)(1997-6#1)(2006-10#1)
to acute and chronic##3##4##(2006-10#1)(2008-1#1)(2008-5#1)
to acute care##2##3##(1993-12#1)(2007-5#1)
to acute exposure to##3##4##(2008-7#1)(2009-4#1)(2012-1#1)
to acute hypoxia##2##3##(1995-12#2)
to acute myelocytic leukemia##2##4##(2008-7#1)(2011-2#1)
to acute myocardial infarction##2##4##(2012-1#1)(2013-1#1)
to acute myocardial##3##3##(1996-9#1)(2012-1#1)(2013-1#1)
to acute psychological stress##2##4##(2008-11#1)(2011-2#1)
to acute respiratory failure##2##4##(2007-8#1)(2012-2#1)
to acute respiratory##3##3##(2007-8#1)(2012-2#2)
to acute stress##7##3##(1994-11#1)(1995-12#1)(2013-1#5)
to acute##95##2##(1991-3#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-2#1)(1992-6#1)(1993-10#1)(1993-12#1)(1993-2#1)(1994-10#1)(1994-11#1)(1994-6#1)(1995-12#5)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-8#2)(1996-9#1)(2005-12#1)(2006-10#4)(2007-1#1)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#3)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#1)(2011-1#2)(2011-2#7)(2012-1#3)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#1)
to acutely##3##2##(1991-6#1)(1995-12#1)(2006-10#1)
to acyclovir##3##2##(1995-6#2)(2008-5#1)
to acylate##2##2##(1992-6#1)(1994-12#1)
to adapt a##3##3##(2007-11#1)(2008-5#2)
to adapt better##2##3##(1997-2#1)(2008-1#1)
to adapt the##15##3##(1990-12#1)(1993-6#1)(1994-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2009-9#1)(2010-11#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
to adapt their##9##3##(1993-8#1)(1995-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-2#1)(2011-1#1)
to adapt them to##2##4##(1991-2#1)(2008-3#1)
to adapt them##3##3##(1991-2#1)(2006-10#1)(2008-3#1)
to adapt themselves to##2##4##(2008-1#1)(2013-1#1)
to adapt to a##4##4##(1994-6#1)(2007-10#1)(2008-11#1)(2008-7#1)
to adapt to chronic##2##4##(1990-8#1)(2012-12#1)
to adapt to new##2##4##(1995-3#1)(2008-10#1)
to adapt to the##6##4##(2008-10#1)(2008-8#2)(2012-1#1)(2012-6#1)(2013-8#1)
to adapt to##27##3##(1990-8#1)(1993-9#2)(1994-12#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-1#1)(2006-10#1)(2006-12#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#3)(2009-6#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-6#1)(2013-8#2)
to adapt##78##2##(1990-12#1)(1990-8#1)(1991-2#1)(1991-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-4#1)(2004-4#1)(2006-10#3)(2006-12#1)(2006-3#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#2)(2008-1#2)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#3)(2008-5#3)(2008-7#2)(2008-8#4)(2009-6#1)(2009-9#1)(2010-11#1)(2010-8#1)(2011-1#2)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#3)(2013-8#3)
to adaptation to##2##3##(2011-2#1)(2012-3#1)
to adaptation##4##2##(1992-4#1)(2008-8#1)(2011-2#1)(2012-3#1)
to adaptations to##2##3##(2008-12#1)(2011-2#1)
to adaptations##3##2##(1995-10#1)(2008-12#1)(2011-2#1)
to adaptive##6##2##(2007-1#1)(2008-11#1)(2008-3#1)(2011-1#1)(2012-1#1)(2012-3#1)
to add a##10##3##(1997-3#1)(2004-3#1)(2006-10#1)(2006-12#1)(2007-7#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)
to add another##2##3##(2007-5#1)(2009-2#1)
to add in the##2##4##(2008-10#1)(2009-9#1)
to add liquid to the##2##5##(2008-11#2)
to add the##2##3##(2008-10#1)(2012-3#1)
to add to the##4##4##(2004-3#1)(2008-7#1)(2009-7#1)(2011-2#1)
to add to##7##3##(1995-3#1)(2004-3#1)(2006-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#1)
to add value##2##3##(1997-1#1)(2004-11#1)
to add##51##2##(1993-6#1)(1995-3#1)(1995-8#1)(1997-1#1)(1997-3#1)(2004-11#1)(2004-3#2)(2005-1#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-7#1)(2009-9#1)(2010-4#2)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-7#1)
to added##2##2##(1992-8#1)(1994-5#1)
to addiction##3##2##(1996-10#1)(2008-6#1)(2013-8#1)
to adding##2##2##(2008-7#1)(2013-7#1)
to addition of##4##3##(1993-12#1)(1993-6#1)(1994-6#1)(2008-11#1)
to addition##7##2##(1993-12#1)(1993-6#1)(1994-6#1)(1996-6#1)(2007-12#1)(2008-11#1)(2008-9#1)
to additional information##2##3##(1996-5#1)(2008-4#1)
to additional##21##2##(1994-3#1)(1996-5#1)(1997-1#1)(2006-10#4)(2007-11#2)(2007-5#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2012-12#1)(2012-2#1)(2013-8#1)
to additionally##2##2##(2010-4#1)(2012-12#1)
to additive##3##2##(2008-2#2)(2008-3#1)
to address NCDs##3##3##(2012-12#1)(2013-8#2)
to address a##6##3##(1994-2#1)(1996-1#1)(2008-12#1)(2008-3#1)(2012-12#1)(2013-7#1)
to address and##3##3##(2006-3#1)(2007-2#1)(2008-3#1)
to address both##3##3##(2006-4#1)(2008-7#1)(2010-1#1)
to address complex##2##3##(1996-3#1)(2009-8#1)
to address concerns about##2##4##(2007-4#1)(2012-3#1)
to address concerns##4##3##(2006-7#1)(2007-4#1)(2012-1#1)(2012-3#1)
to address gaps in##3##4##(1995-12#1)(2008-11#1)(2012-12#1)
to address health disparities##2##4##(2011-2#1)(2012-3#1)
to address health##3##3##(2008-4#1)(2011-2#1)(2012-3#1)
to address how##3##3##(2007-1#1)(2008-1#1)(2012-2#1)
to address issues of##4##4##(1996-8#1)(2007-10#1)(2012-12#1)(2012-3#1)
to address issues##8##3##(1996-3#1)(1996-8#1)(2007-10#1)(2008-1#1)(2010-5#1)(2012-12#2)(2012-3#1)
to address it##3##3##(2009-8#1)(2012-1#1)(2013-1#1)
to address many##2##3##(2007-5#1)(2011-1#1)
to address potential##2##3##(2008-4#1)(2010-5#1)
to address problems##3##3##(1993-12#1)(1994-3#1)(1997-2#1)
to address quality issues and##2##5##(1994-2#2)
to address questions##3##3##(2007-10#1)(2008-7#1)(2013-8#1)
to address several##3##3##(2008-7#1)(2012-1#1)(2012-3#1)
to address some of these##2##5##(2004-2#1)(2007-12#1)
to address some of##3##4##(2004-2#1)(2007-12#1)(2008-12#1)
to address specific##4##3##(1992-1#1)(2008-10#1)(2008-12#1)(2013-1#1)
to address the challenges##3##4##(2005-9#1)(2006-1#1)(2012-3#1)
to address the following##2##4##(1997-4#1)(2007-12#1)
to address the growing##2##4##(2007-10#1)(2007-4#1)
to address the importance of##2##5##(2007-3#1)(2009-11#1)
to address the issue of##4##5##(1991-12#1)(2006-5#1)(2006-7#1)(2009-4#1)
to address the issue##8##4##(1991-12#1)(1992-1#1)(1993-2#1)(2006-5#1)(2006-7#1)(2009-4#1)(2011-2#1)(2013-1#1)
to address the issues##3##4##(1991-1#1)(1991-3#1)(1997-3#1)
to address the lack of##2##5##(1992-1#1)(2011-2#1)
to address the multiple needs of a##2##7##(2012-12#1)(2012-2#1)
to address the multiple##5##4##(2007-1#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#1)
to address the need for##3##5##(2007-7#1)(2008-4#1)(2008-7#1)
to address the need##4##4##(2006-1#1)(2007-7#1)(2008-4#1)(2008-7#1)
to address the needs of##6##5##(1993-12#1)(2008-11#1)(2008-8#1)(2010-8#2)(2011-1#1)
to address the physical##2##4##(1997-2#1)(2011-2#1)
to address the problem of##4##5##(1997-1#1)(2004-10#1)(2007-5#1)(2008-1#1)
to address the problem##7##4##(1997-1#1)(1997-3#1)(2004-10#1)(2006-3#1)(2007-2#1)(2007-5#1)(2008-1#1)
to address the problems of##2##5##(2010-9#1)(2013-8#1)
to address the question of how##2##6##(2005-7#1)(2009-3#1)
to address the question of the##2##6##(1995-7#1)(1996-7#1)
to address the question of whether##2##6##(1994-5#1)(2007-7#1)
to address the question of##6##5##(1994-5#1)(1995-7#1)(1996-7#1)(2005-7#1)(2007-7#1)(2009-3#1)
to address the question##10##4##(1991-12#1)(1994-5#1)(1995-7#1)(1996-7#1)(2005-7#1)(2007-7#1)(2008-12#1)(2009-10#1)(2009-3#1)(2012-12#1)
to address the questions of##2##5##(2008-11#1)(2012-3#1)
to address the questions##3##4##(2007-8#1)(2008-11#1)(2012-3#1)
to address the##134##3##(1990-12#1)(1991-1#1)(1991-12#2)(1991-3#1)(1992-1#2)(1992-11#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#1)(2004-10#1)(2004-3#1)(2005-7#1)(2005-9#1)(2006-1#3)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-11#2)(2009-3#3)(2009-4#2)(2009-5#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-8#5)(2010-9#2)(2011-1#4)(2011-10#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#4)
to address their##5##3##(2008-3#1)(2008-4#1)(2009-12#1)(2009-4#1)(2011-2#1)
to address them##4##3##(1995-2#1)(2006-3#1)(2008-5#1)(2009-5#1)
to address these challenges##2##4##(2006-10#1)(2012-12#1)
to address these concerns##5##4##(2006-11#1)(2007-12#1)(2007-4#1)(2008-12#1)(2008-3#1)
to address these issues##12##4##(2004-10#1)(2005-11#1)(2005-8#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-6#1)(2009-11#1)(2010-12#1)(2012-2#1)(2013-1#1)
to address these problems##7##4##(2006-10#1)(2008-12#1)(2008-8#1)(2009-9#1)(2013-1#2)(2013-8#1)
to address these questions##3##4##(2008-11#1)(2009-1#1)(2013-1#1)
to address these##51##3##(1996-3#1)(1997-2#1)(2004-10#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#2)(2007-12#2)(2007-4#1)(2008-1#2)(2008-11#2)(2008-12#3)(2008-3#2)(2008-6#1)(2008-8#1)(2009-1#1)(2009-11#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-10#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#10)
to address this challenge##2##4##(2009-11#1)(2012-12#1)
to address this gap##2##4##(2007-2#1)(2012-11#1)
to address this issue as well as##2##7##(1994-3#1)(1995-8#1)
to address this issue by##2##5##(1996-1#1)(2009-4#1)
to address this issue##14##4##(1994-3#1)(1995-8#1)(1996-1#1)(2006-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-4#1)(2010-2#1)(2012-1#1)(2012-12#1)(2012-3#2)
to address this need##4##4##(1997-2#1)(2005-8#1)(2008-11#1)(2012-1#1)
to address this problem##7##4##(1993-3#1)(2007-12#1)(2008-7#1)(2011-2#2)(2013-1#2)
to address this question##4##4##(2007-11#1)(2008-11#1)(2008-8#1)(2009-8#1)
to address this##49##3##(1992-6#1)(1993-3#1)(1994-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1997-2#1)(2005-8#1)(2006-10#2)(2006-3#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-2#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
to address those##2##3##(2006-11#1)(2007-7#1)
to address varying##2##3##(2008-10#1)(2010-8#1)
to address whether##2##3##(1997-2#1)(2009-12#1)
to address##409##2##(1990-11#1)(1990-12#2)(1991-1#1)(1991-12#2)(1991-3#2)(1992-1#3)(1992-11#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#2)(1994-12#1)(1994-2#5)(1994-3#3)(1994-5#1)(1995-12#2)(1995-2#1)(1995-6#3)(1995-7#1)(1995-8#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#4)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#6)(1997-3#3)(1997-4#1)(2004-10#2)(2004-2#1)(2004-3#1)(2005-10#2)(2005-11#1)(2005-7#2)(2005-8#3)(2005-9#1)(2006-1#3)(2006-10#5)(2006-11#3)(2006-12#3)(2006-2#3)(2006-3#5)(2006-4#2)(2006-5#5)(2006-7#3)(2006-8#1)(2006-9#1)(2007-1#3)(2007-10#6)(2007-11#1)(2007-12#7)(2007-2#4)(2007-3#2)(2007-4#5)(2007-5#4)(2007-7#7)(2007-8#3)(2008-1#8)(2008-10#4)(2008-11#14)(2008-12#13)(2008-2#2)(2008-3#7)(2008-4#6)(2008-5#5)(2008-6#1)(2008-7#10)(2008-8#9)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#5)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#4)(2009-5#3)(2009-6#3)(2009-8#4)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#4)(2010-2#4)(2010-3#3)(2010-5#3)(2010-6#1)(2010-8#9)(2010-9#2)(2011-1#9)(2011-10#2)(2011-12#2)(2011-2#12)(2012-1#10)(2012-11#3)(2012-12#14)(2012-2#11)(2012-3#12)(2013-1#19)(2013-7#2)(2013-8#21)
to addressing##7##2##(1994-1#1)(1997-2#2)(2006-6#1)(2008-7#2)(2012-2#1)
to adenine##6##2##(1992-1#1)(1992-11#1)(1992-6#1)(1993-11#1)(1994-8#1)(2008-10#1)
to adenocarcinoma of the##3##4##(1991-9#1)(2013-1#2)
to adenosine A1##2##3##(1995-12#1)(1996-9#1)
to adenosine and##3##3##(1994-12#1)(2008-4#2)
to adenosine by##2##3##(2008-4#1)(2008-5#1)
to adenosine diphosphate (ADP)##2##4##(1997-7#1)(2008-4#1)
to adenosine##26##2##(1991-5#1)(1993-11#1)(1994-12#1)(1995-12#4)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(2008-4#9)(2008-5#2)(2012-2#2)(2012-3#2)
to adenylate cyclase##13##3##(1990-10#1)(1991-4#1)(1991-6#1)(1993-11#1)(1993-5#1)(1993-6#1)(1994-12#2)(1994-3#1)(1994-5#2)(1995-7#1)(2008-4#1)
to adenylate##14##2##(1990-10#1)(1991-4#1)(1991-6#1)(1993-11#1)(1993-5#1)(1993-6#1)(1994-12#2)(1994-3#1)(1994-5#2)(1995-7#1)(2008-4#2)
to adenylyl cyclase is dependent on receptor expression##2##8##(1997-8#2)
to adenylyl cyclase##5##3##(1993-3#1)(1996-12#1)(1997-8#3)
to adequacy##2##2##(2007-12#1)(2011-2#1)
to adequate##6##2##(1990-8#1)(2006-10#1)(2007-7#1)(2008-1#1)(2009-6#1)(2013-8#1)
to adequately protect##2##3##(2009-4#1)(2012-12#1)
to adequately treat##2##3##(2006-7#1)(2008-5#1)
to adequately##27##2##(1992-4#1)(1992-8#1)(2006-7#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-4#2)(2009-5#1)(2009-7#1)(2010-11#2)(2010-2#1)(2012-12#1)(2013-1#1)
to adhere and##2##3##(2008-5#2)
to adhere to ART##2##4##(2012-3#1)(2013-1#1)
to adhere to and##2##4##(2008-9#1)(2009-5#1)
to adhere to human##2##4##(2006-8#1)(2012-3#1)
to adhere to the##2##4##(2008-10#1)(2008-4#1)
to adhere to therapy##2##4##(1993-9#1)(2008-11#1)
to adhere to##28##3##(1990-12#1)(1992-11#1)(1992-3#1)(1993-9#1)(1995-9#1)(1996-12#1)(1997-6#1)(2006-6#1)(2006-8#3)(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#4)(2009-4#1)(2009-5#1)(2011-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
to adhere##36##2##(1990-12#1)(1992-11#2)(1992-3#1)(1993-9#2)(1995-9#1)(1996-12#1)(1997-6#1)(2006-6#1)(2006-8#3)(2007-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#4)(2008-9#4)(2009-4#1)(2009-5#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
to adherence##5##2##(2006-10#1)(2008-7#2)(2008-9#1)(2011-1#1)
to adherent cells##2##3##(2008-11#1)(2010-11#1)
to adherent##4##2##(2008-11#1)(2008-4#1)(2010-11#1)(2011-1#1)
to adhesion##2##2##(1991-2#1)(2012-12#1)
to adhesions##2##2##(2012-2#1)(2012-3#1)
to adipocyte##2##2##(1993-2#1)(2012-2#1)
to adiposity and##2##3##(1996-11#1)(2012-5#1)
to adjacent non-eosinophilic cells##2##4##(1994-9#2)
to adjacent regions##2##3##(1991-10#1)(2012-12#1)
to adjacent structures##3##3##(1993-3#1)(2005-5#1)(2009-3#1)
to adjacent##31##2##(1990-3#2)(1991-10#1)(1992-5#1)(1992-6#1)(1993-3#1)(1994-9#2)(1996-11#1)(1997-7#1)(2005-5#1)(2006-10#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-10#7)(2008-2#2)(2008-5#1)(2008-7#2)(2009-3#1)(2012-12#1)(2012-2#1)
to adjust for##11##3##(1990-8#1)(1991-2#1)(1994-3#1)(1995-4#1)(2008-2#1)(2008-3#2)(2011-1#1)(2012-2#2)(2012-3#1)
to adjust posture##2##3##(1994-3#1)(1995-5#1)
to adjust the##23##3##(1991-12#1)(1992-6#2)(1994-9#1)(1995-12#1)(1996-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-2#3)(2008-3#2)(2008-8#2)(2008-9#1)(2011-3#1)
to adjust their##3##3##(2007-11#1)(2009-12#1)(2012-3#1)
to adjust to the##2##4##(2008-5#1)(2009-4#1)
to adjust to##4##3##(1995-3#1)(2008-2#1)(2008-5#1)(2009-4#1)
to adjust##67##2##(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#1)(1992-6#2)(1993-3#1)(1994-3#2)(1994-9#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-5#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#4)(2008-10#5)(2008-2#7)(2008-3#5)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-3#1)(2012-2#3)(2012-3#2)(2013-7#2)
to adjuvant chemotherapy##2##3##(1993-11#1)(1993-9#1)
to adjuvant##4##2##(1992-12#1)(1993-11#1)(1993-9#1)(2006-6#1)
to adjuvants)##2##2##(2007-11#2)
to administer and##5##3##(1997-2#1)(1997-8#1)(2007-12#1)(2010-7#1)(2013-7#1)
to administer medications##2##3##(2007-10#1)(2008-12#1)
to administer##40##2##(1991-10#1)(1991-3#2)(1991-6#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-1#1)(2006-10#2)(2006-7#2)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
to administering##2##2##(1995-12#1)(2008-11#1)
to administration of##7##3##(2006-8#2)(2008-10#1)(2008-3#1)(2008-9#2)(2011-12#1)
to administration##9##2##(2006-8#2)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-12#1)
to administrative##3##2##(1992-12#1)(1994-2#1)(1996-3#1)
to administrators##2##2##(1993-3#1)(2005-12#1)
to admission and##2##3##(1997-8#1)(2009-4#1)
to admission##8##2##(1991-2#1)(1997-8#1)(2007-7#2)(2008-5#1)(2009-4#1)(2010-12#2)
to admissions##2##2##(1995-9#1)(2012-11#1)
to admit##8##2##(1991-12#1)(1992-10#1)(1992-6#1)(1994-3#1)(1997-1#1)(2006-8#1)(2007-4#1)(2008-2#1)
to adolescence##3##2##(1992-2#1)(2012-12#1)(2012-3#1)
to adolescent females?##2##3##(2006-7#1)(2011-12#1)
to adolescent girls##2##3##(2011-2#1)(2013-1#1)
to adolescent smoking##3##3##(2009-7#1)(2009-9#2)
to adolescent substance##3##3##(2008-7#1)(2010-2#2)
to adolescent##16##2##(1996-12#1)(2006-7#1)(2007-2#1)(2008-7#1)(2009-10#1)(2009-7#4)(2009-9#2)(2010-2#2)(2011-12#1)(2011-2#1)(2013-1#1)
to adolescents##10##2##(1995-12#1)(1996-6#1)(2006-1#1)(2007-2#1)(2007-6#1)(2008-9#2)(2009-5#1)(2013-1#2)
to adolescents'##6##2##(2008-7#1)(2009-11#2)(2009-7#2)(2011-1#1)
to adopt PBL##2##3##(2008-12#2)
to adopt a##17##3##(1991-9#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-3#1)(2005-11#1)(2006-10#1)(2006-12#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2010-5#1)(2012-3#1)
to adopt an##6##3##(1990-7#1)(1991-7#1)(1993-1#1)(1994-8#1)(2006-7#1)(2010-11#1)
to adopt appropriate##2##3##(2007-1#1)(2011-1#1)
to adopt different##2##3##(2011-1#1)(2011-2#1)
to adopt in##3##3##(1994-5#1)(2006-10#1)(2008-8#1)
to adopt methods##2##3##(2007-11#1)(2008-11#1)
to adopt more##2##3##(2008-11#1)(2008-8#1)
to adopt new##3##3##(2006-5#1)(2009-3#1)(2011-12#1)
to adopt the##11##3##(1990-2#2)(1995-6#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-8#1)(2013-1#1)
to adopt them for##2##4##(2008-10#1)(2008-11#1)
to adopt these care practices as##2##6##(2007-2#1)(2008-6#1)
to adopt this##2##3##(2008-1#1)(2013-8#1)
to adopt to##2##3##(1995-4#1)(2011-2#1)
to adopt##84##2##(1990-2#2)(1990-7#1)(1991-7#1)(1991-9#1)(1993-1#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1997-1#2)(1997-8#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-11#3)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
to adopting##4##2##(1995-9#1)(2006-4#1)(2008-12#1)(2009-6#1)
to adoption of##4##3##(2007-12#2)(2008-6#1)(2012-12#1)
to adoption##11##2##(1991-7#3)(1997-1#1)(2007-12#3)(2008-6#1)(2009-11#1)(2011-2#1)(2012-12#1)
to adoptive##2##2##(1994-9#1)(2009-12#1)
to adoptively transfer##2##3##(2008-11#1)(2012-2#1)
to adrenal##2##2##(2011-2#1)(2012-11#1)
to adrenalectomy##2##2##(2012-12#2)
to adrenaline##2##2##(2006-4#1)(2008-5#1)
to adrenergic stimulation##2##3##(1993-11#1)(2007-10#1)
to adrenergic##4##2##(1991-12#1)(1993-11#1)(1996-10#1)(2007-10#1)
to adriamycin plus##2##3##(1993-8#2)
to adriamycin##6##2##(1990-2#1)(1991-4#1)(1992-11#1)(1993-8#2)(1997-5#1)
to adsorb selectively##2##3##(1997-3#1)(2007-11#1)
to adsorb##6##2##(1997-3#1)(2005-11#1)(2006-12#1)(2007-11#1)(2008-10#2)
to adsorbed##2##2##(2005-4#1)(2012-2#1)
to adsorption##5##2##(2005-11#2)(2007-8#1)(2008-5#1)(2008-6#1)
to adult HIV services##2##4##(2010-12#2)
to adult care##3##3##(2008-11#1)(2010-12#2)
to adult levels##3##3##(1990-11#1)(1995-7#1)(1997-5#1)
to adult life##2##3##(1994-11#1)(2009-10#1)
to adult rats##2##3##(1995-1#1)(1995-10#1)
to adult##32##2##(1990-11#1)(1991-3#2)(1991-6#1)(1992-11#1)(1993-12#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-10#2)(1995-7#1)(1996-1#1)(1997-5#1)(2004-11#1)(2005-6#1)(2006-10#1)(2006-11#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#2)(2009-3#1)(2010-12#4)(2012-12#1)(2012-2#1)
to adulthood##17##2##(1992-7#1)(1996-5#1)(1997-4#1)(1997-6#1)(2008-8#1)(2009-7#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-2#3)(2013-1#1)
to adults with##2##3##(2009-10#1)(2009-4#1)
to adults##18##2##(1995-10#1)(2004-4#1)(2007-3#1)(2008-10#1)(2008-2#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-7#1)(2011-12#1)(2012-11#2)(2012-2#2)
to advance biomedical research##2##4##(2008-7#1)(2012-12#1)
to advance in##3##3##(2008-5#1)(2008-9#1)(2012-12#1)
to advance our understanding of the##2##6##(2006-10#1)(2007-8#1)
to advance our understanding of##5##5##(2006-10#1)(2007-12#1)(2007-8#1)(2010-5#1)(2013-1#1)
to advance the field of##2##5##(2008-11#1)(2008-7#1)
to advance the##11##3##(1994-12#1)(2004-12#1)(2006-11#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-4#1)(2010-3#1)(2012-1#1)(2013-1#1)
to advance##44##2##(1990-11#1)(1994-12#1)(2004-12#1)(2006-10#3)(2006-11#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-5#2)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#4)(2008-7#4)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-7#1)(2012-1#1)(2012-12#5)(2013-1#2)
to advanced##15##2##(1990-4#1)(1991-12#1)(1995-6#1)(2005-12#1)(2006-1#1)(2008-1#4)(2008-12#1)(2008-4#1)(2008-7#1)(2010-12#1)(2012-1#1)(2012-2#1)
to advances in the##2##4##(2008-10#1)(2013-7#1)
to advances in##13##3##(2004-11#1)(2006-10#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-2#1)(2010-11#1)(2012-12#1)(2013-7#1)(2013-8#1)
to advances##14##2##(2004-11#1)(2006-10#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-2#1)(2010-11#1)(2010-6#1)(2012-12#1)(2013-7#1)(2013-8#1)
to advantages and##2##3##(2008-4#1)(2011-2#1)
to advantages##4##2##(2008-10#1)(2008-4#1)(2011-2#2)
to adverse drug reactions##2##4##(2007-12#1)(2008-11#1)
to adverse effects##3##3##(1990-5#1)(2007-11#1)(2011-1#1)
to adverse environments##2##3##(1993-12#1)(2010-9#1)
to adverse events##3##3##(2004-10#1)(2008-3#1)(2010-12#1)
to adverse outcome##2##3##(2005-10#1)(2007-7#1)
to adverse##25##2##(1990-5#1)(1992-11#1)(1993-12#1)(1994-11#1)(1994-6#1)(1996-3#1)(2004-10#1)(2005-10#1)(2005-7#1)(2005-9#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-11#3)(2008-3#1)(2008-9#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#1)
to adversely affect human development##3##5##(2005-7#3)
to adversely affect##6##3##(1992-4#1)(2005-7#3)(2008-10#1)(2012-1#1)
to advice on##2##3##(1990-10#1)(2005-3#1)
to advice##4##2##(1990-10#1)(1992-4#1)(2005-3#1)(2012-2#1)
to advise the##3##3##(1992-3#1)(2005-3#1)(2007-4#1)
to advise##11##2##(1992-3#1)(1992-9#1)(1995-6#1)(1996-3#1)(2005-3#1)(2007-2#1)(2007-4#1)(2008-8#1)(2009-4#1)(2010-11#1)(2011-1#1)
to advocate for##2##3##(2007-3#1)(2007-8#1)
to advocate##7##2##(2007-3#1)(2007-8#2)(2010-2#1)(2011-1#1)(2012-3#1)(2013-1#1)
to advocating##2##2##(1991-1#1)(2008-10#1)
to aerial##2##2##(2008-10#2)
to aeroallergens##3##2##(2007-2#1)(2013-1#2)
to aerobic##6##2##(1991-8#1)(1995-6#1)(1996-5#2)(2006-8#2)
to aerodynamic##2##2##(2005-10#1)(2008-3#1)
to aerosol##8##2##(1992-3#1)(1997-2#1)(2008-2#3)(2008-3#3)
to aerosols##6##2##(1992-3#1)(2008-11#1)(2008-2#2)(2008-3#2)
to affect IBa##2##3##(1995-12#2)
to affect a##5##3##(2006-10#1)(2007-9#1)(2008-5#1)(2010-12#1)(2013-7#1)
to affect both##2##3##(2007-5#1)(2010-5#1)
to affect cellular##2##3##(2008-10#2)
to affect cessation rates##2##4##(2007-12#1)(2008-11#1)
to affect different##2##3##(2006-11#1)(2008-1#1)
to affect gene expression##2##4##(2008-1#1)(2012-12#1)
to affect growth##2##3##(1995-1#1)(2007-11#1)
to affect neuronal##2##3##(1990-8#1)(1997-5#1)
to affect over##2##3##(2006-10#1)(2012-12#1)
to affect patient##2##3##(2008-3#1)(2010-3#1)
to affect secondary##2##3##(2008-10#1)(2011-2#1)
to affect sexual##3##3##(1993-8#1)(2012-3#2)
to affect the absorption of##2##5##(2008-8#1)(2010-12#1)
to affect the binding of##2##5##(1994-8#1)(2007-1#1)
to affect the expression of##2##5##(2008-4#1)(2012-2#1)
to affect the frequency##2##4##(1991-6#1)(2009-4#1)
to affect the natural##2##4##(2007-6#1)(2007-7#1)
to affect the progression##2##4##(2007-11#1)(2012-2#1)
to affect the rate of##3##5##(1992-7#1)(1993-9#1)(2009-3#1)
to affect the##64##3##(1990-2#1)(1990-3#1)(1990-5#1)(1991-6#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-2#1)(2005-11#2)(2005-4#1)(2006-5#2)(2007-1#1)(2007-11#3)(2007-3#1)(2007-6#1)(2007-7#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)
to affect##208##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#3)(1990-7#1)(1990-8#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#3)(1993-8#1)(1993-9#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#4)(1995-12#5)(1995-2#1)(1995-6#2)(1995-8#2)(1996-12#1)(1996-3#2)(1996-4#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(2004-10#2)(2004-12#1)(2005-11#2)(2005-4#1)(2006-10#2)(2006-11#2)(2006-2#1)(2006-5#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#3)(2007-7#2)(2007-9#1)(2008-1#4)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#8)(2008-9#1)(2009-1#1)(2009-11#1)(2009-3#3)(2009-4#2)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#7)(2012-2#7)(2012-3#6)(2013-1#6)(2013-7#1)(2013-8#1)
to affected patients##2##3##(2006-10#1)(2009-8#1)
to affected##5##2##(2005-9#1)(2006-10#1)(2009-8#1)(2011-1#1)(2012-12#1)
to afferent##2##2##(1990-4#1)(1995-11#1)
to affinity for##2##3##(1992-11#1)(1997-1#1)
to affinity##7##2##(1991-12#1)(1992-11#1)(1993-4#1)(1995-7#1)(1996-8#1)(1997-1#1)(1997-8#1)
to affirm that the##2##4##(1990-10#1)(1992-10#1)
to affirm that##3##3##(1990-10#1)(1992-10#1)(2008-1#1)
to affirm##5##2##(1990-10#1)(1991-12#1)(1992-10#1)(1996-3#1)(2008-1#1)
to afflict##2##2##(2006-4#1)(2008-11#1)
to afford 2##2##3##(1997-2#1)(2005-7#1)
to afford a##5##3##(1995-11#1)(2006-12#1)(2007-11#1)(2012-11#1)(2012-12#1)
to afford the corresponding##3##4##(2007-10#1)(2007-11#2)
to afford the##12##3##(1994-2#1)(1997-1#2)(1997-2#1)(1997-6#1)(2007-10#1)(2007-11#4)(2008-11#1)(2010-5#1)
to afford##50##2##(1990-9#1)(1994-12#1)(1994-2#2)(1994-9#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-1#2)(1997-2#3)(1997-6#1)(1997-7#2)(1997-8#1)(2005-7#1)(2006-12#2)(2007-10#3)(2007-11#13)(2007-7#1)(2008-10#1)(2008-11#3)(2008-6#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-5#1)(2010-6#1)(2012-11#1)(2012-12#1)
to aflatoxin##13##2##(1991-6#1)(1993-7#1)(2008-10#8)(2010-12#1)(2013-1#2)
to again##2##2##(2006-7#1)(2008-12#1)
to agarose##4##2##(1991-10#1)(1993-8#2)(2012-2#1)
to age and sex##3##4##(1996-3#1)(2006-8#1)(2008-1#1)
to age and##12##3##(1991-10#1)(1992-2#1)(1996-3#1)(2004-4#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-1#1)(2010-12#1)(2012-3#1)(2013-1#2)
to age at first##2##4##(1991-9#1)(2006-8#1)
to age at##9##3##(1991-9#2)(1994-6#1)(1995-10#1)(2006-8#1)(2008-9#2)(2009-12#1)(2009-2#1)
to age in##2##3##(1996-3#1)(2009-4#1)
to age of##3##3##(1990-12#1)(1994-2#1)(1996-7#1)
to age or##2##3##(1990-3#1)(2006-8#1)
to age##97##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-9#3)(1992-12#1)(1992-2#2)(1992-5#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-9#1)(1996-3#2)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#3)(2004-4#1)(2004-9#1)(2005-10#1)(2005-3#1)(2006-8#4)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#4)(2008-9#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#2)(2009-9#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
to age- and##2##3##(2004-12#1)(2007-8#1)
to age-##3##2##(2004-12#1)(2007-8#1)(2009-4#1)
to age-matched controls##4##3##(1992-7#1)(1994-11#1)(2008-3#1)(2013-1#1)
to age-matched##7##2##(1992-7#1)(1994-11#1)(2008-3#1)(2009-4#1)(2012-3#1)(2013-1#1)(2013-7#1)
to age-related changes##2##3##(1993-11#1)(2011-2#1)
to age-related##9##2##(1993-11#1)(1994-6#1)(1995-9#1)(2008-1#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-7#1)
to aged Gr##2##3##(1990-5#2)
to aged##7##2##(1990-5#2)(1991-10#1)(1993-11#1)(1993-7#1)(1996-7#1)(2013-1#1)
to agency##2##2##(1991-12#1)(2006-3#1)
to agents that##4##3##(1993-11#1)(1994-5#1)(2005-8#1)(2008-8#1)
to agents##6##2##(1990-3#1)(1993-11#1)(1994-5#1)(1995-12#1)(2005-8#1)(2008-8#1)
to aggregate and##2##3##(1990-12#1)(2008-6#1)
to aggregate in the##2##4##(2005-11#2)
to aggregate##19##2##(1990-12#1)(1990-2#1)(1991-11#2)(1991-7#2)(1993-9#1)(1994-11#2)(1994-3#1)(1995-10#1)(1997-8#1)(2005-11#3)(2007-8#1)(2008-10#1)(2008-6#1)(2012-3#1)
to aggregation##6##2##(1992-3#1)(2005-11#1)(2006-8#1)(2010-4#1)(2011-2#2)
to aggression and##2##3##(2007-3#1)(2008-11#1)
to aggression##5##2##(2007-3#1)(2008-11#3)(2011-2#1)
to aggressive##7##2##(2005-11#1)(2006-10#2)(2006-6#1)(2006-7#1)(2006-8#1)(2011-2#1)
to aggressively##2##2##(2008-1#1)(2008-10#1)
to aging and##3##3##(1993-11#1)(2007-11#1)(2011-2#1)
to aging##19##2##(1990-3#1)(1990-4#1)(1991-12#1)(1992-12#2)(1993-11#1)(1994-5#3)(1996-7#1)(2007-11#1)(2007-2#1)(2008-10#1)(2009-4#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
to agonist##4##2##(1992-5#1)(1995-12#1)(1996-5#1)(2008-9#1)
to agonists##5##2##(1991-8#1)(1992-3#1)(1994-6#1)(1996-7#1)(2008-9#1)
to agree to##3##3##(1991-10#1)(2006-5#1)(2008-1#1)
to agree with the##3##4##(1997-6#1)(2007-12#1)(2007-7#1)
to agree with##15##3##(1990-10#1)(1997-6#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-11#2)(2008-2#2)(2008-3#4)(2010-3#1)
to agree##29##2##(1990-10#1)(1991-10#1)(1991-12#1)(1992-2#2)(1997-1#1)(1997-6#1)(2006-5#1)(2007-12#3)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-2#3)(2008-3#7)(2008-8#1)(2010-3#1)(2012-12#1)
to agricultural and##2##3##(2006-12#1)(2008-10#1)
to agricultural workers##2##3##(2008-11#1)(2008-12#1)
to agricultural##8##2##(2006-10#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-5#1)
to agriculture and##2##3##(1990-2#1)(1991-11#1)
to agriculture##6##2##(1990-2#1)(1991-11#1)(1993-4#1)(1994-6#1)(1997-4#1)(2010-4#1)
to aid clinical##2##3##(2008-5#1)(2011-2#1)
to aid in determining##2##4##(1990-12#1)(2008-2#1)
to aid in gene##2##4##(2008-7#1)(2011-1#1)
to aid in management of##2##5##(2008-10#1)(2013-1#1)
to aid in the##13##4##(1992-3#1)(1993-10#1)(1993-5#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-2#1)(2009-5#1)(2010-11#1)(2012-2#1)(2013-1#1)
to aid in##37##3##(1990-12#1)(1992-3#2)(1993-10#1)(1993-5#1)(2005-11#1)(2005-8#1)(2006-7#4)(2007-12#2)(2007-7#1)(2008-10#3)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#4)
to aid recovery##2##3##(2012-1#1)(2013-8#1)
to aid the decision##2##4##(1992-9#1)(2007-8#1)
to aid the development of##4##5##(2006-3#1)(2008-1#1)(2008-9#1)(2009-12#1)
to aid the##13##3##(1992-9#1)(1993-6#1)(2006-3#1)(2007-8#2)(2008-1#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-12#1)(2012-2#1)(2013-1#1)
to aid##81##2##(1990-12#1)(1991-12#1)(1991-8#1)(1992-3#2)(1992-9#1)(1993-10#1)(1993-5#1)(1993-6#1)(1993-9#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-3#1)(2006-7#4)(2007-12#3)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-2#1)(2009-5#3)(2010-11#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#4)(2013-1#10)(2013-7#1)(2013-8#1)
to aim##2##2##(1992-9#1)(2012-3#1)
to air containing##2##3##(1990-8#1)(1992-1#1)
to air is##2##3##(2007-12#1)(2008-3#1)
to air pollution##5##3##(2004-4#1)(2007-4#1)(2008-1#1)(2008-6#1)(2010-9#1)
to air warming and##2##4##(2012-5#1)(2012-6#1)
to air warming##4##3##(2012-5#1)(2012-6#2)(2012-9#1)
to air##34##2##(1990-8#1)(1992-1#2)(1995-3#2)(2004-4#2)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2010-4#1)(2010-9#1)(2012-5#1)(2012-6#2)(2012-9#1)
to airborne particulate matter##2##4##(2008-9#1)(2010-5#1)
to airborne##6##2##(1994-9#1)(2006-12#1)(2007-4#1)(2008-3#1)(2008-9#1)(2010-5#1)
to airway cells##3##3##(1994-3#3)
to airway epithelial cells##4##4##(1994-11#2)(1994-5#2)
to airway##13##2##(1991-4#1)(1994-11#2)(1994-3#3)(1994-5#2)(1995-12#1)(1997-1#1)(2010-7#1)(2011-2#1)(2012-3#1)
to airways##2##2##(1991-4#1)(2010-10#1)
to alanine##18##2##(1992-8#1)(1994-5#1)(1994-9#1)(1995-5#4)(1995-6#1)(1996-5#3)(1997-6#1)(1997-8#1)(2008-10#3)(2008-9#1)(2011-2#1)
to alarm##2##2##(2008-10#1)(2010-8#1)
to albumin and##3##3##(1990-8#1)(2008-10#2)
to albumin in##2##3##(1990-4#1)(1994-8#1)
to albumin##10##2##(1990-12#1)(1990-4#2)(1990-8#1)(1994-8#1)(1995-5#1)(1995-6#1)(2008-10#2)(2008-11#1)
to alcohol abuse##2##3##(1992-12#1)(2012-2#1)
to alcohol consumption##2##3##(1991-9#1)(1993-9#1)
to alcohol in the##2##4##(1991-1#1)(1994-11#1)
to alcohol in##3##3##(1991-1#1)(1994-11#2)
to alcohol on GD 7##2##5##(1994-11#2)
to alcohol or other##2##4##(2009-11#1)(2009-9#1)
to alcohol or##3##3##(1994-2#1)(2009-11#1)(2009-9#1)
to alcohol use and##2##4##(2007-8#1)(2009-8#1)
to alcohol use##5##3##(2007-8#1)(2009-8#1)(2012-11#1)(2013-1#2)
to alcohol##41##2##(1991-1#2)(1991-8#1)(1991-9#1)(1992-12#1)(1993-4#5)(1993-9#1)(1994-11#5)(1994-2#1)(1994-6#1)(1995-3#1)(1996-6#1)(2006-3#3)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-6#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-7#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-2#2)(2013-1#2)
to alcohol-related##2##2##(2008-12#1)(2010-4#1)
to alcoholic##2##2##(2004-11#1)(2013-8#1)
to alcoholism##11##2##(1994-2#3)(1996-11#1)(1997-5#2)(2006-9#1)(2007-8#2)(2008-11#1)(2008-6#1)
to alcohols##3##2##(2008-6#1)(2010-7#1)(2011-1#1)
to aldehyde##3##2##(1992-8#1)(1993-2#1)(1993-4#1)
to aldosterone##4##2##(1990-11#1)(1994-12#1)(2008-4#2)
to alert clinicians##2##3##(2008-7#1)(2012-3#1)
to alert researchers to##2##4##(2008-4#1)(2009-7#1)
to alert the##4##3##(1992-2#1)(2008-9#1)(2011-2#1)(2013-1#1)
to alert##12##2##(1991-7#1)(1991-8#1)(1992-2#1)(2006-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
to alfalfa depends on##2##4##(2008-10#2)
to alfalfa##3##2##(2008-10#3)
to algae##2##2##(2007-1#1)(2011-2#1)
to algorithms for##2##3##(2008-3#2)
to align and##2##3##(2007-12#1)(2008-3#1)
to align the##4##3##(1992-1#1)(1994-3#1)(2008-2#1)(2009-4#1)
to align##24##2##(1992-1#1)(1993-1#1)(1993-4#1)(1994-3#1)(2007-12#1)(2007-4#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#1)(2009-4#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-11#2)(2013-1#1)
to aliphatic##3##2##(2005-11#1)(2008-10#1)(2009-5#1)
to alkali and alkaline##2##4##(2008-10#2)
to alkali##7##2##(1994-3#1)(2008-10#5)(2013-7#1)
to alkaline hydrolysis##2##3##(2008-10#1)(2008-11#1)
to alkaline phosphatase##7##3##(1990-12#1)(1991-10#1)(1994-9#1)(2006-10#1)(2008-10#1)(2008-11#1)(2012-1#1)
to alkaline##21##2##(1990-12#1)(1990-8#1)(1991-10#1)(1992-4#1)(1993-11#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(2005-8#1)(2006-10#1)(2006-5#1)(2008-10#3)(2008-11#2)(2008-9#1)(2010-5#1)(2012-1#1)(2013-8#1)
to alkaloids##3##2##(2006-12#1)(2007-1#1)(2012-2#1)
to alkylating agents##5##3##(2008-11#4)(2010-3#1)
to alkylation##2##2##(1996-12#1)(2008-11#1)
to all Danish##2##3##(1992-3#1)(1993-3#1)
to all antibiotics tested##2##4##(2007-8#1)(2011-2#1)
to all antibiotics##3##3##(2007-7#1)(2007-8#1)(2011-2#1)
to all areas of the##2##5##(1996-1#1)(2008-12#1)
to all current##2##3##(2007-4#1)(2008-5#1)
to all existing##2##3##(2008-10#1)(2008-5#1)
to all forms of##2##4##(1991-12#1)(2009-1#1)
to all four##3##3##(1994-11#1)(1994-9#1)(2008-10#1)
to all health##3##3##(1996-3#1)(2005-9#1)(2008-11#1)
to all hospitals##2##3##(1990-6#1)(1991-7#1)
to all human##2##3##(1990-6#1)(1992-7#1)
to all individuals##4##3##(1993-9#1)(2007-7#2)(2012-2#1)
to all isolates##2##3##(2008-10#2)
to all its##2##3##(2008-10#1)(2008-9#1)
to all kinds of##3##4##(1990-2#1)(1994-1#1)(2008-2#1)
to all known##2##3##(1992-3#1)(2008-5#1)
to all major##2##3##(2006-10#1)(2008-10#1)
to all medical##2##3##(2007-4#1)(2011-1#1)
to all members of the##3##5##(1994-9#1)(2005-9#1)(2008-3#1)
to all members of##4##4##(1994-9#1)(1995-3#1)(2005-9#1)(2008-3#1)
to all of the##11##4##(1995-5#1)(1997-6#1)(2005-8#1)(2006-8#1)(2008-10#3)(2008-4#1)(2008-5#2)(2013-8#1)
to all of##13##3##(1995-11#1)(1995-5#1)(1996-8#1)(1997-6#1)(2005-8#1)(2006-8#1)(2008-10#3)(2008-4#1)(2008-5#2)(2013-8#1)
to all orders##2##3##(2007-11#1)(2007-12#1)
to all other age groups##2##5##(1996-5#1)(2011-2#1)
to all other groups##2##4##(1991-2#1)(1993-5#1)
to all other treatments##4##4##(2004-10#3)(2008-10#1)
to all other##21##3##(1990-7#1)(1991-2#1)(1992-12#1)(1993-5#1)(1994-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(2004-10#3)(2006-2#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-9#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-12#1)
to all participants##3##3##(2007-2#1)(2008-7#1)(2011-1#1)
to all patients##12##3##(1992-10#1)(1994-3#1)(1996-3#2)(2007-12#1)(2007-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-6#1)(2012-12#2)
to all physicians##2##3##(2006-8#2)
to all plant##2##3##(2008-11#1)(2008-7#1)
to all pregnant women##2##4##(1994-6#1)(2010-8#1)
to all products##2##3##(2007-6#2)
to all races of##2##4##(2008-10#2)
to all races##5##3##(2008-10#5)
to all restraint systems##2##4##(2006-11#2)
to all six##3##3##(2007-2#1)(2008-3#1)(2010-4#1)
to all stakeholders##3##3##(1996-3#1)(2007-4#2)
to all stimuli##2##3##(1995-2#1)(2008-5#1)
to all subjects##4##3##(1997-7#1)(2007-10#1)(2010-10#1)(2011-2#1)
to all surgeons##2##3##(1990-4#1)(2008-4#1)
to all tested##6##3##(2008-10#2)(2008-5#1)(2010-5#1)(2012-2#1)(2013-1#1)
to all the known##2##4##(1994-9#1)(1997-6#1)
to all the offspring##2##4##(2008-8#2)
to all the patients##3##4##(1993-12#1)(2004-10#1)(2011-1#1)
to all the species##2##4##(2006-8#1)(2013-8#1)
to all the##38##3##(1992-9#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-6#1)(1994-9#1)(1995-8#1)(1996-5#1)(1997-6#1)(1997-7#1)(2004-10#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-8#2)(2009-12#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
to all these##2##3##(2008-10#1)(2008-9#1)
to all three fungicides##2##4##(2008-10#2)
to all three##17##3##(1991-7#1)(1992-12#1)(1994-3#1)(1995-12#1)(1996-1#1)(1997-3#1)(2006-8#2)(2008-10#3)(2008-2#1)(2008-5#2)(2008-9#1)(2009-3#1)(2011-2#1)
to all treatments##2##3##(1993-5#1)(2008-10#1)
to all types of##8##4##(1997-8#1)(2007-10#1)(2007-12#1)(2008-11#2)(2008-7#1)(2011-2#1)(2013-1#1)
to all women##2##3##(2007-2#2)
to all##385##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#2)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-7#2)(1992-1#1)(1992-10#2)(1992-12#3)(1992-2#1)(1992-3#2)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-12#1)(1993-2#3)(1993-3#2)(1993-5#2)(1993-6#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-3#2)(1994-6#4)(1994-8#1)(1994-9#4)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#5)(1995-7#1)(1995-8#2)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#4)(1996-5#2)(1996-6#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#4)(1997-7#2)(1997-8#3)(2004-10#4)(2004-12#1)(2005-10#1)(2005-5#1)(2005-8#3)(2005-9#3)(2006-10#4)(2006-11#2)(2006-12#2)(2006-2#2)(2006-4#1)(2006-6#5)(2006-8#10)(2007-10#2)(2007-11#8)(2007-12#10)(2007-2#8)(2007-4#8)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#5)(2008-1#4)(2008-10#42)(2008-11#9)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#6)(2008-5#13)(2008-7#9)(2008-8#5)(2008-9#7)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#3)(2009-8#2)(2009-9#2)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#3)(2010-4#2)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#3)(2011-2#10)(2012-12#6)(2012-2#12)(2012-3#3)(2013-1#9)(2013-7#2)(2013-8#4)
to all-trans retinoic acid##3##4##(1994-12#2)(2013-1#1)
to allay consumer##2##3##(2005-11#1)(2009-7#1)
to allay##3##2##(2005-11#1)(2009-7#1)(2012-2#1)
to allelic differences##2##3##(1990-7#1)(1993-6#1)
to allelic##3##2##(1990-7#1)(1991-1#1)(1993-6#1)
to allergens##2##2##(1992-3#1)(2009-5#1)
to allergic##3##2##(1990-10#1)(2007-2#1)(2011-1#1)
to allergy##2##2##(1996-3#1)(2008-11#1)
to alleviate oxidative stress##2##4##(2010-8#1)(2013-8#1)
to alleviate side##2##3##(1990-5#1)(2008-6#1)
to alleviate the##10##3##(1992-8#1)(1994-11#1)(2006-6#1)(2007-12#2)(2007-8#2)(2008-11#1)(2008-7#1)(2008-9#1)
to alleviate these##2##3##(1991-9#1)(2007-11#1)
to alleviate##34##2##(1990-5#1)(1991-2#2)(1991-9#1)(1992-8#1)(1993-3#1)(1994-11#2)(1995-12#1)(1996-9#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
to alleviating symptoms##2##3##(1993-9#1)(2008-1#1)
to alleviating##3##2##(1993-9#1)(2008-1#1)(2010-6#1)
to alloantigens##2##2##(1991-12#1)(2008-4#1)
to allocate more##3##3##(1992-1#1)(2008-2#1)(2008-5#1)
to allocate resources##4##3##(1992-8#1)(1993-2#1)(2007-7#1)(2008-10#1)
to allocate##13##2##(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-2#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-5#2)(2009-8#1)(2013-1#1)
to allocating##2##2##(2008-9#1)(2009-3#1)
to allogeneic##3##2##(2006-10#2)(2007-11#1)
to allografts##3##2##(1995-2#1)(2007-11#1)(2008-1#1)
to allopurinol##2##2##(2006-10#2)
to allosteric##3##2##(1992-9#1)(2005-8#1)(2007-10#1)
to allow a##8##3##(1992-6#1)(1996-6#1)(2006-5#1)(2008-10#2)(2008-3#1)(2011-2#1)(2012-11#1)
to allow an##5##3##(1990-11#1)(1992-12#1)(2008-10#1)(2009-12#1)(2012-11#1)
to allow both the##2##4##(2008-3#2)
to allow both##3##3##(2008-2#1)(2008-3#2)
to allow comparison##2##3##(2006-5#1)(2008-10#1)
to allow determination of##2##4##(1995-3#1)(1996-11#1)
to allow discrimination between##2##4##(1993-4#1)(2008-3#1)
to allow efficient##2##3##(1994-9#1)(2008-5#1)
to allow for an##2##4##(1994-3#1)(2008-3#1)
to allow for identification and##2##5##(2008-10#1)(2011-2#1)
to allow for meta-analysis##2##4##(2008-10#1)(2008-9#1)
to allow for more##3##4##(1992-3#1)(1992-7#1)(2011-2#1)
to allow for the evaluation of##2##6##(2006-10#1)(2008-7#1)
to allow for the##16##4##(1995-8#1)(2005-5#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)(2013-8#1)
to allow for##63##3##(1990-8#2)(1992-1#1)(1992-3#1)(1992-7#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-5#1)(1995-8#1)(1997-4#1)(2005-5#1)(2006-10#1)(2006-12#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-2#1)(2011-2#5)(2012-3#2)(2013-1#1)(2013-8#2)
to allow further##2##3##(2008-11#1)(2011-2#1)
to allow independent##2##3##(2007-12#1)(2009-2#1)
to allow its##3##3##(1990-3#1)(2008-10#1)(2008-5#1)
to allow new##2##3##(2005-11#1)(2008-11#1)
to allow others to##2##4##(2007-4#2)
to allow patients to##2##4##(2007-11#1)(2008-3#1)
to allow quantitation of##2##4##(1995-1#1)(2008-10#1)
to allow rapid##3##3##(1994-8#1)(2008-10#1)(2010-5#1)
to allow sequential##2##3##(2008-10#2)
to allow simultaneous##2##3##(2008-11#1)(2009-10#1)
to allow the determination of##3##5##(2008-10#2)(2008-2#1)
to allow the quantification of##2##5##(1992-12#1)(2008-2#1)
to allow the simultaneous##2##4##(2008-10#1)(2008-9#1)
to allow the use of##2##5##(2006-11#1)(2008-10#1)
to allow the##52##3##(1990-2#1)(1991-8#1)(1992-1#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-4#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-4#2)(2007-5#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#3)
to allow their##3##3##(1996-5#1)(2004-9#1)(2008-10#1)
to allow them to##3##4##(2004-12#1)(2007-10#1)(2012-12#1)
to allow us to##2##4##(1992-12#1)(2009-6#1)
to allow users to##3##4##(2008-11#1)(2008-4#1)(2008-7#1)
to allow visualization of the##2##5##(1995-12#1)(2010-2#1)
to allow visualization of##4##4##(1995-12#1)(2008-1#1)(2008-4#1)(2010-2#1)
to allow##313##2##(1990-11#1)(1990-2#1)(1990-3#2)(1990-6#1)(1990-7#1)(1990-8#5)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#3)(1992-12#3)(1992-3#2)(1992-5#1)(1992-6#3)(1992-7#1)(1993-12#1)(1993-2#1)(1993-4#2)(1993-6#1)(1994-11#1)(1994-12#2)(1994-3#4)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-6#2)(1997-7#1)(2004-10#1)(2004-12#1)(2004-9#2)(2005-10#1)(2005-11#3)(2005-5#1)(2006-10#7)(2006-11#1)(2006-12#2)(2006-2#1)(2006-5#2)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#7)(2007-2#2)(2007-4#4)(2007-5#4)(2007-7#1)(2007-8#4)(2007-9#3)(2008-1#2)(2008-10#33)(2008-11#11)(2008-12#2)(2008-2#9)(2008-3#20)(2008-4#12)(2008-5#8)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#6)(2009-10#1)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#10)(2012-1#8)(2012-11#3)(2012-12#2)(2012-2#4)(2012-3#7)(2013-1#6)(2013-7#1)(2013-8#2)
to almost all##3##3##(1995-9#1)(2008-10#1)(2012-2#1)
to almost any##3##3##(2008-1#1)(2008-4#1)(2008-9#1)
to almost complete##2##3##(1995-8#1)(2008-10#1)
to almost completely##4##3##(2005-8#1)(2008-11#1)(2008-4#1)(2010-4#1)
to almost normal##3##3##(1997-5#1)(2007-3#1)(2007-8#1)
to almost the##3##3##(1990-10#1)(1991-7#1)(1992-1#1)
to almost##30##2##(1990-10#1)(1990-2#1)(1991-7#1)(1992-1#1)(1993-11#1)(1995-8#1)(1995-9#1)(1997-1#1)(1997-5#1)(1997-6#2)(1997-7#1)(2005-8#1)(2006-12#1)(2007-1#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-9#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-8#1)
to alpha 1##2##3##(1994-12#1)(1994-9#1)
to alpha 1-adrenoceptors##2##3##(1990-10#1)(1990-7#1)
to alpha 2 interferon##2##4##(1990-12#2)
to alpha 2M##3##3##(1993-3#2)(1993-6#1)
to alpha beta##3##3##(1992-6#2)(1993-8#1)
to alpha factor##2##3##(1990-11#2)
to alpha##30##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-7#1)(1991-11#1)(1992-10#1)(1992-12#1)(1992-6#2)(1993-3#2)(1993-6#2)(1993-8#1)(1994-10#1)(1994-12#1)(1994-9#1)(1995-1#1)(1996-12#1)(2005-8#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)
to alpha- and##2##3##(1991-12#1)(1993-5#1)
to alpha-adrenergic##2##2##(1994-2#2)
to alpha-amylase##3##2##(1990-3#3)
to alpha-catenin##2##2##(1997-6#2)
to alpha-helix##3##2##(1992-6#2)(2008-9#1)
to alpha-lactalbumin##2##2##(2008-10#2)
to alpha-tocopherol##3##2##(1991-12#1)(1997-8#1)(2008-5#1)
to alpha-tomatine##2##2##(2008-10#2)
to already existing##2##3##(1995-7#1)(2005-11#1)
to already##6##2##(1995-7#1)(1996-4#1)(2005-11#1)(2007-8#1)(2008-10#1)(2009-7#1)
to also consider##2##3##(2011-3#1)(2012-2#1)
to also##12##2##(1994-9#1)(1997-2#1)(2006-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-3#1)(2010-10#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-8#1)
to alter gene##2##3##(2010-12#1)(2010-5#1)
to alter immune##2##3##(2007-11#1)(2008-10#1)
to alter peripheral##2##3##(1992-6#1)(1996-12#1)
to alter subsequent##2##3##(1993-12#1)(1996-12#1)
to alter the behaviour of##2##5##(2005-11#1)(2008-3#1)
to alter the conformation of##2##5##(2008-6#1)(2012-2#1)
to alter the natural##3##4##(2006-10#1)(2008-7#1)(2010-12#1)
to alter the structure of##2##5##(1994-5#1)(2004-4#1)
to alter the##49##3##(1990-6#1)(1990-7#1)(1991-11#1)(1993-4#1)(1994-11#2)(1994-12#1)(1994-5#2)(1994-9#1)(1995-11#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-5#1)(1997-8#1)(2004-4#1)(2005-11#2)(2006-10#2)(2006-5#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-12#1)(2010-12#2)(2010-8#1)(2012-1#2)(2012-11#1)(2012-2#2)
to alter their##3##3##(2008-11#1)(2009-7#1)(2012-1#1)
to alter##93##2##(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-12#2)(1992-6#1)(1993-11#1)(1993-12#2)(1993-4#1)(1994-11#3)(1994-12#2)(1994-5#3)(1994-9#2)(1995-11#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-5#1)(1997-8#1)(2004-4#1)(2005-11#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#3)(2007-8#1)(2007-9#2)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2009-12#1)(2009-2#1)(2009-7#1)(2010-12#3)(2010-2#1)(2010-5#1)(2010-8#1)(2012-1#3)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
to alteration in##3##3##(1995-3#1)(2009-8#1)(2012-2#1)
to alteration of##2##3##(2009-10#1)(2013-8#1)
to alteration##5##2##(1995-3#1)(2009-10#1)(2009-8#1)(2012-2#1)(2013-8#1)
to alterations in the##5##4##(1990-2#1)(1995-3#1)(1996-4#1)(1997-2#1)(2008-4#1)
to alterations in##16##3##(1990-2#1)(1995-3#1)(1996-4#1)(1996-6#1)(1997-2#1)(2006-10#1)(2007-7#1)(2007-8#2)(2008-4#1)(2008-7#3)(2009-12#2)(2012-2#1)
to alterations of##6##3##(1996-5#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-10#1)(2013-8#1)
to alterations##22##2##(1990-2#1)(1995-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#1)(2006-10#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-12#2)(2010-10#1)(2012-2#1)(2013-8#1)
to altered##28##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-10#1)(1992-8#1)(1995-2#1)(1996-5#1)(1997-1#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-5#1)(2007-11#3)(2007-4#1)(2007-8#1)(2008-1#1)(2008-7#1)(2008-8#2)(2009-7#1)(2010-2#1)(2011-10#1)(2012-12#2)(2012-7#1)(2013-8#1)
to alternating##3##2##(2006-10#1)(2008-10#1)(2008-9#1)
to alternative food##3##3##(2008-8#3)
to alternative models of##2##4##(2007-12#1)(2008-10#1)
to alternative settings##2##3##(1993-5#1)(1995-1#1)
to alternative##23##2##(1991-5#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-5#1)(1995-1#1)(1996-4#1)(1997-4#1)(1997-7#1)(2005-10#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#1)(2012-1#1)
to alternatively##2##2##(1990-8#1)(2012-12#1)
to altitudes##2##2##(2008-3#2)
to aluminium##2##2##(1992-6#2)
to aluminum##4##2##(1991-5#1)(1996-3#1)(2008-10#1)(2009-5#1)
to alveolar hemorrhage##2##3##(2006-10#2)
to alveolar##3##2##(2006-10#2)(2012-12#1)
to always##3##2##(2011-12#1)(2013-1#1)(2013-8#1)
to ambient air##3##3##(2007-10#1)(2008-11#1)(2008-3#1)
to ambient conditions##2##3##(1993-12#1)(2008-10#1)
to ambient temperature##2##3##(2008-2#1)(2012-7#1)
to ambient##15##2##(1993-12#1)(1996-2#1)(2005-11#1)(2007-10#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-9#1)(2012-2#1)(2012-7#1)
to ambiguous##3##2##(2012-2#1)(2013-1#2)
to ambulatory##3##2##(1990-5#1)(1995-12#1)(2011-2#1)
to ameliorate the effects of##2##5##(1994-3#1)(2008-2#1)
to ameliorate the signs##2##4##(2008-5#2)
to ameliorate the##13##3##(1994-3#1)(2004-12#1)(2007-4#1)(2008-1#1)(2008-2#1)(2008-5#3)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
to ameliorate this##2##3##(2006-10#1)(2010-12#1)
to ameliorate##28##2##(1993-11#1)(1994-3#1)(1996-3#1)(1996-7#1)(1997-5#1)(2004-12#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-1#2)(2008-2#1)(2008-5#3)(2008-7#3)(2008-9#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
to amelioration of##2##3##(1993-12#1)(2006-8#1)
to amend the##2##3##(2007-11#1)(2008-6#1)
to amensal##2##2##(2008-12#2)
to amide##2##2##(1997-7#1)(2008-10#1)
to amidoxime groups##2##3##(2008-10#2)
to amikacin##6##2##(2007-3#1)(2007-7#4)(2011-2#1)
to amiloride and##2##3##(1990-2#1)(1991-2#1)
to amiloride##6##2##(1990-11#1)(1990-2#1)(1991-2#1)(1991-5#3)
to amine##2##2##(2007-8#1)(2010-11#1)
to amines##2##2##(1990-8#1)(2010-5#1)
to amino acid changes##3##4##(2007-2#1)(2008-5#1)(2013-1#1)
to amino acid sequences##2##4##(1990-4#1)(1991-10#1)
to amino acid##17##3##(1990-3#1)(1990-4#2)(1991-10#1)(1992-12#1)(1992-3#1)(1993-6#1)(1994-8#2)(1994-9#1)(1996-5#1)(1997-4#1)(2007-2#1)(2008-10#1)(2008-5#1)(2010-8#1)(2013-1#1)
to amino acids##8##3##(1990-6#1)(1992-12#1)(1992-7#1)(1994-11#2)(1994-6#1)(1994-8#1)(1995-10#1)
to amino##26##2##(1990-3#1)(1990-4#2)(1990-6#1)(1991-10#1)(1992-12#2)(1992-3#1)(1992-7#1)(1993-6#1)(1994-11#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-10#1)(1996-11#1)(1996-5#1)(1997-4#1)(2007-2#1)(2008-10#1)(2008-5#1)(2010-8#1)(2013-1#1)
to aminoglycoside antibiotics##2##3##(2009-8#1)(2011-1#1)
to aminoglycosides##6##2##(1995-2#4)(2008-12#1)(2009-8#1)
to ammonia and##3##3##(2008-10#2)(2011-2#1)
to ammonia in##2##3##(2008-10#1)(2011-2#1)
to ammonia##9##2##(1993-8#1)(2005-11#1)(2008-10#3)(2008-7#2)(2011-2#2)
to ammonium ion##2##3##(2008-10#2)
to ammonium##6##2##(1992-11#1)(2008-10#4)(2013-1#1)
to among the##2##3##(2005-8#1)(2009-10#1)
to amount of##2##3##(2008-10#1)(2008-5#1)
to amoxicillin and##2##3##(2008-12#1)(2010-9#1)
to amoxicillin##3##2##(2007-7#1)(2008-12#1)(2010-9#1)
to amoxicillin/clavulanate##2##2##(2007-9#1)(2008-12#1)
to amperometric detection of##3##4##(2008-10#3)
to amperometric##5##2##(2008-10#5)
to amphetamine##6##2##(1993-4#2)(1993-6#1)(1994-11#1)(1996-10#1)(1997-8#1)
to amphotericin B##9##3##(1992-6#1)(2006-10#1)(2007-7#3)(2008-5#4)
to amphotericin##10##2##(1992-6#2)(2006-10#1)(2007-7#3)(2008-5#4)
to ampicillin and##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
to ampicillin##17##2##(1990-6#2)(1993-1#1)(1993-8#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-11#2)(2010-8#2)(2011-2#1)(2012-2#2)(2012-3#2)
to ampicillin-sulbactam##2##2##(2013-8#2)
to amplification of##2##3##(1994-6#1)(2007-11#1)
to amplification##3##2##(1994-6#1)(2007-11#1)(2008-2#1)
to amplified##2##2##(1992-8#1)(2008-10#1)
to amplifier##2##2##(2008-1#1)(2008-2#1)
to amplify DNA##4##3##(1990-7#1)(2008-10#3)
to amplify a##10##3##(1992-8#1)(1993-8#1)(1995-2#1)(1995-3#1)(2006-8#1)(2008-10#3)(2008-2#1)(2009-8#1)
to amplify an##3##3##(1991-9#1)(2006-5#1)(2008-10#1)
to amplify and sequence##2##4##(1993-12#1)(2007-6#1)
to amplify and##4##3##(1991-9#1)(1993-12#1)(2006-10#1)(2007-6#1)
to amplify cDNAs##3##3##(1993-4#1)(1994-12#1)(2008-2#1)
to amplify multiple##2##3##(1994-11#1)(2013-8#1)
to amplify sequences##2##3##(1992-6#1)(2008-10#1)
to amplify the##20##3##(1991-7#1)(1992-4#1)(1996-5#1)(1997-2#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-8#1)(2009-4#1)(2012-12#1)(2013-1#1)
to amplify this##2##3##(2008-10#1)(2009-7#1)
to amplify##77##2##(1990-7#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-4#2)(1993-8#1)(1994-11#1)(1994-12#3)(1995-2#2)(1995-3#1)(1996-10#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#1)(2006-10#2)(2006-4#1)(2006-5#2)(2006-8#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-8#1)(2008-10#22)(2008-11#2)(2008-2#2)(2008-4#3)(2008-5#2)(2008-8#2)(2009-4#1)(2009-7#1)(2009-8#1)(2012-12#1)(2013-1#1)(2013-8#2)
to amplitude and##3##3##(2007-12#3)
to amplitude##4##2##(2007-11#1)(2007-12#3)
to amputation in##3##3##(2007-8#2)(2010-3#1)
to amputation##7##2##(2006-6#1)(2007-8#2)(2008-6#2)(2010-3#1)(2012-3#1)
to amygdala##2##2##(1993-9#1)(2009-4#1)
to amyloid precursor protein##2##4##(1993-11#1)(2006-11#1)
to amyloidosis##4##2##(1990-2#1)(2006-10#1)(2007-7#1)(2012-2#1)
to amylose and##2##3##(1995-1#1)(1995-11#1)
to an &quot##4##3##(1997-2#1)(2006-8#1)(2008-8#1)(2009-6#1)
to an A##2##3##(1990-7#1)(2009-12#1)
to an Alzheimer patient##2##4##(1993-11#2)
to an E##2##3##(1994-12#1)(2013-8#1)
to an MDI##2##3##(1996-1#1)(1997-1#1)
to an N-terminal##2##3##(1994-9#1)(2010-5#1)
to an R-factor of##3##4##(1995-3#1)(1996-6#1)(1997-6#1)
to an R-value of 0##2##5##(1991-12#1)(1992-12#1)
to an RNA##4##3##(1991-9#1)(1994-8#1)(2008-4#2)
to an U3 region##2##4##(1993-12#2)
to an abdominal##2##3##(2009-4#1)(2011-2#1)
to an absence of##2##4##(1996-1#1)(2007-10#1)
to an absorbance##2##3##(1996-8#1)(2008-10#1)
to an abstract##2##3##(2008-12#2)
to an accelerated##4##3##(1997-8#1)(2008-10#2)(2011-1#1)
to an acceptable##5##3##(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2012-12#1)
to an acceptor stream##2##4##(2008-10#2)
to an accumulation of##11##4##(1993-11#1)(1994-2#1)(1995-6#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-6#1)(2009-10#1)(2009-6#1)(2010-7#1)
to an accuracy of better than##2##6##(2008-2#2)
to an accuracy of##11##4##(2008-1#1)(2008-2#3)(2008-3#7)
to an accuracy##14##3##(2008-1#1)(2008-2#5)(2008-3#8)
to an accurate and##2##4##(2008-3#2)
to an accurate##4##3##(2008-2#1)(2008-3#2)(2012-1#1)
to an acidic##4##3##(2008-10#3)(2008-5#1)
to an action##2##3##(1994-2#1)(2013-1#1)
to an activating##2##3##(1997-4#1)(2008-4#1)
to an activation##3##3##(1996-10#1)(2008-4#1)(2008-5#1)
to an active##10##3##(1990-12#1)(1991-4#1)(1991-9#2)(1992-12#1)(1996-4#1)(2006-10#1)(2007-8#1)(2008-6#1)(2009-9#1)
to an activity##2##3##(1994-12#1)(2007-6#1)
to an acute##7##3##(1994-5#1)(2008-12#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-8#1)(2011-1#1)
to an adaptive##2##3##(2008-7#1)(2010-8#1)
to an additional##5##3##(1992-3#1)(2004-11#1)(2007-12#1)(2008-10#1)(2010-8#1)
to an additive##3##3##(1991-8#1)(1996-10#1)(2007-12#1)
to an adequate##3##3##(1992-2#1)(1994-11#1)(2008-5#1)
to an adjacent##3##3##(2008-7#1)(2010-4#1)(2011-2#1)
to an adjuvant##2##3##(2012-2#2)
to an adult##4##3##(1996-3#1)(2006-1#1)(2006-10#1)(2011-2#1)
to an adverse##2##3##(2007-11#1)(2013-7#1)
to an affinity##3##3##(1992-12#1)(1993-6#1)(2008-4#1)
to an aging##3##3##(1994-3#2)(2010-6#1)
to an agreement##2##3##(1993-5#1)(2012-2#1)
to an alanine##5##3##(1991-4#1)(1995-11#2)(1995-3#1)(1996-9#1)
to an alkaline##2##3##(2008-10#1)(2008-9#1)
to an almost complete##2##4##(1990-5#1)(1991-12#1)
to an almost##4##3##(1990-4#1)(1990-5#1)(1991-12#1)(1995-10#1)
to an alpha##3##3##(1990-7#1)(1994-2#1)(1997-7#1)
to an already##2##3##(2006-10#1)(2007-12#1)
to an alteration in the##3##5##(1993-12#1)(1995-9#1)(1996-11#1)
to an alteration in##4##4##(1993-12#1)(1994-8#1)(1995-9#1)(1996-11#1)
to an alteration##5##3##(1993-12#1)(1994-8#1)(1995-1#1)(1995-9#1)(1996-11#1)
to an altered##3##3##(1993-9#2)(2004-11#1)
to an alternate##2##3##(1992-9#1)(2008-3#1)
to an alternating##3##3##(1992-7#2)(1993-7#1)
to an alternative##4##3##(1991-1#1)(1997-7#1)(2008-10#1)(2008-3#1)
to an altitude of##2##4##(2008-1#1)(2008-3#1)
to an altitude##3##3##(2008-1#1)(2008-3#2)
to an ammonia##2##3##(2007-1#1)(2008-10#1)
to an analogous##3##3##(1992-5#1)(2008-7#1)(2012-12#1)
to an analysis of the##2##5##(1992-10#1)(1993-10#1)
to an analysis of##3##4##(1992-10#1)(1993-10#1)(2009-12#1)
to an analysis##4##3##(1992-10#1)(1993-10#1)(2007-8#1)(2009-12#1)
to an anesthetized##2##3##(2008-4#1)(2008-9#1)
to an anion##2##3##(2008-10#1)(2010-5#1)
to an antibiotic##2##3##(1997-3#1)(2008-11#1)
to an antibody##4##3##(1992-12#1)(2005-11#1)(2008-4#1)(2009-3#1)
to an antigen of interest##2##5##(2008-10#1)(2008-4#1)
to an antigen##3##3##(2008-10#2)(2008-4#1)
to an apparent##5##3##(1990-12#1)(1994-12#1)(1994-5#1)(1995-3#1)(2006-4#1)
to an apparently##3##3##(1990-11#1)(1990-7#1)(1991-9#1)
to an application of##2##4##(2004-9#1)(2008-10#1)
to an appropriate##4##3##(1996-3#1)(2006-10#1)(2006-8#1)(2008-10#1)
to an approximately##2##3##(1996-10#1)(2008-11#1)
to an aqueous environment##2##4##(1990-2#1)(2004-9#1)
to an aqueous solution##2##4##(2007-11#1)(2008-10#1)
to an aqueous##6##3##(1990-2#1)(1997-4#1)(2004-9#1)(2007-11#1)(2008-10#2)
to an arbitrary##6##3##(1997-2#1)(2007-12#1)(2008-3#2)(2008-6#1)(2009-11#1)
to an area of##2##4##(2006-10#1)(2007-9#1)
to an area##3##3##(2006-10#1)(2006-4#1)(2007-9#1)
to an array of##4##4##(1992-4#1)(2006-2#1)(2007-12#1)(2008-1#1)
to an arrest of##2##4##(1994-5#1)(1995-5#1)
to an arthrodesis##2##3##(2008-6#1)(2010-5#1)
to an artificial##5##3##(1990-5#1)(1994-2#1)(2008-10#1)(2010-6#1)(2011-2#1)
to an atomic absorption##2##4##(2008-10#2)
to an atomic transition##2##4##(2007-12#1)(2008-2#1)
to an atomic##5##3##(2007-12#1)(2008-10#2)(2008-2#1)(2010-4#1)
to an attractive##2##3##(1993-3#1)(2007-12#1)
to an audience##2##3##(2005-8#1)(2008-5#1)
to an automatic##2##3##(2008-10#1)(2008-3#1)
to an autosomal##2##3##(2008-12#1)(2011-3#1)
to an average adult##2##4##(2006-11#2)
to an average of 6##2##5##(1994-12#1)(2008-9#1)
to an average of##6##4##(1991-7#1)(1993-11#1)(1994-12#1)(1995-9#1)(1997-8#1)(2008-9#1)
to an average##15##3##(1991-10#1)(1991-7#1)(1993-11#1)(1994-12#1)(1995-6#1)(1995-9#1)(1997-8#1)(2006-11#2)(2008-2#1)(2008-6#1)(2008-9#2)(2009-3#2)
to an earlier##8##3##(1990-6#1)(1990-7#1)(1992-5#1)(2008-10#1)(2008-4#1)(2008-6#1)(2011-1#1)(2011-12#1)
to an early##2##3##(1995-8#1)(2009-2#1)
to an effect##3##3##(1990-8#1)(2007-2#1)(2007-8#1)
to an effective##5##3##(1990-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#1)
to an efficiency of##3##4##(2007-12#2)(2008-3#1)
to an efficient##3##3##(2007-3#1)(2008-3#1)(2009-12#1)
to an electric field##3##4##(2007-12#1)(2008-5#1)(2009-12#1)
to an electrical field##3##4##(2008-2#1)(2008-4#1)(2008-5#1)
to an electrical##7##3##(1991-8#1)(2007-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)
to an electrochemical##3##3##(2008-10#2)(2012-1#1)
to an electrostatic##3##3##(1996-5#1)(2008-10#1)(2009-5#1)
to an elevated##3##3##(2006-8#1)(2009-10#1)(2012-3#1)
to an elevation in##2##4##(1991-2#1)(2009-5#1)
to an emerging##4##3##(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
to an end##4##3##(1993-3#1)(2006-2#1)(2008-9#1)(2013-8#1)
to an endemic region##2##4##(2008-10#1)(2011-1#1)
to an endemic##5##3##(2007-2#1)(2008-10#2)(2011-1#1)(2011-2#1)
to an endogenous##2##3##(1994-10#1)(2009-2#1)
to an enduring##2##3##(2008-9#1)(2009-9#1)
to an enhanced##5##3##(1993-9#1)(1995-12#1)(1995-8#1)(2012-1#1)(2012-12#1)
to an enhancement of the##5##5##(1992-9#1)(1993-12#1)(2006-4#1)(2007-12#1)(2007-9#1)
to an enhancement of##7##4##(1992-9#1)(1993-12#1)(1996-10#1)(2006-4#1)(2007-12#1)(2007-9#1)(2008-10#1)
to an enhancement##9##3##(1992-9#1)(1993-12#1)(1995-3#1)(1996-10#1)(2006-4#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#1)
to an enormous##2##3##(2011-1#1)(2012-1#1)
to an enriched##5##3##(1991-12#1)(1992-11#3)(1993-7#1)
to an enrichment##3##3##(2004-11#1)(2008-10#1)(2009-4#1)
to an entire##2##3##(2008-3#1)(2011-2#1)
to an enzyme##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2009-8#1)
to an equilibrium##2##3##(1990-5#1)(1994-8#1)
to an equivalent level in##2##5##(2008-10#1)(2008-8#1)
to an equivalent##6##3##(2005-10#1)(2008-10#2)(2008-8#1)(2012-12#2)
to an essential##2##3##(1990-11#1)(1993-12#1)
to an established##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
to an estimated##8##3##(1991-11#1)(1995-2#2)(1997-7#1)(2007-9#1)(2008-11#1)(2011-2#1)(2012-2#1)
to an even greater extent##2##5##(1995-4#1)(1996-2#1)
to an even greater##3##4##(1995-4#1)(1996-2#1)(2006-12#1)
to an exact solution##2##4##(2007-12#1)(2008-2#1)
to an exact##5##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)
to an example of a##2##5##(2008-3#1)(2008-4#1)
to an excellent##2##3##(2005-8#1)(2012-12#1)
to an expanded##2##3##(2006-10#1)(2013-1#1)
to an expansion of the##3##5##(1990-2#1)(2006-8#1)(2013-1#1)
to an expected##2##3##(2006-4#1)(2010-12#1)
to an experimental group##2##4##(1994-3#1)(2010-2#1)
to an experimental##8##3##(1991-2#1)(1994-3#1)(2007-12#1)(2008-12#1)(2008-4#2)(2008-8#1)(2010-2#1)
to an expert##3##3##(1995-2#1)(2006-4#1)(2010-10#1)
to an exponential##2##3##(2008-10#1)(2012-2#1)
to an expression for the##2##5##(1997-4#1)(2008-10#1)
to an expression##3##3##(1997-4#1)(2008-10#1)(2008-4#1)
to an extended##2##3##(2008-10#1)(2008-3#1)
to an extension##2##3##(2007-7#1)(2008-5#1)
to an extent comparable to that##2##6##(1995-1#1)(1996-5#1)
to an extent that##4##4##(1990-11#1)(1994-6#1)(2005-11#1)(2008-10#1)
to an extent##11##3##(1990-11#1)(1990-9#1)(1994-6#1)(1995-1#1)(1995-2#1)(1996-5#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-7#1)
to an external##8##3##(1990-3#1)(1993-3#1)(2007-12#2)(2007-7#2)(2008-5#1)(2008-7#1)
to an extra##2##3##(1994-3#1)(2010-5#1)
to an extracellular##2##3##(1993-12#1)(2008-4#1)
to an extreme##6##3##(1990-12#1)(2006-7#1)(2007-9#2)(2012-12#1)(2012-2#1)
to an extremely##3##3##(1990-6#1)(2008-2#1)(2011-2#1)
to an ideal##2##3##(2007-12#1)(2008-2#1)
to an image##3##3##(1997-8#1)(2007-12#1)(2008-2#1)
to an immobilized##2##3##(1990-12#1)(1996-12#1)
to an immune response to the##2##6##(1994-11#1)(2008-11#1)
to an immunological##2##3##(1990-5#1)(1991-2#1)
to an impairment of##3##4##(1992-4#1)(1996-10#1)(2008-11#1)
to an impairment##4##3##(1992-4#1)(1994-3#1)(1996-10#1)(2008-11#1)
to an imperfect##2##3##(2007-9#1)(2008-3#1)
to an important##10##3##(1990-10#1)(1991-10#1)(1991-11#1)(1991-9#1)(1992-8#1)(1996-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2012-2#1)
to an imposed##2##3##(1994-9#1)(2008-8#1)
to an improved understanding of##2##5##(2007-8#1)(2010-12#1)
to an improved##12##3##(1994-2#1)(2006-10#1)(2007-8#2)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-4#1)
to an improvement in the##2##5##(2008-2#1)(2008-7#1)
to an improvement in##4##4##(2008-2#2)(2008-6#1)(2008-7#1)
to an improvement of the##3##5##(2008-10#2)(2008-3#1)
to an improvement of##4##4##(2008-10#2)(2008-3#1)(2013-1#1)
to an improvement##11##3##(1990-2#1)(1990-7#1)(1995-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2013-1#1)
to an in vitro##2##4##(1992-8#1)(1993-3#1)
to an in##3##3##(1992-8#1)(1993-3#1)(2008-5#1)
to an in-frame stop codon (UAA)##2##6##(1990-11#1)(1992-11#1)
to an inability to##3##4##(1994-3#1)(2007-2#1)(2008-2#1)
to an inadequate##3##3##(1992-1#1)(2008-4#1)(2013-1#1)
to an incidence of##2##4##(1991-11#1)(2007-2#1)
to an incomplete##2##3##(1996-3#1)(2010-10#1)
to an increase in sensitivity##2##5##(2006-2#1)(2008-2#1)
to an increase in the number of##3##7##(2006-8#1)(2011-12#1)(2012-2#1)
to an increase in the##33##5##(1990-5#2)(1990-7#1)(1991-1#1)(1991-2#1)(1991-4#1)(1994-12#1)(1995-2#1)(1995-3#1)(1997-1#1)(1997-5#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-7#1)(2013-8#1)
to an increase in##97##4##(1990-12#1)(1990-3#1)(1990-5#2)(1990-7#2)(1991-1#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-5#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#3)(1995-4#1)(1995-6#1)(1996-7#2)(1997-1#2)(1997-5#1)(1997-7#4)(2005-11#2)(2005-12#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-3#1)(2006-8#1)(2007-1#1)(2007-12#3)(2007-2#2)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#1)(2008-9#1)(2009-1#1)(2009-8#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
to an increase of the##10##5##(1990-10#1)(1990-7#1)(1991-12#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-11#1)
to an increase of##25##4##(1990-10#1)(1990-3#1)(1990-7#1)(1991-12#2)(1991-6#1)(1991-7#1)(1992-6#1)(1994-10#1)(1994-6#1)(1995-1#2)(1997-3#1)(2005-10#1)(2006-10#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#1)(2009-11#1)(2011-2#1)
to an increase##123##3##(1990-10#1)(1990-12#1)(1990-3#2)(1990-5#2)(1990-7#3)(1991-1#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-5#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-1#2)(1995-2#1)(1995-3#3)(1995-4#1)(1995-6#1)(1996-7#2)(1997-1#3)(1997-3#1)(1997-5#1)(1997-7#4)(2005-10#1)(2005-11#2)(2005-12#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-3#1)(2006-8#1)(2007-1#1)(2007-12#3)(2007-2#2)(2007-7#1)(2007-9#1)(2008-10#6)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#4)(2008-7#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-8#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
to an increased incidence of##2##5##(2007-11#1)(2012-12#1)
to an increased number of##4##5##(1993-11#1)(2007-10#1)(2007-11#1)(2010-7#1)
to an increased risk of##5##5##(1990-8#1)(2006-10#1)(2007-12#1)(2008-3#1)(2011-1#1)
to an increased risk##6##4##(1990-8#1)(2006-10#1)(2007-12#2)(2008-3#1)(2011-1#1)
to an increased susceptibility##2##4##(2006-10#1)(2008-5#1)
to an increased understanding of the##2##6##(2004-11#1)(2010-11#1)
to an increased understanding of##3##5##(2004-11#1)(2006-10#1)(2010-11#1)
to an increased##50##3##(1990-11#1)(1990-7#1)(1990-8#2)(1992-6#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-2#3)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(2004-11#1)(2005-1#1)(2005-10#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#2)(2010-11#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#3)
to an increasing number of##3##5##(1992-3#1)(1997-4#1)(2006-10#1)
to an increasing use of##2##5##(2006-10#1)(2008-7#1)
to an increasing##11##3##(1990-8#1)(1991-5#1)(1992-3#1)(1997-4#1)(2006-10#2)(2008-1#1)(2008-2#1)(2008-7#1)(2009-3#1)(2010-8#1)
to an increasingly##3##3##(1996-9#1)(2005-11#1)(2008-3#1)
to an increment of##2##4##(1990-8#1)(2005-11#1)
to an increment##3##3##(1990-8#1)(1993-7#1)(2005-11#1)
to an independent##2##3##(2007-11#1)(2011-1#1)
to an individual##7##3##(1991-2#1)(2005-8#1)(2006-10#1)(2006-8#1)(2008-3#1)(2008-7#1)(2012-3#1)
to an individual's##5##3##(1997-3#1)(2006-10#1)(2011-2#1)(2012-1#1)(2012-3#1)
to an induction of##4##4##(1994-2#1)(1994-5#1)(2008-10#2)
to an inductively coupled plasma##2##5##(2008-10#2)
to an industrial##2##3##(2008-10#1)(2012-2#1)
to an infection##6##3##(2007-9#1)(2008-11#2)(2010-6#1)(2013-1#2)
to an infectious##3##3##(2007-12#1)(2007-3#1)(2012-2#1)
to an inflammatory##2##3##(1991-7#1)(2009-3#1)
to an influx of##3##4##(1991-12#1)(1995-10#1)(2007-9#1)
to an inhibition of##9##4##(1990-8#2)(1993-7#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-4#1)(2008-5#1)(2012-11#1)
to an inhibitor##2##3##(1994-6#1)(2007-12#1)
to an inhibitory##4##3##(1991-1#1)(1996-1#1)(1997-5#1)(2008-6#1)
to an initial##5##3##(1991-6#1)(1997-6#1)(2007-4#1)(2008-10#1)(2010-6#1)
to an injection##2##3##(2007-12#1)(2008-10#1)
to an injury##2##3##(1990-8#1)(1992-11#1)
to an inner##3##3##(1991-4#1)(1992-5#1)(2007-12#1)
to an inpatient psychiatric##2##4##(1991-2#1)(2007-2#1)
to an inpatient##3##3##(1991-2#1)(2007-2#1)(2008-7#1)
to an insufficient##2##3##(1990-4#1)(2013-1#1)
to an integrated##4##3##(1995-1#1)(1995-3#1)(2008-10#1)(2012-3#1)
to an integrin##2##3##(1996-2#1)(1996-5#1)
to an intensive care unit##3##5##(1991-11#1)(1995-12#1)(2012-12#1)
to an intensive care##4##4##(1991-11#1)(1995-12#1)(2006-4#1)(2012-12#1)
to an intensive##5##3##(1991-11#1)(1995-12#1)(2006-4#1)(2008-4#1)(2012-12#1)
to an interaction of##2##4##(1994-5#1)(1997-7#1)
to an interaction with##3##4##(1992-5#1)(1996-5#1)(2006-12#1)
to an interaction##7##3##(1990-2#1)(1992-5#1)(1994-5#1)(1996-5#1)(1997-7#1)(2006-12#1)(2008-10#1)
to an intermediate##4##3##(1990-12#1)(1993-10#1)(2008-3#1)(2009-12#1)
to an internal##6##3##(1990-10#1)(1990-2#1)(2006-6#1)(2007-3#1)(2008-7#1)(2008-8#1)
to an international##3##3##(1997-7#1)(2006-10#1)(2009-8#1)
to an interventional##2##3##(1997-8#1)(2006-8#1)
to an intracellular##4##3##(1991-2#1)(1996-10#1)(1996-4#1)(2009-10#1)
to an intramolecular##2##3##(1990-4#1)(2006-12#1)
to an invasive##3##3##(1991-12#1)(2008-3#1)(2012-2#1)
to an investigation##2##3##(2008-10#1)(2008-12#1)
to an ion trap mass spectrometer##2##6##(2008-1#1)(2008-10#1)
to an ion##3##3##(1994-8#1)(2008-1#1)(2008-10#1)
to an irradiance##2##3##(2007-12#1)(2008-3#1)
to an irreversible##2##3##(1992-8#1)(1996-6#1)
to an isolate##2##3##(2008-10#2)
to an isotonic##2##3##(1991-1#1)(1995-8#1)
to an object and##3##4##(1997-8#1)(2008-11#1)(2008-3#1)
to an objective##2##3##(2012-1#1)(2012-2#1)
to an odour##2##3##(1990-10#1)(2008-5#1)
to an old##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
to an oligonucleotide##2##3##(1993-3#1)(1995-3#1)
to an open reading frame of##2##6##(1992-8#1)(1994-6#1)
to an open##8##3##(1992-8#1)(1994-6#1)(2006-4#2)(2007-8#2)(2010-3#1)(2012-12#1)
to an optical##11##3##(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#4)(2008-3#1)
to an optical-to-optical efficiency of##2##5##(2008-2#2)
to an optimal##5##3##(1991-5#1)(2008-2#1)(2008-5#1)(2009-7#1)(2012-12#1)
to an optimum##2##3##(1991-3#1)(2008-10#1)
to an order of magnitude##2##5##(1996-11#1)(2008-10#1)
to an ordinary##2##3##(2008-10#1)(2013-8#1)
to an organ##2##3##(2006-10#1)(2008-2#1)
to an organic##4##3##(1993-9#1)(2008-10#2)(2010-4#1)
to an original##3##3##(2007-1#1)(2013-1#2)
to an outbreak of##3##4##(1994-5#1)(2005-7#1)(2012-1#1)
to an outpatient##2##3##(1995-2#1)(2008-7#1)
to an outside##2##3##(2006-5#1)(2013-8#1)
to an over##3##3##(1996-2#1)(2008-5#1)(2010-2#1)
to an overactive bladder##2##4##(1997-5#1)(2009-2#1)
to an overall##8##3##(1995-5#2)(1997-4#1)(2008-4#1)(2008-6#1)(2009-8#1)(2010-12#1)(2012-1#1)
to an unbranched##2##3##(2007-12#1)(2010-11#1)
to an uncharacterized##2##3##(1996-6#1)(2012-2#1)
to an undamaged##2##3##(1995-2#1)(2009-4#1)
to an underestimation of the##2##5##(1995-3#1)(2012-3#1)
to an underlying##3##3##(2007-12#1)(2008-4#1)(2011-1#1)
to an understanding of the##3##5##(1991-9#1)(1994-8#1)(2011-2#1)
to an understanding of##8##4##(1991-8#1)(1991-9#1)(1994-8#1)(2008-9#3)(2010-5#1)(2011-2#1)
to an undetectable level##2##4##(1990-9#1)(1992-1#1)
to an unexpected##2##3##(2008-7#1)(2012-2#1)
to an unfavorable##2##3##(1991-2#1)(2013-1#1)
to an unidentified##5##3##(1995-11#1)(1995-6#1)(1996-10#1)(1997-8#1)(2007-3#1)
to an unknown##3##3##(1994-6#1)(2008-2#1)(2011-2#1)
to an untreated##2##3##(2004-9#1)(2008-5#1)
to an unusual##4##3##(1990-6#1)(2006-5#1)(2008-5#1)(2008-8#1)
to an urban##2##3##(2013-1#2)
to an##1490##2##(1990-10#6)(1990-11#7)(1990-12#14)(1990-2#7)(1990-3#5)(1990-4#3)(1990-5#8)(1990-6#3)(1990-7#11)(1990-8#8)(1990-9#3)(1991-1#7)(1991-10#3)(1991-11#5)(1991-12#12)(1991-2#13)(1991-3#2)(1991-4#4)(1991-5#2)(1991-6#5)(1991-7#6)(1991-8#6)(1991-9#7)(1992-1#6)(1992-10#2)(1992-11#9)(1992-12#7)(1992-2#3)(1992-3#5)(1992-4#2)(1992-5#4)(1992-6#6)(1992-7#5)(1992-8#6)(1992-9#3)(1993-10#2)(1993-11#8)(1993-12#8)(1993-2#4)(1993-3#8)(1993-5#3)(1993-6#6)(1993-7#4)(1993-8#2)(1993-9#6)(1994-10#2)(1994-11#5)(1994-12#13)(1994-2#10)(1994-3#9)(1994-5#8)(1994-6#8)(1994-8#10)(1994-9#2)(1995-1#11)(1995-10#3)(1995-11#6)(1995-12#4)(1995-2#12)(1995-3#13)(1995-4#3)(1995-5#5)(1995-6#13)(1995-8#11)(1995-9#5)(1996-1#6)(1996-10#9)(1996-11#5)(1996-12#5)(1996-2#8)(1996-3#6)(1996-4#4)(1996-5#12)(1996-6#3)(1996-7#4)(1996-8#1)(1996-9#4)(1997-1#7)(1997-2#9)(1997-3#4)(1997-4#9)(1997-5#5)(1997-6#5)(1997-7#10)(1997-8#8)(2004-10#1)(2004-11#6)(2004-8#1)(2004-9#3)(2005-1#1)(2005-10#3)(2005-11#7)(2005-12#2)(2005-7#1)(2005-8#3)(2006-1#3)(2006-10#28)(2006-11#4)(2006-12#10)(2006-2#7)(2006-3#2)(2006-4#9)(2006-5#4)(2006-6#2)(2006-7#3)(2006-8#11)(2007-1#8)(2007-10#5)(2007-11#18)(2007-12#56)(2007-2#9)(2007-3#5)(2007-4#2)(2007-5#2)(2007-6#4)(2007-7#12)(2007-8#17)(2007-9#12)(2008-1#12)(2008-10#123)(2008-11#28)(2008-12#9)(2008-2#43)(2008-3#61)(2008-4#35)(2008-5#41)(2008-6#11)(2008-7#28)(2008-8#14)(2008-9#14)(2009-1#2)(2009-10#5)(2009-11#2)(2009-12#8)(2009-2#4)(2009-3#9)(2009-4#5)(2009-5#4)(2009-6#4)(2009-7#3)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#7)(2010-2#6)(2010-3#3)(2010-4#5)(2010-5#10)(2010-6#6)(2010-7#3)(2010-8#7)(2011-1#19)(2011-12#3)(2011-2#28)(2011-3#2)(2012-1#13)(2012-11#4)(2012-12#24)(2012-2#24)(2012-3#6)(2013-1#33)(2013-7#6)(2013-8#8)
to anaemia in##2##3##(2005-8#1)(2008-1#1)
to anaerobic##2##2##(2006-8#1)(2010-11#1)
to anaesthesia for##2##3##(2006-10#1)(2013-1#1)
to anaesthesia##8##2##(2006-10#3)(2010-7#4)(2013-1#1)
to anaesthetic action##2##3##(1996-1#2)
to anaesthetic##3##2##(1996-1#2)(2007-9#1)
to anakinra##2##2##(2012-2#2)
to analgesia##4##2##(2006-8#1)(2007-2#1)(2007-3#1)(2013-8#1)
to analogous##4##2##(1992-5#1)(1994-5#2)(2008-10#1)
to analogue##2##2##(2005-11#1)(2012-2#1)
to analyse a##3##3##(1994-2#1)(2006-10#1)(2010-5#1)
to analyse and to##2##4##(2008-11#1)(2009-8#1)
to analyse and##5##3##(1990-12#1)(1992-12#1)(1997-3#1)(2008-11#1)(2009-8#1)
to analyse data##2##3##(1993-5#1)(2005-12#1)
to analyse the effects of##3##5##(1991-12#1)(1993-2#1)(2008-7#1)
to analyse the outcome##2##4##(2007-8#1)(2008-7#1)
to analyse the relationship##2##4##(2007-10#1)(2009-5#1)
to analyse the role of##2##5##(1991-3#1)(2011-12#1)
to analyse the##57##3##(1990-2#1)(1991-12#2)(1991-3#1)(1991-7#1)(1993-2#2)(1993-5#2)(1993-6#1)(1993-9#1)(1995-11#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(2004-10#1)(2004-9#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#5)(2009-2#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-12#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
to analyse their##3##3##(2007-12#1)(2008-5#1)(2009-5#1)
to analyse whether##3##3##(1991-5#1)(1992-12#1)(2010-3#1)
to analyse##134##2##(1990-12#1)(1990-2#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#3)(1992-12#3)(1993-2#2)(1993-5#3)(1993-6#2)(1993-9#2)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#3)(2004-10#1)(2004-9#1)(2005-12#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-6#1)(2007-8#4)(2007-9#3)(2008-1#1)(2008-10#18)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#8)(2009-2#1)(2009-5#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#3)(2013-8#1)
to analyses of##4##3##(1997-3#1)(2006-10#1)(2008-10#1)(2008-4#1)
to analyses##6##2##(1997-3#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-3#1)
to analysis by##5##3##(2007-11#1)(2008-10#4)
to analysis of##22##3##(1993-10#1)(1993-12#1)(1993-7#1)(1994-8#1)(2006-10#1)(2007-12#1)(2008-10#10)(2008-4#1)(2008-9#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
to analysis the##3##3##(2005-11#1)(2007-8#1)(2009-2#1)
to analysis##53##2##(1992-7#1)(1993-10#1)(1993-12#1)(1993-7#1)(1994-8#1)(1997-5#1)(2005-11#2)(2005-12#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#23)(2008-4#3)(2008-9#1)(2009-2#1)(2010-2#2)(2010-4#1)(2010-5#1)(2011-1#1)(2012-12#2)(2012-2#2)(2013-8#1)
to analyte##2##2##(2007-8#1)(2008-10#1)
to analytical##14##2##(2007-8#1)(2008-10#6)(2008-5#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#3)
to analytically##7##2##(1994-2#1)(1997-6#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2012-2#1)
to analyze a##7##3##(2008-10#3)(2008-3#1)(2008-8#1)(2010-8#1)(2011-2#1)
to analyze an##2##3##(2008-10#1)(2008-3#1)
to analyze and compare##2##4##(2006-10#1)(2007-2#1)
to analyze and##10##3##(1991-2#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2010-6#1)
to analyze by##3##3##(2008-2#1)(2008-4#2)
to analyze changes in##2##4##(2008-5#1)(2009-1#1)
to analyze data from##2##4##(1993-3#1)(2013-7#1)
to analyze data##4##3##(1993-3#1)(2005-8#1)(2013-1#1)(2013-7#1)
to analyze experimental data##2##4##(2008-4#1)(2013-8#1)
to analyze genetic##2##3##(2008-10#1)(2011-2#1)
to analyze human##3##3##(2008-11#1)(2008-4#1)(2011-2#1)
to analyze in detail the##3##5##(1992-7#1)(1994-12#1)(2013-1#1)
to analyze in vivo##2##4##(2006-3#1)(2008-11#1)
to analyze in##6##3##(1992-7#1)(1994-12#1)(1997-3#1)(2006-3#1)(2008-11#1)(2013-1#1)
to analyze its##3##3##(2008-1#1)(2008-11#1)(2012-2#1)
to analyze our##2##3##(2007-8#1)(2008-9#1)
to analyze patients##2##3##(1993-3#1)(2008-7#1)
to analyze protein##3##3##(2008-2#1)(2008-4#2)
to analyze proteins##2##3##(2007-11#1)(2007-8#1)
to analyze rare##3##3##(2008-2#1)(2008-4#1)(2012-3#1)
to analyze risk factors##2##4##(2011-1#1)(2012-3#1)
to analyze simultaneously##2##3##(2012-12#1)(2012-3#1)
to analyze some##2##3##(2008-3#1)(2009-10#1)
to analyze such##2##3##(2008-10#1)(2008-3#1)
to analyze the activity of##3##5##(1994-12#1)(2008-7#1)(2011-1#1)
to analyze the collected data##2##5##(1992-1#1)(1992-3#1)
to analyze the data from##2##5##(2008-4#1)(2011-1#1)
to analyze the data##10##4##(2007-10#1)(2008-10#1)(2008-4#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#3)
to analyze the distribution##2##4##(2008-8#2)
to analyze the dynamics of##2##5##(1997-1#1)(2008-8#1)
to analyze the effect of the##2##6##(2007-3#1)(2008-10#1)
to analyze the effect of##8##5##(1994-8#1)(1995-8#1)(2006-11#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-12#1)(2011-2#1)
to analyze the effects of##7##5##(1996-3#1)(2007-12#3)(2010-12#1)(2012-12#1)(2013-8#1)
to analyze the expression##2##4##(2008-7#1)(2011-2#1)
to analyze the extent##2##4##(1996-9#1)(2008-9#1)
to analyze the genetic##2##4##(2008-10#1)(2011-2#1)
to analyze the impact of##2##5##(2007-8#1)(2008-9#1)
to analyze the importance of##2##5##(2005-1#1)(2007-8#1)
to analyze the influence of##2##5##(2005-11#1)(2010-1#1)
to analyze the influence##3##4##(2005-11#1)(2009-10#1)(2010-1#1)
to analyze the long-term##3##4##(2007-11#1)(2008-9#1)(2012-3#1)
to analyze the physical##2##4##(2008-8#1)(2009-4#1)
to analyze the protein##2##4##(2008-1#1)(2010-12#1)
to analyze the relationship between##3##5##(1997-8#1)(2007-8#1)(2010-2#1)
to analyze the relationship##4##4##(1997-8#1)(2007-8#1)(2010-2#1)(2011-1#1)
to analyze the results of##2##5##(2012-3#1)(2013-1#1)
to analyze the results##3##4##(2012-2#1)(2012-3#1)(2013-1#1)
to analyze the risk factors associated with##2##7##(2012-12#1)(2012-3#1)
to analyze the risk factors##3##5##(2007-2#1)(2012-12#1)(2012-3#1)
to analyze the spatial##2##4##(2007-7#1)(2008-10#1)
to analyze the structure##2##4##(1996-2#1)(2007-10#1)
to analyze the trends##2##4##(2012-1#1)(2012-2#1)
to analyze the variability##2##4##(2008-10#2)
to analyze the variation of##2##5##(2008-3#1)(2008-8#1)
to analyze the variation##3##4##(2008-3#1)(2008-8#1)(2013-8#1)
to analyze the##199##3##(1990-7#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-8#2)(1996-10#1)(1996-2#1)(1996-3#2)(1996-7#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#2)(1997-8#1)(2004-12#1)(2004-9#2)(2005-1#1)(2005-11#1)(2006-11#1)(2006-12#1)(2006-5#2)(2006-7#1)(2007-10#3)(2007-11#2)(2007-12#5)(2007-2#1)(2007-3#2)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#6)(2008-1#3)(2008-10#19)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#7)(2008-4#4)(2008-5#1)(2008-6#7)(2008-7#4)(2008-8#7)(2008-9#4)(2009-10#1)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#4)(2010-2#2)(2010-8#4)(2010-9#1)(2011-1#5)(2011-12#3)(2011-2#8)(2011-7#1)(2012-1#2)(2012-12#5)(2012-2#4)(2012-3#6)(2013-1#9)(2013-7#2)(2013-8#4)
to analyze these##3##3##(2006-2#1)(2008-9#1)(2009-12#1)
to analyze this##5##3##(2007-11#1)(2007-7#1)(2008-9#1)(2009-10#1)(2010-4#1)
to analyze##450##2##(1990-11#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-7#2)(1993-3#3)(1993-6#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-2#1)(1995-3#3)(1995-8#2)(1996-10#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-5#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#4)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-12#1)(2004-2#1)(2004-9#2)(2005-1#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#3)(2007-11#5)(2007-12#7)(2007-2#3)(2007-3#2)(2007-5#2)(2007-6#2)(2007-7#7)(2007-8#12)(2007-9#1)(2008-1#7)(2008-10#56)(2008-11#15)(2008-12#4)(2008-2#15)(2008-3#19)(2008-4#16)(2008-5#5)(2008-6#9)(2008-7#5)(2008-8#13)(2008-9#16)(2009-1#1)(2009-10#5)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#6)(2009-5#2)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#8)(2010-9#1)(2011-1#9)(2011-12#3)(2011-2#18)(2011-7#1)(2012-1#4)(2012-11#1)(2012-12#8)(2012-2#9)(2012-3#14)(2013-1#17)(2013-7#4)(2013-8#5)
to analyzing the##3##3##(1991-3#1)(2008-2#1)(2009-2#1)
to analyzing##12##2##(1991-3#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-9#1)(2009-2#1)(2009-4#1)(2012-3#2)
to anatomical and##2##3##(2012-1#1)(2013-1#1)
to anatomical##9##2##(1991-12#2)(1996-10#1)(2009-9#1)(2010-6#1)(2011-2#2)(2012-1#1)(2013-1#1)
to ancestral##2##2##(1994-3#1)(2012-12#1)
to anchor the##2##3##(1997-5#1)(2008-10#1)
to anchor##10##2##(1990-7#1)(1990-8#1)(1991-2#1)(1994-12#1)(1997-2#1)(1997-5#1)(2007-11#1)(2008-10#2)(2009-7#1)
to and during pregnancy##3##4##(1995-6#1)(2006-8#1)(2012-1#1)
to and during##4##3##(1995-6#1)(2006-8#1)(2009-9#1)(2012-1#1)
to and facilitators of##2##4##(2013-1#2)
to and following##6##3##(1990-11#1)(1992-3#1)(1995-3#1)(2007-11#1)(2007-12#1)(2010-5#1)
to and from the##6##4##(2007-11#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)
to and from##15##3##(1993-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-8#2)(2009-4#1)(2010-10#1)(2010-6#1)
to and in##3##3##(1995-8#1)(2010-11#1)(2012-3#1)
to and the##2##3##(1993-12#1)(2007-9#1)
to and to##3##3##(2008-12#1)(2008-6#1)(2009-5#1)
to and##175##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-10#2)(1991-12#1)(1991-4#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-3#3)(1992-5#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-12#4)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#2)(1995-8#3)(1996-3#2)(1996-5#1)(1996-8#1)(1997-2#3)(1997-3#3)(1997-4#1)(1997-7#1)(2004-11#2)(2005-10#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#6)(2007-12#3)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#10)(2008-4#3)(2008-5#6)(2008-6#5)(2008-7#2)(2008-8#2)(2008-9#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#4)(2012-11#1)(2012-12#1)(2012-3#3)(2013-1#6)
to androgen##2##2##(2008-4#1)(2009-5#1)
to androgens##6##2##(1990-5#2)(1992-9#1)(1995-12#2)(2012-12#1)
to androstenone and skatole##2##4##(2010-4#2)
to anemia##3##2##(2008-7#1)(2011-1#1)(2012-2#1)
to anesthesia##5##2##(2006-10#5)
to anesthetic##2##2##(2006-10#2)
to aneuploidy##2##2##(2007-2#1)(2008-8#1)
to aneurysm##2##2##(2007-7#1)(2010-4#1)
to angiodysplasia of the##2##4##(2007-8#2)
to angiodysplasia##3##2##(2007-8#2)(2012-2#1)
to angiogenesis##2##2##(2008-11#1)(2011-12#1)
to angiography##2##2##(1990-5#1)(1993-8#1)
to angioplasty##3##2##(2007-11#1)(2008-11#1)(2008-4#1)
to angiotensin II in##2##4##(1992-9#1)(1993-12#1)
to angiotensin II##10##3##(1990-12#2)(1990-2#1)(1992-6#1)(1992-9#1)(1993-12#1)(2006-10#2)(2008-1#1)(2008-9#1)
to angiotensin##19##2##(1990-12#2)(1990-2#1)(1991-12#2)(1992-6#1)(1992-9#2)(1993-12#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-12#2)(2006-10#2)(2008-1#1)(2008-9#1)(2012-3#1)
to angiotensinogen##6##2##(1991-5#6)
to animal models##3##3##(2006-8#1)(2008-2#1)(2008-4#1)
to animal testing##2##3##(2008-10#1)(2008-5#1)
to animal##22##2##(1991-9#1)(1994-11#1)(1996-2#1)(1997-7#1)(2005-5#1)(2006-12#1)(2006-8#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2010-12#1)(2012-1#1)(2013-7#1)
to animals in##3##3##(1993-6#1)(1995-12#1)(2013-8#1)
to animals##20##2##(1990-10#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-12#1)(2005-7#2)(2007-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
to anion exchange chromatography and integrated pulsed electrochemical detection##2##9##(2008-7#2)
to anion##4##2##(1990-8#1)(2008-7#2)(2009-10#1)
to anionic surfactants##2##3##(1992-11#1)(2008-10#1)
to anionic##3##2##(1992-11#1)(1995-2#1)(2008-10#1)
to anisotropic##3##2##(2008-2#1)(2010-4#2)
to anneal##2##2##(2008-4#1)(2009-5#1)
to annotate the##3##3##(2008-9#1)(2013-1#2)
to annotate##9##2##(2008-7#1)(2008-9#1)(2012-3#2)(2013-1#5)
to annual##4##2##(1991-3#1)(1994-2#1)(2008-10#1)(2010-2#1)
to anode##2##2##(1991-5#1)(2007-8#1)
to anomalous##6##2##(1992-8#1)(1996-7#1)(2005-10#1)(2008-3#2)(2012-2#1)
to anorexia nervosa##4##3##(1992-11#1)(1995-9#1)(2005-12#1)(2007-8#1)
to another and##2##3##(2008-2#1)(2012-2#1)
to another class of##2##4##(1995-6#1)(2008-5#1)
to another facility##2##3##(1993-1#1)(2009-3#1)
to another in a##3##4##(1991-3#1)(2007-12#1)(2009-10#1)
to another in##4##3##(1991-3#1)(1994-2#1)(2007-12#1)(2009-10#1)
to another is##3##3##(1995-3#1)(2008-2#1)(2011-12#1)
to another one##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
to another through##2##3##(2006-10#2)
to another##105##2##(1990-12#1)(1990-5#1)(1991-11#2)(1991-3#1)(1991-4#1)(1991-9#1)(1992-3#2)(1992-4#2)(1993-1#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-3#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#5)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#6)(2007-3#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#15)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#5)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-1#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-12#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
to anoxia and reoxygenation##2##4##(1994-9#2)
to anoxia##5##2##(1991-2#1)(1994-12#1)(1994-9#2)(1997-5#1)
to answer a questionnaire##2##4##(2006-10#1)(2013-1#1)
to answer a##5##3##(2006-10#1)(2007-4#1)(2007-7#1)(2010-9#1)(2013-1#1)
to answer important##2##3##(2008-11#1)(2012-1#1)
to answer questions##3##3##(1991-3#1)(2008-11#1)(2008-5#1)
to answer the clinical question##46##5##(2007-8#46)
to answer the following question##2##5##(2012-12#1)(2012-3#1)
to answer the following questions##2##5##(1994-8#1)(1997-3#1)
to answer the following##4##4##(1994-8#1)(1997-3#1)(2012-12#1)(2012-3#1)
to answer the question of##3##5##(2004-9#1)(2009-8#1)(2010-4#1)
to answer the question##14##4##(1994-6#1)(2004-12#1)(2004-9#1)(2006-8#1)(2007-12#1)(2007-8#4)(2008-2#1)(2008-8#1)(2009-8#1)(2010-4#1)(2011-2#1)
to answer the##69##3##(1994-6#1)(1994-8#1)(1997-3#1)(2004-12#1)(2004-9#1)(2006-8#1)(2007-12#1)(2007-8#50)(2008-10#2)(2008-2#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)
to answer these questions##3##4##(2007-2#1)(2008-8#1)(2009-2#1)
to answer these##5##3##(2007-2#1)(2007-6#1)(2008-8#1)(2009-2#1)(2010-3#1)
to answer this question##5##4##(1991-6#1)(2007-6#1)(2007-8#1)(2009-2#1)(2009-6#1)
to answer##110##2##(1990-10#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-2#1)(1993-8#1)(1994-1#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-2#1)(1997-3#1)(2004-12#1)(2004-9#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#2)(2007-7#2)(2007-8#51)(2008-10#2)(2008-11#4)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-2#2)(2009-6#1)(2009-8#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#4)
to antagonize the##6##3##(1991-2#1)(1994-9#1)(1995-12#1)(1997-2#1)(2006-10#1)(2009-6#1)
to antagonize##20##2##(1991-2#1)(1991-4#1)(1992-8#1)(1994-9#2)(1995-12#3)(1995-7#1)(1996-12#1)(1997-2#2)(1997-8#1)(2006-10#1)(2007-12#1)(2008-10#1)(2009-6#1)(2010-10#1)(2012-12#1)(2013-7#1)
to anterior cruciate ligament##2##4##(2006-3#1)(2008-2#1)
to anterior##13##2##(1996-12#1)(2006-3#1)(2008-2#1)(2008-5#1)(2008-7#3)(2009-4#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
to anterograde##2##2##(1991-5#1)(1993-2#1)
to anteroposterior##3##2##(2007-7#1)(2010-2#1)(2011-2#1)
to anthesis##8##2##(2008-10#8)
to anthracnose resistance##2##3##(2008-10#2)
to anthracnose##9##2##(2008-10#9)
to anthracyclines and##2##3##(1991-6#1)(2010-12#1)
to anthracyclines##3##2##(1991-6#1)(1993-12#1)(2010-12#1)
to anthropogenic##4##2##(1996-5#1)(2007-5#1)(2010-8#1)(2012-2#1)
to anthropogenically##2##2##(1995-8#1)(2006-5#1)
to anti##2##2##(1995-10#1)(2007-7#1)
to anti-APO-1-induced apoptosis##2##3##(1997-7#2)
to anti-APO-1-induced##3##2##(1997-7#3)
to anti-HCV##2##2##(2007-7#2)
to anti-TB treatment##3##3##(1996-3#1)(2011-1#1)(2012-2#1)
to anti-TB##4##2##(1996-3#1)(2010-7#1)(2011-1#1)(2012-2#1)
to anti-cancer##2##2##(2008-9#1)(2012-12#1)
to anti-infective##2##2##(2005-8#2)
to anti-inflammatory##2##2##(2007-11#1)(2008-7#1)
to antiangiogenic##2##2##(2005-10#1)(2011-12#1)
to antibacterial agents##2##3##(1991-3#1)(1995-12#1)
to antibacterial##6##2##(1991-3#1)(1992-5#1)(1995-12#1)(2006-12#1)(2008-7#1)(2010-12#1)
to antibiotic therapy##3##3##(2008-1#1)(2008-4#1)(2012-1#1)
to antibiotic##8##2##(2008-1#1)(2008-12#1)(2008-4#1)(2008-9#1)(2011-1#2)(2012-1#1)(2012-12#1)
to antibiotics and##3##3##(2007-7#1)(2013-1#1)(2013-7#1)
to antibiotics having##2##3##(2006-11#1)(2011-2#1)
to antibiotics in##4##3##(2007-12#1)(2008-5#1)(2009-8#1)(2012-3#1)
to antibiotics of##3##3##(1990-6#1)(2010-4#1)(2013-8#1)
to antibiotics was##2##3##(1993-10#1)(2006-10#1)
to antibiotics##43##2##(1990-12#1)(1990-6#1)(1991-3#1)(1993-10#1)(1995-3#1)(1997-4#2)(2004-11#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-4#3)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#2)
to antibodies against##2##3##(1992-12#1)(1997-6#1)
to antibodies and##2##3##(1995-11#1)(2005-7#1)
to antibodies##13##2##(1991-1#1)(1992-12#1)(1995-11#1)(1997-6#1)(2005-7#1)(2006-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-7#1)
to antibody##4##2##(1995-12#1)(1997-1#1)(2007-11#1)(2007-5#1)
to anticancer drugs##7##3##(1995-1#1)(2006-11#1)(2008-11#2)(2008-5#1)(2009-6#1)(2012-12#1)
to anticancer therapies##2##3##(2006-11#1)(2008-7#1)
to anticancer##12##2##(1992-2#1)(1995-1#1)(1997-4#1)(2006-11#2)(2008-11#3)(2008-5#1)(2008-7#1)(2009-6#1)(2012-12#1)
to anticipate complete##2##3##(2007-8#1)(2012-12#1)
to anticipate future##2##3##(2010-2#1)(2013-1#1)
to anticipate the##2##3##(1997-3#1)(2007-7#1)
to anticipate##16##2##(1993-9#1)(1997-3#1)(2004-9#1)(2006-8#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-10#1)(2010-2#1)(2012-12#1)(2013-1#1)
to anticoagulation##4##2##(2006-8#2)(2011-2#2)
to antidepressant##3##2##(2005-9#1)(2008-4#1)(2008-6#1)
to antidepressants##4##2##(2005-9#1)(2008-8#1)(2010-6#1)(2013-8#1)
to antidromic##2##2##(1993-12#1)(1994-2#1)
to antiestrogens##3##2##(1993-10#1)(2008-11#1)(2012-12#1)
to antifungal drugs##2##3##(2007-7#1)(2008-5#1)
to antifungal##7##2##(2006-11#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-5#2)(2011-2#1)
to antigen in##3##3##(1992-4#2)(2008-5#1)
to antigen##17##2##(1991-5#1)(1992-3#1)(1992-4#2)(1992-5#1)(1994-3#1)(1995-2#2)(1996-8#1)(1997-1#1)(2005-12#1)(2006-10#2)(2006-7#1)(2007-3#1)(2008-3#1)(2008-5#1)
to antigenic stimulation##2##3##(1997-1#1)(2008-11#1)
to antigenic##3##2##(1997-1#1)(2005-11#1)(2008-11#1)
to antigens of##4##3##(1992-9#1)(1996-12#1)(2006-10#1)(2007-2#1)
to antigens##9##2##(1992-9#1)(1996-10#1)(1996-12#1)(2006-10#3)(2007-2#1)(2008-10#1)(2012-12#1)
to antihypertensive drugs##2##3##(2009-4#1)(2012-12#1)
to antihypertensive therapy##2##3##(1996-9#1)(2011-1#1)
to antihypertensive##6##2##(1993-8#1)(1996-9#1)(2008-3#1)(2009-4#1)(2011-1#1)(2012-12#1)
to antiinflammatory activity##2##3##(1997-1#1)(2008-10#1)
to antiinflammatory##4##2##(1997-1#1)(2006-10#1)(2008-10#1)(2011-2#1)
to antimalarial##2##2##(2006-10#1)(2012-2#1)
to antimicrobial agents##8##3##(1991-2#1)(1991-8#1)(2005-8#1)(2006-10#1)(2006-11#1)(2008-6#1)(2008-7#1)(2012-12#1)
to antimicrobial##16##2##(1991-2#1)(1991-8#1)(1993-10#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2012-12#2)(2013-1#1)
to antimicrobials##6##2##(2005-11#1)(2008-11#2)(2010-12#1)(2010-4#1)(2013-8#1)
to antimony##3##2##(2006-10#1)(2008-10#1)(2012-12#1)
to antineoplastic drugs##3##3##(2013-1#3)
to antineoplastic##5##2##(2007-1#1)(2008-11#1)(2013-1#3)
to antioxidant##7##2##(1995-5#1)(1996-2#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-8#1)
to antiretroviral therapy in##2##4##(2009-11#1)(2010-11#1)
to antiretroviral therapy##4##3##(2008-4#1)(2009-11#1)(2009-4#1)(2010-11#1)
to antiretroviral treatment##2##3##(2010-12#1)(2012-12#1)
to antiretroviral##12##2##(2008-4#2)(2009-11#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-3#1)(2012-11#2)(2012-12#2)
to antisocial##3##2##(2008-11#1)(2009-4#1)(2011-12#1)
to antithrombin##3##2##(1993-6#2)(1997-2#1)
to antituberculosis##2##2##(2006-9#1)(2007-7#1)
to antitumor##2##2##(1992-2#1)(1996-2#1)
to ants##2##2##(2008-10#2)
to anxiety##3##2##(2010-2#1)(2010-7#1)(2011-1#1)
to anxious##2##2##(1990-11#1)(2008-2#1)
to any cause##2##3##(2008-6#1)(2011-2#1)
to any class of##2##4##(1996-9#1)(2007-9#1)
to any desired##7##3##(2007-12#2)(2008-3#2)(2008-4#1)(2008-9#1)(2010-2#1)
to any extent##2##3##(1990-6#1)(1995-6#1)
to any given##2##3##(2007-6#1)(2009-5#1)
to any known##7##3##(1994-6#1)(1995-1#1)(1996-12#1)(1996-4#1)(2007-1#1)(2008-10#1)(2013-1#1)
to any major##2##3##(2008-10#1)(2011-2#1)
to any membrane##2##3##(1995-11#1)(1996-7#1)
to any of the known##2##5##(1993-6#1)(2008-5#1)
to any of the previously##2##5##(1995-8#1)(2013-7#1)
to any of the##21##4##(1990-9#1)(1992-11#1)(1992-6#1)(1993-6#1)(1995-8#1)(1996-4#1)(1997-3#1)(2004-11#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-5#1)(2010-5#1)(2011-1#1)(2013-7#1)(2013-8#1)
to any of##24##3##(1990-9#1)(1992-11#1)(1992-6#1)(1993-4#1)(1993-6#1)(1995-12#1)(1995-8#1)(1996-4#2)(1997-3#1)(2004-11#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-5#1)(2010-5#1)(2011-1#1)(2013-7#1)(2013-8#1)
to any one of the##2##5##(1994-1#1)(1996-10#1)
to any one of##3##4##(1991-8#1)(1994-1#1)(1996-10#1)
to any one##4##3##(1991-8#1)(1994-1#1)(1996-10#1)(2008-10#1)
to any other known protein##2##5##(1995-2#1)(2005-6#1)
to any other##19##3##(1993-12#1)(1995-2#1)(1996-12#2)(1996-6#1)(1997-2#1)(1997-4#1)(2004-7#1)(2005-11#1)(2005-6#1)(2006-2#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-4#1)(2013-1#1)
to any particular##2##3##(1995-7#1)(2008-11#1)
to any protein##2##3##(1996-5#1)(2008-4#1)
to any reported genes##4##4##(1995-8#2)(1996-10#1)(1996-2#1)
to any researcher##2##3##(2008-7#1)(2008-9#1)
to any sequence##2##3##(2005-11#1)(2008-4#1)
to any sequenced##2##3##(1993-12#1)(2008-2#1)
to any significant extent##2##4##(1990-4#1)(1993-9#1)
to any significant##3##3##(1990-4#1)(1993-9#1)(1994-8#1)
to any single##4##3##(1995-2#1)(1996-12#1)(1996-9#1)(2008-5#1)
to any treatment##2##3##(2004-4#1)(2007-7#1)
to any type of##2##4##(2007-12#1)(2011-1#1)
to any##207##2##(1990-10#1)(1990-11#3)(1990-2#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-1#2)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-6#2)(1992-7#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#3)(1996-10#2)(1996-11#1)(1996-12#4)(1996-2#1)(1996-4#3)(1996-5#1)(1996-6#2)(1996-7#1)(1996-9#2)(1997-2#2)(1997-3#1)(1997-4#1)(2004-11#1)(2004-4#1)(2004-7#1)(2005-11#4)(2005-5#1)(2005-6#1)(2006-10#1)(2006-2#2)(2006-4#1)(2006-5#2)(2006-8#2)(2007-1#1)(2007-11#3)(2007-12#10)(2007-4#2)(2007-6#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#18)(2008-11#4)(2008-2#10)(2008-3#8)(2008-4#10)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#4)(2009-12#1)(2009-3#2)(2009-5#1)(2010-2#2)(2010-4#1)(2010-5#3)(2011-1#3)(2011-2#3)(2012-11#1)(2012-2#4)(2013-1#11)(2013-7#1)(2013-8#2)
to anyone##4##2##(1992-1#1)(1993-12#1)(1995-1#1)(2007-2#1)
to aorta##2##2##(2007-8#1)(2012-3#1)
to aortic root##2##3##(2007-8#2)
to aortic##10##2##(1991-6#1)(1992-12#1)(2007-4#1)(2007-8#4)(2009-6#1)(2010-7#1)(2013-8#1)
to aphid##2##2##(2004-2#2)
to apo A-I##2##3##(1990-8#1)(1996-4#1)
to apo B-containing##2##3##(1995-8#2)
to apo##6##2##(1990-8#1)(1993-4#1)(1995-4#1)(1995-8#2)(1996-4#1)
to apolipoprotein##2##2##(1994-2#1)(1995-6#1)
to apomorphine##4##2##(1993-2#1)(1993-9#1)(1995-12#1)(2008-7#1)
to apoptosis and##8##3##(1993-6#1)(1995-12#1)(2007-5#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-11#1)
to apoptosis in##3##3##(1994-10#1)(2005-10#1)(2008-7#1)
to apoptosis induced by##7##4##(1994-11#1)(1995-3#2)(1995-8#2)(2008-11#1)(2013-1#1)
to apoptosis induction##2##3##(2008-8#2)
to apoptosis##43##2##(1991-10#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#2)(1996-10#1)(1997-2#2)(1997-4#1)(2003-11#1)(2005-10#2)(2005-11#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-8#1)(2009-9#2)(2010-11#2)(2010-3#1)(2011-2#1)(2013-1#3)(2013-8#1)
to apoptotic##3##2##(1996-5#1)(2008-1#1)(2008-11#1)
to apparent homogeneity by##8##4##(1990-2#1)(1990-8#1)(1991-1#1)(1991-4#1)(1991-9#1)(1992-11#1)(1992-12#1)(1996-5#1)
to apparent homogeneity from human##3##5##(1990-12#1)(1990-4#1)(1994-11#1)
to apparent homogeneity from##5##4##(1990-12#1)(1990-4#1)(1994-11#1)(1994-8#1)(1996-5#1)
to apparent homogeneity##20##3##(1990-12#1)(1990-2#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-4#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-8#2)(1995-3#1)(1995-6#1)(1996-5#2)(1997-2#1)
to apparent##22##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-8#2)(1991-1#1)(1991-4#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-8#2)(1995-3#1)(1995-6#1)(1996-5#2)(1997-2#1)(2013-8#1)
to apparently##2##2##(1997-2#1)(2008-5#1)
to appeal to the##2##4##(1991-2#1)(2012-2#1)
to appeal to##3##3##(1991-2#1)(2005-8#1)(2012-2#1)
to appeal##4##2##(1991-2#1)(1991-6#1)(2005-8#1)(2012-2#1)
to appear after##2##3##(2007-7#1)(2008-10#1)
to appear for##3##3##(2006-10#1)(2008-10#1)(2008-2#1)
to appear in the##2##4##(1991-3#1)(1996-11#1)
to appear in##5##3##(1991-3#1)(1996-11#1)(2006-9#1)(2007-4#1)(2011-2#1)
to appear##24##2##(1990-8#1)(1991-3#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-6#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-2#2)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)
to appearance evaluation##2##3##(2007-12#2)
to appearance##4##2##(2007-12#3)(2008-9#1)
to apple##10##2##(2006-5#1)(2008-10#9)
to application of the##4##4##(1990-7#1)(2008-10#2)(2008-3#1)
to application of##12##3##(1990-7#2)(2006-12#1)(2006-8#1)(2008-10#4)(2008-3#1)(2009-3#1)(2012-1#1)(2012-3#1)
to application##18##2##(1990-7#2)(2006-12#1)(2006-8#1)(2007-1#1)(2008-10#5)(2008-3#1)(2009-2#1)(2009-3#1)(2011-2#1)(2012-1#3)(2012-3#1)
to applications in##3##3##(2008-2#1)(2008-4#1)(2010-7#1)
to applications of##4##3##(1991-3#1)(2004-4#1)(2008-10#1)(2010-4#1)
to applications with##2##3##(1992-2#1)(2008-3#1)
to applications##12##2##(1991-3#1)(1992-2#1)(2004-4#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-7#1)
to applied##9##2##(1992-6#1)(1995-1#1)(1996-1#1)(1996-2#1)(2006-8#1)(2007-12#1)(2007-4#1)(2009-4#1)(2013-1#1)
to apply a##13##3##(1991-1#1)(2006-10#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-9#1)(2011-1#2)(2011-2#1)(2013-1#1)
to apply an##5##3##(2006-3#1)(2007-8#1)(2008-5#1)(2011-2#1)(2012-12#1)
to apply and##2##3##(2012-3#1)(2013-1#1)
to apply at##2##3##(1997-7#1)(2007-7#1)
to apply for##3##3##(1991-3#1)(2013-1#2)
to apply force##2##3##(1995-5#1)(2009-7#1)
to apply in##2##3##(2008-10#1)(2009-1#1)
to apply it##2##3##(2008-11#1)(2008-4#1)
to apply molecular##2##3##(2008-10#1)(2008-4#1)
to apply the principles of##2##5##(2008-11#2)
to apply the principles##3##4##(2008-11#2)(2013-1#1)
to apply the##21##3##(1992-10#1)(1997-3#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-11#4)(2008-3#2)(2008-5#1)(2008-6#1)(2009-10#1)(2009-4#1)(2010-10#1)(2010-7#1)(2013-1#2)
to apply their knowledge in##2##5##(1997-3#1)(2008-12#1)
to apply their##3##3##(1997-3#1)(2008-10#1)(2008-12#1)
to apply them to##2##4##(1995-3#1)(2008-10#1)
to apply them##4##3##(1990-12#1)(1995-3#1)(2008-10#1)(2013-8#1)
to apply these methods##2##4##(2007-11#1)(2009-10#1)
to apply these##8##3##(1995-5#1)(1996-3#1)(2007-11#1)(2008-10#1)(2009-10#1)(2009-12#1)(2011-2#1)(2013-7#1)
to apply this method##3##4##(2008-10#2)(2008-4#1)
to apply this##12##3##(1993-9#1)(1995-2#1)(2005-10#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#1)
to apply to other##3##4##(1996-7#1)(2007-8#1)(2010-8#1)
to apply to##13##3##(1994-11#1)(1996-7#1)(1997-3#1)(1997-8#1)(2004-12#1)(2005-9#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-8#1)(2013-7#1)
to apply##170##2##(1990-12#1)(1991-1#1)(1991-10#1)(1991-3#1)(1992-10#1)(1992-3#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-1#1)(1996-3#1)(1996-7#1)(1997-3#3)(1997-7#2)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#10)(2006-11#1)(2006-3#1)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#3)(2007-1#2)(2007-11#5)(2007-12#5)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#25)(2008-11#10)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#3)(2008-8#2)(2008-9#1)(2009-1#2)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#3)(2012-12#2)(2012-3#2)(2013-1#9)(2013-7#2)(2013-8#2)
to applying##2##2##(2008-3#2)
to appoint##3##2##(1990-11#1)(2005-4#1)(2007-9#1)
to appraise the##2##3##(1996-9#1)(2008-10#1)
to appraise##6##2##(1993-12#1)(1994-12#1)(1996-9#1)(2007-7#1)(2008-10#1)(2010-12#1)
to appreciate that##2##3##(1995-12#1)(2004-1#1)
to appreciate the##6##3##(1990-1#1)(1991-12#1)(2006-5#1)(2007-9#1)(2008-8#1)(2010-4#1)
to appreciate##12##2##(1990-1#1)(1991-12#1)(1995-12#1)(2004-1#1)(2005-7#1)(2006-3#1)(2006-5#1)(2007-12#1)(2007-9#1)(2008-8#1)(2010-12#1)(2010-4#1)
to approach the##15##3##(1996-5#1)(2006-10#1)(2006-6#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
to approach##31##2##(1991-1#1)(1993-6#1)(1996-5#1)(2004-12#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
to appropriate therapy##2##3##(2005-11#1)(2008-7#1)
to appropriate treatment##2##3##(2005-10#1)(2007-1#1)
to appropriate##21##2##(1990-4#1)(1991-1#1)(1993-9#1)(2005-10#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#2)(2010-8#1)(2012-12#2)(2012-2#1)
to appropriately##9##2##(1996-3#1)(2005-10#1)(2006-10#1)(2008-10#1)(2008-7#1)(2012-2#2)(2013-1#1)(2013-7#1)
to approval##2##2##(2006-10#1)(2007-11#1)
to approx##6##2##(1990-3#1)(1991-1#1)(1991-6#1)(1995-2#1)(2008-6#2)
to approximate the total##2##4##(1996-5#1)(2006-6#1)
to approximate the##13##3##(1992-12#1)(1996-5#1)(1997-4#1)(2006-10#2)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2011-1#1)
to approximate##20##2##(1992-12#1)(1993-4#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#1)(2006-10#3)(2006-6#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#1)
to approximately 0##10##3##(1991-10#1)(1991-11#2)(1996-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)
to approximately 1##5##3##(1990-12#1)(1992-5#1)(1994-11#1)(2008-10#1)(2008-7#1)
to approximately 10##4##3##(1995-10#1)(2006-10#1)(2008-11#1)(2010-5#1)
to approximately 10%##4##3##(1992-6#1)(1993-12#1)(2008-10#1)(2008-2#1)
to approximately 100##2##3##(2007-9#1)(2012-12#1)
to approximately 15##3##3##(1993-8#1)(2008-10#1)(2008-2#1)
to approximately 2##2##3##(1992-8#1)(2008-2#1)
to approximately 200##2##3##(2008-11#1)(2008-2#1)
to approximately 25##2##3##(1995-6#1)(1996-5#1)
to approximately 3 x##2##4##(2008-11#1)(2008-2#1)
to approximately 3##4##3##(1991-9#1)(1997-4#1)(2008-11#1)(2008-2#1)
to approximately 4##2##3##(2006-8#1)(2007-12#1)
to approximately 40##3##3##(1990-11#1)(2008-2#1)(2008-3#1)
to approximately 45##2##3##(1995-6#1)(2008-4#1)
to approximately 5##3##3##(2007-4#1)(2008-7#1)(2008-9#1)
to approximately 50##3##3##(1996-3#1)(2007-9#1)(2008-10#1)
to approximately 50% of##2##4##(1995-10#1)(1995-8#1)
to approximately 50%##4##3##(1995-10#1)(1995-8#1)(2008-10#2)
to approximately 60%##4##3##(1996-5#1)(2006-8#1)(2008-10#1)(2008-7#1)
to approximately 90%##2##3##(2008-11#1)(2009-3#1)
to approximately half##2##3##(1990-9#1)(2008-3#1)
to approximately the same##3##4##(1991-2#1)(1994-8#1)(2008-7#1)
to approximately the##4##3##(1991-2#1)(1994-8#1)(1996-9#1)(2008-7#1)
to approximately three##2##3##(1995-5#1)(2008-2#1)
to approximately##122##2##(1990-11#1)(1990-12#3)(1990-2#2)(1990-7#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-2#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-10#3)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-9#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#1)(2004-9#2)(2006-10#1)(2006-12#1)(2006-3#1)(2006-8#2)(2007-12#4)(2007-4#1)(2007-9#2)(2008-1#1)(2008-10#19)(2008-11#7)(2008-2#12)(2008-3#6)(2008-4#1)(2008-7#7)(2008-9#2)(2009-3#1)(2010-5#1)(2012-12#1)(2012-3#1)
to aprotinin##2##2##(1990-7#1)(2007-8#1)
to aquatic##3##2##(2004-4#1)(2008-10#1)(2008-12#1)
to aqueous humor##3##3##(2011-2#3)
to aqueous sodium##2##3##(2006-10#1)(2008-2#1)
to aqueous solution##2##3##(2008-10#2)
to aqueous solutions##2##3##(2009-6#2)
to aqueous##15##2##(1990-2#1)(2006-10#1)(2008-10#4)(2008-2#2)(2008-5#1)(2009-6#3)(2011-2#3)
to ara-C##2##2##(1992-5#1)(2007-1#1)
to arachidonate##2##2##(1990-2#2)
to arachidonic acid##5##3##(1993-8#1)(1994-5#1)(1995-11#1)(1997-7#1)(2007-10#1)
to arbitrarily##2##2##(2008-1#1)(2008-2#1)
to arbitrary##4##2##(2007-12#1)(2008-2#1)(2008-8#1)(2012-2#1)
to arbitrate##2##2##(1995-6#1)(2006-7#1)
to archaeological##2##2##(1995-6#1)(2008-10#1)
to archive##2##2##(2008-10#1)(2009-9#1)
to area##2##2##(2008-10#1)(2013-8#1)
to areas of##8##3##(1995-11#1)(2006-5#1)(2007-12#1)(2008-11#1)(2008-8#1)(2009-11#1)(2010-5#1)(2011-1#1)
to areas that##2##3##(1996-5#1)(2008-10#1)
to areas##14##2##(1995-11#1)(1996-5#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-7#1)(2010-4#1)(2010-5#1)(2011-1#1)
to arginine##5##2##(1993-12#1)(1995-9#1)(1996-11#1)(1997-6#1)(2008-10#1)
to argon##5##2##(1993-1#2)(2004-9#1)(2008-10#2)
to argue that the##2##4##(2006-7#1)(2006-9#1)
to argue that##6##3##(1997-8#1)(2006-4#1)(2006-7#1)(2006-9#1)(2007-1#1)(2008-8#1)
to argue##9##2##(1997-8#1)(2006-11#1)(2006-4#1)(2006-7#1)(2006-9#1)(2007-1#1)(2008-8#1)(2008-9#1)(2012-2#1)
to arguments##2##2##(2009-11#1)(2010-4#1)
to arise due to##2##4##(2011-1#1)(2013-1#1)
to arise from a##3##4##(1994-11#1)(1995-10#1)(2007-7#1)
to arise from the interaction of##2##6##(1997-8#1)(2007-12#1)
to arise from the##8##4##(1997-8#1)(2006-1#1)(2007-12#1)(2008-5#1)(2010-12#1)(2010-5#1)(2012-3#1)(2013-7#1)
to arise from##26##3##(1990-7#2)(1994-11#1)(1994-12#1)(1995-10#1)(1995-3#1)(1997-7#1)(1997-8#1)(2006-1#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-12#2)(2010-5#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-7#1)
to arise in the##2##4##(1990-12#1)(2008-4#1)
to arise in##3##3##(1990-12#1)(1990-6#1)(2008-4#1)
to arise through##3##3##(1992-6#1)(2007-10#1)(2008-10#1)
to arise##44##2##(1990-12#1)(1990-6#1)(1990-7#2)(1992-6#2)(1993-12#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-3#1)(1997-7#1)(1997-8#1)(2006-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-12#2)(2010-5#1)(2011-1#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
to arm##3##2##(1996-5#1)(2006-12#1)(2007-4#1)
to aromatic hydrocarbons##2##3##(1990-12#1)(2005-11#1)
to aromatic##8##2##(1990-12#2)(1991-4#1)(1993-2#1)(1994-11#1)(1996-7#1)(2005-11#1)(2010-2#1)
to around##8##2##(1995-7#1)(1996-6#1)(2006-8#1)(2007-5#1)(2008-10#1)(2009-4#1)(2011-2#1)(2012-3#1)
to arrange##4##2##(1990-12#1)(1992-3#1)(1996-11#1)(2007-11#1)
to arrest and##2##3##(2006-5#1)(2008-6#1)
to arrest in##2##3##(1994-3#1)(1997-6#1)
to arrest the cell cycle##3##5##(2008-9#1)(2012-12#2)
to arrest the##7##3##(1996-11#1)(1996-12#1)(2005-11#1)(2008-1#1)(2008-9#1)(2012-12#2)
to arrest##20##2##(1990-11#1)(1994-3#1)(1995-1#1)(1996-11#1)(1996-12#1)(1997-3#1)(1997-6#1)(2005-11#1)(2006-11#1)(2006-5#1)(2006-6#2)(2006-9#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-6#1)(2008-9#1)(2012-12#2)
to arrhythmia##3##2##(2005-10#1)(2007-7#1)(2008-8#1)
to arrhythmias##2##2##(2010-12#1)(2013-7#1)
to arrival##2##2##(2008-10#1)(2008-7#1)
to arrive at a diagnosis##2##5##(2007-7#1)(2013-8#1)
to arrive at a##7##4##(1997-6#1)(2007-7#2)(2008-2#1)(2008-5#1)(2011-2#1)(2013-8#1)
to arrive at an##2##4##(2008-2#1)(2008-3#1)
to arrive at the correct diagnosis##4##6##(1991-7#1)(1995-4#1)(2010-12#1)(2013-1#1)
to arrive at the##6##4##(1991-7#1)(1995-1#1)(1995-4#1)(2010-12#1)(2010-4#1)(2013-1#1)
to arrive at##20##3##(1991-7#1)(1993-9#1)(1994-9#1)(1995-1#1)(1995-4#1)(1997-6#1)(2007-7#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
to arrive##23##2##(1991-7#1)(1993-9#1)(1994-9#1)(1995-1#1)(1995-4#1)(1997-6#1)(1997-7#1)(2007-7#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
to arsenate##2##2##(2008-10#2)
to arsenic##7##2##(2006-11#1)(2008-10#2)(2008-3#2)(2010-2#1)(2011-2#1)
to arsenite and##3##3##(1995-3#1)(2011-12#2)
to arsenite##4##2##(1994-11#1)(1995-3#1)(2011-12#2)
to arsenosugars##2##2##(2008-10#2)
to artemisinin##3##2##(1995-3#1)(1997-4#1)(2009-6#1)
to arterial##16##2##(1993-10#1)(1993-8#1)(1995-7#1)(1995-8#1)(2006-4#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-10#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-12#1)
to arteries##2##2##(2007-11#1)(2008-4#1)
to arthritis##3##2##(1992-12#1)(1996-4#1)(2008-9#1)
to arthroscopic treatment##2##3##(2006-10#1)(2008-8#1)
to artichoke##4##2##(2008-10#4)
to articles and##3##3##(2007-4#2)(2013-8#1)
to articles##5##2##(2007-4#2)(2008-10#1)(2013-8#2)
to articular##2##2##(2007-11#2)
to articulate a##2##3##(2006-7#1)(2008-12#1)
to articulate knowing in practice##2##5##(2008-12#2)
to articulate the##4##3##(2008-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
to articulate##10##2##(2006-7#1)(2008-11#1)(2008-12#3)(2008-5#2)(2011-2#1)(2012-1#1)(2012-2#1)
to artificial selection##3##3##(2008-11#1)(2008-8#1)(2008-9#1)
to artificial##14##2##(1992-12#1)(2006-5#1)(2007-10#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#2)(2008-9#1)(2012-11#2)(2012-7#1)
to as &quot##19##3##(1992-1#1)(1997-5#1)(1997-6#1)(2006-8#2)(2006-9#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-12#1)(2010-3#2)(2010-9#1)(2012-12#1)(2013-7#1)
to as a##9##3##(1991-12#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-4#1)
to as far##2##3##(2008-10#1)(2012-12#1)
to as few as##2##4##(1995-3#1)(2008-10#1)
to as great as##3##4##(2008-2#2)(2008-3#1)
to as high as##8##4##(2008-10#1)(2008-2#2)(2008-3#4)(2010-7#1)
to as little as 0##2##5##(2008-6#1)(2010-6#1)
to as little as##4##4##(1995-12#1)(2008-2#1)(2008-6#1)(2010-6#1)
to as low as 1##2##5##(1994-8#1)(2007-11#1)
to as low as##4##4##(1994-8#1)(2007-11#1)(2008-10#1)(2008-7#1)
to as much as##6##4##(1992-12#1)(2005-11#1)(2008-2#3)(2008-3#1)
to as the &quot##9##4##(1991-2#1)(1996-1#1)(1996-12#1)(1997-4#1)(2007-5#1)(2008-11#1)(2009-10#1)(2011-2#1)(2012-12#1)
to as the##32##3##(1990-2#1)(1990-6#1)(1991-2#1)(1992-1#1)(1992-2#1)(1992-6#1)(1992-9#1)(1994-12#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-4#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-2#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2009-10#1)(2010-4#1)(2011-2#1)(2012-12#2)
to as##244##2##(1990-11#1)(1990-2#1)(1990-6#2)(1991-11#1)(1991-12#1)(1991-2#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#3)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#3)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-11#3)(2005-3#1)(2005-7#2)(2005-9#2)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#3)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-4#3)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#24)(2008-11#5)(2008-12#3)(2008-2#12)(2008-3#16)(2008-4#7)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#4)(2009-10#2)(2009-12#1)(2009-4#3)(2009-5#1)(2010-10#3)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#4)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#8)(2012-1#1)(2012-11#2)(2012-12#7)(2012-2#5)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#2)
to asbestos and##2##3##(2008-6#1)(2010-9#1)
to asbestos at work defines##2##5##(2010-9#2)
to asbestos at work##5##4##(2010-9#5)
to asbestos at##6##3##(2010-9#6)
to asbestos in the##2##4##(1991-12#1)(1997-5#1)
to asbestos in##4##3##(1991-12#3)(1997-5#1)
to asbestos used in railroads##3##5##(1991-12#3)
to asbestos used in##4##4##(1991-12#4)
to asbestos was##3##3##(1991-12#1)(2010-9#2)
to asbestos##42##2##(1991-12#10)(1992-11#1)(1993-9#1)(1995-2#1)(1995-5#1)(1997-5#1)(2008-6#2)(2010-9#25)
to ascertain how the##2##4##(1995-3#1)(2008-9#1)
to ascertain how##4##3##(1994-1#1)(1995-3#1)(1996-9#1)(2008-9#1)
to ascertain if##6##3##(1992-3#1)(2007-11#1)(2008-3#1)(2008-6#1)(2010-12#1)(2011-2#1)
to ascertain that##4##3##(2008-10#1)(2008-7#1)(2009-2#1)(2013-1#1)
to ascertain the effect of##3##5##(2005-11#1)(2008-11#1)(2013-8#1)
to ascertain the role of##4##5##(1990-5#1)(2005-8#1)(2010-2#1)(2011-2#1)
to ascertain the##51##3##(1990-3#1)(1990-5#1)(1991-10#1)(1991-11#1)(1991-12#1)(1994-2#1)(1996-11#1)(1996-3#1)(1997-6#1)(2004-1#1)(2005-11#1)(2005-8#1)(2007-10#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#3)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
to ascertain their perceptions of the##2##6##(2006-7#1)(2010-3#1)
to ascertain their##8##3##(2006-10#1)(2006-7#1)(2007-10#1)(2008-10#1)(2008-12#1)(2009-2#1)(2010-3#1)(2012-2#1)
to ascertain whether a##2##4##(1995-5#1)(2010-8#1)
to ascertain whether the##3##4##(1997-4#1)(2004-1#1)(2006-6#1)
to ascertain whether##12##3##(1992-8#1)(1995-5#1)(1997-4#1)(1997-8#1)(2004-1#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-11#1)(2010-7#1)(2010-8#2)
to ascertain which##2##3##(2006-6#1)(2011-1#1)
to ascertain##106##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-10#1)(1991-11#1)(1991-12#1)(1992-3#1)(1992-8#1)(1993-4#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-9#2)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-1#2)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-6#2)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-2#2)(2009-5#3)(2009-6#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
to ascospore progeny under##2##4##(2008-10#2)
to ascospore##3##2##(2008-10#3)
to ascribe##2##2##(2008-7#1)(2012-2#1)
to aseptic##4##2##(2006-7#1)(2007-7#1)(2008-7#1)(2013-1#1)
to asexual reproduction##2##3##(2008-10#1)(2012-3#1)
to asexual##4##2##(2006-10#1)(2008-10#1)(2010-2#1)(2012-3#1)
to ask whether##5##3##(1992-4#1)(1995-8#1)(1997-8#1)(2006-3#1)(2008-6#1)
to ask why##2##3##(1994-2#1)(2006-10#1)
to ask##21##2##(1992-4#1)(1994-1#1)(1994-2#1)(1995-8#1)(1996-12#2)(1996-3#1)(1997-3#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-3#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2012-3#2)(2013-1#1)
to asparagine##10##2##(1991-12#1)(1992-2#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-8#1)(2006-12#1)(2008-10#1)(2009-8#1)(2011-12#1)
to aspartame##5##2##(2008-8#5)
to aspartate##3##2##(1992-1#1)(1997-8#1)(2012-12#1)
to aspartic acid##5##3##(1990-5#1)(1993-12#2)(1995-2#1)(2007-6#1)
to aspartic##6##2##(1990-5#1)(1993-12#2)(1995-2#1)(2007-6#1)(2009-9#1)
to aspects of the##3##4##(2006-11#1)(2008-2#1)(2008-3#1)
to aspects of##4##3##(2006-11#1)(2008-2#1)(2008-3#1)(2010-8#1)
to aspirate##2##2##(2008-10#1)(2012-2#1)
to aspiration of##2##3##(1993-3#1)(2007-11#1)
to aspiration##6##2##(1993-10#2)(1993-3#1)(2007-11#1)(2010-12#1)(2013-1#1)
to aspirin##9##2##(1991-11#1)(1993-7#1)(2007-8#2)(2008-8#3)(2010-4#1)(2011-1#1)
to assay a##2##3##(2008-4#1)(2008-9#1)
to assay for##3##3##(1991-1#1)(2007-8#1)(2008-10#1)
to assay the##7##3##(1994-10#1)(1994-3#1)(1997-4#1)(2008-10#3)(2008-4#1)
to assay##38##2##(1991-1#1)(1991-5#2)(1992-12#1)(1993-1#1)(1993-6#1)(1994-10#1)(1994-3#1)(1995-1#2)(1996-12#1)(1997-4#1)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#1)(2008-4#6)(2008-7#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-2#1)
to assays of drugs in serum##2##6##(1990-12#1)(1990-8#1)
to assemble a##4##3##(1993-8#1)(2008-10#1)(2008-9#1)(2012-2#1)
to assemble and##3##3##(1996-11#1)(2008-1#1)(2008-10#1)
to assemble into##4##3##(1991-2#1)(1991-3#1)(1997-1#1)(2005-8#1)
to assemble the##11##3##(1990-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-4#3)(2008-8#1)(2011-2#1)(2012-2#1)
to assemble##34##2##(1990-5#1)(1990-9#1)(1991-2#1)(1991-3#1)(1993-8#1)(1996-11#1)(1997-1#2)(1997-4#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-8#3)(2008-9#1)(2009-2#4)(2011-2#1)(2012-11#1)(2012-2#2)
to assembly of##2##3##(2006-2#1)(2011-1#1)
to asses##11##2##(1996-12#1)(2007-11#2)(2007-6#1)(2007-9#1)(2008-12#1)(2008-7#2)(2011-1#1)(2013-1#2)
to assess QoL##2##3##(2008-10#1)(2011-2#1)
to assess a new##2##4##(1996-9#1)(2007-7#1)
to assess a##7##3##(1996-9#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#1)
to assess airway##3##3##(1997-1#1)(2005-11#1)(2008-10#1)
to assess and compare the##2##5##(1993-5#1)(2011-1#1)
to assess and compare##6##4##(1993-5#1)(1997-8#1)(2007-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
to assess and monitor##3##4##(1992-3#1)(2007-12#1)(2013-7#1)
to assess and##18##3##(1992-3#1)(1993-5#1)(1996-2#1)(1997-8#1)(2004-2#1)(2007-11#1)(2007-12#1)(2007-4#2)(2008-5#2)(2009-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
to assess anxiety##2##3##(1993-12#1)(2007-2#1)
to assess at##2##3##(2007-8#1)(2008-8#1)
to assess biological##2##3##(2008-11#1)(2011-2#1)
to assess both the##2##4##(1994-6#1)(2008-10#1)
to assess both##6##3##(1994-6#1)(2006-5#1)(2008-10#2)(2008-4#1)(2009-2#1)
to assess cardiac##2##3##(1994-3#1)(2012-2#1)
to assess cell proliferation##2##4##(2004-9#1)(2008-11#1)
to assess cell##4##3##(2004-9#1)(2008-11#1)(2012-2#2)
to assess changes in the##2##5##(1995-9#1)(2008-10#1)
to assess changes in##10##4##(1995-9#1)(1996-2#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-9#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-2#1)
to assess current##2##3##(1993-12#1)(2006-2#1)
to assess differences in##5##4##(1991-1#1)(1995-1#1)(2007-8#1)(2008-10#1)(2013-1#1)
to assess differences##6##3##(1991-1#1)(1995-1#1)(2007-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
to assess different aspects of##3##5##(2008-4#1)(2008-8#1)(2012-2#1)
to assess different##5##3##(1997-4#1)(2008-4#1)(2008-8#1)(2010-7#1)(2012-2#1)
to assess efficacy of##5##4##(1993-7#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#1)
to assess exposure to##2##4##(2010-5#1)(2010-8#1)
to assess exposure##3##3##(2010-5#1)(2010-8#1)(2011-2#1)
to assess for##6##3##(2004-3#1)(2006-10#1)(2006-12#1)(2007-9#1)(2009-7#1)(2012-3#1)
to assess functional##2##3##(2007-7#1)(2011-8#1)
to assess gene##2##3##(2008-7#1)(2010-10#1)
to assess genetic##4##3##(2005-10#1)(2008-10#3)
to assess global##3##3##(2007-8#1)(2012-12#1)(2013-1#1)
to assess how##6##3##(1996-7#1)(1997-2#1)(2008-2#1)(2008-6#1)(2010-6#1)(2010-8#1)
to assess in vitro the##2##5##(2008-5#1)(2008-9#1)
to assess in vitro##3##4##(2008-10#1)(2008-5#1)(2008-9#1)
to assess in vivo##2##4##(1990-3#1)(2013-1#1)
to assess in##10##3##(1990-3#1)(1996-7#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-9#2)(2013-1#3)
to assess individual##5##3##(1992-1#1)(2006-12#2)(2007-5#1)(2008-9#1)
to assess it##2##3##(2008-1#1)(2011-2#1)
to assess its effects##2##4##(1993-10#1)(2008-11#1)
to assess its##16##3##(1992-2#1)(1993-10#1)(1993-8#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-9#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2009-4#1)(2010-12#1)(2013-1#1)
to assess joint position sense##2##5##(2012-1#2)
to assess local##3##3##(1993-1#1)(1995-12#1)(2011-1#1)
to assess long-term##2##3##(2007-7#1)(2008-11#1)
to assess mental##2##3##(2006-2#1)(2012-2#1)
to assess mortality risk##2##4##(2005-11#1)(2006-6#1)
to assess mortality##3##3##(2005-11#1)(2006-6#1)(2012-12#1)
to assess multiple##2##3##(2009-10#1)(2012-3#1)
to assess myocardial perfusion##2##4##(1997-8#1)(2008-1#1)
to assess myocardial##3##3##(1997-8#1)(2008-1#1)(2009-10#1)
to assess noninvasively the##2##4##(2012-1#1)(2012-2#1)
to assess nutritional improvement##2##4##(2013-1#2)
to assess nutritional status##2##4##(2007-7#1)(2013-1#1)
to assess nutritional##4##3##(2007-7#1)(2013-1#3)
to assess occupational##2##3##(1994-6#1)(2011-1#1)
to assess our##3##3##(2008-11#1)(2008-12#1)(2012-2#1)
to assess outcome##3##3##(2007-7#2)(2008-9#1)
to assess oxidative stress##2##4##(1997-2#1)(2008-10#1)
to assess patient satisfaction##2##4##(1997-2#1)(2012-12#1)
to assess patient##3##3##(1997-2#1)(2012-12#1)(2013-1#1)
to assess patients##4##3##(1995-1#1)(2005-10#1)(2012-2#1)(2013-1#1)
to assess performance##3##3##(1996-1#1)(2013-1#2)
to assess personal##2##3##(2008-2#1)(2008-7#1)
to assess physiological##2##3##(2008-10#1)(2013-8#1)
to assess possible##6##3##(1990-10#1)(1994-6#1)(2006-10#1)(2006-9#1)(2007-8#1)(2013-8#1)
to assess potential##6##3##(2007-3#1)(2008-10#1)(2009-11#1)(2010-6#1)(2011-2#1)(2012-12#1)
to assess progress##2##3##(2007-7#1)(2012-1#1)
to assess progression/regression of##2##4##(2010-12#2)
to assess pulmonary##2##3##(2008-10#1)(2011-2#1)
to assess quality of##2##4##(2006-2#1)(2008-10#1)
to assess quality##3##3##(2006-2#1)(2008-10#1)(2012-12#1)
to assess rates of##2##4##(1991-1#1)(1995-1#1)
to assess resectability##2##3##(2008-3#2)
to assess results and outcomes##2##5##(2009-5#2)
to assess results of##2##4##(2006-8#1)(2008-7#1)
to assess results##4##3##(2006-8#1)(2008-7#1)(2009-5#2)
to assess risk##4##3##(1996-12#1)(2006-12#1)(2008-12#1)(2008-4#1)
to assess safety##3##3##(2005-7#1)(2008-2#1)(2011-2#1)
to assess severity of##2##4##(2008-9#2)
to assess skin##2##3##(2006-12#1)(2008-5#1)
to assess smoking##2##3##(1991-9#1)(1996-12#1)
to assess spatial##2##3##(1993-12#1)(2004-9#1)
to assess steric##2##3##(1992-10#1)(1995-3#1)
to assess student##2##3##(2007-12#1)(2008-6#1)
to assess such##2##3##(2005-5#1)(2008-11#1)
to assess temporal##2##3##(2008-10#1)(2012-1#1)
to assess the ability of pre-registration nursing students' to##2##9##(2008-11#2)
to assess the ability of##6##5##(1991-12#1)(2008-10#1)(2008-11#2)(2008-9#1)(2012-12#1)
to assess the acceptability of PCR##2##6##(2011-2#2)
to assess the acceptability of##3##5##(2007-9#1)(2011-2#2)
to assess the accuracy and##3##5##(2005-8#1)(2007-11#1)(2008-10#1)
to assess the accuracy of the##2##6##(2008-10#1)(2008-2#1)
to assess the accuracy of##6##5##(1994-3#1)(1995-1#1)(1996-8#1)(2008-10#1)(2008-2#1)(2012-12#1)
to assess the accuracy##9##4##(1994-3#1)(1995-1#1)(1996-8#1)(2005-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2012-12#1)
to assess the action of##2##5##(2008-4#2)
to assess the antioxidant##2##4##(2008-10#1)(2010-4#1)
to assess the applicability of##4##5##(1990-7#1)(1995-1#1)(1995-11#1)(1996-7#1)
to assess the applicability##5##4##(1990-7#1)(1995-1#1)(1995-11#1)(1996-7#1)(2011-1#1)
to assess the associated##2##4##(2009-9#1)(2011-2#1)
to assess the association##2##4##(2007-8#1)(2009-10#1)
to assess the awareness of##2##5##(2008-6#1)(2010-7#1)
to assess the awareness##3##4##(2008-6#1)(2010-7#1)(2012-1#1)
to assess the behaviour of##2##5##(2006-2#1)(2008-10#1)
to assess the capacity of##2##5##(2010-10#1)(2013-8#1)
to assess the cognitive##2##4##(2007-2#1)(2011-1#1)
to assess the consequences of##3##5##(1990-2#1)(2006-12#1)(2008-7#1)
to assess the contribution of##3##5##(1993-9#1)(2008-10#1)(2013-1#1)
to assess the correlation##2##4##(2007-3#1)(2010-5#1)
to assess the current##5##4##(1993-9#1)(1994-12#1)(1996-3#1)(2007-2#1)(2008-10#1)
to assess the degree of##9##5##(2006-3#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2012-12#1)
to assess the degree to which the##2##7##(2006-10#1)(2010-6#1)
to assess the degree##11##4##(2006-10#1)(2006-3#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2010-6#1)(2012-12#1)
to assess the development of##2##5##(1992-7#1)(1993-7#1)
to assess the difficulties##2##4##(2007-7#1)(2012-3#1)
to assess the distribution of##2##5##(2011-2#1)(2012-2#1)
to assess the dynamic##2##4##(2010-5#1)(2011-1#1)
to assess the economic##2##4##(2006-12#1)(2007-11#1)
to assess the effect of a##3##6##(1997-7#1)(2008-3#1)(2008-5#1)
to assess the effect of an##2##6##(2010-9#1)(2013-1#1)
to assess the effect of##38##5##(1990-10#1)(1993-1#1)(1993-3#1)(1993-7#1)(1994-3#1)(1995-7#1)(1996-6#1)(1997-1#1)(1997-7#1)(2005-8#1)(2006-9#1)(2007-11#1)(2007-6#2)(2007-8#2)(2008-10#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-8#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-9#1)(2011-2#1)(2012-12#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
to assess the effect##39##4##(1990-10#1)(1993-1#1)(1993-3#1)(1993-7#1)(1994-3#1)(1995-7#1)(1996-6#1)(1997-1#1)(1997-7#1)(2005-8#1)(2006-9#1)(2007-11#1)(2007-6#2)(2007-8#2)(2008-10#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-8#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-9#1)(2011-2#1)(2012-12#3)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
to assess the effectiveness of different##2##6##(2006-10#1)(2008-2#1)
to assess the effectiveness of the##4##6##(1993-1#1)(1993-9#1)(1994-8#1)(2011-3#1)
to assess the effectiveness of this##3##6##(2007-1#1)(2007-11#1)(2008-3#1)
to assess the effectiveness of##25##5##(1990-2#1)(1993-1#1)(1993-9#1)(1994-8#1)(1995-3#1)(2006-10#1)(2007-1#1)(2007-11#2)(2007-7#2)(2008-10#1)(2008-2#2)(2008-3#1)(2010-2#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
to assess the effectiveness##27##4##(1990-2#1)(1993-1#1)(1993-9#1)(1994-8#1)(1995-3#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-7#2)(2008-10#1)(2008-2#2)(2008-3#2)(2010-2#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
to assess the effects of a##2##6##(1995-12#1)(1996-12#1)
to assess the effects of the##3##6##(1990-8#1)(1995-12#1)(2008-10#1)
to assess the effects of##28##5##(1990-12#1)(1990-8#1)(1991-5#1)(1993-7#1)(1994-3#2)(1995-12#2)(1996-12#1)(1997-8#1)(2005-11#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-5#2)(2008-6#1)(2008-8#1)(2010-10#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
to assess the efficacy and safety of##6##7##(1997-1#1)(2005-11#1)(2007-11#1)(2008-8#1)(2010-4#1)(2012-2#1)
to assess the efficacy and##8##5##(1997-1#1)(2005-11#1)(2006-7#1)(2007-11#1)(2008-3#1)(2008-8#1)(2010-4#1)(2012-2#1)
to assess the efficacy of the##3##6##(2008-1#1)(2008-5#1)(2013-1#1)
to assess the efficacy of##13##5##(1992-9#1)(1993-7#1)(2004-12#1)(2004-3#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-12#1)(2012-3#1)(2013-1#2)
to assess the efficacy##23##4##(1992-9#1)(1993-7#1)(1997-1#1)(2004-12#1)(2004-3#1)(2005-11#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-2#1)(2010-12#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#2)
to assess the evidence##3##4##(2008-2#1)(2011-1#1)(2013-8#1)
to assess the extent of##6##5##(1992-6#1)(2007-7#1)(2008-8#1)(2010-6#1)(2011-2#1)(2013-1#1)
to assess the extent to which##5##6##(1995-3#1)(2005-11#1)(2007-9#1)(2013-1#2)
to assess the extent##12##4##(1992-6#1)(1995-3#1)(2005-11#1)(2007-7#1)(2007-9#1)(2008-8#1)(2009-5#1)(2010-6#1)(2011-2#1)(2013-1#3)
to assess the factors##2##4##(2008-7#1)(2013-1#1)
to assess the feasibility and##6##5##(1992-2#1)(2006-6#1)(2007-10#1)(2009-11#1)(2013-1#2)
to assess the feasibility of##7##5##(1993-12#1)(1995-11#1)(1997-8#1)(2007-8#1)(2008-11#1)(2012-1#1)(2012-2#1)
to assess the feasibility##13##4##(1992-2#1)(1993-12#1)(1995-11#1)(1997-8#1)(2006-6#1)(2007-10#1)(2007-8#1)(2008-11#1)(2009-11#1)(2012-1#1)(2012-2#1)(2013-1#2)
to assess the frequency and##2##5##(2004-12#1)(2007-2#1)
to assess the frequency of##2##5##(2007-12#1)(2012-12#1)
to assess the frequency##4##4##(2004-12#1)(2007-12#1)(2007-2#1)(2012-12#1)
to assess the functional##4##4##(2006-7#1)(2007-9#1)(2008-9#2)
to assess the general##2##4##(2008-3#1)(2008-7#1)
to assess the genetic diversity##2##5##(2008-10#1)(2008-7#1)
to assess the genetic##3##4##(2008-10#1)(2008-5#1)(2008-7#1)
to assess the growth##4##4##(1996-3#1)(2007-11#1)(2008-10#1)(2009-4#1)
to assess the health##2##4##(1992-4#1)(2013-8#1)
to assess the impact of a##2##6##(1992-1#1)(2006-1#1)
to assess the impact of the##3##6##(1991-12#1)(1993-6#1)(2007-7#1)
to assess the impact of##32##5##(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-2#1)(1993-6#1)(1995-3#1)(1997-7#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2010-11#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
to assess the impact on##2##5##(2007-8#1)(2011-2#1)
to assess the impact##35##4##(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-2#1)(1993-6#1)(1995-3#1)(1997-7#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2010-11#1)(2010-5#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
to assess the impacts of##2##5##(2007-10#2)
to assess the in##2##4##(1991-9#1)(2008-12#1)
to assess the incidence of##3##5##(2007-8#1)(2012-2#2)
to assess the incidence##4##4##(1990-6#1)(2007-8#1)(2012-2#2)
to assess the independent##2##4##(1993-3#1)(2013-1#1)
to assess the influence of##13##5##(1990-4#1)(1993-12#1)(1994-6#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-10#1)(2013-1#1)(2013-7#1)
to assess the involvement of##2##5##(1991-9#1)(1996-3#1)
to assess the knowledge##4##4##(2008-2#1)(2011-1#1)(2012-12#1)(2013-1#1)
to assess the level of##7##5##(1990-12#1)(1994-4#1)(2006-11#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)
to assess the levels of##2##5##(1993-9#1)(2008-10#1)
to assess the long-term##5##4##(2006-12#1)(2007-7#1)(2007-8#2)(2011-2#1)
to assess the magnitude of##4##5##(2008-11#1)(2010-8#1)(2011-1#1)(2013-8#1)
to assess the mechanism of##2##5##(1991-2#1)(1995-9#1)
to assess the mechanisms##2##4##(1995-1#1)(2009-8#1)
to assess the need##2##4##(2011-1#1)(2012-2#1)
to assess the needs##2##4##(1993-12#1)(2012-12#1)
to assess the number of##2##5##(1994-6#1)(2010-12#1)
to assess the nutritional status of the##2##7##(2007-7#1)(2008-7#1)
to assess the nutritional status##4##5##(2007-7#1)(2008-2#2)(2008-7#1)
to assess the outcome of##3##5##(2007-11#1)(2007-7#1)(2009-9#1)
to assess the outcome##5##4##(2007-11#1)(2007-7#2)(2007-8#1)(2009-9#1)
to assess the overall##3##4##(2007-8#1)(2010-6#1)(2011-2#1)
to assess the patient's##2##4##(2008-4#1)(2012-2#1)
to assess the patients##2##4##(2006-10#1)(2008-4#1)
to assess the pattern of##4##5##(1992-2#1)(2006-8#1)(2011-12#1)(2013-1#1)
to assess the pattern##5##4##(1992-2#1)(2006-8#1)(2011-12#1)(2012-12#1)(2013-1#1)
to assess the perceived##2##4##(1994-2#1)(2013-8#1)
to assess the performance of##3##5##(1996-3#1)(2007-8#1)(2008-4#1)
to assess the performance##4##4##(1996-3#1)(1997-3#1)(2007-8#1)(2008-4#1)
to assess the possibility of##6##5##(2008-4#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#2)
to assess the possible##4##4##(2007-9#1)(2008-11#1)(2012-3#1)(2012-8#1)
to assess the potential for##2##5##(2006-11#1)(2007-10#1)
to assess the potential of this##2##6##(1991-5#1)(2008-3#1)
to assess the potential of##3##5##(1991-5#1)(2008-3#1)(2012-1#1)
to assess the potential##20##4##(1991-5#1)(1996-9#1)(2006-11#1)(2007-10#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
to assess the predictive##3##4##(2010-12#1)(2012-12#2)
to assess the presence of##3##5##(2007-2#1)(2008-5#1)(2010-1#1)
to assess the presence##5##4##(2007-2#1)(2008-5#2)(2010-1#1)(2012-2#1)
to assess the prevalence of##14##5##(1991-5#1)(1991-6#1)(1996-9#1)(2004-10#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-3#2)(2013-8#1)
to assess the prevalence##16##4##(1991-5#1)(1991-6#1)(1996-9#1)(2004-10#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
to assess the prognostic value of##2##6##(2008-11#1)(2011-1#1)
to assess the proposed##2##4##(2008-10#1)(2010-3#1)
to assess the protection##2##4##(2006-11#2)
to assess the purity of##2##5##(2008-4#1)(2013-1#1)
to assess the quality of care in##2##7##(2012-2#1)(2012-3#1)
to assess the quality of the##2##6##(1996-9#1)(2008-1#1)
to assess the quality of##12##5##(1991-3#1)(1993-6#1)(1996-9#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-6#1)(2012-2#2)(2012-3#1)(2013-1#1)
to assess the rate of##2##5##(2007-10#1)(2008-1#1)
to assess the relationship between the##2##6##(2008-6#1)(2012-3#1)
to assess the relationship between##6##5##(2006-7#1)(2008-6#1)(2008-9#1)(2010-8#1)(2012-1#1)(2012-3#1)
to assess the relationship##7##4##(2006-7#1)(2008-6#1)(2008-9#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-1#1)
to assess the relationships between##2##5##(2006-6#1)(2008-10#1)
to assess the relative effects of##2##6##(1995-12#1)(1997-5#1)
to assess the relative importance of##3##6##(2008-10#1)(2008-7#1)(2009-4#1)
to assess the relative##17##4##(1990-11#1)(1990-12#1)(1993-2#1)(1995-12#1)(1996-2#1)(1997-5#1)(2005-10#2)(2007-8#1)(2008-10#4)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)
to assess the reliability of##2##5##(1992-12#1)(2004-11#1)
to assess the reliability##3##4##(1992-12#1)(2004-11#1)(2010-12#1)
to assess the residual risk of##2##6##(2012-2#2)
to assess the residual##3##4##(1990-3#1)(2012-2#2)
to assess the results##2##4##(1990-6#1)(2008-7#1)
to assess the risk of##7##5##(1996-12#1)(2007-11#1)(2007-7#1)(2008-10#1)(2009-5#1)(2012-1#1)(2013-1#1)
to assess the risk##11##4##(1996-12#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2009-5#1)(2009-6#1)(2011-2#1)(2012-1#1)(2013-1#1)
to assess the risks##2##4##(2007-8#1)(2011-1#1)
to assess the robustness of##2##5##(2008-4#1)(2013-1#1)
to assess the role of##6##5##(1995-11#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2013-8#1)
to assess the roles of##2##5##(1995-8#1)(2008-12#1)
to assess the safety and efficacy of##4##7##(2006-11#1)(2008-8#1)(2009-12#1)(2010-4#1)
to assess the safety and##6##5##(2006-11#1)(2007-11#1)(2008-4#1)(2008-8#1)(2009-12#1)(2010-4#1)
to assess the safety##7##4##(2006-11#1)(2007-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2010-4#1)
to assess the sand/rub resistance of##2##6##(2008-5#2)
to assess the seroprevalence of##2##5##(2006-1#1)(2007-2#1)
to assess the severity of##4##5##(1995-11#1)(2007-11#1)(2012-12#1)(2013-1#1)
to assess the significance of the##2##6##(1994-11#1)(1995-8#1)
to assess the significance of##4##5##(1994-11#1)(1995-8#1)(1996-11#1)(1996-9#1)
to assess the skin##2##4##(2008-5#2)
to assess the state of##2##5##(1997-2#1)(2008-11#1)
to assess the suitability of##2##5##(2005-5#1)(2007-10#1)
to assess the total##2##4##(2010-9#1)(2012-2#1)
to assess the true##3##4##(1995-12#1)(2007-7#1)(2012-3#1)
to assess the usefulness of##3##5##(1990-5#1)(1996-3#1)(2013-1#1)
to assess the usefulness##4##4##(1990-5#1)(1996-3#1)(2011-2#1)(2013-1#1)
to assess the utility of the##2##6##(2006-10#1)(2012-3#1)
to assess the validity of the##2##6##(2008-10#1)(2008-3#1)
to assess the validity of##5##5##(1991-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-5#1)
to assess the value of the##2##6##(2008-7#1)(2009-2#1)
to assess the value of##7##5##(1991-9#1)(1992-10#1)(1992-12#1)(2007-1#1)(2007-2#1)(2008-7#1)(2009-2#1)
to assess the viability of the##3##6##(1997-4#1)(2008-10#2)
to assess the water##2##4##(2008-1#1)(2008-5#1)
to assess the##790##3##(1990-10#2)(1990-11#1)(1990-12#4)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-11#3)(1991-12#5)(1991-2#3)(1991-3#1)(1991-5#3)(1991-6#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#2)(1992-12#2)(1992-2#3)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-12#4)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#2)(1993-7#4)(1993-9#5)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#6)(1994-4#1)(1994-6#6)(1994-8#2)(1995-1#3)(1995-11#5)(1995-12#5)(1995-3#3)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#5)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#5)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#2)(1997-7#2)(1997-8#4)(2004-10#1)(2004-11#1)(2004-12#2)(2004-3#1)(2004-9#1)(2005-1#2)(2005-10#3)(2005-11#5)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#3)(2006-1#2)(2006-10#8)(2006-11#7)(2006-12#4)(2006-2#2)(2006-3#1)(2006-5#1)(2006-6#8)(2006-7#3)(2006-8#4)(2006-9#1)(2007-1#6)(2007-10#11)(2007-11#17)(2007-12#3)(2007-2#12)(2007-3#2)(2007-4#1)(2007-6#2)(2007-7#25)(2007-8#24)(2007-9#8)(2008-1#7)(2008-10#55)(2008-11#12)(2008-12#8)(2008-2#12)(2008-3#16)(2008-4#17)(2008-5#29)(2008-6#6)(2008-7#14)(2008-8#12)(2008-9#7)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#4)(2009-5#4)(2009-6#4)(2009-8#2)(2009-9#5)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#9)(2010-2#4)(2010-3#1)(2010-4#7)(2010-5#4)(2010-6#3)(2010-7#2)(2010-8#3)(2010-9#4)(2011-1#14)(2011-12#5)(2011-2#30)(2011-3#1)(2012-1#9)(2012-11#2)(2012-12#21)(2012-2#24)(2012-3#22)(2012-8#1)(2013-1#34)(2013-4#1)(2013-7#8)(2013-8#17)
to assess their association with##2##5##(1996-12#1)(2008-8#1)
to assess their function##2##4##(1992-8#1)(2008-4#1)
to assess their knowledge##3##4##(2008-7#1)(2008-8#1)(2013-8#1)
to assess their validity##2##4##(2006-12#1)(2011-2#1)
to assess their##41##3##(1992-6#1)(1992-8#1)(1993-12#1)(1993-9#1)(1995-2#1)(1996-12#1)(1997-3#1)(2005-7#3)(2006-10#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#6)(2008-7#1)(2008-8#2)(2010-8#1)(2011-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
to assess these##2##3##(2005-7#1)(2011-1#1)
to assess this##5##3##(2007-10#2)(2010-5#1)(2011-2#1)(2012-3#1)
to assess to what##2##4##(2008-11#2)
to assess treatment efficacy##2##4##(2008-3#1)(2010-2#1)
to assess treatment##6##3##(1991-6#1)(2006-7#1)(2008-3#1)(2008-6#2)(2010-2#1)
to assess trends in##2##4##(2008-7#1)(2012-3#1)
to assess tumor##2##3##(1991-8#1)(2008-8#1)
to assess user##3##3##(1996-2#1)(2013-1#2)
to assess various##2##3##(2007-4#1)(2008-12#1)
to assess water quality##2##4##(2007-5#1)(2008-10#1)
to assess water##3##3##(2007-5#1)(2008-10#1)(2011-1#1)
to assess water-contact##2##3##(2008-8#2)
to assess whether a##2##4##(1997-8#1)(2012-2#1)
to assess whether an##2##4##(1991-6#1)(2007-10#1)
to assess whether any##2##4##(1995-11#1)(2006-8#1)
to assess whether the##14##4##(1991-4#1)(1992-2#1)(1994-5#1)(1995-6#1)(1997-2#1)(2005-11#1)(2006-5#1)(2007-7#1)(2008-10#1)(2010-8#1)(2012-2#2)(2013-1#2)
to assess whether there##2##4##(2009-3#1)(2010-9#1)
to assess whether these##5##4##(1991-10#1)(1996-10#1)(1996-5#1)(2008-6#1)(2008-7#1)
to assess whether##55##3##(1991-10#1)(1991-4#1)(1991-6#1)(1992-2#1)(1993-12#1)(1994-3#2)(1994-5#1)(1995-11#1)(1995-6#2)(1996-10#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-11#1)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#1)
to assess which factors##2##4##(2007-10#1)(2012-2#1)
to assess which##5##3##(1993-2#1)(1997-8#1)(2007-10#1)(2007-7#1)(2012-2#1)
to assess##1480##2##(1990-10#4)(1990-11#2)(1990-12#7)(1990-2#3)(1990-3#3)(1990-4#3)(1990-5#2)(1990-6#2)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#3)(1991-12#5)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#5)(1991-8#2)(1991-9#4)(1992-1#3)(1992-10#3)(1992-11#1)(1992-12#2)(1992-2#5)(1992-3#1)(1992-4#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#3)(1993-10#2)(1993-12#11)(1993-2#8)(1993-3#3)(1993-4#2)(1993-5#2)(1993-6#2)(1993-7#5)(1993-8#2)(1993-9#6)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#10)(1994-4#2)(1994-5#2)(1994-6#9)(1994-8#3)(1995-1#8)(1995-10#1)(1995-11#8)(1995-12#8)(1995-2#5)(1995-3#6)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#3)(1995-9#2)(1996-1#4)(1996-10#1)(1996-11#1)(1996-12#9)(1996-2#7)(1996-3#7)(1996-4#1)(1996-5#3)(1996-6#4)(1996-7#3)(1996-8#2)(1996-9#8)(1997-1#4)(1997-2#9)(1997-3#3)(1997-4#6)(1997-5#5)(1997-6#2)(1997-7#2)(1997-8#8)(2004-10#1)(2004-11#1)(2004-12#2)(2004-2#3)(2004-3#2)(2004-4#1)(2004-9#4)(2005-1#2)(2005-10#7)(2005-11#8)(2005-12#1)(2005-5#2)(2005-7#6)(2005-8#4)(2005-9#1)(2006-1#3)(2006-10#21)(2006-11#8)(2006-12#11)(2006-2#7)(2006-3#2)(2006-5#5)(2006-6#10)(2006-7#8)(2006-8#7)(2006-9#4)(2007-1#6)(2007-10#19)(2007-11#24)(2007-12#9)(2007-2#16)(2007-3#4)(2007-4#6)(2007-5#5)(2007-6#3)(2007-7#39)(2007-8#31)(2007-9#18)(2008-1#12)(2008-10#104)(2008-11#34)(2008-12#17)(2008-2#20)(2008-3#23)(2008-4#33)(2008-5#54)(2008-6#16)(2008-7#34)(2008-8#28)(2008-9#19)(2009-10#7)(2009-11#7)(2009-12#3)(2009-2#5)(2009-3#2)(2009-4#8)(2009-5#8)(2009-6#4)(2009-7#2)(2009-8#2)(2009-9#5)(2010-1#1)(2010-10#7)(2010-11#4)(2010-12#15)(2010-2#9)(2010-3#2)(2010-4#8)(2010-5#10)(2010-6#5)(2010-7#4)(2010-8#9)(2010-9#6)(2011-1#27)(2011-12#5)(2011-2#57)(2011-3#1)(2011-8#1)(2012-1#21)(2012-11#2)(2012-12#34)(2012-2#49)(2012-3#33)(2012-8#1)(2013-1#73)(2013-4#1)(2013-7#11)(2013-8#28)
to assessing##10##2##(1991-1#1)(1997-2#1)(2006-6#1)(2007-2#1)(2008-10#1)(2008-8#1)(2010-10#1)(2010-12#1)(2010-2#2)
to assessment and treatment##2##4##(1992-1#1)(2011-1#1)
to assessment of##2##3##(2007-1#1)(2008-9#1)
to assessment##8##2##(1992-1#1)(1993-1#1)(2007-1#1)(2007-3#1)(2008-11#1)(2008-9#1)(2011-1#1)(2011-12#1)
to assessments of##2##3##(1993-5#1)(2008-9#1)
to assign a##4##3##(1995-3#1)(1996-7#1)(2008-2#1)(2008-7#1)
to assign the##6##3##(1991-4#1)(1992-9#1)(1996-2#3)(2012-12#1)
to assign##28##2##(1991-4#1)(1991-5#1)(1992-9#1)(1993-11#1)(1993-9#1)(1995-3#1)(1995-6#1)(1996-2#3)(1996-5#1)(1996-7#1)(1997-6#1)(2004-12#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-4#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
to assimilate the##2##3##(2008-11#1)(2013-1#1)
to assimilate##5##2##(2007-7#1)(2008-11#2)(2008-12#1)(2013-1#1)
to assist clinicians##2##3##(2007-12#1)(2012-12#1)
to assist dental educational researchers in##2##6##(2013-1#2)
to assist emergency##2##3##(2007-7#1)(2008-7#1)
to assist families##2##3##(1997-2#1)(2011-1#1)
to assist in the development of##3##6##(2008-4#1)(2008-5#2)
to assist in the identification of##2##6##(2010-5#1)(2012-3#1)
to assist in the management of##2##6##(2007-6#1)(2008-7#1)
to assist in the##20##4##(1993-9#1)(1997-3#1)(2004-2#1)(2005-11#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#3)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
to assist in their##2##4##(2008-7#1)(2013-8#1)
to assist in##45##3##(1992-6#1)(1993-12#1)(1993-8#1)(1993-9#1)(1995-1#1)(1996-2#1)(1997-3#1)(2004-2#1)(2005-11#1)(2006-12#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-6#1)(2008-1#2)(2008-10#3)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#4)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
to assist medical##3##3##(1992-1#1)(2013-1#2)
to assist patients##2##3##(1992-12#1)(2012-1#1)
to assist readers##2##3##(2005-10#1)(2008-12#1)
to assist the clinician##2##4##(2006-7#1)(2013-1#1)
to assist the patient##2##4##(2012-1#2)
to assist the practitioner##2##4##(2006-8#1)(2008-12#1)
to assist the##25##3##(1991-12#1)(1995-1#1)(2005-3#1)(2006-7#1)(2006-8#1)(2007-2#1)(2007-4#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-12#1)(2011-2#1)(2011-7#1)(2012-1#3)(2013-1#1)
to assist them in##2##4##(2008-3#1)(2011-1#1)
to assist them##5##3##(1995-1#1)(1995-12#1)(2008-3#1)(2010-2#1)(2011-1#1)
to assist these##3##3##(2007-2#1)(2008-4#1)(2010-8#1)
to assist with the##2##4##(2008-3#1)(2009-9#1)
to assist with##6##3##(1993-6#1)(2005-8#1)(2008-3#1)(2009-6#1)(2009-9#1)(2013-1#1)
to assist##168##2##(1991-12#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1995-1#3)(1995-12#1)(1995-3#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-2#2)(1997-3#3)(1997-8#1)(2004-2#1)(2005-10#1)(2005-11#2)(2005-3#1)(2005-8#1)(2006-1#1)(2006-12#1)(2006-3#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#3)(2007-3#3)(2007-4#3)(2007-5#4)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#10)(2008-11#4)(2008-12#7)(2008-2#1)(2008-3#2)(2008-4#6)(2008-5#3)(2008-7#6)(2008-9#1)(2009-10#2)(2009-11#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#4)(2011-7#1)(2012-1#8)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#12)(2013-7#3)(2013-8#1)
to assisted##5##2##(2006-10#1)(2006-11#1)(2010-12#1)(2011-2#1)(2012-2#1)
to assisting##3##2##(1991-12#1)(2008-10#1)(2010-2#1)
to associate a##3##3##(1993-6#1)(2008-10#1)(2009-8#1)
to associate the##3##3##(1993-2#1)(2008-10#1)(2012-1#1)
to associate with DNA##2##4##(1997-4#1)(2005-11#1)
to associate with the##5##4##(1992-8#1)(1993-11#1)(1996-5#1)(1996-8#1)(2008-10#1)
to associate with##18##3##(1992-7#1)(1992-8#1)(1993-11#1)(1994-8#1)(1994-9#1)(1996-5#2)(1996-8#1)(1997-4#1)(2004-11#1)(2005-11#1)(2005-8#1)(2006-11#1)(2008-10#1)(2008-7#1)(2009-9#2)(2010-12#1)
to associate##39##2##(1990-11#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-2#2)(1993-6#2)(1993-9#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-4#2)(2004-11#1)(2005-11#1)(2005-8#1)(2006-11#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-7#1)(2009-8#3)(2009-9#2)(2010-12#1)(2011-12#1)(2012-1#1)(2012-2#1)(2012-3#1)
to associated##10##2##(1997-4#1)(1997-8#1)(2004-1#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-4#1)(2013-1#3)
to association##3##2##(1990-10#1)(2008-8#1)(2013-1#1)
to associations between##3##3##(2008-12#1)(2010-2#1)(2012-3#1)
to assume a##5##3##(1992-1#1)(1994-6#1)(2010-10#1)(2010-11#1)(2012-2#1)
to assume an##2##3##(1994-7#1)(2007-11#1)
to assume responsibility for##2##4##(1992-3#1)(1995-12#1)
to assume that the##2##4##(1991-6#1)(2008-5#1)
to assume that##15##3##(1991-1#1)(1991-6#2)(1992-12#1)(1993-5#1)(1996-6#1)(2005-11#1)(2006-3#1)(2007-10#1)(2008-11#2)(2008-2#1)(2008-5#3)
to assume the##5##3##(1996-2#1)(1997-7#1)(2007-2#1)(2007-7#1)(2008-7#1)
to assume##39##2##(1991-1#1)(1991-6#2)(1992-1#1)(1992-12#1)(1992-3#1)(1993-5#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-12#1)(1996-2#2)(1996-6#1)(1997-7#1)(2005-11#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#3)(2008-7#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-12#1)(2012-2#1)
to assumptions about the##2##4##(2008-7#1)(2010-2#1)
to assumptions##6##2##(1995-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-2#1)
to assure a##4##3##(2010-11#1)(2010-9#1)(2011-1#1)(2012-2#1)
to assure that##6##3##(1994-2#1)(1996-3#1)(1997-8#1)(2007-3#1)(2008-1#1)(2008-3#1)
to assure the delivery of##2##5##(1993-12#1)(1994-12#1)
to assure the##8##3##(1993-12#1)(1994-12#1)(2005-5#1)(2007-4#1)(2008-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
to assure##33##2##(1991-2#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-8#2)(2005-5#1)(2006-11#2)(2007-3#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#2)(2010-11#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#4)(2013-7#1)
to asthma and##3##3##(1992-3#1)(2006-8#1)(2008-5#1)
to asthma##16##2##(1992-3#1)(1997-2#2)(2005-8#1)(2006-8#1)(2007-11#1)(2007-6#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#1)
to astrocytes##2##2##(1996-8#1)(2008-11#1)
to asymmetric##12##2##(1992-7#1)(1997-2#1)(2006-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-6#3)(2012-1#1)(2012-12#2)
to asymptomatic##2##2##(2007-7#1)(2008-3#1)
to at least 100 ng ml(-1)##2##6##(2008-10#2)
to at least 100##5##4##(1995-5#1)(2008-10#4)
to at least 3##2##4##(2005-10#1)(2013-1#1)
to at least four##2##4##(1990-7#1)(1992-5#1)
to at least one conventional##2##5##(2012-12#1)(2013-1#1)
to at least one of##2##5##(2006-10#1)(2008-10#1)
to at least one##9##4##(2006-10#2)(2007-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2012-12#1)(2013-1#1)
to at least the##3##4##(1993-12#1)(2006-12#1)(2008-2#1)
to at least two##5##4##(1993-2#1)(1993-8#1)(1995-2#1)(1996-3#1)(2008-2#1)
to at least##53##3##(1990-7#1)(1991-12#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-8#1)(1995-2#2)(1995-3#2)(1995-5#1)(1996-3#1)(1996-5#1)(1996-9#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-2#1)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#12)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)
to at##56##2##(1990-7#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1995-2#2)(1995-3#2)(1995-5#1)(1996-3#1)(1996-5#1)(1996-9#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-2#1)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#12)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)
to atherosclerosis and##2##3##(1995-12#1)(2008-1#1)
to atherosclerosis##14##2##(1990-4#1)(1991-6#1)(1992-2#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-8#1)(2007-10#1)(2008-1#1)(2008-4#1)(2009-4#1)(2010-12#2)(2013-8#1)
to atherosclerotic##6##2##(1993-10#1)(2007-10#1)(2007-7#1)(2008-4#1)(2010-4#1)(2011-1#1)
to athletes##2##2##(2008-5#2)
to athletes' health##2##3##(1993-3#1)(2010-7#1)
to athletic##2##2##(2006-3#2)
to athymic mice##2##3##(1992-9#1)(2006-9#1)
to atmospheric pressure##3##3##(1990-7#1)(2005-11#1)(2008-10#1)
to atmospheric##11##2##(1990-7#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#4)(2013-8#1)
to atomic absorption or atomic##2##5##(2008-10#2)
to atomic absorption spectrometry##2##4##(1993-11#1)(2008-10#1)
to atomic absorption##4##3##(1993-11#1)(2008-10#3)
to atomic resolution##2##3##(1992-1#1)(1994-8#1)
to atomic##15##2##(1990-6#1)(1992-1#1)(1993-11#1)(1994-8#1)(1995-11#1)(2006-4#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-4#1)(2009-12#1)
to atopic##2##2##(1996-8#1)(2008-7#1)
to atopy##3##2##(2006-10#1)(2010-3#1)(2011-2#1)
to atrial fibrillation##6##3##(1993-4#1)(2006-10#1)(2007-7#1)(2008-12#1)(2010-4#1)(2011-12#1)
to atrial##7##2##(1990-7#1)(1993-4#1)(2006-10#1)(2007-7#1)(2008-12#1)(2010-4#1)(2011-12#1)
to atropine##6##2##(1990-10#6)
to attach to the##3##4##(2008-10#1)(2010-4#1)(2011-1#1)
to attach to##4##3##(2008-10#2)(2010-4#1)(2011-1#1)
to attach##12##2##(1994-5#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#1)
to attachment##2##2##(1991-12#1)(2008-7#1)
to attack by##2##3##(2008-10#1)(2008-9#1)
to attack##12##2##(1992-6#1)(2004-9#1)(2005-11#1)(2006-11#1)(2008-10#2)(2008-12#1)(2008-9#2)(2009-10#1)(2010-1#1)(2011-10#1)
to attain a##7##3##(1993-3#1)(1994-8#1)(1997-8#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-8#1)
to attain an##2##3##(2007-3#1)(2011-2#1)
to attain better##2##3##(2007-11#1)(2010-1#1)
to attain the desired##2##4##(2008-3#1)(2009-6#1)
to attain the highest##2##4##(1995-9#1)(2008-10#1)
to attain the##10##3##(1995-9#1)(2005-11#1)(2008-10#5)(2008-3#1)(2009-6#1)(2010-9#1)
to attain##43##2##(1990-3#1)(1993-3#1)(1993-5#1)(1994-5#1)(1994-8#1)(1995-9#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-11#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#4)(2008-5#1)(2008-8#1)(2009-6#2)(2009-9#1)(2010-1#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-7#1)
to attaining##2##2##(1994-7#1)(2007-12#1)
to attempt to answer##2##4##(1990-8#1)(1992-2#1)
to attempt to##13##3##(1990-8#1)(1991-9#1)(1992-2#1)(1994-12#1)(2006-2#1)(2007-11#2)(2008-10#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-5#1)(2012-3#1)
to attempt##18##2##(1990-10#1)(1990-8#1)(1991-9#1)(1992-2#1)(1993-10#1)(1994-12#1)(1997-2#1)(2006-2#1)(2007-11#2)(2008-10#2)(2008-4#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-5#1)(2012-3#1)
to attempts to##3##3##(2007-11#1)(2008-10#1)(2009-2#1)
to attempts##4##2##(2007-11#1)(2008-10#1)(2009-2#1)(2012-12#1)
to attend and##2##3##(2011-2#1)(2012-11#1)
to attend more than##2##4##(2008-5#1)(2008-7#1)
to attend the##2##3##(2007-10#1)(2012-2#1)
to attend to the##3##4##(1997-1#1)(1997-8#1)(2008-11#1)
to attend to their##2##4##(2006-2#1)(2013-1#1)
to attend to##7##3##(1997-1#1)(1997-8#1)(2006-10#1)(2006-2#1)(2008-11#1)(2012-1#1)(2013-1#1)
to attend##25##2##(1992-2#1)(1992-5#1)(1992-8#1)(1993-3#1)(1997-1#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
to attendance##3##2##(1991-6#1)(2005-8#2)
to attention##2##2##(1996-2#1)(2008-11#1)
to attenuate or##2##3##(2006-10#1)(2011-1#1)
to attenuate the##12##3##(1992-8#1)(1993-12#2)(1993-8#1)(1994-3#1)(1995-12#1)(2006-10#1)(2009-5#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)
to attenuate vecuronium-induced tetanic fade indicates that##2##7##(1997-5#2)
to attenuate##37##2##(1990-5#1)(1992-8#1)(1993-12#2)(1993-8#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-7#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-5#3)(2005-7#1)(2006-10#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)
to attenuated##3##2##(2008-11#1)(2008-5#1)(2008-7#1)
to attitudes toward##3##3##(2009-7#1)(2011-1#1)(2013-1#1)
to attitudes##6##2##(2007-12#1)(2009-7#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#1)
to attract and retain##2##4##(2007-4#1)(2008-8#1)
to attract attention##2##3##(2006-10#1)(2008-8#1)
to attract more##2##3##(1990-4#1)(1994-5#1)
to attract##24##2##(1990-2#1)(1990-4#1)(1993-1#1)(1994-1#2)(1994-5#1)(1995-1#1)(1995-3#1)(1997-3#2)(2006-10#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-8#2)(2009-4#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
to attractant-baited##2##2##(2004-2#2)
to attribute the##3##3##(1992-9#1)(2008-8#1)(2013-1#1)
to attribute##8##2##(1992-9#1)(2004-11#1)(2006-2#1)(2008-8#1)(2012-1#2)(2012-2#1)(2013-1#1)
to atypical##4##2##(2006-10#1)(2010-11#1)(2011-2#1)(2013-1#1)
to audit##2##2##(2008-1#1)(2011-2#1)
to auditory stimuli##5##3##(1992-7#2)(1993-2#2)(2008-11#1)
to auditory##7##2##(1992-7#2)(1993-2#2)(2007-10#1)(2008-11#1)(2012-3#1)
to augment the##14##3##(1992-2#1)(1993-6#1)(1994-8#1)(1997-2#1)(2006-3#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-3#1)(2012-12#2)(2013-1#2)
to augment##33##2##(1991-12#1)(1992-2#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-8#1)(1996-10#1)(1997-2#1)(2005-12#1)(2006-3#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-3#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)
to augmented##2##2##(1990-5#1)(2005-10#1)
to authentic##7##2##(1990-3#1)(1990-6#1)(1991-2#1)(1991-4#1)(1991-9#1)(1994-5#1)(2009-10#1)
to autism##2##2##(2011-2#1)(2012-3#1)
to autoimmune destruction of##2##4##(2007-12#1)(2009-3#1)
to autoimmune disease##2##3##(2008-10#1)(2008-4#1)
to autoimmune diseases##2##3##(2010-4#1)(2012-2#1)
to autoimmune##11##2##(2006-10#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-2#1)
to autoimmunity##5##2##(1997-8#1)(2012-1#1)(2012-2#3)
to automate the##6##3##(2006-10#1)(2008-10#1)(2013-1#4)
to automate##13##2##(1996-6#1)(2006-10#1)(2008-10#3)(2008-3#1)(2010-10#1)(2011-2#1)(2012-1#1)(2013-1#4)
to automated##10##2##(1991-11#1)(1994-6#1)(1997-2#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#2)(2011-2#1)
to automatic##3##2##(2008-2#1)(2008-3#1)(2008-5#1)
to automatically discover &quot##2##4##(2013-1#2)
to automatically##16##2##(1994-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2011-1#1)(2012-1#2)(2012-2#1)(2013-1#6)
to automation##6##2##(1995-12#1)(1996-3#1)(2008-10#4)
to autonomic##3##2##(2006-11#2)(2008-1#1)
to autonomous##3##2##(1993-5#1)(2006-4#1)(2010-7#1)
to autonomy##3##2##(1997-8#1)(2006-8#1)(2011-1#1)
to autophosphorylate##3##2##(1990-12#1)(1992-11#1)(2008-4#1)
to autopsy##3##2##(1993-8#2)(1995-12#1)
to autosomal##2##2##(1996-6#1)(1997-4#1)
to autotransplant##2##2##(2008-6#2)
to auxin##4##2##(2008-8#3)(2009-8#1)
to avail the##2##3##(2007-7#1)(2008-1#1)
to avail##3##2##(2007-7#1)(2008-1#1)(2008-7#1)
to available##11##2##(1991-8#1)(1992-3#1)(2006-11#1)(2006-12#1)(2006-4#1)(2007-12#1)(2007-5#1)(2009-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
to avascular##3##2##(2007-11#1)(2009-3#2)
to average##23##2##(1991-11#1)(1995-10#2)(2007-7#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-8#3)(2008-9#10)(2011-2#1)
to averaging##2##2##(2007-12#1)(2008-2#1)
to aversive##2##2##(1993-2#1)(1996-1#1)
to avert##10##2##(1994-3#1)(1995-2#1)(1997-4#2)(2007-10#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#2)
to averted gaze##2##3##(2008-11#2)
to avian infectious##2##3##(2005-9#1)(2008-5#1)
to avian polyomavirus##2##3##(2008-5#2)
to avian##11##2##(2005-9#1)(2007-6#2)(2008-5#4)(2008-8#1)(2009-7#1)(2012-3#1)(2013-8#1)
to avirulent##3##2##(1995-2#1)(2008-10#1)(2008-5#1)
to avoid &quot##2##3##(2006-11#1)(2011-12#1)
to avoid a##9##3##(1994-1#1)(1994-2#1)(1996-11#1)(2007-4#1)(2008-6#1)(2009-3#1)(2010-10#1)(2011-2#1)(2013-8#1)
to avoid adverse##2##3##(1993-9#1)(2012-12#1)
to avoid an##2##3##(1993-3#1)(1993-5#1)
to avoid and##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2009-10#1)
to avoid any##5##3##(1990-12#1)(1990-3#1)(2008-3#1)(2008-4#1)(2012-3#1)
to avoid complications##8##3##(1991-6#1)(1995-8#1)(2006-10#1)(2006-4#1)(2009-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
to avoid contamination##2##3##(1995-7#1)(2008-12#1)
to avoid damage##2##3##(2007-12#1)(2008-2#1)
to avoid distal endothelial##2##4##(2007-8#2)
to avoid excessive##6##3##(1994-11#1)(2007-8#1)(2008-10#2)(2010-7#2)
to avoid exposure##2##3##(1992-2#1)(2013-8#1)
to avoid further##3##3##(1996-12#1)(2008-3#1)(2009-3#1)
to avoid future##2##3##(2011-2#1)(2012-2#1)
to avoid interference##3##3##(1994-3#1)(2007-12#1)(2008-5#1)
to avoid interferences##2##3##(2008-10#2)
to avoid it##3##3##(1997-3#1)(2006-5#1)(2012-12#1)
to avoid its##2##3##(2009-1#1)(2010-7#1)
to avoid local recurrence##2##4##(2007-4#1)(2011-2#1)
to avoid misdiagnosis##4##3##(1996-3#1)(2008-6#1)(2011-2#1)(2012-2#1)
to avoid misinterpretation of##2##4##(2009-8#1)(2010-9#1)
to avoid of##2##3##(2005-11#1)(2007-5#1)
to avoid or##6##3##(1991-12#1)(1991-6#1)(2006-8#1)(2008-10#1)(2009-3#1)(2012-1#1)
to avoid permanent##2##3##(2009-10#1)(2012-3#1)
to avoid postoperative retroauricular deformity##3##5##(2008-7#3)
to avoid potential##4##3##(1997-2#1)(2006-10#2)(2008-5#1)
to avoid secondary##2##3##(2007-2#1)(2012-2#1)
to avoid serious##3##3##(1997-8#1)(2010-8#1)(2012-2#1)
to avoid subjecting##2##3##(2006-10#1)(2010-12#1)
to avoid the &quot##2##4##(2007-4#1)(2008-4#1)
to avoid the complications of##2##5##(1991-8#1)(2011-2#1)
to avoid the development of##3##5##(1996-11#1)(2006-10#1)(2007-2#1)
to avoid the effect of##2##5##(2008-10#1)(2008-8#1)
to avoid the need for##4##5##(2007-11#1)(2008-4#1)(2008-6#1)(2010-9#1)
to avoid the negative##2##4##(2008-11#1)(2008-9#1)
to avoid the risk of##3##5##(1993-8#1)(1994-11#1)(2006-10#1)
to avoid the use of##3##5##(2007-12#1)(2008-7#1)(2011-2#1)
to avoid the##67##3##(1991-8#1)(1992-12#1)(1992-5#1)(1993-10#1)(1993-3#2)(1993-8#1)(1994-11#1)(1995-11#1)(1996-11#1)(2005-11#1)(2006-10#4)(2006-11#2)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#1)(2007-6#2)(2007-7#3)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-9#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
to avoid them##7##3##(1991-4#1)(1995-2#1)(2006-11#1)(2007-8#1)(2010-8#1)(2011-2#1)(2012-2#1)
to avoid these##6##3##(1995-7#1)(2006-8#1)(2008-7#1)(2009-3#1)(2011-12#1)(2013-8#1)
to avoid this##5##3##(2005-7#1)(2006-10#1)(2008-9#1)(2011-2#1)(2012-2#1)
to avoid underestimation of##2##4##(1990-2#1)(2011-2#1)
to avoid unnecessary surgery##2##4##(2012-2#2)
to avoid unnecessary##6##3##(1993-6#1)(2006-2#1)(2009-6#1)(2010-8#1)(2012-2#2)
to avoid##439##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#4)(1991-2#1)(1991-4#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-2#2)(1993-3#4)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-1#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#2)(1995-5#1)(1995-7#2)(1995-8#4)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#3)(2004-12#1)(2004-8#1)(2004-9#1)(2005-10#2)(2005-11#3)(2005-12#1)(2005-5#4)(2005-7#1)(2005-8#1)(2006-10#12)(2006-11#4)(2006-2#2)(2006-4#2)(2006-5#3)(2006-7#3)(2006-8#3)(2006-9#1)(2007-10#2)(2007-11#8)(2007-12#8)(2007-2#2)(2007-3#1)(2007-4#3)(2007-5#3)(2007-6#2)(2007-7#8)(2007-8#10)(2007-9#3)(2008-1#6)(2008-10#32)(2008-11#13)(2008-12#2)(2008-2#10)(2008-3#11)(2008-4#10)(2008-5#8)(2008-6#7)(2008-7#9)(2008-8#4)(2008-9#9)(2009-1#1)(2009-10#3)(2009-11#1)(2009-2#3)(2009-3#6)(2009-4#4)(2009-5#1)(2009-6#4)(2009-8#5)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#6)(2010-8#5)(2010-9#2)(2011-1#1)(2011-12#4)(2011-2#19)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#9)(2012-2#16)(2012-3#3)(2013-1#10)(2013-7#7)(2013-8#10)
to avoiding##4##2##(1992-12#1)(1997-1#1)(2008-8#1)(2010-6#1)
to axial##3##2##(1997-7#1)(2007-4#1)(2008-10#1)
to axillary lymph nodes##2##4##(2008-4#1)(2009-5#1)
to axillary lymph##3##3##(2004-2#1)(2008-4#1)(2009-5#1)
to axillary##6##2##(2004-2#1)(2007-8#1)(2008-4#1)(2008-5#2)(2009-5#1)
to axonal##3##2##(1990-5#1)(1995-12#1)(1997-4#1)
to axotomy##3##2##(1990-5#1)(1991-10#1)(2008-4#1)
to ayahuasca use##2##3##(2008-7#1)(2013-8#1)
to azathioprine##4##2##(2006-10#1)(2007-11#3)
to azide##3##2##(1991-3#2)(1991-6#1)
to azole##2##2##(2006-11#1)(2006-8#1)
to azoles##3##2##(2005-8#1)(2008-5#2)
to azoxymethane##2##2##(1993-11#1)(2011-2#1)
to b##2##2##(2008-10#2)
to bFGF##5##2##(1991-9#1)(1995-12#2)(2008-11#2)
to back pain##2##3##(2006-8#1)(2008-7#1)
to back##3##2##(2006-5#1)(2006-8#1)(2008-7#1)
to background levels##2##3##(1995-12#1)(2010-4#1)
to background##12##2##(1993-5#1)(1995-12#1)(2008-2#4)(2008-3#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-4#1)(2012-2#1)
to backscattering##3##2##(2008-2#2)(2008-3#1)
to baclofen withdrawal syndrome##2##4##(2011-2#2)
to baclofen##4##2##(1991-8#1)(1996-2#1)(2011-2#2)
to bacteria##10##2##(1997-6#1)(2006-8#2)(2007-11#1)(2007-9#1)(2008-10#1)(2008-5#1)(2010-1#1)(2011-1#1)(2012-3#1)
to bacterial blight##5##3##(2008-10#3)(2008-8#1)(2009-10#1)
to bacterial canker##7##3##(2008-10#7)
to bacterial colonization##3##3##(1991-3#1)(2006-11#1)(2008-1#1)
to bacterial infection##4##3##(1991-12#1)(1991-8#1)(1996-11#1)(2009-12#1)
to bacterial infections##2##3##(1994-2#1)(2013-7#1)
to bacterial lipopolysaccharide##5##3##(1993-8#1)(1994-12#1)(1997-6#1)(2008-10#1)(2011-1#1)
to bacterial pathogens##6##3##(1991-12#1)(2006-10#1)(2008-10#4)
to bacterial persistence##2##3##(2010-9#2)
to bacterial##62##2##(1990-8#1)(1991-12#3)(1991-3#1)(1991-8#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-10#1)(1996-11#1)(1997-1#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#22)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-9#2)(2011-1#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#2)
to bad##2##2##(1996-3#1)(2004-9#1)
to balance both##2##3##(2010-5#1)(2012-6#1)
to balance the##8##3##(1995-6#1)(2006-8#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2013-1#1)
to balance##22##2##(1992-12#1)(1995-6#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-9#1)(2012-2#1)(2012-6#1)(2013-1#4)
to balanced##3##2##(2011-2#1)(2012-2#2)
to balancing selection##2##3##(1996-8#1)(2013-1#1)
to balloon angioplasty##2##3##(1994-11#1)(2005-12#1)
to balloon##4##2##(1994-11#1)(1997-8#1)(2005-12#1)(2008-11#1)
to ban##4##2##(1996-8#1)(2008-8#1)(2010-9#2)
to band 3##3##3##(1994-5#2)(2013-7#1)
to band##11##2##(1990-6#1)(1991-7#1)(1992-11#1)(1994-5#2)(1996-4#1)(1997-2#1)(2008-12#1)(2008-2#1)(2013-1#1)(2013-7#1)
to bariatric surgery##3##3##(1993-3#1)(2006-10#1)(2010-8#1)
to barley in the##2##4##(2008-10#2)
to barley yellow dwarf virus (BYDV)##3##6##(2008-10#2)(2008-8#1)
to barley yellow dwarf virus##4##5##(2008-10#3)(2008-8#1)
to barley##9##2##(2008-10#8)(2008-8#1)
to baroreceptor activation##2##3##(1990-5#1)(1992-7#1)
to baroreceptor##4##2##(1990-5#2)(1992-7#1)(1997-2#1)
to bars##2##2##(1996-1#1)(2011-2#1)
to basal level##2##3##(1990-4#1)(1992-6#1)
to basal levels by##2##4##(1991-10#1)(1996-12#1)
to basal levels##10##3##(1990-8#1)(1991-10#1)(1993-2#1)(1994-6#1)(1996-11#1)(1996-12#1)(2006-5#1)(2008-10#1)(2010-10#1)(2012-1#1)
to basal values##3##3##(1990-10#1)(1990-7#1)(1991-6#1)
to basal##23##2##(1990-10#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-6#1)(1993-2#1)(1994-6#1)(1995-10#1)(1996-11#1)(1996-12#1)(1997-1#1)(2006-5#1)(2007-9#1)(2008-10#1)(2010-10#1)(2012-1#1)(2012-3#1)(2013-8#1)
to base the##2##3##(1992-11#1)(2006-10#1)
to base their##2##3##(2008-12#1)(2013-7#1)
to base##27##2##(1992-11#1)(1992-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1996-5#1)(1997-1#2)(1997-2#1)(2006-10#3)(2006-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
to baseline after##2##3##(1991-12#1)(1995-2#1)
to baseline at##2##3##(1990-7#1)(2013-1#1)
to baseline in##2##3##(1993-12#1)(2008-7#1)
to baseline levels within##2##4##(1990-10#1)(1991-12#1)
to baseline levels##5##3##(1990-10#1)(1991-12#1)(1991-6#1)(1995-7#1)(2012-2#1)
to baseline values##6##3##(1992-12#1)(1994-2#1)(1996-9#1)(2006-6#1)(2013-1#1)(2013-8#1)
to baseline##43##2##(1990-10#1)(1990-7#1)(1991-12#2)(1991-6#1)(1992-12#1)(1992-7#1)(1993-1#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#2)(1995-7#1)(1996-9#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-6#1)(2006-8#2)(2007-11#2)(2007-8#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2010-2#2)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#3)
to basement membrane##2##3##(1994-5#1)(1995-2#1)
to basic and##2##3##(2005-8#1)(2006-7#1)
to basic fibroblast growth factor##2##5##(1994-5#1)(1995-1#1)
to basic health##2##3##(1992-2#1)(2011-2#1)
to basic science##2##3##(2006-10#1)(2007-11#1)
to basic##35##2##(1990-8#1)(1991-9#1)(1992-2#1)(1993-7#1)(1994-5#1)(1995-1#1)(1996-9#1)(2005-8#1)(2006-10#2)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-1#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#2)(2013-7#1)
to basics##2##2##(2005-6#1)(2006-12#1)
to basilar##2##2##(2008-7#1)(2010-2#1)
to basolateral##2##2##(1993-3#1)(2006-10#1)
to batch cultures##2##3##(2008-11#2)
to batch##4##2##(2008-11#3)(2008-7#1)
to bats##2##2##(2007-12#1)(2009-8#1)
to bcl-2##2##2##(1993-3#1)(1994-3#1)
to be &gt##11##3##(1996-2#1)(1996-5#1)(1996-7#1)(2007-7#1)(2008-10#5)(2008-5#1)(2008-8#1)
to be &lt##9##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2013-1#2)
to be &quot##15##3##(1991-3#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-2#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-2#2)(2013-1#2)
to be (1##2##3##(2007-1#1)(2008-10#1)
to be (2##3##3##(2008-2#1)(2008-3#2)
to be (3##4##3##(2007-12#1)(2008-10#2)(2008-3#1)
to be 0##103##3##(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1993-4#1)(1994-6#1)(1995-4#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-4#1)(2006-2#1)(2007-11#2)(2007-12#5)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#48)(2008-2#4)(2008-3#6)(2008-5#1)(2008-8#1)(2009-6#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-11#1)(2012-12#3)(2013-1#1)
to be 1##68##3##(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-4#1)(1994-5#1)(1995-11#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#2)(2007-8#3)(2008-10#29)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-7#1)(2009-11#1)(2009-4#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#2)
to be 10 times##2##4##(1995-8#1)(1997-7#1)
to be 10##14##3##(1990-12#1)(1992-12#1)(1992-9#1)(1995-8#1)(1997-4#1)(1997-7#1)(2004-11#1)(2008-10#5)(2008-3#1)(2008-8#1)
to be 10%##2##3##(1997-4#1)(2007-11#1)
to be 10-fold more##2##4##(1990-11#1)(1992-9#1)
to be 10-fold##3##3##(1990-11#1)(1992-9#1)(1995-11#1)
to be 100##5##3##(1990-12#1)(1992-4#1)(2008-10#1)(2008-4#1)(2010-2#1)
to be 100% and##2##4##(1996-12#1)(2007-8#1)
to be 100%##8##3##(1994-12#1)(1995-12#1)(1996-12#1)(2006-8#1)(2007-7#2)(2007-8#1)(2008-9#1)
to be 11##2##3##(2007-3#1)(2010-5#1)
to be 110##2##3##(2007-12#1)(2008-10#1)
to be 12##4##3##(2007-12#1)(2008-10#1)(2008-5#1)(2012-12#1)
to be 13##3##3##(1992-12#1)(2008-10#1)(2010-12#1)
to be 15##6##3##(1997-3#1)(2005-8#1)(2006-5#1)(2008-10#1)(2008-5#1)(2008-6#1)
to be 16##7##3##(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-9#1)(2012-2#2)
to be 166##2##3##(1993-8#1)(2008-3#1)
to be 17##2##3##(1994-8#1)(2011-2#1)
to be 18##4##3##(2007-10#1)(2007-7#1)(2007-8#1)(2013-8#1)
to be 2##50##3##(1991-9#1)(1992-3#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#2)(2006-12#1)(2007-1#1)(2007-10#1)(2008-10#28)(2008-2#4)(2008-3#1)(2008-5#2)(2010-12#1)(2011-1#1)
to be 2-chloro-4##2##3##(1990-3#1)(2010-2#1)
to be 20 nm##2##4##(2008-3#1)(2009-9#1)
to be 20##9##3##(1993-2#1)(2004-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#2)(2009-9#1)(2010-12#1)
to be 20%##2##3##(2006-10#1)(2007-10#1)
to be 21##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
to be 22##3##3##(1993-9#1)(2007-8#1)(2008-10#1)
to be 23##4##3##(1990-7#1)(1993-8#1)(1996-11#1)(2007-8#1)
to be 24##3##3##(2006-8#1)(2007-12#1)(2008-10#1)
to be 25##3##3##(1990-6#1)(1991-12#1)(2012-12#1)
to be 3 x##3##4##(1996-5#1)(2008-3#2)
to be 3##27##3##(1990-12#1)(1993-8#1)(1996-5#1)(1996-7#1)(1997-2#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-6#1)(2008-10#10)(2008-3#3)(2008-7#1)(2009-6#1)(2010-2#1)(2011-1#1)(2012-2#1)
to be 30##5##3##(1993-12#1)(1997-8#1)(2007-11#1)(2007-2#1)(2008-3#1)
to be 30%##2##3##(2006-10#1)(2006-12#1)
to be 35##2##3##(2006-10#1)(2012-3#1)
to be 37##2##3##(1993-11#1)(1995-11#1)
to be 370##2##3##(1993-2#1)(2007-12#1)
to be 38##2##3##(1990-8#1)(2008-10#1)
to be 4##30##3##(1990-5#1)(1991-7#2)(1993-1#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-8#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#11)(2009-5#1)(2010-12#2)(2012-2#1)(2012-3#1)
to be 40##3##3##(1996-2#1)(2007-8#1)(2009-10#1)
to be 41##2##3##(2006-1#1)(2013-1#1)
to be 5##20##3##(1990-2#1)(1990-5#1)(1991-8#1)(1993-3#1)(1997-2#1)(2006-4#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-11#1)(2013-1#1)
to be 50##7##3##(1990-9#1)(1992-7#1)(1994-12#1)(1994-3#1)(2006-12#1)(2008-3#1)(2011-2#1)
to be 53##2##3##(1995-1#1)(2011-1#1)
to be 55##2##3##(1991-8#1)(2012-2#1)
to be 6##10##3##(1991-2#1)(1992-2#1)(1992-7#1)(1993-12#1)(2008-10#4)(2008-11#1)(2013-8#1)
to be 60##4##3##(1995-2#1)(2008-10#2)(2008-8#1)
to be 62##3##3##(2008-10#2)(2012-2#1)
to be 65##3##3##(1990-8#1)(1992-11#1)(2008-3#1)
to be 7##15##3##(1991-5#1)(1991-7#1)(1996-7#1)(2005-11#1)(2006-4#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-5#2)(2013-1#1)
to be 8##12##3##(1992-11#1)(1992-2#1)(1992-3#1)(1994-5#1)(1996-4#1)(2005-11#1)(2006-12#1)(2008-10#3)(2008-2#1)(2008-3#1)
to be 80%##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
to be 87##2##3##(1990-11#1)(2008-10#1)
to be 9##7##3##(1991-4#1)(1991-5#1)(1994-2#1)(1995-11#1)(2008-10#2)(2009-6#1)
to be 90##4##3##(1997-6#1)(2007-12#1)(2008-3#1)(2008-5#1)
to be 90%##2##3##(2007-8#1)(2008-3#1)
to be 94%##3##3##(1993-5#1)(2007-10#1)(2008-3#1)
to be 97##2##3##(1997-2#1)(2008-3#1)
to be 98##3##3##(1995-3#1)(2008-10#1)(2008-2#1)
to be 99##10##3##(1996-12#1)(2008-10#5)(2008-2#1)(2010-1#1)(2010-2#1)(2013-1#1)
to be F##2##3##(2008-10#2)
to be HIV positive##4##4##(2006-8#1)(2007-7#2)(2010-9#1)
to be HIV##5##3##(2006-8#1)(2007-7#2)(2010-9#1)(2011-1#1)
to be HIV-positive##4##3##(1991-7#1)(1995-6#1)(2008-11#1)(2010-9#1)
to be HPV and p16 positive##2##6##(2010-7#2)
to be N-glycosylated##2##3##(1994-11#1)(2013-8#1)
to be Neisseria##4##3##(2013-1#4)
to be US##2##3##(2005-8#1)(2008-3#1)
to be a &quot##3##4##(2008-10#1)(2009-7#1)(2011-1#1)
to be a Na+##2##4##(1993-3#1)(1997-8#1)
to be a beneficial##3##4##(1997-1#1)(2008-7#1)(2010-12#1)
to be a benign tumor##2##5##(2008-10#1)(2008-12#1)
to be a benign##4##4##(2007-11#1)(2008-10#1)(2008-12#1)(2010-9#1)
to be a better##5##4##(1996-1#1)(1996-8#1)(2004-3#1)(2008-10#1)(2010-5#1)
to be a branched##2##4##(1993-12#1)(1996-2#1)
to be a case of##3##5##(2007-7#1)(2012-2#2)
to be a causative##2##4##(2006-10#1)(2010-12#1)
to be a cause of##4##5##(1994-6#1)(2006-2#1)(2008-11#1)(2009-5#1)
to be a cavernous##2##4##(2008-10#1)(2011-1#1)
to be a cell##2##4##(2008-10#1)(2012-12#1)
to be a cellular##2##4##(2006-10#1)(2008-4#1)
to be a central##3##4##(2010-10#1)(2013-1#2)
to be a challenge to##3##5##(1992-1#1)(2008-6#1)(2009-5#1)
to be a challenge##6##4##(1992-1#1)(2008-6#1)(2009-5#1)(2011-1#1)(2013-1#2)
to be a challenging task##2##5##(2008-10#1)(2012-2#1)
to be a challenging##3##4##(2008-10#1)(2009-10#1)(2012-2#1)
to be a characteristic of##3##5##(1995-6#1)(2008-10#1)(2009-9#1)
to be a characteristic##4##4##(1995-6#1)(2008-10#2)(2009-9#1)
to be a cloning artifact##2##5##(1991-12#2)
to be a close##2##4##(1995-2#1)(2010-10#1)
to be a common cause of##2##6##(1993-11#1)(2010-1#1)
to be a common feature of##2##6##(1991-10#1)(1991-9#1)
to be a common feature##3##5##(1991-10#1)(1991-9#1)(2008-10#1)
to be a common##16##4##(1991-10#1)(1991-4#1)(1991-9#1)(1993-11#1)(1993-2#1)(1995-1#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-1#1)(2011-1#2)
to be a competitive inhibitor of##2##6##(1992-6#1)(1997-1#1)
to be a competitive inhibitor##3##5##(1992-6#1)(1995-10#1)(1997-1#1)
to be a competitive##5##4##(1992-6#1)(1995-10#1)(1997-1#1)(2011-1#1)(2011-2#1)
to be a complex##3##4##(1992-2#1)(1995-12#1)(2008-3#1)
to be a component of##2##5##(1991-11#1)(1992-6#1)
to be a consequence of the##2##6##(1996-10#1)(1996-6#1)
to be a consequence of##6##5##(1992-6#1)(1996-10#2)(1996-6#1)(1997-3#1)(2009-12#1)
to be a constant##3##4##(1992-12#1)(2007-12#1)(2008-3#1)
to be a continuous##2##4##(2008-7#1)(2010-8#1)
to be a contributory cause##2##5##(1993-2#1)(1994-2#1)
to be a convenient##5##4##(1992-8#1)(1995-4#1)(1996-8#1)(2008-10#1)(2010-5#1)
to be a cost-effective##3##4##(2007-11#1)(2008-10#1)(2008-7#1)
to be a critical##5##4##(1990-4#1)(1994-2#1)(1996-10#1)(2007-5#1)(2010-7#1)
to be a crucial##2##4##(1991-12#1)(2010-12#1)
to be a decline in##2##5##(2007-2#1)(2010-4#1)
to be a diagnostic##2##4##(2007-7#1)(2010-8#1)
to be a direct##5##4##(1991-12#1)(1994-8#1)(1995-12#1)(2007-12#1)(2008-11#1)
to be a distinct##3##4##(2008-10#1)(2010-12#1)(2011-1#1)
to be a dominant##2##4##(2005-11#1)(2008-4#1)
to be a dynamic##2##4##(2005-7#1)(2007-10#1)
to be a factor determining##2##5##(1991-3#1)(2008-3#1)
to be a factor##8##4##(1991-3#1)(2006-8#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-1#1)(2009-2#1)
to be a fast and accurate##2##6##(2008-10#1)(2008-3#1)
to be a fast and##5##5##(2008-10#1)(2008-11#1)(2008-3#1)(2009-12#1)(2012-1#1)
to be a feasible and##2##5##(2012-12#2)
to be a feasible##3##4##(2007-11#1)(2012-12#2)
to be a form of##3##5##(1992-6#1)(2006-10#1)(2012-3#1)
to be a function of the##7##6##(1991-3#1)(1991-5#1)(2008-2#3)(2008-7#1)(2011-1#1)
to be a function of##12##5##(1991-3#1)(1991-5#1)(1993-6#1)(2006-10#1)(2008-10#3)(2008-2#3)(2008-7#1)(2011-1#1)
to be a functional##3##4##(1990-9#1)(1993-11#1)(1996-4#1)
to be a fundamental##3##4##(2007-12#1)(2008-3#1)(2011-2#1)
to be a general##9##4##(1990-11#1)(1990-12#1)(1995-1#1)(1995-3#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-8#2)
to be a good alternative to##2##6##(2007-7#1)(2009-1#1)
to be a good alternative##3##5##(2007-7#1)(2007-8#1)(2009-1#1)
to be a good candidate as a##2##7##(2008-10#1)(2010-4#1)
to be a good candidate##3##5##(1996-11#1)(2008-10#1)(2010-4#1)
to be a good indicator of the##2##7##(1997-2#1)(2008-10#1)
to be a good indicator##3##5##(1997-2#1)(2008-10#1)(2008-3#1)
to be a good predictor of##2##6##(2007-7#1)(2013-7#1)
to be a good solution in##2##6##(2007-9#1)(2009-4#1)
to be a good target for##2##6##(2008-1#1)(2008-9#1)
to be a good tool##3##5##(2008-7#1)(2009-3#1)(2009-8#1)
to be a good##34##4##(1990-7#1)(1991-4#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-9#1)(1996-11#1)(1997-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-3#3)(2008-7#1)(2008-9#1)(2009-1#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-4#2)(2013-1#1)(2013-7#1)
to be a hallmark of##2##5##(2005-10#1)(2007-10#1)
to be a hallmark##3##4##(2005-10#1)(2007-10#1)(2009-4#1)
to be a high##5##4##(1992-12#1)(1993-9#1)(1994-5#1)(2008-11#1)(2008-8#1)
to be a highly effective catalyst for the##2##8##(2008-8#1)(2010-2#1)
to be a highly effective##4##5##(2005-7#1)(2008-10#1)(2008-8#1)(2010-2#1)
to be a highly##8##4##(1991-5#1)(2005-7#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-12#1)(2010-2#1)
to be a hydrophobic##2##4##(1992-1#1)(1993-6#1)
to be a key factor in##3##6##(2003-11#1)(2008-11#1)(2010-8#1)
to be a key factor##4##5##(2003-11#1)(2008-11#1)(2009-8#1)(2010-8#1)
to be a key##10##4##(1997-8#1)(2003-11#1)(2008-11#2)(2008-5#2)(2009-8#1)(2010-8#2)(2013-8#1)
to be a lack of##5##5##(1992-8#1)(1997-8#1)(2007-1#1)(2007-2#1)(2007-9#1)
to be a large##3##4##(1992-12#1)(1997-6#1)(2007-8#1)
to be a leading##2##4##(1996-12#1)(2007-4#1)
to be a less##2##4##(1991-11#1)(1991-4#1)
to be a low-risk##2##4##(2007-11#1)(2008-8#1)
to be a main##2##4##(1994-9#1)(2008-5#1)
to be a major cause of##5##6##(1991-12#1)(1992-12#1)(1995-3#1)(2006-10#1)(2012-12#1)
to be a major component of##2##6##(2008-10#1)(2008-5#1)
to be a major determinant of##3##6##(1992-9#1)(2005-10#1)(2008-3#1)
to be a major factor in##4##6##(1992-1#1)(1994-11#1)(2008-6#1)(2013-7#1)
to be a major factor##5##5##(1991-9#1)(1992-1#1)(1994-11#1)(2008-6#1)(2013-7#1)
to be a major health##3##5##(2005-12#1)(2006-10#1)(2008-4#1)
to be a major##42##4##(1990-7#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-9#2)(1993-11#1)(1994-11#2)(1995-3#1)(1997-6#1)(2005-10#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-2#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2010-10#1)(2010-5#1)(2010-7#1)(2012-12#2)(2012-3#2)(2013-7#1)
to be a marker of##5##5##(2006-10#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-1#1)
to be a marker##6##4##(2006-10#1)(2009-10#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-1#1)
to be a member of the##5##6##(1992-3#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-5#1)
to be a member of##8##5##(1992-3#1)(1993-2#1)(1993-4#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-5#1)(2006-8#1)
to be a membrane-bound##2##4##(1990-9#1)(1996-2#1)
to be a meningioma##2##4##(2005-5#1)(2006-12#1)
to be a metastasis of##2##5##(1992-6#1)(2008-6#1)
to be a metastasis##3##4##(1992-6#1)(1993-12#1)(2008-6#1)
to be a mild##2##4##(2006-2#1)(2008-5#1)
to be a minor##2##4##(1996-12#1)(2011-12#1)
to be a molecular##2##4##(2008-4#1)(2008-6#1)
to be a more effective##2##5##(1990-11#1)(2011-2#1)
to be a more potent inhibitor of##2##7##(1994-11#1)(2008-5#1)
to be a more potent##5##5##(1990-2#1)(1994-11#1)(1996-12#1)(2008-5#2)
to be a more sensitive and##2##6##(2008-10#1)(2010-4#1)
to be a more sensitive##4##5##(1993-10#1)(1995-2#1)(2008-10#1)(2010-4#1)
to be a more##22##4##(1990-11#2)(1990-2#1)(1991-3#1)(1993-10#1)(1994-11#1)(1994-5#1)(1995-2#1)(1996-12#1)(2006-10#1)(2008-10#5)(2008-5#2)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)
to be a much##2##4##(1993-7#1)(2010-8#1)
to be a nearly##2##4##(2007-12#2)
to be a need##2##4##(1995-1#1)(2006-8#1)
to be a new##5##4##(1996-8#1)(2007-8#1)(2008-10#1)(2008-3#2)
to be a normal##2##4##(1990-11#1)(1993-4#1)
to be a novel##12##4##(1997-4#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#7)(2011-2#1)
to be a nurse?##2##4##(2005-12#1)(2013-8#1)
to be a partial##3##4##(1990-7#1)(1995-6#1)(1997-1#1)
to be a passive##2##4##(2008-3#1)(2009-7#1)
to be a positive##3##4##(2006-2#1)(2007-10#1)(2008-11#1)
to be a possible##4##4##(1990-7#1)(1992-11#1)(1995-11#1)(2011-2#1)
to be a potent inducer of##3##6##(1991-7#1)(1993-12#1)(2008-10#1)
to be a potent inhibitor of##4##6##(1990-10#1)(1992-8#1)(2006-10#1)(2008-5#1)
to be a potent##23##4##(1990-10#3)(1990-6#1)(1991-1#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-12#1)(1995-12#1)(1996-8#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-8#1)
to be a potential##4##4##(1991-10#1)(1991-2#1)(2006-8#1)(2012-2#1)
to be a powerful and##2##5##(2008-11#1)(2011-2#1)
to be a powerful determinant of##2##6##(1996-10#1)(2008-11#1)
to be a powerful means##2##5##(2008-11#1)(2008-3#1)
to be a powerful method##2##5##(1990-11#1)(1993-8#1)
to be a powerful predictor of##2##6##(1994-2#1)(2008-1#1)
to be a powerful tool for the##2##7##(2007-12#1)(2008-10#1)
to be a powerful tool for##4##6##(2007-12#2)(2008-10#1)(2008-4#1)
to be a powerful tool in##3##6##(2008-11#1)(2008-3#1)(2009-5#1)
to be a powerful tool##8##5##(1993-2#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-5#1)
to be a powerful##23##4##(1990-11#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-2#1)(1994-9#1)(1996-10#1)(2006-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#4)(2008-3#3)(2008-4#1)(2009-5#1)(2011-2#1)
to be a practical and##2##5##(2007-11#1)(2008-2#1)
to be a practical##5##4##(1997-2#1)(2007-11#1)(2008-2#1)(2008-3#1)(2009-5#1)
to be a precursor##2##4##(1992-11#1)(2008-3#1)
to be a predictable##2##4##(2007-12#1)(2012-1#1)
to be a prerequisite for##3##5##(1992-1#1)(1995-1#1)(1997-1#1)
to be a prerequisite##4##4##(1991-2#1)(1992-1#1)(1995-1#1)(1997-1#1)
to be a primary source of##2##6##(1995-1#1)(2010-2#1)
to be a primary##6##4##(1992-4#1)(1993-12#1)(1995-1#1)(2008-10#1)(2010-2#1)(2010-3#1)
to be a priority##2##4##(2007-6#1)(2008-11#1)
to be a problem for##2##5##(1993-9#1)(2008-10#1)
to be a problem in##2##5##(1991-12#1)(2007-8#1)
to be a problem##5##4##(1991-12#1)(1993-9#1)(2007-8#1)(2008-10#1)(2008-3#1)
to be a procedure##2##4##(2006-8#1)(2012-3#1)
to be a product##2##4##(1991-12#1)(1994-12#1)
to be a promising addition to##2##6##(1992-4#1)(2008-5#1)
to be a promising alternative##2##5##(1997-4#1)(2008-2#1)
to be a promising approach##2##5##(2008-5#1)(2010-9#1)
to be a promising therapeutic##4##5##(2008-5#1)(2009-8#1)(2011-2#1)(2012-11#1)
to be a promising tool to##2##6##(1997-4#1)(2006-12#1)
to be a promising tool##3##5##(1992-6#1)(1997-4#1)(2006-12#1)
to be a promising##26##4##(1990-11#1)(1991-2#1)(1992-4#1)(1992-6#1)(1995-1#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-4#2)(2006-12#2)(2008-2#1)(2008-3#2)(2008-5#3)(2008-9#1)(2009-8#1)(2010-11#1)(2010-9#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-11#1)
to be a prophylactic##2##4##(1990-2#1)(2007-8#1)
to be a protective##3##4##(1993-6#1)(1994-6#1)(2011-1#1)
to be a pseudogene##2##4##(1994-6#1)(1997-2#1)
to be a rapid and##2##5##(2007-11#1)(2008-10#1)
to be a rapid##5##4##(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)
to be a rare##5##4##(2006-10#1)(2006-5#1)(2007-7#1)(2008-1#1)(2010-7#1)
to be a rational##2##4##(1990-5#1)(2009-5#1)
to be a reasonable##5##4##(1992-3#1)(1993-1#1)(2006-10#1)(2012-2#1)(2013-7#1)
to be a record##2##4##(2007-11#1)(2007-12#1)
to be a relatively safe##2##5##(2007-1#1)(2012-2#1)
to be a relatively##3##4##(2007-1#1)(2012-2#1)(2013-1#1)
to be a reliable and##3##5##(1993-9#1)(2008-11#1)(2008-12#1)
to be a reliable technique##2##5##(1996-6#1)(2012-2#1)
to be a reliable##15##4##(1993-7#1)(1993-9#1)(1994-2#1)(1995-12#1)(1996-6#1)(2004-9#1)(2006-3#1)(2006-6#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2012-2#1)
to be a research##2##4##(1993-3#1)(2008-3#1)
to be a result of the##2##6##(2008-11#1)(2010-12#1)
to be a result of##8##5##(1993-12#1)(1993-9#1)(1995-6#1)(2007-12#1)(2008-11#1)(2009-2#1)(2010-12#1)(2012-12#1)
to be a rich source of##2##6##(1994-3#1)(2007-1#1)
to be a risk factor for##4##6##(1991-10#1)(2006-10#2)(2010-4#1)
to be a risk factor in##2##6##(1991-4#1)(1992-3#1)
to be a risk factor##7##5##(1991-10#1)(1991-4#1)(1992-3#1)(1996-8#1)(2006-10#2)(2010-4#1)
to be a robust##3##4##(2008-10#1)(2008-2#1)(2012-2#1)
to be a safe and effective technique for the##2##9##(2006-10#1)(2006-8#1)
to be a safe and effective technique##4##7##(2006-10#1)(2006-6#1)(2006-8#1)(2011-2#1)
to be a safe and effective##7##6##(2006-1#1)(2006-10#1)(2006-6#1)(2006-8#1)(2006-9#1)(2011-2#2)
to be a safe and potentially##2##6##(2006-10#1)(2007-10#1)
to be a safe and##13##5##(1990-11#1)(1996-9#1)(2006-1#1)(2006-10#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#1)(2011-2#2)(2012-12#1)
to be a safe procedure##2##5##(1993-8#1)(2011-12#1)
to be a safe##22##4##(1990-11#1)(1992-2#1)(1992-3#1)(1993-8#1)(1996-9#1)(2006-1#1)(2006-10#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-8#1)(2009-8#1)(2010-7#1)(2011-12#1)(2011-2#3)(2012-12#1)(2013-8#1)
to be a selective##3##4##(1992-3#1)(2007-1#1)(2008-10#1)
to be a sensitive and##2##5##(1994-11#1)(2008-10#1)
to be a sensitive indicator of##2##6##(2005-8#1)(2008-7#1)
to be a sensitive##11##4##(1994-11#1)(1994-8#1)(1996-9#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-2#1)(2012-12#1)(2012-3#1)
to be a serious##3##4##(2008-12#1)(2009-9#1)(2010-5#1)
to be a sign of##3##5##(1990-3#1)(2007-2#1)(2008-10#1)
to be a significant clinical##2##5##(1993-9#1)(1995-3#1)
to be a significant factor##3##5##(2007-2#1)(2007-4#1)(2008-6#1)
to be a significant predictor of##2##6##(1991-3#1)(1996-3#1)
to be a significant risk factor for##2##7##(2006-8#1)(2007-11#1)
to be a significant source of##2##6##(1995-3#1)(2012-2#1)
to be a significant##23##4##(1991-3#1)(1991-4#1)(1993-9#1)(1995-3#2)(1996-12#1)(1996-3#1)(1996-7#1)(2006-11#1)(2006-8#1)(2007-1#2)(2007-11#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-7#2)(2011-2#1)(2012-2#1)(2013-8#1)
to be a simple and##4##5##(1993-5#1)(1995-2#1)(2006-5#1)(2012-2#1)
to be a simple##8##4##(1993-5#1)(1995-2#1)(2004-12#1)(2006-5#1)(2007-8#1)(2008-10#2)(2012-2#1)
to be a single##6##4##(1990-11#1)(1990-3#1)(1994-8#1)(1995-8#1)(2007-7#1)(2011-2#1)
to be a source of##3##5##(2006-10#1)(2008-10#1)(2010-6#1)
to be a specific##6##4##(1990-7#1)(1991-6#1)(1992-11#1)(1992-6#1)(2007-11#1)(2010-1#1)
to be a standard##2##4##(1994-1#1)(2010-9#1)
to be a strong##6##4##(1997-7#1)(2007-12#1)(2008-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
to be a substantial##3##4##(1991-12#1)(2006-7#1)(2008-3#1)
to be a substrate for##4##5##(1992-2#1)(1995-2#1)(1996-1#1)(2013-1#1)
to be a subunit of##2##5##(1994-9#1)(1995-5#1)
to be a successful##2##4##(2005-10#1)(2009-8#1)
to be a suitable replacement for##2##6##(2008-11#1)(2008-5#1)
to be a suitable##14##4##(1994-10#1)(1997-7#1)(2004-1#1)(2006-10#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-5#1)(2009-7#1)(2012-1#1)(2013-8#1)
to be a superior##2##4##(1996-12#1)(2007-8#1)
to be a trophic factor##2##5##(1994-5#1)(1997-6#1)
to be a tumor##2##4##(1992-5#1)(1993-9#1)
to be a unique##2##4##(1997-1#1)(1997-6#1)
to be a useful marker##2##5##(1994-3#1)(2008-4#1)
to be a useful option in the##2##7##(2006-12#1)(2007-12#1)
to be a useful tool for##4##6##(1990-2#1)(1994-7#1)(1995-11#1)(2006-12#1)
to be a useful tool in the##3##7##(1994-3#1)(1996-9#1)(2008-2#1)
to be a useful tool in##9##6##(1991-11#1)(1992-1#1)(1994-3#1)(1996-9#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-7#1)(2012-2#1)
to be a useful tool to##4##6##(2006-2#1)(2008-10#1)(2011-2#1)(2012-12#1)
to be a useful tool##17##5##(1990-2#1)(1991-11#1)(1992-1#1)(1994-3#1)(1994-7#1)(1995-11#1)(1996-9#1)(2006-12#1)(2006-2#1)(2008-10#2)(2008-2#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
to be a useful##42##4##(1990-1#1)(1990-2#1)(1991-11#1)(1992-1#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-7#1)(1995-11#1)(1995-3#1)(1996-9#1)(1997-3#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)
to be a valid##4##4##(2007-8#1)(2008-10#1)(2008-3#1)(2012-11#1)
to be a valuable model##2##5##(1992-4#1)(1995-8#1)
to be a valuable tool##2##5##(2007-8#1)(2010-5#1)
to be a valuable##10##4##(1992-4#1)(1994-6#1)(1995-8#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-11#1)(2010-5#1)(2010-7#1)(2013-8#1)
to be a very sensitive##3##5##(1993-12#1)(1996-1#1)(2008-10#1)
to be a very useful##4##5##(1990-11#1)(1996-12#1)(2005-7#1)(2006-5#1)
to be a very##27##4##(1990-10#1)(1990-11#1)(1990-9#2)(1991-2#1)(1991-5#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-8#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2012-12#1)(2012-2#2)
to be a viable alternative to##2##6##(2008-10#2)
to be a viable##8##4##(1994-6#1)(2005-11#1)(2007-5#1)(2008-10#3)(2008-11#1)(2013-1#1)
to be a vital##2##4##(1991-11#1)(2008-9#1)
to be a##1152##3##(1990-1#1)(1990-10#5)(1990-11#10)(1990-12#4)(1990-2#5)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#10)(1990-8#2)(1990-9#6)(1991-1#2)(1991-10#4)(1991-11#5)(1991-12#11)(1991-2#4)(1991-3#6)(1991-4#6)(1991-5#6)(1991-6#3)(1991-7#2)(1991-8#2)(1991-9#3)(1992-1#7)(1992-11#5)(1992-12#8)(1992-2#3)(1992-3#7)(1992-4#3)(1992-5#1)(1992-6#8)(1992-8#6)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#5)(1993-12#7)(1993-2#5)(1993-3#2)(1993-4#3)(1993-5#2)(1993-6#4)(1993-7#2)(1993-8#3)(1993-9#7)(1994-1#2)(1994-10#1)(1994-11#10)(1994-12#8)(1994-2#8)(1994-3#6)(1994-4#1)(1994-5#7)(1994-6#8)(1994-7#1)(1994-8#5)(1994-9#5)(1995-1#8)(1995-10#2)(1995-11#3)(1995-12#7)(1995-2#6)(1995-3#7)(1995-4#2)(1995-5#4)(1995-6#3)(1995-8#4)(1996-1#5)(1996-10#4)(1996-11#1)(1996-12#8)(1996-2#4)(1996-3#3)(1996-4#3)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#8)(1996-9#3)(1997-1#9)(1997-2#5)(1997-3#4)(1997-4#7)(1997-5#1)(1997-6#6)(1997-7#3)(1997-8#6)(2003-11#1)(2004-1#1)(2004-12#2)(2004-3#1)(2004-7#1)(2004-8#1)(2004-9#2)(2005-10#5)(2005-11#6)(2005-12#2)(2005-5#1)(2005-7#6)(2005-8#4)(2006-1#3)(2006-10#37)(2006-11#2)(2006-12#10)(2006-2#5)(2006-3#3)(2006-5#4)(2006-6#3)(2006-7#4)(2006-8#11)(2006-9#2)(2007-1#9)(2007-10#4)(2007-11#20)(2007-12#19)(2007-2#9)(2007-3#3)(2007-4#3)(2007-5#3)(2007-6#3)(2007-7#9)(2007-8#19)(2007-9#7)(2008-1#11)(2008-10#86)(2008-11#29)(2008-12#6)(2008-2#21)(2008-3#37)(2008-4#12)(2008-5#22)(2008-6#14)(2008-7#16)(2008-8#13)(2008-9#8)(2009-1#3)(2009-10#6)(2009-12#5)(2009-2#4)(2009-3#3)(2009-4#4)(2009-5#6)(2009-6#2)(2009-7#6)(2009-8#10)(2009-9#4)(2010-1#2)(2010-10#5)(2010-11#2)(2010-12#12)(2010-2#5)(2010-3#3)(2010-4#7)(2010-5#7)(2010-6#6)(2010-7#8)(2010-8#10)(2010-9#3)(2011-1#12)(2011-12#4)(2011-2#23)(2011-7#1)(2012-1#7)(2012-11#4)(2012-12#14)(2012-2#24)(2012-3#10)(2013-1#17)(2013-7#6)(2013-8#16)
to be aberrant in##2##4##(1993-8#1)(2008-5#1)
to be able to bind##4##5##(1990-2#1)(1994-11#1)(1994-9#1)(2008-10#1)
to be able to control##2##5##(1994-6#1)(2006-12#1)
to be able to detect##2##5##(1995-7#1)(2012-2#1)
to be able to distinguish##3##5##(2006-8#1)(2008-2#1)(2013-1#1)
to be able to enhance##2##5##(2006-10#1)(2008-10#1)
to be able to examine##2##5##(1993-12#1)(2006-5#1)
to be able to identify##5##5##(1993-3#1)(2008-11#1)(2008-7#2)(2013-8#1)
to be able to improve##2##5##(2006-2#1)(2012-12#1)
to be able to interact with##4##6##(2008-8#1)(2012-12#1)(2013-1#2)
to be able to make##3##5##(1996-3#1)(1996-8#1)(2008-12#1)
to be able to perform##2##5##(1990-4#1)(2008-3#1)
to be able to provide complete##2##6##(2008-12#1)(2012-11#1)
to be able to provide##7##5##(1992-9#1)(1995-3#1)(2008-10#1)(2008-12#1)(2012-11#1)(2013-1#1)(2013-8#1)
to be able to respond to##2##6##(2005-5#1)(2011-2#1)
to be able to##100##4##(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-6#1)(1994-9#2)(1995-12#1)(1995-3#1)(1995-5#2)(1995-7#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#2)(1997-1#1)(2005-5#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#4)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#4)(2013-8#3)
to be able##102##3##(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-6#1)(1994-9#2)(1995-12#1)(1995-3#1)(1995-5#2)(1995-7#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#2)(1997-1#1)(2005-5#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#4)(2008-10#8)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#4)(2013-8#3)
to be abnormal in##2##4##(1991-12#1)(2008-12#1)
to be abnormal##5##3##(1991-12#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-12#1)
to be about 0##2##4##(1992-1#1)(2008-10#1)
to be about 3##2##4##(1990-10#1)(2007-12#1)
to be about##23##3##(1990-10#1)(1990-6#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-4#1)(1993-3#2)(1993-4#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-5#1)(1996-6#1)(1997-8#1)(2005-11#1)(2006-3#1)(2007-12#1)(2008-10#2)(2008-8#1)(2011-2#1)(2013-8#1)
to be absent in##3##4##(1990-9#1)(2004-9#1)(2011-1#1)
to be absent##6##3##(1990-9#1)(1994-3#1)(1996-6#1)(2004-9#1)(2008-11#1)(2011-1#1)
to be absorbed##2##3##(2008-10#1)(2008-5#1)
to be abundant in##2##4##(1990-7#1)(1993-7#1)
to be acceptable to##2##4##(1993-3#1)(2013-1#1)
to be acceptable##9##3##(1993-3#1)(2006-6#1)(2007-12#1)(2007-4#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
to be accepted by##2##4##(2007-7#1)(2011-2#1)
to be accepted##5##3##(2005-7#1)(2007-7#2)(2009-4#1)(2011-2#1)
to be accessible##2##3##(1995-2#1)(2012-3#1)
to be accommodated##3##3##(1994-11#1)(1997-3#1)(2008-11#1)
to be accompanied by##5##4##(1991-6#1)(1992-8#1)(1993-11#1)(2007-11#1)(2007-4#1)
to be accomplished##2##3##(2006-10#1)(2008-11#1)
to be accounted for##3##4##(2006-2#1)(2008-2#1)(2009-5#1)
to be accurate##16##3##(1995-11#1)(2004-10#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#2)(2010-11#1)(2010-2#1)(2010-8#1)(2012-12#2)(2012-2#1)
to be accurately##3##3##(2008-10#1)(2008-2#1)(2008-9#1)
to be achievable##3##3##(1996-12#1)(2007-12#1)(2008-2#1)
to be achieved by##2##4##(2012-12#1)(2013-1#1)
to be achieved in a single##2##6##(2008-7#1)(2013-1#1)
to be achieved in##3##4##(1992-9#1)(2008-7#1)(2013-1#1)
to be achieved using##2##4##(2007-8#1)(2011-1#1)
to be achieved##21##3##(1992-2#1)(1992-9#1)(1994-8#1)(1995-2#1)(1996-3#1)(1996-8#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-12#2)(2013-1#3)
to be acknowledged and##2##4##(2012-2#1)(2012-3#1)
to be acknowledged##3##3##(2006-10#1)(2012-2#1)(2012-3#1)
to be acquired##2##3##(2004-9#1)(2011-1#1)
to be activated by the##3##5##(1995-6#1)(1996-8#1)(2008-11#1)
to be activated by##11##4##(1992-7#1)(1993-12#1)(1994-5#1)(1995-6#3)(1996-8#1)(1997-6#2)(2008-11#1)(2013-8#1)
to be activated##17##3##(1990-9#1)(1992-7#1)(1993-12#1)(1993-3#1)(1994-5#1)(1995-6#3)(1996-5#1)(1996-8#1)(1997-6#2)(2006-10#1)(2008-11#1)(2009-5#1)(2010-7#1)(2013-8#1)
to be active against##6##4##(1996-2#1)(2007-11#2)(2008-5#1)(2008-8#1)(2011-1#1)
to be active as##3##4##(1991-7#1)(1992-10#1)(1994-3#1)
to be active in##6##4##(1995-3#1)(1997-4#1)(2006-8#1)(2008-5#1)(2008-6#1)(2010-2#1)
to be active##27##3##(1991-7#1)(1992-10#1)(1994-3#1)(1995-3#2)(1996-2#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(2006-8#1)(2007-11#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-6#1)(2008-8#2)(2009-3#1)(2010-2#1)(2011-1#2)
to be actively##2##3##(1990-10#1)(1990-9#1)
to be adapted to##6##4##(2005-12#1)(2008-10#1)(2008-7#1)(2009-8#1)(2012-12#1)(2013-1#1)
to be adapted##9##3##(2005-12#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-8#1)(2012-12#1)(2013-1#1)
to be adaptive##2##3##(2008-9#1)(2009-6#1)
to be added to the##4##5##(2006-5#1)(2008-11#1)(2008-2#2)
to be added to##7##4##(1995-2#1)(2006-5#1)(2008-11#1)(2008-2#2)(2008-7#1)(2010-4#1)
to be added##15##3##(1990-8#1)(1994-6#1)(1995-2#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-7#2)(2010-4#1)(2012-2#1)
to be addressed are##3##4##(2008-11#1)(2009-3#1)(2011-2#1)
to be addressed before##3##4##(2010-10#2)(2011-2#1)
to be addressed by health##2##5##(1991-3#1)(1996-2#1)
to be addressed by##3##4##(1991-3#1)(1996-2#1)(2012-2#1)
to be addressed for the administrative##4##6##(2013-8#4)
to be addressed for##6##4##(2007-12#1)(2009-3#1)(2013-8#4)
to be addressed from a##2##5##(1994-2#1)(2006-2#1)
to be addressed in future##3##5##(1990-12#1)(2011-2#1)(2012-2#1)
to be addressed in order to##3##6##(1994-1#1)(2006-5#1)(2006-6#1)
to be addressed in the##5##5##(1992-9#1)(1994-12#1)(1997-5#1)(2008-4#1)(2008-7#1)
to be addressed in##16##4##(1990-12#1)(1992-9#1)(1994-1#1)(1994-12#1)(1997-2#1)(1997-5#1)(2006-12#1)(2006-5#1)(2006-6#1)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
to be addressed when##2##4##(2008-10#1)(2008-9#1)
to be addressed##80##3##(1990-12#1)(1991-3#1)(1992-9#1)(1993-11#1)(1993-3#2)(1994-1#4)(1994-12#2)(1994-2#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-5#1)(2004-12#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#2)(2009-3#2)(2009-7#1)(2010-10#2)(2010-3#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-12#2)(2012-2#2)(2013-1#4)(2013-8#15)
to be adequate for##4##4##(1996-12#1)(2008-10#2)(2013-7#1)
to be adequate to##2##4##(2007-8#1)(2008-10#1)
to be adequate##12##3##(1990-12#1)(1991-12#1)(1996-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-7#1)
to be adequately##4##3##(2006-10#1)(2007-9#1)(2008-10#1)(2008-6#1)
to be adjusted to##2##4##(1996-6#1)(2008-12#1)
to be adjusted##4##3##(1996-6#1)(2007-12#1)(2008-12#1)(2012-12#1)
to be administered in##2##4##(1992-2#1)(1995-5#1)
to be administered##8##3##(1992-2#1)(1992-8#2)(1995-5#1)(2007-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
to be admitted##4##3##(1990-3#1)(1993-4#1)(1996-3#1)(2007-12#1)
to be adopted##4##3##(1994-4#1)(2007-4#1)(2011-1#1)(2013-8#1)
to be advantageous for##2##4##(2008-12#1)(2008-3#1)
to be advantageous in##2##4##(2006-10#1)(2008-8#1)
to be advantageous##7##3##(2006-10#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
to be adverse##2##3##(2008-7#1)(2009-10#1)
to be affected by a##2##5##(1990-2#1)(1994-11#1)
to be affected by the##4##5##(1992-12#1)(1995-1#1)(1995-3#1)(2007-7#1)
to be affected by##19##4##(1990-2#1)(1992-11#1)(1992-12#1)(1993-6#1)(1994-11#1)(1995-1#1)(1995-3#1)(1997-4#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
to be affected in##3##4##(1992-3#1)(1997-1#1)(2012-3#1)
to be affected##26##3##(1990-2#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-6#1)(1994-11#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-4#1)(2006-10#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-10#1)(2011-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
to be alert to##3##4##(2006-8#1)(2008-8#1)(2012-2#1)
to be alert##6##3##(2006-10#1)(2006-8#1)(2008-12#1)(2008-8#1)(2009-9#1)(2012-2#1)
to be aligned##2##3##(1995-1#1)(2011-1#1)
to be allergic to##2##4##(1992-6#1)(2006-10#1)
to be allergic##3##3##(1992-6#1)(1995-3#1)(2006-10#1)
to be allowed to##2##4##(2009-7#1)(2012-3#1)
to be almost identical to##3##5##(1991-2#1)(1996-5#1)(2013-1#1)
to be almost identical##4##4##(1991-2#1)(1995-7#1)(1996-5#1)(2013-1#1)
to be almost##11##3##(1991-2#1)(1991-4#1)(1991-8#1)(1993-5#1)(1994-9#1)(1995-7#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-11#1)(2013-1#1)
to be also useful in##2##5##(1994-6#1)(2008-10#1)
to be also useful##3##4##(1994-6#1)(2008-10#1)(2008-11#1)
to be also##9##3##(1991-9#1)(1994-6#1)(1994-9#1)(1996-2#1)(2008-10#2)(2008-11#1)(2010-4#1)(2013-8#1)
to be altered by##4##4##(1993-12#1)(2007-11#1)(2008-1#1)(2012-12#1)
to be altered in##6##4##(1990-6#1)(1994-3#1)(1996-12#1)(2008-11#1)(2008-6#1)(2010-12#1)
to be altered##14##3##(1990-6#1)(1993-12#1)(1993-7#1)(1994-3#1)(1996-12#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-6#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-2#1)
to be always##2##3##(1994-9#1)(2005-3#1)
to be among the best##2##5##(1996-9#1)(2006-10#1)
to be among the most##5##5##(1994-9#1)(2008-1#1)(2008-11#1)(2008-5#1)(2013-7#1)
to be among the##8##4##(1994-9#1)(1996-9#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2013-7#1)
to be amongst the##2##4##(2008-7#1)(2011-2#1)
to be amorphous##4##3##(2005-11#1)(2007-12#1)(2008-10#2)
to be an absolute requirement##2##5##(1991-7#1)(1992-1#1)
to be an accurate##2##4##(2007-11#1)(2008-5#1)
to be an active##3##4##(1992-2#1)(1993-9#1)(2006-10#1)
to be an additional##2##4##(1994-11#1)(1995-3#1)
to be an adequate##3##4##(2007-12#1)(2008-11#1)(2008-3#1)
to be an adrenergic##2##4##(1993-3#1)(1994-8#1)
to be an aggressive##2##4##(2006-10#1)(2013-8#1)
to be an alternative##3##4##(2008-10#1)(2008-5#1)(2013-1#1)
to be an antagonist##2##4##(1995-3#1)(1996-12#1)
to be an appropriate##5##4##(1990-12#1)(2006-7#1)(2007-10#1)(2008-9#1)(2013-1#1)
to be an attractive alternative##2##5##(2008-10#1)(2008-11#1)
to be an attractive##4##4##(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)
to be an early##4##4##(1994-11#1)(1994-2#1)(2007-10#1)(2012-12#1)
to be an easier##2##4##(2006-8#1)(2007-7#1)
to be an economic##2##4##(2008-10#1)(2010-9#1)
to be an effective alternative##2##5##(2007-11#1)(2008-5#1)
to be an effective and safe##3##6##(2004-10#1)(2007-7#1)(2008-12#1)
to be an effective and##5##5##(2004-10#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-12#1)
to be an effective means##3##5##(1994-11#1)(2006-10#1)(2007-12#1)
to be an effective method for##2##6##(1992-1#1)(2011-2#1)
to be an effective method of##3##6##(1991-7#1)(2005-11#1)(2008-10#1)
to be an effective method##6##5##(1991-7#1)(1992-1#1)(2005-11#1)(2008-10#2)(2011-2#1)
to be an effective tool for##2##6##(2008-10#1)(2010-5#1)
to be an effective tool##3##5##(2008-10#2)(2010-5#1)
to be an effective treatment of##3##6##(2006-10#1)(2006-3#1)(2006-6#1)
to be an effective treatment##7##5##(1992-8#1)(1997-6#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-7#1)(2008-7#1)
to be an effective way to##2##6##(2005-11#1)(2010-2#1)
to be an effective way##3##5##(2005-11#1)(2010-2#1)(2010-8#1)
to be an effective##50##4##(1990-10#1)(1991-10#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-2#1)(1992-8#1)(1993-7#1)(1994-11#1)(1994-9#1)(1997-1#1)(1997-6#1)(2004-10#1)(2004-11#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-3#1)(2006-6#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#2)(2008-10#7)(2008-11#1)(2008-12#3)(2008-5#1)(2008-7#2)(2010-2#1)(2010-5#1)(2010-8#2)(2011-2#2)
to be an efficient and##2##5##(2007-8#1)(2013-8#1)
to be an efficient means##3##5##(2006-4#1)(2007-8#1)(2008-2#1)
to be an efficient##16##4##(1990-4#1)(1991-12#1)(1991-7#1)(1993-11#1)(1994-3#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-2#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
to be an essential component of the##2##7##(1991-6#1)(1994-11#1)
to be an essential component of##5##6##(1991-6#1)(1992-1#1)(1994-11#1)(2006-2#1)(2013-8#1)
to be an essential##12##4##(1991-6#1)(1992-1#1)(1993-12#1)(1994-11#1)(1994-12#1)(1995-3#1)(1996-2#1)(2006-2#1)(2007-1#1)(2007-11#1)(2008-5#1)(2013-8#1)
to be an excellent##7##4##(1995-2#1)(2005-9#1)(2007-12#1)(2008-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
to be an extremely##3##4##(1991-5#1)(2008-4#1)(2008-8#1)
to be an ideal##4##4##(1993-4#1)(2005-7#1)(2011-1#1)(2012-2#1)
to be an important cause of##4##6##(2005-8#1)(2007-8#1)(2008-4#1)(2009-7#1)
to be an important component##2##5##(2005-10#1)(2008-10#1)
to be an important determinant of##7##6##(1990-12#1)(1990-2#1)(1994-5#1)(1994-9#1)(2008-7#2)(2009-12#1)
to be an important factor for##3##6##(2005-8#1)(2007-9#1)(2008-6#1)
to be an important factor in the development##2##8##(1993-9#1)(1997-5#1)
to be an important factor in the##3##7##(1990-10#1)(1993-9#1)(1997-5#1)
to be an important factor in##5##6##(1990-10#1)(1993-9#1)(1996-12#1)(1997-5#1)(2007-6#1)
to be an important factor##12##5##(1990-10#1)(1992-3#1)(1993-9#1)(1996-12#1)(1997-5#1)(2005-8#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-9#1)(2008-6#1)(2009-11#1)
to be an important mechanism##3##5##(1993-2#1)(2008-10#2)
to be an important process##2##5##(1995-3#1)(2008-10#1)
to be an important step in##2##6##(1995-6#1)(2008-3#1)
to be an important step##3##5##(1995-6#1)(2006-2#1)(2008-3#1)
to be an important therapeutic##2##5##(2007-11#1)(2008-5#1)
to be an important tool##3##5##(1991-3#1)(2007-1#1)(2009-7#1)
to be an important##67##4##(1990-10#1)(1990-12#1)(1990-2#1)(1991-10#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-2#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-5#1)(2005-10#1)(2005-8#2)(2006-10#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
to be an increase##3##4##(1990-10#1)(1992-2#1)(2008-5#1)
to be an independent risk factor for##2##7##(2006-10#1)(2010-2#1)
to be an independent##5##4##(1995-4#1)(2006-10#1)(2008-7#1)(2010-2#1)(2012-12#1)
to be an innovative##2##4##(1992-12#1)(2011-1#1)
to be an integral membrane protein##3##6##(1990-11#1)(1990-12#1)(1997-1#1)
to be an integral part of the##2##7##(2007-3#1)(2009-3#1)
to be an integral part of##4##6##(1997-2#1)(2007-3#1)(2008-8#1)(2009-3#1)
to be an integral##9##4##(1990-11#1)(1990-12#1)(1994-10#1)(1997-1#1)(1997-2#1)(2007-3#1)(2008-10#1)(2008-8#1)(2009-3#1)
to be an interesting##4##4##(1997-2#1)(2007-8#1)(2008-11#1)(2012-12#1)
to be an intrinsic##2##4##(1990-11#1)(1995-12#1)
to be an overall##2##4##(1995-6#1)(2007-4#1)
to be an overview##2##4##(2008-12#1)(2008-4#1)
to be an##321##3##(1990-10#3)(1990-11#2)(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#1)(1990-8#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#5)(1992-1#8)(1992-12#1)(1992-2#4)(1992-3#3)(1992-7#1)(1992-8#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#5)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#5)(1995-4#2)(1995-6#3)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#3)(1996-5#1)(1996-7#1)(1997-1#3)(1997-2#3)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#1)(2004-10#1)(2004-11#2)(2004-3#1)(2004-4#1)(2005-10#1)(2005-11#2)(2005-7#2)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#6)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#2)(2007-1#2)(2007-10#4)(2007-11#9)(2007-12#11)(2007-2#3)(2007-3#2)(2007-4#2)(2007-6#1)(2007-7#5)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#23)(2008-11#4)(2008-12#5)(2008-2#3)(2008-3#3)(2008-4#5)(2008-5#12)(2008-6#3)(2008-7#5)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#6)(2012-12#5)(2012-2#6)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#8)
to be analysed in##2##4##(1990-9#1)(2008-11#1)
to be analysed##9##3##(1990-9#1)(1993-2#1)(1994-3#1)(1996-1#1)(2005-5#1)(2008-11#1)(2008-5#1)(2009-7#1)(2011-2#1)
to be analyzed by##2##4##(2008-8#1)(2011-2#1)
to be analyzed##8##3##(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)
to be anchored##2##3##(1992-3#1)(1997-2#1)
to be annotated##2##3##(2008-7#1)(2012-2#1)
to be answered before##3##4##(1995-8#1)(2008-5#1)(2012-1#1)
to be answered in##2##4##(1990-10#1)(2013-1#1)
to be answered##26##3##(1990-10#1)(1990-12#1)(1992-11#1)(1993-11#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-2#1)(2006-10#2)(2006-9#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#2)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
to be any##5##3##(1997-7#1)(2008-2#1)(2009-8#1)(2010-6#1)(2012-2#1)
to be applicable for the##3##5##(2007-8#1)(2008-10#1)(2010-4#1)
to be applicable for##6##4##(2007-8#1)(2008-10#2)(2008-5#1)(2009-10#1)(2010-4#1)
to be applicable in##3##4##(2007-12#1)(2008-1#1)(2008-10#1)
to be applicable to a##2##5##(2008-10#2)
to be applicable to the##2##5##(2008-10#1)(2008-5#1)
to be applicable to##11##4##(1990-6#1)(1995-1#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-5#1)(2012-12#1)
to be applicable##21##3##(1990-6#1)(1995-1#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#7)(2008-2#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-4#1)(2012-12#1)
to be applied at##3##4##(2006-12#1)(2010-8#2)
to be applied during##2##4##(2006-6#1)(2008-10#1)
to be applied for##4##4##(2005-12#1)(2008-2#1)(2008-8#1)(2012-1#1)
to be applied in##3##4##(2007-6#1)(2008-10#1)(2010-12#1)
to be applied on##2##4##(2008-4#1)(2012-1#1)
to be applied to a##2##5##(2007-11#1)(2008-3#1)
to be applied to the##8##5##(1997-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2010-8#1)
to be applied to##15##4##(1991-7#1)(1995-1#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#2)(2010-8#1)
to be applied##40##3##(1991-7#1)(1993-6#1)(1994-9#1)(1995-1#1)(1997-3#1)(1997-8#1)(2005-12#1)(2006-12#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#6)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2010-12#2)(2010-4#1)(2010-8#5)(2012-1#2)
to be appreciated##3##3##(1993-11#1)(2010-8#1)(2011-1#1)
to be approached##3##3##(1991-12#1)(2005-10#1)(2008-10#1)
to be appropriate for##5##4##(2007-12#1)(2010-1#1)(2010-12#2)(2010-2#1)
to be appropriate in##2##4##(2009-2#1)(2013-1#1)
to be appropriate##15##3##(1997-8#1)(2004-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2009-2#1)(2010-1#1)(2010-12#3)(2010-2#2)(2011-2#1)(2013-1#1)
to be appropriately##2##3##(1995-2#1)(2007-10#1)
to be approved for##2##4##(2008-1#1)(2008-3#1)
to be approved##3##3##(2005-7#1)(2008-1#1)(2008-3#1)
to be approximately 0##2##4##(1995-4#1)(2008-10#1)
to be approximately 1##2##4##(1995-4#1)(2008-2#1)
to be approximately 15##3##4##(1994-11#1)(1995-6#1)(1997-2#1)
to be approximately 3##4##4##(1993-4#1)(1995-1#1)(2008-2#2)
to be approximately 6##2##4##(1995-10#1)(2008-3#1)
to be approximately 60##2##4##(2007-12#1)(2008-3#1)
to be approximately##48##3##(1991-12#1)(1991-9#1)(1992-11#1)(1993-4#1)(1994-11#1)(1995-1#1)(1995-10#1)(1995-4#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#2)(1997-8#2)(2007-11#1)(2007-12#3)(2008-10#9)(2008-11#1)(2008-2#5)(2008-3#4)(2008-5#2)(2010-12#1)(2010-9#1)(2011-2#1)
to be arising from##2##4##(2008-7#1)(2011-2#1)
to be around##6##3##(1995-2#1)(2007-4#1)(2008-10#2)(2008-6#1)(2013-8#1)
to be as a##2##4##(2007-11#1)(2011-2#1)
to be as close as possible to##2##7##(2008-5#2)
to be as effective as##7##5##(1991-3#1)(1992-12#1)(1994-12#1)(1996-1#1)(2007-11#1)(2007-7#1)(2008-10#1)
to be as effective in reducing##2##6##(2011-11#1)(2011-2#1)
to be as effective##9##4##(1991-3#1)(1992-12#1)(1994-12#1)(1996-1#1)(2007-11#1)(2007-7#1)(2008-10#1)(2011-11#1)(2011-2#1)
to be as follows##5##4##(1994-12#1)(1994-3#1)(1996-2#1)(1997-2#1)(2008-3#1)
to be as high as##5##5##(1992-8#1)(2006-9#1)(2007-10#1)(2007-6#1)(2008-9#1)
to be as important as##2##5##(2008-11#2)
to be as important##3##4##(1995-6#1)(2008-11#2)
to be as low as##3##5##(2006-2#1)(2008-2#2)
to be as much as##2##5##(2007-12#1)(2008-1#1)
to be as potent as##2##5##(1991-12#1)(1992-7#1)
to be as##43##3##(1991-12#1)(1991-3#1)(1992-12#1)(1992-7#1)(1992-8#1)(1994-12#2)(1994-3#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-2#1)(2004-11#1)(2005-11#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#1)(2008-5#4)(2008-9#1)(2011-11#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)
to be ascertained##5##3##(1991-2#1)(1995-12#1)(2008-3#1)(2013-8#2)
to be assessed by##2##4##(1996-6#1)(1997-4#1)
to be assessed in##2##4##(2007-11#1)(2010-5#1)
to be assessed##17##3##(1993-10#1)(1993-4#1)(1995-11#1)(1996-6#1)(1997-4#2)(2005-10#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-7#1)(2010-5#1)(2010-8#1)
to be assigned to##2##4##(1994-2#1)(2008-7#1)
to be assigned##3##3##(1994-2#1)(1997-4#1)(2008-7#1)
to be assisted by##3##4##(1996-4#1)(2011-1#2)
to be assisted##4##3##(1993-9#1)(1996-4#1)(2011-1#2)
to be associated in##2##4##(1993-12#1)(2012-2#1)
to be associated to##2##4##(1996-11#1)(2008-11#1)
to be associated with a high##2##6##(1993-9#1)(1995-6#1)
to be associated with a higher##2##6##(2011-2#1)(2013-1#1)
to be associated with a large##2##6##(1990-1#1)(1997-7#1)
to be associated with a lower##2##6##(1996-9#1)(2008-7#1)
to be associated with a poor##3##6##(1994-12#1)(2007-10#1)(2007-12#1)
to be associated with a variety of##3##7##(2007-8#1)(2011-2#1)(2012-3#1)
to be associated with a##23##5##(1990-1#1)(1990-8#1)(1992-8#1)(1993-9#1)(1994-12#1)(1995-6#1)(1996-9#1)(1997-1#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-4#2)(2008-7#2)(2010-7#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
to be associated with alterations in##2##6##(1995-11#1)(2006-8#1)
to be associated with an increase in##2##7##(2007-2#1)(2010-4#1)
to be associated with an increased risk of##4##8##(1992-11#1)(2007-1#1)(2010-12#1)(2013-1#1)
to be associated with an increased##5##6##(1992-11#1)(2007-1#1)(2007-7#1)(2010-12#1)(2013-1#1)
to be associated with an##10##5##(1992-11#1)(1994-11#1)(1994-3#1)(1996-8#1)(2007-1#1)(2007-2#1)(2007-7#1)(2010-12#1)(2010-4#1)(2013-1#1)
to be associated with autism##2##5##(1997-8#1)(2009-4#1)
to be associated with cell##2##5##(1996-8#1)(2010-12#1)
to be associated with changes in##2##6##(1990-2#1)(2008-12#1)
to be associated with chronic##2##5##(2006-8#1)(2008-9#1)
to be associated with clinical##2##5##(2006-12#1)(2013-1#1)
to be associated with concurrent##2##5##(1997-5#1)(2007-6#1)
to be associated with distinct##2##5##(1991-7#1)(2013-8#1)
to be associated with high##4##5##(2007-2#1)(2007-6#1)(2008-10#1)(2010-12#1)
to be associated with increased##4##5##(2005-10#1)(2008-6#1)(2008-7#1)(2012-12#1)
to be associated with mitochondria##2##5##(2005-8#2)
to be associated with poorer##2##5##(2004-2#1)(2013-1#1)
to be associated with several##2##5##(1994-11#1)(2012-12#1)
to be associated with the##21##5##(1990-5#1)(1992-12#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-6#2)(1997-4#1)(2005-6#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-3#1)(2008-2#1)(2008-4#1)(2008-6#1)(2010-1#1)(2010-4#1)
to be associated with these##2##5##(2008-10#1)(2010-10#1)
to be associated with very##2##5##(1993-3#1)(2007-9#1)
to be associated with##192##4##(1990-1#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-7#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-11#2)(1995-5#1)(1995-6#3)(1996-8#2)(1996-9#1)(1997-1#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-1#1)(2004-12#1)(2004-2#1)(2005-10#3)(2005-11#2)(2005-6#1)(2005-8#4)(2006-10#6)(2006-12#3)(2006-6#1)(2006-8#4)(2006-9#3)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#3)(2007-2#3)(2007-3#3)(2007-6#3)(2007-7#3)(2007-8#2)(2007-9#3)(2008-1#3)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#3)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#3)(2009-12#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-4#2)(2010-7#3)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#4)
to be associated##202##3##(1990-1#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-7#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-11#2)(1995-5#1)(1995-6#3)(1996-11#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-1#1)(2004-12#1)(2004-2#1)(2005-10#3)(2005-11#2)(2005-6#1)(2005-8#4)(2006-10#6)(2006-12#3)(2006-6#1)(2006-8#4)(2006-9#3)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#3)(2007-2#4)(2007-3#3)(2007-6#3)(2007-7#3)(2007-8#2)(2007-9#3)(2008-1#3)(2008-10#5)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#3)(2009-12#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-4#2)(2010-7#3)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#7)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#4)
to be assumed##2##3##(1993-11#1)(2009-8#1)
to be assured##2##3##(1992-2#1)(2008-10#1)
to be at a##2##4##(2011-2#1)(2012-12#1)
to be at an increased risk of##2##7##(2006-10#1)(2008-4#1)
to be at greater risk##2##5##(1996-11#1)(2013-8#1)
to be at high risk##3##5##(1991-10#1)(2011-1#1)(2012-3#1)
to be at high##4##4##(1991-10#1)(1993-3#1)(2011-1#1)(2012-3#1)
to be at increased risk of##2##6##(2008-11#1)(2008-7#1)
to be at increased risk##3##5##(2007-12#1)(2008-11#1)(2008-7#1)
to be at least as effective as##4##7##(2005-11#1)(2007-10#1)(2008-4#1)(2008-5#1)
to be at least as##6##5##(2005-11#1)(2007-10#1)(2007-9#1)(2008-4#1)(2008-5#1)(2010-12#1)
to be at least in part##2##6##(1990-4#1)(1997-2#1)
to be at least##15##4##(1990-4#1)(1991-2#1)(1994-6#1)(1996-5#1)(1997-2#1)(2005-11#1)(2007-1#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-3#1)
to be at or##2##4##(1993-3#1)(2008-5#1)
to be at risk for##2##5##(2009-2#1)(2011-2#1)
to be at risk##7##4##(1990-5#1)(1997-3#1)(2005-10#1)(2009-2#1)(2010-2#1)(2011-2#1)(2012-12#1)
to be at the origin of##2##6##(2010-4#1)(2013-1#1)
to be at the##7##4##(1991-5#1)(1992-10#1)(1994-12#1)(2007-4#1)(2008-10#1)(2010-4#1)(2013-1#1)
to be at##55##3##(1990-4#1)(1990-5#3)(1991-10#1)(1991-2#1)(1991-5#1)(1992-10#1)(1993-3#2)(1994-12#1)(1994-6#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-9#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#3)(2013-1#1)(2013-8#1)
to be attached to##2##4##(1990-4#1)(2010-8#1)
to be attached##4##3##(1990-4#1)(2008-5#1)(2010-3#1)(2010-8#1)
to be attacked by##2##4##(2010-2#1)(2011-12#1)
to be attained##5##3##(1990-5#1)(2007-10#1)(2007-12#1)(2008-12#1)(2008-2#1)
to be attenuated by##2##4##(2009-7#1)(2011-2#1)
to be attenuated##3##3##(1997-8#1)(2009-7#1)(2011-2#1)
to be attributable to##3##4##(2006-10#1)(2008-5#2)
to be attributable##4##3##(1992-8#1)(2006-10#1)(2008-5#2)
to be attributed to##3##4##(1992-5#1)(2007-8#1)(2011-1#1)
to be atypical##2##3##(2007-7#1)(2007-8#1)
to be augmented##2##3##(2007-3#1)(2009-8#1)
to be automated##2##3##(2008-10#2)
to be available in the##4##5##(2007-4#1)(2008-12#3)
to be available##14##3##(1993-12#1)(1995-1#1)(1996-1#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-12#3)(2008-7#1)(2008-8#1)(2009-1#1)(2011-1#1)(2011-3#1)
to be avoided as##2##4##(2007-7#1)(2009-4#1)
to be avoided##16##3##(1992-3#2)(2004-9#1)(2005-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2009-4#1)(2013-1#1)(2013-8#1)
to be aware of and##2##5##(2007-2#1)(2007-6#1)
to be aware of the##14##5##(1996-2#2)(2007-2#1)(2007-4#2)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2012-2#2)(2012-3#1)
to be aware of##33##4##(1995-1#1)(1996-2#3)(2005-11#1)(2006-3#1)(2007-10#1)(2007-2#3)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#3)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-9#2)(2010-4#1)(2012-2#2)(2012-3#3)
to be aware that##3##4##(1993-12#1)(2012-12#1)(2012-2#1)
to be aware##39##3##(1993-12#1)(1995-1#1)(1996-2#3)(2005-11#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-2#3)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-6#1)(2009-9#2)(2010-4#1)(2012-12#1)(2012-2#3)(2012-3#3)
to be barely##2##3##(2008-10#1)(2010-11#1)
to be based on a##2##5##(1991-2#2)
to be based on##9##4##(1991-2#2)(1994-12#1)(1996-6#1)(1997-6#1)(2005-10#1)(2008-10#1)(2008-11#1)(2008-6#1)
to be based upon##2##4##(1993-2#1)(2008-4#1)
to be based##11##3##(1991-2#2)(1993-2#1)(1994-12#1)(1996-6#1)(1997-6#1)(2005-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)
to be because##3##3##(1992-12#1)(2008-5#1)(2013-8#1)
to be benchmarked##2##3##(1995-12#1)(2013-8#1)
to be beneficial and##2##4##(2007-11#1)(2007-8#1)
to be beneficial for##3##4##(1992-7#1)(2008-1#1)(2008-5#1)
to be beneficial in animal##2##5##(2007-11#1)(2008-2#1)
to be beneficial in##10##4##(2005-10#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-8#1)(2008-2#1)(2010-12#1)(2011-3#1)
to be beneficial##23##3##(1992-7#1)(1995-2#1)(2005-10#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-7#1)(2007-8#2)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#2)(2010-12#1)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
to be benign##7##3##(1996-4#1)(2003-11#1)(2007-6#1)(2008-5#1)(2012-3#2)(2013-1#1)
to be best suited##2##4##(1996-5#1)(2007-8#1)
to be best##3##3##(1996-5#1)(2007-7#1)(2007-8#1)
to be better in##3##4##(2007-11#1)(2008-1#1)(2009-3#1)
to be better suited for##2##5##(2008-1#1)(2008-10#1)
to be better than##13##4##(2006-10#1)(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#3)(2008-5#1)(2012-1#1)
to be better##27##3##(1990-9#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-1#2)(2008-10#6)(2008-2#1)(2008-3#3)(2008-5#1)(2009-3#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
to be between 0##6##4##(1990-11#2)(1992-6#1)(2006-7#1)(2008-10#2)
to be between##23##3##(1990-11#2)(1991-9#1)(1992-6#1)(1994-2#1)(1996-3#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#2)(2010-4#1)(2011-2#2)(2013-7#1)
to be biased toward##2##4##(2008-8#1)(2012-11#1)
to be bilateral##2##3##(2007-10#1)(2008-7#1)
to be bioavailable##2##3##(1994-6#1)(2005-7#1)
to be biologically active##2##4##(1990-10#1)(1993-12#1)
to be biologically plausible##2##4##(2005-10#1)(2012-2#1)
to be biologically##6##3##(1990-10#1)(1993-12#1)(2005-10#1)(2008-10#1)(2008-7#1)(2012-2#1)
to be blocked##2##3##(1994-10#1)(1994-2#1)
to be borne##3##3##(1994-9#1)(1995-2#1)(2008-1#1)
to be both effective and safe##2##6##(2007-6#1)(2011-2#1)
to be both effective and##4##5##(1991-11#1)(2007-6#1)(2008-10#1)(2011-2#1)
to be both##18##3##(1990-3#1)(1991-11#1)(1993-12#1)(1993-5#1)(1996-5#1)(1997-4#1)(2006-10#1)(2006-7#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-10#3)(2009-5#1)(2011-2#2)
to be bound to the##2##5##(1992-7#1)(1994-8#1)
to be bound##6##3##(1990-12#1)(1992-7#2)(1994-8#1)(1995-9#1)(2010-11#1)
to be broadly##2##3##(2009-3#1)(2009-4#1)
to be broken##3##3##(1993-10#1)(2008-8#1)(2011-2#1)
to be brought##2##3##(2006-11#1)(2008-10#1)
to be built up##2##4##(2006-6#1)(2008-7#1)
to be built##5##3##(2006-6#1)(2007-4#1)(2008-2#1)(2008-7#1)(2011-1#1)
to be calculated##9##3##(1996-4#1)(2008-10#1)(2008-2#1)(2008-3#4)(2010-5#1)(2011-1#1)
to be capable of##25##4##(1991-1#1)(1991-10#1)(1993-12#1)(1994-9#1)(1995-3#1)(1997-8#1)(2005-12#1)(2006-6#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
to be captured and##2##4##(2008-12#1)(2012-2#1)
to be captured##3##3##(2007-12#1)(2008-12#1)(2012-2#1)
to be cared for##2##4##(2008-3#1)(2008-8#1)
to be carefully considered##2##4##(1995-11#1)(2007-11#1)
to be carefully controlled##2##4##(2008-10#1)(2008-7#1)
to be carefully monitored##2##4##(2006-6#1)(2007-10#1)
to be carefully##13##3##(1990-12#1)(1995-11#1)(1995-2#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#3)(2008-8#1)(2013-8#1)
to be carried out by##2##5##(2008-10#2)
to be carried out for##2##5##(1993-8#1)(2008-10#1)
to be carried out in##3##5##(2005-12#1)(2008-10#1)(2008-2#1)
to be carried out##13##4##(1993-8#1)(2005-12#2)(2008-10#6)(2008-12#1)(2008-2#1)(2010-12#1)(2013-1#1)
to be carried##15##3##(1993-8#1)(2005-12#2)(2006-5#1)(2008-10#6)(2008-12#1)(2008-2#1)(2010-12#1)(2012-2#1)(2013-1#1)
to be catalysed by##2##4##(1991-2#1)(2008-10#1)
to be catalytically##4##3##(1990-7#1)(1994-8#1)(1994-9#1)(2006-10#1)
to be causally##2##3##(1992-9#1)(2006-10#1)
to be causative##2##3##(1994-5#1)(2005-7#1)
to be caused by a##8##5##(1994-9#1)(1995-5#1)(1996-6#1)(1997-6#1)(2006-5#1)(2008-10#1)(2008-11#1)(2009-6#1)
to be caused by mutations in##2##6##(2008-4#1)(2010-12#1)
to be caused by the##7##5##(1995-8#1)(1996-6#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-5#1)(2010-3#1)
to be caused by##41##4##(1990-11#1)(1992-1#2)(1993-2#1)(1994-4#1)(1994-9#3)(1995-5#1)(1995-8#1)(1995-9#1)(1996-5#1)(1996-6#2)(1997-6#1)(2006-10#3)(2006-5#1)(2006-8#2)(2007-11#2)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#2)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#1)
to be caused##44##3##(1990-11#1)(1992-1#2)(1993-2#1)(1994-4#1)(1994-9#4)(1995-5#1)(1995-8#1)(1995-9#1)(1996-5#1)(1996-6#2)(1997-6#1)(2006-10#4)(2006-5#1)(2006-8#2)(2007-11#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#2)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#1)
to be cautious when##2##4##(2007-9#1)(2008-3#1)
to be cautious while using##2##5##(1992-11#1)(2012-2#1)
to be cautious##5##3##(1992-11#1)(2007-9#1)(2008-3#1)(2008-7#1)(2012-2#1)
to be central to##3##4##(1995-3#1)(2008-9#1)(2012-12#1)
to be central##4##3##(1995-3#1)(1997-1#1)(2008-9#1)(2012-12#1)
to be challenging##4##3##(1995-3#1)(2009-12#1)(2011-1#1)(2013-1#1)
to be changed##6##3##(1991-12#1)(1996-1#1)(2007-12#1)(2007-7#1)(2008-3#1)(2009-12#1)
to be characterised##3##3##(1996-12#1)(2009-9#1)(2011-2#1)
to be characteristic for##2##4##(2006-12#1)(2012-2#1)
to be characteristic of##4##4##(1995-8#1)(1997-5#1)(2008-5#1)(2009-4#1)
to be characteristic##7##3##(1995-8#1)(1997-5#1)(2006-12#1)(2008-10#1)(2008-5#1)(2009-4#1)(2012-2#1)
to be characterized by a##3##5##(1990-4#1)(2008-11#1)(2008-6#1)
to be characterized by##9##4##(1990-3#1)(1990-4#1)(1992-8#1)(1996-1#1)(2008-11#1)(2008-6#1)(2012-1#1)(2012-12#1)(2013-8#1)
to be characterized##19##3##(1990-3#1)(1990-4#1)(1992-8#1)(1994-3#1)(1994-5#1)(1996-1#1)(1996-5#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2010-9#1)(2012-1#1)(2012-12#1)(2013-8#3)
to be checked and##2##4##(2005-9#1)(2008-3#1)
to be checked##3##3##(1990-8#1)(2005-9#1)(2008-3#1)
to be chemically##3##3##(1994-5#1)(2008-10#2)
to be chosen##5##3##(1995-1#1)(2006-2#1)(2007-8#1)(2011-2#1)(2013-8#1)
to be clarified in##2##4##(2006-10#1)(2011-2#1)
to be clarified##12##3##(1995-2#1)(1996-6#1)(2006-10#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-2#1)(2011-2#1)(2013-8#1)
to be classified as##4##4##(2008-10#1)(2009-6#1)(2011-1#1)(2013-1#1)
to be classified on the basis of##2##7##(1992-6#1)(2008-10#1)
to be classified##11##3##(1992-6#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-4#1)(2009-6#1)(2010-8#1)(2011-1#1)(2013-1#1)
to be cleaned##2##3##(2008-10#1)(2013-8#1)
to be clearly communicated##2##4##(1996-4#1)(2007-2#1)
to be clearly##11##3##(1996-4#1)(2004-9#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-5#2)(2011-2#1)
to be cleaved by the##3##5##(1990-10#1)(1995-2#1)(2008-5#1)
to be cleaved by##6##4##(1990-10#1)(1992-7#1)(1995-2#1)(2005-8#1)(2008-5#1)(2009-12#1)
to be cleaved##9##3##(1990-10#1)(1991-7#1)(1992-7#1)(1995-2#1)(2005-8#1)(2008-4#1)(2008-5#1)(2009-12#2)
to be clinically relevant##3##4##(2006-10#1)(2008-5#1)(2009-11#1)
to be clinically##10##3##(1990-10#1)(1995-5#1)(1996-6#1)(2006-10#1)(2006-9#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-11#1)(2011-2#1)
to be clonal lineages##2##4##(2008-10#2)
to be cloned##6##3##(1994-2#1)(1994-9#1)(1997-2#1)(2008-2#1)(2008-4#2)
to be close to that of##2##6##(1995-11#1)(2005-11#1)
to be close to the##4##5##(1990-11#1)(1995-3#1)(2008-3#1)(2012-2#1)
to be close to##13##4##(1990-11#1)(1992-5#1)(1995-11#1)(1995-3#1)(2005-11#1)(2008-10#2)(2008-3#2)(2008-9#1)(2009-5#1)(2012-12#1)(2012-2#1)
to be closely linked##2##4##(1995-6#1)(2011-2#1)
to be closely related to the##3##6##(1990-5#1)(1994-12#1)(2008-10#1)
to be closely related to##7##5##(1990-5#2)(1994-12#1)(1996-7#1)(2006-4#1)(2008-10#1)(2008-8#1)
to be closely related##11##4##(1990-5#2)(1992-9#1)(1994-12#1)(1996-7#1)(2006-4#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#2)
to be closely##21##3##(1990-5#2)(1992-9#1)(1994-12#1)(1995-6#1)(1995-8#1)(1996-7#1)(2006-4#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#2)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
to be closest to the##2##5##(1997-6#1)(2009-5#1)
to be collected and##2##4##(2008-10#1)(2008-6#1)
to be collected##6##3##(1994-6#1)(2008-10#2)(2008-6#1)(2010-9#1)(2011-2#1)
to be colonized by##3##4##(1991-3#1)(1997-3#1)(2008-10#1)
to be colonized##5##3##(1991-3#1)(1997-3#1)(2008-10#1)(2008-9#1)(2010-4#1)
to be combined to##2##4##(2008-8#1)(2009-4#1)
to be combined with##5##4##(2007-8#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
to be combined##7##3##(2007-8#1)(2008-8#1)(2009-4#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
to be commercially##2##3##(2007-5#1)(2012-2#1)
to be common among##4##4##(2005-10#1)(2006-4#1)(2007-10#1)(2012-3#1)
to be common in the##2##5##(2005-11#1)(2008-12#1)
to be common in##3##4##(1990-4#1)(2005-11#1)(2008-12#1)
to be common##15##3##(1990-4#1)(1991-7#1)(1994-2#1)(2004-3#1)(2005-10#1)(2005-11#1)(2006-12#1)(2006-4#1)(2007-10#1)(2008-1#1)(2008-12#2)(2008-4#1)(2009-4#1)(2012-3#1)
to be commoner##2##3##(2008-4#1)(2012-2#1)
to be comparable to that of##4##6##(1994-12#1)(2006-10#1)(2007-11#1)(2007-2#1)
to be comparable to that##5##5##(1994-12#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#1)
to be comparable to the##2##5##(1992-1#1)(2008-10#1)
to be comparable to those##3##5##(1992-10#1)(2008-10#1)(2008-7#1)
to be comparable to##11##4##(1990-10#1)(1992-1#1)(1992-10#1)(1994-12#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-7#1)
to be comparable with the##2##5##(2008-10#1)(2008-5#1)
to be comparable with##7##4##(2007-12#1)(2008-10#4)(2008-5#1)(2013-7#1)
to be comparable##20##3##(1990-10#1)(1992-1#1)(1992-10#1)(1994-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#8)(2008-12#1)(2008-5#1)(2008-7#1)(2013-7#1)
to be comparatively##2##3##(2007-10#1)(2008-4#1)
to be compared##5##3##(1990-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2013-1#1)
to be compatible with the##6##5##(1990-9#1)(2007-2#1)(2008-10#2)(2008-5#1)(2008-7#1)
to be compatible with##10##4##(1990-9#1)(2007-2#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)
to be compatible##11##3##(1990-9#1)(2007-2#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)
to be compensated by a##2##5##(1995-5#1)(2008-10#1)
to be compensated by##4##4##(1995-5#1)(1997-4#1)(2008-10#1)(2013-1#1)
to be compensated for by##2##5##(1990-2#1)(2010-12#1)
to be compensated for##3##4##(1990-2#1)(2007-11#1)(2010-12#1)
to be compensated##9##3##(1990-2#1)(1995-3#1)(1995-5#1)(1997-4#1)(2007-11#1)(2008-10#2)(2010-12#1)(2013-1#1)
to be competitive inhibitors of##2##5##(1991-7#1)(1991-8#1)
to be competitive##4##3##(1991-7#1)(1991-8#1)(1993-2#1)(1996-6#1)
to be complementary to##3##4##(1994-9#1)(2007-12#1)(2008-10#1)
to be complementary##4##3##(1994-9#1)(2006-10#1)(2007-12#1)(2008-10#1)
to be complete##3##3##(1997-8#1)(2007-8#1)(2008-11#1)
to be completed##7##3##(1996-7#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-4#1)(2013-1#1)
to be completely##13##3##(1990-7#1)(1992-9#1)(1994-6#1)(1996-5#1)(1997-2#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-2#1)(2008-7#1)(2013-1#1)
to be complex and##2##4##(2008-8#1)(2012-3#1)
to be complex##7##3##(1992-5#1)(1993-3#1)(1995-2#1)(2008-2#1)(2008-8#1)(2009-4#1)(2012-3#1)
to be complicated##3##3##(1992-11#1)(2008-3#1)(2010-3#1)
to be composed of##8##4##(1992-12#1)(1994-6#1)(1997-4#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-2#1)
to be composed##9##3##(1992-12#1)(1994-6#1)(1997-4#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-2#1)
to be comprised of##4##4##(1990-12#1)(1992-1#1)(2009-10#1)(2013-8#1)
to be computationally##2##3##(1997-8#1)(2008-2#1)
to be computed##2##3##(2007-11#1)(2008-2#1)
to be concentrated at##2##4##(2009-8#1)(2013-1#1)
to be concentrated##7##3##(1991-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-8#1)(2011-1#1)(2013-1#1)
to be concerned##3##3##(1992-1#1)(1994-3#1)(2011-1#1)
to be conditioned by##2##4##(1997-2#1)(2008-10#1)
to be conducted in##4##4##(2006-4#1)(2007-7#1)(2007-8#1)(2007-9#1)
to be conducted on a##2##5##(2011-2#2)
to be conducted on##4##4##(2006-8#1)(2008-9#1)(2011-2#2)
to be conducted to##6##4##(2005-11#1)(2009-4#1)(2010-11#1)(2010-8#2)(2013-8#1)
to be conducted##18##3##(1994-6#1)(2005-11#1)(2006-4#1)(2006-8#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#2)(2013-8#1)
to be confident##2##3##(2005-10#1)(2009-7#1)
to be confined only to##2##5##(1992-7#1)(2009-5#1)
to be confined to the##2##5##(1994-9#1)(1997-6#1)
to be confined to##4##4##(1992-8#1)(1994-6#1)(1994-9#1)(1997-6#1)
to be confined##7##3##(1992-7#1)(1992-8#1)(1994-6#1)(1994-9#1)(1997-6#1)(2007-12#1)(2009-5#1)
to be confirmed by##6##4##(1992-10#1)(2007-1#1)(2007-12#1)(2008-12#1)(2009-12#1)(2013-8#1)
to be confirmed in##4##4##(2007-9#1)(2008-3#1)(2012-1#1)(2013-1#1)
to be confirmed on a##2##5##(2006-5#1)(2008-7#1)
to be confirmed##14##3##(1992-10#1)(2006-5#1)(2007-1#1)(2007-12#1)(2007-9#2)(2008-12#1)(2008-3#2)(2008-7#1)(2009-12#1)(2012-1#1)(2013-1#1)(2013-8#1)
to be connected to##4##4##(2007-7#1)(2008-10#1)(2008-11#1)(2012-2#1)
to be connected##5##3##(2007-7#1)(2008-10#2)(2008-11#1)(2012-2#1)
to be conservative##2##3##(2007-1#1)(2008-8#1)
to be conserved in##2##4##(1991-4#1)(1995-5#1)
to be conserved##6##3##(1990-8#1)(1991-4#1)(1995-5#1)(1997-1#1)(1997-2#1)(2012-1#1)
to be considerable##3##3##(2005-10#1)(2007-11#1)(2013-1#1)
to be considered a##2##4##(2007-11#1)(2010-12#1)
to be considered an##3##4##(1995-7#1)(1996-6#1)(2011-2#1)
to be considered as a##3##5##(1992-3#1)(1993-11#1)(2008-10#1)
to be considered as an##2##5##(1996-8#1)(2007-9#1)
to be considered as##8##4##(1992-3#1)(1993-11#1)(1994-9#1)(1996-8#1)(2007-9#1)(2008-10#1)(2011-2#1)(2011-3#1)
to be considered during##2##4##(2006-10#1)(2008-4#1)
to be considered for the##3##5##(2006-6#1)(2008-3#2)
to be considered for##8##4##(2006-6#1)(2008-3#2)(2008-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
to be considered in any##3##5##(1993-11#1)(2006-2#1)(2008-11#1)
to be considered in future##2##5##(1992-9#1)(2008-1#1)
to be considered in the differential diagnosis of##2##8##(1996-12#1)(2012-3#1)
to be considered in the##8##5##(1996-12#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-12#1)(2012-3#2)
to be considered in##28##4##(1992-9#1)(1993-11#1)(1996-12#1)(2005-6#1)(2006-10#2)(2006-2#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-7#2)(2009-8#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#2)
to be considered since##2##4##(1996-6#1)(1996-8#1)
to be considered when##11##4##(1993-2#2)(2005-12#1)(2006-5#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-1#1)(2012-11#1)
to be considered##101##3##(1990-6#3)(1991-8#1)(1992-3#1)(1992-9#1)(1993-11#3)(1993-2#2)(1994-9#1)(1995-7#1)(1996-12#1)(1996-6#2)(1996-8#4)(1997-3#1)(2005-10#2)(2005-12#1)(2005-6#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-5#1)(2006-6#2)(2007-11#3)(2007-12#1)(2007-4#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-1#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
to be consistent and##3##4##(2009-12#1)(2013-1#2)
to be consistent with a##2##5##(1991-8#1)(2008-10#1)
to be consistent with the##9##5##(1992-3#1)(1995-5#1)(1995-8#1)(2008-2#2)(2008-3#2)(2008-7#1)(2013-8#1)
to be consistent with##25##4##(1991-8#1)(1992-3#2)(1995-10#1)(1995-5#1)(1995-8#1)(1996-8#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-2#5)(2008-3#4)(2008-7#1)(2009-2#2)(2012-11#1)(2013-8#1)
to be consistent##32##3##(1991-8#1)(1992-3#2)(1995-10#1)(1995-5#1)(1995-8#1)(1996-8#1)(1997-1#1)(2005-10#1)(2007-12#1)(2008-10#2)(2008-2#5)(2008-3#4)(2008-7#1)(2009-12#1)(2009-2#2)(2010-4#1)(2011-1#1)(2012-11#1)(2012-12#1)(2013-1#2)(2013-8#1)
to be consistently##3##3##(2006-12#1)(2008-5#1)(2012-3#1)
to be constant over##3##4##(1990-12#1)(1992-6#1)(2007-12#1)
to be constant##7##3##(1990-12#2)(1991-5#1)(1992-6#1)(2005-11#1)(2007-12#1)(2008-10#1)
to be constitutively##2##3##(1992-5#1)(1994-3#1)
to be constrained##3##3##(2008-3#1)(2012-12#2)
to be constructed that##2##4##(1994-3#1)(2009-5#1)
to be constructed##8##3##(1994-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-5#1)(2012-3#1)
to be contained in##3##4##(1991-6#1)(1994-2#1)(1995-3#1)
to be contained##5##3##(1991-12#1)(1991-6#1)(1994-11#1)(1994-2#1)(1995-3#1)
to be contaminated with##4##4##(1995-11#1)(2008-11#1)(2008-5#1)(2010-5#1)
to be contaminated##7##3##(1991-2#1)(1994-3#1)(1995-11#1)(2008-11#1)(2008-5#1)(2010-5#1)(2011-2#1)
to be continued##3##3##(2006-2#1)(2007-5#1)(2013-8#1)
to be contributing##2##3##(1997-2#1)(2008-8#1)
to be controlled at##2##4##(2008-2#1)(2008-5#1)
to be controlled by a single##2##6##(2008-10#1)(2008-5#1)
to be controlled by a##3##5##(2008-10#1)(2008-5#1)(2008-9#1)
to be controlled by##9##4##(1992-3#1)(1994-3#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-5#2)(2008-9#1)(2009-10#1)
to be controlled with##2##4##(1997-1#1)(2012-1#1)
to be controlled##25##3##(1992-3#1)(1994-3#1)(1995-11#1)(1995-12#2)(1997-1#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-2#3)(2008-5#3)(2008-9#1)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
to be controversial##3##3##(1993-1#1)(1993-9#1)(2009-4#1)
to be convenient##2##3##(2007-7#1)(2008-4#1)
to be converted##3##3##(1993-9#1)(1996-8#1)(2007-11#1)
to be correct##5##3##(1993-1#1)(1994-5#1)(1997-8#1)(2007-8#1)(2008-7#1)
to be corrected for##3##4##(2007-11#1)(2007-12#1)(2012-1#1)
to be corrected##5##3##(2007-11#1)(2007-12#1)(2008-3#2)(2012-1#1)
to be correlated with a##2##5##(1991-6#1)(1994-11#1)
to be correlated with the##5##5##(1991-11#1)(1991-6#1)(1992-6#1)(1993-2#1)(2008-10#1)
to be correlated with##15##4##(1990-4#1)(1991-11#1)(1991-6#2)(1992-6#1)(1993-2#1)(1993-5#1)(1994-11#1)(1995-12#1)(2005-11#1)(2007-1#1)(2008-10#2)(2008-3#1)(2009-12#1)
to be correlated##17##3##(1990-4#1)(1991-11#1)(1991-6#2)(1992-6#1)(1993-2#1)(1993-5#1)(1994-11#1)(1995-12#1)(2005-11#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-12#1)
to be cost effective##3##4##(2006-8#1)(2007-11#1)(2012-2#1)
to be cost-effective when##2##4##(1993-1#1)(2012-12#1)
to be cost-effective##3##3##(1993-1#1)(1997-7#1)(2012-12#1)
to be costly##2##3##(1992-11#1)(2008-1#1)
to be coupled to##4##4##(1992-3#1)(1995-8#1)(2008-10#1)(2008-4#1)
to be coupled##7##3##(1992-3#1)(1995-8#1)(1996-1#1)(2008-10#1)(2008-3#2)(2008-4#1)
to be covalently bound to##2##5##(1990-2#1)(1993-6#1)
to be covalently##6##3##(1990-2#1)(1991-6#1)(1992-3#1)(1993-6#1)(1997-6#1)(2008-5#1)
to be covered by##2##4##(1990-2#1)(1994-3#1)
to be covered##6##3##(1990-2#1)(1994-3#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-11#1)
to be created##6##3##(2007-11#1)(2007-7#1)(2008-2#1)(2010-11#1)(2010-4#1)(2010-7#1)
to be critical for##8##4##(1993-3#1)(1997-9#1)(2006-2#1)(2008-11#2)(2008-8#1)(2010-2#2)
to be critical in##2##4##(2007-11#1)(2008-7#1)
to be critical to the##4##5##(1994-9#1)(1996-8#1)(2008-10#1)(2008-3#1)
to be critical to##8##4##(1994-9#1)(1996-8#1)(1997-5#1)(2005-11#2)(2008-10#1)(2008-3#1)(2012-2#1)
to be critical##21##3##(1990-12#1)(1992-6#1)(1993-3#1)(1994-9#1)(1995-6#1)(1996-8#1)(1997-5#1)(1997-9#1)(2005-11#2)(2006-2#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-2#2)(2012-2#1)
to be critically##3##3##(2008-1#1)(2008-10#1)(2013-1#1)
to be crucial for the##2##5##(1995-3#1)(2007-2#1)
to be crucial for##9##4##(1995-3#1)(1995-8#1)(1996-8#1)(2006-12#1)(2006-6#1)(2007-2#1)(2008-5#1)(2009-5#1)(2009-6#1)
to be crucial to the##2##5##(1991-2#1)(1997-3#1)
to be crucial to##7##4##(1991-2#1)(1996-7#1)(1997-3#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-2#1)
to be crucial##22##3##(1991-2#1)(1995-3#1)(1995-8#1)(1996-7#1)(1996-8#2)(1997-3#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-6#1)(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
to be curative##2##3##(2006-9#1)(2012-12#1)
to be cured##2##3##(1994-9#1)(1995-9#1)
to be current smokers##2##4##(2007-11#1)(2008-3#1)
to be cytotoxic##4##3##(1993-12#1)(2010-4#1)(2010-7#1)(2013-1#1)
to be dealt with##2##4##(1996-2#1)(2008-3#1)
to be debated##4##3##(1996-11#1)(2006-10#1)(2008-11#1)(2008-8#1)
to be declining in##2##4##(2006-10#1)(2008-1#1)
to be decreased by##6##4##(1990-10#1)(1992-11#2)(1994-6#1)(1995-3#1)(2012-2#1)
to be decreased in##3##4##(1993-3#1)(2006-12#1)(2013-1#1)
to be decreased##14##3##(1990-10#1)(1990-2#1)(1992-11#2)(1993-3#1)(1994-6#1)(1995-3#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-2#2)(2013-1#1)
to be decreasing##3##3##(2006-10#1)(2008-8#1)(2010-12#1)
to be deduced##2##3##(1996-2#1)(2008-2#1)
to be defective in the##3##5##(1994-2#1)(2008-8#1)(2009-5#1)
to be defective in##6##4##(1994-2#1)(1995-8#1)(1996-10#1)(2003-11#1)(2008-8#1)(2009-5#1)
to be defective##7##3##(1994-2#1)(1995-8#1)(1996-10#1)(2003-11#1)(2008-8#1)(2009-5#1)(2009-8#1)
to be deficient##3##3##(1990-10#1)(1995-12#1)(2009-4#1)
to be defined and##3##4##(1997-4#1)(2012-2#1)(2013-1#1)
to be defined in##2##4##(2007-11#1)(2008-6#1)
to be defined##26##3##(1991-5#1)(1994-11#1)(1994-5#1)(1994-6#1)(1996-4#2)(1996-9#2)(1997-4#1)(1997-8#1)(2006-10#2)(2007-11#2)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-11#1)(2012-2#1)(2013-1#3)
to be degraded in##2##4##(2007-11#1)(2009-5#1)
to be degraded##10##3##(1990-4#2)(1995-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-5#1)(2013-8#1)
to be delineated##2##3##(2008-4#1)(2013-8#1)
to be delivered to the##3##5##(2007-11#1)(2008-3#1)(2008-5#1)
to be delivered to##5##4##(1990-9#1)(2007-11#1)(2008-3#1)(2008-5#1)(2013-8#1)
to be delivered##9##3##(1990-9#1)(1994-11#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-1#1)(2013-8#1)
to be demonstrated in##3##4##(1995-2#1)(1997-5#1)(2007-11#1)
to be demonstrated##11##3##(1992-5#1)(1994-9#1)(1995-2#1)(1997-5#1)(2005-7#1)(2006-5#1)(2007-11#2)(2007-8#1)(2008-2#1)(2008-3#1)
to be dependent on the presence of##3##7##(1991-3#1)(2008-11#1)(2011-1#1)
to be dependent on the##17##5##(1991-3#1)(1991-5#1)(1991-9#1)(1994-10#1)(1994-11#1)(1995-1#1)(1995-6#1)(2005-12#1)(2008-10#2)(2008-11#3)(2008-5#1)(2010-12#1)(2010-5#1)(2011-1#1)
to be dependent on##34##4##(1990-11#1)(1990-5#1)(1991-3#1)(1991-5#1)(1991-9#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-8#1)(2005-12#1)(2006-11#1)(2007-11#1)(2008-10#4)(2008-11#4)(2008-5#2)(2008-6#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)
to be dependent upon the##12##5##(1991-5#1)(1992-6#1)(1994-9#1)(1996-1#1)(2004-9#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)
to be dependent upon##15##4##(1991-5#1)(1992-6#1)(1994-9#1)(1996-1#1)(2004-9#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2010-11#1)(2010-7#1)(2011-2#1)
to be dependent##51##3##(1990-11#1)(1990-5#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-6#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-8#1)(1997-1#1)(2004-9#1)(2005-11#1)(2005-12#1)(2006-11#1)(2007-11#1)(2008-10#6)(2008-11#5)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)
to be depleted##3##3##(1992-11#1)(2008-5#1)(2008-7#1)
to be deposited##2##3##(1996-9#1)(2008-11#1)
to be depressed in##2##4##(1996-5#1)(2007-11#1)
to be depressed##3##3##(1996-5#1)(2007-11#1)(2009-10#1)
to be derived from a##3##5##(1996-2#1)(2007-12#1)(2008-11#1)
to be derived from the##3##5##(1990-5#1)(1992-6#1)(2008-6#1)
to be derived from##21##4##(1990-10#1)(1990-5#1)(1991-8#1)(1991-9#1)(1992-6#1)(1993-12#1)(1993-4#1)(1994-3#1)(1995-8#1)(1996-2#1)(1997-7#1)(2005-11#1)(2007-1#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-2#1)
to be derived##25##3##(1990-10#1)(1990-5#1)(1991-8#1)(1991-9#1)(1992-6#1)(1993-12#1)(1993-4#1)(1994-3#1)(1995-8#1)(1996-2#1)(1997-7#1)(2005-11#1)(2007-1#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-2#1)(2013-1#1)
to be described in##3##4##(1994-5#1)(1996-7#1)(1997-1#1)
to be described##6##3##(1990-7#1)(1994-5#1)(1996-7#1)(1997-1#1)(2008-10#1)(2011-1#1)
to be designed##2##3##(2008-10#1)(2008-3#1)
to be desired##4##3##(1992-3#1)(2007-10#1)(2007-2#1)(2013-1#1)
to be detectable in the##2##5##(1992-1#1)(2008-5#1)
to be detectable in##3##4##(1992-1#1)(1997-6#1)(2008-5#1)
to be detectable##4##3##(1992-1#1)(1997-6#1)(2008-1#1)(2008-5#1)
to be detected and##4##4##(1990-10#1)(2008-10#2)(2008-8#1)
to be detected by##3##4##(1997-2#1)(1997-4#1)(2013-8#1)
to be detected in##3##4##(2008-3#1)(2008-7#1)(2010-5#1)
to be detected with##5##4##(1991-3#1)(1996-5#1)(2008-2#1)(2008-8#1)(2010-1#1)
to be detected##28##3##(1990-10#2)(1991-3#1)(1992-9#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-4#1)(2006-10#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2010-1#1)(2010-5#2)(2011-1#1)(2012-2#2)(2013-8#2)
to be determined and##5##4##(1990-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)
to be determined by the##2##5##(1995-8#1)(2007-12#1)
to be determined by##10##4##(1995-8#1)(1996-7#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)(2009-10#1)
to be determined for##3##4##(2008-10#2)(2010-10#1)
to be determined from##2##4##(2008-10#1)(2011-2#1)
to be determined in an##2##5##(2010-3#1)(2013-1#1)
to be determined in##6##4##(2005-11#1)(2007-8#1)(2009-5#1)(2010-12#1)(2010-3#1)(2013-1#1)
to be determined simultaneously##2##4##(2007-12#1)(2008-10#1)
to be determined whether##9##4##(1990-5#1)(1994-4#1)(2004-1#1)(2006-10#1)(2007-12#1)(2008-11#1)(2010-12#1)(2010-8#1)(2012-12#1)
to be determined with##2##4##(1996-3#1)(2008-10#1)
to be determined##126##3##(1990-3#1)(1990-5#2)(1990-8#1)(1990-9#1)(1992-1#1)(1992-4#1)(1993-9#1)(1994-4#2)(1994-5#1)(1994-8#2)(1995-2#4)(1995-3#1)(1995-8#2)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-1#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#9)(2006-11#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#12)(2008-11#1)(2008-2#5)(2008-3#11)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#3)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#2)(2012-7#1)(2013-1#3)
to be detrimental to##3##4##(1992-2#1)(2008-11#1)(2008-12#1)
to be developed and##3##4##(2006-10#1)(2007-9#1)(2008-11#1)
to be developed as##2##4##(2004-2#1)(2005-7#1)
to be developed for##3##4##(1992-2#1)(1994-3#1)(2007-2#1)
to be developed in##2##4##(1994-7#1)(2011-1#1)
to be developed that##2##4##(1994-6#1)(2008-11#1)
to be developed to##5##4##(2006-2#1)(2007-12#1)(2008-11#1)(2008-3#1)(2013-7#1)
to be developed##43##3##(1992-12#1)(1992-2#1)(1992-8#1)(1994-3#1)(1994-6#1)(1994-7#1)(1995-1#1)(1996-1#1)(1996-8#1)(1996-9#1)(1997-2#1)(2004-2#1)(2005-7#3)(2006-10#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-4#1)(2010-11#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
to be devised##2##3##(1996-3#1)(2007-11#1)
to be diagnosed##7##3##(1990-11#1)(1990-9#1)(2008-4#1)(2010-12#1)(2010-9#1)(2013-1#1)(2013-8#1)
to be different from that##5##5##(1996-1#1)(1996-5#1)(2005-11#1)(2008-11#1)(2008-7#1)
to be different from##12##4##(1994-12#1)(1996-1#1)(1996-5#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-10#1)
to be different in the##3##5##(1993-11#1)(2007-1#1)(2008-10#1)
to be different in##4##4##(1990-12#1)(1993-11#1)(2007-1#1)(2008-10#1)
to be different##28##3##(1990-12#1)(1990-4#1)(1991-6#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-8#1)(1996-1#1)(1996-5#1)(1997-4#1)(2005-11#1)(2007-1#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#2)(2009-9#1)(2010-10#1)(2012-2#1)
to be differentially expressed##3##4##(1991-2#1)(2008-10#1)(2010-4#1)
to be differentially##8##3##(1991-2#1)(1995-2#1)(2005-11#1)(2008-10#2)(2009-9#1)(2010-4#1)(2011-1#1)
to be differentiated from##4##4##(2007-11#1)(2008-12#1)(2010-4#1)(2011-1#1)
to be differentiated##10##3##(1992-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-2#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-2#1)
to be difficult and##2##4##(2008-12#1)(2010-2#1)
to be difficult to##5##4##(1993-8#1)(2007-8#1)(2008-10#1)(2008-2#1)(2012-8#1)
to be difficult##11##3##(1993-8#1)(1996-1#1)(2005-9#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2010-2#1)(2012-8#1)
to be directed at##3##4##(1997-8#1)(2008-2#1)(2009-5#1)
to be directed##6##3##(1995-3#1)(1997-8#1)(2007-11#1)(2008-2#1)(2009-5#1)(2011-2#1)
to be directly##13##3##(1993-2#1)(1993-5#1)(1993-6#1)(1994-12#1)(1995-1#1)(1996-6#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-1#1)
to be discharged##2##3##(2006-10#1)(2007-10#1)
to be discontinued##5##3##(1990-2#1)(1991-3#1)(1991-6#1)(1995-6#1)(2006-8#1)
to be discovered about##2##4##(2011-2#1)(2013-1#1)
to be discovered##8##3##(1991-12#1)(1995-12#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
to be discriminated##2##3##(1992-11#1)(2008-3#1)
to be discussed##6##3##(1992-4#1)(1992-5#1)(2007-4#1)(2009-10#1)(2012-3#1)(2013-8#1)
to be disease-free##2##3##(1990-6#1)(2008-5#1)
to be displaced by##2##4##(1991-1#1)(1997-1#1)
to be displaced##3##3##(1991-1#1)(1997-1#1)(2007-8#1)
to be displayed##2##3##(1990-8#1)(2008-4#1)
to be disproportionately represented##2##4##(2007-2#1)(2010-11#1)
to be disproportionately##3##3##(2005-8#1)(2007-2#1)(2010-11#1)
to be dissolved##2##3##(2004-9#1)(2008-10#1)
to be distinct from the##4##5##(1992-3#1)(1994-12#1)(1995-2#1)(2008-4#1)
to be distinct from##6##4##(1992-3#1)(1994-12#1)(1995-11#1)(1995-2#1)(2006-10#1)(2008-4#1)
to be distinct##8##3##(1992-3#1)(1994-12#1)(1995-11#1)(1995-2#1)(2006-10#1)(2008-10#1)(2008-4#1)(2012-2#1)
to be distinctly different##2##4##(2008-5#1)(2012-2#1)
to be distinguished from##5##4##(2008-3#1)(2009-3#1)(2012-2#3)
to be distinguished##10##3##(2007-11#1)(2008-1#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-8#1)(2012-2#3)
to be distributed##3##3##(1990-5#1)(1996-11#1)(2007-7#1)
to be disturbed##2##3##(1991-4#1)(2012-12#1)
to be documented in##2##4##(2007-2#1)(2007-8#1)
to be documented##5##3##(2006-10#2)(2007-2#1)(2007-8#1)(2008-10#1)
to be dominant##3##3##(1993-9#1)(2007-12#1)(2008-10#1)
to be dominated by##6##4##(1990-6#1)(1992-9#1)(1995-8#1)(2007-9#1)(2008-3#1)(2011-2#1)
to be done before##2##4##(2007-4#1)(2008-10#1)
to be done by##2##4##(2011-2#1)(2013-1#1)
to be done in this##2##5##(2006-10#1)(2008-8#1)
to be done in##6##4##(2006-10#1)(2006-7#1)(2008-10#1)(2008-8#1)(2009-7#1)(2013-8#1)
to be done on##3##4##(2008-10#1)(2008-7#1)(2010-9#1)
to be done to##7##4##(1991-1#1)(1995-6#1)(2006-7#1)(2007-8#2)(2009-1#1)(2011-2#1)
to be done##31##3##(1991-1#1)(1992-3#1)(1994-3#1)(1995-6#1)(2006-10#1)(2006-7#2)(2007-2#2)(2007-4#1)(2007-8#2)(2008-10#6)(2008-3#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
to be dose dependent and##2##5##(1992-5#1)(2008-8#1)
to be dose dependent##3##4##(1992-5#1)(2008-5#1)(2008-8#1)
to be dose##4##3##(1992-5#1)(2005-7#1)(2008-5#1)(2008-8#1)
to be dose-dependent and##3##4##(1993-4#1)(1994-6#1)(2004-3#1)
to be dose-dependent##6##3##(1993-3#1)(1993-4#1)(1994-6#1)(1996-3#1)(2004-3#1)(2008-3#1)
to be dramatically reduced##2##4##(1995-1#1)(2008-10#1)
to be dramatically##4##3##(1992-8#1)(1995-1#1)(2008-10#1)(2008-3#1)
to be drawn##4##3##(1994-9#1)(2007-11#1)(2013-1#2)
to be driven by##5##4##(1991-4#1)(1993-9#1)(2008-10#1)(2011-12#1)(2013-1#1)
to be dropped##2##3##(1993-5#1)(2013-8#1)
to be due primarily to##4##5##(1997-7#1)(2008-3#1)(2008-8#2)
to be due to a &quot##2##6##(1991-7#1)(1995-3#1)
to be due to a##17##5##(1990-8#2)(1991-12#1)(1991-7#1)(1994-2#1)(1995-1#1)(1995-3#1)(1996-8#1)(2005-11#1)(2006-4#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-7#1)(2011-2#1)
to be due to activation of##2##6##(1992-12#1)(2005-8#1)
to be due to an##4##5##(1990-8#1)(1991-12#1)(1991-7#1)(2008-7#1)
to be due to differences##2##5##(2007-12#1)(2012-12#1)
to be due to the fact that##2##7##(2008-11#1)(2009-2#1)
to be due to the##16##5##(1990-10#1)(1990-12#1)(1992-4#1)(1994-8#1)(1994-9#1)(1995-1#1)(1996-2#1)(2005-8#1)(2007-5#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-2#1)
to be due to##90##4##(1990-10#1)(1990-12#1)(1990-6#1)(1990-7#1)(1990-8#4)(1991-11#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-7#2)(1992-12#2)(1992-4#2)(1992-8#1)(1993-1#2)(1993-11#1)(1993-9#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-3#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-8#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#2)(2006-10#1)(2006-2#1)(2006-4#1)(2007-1#1)(2007-12#2)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#6)(2008-11#6)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-2#1)(2009-7#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#2)
to be due##98##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#4)(1991-11#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-7#2)(1992-12#2)(1992-4#2)(1992-8#1)(1993-1#2)(1993-11#2)(1993-8#1)(1993-9#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-3#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-8#1)(1997-7#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#2)(2006-10#1)(2006-2#1)(2006-4#1)(2007-1#1)(2007-12#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#6)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-2#1)(2009-7#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#2)
to be durable##3##3##(2008-10#2)(2008-6#1)
to be dynamic##3##3##(1994-3#1)(2007-10#1)(2008-11#1)
to be dynamically##2##3##(1994-8#1)(1996-2#1)
to be early##3##3##(1995-3#1)(2006-10#1)(2008-11#1)
to be easily##11##3##(1991-5#1)(1994-11#1)(2006-3#1)(2006-8#1)(2007-12#1)(2008-3#2)(2008-5#1)(2009-9#1)(2011-2#1)(2012-12#1)
to be educated on##2##4##(2007-2#1)(2010-1#1)
to be effective against##9##4##(1992-10#1)(1995-3#1)(1997-6#1)(2005-8#1)(2006-11#1)(2006-8#1)(2007-11#1)(2009-6#1)(2012-2#1)
to be effective and safe##2##5##(2010-4#1)(2012-2#1)
to be effective and##12##4##(1990-4#1)(1990-5#1)(1993-9#1)(1994-2#1)(2005-8#1)(2006-2#1)(2007-8#2)(2008-1#2)(2010-4#1)(2012-2#1)
to be effective are##2##4##(2008-6#1)(2010-4#1)
to be effective as an adjunct##2##6##(2006-6#1)(2008-11#1)
to be effective as an##3##5##(1990-12#1)(2006-6#1)(2008-11#1)
to be effective as##6##4##(1990-12#1)(2006-6#1)(2007-9#1)(2008-10#1)(2008-11#1)(2010-7#1)
to be effective at##3##4##(1993-4#1)(2007-11#1)(2013-1#1)
to be effective for the treatment of##4##7##(2007-7#1)(2009-9#1)(2012-12#1)(2013-1#1)
to be effective for the##9##5##(1997-2#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-9#1)(2012-12#1)(2012-6#1)(2013-1#1)
to be effective for##20##4##(1994-6#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-6#1)(2013-1#1)
to be effective in both##2##5##(2006-4#1)(2007-4#1)
to be effective in improving##4##5##(1993-11#1)(2007-10#1)(2008-1#1)(2009-4#1)
to be effective in managing##3##5##(1994-7#1)(2006-8#1)(2007-8#1)
to be effective in preventing##4##5##(1992-3#1)(2007-10#1)(2007-7#1)(2010-7#1)
to be effective in reducing the##3##6##(1990-3#1)(2008-8#1)(2010-2#1)
to be effective in reducing##7##5##(1990-3#1)(1994-7#1)(2006-12#1)(2008-8#1)(2010-2#1)(2012-12#1)(2013-8#1)
to be effective in terms of##2##6##(1992-12#1)(2008-7#1)
to be effective in the management of##2##7##(2007-3#1)(2008-3#1)
to be effective in the treatment of##8##7##(1993-12#1)(1996-1#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-3#1)(2008-5#1)(2011-2#1)
to be effective in the treatment##9##6##(1993-12#1)(1996-1#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-3#1)(2008-5#1)(2011-2#1)
to be effective in the##13##5##(1992-4#1)(1993-12#1)(1996-1#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-3#2)(2007-8#1)(2008-3#1)(2008-5#1)(2011-2#1)
to be effective in vitro##2##5##(2007-6#1)(2008-11#1)
to be effective in##91##4##(1990-3#1)(1990-5#1)(1991-6#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-12#2)(1994-3#1)(1994-7#2)(1995-9#1)(1996-1#1)(1997-6#1)(2005-10#2)(2006-10#6)(2006-12#3)(2006-4#1)(2006-6#3)(2006-8#2)(2007-10#2)(2007-11#5)(2007-3#3)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-11#3)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-4#3)(2009-8#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#5)(2012-1#1)(2012-12#4)(2012-3#1)(2013-1#2)(2013-8#2)
to be effective is##2##4##(1996-8#1)(2007-9#1)
to be effective not only##2##5##(2008-11#1)(2008-7#1)
to be effective only in##2##5##(1990-8#1)(1991-2#1)
to be effective##199##3##(1990-10#2)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#4)(1990-8#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#2)(1991-7#1)(1992-1#1)(1992-10#1)(1992-12#4)(1992-3#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-4#1)(1993-8#1)(1993-9#3)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#2)(1995-11#1)(1995-2#1)(1995-3#2)(1995-9#1)(1996-1#2)(1996-2#1)(1996-8#1)(1997-2#1)(1997-6#2)(2005-10#2)(2005-11#1)(2005-8#2)(2006-10#7)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#2)(2006-6#4)(2006-7#1)(2006-8#4)(2007-10#5)(2007-11#10)(2007-3#3)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#7)(2007-9#4)(2008-1#4)(2008-10#2)(2008-11#8)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#2)(2009-10#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#1)(2012-6#1)(2013-1#5)(2013-8#3)
to be effectively##3##3##(1994-12#1)(1994-3#1)(1994-8#1)
to be efficacious and##2##4##(2008-8#1)(2012-2#1)
to be efficacious in treating##2##5##(2006-10#1)(2010-11#1)
to be efficacious in##5##4##(1994-11#1)(2006-10#1)(2007-11#1)(2008-10#1)(2010-11#1)
to be efficacious##12##3##(1991-4#1)(1994-11#1)(2005-10#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-9#1)(2010-11#1)(2010-7#1)(2012-1#1)(2012-2#1)
to be efficient for##2##4##(2008-10#2)
to be efficient in##3##4##(2007-11#1)(2008-10#1)(2012-2#1)
to be efficient##15##3##(1994-11#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-3#2)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
to be efficiently analyzed by high-performance liquid chromatography##2##8##(2008-10#2)
to be efficiently##5##3##(2006-6#1)(2008-10#2)(2008-2#1)(2008-9#1)
to be either a##2##4##(1996-3#1)(2008-3#1)
to be either##14##3##(1990-5#1)(1992-5#1)(1995-11#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)(2011-12#1)
to be elevated in##6##4##(1993-8#1)(1995-2#1)(2004-10#1)(2008-5#1)(2010-11#1)(2010-6#1)
to be elevated##10##3##(1990-4#1)(1992-8#1)(1993-8#1)(1994-2#1)(1995-2#1)(1996-5#1)(2004-10#1)(2008-5#1)(2010-11#1)(2010-6#1)
to be eliminated##3##3##(1996-11#1)(2008-10#1)(2010-1#1)
to be elucidated in##2##4##(2007-9#1)(2008-7#1)
to be elucidated##48##3##(1990-5#1)(1991-10#1)(1991-2#1)(1993-2#1)(1993-3#1)(1993-5#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-4#2)(1996-6#1)(1997-6#2)(1997-7#2)(2004-2#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-7#2)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#2)
to be eluted##2##3##(1992-6#1)(2008-10#1)
to be employed as##3##4##(2008-1#1)(2008-10#1)(2011-12#1)
to be employed for##2##4##(2008-10#1)(2009-7#1)
to be employed in##3##4##(2008-6#1)(2009-4#1)(2011-12#1)
to be employed##14##3##(1991-4#1)(1992-8#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-6#1)(2009-4#1)(2009-5#1)(2009-7#1)(2011-12#2)(2013-1#1)
to be encoded by the##2##5##(1993-6#1)(1994-3#1)
to be encoded by##6##4##(1991-6#1)(1993-6#1)(1994-3#1)(1996-4#1)(1996-5#1)(2013-8#1)
to be encoded##8##3##(1991-6#1)(1993-6#1)(1994-3#1)(1996-4#1)(1996-5#1)(2007-12#1)(2008-1#1)(2013-8#1)
to be encountered in clinical##2##5##(2006-10#1)(2011-1#1)
to be encountered in##4##4##(1993-9#1)(2006-10#1)(2008-3#1)(2011-1#1)
to be encountered##6##3##(1993-9#1)(2006-10#2)(2008-3#1)(2011-1#1)(2012-2#1)
to be encouraged##3##3##(1991-8#1)(2009-9#1)(2010-11#1)
to be endemic in##2##4##(2008-1#1)(2011-2#1)
to be endemic##4##3##(2007-12#1)(2008-1#1)(2010-8#1)(2011-2#1)
to be engaged##2##3##(1995-12#1)(2007-12#1)
to be enhanced by##3##4##(1991-10#1)(1994-6#1)(2010-4#1)
to be enhanced in##3##4##(1990-11#1)(1990-4#1)(1995-1#1)
to be enhanced##12##3##(1990-11#1)(1990-4#1)(1991-10#1)(1994-6#1)(1995-1#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-2#1)(2010-3#1)(2010-4#1)
to be enlarged##2##3##(2007-2#1)(2013-7#1)
to be enriched##5##3##(1990-2#1)(1994-11#1)(2008-10#2)(2009-9#1)
to be enrolled in##2##4##(1996-12#1)(2006-6#1)
to be ensured##2##3##(2006-12#1)(2008-8#1)
to be entirely##2##3##(1994-12#1)(2005-11#1)
to be equal to the##3##5##(1994-2#1)(2007-8#1)(2008-10#1)
to be equal to##9##4##(1991-5#1)(1994-2#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-2#1)(2010-12#1)
to be equal##12##3##(1991-5#1)(1994-2#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#1)(2010-12#1)(2012-12#2)
to be equally as##2##4##(1991-3#1)(2007-8#1)
to be equally effective as##2##5##(1995-3#1)(2006-6#1)
to be equally effective##7##4##(1993-6#1)(1995-3#1)(1996-2#1)(2006-10#1)(2006-6#1)(2008-2#1)(2010-7#1)
to be equally##14##3##(1991-3#1)(1993-2#1)(1993-6#1)(1995-3#1)(1996-2#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-2#1)(2010-7#1)
to be equipotent##3##3##(1996-9#1)(2007-11#1)(2010-3#1)
to be equivalent to the##2##5##(2008-2#1)(2010-12#1)
to be equivalent to##10##4##(1993-12#1)(1995-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2010-12#1)
to be equivalent##12##3##(1993-12#1)(1995-12#1)(1996-2#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2010-12#1)
to be equivocal##5##3##(2006-11#1)(2008-8#1)(2008-9#3)
to be eradicated##2##3##(1992-5#1)(1993-12#1)
to be especially suitable##2##4##(2008-5#1)(2009-10#1)
to be especially useful##2##4##(2006-10#1)(2007-7#1)
to be especially##7##3##(2006-10#1)(2006-2#1)(2007-1#1)(2007-7#1)(2008-5#1)(2008-7#1)(2009-10#1)
to be essential for growth##3##5##(1990-5#1)(1997-1#1)(2008-11#1)
to be essential for the activity of##2##7##(1990-5#1)(1994-6#1)
to be essential for the##8##5##(1990-5#1)(1992-4#1)(1994-6#1)(1995-12#1)(2005-11#1)(2005-7#1)(2008-4#1)(2008-5#1)
to be essential for##44##4##(1990-5#2)(1990-6#1)(1992-12#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-12#2)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-12#1)(2007-11#2)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-6#1)(2010-2#1)(2011-2#1)(2012-2#1)
to be essential in##4##4##(1993-3#1)(1994-9#1)(2010-7#1)(2011-1#1)
to be essential to##4##4##(1996-9#1)(2004-10#1)(2005-11#1)(2010-4#1)
to be essential##57##3##(1990-11#1)(1990-12#1)(1990-5#2)(1990-6#1)(1992-12#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-12#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-10#1)(2005-10#1)(2005-11#2)(2005-7#1)(2006-12#1)(2007-11#3)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-6#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
to be essentially identical##2##4##(1990-5#1)(1994-11#1)
to be essentially##7##3##(1990-5#1)(1994-11#1)(2006-3#1)(2007-11#1)(2008-2#2)(2008-5#1)
to be established between##2##4##(1991-2#1)(2008-10#1)
to be established for##2##4##(2007-12#1)(2008-11#1)
to be established in##3##4##(1991-2#1)(2008-11#1)(2008-4#1)
to be established##62##3##(1990-10#2)(1990-12#1)(1990-5#1)(1991-1#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#2)(1993-1#1)(1994-3#1)(1995-5#1)(1995-6#1)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-7#1)(2006-10#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#1)
to be estimated at##2##4##(2005-11#1)(2008-10#1)
to be estimated##10##3##(1990-9#1)(1992-12#1)(1996-3#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2009-6#1)
to be evaluated in the##2##5##(2006-6#1)(2008-5#1)
to be evaluated in##10##4##(1996-3#1)(1996-5#1)(2006-10#1)(2006-6#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-1#1)(2010-10#1)
to be evaluated##35##3##(1991-11#1)(1991-5#1)(1991-6#1)(1994-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(2006-10#3)(2006-6#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
to be even more##5##4##(1990-9#1)(1993-12#1)(2008-9#1)(2011-2#1)(2013-1#1)
to be even##6##3##(1990-9#1)(1992-2#1)(1993-12#1)(2008-9#1)(2011-2#1)(2013-1#1)
to be evenly distributed##2##4##(1993-7#1)(2010-12#1)
to be evident##2##3##(1995-8#1)(2011-1#1)
to be evolving##2##3##(2006-10#1)(2006-4#1)
to be examined in##3##4##(1995-3#1)(1996-1#1)(2013-1#1)
to be examined##13##3##(1992-11#1)(1992-12#1)(1994-8#1)(1995-3#1)(1996-1#1)(2005-10#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-2#1)(2011-1#1)(2013-1#1)
to be excellent##5##3##(1992-11#1)(1997-2#1)(2007-7#1)(2007-8#1)(2008-5#1)
to be exceptionally##2##3##(2008-4#1)(2008-7#1)
to be excessive##2##3##(2008-8#1)(2010-4#1)
to be excised##2##3##(2007-9#1)(2011-1#1)
to be excluded from the##2##5##(2005-9#1)(2007-3#1)
to be excluded##8##3##(1996-8#1)(2005-9#1)(2006-4#1)(2007-3#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-2#1)
to be exclusively##6##3##(1993-4#1)(1995-10#1)(2006-2#1)(2007-3#1)(2010-5#1)(2011-1#1)
to be exercised##2##3##(1996-12#1)(2009-8#1)
to be exerted through##2##4##(1990-12#1)(1994-11#1)
to be expanded##2##3##(2008-11#1)(2011-1#1)
to be expected to##2##4##(1991-3#1)(2008-6#1)
to be expected##17##3##(1990-8#2)(1991-3#1)(1994-3#1)(1994-4#1)(1995-7#1)(1996-6#1)(1996-9#1)(1997-6#1)(2007-12#1)(2007-6#1)(2008-3#1)(2008-6#2)(2009-4#1)(2010-12#1)(2010-3#1)
to be explained in terms of##2##6##(2008-8#1)(2012-2#1)
to be explained##5##3##(1995-4#1)(1997-7#1)(2008-11#1)(2008-8#1)(2012-2#1)
to be exploited##2##3##(2008-10#1)(2008-7#1)
to be explored##19##3##(1990-2#1)(1994-2#1)(2006-10#2)(2006-6#1)(2006-9#1)(2007-10#1)(2007-12#3)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2013-1#2)(2013-7#2)
to be exponential##2##3##(2008-3#1)(2011-12#1)
to be exposed to the##2##5##(1993-7#1)(1995-10#1)
to be exposed to##6##4##(1993-7#1)(1995-10#1)(2007-12#1)(2008-10#1)(2009-2#1)(2011-2#1)
to be exposed##7##3##(1993-7#1)(1995-10#1)(2006-5#1)(2007-12#1)(2008-10#1)(2009-2#1)(2011-2#1)
to be expressed as##4##4##(1996-12#1)(1997-4#1)(2008-10#1)(2012-3#1)
to be expressed at the##2##5##(1990-8#1)(2008-11#1)
to be expressed at##5##4##(1990-8#1)(1991-6#1)(1996-12#1)(2008-11#1)(2010-11#1)
to be expressed by##2##4##(1990-11#1)(1992-11#1)
to be expressed from##2##4##(1991-7#1)(1997-2#1)
to be expressed in a##4##5##(1992-3#1)(1996-10#1)(2008-2#1)(2010-12#1)
to be expressed in the##6##5##(1993-6#2)(1994-10#1)(2010-12#1)(2010-5#1)(2013-8#1)
to be expressed in##26##4##(1990-11#1)(1991-5#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-6#2)(1994-10#1)(1994-11#1)(1994-9#1)(1995-6#1)(1996-10#1)(1996-5#1)(2008-10#1)(2008-2#2)(2010-12#2)(2010-5#2)(2011-1#2)(2011-12#1)(2012-3#2)(2013-8#1)
to be expressed more##2##4##(1993-2#1)(2008-11#1)
to be expressed only##2##4##(1992-9#1)(2009-12#1)
to be expressed predominantly##2##4##(1992-12#1)(1995-8#1)
to be expressed##51##3##(1990-11#2)(1990-8#1)(1991-5#1)(1991-6#1)(1991-7#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-2#1)(1993-6#2)(1994-10#1)(1994-11#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-4#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-7#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-12#2)(2010-5#2)(2011-1#2)(2011-12#1)(2012-2#1)(2012-3#3)(2013-8#1)
to be extended from##2##4##(2008-10#1)(2008-8#1)
to be extended to##4##4##(2008-10#1)(2008-3#1)(2009-12#1)(2009-2#1)
to be extended##9##3##(1992-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-12#1)(2009-2#1)
to be extensively##2##3##(1996-8#1)(2008-10#1)
to be extracted from##2##4##(1996-12#1)(2012-1#1)
to be extracted##8##3##(1996-12#1)(2008-10#4)(2012-1#1)(2013-1#2)
to be extremely sensitive to##2##5##(1994-9#1)(1996-2#1)
to be extremely sensitive##3##4##(1994-9#1)(1996-2#1)(2008-10#1)
to be extremely##17##3##(1993-9#1)(1994-12#1)(1994-9#1)(1995-2#1)(1996-2#1)(1997-2#1)(2005-12#1)(2006-10#1)(2007-11#2)(2007-5#1)(2008-10#2)(2008-3#1)(2010-12#1)(2011-1#1)(2011-2#1)
to be facilitated by the##2##5##(2008-7#1)(2011-1#1)
to be facilitated by##3##4##(2008-7#2)(2011-1#1)
to be facilitated##4##3##(2008-11#1)(2008-7#2)(2011-1#1)
to be factors##2##3##(1991-12#1)(2007-7#1)
to be false positive##2##4##(1991-3#1)(2009-3#1)
to be familiar with the##6##5##(1992-2#1)(1996-3#1)(2004-3#1)(2006-10#1)(2007-8#1)(2008-2#1)
to be familiar with these##2##5##(2007-12#1)(2007-4#1)
to be familiar with##12##4##(1992-2#1)(1996-3#1)(2004-3#1)(2006-10#1)(2007-12#1)(2007-4#2)(2007-8#1)(2008-11#1)(2008-2#1)(2009-5#1)(2011-1#1)
to be familiar##13##3##(1992-2#1)(1996-3#1)(2004-3#2)(2006-10#1)(2007-12#1)(2007-4#2)(2007-8#1)(2008-11#1)(2008-2#1)(2009-5#1)(2011-1#1)
to be far more##3##4##(2009-5#1)(2011-2#1)(2013-8#1)
to be far superior to##2##5##(1993-5#1)(2008-11#1)
to be far##7##3##(1993-5#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-5#1)(2011-2#1)(2013-8#1)
to be fast##5##3##(1990-11#1)(2007-8#1)(2008-10#1)(2012-12#2)
to be faster##4##3##(1990-12#1)(1995-10#1)(2009-2#1)(2012-1#1)
to be favored by##2##4##(2008-9#1)(2009-3#1)
to be favored##3##3##(1991-4#1)(2008-9#1)(2009-3#1)
to be feasible and##3##4##(2008-11#1)(2010-7#1)(2011-2#1)
to be feasible##10##3##(1996-8#1)(2006-7#1)(2008-11#2)(2008-3#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-1#1)
to be fed##2##3##(2008-7#1)(2013-8#1)
to be female##3##3##(1991-10#1)(1995-3#1)(2008-10#1)
to be fertile##2##3##(2006-8#1)(2008-5#1)
to be filled with##2##4##(2008-10#1)(2008-9#1)
to be filled##5##3##(1990-4#1)(2008-10#1)(2008-7#2)(2008-9#1)
to be first##3##3##(2006-3#1)(2007-12#1)(2008-2#1)
to be fit for purpose##2##5##(2007-8#1)(2012-12#1)
to be fit for##3##4##(1991-3#1)(2007-8#1)(2012-12#1)
to be flawed##2##3##(1995-6#1)(2007-9#1)
to be flexible##2##3##(1997-3#1)(2010-9#1)
to be followed by##5##4##(2006-10#1)(2008-10#1)(2008-7#2)(2012-2#1)
to be followed##13##3##(1993-11#1)(1995-8#2)(2006-10#1)(2006-2#1)(2008-10#3)(2008-6#1)(2008-7#2)(2012-2#2)
to be formed from##2##4##(1994-9#2)
to be formed in the##2##5##(2008-11#1)(2010-9#1)
to be formed in##3##4##(2008-10#1)(2008-11#1)(2010-9#1)
to be formed upon the action of Corynebacteria##2##8##(2006-12#1)(2008-5#1)
to be formed##15##3##(1994-9#3)(1995-6#1)(1996-5#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-9#1)
to be found from##2##4##(2008-3#1)(2008-5#1)
to be found in the##4##5##(1990-12#1)(1996-3#1)(2007-12#1)(2008-2#1)
to be found in##10##4##(1990-12#2)(1996-3#1)(2005-11#1)(2007-12#2)(2007-8#1)(2008-12#1)(2008-2#1)(2011-2#1)
to be found to##2##4##(2006-6#1)(2009-10#1)
to be found##25##3##(1990-12#2)(1996-3#2)(1997-3#1)(2005-11#1)(2006-6#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-9#1)(2010-12#1)(2011-2#2)
to be free from##5##4##(1991-6#1)(1992-1#1)(2008-10#2)(2008-2#1)
to be free of##3##4##(1993-12#1)(1994-3#1)(1995-6#1)
to be free##9##3##(1991-6#1)(1992-1#1)(1993-12#1)(1994-3#1)(1995-6#1)(2008-10#2)(2008-2#1)(2008-5#1)
to be frequent##3##3##(1997-6#1)(2013-1#2)
to be frequently associated with##2##5##(2012-1#1)(2013-8#1)
to be frequently##6##3##(1995-4#1)(2005-7#1)(2008-8#1)(2009-8#1)(2012-1#1)(2013-8#1)
to be from 1##2##4##(2006-8#1)(2009-7#1)
to be from##8##3##(1991-4#1)(2005-12#1)(2006-3#1)(2006-8#1)(2007-9#1)(2008-11#2)(2009-7#1)
to be fulfilled##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
to be fully defined##2##4##(1991-7#1)(2006-10#1)
to be fully elucidated##6##4##(2008-12#1)(2008-4#1)(2008-5#1)(2009-3#1)(2011-2#1)(2013-1#1)
to be fully exploited##2##4##(2008-1#1)(2008-9#1)
to be fully functional##2##4##(1994-10#1)(1994-2#1)
to be fully informed##2##4##(2006-3#1)(2012-2#1)
to be fully sequenced##2##4##(2008-11#1)(2008-8#1)
to be fully##39##3##(1991-7#1)(1992-1#1)(1994-10#1)(1994-2#1)(1994-3#1)(1995-12#1)(1997-4#1)(1997-5#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
to be functional in##2##4##(1993-3#1)(1994-5#1)
to be functional##8##3##(1993-3#1)(1994-2#1)(1994-5#1)(1995-8#1)(1995-9#1)(2008-11#1)(2009-10#2)
to be functionally equivalent to##2##5##(2007-12#1)(2008-7#1)
to be functionally involved in##2##5##(1990-11#1)(1992-8#1)
to be functionally##11##3##(1990-11#1)(1990-2#1)(1992-8#1)(1995-2#1)(1995-8#1)(1996-11#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
to be further defined in##2##5##(2007-11#1)(2008-5#1)
to be further explored##3##4##(2007-7#1)(2008-12#1)(2013-1#1)
to be further investigated##4##4##(1997-7#1)(2008-5#1)(2008-8#1)(2011-1#1)
to be further##18##3##(1994-9#1)(1997-2#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-8#2)(2011-1#1)(2012-2#2)(2013-1#2)
to be gained from##4##4##(1994-3#1)(2006-10#1)(2010-10#1)(2011-10#1)
to be gained##9##3##(1994-2#1)(1994-3#1)(2006-10#1)(2009-12#1)(2010-10#1)(2010-6#1)(2011-10#1)(2011-2#1)(2013-1#1)
to be gathered##2##3##(1991-11#1)(1996-2#1)
to be general##3##3##(1995-3#1)(2008-10#1)(2008-11#1)
to be generally applicable##2##4##(1991-11#1)(1991-2#1)
to be generally##13##3##(1991-11#1)(1991-2#1)(1995-5#1)(1996-2#1)(2006-8#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#2)(2010-2#1)
to be generated by alternative splicing##2##6##(1991-6#1)(1993-9#1)
to be generated by##6##4##(1990-5#1)(1991-6#1)(1993-9#1)(1994-10#1)(1995-2#1)(1996-5#1)
to be generated in##3##4##(1991-5#1)(2007-12#1)(2008-10#1)
to be generated##15##3##(1990-5#1)(1991-5#2)(1991-6#1)(1993-9#1)(1994-10#1)(1995-2#1)(1996-5#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-2#1)
to be genetically##8##3##(1990-11#1)(1991-12#1)(1996-12#1)(2008-10#1)(2008-9#1)(2009-4#1)(2011-1#1)(2012-2#1)
to be geographically##2##3##(2009-9#1)(2010-8#1)
to be given by##2##4##(2007-2#1)(2007-9#1)
to be given for##3##4##(2007-9#2)(2008-6#1)
to be given to##6##4##(1992-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-3#1)
to be given##21##3##(1991-5#1)(1992-12#1)(1996-9#1)(2005-7#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#4)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2011-1#1)(2012-3#1)(2013-1#2)
to be globally##2##3##(2008-2#1)(2010-4#1)
to be glycosylated##4##3##(1991-1#1)(1992-5#1)(1994-3#1)(1994-9#1)
to be good or##2##4##(1993-5#1)(1996-1#1)
to be good predictors##2##4##(2007-6#1)(2011-2#1)
to be good##19##3##(1990-6#1)(1992-11#1)(1993-5#1)(1996-1#1)(1996-10#1)(1996-3#1)(1997-8#1)(2006-11#1)(2007-1#1)(2007-6#1)(2008-10#5)(2009-4#1)(2009-5#1)(2011-2#1)(2013-8#1)
to be governed by##2##4##(2006-1#1)(2006-12#1)
to be governed##3##3##(2006-1#1)(2006-12#1)(2008-5#1)
to be greater for##4##4##(1993-6#1)(1994-3#1)(2008-10#1)(2008-2#1)
to be greater in the##4##5##(1997-4#1)(2008-5#1)(2011-12#1)(2011-2#1)
to be greater in##11##4##(1996-12#1)(1996-7#1)(1997-4#1)(2004-11#1)(2007-4#2)(2008-3#1)(2008-5#1)(2010-3#1)(2011-12#1)(2011-2#1)
to be greater than##12##4##(1990-12#2)(1992-1#1)(1996-8#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-2#2)(2012-11#1)(2013-1#1)
to be greater##30##3##(1990-12#2)(1992-1#1)(1993-12#1)(1993-6#1)(1994-3#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-4#1)(2004-11#1)(2006-6#1)(2007-11#1)(2007-4#2)(2008-10#4)(2008-2#3)(2008-3#1)(2008-5#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-11#1)(2013-1#2)
to be greatest##3##3##(1996-5#1)(2004-4#1)(2005-8#1)
to be guided by##3##4##(2007-10#1)(2007-4#1)(2008-8#1)
to be guided##4##3##(2007-10#1)(2007-12#1)(2007-4#1)(2008-8#1)
to be hampered by##2##4##(2006-5#1)(2011-2#1)
to be harmful##3##3##(2004-4#1)(2012-3#1)(2013-1#1)
to be harvested##2##3##(2006-8#1)(2008-5#1)
to be hazardous to##2##4##(2008-11#1)(2010-8#1)
to be healthy and##2##4##(2008-10#1)(2013-7#1)
to be healthy##5##3##(1996-6#2)(2007-12#1)(2008-10#1)(2013-7#1)
to be heavily##4##3##(2005-5#1)(2006-10#1)(2008-11#1)(2011-2#1)
to be held in##2##4##(2004-12#1)(2011-4#1)
to be held##4##3##(1991-5#1)(2004-12#1)(2007-1#1)(2011-4#1)
to be helpful for##4##4##(1997-7#1)(2008-4#1)(2013-1#2)
to be helpful in##4##4##(2006-10#2)(2008-3#1)(2012-2#1)
to be helpful##10##3##(1997-7#1)(2005-11#1)(2006-10#2)(2008-3#1)(2008-4#1)(2009-2#1)(2012-2#1)(2013-1#2)
to be heterogeneous##3##3##(1992-9#1)(2004-11#1)(2010-4#1)
to be heterosexual##2##3##(1991-8#1)(2009-7#1)
to be high and##2##4##(1996-12#1)(2008-8#1)
to be high##14##3##(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1996-12#1)(1996-8#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-7#1)(2009-9#1)(2010-8#1)(2011-1#1)
to be higher and##3##4##(2008-3#1)(2008-7#1)(2013-1#1)
to be higher for##3##4##(2008-5#1)(2010-4#1)(2011-2#1)
to be higher in males than in females##2##8##(2010-3#1)(2013-1#1)
to be higher in men##2##5##(1994-5#1)(2008-6#1)
to be higher in patients with##2##6##(1993-12#1)(1996-9#1)
to be higher in patients##3##5##(1993-12#1)(1996-9#1)(2008-8#1)
to be higher in the##4##5##(1990-7#1)(1994-6#1)(2008-3#1)(2009-4#1)
to be higher in##23##4##(1990-7#1)(1993-12#1)(1993-5#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-3#1)(1996-9#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-3#1)(2012-2#1)(2013-1#4)(2013-8#2)
to be higher than that of the##3##7##(1993-8#1)(1994-11#1)(2008-5#1)
to be higher than that##7##5##(1990-9#1)(1993-8#1)(1994-11#1)(1996-1#1)(2006-8#1)(2008-11#1)(2008-5#1)
to be higher than the##2##5##(2011-2#1)(2013-1#1)
to be higher than those##4##5##(2004-11#1)(2008-10#1)(2008-11#1)(2008-2#1)
to be higher than##20##4##(1990-9#1)(1993-8#2)(1994-11#1)(1996-1#1)(2004-11#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-5#1)(2009-6#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#1)
to be higher##55##3##(1990-7#1)(1990-9#1)(1993-12#1)(1993-5#1)(1993-8#2)(1994-11#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-3#1)(1996-1#2)(1996-9#1)(2004-11#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#5)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-3#1)(2010-4#1)(2011-2#3)(2012-11#1)(2012-2#1)(2013-1#6)(2013-8#3)
to be highest in##2##4##(1993-6#1)(2008-10#1)
to be highest##7##3##(1993-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-4#2)(2012-12#1)
to be highly accurate##2##4##(2008-2#1)(2010-4#1)
to be highly conserved##5##4##(1990-11#1)(1990-6#1)(1992-11#1)(1994-3#1)(2006-8#1)
to be highly correlated##5##4##(1996-7#1)(1997-2#1)(2008-10#1)(2008-6#1)(2008-7#1)
to be highly dependent on##2##5##(1992-2#1)(2007-11#1)
to be highly dependent##3##4##(1992-2#1)(2007-11#1)(2008-10#1)
to be highly effective in the##2##6##(2007-11#1)(2008-5#1)
to be highly effective in##5##5##(2006-12#1)(2007-11#1)(2007-8#1)(2008-5#1)(2012-2#1)
to be highly effective##6##4##(2006-12#1)(2007-11#1)(2007-8#1)(2008-5#1)(2012-11#1)(2012-2#1)
to be highly expressed in##2##5##(2011-1#1)(2013-8#1)
to be highly expressed##3##4##(2011-1#1)(2011-2#1)(2013-8#1)
to be highly homologous to##2##5##(1991-7#1)(1994-3#1)
to be highly immunogenic##3##4##(2007-11#1)(2008-4#1)(2013-8#1)
to be highly relevant to##2##5##(2008-3#1)(2008-5#1)
to be highly resistant to##3##5##(2008-10#1)(2008-11#1)(2008-8#1)
to be highly selective for##2##5##(2008-10#2)
to be highly selective##4##4##(1991-4#1)(2008-10#3)
to be highly sensitive and specific##2##6##(2008-10#1)(2008-3#1)
to be highly sensitive##5##4##(1992-12#1)(2008-10#2)(2008-3#1)(2008-7#1)
to be highly significant (P&lt##2##5##(1997-6#1)(2011-1#1)
to be highly significant##6##4##(1997-6#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-6#1)(2011-1#1)
to be highly similar to##2##5##(1991-5#1)(1995-6#1)
to be highly suitable for##2##5##(2008-1#1)(2008-10#1)
to be highly unstable and##2##5##(1990-12#1)(1991-4#1)
to be highly unstable##3##4##(1990-12#1)(1991-4#1)(1995-2#1)
to be highly##104##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#1)(1991-4#2)(1991-5#2)(1991-7#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#2)(1993-12#1)(1993-3#1)(1994-3#2)(1994-5#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-11#1)(2005-8#2)(2006-12#3)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#3)(2009-7#1)(2010-4#1)(2010-6#1)(2011-1#5)(2011-2#5)(2012-11#1)(2012-2#2)(2012-3#3)(2013-8#4)
to be homogeneous##5##3##(1990-5#1)(1992-8#1)(1994-6#1)(1997-6#1)(2008-3#1)
to be homologous to the##2##5##(1990-11#1)(1992-9#1)
to be homologous to##4##4##(1990-11#1)(1992-9#1)(1995-2#1)(2008-8#1)
to be homologous##7##3##(1990-11#1)(1991-12#1)(1992-9#1)(1995-2#1)(1995-3#1)(1996-12#1)(2008-8#1)
to be homozygous##2##3##(1995-2#1)(2008-5#1)
to be hospitalized##5##3##(1990-8#1)(1995-2#1)(1995-6#1)(2008-3#1)(2010-6#1)
to be hydrolyzed##2##3##(1990-4#1)(2008-6#1)
to be hydrophilic##3##3##(1994-12#1)(1996-12#1)(2006-8#1)
to be hydrophobic##2##3##(1997-8#1)(2006-10#1)
to be hypertensive##2##3##(2008-11#1)(2008-7#1)
to be identical except for##2##5##(1990-8#1)(1991-10#1)
to be identical in##3##4##(1993-9#1)(1997-6#1)(2007-6#1)
to be identical to that of the##2##7##(1991-10#1)(1997-8#1)
to be identical to that of##4##6##(1990-2#1)(1991-10#1)(1996-12#1)(1997-8#1)
to be identical to that##5##5##(1990-2#1)(1991-10#1)(1996-12#1)(1997-8#1)(2008-10#1)
to be identical to the##2##5##(1994-12#1)(1995-6#1)
to be identical to those of##3##6##(1991-3#1)(1991-8#1)(1992-3#1)
to be identical to##16##4##(1990-2#1)(1990-3#1)(1991-10#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-12#1)(1992-3#1)(1994-12#1)(1995-6#1)(1996-12#1)(1997-6#1)(1997-8#1)(2008-10#2)
to be identical with##4##4##(1990-5#1)(1991-2#1)(1991-8#1)(1992-11#1)
to be identical##30##3##(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-10#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#3)(1992-11#1)(1992-12#1)(1992-3#1)(1993-9#1)(1994-12#1)(1995-6#1)(1996-12#1)(1997-6#2)(1997-8#1)(2006-3#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)
to be identified and##5##4##(1993-9#1)(2008-4#1)(2009-6#1)(2010-12#1)(2011-1#1)
to be identified as##7##4##(1990-2#1)(1991-8#1)(1997-1#1)(2008-10#2)(2013-8#2)
to be identified in##2##4##(2007-9#1)(2008-10#1)
to be identified to##2##4##(2008-5#1)(2010-11#1)
to be identified##49##3##(1990-12#1)(1990-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1993-9#1)(1994-12#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1997-1#1)(1997-4#1)(1997-7#2)(2004-2#1)(2006-10#1)(2006-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-6#2)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#3)
to be ignored##2##3##(2008-3#1)(2013-1#1)
to be imaged##2##3##(2008-12#1)(2008-3#1)
to be immersed in##2##4##(2008-11#1)(2008-3#1)
to be immobilized on##2##4##(2007-8#1)(2008-11#1)
to be immunogenic and##2##4##(2005-7#1)(2007-10#1)
to be immunogenic##3##3##(2005-7#1)(2007-10#1)(2008-11#1)
to be impacted by##2##4##(2008-5#1)(2011-2#1)
to be impaired in##5##4##(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-1#1)
to be impaired##11##3##(1990-11#1)(1995-5#1)(1995-6#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-7#2)(2011-2#1)(2012-1#1)
to be implemented by##2##4##(2007-12#1)(2008-11#1)
to be implemented in##2##4##(2007-11#1)(2008-7#1)
to be implemented with##2##4##(2007-12#1)(2008-3#1)
to be implemented##22##3##(1992-1#1)(1992-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-3#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-9#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2011-2#1)(2013-1#1)
to be implicated in##6##4##(1991-5#1)(2007-12#1)(2009-4#1)(2009-8#1)(2010-4#1)(2012-2#1)
to be implicated##8##3##(1991-5#1)(2007-12#2)(2007-8#1)(2009-4#1)(2009-8#1)(2010-4#1)(2012-2#1)
to be important determinants of##3##5##(1996-5#1)(2008-8#1)(2009-7#1)
to be important factors##3##4##(2008-10#2)(2008-11#1)
to be important for the##9##5##(1991-3#1)(1994-8#2)(1996-1#1)(1996-2#1)(1996-5#1)(1996-9#1)(2008-3#1)(2008-4#1)
to be important for##33##4##(1990-4#1)(1990-9#1)(1991-3#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-3#2)(1993-5#1)(1994-8#3)(1995-6#2)(1996-1#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-6#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#1)(2009-8#2)(2013-1#1)
to be important in a##2##5##(1996-3#1)(2008-3#1)
to be important in the##16##5##(1990-2#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-6#1)(1995-5#1)(1996-2#1)(1996-6#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-5#1)
to be important in##37##4##(1990-2#1)(1990-8#1)(1991-5#1)(1992-10#1)(1992-8#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-6#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-2#1)(1996-3#1)(1996-6#1)(2004-4#1)(2006-10#2)(2007-2#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-8#1)
to be important to the##3##5##(2007-2#1)(2010-5#1)(2012-3#1)
to be important to##7##4##(2007-11#1)(2007-2#1)(2008-6#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-7#1)
to be important##122##3##(1990-11#1)(1990-2#1)(1990-4#1)(1990-8#2)(1990-9#1)(1991-3#1)(1991-4#1)(1991-5#2)(1992-10#1)(1992-12#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-12#2)(1993-3#2)(1993-5#2)(1993-9#1)(1994-6#1)(1994-8#3)(1995-3#1)(1995-5#1)(1995-6#3)(1995-7#1)(1996-1#2)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-6#2)(2004-10#1)(2004-12#1)(2004-4#1)(2006-10#5)(2006-12#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-2#2)(2008-1#2)(2008-10#7)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#4)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
to be improved by##3##4##(2008-10#1)(2013-1#2)
to be improved in the##3##5##(2007-2#1)(2009-3#1)(2012-12#1)
to be improved in##5##4##(2006-11#1)(2007-2#1)(2007-8#1)(2009-3#1)(2012-12#1)
to be improved significantly##2##4##(2009-3#1)(2010-8#1)
to be improved##27##3##(1992-12#1)(1994-2#1)(1997-3#1)(2006-10#2)(2006-11#1)(2006-4#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-7#1)(2009-3#2)(2009-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
to be in a##13##4##(1990-8#1)(1993-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-12#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#1)(2009-3#1)
to be in agreement with##6##5##(1996-8#1)(2007-12#1)(2008-10#2)(2008-3#1)(2012-12#1)
to be in agreement##7##4##(1996-8#1)(2007-12#1)(2008-10#2)(2008-3#2)(2012-12#1)
to be in an##3##4##(1990-3#1)(2008-4#1)(2011-2#1)
to be in equilibrium##2##4##(1991-2#1)(2008-7#1)
to be in excellent agreement with a##2##7##(2007-12#1)(2008-3#1)
to be in excellent agreement with##7##6##(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-9#1)(2012-11#1)
to be in good agreement with the observed##2##8##(1992-11#1)(2007-12#1)
to be in good agreement with the##12##7##(1992-11#1)(2006-2#1)(2007-11#1)(2007-12#4)(2008-10#2)(2008-2#3)
to be in good agreement with theory##2##7##(2007-12#1)(2008-2#1)
to be in good agreement with##23##6##(1992-11#1)(2006-2#1)(2006-7#1)(2007-11#2)(2007-12#5)(2008-10#4)(2008-2#6)(2008-3#2)(2008-8#1)
to be in good agreement##26##5##(1992-11#1)(2006-2#1)(2006-7#1)(2007-11#2)(2007-12#5)(2008-10#5)(2008-2#7)(2008-3#3)(2008-8#1)
to be in good##28##4##(1992-11#1)(2006-2#1)(2006-7#1)(2007-11#2)(2007-12#5)(2007-9#1)(2008-10#6)(2008-2#7)(2008-3#3)(2008-8#1)
to be in keeping with##2##5##(2006-4#1)(2007-11#1)
to be in linkage##2##4##(2008-7#1)(2012-3#1)
to be in more##2##4##(2007-11#1)(2008-4#1)
to be in part##2##4##(1994-6#1)(2006-2#1)
to be in place##4##4##(2007-12#1)(2008-12#1)(2009-4#1)(2011-2#1)
to be in the form of##2##6##(2008-10#1)(2008-2#1)
to be in the range of##16##6##(1995-8#1)(1996-1#1)(2005-7#1)(2006-10#1)(2008-10#7)(2008-3#1)(2009-10#1)(2010-12#1)(2010-2#1)(2010-5#1)
to be in the range##20##5##(1995-8#1)(1996-1#1)(1997-1#1)(2005-7#1)(2006-10#1)(2008-10#9)(2008-3#1)(2009-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2013-8#1)
to be in the##39##4##(1990-12#1)(1993-11#1)(1993-8#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#1)(2008-10#12)(2008-2#2)(2008-3#1)(2009-10#1)(2010-12#1)(2010-2#1)(2010-5#2)(2012-12#1)(2013-1#2)(2013-8#1)
to be in this##2##4##(2006-4#1)(2008-10#1)
to be in##152##3##(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-2#2)(1991-3#1)(1991-7#2)(1991-8#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#2)(1997-6#1)(1997-8#1)(2004-11#1)(2005-11#3)(2005-7#2)(2005-8#2)(2006-10#3)(2006-2#2)(2006-4#2)(2006-7#1)(2007-11#4)(2007-12#9)(2007-9#1)(2008-10#24)(2008-12#2)(2008-2#14)(2008-3#7)(2008-4#3)(2008-7#3)(2008-8#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#2)(2011-2#4)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
to be inaccurate##2##3##(2011-2#1)(2013-1#1)
to be inactivated##4##3##(1994-3#1)(1995-6#1)(2007-4#1)(2008-5#1)
to be inactive##10##3##(1990-7#1)(1992-5#1)(1992-6#1)(1994-8#1)(1996-5#3)(2006-12#1)(2008-10#1)(2008-5#1)
to be inadequate for##2##4##(2009-1#1)(2012-12#1)
to be inadequate##6##3##(1995-11#1)(2005-12#1)(2009-1#1)(2010-11#2)(2012-12#1)
to be included in the##7##5##(1992-8#1)(2005-11#1)(2006-10#1)(2008-1#1)(2008-2#1)(2009-7#1)(2012-3#1)
to be included in##12##4##(1990-3#1)(1992-8#1)(2005-11#1)(2006-10#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-7#1)(2010-11#1)(2012-3#1)
to be included##16##3##(1990-3#1)(1992-8#1)(2005-11#1)(2006-10#1)(2006-6#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#2)(2009-7#1)(2010-11#2)(2012-3#1)(2013-8#1)
to be incompatible with##4##4##(1993-7#1)(1994-11#1)(2008-5#1)(2011-2#1)
to be incompatible##5##3##(1993-7#1)(1994-11#1)(2008-5#1)(2008-9#1)(2011-2#1)
to be incomplete and##2##4##(1993-12#1)(2008-11#1)
to be incomplete##4##3##(1993-12#1)(2008-11#1)(2008-5#1)(2008-8#1)
to be incorporated in##3##4##(2008-11#1)(2008-12#1)(2009-7#1)
to be incorporated into the##3##5##(1997-1#1)(2008-3#1)(2008-9#1)
to be incorporated into##6##4##(1997-1#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-12#1)
to be incorporated##12##3##(1991-12#1)(1997-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-2#1)(2012-12#1)
to be increased by a##2##5##(2008-3#1)(2008-7#1)
to be increased by##8##4##(1992-9#1)(1993-7#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-7#2)(2011-2#1)
to be increased during##2##4##(1993-2#1)(2004-12#1)
to be increased in##14##4##(1990-2#1)(1992-8#1)(1994-8#1)(1995-9#1)(1996-1#1)(1996-7#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#2)(2012-12#1)(2013-8#2)
to be increased##38##3##(1990-11#1)(1990-2#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-7#1)(1994-12#1)(1994-8#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-7#1)(1997-2#1)(1997-3#1)(2004-12#1)(2004-3#1)(2007-11#4)(2007-8#2)(2008-1#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-7#4)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#2)
to be increasing in##2##4##(2011-2#2)
to be increasing##10##3##(1994-6#1)(2005-8#1)(2006-2#1)(2007-3#1)(2009-9#1)(2010-6#1)(2011-2#2)(2012-12#1)(2013-8#1)
to be increasingly##3##3##(2005-9#1)(2006-8#1)(2009-12#1)
to be independent factors##2##4##(2007-10#1)(2009-12#1)
to be independent of age##2##5##(2008-1#1)(2008-3#1)
to be independent of the##14##5##(1995-12#1)(1995-3#1)(1997-2#1)(2005-11#1)(2006-7#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#1)
to be independent of##28##4##(1990-2#1)(1991-11#1)(1991-9#1)(1994-9#1)(1995-12#1)(1995-3#1)(1997-2#1)(1997-8#1)(2005-11#2)(2006-7#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-7#1)(2009-8#1)(2010-5#1)(2011-11#1)(2012-2#1)
to be independent prognostic factors##2##5##(1994-7#1)(2007-8#1)
to be independent risk factors for##2##6##(2007-10#1)(2010-8#1)
to be independent##38##3##(1990-12#1)(1990-2#1)(1991-11#1)(1991-9#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-2#1)(1997-8#2)(2005-11#2)(2006-7#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-11#1)(2012-2#1)
to be independently associated with##3##5##(1995-8#1)(2011-2#1)(2012-3#1)
to be independently##5##3##(1992-9#1)(1995-8#1)(2008-2#1)(2011-2#1)(2012-3#1)
to be indicated##3##3##(1993-12#1)(1996-9#1)(2013-1#1)
to be indicative of##2##4##(2006-8#1)(2008-8#1)
to be indicative##3##3##(1993-10#1)(2006-8#1)(2008-8#1)
to be indistinguishable from the##4##5##(1991-9#1)(1993-11#1)(1995-2#1)(2005-11#1)
to be indistinguishable from##6##4##(1991-9#1)(1993-11#1)(1995-2#1)(2005-11#1)(2006-3#1)(2012-2#1)
to be indistinguishable##7##3##(1991-9#1)(1993-11#1)(1995-2#1)(1995-8#1)(2005-11#1)(2006-3#1)(2012-2#1)
to be individualized##2##3##(2006-10#1)(2008-7#1)
to be induced by the##2##5##(1996-6#1)(2007-3#1)
to be induced by##10##4##(1991-7#1)(1992-7#1)(1994-12#1)(1994-2#1)(1996-6#1)(1996-9#1)(2007-3#1)(2008-10#1)(2008-2#1)(2012-12#1)
to be induced in##3##4##(1995-5#1)(2012-2#1)(2013-8#1)
to be induced##18##3##(1991-7#1)(1992-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-5#2)(1996-6#1)(1996-9#1)(2006-10#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
to be ineffective in the##2##5##(2012-2#1)(2013-8#1)
to be ineffective in##6##4##(1994-2#1)(1995-12#1)(2005-11#1)(2012-12#1)(2012-2#1)(2013-8#1)
to be ineffective##15##3##(1990-3#1)(1994-2#1)(1995-12#1)(1996-2#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-9#1)(2010-5#1)(2012-12#3)(2012-2#1)(2013-8#1)
to be infected by##3##4##(2008-10#2)(2012-12#1)
to be infected with HIV##2##5##(1993-6#1)(1997-5#1)
to be infected with##4##4##(1993-6#1)(1997-5#1)(2007-4#1)(2008-10#1)
to be infected##12##3##(1993-6#1)(1997-4#1)(1997-5#1)(2007-4#2)(2008-10#4)(2008-9#1)(2011-2#1)(2012-12#1)
to be infective##2##3##(2007-6#1)(2008-4#1)
to be inferior to##2##4##(1994-5#1)(1995-12#1)
to be inferred##4##3##(2006-3#1)(2007-12#1)(2008-3#2)
to be influenced by the##11##5##(1990-9#1)(1991-12#1)(1994-5#1)(1996-12#1)(1997-7#1)(2006-6#1)(2008-10#2)(2008-7#1)(2009-10#1)(2010-6#1)
to be influenced by##28##4##(1990-9#1)(1991-10#1)(1991-12#1)(1991-7#1)(1993-6#1)(1994-3#1)(1994-5#2)(1995-5#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-7#1)(2005-3#1)(2006-10#1)(2006-6#1)(2007-10#2)(2008-10#3)(2008-11#1)(2008-7#1)(2009-10#1)(2010-2#1)(2010-6#1)(2011-12#1)(2011-2#1)
to be influenced##30##3##(1990-9#1)(1991-10#1)(1991-12#1)(1991-7#1)(1993-6#1)(1994-3#1)(1994-5#2)(1995-5#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-7#1)(2005-3#1)(2006-10#1)(2006-6#1)(2007-10#2)(2008-10#3)(2008-11#1)(2008-7#1)(2009-10#1)(2009-11#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)
to be informative for##2##4##(1997-5#1)(2008-12#1)
to be informative##5##3##(1993-8#1)(1995-2#1)(1997-5#1)(2006-9#1)(2008-12#1)
to be informed about##3##4##(1996-2#1)(2005-8#1)(2012-2#1)
to be informed of the##2##5##(1993-8#1)(1996-1#1)
to be informed##7##3##(1992-2#1)(1993-8#1)(1996-1#1)(1996-2#1)(2004-4#1)(2005-8#1)(2012-2#1)
to be inherently##3##3##(2008-3#1)(2010-8#1)(2012-2#1)
to be inhibited by##7##4##(1990-11#1)(1992-6#1)(1993-8#1)(1996-5#2)(2006-10#1)(2008-8#1)
to be inhibited##10##3##(1990-11#1)(1991-4#1)(1992-6#1)(1993-8#1)(1996-5#2)(1996-6#1)(2006-10#1)(2008-5#1)(2008-8#1)
to be inhibitors of##2##4##(2006-12#1)(2007-1#1)
to be inhibitory##4##3##(1992-6#1)(1996-2#1)(1996-9#1)(2008-11#1)
to be initiated by the##2##5##(1996-1#1)(2008-11#1)
to be initiated by##5##4##(1990-11#1)(1996-1#1)(2008-11#1)(2008-4#2)
to be initiated##12##3##(1990-11#1)(1991-11#1)(1992-12#1)(1994-4#2)(1996-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-8#1)(2012-2#1)
to be injected##5##3##(2007-1#1)(2008-10#1)(2010-11#1)(2011-1#1)(2012-2#1)
to be innovative##3##3##(2007-2#1)(2012-2#1)(2013-1#1)
to be insensitive to the##4##5##(1990-5#1)(1995-3#1)(2008-1#1)(2008-3#1)
to be insensitive to##13##4##(1990-5#1)(1990-7#1)(1991-8#1)(1995-3#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#1)(2011-2#1)
to be insensitive##14##3##(1990-5#1)(1990-7#1)(1991-8#1)(1995-3#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#1)(2011-2#1)
to be inserted into the##3##5##(1997-7#2)(2008-10#1)
to be inserted##5##3##(1997-7#2)(2008-10#1)(2011-1#1)(2012-3#1)
to be insignificant##4##3##(2007-7#1)(2008-2#1)(2009-3#1)(2011-2#1)
to be instrumental in the##3##5##(2007-12#1)(2008-10#1)(2009-11#1)
to be instrumental##4##3##(1993-11#1)(2007-12#1)(2008-10#1)(2009-11#1)
to be insufficient##3##3##(2005-11#1)(2008-12#1)(2010-6#1)
to be insured##2##3##(1993-6#1)(2010-9#1)
to be intact and##2##4##(2008-11#1)(2008-7#1)
to be intact##4##3##(1993-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
to be integral membrane proteins##2##5##(1992-8#1)(1995-8#1)
to be integral to the##2##5##(2006-8#1)(2012-3#1)
to be integral##5##3##(1992-12#1)(1992-8#1)(1995-8#1)(2006-8#1)(2012-3#1)
to be integrated and##4##4##(2005-12#1)(2006-10#1)(2013-1#2)
to be integrated into the host##2##6##(1990-10#1)(1995-2#1)
to be integrated into the##4##5##(1990-10#1)(1992-5#1)(1995-2#1)(2009-4#1)
to be integrated into##5##4##(1990-10#1)(1992-5#1)(1995-2#1)(2009-4#1)(2010-1#1)
to be integrated##11##3##(1990-10#1)(1992-5#1)(1992-9#1)(1995-2#1)(2005-12#1)(2006-10#1)(2008-8#1)(2009-4#1)(2010-1#1)(2013-1#2)
to be interesting##2##3##(2007-1#1)(2010-8#1)
to be intermediate between##2##4##(1990-11#1)(1994-8#1)
to be internalized##3##3##(1991-9#1)(1994-8#1)(1997-7#1)
to be interpreted with caution##3##5##(1992-2#1)(1996-7#1)(2009-8#1)
to be interpreted##7##3##(1991-6#1)(1992-2#1)(1996-7#1)(2007-12#1)(2009-8#1)(2012-11#2)
to be interrelated##2##3##(2008-3#1)(2013-1#1)
to be interrupted##4##3##(1991-8#1)(1995-8#1)(1996-4#1)(2007-7#1)
to be interviewed##3##3##(2008-2#1)(2009-6#1)(2013-1#1)
to be intimately##2##3##(1996-11#1)(2004-11#1)
to be intracellular##2##3##(1994-9#1)(1995-5#1)
to be introduced in the##2##5##(1994-3#1)(2008-1#1)
to be introduced in##3##4##(1994-3#1)(2008-1#1)(2008-3#1)
to be introduced into##2##4##(1996-1#1)(2012-12#1)
to be introduced on a##2##5##(2005-8#1)(2013-1#1)
to be introduced to##2##4##(2006-10#1)(2009-2#1)
to be introduced##15##3##(1993-12#1)(1994-3#1)(1996-1#1)(1997-3#1)(2005-8#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-2#1)(2012-12#2)(2013-1#1)
to be invaded by##2##4##(2008-5#1)(2008-9#1)
to be invalid##4##3##(1995-2#1)(2007-12#1)(2010-2#1)(2013-1#1)
to be invariant to##2##4##(2008-2#1)(2008-3#1)
to be invariant##3##3##(2008-2#1)(2008-3#1)(2013-7#1)
to be inversely proportional to##2##5##(2004-12#1)(2008-10#1)
to be inversely related to##2##5##(1997-8#1)(2009-8#1)
to be inversely##4##3##(1997-8#1)(2004-12#1)(2008-10#1)(2009-8#1)
to be investigated in##3##4##(1996-3#1)(1996-4#1)(2008-10#1)
to be investigated##25##3##(1990-3#1)(1991-7#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-4#1)(1997-4#1)(1997-5#3)(2006-10#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-4#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
to be involved both##2##4##(2009-6#1)(2010-5#1)
to be involved in DNA binding##2##6##(1993-2#1)(2010-10#1)
to be involved in DNA##3##5##(1993-12#1)(1993-2#1)(2010-10#1)
to be involved in binding##3##5##(1994-3#1)(1994-5#1)(1996-12#1)
to be involved in cell##2##5##(1997-2#1)(2012-12#1)
to be involved in decisions##2##5##(1993-12#2)
to be involved in iron##2##5##(1997-2#1)(2010-12#1)
to be involved in its##2##5##(1991-10#1)(2008-10#1)
to be involved in many##3##5##(1994-12#1)(2008-1#1)(2013-8#1)
to be involved in membrane##2##5##(1997-6#1)(2008-7#1)
to be involved in mitosis##2##5##(2004-12#1)(2011-1#1)
to be involved in regulation of##2##6##(1991-7#1)(1996-4#1)
to be involved in signal transduction##2##6##(1995-6#1)(2008-11#1)
to be involved in the binding##2##6##(1992-12#1)(1994-5#1)
to be involved in the cellular##2##6##(1994-2#1)(2007-11#1)
to be involved in the control of##2##7##(1993-9#1)(2005-10#1)
to be involved in the pathogenesis of diabetic##2##8##(2006-1#1)(2008-1#1)
to be involved in the pathogenesis of several##2##8##(1995-12#1)(2013-8#1)
to be involved in the pathogenesis of##10##7##(1991-10#1)(1995-12#1)(1996-10#1)(1996-11#1)(2006-1#1)(2008-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2013-8#1)
to be involved in the pathophysiology of##2##7##(1993-3#1)(2008-8#1)
to be involved in the process##2##6##(2008-10#1)(2008-4#1)
to be involved in the regulation of##5##7##(1995-5#1)(1997-1#1)(1997-4#1)(2007-1#1)(2009-8#1)
to be involved in the regulation##6##6##(1995-5#1)(1997-1#1)(1997-4#1)(2007-1#1)(2009-8#1)(2011-12#1)
to be involved in the##81##5##(1990-7#2)(1990-9#1)(1991-10#1)(1991-2#2)(1991-4#1)(1991-7#1)(1992-12#1)(1992-3#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-9#1)(1994-2#3)(1994-5#1)(1994-6#2)(1995-12#3)(1995-2#1)(1995-5#1)(1995-8#1)(1996-10#2)(1996-11#1)(1996-3#1)(1996-5#2)(1997-1#2)(1997-4#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-4#4)(2008-6#1)(2008-7#2)(2008-8#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-12#1)(2011-2#2)(2013-8#2)
to be involved in##190##4##(1990-12#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-10#2)(1991-2#2)(1991-4#1)(1991-7#2)(1991-8#2)(1992-11#1)(1992-12#1)(1992-3#3)(1992-5#1)(1992-8#3)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#2)(1993-7#2)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#5)(1994-3#2)(1994-5#2)(1994-6#2)(1995-1#1)(1995-12#5)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-10#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#2)(1996-5#2)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#3)(2004-12#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#14)(2008-11#5)(2008-3#1)(2008-4#8)(2008-6#1)(2008-7#5)(2008-8#2)(2009-10#1)(2009-11#1)(2009-5#1)(2009-8#3)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#6)(2012-1#2)(2012-12#3)(2013-1#1)(2013-8#4)
to be involved with##3##4##(2007-12#1)(2009-10#1)(2009-7#1)
to be involved##209##3##(1990-12#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-10#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-7#2)(1991-8#2)(1992-11#1)(1992-12#1)(1992-3#3)(1992-5#1)(1992-8#3)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#2)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#5)(1994-3#2)(1994-5#2)(1994-6#2)(1995-1#1)(1995-12#5)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#2)(1996-5#2)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#3)(2004-12#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#16)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#2)(2009-10#2)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#3)(2010-11#2)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#6)(2012-1#2)(2012-12#3)(2013-1#1)(2013-8#5)
to be irreversible##4##3##(1990-2#1)(1992-9#1)(2006-10#1)(2007-1#1)
to be isolated from##2##4##(1994-2#1)(2008-6#1)
to be isolated##4##3##(1994-2#1)(2008-5#1)(2008-6#1)(2008-8#1)
to be joined##3##3##(2008-4#2)(2011-1#1)
to be justifiable##2##3##(2006-8#2)
to be justified##5##3##(1992-6#1)(1995-6#1)(2006-10#1)(2007-1#1)(2007-8#1)
to be kept in mind##2##5##(2008-7#1)(2011-3#1)
to be kept in##3##4##(1994-4#1)(2008-7#1)(2011-3#1)
to be kept##6##3##(1994-4#1)(1995-4#1)(2007-5#1)(2008-11#1)(2008-7#1)(2011-3#1)
to be key##4##3##(2005-7#1)(2009-9#1)(2012-12#1)(2012-3#1)
to be kinetically##2##3##(1992-1#1)(1992-9#1)
to be known about the##2##5##(1993-12#1)(2010-8#1)
to be known##9##3##(1992-12#1)(1993-12#1)(1996-5#1)(1997-8#1)(2006-10#1)(2008-2#1)(2010-2#1)(2010-8#1)(2012-1#1)
to be labeled##2##3##(1990-2#1)(1991-1#1)
to be labile##2##3##(1990-9#1)(2010-12#1)
to be laid down##2##4##(2008-10#1)(2008-7#1)
to be largely##10##3##(1990-6#1)(1995-10#1)(2004-2#1)(2007-11#2)(2008-10#1)(2009-11#1)(2010-10#1)(2011-2#1)(2013-1#1)
to be larger in##2##4##(2008-1#1)(2008-8#1)
to be larger than that of##2##6##(1996-7#1)(2007-3#1)
to be larger than the##3##5##(1990-4#1)(2008-10#1)(2008-11#1)
to be larger than##8##4##(1990-4#1)(1996-7#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#2)(2010-11#1)
to be larger##12##3##(1990-4#1)(1996-11#1)(1996-7#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-8#2)(2010-11#1)
to be launched in##2##4##(2008-3#1)(2008-5#1)
to be learned from the##2##5##(1991-11#1)(1992-2#1)
to be learned##12##3##(1991-11#1)(1992-2#1)(1993-1#1)(1994-3#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-5#1)(2010-5#1)
to be learnt##3##3##(1993-10#1)(2008-12#1)(2009-9#1)
to be least##2##3##(1990-4#1)(2008-12#1)
to be led by##2##4##(2008-10#1)(2008-7#1)
to be left##3##3##(1992-8#1)(2007-8#1)(2007-9#1)
to be less active##2##4##(2007-3#1)(2009-6#1)
to be less common##2##4##(2006-10#1)(2006-9#1)
to be less efficient##2##4##(1995-6#1)(2012-12#1)
to be less important##3##4##(2005-10#1)(2008-10#1)(2008-7#1)
to be less likely to##3##5##(2008-9#2)(2011-2#1)
to be less likely##4##4##(2008-9#2)(2011-12#1)(2011-2#1)
to be less sensitive to##4##5##(1996-5#1)(2008-10#1)(2008-2#2)
to be less than one##2##5##(2007-10#1)(2008-10#1)
to be less than or equal to##2##7##(1991-1#1)(2008-2#1)
to be less than that##2##5##(1995-5#1)(2006-1#1)
to be less than those of the##2##7##(2008-11#1)(2008-9#1)
to be less than##29##4##(1990-11#1)(1991-1#1)(1995-5#1)(1996-1#1)(2006-1#1)(2006-8#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#4)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2012-3#1)
to be less##76##3##(1990-11#1)(1990-12#1)(1991-1#1)(1991-7#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-3#1)(1994-6#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-5#1)(2005-10#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-2#5)(2008-3#4)(2008-7#2)(2008-9#4)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-8#1)
to be limited by the##2##5##(2008-2#2)
to be limited by##5##4##(1991-3#1)(2008-2#3)(2008-3#1)
to be limited in##2##4##(2006-11#1)(2007-1#1)
to be limited to##7##4##(1995-11#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-5#1)(2008-10#2)
to be limited##18##3##(1991-3#1)(1993-8#1)(1995-11#1)(1997-3#1)(1997-7#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-5#1)(2008-10#2)(2008-2#3)(2008-3#1)(2009-5#1)(2012-2#1)(2012-3#1)
to be linear and##2##4##(1994-5#1)(2007-4#1)
to be linear in the range of##4##7##(2008-10#4)
to be linear over the##4##5##(2008-10#4)
to be linear up to##2##5##(2008-10#2)
to be linear##23##3##(1992-5#1)(1993-2#2)(1994-5#1)(2007-4#1)(2007-8#1)(2008-10#13)(2008-11#1)(2010-2#2)(2012-2#1)
to be linearly proportional to the##3##6##(1994-3#1)(2008-10#1)(2008-3#1)
to be linearly proportional##4##4##(1994-3#1)(1995-3#1)(2008-10#1)(2008-3#1)
to be linearly##8##3##(1994-3#1)(1995-3#1)(2007-4#2)(2008-10#2)(2008-3#1)(2008-7#1)
to be linked to a##3##5##(1991-1#1)(2006-10#1)(2008-5#1)
to be linked to the##2##5##(2006-12#1)(2008-7#1)
to be linked to##18##4##(1990-2#1)(1991-1#1)(1992-2#1)(1994-4#1)(1996-1#1)(2006-10#1)(2006-12#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#1)(2010-3#3)(2012-3#1)
to be linked##23##3##(1990-2#1)(1991-1#1)(1991-9#1)(1992-2#1)(1993-9#1)(1994-4#1)(1996-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#1)(2010-3#3)(2012-3#1)
to be little##4##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)
to be loaded##2##3##(2005-7#1)(2008-12#1)
to be localized in the##4##5##(1990-2#1)(1992-7#1)(1995-2#1)(1997-5#1)
to be localized in##7##4##(1990-2#1)(1992-7#1)(1995-2#1)(1995-6#1)(1997-5#1)(2004-9#1)(2007-12#1)
to be localized to the##2##5##(1995-2#1)(1997-6#1)
to be localized to##3##4##(1995-2#1)(1997-6#1)(2008-9#1)
to be localized within##2##4##(1992-3#1)(2009-10#1)
to be localized##14##3##(1990-2#1)(1992-3#1)(1992-7#1)(1995-2#2)(1995-6#1)(1997-5#1)(1997-6#1)(2004-9#1)(2007-12#2)(2008-5#1)(2008-9#1)(2009-10#1)
to be located at the##3##5##(1994-11#1)(2008-10#1)(2008-11#1)
to be located at##6##4##(1990-11#1)(1990-12#1)(1994-11#1)(1996-4#1)(2008-10#1)(2008-11#1)
to be located in the##7##5##(1990-5#1)(1991-4#1)(1992-8#1)(1994-5#1)(2008-8#1)(2009-5#1)(2010-8#1)
to be located in##10##4##(1990-5#1)(1991-4#2)(1992-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(2008-8#1)(2009-5#1)(2010-8#1)
to be located on the##2##5##(2008-11#1)(2010-12#1)
to be located on##4##4##(2008-11#1)(2008-3#1)(2008-5#1)(2010-12#1)
to be located within##2##4##(1990-11#1)(2007-8#1)
to be located##31##3##(1990-11#2)(1990-12#1)(1990-5#1)(1990-9#1)(1991-4#2)(1991-7#1)(1992-6#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-4#1)(1997-6#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#2)(2008-8#1)(2009-5#1)(2010-12#1)(2010-8#1)
to be longer##4##3##(2008-5#2)(2010-2#1)(2013-8#1)
to be lost after the##2##5##(2011-12#1)(2012-3#1)
to be lost##6##3##(1993-11#1)(1993-12#1)(2008-10#1)(2008-5#1)(2011-12#1)(2012-3#1)
to be low in##5##4##(1991-5#1)(2007-2#1)(2008-12#1)(2008-7#1)(2011-2#1)
to be low##14##3##(1991-5#1)(1996-4#1)(2004-4#1)(2006-10#1)(2006-12#1)(2007-2#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-5#1)(2011-2#2)
to be lower in the##5##5##(1990-10#2)(2007-5#1)(2008-10#1)(2008-7#1)
to be lower in##9##4##(1990-10#2)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-7#1)(2010-7#1)(2011-2#1)
to be lower than that of##3##6##(2008-4#1)(2009-2#1)(2011-12#1)
to be lower than that##4##5##(2008-4#1)(2009-2#1)(2011-12#1)(2011-2#1)
to be lower than##11##4##(1993-12#1)(2006-10#1)(2007-8#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-12#1)(2011-2#2)
to be lower##24##3##(1990-10#2)(1993-12#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-7#1)(2011-12#1)(2011-2#4)(2013-8#1)
to be lowest##2##3##(1996-12#1)(2010-12#1)
to be made about the##2##5##(1996-5#1)(2005-10#1)
to be made about##3##4##(1990-12#1)(1996-5#1)(2005-10#1)
to be made and##4##4##(1990-6#1)(1992-9#1)(2006-8#1)(2008-5#1)
to be made at the##2##5##(2008-10#1)(2008-7#1)
to be made between##3##4##(1990-7#1)(1995-7#1)(2008-3#1)
to be made in the##3##5##(2006-11#1)(2007-8#1)(2008-4#1)
to be made in##9##4##(1992-9#1)(2006-10#1)(2006-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-4#1)(2012-1#1)
to be made on the##3##5##(1993-11#1)(2008-8#1)(2009-10#1)
to be made on##4##4##(1993-11#1)(2006-2#1)(2008-8#1)(2009-10#1)
to be made over##2##4##(2007-12#1)(2008-4#1)
to be made to##4##4##(1996-3#1)(2004-12#1)(2006-10#1)(2008-9#1)
to be made up of##2##5##(1993-11#1)(1996-7#1)
to be made with##4##4##(2007-12#1)(2008-10#1)(2008-2#1)(2012-12#1)
to be made##60##3##(1990-12#1)(1990-6#1)(1990-7#1)(1991-5#1)(1992-9#2)(1993-11#2)(1994-1#1)(1994-10#1)(1995-6#2)(1995-7#1)(1996-1#1)(1996-3#1)(1996-5#1)(1996-7#1)(2004-12#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#5)(2006-11#1)(2006-2#1)(2006-8#1)(2007-12#4)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#2)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#1)
to be mainly due to##4##5##(1991-1#1)(1994-10#1)(1996-4#1)(1997-3#1)
to be mainly related to the##2##6##(2008-11#1)(2008-5#1)
to be mainly##15##3##(1990-12#1)(1990-7#1)(1991-1#1)(1994-10#1)(1995-6#1)(1996-4#1)(1996-6#1)(1997-3#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2012-2#1)
to be maintained in##3##4##(2008-9#1)(2010-12#1)(2013-8#1)
to be maintained through##2##4##(1993-8#1)(2008-8#1)
to be maintained##13##3##(1992-3#1)(1993-8#1)(1995-11#1)(1996-4#1)(1997-4#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-8#1)
to be major##6##3##(1991-3#1)(1994-11#1)(1994-3#1)(2006-10#1)(2008-10#1)(2008-5#1)
to be male##4##3##(2006-1#1)(2007-9#1)(2008-11#1)(2013-1#1)
to be malignant##7##3##(1995-2#1)(1997-2#1)(2006-9#1)(2007-8#2)(2008-6#1)(2012-3#1)
to be managed##5##3##(1995-2#1)(1997-3#1)(2006-4#1)(2008-7#1)(2012-12#1)
to be manipulated##4##3##(1997-4#1)(2007-12#1)(2008-10#1)(2009-11#1)
to be many##2##3##(2006-3#1)(2012-3#1)
to be marked##2##3##(2008-11#1)(2008-4#1)
to be matched##2##3##(2007-8#1)(2008-2#1)
to be measured from##2##4##(1996-11#1)(2008-3#1)
to be measured in##2##4##(1990-8#1)(1994-3#1)
to be measured##25##3##(1990-6#1)(1990-8#1)(1994-3#1)(1995-1#1)(1996-11#1)(1996-9#1)(2007-11#1)(2008-10#2)(2008-2#3)(2008-3#7)(2008-7#2)(2008-9#1)(2009-10#1)(2009-4#1)(2012-2#1)
to be mediated at least##2##5##(1993-12#1)(1994-8#1)
to be mediated by a##5##5##(1994-8#1)(1995-3#1)(2005-10#1)(2008-11#1)(2009-1#1)
to be mediated by the##7##5##(1990-6#1)(1991-3#1)(1995-12#1)(1995-6#1)(1995-9#1)(1997-2#1)(2009-10#1)
to be mediated by##44##4##(1990-6#1)(1991-3#1)(1991-5#2)(1991-6#1)(1992-3#1)(1992-6#1)(1993-11#2)(1994-11#1)(1994-8#2)(1995-12#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-9#1)(1996-10#1)(1996-12#3)(1996-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(2005-10#1)(2006-10#2)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-10#1)(2009-5#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-8#1)
to be mediated through a##2##5##(1992-6#2)
to be mediated through an##2##5##(1990-5#1)(1997-2#1)
to be mediated through##12##4##(1990-5#1)(1992-6#3)(1994-11#1)(1995-3#1)(1996-12#1)(1997-2#1)(2008-4#1)(2009-8#1)(2012-12#2)
to be mediated via the##2##5##(1991-10#1)(1997-8#1)
to be mediated via##6##4##(1991-10#1)(1991-11#1)(1996-1#1)(1996-2#1)(1997-8#1)(2008-8#1)
to be mediated##67##3##(1990-5#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-5#2)(1991-6#1)(1992-3#1)(1992-6#4)(1993-11#2)(1993-12#1)(1994-11#2)(1994-8#3)(1995-12#1)(1995-3#3)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#4)(1996-2#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-5#1)(1997-6#2)(1997-8#1)(2005-10#1)(2006-10#2)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#2)(2013-8#1)
to be medically##3##3##(2008-7#1)(2010-12#1)(2012-1#1)
to be membrane##3##3##(1990-10#1)(1990-11#1)(1992-12#1)
to be merely the##2##4##(1994-12#1)(2006-2#1)
to be merely##3##3##(1994-12#1)(1997-8#1)(2006-2#1)
to be merged##2##3##(1996-12#1)(2008-10#1)
to be met in##2##4##(2009-9#1)(2012-12#1)
to be met##10##3##(1990-12#1)(1995-12#1)(1996-2#1)(2006-12#1)(2008-11#2)(2008-7#1)(2009-9#1)(2012-12#1)(2013-8#1)
to be methylated##3##3##(1990-5#1)(2007-11#1)(2008-7#1)
to be mild##2##3##(2008-8#1)(2011-2#1)
to be mindful of##2##4##(1991-2#1)(2008-11#1)
to be minimal##3##3##(1996-6#1)(2007-12#1)(2008-3#1)
to be minimized in##2##4##(1993-12#1)(2008-2#1)
to be minimized##7##3##(1993-12#1)(1995-5#1)(2008-10#2)(2008-2#2)(2008-5#1)
to be minimum##2##3##(2008-2#1)(2008-3#1)
to be missed##3##3##(2007-2#1)(2012-2#1)(2013-1#1)
to be mitogenic##2##3##(1995-3#1)(2006-10#1)
to be modeled##2##3##(2008-1#1)(2008-4#1)
to be moderately resistant to powdery mildew##2##7##(2008-10#2)
to be moderately##6##3##(2008-10#3)(2012-12#2)(2013-8#1)
to be modest##2##3##(1993-5#1)(2012-2#1)
to be modified by##5##4##(1996-2#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-9#1)
to be modified in##3##4##(1991-2#1)(1993-12#1)(1997-1#1)
to be modified to##3##4##(1995-12#1)(2007-5#1)(2008-3#1)
to be modified##17##3##(1991-2#1)(1991-5#1)(1992-3#1)(1993-1#1)(1993-12#1)(1995-12#1)(1996-2#1)(1997-1#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-3#3)(2008-9#1)(2009-6#1)(2013-1#1)
to be modulated by##4##4##(1992-8#1)(1993-8#1)(2008-9#1)(2012-2#1)
to be modulated##5##3##(1992-8#1)(1993-4#1)(1993-8#1)(2008-9#1)(2012-2#1)
to be monitored and controlled##2##5##(2008-2#1)(2013-1#1)
to be monitored and##3##4##(2008-2#1)(2008-5#1)(2013-1#1)
to be monitored in##2##4##(1997-1#1)(2007-12#1)
to be monitored simultaneously##2##4##(2008-7#1)(2013-1#1)
to be monitored##18##3##(1991-12#1)(1992-2#1)(1994-11#1)(1997-1#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2011-2#1)(2013-1#2)
to be monomeric##2##3##(1990-6#1)(1993-6#1)
to be monomers##3##3##(1996-11#1)(1996-7#1)(2006-8#1)
to be more accurate for##2##5##(2008-7#1)(2013-7#1)
to be more accurate##3##4##(2008-1#1)(2008-7#1)(2013-7#1)
to be more active in the cold plate##2##8##(2006-12#2)
to be more active than the##2##6##(2007-1#1)(2008-5#1)
to be more active##5##4##(2006-12#2)(2007-1#1)(2008-5#1)(2013-7#1)
to be more affected by##2##5##(1997-4#1)(2012-7#1)
to be more aggressive##2##4##(1990-2#1)(2007-12#1)
to be more appropriate##2##4##(2008-3#1)(2011-2#1)
to be more comfortable##2##4##(1992-11#1)(2013-8#1)
to be more common##3##4##(2007-7#1)(2013-1#2)
to be more complex than##2##5##(1993-12#1)(2010-12#1)
to be more complex##3##4##(1993-12#1)(2010-12#1)(2012-1#1)
to be more concerned##2##4##(1997-1#1)(2010-2#1)
to be more consistent with##2##5##(1994-8#1)(2006-10#1)
to be more dependent##2##4##(1992-9#1)(2008-5#1)
to be more effective at##3##5##(1995-5#1)(2007-11#1)(2008-10#1)
to be more effective for##2##5##(2010-4#2)
to be more effective in the##2##6##(2006-2#1)(2008-10#1)
to be more effective in##8##5##(2004-12#1)(2006-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-4#1)
to be more effective than the##2##6##(2007-11#1)(2008-3#1)
to be more effective than##8##5##(1992-9#1)(2007-10#3)(2007-11#1)(2008-3#2)(2008-7#1)
to be more effective##31##4##(1992-5#1)(1992-9#1)(1993-4#1)(1995-5#1)(2004-12#2)(2006-2#1)(2007-10#3)(2007-11#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#2)(2009-7#1)(2010-12#1)(2010-4#3)(2011-12#1)(2012-2#2)
to be more efficient in##2##5##(1992-8#1)(2009-5#1)
to be more efficient than##2##5##(2008-11#1)(2011-1#1)
to be more efficient##9##4##(1992-8#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-1#1)
to be more favorable than##2##5##(1996-9#1)(2008-10#1)
to be more frequent##3##4##(2007-12#1)(2008-9#1)(2010-3#1)
to be more important than##2##5##(1997-8#1)(2009-3#1)
to be more important##3##4##(1997-8#1)(2006-10#1)(2009-3#1)
to be more inclusive of##2##5##(2007-2#1)(2012-1#1)
to be more inclusive##3##4##(2007-2#1)(2010-2#1)(2012-1#1)
to be more intense##2##4##(2008-8#1)(2012-2#1)
to be more knowledgeable##2##4##(2011-2#1)(2013-1#1)
to be more likely##3##4##(1990-3#1)(1993-12#1)(2008-8#1)
to be more marked##2##4##(1991-12#1)(1991-3#1)
to be more of##2##4##(2006-10#1)(2012-2#1)
to be more potent in##2##5##(1991-5#1)(2008-5#1)
to be more potent##8##4##(1990-12#1)(1990-7#1)(1990-9#1)(1991-5#1)(1991-9#1)(1995-3#1)(2005-8#1)(2008-5#1)
to be more prevalent##3##4##(2008-1#2)(2012-12#1)
to be more promising##2##4##(2008-10#1)(2008-3#1)
to be more reliable##2##4##(1991-7#1)(1996-3#1)
to be more resistant to the##2##6##(1996-5#1)(1996-9#1)
to be more resistant to##6##5##(1996-5#1)(1996-9#1)(2004-4#1)(2007-12#1)(2008-10#1)(2009-3#1)
to be more responsive##2##4##(1995-3#1)(2006-8#1)
to be more selective##2##4##(2006-12#1)(2010-4#1)
to be more sensitive than the##2##6##(1993-4#1)(1997-2#1)
to be more sensitive than##5##5##(1990-12#1)(1993-4#1)(1997-2#1)(2008-10#1)(2012-1#1)
to be more sensitive to##6##5##(1993-2#1)(1994-4#1)(1995-5#1)(1997-2#1)(2007-7#1)(2008-5#1)
to be more sensitive##17##4##(1990-12#2)(1993-2#1)(1993-4#1)(1994-4#1)(1995-5#1)(1997-2#2)(2007-10#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2012-1#1)(2012-2#1)
to be more specific in##2##5##(1993-2#1)(2009-9#1)
to be more stable than the##4##6##(2007-11#1)(2008-5#1)(2009-10#1)(2009-8#1)
to be more stable than##6##5##(1991-4#1)(1992-11#1)(2007-11#1)(2008-5#1)(2009-10#1)(2009-8#1)
to be more stable##7##4##(1991-4#1)(1992-11#1)(2007-11#1)(2008-1#1)(2008-5#1)(2009-10#1)(2009-8#1)
to be more strongly associated with##3##6##(2004-3#2)(2013-1#1)
to be more strongly##4##4##(2004-3#2)(2009-7#1)(2013-1#1)
to be more successful##3##4##(2011-2#1)(2013-1#2)
to be more susceptible to##8##5##(1992-3#1)(1992-9#1)(1997-3#1)(2006-3#1)(2006-8#1)(2008-10#1)(2009-5#1)(2011-2#1)
to be more than##7##4##(1994-12#1)(1996-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)
to be more virulent than##2##5##(2008-5#1)(2013-1#1)
to be more vulnerable to##4##5##(2007-12#1)(2007-9#1)(2008-10#1)(2010-9#1)
to be more vulnerable##6##4##(1990-2#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2010-9#1)
to be more##274##3##(1990-12#3)(1990-2#3)(1990-3#1)(1990-6#1)(1990-7#1)(1990-9#2)(1991-12#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#2)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#3)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#2)(1994-12#1)(1994-3#1)(1994-4#1)(1994-8#1)(1995-1#1)(1995-3#2)(1995-4#1)(1995-5#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#2)(1997-5#1)(1997-8#1)(2004-10#1)(2004-12#2)(2004-2#1)(2004-3#2)(2004-4#1)(2005-11#4)(2005-8#2)(2006-10#5)(2006-12#5)(2006-2#2)(2006-3#1)(2006-6#2)(2006-7#2)(2006-8#2)(2007-1#1)(2007-10#5)(2007-11#8)(2007-12#7)(2007-2#2)(2007-3#1)(2007-6#2)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#16)(2008-11#8)(2008-2#4)(2008-3#7)(2008-4#3)(2008-5#14)(2008-6#4)(2008-7#5)(2008-8#6)(2008-9#3)(2009-10#2)(2009-3#2)(2009-4#3)(2009-5#2)(2009-7#5)(2009-8#3)(2009-9#1)(2010-12#2)(2010-2#3)(2010-3#2)(2010-4#4)(2010-5#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#3)(2012-12#4)(2012-2#10)(2012-7#1)(2013-1#10)(2013-7#3)(2013-8#2)
to be most closely related to the##2##7##(1996-12#1)(2008-10#1)
to be most closely related to##3##6##(1993-3#1)(1996-12#1)(2008-10#1)
to be most effective##6##4##(2005-11#1)(2006-5#1)(2007-2#1)(2007-3#1)(2008-5#1)(2011-12#1)
to be most important##2##4##(1990-8#1)(2005-3#1)
to be most suitable##2##4##(1993-12#1)(2008-5#1)
to be most useful##3##4##(1990-10#1)(2008-11#1)(2012-2#1)
to be most##37##3##(1990-10#1)(1990-12#1)(1990-8#2)(1993-12#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-6#1)(1996-12#1)(2005-11#1)(2005-3#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#4)(2008-6#1)(2009-11#1)(2009-5#1)(2011-12#1)(2012-2#1)(2013-8#1)
to be mostly##5##3##(1995-2#1)(2008-10#1)(2009-11#1)(2012-2#1)(2012-3#1)
to be motivated##2##3##(1990-5#1)(1992-3#1)
to be much better##2##4##(2008-10#1)(2010-2#1)
to be much faster##2##4##(1994-6#1)(2008-10#1)
to be much less than##2##5##(1990-11#1)(2008-3#1)
to be much less##3##4##(1990-11#1)(2008-3#1)(2011-2#1)
to be much lower##4##4##(1995-3#1)(2008-10#2)(2013-1#1)
to be much more##7##4##(1991-9#1)(1992-2#1)(1993-2#1)(1995-10#1)(1996-7#1)(2007-4#1)(2008-11#1)
to be much##26##3##(1990-11#1)(1991-9#1)(1992-11#1)(1992-2#1)(1993-2#1)(1994-6#1)(1995-10#1)(1995-3#1)(1996-7#1)(2006-10#1)(2006-2#1)(2007-4#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-7#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
to be multifaceted##2##3##(1991-12#1)(2008-12#1)
to be multifactorial##3##3##(2007-11#1)(2008-1#1)(2011-2#1)
to be multiple##2##3##(2007-11#1)(2008-8#1)
to be mutagenic##3##3##(1992-5#1)(1993-7#1)(2011-12#1)
to be mutually##2##3##(1990-12#1)(2008-8#1)
to be named##2##3##(1995-6#1)(2011-1#1)
to be near##3##3##(1994-9#1)(1995-10#1)(2007-12#1)
to be nearly identical to##3##5##(1991-4#1)(1996-8#1)(2008-10#1)
to be nearly identical##6##4##(1991-12#1)(1991-4#1)(1991-7#1)(1995-11#1)(1996-8#1)(2008-10#1)
to be nearly##12##3##(1991-12#1)(1991-4#1)(1991-7#1)(1995-11#1)(1996-8#1)(1997-4#2)(2007-12#1)(2008-10#1)(2008-2#2)(2010-2#1)
to be necessary for a##2##5##(1996-3#1)(2008-9#1)
to be necessary for the##2##5##(1992-12#1)(2006-10#1)
to be necessary for##17##4##(1990-8#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-6#1)(1996-3#2)(2005-7#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-8#1)(2011-2#1)
to be necessary to##6##4##(1990-10#1)(1997-7#1)(2006-4#1)(2008-10#2)(2008-8#1)
to be necessary##30##3##(1990-10#1)(1990-12#1)(1990-8#1)(1992-1#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-6#1)(1996-3#2)(1997-1#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2010-8#1)(2011-2#1)
to be negative##8##3##(1993-2#1)(2004-10#1)(2007-10#2)(2007-11#1)(2013-1#2)(2013-8#1)
to be negatively associated with##2##5##(1990-12#1)(2009-9#1)
to be negatively##8##3##(1990-12#1)(1991-5#1)(1994-5#1)(1996-3#1)(2005-10#1)(2005-11#1)(2009-9#1)(2011-2#1)
to be negligible##15##3##(1990-12#1)(1990-5#1)(1992-9#1)(1996-9#1)(1997-7#1)(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#2)
to be neuroprotective##2##3##(1997-8#2)
to be neurotoxic##2##3##(2008-5#1)(2011-1#1)
to be new##16##3##(1997-2#1)(2008-3#14)(2008-4#1)
to be no##18##3##(1990-9#1)(1992-11#1)(1994-7#1)(1996-2#1)(1996-6#1)(1996-9#1)(2004-10#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-4#1)(2010-7#1)(2013-1#1)
to be normal in##2##4##(1995-1#1)(2007-11#1)
to be normal##18##3##(1990-12#1)(1990-8#1)(1991-6#1)(1992-9#1)(1994-6#1)(1995-1#1)(1996-11#1)(1996-8#1)(2005-11#2)(2005-12#2)(2006-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2010-9#1)(2011-1#1)
to be normally##2##3##(1996-10#1)(2008-4#1)
to be not only##2##4##(2007-12#1)(2008-1#1)
to be not##11##3##(1990-5#1)(1994-11#1)(1996-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-4#1)
to be noted##2##3##(2006-1#1)(2009-3#1)
to be novel##10##3##(1997-4#1)(2008-10#1)(2008-2#1)(2008-3#7)
to be observed in##3##4##(1990-10#1)(2008-2#1)(2008-8#1)
to be observed##13##3##(1990-10#1)(1990-8#1)(1992-9#1)(2007-11#1)(2008-1#2)(2008-11#1)(2008-2#2)(2008-8#1)(2010-4#1)(2012-3#1)(2013-8#1)
to be obtained for##5##4##(1990-11#1)(1992-1#1)(1994-12#1)(1995-8#1)(2008-10#1)
to be obtained from##4##4##(1992-3#1)(2007-8#1)(2009-6#1)(2012-2#1)
to be obtained in##3##4##(2007-12#1)(2009-10#1)(2011-2#1)
to be obtained##33##3##(1990-11#1)(1992-1#1)(1992-3#1)(1993-10#1)(1994-12#1)(1995-8#1)(1997-8#1)(2006-5#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#6)(2008-2#3)(2008-3#4)(2008-4#2)(2009-10#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#2)
to be occupied by##2##4##(1990-8#1)(1997-1#1)
to be of a##2##4##(1990-10#1)(1993-6#1)
to be of benefit in##2##5##(2006-4#1)(2010-8#1)
to be of benefit##6##4##(2006-11#1)(2006-4#1)(2007-2#1)(2010-12#1)(2010-2#1)(2010-8#1)
to be of clinical##2##4##(1991-12#1)(2006-10#1)
to be of comparable##2##4##(2008-2#1)(2012-2#1)
to be of great use##2##5##(2008-2#1)(2012-2#1)
to be of great value in##2##6##(1991-6#1)(2007-8#1)
to be of great value##4##5##(1991-6#1)(1992-8#1)(2007-8#1)(2007-9#1)
to be of great##9##4##(1991-6#1)(1992-8#1)(2006-10#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-5#1)(2012-2#1)
to be of greater##3##4##(1994-2#1)(2008-10#1)(2010-4#1)
to be of high##2##4##(1990-10#1)(2006-6#1)
to be of importance in##3##5##(1994-12#1)(1995-10#1)(2011-2#1)
to be of importance##8##4##(1992-4#1)(1993-7#1)(1994-12#1)(1995-10#1)(2006-6#1)(2008-3#1)(2011-2#2)
to be of interest##2##4##(2004-9#1)(2008-10#1)
to be of limited##3##4##(1995-12#1)(2006-10#1)(2008-10#1)
to be of little##3##4##(1991-2#1)(1997-8#1)(2008-3#1)
to be of low##2##4##(1991-1#1)(2008-1#1)
to be of major importance##3##5##(1992-10#1)(1997-6#1)(2012-2#1)
to be of minor##2##4##(2008-10#1)(2010-3#1)
to be of particular importance##7##5##(1991-8#1)(1992-4#1)(1994-9#1)(1997-8#1)(2004-12#1)(2006-7#1)(2008-9#1)
to be of secondary importance##2##5##(2006-11#1)(2007-8#1)
to be of significant##3##4##(1996-9#1)(2005-11#1)(2005-7#1)
to be of the order of##6##6##(1990-4#1)(1992-3#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-3#1)
to be of the##9##4##(1990-4#1)(1991-12#1)(1991-5#1)(1992-3#1)(2006-4#1)(2007-12#1)(2008-10#2)(2008-3#1)
to be of value in the##2##6##(1994-6#1)(2008-9#1)
to be of value in##5##5##(1992-1#1)(1994-6#1)(2006-10#1)(2008-9#2)
to be of value##6##4##(1992-1#1)(1994-6#1)(1996-1#1)(2006-10#1)(2008-9#2)
to be of##110##3##(1990-10#2)(1990-4#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-8#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-7#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-6#1)(1997-8#2)(2004-12#1)(2004-9#1)(2005-11#1)(2005-5#1)(2005-7#1)(2005-9#2)(2006-10#4)(2006-11#2)(2006-12#1)(2006-4#2)(2006-6#2)(2006-7#1)(2007-12#2)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#9)(2008-2#4)(2008-3#3)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#3)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
to be offered to physicians##2##5##(1992-3#1)(1993-3#1)
to be offered##6##3##(1992-3#1)(1993-3#1)(1994-2#1)(1995-12#1)(2007-2#1)(2009-4#1)
to be older and##2##4##(1994-12#1)(2011-2#1)
to be older than##2##4##(2007-12#1)(2008-10#1)
to be older##7##3##(1992-3#1)(1994-12#1)(1995-3#1)(2007-10#1)(2007-12#1)(2008-10#1)(2011-2#1)
to be on the decline##2##5##(2008-4#1)(2008-9#1)
to be on the##12##4##(1991-12#1)(1993-11#1)(1997-5#2)(2005-11#1)(2005-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-4#1)
to be on##20##3##(1991-12#1)(1993-11#2)(1997-5#3)(2005-11#1)(2005-8#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-4#1)(2013-7#1)
to be one of the causes of##2##7##(1997-1#1)(2010-12#1)
to be one of the leading##3##6##(2006-5#1)(2012-12#1)(2013-8#1)
to be one of the main##3##6##(2005-7#1)(2008-10#1)(2008-8#1)
to be one of the major##3##6##(1992-3#1)(2011-1#1)(2012-1#1)
to be one of the most active##2##7##(2005-11#1)(2008-6#1)
to be one of the most common##3##7##(2006-12#1)(2013-1#1)(2013-8#1)
to be one of the most important##6##7##(1990-12#1)(1990-5#1)(2007-8#1)(2008-11#1)(2010-5#1)(2013-1#1)
to be one of the most##23##6##(1990-12#2)(1990-5#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-6#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
to be one of the##45##5##(1990-12#2)(1990-5#1)(1992-3#1)(1993-2#1)(1993-8#1)(1995-10#1)(1995-8#2)(1997-1#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#2)(2009-6#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
to be one of two##2##5##(1995-3#1)(1997-3#1)
to be one of##51##4##(1990-12#2)(1990-5#1)(1992-3#1)(1993-2#1)(1993-8#1)(1995-10#1)(1995-3#1)(1995-8#2)(1997-1#1)(1997-3#1)(2005-11#1)(2005-3#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-6#1)(2008-8#2)(2009-6#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
to be one##57##3##(1990-12#2)(1990-5#1)(1992-3#1)(1993-2#1)(1993-5#1)(1993-8#1)(1995-10#1)(1995-3#1)(1995-8#2)(1997-1#1)(1997-3#1)(2005-10#1)(2005-11#1)(2005-3#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
to be only about##2##4##(1990-11#1)(2008-10#1)
to be only one##2##4##(2006-5#1)(2008-8#1)
to be only the##2##4##(1994-9#1)(2008-10#1)
to be only##16##3##(1990-11#1)(1991-9#1)(1992-6#1)(1993-6#1)(1994-9#1)(1995-2#1)(1997-1#1)(2006-5#1)(2006-7#1)(2007-12#1)(2008-10#3)(2008-8#1)(2010-11#1)(2012-2#1)
to be open to##2##4##(1992-6#1)(2008-1#1)
to be open##3##3##(1991-2#1)(1992-6#1)(2008-1#1)
to be opened##2##3##(2007-11#2)
to be operated##4##3##(1992-2#1)(2006-10#1)(2007-11#1)(2007-8#1)
to be operative##2##3##(2007-1#1)(2012-3#1)
to be opportunistic##2##3##(2006-10#1)(2013-7#1)
to be optically##2##3##(2007-8#1)(2008-3#1)
to be optimal for##4##4##(1991-10#1)(1996-8#1)(2008-7#1)(2008-8#1)
to be optimal in terms of##2##6##(2008-2#1)(2011-2#1)
to be optimal when##2##4##(2007-12#1)(2012-3#1)
to be optimal##12##3##(1990-9#1)(1991-10#1)(1992-8#1)(1996-8#1)(1997-2#1)(2006-12#1)(2007-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
to be optimally##2##3##(2007-4#1)(2008-11#1)
to be optimized for##3##4##(2007-8#1)(2008-11#1)(2010-4#1)
to be optimized##7##3##(2007-8#1)(2008-10#1)(2008-11#2)(2008-6#1)(2010-4#1)(2011-2#1)
to be or##2##3##(1993-8#1)(2012-3#1)
to be organized##2##3##(2006-7#1)(2008-7#1)
to be outcompeted by##2##4##(2012-2#2)
to be over##5##3##(1995-3#1)(1997-8#1)(2008-10#1)(2008-5#1)(2010-4#1)
to be overcome before it##2##5##(2006-10#1)(2007-5#1)
to be overcome before##7##4##(1997-6#1)(2006-10#1)(2007-5#1)(2008-2#1)(2009-12#1)(2011-1#1)(2012-12#1)
to be overcome to##2##4##(2005-6#1)(2009-3#1)
to be overcome##19##3##(1990-6#1)(1997-6#1)(2005-6#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-6#1)(2009-12#1)(2009-3#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-12#2)
to be overestimated##2##3##(2007-9#1)(2008-11#1)
to be overweight##5##3##(1997-7#1)(2007-7#1)(2010-11#3)
to be oxidized##2##3##(1990-5#1)(2013-1#1)
to be pH##6##3##(1990-7#1)(1992-9#1)(1993-3#1)(1996-8#1)(1997-3#1)(2008-10#1)
to be paid to the##4##5##(1997-1#1)(2006-6#1)(2008-1#1)(2012-12#1)
to be paid to##5##4##(1997-1#1)(2006-6#1)(2008-1#1)(2008-10#1)(2012-12#1)
to be paid##7##3##(1997-1#1)(1997-6#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2012-12#1)
to be part of a##3##5##(1992-3#1)(1997-3#1)(2008-11#1)
to be part of an##2##5##(1993-12#1)(1994-10#1)
to be part of the##5##5##(1991-4#1)(2007-12#1)(2008-4#1)(2010-11#1)(2013-1#1)
to be part of##12##4##(1991-4#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-10#1)(1997-3#1)(2007-12#1)(2008-11#1)(2008-4#1)(2010-11#1)(2012-2#1)(2013-1#1)
to be partial##2##3##(1991-12#1)(2008-3#1)
to be partially##12##3##(1993-9#1)(1994-2#3)(1995-1#1)(1995-8#1)(1996-5#1)(2004-9#1)(2005-11#1)(2008-10#1)(2011-1#1)(2013-1#1)
to be particularly effective##3##4##(1994-9#1)(2007-10#1)(2007-8#1)
to be particularly sensitive##2##4##(1993-1#1)(1995-12#1)
to be particularly useful##2##4##(1995-8#1)(2008-1#1)
to be particularly vulnerable##2##4##(1991-1#1)(2013-1#1)
to be particularly##23##3##(1990-2#1)(1991-1#1)(1991-3#1)(1993-1#1)(1994-9#1)(1995-12#1)(1995-8#1)(1997-3#1)(2005-12#1)(2005-8#1)(2006-8#2)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#3)(2009-11#1)(2009-6#1)(2009-8#1)(2013-1#1)(2013-8#1)
to be partly##5##3##(1991-11#1)(1991-9#1)(1992-3#1)(2008-10#1)(2012-1#1)
to be pathogenic on##2##4##(2008-10#2)
to be pathogenic##4##3##(2008-10#2)(2008-4#1)(2011-2#1)
to be pathognomonic##2##3##(2006-10#1)(2007-7#1)
to be perceived by##2##4##(2009-8#1)(2012-3#1)
to be perceived##4##3##(1990-9#1)(2009-8#1)(2012-11#1)(2012-3#1)
to be performed and##2##4##(2007-7#1)(2008-3#1)
to be performed at##3##4##(1990-11#2)(1993-11#1)
to be performed by the##2##5##(1993-12#1)(2012-3#1)
to be performed by##4##4##(1993-12#1)(1995-9#1)(2007-4#1)(2012-3#1)
to be performed endoscopically##2##4##(2006-6#1)(2010-12#1)
to be performed in a##2##5##(1995-9#1)(2008-3#1)
to be performed in the##2##5##(1995-9#1)(2009-2#1)
to be performed in##9##4##(1995-9#2)(2006-6#1)(2007-11#1)(2007-12#2)(2008-3#1)(2009-2#1)(2013-8#1)
to be performed on##5##4##(1992-8#1)(1995-1#1)(2007-10#1)(2008-3#1)(2011-2#1)
to be performed under##2##4##(1990-4#1)(1996-8#1)
to be performed with##3##4##(2007-5#1)(2008-1#1)(2013-8#1)
to be performed##54##3##(1990-11#2)(1990-4#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-9#3)(1996-6#1)(1996-8#1)(2006-10#1)(2006-6#4)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#3)(2008-6#1)(2009-2#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#2)
to be phased##3##3##(1992-1#1)(1996-2#1)(2008-3#1)
to be phosphorylated by##3##4##(1990-10#1)(1990-6#1)(1993-6#1)
to be phosphorylated in##4##4##(1993-11#1)(1995-6#1)(1996-5#1)(2009-6#1)
to be phosphorylated##11##3##(1990-10#1)(1990-12#1)(1990-6#1)(1993-11#1)(1993-6#1)(1995-6#1)(1996-5#2)(2008-5#1)(2009-6#1)(2011-2#1)
to be photochemically##2##3##(1996-2#1)(1997-6#1)
to be phylogenetically##2##3##(1997-2#1)(2008-10#1)
to be physiologically##3##3##(1995-2#1)(2008-8#1)(2010-11#1)
to be placed in##2##4##(1992-12#1)(2008-11#1)
to be placed on##3##4##(2005-10#1)(2006-2#1)(2008-11#1)
to be placed##8##3##(1992-12#1)(2005-10#1)(2006-2#1)(2006-3#1)(2008-11#3)(2008-9#1)
to be polygenic##2##3##(2008-10#1)(2011-2#1)
to be polymorphic##4##3##(1992-11#1)(1995-3#1)(1996-4#1)(2012-12#1)
to be poor##5##3##(1991-5#1)(1993-4#1)(2011-1#2)(2013-1#1)
to be poorly responsive to##3##5##(2008-1#1)(2012-12#1)(2012-2#1)
to be poorly##6##3##(1992-5#1)(2008-1#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
to be positive and##2##4##(2006-10#1)(2011-2#1)
to be positive by##3##4##(1991-6#1)(1995-2#1)(2008-4#1)
to be positive for##14##4##(1990-10#1)(1995-5#1)(2005-12#1)(2006-1#1)(2006-12#1)(2007-7#2)(2008-5#2)(2012-2#1)(2013-1#2)(2013-8#2)
to be positive in##3##4##(2010-8#1)(2012-12#1)(2013-8#1)
to be positive##32##3##(1990-10#1)(1991-6#1)(1995-2#1)(1995-5#1)(1997-7#2)(2005-10#1)(2005-11#2)(2005-12#2)(2006-1#1)(2006-10#1)(2006-12#1)(2007-7#3)(2008-1#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#3)
to be positively associated with##5##5##(1993-6#1)(1996-3#1)(2007-9#1)(2008-11#1)(2009-11#1)
to be positively correlated with the##3##6##(1991-12#1)(2008-6#1)(2010-8#1)
to be positively##13##3##(1991-12#1)(1993-6#1)(1994-5#1)(1995-11#1)(1996-3#1)(2007-9#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-8#1)(2011-12#1)
to be possible by##2##4##(2006-10#1)(2013-8#1)
to be possible for##2##4##(2007-8#1)(2008-8#1)
to be possible##12##3##(1993-12#1)(1994-3#1)(1995-11#1)(1997-8#1)(2004-9#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-5#1)(2008-8#1)(2013-8#1)
to be potent hypolipidemic agents##3##5##(2007-11#1)(2008-5#2)
to be potent##12##3##(1990-2#1)(1991-4#1)(1991-5#1)(1994-11#1)(1997-1#1)(2006-12#1)(2007-11#2)(2008-10#1)(2008-5#3)
to be potentially useful for##2##5##(2007-12#1)(2009-7#1)
to be potentially useful##3##4##(1990-8#1)(2007-12#1)(2009-7#1)
to be potentially##8##3##(1990-8#1)(1994-3#1)(2006-11#1)(2007-12#1)(2009-7#1)(2009-9#1)(2010-1#1)(2013-8#1)
to be powerful##2##3##(2007-11#1)(2008-10#1)
to be practical##2##3##(1994-12#1)(2008-10#1)
to be practiced##2##3##(2012-1#1)(2012-2#1)
to be preceded by##3##4##(1990-11#1)(1996-4#1)(2008-11#1)
to be precise and##2##4##(1993-2#1)(2008-2#1)
to be precise##5##3##(1990-11#1)(1993-2#1)(1996-11#1)(2008-10#1)(2008-2#1)
to be precursors of##2##4##(1991-9#1)(2007-1#1)
to be predicted##3##3##(1990-12#1)(2008-10#1)(2010-4#1)
to be predictive of##3##4##(1995-2#1)(2006-10#1)(2012-12#1)
to be predictive##7##3##(1993-5#1)(1995-2#1)(2006-10#1)(2007-12#1)(2007-2#1)(2011-1#1)(2012-12#1)
to be predominant in##3##4##(2008-10#2)(2009-10#1)
to be predominant##6##3##(1990-6#1)(1996-5#1)(2008-10#2)(2008-11#1)(2009-10#1)
to be predominantly##4##3##(1990-11#1)(1991-1#1)(1993-9#1)(1997-4#1)
to be preferable for##3##4##(2008-10#3)
to be preferable to a##2##5##(1996-2#1)(2008-10#1)
to be preferable to##4##4##(1993-3#1)(1996-2#1)(2008-10#1)(2008-7#1)
to be preferable##9##3##(1993-3#1)(1996-2#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-7#1)
to be preferred##6##3##(1991-10#1)(1992-11#1)(1992-3#1)(1993-11#1)(1995-1#1)(2008-3#1)
to be prepared for##4##4##(1995-8#1)(2008-11#1)(2009-10#1)(2012-2#1)
to be prepared##6##3##(1995-8#1)(2008-11#1)(2009-10#1)(2009-12#1)(2012-12#1)(2012-2#1)
to be prescribed on##2##4##(2008-11#1)(2013-1#1)
to be prescribed##5##3##(2007-12#1)(2007-8#1)(2008-11#1)(2008-8#1)(2013-1#1)
to be present and##2##4##(1990-10#1)(2008-4#1)
to be present as##3##4##(1991-5#1)(1995-2#1)(2008-1#1)
to be present at the##2##5##(1996-8#1)(2008-7#1)
to be present in a##3##5##(1991-6#1)(2008-10#2)
to be present in the##9##5##(1990-8#1)(1991-6#1)(1991-8#1)(1992-11#1)(1994-12#1)(1994-7#1)(1995-6#1)(2008-10#1)(2010-4#1)
to be present in##44##4##(1990-5#1)(1990-7#1)(1990-8#1)(1991-6#3)(1991-8#1)(1992-11#1)(1993-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#3)(1995-6#2)(1995-8#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-7#1)(2004-3#1)(2006-11#1)(2006-5#1)(2007-10#2)(2008-1#1)(2008-10#5)(2008-12#3)(2008-3#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-4#1)
to be present mainly##3##4##(1991-5#1)(2008-10#1)(2008-5#1)
to be present on##3##4##(1995-2#1)(1995-8#1)(2008-4#1)
to be present##69##3##(1990-10#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#2)(1993-11#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-7#1)(1994-8#2)(1994-9#3)(1995-2#2)(1995-6#2)(1995-8#2)(1996-12#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-7#1)(2004-3#1)(2005-5#1)(2006-11#1)(2006-5#1)(2007-10#2)(2008-1#3)(2008-10#6)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-3#1)(2010-4#2)
to be presented##5##3##(2006-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2011-1#1)
to be preserved in the##2##5##(2005-12#1)(2007-10#1)
to be preserved##3##3##(2005-12#1)(2007-10#1)(2007-11#1)
to be presynaptic##2##3##(1992-8#1)(1997-7#1)
to be prevented##2##3##(1993-1#1)(1995-8#1)
to be previously##2##3##(2008-10#1)(2008-2#1)
to be primarily##11##3##(1990-3#3)(1992-12#1)(1993-8#1)(1995-11#1)(1995-3#1)(2007-5#1)(2008-11#1)(2008-8#1)(2011-1#1)
to be primary##2##3##(2008-10#1)(2008-5#1)
to be primed##2##3##(1997-2#1)(2008-2#1)
to be processed to##3##4##(1990-5#1)(1995-2#1)(2008-10#1)
to be processed##7##3##(1990-5#1)(1995-2#1)(1997-2#1)(2005-10#1)(2007-11#1)(2008-10#1)(2010-8#1)
to be produced at##3##4##(1994-9#1)(2008-10#1)(2008-6#1)
to be produced by the##2##5##(1995-11#1)(2008-2#1)
to be produced by##3##4##(1995-11#1)(1997-1#1)(2008-2#1)
to be produced from##2##4##(1991-2#1)(2006-2#1)
to be produced in##2##4##(1993-9#1)(2008-2#1)
to be produced##16##3##(1990-3#1)(1991-2#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-11#1)(1997-1#1)(1997-3#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-6#1)
to be progressive##2##3##(2004-11#1)(2007-8#1)
to be progressively##4##3##(2007-2#1)(2008-3#1)(2009-4#1)(2011-2#1)
to be prolonged##2##3##(2010-7#1)(2013-1#1)
to be promising for##3##4##(2006-10#1)(2008-11#1)(2013-1#1)
to be promising in##2##4##(2008-11#1)(2012-2#1)
to be promising##12##3##(1996-8#1)(2006-10#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2010-4#1)(2010-7#1)(2012-2#1)(2013-1#1)
to be prone to##2##4##(1994-11#1)(2009-2#1)
to be properly##8##3##(1997-4#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-12#1)(2013-1#2)
to be proportional to the relative##2##6##(2007-12#1)(2010-4#1)
to be proportional to the##13##5##(1990-3#1)(1991-7#1)(1991-9#1)(1992-6#1)(2006-6#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#1)(2010-4#1)
to be proportional to##15##4##(1990-3#1)(1991-7#1)(1991-9#1)(1992-6#1)(1992-9#1)(2006-6#1)(2007-12#3)(2008-10#2)(2008-2#2)(2008-3#1)(2010-4#1)
to be protected against##3##4##(1993-7#1)(1995-5#1)(2010-7#1)
to be protected by##2##4##(2008-10#1)(2010-1#1)
to be protected##7##3##(1993-7#1)(1995-5#1)(2004-11#1)(2008-10#1)(2009-11#1)(2010-1#1)(2010-7#1)
to be protective against##4##4##(1993-9#1)(2006-5#1)(2008-8#1)(2013-1#1)
to be protective##6##3##(1993-9#1)(2006-5#1)(2008-12#1)(2008-8#1)(2011-2#1)(2013-1#1)
to be provided##4##3##(2005-5#1)(2006-5#1)(2007-7#1)(2013-8#1)
to be published in a##2##5##(2006-11#1)(2007-3#1)
to be published in the##2##5##(1994-1#1)(1994-2#1)
to be published in##4##4##(1994-1#1)(1994-2#1)(2006-11#1)(2007-3#1)
to be published##10##3##(1991-5#1)(1994-1#1)(1994-2#1)(1996-1#1)(2006-11#1)(2007-10#1)(2007-3#1)(2011-2#2)(2012-2#1)
to be pure##2##3##(2005-12#1)(2008-5#1)
to be purified##3##3##(1993-12#1)(2008-4#2)
to be put to##2##4##(1993-4#1)(1997-3#1)
to be put##4##3##(1993-4#1)(1997-2#1)(1997-3#1)(2006-5#1)
to be quantified##5##3##(2007-11#1)(2008-3#1)(2008-5#1)(2008-7#2)
to be quantitative##2##3##(1997-4#1)(2008-10#1)
to be quantitatively##2##3##(2008-10#1)(2011-2#1)
to be quite different from##3##5##(1996-5#1)(2010-11#1)(2012-2#1)
to be quite##22##3##(1990-11#1)(1992-3#1)(1994-2#1)(1995-6#1)(1996-5#1)(1997-1#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2009-2#1)(2010-11#1)(2010-4#1)(2012-1#1)(2012-2#1)(2013-1#1)
to be raised##4##3##(2007-12#1)(2008-12#1)(2009-11#1)(2012-2#1)
to be randomized##2##3##(2008-10#2)
to be rapid##6##3##(1992-2#1)(2008-10#2)(2008-8#1)(2010-4#1)(2012-12#1)
to be rapidly##3##3##(1996-5#1)(2007-11#1)(2008-10#1)
to be rare in##4##4##(2006-10#1)(2007-11#1)(2009-4#1)(2012-12#1)
to be rare##7##3##(2005-10#1)(2006-10#1)(2007-11#1)(2009-4#1)(2011-11#1)(2012-11#1)(2012-12#1)
to be rarely##2##3##(2006-10#1)(2007-12#1)
to be rather##6##3##(1990-7#1)(1995-11#1)(2008-10#2)(2008-8#1)(2010-7#1)
to be rational##2##3##(2007-11#1)(2008-11#1)
to be re-evaluated##2##3##(2007-2#1)(2008-7#1)
to be re-examined and##2##4##(2007-4#1)(2008-7#1)
to be re-examined##4##3##(2007-4#1)(2007-7#1)(2008-10#1)(2008-7#1)
to be reached##6##3##(1992-3#1)(1993-9#1)(1996-8#1)(2008-10#1)(2010-4#1)(2012-2#1)
to be reactive##2##3##(1990-12#1)(2008-11#1)
to be read##4##3##(2007-8#1)(2008-3#1)(2009-4#1)(2009-8#1)
to be readily##7##3##(1990-3#1)(1995-11#1)(2004-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-5#1)
to be realized##5##3##(1995-12#1)(2007-9#1)(2008-1#1)(2011-2#1)(2012-2#1)
to be reasonably##2##3##(1994-5#1)(2005-11#1)
to be receptor-mediated##2##3##(1992-8#1)(1992-9#1)
to be recognised##2##3##(1991-9#1)(2005-5#1)
to be recognized as##3##4##(2008-1#1)(2008-5#1)(2011-2#1)
to be recognized##15##3##(1995-11#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-8#1)(2007-2#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#2)(2010-4#1)(2011-2#2)(2012-12#1)
to be recommended for routine##2##5##(1996-8#1)(2008-10#1)
to be recommended for##3##4##(1990-8#1)(1996-8#1)(2008-10#1)
to be recommended##7##3##(1990-8#1)(1991-3#1)(1992-11#1)(1993-1#1)(1996-8#1)(2008-10#1)(2011-2#1)
to be reconsidered##2##3##(2007-12#1)(2011-2#1)
to be reconstructed from##2##4##(2008-2#1)(2008-7#1)
to be reconstructed##9##3##(1993-8#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)(2008-7#1)(2012-1#1)
to be record##3##3##(2007-11#1)(2007-12#2)
to be recorded##2##3##(1996-6#1)(2008-9#1)
to be reduced by##5##4##(1991-9#1)(1992-2#1)(1992-6#1)(2008-2#1)(2013-8#1)
to be reduced in##3##4##(1997-1#1)(1997-5#1)(2013-8#1)
to be reduced to##3##4##(2008-2#1)(2008-4#1)(2008-5#1)
to be reduced##20##3##(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1994-5#1)(1997-1#1)(1997-2#1)(1997-5#1)(2007-6#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)(2012-12#1)(2013-1#1)(2013-8#2)
to be referred to the##2##5##(2008-4#1)(2009-2#1)
to be referred##3##3##(2008-4#1)(2009-2#1)(2010-10#1)
to be refined##5##3##(1993-9#1)(2007-8#1)(2007-9#1)(2008-9#1)(2009-12#1)
to be regarded as##2##4##(2006-10#1)(2008-7#1)
to be regarded##3##3##(1996-11#1)(2006-10#1)(2008-7#1)
to be region-specific##2##3##(1993-4#1)(2008-3#1)
to be registered##4##3##(1991-11#1)(2007-11#1)(2008-3#1)(2008-6#1)
to be regulated at the##2##5##(1990-12#1)(1995-2#1)
to be regulated by a##2##5##(1997-1#1)(2009-8#1)
to be regulated by p53##2##5##(1997-2#1)(2010-12#1)
to be regulated by protein##2##5##(1991-2#1)(1993-8#1)
to be regulated by the##3##5##(1991-3#1)(1997-2#1)(2008-10#1)
to be regulated by##24##4##(1990-4#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-9#1)(1993-6#1)(1993-8#2)(1994-11#1)(1995-8#2)(1996-1#1)(1996-8#1)(1997-1#1)(1997-2#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#2)(2009-8#1)(2010-12#1)(2013-8#1)
to be regulated in##3##4##(1991-12#1)(1997-4#1)(2011-2#1)
to be regulated##38##3##(1990-12#1)(1990-4#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-8#2)(1996-1#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-8#3)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-8#1)
to be rejected##3##3##(2007-12#1)(2008-2#2)
to be related not##2##4##(1995-2#1)(2008-5#1)
to be related to a##8##5##(1992-6#1)(1994-8#1)(2006-10#2)(2006-6#1)(2006-9#1)(2010-12#1)(2012-12#1)
to be related to both##2##5##(1997-4#1)(2013-1#1)
to be related to differences in##3##6##(1994-2#1)(2007-8#1)(2009-7#1)
to be related to each other##2##6##(2007-2#1)(2009-7#1)
to be related to its##2##5##(1997-1#1)(2008-7#1)
to be related to the clinical##2##6##(1991-6#1)(1996-8#1)
to be related to the occurrence of##2##7##(2007-10#1)(2007-9#1)
to be related to the##40##5##(1990-3#1)(1990-5#1)(1991-3#2)(1991-6#1)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1994-2#1)(1994-5#1)(1995-3#1)(1995-6#1)(1996-8#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#2)(2007-10#1)(2007-11#1)(2007-9#2)(2008-10#4)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)
to be related to tumor growth##2##6##(1991-9#1)(1993-11#1)
to be related to tumor##3##5##(1991-7#1)(1991-9#1)(1993-11#1)
to be related to##120##4##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-3#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-8#1)(1997-1#2)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#3)(2006-10#3)(2006-12#1)(2006-2#2)(2006-5#1)(2006-6#5)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#3)(2008-10#8)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#6)(2009-1#1)(2009-2#1)(2009-4#1)(2009-7#3)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
to be related with the##3##5##(1993-11#1)(2005-11#1)(2011-2#1)
to be related with##6##4##(1990-6#1)(1993-11#1)(2005-11#1)(2007-11#1)(2011-2#1)(2012-3#1)
to be related##132##3##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-3#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#1)(1993-8#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-8#1)(1997-1#2)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#3)(2005-11#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-5#1)(2006-6#5)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#3)(2008-10#9)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#6)(2008-8#2)(2008-9#6)(2009-1#1)(2009-2#1)(2009-4#1)(2009-7#3)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)
to be relatively common##2##4##(2005-10#1)(2008-2#1)
to be relatively high##2##4##(1995-5#1)(2008-7#1)
to be relatively insensitive to the##3##6##(1994-5#1)(2006-11#1)(2008-9#1)
to be relatively low##2##4##(2007-7#1)(2008-3#1)
to be relatively safe##2##4##(2007-11#1)(2008-10#1)
to be relatively small##3##4##(2007-3#1)(2008-2#1)(2008-3#1)
to be relatively##33##3##(1994-5#1)(1994-6#1)(1994-9#1)(1995-5#1)(1996-6#1)(2005-10#1)(2005-11#2)(2006-11#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#2)(2008-9#1)(2010-7#2)(2010-8#1)(2012-2#1)
to be released by##2##4##(1992-12#1)(2008-5#1)
to be released from the##2##5##(1994-11#1)(2008-6#1)
to be released from##3##4##(1992-8#1)(1994-11#1)(2008-6#1)
to be released in##2##4##(1991-2#1)(2009-10#1)
to be released##22##3##(1991-12#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-5#1)(1994-11#1)(1995-8#1)(1997-4#1)(1997-6#2)(2005-7#1)(2005-9#1)(2006-3#1)(2007-12#1)(2008-10#2)(2008-5#2)(2008-6#1)(2009-10#1)
to be relevant in the##3##5##(2006-12#1)(2007-11#1)(2008-10#1)
to be relevant in##4##4##(1990-9#1)(2006-12#1)(2007-11#1)(2008-10#1)
to be relevant to##2##4##(1990-7#1)(2007-8#1)
to be relevant##14##3##(1990-7#1)(1990-9#1)(1992-4#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)
to be reliable and##3##4##(2007-10#1)(2007-12#1)(2008-10#1)
to be reliable in##2##4##(1993-1#1)(2013-1#1)
to be reliable##13##3##(1992-3#2)(1993-1#1)(1996-3#2)(2006-4#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-7#1)(2011-2#1)(2013-1#1)
to be reliably##2##3##(2008-4#1)(2011-1#1)
to be remarkably##4##3##(1990-7#1)(1994-3#1)(2008-10#1)(2008-11#1)
to be remembered as##2##4##(2008-4#1)(2011-2#1)
to be removed by##4##4##(1996-5#1)(2007-12#1)(2008-10#1)(2011-2#1)
to be removed on##2##4##(1990-8#1)(1991-12#1)
to be removed##25##3##(1990-8#2)(1991-12#1)(1991-2#1)(1991-6#1)(1996-5#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2011-2#5)(2013-8#1)
to be renal##2##3##(2008-7#1)(2010-12#1)
to be renoprotective##2##3##(2010-7#1)(2012-3#1)
to be repeated##3##3##(1995-8#1)(1997-6#1)(2008-7#1)
to be replaced by a##2##5##(2007-12#1)(2012-2#1)
to be replaced by##6##4##(1990-10#1)(1995-3#1)(1996-11#1)(2007-12#1)(2007-7#1)(2012-2#1)
to be replaced##12##3##(1990-10#1)(1993-2#1)(1995-3#1)(1996-11#1)(2005-5#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-7#1)(2012-2#1)
to be replicated##6##3##(1995-1#2)(1997-3#1)(2008-2#1)(2008-7#1)(2008-9#1)
to be reported in the##3##5##(1993-6#1)(2008-7#1)(2013-1#1)
to be reported in##7##4##(1992-6#1)(1993-6#1)(2006-7#1)(2008-10#1)(2008-12#1)(2008-7#1)(2013-1#1)
to be reported##19##3##(1990-5#1)(1992-6#1)(1993-6#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
to be representative of##4##4##(1991-3#1)(1994-6#1)(2006-11#1)(2012-2#1)
to be representative##5##3##(1991-3#1)(1994-6#1)(2006-11#1)(2007-4#1)(2012-2#1)
to be represented##3##3##(2008-3#1)(2009-2#1)(2009-4#1)
to be repressed##2##3##(1992-4#1)(1996-3#1)
to be reproducible##3##3##(2007-8#2)(2008-10#1)
to be required for the##7##5##(1990-7#1)(1990-8#1)(1992-5#1)(1995-3#1)(1996-4#1)(2004-11#1)(2007-12#1)
to be required for##26##4##(1990-7#1)(1990-8#1)(1991-7#1)(1992-11#2)(1992-5#1)(1993-6#1)(1993-9#1)(1994-12#2)(1995-1#1)(1995-3#1)(1995-4#1)(1996-2#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-7#1)(2004-11#1)(2007-12#1)(2008-10#2)(2008-9#1)(2009-8#1)(2010-3#1)
to be required in##2##4##(1995-8#1)(2008-11#1)
to be required to##3##4##(2006-10#1)(2009-12#1)(2011-2#1)
to be required##32##3##(1990-7#1)(1990-8#1)(1991-7#1)(1992-11#2)(1992-5#1)(1993-6#1)(1993-9#1)(1994-12#2)(1995-1#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-7#1)(2004-11#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-2#1)
to be researched##2##3##(2006-10#1)(2008-12#1)
to be resected##3##3##(2007-5#1)(2008-5#1)(2013-8#1)
to be resistant to all##2##5##(2010-10#1)(2010-5#1)
to be resistant to##12##4##(1992-9#2)(1993-5#1)(1993-9#1)(1994-10#1)(2006-9#1)(2008-10#2)(2008-5#1)(2010-10#1)(2010-2#1)(2010-5#1)
to be resistant##15##3##(1990-3#1)(1992-9#2)(1993-4#1)(1993-5#1)(1993-9#1)(1994-10#1)(2006-9#1)(2008-10#3)(2008-5#1)(2010-10#1)(2010-2#1)(2010-5#1)
to be resolved##16##3##(1990-7#1)(1991-2#1)(1992-1#1)(1995-11#1)(1995-3#1)(1996-6#1)(2006-5#1)(2007-11#2)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-2#1)
to be responsible for a##2##5##(2012-12#1)(2012-2#1)
to be responsible for the##31##5##(1990-9#1)(1991-2#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-12#1)(1995-1#3)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#2)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#2)(2009-2#1)(2009-5#1)(2010-12#1)(2011-1#1)
to be responsible for these##3##5##(2006-3#1)(2007-11#1)(2009-5#1)
to be responsible for this##2##5##(1995-10#1)(2008-8#1)
to be responsible for##67##4##(1990-5#1)(1990-9#2)(1991-12#1)(1991-2#1)(1992-4#1)(1992-6#1)(1993-10#1)(1993-11#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-7#1)(1994-8#1)(1995-1#3)(1995-10#1)(1995-11#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-8#2)(2004-9#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-3#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#2)(2008-8#1)(2009-2#1)(2009-5#2)(2010-10#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)
to be responsible##73##3##(1990-5#1)(1990-9#2)(1991-12#1)(1991-2#1)(1992-4#1)(1992-6#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-8#2)(2004-12#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-3#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-2#1)(2009-5#2)(2010-10#1)(2010-12#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)
to be responsive to##3##4##(1995-11#1)(2006-2#1)(2008-9#1)
to be restored##4##3##(1996-2#1)(2006-3#1)(2013-1#2)
to be restricted in##2##4##(1992-7#1)(1994-2#1)
to be restricted to the##4##5##(1991-6#1)(1995-8#1)(2008-5#1)(2008-7#1)
to be restricted to##8##4##(1991-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(2007-1#1)(2008-5#1)(2008-7#2)
to be restricted##13##3##(1991-6#1)(1992-7#1)(1994-2#1)(1995-8#1)(1996-2#1)(1996-5#1)(2006-10#1)(2007-1#1)(2008-5#1)(2008-7#2)(2013-1#2)
to be retained in the##2##5##(1991-10#1)(1997-4#1)
to be retained##6##3##(1991-10#1)(1992-2#1)(1997-4#1)(2007-2#1)(2008-10#1)(2008-7#1)
to be retracted##2##3##(1994-2#1)(2006-11#1)
to be reusable##2##3##(2008-10#1)(2009-2#1)
to be revealed##3##3##(1994-5#1)(2006-10#2)
to be reversible and##2##4##(2008-10#1)(2011-2#1)
to be reversible##8##3##(1993-11#1)(1994-12#1)(1995-12#1)(2005-11#1)(2008-10#1)(2008-5#1)(2010-5#1)(2011-2#1)
to be reviewed##2##3##(2008-6#1)(2011-2#1)
to be revised##2##3##(2007-8#1)(2008-4#1)
to be rich in##5##4##(1995-11#1)(2007-1#1)(2008-11#2)(2008-4#1)
to be rich##6##3##(1995-11#1)(2006-12#1)(2007-1#1)(2008-11#2)(2008-4#1)
to be risk factors##3##4##(2007-8#1)(2011-2#2)
to be robust to##2##4##(2008-2#1)(2010-9#1)
to be robust##10##3##(2006-7#1)(2008-11#1)(2008-2#1)(2008-6#1)(2010-12#3)(2010-3#1)(2010-9#1)(2012-3#1)
to be rotated##2##3##(2007-11#1)(2007-12#1)
to be roughly##2##3##(2005-11#1)(2008-11#1)
to be run##4##3##(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#1)
to be safe and effective##9##5##(2006-5#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-4#1)(2011-1#1)(2013-1#1)
to be safe and may##2##5##(2007-9#1)(2008-1#1)
to be safe and well tolerated##3##6##(1992-8#1)(2010-5#1)(2013-1#1)
to be safe and##27##4##(1991-12#1)(1992-8#1)(1994-6#1)(1995-5#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-1#2)(2009-2#1)(2009-4#1)(2009-5#1)(2010-5#1)(2011-1#1)(2013-1#2)
to be safe in##3##4##(1993-11#1)(2006-10#1)(2007-9#1)
to be safe##44##3##(1991-12#1)(1992-5#1)(1992-8#1)(1993-11#1)(1994-6#1)(1995-5#1)(1996-2#1)(1997-6#1)(2005-7#2)(2006-10#2)(2006-2#1)(2006-5#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-1#3)(2009-2#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-12#1)(2013-1#4)(2013-7#1)
to be safer##2##3##(2006-11#1)(2008-7#1)
to be sampled at##2##4##(2008-2#1)(2008-3#1)
to be sampled##7##3##(2008-10#4)(2008-2#1)(2008-3#2)
to be satisfactory##10##3##(1990-10#1)(1996-1#1)(1996-7#1)(2005-4#1)(2007-1#1)(2007-11#1)(2008-10#3)(2012-12#1)
to be satisfied##5##3##(1996-3#1)(2006-6#1)(2008-9#2)(2012-3#1)
to be screened for##3##4##(1990-12#1)(1992-10#1)(2008-10#1)
to be screened##7##3##(1990-12#2)(1992-10#1)(1995-7#1)(1996-12#1)(2008-10#1)(2009-12#1)
to be secondary to##9##4##(1991-9#1)(1994-6#1)(2006-10#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-6#1)(2010-5#1)
to be secreted by##2##4##(1990-7#1)(1994-11#1)
to be secreted##6##3##(1990-7#1)(1990-8#1)(1994-11#1)(1997-1#2)(2008-11#1)
to be seen in##2##4##(2007-11#1)(2008-8#1)
to be seen##19##3##(1992-2#1)(1994-3#1)(1994-9#1)(1996-11#1)(2006-10#1)(2006-7#1)(2007-11#3)(2007-4#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#1)
to be segmented##2##3##(1996-10#1)(2009-10#1)
to be selected for##3##4##(1996-3#1)(2004-9#1)(2008-10#1)
to be selected##6##3##(1994-11#1)(1996-3#1)(2004-9#1)(2008-10#2)(2012-9#1)
to be selective for the##2##5##(1991-9#1)(2008-8#1)
to be selective for##3##4##(1991-9#2)(2008-8#1)
to be selective##7##3##(1991-9#2)(2008-10#1)(2008-5#1)(2008-8#1)(2009-5#1)(2012-12#1)
to be selectively##3##3##(2007-12#1)(2008-3#1)(2008-5#1)
to be sensed##2##3##(2007-5#1)(2008-2#1)
to be sensitive and##3##4##(1990-11#1)(2008-10#1)(2011-2#1)
to be sensitive to both##2##5##(2008-5#1)(2009-4#1)
to be sensitive to the##11##5##(1990-7#1)(1995-11#1)(1996-7#1)(2007-1#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-12#2)(2012-3#1)
to be sensitive to##36##4##(1990-12#2)(1990-2#1)(1990-7#1)(1991-10#1)(1991-9#1)(1994-12#2)(1994-2#1)(1995-11#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(2006-11#1)(2007-1#1)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-8#2)(2009-4#1)(2010-8#1)(2011-12#1)(2012-12#3)(2012-2#1)(2012-3#1)
to be sensitive##45##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-7#1)(1991-10#1)(1991-9#1)(1994-12#2)(1994-2#1)(1995-11#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-1#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#3)(2008-5#2)(2008-8#2)(2009-4#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#1)
to be sensitized##2##3##(1991-11#1)(2011-1#1)
to be sent##2##3##(2010-12#1)(2010-5#1)
to be separated from##4##4##(1990-5#1)(2008-10#1)(2008-2#1)(2008-7#1)
to be separated##6##3##(1990-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)
to be sequenced##5##3##(2008-10#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
to be sequential##2##3##(1990-3#1)(2010-12#1)
to be serine##2##3##(1991-7#1)(1993-11#1)
to be serious##2##3##(2007-2#1)(2008-9#1)
to be seriously##2##3##(2008-10#1)(2008-5#1)
to be served by##2##4##(1991-11#1)(1997-2#1)
to be set up##2##4##(1993-5#1)(2009-10#1)
to be set##5##3##(1993-5#1)(1996-2#1)(2009-10#1)(2010-9#1)(2013-8#1)
to be several##2##3##(1991-10#1)(1997-1#1)
to be severe##3##3##(1990-6#1)(2008-5#1)(2011-1#1)
to be severely##4##3##(1995-1#1)(1995-3#1)(2008-3#1)(2008-8#1)
to be sexually##3##3##(2009-7#1)(2012-12#1)(2013-1#1)
to be shared##2##3##(2006-10#1)(2008-8#1)
to be short-lived##2##3##(1995-5#1)(2006-10#1)
to be shown##9##3##(1990-7#1)(1991-7#1)(1993-8#1)(2005-8#1)(2006-10#1)(2008-10#2)(2009-6#1)(2013-8#1)
to be significant and##2##4##(2006-10#1)(2008-2#1)
to be significant in##3##4##(1990-12#1)(1993-11#1)(2008-10#1)
to be significant##26##3##(1990-12#1)(1993-11#1)(1993-9#2)(1997-2#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)(2013-1#3)(2013-8#1)
to be significantly affected by##2##5##(2008-10#1)(2010-4#1)
to be significantly associated with high##2##6##(2009-9#1)(2011-1#1)
to be significantly associated with##16##5##(1994-7#1)(2004-4#1)(2005-10#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#2)(2012-1#1)(2012-2#2)
to be significantly associated##18##4##(1994-7#1)(2004-4#1)(2005-10#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-8#2)(2009-9#1)(2010-11#1)(2010-12#2)(2011-1#2)(2012-1#1)(2012-2#3)
to be significantly different from those of##2##7##(2008-5#1)(2011-2#1)
to be significantly different##7##4##(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2011-1#1)(2011-2#1)
to be significantly elevated##3##4##(2008-3#1)(2008-7#1)(2011-12#1)
to be significantly higher in females##2##6##(2007-1#1)(2012-11#1)
to be significantly higher in the##2##6##(2007-12#1)(2008-10#1)
to be significantly higher in##9##5##(1990-11#1)(1996-2#1)(2007-1#1)(2007-12#1)(2008-10#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-11#1)
to be significantly higher than that of##2##7##(1992-7#1)(2007-8#1)
to be significantly higher than##4##5##(1992-7#1)(1995-12#1)(1996-1#1)(2007-8#1)
to be significantly higher##20##4##(1990-11#1)(1990-7#1)(1992-7#1)(1994-8#1)(1995-12#1)(1996-1#1)(1996-2#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-4#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-11#1)(2013-8#1)
to be significantly less##3##4##(1996-12#1)(2006-10#1)(2013-1#1)
to be significantly longer##2##4##(1990-3#1)(1995-6#1)
to be significantly lower than##3##5##(1993-8#1)(2007-2#1)(2008-10#1)
to be significantly lower##9##4##(1993-8#1)(2007-1#1)(2007-2#1)(2008-10#2)(2008-3#1)(2013-7#1)(2013-8#2)
to be significantly lowered in##2##5##(2006-8#1)(2011-2#1)
to be significantly more effective than##3##6##(2005-7#1)(2007-11#2)
to be significantly more##7##4##(1996-7#1)(2005-7#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-3#1)
to be significantly reduced##4##4##(1990-8#1)(1992-11#1)(1993-11#1)(2008-3#1)
to be significantly related to the##2##6##(1996-12#1)(1996-3#1)
to be significantly related to##7##5##(1996-1#1)(1996-12#1)(1996-3#1)(2007-12#1)(2008-12#1)(2008-7#1)(2009-7#1)
to be significantly##122##3##(1990-11#1)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#2)(1992-11#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-7#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-4#1)(1995-6#1)(1996-1#2)(1996-12#3)(1996-2#1)(1996-3#2)(1996-7#2)(1997-3#1)(1997-4#2)(1997-5#1)(2004-11#1)(2004-4#1)(2005-10#1)(2005-11#2)(2005-7#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-8#2)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#4)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2009-1#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-4#1)(2011-1#4)(2011-12#3)(2011-2#3)(2012-1#2)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
to be similar at##3##4##(1997-7#2)(2007-1#1)
to be similar for both##2##5##(2005-11#1)(2008-10#1)
to be similar for##3##4##(2005-11#1)(2007-8#1)(2008-10#1)
to be similar in both##3##5##(1995-5#1)(2004-10#1)(2008-5#1)
to be similar in the##2##5##(1993-3#1)(2008-10#1)
to be similar in##10##4##(1990-1#1)(1991-5#1)(1993-3#1)(1995-5#1)(2004-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-5#1)
to be similar to that of the##4##7##(1992-11#1)(2006-11#1)(2007-11#1)(2008-5#1)
to be similar to that of##10##6##(1990-5#1)(1991-2#1)(1992-11#1)(1996-6#1)(2006-11#1)(2007-11#3)(2008-5#2)
to be similar to that##12##5##(1990-2#1)(1990-5#1)(1991-2#1)(1992-11#1)(1996-12#1)(1996-6#1)(2006-11#1)(2007-11#3)(2008-5#2)
to be similar to the##6##5##(1993-11#1)(1994-11#1)(1994-9#1)(1997-8#1)(2008-10#1)(2008-4#1)
to be similar to those observed##2##6##(2008-7#1)(2011-2#1)
to be similar to those of the##2##7##(1991-2#1)(2008-9#1)
to be similar to those of##3##6##(1991-2#1)(1991-9#1)(2008-9#1)
to be similar to those##9##5##(1991-2#1)(1991-9#1)(1995-3#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)
to be similar to what##2##5##(2005-11#1)(2006-10#1)
to be similar to##35##4##(1990-2#1)(1990-5#1)(1990-7#1)(1991-2#2)(1991-9#2)(1992-11#1)(1993-11#1)(1993-9#1)(1994-11#2)(1994-9#1)(1995-3#1)(1996-12#1)(1996-6#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-11#3)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)
to be similar##65##3##(1990-1#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-2#2)(1991-5#1)(1991-9#2)(1992-11#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-9#1)(1995-3#1)(1995-5#2)(1996-12#1)(1996-2#1)(1996-6#1)(1997-7#2)(1997-8#1)(2004-10#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#5)(2007-8#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#1)
to be simple##8##3##(1994-6#1)(1996-2#1)(2008-10#2)(2008-5#1)(2008-6#1)(2010-12#1)(2010-5#1)
to be single##4##3##(1990-5#1)(1991-3#1)(2007-7#1)(2011-1#1)
to be situated##2##3##(2007-11#1)(2009-6#1)
to be slightly higher than##3##5##(1993-2#1)(1995-3#1)(2008-2#1)
to be slightly higher##4##4##(1993-2#1)(1995-3#1)(2007-2#1)(2008-2#1)
to be slightly more effective than##2##6##(1993-12#1)(2008-5#1)
to be slightly more##8##4##(1990-10#1)(1990-12#1)(1993-12#1)(1995-10#1)(1995-5#2)(2007-11#1)(2008-5#1)
to be slightly##17##3##(1990-10#1)(1990-12#1)(1990-3#1)(1990-4#1)(1993-12#1)(1993-2#1)(1995-10#1)(1995-3#1)(1995-5#2)(2004-9#1)(2007-11#1)(2007-2#1)(2008-2#1)(2008-5#2)(2008-7#1)
to be slow and##2##4##(1996-1#1)(2004-9#1)
to be slow##3##3##(1995-9#1)(1996-1#1)(2004-9#1)
to be slowly##2##3##(1996-4#1)(2008-5#1)
to be small##6##3##(1990-5#1)(2005-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2013-1#1)
to be smaller in##2##4##(2007-4#1)(2012-2#1)
to be smaller than expected##2##5##(1997-7#1)(2008-7#1)
to be smaller than##6##4##(1997-7#1)(2008-3#3)(2008-7#1)(2010-8#1)
to be smaller##10##3##(1991-9#1)(1997-7#1)(2007-4#1)(2008-3#4)(2008-7#1)(2010-8#1)(2012-2#1)
to be so##4##3##(1991-6#1)(1992-2#1)(2007-6#1)(2010-10#1)
to be soluble and##2##4##(1992-7#2)
to be soluble in##2##4##(2004-8#1)(2008-10#1)
to be soluble##5##3##(1992-6#1)(1992-7#2)(2004-8#1)(2008-10#1)
to be solved before##2##4##(1994-12#1)(2006-5#1)
to be solved##12##3##(1990-2#1)(1991-4#1)(1992-9#1)(1994-12#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-3#1)(2010-1#1)(2010-8#1)(2011-1#1)(2013-1#1)
to be some##3##3##(1990-4#1)(1992-8#1)(2007-12#1)
to be somewhat less##2##4##(2008-2#1)(2010-5#1)
to be somewhat##5##3##(1994-11#1)(2007-11#1)(2008-2#1)(2010-5#1)(2012-12#1)
to be sorted##2##3##(1991-1#1)(2011-2#1)
to be specific for##8##4##(1990-7#1)(1991-12#1)(1992-3#1)(1994-12#1)(1996-11#1)(1997-7#1)(2008-10#1)(2008-11#1)
to be specific since##2##4##(1991-10#1)(2008-6#1)
to be specific to the##3##5##(1993-6#1)(2006-12#1)(2007-12#1)
to be specific to##4##4##(1991-12#1)(1993-6#1)(2006-12#1)(2007-12#1)
to be specific##18##3##(1990-7#1)(1991-10#2)(1991-12#2)(1992-3#1)(1993-6#1)(1994-12#1)(1996-11#1)(1997-7#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2013-7#1)
to be specifically##7##3##(1990-2#1)(1991-12#1)(1992-8#1)(1993-9#1)(1996-6#1)(2008-11#1)(2008-7#1)
to be specified##4##3##(1991-5#1)(2007-7#1)(2008-2#1)(2008-7#1)
to be stabilized##3##3##(1990-10#1)(1990-8#1)(2008-3#1)
to be stable after##2##4##(1997-7#1)(2008-11#1)
to be stable and##2##4##(1997-1#1)(2008-3#1)
to be stable for at least##2##6##(1993-2#1)(1996-7#1)
to be stable for##7##4##(1993-2#1)(1996-7#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-7#1)
to be stable in the##2##5##(1992-6#1)(2008-10#1)
to be stable in##5##4##(1992-6#1)(1996-9#1)(2008-10#1)(2011-2#1)(2013-1#1)
to be stable on##2##4##(2007-9#1)(2008-2#1)
to be stable over##2##4##(2008-11#1)(2010-7#1)
to be stable##31##3##(1990-5#1)(1990-7#1)(1992-6#1)(1993-2#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-7#1)(2005-11#2)(2006-3#1)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#3)(2008-7#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-1#1)
to be statistically significant##8##4##(1990-2#2)(1993-12#1)(1997-4#1)(2007-8#1)(2008-5#2)(2008-8#1)
to be statistically##21##3##(1990-2#2)(1993-11#1)(1993-12#1)(1997-2#1)(1997-4#1)(2007-2#1)(2007-8#2)(2008-10#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#3)
to be sterile##2##3##(2007-2#1)(2012-2#1)
to be still present##2##4##(2008-7#1)(2008-8#1)
to be still##5##3##(1990-7#1)(2008-2#1)(2008-7#1)(2008-8#1)(2013-1#1)
to be stimulated by the##2##5##(1990-5#1)(1992-6#1)
to be stimulated by##4##4##(1990-5#1)(1992-6#1)(1995-6#1)(2009-8#1)
to be stimulated##5##3##(1990-5#1)(1992-6#1)(1995-6#1)(1996-11#1)(2009-8#1)
to be stored##2##3##(2008-2#2)
to be strengthened##3##3##(1990-10#1)(2008-2#1)(2012-12#1)
to be strictly##5##3##(1996-8#1)(1997-2#1)(2004-9#1)(2007-6#1)(2010-5#1)
to be strong##4##3##(1990-10#1)(1992-8#1)(1994-12#1)(2008-9#1)
to be stronger in subjects with##2##6##(2008-3#1)(2008-5#1)
to be stronger in##5##4##(2005-10#1)(2008-3#1)(2008-5#1)(2009-1#1)(2010-2#1)
to be stronger than##2##4##(1997-8#1)(2013-1#1)
to be stronger##8##3##(1990-11#1)(1997-8#1)(2005-10#1)(2008-3#1)(2008-5#1)(2009-1#1)(2010-2#1)(2013-1#1)
to be strongly associated with##4##5##(2009-4#1)(2010-12#1)(2011-2#1)(2012-2#1)
to be strongly correlated with##2##5##(2006-2#1)(2008-2#1)
to be strongly correlated##5##4##(1991-12#1)(2006-2#1)(2007-12#1)(2008-2#1)(2009-10#1)
to be strongly dependent on the##6##6##(1997-1#1)(2005-11#1)(2007-12#1)(2008-7#1)(2009-3#1)(2011-2#1)
to be strongly dependent on##8##5##(1997-1#1)(2005-11#1)(2007-12#1)(2008-2#1)(2008-7#1)(2009-3#1)(2011-2#1)(2013-1#1)
to be strongly dependent upon##2##5##(1994-12#1)(2006-10#1)
to be strongly dependent##10##4##(1994-12#1)(1997-1#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-7#1)(2009-3#1)(2011-2#1)(2013-1#1)
to be strongly influenced by the##2##6##(2005-11#1)(2008-1#1)
to be strongly influenced by##4##5##(1991-2#1)(2005-11#1)(2008-1#1)(2011-12#1)
to be strongly##36##3##(1990-10#1)(1991-12#2)(1991-2#1)(1994-11#1)(1994-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(2005-11#2)(2005-12#1)(2006-10#1)(2006-2#1)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2010-12#2)(2011-12#2)(2011-2#2)(2012-2#1)(2013-1#1)
to be structurally##3##3##(1990-8#1)(1994-5#1)(1996-10#1)
to be studied and##4##4##(2006-5#1)(2008-10#1)(2012-11#2)
to be studied by##2##4##(1992-12#1)(2010-8#1)
to be studied directly##2##4##(2007-12#1)(2007-9#1)
to be studied in##4##4##(2007-11#1)(2007-7#1)(2008-4#1)(2009-9#1)
to be studied##26##3##(1991-10#1)(1991-11#1)(1992-12#1)(1992-8#1)(1994-9#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#2)(2007-9#2)(2008-10#3)(2008-3#1)(2008-4#2)(2008-9#1)(2009-9#1)(2010-11#1)(2010-8#1)(2012-11#2)
to be subject to##5##4##(1990-3#1)(2005-11#1)(2007-12#1)(2007-5#1)(2008-5#1)
to be subjected to##2##4##(1995-5#1)(1997-2#1)
to be submitted on##2##4##(2011-2#1)(2012-12#1)
to be submitted to##2##4##(2008-5#1)(2011-2#1)
to be submitted##5##3##(2006-7#1)(2008-5#1)(2011-2#2)(2012-12#1)
to be substantially##3##3##(1992-11#1)(2007-12#1)(2008-2#1)
to be successful even where there was severe overlap of spectra##2##11##(2008-10#2)
to be successful for##4##4##(2007-8#2)(2008-10#1)(2010-5#1)
to be successful in##11##4##(1990-12#1)(1991-2#1)(1992-6#1)(1993-9#1)(1994-9#1)(2008-1#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-3#2)
to be successful##33##3##(1990-12#2)(1991-2#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-9#1)(1994-1#1)(1994-9#1)(1995-12#1)(1996-3#1)(1996-8#1)(1997-1#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#2)(2010-3#2)(2010-5#2)(2011-1#1)
to be successfully##4##3##(2006-12#1)(2008-12#1)(2009-4#1)(2009-6#1)
to be suffering from##5##4##(1990-2#1)(2008-10#1)(2008-5#1)(2009-7#1)(2011-1#1)
to be sufficient for a##2##5##(2005-9#1)(2008-3#1)
to be sufficient for the##2##5##(1996-5#1)(2007-11#1)
to be sufficient for##7##4##(1995-2#1)(1996-3#1)(1996-5#1)(2005-9#1)(2007-11#1)(2008-3#1)(2009-12#1)
to be sufficient to##6##4##(1990-10#1)(1997-1#1)(1997-4#1)(2006-11#1)(2007-12#1)(2011-2#1)
to be sufficient##18##3##(1990-10#1)(1995-2#1)(1995-3#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-4#1)(2005-9#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-3#1)(2009-12#1)(2010-11#1)(2011-2#1)
to be sufficiently##3##3##(1996-8#1)(2009-3#1)(2010-4#1)
to be suitable for measuring##2##5##(1993-11#1)(1994-3#1)
to be suitable for routine##2##5##(2005-5#1)(2008-10#1)
to be suitable for the separation##2##6##(1991-11#1)(2008-10#1)
to be suitable for the##15##5##(1990-12#1)(1991-11#1)(1993-11#1)(1993-12#2)(1996-3#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-7#1)(2011-1#1)
to be suitable for##35##4##(1990-12#1)(1991-11#1)(1991-12#1)(1991-8#1)(1992-2#1)(1992-8#1)(1993-11#2)(1993-12#2)(1994-12#1)(1994-3#1)(1995-2#1)(1995-4#1)(1996-3#1)(1997-8#1)(2005-5#1)(2007-10#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-7#1)(2011-1#1)
to be suitable##43##3##(1990-12#1)(1991-11#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-8#2)(1993-11#2)(1993-12#2)(1994-12#1)(1994-3#1)(1995-2#1)(1995-4#1)(1996-3#1)(1997-8#1)(2005-5#1)(2007-10#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-7#1)(2011-1#1)(2012-1#1)
to be superior in terms of##2##6##(2008-10#1)(2010-8#1)
to be superior to the##9##5##(1992-8#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-2#2)(2008-8#1)(2012-3#1)(2013-1#1)
to be superior to##28##4##(1992-8#2)(1996-2#1)(1997-2#1)(2004-3#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-11#5)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-8#1)(2012-3#1)(2013-1#1)
to be superior when##2##4##(2004-2#2)
to be superior##39##3##(1992-12#1)(1992-8#2)(1995-3#1)(1996-2#1)(1997-2#1)(2004-2#2)(2004-3#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-11#5)(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-8#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
to be supplemented##2##3##(1992-12#1)(2009-5#1)
to be supplied##2##3##(1992-9#1)(2008-2#1)
to be supported by##8##4##(1991-11#1)(1992-3#1)(1993-3#1)(1996-1#1)(2006-4#1)(2008-11#1)(2008-12#1)(2008-7#1)
to be supported##11##3##(1991-11#1)(1992-3#1)(1993-3#1)(1996-1#1)(2006-4#1)(2008-11#1)(2008-12#1)(2008-7#2)(2009-9#1)(2011-2#1)
to be suppressed##3##3##(1995-11#1)(2007-12#1)(2008-3#1)
to be sure##4##3##(1993-1#1)(2008-5#1)(2008-8#1)(2011-2#1)
to be surprisingly##2##3##(1991-5#1)(2008-3#1)
to be susceptible to##9##4##(1990-12#1)(1994-9#1)(2007-12#1)(2007-2#1)(2008-10#3)(2010-2#1)(2012-3#1)
to be susceptible##10##3##(1990-12#1)(1994-9#1)(2007-12#1)(2007-2#1)(2008-10#4)(2010-2#1)(2012-3#1)
to be sustainable##4##3##(1997-7#1)(2007-9#1)(2010-7#1)(2013-8#1)
to be sustained##3##3##(2008-9#1)(2013-1#2)
to be synonymous##2##3##(2008-10#1)(2010-3#1)
to be synthesized and secreted##2##5##(1990-11#1)(1991-2#1)
to be synthesized in the##2##5##(1990-11#1)(1992-1#1)
to be synthesized in##5##4##(1990-11#1)(1990-6#1)(1991-6#1)(1992-1#1)(1994-6#1)
to be synthesized##8##3##(1990-11#2)(1990-6#1)(1991-2#1)(1991-6#1)(1992-1#1)(1994-6#1)(1997-1#1)
to be systematic##2##3##(1994-2#1)(2005-11#1)
to be tackled##2##3##(2007-3#1)(2008-3#1)
to be tailored##2##3##(2008-10#1)(2013-8#1)
to be taken before##4##4##(2006-3#1)(2010-12#1)(2011-2#1)(2012-2#1)
to be taken by##3##4##(1993-3#1)(2008-11#1)(2013-1#1)
to be taken during##2##4##(1996-7#1)(2007-8#1)
to be taken for##4##4##(1990-10#1)(1994-12#1)(1995-3#1)(2010-12#1)
to be taken in##3##4##(1996-6#1)(1997-3#1)(2012-2#1)
to be taken into account in the##3##7##(1997-1#1)(2006-11#1)(2008-10#1)
to be taken into account in##7##6##(1997-1#1)(2006-11#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2012-12#1)
to be taken into account##18##5##(1992-4#1)(1993-5#1)(1994-3#1)(1997-1#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2010-9#1)(2012-12#1)(2012-2#2)
to be taken into consideration##5##5##(2006-3#1)(2009-4#1)(2012-12#2)(2012-3#1)
to be taken into##23##4##(1992-4#1)(1993-5#1)(1994-3#1)(1997-1#1)(2006-11#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-9#1)(2012-12#3)(2012-2#2)(2012-3#1)
to be taken seriously##2##4##(1996-12#1)(2008-10#1)
to be taken to##4##4##(2006-6#1)(2007-10#1)(2008-10#1)(2010-8#1)
to be taken up##5##4##(1991-8#1)(1996-1#1)(1996-12#1)(1996-8#1)(1997-4#1)
to be taken##69##3##(1990-10#1)(1990-4#1)(1991-8#1)(1992-4#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-12#3)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(2005-10#1)(2006-11#1)(2006-3#2)(2006-6#1)(2006-8#1)(2007-10#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-10#6)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#4)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
to be tandemly##2##3##(1994-12#1)(1997-4#1)
to be targeted for##2##4##(2008-4#1)(2010-5#1)
to be targeted to##2##4##(1994-12#1)(2005-7#1)
to be targeted##8##3##(1994-12#1)(1997-5#1)(2005-12#1)(2005-7#1)(2006-10#1)(2007-7#1)(2008-4#1)(2010-5#1)
to be taught##2##3##(1997-3#1)(2006-10#1)
to be technically##2##3##(1993-11#1)(2013-1#1)
to be technologically##2##3##(1990-12#1)(2012-2#1)
to be temperature##2##3##(1994-8#1)(2006-9#1)
to be teratogenic##2##3##(2008-8#1)(2013-1#1)
to be terminated##2##3##(1991-7#1)(2008-2#1)
to be tested as##3##4##(2008-10#2)(2008-5#1)
to be tested for HIV antibodies##3##6##(1995-12#1)(1996-11#1)(1996-5#1)
to be tested for HIV##5##5##(1993-3#1)(1995-12#1)(1996-11#2)(1996-5#1)
to be tested for##6##4##(1993-3#1)(1995-12#1)(1996-11#2)(1996-5#1)(2008-4#1)
to be tested in a##2##5##(2006-10#1)(2008-9#1)
to be tested in clinical trials##2##6##(2005-7#1)(2008-8#1)
to be tested in##9##4##(1993-5#1)(1995-5#1)(1997-4#1)(2005-7#1)(2006-10#1)(2008-10#1)(2008-8#1)(2008-9#1)(2013-7#1)
to be tested on##2##4##(2008-9#1)(2010-6#1)
to be tested were##2##4##(2006-10#1)(2012-12#1)
to be tested##37##3##(1992-7#1)(1993-3#1)(1993-5#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-11#3)(1996-3#1)(1996-5#1)(1997-4#1)(2005-7#1)(2006-10#2)(2006-7#1)(2007-1#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-4#3)(2008-5#1)(2008-8#2)(2008-9#2)(2009-5#1)(2010-6#1)(2012-12#3)(2013-7#1)
to be that of##3##4##(2007-2#1)(2008-10#1)(2008-4#1)
to be that##10##3##(1990-5#1)(1994-6#1)(1996-3#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
to be the &quot##2##4##(1995-6#1)(2009-7#1)
to be the P2Y(15) receptor activated by##2##7##(2008-4#2)
to be the basic##2##4##(2008-10#1)(2012-12#1)
to be the basis for##2##5##(1996-11#1)(2006-12#1)
to be the basis of##2##5##(2006-2#1)(2008-6#1)
to be the basis##4##4##(1996-11#1)(2006-12#1)(2006-2#1)(2008-6#1)
to be the best alternative##2##5##(2008-1#1)(2008-10#1)
to be the best method##4##5##(1992-1#1)(1994-5#1)(2005-1#1)(2007-4#1)
to be the best therapeutic##2##5##(1994-6#1)(2009-7#1)
to be the best##32##4##(1990-9#1)(1992-1#1)(1994-5#1)(1994-6#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-9#1)(1997-2#1)(2004-9#1)(2005-1#1)(2006-6#1)(2007-4#1)(2008-1#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-7#2)(2010-2#1)(2010-4#1)(2011-2#1)(2012-2#1)
to be the binding##2##4##(1995-3#1)(2008-10#1)
to be the case##7##4##(1990-6#1)(1990-9#1)(1993-6#1)(2006-12#1)(2006-6#1)(2006-8#1)(2008-9#1)
to be the cause of death##2##6##(1990-11#1)(2008-7#1)
to be the cause of the##4##6##(1994-11#1)(1997-2#1)(2008-5#1)(2008-7#1)
to be the cause of##15##5##(1990-11#1)(1991-6#1)(1994-11#1)(1994-3#1)(1995-9#2)(1996-8#1)(1997-1#1)(1997-2#1)(2006-12#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-7#2)
to be the cause##20##4##(1990-11#1)(1991-6#1)(1994-11#1)(1994-3#1)(1995-9#2)(1996-12#1)(1996-8#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2011-2#1)
to be the commonest##2##4##(1991-8#1)(2006-8#1)
to be the consequence of##4##5##(1997-5#1)(2007-11#1)(2010-9#1)(2012-2#1)
to be the critical##3##4##(1990-12#1)(1990-9#1)(1993-3#1)
to be the current##2##4##(2007-7#1)(2011-2#1)
to be the direct##2##4##(1992-11#1)(2012-3#1)
to be the dominant##6##4##(1991-2#1)(1997-1#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-3#1)
to be the etiologic##2##4##(1992-3#1)(2006-10#1)
to be the first case of##3##6##(2006-7#1)(2008-5#1)(2009-3#1)
to be the first demonstration of a##2##7##(2007-12#1)(2008-1#1)
to be the first demonstration of##9##6##(1992-8#1)(2007-12#6)(2008-1#2)
to be the first demonstration##10##5##(1992-8#1)(2007-12#7)(2008-1#2)
to be the first example of##2##6##(1992-12#1)(2007-11#1)
to be the first experimental demonstration of##5##7##(2007-12#4)(2008-1#1)
to be the first experimental##10##5##(2007-11#1)(2007-12#7)(2008-1#2)
to be the first reported case of##2##7##(2007-8#1)(2012-2#1)
to be the first reported##3##5##(2007-8#1)(2008-6#1)(2012-2#1)
to be the first time##34##5##(2007-11#13)(2007-12#19)(2008-1#1)(2008-3#1)
to be the first use of a##2##7##(2007-12#2)
to be the first use of##3##6##(2007-12#2)(2008-3#1)
to be the first##109##4##(1992-12#2)(1992-8#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-3#1)(1997-1#1)(2005-10#1)(2006-7#1)(2007-11#20)(2007-12#56)(2007-7#1)(2007-8#1)(2008-1#7)(2008-10#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-6#1)(2009-3#1)(2010-12#1)(2011-1#1)(2012-2#1)
to be the focus of##2##5##(2005-10#1)(2007-10#1)
to be the gene##2##4##(1994-8#1)(1995-11#1)
to be the gold standard##4##5##(2006-10#1)(2008-4#1)(2013-1#2)
to be the highest##3##4##(2007-11#1)(2009-3#1)(2010-8#1)
to be the important##2##4##(1994-8#1)(2011-3#1)
to be the initial##2##4##(1991-2#1)(2008-1#1)
to be the key factors##2##5##(2007-11#1)(2008-5#1)
to be the key##6##4##(2006-2#1)(2007-11#2)(2008-10#1)(2008-5#1)(2010-8#1)
to be the lack of##2##5##(2006-12#1)(2007-7#1)
to be the leading cause of##3##6##(2007-7#1)(2008-1#1)(2008-3#1)
to be the leading##4##4##(2007-7#1)(2008-1#1)(2008-3#1)(2008-8#1)
to be the main cause of##3##6##(2007-10#1)(2008-11#1)(2008-5#1)
to be the main reason for##2##6##(2007-10#1)(2009-11#1)
to be the main source##2##5##(1991-1#1)(2011-1#1)
to be the main##35##4##(1991-1#1)(1992-6#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-8#2)(2005-8#1)(2007-10#2)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-11#4)(2008-5#3)(2008-7#1)(2008-8#1)(2009-11#1)(2010-12#1)(2011-1#3)(2012-2#1)(2013-1#1)(2013-7#1)
to be the major cause of##2##6##(1993-12#1)(2008-7#1)
to be the major component##2##5##(2008-10#1)(2008-5#1)
to be the major##33##4##(1990-4#1)(1991-12#1)(1991-6#1)(1992-7#1)(1993-12#1)(1994-8#1)(1996-1#1)(1996-10#1)(1997-2#1)(2005-3#1)(2006-10#1)(2006-12#1)(2007-4#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#3)(2010-12#1)(2010-6#1)(2012-1#1)(2012-2#1)
to be the mechanism##4##4##(1993-2#1)(1997-8#1)(2007-9#1)(2008-3#1)
to be the method of##2##5##(1993-8#1)(2007-7#1)
to be the more##5##4##(1991-5#1)(2006-5#1)(2007-6#1)(2008-5#1)(2009-7#1)
to be the most appropriate##2##5##(2007-11#1)(2009-7#1)
to be the most common##8##5##(2007-10#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
to be the most effective##17##5##(1990-5#1)(1993-8#1)(1996-1#1)(1996-5#1)(2006-10#1)(2006-6#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#1)
to be the most efficient##8##5##(1990-3#2)(1990-9#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-6#1)
to be the most favorable##2##5##(1996-9#1)(2008-6#1)
to be the most important determinant of##2##7##(1991-4#1)(2007-7#1)
to be the most important##16##5##(1991-4#1)(1992-4#1)(1994-12#1)(1994-6#1)(2005-11#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-3#1)(2009-6#2)(2009-7#1)(2013-1#1)(2013-8#1)
to be the most popular##2##5##(1997-6#1)(2008-4#1)
to be the most potent##6##5##(1991-7#1)(1995-12#1)(1996-8#1)(2008-8#1)(2012-11#1)(2013-8#1)
to be the most promising##3##5##(2006-10#1)(2008-10#1)(2013-1#1)
to be the most reliable##3##5##(2007-3#1)(2007-7#1)(2008-7#1)
to be the most sensitive to##2##6##(1993-11#1)(1996-3#1)
to be the most sensitive##9##5##(1992-6#1)(1993-11#1)(1996-3#1)(1997-3#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-12#1)
to be the most significant##4##5##(2006-10#1)(2008-10#1)(2008-9#1)(2010-3#1)
to be the most successful##4##5##(1990-12#1)(1994-3#1)(2011-1#1)(2012-2#1)
to be the most suitable for##3##6##(2008-10#2)(2009-8#1)
to be the most suitable##9##5##(1997-8#1)(2006-10#1)(2007-8#1)(2008-10#4)(2009-8#1)(2012-2#1)
to be the most useful##5##5##(1991-6#1)(1992-1#1)(2005-12#1)(2009-12#1)(2013-7#1)
to be the most##135##4##(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-9#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-4#1)(1992-6#1)(1993-11#2)(1993-3#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-12#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-2#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#5)(2006-2#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#3)(2007-8#4)(2008-1#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#4)(2013-8#3)
to be the next##2##4##(2004-5#1)(2006-10#1)
to be the only effective##3##5##(1996-11#1)(2007-7#1)(2009-8#1)
to be the only##13##4##(1993-4#1)(1994-9#1)(1996-11#1)(2006-3#1)(2007-12#1)(2007-7#2)(2008-6#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
to be the optimal##2##4##(1995-2#1)(2007-8#1)
to be the optimum##2##4##(2007-10#1)(2008-10#1)
to be the origin of##2##5##(1996-7#1)(2009-2#1)
to be the precursor##3##4##(1991-2#1)(1994-11#1)(2008-10#1)
to be the predominant##2##4##(2008-9#1)(2010-8#1)
to be the preferred##2##4##(1996-5#1)(2008-5#1)
to be the primary##6##4##(1994-9#1)(1995-10#1)(1997-6#1)(2008-2#1)(2009-11#1)(2009-5#1)
to be the principal##3##4##(1990-4#1)(1991-8#1)(2005-12#1)
to be the rate-limiting step##2##5##(1995-2#1)(2006-10#1)
to be the reason##2##4##(2008-10#1)(2009-11#1)
to be the result of a##4##6##(1990-12#1)(2008-7#1)(2008-9#1)(2010-6#1)
to be the result of an##3##6##(1993-4#1)(2008-10#1)(2008-3#1)
to be the result of##19##5##(1990-12#1)(1992-12#1)(1993-4#1)(1996-12#1)(2006-10#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#3)(2008-7#1)(2008-9#1)(2010-6#1)(2012-2#1)(2012-3#1)
to be the same as that of##3##7##(2005-11#1)(2008-8#2)
to be the same as that##5##6##(2005-11#1)(2008-2#1)(2008-3#1)(2008-8#2)
to be the same as the##4##6##(1991-9#1)(1994-10#1)(1995-2#1)(2008-9#1)
to be the same as##10##5##(1991-9#1)(1994-10#1)(1995-2#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#1)
to be the same##18##4##(1991-9#1)(1993-3#1)(1994-10#1)(1995-2#1)(1997-1#1)(2005-11#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-11#1)(2012-1#1)
to be the second##3##4##(1991-6#1)(1992-4#1)(1993-12#1)
to be the smallest##3##4##(2007-12#2)(2011-12#1)
to be the source of infection##2##6##(1994-4#1)(2006-8#1)
to be the source of##3##5##(1994-4#1)(2006-8#1)(2007-12#1)
to be the strongest##2##4##(2011-2#1)(2012-12#1)
to be the subject of##2##5##(1993-11#1)(2008-7#1)
to be the sum##2##4##(2008-10#1)(2009-3#1)
to be the treatment of choice for##2##7##(1994-6#1)(2007-11#1)
to be the treatment of choice##5##6##(1992-9#1)(1994-6#1)(2006-6#1)(2007-11#1)(2007-7#1)
to be the##704##3##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#2)(1990-3#2)(1990-4#3)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#4)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#4)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#4)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#3)(1992-11#3)(1992-12#6)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#2)(1992-9#3)(1993-11#4)(1993-12#3)(1993-2#1)(1993-3#4)(1993-4#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#4)(1994-3#5)(1994-4#1)(1994-5#1)(1994-6#4)(1994-8#5)(1994-9#5)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#3)(1995-7#2)(1995-9#3)(1996-1#2)(1996-10#2)(1996-11#2)(1996-12#5)(1996-2#2)(1996-3#4)(1996-5#5)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#3)(1997-1#5)(1997-2#5)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#4)(1997-8#4)(2004-11#1)(2004-2#1)(2004-5#1)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#3)(2005-12#3)(2005-3#1)(2005-4#1)(2005-8#2)(2006-10#17)(2006-12#5)(2006-2#5)(2006-3#1)(2006-5#3)(2006-6#7)(2006-7#2)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#6)(2007-11#33)(2007-12#64)(2007-2#2)(2007-3#3)(2007-4#3)(2007-5#3)(2007-6#1)(2007-7#19)(2007-8#13)(2007-9#1)(2008-1#17)(2008-10#48)(2008-11#9)(2008-12#2)(2008-2#8)(2008-3#19)(2008-4#11)(2008-5#15)(2008-6#9)(2008-7#15)(2008-8#10)(2008-9#9)(2009-10#1)(2009-11#4)(2009-12#1)(2009-2#1)(2009-3#5)(2009-4#2)(2009-5#3)(2009-6#3)(2009-7#6)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#7)(2010-2#2)(2010-3#1)(2010-4#3)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#9)(2011-12#1)(2011-2#9)(2011-3#1)(2012-1#5)(2012-11#2)(2012-12#4)(2012-2#13)(2012-3#4)(2013-1#10)(2013-7#7)(2013-8#5)
to be their##2##3##(1991-3#1)(1993-9#1)
to be thin and##2##4##(2007-12#2)
to be thinner##2##3##(2007-12#2)
to be thoroughly##2##3##(2008-3#1)(2010-11#1)
to be those##3##3##(2006-6#1)(2008-10#1)(2010-4#1)
to be three##4##3##(1991-4#2)(2006-10#1)(2008-3#1)
to be through##3##3##(1995-5#1)(2006-10#1)(2008-5#1)
to be tight##2##3##(1992-11#1)(2008-11#1)
to be tightly##3##3##(1993-8#1)(1996-3#1)(2009-8#1)
to be time##2##3##(1992-6#1)(2008-10#1)
to be tissue##2##3##(1994-12#1)(2008-10#1)
to be to##4##3##(1992-5#1)(1992-7#1)(2010-11#1)(2012-2#1)
to be tolerant##3##3##(2008-10#2)(2008-8#1)
to be tolerated##2##3##(2008-11#1)(2012-3#1)
to be too##5##3##(1990-2#1)(1995-6#1)(2006-4#1)(2011-2#1)(2012-2#1)
to be totally##2##3##(2005-10#1)(2007-12#1)
to be toxic and carcinogenic##2##5##(2008-10#2)
to be toxic to##3##4##(1992-12#1)(1995-10#1)(1996-9#1)
to be toxic##6##3##(1992-12#1)(1995-10#1)(1996-9#1)(2008-10#2)(2008-8#1)
to be trained in##2##4##(2008-10#1)(2008-11#1)
to be trained##5##3##(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#2)
to be transcribed from##2##4##(2008-11#1)(2008-8#1)
to be transcribed##5##3##(1994-12#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-9#1)
to be transfected##2##3##(2008-11#1)(2011-1#1)
to be transferred##6##3##(1992-1#1)(1993-12#1)(1994-5#1)(1997-8#1)(2005-5#1)(2008-10#1)
to be transformed into##2##4##(2008-11#1)(2011-1#1)
to be transformed##4##3##(2008-10#1)(2008-11#1)(2010-5#1)(2011-1#1)
to be transient##3##3##(1992-6#1)(2008-8#1)(2010-10#1)
to be translated##3##3##(2008-5#1)(2011-2#1)(2012-12#1)
to be transmitted##4##3##(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)
to be transported by##2##4##(1996-12#1)(2008-7#1)
to be transported##8##3##(1994-9#2)(1995-1#1)(1995-3#1)(1996-12#1)(1996-9#1)(2008-10#1)(2008-7#1)
to be trapped##3##3##(2005-7#1)(2008-10#1)(2008-5#1)
to be treated as##6##4##(1990-9#1)(2006-7#1)(2007-10#1)(2007-8#2)(2007-9#1)
to be treated surgically##2##4##(1991-6#1)(2012-3#1)
to be treated with##13##4##(1990-2#1)(1991-6#1)(2006-10#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2013-1#1)(2013-7#1)
to be treated##34##3##(1990-2#1)(1990-6#1)(1990-9#1)(1991-6#2)(1994-12#1)(1996-6#1)(1997-6#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-7#2)(2006-9#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-11#2)(2012-3#1)(2013-1#1)(2013-7#1)
to be triggered by##2##4##(2008-11#1)(2009-10#1)
to be triggered##3##3##(1991-2#1)(2008-11#1)(2009-10#1)
to be tuned to##2##4##(2007-9#1)(2008-2#1)
to be tuned##3##3##(2007-9#1)(2008-2#1)(2008-6#1)
to be typical for##2##4##(1991-12#1)(2009-2#1)
to be typical of##3##4##(1995-8#1)(2007-6#1)(2008-3#1)
to be typical##6##3##(1991-12#1)(1995-4#1)(1995-8#1)(2007-6#1)(2008-3#1)(2009-2#1)
to be typically##2##3##(1993-11#1)(2008-3#1)
to be tyrosine##2##3##(1997-8#1)(2012-3#1)
to be ubiquitous in##2##4##(2006-10#1)(2012-2#1)
to be unable to synthesize##3##5##(1992-12#2)(2008-11#1)
to be unable to##7##4##(1992-12#2)(1995-5#1)(1995-6#1)(1997-5#1)(2006-12#1)(2008-11#1)
to be unable##8##3##(1992-12#2)(1995-5#1)(1995-6#1)(1996-9#1)(1997-5#1)(2006-12#1)(2008-11#1)
to be unacceptable##2##3##(2007-4#1)(2008-7#1)
to be unaffected by##6##4##(1992-9#1)(2007-12#1)(2008-10#1)(2010-4#1)(2011-1#1)(2012-4#1)
to be unaffected##7##3##(1992-9#1)(2005-11#1)(2007-12#1)(2008-10#1)(2010-4#1)(2011-1#1)(2012-4#1)
to be uncertain##2##3##(2009-12#1)(2013-7#1)
to be uncommon##3##3##(2006-10#1)(2007-12#1)(2008-4#1)
to be under the control of a##2##7##(1992-10#1)(1996-3#1)
to be under the##3##4##(1992-10#1)(1996-3#1)(2008-5#1)
to be under##7##3##(1990-11#1)(1992-10#1)(1994-11#1)(1996-3#1)(2008-10#2)(2008-5#1)
to be undergoing##2##3##(2006-6#1)(2011-2#1)
to be understood##13##3##(1997-6#1)(1997-7#1)(2005-7#1)(2006-10#2)(2006-11#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-8#1)
to be undertaken##5##3##(1993-5#1)(2006-10#1)(2008-4#1)(2008-8#1)(2011-12#1)
to be underused in##2##4##(2008-12#1)(2008-3#1)
to be unfavorable##2##3##(2010-5#1)(2011-2#1)
to be unfounded##2##3##(2007-12#1)(2011-2#1)
to be uniform##3##3##(2008-10#1)(2010-8#1)(2012-3#1)
to be uniformly##2##3##(1990-5#1)(1994-9#1)
to be unimportant##2##3##(1997-4#1)(2008-3#1)
to be unique to##8##4##(1991-2#1)(1992-12#1)(1994-9#1)(1996-11#1)(2005-7#1)(2006-11#1)(2006-4#1)(2009-8#1)
to be unique##17##3##(1991-2#1)(1992-12#2)(1992-5#1)(1993-9#1)(1994-9#1)(1996-11#1)(2005-7#1)(2006-11#1)(2006-4#1)(2008-10#3)(2008-4#1)(2008-7#1)(2009-8#1)(2013-8#1)
to be uniquely##4##3##(1990-5#1)(1991-12#1)(2009-8#1)(2012-12#1)
to be universal##3##3##(1990-12#1)(2007-8#1)(2008-3#1)
to be universally##3##3##(2008-5#1)(2010-2#1)(2010-6#1)
to be unknown##2##3##(2008-3#1)(2012-2#1)
to be unmethylated##2##3##(1997-7#1)(2007-11#1)
to be unrelated to the##5##5##(1993-9#1)(1995-12#2)(1996-1#1)(2007-4#1)
to be unrelated to##10##4##(1992-3#1)(1993-9#1)(1995-12#2)(1996-1#1)(1996-10#1)(1996-12#1)(2007-11#1)(2007-3#1)(2007-4#1)
to be unreliable##2##3##(2008-5#1)(2012-12#1)
to be unstable and##2##4##(1995-8#2)
to be unstable in##4##4##(1990-11#1)(1991-2#1)(1991-8#1)(1995-8#1)
to be unstable##10##3##(1990-11#1)(1991-2#2)(1991-8#1)(1995-3#1)(1995-8#3)(2008-6#1)(2013-1#1)
to be up to##3##4##(1997-1#1)(2007-12#1)(2011-1#1)
to be up-regulated in##3##4##(2006-10#1)(2008-10#1)(2012-12#1)
to be up-regulated##4##3##(1995-12#1)(2006-10#1)(2008-10#1)(2012-12#1)
to be upregulated##3##3##(1995-12#1)(2009-8#2)
to be usable##3##3##(2013-1#2)(2013-8#1)
to be used as a##15##5##(1993-12#1)(1995-8#1)(1996-12#1)(2005-10#1)(2005-11#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-11#1)
to be used as an##2##5##(1991-9#1)(2008-10#1)
to be used as part of##2##6##(2008-2#1)(2012-12#1)
to be used as the##5##5##(1994-3#1)(2008-10#2)(2008-2#1)(2013-7#1)
to be used as##44##4##(1991-9#1)(1992-5#1)(1993-12#2)(1994-3#1)(1995-8#1)(1996-11#1)(1996-12#1)(2005-10#1)(2005-11#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#3)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-7#1)
to be used for a##3##5##(2005-11#1)(2008-2#1)(2008-3#1)
to be used for detection##2##5##(2008-10#1)(2011-1#1)
to be used for determining##2##5##(2008-2#1)(2008-4#1)
to be used for the treatment of##2##7##(1996-9#1)(2006-12#1)
to be used for the##9##5##(1991-11#1)(1991-3#1)(1996-9#1)(1997-8#1)(2006-12#2)(2008-11#1)(2008-5#1)(2011-1#1)
to be used for##38##4##(1991-11#1)(1991-3#1)(1994-6#1)(1996-6#1)(1996-9#1)(1997-8#1)(2005-11#2)(2005-4#1)(2006-12#3)(2006-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#6)(2008-3#1)(2008-4#6)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#1)
to be used in a##5##5##(2008-10#3)(2008-2#1)(2008-3#1)
to be used in conjunction with##2##6##(2007-8#1)(2008-10#1)
to be used in further##2##5##(1997-8#1)(2008-2#1)
to be used in order to##3##6##(2008-10#1)(2008-5#1)(2008-6#1)
to be used in subsequent##2##5##(2005-9#1)(2008-10#1)
to be used in the field of##2##7##(2008-10#2)
to be used in the treatment of##3##7##(2007-11#1)(2008-11#1)(2012-2#1)
to be used in the##14##5##(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
to be used in##63##4##(1990-3#2)(1992-12#1)(1992-3#1)(1997-1#1)(1997-6#1)(1997-8#2)(2005-9#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#8)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-11#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)
to be used to##17##4##(2004-10#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-12#1)(2011-1#1)(2013-8#1)
to be used with a##2##5##(2010-5#1)(2011-2#1)
to be used with the##2##5##(1997-2#1)(2008-2#1)
to be used with##10##4##(1996-11#1)(1997-2#1)(1997-7#1)(2006-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-4#1)(2010-5#1)(2011-2#1)
to be used within##2##4##(1997-8#1)(2008-11#1)
to be used##216##3##(1990-3#2)(1990-5#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#2)(1994-3#1)(1994-6#1)(1994-7#1)(1995-3#1)(1995-8#1)(1996-11#2)(1996-12#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#4)(2004-10#1)(2005-10#1)(2005-11#3)(2005-4#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#5)(2007-12#8)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#25)(2008-11#6)(2008-12#1)(2008-2#20)(2008-3#8)(2008-4#12)(2008-5#10)(2008-6#4)(2008-7#4)(2008-8#2)(2008-9#5)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#5)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#3)(2013-7#3)(2013-8#2)
to be useful and##4##4##(2008-8#1)(2009-9#1)(2013-1#2)
to be useful as a##3##5##(1993-1#1)(2008-10#1)(2011-1#1)
to be useful as##6##4##(1993-1#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
to be useful for identifying##3##5##(2008-11#1)(2013-1#2)
to be useful for the treatment##2##6##(2006-10#1)(2011-1#1)
to be useful for the##12##5##(1991-10#1)(1994-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-4#1)(2008-10#2)(2008-9#1)(2011-1#1)
to be useful for##43##4##(1991-10#1)(1991-8#1)(1994-3#2)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(2005-3#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-1#2)(2012-11#1)(2013-1#2)
to be useful in a##2##5##(1996-5#1)(1997-3#1)
to be useful in determining the##2##6##(1997-6#1)(2005-6#1)
to be useful in identifying##2##5##(2006-7#1)(2012-12#1)
to be useful in selecting##2##5##(2008-10#1)(2008-8#1)
to be useful in the area of##2##7##(2008-10#1)(2009-10#1)
to be useful in the prediction of##2##7##(1995-8#1)(2008-9#1)
to be useful in the##9##5##(1995-8#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-9#1)(2009-10#1)(2013-8#1)
to be useful in##39##4##(1990-10#1)(1992-1#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-6#1)(2005-6#2)(2006-10#1)(2006-5#1)(2006-7#1)(2007-12#3)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2012-12#1)(2013-1#2)(2013-8#1)
to be useful indicators##2##4##(1994-6#1)(2007-12#1)
to be useful to##4##4##(1997-8#1)(2008-4#1)(2011-12#1)(2012-2#1)
to be useful tools##2##4##(2006-12#1)(2012-2#1)
to be useful##117##3##(1990-10#1)(1990-6#1)(1991-10#1)(1991-8#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-3#2)(1994-6#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#1)(2005-3#1)(2005-6#2)(2006-10#2)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#3)(2007-12#5)(2007-2#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#6)(2008-9#3)(2009-10#1)(2009-9#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#5)(2013-1#7)(2013-8#1)
to be user-friendly##2##3##(2007-11#1)(2007-9#1)
to be utilised##2##3##(2007-11#1)(2008-11#1)
to be utilized as##2##4##(2007-9#1)(2008-4#1)
to be utilized for##3##4##(2008-10#1)(2008-2#1)(2008-5#1)
to be utilized##8##3##(1997-2#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-7#1)
to be vaccinated##8##3##(1996-11#1)(1997-6#1)(2007-2#2)(2009-12#1)(2009-5#1)(2011-2#2)
to be valid##6##3##(1992-10#1)(1993-6#1)(1997-3#1)(2008-10#2)(2009-6#1)
to be validated##3##3##(2007-4#1)(2008-6#1)(2011-7#1)
to be valuable for##2##4##(2006-10#1)(2008-8#1)
to be valuable in##2##4##(1990-11#1)(2011-7#1)
to be valuable##8##3##(1990-11#1)(1991-2#1)(1992-5#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-8#1)(2011-7#1)
to be variable##3##3##(1993-12#1)(2007-7#1)(2013-8#1)
to be varied##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
to be verified##5##3##(1993-11#1)(2007-4#1)(2008-7#1)(2009-12#1)(2013-8#1)
to be very difficult##2##4##(2007-11#1)(2012-12#1)
to be very effective in##9##5##(1991-6#1)(1994-8#1)(2005-9#1)(2006-10#1)(2007-7#1)(2012-11#2)(2012-2#1)(2013-1#1)
to be very effective##13##4##(1991-6#1)(1994-8#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2011-2#1)(2012-11#2)(2012-2#1)(2013-1#2)
to be very important for##2##5##(2008-10#1)(2008-5#1)
to be very important##5##4##(1996-12#1)(2007-11#1)(2008-10#2)(2008-5#1)
to be very low##4##4##(1997-3#1)(1997-8#1)(2005-11#1)(2007-12#1)
to be very powerful##3##4##(1995-12#1)(2008-10#1)(2013-1#1)
to be very reliable##2##4##(2007-5#1)(2008-10#1)
to be very sensitive to##4##5##(1990-5#1)(1990-7#1)(2006-11#1)(2013-8#1)
to be very sensitive##8##4##(1990-5#1)(1990-7#1)(1992-7#1)(2006-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2013-8#1)
to be very similar to##4##5##(1991-1#1)(1995-1#1)(1995-5#1)(2008-3#1)
to be very similar##6##4##(1991-1#1)(1991-12#1)(1993-9#1)(1995-1#1)(1995-5#1)(2008-3#1)
to be very successful##2##4##(1997-4#1)(2006-5#1)
to be very suitable for the##2##6##(2008-10#2)
to be very suitable##3##4##(2008-10#3)
to be very useful in##4##5##(1994-6#1)(1997-6#1)(1997-8#1)(2008-11#1)
to be very useful##9##4##(1994-2#1)(1994-3#1)(1994-6#1)(1997-6#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
to be very##95##3##(1990-5#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-7#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#3)(2005-11#2)(2005-7#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-5#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#18)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-10#1)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
to be via##2##3##(2006-10#1)(2012-12#1)
to be viable##4##3##(1992-1#1)(1996-8#1)(1997-1#1)(2012-12#1)
to be viewed as##2##4##(1991-3#1)(2013-1#1)
to be viewed##3##3##(1991-3#1)(1997-8#1)(2013-1#1)
to be vigilant##4##3##(1996-8#1)(2010-12#1)(2010-4#1)(2010-9#1)
to be virtually insensitive to##2##5##(2007-11#2)
to be virtually##4##3##(1991-10#1)(2007-11#2)(2010-10#1)
to be visible##2##3##(2007-12#1)(2008-6#1)
to be visualized in##3##4##(2006-10#1)(2009-11#1)(2012-2#1)
to be visualized##4##3##(2005-5#1)(2006-10#1)(2009-11#1)(2012-2#1)
to be vital##2##3##(2012-2#1)(2013-1#1)
to be vulnerable##2##3##(2007-2#1)(2009-5#1)
to be warned of##2##4##(2007-2#1)(2008-12#1)
to be weak##3##3##(1997-4#1)(2006-12#1)(2008-8#1)
to be weakly##2##3##(1992-7#1)(2008-10#1)
to be weighed against##2##4##(2008-11#1)(2010-12#1)
to be weighed##4##3##(1997-8#1)(2008-11#1)(2008-4#1)(2010-12#1)
to be well described by a##2##6##(1992-11#1)(2007-12#1)
to be well informed##2##4##(2005-11#1)(2009-9#1)
to be well suited for##3##5##(2008-10#2)(2008-12#1)
to be well tolerated and##3##5##(2006-2#1)(2007-9#1)(2012-12#1)
to be well tolerated##9##4##(1996-2#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-5#1)(2012-12#1)
to be well##31##3##(1992-11#1)(1993-1#1)(1994-2#1)(1996-2#2)(1997-2#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-2#2)(2006-5#1)(2006-9#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-2#1)(2010-8#1)(2012-12#1)
to be widely distributed##3##4##(1997-2#1)(2004-4#1)(2007-11#1)
to be widely used for##2##5##(1995-3#1)(2010-12#1)
to be widely used##5##4##(1995-3#1)(1997-3#1)(2004-1#1)(2006-10#1)(2010-12#1)
to be widely##10##3##(1995-3#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-1#1)(2004-4#1)(2006-10#1)(2007-11#1)(2010-12#1)(2013-1#1)
to be widespread##3##3##(2008-10#1)(2012-2#1)(2013-7#1)
to be willing to##3##4##(1991-2#1)(2007-2#1)(2012-3#1)
to be withdrawn##2##3##(1991-4#1)(2007-7#1)
to be within the##8##4##(1994-8#1)(1996-3#1)(1996-8#1)(2008-10#1)(2008-2#1)(2009-5#1)(2010-11#1)(2013-1#1)
to be within##16##3##(1992-1#1)(1994-8#1)(1996-3#1)(1996-8#1)(1997-3#1)(2007-5#1)(2008-10#1)(2008-2#2)(2008-3#2)(2009-5#1)(2010-11#1)(2013-1#2)(2013-7#1)
to be without##5##3##(1994-10#1)(1995-5#1)(1997-7#1)(2010-12#1)(2010-5#1)
to be working##2##3##(1992-12#1)(2007-4#1)
to be worse than for##2##5##(1993-10#1)(2008-7#1)
to be worse than##3##4##(1992-7#1)(1993-10#1)(2008-7#1)
to be worthy of##2##4##(2004-12#1)(2012-3#1)
to be worthy##3##3##(2004-12#1)(2008-1#1)(2012-3#1)
to be written##7##3##(1996-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-4#1)(2010-8#1)
to be young##2##3##(1991-12#1)(2010-11#1)
to be younger##8##3##(1993-1#1)(1996-12#1)(1996-2#1)(2007-12#1)(2007-9#1)(2008-8#1)(2011-2#1)(2012-3#1)
to be zero##3##3##(1995-6#1)(2008-10#1)(2009-9#1)
to be##14411##2##(1990-1#3)(1990-10#57)(1990-11#67)(1990-12#78)(1990-2#51)(1990-3#38)(1990-4#35)(1990-5#68)(1990-6#39)(1990-7#58)(1990-8#51)(1990-9#40)(1991-1#22)(1991-10#34)(1991-11#30)(1991-12#72)(1991-2#63)(1991-3#42)(1991-4#39)(1991-5#56)(1991-6#43)(1991-7#54)(1991-8#42)(1991-9#52)(1992-1#47)(1992-10#13)(1992-11#55)(1992-12#74)(1992-2#40)(1992-3#73)(1992-4#23)(1992-5#31)(1992-6#52)(1992-7#28)(1992-8#57)(1992-9#54)(1993-1#25)(1993-10#10)(1993-11#66)(1993-12#86)(1993-2#42)(1993-3#52)(1993-4#29)(1993-5#31)(1993-6#42)(1993-7#19)(1993-8#42)(1993-9#55)(1994-1#10)(1994-10#19)(1994-11#69)(1994-12#77)(1994-2#65)(1994-3#77)(1994-4#13)(1994-5#51)(1994-6#57)(1994-7#13)(1994-8#60)(1994-9#81)(1995-1#49)(1995-10#23)(1995-11#50)(1995-12#61)(1995-2#79)(1995-3#86)(1995-4#16)(1995-5#54)(1995-6#69)(1995-7#12)(1995-8#71)(1995-9#17)(1996-1#49)(1996-10#19)(1996-11#43)(1996-12#73)(1996-2#74)(1996-3#64)(1996-4#31)(1996-5#63)(1996-6#43)(1996-7#35)(1996-8#69)(1996-9#40)(1997-1#76)(1997-2#83)(1997-3#54)(1997-4#80)(1997-5#31)(1997-6#70)(1997-7#59)(1997-8#85)(1997-9#1)(2003-11#3)(2004-1#6)(2004-10#12)(2004-11#19)(2004-12#16)(2004-2#9)(2004-3#11)(2004-4#9)(2004-5#1)(2004-7#2)(2004-8#2)(2004-9#20)(2005-1#1)(2005-10#57)(2005-11#106)(2005-12#27)(2005-3#6)(2005-4#5)(2005-5#15)(2005-6#6)(2005-7#51)(2005-8#44)(2005-9#17)(2006-1#15)(2006-10#318)(2006-11#37)(2006-12#102)(2006-2#58)(2006-3#26)(2006-4#34)(2006-5#44)(2006-6#70)(2006-7#39)(2006-8#94)(2006-9#31)(2007-1#50)(2007-10#92)(2007-11#312)(2007-12#358)(2007-2#92)(2007-3#42)(2007-4#62)(2007-5#37)(2007-6#39)(2007-7#131)(2007-8#204)(2007-9#100)(2008-1#157)(2008-10#1341)(2008-11#350)(2008-12#101)(2008-2#352)(2008-3#452)(2008-4#189)(2008-5#360)(2008-6#111)(2008-7#283)(2008-8#233)(2008-9#140)(2009-1#16)(2009-10#48)(2009-11#28)(2009-12#49)(2009-2#43)(2009-3#36)(2009-4#61)(2009-5#58)(2009-6#46)(2009-7#57)(2009-8#64)(2009-9#48)(2010-1#17)(2010-10#34)(2010-11#47)(2010-12#129)(2010-2#61)(2010-3#45)(2010-4#81)(2010-5#65)(2010-6#23)(2010-7#47)(2010-8#78)(2010-9#30)(2011-1#178)(2011-10#1)(2011-11#3)(2011-12#44)(2011-2#325)(2011-3#7)(2011-4#1)(2011-7#3)(2012-1#75)(2012-10#2)(2012-11#36)(2012-12#187)(2012-2#259)(2012-3#119)(2012-4#1)(2012-6#2)(2012-7#2)(2012-8#1)(2012-9#1)(2013-1#302)(2013-7#54)(2013-8#195)
to beam direction) target motion##2##5##(2009-8#2)
to beam##7##2##(2007-12#3)(2008-2#1)(2008-3#1)(2009-8#2)
to bean##5##2##(2007-7#1)(2008-10#2)(2008-8#2)
to bear on the##3##4##(1992-1#1)(1994-2#1)(2010-8#1)
to bear on##6##3##(1992-1#1)(1994-2#1)(1996-2#1)(2010-1#1)(2010-8#1)(2010-9#1)
to bear the##2##3##(1996-5#1)(2013-8#1)
to bear##15##2##(1992-1#1)(1994-12#1)(1994-2#2)(1996-2#1)(1996-5#1)(2005-7#1)(2007-12#1)(2008-8#1)(2009-5#1)(2010-1#1)(2010-8#1)(2010-9#1)(2013-1#1)(2013-8#1)
to beat##3##2##(1991-5#1)(1997-4#1)(2007-9#1)
to become a new##2##4##(2006-12#1)(2007-9#1)
to become a powerful##2##4##(2008-9#1)(2010-7#1)
to become a reality##2##4##(2008-9#1)(2013-8#1)
to become a##25##3##(1990-5#1)(1994-1#1)(1996-5#1)(1997-8#1)(2006-12#1)(2006-2#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#4)(2009-6#1)(2010-12#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
to become activated##2##3##(1995-7#1)(2010-2#1)
to become active##3##3##(2005-10#1)(2008-4#1)(2013-1#1)
to become an accepted treatment##2##5##(2007-11#1)(2010-11#1)
to become an##11##3##(2005-11#1)(2005-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2009-9#1)(2010-11#1)(2011-2#1)(2011-7#1)(2012-2#1)(2012-3#1)
to become available##4##3##(1993-11#1)(2004-12#1)(2007-11#1)(2008-6#1)
to become aware of##2##4##(1991-5#1)(2011-1#1)
to become capable##2##3##(2008-11#1)(2013-8#1)
to become effective##2##3##(2008-11#1)(2009-4#1)
to become even##2##3##(2009-3#1)(2009-6#1)
to become familiar with the##5##5##(1991-1#1)(1997-3#1)(2007-12#1)(2010-8#1)(2012-1#1)
to become familiar with##10##4##(1990-3#1)(1991-1#1)(1997-3#1)(2004-2#1)(2005-7#1)(2007-12#1)(2010-2#1)(2010-8#1)(2012-1#1)(2013-1#1)
to become familiar##12##3##(1990-3#1)(1991-1#1)(1997-3#1)(2004-2#1)(2005-7#1)(2007-12#1)(2008-4#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
to become highly##2##3##(2007-12#1)(2010-7#1)
to become important##2##3##(2007-11#1)(2008-11#1)
to become increasingly##3##3##(1994-2#1)(2007-11#1)(2011-2#1)
to become infected##2##3##(2008-10#2)
to become involved in##2##4##(1996-1#1)(2008-11#1)
to become involved##4##3##(1994-1#1)(1996-1#1)(2007-2#1)(2008-11#1)
to become more muscular##2##4##(2007-12#2)
to become more##20##3##(1991-5#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-2#2)(1995-1#1)(1997-3#1)(2004-3#1)(2005-11#1)(2006-6#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#3)(2013-1#1)
to become much##2##3##(1991-3#1)(1992-7#1)
to become part of##2##4##(1992-1#1)(2010-9#1)
to become pregnant##6##3##(1990-2#1)(1990-6#1)(1997-5#1)(2008-3#1)(2009-1#1)(2011-2#1)
to become slightly##2##3##(1990-4#1)(2008-4#1)
to become stronger##2##3##(2010-10#1)(2010-5#1)
to become the##9##3##(1994-12#1)(1994-9#1)(1995-3#1)(2006-1#1)(2006-5#1)(2007-12#1)(2009-6#1)(2010-8#1)(2012-12#1)
to become##210##2##(1990-1#1)(1990-11#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-1#2)(1994-12#4)(1994-2#3)(1994-5#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-7#1)(1996-1#1)(1996-12#3)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#4)(1997-5#2)(1997-8#1)(2004-12#1)(2004-2#1)(2004-3#3)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#2)(2006-9#1)(2007-11#5)(2007-12#10)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#6)(2008-10#9)(2008-11#10)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#5)(2009-1#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#4)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-5#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#7)(2011-7#1)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#4)
to becoming a##5##3##(2007-8#1)(2007-9#1)(2008-11#2)(2008-8#1)
to becoming##9##2##(2005-7#1)(2007-8#1)(2007-9#2)(2008-11#2)(2008-8#1)(2012-12#1)(2013-8#1)
to bed and##2##3##(1995-11#1)(2008-9#1)
to bed##7##2##(1990-1#1)(1990-7#1)(1991-4#1)(1995-11#1)(2007-3#1)(2008-2#1)(2008-9#1)
to bedside##9##2##(1995-12#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-7#1)(2012-10#1)(2012-2#1)
to beef up##2##3##(1996-2#1)(2007-9#1)
to beef##3##2##(1996-2#1)(2007-9#1)(2010-4#1)
to before##2##2##(1994-12#1)(2006-6#1)
to begin an##4##3##(1990-3#1)(2007-10#1)(2008-7#1)(2008-9#1)
to begin in the##3##4##(2007-2#1)(2008-5#2)
to begin investigating the##2##4##(2008-11#1)(2012-2#1)
to begin on its own##3##5##(2007-2#2)(2008-6#1)
to begin shortly##3##3##(1996-5#1)(2005-7#1)(2008-10#1)
to begin to explore##2##4##(1990-12#1)(1994-6#1)
to begin to##11##3##(1990-10#1)(1990-12#1)(1993-12#1)(1994-6#1)(2004-2#1)(2008-1#1)(2010-3#1)(2010-9#1)(2012-1#1)(2013-1#1)(2013-8#1)
to begin with##2##3##(2005-12#1)(2011-2#1)
to begin##58##2##(1990-10#1)(1990-12#2)(1990-3#1)(1993-12#1)(1993-2#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-11#1)(1996-5#2)(1997-2#1)(2004-2#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-11#2)(2006-2#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#4)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#4)(2013-1#2)(2013-8#1)
to behave as a##3##4##(1990-11#1)(2008-10#1)(2011-1#1)
to behave as##5##3##(1990-11#1)(2007-12#1)(2008-10#1)(2011-1#2)
to behave in##3##3##(2008-1#1)(2008-11#1)(2008-3#1)
to behave like##2##3##(1997-6#1)(2006-10#1)
to behave##15##2##(1990-11#1)(1995-1#1)(1995-8#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2011-1#2)(2012-12#1)(2012-2#1)
to behavior##4##2##(2006-7#1)(2008-3#1)(2009-6#1)(2013-7#1)
to behavior-modifying##2##2##(2011-12#2)
to behavioral##8##2##(1991-8#1)(1996-10#1)(2005-8#1)(2006-2#1)(2007-8#1)(2008-2#1)(2008-8#1)(2012-2#1)
to behaviour##4##2##(1990-12#1)(1992-12#1)(1993-12#1)(2011-12#1)
to behavioural changes##2##3##(2008-9#1)(2011-1#1)
to behavioural##6##2##(1990-10#1)(2008-9#3)(2010-8#1)(2011-1#1)
to being a##6##3##(2007-10#1)(2010-3#1)(2012-12#1)(2012-3#2)(2013-1#1)
to being an##2##3##(1991-11#1)(2012-2#1)
to being##37##2##(1990-11#1)(1991-11#1)(1991-3#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-3#1)(1995-1#1)(2005-10#1)(2005-11#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-3#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
to beliefs##2##2##(2007-12#1)(2008-2#1)
to believe in##2##3##(2008-10#1)(2013-1#1)
to believe that the##2##4##(1995-1#1)(2009-4#1)
to believe that they##2##4##(2008-9#1)(2013-7#1)
to believe that##15##3##(1993-12#1)(1994-6#1)(1995-1#1)(1996-4#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#3)(2009-11#1)(2009-4#1)(2010-4#1)(2012-2#1)(2013-7#1)
to believe this##2##3##(2011-1#1)(2012-3#1)
to believe##23##2##(1993-12#1)(1994-6#1)(1995-1#1)(1996-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-9#3)(2009-11#1)(2009-3#1)(2009-4#1)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
to belong to a##2##4##(2008-10#1)(2008-3#1)
to belong to the##10##4##(1991-8#1)(1992-3#1)(1994-3#1)(1994-6#1)(2008-10#3)(2008-5#1)(2008-8#1)(2012-11#1)
to belong to##18##3##(1991-8#1)(1992-3#1)(1994-3#1)(1994-6#1)(1996-7#1)(2006-9#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-11#1)
to belong##19##2##(1991-8#1)(1992-3#1)(1994-3#1)(1994-6#1)(1996-7#1)(1997-7#1)(2006-9#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-11#1)
to below the##2##3##(1993-7#1)(2008-10#1)
to below##17##2##(1991-6#1)(1993-7#1)(1994-12#1)(1994-6#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2010-4#1)(2011-2#2)
to benchmark##5##2##(1995-3#1)(1997-1#1)(2005-12#1)(2008-12#1)(2008-5#1)
to benchmarking##2##2##(1995-3#1)(2008-1#1)
to bend##5##2##(1992-5#1)(1993-12#1)(1997-1#1)(2006-12#1)(2006-6#1)
to bending##2##2##(2007-1#1)(2008-8#1)
to beneficial##2##2##(2008-10#1)(2011-2#1)
to benefit by the end of therapy##2##7##(2012-2#2)
to benefit from the##6##4##(1994-2#1)(1997-6#1)(2006-4#1)(2007-8#1)(2009-6#1)(2011-1#1)
to benefit from this##4##4##(1995-9#1)(2008-12#1)(2011-2#1)(2013-8#1)
to benefit from treatment with##2##5##(2007-11#1)(2011-2#1)
to benefit from treatment##3##4##(2007-11#1)(2007-9#1)(2011-2#1)
to benefit from##35##3##(1992-5#1)(1993-12#1)(1993-8#1)(1994-2#1)(1995-9#1)(1997-6#1)(2004-2#1)(2006-10#1)(2006-12#2)(2006-4#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#2)(2009-2#1)(2009-6#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#3)(2013-1#1)(2013-8#1)
to benefit more from##2##4##(2007-1#1)(2012-12#1)
to benefit or##2##3##(1997-3#1)(2012-2#1)
to benefit patients##3##3##(2006-10#1)(2006-12#1)(2009-8#1)
to benefit the##4##3##(1995-2#1)(1996-2#1)(2007-2#1)(2008-5#1)
to benefit##62##2##(1992-5#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-2#1)(1995-2#1)(1995-9#1)(1996-2#1)(1997-3#1)(1997-6#1)(2004-2#1)(2005-11#1)(2006-10#4)(2006-12#3)(2006-4#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-5#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#2)(2009-2#1)(2009-6#2)(2009-8#2)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-12#2)(2012-2#6)(2013-1#1)(2013-8#1)
to benefits of##2##3##(2009-9#1)(2013-7#1)
to benefits##8##2##(1995-12#1)(1997-1#1)(1997-2#1)(2008-3#2)(2009-9#1)(2013-7#2)
to benign##8##2##(1993-10#1)(1995-4#1)(2006-10#1)(2006-12#1)(2006-8#1)(2008-11#1)(2010-12#1)(2012-3#1)
to benomyl at##3##3##(2008-10#3)
to benomyl##5##2##(1990-5#1)(2008-10#4)
to benzene##8##2##(1997-3#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)
to benzimidazole##2##2##(1997-2#1)(2008-10#1)
to benznidazole##4##2##(2012-12#4)
to benzoate##4##2##(1993-11#1)(2006-8#3)
to benzodiazepine receptors##2##3##(1990-3#1)(1995-5#1)
to benzodiazepines##4##2##(1991-10#1)(1993-8#1)(1995-11#1)(2004-4#1)
to best meet##2##3##(2007-2#1)(2008-7#1)
to best serve##2##3##(2008-12#1)(2008-8#1)
to best use##2##3##(1992-2#1)(2008-6#1)
to best##25##2##(1992-2#1)(1994-10#1)(1994-3#1)(1996-12#1)(2006-10#1)(2007-2#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#4)(2008-7#1)(2008-8#1)(2009-1#1)(2009-9#1)(2010-12#1)(2010-8#1)(2012-2#3)
to beta 1##2##3##(1991-9#1)(1992-2#1)
to beta##16##2##(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#1)(1994-8#2)(1996-9#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-5#1)
to beta-CCE##2##2##(1996-2#2)
to beta-CD##3##2##(2008-10#1)(2008-11#1)(2008-6#1)
to beta-adrenergic##2##2##(2008-9#1)(2010-4#1)
to beta-adrenoceptors##2##2##(1990-2#2)
to beta-amyloid##3##2##(1992-12#2)(2010-2#1)
to beta-carotene##2##2##(1990-1#1)(1993-12#1)
to beta-cell##4##2##(1996-6#1)(2007-5#1)(2008-1#2)
to beta-cyclodextrin##3##2##(2006-12#1)(2008-10#1)(2008-5#1)
to beta-galactosidase##2##2##(1990-8#1)(1994-11#1)
to beta-lactams##5##2##(1996-3#1)(2006-10#1)(2008-12#2)(2008-7#1)
to beta-sheet##2##2##(1992-6#1)(1996-4#1)
to better adapt##2##3##(2007-10#1)(2012-12#1)
to better articulate##2##3##(1992-3#1)(2008-7#1)
to better characterize the##4##4##(2007-4#2)(2010-12#1)(2012-2#1)
to better characterize##5##3##(2007-4#2)(2009-4#1)(2010-12#1)(2012-2#1)
to better compliance##2##3##(1990-2#1)(2011-2#1)
to better control of##4##4##(1992-8#1)(2008-11#1)(2008-7#1)(2012-12#1)
to better control##5##3##(1992-8#1)(2008-11#1)(2008-2#1)(2008-7#1)(2012-12#1)
to better define the##8##4##(1990-6#1)(2007-4#2)(2007-7#1)(2008-10#2)(2011-2#1)(2013-1#1)
to better define##14##3##(1990-6#1)(1990-8#1)(2005-8#2)(2006-10#2)(2007-4#2)(2007-7#1)(2008-10#3)(2011-2#1)(2013-1#1)
to better delineate the##2##4##(2006-10#1)(2013-1#1)
to better describe the##2##4##(2008-10#1)(2008-7#1)
to better describe##3##3##(2008-10#1)(2008-7#1)(2009-12#1)
to better elucidate##2##3##(1993-9#1)(2009-5#1)
to better fit##2##3##(2006-10#1)(2007-1#1)
to better health##4##3##(1997-1#1)(2008-7#1)(2010-2#2)
to better identify##5##3##(2005-8#1)(2007-6#1)(2010-1#1)(2010-12#1)(2010-9#1)
to better illustrate##2##3##(2007-10#1)(2008-2#1)
to better integrate##2##3##(2010-12#1)(2011-1#1)
to better interventions##2##3##(2010-10#1)(2012-3#1)
to better manage##3##3##(1994-2#1)(2004-2#1)(2008-8#1)
to better management##2##3##(2007-2#1)(2008-3#1)
to better meet the needs of patients##2##7##(1996-12#1)(1996-2#1)
to better meet the needs of##4##6##(1996-12#1)(1996-2#1)(2008-7#1)(2010-7#1)
to better meet##6##3##(1994-2#1)(1996-12#1)(1996-2#2)(2008-7#1)(2010-7#1)
to better performance##3##3##(1993-2#1)(2008-12#1)(2008-3#1)
to better prepare##3##3##(2007-2#1)(2007-9#1)(2009-9#1)
to better protect##2##3##(2009-4#1)(2009-8#1)
to better quality##2##3##(1990-6#1)(1994-9#1)
to better reflect##2##3##(2008-10#1)(2013-8#1)
to better results##5##3##(2007-11#2)(2008-10#2)(2008-11#1)
to better serve##2##3##(1993-2#1)(2012-12#1)
to better than 0##3##4##(2008-2#2)(2008-3#1)
to better than 1##2##4##(2008-2#1)(2008-3#1)
to better than##12##3##(1992-11#1)(2007-12#1)(2008-2#4)(2008-3#5)(2011-1#1)
to better understand and treat##2##5##(2007-12#1)(2008-6#1)
to better understand and##5##4##(2007-12#1)(2007-9#1)(2008-12#1)(2008-6#1)(2010-10#1)
to better understand how##6##4##(2008-11#1)(2008-12#1)(2008-3#1)(2009-7#1)(2010-9#1)(2013-1#1)
to better understand the current##2##5##(2007-4#1)(2012-12#1)
to better understand the dynamics and##2##6##(2012-3#2)
to better understand the dynamics of##3##6##(2008-10#1)(2010-9#1)(2012-1#1)
to better understand the dynamics##5##5##(2008-10#1)(2010-9#1)(2012-1#1)(2012-3#2)
to better understand the role of##2##6##(2008-11#1)(2008-7#1)
to better understand the structural##2##5##(1995-3#1)(1997-9#1)
to better understand the##57##4##(1990-8#1)(1993-1#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-6#1)(1995-3#1)(1997-7#1)(1997-9#1)(2006-10#2)(2007-10#1)(2007-12#2)(2007-3#1)(2007-4#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#1)
to better understand their##2##4##(2008-8#1)(2013-1#1)
to better understand##94##3##(1990-8#1)(1993-1#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1997-7#1)(1997-9#1)(2006-10#4)(2007-10#1)(2007-12#4)(2007-3#1)(2007-4#4)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-11#2)(2009-4#1)(2009-5#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#10)(2013-7#1)
to better understanding of##7##4##(1994-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2009-10#1)(2009-11#1)(2010-9#1)
to better understanding##8##3##(1994-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-9#1)
to better##274##2##(1990-2#1)(1990-5#1)(1990-6#2)(1990-8#2)(1992-11#1)(1992-3#1)(1992-8#2)(1993-1#1)(1993-12#2)(1993-2#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-9#2)(1996-12#1)(1996-2#2)(1996-7#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(1997-9#1)(2004-2#1)(2005-10#1)(2005-11#1)(2005-8#4)(2006-10#8)(2006-11#3)(2006-12#2)(2006-7#2)(2006-8#2)(2007-1#1)(2007-10#4)(2007-11#5)(2007-12#6)(2007-2#2)(2007-3#1)(2007-4#8)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#2)(2008-10#17)(2008-11#5)(2008-12#6)(2008-2#9)(2008-3#11)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#10)(2008-8#6)(2008-9#5)(2009-10#2)(2009-11#3)(2009-12#2)(2009-3#1)(2009-4#3)(2009-5#5)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#6)(2010-2#3)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#4)(2011-1#5)(2011-2#6)(2012-1#1)(2012-12#9)(2012-2#2)(2012-3#8)(2012-7#1)(2013-1#18)(2013-7#2)(2013-8#2)
to between 0##2##3##(1990-5#1)(2012-12#1)
to between 4##2##3##(1990-4#1)(1997-5#1)
to between##14##2##(1990-4#1)(1990-5#2)(1991-9#1)(1994-3#1)(1995-11#1)(1997-2#1)(1997-5#1)(2007-11#1)(2008-5#1)(2008-7#1)(2012-12#3)
to beyond 5 years##3##4##(1995-2#3)
to beyond 5##4##3##(1995-2#3)(2008-1#1)
to beyond##8##2##(1994-9#1)(1995-2#3)(1996-9#1)(2007-12#1)(2008-1#1)(2008-2#1)
to bias##9##2##(1994-4#1)(1997-8#1)(2005-10#1)(2008-8#1)(2009-3#1)(2011-2#2)(2012-2#1)(2013-8#1)
to biases##2##2##(2008-3#1)(2012-2#1)
to bicuculline##3##2##(1993-12#1)(1995-5#1)(1997-2#1)
to bid##2##2##(1995-7#1)(1995-8#1)
to big ET-1##4##3##(1990-10#1)(1991-10#1)(1995-1#2)
to big##10##2##(1990-10#1)(1990-9#1)(1991-10#1)(1991-6#1)(1992-7#2)(1992-8#1)(1995-1#2)(2011-1#1)
to bilateral renal##2##3##(1991-6#1)(2008-10#1)
to bilateral##17##2##(1991-6#1)(1993-10#1)(1996-9#1)(2006-6#1)(2007-8#1)(2008-10#2)(2008-6#1)(2008-8#1)(2009-12#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
to bile acids##2##3##(1990-2#1)(1996-7#1)
to bile##3##2##(1990-2#1)(1991-3#1)(1996-7#1)
to billing##3##2##(1994-1#1)(2013-1#2)
to binary##5##2##(1996-12#1)(2007-12#1)(2008-10#1)(2010-2#1)(2010-4#1)
to bind A beta in##2##5##(1994-8#1)(2008-7#1)
to bind DNA##4##3##(1991-4#1)(1992-5#1)(1994-3#1)(1996-8#1)
to bind SKv cells##2##4##(1993-7#2)
to bind a##5##3##(1991-12#1)(1994-9#1)(1995-3#1)(1996-7#1)(2011-1#1)
to bind and##7##3##(1991-12#2)(1991-5#1)(1992-7#1)(1995-3#1)(1995-6#1)(2010-8#1)
to bind both##3##3##(1990-5#1)(1991-2#1)(1995-8#1)
to bind certain##2##3##(1992-3#1)(1996-11#1)
to bind covalently##2##3##(1993-7#1)(1997-2#1)
to bind human##2##3##(1993-9#1)(1994-12#1)
to bind in the##2##4##(1992-5#1)(1997-2#1)
to bind in##5##3##(1992-5#1)(1994-8#1)(1994-9#1)(1995-3#1)(1997-2#1)
to bind lipocortin##2##3##(1993-4#2)
to bind selectively to##2##4##(1994-8#1)(1997-2#1)
to bind specifically to##5##4##(1991-10#1)(1995-3#1)(1995-6#1)(2008-9#1)(2012-2#1)
to bind specifically##6##3##(1991-10#1)(1993-6#1)(1995-3#1)(1995-6#1)(2008-9#1)(2012-2#1)
to bind the HIV-1 enhancer##2##5##(1994-8#2)
to bind the##24##3##(1990-2#1)(1991-3#1)(1992-8#1)(1993-6#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-5#3)(1996-8#1)(1997-1#1)(1997-2#2)(2006-12#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-2#1)
to bind their##2##3##(1994-8#1)(2008-9#1)
to bind this##2##3##(1992-12#1)(2008-10#1)
to bind to DNA##4##4##(1990-2#1)(1995-2#1)(1995-5#1)(2008-8#1)
to bind to a##4##4##(1992-12#1)(1994-11#2)(2010-7#1)
to bind to and activate##2##5##(1991-4#1)(1995-6#1)
to bind to and##6##4##(1991-4#1)(1994-9#1)(1995-3#1)(1995-6#1)(1995-8#1)(2008-4#1)
to bind to both##2##4##(1990-9#1)(1997-7#1)
to bind to its##2##4##(1995-6#1)(1997-7#1)
to bind to major histocompatibility complex##2##6##(1997-4#1)(2006-11#1)
to bind to membranes and##2##5##(1995-6#1)(1997-5#1)
to bind to native##2##4##(1992-8#1)(1995-11#1)
to bind to the##23##4##(1990-3#1)(1991-1#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-8#2)(1996-3#1)(1996-7#1)(2007-11#2)(2008-4#1)(2008-5#1)(2012-12#1)(2013-1#1)
to bind to##103##3##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-4#2)(1991-6#1)(1991-7#1)(1992-12#4)(1992-3#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#5)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#3)(1995-5#1)(1995-6#5)(1995-8#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#3)(1996-7#1)(1997-1#1)(1997-4#4)(1997-5#1)(1997-7#2)(2005-12#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-8#2)(2008-10#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-8#1)(2010-7#1)(2012-12#1)(2013-1#3)
to bind various##2##3##(2012-2#1)(2013-7#1)
to bind with a##2##4##(1995-5#1)(2008-10#1)
to bind with high affinity to##4##6##(1990-8#1)(1994-5#1)(2008-2#1)(2008-4#1)
to bind with the##3##4##(1992-10#1)(1994-9#1)(1996-5#1)
to bind with##12##3##(1990-8#1)(1992-10#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-5#1)(2005-4#1)(2008-10#2)(2008-2#1)(2008-4#1)
to bind##294##2##(1990-10#2)(1990-11#1)(1990-12#4)(1990-2#4)(1990-3#3)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#3)(1991-10#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-4#3)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#1)(1992-10#1)(1992-11#2)(1992-12#5)(1992-2#1)(1992-3#2)(1992-5#3)(1992-6#2)(1992-7#4)(1992-8#3)(1992-9#2)(1993-11#2)(1993-12#1)(1993-3#2)(1993-4#2)(1993-6#3)(1993-7#4)(1993-8#2)(1993-9#3)(1994-10#1)(1994-11#6)(1994-12#6)(1994-2#4)(1994-3#3)(1994-5#4)(1994-6#2)(1994-8#9)(1994-9#14)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#8)(1995-3#10)(1995-5#5)(1995-6#8)(1995-8#7)(1996-11#1)(1996-2#3)(1996-3#1)(1996-4#3)(1996-5#4)(1996-6#3)(1996-7#2)(1996-8#3)(1997-1#2)(1997-2#5)(1997-3#1)(1997-4#7)(1997-5#3)(1997-6#1)(1997-7#2)(2005-12#1)(2005-4#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-8#2)(2007-1#1)(2007-11#3)(2007-12#2)(2007-8#2)(2007-9#1)(2008-10#11)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#5)(2013-1#3)(2013-7#1)
to binding of##7##3##(1990-11#1)(1991-8#1)(1993-3#1)(1994-3#1)(1997-7#2)(2012-2#1)
to binding site##2##3##(2007-8#1)(2008-3#1)
to binding to the##2##4##(1990-12#1)(2008-9#1)
to binding to##5##3##(1990-12#1)(1992-11#1)(1995-8#1)(2008-10#1)(2008-9#1)
to binding##27##2##(1990-11#1)(1990-12#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-7#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-8#1)(1997-1#1)(1997-7#2)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-10#1)(2012-2#1)
to bioassays##2##2##(2007-3#1)(2008-3#1)
to biochar mass ratio##2##4##(2008-6#2)
to biochemical##6##2##(1991-5#1)(2006-10#1)(2008-2#1)(2008-7#1)(2010-10#1)(2010-12#1)
to bioconvert##2##2##(2008-6#1)(2012-2#1)
to biodegradation##3##2##(2008-5#2)(2009-3#1)
to biodiesel##2##2##(2009-3#1)(2013-1#1)
to biodiversity##2##2##(2012-3#1)(2013-7#1)
to biologic##2##2##(1990-2#1)(2010-9#1)
to biological activity##3##3##(1990-9#1)(1993-1#1)(2005-8#1)
to biological and##2##3##(1990-8#1)(2008-10#1)
to biological control##3##3##(2007-12#1)(2008-10#2)
to biological macromolecules##2##3##(2006-10#1)(2008-11#1)
to biological problems##2##3##(1994-9#1)(2009-9#1)
to biological samples##2##3##(1996-12#1)(2008-8#1)
to biological systems##2##3##(1992-3#1)(2008-5#1)
to biological therapy##2##3##(2010-9#1)(2013-8#1)
to biological##46##2##(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#1)(1992-3#1)(1993-1#1)(1994-9#1)(1995-3#2)(1995-8#1)(1996-12#1)(1997-1#1)(2005-8#1)(2006-10#3)(2006-5#1)(2006-7#1)(2007-12#2)(2007-8#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-9#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-7#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
to biologically##3##2##(2006-8#1)(2008-12#1)(2013-1#1)
to biologists##5##2##(2006-5#1)(2008-2#1)(2008-4#1)(2012-12#2)
to biology##2##2##(2006-4#1)(2008-7#1)
to biomarker##3##2##(1992-12#1)(2010-5#1)(2010-7#1)
to biomass##8##2##(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#3)(2011-2#1)(2012-3#1)
to biomaterials is##2##3##(2004-9#2)
to biomaterials##8##2##(1991-3#1)(2004-9#5)(2008-5#1)(2010-12#1)
to biomedical##5##2##(1991-6#1)(1992-10#1)(2006-10#1)(2008-7#1)(2013-1#1)
to biomolecular##2##2##(2010-10#1)(2012-12#1)
to biopolymers##2##2##(1997-6#1)(2006-12#1)
to biopsy##7##2##(1990-10#1)(1996-9#1)(2007-8#1)(2008-5#1)(2008-9#1)(2012-2#2)
to bioreactor##2##2##(2008-11#2)
to biosynthetically##2##2##(2008-1#2)
to biotin and##2##3##(1993-11#1)(1995-2#1)
to biotin##7##2##(1992-6#1)(1993-11#1)(1993-8#1)(1995-2#1)(2008-11#1)(2008-7#1)(2009-9#1)
to biotinylated##2##2##(1993-6#2)
to biotype##2##2##(2007-7#1)(2011-2#1)
to bipolar disorder##6##3##(1997-5#3)(2009-7#2)(2012-2#1)
to birds##4##2##(1997-6#1)(2007-2#1)(2008-5#1)(2013-8#1)
to birth and##2##3##(1991-5#1)(2007-2#1)
to birth defects##3##3##(1993-8#1)(2012-1#1)(2012-12#1)
to birth weight##2##3##(1994-4#1)(2009-4#1)
to birth##15##2##(1990-2#1)(1991-5#1)(1993-6#1)(1993-8#1)(1994-4#1)(1996-10#1)(1997-5#1)(1997-7#1)(2007-2#1)(2007-7#1)(2008-10#1)(2009-4#1)(2012-1#1)(2012-12#2)
to bis-spiroacetals##2##2##(2007-11#2)
to bisphosphonate##3##2##(2005-3#1)(2008-3#1)(2012-3#1)
to bite##2##2##(1992-1#1)(1996-12#1)
to black currant reversion associated virus##2##6##(2008-10#2)
to black##9##2##(1994-9#1)(2006-12#1)(2008-10#4)(2008-3#1)(2011-12#1)(2013-7#1)
to bladder##6##2##(1997-4#1)(1997-5#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-1#1)
to blame##5##2##(1994-12#1)(1996-3#1)(2004-9#1)(2007-9#2)
to blame?##4##2##(2006-10#1)(2007-12#1)(2010-12#1)(2010-2#1)
to blast in##2##3##(2008-10#2)
to blast##14##2##(1990-9#1)(2007-12#2)(2008-10#9)(2008-7#1)(2012-2#1)
to blastocysts in##2##3##(1994-3#1)(2006-5#1)
to blastocysts##3##2##(1994-3#1)(2006-5#1)(2013-1#1)
to bleaching##2##2##(1992-8#1)(2007-12#1)
to bleed##4##2##(1991-11#1)(2007-8#1)(2008-12#1)(2011-1#1)
to blend in##2##3##(2007-2#1)(2013-8#1)
to blend##4##2##(2007-2#1)(2009-7#2)(2013-8#1)
to blind##2##2##(2006-2#1)(2008-3#1)
to blindness##4##2##(1993-11#1)(2007-12#1)(2011-9#1)(2013-8#1)
to block NMDA##2##3##(1993-7#1)(1995-7#1)
to block a##3##3##(1995-9#1)(2006-7#1)(2009-7#1)
to block binding##2##3##(1992-9#1)(1996-10#1)
to block cell##2##3##(1990-2#1)(1995-1#1)
to block non-specific##2##3##(1991-5#1)(2004-9#1)
to block the effects of##2##5##(1994-3#1)(1996-12#1)
to block the growth##2##4##(1995-6#2)
to block the##27##3##(1990-2#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-10#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-12#2)(1995-6#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1997-1#1)(1997-5#1)(2007-12#1)(2008-2#1)(2009-8#1)(2010-12#1)(2013-7#1)(2013-8#1)
to block this##2##3##(1991-5#1)(2012-3#1)
to block##95##2##(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-5#3)(1991-9#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-3#2)(1993-7#1)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#5)(1995-2#1)(1995-6#3)(1995-7#1)(1995-9#1)(1996-10#3)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#3)(1996-5#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#3)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#1)(2009-11#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
to blockade by##2##3##(1992-10#1)(2006-11#1)
to blockade of##4##3##(1993-12#1)(1994-9#1)(1996-12#1)(1997-7#1)
to blockade##7##2##(1992-10#1)(1993-12#1)(1994-9#1)(1996-12#1)(1997-5#1)(1997-7#1)(2006-11#1)
to blockage of the##3##4##(1995-12#1)(1997-2#1)(2011-2#1)
to blocking of##3##3##(1994-9#1)(2004-8#1)(2006-10#1)
to blocking##7##2##(1993-6#1)(1994-8#1)(1994-9#1)(2004-8#1)(2006-10#2)(2012-12#1)
to blood coagulation##2##3##(1990-11#1)(2012-11#1)
to blood loss##3##3##(1996-12#1)(2006-10#1)(2013-1#1)
to blood pressure##5##3##(1992-8#1)(1992-9#1)(1993-1#1)(1996-6#1)(2011-2#1)
to blood samples##3##3##(1993-2#1)(1995-1#1)(2011-2#1)
to blood vessels##3##3##(1997-6#1)(2008-4#1)(2009-7#1)
to blood##41##2##(1990-11#2)(1990-12#2)(1990-3#1)(1990-5#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-2#1)(1995-1#1)(1995-12#1)(1995-4#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-4#1)(1997-6#1)(2006-10#2)(2007-2#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2009-10#1)(2009-7#1)(2011-2#2)(2012-11#1)(2013-1#1)(2013-8#1)
to bloom##3##2##(2008-10#3)
to blossom##2##2##(1992-2#1)(2008-10#1)
to blow##2##2##(2008-11#1)(2011-2#1)
to blue color##2##3##(2008-10#1)(2010-2#1)
to blue##11##2##(1995-8#2)(2007-12#1)(2008-10#5)(2008-8#1)(2010-1#1)(2010-2#1)
to blunt trauma##2##3##(2009-2#1)(2011-2#1)
to blunt##7##2##(2006-4#1)(2007-4#1)(2008-8#1)(2009-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
to board##2##2##(1993-1#1)(1995-2#1)
to boceprevir##2##2##(2012-1#2)
to body and##3##3##(2011-1#1)(2012-11#2)
to body composition and##2##4##(2006-6#1)(2011-2#1)
to body composition##3##3##(2006-6#1)(2008-11#1)(2011-2#1)
to body dissatisfaction##4##3##(2007-12#4)
to body esteem##3##3##(2007-12#3)
to body fat##2##3##(2006-6#1)(2013-7#1)
to body image and##2##4##(2006-7#1)(2007-12#1)
to body image##8##3##(2006-7#1)(2007-12#6)(2007-7#1)
to body mass index##4##4##(1994-12#1)(2007-12#1)(2008-4#1)(2011-2#1)
to body mass##5##3##(1994-12#1)(1996-3#1)(2007-12#1)(2008-4#1)(2011-2#1)
to body satisfaction##4##3##(2007-12#4)
to body temperature##3##3##(1990-10#1)(1990-12#1)(2006-6#1)
to body weight##7##3##(1994-3#1)(1994-8#1)(2006-1#1)(2007-3#1)(2008-5#2)(2008-7#1)
to body##51##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1991-12#1)(1994-12#1)(1994-3#1)(1994-8#1)(1996-3#1)(2006-1#1)(2006-6#3)(2006-7#1)(2007-12#19)(2007-3#1)(2007-7#2)(2008-11#2)(2008-4#1)(2008-5#3)(2008-7#2)(2011-1#1)(2011-2#2)(2012-11#2)(2013-7#1)(2013-8#1)
to boiling##3##2##(1994-9#1)(2008-10#1)(2008-2#1)
to bond##2##2##(2008-3#1)(2009-9#1)
to bone and##5##3##(1990-8#1)(1994-12#1)(2008-8#1)(2010-3#1)(2011-2#1)
to bone deformity##2##3##(1997-3#2)
to bone marrow transplantation##2##4##(1997-5#1)(2007-4#1)
to bone marrow##6##3##(1995-12#2)(1997-5#1)(2007-4#1)(2007-8#1)(2008-7#1)
to bone metastases##8##3##(2007-11#7)(2008-10#1)
to bone mineral density##2##4##(2009-3#1)(2012-2#1)
to bone resorption##2##3##(1991-4#1)(1994-3#1)
to bone##48##2##(1990-8#1)(1991-4#2)(1992-7#1)(1993-9#1)(1994-12#2)(1994-3#1)(1995-12#2)(1996-9#1)(1997-3#2)(1997-5#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-11#8)(2007-12#1)(2007-4#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-3#3)(2010-3#1)(2011-2#1)(2012-2#1)
to bones##3##2##(2006-8#1)(2007-11#1)(2009-10#1)
to books##2##2##(2008-9#1)(2009-5#1)
to boost its##3##3##(1994-3#3)
to boost the immune response##2##5##(1993-12#1)(2008-2#1)
to boost the##6##3##(1993-12#1)(2007-4#1)(2007-7#1)(2008-2#1)(2008-6#2)
to boost##17##2##(1993-12#1)(1994-3#3)(1994-5#1)(1995-7#1)(2007-4#1)(2007-7#1)(2007-9#2)(2008-2#1)(2008-3#1)(2008-6#2)(2010-1#1)(2010-9#1)(2011-2#1)
to border##2##2##(2008-10#1)(2008-9#1)
to borrow##2##2##(1994-2#1)(2009-4#1)
to bortezomib##3##2##(2009-4#1)(2010-8#1)(2011-2#1)
to both PSV isolates##2##4##(2012-11#2)
to both TNF-alpha and##2##4##(2008-11#1)(2008-5#1)
to both a##7##3##(1992-7#1)(1996-3#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-3#1)
to both age and##2##4##(1991-3#1)(2007-9#1)
to both changes in##2##4##(1994-9#1)(2006-4#1)
to both direct and indirect##2##5##(1990-5#1)(1996-2#1)
to both drugs##2##3##(2008-5#2)
to both enzymes##3##3##(1991-2#1)(1995-10#1)(1995-3#1)
to both familiar##3##3##(2008-5#1)(2008-7#2)
to both forms##2##3##(1991-11#1)(2008-12#1)
to both fungicides##4##3##(2008-10#4)
to both groups of##2##4##(1995-5#1)(2013-1#1)
to both heat and##2##4##(1997-7#1)(2008-9#1)
to both human and##3##4##(1992-10#1)(1995-8#1)(2012-1#1)
to both human##4##3##(1992-10#1)(1995-12#1)(1995-8#1)(2012-1#1)
to both in##2##3##(1997-5#1)(2007-7#1)
to both injury and##2##4##(2007-12#1)(2013-8#1)
to both internal##2##3##(1991-4#1)(2007-2#1)
to both local##2##3##(1994-2#2)
to both lower##2##3##(2006-12#1)(2007-2#1)
to both microtubules and##2##4##(1995-2#2)
to both modes of##2##4##(1997-5#1)(2012-3#1)
to both mu##3##3##(1993-3#1)(1996-8#2)
to both natural and##2##4##(2008-10#1)(2008-5#1)
to both natural##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
to both of these##5##4##(1991-11#1)(1991-5#1)(1992-2#1)(1996-11#1)(2008-4#1)
to both of##6##3##(1991-11#1)(1991-5#1)(1992-2#1)(1992-4#1)(1996-11#1)(2008-4#1)
to both pathogens##4##3##(2006-12#1)(2008-10#3)
to both patient##2##3##(2010-8#1)(2011-2#1)
to both peptides##2##3##(1990-5#2)
to both prevent##2##3##(1993-9#1)(2011-2#1)
to both proteins##3##3##(1995-12#1)(2008-9#1)(2009-5#1)
to both races##2##3##(2008-10#2)
to both rat##2##3##(1992-11#1)(1997-4#1)
to both samples##2##3##(2008-10#1)(2008-2#1)
to both sides of the##2##5##(1992-3#1)(2008-10#1)
to both stimuli##2##3##(1996-5#1)(1996-8#1)
to both students and##2##4##(1996-1#1)(2008-12#1)
to both systems##2##3##(1990-8#1)(1991-8#1)
to both the chemical##2##4##(1995-1#1)(2008-10#1)
to both the standard##2##4##(1994-9#1)(2008-10#1)
to both the##73##3##(1990-10#1)(1990-4#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-3#2)(1992-6#2)(1992-7#1)(1992-9#1)(1993-12#2)(1994-11#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-4#2)(1997-6#2)(1997-7#2)(2004-12#1)(2005-5#1)(2006-10#1)(2007-10#2)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
to both total##2##3##(1993-12#2)
to both types of##3##4##(1996-4#1)(2009-4#1)(2009-5#1)
to both variation in##2##4##(2007-12#1)(2008-9#1)
to both##534##2##(1990-10#3)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#3)(1990-4#2)(1990-5#5)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#3)(1991-3#3)(1991-4#2)(1991-5#5)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#5)(1992-3#6)(1992-4#3)(1992-5#1)(1992-6#7)(1992-7#3)(1992-8#4)(1992-9#5)(1993-1#1)(1993-12#6)(1993-2#2)(1993-3#3)(1993-4#1)(1993-6#1)(1993-9#2)(1994-11#2)(1994-12#3)(1994-2#7)(1994-6#3)(1994-8#1)(1994-9#3)(1995-1#4)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#4)(1995-3#4)(1995-5#4)(1995-6#3)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#4)(1996-12#3)(1996-2#1)(1996-3#3)(1996-4#3)(1996-5#5)(1996-6#3)(1996-7#1)(1996-8#5)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#7)(1997-5#5)(1997-6#3)(1997-7#7)(1997-8#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-4#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-5#1)(2005-8#2)(2006-10#7)(2006-11#2)(2006-12#5)(2006-2#2)(2006-4#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#3)(2007-12#8)(2007-2#3)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#5)(2007-9#2)(2008-1#4)(2008-10#56)(2008-11#6)(2008-12#9)(2008-2#10)(2008-3#13)(2008-4#7)(2008-5#19)(2008-6#2)(2008-7#12)(2008-8#4)(2008-9#7)(2009-1#1)(2009-10#1)(2009-11#6)(2009-12#1)(2009-2#1)(2009-3#8)(2009-4#2)(2009-5#3)(2009-6#2)(2009-7#4)(2009-8#6)(2009-9#2)(2010-2#1)(2010-3#1)(2010-5#5)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#10)(2012-1#4)(2012-11#2)(2012-12#11)(2012-2#8)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#3)
to bottom##6##2##(1995-1#1)(2005-11#1)(2007-9#1)(2008-10#1)(2011-12#1)(2013-8#1)
to botulinum neurotoxin##2##3##(1990-5#1)(1996-9#1)
to bound the##2##3##(2006-10#1)(2008-2#1)
to bound##5##2##(1990-5#1)(2006-10#2)(2008-2#1)(2010-5#1)
to boundary##2##2##(1997-2#1)(2012-12#1)
to bovine and##2##3##(1992-2#1)(1994-9#1)
to bovine brain membranes##2##4##(1990-8#2)
to bovine brain##3##3##(1990-8#2)(1991-4#1)
to bovine heart##2##3##(1994-9#1)(1995-2#1)
to bovine lactoferrin##2##3##(1996-12#2)
to bovine pancreatic trypsin inhibitor##2##5##(1994-9#1)(1995-2#1)
to bovine serum albumin (BSA) and##2##6##(2006-12#1)(2007-8#1)
to bovine serum albumin (BSA)##8##5##(1992-11#1)(1995-12#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)
to bovine serum albumin##12##4##(1992-11#2)(1992-8#1)(1995-12#1)(1996-9#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)
to bovine spongiform encephalopathy##3##4##(2007-9#2)(2011-2#1)
to bovine##46##2##(1990-12#1)(1990-8#4)(1990-9#1)(1991-11#1)(1991-4#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-8#1)(1994-9#3)(1995-12#1)(1995-2#3)(1995-8#1)(1996-12#3)(1996-9#1)(1997-3#1)(1997-5#1)(2004-9#1)(2006-12#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2011-2#1)
to bowel##2##2##(1992-8#1)(2006-8#1)
to boys##5##2##(1990-12#1)(2007-2#1)(2009-8#1)(2010-7#1)(2012-2#1)
to bp##2##2##(1993-3#1)(1996-7#1)
to brachial##2##2##(1994-7#1)(2006-8#1)
to bradykinin##4##2##(1990-12#2)(1991-12#1)(1991-5#1)
to brain PI##2##3##(1996-2#2)
to brain and##3##3##(1990-2#1)(2009-6#1)(2011-2#1)
to brain cells##3##3##(2008-4#1)(2012-1#2)
to brain damage##2##3##(1996-5#1)(2006-8#1)
to brain injury##3##3##(1991-11#1)(1994-11#1)(1997-3#1)
to brain regions##2##3##(1997-2#1)(2009-10#1)
to brain tumors##4##3##(1991-4#1)(2007-10#2)(2008-5#1)
to brain##42##2##(1990-2#1)(1990-3#1)(1990-7#1)(1991-11#1)(1991-4#1)(1991-5#1)(1993-12#1)(1994-11#1)(1996-2#2)(1996-5#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-1#2)(2005-8#1)(2006-5#1)(2006-8#1)(2007-10#3)(2008-1#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2009-10#1)(2009-4#1)(2009-6#1)(2011-2#3)(2012-1#2)(2012-3#1)
to branchial##2##2##(2004-4#1)(2008-5#1)
to bread wheat##3##3##(2006-4#1)(2008-10#2)
to break down in##2##4##(2008-5#1)(2010-12#1)
to break down##6##3##(1990-11#1)(1997-6#1)(2006-12#1)(2008-3#1)(2008-5#1)(2010-12#1)
to break the##12##3##(1991-4#1)(1992-12#1)(2006-12#1)(2006-6#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-3#1)(2011-1#1)
to break this##2##3##(1994-12#1)(2008-11#1)
to break up##2##3##(2008-11#1)(2008-8#1)
to break##30##2##(1990-11#1)(1991-4#1)(1992-12#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-5#1)(1997-3#1)(1997-6#1)(2006-12#2)(2006-6#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)
to breakage of the##2##4##(2008-2#1)(2009-3#1)
to breakdown##6##2##(1991-5#1)(2006-7#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-9#1)
to breaking##2##2##(2004-9#1)(2009-4#1)
to breast and##2##3##(1991-7#1)(1997-1#1)
to breast cancer in##2##4##(1992-2#1)(2007-11#1)
to breast cancer##21##3##(1990-8#1)(1992-2#1)(1993-1#1)(1993-10#1)(1994-2#1)(1995-1#1)(1995-9#1)(1996-9#1)(1997-1#1)(1997-3#1)(2007-10#2)(2007-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-2#1)(2009-5#2)(2010-12#1)(2011-2#1)
to breast conserving surgery##2##4##(1997-7#1)(2004-1#1)
to breast feed##2##3##(1990-2#1)(1994-4#1)
to breast feeding and##2##4##(2004-8#1)(2007-10#1)
to breast milk##2##3##(2006-8#1)(2008-3#1)
to breast##34##2##(1990-2#1)(1990-8#1)(1991-7#1)(1992-2#1)(1993-1#1)(1993-10#3)(1994-2#1)(1994-4#1)(1995-1#1)(1995-9#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-7#1)(2004-1#1)(2004-8#1)(2006-8#1)(2007-10#3)(2007-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-2#1)(2009-5#2)(2010-12#1)(2011-2#1)(2011-3#1)
to breastfeed in public##2##4##(2006-9#2)
to breastfeed in##3##3##(2006-9#2)(2007-9#1)
to breastfeed##9##2##(2006-2#1)(2006-9#2)(2007-2#4)(2007-9#1)(2013-1#1)
to breastfeeding##5##2##(2007-2#3)(2008-4#1)(2012-2#1)
to breathe##2##2##(1993-3#1)(2011-2#1)
to breathing##4##2##(1992-2#1)(2005-11#1)(2008-12#1)(2013-7#1)
to breed##4##2##(1992-12#1)(2008-10#1)(2008-5#1)(2008-8#1)
to breeders##2##2##(2008-10#1)(2009-2#1)
to breeding##4##2##(2008-8#3)(2011-1#1)
to bridge between the##2##4##(1990-12#1)(1994-12#1)
to bridge the gap between evidence and##2##7##(1993-12#1)(2008-3#1)
to bridge the gap between##4##5##(1993-12#1)(2008-11#1)(2008-3#1)(2008-5#1)
to bridge the gap##5##4##(1991-1#1)(1993-12#1)(2008-11#1)(2008-3#1)(2008-5#1)
to bridge the##9##3##(1991-1#1)(1993-12#1)(1995-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)
to bridge this##2##3##(2006-4#1)(2010-8#1)
to bridge##24##2##(1990-12#1)(1991-1#1)(1993-12#1)(1994-12#1)(1995-1#1)(1996-11#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-8#1)(2012-2#1)(2013-7#1)
to brief##3##2##(1992-11#1)(1996-4#1)(2010-11#1)
to briefly review##3##3##(2007-1#1)(2008-11#1)(2010-3#1)
to briefly##13##2##(1991-9#1)(1993-1#1)(1996-3#1)(2005-8#1)(2006-10#1)(2007-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-3#1)(2011-3#1)(2012-1#1)
to bright light##4##3##(1997-6#1)(2012-1#3)
to bright##5##2##(1997-6#1)(2007-11#1)(2012-1#3)
to bring about a##2##4##(1990-2#1)(2007-4#1)
to bring about##14##3##(1990-12#1)(1990-2#1)(1993-12#1)(1997-3#1)(2007-4#1)(2007-8#1)(2008-11#2)(2010-1#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#2)
to bring attention to##2##4##(2010-2#1)(2013-8#1)
to bring down the incidence##2##5##(1996-11#1)(2011-1#1)
to bring in##3##3##(1992-12#1)(1997-8#1)(2008-5#1)
to bring it##2##3##(1992-1#1)(2007-4#1)
to bring order##2##3##(2006-10#1)(2007-4#1)
to bring the system##2##4##(2007-11#1)(2008-3#1)
to bring the##13##3##(1990-8#1)(1992-1#1)(1994-12#1)(1995-6#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#2)(2012-3#1)(2013-1#1)
to bring this##3##3##(2007-7#1)(2008-9#1)(2010-7#1)
to bring together the##5##4##(2005-8#1)(2006-2#1)(2008-2#1)(2011-1#1)(2013-8#1)
to bring together##12##3##(1992-11#1)(1993-3#1)(2005-8#1)(2006-2#1)(2007-11#1)(2008-2#1)(2008-7#1)(2011-1#2)(2012-11#1)(2013-8#2)
to bring##89##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-1#1)(1991-5#1)(1992-1#2)(1992-11#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-6#2)(1996-11#2)(1996-12#1)(1996-2#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-3#1)(2005-6#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-4#3)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#7)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#2)(2011-1#4)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#4)
to broad spectrum##2##3##(2007-11#1)(2009-2#1)
to broad##6##2##(2007-11#1)(2008-7#1)(2009-11#1)(2009-2#1)(2011-1#1)(2012-12#1)
to broad-spectrum##2##2##(2005-8#1)(2010-6#1)
to broadcast##2##2##(1994-3#1)(2010-12#1)
to broaden our##2##3##(2009-10#1)(2012-2#1)
to broaden the range of##2##5##(1994-9#1)(1995-5#1)
to broaden the##10##3##(1990-10#1)(1994-9#1)(1995-5#1)(1996-2#1)(2007-11#1)(2008-1#1)(2008-8#2)(2008-9#1)(2011-2#1)
to broaden their##3##3##(2005-9#1)(2008-11#1)(2011-2#1)
to broaden##24##2##(1990-10#1)(1994-9#1)(1995-1#1)(1995-5#2)(1996-2#2)(2005-11#1)(2005-9#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-8#2)(2008-9#1)(2009-10#1)(2011-2#3)(2012-11#1)(2012-2#1)(2013-1#1)
to broadening##2##2##(1992-1#1)(2008-10#1)
to bronchodilator##3##2##(2011-2#3)
to brown stem rot##4##4##(2008-10#4)
to brown##9##2##(2008-10#7)(2008-12#1)(2011-1#1)
to brush border membranes##2##4##(1996-3#2)
to brush##4##2##(1996-3#2)(1997-4#1)(2006-7#1)
to brushing##2##2##(2012-2#1)(2013-1#1)
to bryostatin-1##3##2##(1992-6#3)
to bud##3##2##(2008-10#2)(2012-8#1)
to budding of##2##3##(2008-5#1)(2009-6#1)
to budding##3##2##(2008-2#1)(2008-5#1)(2009-6#1)
to buffer##5##2##(1991-6#1)(2008-2#1)(2008-4#1)(2008-8#1)(2011-2#1)
to buffered##3##2##(1990-4#1)(2008-10#1)(2008-11#1)
to build a more##2##4##(2006-5#1)(2013-1#1)
to build a##30##3##(1993-12#1)(1994-2#2)(1995-12#1)(1996-3#2)(1997-1#1)(2006-12#1)(2006-5#2)(2007-11#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#2)
to build an##8##3##(2008-11#1)(2008-7#3)(2009-10#1)(2010-12#1)(2013-1#2)
to build and##3##3##(1996-1#1)(2008-4#1)(2011-7#1)
to build high##2##3##(1994-12#1)(2008-3#1)
to build new##3##3##(2006-6#1)(2008-3#1)(2013-7#1)
to build on##2##3##(2009-12#1)(2010-11#1)
to build the##8##3##(2008-10#3)(2008-12#1)(2009-2#1)(2009-9#1)(2010-8#1)(2011-2#1)
to build up a##4##4##(1996-10#1)(2008-10#2)(2008-7#1)
to build up the##3##4##(2008-1#1)(2011-1#2)
to build up##11##3##(1993-7#1)(1996-10#1)(2006-2#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#1)(2011-1#2)
to build upon##2##3##(1992-5#1)(2006-7#1)
to build##116##2##(1991-11#1)(1992-5#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-12#2)(1994-2#2)(1995-12#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-3#2)(1997-1#1)(1997-2#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#1)(2006-7#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#6)(2008-3#5)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#6)(2008-9#1)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#3)(2011-7#1)(2012-12#1)(2012-2#4)(2013-1#5)(2013-7#1)(2013-8#1)
to building##6##2##(2007-12#1)(2008-5#1)(2010-12#1)(2011-1#1)(2013-1#2)
to bulk##10##2##(1992-11#1)(2005-11#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#2)(2013-8#1)
to bundle##2##2##(1992-12#1)(1995-8#1)
to bupivacaine##5##2##(2006-10#1)(2006-8#1)(2010-7#2)(2013-7#1)
to burn##2##2##(2007-11#1)(2010-9#1)
to burnout##7##2##(1992-1#1)(2007-4#1)(2008-10#2)(2012-2#1)(2013-1#1)(2013-7#1)
to business##4##2##(1991-2#1)(1993-2#1)(2013-1#2)
to but##8##2##(1990-10#1)(1990-4#1)(1991-5#1)(1994-10#1)(1996-5#1)(2009-10#1)(2009-7#1)(2009-8#1)
to buthionine sulfoximine (BSO)##2##4##(1995-1#1)(2009-10#1)
to butyl##2##2##(2008-5#2)
to butyrate##3##2##(1992-3#1)(1996-7#1)(2008-11#1)
to buy time##2##3##(2006-10#1)(2007-4#1)
to buy##18##2##(1990-2#1)(1991-9#1)(1992-12#4)(1992-8#1)(1993-3#1)(1993-5#1)(1995-2#1)(1995-5#1)(1996-11#1)(2006-10#2)(2006-5#1)(2007-4#1)(2012-12#1)(2012-2#1)
to by##5##2##(1994-3#1)(2008-12#1)(2008-3#1)(2010-3#1)(2011-2#1)
to bypass the##5##3##(1993-3#1)(1997-8#1)(2008-2#1)(2008-9#1)(2012-3#1)
to bypass##12##2##(1992-8#1)(1993-3#1)(1995-6#1)(1997-8#1)(2005-10#1)(2006-11#1)(2007-9#1)(2008-2#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-7#1)
to c##3##2##(2007-12#2)(2008-11#1)
to cAMP##11##2##(1990-8#1)(1991-12#1)(1991-2#1)(1992-6#1)(1993-7#1)(1994-12#1)(1995-3#2)(1995-8#1)(1996-12#1)(1996-2#1)
to cDNA##4##2##(1995-11#1)(2006-4#1)(2008-4#1)(2008-9#1)
to cE##2##2##(1990-5#2)
to cGMP##3##2##(1993-9#1)(1995-2#1)(2005-1#1)
to ca##9##2##(1996-7#1)(2005-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)(2012-2#1)
to cacao##2##2##(2008-10#2)
to cachexia and##2##3##(2007-3#1)(2008-10#1)
to cachexia##3##2##(2007-12#1)(2007-3#1)(2008-10#1)
to cadmium and##4##3##(1993-4#1)(2008-10#1)(2008-11#1)(2008-8#1)
to cadmium cytotoxicity is induced by zinc##2##7##(1997-3#2)
to cadmium cytotoxicity##3##3##(1997-3#3)
to cadmium##10##2##(1993-12#1)(1993-4#1)(1997-3#3)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)
to caffeine##4##2##(1991-10#1)(1994-12#2)(1995-8#1)
to cage##4##2##(2007-11#1)(2008-11#3)
to calbindin D9k##2##3##(1994-11#2)
to calbindin-D##2##2##(1991-9#2)
to calcification##3##2##(2004-9#1)(2008-1#1)(2013-1#1)
to calcineurin##3##2##(1993-11#1)(1995-6#1)(2009-2#1)
to calcitonin gene-related peptide##2##4##(1992-6#1)(1993-11#1)
to calcitonin##6##2##(1991-8#1)(1992-6#1)(1992-8#1)(1993-11#1)(2006-10#1)(2006-12#1)
to calcium binding##2##3##(1990-7#1)(1991-7#1)
to calcium mobilization##2##3##(1992-6#1)(1994-12#1)
to calcium##20##2##(1990-11#1)(1990-7#1)(1991-3#3)(1991-7#1)(1991-8#2)(1992-6#1)(1994-12#1)(1994-3#1)(1995-2#2)(1995-8#1)(1996-9#2)(2005-10#1)(2007-11#1)(2008-5#1)(2010-11#1)
to calculate a##5##3##(1993-11#1)(2004-11#1)(2006-12#1)(2008-10#1)(2009-8#1)
to calculate absorption##2##3##(1997-6#1)(2007-11#1)
to calculate radiation##2##3##(2008-3#1)(2008-7#1)
to calculate the binding##3##4##(1995-2#1)(2006-12#1)(2010-7#1)
to calculate the concentration of##2##5##(2008-10#2)
to calculate the corresponding##3##4##(2008-10#2)(2008-2#1)
to calculate the dispersion##2##4##(2007-12#1)(2008-11#1)
to calculate the net##2##4##(2008-11#1)(2011-2#1)
to calculate the number of##2##5##(2006-10#1)(2008-7#1)
to calculate the optical##2##4##(2008-2#2)
to calculate the point##2##4##(2005-11#1)(2008-10#1)
to calculate the potential##2##4##(2005-11#1)(2006-2#1)
to calculate the protein concentration##2##5##(2008-1#1)(2008-2#1)
to calculate the relative##3##4##(1996-1#1)(1996-3#1)(2008-10#1)
to calculate the surface##3##4##(2005-11#2)(2008-2#1)
to calculate the time##2##4##(2007-12#1)(2008-5#1)
to calculate the##155##3##(1990-7#1)(1991-2#2)(1991-5#1)(1992-2#1)(1992-4#1)(1993-3#1)(1995-2#1)(1996-1#2)(1996-12#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-7#1)(2005-11#6)(2005-5#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-2#1)(2007-11#2)(2007-12#12)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#23)(2008-11#4)(2008-12#3)(2008-2#18)(2008-3#20)(2008-4#2)(2008-5#6)(2008-7#4)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#4)(2011-12#1)(2011-2#5)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
to calculate##237##2##(1990-4#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-2#2)(1991-5#1)(1992-2#2)(1992-4#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#3)(1995-9#1)(1996-1#2)(1996-12#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-6#2)(1997-7#1)(2004-11#1)(2005-11#6)(2005-5#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#1)(2006-7#1)(2007-11#4)(2007-12#13)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#33)(2008-11#7)(2008-12#4)(2008-2#29)(2008-3#29)(2008-4#3)(2008-5#7)(2008-7#6)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-6#1)(2010-7#1)(2011-1#5)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#3)
to calculated##3##2##(1995-7#1)(2009-11#1)(2011-2#1)
to calf thymus DNA in vitro##2##6##(1992-1#1)(1992-7#1)
to calf thymus DNA in##3##5##(1992-1#2)(1992-7#1)
to calf thymus DNA is##2##5##(1990-2#1)(2008-5#1)
to calf thymus DNA##12##4##(1990-2#3)(1992-1#2)(1992-2#1)(1992-7#1)(1995-11#1)(1995-2#1)(2006-10#1)(2008-5#2)
to calf##13##2##(1990-2#3)(1992-1#2)(1992-2#1)(1992-7#1)(1995-11#1)(1995-2#1)(1997-7#1)(2006-10#1)(2008-5#2)
to calibrate a##5##3##(2006-10#1)(2008-4#2)(2009-3#1)(2012-2#1)
to calibrate and##2##3##(2008-3#1)(2008-6#1)
to calibrate for##2##3##(2008-2#1)(2008-3#1)
to calibrate the##7##3##(1990-12#1)(1992-4#1)(2008-2#1)(2008-3#4)
to calibrate##23##2##(1990-12#1)(1992-4#1)(2006-10#1)(2008-10#1)(2008-2#3)(2008-3#10)(2008-4#2)(2008-6#1)(2008-9#1)(2009-3#1)(2012-2#1)
to calibration##5##2##(2008-10#1)(2008-3#1)(2010-11#1)(2013-1#2)
to call attention to##2##4##(2007-8#1)(2008-12#1)
to call into question##2##4##(1992-12#1)(2005-12#1)
to call it##2##3##(2008-7#1)(2012-2#1)
to call the##2##3##(2008-10#1)(2012-12#1)
to call##15##2##(1992-12#1)(1996-7#1)(2005-12#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
to calls for##2##3##(1994-3#1)(2006-10#1)
to calls from midwife obstetric units##2##6##(2010-3#2)
to calls from##3##3##(2010-3#3)
to calls##5##2##(1994-3#1)(2006-10#1)(2010-3#3)
to calm##3##2##(2008-3#1)(2008-4#1)(2009-9#1)
to calmodulin##5##2##(1991-2#1)(1992-12#1)(1992-3#1)(1995-1#1)(1995-8#1)
to calorie restriction##2##3##(2008-4#2)
to calreticulin##4##2##(1992-7#2)(1994-11#2)
to camptothecin##3##2##(1994-8#2)(1995-7#1)
to cancel the##3##3##(1992-2#1)(2007-12#1)(2008-2#1)
to cancel##9##2##(1992-2#1)(1993-12#1)(1995-12#1)(2007-12#2)(2008-2#1)(2008-3#2)(2012-3#1)
to cancer and##3##3##(2008-4#1)(2010-12#1)(2011-1#1)
to cancer are##2##3##(2009-3#1)(2009-4#1)
to cancer cell##4##3##(2008-11#1)(2009-3#1)(2009-4#1)(2012-12#1)
to cancer detection##2##3##(1991-12#1)(2007-2#1)
to cancer diagnosis##2##3##(1992-10#1)(2010-6#1)
to cancer immunotherapy##2##3##(1990-12#1)(2006-10#1)
to cancer in##6##3##(1990-9#1)(1997-1#1)(2006-10#2)(2006-2#1)(2007-9#1)
to cancer of the##2##4##(1994-2#1)(2012-12#1)
to cancer of##3##3##(1994-2#1)(2012-12#1)(2012-3#1)
to cancer patients##6##3##(1992-3#1)(1992-5#1)(1995-2#1)(2005-10#1)(2011-1#1)(2011-2#1)
to cancer prevention##2##3##(2009-12#1)(2011-2#1)
to cancer progression##2##3##(2009-3#1)(2009-5#1)
to cancer research##4##3##(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#1)
to cancer therapy##7##3##(2007-10#1)(2008-1#3)(2008-4#1)(2009-3#1)(2011-2#1)
to cancer##88##2##(1990-12#1)(1990-9#1)(1991-12#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-2#2)(1995-2#1)(1995-9#2)(1996-10#1)(1996-9#1)(1997-1#1)(1997-3#1)(2004-8#1)(2005-10#2)(2006-10#3)(2006-2#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-9#2)(2008-1#4)(2008-11#4)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#2)(2009-12#3)(2009-3#4)(2009-4#4)(2009-5#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#4)(2011-2#5)(2011-3#1)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
to cancers of the breast##2##5##(1995-9#1)(2008-11#1)
to cancers of the##3##4##(1995-5#1)(1995-9#1)(2008-11#1)
to cancers##5##2##(1995-5#1)(1995-9#1)(2008-11#2)(2012-12#1)
to canker##2##2##(2008-10#2)
to cannabinoid receptors##2##3##(1991-6#1)(1995-6#1)
to cannabis##4##2##(2005-10#1)(2006-9#1)(2009-7#1)(2012-12#1)
to cannulation##2##2##(1990-8#1)(2007-7#1)
to canopy##3##2##(2008-10#1)(2013-7#2)
to cap##2##2##(1993-8#1)(1994-2#1)
to capillary electrophoresis##2##3##(2008-10#2)
to capillary##4##2##(2008-1#1)(2008-10#2)(2008-3#1)
to capital##3##2##(1992-2#1)(1997-6#1)(2008-7#1)
to capitalize on the##3##4##(1994-3#1)(1995-2#1)(2008-7#1)
to capitalize on##6##3##(1994-3#1)(1995-2#1)(2008-7#1)(2010-9#1)(2011-2#1)(2012-3#1)
to capitation##4##2##(1994-10#1)(1995-2#1)(1997-1#1)(1997-2#1)
to capsaicin##7##2##(1990-5#1)(1992-11#1)(1992-6#1)(1993-4#1)(1997-5#1)(2008-11#1)(2012-3#1)
to capture a##2##3##(2008-1#1)(2009-12#1)
to capture and##6##3##(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2013-1#2)
to capture important features of##2##5##(2008-10#1)(2009-12#1)
to capture only those studies that##2##6##(2006-2#2)
to capture patient##2##3##(2007-12#1)(2007-9#1)
to capture prey##2##3##(2007-12#1)(2012-12#1)
to capture some##2##3##(2008-1#1)(2011-2#1)
to capture the essence of##2##5##(2008-11#1)(2008-2#1)
to capture the spatial##2##4##(2007-9#1)(2010-2#1)
to capture the##23##3##(1990-12#1)(2006-10#2)(2006-7#1)(2007-12#2)(2007-6#1)(2007-9#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#2)(2008-7#1)(2009-8#1)(2010-2#1)(2010-5#1)(2012-1#1)(2012-3#1)(2013-7#1)
to capture##98##2##(1990-12#1)(1993-12#1)(1995-5#1)(1996-3#2)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#4)(2008-11#4)(2008-2#5)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-12#2)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#3)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#12)(2013-7#1)(2013-8#1)
to capturing##2##2##(2008-11#1)(2013-8#1)
to car##2##2##(2010-5#1)(2011-1#1)
to carbachol and##2##3##(2004-12#1)(2008-3#1)
to carbachol was##2##3##(1995-3#1)(1996-5#1)
to carbachol##10##2##(1990-5#1)(1990-7#1)(1993-7#1)(1995-12#1)(1995-3#1)(1996-5#1)(1997-1#1)(2004-12#2)(2008-3#1)
to carbamazepine##3##2##(2006-11#1)(2010-12#1)(2011-2#1)
to carbohydrate##3##2##(1991-5#1)(1992-11#1)(2012-3#1)
to carbon catabolite repression by##2##5##(1993-12#1)(2008-10#1)
to carbon dioxide##4##3##(1993-12#1)(2006-6#1)(2008-10#1)(2008-2#1)
to carbon monoxide##2##3##(1992-12#1)(1997-6#1)
to carbon nanotubes##2##3##(2007-8#1)(2010-12#1)
to carbon##20##2##(1992-12#1)(1993-12#2)(1994-2#1)(1997-6#1)(2005-4#1)(2006-6#1)(2006-7#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-4#1)(2013-8#1)
to carbonyl##2##2##(2010-5#1)(2010-7#1)
to carboplatin##2##2##(2006-12#1)(2008-8#1)
to carboxylate##3##2##(1990-12#1)(2006-12#1)(2008-7#1)
to carcinogen##2##2##(1993-9#2)
to carcinogenesis in##2##3##(2012-1#1)(2013-1#1)
to carcinogenesis##7##2##(2007-2#1)(2008-10#1)(2009-12#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
to carcinoma in##2##3##(1997-7#1)(2008-1#1)
to carcinoma##11##2##(1991-10#1)(1997-7#1)(2005-11#1)(2006-10#2)(2008-1#1)(2008-4#1)(2008-9#1)(2009-5#1)(2011-2#1)(2013-8#1)
to cardiac allografts##2##3##(1995-2#1)(2005-10#1)
to cardiac catheterization##2##3##(2010-10#1)(2013-1#1)
to cardiac dysfunction##2##3##(2011-2#2)
to cardiac hypertrophy##2##3##(2008-12#2)
to cardiac rehabilitation##2##3##(1991-7#1)(2008-11#1)
to cardiac resynchronization therapy##2##4##(2012-2#2)
to cardiac surgery##2##3##(2007-8#1)(2007-9#1)
to cardiac tamponade##3##3##(2007-7#1)(2007-8#1)(2008-11#1)
to cardiac##41##2##(1991-7#1)(1992-3#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2005-10#1)(2007-4#1)(2007-7#3)(2007-8#5)(2007-9#1)(2008-10#1)(2008-11#3)(2008-12#2)(2009-4#1)(2009-5#1)(2010-10#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-2#3)(2013-1#1)(2013-7#1)
to cardiogenic##2##2##(1996-3#1)(2013-1#1)
to cardiolipin but##2##3##(1990-6#1)(1996-5#1)
to cardiolipin##4##2##(1990-6#2)(1996-5#2)
to cardiologists##2##2##(2008-10#1)(2010-1#1)
to cardiopulmonary bypass##3##3##(2006-10#1)(2007-8#1)(2007-9#1)
to cardiopulmonary##6##2##(2006-10#1)(2006-4#1)(2007-8#1)(2007-9#1)(2010-5#1)(2012-3#1)
to cardiovascular complications##2##3##(2008-12#1)(2012-3#1)
to cardiovascular disease and##3##4##(2005-10#1)(2007-8#1)(2008-3#1)
to cardiovascular disease##18##3##(1990-5#1)(1990-9#1)(1992-2#1)(1992-4#1)(1994-5#1)(1997-3#1)(2005-10#2)(2007-8#1)(2008-12#1)(2008-3#3)(2008-9#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)
to cardiovascular diseases##4##3##(1990-10#1)(2008-10#1)(2013-1#1)(2013-7#1)
to cardiovascular events##3##3##(2010-9#1)(2011-12#1)(2011-2#1)
to cardiovascular risk factors in##3##5##(2010-4#1)(2011-1#1)(2012-2#1)
to cardiovascular##45##2##(1990-10#1)(1990-5#2)(1990-9#1)(1991-2#1)(1992-2#1)(1992-4#1)(1992-6#1)(1994-5#1)(1997-3#1)(2005-10#2)(2005-6#1)(2005-8#2)(2006-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#3)(2008-9#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
to care and##5##3##(1996-1#1)(2007-12#1)(2008-7#1)(2012-12#1)(2013-1#1)
to care as##2##3##(1997-4#1)(2011-2#1)
to care for and##2##4##(2005-10#1)(2011-2#1)
to care for bereaved parents##2##5##(2008-11#2)
to care for children##3##4##(2012-2#2)(2013-8#1)
to care for patients##3##4##(1991-2#1)(1995-3#1)(2004-4#1)
to care for people with mental health problems##2##8##(2008-11#2)
to care for the##9##4##(1995-1#1)(1996-1#1)(1996-3#1)(1997-2#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-5#1)
to care for their##2##4##(2008-11#1)(2008-12#1)
to care for themselves##2##4##(2006-10#1)(2011-1#1)
to care for##47##3##(1991-11#1)(1991-2#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-3#1)(1995-1#1)(1995-12#2)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(2004-4#1)(2005-10#1)(2006-10#3)(2007-10#1)(2007-12#1)(2008-1#1)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#4)(2013-8#1)
to care in##2##3##(1996-3#1)(2011-2#1)
to care of the older person##3##6##(2010-10#3)
to care of##4##3##(2010-10#3)(2013-1#1)
to care was##2##3##(2011-2#1)(2012-2#1)
to care##117##2##(1991-11#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-1#1)(1994-3#4)(1994-6#1)(1995-1#1)(1995-12#9)(1995-3#3)(1996-1#2)(1996-2#1)(1996-3#5)(1996-7#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(2004-4#1)(2005-10#1)(2006-10#3)(2007-10#3)(2007-12#2)(2007-3#1)(2008-1#1)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#1)(2010-10#3)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#13)(2012-1#1)(2012-12#2)(2012-2#8)(2012-3#1)(2013-1#4)(2013-8#2)
to care?##2##2##(1991-2#1)(2007-10#1)
to careers in##2##3##(1992-7#1)(2012-3#1)
to careers##3##2##(1992-7#1)(2010-10#1)(2012-3#1)
to careful##2##2##(2005-6#1)(2008-4#1)
to carefully consider##2##3##(2006-9#1)(2007-2#1)
to carefully##10##2##(1992-11#1)(1995-12#1)(2004-9#1)(2006-9#1)(2007-2#1)(2008-6#1)(2008-8#1)(2013-1#1)(2013-8#2)
to caregivers of##3##3##(1994-1#1)(2008-6#2)
to caregivers##9##2##(1991-1#1)(1994-1#1)(1996-1#1)(2007-12#1)(2008-1#1)(2008-6#2)(2009-9#1)(2013-8#1)
to caries##3##2##(2006-8#1)(2010-2#1)(2013-1#1)
to caring##7##2##(1994-2#1)(2008-1#1)(2009-5#2)(2011-2#1)(2013-1#2)
to carnitine##2##2##(1991-7#1)(2011-2#1)
to carotid artery##2##3##(1990-7#1)(2012-12#1)
to carotid##10##2##(1990-12#1)(1990-7#1)(1993-12#2)(1994-10#1)(2007-8#2)(2008-5#1)(2008-7#1)(2012-12#1)
to carp##2##2##(1993-3#1)(2004-4#1)
to carrier##9##2##(1990-5#1)(1992-12#1)(2008-10#1)(2008-11#5)(2008-2#1)
to carry a##5##3##(1992-3#1)(1996-1#1)(2006-10#1)(2008-3#1)(2009-6#1)
to carry light##2##3##(2008-10#1)(2008-3#1)
to carry on##2##3##(1991-9#1)(2008-11#1)
to carry out a##6##4##(2006-2#1)(2007-12#1)(2007-2#1)(2008-3#1)(2011-1#1)(2013-1#1)
to carry out activities##2##4##(2008-7#1)(2012-12#1)
to carry out an##6##4##(1990-3#1)(1991-5#1)(2006-2#1)(2009-9#1)(2011-2#1)(2011-3#1)
to carry out analyses of##2##5##(1996-3#1)(2008-10#1)
to carry out the calibration for the##2##7##(2008-2#2)
to carry out the##20##4##(1990-2#1)(1992-3#1)(1993-5#1)(1994-2#1)(1995-12#1)(1997-7#1)(2008-10#5)(2008-2#5)(2008-3#2)(2010-12#1)(2011-2#1)
to carry out this##4##4##(2007-1#1)(2007-4#1)(2010-9#1)(2012-2#1)
to carry out##92##3##(1990-2#2)(1990-3#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-5#1)(1991-9#1)(1992-3#2)(1992-5#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-6#2)(1997-7#1)(2004-9#1)(2005-7#1)(2006-2#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#2)(2007-5#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#4)(2008-4#2)(2008-7#2)(2008-8#1)(2009-9#2)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-12#3)(2012-2#3)(2013-1#2)(2013-8#2)
to carry the##12##3##(1990-1#1)(1991-8#1)(1992-12#1)(1994-10#1)(1994-6#1)(1996-6#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-11#1)(2009-11#1)
to carry##130##2##(1990-1#1)(1990-2#2)(1990-3#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-3#3)(1992-5#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-3#1)(1996-6#1)(1997-6#2)(1997-7#1)(2004-9#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-2#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-4#2)(2007-5#1)(2008-1#1)(2008-10#18)(2008-11#4)(2008-12#2)(2008-2#5)(2008-3#6)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#2)(2009-6#1)(2009-7#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-12#3)(2012-2#3)(2013-1#2)(2013-8#2)
to carrying out##2##3##(2010-5#1)(2010-8#1)
to carrying##3##2##(2008-8#1)(2010-5#1)(2010-8#1)
to cartilage##3##2##(2007-11#1)(2010-10#1)(2012-2#1)
to carve##3##2##(2007-9#1)(2013-1#2)
to case management##4##3##(1992-3#1)(1997-3#1)(2006-1#1)(2010-2#1)
to case##10##2##(1992-3#1)(1996-12#1)(1997-3#1)(2006-1#1)(2007-11#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
to casein##2##2##(1991-8#1)(2007-11#1)
to cases in##2##3##(1996-6#1)(2005-8#1)
to cases of##3##3##(2006-10#1)(2007-11#1)(2011-2#1)
to cases##9##2##(1996-6#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)
to caspofungin and micafungin##2##4##(2007-12#1)(2008-3#1)
to caspofungin##3##2##(2007-12#1)(2008-3#2)
to cast##4##2##(1992-3#1)(1995-1#1)(2008-5#1)(2013-8#1)
to castration##3##2##(1994-5#2)(2008-5#1)
to cat##2##2##(1994-12#1)(2009-2#1)
to catabolite repression by glucose##2##5##(1990-12#1)(1994-12#1)
to catabolite##3##2##(1990-12#1)(1994-12#1)(2006-9#1)
to catabolize##4##2##(1993-3#1)(2008-10#2)(2010-8#1)
to catalepsy##4##2##(2008-4#1)(2010-12#1)(2013-1#2)
to catalyse the formation of##2##5##(1990-7#1)(1997-2#1)
to catalyse the reaction##2##4##(1997-6#1)(2006-10#1)
to catalyse the##6##3##(1990-7#1)(1997-2#1)(1997-6#1)(2005-7#1)(2006-10#1)(2008-5#1)
to catalyse##7##2##(1990-7#1)(1997-2#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-2#1)(2008-5#1)
to catalysis##5##2##(1991-4#1)(1995-1#1)(1995-10#2)(1995-6#1)
to catalyst##2##2##(2009-2#1)(2010-6#1)
to catalytic##4##2##(1992-3#1)(1992-6#1)(1996-5#1)(2008-10#1)
to catalyze the formation of##2##5##(1990-2#1)(2008-1#1)
to catalyze the oxidation of##2##5##(1990-12#1)(1991-3#1)
to catalyze the##19##3##(1990-11#2)(1990-12#1)(1990-2#1)(1991-3#1)(1994-9#1)(1995-5#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#2)(2009-12#1)(2009-6#1)(2010-5#1)(2012-2#1)(2013-8#1)
to catalyze their own##2##4##(1992-6#1)(1996-5#1)
to catalyze##35##2##(1990-11#2)(1990-12#3)(1990-2#1)(1990-4#1)(1990-8#1)(1991-3#1)(1992-6#1)(1994-12#1)(1994-9#1)(1995-5#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-7#1)(2005-11#2)(2006-10#1)(2006-3#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-10#2)(2009-12#1)(2009-6#1)(2010-5#2)(2012-12#1)(2012-2#1)(2013-8#1)
to catch up##2##3##(1995-1#1)(2007-3#1)
to catch##7##2##(1992-5#1)(1992-6#1)(1993-4#1)(1995-1#1)(1995-3#1)(2007-3#1)(2008-8#1)
to catechol##3##2##(2008-10#3)
to catecholamines##4##2##(1994-6#3)(2008-12#1)
to categorical##2##2##(2004-3#1)(2010-12#1)
to categorize the##5##3##(1993-9#1)(1996-12#1)(2005-5#1)(2008-11#1)(2013-8#1)
to categorize##15##2##(1993-12#1)(1993-9#1)(1995-2#1)(1996-12#1)(1997-1#1)(2005-5#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-5#1)(2010-4#1)(2012-3#1)(2013-8#1)
to cater to##2##3##(2007-8#1)(2010-8#1)
to cater##5##2##(2005-8#1)(2005-9#1)(2007-8#1)(2008-7#1)(2010-8#1)
to cathepsin##6##2##(1990-6#1)(1991-2#2)(1995-2#3)
to cation##3##2##(2008-10#1)(2008-8#2)
to cations##5##2##(1990-5#2)(2005-11#1)(2008-10#1)(2008-7#1)
to cattle##5##2##(1990-6#1)(1997-6#1)(1997-7#1)(2006-10#1)(2011-2#1)
to caudal##2##2##(2008-10#1)(2010-7#1)
to causal##3##2##(1997-3#1)(2009-10#1)(2010-8#1)
to cause a reduction##2##4##(1991-12#1)(2008-10#1)
to cause a significant##2##4##(2008-4#1)(2008-8#1)
to cause a variety of##2##5##(1993-9#1)(2007-7#1)
to cause a wide##2##4##(2006-9#1)(2011-1#1)
to cause a##30##3##(1991-12#1)(1991-5#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1997-4#1)(1997-6#2)(2006-5#1)(2006-9#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-2#2)(2008-4#2)(2008-8#2)(2009-12#1)(2011-1#1)(2012-12#1)(2013-8#1)
to cause adverse effects on reproduction and development in humans##3##10##(2005-7#2)(2006-12#1)
to cause adverse effects##4##4##(2005-7#2)(2006-12#1)(2008-11#1)
to cause an##8##3##(1992-8#1)(1995-12#1)(1995-5#1)(2006-8#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
to cause any##3##3##(1994-3#1)(2007-9#1)(2008-3#1)
to cause big-vein##2##3##(2008-10#2)
to cause cellular##2##3##(1991-1#1)(2012-1#1)
to cause chemical##2##3##(2012-2#2)
to cause disease in##2##4##(2011-1#1)(2013-8#1)
to cause disease##5##3##(2008-10#3)(2011-1#1)(2013-8#1)
to cause failure##2##3##(2008-10#1)(2013-1#1)
to cause less##2##3##(2006-10#1)(2008-3#1)
to cause many##4##3##(2007-11#1)(2007-7#1)(2008-2#1)(2009-6#1)
to cause oxidative##2##3##(2009-5#1)(2011-1#1)
to cause respiratory##2##3##(1997-2#1)(2004-4#1)
to cause serious##2##3##(2007-11#1)(2013-8#1)
to cause severe damage to##2##5##(2008-10#1)(2008-7#1)
to cause severe##5##3##(1991-12#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-8#1)
to cause significant##5##3##(1993-4#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-10#1)
to cause some of the##2##5##(2008-10#1)(2008-8#1)
to cause some##4##3##(1991-11#1)(2006-8#1)(2008-10#1)(2008-8#1)
to cause such##3##3##(1990-11#1)(1996-3#1)(2007-7#1)
to cause symptoms##3##3##(2008-10#1)(2013-1#2)
to cause the##11##3##(1993-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-6#1)(2004-1#1)(2007-11#1)(2008-10#1)(2008-12#1)(2010-10#1)
to cause various##2##3##(2008-4#1)(2013-8#1)
to cause##262##2##(1990-11#1)(1990-5#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-5#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-10#2)(1994-3#6)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#5)(1997-7#1)(2004-1#1)(2004-4#1)(2004-9#2)(2005-11#1)(2005-4#1)(2005-7#3)(2006-10#10)(2006-12#2)(2006-2#2)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-2#1)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#34)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#4)(2009-10#2)(2009-12#1)(2009-3#1)(2009-5#4)(2009-6#3)(2010-10#3)(2010-12#3)(2010-7#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#5)(2012-1#4)(2012-11#2)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#6)(2013-8#5)
to causes##5##2##(1995-6#1)(2004-7#1)(2007-9#1)(2012-2#2)
to causing##2##2##(2008-12#1)(2010-12#1)
to cavity##3##2##(1991-2#1)(2008-3#2)
to cease the##2##3##(2007-11#1)(2008-10#1)
to cease##6##2##(1991-11#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-10#1)
to cefazolin##2##2##(2011-2#2)
to cefotaxime##2##2##(1990-6#1)(2007-7#1)
to cefoxitin##2##2##(2006-8#1)(2008-12#1)
to ceftazidime and##2##3##(1991-3#1)(2007-7#1)
to celebrate##3##2##(2007-2#2)(2008-10#1)
to cell adhesion##2##3##(2007-8#1)(2012-12#1)
to cell biology##2##3##(2007-6#1)(2008-11#1)
to cell contact##2##3##(2009-8#1)(2011-1#1)
to cell culture##2##3##(2008-11#2)
to cell cultures##5##3##(1991-12#1)(1997-6#1)(2008-5#3)
to cell cycle progression##2##4##(1991-4#1)(1993-9#1)
to cell cycle##6##3##(1990-11#2)(1991-4#1)(1993-9#1)(2010-10#1)(2011-2#1)
to cell damage##3##3##(1997-8#1)(2008-7#1)(2011-3#1)
to cell death and##2##4##(2008-11#1)(2010-1#1)
to cell death##23##3##(1990-7#1)(1991-9#1)(1992-6#1)(1994-5#1)(1995-10#1)(1997-6#1)(2005-7#1)(2006-12#1)(2006-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
to cell destruction##2##3##(2008-2#1)(2011-2#1)
to cell growth and##3##4##(1994-11#1)(2008-11#1)(2010-12#1)
to cell growth##8##3##(1991-10#1)(1993-8#1)(1994-11#1)(2008-11#1)(2008-4#1)(2008-6#1)(2010-12#1)(2011-1#1)
to cell membrane##2##3##(2008-8#1)(2012-2#1)
to cell membranes##3##3##(1991-12#1)(1996-10#1)(2008-12#1)
to cell proliferation and##2##4##(1991-2#1)(1992-11#1)
to cell proliferation##9##3##(1991-2#2)(1991-9#1)(1992-11#1)(1993-4#1)(1993-8#1)(2008-11#1)(2009-9#1)(2012-8#1)
to cell signaling##2##3##(2006-9#1)(2009-5#1)
to cell surface receptors##3##4##(1992-7#1)(1992-8#1)(2008-4#1)
to cell surface##10##3##(1992-7#1)(1992-8#2)(1994-9#1)(1995-11#1)(1995-2#1)(1996-2#1)(1997-7#1)(2008-4#1)(2008-9#1)
to cell survival##3##3##(1996-3#1)(1996-5#1)(2010-2#1)
to cell viability##3##3##(1992-11#1)(1994-11#1)(2010-1#1)
to cell##133##2##(1990-11#2)(1990-5#2)(1990-7#1)(1991-10#3)(1991-12#4)(1991-2#2)(1991-4#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-6#2)(1992-7#1)(1992-8#2)(1993-4#1)(1993-8#2)(1993-9#2)(1994-11#2)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-4#3)(1997-6#2)(1997-7#1)(1997-8#2)(2005-11#1)(2005-7#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-9#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#13)(2008-12#1)(2008-2#1)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#4)(2009-10#1)(2009-5#1)(2009-6#2)(2009-8#4)(2009-9#2)(2010-1#2)(2010-10#1)(2010-12#2)(2010-2#2)(2010-7#1)(2011-1#3)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#3)(2012-8#1)(2013-7#1)(2013-8#2)
to cell-associated##2##2##(1994-8#1)(2008-11#1)
to cell-cycle##4##2##(2008-11#2)(2009-5#1)(2013-8#1)
to cell-surface##2##2##(1990-12#1)(1994-11#1)
to cells and tissues##2##4##(1996-4#1)(2009-12#1)
to cells and##8##3##(1996-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-10#1)(2009-12#1)(2009-5#1)
to cells by##2##3##(1996-5#1)(2011-1#1)
to cells cultured in##4##4##(1992-8#2)(2008-11#1)(2008-5#1)
to cells from##6##3##(1992-9#1)(1993-9#1)(1995-12#1)(2008-4#1)(2012-11#2)
to cells grown in##2##4##(1992-3#1)(2012-12#1)
to cells in the##2##4##(1991-8#1)(2009-8#1)
to cells in vitro##2##4##(2008-11#1)(2008-5#1)
to cells in##5##3##(1991-8#1)(1992-6#1)(2008-11#1)(2008-5#1)(2009-8#1)
to cells of the##2##4##(1992-11#1)(1994-5#1)
to cells of##3##3##(1992-11#1)(1994-5#1)(2007-12#1)
to cells that##2##3##(1994-12#1)(2011-1#1)
to cells treated##3##3##(1992-3#1)(1996-12#1)(1997-2#1)
to cells with##3##3##(2008-9#1)(2012-3#1)(2013-7#1)
to cells##77##2##(1990-11#1)(1990-8#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#3)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#5)(2008-2#1)(2008-4#3)(2008-5#2)(2008-9#1)(2009-10#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-3#1)(2013-7#1)
to cellular components##2##3##(1991-4#1)(2008-8#1)
to cellular damage##2##3##(1994-5#1)(1997-7#1)
to cellular death##2##3##(1991-2#1)(2008-10#1)
to cellular iron##2##3##(2005-8#1)(2013-8#1)
to cellular pathways##2##3##(1995-8#1)(2008-7#1)
to cellular signal transduction##2##4##(2006-10#1)(2008-4#1)
to cellular stresses##2##3##(1996-2#2)
to cellular transformation##2##3##(1997-7#1)(2012-2#1)
to cellular##54##2##(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1993-12#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-5#2)(1995-4#1)(1995-5#1)(1995-7#1)(1995-8#2)(1996-11#1)(1996-2#3)(1997-7#2)(2005-8#1)(2006-10#1)(2006-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
to cellulose##9##2##(1991-2#2)(1997-4#1)(2006-8#4)(2008-10#2)
to cement dust##3##3##(2009-5#3)
to cement##4##2##(2009-5#3)(2013-1#1)
to center layer##2##3##(2013-8#2)
to center##5##2##(1996-6#1)(2005-11#1)(2007-12#1)(2013-8#2)
to central metabolism##2##3##(2013-8#2)
to central nervous system##3##4##(1991-9#1)(2008-4#1)(2012-2#1)
to central venous##3##3##(2006-6#1)(2007-7#1)(2013-8#1)
to central##23##2##(1991-9#1)(1993-4#1)(1994-11#2)(1994-6#1)(1995-5#1)(1996-5#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-6#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#3)
to centrally##2##2##(1995-7#1)(2011-1#1)
to centre##2##2##(2004-10#1)(2006-2#1)
to centrosome##2##2##(2008-8#1)(2008-9#1)
to cephalexin##2##2##(2007-7#2)
to cephalosporin##3##2##(2007-12#1)(2011-1#1)(2011-2#1)
to cephalosporins##3##2##(2006-10#1)(2011-2#2)
to cephalothin and##2##3##(2008-1#1)(2011-2#1)
to cephalothin##4##2##(2008-1#1)(2011-2#3)
to cereal gluten proteins##2##4##(2011-1#1)(2011-2#1)
to cereal##4##2##(2010-10#2)(2011-1#1)(2011-2#1)
to cerebellar##3##2##(1993-12#1)(1994-7#1)(2012-3#1)
to cerebellum##2##2##(1995-12#1)(1996-12#1)
to cerebral edema##2##3##(2006-10#1)(2008-8#1)
to cerebral infarction##3##3##(2004-12#1)(2008-7#1)(2012-12#1)
to cerebral##19##2##(1990-3#1)(1991-2#1)(1992-10#1)(1995-3#1)(1996-3#1)(2004-12#1)(2006-10#1)(2006-2#1)(2007-9#1)(2008-7#2)(2008-8#1)(2011-2#2)(2012-11#1)(2012-12#1)(2013-1#3)
to cerebrospinal fluid##2##3##(1994-8#1)(2007-9#1)
to certain of##2##3##(1991-7#1)(2008-3#1)
to certain other##2##3##(1990-5#1)(2008-5#1)
to certain stimuli##2##3##(2008-4#1)(2008-7#1)
to certain types of##2##4##(1994-9#1)(2009-8#1)
to certain##55##2##(1990-2#1)(1990-3#1)(1990-5#3)(1990-7#1)(1991-5#1)(1991-7#1)(1992-2#2)(1992-3#1)(1993-10#1)(1993-11#1)(1993-12#1)(1994-3#1)(1994-9#2)(1995-8#1)(1996-8#1)(2005-10#1)(2005-11#1)(2005-8#2)(2006-10#2)(2006-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-5#2)(2011-2#3)(2012-3#2)(2013-1#3)
to certification##3##2##(1991-3#1)(2005-5#1)(2012-2#1)
to certify the##2##3##(2008-11#1)(2013-1#1)
to certify##4##2##(1996-6#1)(2005-5#1)(2008-11#1)(2013-1#1)
to cervical cancer screening##4##4##(2007-4#1)(2007-8#2)(2011-9#1)
to cervical cancer##13##3##(2007-4#1)(2007-8#2)(2008-11#1)(2010-12#1)(2011-2#3)(2011-9#1)(2012-12#1)(2012-2#3)
to cervical##22##2##(1994-5#1)(2006-10#2)(2006-8#2)(2007-10#1)(2007-3#1)(2007-4#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#1)(2011-2#3)(2011-9#1)(2012-12#1)(2012-2#3)
to cetuximab##2##2##(2013-8#2)
to chain##5##2##(1991-2#1)(1994-5#1)(2008-3#2)(2012-3#1)
to challenge the##9##3##(1995-1#1)(1996-5#1)(1997-3#1)(2006-2#1)(2007-2#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-3#1)
to challenge with##5##3##(1993-9#1)(1995-8#1)(1997-3#1)(2006-8#1)(2008-10#1)
to challenge##30##2##(1990-11#1)(1991-3#1)(1993-12#1)(1993-9#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-3#2)(2005-11#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-7#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
to challenging##3##2##(2008-1#1)(2008-2#1)(2009-3#1)
to chance##3##2##(2005-10#1)(2008-9#1)(2009-11#1)
to change and##5##3##(1992-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
to change between##2##3##(1991-1#1)(2008-2#1)
to change from##2##3##(2010-6#1)(2011-2#1)
to change health behaviors##3##4##(2007-2#1)(2012-2#2)
to change health##4##3##(2007-2#2)(2012-2#2)
to change in a##3##4##(2006-7#1)(2007-4#1)(2009-4#1)
to change in the number of##2##6##(1991-1#1)(2008-10#1)
to change in the##3##4##(1990-4#1)(1991-1#1)(2008-10#1)
to change in##21##3##(1990-4#1)(1991-1#1)(1991-2#1)(2004-11#1)(2005-11#1)(2006-7#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-8#1)(2009-12#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
to change into##2##3##(2007-12#1)(2013-8#1)
to change its##2##3##(1991-7#1)(2008-11#1)
to change my##2##3##(1997-3#1)(2010-12#1)
to change of##2##3##(1994-6#1)(2005-10#1)
to change the name of##2##5##(2007-11#1)(2008-10#1)
to change the way the##2##5##(2006-10#1)(2008-11#1)
to change the way they##2##5##(1997-2#1)(2007-7#1)
to change the way##5##4##(1997-2#1)(2006-10#1)(2006-5#1)(2007-7#1)(2008-11#1)
to change the##46##3##(1990-7#1)(1990-9#1)(1991-1#3)(1991-4#1)(1993-11#1)(1993-8#1)(1994-1#1)(1994-11#1)(1996-2#1)(1997-2#1)(2005-12#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#3)(2008-8#3)(2009-9#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
to change their shape##2##4##(1997-6#1)(2007-12#1)
to change their##8##3##(1992-2#1)(1994-2#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-9#1)(2011-12#1)
to change to##4##3##(1991-6#1)(2006-8#1)(2008-10#1)(2011-2#1)
to change under##2##3##(1991-12#1)(1992-10#1)
to change##210##2##(1990-12#1)(1990-4#1)(1990-7#1)(1990-9#1)(1991-1#6)(1991-12#2)(1991-2#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-11#2)(1993-3#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-4#1)(1994-6#1)(1995-1#3)(1995-12#2)(1995-3#1)(1995-5#1)(1996-1#2)(1996-11#2)(1996-2#1)(1996-7#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-6#2)(1997-8#2)(2004-11#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#3)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#2)(2007-1#1)(2007-11#4)(2007-12#2)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#4)(2007-9#4)(2008-1#4)(2008-10#9)(2008-11#9)(2008-12#2)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#4)(2008-9#4)(2009-11#3)(2009-12#3)(2009-2#1)(2009-4#4)(2009-7#1)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#2)(2011-1#4)(2011-12#2)(2011-2#8)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#5)
to changed##3##2##(1995-5#1)(2011-12#1)(2011-2#1)
to changes at the##2##4##(1990-8#1)(1994-8#1)
to changes in blood##4##4##(1990-6#1)(1992-1#1)(2007-10#1)(2010-12#1)
to changes in cell##2##4##(1990-8#1)(2010-12#1)
to changes in disease##2##4##(2008-10#1)(2011-1#1)
to changes in environmental##4##4##(1991-11#1)(1992-12#1)(1995-11#1)(2008-6#1)
to changes in flow##2##4##(1991-9#1)(2008-9#1)
to changes in food##3##4##(2008-11#1)(2008-9#1)(2012-2#1)
to changes in gene expression##2##5##(1996-8#1)(2012-2#1)
to changes in its environment##2##5##(2008-7#1)(2013-8#1)
to changes in plasma##2##4##(1997-2#1)(2010-8#1)
to changes in temperature##5##4##(1990-8#1)(2007-12#1)(2008-12#1)(2008-3#1)(2009-2#1)
to changes in the rate of returning##2##7##(2008-8#2)
to changes in the rate##3##5##(2006-10#1)(2008-8#2)
to changes in the##44##4##(1991-11#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-6#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-6#1)(1997-4#1)(1997-7#1)(2006-10#3)(2006-12#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-10#4)(2008-2#3)(2008-3#2)(2008-8#2)(2009-10#1)(2009-12#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
to changes in their##3##4##(1994-11#1)(2006-8#1)(2010-3#1)
to changes in variables##2##4##(2008-10#2)
to changes in##143##3##(1990-6#1)(1990-8#3)(1991-10#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-6#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-10#2)(1995-11#2)(1995-12#1)(1995-3#1)(1995-6#1)(1995-7#2)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-8#2)(2007-10#2)(2007-12#5)(2007-3#1)(2007-8#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#3)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#3)(2012-7#1)(2013-1#6)(2013-8#2)
to changes occurring in##2##4##(2008-6#1)(2009-4#1)
to changes occurring##3##3##(2008-5#1)(2008-6#1)(2009-4#1)
to changes of the##4##4##(1991-9#1)(1997-6#1)(2006-6#2)
to changes of##10##3##(1990-8#1)(1991-9#1)(1992-11#1)(1993-9#2)(1994-12#1)(1997-6#1)(2006-6#2)(2008-10#1)
to changes##170##2##(1990-6#1)(1990-8#5)(1991-10#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-1#1)(1993-6#1)(1993-9#3)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-10#2)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#2)(2007-10#2)(2007-12#5)(2007-3#2)(2007-8#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#6)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#3)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#3)(2012-7#1)(2013-1#8)(2013-8#4)
to changing environmental conditions##2##4##(2006-12#1)(2008-9#1)
to changing environmental##3##3##(2006-12#1)(2007-12#1)(2008-9#1)
to changing environments##2##3##(2008-7#1)(2009-6#1)
to changing##23##2##(1991-1#1)(1992-2#1)(1995-1#1)(1997-3#1)(1997-6#1)(2006-12#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-6#2)(2010-3#1)(2011-12#1)(2012-1#1)(2012-2#1)(2012-3#1)(2012-5#1)
to channel##8##2##(1994-12#1)(1994-2#1)(1994-3#1)(2007-11#1)(2008-2#3)(2008-8#1)
to chaos##4##2##(1996-2#1)(2007-11#1)(2007-12#2)
to chaotic##4##2##(1995-10#1)(2006-2#1)(2007-12#1)(2008-9#1)
to characterise the##17##3##(1990-11#1)(1990-2#1)(1991-9#1)(1994-11#1)(1994-12#1)(1994-9#1)(1996-4#1)(1997-5#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-10#1)(2010-4#1)(2012-12#1)(2013-8#1)
to characterise##30##2##(1990-11#1)(1990-2#1)(1991-7#1)(1991-9#1)(1994-11#1)(1994-12#1)(1994-9#1)(1996-4#1)(1997-5#1)(2005-10#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-10#2)(2010-4#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
to characteristics of the##2##4##(2008-11#1)(2010-10#1)
to characteristics of##3##3##(2008-11#1)(2010-10#1)(2010-8#1)
to characteristics##4##2##(2008-11#1)(2008-8#1)(2010-10#1)(2010-8#1)
to characterization of##2##3##(1994-11#1)(2012-1#1)
to characterize a new##2##4##(1991-1#1)(1996-7#1)
to characterize a number of##2##5##(2008-2#1)(2010-12#1)
to characterize a region##2##4##(1992-12#1)(1997-6#1)
to characterize a##14##3##(1991-1#1)(1992-12#1)(1996-7#2)(1997-1#1)(1997-6#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-12#1)(2012-3#1)
to characterize and compare##3##4##(2008-11#1)(2012-3#1)(2013-1#1)
to characterize and improve##2##4##(1996-12#1)(2007-12#1)
to characterize and to##2##4##(1997-3#1)(2013-1#1)
to characterize and##14##3##(1991-1#1)(1996-12#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2012-3#1)(2013-1#2)
to characterize biological##2##3##(2008-10#1)(2008-7#1)
to characterize both##2##3##(2009-6#1)(2012-2#1)
to characterize cellular##3##3##(2008-7#1)(2010-11#1)(2010-9#1)
to characterize early##2##3##(2007-11#1)(2008-4#1)
to characterize exendin receptors on dispersed pancreatic acini and gastric chief cells from guinea pig##2##15##(1994-8#2)
to characterize gene##2##3##(1991-7#1)(2008-10#1)
to characterize isolates##2##3##(2008-10#1)(2008-5#1)
to characterize its##3##3##(1990-3#1)(1994-4#1)(2008-2#1)
to characterize pathogenic##2##3##(2008-10#2)
to characterize quantitatively the##2##4##(1994-8#1)(2011-2#1)
to characterize the association##2##4##(1996-8#1)(2008-10#1)
to characterize the bacterial##2##4##(2007-12#1)(2008-10#1)
to characterize the baseline##2##4##(2008-10#1)(2008-11#1)
to characterize the degree##2##4##(2005-11#1)(2010-7#1)
to characterize the effect of##2##5##(2008-10#1)(2008-2#1)
to characterize the effects of##6##5##(1990-7#1)(1994-2#1)(1995-11#1)(1995-7#1)(2007-7#1)(2008-10#1)
to characterize the functional##2##4##(1992-2#1)(1996-11#1)
to characterize the impact of##2##5##(2007-10#1)(2008-4#1)
to characterize the interaction between##2##5##(2007-1#1)(2009-6#1)
to characterize the nonlinear##2##4##(2007-11#1)(2007-12#1)
to characterize the performance of##4##5##(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)
to characterize the population##2##4##(2008-10#1)(2011-2#1)
to characterize the relative##2##4##(1993-9#1)(1995-12#1)
to characterize the role##2##4##(1994-12#1)(2008-1#1)
to characterize the stoichiometry##2##4##(1991-11#1)(2007-12#1)
to characterize the structure of the##2##6##(1990-2#1)(1997-4#1)
to characterize the structure##3##4##(1990-2#1)(1997-4#1)(2008-3#1)
to characterize the surface##2##4##(2004-9#1)(2008-3#1)
to characterize the##203##3##(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#3)(1991-10#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-2#2)(1992-3#2)(1992-8#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-7#1)(1996-1#2)(1996-11#1)(1996-2#2)(1996-3#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(2004-9#1)(2005-11#5)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#10)(2007-2#1)(2007-7#2)(2007-8#3)(2008-1#7)(2008-10#32)(2008-11#4)(2008-12#1)(2008-2#9)(2008-3#16)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#3)(2013-1#1)(2013-8#4)
to characterize their abilities as##2##5##(2008-10#2)
to characterize their##7##3##(2006-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-7#1)
to characterize these##5##3##(2007-5#1)(2008-10#1)(2008-7#1)(2009-9#1)(2011-2#1)
to characterize thin##2##3##(2006-12#2)
to characterize this##5##3##(1991-9#1)(2006-8#1)(2007-2#1)(2008-2#1)(2008-7#1)
to characterize ultrashort pulses##2##4##(2007-12#2)
to characterize ultrashort##3##3##(2007-11#1)(2007-12#2)
to characterize##415##2##(1990-10#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#3)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-9#2)(1992-12#1)(1992-2#2)(1992-3#3)(1992-7#2)(1992-8#2)(1993-1#1)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#4)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#2)(1995-7#1)(1996-1#2)(1996-11#3)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-7#2)(1996-8#3)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#2)(2004-11#1)(2004-9#2)(2005-11#5)(2006-1#1)(2006-10#1)(2006-11#4)(2006-12#3)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#3)(2007-10#2)(2007-11#6)(2007-12#20)(2007-2#3)(2007-5#1)(2007-7#3)(2007-8#3)(2008-1#12)(2008-10#61)(2008-11#11)(2008-12#3)(2008-2#16)(2008-3#25)(2008-4#14)(2008-5#10)(2008-6#2)(2008-7#13)(2008-8#1)(2008-9#5)(2009-10#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#3)(2010-11#3)(2010-12#2)(2010-2#4)(2010-4#4)(2010-5#1)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#3)(2011-11#1)(2011-2#10)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#3)(2013-1#6)(2013-7#2)(2013-8#5)
to characterizing##5##2##(1993-12#1)(2007-11#1)(2008-10#1)(2008-8#1)(2010-5#1)
to charge separation after direct excitation of##2##7##(1997-4#2)
to charge##12##2##(1990-5#1)(1991-11#1)(1997-4#2)(2005-12#1)(2006-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)
to charged##3##2##(2008-10#1)(2010-7#1)(2011-1#1)
to charges##3##2##(1992-2#1)(1996-11#1)(2006-7#1)
to chart a##2##3##(1995-3#1)(2009-10#1)
to chart the##3##3##(2010-12#1)(2011-1#1)(2012-11#1)
to chart##7##2##(1995-3#1)(2009-10#1)(2010-12#1)(2010-9#1)(2011-1#2)(2012-11#1)
to cheap##2##2##(2005-11#1)(2007-8#1)
to cheat##3##2##(2008-9#1)(2010-11#1)(2010-8#1)
to cheating##2##2##(1997-4#1)(2008-8#1)
to check by##2##3##(1997-3#1)(2008-6#1)
to check for the presence of##2##6##(2007-3#1)(2010-4#1)
to check for the##3##4##(2007-3#2)(2010-4#1)
to check for##6##3##(2007-3#2)(2008-4#1)(2009-4#1)(2010-4#1)(2011-2#1)
to check its##4##3##(1990-3#1)(1991-3#1)(2007-11#1)(2008-3#1)
to check our##2##3##(2008-11#1)(2012-2#1)
to check the procedures##2##4##(1991-2#1)(2010-8#1)
to check the validity of the##2##6##(2007-4#1)(2007-5#1)
to check the##35##3##(1991-2#1)(1991-9#1)(1993-11#1)(1994-10#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#2)
to check##74##2##(1990-3#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-5#1)(1993-11#1)(1993-6#1)(1994-10#1)(1995-8#2)(1997-3#2)(1997-4#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#9)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-7#1)(2013-1#2)(2013-8#1)
to checking##2##2##(1996-8#1)(2009-12#1)
to chemical analysis##3##3##(1990-4#1)(2007-11#1)(2008-10#1)
to chemical and##4##3##(1997-2#1)(2006-8#1)(2008-2#1)(2008-3#1)
to chemical or##2##3##(1990-9#1)(2008-10#1)
to chemical problems##2##3##(2008-10#1)(2010-12#1)
to chemical stimuli##2##3##(2005-10#1)(2011-12#1)
to chemical##46##2##(1990-12#1)(1990-4#1)(1990-9#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-3#1)(1997-2#2)(1997-8#1)(2005-10#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-12#3)(2010-7#1)(2010-8#1)(2011-12#2)(2011-2#1)(2013-1#1)
to chemically##10##2##(1993-3#1)(1995-11#1)(2004-9#1)(2006-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-5#1)(2010-8#1)
to chemicals##7##2##(1991-7#1)(1992-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2010-8#1)(2012-2#1)
to chemometric##3##2##(2008-10#2)(2012-12#1)
to chemotherapeutic agents##7##3##(1993-9#1)(1997-5#1)(1997-7#1)(2008-11#2)(2012-1#1)(2013-7#1)
to chemotherapeutic drugs##3##3##(1997-7#2)(2008-11#1)
to chemotherapeutic##10##2##(1993-9#1)(1997-5#1)(1997-7#3)(2008-11#3)(2012-1#1)(2013-7#1)
to chemotherapy and radiation##2##4##(2006-8#1)(2010-3#1)
to chemotherapy and##6##3##(2004-1#1)(2005-10#1)(2006-8#1)(2007-11#1)(2010-3#1)(2012-3#1)
to chemotherapy in##2##3##(2009-7#1)(2010-3#1)
to chemotherapy of##3##3##(2011-2#1)(2013-1#2)
to chemotherapy##53##2##(1990-12#1)(1990-8#1)(1991-4#2)(1991-5#1)(1992-10#2)(1992-6#1)(1994-2#1)(1997-7#1)(2004-1#2)(2004-2#1)(2005-10#1)(2006-11#1)(2006-6#1)(2006-8#2)(2007-11#2)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-3#1)(2009-7#1)(2010-3#6)(2011-1#4)(2011-2#3)(2012-1#1)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#1)
to chest pain##2##3##(2007-7#1)(2008-3#1)
to chest wall reconstruction##2##4##(2012-2#2)
to chest wall##3##3##(1991-4#1)(2012-2#2)
to chest##6##2##(1991-4#1)(2007-7#1)(2007-8#1)(2008-3#1)(2012-2#2)
to chick##4##2##(1991-1#1)(1994-9#1)(1996-4#1)(1997-2#1)
to chicken feed##2##3##(2008-12#1)(2011-12#1)
to chicken##11##2##(1991-12#1)(1991-3#2)(1993-6#1)(2007-12#2)(2008-12#1)(2008-5#3)(2011-12#1)
to chickens##3##2##(1997-6#1)(2008-5#1)(2011-12#1)
to child survival##2##3##(1997-4#1)(2009-4#1)
to child transmission##6##3##(2007-2#1)(2008-8#1)(2009-3#1)(2012-2#2)(2013-1#1)
to child##17##2##(1991-7#1)(1994-6#1)(1997-4#1)(2007-2#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-7#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)
to childbearing##2##2##(2007-2#2)
to childbirth education##2##3##(2007-2#2)
to childbirth educators##3##3##(2007-2#2)(2008-9#1)
to childbirth##7##2##(1995-1#1)(2007-2#5)(2008-9#1)
to childhood##8##2##(1997-4#1)(2006-4#1)(2008-12#2)(2008-9#1)(2012-2#1)(2013-7#2)
to children and adolescents##2##4##(2008-8#1)(2008-9#1)
to children and their families##2##5##(2005-11#1)(2008-11#1)
to children and their##3##4##(2005-11#1)(2008-11#2)
to children and young adults##2##5##(2007-8#1)(2010-3#1)
to children and##11##3##(2005-11#1)(2006-1#1)(2007-8#1)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-4#1)(2010-5#1)
to children for the purpose of##2##6##(1991-10#1)(2010-10#1)
to children for##3##3##(1991-10#1)(2010-10#1)(2011-12#1)
to children from##3##3##(2007-4#1)(2008-11#1)(2011-1#1)
to children in##5##3##(1991-6#1)(1994-6#1)(2004-10#1)(2010-2#1)(2012-3#1)
to children of##2##3##(2006-9#1)(2013-1#1)
to children under the age of 18##2##7##(1990-5#1)(2008-12#1)
to children under##3##3##(1990-5#1)(2008-12#1)(2013-1#1)
to children who##4##3##(1996-3#1)(2007-12#1)(2008-11#1)(2008-6#1)
to children with cancer##2##4##(1992-12#1)(2008-11#1)
to children with##9##3##(1991-3#1)(1992-12#1)(1995-8#1)(2005-11#1)(2008-11#1)(2008-5#1)(2010-2#1)(2010-7#1)(2011-2#1)
to children##71##2##(1990-5#1)(1991-10#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-8#1)(1996-3#1)(2004-10#1)(2005-11#2)(2005-8#1)(2006-1#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-11#6)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-10#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
to children's perceptions##4##3##(2008-12#3)(2009-4#1)
to children's##14##2##(2007-11#1)(2007-12#1)(2008-12#3)(2009-4#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-12#2)(2013-1#1)
to chiral##3##2##(1990-4#1)(1995-6#2)
to chiropractic##3##2##(2008-5#2)(2009-8#1)
to chirp##2##2##(2007-12#1)(2008-1#1)
to chitosan##2##2##(2010-3#1)(2013-7#1)
to chlJ of Escherichia coli##2##5##(1990-6#2)
to chloramphenicol and##2##3##(1993-1#1)(2010-4#1)
to chloramphenicol##9##2##(1990-6#1)(1993-1#1)(1994-12#1)(2007-7#1)(2008-1#1)(2008-12#1)(2010-4#1)(2011-2#2)
to chloride##2##2##(1990-8#1)(2008-10#1)
to chlorinated drinking water##4##4##(2009-6#4)
to chlorinated##5##2##(2007-8#1)(2009-6#4)
to chlorine##5##2##(1992-5#1)(2008-10#4)
to chloroform##2##2##(1996-11#1)(2008-10#1)
to chlorophyll##3##2##(1994-8#1)(2008-10#1)(2008-9#1)
to chloroplast##2##2##(1990-12#1)(2008-10#1)
to chloroplasts##2##2##(1995-2#1)(2008-1#1)
to chloroquine##8##2##(1992-6#1)(1993-8#1)(1994-12#1)(2006-11#1)(2006-2#2)(2006-4#1)(2010-12#1)
to chlorpyrifos##2##2##(1997-3#1)(2007-10#1)
to choice of##2##3##(1997-8#1)(2008-8#1)
to choice##6##2##(1995-3#1)(1997-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2013-1#1)
to cholecystectomy##2##2##(1993-3#1)(2008-3#1)
to cholecystokinin (CCK)##2##3##(1991-2#1)(1992-8#1)
to choledocholithiasis##2##2##(2006-10#1)(2009-9#1)
to cholera toxin B subunit (CTB)##2##6##(1990-4#1)(1997-4#1)
to cholera toxin##3##3##(1990-4#1)(1992-9#1)(1997-4#1)
to cholera##4##2##(1990-4#1)(1992-9#1)(1997-4#1)(1997-7#1)
to cholesterol and##4##3##(1992-9#1)(1996-8#1)(2007-8#1)(2008-8#1)
to cholesterol biosensor##2##3##(2007-9#1)(2008-10#1)
to cholesterol in##2##3##(1992-6#1)(1996-8#1)
to cholesterol oxidase##2##3##(1997-7#1)(2008-10#1)
to cholesterol translocation##2##3##(1990-12#1)(1995-12#1)
to cholesterol##22##2##(1990-12#1)(1991-2#1)(1992-6#1)(1992-9#1)(1994-8#2)(1995-12#1)(1996-5#1)(1996-7#1)(1996-8#3)(1997-2#1)(1997-7#1)(2005-8#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-6#1)(2008-8#1)
to cholinergic antagonists##2##3##(1993-11#1)(2008-7#1)
to cholinergic##9##2##(1990-2#1)(1992-8#1)(1993-11#1)(1993-4#1)(1993-9#1)(1997-8#1)(2007-7#1)(2008-11#1)(2008-7#1)
to chondrosarcoma##2##2##(2008-6#1)(2009-1#1)
to choose a##8##3##(1993-11#1)(2006-9#1)(2007-11#1)(2008-6#2)(2012-2#1)(2012-3#2)
to choose adequate##2##3##(1997-4#1)(2008-7#1)
to choose an appropriate##3##4##(2008-4#2)(2009-5#1)
to choose an##4##3##(2008-4#2)(2009-5#1)(2011-2#1)
to choose between hospitals in these##2##6##(2008-7#2)
to choose between##4##3##(1992-2#1)(2008-7#2)(2012-11#1)
to choose from##3##3##(1993-12#1)(2008-3#1)(2011-1#1)
to choose the appropriate##2##4##(2007-11#1)(2008-7#1)
to choose the##17##3##(1993-5#1)(1994-11#1)(2007-11#3)(2007-5#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#2)(2010-3#1)(2010-4#1)(2010-9#1)(2013-8#1)
to choose their##2##3##(1994-12#1)(2006-7#1)
to choose to##2##3##(1995-9#1)(2012-1#1)
to choose##70##2##(1990-12#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-9#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-12#1)(2005-4#1)(2006-10#1)(2006-7#2)(2006-9#1)(2007-10#1)(2007-11#5)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-6#4)(2008-7#7)(2009-11#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#3)(2013-8#2)
to choosing##2##2##(1995-5#1)(2013-7#1)
to chose##3##2##(2005-3#1)(2006-10#1)(2007-12#1)
to chromaffin##2##2##(1992-8#1)(2007-10#1)
to chromatin##5##2##(1990-7#1)(1992-4#1)(2008-2#1)(2012-12#2)
to chromatographic##8##2##(1991-8#2)(2008-10#4)(2011-1#2)
to chromatography##2##2##(1992-6#1)(2007-11#1)
to chromium (VI)##3##3##(1996-12#1)(2008-10#2)
to chromium##5##2##(1996-12#1)(2008-10#3)(2009-10#1)
to chromium(VI) by##2##3##(2008-10#2)
to chromosomal##4##2##(1990-9#1)(2007-8#1)(2008-8#2)
to chromosome 1 and##2##4##(1991-2#1)(2005-10#1)
to chromosome 16p12##2##3##(1994-11#1)(2007-7#1)
to chromosome 17##4##3##(1993-7#1)(1995-5#1)(2007-7#1)(2008-7#1)
to chromosome 1q21##2##3##(1996-8#1)(2007-7#1)
to chromosome 2##2##3##(2008-8#1)(2011-1#1)
to chromosome 5##2##3##(1991-4#1)(1997-4#1)
to chromosome 6##2##3##(1992-3#1)(2006-10#1)
to chromosome 9##2##3##(1997-2#1)(2007-11#1)
to chromosome VI and##2##4##(1990-5#1)(1996-7#1)
to chromosome band##3##3##(1994-12#1)(1994-8#1)(1997-7#1)
to chromosome breakage##2##3##(2012-3#2)
to chromosome##54##2##(1990-5#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-5#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-6#2)(1996-3#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#3)(2005-10#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-7#4)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2011-1#1)(2012-11#1)(2012-3#3)
to chromosomes 3##2##3##(2008-10#2)
to chromosomes##8##2##(1993-11#1)(1993-12#1)(1996-12#1)(1997-5#1)(2008-10#2)(2008-5#1)(2012-11#1)
to chronic alcoholism##2##3##(1995-1#1)(1996-2#1)
to chronic bronchitis##3##3##(1991-4#1)(2006-10#2)
to chronic daily##2##3##(1994-2#2)
to chronic disease##3##3##(1997-2#1)(2006-2#1)(2010-2#1)
to chronic eosinophilic##2##3##(2008-1#1)(2010-12#1)
to chronic exposure to##2##4##(1995-10#1)(2013-1#1)
to chronic hypoxia##2##3##(2010-4#2)
to chronic illness##2##3##(2008-3#1)(2012-1#1)
to chronic infection##4##3##(2007-8#2)(2008-10#1)(2008-11#1)
to chronic inflammation##4##3##(1997-8#1)(2008-5#1)(2009-8#1)(2012-12#1)
to chronic kidney disease##2##4##(2007-7#1)(2011-2#1)
to chronic kidney##3##3##(2007-7#1)(2011-2#2)
to chronic liver disease##2##4##(2007-11#1)(2011-2#1)
to chronic liver##3##3##(2007-11#1)(2007-8#1)(2011-2#1)
to chronic low back pain##2##5##(2006-8#2)
to chronic lymphocytic leukemia##2##4##(2009-10#2)
to chronic pain##4##3##(2005-11#1)(2008-5#1)(2010-8#1)(2013-1#1)
to chronic pulmonary diseases##2##4##(2006-8#1)(2007-11#1)
to chronic pulmonary##3##3##(2006-8#1)(2007-11#1)(2011-2#1)
to chronic renal failure##6##4##(1996-1#1)(2007-7#1)(2008-1#2)(2008-3#1)(2011-12#1)
to chronic stress##3##3##(1994-11#1)(1995-12#2)
to chronic##106##2##(1990-2#1)(1990-8#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-11#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-12#2)(1996-1#2)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#2)(2005-11#2)(2005-7#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-8#4)(2007-11#6)(2007-2#3)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-3#2)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#2)(2009-12#1)(2009-5#1)(2009-8#2)(2009-9#2)(2010-12#2)(2010-2#1)(2010-4#3)(2010-6#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#3)
to chronically##3##2##(1990-8#1)(1995-2#1)(2012-12#1)
to cigarette smoke##7##3##(1993-8#1)(2005-10#1)(2008-5#4)(2011-12#1)
to cigarette smoking##4##3##(1991-9#2)(2005-8#1)(2007-12#1)
to cigarette##11##2##(1991-9#2)(1993-8#1)(2005-10#1)(2005-8#1)(2007-12#1)(2008-5#4)(2011-12#1)
to ciprofloxacin##6##2##(2005-7#1)(2006-10#1)(2007-7#1)(2008-7#1)(2012-3#2)
to circadian rhythms##2##3##(1996-2#1)(2013-7#1)
to circadian##4##2##(1996-2#1)(2008-5#1)(2008-8#1)(2013-7#1)
to circular dichroism##3##3##(1993-11#1)(1995-2#1)(2008-10#1)
to circular##5##2##(1993-11#1)(1995-2#1)(2008-10#1)(2008-2#1)(2008-3#1)
to circulate##6##2##(1991-5#1)(1992-12#1)(1997-2#1)(2008-1#1)(2013-8#2)
to circulating##6##2##(1992-12#1)(1995-5#1)(1996-12#1)(2008-8#1)(2009-3#1)(2010-5#1)
to circumvent the##9##3##(1995-2#1)(2007-10#1)(2007-11#1)(2008-8#1)(2009-12#1)(2010-1#1)(2010-3#2)(2012-2#1)
to circumvent these problems##2##4##(2007-11#1)(2012-1#1)
to circumvent these##4##3##(1994-11#1)(2007-11#1)(2007-8#1)(2012-1#1)
to circumvent this problem##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
to circumvent this##5##3##(2007-12#1)(2008-10#2)(2008-2#1)(2012-2#1)
to circumvent##26##2##(1994-1#1)(1994-11#1)(1995-2#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-8#1)(2009-12#1)(2010-1#1)(2010-3#2)(2012-1#1)(2012-2#2)
to cirrhosis and##3##3##(2006-2#1)(2007-5#1)(2008-5#1)
to cirrhosis is##2##3##(2006-10#1)(2006-2#1)
to cirrhosis##12##2##(2005-10#1)(2006-10#2)(2006-2#2)(2007-5#1)(2008-5#2)(2009-8#1)(2010-12#1)(2011-1#2)
to cis##2##2##(2008-10#1)(2012-1#1)
to cisplatin and##3##3##(1993-1#1)(2005-11#1)(2008-4#1)
to cisplatin##19##2##(1991-7#1)(1992-2#1)(1993-1#1)(1993-9#1)(1994-8#1)(1995-5#2)(1996-11#5)(2005-11#1)(2008-4#1)(2008-5#2)(2008-9#2)(2012-2#1)
to cite##4##2##(2005-7#2)(2011-12#2)
to citizenship##2##2##(2008-9#1)(2010-4#1)
to citrate##3##2##(1991-7#1)(1995-9#1)(1996-8#1)
to citrulline##2##2##(1991-6#1)(2008-10#1)
to citrus##4##2##(2008-10#3)(2008-5#1)
to cladding modes##2##3##(2008-1#1)(2008-3#1)
to claim##2##2##(1990-11#1)(2008-12#1)
to claims##2##2##(1995-12#1)(2006-7#1)
to clarify its role##2##4##(2006-10#1)(2008-4#1)
to clarify its##4##3##(2006-10#1)(2008-10#1)(2008-2#1)(2008-4#1)
to clarify mechanisms##2##3##(1994-9#1)(2008-3#1)
to clarify some##4##3##(2006-6#1)(2007-12#1)(2008-12#1)(2009-2#1)
to clarify the definition##2##4##(1993-2#1)(2008-1#1)
to clarify the effect of##3##5##(2008-6#1)(2013-8#2)
to clarify the effects of##3##5##(2010-12#1)(2011-2#1)(2012-3#1)
to clarify the functional##2##4##(1992-3#1)(1994-9#1)
to clarify the influence of##2##5##(1993-7#1)(2011-12#1)
to clarify the mechanism by which##2##6##(1993-3#1)(2008-5#1)
to clarify the mechanism of##4##5##(1992-12#1)(2007-10#1)(2009-7#1)(2011-2#1)
to clarify the mechanism##8##4##(1992-12#1)(1993-3#1)(1995-1#1)(2007-10#1)(2007-9#1)(2008-5#1)(2009-7#1)(2011-2#1)
to clarify the mechanisms that##2##5##(2008-11#1)(2013-1#1)
to clarify the mechanisms##4##4##(1993-11#1)(2008-11#1)(2011-2#1)(2013-1#1)
to clarify the molecular##2##4##(1995-8#1)(2006-10#1)
to clarify the optimal##2##4##(2006-10#1)(2008-1#1)
to clarify the pathogenesis of##2##5##(1990-8#1)(2010-5#1)
to clarify the possible##2##4##(1997-8#1)(2008-7#1)
to clarify the relationship between##8##5##(1991-12#1)(1991-2#1)(1995-6#2)(1997-7#1)(2005-7#1)(2008-9#1)(2009-11#1)
to clarify the relationship##9##4##(1991-12#1)(1991-2#1)(1995-6#2)(1997-7#1)(2005-7#1)(2008-9#1)(2009-11#1)(2013-8#1)
to clarify the role of the##3##6##(1991-2#1)(2007-8#1)(2008-4#1)
to clarify the role of these##2##6##(1994-8#1)(2013-8#1)
to clarify the role of##9##5##(1991-12#1)(1991-2#1)(1994-6#1)(1994-8#1)(1996-6#1)(2007-8#1)(2008-10#1)(2008-4#1)(2013-8#1)
to clarify the role##10##4##(1991-12#1)(1991-2#1)(1994-6#1)(1994-8#1)(1996-6#1)(2007-8#1)(2008-10#1)(2008-4#1)(2011-2#1)(2013-8#1)
to clarify the roles of##2##5##(1990-5#1)(2012-3#1)
to clarify the situation##2##4##(2008-4#1)(2012-2#1)
to clarify the##115##3##(1990-5#1)(1990-8#1)(1991-12#2)(1991-2#2)(1991-7#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-2#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-6#2)(1995-8#2)(1996-11#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-11#3)(2005-10#2)(2005-11#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-12#3)(2011-2#5)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#8)
to clarify their##3##3##(1994-6#1)(2007-2#1)(2011-2#1)
to clarify this issue##2##4##(2007-10#1)(2008-9#1)
to clarify this##5##3##(2006-8#1)(2007-10#2)(2008-9#1)(2009-5#1)
to clarify those##2##3##(2008-10#1)(2009-4#1)
to clarify whether the##3##4##(1994-6#1)(2007-10#1)(2008-1#1)
to clarify whether##15##3##(1990-4#1)(1991-3#1)(1991-5#1)(1994-6#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-8#1)(2011-1#1)(2013-8#1)
to clarify which##4##3##(2006-10#1)(2007-8#1)(2011-2#1)(2013-8#1)
to clarify##175##2##(1990-12#1)(1990-4#2)(1990-5#1)(1990-8#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-6#4)(1994-8#1)(1994-9#3)(1995-1#2)(1995-11#1)(1995-6#2)(1995-8#2)(1996-11#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-11#3)(2005-10#2)(2005-11#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#2)(2007-10#5)(2007-11#2)(2007-12#2)(2007-2#2)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-1#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-5#2)(2010-8#1)(2011-1#3)(2011-12#3)(2011-2#8)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#10)
to clarithromycin and##2##3##(2006-6#1)(2012-12#1)
to clarithromycin##5##2##(2006-6#2)(2006-8#1)(2012-12#2)
to class I MHC proteins##2##5##(1997-4#1)(2006-12#1)
to class I MHC##3##4##(1997-4#2)(2006-12#1)
to class I##8##3##(1990-11#1)(1992-12#1)(1994-11#1)(1997-4#3)(2006-12#1)(2008-4#1)
to class II MHC##4##4##(1993-3#3)(1993-6#1)
to class II major histocompatibility complex##2##6##(1993-6#1)(1995-2#1)
to class II major histocompatibility##3##5##(1990-6#1)(1993-6#1)(1995-2#1)
to class II##7##3##(1990-6#1)(1993-3#3)(1993-6#2)(1995-2#1)
to class##19##2##(1990-11#1)(1990-6#1)(1992-12#1)(1993-3#3)(1993-6#2)(1994-11#1)(1995-2#1)(1997-4#3)(2006-12#1)(2007-8#1)(2008-1#2)(2008-4#1)(2013-7#1)
to classical neuroleptic treatment##2##4##(1996-2#2)
to classical##27##2##(1993-3#1)(1993-6#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-2#2)(1997-4#1)(2005-4#1)(2005-7#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-12#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-9#2)(2010-4#1)(2010-7#2)(2012-2#1)(2013-8#1)
to classification##6##2##(2007-8#2)(2008-10#2)(2010-12#1)(2011-1#1)
to classify a##3##3##(1993-12#1)(2008-10#1)(2012-2#1)
to classify and##4##3##(2007-11#1)(2008-10#1)(2009-8#1)(2013-7#1)
to classify compounds##2##3##(1993-4#1)(2008-10#1)
to classify patients into##2##4##(2006-5#1)(2007-8#1)
to classify patients##5##3##(1997-3#1)(2006-5#1)(2007-8#1)(2010-4#1)(2013-8#1)
to classify the##13##3##(2007-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
to classify their##3##3##(1991-12#1)(1995-2#1)(2008-5#1)
to classify them##2##3##(1990-8#1)(2008-3#1)
to classify these##3##3##(1994-6#1)(1996-9#1)(2008-10#1)
to classify##91##2##(1990-8#1)(1991-12#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-4#1)(1994-10#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-9#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-5#2)(2007-11#2)(2007-3#1)(2007-8#3)(2008-10#19)(2008-11#4)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#7)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2012-1#3)(2012-12#2)(2012-2#4)(2013-1#3)(2013-7#5)(2013-8#2)
to clean the##4##3##(2006-10#1)(2006-2#1)(2007-8#1)(2012-3#1)
to clean up and##2##4##(1996-5#1)(2008-2#1)
to clean up the##2##4##(1991-5#1)(2009-10#1)
to clean up##5##3##(1991-5#1)(1996-5#1)(2008-10#1)(2008-2#1)(2009-10#1)
to clean##18##2##(1991-5#1)(1993-2#1)(1996-5#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-6#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-8#1)
to clear the##5##3##(2006-10#2)(2008-10#1)(2012-2#1)(2013-1#1)
to clear##13##2##(1991-8#1)(1996-12#1)(2005-11#1)(2006-10#2)(2006-2#1)(2008-10#1)(2010-5#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
to clearance of infection##2##4##(2006-10#1)(2012-12#1)
to clearance of##3##3##(2006-10#1)(2008-8#1)(2012-12#1)
to clearance##4##2##(2005-8#1)(2006-10#1)(2008-8#1)(2012-12#1)
to clearly define the##2##4##(1992-11#1)(2011-1#1)
to clearly define##4##3##(1992-11#1)(2006-8#1)(2008-7#1)(2011-1#1)
to clearly show##2##3##(1994-6#1)(2012-3#1)
to clearly##10##2##(1992-11#1)(1994-6#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#2)(2011-1#1)(2012-3#1)
to cleavage by##3##3##(1990-11#1)(1993-12#1)(1993-3#1)
to cleavage##9##2##(1990-11#1)(1990-12#1)(1991-10#1)(1991-2#1)(1993-12#1)(1993-3#1)(1995-1#1)(1996-7#1)(2008-4#1)
to cleave DNA##3##3##(1992-7#1)(2008-4#1)(2008-5#1)
to cleave a##3##3##(1991-12#1)(1992-7#1)(1995-8#1)
to cleave supercoiled##2##3##(1994-5#2)
to cleave the##7##3##(1991-10#1)(1991-9#1)(1994-3#1)(1994-5#1)(2006-12#1)(2008-5#1)(2008-8#1)
to cleave##30##2##(1990-3#2)(1991-10#1)(1991-12#1)(1991-9#1)(1992-7#2)(1993-6#1)(1994-3#1)(1994-5#4)(1995-8#1)(1996-5#2)(1996-9#1)(1997-4#2)(2006-12#2)(2006-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#2)(2010-5#1)
to cleft##2##2##(2012-2#1)(2013-8#1)
to clients##6##2##(1991-10#1)(1996-3#1)(2006-12#1)(2007-7#2)(2010-5#1)
to clients'##2##2##(1995-12#1)(2010-3#1)
to climate and##2##3##(2007-7#1)(2008-8#1)
to climate change##9##3##(2007-9#1)(2008-8#4)(2008-9#1)(2009-12#1)(2012-12#1)(2012-7#1)
to climate##14##2##(2007-7#1)(2007-9#1)(2008-8#5)(2008-9#1)(2009-12#1)(2012-12#2)(2012-7#2)(2012-9#1)
to climatic##6##2##(1992-3#1)(2006-7#1)(2008-8#3)(2011-12#1)
to clindamycin in##2##3##(2008-11#2)
to clindamycin##7##2##(2006-8#4)(2008-11#3)
to clinic##2##2##(2004-12#1)(2010-10#1)
to clinical and laboratory##3##4##(2006-8#1)(2007-2#1)(2011-1#1)
to clinical and##8##3##(1991-9#1)(1994-1#1)(2006-8#1)(2007-2#1)(2008-1#1)(2008-6#1)(2009-10#1)(2011-1#1)
to clinical application##9##3##(1991-9#1)(2005-7#1)(2005-8#1)(2006-12#1)(2007-8#1)(2009-4#1)(2010-5#1)(2012-7#1)(2013-8#1)
to clinical applications##3##3##(2008-11#1)(2008-2#1)(2009-8#1)
to clinical benefits##2##3##(2006-10#1)(2010-5#1)
to clinical care##2##3##(2007-5#1)(2010-7#1)
to clinical change and##2##4##(1996-8#1)(2006-2#1)
to clinical data##2##3##(2008-5#1)(2011-2#1)
to clinical evaluation##2##3##(1990-2#1)(2008-5#1)
to clinical examination and##3##4##(1991-2#1)(2007-7#1)(2008-3#1)
to clinical examination##4##3##(1991-2#1)(2005-1#1)(2007-7#1)(2008-3#1)
to clinical factors##2##3##(2007-10#1)(2007-11#1)
to clinical features##3##3##(1991-4#1)(1996-8#1)(2007-7#1)
to clinical findings##2##3##(2008-8#1)(2009-7#1)
to clinical improvement##2##3##(1995-9#1)(2008-3#1)
to clinical information##3##3##(1993-3#1)(2007-10#1)(2008-11#1)
to clinical interview##2##3##(2007-11#1)(2011-2#1)
to clinical investigators##2##3##(1993-11#1)(1997-8#1)
to clinical laboratories##2##3##(2008-10#1)(2008-7#1)
to clinical management##2##3##(2007-9#1)(2011-1#1)
to clinical manifestations##2##3##(2005-8#1)(2010-9#1)
to clinical outcome##2##3##(1990-8#1)(2009-4#1)
to clinical outcomes##3##3##(1992-12#1)(2011-2#1)(2012-12#1)
to clinical practice as##2##4##(1992-7#1)(2010-4#1)
to clinical practice in##2##4##(1993-3#1)(2006-12#1)
to clinical practice is##2##4##(2007-3#1)(2008-1#1)
to clinical practice##38##3##(1992-7#1)(1993-3#2)(1994-5#1)(1996-3#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-6#1)(2009-3#1)(2009-4#1)(2010-10#9)(2010-11#3)(2010-4#1)(2012-1#2)(2012-12#1)(2013-1#2)
to clinical practice]##2##3##(1996-9#1)(2012-11#1)
to clinical presentation##3##3##(2007-6#1)(2008-1#1)(2012-2#1)
to clinical response##2##3##(1991-6#1)(2013-8#1)
to clinical status##2##3##(1997-8#1)(2012-2#1)
to clinical studies##3##3##(2006-10#1)(2008-5#1)(2012-12#1)
to clinical testing##2##3##(1991-12#1)(2013-8#1)
to clinical transplantation##2##3##(2006-10#1)(2010-7#1)
to clinical trial##2##3##(2004-3#1)(2012-3#1)
to clinical trials of##2##4##(2005-7#1)(2010-11#1)
to clinical trials##15##3##(1992-12#1)(1994-5#1)(1997-3#1)(2005-11#1)(2005-7#1)(2006-10#1)(2008-11#1)(2008-4#1)(2008-8#2)(2009-12#1)(2010-11#1)(2011-12#1)(2012-3#1)(2013-1#1)
to clinical use##3##3##(2007-8#1)(2013-1#2)
to clinical##211##2##(1990-2#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#2)(1992-12#3)(1992-7#1)(1993-11#2)(1993-12#1)(1993-3#4)(1993-6#1)(1993-8#1)(1994-1#1)(1994-5#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#2)(1996-1#2)(1996-3#1)(1996-8#3)(1996-9#1)(1997-3#1)(1997-6#1)(1997-8#2)(2004-12#1)(2004-3#1)(2005-1#1)(2005-10#2)(2005-11#2)(2005-7#3)(2005-8#3)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#3)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#3)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#6)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#4)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#10)(2010-11#7)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#3)(2012-11#2)(2012-12#6)(2012-2#3)(2012-3#2)(2012-7#1)(2012-8#1)(2013-1#10)(2013-7#1)(2013-8#3)
to clinically significant##3##3##(2008-4#1)(2010-7#2)
to clinically##16##2##(1992-1#1)(1997-1#1)(2005-11#1)(2006-11#1)(2007-4#2)(2008-3#1)(2008-4#3)(2008-7#1)(2009-12#1)(2010-7#2)(2011-1#1)(2012-3#1)
to clinicians and patients##2##4##(1991-9#1)(2009-8#1)
to clinicians and researchers##3##4##(2005-10#1)(2013-1#2)
to clinicians and##9##3##(1991-9#1)(1992-7#1)(1996-7#1)(2005-10#1)(2005-8#1)(2007-2#1)(2009-8#1)(2013-1#2)
to clinicians in##2##3##(1997-1#1)(2011-12#1)
to clinicians##37##2##(1991-9#1)(1992-7#1)(1993-9#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-3#2)(2005-10#1)(2005-8#1)(2006-12#3)(2007-11#1)(2007-2#1)(2008-11#1)(2008-3#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#8)
to clinics##2##2##(2011-12#1)(2012-12#1)
to clonal deletion##2##3##(1991-12#2)
to clonal##3##2##(1991-12#2)(1995-2#1)
to clone a##3##3##(1990-11#1)(1993-3#1)(1997-8#1)
to clone and sequence##2##4##(1993-2#1)(2008-4#1)
to clone and##5##3##(1991-12#1)(1991-9#1)(1993-2#1)(1997-2#1)(2008-4#1)
to clone full-length##2##3##(1995-3#1)(2013-8#1)
to clone the##4##3##(1994-5#1)(1994-9#1)(2006-8#1)(2008-10#1)
to clone##22##2##(1990-11#1)(1990-9#1)(1991-12#1)(1991-9#2)(1992-4#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-5#1)(1994-9#1)(1995-3#1)(1997-2#2)(1997-7#1)(1997-8#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-4#2)(2013-8#1)
to cloning##2##2##(2008-10#1)(2008-8#1)
to clopidogrel##3##2##(2008-3#1)(2008-4#2)
to close the gap between##2##5##(2007-9#1)(2010-12#1)
to close the##13##3##(1992-3#1)(1993-12#1)(1996-3#1)(2007-8#2)(2007-9#1)(2008-11#2)(2009-11#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-12#1)
to close##27##2##(1991-10#1)(1992-3#2)(1993-12#1)(1994-9#1)(1995-1#1)(1995-5#1)(1996-3#1)(1997-7#1)(2006-10#1)(2007-8#2)(2007-9#1)(2008-11#4)(2008-5#1)(2009-11#2)(2010-10#1)(2010-12#2)(2011-1#1)(2011-12#1)(2012-2#1)(2012-8#1)
to close?##2##2##(2008-11#1)(2009-4#1)
to closely##8##2##(1991-1#1)(1993-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2010-4#1)
to closer##2##2##(2007-9#2)
to closing##2##2##(2007-8#1)(2008-7#1)
to closure##3##2##(2008-11#1)(2012-12#2)
to clot##3##2##(1990-12#1)(1992-8#1)(2004-11#1)
to clotrimazole##3##2##(2007-7#1)(2008-5#2)
to clozapine##7##2##(1995-12#1)(1995-3#1)(1995-9#2)(1996-10#1)(2005-8#1)(2008-9#1)
to cluster the##3##3##(2008-7#1)(2008-8#1)(2011-1#1)
to cluster##14##2##(1990-9#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
to clustered##2##2##(1993-11#1)(2009-9#1)
to clustering##3##2##(1993-10#1)(2008-5#1)(2008-7#1)
to clusters##5##2##(1995-4#1)(1997-7#1)(2006-8#2)(2008-3#1)
to co-precipitate##2##2##(1995-3#1)(2008-5#1)
to co-trimoxazole##2##2##(1990-6#1)(2007-7#1)
to coagulase-negative##2##2##(1991-3#1)(2010-12#1)
to coalesce##2##2##(1990-3#1)(1993-5#1)
to coarse##2##2##(2004-9#1)(2008-5#1)
to coastal##2##2##(2007-5#1)(2008-10#1)
to coat the##3##3##(1990-12#1)(2008-10#2)
to coat##8##2##(1990-12#1)(2005-11#2)(2007-2#1)(2008-10#3)(2008-5#1)
to coating##4##2##(1994-9#1)(2004-9#1)(2006-2#1)(2010-12#1)
to coax##4##2##(1997-3#1)(2006-10#1)(2007-9#1)(2008-10#1)
to cobalt containing dust##2##4##(1994-6#2)
to cobalt containing##3##3##(1994-6#3)
to cobalt in the##2##4##(1994-6#2)
to cobalt in##4##3##(1994-6#4)
to cobalt##35##2##(1994-6#33)(2008-10#1)(2008-3#1)
to cocaine and##2##3##(1996-10#1)(2010-11#1)
to cocaine in its environment##2##5##(1996-10#2)
to cocaine in##3##3##(1996-10#3)
to cocaine use##2##3##(1991-1#1)(2004-3#1)
to cocaine was##2##3##(1991-2#1)(1996-10#1)
to cocaine##30##2##(1990-7#1)(1991-1#3)(1991-2#1)(1991-5#1)(1995-10#3)(1995-12#1)(1996-1#1)(1996-10#11)(1996-12#1)(2004-3#1)(2008-11#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-2#2)
to cocaine-induced##2##2##(1996-10#1)(2010-3#1)
to cochlear implant##2##3##(2008-9#2)
to cochlear##7##2##(2008-9#6)(2012-2#1)
to code for a##4##4##(1990-3#1)(1995-2#1)(2006-12#1)(2008-10#1)
to code for##9##3##(1990-3#2)(1993-6#2)(1994-9#1)(1995-2#1)(2006-12#2)(2008-10#1)
to code the##3##3##(2007-11#1)(2008-3#2)
to code##17##2##(1990-3#3)(1992-11#1)(1993-6#2)(1994-9#1)(1995-2#1)(2006-12#2)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#2)(2012-12#1)
to codeine##2##2##(1994-10#1)(1996-3#1)
to coenzyme Q##2##3##(1992-11#1)(1995-6#1)
to coercion##2##2##(2006-5#1)(2009-4#1)
to coercive measures##2##3##(1991-5#1)(2009-6#1)
to coevolve##2##2##(2008-8#1)(2010-12#1)
to coexist in a##2##4##(1991-4#1)(1995-5#1)
to coexist with##2##3##(1993-3#1)(2006-4#1)
to coexist##9##2##(1991-4#1)(1993-3#1)(1995-5#2)(2006-4#1)(2008-8#3)(2008-9#1)
to coexistence##3##2##(2008-8#3)
to coexisting##2##2##(2007-12#1)(2008-5#1)
to coffee production in Africa##2##5##(2008-10#2)
to coffee##5##2##(1993-9#1)(2006-10#1)(2008-10#2)(2008-5#1)
to cognate##4##2##(1991-12#1)(1991-2#1)(1996-2#1)(2012-2#1)
to cognitive and motor##2##4##(2008-11#1)(2010-12#1)
to cognitive and##4##3##(2008-11#1)(2008-5#1)(2009-4#1)(2010-12#1)
to cognitive impairment##4##3##(1991-11#1)(1996-9#1)(2006-10#2)
to cognitive science##2##3##(2008-10#1)(2008-5#1)
to cognitive##21##2##(1991-11#1)(1992-12#1)(1996-9#1)(2006-10#2)(2006-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#3)(2009-10#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
to cohere##2##2##(1991-7#2)
to coherence##4##2##(1991-7#1)(2006-5#1)(2008-3#1)(2009-2#1)
to coherent##6##2##(1997-7#1)(2007-11#2)(2007-12#2)(2008-2#1)
to coiled-coil stability##2##3##(1993-3#2)
to coincide in##2##3##(1993-4#1)(2009-10#1)
to coincide with a##2##4##(2007-11#1)(2008-11#1)
to coincide with the##3##4##(1993-11#1)(2005-11#1)(2012-12#1)
to coincide with##8##3##(1993-11#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-11#2)(2010-6#1)(2012-12#1)
to coincide##10##2##(1993-11#1)(1993-4#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-11#2)(2009-10#1)(2010-6#1)(2012-12#1)
to colchicine and##2##3##(1994-11#1)(1995-6#1)
to colchicine##4##2##(1992-9#1)(1994-11#2)(1995-6#1)
to cold shock##2##3##(2006-5#1)(2008-7#1)
to cold stress##3##3##(1997-7#2)(2011-12#1)
to cold temperatures##2##3##(2006-10#1)(2011-2#1)
to cold##28##2##(1990-5#1)(1991-2#2)(1991-8#1)(1994-11#1)(1994-9#1)(1997-7#2)(2005-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-3#1)(2007-7#2)(2008-3#1)(2008-7#1)(2009-8#1)(2011-12#1)(2011-2#5)(2013-1#2)(2013-8#1)
to collaborate more##2##3##(2008-6#1)(2010-8#1)
to collaborate with the##4##4##(1993-3#1)(2007-4#1)(2008-11#1)(2013-1#1)
to collaborate with##7##3##(1991-10#1)(1993-3#1)(2007-4#1)(2008-11#1)(2008-6#1)(2011-1#1)(2013-1#1)
to collaborate##18##2##(1991-10#1)(1993-3#1)(1995-3#1)(2007-4#1)(2007-5#1)(2008-11#1)(2008-6#2)(2010-8#1)(2011-1#4)(2012-12#2)(2013-1#3)
to collaborative##5##2##(1993-12#1)(1994-3#1)(2008-10#1)(2008-12#1)(2011-2#1)
to collagen and##3##3##(1991-3#1)(1996-5#1)(2008-11#1)
to collagen fibrils##2##3##(1992-11#1)(2007-9#1)
to collagen type##3##3##(1990-11#1)(2009-3#1)(2012-11#1)
to collagen##23##2##(1990-11#1)(1990-12#5)(1991-3#1)(1992-11#1)(1994-10#2)(1996-2#3)(1996-5#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-8#4)(2009-3#1)(2012-11#1)
to collagen-coated##2##2##(2008-11#2)
to collagenase IV##3##3##(2008-8#3)
to collagenous##2##2##(1993-7#1)(2008-11#1)
to collapse of the##3##4##(2008-11#1)(2008-8#1)(2009-3#1)
to collapse##11##2##(1992-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2009-12#1)(2009-3#1)(2012-12#1)(2012-3#1)
to collapsing##2##2##(2008-3#1)(2012-3#1)
to collate and##2##3##(2008-7#1)(2013-7#1)
to collate##4##2##(1993-12#1)(2008-7#1)(2008-8#1)(2013-7#1)
to collect REL data##2##4##(2013-1#2)
to collect a##3##3##(2007-12#1)(2008-4#2)
to collect and analyze data##2##5##(1997-3#1)(2006-2#1)
to collect and analyze##4##4##(1997-1#1)(1997-3#1)(2006-2#1)(2011-2#1)
to collect and store##2##4##(2007-11#1)(2010-8#1)
to collect and##11##3##(1990-12#1)(1997-1#1)(1997-3#1)(2006-2#1)(2007-11#1)(2008-10#1)(2009-2#1)(2010-8#2)(2010-9#1)(2011-2#1)
to collect data about##2##4##(2007-11#1)(2011-2#1)
to collect data and##2##4##(2007-4#1)(2012-2#1)
to collect data from##5##4##(1994-2#1)(2006-2#1)(2008-11#1)(2012-12#1)(2013-1#1)
to collect data on##5##4##(1992-11#1)(2007-11#1)(2008-3#1)(2008-7#1)(2013-8#1)
to collect data##24##3##(1992-11#1)(1992-2#1)(1994-2#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-4#1)(2008-11#2)(2008-3#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
to collect information on the##3##5##(1996-2#1)(2007-1#1)(2008-2#1)
to collect information on##4##4##(1996-2#1)(2007-1#1)(2008-2#1)(2011-2#1)
to collect information##7##3##(1996-2#1)(2007-1#2)(2008-11#1)(2008-2#1)(2011-2#1)(2012-3#1)
to collect outcome information##2##4##(1995-3#1)(2008-6#1)
to collect preliminary data##3##4##(2008-10#1)(2008-8#1)(2010-3#1)
to collect qualitative data##2##4##(2008-11#1)(2010-7#1)
to collect standardized##2##3##(1993-2#1)(2013-1#1)
to collect the##10##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-5#1)(2011-12#1)(2012-12#1)(2013-8#1)
to collect##122##2##(1990-12#1)(1992-11#2)(1992-2#1)(1993-2#1)(1994-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-5#1)(2004-11#1)(2006-2#2)(2006-4#1)(2006-5#1)(2007-1#3)(2007-10#2)(2007-11#4)(2007-12#2)(2007-2#2)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#10)(2008-11#8)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#2)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-12#2)(2011-2#5)(2012-11#1)(2012-12#8)(2012-2#1)(2012-3#3)(2013-1#10)(2013-7#1)(2013-8#2)
to collectively##2##2##(2008-1#1)(2012-12#1)
to collimate##2##2##(2008-2#1)(2008-3#1)
to collisions##2##2##(2007-12#1)(2010-1#1)
to colloidal##3##2##(2008-10#1)(2008-7#1)(2009-12#1)
to colon##5##2##(1992-8#1)(1993-8#1)(1994-12#1)(2008-10#1)(2010-11#1)
to colonic##2##2##(2011-1#1)(2012-3#1)
to colonies##2##2##(1990-7#1)(2008-10#1)
to colonization and##2##3##(2008-10#2)
to colonization by##3##3##(2008-10#2)(2008-5#1)
to colonization##10##2##(1996-6#1)(2007-6#1)(2008-10#7)(2008-5#1)
to colonize the intestine##3##4##(2005-9#1)(2007-6#1)(2011-1#1)
to colonize the##8##3##(2005-9#1)(2007-6#2)(2008-10#3)(2011-1#2)
to colonize##14##2##(1991-11#1)(2005-9#2)(2007-6#2)(2008-10#5)(2008-8#2)(2011-1#2)
to colonoscopy##3##2##(1995-10#1)(2011-2#2)
to colony##3##2##(1990-12#1)(1995-10#1)(2008-6#1)
to color images##2##3##(2008-2#2)
to color##7##2##(1997-1#2)(2008-10#1)(2008-2#3)(2008-4#1)
to colorectal cancer##5##3##(1995-3#1)(1995-9#1)(2006-10#1)(2008-10#1)(2012-1#1)
to colorectal distension##2##3##(2008-4#2)
to colorectal##13##2##(1995-3#1)(1995-9#1)(2006-10#2)(2008-10#1)(2008-4#2)(2009-12#2)(2010-11#1)(2010-2#2)(2012-1#1)
to colored##2##2##(2007-11#1)(2013-1#1)
to colorimetric##3##2##(1992-9#1)(2005-12#1)(2007-12#1)
to colour##2##2##(2008-10#1)(2010-4#1)
to colposcopy##3##2##(2006-10#1)(2007-12#1)(2011-1#1)
to combat AIDS##2##3##(1990-11#1)(1991-2#1)
to combat fraud##2##3##(1991-12#1)(2006-8#1)
to combat infections##2##3##(2008-7#1)(2011-1#1)
to combat such##2##3##(2006-9#1)(2009-6#1)
to combat the disease##4##4##(1994-10#1)(1997-2#1)(2008-3#1)(2008-5#1)
to combat the problem of##2##5##(2007-11#1)(2010-9#1)
to combat the spread of##2##5##(2007-7#1)(2008-10#1)
to combat the##16##3##(1994-10#1)(1996-11#1)(1997-2#1)(2005-7#1)(2005-8#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-9#1)(2011-1#1)(2013-8#1)
to combat this disease##2##4##(2008-1#1)(2012-2#1)
to combat##64##2##(1990-11#1)(1991-12#1)(1991-2#1)(1993-11#1)(1993-7#1)(1994-10#2)(1994-2#1)(1994-3#1)(1996-1#1)(1996-11#1)(1997-2#1)(2005-10#1)(2005-7#2)(2005-8#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-8#2)(2006-9#2)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#3)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#4)(2008-7#2)(2008-8#1)(2009-6#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#6)(2013-1#1)(2013-8#2)
to combination chemotherapy with##2##4##(1994-3#1)(1997-7#1)
to combination chemotherapy##3##3##(1994-3#1)(1997-7#1)(2008-7#1)
to combination##10##2##(1994-3#1)(1997-7#1)(2005-8#1)(2006-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-3#1)
to combinations of##2##3##(1991-11#1)(2007-11#1)
to combine a##2##3##(1995-5#1)(2009-12#1)
to combine in##2##3##(1996-7#1)(2007-11#1)
to combine information##2##3##(2008-2#1)(2012-3#1)
to combine results from##2##4##(1996-3#1)(1997-8#1)
to combine the advantages of##2##5##(2007-5#1)(2013-1#1)
to combine the results##2##4##(2008-2#2)
to combine the##17##3##(1995-5#1)(2004-9#1)(2006-5#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-2#2)(2008-7#1)(2010-12#2)(2011-1#1)(2011-2#1)(2013-1#2)
to combine them##2##3##(1993-11#1)(2008-2#1)
to combine these approaches##2##4##(2008-7#1)(2008-8#1)
to combine these two##3##4##(2006-3#1)(2007-12#1)(2009-12#1)
to combine these##8##3##(2006-3#1)(2007-12#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-9#1)(2013-1#2)
to combine this##2##3##(2012-3#1)(2013-1#1)
to combine with##3##3##(1997-1#1)(2010-10#1)(2012-12#1)
to combine##70##2##(1991-11#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-2#1)(1995-5#2)(1996-3#1)(1996-6#2)(1996-7#1)(1997-1#1)(1997-4#1)(1997-8#1)(2004-9#1)(2005-9#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#5)(2008-7#5)(2008-8#1)(2009-12#2)(2009-5#1)(2009-9#2)(2010-10#1)(2010-12#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-3#2)(2013-1#8)
to combined treatment##2##3##(1992-10#1)(2013-1#1)
to combined##5##2##(1992-10#1)(2006-2#1)(2009-4#1)(2013-1#2)
to combustion toxicology##2##3##(1996-12#2)
to combustion##4##2##(1996-12#2)(2008-2#1)(2008-3#1)
to come from the##2##4##(1990-12#1)(2008-10#1)
to come from##8##3##(1990-12#1)(1995-2#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2009-7#1)(2010-7#1)
to come in##2##3##(1995-11#1)(2008-3#1)
to come to grips with##2##5##(1995-2#1)(2006-7#1)
to come to the clinic for##2##6##(1995-9#1)(1996-12#1)
to come to the##3##4##(1995-9#1)(1996-12#1)(2012-2#1)
to come to##11##3##(1993-5#1)(1995-2#1)(1995-9#1)(1996-12#2)(2006-7#1)(2008-12#1)(2011-2#1)(2012-2#1)(2012-3#2)
to come together##2##3##(1996-12#1)(2010-11#1)
to come up with a##2##5##(2008-8#1)(2009-6#1)
to come up with##4##4##(2004-4#1)(2005-5#1)(2008-8#1)(2009-6#1)
to come##57##2##(1990-11#1)(1990-12#2)(1991-8#1)(1993-2#1)(1993-5#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-9#1)(1996-11#1)(1996-12#3)(1996-3#2)(1996-6#1)(1997-1#1)(1997-8#1)(2004-4#1)(2005-5#1)(2006-10#4)(2006-2#1)(2006-7#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)
to commence a##3##3##(1994-9#1)(2008-5#2)
to commence##5##2##(1992-9#1)(1994-9#1)(2005-6#1)(2008-5#2)
to comment alcoholaemia##2##3##(2011-2#2)
to comment on the##2##4##(1991-2#1)(2009-10#1)
to comment on##7##3##(1991-2#1)(2007-11#2)(2007-12#1)(2008-1#1)(2009-10#1)(2012-3#1)
to comment##14##2##(1991-2#1)(2005-8#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#2)(2009-10#1)(2011-2#2)(2012-3#1)
to comments##3##2##(1990-12#1)(2007-11#2)
to commercial##19##2##(1990-6#1)(1996-2#1)(1996-3#2)(2005-12#1)(2008-10#10)(2010-1#1)(2010-2#1)(2010-3#1)(2011-1#1)
to commercialize##2##2##(2008-5#1)(2008-7#1)
to commercially available##6##3##(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2012-2#1)
to commercially##7##2##(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-2#1)
to commit suicide##2##3##(2005-8#1)(2010-9#1)
to commit##12##2##(1996-12#1)(1996-5#1)(1996-9#1)(2005-10#1)(2005-8#1)(2007-7#1)(2008-10#2)(2010-9#1)(2012-12#3)
to common bean (Phaseolus vulgaris L##2##6##(2008-12#2)
to common bean (Phaseolus##3##4##(2008-10#1)(2008-12#2)
to common bean##4##3##(2008-10#2)(2008-12#2)
to common clinical##2##3##(2007-10#1)(2011-12#1)
to common##49##2##(1990-5#1)(1991-4#1)(1992-1#1)(1992-9#1)(1993-11#2)(1994-12#1)(1994-2#1)(1996-1#1)(1997-7#1)(1997-8#1)(2004-2#1)(2006-10#3)(2007-10#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#1)
to commonly used##11##3##(1990-3#1)(1994-5#1)(1996-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-3#2)
to commonly##14##2##(1990-3#1)(1994-5#1)(1996-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-12#1)(2011-2#2)(2012-3#2)
to communicate the##3##3##(2009-4#1)(2013-1#2)
to communicate with##6##3##(2008-10#1)(2009-1#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)
to communicate##34##2##(1992-2#1)(1993-2#1)(1994-3#1)(1995-1#1)(1997-5#2)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-1#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
to communication and##4##3##(2008-10#1)(2011-1#2)(2013-1#1)
to communication between##2##3##(2007-1#1)(2012-1#1)
to communication##9##2##(2006-1#1)(2007-1#1)(2007-3#1)(2008-10#1)(2010-8#1)(2011-1#2)(2012-1#1)(2013-1#1)
to community resources##2##3##(2008-11#1)(2008-2#1)
to community##24##2##(1994-1#3)(1994-3#1)(1995-2#2)(1995-3#1)(1996-12#1)(1996-3#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2009-12#1)(2009-4#1)(2010-8#1)(2012-2#2)(2013-1#2)
to community-based##4##2##(1993-12#1)(2005-12#1)(2009-4#1)(2010-3#1)
to comorbid##3##2##(2004-3#1)(2013-1#1)(2013-8#1)
to comparable##8##2##(1990-8#1)(1994-8#1)(1995-3#1)(1997-2#1)(2008-4#1)(2008-8#1)(2010-2#1)(2012-2#1)
to comparative##5##2##(2006-2#1)(2007-5#1)(2008-10#2)(2008-7#1)
to comparatively##4##2##(1997-8#1)(2008-9#1)(2011-1#1)(2012-2#1)
to compare 2##2##3##(2004-9#1)(2013-1#1)
to compare a##4##3##(2008-5#1)(2008-9#1)(2013-1#2)
to compare and contrast the##3##5##(2007-1#1)(2008-9#1)(2012-2#1)
to compare and contrast##5##4##(2007-1#1)(2008-9#1)(2012-1#1)(2012-2#1)(2012-3#1)
to compare and##8##3##(2007-1#1)(2008-10#2)(2008-9#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
to compare both##3##3##(1994-5#1)(2007-8#1)(2010-8#1)
to compare characteristics##2##3##(2006-7#1)(2008-5#1)
to compare clinical##4##3##(1997-8#1)(2008-12#1)(2011-2#1)(2012-12#1)
to compare data##3##3##(2008-10#1)(2013-7#1)(2013-8#1)
to compare demographic##2##3##(2007-1#1)(2011-2#1)
to compare differences in##3##4##(2007-9#1)(2008-12#1)(2011-2#1)
to compare differences##4##3##(1995-2#1)(2007-9#1)(2008-12#1)(2011-2#1)
to compare different##5##3##(1996-12#1)(1996-5#1)(1997-2#1)(2008-3#1)(2013-1#1)
to compare efficacy and safety of##2##6##(1990-9#1)(2004-1#1)
to compare efficacy##3##3##(1990-9#1)(2004-1#1)(2008-3#1)
to compare groups##2##3##(2006-10#1)(2007-2#1)
to compare it with##9##4##(1990-7#1)(2006-10#1)(2007-10#1)(2010-12#1)(2010-5#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-8#1)
to compare its##9##3##(1997-5#1)(2004-11#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-3#2)(2013-1#1)(2013-8#1)
to compare our results with those##2##6##(2007-7#1)(2008-7#1)
to compare our##4##3##(1994-3#2)(2007-7#1)(2008-7#1)
to compare performance of##2##4##(2008-10#1)(2009-5#1)
to compare pregnancy##2##3##(2006-5#1)(2007-3#1)
to compare rates##2##3##(2006-8#1)(2013-1#1)
to compare relative##2##3##(2008-10#1)(2011-2#1)
to compare responses##2##3##(2008-2#1)(2012-2#1)
to compare six##2##3##(2008-12#1)(2012-2#1)
to compare the ability of##4##5##(1996-10#1)(2007-7#1)(2007-9#1)(2013-8#1)
to compare the accuracy of the##2##6##(2012-2#1)(2013-1#1)
to compare the accuracy of##4##5##(2007-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
to compare the cytological##2##4##(2008-10#1)(2013-8#1)
to compare the data##2##4##(1994-3#1)(2008-10#1)
to compare the development##2##4##(2007-7#1)(2013-1#1)
to compare the diagnostic##3##4##(2007-9#1)(2008-5#1)(2013-1#1)
to compare the different##2##4##(2008-7#1)(2009-11#1)
to compare the distribution of##2##5##(1995-5#1)(2008-7#1)
to compare the distribution##3##4##(1992-11#1)(1995-5#1)(2008-7#1)
to compare the effect of##6##5##(1990-7#1)(1991-8#1)(2007-7#1)(2007-9#1)(2008-1#1)(2010-8#1)
to compare the effect##7##4##(1990-7#1)(1991-8#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#1)(2010-8#1)
to compare the effectiveness of##5##5##(1990-8#1)(1994-7#1)(1995-4#1)(2007-7#1)(2008-10#1)
to compare the effectiveness##6##4##(1990-8#1)(1994-7#1)(1995-4#1)(2007-7#1)(2008-10#1)(2013-8#1)
to compare the effects of two##2##6##(1994-12#1)(2008-11#1)
to compare the effects of##13##5##(1993-4#2)(1994-12#1)(1995-11#1)(2005-10#1)(2006-11#1)(2007-8#3)(2008-11#1)(2008-8#1)(2012-12#1)(2013-1#1)
to compare the effects##14##4##(1993-4#2)(1994-12#1)(1994-5#1)(1995-11#1)(2005-10#1)(2006-11#1)(2007-8#3)(2008-11#1)(2008-8#1)(2012-12#1)(2013-1#1)
to compare the efficacy and safety##2##6##(2007-7#1)(2007-8#1)
to compare the efficacy and##4##5##(2006-10#1)(2007-7#1)(2007-8#1)(2011-1#1)
to compare the efficacy of##12##5##(1991-9#1)(1993-4#1)(1997-2#1)(2007-9#1)(2008-3#1)(2010-7#2)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
to compare the efficacy##16##4##(1991-9#1)(1993-4#1)(1997-2#1)(2006-10#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-3#1)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
to compare the efficiency of the##3##6##(1997-8#1)(2008-5#1)(2011-2#1)
to compare the efficiency of##5##5##(1997-8#1)(2008-2#1)(2008-5#1)(2011-2#1)(2012-3#1)
to compare the genetic##4##4##(2008-10#2)(2012-1#1)(2013-1#1)
to compare the influence of##2##5##(2007-11#1)(2008-7#1)
to compare the influence##3##4##(2007-11#1)(2008-2#1)(2008-7#1)
to compare the intrinsic##2##4##(1995-4#1)(2008-3#1)
to compare the mean##3##4##(2006-11#1)(2008-1#1)(2011-2#1)
to compare the patterns of##2##5##(1996-8#1)(2011-1#1)
to compare the performance of the##2##6##(2008-2#2)
to compare the performance of##4##5##(2008-2#2)(2008-4#1)(2008-6#1)
to compare the performance##6##4##(2008-2#3)(2008-4#1)(2008-6#1)(2008-9#1)
to compare the pregnancy rates##2##5##(1991-12#1)(2011-1#1)
to compare the prevalence of##4##5##(2006-10#1)(2006-6#1)(2008-8#1)(2011-2#1)
to compare the quality of##7##5##(1993-12#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#2)
to compare the quantitative##2##4##(2011-2#1)(2013-7#1)
to compare the relative##2##4##(1995-2#1)(2008-3#1)
to compare the results obtained##3##5##(2007-7#1)(2008-10#1)(2013-1#1)
to compare the results of##4##5##(2006-10#1)(2007-7#1)(2007-8#1)(2008-12#1)
to compare the results with those##3##6##(2006-12#1)(2007-10#1)(2009-3#1)
to compare the results##13##4##(2006-10#1)(2006-12#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-3#1)(2012-12#1)(2013-1#1)
to compare the safety and efficacy of##4##7##(1996-3#1)(2007-10#2)(2013-8#1)
to compare the safety and##5##5##(1996-3#1)(2007-10#2)(2012-2#1)(2013-8#1)
to compare the sensitivity##4##4##(1992-5#1)(1997-3#1)(2007-3#1)(2008-3#1)
to compare the signal intensity##2##5##(1996-2#1)(2008-7#1)
to compare the survival##2##4##(1994-6#1)(2006-10#1)
to compare the temporal##4##4##(1996-7#1)(2006-6#1)(2007-10#1)(2010-5#1)
to compare the three##2##4##(2004-2#1)(2008-2#1)
to compare the use of##3##5##(2008-7#1)(2010-9#1)(2012-3#1)
to compare the##296##3##(1990-10#1)(1990-7#2)(1990-8#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-12#2)(1993-4#4)(1993-9#2)(1994-12#2)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#2)(1994-7#1)(1995-11#2)(1995-2#1)(1995-4#2)(1995-5#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-2#1)(1996-3#4)(1996-6#1)(1996-7#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-8#2)(2004-1#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#5)(2006-11#3)(2006-12#3)(2006-6#2)(2007-10#5)(2007-11#4)(2007-2#2)(2007-3#3)(2007-4#1)(2007-5#1)(2007-7#12)(2007-8#9)(2007-9#5)(2008-1#3)(2008-10#18)(2008-11#2)(2008-12#3)(2008-2#12)(2008-3#10)(2008-4#2)(2008-5#11)(2008-6#4)(2008-7#8)(2008-8#5)(2008-9#6)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#2)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#18)(2012-1#1)(2012-12#6)(2012-2#5)(2012-3#2)(2013-1#13)(2013-7#2)(2013-8#9)
to compare their##11##3##(1990-11#1)(1994-12#1)(2005-9#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-10#1)(2012-12#1)(2013-1#2)
to compare them##8##3##(1991-7#1)(1994-4#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-12#1)
to compare these##6##3##(1992-10#1)(1996-2#1)(2006-8#1)(2008-3#1)(2008-9#1)(2011-1#1)
to compare this##4##3##(2006-8#1)(2007-8#1)(2008-4#1)(2009-12#1)
to compare three##3##3##(1990-12#1)(2008-10#1)(2008-6#1)
to compare total##3##3##(1993-12#1)(2004-9#1)(2011-1#1)
to compare treatment##2##3##(2008-5#1)(2011-2#1)
to compare two different##2##4##(2008-5#1)(2013-1#1)
to compare two##9##3##(1994-12#1)(1997-6#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2012-1#1)(2013-1#2)
to compare with the##2##4##(2008-1#1)(2012-3#1)
to compare with##6##3##(2005-9#1)(2008-1#1)(2008-10#1)(2009-5#1)(2012-3#2)
to compare##582##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#3)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-7#1)(1993-1#1)(1993-12#5)(1993-2#1)(1993-4#4)(1993-5#1)(1993-7#1)(1993-9#2)(1994-12#4)(1994-2#3)(1994-3#6)(1994-4#1)(1994-5#5)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#2)(1995-11#2)(1995-2#2)(1995-4#2)(1995-5#3)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#2)(1996-2#2)(1996-3#7)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#4)(1997-6#1)(1997-8#5)(2004-1#3)(2004-11#1)(2004-2#1)(2004-9#3)(2005-10#2)(2005-11#1)(2005-12#1)(2005-8#2)(2005-9#2)(2006-10#9)(2006-11#5)(2006-12#4)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#6)(2007-1#3)(2007-10#8)(2007-11#8)(2007-2#4)(2007-3#4)(2007-4#1)(2007-5#1)(2007-7#19)(2007-8#17)(2007-9#7)(2008-1#5)(2008-10#38)(2008-11#4)(2008-12#8)(2008-2#18)(2008-3#18)(2008-4#6)(2008-5#23)(2008-6#5)(2008-7#11)(2008-8#11)(2008-9#14)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#4)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#6)(2010-9#4)(2011-1#11)(2011-12#2)(2011-2#31)(2012-1#5)(2012-12#12)(2012-2#11)(2012-3#11)(2013-1#32)(2013-7#4)(2013-8#16)
to comparing##5##2##(2004-4#1)(2008-11#2)(2008-4#2)
to comparison##3##2##(1991-12#1)(1996-7#1)(2012-12#1)
to compatibility##3##2##(1993-3#1)(2008-10#1)(2010-9#1)
to compatible##2##2##(2008-10#2)
to compensate completely for##2##4##(1990-8#1)(2007-12#1)
to compensate for loss of##2##5##(1993-5#1)(2008-2#1)
to compensate for seasonal##2##4##(2008-5#2)
to compensate for the##26##4##(1994-2#1)(1997-1#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-2#2)(2008-3#6)(2008-5#1)(2008-7#1)(2009-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
to compensate for##57##3##(1992-9#1)(1993-5#1)(1994-2#1)(1997-1#1)(2005-4#1)(2006-2#1)(2006-5#1)(2007-11#8)(2007-12#8)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#11)(2008-5#3)(2008-7#2)(2009-10#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)
to compensate the##6##3##(1997-7#1)(1997-8#1)(2005-11#1)(2008-10#2)(2008-7#1)
to compensate##79##2##(1990-8#1)(1992-9#1)(1993-5#1)(1994-2#1)(1996-11#1)(1997-1#2)(1997-7#1)(1997-8#1)(2005-11#1)(2005-4#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-11#8)(2007-12#9)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#4)(2008-3#14)(2008-5#3)(2008-7#3)(2009-10#1)(2009-11#1)(2009-12#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
to compensation##4##2##(1991-7#1)(1992-11#1)(1996-2#1)(2007-11#1)
to compensatory##2##2##(2008-11#1)(2008-5#1)
to compete for binding##2##4##(1997-6#1)(2008-4#1)
to compete for##11##3##(1992-6#1)(1993-8#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-6#1)(2007-4#1)(2008-4#1)(2008-8#1)(2010-8#2)
to compete on##2##3##(1997-1#1)(2008-5#1)
to compete successfully##2##3##(1993-12#1)(2006-10#1)
to compete with Gt alpha for binding to Gt beta gamma##2##11##(1994-9#2)
to compete with the##6##4##(1992-12#1)(1994-5#1)(1995-3#1)(1995-5#1)(2007-10#1)(2013-8#1)
to compete with##21##3##(1992-12#2)(1993-3#1)(1994-12#1)(1994-5#1)(1994-9#2)(1995-3#1)(1995-5#1)(1996-8#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
to compete##41##2##(1992-12#2)(1992-6#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#2)(1996-2#1)(1996-8#1)(1997-1#1)(1997-6#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-4#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2010-8#2)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
to competent##2##2##(2011-2#1)(2012-11#1)
to competition between the##2##4##(1993-8#1)(2007-12#1)
to competition between##4##3##(1993-8#1)(2007-11#1)(2007-12#1)(2008-8#1)
to competition for##2##3##(2008-5#1)(2008-8#1)
to competition##12##2##(1991-3#1)(1993-8#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#1)(2012-2#1)
to competitive inhibition##2##3##(1996-11#1)(2008-11#1)
to competitive##8##2##(1996-11#1)(2005-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-5#1)(2010-1#1)
to competitively inhibit##2##3##(1994-12#1)(1996-10#1)
to competitively##4##2##(1994-12#1)(1996-10#1)(2008-10#1)(2011-2#1)
to compile the##3##3##(2007-6#1)(2008-9#1)(2012-2#1)
to compile##9##2##(1990-3#1)(1996-12#1)(1996-2#1)(1997-4#1)(2007-6#1)(2008-3#1)(2008-9#1)(2012-2#1)(2013-1#1)
to complain##3##2##(1992-4#1)(1993-12#2)
to complement a##4##3##(1994-3#1)(1995-5#1)(1996-3#1)(1996-6#1)
to complement and enhance##2##4##(2005-10#1)(2008-7#1)
to complement and##3##3##(2005-10#1)(2006-12#1)(2008-7#1)
to complement the##13##3##(1990-9#1)(1992-10#1)(1993-12#1)(1994-12#1)(1995-8#1)(2008-10#3)(2008-8#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)
to complement this##2##3##(2007-11#1)(2008-7#1)
to complement##44##2##(1990-2#1)(1990-5#2)(1990-9#1)(1991-3#1)(1992-10#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-4#1)(1995-5#2)(1995-8#1)(1995-9#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-4#1)(2005-10#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-3#2)(2013-8#1)
to complementary##4##2##(2007-2#1)(2008-4#2)(2009-2#1)
to complementation group##2##3##(1995-6#1)(1997-1#1)
to complete a questionnaire in##2##5##(1992-12#1)(2008-7#1)
to complete a questionnaire##6##4##(1992-12#1)(2004-3#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-2#1)
to complete a##16##3##(1990-11#1)(1992-10#1)(1992-12#1)(1995-2#1)(1997-2#1)(2004-3#1)(2008-10#1)(2008-12#1)(2008-7#2)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-7#1)
to complete all the##2##4##(1990-4#1)(2008-5#1)
to complete and##2##3##(2007-8#1)(2010-2#1)
to complete healing##2##3##(2007-11#1)(2008-6#1)
to complete loss of##4##4##(1994-10#1)(1994-3#1)(1995-6#1)(1996-9#1)
to complete recovery##2##3##(2006-10#1)(2009-7#1)
to complete remission##2##3##(1991-7#1)(2011-2#1)
to complete the task##2##4##(1991-2#1)(2012-1#1)
to complete the treatment##2##4##(2008-10#1)(2008-6#1)
to complete the##32##3##(1991-2#1)(1993-2#1)(1995-2#1)(1996-1#1)(1997-3#1)(2005-10#1)(2005-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-2#1)(2010-8#2)(2011-1#2)(2012-1#1)(2012-3#2)(2013-1#2)
to complete##140##2##(1990-11#1)(1990-2#1)(1990-4#2)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#3)(1991-7#1)(1992-10#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#3)(1995-6#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#2)(1997-3#1)(2004-3#1)(2005-10#3)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#1)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#4)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#3)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-12#3)(2010-2#2)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#6)(2013-7#2)
to completely block##5##3##(1996-8#1)(2007-2#1)(2008-10#1)(2008-8#1)(2010-4#1)
to completely inhibit##2##3##(1991-2#1)(1991-6#1)
to completely prevent##3##3##(1994-6#1)(1997-3#1)(2006-11#1)
to completely recover from##2##4##(2006-10#1)(2008-2#1)
to completely reverse##2##3##(1991-9#1)(2008-7#1)
to completely##31##2##(1991-2#1)(1991-6#1)(1991-9#1)(1994-6#1)(1995-2#1)(1996-8#1)(1997-3#1)(2004-4#1)(2004-9#1)(2005-4#1)(2006-10#1)(2006-11#1)(2007-2#1)(2007-5#1)(2007-8#2)(2008-10#6)(2008-2#1)(2008-7#2)(2008-8#1)(2009-7#1)(2010-4#1)(2011-1#1)(2012-12#2)
to completion of the##4##4##(1991-6#1)(2008-6#1)(2010-3#1)(2012-11#1)
to completion of##8##3##(1991-6#1)(2007-8#1)(2008-6#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-11#1)
to completion##15##2##(1990-3#1)(1991-6#1)(1995-7#1)(1995-8#1)(2005-11#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)
to complex and##3##3##(2006-6#1)(2008-4#1)(2009-8#1)
to complex diseases##2##3##(2007-2#1)(2008-2#1)
to complex formation##2##3##(2008-10#1)(2010-4#1)
to complex systems##2##3##(1990-2#1)(1995-8#1)
to complex with##2##3##(1990-3#1)(1997-4#1)
to complex##39##2##(1990-11#1)(1990-2#1)(1990-3#1)(1992-12#2)(1992-6#1)(1995-11#1)(1995-8#1)(1996-6#1)(1996-7#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-11#4)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2009-10#1)(2009-8#1)(2010-12#2)(2010-4#1)(2012-2#1)(2012-3#1)
to complexes##3##2##(1990-2#1)(2008-10#1)(2008-5#1)
to compliance with##2##3##(2005-8#1)(2008-10#1)
to compliance##5##2##(2005-8#2)(2007-9#2)(2008-10#1)
to complicate##3##2##(2006-10#1)(2010-3#1)(2013-1#1)
to complications of##5##3##(2006-2#1)(2007-8#1)(2011-1#1)(2012-2#2)
to complications such as##3##4##(2006-9#1)(2009-5#1)(2012-2#1)
to complications##15##2##(1993-3#1)(2006-2#1)(2006-3#1)(2006-9#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#3)(2013-8#1)
to compliment##2##2##(2008-3#1)(2011-2#1)
to comply with a##2##4##(2008-10#1)(2008-11#1)
to comply with the##9##4##(1993-2#1)(1993-3#1)(1995-2#1)(1996-2#1)(2006-7#1)(2006-8#2)(2008-1#1)(2013-1#1)
to comply with##17##3##(1991-4#1)(1993-2#2)(1993-3#1)(1995-2#1)(1996-2#1)(1997-1#1)(2006-5#1)(2006-7#1)(2006-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2010-11#1)(2013-1#2)
to comply##21##2##(1991-4#1)(1993-2#2)(1993-3#1)(1995-2#1)(1996-2#1)(1997-1#1)(2006-5#1)(2006-7#1)(2006-8#3)(2006-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-11#1)(2010-3#1)(2013-1#2)
to component##4##2##(2008-4#2)(2011-1#1)(2012-3#1)
to components of the##2##4##(1994-5#1)(2008-7#1)
to components##3##2##(1993-6#1)(1994-5#1)(2008-7#1)
to compose##2##2##(2008-2#1)(2012-3#1)
to composing##2##2##(2008-2#1)(2008-8#1)
to composite##3##2##(2005-11#1)(2009-6#1)(2013-1#1)
to compound##5##2##(2006-12#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)
to compounds##2##2##(1993-4#1)(2008-10#1)
to comprehend the##6##3##(2008-12#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-10#1)(2011-2#1)
to comprehend##13##2##(1992-4#1)(1996-3#1)(2006-7#1)(2007-6#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-1#2)
to comprehensive##7##2##(1993-3#1)(1995-1#1)(1997-2#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-12#1)
to comprehensively assess##2##3##(2008-10#1)(2012-3#1)
to comprehensively##10##2##(2008-10#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2012-2#1)(2012-3#2)(2013-7#1)
to compress pulses##2##3##(2007-12#2)
to compress the##4##3##(2007-12#2)(2011-1#1)(2013-1#1)
to compress##9##2##(2007-12#5)(2007-4#1)(2008-10#1)(2011-1#1)(2013-1#1)
to compression of the##3##4##(1992-9#1)(2007-8#1)(2008-7#1)
to compression of##5##3##(1992-9#1)(2007-8#1)(2008-1#1)(2008-7#1)(2012-12#1)
to compression##10##2##(1992-9#1)(1993-12#1)(1993-3#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#2)(2012-1#1)(2012-12#1)
to comprise the##3##3##(1993-3#1)(2006-3#1)(2009-3#1)
to comprise##10##2##(1990-12#1)(1990-4#1)(1993-3#1)(1995-12#1)(1997-3#1)(2006-3#1)(2006-6#1)(2008-2#1)(2008-7#1)(2009-3#1)
to compromise the##2##3##(1996-12#1)(2010-9#1)
to compromise##6##2##(1990-5#1)(1996-12#1)(1997-5#1)(2005-8#1)(2009-5#1)(2010-9#1)
to compromised##2##2##(2008-1#1)(2008-4#1)
to computation##2##2##(2008-3#1)(2008-7#1)
to compute a##5##3##(2006-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-9#1)
to compute and##2##3##(2008-4#1)(2008-7#1)
to compute electrostatic##2##3##(2008-10#1)(2008-4#1)
to compute the field##2##4##(2008-2#2)
to compute the optimal##2##4##(2008-2#1)(2011-3#1)
to compute the scattering##2##4##(2008-2#2)
to compute the##38##3##(2005-11#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#12)(2008-3#8)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-2#2)(2010-3#1)(2010-5#1)(2011-3#1)(2012-1#1)
to compute##83##2##(1992-9#2)(2005-11#2)(2006-10#2)(2006-12#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-9#3)(2008-10#2)(2008-11#1)(2008-2#16)(2008-3#12)(2008-4#5)(2008-6#6)(2008-7#5)(2008-8#3)(2009-10#1)(2009-12#1)(2009-5#1)(2009-9#2)(2010-2#2)(2010-3#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#2)
to computed tomography##6##3##(1993-5#1)(2006-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2012-12#1)
to computer##3##2##(2004-9#1)(2008-11#1)(2009-9#1)
to computers##2##2##(1996-1#1)(2008-11#1)
to concanavalin A##3##3##(1990-11#1)(1990-2#1)(1992-9#1)
to concanavalin##4##2##(1990-11#1)(1990-2#1)(1992-9#1)(1993-6#1)
to conceal their##2##3##(1995-6#1)(2010-4#1)
to conceal##4##2##(1995-6#1)(1996-11#1)(1997-5#1)(2010-4#1)
to conceive and##2##3##(2008-11#1)(2012-3#1)
to conceive of##4##3##(1995-3#1)(2006-3#1)(2009-9#1)(2010-8#1)
to conceive##13##2##(1994-7#1)(1995-3#1)(1997-5#1)(2005-7#1)(2006-3#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-9#1)(2010-12#1)(2010-8#1)(2012-3#1)(2013-8#1)
to concentrate and separate##2##4##(2008-10#2)
to concentrate and##4##3##(2008-10#2)(2008-2#1)(2010-7#1)
to concentrate in the##2##4##(1990-12#1)(2011-2#1)
to concentrate the##3##3##(1995-2#1)(2007-12#1)(2008-11#1)
to concentrate##25##2##(1990-12#2)(1992-2#1)(1993-9#1)(1995-2#1)(1997-7#2)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-4#1)(2010-7#1)(2011-2#1)
to concentrated##2##2##(2005-10#1)(2008-10#1)
to concentration of##7##3##(1992-3#1)(2005-12#1)(2008-10#5)
to concentration##14##2##(1992-3#1)(2005-12#1)(2008-10#10)(2008-11#1)(2010-12#1)
to concentrations of the##2##4##(2008-10#1)(2008-5#1)
to concentrations of##7##3##(1991-12#1)(1994-6#1)(1996-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-3#1)
to concentrations##10##2##(1990-11#1)(1991-12#1)(1992-8#1)(1994-6#1)(1996-1#1)(2004-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-3#1)
to conception##3##2##(1994-8#1)(1995-2#1)(2006-8#1)
to concepts##8##2##(1996-2#1)(2008-9#1)(2013-1#6)
to concern for##3##3##(1992-4#1)(2013-1#2)
to concern##4##2##(1992-4#1)(2006-7#1)(2013-1#2)
to concerns about##4##3##(2011-1#1)(2012-1#1)(2012-11#1)(2013-1#1)
to concerns##6##2##(1996-3#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#1)
to conclude a##2##3##(2008-10#1)(2010-12#1)
to conclude that a##2##4##(1997-5#1)(2008-10#1)
to conclude that one##2##4##(1991-10#1)(1995-3#1)
to conclude that the##8##4##(1991-10#1)(1993-8#1)(1995-3#1)(1996-12#1)(2007-11#1)(2008-10#2)(2013-7#1)
to conclude that##41##3##(1990-6#1)(1990-9#1)(1991-10#2)(1991-2#1)(1991-3#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-3#2)(1996-12#1)(1997-2#1)(1997-5#1)(2005-7#1)(2006-6#1)(2007-11#2)(2007-5#1)(2008-10#7)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#2)(2013-7#2)
to conclude the##3##3##(1996-11#1)(2008-7#2)
to conclude whether##2##3##(2008-11#1)(2008-6#1)
to conclude##59##2##(1990-4#1)(1990-6#1)(1990-9#1)(1991-10#2)(1991-2#1)(1991-3#1)(1991-6#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-3#2)(1996-11#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-5#1)(2005-7#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-5#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-12#1)(2011-2#2)(2013-7#3)
to conclusions##2##2##(2009-9#1)(2012-1#1)
to conclusively document the##2##4##(2007-9#1)(2013-7#1)
to concomitant##7##2##(1992-3#1)(2006-12#1)(2006-9#1)(2007-8#2)(2008-5#1)(2012-2#1)
to concomitantly##2##2##(1993-6#1)(2008-11#1)
to concurrent##3##2##(2008-10#2)(2008-8#1)
to concurrently##4##2##(1993-9#1)(2008-9#1)(2012-12#1)(2012-2#1)
to condemn##3##2##(1993-5#1)(1994-2#1)(2005-10#1)
to condition##3##2##(2008-10#2)(2012-1#1)
to conditional##2##2##(2006-5#1)(2008-9#1)
to conditioned##3##2##(1991-5#2)(1992-12#1)
to conditioning##2##2##(1996-12#1)(2008-10#1)
to conditions of##2##3##(2006-1#1)(2009-10#1)
to conditions##6##2##(1991-12#1)(1997-2#1)(2006-1#1)(2006-8#1)(2008-5#1)(2009-10#1)
to condom breakage##2##3##(2012-3#2)
to condom use##2##3##(2006-7#1)(2012-3#1)
to condom##4##2##(2006-7#1)(2012-3#3)
to condoms##2##2##(1993-2#1)(2012-3#1)
to conduct a systematic review##2##5##(2008-10#1)(2013-8#1)
to conduct a systematic##3##4##(2008-10#1)(2008-2#1)(2013-8#1)
to conduct a##20##3##(1994-2#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-6#1)(2012-12#3)(2013-1#1)(2013-8#2)
to conduct an##5##3##(1996-12#1)(1997-8#1)(2007-11#1)(2008-4#1)(2009-6#1)
to conduct analyses##2##3##(1997-8#1)(2010-3#1)
to conduct further##2##3##(2007-6#1)(2008-3#1)
to conduct our##2##3##(2007-11#1)(2008-1#1)
to conduct research in##2##4##(2005-7#1)(2009-6#1)
to conduct research##5##3##(2005-7#1)(2007-10#1)(2008-1#1)(2009-6#1)(2010-10#1)
to conduct such##2##3##(1991-2#1)(2012-2#1)
to conduct the##5##3##(2007-7#1)(2007-8#1)(2008-9#1)(2010-3#1)(2013-8#1)
to conduct##95##2##(1990-3#1)(1991-2#1)(1992-10#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-3#1)(1997-6#1)(1997-8#2)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#1)(2007-10#1)(2007-11#4)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#3)(2008-9#1)(2009-1#1)(2009-3#1)(2009-6#3)(2010-10#1)(2010-12#1)(2010-3#3)(2010-5#3)(2011-1#2)(2011-2#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#8)(2013-8#3)
to conducting##6##2##(1990-10#1)(2008-1#1)(2008-10#2)(2009-11#1)(2009-12#1)
to conduction##3##2##(2006-9#1)(2008-8#1)(2011-2#1)
to confer a##3##3##(1993-11#1)(1995-5#1)(2008-10#1)
to confer both##3##3##(1994-12#1)(1997-4#1)(2012-11#1)
to confer in##2##3##(2006-12#1)(2011-2#1)
to confer increased virulence##2##4##(2013-8#2)
to confer increased##5##3##(1995-3#1)(2008-10#1)(2013-8#3)
to confer resistance against##2##4##(1996-4#1)(2008-10#1)
to confer resistance to##8##4##(1991-2#1)(1993-12#1)(1994-11#3)(2008-10#2)(2008-5#1)
to confer resistance##10##3##(1991-2#1)(1993-12#1)(1994-11#3)(1996-4#1)(2008-10#3)(2008-5#1)
to confer the##4##3##(1994-9#1)(2008-7#1)(2009-8#1)(2010-4#1)
to confer##70##2##(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#2)(1991-7#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-11#4)(1994-12#3)(1994-9#5)(1995-1#1)(1995-2#1)(1995-3#3)(1995-5#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-11#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-11#2)(2013-8#3)
to confidently##6##2##(1997-1#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-1#1)(2013-7#1)
to configure##5##2##(1994-6#1)(2007-1#1)(2008-3#1)(2009-11#1)(2013-1#1)
to confine the##2##3##(1991-11#1)(1991-4#1)
to confine##4##2##(1991-11#1)(1991-4#1)(1996-2#1)(2007-12#1)
to confirm a##4##3##(1995-12#1)(2006-10#1)(2012-12#1)(2013-8#1)
to confirm and extend##2##4##(1995-12#1)(2012-3#1)
to confirm and##5##3##(1995-12#1)(2008-10#1)(2010-12#1)(2010-4#1)(2012-3#1)
to confirm correct##2##3##(2006-10#1)(2008-7#1)
to confirm its##7##3##(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2011-2#1)(2012-3#1)
to confirm or exclude##4##4##(1990-2#1)(2008-1#1)(2008-3#1)(2010-12#1)
to confirm or rule out##3##5##(2007-10#1)(2008-1#1)(2012-12#1)
to confirm or##11##3##(1990-2#1)(1991-11#1)(1997-4#1)(1997-8#1)(2007-10#1)(2008-1#2)(2008-3#1)(2008-9#1)(2010-12#1)(2012-12#1)
to confirm our##2##3##(1992-2#1)(2011-2#1)
to confirm some##2##3##(2008-5#1)(2008-8#1)
to confirm that the##5##4##(2008-2#1)(2008-3#2)(2010-6#1)(2013-8#1)
to confirm that##15##3##(1992-3#1)(1997-3#1)(2004-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#2)(2010-6#1)(2013-1#2)(2013-7#1)(2013-8#1)
to confirm the clinical diagnosis##2##5##(1996-2#1)(2006-9#1)
to confirm the clinical##3##4##(1996-2#1)(2006-9#1)(2011-2#1)
to confirm the diagnosis of##6##5##(2006-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-8#1)
to confirm the diagnosis##26##4##(1990-9#1)(1994-6#1)(1996-8#1)(1996-9#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#2)
to confirm the efficacy of##2##5##(1991-7#1)(2013-8#1)
to confirm the efficacy##3##4##(1991-7#1)(2008-7#1)(2013-8#1)
to confirm the existence of##2##5##(1996-3#1)(2007-12#1)
to confirm the importance of##2##5##(2007-3#1)(2008-10#1)
to confirm the potential##2##4##(1991-7#1)(2008-11#1)
to confirm the presence of##9##5##(1990-6#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-7#1)
to confirm the presence##10##4##(1990-6#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-7#1)
to confirm the results##2##4##(2005-4#1)(2008-10#1)
to confirm the role of##2##5##(2006-6#1)(2009-4#1)
to confirm the stability of the##2##6##(1997-6#1)(2012-2#1)
to confirm the stability of##4##5##(1991-5#1)(1997-6#1)(2011-2#1)(2012-2#1)
to confirm the validity of##2##5##(1992-6#1)(2008-2#1)
to confirm the##113##3##(1990-5#1)(1990-6#2)(1990-9#1)(1991-12#1)(1991-5#1)(1991-7#2)(1992-12#1)(1992-6#1)(1994-2#1)(1994-6#1)(1994-7#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-5#1)(1997-6#2)(2005-11#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-6#1)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-2#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-4#2)(2010-8#2)(2011-1#1)(2011-2#5)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#5)
to confirm their##6##3##(1993-2#1)(1995-9#1)(2007-10#1)(2008-10#2)(2012-3#1)
to confirm these findings and to##2##6##(2006-4#1)(2011-2#1)
to confirm these findings##8##4##(1994-10#1)(1997-4#1)(2004-3#1)(2006-4#1)(2008-4#1)(2009-7#1)(2011-2#2)
to confirm these preliminary findings##2##5##(2004-2#1)(2008-10#1)
to confirm these preliminary##3##4##(2004-2#1)(2008-10#1)(2010-12#1)
to confirm these results##6##4##(2006-12#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-3#1)(2011-2#1)
to confirm these##22##3##(1994-10#1)(1997-4#1)(2004-1#1)(2004-2#1)(2004-3#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-8#3)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-7#1)(2010-12#1)(2011-2#4)
to confirm this hypothesis##4##4##(1991-1#1)(1991-11#1)(2008-10#1)(2008-12#1)
to confirm this##12##3##(1990-5#1)(1991-1#1)(1991-11#1)(2006-1#1)(2006-2#1)(2006-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2013-1#1)
to confirm whether the##2##4##(2008-10#2)
to confirm whether##3##3##(2008-10#3)
to confirm##244##2##(1990-2#1)(1990-5#2)(1990-6#2)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-5#1)(1991-7#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1993-2#1)(1994-10#1)(1994-2#1)(1994-6#1)(1994-7#1)(1995-12#2)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-8#2)(2004-1#1)(2004-12#1)(2004-2#1)(2004-3#1)(2005-11#1)(2005-4#1)(2006-1#1)(2006-10#3)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-10#5)(2007-11#5)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#2)(2007-8#12)(2008-1#4)(2008-10#29)(2008-11#4)(2008-12#2)(2008-2#6)(2008-3#6)(2008-4#9)(2008-5#7)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#12)(2012-1#1)(2012-12#9)(2012-2#5)(2012-3#4)(2013-1#8)(2013-7#2)(2013-8#7)
to confirming the##2##3##(2012-11#1)(2012-2#1)
to conflict##2##2##(1994-6#1)(2008-8#1)
to conflicting##3##2##(1997-1#1)(2011-2#1)(2013-8#1)
to confluent##2##2##(2010-6#1)(2013-1#1)
to confocal##2##2##(2008-1#1)(2011-1#1)
to conform to a##2##4##(1995-1#1)(2006-12#1)
to conform to the##5##4##(1990-11#1)(1991-4#1)(1992-9#1)(2007-11#1)(2008-11#1)
to conform to##11##3##(1990-11#1)(1991-12#1)(1991-4#1)(1992-9#1)(1995-1#1)(2006-12#1)(2007-11#1)(2008-11#1)(2012-2#1)(2013-1#2)
to conform##13##2##(1990-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-2#1)(1992-9#1)(1995-1#1)(2006-12#1)(2007-11#1)(2008-11#1)(2012-2#1)(2013-1#2)
to conformational##10##2##(1991-5#1)(1992-3#1)(1992-7#1)(1995-3#2)(1996-8#1)(2006-10#1)(2008-7#1)(2008-8#1)(2012-2#1)
to confound the##2##3##(2008-10#1)(2009-10#1)
to confound##3##2##(2006-4#1)(2008-10#1)(2009-10#1)
to confounding##3##2##(1992-3#1)(2008-7#1)(2008-9#1)
to confront the##2##3##(2009-9#1)(2013-7#1)
to confront this##2##3##(1994-3#1)(2009-12#1)
to confront##8##2##(1994-3#1)(1996-2#1)(2008-6#1)(2009-12#1)(2009-4#1)(2009-9#1)(2011-2#1)(2013-7#1)
to confusion##5##2##(1991-2#1)(1993-8#1)(1995-5#1)(2006-9#1)(2013-1#1)
to congenital limb deformity in humans##2##6##(2009-3#2)
to congenital##13##2##(1990-5#1)(1992-12#1)(1994-3#1)(2008-3#1)(2008-7#1)(2009-3#3)(2010-11#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
to conidial germination and##2##4##(2008-10#2)
to conidial germination##3##3##(2008-10#3)
to conidial inoculations##3##3##(2008-10#3)
to conidial##7##2##(2008-10#7)
to conjugal##3##2##(1993-6#1)(2008-2#2)
to conjugate##3##2##(1991-7#1)(1995-5#1)(2008-10#1)
to connect the##3##3##(2007-8#1)(2008-7#1)(2013-1#1)
to connect to##2##3##(2008-5#1)(2008-7#1)
to connect##14##2##(2007-12#1)(2007-8#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-3#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
to consanguinity##2##2##(2007-2#2)
to conscious rats##2##3##(1990-4#1)(1995-12#1)
to conscious##5##2##(1990-2#2)(1990-4#1)(1995-12#1)(2007-9#1)
to consciousness##3##2##(1991-11#1)(2008-2#1)(2008-9#1)
to consensus sequences##2##3##(1990-3#1)(1997-2#1)
to consensus##4##2##(1990-10#1)(1990-3#1)(1995-3#1)(1997-2#1)
to consent to##3##3##(1992-3#1)(2008-7#1)(2010-11#1)
to consent##7##2##(1992-3#1)(1995-5#1)(2008-7#2)(2009-4#1)(2010-11#1)(2012-12#1)
to conservative care##3##3##(2006-12#2)(2006-8#1)
to conservative management##4##3##(1990-9#1)(2007-10#1)(2013-1#2)
to conservative measures##5##3##(2005-10#1)(2006-12#1)(2006-8#1)(2008-9#1)(2013-7#1)
to conservative therapy##3##3##(2006-7#1)(2006-8#1)(2013-1#1)
to conservative treatment for##3##4##(2005-10#1)(2006-8#1)(2010-3#1)
to conservative treatment##9##3##(1993-11#1)(2005-10#1)(2005-12#1)(2006-8#1)(2007-11#1)(2009-2#1)(2010-3#1)(2011-2#1)(2013-1#1)
to conservative##30##2##(1990-10#1)(1990-6#1)(1990-9#1)(1993-11#1)(1994-3#1)(2005-10#2)(2005-12#1)(2006-12#3)(2006-7#1)(2006-8#5)(2007-10#1)(2007-11#1)(2008-9#1)(2009-2#1)(2010-3#1)(2011-2#1)(2013-1#6)(2013-7#1)
to conserve the##2##3##(1997-1#1)(2008-11#1)
to conserve##8##2##(1992-2#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#2)(2010-4#1)(2013-8#1)
to conserved##4##2##(1993-11#1)(1993-2#1)(1994-12#1)(2008-10#1)
to consider a##5##3##(2005-11#1)(2007-5#1)(2008-8#1)(2008-9#1)(2010-8#1)
to consider all##2##3##(1991-2#1)(2006-10#1)
to consider and##4##3##(1997-7#1)(2006-10#1)(2006-8#1)(2011-2#1)
to consider any##2##3##(2011-2#1)(2012-2#1)
to consider as they##2##4##(1993-1#1)(2010-7#1)
to consider as##3##3##(1993-1#1)(2008-11#1)(2010-7#1)
to consider before##4##3##(1997-4#1)(2006-5#1)(2008-10#1)(2013-7#1)
to consider how##7##3##(1996-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2012-1#1)(2013-1#1)
to consider in developing##2##4##(2007-5#1)(2012-12#1)
to consider in##14##3##(1993-1#1)(2005-7#1)(2006-10#2)(2007-10#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-12#1)(2012-12#3)(2012-2#1)
to consider new##2##3##(1995-1#1)(2012-12#1)
to consider other##2##3##(1993-6#1)(2008-7#1)
to consider possible##2##3##(2006-10#1)(2011-2#1)
to consider some##2##3##(1993-3#1)(2013-1#1)
to consider such##2##3##(2008-5#1)(2009-4#1)
to consider that##6##3##(2006-2#1)(2007-7#1)(2008-7#1)(2010-11#1)(2012-3#1)(2013-8#1)
to consider the biological##2##4##(1997-1#1)(2008-11#1)
to consider the impact of##3##5##(2010-3#1)(2010-7#1)(2012-3#1)
to consider the role of##2##5##(2008-3#1)(2013-8#1)
to consider the##49##3##(1991-4#1)(1992-8#1)(1994-5#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-6#1)(2005-1#1)(2005-3#1)(2005-5#1)(2005-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#3)(2007-3#1)(2007-8#2)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-12#1)(2009-6#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#3)(2013-8#2)
to consider their##6##3##(1994-5#1)(2008-11#1)(2008-3#1)(2008-8#2)(2012-12#1)
to consider them as##2##4##(2004-2#1)(2007-2#1)
to consider them##3##3##(2004-2#1)(2007-2#1)(2012-3#1)
to consider these##3##3##(2006-12#1)(2008-3#1)(2012-1#1)
to consider this##5##3##(1990-6#1)(2006-10#1)(2007-2#1)(2012-12#1)(2012-3#1)
to consider using##2##3##(2005-7#1)(2007-4#1)
to consider what##2##3##(2006-12#1)(2012-2#1)
to consider when selecting##2##4##(1991-12#1)(1996-4#1)
to consider when##11##3##(1991-12#1)(1995-2#1)(1996-4#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-11#2)(2009-10#1)(2009-8#1)(2011-2#1)
to consider whether##2##3##(1991-12#1)(2008-12#1)
to considerable improvement##2##3##(1990-9#1)(1995-9#1)
to considerable##14##2##(1990-9#1)(1995-11#1)(1995-9#1)(1996-12#1)(2007-10#1)(2007-11#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-8#1)(2009-12#1)(2011-2#2)
to considerably##2##2##(2008-11#1)(2009-4#1)
to considering##4##2##(2007-1#1)(2011-1#1)(2011-2#1)(2012-2#1)
to consist of a##3##4##(1993-6#2)(2008-11#1)
to consist of three##4##4##(1994-8#1)(2008-1#1)(2008-2#1)(2008-5#1)
to consist of two##5##4##(1991-10#1)(1992-5#1)(1996-9#1)(2005-11#1)(2008-3#1)
to consist of##30##3##(1990-2#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-3#1)(1992-5#1)(1993-6#2)(1994-12#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-7#1)(2005-11#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)
to consistent##4##2##(2008-7#1)(2008-8#1)(2008-9#1)(2012-1#1)
to consistently produce##2##3##(2007-12#1)(2008-9#1)
to consistently##12##2##(1991-10#1)(1995-1#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-9#1)(2009-6#1)(2012-2#1)(2012-3#1)
to consolidate##5##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
to consolidation##2##2##(1994-5#1)(2008-10#1)
to conspecific and heterospecific##2##4##(2010-8#1)(2011-12#1)
to conspecific##4##2##(1995-12#1)(2010-8#2)(2011-12#1)
to constant##14##2##(1991-12#1)(1992-3#1)(1996-8#1)(2005-11#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-8#1)(2012-1#1)(2012-4#1)(2013-8#1)
to constantly##4##2##(1993-2#1)(2008-8#1)(2009-8#1)(2011-1#1)
to constitute a##10##3##(1990-5#1)(1991-8#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2010-4#1)
to constitute the##7##3##(1994-11#1)(1995-12#1)(1995-8#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#1)
to constitute##19##2##(1990-5#1)(1991-8#1)(1994-11#1)(1995-12#1)(1995-8#1)(1997-4#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)(2010-4#1)(2013-8#1)
to constitutive##2##2##(2006-11#1)(2012-1#1)
to constitutively##2##2##(1993-12#1)(1995-12#1)
to constrain the##6##3##(1990-2#1)(1994-3#1)(2008-4#2)(2013-1#2)
to constrain##11##2##(1990-2#1)(1991-12#1)(1994-3#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-8#1)(2013-1#2)
to construct a high##2##4##(2008-2#1)(2012-3#1)
to construct a library##3##4##(1995-10#1)(2008-4#1)(2011-1#1)
to construct a simple##3##4##(1991-4#1)(2008-10#1)(2008-2#1)
to construct a##75##3##(1990-11#1)(1990-7#1)(1990-8#1)(1991-4#2)(1992-3#1)(1992-6#1)(1993-8#1)(1994-5#1)(1994-9#1)(1995-10#2)(1995-12#1)(1995-2#1)(1995-3#2)(1996-4#1)(1996-6#1)(1997-1#1)(2006-10#1)(2007-12#3)(2007-3#1)(2007-8#1)(2008-10#10)(2008-11#2)(2008-2#7)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-12#1)(2009-4#2)(2010-2#1)(2010-3#2)(2010-5#1)(2011-1#2)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
to construct an##16##3##(1991-8#1)(1997-2#1)(2005-11#1)(2006-2#1)(2007-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-9#1)(2009-2#1)(2010-1#1)(2010-5#1)(2013-7#1)(2013-8#1)
to construct and use##2##4##(2008-3#1)(2008-9#1)
to construct and##7##3##(1995-6#1)(2005-7#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-2#1)
to construct molecular##2##3##(2008-10#1)(2008-9#1)
to construct oligonucleotide##2##3##(2008-10#1)(2008-4#1)
to construct several##2##3##(1993-8#1)(1996-9#1)
to construct surgical##4##3##(2013-1#4)
to construct the calibration##2##4##(2008-10#2)
to construct the##14##3##(2006-6#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
to construct##185##2##(1990-11#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-4#2)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-8#2)(1994-12#1)(1994-5#1)(1994-9#1)(1995-10#2)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#3)(2005-10#1)(2005-11#2)(2005-7#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#1)(2007-11#4)(2007-12#3)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#22)(2008-11#5)(2008-2#15)(2008-3#9)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#7)(2008-8#6)(2008-9#6)(2009-12#2)(2009-2#2)(2009-4#2)(2009-5#1)(2010-1#1)(2010-12#1)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#3)(2010-9#1)(2011-1#4)(2011-2#2)(2011-3#1)(2012-1#3)(2012-2#2)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#3)
to constructing##3##2##(1994-12#1)(1996-12#1)(2008-8#1)
to construction of##2##3##(2008-6#1)(2012-2#1)
to construction##4##2##(1995-12#1)(2008-3#1)(2008-6#1)(2012-2#1)
to consult a##2##3##(2010-11#1)(2013-8#1)
to consult##10##2##(1994-11#1)(2005-12#1)(2008-11#2)(2008-5#1)(2009-7#1)(2010-11#1)(2011-12#1)(2013-1#1)(2013-8#1)
to consultation##4##2##(2008-11#3)(2008-2#1)
to consume##17##2##(1991-5#1)(1992-3#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-9#1)(2012-2#1)(2013-1#4)(2013-7#2)
to consumer##6##2##(1991-3#1)(1993-12#1)(1996-3#1)(1997-3#1)(2008-8#1)(2013-1#1)
to consumers and##4##3##(1992-2#1)(1994-2#1)(1996-2#1)(2008-2#1)
to consumers##14##2##(1992-1#1)(1992-2#1)(1994-2#1)(1996-2#1)(1996-3#1)(1997-3#2)(2005-8#1)(2006-10#1)(2008-2#1)(2011-1#1)(2013-1#2)(2013-8#1)
to consumers'##2##2##(2008-2#1)(2010-4#1)
to consumption of##3##3##(2004-11#1)(2008-6#1)(2012-3#1)
to consumption##6##2##(2004-11#1)(2008-11#1)(2008-6#1)(2008-8#1)(2011-1#1)(2012-3#1)
to contact lens##2##3##(2005-11#2)
to contact the##4##3##(1996-9#1)(2006-8#1)(2007-11#1)(2007-12#1)
to contact with the##3##4##(2006-11#1)(2008-10#2)
to contact with##9##3##(1993-8#1)(2006-10#1)(2006-11#1)(2008-10#2)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
to contact##26##2##(1992-3#1)(1993-8#1)(1995-2#1)(1996-9#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-8#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-8#1)(2009-4#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#2)
to contain a cluster of##2##5##(1993-11#1)(2008-10#1)
to contain a##26##3##(1990-5#2)(1991-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-11#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-7#1)(1997-5#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-2#1)(2009-8#1)
to contain an open reading frame of 1##2##8##(1992-6#1)(2008-9#1)
to contain an open reading frame##3##6##(1992-6#1)(1994-11#1)(2008-9#1)
to contain an##10##3##(1991-10#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-6#1)(1994-11#1)(1994-12#1)(1997-6#1)(2008-10#1)(2008-9#1)
to contain both##3##3##(1991-9#1)(2006-10#1)(2008-5#1)
to contain costs##7##3##(1990-12#2)(1991-1#1)(1992-12#1)(1994-3#2)(1996-2#1)
to contain detectable##2##3##(1992-11#1)(1992-12#1)
to contain different##2##3##(1992-5#1)(1995-11#1)
to contain either##2##3##(1992-4#1)(1994-12#1)
to contain four##4##3##(1992-12#1)(1993-8#1)(1994-2#1)(1996-8#1)
to contain high##2##3##(1990-9#1)(1992-1#1)
to contain only##4##3##(1992-9#1)(2008-10#1)(2008-2#2)
to contain single-stranded##2##3##(2007-8#1)(2008-10#1)
to contain some of the##2##5##(2006-4#1)(2012-3#1)
to contain some##5##3##(1997-3#1)(2006-4#1)(2008-12#1)(2008-4#1)(2012-3#1)
to contain the disease##2##4##(1994-9#1)(2011-12#1)
to contain the##23##3##(1991-12#1)(1991-5#2)(1991-6#1)(1993-6#1)(1994-6#2)(1994-9#1)(1995-10#1)(1995-8#1)(1996-12#1)(1996-2#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-2#1)(2010-4#1)(2011-12#1)(2012-12#1)(2013-1#1)
to contain three##2##3##(1990-7#1)(2013-1#1)
to contain two##10##3##(1990-5#1)(1991-11#1)(1993-11#2)(1993-12#1)(1993-8#1)(1995-6#1)(1996-10#1)(1996-7#1)(2013-7#1)
to contain##218##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#5)(1990-6#1)(1990-7#3)(1990-9#1)(1991-1#3)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#4)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#6)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#4)(1993-12#3)(1993-2#1)(1993-5#1)(1993-6#7)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#4)(1994-8#2)(1994-9#4)(1995-10#2)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-7#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#4)(1996-4#1)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-8#4)(2008-10#18)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#10)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
to contaminate##4##2##(1997-4#1)(2008-11#2)(2008-2#1)
to contaminated##7##2##(1994-7#1)(2004-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-8#1)(2011-2#1)
to contamination##12##2##(1995-7#1)(1997-5#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-9#1)(2012-1#1)(2012-2#1)(2012-3#1)
to contemplate##2##2##(1991-9#1)(2013-8#1)
to contemporary##14##2##(1993-3#1)(1995-2#1)(2005-5#1)(2005-8#1)(2006-7#1)(2008-10#2)(2008-12#2)(2008-5#1)(2009-4#1)(2012-2#1)(2013-1#1)(2013-7#1)
to content##4##2##(2008-12#1)(2008-2#3)
to contextual##4##2##(2008-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
to contingencies in##2##3##(1997-8#2)
to continually monitor##2##3##(2007-5#1)(2012-1#1)
to continually##5##2##(2006-10#1)(2007-5#1)(2008-4#1)(2012-1#1)(2012-2#1)
to continue as##2##3##(1991-3#1)(2011-2#1)
to continue attendance##2##3##(2008-6#1)(2012-12#1)
to continue breastfeeding for 1 year##2##6##(2006-2#2)
to continue breastfeeding##3##3##(2006-2#2)(2006-8#1)
to continue care##2##3##(2005-8#1)(2012-2#1)
to continue development of the##2##5##(2004-9#1)(2007-4#1)
to continue for##2##3##(2007-7#1)(2010-9#1)
to continue in##2##3##(2010-5#1)(2012-2#1)
to continue its##3##3##(1993-2#1)(2012-3#2)
to continue or##2##3##(1996-11#1)(2011-1#1)
to continue the##5##3##(1997-6#1)(2006-4#1)(2008-10#1)(2008-12#1)(2008-8#1)
to continue this##3##3##(2007-8#1)(2008-1#1)(2012-12#1)
to continue to increase##2##4##(2005-7#1)(2011-12#1)
to continue to make##2##4##(1994-2#1)(2010-3#1)
to continue to use##2##4##(2006-8#1)(2012-2#1)
to continue to##23##3##(1990-12#2)(1992-2#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-12#1)(1997-1#1)(2005-7#1)(2006-8#1)(2008-5#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#2)
to continue treatment##2##3##(1993-9#1)(1995-12#1)
to continue using##2##3##(1991-3#1)(2008-5#1)
to continue with##5##3##(1993-10#1)(1993-11#1)(2007-6#1)(2007-8#1)(2012-2#1)
to continue working##2##3##(2007-2#1)(2011-2#1)
to continue##112##2##(1990-12#2)(1990-6#1)(1991-1#1)(1991-12#1)(1991-3#2)(1992-2#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-9#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-12#2)(1995-2#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-9#1)(2005-12#1)(2005-7#2)(2005-8#1)(2006-2#2)(2006-4#1)(2006-8#2)(2007-11#2)(2007-2#4)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-4#2)(2008-5#2)(2008-6#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#6)(2012-2#7)(2012-3#2)(2013-1#4)(2013-8#1)
to continued##4##2##(1992-12#1)(2006-10#1)(2008-7#1)(2009-7#1)
to continuing##6##2##(1993-3#1)(2007-1#1)(2007-8#1)(2008-10#1)(2010-5#1)(2011-2#1)
to continuous improvement##2##3##(1995-1#1)(1995-3#1)
to continuous quality improvement##7##4##(1993-12#1)(1993-3#2)(1994-2#2)(1994-3#1)(1996-1#1)
to continuous##30##2##(1990-10#1)(1990-8#1)(1991-3#1)(1991-8#1)(1992-2#1)(1993-12#1)(1993-3#2)(1994-2#2)(1994-3#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-8#1)(2006-8#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-9#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-3#1)(2013-1#1)
to continuously generate##2##3##(2009-8#2)
to continuously measure##2##3##(2008-10#1)(2012-2#1)
to continuously##10##2##(1994-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#2)(2012-12#2)(2012-2#1)(2013-7#1)
to contraceptive##3##2##(1990-6#1)(2006-4#1)(2013-1#1)
to contract the##2##3##(1997-7#1)(2007-12#1)
to contract with##2##3##(1992-11#1)(1992-3#1)
to contract##13##2##(1990-7#1)(1992-11#1)(1992-3#1)(1992-4#1)(1995-6#1)(1997-5#1)(1997-7#1)(2005-7#2)(2007-12#1)(2009-1#1)(2011-2#2)
to contraction##2##2##(1991-5#1)(2008-10#1)
to contradictory results##2##3##(2006-4#1)(2010-11#1)
to contradictory##3##2##(2004-12#1)(2006-4#1)(2010-11#1)
to contralateral##4##2##(1994-12#1)(1995-10#1)(1995-12#1)(2008-7#1)
to contrast media##2##3##(1990-3#2)
to contrast##9##2##(1990-3#2)(1993-10#1)(1995-1#1)(1995-3#1)(2009-5#2)(2009-8#1)(2010-11#1)
to contrast-enhanced computed tomography##2##4##(2008-7#1)(2010-12#1)
to contrasting##3##2##(2008-9#1)(2012-12#1)(2013-1#1)
to contribute significantly to the##3##5##(1995-4#1)(2008-3#1)(2011-2#1)
to contribute significantly to##4##4##(1995-4#1)(1996-3#1)(2008-3#1)(2011-2#1)
to contribute significantly##5##3##(1994-11#1)(1995-4#1)(1996-3#1)(2008-3#1)(2011-2#1)
to contribute to a better understanding of##2##7##(1990-12#1)(2008-4#1)
to contribute to a##7##4##(1990-12#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-1#1)
to contribute to an understanding of##2##6##(2008-9#1)(2010-5#1)
to contribute to disease##2##4##(2010-4#1)(2012-2#1)
to contribute to neuronal cell death##2##6##(1995-11#1)(2009-12#1)
to contribute to the biological##2##5##(1995-6#1)(2008-10#1)
to contribute to the development of##5##6##(2005-8#1)(2008-4#1)(2008-5#1)(2009-3#1)(2010-12#1)
to contribute to the discussion##2##5##(1993-3#1)(2011-2#1)
to contribute to the increased##2##5##(1992-2#1)(2012-2#1)
to contribute to the limited##2##5##(1994-5#1)(2011-2#1)
to contribute to the understanding of##2##6##(2007-9#1)(2008-5#1)
to contribute to the##58##4##(1991-7#1)(1992-12#1)(1992-2#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-6#1)(1996-12#1)(1996-6#1)(1996-8#1)(2005-5#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-2#2)(2012-3#1)(2013-7#2)
to contribute to their##2##4##(1991-9#1)(2008-11#1)
to contribute to these##3##4##(1995-12#1)(2008-5#1)(2012-12#1)
to contribute to this##2##4##(2008-10#1)(2008-5#1)
to contribute to##118##3##(1990-12#1)(1991-1#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-5#2)(2004-10#2)(2004-3#1)(2005-5#1)(2005-8#2)(2006-10#4)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#8)(2008-7#3)(2008-8#1)(2008-9#4)(2009-12#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-12#4)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-7#2)(2013-8#1)
to contribute towards##2##3##(2007-11#1)(2012-3#1)
to contribute##133##2##(1990-12#1)(1991-1#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-4#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-5#2)(2004-10#2)(2004-3#1)(2005-5#1)(2005-8#2)(2006-10#4)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#8)(2008-11#6)(2008-12#2)(2008-3#2)(2008-4#3)(2008-5#8)(2008-7#3)(2008-8#1)(2008-9#4)(2009-12#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-12#4)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#3)(2013-7#3)(2013-8#1)
to control BP##2##3##(2007-1#1)(2012-3#1)
to control LDL##2##3##(1991-2#1)(1992-5#1)
to control Septoria##2##3##(2008-10#2)
to control a##10##3##(2006-10#1)(2007-10#1)(2007-6#1)(2008-10#1)(2008-2#1)(2009-6#1)(2011-2#1)(2012-1#3)
to control access to##2##4##(2008-5#1)(2012-2#1)
to control access##3##3##(1997-1#1)(2008-5#1)(2012-2#1)
to control active participation##2##4##(2012-1#2)
to control active##3##3##(1995-9#1)(2012-1#2)
to control and##10##3##(1996-2#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-12#1)(2010-12#1)(2011-3#1)(2012-12#1)(2012-6#1)
to control animals##5##3##(1990-11#1)(1996-9#1)(2006-6#1)(2009-4#1)(2013-1#1)
to control because of##2##4##(2007-12#1)(2007-6#1)
to control biofilm formation##2##4##(2011-1#2)
to control bleeding##3##3##(2007-11#1)(2007-8#1)(2013-1#1)
to control blood pressure##2##4##(2006-10#1)(2008-1#1)
to control blood##4##3##(1993-2#1)(2006-10#1)(2008-1#1)(2010-11#1)
to control blue##2##3##(2008-10#2)
to control body##3##3##(1996-1#2)(1997-4#1)
to control cases##2##3##(2008-2#1)(2009-6#1)
to control cell##4##3##(2006-6#1)(2008-11#1)(2008-4#1)(2009-10#1)
to control cells##7##3##(1990-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-8#1)(1997-6#1)(2008-11#1)
to control cellular##2##3##(1997-7#1)(2006-10#1)
to control conditions##2##3##(1990-4#1)(1995-12#1)
to control costs##4##3##(1990-12#1)(1994-12#1)(1995-1#1)(1997-2#1)
to control disease##2##3##(2008-11#1)(2008-8#1)
to control for the##4##4##(1993-2#1)(2008-10#1)(2008-9#1)(2012-2#1)
to control for##18##3##(1993-2#1)(1994-1#1)(1996-10#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-9#1)(2012-2#1)
to control fungal pathogens##2##4##(2008-10#2)
to control group##8##3##(2007-11#1)(2007-8#1)(2007-9#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-3#1)
to control groups##4##3##(1995-1#1)(1995-12#1)(2006-2#1)(2008-7#1)
to control health care costs##2##5##(1994-12#1)(1994-2#1)
to control health care##3##4##(1994-12#1)(1994-2#1)(1997-2#1)
to control in##2##3##(1995-5#1)(2012-12#1)
to control infection##3##3##(1994-6#1)(2005-8#1)(2006-10#1)
to control inflammation##2##3##(2007-11#1)(2008-7#1)
to control its##2##3##(1996-9#1)(2011-2#1)
to control late blight##2##4##(2008-10#2)
to control level##3##3##(1992-6#1)(1993-12#1)(1997-8#1)
to control levels after##3##4##(1994-3#1)(2007-11#1)(2008-7#1)
to control levels by##2##4##(1990-10#1)(1995-12#1)
to control levels##25##3##(1990-10#1)(1990-12#1)(1991-12#1)(1991-5#2)(1992-3#1)(1992-8#1)(1993-11#1)(1993-7#1)(1994-3#1)(1994-5#1)(1995-12#2)(1995-3#1)(1996-12#3)(2004-11#1)(2005-10#1)(2007-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-5#1)
to control mice##5##3##(1991-12#1)(1996-10#1)(1997-7#1)(2008-12#1)(2012-2#1)
to control of##14##3##(1991-2#1)(1992-10#1)(1992-3#1)(1996-2#1)(2006-10#1)(2008-10#5)(2010-12#1)(2010-4#1)(2010-8#1)(2012-2#1)
to control or##5##3##(1995-3#1)(1997-7#1)(2006-10#1)(2007-10#1)(2009-3#1)
to control pain and improve##2##5##(2008-10#1)(2010-11#1)
to control pain##6##3##(2006-2#1)(2008-10#2)(2010-11#2)(2010-8#1)
to control patients##2##3##(1991-2#1)(2008-8#1)
to control perioperative bleeding##2##4##(2007-8#2)
to control plant diseases##2##4##(2008-10#2)
to control plants##2##3##(1997-6#1)(2008-10#1)
to control protein##2##3##(2009-12#1)(2013-8#1)
to control rats##3##3##(1993-12#1)(2008-7#1)(2013-1#1)
to control slices##2##3##(1997-5#1)(2008-10#1)
to control specific##2##3##(2008-11#1)(2009-8#1)
to control subjects##4##3##(1995-9#1)(2011-1#1)(2012-2#2)
to control symptoms##2##3##(2010-11#1)(2012-12#1)
to control take-all of wheat##2##5##(2008-10#2)
to control than##2##3##(1992-5#1)(2008-10#1)
to control the cost of##2##5##(1995-3#1)(2008-11#1)
to control the direction and##2##5##(2007-12#1)(2008-7#1)
to control the disease##11##4##(2006-1#1)(2007-11#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-8#1)(2011-2#2)(2012-3#1)
to control the effect of##2##5##(2008-10#1)(2008-11#1)
to control the index##2##4##(2007-12#1)(2008-3#1)
to control the movement of##2##5##(2008-10#1)(2009-2#1)
to control the number of##2##5##(2004-11#1)(2008-5#1)
to control the output##3##4##(2007-12#1)(2008-2#1)(2008-5#1)
to control the pH##2##4##(2008-10#2)
to control the possible##2##4##(2008-5#1)(2013-8#1)
to control the pulmonary##2##4##(2007-8#1)(2008-11#1)
to control the rate##2##4##(2008-10#1)(2008-5#1)
to control the release##3##4##(2008-5#1)(2010-10#1)(2010-2#1)
to control the size and##2##5##(2008-2#1)(2010-12#1)
to control the size##3##4##(2008-10#1)(2008-2#1)(2010-12#1)
to control the spread of##3##5##(1996-6#1)(2008-1#1)(2011-2#1)
to control the system and##2##5##(2008-10#2)
to control the##151##3##(1991-4#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-7#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#3)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-7#2)(2004-11#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#2)(2007-10#2)(2007-11#5)(2007-12#6)(2007-3#1)(2007-7#4)(2007-8#2)(2008-1#2)(2008-10#19)(2008-11#8)(2008-2#9)(2008-3#8)(2008-5#8)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-11#1)(2009-2#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#5)(2013-1#1)(2013-8#4)
to control their##5##3##(1994-8#1)(2006-10#1)(2007-8#1)(2008-5#1)(2011-2#1)
to control them##3##3##(2009-3#1)(2009-4#1)(2013-7#1)
to control these##3##3##(1997-5#1)(2007-11#1)(2009-12#1)
to control this##4##3##(2005-10#1)(2007-4#1)(2008-10#1)(2011-1#1)
to control transgene##2##3##(2008-11#1)(2008-2#1)
to control values after##2##4##(1995-5#1)(2006-1#1)
to control values##14##3##(1990-7#1)(1990-9#1)(1991-2#1)(1991-5#1)(1993-9#1)(1994-11#1)(1994-5#2)(1994-8#1)(1995-10#1)(1995-5#1)(1995-8#1)(2006-1#1)(2013-1#1)
to control##667##2##(1990-10#3)(1990-11#2)(1990-12#4)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-10#2)(1991-12#3)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#3)(1991-8#2)(1992-10#3)(1992-11#1)(1992-12#2)(1992-3#4)(1992-4#1)(1992-5#3)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#3)(1993-7#2)(1993-9#2)(1994-1#2)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#5)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#3)(1995-10#1)(1995-12#8)(1995-2#1)(1995-3#3)(1995-5#2)(1995-8#1)(1995-9#3)(1996-1#5)(1996-10#2)(1996-11#2)(1996-12#8)(1996-2#2)(1996-5#1)(1996-6#2)(1996-9#2)(1997-1#3)(1997-2#6)(1997-3#2)(1997-4#2)(1997-5#4)(1997-6#4)(1997-7#6)(1997-8#2)(2004-1#1)(2004-11#2)(2004-12#1)(2004-9#1)(2005-10#2)(2005-12#2)(2005-2#1)(2005-5#1)(2005-8#1)(2006-1#2)(2006-10#17)(2006-11#1)(2006-12#3)(2006-2#4)(2006-4#3)(2006-5#1)(2006-6#5)(2006-8#3)(2007-1#2)(2007-10#7)(2007-11#14)(2007-12#12)(2007-2#5)(2007-3#2)(2007-4#2)(2007-5#2)(2007-6#3)(2007-7#7)(2007-8#11)(2007-9#1)(2008-1#6)(2008-10#66)(2008-11#21)(2008-12#3)(2008-2#15)(2008-3#15)(2008-4#11)(2008-5#21)(2008-6#5)(2008-7#18)(2008-8#11)(2008-9#5)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#5)(2009-5#5)(2009-6#6)(2009-8#5)(2009-9#4)(2010-1#2)(2010-10#3)(2010-11#4)(2010-12#12)(2010-2#2)(2010-3#2)(2010-4#9)(2010-5#2)(2010-7#1)(2010-8#4)(2010-9#3)(2011-1#14)(2011-12#2)(2011-2#15)(2011-3#1)(2012-1#7)(2012-11#1)(2012-12#12)(2012-2#22)(2012-3#8)(2012-6#1)(2012-8#1)(2013-1#15)(2013-7#1)(2013-8#8)
to controlled clinical trials##2##4##(2010-7#1)(2013-1#1)
to controlled substance agreements##2##4##(2006-8#2)
to controlled##15##2##(1993-12#2)(1994-7#1)(2006-12#1)(2006-8#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
to controlling##4##2##(1994-1#1)(1997-1#1)(2005-7#1)(2008-11#1)
to controls and##2##3##(2006-12#1)(2008-7#1)
to controls at##3##3##(2006-11#1)(2007-10#1)(2008-5#1)
to controls in##2##3##(1990-8#1)(1995-10#1)
to controls with##3##3##(2008-11#1)(2008-5#1)(2010-4#1)
to controls##125##2##(1990-11#1)(1990-4#1)(1990-5#1)(1990-8#2)(1991-2#1)(1991-3#2)(1991-4#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-3#2)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#2)(1993-7#2)(1994-12#3)(1994-3#3)(1994-5#2)(1994-6#2)(1994-9#4)(1995-10#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-12#2)(1996-3#2)(1996-4#1)(1996-9#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#1)(2004-11#1)(2004-4#1)(2006-11#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-7#2)(2008-1#2)(2008-10#3)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#6)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#3)(2009-9#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#2)(2013-1#3)
to controversy##2##2##(1991-4#1)(2007-2#1)
to conventional HPLC methods##2##4##(2007-1#1)(2008-10#1)
to conventional HPLC##3##3##(2007-1#1)(2008-10#2)
to conventional and##3##3##(1991-6#1)(1993-7#1)(2010-12#1)
to conventional antibiotics##2##3##(2005-7#1)(2013-1#1)
to conventional bronchoscopy##3##3##(2008-5#3)
to conventional cell##2##3##(1996-2#1)(2009-12#1)
to conventional interferon and##2##4##(2010-12#1)(2013-7#1)
to conventional liposomes##2##3##(1996-1#1)(2010-12#1)
to conventional medicine##2##3##(2008-10#1)(2013-1#1)
to conventional methods for##2##4##(2008-10#1)(2012-2#1)
to conventional methods##4##3##(2008-10#2)(2010-3#1)(2012-2#1)
to conventional open##2##3##(2006-5#1)(2008-3#1)
to conventional protein##2##3##(2005-7#1)(2012-2#1)
to conventional radiography##2##3##(2010-3#1)(2013-1#1)
to conventional surgical##2##3##(2006-10#1)(2008-1#1)
to conventional technique##2##3##(1994-3#1)(2011-12#1)
to conventional therapies##4##3##(2006-12#1)(2008-3#1)(2010-12#1)(2010-9#1)
to conventional therapy##17##3##(1993-11#1)(1993-8#2)(1995-6#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-2#2)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
to conventional treatment##6##3##(1994-2#1)(2006-10#1)(2008-12#1)(2010-8#1)(2011-2#1)(2012-12#1)
to conventional treatments##2##3##(1990-6#1)(2009-2#1)
to conventional##188##2##(1990-5#1)(1990-6#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-1#1)(1993-11#1)(1993-7#1)(1993-8#2)(1994-2#1)(1994-3#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-9#1)(2004-11#1)(2004-2#1)(2005-7#3)(2005-8#1)(2006-10#7)(2006-12#4)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#6)(2007-12#3)(2007-2#2)(2007-5#1)(2007-7#3)(2007-8#6)(2007-9#1)(2008-1#4)(2008-10#14)(2008-11#6)(2008-12#3)(2008-2#6)(2008-3#6)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#2)(2009-4#1)(2009-7#2)(2010-12#7)(2010-2#4)(2010-3#4)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#2)
to conventionally##2##2##(1996-5#1)(2008-11#1)
to converge on a##3##4##(2008-2#1)(2008-9#1)(2009-6#1)
to converge to##3##3##(2006-1#1)(2008-2#1)(2008-7#1)
to converge##7##2##(2006-1#1)(2008-2#2)(2008-7#1)(2008-9#1)(2009-6#1)(2012-2#1)
to convergent##3##2##(1991-8#1)(1997-7#1)(2011-2#1)
to converse##2##2##(2012-1#1)(2012-2#1)
to conversion##2##2##(1995-8#1)(2007-11#1)
to convert O6-benzylguanine to guanine##2##5##(1995-5#2)
to convert a##4##3##(1991-4#1)(2006-12#1)(2008-4#1)(2009-12#1)
to convert the##15##3##(1991-9#1)(1995-11#1)(1997-1#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-5#1)(2010-5#1)(2011-2#1)(2013-8#1)
to convert##64##2##(1990-12#3)(1990-5#1)(1990-8#1)(1991-4#1)(1991-8#1)(1991-9#1)(1993-12#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-1#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-4#2)(2006-12#3)(2007-12#4)(2007-8#3)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-9#1)(2009-12#1)(2009-8#1)(2010-2#1)(2010-5#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
to convey the##3##3##(1993-9#1)(2007-4#1)(2008-3#1)
to convey##10##2##(1993-9#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-3#1)(2012-2#1)
to convince##4##2##(1991-5#1)(1997-7#1)(2007-2#1)(2010-4#1)
to cool##2##2##(2008-2#1)(2010-9#1)
to cooling##2##2##(2008-8#1)(2009-6#1)
to cooperate in the##2##4##(2007-8#1)(2010-3#1)
to cooperate in##3##3##(2006-8#1)(2007-8#1)(2010-3#1)
to cooperate with the##2##4##(1990-2#1)(1995-4#1)
to cooperate with##6##3##(1990-2#1)(1995-4#1)(1995-8#1)(1996-2#1)(2009-10#1)(2011-1#1)
to cooperate##16##2##(1990-2#1)(1993-9#1)(1995-4#1)(1995-8#1)(1996-2#2)(2006-10#1)(2006-7#1)(2006-8#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-4#1)(2009-10#1)(2010-3#1)(2011-1#1)
to cooperation##2##2##(1995-1#1)(1995-2#1)
to cooperative care##2##3##(1995-1#2)
to cooperative##4##2##(1995-1#2)(2006-10#1)(2008-8#1)
to coordinate care##3##3##(1995-12#1)(1996-2#1)(2012-2#1)
to coordinate the##7##3##(1992-1#1)(1995-5#1)(1997-4#1)(2009-10#1)(2009-6#1)(2011-2#1)(2012-2#1)
to coordinate with##2##3##(2004-12#1)(2006-3#1)
to coordinate##34##2##(1990-12#1)(1990-6#1)(1991-7#1)(1992-1#1)(1992-3#1)(1995-12#3)(1995-5#1)(1995-8#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-4#1)(2004-12#1)(2006-3#1)(2007-12#1)(2007-2#2)(2007-9#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-6#2)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#2)
to coordination of the##2##4##(1994-8#1)(1995-5#1)
to coordination of##3##3##(1994-8#1)(1995-5#1)(2008-2#1)
to coordination##4##2##(1994-8#1)(1995-5#1)(1996-8#1)(2008-2#1)
to copABCD##2##2##(2008-10#2)
to cope and##3##3##(1995-9#1)(2006-7#1)(2009-5#1)
to cope better##2##3##(1996-8#1)(2013-8#1)
to cope in##2##3##(1992-3#1)(2010-10#1)
to cope more##2##3##(1997-8#1)(2013-1#1)
to cope with a##6##4##(2005-10#1)(2007-12#1)(2009-4#1)(2010-2#1)(2011-2#1)(2013-8#1)
to cope with his##2##4##(1995-8#1)(2004-3#1)
to cope with oxidative##2##4##(2005-9#1)(2008-11#1)
to cope with road traffic##3##5##(1993-5#3)
to cope with stress##4##4##(2006-9#1)(2007-2#1)(2009-12#1)(2010-10#1)
to cope with the##17##4##(1992-6#1)(1993-10#1)(1993-6#1)(1994-12#1)(1995-4#1)(2005-11#1)(2005-8#2)(2006-10#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-5#1)
to cope with their##3##4##(1993-12#1)(2007-7#2)
to cope with this##2##4##(2008-7#1)(2011-2#1)
to cope with##64##3##(1992-3#1)(1992-6#1)(1993-10#1)(1993-12#2)(1993-5#3)(1993-6#1)(1994-12#3)(1995-4#1)(1995-8#1)(1997-5#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-8#2)(2005-9#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#3)(2008-10#2)(2008-11#6)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2013-8#2)
to cope##80##2##(1992-3#2)(1992-5#1)(1992-6#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-5#3)(1993-6#1)(1994-12#3)(1995-4#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-8#1)(1997-5#1)(1997-8#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-8#2)(2005-9#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#3)(2008-10#2)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-10#4)(2010-11#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#3)
to coping##2##2##(1994-2#1)(2010-1#1)
to copper and##5##3##(1991-2#1)(2004-4#2)(2008-10#1)(2013-8#1)
to copper supplementation##2##3##(2005-7#2)
to copper##18##2##(1991-2#1)(1995-11#1)(1995-3#1)(2004-4#4)(2005-7#2)(2007-11#1)(2008-10#4)(2008-5#1)(2008-7#1)(2011-2#1)(2013-8#1)
to copper(I)##2##2##(2008-10#1)(2010-5#1)
to copper(II)##3##2##(2007-8#2)(2008-10#1)
to coral##2##2##(2007-3#1)(2011-2#1)
to core##5##2##(1995-6#1)(1996-8#1)(2004-9#1)(2006-10#1)(2008-10#1)
to corn##6##2##(2008-10#3)(2011-2#3)
to coronary artery bypass surgery##2##5##(2008-11#1)(2013-1#1)
to coronary artery bypass##5##4##(2007-8#2)(2008-11#2)(2013-1#1)
to coronary artery##6##3##(1995-6#1)(2007-8#2)(2008-11#2)(2013-1#1)
to coronary heart disease (CHD)##2##5##(1995-9#1)(2005-10#1)
to coronary heart disease##9##4##(1991-12#1)(1991-6#1)(1993-5#1)(1995-9#1)(2005-10#1)(2006-2#1)(2006-4#2)(2007-11#1)
to coronary sinus##3##3##(2007-8#2)(2012-2#1)
to coronary##26##2##(1991-12#1)(1991-6#1)(1993-11#1)(1993-5#1)(1995-6#1)(1995-9#1)(1996-9#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-2#1)(2006-4#2)(2006-6#1)(2007-11#1)(2007-8#6)(2008-11#2)(2010-9#1)(2012-2#1)(2013-1#1)
to corpus##2##2##(1995-7#1)(2009-7#1)
to correct aberrations in a##2##5##(2007-12#1)(2008-3#1)
to correct all the##2##4##(2006-3#2)
to correct congenital##2##3##(2006-10#1)(2012-2#1)
to correct deformity##2##3##(2008-4#1)(2008-9#1)
to correct experimental##2##3##(2008-3#1)(2011-1#1)
to correct for the##8##4##(1991-3#1)(2008-11#1)(2008-2#2)(2008-3#4)
to correct for variations in the##2##6##(2007-11#1)(2008-1#1)
to correct for##26##3##(1991-3#1)(1993-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#7)(2008-8#1)(2009-8#1)(2011-1#3)(2012-3#1)
to correct gene defects##2##4##(2007-11#1)(2007-3#1)
to correct results##2##3##(2008-10#1)(2008-2#1)
to correct the phase##3##4##(2008-2#2)(2008-3#1)
to correct the##31##3##(1992-8#1)(1993-8#1)(1995-12#1)(1997-1#2)(2005-11#1)(2005-4#1)(2006-5#1)(2006-9#1)(2007-12#3)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#7)(2008-5#1)(2009-10#1)(2009-4#1)(2012-2#1)(2013-1#1)
to correct this##3##3##(1990-9#1)(2008-2#1)(2013-1#1)
to correct##135##2##(1990-8#1)(1990-9#1)(1991-3#1)(1991-9#1)(1992-8#1)(1993-1#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-12#3)(1997-1#2)(2005-11#1)(2005-4#1)(2006-10#4)(2006-3#2)(2006-5#1)(2006-9#1)(2007-11#2)(2007-12#8)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#9)(2008-11#2)(2008-2#16)(2008-3#24)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#7)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
to correcting##2##2##(2007-12#1)(2008-3#1)
to correction of##4##3##(1996-10#1)(2005-11#1)(2007-11#1)(2007-7#1)
to correction##5##2##(1996-10#1)(1997-5#1)(2005-11#1)(2007-11#1)(2007-7#1)
to corrective##2##2##(2008-9#1)(2011-1#1)
to correctly identify##5##3##(1995-1#1)(2010-3#1)(2011-2#2)(2013-1#1)
to correctly##29##2##(1993-12#1)(1995-1#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-2#1)(2006-3#2)(2007-10#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
to correlate the expression of##2##5##(2007-12#1)(2013-8#1)
to correlate the##16##3##(1990-8#1)(2005-11#1)(2006-10#1)(2007-10#2)(2007-12#1)(2007-3#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-4#1)(2012-11#1)(2012-2#1)(2012-9#1)(2013-8#2)
to correlate these##3##3##(1992-12#1)(2008-5#1)(2010-8#1)
to correlate this##2##3##(2008-10#2)
to correlate well with##3##4##(1992-2#1)(1995-2#1)(1997-7#1)
to correlate with a##2##4##(1996-6#1)(2007-3#1)
to correlate with an##3##4##(1994-12#1)(1996-12#1)(1997-4#1)
to correlate with clinical##2##4##(2007-7#1)(2008-6#1)
to correlate with each other##2##5##(1992-1#1)(2010-12#1)
to correlate with growth##2##4##(1992-9#1)(2011-1#1)
to correlate with the risk of##2##6##(2008-9#1)(2009-12#1)
to correlate with the##8##4##(1992-6#1)(1993-6#1)(1997-5#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-12#1)
to correlate with##56##3##(1990-12#1)(1990-2#2)(1992-1#1)(1992-6#1)(1992-9#1)(1993-6#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-6#1)(1997-4#1)(1997-5#1)(2005-11#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-7#2)(2007-9#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-11#1)(2009-12#1)(2009-8#1)(2010-12#2)(2010-2#1)(2011-1#2)(2011-2#4)(2012-2#1)(2013-1#1)(2013-7#1)
to correlate##116##2##(1990-12#1)(1990-2#2)(1990-8#2)(1991-10#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-8#1)(1995-2#2)(1996-1#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-10#1)(2004-12#1)(2005-11#2)(2006-10#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-3#4)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#4)(2009-11#1)(2009-12#1)(2009-4#2)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-11#1)(2012-2#3)(2012-9#1)(2013-1#3)(2013-7#1)(2013-8#4)
to correlation##3##2##(1993-2#1)(2010-4#1)(2011-1#1)
to correspond to a##2##4##(2006-11#1)(2008-10#1)
to correspond to the##7##4##(1991-5#1)(1993-5#1)(1994-5#1)(2006-12#1)(2008-10#1)(2008-3#1)(2012-12#1)
to correspond to those##2##4##(1994-5#1)(2008-10#1)
to correspond to##23##3##(1991-11#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1993-5#1)(1994-11#1)(1994-5#2)(1997-4#1)(2006-11#1)(2006-12#1)(2008-10#6)(2008-11#1)(2008-3#1)(2009-11#1)(2012-12#1)
to correspond##26##2##(1991-11#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1993-5#1)(1994-11#1)(1994-5#2)(1997-4#1)(2006-11#1)(2006-12#1)(2007-4#2)(2008-10#6)(2008-11#2)(2008-3#1)(2009-11#1)(2012-12#1)
to corresponding##7##2##(1991-1#1)(1993-9#1)(1997-3#1)(2008-3#2)(2008-4#1)(2010-4#1)
to corroborate the##2##3##(2007-12#1)(2007-2#1)
to corroborate these results##2##4##(2008-10#1)(2008-2#1)
to corroborate this##2##3##(1993-3#1)(2008-12#1)
to corroborate##10##2##(1993-3#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-10#1)(2010-1#1)(2010-7#1)
to cortical##11##2##(1991-11#1)(1992-11#1)(1995-11#1)(1997-6#2)(2004-9#1)(2007-12#1)(2007-9#1)(2008-1#2)(2013-1#1)
to corticosteroid therapy##2##3##(2005-8#1)(2008-1#1)
to corticosteroid##6##2##(2005-8#1)(2006-10#2)(2007-7#1)(2008-1#1)(2008-9#1)
to corticosteroids##8##2##(1994-11#2)(2005-8#1)(2006-10#3)(2007-8#1)(2010-12#1)
to corticosterone and 18-hydroxydeoxycorticosterone##2##4##(1994-2#1)(1995-10#1)
to corticosterone##5##2##(1994-2#2)(1994-5#1)(1995-10#1)(1995-12#1)
to cortisol##6##2##(1996-11#1)(1997-1#1)(2006-3#1)(2008-5#1)(2010-2#2)
to cosmetic##6##2##(2007-11#2)(2007-12#1)(2008-5#3)
to cosmetics##3##2##(2007-7#2)(2008-5#1)
to cost savings##2##3##(1995-2#1)(2010-8#1)
to cost##14##2##(1990-12#2)(1991-2#1)(1993-5#1)(1993-8#1)(1994-3#1)(1995-12#1)(1995-2#1)(1997-2#1)(2007-11#1)(2008-2#1)(2008-7#1)(2010-8#2)
to cost-effective##2##2##(1993-12#1)(2008-10#1)
to costs##2##2##(2009-10#1)(2012-12#1)
to cotton##6##2##(2008-10#4)(2011-2#2)
to cough##2##2##(1990-10#1)(1993-7#1)
to counsel and##2##3##(2012-2#1)(2013-1#1)
to counsel##9##2##(1990-6#1)(1992-12#1)(1993-3#1)(2007-4#1)(2008-11#1)(2009-9#1)(2012-2#1)(2013-1#2)
to counseling##2##2##(2008-3#1)(2008-7#1)
to count the##3##3##(1997-7#1)(2005-11#1)(2008-6#1)
to count##6##2##(1997-7#1)(2004-12#1)(2005-11#1)(2008-6#1)(2008-9#1)(2011-1#1)
to counter the##4##3##(1997-8#1)(2005-10#1)(2008-2#1)(2008-5#1)
to counter##16##2##(1994-6#1)(1996-8#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-3#2)(2007-2#1)(2008-2#4)(2008-5#1)(2008-6#1)(2009-6#1)(2012-3#1)
to counteract such##2##3##(2010-12#1)(2012-12#1)
to counteract the##9##3##(1990-9#1)(1994-11#1)(2006-8#1)(2007-2#2)(2008-10#2)(2008-4#1)(2009-8#1)
to counteract this##2##3##(1996-2#1)(2009-12#1)
to counteract##21##2##(1990-9#1)(1994-11#1)(1994-3#1)(1996-2#1)(2006-8#1)(2007-10#1)(2007-2#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-6#1)(2009-8#2)(2010-12#2)(2010-7#1)(2012-12#1)
to counterbalance##2##2##(2007-7#1)(2009-5#1)
to countries with high##2##4##(2007-2#1)(2007-5#1)
to countries with##4##3##(2006-10#1)(2007-2#1)(2007-5#1)(2008-1#1)
to countries##7##2##(2006-10#1)(2006-2#1)(2007-2#1)(2007-5#1)(2008-1#1)(2009-7#1)(2011-2#1)
to country##7##2##(1993-2#1)(1994-1#1)(2006-5#1)(2006-9#1)(2008-10#1)(2008-7#1)(2010-10#1)
to couple a##3##3##(1997-6#1)(2007-12#1)(2008-3#1)
to couple light##2##3##(2008-2#1)(2010-5#1)
to couple the##8##3##(1997-6#1)(2005-7#1)(2007-8#1)(2008-10#2)(2008-2#2)(2010-4#1)
to couple##27##2##(1991-10#1)(1995-3#1)(1996-8#1)(1997-4#1)(1997-6#2)(2005-7#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-2#3)(2008-3#2)(2008-4#1)(2009-8#1)(2010-4#2)(2010-5#1)(2012-2#4)
to couples##2##2##(1997-2#1)(2010-8#1)
to coupling##4##2##(1992-3#1)(2005-11#1)(2007-12#1)(2008-10#1)
to court##4##2##(1994-2#1)(1995-12#1)(2007-6#1)(2010-12#1)
to covalent binding of##2##4##(1990-7#1)(2012-12#1)
to covalent binding##3##3##(1990-7#1)(2007-9#1)(2012-12#1)
to covalent##8##2##(1990-7#1)(1993-11#1)(1993-6#1)(1993-7#1)(2005-11#1)(2007-9#1)(2009-9#1)(2012-12#1)
to covalently immobilize##2##3##(1990-2#1)(2008-5#1)
to covalently##5##2##(1990-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-4#1)
to cover a large##2##4##(2005-11#1)(2011-2#1)
to cover a##6##3##(2005-11#1)(2007-12#1)(2007-4#1)(2008-2#1)(2009-10#1)(2011-2#1)
to cover all##3##3##(2008-2#1)(2008-7#1)(2012-3#1)
to cover more than##2##4##(1996-10#2)
to cover the defect##3##4##(2011-2#2)(2013-1#1)
to cover the whole##4##4##(1997-2#1)(2008-10#1)(2008-2#1)(2008-5#1)
to cover the##33##3##(1990-2#1)(1992-3#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-12#1)(1997-2#1)(2005-8#2)(2006-3#1)(2006-6#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
to cover##70##2##(1990-12#2)(1990-2#1)(1991-2#2)(1992-3#1)(1993-3#1)(1994-3#1)(1995-11#1)(1995-2#2)(1996-1#1)(1996-10#2)(1996-12#1)(1996-6#2)(1997-2#1)(2005-11#1)(2005-8#3)(2006-1#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-12#2)(2007-4#2)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-3#2)(2013-1#1)
to covered##2##2##(2007-4#1)(2008-10#1)
to cows##3##2##(2005-7#1)(2012-2#2)
to cranial vault##2##3##(2007-12#2)
to cranial##7##2##(1996-8#1)(2006-9#1)(2007-12#2)(2008-4#1)(2008-9#1)(2012-2#1)
to craniotomy##2##2##(1997-6#1)(2007-10#1)
to create &quot##2##3##(2008-4#1)(2011-2#1)
to create a new##6##4##(1991-1#1)(1992-1#1)(1996-3#1)(2008-11#1)(2008-5#1)(2010-11#1)
to create a set of##2##5##(2008-3#2)
to create a single##2##4##(2008-12#1)(2009-11#1)
to create a specific##2##4##(1990-8#1)(1994-8#1)
to create a system##2##4##(2009-4#1)(2011-2#1)
to create a thin##2##4##(2007-12#1)(2008-10#1)
to create a##97##3##(1990-8#1)(1991-1#1)(1992-1#1)(1992-2#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-8#1)(2005-10#1)(2005-5#1)(2005-8#1)(2006-10#1)(2006-12#3)(2006-6#1)(2006-8#2)(2007-12#4)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#3)(2008-7#6)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#4)(2011-9#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#6)(2013-8#1)
to create adequate##2##3##(2008-1#1)(2012-2#1)
to create an environment##3##4##(1997-3#1)(2009-9#1)(2011-1#1)
to create an##24##3##(1991-3#1)(1996-3#1)(1997-3#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-10#2)(2011-1#1)(2011-12#1)(2012-2#1)(2013-1#2)
to create and##11##3##(1991-12#1)(1992-2#1)(2007-2#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-10#1)(2010-9#1)
to create awareness among##4##4##(2008-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
to create awareness##8##3##(1992-12#1)(1997-6#1)(2007-12#1)(2008-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
to create complete##2##3##(2010-11#1)(2010-8#1)
to create functional##2##3##(2008-10#1)(2010-4#1)
to create good##3##3##(1990-5#1)(2006-6#2)
to create health##2##3##(1993-3#1)(1996-12#1)
to create models##2##3##(2010-4#1)(2010-8#1)
to create more##2##3##(2007-1#1)(2010-2#1)
to create new##8##3##(1990-8#1)(1996-3#1)(2006-11#1)(2007-11#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)
to create novel##3##3##(2010-7#1)(2012-1#1)(2012-11#1)
to create patterns##2##3##(2007-12#1)(2010-4#1)
to create scale##2##3##(2008-8#1)(2009-11#1)
to create social##2##3##(2008-11#1)(2010-12#1)
to create such##3##3##(2007-6#1)(2008-7#1)(2010-10#1)
to create sustainable##2##3##(1995-3#1)(2012-1#1)
to create the most##2##4##(2008-7#1)(2013-8#1)
to create the##29##3##(1991-2#1)(1991-6#1)(1991-9#1)(1992-1#1)(1994-6#1)(1995-11#1)(1995-4#1)(2005-10#2)(2005-11#1)(2006-12#1)(2007-12#2)(2007-2#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-7#2)(2009-8#1)(2010-5#1)(2012-2#1)(2013-7#1)(2013-8#1)
to create their##2##3##(1996-12#1)(2006-5#1)
to create tools##2##3##(2005-10#1)(2011-9#1)
to create two##3##3##(1990-12#1)(2008-1#1)(2008-10#1)
to create##342##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#3)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#3)(1993-11#1)(1993-2#1)(1993-3#1)(1993-9#2)(1994-2#1)(1994-3#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-1#3)(1995-11#1)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#3)(1996-12#2)(1996-3#4)(1996-4#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-10#5)(2005-11#1)(2005-5#2)(2005-8#2)(2006-10#3)(2006-11#2)(2006-12#6)(2006-3#1)(2006-5#2)(2006-6#3)(2006-8#3)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#11)(2007-2#3)(2007-4#1)(2007-5#1)(2007-6#4)(2007-7#5)(2007-8#1)(2007-9#2)(2008-1#6)(2008-10#19)(2008-11#13)(2008-12#3)(2008-2#9)(2008-3#13)(2008-4#8)(2008-5#5)(2008-6#2)(2008-7#14)(2008-8#4)(2008-9#7)(2009-10#2)(2009-11#3)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#4)(2009-6#1)(2009-7#4)(2009-8#1)(2009-9#3)(2010-10#4)(2010-11#2)(2010-12#3)(2010-2#6)(2010-4#8)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#8)(2011-9#3)(2012-1#4)(2012-11#1)(2012-12#5)(2012-2#5)(2012-3#4)(2013-1#14)(2013-7#3)(2013-8#3)
to creatine##2##2##(1993-11#1)(2008-5#1)
to creating##8##2##(1996-5#1)(1997-1#1)(2008-10#1)(2008-5#1)(2010-2#1)(2011-2#1)(2013-1#2)
to creatinine ratio##5##3##(2007-2#1)(2008-5#1)(2012-2#1)(2013-1#2)
to creatinine##10##2##(1995-4#1)(1997-2#1)(1997-8#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2012-2#1)(2013-1#2)
to creation of##2##3##(2005-11#1)(2011-1#1)
to creep##2##2##(1990-12#1)(1996-4#1)
to criminal##3##2##(2008-11#1)(2009-4#1)(2011-2#1)
to crisis##2##2##(1990-12#1)(2008-4#1)
to criteria##2##2##(1994-2#1)(2008-4#1)
to criterion and##2##3##(1993-3#1)(2011-2#1)
to criterion##6##2##(1991-2#1)(1993-2#1)(1993-3#1)(1993-7#1)(2011-2#2)
to critical care##2##3##(2007-11#1)(2007-9#1)
to critical incidents##2##3##(2008-11#1)(2012-1#1)
to critical review##2##3##(2005-7#1)(2007-4#1)
to critical##21##2##(1992-12#1)(1993-3#1)(1997-2#1)(2005-7#1)(2006-6#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-11#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-1#1)(2010-11#1)(2012-1#2)(2012-12#2)
to critically analyse##3##3##(2005-8#1)(2011-2#1)(2013-1#1)
to critically evaluate##3##3##(1992-1#1)(2006-9#1)(2012-3#1)
to critically examine##3##3##(2008-2#1)(2008-9#1)(2009-4#1)
to critically ill patients##3##4##(2005-10#1)(2005-8#1)(2006-10#1)
to critically ill##4##3##(2005-10#1)(2005-8#1)(2006-10#1)(2010-7#1)
to critically review the##3##4##(2008-11#1)(2009-7#1)(2010-10#1)
to critically##24##2##(1992-1#1)(2005-10#1)(2005-8#3)(2006-10#1)(2006-9#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
to criticism##3##2##(1991-6#1)(1997-3#1)(2008-5#1)
to critique the##2##3##(2008-7#1)(2011-1#1)
to critique##4##2##(2007-9#1)(2008-7#1)(2010-2#1)(2011-1#1)
to crop plants##2##3##(2006-12#1)(2008-12#1)
to crop productivity##2##3##(2008-10#1)(2011-2#1)
to crop##9##2##(2006-12#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
to crops##3##2##(2008-10#1)(2012-2#2)
to cross react##2##3##(1991-4#1)(2008-3#1)
to cross the blood-brain barrier##3##5##(1996-11#1)(1997-2#1)(2005-9#1)
to cross the##12##3##(1996-11#1)(1997-2#2)(1997-5#1)(2005-9#1)(2007-12#1)(2008-10#1)(2009-8#2)(2010-5#1)(2010-6#1)(2011-2#1)
to cross##24##2##(1991-4#1)(1992-12#1)(1992-9#1)(1996-11#1)(1997-2#2)(1997-5#1)(2005-11#1)(2005-9#1)(2006-4#1)(2006-7#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-8#2)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#1)(2013-1#1)
to cross-link##6##2##(1992-9#1)(1993-11#3)(1995-12#1)(2008-2#1)
to cross-linked##3##2##(1993-5#1)(1996-3#2)
to cross-linking##2##2##(1996-5#1)(2008-6#1)
to cross-phase modulation can##2##4##(2007-12#2)
to cross-react with##2##3##(1997-1#1)(2008-7#1)
to cross-resistance##2##2##(2008-10#1)(2011-2#1)
to crossing##2##2##(2009-5#1)(2011-1#1)
to crosslink##2##2##(1991-1#1)(1993-8#1)
to crosslinking##2##2##(2008-10#1)(2012-2#1)
to crossover##2##2##(1995-8#1)(2005-11#1)
to crown rust were##2##4##(2008-10#2)
to crown rust##4##3##(2008-10#4)
to crown-7##2##2##(2008-10#2)
to crown-8##2##2##(2008-10#2)
to crude cyanobacterial extracts##2##4##(2008-10#2)
to crude##5##2##(1992-8#1)(1992-9#1)(2008-10#2)(2012-1#1)
to crush##2##2##(2008-9#1)(2010-9#1)
to crystal##4##2##(1990-7#1)(1997-1#1)(2007-12#1)(2008-2#1)
to crystalline silica##2##3##(2009-12#2)
to crystalline##6##2##(2009-12#2)(2010-6#2)(2010-7#2)
to crystallographic##2##2##(1995-5#1)(2006-4#1)
to cucumber##2##2##(2008-10#2)
to cue##2##2##(1990-12#1)(1997-7#1)
to cues of##2##3##(2009-9#1)(2010-8#1)
to cues which##2##3##(1993-6#1)(1995-5#1)
to cues##6##2##(1993-6#1)(1995-5#1)(2009-11#1)(2009-9#1)(2010-8#1)(2012-2#1)
to cultivar##3##2##(2008-10#2)(2011-10#1)
to cultivars##3##2##(2008-10#1)(2008-12#1)(2013-8#1)
to cultivate##11##2##(1991-9#1)(1992-12#1)(2007-4#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2009-8#1)(2010-4#1)(2013-1#1)
to cultivated##5##2##(2007-3#1)(2008-10#2)(2008-12#1)(2011-12#1)
to cultivation##2##2##(1991-11#1)(2008-11#1)
to cultural##8##2##(2005-10#1)(2006-7#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2010-7#1)(2011-2#1)
to culturally##4##2##(2004-12#1)(2008-4#1)(2009-3#1)(2010-7#1)
to culture and##3##3##(1995-12#1)(1997-8#1)(2008-4#1)
to culture dishes##2##3##(1996-5#1)(2008-11#1)
to culture medium##2##3##(1991-2#1)(2006-8#1)
to culture methods for##2##4##(2006-10#1)(2008-5#1)
to culture the##5##3##(1992-5#2)(2007-11#1)(2008-10#1)(2008-9#1)
to culture##33##2##(1990-9#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-5#2)(1993-12#1)(1993-2#1)(1994-6#1)(1995-12#1)(1996-5#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2011-1#2)
to cultured endothelial##2##3##(1994-5#1)(2008-1#1)
to cultured human##2##3##(1996-2#1)(2006-8#1)
to cultured mammalian cells##2##4##(2008-9#1)(2012-3#1)
to cultured##19##2##(1990-2#1)(1990-7#1)(1991-9#1)(1993-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-2#1)(1997-2#1)(2006-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-10#1)(2012-2#1)(2012-3#1)
to cultures of##7##3##(1991-11#1)(1993-9#1)(1996-4#1)(1996-8#1)(1996-9#1)(2008-11#1)(2011-2#1)
to cultures##12##2##(1990-11#1)(1991-1#1)(1991-10#1)(1991-11#1)(1993-9#1)(1995-10#1)(1996-4#1)(1996-8#1)(1996-9#1)(2008-10#1)(2008-11#1)(2011-2#1)
to cumulative##6##2##(2008-10#4)(2008-5#1)(2008-6#1)
to cupric##2##2##(2006-10#1)(2008-10#1)
to curative##2##2##(1994-3#1)(2007-8#1)
to curb the##4##3##(1997-5#1)(2007-4#1)(2007-6#1)(2010-5#1)
to curb##5##2##(1997-5#1)(2007-4#1)(2007-6#1)(2010-5#1)(2013-1#1)
to curbing##2##2##(2008-7#1)(2008-8#1)
to cure CML##3##3##(2010-4#2)(2011-1#1)
to cure a##2##3##(1993-2#1)(2008-1#1)
to cure or##3##3##(2007-3#1)(2008-1#1)(2013-7#1)
to cure patients with##2##4##(1993-2#1)(2008-1#1)
to cure the##6##3##(1995-8#1)(2007-11#1)(2007-8#1)(2008-6#1)(2010-12#1)(2012-3#1)
to cure##33##2##(1993-2#2)(1995-8#1)(1996-12#1)(2004-10#1)(2005-10#1)(2006-10#2)(2007-11#1)(2007-3#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#2)(2010-12#2)(2010-4#2)(2011-1#1)(2012-12#2)(2012-3#3)(2013-1#2)(2013-7#1)
to current and future##2##4##(2008-10#1)(2012-1#1)
to current reproduction##3##3##(2008-8#3)
to current therapy##2##3##(2009-5#1)(2010-1#1)
to current treatments##3##3##(2007-8#1)(2008-4#1)(2013-1#1)
to current work##2##3##(2008-11#1)(2008-12#1)
to current##54##2##(1994-9#1)(1995-7#1)(1996-1#1)(1996-2#2)(1996-5#1)(1997-4#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#5)(2009-2#2)(2009-5#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
to currently available##7##3##(1996-8#1)(2006-10#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-5#1)(2012-12#1)
to currently used##5##3##(1997-8#1)(2004-9#1)(2007-8#1)(2013-1#2)
to currently##17##2##(1990-6#1)(1996-8#1)(1997-8#1)(2004-9#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#2)(2009-12#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#2)
to curtail the##2##3##(2005-11#1)(2007-9#1)
to curtail##6##2##(1994-11#1)(1997-3#1)(2005-11#1)(2007-2#1)(2007-9#1)(2008-10#1)
to curved##2##2##(2007-12#1)(2011-2#1)
to customer##3##2##(1994-2#2)(1995-2#1)
to customers##6##2##(1995-12#1)(1995-3#1)(1996-7#1)(1997-3#1)(2007-2#1)(2007-5#1)
to customize##7##2##(1993-11#1)(2007-3#1)(2012-2#1)(2013-1#4)
to cut costs and##2##4##(1995-1#1)(1996-3#1)
to cut costs##5##3##(1990-4#1)(1995-1#1)(1996-3#1)(1997-2#1)(2008-9#1)
to cut the##3##3##(1996-1#1)(2006-6#1)(2011-1#1)
to cut##15##2##(1990-4#2)(1991-9#1)(1995-1#1)(1995-5#1)(1996-1#1)(1996-3#1)(1997-2#1)(2006-6#1)(2007-9#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-7#1)
to cutaneous##5##2##(1991-11#1)(2007-7#1)(2008-5#2)(2008-7#1)
to cw##3##2##(2007-12#1)(2008-1#1)(2008-2#1)
to cyanide##2##2##(1994-12#1)(2008-10#1)
to cyanogen bromide activated##2##4##(1990-5#1)(2008-7#1)
to cyclic AMP##3##3##(1992-6#1)(1995-1#1)(1997-2#1)
to cyclic##14##2##(1991-9#1)(1992-12#1)(1992-6#1)(1994-6#1)(1995-1#1)(1995-9#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-7#2)(2010-4#1)
to cyclical##2##2##(1995-11#1)(2008-11#1)
to cyclin##3##2##(1990-11#1)(1993-6#1)(2007-9#1)
to cycling##2##2##(1993-2#1)(2011-2#1)
to cyclists##3##2##(1990-6#3)
to cyclophosphamide##3##2##(1993-2#1)(2008-10#1)(2008-12#1)
to cyclosporin##2##2##(2007-11#2)
to cypermethrin##2##2##(2008-12#2)
to cyromazine##2##2##(2011-2#2)
to cyst##3##2##(1995-2#1)(2006-10#1)(2006-5#1)
to cystamine to##2##3##(2011-2#2)
to cysteine by##2##3##(1990-10#1)(1991-5#1)
to cysteine##11##2##(1990-10#1)(1991-5#1)(1992-8#2)(1993-11#1)(1993-9#1)(1994-8#1)(1995-8#1)(2008-10#1)(2008-3#1)(2012-12#1)
to cystic##5##2##(1992-9#1)(2005-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
to cytochrome P450##5##3##(1990-5#1)(1994-8#2)(1997-2#1)(2013-8#1)
to cytochrome c oxidase##2##4##(1994-9#1)(1995-2#1)
to cytochrome c##9##3##(1991-2#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#3)(1997-4#1)(2008-10#1)
to cytochrome oxidase##3##3##(1990-3#2)(1990-7#1)
to cytochrome##19##2##(1990-3#2)(1990-5#1)(1990-7#1)(1991-2#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#3)(1997-2#1)(1997-4#1)(2008-10#2)(2013-8#1)
to cytogenetic##2##2##(2007-11#1)(2010-4#1)
to cytokine therapy##2##3##(1996-10#1)(2009-11#1)
to cytokine##7##2##(1992-11#1)(1995-12#1)(1996-10#1)(1996-12#1)(2008-10#1)(2009-11#1)(2012-2#1)
to cytokine-activated##2##2##(1995-3#2)
to cytokine-induced##2##2##(2010-11#1)(2011-1#1)
to cytokines##5##2##(1990-2#1)(1996-5#1)(2007-12#1)(2008-4#1)(2010-11#1)
to cytomegalovirus (CMV)##2##3##(1992-6#1)(2009-2#1)
to cytomegalovirus##3##2##(1992-6#1)(2009-2#2)
to cytoplasm##2##2##(1991-2#1)(1997-7#1)
to cytoplasmic##8##2##(1990-7#1)(1991-10#1)(1994-9#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-9#1)
to cytosine##3##2##(1991-12#1)(1991-2#1)(2007-8#1)
to cytoskeletal-associated proteins##2##3##(1994-8#1)(1994-9#1)
to cytosol##2##2##(1992-5#1)(1994-3#1)
to cytosolic##3##2##(1994-5#1)(1994-9#1)(2008-7#1)
to cytotoxic agents##3##3##(1994-2#1)(2008-11#1)(2010-9#1)
to cytotoxic drugs##4##3##(1994-11#1)(2008-11#2)(2008-9#1)
to cytotoxic therapy##3##3##(1995-5#1)(2006-10#1)(2006-11#1)
to cytotoxic##16##2##(1990-1#1)(1991-12#1)(1992-7#1)(1994-11#1)(1994-2#1)(1995-5#1)(2006-10#1)(2006-11#1)(2008-11#4)(2008-7#1)(2008-9#1)(2010-9#1)(2013-1#1)
to cytotoxicity##5##2##(1993-11#1)(1994-2#1)(1995-7#1)(2008-5#1)(2010-12#1)
to d##2##2##(1994-9#1)(2008-10#1)
to d-lactic acid##2##3##(2008-11#2)
to dACT##2##2##(2008-9#2)
to dAMP##2##2##(1990-3#1)(1991-1#1)
to daily activities##2##3##(2009-6#1)(2009-8#1)
to daily fluctuations in##2##4##(2005-12#2)
to daily practice##2##3##(1992-9#1)(2007-10#1)
to daily##21##2##(1992-9#2)(1996-3#1)(1996-8#1)(1997-7#1)(2005-12#2)(2007-10#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2012-1#2)(2013-7#1)
to damage by##3##3##(1994-12#1)(1994-2#1)(2006-12#1)
to damage in##3##3##(1996-12#1)(2008-10#1)(2012-3#1)
to damage the##4##3##(1990-5#1)(1993-11#1)(1996-1#1)(1996-2#1)
to damage to##4##3##(1991-8#1)(1992-11#1)(1993-6#1)(2006-6#1)
to damage##37##2##(1990-12#1)(1990-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-7#1)(1993-11#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(2006-12#2)(2006-6#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2011-2#2)(2012-2#1)(2012-3#1)
to damaged##3##2##(1994-9#1)(1995-2#1)(2011-2#1)
to damaging##3##2##(1992-12#1)(1994-12#1)(2013-1#1)
to dams##2##2##(1992-9#1)(2008-10#1)
to dark brown##2##3##(2008-10#2)
to dark skin##2##3##(2008-11#1)(2008-5#1)
to dark##5##2##(2008-10#2)(2008-11#2)(2008-5#1)
to dasatinib##2##2##(2012-2#2)
to data analysis##4##3##(1995-6#1)(1996-6#1)(2008-12#1)(2008-4#1)
to data collected##3##3##(2008-5#1)(2010-5#1)(2010-8#1)
to data describing change in the number of##2##8##(2008-10#2)
to data describing##3##3##(2008-10#3)
to data for##4##3##(1993-12#1)(1996-11#1)(2005-11#1)(2008-2#1)
to data from a##5##4##(1993-9#1)(1997-3#2)(2010-1#1)(2010-8#1)
to data from the##6##4##(1992-3#1)(1997-3#1)(1997-8#1)(2007-5#1)(2009-7#1)(2011-12#1)
to data from##20##3##(1992-3#1)(1993-9#2)(1995-11#1)(1997-2#1)(1997-3#3)(1997-8#1)(2006-9#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-1#1)(2010-8#1)(2011-12#1)
to data obtained##3##3##(1990-10#1)(1994-2#1)(1997-6#1)
to data of##4##3##(1992-8#1)(1993-1#1)(2008-2#1)(2012-3#1)
to data on##7##3##(1995-3#1)(1997-7#1)(2004-2#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-1#1)
to data publishers##3##3##(2012-3#3)
to data##96##2##(1990-10#1)(1991-3#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-8#1)(1993-9#2)(1994-2#2)(1994-3#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-3#4)(1997-6#1)(1997-7#1)(1997-8#1)(2004-2#1)(2005-11#2)(2006-12#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-5#2)(2010-8#3)(2011-1#1)(2011-12#1)(2012-2#1)(2012-3#8)(2013-1#4)
to databases##2##2##(1996-6#1)(2008-4#1)
to date a##2##3##(2007-12#1)(2007-8#1)
to date about##3##3##(2005-9#1)(2007-12#1)(2011-2#1)
to date and##9##3##(1990-7#1)(1994-6#1)(2005-7#1)(2006-5#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-6#1)(2013-8#1)
to date are##5##3##(1995-8#1)(1997-3#1)(2007-11#1)(2009-3#1)(2012-2#1)
to date for the##2##4##(2007-11#1)(2007-8#1)
to date for##7##3##(2004-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2009-12#1)(2010-8#1)
to date from##5##3##(1993-11#1)(1997-5#1)(2008-2#2)(2010-9#1)
to date has##4##3##(2007-8#1)(2008-8#1)(2012-2#1)(2012-3#1)
to date have been##4##4##(1995-2#1)(2007-11#1)(2008-10#1)(2010-8#1)
to date have not##3##4##(2006-10#1)(2008-12#1)(2011-2#1)
to date have##17##3##(1995-12#2)(1995-2#1)(2006-10#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-11#1)(2010-8#1)(2011-2#2)(2012-1#1)(2013-1#1)
to date in patients with##2##5##(2008-5#1)(2010-12#1)
to date in##18##3##(1992-6#1)(1996-3#1)(1997-2#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-12#1)
to date include##2##3##(2007-11#1)(2008-4#1)
to date indicate that##2##4##(1993-8#1)(2008-1#1)
to date is that##2##4##(2008-1#1)(2008-3#1)
to date is##5##3##(1997-9#1)(2008-1#1)(2008-3#1)(2010-5#1)(2012-1#1)
to date it has been##2##5##(1994-4#1)(2008-2#1)
to date its##2##3##(2006-10#1)(2008-9#1)
to date make##2##3##(1991-12#1)(2007-8#1)
to date most##2##3##(2008-7#1)(2008-8#1)
to date no##2##3##(2008-5#1)(2009-2#1)
to date of a##2##4##(1990-3#1)(2008-8#1)
to date of the##2##4##(2007-11#1)(2013-1#1)
to date of##7##3##(1990-3#1)(2006-10#1)(2007-11#1)(2008-4#1)(2008-8#1)(2010-3#1)(2013-1#1)
to date on the##3##4##(2008-10#1)(2008-4#1)(2012-2#1)
to date on##8##3##(2006-10#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-4#1)(2010-9#1)(2012-2#1)
to date only##2##3##(1990-12#1)(2012-2#1)
to date show##2##3##(2006-2#1)(2011-2#1)
to date suggest that the##2##5##(2007-10#1)(2007-11#1)
to date suggest that##4##4##(2006-6#1)(2007-10#1)(2007-11#1)(2008-7#1)
to date suggests that##2##4##(1997-1#1)(2005-7#1)
to date supports the##2##4##(2007-11#1)(2008-10#1)
to date that##2##3##(1995-1#1)(2010-8#1)
to date the##5##3##(1991-10#1)(1993-12#2)(1995-7#1)(2008-10#1)
to date there are no##2##5##(2007-12#1)(2008-1#1)
to date there has been##2##5##(1992-1#1)(2008-8#1)
to date there have been no##2##6##(2008-7#1)(2010-12#1)
to date there##6##3##(1992-1#1)(2007-12#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-12#1)
to date with the##2##4##(2007-11#1)(2008-7#1)
to date##350##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#2)(1990-6#2)(1990-7#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-4#1)(1994-6#2)(1994-8#1)(1995-1#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-4#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#3)(1997-9#1)(2004-8#1)(2005-10#1)(2005-12#1)(2005-7#4)(2005-9#2)(2006-10#10)(2006-11#1)(2006-12#3)(2006-2#2)(2006-4#2)(2006-5#1)(2006-6#2)(2007-1#2)(2007-10#1)(2007-11#20)(2007-12#9)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#3)(2007-8#7)(2008-1#10)(2008-10#12)(2008-11#9)(2008-12#2)(2008-2#8)(2008-3#9)(2008-4#6)(2008-5#5)(2008-6#4)(2008-7#16)(2008-8#6)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#6)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#10)(2012-1#6)(2012-11#1)(2012-12#6)(2012-2#10)(2012-3#4)(2013-1#13)(2013-7#2)(2013-8#3)
to date)##2##2##(1993-9#1)(2013-1#1)
to daughter cells##3##3##(1992-11#1)(2008-9#1)(2009-3#1)
to daughters##2##2##(2006-12#1)(2012-3#1)
to day 10##2##3##(2008-5#1)(2010-7#1)
to day 14##5##3##(1996-12#1)(1997-6#1)(2006-6#1)(2008-8#1)(2011-2#1)
to day 16##2##3##(1996-12#1)(2008-9#1)
to day 21##2##3##(1996-12#1)(2013-8#1)
to day 3##2##3##(1996-5#1)(2009-9#1)
to day 6##4##3##(1995-2#1)(1997-4#1)(2009-3#1)(2010-7#1)
to day##39##2##(1992-10#1)(1993-12#1)(1993-7#1)(1994-2#1)(1995-2#1)(1996-12#3)(1996-5#1)(1997-3#1)(1997-4#1)(1997-6#2)(2006-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-9#1)(2010-7#4)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
to days##5##2##(2006-8#1)(2007-11#2)(2007-4#1)(2008-10#1)
to de##2##2##(2007-5#1)(2009-8#1)
to deactivate##4##2##(1995-8#1)(2006-10#1)(2008-5#1)(2010-1#1)
to deal with a##7##4##(2006-10#2)(2008-2#1)(2008-3#2)(2010-5#1)(2013-1#1)
to deal with daily##2##4##(2008-1#1)(2012-1#1)
to deal with many of the##2##6##(1996-1#1)(2008-10#1)
to deal with students##2##4##(2008-11#1)(2012-3#1)
to deal with such##2##4##(2007-4#1)(2012-3#1)
to deal with the issue##2##5##(2007-11#1)(2008-10#1)
to deal with the problem##2##5##(2008-4#1)(2012-3#1)
to deal with the problems##2##5##(1994-2#1)(1995-8#1)
to deal with the situation##3##5##(2008-2#1)(2010-12#1)(2012-2#1)
to deal with the##25##4##(1990-4#1)(1994-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-8#1)(1997-3#1)(1997-5#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
to deal with them##3##4##(2007-10#1)(2008-2#1)(2012-12#1)
to deal with these problems##3##5##(2006-10#1)(2008-2#1)(2010-10#1)
to deal with these##6##4##(1996-1#1)(2006-10#1)(2008-11#2)(2008-2#1)(2010-10#1)
to deal with this problem##2##5##(2007-10#1)(2008-6#1)
to deal with this##10##4##(1993-3#1)(1993-6#1)(2006-10#2)(2007-10#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-6#1)(2012-2#1)
to deal with violence##2##4##(1996-2#1)(2011-12#1)
to deal with##113##3##(1990-4#1)(1991-3#1)(1992-10#1)(1992-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-3#2)(1997-5#1)(2005-6#1)(2006-10#7)(2006-12#1)(2006-6#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-2#7)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#1)
to deal##120##2##(1990-4#1)(1991-3#1)(1992-10#1)(1992-12#1)(1993-1#1)(1993-2#2)(1993-3#2)(1993-6#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-3#2)(1997-5#1)(2005-6#1)(2006-10#7)(2006-12#1)(2006-6#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#7)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#5)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#1)
to dealing with##3##3##(1995-2#2)(2008-10#1)
to death and##3##3##(1995-1#1)(2006-10#1)(2011-2#1)
to death due to##2##4##(2009-4#1)(2011-2#1)
to death in##3##3##(2012-11#2)(2013-8#1)
to death of##3##3##(1992-10#1)(1996-7#1)(2006-1#1)
to death was##2##3##(1990-11#1)(2011-2#1)
to death within##3##3##(1997-3#1)(2010-12#1)(2012-3#1)
to death##50##2##(1990-11#1)(1991-1#1)(1991-12#1)(1992-10#1)(1993-6#2)(1993-7#1)(1995-1#1)(1995-2#1)(1996-7#2)(1997-3#1)(1997-4#1)(1997-8#1)(2004-11#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-4#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-9#3)(2009-2#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-11#2)(2012-3#2)(2013-1#2)(2013-8#1)
to deaths##2##2##(2006-10#1)(2008-6#1)
to debate##4##2##(2008-11#1)(2008-2#1)(2008-7#1)(2011-2#1)
to debilitating##3##2##(2006-11#1)(2007-7#1)(2010-12#1)
to debriefing##2##2##(2007-5#1)(2007-8#1)
to debulk##2##2##(2008-5#1)(2013-1#1)
to decay at##2##3##(1994-9#1)(2008-10#1)
to decay##5##2##(1994-9#1)(2007-12#1)(2008-10#2)(2008-2#1)
to decentralize##3##2##(2012-3#2)(2013-1#1)
to decentralized##2##2##(1992-12#1)(1994-2#1)
to decide between these##2##4##(1994-2#1)(1996-6#1)
to decide between##3##3##(1990-4#1)(1994-2#1)(1996-6#1)
to decide on the best##2##5##(1991-3#1)(2006-10#1)
to decide on the##7##4##(1991-3#1)(1993-6#1)(1995-2#1)(2006-10#2)(2009-8#1)(2010-12#1)
to decide on##9##3##(1991-3#1)(1992-9#1)(1993-6#1)(1995-2#1)(2006-10#2)(2007-11#1)(2009-8#1)(2010-12#1)
to decide the##12##3##(1992-4#1)(1993-2#1)(1996-2#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-8#1)
to decide when to##2##4##(2006-10#1)(2009-4#1)
to decide whether a##2##4##(1996-12#1)(2006-6#1)
to decide whether or not##2##5##(1995-4#1)(2007-2#1)
to decide whether the##2##4##(1993-2#1)(2008-11#1)
to decide whether to##3##4##(2007-7#1)(2008-2#1)(2012-2#1)
to decide whether##15##3##(1993-2#1)(1995-4#1)(1996-12#1)(2006-6#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-7#1)(2010-7#1)(2012-1#1)(2012-2#1)(2013-8#1)
to decide which##3##3##(2006-11#1)(2007-5#1)(2011-2#1)
to decide who##2##3##(1996-12#1)(2012-2#1)
to decide##59##2##(1990-4#1)(1991-3#1)(1992-4#1)(1992-9#1)(1993-2#2)(1993-6#1)(1994-2#1)(1995-2#1)(1995-4#1)(1995-9#1)(1996-12#2)(1996-2#2)(1996-6#1)(1997-7#1)(2005-3#1)(2006-10#3)(2006-11#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-8#2)
to deciding##2##2##(2009-10#1)(2011-2#1)
to decipher the##5##3##(1997-9#1)(2008-10#1)(2008-5#1)(2009-8#1)(2011-1#1)
to decipher##9##2##(1997-9#1)(2007-4#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-8#1)(2011-1#1)
to deciphering##2##2##(2007-12#1)(2008-8#1)
to decision makers##3##3##(1996-1#1)(2008-3#1)(2008-9#1)
to decision making##2##3##(2005-10#1)(2007-8#1)
to decision##6##2##(1993-12#1)(1996-1#1)(2005-10#1)(2007-8#1)(2008-3#1)(2008-9#1)
to decision-makers in##2##3##(2006-2#1)(2009-4#1)
to decision-makers##3##2##(2006-2#1)(2009-3#1)(2009-4#1)
to decision-making##3##2##(1996-1#1)(2009-2#1)(2011-2#1)
to decisions##3##2##(1996-6#1)(2008-10#1)(2008-11#1)
to declare##2##2##(2008-1#1)(2010-5#1)
to decline during##2##3##(1996-3#1)(1997-1#1)
to decline in the##3##4##(1997-2#1)(2011-2#2)
to decline in##4##3##(1997-2#1)(2006-10#1)(2011-2#2)
to decline to##2##3##(2006-9#1)(2008-4#1)
to decline with##2##3##(1990-2#1)(2009-3#1)
to decline##33##2##(1990-2#2)(1990-5#1)(1993-4#1)(1995-10#1)(1995-12#2)(1995-5#1)(1996-3#1)(1997-1#1)(1997-2#3)(1997-6#1)(2004-9#1)(2006-10#3)(2006-9#1)(2008-10#2)(2008-4#1)(2009-3#1)(2010-10#1)(2010-2#1)(2010-8#2)(2011-12#2)(2011-2#2)(2012-12#1)(2012-3#1)
to declining##2##2##(1992-3#1)(2008-1#1)
to decode a##2##3##(2008-2#1)(2008-3#1)
to decode the##2##3##(2007-12#1)(2008-3#1)
to decode##9##2##(2007-12#1)(2008-2#1)(2008-3#2)(2010-8#1)(2012-12#4)
to decompensated##2##2##(2011-2#1)(2013-1#1)
to decompose##8##2##(2006-10#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)
to decompress the spinal cord##2##5##(2006-8#1)(2007-11#1)
to decompress the##5##3##(2006-8#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-2#1)
to deconstruct##4##2##(2006-5#1)(2007-10#1)(2010-12#1)(2012-3#1)
to decontaminate##2##2##(2008-11#1)(2013-1#1)
to decorrelation##2##2##(2007-12#1)(2008-2#1)
to decouple##3##2##(2008-10#1)(2010-5#1)(2011-1#1)
to decrease after the##2##4##(1992-6#1)(2013-1#1)
to decrease after##4##3##(1992-6#1)(1997-6#1)(2010-4#1)(2013-1#1)
to decrease anxiety and##2##4##(1995-1#1)(2007-2#1)
to decrease as the##2##4##(1997-2#1)(2008-10#1)
to decrease as##4##3##(1995-2#1)(1997-2#1)(2008-10#1)(2009-5#1)
to decrease bone resorption##2##4##(1993-11#1)(1993-9#1)
to decrease cardiovascular##2##3##(2012-2#1)(2012-3#1)
to decrease from##2##3##(2008-6#1)(2008-8#1)
to decrease hot flashes##2##4##(2008-7#2)
to decrease in the##6##4##(2004-11#1)(2007-1#1)(2008-10#1)(2008-11#1)(2009-6#1)(2011-2#1)
to decrease in##19##3##(1992-6#1)(1992-8#1)(1994-12#1)(1994-5#1)(1995-1#1)(1997-4#1)(2004-11#1)(2006-8#1)(2007-1#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-7#1)(2009-4#1)(2009-6#1)(2011-2#1)
to decrease linearly##2##3##(1992-6#1)(1994-4#1)
to decrease morbidity and mortality##2##5##(2007-12#1)(2008-7#1)
to decrease morbidity##3##3##(2007-12#1)(2008-4#1)(2008-7#1)
to decrease of##3##3##(2005-8#1)(2010-4#1)(2011-12#1)
to decrease or##2##3##(2006-10#1)(2010-12#1)
to decrease over##2##3##(2008-6#1)(2012-12#1)
to decrease pain and anxiety##2##5##(2010-3#2)
to decrease risk##2##3##(2013-1#2)
to decrease significantly##2##3##(1996-12#1)(2004-9#1)
to decrease the detection limit##3##5##(2008-10#3)
to decrease the duration of##2##5##(1995-1#1)(2007-8#1)
to decrease the incidence of##5##5##(1993-3#1)(2006-10#1)(2008-1#1)(2011-2#2)
to decrease the incidence##8##4##(1993-3#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#2)(2012-1#1)
to decrease the level of##2##5##(1997-1#1)(2008-5#1)
to decrease the number of##6##5##(2006-6#1)(2007-7#1)(2008-3#1)(2011-2#2)(2012-3#1)
to decrease the production##2##4##(2006-10#1)(2008-10#1)
to decrease the rate of##5##5##(1990-12#1)(1997-4#1)(2010-4#1)(2011-1#1)(2011-2#1)
to decrease the risk of##12##5##(1990-6#1)(1991-2#1)(2006-5#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-6#1)
to decrease the risk##13##4##(1990-6#1)(1991-2#1)(2004-12#1)(2006-5#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-6#1)
to decrease the time##2##4##(2006-10#1)(2008-11#1)
to decrease the##86##3##(1990-12#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-2#1)(1991-7#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-6#1)(1995-1#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-12#1)(2004-9#1)(2006-10#4)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2009-10#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-4#2)(2011-1#1)(2011-2#8)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
to decrease their##5##3##(2008-1#1)(2008-12#1)(2008-2#1)(2010-9#1)(2012-2#1)
to decrease with increase in##2##5##(2005-11#1)(2013-1#1)
to decrease with the increase##2##5##(2007-11#1)(2008-10#1)
to decrease with the##4##4##(2006-6#1)(2007-11#1)(2008-10#1)(2008-3#1)
to decrease with##15##3##(1992-6#1)(1996-3#1)(1996-7#1)(2004-9#1)(2005-11#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-5#1)(2011-2#1)(2013-1#1)
to decrease##269##2##(1990-12#1)(1990-2#2)(1990-5#4)(1990-6#1)(1991-10#1)(1991-2#2)(1991-4#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-6#5)(1992-8#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#4)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(2004-11#1)(2004-12#2)(2004-9#4)(2005-11#2)(2005-8#1)(2006-10#10)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#6)(2007-2#3)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#5)(2008-10#20)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#10)(2008-4#5)(2008-5#4)(2008-6#3)(2008-7#10)(2008-8#6)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#3)(2010-4#5)(2010-8#1)(2010-9#4)(2011-1#3)(2011-12#1)(2011-2#13)(2011-7#1)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#5)(2012-3#5)(2013-1#9)(2013-8#3)
to decreased availability of##2##4##(2008-6#1)(2013-7#1)
to decreased cellular##4##3##(1996-12#2)(2006-10#1)(2009-6#1)
to decreased synthesis of##2##4##(2006-10#2)
to decreased##50##2##(1991-10#2)(1993-3#1)(1994-5#2)(1995-1#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-12#4)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-7#2)(2005-8#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-6#2)(2010-1#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
to decreases in##6##3##(1994-11#1)(2006-12#1)(2007-11#1)(2009-5#1)(2012-12#2)
to decreases##7##2##(1994-11#1)(2006-12#1)(2007-11#1)(2008-7#1)(2009-5#1)(2012-12#2)
to decreasing##5##2##(1994-5#1)(2008-1#1)(2009-8#1)(2010-7#1)(2011-12#1)
to dedifferentiate##2##2##(2008-11#1)(2008-9#1)
to deduce the##11##3##(1990-12#1)(1992-12#1)(2005-11#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-8#1)(2009-5#1)(2010-7#1)
to deduce##24##2##(1990-12#1)(1992-12#1)(1993-2#1)(1995-11#1)(1997-4#1)(1997-6#1)(2005-11#1)(2007-10#1)(2007-12#3)(2008-10#2)(2008-2#4)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-7#1)
to deep##11##2##(1992-1#1)(1992-3#1)(1993-12#2)(1993-4#1)(1997-5#1)(2006-10#1)(2007-7#1)(2010-10#1)(2012-3#1)(2013-8#1)
to deepen the##3##3##(2006-2#1)(2009-10#1)(2009-4#1)
to deepen##6##2##(1997-5#1)(2006-2#1)(2008-10#1)(2009-10#1)(2009-4#1)(2013-7#1)
to defect##2##2##(1995-8#1)(2009-2#1)
to defective##5##2##(1991-4#1)(1992-10#1)(2008-4#1)(2011-1#1)(2012-2#1)
to defects in the##5##4##(1993-6#1)(2007-10#1)(2008-5#1)(2012-12#2)
to defects in##10##3##(1990-5#1)(1993-6#1)(1995-8#1)(2006-11#1)(2007-10#2)(2008-1#1)(2008-5#1)(2012-12#2)
to defects##12##2##(1990-5#1)(1993-6#1)(1995-8#1)(2006-11#1)(2006-3#1)(2007-10#2)(2008-1#1)(2008-3#1)(2008-5#1)(2012-12#2)
to defence##2##2##(1992-12#1)(1994-6#1)
to defend against##4##3##(1995-6#1)(1997-5#1)(2008-2#1)(2012-1#1)
to defend themselves against##2##4##(1993-3#1)(1997-5#1)
to defend themselves##6##3##(1990-9#1)(1993-3#1)(1997-5#2)(2008-10#1)(2012-12#1)
to defend##15##2##(1990-9#1)(1993-3#1)(1995-6#1)(1997-5#3)(2004-1#1)(2006-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-3#1)(2012-1#1)(2012-12#1)
to defense and##2##3##(2008-8#1)(2009-8#1)
to defense##3##2##(1992-11#1)(2008-8#1)(2009-8#1)
to deficiencies in##2##3##(1996-2#1)(2011-2#1)
to deficiencies##3##2##(1996-2#1)(2007-10#1)(2011-2#1)
to deficiency of##2##3##(2008-4#1)(2012-2#1)
to deficiency##3##2##(2006-10#1)(2008-4#1)(2012-2#1)
to deficits##2##2##(2007-10#2)
to define a##18##3##(1990-11#1)(1994-2#1)(2006-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#4)
to define an##6##3##(1991-12#1)(2006-10#1)(2008-1#1)(2010-9#1)(2013-1#2)
to define and##13##3##(1996-12#1)(1997-3#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-4#1)(2008-9#1)(2009-4#1)(2011-1#1)(2011-2#2)(2013-1#2)
to define clinical##2##3##(1991-5#1)(2005-8#1)
to define further##2##3##(2007-8#1)(2010-2#1)
to define in##5##3##(1995-3#1)(2006-10#1)(2010-7#2)(2012-3#1)
to define its role##3##4##(1994-3#1)(1996-12#1)(2008-10#1)
to define its##7##3##(1990-4#1)(1994-3#1)(1996-12#1)(2008-10#2)(2008-5#1)(2008-7#1)
to define more##6##3##(2005-10#1)(2006-10#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-7#1)
to define optimal##3##3##(2007-12#1)(2011-2#2)
to define specific reading disability##2##5##(2004-10#2)
to define specific##4##3##(1990-11#1)(2004-10#2)(2013-8#1)
to define susceptibility##2##3##(1997-8#1)(2007-7#1)
to define the best##3##4##(1992-9#1)(2007-12#1)(2007-7#1)
to define the mechanisms##2##4##(1992-9#1)(2008-11#1)
to define the potential##2##4##(1994-5#1)(2010-12#1)
to define the role of##10##5##(1990-12#1)(1993-11#1)(1993-3#1)(1994-11#1)(1995-2#1)(1995-5#1)(2007-11#1)(2007-7#1)(2008-4#1)(2009-3#1)
to define the role##12##4##(1990-12#1)(1992-12#1)(1993-11#1)(1993-3#1)(1994-11#1)(1995-2#1)(1995-5#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-4#1)(2009-3#1)
to define the scope of the##2##6##(2004-7#1)(2008-11#1)
to define the severity of##3##5##(2009-5#1)(2013-1#1)(2013-8#1)
to define the term##3##4##(1996-8#1)(2013-1#2)
to define the##136##3##(1990-12#2)(1990-4#1)(1991-1#1)(1991-10#1)(1991-4#1)(1991-5#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-9#3)(1993-11#1)(1993-2#1)(1993-3#2)(1993-7#1)(1994-11#1)(1994-2#2)(1994-5#1)(1994-6#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-6#1)(1996-7#1)(1996-8#3)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-7#1)(2005-7#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#2)
to define their##2##3##(2009-3#1)(2012-2#1)
to define these##2##3##(1995-12#1)(2006-10#1)
to define this##3##3##(1997-6#1)(2008-2#1)(2012-11#1)
to define whether##3##3##(1996-11#1)(2008-3#1)(2013-7#1)
to define which##2##3##(2011-2#1)(2012-11#1)
to define##322##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-4#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-4#1)(1991-5#2)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-9#5)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#2)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-2#3)(1995-3#3)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-11#3)(1996-12#3)(1996-2#3)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#3)(1997-1#1)(1997-3#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#4)(2004-10#2)(2004-7#1)(2005-10#1)(2005-7#2)(2005-8#3)(2006-10#11)(2006-11#5)(2006-12#1)(2006-2#4)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#3)(2007-10#1)(2007-11#6)(2007-12#5)(2007-2#1)(2007-3#2)(2007-4#3)(2007-5#1)(2007-7#6)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#9)(2008-3#11)(2008-4#3)(2008-5#4)(2008-6#4)(2008-7#11)(2008-8#2)(2008-9#8)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#6)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#3)(2010-8#1)(2010-9#3)(2011-1#7)(2011-2#11)(2012-1#1)(2012-11#3)(2012-12#4)(2012-2#5)(2012-3#6)(2013-1#17)(2013-7#3)(2013-8#3)
to defined##11##2##(1990-11#1)(1994-5#1)(1995-12#1)(1995-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-7#1)
to defining##6##2##(1991-6#1)(1997-1#1)(1997-4#1)(2007-3#1)(2008-6#1)(2010-4#1)
to definite##2##2##(2006-2#1)(2008-10#1)
to definitely##2##2##(1994-5#1)(2008-4#1)
to definitive##2##2##(1991-10#1)(2010-6#1)
to definitively##3##2##(1992-5#1)(2007-11#1)(2010-12#1)
to deflect##3##2##(1990-3#1)(2006-11#1)(2009-6#1)
to deform##5##2##(2006-7#1)(2007-6#1)(2009-7#2)(2010-5#1)
to deformation##5##2##(2007-8#1)(2008-2#1)(2008-8#1)(2013-8#2)
to degenerate##2##2##(1992-12#1)(2007-12#1)
to degeneration##4##2##(1991-10#1)(1996-9#1)(2007-11#1)(2011-2#1)
to degenerative##5##2##(1990-2#1)(1997-6#1)(2006-2#1)(2006-8#1)(2008-12#1)
to deglycosylated##4##2##(1990-2#1)(1990-8#1)(1991-12#1)(1991-9#1)
to degradation by##3##3##(1990-9#1)(1993-3#1)(1995-8#1)
to degradation of the##2##4##(2008-10#1)(2013-1#1)
to degradation of##4##3##(1990-10#1)(1991-8#1)(2008-10#1)(2013-1#1)
to degradation##16##2##(1990-10#1)(1990-5#1)(1990-9#1)(1991-8#1)(1991-9#1)(1993-3#1)(1993-7#1)(1995-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)(2013-1#1)
to degrade cell##2##3##(1990-1#1)(1991-4#1)
to degrade cellulose##2##3##(2006-8#1)(2011-2#1)
to degrade the##3##3##(1992-9#1)(2008-1#1)(2011-1#1)
to degrade these##2##3##(2006-10#1)(2008-5#1)
to degrade##37##2##(1990-1#1)(1990-10#2)(1990-2#1)(1990-8#1)(1991-4#1)(1992-9#1)(1995-11#1)(1997-2#1)(1997-7#1)(2004-4#2)(2006-10#1)(2006-3#1)(2006-8#1)(2008-1#1)(2008-10#5)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-8#1)
to degranulate##2##2##(2006-10#1)(2011-2#1)
to degranulation##2##2##(1991-8#1)(1994-2#1)
to dehydration##2##2##(2007-12#1)(2012-2#1)
to dehydrogenation##2##2##(1993-4#1)(1993-6#1)
to delay a##2##3##(2007-9#1)(2011-2#1)
to delay in##2##3##(1990-3#1)(2007-10#1)
to delay or prevent##2##4##(2006-11#1)(2008-10#1)
to delay or##8##3##(1990-11#1)(1994-5#1)(1997-4#1)(2006-11#1)(2008-1#1)(2008-10#1)(2009-5#1)(2011-2#1)
to delay the##13##3##(1990-3#1)(1993-11#1)(1993-3#1)(1995-12#1)(1996-3#1)(2007-7#1)(2008-10#1)(2008-5#2)(2009-8#1)(2010-4#1)(2012-3#1)(2013-8#1)
to delay##41##2##(1990-11#1)(1990-3#2)(1993-11#1)(1993-3#1)(1994-2#1)(1994-5#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-4#1)(2004-1#1)(2004-9#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2009-5#2)(2009-8#1)(2010-12#1)(2010-4#2)(2011-2#2)(2012-12#2)(2012-3#2)(2013-8#1)
to delayed diagnosis and##2##4##(2007-2#1)(2007-5#1)
to delayed##22##2##(1990-3#1)(1992-3#1)(1994-2#1)(1996-10#1)(1997-3#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-1#1)(2011-12#1)(2012-11#1)(2012-2#2)(2013-1#1)
to delays##2##2##(2008-5#1)(2009-8#1)
to delete the##2##3##(1990-2#1)(2012-3#1)
to delete##9##2##(1990-2#1)(1990-3#1)(1992-4#1)(1995-1#1)(2008-4#1)(2008-8#2)(2010-2#1)(2012-3#1)
to deletions##3##2##(2008-10#1)(2008-6#1)(2012-3#1)
to deliberate##2##2##(1996-2#1)(2009-4#1)
to delimit the##3##3##(2008-10#1)(2011-12#1)(2012-12#1)
to delimit##6##2##(2006-10#1)(2008-10#2)(2010-9#1)(2011-12#1)(2012-12#1)
to delineate a##3##3##(1992-12#1)(2008-6#1)(2012-2#1)
to delineate the##20##3##(1990-2#1)(1990-6#1)(1994-9#1)(1995-10#1)(1996-1#1)(2005-8#1)(2006-10#1)(2007-6#1)(2008-5#2)(2009-4#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#3)
to delineate##43##2##(1990-2#2)(1990-3#1)(1990-6#1)(1992-12#1)(1993-7#1)(1994-9#1)(1995-10#1)(1995-5#1)(1996-1#1)(1997-6#1)(1997-7#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-3#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-4#1)(2009-6#1)(2010-12#2)(2010-6#2)(2011-1#1)(2012-12#2)(2012-2#2)(2013-1#6)
to delinquent##2##2##(2009-7#1)(2010-5#1)
to delirium##2##2##(2011-12#1)(2013-1#1)
to deliver DNA##2##3##(1994-3#1)(2008-4#1)
to deliver a##12##3##(1994-8#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-10#1)(2011-2#2)(2012-3#1)
to deliver and##4##3##(2007-8#1)(2008-3#1)(2008-8#1)(2010-10#1)
to deliver genes##2##3##(2008-4#1)(2008-7#1)
to deliver high quality##2##4##(1994-3#1)(1997-1#1)
to deliver high##3##3##(1994-3#1)(1997-1#2)
to deliver live cells##2##4##(2009-8#2)
to deliver multiple##3##3##(1994-2#1)(2006-10#1)(2010-8#1)
to deliver the##17##3##(2005-7#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#1)(2009-4#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)
to deliver therapeutic##2##3##(2009-8#1)(2012-1#1)
to deliver therapy##2##3##(2009-10#1)(2011-2#1)
to deliver throughputs in##2##4##(2008-7#2)
to deliver##146##2##(1990-12#1)(1991-1#1)(1991-11#1)(1992-12#1)(1992-5#1)(1993-2#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#3)(1997-1#3)(1997-3#1)(1997-4#2)(2005-12#1)(2005-7#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#4)(2007-2#3)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#6)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#5)(2008-5#7)(2008-6#2)(2008-7#11)(2008-8#3)(2008-9#1)(2009-10#3)(2009-11#1)(2009-2#2)(2009-4#4)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#4)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#6)
to delivered##2##2##(2007-12#1)(2008-6#1)
to delivering##6##2##(2006-10#1)(2008-7#1)(2009-9#1)(2013-1#3)
to delivery of##3##3##(1994-3#1)(2011-1#1)(2012-1#1)
to delivery##14##2##(1990-9#2)(1994-3#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-6#1)(2006-1#1)(2007-12#1)(2008-5#1)(2008-8#1)(2011-1#1)(2012-1#1)(2012-2#1)
to delta 9-THC##2##3##(1991-4#1)(1995-10#1)
to delta 9-tetrahydrocannabinol##3##3##(1991-4#1)(1995-10#2)
to delta delta##2##3##(1991-7#1)(1994-11#1)
to delta##10##2##(1991-4#2)(1991-7#1)(1994-11#1)(1994-8#1)(1995-10#3)(1995-6#1)(1997-2#1)
to delta-##2##2##(1990-2#1)(1996-12#1)
to demand or##2##3##(1995-12#1)(1996-3#1)
to demand##8##2##(1990-9#1)(1991-6#1)(1995-12#1)(1996-3#1)(1997-1#1)(2006-8#1)(2008-11#1)(2010-3#1)
to demands##2##2##(1993-4#1)(2007-5#1)
to dementia care##2##3##(2010-11#1)(2011-2#1)
to dementia##8##2##(1996-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-11#1)(2010-11#1)(2011-2#1)(2013-8#1)
to demethylation inhibitor fungicides##2##4##(2008-10#2)
to demodulate##4##2##(2008-3#4)
to demographic and##3##3##(2006-10#1)(2009-5#1)(2011-11#1)
to demographic variables##2##3##(1996-9#1)(2012-2#1)
to demographic##10##2##(1996-9#1)(1997-5#1)(1997-6#1)(2006-10#1)(2007-2#2)(2009-5#1)(2010-9#1)(2011-11#1)(2012-2#1)
to demonstrate a##17##3##(1990-12#1)(1991-6#1)(1992-8#1)(1993-11#1)(1995-5#2)(2004-1#1)(2006-10#2)(2007-11#2)(2007-7#1)(2008-2#1)(2008-7#1)(2009-9#1)(2012-2#1)(2012-3#1)
to demonstrate an association between##3##5##(2008-3#1)(2011-1#1)(2012-3#1)
to demonstrate an##9##3##(1994-6#1)(1997-4#1)(2007-12#1)(2008-3#2)(2008-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
to demonstrate and##3##3##(1990-11#1)(1996-11#1)(2005-11#1)
to demonstrate any##4##3##(1990-6#1)(1991-12#1)(2009-4#1)(2011-1#1)
to demonstrate binding##2##3##(2006-12#1)(2008-5#1)
to demonstrate different##2##3##(1991-2#1)(2008-3#1)
to demonstrate efficacy##2##3##(2007-11#1)(2013-1#1)
to demonstrate his##2##3##(2007-5#1)(2008-12#1)
to demonstrate how##12##3##(1991-2#1)(1992-2#1)(2005-12#1)(2005-7#1)(2007-9#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-3#1)(2012-12#1)(2013-1#1)
to demonstrate its potential##2##4##(2007-12#1)(2008-3#1)
to demonstrate its##5##3##(1992-1#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-3#1)
to demonstrate statistically##2##3##(1997-5#1)(2008-1#1)
to demonstrate that PptT##2##4##(2013-1#2)
to demonstrate that a##3##4##(1990-5#1)(2006-10#1)(2008-10#1)
to demonstrate that the##18##4##(1991-10#1)(1991-3#1)(1991-7#1)(1993-6#1)(1995-1#1)(1997-1#1)(1997-4#1)(2007-11#1)(2007-5#1)(2008-10#4)(2008-2#1)(2010-11#1)(2011-1#1)(2012-2#1)(2012-3#1)
to demonstrate that there##2##4##(1991-2#1)(1997-7#1)
to demonstrate that##73##3##(1990-10#1)(1990-5#1)(1991-10#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-12#2)(1992-7#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-12#1)(1994-2#1)(1995-1#3)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-11#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#3)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
to demonstrate the antibacterial##2##4##(2008-5#2)
to demonstrate the applicability##2##4##(2008-10#1)(2008-3#1)
to demonstrate the capabilities of the##2##6##(2007-7#1)(2008-2#1)
to demonstrate the capability of the##2##6##(2008-10#1)(2008-2#1)
to demonstrate the capability##3##4##(2008-10#1)(2008-2#1)(2008-5#1)
to demonstrate the concept##2##4##(2008-2#1)(2008-3#1)
to demonstrate the effect of##3##5##(2008-2#1)(2008-7#1)(2012-2#1)
to demonstrate the effectiveness of the##2##6##(2008-3#1)(2010-2#1)
to demonstrate the effects of##2##5##(1990-8#1)(1995-5#1)
to demonstrate the effects##3##4##(1990-8#1)(1995-5#1)(2007-12#1)
to demonstrate the efficacy of##4##5##(2005-9#1)(2008-8#2)(2013-1#1)
to demonstrate the feasibility of the##4##6##(2008-11#1)(2008-3#2)(2011-2#1)
to demonstrate the feasibility of##13##5##(2005-8#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-9#1)(2011-2#1)(2013-1#1)
to demonstrate the high##2##4##(2008-10#2)
to demonstrate the importance of##2##5##(2008-3#1)(2009-4#1)
to demonstrate the performance of the##3##6##(2007-9#1)(2008-10#2)
to demonstrate the performance of##4##5##(2007-9#1)(2008-10#2)(2008-3#1)
to demonstrate the potential of this##2##6##(2008-3#1)(2012-1#1)
to demonstrate the potential of##5##5##(2006-2#1)(2007-12#1)(2008-3#2)(2012-1#1)
to demonstrate the potential##7##4##(2006-2#1)(2007-12#1)(2008-12#1)(2008-3#2)(2008-8#1)(2012-1#1)
to demonstrate the presence of##4##5##(1994-11#1)(2007-12#1)(2010-12#1)(2013-8#1)
to demonstrate the reliability##2##4##(2008-10#1)(2012-3#1)
to demonstrate the significance of the##2##6##(1991-12#1)(2008-10#1)
to demonstrate the use of##5##5##(1995-2#1)(2008-11#1)(2008-2#1)(2009-8#1)(2010-2#1)
to demonstrate the usefulness of this##2##6##(2008-10#1)(2011-1#1)
to demonstrate the utility of##2##5##(1996-8#1)(2008-7#1)
to demonstrate the validity##2##4##(2008-10#1)(2008-3#1)
to demonstrate the##151##3##(1990-5#2)(1990-8#1)(1991-12#1)(1993-7#1)(1994-11#3)(1994-2#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-2#1)(1996-8#2)(1997-6#2)(2005-10#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-2#2)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#6)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#21)(2008-11#3)(2008-12#1)(2008-2#9)(2008-3#15)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#4)(2009-12#2)(2009-2#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#5)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
to demonstrate their##7##3##(1996-5#1)(2005-8#1)(2006-12#1)(2007-5#1)(2008-10#1)(2008-5#2)
to demonstrate these##2##3##(1992-6#1)(2008-6#1)
to demonstrate this##4##3##(1993-7#1)(1996-7#1)(2008-3#1)(2008-6#1)
to demonstrate to##2##3##(2006-8#1)(2012-3#1)
to demonstrate whether##3##3##(2008-10#1)(2008-9#1)(2010-4#1)
to demonstrate##389##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-12#4)(1991-2#3)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#1)(1994-2#3)(1994-6#2)(1995-1#3)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#4)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#1)(2004-1#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-7#1)(2005-8#4)(2005-9#1)(2006-10#10)(2006-11#1)(2006-12#4)(2006-2#3)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#7)(2007-12#11)(2007-2#2)(2007-4#1)(2007-5#4)(2007-7#6)(2007-8#2)(2007-9#4)(2008-1#3)(2008-10#34)(2008-11#7)(2008-12#4)(2008-2#15)(2008-3#24)(2008-4#5)(2008-5#13)(2008-6#4)(2008-7#15)(2008-8#8)(2008-9#6)(2009-12#3)(2009-2#3)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-11#3)(2010-12#3)(2010-2#3)(2010-3#3)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#11)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#5)(2013-1#12)(2013-8#2)
to demonstrating##4##2##(1996-8#1)(2007-12#1)(2011-2#1)(2012-2#1)
to denaturation##4##2##(1990-8#1)(2008-3#1)(2008-4#1)(2008-7#1)
to denature##3##2##(1993-2#1)(1996-5#1)(2008-8#1)
to denaturing##2##2##(1994-8#1)(1994-9#1)
to dendrites##2##2##(1997-8#1)(2010-2#1)
to dendritic##2##2##(2007-12#1)(2008-11#1)
to dengue##2##2##(2004-11#1)(2008-1#1)
to denote##3##2##(1992-4#1)(2007-7#1)(2012-2#1)
to density##3##2##(2008-10#1)(2008-8#1)(2010-8#1)
to dental care##3##3##(2006-2#1)(2008-9#1)(2012-2#1)
to dental caries##2##3##(2007-7#1)(2008-9#1)
to dental treatment##5##3##(2005-3#1)(2008-1#1)(2011-2#1)(2012-11#1)(2012-2#1)
to dental##26##2##(1990-5#1)(1991-3#1)(1991-6#1)(2004-9#1)(2005-3#1)(2006-2#4)(2007-7#1)(2008-1#3)(2008-7#1)(2008-9#2)(2010-2#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-2#2)(2013-8#2)
to dentin##4##2##(1990-2#1)(2009-9#1)(2011-12#1)(2013-1#1)
to dentistry##3##2##(2009-4#1)(2012-1#1)(2012-3#1)
to dentists##3##2##(2006-8#1)(2008-9#1)(2013-1#1)
to denture##2##2##(2013-8#2)
to deny##8##2##(1991-2#1)(1994-12#1)(1996-12#1)(2006-10#1)(2008-12#1)(2009-11#1)(2009-9#1)(2012-3#1)
to department##2##2##(1993-2#1)(2008-1#1)
to depend crucially on##2##4##(1994-8#1)(2011-1#1)
to depend on a##4##4##(1990-6#1)(1994-12#1)(2008-10#1)(2008-8#1)
to depend on the##26##4##(1990-3#1)(1991-1#1)(1991-2#1)(1991-4#1)(1992-12#1)(1992-6#1)(1994-11#1)(1996-1#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-7#4)(2008-8#1)(2011-1#1)(2013-1#1)
to depend on##57##3##(1990-3#1)(1990-6#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-6#2)(2005-10#1)(2005-11#2)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#3)(2008-3#2)(2008-7#6)(2008-8#4)(2008-9#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#1)
to depend primarily on the##2##5##(1992-6#1)(2007-10#1)
to depend strongly on the##6##5##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-5#1)
to depend strongly on##8##4##(2007-11#2)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)
to depend upon their##2##4##(1991-2#1)(1996-6#1)
to depend upon##6##3##(1991-2#1)(1992-6#1)(1992-9#1)(1995-5#1)(1996-6#1)(1997-8#1)
to depend##82##2##(1990-3#2)(1990-6#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1992-12#1)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#3)(2006-10#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#3)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#6)(2008-8#4)(2008-9#2)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#1)
to dephosphorylate##2##2##(1994-9#1)(2012-2#1)
to depict the##5##3##(1991-1#1)(2010-10#1)(2010-12#2)(2012-1#1)
to depict##10##2##(1991-1#1)(2004-11#1)(2007-4#1)(2010-10#1)(2010-12#3)(2010-4#1)(2012-1#1)(2012-12#1)
to deplete the##4##3##(1992-12#1)(1994-6#1)(2008-4#1)(2008-9#1)
to deplete##12##2##(1992-12#1)(1992-8#1)(1993-12#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-4#1)(1997-6#1)(2008-3#1)(2008-4#1)(2008-9#1)
to depletion of##5##3##(1994-3#1)(1996-8#1)(1996-9#1)(2008-7#1)(2012-2#1)
to deploy##5##2##(1996-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2012-1#1)
to deployment of##2##3##(2008-10#1)(2011-2#1)
to deployment##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
to depolarization##8##2##(1991-7#1)(1994-2#1)(1996-3#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-2#2)
to depolarizing##3##2##(1992-12#1)(1995-12#2)
to deposit the##2##3##(1994-12#1)(2008-10#1)
to deposit##10##2##(1992-1#1)(1994-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2010-4#1)(2012-1#1)(2013-1#1)
to deposition and##2##3##(1997-1#1)(2012-11#1)
to deposition##4##2##(1997-1#1)(2008-10#1)(2009-2#1)(2012-11#1)
to deposits##2##2##(2007-9#1)(2008-10#1)
to depress##2##2##(1992-6#1)(2013-8#1)
to depressed##6##2##(1997-8#1)(2006-3#1)(2006-6#1)(2008-3#1)(2011-1#1)(2011-2#1)
to depression and##2##3##(2006-7#1)(2008-7#1)
to depression##11##2##(2004-3#1)(2006-7#1)(2007-12#2)(2008-1#1)(2008-12#1)(2008-7#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-2#1)
to depressive symptoms##2##3##(2007-12#1)(2011-2#1)
to depressive##4##2##(2007-12#1)(2007-7#1)(2009-5#1)(2011-2#1)
to deproteinize##2##2##(1997-8#1)(2010-4#1)
to deprotonation of the##2##4##(2006-10#1)(2008-10#1)
to deprotonation of##3##3##(2006-10#1)(2008-10#2)
to depth##4##2##(2006-12#1)(2008-2#1)(2008-5#1)(2011-2#1)
to depths of##3##3##(2007-12#1)(2008-3#1)(2009-4#1)
to depths##4##2##(2007-12#1)(2008-3#2)(2009-4#1)
to derepression##2##2##(1991-6#1)(2011-2#1)
to derivatization##3##2##(1990-8#1)(1991-8#1)(1993-2#1)
to derivatize##2##2##(2008-10#2)
to derive a##22##3##(1991-7#1)(1992-12#1)(1992-3#1)(1995-8#1)(2007-12#2)(2007-8#2)(2008-10#3)(2008-2#1)(2008-3#2)(2008-7#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-12#2)(2013-7#1)
to derive accurate##2##3##(2008-2#1)(2008-8#1)
to derive an exact##2##4##(2007-12#1)(2010-12#1)
to derive an##5##3##(2007-12#2)(2009-3#1)(2010-12#1)(2012-2#1)
to derive any##2##3##(1993-1#1)(2008-5#1)
to derive from the##3##4##(1992-3#1)(1993-12#1)(2012-12#1)
to derive the optical##2##4##(2008-2#2)
to derive the##29##3##(1995-9#1)(1996-7#1)(1997-2#1)(2006-10#2)(2007-7#1)(2008-11#1)(2008-2#8)(2008-3#8)(2008-5#1)(2008-7#2)(2008-8#1)(2009-7#1)(2012-2#1)
to derive##111##2##(1991-7#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-1#1)(1993-12#1)(1994-3#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#1)(2005-11#2)(2006-10#2)(2006-9#2)(2007-11#1)(2007-12#4)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#14)(2008-3#15)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-7#3)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#5)(2012-2#3)(2013-7#1)
to dermatologists##3##2##(2008-1#1)(2008-5#1)(2010-8#1)
to describe a case of##5##5##(2007-3#2)(2011-1#1)(2011-2#1)(2013-1#1)
to describe a case##6##4##(2007-3#2)(2007-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
to describe a##36##3##(1990-9#1)(1991-2#1)(1994-1#1)(1994-2#1)(1997-5#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#2)
to describe an##3##3##(2004-10#1)(2008-5#1)(2012-2#1)
to describe and classify##3##4##(2008-11#1)(2008-2#1)(2012-11#1)
to describe and compare##3##4##(2008-10#1)(2013-1#1)(2013-7#1)
to describe and explain##2##4##(2007-1#1)(2008-5#1)
to describe and##20##3##(1992-12#2)(2007-1#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#1)(2009-5#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-11#1)(2012-12#3)(2013-1#1)(2013-7#1)
to describe by##2##3##(2008-11#1)(2011-12#1)
to describe cases##2##3##(1993-7#1)(2013-1#1)
to describe correctly the##2##4##(2008-2#2)
to describe general##2##3##(1996-12#1)(2007-2#1)
to describe how the##2##4##(1994-3#1)(2012-2#1)
to describe how##9##3##(1992-2#1)(1994-3#1)(2006-10#1)(2007-12#1)(2008-4#1)(2008-8#1)(2009-4#1)(2012-2#1)(2013-1#1)
to describe human##2##3##(2008-2#1)(2011-1#1)
to describe in more detail##2##5##(2006-10#1)(2008-3#1)
to describe in##3##3##(2006-10#1)(2008-1#1)(2008-3#1)
to describe its##3##3##(2007-12#1)(2008-6#1)(2011-2#1)
to describe our##3##3##(2008-2#1)(2011-12#1)(2012-1#1)
to describe quantitatively the##2##4##(1994-7#1)(2007-6#1)
to describe some##2##3##(2010-11#1)(2011-2#1)
to describe the basic##2##4##(2008-3#1)(2011-2#1)
to describe the changes in##2##5##(2006-6#1)(2006-8#1)
to describe the characteristics##2##4##(2011-1#1)(2013-1#1)
to describe the clinical features##2##5##(2010-5#1)(2012-2#1)
to describe the clinical##5##4##(2007-12#1)(2007-2#1)(2007-8#1)(2010-5#1)(2012-2#1)
to describe the current##2##4##(2006-2#1)(2011-1#1)
to describe the distribution of##3##5##(1992-8#1)(1996-5#1)(2006-8#1)
to describe the distribution##4##4##(1992-8#1)(1996-5#1)(2006-8#1)(2011-2#1)
to describe the dynamics of##2##5##(2008-10#1)(2012-3#1)
to describe the epidemiology##2##4##(2005-8#1)(2009-4#1)
to describe the evolution##2##4##(2005-11#1)(2007-11#1)
to describe the experience of##2##5##(2010-3#1)(2013-1#1)
to describe the frequency##2##4##(1991-2#1)(2007-7#1)
to describe the general##2##4##(2007-11#1)(2008-9#1)
to describe the incidence##2##4##(2012-12#2)
to describe the increase##2##4##(1995-11#1)(2008-2#1)
to describe the influence of##2##5##(2008-2#1)(2008-3#1)
to describe the kinetics##2##4##(2008-5#1)(2010-5#1)
to describe the normal##2##4##(1994-4#1)(2012-2#1)
to describe the process of##3##5##(2008-3#1)(2012-1#1)(2013-7#1)
to describe the process##5##4##(2008-3#1)(2008-9#1)(2009-9#1)(2012-1#1)(2013-7#1)
to describe the propagation##2##4##(2008-3#1)(2008-7#1)
to describe the relation between##2##5##(1991-11#1)(2008-2#1)
to describe the relationship between##5##5##(2006-10#1)(2008-10#1)(2008-6#1)(2010-8#1)(2011-1#1)
to describe the role of##2##5##(1992-1#1)(2012-12#1)
to describe the time##2##4##(2008-7#1)(2010-12#1)
to describe the type##2##4##(2009-3#1)(2011-2#1)
to describe the use of##3##5##(2008-6#1)(2011-2#1)(2012-2#1)
to describe the##270##3##(1990-11#2)(1990-12#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-2#2)(1992-1#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#2)(1993-12#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-2#1)(1994-4#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1996-1#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#4)(1997-4#1)(2004-2#1)(2005-10#3)(2005-11#3)(2005-8#1)(2006-10#8)(2006-12#2)(2006-2#3)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#5)(2007-10#2)(2007-11#9)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#16)(2008-11#10)(2008-12#2)(2008-2#12)(2008-3#21)(2008-4#3)(2008-5#5)(2008-6#5)(2008-7#6)(2008-8#3)(2008-9#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-5#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#14)(2011-3#1)(2012-1#4)(2012-12#8)(2012-2#8)(2012-3#5)(2013-1#9)(2013-7#3)(2013-8#3)
to describe their##6##3##(1990-12#1)(1993-1#1)(2008-12#1)(2011-1#1)(2012-2#2)
to describe this##8##3##(1990-9#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-4#1)(2011-12#1)(2012-12#1)
to describe trends##2##3##(2008-7#1)(2011-12#1)
to describe two##2##3##(1996-1#1)(2006-3#1)
to describe what##2##3##(2009-4#1)(2010-7#1)
to describe##542##2##(1990-11#3)(1990-12#2)(1990-5#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#4)(1992-1#2)(1992-12#2)(1992-2#4)(1992-3#1)(1992-6#3)(1992-8#2)(1992-9#1)(1993-1#3)(1993-12#4)(1993-3#1)(1993-7#1)(1993-9#1)(1994-1#2)(1994-11#2)(1994-2#2)(1994-3#1)(1994-4#4)(1994-6#1)(1994-7#2)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-5#1)(1996-1#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#2)(1997-2#4)(1997-4#1)(1997-5#1)(1997-8#4)(2004-10#1)(2004-11#2)(2004-12#1)(2004-2#1)(2005-1#1)(2005-10#3)(2005-11#7)(2005-5#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#15)(2006-12#3)(2006-2#3)(2006-3#1)(2006-5#2)(2006-6#3)(2006-7#4)(2006-8#6)(2007-1#2)(2007-10#2)(2007-11#14)(2007-12#9)(2007-2#4)(2007-3#5)(2007-4#4)(2007-5#2)(2007-6#3)(2007-7#5)(2007-8#9)(2007-9#2)(2008-1#6)(2008-10#32)(2008-11#19)(2008-12#7)(2008-2#28)(2008-3#25)(2008-4#7)(2008-5#9)(2008-6#8)(2008-7#15)(2008-8#7)(2008-9#9)(2009-10#1)(2009-2#1)(2009-3#2)(2009-4#6)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#8)(2010-12#3)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#4)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#8)(2011-12#4)(2011-2#22)(2011-3#1)(2011-7#1)(2012-1#8)(2012-11#1)(2012-12#14)(2012-2#17)(2012-3#9)(2013-1#27)(2013-7#4)(2013-8#4)
to describing the##4##3##(1994-12#1)(2006-8#1)(2007-11#1)(2008-2#1)
to describing##5##2##(1994-12#1)(2006-8#1)(2007-11#1)(2008-2#1)(2008-8#1)
to desensitization##2##2##(1992-2#1)(2012-3#1)
to desiccation##3##2##(2008-10#1)(2008-4#1)(2008-5#1)
to design a new##2##4##(1993-12#1)(2007-12#1)
to design a##18##3##(1991-3#1)(1992-3#1)(1993-12#1)(1995-3#1)(1996-10#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#1)(2010-12#1)(2012-2#1)
to design agents that##2##4##(1996-12#1)(2006-11#1)
to design an##9##3##(1992-5#1)(1994-2#1)(1996-1#1)(2006-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-5#1)(2012-1#1)
to design and implement##3##4##(1993-12#1)(2007-8#1)(2008-2#1)
to design and##17##3##(1993-12#1)(1995-12#1)(1996-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#1)(2012-3#1)
to design better##3##3##(2005-8#1)(2006-5#1)(2008-10#1)
to design effective##3##3##(1994-2#1)(2007-11#1)(2008-3#1)
to design experimental##2##3##(1997-2#1)(2010-11#1)
to design more##2##3##(2013-1#1)(2013-7#1)
to design new##7##3##(1997-3#1)(1997-6#1)(2005-10#1)(2005-11#1)(2008-5#1)(2009-12#1)(2012-2#1)
to design novel##4##3##(1992-11#1)(2007-11#1)(2010-7#1)(2013-1#1)
to design predictive models of##2##5##(2007-11#2)
to design species-specific##2##3##(2008-10#2)
to design the##13##3##(1995-5#1)(1996-1#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-9#1)(2010-11#1)(2010-8#1)(2012-2#1)
to design their##2##3##(2008-4#1)(2012-3#1)
to design##161##2##(1990-6#1)(1991-3#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#2)(1994-10#1)(1994-2#3)(1995-12#1)(1995-3#1)(1995-5#1)(1996-1#2)(1996-10#2)(1996-12#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#6)(1997-3#1)(1997-6#1)(2005-10#1)(2005-11#1)(2005-8#2)(2006-10#1)(2006-11#2)(2006-5#3)(2006-7#1)(2006-8#1)(2007-11#7)(2007-12#5)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#21)(2008-11#7)(2008-12#1)(2008-2#7)(2008-3#8)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#3)(2008-9#3)(2009-12#2)(2009-5#2)(2009-9#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#1)
to designate##5##2##(1991-3#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-9#1)
to designing##4##2##(2005-7#1)(2008-10#1)(2008-2#1)(2009-9#1)
to desirable##3##2##(1993-2#1)(1993-9#1)(2009-10#1)
to desire##2##2##(2008-9#1)(2011-2#1)
to desired##11##2##(2005-11#1)(2007-11#1)(2007-12#4)(2008-2#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
to desmopressin##2##2##(1992-11#1)(2013-8#1)
to desorb and##3##3##(2008-10#2)(2008-2#1)
to desorb##5##2##(2008-10#4)(2008-2#1)
to destabilize the##5##3##(1991-8#1)(1997-6#1)(2006-11#1)(2011-1#1)(2012-2#1)
to destabilize##7##2##(1991-8#1)(1991-9#1)(1994-9#1)(1997-6#1)(2006-11#1)(2011-1#1)(2012-2#1)
to destroy the##9##3##(2006-6#2)(2007-11#1)(2008-10#2)(2008-11#1)(2010-1#1)(2010-3#1)(2010-4#1)
to destroy##16##2##(1992-1#1)(1993-4#1)(1994-3#1)(2006-1#1)(2006-6#2)(2007-11#1)(2008-10#2)(2008-11#1)(2009-10#1)(2009-2#1)(2010-1#1)(2010-3#2)(2010-4#1)
to destruction of the##2##4##(1990-12#1)(2008-10#1)
to destruction of##5##3##(1990-12#1)(1995-3#1)(2008-10#1)(2010-12#1)(2013-7#1)
to destruction##6##2##(1990-12#1)(1995-3#1)(2008-10#1)(2010-12#1)(2013-7#2)
to detach the cells from##2##5##(2008-11#1)(2009-8#1)
to detach##5##2##(1990-9#1)(1994-10#1)(2008-11#1)(2009-3#1)(2009-8#1)
to detached##2##2##(2008-10#2)
to detachment##2##2##(1996-9#1)(2008-11#1)
to detail the##4##3##(2005-7#1)(2006-3#1)(2009-10#1)(2012-3#1)
to detail##12##2##(1996-3#1)(2005-7#1)(2006-3#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-4#2)(2009-10#1)(2010-3#1)(2011-2#1)(2012-3#1)
to detailed##6##2##(1994-11#1)(1995-1#1)(1996-1#1)(1997-8#1)(2007-7#1)(2007-8#1)
to detect COA##2##3##(2007-3#2)
to detect DNA damage##4##4##(1994-10#2)(1996-2#1)(2008-4#1)
to detect DNA of agents of human granulocytic anaplasmosis and monocytic##2##11##(2013-1#2)
to detect DNA##10##3##(1994-10#2)(1996-2#1)(1997-3#1)(2008-10#1)(2008-4#2)(2013-1#3)
to detect E##2##3##(2008-10#1)(2012-2#1)
to detect H##2##3##(2008-5#2)
to detect H(2)O(2)##2##3##(2008-10#2)
to detect HIV##3##3##(1992-7#1)(1996-12#1)(2008-4#1)
to detect M##5##3##(1993-7#1)(2008-10#3)(2012-3#1)
to detect OTA in##2##4##(2008-10#2)
to detect P##3##3##(2008-10#2)(2008-12#1)
to detect PLRV##2##3##(2008-10#2)
to detect a given##2##4##(1992-9#1)(2008-7#1)
to detect a wide##2##4##(2007-12#1)(2008-5#1)
to detect a##34##3##(1990-3#1)(1992-6#1)(1992-9#1)(1995-12#1)(1995-4#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-9#4)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-4#1)(2011-2#1)(2012-3#2)(2013-1#2)
to detect abnormal##2##3##(2008-10#1)(2011-1#1)
to detect activation##3##3##(1994-8#1)(2008-1#1)(2008-2#1)
to detect alcohols##3##3##(2011-1#3)
to detect all##6##3##(1996-12#1)(2005-11#1)(2008-10#1)(2009-11#1)(2012-2#1)(2012-3#1)
to detect an increase in##2##5##(1990-11#1)(2008-7#1)
to detect an##11##3##(1990-11#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-10#1)
to detect and analyze##2##4##(2008-11#1)(2009-8#1)
to detect and characterize##3##4##(1991-8#1)(2007-11#2)
to detect and differentiate##2##4##(2008-5#1)(2013-1#1)
to detect and discriminate##2##4##(2008-2#1)(2008-4#1)
to detect and eliminate the##2##5##(1994-3#1)(2007-12#1)
to detect and identify##3##4##(2008-3#1)(2009-5#1)(2010-5#1)
to detect and image##2##4##(2007-12#1)(2011-2#1)
to detect and measure##2##4##(2008-3#1)(2010-4#1)
to detect and monitor the##2##5##(1993-2#1)(2008-4#1)
to detect and monitor##3##4##(1993-2#1)(2008-4#1)(2010-6#1)
to detect and quantify the##4##5##(2008-10#3)(2008-3#1)
to detect and quantify##16##4##(1997-4#1)(2008-10#10)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
to detect and remove##2##4##(2008-2#1)(2009-12#1)
to detect and respond to a##2##6##(1993-3#1)(2008-8#1)
to detect and respond to##6##5##(1991-6#1)(1992-11#1)(1993-3#1)(2007-12#1)(2008-8#2)
to detect and respond##7##4##(1991-6#1)(1992-11#1)(1993-3#1)(2007-12#1)(2008-8#2)(2011-2#1)
to detect and treat##3##4##(2008-3#1)(2012-12#1)(2013-8#1)
to detect and##66##3##(1991-6#2)(1991-8#1)(1992-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-3#1)(1997-2#1)(1997-4#1)(2005-8#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-2#5)(2008-3#4)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#3)(2009-12#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-8#1)
to detect antibodies in##2##4##(1995-1#1)(2013-8#1)
to detect antibodies to##2##4##(1992-6#1)(1997-3#1)
to detect antibodies##6##3##(1992-6#1)(1995-1#1)(1995-2#1)(1997-3#1)(2008-5#1)(2013-8#1)
to detect antibody##2##3##(1997-3#1)(2005-11#1)
to detect antigens##2##3##(1992-8#1)(1993-2#1)
to detect any##19##3##(1991-4#1)(1993-2#1)(1996-2#1)(1996-3#1)(1997-6#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-7#1)(2009-11#1)(2009-5#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
to detect apoptosis##3##3##(1994-10#2)(2008-4#1)
to detect as little as 0##2##6##(2008-10#2)
to detect as little as##4##5##(2008-10#3)(2013-1#1)
to detect as##5##3##(2008-10#4)(2013-1#1)
to detect association##2##3##(2012-3#2)
to detect associations between##3##4##(2012-12#1)(2012-3#2)
to detect associations with##2##4##(2012-3#2)
to detect associations##7##3##(2012-12#1)(2012-3#6)
to detect both##2##3##(2008-10#1)(2008-4#1)
to detect breast cancer at##2##5##(2008-10#1)(2009-7#1)
to detect breast cancer##5##4##(1990-12#1)(2008-10#1)(2008-4#1)(2009-7#1)(2010-6#1)
to detect causal##2##3##(2012-3#2)
to detect cell##3##3##(2008-1#1)(2008-4#1)(2008-9#1)
to detect changes in the##3##5##(2007-12#1)(2007-6#1)(2008-1#1)
to detect changes in##12##4##(1994-10#1)(1996-3#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-3#1)(2010-4#1)
to detect changes##13##3##(1994-10#1)(1996-3#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2009-3#1)(2010-4#1)
to detect coronary##2##3##(2008-7#1)(2011-1#1)
to detect cortical##2##3##(1996-2#1)(2006-9#1)
to detect differences in the##2##5##(1995-11#1)(1996-2#1)
to detect differences in##3##4##(1992-11#1)(1995-11#1)(1996-2#1)
to detect differences##4##3##(1992-11#1)(1995-11#1)(1996-2#1)(2004-1#1)
to detect different##2##3##(2008-3#1)(2011-2#1)
to detect early##5##3##(1995-11#1)(2006-10#1)(2007-11#1)(2009-6#1)(2010-6#1)
to detect expression of##2##4##(1993-5#1)(2008-4#1)
to detect fungal##2##3##(2008-10#2)
to detect genes with##3##4##(2008-4#1)(2012-3#2)
to detect genes##6##3##(1997-5#1)(2008-4#2)(2012-3#2)(2013-8#1)
to detect genetic variants that##2##5##(2009-5#1)(2012-3#1)
to detect genetic##3##3##(2008-4#1)(2009-5#1)(2012-3#1)
to detect in the##2##4##(1991-1#1)(1997-5#1)
to detect in##5##3##(1991-1#1)(1997-5#1)(2006-11#1)(2007-3#1)(2007-9#1)
to detect individuals##2##3##(1990-3#1)(1993-8#1)
to detect infection##3##3##(2008-10#1)(2008-4#2)
to detect it##2##3##(1997-5#1)(2006-7#1)
to detect latent##2##3##(2008-10#1)(2010-6#1)
to detect long-term##2##3##(2008-3#1)(2010-8#1)
to detect low levels of##2##5##(1991-3#1)(1997-2#1)
to detect low##4##3##(1991-3#1)(1997-2#1)(2007-8#1)(2009-9#1)
to detect mRNA##3##3##(1990-12#1)(2008-7#1)(2013-1#1)
to detect microorganisms##2##3##(2006-10#1)(2008-9#1)
to detect more##2##3##(2007-5#1)(2012-3#1)
to detect multiple##2##3##(2008-9#1)(2012-3#1)
to detect mutations##2##3##(2008-4#2)
to detect new##4##3##(2006-10#1)(2007-8#1)(2008-3#1)(2008-7#1)
to detect nitrite##2##3##(2008-10#2)
to detect occult##3##3##(1990-8#1)(2007-11#1)(2012-12#1)
to detect of the##2##4##(1997-3#1)(2008-10#1)
to detect only##2##3##(1991-10#1)(2012-2#1)
to detect or##4##3##(1991-2#1)(2008-4#1)(2010-12#1)(2013-8#1)
to detect patients##2##3##(2008-1#1)(2011-2#1)
to detect persistent##2##3##(2004-4#1)(2007-7#1)
to detect possible##3##3##(2008-9#1)(2011-1#1)(2013-1#1)
to detect potential##4##3##(2008-11#1)(2012-1#1)(2012-2#1)(2013-1#1)
to detect preclinical##2##3##(2008-11#2)
to detect rare variants##5##4##(2012-3#5)
to detect rare##10##3##(1996-12#1)(2010-9#1)(2011-2#1)(2012-3#7)
to detect regions of##2##4##(2008-2#1)(2008-4#1)
to detect resistance to##2##4##(1992-5#1)(2011-2#1)
to detect serum##2##3##(1997-7#1)(2005-11#1)
to detect significant changes##2##4##(2006-6#1)(2011-2#1)
to detect significant differences between##2##5##(2007-6#1)(2012-3#1)
to detect significant##8##3##(2006-6#1)(2007-6#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
to detect single##3##3##(2008-10#1)(2008-4#1)(2011-2#1)
to detect single-nucleotide polymorphisms##2##4##(2012-3#2)
to detect small##9##3##(1996-2#1)(1997-3#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-4#1)(2009-11#1)
to detect smaller##2##3##(1997-3#1)(2008-2#1)
to detect some##4##3##(1992-2#1)(1994-6#1)(2008-10#1)(2011-1#1)
to detect specific##7##3##(1990-5#1)(2007-2#1)(2008-4#1)(2008-5#1)(2009-3#1)(2010-5#1)(2011-1#1)
to detect subtle##2##3##(2009-12#1)(2013-1#1)
to detect such##5##3##(1990-5#1)(2010-5#1)(2010-8#1)(2011-1#1)(2013-8#1)
to detect temporal##2##3##(1991-2#1)(1995-5#1)
to detect the DNA##3##4##(2008-10#2)(2013-1#1)
to detect the associated##3##4##(2008-7#1)(2012-3#2)
to detect the cellular##2##4##(1995-7#1)(1996-5#1)
to detect the effect of##2##5##(1990-10#1)(2012-3#1)
to detect the effects of##2##5##(2008-3#2)
to detect the exact##2##4##(2008-1#1)(2012-12#1)
to detect the expression of##2##5##(2008-10#1)(2011-2#1)
to detect the hybridization of##2##5##(2008-10#1)(2009-2#1)
to detect the hybridization##3##4##(2008-10#2)(2009-2#1)
to detect the lead content in##2##6##(2008-10#2)
to detect the levels of##3##5##(2011-1#2)(2011-12#1)
to detect the light##3##4##(2006-2#1)(2007-12#1)(2008-2#1)
to detect the number##2##4##(1992-1#1)(2009-10#1)
to detect the oxygen##2##4##(2007-8#1)(2013-8#1)
to detect the pathogen##2##4##(2008-10#2)
to detect the presence of a##3##6##(2008-4#1)(2011-2#1)(2012-3#1)
to detect the presence of the##2##6##(1994-3#1)(2007-6#1)
to detect the presence of##23##5##(1994-3#1)(2004-11#1)(2006-2#2)(2006-8#1)(2007-10#2)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
to detect the presence##24##4##(1994-3#1)(2004-11#1)(2006-2#2)(2006-8#1)(2007-10#2)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
to detect the related##2##4##(2011-1#1)(2011-12#1)
to detect the risk of##2##5##(2006-9#1)(2007-8#1)
to detect the true##3##4##(2007-1#1)(2013-1#2)
to detect the##163##3##(1990-10#1)(1991-12#2)(1991-5#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-9#1)(1994-10#1)(1994-3#2)(1995-1#1)(1995-3#1)(1995-7#2)(1996-12#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-4#1)(2004-11#1)(2005-11#1)(2005-5#1)(2006-10#2)(2006-2#3)(2006-6#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#2)(2007-12#4)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#29)(2008-11#1)(2008-2#7)(2008-3#10)(2008-4#5)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#3)(2009-2#4)(2009-4#1)(2009-5#1)(2010-10#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#7)(2011-12#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#7)(2013-8#2)
to detect them##3##3##(2008-3#1)(2010-1#1)(2010-5#1)
to detect these##8##3##(1993-11#1)(1994-6#1)(1995-10#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-2#1)(2010-9#1)
to detect this##3##3##(1990-9#1)(2008-10#1)(2008-6#1)
to detect two##7##3##(1992-11#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-11#1)
to detect whether a##3##4##(1997-4#1)(2013-1#2)
to detect whether##6##3##(1993-12#1)(1997-4#1)(2007-8#1)(2012-2#1)(2013-1#2)
to detect which##2##3##(1992-6#1)(2011-2#1)
to detect##990##2##(1990-10#1)(1990-11#4)(1990-12#5)(1990-2#2)(1990-3#3)(1990-5#3)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#4)(1991-7#1)(1991-8#3)(1992-1#3)(1992-11#4)(1992-12#1)(1992-2#5)(1992-4#1)(1992-5#2)(1992-6#5)(1992-7#2)(1992-8#5)(1992-9#5)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#8)(1994-11#3)(1994-12#1)(1994-2#6)(1994-3#3)(1994-6#3)(1994-8#2)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#1)(1995-4#1)(1995-5#1)(1995-7#2)(1995-9#1)(1996-11#2)(1996-12#8)(1996-2#6)(1996-3#4)(1996-4#1)(1996-5#5)(1996-6#4)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#5)(1997-3#9)(1997-4#5)(1997-5#8)(1997-6#3)(1997-7#4)(1997-8#5)(2004-1#1)(2004-11#1)(2004-2#1)(2004-4#1)(2005-10#1)(2005-11#6)(2005-12#2)(2005-5#1)(2005-8#3)(2006-10#13)(2006-11#1)(2006-12#1)(2006-2#3)(2006-4#1)(2006-6#3)(2006-7#1)(2006-8#3)(2006-9#3)(2007-1#2)(2007-10#5)(2007-11#10)(2007-12#17)(2007-2#3)(2007-3#6)(2007-5#3)(2007-6#5)(2007-7#11)(2007-8#20)(2007-9#8)(2008-1#13)(2008-10#150)(2008-11#20)(2008-12#6)(2008-2#31)(2008-3#31)(2008-4#48)(2008-5#28)(2008-6#4)(2008-7#20)(2008-8#11)(2008-9#20)(2009-10#5)(2009-11#5)(2009-12#2)(2009-2#6)(2009-3#4)(2009-4#2)(2009-5#5)(2009-6#3)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#4)(2010-10#4)(2010-11#4)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#6)(2010-5#7)(2010-6#5)(2010-7#1)(2010-8#9)(2010-9#3)(2011-1#30)(2011-12#4)(2011-2#22)(2011-3#1)(2012-1#3)(2012-12#13)(2012-2#14)(2012-3#45)(2013-1#30)(2013-7#2)(2013-8#12)
to detecting and##2##3##(2007-3#1)(2007-9#1)
to detecting##7##2##(2006-6#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-10#1)(2013-1#1)
to detection in##2##3##(2006-6#1)(2012-12#1)
to detection limit##2##3##(2008-10#2)
to detection of##5##3##(2008-10#2)(2008-6#1)(2010-4#1)(2013-1#1)
to detection##19##2##(2006-6#1)(2007-8#1)(2008-10#6)(2008-3#3)(2008-5#2)(2008-6#1)(2008-9#1)(2010-4#1)(2012-12#2)(2013-1#1)
to detector##2##2##(2008-10#1)(2008-2#1)
to deter##3##2##(1991-7#1)(1993-12#1)(2012-2#1)
to deteriorate##8##2##(1991-10#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-3#2)(2010-12#1)(2010-3#1)
to deterioration##4##2##(1990-6#1)(2006-10#1)(2007-10#1)(2007-8#1)
to determinants of##2##3##(2006-11#1)(2009-10#1)
to determinate##2##2##(2011-2#2)
to determination of these##2##4##(2008-10#2)
to determination of trace##2##4##(2008-10#2)
to determination of##25##3##(2008-1#1)(2008-10#23)(2010-9#1)
to determination##28##2##(2008-1#1)(2008-10#26)(2010-9#1)
to determinations of##3##3##(1994-12#1)(1996-2#1)(2008-10#1)
to determinations##4##2##(1994-12#1)(1996-2#1)(2008-10#2)
to determine (1) the##2##4##(1994-2#1)(2007-8#1)
to determine (i)##3##3##(2008-3#1)(2013-1#2)
to determine Cd##3##3##(1993-4#1)(1996-3#1)(2008-10#1)
to determine Cys##2##3##(2008-10#2)
to determine a##21##3##(1992-8#1)(1993-12#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)(2013-1#1)
to determine absolute##3##3##(2007-12#1)(2008-9#1)(2010-11#1)
to determine all the##3##4##(1993-11#1)(2008-10#2)
to determine all##4##3##(1993-11#1)(1997-1#1)(2008-10#2)
to determine aluminum##2##3##(2008-10#2)
to determine amino##2##3##(1995-11#1)(2008-10#1)
to determine amounts of##2##4##(2008-10#2)
to determine an effective##3##4##(1992-12#1)(1996-5#1)(2008-3#1)
to determine an##6##3##(1990-2#1)(1992-12#1)(1996-5#1)(2008-10#1)(2008-3#2)
to determine and compare the##4##5##(1993-12#1)(2011-11#1)(2012-2#1)(2013-8#1)
to determine and##9##3##(1993-12#1)(2008-10#1)(2008-5#1)(2009-11#1)(2009-8#1)(2010-8#1)(2011-11#1)(2012-2#1)(2013-8#1)
to determine aniline##2##3##(2008-10#2)
to determine antibody##3##3##(2007-2#1)(2008-10#1)(2008-4#1)
to determine any changes in##2##5##(1994-10#1)(2012-12#1)
to determine any clinical##2##4##(2009-8#1)(2011-2#1)
to determine any##7##3##(1994-10#1)(2008-10#2)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
to determine appropriate##3##3##(1996-11#1)(2007-12#1)(2007-9#1)
to determine arsenic##2##3##(2008-10#1)(2010-5#1)
to determine associations between##4##4##(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
to determine attitudes##2##3##(1996-3#1)(2006-2#1)
to determine binding##4##3##(2007-8#1)(2008-4#3)
to determine blood##3##3##(2006-10#1)(2008-10#1)(2011-2#1)
to determine both the##6##4##(1995-7#1)(2005-11#1)(2008-3#2)(2009-2#1)(2010-2#1)
to determine both##11##3##(1995-7#1)(2005-11#1)(2007-12#1)(2008-10#4)(2008-3#2)(2009-2#1)(2010-2#1)
to determine by the##2##4##(2007-2#1)(2008-10#1)
to determine by##3##3##(1993-9#1)(2007-2#1)(2008-10#1)
to determine cell##2##3##(2008-11#1)(2013-8#1)
to determine changes in##7##4##(1991-2#1)(1993-12#1)(1995-7#1)(2007-9#1)(2008-10#1)(2008-3#1)(2010-5#1)
to determine chromium##3##3##(2008-10#3)
to determine clinical##2##3##(2007-10#1)(2010-4#1)
to determine compounds##2##3##(2008-10#2)
to determine copper##3##3##(2008-10#3)
to determine demographic##2##3##(2007-6#1)(2013-7#1)
to determine diclofenac in##2##4##(2008-10#2)
to determine diclofenac##3##3##(2008-10#3)
to determine differences between##5##4##(1990-10#1)(1995-10#1)(2006-10#1)(2007-7#1)(2009-7#1)
to determine directly##2##3##(1995-3#1)(2008-2#1)
to determine effective##3##3##(1996-2#1)(2004-3#1)(2008-10#1)
to determine effects of##2##4##(1991-5#1)(2011-12#1)
to determine ethanol##2##3##(1993-12#1)(2008-10#1)
to determine factors and##2##4##(2007-2#1)(2013-8#1)
to determine factors associated with##3##5##(1990-12#1)(2007-10#1)(2013-7#1)
to determine factors##6##3##(1990-12#1)(2007-10#1)(2007-2#1)(2008-4#1)(2013-7#1)(2013-8#1)
to determine functional##2##3##(2005-8#2)
to determine furosemide in##2##4##(2008-10#2)
to determine furosemide##3##3##(2008-10#3)
to determine genetic relationships among##2##5##(2008-10#2)
to determine genetic relationships##3##4##(2008-10#3)
to determine genetic##6##3##(2004-11#1)(2007-10#1)(2008-10#3)(2008-8#1)
to determine how consistently##2##4##(2005-10#1)(2009-11#1)
to determine how it##2##4##(1995-11#1)(2006-5#1)
to determine how many##4##4##(1996-1#1)(2008-4#2)(2008-9#1)
to determine how much##3##4##(1990-3#1)(2006-12#1)(2007-4#1)
to determine how the##6##4##(1991-3#1)(1991-7#1)(1996-2#1)(2007-12#1)(2008-11#1)(2008-2#1)
to determine how these factors##2##5##(2008-10#1)(2013-1#1)
to determine how they##2##4##(2008-10#1)(2008-5#1)
to determine how to##3##4##(2008-10#1)(2008-6#1)(2012-2#1)
to determine how well the##2##5##(2007-12#1)(2008-7#1)
to determine how well##5##4##(1995-5#1)(2007-12#1)(2008-7#1)(2009-11#1)(2010-1#1)
to determine how##56##3##(1990-3#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-7#1)(1992-1#1)(1992-7#1)(1993-2#1)(1995-11#1)(1995-5#1)(1996-1#1)(1996-2#1)(2005-10#2)(2006-10#1)(2006-12#2)(2006-5#1)(2007-10#1)(2007-12#5)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#3)(2008-2#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#2)(2010-1#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
to determine if VIP##2##4##(1997-8#2)
to determine if a##10##4##(1992-3#1)(1997-3#1)(2006-1#1)(2008-12#1)(2008-9#1)(2009-10#1)(2010-8#2)(2011-2#1)(2012-2#1)
to determine if an##2##4##(1993-7#1)(1996-8#1)
to determine if it##4##4##(1994-2#1)(1996-5#1)(2006-8#1)(2008-5#1)
to determine if members of##2##5##(1994-8#1)(2010-11#1)
to determine if significant differences##2##5##(1995-2#1)(2012-12#1)
to determine if spinal##2##4##(1995-11#1)(1997-8#1)
to determine if such##2##4##(1991-1#1)(2008-10#1)
to determine if the##38##4##(1990-2#1)(1991-2#2)(1992-2#1)(1993-12#1)(1994-2#1)(1995-11#1)(1996-5#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
to determine if their##4##4##(1990-11#1)(2006-10#2)(2010-8#1)
to determine if there is any##2##6##(2012-12#1)(2012-3#1)
to determine if there is##4##5##(2010-1#1)(2011-1#1)(2012-12#1)(2012-3#1)
to determine if there was##2##5##(2008-10#2)
to determine if there##6##4##(2008-10#2)(2010-1#1)(2011-1#1)(2012-12#1)(2012-3#1)
to determine if these##5##4##(1997-3#1)(2006-6#1)(2008-10#2)(2012-2#1)
to determine if they##5##4##(1993-3#1)(1996-5#1)(2008-6#1)(2009-11#1)(2010-8#1)
to determine if this##7##4##(1990-12#1)(1996-10#1)(1997-2#1)(2006-10#1)(2007-6#1)(2008-10#1)(2011-2#1)
to determine if treatment##2##4##(1997-5#1)(2007-12#1)
to determine if we##2##4##(1990-11#1)(2007-11#1)
to determine if##182##3##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1991-1#1)(1991-2#2)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#2)(1994-12#1)(1994-2#4)(1994-6#1)(1994-8#2)(1995-11#2)(1995-2#2)(1995-3#2)(1995-6#1)(1996-10#2)(1996-11#1)(1996-2#1)(1996-5#4)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#3)(1997-5#1)(1997-8#3)(2005-10#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-12#3)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#19)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#1)(2009-2#2)(2009-4#2)(2009-5#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#3)(2010-8#4)(2010-9#1)(2011-1#3)(2011-2#5)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
to determine in##4##3##(1990-2#1)(1995-1#1)(2007-5#1)(2011-1#1)
to determine incidence of##2##4##(2007-7#1)(2008-10#1)
to determine incidence##3##3##(2007-7#1)(2008-10#1)(2012-2#1)
to determine its effect on the##2##6##(1992-7#1)(2008-10#1)
to determine its effect on##5##5##(1992-7#1)(1995-3#1)(2008-10#1)(2008-7#1)(2013-7#1)
to determine its efficacy##2##4##(2006-6#1)(2010-3#1)
to determine its##25##3##(1990-10#1)(1992-7#1)(1993-2#1)(1994-11#1)(1995-3#1)(1996-8#1)(2006-6#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#2)(2009-1#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
to determine kinetic##2##3##(1994-11#1)(1996-5#1)
to determine lead##2##3##(2008-10#2)
to determine levels of##3##4##(1993-2#1)(1997-4#1)(2008-10#1)
to determine material##2##3##(2006-11#1)(2009-7#1)
to determine mercury##3##3##(2008-10#3)
to determine minimum##3##3##(2005-11#1)(2007-7#1)(2007-8#1)
to determine molecular##2##3##(1993-7#1)(2010-10#1)
to determine not only##2##4##(2008-2#1)(2010-6#1)
to determine optical properties##2##4##(2008-2#1)(2008-3#1)
to determine optimal##5##3##(1990-9#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-12#1)
to determine optimum##2##3##(2008-10#1)(2008-3#1)
to determine organic pollutants##2##4##(2008-10#2)
to determine organic##3##3##(2008-10#3)
to determine parameters##2##3##(1997-2#1)(2008-10#1)
to determine patient##3##3##(2006-10#1)(2008-8#1)(2012-2#1)
to determine perceptions of##2##4##(1993-2#1)(1995-1#1)
to determine possible##5##3##(1993-5#1)(2007-4#1)(2008-10#1)(2012-12#1)(2013-1#1)
to determine potential##6##3##(1991-9#1)(1997-4#1)(2007-5#1)(2008-10#1)(2009-4#1)(2013-1#1)
to determine presence##2##3##(2006-10#1)(2010-8#1)
to determine profiles of the##2##5##(2008-2#2)
to determine prognostic##2##3##(2006-10#1)(2011-2#1)
to determine quantitatively the##2##4##(2008-10#1)(2008-2#1)
to determine rates of##2##4##(1996-8#1)(2004-9#1)
to determine receptor##2##3##(1992-10#1)(1994-6#1)
to determine relative##2##3##(1991-8#1)(2011-1#1)
to determine risk factors for##3##5##(2007-10#1)(2011-2#1)(2013-7#1)
to determine risk factors##4##4##(2007-10#1)(2007-12#1)(2011-2#1)(2013-7#1)
to determine risk##5##3##(2007-10#1)(2007-12#1)(2011-2#1)(2012-2#1)(2013-7#1)
to determine scale##2##3##(2006-11#1)(2008-5#1)
to determine sensitivity##3##3##(2006-10#1)(2011-2#2)
to determine serum##4##3##(1991-8#1)(2007-9#1)(2011-2#1)(2013-1#1)
to determine several##2##3##(2007-9#1)(2008-10#1)
to determine significant##3##3##(2007-7#1)(2008-10#1)(2012-2#1)
to determine simultaneously##2##3##(2007-12#1)(2008-8#1)
to determine sites of##2##4##(1992-2#1)(2008-10#1)
to determine some##2##3##(1996-8#1)(2008-10#1)
to determine spatial##2##3##(2007-5#1)(2008-10#1)
to determine specific##2##3##(2008-10#1)(2012-2#1)
to determine suitability for##2##4##(2010-11#1)(2013-1#1)
to determine surface##2##3##(2007-2#1)(2009-12#1)
to determine that the##3##4##(1992-12#1)(1995-11#1)(2008-3#1)
to determine that##5##3##(1992-12#1)(1993-8#1)(1995-11#1)(2008-10#1)(2008-3#1)
to determine the ability of##8##5##(2006-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
to determine the absolute##2##4##(2008-9#1)(2009-10#1)
to determine the accuracy of##5##5##(1990-9#1)(1994-3#1)(2008-7#1)(2012-1#1)(2012-2#1)
to determine the active##2##4##(2008-10#2)
to determine the activity of##2##5##(2005-12#1)(2006-10#1)
to determine the activity##3##4##(1994-12#1)(2005-12#1)(2006-10#1)
to determine the aerosol##2##4##(2008-2#1)(2008-3#1)
to determine the amino acid##3##5##(1994-9#1)(2008-10#1)(2010-4#1)
to determine the amount of##10##5##(1992-6#1)(2008-10#5)(2008-2#1)(2008-4#1)(2011-2#1)(2012-1#1)
to determine the apparent##2##4##(2008-10#2)
to determine the appropriate##9##4##(1993-2#1)(1994-12#1)(2008-10#1)(2008-4#1)(2008-5#2)(2009-4#1)(2011-2#1)(2013-1#1)
to determine the association##3##4##(2005-9#1)(2007-8#1)(2012-3#1)
to determine the average##2##4##(2007-5#1)(2009-7#1)
to determine the best method##2##5##(2006-12#1)(2008-2#1)
to determine the best##12##4##(1994-6#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)
to determine the binding##3##4##(1997-2#1)(2008-1#1)(2008-10#1)
to determine the bioactive##2##4##(2010-11#1)(2011-12#1)
to determine the body##2##4##(1997-7#1)(2008-3#1)
to determine the cause of##2##5##(2006-2#1)(2006-3#1)
to determine the cause##3##4##(2006-2#1)(2006-3#1)(2010-7#1)
to determine the cellular localization of##2##6##(1994-10#1)(2008-2#1)
to determine the cellular##3##4##(1994-10#1)(1995-11#1)(2008-2#1)
to determine the change##2##4##(1994-12#1)(2012-12#1)
to determine the changes in the##2##6##(2008-3#1)(2011-1#1)
to determine the changes in##5##5##(1991-11#1)(2008-3#1)(2011-1#1)(2012-2#2)
to determine the changes##6##4##(1991-11#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-2#2)
to determine the characteristics of the##2##6##(1995-6#1)(1996-9#1)
to determine the characteristics of##4##5##(1995-12#1)(1995-6#1)(1996-9#1)(2008-5#1)
to determine the characteristics##5##4##(1995-12#1)(1995-6#1)(1996-9#1)(2008-5#1)(2011-2#1)
to determine the chromosomal##2##4##(2008-10#1)(2008-4#1)
to determine the clinical features##2##5##(2007-2#1)(2007-9#1)
to determine the clinical##6##4##(1992-10#1)(2004-9#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-9#1)
to determine the complex index of refraction##2##7##(2008-2#1)(2008-3#1)
to determine the composition of the##2##6##(1992-1#1)(2008-10#1)
to determine the composition of##7##5##(1990-9#1)(1992-1#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)
to determine the concentration of##15##5##(1991-12#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-2#1)(2008-4#1)(2008-9#2)
to determine the concentration##17##4##(1991-12#1)(2005-8#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-2#1)(2008-4#1)(2008-9#2)(2010-4#1)
to determine the concentrations of##3##5##(1992-8#1)(2008-10#1)(2008-3#1)
to determine the conformations of##2##5##(1990-5#1)(1993-3#1)
to determine the conformations##3##4##(1990-5#1)(1993-3#1)(1995-11#1)
to determine the consequences##2##4##(1997-5#1)(2011-2#1)
to determine the content of##4##5##(2008-10#4)
to determine the content##5##4##(1996-1#1)(2008-10#4)
to determine the contents of##2##5##(1992-11#1)(2008-10#1)
to determine the correct##4##4##(1992-7#1)(2007-8#1)(2008-4#1)(2008-8#1)
to determine the correlation of##4##5##(1992-3#1)(1996-11#1)(2008-5#1)(2010-4#1)
to determine the correlation##5##4##(1992-3#1)(1996-11#1)(2008-1#1)(2008-5#1)(2010-4#1)
to determine the critical##2##4##(2008-10#2)
to determine the current##2##4##(1996-12#1)(2010-8#1)
to determine the degree of##8##5##(2006-5#1)(2007-10#1)(2007-3#1)(2008-10#1)(2008-2#2)(2008-5#1)(2010-12#1)
to determine the degree##9##4##(2006-5#1)(2007-10#1)(2007-3#1)(2008-10#1)(2008-2#2)(2008-5#1)(2010-12#1)(2011-2#1)
to determine the dependence of the##2##6##(2008-2#1)(2009-7#1)
to determine the differences between##2##5##(1997-4#1)(2010-5#1)
to determine the differences##4##4##(1997-4#1)(2007-2#1)(2010-5#1)(2012-2#1)
to determine the different##3##4##(1990-12#1)(2007-7#1)(2008-10#1)
to determine the distribution of##4##5##(1995-6#1)(1996-9#1)(2007-3#1)(2011-2#1)
to determine the effect of a##2##6##(2006-10#1)(2008-10#1)
to determine the effect of different##2##6##(1996-2#1)(2013-1#1)
to determine the effect of the##3##6##(1997-1#1)(2013-1#2)
to determine the effect of##54##5##(1990-11#1)(1990-5#1)(1991-8#1)(1992-10#1)(1994-2#1)(1995-12#1)(1995-3#2)(1995-7#2)(1996-2#2)(1996-8#1)(1997-1#1)(2005-11#1)(2006-10#1)(2006-3#1)(2007-1#2)(2008-10#5)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-2#1)(2013-1#4)
to determine the effect on##6##5##(1996-7#1)(1997-8#1)(2004-9#1)(2007-7#1)(2008-10#1)(2008-8#1)
to determine the effect that##2##5##(2006-1#1)(2013-7#1)
to determine the effect##62##4##(1990-11#1)(1990-5#1)(1991-8#1)(1992-10#1)(1994-2#1)(1995-12#1)(1995-3#2)(1995-7#2)(1996-2#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-3#1)(2007-1#2)(2007-7#1)(2008-10#6)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#2)(2008-9#1)(2009-6#1)(2009-7#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-2#1)(2013-1#4)(2013-7#1)
to determine the effective##2##4##(1990-7#1)(2008-11#1)
to determine the effectiveness of a##2##6##(1990-6#1)(2008-12#1)
to determine the effectiveness of##9##5##(1990-10#1)(1990-6#1)(1992-1#1)(1996-3#1)(2006-12#1)(2006-8#1)(2008-12#1)(2012-3#1)(2013-1#1)
to determine the effects of a##4##6##(1996-11#1)(2006-10#1)(2008-1#1)(2012-3#1)
to determine the effects of acute##2##6##(1995-7#1)(2007-2#1)
to determine the effects of the##5##6##(2008-2#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
to determine the effects of##54##5##(1990-5#2)(1991-6#1)(1993-7#1)(1994-11#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-7#1)(1996-11#1)(1996-2#1)(1996-7#1)(2005-12#1)(2005-8#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#4)(2008-7#1)(2009-7#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#4)
to determine the efficacy of##5##5##(1994-3#1)(2006-5#1)(2007-7#1)(2011-2#1)(2012-3#1)
to determine the efficacy##7##4##(1994-3#1)(2006-5#1)(2007-7#2)(2008-6#1)(2011-2#1)(2012-3#1)
to determine the efficiency of##3##5##(2007-2#1)(2008-2#1)(2010-7#1)
to determine the estimates##2##4##(1992-3#1)(1995-8#1)
to determine the etiology of##3##5##(2006-8#1)(2008-4#1)(2010-3#1)
to determine the etiology##4##4##(2006-8#1)(2008-4#1)(2010-2#1)(2010-3#1)
to determine the exact##3##4##(2008-10#1)(2008-7#1)(2009-8#1)
to determine the extent and##3##5##(2006-8#1)(2007-8#1)(2012-12#1)
to determine the extent of##11##5##(1996-12#1)(2005-11#1)(2007-1#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-1#1)(2013-1#3)
to determine the extent to which the##2##7##(1990-10#1)(2010-8#1)
to determine the extent to which##9##6##(1990-10#1)(1992-6#1)(1996-3#1)(2006-2#1)(2006-8#1)(2007-7#1)(2008-5#1)(2010-2#1)(2010-8#1)
to determine the extent##23##4##(1990-10#1)(1992-6#1)(1996-12#1)(1996-3#1)(2005-11#1)(2006-2#1)(2006-8#2)(2007-1#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#3)
to determine the factors that influence##2##6##(2007-3#1)(2008-6#1)
to determine the factors that##4##5##(1995-3#1)(2007-3#1)(2008-6#1)(2011-1#1)
to determine the factors##8##4##(1990-6#1)(1995-3#2)(2007-3#1)(2007-8#1)(2008-1#1)(2008-6#1)(2011-1#1)
to determine the fate of##2##5##(1996-8#1)(2010-11#1)
to determine the feasibility and##2##5##(2008-6#1)(2011-2#1)
to determine the feasibility of##6##5##(1991-9#1)(2006-8#1)(2007-8#1)(2008-5#1)(2008-8#1)(2011-1#1)
to determine the feasibility##8##4##(1991-9#1)(2006-8#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#1)
to determine the final##2##4##(1992-1#1)(2008-3#1)
to determine the following##2##4##(1996-12#1)(2006-8#1)
to determine the formation of##3##5##(1991-9#1)(2008-4#1)(2010-9#1)
to determine the formation##4##4##(1991-9#1)(2008-10#1)(2008-4#1)(2010-9#1)
to determine the fractional##2##4##(1997-1#1)(2007-12#1)
to determine the frequency and##2##5##(2006-8#1)(2008-8#1)
to determine the frequency of##12##5##(1991-11#1)(1995-1#1)(1996-6#1)(2005-12#1)(2007-2#3)(2007-5#1)(2008-10#1)(2009-5#1)(2011-12#1)(2011-2#1)
to determine the frequency##15##4##(1991-11#1)(1995-1#1)(1996-6#1)(2005-12#1)(2006-8#1)(2007-2#3)(2007-5#1)(2008-10#1)(2008-8#1)(2009-5#1)(2011-12#1)(2011-2#2)
to determine the full##2##4##(2007-6#1)(2008-10#1)
to determine the function of##3##5##(2008-8#1)(2008-9#1)(2009-10#1)
to determine the functional##5##4##(1991-3#1)(1992-2#1)(2008-10#1)(2008-4#1)(2013-1#1)
to determine the genetic diversity of##2##6##(2007-2#1)(2008-10#1)
to determine the genetic diversity##3##5##(2006-4#1)(2007-2#1)(2008-10#1)
to determine the genetic##8##4##(2006-10#1)(2006-4#1)(2007-2#1)(2008-10#4)(2011-1#1)
to determine the growth##2##4##(1990-10#1)(2008-10#1)
to determine the health##2##4##(2008-6#1)(2012-2#1)
to determine the human##2##4##(2010-3#1)(2012-12#1)
to determine the identity and##3##5##(1991-5#1)(2008-10#1)(2012-2#1)
to determine the identity##4##4##(1991-5#1)(1992-9#1)(2008-10#1)(2012-2#1)
to determine the impact of the##3##6##(1995-1#1)(1997-5#1)(2006-11#1)
to determine the impact of##12##5##(1993-2#1)(1995-1#1)(1997-5#1)(2006-10#1)(2006-11#1)(2008-9#1)(2010-2#1)(2011-2#2)(2012-1#2)(2013-1#1)
to determine the impact on##2##5##(1996-7#1)(2012-3#1)
to determine the impact##14##4##(1993-2#1)(1995-1#1)(1996-7#1)(1997-5#1)(2006-10#1)(2006-11#1)(2008-9#1)(2010-2#1)(2011-2#2)(2012-1#2)(2012-3#1)(2013-1#1)
to determine the importance of the##2##6##(1992-7#1)(2008-2#1)
to determine the importance of##5##5##(1992-7#1)(2006-10#1)(2007-8#1)(2008-2#1)(2008-7#1)
to determine the in vitro##2##5##(2008-5#1)(2008-8#1)
to determine the in vivo##2##5##(1994-5#1)(2008-11#1)
to determine the in##4##4##(1994-5#1)(2008-11#1)(2008-5#1)(2008-8#1)
to determine the incidence and##3##5##(2005-12#1)(2008-7#1)(2013-1#1)
to determine the incidence of##9##5##(1991-11#1)(2005-10#1)(2007-10#1)(2007-7#1)(2008-4#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
to determine the incidence##12##4##(1991-11#1)(2005-10#1)(2005-12#1)(2007-10#1)(2007-7#1)(2008-4#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
to determine the indices of refraction of liquids##2##8##(2008-3#2)
to determine the infection##2##4##(1993-2#1)(2007-7#1)
to determine the influence of different##2##6##(2008-10#1)(2011-2#1)
to determine the influence of the##6##6##(1995-8#1)(1996-5#1)(2004-11#1)(2008-11#1)(2010-4#1)(2011-2#1)
to determine the influence of##25##5##(1995-8#1)(1996-5#1)(1997-6#1)(2004-11#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#2)(2009-5#1)(2010-11#1)(2010-4#1)(2011-2#4)
to determine the interactions##2##4##(2008-10#2)
to determine the kinetic parameters##2##5##(1994-5#1)(2008-10#1)
to determine the kinetic##3##4##(1994-5#1)(1996-8#1)(2008-10#1)
to determine the kinetics of##3##5##(1995-3#1)(2004-12#1)(2008-9#1)
to determine the kinetics##4##4##(1995-12#1)(1995-3#1)(2004-12#1)(2008-9#1)
to determine the knowledge##3##4##(2004-10#1)(2009-5#1)(2011-2#1)
to determine the level of##10##5##(1990-8#1)(1991-8#1)(1993-3#1)(1994-6#1)(1995-7#1)(2007-2#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-8#1)
to determine the levels of##4##5##(1993-2#1)(1993-3#1)(2006-9#1)(2008-12#1)
to determine the levels##5##4##(1990-2#1)(1993-2#1)(1993-3#1)(2006-9#1)(2008-12#1)
to determine the likelihood of##3##5##(1997-8#1)(2008-7#1)(2010-8#1)
to determine the local##2##4##(1994-3#1)(2008-3#1)
to determine the localization##3##4##(1990-3#1)(2008-8#1)(2009-2#1)
to determine the location of##3##5##(1992-3#1)(2008-10#1)(2012-1#1)
to determine the location##4##4##(1992-3#1)(2008-10#1)(2010-2#1)(2012-1#1)
to determine the locations of##2##5##(1990-9#1)(1994-8#1)
to determine the long-term##3##4##(1996-12#1)(2008-8#1)(2011-2#1)
to determine the magnitude of the##2##6##(2007-6#1)(2008-7#1)
to determine the magnitude of##5##5##(2007-12#1)(2007-6#1)(2008-2#1)(2008-7#1)(2008-8#1)
to determine the magnitude##6##4##(2007-12#1)(2007-6#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-8#1)
to determine the major##3##4##(1992-1#1)(1995-12#1)(2008-10#1)
to determine the maximum##2##4##(2008-6#1)(2012-2#1)
to determine the mechanical behavior of##2##6##(2004-9#2)
to determine the mechanism by which##3##6##(1993-9#1)(2008-6#1)(2011-1#1)
to determine the mechanism of##4##5##(1991-9#1)(1994-11#1)(1997-4#1)(2008-10#1)
to determine the mechanism##7##4##(1991-9#1)(1993-9#1)(1994-11#1)(1997-4#1)(2008-10#1)(2008-6#1)(2011-1#1)
to determine the mechanisms underlying##2##5##(2012-2#1)(2013-8#1)
to determine the mechanisms##3##4##(1996-8#1)(2012-2#1)(2013-8#1)
to determine the minimal##3##4##(1990-11#1)(2007-7#1)(2011-2#1)
to determine the minimum##3##4##(2008-2#1)(2008-9#1)(2010-4#1)
to determine the molecular##5##4##(1995-1#1)(1997-5#1)(2006-2#1)(2008-10#1)(2008-4#1)
to determine the morphology##2##4##(1995-11#1)(2008-10#1)
to determine the mortality rate##2##5##(1994-7#1)(2007-2#1)
to determine the most appropriate##4##5##(2007-5#1)(2007-6#1)(2008-5#1)(2009-11#1)
to determine the most effective##3##5##(1993-2#1)(2007-12#1)(2008-5#1)
to determine the most##10##4##(1992-12#1)(1993-2#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-10#2)(2008-5#2)(2009-11#1)
to determine the nature and##2##5##(2007-9#1)(2008-3#1)
to determine the nature of the##4##6##(1991-2#1)(1993-11#1)(2008-10#1)(2008-2#1)
to determine the nature of##7##5##(1991-2#1)(1993-11#1)(1996-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#1)
to determine the nature##9##4##(1991-2#1)(1993-11#1)(1996-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#1)
to determine the number and identity of##2##7##(2008-10#2)
to determine the number and##4##5##(2006-5#1)(2008-10#3)
to determine the number of##16##5##(1993-3#1)(1994-5#1)(1995-11#1)(1995-4#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-4#3)(2010-4#1)(2013-1#2)
to determine the number##20##4##(1993-3#1)(1994-5#1)(1995-11#1)(1995-4#1)(2006-10#1)(2006-5#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-4#3)(2010-4#1)(2013-1#2)
to determine the onset of##2##5##(1997-2#1)(2008-3#1)
to determine the optical properties of##4##6##(2007-12#1)(2008-2#1)(2008-3#2)
to determine the optical##9##4##(2007-12#2)(2008-2#3)(2008-3#3)(2009-5#1)
to determine the optimal##15##4##(1997-6#1)(2006-10#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2010-5#2)(2011-2#1)(2012-3#1)
to determine the optimum conditions for the##3##7##(1992-2#1)(2008-10#2)
to determine the optimum conditions for##6##6##(1992-2#1)(1994-3#1)(2008-10#3)(2008-5#1)
to determine the optimum##15##4##(1992-2#1)(1994-3#1)(2005-5#1)(2006-7#1)(2007-9#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#1)(2009-5#1)(2012-2#1)
to determine the order of##3##5##(1991-2#1)(1997-8#1)(2007-9#1)
to determine the origin of##4##5##(1992-12#1)(1996-2#1)(1996-3#1)(1996-9#1)
to determine the overall##5##4##(2008-10#4)(2009-4#1)
to determine the parameters##4##4##(2007-12#1)(2008-10#1)(2008-3#1)(2010-1#1)
to determine the pattern of##4##5##(2007-12#1)(2008-10#1)(2008-3#1)(2010-8#1)
to determine the peak##2##4##(2008-10#1)(2008-2#1)
to determine the performance of##2##5##(2008-3#1)(2013-8#1)
to determine the pharmacokinetics##2##4##(1995-3#1)(1997-3#1)
to determine the pharmacological##2##4##(1993-3#1)(1994-5#1)
to determine the phase##2##4##(1990-6#1)(2008-3#1)
to determine the position of##2##5##(2008-10#1)(2008-2#1)
to determine the possibility of##2##5##(1997-6#1)(2007-11#1)
to determine the possible role of##2##6##(2008-4#1)(2011-2#1)
to determine the possible##7##4##(1995-9#1)(1997-4#1)(2004-10#1)(2008-11#1)(2008-4#2)(2011-2#1)
to determine the potential##6##4##(2007-4#1)(2008-7#1)(2009-4#1)(2010-2#1)(2011-12#1)(2013-8#1)
to determine the precise##6##4##(1996-7#1)(2005-7#1)(2007-11#1)(2008-4#1)(2009-4#1)(2012-2#1)
to determine the predictive##2##4##(2010-12#1)(2013-1#1)
to determine the predictors of##2##5##(2007-2#1)(2008-11#1)
to determine the preferred##2##4##(1996-2#1)(2013-8#1)
to determine the presence and##3##5##(1995-5#1)(2010-2#1)(2012-12#1)
to determine the presence of##10##5##(1991-12#1)(1994-11#1)(2004-11#1)(2006-10#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-2#1)(2010-1#1)(2012-12#1)
to determine the presence or absence of##3##7##(2005-8#2)(2008-10#1)
to determine the presence##17##4##(1991-12#1)(1994-11#1)(1995-5#1)(2004-11#1)(2005-8#2)(2006-10#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-1#1)(2010-2#1)(2012-12#2)
to determine the prevalence and causes of##2##7##(2007-1#1)(2012-1#1)
to determine the prevalence and##10##5##(2006-10#3)(2006-8#1)(2007-1#1)(2010-9#1)(2011-1#2)(2012-1#1)(2013-1#1)
to determine the prevalence of facet##2##6##(2006-7#1)(2006-8#1)
to determine the prevalence of the##2##6##(2008-3#1)(2012-12#1)
to determine the prevalence of##40##5##(1993-12#1)(1996-12#1)(2006-7#1)(2006-8#4)(2007-2#3)(2007-7#2)(2008-10#1)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#3)(2009-10#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
to determine the prevalence##54##4##(1993-12#1)(1996-12#1)(2006-10#3)(2006-7#1)(2006-8#5)(2007-1#1)(2007-2#3)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#3)(2009-10#1)(2010-12#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#2)
to determine the prognosis##2##4##(1991-3#1)(2007-12#1)
to determine the proportion of patients with##2##7##(1997-6#1)(2012-12#1)
to determine the proportion of##4##5##(1995-6#1)(1997-6#1)(2008-4#1)(2012-12#1)
to determine the proportion##5##4##(1995-6#1)(1997-6#1)(2008-4#1)(2012-12#2)
to determine the protective##2##4##(1992-10#1)(2008-7#1)
to determine the range of##2##5##(1993-9#1)(2008-7#1)
to determine the rate of##4##5##(1996-12#1)(2007-10#1)(2007-6#1)(2008-4#1)
to determine the rate##9##4##(1992-9#1)(1996-12#1)(1996-4#1)(2007-10#1)(2007-6#1)(2008-10#2)(2008-4#1)(2013-1#1)
to determine the reaction##2##4##(1997-8#1)(2008-5#1)
to determine the refractive index##2##5##(2008-10#1)(2008-3#1)
to determine the relationship between the number of##2##8##(2008-12#1)(2013-1#1)
to determine the relationship between the##6##6##(2008-10#2)(2008-12#1)(2010-2#1)(2013-1#1)(2013-8#1)
to determine the relationship between##17##5##(2006-5#1)(2007-3#2)(2007-9#1)(2008-10#3)(2008-12#2)(2009-10#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
to determine the relationship of##7##5##(1993-8#1)(1996-3#1)(2006-4#1)(2006-8#1)(2009-5#1)(2011-1#1)(2011-2#1)
to determine the relationship##24##4##(1993-8#1)(1996-3#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-3#2)(2007-9#1)(2008-10#3)(2008-12#2)(2009-10#1)(2009-5#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
to determine the relationships between##3##5##(1995-2#1)(1996-8#1)(2010-2#1)
to determine the relative contributions of##2##6##(2008-10#1)(2008-9#1)
to determine the relative##20##4##(1991-1#1)(1992-11#1)(1992-8#1)(1996-12#1)(1997-7#1)(2005-11#1)(2005-7#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-8#1)(2011-1#1)
to determine the relevance of##3##5##(1990-3#1)(1996-2#1)(2008-10#1)
to determine the reliability of##2##5##(1993-1#1)(2006-5#1)
to determine the requirements##2##4##(2008-10#1)(2013-1#1)
to determine the resistance to##2##5##(2008-5#1)(2008-7#1)
to determine the risk of##3##5##(1990-8#1)(1992-12#1)(2011-2#1)
to determine the role of the##2##6##(1995-2#1)(1997-8#1)
to determine the role of this##2##6##(1992-5#1)(1994-9#1)
to determine the role of##21##5##(1992-5#1)(1993-11#2)(1993-4#1)(1994-10#1)(1994-11#1)(1994-8#2)(1994-9#1)(1995-2#1)(1997-8#1)(2004-11#1)(2007-3#1)(2007-7#1)(2008-3#1)(2008-7#2)(2009-12#1)(2009-4#1)(2009-8#1)(2013-1#1)
to determine the role that##2##5##(1993-1#1)(1996-3#1)
to determine the role##26##4##(1992-5#1)(1993-1#1)(1993-11#2)(1993-4#1)(1994-10#1)(1994-11#1)(1994-8#2)(1994-9#1)(1995-2#1)(1996-3#1)(1997-8#1)(2004-11#1)(2007-3#1)(2007-7#2)(2008-11#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-8#1)(2013-1#1)
to determine the roles of the##2##6##(1993-12#1)(2008-4#1)
to determine the safety of##2##5##(2007-2#1)(2008-9#1)
to determine the safety##3##4##(2006-8#1)(2007-2#1)(2008-9#1)
to determine the sensitivity and##2##5##(1993-3#1)(2007-9#1)
to determine the sensitivity of##4##5##(1990-12#1)(1994-2#1)(2008-10#1)(2012-6#1)
to determine the sensitivity##6##4##(1990-12#1)(1993-3#1)(1994-2#1)(2007-9#1)(2008-10#1)(2012-6#1)
to determine the seroprevalence of##3##5##(2007-2#1)(2007-8#1)(2011-2#1)
to determine the set of##2##5##(2011-1#1)(2012-3#1)
to determine the sexual##2##4##(2007-7#1)(2012-12#1)
to determine the shape of##2##5##(2008-2#2)
to determine the shear##2##4##(2005-11#1)(2006-8#1)
to determine the significance of##4##5##(2006-12#1)(2008-10#1)(2008-5#1)(2011-2#1)
to determine the site of##3##5##(1990-11#1)(1993-11#1)(2007-12#1)
to determine the site##4##4##(1990-11#1)(1993-11#1)(2007-12#1)(2008-6#1)
to determine the sites##2##4##(1997-8#1)(2010-4#1)
to determine the size and##2##5##(1995-2#1)(2008-3#1)
to determine the size of##3##5##(2007-12#1)(2010-12#1)(2013-1#1)
to determine the size##5##4##(1995-2#1)(2007-12#1)(2008-3#1)(2010-12#1)(2013-1#1)
to determine the source##2##4##(1996-3#1)(2007-8#1)
to determine the spatial##5##4##(1997-8#1)(2008-10#3)(2008-2#1)
to determine the specific##3##4##(1995-5#1)(2011-1#1)(2013-8#1)
to determine the stability constants of the MA and MA(2) complex species formed##2##13##(2008-10#2)
to determine the stability constants of the##3##7##(2008-10#3)
to determine the stability of##3##5##(1996-6#1)(2008-10#1)(2008-6#1)
to determine the stability##6##4##(1996-6#1)(2008-10#4)(2008-6#1)
to determine the stage of##2##5##(2007-8#1)(2013-1#1)
to determine the structural##2##4##(1993-2#1)(2008-9#1)
to determine the structure of##3##5##(1992-9#1)(1995-5#1)(1995-8#1)
to determine the success of##2##5##(2011-2#1)(2012-3#1)
to determine the temporal##2##4##(1990-7#1)(2006-11#1)
to determine the time of##2##5##(1995-6#1)(2008-11#1)
to determine the time##4##4##(1995-11#1)(1995-6#1)(1997-7#1)(2008-11#1)
to determine the total##2##4##(2007-8#1)(2008-10#1)
to determine the trace##3##4##(2009-6#1)(2011-2#1)(2013-7#1)
to determine the trends##2##4##(2008-10#1)(2012-12#1)
to determine the true##2##4##(2007-9#1)(2012-3#1)
to determine the type of##2##5##(2008-10#1)(2013-7#1)
to determine the type##3##4##(2008-10#1)(2010-4#1)(2013-7#1)
to determine the unknown##2##4##(2008-10#1)(2008-3#1)
to determine the use and##2##5##(2006-10#1)(2012-12#1)
to determine the use##3##4##(1995-2#1)(2006-10#1)(2012-12#1)
to determine the usefulness of##3##5##(2005-12#1)(2008-5#1)(2013-8#1)
to determine the utility of##2##5##(2006-7#1)(2007-12#1)
to determine the value of##3##5##(1995-9#1)(2008-1#1)(2008-10#1)
to determine the value##4##4##(1993-2#1)(1995-9#1)(2008-1#1)(2008-10#1)
to determine the viability and##2##5##(1994-1#1)(2013-1#1)
to determine the viability of##2##5##(2007-6#1)(2010-5#1)
to determine the viability##5##4##(1994-1#1)(2007-6#1)(2008-11#1)(2010-5#1)(2013-1#1)
to determine the volume##2##4##(2007-12#1)(2008-2#1)
to determine the##1427##3##(1990-10#3)(1990-11#4)(1990-12#4)(1990-2#1)(1990-3#3)(1990-4#2)(1990-5#4)(1990-6#3)(1990-7#3)(1990-8#2)(1990-9#3)(1991-1#1)(1991-11#3)(1991-12#2)(1991-2#3)(1991-3#3)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#3)(1991-9#4)(1992-1#4)(1992-10#3)(1992-11#3)(1992-12#5)(1992-2#4)(1992-3#3)(1992-5#2)(1992-6#4)(1992-7#3)(1992-8#2)(1992-9#3)(1993-1#2)(1993-11#7)(1993-12#3)(1993-2#7)(1993-3#8)(1993-4#1)(1993-5#1)(1993-7#2)(1993-8#4)(1993-9#2)(1994-1#3)(1994-10#2)(1994-11#4)(1994-12#3)(1994-2#2)(1994-3#5)(1994-5#4)(1994-6#4)(1994-7#1)(1994-8#4)(1994-9#2)(1995-1#3)(1995-10#2)(1995-11#11)(1995-12#4)(1995-2#7)(1995-3#7)(1995-4#1)(1995-5#3)(1995-6#4)(1995-7#5)(1995-8#5)(1995-9#2)(1996-1#2)(1996-10#1)(1996-11#3)(1996-12#10)(1996-2#6)(1996-3#6)(1996-4#2)(1996-5#3)(1996-6#3)(1996-7#5)(1996-8#5)(1996-9#3)(1997-1#3)(1997-2#4)(1997-3#5)(1997-4#4)(1997-5#3)(1997-6#5)(1997-7#4)(1997-8#8)(2004-10#2)(2004-11#3)(2004-12#1)(2004-9#6)(2005-10#1)(2005-11#9)(2005-12#5)(2005-5#1)(2005-7#3)(2005-8#7)(2005-9#2)(2006-1#1)(2006-10#17)(2006-11#3)(2006-12#7)(2006-2#6)(2006-3#2)(2006-4#3)(2006-5#7)(2006-7#4)(2006-8#20)(2006-9#3)(2007-1#6)(2007-10#8)(2007-11#12)(2007-12#23)(2007-2#24)(2007-3#8)(2007-4#3)(2007-5#5)(2007-6#6)(2007-7#18)(2007-8#24)(2007-9#15)(2008-1#12)(2008-10#188)(2008-11#18)(2008-12#23)(2008-2#62)(2008-3#61)(2008-4#36)(2008-5#37)(2008-6#14)(2008-7#24)(2008-8#21)(2008-9#18)(2009-10#5)(2009-11#1)(2009-12#3)(2009-2#3)(2009-3#1)(2009-4#6)(2009-5#8)(2009-6#4)(2009-7#5)(2009-8#2)(2010-1#2)(2010-10#5)(2010-11#5)(2010-12#10)(2010-2#13)(2010-3#5)(2010-4#12)(2010-5#5)(2010-6#4)(2010-7#4)(2010-8#14)(2010-9#3)(2011-1#20)(2011-12#3)(2011-2#48)(2012-1#10)(2012-11#3)(2012-12#20)(2012-2#29)(2012-3#16)(2012-6#1)(2013-1#45)(2013-3#1)(2013-7#8)(2013-8#23)
to determine their concentrations##2##4##(2008-10#1)(2012-2#1)
to determine their correlation with##2##5##(2007-10#1)(2012-2#1)
to determine their efficacy in##2##5##(2011-2#1)(2013-7#1)
to determine their functional##2##4##(2007-12#1)(2012-2#1)
to determine their genetic diversity and##2##6##(2008-10#2)
to determine their genetic##3##4##(2008-10#3)
to determine their morphological##2##4##(2008-10#1)(2008-12#1)
to determine their potential##3##4##(2008-11#2)(2013-8#1)
to determine their##59##3##(1990-5#1)(1991-2#2)(1991-5#1)(1992-12#1)(1994-1#1)(1995-10#1)(2005-10#2)(2005-11#2)(2006-11#2)(2006-2#1)(2007-10#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
to determine thermodynamic##2##3##(1993-8#1)(2008-10#1)
to determine these##7##3##(1992-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2012-12#1)
to determine this##4##3##(2005-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
to determine to what extent##3##5##(1997-5#1)(2008-10#1)(2011-1#1)
to determine total##7##3##(1994-2#1)(2007-2#1)(2008-10#3)(2008-4#1)(2009-4#1)
to determine trace##7##3##(2005-4#1)(2008-10#6)
to determine traces of##3##4##(2008-10#3)
to determine treatment##2##3##(1996-12#1)(2013-1#1)
to determine unambiguously the##3##4##(1993-2#1)(1994-8#1)(1995-12#1)
to determine vertebral body##2##4##(2006-11#1)(2007-8#1)
to determine water-vapor##2##3##(2008-2#2)
to determine what factors##3##4##(2008-7#1)(2012-2#1)(2013-8#1)
to determine what##19##3##(1991-2#1)(1991-3#1)(1992-12#1)(1993-7#1)(1994-1#1)(1994-12#1)(1994-5#1)(1997-6#1)(1997-8#1)(2004-11#1)(2006-2#1)(2006-5#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-7#1)(2013-8#1)
to determine when##7##3##(1996-4#1)(2006-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2010-8#1)
to determine whether B##2##4##(2008-10#1)(2012-2#1)
to determine whether a##16##4##(1992-4#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-7#1)(2006-7#1)(2007-11#3)(2008-1#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-12#1)(2011-1#1)(2012-2#1)
to determine whether an##3##4##(1993-9#1)(2007-8#1)(2008-8#1)
to determine whether and##3##4##(2007-11#1)(2010-8#1)(2011-2#1)
to determine whether any##2##4##(1991-8#1)(2010-3#1)
to determine whether cells##2##4##(2008-4#2)
to determine whether changes in##2##5##(2006-6#1)(2010-2#1)
to determine whether citalopram plus celecoxib dual therapy##2##8##(2011-2#2)
to determine whether dietary##2##4##(1996-7#1)(2008-4#1)
to determine whether differences in##3##5##(1996-4#1)(1997-5#1)(2008-10#1)
to determine whether differences##4##4##(1996-4#1)(1997-5#1)(2007-9#1)(2008-10#1)
to determine whether different##2##4##(2010-2#1)(2012-3#1)
to determine whether hepatic##2##4##(1995-8#1)(2007-8#1)
to determine whether it is##2##5##(2008-5#1)(2008-6#1)
to determine whether it was likely##2##6##(1994-3#1)(2007-11#1)
to determine whether it was##3##5##(1994-3#1)(1995-12#1)(2007-11#1)
to determine whether it##7##4##(1993-11#1)(1994-12#1)(1994-3#1)(1995-12#1)(2007-11#1)(2008-5#1)(2008-6#1)
to determine whether its##2##4##(1992-5#1)(1994-6#1)
to determine whether or not the##3##6##(1996-4#1)(2006-8#1)(2007-7#1)
to determine whether or not##12##5##(1996-4#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-5#3)(2008-6#2)(2012-1#1)(2012-3#1)
to determine whether such##4##4##(2004-2#1)(2006-7#1)(2008-10#1)(2013-1#1)
to determine whether the use of##3##6##(1993-8#1)(2007-8#1)(2008-10#1)
to determine whether the##61##4##(1990-11#1)(1990-8#1)(1991-10#1)(1991-9#1)(1992-10#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-7#1)(1997-8#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-9#1)(2009-12#1)(2009-2#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#2)
to determine whether their##3##4##(1993-1#1)(1995-2#1)(2007-12#1)
to determine whether there are##3##5##(1996-9#1)(2008-7#1)(2010-7#1)
to determine whether there is a##2##6##(1997-2#1)(2008-8#1)
to determine whether there is##4##5##(1997-2#1)(1997-5#1)(2008-8#1)(2009-12#1)
to determine whether there was a##2##6##(2004-1#1)(2007-12#1)
to determine whether there was##5##5##(1995-12#1)(2004-1#1)(2007-10#1)(2007-12#1)(2008-4#1)
to determine whether there##14##4##(1995-12#1)(1995-6#1)(1996-9#1)(1997-2#1)(1997-5#1)(2004-1#1)(2007-10#1)(2007-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-7#1)(2013-7#1)
to determine whether these##10##4##(1997-7#1)(1997-8#1)(2005-10#1)(2006-12#1)(2007-10#1)(2007-5#1)(2008-12#1)(2008-5#1)(2011-1#1)(2013-1#1)
to determine whether they are##5##5##(1991-6#1)(2007-5#1)(2008-7#1)(2010-4#1)(2011-2#1)
to determine whether they##8##4##(1991-6#1)(2007-5#1)(2008-7#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-7#1)
to determine whether this is##3##5##(1991-5#1)(1995-9#1)(1996-4#1)
to determine whether this##15##4##(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1995-11#1)(1995-12#1)(1995-9#1)(1996-4#1)(2005-10#1)(2005-7#1)(2008-8#1)(2009-4#1)(2011-2#2)(2013-1#1)
to determine whether to##2##4##(2008-12#1)(2011-2#1)
to determine whether##353##3##(1990-10#1)(1990-11#3)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#2)(1991-1#2)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#2)(1992-3#2)(1992-4#1)(1992-5#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#2)(1993-8#4)(1993-9#4)(1994-11#1)(1994-12#5)(1994-2#2)(1994-3#2)(1994-6#2)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#5)(1995-2#2)(1995-3#4)(1995-5#4)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#3)(1996-6#4)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#2)(1997-7#4)(1997-8#3)(2004-1#1)(2004-11#2)(2004-12#1)(2004-2#1)(2005-10#3)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#3)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#7)(2007-11#8)(2007-12#7)(2007-2#2)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#19)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#7)(2008-5#12)(2008-6#8)(2008-7#5)(2008-8#6)(2008-9#3)(2009-10#2)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#5)(2011-1#6)(2011-2#17)(2012-1#4)(2012-12#2)(2012-2#7)(2012-3#7)(2012-5#1)(2013-1#10)(2013-7#3)(2013-8#7)
to determine which of##4##4##(1994-3#1)(1994-8#1)(2006-9#1)(2007-11#1)
to determine which operational parameters should be included in the optimization##2##11##(2008-10#2)
to determine which##43##3##(1990-2#1)(1991-6#1)(1992-7#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-5#2)(1997-2#1)(2004-11#1)(2006-1#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-8#2)(2008-10#6)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
to determine with##4##3##(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)
to determine##2977##2##(1990-10#6)(1990-11#10)(1990-12#9)(1990-2#5)(1990-3#7)(1990-4#2)(1990-5#11)(1990-6#4)(1990-7#4)(1990-8#6)(1990-9#4)(1991-1#4)(1991-10#2)(1991-11#5)(1991-12#7)(1991-2#13)(1991-3#7)(1991-4#2)(1991-5#6)(1991-6#3)(1991-7#3)(1991-8#10)(1991-9#9)(1992-1#8)(1992-10#5)(1992-11#8)(1992-12#12)(1992-2#8)(1992-3#7)(1992-4#1)(1992-5#5)(1992-6#5)(1992-7#8)(1992-8#7)(1992-9#6)(1993-1#3)(1993-11#12)(1993-12#13)(1993-2#16)(1993-3#11)(1993-4#4)(1993-5#3)(1993-6#4)(1993-7#9)(1993-8#10)(1993-9#9)(1994-1#5)(1994-10#5)(1994-11#9)(1994-12#12)(1994-2#11)(1994-3#10)(1994-5#6)(1994-6#8)(1994-7#1)(1994-8#11)(1994-9#6)(1995-1#5)(1995-10#5)(1995-11#17)(1995-12#11)(1995-2#13)(1995-3#16)(1995-4#1)(1995-5#10)(1995-6#9)(1995-7#7)(1995-8#7)(1995-9#4)(1996-1#7)(1996-10#4)(1996-11#7)(1996-12#17)(1996-2#10)(1996-3#11)(1996-4#7)(1996-5#10)(1996-6#7)(1996-7#7)(1996-8#10)(1996-9#5)(1997-1#8)(1997-2#11)(1997-3#11)(1997-4#9)(1997-5#7)(1997-6#7)(1997-7#9)(1997-8#17)(2004-1#2)(2004-10#2)(2004-11#11)(2004-12#2)(2004-2#1)(2004-3#1)(2004-9#7)(2005-10#10)(2005-11#16)(2005-12#6)(2005-4#4)(2005-5#2)(2005-7#4)(2005-8#11)(2005-9#3)(2006-1#4)(2006-10#33)(2006-11#9)(2006-12#15)(2006-2#12)(2006-3#3)(2006-4#5)(2006-5#17)(2006-6#3)(2006-7#8)(2006-8#26)(2006-9#5)(2007-1#8)(2007-10#30)(2007-11#29)(2007-12#54)(2007-2#37)(2007-3#12)(2007-4#8)(2007-5#16)(2007-6#9)(2007-7#34)(2007-8#59)(2007-9#25)(2008-1#24)(2008-10#489)(2008-11#47)(2008-12#36)(2008-2#91)(2008-3#92)(2008-4#67)(2008-5#77)(2008-6#27)(2008-7#51)(2008-8#38)(2008-9#29)(2009-1#1)(2009-10#12)(2009-11#6)(2009-12#8)(2009-2#8)(2009-3#4)(2009-4#18)(2009-5#10)(2009-6#4)(2009-7#10)(2009-8#6)(2009-9#3)(2010-1#4)(2010-10#7)(2010-11#10)(2010-12#22)(2010-2#17)(2010-3#10)(2010-4#20)(2010-5#10)(2010-6#10)(2010-7#6)(2010-8#29)(2010-9#6)(2011-1#40)(2011-11#1)(2011-12#4)(2011-2#99)(2012-1#17)(2012-11#3)(2012-12#37)(2012-2#62)(2012-3#27)(2012-5#1)(2012-6#1)(2012-8#1)(2013-1#82)(2013-3#1)(2013-7#20)(2013-8#46)
to determined##2##2##(2008-12#1)(2011-2#1)
to determining the##10##3##(1991-12#1)(2006-9#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-11#1)
to determining##13##2##(1991-12#1)(1995-3#1)(2005-4#1)(2006-9#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-11#1)
to detoxicate##2##2##(2008-3#1)(2008-5#1)
to detoxify##8##2##(1991-1#1)(1993-5#1)(1994-11#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-5#1)(2010-7#1)
to detrimental##5##2##(2012-3#5)
to devascularize##2##2##(2006-12#1)(2006-9#1)
to develop &quot##4##3##(1995-3#1)(2007-7#1)(2013-1#2)
to develop a baseline##2##4##(1997-4#1)(2008-12#1)
to develop a better understanding of the##2##7##(1992-11#1)(2007-4#1)
to develop a better understanding of##4##6##(1992-11#1)(2007-4#1)(2008-7#1)(2010-9#1)
to develop a better##6##4##(1992-11#1)(2007-11#1)(2007-4#1)(2008-7#1)(2010-9#1)(2012-2#1)
to develop a clinical##5##4##(2006-1#1)(2007-7#1)(2013-1#3)
to develop a comprehensive##5##4##(1994-12#1)(2007-9#1)(2008-3#1)(2012-1#1)(2013-1#1)
to develop a critical##2##4##(2008-3#1)(2010-7#1)
to develop a culture##3##4##(2007-5#1)(2008-11#1)(2008-5#1)
to develop a detailed##2##4##(2008-8#1)(2009-12#1)
to develop a device##2##4##(2007-7#2)
to develop a dose-response##2##4##(1997-3#1)(2010-12#1)
to develop a finite element##2##5##(2007-4#2)
to develop a fully##2##4##(2008-10#1)(2008-9#1)
to develop a method for##2##5##(2009-8#1)(2012-4#1)
to develop a method of##4##5##(2007-4#1)(2008-6#2)(2010-9#1)
to develop a method to##2##5##(1992-6#1)(1997-2#1)
to develop a method##9##4##(1992-6#1)(1997-2#1)(2007-4#1)(2008-6#2)(2009-8#1)(2010-2#1)(2010-9#1)(2012-4#1)
to develop a model for##3##5##(1996-3#1)(2007-7#1)(2008-10#1)
to develop a model##5##4##(1996-3#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-11#1)
to develop a more##3##4##(2007-8#1)(2008-11#1)(2009-4#1)
to develop a new experimental##2##5##(2008-10#1)(2012-1#1)
to develop a new method for##2##6##(1993-11#1)(1994-9#1)
to develop a new##19##4##(1992-11#1)(1993-11#1)(1993-3#1)(1994-9#1)(2004-9#1)(2005-7#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-6#1)(2009-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
to develop a novel##5##4##(2007-12#1)(2008-10#3)(2010-11#1)
to develop a quantitative##2##4##(2007-8#1)(2012-1#1)
to develop a rapid##3##4##(2008-10#3)
to develop a reliable##4##4##(1990-5#1)(2008-10#1)(2008-7#1)(2013-1#1)
to develop a simple and efficient##2##6##(1993-4#1)(2008-10#1)
to develop a simple and##3##5##(1993-4#1)(2008-10#1)(2008-5#1)
to develop a simple##10##4##(1993-4#1)(2008-1#1)(2008-10#5)(2008-5#2)(2013-7#1)
to develop a solid##2##4##(2008-10#2)
to develop a specific##2##4##(2008-10#1)(2010-3#1)
to develop a strategic##2##4##(1997-2#1)(2008-7#1)
to develop a system##3##4##(2009-8#1)(2010-2#1)(2011-2#1)
to develop a systematic##2##4##(2008-3#1)(2012-3#1)
to develop a totally##2##4##(2008-10#1)(2009-10#1)
to develop a unified##2##4##(2007-12#1)(2008-2#1)
to develop a vaccine against##4##5##(2006-10#1)(2009-6#1)(2010-1#1)(2013-1#1)
to develop a vaccine##5##4##(2006-10#1)(2007-11#1)(2009-6#1)(2010-1#1)(2013-1#1)
to develop a variety of##2##5##(1994-3#1)(2009-8#1)
to develop a##272##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#2)(1992-11#2)(1992-2#2)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-9#2)(1995-11#1)(1995-5#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-7#1)(1997-2#5)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-10#2)(2007-11#5)(2007-12#2)(2007-2#4)(2007-4#8)(2007-5#3)(2007-7#7)(2007-8#4)(2007-9#4)(2008-1#6)(2008-10#29)(2008-11#14)(2008-12#2)(2008-2#4)(2008-3#6)(2008-4#3)(2008-5#9)(2008-6#6)(2008-7#7)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#2)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#1)(2010-7#3)(2010-9#3)(2011-1#4)(2011-2#4)(2012-1#6)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#3)(2012-4#1)(2013-1#15)(2013-7#3)(2013-8#2)
to develop adequate##2##3##(2005-9#1)(2012-2#1)
to develop algorithms##2##3##(2008-2#1)(2010-7#1)
to develop alternative##3##3##(1996-2#1)(2004-9#1)(2008-8#1)
to develop an accurate##2##4##(2008-1#1)(2008-10#1)
to develop an action plan##2##5##(1995-12#1)(2007-4#1)
to develop an approach for##4##5##(1991-12#1)(1997-2#1)(2013-1#2)
to develop an assay##2##4##(1990-12#1)(1992-6#1)
to develop an automatic##2##4##(1991-5#1)(2008-2#1)
to develop an effective##4##4##(2005-7#1)(2008-6#1)(2010-12#1)(2012-2#1)
to develop an efficient##4##4##(2008-10#1)(2008-11#2)(2008-2#1)
to develop an evidence-based approach to##2##6##(2008-8#1)(2010-11#1)
to develop an evidence-based##4##4##(2008-6#2)(2008-8#1)(2010-11#1)
to develop an in##2##4##(2008-11#1)(2013-1#1)
to develop an objective##2##4##(2007-8#1)(2012-2#1)
to develop an##72##3##(1990-12#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-3#2)(1994-11#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1997-1#2)(1997-2#1)(2005-7#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#3)(2008-8#1)(2009-4#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-2#3)(2012-2#4)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#2)
to develop and apply##4##4##(1995-8#1)(2008-10#1)(2008-5#1)(2012-12#1)
to develop and evaluate a##3##5##(2008-10#1)(2010-7#1)(2012-2#1)
to develop and evaluate the##2##5##(2008-11#1)(2011-12#1)
to develop and evaluate##9##4##(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2010-7#1)(2011-12#1)(2012-2#1)
to develop and implement a##7##5##(1991-12#1)(1993-1#1)(1995-2#1)(2006-2#1)(2007-4#1)(2008-9#1)(2013-1#1)
to develop and implement an##2##5##(1992-2#1)(1997-3#1)
to develop and implement##12##4##(1991-12#1)(1992-2#1)(1993-1#1)(1995-2#1)(1997-3#1)(2006-2#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-9#1)(2013-1#1)
to develop and maintain##2##4##(1990-12#1)(2010-11#1)
to develop and test##7##4##(2006-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-1#2)
to develop and to##2##4##(2008-10#1)(2012-3#1)
to develop and validate a##6##5##(2006-11#1)(2007-4#1)(2008-10#1)(2008-5#1)(2012-1#1)(2012-2#1)
to develop and validate an##3##5##(2008-10#1)(2010-11#1)(2011-1#1)
to develop and validate##12##4##(2006-11#1)(2006-5#1)(2007-4#1)(2008-10#2)(2008-5#1)(2008-6#1)(2010-11#1)(2011-1#1)(2012-1#2)(2012-2#1)
to develop and##69##3##(1990-12#1)(1991-12#2)(1991-3#1)(1992-2#1)(1993-1#1)(1994-1#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-1#1)(1997-3#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-4#3)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#1)(2010-11#2)(2010-12#1)(2010-7#1)(2010-9#3)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#6)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
to develop and/or##2##3##(2006-1#1)(2008-12#1)
to develop appropriate##2##3##(2004-12#1)(2007-12#1)
to develop better##6##3##(1994-3#1)(1996-12#1)(2004-9#1)(2009-12#1)(2010-2#1)(2010-8#1)
to develop clinical##7##3##(1993-12#1)(2007-2#1)(2007-7#1)(2008-12#1)(2010-12#1)(2010-6#1)(2013-1#1)
to develop common##2##3##(1996-3#1)(2008-10#1)
to develop comprehensive##2##3##(2010-8#1)(2013-1#1)
to develop consensus##2##3##(2009-7#1)(2009-8#1)
to develop critical##2##3##(2008-12#2)
to develop diagnostic##3##3##(2007-8#1)(2008-11#1)(2011-2#1)
to develop disease##2##3##(2006-12#1)(2008-10#1)
to develop drug##2##3##(1993-6#1)(2006-11#1)
to develop effective and##2##4##(2006-10#1)(2008-10#1)
to develop effective interventions##2##4##(2008-12#1)(2013-8#1)
to develop effective##13##3##(1990-10#1)(1992-2#1)(1994-3#1)(2006-10#1)(2006-11#1)(2006-2#1)(2008-10#1)(2008-12#1)(2010-12#1)(2010-3#1)(2012-12#2)(2013-8#1)
to develop efficient##4##3##(1997-3#1)(2008-10#1)(2009-8#1)(2013-1#1)
to develop from##2##3##(2007-12#1)(2008-11#1)
to develop fully##2##3##(1997-2#1)(2008-11#1)
to develop functional##2##3##(2007-11#1)(2012-12#1)
to develop future##2##3##(2007-7#1)(2013-1#1)
to develop guidelines for the##2##5##(2007-10#1)(2010-7#1)
to develop guidelines for##3##4##(2006-9#1)(2007-10#1)(2010-7#1)
to develop guidelines##5##3##(2006-9#1)(2007-10#2)(2010-7#1)(2011-2#1)
to develop health##2##3##(1991-2#1)(2007-2#1)
to develop his##2##3##(2005-12#1)(2008-7#1)
to develop in##8##3##(2007-11#1)(2008-1#1)(2008-11#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
to develop interventions##2##3##(2007-2#1)(2008-6#1)
to develop into##4##3##(1995-1#1)(2006-5#1)(2007-5#1)(2008-3#1)
to develop it##2##3##(1992-3#1)(2007-9#1)
to develop local##2##3##(2008-1#1)(2008-7#1)
to develop management##2##3##(2006-8#1)(2008-1#1)
to develop measures##2##3##(1992-2#1)(2010-12#1)
to develop methodology##2##3##(2007-7#1)(2012-2#1)
to develop methods for##3##4##(2008-3#1)(2008-9#1)(2012-11#1)
to develop methods of##2##4##(1991-12#1)(2010-12#1)
to develop methods##7##3##(1991-12#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-12#1)(2012-11#1)(2012-12#1)
to develop models for##2##4##(2008-7#1)(2009-3#1)
to develop models of##2##4##(2009-3#1)(2010-3#1)
to develop models##5##3##(2008-10#1)(2008-7#1)(2009-3#2)(2010-3#1)
to develop molecular##3##3##(1994-5#1)(2008-10#1)(2010-3#1)
to develop more effective treatments##2##5##(2008-6#1)(2013-7#1)
to develop more effective##9##4##(1993-6#1)(1996-2#1)(1996-8#1)(2008-12#1)(2008-3#1)(2008-6#1)(2010-8#1)(2011-2#1)(2013-7#1)
to develop more efficient##2##4##(2007-11#1)(2008-5#1)
to develop more##16##3##(1993-6#1)(1994-1#1)(1996-2#1)(1996-8#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#2)(2013-7#1)
to develop new agents##2##4##(2008-10#2)
to develop new drugs##4##4##(2005-7#1)(2006-10#1)(2009-6#1)(2010-12#1)
to develop new treatment##3##4##(1994-5#1)(2007-11#1)(2008-8#1)
to develop new##26##3##(1990-3#1)(1992-3#1)(1994-5#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-5#1)(2006-9#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#2)
to develop newer##2##3##(2007-6#1)(2011-2#1)
to develop novel therapeutic##2##4##(2005-11#1)(2010-5#1)
to develop novel##17##3##(1992-11#1)(1992-3#1)(1992-4#1)(1997-4#1)(1997-5#1)(2005-11#1)(2005-7#1)(2008-10#1)(2008-2#1)(2008-5#3)(2009-4#1)(2010-5#1)(2011-1#1)(2012-11#1)(2012-3#1)
to develop obesity##2##3##(2006-1#1)(2012-1#1)
to develop on##3##3##(2008-10#2)(2009-3#1)
to develop or##10##3##(2006-10#8)(2008-10#1)(2013-1#1)
to develop our understanding##2##4##(1996-8#1)(2010-7#1)
to develop policies##2##3##(2010-7#1)(2010-8#1)
to develop practical##2##3##(1997-6#1)(2008-1#1)
to develop practice##3##3##(1997-7#1)(2006-12#1)(2008-12#1)
to develop preventive strategies##2##4##(2006-8#1)(2012-2#1)
to develop preventive##3##3##(2006-8#1)(2008-10#1)(2012-2#1)
to develop programs##2##3##(1994-1#1)(2005-8#1)
to develop protocols##3##3##(2006-6#1)(2007-5#1)(2008-9#1)
to develop rapid##2##3##(2008-5#1)(2008-8#1)
to develop rapidly##2##3##(1996-12#1)(2006-12#1)
to develop rational##2##3##(1995-3#1)(1997-8#1)
to develop reflective thinking and practice##2##6##(2012-12#2)
to develop reflective##3##3##(1997-4#1)(2012-12#2)
to develop reliable##3##3##(1997-4#1)(2008-10#1)(2008-2#1)
to develop resistance to##3##4##(2005-7#1)(2005-8#1)(2011-2#1)
to develop resistance##5##3##(2005-7#1)(2005-8#1)(2008-5#1)(2011-2#2)
to develop sampling##2##3##(2008-10#1)(2011-12#1)
to develop several##2##3##(2008-10#1)(2012-11#1)
to develop severe##3##3##(1990-6#1)(2006-2#1)(2012-3#1)
to develop simple##3##3##(2008-10#1)(2008-7#1)(2010-2#1)
to develop skills in##2##4##(1993-12#1)(2006-2#1)
to develop skills##4##3##(1993-12#1)(2006-2#1)(2008-11#2)
to develop specific##5##3##(2008-3#1)(2008-7#2)(2012-12#2)
to develop standardized##2##3##(2009-11#1)(2012-12#1)
to develop standards##2##3##(1996-8#1)(1997-7#1)
to develop strategies for##4##4##(2008-10#1)(2008-11#1)(2010-5#1)(2011-1#1)
to develop strategies to##4##4##(2007-2#1)(2007-3#1)(2008-5#1)(2008-6#1)
to develop strategies##9##3##(2007-2#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2010-5#1)(2011-1#1)
to develop such a##3##4##(2007-10#1)(2008-10#1)(2013-1#1)
to develop such##6##3##(1993-5#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-8#1)(2013-1#1)
to develop suitable##3##3##(2007-8#1)(2008-10#1)(2011-1#1)
to develop tailored##2##3##(1997-3#1)(2009-11#1)
to develop the concept##2##4##(2008-9#1)(2012-2#1)
to develop the instrument##2##4##(2008-10#2)
to develop the model##3##4##(2007-10#1)(2013-1#2)
to develop the necessary##2##4##(1995-12#1)(2008-8#1)
to develop the##44##3##(1990-8#1)(1992-7#1)(1994-2#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-2#1)(2005-10#1)(2005-8#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-4#2)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
to develop their competencies##2##4##(2008-12#1)(2013-1#1)
to develop their professional##2##4##(2008-1#1)(2008-11#1)
to develop their##6##3##(2008-1#1)(2008-11#1)(2008-12#1)(2010-10#1)(2013-1#1)(2013-8#1)
to develop therapeutic approaches##2##4##(2008-1#1)(2010-11#1)
to develop therapeutic##3##3##(2008-1#2)(2010-11#1)
to develop therapeutics##3##3##(2005-7#1)(2008-5#1)(2013-1#1)
to develop therapies##3##3##(2008-11#1)(2008-7#1)(2012-12#1)
to develop these##4##3##(1994-2#1)(2005-7#1)(2007-8#1)(2013-1#1)
to develop this##3##3##(2005-7#1)(2008-10#2)
to develop three##2##3##(2008-10#1)(2012-2#1)
to develop to##2##3##(2006-5#2)
to develop tools##2##3##(2008-10#1)(2008-7#1)
to develop training##2##3##(1996-3#1)(2008-12#1)
to develop treatments##2##3##(2008-10#1)(2010-7#1)
to develop two##3##3##(2007-8#1)(2008-10#1)(2008-11#1)
to develop##1090##2##(1990-10#2)(1990-12#4)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#6)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#3)(1992-11#4)(1992-12#1)(1992-2#6)(1992-3#3)(1992-4#2)(1992-6#3)(1992-7#1)(1992-9#2)(1993-1#2)(1993-11#3)(1993-12#6)(1993-2#3)(1993-3#5)(1993-4#1)(1993-5#1)(1993-6#4)(1993-7#1)(1993-9#1)(1994-1#4)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#9)(1994-4#1)(1994-5#4)(1994-9#5)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#2)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#6)(1996-2#9)(1996-3#5)(1996-5#1)(1996-7#1)(1996-8#3)(1997-1#5)(1997-2#8)(1997-3#4)(1997-4#6)(1997-5#2)(1997-6#3)(1997-7#3)(1997-8#6)(2004-10#1)(2004-12#1)(2004-9#3)(2005-10#4)(2005-11#1)(2005-12#1)(2005-7#8)(2005-8#6)(2005-9#3)(2006-1#3)(2006-10#23)(2006-11#7)(2006-12#6)(2006-2#6)(2006-4#1)(2006-5#7)(2006-6#9)(2006-7#3)(2006-8#6)(2006-9#4)(2007-1#3)(2007-10#10)(2007-11#16)(2007-12#8)(2007-2#11)(2007-3#3)(2007-4#16)(2007-5#6)(2007-6#1)(2007-7#15)(2007-8#12)(2007-9#7)(2008-1#23)(2008-10#107)(2008-11#51)(2008-12#20)(2008-2#17)(2008-3#20)(2008-4#9)(2008-5#31)(2008-6#14)(2008-7#30)(2008-8#16)(2008-9#9)(2009-10#6)(2009-11#8)(2009-12#3)(2009-2#1)(2009-3#5)(2009-4#5)(2009-5#3)(2009-6#5)(2009-7#5)(2009-8#9)(2009-9#3)(2010-1#2)(2010-10#2)(2010-11#9)(2010-12#16)(2010-2#10)(2010-3#7)(2010-4#4)(2010-5#10)(2010-6#4)(2010-7#12)(2010-8#8)(2010-9#8)(2011-1#11)(2011-10#1)(2011-12#3)(2011-2#27)(2011-3#1)(2012-1#19)(2012-11#6)(2012-12#20)(2012-2#26)(2012-3#10)(2012-4#1)(2013-1#48)(2013-7#5)(2013-8#9)
to developed##2##2##(2007-2#1)(2008-10#1)
to developing a##3##3##(1993-2#1)(2008-11#1)(2008-4#1)
to developing an##2##3##(1996-3#1)(2007-12#1)
to developing and implementing##2##4##(2007-11#1)(2011-1#1)
to developing countries##5##3##(1991-4#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#1)
to developing countries]##2##3##(2005-5#1)(2011-2#1)
to developing effective##2##3##(2006-7#1)(2007-11#1)
to developing such##2##3##(2007-12#1)(2008-2#1)
to developing##52##2##(1991-4#1)(1992-3#1)(1993-2#1)(1994-4#1)(1996-12#1)(1996-3#1)(1997-6#1)(2005-12#1)(2005-5#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-11#3)(2007-12#3)(2007-6#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-12#3)(2010-8#3)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
to development of a##2##4##(2008-6#1)(2011-2#1)
to development of increased##2##4##(1995-7#1)(2008-12#1)
to development of##33##3##(1990-5#1)(1991-7#1)(1993-2#1)(1995-12#1)(1995-7#1)(1996-4#1)(2005-7#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#4)(2008-6#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
to development##43##2##(1990-5#1)(1991-5#1)(1991-7#1)(1993-2#1)(1995-12#1)(1995-7#1)(1996-4#1)(2005-7#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#4)(2008-6#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)
to developmental and##2##3##(2008-11#1)(2009-8#1)
to developmental##14##2##(1993-12#1)(1995-8#1)(1997-3#1)(2006-9#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-9#1)(2011-1#1)(2012-12#1)
to developmentally##4##2##(1992-12#1)(2008-8#1)(2009-4#1)(2010-4#1)
to developments##2##2##(2006-2#1)(2008-10#1)
to deviate##2##2##(2007-8#1)(2008-10#1)
to device##8##2##(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-2#1)(2010-5#1)(2010-9#1)(2013-1#1)
to devices##2##2##(2008-11#1)(2008-3#1)
to devise a##10##3##(1994-2#1)(2005-8#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-12#1)(2012-12#2)(2013-1#1)
to devise strategies that would minimize incidence of this complication in the future##2##13##(2013-1#2)
to devise strategies##3##3##(2009-4#1)(2013-1#2)
to devise##19##2##(1994-1#1)(1994-2#1)(2005-8#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2009-4#1)(2010-7#1)(2010-9#1)(2012-12#2)(2013-1#4)
to devote more##2##3##(2008-8#1)(2011-2#1)
to devote##5##2##(1990-4#1)(1994-1#1)(2008-7#1)(2008-8#1)(2011-2#1)
to dexamethasone##6##2##(1991-12#2)(1991-6#1)(1993-2#1)(1996-2#1)(2012-2#1)
to diabetes and##3##3##(2008-11#1)(2008-3#1)(2013-8#1)
to diabetes mellitus##4##3##(2007-9#1)(2008-7#1)(2009-5#1)(2013-8#1)
to diabetes##28##2##(1993-12#1)(1994-12#1)(1994-6#1)(2005-10#1)(2006-2#2)(2007-1#1)(2007-3#1)(2007-9#1)(2008-1#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#2)(2010-5#1)(2011-2#1)(2012-3#1)(2013-8#2)
to diabetes?##2##2##(2009-5#1)(2012-2#1)
to diabetic nephropathy##3##3##(1997-8#1)(2008-1#1)(2011-2#1)
to diabetic neuropathy##2##3##(2008-1#1)(2010-11#1)
to diabetic rats##4##3##(1994-3#1)(1996-3#1)(2008-8#1)(2010-1#1)
to diabetic retinopathy##2##3##(1995-9#1)(2009-4#1)
to diabetic##17##2##(1994-3#1)(1995-9#1)(1996-3#1)(1997-8#1)(2007-11#1)(2008-1#6)(2008-8#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-11#1)(2011-2#1)
to diacylglycerol##2##2##(1990-12#1)(1991-12#1)
to diagnose TB##2##3##(2010-5#1)(2012-2#1)
to diagnose a##5##3##(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2010-12#1)
to diagnose acute##2##3##(1997-2#1)(2006-10#1)
to diagnose and manage##2##4##(2007-8#1)(2011-2#1)
to diagnose and treat##7##4##(1995-5#1)(2006-7#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-12#1)
to diagnose and##25##3##(1992-5#1)(1995-5#1)(1997-1#1)(2006-10#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-8#2)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#2)(2013-8#1)
to diagnose breast cancer##2##4##(1991-9#1)(2004-1#1)
to diagnose disease##2##3##(2010-12#1)(2013-1#1)
to diagnose early Alzheimer's disease##2##5##(1995-11#2)
to diagnose in##2##3##(2010-10#1)(2010-9#1)
to diagnose it##3##3##(2008-7#2)(2011-1#1)
to diagnose myocardial##2##3##(2008-10#1)(2009-10#1)
to diagnose occupational##2##3##(2010-9#2)
to diagnose or manage##2##4##(2005-8#1)(2010-9#1)
to diagnose or##6##3##(2005-8#1)(2007-4#1)(2010-5#1)(2010-9#1)(2011-2#1)(2013-1#1)
to diagnose preoperatively##2##3##(2012-2#1)(2013-7#1)
to diagnose primary localization of the##2##6##(2007-11#2)
to diagnose than##2##3##(2009-12#1)(2012-1#1)
to diagnose the condition##2##4##(1993-9#1)(2009-5#1)
to diagnose the##12##3##(1990-5#1)(1993-6#1)(1993-9#1)(1996-3#1)(2005-12#1)(2006-10#1)(2009-3#1)(2009-5#2)(2010-7#1)(2011-1#1)(2012-3#1)
to diagnose these##2##3##(1992-12#1)(2006-9#1)
to diagnose this syndrome##2##4##(1994-12#1)(2011-2#1)
to diagnose this##9##3##(1994-12#1)(2007-7#1)(2008-9#1)(2009-12#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
to diagnose using##2##3##(1991-4#1)(2007-2#1)
to diagnose##172##2##(1990-5#1)(1990-6#2)(1990-8#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-5#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-11#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1995-7#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-8#1)(2004-1#1)(2004-2#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#2)(2006-10#5)(2006-12#2)(2006-7#2)(2006-8#1)(2006-9#2)(2007-10#4)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#6)(2008-1#1)(2008-10#9)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-3#3)(2009-5#4)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#5)(2011-1#5)(2011-12#1)(2011-2#9)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#4)(2012-3#4)(2013-1#9)(2013-7#2)(2013-8#3)
to diagnoses of##2##3##(2008-9#1)(2011-2#1)
to diagnosing the##2##3##(2010-12#1)(2010-2#1)
to diagnosing##5##2##(2006-2#1)(2008-11#1)(2008-8#1)(2010-12#1)(2010-2#1)
to diagnosis and therapy##4##4##(1994-8#1)(2005-8#1)(2008-5#1)(2009-9#1)
to diagnosis and treatment##5##4##(2008-7#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)
to diagnosis and##15##3##(1993-9#1)(1994-8#1)(2005-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)
to diagnosis in##2##3##(2005-8#1)(2008-10#1)
to diagnosis is##4##3##(1990-4#1)(1990-6#1)(1991-4#1)(2011-12#1)
to diagnosis of##9##3##(1993-8#1)(1996-3#1)(1997-3#1)(1997-7#1)(2005-5#1)(2008-10#1)(2008-8#1)(2010-3#1)(2013-8#1)
to diagnosis##56##2##(1990-12#1)(1990-4#1)(1990-6#2)(1991-4#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-8#1)(1996-3#1)(1996-7#1)(1997-3#1)(1997-7#1)(2005-5#1)(2005-8#3)(2006-10#1)(2006-7#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-11#1)(2012-2#1)(2013-1#2)(2013-8#2)
to diagnostic errors##2##3##(2010-12#1)(2012-2#1)
to diagnostic imaging##3##3##(1995-8#1)(1997-6#1)(2007-4#1)
to diagnostic testing##2##3##(2005-7#1)(2007-7#1)
to diagnostic##23##2##(1991-12#1)(1992-5#1)(1993-12#1)(1995-8#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-4#2)(2007-7#1)(2008-2#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
to dialysis and##2##3##(2008-1#1)(2010-7#1)
to dialysis##10##2##(1994-8#1)(1995-2#1)(2008-1#4)(2008-10#1)(2008-8#1)(2010-7#1)(2011-2#1)
to diameter##3##2##(2008-10#1)(2008-5#1)(2010-8#1)
to diameters##2##2##(2007-12#1)(2008-2#1)
to dibutyltin dichloride##2##3##(2008-10#2)
to dichloroacetic acid##9##3##(2008-9#9)
to dicyclohexylcarbodiimide##2##2##(2008-9#2)
to die and##2##3##(1995-5#1)(2007-10#1)
to die as##2##3##(1995-2#1)(2008-10#1)
to die at##2##3##(1993-3#1)(2010-8#1)
to die by##3##3##(1994-8#2)(2008-7#1)
to die in a##2##4##(1996-8#1)(2008-11#1)
to die in##7##3##(1990-7#1)(1994-7#1)(1996-8#1)(2007-9#1)(2008-11#1)(2011-2#2)
to die of##4##3##(1993-6#1)(2006-6#1)(2007-9#1)(2008-7#1)
to die##39##2##(1990-12#1)(1990-7#1)(1991-11#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-6#1)(2006-4#2)(2006-6#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-5#2)(2010-8#1)(2011-2#2)(2012-12#1)
to die?##2##2##(1997-5#1)(2005-9#1)
to diesel oil##2##3##(2009-8#1)(2011-1#1)
to diesel##3##2##(2006-6#1)(2009-8#1)(2011-1#1)
to diet and physical activity##2##5##(2006-10#1)(2010-3#1)
to diet and##3##3##(1994-11#1)(2006-10#1)(2010-3#1)
to diet##5##2##(1991-7#1)(1992-8#1)(1994-11#1)(2006-10#1)(2010-3#1)
to dietary and##2##3##(1991-2#1)(1991-5#1)
to dietary factors##2##3##(1994-2#1)(2006-12#1)
to dietary habits##2##3##(2008-10#1)(2011-2#1)
to dietary##26##2##(1991-12#1)(1991-2#1)(1991-5#1)(1994-2#1)(1994-6#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-2#2)(2013-7#1)
to diethyl##2##2##(1991-9#1)(2008-11#1)
to diethylpyrocarbonate##2##2##(1992-7#1)(1993-9#1)
to diethylstilbestrol (DES) and##2##4##(1990-7#1)(2008-10#1)
to diethylstilbestrol##5##2##(1990-7#2)(2008-10#2)(2010-9#1)
to diets##2##2##(2008-10#1)(2008-3#1)
to differ between##3##3##(1991-5#1)(1993-8#1)(2007-3#1)
to differ from that in##2##5##(1995-11#1)(2007-10#1)
to differ from that##4##4##(1990-5#1)(1995-11#1)(2007-10#1)(2011-2#1)
to differ from the##2##4##(1992-11#1)(2008-10#1)
to differ from##14##3##(1990-11#1)(1990-5#1)(1990-7#1)(1992-11#1)(1992-12#1)(1995-11#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-5#2)(2010-12#1)(2011-2#1)
to differ in their##5##4##(1996-12#1)(2005-11#1)(2007-12#1)(2009-12#1)(2013-1#1)
to differ in##10##3##(1990-11#1)(1991-12#1)(1996-12#1)(2005-11#1)(2007-12#1)(2008-8#1)(2009-12#1)(2010-5#1)(2011-12#1)(2013-1#1)
to differ##41##2##(1990-11#2)(1990-5#1)(1990-7#2)(1990-9#1)(1991-10#1)(1991-11#3)(1991-12#1)(1991-5#1)(1992-11#1)(1992-12#1)(1993-3#1)(1993-8#1)(1995-11#1)(1995-5#1)(1996-12#1)(2005-10#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#1)(2008-10#2)(2008-3#2)(2008-5#3)(2008-8#1)(2009-12#1)(2010-12#1)(2010-5#1)(2011-12#1)(2011-2#1)(2013-1#1)
to difference in##2##3##(2008-12#1)(2008-8#1)
to differences among##3##3##(2008-10#2)(2010-10#1)
to differences between##3##3##(2008-10#2)(2008-6#1)
to differences in the##19##4##(1991-1#1)(1991-11#1)(1992-9#1)(1993-11#1)(1993-3#1)(1996-8#1)(1997-2#1)(2005-11#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#1)
to differences in their##2##4##(2008-10#2)
to differences in##72##3##(1990-4#1)(1990-6#1)(1991-1#1)(1991-11#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-9#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-7#1)(2004-4#1)(2004-9#1)(2005-11#2)(2006-2#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-5#4)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-7#2)(2010-3#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#1)
to differences##83##2##(1990-4#1)(1990-6#1)(1991-1#1)(1991-11#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-9#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-7#1)(2004-4#1)(2004-9#1)(2005-11#2)(2006-2#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-5#4)(2008-6#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-7#2)(2010-10#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
to different AR##2##3##(2012-2#2)
to different antibiotics##3##3##(1992-10#1)(2012-12#1)(2012-3#1)
to different applications##2##3##(1994-6#1)(2008-4#1)
to different beam##2##3##(2007-11#1)(2007-12#1)
to different cell##3##3##(2006-12#1)(2008-11#1)(2010-11#1)
to different classes of##2##4##(1997-7#1)(2013-8#1)
to different classes##3##3##(1993-4#1)(1997-7#1)(2013-8#1)
to different clinical##2##3##(2006-11#1)(2008-5#1)
to different concentrations of##6##4##(1993-6#1)(1997-4#1)(2008-10#1)(2008-12#1)(2012-2#1)(2013-1#1)
to different degrees for##2##4##(1994-5#1)(2008-10#1)
to different degrees##7##3##(1993-6#1)(1993-7#1)(1994-5#1)(2006-7#1)(2008-10#1)(2008-12#1)(2013-8#1)
to different doses of##2##4##(2007-10#1)(2013-1#1)
to different environmental conditions##3##4##(2007-8#1)(2010-10#2)
to different environmental##5##3##(1992-4#1)(2006-7#1)(2007-8#1)(2010-10#2)
to different environments##5##3##(2008-5#1)(2008-9#1)(2011-2#2)(2012-3#1)
to different experimental##2##3##(1991-5#1)(2008-1#1)
to different extent##3##3##(1995-12#1)(2008-9#1)(2010-12#1)
to different extents##8##3##(1992-8#1)(1995-1#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-7#1)
to different forms of##3##4##(1990-9#1)(1996-6#1)(2009-6#1)
to different genetic##2##3##(2009-3#1)(2013-1#1)
to different groups##2##3##(2008-6#1)(2012-2#1)
to different growth##2##3##(1991-12#1)(2010-11#1)
to different hosts##3##3##(2008-10#3)
to different kinds of##4##4##(1996-6#1)(2005-11#1)(2006-5#1)(2008-10#1)
to different levels in##2##4##(1997-7#1)(2008-10#1)
to different levels of##6##4##(2004-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-2#1)
to different levels##8##3##(1997-7#1)(2004-4#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2012-2#1)
to different medical##2##3##(2008-6#1)(2008-8#1)
to different organs##2##3##(2007-9#1)(2008-10#1)
to different parts of the##2##5##(1995-4#1)(2010-6#1)
to different pathogens##4##3##(2006-12#1)(2006-5#1)(2008-10#2)
to different peripheral targets##2##4##(1991-10#1)(1992-8#1)
to different physiological##2##3##(2008-10#1)(2010-12#1)
to different production##2##3##(2007-8#1)(2008-7#1)
to different regions of the##2##5##(1992-5#1)(2006-11#1)
to different regions##3##3##(1992-5#1)(2006-11#1)(2008-4#1)
to different sample##2##3##(2008-10#1)(2012-12#1)
to different sides of##2##4##(2009-10#2)
to different sites##2##3##(1992-3#1)(1996-6#1)
to different stages of##2##4##(1994-8#1)(2010-2#1)
to different stimuli##3##3##(1991-11#1)(2006-10#1)(2007-2#1)
to different surface##2##3##(2004-9#1)(2008-12#1)
to different temperatures##2##3##(1996-12#1)(1997-7#1)
to different therapeutic##3##3##(2008-9#1)(2010-11#1)(2011-2#1)
to different treatment##2##3##(1994-6#1)(2008-4#1)
to different types of##11##4##(1990-3#1)(1991-1#1)(1991-2#1)(1993-5#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-12#2)
to different##361##2##(1990-1#1)(1990-10#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#2)(1995-1#3)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#1)(1996-10#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#3)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-7#3)(2004-4#1)(2004-9#1)(2005-11#2)(2005-4#1)(2006-1#1)(2006-10#3)(2006-11#4)(2006-12#5)(2006-2#1)(2006-5#2)(2006-7#2)(2006-8#2)(2007-1#2)(2007-10#1)(2007-11#7)(2007-12#7)(2007-2#3)(2007-4#3)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#6)(2007-9#3)(2008-1#1)(2008-10#53)(2008-11#4)(2008-12#6)(2008-2#4)(2008-3#7)(2008-4#4)(2008-5#11)(2008-6#3)(2008-7#7)(2008-8#9)(2008-9#4)(2009-10#5)(2009-11#2)(2009-2#4)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-11#5)(2010-12#4)(2010-2#3)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#5)(2010-9#1)(2011-1#6)(2011-2#7)(2012-1#1)(2012-12#7)(2012-2#12)(2012-3#9)(2013-1#12)(2013-7#4)(2013-8#5)
to differential##22##2##(1991-12#1)(1991-5#1)(1992-9#1)(1995-5#2)(2006-6#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-2#5)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)
to differentially##2##2##(1992-7#1)(2008-12#1)
to differentials with Pc genes from A##2##7##(2008-10#2)
to differentials with Pc genes from##3##6##(2008-10#3)
to differentiate among##5##3##(1994-1#1)(2008-10#3)(2013-8#1)
to differentiate and classify different##2##5##(2006-12#1)(2008-4#1)
to differentiate and##5##3##(1992-1#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-8#1)
to differentiate between an##2##4##(2006-10#1)(2008-7#1)
to differentiate between groups of##2##5##(1994-9#1)(2013-7#1)
to differentiate between healthy##3##4##(1997-2#1)(2011-1#1)(2012-2#1)
to differentiate between the##3##4##(1991-1#1)(1992-12#1)(2007-3#1)
to differentiate between these two##2##5##(1996-5#1)(2011-2#1)
to differentiate between##40##3##(1991-1#1)(1992-12#1)(1993-5#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-1#1)(1996-5#1)(1996-6#1)(1997-2#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
to differentiate by##4##3##(1992-9#1)(1993-3#1)(1994-9#1)(2008-12#1)
to differentiate from##6##3##(1992-3#1)(1996-1#1)(2006-12#1)(2007-12#1)(2011-2#1)(2013-8#1)
to differentiate in vitro into##2##5##(2008-11#2)
to differentiate in vitro##3##4##(1995-2#1)(2008-11#2)
to differentiate in##5##3##(1992-12#1)(1995-2#1)(2008-11#2)(2013-1#1)
to differentiate into basophils##2##4##(2008-11#2)
to differentiate into cells with##2##5##(1995-1#1)(2008-9#1)
to differentiate into cells##5##4##(1995-1#1)(2007-12#1)(2008-1#1)(2008-8#1)(2008-9#1)
to differentiate into neurons and##2##5##(2008-7#1)(2012-12#1)
to differentiate into neurons##4##4##(2008-7#1)(2012-12#3)
to differentiate into##30##3##(1991-11#1)(1992-8#1)(1993-12#1)(1995-1#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#5)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#3)(2010-11#1)(2012-12#7)(2012-4#1)
to differentiate it from other##4##5##(1994-6#1)(2006-8#1)(2010-12#1)(2012-3#1)
to differentiate it from##6##4##(1994-6#2)(2006-4#1)(2006-8#1)(2010-12#1)(2012-3#1)
to differentiate spontaneously##2##3##(1990-5#2)
to differentiate the##16##3##(1996-11#1)(2006-12#1)(2007-9#1)(2008-10#5)(2008-12#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-4#1)(2012-1#1)(2012-5#1)(2013-1#1)
to differentiate them##4##3##(1990-8#1)(2007-10#1)(2008-2#1)(2013-1#1)
to differentiate these##5##3##(1996-12#1)(2008-11#1)(2008-9#1)(2011-1#1)(2012-2#1)
to differentiate##198##2##(1990-5#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1994-1#1)(1994-11#1)(1994-2#2)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#2)(1995-2#1)(1995-4#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#2)(2005-8#1)(2006-10#3)(2006-12#5)(2006-3#2)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#5)(2007-3#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#21)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#5)(2008-7#7)(2008-8#3)(2008-9#4)(2009-10#3)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#11)(2012-2#3)(2012-3#2)(2012-4#1)(2012-5#2)(2013-1#8)(2013-7#1)(2013-8#3)
to differentiated##3##2##(2004-2#1)(2008-5#1)(2012-2#1)
to differentiating##2##2##(1996-4#1)(2008-9#1)
to differentiation into##2##3##(2010-3#1)(2012-1#1)
to differentiation##9##2##(1990-11#1)(1992-1#1)(1992-7#1)(2008-4#1)(2008-8#1)(2010-3#1)(2011-2#2)(2012-1#1)
to differing##5##2##(1992-12#1)(1994-9#1)(2005-11#1)(2010-11#1)(2011-2#1)
to difficult##4##2##(2005-4#1)(2008-2#1)(2010-2#1)(2012-2#1)
to difficulties in##6##3##(1992-5#1)(1995-7#1)(2005-8#1)(2008-11#1)(2012-2#1)(2013-1#1)
to difficulties with##3##3##(2007-12#1)(2008-2#1)(2012-1#1)
to difficulties##11##2##(1992-5#1)(1995-7#1)(2005-8#1)(2007-12#1)(2008-11#1)(2008-2#1)(2012-1#1)(2012-2#1)(2013-1#3)
to difficulty in##3##3##(2007-11#1)(2008-1#1)(2008-8#1)
to difficulty##7##2##(2007-11#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-2#2)
to diffraction##4##2##(2006-5#1)(2007-11#1)(2007-12#1)(2008-3#1)
to diffraction-limited##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
to diffuse##9##2##(1995-2#1)(2005-11#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-6#1)
to diffusely##3##2##(2008-2#2)(2012-2#1)
to diffusion of the##2##4##(2007-7#1)(2008-10#1)
to diffusion of##4##3##(2005-11#1)(2007-7#1)(2008-10#1)(2009-3#1)
to diffusion##10##2##(1994-3#1)(1995-1#1)(1997-1#1)(2005-11#1)(2007-7#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-3#1)
to digest##5##2##(1991-7#1)(1994-12#1)(2006-8#1)(2008-10#1)(2009-8#1)
to digestion by##2##3##(1990-11#1)(2008-6#1)
to digestion with##3##3##(1990-2#1)(1990-9#1)(2008-10#1)
to digestion##8##2##(1990-11#1)(1990-2#1)(1990-9#1)(1994-12#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-9#1)
to digestive##3##2##(1990-12#1)(2010-12#1)(2011-2#1)
to digital microscopy##2##3##(2008-3#1)(2011-2#1)
to digital##8##2##(2004-11#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-5#1)(2011-1#2)(2011-2#1)
to dignity##3##2##(1996-9#1)(2010-10#1)(2012-12#1)
to dihydrofolate##4##2##(1990-5#2)(1991-5#1)(2007-11#1)
to dihydropyridines##2##2##(1993-11#1)(1993-3#1)
to dihydrotestosterone (DHT)##2##3##(1994-11#1)(2008-2#1)
to dihydrotestosterone and hydrocortisone##2##4##(1992-7#2)
to dihydrotestosterone##4##2##(1992-7#2)(1994-11#1)(2008-2#1)
to dilatation##2##2##(1990-12#1)(2005-10#1)
to dilate##4##2##(2005-10#1)(2006-11#1)(2010-12#2)
to dilation##2##2##(2010-12#1)(2011-1#1)
to dilute##5##2##(2006-10#1)(2008-7#3)(2009-8#1)
to diluted##3##2##(1992-2#1)(2008-10#1)(2012-2#1)
to dilution##3##2##(1997-4#1)(2008-10#1)(2011-1#1)
to dimer and##2##3##(1992-1#1)(1993-4#1)
to dimer##3##2##(1992-1#1)(1993-4#1)(2008-10#1)
to dimerize and##2##3##(1994-12#1)(2008-10#1)
to dimerize##5##2##(1994-12#1)(1994-9#1)(2007-11#1)(2008-10#1)(2010-12#1)
to dimethylarsinic acid##2##3##(1993-3#2)
to diminish the risk of##2##5##(2006-10#1)(2008-4#1)
to diminish the##10##3##(1991-8#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-9#1)(2008-3#1)(2008-4#1)(2010-12#1)(2012-12#1)
to diminish with##3##3##(1997-7#1)(2007-9#2)
to diminish##28##2##(1990-3#1)(1991-8#1)(1993-3#1)(1993-8#1)(1994-9#1)(1995-3#1)(1997-7#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-9#3)(2008-3#1)(2008-4#2)(2009-11#1)(2010-12#1)(2012-11#1)(2012-12#2)(2012-2#1)
to diminished##3##2##(1994-5#1)(1996-9#1)(2007-7#1)
to dimyristoylphosphatidylcholine##2##2##(1990-2#1)(1996-1#1)
to diode##4##2##(2008-10#1)(2008-3#1)(2011-1#2)
to dioxins##2##2##(2008-10#1)(2008-7#1)
to direct clinical##2##3##(1997-1#1)(2004-11#1)
to direct different##2##3##(2008-10#1)(2009-8#1)
to direct effects##2##3##(2008-9#1)(2012-2#1)
to direct expression of a##2##5##(1991-6#1)(1994-5#1)
to direct expression##3##3##(1991-12#1)(1991-6#1)(1994-5#1)
to direct our##2##3##(1995-1#1)(2007-6#1)
to direct patient care##2##4##(1992-1#1)(1995-3#1)
to direct patient##3##3##(1992-1#1)(1995-3#1)(2012-3#1)
to direct stimulation of##3##4##(1991-7#1)(2008-10#1)(2008-11#1)
to direct sunlight##2##3##(1994-1#1)(2008-10#1)
to direct the synthesis of##2##5##(1991-9#1)(2008-7#1)
to direct the##19##3##(1990-12#1)(1990-5#2)(1990-9#2)(1991-9#1)(1995-8#2)(1996-5#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2009-4#1)(2013-1#1)(2013-8#1)
to direct their##2##3##(1995-11#1)(2008-11#1)
to direct transcription of##3##4##(1993-12#1)(1994-2#1)(1995-3#1)
to direct##107##2##(1990-12#1)(1990-2#1)(1990-5#3)(1990-9#2)(1991-12#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-1#1)(1992-5#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#3)(1995-8#4)(1996-10#2)(1996-5#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(2004-11#1)(2006-1#1)(2007-1#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-2#2)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#2)(2009-8#3)(2010-11#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#2)(2012-7#1)(2013-1#1)(2013-7#1)(2013-8#1)
to directed##4##2##(2007-12#2)(2008-7#1)(2012-2#1)
to directional##3##2##(2008-11#1)(2008-3#1)(2010-8#1)
to directly affect the##2##4##(1990-6#1)(1994-2#1)
to directly assess##2##3##(1997-2#1)(2011-1#1)
to directly compare the##2##4##(2005-11#1)(2008-10#1)
to directly determine the##2##4##(2006-10#1)(2008-10#1)
to directly determine##3##3##(2006-10#1)(2008-10#2)
to directly evaluate##2##3##(2009-12#1)(2011-1#1)
to directly examine##2##3##(2008-9#1)(2009-11#1)
to directly identify##2##3##(2008-11#1)(2012-11#1)
to directly inhibit##2##3##(1994-6#1)(1996-4#1)
to directly measure the##3##4##(1995-1#1)(2008-10#1)(2013-8#1)
to directly measure##6##3##(1992-9#1)(1995-1#1)(2008-10#1)(2008-4#1)(2009-12#1)(2013-8#1)
to directly stimulate##5##3##(1996-9#1)(2005-11#1)(2008-1#1)(2008-11#1)(2010-3#1)
to directly study##2##3##(1992-11#1)(1992-9#1)
to directly target the##2##4##(1997-1#1)(2010-7#1)
to directly target##3##3##(1997-1#1)(2006-10#1)(2010-7#1)
to directly##60##2##(1990-5#1)(1990-6#1)(1991-7#1)(1992-11#1)(1992-9#2)(1994-11#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(2005-11#2)(2006-10#4)(2006-12#1)(2006-2#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-12#3)(2009-7#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#2)(2012-1#1)(2012-11#1)(2013-8#1)
to disability##5##2##(1997-6#1)(2008-2#1)(2008-6#1)(2012-12#2)
to disaggregate##2##2##(1992-12#1)(2008-10#1)
to disambiguate##4##2##(2013-1#4)
to disappear##9##2##(1990-10#1)(1993-2#1)(1995-3#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-8#1)
to disappearance of##4##3##(1990-8#1)(1994-8#1)(1997-7#1)(2009-12#1)
to disasters##2##2##(1991-11#1)(2009-1#1)
to disc##4##2##(2006-7#2)(2007-12#1)(2008-12#1)
to discard##4##2##(1995-4#1)(2011-2#2)(2012-3#1)
to discern the##6##3##(1993-9#1)(2004-4#1)(2007-12#1)(2007-5#1)(2008-3#1)(2008-9#1)
to discern##21##2##(1992-9#1)(1993-9#1)(1995-2#1)(1996-1#1)(1996-3#1)(2004-4#1)(2004-9#2)(2006-12#1)(2006-9#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-9#1)(2010-2#1)(2011-2#1)(2013-1#2)
to discharge patients to##3##4##(1990-12#3)
to discharge service members##2##4##(1995-6#1)(1996-5#1)
to discharge##25##2##(1990-12#3)(1991-7#1)(1994-2#1)(1995-6#1)(1996-5#1)(2006-10#2)(2007-10#3)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#2)(2010-11#1)(2010-4#1)(2012-1#1)(2012-11#2)(2012-2#1)
to discipline##2##2##(2009-7#1)(2012-12#1)
to disclose the##7##3##(1990-12#1)(1991-7#1)(2006-12#1)(2007-10#1)(2008-7#3)
to disclose their HIV status##2##5##(2004-9#1)(2010-4#1)
to disclose##24##2##(1990-12#1)(1991-12#1)(1991-7#1)(1992-11#2)(1992-12#1)(1995-2#1)(1995-4#1)(1996-12#1)(2004-9#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#4)(2010-4#2)(2011-1#1)(2012-3#1)(2013-1#1)
to discomfort##2##2##(2008-12#1)(2009-1#1)
to discontinuation##3##2##(2008-3#1)(2008-5#1)(2011-1#1)
to discontinue the##4##3##(1990-2#1)(1992-12#1)(1993-11#1)(2005-8#1)
to discontinue therapy##2##3##(1994-6#1)(2007-8#1)
to discontinue treatment##6##3##(1991-3#1)(1993-2#1)(2007-7#2)(2011-1#2)
to discontinue##20##2##(1990-2#1)(1991-2#1)(1991-3#1)(1992-12#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-6#1)(1995-5#1)(2005-8#1)(2007-7#2)(2007-8#1)(2008-7#1)(2009-7#1)(2011-1#2)(2012-2#1)(2013-8#1)
to discount the##2##3##(2009-7#1)(2009-9#1)
to discount##3##2##(1994-3#1)(2009-7#1)(2009-9#1)
to discourage##2##2##(2008-10#1)(2008-9#1)
to discourse##3##2##(2008-11#1)(2009-2#1)(2013-1#1)
to discover a##2##3##(2006-10#1)(2007-9#1)
to discover an##2##3##(1993-10#1)(2008-4#1)
to discover and##3##3##(2008-5#2)(2013-8#1)
to discover new##3##3##(2006-12#1)(2008-3#1)(2012-3#1)
to discover novel##4##3##(2005-7#1)(2008-9#1)(2013-1#2)
to discover the##9##3##(1990-4#1)(1993-1#1)(1993-5#1)(1993-7#1)(1995-3#1)(2006-2#1)(2008-11#1)(2012-3#2)
to discover unknown##2##3##(2008-10#1)(2010-2#1)
to discover whether##2##3##(1991-10#1)(1991-7#1)
to discover which##3##3##(1993-10#1)(1995-2#1)(2010-8#1)
to discover##64##2##(1990-4#1)(1991-10#1)(1991-7#1)(1992-4#1)(1993-1#1)(1993-10#2)(1993-11#1)(1993-5#1)(1993-7#1)(1994-12#1)(1995-2#2)(1995-3#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#2)(2009-12#2)(2009-5#1)(2009-7#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#6)(2013-1#2)(2013-8#3)
to discovery of##4##3##(2008-7#2)(2009-8#1)(2013-1#1)
to discovery##7##2##(2005-7#1)(2005-9#1)(2008-7#2)(2009-8#1)(2010-7#1)(2013-1#1)
to discredit##2##2##(1995-2#1)(2006-12#1)
to discrete##9##2##(1994-2#1)(1994-9#1)(1996-12#1)(1997-2#1)(1997-7#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-6#1)
to discretize##2##2##(2010-12#1)(2012-2#1)
to discriminate a##3##3##(2008-10#1)(2012-1#2)
to discriminate against##9##3##(1994-2#1)(1994-3#1)(1996-11#1)(2007-12#2)(2008-2#1)(2008-8#2)(2013-1#1)
to discriminate among##2##3##(2007-8#1)(2009-11#1)
to discriminate angular differences of 5 degrees##2##7##(1990-10#2)
to discriminate between a##3##4##(1996-10#1)(1996-11#1)(2010-2#1)
to discriminate between different##2##4##(1992-9#1)(2010-10#1)
to discriminate between familiar and unfamiliar##2##6##(2010-2#2)
to discriminate between familiar##3##4##(2010-2#3)
to discriminate between the##4##4##(2008-10#1)(2008-11#1)(2010-12#1)(2012-12#1)
to discriminate between two##3##4##(1994-6#1)(2010-2#1)(2012-2#1)
to discriminate between various##2##4##(2007-6#1)(2008-10#1)
to discriminate between##58##3##(1990-4#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-5#2)(1992-9#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-6#2)(2006-3#1)(2007-11#2)(2007-6#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-2#7)(2010-4#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
to discriminate both##2##3##(2006-11#1)(2010-8#1)
to discriminate more##2##3##(1997-5#1)(1997-8#1)
to discriminate symmetry##2##3##(2008-8#2)
to discriminate the##9##3##(1993-8#1)(1996-8#1)(1997-5#1)(2007-10#1)(2008-7#2)(2011-1#1)(2012-1#2)
to discriminate these##2##3##(1996-8#1)(2008-10#1)
to discriminate##146##2##(1990-10#3)(1990-11#1)(1990-4#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-10#1)(1992-5#2)(1992-9#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-7#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-3#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-8#4)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#7)(2008-8#6)(2008-9#5)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-2#7)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#8)(2012-12#2)(2012-2#4)(2013-1#4)(2013-7#1)(2013-8#2)
to discrimination between##2##3##(2007-12#1)(2008-2#1)
to discrimination##5##2##(1992-12#1)(2007-12#1)(2008-2#1)(2010-8#1)(2011-12#1)
to discuss and##5##3##(2006-10#1)(2007-3#1)(2008-10#1)(2008-8#1)(2009-8#1)
to discuss current##2##3##(2008-3#1)(2008-7#1)
to discuss how##4##3##(1996-3#1)(2008-12#1)(2008-4#1)(2010-1#1)
to discuss issues##2##3##(2007-2#1)(2010-11#1)
to discuss recent##3##3##(2007-9#1)(2009-4#1)(2009-5#1)
to discuss some of the##2##5##(2004-4#1)(2008-7#1)
to discuss some of these issues##2##6##(2007-7#1)(2008-1#1)
to discuss some of these##3##5##(2007-7#1)(2008-1#2)
to discuss some of##5##4##(2004-4#1)(2007-7#1)(2008-1#2)(2008-7#1)
to discuss some##7##3##(1991-1#1)(2004-4#1)(2006-9#1)(2007-7#1)(2008-1#2)(2008-7#1)
to discuss the advantages##2##4##(2004-10#1)(2012-3#1)
to discuss the case##2##4##(1994-8#1)(2008-5#1)
to discuss the effect of##3##5##(2006-9#1)(2007-11#1)(2008-7#1)
to discuss the following questions##2##5##(2009-10#1)(2009-4#1)
to discuss the following##3##4##(2008-10#1)(2009-10#1)(2009-4#1)
to discuss the issues##2##4##(2005-8#1)(2008-11#1)
to discuss the possible##2##4##(1994-11#1)(2008-9#1)
to discuss the results##2##4##(2010-4#1)(2010-9#1)
to discuss the role of##4##5##(2006-9#1)(2008-10#1)(2008-8#1)(2013-8#1)
to discuss the##62##3##(1991-6#1)(1994-11#1)(1994-8#1)(1997-4#1)(2004-10#1)(2005-8#1)(2006-9#3)(2007-1#2)(2007-11#1)(2007-2#2)(2007-4#5)(2007-7#3)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#5)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
to discuss their##7##3##(2006-7#2)(2007-5#1)(2007-7#1)(2007-8#1)(2012-12#1)(2013-7#1)
to discuss these##3##3##(1995-1#1)(2007-12#1)(2008-10#1)
to discuss treatment##2##3##(2006-1#1)(2006-3#1)
to discuss with##2##3##(1990-5#1)(2013-1#1)
to discuss##136##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-1#1)(1991-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-1#1)(1996-10#1)(1996-2#1)(1996-3#1)(1997-4#1)(2004-10#1)(2004-4#1)(2005-6#1)(2005-8#2)(2006-1#1)(2006-10#1)(2006-3#1)(2006-7#2)(2006-9#4)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#4)(2007-3#1)(2007-4#6)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-7#6)(2008-8#4)(2008-9#2)(2009-10#2)(2009-11#1)(2009-4#3)(2009-5#2)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-12#5)(2012-2#5)(2012-3#4)(2013-1#3)(2013-7#2)(2013-8#1)
to discussion of##2##3##(2008-10#1)(2013-8#1)
to discussion##6##2##(1994-12#1)(1994-4#1)(1997-6#1)(2008-10#1)(2013-1#1)(2013-8#1)
to discussions##3##2##(1996-8#1)(2006-2#1)(2008-11#1)
to disease activity##2##3##(2006-10#1)(2008-8#1)
to disease and death##2##4##(1997-7#1)(2012-2#1)
to disease and##7##3##(1997-7#1)(2006-7#1)(2008-10#2)(2008-8#1)(2010-7#1)(2012-2#1)
to disease development##6##3##(2007-5#1)(2008-10#5)
to disease diagnosis##2##3##(2006-10#1)(2010-7#1)
to disease expression##2##3##(2006-10#1)(2006-5#1)
to disease in##3##3##(1990-10#1)(2006-10#1)(2013-8#1)
to disease incidence##4##3##(2008-10#4)
to disease increase##4##3##(2008-10#4)
to disease management programs##2##4##(2008-10#1)(2008-11#1)
to disease management##3##3##(2008-10#1)(2008-11#1)(2010-12#1)
to disease onset##2##3##(2008-10#2)
to disease progression##10##3##(1997-8#1)(2005-8#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2012-2#1)
to disease risk assessment##2##4##(2008-10#2)
to disease severity in##2##4##(2008-10#1)(2009-2#1)
to disease severity##7##3##(2008-10#1)(2008-7#1)(2009-2#3)(2011-1#1)(2011-2#1)
to disease suppression##4##3##(2008-10#4)
to disease##111##2##(1990-10#1)(1993-1#1)(1994-9#2)(1997-7#1)(1997-8#2)(2004-1#1)(2005-8#1)(2006-1#1)(2006-10#7)(2006-5#2)(2006-7#2)(2007-11#3)(2007-12#1)(2007-2#3)(2007-5#1)(2008-10#37)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-2#3)(2009-4#1)(2009-8#1)(2010-12#3)(2010-4#2)(2010-7#3)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#3)(2013-8#1)
to disease-modifying antirheumatic drugs##2##4##(2008-3#2)
to diseases of the##4##4##(2006-8#2)(2007-11#1)(2007-5#1)
to diseases of##5##3##(2006-8#2)(2007-11#1)(2007-5#1)(2010-1#1)
to diseases##15##2##(1992-5#1)(1997-8#1)(2005-7#2)(2006-10#2)(2006-8#2)(2007-11#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-1#1)(2013-1#1)
to disentangle the##4##3##(1991-1#1)(2008-9#1)(2011-2#1)(2012-2#1)
to disentangle##5##2##(1991-1#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
to disinfect##3##2##(1994-3#1)(2012-3#1)(2013-1#1)
to disk##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2009-5#1)
to dismantle##2##2##(1993-5#1)(1994-12#1)
to dismiss a##3##3##(1996-11#1)(2008-12#1)(2010-12#1)
to dismiss##9##2##(1995-12#1)(1995-6#1)(1996-11#1)(1996-5#1)(2007-8#1)(2008-12#3)(2010-12#1)
to disordered##4##2##(1996-9#1)(2007-12#1)(2008-10#1)(2008-7#1)
to disorders of##2##3##(2008-11#1)(2008-4#1)
to disorders##4##2##(2007-8#1)(2008-11#1)(2008-12#1)(2008-4#1)
to disparate##2##2##(1997-9#1)(2008-7#1)
to disparities in##3##3##(1993-12#1)(2006-10#1)(2013-1#1)
to disparities##4##2##(1991-1#1)(1993-12#1)(2006-10#1)(2013-1#1)
to dispel##2##2##(1993-3#1)(2012-2#1)
to dispense EC within 24 hours and##2##7##(2013-1#2)
to dispense a##3##3##(1995-1#2)(1996-1#1)
to dispense##8##2##(1991-3#1)(1995-1#2)(1996-1#1)(1996-11#1)(1997-7#1)(2013-1#2)
to dispersal and##2##3##(2008-8#1)(2010-8#1)
to dispersal##6##2##(2008-5#1)(2008-8#4)(2010-8#1)
to disperse in##2##3##(2008-10#1)(2010-7#1)
to disperse##7##2##(1992-6#1)(2008-10#2)(2008-2#1)(2008-8#2)(2010-7#1)
to dispersed##2##2##(1991-3#1)(2010-7#1)
to dispersion of##2##3##(2007-11#1)(2012-12#1)
to dispersion##5##2##(2007-11#3)(2007-12#1)(2012-12#1)
to displace the##4##3##(1990-9#1)(1992-3#1)(1992-4#1)(2008-2#1)
to displace##17##2##(1990-9#1)(1992-3#2)(1992-4#1)(1994-10#1)(1994-12#1)(1994-3#1)(1997-1#1)(2004-11#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#2)(2011-1#1)
to displacement by##2##3##(1994-9#1)(2008-8#1)
to displacement of the##2##4##(2010-10#1)(2012-2#1)
to displacement##7##2##(1991-12#1)(1994-9#1)(2007-12#1)(2008-8#2)(2010-10#1)(2012-2#1)
to display a##6##3##(1990-8#1)(1996-10#1)(2008-2#1)(2008-4#1)(2009-11#1)(2012-2#1)
to display an##2##3##(2006-12#1)(2008-10#1)
to display greater##2##3##(1995-1#1)(1995-2#1)
to display the##9##3##(1992-2#1)(1993-2#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-2#1)
to display##64##2##(1990-12#3)(1990-7#1)(1990-8#1)(1992-2#1)(1993-2#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-2#1)(1996-9#1)(1997-4#1)(2006-11#1)(2006-12#1)(2006-8#3)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#6)(2008-4#3)(2008-6#1)(2008-7#2)(2008-9#3)(2009-11#1)(2010-2#3)(2010-8#1)(2011-1#1)(2012-2#3)(2012-3#1)(2013-1#2)
to dispose##2##2##(2008-11#1)(2008-12#1)
to disprove##2##2##(1996-7#1)(2005-12#1)
to disrupt mitochondrial##2##3##(1990-11#2)
to disrupt the##16##3##(1990-2#1)(1990-7#1)(1991-3#1)(1994-11#1)(1995-1#2)(1995-8#1)(1997-6#1)(2004-2#1)(2008-1#1)(2008-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
to disrupt this##2##3##(1997-1#1)(2012-2#1)
to disrupt##31##2##(1990-11#2)(1990-2#2)(1990-7#1)(1991-2#1)(1991-3#1)(1992-12#1)(1994-11#1)(1994-9#1)(1995-1#2)(1995-8#1)(1997-1#1)(1997-6#1)(2004-2#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-7#1)
to disruption of##7##3##(1994-11#1)(1997-4#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2011-2#1)
to disruption##8##2##(1994-11#1)(1997-4#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2010-5#1)(2011-2#1)
to dissect complex biological##2##4##(2008-7#1)(2013-7#1)
to dissect protein##2##3##(1990-9#1)(2008-4#1)
to dissect the##12##3##(1994-12#1)(1996-4#1)(1997-1#1)(1997-4#1)(2008-11#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-8#2)(2010-11#1)(2011-2#1)
to dissect##23##2##(1990-9#1)(1994-12#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-4#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-10#2)(2009-3#1)(2009-8#2)(2010-11#1)(2011-2#1)(2012-12#1)(2013-7#1)
to dissection##3##2##(1993-5#1)(2006-10#1)(2013-8#1)
to disseminate health##2##3##(2006-8#1)(2007-7#1)
to disseminate important information##2##4##(1996-6#1)(2013-1#1)
to disseminate information##2##3##(1996-1#1)(2007-7#1)
to disseminate##18##2##(1991-1#1)(1996-1#1)(1996-2#1)(1996-6#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-7#3)(2008-11#1)(2011-1#1)(2012-11#1)(2012-2#2)(2013-1#1)(2013-8#1)
to disseminated##3##2##(2007-2#2)(2008-10#1)
to dissemination##3##2##(1996-11#1)(2007-4#1)(2012-12#1)
to dissipate##4##2##(2008-2#1)(2009-12#1)(2012-12#2)
to dissociate from##2##3##(1996-8#2)
to dissociate the##2##3##(1990-4#1)(1995-2#1)
to dissociate##16##2##(1990-4#1)(1992-6#2)(1993-6#1)(1994-9#1)(1995-1#2)(1995-2#2)(1996-11#1)(1996-8#2)(2008-10#1)(2008-4#2)(2013-8#1)
to dissociation of the##3##4##(1997-2#2)(2012-12#1)
to dissociation##8##2##(1993-8#1)(1994-9#1)(1995-3#1)(1996-7#1)(1997-2#2)(2006-4#1)(2012-12#1)
to dissolve both##2##3##(1995-2#2)
to dissolve the##4##3##(1992-4#1)(1994-8#1)(2010-4#1)(2012-12#1)
to dissolve##9##2##(1992-4#1)(1994-8#1)(1995-2#3)(2008-7#1)(2008-9#1)(2010-4#1)(2012-12#1)
to distal##10##2##(1991-8#1)(2007-8#3)(2007-9#1)(2008-5#1)(2010-1#1)(2010-6#1)(2012-3#1)(2013-3#1)
to distance and##2##3##(2008-10#1)(2011-2#1)
to distance##7##2##(2006-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#1)(2011-2#1)
to distant sites##4##3##(1993-4#1)(1995-4#1)(2009-5#1)(2012-3#1)
to distant##13##2##(1993-3#2)(1993-4#1)(1995-4#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-5#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
to distilled water##2##3##(1996-5#1)(2012-2#1)
to distinct factors##2##3##(1996-3#1)(2013-7#1)
to distinct##24##2##(1990-7#1)(1991-5#1)(1992-4#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#2)(2007-12#1)(2008-10#3)(2008-8#1)(2009-8#1)(2010-5#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-7#1)
to distinctive##2##2##(2006-11#1)(2008-4#1)
to distinguish Case Management from Assertive Community Treatment##2##8##(2008-2#2)
to distinguish a##5##3##(1993-1#1)(2008-3#2)(2008-5#2)
to distinguish among different##2##4##(2007-12#1)(2008-10#1)
to distinguish among##8##3##(1991-4#1)(1993-6#1)(2007-12#1)(2008-10#2)(2008-8#2)(2011-1#1)
to distinguish and##4##3##(2006-8#1)(2008-4#1)(2008-9#1)(2010-4#1)
to distinguish between normal##2##4##(1993-10#1)(2011-1#1)
to distinguish between the two##2##5##(1994-2#1)(2012-2#1)
to distinguish between the##8##4##(1994-2#1)(1996-3#1)(1996-5#1)(2006-10#1)(2008-10#2)(2009-12#1)(2012-2#1)
to distinguish between these##2##4##(1991-1#1)(2012-3#1)
to distinguish between##58##3##(1990-3#1)(1990-7#1)(1991-1#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-2#2)(1993-3#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-9#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#1)(2008-1#1)(2008-10#12)(2008-4#2)(2008-6#1)(2008-9#3)(2009-12#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
to distinguish cases of##2##4##(2006-2#1)(2013-1#1)
to distinguish different##4##3##(1996-12#2)(2007-7#1)(2013-8#1)
to distinguish it from##3##4##(2005-8#1)(2006-10#1)(2008-4#1)
to distinguish its##2##3##(1997-5#1)(2008-2#1)
to distinguish patients##2##3##(2012-2#1)(2013-1#1)
to distinguish the different##2##4##(2005-11#1)(2012-1#1)
to distinguish the two##2##4##(2008-10#1)(2008-11#1)
to distinguish the##24##3##(1993-11#1)(1994-3#1)(1995-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(2005-11#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)
to distinguish them from##2##4##(2008-12#1)(2012-12#1)
to distinguish them##3##3##(2008-12#1)(2008-2#1)(2012-12#1)
to distinguish these##2##3##(2008-10#1)(2009-12#1)
to distinguish this##4##3##(1996-9#1)(2007-9#1)(2011-1#1)(2012-2#1)
to distinguish whether##4##3##(2008-10#1)(2011-2#1)(2013-1#2)
to distinguish##216##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-4#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#3)(1994-4#1)(1994-8#1)(1994-9#1)(1995-1#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-7#2)(1997-8#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#3)(2006-8#1)(2006-9#1)(2007-1#4)(2007-10#2)(2007-11#2)(2007-12#4)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#36)(2008-11#1)(2008-12#3)(2008-2#5)(2008-3#5)(2008-4#7)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#7)(2009-12#3)(2009-2#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-3#4)(2010-4#3)(2010-7#1)(2010-8#4)(2011-1#5)(2011-10#1)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#1)(2012-9#1)(2013-1#8)(2013-7#1)(2013-8#4)
to distinguishing##4##2##(1991-1#1)(1992-7#1)(2008-10#1)(2008-5#1)
to distort the##2##3##(2011-1#1)(2012-2#1)
to distort##3##2##(2011-1#1)(2012-12#1)(2012-2#1)
to distortion##3##2##(1991-1#1)(1992-12#1)(2008-2#1)
to distraction##4##2##(2011-2#1)(2012-12#1)(2012-3#2)
to distress##3##2##(1990-12#1)(2011-1#1)(2013-7#1)
to distribute the##3##3##(1992-3#1)(2005-7#1)(2008-3#1)
to distribute##11##2##(1991-2#1)(1992-3#1)(1993-3#1)(1994-8#1)(1996-8#1)(1997-6#1)(2005-7#1)(2008-3#3)(2008-9#1)
to distributed##5##2##(2006-5#1)(2007-11#3)(2012-2#1)
to distribution##5##2##(1991-8#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-5#1)
to disturb the##4##3##(1994-8#1)(2005-7#1)(2006-8#1)(2008-5#1)
to disturb##5##2##(1994-8#1)(2005-7#1)(2006-8#1)(2007-4#1)(2008-5#1)
to disturbance##9##2##(2008-7#1)(2008-8#7)(2013-7#1)
to disturbances in##3##3##(1992-10#1)(1995-12#1)(2012-1#1)
to disturbances##4##2##(1992-10#1)(1995-12#1)(2006-9#1)(2012-1#1)
to dithiothreitol##2##2##(1990-11#1)(1991-9#1)
to diurnal##2##2##(1992-11#1)(2007-12#1)
to divalent cations##2##3##(1990-5#1)(2008-10#1)
to divalent ions##2##3##(2008-10#2)
to divalent##4##2##(1990-5#1)(2008-10#3)
to diverge##4##2##(1992-8#1)(1993-12#1)(2008-9#1)(2010-12#1)
to divergent selection##2##3##(2012-3#1)(2013-1#1)
to divergent##6##2##(1993-12#1)(1997-7#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
to diverse neuronal##2##3##(2008-3#1)(2012-2#1)
to diverse##28##2##(1996-5#1)(1997-2#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-8#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#5)(2012-2#1)(2013-8#1)
to diversify##4##2##(1991-4#1)(2007-1#1)(2008-11#2)
to diversity##4##2##(1993-6#1)(1994-12#1)(2008-10#2)
to divert the##3##3##(1993-2#1)(1994-2#1)(2012-3#1)
to divert##6##2##(1991-1#1)(1993-2#1)(1994-2#1)(1994-9#1)(2012-11#1)(2012-3#1)
to divide##9##2##(1993-3#1)(1997-6#1)(1997-7#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-10#1)(2011-12#1)
to divide)##2##2##(2009-12#2)
to divine##2##2##(1992-5#1)(1996-1#1)
to do a##2##3##(2008-8#1)(2013-8#1)
to do an##2##3##(2007-10#1)(2008-4#1)
to do is to##3##4##(2007-7#1)(2013-1#2)
to do is##4##3##(1991-1#1)(2007-7#1)(2013-1#2)
to do it##7##3##(1994-1#1)(1995-1#1)(1995-12#1)(1997-1#1)(2006-10#1)(2007-8#1)(2008-4#1)
to do otherwise##5##3##(1996-12#1)(2006-6#1)(2007-12#1)(2010-12#2)
to do research##2##3##(1992-6#1)(2012-3#1)
to do so by##2##4##(2008-11#1)(2008-3#1)
to do so in this##2##5##(1996-12#1)(2008-5#1)
to do so in##7##4##(1996-10#1)(1996-12#1)(1997-1#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-5#1)
to do so with##3##4##(2008-11#1)(2008-2#1)(2008-4#1)
to do so##45##3##(1990-12#1)(1990-6#1)(1991-12#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-6#1)(2006-10#3)(2006-2#1)(2006-5#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-2#1)(2012-1#1)(2012-11#1)(2012-2#3)(2012-6#1)
to do the##5##3##(1993-4#1)(2006-8#1)(2008-10#1)(2012-2#1)(2013-1#1)
to do their jobs##2##4##(1997-3#1)(2007-1#1)
to do their##6##3##(1997-3#1)(2006-6#1)(2007-1#1)(2007-2#1)(2012-12#1)(2013-8#1)
to do this is##2##4##(2007-5#1)(2008-4#1)
to do this##10##3##(1997-2#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-4#1)(2010-4#1)
to do very##2##3##(2006-8#1)(2010-3#1)
to do well in##2##4##(1996-1#1)(2007-2#1)
to do well##4##3##(1996-1#1)(1997-8#1)(2006-7#1)(2007-2#1)
to do what##2##3##(1995-2#1)(2007-8#1)
to do whatever##2##3##(1992-3#1)(1993-1#1)
to do when##2##3##(2007-7#1)(2007-9#1)
to do with the##8##4##(2005-11#1)(2006-12#1)(2006-6#1)(2007-4#1)(2008-10#1)(2008-5#1)(2009-4#1)(2010-12#1)
to do with##25##3##(1991-1#1)(1991-2#1)(1992-2#1)(1994-3#1)(1994-4#1)(1997-5#1)(2005-11#2)(2005-7#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-4#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-8#1)
to do##176##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-1#1)(1994-3#3)(1994-4#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#3)(1996-3#2)(1997-1#4)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-8#1)(2005-11#2)(2005-7#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#3)(2006-7#3)(2006-8#3)(2007-1#2)(2007-10#5)(2007-11#3)(2007-12#4)(2007-2#5)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#6)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-4#3)(2009-5#1)(2009-6#1)(2009-9#2)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#1)(2010-8#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#6)(2012-3#3)(2012-6#1)(2013-1#5)(2013-8#3)
to do?]##2##2##(1995-9#1)(1996-1#1)
to docetaxel##2##2##(2009-8#1)(2010-6#1)
to dock##2##2##(1997-1#1)(2008-5#1)
to doctors##5##2##(1991-8#1)(1996-11#1)(2006-7#1)(2006-8#1)(2008-7#1)
to document a##2##3##(2007-9#1)(2008-2#1)
to document and##3##3##(1995-3#1)(2008-10#1)(2009-4#1)
to document the presence of##3##5##(2006-8#1)(2010-6#1)(2011-2#1)
to document the##20##3##(1996-6#2)(1997-6#1)(2006-8#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-6#1)(2011-2#3)(2012-2#1)
to document their##6##3##(2005-11#1)(2007-4#1)(2007-8#1)(2008-2#1)(2008-4#1)(2011-2#1)
to document##57##2##(1991-2#1)(1992-3#1)(1995-3#1)(1996-3#1)(1996-6#2)(1997-6#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-4#1)(2006-8#2)(2007-10#1)(2007-3#1)(2007-4#3)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#4)
to documentation##3##2##(2007-12#1)(2008-5#1)(2012-12#1)
to documented##2##2##(1990-11#1)(1995-6#1)
to dodine##3##2##(2008-10#3)
to dogs##4##2##(1996-12#2)(2004-1#1)(2006-12#1)
to domain B##2##3##(1990-3#2)
to domain##7##2##(1990-3#3)(1994-6#2)(1996-5#2)
to domains##2##2##(1997-6#1)(1997-7#1)
to domestic violence##2##3##(2009-11#1)(2012-11#1)
to domestic##3##2##(2009-11#1)(2011-2#1)(2012-11#1)
to dominant##3##2##(1993-5#1)(2007-7#1)(2008-2#1)
to dominate the##6##3##(1995-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
to dominate##10##2##(1991-12#1)(1995-10#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-7#1)(2012-1#1)
to donate a##3##3##(1993-3#1)(2007-10#1)(2009-3#1)
to donate blood##3##3##(1991-9#1)(1994-3#1)(2013-8#1)
to donate##13##2##(1991-5#1)(1991-9#1)(1992-4#1)(1992-8#1)(1993-3#1)(1994-3#1)(2005-7#1)(2007-10#2)(2009-3#1)(2012-11#2)(2013-8#1)
to donor and##2##3##(1995-2#1)(2011-2#1)
to donor##5##2##(1992-3#1)(1995-2#1)(2007-11#1)(2008-11#1)(2011-2#1)
to donors##3##2##(1995-3#1)(1996-3#1)(2005-10#1)
to dopamine (DA)##2##3##(1994-2#1)(1996-11#1)
to dopamine##15##2##(1990-2#2)(1992-12#1)(1993-12#1)(1994-2#1)(1995-12#2)(1995-8#1)(1996-11#1)(1996-2#1)(2008-10#1)(2008-11#1)(2009-12#1)(2010-10#1)(2010-12#1)
to dopaminergic and##3##3##(1993-9#1)(2005-8#1)(2008-2#1)
to dopaminergic medications##2##3##(2013-8#2)
to dopaminergic##9##2##(1993-9#2)(2005-8#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-12#1)(2013-8#2)
to dope##2##2##(2007-11#1)(2007-9#1)
to doping##3##2##(2008-10#1)(2009-11#1)(2010-4#1)
to dorsal##3##2##(1991-9#1)(2006-3#1)(2006-4#1)
to dosage of##2##3##(1994-3#1)(2010-5#1)
to dosage##7##2##(1990-4#2)(1992-5#1)(1994-3#1)(2008-3#1)(2010-5#1)(2012-12#1)
to dose and##3##3##(1991-4#1)(1994-9#1)(2012-3#1)
to dose##19##2##(1991-4#1)(1993-4#2)(1994-9#1)(1995-12#1)(1995-6#1)(1997-2#1)(1997-8#1)(2007-3#1)(2008-10#2)(2008-7#3)(2009-9#1)(2010-9#1)(2011-2#1)(2012-3#2)
to doses of##2##3##(1992-7#1)(2008-7#1)
to doses##3##2##(1992-7#1)(2008-10#1)(2008-7#1)
to double stranded##2##3##(1994-3#1)(2007-11#1)
to double the##2##3##(2007-12#1)(2008-7#1)
to double##15##2##(1994-3#1)(1996-12#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-10#1)(2011-2#2)(2012-3#1)
to double-strand##2##2##(1995-12#1)(1997-1#1)
to double-stranded DNA##3##3##(1997-4#1)(2008-8#1)(2008-9#1)
to double-stranded##5##2##(1995-11#1)(1997-4#1)(2008-10#1)(2008-8#1)(2008-9#1)
to down##3##2##(1994-2#1)(2007-2#1)(2007-3#1)
to down-modulate##2##2##(1995-2#1)(2013-1#1)
to down-regulate the##2##3##(1994-6#1)(2006-11#1)
to down-regulate##9##2##(1991-5#1)(1992-5#1)(1994-6#1)(1995-1#1)(1995-2#1)(1996-7#1)(2006-11#1)(2007-12#1)(2011-1#1)
to down-regulation of the##3##4##(1991-5#1)(2007-12#1)(2012-2#1)
to down-regulation of##6##3##(1991-5#1)(1992-2#1)(2007-12#1)(2008-5#1)(2011-1#1)(2012-2#1)
to download##2##2##(2008-9#1)(2009-4#1)
to downregulate the##2##3##(1993-7#1)(2010-5#1)
to downregulate##6##2##(1993-7#1)(2008-8#1)(2009-8#1)(2010-3#1)(2010-5#1)(2013-1#1)
to downregulation##2##2##(1992-12#1)(2008-5#1)
to downsizing##2##2##(1993-1#1)(1996-12#1)
to downstream effectors##3##3##(1993-3#1)(2010-11#1)(2012-12#1)
to downstream signaling pathways##2##4##(2008-11#1)(2009-6#1)
to downstream##10##2##(1993-12#1)(1993-3#1)(1997-4#1)(2008-11#1)(2009-6#1)(2009-8#1)(2010-11#1)(2011-2#2)(2012-12#1)
to downward##2##2##(2008-10#1)(2012-2#1)
to downy mildew##4##3##(2008-10#4)
to dox##2##2##(2008-6#2)
to doxorubicin##7##2##(1990-2#1)(1991-6#1)(1997-4#1)(2006-6#1)(2008-11#1)(2012-1#2)
to doxycycline##2##2##(1994-8#1)(2007-12#1)
to drain##12##2##(1993-5#1)(2005-8#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-3#1)(2013-1#1)(2013-8#1)
to drainage##2##2##(1997-8#1)(2007-8#1)
to dramatic##4##2##(2007-7#1)(2008-7#2)(2013-8#1)
to dramatically reduce the##2##4##(2008-10#1)(2011-2#1)
to dramatically reduce##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
to dramatically##10##2##(1995-12#1)(2007-4#1)(2008-10#2)(2008-8#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#2)
to drastic##3##2##(2006-1#1)(2010-8#1)(2011-12#1)
to drastically reduce##3##3##(1991-1#1)(2005-7#1)(2013-1#1)
to drastically##4##2##(1991-1#1)(1991-4#1)(2005-7#1)(2013-1#1)
to draw a##5##3##(1997-6#1)(2007-12#1)(2012-12#2)(2013-8#1)
to draw any##2##3##(2006-12#1)(2009-10#1)
to draw attention to an##2##5##(2007-11#1)(2011-2#1)
to draw attention to the##3##5##(1993-2#1)(2007-8#1)(2008-1#1)
to draw attention to##11##4##(1990-9#1)(1991-12#1)(1993-2#1)(2005-8#1)(2007-11#1)(2007-8#2)(2008-1#1)(2011-1#1)(2011-2#1)(2012-3#1)
to draw attention##12##3##(1990-9#1)(1991-12#1)(1993-2#1)(2005-8#1)(2007-11#1)(2007-8#2)(2008-1#1)(2011-1#1)(2011-2#2)(2012-3#1)
to draw blood##3##3##(1996-11#1)(2007-7#1)(2009-4#1)
to draw conclusions##4##3##(2006-12#1)(2007-7#1)(2008-6#1)(2010-3#1)
to draw definite conclusions##2##4##(2008-10#1)(2009-7#1)
to draw definitive conclusions##2##4##(2008-1#1)(2008-6#1)
to draw out##2##3##(2008-1#1)(2010-2#1)
to draw the attention of the##2##6##(1991-6#1)(2012-2#1)
to draw the attention of##4##5##(1991-6#1)(2007-7#1)(2010-3#1)(2012-2#1)
to draw the##9##3##(1991-6#1)(1994-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-5#1)(2010-12#1)(2010-3#1)(2012-2#1)
to draw up a##2##4##(1997-5#1)(2008-9#1)
to draw up##4##3##(1997-5#1)(2008-11#1)(2008-9#2)
to draw##65##2##(1990-9#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-11#1)(1993-2#1)(1993-5#1)(1994-12#1)(1995-1#1)(1996-11#1)(1996-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-8#1)(2006-12#2)(2007-11#3)(2007-12#2)(2007-7#4)(2007-8#3)(2008-1#4)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-8#2)
to dream##2##2##(1991-3#1)(2008-3#1)
to dried##2##2##(1997-1#1)(2008-10#1)
to drift##3##2##(2004-9#1)(2008-10#1)(2013-1#1)
to drink beer##2##3##(2007-6#2)
to drink##15##2##(1990-4#1)(1991-6#1)(1992-3#1)(1995-5#2)(2007-6#2)(2008-1#1)(2008-11#1)(2008-5#2)(2009-5#1)(2010-12#1)(2013-1#1)(2013-7#1)
to drinking water##16##3##(1992-5#1)(1993-8#1)(2007-2#1)(2008-10#1)(2008-9#10)(2012-3#1)(2013-1#1)
to drinking##18##2##(1992-5#1)(1993-8#1)(1993-9#1)(1994-2#1)(2007-2#1)(2008-10#1)(2008-9#10)(2012-3#1)(2013-1#1)
to drive a##3##3##(2006-11#1)(2007-12#2)
to drive an##2##3##(2006-11#1)(2008-2#1)
to drive and##2##3##(1995-4#1)(1996-12#1)
to drive expression of##3##4##(1996-10#1)(2006-12#1)(2007-12#1)
to drive quality##2##3##(2007-4#1)(2009-4#1)
to drive the production of##2##5##(1996-1#1)(2008-11#1)
to drive the##20##3##(1994-6#1)(1994-8#1)(1995-8#1)(1996-1#1)(1997-4#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-8#2)(2009-8#1)(2010-5#2)(2012-1#1)
to drive##71##2##(1990-8#1)(1991-3#1)(1993-5#6)(1994-6#1)(1994-8#1)(1995-4#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1997-4#2)(1997-8#1)(2006-11#2)(2006-12#2)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#4)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#3)(2008-11#5)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#4)(2009-12#1)(2009-4#2)(2009-8#2)(2009-9#1)(2010-5#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-3#1)
to driving##3##2##(1996-1#1)(2008-8#1)(2012-12#1)
to drop##8##2##(1990-5#1)(1992-11#1)(1995-1#1)(2005-11#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-3#1)
to droplet##3##2##(1995-3#1)(2005-11#2)
to droplets##2##2##(2008-2#2)
to drought and##2##3##(2012-5#1)(2012-7#1)
to drought stress##4##3##(2006-12#1)(2008-12#1)(2008-7#1)(2009-8#1)
to drought##19##2##(2004-4#1)(2006-12#2)(2008-10#1)(2008-12#2)(2008-7#1)(2008-8#1)(2009-8#3)(2011-2#1)(2012-5#2)(2012-7#3)(2012-8#2)
to drug administration##4##3##(2006-12#1)(2008-4#1)(2008-8#1)(2012-2#1)
to drug and##2##3##(2006-10#1)(2007-9#1)
to drug delivery##2##3##(2010-9#1)(2012-2#1)
to drug design##2##3##(2005-7#1)(2008-5#1)
to drug development##5##3##(1991-3#1)(2008-5#1)(2010-11#1)(2010-2#1)(2011-2#1)
to drug discovery##3##3##(2005-7#1)(2005-8#1)(2010-5#1)
to drug metabolism##2##3##(1996-5#1)(2010-12#1)
to drug resistance##3##3##(1995-1#1)(2008-11#1)(2008-4#1)
to drug safety assessment##2##4##(2005-8#1)(2008-10#1)
to drug therapy##4##3##(1991-6#1)(2005-7#1)(2008-4#1)(2008-7#1)
to drug treatment##6##3##(1995-12#1)(1996-9#1)(2008-11#1)(2008-9#1)(2011-2#2)
to drug use##3##3##(2009-3#1)(2009-7#1)(2010-2#1)
to drug##67##2##(1991-12#1)(1991-3#1)(1991-6#1)(1992-8#1)(1992-9#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-5#2)(1996-9#1)(1997-4#1)(2005-7#3)(2005-8#5)(2006-10#2)(2006-12#1)(2006-5#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#2)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-5#1)(2010-9#1)(2011-2#6)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
to drug-induced##3##2##(1997-5#1)(2007-10#1)(2008-10#1)
to drugs and##6##3##(1991-7#1)(1993-10#1)(1993-11#1)(2006-12#1)(2007-12#1)(2011-1#1)
to drugs is##2##3##(2008-3#1)(2008-8#1)
to drugs that##2##3##(2008-10#1)(2008-6#1)
to drugs used##2##3##(2006-10#1)(2008-8#1)
to drugs with##2##3##(1997-5#1)(2008-7#1)
to drugs##40##2##(1990-12#1)(1991-2#1)(1991-7#2)(1992-8#1)(1993-10#1)(1993-11#1)(1994-9#1)(1995-2#1)(1997-5#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-9#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2009-6#1)(2011-1#3)(2013-1#2)(2013-8#1)
to dry and##2##3##(2008-5#2)
to dry eye##2##3##(2007-1#2)
to dry out##2##3##(2008-10#1)(2008-9#1)
to dry semi-ground Purina chow food##3##6##(1991-2#3)
to dry weight##3##3##(1993-7#3)
to dry wines##2##3##(2008-10#2)
to dry##27##2##(1991-2#3)(1993-7#3)(2005-12#1)(2007-1#2)(2008-10#9)(2008-5#2)(2008-8#1)(2008-9#1)(2010-4#2)(2010-9#1)(2013-1#1)(2013-8#1)
to drying##2##2##(2010-7#1)(2012-2#1)
to dryness on a##2##4##(2008-10#2)
to dryness under##3##3##(1997-3#1)(2008-10#1)(2013-7#1)
to dryness##19##2##(1993-2#2)(1996-8#1)(1997-3#2)(2005-12#1)(2008-10#12)(2013-7#1)
to dsDNA##2##2##(2008-1#1)(2008-8#1)
to dsRNA##3##2##(1996-9#1)(2008-10#2)
to dual##2##2##(2007-10#1)(2009-11#1)
to duck##3##2##(1992-12#1)(1993-4#1)(1996-8#1)
to ducklings##2##2##(1992-9#1)(2008-10#1)
to duct##2##2##(1993-10#1)(2012-12#1)
to duplex DNA##2##3##(1991-3#1)(1995-2#1)
to duplex##8##2##(1991-3#1)(1995-2#1)(2005-10#3)(2006-10#1)(2007-9#1)(2008-12#1)
to duplicate##4##2##(1991-3#1)(1993-11#1)(2006-5#1)(2008-9#1)
to dural##4##2##(2006-12#1)(2008-7#1)(2009-10#1)(2012-3#1)
to duration of##4##3##(1992-2#1)(1993-12#2)(1996-12#1)
to duration##5##2##(1992-2#1)(1993-12#2)(1996-12#1)(2006-6#1)
to during##3##2##(2008-9#1)(2010-8#2)
to dust##6##2##(1991-4#1)(2006-6#2)(2007-1#1)(2012-11#2)
to dwarfism##2##2##(1993-4#1)(1995-8#1)
to dye##5##2##(1997-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-1#1)
to dye-loaded##2##2##(2008-10#1)(2009-2#1)
to dying##3##2##(2004-3#1)(2010-2#1)(2012-12#1)
to dynamic##12##2##(1996-4#1)(2006-11#3)(2007-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)
to dynamical##2##2##(2008-8#1)(2010-8#1)
to dynamically stable##2##3##(2007-8#1)(2008-8#1)
to dynamically##5##2##(2007-8#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-2#1)
to dysfunction of the##3##4##(1993-12#1)(2009-2#1)(2010-12#1)
to dysfunction of##7##3##(1993-12#1)(1993-2#1)(1997-5#1)(2009-2#1)(2010-12#1)(2013-1#2)
to dysfunction##8##2##(1993-12#1)(1993-2#1)(1997-4#1)(1997-5#1)(2009-2#1)(2010-12#1)(2013-1#2)
to dyslipidemia##3##2##(1994-2#1)(2008-5#1)(2013-7#1)
to dysphagia##2##2##(1993-2#1)(2012-2#1)
to dyspnea##4##2##(2006-10#1)(2006-9#1)(2008-3#1)(2013-1#1)
to eHealth##2##2##(2007-10#2)
to each case##4##3##(1991-7#1)(2006-8#1)(2009-4#1)(2010-8#1)
to each dimension##2##3##(2010-10#1)(2011-2#1)
to each drug##5##3##(1993-8#1)(1994-6#1)(2008-10#1)(2008-6#1)(2012-12#1)
to each electrical##2##3##(1994-2#1)(1997-4#1)
to each individual##2##3##(2008-10#1)(2010-8#1)
to each method##3##3##(1995-11#1)(2012-3#1)(2013-8#1)
to each nurse##2##3##(1993-12#1)(2008-11#1)
to each of four##3##4##(1990-7#1)(1997-2#1)(2008-10#1)
to each of the three##3##5##(2007-11#1)(2008-10#2)
to each of the##25##4##(1993-12#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-9#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)(2009-11#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
to each of these##8##4##(1995-11#1)(1996-8#1)(2007-12#1)(2008-10#3)(2008-7#1)(2008-9#1)
to each of##37##3##(1990-7#1)(1993-12#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-3#2)(1996-5#1)(1996-8#2)(1997-2#1)(1997-9#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
to each one##2##3##(1994-2#1)(2008-10#1)
to each other and to the##6##6##(1991-5#1)(1997-6#1)(2008-10#1)(2012-12#2)(2013-1#1)
to each other and to those##2##6##(1996-4#1)(2013-1#1)
to each other and to##11##5##(1990-7#1)(1991-5#1)(1996-4#1)(1996-7#1)(1997-6#1)(2008-10#1)(2012-12#2)(2012-3#1)(2013-1#2)
to each other and##25##4##(1990-7#1)(1991-5#1)(1993-11#2)(1993-3#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-6#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
to each other as##2##4##(1992-5#1)(2010-9#1)
to each other but##3##4##(1995-2#1)(1997-3#1)(2008-10#1)
to each other by##4##4##(1996-2#2)(2007-12#1)(2008-4#1)
to each other in the##2##5##(2008-10#1)(2008-4#1)
to each other in##4##4##(1990-12#1)(2008-10#1)(2008-4#1)(2013-8#1)
to each other on the##2##5##(1995-11#1)(2006-12#1)
to each other only##2##4##(1992-12#1)(2008-8#1)
to each other than are##2##5##(1993-6#1)(2008-8#1)
to each other than to any other##2##7##(2006-5#1)(2008-10#1)
to each other than##5##4##(1993-6#1)(2006-5#1)(2008-10#2)(2008-8#1)
to each other to##2##4##(2007-10#1)(2008-3#1)
to each other with##3##4##(2008-1#1)(2008-2#1)(2008-8#1)
to each other##130##3##(1990-11#1)(1990-12#1)(1990-4#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-11#2)(1993-3#2)(1993-6#2)(1993-9#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#1)(1996-10#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-11#1)(2006-1#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#1)(2008-1#2)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#3)(2008-8#4)(2008-9#3)(2009-3#1)(2009-7#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#5)
to each other's##3##3##(1996-7#1)(2010-11#1)(2012-1#1)
to each participant##3##3##(2007-12#1)(2007-8#1)(2008-11#1)
to each patient##6##3##(1992-6#1)(1994-8#1)(2004-10#1)(2006-9#1)(2008-10#1)(2011-2#1)
to each patient's##2##3##(2008-6#1)(2010-11#1)
to each person##2##3##(1994-7#1)(1996-5#1)
to each site##2##3##(1995-8#1)(1997-2#1)
to each target group##2##4##(2012-3#2)
to each target##3##3##(2010-2#1)(2012-3#2)
to each virus##2##3##(2008-10#2)
to each##331##2##(1990-11#2)(1990-12#3)(1990-4#1)(1990-6#1)(1990-7#2)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#2)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1993-11#2)(1993-12#3)(1993-3#3)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#3)(1994-2#2)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-11#3)(1995-2#3)(1995-3#3)(1995-5#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#3)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#2)(1997-9#1)(2004-10#1)(2005-11#3)(2006-1#1)(2006-10#2)(2006-12#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#6)(2007-12#7)(2007-2#3)(2007-4#4)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#46)(2008-11#11)(2008-12#1)(2008-2#13)(2008-3#5)(2008-4#4)(2008-5#5)(2008-6#5)(2008-7#5)(2008-8#6)(2008-9#8)(2009-10#3)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#5)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#7)(2012-1#3)(2012-12#7)(2012-2#4)(2012-3#6)(2013-1#12)(2013-4#1)(2013-7#3)(2013-8#7)
to ear##4##2##(1993-2#2)(2008-10#2)
to earlier diagnosis##2##3##(1994-7#1)(2011-2#1)
to earlier published##2##3##(2007-11#1)(2008-6#1)
to earlier reports##4##3##(1991-7#1)(2007-1#2)(2008-3#1)
to earlier studies##2##3##(1993-6#1)(2012-12#1)
to earlier##27##2##(1990-5#2)(1991-7#1)(1992-4#1)(1992-5#1)(1993-6#1)(1994-7#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-1#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#1)
to early and late##4##4##(1994-12#1)(1995-5#1)(2008-4#1)(2013-1#1)
to early and##5##3##(1994-12#1)(1995-5#1)(2008-4#1)(2008-7#1)(2013-1#1)
to early detection of##4##4##(1991-4#1)(2008-8#1)(2009-5#1)(2013-1#1)
to early detection##6##3##(1991-4#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-5#1)(2013-1#1)
to early diagnosis and##2##4##(2006-10#1)(2011-2#1)
to early diagnosis of##2##4##(2005-11#1)(2007-10#1)
to early diagnosis##5##3##(2005-11#1)(2006-10#1)(2007-10#1)(2011-2#1)(2012-1#1)
to early intervention##5##3##(1992-5#1)(2006-10#1)(2006-7#1)(2009-10#1)(2009-8#1)
to early onset##2##3##(2008-4#1)(2008-5#1)
to early recognition##3##3##(2010-12#1)(2011-2#1)(2012-3#1)
to early stages of##2##4##(1997-8#1)(2008-10#1)
to early##77##2##(1991-4#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-8#1)(1994-12#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-6#1)(2006-7#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#2)(2010-12#4)(2010-2#2)(2010-5#1)(2010-9#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2012-7#1)(2013-1#2)(2013-7#1)(2013-8#1)
to earn a##2##3##(2007-2#1)(2008-12#1)
to earn##4##2##(1991-10#1)(1992-12#1)(2007-2#1)(2008-12#1)
to earthquake prediction##3##3##(1996-4#3)
to earthquake##4##2##(1996-4#4)
to ease of##2##3##(2007-11#1)(2007-7#1)
to ease the##3##3##(2006-12#1)(2013-1#2)
to ease##16##2##(1995-5#1)(1996-6#2)(2006-12#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-2#2)(2008-5#1)(2008-9#1)(2009-4#1)(2009-9#1)(2013-1#2)(2013-8#1)
to easily##17##2##(1992-9#1)(1993-2#1)(1996-12#1)(1997-3#1)(2005-11#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2010-3#1)(2012-12#3)(2012-2#2)
to eastern##2##2##(1995-4#1)(2008-10#1)
to eat it##3##3##(1993-6#3)
to eat less##2##3##(2008-2#1)(2010-4#1)
to eat the##2##3##(2004-4#1)(2012-2#1)
to eat##21##2##(1990-12#1)(1990-6#2)(1992-9#1)(1993-6#3)(1994-11#1)(1994-4#1)(1997-4#1)(2004-4#1)(2006-10#1)(2006-7#1)(2008-2#1)(2009-8#1)(2010-4#2)(2010-7#1)(2011-2#2)(2012-2#1)
to eating disorders##2##3##(2006-7#2)
to eating##3##2##(2006-7#3)
to eccentric##2##2##(2006-11#1)(2010-3#1)
to echocardiographic##2##2##(2010-7#1)(2011-2#1)
to echocardiography##3##2##(2007-9#1)(2008-3#1)(2011-2#1)
to eclosion##2##2##(1991-10#1)(2010-2#1)
to ecological and##3##3##(1994-3#1)(2009-8#1)(2012-12#1)
to ecological##9##2##(1994-3#1)(1996-4#1)(2006-5#1)(2008-8#1)(2009-8#1)(2011-1#1)(2012-12#1)(2013-7#2)
to ecology##2##2##(2008-10#1)(2009-8#1)
to economic##10##2##(1991-4#1)(1994-2#1)(1997-2#2)(2008-1#1)(2008-11#1)(2009-7#1)(2010-5#1)(2011-2#1)(2012-2#1)
to ectopic##2##2##(1990-3#1)(1994-3#1)
to edges##2##2##(2008-9#2)
to edible##2##2##(1994-6#1)(2007-8#1)
to editing##2##2##(1992-11#1)(1994-11#1)
to editorial##7##2##(1993-12#1)(1993-9#2)(2007-9#1)(2010-12#3)
to educate and##5##3##(1995-12#1)(1997-6#1)(2006-12#1)(2011-1#1)(2011-12#1)
to educate both##2##3##(2008-12#1)(2009-11#1)
to educate patients##3##3##(2007-9#1)(2008-3#1)(2010-4#1)
to educate the public##2##4##(1994-5#1)(2011-2#1)
to educate the##5##3##(1994-1#2)(1994-5#1)(2007-2#1)(2011-2#1)
to educate##38##2##(1991-6#1)(1993-12#2)(1994-1#2)(1994-5#1)(1995-12#1)(1995-2#1)(1997-3#1)(1997-6#1)(2004-10#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-2#2)(2007-4#1)(2007-9#1)(2008-11#1)(2008-12#5)(2008-3#1)(2008-6#1)(2009-11#1)(2009-2#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-7#1)
to educating##2##2##(2006-6#1)(2009-4#1)
to education and##4##3##(2004-3#1)(2006-2#1)(2007-4#1)(2008-11#1)
to education##13##2##(1994-2#1)(1995-2#1)(2004-3#1)(2006-2#2)(2007-10#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-12#1)(2011-2#1)
to educational##6##2##(2006-2#1)(2006-6#1)(2007-6#2)(2008-12#1)(2012-2#1)
to effect a change##2##4##(1991-4#1)(2008-3#1)
to effect a##9##3##(1991-4#1)(1996-10#1)(2004-1#1)(2006-4#1)(2008-3#1)(2008-4#2)(2008-6#1)(2009-8#1)
to effect cost##2##3##(1994-12#1)(2006-10#1)
to effect the##2##3##(1994-9#1)(2008-2#1)
to effect##41##2##(1990-11#1)(1991-4#1)(1992-3#1)(1993-4#1)(1994-1#1)(1994-12#1)(1994-9#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-5#1)(1997-1#3)(2004-1#1)(2006-10#2)(2006-4#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#1)(2009-4#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-3#1)
to effective care##3##3##(2007-3#1)(2008-1#1)(2012-1#1)
to effective management of##2##4##(2006-10#1)(2008-10#1)
to effective management##3##3##(2006-10#1)(2007-12#1)(2008-10#1)
to effective therapeutic##2##3##(1994-11#1)(2008-7#1)
to effective##32##2##(1990-9#1)(1993-1#1)(1994-1#1)(1994-11#1)(1994-3#1)(1995-3#1)(1995-5#1)(1997-3#1)(2005-10#2)(2005-8#1)(2006-10#2)(2006-8#1)(2007-12#1)(2007-3#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2012-1#1)(2013-1#2)(2013-8#1)
to effectively and##2##3##(2006-2#1)(2008-1#1)
to effectively block##2##3##(2004-9#1)(2006-10#1)
to effectively control the##2##4##(2007-11#1)(2008-7#1)
to effectively control##3##3##(2007-11#1)(2008-7#1)(2012-3#1)
to effectively deliver##3##3##(2008-11#1)(2012-11#2)
to effectively implement##2##3##(2008-2#1)(2008-3#1)
to effectively increase##3##3##(2008-5#1)(2012-12#2)
to effectively inhibit##3##3##(2010-2#1)(2011-1#1)(2011-2#1)
to effectively manage##4##3##(2006-8#1)(2007-11#1)(2007-6#1)(2009-8#1)
to effectively plan##2##3##(1997-1#1)(2012-11#1)
to effectively prevent##3##3##(2007-11#1)(2008-6#1)(2013-1#1)
to effectively produce##2##3##(2008-10#1)(2008-11#1)
to effectively provide##2##3##(1997-2#1)(2012-1#1)
to effectively reduce##2##3##(1996-3#1)(2007-11#1)
to effectively represent the##2##4##(2008-11#1)(2013-1#1)
to effectively treat##3##3##(2007-11#1)(2008-4#1)(2008-8#1)
to effectively##90##2##(1992-9#1)(1995-1#2)(1996-3#2)(1997-1#1)(1997-2#2)(1997-5#1)(2004-9#1)(2005-12#1)(2005-3#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-11#6)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#1)(2009-10#3)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#3)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
to effectiveness of##2##3##(1992-12#1)(2007-9#1)
to effectiveness##4##2##(1991-1#1)(1992-12#1)(2007-9#1)(2011-2#1)
to effects of##7##3##(1991-4#1)(1992-5#1)(1994-5#1)(2007-12#1)(2008-8#2)(2008-9#1)
to effects on the##2##4##(2008-8#2)
to effects on##6##3##(1995-1#1)(1996-9#1)(2008-8#3)(2012-12#1)
to effects##14##2##(1991-4#1)(1992-5#1)(1994-5#1)(1995-1#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-8#5)(2008-9#1)(2012-12#1)
to effectuate##2##2##(1990-11#1)(2008-10#1)
to efficacy##5##2##(1995-5#1)(1996-5#1)(2007-6#1)(2008-5#1)(2011-2#1)
to efficient##10##2##(1990-8#1)(1991-8#1)(1996-2#1)(1996-3#1)(2008-10#2)(2008-6#2)(2008-7#1)(2013-1#1)
to efficiently collect##2##3##(2008-2#2)
to efficiently deliver##3##3##(2008-11#1)(2009-9#1)(2013-8#1)
to efficiently produce##2##3##(2008-2#1)(2008-6#1)
to efficiently suppress##2##3##(2006-12#1)(2008-11#1)
to efficiently##42##2##(1991-8#1)(1994-5#2)(1995-2#2)(1996-12#1)(1997-7#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-2#5)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-4#2)(2011-12#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
to efflux##2##2##(2007-11#1)(2008-5#1)
to efforts to increase##2##4##(2007-4#1)(2008-11#1)
to efforts to##4##3##(2007-4#1)(2007-9#1)(2008-11#1)(2013-1#1)
to efforts##7##2##(1994-3#1)(2007-4#1)(2007-9#2)(2008-11#1)(2011-2#1)(2013-1#1)
to egg conversion ratio##2##4##(2008-7#2)
to egg##8##2##(1997-5#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#1)
to eggs and##2##3##(1995-6#1)(2013-1#1)
to eggs##7##2##(1995-6#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-8#2)(2013-1#1)
to eight days##2##3##(1990-10#1)(2010-11#1)
to eight different##3##3##(2008-10#2)(2009-9#1)
to eight times##2##3##(2008-10#1)(2008-5#1)
to eight years##3##3##(2006-10#1)(2009-4#2)
to eight##41##2##(1990-10#1)(1990-7#1)(1991-7#1)(1992-9#1)(1994-6#1)(1995-1#1)(1996-10#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-2#1)(2007-3#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-5#6)(2008-7#1)(2008-9#2)(2009-10#1)(2009-4#2)(2009-9#1)(2010-11#1)(2011-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
to eightfold##3##2##(1997-7#1)(2008-10#2)
to either a##14##3##(1991-1#1)(1991-12#1)(1993-2#1)(1993-5#1)(2006-5#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-12#1)(2010-2#1)(2010-3#1)(2013-1#1)
to either an##7##3##(1994-2#1)(1995-5#1)(1997-3#1)(2007-11#1)(2007-8#1)(2009-9#1)(2013-7#1)
to either enhance or suppress##2##5##(2009-8#1)(2011-2#1)
to either enhance or##3##4##(1993-9#1)(2009-8#1)(2011-2#1)
to either enhance##4##3##(1993-9#1)(2009-7#1)(2009-8#1)(2011-2#1)
to either of the two##2##5##(1991-12#1)(1994-8#1)
to either of##5##3##(1991-12#1)(1992-3#1)(1994-8#1)(2013-1#2)
to either prevent##2##3##(2006-10#1)(2010-5#1)
to either side##2##3##(1995-8#1)(2008-6#1)
to either the##30##3##(1991-3#1)(1992-9#1)(1994-5#2)(1995-11#1)(1995-12#1)(1995-3#1)(1996-5#1)(1996-7#1)(1997-5#1)(1997-6#1)(2006-11#1)(2006-12#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#1)(2008-6#1)(2009-10#1)(2009-11#1)(2012-2#1)(2013-1#1)
to either##207##2##(1990-12#5)(1990-2#1)(1990-5#1)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-6#3)(1992-1#1)(1992-3#1)(1992-6#3)(1992-7#1)(1992-9#2)(1993-10#1)(1993-12#3)(1993-2#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#3)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#2)(1995-11#3)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#3)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#3)(1996-7#1)(1996-9#2)(1997-2#2)(1997-3#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-1#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-5#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-2#3)(2007-8#2)(2008-1#2)(2008-10#18)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#6)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#3)(2010-4#5)(2010-5#2)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#2)
to ejaculation##7##2##(1991-2#3)(1992-12#1)(1993-7#1)(1994-2#1)(1994-6#1)
to elaborate on the##2##4##(2006-10#1)(2013-1#1)
to elaborate on##3##3##(2006-10#1)(2012-12#1)(2013-1#1)
to elaborate##12##2##(1993-9#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-8#1)(2010-1#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
to elastase##2##2##(1992-12#1)(1993-11#1)
to elastic##2##2##(2006-6#1)(2011-2#1)
to elder abuse##2##3##(1991-2#2)
to elder##3##2##(1991-2#2)(1994-2#1)
to elderly patients##2##3##(2006-2#1)(2012-3#1)
to elderly people in##2##4##(2009-8#1)(2011-2#1)
to elderly people##3##3##(1990-3#1)(2009-8#1)(2011-2#1)
to elderly##14##2##(1990-3#1)(1993-12#2)(1997-2#1)(2006-11#1)(2006-2#2)(2007-7#1)(2009-8#1)(2010-2#1)(2011-2#2)(2012-3#2)
to elective##2##2##(2010-7#1)(2013-1#1)
to electric##7##2##(1994-5#1)(1995-12#1)(1997-6#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-7#1)
to electrical cardioversion##2##3##(2006-10#2)
to electrical field stimulation##5##4##(1990-7#1)(1993-11#3)(2008-4#1)
to electrical field##6##3##(1990-7#1)(1993-11#3)(1993-12#1)(2008-4#1)
to electrical stimulation of the##4##5##(1990-7#1)(1992-8#1)(1992-9#1)(1993-12#1)
to electrical stimulation of##5##4##(1990-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)
to electrical stimulation##10##3##(1990-5#1)(1990-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1995-12#1)(1996-12#2)(2008-7#1)
to electrical##27##2##(1990-5#1)(1990-7#2)(1990-9#1)(1991-5#2)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#2)(1993-3#1)(1994-8#1)(1995-12#1)(1996-12#2)(1996-5#1)(1997-1#1)(2006-10#2)(2006-2#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#1)
to electroanalytical##2##2##(2008-10#2)
to electrochemical##2##2##(2008-10#2)
to electrochemically##2##2##(2007-11#1)(2008-10#1)
to electrode##4##2##(2008-10#3)(2008-11#1)
to electrodes##2##2##(2008-2#1)(2008-7#1)
to electromagnetic##2##2##(2008-2#1)(2013-8#1)
to electron beam##2##3##(1992-12#1)(2007-10#1)
to electron transfer##2##3##(1991-5#1)(1995-8#1)
to electron##8##2##(1991-5#2)(1992-12#1)(1995-8#1)(2007-10#1)(2008-1#1)(2008-3#1)(2011-12#1)
to electronic##11##2##(2007-12#2)(2007-4#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2009-7#1)(2010-1#1)(2010-11#1)
to electrophoresis##2##2##(1990-3#1)(2008-9#1)
to electrophoretic homogeneity by##2##4##(1990-6#1)(2005-11#1)
to electrophoretic homogeneity from the##2##5##(1990-3#1)(1990-4#1)
to electrophoretic homogeneity from##3##4##(1990-3#1)(1990-4#1)(1994-8#1)
to electrophoretic homogeneity##11##3##(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-2#1)(1992-1#1)(1993-8#1)(1994-8#1)(1995-2#1)(2005-11#1)(2008-10#1)
to electrophoretic##12##2##(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-2#1)(1992-1#1)(1993-8#1)(1994-8#1)(1995-2#1)(1997-2#1)(2005-11#1)(2008-10#1)
to electrophysiological##3##2##(1997-6#1)(2007-12#1)(2008-7#1)
to electrostatic interactions##4##3##(1990-11#1)(2006-2#1)(2008-10#1)(2008-6#1)
to electrostatic##9##2##(1990-11#1)(1993-3#1)(1996-8#1)(1997-3#1)(2005-11#1)(2006-2#1)(2008-10#1)(2008-6#1)(2013-8#1)
to element##4##2##(1997-7#1)(2008-2#1)(2008-5#1)(2008-7#1)
to elemental##4##2##(2005-11#1)(2007-12#1)(2008-10#2)
to elementary##2##2##(1995-10#1)(2013-1#1)
to elements within##2##3##(1995-6#1)(1996-4#1)
to elements##5##2##(1995-1#1)(1995-6#1)(1996-4#1)(2007-12#2)
to elevate and##2##3##(2007-11#1)(2008-10#1)
to elevate blood##2##3##(1992-8#1)(1996-10#1)
to elevate intracellular cAMP##2##4##(1994-11#1)(1994-12#1)
to elevate the##7##3##(1993-12#1)(1993-9#1)(1997-2#1)(2004-11#1)(2008-10#1)(2008-6#1)(2010-4#1)
to elevate##25##2##(1990-11#1)(1991-1#1)(1992-8#3)(1993-12#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-8#1)(1996-10#1)(1997-1#1)(1997-2#1)(2004-11#1)(2005-10#1)(2007-11#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-4#1)
to elevated extracellular calcium##2##4##(1990-2#2)
to elevated glucose##3##3##(1992-8#2)(2010-11#1)
to elevated intracellular##2##3##(1992-11#1)(2005-8#1)
to elevated temperature##3##3##(2006-5#1)(2007-11#1)(2008-4#1)
to elevated##30##2##(1990-2#2)(1992-11#1)(1992-4#1)(1992-8#2)(1993-9#1)(1994-11#1)(1995-2#1)(1995-3#1)(2004-4#1)(2005-8#1)(2006-3#2)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-11#1)(2011-2#2)(2012-12#1)(2012-7#1)(2013-8#1)
to eleven##3##2##(2007-4#1)(2008-5#1)(2009-5#1)
to elicit a##9##3##(1993-12#1)(1993-6#1)(1994-5#1)(1995-11#1)(1995-5#1)(2005-8#2)(2008-10#1)(2008-4#1)
to elicit an##5##3##(1990-12#1)(1996-10#1)(1996-9#1)(2004-11#1)(2008-10#1)
to elicit changes in##2##4##(1992-7#1)(1992-8#1)
to elicit information on##2##4##(2007-7#1)(2009-11#1)
to elicit information##5##3##(2007-12#1)(2007-3#1)(2007-7#1)(2008-6#1)(2009-11#1)
to elicit pro-inflammatory##2##3##(2003-11#1)(2008-10#1)
to elicit the patient's##2##4##(1992-3#1)(1996-3#1)
to elicit the##12##3##(1991-2#1)(1992-3#1)(1996-3#1)(2007-3#1)(2008-11#2)(2008-3#1)(2009-5#1)(2011-1#2)(2011-2#1)(2013-8#1)
to elicit##83##2##(1990-12#1)(1990-7#1)(1991-2#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-12#2)(1993-6#1)(1994-10#1)(1994-11#2)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-12#3)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(2003-11#1)(2004-11#1)(2005-8#2)(2006-12#1)(2007-12#2)(2007-3#2)(2007-6#1)(2007-7#2)(2008-10#4)(2008-11#5)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-4#1)(2009-5#1)(2010-10#1)(2011-1#3)(2011-2#2)(2012-1#3)(2013-1#4)(2013-8#1)
to elicitins##2##2##(2008-10#2)
to eliminate an##2##3##(1992-9#1)(2006-2#1)
to eliminate cranial tibial##2##4##(2005-7#1)(2012-3#1)
to eliminate errors##2##3##(2006-6#1)(2008-4#1)
to eliminate it##2##3##(2008-10#1)(2008-4#1)
to eliminate malaria##2##3##(2012-12#1)(2012-3#1)
to eliminate or control##2##4##(2007-12#1)(2012-3#1)
to eliminate or##5##3##(2007-12#1)(2010-11#1)(2012-3#1)(2013-8#2)
to eliminate sample matrix interferences##2##5##(2008-10#2)
to eliminate the false##2##4##(1997-4#1)(2008-3#1)
to eliminate the infection##2##4##(1991-1#1)(2007-12#1)
to eliminate the influence of##2##5##(2007-8#1)(2008-10#1)
to eliminate the interference##2##4##(1996-6#1)(2008-1#1)
to eliminate the need for##2##5##(2008-10#1)(2008-2#1)
to eliminate the risk##2##4##(2004-12#1)(2006-5#1)
to eliminate the##50##3##(1990-10#1)(1991-1#1)(1991-12#1)(1994-3#1)(1996-12#1)(1996-6#1)(1997-4#1)(1997-7#1)(2004-12#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-5#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#8)(2008-2#4)(2008-3#4)(2008-6#1)(2008-8#1)(2009-12#1)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#2)(2013-1#1)
to eliminate them##2##3##(1996-3#1)(2013-7#1)
to eliminate transgene expression from the##2##6##(2007-12#2)
to eliminate undesired fermentation products##2##5##(2008-6#2)
to eliminate##146##2##(1990-10#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-9#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-12#1)(2005-11#2)(2005-12#1)(2005-7#2)(2005-8#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#4)(2007-2#1)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#14)(2008-11#2)(2008-2#7)(2008-3#10)(2008-4#5)(2008-6#3)(2008-8#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-11#2)(2010-12#3)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#4)
to eliminating##2##2##(2008-3#1)(2009-10#1)
to elimination of the##3##4##(1992-3#1)(2006-10#1)(2006-5#1)
to elimination of##8##3##(1992-3#1)(1996-2#1)(1996-5#1)(1997-2#1)(2006-10#1)(2006-5#1)(2006-6#1)(2011-1#1)
to elimination##11##2##(1992-3#1)(1996-2#1)(1996-5#1)(1997-2#1)(2006-10#1)(2006-5#1)(2006-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
to elite##2##2##(2008-10#1)(2009-1#1)
to elliptical##2##2##(1992-1#1)(2006-12#1)
to elongate##2##2##(1994-11#2)
to elongation factor 1##2##4##(1991-5#1)(1994-12#1)
to elongation##3##2##(1991-5#1)(1991-6#1)(1994-12#1)
to elucidate RNA folding pathways##2##5##(2008-4#2)
to elucidate and##2##3##(2004-12#1)(2010-5#1)
to elucidate biochemical##2##3##(2013-7#2)
to elucidate how the##2##4##(1994-12#1)(2008-10#1)
to elucidate if##2##3##(2007-5#1)(2009-5#1)
to elucidate its##5##3##(2006-10#1)(2008-10#1)(2008-5#1)(2012-2#1)(2013-1#1)
to elucidate potential mechanisms##3##4##(2006-10#1)(2008-10#1)(2012-1#1)
to elucidate some of the##2##5##(2006-5#1)(2007-8#1)
to elucidate some##4##3##(1993-3#1)(2006-5#1)(2007-8#1)(2008-10#1)
to elucidate the association between##2##5##(1992-8#1)(2013-8#1)
to elucidate the cellular##2##4##(1992-4#1)(2007-12#1)
to elucidate the chemical##2##4##(2008-10#1)(2008-3#1)
to elucidate the complex##2##4##(2007-6#1)(2009-6#1)
to elucidate the difference##2##4##(2005-8#1)(2006-11#1)
to elucidate the effect of##2##5##(2008-10#1)(2012-2#1)
to elucidate the functional role of##2##6##(1993-3#1)(1995-6#1)
to elucidate the functional##3##4##(1993-3#1)(1994-3#1)(1995-6#1)
to elucidate the impact of##2##5##(1996-4#1)(2008-7#1)
to elucidate the influence of##2##5##(2009-7#1)(2012-6#1)
to elucidate the mechanism by which##4##6##(1990-7#1)(1994-5#1)(2005-8#1)(2008-11#1)
to elucidate the mechanism of##5##5##(1990-1#1)(1990-7#1)(1997-7#1)(2008-10#1)(2008-5#1)
to elucidate the mechanism underlying their##2##6##(1996-12#1)(2010-8#1)
to elucidate the mechanism underlying##3##5##(1996-12#1)(2010-8#1)(2012-2#1)
to elucidate the mechanism##12##4##(1990-1#1)(1990-7#2)(1994-5#1)(1996-12#1)(1997-7#1)(2005-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-8#1)(2012-2#1)
to elucidate the mechanisms of##6##5##(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-9#1)(2012-12#1)
to elucidate the mechanisms that##3##5##(1995-8#1)(2009-5#1)(2010-12#1)
to elucidate the mechanisms##12##4##(1995-8#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-9#1)(2012-12#1)
to elucidate the mode of##2##5##(2008-10#1)(2008-5#1)
to elucidate the molecular mechanism##2##5##(2008-10#1)(2008-8#1)
to elucidate the molecular mechanisms of##2##6##(1996-11#1)(1997-7#1)
to elucidate the molecular##4##4##(1996-11#1)(1997-7#1)(2008-10#1)(2008-8#1)
to elucidate the nature of##5##5##(1992-4#1)(1995-6#1)(2008-10#1)(2008-11#1)(2012-12#1)
to elucidate the origin of##2##5##(2006-12#1)(2008-10#1)
to elucidate the possible##4##4##(1992-4#1)(1994-6#1)(1994-8#1)(2008-5#1)
to elucidate the potential##4##4##(1995-7#1)(2010-10#1)(2011-2#2)
to elucidate the relationship between the##2##6##(1997-2#1)(1997-8#1)
to elucidate the relationship between##5##5##(1997-2#1)(1997-8#1)(2005-10#1)(2008-10#1)(2010-4#1)
to elucidate the relationships among##2##5##(2008-10#1)(2012-1#1)
to elucidate the role of different##2##6##(2008-10#1)(2009-8#1)
to elucidate the role of the##3##6##(1992-3#1)(1992-6#1)(1996-1#1)
to elucidate the role of these##3##6##(1995-2#1)(2008-10#1)(2009-5#1)
to elucidate the role of##13##5##(1992-3#1)(1992-6#1)(1995-2#1)(1996-1#2)(2007-8#1)(2008-1#1)(2008-10#2)(2009-10#1)(2009-5#1)(2009-8#1)(2013-1#1)
to elucidate the roles of##2##5##(1992-7#1)(1993-12#1)
to elucidate the structural##4##4##(1990-5#1)(1995-3#1)(1996-9#1)(1997-1#1)
to elucidate the structure of the##2##6##(1993-11#1)(2008-10#1)
to elucidate the##164##3##(1990-1#1)(1990-3#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-2#1)(1991-6#1)(1992-3#1)(1992-4#3)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#2)(1997-8#3)(2005-10#1)(2005-11#1)(2005-8#3)(2006-10#3)(2006-11#1)(2006-12#2)(2006-9#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#22)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#3)(2010-10#1)(2010-12#1)(2010-2#3)(2010-4#2)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#4)(2012-12#4)(2012-2#3)(2012-3#2)(2012-6#1)(2013-1#1)(2013-8#1)
to elucidate their##10##3##(1994-3#1)(1994-8#1)(1995-1#1)(1997-6#1)(2007-3#1)(2008-2#1)(2008-5#1)(2010-11#1)(2010-4#1)(2012-3#1)
to elucidate whether##5##3##(1992-12#1)(1997-5#1)(2007-3#1)(2007-8#1)(2013-1#1)
to elucidate##243##2##(1990-1#1)(1990-3#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#3)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#4)(1995-1#3)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-4#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#4)(2004-12#1)(2005-10#1)(2005-11#1)(2005-8#3)(2006-10#6)(2006-11#1)(2006-12#2)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#3)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-8#4)(2007-9#3)(2008-1#4)(2008-10#32)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#6)(2008-5#7)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#3)(2009-10#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#5)(2012-12#5)(2012-2#5)(2012-3#3)(2012-6#1)(2013-1#3)(2013-7#2)(2013-8#1)
to elucidating the mechanisms of##2##5##(2008-8#1)(2012-1#1)
to elucidating the##3##3##(2008-8#1)(2011-1#1)(2012-1#1)
to elucidating##4##2##(2008-8#1)(2009-12#1)(2011-1#1)(2012-1#1)
to elucidation of##2##3##(1991-7#1)(1994-3#1)
to elute the##2##3##(2007-8#1)(2008-10#1)
to elute##6##2##(1990-5#2)(2007-8#1)(2008-10#1)(2008-4#1)(2010-5#1)
to elution##2##2##(2008-10#1)(2008-4#1)
to embark on##4##3##(1994-2#1)(1996-2#1)(2008-12#1)(2008-8#1)
to embed and##2##3##(2008-11#2)
to embed##3##2##(2008-1#1)(2008-11#2)
to embolic##2##2##(2007-12#1)(2009-3#1)
to embrace the##3##3##(1994-12#1)(2008-1#1)(2010-8#1)
to embrace##11##2##(1993-6#1)(1994-1#1)(1994-12#1)(1997-2#1)(2006-5#1)(2008-1#2)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#1)
to embryonic##2##2##(1996-8#1)(2011-2#1)
to embryos##3##2##(1991-5#1)(1992-3#1)(2008-9#1)
to emerge as a##3##4##(2007-11#1)(2007-12#1)(2010-7#1)
to emerge as##4##3##(2006-10#1)(2007-11#1)(2007-12#1)(2010-7#1)
to emerge from this##4##4##(1993-3#1)(2005-10#1)(2008-11#1)(2012-12#1)
to emerge from##12##3##(1993-3#1)(1995-12#1)(1997-8#1)(2005-10#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-11#2)(2009-2#1)(2010-4#1)(2012-12#1)
to emerge in the##3##4##(1996-5#1)(2005-10#1)(2008-1#1)
to emerge in##4##3##(1996-5#1)(2005-10#1)(2007-8#1)(2008-1#1)
to emerge was that##2##4##(2005-8#1)(2007-11#1)
to emerge##51##2##(1993-3#2)(1994-11#1)(1995-12#2)(1995-9#1)(1996-3#1)(1996-5#1)(1997-8#1)(2005-10#2)(2005-8#1)(2006-10#4)(2006-9#2)(2007-11#3)(2007-12#4)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-11#3)(2008-3#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-8#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#2)
to emergence of##3##3##(1996-1#1)(2006-12#1)(2012-2#1)
to emergency medicine##2##3##(2007-3#1)(2007-5#1)
to emergency##16##2##(1991-12#1)(1992-9#1)(1997-8#1)(2006-4#1)(2006-8#1)(2007-3#1)(2007-5#1)(2008-11#1)(2008-4#1)(2008-6#2)(2009-1#1)(2009-4#1)(2011-1#3)
to emergent##3##2##(2006-10#1)(2008-5#1)(2008-9#1)
to emerging health##2##3##(2008-7#1)(2012-2#1)
to emerging infectious diseases##2##4##(2007-12#2)
to emerging##9##2##(2007-12#2)(2008-10#2)(2008-7#1)(2010-3#1)(2010-8#1)(2010-9#1)(2012-2#1)
to emissions from the vehicles##2##5##(2004-4#2)
to emit a##2##3##(1993-2#1)(2012-2#1)
to emit light##2##3##(2008-2#1)(2008-4#1)
to emit##7##2##(1990-7#1)(1993-2#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-2#1)
to emotion##2##2##(2010-3#1)(2012-12#1)
to emotional and##2##3##(2004-12#1)(2013-1#1)
to emotional processes##2##3##(1993-5#1)(2006-3#1)
to emotional well-being##2##3##(2012-12#1)(2013-1#1)
to emotional##22##2##(1992-3#1)(1993-5#1)(1995-12#3)(2004-12#1)(2006-3#1)(2007-10#1)(2007-11#2)(2008-11#3)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#3)(2013-1#2)(2013-8#1)
to emotionally##2##2##(1990-10#1)(2007-11#1)
to emphasize that the##2##4##(1997-1#1)(2008-2#1)
to emphasize that##8##3##(1991-9#1)(1994-11#1)(1997-1#1)(2007-8#1)(2008-2#1)(2008-4#1)(2011-1#1)(2012-2#1)
to emphasize the importance of##3##5##(2008-12#1)(2008-8#1)(2013-1#1)
to emphasize the##18##3##(1992-3#1)(1994-11#1)(1995-4#1)(1996-5#2)(2004-2#1)(2007-8#2)(2008-12#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-11#1)(2010-4#1)(2012-12#2)(2013-1#2)
to emphasize##37##2##(1991-9#1)(1992-3#2)(1993-9#1)(1994-11#2)(1995-4#1)(1996-12#1)(1996-5#2)(1997-1#1)(2004-2#1)(2004-3#1)(2006-10#1)(2007-8#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-4#1)(2011-1#2)(2012-12#4)(2012-2#2)(2013-1#3)
to emphysema##2##2##(1997-8#1)(2005-8#1)
to empirical phylogenetic study##2##4##(2010-6#2)
to empirical##5##2##(2007-3#1)(2008-8#2)(2010-6#2)
to empirically##3##2##(2006-10#1)(2008-5#1)(2012-3#1)
to employ a##9##3##(1990-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-11#1)(2013-1#2)
to employ in the##2##4##(2012-12#1)(2013-8#1)
to employ in##3##3##(2007-9#1)(2012-12#1)(2013-8#1)
to employ these methods in##2##5##(2008-8#1)(2010-12#1)
to employ##34##2##(1990-12#1)(1990-2#3)(1990-9#1)(1994-12#1)(1994-6#1)(1995-4#1)(1996-6#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2009-2#1)(2010-1#1)(2010-11#1)(2010-12#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
to employee##5##2##(1993-2#1)(1995-2#1)(1996-5#1)(1997-3#1)(2011-1#1)
to employees with##2##3##(1996-11#1)(2010-2#1)
to employees##8##2##(1991-2#1)(1993-3#1)(1994-1#1)(1994-3#1)(1996-11#1)(1996-3#1)(2007-10#1)(2010-2#1)
to employers and##2##3##(1994-1#1)(2008-3#1)
to employment##3##2##(2009-9#1)(2010-2#2)
to empower##5##2##(1992-3#1)(2006-2#1)(2007-2#1)(2010-12#1)(2011-2#1)
to empty##2##2##(2008-7#1)(2012-12#1)
to emulate##6##2##(1994-12#1)(2006-12#1)(2008-3#1)(2010-5#1)(2012-1#1)(2012-12#1)
to enable a##8##3##(2007-5#1)(2007-7#1)(2008-11#1)(2008-2#2)(2008-7#1)(2012-1#1)(2013-1#1)
to enable an##2##3##(1991-5#1)(2006-5#1)
to enable future##2##3##(1990-12#1)(2007-8#1)
to enable health##3##3##(2008-11#1)(2008-2#1)(2013-1#1)
to enable informed##3##3##(1994-7#1)(2005-10#1)(2009-4#1)
to enable nursing##2##3##(2007-11#1)(2010-9#1)
to enable older people to remain##2##6##(2013-1#2)
to enable older##3##3##(2013-1#3)
to enable people##2##3##(2010-2#1)(2013-1#1)
to enable researchers to##2##4##(2008-11#1)(2010-3#1)
to enable students##2##3##(2008-11#1)(2008-12#1)
to enable the sensitive##2##4##(2008-10#2)
to enable the##26##3##(1994-2#1)(1995-1#1)(1995-4#1)(1997-4#1)(1997-6#1)(2005-7#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-10#2)
to enable them to##4##4##(1994-9#1)(2005-5#1)(2011-2#1)(2012-1#1)
to enable us to##2##4##(2008-7#1)(2010-12#1)
to enable us##3##3##(2007-1#1)(2008-7#1)(2010-12#1)
to enable women##2##3##(2010-12#1)(2011-1#1)
to enable##138##2##(1990-12#1)(1991-11#1)(1991-5#1)(1993-12#1)(1994-2#1)(1994-7#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-2#2)(1996-3#1)(1997-4#1)(1997-6#1)(2005-10#2)(2005-12#1)(2005-5#1)(2005-7#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-1#2)(2007-11#4)(2007-12#1)(2007-2#1)(2007-5#2)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#10)(2008-11#10)(2008-12#4)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#2)(2009-12#3)(2009-2#1)(2009-4#3)(2009-9#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#4)(2012-2#3)(2012-3#1)(2013-1#11)
to enact##5##2##(1991-2#1)(1995-12#1)(2008-11#1)(2010-2#1)(2011-1#1)
to enantiomerically pure L-amino acids##3##5##(1992-11#1)(1995-3#2)
to encapsulate##6##2##(2005-11#1)(2005-12#1)(2006-12#1)(2008-4#1)(2010-1#1)(2013-1#1)
to enclose##2##2##(1995-8#1)(2007-12#1)
to encode a novel##2##4##(1992-4#1)(2007-7#1)
to encode a protein of##7##5##(1990-8#1)(1991-7#1)(1993-12#1)(1995-8#1)(1996-6#1)(1996-9#1)(2008-10#1)
to encode a##32##3##(1990-10#1)(1990-6#1)(1990-8#1)(1991-7#1)(1992-4#2)(1993-12#2)(1994-12#2)(1995-6#1)(1995-8#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-4#2)(1997-6#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-2#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)
to encode an##3##3##(1992-10#1)(2008-2#1)(2008-3#1)
to encode its##2##3##(1990-8#1)(1991-12#1)
to encode proteins##2##3##(1994-9#1)(1995-8#1)
to encode the##11##3##(1990-10#1)(1990-2#1)(1994-12#2)(1995-1#1)(1996-5#1)(2008-3#1)(2008-7#1)(2009-4#1)(2011-2#2)
to encode##74##2##(1990-10#2)(1990-2#1)(1990-6#1)(1990-8#2)(1991-12#1)(1991-7#1)(1992-10#1)(1992-4#2)(1992-7#1)(1993-12#2)(1993-9#1)(1994-12#4)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-6#1)(1995-8#3)(1996-10#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-4#2)(1997-6#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#4)(2008-3#5)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
to encompass the##3##3##(1993-7#1)(1997-2#1)(2011-2#1)
to encompass##16##2##(1991-1#1)(1993-11#1)(1993-7#1)(1994-11#1)(1995-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(2005-8#1)(2006-10#2)(2007-5#1)(2008-8#1)(2010-9#1)(2011-2#1)(2012-2#1)
to encounter##6##2##(1991-12#1)(1994-11#1)(2007-3#1)(2008-10#1)(2008-9#1)(2012-12#1)
to encourage and##3##3##(1991-2#1)(1994-12#1)(2008-9#1)
to encourage interest##2##3##(2005-10#1)(2008-5#1)
to encourage new##2##3##(2008-4#1)(2008-6#1)
to encourage nursing##2##3##(2008-11#1)(2010-10#1)
to encourage physical activity##2##4##(2011-2#1)(2012-11#1)
to encourage the use of##2##5##(1996-1#1)(2008-11#1)
to encourage the##9##3##(1994-3#1)(1996-1#1)(2007-4#1)(2008-1#1)(2008-11#1)(2009-7#1)(2010-1#1)(2013-1#1)(2013-8#1)
to encourage##72##2##(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(1993-1#1)(1994-1#1)(1994-12#1)(1994-3#2)(1994-4#1)(1994-7#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-3#2)(1997-6#1)(2005-10#1)(2005-6#1)(2006-10#1)(2006-4#1)(2006-7#2)(2007-10#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-11#6)(2008-12#1)(2008-3#2)(2008-4#5)(2008-5#2)(2008-6#1)(2008-9#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#2)
to encouraging##2##2##(2007-8#1)(2008-10#1)
to end of##2##3##(1997-4#1)(2008-10#1)
to end stage renal disease (ESRD)##2##6##(2007-7#1)(2008-1#1)
to end stage renal disease##3##5##(2007-7#2)(2008-1#1)
to end users##2##3##(1993-3#1)(1995-3#1)
to end##21##2##(1991-6#1)(1992-6#1)(1993-3#1)(1993-5#1)(1995-12#2)(1995-3#1)(1996-3#1)(1997-4#1)(1997-6#1)(2006-6#1)(2007-3#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2012-1#1)(2012-12#2)
to end-organ##3##2##(2005-6#1)(2008-1#1)(2011-1#1)
to end-stage renal disease##4##4##(2008-1#2)(2010-10#1)(2013-7#1)
to end-stage renal failure##4##4##(2006-8#2)(2008-1#1)(2012-12#1)
to end-stage renal##9##3##(2006-8#2)(2008-1#3)(2008-7#1)(2010-10#1)(2012-12#1)(2013-7#1)
to end-stage##13##2##(2005-8#1)(2006-10#1)(2006-8#2)(2008-1#3)(2008-7#1)(2010-10#2)(2012-12#1)(2012-3#1)(2013-7#1)
to endemic areas##6##3##(2006-10#2)(2007-2#1)(2008-10#1)(2011-1#1)(2011-2#1)
to endemic##7##2##(2006-10#2)(2007-2#2)(2008-10#1)(2011-1#1)(2011-2#1)
to endo-beta-N-acetylglucosaminidase H##2##3##(1990-12#1)(1994-10#1)
to endocarditis##2##2##(1995-2#1)(2007-8#1)
to endocrine cells##3##3##(1993-7#1)(2008-7#1)(2008-8#1)
to endocrine therapy##3##3##(1993-9#1)(1996-4#1)(2007-10#1)
to endocrine##15##2##(1993-7#1)(1993-9#1)(1996-4#1)(1996-6#1)(2007-10#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-12#1)(2013-1#1)
to endogenous and##2##3##(2008-5#1)(2009-9#1)
to endogenous levels##2##3##(1995-2#1)(2008-10#1)
to endogenous##22##2##(1991-1#1)(1992-12#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-5#1)(1995-10#1)(1995-2#1)(1997-5#1)(2005-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#2)(2009-12#1)(2009-3#1)(2009-9#1)(2010-11#1)(2012-12#1)(2012-2#1)
to endometrial##5##2##(1994-9#1)(1996-3#1)(2007-10#1)(2007-3#1)(2011-2#1)
to endometriosis##5##2##(1996-8#1)(2006-4#1)(2008-3#2)(2010-2#1)
to endophytic sites##2##3##(2008-10#2)
to endorse##5##2##(1990-12#1)(1992-10#1)(2010-3#1)(2013-1#2)
to endorsement of##2##3##(2007-6#1)(2008-9#1)
to endoscopic sphincterotomy##2##3##(2006-2#1)(2007-8#1)
to endoscopic surgery##2##3##(1994-9#1)(2006-6#1)
to endoscopic treatment##2##3##(1993-6#1)(2007-5#1)
to endoscopic##17##2##(1993-6#1)(1994-9#1)(2006-10#1)(2006-2#2)(2006-6#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-2#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-3#1)
to endoscopy##5##2##(1991-11#1)(2005-11#1)(2006-8#1)(2007-3#1)(2007-8#1)
to endothelial cell##2##3##(1993-3#1)(2008-1#1)
to endothelial cells was##2##4##(1991-2#1)(1992-12#1)
to endothelial cells##17##3##(1991-2#2)(1992-12#2)(1994-5#1)(1994-8#1)(1995-12#2)(1996-3#1)(1997-1#2)(1997-2#1)(1997-7#1)(2008-12#1)(2009-3#2)(2011-2#1)
to endothelial dysfunction##3##3##(2008-3#1)(2009-10#1)(2010-10#1)
to endothelial##26##2##(1991-2#2)(1992-12#2)(1992-6#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-12#2)(1996-3#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-12#1)(2008-3#1)(2009-10#1)(2009-3#2)(2010-10#1)(2011-2#2)
to endothelin##7##2##(1990-2#2)(1990-9#2)(1994-11#2)(1996-12#1)
to endothelin-1 in##3##3##(1991-1#1)(1991-6#2)
to endothelin-1##16##2##(1990-8#3)(1991-1#1)(1991-6#4)(1991-7#1)(1995-1#2)(1995-12#4)(2009-11#1)
to endothelium##7##2##(1991-2#1)(1992-12#2)(1995-2#2)(2008-4#1)(2012-2#1)
to endotoxin##6##2##(1991-9#1)(1996-10#1)(1996-12#1)(2007-11#1)(2013-1#2)
to endotracheal intubation##3##3##(1995-4#2)(2006-10#1)
to endurance##2##2##(2008-5#1)(2008-7#1)
to endure##2##2##(2007-9#1)(2008-8#1)
to energetic##2##2##(1991-11#1)(2008-2#1)
to energy acquisition (food intake)##2##5##(1995-12#2)
to energy and##2##3##(2005-8#1)(2012-2#1)
to energy intake##2##3##(2009-8#1)(2010-8#1)
to energy##14##2##(1995-12#2)(2005-3#1)(2005-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-8#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#2)
to energy-matched continuous exercise##2##4##(2013-8#2)
to enforce the##2##3##(1993-12#1)(2006-8#1)
to enforce these##2##3##(2007-3#1)(2009-4#1)
to enforce##16##2##(1992-1#1)(1993-12#1)(1997-4#1)(2006-8#1)(2007-10#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-4#1)(2010-9#1)(2012-12#2)(2013-1#3)
to engage and##2##3##(2007-11#1)(2012-3#1)
to engage children##3##3##(2006-10#1)(2013-1#2)
to engage consumers##2##3##(2013-1#2)
to engage in &quot##2##4##(1990-2#1)(2007-12#1)
to engage in health disparities research##2##6##(2012-3#2)
to engage in more##2##4##(2006-7#1)(2009-4#1)
to engage in multiple##2##4##(2006-11#1)(2011-2#1)
to engage in risky##2##4##(2007-7#1)(2008-3#1)
to engage in the##3##4##(2006-5#1)(2008-12#1)(2013-7#1)
to engage in treatment##2##4##(2013-1#2)
to engage in##52##3##(1990-2#1)(1992-6#1)(1993-7#1)(1994-3#1)(1997-3#1)(2005-8#1)(2005-9#1)(2006-11#1)(2006-3#1)(2006-5#1)(2006-7#2)(2007-11#1)(2007-12#3)(2007-7#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#4)(2008-3#1)(2008-4#1)(2009-4#2)(2009-5#1)(2009-7#2)(2010-12#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-3#7)(2013-1#5)(2013-7#2)(2013-8#1)
to engage patients##2##3##(2008-3#1)(2012-1#1)
to engage the##6##3##(1996-2#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-7#1)(2012-1#1)
to engage youth##3##3##(2008-7#2)(2012-2#1)
to engage##87##2##(1990-2#1)(1992-6#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-3#1)(1996-2#1)(1997-3#1)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-3#1)(2006-5#1)(2006-7#2)(2007-10#1)(2007-11#2)(2007-12#4)(2007-7#2)(2007-8#1)(2008-1#2)(2008-11#2)(2008-12#6)(2008-3#2)(2008-4#1)(2008-7#4)(2009-4#2)(2009-5#1)(2009-7#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#3)(2012-2#6)(2012-3#9)(2013-1#10)(2013-7#2)(2013-8#1)
to engagement##2##2##(2005-10#1)(2011-2#1)
to engender##2##2##(1991-12#1)(2009-4#1)
to engineer a##3##3##(2006-6#1)(2008-11#2)
to engineer the##3##3##(2006-5#1)(2010-12#1)(2012-2#1)
to engineer##25##2##(1994-6#1)(2006-5#2)(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#4)(2008-5#1)(2008-7#1)(2009-6#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-11#2)(2012-2#2)
to engraft##5##2##(1995-12#1)(2008-11#1)(2010-11#2)(2012-12#1)
to enhance CRC survivorship##2##4##(2008-7#2)
to enhance a variety of##2##5##(1994-3#1)(2010-9#1)
to enhance a##3##3##(1994-3#1)(1997-8#1)(2010-9#1)
to enhance adenoviral##2##3##(2008-6#2)
to enhance an##2##3##(2008-10#1)(2008-5#1)
to enhance and##3##3##(2008-2#1)(2008-4#1)(2010-12#1)
to enhance antibody##2##3##(1995-12#1)(1996-10#1)
to enhance bone##2##3##(2008-8#1)(2009-8#1)
to enhance both##2##3##(2011-1#1)(2013-8#1)
to enhance cell growth and##2##5##(2008-11#2)
to enhance communication##3##3##(1991-12#1)(1996-7#1)(2012-1#1)
to enhance equity##2##3##(2008-1#1)(2012-1#1)
to enhance fungicide resistance in##2##5##(2011-12#2)
to enhance future##2##3##(2011-1#1)(2012-12#1)
to enhance injury##2##3##(2006-11#1)(2010-12#1)
to enhance it##2##3##(1994-5#1)(2010-5#1)
to enhance its##4##3##(1991-4#1)(1995-3#1)(2008-3#1)(2008-4#1)
to enhance learning and memory##2##5##(2008-1#1)(2012-2#1)
to enhance learning##3##3##(2008-1#1)(2008-11#1)(2012-2#1)
to enhance medication safety for##2##5##(2010-8#2)
to enhance medication safety##3##4##(2010-8#2)(2011-1#1)
to enhance medication##4##3##(2010-8#2)(2011-1#1)(2013-8#1)
to enhance or##2##3##(1995-3#1)(2008-5#1)
to enhance our understanding of##3##5##(2008-7#1)(2009-5#1)(2010-3#1)
to enhance our understanding##4##4##(2005-11#1)(2008-7#1)(2009-5#1)(2010-3#1)
to enhance our##5##3##(2005-11#1)(2008-10#1)(2008-7#1)(2009-5#1)(2010-3#1)
to enhance patient care##2##4##(2008-10#1)(2008-11#1)
to enhance patient##7##3##(1997-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2010-2#1)(2010-3#2)
to enhance performance##2##3##(2006-9#1)(2008-10#1)
to enhance plant##2##3##(2008-10#2)
to enhance primary##3##3##(2008-7#1)(2010-11#2)
to enhance professional##2##3##(2008-12#1)(2013-8#1)
to enhance quality of##2##4##(1996-12#1)(1996-2#1)
to enhance research##2##3##(2007-4#1)(2007-6#1)
to enhance self-efficacy##2##3##(2012-12#2)
to enhance specific##2##3##(2008-1#1)(2008-10#1)
to enhance student learning##2##4##(2008-11#1)(2008-12#1)
to enhance student##3##3##(2008-11#2)(2008-12#1)
to enhance successful##2##3##(1992-3#1)(2008-8#1)
to enhance survival##2##3##(1994-5#1)(2011-2#1)
to enhance survivorship##2##3##(2008-11#1)(2008-7#1)
to enhance systemic##2##3##(2008-10#1)(2009-8#1)
to enhance the CL##2##4##(2008-10#2)
to enhance the accuracy##2##4##(2008-10#2)
to enhance the antiproliferative##2##4##(1990-2#1)(1991-4#1)
to enhance the cell##2##4##(1993-8#1)(2008-11#1)
to enhance the contrast##2##4##(2008-1#1)(2008-3#1)
to enhance the detection of##2##5##(1994-3#2)
to enhance the detection##3##4##(1994-3#2)(2008-3#1)
to enhance the effectiveness of##5##5##(1993-4#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-6#1)
to enhance the efficacy of##2##5##(2008-9#1)(2010-3#1)
to enhance the efficiency of##2##5##(2008-10#1)(2010-5#1)
to enhance the efficiency##3##4##(2008-10#1)(2008-2#1)(2010-5#1)
to enhance the expression of##2##5##(1991-10#1)(1994-5#1)
to enhance the image##2##4##(2009-10#1)(2011-1#1)
to enhance the in##2##4##(2007-11#1)(2010-12#1)
to enhance the intensity##2##4##(2008-1#1)(2011-1#1)
to enhance the learning##2##4##(2011-2#1)(2012-2#1)
to enhance the number##3##4##(2007-8#1)(2008-11#1)(2010-4#1)
to enhance the overall##2##4##(2008-12#1)(2008-7#1)
to enhance the productivity##2##4##(1990-11#1)(2008-11#1)
to enhance the rate of##2##5##(1991-2#1)(2008-1#1)
to enhance the rate##3##4##(1991-2#1)(1992-8#1)(2008-1#1)
to enhance the responses##2##4##(1995-12#1)(2011-1#1)
to enhance the secretion of##3##5##(1991-2#1)(2008-11#2)
to enhance the sensitivity of##4##5##(2007-8#1)(2008-10#2)(2009-4#1)
to enhance the sensitivity##6##4##(1994-6#1)(2007-8#1)(2008-10#2)(2008-2#1)(2009-4#1)
to enhance the separation of##2##5##(1994-9#1)(2008-10#1)
to enhance the signal-to-noise ratio##2##5##(2007-8#1)(2008-10#1)
to enhance the signal-to-noise##3##4##(2007-8#2)(2008-10#1)
to enhance the##184##3##(1990-11#1)(1990-2#1)(1990-3#2)(1991-1#1)(1991-10#1)(1991-2#2)(1991-4#1)(1991-6#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-12#2)(1993-3#2)(1993-4#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-9#1)(1995-12#3)(1995-3#1)(1996-1#1)(1996-12#2)(1997-2#1)(1997-5#2)(2004-12#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-6#1)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#5)(2007-2#1)(2007-4#2)(2007-8#6)(2008-1#5)(2008-10#22)(2008-11#12)(2008-12#6)(2008-2#4)(2008-3#10)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#4)(2011-12#1)(2011-2#3)(2012-1#4)(2012-12#4)(2012-2#2)(2012-3#3)(2013-8#1)
to enhance their##14##3##(1990-12#1)(1992-3#1)(2006-1#1)(2008-1#1)(2008-10#1)(2008-12#3)(2008-6#1)(2009-3#1)(2010-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
to enhance training##2##3##(2007-8#1)(2008-5#1)
to enhance understanding of##3##4##(2007-10#1)(2011-2#1)(2013-1#1)
to enhance##489##2##(1990-11#1)(1990-12#2)(1990-2#6)(1990-3#2)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#3)(1991-4#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#5)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#5)(1995-2#1)(1995-3#4)(1995-5#1)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#4)(1996-2#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#3)(1997-7#1)(1997-8#3)(2004-12#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#6)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#4)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#10)(2007-12#9)(2007-2#1)(2007-4#4)(2007-6#1)(2007-7#4)(2007-8#11)(2007-9#1)(2008-1#12)(2008-10#45)(2008-11#25)(2008-12#12)(2008-2#8)(2008-3#17)(2008-4#7)(2008-5#14)(2008-6#8)(2008-7#15)(2008-8#6)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#3)(2009-4#4)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#4)(2010-1#3)(2010-10#1)(2010-11#6)(2010-12#5)(2010-2#4)(2010-3#6)(2010-4#3)(2010-5#5)(2010-6#1)(2010-7#2)(2010-8#6)(2010-9#1)(2011-1#9)(2011-12#4)(2011-2#9)(2011-9#1)(2012-1#8)(2012-11#2)(2012-12#9)(2012-2#11)(2012-3#5)(2012-4#1)(2013-1#13)(2013-7#1)(2013-8#6)
to enhanced immune##2##3##(2007-11#1)(2009-4#1)
to enhanced##44##2##(1990-10#1)(1990-8#1)(1991-10#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1995-6#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-7#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#4)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2012-2#1)(2012-5#1)(2013-1#2)
to enhancement of##4##3##(1991-5#1)(2008-10#1)(2010-12#1)(2011-2#1)
to enhancement##5##2##(1991-5#1)(2008-10#1)(2010-12#1)(2010-7#1)(2011-2#1)
to enhancing the##2##3##(2007-12#1)(2008-5#1)
to enhancing##7##2##(1991-2#1)(2007-10#1)(2007-12#2)(2008-5#1)(2010-11#2)
to enjoin##2##2##(1990-5#1)(1995-9#1)
to enjoy##6##2##(1991-12#1)(2008-1#1)(2008-11#1)(2008-9#1)(2011-1#1)(2011-2#1)
to enlarge the##4##3##(1991-5#1)(2008-10#1)(2008-2#1)(2013-7#1)
to enrich for##4##3##(2008-1#1)(2008-4#3)
to enrich the##5##3##(1997-3#1)(2007-8#1)(2008-11#1)(2012-3#1)(2013-1#1)
to enrich##22##2##(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#4)(2008-7#2)(2008-9#1)(2010-1#1)(2010-12#2)(2010-3#1)(2012-1#1)(2012-3#1)(2013-1#1)
to enrichment##2##2##(2007-3#1)(2008-8#1)
to enrofloxacin##2##2##(2008-5#1)(2011-1#1)
to enrol their children in##2##5##(2009-6#2)
to enrol##4##2##(2009-6#3)(2010-9#1)
to enroll in##3##3##(1994-3#1)(2007-12#1)(2008-3#1)
to enroll##8##2##(1994-3#1)(1995-12#1)(2007-10#2)(2007-12#1)(2007-7#1)(2008-3#1)(2008-5#1)
to ensure a complete##2##4##(1992-1#1)(2004-3#1)
to ensure a good##2##4##(2008-2#2)
to ensure a high##2##4##(2012-3#2)
to ensure a smooth transition##2##5##(2005-10#1)(2008-6#1)
to ensure a stronger##2##4##(1990-10#1)(1996-3#1)
to ensure a##25##3##(1990-10#1)(1992-1#1)(1993-5#1)(1995-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(2004-3#1)(2004-5#1)(2005-10#1)(2006-9#1)(2007-12#1)(2007-7#1)(2008-12#1)(2008-2#2)(2008-6#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#2)
to ensure access to##2##4##(2008-5#1)(2010-1#1)
to ensure accuracy##2##3##(2008-3#1)(2008-4#1)
to ensure adequate##8##3##(1990-5#1)(1995-8#1)(2005-11#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)
to ensure an##3##3##(2010-3#1)(2012-2#2)
to ensure and##2##3##(2007-7#1)(2010-9#1)
to ensure appropriate patient selection##3##5##(2010-9#3)
to ensure appropriate##9##3##(1994-3#1)(2008-10#1)(2009-4#1)(2010-9#4)(2011-1#1)(2013-8#1)
to ensure better##2##3##(2010-12#1)(2013-8#1)
to ensure complete##6##3##(2004-3#1)(2008-10#1)(2008-11#2)(2010-11#1)(2013-1#1)
to ensure compliance##2##3##(2006-8#1)(2012-3#1)
to ensure continuity##3##3##(1993-1#1)(2012-11#1)(2012-3#1)
to ensure control##2##3##(1993-12#1)(1993-6#1)
to ensure effective##3##3##(1997-3#1)(2007-3#1)(2013-1#1)
to ensure future##2##3##(2011-1#2)
to ensure good##2##3##(1996-12#1)(2010-10#1)
to ensure high quality##2##4##(1995-6#1)(2008-11#1)
to ensure high##4##3##(1995-6#1)(2008-11#1)(2008-3#1)(2012-12#1)
to ensure it##2##3##(2008-1#1)(2008-11#1)
to ensure its##5##3##(1994-9#1)(2008-10#2)(2008-5#1)(2011-2#1)
to ensure normal##2##3##(2010-2#1)(2012-3#1)
to ensure optimal##3##3##(2008-10#1)(2008-6#1)(2010-10#1)
to ensure proper##4##3##(1991-11#1)(2006-5#1)(2008-11#1)(2008-4#1)
to ensure safe##5##3##(2004-5#1)(2006-10#1)(2011-2#1)(2013-1#2)
to ensure safety and##2##4##(1994-12#1)(2011-2#1)
to ensure success##2##3##(2008-10#1)(2008-2#1)
to ensure successful##2##3##(2010-3#1)(2011-1#1)
to ensure that a##10##4##(1993-3#1)(1993-4#1)(1996-3#1)(2008-11#1)(2008-2#2)(2008-7#1)(2013-1#2)(2013-7#1)
to ensure that all##3##4##(1996-12#1)(2012-3#1)(2013-1#1)
to ensure that an##2##4##(1996-9#1)(2008-9#1)
to ensure that changes in##2##5##(2008-11#1)(2010-8#1)
to ensure that each##2##4##(1993-2#1)(2012-3#1)
to ensure that health care##2##5##(2007-6#1)(2010-1#1)
to ensure that no##2##4##(2007-8#1)(2008-11#1)
to ensure that populations##2##4##(2009-6#1)(2013-1#1)
to ensure that staff##2##4##(2005-5#1)(2012-12#1)
to ensure that the needs##2##5##(1996-2#1)(2007-4#1)
to ensure that the##33##4##(1990-12#1)(1992-6#1)(1994-2#1)(1994-3#1)(1994-7#1)(1996-11#1)(1996-2#1)(1997-8#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2010-12#1)(2010-3#1)(2012-2#1)(2013-1#4)
to ensure that their##3##4##(2007-11#1)(2010-12#1)(2010-2#1)
to ensure that they are##5##5##(2006-7#1)(2007-12#1)(2007-2#1)(2008-12#1)(2011-2#1)
to ensure that they##7##4##(2006-7#2)(2007-12#1)(2007-2#1)(2008-12#1)(2011-2#2)
to ensure that this##2##4##(1995-5#1)(2009-10#1)
to ensure that women##2##4##(2007-4#1)(2007-7#1)
to ensure that##132##3##(1990-12#1)(1990-5#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-2#2)(1994-3#1)(1994-7#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-8#1)(2005-10#1)(2005-5#2)(2005-9#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#3)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-4#3)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#10)(2008-12#2)(2008-2#5)(2008-3#6)(2008-4#5)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#5)(2009-10#2)(2009-4#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#13)(2013-7#1)
to ensure the best possible##2##5##(2005-9#1)(2013-1#1)
to ensure the best##3##4##(2005-9#1)(2008-10#1)(2013-1#1)
to ensure the convergence##2##4##(2007-12#1)(2013-1#1)
to ensure the maintenance of##2##5##(2008-5#1)(2013-7#1)
to ensure the proper##2##4##(1994-12#1)(2008-7#1)
to ensure the risk##2##4##(2007-11#1)(2008-10#1)
to ensure the safety of##4##5##(1991-1#1)(2008-4#1)(2008-9#1)(2011-2#1)
to ensure the success of##2##5##(2007-11#1)(2008-10#1)
to ensure the validity of the##2##6##(2008-2#1)(2008-4#1)
to ensure the##53##3##(1991-1#1)(1991-5#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-7#1)(1995-12#1)(1996-2#1)(1997-1#1)(2005-11#1)(2005-7#2)(2005-9#1)(2006-1#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#1)(2010-10#1)(2010-12#1)(2010-5#3)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)(2012-9#1)(2013-1#2)(2013-7#1)
to ensure their##3##3##(2007-4#1)(2008-6#1)(2008-9#1)
to ensure they##2##3##(1994-2#1)(2013-1#1)
to ensure##407##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-7#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#2)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#3)(1994-7#2)(1994-9#1)(1995-1#2)(1995-12#3)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#3)(1996-12#2)(1996-2#4)(1996-3#3)(1996-6#1)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-2#1)(2004-3#2)(2004-5#2)(2005-10#3)(2005-11#2)(2005-5#2)(2005-7#2)(2005-9#2)(2006-1#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#4)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#7)(2007-2#3)(2007-3#2)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#5)(2007-9#2)(2008-1#3)(2008-10#21)(2008-11#23)(2008-12#6)(2008-2#11)(2008-3#12)(2008-4#11)(2008-5#7)(2008-6#4)(2008-7#5)(2008-8#3)(2008-9#11)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#4)(2010-11#3)(2010-12#5)(2010-2#4)(2010-3#4)(2010-4#1)(2010-5#5)(2010-7#2)(2010-8#1)(2010-9#6)(2011-1#8)(2011-12#2)(2011-2#9)(2012-1#1)(2012-11#3)(2012-12#8)(2012-2#12)(2012-3#9)(2012-9#1)(2013-1#24)(2013-7#2)(2013-8#4)
to ensuring##9##2##(1990-12#1)(1992-3#1)(1996-11#1)(1997-2#1)(2007-12#2)(2008-10#2)(2008-12#1)
to enter S##2##3##(1990-11#1)(1996-4#1)
to enter a##2##3##(1994-5#1)(2008-11#1)
to enter clinical trials##2##4##(2005-7#1)(2005-8#1)
to enter into the##2##4##(1991-2#1)(2008-5#1)
to enter into##7##3##(1990-12#1)(1991-2#1)(1991-3#1)(1993-3#1)(2006-12#1)(2007-11#1)(2008-5#1)
to enter the brain##3##4##(1996-4#2)(2007-11#1)
to enter the medical##2##4##(2008-12#1)(2012-3#1)
to enter the study##2##4##(1990-5#1)(2007-7#1)
to enter the##26##3##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#2)(1992-12#1)(1996-4#2)(1997-2#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-2#1)(2011-2#1)(2012-3#1)
to enter##62##2##(1990-11#1)(1990-12#2)(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#1)(1992-12#2)(1992-5#1)(1993-10#1)(1993-3#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1996-12#1)(1996-3#1)(1996-4#3)(1997-2#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#2)(2007-11#2)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)
to enteral nutrition##2##3##(2006-10#2)
to enteral##3##2##(2005-10#1)(2006-10#2)
to enteric##5##2##(1990-5#1)(2006-10#2)(2008-5#1)(2012-12#1)
to entering##7##2##(1993-1#1)(1994-12#1)(1994-3#1)(1997-3#1)(2006-5#1)(2008-11#1)(2011-1#1)
to enterprise##3##2##(2006-7#1)(2008-12#2)
to entrain a##2##3##(1994-11#1)(2012-12#1)
to entrain##3##2##(1994-11#1)(2006-9#1)(2012-12#1)
to entrapment##2##2##(2008-5#1)(2011-2#1)
to entry##5##2##(1990-12#1)(1995-3#1)(1997-6#1)(2006-12#1)(2009-4#1)
to enumerate##2##2##(2008-4#1)(2010-8#1)
to environment##4##2##(2008-1#1)(2008-10#1)(2008-12#1)(2011-12#1)
to environmental and##3##3##(2008-12#1)(2008-8#1)(2011-1#1)
to environmental carcinogens##2##3##(2010-12#1)(2011-2#1)
to environmental challenges##2##3##(2009-9#1)(2013-8#1)
to environmental changes and##2##4##(2009-8#1)(2012-3#1)
to environmental changes##9##3##(1994-12#1)(1995-1#1)(2007-3#1)(2008-9#1)(2009-6#1)(2009-8#1)(2012-3#1)(2013-8#2)
to environmental conditions##10##3##(1990-6#1)(1994-9#1)(1995-8#1)(2006-3#1)(2007-3#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
to environmental cues and##2##4##(2012-1#1)(2012-12#1)
to environmental cues##5##3##(2009-6#1)(2012-1#2)(2012-12#1)(2012-2#1)
to environmental factors are##2##4##(2011-2#1)(2012-5#1)
to environmental factors such as##2##5##(2008-10#1)(2013-1#1)
to environmental factors##15##3##(1991-4#1)(2006-1#1)(2006-2#1)(2008-10#3)(2008-5#2)(2010-12#1)(2011-2#1)(2012-3#2)(2012-5#1)(2013-1#2)
to environmental features of##2##4##(2008-8#1)(2012-9#1)
to environmental fluctuations##3##3##(2008-8#2)(2009-8#1)
to environmental hazards##2##3##(1996-1#1)(2010-9#1)
to environmental influences##2##3##(2007-12#1)(2012-12#1)
to environmental pollutants##3##3##(1992-4#1)(2004-4#1)(2011-2#1)
to environmental samples##6##3##(2007-8#1)(2008-10#3)(2011-1#1)(2011-2#1)
to environmental stimuli##4##3##(1991-6#1)(1992-6#1)(2008-7#1)(2009-11#1)
to environmental stress##5##3##(1994-3#2)(1996-8#1)(2010-4#1)(2012-2#1)
to environmental stresses##3##3##(2008-1#1)(2009-8#1)(2013-8#1)
to environmental stressors##4##3##(2010-4#3)(2012-2#1)
to environmental tobacco smoke##5##4##(1993-2#1)(1995-6#1)(2005-10#1)(2007-8#1)(2008-1#1)
to environmental toxins##2##3##(2008-7#1)(2011-12#1)
to environmental##122##2##(1990-6#1)(1991-4#1)(1991-6#1)(1992-12#1)(1992-4#1)(1992-6#2)(1993-2#1)(1994-12#1)(1994-3#2)(1994-9#2)(1995-1#1)(1995-11#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-8#1)(1996-9#1)(2004-4#1)(2005-10#1)(2006-1#1)(2006-2#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-12#2)(2007-3#3)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#1)(2009-11#1)(2009-6#2)(2009-8#3)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#4)(2010-5#1)(2010-8#1)(2010-9#3)(2011-1#4)(2011-12#1)(2011-2#6)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#3)(2012-5#1)(2012-9#1)(2013-1#2)(2013-7#1)(2013-8#5)
to environmentally##2##2##(1993-11#1)(2008-5#1)
to envisage##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
to envision##5##2##(1994-2#1)(2006-11#1)(2009-4#1)(2011-1#1)(2012-12#1)
to enzootic##2##2##(2011-2#1)(2012-12#1)
to enzymatic degradation##3##3##(1991-2#1)(1993-2#1)(2008-5#1)
to enzymatic hydrolysis##6##3##(1994-9#2)(2008-5#2)(2009-8#1)(2013-1#1)
to enzymatic##15##2##(1991-2#1)(1993-2#1)(1994-3#1)(1994-9#2)(1995-8#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2009-8#1)(2013-1#1)
to enzyme activity##2##3##(1993-1#1)(1996-11#1)
to enzyme##14##2##(1990-11#1)(1991-7#1)(1993-1#1)(1994-11#3)(1996-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-8#1)(2012-2#1)
to enzymes##3##2##(1992-3#1)(2008-4#1)(2011-1#1)
to eosinophil##2##2##(1994-9#1)(2010-12#1)
to epidemic proportions##2##3##(2009-6#1)(2012-12#1)
to epidemic##6##2##(1991-12#1)(2007-2#1)(2008-10#2)(2009-6#1)(2012-12#1)
to epidemics##2##2##(1996-11#1)(2008-10#1)
to epidemiologic studies##2##3##(2006-10#1)(2009-12#1)
to epidemiologic##3##2##(1993-4#1)(2006-10#1)(2009-12#1)
to epidemiological##2##2##(1991-12#1)(2010-9#1)
to epidemiologists##2##2##(2008-10#1)(2008-11#1)
to epidemiology##3##2##(1997-7#1)(2010-12#1)(2011-2#1)
to epidermal growth factor (EGF)##4##5##(1991-2#1)(1993-3#1)(1996-5#1)(2008-11#1)
to epidermal growth factor receptor##2##5##(2009-4#1)(2012-1#1)
to epidermal growth factor##9##4##(1990-11#1)(1991-2#2)(1993-3#1)(1994-5#1)(1996-5#1)(2008-11#1)(2009-4#1)(2012-1#1)
to epidermal##14##2##(1990-11#1)(1990-5#1)(1991-2#2)(1993-3#1)(1994-5#1)(1996-5#1)(2005-11#1)(2006-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-4#1)(2012-1#1)
to epidural analgesia##3##3##(1993-4#2)(2008-6#1)
to epidural block##2##3##(2006-10#1)(2011-12#1)
to epidural##9##2##(1993-4#2)(2006-10#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-6#1)(2011-12#2)
to epigenetic##3##2##(2008-7#1)(2010-12#1)(2012-12#1)
to epileptic##3##2##(1992-7#1)(1994-2#2)
to epinephrine##2##2##(1990-7#1)(2007-7#1)
to epiphyseal##2##2##(1990-11#1)(2011-2#1)
to episodes of##2##3##(2010-1#1)(2010-11#1)
to episodic##2##2##(2008-11#1)(2009-10#1)
to epithelial and##2##3##(2008-4#1)(2013-8#1)
to epithelial cells##3##3##(2008-10#1)(2008-5#2)
to epithelial##11##2##(1997-5#1)(1997-6#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#3)(2013-1#2)(2013-8#1)
to epitopes##4##2##(1993-12#1)(1995-2#1)(1996-4#1)(2006-6#1)
to epoetin-alpha##3##2##(2007-11#3)
to equal##6##2##(1990-4#1)(1995-1#1)(1996-6#1)(2006-2#1)(2008-10#2)
to equally##2##2##(1994-11#1)(1995-6#1)
to equilibrate with##2##3##(1995-10#1)(2008-12#1)
to equilibrate##6##2##(1990-2#1)(1991-11#1)(1995-10#1)(2008-12#1)(2008-8#1)(2011-1#1)
to equilibrium thermodynamics##2##3##(1991-2#1)(2005-11#1)
to equilibrium##9##2##(1991-2#1)(1993-9#1)(1994-3#1)(1995-1#1)(2005-11#1)(2005-4#1)(2006-10#1)(2008-10#1)(2008-11#1)
to equine##2##2##(1992-1#1)(2006-5#1)
to equip##5##2##(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-3#1)
to equipment##4##2##(1994-2#1)(1996-2#1)(2008-12#1)(2011-2#1)
to equivalent##5##2##(1996-1#1)(2007-2#1)(2008-7#1)(2011-1#2)
to equivocal##2##2##(1991-3#1)(2009-10#1)
to eradicate polio##4##3##(1994-9#3)(2004-12#1)
to eradicate poliomyelitis##2##3##(2007-2#1)(2008-8#1)
to eradicate the disease##3##4##(1994-9#2)(2011-2#1)
to eradicate the##8##3##(1994-9#2)(2006-10#2)(2008-1#1)(2008-8#1)(2011-2#1)(2013-7#1)
to eradicate##28##2##(1990-6#1)(1991-9#1)(1993-12#1)(1994-9#5)(1997-4#1)(1997-6#1)(1997-7#1)(2004-12#1)(2006-10#2)(2007-11#2)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-8#2)(2009-3#1)(2011-2#1)(2012-12#1)(2013-7#1)
to erase##2##2##(2010-3#1)(2012-2#1)
to erectile dysfunction##3##3##(2008-10#1)(2012-12#1)(2013-8#1)
to erode##2##2##(1991-2#1)(1994-7#1)
to erosion of##2##3##(1991-5#1)(2008-9#1)
to error due to##2##4##(2008-10#1)(2008-4#1)
to error##6##2##(2008-10#2)(2008-2#2)(2008-4#1)(2012-1#1)
to errors in the##3##4##(2008-2#1)(2008-3#2)
to errors in##10##3##(2006-8#1)(2008-2#2)(2008-3#3)(2008-4#1)(2009-10#1)(2010-8#1)(2011-2#1)
to errors##19##2##(2006-8#1)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#2)(2008-9#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
to erythema##2##2##(1996-6#1)(2009-5#1)
to erythrocytes##9##2##(1992-4#3)(1992-8#1)(1993-11#2)(1994-5#1)(1996-12#1)(2006-10#1)
to erythromycin and clindamycin##2##4##(2007-7#1)(2008-11#1)
to erythromycin and spiramycin##2##4##(2008-5#2)
to erythromycin and##5##3##(2007-7#1)(2008-11#2)(2008-5#2)
to erythromycin or##2##3##(2010-6#2)
to erythromycin##12##2##(2006-8#1)(2007-12#1)(2007-7#1)(2008-11#3)(2008-5#2)(2010-6#2)(2011-2#1)(2012-2#1)
to escalate##4##2##(1991-12#1)(2007-2#1)(2007-4#1)(2008-3#1)
to escalating costs##2##3##(2008-1#1)(2012-12#1)
to escape from the##5##4##(1996-12#1)(2008-10#1)(2008-8#1)(2009-3#1)(2009-6#1)
to escape from##9##3##(1994-6#1)(1996-12#2)(2008-10#1)(2008-8#1)(2009-3#2)(2009-6#1)(2011-2#1)
to escape into the##2##4##(2008-1#1)(2013-1#1)
to escape the##4##3##(2007-10#1)(2007-11#1)(2008-9#1)(2009-9#1)
to escape##20##2##(1991-1#1)(1991-5#1)(1994-2#1)(1994-6#1)(1996-12#3)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#2)(2009-6#1)(2009-9#1)(2011-2#1)(2013-1#1)
to essential hypertension##4##3##(2008-9#3)(2010-4#1)
to essential##11##2##(2008-5#1)(2008-6#1)(2008-9#3)(2009-5#2)(2010-1#1)(2010-4#1)(2010-6#1)(2012-2#1)
to essentially##2##2##(1996-5#1)(2009-10#1)
to establish a &quot##2##4##(2007-11#1)(2010-5#1)
to establish a cell##2##4##(2008-11#1)(2008-7#1)
to establish a classification##2##4##(2008-5#2)
to establish a diagnosis of##2##5##(1994-2#1)(2011-2#1)
to establish a diagnosis##3##4##(1994-2#1)(2008-4#1)(2011-2#1)
to establish a firm##2##4##(2005-11#1)(2008-11#1)
to establish a framework##2##4##(1994-3#1)(2008-10#1)
to establish a good##2##4##(1991-1#1)(2008-11#1)
to establish a method for##2##5##(1996-6#1)(2013-1#1)
to establish a method##3##4##(1996-6#1)(2011-1#1)(2013-1#1)
to establish a methodology##2##4##(2007-4#1)(2008-11#1)
to establish a model for##3##5##(1996-4#1)(2007-10#1)(2011-2#1)
to establish a new##3##4##(2007-4#1)(2011-12#1)(2013-8#1)
to establish a possible##2##4##(2005-11#1)(2007-5#1)
to establish a relationship between##2##5##(1990-10#1)(2008-10#1)
to establish a standard##2##4##(1990-11#1)(1994-2#1)
to establish a system##3##4##(1992-3#1)(2005-10#1)(2008-7#1)
to establish a therapeutic##2##4##(1996-11#1)(2008-3#1)
to establish a##105##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1991-1#1)(1991-6#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-2#2)(1994-3#1)(1994-4#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-4#2)(1997-6#1)(2005-10#1)(2005-11#2)(2005-5#1)(2006-6#2)(2007-10#3)(2007-11#1)(2007-2#2)(2007-3#2)(2007-4#3)(2007-5#1)(2007-7#1)(2008-10#4)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#5)(2008-8#2)(2008-9#1)(2010-12#1)(2010-5#1)(2010-6#2)(2011-1#3)(2011-12#1)(2011-2#5)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
to establish an##15##3##(1990-11#2)(1992-5#1)(1996-1#1)(1997-5#1)(1997-8#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-11#1)(2010-4#1)(2010-8#1)
to establish and maintain##4##4##(1995-2#1)(2008-2#1)(2008-4#1)(2012-2#1)
to establish and##10##3##(1991-1#1)(1995-2#1)(1996-8#1)(1997-8#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2012-2#1)
to establish appropriate##3##3##(2007-11#1)(2008-4#1)(2009-12#1)
to establish baseline##3##3##(1993-1#1)(2008-11#1)(2009-4#1)
to establish causal##2##3##(2006-8#1)(2008-9#1)
to establish clinical##2##3##(2007-12#1)(2007-4#1)
to establish correlations between##2##4##(2008-10#2)
to establish correlations##3##3##(2008-10#2)(2010-5#1)
to establish different##2##3##(2008-10#1)(2010-5#1)
to establish dosing##2##3##(1996-4#1)(2005-8#1)
to establish early##2##3##(1997-1#1)(2008-1#1)
to establish efficacy##2##3##(2007-11#1)(2007-2#1)
to establish guidelines for##2##4##(1994-2#1)(2009-7#1)
to establish homology##2##3##(1994-6#1)(2007-6#1)
to establish if##4##3##(1994-11#1)(2007-11#1)(2011-1#1)(2011-12#1)
to establish in##3##3##(1996-9#1)(2008-11#1)(2012-2#1)
to establish its##9##3##(1990-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-7#1)(2012-2#1)
to establish more effective##2##4##(2010-2#1)(2013-8#1)
to establish more precisely the##2##5##(1996-2#1)(2008-10#1)
to establish more##4##3##(1996-2#1)(2008-10#1)(2010-2#1)(2013-8#1)
to establish new##2##3##(1997-2#1)(2011-2#1)
to establish potential##3##3##(2012-3#1)(2013-1#2)
to establish reference##3##3##(2004-9#1)(2005-7#1)(2006-10#1)
to establish some##3##3##(1992-3#1)(2006-11#1)(2011-2#1)
to establish stem##2##3##(2008-10#1)(2012-12#1)
to establish suitable##2##3##(2008-10#1)(2011-2#1)
to establish surgical##2##3##(1997-7#1)(2012-12#1)
to establish systemic infection##2##4##(2008-10#2)
to establish systemic##3##3##(2008-10#3)
to establish that##8##3##(1990-11#1)(1991-7#1)(1992-3#1)(1995-9#1)(2005-12#1)(2007-12#1)(2008-3#1)(2013-1#1)
to establish the accuracy and##2##5##(2006-2#1)(2008-3#1)
to establish the accuracy##3##4##(1994-2#1)(2006-2#1)(2008-3#1)
to establish the actual##2##4##(2006-10#1)(2007-5#1)
to establish the analytical##2##4##(2007-8#1)(2010-7#1)
to establish the average##2##4##(2007-2#1)(2013-8#1)
to establish the best##3##4##(2008-10#3)
to establish the correct diagnosis##3##5##(1997-5#1)(2007-7#1)(2010-3#1)
to establish the criteria for##2##5##(1996-12#1)(2007-11#1)
to establish the diagnosis##7##4##(2006-8#1)(2007-5#1)(2007-8#1)(2007-9#1)(2010-4#1)(2010-6#1)(2012-12#1)
to establish the effectiveness of##2##5##(1992-3#1)(2008-4#1)
to establish the extent of##3##5##(1991-6#1)(2007-11#1)(2010-4#1)
to establish the extent to which##3##6##(2007-6#1)(2008-7#1)(2011-2#1)
to establish the extent##7##4##(1991-6#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-7#1)(2010-4#1)(2011-2#1)
to establish the identity##2##4##(2008-10#1)(2011-1#1)
to establish the impact of enquiry based learning##2##8##(2008-11#2)
to establish the major##2##4##(1995-1#1)(2008-7#1)
to establish the most##5##4##(1996-6#1)(2007-10#1)(2008-10#1)(2010-5#1)(2013-8#1)
to establish the new##2##4##(2008-10#1)(2008-9#1)
to establish the optimum##2##4##(1996-9#1)(2008-10#1)
to establish the position of##2##5##(2007-7#1)(2009-8#1)
to establish the prevalence of##3##5##(1992-1#1)(2007-3#1)(2013-8#1)
to establish the relationship##2##4##(1993-5#1)(1997-4#1)
to establish the reliability##2##4##(1992-2#1)(2008-12#1)
to establish the role of##4##5##(1991-12#1)(1995-2#1)(2008-10#1)(2012-2#1)
to establish the safety##2##4##(2007-10#1)(2012-1#1)
to establish the##154##3##(1991-12#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#2)(1992-8#1)(1993-5#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-9#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-9#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-11#1)(2005-12#1)(2006-1#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#1)(2007-2#1)(2007-3#3)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#2)(2008-10#16)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#4)
to establish their##7##3##(2007-8#1)(2008-10#1)(2008-2#1)(2010-4#2)(2010-7#1)(2013-1#1)
to establish therapeutic##2##3##(2007-12#1)(2012-2#1)
to establish these##2##3##(2008-1#1)(2008-7#1)
to establish this##4##3##(1995-12#1)(2008-11#1)(2008-7#1)(2008-9#1)
to establish whether a##3##4##(1992-10#1)(1994-3#1)(2013-7#1)
to establish whether the##2##4##(2009-10#1)(2011-2#1)
to establish whether these##2##4##(2007-4#1)(2008-9#1)
to establish whether this##2##4##(2004-10#1)(2007-2#1)
to establish whether##21##3##(1992-10#1)(1993-10#1)(1994-3#1)(1995-5#1)(1996-12#1)(1997-4#1)(2004-10#1)(2004-11#1)(2006-8#1)(2007-2#2)(2007-4#1)(2007-5#1)(2008-11#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#2)(2013-7#1)(2013-8#1)
to establish which##2##3##(1991-5#1)(2005-10#1)
to establish##552##2##(1990-10#1)(1990-11#4)(1990-12#2)(1990-2#2)(1990-3#2)(1991-1#3)(1991-12#2)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#6)(1992-5#1)(1992-8#2)(1993-1#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#6)(1994-3#2)(1994-4#1)(1994-6#2)(1994-7#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#3)(1995-4#2)(1995-5#2)(1995-6#2)(1995-7#1)(1995-9#2)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#3)(1996-3#1)(1996-4#3)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#5)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#4)(1997-5#3)(1997-6#2)(1997-7#1)(1997-8#2)(2004-10#1)(2004-11#1)(2004-2#1)(2004-4#1)(2004-9#2)(2005-10#3)(2005-11#4)(2005-12#3)(2005-5#2)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#3)(2006-2#2)(2006-5#2)(2006-6#2)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#7)(2007-11#11)(2007-12#5)(2007-2#8)(2007-3#5)(2007-4#6)(2007-5#6)(2007-6#2)(2007-7#6)(2007-8#11)(2007-9#4)(2008-1#7)(2008-10#42)(2008-11#22)(2008-12#4)(2008-2#10)(2008-3#14)(2008-4#6)(2008-5#14)(2008-6#2)(2008-7#16)(2008-8#5)(2008-9#9)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#5)(2009-4#2)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#6)(2010-2#3)(2010-3#4)(2010-4#6)(2010-5#6)(2010-6#3)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#8)(2011-12#2)(2011-2#24)(2011-7#1)(2012-1#2)(2012-11#3)(2012-12#10)(2012-2#18)(2012-3#5)(2013-1#16)(2013-7#3)(2013-8#12)
to established procedures##2##3##(1991-11#1)(2007-5#1)
to established##21##2##(1991-11#1)(1993-1#1)(1993-3#1)(1994-2#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-7#2)(2010-10#1)(2010-8#1)(2011-1#1)
to establishing a##3##3##(1991-5#1)(2005-5#1)(2007-10#1)
to establishing and maintaining##2##4##(2010-7#1)(2012-11#1)
to establishing and##3##3##(1992-3#1)(2010-7#1)(2012-11#1)
to establishing##11##2##(1991-5#1)(1992-3#1)(1997-3#1)(2005-5#1)(2007-10#1)(2008-1#1)(2008-7#1)(2010-7#1)(2012-1#1)(2012-11#1)(2012-12#1)
to estimate DNA##3##3##(1997-4#1)(2008-10#2)
to estimate a##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
to estimate accurately##2##3##(1993-8#1)(1994-8#1)
to estimate and##2##3##(2008-2#1)(2008-9#1)
to estimate both the##2##4##(2008-4#1)(2011-2#1)
to estimate both##3##3##(2008-4#1)(2010-2#1)(2011-2#1)
to estimate changes in##3##4##(1990-10#1)(1992-8#1)(2008-5#1)
to estimate confidence intervals##2##4##(1993-1#1)(2010-8#1)
to estimate hazard ratios##2##4##(2007-10#1)(2007-8#1)
to estimate how##3##3##(1995-12#1)(2011-1#2)
to estimate individual##2##3##(2010-9#1)(2012-3#1)
to estimate long-term##3##3##(2008-8#1)(2011-2#2)
to estimate model parameters##2##4##(2006-7#1)(2008-10#1)
to estimate odds ratios##2##4##(2007-10#1)(2011-2#1)
to estimate parameters##5##3##(1997-7#1)(2008-10#1)(2011-3#1)(2013-1#2)
to estimate relative##3##3##(1993-3#1)(2008-10#1)(2008-11#1)
to estimate risk##2##3##(2007-1#1)(2013-1#1)
to estimate survival##2##3##(1990-9#1)(2008-10#1)
to estimate that##2##3##(1996-5#1)(2008-5#1)
to estimate the absorption and##2##5##(2008-3#1)(2008-5#1)
to estimate the absorption##3##4##(2008-2#1)(2008-3#1)(2008-5#1)
to estimate the age-specific incidence of an irreversible disease##2##9##(1994-11#2)
to estimate the amount of##4##5##(2008-10#1)(2008-2#1)(2010-8#2)
to estimate the apparent##2##4##(2008-10#2)
to estimate the average##2##4##(2007-12#2)
to estimate the calibration##2##4##(2008-10#1)(2008-3#1)
to estimate the cell##2##4##(1995-9#1)(2008-11#1)
to estimate the concentration of##4##5##(2007-10#1)(2007-12#1)(2008-10#2)
to estimate the conditional##2##4##(2009-3#1)(2012-3#1)
to estimate the contribution of##4##5##(1992-12#1)(2008-10#2)(2010-11#1)
to estimate the depth of##2##5##(2008-3#1)(2011-2#1)
to estimate the distances between##2##5##(1995-8#1)(2008-8#1)
to estimate the dynamic##2##4##(2008-12#1)(2009-9#1)
to estimate the economic##2##4##(2006-12#1)(2011-2#1)
to estimate the effective##2##4##(2006-5#1)(2008-3#1)
to estimate the effects of##2##5##(2007-6#1)(2008-7#1)
to estimate the efficacy##2##4##(1992-10#1)(2008-4#1)
to estimate the extent of##2##5##(2008-7#1)(2013-8#1)
to estimate the extent##4##4##(2008-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
to estimate the frequency of##3##5##(1994-3#2)(2006-8#1)
to estimate the frequency##4##4##(1994-3#2)(2006-8#1)(2007-1#1)
to estimate the impact of##3##5##(1996-3#1)(2006-6#1)(2008-10#1)
to estimate the impact##4##4##(1996-3#1)(2006-6#1)(2008-10#1)(2011-2#1)
to estimate the importance of##3##5##(1990-8#1)(1994-3#1)(2008-10#1)
to estimate the incidence##3##4##(2006-7#1)(2008-8#1)(2012-2#1)
to estimate the level of##2##5##(2008-11#1)(2012-12#1)
to estimate the levels of##2##5##(2006-10#1)(2012-2#1)
to estimate the likelihood of##3##5##(2008-2#1)(2012-11#1)(2013-7#1)
to estimate the local##2##4##(2008-6#1)(2013-8#1)
to estimate the long-term##2##4##(1991-11#1)(2007-1#1)
to estimate the magnitude of##3##5##(2004-4#1)(2007-7#1)(2011-2#1)
to estimate the maximum##2##4##(2007-11#1)(2008-3#1)
to estimate the mean##4##4##(1993-5#1)(2008-10#1)(2008-3#1)(2010-2#1)
to estimate the measurement##2##4##(2008-10#1)(2008-2#1)
to estimate the minimum##3##4##(2007-9#1)(2008-2#1)(2010-2#1)
to estimate the number of##7##5##(1995-4#1)(1996-9#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
to estimate the number##8##4##(1995-4#1)(1996-9#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
to estimate the odds##2##4##(2010-6#1)(2011-2#1)
to estimate the optimal##2##4##(2008-10#1)(2008-7#1)
to estimate the parameters of##3##5##(1996-8#1)(2005-11#1)(2008-3#1)
to estimate the parameters##5##4##(1996-8#1)(2005-11#1)(2008-10#1)(2008-3#1)(2009-5#1)
to estimate the percentage of##2##5##(2008-4#1)(2011-2#1)
to estimate the potential public health impact##2##7##(1991-3#1)(2012-12#1)
to estimate the potential##8##4##(1991-3#1)(2006-11#1)(2007-2#1)(2008-10#3)(2011-2#1)(2012-12#1)
to estimate the prevalence and##2##5##(2012-1#1)(2013-7#1)
to estimate the prevalence of##12##5##(1990-12#1)(1994-3#1)(1994-9#1)(1995-10#1)(2007-3#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-10#1)(2013-8#2)
to estimate the prevalence##15##4##(1990-12#1)(1994-3#1)(1994-9#1)(1995-10#1)(2007-3#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-10#1)(2012-1#1)(2013-7#1)(2013-8#2)
to estimate the rates##2##4##(2008-11#1)(2013-8#1)
to estimate the relative##4##4##(1996-4#1)(2008-10#1)(2008-8#1)(2011-2#1)
to estimate the risk##3##4##(1990-1#1)(1995-8#1)(2008-7#1)
to estimate the safety effects##2##5##(2012-12#2)
to estimate the sensitivity and specificity of DNA-amplification tests for Chlamydia trachomatis such as the##2##15##(1996-8#1)(1997-6#1)
to estimate the sensitivity and specificity of##3##7##(1994-11#1)(1996-8#1)(1997-6#1)
to estimate the sensitivity##4##4##(1994-11#1)(1996-8#1)(1997-6#1)(2008-7#1)
to estimate the specific growth rate##2##6##(2008-7#2)
to estimate the specific##3##4##(1996-12#1)(2008-7#2)
to estimate the survival##2##4##(1995-12#1)(2008-8#1)
to estimate the thickness##2##4##(1991-5#1)(2008-2#1)
to estimate the total##6##4##(2004-11#2)(2007-12#1)(2008-10#2)(2008-7#1)
to estimate the underlying##2##4##(2008-2#1)(2010-11#1)
to estimate the vertical##2##4##(2008-3#2)
to estimate the##326##3##(1990-1#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-5#4)(1991-8#2)(1992-10#1)(1992-12#2)(1992-2#1)(1993-5#1)(1993-6#1)(1994-11#5)(1994-2#1)(1994-3#4)(1994-6#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-4#2)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#3)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#3)(2004-4#1)(2005-11#3)(2006-10#4)(2006-11#1)(2006-12#3)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-1#4)(2007-10#2)(2007-11#3)(2007-12#7)(2007-2#2)(2007-3#1)(2007-6#2)(2007-7#3)(2007-8#3)(2007-9#3)(2008-1#2)(2008-10#41)(2008-11#9)(2008-12#3)(2008-2#23)(2008-3#25)(2008-4#5)(2008-5#6)(2008-6#2)(2008-7#13)(2008-8#5)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-5#2)(2009-8#3)(2009-9#1)(2010-11#2)(2010-2#2)(2010-3#2)(2010-5#3)(2010-6#2)(2010-8#3)(2011-1#4)(2011-2#15)(2012-1#3)(2012-11#1)(2012-12#8)(2012-2#3)(2012-3#5)(2013-1#4)(2013-7#3)(2013-8#9)
to estimate these##2##3##(2008-10#1)(2013-1#1)
to estimate treatment effects##2##4##(1997-2#1)(2013-8#1)
to estimate zinc##2##3##(2008-10#2)
to estimate##548##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#2)(1990-9#2)(1991-11#2)(1991-3#2)(1991-5#4)(1991-8#2)(1992-10#1)(1992-12#3)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#3)(1993-8#1)(1994-11#5)(1994-12#1)(1994-2#1)(1994-3#5)(1994-6#2)(1994-8#1)(1994-9#4)(1995-1#2)(1995-10#1)(1995-12#3)(1995-2#2)(1995-4#2)(1995-5#1)(1995-6#4)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-2#5)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#3)(2004-4#1)(2005-11#4)(2005-12#1)(2005-9#2)(2006-10#7)(2006-11#2)(2006-12#3)(2006-5#3)(2006-6#2)(2006-7#2)(2006-8#5)(2007-1#6)(2007-10#4)(2007-11#6)(2007-12#8)(2007-2#3)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#4)(2007-8#5)(2007-9#5)(2008-1#2)(2008-10#70)(2008-11#12)(2008-12#5)(2008-2#34)(2008-3#41)(2008-4#8)(2008-5#8)(2008-6#3)(2008-7#15)(2008-8#12)(2008-9#7)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-5#2)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#2)(2010-11#2)(2010-12#1)(2010-2#4)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#3)(2010-8#9)(2010-9#2)(2011-1#8)(2011-12#2)(2011-2#22)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#9)(2012-2#4)(2012-3#9)(2012-8#1)(2013-1#18)(2013-7#6)(2013-8#12)
to estimated##3##2##(1995-1#1)(2010-5#1)(2010-7#1)
to estimates of the##3##4##(1996-5#1)(2008-10#1)(2008-2#1)
to estimates of##7##3##(1991-2#2)(1992-5#1)(1996-5#1)(2006-3#1)(2008-10#1)(2008-2#1)
to estimates##9##2##(1991-2#2)(1992-5#1)(1996-5#1)(2004-11#1)(2006-3#1)(2008-10#1)(2008-2#1)(2008-5#1)
to estimating the##2##3##(2008-3#1)(2012-1#1)
to estimating##8##2##(1994-11#1)(1995-9#1)(1996-12#1)(2008-2#1)(2008-3#2)(2010-10#1)(2012-1#1)
to estimation of##5##3##(1996-12#1)(1997-3#1)(2008-3#1)(2008-9#1)(2012-1#1)
to estradiol##5##2##(1994-3#1)(1994-8#1)(1995-1#1)(1996-11#1)(2009-7#1)
to estrogen in##3##3##(1992-9#2)(2008-11#1)
to estrogen##18##2##(1990-5#1)(1991-2#1)(1992-9#3)(1994-8#1)(1995-4#1)(1996-4#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#2)(2009-2#2)(2011-2#1)
to estrogens##4##2##(1994-8#1)(2006-1#1)(2011-1#2)
to etanercept##2##2##(2006-10#2)
to ethanol and CO2##2##4##(1994-8#1)(2008-6#1)
to ethanol and##6##3##(1994-10#1)(1994-8#1)(1995-3#2)(2005-10#1)(2008-6#1)
to ethanol by##2##3##(2004-11#1)(2008-6#1)
to ethanol in##2##3##(1995-3#1)(2008-10#1)
to ethanol than##3##3##(1992-7#1)(1994-5#1)(2008-5#1)
to ethanol using##2##3##(2008-5#1)(2008-6#1)
to ethanol##51##2##(1990-2#2)(1991-11#1)(1992-7#1)(1993-11#1)(1993-4#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-5#1)(1994-8#1)(1995-3#4)(1995-6#1)(1996-10#1)(2004-11#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#4)(2008-6#9)(2008-7#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
to ethical concerns##2##3##(2006-11#1)(2008-12#1)
to ethical##7##2##(1996-12#1)(2006-11#1)(2007-8#1)(2008-12#2)(2008-6#1)(2013-8#1)
to ethics##6##2##(1991-7#1)(1995-3#1)(2006-10#1)(2008-11#2)(2009-4#1)
to ethnic nepotism##3##3##(2006-7#3)
to ethnic##7##2##(2006-7#3)(2008-10#1)(2009-7#2)(2011-2#1)
to ethnicity##3##2##(2006-7#1)(2009-7#2)
to ethyl##3##2##(1991-8#1)(1996-2#1)(2009-12#1)
to ethylene and##2##3##(2008-10#1)(2009-8#1)
to ethylene##8##2##(1992-3#1)(1992-5#1)(2008-10#1)(2009-8#5)
to etiology of##2##3##(1996-8#1)(2013-8#1)
to etiology##7##2##(1992-6#1)(1996-8#2)(2004-10#1)(2006-12#1)(2007-9#1)(2013-8#1)
to etoposide##3##2##(1991-11#1)(1991-7#1)(1992-10#1)
to eucalyptus##3##2##(2008-5#2)(2008-6#1)
to eukaryotes##2##2##(1993-9#1)(1995-2#1)
to eukaryotic##7##2##(1992-5#1)(1993-11#2)(1995-2#1)(2008-9#1)(2009-2#1)(2011-1#1)
to evacuate##3##2##(2008-7#2)(2010-2#1)
to evacuation##2##2##(2010-2#1)(2012-2#1)
to evade the##2##3##(1992-4#1)(2007-11#1)
to evade##6##2##(1992-4#1)(1996-7#1)(2007-11#1)(2008-10#2)(2010-6#1)
to evaluate a model of##2##5##(2008-6#1)(2008-7#1)
to evaluate a model##4##4##(2008-10#1)(2008-6#1)(2008-7#1)(2012-2#1)
to evaluate a new##4##4##(1991-1#1)(1997-4#1)(2006-10#1)(2007-7#1)
to evaluate a total##2##4##(2006-8#1)(2008-10#1)
to evaluate a##37##3##(1991-1#1)(1995-4#1)(1996-1#1)(1996-9#1)(1997-4#1)(2004-9#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-6#2)(2008-7#3)(2009-5#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#2)
to evaluate additional##2##3##(2008-10#1)(2008-5#1)
to evaluate alternative##2##3##(1992-2#1)(2012-12#1)
to evaluate an##4##3##(2006-7#1)(2007-11#1)(2009-2#1)(2011-1#1)
to evaluate and compare the##8##5##(2006-8#1)(2007-11#1)(2011-1#2)(2011-12#1)(2012-12#1)(2013-8#2)
to evaluate and compare##11##4##(2006-8#2)(2007-11#1)(2010-8#1)(2011-1#2)(2011-12#1)(2012-12#2)(2013-8#2)
to evaluate and validate##2##4##(2010-7#1)(2013-8#1)
to evaluate and##30##3##(1992-12#1)(1993-1#1)(1995-2#1)(1996-2#1)(1997-1#1)(2004-2#1)(2005-8#1)(2006-8#4)(2007-11#1)(2007-8#1)(2008-10#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#3)(2013-7#2)(2013-8#4)
to evaluate antibiotic##2##3##(2013-1#1)(2013-8#1)
to evaluate any##3##3##(1993-9#1)(1997-2#1)(2008-9#1)
to evaluate body##2##3##(2007-12#2)
to evaluate bone##3##3##(2007-11#1)(2007-8#1)(2007-9#1)
to evaluate both##3##3##(2008-5#1)(2012-2#1)(2012-3#1)
to evaluate brain##2##3##(1997-5#1)(2008-6#1)
to evaluate by##2##3##(2008-8#1)(2013-8#1)
to evaluate changes in cell##2##5##(1997-2#1)(2010-5#1)
to evaluate changes in##9##4##(1990-10#1)(1991-9#1)(1994-12#1)(1997-2#1)(2006-6#1)(2008-10#1)(2008-12#1)(2010-5#1)(2012-2#1)
to evaluate changes##10##3##(1990-10#1)(1991-9#1)(1994-12#1)(1997-2#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-12#1)(2010-5#1)(2012-2#1)
to evaluate characteristics##2##3##(2010-10#1)(2012-12#1)
to evaluate clinical and##4##4##(1993-8#1)(2007-11#1)(2007-9#1)(2013-8#1)
to evaluate clinical##10##3##(1993-8#1)(1995-2#1)(2007-11#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#1)(2010-3#1)(2013-8#1)
to evaluate differences in##4##4##(1994-3#1)(2008-10#2)(2009-4#1)
to evaluate differences##6##3##(1994-3#1)(2007-9#1)(2008-10#2)(2009-4#1)(2011-2#1)
to evaluate disease##3##3##(2008-10#2)(2013-8#1)
to evaluate each##2##3##(2008-10#2)
to evaluate effects of##5##4##(2008-12#1)(2010-7#1)(2011-12#1)(2013-1#2)
to evaluate efficacy of##2##4##(2007-2#1)(2012-2#1)
to evaluate efficacy##6##3##(2007-2#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-2#2)
to evaluate efficiency##2##3##(2008-1#1)(2010-8#1)
to evaluate estrogenic potency of dietary phytoestrogens##2##7##(2008-10#2)
to evaluate estrogenic potency##3##4##(2008-10#3)
to evaluate existing##2##3##(1994-2#1)(2008-10#1)
to evaluate exposure-response##2##3##(2008-7#2)
to evaluate factors##3##3##(2007-7#1)(2008-1#1)(2013-1#1)
to evaluate for##5##3##(2008-1#1)(2008-10#1)(2009-6#1)(2010-5#1)(2013-1#1)
to evaluate further the##2##4##(1991-5#1)(1992-7#1)
to evaluate how they##2##4##(1993-2#1)(2013-7#1)
to evaluate how##10##3##(1993-2#1)(2006-11#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-12#1)(2010-2#1)(2013-7#1)(2013-8#2)
to evaluate if a##2##4##(2008-4#1)(2013-1#1)
to evaluate if the##2##4##(2008-6#1)(2011-2#1)
to evaluate if##11##3##(1994-6#1)(1996-3#1)(1996-9#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-4#1)(2008-6#1)(2011-2#1)(2013-1#2)
to evaluate in##4##3##(1990-8#1)(2005-1#1)(2009-6#1)(2010-6#1)
to evaluate its clinical##2##4##(2008-10#1)(2010-12#1)
to evaluate its impact##2##4##(2010-9#1)(2011-1#1)
to evaluate its suitability##2##4##(2008-2#1)(2013-1#1)
to evaluate its##25##3##(1990-12#1)(1990-2#1)(1991-9#1)(1994-7#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-2#2)(2008-5#2)(2010-11#1)(2010-12#2)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
to evaluate levels of##2##4##(1997-8#1)(2007-8#1)
to evaluate local##2##3##(1996-3#1)(2008-9#1)
to evaluate long-term##2##3##(1990-6#1)(2008-10#1)
to evaluate mechanisms##2##3##(1995-12#1)(1996-8#1)
to evaluate melanosome transfer##3##4##(2008-8#1)(2012-12#2)
to evaluate methods of##2##4##(2007-7#1)(2010-9#1)
to evaluate other##2##3##(2008-4#1)(2008-6#1)
to evaluate our##2##3##(2007-8#2)
to evaluate outcome in##2##4##(2007-7#2)
to evaluate outcome##3##3##(2007-11#1)(2007-7#2)
to evaluate oxidative##2##3##(2008-10#1)(2013-1#1)
to evaluate patients with##2##4##(2008-3#1)(2013-8#1)
to evaluate patients##3##3##(2008-3#2)(2013-8#1)
to evaluate patients'##2##3##(2006-10#1)(2011-2#1)
to evaluate pediatric patients with##2##5##(2008-4#1)(2008-9#1)
to evaluate performance##2##3##(2007-10#1)(2012-1#1)
to evaluate platelet##3##3##(1990-12#1)(2008-9#2)
to evaluate possible##10##3##(1990-8#1)(1992-11#1)(1997-2#1)(2007-10#2)(2007-11#1)(2007-7#1)(2008-10#1)(2011-2#1)(2012-3#1)
to evaluate postoperative##2##3##(1992-3#1)(2011-2#1)
to evaluate potential##5##3##(2008-10#1)(2008-4#2)(2008-6#1)(2010-12#1)
to evaluate recovery##2##3##(1996-12#1)(2008-1#1)
to evaluate regional##2##3##(1996-5#1)(2005-1#1)
to evaluate relative##2##3##(1996-3#1)(2013-1#1)
to evaluate risk##2##3##(2008-8#2)
to evaluate salinity tolerance##2##4##(2008-12#2)
to evaluate scientific##3##3##(1991-11#1)(2008-5#1)(2013-8#1)
to evaluate severity##2##3##(1992-2#1)(2011-2#1)
to evaluate the CLB##2##4##(2007-10#2)
to evaluate the ability of the##2##6##(2008-10#1)(2008-4#1)
to evaluate the ability of this##2##6##(1990-2#1)(1995-5#1)
to evaluate the ability of##8##5##(1990-2#1)(1993-9#1)(1995-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2013-8#1)
to evaluate the accuracy##2##4##(1995-1#1)(2013-1#1)
to evaluate the activity and##2##5##(2005-11#1)(2006-6#1)
to evaluate the activity##3##4##(2005-11#1)(2006-6#1)(2008-7#1)
to evaluate the actual##2##4##(2009-4#1)(2009-5#1)
to evaluate the antimicrobial##3##4##(2008-5#1)(2011-1#1)(2011-12#1)
to evaluate the association between##7##5##(1992-4#1)(2006-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#2)
to evaluate the association of##2##5##(2009-6#1)(2012-3#1)
to evaluate the association##9##4##(1992-4#1)(2006-6#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
to evaluate the associations between##2##5##(2006-6#1)(2011-2#1)
to evaluate the attitude of the physicians in##2##8##(2007-7#1)(2008-1#1)
to evaluate the benefits##2##4##(2006-6#1)(2013-1#1)
to evaluate the binding##2##4##(1990-12#1)(2008-10#1)
to evaluate the capacity of##3##5##(2006-12#1)(2013-1#2)
to evaluate the cardiovascular risk##2##5##(2008-10#1)(2008-7#1)
to evaluate the cardiovascular##5##4##(2007-4#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-4#1)
to evaluate the changes in the##2##6##(1996-6#1)(2008-3#1)
to evaluate the changes in##3##5##(1996-6#1)(2008-3#1)(2010-11#1)
to evaluate the clinical outcome##2##5##(2006-10#1)(2007-8#1)
to evaluate the clinical##12##4##(1990-10#1)(1995-3#1)(2006-10#2)(2006-12#1)(2007-8#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)
to evaluate the combined effects of##2##6##(2008-10#1)(2010-4#1)
to evaluate the composition of##2##5##(1995-3#1)(2008-10#1)
to evaluate the consequences of##2##5##(1993-3#1)(2007-8#1)
to evaluate the consequences##3##4##(1993-3#1)(2007-8#1)(2008-9#1)
to evaluate the content of##3##5##(2008-10#2)(2011-12#1)
to evaluate the contribution of specific##2##6##(1996-6#1)(2008-9#1)
to evaluate the contribution of##6##5##(1994-1#1)(1996-6#1)(2008-9#1)(2009-4#2)(2011-1#1)
to evaluate the correlation between##2##5##(2006-8#1)(2008-5#1)
to evaluate the correlation##3##4##(2006-10#1)(2006-8#1)(2008-5#1)
to evaluate the cost of water fluoridation in##2##8##(2006-8#2)
to evaluate the cost-effectiveness of##2##5##(2006-2#1)(2008-9#1)
to evaluate the course##2##4##(2008-11#1)(2011-1#1)
to evaluate the current##2##4##(2007-1#1)(2008-5#1)
to evaluate the degree of##4##5##(1996-1#1)(2008-10#1)(2008-3#1)(2008-4#1)
to evaluate the development of the##2##6##(2004-12#1)(2007-11#1)
to evaluate the diagnostic##4##4##(1991-2#1)(2007-6#1)(2011-2#1)(2012-12#1)
to evaluate the different##3##4##(1990-9#1)(2008-7#1)(2013-7#1)
to evaluate the dynamics of##3##5##(1997-1#1)(2008-10#1)(2010-11#1)
to evaluate the early and##3##5##(2007-8#1)(2008-12#1)(2008-8#1)
to evaluate the early##4##4##(2007-7#1)(2007-8#1)(2008-12#1)(2008-8#1)
to evaluate the effect of a##4##6##(1995-11#1)(1997-4#1)(2008-2#1)(2012-3#1)
to evaluate the effect of different##4##6##(2006-1#1)(2008-12#1)(2008-5#1)(2012-2#1)
to evaluate the effect of feeding##2##6##(2008-12#1)(2012-2#1)
to evaluate the effect of intravenous##2##6##(2007-10#1)(2007-7#1)
to evaluate the effect of the##4##6##(2004-12#1)(2008-1#1)(2008-10#1)(2008-12#1)
to evaluate the effect of##59##5##(1990-3#1)(1991-4#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-2#1)(1996-2#2)(1996-8#1)(1997-4#1)(1997-6#1)(2004-1#2)(2004-12#1)(2006-1#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#5)(2008-2#1)(2008-3#1)(2008-5#6)(2008-7#2)(2009-12#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
to evaluate the effect##63##4##(1990-3#1)(1991-4#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-2#1)(1996-2#2)(1996-8#1)(1997-4#1)(1997-6#1)(2004-1#2)(2004-12#1)(2006-1#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#5)(2008-2#1)(2008-3#1)(2008-5#7)(2008-7#2)(2008-9#1)(2009-12#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
to evaluate the effectiveness of a##9##6##(1992-1#2)(1996-11#1)(2006-2#1)(2006-6#1)(2007-7#1)(2008-4#1)(2008-9#1)(2009-10#1)
to evaluate the effectiveness of surgical##2##6##(2007-11#1)(2007-7#1)
to evaluate the effectiveness of the##8##6##(2005-9#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#1)(2011-1#1)(2012-1#1)
to evaluate the effectiveness of##38##5##(1991-10#1)(1992-1#2)(1994-6#1)(1996-11#1)(1997-1#2)(2005-9#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-6#1)(2007-7#5)(2007-8#3)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)(2009-10#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#2)(2013-7#1)
to evaluate the effectiveness##39##4##(1991-10#1)(1992-1#2)(1994-6#1)(1996-11#1)(1997-1#2)(2005-9#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-6#1)(2007-7#5)(2007-8#3)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#2)(2013-7#1)
to evaluate the effects of different##4##6##(2008-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
to evaluate the effects of the##3##6##(1993-12#1)(2008-10#1)(2008-3#1)
to evaluate the effects of these##2##6##(2012-12#1)(2012-3#1)
to evaluate the effects of two##2##6##(2008-10#1)(2012-12#1)
to evaluate the effects of##43##5##(1991-12#1)(1993-12#1)(1995-2#1)(1996-2#1)(1997-2#1)(2006-5#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#4)(2008-3#1)(2008-5#3)(2008-6#1)(2009-11#1)(2009-7#2)(2010-1#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
to evaluate the effects##46##4##(1991-12#1)(1993-12#1)(1995-2#1)(1996-2#1)(1997-2#1)(2006-12#1)(2006-5#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#4)(2008-3#1)(2008-5#3)(2008-6#1)(2009-11#1)(2009-7#2)(2010-1#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
to evaluate the efficacy and safety of these combinations##2##9##(2009-11#2)
to evaluate the efficacy and safety of##6##7##(2007-10#1)(2007-7#1)(2008-10#1)(2009-11#2)(2012-12#1)
to evaluate the efficacy and tolerability of##2##7##(1992-4#1)(2006-2#1)
to evaluate the efficacy and##10##5##(1990-2#1)(1992-4#2)(2006-2#1)(2007-10#1)(2007-7#1)(2008-10#1)(2009-11#2)(2012-12#1)
to evaluate the efficacy of a##7##6##(1997-8#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2012-3#1)(2013-1#1)
to evaluate the efficacy of new drugs##2##7##(2010-12#1)(2011-2#1)
to evaluate the efficacy of the##3##6##(1994-11#1)(2007-9#1)(2013-7#1)
to evaluate the efficacy of##40##5##(1993-1#1)(1994-11#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-3#1)(2006-1#1)(2006-10#2)(2007-2#2)(2007-3#1)(2007-7#4)(2007-9#2)(2008-1#2)(2008-10#4)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
to evaluate the efficacy##50##4##(1990-2#1)(1992-4#2)(1993-1#1)(1994-11#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-3#1)(2006-1#1)(2006-10#2)(2006-2#1)(2007-10#1)(2007-2#2)(2007-3#1)(2007-7#5)(2007-9#2)(2008-1#2)(2008-10#5)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#2)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
to evaluate the efficiency of##4##5##(2008-3#1)(2008-7#1)(2010-8#2)
to evaluate the etiology##3##4##(2007-8#1)(2008-4#1)(2013-1#1)
to evaluate the evidence##3##4##(1993-12#1)(2010-6#1)(2012-2#1)
to evaluate the expression of##3##5##(2007-6#1)(2011-2#1)(2013-1#1)
to evaluate the extent of##4##5##(2006-6#1)(2007-8#1)(2008-10#1)(2008-8#1)
to evaluate the extent to which##2##6##(2008-11#1)(2008-3#1)
to evaluate the extent##7##4##(2006-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2013-1#1)
to evaluate the extraction##2##4##(2008-10#2)
to evaluate the feasibility and##4##5##(1991-3#1)(2010-9#1)(2013-1#1)(2013-8#1)
to evaluate the feasibility of using##2##6##(2006-6#1)(2008-10#1)
to evaluate the feasibility of##7##5##(1992-12#1)(2006-11#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-2#1)(2011-2#1)
to evaluate the feasibility##11##4##(1991-3#1)(1992-12#1)(2006-11#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-2#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
to evaluate the formation of##2##5##(1993-8#1)(2012-2#1)
to evaluate the frequency of##7##5##(1992-6#1)(1994-12#1)(1996-8#1)(2007-8#1)(2013-1#2)(2013-8#1)
to evaluate the frequency##9##4##(1992-6#1)(1994-12#1)(1996-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2013-1#2)(2013-8#1)
to evaluate the functional status of##2##6##(1997-8#1)(2008-4#1)
to evaluate the functional##3##4##(1995-10#1)(1997-8#1)(2008-4#1)
to evaluate the genetic diversity of##3##6##(2005-11#1)(2008-10#1)(2010-4#1)
to evaluate the genetic##4##4##(2005-11#1)(2006-3#1)(2008-10#1)(2010-4#1)
to evaluate the human##2##4##(2008-10#1)(2012-1#1)
to evaluate the impact of a##3##6##(1996-1#1)(2008-3#1)(2012-3#1)
to evaluate the impact of the##2##6##(2008-12#1)(2010-4#1)
to evaluate the impact of##17##5##(1996-1#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-1#1)
to evaluate the impact##18##4##(1996-1#1)(2006-8#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-1#1)
to evaluate the importance of##4##5##(1996-6#1)(2006-5#1)(2007-12#1)(2010-8#1)
to evaluate the importance##5##4##(1996-6#1)(2006-5#1)(2006-6#1)(2007-12#1)(2010-8#1)
to evaluate the in##3##4##(2007-9#1)(2008-5#2)
to evaluate the incidence and##2##5##(2008-10#1)(2008-2#1)
to evaluate the incidence of##4##5##(1990-10#1)(2010-2#1)(2013-1#1)(2013-8#1)
to evaluate the incidence##6##4##(1990-10#1)(2008-10#1)(2008-2#1)(2010-2#1)(2013-1#1)(2013-8#1)
to evaluate the indications##2##4##(1990-9#1)(2006-6#1)
to evaluate the individual##2##4##(1995-6#1)(2008-12#1)
to evaluate the influence of the##4##6##(1990-2#1)(2006-10#1)(2008-12#1)(2009-8#1)
to evaluate the influence of##20##5##(1990-2#1)(1996-9#1)(2004-12#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-7#1)(2007-9#2)(2008-10#2)(2008-12#2)(2008-5#1)(2009-8#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
to evaluate the influence##21##4##(1990-2#1)(1996-9#1)(2004-12#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-7#1)(2007-9#2)(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#1)(2009-8#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
to evaluate the interaction of##2##5##(2007-8#1)(2008-1#1)
to evaluate the level of##2##5##(2008-4#1)(2011-1#1)
to evaluate the levels of##2##5##(2007-1#1)(2008-1#1)
to evaluate the local##3##4##(1995-2#1)(2008-2#1)(2008-3#1)
to evaluate the long-term##8##4##(1990-6#1)(2009-8#1)(2010-3#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-3#1)(2013-1#1)
to evaluate the most##2##4##(1995-4#1)(2008-5#1)
to evaluate the new##2##4##(2007-1#1)(2008-10#1)
to evaluate the outcome of##2##5##(2007-7#1)(2010-5#1)
to evaluate the overall##3##4##(2008-8#1)(2009-11#1)(2011-1#1)
to evaluate the percentage of##3##5##(1992-6#1)(1994-12#1)(2006-12#1)
to evaluate the performance of a##4##6##(1997-6#1)(2007-8#1)(2008-3#1)(2011-2#1)
to evaluate the performance of the##4##6##(2007-8#1)(2008-2#1)(2010-8#1)(2012-3#1)
to evaluate the performance of##15##5##(1994-5#1)(1997-6#1)(2007-10#1)(2007-8#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)
to evaluate the physiological##2##4##(2012-2#1)(2013-7#1)
to evaluate the possibility that##2##5##(1994-9#1)(2007-8#1)
to evaluate the possibility##4##4##(1994-9#1)(2007-7#1)(2007-8#1)(2010-12#1)
to evaluate the possible##6##4##(2008-1#1)(2008-3#1)(2008-5#2)(2012-8#1)(2013-1#1)
to evaluate the potential of##2##5##(2006-6#1)(2008-10#1)
to evaluate the potential relationship##2##5##(2008-1#1)(2008-3#1)
to evaluate the potential##11##4##(1991-7#1)(1992-9#1)(1993-12#1)(2005-7#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#2)
to evaluate the predictive##2##4##(2008-2#1)(2012-3#1)
to evaluate the presence of##2##5##(2008-10#1)(2011-1#1)
to evaluate the prevalence and##2##5##(2007-7#1)(2013-8#1)
to evaluate the prevalence of##7##5##(2007-8#1)(2008-12#2)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
to evaluate the prevalence##9##4##(2007-7#1)(2007-8#1)(2008-12#2)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
to evaluate the procedure##2##4##(2008-5#1)(2008-7#1)
to evaluate the prognostic value##2##5##(1997-8#1)(2007-8#1)
to evaluate the prognostic##4##4##(1997-8#1)(2007-8#2)(2010-6#1)
to evaluate the protective effect of##3##6##(2007-2#1)(2008-5#1)(2013-1#1)
to evaluate the protective##5##4##(2007-2#1)(2008-5#2)(2008-6#1)(2013-1#1)
to evaluate the purity##3##4##(2008-1#1)(2008-4#1)(2008-8#1)
to evaluate the quality of life in##2##7##(2009-8#1)(2012-2#1)
to evaluate the quality of life##3##6##(2007-11#1)(2009-8#1)(2012-2#1)
to evaluate the quality of the##2##6##(2007-8#1)(2008-10#1)
to evaluate the quality of##11##5##(1994-3#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)(2012-2#2)(2012-3#1)
to evaluate the quality##12##4##(1994-3#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)(2012-2#3)(2012-3#1)
to evaluate the rate of##3##5##(1994-6#1)(2010-5#1)(2012-1#1)
to evaluate the rate##4##4##(1994-6#1)(2010-5#1)(2011-2#1)(2012-1#1)
to evaluate the relationship between##5##5##(1995-8#1)(2008-10#1)(2009-10#1)(2012-2#2)
to evaluate the relationship of##3##5##(2011-1#1)(2011-12#2)
to evaluate the relationship##9##4##(1995-8#1)(2008-10#1)(2008-6#1)(2009-10#1)(2011-1#1)(2011-12#2)(2012-2#2)
to evaluate the relative##4##4##(1996-8#1)(2006-6#1)(2008-10#1)(2011-2#1)
to evaluate the reliability of##3##5##(1996-11#1)(2007-12#1)(2012-1#1)
to evaluate the reliability##4##4##(1996-11#1)(2007-12#1)(2010-10#1)(2012-1#1)
to evaluate the reproducibility of##3##5##(2008-10#2)(2008-12#1)
to evaluate the reproducibility##4##4##(2008-10#2)(2008-12#1)(2009-11#1)
to evaluate the response of##2##5##(1997-6#1)(2006-2#1)
to evaluate the results of##8##5##(1997-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-9#1)(2011-2#1)
to evaluate the results##9##4##(1997-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-9#1)(2009-10#1)(2011-2#1)
to evaluate the risk factors for##2##6##(2008-1#1)(2013-1#1)
to evaluate the risk factors##3##5##(2008-1#1)(2011-1#1)(2013-1#1)
to evaluate the risk of##6##5##(1995-9#1)(2007-11#2)(2008-8#1)(2011-2#2)
to evaluate the risk##14##4##(1995-9#1)(2007-11#2)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-11#2)(2013-1#1)
to evaluate the robustness of##2##5##(2008-10#1)(2011-1#1)
to evaluate the role of this residue in##2##8##(1995-2#1)(1996-2#1)
to evaluate the role of##29##5##(1990-10#2)(1990-5#1)(1992-9#1)(1994-10#1)(1994-6#1)(1994-9#1)(1995-2#1)(1996-2#1)(2005-10#1)(2006-6#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#1)(2010-10#1)(2011-2#2)(2013-1#1)
to evaluate the roles of##2##5##(2008-10#1)(2008-9#1)
to evaluate the safety and efficacy of the##3##8##(2006-8#1)(2008-11#2)
to evaluate the safety and efficacy of##6##7##(2006-8#1)(2008-11#3)(2010-12#1)(2012-2#1)
to evaluate the safety and feasibility of##2##7##(2006-6#1)(2007-10#1)
to evaluate the safety and##9##5##(2006-6#1)(2006-8#1)(2007-10#1)(2008-11#3)(2008-7#1)(2010-12#1)(2012-2#1)
to evaluate the safety of##3##5##(1996-3#1)(2008-11#1)(2011-1#1)
to evaluate the safety##13##4##(1992-11#1)(1996-3#1)(2006-6#1)(2006-8#1)(2007-10#1)(2008-11#4)(2008-7#1)(2010-12#1)(2011-1#1)(2012-2#1)
to evaluate the sampling##2##4##(2008-10#1)(2009-5#1)
to evaluate the scientific##2##4##(2008-3#1)(2011-2#1)
to evaluate the severity of##2##5##(2008-6#1)(2012-12#1)
to evaluate the short term##2##5##(1994-9#1)(2010-9#1)
to evaluate the significance of##2##5##(1993-12#1)(2011-2#1)
to evaluate the skin##3##4##(1991-4#1)(2008-5#2)
to evaluate the spatial##2##4##(1994-3#1)(2008-10#1)
to evaluate the stability of##3##5##(1992-2#1)(1994-3#1)(2010-3#1)
to evaluate the stability##4##4##(1992-2#1)(1994-3#1)(2008-12#1)(2010-3#1)
to evaluate the status of##3##5##(2006-12#1)(2011-2#1)(2013-8#1)
to evaluate the suitability of##4##5##(2008-10#2)(2010-4#1)(2010-9#1)
to evaluate the suitability##5##4##(2005-5#1)(2008-10#2)(2010-4#1)(2010-9#1)
to evaluate the survival of##2##5##(1994-12#1)(2012-12#1)
to evaluate the survival##3##4##(1994-12#1)(2006-6#1)(2012-12#1)
to evaluate the susceptibility##2##4##(2008-12#1)(2009-2#1)
to evaluate the therapeutic potential of##2##6##(2009-3#1)(2013-8#1)
to evaluate the therapeutic##5##4##(1990-2#1)(2008-10#1)(2009-10#1)(2009-3#1)(2013-8#1)
to evaluate the time##2##4##(1992-3#1)(2008-2#1)
to evaluate the underlying##2##4##(2008-7#1)(2010-8#1)
to evaluate the urinary excretion of##2##6##(1994-6#1)(2008-7#1)
to evaluate the use of##9##5##(1990-11#1)(1996-1#1)(2006-10#1)(2006-2#1)(2008-1#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)
to evaluate the usefulness of##5##5##(2007-11#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-6#1)
to evaluate the usefulness##6##4##(2006-8#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-6#1)
to evaluate the utility of##3##5##(2007-7#1)(2008-10#1)(2008-7#1)
to evaluate the validity of##3##5##(2007-8#1)(2012-1#1)(2013-8#1)
to evaluate the validity##5##4##(2007-12#1)(2007-8#1)(2010-3#1)(2012-1#1)(2013-8#1)
to evaluate the whole##2##4##(2008-10#1)(2008-12#1)
to evaluate the wound-healing##2##4##(2008-10#1)(2008-5#1)
to evaluate the##1020##3##(1990-10#5)(1990-11#2)(1990-12#2)(1990-2#5)(1990-3#2)(1990-5#1)(1990-6#2)(1990-9#2)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#3)(1991-7#1)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#3)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#4)(1993-3#3)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#4)(1994-1#1)(1994-10#1)(1994-11#4)(1994-12#3)(1994-2#2)(1994-3#4)(1994-5#2)(1994-6#5)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#4)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#3)(1996-1#3)(1996-11#2)(1996-2#5)(1996-3#2)(1996-6#3)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#4)(1997-7#1)(1997-8#8)(2004-1#2)(2004-10#1)(2004-12#4)(2004-3#1)(2005-10#1)(2005-11#3)(2005-5#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#11)(2006-11#6)(2006-12#7)(2006-2#6)(2006-3#3)(2006-5#4)(2006-6#16)(2006-7#1)(2006-8#10)(2006-9#2)(2007-1#5)(2007-10#9)(2007-11#21)(2007-12#5)(2007-2#8)(2007-3#2)(2007-4#6)(2007-5#2)(2007-6#4)(2007-7#32)(2007-8#33)(2007-9#13)(2008-1#15)(2008-10#91)(2008-11#17)(2008-12#28)(2008-2#14)(2008-3#30)(2008-4#9)(2008-5#50)(2008-6#15)(2008-7#21)(2008-8#10)(2008-9#13)(2009-10#5)(2009-11#5)(2009-12#4)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#4)(2009-6#2)(2009-7#4)(2009-8#7)(2010-1#2)(2010-10#5)(2010-11#2)(2010-12#8)(2010-2#2)(2010-3#5)(2010-4#10)(2010-5#4)(2010-6#4)(2010-7#2)(2010-8#11)(2010-9#4)(2011-1#21)(2011-12#9)(2011-2#45)(2011-7#1)(2012-1#13)(2012-11#4)(2012-12#14)(2012-2#28)(2012-3#19)(2012-8#1)(2013-1#41)(2013-7#9)(2013-8#24)
to evaluate their developmental##2##4##(2010-12#1)(2012-2#1)
to evaluate their experiences with##2##5##(2007-7#1)(2008-10#1)
to evaluate their experiences##3##4##(2007-7#1)(2008-10#2)
to evaluate their impact##2##4##(2008-10#1)(2009-11#1)
to evaluate their potential##2##4##(1992-5#1)(2008-11#1)
to evaluate their##39##3##(1992-5#1)(1994-3#2)(2005-11#1)(2006-11#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-11#1)(2010-10#1)(2010-12#1)(2011-1#2)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
to evaluate these##8##3##(1990-6#1)(2007-11#2)(2008-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
to evaluate this##8##3##(1993-3#1)(1993-6#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)(2011-3#1)
to evaluate three##4##3##(2004-12#1)(2010-11#1)(2013-1#1)(2013-8#1)
to evaluate to what extent##2##5##(2008-10#1)(2011-1#1)
to evaluate to##3##3##(1994-3#1)(2008-10#1)(2011-1#1)
to evaluate total##2##3##(2011-1#1)(2011-2#1)
to evaluate treatment response##2##4##(2008-7#1)(2010-9#1)
to evaluate treatment##3##3##(2007-7#1)(2008-7#1)(2010-9#1)
to evaluate two##2##3##(2006-7#1)(2011-12#1)
to evaluate various##2##3##(1992-3#1)(2007-4#1)
to evaluate virulence of##2##4##(2010-12#2)
to evaluate what##2##3##(2011-2#1)(2012-12#1)
to evaluate whether an##2##4##(2007-7#1)(2010-8#1)
to evaluate whether in##2##4##(1993-9#1)(2011-2#1)
to evaluate whether or not##2##5##(1990-11#1)(2008-10#1)
to evaluate whether the##16##4##(1992-12#1)(1993-8#2)(1995-12#1)(1997-3#1)(2006-8#1)(2008-10#1)(2008-4#1)(2008-5#2)(2012-1#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
to evaluate whether##50##3##(1990-11#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-12#1)(1995-12#1)(1997-3#1)(2006-10#1)(2006-11#1)(2006-8#3)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-4#1)(2010-11#2)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
to evaluate which##3##3##(1990-6#1)(2008-11#1)(2011-1#1)
to evaluate##1747##2##(1990-10#6)(1990-11#4)(1990-12#6)(1990-2#6)(1990-3#3)(1990-4#1)(1990-5#2)(1990-6#5)(1990-7#1)(1990-8#2)(1990-9#3)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#4)(1991-4#3)(1991-5#1)(1991-7#3)(1991-8#1)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#4)(1992-12#5)(1992-2#5)(1992-3#6)(1992-4#5)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#3)(1993-10#1)(1993-11#3)(1993-12#6)(1993-2#1)(1993-3#4)(1993-4#1)(1993-6#2)(1993-8#4)(1993-9#7)(1994-1#1)(1994-10#2)(1994-11#4)(1994-12#6)(1994-2#6)(1994-3#8)(1994-5#4)(1994-6#6)(1994-7#1)(1994-8#1)(1994-9#5)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#6)(1995-3#3)(1995-4#2)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#3)(1996-1#4)(1996-11#2)(1996-12#2)(1996-2#7)(1996-3#8)(1996-5#2)(1996-6#4)(1996-7#2)(1996-8#5)(1996-9#4)(1997-1#5)(1997-2#6)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#15)(2004-1#2)(2004-10#1)(2004-12#5)(2004-2#2)(2004-3#1)(2004-9#2)(2005-1#2)(2005-10#2)(2005-11#5)(2005-5#2)(2005-7#3)(2005-8#2)(2005-9#1)(2006-1#2)(2006-10#18)(2006-11#12)(2006-12#10)(2006-2#8)(2006-3#3)(2006-4#1)(2006-5#8)(2006-6#18)(2006-7#5)(2006-8#30)(2006-9#3)(2007-1#6)(2007-10#16)(2007-11#40)(2007-12#12)(2007-2#12)(2007-3#5)(2007-4#13)(2007-5#5)(2007-6#6)(2007-7#49)(2007-8#56)(2007-9#21)(2008-1#25)(2008-10#148)(2008-11#28)(2008-12#37)(2008-2#24)(2008-3#45)(2008-4#22)(2008-5#78)(2008-6#23)(2008-7#38)(2008-8#18)(2008-9#28)(2009-10#8)(2009-11#8)(2009-12#6)(2009-2#3)(2009-3#1)(2009-4#7)(2009-5#8)(2009-6#6)(2009-7#5)(2009-8#9)(2009-9#2)(2010-1#3)(2010-10#7)(2010-11#7)(2010-12#18)(2010-2#4)(2010-3#10)(2010-4#10)(2010-5#9)(2010-6#9)(2010-7#4)(2010-8#19)(2010-9#8)(2011-1#35)(2011-12#14)(2011-2#75)(2011-3#1)(2011-7#1)(2012-1#21)(2012-11#5)(2012-12#26)(2012-2#47)(2012-3#31)(2012-8#1)(2013-1#76)(2013-7#17)(2013-8#45)
to evaluated the##2##3##(2006-6#1)(2007-8#1)
to evaluating the##2##3##(2006-5#1)(2007-12#1)
to evaluating##3##2##(1995-12#1)(2006-5#1)(2007-12#1)
to evaluation of##6##3##(1991-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-9#1)(2010-11#1)
to evaluation##10##2##(1991-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-9#1)(2010-11#1)(2012-2#1)(2013-1#2)
to evanescent wave##2##3##(2008-10#1)(2008-3#1)
to evaporate##2##2##(1995-12#1)(2008-11#1)
to evaporation##3##2##(2007-1#1)(2007-8#1)(2008-10#1)
to even the##2##3##(1993-12#1)(2008-5#1)
to even##8##2##(1993-12#1)(1995-1#1)(1995-6#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2012-12#1)
to events in##2##3##(1991-9#1)(1995-1#1)
to events##3##2##(1991-9#1)(1995-1#1)(2008-11#1)
to eventually produce##2##3##(2006-7#1)(2011-1#1)
to eventually##6##2##(1995-12#1)(2006-7#1)(2007-11#1)(2007-4#1)(2010-9#1)(2011-1#1)
to ever##2##2##(2009-3#1)(2011-1#1)
to every other##2##3##(2010-2#1)(2013-8#1)
to every##18##2##(1991-3#1)(1995-3#1)(1996-1#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-5#1)(2008-9#1)(2009-5#1)(2010-2#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
to everyday##5##2##(1994-6#1)(1997-8#1)(2010-12#1)(2010-4#1)(2012-1#1)
to everyone##2##2##(2012-11#1)(2013-7#1)
to evict##2##2##(1996-12#1)(1996-6#1)
to evidence##9##2##(1993-9#1)(2008-3#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
to evidence-based practice##4##3##(2013-1#4)
to evidence-based##11##2##(2006-10#1)(2006-9#1)(2007-5#1)(2008-1#1)(2008-8#1)(2011-2#1)(2013-1#5)
to evoke a##2##3##(1991-11#1)(2009-4#1)
to evoke##13##2##(1991-11#1)(1991-2#1)(1992-3#1)(1993-12#2)(1993-3#1)(1995-2#1)(1996-3#1)(2007-11#2)(2008-1#1)(2009-4#1)(2012-1#1)
to evolution##6##2##(1995-3#1)(1997-6#1)(2008-8#1)(2012-2#1)(2012-3#2)
to evolutionary pressures##2##3##(1991-11#1)(2009-3#1)
to evolutionary##10##2##(1991-11#1)(1995-8#1)(1996-8#1)(2006-12#1)(2006-7#1)(2007-12#2)(2008-8#1)(2009-3#1)(2010-3#1)
to evolve and##7##3##(2007-4#1)(2008-10#1)(2008-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
to evolve as##3##3##(2006-10#1)(2007-4#1)(2008-10#1)
to evolve from##2##3##(2006-10#1)(2013-8#1)
to evolve in response to##2##5##(2008-8#1)(2009-8#1)
to evolve in##8##3##(1994-12#1)(2006-6#1)(2007-12#1)(2008-8#2)(2009-8#1)(2010-3#1)(2011-2#1)
to evolve into##2##3##(2008-3#1)(2009-12#1)
to evolve rapidly##3##3##(2007-12#1)(2008-6#1)(2010-3#1)
to evolve to##5##3##(1997-3#1)(2007-11#1)(2007-9#1)(2010-2#1)(2011-2#1)
to evolve##68##2##(1994-12#2)(1994-3#1)(1995-3#1)(1995-8#1)(1997-3#1)(2004-11#1)(2005-8#1)(2006-10#8)(2006-3#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-4#3)(2007-5#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-6#1)(2008-8#7)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-10#3)(2010-12#1)(2010-2#1)(2010-3#3)(2010-8#2)(2011-12#1)(2011-2#4)(2012-12#1)(2013-1#2)(2013-8#2)
to evolving##2##2##(2008-9#2)
to ex vivo##3##3##(2006-12#1)(2008-11#1)(2011-3#1)
to ex##5##2##(2006-12#1)(2008-11#1)(2009-2#1)(2009-8#1)(2011-3#1)
to exacerbate the##3##3##(2008-12#1)(2012-12#1)(2013-1#1)
to exacerbate##5##2##(1996-4#1)(2008-12#1)(2008-8#1)(2012-12#1)(2013-1#1)
to exacerbation of##2##3##(2004-3#1)(2005-11#1)
to exactly##3##2##(2007-12#1)(2009-11#1)(2010-8#1)
to exalt the##2##3##(2010-6#1)(2012-2#1)
to examinations of##2##3##(2008-11#1)(2008-3#1)
to examine a##7##3##(1996-12#1)(2005-7#1)(2007-11#1)(2008-11#1)(2008-5#1)(2011-12#1)(2012-2#1)
to examine and##6##3##(1992-11#1)(1993-12#1)(1995-11#1)(2006-12#1)(2007-6#1)(2010-9#1)
to examine associations between##2##4##(2008-9#1)(2012-1#1)
to examine associations##3##3##(2007-12#1)(2008-9#1)(2012-1#1)
to examine barriers##2##3##(2008-6#1)(2013-1#1)
to examine both##3##3##(2008-1#2)(2013-7#1)
to examine certain##2##3##(2006-7#1)(2008-7#1)
to examine changes in##2##4##(2007-2#1)(2012-2#1)
to examine changes##3##3##(2007-2#1)(2008-10#1)(2012-2#1)
to examine developmental changes in the##2##6##(1997-2#1)(2008-11#1)
to examine differences in##4##4##(2006-6#1)(2007-10#1)(2008-10#1)(2011-2#1)
to examine effects of##5##4##(1992-2#1)(1996-3#1)(2007-8#1)(2008-8#1)(2010-2#1)
to examine expression##2##3##(1997-5#1)(2011-2#1)
to examine factors associated with##2##5##(2006-4#1)(2007-7#1)
to examine factors that contribute to##2##6##(2007-10#1)(2008-7#1)
to examine factors##5##3##(2006-4#1)(2007-10#1)(2007-7#1)(2008-7#1)(2011-2#1)
to examine for##2##3##(1997-5#1)(2008-12#1)
to examine further the##3##4##(1994-8#1)(1995-2#1)(2008-9#1)
to examine how##14##3##(1993-2#1)(1994-12#1)(1995-6#1)(2005-11#1)(2007-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
to examine if##9##3##(1992-11#1)(1996-3#1)(1996-7#1)(2004-12#1)(2005-10#1)(2007-2#1)(2008-11#1)(2008-9#1)(2012-12#1)
to examine in##4##3##(1994-2#1)(2007-12#1)(2007-9#1)(2009-7#1)
to examine its psychometric properties##2##5##(2012-2#2)
to examine its##9##3##(1994-9#1)(2005-7#1)(2007-11#2)(2007-7#1)(2008-2#1)(2009-4#1)(2012-2#2)
to examine job satisfaction##2##4##(1994-1#1)(2008-11#1)
to examine mechanisms##2##3##(2007-1#1)(2008-4#1)
to examine molecular##2##3##(2008-7#1)(2008-9#1)
to examine nursing##2##3##(2008-12#1)(2010-10#1)
to examine our##2##3##(1995-5#1)(2007-3#1)
to examine patients'##2##3##(1990-4#1)(2009-12#1)
to examine patterns of##3##4##(1996-4#1)(2008-10#1)(2008-6#1)
to examine possible##4##3##(2007-2#1)(2008-11#1)(2008-4#1)(2010-7#1)
to examine sex differences in##2##5##(1993-4#1)(1996-12#1)
to examine specific##3##3##(2007-12#1)(2007-6#1)(2013-7#1)
to examine the association between##7##5##(1995-2#1)(2006-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-2#1)(2013-8#1)
to examine the association##8##4##(1995-2#1)(2006-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-2#2)(2013-8#1)
to examine the binding##2##4##(1994-9#1)(1995-12#1)
to examine the changes in##3##5##(2007-8#1)(2008-4#1)(2013-8#1)
to examine the conditions##2##4##(2008-8#1)(2009-7#1)
to examine the consequences of##3##5##(1995-6#1)(2008-2#1)(2008-8#1)
to examine the contribution of##3##5##(2008-10#1)(2008-3#1)(2013-8#1)
to examine the contribution##4##4##(1993-2#1)(2008-10#1)(2008-3#1)(2013-8#1)
to examine the correlations##2##4##(1993-12#1)(2007-12#1)
to examine the crack##2##4##(2009-7#2)
to examine the demographic##2##4##(2008-8#1)(2012-3#1)
to examine the development of##3##5##(2005-8#1)(2008-11#1)(2008-5#1)
to examine the distribution of the##2##6##(1997-5#1)(2010-6#1)
to examine the distribution of##6##5##(1991-8#1)(1996-3#1)(1997-5#1)(2008-5#1)(2008-8#1)(2010-6#1)
to examine the effect of a##2##6##(2010-2#2)
to examine the effect of the##5##6##(1990-2#1)(1996-6#1)(2009-4#2)(2010-11#1)
to examine the effect of##37##5##(1990-2#1)(1991-10#2)(1992-6#1)(1993-12#2)(1993-3#1)(1994-11#1)(1995-10#1)(1996-12#1)(1996-6#1)(2006-7#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#2)(2009-12#1)(2009-4#2)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-6#1)(2010-9#1)(2012-12#1)(2012-2#2)(2013-1#1)
to examine the effect##38##4##(1990-2#1)(1991-10#2)(1992-6#1)(1993-12#2)(1993-3#1)(1994-11#1)(1995-10#1)(1996-12#1)(1996-6#1)(1997-2#1)(2006-7#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#2)(2009-12#1)(2009-4#2)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-6#1)(2010-9#1)(2012-12#1)(2012-2#2)(2013-1#1)
to examine the effects of a physical activity and nutrition intervention on##2##12##(2007-12#2)
to examine the effects of a##6##6##(1994-2#1)(2007-12#3)(2009-3#1)(2013-8#1)
to examine the effects of the##3##6##(2005-11#1)(2009-7#1)(2012-2#1)
to examine the effects of##39##5##(1990-2#1)(1991-12#1)(1992-1#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-11#1)(1996-3#1)(1997-4#1)(1997-5#1)(2005-11#3)(2006-10#1)(2006-6#1)(2007-12#3)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-3#1)(2009-7#1)(2010-8#1)(2012-2#2)(2013-1#1)(2013-8#4)
to examine the evolution of##2##5##(1996-11#1)(2009-8#1)
to examine the experiences of##3##5##(1995-1#1)(2008-12#1)(2010-12#1)
to examine the expression of the##2##6##(1992-12#1)(1996-9#1)
to examine the expression of##6##5##(1992-12#1)(1992-8#1)(1994-6#1)(1996-9#1)(2007-8#1)(2008-8#1)
to examine the expression##7##4##(1991-5#1)(1992-12#1)(1992-8#1)(1994-6#1)(1996-9#1)(2007-8#1)(2008-8#1)
to examine the extent to which##6##6##(2008-1#1)(2008-3#1)(2008-8#1)(2009-4#1)(2009-9#1)(2012-2#1)
to examine the extent##9##4##(2006-10#1)(2008-1#1)(2008-3#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-9#1)(2012-1#1)(2012-2#1)
to examine the factors##2##4##(2008-3#1)(2012-3#1)
to examine the feasibility of using##2##6##(1997-5#1)(2008-11#1)
to examine the feasibility of##8##5##(1995-2#1)(1997-5#1)(2007-8#1)(2008-11#1)(2008-9#1)(2010-12#1)(2013-1#2)
to examine the functional role of##2##6##(1996-5#1)(2008-11#1)
to examine the functional##4##4##(1996-5#2)(2008-10#1)(2008-11#1)
to examine the genetic##4##4##(2007-10#1)(2008-10#1)(2008-4#1)(2009-5#1)
to examine the impact of##9##5##(1991-3#1)(1994-2#1)(1997-2#1)(1997-6#1)(2006-2#1)(2007-10#1)(2008-8#1)(2009-9#1)(2011-2#1)
to examine the impacts of##2##5##(2008-1#1)(2012-12#1)
to examine the importance of##3##5##(1992-6#1)(1994-9#1)(2008-7#1)
to examine the in vitro##2##5##(1990-3#1)(1997-2#1)
to examine the influence of##7##5##(1995-3#1)(2005-10#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-12#1)(2010-12#1)
to examine the interaction of##2##5##(1997-6#1)(2008-3#1)
to examine the interactions##2##4##(2006-10#1)(2008-7#1)
to examine the kinetics of##2##5##(1990-11#1)(1996-7#1)
to examine the mechanisms by which##2##6##(2008-7#1)(2009-2#1)
to examine the mechanisms##5##4##(1996-11#1)(2007-4#1)(2008-2#1)(2008-7#1)(2009-2#1)
to examine the metabolic##2##4##(2008-10#1)(2008-3#1)
to examine the neural correlates of##2##6##(2010-2#1)(2012-2#1)
to examine the neural##4##4##(2008-11#2)(2010-2#1)(2012-2#1)
to examine the pattern of##2##5##(1991-12#1)(2007-7#1)
to examine the patterns of##2##5##(2008-7#1)(2012-12#1)
to examine the possibility of##2##5##(2007-9#1)(2008-5#1)
to examine the possibility##3##4##(1991-8#1)(2007-9#1)(2008-5#1)
to examine the possible role of##2##6##(1994-11#1)(1996-2#1)
to examine the possible##6##4##(1994-11#1)(1996-2#1)(2005-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
to examine the potential##3##4##(2007-1#1)(2008-11#1)(2012-12#1)
to examine the presence##2##4##(1991-7#1)(1994-2#1)
to examine the prevalence and##2##5##(2009-5#1)(2011-1#1)
to examine the prevalence##5##4##(2007-3#1)(2008-5#1)(2009-5#1)(2010-3#1)(2011-1#1)
to examine the psychometric properties of the##2##7##(2010-11#1)(2013-1#1)
to examine the reactions of##2##5##(2008-11#1)(2008-7#1)
to examine the regulation of##3##5##(1996-8#1)(2008-4#1)(2008-9#1)
to examine the relation between##2##5##(2008-2#1)(2011-1#1)
to examine the relation of##3##5##(1997-6#1)(2006-8#1)(2009-7#1)
to examine the relation##5##4##(1997-6#1)(2006-8#1)(2008-2#1)(2009-7#1)(2011-1#1)
to examine the relationship between body##3##6##(2007-12#1)(2009-5#1)(2011-1#1)
to examine the relationship between the##4##6##(1997-7#1)(2008-10#1)(2013-8#2)
to examine the relationship between##28##5##(1990-4#1)(1992-2#1)(1995-3#1)(1997-7#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-12#2)(2008-10#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-2#2)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
to examine the relationship of##2##5##(2008-4#1)(2011-2#1)
to examine the relationship##30##4##(1990-4#1)(1992-2#1)(1995-3#1)(1997-7#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-12#2)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-2#2)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
to examine the relationships between these##2##6##(2007-10#1)(2011-2#1)
to examine the relationships between##8##5##(1996-12#1)(1997-2#1)(2007-10#1)(2008-10#1)(2009-12#1)(2010-4#1)(2011-1#1)(2011-2#1)
to examine the relationships##9##4##(1996-12#1)(1997-2#1)(2007-10#2)(2008-10#1)(2009-12#1)(2010-4#1)(2011-1#1)(2011-2#1)
to examine the relative##2##4##(1996-1#1)(2008-8#1)
to examine the results of##2##5##(2007-10#1)(2009-12#1)
to examine the role of the##4##6##(1993-12#1)(1996-5#1)(2005-10#1)(2005-11#1)
to examine the role of##15##5##(1990-11#1)(1993-12#1)(1994-11#1)(1996-10#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(2004-2#1)(2005-10#1)(2005-11#1)(2006-8#1)(2007-2#1)(2008-2#1)(2008-8#1)
to examine the role##17##4##(1990-11#1)(1993-12#1)(1994-11#1)(1996-10#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(2004-2#1)(2005-10#1)(2005-11#1)(2006-8#1)(2007-2#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-7#1)
to examine the significance of##3##5##(2006-9#1)(2008-3#1)(2012-2#1)
to examine the social##2##4##(2009-4#1)(2011-2#1)
to examine the spatial##2##4##(2008-10#2)
to examine the specificity of the##2##6##(1992-6#1)(1994-9#1)
to examine the structure of the##3##6##(1995-2#1)(1995-3#1)(2008-2#1)
to examine the temporal##2##4##(2008-3#2)
to examine the therapeutic##2##4##(2005-8#1)(2010-5#1)
to examine the utility##2##4##(2009-8#1)(2010-3#1)
to examine the##497##3##(1990-10#1)(1990-11#2)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-10#3)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#4)(1992-6#3)(1992-7#1)(1992-8#4)(1993-12#7)(1993-2#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#4)(1994-12#2)(1994-2#5)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#3)(1995-1#2)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#5)(1995-4#2)(1995-5#2)(1995-6#1)(1996-1#3)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#2)(1996-3#3)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#5)(1997-3#1)(1997-4#3)(1997-5#4)(1997-6#3)(1997-7#1)(1997-8#2)(2004-1#2)(2004-10#1)(2004-2#1)(2005-10#4)(2005-11#6)(2005-8#2)(2006-1#1)(2006-10#4)(2006-11#2)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#4)(2006-9#1)(2007-1#3)(2007-10#14)(2007-11#4)(2007-12#11)(2007-2#2)(2007-3#2)(2007-4#4)(2007-5#1)(2007-7#3)(2007-8#6)(2007-9#3)(2008-1#4)(2008-10#26)(2008-11#19)(2008-12#9)(2008-2#9)(2008-3#11)(2008-4#7)(2008-5#13)(2008-6#1)(2008-7#16)(2008-8#16)(2008-9#6)(2009-10#2)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#5)(2009-7#7)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#7)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#9)(2011-2#15)(2012-1#3)(2012-11#2)(2012-12#8)(2012-2#12)(2012-3#6)(2013-1#14)(2013-7#1)(2013-8#11)
to examine their##9##3##(1995-8#1)(1996-11#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-8#1)(2009-9#1)
to examine these##9##3##(1993-12#1)(2006-3#1)(2007-12#1)(2007-2#1)(2008-6#1)(2009-10#1)(2010-7#1)(2012-2#1)(2012-3#1)
to examine this possibility##2##4##(1996-3#1)(2009-6#1)
to examine this##7##3##(1996-3#1)(2007-12#1)(2009-10#1)(2009-11#1)(2009-6#1)(2010-2#2)
to examine ultrastructural##2##3##(2007-5#1)(2008-10#1)
to examine what##2##3##(2010-12#1)(2012-11#1)
to examine whether a##3##4##(2008-10#1)(2010-5#1)(2012-12#1)
to examine whether individuals with##2##5##(1997-2#1)(2009-4#1)
to examine whether or not##2##5##(1996-3#1)(2007-6#1)
to examine whether the##10##4##(1993-12#1)(1994-10#1)(1996-2#1)(1996-7#2)(2004-11#1)(2008-5#1)(2009-4#2)(2011-1#1)
to examine whether these##2##4##(2006-10#1)(2009-1#1)
to examine whether this##2##4##(1993-4#1)(2012-1#1)
to examine whether##43##3##(1991-10#1)(1991-3#1)(1991-9#1)(1993-12#1)(1993-4#1)(1994-10#1)(1994-2#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-7#2)(1997-2#2)(1997-5#1)(1997-8#1)(2004-11#1)(2006-10#1)(2006-7#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2009-1#1)(2009-4#3)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#1)
to examine which##2##3##(1994-5#1)(2009-2#1)
to examine why##2##3##(2008-10#1)(2009-5#1)
to examine##867##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#3)(1990-5#3)(1990-6#1)(1990-8#1)(1991-10#4)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#2)(1992-10#2)(1992-11#3)(1992-12#1)(1992-2#6)(1992-3#2)(1992-6#4)(1992-7#1)(1992-8#4)(1993-12#10)(1993-2#2)(1993-3#1)(1993-4#3)(1993-5#1)(1993-9#1)(1994-1#2)(1994-10#1)(1994-11#6)(1994-12#4)(1994-2#7)(1994-3#1)(1994-5#3)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#5)(1995-1#3)(1995-10#3)(1995-11#2)(1995-12#2)(1995-2#5)(1995-3#6)(1995-4#2)(1995-5#4)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#3)(1996-12#7)(1996-2#4)(1996-3#7)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#4)(1996-8#1)(1996-9#2)(1997-2#8)(1997-3#2)(1997-4#3)(1997-5#9)(1997-6#3)(1997-7#1)(1997-8#4)(2004-1#2)(2004-10#1)(2004-11#1)(2004-12#1)(2004-2#1)(2005-1#2)(2005-10#6)(2005-11#7)(2005-7#4)(2005-8#2)(2006-1#2)(2006-10#8)(2006-11#2)(2006-12#3)(2006-2#3)(2006-3#2)(2006-4#4)(2006-5#2)(2006-6#3)(2006-7#5)(2006-8#5)(2006-9#3)(2007-1#5)(2007-10#16)(2007-11#7)(2007-12#22)(2007-2#8)(2007-3#4)(2007-4#5)(2007-5#3)(2007-6#5)(2007-7#6)(2007-8#12)(2007-9#5)(2008-1#7)(2008-10#41)(2008-11#40)(2008-12#16)(2008-2#12)(2008-3#12)(2008-4#14)(2008-5#20)(2008-6#8)(2008-7#24)(2008-8#21)(2008-9#12)(2009-1#1)(2009-10#5)(2009-11#1)(2009-12#8)(2009-2#3)(2009-3#1)(2009-4#8)(2009-5#10)(2009-6#3)(2009-7#9)(2009-8#4)(2009-9#4)(2010-10#4)(2010-11#3)(2010-12#10)(2010-2#13)(2010-3#4)(2010-4#4)(2010-5#4)(2010-6#4)(2010-7#5)(2010-8#4)(2010-9#5)(2011-1#15)(2011-12#1)(2011-2#26)(2012-1#8)(2012-11#3)(2012-12#15)(2012-2#24)(2012-3#11)(2013-1#24)(2013-7#4)(2013-8#15)
to examining the##2##3##(2008-3#1)(2013-1#1)
to examining##6##2##(2008-3#1)(2008-5#1)(2010-2#1)(2013-1#3)
to exceed a##3##3##(2008-10#2)(2008-7#1)
to exceed that##3##3##(2006-12#1)(2008-10#1)(2010-2#1)
to exceed the##6##3##(1990-10#1)(1995-3#1)(2007-5#1)(2008-3#2)(2009-4#1)
to exceed##21##2##(1990-10#1)(1994-12#1)(1995-3#1)(2005-8#1)(2006-12#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-3#5)(2008-7#1)(2008-8#1)(2009-4#1)(2010-2#1)(2012-11#2)
to excellent yields##7##3##(2005-8#2)(2007-11#2)(2008-9#1)(2010-6#1)(2010-8#1)
to excellent##19##2##(2005-8#2)(2006-12#1)(2006-3#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-5#1)(2008-10#1)(2008-9#1)(2009-12#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-12#1)
to exceptionally##3##2##(2007-9#1)(2008-4#2)
to excess##9##2##(1990-7#1)(1993-1#1)(1996-5#1)(2005-10#1)(2006-1#1)(2008-10#1)(2008-11#1)(2010-4#1)(2011-1#1)
to excessive##26##2##(1992-5#1)(1994-10#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-7#1)(2005-7#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-1#1)(2007-9#1)(2008-11#1)(2008-2#2)(2008-4#1)(2009-3#1)(2009-4#1)(2010-6#1)(2010-8#1)(2011-12#1)(2012-12#2)(2013-1#1)
to exchange the##2##3##(1997-1#1)(2008-10#1)
to exchange##19##2##(1995-8#1)(1997-1#2)(1997-8#1)(2005-9#1)(2006-5#1)(2008-10#3)(2008-5#1)(2010-8#3)(2011-2#2)(2012-2#2)(2013-1#2)
to excise##2##2##(1994-3#1)(2006-10#1)
to excitatory##2##2##(1995-11#1)(1996-12#1)
to excite fluorescence##2##3##(2008-9#1)(2012-2#1)
to excite the##6##3##(1991-3#1)(2007-12#1)(2007-9#2)(2008-2#1)(2008-3#1)
to excite##14##2##(1991-3#1)(1992-3#1)(1992-7#1)(2007-12#2)(2007-9#2)(2008-2#1)(2008-3#2)(2008-9#1)(2010-12#1)(2011-1#1)(2012-2#1)
to excited##3##2##(2008-10#1)(2009-11#1)(2010-1#1)
to excited-state absorption##3##3##(2007-12#1)(2008-3#2)
to excited-state##4##2##(2007-12#2)(2008-3#2)
to excitotoxic##2##2##(1990-7#1)(1995-5#1)
to exclude a possible##2##4##(1991-12#1)(2007-8#1)
to exclude a##7##3##(1991-12#1)(1993-4#1)(2007-8#2)(2008-12#1)(2008-8#1)(2012-1#1)
to exclude an infectious##2##4##(2007-10#1)(2011-2#1)
to exclude an##5##3##(1993-1#1)(2006-2#1)(2007-10#1)(2008-1#1)(2011-2#1)
to exclude other##7##3##(1990-4#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-3#1)(2009-8#1)(2012-3#1)
to exclude secondary##2##3##(2007-9#1)(2008-4#1)
to exclude that the##2##4##(1991-3#1)(2008-6#1)
to exclude the diagnosis##4##4##(1991-12#1)(1992-3#1)(2006-10#1)(2008-9#1)
to exclude the possibility##2##4##(2007-6#1)(2013-8#1)
to exclude the##11##3##(1991-12#1)(1992-3#1)(1994-10#1)(2006-10#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-9#1)(2011-2#1)(2013-8#1)
to exclude##61##2##(1990-12#1)(1990-4#1)(1990-5#1)(1991-12#2)(1991-3#1)(1992-3#1)(1993-1#2)(1993-3#1)(1993-4#1)(1993-9#1)(1994-10#1)(1994-6#1)(1995-12#1)(1995-9#1)(1996-3#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-10#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
to exclusion##3##2##(2008-9#1)(2009-9#1)(2013-1#1)
to exclusive##2##2##(1994-9#1)(1997-4#1)
to excrete##4##2##(2005-11#1)(2008-7#1)(2010-1#1)(2013-1#1)
to execute the##3##3##(2008-11#1)(2009-10#1)(2012-3#1)
to execute##17##2##(1990-10#1)(1991-3#1)(1992-2#1)(1993-2#1)(1994-6#1)(2006-4#1)(2008-11#2)(2008-2#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#2)
to executive##2##2##(2006-3#1)(2008-9#1)
to exemplify the##4##3##(1995-1#1)(2004-3#1)(2010-12#1)(2010-9#1)
to exemplify##5##2##(1995-1#1)(2004-3#1)(2005-8#1)(2010-12#1)(2010-9#1)
to exempt##2##2##(1996-11#1)(2008-10#1)
to exercise and##2##3##(2006-8#1)(2008-2#1)
to exercise in##2##3##(1996-9#1)(2012-12#1)
to exercise may##2##3##(1992-3#1)(2007-1#1)
to exercise on##2##3##(2009-1#1)(2012-2#1)
to exercise their##2##3##(2008-11#1)(2012-2#1)
to exercise##46##2##(1990-11#1)(1990-12#1)(1992-3#1)(1993-2#1)(1996-2#1)(1996-9#1)(1997-5#1)(1997-7#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-5#2)(2007-6#2)(2008-1#1)(2008-11#2)(2008-2#2)(2008-5#2)(2008-7#2)(2009-1#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-11#2)(2012-12#2)(2012-2#2)(2013-8#3)
to exercise-induced cardioprotection##2##3##(2008-1#2)
to exercise-induced##4##2##(1992-9#1)(2008-1#2)(2010-1#1)
to exert a direct##3##4##(1992-6#1)(1994-2#1)(2007-11#1)
to exert a dual##2##4##(2006-2#1)(2008-4#1)
to exert a##17##3##(1990-12#1)(1992-6#1)(1994-2#1)(1994-6#1)(1996-9#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-8#1)(2011-2#1)
to exert an##4##3##(1995-5#1)(2007-5#1)(2008-5#1)(2008-6#1)
to exert its biological##2##4##(1991-8#1)(1997-4#1)
to exert its##8##3##(1991-8#1)(1993-12#1)(1996-8#1)(1997-4#1)(1997-5#1)(2011-1#1)(2012-2#2)
to exert their##2##3##(1994-11#1)(2006-10#1)
to exert##63##2##(1990-12#1)(1990-8#2)(1991-1#2)(1991-8#1)(1992-1#1)(1992-2#1)(1992-6#2)(1993-12#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-3#1)(1995-5#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-5#1)(2005-11#1)(2006-10#2)(2006-2#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
to exfoliated##2##2##(1993-9#1)(2005-11#1)
to exhaustion##11##2##(2007-5#1)(2008-5#1)(2011-2#3)(2013-8#6)
to exhibit a##13##3##(1990-2#1)(1991-2#1)(1993-12#1)(1994-2#1)(1997-2#1)(2008-1#1)(2008-10#5)(2008-3#1)(2012-2#1)
to exhibit an##3##3##(1996-3#1)(1997-2#1)(2009-12#1)
to exhibit any##3##3##(1991-10#1)(1996-3#1)(1997-4#1)
to exhibit enhanced##3##3##(1995-2#1)(2007-8#1)(2010-3#1)
to exhibit excellent##2##3##(2008-10#1)(2008-7#1)
to exhibit high##2##3##(2007-12#1)(2008-12#1)
to exhibit improved##2##3##(1990-8#1)(2005-11#1)
to exhibit its##3##3##(1990-12#1)(1990-7#1)(2008-11#1)
to exhibit significant##2##3##(2007-9#1)(2010-10#1)
to exhibit some##2##3##(1994-8#1)(1995-8#1)
to exhibit the lowest##2##4##(1997-2#1)(2013-8#1)
to exhibit the##8##3##(1990-12#1)(1992-5#1)(1994-11#1)(1997-2#1)(2008-11#1)(2008-3#1)(2008-5#1)(2013-8#1)
to exhibit##89##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1992-5#1)(1993-12#3)(1993-4#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-2#2)(1995-8#2)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#1)(1997-2#3)(1997-4#1)(1997-5#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#4)(2008-7#3)(2008-8#1)(2009-12#3)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-8#2)
to exist as##4##3##(1990-12#1)(1990-2#1)(2008-10#1)(2011-3#1)
to exist at the##2##4##(1995-8#1)(2008-10#1)
to exist between the##2##4##(1991-2#1)(1994-5#1)
to exist between##7##3##(1991-2#1)(1992-4#1)(1994-5#1)(1995-12#1)(2008-10#2)(2010-12#1)
to exist in a##2##4##(1994-9#1)(1995-4#1)
to exist in the##7##4##(1990-8#1)(1993-12#1)(2008-1#1)(2008-10#2)(2008-9#1)(2011-2#1)
to exist in##21##3##(1990-8#1)(1991-10#1)(1992-5#2)(1993-12#1)(1993-8#1)(1994-9#1)(1995-11#1)(1995-4#1)(1996-3#1)(1996-6#1)(1997-4#1)(2006-7#1)(2008-1#2)(2008-10#2)(2008-9#2)(2011-2#1)(2012-2#1)
to exist##64##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-6#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-9#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-4#1)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#2)(1997-3#1)(1997-4#1)(2005-11#1)(2006-7#1)(2006-9#1)(2007-12#1)(2008-1#3)(2008-10#9)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#2)(2010-1#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-11#1)(2012-2#2)
to existing methods##3##3##(2007-8#1)(2008-10#1)(2008-8#1)
to existing##40##2##(1990-7#1)(1992-1#1)(1993-8#1)(1994-1#1)(1994-12#1)(1995-3#1)(1997-3#1)(1997-7#1)(2005-7#2)(2006-12#1)(2006-5#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-2#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-9#1)(2010-11#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#3)
to exit##2##2##(2006-2#1)(2013-1#1)
to exogenous carcinogens##2##3##(2007-2#1)(2012-12#1)
to exogenous hormones##2##3##(2008-7#1)(2008-8#1)
to exogenous noradrenaline##2##3##(1990-10#1)(1997-5#1)
to exogenous##32##2##(1990-10#2)(1990-9#1)(1992-9#2)(1993-3#1)(1994-3#3)(1996-8#1)(1997-1#1)(1997-5#1)(1997-7#1)(2005-7#1)(2006-5#1)(2007-11#2)(2007-2#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2012-12#1)(2013-1#1)(2013-7#1)
to exon 3##2##3##(1992-5#2)
to exon##10##2##(1990-7#1)(1991-6#1)(1992-1#1)(1992-5#3)(1996-2#1)(1996-5#2)(2009-10#1)
to expand and##7##3##(1991-11#1)(2006-10#3)(2008-11#1)(2011-2#1)(2012-11#1)
to expand its##2##3##(2005-7#1)(2008-5#1)
to expand on##3##3##(2008-11#1)(2008-9#1)(2009-10#1)
to expand our knowledge##2##4##(1993-12#1)(2006-11#1)
to expand our understanding of the##3##6##(2007-12#1)(2009-9#1)(2010-11#1)
to expand our##7##3##(1993-12#1)(2006-11#1)(2007-12#1)(2009-9#1)(2010-11#1)(2013-1#2)
to expand the donor pool##2##5##(2007-7#1)(2008-12#1)
to expand the host range of##2##6##(1997-4#2)
to expand the scope of##2##5##(1997-7#1)(2006-12#1)
to expand the traditional##2##4##(2008-3#1)(2009-4#1)
to expand the##34##3##(1994-2#1)(1995-12#1)(1997-4#2)(1997-5#1)(1997-7#1)(2005-5#1)(2005-9#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-5#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-4#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-7#1)
to expand their##2##3##(2008-8#1)(2009-5#1)
to expand this##2##3##(1994-3#1)(1995-12#1)
to expand##97##2##(1990-12#2)(1991-11#2)(1991-4#1)(1992-1#1)(1992-2#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-12#3)(1995-5#1)(1996-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(2005-5#1)(2005-7#1)(2005-9#1)(2006-10#11)(2006-11#1)(2006-12#2)(2006-2#2)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#2)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-4#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2011-2#4)(2012-11#2)(2012-12#2)(2012-2#4)(2013-1#4)(2013-7#1)
to expansion of##5##3##(1995-11#1)(1997-5#1)(2010-12#1)(2011-2#1)(2012-2#1)
to expect from##2##3##(1994-7#1)(2007-9#1)
to expect that##2##3##(1991-5#1)(2010-4#1)
to expect##13##2##(1991-5#1)(1992-6#1)(1994-3#1)(1994-7#1)(1996-2#1)(2007-2#2)(2007-7#1)(2007-9#1)(2008-2#1)(2008-7#1)(2009-4#1)(2010-4#1)
to expectation##7##2##(1996-5#1)(2006-12#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-2#1)
to expectations##10##2##(1993-2#1)(1996-2#1)(1996-4#1)(1996-8#1)(2008-10#2)(2008-3#1)(2009-4#1)(2010-8#1)(2012-12#1)
to expected##5##2##(1991-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)
to expedite the##4##3##(2006-3#1)(2008-12#1)(2008-2#1)(2009-11#1)
to expedite##10##2##(1991-4#1)(1992-2#1)(2006-12#2)(2006-3#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-11#1)
to expel##3##2##(2008-11#1)(2008-3#1)(2012-2#1)
to experience a##2##3##(2008-3#1)(2008-6#1)
to experience emotional distress and##2##5##(2011-1#2)
to experience emotional distress##4##4##(2011-1#4)
to experience positive##2##3##(1997-8#1)(2007-8#1)
to experience the##5##3##(1996-9#1)(2006-11#1)(2006-7#1)(2008-9#1)(2012-3#1)
to experience##52##2##(1991-3#1)(1992-3#1)(1994-3#1)(1994-5#1)(1995-11#1)(1996-10#1)(1996-9#1)(1997-5#1)(1997-8#2)(2006-10#1)(2006-11#1)(2006-5#1)(2006-7#2)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#3)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#2)(2010-10#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#4)
to experienced##5##2##(1992-3#1)(1997-1#1)(2008-11#1)(2009-10#1)(2011-2#1)
to experiencing##2##2##(2007-7#1)(2013-1#1)
to experiment##4##2##(1991-3#1)(1992-9#1)(2008-12#1)(2008-7#1)
to experimental and##2##3##(1996-12#1)(2006-5#1)
to experimental animals##3##3##(1993-3#1)(1996-5#1)(1997-1#1)
to experimental data##11##3##(1995-4#1)(2005-11#2)(2007-11#1)(2008-10#1)(2008-3#3)(2008-7#2)(2013-1#1)
to experimental findings##2##3##(2006-10#1)(2006-11#1)
to experimental group##2##3##(2009-5#1)(2010-6#1)
to experimental results##4##3##(1997-2#1)(2008-3#1)(2009-8#1)(2011-2#1)
to experimental spectra##2##3##(2008-2#2)
to experimental##51##2##(1991-10#1)(1993-3#1)(1994-2#2)(1995-4#1)(1995-9#1)(1996-12#2)(1996-5#1)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-11#3)(2006-10#1)(2006-11#1)(2006-5#1)(2007-11#1)(2007-3#1)(2008-10#3)(2008-2#4)(2008-3#6)(2008-4#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-8#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#1)
to experimentally induced##2##3##(1990-11#1)(2007-12#1)
to experimentally test the hypothesis that##2##6##(1994-6#1)(2009-11#1)
to experimentally test##4##3##(1994-6#1)(2009-11#1)(2009-2#1)(2013-1#1)
to experimentally verify the##2##4##(2008-10#2)
to experimentally##15##2##(1990-11#1)(1994-6#1)(1995-10#1)(2007-12#3)(2008-10#2)(2008-4#1)(2009-11#1)(2009-2#1)(2010-2#1)(2012-1#1)(2013-1#2)
to experiments in##2##3##(2008-7#1)(2010-2#1)
to experiments##5##2##(2008-10#1)(2008-7#1)(2008-8#1)(2010-2#2)
to expert##4##2##(1994-2#1)(2007-4#1)(2008-10#1)(2010-10#1)
to experts##5##2##(1995-6#1)(2004-9#1)(2007-9#1)(2008-1#1)(2008-12#1)
to explain differences in##2##4##(2004-3#1)(2008-10#1)
to explain how the##3##4##(1990-12#1)(1994-8#1)(2008-3#1)
to explain how##15##3##(1990-12#1)(1993-2#1)(1994-8#1)(1995-3#1)(1997-6#1)(2004-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#2)(2009-11#1)(2009-4#1)(2012-12#1)(2012-2#1)
to explain in##4##3##(1995-2#1)(2007-12#1)(2007-7#1)(2012-2#1)
to explain its##3##3##(1996-8#1)(2011-2#1)(2013-8#1)
to explain some of the##2##5##(2008-8#1)(2012-3#1)
to explain some##3##3##(1992-7#1)(2008-8#1)(2012-3#1)
to explain that##3##3##(1996-5#1)(2005-4#1)(2012-2#1)
to explain the adaptation##2##4##(1991-2#1)(2007-3#1)
to explain the complex##2##4##(1994-8#1)(2010-3#1)
to explain the current##2##4##(2008-10#1)(2008-11#1)
to explain the development of##2##5##(2008-11#1)(2008-3#1)
to explain the different##2##4##(1994-3#1)(1996-5#1)
to explain the effect##2##4##(1994-5#1)(2008-3#1)
to explain the effects of##2##5##(2008-10#1)(2009-6#1)
to explain the evolution of##2##5##(2007-12#1)(2012-3#1)
to explain the experimental results##2##5##(2007-11#1)(2008-9#1)
to explain the high##2##4##(1996-8#1)(2008-10#1)
to explain the importance of##2##5##(2007-7#1)(2012-1#1)
to explain the maintenance of##2##5##(1997-7#1)(2008-8#1)
to explain the maternal imagination's##2##5##(2009-2#2)
to explain the observations##2##4##(2007-11#1)(2008-10#1)
to explain the observed##8##4##(1995-8#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2010-4#1)
to explain the regional##2##4##(1994-2#1)(2010-3#1)
to explain the relationship between##2##5##(2005-8#1)(2012-2#1)
to explain the results##4##4##(1992-4#1)(1997-1#1)(2005-11#1)(2008-12#1)
to explain the role of##2##5##(2008-3#1)(2011-1#1)
to explain the variable##2##4##(2008-4#1)(2012-2#1)
to explain the##161##3##(1990-1#1)(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-8#2)(1991-2#1)(1991-8#1)(1992-2#1)(1992-4#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#2)(1994-1#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-5#1)(1996-8#2)(1997-1#2)(1997-5#1)(1997-6#1)(1997-7#1)(2004-7#1)(2005-10#1)(2005-11#6)(2005-7#1)(2005-8#3)(2006-10#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#5)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#16)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#8)(2008-4#2)(2008-5#3)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#1)(2009-6#2)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#4)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#4)
to explain their##3##3##(1993-12#1)(2008-9#1)(2012-2#1)
to explain these results##2##4##(1997-7#1)(2008-3#1)
to explain these##10##3##(1994-9#1)(1995-6#1)(1996-3#1)(1996-8#1)(1997-7#1)(2005-8#1)(2008-3#1)(2009-12#1)(2009-2#1)(2012-2#1)
to explain this phenomenon##2##4##(2006-10#1)(2008-4#1)
to explain this##12##3##(1991-3#1)(1997-1#1)(2006-10#1)(2006-4#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-10#1)(2012-12#1)(2012-3#1)
to explain why##15##3##(1993-9#1)(1997-5#1)(2005-7#1)(2006-10#1)(2007-9#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-5#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
to explain##309##2##(1990-1#1)(1990-10#1)(1990-12#7)(1990-2#1)(1990-3#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-8#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-5#3)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#4)(1993-2#1)(1993-9#1)(1994-1#1)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-5#3)(1996-7#1)(1996-8#5)(1996-9#1)(1997-1#3)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#1)(2004-12#1)(2004-3#1)(2004-7#1)(2005-10#1)(2005-11#7)(2005-4#1)(2005-7#2)(2005-8#4)(2006-10#5)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#6)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#5)(2008-1#5)(2008-10#27)(2008-11#8)(2008-12#1)(2008-2#3)(2008-3#13)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#5)(2008-9#7)(2009-10#2)(2009-11#4)(2009-12#5)(2009-2#4)(2009-3#1)(2009-4#4)(2009-5#3)(2009-6#2)(2009-7#2)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#5)(2010-4#3)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#5)(2012-1#2)(2012-12#5)(2012-2#12)(2012-3#7)(2012-4#1)(2013-1#4)(2013-8#4)
to explaining the##2##3##(1993-11#1)(2008-8#1)
to explaining##3##2##(1993-11#1)(2008-8#2)
to explanation of##2##3##(2008-8#1)(2010-12#1)
to explicate##4##2##(2008-12#1)(2009-2#1)(2010-10#1)(2013-7#1)
to explicit##2##2##(2006-10#1)(2008-5#1)
to explicitly##2##2##(2008-9#1)(2009-8#1)
to exploit the##17##3##(1990-11#1)(1992-2#1)(2006-10#1)(2007-12#3)(2008-10#2)(2008-11#2)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-10#1)
to exploit this##5##3##(2008-4#1)(2008-7#1)(2009-3#1)(2009-9#1)(2012-3#1)
to exploit##35##2##(1990-11#1)(1992-2#1)(1997-4#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#5)(2008-4#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2012-12#1)(2012-3#2)
to exploitation##2##2##(1995-5#1)(2011-2#1)
to exploiting##2##2##(1994-11#1)(2008-3#1)
to explore a##4##3##(2006-2#1)(2008-11#1)(2013-1#1)(2013-7#1)
to explore alternative##2##3##(2008-11#1)(2008-12#1)
to explore and describe the experiences of##2##7##(2010-3#1)(2012-12#1)
to explore and discuss##2##4##(2008-11#1)(2010-1#1)
to explore and##12##3##(2007-8#1)(2008-10#1)(2008-11#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-7#1)(2010-8#1)(2012-12#1)
to explore further the##3##4##(1991-3#1)(1994-12#1)(2008-7#1)
to explore how##13##3##(1995-12#1)(1997-3#1)(2006-7#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-4#1)(2012-1#1)(2012-11#2)(2012-3#1)(2013-1#1)
to explore if##2##3##(2010-4#1)(2013-8#1)
to explore in##2##3##(2012-3#1)(2013-1#1)
to explore new##2##3##(1990-12#1)(2010-3#1)
to explore possible##4##3##(2006-10#1)(2008-11#1)(2011-1#1)(2011-2#1)
to explore potential research##2##4##(2007-12#1)(2009-4#1)
to explore potential##5##3##(2006-9#1)(2007-12#1)(2007-8#1)(2009-4#1)(2012-2#1)
to explore some of the##5##5##(1994-1#1)(1994-11#1)(2008-7#1)(2010-5#1)(2012-2#1)
to explore the benefits of##2##5##(1994-3#1)(2013-8#1)
to explore the changes##2##4##(1995-2#1)(2008-3#1)
to explore the consequences##2##4##(2008-9#1)(2010-10#1)
to explore the effect of##5##5##(1990-12#1)(1991-10#1)(2007-1#1)(2007-5#1)(2008-1#1)
to explore the effects of##6##5##(1991-1#1)(1991-9#1)(2007-12#1)(2008-6#1)(2008-9#1)(2010-9#1)
to explore the feasibility of##4##5##(2006-8#1)(2007-2#1)(2010-10#1)(2012-1#1)
to explore the feasibility##5##4##(2006-8#1)(2007-2#1)(2008-10#1)(2010-10#1)(2012-1#1)
to explore the impact of##4##5##(2006-10#1)(2012-3#1)(2013-1#2)
to explore the influence of##2##5##(2008-8#1)(2011-2#1)
to explore the lived experience of the##2##7##(2008-4#1)(2013-1#1)
to explore the meaning##2##4##(2007-3#1)(2008-11#1)
to explore the mechanism of##6##5##(1994-6#2)(2006-12#1)(2006-4#1)(2008-8#1)(2010-11#1)
to explore the pathogenesis of AMD in Chinese population##2##9##(2013-1#2)
to explore the pathogenesis of##3##5##(2008-9#1)(2013-1#2)
to explore the perceptions and##2##5##(2009-5#1)(2011-2#1)
to explore the possibility of using##2##6##(1993-3#1)(2008-11#1)
to explore the possibility of##5##5##(1993-3#1)(2006-10#1)(2008-11#1)(2010-1#1)(2012-3#1)
to explore the possible##3##4##(1995-12#1)(2010-2#1)(2011-2#1)
to explore the potential of##3##5##(2008-2#1)(2008-4#1)(2010-2#1)
to explore the potential##6##4##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-2#1)
to explore the prevalence of##2##5##(2006-12#1)(2013-7#1)
to explore the relation between##3##5##(2004-12#1)(2007-7#1)(2008-4#1)
to explore the relation##4##4##(2004-12#1)(2007-7#1)(2007-8#1)(2008-4#1)
to explore the relationship between##11##5##(1992-4#1)(1993-2#1)(2005-10#1)(2006-8#1)(2007-3#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)
to explore the relationship##12##4##(1992-4#1)(1993-2#1)(2005-10#1)(2006-8#1)(2007-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)
to explore the relationships between##3##5##(2010-8#1)(2011-2#1)(2012-2#1)
to explore the role of##6##5##(1994-10#1)(1996-11#1)(1996-5#1)(2008-1#1)(2008-8#1)(2012-1#1)
to explore the role##7##4##(1994-10#1)(1996-11#1)(1996-5#1)(2008-1#1)(2008-8#1)(2012-1#1)(2013-1#1)
to explore the use of##4##5##(2008-10#2)(2008-5#1)(2010-12#1)
to explore the validity of this##2##6##(2008-4#1)(2009-11#1)
to explore the views of##2##5##(2006-10#1)(2011-2#1)
to explore the##201##3##(1990-12#2)(1990-2#1)(1990-3#1)(1991-1#1)(1991-10#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-4#2)(1992-5#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#2)(1994-10#1)(1994-3#1)(1994-6#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-6#1)(2004-12#1)(2004-9#1)(2005-10#1)(2005-7#1)(2006-10#3)(2006-12#2)(2006-2#2)(2006-4#1)(2006-8#2)(2007-1#1)(2007-10#5)(2007-12#7)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#9)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#7)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#4)(2009-10#2)(2009-11#4)(2009-12#2)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#3)(2010-12#4)(2010-2#4)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#6)(2013-1#12)(2013-7#1)(2013-8#4)
to explore their##6##3##(1994-6#1)(2004-10#1)(2008-8#1)(2010-8#1)(2011-2#2)
to explore these##3##3##(2007-9#1)(2008-12#1)(2012-12#1)
to explore this##6##3##(1993-11#1)(1997-1#1)(2008-8#2)(2009-10#1)(2012-1#1)
to explore ways##2##3##(1997-1#1)(2011-2#1)
to explore what##2##3##(2010-5#1)(2012-12#1)
to explore whether##7##3##(1996-12#1)(2007-9#1)(2008-10#1)(2008-12#1)(2012-3#1)(2013-1#2)
to explore##377##2##(1990-12#3)(1990-2#1)(1990-3#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-4#2)(1992-5#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-9#2)(1994-1#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-6#4)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-7#1)(1997-1#3)(1997-3#1)(1997-6#1)(1997-7#1)(2004-10#1)(2004-12#1)(2004-9#1)(2005-10#1)(2005-12#1)(2005-7#1)(2006-10#6)(2006-12#3)(2006-2#4)(2006-4#1)(2006-7#3)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#9)(2007-11#2)(2007-12#12)(2007-2#2)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#3)(2008-1#6)(2008-10#13)(2008-11#15)(2008-12#9)(2008-2#4)(2008-3#3)(2008-4#7)(2008-5#4)(2008-6#1)(2008-7#9)(2008-8#11)(2008-9#5)(2009-10#3)(2009-11#4)(2009-12#3)(2009-4#3)(2009-5#6)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#3)(2010-1#2)(2010-10#8)(2010-11#4)(2010-12#5)(2010-2#4)(2010-3#3)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#4)(2010-8#5)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#12)(2011-3#2)(2012-1#6)(2012-11#3)(2012-12#8)(2012-2#5)(2012-3#13)(2013-1#28)(2013-7#3)(2013-8#6)
to exponentially amplify##3##3##(2008-2#2)(2008-9#1)
to exponentially##4##2##(2008-10#1)(2008-2#2)(2008-9#1)
to export##3##2##(1991-6#1)(1995-3#1)(2008-2#1)
to expose the##10##3##(1990-8#1)(1994-8#1)(2006-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2012-1#1)(2012-12#1)(2012-3#1)
to expose##23##2##(1990-5#1)(1990-8#1)(1991-2#1)(1994-8#1)(1996-12#1)(1997-5#1)(2006-12#1)(2006-6#1)(2006-8#2)(2007-4#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#2)
to exposed##3##2##(1993-7#1)(2007-1#1)(2010-12#1)
to exposure concentration##2##3##(1990-5#1)(2008-7#1)
to exposure of##2##3##(1991-2#1)(2011-2#1)
to exposure to a##3##4##(1997-8#1)(2008-7#2)
to exposure to##22##3##(1992-9#1)(1996-3#1)(1997-8#1)(2006-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#4)(2010-9#2)(2011-2#3)
to exposure##32##2##(1990-5#1)(1991-2#1)(1992-9#1)(1994-2#1)(1995-2#1)(1996-3#1)(1997-8#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-9#1)(2010-9#2)(2011-2#4)
to express a##5##3##(1992-12#1)(1995-3#1)(2006-12#1)(2007-12#1)(2008-11#1)
to express an##6##3##(1991-9#1)(1993-6#1)(1995-10#1)(1996-4#1)(1996-5#1)(2007-10#1)
to express and purify##3##4##(1995-10#1)(2008-4#1)(2012-2#1)
to express and##5##3##(1995-1#1)(1995-10#1)(2008-4#2)(2012-2#1)
to express both the##2##4##(2008-11#1)(2008-5#1)
to express both##5##3##(1991-1#1)(1993-12#1)(2007-11#1)(2008-11#1)(2008-5#1)
to express cellular##2##3##(1991-3#1)(1994-3#1)
to express full-length##2##3##(1995-5#1)(1996-12#1)
to express genes##2##3##(1993-11#1)(1994-3#1)
to express high levels of##3##5##(1990-7#1)(2008-4#2)
to express high##4##3##(1990-7#1)(1997-7#1)(2008-4#2)
to express human##2##3##(1995-8#1)(2008-8#1)
to express in##4##3##(1995-1#2)(2008-2#1)(2008-4#1)
to express recombinant human##2##4##(2008-11#2)
to express recombinant##3##3##(2008-11#2)(2008-7#1)
to express the protein##2##4##(1997-1#1)(2008-4#1)
to express the recombinant##2##4##(1994-8#1)(2008-9#1)
to express the##26##3##(1990-5#1)(1992-7#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-1#2)(1997-4#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-2#1)
to express their needs and##2##5##(2007-6#1)(2009-9#1)
to express their##3##3##(2007-6#1)(2007-7#1)(2009-9#1)
to express this##3##3##(1994-5#1)(2007-11#1)(2008-10#1)
to express##140##2##(1990-10#3)(1990-5#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#2)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#3)(1995-10#2)(1995-11#3)(1995-12#3)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#2)(1995-8#4)(1996-10#1)(1996-12#4)(1996-2#1)(1996-4#3)(1996-5#3)(1996-7#1)(1997-1#2)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2004-10#2)(2005-10#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#9)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)
to expressed##2##2##(1991-2#1)(1995-11#1)
to expression of##4##3##(1993-4#1)(1995-2#1)(2008-10#2)
to expression##7##2##(1993-4#1)(1995-2#1)(2005-8#1)(2008-10#2)(2008-7#1)(2013-7#1)
to extend a##2##3##(1996-2#1)(2008-7#1)
to extend beyond the##2##4##(2008-6#1)(2009-12#1)
to extend beyond##4##3##(2008-10#1)(2008-2#1)(2008-6#1)(2009-12#1)
to extend life span##2##4##(2008-10#1)(2010-2#1)
to extend our##2##3##(2010-5#1)(2012-2#1)
to extend research on##2##4##(2007-12#1)(2010-2#1)
to extend studies##2##3##(2010-2#1)(2012-3#1)
to extend the same##2##4##(2008-10#1)(2008-11#1)
to extend the sensitivity##2##4##(2008-10#1)(2008-7#1)
to extend the use of##2##5##(2006-10#1)(2012-2#1)
to extend the##50##3##(1991-5#1)(1992-3#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-5#1)(1997-8#1)(2006-10#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-11#1)(2009-2#1)(2009-3#1)(2010-12#3)(2010-5#1)(2010-7#1)(2012-11#1)(2012-2#2)(2013-1#1)
to extend their##4##3##(1993-3#1)(1994-8#1)(2008-11#1)(2010-12#1)
to extend this##2##3##(2008-6#1)(2009-8#1)
to extend to the##2##4##(2007-11#2)
to extend to##5##3##(1995-6#1)(2007-11#3)(2010-4#1)
to extend##103##2##(1990-12#1)(1991-4#1)(1991-5#1)(1992-3#1)(1993-3#1)(1993-4#2)(1994-8#1)(1995-3#1)(1995-6#3)(1995-7#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-8#1)(2006-10#2)(2006-4#1)(2006-5#2)(2007-11#5)(2007-12#4)(2007-8#1)(2008-1#2)(2008-10#17)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-12#4)(2010-2#4)(2010-4#1)(2010-5#2)(2010-7#1)(2011-2#2)(2012-11#1)(2012-2#4)(2012-3#2)(2013-1#3)
to extended##6##2##(1994-2#1)(1995-8#1)(2007-7#1)(2008-8#1)(2010-12#1)(2011-2#1)
to extension##2##2##(2007-4#2)
to extensive necrosis##2##3##(1994-5#1)(2012-2#1)
to extensive##22##2##(1990-11#1)(1991-9#1)(1993-7#1)(1994-5#1)(1995-9#1)(1996-1#1)(1997-7#1)(2004-7#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2012-2#2)
to extent of##2##3##(2007-11#1)(2008-10#1)
to extent##3##2##(2007-11#1)(2007-8#1)(2008-10#1)
to external and internal##3##4##(1993-1#1)(2008-5#1)(2009-10#1)
to external optical feedback##2##4##(2007-12#1)(2008-2#1)
to external optical##4##3##(2007-11#2)(2007-12#1)(2008-2#1)
to external pH changes##2##4##(2012-12#2)
to external pressures##2##3##(2008-11#1)(2008-7#1)
to external stimulation##2##3##(1995-11#1)(2012-2#1)
to external stimuli and##2##4##(1990-9#1)(2009-9#1)
to external stimuli##8##3##(1990-9#1)(1991-11#1)(2008-11#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2012-2#1)
to external##60##2##(1990-11#1)(1990-9#1)(1991-11#1)(1992-4#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-5#1)(1995-11#1)(1995-3#1)(1996-2#1)(2005-11#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-8#2)(2008-10#1)(2008-11#3)(2008-2#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-8#3)(2009-9#1)(2010-10#2)(2010-12#3)(2010-2#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2013-8#1)
to externally added##2##3##(1991-9#1)(1992-1#1)
to externally##3##2##(1991-9#1)(1992-1#1)(2008-4#1)
to extinction##17##2##(2007-9#1)(2008-2#1)(2008-8#4)(2008-9#7)(2012-2#1)(2013-1#2)(2013-7#1)
to extra##3##2##(2008-7#1)(2011-1#2)
to extracellular ATP##3##3##(2008-4#3)
to extracellular matrix##5##3##(1991-5#1)(1993-3#1)(1997-7#2)(2008-11#1)
to extracellular nucleotides##2##3##(2008-4#2)
to extracellular##26##2##(1991-10#1)(1991-5#1)(1993-3#1)(1994-12#1)(1994-9#1)(1996-2#2)(1996-5#1)(1997-7#2)(2005-7#1)(2006-10#1)(2008-11#1)(2008-4#8)(2008-7#1)(2009-4#1)(2009-7#1)(2011-12#1)(2012-2#1)
to extracorporeal##3##2##(2007-9#1)(2013-1#2)
to extract a##4##3##(1997-3#1)(2007-12#1)(2008-6#1)(2009-8#1)
to extract accurate##2##3##(2008-2#1)(2008-3#1)
to extract and determine##2##4##(2005-4#1)(2008-10#1)
to extract and##7##3##(2005-4#1)(2008-10#5)(2008-3#1)
to extract certain##2##3##(2008-10#1)(2008-2#1)
to extract from the##2##4##(1990-9#1)(2008-10#1)
to extract from##4##3##(1990-9#1)(2006-3#1)(2008-10#1)(2008-3#1)
to extract information about##3##4##(2008-10#1)(2009-8#1)(2011-1#1)
to extract information on##2##4##(2008-2#1)(2008-3#1)
to extract information##7##3##(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-8#1)(2011-1#1)
to extract kinetic##2##3##(1997-6#1)(2008-9#1)
to extract quantitative##2##3##(2008-9#1)(2009-4#1)
to extract representative variables##2##4##(2007-8#2)
to extract single##2##3##(2013-7#1)(2013-8#1)
to extract sparse##2##3##(1997-8#1)(2008-3#1)
to extract the target##2##4##(2006-5#1)(2008-10#1)
to extract the velocity##2##4##(2008-3#2)
to extract the##30##3##(1997-2#1)(2006-5#2)(2007-1#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#8)(2008-2#1)(2008-3#8)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
to extract these##2##3##(1992-9#1)(2008-10#1)
to extract this##2##3##(2008-11#1)(2010-2#1)
to extract##144##2##(1990-12#1)(1990-4#1)(1990-9#1)(1992-9#1)(1993-7#1)(1995-2#1)(1995-5#1)(1997-2#3)(1997-3#1)(1997-6#1)(1997-8#1)(2004-8#1)(2005-4#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#2)(2007-1#2)(2007-11#1)(2007-12#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#4)(2008-10#44)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#14)(2008-4#3)(2008-6#3)(2008-7#1)(2008-9#3)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-2#1)(2010-3#1)(2010-5#3)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#2)
to extracted##3##2##(1994-8#1)(2012-11#2)
to extraction by##2##3##(1990-11#1)(1991-1#1)
to extraction of the##2##4##(2008-2#1)(2011-2#1)
to extraction of##3##3##(2008-2#1)(2011-2#2)
to extraction##10##2##(1990-11#1)(1991-1#1)(2007-8#1)(2008-10#3)(2008-2#1)(2011-2#2)(2013-8#1)
to extracts of##3##3##(1991-5#2)(1995-6#1)
to extrapolate from##2##3##(2008-11#1)(2010-8#1)
to extrapolate the##2##3##(1990-5#1)(2008-11#1)
to extrapolate to##2##3##(2006-3#1)(2010-12#1)
to extrapolate##14##2##(1990-5#1)(1995-4#1)(1996-10#1)(1996-6#1)(2006-10#1)(2006-3#2)(2008-11#2)(2008-5#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-1#1)
to extreme temperatures##2##3##(1995-6#1)(2007-3#1)
to extreme##9##2##(1995-6#1)(2007-10#2)(2007-3#1)(2008-11#1)(2008-2#1)(2009-2#1)(2011-2#1)(2013-8#1)
to extremely low frequency electromagnetic fields##2##6##(1992-11#1)(2008-12#1)
to extremely low##5##3##(1992-11#1)(1996-7#1)(2008-12#1)(2008-2#1)(2008-6#1)
to extremely small##2##3##(2010-2#1)(2012-2#1)
to extremely##12##2##(1992-11#1)(1996-7#1)(2007-2#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-6#1)(2009-7#1)(2010-2#1)(2011-1#1)(2012-2#1)
to extrinsic##4##2##(1990-6#1)(1992-10#1)(2006-10#1)(2008-9#1)
to extrude##3##2##(1995-6#1)(2007-11#1)(2008-10#1)
to extrusion##3##2##(2007-12#1)(2008-10#1)(2008-5#1)
to eye opening##2##3##(2008-7#2)
to eye##6##2##(2008-11#1)(2008-5#1)(2008-7#2)(2012-1#1)(2013-1#1)
to eyecare practitioners##2##3##(2005-11#2)
to eyes##3##2##(1996-8#1)(1997-3#1)(2008-5#1)
to fabA##2##2##(1994-12#2)
to fabricate a wide##2##4##(2006-12#1)(2006-6#1)
to fabricate a##10##3##(2006-12#1)(2006-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2009-11#1)(2011-1#1)
to fabricate and##3##3##(2007-12#1)(2008-11#1)(2008-2#1)
to fabricate artificial heart##2##4##(2008-8#2)
to fabricate the##6##3##(2007-12#1)(2007-8#1)(2008-12#2)(2008-2#2)
to fabricate##70##2##(2006-12#1)(2006-6#1)(2007-11#3)(2007-12#8)(2007-2#1)(2007-8#2)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#7)(2008-3#7)(2008-5#5)(2008-7#3)(2008-8#3)(2009-11#4)(2009-12#1)(2009-2#1)(2010-12#1)(2010-4#2)(2010-7#1)(2010-9#2)(2011-1#1)(2012-11#2)(2013-1#1)
to fabrication of engineered constructs by seeding of natural or synthetic scaffolds with cells##2##14##(2012-12#2)
to fabrication##3##2##(2009-5#1)(2012-12#2)
to face perception##2##3##(2009-4#2)
to face recognition##2##3##(2008-3#1)(2009-4#1)
to face the##7##3##(2005-7#1)(2006-1#1)(2007-6#1)(2008-6#1)(2009-5#1)(2010-2#1)(2013-1#1)
to face this reality##2##4##(2009-8#1)(2011-2#1)
to face with##4##3##(2007-10#1)(2008-10#1)(2008-6#1)(2011-2#1)
to face##44##2##(1994-12#2)(1995-5#1)(1996-11#2)(1996-3#1)(1996-8#1)(1996-9#1)(2005-7#1)(2005-8#1)(2006-1#1)(2007-10#1)(2007-6#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#1)(2008-6#3)(2009-10#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
to faces##2##2##(2009-4#1)(2012-12#1)
to facial identity##2##3##(2008-4#2)
to facial##6##2##(2006-12#1)(2008-11#1)(2008-4#2)(2008-6#1)(2009-4#1)
to facilitate a##4##3##(2007-10#1)(2008-4#1)(2011-1#1)(2012-2#1)
to facilitate access to##2##4##(2005-10#1)(2007-5#1)
to facilitate and##5##3##(2007-2#1)(2008-12#1)(2010-8#1)(2013-1#2)
to facilitate communication between##2##4##(2008-7#2)
to facilitate conversion from##2##4##(1990-3#1)(2008-3#1)
to facilitate data##5##3##(2008-7#2)(2010-5#1)(2013-1#2)
to facilitate early##2##3##(2007-9#1)(2011-2#1)
to facilitate effective##2##3##(1992-3#1)(2008-11#1)
to facilitate efficient##2##3##(1990-3#1)(2008-2#1)
to facilitate egg##2##3##(2008-5#2)
to facilitate identification of##2##4##(1994-6#1)(1997-7#1)
to facilitate improved##2##3##(2007-12#1)(2008-11#1)
to facilitate increased##2##3##(2006-3#1)(2007-4#1)
to facilitate its##5##3##(2008-10#1)(2008-4#1)(2008-7#2)(2013-8#1)
to facilitate learning in##2##4##(2007-2#1)(2008-12#1)
to facilitate learning##5##3##(2007-2#1)(2008-12#3)(2013-8#1)
to facilitate maintenance##2##3##(1992-11#1)(2009-10#1)
to facilitate molecular##2##3##(1997-2#1)(2008-9#1)
to facilitate nonlinear calibration##3##4##(2008-10#3)
to facilitate nursing##2##3##(2007-11#1)(2008-11#1)
to facilitate preleptotene spermatocyte migration##2##5##(2009-10#2)
to facilitate protein##2##3##(1991-2#1)(1995-8#1)
to facilitate purification of##2##4##(1992-6#1)(1994-12#1)
to facilitate risk##2##3##(1995-1#1)(2006-10#1)
to facilitate simultaneous##2##3##(2010-5#1)(2012-2#1)
to facilitate subsequent##3##3##(2008-5#1)(2013-1#2)
to facilitate such##2##3##(2008-3#1)(2008-7#1)
to facilitate surgical##2##3##(1996-3#1)(2008-9#1)
to facilitate the cloning##2##4##(1991-7#1)(1994-12#1)
to facilitate the creation and##2##5##(2013-1#2)
to facilitate the development of new##3##6##(1992-1#1)(2008-11#1)(2012-12#1)
to facilitate the development of the##2##6##(2008-12#1)(2011-12#1)
to facilitate the development of##9##5##(1992-1#1)(2008-11#3)(2008-12#2)(2010-3#1)(2011-12#1)(2012-12#1)
to facilitate the development##10##4##(1992-1#1)(2008-11#3)(2008-12#2)(2010-3#1)(2010-5#1)(2011-12#1)(2012-12#1)
to facilitate the dissolution of##2##5##(2008-10#2)
to facilitate the implementation of##5##5##(1993-3#1)(1997-2#1)(2005-5#1)(2009-12#1)(2010-9#1)
to facilitate the implementation##6##4##(1993-3#1)(1997-2#1)(2005-5#1)(2008-2#1)(2009-12#1)(2010-9#1)
to facilitate the use of##3##5##(1990-12#1)(2013-1#2)
to facilitate the##85##3##(1990-12#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-7#2)(1992-1#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-12#1)(1996-3#1)(1997-2#1)(2005-5#1)(2005-7#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-7#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#2)(2009-9#1)(2010-3#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
to facilitate their study##2##4##(2008-10#1)(2009-2#1)
to facilitate their##6##3##(1997-8#1)(2007-8#1)(2008-10#1)(2009-2#2)(2009-3#1)
to facilitate this process##2##4##(2006-10#1)(2012-3#1)
to facilitate this##3##3##(2006-10#1)(2008-5#1)(2012-3#1)
to facilitate understanding of##2##4##(2006-9#1)(2008-4#1)
to facilitate understanding##3##3##(2006-9#1)(2008-3#1)(2008-4#1)
to facilitate use of##2##4##(2008-3#2)
to facilitate ventilation##2##3##(2007-11#2)
to facilitate##345##2##(1990-12#1)(1990-3#2)(1990-7#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#2)(1993-11#2)(1993-12#2)(1993-3#1)(1993-7#1)(1993-8#2)(1994-1#1)(1994-12#4)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#2)(1996-10#1)(1996-12#2)(1996-3#4)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#7)(2006-11#1)(2006-12#2)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#3)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#7)(2007-2#2)(2007-3#4)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#1)(2007-8#4)(2007-9#3)(2008-1#4)(2008-10#17)(2008-11#18)(2008-12#10)(2008-2#7)(2008-3#10)(2008-4#13)(2008-5#5)(2008-6#4)(2008-7#13)(2008-8#5)(2008-9#6)(2009-10#5)(2009-11#1)(2009-12#3)(2009-2#3)(2009-3#1)(2009-4#4)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#5)(2010-6#1)(2010-7#3)(2010-8#3)(2010-9#4)(2011-1#3)(2011-12#2)(2011-2#5)(2012-1#4)(2012-11#6)(2012-12#1)(2012-2#8)(2012-3#3)(2013-1#27)(2013-8#4)
to facilitating the##2##3##(2008-11#1)(2009-7#1)
to facilitation##3##2##(1994-11#1)(2008-6#1)(2012-1#1)
to facilities##2##2##(1997-8#1)(2008-2#1)
to facility##2##2##(2007-4#1)(2012-3#1)
to factor##4##2##(1993-8#1)(1994-3#2)(2013-7#1)
to factors other than##2##4##(1991-2#1)(1993-2#1)
to factors that##3##3##(2006-7#1)(2009-4#1)(2012-11#1)
to factors##14##2##(1991-2#1)(1993-2#1)(1994-3#1)(2005-12#1)(2005-7#1)(2006-7#1)(2007-7#1)(2008-5#1)(2009-4#1)(2009-8#1)(2010-3#1)(2010-7#1)(2012-11#1)(2012-12#1)
to faculty development##2##3##(2005-12#1)(2011-1#1)
to faculty##4##2##(2005-12#1)(2007-4#1)(2008-11#1)(2011-1#1)
to fail at##2##3##(2008-7#1)(2009-7#1)
to fail to##2##3##(1997-1#1)(2011-2#1)
to fail##13##2##(1993-7#1)(1995-1#1)(1997-1#1)(2006-7#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-7#1)(2010-3#1)(2011-2#1)
to failure and##2##3##(2004-1#1)(2008-9#1)
to failure in the##3##4##(2011-1#1)(2011-2#1)(2013-8#1)
to failure in##7##3##(2006-11#1)(2008-11#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
to failure of##6##3##(1995-5#1)(2008-7#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-3#1)
to failure to##3##3##(1997-2#1)(2010-8#1)(2011-2#1)
to failure##38##2##(1995-5#1)(1997-2#1)(1997-7#1)(2004-1#1)(2006-11#1)(2006-8#1)(2007-4#1)(2007-8#4)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#5)(2009-10#1)(2009-2#2)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
to fall asleep##2##3##(1990-5#1)(2007-6#1)
to fall in##3##3##(1996-11#1)(2008-10#1)(2008-7#1)
to fall into three##2##4##(2008-10#1)(2011-2#1)
to fall into##6##3##(1992-3#1)(1994-12#1)(1997-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
to fall out of##2##4##(2008-3#1)(2011-2#1)
to fall outside the##2##4##(1996-8#1)(2008-2#1)
to fall within the##2##4##(1990-2#1)(2012-12#1)
to fall within##4##3##(1990-2#1)(1996-8#1)(2005-3#1)(2012-12#1)
to fall##27##2##(1990-2#1)(1990-5#1)(1992-3#1)(1994-12#1)(1994-3#1)(1996-11#1)(1996-8#2)(1997-1#1)(2005-10#1)(2005-3#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2011-2#2)(2012-12#1)
to falls##4##2##(2007-11#2)(2010-10#1)(2013-8#1)
to false positive##3##3##(2008-10#1)(2009-8#1)(2012-3#1)
to false##5##2##(2008-10#1)(2009-1#1)(2009-8#1)(2010-7#1)(2012-3#1)
to false-positive results##2##3##(2006-10#1)(2008-11#1)
to false-positive##4##2##(2006-10#1)(2008-11#1)(2012-2#2)
to familial CLL##2##3##(2009-10#2)
to familial Mediterranean fever##3##4##(1997-5#1)(2006-10#1)(2009-10#1)
to familial##9##2##(1991-5#1)(1993-10#2)(1997-5#1)(2006-10#1)(2009-10#4)
to familiarity##3##2##(2008-7#2)(2012-1#1)
to familiarize themselves with##2##4##(2007-8#1)(2009-6#1)
to familiarize##8##2##(2007-12#1)(2007-8#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-3#1)
to families B and##2##4##(1996-6#2)
to families of##2##3##(1990-12#1)(2007-2#1)
to families who##2##3##(1995-1#1)(1997-2#1)
to families##15##2##(1990-12#1)(1991-1#1)(1991-12#4)(1991-8#1)(1995-1#2)(1996-6#2)(1997-2#1)(2007-2#1)(2008-11#1)(2008-9#1)
to family and##4##3##(2007-4#1)(2007-7#1)(2013-1#2)
to family environment##2##3##(2004-11#1)(2010-12#1)
to family functioning##2##3##(2008-12#1)(2008-7#1)
to family history##2##3##(1991-12#1)(2005-7#1)
to family members##3##3##(1991-2#1)(2008-9#1)(2009-5#1)
to family of##2##3##(2012-2#1)(2013-8#1)
to family physicians##2##3##(2007-12#1)(2010-11#1)
to family planning##4##3##(1990-9#1)(1991-10#1)(1991-6#1)(2006-2#1)
to family##44##2##(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-6#1)(1995-12#1)(1995-2#1)(2004-11#1)(2004-3#1)(2005-7#2)(2006-2#1)(2006-4#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#4)(2008-12#4)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
to far##5##2##(2008-2#2)(2008-6#1)(2008-7#1)(2012-12#1)
to far-field##2##2##(2006-7#1)(2007-12#1)
to far-lateral##2##2##(2006-8#2)
to farm##3##2##(2008-12#1)(2008-5#1)(2010-4#1)
to farming##4##2##(2007-8#1)(2008-11#1)(2008-12#2)
to farnesylate##2##2##(1995-2#2)
to farnesyltransferase##2##2##(1996-4#2)
to fascinate##2##2##(2007-8#1)(2012-2#1)
to fast##10##2##(1997-1#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-5#2)(2008-8#1)(2010-5#1)(2013-1#2)
to fasted##2##2##(1990-3#1)(1996-12#1)
to faster##7##2##(1995-1#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-7#2)(2011-1#1)
to fasting##6##2##(1994-12#1)(2006-10#1)(2008-3#2)(2011-1#1)(2011-2#1)
to fat mass##3##3##(2006-9#2)(2007-11#1)
to fat##14##2##(1990-2#2)(1997-4#1)(2006-9#2)(2007-11#1)(2007-12#2)(2008-10#1)(2008-5#1)(2010-4#1)(2012-1#1)(2012-2#1)(2013-7#1)
to fatal outcome##2##3##(2006-4#1)(2008-9#1)
to fatal##10##2##(2006-10#2)(2006-4#1)(2007-7#1)(2007-8#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-9#1)(2012-12#1)
to fatigue##9##2##(2008-10#1)(2008-3#1)(2008-7#3)(2009-7#3)(2010-8#1)
to fatty acids##3##3##(1994-5#1)(2008-1#1)(2008-10#1)
to fatty##4##2##(1994-5#1)(2008-1#1)(2008-10#1)(2010-4#1)
to favor the##10##3##(1992-3#1)(1992-9#1)(1996-3#1)(1997-5#1)(2006-5#1)(2007-5#1)(2008-10#1)(2008-8#1)(2009-10#1)(2012-12#1)
to favor##26##2##(1992-3#1)(1992-9#1)(1996-3#1)(1997-1#1)(1997-5#1)(2006-2#1)(2006-5#1)(2007-5#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-3#1)(2010-2#1)(2011-2#1)(2012-12#3)
to favorable##6##2##(1996-7#1)(1996-8#1)(2008-10#3)(2012-3#1)
to favorably modify##2##3##(2007-8#1)(2013-7#1)
to favorably##3##2##(2007-12#1)(2007-8#1)(2013-7#1)
to favour the##3##3##(2006-10#1)(2011-12#1)(2012-11#1)
to favour##12##2##(1990-3#1)(1994-6#1)(1995-3#1)(2004-9#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-6#1)(2008-5#1)(2011-12#1)(2012-11#1)(2013-1#1)
to favourable##3##2##(1990-6#1)(2008-11#1)(2009-10#1)
to fear and##2##3##(1994-4#1)(2013-8#1)
to fear##8##2##(1994-4#1)(1996-6#1)(2008-11#1)(2009-2#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
to fearful##5##2##(2006-3#2)(2009-3#3)
to features##2##2##(2012-3#1)(2013-1#1)
to febrile neutropenia##2##3##(2008-11#1)(2008-7#1)
to federal and##4##3##(2005-7#2)(2006-12#1)(2010-12#1)
to federal##6##2##(2005-7#2)(2006-12#1)(2007-9#1)(2010-12#1)(2011-9#1)
to fee-for-service##3##2##(1994-1#2)(2007-2#1)
to feed on##3##3##(2008-10#1)(2009-6#1)(2013-1#1)
to feed the##5##3##(2004-2#1)(2005-9#1)(2008-6#1)(2012-12#1)(2012-2#1)
to feed##18##2##(1991-6#1)(2004-2#1)(2005-9#1)(2006-10#1)(2007-3#1)(2007-9#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-6#1)(2010-8#1)(2012-12#1)(2012-2#2)(2013-1#1)
to feedback##3##2##(1990-2#1)(2006-10#1)(2007-12#1)
to feeding on##2##3##(1991-11#1)(1994-4#1)
to feeding##11##2##(1991-11#1)(1994-12#1)(1994-4#1)(2006-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-6#1)(2011-2#1)(2013-8#1)
to feel##9##2##(1992-3#2)(1993-10#1)(1996-11#1)(1997-4#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-9#1)
to feeling##2##2##(2004-10#1)(2007-12#1)
to female ratio was 1##3##5##(2006-2#1)(2007-2#1)(2012-2#1)
to female ratio was##9##4##(2005-8#1)(2006-2#1)(2006-8#1)(2007-2#2)(2007-7#1)(2007-8#2)(2012-2#1)
to female ratio##16##3##(2005-8#1)(2006-2#1)(2006-8#1)(2007-2#2)(2007-7#3)(2007-8#2)(2008-1#1)(2008-5#1)(2011-2#1)(2012-2#2)(2012-3#1)
to female sex##4##3##(1995-11#2)(1997-7#1)(2008-7#1)
to female##50##2##(1990-12#2)(1990-2#1)(1991-6#1)(1992-11#1)(1992-8#1)(1993-9#1)(1994-2#2)(1995-11#2)(1996-12#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-8#2)(2007-2#3)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#3)(2008-7#2)(2008-9#3)(2009-7#1)(2011-12#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
to females in##3##3##(1991-3#1)(2007-12#1)(2009-8#1)
to females##23##2##(1990-8#1)(1991-3#1)(1991-6#1)(1994-11#1)(1995-6#2)(1997-5#1)(2006-1#1)(2006-5#1)(2007-12#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-8#3)(2010-8#1)(2011-2#1)(2012-2#2)
to femoral access##2##3##(2007-7#1)(2011-2#1)
to femoral artery##4##3##(2007-8#3)(2011-2#1)
to femoral##9##2##(2007-7#2)(2007-8#3)(2009-3#2)(2011-2#2)
to femtosecond laser##2##3##(2007-12#1)(2011-1#1)
to fenbuconazole##3##2##(2008-10#1)(2011-12#2)
to fentanyl##2##2##(1993-1#1)(2006-12#1)
to ferment glucose##2##3##(1990-3#1)(2008-6#1)
to ferment##9##2##(1990-3#1)(1993-12#1)(1995-4#1)(2006-8#1)(2008-5#1)(2008-6#2)(2011-2#1)(2012-3#1)
to fermentation##2##2##(1990-12#1)(2012-2#1)
to ferric##2##2##(1997-7#1)(2006-8#1)
to ferricenium ions##2##3##(1995-2#2)
to ferricyanide by##2##3##(1993-4#1)(2008-10#1)
to ferricyanide##3##2##(1993-4#1)(2008-10#2)
to ferrocyanide##2##2##(2008-10#1)(2010-4#1)
to ferrous iron##2##3##(1995-6#1)(2007-12#1)
to ferrous##3##2##(1994-6#1)(1995-6#1)(2007-12#1)
to fertile##2##2##(2008-5#1)(2013-7#1)
to fertility##4##2##(2008-5#1)(2008-9#2)(2010-3#1)
to fertilization##4##2##(1996-9#1)(2006-5#1)(2009-2#1)(2011-2#1)
to fertilize all##3##3##(2008-8#1)(2012-12#2)
to fertilize##8##2##(2005-10#1)(2007-12#1)(2008-7#1)(2008-8#2)(2009-6#1)(2012-12#2)
to fetal bovine serum (FBS)##2##5##(2008-11#2)
to fetal bovine serum##3##4##(2008-11#3)
to fetal##14##2##(1992-12#2)(1996-10#1)(1996-11#1)(1996-12#2)(1997-5#1)(2008-1#1)(2008-10#1)(2008-11#4)(2011-12#1)
to fever##2##2##(2006-10#1)(2013-8#1)
to few##3##2##(2008-10#3)
to fewer negative self-statements about##2##5##(2006-6#2)
to fewer than##2##3##(2007-1#1)(2008-11#1)
to fewer##14##2##(1990-10#1)(1994-11#1)(1997-2#2)(2006-6#2)(2007-1#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-7#1)(2013-1#2)
to fiber Bragg##2##3##(2007-12#2)
to fiber##6##2##(2007-11#2)(2007-12#2)(2008-10#1)(2008-3#1)
to fibers##2##2##(1993-9#1)(2008-3#1)
to fibre##2##2##(1991-11#1)(2009-7#1)
to fibrils##2##2##(2011-1#2)
to fibrin gels##2##3##(2006-10#1)(2009-4#1)
to fibrin##8##2##(1990-11#3)(1990-12#1)(1991-7#1)(1995-12#1)(2006-10#1)(2009-4#1)
to fibrin/Celite was##2##3##(1990-12#2)
to fibrinogen##5##2##(1990-5#1)(1994-12#1)(1997-7#3)
to fibroblasts##3##2##(1991-1#1)(1995-5#1)(1996-7#1)
to fibronectin and##2##3##(1992-9#1)(1997-6#1)
to fibronectin##13##2##(1990-8#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-8#1)(1992-9#1)(1994-12#3)(1997-6#2)(2008-4#1)(2008-5#1)
to fibrosis and##3##3##(2005-8#1)(2012-12#2)
to fibrosis in##2##3##(2006-10#1)(2012-12#1)
to fibrosis##12##2##(1996-11#3)(1996-8#1)(2005-8#1)(2006-10#1)(2011-2#1)(2012-12#4)(2012-2#1)
to field##14##2##(1993-5#1)(2006-12#1)(2007-1#1)(2007-6#1)(2008-10#5)(2008-2#1)(2008-3#1)(2010-10#1)(2011-2#2)
to fields such as##2##4##(2005-11#1)(2008-3#1)
to fields##3##2##(2005-11#1)(2007-9#1)(2008-3#1)
to fifth##3##2##(2007-8#1)(2010-3#1)(2013-1#1)
to fight against##5##3##(1993-6#1)(2007-2#1)(2008-5#1)(2010-9#1)(2012-2#1)
to fight the##4##3##(1994-3#1)(2007-2#1)(2008-11#1)(2009-7#1)
to fight##34##2##(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-2#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#2)(2009-12#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-9#1)(2012-12#1)(2012-2#2)
to figure out##3##3##(1996-3#1)(2005-9#1)(2007-9#1)
to filament##2##2##(1990-10#1)(1993-9#1)
to file for##2##3##(2005-8#1)(2005-9#1)
to file##3##2##(1995-12#1)(2005-8#1)(2005-9#1)
to fill a##3##3##(1997-4#1)(2007-3#1)(2008-10#1)
to fill in the##2##4##(2006-10#1)(2010-9#1)
to fill in##7##3##(2006-10#1)(2007-5#1)(2008-10#1)(2008-7#1)(2010-11#1)(2010-9#1)(2013-1#1)
to fill out##3##3##(2011-2#1)(2012-12#1)(2013-8#1)
to fill the gap between##3##5##(2007-4#1)(2013-1#2)
to fill the gap##5##4##(2007-4#1)(2007-7#2)(2013-1#2)
to fill the sampling##2##4##(2008-10#2)
to fill the##14##3##(2007-11#1)(2007-4#1)(2007-7#3)(2008-1#2)(2008-10#3)(2008-3#1)(2013-1#2)(2013-7#1)
to fill this gap##2##4##(2010-9#1)(2012-3#1)
to fill this##3##3##(2010-9#1)(2012-12#1)(2012-3#1)
to fill##43##2##(1991-2#1)(1992-9#1)(1995-2#1)(1997-4#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-3#2)(2007-4#2)(2007-5#1)(2007-7#3)(2008-1#2)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#2)(2009-3#1)(2010-11#1)(2010-6#1)(2010-9#2)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
to filling##2##2##(2012-3#1)(2013-1#1)
to film##2##2##(2008-12#1)(2008-2#1)
to filter off##2##3##(2008-2#1)(2012-3#1)
to filter the##2##3##(2008-10#1)(2009-12#1)
to filter##12##2##(2007-12#2)(2008-10#3)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-12#1)(2012-3#1)
to filtered##4##2##(2005-10#1)(2008-10#1)(2012-1#1)(2013-1#1)
to final##8##2##(1991-7#1)(1992-9#1)(1997-4#1)(2008-10#2)(2010-4#1)(2011-1#1)(2012-12#1)
to finally##4##2##(1995-6#1)(2006-10#1)(2008-10#1)(2009-8#1)
to finance##6##2##(1991-2#1)(1992-2#1)(1993-8#1)(1994-1#1)(1996-3#1)(2007-4#1)
to financial##13##2##(2007-2#2)(2007-4#1)(2007-7#1)(2008-4#1)(2009-5#1)(2009-7#1)(2010-10#3)(2010-5#1)(2011-1#1)(2012-11#1)
to finasteride##2##2##(2006-9#1)(2008-5#1)
to find a common##2##4##(2007-12#1)(2011-2#1)
to find a new##3##4##(1995-2#1)(2008-2#1)(2008-5#1)
to find a permanent##2##4##(1991-4#1)(2007-8#1)
to find a possible##2##4##(2011-2#1)(2012-3#1)
to find a single##2##4##(1995-6#1)(2009-6#1)
to find a suitable##3##4##(2008-10#1)(2010-12#1)(2012-12#1)
to find a##47##3##(1991-4#1)(1992-10#1)(1993-3#1)(1993-8#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-6#2)(1997-7#1)(2005-11#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-3#2)
to find an appropriate##2##4##(1992-6#1)(2008-10#1)
to find an effective##2##4##(2008-1#1)(2009-5#1)
to find an##15##3##(1992-6#1)(1994-6#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-2#2)(2011-2#1)(2012-12#1)(2012-2#1)
to find and##3##3##(1994-1#1)(1994-3#1)(1996-8#1)
to find any##5##3##(2007-12#1)(2007-7#1)(2007-9#2)(2012-2#1)
to find appropriate##2##3##(1996-4#1)(2008-2#1)
to find better##3##3##(2007-11#1)(2010-4#1)(2012-2#1)
to find candidate transitions for CO(2) detection##2##7##(2008-2#1)(2008-3#1)
to find candidate##3##3##(2008-2#1)(2008-3#1)(2011-1#1)
to find evidence##3##3##(2007-5#2)(2007-9#1)
to find its##4##3##(1992-5#1)(1996-1#1)(2007-12#1)(2008-3#1)
to find more##3##3##(1992-12#1)(2011-2#2)
to find new##6##3##(2005-4#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-12#1)(2011-2#1)
to find optimal##2##3##(2008-10#1)(2008-3#1)
to find other##2##3##(2004-3#1)(2009-6#1)
to find out how##4##4##(1992-8#1)(1993-5#1)(2007-6#1)(2008-5#1)
to find out if any##2##5##(2006-10#1)(2007-2#1)
to find out if the##3##5##(1993-6#1)(1994-9#1)(1996-6#1)
to find out if##10##4##(1990-8#1)(1993-6#1)(1994-2#1)(1994-9#1)(1996-6#1)(2006-10#1)(2006-7#1)(2007-2#1)(2007-3#2)
to find out the exact##2##5##(2007-7#1)(2010-9#1)
to find out the most##2##5##(2007-8#1)(2009-4#1)
to find out the prevalence and##2##6##(2007-7#1)(2008-1#1)
to find out the prevalence of##2##6##(2007-8#1)(2009-6#1)
to find out the prevalence##4##5##(2007-7#1)(2007-8#1)(2008-1#1)(2009-6#1)
to find out the##33##4##(1990-2#1)(1997-2#1)(2006-4#2)(2006-8#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-3#1)(2008-8#1)(2009-4#1)(2009-6#2)(2010-8#1)(2010-9#1)(2011-1#3)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#3)
to find out whether##7##4##(1990-10#1)(1991-11#1)(2006-8#1)(2007-1#1)(2009-6#1)(2011-1#1)(2012-2#1)
to find out##77##3##(1990-10#1)(1990-2#3)(1990-6#1)(1990-8#1)(1991-11#1)(1991-6#1)(1992-8#1)(1993-5#1)(1993-6#1)(1994-2#1)(1994-9#1)(1996-6#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-4#2)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-2#2)(2007-3#3)(2007-6#4)(2007-7#3)(2007-8#4)(2008-1#3)(2008-3#1)(2008-5#3)(2008-8#2)(2009-4#1)(2009-6#3)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#4)
to find possible##2##3##(2008-7#1)(2013-8#1)
to find publications##3##3##(2007-6#1)(2013-1#2)
to find specific##2##3##(2011-2#1)(2012-2#1)
to find such##3##3##(1995-11#1)(2013-1#2)
to find suitable##2##3##(2008-10#1)(2008-8#1)
to find that##6##3##(2006-6#1)(2007-8#1)(2008-3#2)(2008-4#1)(2012-3#1)
to find the association##2##4##(2012-12#1)(2012-2#1)
to find the best##9##4##(1996-9#1)(2006-10#1)(2007-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-7#1)
to find the conditions##2##4##(2008-3#1)(2008-5#1)
to find the exact##2##4##(2007-11#1)(2008-2#1)
to find the optimal##9##4##(2006-10#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)(2011-2#1)
to find the prevalence##2##4##(2007-8#2)
to find the##83##3##(1990-12#1)(1993-7#1)(1993-9#1)(1995-12#1)(1995-7#1)(1995-8#1)(1996-9#1)(2006-10#5)(2006-3#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#9)(2008-11#1)(2008-12#3)(2008-2#12)(2008-3#7)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2009-7#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
to find ways of##2##4##(1990-9#1)(2009-6#1)
to find ways to##5##4##(1992-12#1)(1995-9#1)(1996-11#1)(2005-12#1)(2008-9#1)
to find ways##8##3##(1990-9#1)(1992-12#1)(1995-9#1)(1996-11#1)(2005-12#1)(2005-5#1)(2008-9#1)(2009-6#1)
to find whether##3##3##(1990-5#2)(2007-9#1)
to find##395##2##(1990-10#1)(1990-12#1)(1990-2#3)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-4#2)(1991-6#1)(1992-10#1)(1992-12#2)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-3#1)(1993-5#2)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-6#4)(1997-7#1)(2004-10#1)(2004-3#2)(2004-9#1)(2005-11#2)(2005-12#1)(2005-4#1)(2005-5#1)(2005-8#2)(2006-10#9)(2006-12#1)(2006-2#3)(2006-3#2)(2006-4#2)(2006-6#3)(2006-7#2)(2006-8#5)(2006-9#2)(2007-1#2)(2007-10#3)(2007-11#4)(2007-12#5)(2007-2#4)(2007-3#3)(2007-5#3)(2007-6#6)(2007-7#5)(2007-8#10)(2007-9#8)(2008-1#8)(2008-10#31)(2008-11#7)(2008-12#3)(2008-2#19)(2008-3#16)(2008-4#9)(2008-5#9)(2008-6#5)(2008-7#6)(2008-8#6)(2008-9#8)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#9)(2009-7#1)(2010-11#2)(2010-12#3)(2010-2#5)(2010-3#2)(2010-4#3)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#9)(2011-12#1)(2011-2#11)(2011-3#2)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#13)(2012-3#8)(2013-1#12)(2013-7#1)(2013-8#3)
to finding a##2##3##(2008-5#1)(2012-12#1)
to finding the##2##3##(2008-10#1)(2009-5#1)
to finding##11##2##(2008-10#1)(2008-5#1)(2009-11#1)(2009-12#2)(2009-5#1)(2010-11#1)(2010-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
to findings of##2##3##(1995-1#1)(2013-8#1)
to findings##8##2##(1992-10#1)(1992-6#1)(1994-12#1)(1995-1#2)(2007-12#1)(2012-3#1)(2013-8#1)
to fine##7##2##(1997-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-8#1)(2012-11#1)
to fine-tune the##3##3##(2006-12#1)(2011-1#1)(2013-1#1)
to fine-tune##6##2##(2006-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-1#1)(2013-1#1)
to finely tune##3##3##(2009-6#1)(2009-8#1)(2010-8#1)
to fingerprint##2##2##(2008-2#1)(2011-1#1)
to finish the##2##3##(2008-11#2)
to finish##4##2##(2005-8#1)(2008-11#2)(2010-4#1)
to finite##2##2##(2006-10#1)(2008-3#1)
to fire##5##2##(1996-12#1)(2008-10#2)(2009-8#1)(2012-1#1)
to firm##3##2##(1990-12#1)(2007-2#1)(2013-1#1)
to first arch##2##3##(1993-12#2)
to first calving##2##3##(2006-5#1)(2007-8#1)
to first cigarette in the morning##2##6##(2008-8#2)
to first order##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
to first##34##2##(1993-12#2)(1994-1#1)(1995-2#1)(1996-12#1)(1997-4#1)(2006-5#4)(2007-10#1)(2007-12#2)(2007-8#2)(2008-10#2)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#3)(2010-10#1)(2010-2#1)(2010-7#1)(2011-12#1)(2013-1#1)
to first-generation##2##2##(2006-11#1)(2009-11#1)
to first-line therapy##2##3##(1996-9#1)(2013-1#1)
to first-line treatment of##2##4##(1996-9#1)(2008-8#1)
to first-line treatment##3##3##(1996-9#1)(2008-5#1)(2008-8#1)
to first-line##8##2##(1992-8#1)(1996-9#2)(2007-10#1)(2008-5#1)(2008-8#1)(2010-12#1)(2013-1#1)
to first-order##2##2##(1997-1#1)(2007-12#1)
to fish lymphocytes##2##3##(2008-10#2)
to fish##13##2##(1991-10#1)(1994-2#1)(1996-11#1)(1996-7#1)(1996-8#1)(2006-12#1)(2007-8#1)(2008-10#3)(2008-9#1)(2010-8#2)
to fishing##2##2##(2009-7#1)(2013-7#1)
to fit a##3##3##(1991-5#1)(1996-5#1)(2008-1#1)
to fit and##2##3##(1997-2#1)(2008-4#1)
to fit experimental##3##3##(2005-11#1)(2007-8#1)(2008-3#1)
to fit in##4##3##(1994-2#1)(2008-2#1)(2009-6#1)(2013-1#1)
to fit into a##2##4##(1997-3#1)(2008-2#1)
to fit into the##3##4##(1990-2#1)(1992-3#1)(2009-6#1)
to fit into##7##3##(1990-2#1)(1992-3#1)(1995-6#1)(1996-11#1)(1997-3#1)(2008-2#1)(2009-6#1)
to fit the data##2##4##(1997-1#1)(2008-5#1)
to fit the##22##3##(1990-8#2)(1997-1#1)(2004-12#1)(2006-12#1)(2007-12#2)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#2)(2011-2#1)(2012-3#1)(2013-1#1)
to fit these##2##3##(1997-8#1)(2006-4#1)
to fit##66##2##(1990-2#1)(1990-8#2)(1991-5#1)(1992-3#1)(1994-2#1)(1995-6#1)(1996-11#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-12#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#3)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-6#2)(2009-8#2)(2009-9#1)(2010-10#1)(2011-1#2)(2011-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
to fitness##3##2##(2008-1#1)(2010-1#1)(2013-1#1)
to five days##5##3##(1990-10#1)(1992-5#1)(1996-8#1)(1997-4#1)(2007-10#1)
to five different##2##3##(1993-12#1)(1995-8#1)
to five genes##2##3##(1997-4#1)(2008-10#1)
to five of the##2##4##(2006-8#1)(2008-10#1)
to five pathogens##2##3##(2008-10#2)
to five times##6##3##(1993-1#1)(2006-9#1)(2008-10#2)(2008-3#1)(2010-4#1)
to five weeks##2##3##(2007-1#1)(2012-2#1)
to five years##5##3##(1994-9#1)(1995-7#1)(1995-9#1)(2008-11#1)(2012-12#1)
to five##74##2##(1990-10#1)(1991-1#1)(1991-2#1)(1991-4#1)(1992-11#1)(1992-5#1)(1993-1#2)(1993-12#1)(1993-2#1)(1994-11#1)(1994-5#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-8#1)(1997-3#1)(1997-4#2)(1997-7#1)(2005-10#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#19)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-4#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
to five-fold##2##2##(1994-5#1)(2009-7#1)
to fivefold higher##2##3##(1993-2#1)(2008-10#1)
to fivefold##3##2##(1993-2#1)(1995-12#1)(2008-10#1)
to fix the##6##3##(1994-9#1)(1995-1#1)(1997-6#1)(2008-4#1)(2008-7#1)(2008-9#1)
to fix##16##2##(1994-9#1)(1995-1#1)(1997-6#1)(2008-11#2)(2008-4#1)(2008-5#7)(2008-7#1)(2008-9#1)(2010-11#1)
to fixate##4##2##(2008-10#1)(2008-2#1)(2009-2#1)(2009-8#1)
to fixation##7##2##(2004-9#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-9#1)(2009-5#1)(2010-10#1)
to fixed##5##2##(1992-2#1)(1994-8#1)(2007-10#1)(2008-4#1)(2008-8#1)
to fixed-angle##2##2##(2006-3#2)
to fixed-point math##2##3##(2008-2#1)(2011-1#1)
to flame atomic absorption spectrometry (FAAS)##3##6##(2008-10#3)
to flame atomic absorption##6##4##(2008-10#6)
to flame##8##2##(2008-10#8)
to flat##5##2##(1993-8#1)(2007-11#1)(2008-10#2)(2010-4#1)
to flavin##2##2##(1993-6#1)(1994-11#1)
to flesh out##2##3##(2010-2#2)
to flex the##2##3##(2008-9#1)(2012-1#1)
to flex##4##2##(2007-12#1)(2008-9#2)(2012-1#1)
to flexible##3##2##(2008-1#1)(2008-11#1)(2008-7#1)
to float##2##2##(1993-12#1)(2008-9#1)
to flooding##2##2##(2012-5#2)
to flour##3##2##(1990-3#2)(2008-10#1)
to flourish##2##2##(1994-1#1)(2009-6#1)
to flow cytometry data##2##4##(2008-8#1)(2008-9#1)
to flow cytometry##6##3##(2008-1#1)(2008-4#2)(2008-8#1)(2008-9#2)
to flow from##2##3##(2005-7#1)(2008-12#1)
to flow injection (FI)##3##4##(2008-10#3)
to flow injection##6##3##(2008-10#6)
to flow##21##2##(2005-7#1)(2006-5#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#2)(2010-9#1)
to flower##4##2##(2008-10#2)(2008-5#2)
to flowering##6##2##(1991-9#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-8#1)(2012-11#1)
to flowers##3##2##(2008-10#1)(2008-8#1)(2009-5#1)
to fluconazole and amphotericin B in##2##6##(2008-5#2)
to fluconazole and amphotericin##4##4##(1996-11#1)(2006-4#1)(2008-5#2)
to fluconazole and ketoconazole was##2##5##(2008-5#2)
to fluconazole and##8##3##(1996-11#1)(2006-4#1)(2007-7#1)(2008-5#5)
to fluconazole##14##2##(1996-11#1)(2005-8#1)(2006-4#1)(2007-7#1)(2008-10#1)(2008-5#9)
to fluctuate##3##2##(1997-8#1)(2008-3#1)(2009-10#1)
to fluctuating##2##2##(2008-10#1)(2010-7#1)
to fluctuations in the##2##4##(2008-3#1)(2008-7#1)
to fluctuations in##3##3##(1990-8#1)(2008-3#1)(2008-7#1)
to fluctuations##4##2##(1990-8#1)(2007-8#1)(2008-3#1)(2008-7#1)
to fluid##11##2##(1990-4#1)(1995-3#1)(1997-8#1)(2005-8#1)(2007-11#1)(2008-2#1)(2008-8#1)(2009-5#2)(2010-1#1)(2012-2#1)
to fluorescence##12##2##(1991-1#1)(1993-2#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-8#1)(2009-3#1)(2012-12#1)
to fluorescent##4##2##(1993-11#1)(1995-3#1)(2008-10#2)
to fluoride##6##2##(2007-8#1)(2008-10#2)(2008-12#1)(2011-1#1)(2013-1#1)
to fluoropyrimidine##2##2##(1992-8#1)(2009-2#1)
to fluoroquinolones##7##2##(2005-8#1)(2006-10#1)(2007-7#1)(2008-4#1)(2008-7#2)(2010-11#1)
to fluorouracil##4##2##(1990-2#4)
to fluoxetine##5##2##(2005-9#1)(2006-5#1)(2007-7#1)(2007-9#1)(2013-1#1)
to flusilazole##2##2##(2008-10#2)
to fly##4##2##(1994-3#1)(2007-12#1)(2007-2#1)(2008-3#1)
to foam cell formation##2##4##(1992-5#1)(1995-3#1)
to foam##4##2##(1992-5#1)(1995-3#1)(2005-11#1)(2013-1#1)
to focal##3##2##(1990-9#1)(1992-8#1)(2011-2#1)
to focus and deflect##2##4##(2007-12#1)(2008-2#1)
to focus attention on##4##4##(1992-2#1)(1993-7#1)(2007-7#1)(2013-1#1)
to focus more attention##2##4##(1997-1#1)(2007-7#1)
to focus more on##3##4##(2007-8#1)(2012-1#1)(2012-2#1)
to focus more##6##3##(1997-1#1)(2007-7#1)(2007-8#1)(2008-11#1)(2012-1#1)(2012-2#1)
to focus on prevention##2##4##(1994-12#1)(2006-10#1)
to focus on the development of##2##6##(2004-12#1)(2009-4#1)
to focus on the##22##4##(1993-8#1)(1994-1#1)(1994-2#2)(1996-1#1)(2004-12#1)(2006-10#2)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-11#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-5#1)(2011-2#1)(2013-1#1)
to focus on##49##3##(1990-11#1)(1991-6#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#2)(1995-12#1)(1996-1#1)(1996-2#1)(1996-8#1)(1997-2#1)(2004-12#2)(2005-10#1)(2006-10#5)(2006-8#1)(2007-10#1)(2007-12#3)(2007-6#1)(2007-8#1)(2008-1#2)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#2)(2013-1#2)
to focus the##4##3##(1997-7#1)(2007-12#1)(2008-2#1)(2010-3#1)
to focus their attention##3##4##(2006-10#1)(2008-12#1)(2008-7#1)
to focus##87##2##(1990-11#1)(1991-6#1)(1992-2#1)(1993-7#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#2)(1995-12#1)(1995-2#1)(1996-1#2)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-12#2)(2005-10#1)(2005-11#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-12#5)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
to focused##3##2##(1991-8#1)(2007-12#1)(2008-5#1)
to focusing##2##2##(2008-3#2)
to foetal##3##2##(2005-7#1)(2008-11#1)(2008-3#1)
to folate##5##2##(1992-6#2)(1992-9#1)(2006-10#1)(2011-1#1)
to fold in##2##3##(1991-7#1)(1993-9#1)
to fold into##3##3##(1994-3#2)(2006-10#1)
to fold##14##2##(1991-7#1)(1992-9#1)(1993-9#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-4#1)(1996-6#2)(2005-10#1)(2006-10#1)(2006-5#1)(2011-2#1)
to folding##2##2##(1997-4#1)(2011-12#1)
to foliar##4##2##(2008-10#3)(2013-8#1)
to follicular growth##2##3##(2008-12#2)
to follicular##5##2##(1995-12#1)(2006-12#1)(2008-12#2)(2008-8#1)
to follow a##13##3##(1990-4#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-2#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
to follow an##2##3##(2008-10#1)(2012-1#1)
to follow changes in the##3##5##(1996-12#1)(2004-11#1)(2008-4#1)
to follow in##4##3##(2006-8#1)(2008-2#1)(2008-3#1)(2009-11#1)
to follow its##2##3##(1991-3#1)(2008-11#1)
to follow the changes in##2##5##(2007-12#1)(2007-7#1)
to follow the course of##2##5##(1992-12#1)(2008-5#1)
to follow the development of##2##5##(1991-11#1)(2009-4#1)
to follow the development##3##4##(1991-11#1)(2007-8#1)(2009-4#1)
to follow the distribution of##2##5##(1990-5#1)(1991-12#1)
to follow the evolution of##2##5##(2008-10#2)
to follow the progress##2##4##(1997-8#1)(2006-10#1)
to follow the##51##3##(1990-11#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-12#2)(1992-2#2)(1993-2#1)(1994-12#2)(1994-5#1)(1994-6#1)(1995-9#1)(1997-2#2)(1997-8#1)(2005-11#1)(2006-10#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-9#1)(2009-4#1)(2009-9#1)(2012-1#1)(2012-12#1)(2012-3#2)
to follow their##2##3##(2007-2#1)(2007-9#1)
to follow up the##5##4##(1992-3#1)(1993-5#1)(2008-10#1)(2008-4#1)(2009-10#1)
to follow up##11##3##(1992-3#1)(1993-12#1)(1993-5#1)(1995-5#1)(1996-3#1)(2006-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-10#1)(2011-2#1)
to follow will##2##3##(1990-12#1)(2008-6#1)
to follow##143##2##(1990-11#2)(1990-12#1)(1990-4#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-12#2)(1994-5#1)(1994-6#2)(1995-5#1)(1995-9#1)(1996-12#1)(1996-3#3)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-6#1)(1997-8#1)(2004-11#1)(2004-3#1)(2005-11#3)(2005-12#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-4#2)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#1)
to follow-up of##2##3##(1996-12#1)(2005-11#1)
to follow-up##31##2##(1991-12#2)(1992-4#1)(1992-5#1)(1992-8#1)(1993-12#1)(1996-12#1)(1996-3#1)(2005-11#1)(2006-4#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#2)(2009-3#2)(2010-2#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)
to following##3##2##(1992-12#1)(1995-4#1)(2008-9#1)
to food and##3##3##(2008-10#1)(2009-8#1)(2012-2#1)
to food in##2##3##(2006-10#1)(2008-7#1)
to food insecurity##2##3##(1994-12#1)(2011-1#1)
to food proteins##2##3##(2006-10#1)(2012-2#1)
to food samples were quantitative##2##5##(2008-10#2)
to food samples##3##3##(2008-10#3)
to food##39##2##(1990-9#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1996-1#1)(1997-2#1)(2006-10#3)(2007-10#1)(2007-12#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-8#3)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#5)(2013-7#1)
to foods##6##2##(1991-11#1)(2005-5#1)(2008-1#1)(2009-2#1)(2012-12#1)(2013-1#1)
to for##3##2##(2007-2#1)(2008-9#1)(2012-1#1)
to forage##6##2##(2008-9#5)(2010-8#1)
to foraging##2##2##(1991-8#1)(2008-9#1)
to force him##2##3##(1996-5#2)
to force the##2##3##(1997-7#1)(2008-2#1)
to force##19##2##(1995-8#1)(1996-5#2)(1997-4#1)(1997-5#3)(1997-7#1)(2005-8#1)(2006-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-9#1)
to forced swim##2##3##(2008-11#2)
to forced##5##2##(1991-10#1)(2006-5#1)(2008-11#2)(2012-1#1)
to forces##2##2##(1990-5#1)(2006-11#1)
to forearm##5##2##(1994-4#1)(2006-11#1)(2007-4#2)(2012-1#1)
to forebrain##4##2##(1994-12#1)(1995-12#2)(1997-8#1)
to forecast the##3##3##(1996-6#1)(2010-5#1)(2012-3#1)
to forecast##8##2##(1996-6#1)(2008-1#1)(2008-10#1)(2009-11#1)(2009-8#1)(2010-5#1)(2012-3#1)(2013-8#1)
to forecasting##2##2##(2008-8#1)(2013-8#1)
to foreign antigens##2##3##(1994-3#1)(2008-4#1)
to foreign##11##2##(1990-3#1)(1994-3#1)(1995-8#1)(2006-5#1)(2006-8#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#2)
to forensic scientists##3##3##(1995-6#1)(2008-10#1)(2013-7#1)
to forensic##12##2##(1990-7#1)(1995-6#2)(1996-5#1)(1996-7#1)(1997-2#1)(2008-10#2)(2008-12#2)(2008-6#1)(2013-7#1)
to foresee##4##2##(1991-2#1)(1997-1#1)(2013-1#2)
to forest trees##5##3##(2006-12#3)(2008-10#1)(2008-8#1)
to forest##7##2##(2006-12#3)(2008-10#1)(2008-8#1)(2008-9#1)(2010-5#1)
to forge##4##2##(1995-2#1)(2007-12#1)(2007-2#1)(2008-7#1)
to forget##3##2##(1991-2#1)(2007-4#1)(2012-12#1)
to form &quot##3##3##(2005-11#1)(2013-1#2)
to form 1##2##3##(1990-6#1)(1991-5#1)
to form 2##2##3##(1995-6#1)(2008-10#1)
to form DNA##2##3##(1994-8#1)(1995-3#1)
to form a 1##10##4##(1995-11#1)(2008-10#9)
to form a blue complex##2##5##(2008-10#2)
to form a blue##3##4##(1990-2#1)(2008-10#2)
to form a calcium phosphate precipitate that is directly layered onto the cells##3##13##(2008-1#1)(2008-2#1)(2008-4#1)
to form a catalytically active complex##2##6##(1995-1#1)(1997-5#1)
to form a chelate##2##4##(2008-10#2)
to form a colored complex##3##5##(2008-10#3)
to form a colored compound##2##5##(2008-10#2)
to form a colored##8##4##(2008-10#8)
to form a complex with##2##5##(1994-11#1)(2008-10#1)
to form a complex##4##4##(1994-11#1)(2008-10#2)(2008-9#1)
to form a diazonium##2##4##(2008-10#1)(2008-5#1)
to form a disulfide##2##4##(1995-1#1)(1996-5#1)
to form a functional##2##4##(1996-5#1)(2008-2#1)
to form a highly##3##4##(2007-7#1)(2007-8#1)(2013-1#1)
to form a new##3##4##(1993-9#1)(2008-5#1)(2012-11#1)
to form a precipitate##2##4##(2008-10#2)
to form a primary##2##4##(2008-1#1)(2008-12#1)
to form a salt bridge##2##5##(1991-7#1)(1993-3#1)
to form a specific##3##4##(1996-10#1)(2008-10#2)
to form a stable complex##2##5##(1994-8#1)(1996-5#1)
to form a stable##7##4##(1990-2#1)(1990-7#1)(1993-11#1)(1993-9#1)(1994-8#1)(1996-5#1)(2008-4#1)
to form a ternary complex##3##5##(2008-10#1)(2012-12#2)
to form a thin film##2##5##(2008-10#1)(2010-7#1)
to form a violet##3##4##(2008-10#2)(2010-2#1)
to form a yellow##3##4##(2008-10#3)
to form a##211##3##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-7#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-6#1)(1993-11#2)(1993-3#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#4)(1994-5#1)(1994-8#3)(1994-9#2)(1995-1#3)(1995-11#2)(1995-2#3)(1995-4#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#3)(1997-2#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#3)(2005-4#2)(2005-6#1)(2005-7#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#7)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#63)(2008-11#1)(2008-12#2)(2008-2#8)(2008-3#1)(2008-4#5)(2008-5#6)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-11#1)(2012-12#4)(2012-2#2)(2013-1#2)
to form advanced glycation end products##2##6##(2007-11#1)(2008-7#1)
to form aggregates in##2##4##(1991-2#1)(1994-12#1)
to form aggregates##5##3##(1991-2#1)(1993-4#1)(1994-12#1)(2007-12#1)(2008-11#1)
to form an amorphous phase of##2##6##(2006-7#2)
to form an image##2##4##(2008-2#1)(2008-3#1)
to form an intermediate##2##4##(1994-6#1)(1996-2#1)
to form an intrasubunit disulfide##2##5##(1990-12#1)(1994-5#1)
to form an##44##3##(1990-12#1)(1990-2#1)(1991-2#1)(1991-3#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-5#1)(2011-2#1)
to form and##3##3##(2006-12#1)(2008-5#1)(2008-8#1)
to form any##2##3##(2007-6#1)(2013-1#1)
to form association particles##2##4##(2008-10#2)
to form at##2##3##(2006-12#1)(2007-12#1)
to form channels in##2##4##(1994-11#1)(1994-6#1)
to form complexes with##7##4##(1995-5#1)(1995-8#1)(2008-10#2)(2008-7#1)(2009-8#1)(2010-11#1)
to form dimers##2##3##(1994-12#1)(2008-4#1)
to form either##2##3##(1997-4#1)(2008-10#1)
to form glucose##2##3##(1997-7#1)(2008-10#1)
to form high##2##3##(1995-3#1)(2007-8#1)
to form highly##5##3##(1995-2#1)(1996-5#1)(1997-4#1)(2009-11#1)(2010-4#1)
to form in##7##3##(1990-4#1)(1997-4#1)(2005-11#1)(2007-8#1)(2008-1#1)(2008-6#1)(2010-9#1)
to form ion##3##3##(2006-10#1)(2008-10#2)
to form its##2##3##(1992-9#1)(2008-10#1)
to form large##4##3##(1994-11#1)(2005-7#1)(2008-10#1)(2008-11#1)
to form long##3##3##(1991-7#1)(1997-7#1)(2009-7#1)
to form many##2##3##(2008-11#1)(2008-3#1)
to form more##2##3##(2008-12#1)(2008-3#1)
to form new##2##3##(1991-7#1)(2008-5#1)
to form oospores in##2##4##(2008-10#2)
to form particles##3##3##(1994-12#1)(1994-3#1)(1995-5#1)
to form plaques##2##3##(1994-5#1)(1997-3#1)
to form products##2##3##(2006-10#1)(2011-1#1)
to form red##2##3##(2008-10#2)
to form site-specific cross-links##2##4##(2008-4#2)
to form small##3##3##(1994-5#1)(2008-10#1)(2010-8#1)
to form spheroids##2##3##(2008-11#2)
to form stable complexes with##3##5##(1995-5#1)(2008-10#1)(2010-11#1)
to form stable##14##3##(1990-10#1)(1991-6#1)(1993-11#1)(1993-6#1)(1995-5#1)(1995-8#1)(1996-11#1)(2005-11#1)(2008-10#5)(2010-11#1)
to form the basis of the##2##6##(2005-8#1)(2008-5#1)
to form the basis of##3##5##(2005-8#1)(2008-5#1)(2008-9#1)
to form the basis##4##4##(2005-8#1)(2008-5#1)(2008-9#1)(2013-8#1)
to form the complex##3##4##(1995-4#1)(1997-4#1)(2008-10#1)
to form the corresponding thioquinone derivatives##2##6##(2007-8#1)(2008-10#1)
to form the corresponding##7##4##(1996-6#1)(2007-8#1)(2008-10#5)
to form the fluorescent##2##4##(1991-8#1)(2008-10#1)
to form the membrane##2##4##(2008-10#1)(2011-2#1)
to form the specific##2##4##(1996-11#1)(2013-8#1)
to form the##83##3##(1990-2#4)(1990-3#2)(1990-5#2)(1991-8#1)(1991-9#1)(1994-12#1)(1994-3#1)(1994-9#4)(1995-11#1)(1995-2#1)(1995-4#2)(1996-11#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-8#1)(2006-11#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-8#3)(2007-9#1)(2008-10#15)(2008-11#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#4)(2009-3#1)(2009-4#1)(2009-5#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-7#1)(2013-8#2)
to form this##3##3##(1990-4#1)(2007-12#1)(2008-5#1)
to form two##5##3##(1994-5#1)(1995-5#1)(1996-2#1)(2007-12#1)(2008-10#1)
to form two-dimensional##2##3##(1991-11#1)(2008-3#1)
to form##756##2##(1990-10#2)(1990-11#5)(1990-12#2)(1990-2#8)(1990-3#3)(1990-4#2)(1990-5#7)(1990-6#2)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#3)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#4)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#5)(1991-8#2)(1991-9#2)(1992-1#2)(1992-10#4)(1992-12#2)(1992-2#5)(1992-6#4)(1992-7#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#7)(1993-12#2)(1993-3#1)(1993-4#1)(1993-6#5)(1993-7#2)(1993-8#1)(1993-9#3)(1994-11#5)(1994-12#11)(1994-2#2)(1994-3#3)(1994-5#7)(1994-6#4)(1994-8#6)(1994-9#9)(1995-1#6)(1995-10#4)(1995-11#3)(1995-2#7)(1995-3#4)(1995-4#3)(1995-5#5)(1995-6#5)(1995-7#1)(1995-8#5)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#2)(1996-2#10)(1996-4#2)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#4)(1997-2#4)(1997-3#1)(1997-4#6)(1997-5#2)(1997-6#4)(1997-7#5)(1997-8#2)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#13)(2005-12#1)(2005-4#3)(2005-6#1)(2005-7#2)(2005-8#3)(2006-10#3)(2006-11#1)(2006-12#7)(2006-3#6)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#9)(2007-12#22)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#13)(2007-9#2)(2008-1#9)(2008-10#146)(2008-11#18)(2008-12#3)(2008-2#20)(2008-3#12)(2008-4#14)(2008-5#17)(2008-6#6)(2008-7#14)(2008-8#14)(2008-9#11)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#2)(2009-7#4)(2009-8#3)(2009-9#1)(2010-11#3)(2010-12#2)(2010-2#4)(2010-3#3)(2010-4#5)(2010-5#5)(2010-7#3)(2010-8#4)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#4)(2012-12#15)(2012-2#11)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#2)
to formal##4##2##(1994-9#1)(1997-2#1)(2007-7#1)(2011-12#1)
to formaldehyde##6##2##(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#2)
to formally evaluate##2##3##(2013-1#2)
to formally##4##2##(2008-11#1)(2012-11#1)(2013-1#2)
to formate##3##2##(1994-11#1)(2005-12#2)
to formation of a##2##4##(1991-9#1)(2007-8#1)
to formation of an##2##4##(2007-12#1)(2008-3#1)
to formation of the##3##4##(1996-7#1)(2006-6#1)(2008-5#1)
to formation of##24##3##(1991-1#1)(1991-3#1)(1991-9#1)(1994-2#1)(1994-8#2)(1996-2#1)(1996-7#1)(1996-8#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-3#1)(2012-12#1)(2013-1#1)
to formetanate##2##2##(2011-2#2)
to forms##3##2##(1997-7#1)(2011-1#1)(2012-11#1)
to formulate a##7##3##(1996-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-5#1)(2011-1#1)
to formulate an##5##3##(2006-2#1)(2007-12#1)(2008-5#1)(2009-8#1)(2012-7#1)
to formulate and evaluate##2##4##(2010-2#2)
to formulate and##8##3##(2006-4#1)(2007-6#1)(2008-12#1)(2010-2#2)(2011-1#2)(2013-8#1)
to formulate the##4##3##(2007-9#1)(2008-2#2)(2008-5#1)
to formulate treatment##2##3##(2007-7#1)(2013-1#1)
to formulate##52##2##(1991-4#1)(1996-12#1)(1996-4#1)(1997-3#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-7#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#6)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-2#2)(2010-5#2)(2011-1#4)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#1)(2013-8#2)
to formulations##2##2##(2007-8#1)(2012-2#1)
to forskolin and##2##3##(1995-5#1)(1996-6#1)
to forskolin##4##2##(1995-5#1)(1995-8#1)(1996-6#1)(1997-2#1)
to fortify##3##2##(2008-10#1)(2008-11#1)(2012-12#1)
to forward##2##2##(1993-1#1)(2012-2#1)
to fosmidomycin##2##2##(2008-11#2)
to fossil##2##2##(1991-9#1)(2011-2#1)
to foster a##4##3##(1990-11#1)(2008-10#1)(2008-4#1)(2008-6#1)
to foster more##2##3##(2007-9#1)(2008-11#1)
to foster the##4##3##(1993-1#1)(2005-1#1)(2008-4#1)(2009-6#1)
to foster this##2##3##(2006-5#1)(2013-1#1)
to foster##28##2##(1990-11#1)(1991-12#1)(1993-1#1)(1995-3#2)(2005-1#1)(2006-10#1)(2006-5#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
to fouling##6##2##(2008-10#2)(2008-6#1)(2009-2#1)(2013-1#2)
to found a##2##3##(1992-10#1)(2011-4#1)
to found##4##2##(1990-12#1)(1992-10#1)(1994-12#1)(2011-4#1)
to four clinical scenarios##2##4##(2006-4#1)(2008-7#1)
to four cycles of##2##4##(2008-10#1)(2009-8#1)
to four days##3##3##(1992-9#1)(2008-10#1)(2008-11#1)
to four different##6##3##(1995-12#1)(1997-2#1)(2007-8#1)(2008-10#3)
to four groups##6##3##(2006-12#1)(2006-8#1)(2007-8#1)(2010-8#1)(2012-2#1)(2013-8#1)
to four the##2##3##(2008-10#1)(2008-2#1)
to four times the##2##4##(2008-2#1)(2008-5#1)
to four times##10##3##(1992-8#1)(1995-9#1)(1997-7#1)(2006-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#3)
to four water molecules##2##4##(1996-7#1)(2006-1#1)
to four weekly##2##3##(1992-4#1)(2008-12#1)
to four weeks##2##3##(1991-12#1)(2006-4#1)
to four years##4##3##(1990-11#1)(1991-8#1)(1993-2#1)(1993-9#1)
to four##131##2##(1990-11#2)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#2)(1992-11#1)(1992-3#2)(1992-4#1)(1992-8#1)(1992-9#3)(1993-2#1)(1993-8#1)(1993-9#1)(1994-9#2)(1995-1#2)(1995-12#1)(1995-3#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-4#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-4#2)(2006-8#1)(2006-9#1)(2007-12#2)(2007-5#1)(2007-8#6)(2008-10#25)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#2)(2008-5#6)(2008-6#2)(2008-7#4)(2008-9#3)(2009-1#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-2#1)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#3)
to four)##2##2##(2008-10#1)(2008-5#1)
to four-fold##2##2##(1997-8#1)(2008-11#1)
to fourfold higher##2##3##(1992-11#1)(2008-7#1)
to fourfold##7##2##(1992-11#1)(1997-3#1)(2005-10#1)(2007-12#1)(2008-1#1)(2008-7#1)(2009-4#1)
to fourth-order##2##2##(2007-11#1)(2009-10#1)
to fractionate##7##2##(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#2)
to fractionated##2##2##(1995-9#1)(1996-5#1)
to fracture healing##2##3##(2007-11#1)(2013-1#1)
to fracture risk##2##3##(2007-9#1)(2008-9#1)
to fracture##14##2##(2006-10#1)(2006-11#1)(2006-6#1)(2007-11#3)(2007-9#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-10#1)(2013-1#2)
to fragment##2##2##(1995-6#1)(1997-6#1)
to fragmentation##2##2##(2008-1#1)(2013-8#1)
to fragments from##2##3##(1994-9#1)(2008-2#1)
to fragments of##2##3##(1993-6#1)(1994-8#1)
to fragments##7##2##(1990-11#1)(1992-11#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(2008-2#1)
to frailty##2##2##(2008-7#1)(2012-12#1)
to frame##8##2##(1996-3#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-4#1)(2011-1#1)(2012-3#2)
to frank##2##2##(2007-3#1)(2008-9#1)
to fraud##2##2##(1993-12#1)(1994-2#1)
to free Ca2+ levels of ca##2##6##(1990-11#2)
to free N-acetylneuraminic acid##2##4##(1990-2#2)
to free amino##2##3##(1992-4#1)(2008-5#1)
to free enzyme##2##3##(1994-3#1)(1995-1#1)
to free radical generation##2##4##(1994-11#1)(2009-9#1)
to free radical##7##3##(1991-9#1)(1994-11#1)(1995-3#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-9#1)
to free##37##2##(1990-11#2)(1990-2#2)(1990-4#1)(1991-9#2)(1992-4#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1997-6#1)(2006-3#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-5#3)(2009-9#1)(2010-12#1)(2010-2#1)(2012-12#1)
to free-living##2##2##(2010-6#1)(2012-12#1)
to freely##4##2##(1990-2#1)(1997-6#1)(2006-3#1)(2012-2#1)
to freeway##2##2##(2012-12#2)
to freeze##4##2##(1993-3#1)(2008-1#1)(2008-10#1)(2008-4#1)
to freezing##5##2##(1994-9#1)(2006-6#1)(2009-8#1)(2011-1#1)(2012-2#1)
to frequencies##2##2##(1990-4#1)(2008-2#1)
to frequency of##4##3##(1997-6#1)(2007-10#1)(2008-5#1)(2010-2#1)
to frequency##13##2##(1997-6#1)(1997-8#1)(2007-10#1)(2007-12#4)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2010-2#1)
to frequency-domain##2##2##(2008-1#1)(2008-3#1)
to frequency-shifted optical feedback##3##4##(2007-12#2)(2008-3#1)
to frequent##9##2##(1991-4#1)(2004-10#1)(2005-7#1)(2005-8#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
to frequently##3##2##(1994-6#1)(2008-2#1)(2008-4#1)
to fresh##12##2##(1995-7#1)(1997-2#2)(1997-4#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-7#1)(2010-12#1)(2010-4#1)(2010-8#1)
to freshly##2##2##(1994-6#1)(2011-2#1)
to freshwater##4##2##(2010-8#3)(2012-2#1)
to frog##3##2##(1993-12#1)(1996-2#1)(2007-2#1)
to frontal##4##2##(1996-12#1)(2007-4#2)(2012-8#1)
to frontline##2##2##(1993-1#1)(2008-2#1)
to frost##2##2##(2008-10#1)(2008-5#1)
to frozen##2##2##(1996-2#1)(2006-3#1)
to fructose-2##2##2##(1990-3#1)(1990-5#1)
to fruit##12##2##(1991-5#1)(2008-10#8)(2008-12#2)(2008-5#1)
to fruition##3##2##(2008-10#1)(2010-10#1)(2011-2#1)
to frustration##2##2##(1996-3#1)(2006-12#1)
to fuel##7##2##(1993-4#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-8#1)(2010-4#1)
to fulfil the##3##3##(1997-2#1)(2006-3#1)(2007-3#1)
to fulfil their##3##3##(2005-7#1)(2007-10#1)(2007-11#1)
to fulfil##14##2##(1991-3#1)(1994-11#1)(1995-8#1)(1997-2#1)(1997-6#1)(2005-7#1)(2006-2#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-11#1)(2009-12#1)(2012-2#1)
to fulfill the##7##3##(1996-11#1)(2006-10#1)(2006-6#1)(2006-8#1)(2009-6#1)(2011-1#1)(2012-1#1)
to fulfill their##2##3##(2010-9#1)(2012-11#1)
to fulfill##25##2##(1990-12#1)(1991-12#1)(1995-1#3)(1995-11#1)(1996-11#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2008-2#1)(2008-6#1)(2009-5#1)(2009-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
to full activity##2##3##(1993-3#1)(2008-7#1)
to full length##2##3##(1997-2#1)(2008-10#1)
to full recovery##3##3##(2007-8#1)(2008-9#1)(2009-7#1)
to full restoration of##2##4##(1996-12#1)(2007-7#1)
to full##30##2##(1990-8#1)(1993-3#1)(1996-12#1)(1997-2#1)(2004-3#1)(2005-7#1)(2006-3#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-2#1)
to full-blown##3##2##(2005-11#1)(2009-8#2)
to full-field##2##2##(2007-4#1)(2009-7#1)
to full-length##4##2##(1991-5#1)(1993-8#1)(1995-2#1)(1997-2#1)
to fully automated##2##3##(2005-7#1)(2008-4#1)
to fully define the##2##4##(1997-5#1)(2009-7#1)
to fully realize the value of##3##6##(2008-7#1)(2013-1#2)
to fully realize the##4##4##(2008-7#1)(2012-11#1)(2013-1#2)
to fully recover##2##3##(1996-11#1)(2013-8#1)
to fully understand the##7##4##(2006-8#1)(2007-2#1)(2008-11#1)(2009-3#1)(2010-12#1)(2011-1#1)(2012-12#1)
to fully understand##10##3##(1990-12#1)(2006-8#1)(2007-2#1)(2008-11#1)(2008-4#1)(2009-3#1)(2010-1#1)(2010-12#1)(2011-1#1)(2012-12#1)
to fully utilize##2##3##(2008-11#1)(2008-2#1)
to fully validate##2##3##(2007-4#1)(2007-8#1)
to fully##55##2##(1990-11#1)(1990-12#1)(1992-1#1)(1992-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-10#1)(1996-11#1)(1996-8#1)(1997-5#1)(1997-8#2)(2005-7#1)(2005-8#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-4#2)(2007-8#2)(2008-10#3)(2008-11#3)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#1)(2009-1#2)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-1#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
to fulminant hepatic failure##2##4##(1992-5#1)(2005-12#1)
to fulminant##4##2##(1992-5#1)(1993-10#1)(2005-12#1)(2013-1#1)
to fumigated field##2##3##(2008-10#2)
to fumonisin##4##2##(2008-10#4)
to function after##2##3##(2007-2#1)(2008-10#1)
to function as a sequence-specific transcriptional activator##2##7##(1995-6#1)(1996-10#1)
to function as a##24##4##(1990-9#1)(1991-9#1)(1992-12#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-8#1)(2009-2#1)(2009-6#1)(2010-10#1)(2013-1#1)
to function as an##6##4##(1993-3#1)(1994-8#1)(1995-3#1)(2007-11#1)(2009-10#1)(2012-2#1)
to function as the##3##4##(1991-12#1)(1993-12#1)(1993-5#1)
to function as##45##3##(1990-11#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-8#1)(1995-12#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-3#2)(1996-4#1)(1996-5#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#1)(2009-9#1)(2010-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
to function better##3##3##(2006-10#1)(2007-10#1)(2007-7#1)
to function both##2##3##(1991-9#1)(1997-8#1)
to function effectively in##3##4##(2008-11#1)(2008-12#1)(2008-9#1)
to function effectively##4##3##(1990-12#1)(2008-11#1)(2008-12#1)(2008-9#1)
to function in a##4##4##(1991-2#1)(1993-3#1)(1995-1#1)(1996-5#1)
to function in the maintenance of##2##6##(1997-4#1)(2008-8#1)
to function in the##6##4##(1992-7#1)(1993-9#1)(1997-4#1)(1997-7#1)(2007-4#1)(2008-8#1)
to function in##36##3##(1990-10#1)(1990-4#1)(1991-2#1)(1992-11#1)(1992-7#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-12#2)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-5#1)(2010-6#1)(2012-1#1)(2012-2#1)
to function like##2##3##(1990-2#1)(2007-9#1)
to function normally##3##3##(1995-2#1)(2008-7#1)(2009-8#1)
to function with##2##3##(1991-7#1)(2008-3#1)
to function##127##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-9#2)(1992-11#2)(1992-12#1)(1992-7#1)(1993-12#1)(1993-3#2)(1993-5#2)(1993-6#2)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#2)(1996-8#2)(1997-2#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-2#1)(2006-10#3)(2006-12#2)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#2)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-5#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
to functional assays##2##3##(2008-4#2)
to functional changes##2##3##(2012-2#1)(2013-1#1)
to functional impairment##2##3##(1996-5#1)(2008-3#1)
to functional properties##2##3##(1993-2#1)(2006-10#1)
to functional##41##2##(1990-12#1)(1990-5#1)(1991-3#1)(1991-5#1)(1992-8#1)(1993-2#1)(1994-1#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-5#1)(1997-8#1)(2006-10#2)(2006-11#2)(2006-12#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#2)(2009-4#2)(2010-9#1)(2011-1#2)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#1)
to functionally##12##2##(1991-5#1)(1993-11#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-8#1)(2006-10#1)(2007-11#1)(2008-5#1)(2009-12#1)(2011-2#1)(2012-3#1)
to functions##5##2##(1991-1#1)(2006-10#1)(2008-7#1)(2009-6#1)(2012-2#1)
to fund the##3##3##(1991-1#1)(1997-1#1)(2004-2#1)
to fund##11##2##(1991-1#1)(1991-12#1)(1991-9#1)(1995-8#1)(1997-1#2)(2004-2#1)(2005-6#1)(2007-4#1)(2007-9#1)(2008-4#1)
to fundamental##10##2##(1990-7#1)(1994-12#1)(1996-1#1)(2007-3#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2013-1#1)(2013-7#1)
to funding##3##2##(2006-5#1)(2011-2#1)(2012-3#1)
to fungal attack##3##3##(2008-10#3)
to fungal infection##2##3##(2008-8#1)(2010-12#1)
to fungal pathogens##2##3##(2008-10#2)
to fungal##20##2##(1990-6#1)(1992-11#1)(2005-11#1)(2006-12#1)(2008-10#12)(2008-8#1)(2010-12#1)(2011-1#1)(2011-10#1)
to fungicide##3##2##(2008-10#2)(2011-12#1)
to fungicides##3##2##(2008-10#3)
to furnish a##3##3##(1997-3#1)(2007-11#1)(2009-11#1)
to furnish the##2##3##(1996-5#1)(1996-8#1)
to furnish##12##2##(1991-1#1)(1992-12#1)(1994-2#1)(1996-5#1)(1996-8#1)(1997-3#2)(2007-11#1)(2008-2#1)(2009-11#1)(2009-4#1)(2010-7#1)
to furosemide##2##2##(1992-9#1)(1995-6#1)
to further advance##2##3##(2010-3#1)(2012-2#1)
to further assess##3##3##(1993-12#1)(1997-4#1)(2008-6#1)
to further characterise##2##3##(1991-12#1)(2008-7#1)
to further characterize the##13##4##(1991-9#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-5#1)(1997-4#1)(2006-10#1)(2008-10#2)(2008-11#1)(2009-2#1)(2009-5#1)
to further characterize this##2##4##(1990-11#1)(2009-3#1)
to further characterize##17##3##(1990-11#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-5#1)(1995-11#1)(1997-4#1)(2006-10#1)(2008-10#2)(2008-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-2#1)
to further clarify the##4##4##(2008-10#2)(2009-11#1)(2010-12#1)
to further confirm##2##3##(2007-2#1)(2010-2#1)
to further define the##3##4##(1996-5#1)(2008-10#1)(2008-8#1)
to further delineate the role##2##5##(1996-10#1)(2006-8#1)
to further delineate the##3##4##(1995-2#1)(1996-10#1)(2006-8#1)
to further develop its##2##4##(1990-10#1)(2012-2#1)
to further develop the##3##4##(2006-1#1)(2008-12#1)(2012-12#1)
to further develop##10##3##(1990-10#1)(2006-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2010-1#1)(2010-10#1)(2012-12#1)(2012-2#2)
to further elucidate the functional role of##2##7##(1992-8#1)(1995-12#1)
to further elucidate the##5##4##(1992-8#1)(1995-12#1)(2008-1#1)(2008-10#1)(2008-5#1)
to further elucidate##6##3##(1992-8#1)(1995-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)
to further enhance##5##3##(1995-12#1)(2008-11#2)(2008-3#1)(2010-12#1)
to further evaluate the##6##4##(1995-2#1)(1996-12#1)(2007-11#1)(2008-7#1)(2010-8#1)(2011-2#1)
to further evaluate##8##3##(1995-2#1)(1996-12#1)(2007-11#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#2)
to further examine the##2##4##(1996-12#1)(1997-5#1)
to further expand the##4##4##(2007-8#1)(2008-11#1)(2009-2#1)(2011-1#1)
to further expand##5##3##(2005-7#1)(2007-8#1)(2008-11#1)(2009-2#1)(2011-1#1)
to further exploration of##2##4##(1993-12#1)(2007-12#1)
to further explore the##8##4##(1993-2#1)(1995-11#1)(2006-8#1)(2008-2#1)(2008-5#1)(2010-10#1)(2011-2#2)
to further explore##11##3##(1993-2#1)(1995-11#1)(2006-8#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-10#1)(2011-2#3)
to further extend the##2##4##(2009-4#1)(2009-5#1)
to further improve the##10##4##(1995-6#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-5#1)(2013-1#1)(2013-8#1)
to further improve##17##3##(1995-3#1)(1995-6#1)(2006-11#1)(2007-12#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#2)(2009-4#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
to further increase the##2##4##(2005-8#1)(2012-2#1)
to further investigate the##4##4##(1991-2#1)(1995-11#1)(2008-10#1)(2011-1#1)
to further investigate##8##3##(1991-2#1)(1995-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-8#1)(2011-1#1)(2013-7#1)
to further optimize##2##3##(2007-12#1)(2008-7#1)
to further our understanding of the##3##6##(2006-8#1)(2007-4#1)(2008-7#1)
to further our understanding of##7##5##(1990-12#1)(1996-8#1)(2006-8#1)(2007-4#1)(2008-7#2)(2013-8#1)
to further our##8##3##(1990-12#1)(1994-1#1)(1996-8#1)(2006-8#1)(2007-4#1)(2008-7#2)(2013-8#1)
to further progress in##2##4##(2008-12#1)(2009-4#1)
to further progress##3##3##(1996-1#1)(2008-12#1)(2009-4#1)
to further reduce the##6##4##(1990-8#1)(2006-10#1)(2007-10#1)(2008-10#1)(2010-7#1)(2012-12#1)
to further reduce##9##3##(1990-8#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-11#1)(2008-10#1)(2010-7#1)(2012-12#1)
to further refine the##2##4##(2008-3#1)(2009-7#1)
to further refine##4##3##(2005-7#1)(2008-11#1)(2008-3#1)(2009-7#1)
to further research on##2##4##(1992-3#1)(2009-4#1)
to further research##3##3##(1992-3#1)(2009-4#1)(2012-3#1)
to further stimulation##2##3##(1994-3#1)(1996-6#1)
to further studies on the##2##5##(1996-12#1)(2008-10#1)
to further studies##3##3##(1996-12#1)(2008-10#1)(2010-10#1)
to further study the##5##4##(2007-1#1)(2008-10#2)(2008-9#2)
to further study##6##3##(1996-7#1)(2007-1#1)(2008-10#2)(2008-9#2)
to further support##3##3##(2006-10#1)(2008-12#1)(2010-6#1)
to further test the##2##4##(1992-2#1)(2008-5#1)
to further test##4##3##(1992-2#1)(2008-5#1)(2010-6#1)(2012-2#1)
to further the##7##3##(2008-11#1)(2008-12#2)(2008-7#1)(2009-6#1)(2010-8#1)(2012-12#1)
to further understand the##12##4##(1996-4#1)(1996-8#2)(2006-5#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-1#1)(2012-12#1)(2013-8#1)
to further understand this##3##4##(2007-12#1)(2008-10#1)(2009-9#1)
to further understand##17##3##(1996-4#1)(1996-8#2)(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
to further verify the##3##4##(2007-8#1)(2008-10#2)
to further##259##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#3)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-5#2)(1993-7#1)(1994-1#1)(1994-3#2)(1994-9#1)(1995-11#3)(1995-12#2)(1995-2#2)(1995-3#2)(1995-6#1)(1996-1#3)(1996-10#1)(1996-12#3)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#3)(1997-1#1)(1997-4#2)(1997-5#2)(1997-7#1)(2003-11#1)(2005-10#2)(2005-7#2)(2005-8#1)(2006-1#2)(2006-10#6)(2006-11#1)(2006-3#1)(2006-5#1)(2006-8#5)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-2#2)(2007-4#2)(2007-6#1)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#20)(2008-11#16)(2008-12#7)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#6)(2008-6#5)(2008-7#7)(2008-8#5)(2008-9#3)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#4)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#3)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#8)(2012-12#4)(2012-2#10)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#6)
to fusarium##4##2##(2008-10#4)
to fuse with each other##2##5##(1997-6#1)(2008-2#1)
to fuse with the##2##4##(1992-12#1)(2008-10#1)
to fuse with##4##3##(1992-12#1)(1997-6#1)(2008-10#1)(2008-2#1)
to fuse##10##2##(1991-4#1)(1991-8#1)(1992-12#1)(1997-6#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-12#1)(2011-1#1)
to fusion##7##2##(1995-6#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-5#1)(2012-2#1)
to future development##3##3##(1992-2#2)(2007-8#1)
to future research and##2##4##(2007-11#1)(2008-12#1)
to future research##3##3##(1996-8#1)(2007-11#1)(2008-12#1)
to future studies##2##3##(2008-10#1)(2008-7#1)
to future##38##2##(1992-2#2)(1992-3#2)(1992-9#1)(1993-12#2)(1994-12#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-8#1)(2006-10#3)(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#2)(2009-7#2)(2010-11#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-3#1)(2012-4#1)(2013-1#1)(2013-8#1)
to gain a better understanding of the##3##7##(1994-11#1)(2005-7#1)(2011-1#1)
to gain a better understanding of##6##6##(1994-11#1)(2005-7#1)(2007-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
to gain a better understanding##7##5##(1994-11#1)(2005-7#1)(2006-11#1)(2007-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
to gain a better##8##4##(1994-11#1)(2005-7#1)(2006-11#1)(2007-12#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
to gain a deeper##2##4##(1993-8#1)(2010-9#1)
to gain a more##2##4##(1996-12#1)(1997-5#1)
to gain a##21##3##(1993-2#1)(1993-8#1)(1994-11#1)(1996-12#1)(1997-5#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-5#2)(2010-10#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
to gain access to the##5##5##(1994-2#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-12#1)
to gain access to##7##4##(1994-2#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-4#1)
to gain access##9##3##(1994-2#1)(1997-7#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-4#1)(2010-12#1)
to gain an insight##2##4##(2008-11#1)(2010-3#1)
to gain an understanding of the##2##6##(1995-11#1)(2009-10#1)
to gain an understanding of##3##5##(1995-11#1)(2009-10#1)(2009-6#1)
to gain an##7##3##(1995-11#1)(2008-11#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-3#1)(2010-9#1)
to gain control of the##3##5##(1994-3#2)(2007-9#1)
to gain control##5##3##(1994-3#2)(1995-4#1)(2007-2#1)(2007-9#1)
to gain deeper##2##3##(2009-8#1)(2013-8#1)
to gain experience in##2##4##(2008-10#1)(2008-4#1)
to gain experience##3##3##(1993-3#1)(2008-10#1)(2008-4#1)
to gain from##2##3##(2006-10#1)(2008-8#1)
to gain further insight into the##2##6##(1994-5#1)(1995-11#1)
to gain further insight into##4##5##(1994-5#1)(1995-11#1)(2010-10#1)(2012-12#1)
to gain information on##2##4##(2007-8#1)(2012-2#1)
to gain information##3##3##(2006-11#1)(2007-8#1)(2012-2#1)
to gain insight into the##10##5##(1992-6#1)(1995-8#1)(2007-11#1)(2007-7#1)(2007-9#2)(2008-10#1)(2009-4#1)(2010-12#1)(2013-1#1)
to gain insight into their##2##5##(2008-10#1)(2008-4#1)
to gain insight into##16##4##(1992-6#1)(1993-6#1)(1995-8#1)(2007-11#1)(2007-7#1)(2007-9#2)(2008-10#3)(2008-4#1)(2008-7#1)(2009-4#1)(2010-12#2)(2013-1#1)
to gain insight##18##3##(1992-6#1)(1993-6#1)(1995-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-12#2)(2013-1#1)
to gain insights into##3##4##(2007-12#1)(2008-10#1)(2008-5#1)
to gain insights##5##3##(2007-12#1)(2007-3#1)(2008-10#1)(2008-5#1)(2010-6#1)
to gain knowledge about##2##4##(2008-9#1)(2011-1#1)
to gain knowledge of##2##4##(1992-2#1)(2012-2#1)
to gain knowledge##6##3##(1992-2#1)(2007-2#1)(2008-11#1)(2008-9#1)(2011-1#1)(2012-2#1)
to gain more insight into the##2##6##(2008-10#1)(2008-11#1)
to gain more##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
to gain new##2##3##(2008-6#1)(2008-9#1)
to gain or##2##3##(2007-10#1)(2008-9#1)
to gain the##8##3##(1994-2#1)(1994-3#1)(1996-2#1)(2008-10#1)(2010-5#1)(2011-2#2)(2013-1#1)
to gain understanding##2##3##(2008-10#1)(2013-8#1)
to gain valuable##2##3##(1997-8#1)(2008-11#1)
to gain weight##3##3##(2007-12#1)(2007-3#1)(2012-2#1)
to gain##150##2##(1992-2#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#1)(1995-1#1)(1995-11#2)(1995-4#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-5#1)(1997-7#1)(1997-8#2)(2005-7#1)(2006-10#3)(2006-11#4)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#3)(2007-3#2)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-10#12)(2008-11#8)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#5)(2009-10#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#2)(2009-9#1)(2010-10#2)(2010-12#4)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-9#3)(2011-1#3)(2011-2#6)(2012-12#4)(2012-2#7)(2012-3#1)(2013-1#3)(2013-8#2)
to galactose##3##2##(1990-5#1)(1991-9#1)(2008-8#1)
to gallbladder carcinoma##4##3##(2006-10#1)(2009-7#3)
to gamble##2##2##(1992-6#1)(2012-12#1)
to game play##2##3##(2006-7#2)
to game##3##2##(2006-7#2)(2007-4#1)
to gamma##7##2##(1990-11#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#1)(1992-11#1)(1995-12#1)
to gamma-aminobutyric acid##2##3##(1994-2#2)
to gamma-cyhalothrin##4##2##(2011-2#4)
to gamma-rays##3##2##(1995-6#1)(2008-7#2)
to ganglion##3##2##(1991-9#1)(1996-3#1)(2007-12#1)
to gaps##2##2##(1996-3#1)(2008-10#1)
to gas chromatography##2##3##(2008-10#2)
to gas##10##2##(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-11#1)
to gasoline##2##2##(1992-3#1)(2008-10#1)
to gastric cancer##3##3##(1990-9#1)(2011-1#1)(2011-2#1)
to gastric ulcer##2##3##(2006-8#1)(2007-11#1)
to gastric##20##2##(1990-9#1)(1993-3#1)(1993-5#1)(1995-2#1)(1996-12#1)(2005-8#1)(2006-10#3)(2006-8#1)(2007-11#1)(2007-8#2)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-5#1)(2013-8#1)
to gastrin##2##2##(1997-1#2)
to gastroduodenal##3##2##(1990-5#1)(1993-11#1)(2006-10#1)
to gastrointestinal##9##2##(1993-10#1)(1997-6#1)(2006-2#1)(2007-2#1)(2007-8#1)(2012-1#2)(2013-8#2)
to gate##2##2##(2006-4#1)(2008-9#1)
to gather and##2##3##(2007-4#1)(2008-7#1)
to gather data on##2##4##(2008-10#1)(2010-11#1)
to gather data##7##3##(2006-10#1)(2007-7#2)(2008-10#1)(2008-11#2)(2010-11#1)
to gather firewood##2##3##(2011-2#2)
to gather information about##4##4##(1991-1#1)(1992-12#1)(2006-10#1)(2008-1#1)
to gather information from##3##4##(1996-2#1)(2006-6#1)(2007-8#1)
to gather information on the##2##5##(1994-10#1)(1996-12#1)
to gather information on##5##4##(1994-10#1)(1996-12#1)(2006-10#1)(2009-6#1)(2011-2#1)
to gather information##15##3##(1991-1#1)(1992-12#1)(1992-2#1)(1994-10#1)(1996-12#1)(1996-2#1)(2006-10#2)(2006-6#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-2#1)(2009-6#1)(2011-2#1)
to gather the information##2##4##(1996-2#1)(1997-8#1)
to gather##45##2##(1990-3#1)(1991-1#1)(1992-12#1)(1992-2#1)(1994-10#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-8#1)(2006-10#4)(2006-6#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-4#1)(2011-12#1)(2011-2#6)(2012-11#1)(2012-12#1)
to gauge the##7##3##(1996-5#2)(2008-1#1)(2008-6#1)(2012-2#1)(2013-1#2)
to gauge##17##2##(1992-9#1)(1993-7#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-2#1)(2004-9#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-1#3)
to gaze shifts##3##3##(2008-11#3)
to gaze##5##2##(2008-11#4)(2012-1#1)
to gefitinib##3##2##(2010-5#3)
to gel filtration##5##3##(1990-12#1)(1990-2#1)(1990-7#1)(1991-9#1)(1997-6#1)
to gel##10##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-9#1)(1997-6#1)(2005-11#1)(2008-2#1)(2008-9#1)(2011-1#1)(2011-2#1)
to gelatin plasma expanders##4##4##(1994-7#4)
to gender and age of##2##5##(2010-8#1)(2011-1#1)
to gender and##7##3##(1996-6#1)(2007-12#1)(2010-4#1)(2010-8#1)(2011-1#3)
to gender differences in##3##4##(2006-1#1)(2008-6#1)(2009-8#1)
to gender##27##2##(1991-12#1)(1994-6#1)(1996-6#1)(2006-1#1)(2006-8#1)(2006-9#1)(2007-12#2)(2007-4#2)(2007-9#1)(2008-3#1)(2008-6#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
to gene expression in##2##4##(1994-3#1)(2008-9#1)
to gene expression##4##3##(1994-3#1)(1995-2#1)(2008-7#1)(2008-9#1)
to gene flow between##2##4##(2008-10#1)(2008-5#1)
to gene flow##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
to gene function##2##3##(2005-8#1)(2008-7#1)
to gene therapy of##3##4##(1996-4#1)(2008-8#2)
to gene therapy##5##3##(1996-4#1)(2007-11#1)(2008-5#1)(2008-8#2)
to gene##32##2##(1993-6#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-4#1)(1996-11#1)(1996-4#1)(1996-7#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#2)(2009-3#1)(2009-5#1)(2010-10#1)(2011-2#2)(2012-12#1)
to gene-for-gene##2##2##(2008-10#1)(2008-9#1)
to general anesthesia##2##3##(1996-12#1)(2013-1#1)
to general medical##2##3##(1995-5#1)(1995-9#1)
to general practice##6##3##(1990-4#1)(1995-9#2)(1996-8#1)(2011-2#2)
to general practitioners in##2##4##(1991-4#1)(2008-8#1)
to general practitioners##7##3##(1991-4#2)(1992-5#1)(2007-2#1)(2008-8#1)(2010-11#1)(2011-2#1)
to general##46##2##(1990-4#1)(1991-4#4)(1991-8#1)(1992-5#1)(1992-9#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-5#2)(1995-9#3)(1996-1#1)(1996-12#1)(1996-8#1)(2007-2#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#2)
to generalize the##7##3##(1996-3#1)(2008-10#1)(2008-2#1)(2009-7#1)(2012-12#1)(2013-1#2)
to generalize to##2##3##(2007-8#1)(2008-11#1)
to generalize##15##2##(1992-10#1)(1995-5#1)(1996-3#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-6#1)(2009-7#1)(2012-12#1)(2012-2#1)(2013-1#2)
to generalized##7##2##(1996-5#1)(2008-11#1)(2008-3#1)(2008-5#2)(2010-1#1)(2012-2#1)
to generate CL##2##3##(2008-10#2)
to generate a focused##2##4##(2007-12#1)(2008-3#1)
to generate a high##3##4##(2007-8#1)(2008-7#1)(2008-8#1)
to generate a homogenous irradiance##2##5##(2008-3#2)
to generate a new##2##4##(2008-2#2)
to generate a product##2##4##(1991-12#2)
to generate a stable##2##4##(1993-3#1)(2007-12#1)
to generate a##85##3##(1990-10#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-9#1)(1992-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-7#1)(1994-8#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-7#2)(2006-10#2)(2006-12#2)(2006-5#1)(2006-7#1)(2007-1#1)(2007-11#4)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#8)(2008-3#5)(2008-4#4)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-8#2)(2010-12#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-3#2)(2013-8#1)
to generate acid##2##3##(2008-10#1)(2009-10#1)
to generate action potentials##3##4##(1993-2#1)(1996-7#1)(2008-7#1)
to generate action##4##3##(1993-2#1)(1996-7#1)(1996-9#1)(2008-7#1)
to generate amplified##2##3##(1990-2#1)(1993-12#1)
to generate an active##2##4##(1996-4#1)(2007-8#1)
to generate an##21##3##(1996-1#1)(1996-4#1)(1997-2#1)(2006-12#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#2)(2011-2#1)
to generate and maintain##2##4##(1992-11#1)(2011-2#1)
to generate and##12##3##(1992-11#1)(1993-11#1)(1997-5#1)(2006-2#1)(2008-2#2)(2009-12#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
to generate antibodies##2##3##(1990-6#1)(2012-3#1)
to generate antibody##2##3##(1993-2#1)(2011-2#1)
to generate both the##2##4##(2008-10#1)(2008-3#1)
to generate both##5##3##(1994-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-6#1)
to generate cartilage##2##3##(2007-11#2)
to generate cellular##2##3##(2007-12#1)(2010-3#1)
to generate complex##3##3##(2008-3#1)(2012-11#1)(2012-2#1)
to generate different##3##3##(1994-8#1)(2008-10#1)(2008-7#1)
to generate free radicals##2##4##(1990-12#1)(1995-6#1)
to generate functional##3##3##(1995-2#1)(2008-11#1)(2012-2#1)
to generate good##2##3##(1995-6#1)(2013-1#1)
to generate high-resolution##2##3##(2007-11#1)(2008-2#1)
to generate human mAbs##2##4##(2008-11#2)
to generate human##4##3##(1992-8#1)(2008-11#2)(2010-12#1)
to generate hydroxyl##2##3##(2005-11#1)(2008-10#1)
to generate hypotheses##2##3##(2008-10#1)(2012-2#1)
to generate information##2##3##(1996-1#1)(2010-11#1)
to generate large##2##3##(2008-1#1)(2012-3#1)
to generate many##2##3##(2008-5#1)(2012-12#1)
to generate mice##2##3##(1995-1#1)(1995-2#1)
to generate more##3##3##(2008-1#1)(2008-11#1)(2009-11#1)
to generate mouse##2##3##(1992-7#1)(1995-8#1)
to generate multiple##3##3##(2007-12#1)(2008-3#1)(2008-4#1)
to generate mutants##2##3##(2008-10#2)
to generate new##5##3##(2005-4#1)(2006-7#1)(2008-11#1)(2008-4#1)(2012-12#1)
to generate novel##2##3##(2008-11#1)(2008-6#1)
to generate optical##2##3##(2007-11#1)(2008-3#1)
to generate reactive##2##3##(1992-6#1)(2008-4#1)
to generate recombinant##4##3##(1994-3#1)(2008-4#2)(2010-7#1)
to generate several##3##3##(1994-6#1)(2008-2#1)(2010-9#1)
to generate specific##2##3##(1991-8#1)(2009-3#1)
to generate structures##2##3##(2010-2#1)(2012-2#1)
to generate such##2##3##(2007-5#1)(2010-7#1)
to generate superoxide##3##3##(1990-11#1)(1991-9#1)(1996-9#1)
to generate the mature##4##4##(1990-2#1)(1992-6#1)(1993-8#1)(1997-7#1)
to generate the##47##3##(1990-2#3)(1990-3#1)(1992-6#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-2#2)(1996-12#2)(1997-7#2)(2005-11#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#3)(2008-2#4)(2008-3#5)(2008-4#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-1#2)(2013-1#1)
to generate them##3##3##(2008-10#1)(2013-1#2)
to generate three##2##3##(2008-2#1)(2010-8#1)
to generate transgenic mice##2##4##(1993-11#1)(2008-4#1)
to generate transgenic##6##3##(1993-11#1)(1994-8#1)(2008-11#2)(2008-4#1)(2012-3#1)
to generate variants##2##3##(2008-11#1)(2009-6#1)
to generate##515##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#1)(1990-8#2)(1990-9#2)(1991-11#2)(1991-12#2)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#2)(1992-12#1)(1992-6#3)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#3)(1993-12#4)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#3)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#5)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#4)(1994-9#1)(1995-1#3)(1995-11#1)(1995-2#9)(1995-5#1)(1995-6#3)(1995-8#3)(1996-1#2)(1996-10#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#2)(1996-7#1)(1996-9#3)(1997-2#5)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#4)(1997-8#3)(2004-11#1)(2005-11#4)(2005-4#2)(2005-7#3)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#2)(2006-7#2)(2006-8#1)(2007-1#3)(2007-11#15)(2007-12#28)(2007-4#2)(2007-5#1)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#9)(2008-10#37)(2008-11#23)(2008-12#1)(2008-2#31)(2008-3#23)(2008-4#25)(2008-5#6)(2008-6#8)(2008-7#10)(2008-8#7)(2008-9#13)(2009-10#4)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#2)(2010-5#3)(2010-6#1)(2010-7#6)(2010-8#1)(2010-9#2)(2011-1#7)(2011-12#2)(2011-2#7)(2011-3#2)(2012-1#5)(2012-11#1)(2012-12#6)(2012-2#6)(2012-3#10)(2013-1#12)(2013-7#1)(2013-8#5)
to generating##3##2##(2007-12#1)(2008-3#1)(2010-2#1)
to generation of a##3##4##(1997-8#1)(2007-11#1)(2007-12#1)
to generation of##9##3##(1995-12#1)(1996-2#2)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-3#1)(2012-2#1)
to generation##11##2##(1995-12#1)(1996-2#2)(1996-5#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-3#1)(2012-2#1)
to generic##2##2##(2010-5#1)(2012-4#1)
to genes and gene##2##4##(2008-9#1)(2012-2#1)
to genes encoding proteins##2##4##(2008-7#1)(2009-6#1)
to genes that control##2##4##(1995-6#1)(2005-7#1)
to genes that##3##3##(1995-1#1)(1995-6#1)(2005-7#1)
to genes with a##2##4##(2008-10#1)(2012-3#1)
to genes##19##2##(1990-8#1)(1993-9#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-7#1)(2005-7#1)(2008-10#3)(2008-4#1)(2008-7#3)(2008-9#1)(2009-6#1)(2012-2#1)(2012-3#1)
to genetic and environmental factors##2##5##(2008-10#1)(2008-11#1)
to genetic and environmental##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
to genetic and##5##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-12#1)
to genetic defects##4##3##(1991-3#1)(2006-10#1)(2011-1#1)(2013-8#1)
to genetic differences##2##3##(1995-12#1)(2008-2#1)
to genetic factors controlling##2##4##(2008-5#2)
to genetic factors##6##3##(1993-5#1)(2006-1#1)(2008-10#1)(2008-5#2)(2010-12#1)
to genetic testing##2##3##(2008-4#1)(2010-2#1)
to genetic##47##2##(1991-3#1)(1993-5#1)(1995-12#1)(1995-6#1)(1995-8#1)(2005-10#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-11#1)(2007-11#2)(2007-2#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-4#4)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#1)(2010-12#2)(2010-2#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
to genetically modified##2##3##(2008-11#1)(2013-7#1)
to genetically##9##2##(2006-10#1)(2006-12#1)(2008-10#2)(2008-11#1)(2009-3#1)(2012-12#1)(2012-3#1)(2013-7#1)
to genetics##3##2##(2009-2#1)(2009-8#1)(2012-2#1)
to genital##3##2##(2006-10#1)(2007-7#1)(2013-1#1)
to genome##7##2##(2007-12#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-11#1)(2013-1#1)
to genomic DNA from various##2##5##(1993-8#1)(1993-9#1)
to genomic DNA from##4##4##(1993-2#1)(1993-8#1)(1993-9#2)
to genomic DNA##5##3##(1993-2#1)(1993-8#1)(1993-9#2)(2011-10#1)
to genomic instability##2##3##(2008-8#1)(2012-3#1)
to genomic##12##2##(1993-2#1)(1993-8#1)(1993-9#2)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-2#1)(2011-10#1)(2012-3#1)
to genomics##6##2##(2007-4#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-5#1)
to genomospecies 1##3##3##(2008-10#3)
to genomospecies##4##2##(2008-10#4)
to genotoxic##3##2##(1993-3#1)(2008-5#1)(2011-2#1)
to genotype 4##2##3##(2007-3#1)(2012-2#1)
to genotype and##2##3##(2008-2#1)(2012-3#1)
to genotype##20##2##(1995-2#1)(1996-1#1)(1997-5#1)(2007-3#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-8#2)(2009-4#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
to gentamicin and##2##3##(1993-5#1)(2011-2#1)
to gentamicin##7##2##(1993-5#1)(1995-8#1)(2007-7#3)(2011-2#1)(2012-2#1)
to genus##4##2##(2007-5#1)(2008-5#2)(2011-12#1)
to geographic##6##2##(2004-12#1)(2008-10#1)(2008-4#1)(2010-10#1)(2010-8#1)(2012-12#1)
to geographical location##2##3##(2006-10#1)(2011-2#1)
to geographical##7##2##(1993-12#1)(2006-10#1)(2008-10#3)(2010-6#1)(2011-2#1)
to geometric##2##2##(1994-8#1)(2013-7#1)
to geometrical distortions##2##3##(2008-2#2)
to geometrical##4##2##(2005-11#1)(2008-2#3)
to geriatric##2##2##(2008-7#1)(2011-2#1)
to germ plasm##2##3##(2008-10#1)(2009-3#1)
to germ##4##2##(2008-10#2)(2009-10#1)(2009-3#1)
to germinal centers##2##3##(1990-8#2)
to germinate and##3##3##(2008-10#2)(2011-2#1)
to germinate##9##2##(2008-10#7)(2008-12#1)(2011-2#1)
to germination##2##2##(2008-10#2)
to germline sequences##2##3##(1993-5#1)(1995-2#1)
to gestational age##3##3##(1993-5#1)(2009-4#1)(2013-1#1)
to gestational##4##2##(1993-5#1)(1996-10#1)(2009-4#1)(2013-1#1)
to get a better understanding of the##2##7##(1993-9#1)(2008-3#1)
to get a better##4##4##(1993-9#1)(2008-10#1)(2008-3#2)
to get a deeper##2##4##(2008-10#1)(2010-11#1)
to get a high##2##4##(2004-9#1)(2013-8#1)
to get a##26##3##(1993-9#1)(2004-9#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#1)(2013-8#4)
to get access to##2##4##(2012-3#1)(2013-1#1)
to get an insight into this##2##6##(2009-12#1)(2010-12#1)
to get an insight into##4##5##(2008-11#1)(2008-7#1)(2009-12#1)(2010-12#1)
to get an##10##3##(1990-5#1)(1994-12#1)(2005-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-12#1)(2010-12#1)(2012-2#1)(2013-1#1)
to get at the##3##4##(1994-8#1)(2007-9#1)(2013-8#1)
to get at##4##3##(1994-8#1)(2007-9#2)(2013-8#1)
to get better##3##3##(2008-10#1)(2011-1#1)(2012-2#1)
to get cured##2##3##(2007-7#2)
to get in##2##3##(2005-8#1)(2008-11#1)
to get information on##3##4##(1995-8#1)(2005-11#1)(2008-5#1)
to get information##5##3##(1995-8#1)(2005-11#1)(2008-10#1)(2008-4#1)(2008-5#1)
to get into the##2##4##(1996-4#1)(2008-5#1)
to get involved##4##3##(1990-11#1)(1994-3#1)(1995-1#1)(2008-4#1)
to get more insight##2##4##(2006-10#1)(2009-4#1)
to get rid of the##3##5##(2007-12#1)(2007-8#1)(2007-9#1)
to get rid of##6##4##(1996-1#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-4#1)(2009-11#1)
to get the best##3##4##(2007-8#1)(2008-7#1)(2013-1#1)
to get the##24##3##(1994-3#1)(1996-1#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-11#2)(2006-1#1)(2006-10#1)(2006-4#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-7#1)(2010-8#2)(2012-3#1)(2013-1#1)(2013-8#1)
to get their##2##3##(2006-2#1)(2013-8#1)
to get to##4##3##(1992-8#1)(2005-11#1)(2008-11#1)(2008-3#1)
to get##159##2##(1990-11#1)(1990-5#1)(1991-1#1)(1992-8#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-12#2)(1996-4#1)(1996-7#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#1)(2004-9#1)(2005-11#4)(2005-3#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-2#2)(2006-4#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#4)(2007-9#7)(2008-10#15)(2008-11#7)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#3)(2008-7#4)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#4)(2011-1#3)(2011-2#1)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#9)
to getting##2##2##(1994-1#1)(2007-9#1)
to giant##3##2##(2011-2#1)(2012-12#1)(2012-2#1)
to girls in the##2##4##(2009-7#1)(2013-1#1)
to girls in##3##3##(2009-7#1)(2010-4#1)(2013-1#1)
to girls##6##2##(2007-12#1)(2009-7#1)(2010-4#1)(2012-2#1)(2013-1#2)
to give a common##2##4##(1996-4#1)(2011-2#1)
to give a current##2##4##(1995-5#1)(2008-1#1)
to give a high##2##4##(1990-6#1)(2008-3#1)
to give a qualitative##2##4##(1996-12#1)(2008-7#1)
to give a review##2##4##(1995-5#1)(2008-12#1)
to give a##79##3##(1990-3#1)(1990-5#2)(1990-6#1)(1991-2#1)(1991-3#2)(1991-4#1)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-10#2)(1995-3#1)(1995-5#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-7#1)(2004-4#1)(2005-11#2)(2005-7#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#4)(2008-7#2)(2009-11#1)(2009-2#1)(2010-5#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#3)
to give an intermediate##2##4##(1996-2#1)(2007-11#1)
to give an overview of the##3##6##(2005-7#1)(2008-5#1)(2011-2#1)
to give an overview of##7##5##(2005-7#1)(2005-9#1)(2007-11#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
to give an##21##3##(1996-2#1)(2005-7#1)(2005-9#1)(2007-11#4)(2007-7#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
to give and##2##3##(1994-3#1)(2011-2#1)
to give basic information##2##4##(2006-2#1)(2010-5#1)
to give birth at home##2##5##(2010-12#1)(2013-1#1)
to give birth naturally##3##4##(2007-2#3)
to give birth##15##3##(2007-12#1)(2007-2#7)(2010-12#2)(2010-2#1)(2010-9#3)(2013-1#1)
to give complexes##2##3##(1992-3#1)(2008-5#1)
to give evidence##2##3##(1993-4#2)
to give feedback##2##3##(1995-1#1)(2007-12#1)
to give form III with rate constant##2##7##(1997-1#2)
to give form##3##3##(1997-1#3)
to give higher##4##3##(1993-3#1)(2007-11#1)(2008-10#1)(2008-11#1)
to give him##2##3##(1990-8#1)(2008-6#1)
to give information about##2##4##(1991-5#1)(2008-4#1)
to give information##5##3##(1991-5#1)(1994-11#1)(1995-9#1)(2008-11#1)(2008-4#1)
to give its##2##3##(2008-11#1)(2008-2#1)
to give low##2##3##(1996-5#1)(2008-10#1)
to give mature forms of the enzyme##2##7##(1992-12#2)
to give more##4##3##(2008-10#1)(2008-4#1)(2009-2#1)(2012-2#1)
to give much##3##3##(2005-7#1)(2008-10#1)(2008-2#1)
to give precise##2##3##(1993-3#1)(1996-3#1)
to give reliable##2##3##(2007-11#1)(2008-2#1)
to give rise to a new##2##6##(2008-3#1)(2009-3#1)
to give rise to all cell types##2##7##(2008-1#1)(2008-8#1)
to give rise to the##3##5##(2012-12#2)(2012-2#1)
to give rise to##20##4##(1991-9#1)(1995-5#1)(2005-11#1)(2007-8#1)(2008-1#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#2)(2012-12#2)(2012-2#1)
to give rise##21##3##(1991-9#1)(1995-5#1)(2005-11#1)(2007-8#1)(2008-1#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#2)(2012-12#2)(2012-2#1)
to give satisfactory results##3##4##(2007-8#1)(2008-10#2)
to give satisfactory##5##3##(1995-8#1)(2007-8#1)(2008-10#3)
to give similar##2##3##(2008-10#1)(2008-2#1)
to give some##2##3##(2006-10#1)(2009-10#1)
to give support to##2##4##(2007-9#1)(2010-5#1)
to give the best##3##4##(1996-12#1)(2006-5#1)(2008-10#1)
to give the corresponding##8##4##(1991-5#1)(2007-10#1)(2007-11#3)(2008-4#1)(2008-5#1)(2009-3#1)
to give the highest##3##4##(2008-11#1)(2008-5#2)
to give the individual##2##4##(1992-2#1)(1994-9#1)
to give the most##2##4##(1991-11#1)(2008-10#1)
to give the reader a##2##5##(2008-1#1)(2008-9#1)
to give the##76##3##(1990-3#1)(1990-5#1)(1991-11#1)(1991-5#1)(1992-10#1)(1992-2#1)(1992-6#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-4#1)(1996-12#1)(1996-2#1)(1996-5#3)(1996-6#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-5#1)(2007-10#3)(2007-11#9)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#6)(2008-3#2)(2008-4#3)(2008-5#6)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-5#4)
to give their views##2##4##(1992-4#1)(2013-8#1)
to give their##5##3##(1992-1#1)(1992-4#1)(2007-2#1)(2009-6#1)(2013-8#1)
to give them a##2##4##(1995-1#1)(2008-1#1)
to give two##2##3##(1992-8#1)(2008-5#1)
to give up##4##3##(1990-8#1)(2008-2#1)(2008-5#1)(2009-2#1)
to give##434##2##(1990-11#1)(1990-3#2)(1990-5#4)(1990-6#1)(1990-8#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#3)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#2)(1992-3#8)(1992-4#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#2)(1993-11#1)(1993-2#1)(1993-3#3)(1993-4#4)(1993-6#2)(1993-9#1)(1994-10#1)(1994-11#3)(1994-2#1)(1994-3#5)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-10#2)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#4)(1995-8#3)(1995-9#1)(1996-12#3)(1996-2#10)(1996-3#3)(1996-4#1)(1996-5#10)(1996-6#1)(1996-7#2)(1997-1#4)(1997-2#4)(1997-4#1)(1997-6#1)(1997-7#1)(2004-4#1)(2004-9#2)(2005-10#1)(2005-11#4)(2005-7#4)(2005-9#1)(2006-10#3)(2006-11#2)(2006-12#5)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#2)(2006-6#1)(2007-1#1)(2007-10#5)(2007-11#27)(2007-12#5)(2007-2#8)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#6)(2007-9#5)(2008-1#8)(2008-10#51)(2008-11#16)(2008-12#2)(2008-2#10)(2008-3#8)(2008-4#11)(2008-5#25)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#4)(2009-3#5)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-5#8)(2010-6#1)(2010-7#1)(2010-9#3)(2011-1#1)(2011-2#7)(2011-3#1)(2012-1#3)(2012-11#2)(2012-12#3)(2012-2#7)(2012-3#2)(2013-1#2)(2013-8#3)
to given##2##2##(1996-10#1)(2007-11#1)
to gizzard##2##2##(1990-5#1)(1993-8#1)
to glandular##2##2##(2008-11#1)(2008-5#1)
to glass and##2##3##(1992-1#1)(2008-10#1)
to glass beads##2##3##(2008-10#1)(2008-7#1)
to glass surfaces than the##2##5##(2008-10#2)
to glass surfaces##3##3##(2008-10#2)(2008-4#1)
to glass##13##2##(1990-8#1)(1992-1#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-9#1)
to glean##2##2##(2009-9#1)(2012-2#1)
to global warming##3##3##(2012-12#1)(2012-5#1)(2012-8#1)
to global##27##2##(1993-7#1)(1995-9#1)(1996-9#1)(1997-1#1)(2006-4#1)(2006-5#2)(2007-2#2)(2007-9#1)(2008-10#3)(2008-2#1)(2009-9#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2012-5#1)(2012-8#1)(2013-1#1)(2013-3#1)(2013-7#1)(2013-8#1)
to globally##2##2##(1991-4#1)(2010-7#1)
to glomerular##2##2##(2005-12#1)(2008-1#1)
to glomerulonephritis##2##2##(2008-1#2)
to glucagon##4##2##(1995-6#1)(1995-8#1)(1996-2#1)(2008-3#1)
to glucoamylase##2##2##(1991-5#1)(2005-7#1)
to glucocorticoid##5##2##(1994-10#1)(1996-3#1)(1997-4#1)(2008-11#1)(2008-7#1)
to glucocorticoids##12##2##(1990-11#1)(1990-12#1)(1994-11#1)(1994-2#2)(1995-10#2)(1995-12#1)(1996-5#1)(1996-7#1)(2006-10#1)(2008-11#1)
to glucose and##6##3##(1995-8#2)(1996-3#1)(2008-10#1)(2008-11#1)(2008-5#1)
to glucose as##3##3##(1995-5#1)(2008-5#1)(2008-6#1)
to glucose at##2##3##(2008-10#2)
to glucose by##3##3##(1993-8#1)(2008-6#2)
to glucose intolerance##2##3##(2008-4#1)(2010-11#1)
to glucose starvation##3##3##(1995-1#1)(2009-3#2)
to glucose##57##2##(1990-12#1)(1990-5#1)(1991-7#1)(1992-2#1)(1992-7#1)(1993-8#2)(1994-8#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-7#2)(1995-8#3)(1996-2#2)(1996-3#1)(1996-7#1)(1997-4#1)(2005-10#2)(2006-6#2)(2006-8#1)(2007-1#1)(2007-7#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#4)(2009-3#2)(2010-11#2)(2010-12#1)(2012-11#1)
to glutamate##19##2##(1990-11#1)(1992-5#1)(1993-12#2)(1994-10#1)(1995-12#1)(1995-7#1)(1996-1#1)(1996-7#1)(1997-5#1)(1997-8#1)(2007-12#1)(2007-9#2)(2008-1#1)(2008-11#1)(2008-4#1)(2010-12#2)
to glutamic acid##4##3##(1990-10#1)(1995-5#1)(1995-8#1)(2006-7#1)
to glutamine##8##2##(1990-3#1)(1992-4#1)(1993-11#1)(1994-12#1)(1994-2#2)(1995-8#1)(1997-6#1)
to glutathione S-transferase##2##3##(1994-9#1)(1995-3#1)
to glutathione within the cell##2##5##(1995-11#2)
to glutathione##7##2##(1991-9#1)(1993-3#1)(1994-9#1)(1995-11#2)(1995-3#1)(2008-1#1)
to glycemic control##3##3##(2005-10#1)(2008-1#1)(2008-7#1)
to glycemic##4##2##(2005-10#1)(2008-1#1)(2008-7#1)(2012-2#1)
to glycerol##2##2##(1993-6#1)(1995-8#1)
to glycine##5##2##(1994-9#1)(1995-5#1)(1997-1#2)(1997-2#1)
to glycogen##5##2##(1992-1#1)(1995-8#3)(2008-10#1)
to glycopeptides (vancomycin##2##3##(1993-5#1)(2005-8#1)
to glycopeptides##4##2##(1993-5#1)(2005-8#1)(2006-10#1)(2009-2#1)
to glycoproteins##2##2##(1990-12#1)(2008-4#1)
to glycosylation##3##2##(1992-6#1)(1994-11#1)(1997-2#1)
to glyphosate##2##2##(2008-10#1)(2008-6#1)
to go around the##2##4##(2008-11#1)(2011-2#1)
to go beyond the##3##4##(2007-8#1)(2008-10#1)(2010-8#1)
to go beyond##8##3##(1995-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2010-8#1)
to go for##2##3##(1995-9#1)(2008-5#1)
to go in##4##3##(1991-12#1)(1992-10#1)(1994-7#1)(2005-10#1)
to go into##3##3##(1990-8#1)(2007-9#1)(2008-7#1)
to go through##4##3##(1991-6#1)(1995-12#1)(2007-2#1)(2012-2#1)
to go to##5##3##(2006-10#1)(2007-2#1)(2008-9#1)(2012-2#1)(2013-8#1)
to go##48##2##(1990-8#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-10#1)(1992-12#1)(1993-1#1)(1994-7#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-9#1)(1996-2#1)(1996-6#1)(2005-10#1)(2006-10#2)(2007-2#2)(2007-7#1)(2007-8#1)(2007-9#3)(2008-10#2)(2008-11#4)(2008-5#2)(2008-7#2)(2008-9#2)(2009-10#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
to goal##4##2##(2008-11#1)(2009-12#1)(2010-2#1)(2010-6#1)
to goat##2##2##(1990-12#1)(2008-10#1)
to gold##6##2##(1993-10#1)(2008-10#1)(2008-7#1)(2009-7#1)(2010-1#2)
to goldfish##2##2##(1990-7#2)
to good agreement##2##3##(2006-7#1)(2008-7#1)
to good and##2##3##(2007-11#1)(2008-5#1)
to good oral##2##3##(1992-5#1)(2012-12#1)
to good yields##4##3##(2007-11#1)(2008-5#1)(2010-6#2)
to good##40##2##(1992-5#2)(1996-3#1)(1996-7#1)(1997-3#1)(2004-10#1)(2005-5#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-8#2)(2008-11#1)(2008-5#2)(2008-7#5)(2010-3#1)(2010-6#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-8#1)
to govern the##3##3##(1996-6#1)(2004-3#1)(2007-4#1)
to govern##6##2##(1994-12#1)(1996-6#1)(2004-3#1)(2007-4#1)(2008-10#1)(2013-8#1)
to governance##2##2##(1991-1#1)(2009-4#1)
to government##4##2##(2006-8#1)(2008-5#1)(2009-4#1)(2012-2#1)
to governmental##2##2##(1991-3#1)(2007-4#1)
to gp120##3##2##(1990-6#1)(2013-1#2)
to grade 3##2##3##(1991-8#1)(2008-4#1)
to grade##7##2##(1990-6#1)(1991-8#1)(2006-12#1)(2008-4#1)(2008-7#1)(2010-8#1)(2013-8#1)
to grade-I##5##2##(2007-7#5)
to graded##7##2##(1992-9#1)(1995-12#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-8#1)
to gradually##4##2##(1996-10#1)(1997-4#1)(2007-2#1)(2012-2#1)
to graduate##5##2##(2004-12#1)(2005-11#1)(2006-10#1)(2010-3#1)(2011-2#1)
to graft failure##2##3##(2005-12#1)(2009-2#1)
to graft##9##2##(2005-12#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-8#1)(2009-2#1)(2009-5#1)(2013-1#2)
to grafting##5##2##(1991-5#1)(1995-7#1)(2005-10#1)(2008-4#1)(2010-3#1)
to grain##3##2##(1991-12#1)(2007-11#1)(2008-3#1)
to gram##2##2##(1996-2#1)(2007-7#1)
to gram-positive##3##2##(2008-5#1)(2013-1#2)
to grammatical errors##2##3##(2008-11#2)
to grammatical##3##2##(2008-11#3)
to grant##8##2##(1995-6#2)(1996-2#1)(1996-5#1)(2006-10#1)(2007-4#1)(2007-9#1)(2009-5#1)
to granule##2##2##(1991-6#1)(1997-7#1)
to granulocyte##3##2##(1992-3#2)(1994-11#1)
to grape##3##2##(2008-10#3)
to grapevines##2##2##(2008-10#2)
to graphite##2##2##(1992-2#1)(2008-10#1)
to grapple with##2##3##(2005-7#1)(2008-12#1)
to grasp an object##3##4##(1992-9#1)(1993-7#2)
to grasp and##2##3##(1990-10#1)(2011-1#1)
to grasp the##4##3##(1996-2#1)(1996-3#1)(2008-6#1)(2011-1#1)
to grasp##15##2##(1990-10#1)(1991-1#1)(1992-9#1)(1993-7#5)(1996-2#2)(1996-3#1)(2008-6#1)(2008-7#1)(2011-1#2)
to grave##2##2##(2006-2#1)(2013-8#1)
to gravitational##2##2##(2005-11#1)(2008-10#1)
to gravity##9##2##(1991-6#1)(2008-10#1)(2008-11#3)(2008-2#1)(2009-6#2)(2012-12#1)
to gray leaf spot##4##4##(2008-10#4)
to gray##7##2##(2008-10#5)(2008-7#1)(2012-3#1)
to grazing##2##2##(1993-8#1)(2008-8#1)
to great advances##2##3##(2007-3#1)(2013-1#1)
to great##4##2##(2007-3#1)(2008-10#1)(2008-8#1)(2013-1#1)
to greater than 100##2##4##(2008-2#1)(2008-7#1)
to greater than 2##2##4##(1991-7#1)(2008-3#1)
to greater than##12##3##(1990-4#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-5#1)(2007-4#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)
to greater understanding of the##2##5##(1994-5#1)(1995-6#1)
to greater weight##2##3##(2006-7#1)(2008-3#1)
to greater##45##2##(1990-4#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-1#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-5#1)(1995-6#1)(1995-9#1)(2005-8#1)(2006-7#1)(2007-11#1)(2007-4#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-7#2)(2011-12#1)(2011-2#3)(2012-1#3)(2013-1#2)
to greatest##2##2##(2007-5#1)(2011-1#1)
to greatly enhance##3##3##(1994-6#1)(2008-10#1)(2008-4#1)
to greatly improve##2##3##(2007-11#1)(2010-12#1)
to greatly influence##2##3##(1994-12#1)(2012-11#1)
to greatly reduce the##2##4##(1991-7#1)(2008-2#1)
to greatly reduce##3##3##(1991-7#1)(2005-10#1)(2008-2#1)
to greatly##14##2##(1991-7#1)(1994-12#1)(1994-6#1)(2005-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-11#1)
to green##4##2##(1997-4#1)(2007-11#1)(2007-8#1)(2008-5#1)
to greenhouse##3##2##(1993-4#1)(2007-3#1)(2008-10#1)
to grinding##2##2##(2010-4#2)
to grip##2##2##(2004-11#1)(2007-12#1)
to gross##5##2##(1991-8#1)(1994-3#1)(2008-5#2)(2012-2#1)
to ground##6##2##(2006-5#1)(2008-10#2)(2009-2#1)(2010-3#1)(2012-11#1)
to groundwater##3##2##(2008-10#1)(2009-11#1)(2011-2#1)
to group 1##6##3##(1996-9#1)(2007-1#2)(2008-11#1)(2009-5#2)
to group A##3##3##(2007-7#1)(2008-10#1)(2011-2#1)
to group B##3##3##(2007-7#1)(2007-8#1)(2007-9#1)
to group I##4##3##(2008-10#2)(2009-3#2)
to group III##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
to group patients##3##3##(1995-12#1)(2010-12#1)(2010-8#1)
to group the##2##3##(2008-10#1)(2008-5#1)
to group##46##2##(1992-1#1)(1993-1#1)(1993-12#1)(1995-12#1)(1996-7#2)(1996-9#2)(2007-1#2)(2007-7#3)(2007-8#2)(2007-9#4)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-3#2)(2009-4#2)(2009-5#3)(2009-8#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-7#1)
to group-velocity##2##2##(2007-12#2)
to groups of male##2##4##(1997-2#1)(2005-10#1)
to groups of##8##3##(1996-11#1)(1996-12#1)(1997-2#1)(2005-10#1)(2006-8#1)(2007-6#1)(2008-5#1)(2009-9#1)
to groups##20##2##(1990-6#1)(1991-3#1)(1993-4#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-2#1)(2005-10#1)(2006-8#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)(2009-5#1)(2009-9#1)(2010-4#2)
to grow and differentiate##2##4##(2007-11#1)(2012-12#1)
to grow and to##2##4##(2006-10#1)(2006-8#1)
to grow and##13##3##(1990-11#1)(1993-1#1)(1996-1#1)(1996-2#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-11#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
to grow as##2##3##(2004-3#1)(2008-11#1)
to grow at a##3##4##(1995-1#1)(2008-11#1)(2012-2#1)
to grow at##8##3##(1991-12#1)(1995-1#1)(2008-10#2)(2008-11#1)(2011-2#2)(2012-2#1)
to grow by##4##3##(1991-1#1)(1997-1#1)(2007-4#1)(2011-2#1)
to grow faster than##2##4##(1997-1#1)(2010-8#1)
to grow in a##2##4##(1996-5#1)(2008-10#1)
to grow in chicken##2##4##(2008-5#1)(2008-9#1)
to grow in suspension##2##4##(2008-11#1)(2008-4#1)
to grow in the presence of##3##6##(2006-5#1)(2008-11#1)(2010-4#1)
to grow in the##4##4##(2006-5#1)(2008-11#1)(2008-7#1)(2010-4#1)
to grow in##24##3##(1991-12#1)(1991-3#1)(1992-1#1)(1995-2#1)(1996-5#1)(1996-8#1)(2006-5#1)(2008-1#1)(2008-10#2)(2008-11#8)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-4#1)
to grow on non-fermentable carbon sources##2##6##(1992-11#1)(1996-7#1)
to grow on##16##3##(1990-5#1)(1992-11#1)(1994-9#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-10#5)(2008-5#1)(2008-6#1)(2008-8#1)
to grow or##2##3##(1990-7#1)(2008-9#1)
to grow primary##2##3##(2008-1#1)(2009-10#1)
to grow the##2##3##(2008-7#1)(2008-9#1)
to grow through##2##3##(2006-10#1)(2008-10#1)
to grow to##4##3##(1991-3#1)(2008-11#1)(2012-2#1)(2013-1#1)
to grow under##5##3##(1995-11#1)(2008-11#2)(2008-4#1)(2013-8#1)
to grow up##2##3##(1992-1#1)(2005-9#1)
to grow well##3##3##(2008-10#1)(2008-11#1)(2013-7#1)
to grow when##2##3##(2006-3#1)(2012-2#1)
to grow##154##2##(1990-11#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#2)(1992-1#2)(1992-11#1)(1993-1#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#4)(1996-1#2)(1996-2#1)(1996-3#3)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(2004-3#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-10#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-4#1)(2007-5#1)(2008-1#2)(2008-10#15)(2008-11#19)(2008-12#1)(2008-4#5)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#8)(2009-10#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#1)(2012-8#1)(2013-1#1)(2013-7#2)(2013-8#1)
to growing##7##2##(1991-4#1)(1993-3#1)(2010-4#1)(2012-2#1)(2013-1#2)(2013-8#1)
to growth and survival##2##4##(2008-7#1)(2011-2#1)
to growth and##5##3##(2006-9#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#1)
to growth arrest##3##3##(1991-1#1)(2008-7#1)(2009-4#1)
to growth factors##17##3##(1990-12#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-10#1)(1992-11#1)(1993-3#1)(1994-5#1)(1994-8#2)(1995-10#1)(1995-3#1)(1995-6#1)(2006-6#1)(2008-4#1)(2008-5#1)(2011-2#1)
to growth hormone releasing hormone##2##5##(1992-6#1)(2007-7#1)
to growth hormone##5##3##(1990-12#1)(1992-6#1)(1997-2#1)(2007-7#1)(2008-5#1)
to growth hormone-releasing hormone 1-44 NH2##2##6##(1992-9#2)
to growth in##5##3##(1994-5#1)(2005-9#1)(2008-11#2)(2008-4#1)
to growth inhibition by##3##4##(1992-9#1)(2006-5#1)(2008-11#1)
to growth inhibition##6##3##(1992-9#1)(1994-3#2)(2006-5#1)(2008-11#1)(2011-2#1)
to growth of##5##3##(2008-10#1)(2009-10#1)(2011-2#1)(2013-1#2)
to growth stimulation##4##3##(1992-12#1)(1992-9#1)(2008-11#2)
to growth##81##2##(1990-12#2)(1990-2#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-9#4)(1993-3#1)(1993-6#1)(1994-3#2)(1994-5#2)(1994-8#3)(1995-10#1)(1995-11#1)(1995-3#1)(1995-6#1)(1997-2#1)(2005-12#2)(2005-9#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-7#2)(2008-10#2)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#5)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-7#2)(2011-2#7)(2012-2#1)(2012-5#1)(2013-1#2)(2013-7#1)
to guanine##7##2##(1991-6#1)(1993-9#2)(1994-12#1)(1995-5#2)(1996-7#1)
to guanosine##5##2##(1990-7#1)(1990-8#1)(2007-9#1)(2008-4#1)(2008-7#1)
to guarantee a##2##3##(2006-2#1)(2006-8#1)
to guarantee good##2##3##(2007-8#1)(2008-3#1)
to guarantee sufficient##2##3##(2007-11#1)(2008-10#1)
to guarantee that##2##3##(2005-5#1)(2012-3#1)
to guarantee the existence##2##4##(2007-12#1)(2008-2#1)
to guarantee the##9##3##(1995-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)(2011-2#1)(2013-8#1)
to guarantee##33##2##(1993-12#1)(1993-3#1)(1995-3#1)(1996-1#1)(1996-3#1)(2005-5#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-8#2)
to guard against##3##3##(1997-7#1)(2012-12#1)(2012-3#1)
to guard##4##2##(1990-10#1)(1997-7#1)(2012-12#1)(2012-3#1)
to guide a##5##3##(2008-2#1)(2010-8#2)(2010-9#1)(2012-2#1)
to guide and##5##3##(1995-12#1)(2008-10#1)(2008-2#1)(2009-12#1)(2009-2#1)
to guide clinicians##2##3##(2007-10#1)(2008-7#1)
to guide development##2##3##(2008-11#1)(2009-10#1)
to guide empirical##2##3##(2005-8#1)(2011-2#1)
to guide further##3##3##(1994-3#1)(2008-11#1)(2009-9#1)
to guide future research##2##4##(1996-12#1)(2010-12#1)
to guide future##5##3##(1996-12#2)(2007-2#1)(2010-12#1)(2013-1#1)
to guide health##2##3##(1994-3#2)
to guide its##2##3##(2006-10#1)(2007-10#1)
to guide management##2##3##(2008-12#1)(2011-12#1)
to guide mental health##2##4##(2011-2#1)(2012-3#1)
to guide nursing##2##3##(2007-3#1)(2011-2#1)
to guide public##2##3##(2006-7#1)(2012-3#1)
to guide students##2##3##(2007-12#1)(2010-3#1)
to guide surgical##2##3##(2005-5#1)(2006-6#1)
to guide the choice of the##2##6##(2006-6#1)(2008-10#1)
to guide the choice of##5##5##(2006-6#1)(2006-8#1)(2008-10#1)(2008-9#1)(2013-1#1)
to guide the development of##2##5##(1994-3#1)(2007-4#1)
to guide the process of##2##5##(2008-11#1)(2008-12#1)
to guide the selection of##3##5##(1996-8#1)(2008-10#2)
to guide the##47##3##(1994-1#1)(1994-3#2)(1995-3#2)(1996-8#1)(2006-10#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#4)(2007-8#4)(2007-9#1)(2008-10#4)(2008-11#4)(2008-12#3)(2008-3#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-7#1)(2012-12#3)(2013-1#2)
to guide their##2##3##(1993-12#1)(2007-10#1)
to guide this##3##3##(2007-2#1)(2008-9#1)(2012-12#1)
to guide##157##2##(1992-12#1)(1993-10#2)(1993-12#1)(1993-2#1)(1994-1#1)(1994-3#6)(1995-12#2)(1995-3#2)(1996-12#2)(1996-2#1)(1996-8#1)(1997-8#1)(2005-5#1)(2005-8#1)(2006-10#6)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#6)(2007-11#1)(2007-12#2)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#5)(2007-8#6)(2007-9#4)(2008-1#2)(2008-10#6)(2008-11#8)(2008-12#5)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#1)(2009-4#1)(2009-5#2)(2009-9#2)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#6)(2012-2#5)(2012-3#5)(2013-1#9)
to guidelines##9##2##(1994-3#1)(1996-11#1)(2005-5#1)(2007-4#1)(2007-5#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)
to guinea pig##3##3##(1994-12#1)(1997-2#1)(2008-4#1)
to guinea##4##2##(1994-12#1)(1995-12#1)(1997-2#1)(2008-4#1)
to guinea-pigs##2##2##(1993-9#1)(1995-12#1)
to gut##2##2##(2006-10#1)(2008-4#1)
to hCG##3##2##(1994-5#1)(1997-1#1)(1997-4#1)
to hVEGF(165)##2##2##(2008-8#2)
to habitat loss##4##3##(2008-9#2)(2009-8#2)
to habitat##11##2##(2007-5#1)(2008-10#1)(2008-8#3)(2008-9#2)(2009-8#2)(2010-6#1)(2013-7#1)
to haemodynamic##2##2##(2006-10#1)(2007-9#1)
to haemorrhage##2##2##(1997-3#1)(2011-2#1)
to hair##13##2##(1991-1#1)(2007-2#1)(2008-5#5)(2011-1#1)(2011-2#1)(2012-11#2)(2012-2#2)
to half its##2##3##(2008-3#1)(2008-5#1)
to half of##6##3##(1990-9#1)(1994-3#1)(1996-11#1)(2007-11#1)(2013-1#1)(2013-8#1)
to half the##2##3##(2007-7#1)(2008-5#1)
to half##14##2##(1990-9#1)(1994-3#1)(1996-11#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-3#1)(2008-5#3)(2008-7#1)(2013-1#2)(2013-8#1)
to halofantrine##2##2##(2006-4#2)
to halogen)##2##2##(2008-10#2)
to haloperidol##5##2##(1990-2#2)(1996-8#1)(1997-7#1)(2005-7#1)
to halothane##2##2##(1992-9#1)(1995-3#1)
to halt or reverse the##2##5##(2008-11#2)
to halt or##3##3##(1997-3#1)(2008-11#2)
to halt the##2##3##(2010-4#1)(2012-2#1)
to halt##10##2##(1997-3#1)(2007-10#2)(2007-5#1)(2008-11#2)(2008-3#1)(2008-5#1)(2010-4#1)(2012-2#1)
to hamstring##2##2##(2008-4#1)(2013-7#1)
to hand and##2##3##(1994-8#1)(2007-3#1)
to hand hygiene##2##3##(2008-12#2)
to hand##9##2##(1994-8#1)(1996-1#1)(1997-5#1)(2006-11#1)(2007-3#2)(2008-11#1)(2008-12#2)
to handle a##4##3##(2006-4#1)(2008-10#1)(2008-11#2)
to handle and##6##3##(2004-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)
to handle most##2##3##(1992-12#1)(2009-9#1)
to handle multiple##2##3##(2008-4#1)(2008-6#1)
to handle the##5##3##(2006-6#1)(2008-1#1)(2008-6#1)(2011-3#1)(2012-1#1)
to handle these##2##3##(2009-12#1)(2012-11#1)
to handle this##3##3##(1994-3#1)(2008-2#1)(2008-7#1)
to handle##72##2##(1990-6#1)(1990-8#2)(1991-1#1)(1992-12#1)(1994-12#1)(1994-3#1)(1996-1#1)(2004-9#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-6#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-6#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#6)(2008-6#3)(2008-7#1)(2008-9#1)(2009-12#2)(2009-4#1)(2009-9#1)(2010-9#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-1#1)(2012-11#1)(2012-2#2)(2013-1#4)(2013-8#1)
to handling and confinement##2##4##(2010-8#2)
to handling##5##2##(2007-11#1)(2007-3#1)(2009-4#1)(2010-8#2)
to haplotype##2##2##(1993-9#1)(2008-10#1)
to happen##8##2##(1992-12#1)(1995-12#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-3#1)(2009-4#1)
to haptens##2##2##(2005-11#1)(2008-4#1)
to harbor##6##2##(1996-9#1)(2008-10#4)(2012-3#1)
to hard metal##6##3##(1992-1#1)(1994-6#5)
to hard##9##2##(1992-1#1)(1994-6#6)(2008-10#1)(2011-12#1)
to harden##2##2##(1995-6#1)(2004-9#1)
to hardness##3##2##(2007-12#2)(2009-7#1)
to hardware##2##2##(2008-2#1)(2011-1#1)
to harm the##3##3##(1996-11#1)(2004-3#1)(2008-10#1)
to harm##4##2##(1994-11#1)(1996-11#1)(2004-3#1)(2008-10#1)
to harmful##5##2##(1990-8#1)(2008-12#1)(2008-5#1)(2009-12#1)(2011-2#1)
to harmonize##3##2##(2006-7#1)(2007-1#1)(2013-8#1)
to harness the potential of##2##5##(2008-4#1)(2008-7#1)
to harness the power of##2##5##(2010-9#1)(2012-3#1)
to harness the##8##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2010-9#1)(2011-1#1)(2012-3#1)
to harness##15##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-8#1)(2010-6#1)(2010-9#1)(2011-1#2)(2012-11#2)(2012-3#2)
to harnessing the##2##3##(2008-11#1)(2010-3#1)
to harvest and##2##3##(2007-8#1)(2008-10#1)
to harvest##12##2##(1992-11#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2011-12#1)
to hasten the##2##3##(1995-8#1)(2006-12#1)
to hasten##3##2##(1990-12#1)(1995-8#1)(2006-12#1)
to have 4##2##3##(1990-2#1)(2008-12#1)
to have CP##2##3##(2011-2#1)(2012-2#1)
to have a beneficial effect on##5##6##(1991-11#1)(1991-6#1)(1995-9#1)(2012-3#1)(2013-1#1)
to have a better##7##4##(1993-4#1)(1995-5#1)(2006-10#2)(2008-10#1)(2012-2#1)(2013-7#1)
to have a broad##3##4##(1994-6#1)(2011-2#1)(2012-12#1)
to have a child##2##4##(1997-5#2)
to have a genetic##2##4##(2011-1#1)(2012-2#1)
to have a good prospect of##2##6##(2008-5#1)(2012-3#1)
to have a good##5##4##(2007-11#2)(2008-5#2)(2012-3#1)
to have a great##3##4##(1992-6#1)(2007-11#1)(2008-5#1)
to have a greater##6##4##(1992-5#1)(2007-11#2)(2008-3#1)(2008-5#1)(2009-4#1)
to have a high incidence of##3##6##(2007-10#1)(2010-5#1)(2010-8#1)
to have a high##14##4##(1997-6#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#2)(2009-2#1)(2010-5#1)(2010-8#2)(2011-1#1)(2012-2#1)(2013-7#1)
to have a higher risk of##2##6##(1996-9#1)(2006-12#1)
to have a higher##8##4##(1990-12#1)(1991-6#1)(1996-9#1)(2006-12#1)(2008-7#1)(2009-9#1)(2011-2#1)(2013-8#1)
to have a highly##3##4##(1992-8#1)(2008-10#1)(2008-11#1)
to have a key role in the##2##7##(1991-2#1)(2006-7#1)
to have a key role in##3##6##(1991-2#1)(2006-10#1)(2006-7#1)
to have a large##6##4##(2007-9#1)(2008-10#1)(2008-3#3)(2008-5#1)
to have a larger##2##4##(1994-3#1)(2012-2#1)
to have a low##5##4##(1996-7#1)(1997-1#1)(1997-2#1)(2009-7#1)(2012-2#1)
to have a lower##2##4##(1995-10#1)(1995-7#1)
to have a major impact##2##5##(1991-3#1)(1995-11#1)
to have a minimal##2##4##(1990-6#1)(2008-10#1)
to have a molecular mass of##2##6##(1993-6#1)(1996-5#1)
to have a molecular mass##3##5##(1993-6#1)(1993-9#1)(1996-5#1)
to have a molecular weight##2##5##(1994-12#1)(1994-8#1)
to have a molecular##5##4##(1993-6#1)(1993-9#1)(1994-12#1)(1994-8#1)(1996-5#1)
to have a more##6##4##(1990-2#1)(1992-2#1)(1995-6#1)(2008-11#1)(2011-2#1)(2013-7#1)
to have a negative##2##4##(2010-12#1)(2010-8#1)
to have a normal##2##4##(2006-6#1)(2009-3#1)
to have a novel##2##4##(1993-3#2)
to have a number of##3##5##(1993-12#1)(2006-6#1)(2007-11#1)
to have a pivotal role in##2##6##(1993-9#1)(2009-7#1)
to have a poor prognosis##2##5##(2007-12#1)(2008-12#1)
to have a poor##3##4##(2007-12#1)(2008-12#1)(2010-6#1)
to have a positive effect on##2##6##(2008-12#1)(2012-2#1)
to have a positive effect##3##5##(2008-12#1)(2011-2#1)(2012-2#1)
to have a positive impact on##3##6##(1997-1#1)(2008-11#1)(2008-3#1)
to have a positive##11##4##(1990-6#1)(1991-4#1)(1992-5#1)(1997-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
to have a prevalence##2##4##(2006-9#1)(2013-8#1)
to have a profound effect on the##2##7##(2008-3#1)(2011-12#1)
to have a profound effect on##3##6##(1997-8#1)(2008-3#1)(2011-12#1)
to have a profound##4##4##(1997-8#1)(2007-11#1)(2008-3#1)(2011-12#1)
to have a protective##2##4##(2006-10#1)(2010-12#1)
to have a reduced##2##4##(2010-1#1)(2010-12#1)
to have a relatively##3##4##(1993-12#1)(2008-8#1)(2010-5#1)
to have a reliable##2##4##(1993-11#1)(1993-9#1)
to have a role in##3##5##(1996-2#1)(2008-7#1)(2013-8#1)
to have a role##4##4##(1996-2#1)(2008-4#1)(2008-7#1)(2013-8#1)
to have a significant impact on##4##6##(2007-10#1)(2007-7#1)(2008-1#1)(2008-12#1)
to have a significant influence on the##3##7##(1991-2#1)(2007-12#1)(2008-5#1)
to have a significant influence on##4##6##(1991-10#1)(1991-2#1)(2007-12#1)(2008-5#1)
to have a significant influence##5##5##(1991-10#1)(1991-2#1)(2007-12#1)(2008-5#1)(2011-2#1)
to have a significant##21##4##(1991-10#1)(1991-2#1)(1994-3#1)(2005-8#1)(2006-12#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
to have a significantly##2##4##(1995-7#1)(2012-2#1)
to have a similar##4##4##(1991-8#1)(2005-7#1)(2008-10#1)(2010-2#1)
to have a single##3##4##(1991-11#1)(2008-12#1)(2010-10#1)
to have a slightly##2##4##(2008-3#1)(2011-2#1)
to have a small##3##4##(1994-5#1)(2005-11#1)(2008-2#1)
to have a somewhat higher##2##5##(1996-9#1)(2008-5#1)
to have a somewhat##3##4##(1996-9#1)(2008-5#1)(2008-6#1)
to have a specific##3##4##(2008-11#1)(2008-2#1)(2008-6#1)
to have a strong##4##4##(1994-12#1)(2008-3#1)(2011-1#1)(2012-3#1)
to have a therapeutic##2##4##(1993-3#1)(1993-5#1)
to have a typical##2##4##(1997-4#1)(2007-12#1)
to have a variety of##2##5##(2006-10#1)(2012-3#1)
to have a very##2##4##(1993-12#1)(2007-11#1)
to have a wide##4##4##(2005-10#1)(2007-9#1)(2008-10#1)(2008-7#1)
to have a##376##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#2)(1990-8#2)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#2)(1991-9#1)(1992-2#2)(1992-3#1)(1992-5#2)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#4)(1993-3#4)(1993-4#2)(1993-5#1)(1993-6#2)(1993-9#5)(1994-11#2)(1994-12#2)(1994-3#2)(1994-5#3)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-7#2)(1995-9#1)(1996-10#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#4)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#1)(2004-3#1)(2004-8#1)(2005-10#2)(2005-11#2)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#9)(2006-12#3)(2006-2#1)(2006-6#5)(2006-7#2)(2006-8#5)(2006-9#3)(2007-10#6)(2007-11#14)(2007-12#4)(2007-2#1)(2007-4#3)(2007-6#1)(2007-7#5)(2007-8#7)(2007-9#2)(2008-1#4)(2008-10#12)(2008-11#7)(2008-12#7)(2008-2#10)(2008-3#17)(2008-4#3)(2008-5#12)(2008-6#4)(2008-7#8)(2008-8#2)(2008-9#3)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#3)(2010-3#1)(2010-4#4)(2010-5#2)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#10)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#10)(2012-3#4)(2013-1#8)(2013-7#3)(2013-8#5)
to have abnormal##2##3##(2007-12#1)(2008-9#1)
to have access to##3##4##(1995-3#1)(2007-2#1)(2008-11#1)
to have accumulated##2##3##(2008-10#1)(2011-2#1)
to have accurate##2##3##(2008-3#1)(2009-6#1)
to have acquired a##2##4##(2008-11#2)
to have active##2##3##(1997-8#1)(2008-10#1)
to have activity##2##3##(2008-4#1)(2008-7#1)
to have additional##2##3##(2008-6#1)(2012-3#1)
to have adequate##2##3##(2006-12#1)(2011-2#1)
to have adverse effects on##2##5##(2007-11#1)(2008-10#1)
to have adverse##6##3##(2006-10#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-6#1)
to have altered##2##3##(1995-8#1)(2012-12#1)
to have an accurate##2##4##(2008-11#1)(2011-1#1)
to have an adverse effect on##2##6##(1997-2#1)(2008-10#1)
to have an early##2##4##(2006-2#1)(2008-10#1)
to have an effect in##2##5##(2007-11#1)(2008-9#1)
to have an effect on##2##5##(1997-4#1)(2008-2#1)
to have an effect##4##4##(1997-4#1)(2007-11#1)(2008-2#1)(2008-9#1)
to have an impact on the##2##6##(2007-8#1)(2009-7#1)
to have an impact on##5##5##(1994-2#1)(2007-7#1)(2007-8#1)(2009-7#1)(2010-12#1)
to have an important role in the##2##7##(1993-9#1)(1995-10#1)
to have an important role in##4##6##(1992-7#1)(1993-9#1)(1995-10#1)(2009-12#1)
to have an important##6##4##(1992-7#1)(1993-9#1)(1995-10#1)(1995-5#1)(2008-3#1)(2009-12#1)
to have an increased risk##3##5##(2008-12#1)(2009-7#1)(2012-3#1)
to have an increased##5##4##(2006-1#1)(2008-12#1)(2008-7#1)(2009-7#1)(2012-3#1)
to have an influence on the##2##6##(2008-10#1)(2008-11#1)
to have an influence on##4##5##(2006-5#1)(2008-10#1)(2008-11#1)(2012-3#1)
to have an opinion##2##4##(2007-4#2)
to have an understanding of the##4##6##(2006-11#1)(2007-2#1)(2007-8#1)(2012-12#1)
to have an unusual##2##4##(2008-4#1)(2008-7#1)
to have an##103##3##(1990-12#4)(1990-2#1)(1991-12#1)(1991-5#1)(1991-8#3)(1992-7#1)(1993-3#1)(1993-9#2)(1994-2#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-5#2)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#3)(1997-8#1)(2005-10#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-5#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#2)(2007-8#2)(2008-10#5)(2008-11#5)(2008-12#2)(2008-2#5)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#5)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#4)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-3#3)(2013-1#2)
to have anti-inflammatory##4##3##(2005-3#1)(2010-4#1)(2011-3#1)(2013-8#1)
to have antibacterial activity##2##4##(2006-8#1)(2008-8#1)
to have antiviral##2##3##(1991-3#1)(2008-1#1)
to have any deleterious##2##4##(1992-1#1)(2008-10#1)
to have any effect on##3##5##(1990-5#1)(1991-4#1)(1994-6#1)
to have any##9##3##(1990-5#1)(1991-4#1)(1992-1#1)(1994-3#1)(1994-6#1)(1997-3#1)(2007-2#1)(2008-10#1)(2008-11#1)
to have applications in##2##4##(2008-9#1)(2011-7#1)
to have applications##3##3##(1992-10#1)(2008-9#1)(2011-7#1)
to have arisen##3##3##(1994-11#1)(2008-10#1)(2008-8#1)
to have asthma##3##3##(2007-2#2)(2007-3#1)
to have at least one##3##5##(2008-10#1)(2008-5#1)(2011-2#1)
to have at least##6##4##(1994-12#1)(2008-10#1)(2008-12#1)(2008-5#2)(2011-2#1)
to have become##3##3##(2007-7#1)(2008-1#1)(2012-2#1)
to have been a##3##4##(1996-6#1)(2007-9#1)(2010-5#1)
to have been described##2##4##(1996-12#1)(2007-8#1)
to have been more##2##4##(1992-1#1)(2008-10#1)
to have been of benefit##2##5##(1992-11#1)(2006-8#1)
to have been plagiarized from##4##5##(2008-10#4)
to have been present##4##4##(1990-3#1)(2008-10#1)(2008-2#1)(2008-9#1)
to have been the##3##4##(2006-7#1)(2006-8#1)(2008-10#1)
to have been transmitted##2##4##(1990-3#1)(1990-9#1)
to have been##63##3##(1990-11#1)(1990-12#1)(1990-3#2)(1990-9#1)(1991-11#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-12#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-4#1)(2009-5#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#2)
to have beneficial effects on##4##5##(1991-9#1)(2008-3#1)(2008-7#1)(2009-3#1)
to have beneficial effects##7##4##(1991-9#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-3#1)(2010-5#1)
to have beneficial##9##3##(1991-9#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-3#1)(2010-5#1)
to have better##10##3##(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#1)(2010-7#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
to have blood##2##3##(2007-2#1)(2008-1#1)
to have both##7##3##(1992-5#1)(1994-12#1)(1996-2#1)(2006-10#1)(2007-10#1)(2008-4#1)(2010-4#1)
to have broad##2##3##(1993-11#1)(2008-9#1)
to have cancer##3##3##(2008-4#1)(2009-11#1)(2012-2#1)
to have caused the##4##4##(2006-4#1)(2008-2#1)(2008-9#1)(2012-2#1)
to have caused##9##3##(1992-6#1)(2006-4#1)(2008-2#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#2)
to have changed##2##3##(1991-4#1)(2006-4#1)
to have characteristics##2##3##(2006-5#1)(2009-10#1)
to have children##10##3##(1992-2#1)(1997-5#1)(2007-3#1)(2007-7#1)(2008-8#1)(2009-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)
to have chronic##4##3##(1997-8#1)(2008-4#1)(2013-1#2)
to have clear##2##3##(2009-3#1)(2010-4#1)
to have clinical##2##3##(2006-10#1)(2010-5#1)
to have come##2##3##(1993-6#1)(2007-9#1)
to have considerable effects on##2##5##(2008-10#1)(2011-12#1)
to have considerable impact on##2##5##(1993-6#1)(2008-9#1)
to have considerable##8##3##(1990-3#1)(1993-6#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-12#1)
to have contributed to##2##4##(2010-6#1)(2012-3#1)
to have contributed##4##3##(1990-2#1)(2008-5#1)(2010-6#1)(2012-3#1)
to have decreased##2##3##(2005-12#1)(2011-1#1)
to have depressive##2##3##(2009-10#1)(2009-5#1)
to have diabetes##3##3##(2005-10#1)(2006-10#1)(2007-8#1)
to have died##2##3##(1994-7#1)(2005-7#1)
to have different modes of##2##5##(1996-6#1)(2011-1#1)
to have different##11##3##(1992-11#1)(1992-9#1)(1993-9#2)(1996-6#1)(1996-8#1)(1997-8#1)(2008-10#1)(2010-8#1)(2011-1#2)
to have differing##2##3##(1994-6#1)(2008-11#1)
to have diverged##2##3##(1992-5#1)(2006-7#1)
to have dual##2##3##(2009-2#1)(2013-7#1)
to have effects on##3##4##(1994-6#1)(2007-11#1)(2008-10#1)
to have effects##4##3##(1994-6#1)(2007-11#1)(2007-8#1)(2008-10#1)
to have elevated##5##3##(1995-7#1)(1997-7#1)(2009-2#1)(2011-2#1)(2013-1#1)
to have entered the##2##4##(2009-8#1)(2012-2#1)
to have entered##3##3##(1994-11#1)(2009-8#1)(2012-2#1)
to have equivalent##2##3##(1993-9#1)(2011-1#1)
to have ever had sex##2##5##(2011-1#2)
to have ever##3##3##(2007-3#1)(2011-1#2)
to have evolved##10##3##(1992-5#1)(1995-8#1)(2006-5#1)(2007-11#1)(2007-6#1)(2008-7#2)(2009-6#1)(2010-3#2)
to have excellent##4##3##(2005-4#1)(2008-11#1)(2008-4#1)(2012-2#1)
to have extensive##2##3##(1991-8#1)(2007-8#1)
to have fewer adverse effects##2##5##(1993-8#1)(2009-7#1)
to have function##2##3##(2008-5#1)(2013-1#1)
to have global##2##3##(1990-2#1)(2007-8#1)
to have good##15##3##(1994-9#1)(1996-7#1)(2006-10#1)(2006-6#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-3#2)(2008-6#1)(2008-9#1)(2009-10#1)(2010-2#1)(2011-2#1)(2012-2#1)
to have great##4##3##(1996-5#1)(2004-3#1)(2008-10#2)
to have greater##10##3##(1995-5#1)(1997-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2012-1#1)(2012-2#1)
to have greatly##2##3##(1996-2#1)(2004-9#1)
to have had a##2##4##(1997-1#1)(2010-12#1)
to have had##15##3##(1990-6#1)(1991-11#1)(1994-2#1)(1994-8#1)(1995-8#1)(1996-1#1)(1996-9#1)(1997-1#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-12#1)(2012-11#1)(2012-3#1)
to have high##10##3##(1994-9#1)(1996-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#2)
to have higher antioxidant activity than##2##6##(2013-8#2)
to have higher##14##3##(1994-2#1)(1996-7#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-2#1)(2008-5#1)(2010-2#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#2)
to have highly##2##3##(2010-11#1)(2010-8#1)
to have identical##2##3##(1990-12#1)(1993-9#1)
to have important##2##3##(1993-11#1)(2013-8#1)
to have improved##2##3##(1991-3#1)(1997-2#1)
to have increased##12##3##(1992-9#1)(1995-6#1)(2005-7#1)(2006-10#1)(2006-7#1)(2006-8#2)(2008-2#1)(2008-7#1)(2009-11#1)(2009-4#1)(2011-1#1)
to have insufficient##2##3##(2008-1#1)(2008-5#1)
to have its##4##3##(1996-8#1)(2006-10#1)(2008-5#1)(2011-2#1)
to have knowledge##2##3##(2010-7#1)(2013-7#1)
to have led to##2##4##(1996-6#1)(2010-7#1)
to have less##4##3##(1997-6#1)(2007-11#1)(2008-7#1)(2010-8#1)
to have limited##2##3##(1990-4#1)(2006-8#1)
to have little effect on the##2##6##(2008-2#1)(2008-5#1)
to have little or no##2##5##(1996-7#1)(2012-2#1)
to have little##13##3##(1991-6#1)(1991-7#1)(1993-2#1)(1996-7#1)(2006-8#1)(2008-2#1)(2008-5#1)(2010-6#1)(2011-1#2)(2012-1#1)(2012-2#1)(2012-3#1)
to have long##2##3##(2008-11#1)(2008-5#1)
to have longer##2##3##(1990-12#1)(2006-7#1)
to have lost##3##3##(2007-10#1)(2007-12#1)(2008-10#1)
to have low##7##3##(1992-7#1)(1995-12#1)(1995-6#1)(1996-7#1)(2008-4#1)(2009-4#1)(2013-1#1)
to have lower##7##3##(1997-2#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-8#1)(2010-10#1)(2012-2#1)
to have major##3##3##(2004-12#1)(2006-4#1)(2008-8#1)
to have malignant##3##3##(1991-2#1)(2007-8#1)(2008-5#1)
to have many##3##3##(1991-5#1)(2008-11#1)(2011-1#1)
to have minimal##2##3##(2006-4#1)(2008-5#1)
to have moderate##2##3##(2008-5#1)(2012-2#1)
to have more activity in the second phase of the formalin test##2##12##(2006-12#2)
to have more problems##2##4##(1992-10#1)(1994-3#1)
to have more severe symptoms and##2##6##(2010-6#1)(2012-2#1)
to have more##18##3##(1992-10#1)(1994-3#1)(1995-2#1)(2006-12#3)(2007-10#2)(2007-12#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)
to have most##2##3##(2007-2#1)(2010-7#1)
to have much##2##3##(1995-3#1)(2008-2#1)
to have multiple##5##3##(1991-9#1)(2008-2#1)(2009-6#1)(2011-2#1)(2012-3#1)
to have negative##2##3##(2008-11#1)(2010-12#1)
to have no detectable##2##4##(1992-8#1)(1996-7#1)
to have no effect on the##2##6##(1994-8#1)(2008-10#1)
to have no effect on##4##5##(1994-8#1)(2007-10#1)(2008-10#1)(2012-2#1)
to have no effect##5##4##(1994-8#1)(1996-3#1)(2007-10#1)(2008-10#1)(2012-2#1)
to have no influence on##2##5##(2008-4#1)(2012-2#1)
to have no##27##3##(1990-11#1)(1991-2#1)(1992-12#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-8#1)(1995-10#1)(1995-2#1)(1996-3#1)(1996-7#1)(1997-7#1)(2005-9#2)(2006-7#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-2#1)(2011-1#1)(2012-2#2)
to have normal##5##3##(1993-6#1)(1997-1#1)(2006-6#1)(2008-1#1)(2008-9#1)
to have occurred in##5##4##(1995-2#1)(2006-10#1)(2006-9#1)(2007-7#1)(2012-2#1)
to have occurred##11##3##(1994-11#1)(1995-2#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-7#1)(2007-8#1)(2007-9#1)(2009-8#1)(2010-6#1)(2012-2#1)
to have one##3##3##(1990-3#1)(2008-5#1)(2010-8#1)
to have only a small##3##5##(1991-3#1)(2007-11#1)(2009-10#1)
to have only a##5##4##(1991-3#2)(1994-5#1)(2007-11#1)(2009-10#1)
to have only##7##3##(1991-3#2)(1994-5#1)(2007-1#1)(2007-11#1)(2009-10#1)(2010-1#1)
to have originated from##2##4##(1991-10#1)(2009-2#1)
to have originated##3##3##(1991-10#1)(2009-2#1)(2011-2#1)
to have other##2##3##(2006-10#1)(2013-7#1)
to have positive##3##3##(2006-7#1)(2008-3#1)(2010-5#1)
to have potent##4##3##(1991-9#1)(1995-7#1)(2007-11#1)(2008-5#1)
to have potential for##2##4##(2010-6#1)(2013-1#1)
to have potential##4##3##(2008-5#1)(2010-6#1)(2013-1#2)
to have profound##2##3##(2005-11#1)(2010-2#1)
to have prognostic significance in##2##5##(1997-7#1)(2006-9#1)
to have prognostic value##3##4##(1990-5#1)(2005-9#1)(2010-6#1)
to have prognostic##5##3##(1990-5#1)(1997-7#1)(2005-9#1)(2006-9#1)(2010-6#1)
to have proper##2##3##(1994-9#1)(2008-1#1)
to have pulmonary metastases##2##4##(2008-6#1)(2013-8#1)
to have raised##2##3##(2007-7#1)(2008-11#1)
to have reached a##2##4##(1994-2#1)(2010-3#1)
to have reached##4##3##(1994-2#1)(1995-6#1)(2007-11#1)(2010-3#1)
to have received##4##3##(1995-2#1)(2008-9#1)(2009-5#1)(2010-3#1)
to have recently##3##3##(1991-10#1)(2008-10#1)(2012-2#1)
to have recurrence##2##3##(2006-9#1)(2013-1#1)
to have reduced##3##3##(1994-11#2)(2008-7#1)
to have refined the##2##4##(2008-5#1)(2012-12#1)
to have relatively##2##3##(2008-3#2)
to have responded to##2##4##(2008-9#1)(2011-2#1)
to have resulted in##2##4##(1992-1#1)(1992-11#1)
to have resulted##3##3##(1992-1#1)(1992-11#1)(2008-7#1)
to have severe##4##3##(2006-12#1)(2008-8#1)(2011-1#1)(2011-2#1)
to have significant effects##2##4##(1991-1#1)(2013-1#1)
to have significant impact on##2##5##(1993-2#1)(2012-2#1)
to have significant impact##3##4##(1993-2#1)(2011-1#1)(2012-2#1)
to have significant influence on##4##5##(2006-11#1)(2008-10#2)(2012-3#1)
to have significant##26##3##(1991-1#1)(1991-12#1)(1992-3#1)(1993-2#1)(1994-3#1)(1994-8#1)(1995-3#1)(2006-11#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#1)(2011-1#2)(2011-12#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
to have significantly##6##3##(1993-6#1)(1995-12#1)(2006-12#1)(2007-2#1)(2008-2#1)(2008-3#1)
to have similar##11##3##(1990-5#1)(1990-7#1)(1991-4#1)(1992-4#1)(2006-4#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-10#1)(2012-12#1)
to have small##3##3##(2008-1#1)(2008-11#1)(2008-3#1)
to have smaller##2##3##(1996-7#1)(2010-8#1)
to have some##7##3##(1991-4#1)(1993-1#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-6#1)
to have specific##3##3##(1994-5#1)(1996-8#1)(2007-10#1)
to have statistically significant##2##4##(2007-2#1)(2012-12#1)
to have strong##9##3##(1990-12#1)(1991-7#1)(1992-8#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-12#1)
to have suboptimal##2##3##(1995-4#1)(2009-5#1)
to have substantial##2##3##(2008-8#1)(2009-3#1)
to have substantially higher##2##4##(1993-1#1)(1995-2#1)
to have sufficient##2##3##(2007-11#1)(2008-10#1)
to have surgery##2##3##(1994-2#1)(2008-2#1)
to have taken place##3##4##(1991-9#1)(2006-10#1)(2012-2#1)
to have taken##4##3##(1991-9#1)(1995-11#1)(2006-10#1)(2012-2#1)
to have the ability to##2##5##(2008-1#1)(2009-8#1)
to have the best##3##4##(1997-2#1)(2008-10#1)(2009-5#1)
to have the capability##2##4##(2007-12#1)(2008-3#1)
to have the capacity to##3##5##(2007-4#1)(2008-11#2)
to have the disease##2##4##(1996-2#1)(2012-2#1)
to have the following##3##4##(1991-12#1)(1993-3#1)(1995-3#1)
to have the greatest impact##2##5##(1994-5#1)(2011-2#1)
to have the greatest##6##4##(1994-5#1)(2006-10#1)(2008-10#1)(2011-2#2)(2012-3#1)
to have the highest##3##4##(1996-8#1)(2006-10#1)(2009-4#1)
to have the knowledge##3##4##(2007-7#2)(2011-1#1)
to have the lowest##4##4##(1990-5#1)(2006-7#1)(2008-2#1)(2010-8#1)
to have the most##2##4##(1994-2#1)(2008-9#1)
to have the potential to##3##5##(1997-8#1)(2007-11#1)(2008-5#1)
to have the potential##4##4##(1997-8#1)(2007-11#1)(2008-2#1)(2008-5#1)
to have the same##10##4##(1993-6#1)(1993-9#1)(1994-12#1)(1995-4#1)(2006-10#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-8#1)
to have the##87##3##(1990-5#1)(1990-8#1)(1991-12#1)(1991-8#1)(1992-12#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#2)(1995-2#1)(1995-3#1)(1995-4#2)(1995-5#1)(1995-9#1)(1996-12#1)(1996-2#3)(1996-8#1)(1997-2#1)(1997-8#1)(2006-10#4)(2006-12#2)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-4#2)(2007-7#3)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
to have their##7##3##(1990-2#1)(2007-4#1)(2008-11#2)(2008-8#1)(2010-2#1)(2012-2#1)
to have this diagnosis in mind##2##6##(1992-4#1)(1993-8#1)
to have this##4##3##(1992-4#1)(1993-8#1)(1994-2#1)(1994-5#1)
to have three##3##3##(2006-8#1)(2010-12#1)(2013-1#1)
to have time##2##3##(2008-11#1)(2012-12#1)
to have two to##2##4##(2008-10#2)
to have two##13##3##(1990-11#1)(1991-7#1)(1994-12#1)(1994-9#1)(1995-3#1)(1996-5#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-9#1)
to have undergone##2##3##(1994-8#1)(1996-6#1)
to have used##4##3##(2007-10#1)(2007-3#1)(2007-7#1)(2012-3#1)
to have very##4##3##(1991-3#1)(1993-9#1)(1994-6#1)(2009-3#1)
to having##14##2##(1991-2#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
to hazardous##3##2##(1993-3#1)(2008-8#1)(2010-2#1)
to he##4##2##(1990-11#1)(1992-12#1)(1994-3#1)(2008-8#1)
to head and neck##3##4##(2008-7#1)(2010-7#2)
to head trauma##3##3##(2012-2#1)(2013-1#2)
to head##12##2##(1990-11#1)(1996-11#1)(2007-1#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-7#2)(2012-2#1)(2013-1#2)
to headache##3##2##(1994-9#1)(2004-3#1)(2013-1#1)
to heading##3##2##(2008-10#3)
to heal itself##2##3##(1997-6#1)(2007-11#1)
to heal with##2##3##(2010-6#1)(2013-1#1)
to heal##12##2##(1993-1#1)(1996-1#1)(1997-6#1)(2006-11#1)(2006-3#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-5#1)(2010-6#1)(2012-2#1)(2013-1#1)
to healing##2##2##(1991-3#1)(2006-8#1)
to health and disease##3##4##(2012-2#1)(2013-1#2)
to health and##12##3##(1991-11#1)(1994-12#1)(1994-4#1)(1996-2#1)(1997-8#1)(2005-10#1)(2005-7#1)(2008-12#1)(2008-3#1)(2012-2#1)(2013-1#2)
to health are##2##3##(1991-2#1)(2012-12#1)
to health behavior##2##3##(2008-4#1)(2011-1#1)
to health care and##5##4##(1996-11#1)(2006-4#1)(2012-12#1)(2013-1#1)(2013-8#1)
to health care facilities##2##4##(1997-3#1)(2007-12#1)
to health care for##3##4##(1991-3#1)(1995-12#1)(1996-2#1)
to health care in##5##4##(1995-12#1)(1995-3#1)(2008-11#1)(2009-4#1)(2010-4#1)
to health care professionals'##2##4##(2007-11#1)(2007-2#1)
to health care providers##6##4##(1993-12#1)(2007-4#1)(2008-8#1)(2012-2#1)(2013-1#2)
to health care workers in##2##5##(1993-2#1)(1996-12#1)
to health care workers##4##4##(1993-2#1)(1995-2#1)(1996-12#1)(2012-3#1)
to health care##91##3##(1990-12#1)(1990-2#1)(1991-3#2)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-9#2)(1994-1#3)(1994-12#3)(1994-2#3)(1995-1#4)(1995-12#4)(1995-2#2)(1995-3#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-7#1)(1997-2#3)(1997-3#2)(2006-2#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-11#3)(2008-12#2)(2008-4#1)(2008-6#1)(2008-8#3)(2009-4#3)(2009-5#1)(2010-11#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#4)
to health care?##2##3##(1995-2#1)(2012-12#1)
to health in##2##3##(2012-12#1)(2012-3#1)
to health insurance##4##3##(1994-3#1)(2006-3#1)(2012-1#1)(2013-1#1)
to health maintenance organizations (HMOs)##2##5##(1991-1#1)(1993-3#1)
to health maintenance organizations and##2##5##(1991-3#2)
to health maintenance organizations##6##4##(1991-1#2)(1991-3#2)(1993-1#1)(1993-3#1)
to health maintenance##7##3##(1991-1#2)(1991-3#2)(1993-1#1)(1993-3#1)(2006-10#1)
to health outcomes##2##3##(2012-2#1)(2013-8#1)
to health problems##2##3##(1995-6#1)(2012-1#1)
to health professionals##4##3##(1995-3#1)(2007-1#1)(2008-6#1)(2012-2#1)
to health promotion and##2##4##(1991-1#1)(1993-12#1)
to health promotion##5##3##(1991-1#1)(1993-1#1)(1993-12#1)(2011-2#1)(2012-1#1)
to health reform##2##3##(1993-3#1)(1994-1#1)
to health risk##3##3##(2005-10#1)(2008-7#1)(2010-12#1)
to health service##2##3##(2008-1#1)(2011-1#1)
to health services in##2##4##(1997-3#1)(2012-3#1)
to health services##18##3##(1992-2#2)(1994-1#1)(1995-12#1)(1997-3#1)(2006-8#1)(2007-9#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-1#3)(2012-1#1)(2012-12#1)(2012-3#2)
to health systems##3##3##(2008-7#1)(2010-10#1)(2012-2#1)
to health##218##2##(1990-12#3)(1990-2#1)(1991-1#3)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#4)(1991-7#1)(1992-11#1)(1992-2#2)(1992-3#1)(1993-1#3)(1993-12#4)(1993-2#2)(1993-3#4)(1993-6#1)(1993-9#2)(1994-1#5)(1994-12#4)(1994-2#4)(1994-3#1)(1994-4#1)(1995-1#4)(1995-12#5)(1995-2#4)(1995-3#3)(1995-6#1)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#4)(1997-5#1)(1997-8#1)(2004-4#1)(2005-10#2)(2005-7#1)(2006-10#2)(2006-2#3)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#3)(2008-10#1)(2008-11#8)(2008-12#4)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#5)(2009-4#5)(2009-5#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2011-1#8)(2011-2#3)(2012-1#6)(2012-12#7)(2012-2#8)(2012-3#8)(2013-1#8)(2013-7#2)(2013-8#5)
to health-related##2##2##(2006-2#1)(2008-6#1)
to healthcare management##2##3##(2007-1#1)(2009-3#1)
to healthcare professionals##2##3##(2010-12#1)(2012-12#1)
to healthcare providers##2##3##(2009-9#1)(2012-2#1)
to healthcare##31##2##(1991-1#1)(1991-4#1)(1992-6#1)(1997-7#1)(2006-5#2)(2007-1#1)(2007-12#1)(2008-4#1)(2008-9#8)(2009-3#1)(2009-4#1)(2009-9#1)(2010-12#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
to healthy control##3##3##(2009-6#1)(2011-2#1)(2013-1#1)
to healthy controls##10##3##(1993-2#1)(1996-7#1)(2006-8#1)(2008-1#1)(2008-8#1)(2009-10#1)(2009-6#1)(2013-1#3)
to healthy individuals##5##3##(1992-7#1)(1997-5#1)(2009-11#1)(2009-8#1)(2012-2#1)
to healthy rats##3##3##(1994-11#1)(2008-10#2)
to healthy seedlings##2##3##(2008-10#2)
to healthy subjects##6##3##(2007-9#1)(2010-12#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
to healthy##57##2##(1990-2#1)(1990-3#1)(1990-4#2)(1990-8#1)(1992-7#1)(1992-8#1)(1993-2#1)(1994-11#1)(1995-3#2)(1996-7#1)(1997-5#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#2)(2009-2#1)(2009-6#3)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#1)
to hear the case##2##4##(1992-6#1)(1995-6#1)
to hear the##3##3##(1992-6#1)(1995-6#1)(2007-11#1)
to hearing loss)##2##3##(2007-4#2)
to hearing##6##2##(2007-4#2)(2007-7#1)(2010-12#1)(2011-12#1)(2012-2#1)
to heart attack##2##3##(2008-3#1)(2010-12#1)
to heart disease##2##3##(1996-9#1)(2013-8#1)
to heart failure##8##3##(2008-10#1)(2008-7#1)(2009-4#1)(2010-4#1)(2011-2#1)(2012-12#2)(2013-1#1)
to heart##22##2##(1990-10#1)(1990-11#1)(1993-10#1)(1993-2#1)(1994-5#1)(1995-12#1)(1996-9#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
to heat and acid##2##4##(1994-11#2)
to heat and to##2##4##(2008-10#1)(2008-8#1)
to heat and##5##3##(1994-11#2)(1994-9#1)(2008-10#1)(2008-8#1)
to heat shock##7##3##(1990-12#1)(1990-4#1)(1992-1#1)(1995-11#1)(2006-10#1)(2008-7#2)
to heat stress##4##3##(1992-1#1)(1995-5#2)(2008-5#1)
to heat the##2##3##(1990-10#1)(2008-10#1)
to heat##42##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)(1992-1#2)(1992-3#1)(1994-11#3)(1994-2#2)(1994-9#1)(1995-11#1)(1995-5#2)(1995-6#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-9#1)(2006-10#2)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-3#1)(2009-8#1)(2010-9#1)
to heating at##2##3##(1990-3#1)(1993-3#1)
to heating##5##2##(1990-3#1)(1993-3#1)(2007-12#1)(2008-3#1)(2012-3#1)
to heavy metal##4##3##(1997-2#1)(1997-4#1)(2008-10#1)(2008-7#1)
to heavy metals##9##3##(1997-7#1)(2008-10#4)(2008-7#2)(2013-1#2)
to heavy##20##2##(1993-2#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-7#3)(2010-8#1)(2013-1#2)
to height##2##2##(1996-8#1)(2007-1#1)
to heighten awareness of##2##4##(1992-12#1)(1993-8#1)
to heighten the##2##3##(1997-4#1)(2008-8#1)
to heighten##5##2##(1992-12#1)(1993-8#1)(1997-4#1)(2008-7#1)(2008-8#1)
to heightened##2##2##(2007-11#1)(2011-2#1)
to heir##2##2##(1997-5#1)(2013-7#1)
to helical##2##2##(2008-11#1)(2008-2#1)
to help a##2##3##(1995-6#1)(1997-2#1)
to help achieve##3##3##(1996-2#1)(2005-8#1)(2007-2#1)
to help analyze##2##3##(2006-10#1)(2012-12#1)
to help answer##2##3##(2006-8#1)(2008-11#1)
to help avoid##3##3##(1992-1#1)(2009-7#1)(2010-4#1)
to help clarify the##2##4##(2008-5#1)(2011-2#1)
to help clarify##4##3##(2008-12#1)(2008-5#1)(2009-2#1)(2011-2#1)
to help consumers##2##3##(1996-3#1)(2010-2#1)
to help control##3##3##(1997-6#1)(2008-3#1)(2012-3#1)
to help countries##3##3##(2009-5#1)(2012-12#1)(2013-1#1)
to help curb the spread of##2##6##(2010-8#2)
to help define the##3##4##(1991-6#1)(2008-7#1)(2011-1#1)
to help define##5##3##(1991-6#2)(1994-11#1)(2008-7#1)(2011-1#1)
to help determine the##3##4##(1992-1#1)(1996-6#1)(2007-11#1)
to help determine##5##3##(1992-1#1)(1996-6#1)(2007-11#1)(2008-1#1)(2009-12#1)
to help develop##2##3##(2009-7#1)(2009-8#1)
to help discriminate##2##3##(1996-1#1)(2007-9#1)
to help eliminate##2##3##(2008-3#1)(2013-7#1)
to help ensure that the##2##5##(1996-9#1)(2008-2#1)
to help ensure that##4##4##(1996-9#1)(2006-5#1)(2006-8#1)(2008-2#1)
to help ensure##7##3##(1996-9#1)(2006-5#1)(2006-8#1)(2008-10#2)(2008-2#1)(2010-5#1)
to help estimate text difficulty##2##5##(2013-1#2)
to help families assist##2##4##(2011-2#2)
to help guide the##2##4##(2008-10#1)(2010-8#1)
to help guide##7##3##(2006-10#1)(2008-10#1)(2008-12#1)(2009-4#2)(2010-4#1)(2010-8#1)
to help heal##2##3##(1996-2#1)(2007-1#1)
to help health##2##3##(1996-1#1)(2008-12#1)
to help healthcare##2##3##(2011-2#1)(2012-12#1)
to help identify##7##3##(1991-2#1)(1992-8#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-12#1)(2012-3#1)
to help improve the##3##4##(2008-2#1)(2008-7#1)(2013-7#1)
to help improve##7##3##(1994-12#1)(2008-2#1)(2008-7#1)(2009-9#1)(2012-3#1)(2013-1#1)(2013-7#1)
to help in the##3##4##(1995-2#1)(2007-4#1)(2013-1#1)
to help in##13##3##(1995-2#1)(2007-3#1)(2007-4#1)(2008-10#2)(2008-3#1)(2009-2#1)(2010-2#1)(2010-4#1)(2010-8#2)(2012-12#1)(2013-1#1)
to help increase##2##3##(2005-3#1)(2010-4#1)
to help individuals##3##3##(1995-9#1)(2008-7#2)
to help maintain the##2##4##(2008-3#1)(2009-11#1)
to help maintain##3##3##(1996-3#1)(2008-3#1)(2009-11#1)
to help make##4##3##(2007-1#1)(2007-2#1)(2008-10#1)(2008-3#1)
to help manage##8##3##(1991-1#1)(1997-2#1)(2008-10#2)(2010-7#1)(2011-1#1)(2013-1#2)
to help managers##2##3##(1992-2#1)(2007-10#1)
to help minimize##2##3##(2008-5#1)(2013-1#1)
to help nurses##3##3##(1996-1#1)(1997-7#1)(2004-10#1)
to help others##2##3##(2004-3#1)(2013-1#1)
to help patients##6##3##(2005-8#1)(2007-6#1)(2008-11#1)(2011-1#1)(2011-2#2)
to help people##5##3##(1990-12#1)(2009-4#1)(2010-9#1)(2012-1#2)
to help pharmacy##2##3##(2011-1#2)
to help physicians##2##3##(2006-10#1)(2008-11#1)
to help prevent the##2##4##(2008-12#1)(2012-12#1)
to help prevent##7##3##(1991-7#1)(2007-2#1)(2008-12#1)(2010-1#1)(2010-12#1)(2012-12#1)(2013-7#1)
to help reduce the##4##4##(1991-6#1)(2006-2#1)(2007-2#1)(2009-5#1)
to help reduce##6##3##(1991-6#1)(2006-2#1)(2007-2#1)(2008-1#1)(2008-12#1)(2009-5#1)
to help researchers##2##3##(2008-10#1)(2008-4#1)
to help resolve##2##3##(2009-11#1)(2013-8#1)
to help select##2##3##(1992-2#1)(1995-3#1)
to help staff##2##3##(2010-10#1)(2012-1#1)
to help standardize##2##3##(2007-10#1)(2008-11#1)
to help surgeons##2##3##(2007-2#1)(2009-4#1)
to help the patient##5##4##(1994-8#1)(2008-11#1)(2008-4#1)(2009-8#1)(2010-9#1)
to help the##28##3##(1991-2#1)(1991-5#1)(1992-2#1)(1994-8#1)(1995-12#1)(2005-12#1)(2006-1#1)(2006-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2009-6#1)(2009-8#1)(2010-8#1)(2010-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
to help their patients##2##4##(1994-1#1)(2010-9#1)
to help their##4##3##(1994-1#1)(2008-11#1)(2010-9#1)(2011-2#1)
to help them develop##2##4##(1993-2#1)(2010-10#1)
to help them##15##3##(1991-2#1)(1992-2#1)(1993-2#1)(2005-8#1)(2007-5#1)(2008-6#1)(2009-10#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#3)
to help to##3##3##(1994-6#1)(2008-2#1)(2010-8#1)
to help understand the##4##4##(2007-11#1)(2008-5#1)(2008-7#1)(2010-12#1)
to help understand##6##3##(2007-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-2#1)
to help unravel the##2##4##(2008-4#1)(2012-12#1)
to help us##5##3##(1995-11#1)(2007-12#1)(2008-2#2)(2009-10#1)
to help users##4##3##(2008-9#1)(2011-2#1)(2013-1#2)
to help with##2##3##(2010-12#1)(2013-8#1)
to help women##2##3##(1994-3#1)(2010-3#1)
to help you##6##3##(1992-3#1)(1994-1#1)(1995-12#1)(1995-2#1)(2006-5#1)(2007-4#1)
to help##361##2##(1990-12#2)(1991-1#1)(1991-2#3)(1991-5#1)(1991-6#4)(1991-7#1)(1992-1#4)(1992-12#1)(1992-2#5)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#2)(1995-6#2)(1995-7#1)(1995-9#1)(1996-1#4)(1996-2#2)(1996-3#5)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-5#1)(1997-6#1)(1997-7#2)(2004-10#2)(2004-12#1)(2004-3#1)(2004-4#1)(2005-10#1)(2005-12#1)(2005-3#1)(2005-8#3)(2006-1#1)(2006-10#4)(2006-2#2)(2006-3#1)(2006-5#2)(2006-6#1)(2006-8#4)(2007-1#2)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#5)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#4)(2007-9#4)(2008-1#7)(2008-10#15)(2008-11#9)(2008-12#8)(2008-2#9)(2008-3#6)(2008-4#6)(2008-5#5)(2008-6#3)(2008-7#8)(2008-8#4)(2008-9#6)(2009-10#6)(2009-11#6)(2009-12#1)(2009-2#2)(2009-4#6)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#4)(2010-2#4)(2010-3#1)(2010-4#5)(2010-5#1)(2010-7#1)(2010-8#10)(2010-9#7)(2011-1#9)(2011-2#13)(2012-1#5)(2012-11#1)(2012-12#11)(2012-2#5)(2012-3#4)(2013-1#20)(2013-7#5)(2013-8#3)
to help'##2##2##(2012-3#2)
to helping##5##2##(1995-12#1)(2004-12#1)(2007-6#1)(2008-8#2)
to hematoma##2##2##(2009-3#1)(2012-3#1)
to hematopoietic##3##2##(2010-12#1)(2011-1#1)(2012-12#1)
to heme##5##2##(1992-12#1)(1992-8#1)(1993-8#1)(1997-2#1)(2007-11#1)
to hemin##2##2##(1995-11#1)(1995-3#1)
to hemodialysis##9##2##(1994-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-3#1)(2011-2#2)(2013-8#1)
to hemodynamic##2##2##(1990-12#1)(2013-7#1)
to hemoglobin S##2##3##(1994-11#1)(1996-6#1)
to hemoglobin was##2##3##(1996-6#1)(2006-8#1)
to hemoglobin##8##2##(1990-8#1)(1994-11#1)(1994-9#1)(1996-6#2)(1996-9#1)(2006-8#1)(2011-1#1)
to hemolytic anemia##2##3##(1997-6#2)
to hemolytic##4##2##(1997-6#2)(2013-1#2)
to hemophilia##2##2##(2007-10#1)(2008-11#1)
to hemorrhage##2##2##(2006-10#1)(2007-10#1)
to hemorrhagic shock##3##3##(1992-7#2)(2012-3#1)
to heparin alone##2##3##(1993-2#2)
to heparin as##2##3##(1994-4#1)(2007-11#1)
to heparin inhibition##2##3##(1991-2#2)
to heparin##21##2##(1990-12#1)(1991-2#3)(1993-2#2)(1994-3#1)(1994-4#3)(1997-1#2)(2005-7#2)(2007-11#3)(2007-3#1)(2007-8#1)(2008-5#1)(2013-1#1)
to heparin-Sepharose##2##2##(1990-7#1)(1995-8#1)
to hepatectomy##2##2##(2008-10#1)(2013-1#1)
to hepatic and##2##3##(1992-2#1)(1997-8#1)
to hepatic failure##2##3##(2006-6#1)(2012-3#1)
to hepatic##16##2##(1990-11#1)(1992-1#1)(1992-2#1)(1997-8#1)(2006-10#1)(2006-4#1)(2006-6#3)(2007-2#1)(2007-5#1)(2008-5#1)(2009-7#1)(2010-2#1)(2011-1#1)(2012-3#1)
to hepatitis A##2##3##(1993-2#1)(2007-1#1)
to hepatitis B surface##2##4##(1994-11#1)(2009-12#1)
to hepatitis B vaccine##3##4##(2009-12#1)(2012-2#1)(2013-1#1)
to hepatitis B virus and##2##5##(1990-8#1)(2010-12#1)
to hepatitis B virus##3##4##(1990-8#1)(2010-12#1)(2013-1#1)
to hepatitis B##13##3##(1990-8#2)(1994-11#1)(2007-7#1)(2009-12#2)(2009-9#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#2)
to hepatitis C virus##4##4##(1991-3#1)(2006-1#1)(2007-7#1)(2008-8#1)
to hepatitis C##6##3##(1991-3#1)(1992-11#1)(2006-1#1)(2007-7#1)(2008-6#1)(2008-8#1)
to hepatitis##24##2##(1990-8#2)(1991-3#1)(1992-11#1)(1993-2#1)(1994-11#1)(2006-1#1)(2006-10#1)(2007-1#1)(2007-7#2)(2008-6#2)(2008-8#1)(2009-12#2)(2009-7#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#2)
to hepatocellular carcinoma##7##3##(1993-7#1)(2006-10#1)(2006-2#1)(2010-12#1)(2012-11#2)(2012-3#1)
to hepatocytes##6##2##(1990-5#1)(1990-9#1)(1992-5#1)(2006-10#1)(2008-1#1)(2009-4#1)
to her death##4##3##(1995-12#1)(1997-3#1)(2006-10#1)(2011-2#1)
to her medical##2##3##(1996-6#1)(2012-12#1)
to her primary care physician##2##5##(2008-12#1)(2012-2#1)
to her##33##2##(1994-6#1)(1995-12#1)(1996-11#1)(1996-6#1)(1997-3#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-7#1)(2007-2#2)(2007-4#1)(2007-6#2)(2007-7#1)(2008-12#2)(2008-7#1)(2008-9#1)(2009-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#2)
to herbal##2##2##(2008-11#1)(2010-5#1)
to herbivore##4##2##(2008-8#2)(2008-9#1)(2009-8#1)
to herbivory##3##2##(1995-8#1)(2008-8#2)
to here as##7##3##(1994-2#1)(1997-4#1)(2008-3#1)(2008-4#3)(2011-2#1)
to here##8##2##(1994-2#1)(1997-4#1)(2005-11#1)(2008-3#1)(2008-4#3)(2011-2#1)
to hereditary##2##2##(1993-10#1)(2012-1#1)
to heritable##3##2##(2009-2#1)(2011-1#1)(2012-1#1)
to herniated##2##2##(2006-7#1)(2006-8#1)
to heroin##3##2##(1997-2#2)(2007-2#1)
to herpes##2##2##(2006-10#1)(2007-7#1)
to heterogeneity in##2##3##(2008-10#1)(2009-6#1)
to heterogeneity of##2##3##(2006-6#1)(2013-8#1)
to heterogeneity##4##2##(2006-6#1)(2008-10#1)(2009-6#1)(2013-8#1)
to heterogeneous##3##2##(2006-5#1)(2010-12#1)(2012-1#1)
to heterosis##2##2##(2012-3#2)
to heterozygous##2##2##(2010-3#1)(2013-1#1)
to hexagonal phase##3##3##(1990-12#1)(1991-9#1)(1994-12#1)
to hexagonal##7##2##(1990-12#1)(1990-2#1)(1991-9#2)(1994-12#1)(2008-2#1)(2008-3#1)
to hexaploid##2##2##(2008-10#2)
to hidden##3##2##(2008-4#2)(2012-2#1)
to hide the##2##3##(2007-9#1)(2010-8#1)
to hide##3##2##(2007-9#1)(2008-10#1)(2010-8#1)
to hierarchical##2##2##(2010-1#1)(2010-4#1)
to hierarchically##4##2##(2008-10#1)(2008-2#1)(2008-7#1)(2009-11#1)
to high affinity##3##3##(1993-1#1)(1997-7#1)(2008-5#1)
to high altitude##3##3##(1992-2#1)(2012-2#2)
to high amounts of##2##4##(2007-8#1)(2012-3#1)
to high cell densities##2##4##(1994-2#1)(2008-11#1)
to high concentrations of##5##4##(1991-9#1)(1997-3#1)(2007-12#1)(2008-4#2)
to high density##4##3##(1991-9#1)(1995-5#1)(2006-5#1)(2008-11#1)
to high dose##4##3##(1995-12#1)(1996-6#1)(2006-4#1)(2008-1#1)
to high doses of##6##4##(1990-8#1)(1996-2#1)(1996-4#1)(1997-8#1)(2008-7#1)(2010-10#1)
to high doses##10##3##(1990-8#1)(1995-10#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-8#1)(2007-11#1)(2008-7#1)(2009-5#1)(2010-10#1)
to high emotional##2##3##(1994-2#1)(2009-7#1)
to high frequency##2##3##(2008-11#1)(2010-3#1)
to high glucose##5##3##(1992-6#1)(1994-2#1)(1995-3#1)(1996-5#1)(2010-11#1)
to high incidence##2##3##(1991-5#1)(2012-2#1)
to high levels of expression of##2##6##(1997-4#1)(2008-11#1)
to high levels of##15##4##(1994-11#1)(1995-12#2)(1995-5#1)(1997-4#1)(2004-2#1)(2004-4#1)(2008-10#1)(2008-11#1)(2008-4#2)(2009-3#1)(2009-7#1)(2010-4#1)(2012-2#1)
to high levels##19##3##(1991-5#1)(1994-11#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-5#1)(1997-4#1)(2004-2#1)(2004-4#1)(2008-10#2)(2008-11#1)(2008-4#2)(2009-3#1)(2009-7#1)(2010-4#1)(2012-2#1)
to high molecular weight##4##4##(1994-10#1)(2006-8#1)(2008-10#1)(2008-7#1)
to high performance liquid chromatography##3##5##(2008-10#3)
to high performance liquid##4##4##(2008-10#4)
to high resolution##5##3##(1991-11#1)(1991-2#1)(2008-10#1)(2008-2#1)(2010-5#1)
to high risk of##2##4##(2011-12#1)(2011-2#1)
to high risk##8##3##(1993-11#1)(2008-11#1)(2009-3#1)(2009-5#1)(2009-7#1)(2011-12#1)(2011-2#1)(2012-12#1)
to high sensitivity##3##3##(2007-8#1)(2008-10#2)
to high spatial resolution##2##4##(2008-2#1)(2010-12#1)
to high temperature##5##3##(1995-8#1)(2008-12#2)(2008-5#1)(2012-1#1)
to high temperatures and##2##4##(2008-12#1)(2009-2#1)
to high temperatures##6##3##(2008-10#2)(2008-12#1)(2008-7#1)(2009-2#1)(2010-8#1)
to high yields##5##3##(2007-10#3)(2007-11#2)
to high##226##2##(1990-3#2)(1990-7#1)(1990-8#2)(1991-11#1)(1991-2#1)(1991-5#3)(1991-9#2)(1992-12#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-11#2)(1993-4#1)(1993-8#2)(1994-10#1)(1994-11#2)(1994-2#4)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#3)(1995-3#2)(1995-5#3)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#3)(1996-6#3)(1996-8#2)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-2#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-10#3)(2007-11#5)(2007-12#4)(2007-4#1)(2007-8#2)(2007-9#3)(2008-1#3)(2008-10#27)(2008-11#9)(2008-12#4)(2008-2#4)(2008-3#3)(2008-4#7)(2008-5#7)(2008-6#2)(2008-7#7)(2008-9#2)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#4)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#5)(2011-12#3)(2011-2#4)(2012-1#3)(2012-12#1)(2012-2#8)(2012-3#4)(2013-1#4)(2013-8#1)
to high-affinity##5##2##(1993-8#1)(2008-1#1)(2008-4#1)(2008-8#1)(2008-9#1)
to high-altitude conditions##2##3##(2012-1#2)
to high-density lipoprotein cholesterol##2##4##(1990-5#1)(2008-3#1)
to high-density##3##2##(1990-5#1)(1993-3#1)(2008-3#1)
to high-dose##4##2##(2006-7#1)(2007-11#1)(2008-8#1)(2011-1#1)
to high-energy##2##2##(2008-3#1)(2010-9#1)
to high-frequency##2##2##(1995-12#1)(2009-4#1)
to high-income##2##2##(2010-12#1)(2013-1#1)
to high-intensity##4##2##(1992-11#1)(2005-11#1)(2007-11#1)(2008-4#1)
to high-performance liquid chromatography (HPLC)##2##5##(2008-10#2)
to high-performance liquid chromatography##4##4##(1990-6#1)(1991-7#1)(2008-10#2)
to high-performance##5##2##(1990-6#1)(1991-7#1)(1993-12#1)(2008-10#2)
to high-pressure##2##2##(2007-12#1)(2008-3#1)
to high-quality##4##2##(2005-7#1)(2007-11#1)(2007-12#1)(2010-8#1)
to high-resolution##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-11#1)
to high-risk populations##2##3##(2012-3#2)
to high-risk##13##2##(1992-2#1)(2006-10#1)(2007-3#1)(2007-7#1)(2008-2#1)(2009-2#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
to high-speed##2##2##(2006-11#2)
to high-throughput##5##2##(2008-4#1)(2008-7#1)(2009-12#1)(2010-12#1)(2010-2#1)
to higher bit rates##2##4##(2007-12#1)(2008-1#1)
to higher frequencies##2##3##(1995-7#1)(2006-10#1)
to higher levels of##5##4##(1991-11#1)(1993-3#1)(2008-7#1)(2009-7#1)(2010-3#1)
to higher levels##7##3##(1991-11#1)(1993-3#1)(2008-10#1)(2008-7#1)(2009-7#1)(2010-3#1)(2013-8#1)
to higher order##4##3##(1990-7#1)(2007-12#1)(2012-11#1)(2012-2#1)
to higher plants##2##3##(2006-12#1)(2009-10#1)
to higher quality##2##3##(1992-11#1)(1992-3#1)
to higher rates##2##3##(2012-12#1)(2012-2#1)
to higher sensitivity##2##3##(2008-7#1)(2012-3#1)
to higher temperatures##2##3##(1995-8#1)(2008-3#1)
to higher than expected##2##4##(1990-5#1)(2008-10#1)
to higher##109##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-11#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-9#2)(1993-3#1)(1993-5#1)(1994-12#3)(1994-2#2)(1995-12#1)(1995-7#2)(1995-8#1)(1996-7#1)(1996-8#1)(1996-9#1)(2004-4#1)(2005-11#2)(2005-12#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-12#8)(2007-2#1)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-6#1)(2009-7#3)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-7#1)(2012-11#2)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#4)
to higher-order##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
to highest##2##2##(2008-9#1)(2010-12#1)
to highlight important##3##3##(2005-7#1)(2006-10#1)(2006-5#1)
to highlight its##3##3##(1995-3#1)(2007-7#1)(2008-3#1)
to highlight new##2##3##(2006-9#1)(2008-5#1)
to highlight some of the##3##5##(1994-10#1)(2005-8#1)(2007-7#1)
to highlight some##4##3##(1994-10#1)(2005-8#1)(2007-7#1)(2008-11#1)
to highlight that##3##3##(2010-11#1)(2012-3#1)(2013-8#1)
to highlight the importance of##4##5##(2007-5#1)(2008-10#1)(2010-12#1)(2011-1#1)
to highlight the##41##3##(1992-8#1)(1994-12#1)(1994-2#1)(1997-4#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#2)(2007-7#2)(2008-1#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#3)
to highlight their##2##3##(1995-4#1)(2013-1#1)
to highlight##87##2##(1992-8#1)(1994-10#1)(1994-12#1)(1994-2#1)(1995-3#2)(1995-4#1)(1997-4#1)(2005-11#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#2)(2006-2#2)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#2)(2007-7#4)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-4#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
to highly active antiretroviral therapy##4##5##(2009-7#1)(2010-6#1)(2010-9#2)
to highly active##5##3##(2009-7#1)(2010-6#1)(2010-7#1)(2010-9#2)
to highly aggressive##2##3##(2012-2#1)(2013-8#1)
to highly malignant##2##3##(1995-11#1)(2009-4#1)
to highly pleasurable##2##3##(2012-2#2)
to highly resistant##3##3##(2008-10#3)
to highly structured##2##3##(1995-3#1)(2013-8#1)
to highly variable##3##3##(2007-7#1)(2008-8#1)(2013-7#1)
to highly##43##2##(1990-5#1)(1991-2#1)(1992-2#1)(1995-11#1)(1995-3#1)(1995-5#1)(1997-1#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#2)
to him##3##2##(1990-11#1)(1991-3#1)(1993-3#1)
to himself or##2##3##(1990-2#1)(1994-11#1)
to himself##4##2##(1990-2#1)(1994-11#1)(2007-8#1)(2008-2#1)
to hinder##3##2##(2008-11#1)(2008-4#1)(2009-6#1)
to hinge##2##2##(2004-12#1)(2012-2#1)
to hip##6##2##(2006-7#1)(2006-9#1)(2007-4#1)(2008-11#1)(2011-2#1)(2013-7#1)
to hippocampal##7##2##(1991-3#1)(1991-6#1)(1992-9#1)(1993-5#1)(1995-12#1)(1997-4#1)(2008-4#1)
to hire a##2##3##(1992-12#1)(2007-4#1)
to hire##5##2##(1992-12#1)(2007-4#3)(2008-2#1)
to his or her##6##4##(1994-2#1)(1994-8#1)(2006-7#1)(2007-3#1)(2008-3#1)(2012-3#1)
to his patients##2##3##(2007-11#1)(2008-10#1)
to his physician##2##3##(1990-6#1)(2013-1#1)
to his right##2##3##(1996-2#1)(2010-10#1)
to his##61##2##(1990-6#1)(1991-2#1)(1992-2#1)(1992-6#2)(1993-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#1)(1997-5#1)(2006-4#3)(2006-7#3)(2007-1#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-6#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#4)(2013-8#2)
to his/her##6##2##(2006-1#1)(2008-9#1)(2012-1#1)(2012-2#1)(2013-8#2)
to histamine in##2##3##(1995-3#1)(2007-2#1)
to histamine##12##2##(1990-7#2)(1992-9#1)(1995-12#1)(1995-3#1)(1997-1#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-5#2)(2012-12#1)
to histidine##7##2##(1991-8#1)(1992-6#1)(1992-9#1)(1995-5#1)(1996-5#1)(1997-3#1)(2013-1#1)
to histologic##3##2##(1990-3#1)(1991-2#1)(2004-1#1)
to histological subtype##2##3##(2008-7#1)(2012-12#1)
to histological##8##2##(1993-9#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
to histologically##3##2##(1992-10#1)(2010-12#1)(2012-3#1)
to histone##4##2##(1992-12#1)(2007-10#1)(2008-8#1)(2011-1#1)
to histones and##2##3##(1994-9#1)(2013-8#1)
to histones##4##2##(1994-9#1)(1995-8#1)(2009-9#1)(2013-8#1)
to historical##8##2##(2006-5#2)(2007-7#1)(2009-5#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-1#1)
to history of##3##3##(2006-10#1)(2007-9#1)(2013-1#1)
to history##4##2##(2006-10#1)(2007-9#1)(2013-1#1)(2013-7#1)
to hit the##2##3##(2007-4#1)(2011-2#1)
to hit##7##2##(1991-3#1)(1994-3#1)(2007-4#1)(2008-6#1)(2011-2#2)(2012-1#1)
to hold a##3##3##(2005-12#1)(2007-11#1)(2010-10#1)
to hold for##4##3##(1995-2#1)(2005-11#1)(2006-10#1)(2008-10#1)
to hold the##4##3##(1996-2#1)(2006-5#1)(2007-8#1)(2008-12#1)
to hold##32##2##(1990-12#1)(1991-11#1)(1992-1#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-8#2)(2005-11#1)(2005-12#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-2#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)
to holographic##3##2##(2008-2#1)(2008-3#2)
to home and##2##3##(1991-12#1)(1993-12#1)
to home care##4##3##(1991-12#1)(1995-3#2)(2006-5#1)
to home for##2##3##(2006-7#1)(2007-10#1)
to home##26##2##(1990-12#1)(1991-10#1)(1991-12#4)(1991-2#2)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#1)(1995-3#2)(2005-10#1)(2006-5#1)(2006-7#1)(2007-10#2)(2007-8#2)(2008-1#1)(2008-8#1)(2010-5#1)(2011-2#1)(2013-1#1)
to home-based##2##2##(2012-12#1)(2012-3#1)
to homeostasis##2##2##(2011-2#1)(2012-12#1)
to homicide##3##2##(2010-7#2)(2011-2#1)
to homogeneity and##15##3##(1990-2#2)(1990-4#1)(1990-7#1)(1991-2#1)(1992-7#1)(1992-8#1)(1994-11#1)(1994-12#1)(1995-10#1)(1995-11#1)(1995-3#1)(1996-5#1)(1996-7#1)(1997-4#1)
to homogeneity as judged by##2##5##(1990-10#1)(1990-11#1)
to homogeneity by a##6##4##(1990-7#1)(1990-8#1)(1991-2#2)(1991-8#1)(1994-3#1)
to homogeneity by##25##3##(1990-5#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-2#2)(1991-8#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-3#1)(1995-3#1)(1995-8#1)(1997-4#2)(1997-8#1)(2005-11#1)(2008-4#1)(2008-8#1)(2009-3#1)(2010-4#1)
to homogeneity in##2##3##(1994-12#2)
to homogeneity with##3##3##(1990-12#1)(1990-5#1)(1995-12#1)
to homogeneity##119##2##(1990-1#1)(1990-10#1)(1990-11#5)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#3)(1990-7#5)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#4)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#3)(1993-11#2)(1993-12#2)(1993-3#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#5)(1994-2#1)(1994-3#2)(1994-8#2)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#4)(1995-6#1)(1995-8#2)(1996-3#1)(1996-5#3)(1996-7#2)(1997-2#1)(1997-4#4)(1997-6#2)(1997-8#1)(2005-11#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#4)(2009-3#1)(2010-4#2)(2013-8#1)
to homogeneous##4##2##(2008-10#1)(2008-3#2)(2010-5#1)
to homogenize##3##2##(1994-4#1)(2008-10#1)(2010-5#1)
to homologous##6##2##(1990-3#1)(1995-10#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-9#1)
to homozygosity##2##2##(1990-5#1)(2009-2#1)
to honey##2##2##(2006-12#1)(2008-10#1)
to honor##5##2##(1992-12#1)(1996-2#1)(2007-8#1)(2007-9#1)(2009-5#1)
to horizontally##3##2##(1992-7#1)(2008-3#1)(2009-9#1)
to hormonal and##2##3##(1991-3#1)(2009-5#1)
to hormonal changes##2##3##(2012-2#1)(2013-8#1)
to hormonal##10##2##(1991-3#1)(1992-4#1)(1994-3#1)(1994-9#1)(2006-10#1)(2008-5#1)(2009-5#1)(2012-2#1)(2012-3#1)(2013-8#1)
to hormones and##2##3##(1996-11#1)(2008-7#1)
to hormones##6##2##(1992-7#1)(1993-8#1)(1994-11#1)(1996-11#1)(2008-1#1)(2008-7#1)
to horseradish peroxidase##5##3##(1991-2#1)(1992-9#1)(1997-3#1)(2008-1#1)(2008-7#1)
to hospice care##5##3##(1993-12#3)(1995-1#1)(2012-12#1)
to hospice##6##2##(1992-12#1)(1993-12#3)(1995-1#1)(2012-12#1)
to hospital admission##4##3##(1991-9#1)(2005-8#1)(2006-6#1)(2009-6#1)
to hospital after##2##3##(1990-2#1)(2012-2#1)
to hospital and##8##3##(1991-11#1)(1991-12#1)(1992-4#1)(1996-1#1)(2006-10#1)(2006-6#1)(2007-8#1)(2012-2#1)
to hospital care##3##3##(1992-2#2)(1996-2#1)
to hospital cost##2##3##(1992-12#1)(1996-12#1)
to hospital discharge##2##3##(2007-9#1)(2008-3#1)
to hospital emergency##3##3##(1995-10#1)(1995-4#1)(2009-9#1)
to hospital for##8##3##(1991-5#1)(1992-5#1)(1993-9#2)(2006-6#1)(2007-2#2)(2011-2#1)
to hospital had##2##3##(1995-8#1)(2011-1#1)
to hospital in##2##3##(1990-9#1)(2010-7#1)
to hospital security##2##3##(1993-2#1)(1997-2#1)
to hospital was##3##3##(1991-8#1)(1995-5#1)(2006-10#1)
to hospital with##15##3##(1990-5#1)(1992-6#1)(1993-10#1)(1993-3#1)(2005-12#1)(2006-10#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-7#1)(2011-2#2)(2012-12#1)(2012-2#1)
to hospital##119##2##(1990-2#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-11#2)(1992-12#1)(1992-2#4)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-10#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-9#2)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-10#1)(1995-4#2)(1995-5#1)(1995-7#1)(1995-8#2)(1995-9#3)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2004-10#1)(2005-12#1)(2005-8#1)(2006-10#5)(2006-12#1)(2006-4#1)(2006-6#3)(2006-8#1)(2006-9#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-3#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#1)(2013-8#3)
to hospital-based##2##2##(1991-2#1)(1992-1#1)
to hospitalization for##2##3##(1992-1#1)(2012-2#1)
to hospitalization##13##2##(1991-1#1)(1991-2#2)(1992-1#1)(1992-10#1)(1995-1#1)(1995-10#1)(1995-5#1)(2007-11#1)(2008-1#1)(2009-5#1)(2012-2#2)
to hospitals and##5##3##(1993-6#1)(1995-1#1)(2008-1#1)(2008-11#1)(2008-4#1)
to hospitals for##2##3##(1995-5#1)(2012-3#1)
to hospitals in##2##3##(1995-11#1)(2008-4#1)
to hospitals with##4##3##(1990-6#1)(1993-1#1)(2008-3#1)(2008-8#1)
to hospitals##27##2##(1990-6#1)(1991-1#2)(1991-3#1)(1992-1#1)(1992-10#1)(1992-3#1)(1993-1#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-1#1)(1995-1#1)(1995-11#1)(1995-5#1)(1997-1#1)(2008-1#1)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)
to host cell##4##3##(2005-11#3)(2008-10#1)
to host cells##7##3##(1990-10#1)(1992-5#1)(1994-3#1)(2005-8#1)(2008-10#2)(2012-1#1)
to host immune##2##3##(1994-3#1)(2013-1#1)
to host resistance##3##3##(2008-10#3)
to host size##4##3##(2008-10#1)(2008-5#1)(2008-9#2)
to host species##2##3##(2008-10#2)
to host tissue##2##3##(2008-10#1)(2011-1#1)
to host##53##2##(1990-10#1)(1990-8#1)(1992-5#1)(1994-3#2)(1994-5#1)(1995-12#1)(1996-1#1)(2005-11#4)(2005-8#1)(2007-12#3)(2008-10#21)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#3)(2011-1#3)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#1)
to hosts##4##2##(2011-12#2)(2013-1#1)(2013-8#1)
to hot wax##2##3##(1992-6#2)
to hot##8##2##(1992-6#2)(2006-7#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-12#1)
to hours##4##2##(2008-4#1)(2008-9#1)(2010-3#1)(2011-1#1)
to house dust mite##3##4##(2008-10#1)(2012-3#2)
to house dust##4##3##(2008-10#1)(2012-3#2)(2013-8#1)
to house##7##2##(2008-10#1)(2010-8#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
to household##3##2##(2006-4#1)(2009-4#1)(2012-12#1)
to housing##4##2##(1996-5#1)(2012-12#1)(2013-1#2)
to how it##3##3##(1992-3#1)(2008-10#1)(2008-7#1)
to how many of##2##4##(2006-2#1)(2007-9#1)
to how much##2##3##(1992-12#1)(2007-11#1)
to how they##5##3##(1990-12#1)(1996-1#1)(2006-10#1)(2010-9#2)
to how to##2##3##(2008-8#1)(2011-1#1)
to how##44##2##(1990-12#1)(1990-2#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-2#1)(1994-3#1)(1996-1#1)(1997-4#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-9#2)(2011-1#2)(2011-2#1)(2013-1#2)
to hsp##2##2##(1995-2#1)(2012-12#1)
to huge##3##2##(1997-6#1)(2008-1#1)(2008-3#1)
to human MHC##2##3##(1996-4#1)(2008-8#1)
to human activities##2##3##(2007-3#1)(2012-9#1)
to human and animal health##2##5##(1997-3#1)(2012-2#1)
to human and animal##5##4##(1997-3#1)(2008-10#2)(2008-9#1)(2012-2#1)
to human and rat##2##4##(1995-2#1)(1996-5#1)
to human and##15##3##(1991-2#1)(1995-2#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-3#1)(2004-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2012-2#1)(2013-8#1)
to human antithrombin##2##3##(1992-10#2)
to human behavior##2##3##(2006-2#1)(2008-4#1)
to human blood##2##3##(1994-3#1)(2007-8#1)
to human brain##6##3##(1990-8#1)(1996-2#1)(2008-3#1)(2009-10#1)(2013-1#2)
to human breast##2##3##(1993-1#1)(2009-10#1)
to human cancer##3##3##(2008-8#1)(2009-12#1)(2009-4#1)
to human cells##2##3##(2006-6#1)(2012-12#1)
to human chromosome 1##2##4##(1995-2#1)(1997-8#1)
to human chromosome 21q22##2##4##(1997-1#1)(1997-8#1)
to human chromosome##11##3##(1992-8#1)(1994-12#2)(1995-2#1)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#2)(2008-7#1)(2008-9#1)
to human colon##2##3##(2006-8#1)(2008-11#1)
to human development##2##3##(2008-11#1)(2008-2#1)
to human disease##5##3##(2006-11#1)(2008-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
to human diseases##2##3##(1997-8#1)(2013-8#1)
to human erythrocyte##3##3##(1992-1#1)(1993-3#1)(1994-12#1)
to human estrogen receptor##2##4##(1995-11#1)(2006-5#1)
to human genes##2##3##(1995-4#1)(2006-10#1)
to human health and##2##4##(2009-7#1)(2012-2#1)
to human health##23##3##(1992-2#1)(1993-12#1)(1994-3#2)(2006-2#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)
to human hemoglobin##2##3##(1990-8#1)(1992-8#1)
to human immunodeficiency virus##3##4##(1991-9#1)(1993-12#1)(2007-7#1)
to human immunodeficiency##4##3##(1991-9#1)(1992-12#1)(1993-12#1)(2007-7#1)
to human liver##2##3##(1991-3#1)(1997-2#1)
to human mast cells##2##4##(1990-9#1)(2008-4#1)
to human papillomavirus##2##3##(2008-2#1)(2012-2#1)
to human physiology##2##3##(2006-10#1)(2011-2#1)
to human plasma samples##2##4##(1993-2#1)(2008-10#1)
to human plasma##3##3##(1993-2#1)(1993-6#1)(2008-10#1)
to human platelet##2##3##(1990-10#1)(1995-3#1)
to human platelets##2##3##(1990-9#1)(1992-12#1)
to human proteins##2##3##(2006-10#1)(2013-1#1)
to human prothrombin##2##3##(1993-9#2)
to human serum albumin (HSA) and##2##6##(1994-8#1)(2008-10#1)
to human serum albumin (HSA)##4##5##(1994-8#1)(1996-11#1)(2008-10#2)
to human serum albumin##12##4##(1990-12#1)(1990-4#1)(1990-6#2)(1994-3#1)(1994-8#1)(1996-11#2)(2008-10#3)(2008-3#1)
to human serum##14##3##(1990-12#1)(1990-4#1)(1990-6#2)(1991-10#1)(1994-3#1)(1994-8#1)(1996-11#2)(2008-10#3)(2008-12#1)(2008-3#1)
to human skin##4##3##(2004-11#1)(2008-5#2)(2012-3#1)
to human trypsin 1##2##4##(1995-3#1)(1996-6#1)
to human umbilical vein endothelial cells##3##6##(1990-4#1)(1991-1#1)(1996-3#1)
to human umbilical vein endothelial##4##5##(1990-4#1)(1991-1#1)(1996-3#1)(2008-11#1)
to human##305##2##(1990-1#2)(1990-10#1)(1990-12#2)(1990-3#1)(1990-4#4)(1990-5#1)(1990-6#3)(1990-7#2)(1990-8#2)(1990-9#2)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#3)(1991-3#2)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#2)(1992-10#2)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#3)(1992-6#1)(1992-7#1)(1992-8#4)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#5)(1993-2#4)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#4)(1994-11#1)(1994-12#3)(1994-3#7)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-10#4)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#3)(1996-6#3)(1996-7#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#6)(2004-11#2)(2005-11#2)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#2)(2006-5#2)(2006-6#2)(2006-8#6)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#8)(2008-12#3)(2008-2#5)(2008-3#2)(2008-4#5)(2008-5#8)(2008-6#2)(2008-7#4)(2008-8#8)(2008-9#7)(2009-10#5)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#8)(2012-3#1)(2012-9#1)(2013-1#10)(2013-8#6)
to humans after##2##3##(2008-10#1)(2008-8#1)
to humans and##7##3##(2005-8#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-8#1)(2011-2#1)
to humans as##2##3##(1996-8#1)(2007-7#1)
to humans by##3##3##(1997-6#1)(2008-1#1)(2011-2#1)
to humans for##2##3##(2008-2#1)(2009-8#1)
to humans in##2##3##(2004-11#1)(2011-2#1)
to humans##59##2##(1990-5#1)(1991-12#1)(1991-5#1)(1992-5#1)(1994-3#1)(1994-6#1)(1995-11#1)(1996-10#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-11#2)(2005-8#2)(2006-12#1)(2006-7#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-4#2)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#3)
to humic acid##2##3##(2008-10#2)
to humic##3##2##(2008-10#3)
to humidity##2##2##(2008-10#2)
to humoral immunity##2##3##(2008-11#1)(2008-12#1)
to humoral##3##2##(2006-10#1)(2008-11#1)(2008-12#1)
to hundreds of kilobases##2##4##(2008-2#1)(2008-8#1)
to hundreds of##9##3##(1997-2#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)(2011-2#2)
to hyaluronan##4##2##(1994-12#1)(1994-2#1)(1997-6#2)
to hybrid##6##2##(1991-9#1)(1995-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-3#1)
to hybridization##4##2##(1996-7#1)(2006-12#1)(2008-4#1)(2009-4#1)
to hybridize to##6##3##(1990-4#1)(1993-11#1)(1993-9#1)(1994-9#1)(2008-1#1)(2008-8#1)
to hybridize with##2##3##(2008-10#1)(2008-2#1)
to hybridize##9##2##(1990-4#1)(1993-11#1)(1993-9#1)(1994-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)
to hybridoma##3##2##(1994-11#1)(2008-11#1)(2008-7#1)
to hydride generation##2##3##(2008-10#2)
to hydride##3##2##(1996-7#1)(2008-10#2)
to hydrogen ion##3##3##(2008-10#3)
to hydrogen peroxide##12##3##(1990-4#1)(1993-4#2)(1994-3#1)(1995-5#1)(1996-1#1)(1996-8#3)(2008-10#2)(2008-7#1)
to hydrogen##26##2##(1990-4#1)(1992-5#1)(1992-9#1)(1993-4#2)(1994-3#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-8#3)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#9)(2008-7#1)
to hydrogen-bonded##2##2##(1995-5#1)(2007-12#1)
to hydrolyse##4##2##(1991-6#1)(2006-8#1)(2009-3#1)(2011-1#1)
to hydrolysis and##3##3##(1994-11#1)(2008-10#1)(2008-5#1)
to hydrolysis by LPL##2##4##(1995-4#2)
to hydrolysis by##5##3##(1990-2#1)(1991-5#1)(1994-11#1)(1995-4#2)
to hydrolysis of##3##3##(1992-12#1)(1993-8#1)(2005-11#1)
to hydrolysis##19##2##(1990-2#1)(1991-5#1)(1992-12#1)(1993-8#1)(1994-11#2)(1995-4#2)(2004-9#1)(2005-11#1)(2008-10#1)(2008-5#2)(2008-7#1)(2012-11#2)(2013-1#3)
to hydrolyze ATP##2##3##(1993-8#1)(1995-1#1)
to hydrolyze the##2##3##(1992-9#1)(2008-5#1)
to hydrolyze##20##2##(1990-2#1)(1991-12#1)(1991-5#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-8#1)(1997-1#1)(2008-10#2)(2008-4#2)(2008-5#2)(2011-1#1)
to hydrophobic##2##2##(1990-5#1)(2011-1#1)
to hydroxyapatite cement##2##3##(2011-2#2)
to hydroxyapatite surfaces##3##3##(2013-8#3)
to hydroxyapatite##9##2##(2004-9#1)(2008-11#2)(2008-5#1)(2011-2#2)(2013-8#3)
to hydroxychloroquine##5##2##(2010-8#1)(2013-1#4)
to hydroxylamine##2##2##(1990-11#1)(1997-2#1)
to hydroxylate##3##2##(1991-9#1)(1994-8#1)(1994-9#1)
to hydroxylated##3##2##(1995-7#1)(2008-4#1)(2009-3#1)
to hydroxyurea##3##2##(1990-5#1)(1994-8#1)(2012-3#1)
to hygiene##4##2##(1991-5#1)(2008-9#1)(2010-8#1)(2011-2#1)
to hygromycin B##4##3##(1995-2#1)(2008-10#3)
to hygromycin##6##2##(1995-2#1)(2008-10#5)
to hyperactivity##2##2##(2008-9#1)(2010-12#1)
to hyperbaric oxygen##3##3##(1991-2#1)(1993-12#2)
to hyperbaric##4##2##(1991-2#1)(1993-12#2)(2012-2#1)
to hypercapnia##2##2##(1997-5#2)
to hypercapnic acidosis in##2##4##(1994-10#2)
to hypercapnic acidosis##3##3##(1994-10#3)
to hypercapnic##4##2##(1994-10#3)(2012-12#1)
to hypercholesterolemia##3##2##(1990-4#1)(1992-4#1)(1993-9#1)
to hyperglycaemia##2##2##(2008-1#1)(2008-7#1)
to hyperglycemia##4##2##(2007-8#2)(2009-11#1)(2013-1#1)
to hyperosmotic stress##3##3##(2006-5#3)
to hyperosmotic##4##2##(2006-5#3)(2008-5#1)
to hyperoxia##2##2##(1995-8#2)
to hyperpolarizing##2##2##(1993-8#1)(2009-2#1)
to hypersaline##2##2##(2006-10#1)(2013-1#1)
to hypersensitivity reactions##2##3##(2005-11#1)(2008-8#1)
to hypersensitivity##4##2##(1994-6#1)(1995-8#1)(2005-11#1)(2008-8#1)
to hypertension and##2##3##(2006-2#1)(2008-12#1)
to hypertension##16##2##(1990-2#1)(1992-8#1)(1994-11#1)(1996-9#1)(2006-2#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-12#1)(2009-7#2)(2010-4#1)(2013-1#2)
to hypertensive##5##2##(2006-10#1)(2007-7#1)(2008-4#1)(2009-1#1)(2010-4#1)
to hyperthermia##3##2##(2006-6#2)(2008-11#1)
to hyperthyroidism##3##2##(1996-5#1)(2007-9#1)(2011-1#1)
to hypertrophic cardiomyopathy##2##3##(1992-8#1)(2010-11#1)
to hypertrophic##3##2##(1992-8#1)(2010-11#1)(2013-8#1)
to hyperventilation##3##2##(2008-7#3)
to hypochlorite##2##2##(2007-7#1)(2008-10#1)
to hypoglycemia##4##2##(1995-6#1)(2010-11#1)(2012-11#1)(2012-2#1)
to hypogonadism##2##2##(2006-10#1)(2012-12#1)
to hypoosmotic##4##2##(1990-7#2)(2008-11#2)
to hypotension and##3##3##(2008-6#1)(2013-7#1)(2013-8#1)
to hypotension##4##2##(2008-1#1)(2008-6#1)(2013-7#1)(2013-8#1)
to hypothalamic##4##2##(1994-3#2)(1994-9#1)(1996-2#1)
to hypothermia##2##2##(1990-3#1)(1995-3#1)
to hypothermic circulatory arrest##2##4##(2007-8#2)
to hypothermic circulatory##3##3##(2007-8#3)
to hypothermic##5##2##(1990-12#1)(2007-8#4)
to hypotheses##4##2##(1991-3#1)(2009-5#1)(2009-7#1)(2010-3#1)
to hypothesize that the##2##4##(2008-10#1)(2010-12#1)
to hypothesize that##6##3##(2006-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-12#1)(2013-8#1)
to hypothesize the##2##3##(2007-8#1)(2009-7#1)
to hypothesize##9##2##(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-4#1)(2009-7#1)(2010-12#1)(2013-8#1)
to hypothetical##4##2##(1993-12#1)(1996-12#2)(1997-4#1)
to hypothyroidism##3##2##(1997-8#1)(2006-11#1)(2011-2#1)
to hypotonic##3##2##(1990-3#2)(1992-3#1)
to hypovolemia##2##2##(2006-10#1)(2011-2#1)
to hypoxia and##3##3##(1995-1#1)(1996-12#1)(2013-1#1)
to hypoxia in##2##3##(1990-7#1)(2013-1#1)
to hypoxia is##2##3##(2008-1#1)(2013-1#1)
to hypoxia##37##2##(1990-6#1)(1990-7#3)(1991-2#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-9#1)(1995-1#1)(1995-12#1)(1996-12#1)(1997-5#1)(2005-9#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#1)(2009-12#1)(2010-11#1)(2010-4#1)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#5)(2013-8#2)
to hypoxia-ischemia##2##2##(1993-2#1)(1994-2#1)
to hypoxic stress in##2##4##(1997-8#1)(2010-11#1)
to hypoxic##8##2##(1991-1#1)(1997-8#1)(2005-8#1)(2008-1#1)(2008-7#1)(2009-3#1)(2010-11#1)(2012-1#1)
to hypoxic-ischemic brain##2##3##(1996-5#2)
to hypoxic-ischemic##3##2##(1996-5#3)
to hysterectomy##7##2##(1990-12#1)(1991-3#1)(1994-12#1)(1994-6#1)(1994-9#1)(2008-8#1)(2013-1#1)
to i##8##2##(1990-7#1)(1992-3#2)(1992-7#1)(1992-8#2)(1994-2#1)(2008-5#1)
to i)##4##2##(2006-10#1)(2009-12#1)(2009-8#1)(2010-8#1)
to iatrogenic##4##2##(1990-3#1)(1992-4#1)(1995-8#1)(2012-2#1)
to ibuprofen##3##2##(1993-11#1)(2008-7#1)(2011-2#1)
to ice##2##2##(1991-10#1)(2008-2#1)
to ideal##5##2##(2006-5#1)(2007-9#1)(2008-12#1)(2008-9#1)(2012-12#1)
to identifiable##3##2##(1990-9#1)(1991-8#1)(1995-12#1)
to identification of##10##3##(1993-9#1)(1996-8#1)(2006-12#1)(2006-8#1)(2007-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
to identification##13##2##(1993-9#1)(1996-6#1)(1996-8#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-5#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
to identify &quot##3##3##(1995-1#1)(2006-8#1)(2008-10#1)
to identify CAD##2##3##(2008-3#1)(2010-4#1)
to identify DNA##2##3##(1994-8#1)(2008-10#1)
to identify S##2##3##(1995-1#1)(2011-1#1)
to identify a &quot##2##4##(2006-2#1)(2012-3#1)
to identify a large##2##4##(1994-6#1)(2008-5#1)
to identify a set of##2##5##(2007-12#1)(2012-3#1)
to identify a single##2##4##(1993-1#1)(2006-5#1)
to identify a specific DNA##2##5##(1990-11#1)(2008-10#1)
to identify a subset of patients##2##6##(1993-3#1)(2008-9#1)
to identify a##55##3##(1990-10#1)(1990-11#1)(1990-12#1)(1991-5#1)(1991-6#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#2)(1997-1#1)(1997-2#1)(1997-7#1)(2006-1#1)(2006-11#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
to identify activated##2##3##(1994-9#1)(2008-6#1)
to identify additional##3##3##(2005-8#1)(2011-12#1)(2013-1#1)
to identify all the##2##4##(2006-12#1)(2010-3#1)
to identify all##7##3##(1992-5#1)(2006-12#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
to identify an##7##3##(1991-9#1)(1993-6#1)(1994-9#1)(1996-1#1)(2008-1#1)(2008-3#1)(2008-7#1)
to identify and address##2##4##(1997-8#1)(2008-5#1)
to identify and characterize genes##2##5##(1997-2#1)(2008-8#1)
to identify and characterize the##3##5##(1995-2#1)(1996-5#1)(2008-12#1)
to identify and characterize##10##4##(1991-11#1)(1995-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(2005-8#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-3#1)
to identify and describe the##2##5##(2009-8#1)(2011-2#1)
to identify and describe##3##4##(2007-2#1)(2009-8#1)(2011-2#1)
to identify and differentiate##2##4##(2008-10#2)
to identify and distinguish##2##4##(2006-4#1)(2008-5#1)
to identify and evaluate the##2##5##(2007-12#1)(2013-1#1)
to identify and evaluate##3##4##(2007-12#1)(2008-8#1)(2013-1#1)
to identify and investigate##2##4##(2006-10#1)(2010-11#1)
to identify and isolate##4##4##(1995-1#2)(2006-8#1)(2008-4#1)
to identify and locate##2##4##(2008-3#1)(2012-3#1)
to identify and manage##2##4##(2010-3#1)(2011-2#1)
to identify and prioritize##3##4##(2007-4#1)(2013-1#2)
to identify and purify##3##4##(1993-8#1)(1995-1#1)(2008-9#1)
to identify and quantify##6##4##(2008-10#1)(2008-5#1)(2008-9#1)(2010-4#1)(2013-1#2)
to identify and react##2##4##(1993-3#1)(2012-12#1)
to identify and remove##2##4##(2008-10#1)(2008-3#1)
to identify and resolve##2##4##(1994-1#1)(2007-4#1)
to identify and study##2##4##(1994-5#1)(2008-9#1)
to identify and test##2##4##(2007-6#1)(2011-2#1)
to identify and to##3##4##(1991-12#1)(1991-2#1)(1994-8#1)
to identify and treat##4##4##(1992-6#1)(2006-8#1)(2008-10#1)(2012-11#1)
to identify and understand the##3##5##(2008-12#1)(2008-4#1)(2010-5#1)
to identify and##112##3##(1991-11#1)(1991-12#2)(1991-2#1)(1992-6#1)(1993-3#2)(1993-8#1)(1994-1#1)(1994-5#1)(1994-8#1)(1995-1#3)(1995-2#1)(1995-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-8#1)(2005-12#1)(2005-8#1)(2006-10#3)(2006-4#1)(2006-7#1)(2006-8#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#2)(2010-11#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#1)
to identify any##11##3##(1995-1#1)(1995-12#1)(1997-7#1)(2007-11#1)(2007-8#2)(2008-5#2)(2008-9#1)(2011-1#1)(2012-12#1)
to identify apoptotic cells##2##4##(2008-4#1)(2008-9#1)
to identify apoptotic##3##3##(2008-4#1)(2008-7#1)(2008-9#1)
to identify approaches##2##3##(2008-6#1)(2009-4#1)
to identify appropriate##2##3##(2007-11#1)(2012-3#1)
to identify approximately##2##3##(1995-8#1)(2006-12#1)
to identify areas for##3##4##(2007-2#1)(2008-11#1)(2009-10#1)
to identify areas of##3##4##(2004-11#1)(2007-10#1)(2008-11#1)
to identify areas##8##3##(2004-11#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-11#2)(2008-12#1)(2009-10#1)
to identify as bisexual##2##4##(2008-12#2)
to identify as gay##2##4##(2008-12#2)
to identify as##4##3##(2008-12#4)
to identify aspects of##2##4##(2007-12#1)(2013-1#1)
to identify associations##2##3##(2008-4#1)(2012-3#1)
to identify at-risk##3##3##(1997-1#1)(2013-1#2)
to identify barriers to the##2##5##(2005-12#1)(2007-12#1)
to identify barriers to##3##4##(1997-1#1)(2005-12#1)(2007-12#1)
to identify binding sites##2##4##(1990-12#1)(2009-8#1)
to identify both##2##3##(2008-6#1)(2008-7#1)
to identify brain regions##2##4##(1995-12#1)(2009-2#1)
to identify candidate genes##3##4##(2008-10#2)(2011-1#1)
to identify candidate##7##3##(1996-11#1)(2006-4#1)(2008-10#3)(2008-7#1)(2011-1#1)
to identify candidates##3##3##(1993-12#2)(2012-12#1)
to identify cases##6##3##(2005-8#1)(2006-10#1)(2009-10#1)(2012-12#1)(2013-1#2)
to identify cells that##2##4##(2008-4#1)(2008-9#1)
to identify cells##4##3##(1997-5#1)(2008-4#1)(2008-9#1)(2011-1#1)
to identify cellular##2##3##(2008-7#1)(2013-1#1)
to identify certain##3##3##(1992-3#1)(1997-4#1)(2008-7#1)
to identify challenges##2##3##(1997-2#1)(2012-3#1)
to identify changes in the##2##5##(2008-11#1)(2008-4#1)
to identify changes in##3##4##(2008-1#1)(2008-11#1)(2008-4#1)
to identify changes##6##3##(2008-1#1)(2008-11#1)(2008-4#1)(2010-11#1)(2013-1#2)
to identify characteristics##2##3##(2012-3#1)(2013-1#1)
to identify children##3##3##(1992-6#1)(2006-10#1)(2010-3#1)
to identify chromosomal##2##3##(2008-8#1)(2008-9#1)
to identify clinical and##2##4##(2005-5#1)(2013-1#1)
to identify clinical##5##3##(2005-5#1)(2006-2#1)(2013-1#3)
to identify combinations##2##3##(2008-3#1)(2012-3#1)
to identify common concepts##2##4##(2007-8#1)(2013-1#1)
to identify common##8##3##(1994-2#1)(2005-10#1)(2007-8#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
to identify compounds##3##3##(1994-9#1)(2007-9#1)(2009-3#1)
to identify conserved##2##3##(1995-2#1)(1997-2#1)
to identify controlled trials##2##4##(1995-5#1)(2011-2#1)
to identify correlations between##2##4##(1996-12#1)(2011-1#1)
to identify critical##6##3##(1996-8#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-6#1)
to identify data##3##3##(2008-4#1)(2013-1#2)
to identify defects##2##3##(2008-12#1)(2008-3#1)
to identify deletion##2##3##(2012-3#2)
to identify determinants of##4##4##(1990-2#1)(1993-6#1)(2006-2#1)(2009-4#1)
to identify different##2##3##(2008-6#1)(2012-3#1)
to identify differentially expressed##3##4##(2008-2#1)(2008-7#1)(2010-12#1)
to identify diseases##2##3##(1997-3#1)(2008-10#1)
to identify distinct##2##3##(2008-9#1)(2011-1#1)
to identify dominant##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
to identify each##2##3##(2007-12#1)(2008-2#1)
to identify effects##2##3##(1994-6#1)(2012-3#1)
to identify environmental##2##3##(1991-1#1)(2008-8#1)
to identify factors associated with##6##5##(1995-2#1)(2007-2#1)(2009-4#1)(2012-12#1)(2013-1#1)(2013-8#1)
to identify factors contributing to##2##5##(2008-12#1)(2011-1#1)
to identify factors other than##2##5##(2004-2#1)(2011-1#1)
to identify factors that influence the##2##6##(2008-9#1)(2013-8#1)
to identify factors that influence##4##5##(2008-9#1)(2013-1#2)(2013-8#1)
to identify factors that##15##4##(2006-10#1)(2007-10#3)(2007-7#1)(2008-9#1)(2009-11#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#2)
to identify factors##32##3##(1995-10#1)(1995-2#1)(2004-2#1)(2006-10#1)(2006-6#1)(2007-10#3)(2007-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-7#1)(2010-11#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#4)
to identify family##2##3##(1992-1#1)(2013-8#1)
to identify features##2##3##(1992-12#1)(1993-11#1)
to identify four##2##3##(1992-7#1)(2008-10#1)
to identify functionally##2##3##(1996-2#1)(2008-11#1)
to identify future##2##3##(2006-11#1)(2013-8#1)
to identify gene##2##3##(2008-4#1)(2009-12#1)
to identify general##2##3##(2006-2#1)(2008-10#1)
to identify genes in##2##4##(2008-7#1)(2012-3#1)
to identify genes that are##3##5##(2008-7#2)(2009-9#1)
to identify genes that##9##4##(1991-5#1)(1992-9#1)(1994-3#1)(1995-1#1)(2008-7#2)(2009-9#1)(2011-2#1)(2012-3#1)
to identify genes##23##3##(1991-5#1)(1992-9#1)(1994-3#1)(1995-1#1)(1995-11#1)(1996-5#1)(2007-6#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-3#3)
to identify genetic alterations##3##4##(2010-3#1)(2011-2#2)
to identify genetic##10##3##(1996-3#1)(2008-10#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-3#3)
to identify groups of##2##4##(2005-10#1)(2008-2#1)
to identify health##2##3##(1996-12#1)(2008-11#1)
to identify high##3##3##(1994-12#1)(2008-4#2)
to identify high-risk##2##3##(1996-2#1)(2013-1#1)
to identify how##3##3##(2005-2#1)(2010-12#1)(2011-1#1)
to identify important##4##3##(2008-11#1)(2008-2#1)(2008-7#1)(2012-3#1)
to identify in the##2##4##(2008-10#1)(2013-7#1)
to identify in##5##3##(1995-3#1)(2008-10#1)(2013-1#2)(2013-7#1)
to identify incidence and##3##4##(2007-10#1)(2013-1#2)
to identify incidence##4##3##(2007-10#1)(2007-12#1)(2013-1#2)
to identify individual##3##3##(2007-12#1)(2008-1#1)(2008-9#1)
to identify individuals with##3##4##(2008-10#1)(2008-3#1)(2013-7#1)
to identify individuals##6##3##(1990-7#1)(2007-4#2)(2008-10#1)(2008-3#1)(2013-7#1)
to identify infants with##2##4##(1992-7#1)(2010-9#1)
to identify informative##3##3##(2010-12#1)(2011-3#2)
to identify isolates##2##3##(2006-10#1)(2008-10#1)
to identify its##4##3##(1995-11#1)(1996-7#1)(2007-7#1)(2008-8#1)
to identify key themes##2##4##(2011-2#1)(2012-11#1)
to identify key##7##3##(1993-2#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)
to identify major##2##3##(2006-8#1)(2010-2#1)
to identify microorganisms##2##3##(2007-9#1)(2008-5#1)
to identify molecular markers for##2##5##(2008-10#2)
to identify molecular markers##4##4##(2005-10#1)(2008-10#3)
to identify molecular##9##3##(2005-10#1)(2006-12#1)(2008-10#3)(2008-2#1)(2012-11#1)(2012-2#1)(2013-8#1)
to identify morphological##3##3##(2007-12#1)(2010-12#1)(2011-1#1)
to identify mutants##2##3##(1995-2#1)(2012-3#1)
to identify mutations in##2##4##(1994-3#1)(2008-4#1)
to identify mutations##3##3##(1993-6#1)(1994-3#1)(2008-4#1)
to identify new molecular##2##4##(2010-12#1)(2010-3#1)
to identify new therapeutic##2##4##(2008-1#1)(2010-7#1)
to identify new##20##3##(2007-6#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-8#4)(2009-12#1)(2010-12#1)(2010-3#3)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
to identify novel proteins##2##4##(1996-5#1)(2009-4#1)
to identify novel targets##3##4##(2005-8#1)(2008-8#1)(2010-6#1)
to identify novel##19##3##(1991-3#1)(1993-11#1)(1996-5#1)(1997-5#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-6#2)(2013-1#1)
to identify opportunities for##4##4##(1995-12#1)(1996-3#1)(1997-1#1)(2008-5#1)
to identify opportunities##5##3##(1993-9#1)(1995-12#1)(1996-3#1)(1997-1#1)(2008-5#1)
to identify optimal##6##3##(2007-10#1)(2008-1#1)(2008-11#1)(2008-9#1)(2010-2#1)(2013-1#1)
to identify other##6##3##(1991-12#1)(1994-2#1)(1997-4#1)(2005-11#1)(2008-10#1)(2008-4#1)
to identify patients at risk##4##5##(2006-10#1)(2008-10#1)(2012-12#1)(2012-2#1)
to identify patients at##6##4##(2006-10#1)(2006-12#1)(2008-1#1)(2008-10#1)(2012-12#1)(2012-2#1)
to identify patients who##4##4##(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#1)
to identify patients with early##2##5##(2006-10#1)(2011-2#1)
to identify patients with##12##4##(1992-11#1)(2006-10#1)(2007-9#1)(2008-11#1)(2008-8#1)(2011-2#2)(2013-1#1)(2013-8#4)
to identify patients##28##3##(1992-11#1)(1993-10#1)(2005-10#1)(2005-9#1)(2006-10#2)(2006-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#4)
to identify patterns##2##3##(1992-2#1)(2011-1#1)
to identify peptides with##2##4##(2007-11#1)(2010-2#1)
to identify peptides##5##3##(1993-12#1)(2007-11#1)(2008-4#2)(2010-2#1)
to identify physicians##2##3##(2010-11#2)
to identify populations##3##3##(1995-12#1)(1995-3#1)(2008-9#1)
to identify possible##11##3##(2006-10#1)(2007-2#1)(2007-8#1)(2008-10#1)(2009-4#1)(2011-2#1)(2012-12#2)(2013-7#2)(2013-8#1)
to identify potential targets##3##4##(2007-6#1)(2011-1#1)(2012-12#1)
to identify potential##24##3##(1990-8#1)(1992-11#1)(1993-2#1)(1995-3#1)(2005-9#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#1)
to identify potentially##2##3##(1991-12#1)(2010-12#1)
to identify predictors of##9##4##(2007-10#2)(2007-7#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2012-3#1)(2013-1#1)
to identify primary##2##3##(1993-1#1)(2010-11#1)
to identify problems and to##2##5##(2006-2#1)(2009-5#1)
to identify problems and##3##4##(2006-2#1)(2008-2#1)(2009-5#1)
to identify problems##4##3##(1993-2#1)(2006-2#1)(2008-2#1)(2009-5#1)
to identify prognostic##2##3##(2008-6#2)
to identify promising mutants for further##2##6##(2013-8#2)
to identify promising##4##3##(2008-5#1)(2013-8#3)
to identify protein##3##3##(1997-8#1)(2008-4#1)(2010-11#1)
to identify proteins##4##3##(1992-8#1)(2006-10#1)(2008-9#2)
to identify published reports##2##4##(2012-12#1)(2013-1#1)
to identify quantitative trait loci (QTL) associated with##2##8##(2008-10#2)
to identify quantitative trait loci (QTL)##4##6##(2008-10#4)
to identify quantitative trait loci##6##5##(2008-10#4)(2012-3#2)
to identify quantitative##7##3##(2005-5#1)(2008-10#4)(2012-3#2)
to identify rare variants##2##4##(2012-3#2)
to identify regions of##2##4##(1997-5#1)(2012-3#1)
to identify regions##3##3##(1997-5#1)(2007-12#1)(2012-3#1)
to identify relevant studies##2##4##(2011-1#1)(2013-1#1)
to identify relevant##8##3##(1993-12#1)(2006-2#1)(2007-11#1)(2010-12#1)(2011-1#1)(2011-8#1)(2013-1#1)(2013-7#1)
to identify research gaps##2##4##(2009-3#2)
to identify resistance##3##3##(2008-10#3)
to identify risk factors associated with##3##6##(2010-10#1)(2013-1#2)
to identify risk factors for##5##5##(2008-1#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
to identify risk factors##13##4##(1996-12#1)(1996-7#1)(2004-10#1)(2008-1#1)(2008-7#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#4)
to identify risk of malnutrition##2##5##(2010-9#1)(2012-12#1)
to identify risk##16##3##(1996-12#1)(1996-7#1)(2004-10#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-10#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-12#2)(2013-1#4)
to identify sequences##2##3##(1992-6#1)(2008-4#1)
to identify several##2##3##(2007-2#1)(2012-3#1)
to identify significant##6##3##(2007-1#1)(2008-8#1)(2010-2#2)(2010-4#1)(2012-3#1)
to identify similar##3##3##(2008-4#1)(2008-7#1)(2012-2#1)
to identify small molecules##2##4##(2007-8#2)
to identify small##3##3##(2007-8#2)(2009-2#1)
to identify solutions to clinical practice problems##3##7##(2010-11#3)
to identify some of the##4##5##(1990-12#1)(1992-9#1)(1997-7#1)(2007-5#1)
to identify some##7##3##(1990-12#1)(1992-9#1)(1997-7#1)(2007-5#1)(2007-7#1)(2008-10#2)
to identify specific##18##3##(1990-2#1)(1995-10#1)(1996-12#1)(1997-8#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#3)(2008-7#1)(2010-11#1)(2012-12#1)(2012-2#2)(2013-1#1)
to identify strategies##3##3##(1993-2#1)(2008-11#1)(2008-4#1)
to identify students with##2##4##(2008-12#1)(2013-7#1)
to identify students##3##3##(2006-12#1)(2008-12#1)(2013-7#1)
to identify studies##5##3##(2012-12#3)(2013-1#2)
to identify subjects with##2##4##(2010-6#1)(2011-2#1)
to identify subjects##5##3##(2007-10#1)(2010-6#1)(2011-2#1)(2013-1#2)
to identify successful##2##3##(2005-9#1)(2008-11#1)
to identify such##3##3##(2005-9#1)(2008-7#1)(2010-10#1)
to identify suitable articles##2##4##(2012-2#1)(2013-1#1)
to identify suitable husbandry conditions for maintaining multi-generation populations##2##9##(2008-11#2)
to identify suitable##4##3##(2008-11#2)(2012-2#1)(2013-1#1)
to identify targets##3##3##(2006-10#1)(2008-11#1)(2008-2#1)
to identify the active##2##4##(1992-5#1)(2008-1#1)
to identify the actual##2##4##(2011-2#1)(2013-8#1)
to identify the appropriate##3##4##(2008-2#1)(2013-1#2)
to identify the attitudes of##2##5##(2008-8#1)(2010-10#1)
to identify the best##5##4##(1993-12#1)(1995-2#1)(2007-11#1)(2008-1#1)(2008-4#1)
to identify the cases##2##4##(1992-10#1)(2008-6#1)
to identify the cause of##2##5##(2008-11#1)(2010-4#1)
to identify the causes of##3##5##(2005-7#1)(2008-6#1)(2011-2#1)
to identify the causes##4##4##(2005-7#1)(2008-11#1)(2008-6#1)(2011-2#1)
to identify the cellular##2##4##(2006-10#1)(2008-7#1)
to identify the challenges##3##4##(2012-11#2)(2013-1#1)
to identify the correct##2##4##(2007-2#1)(2007-5#1)
to identify the difficulties##2##4##(2011-2#2)
to identify the disease##2##4##(2006-4#1)(2008-2#1)
to identify the effectiveness of##2##5##(2007-3#1)(2010-1#1)
to identify the extent of##2##5##(1997-2#1)(2007-2#1)
to identify the extent##3##4##(1997-2#1)(2007-2#1)(2008-10#1)
to identify the factors associated with##4##6##(2011-2#1)(2012-2#1)(2013-1#2)
to identify the factors influencing the##2##6##(1990-8#1)(2010-12#1)
to identify the factors that are##2##6##(2007-6#1)(2008-1#1)
to identify the factors that##4##5##(1990-10#1)(2007-1#1)(2007-6#1)(2008-1#1)
to identify the factors##13##4##(1990-10#1)(1990-8#1)(2007-1#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
to identify the functional##2##4##(2008-7#1)(2009-5#1)
to identify the gene##5##4##(1995-6#1)(1997-4#1)(2008-5#1)(2008-9#1)(2011-3#1)
to identify the genes##3##4##(1990-9#1)(2008-11#1)(2012-2#1)
to identify the genetic basis##2##5##(2012-11#1)(2012-3#1)
to identify the genetic##4##4##(2006-2#1)(2010-10#1)(2012-11#1)(2012-3#1)
to identify the global##2##4##(2008-4#2)
to identify the health##2##4##(2005-12#1)(2008-1#1)
to identify the important##2##4##(2006-8#1)(2008-11#1)
to identify the key##5##4##(2007-12#1)(2008-3#1)(2008-6#1)(2013-8#2)
to identify the likely##2##4##(2008-9#1)(2013-7#1)
to identify the location of##4##5##(1996-11#1)(2008-1#1)(2008-2#1)(2012-2#1)
to identify the main##6##4##(2008-10#3)(2009-10#1)(2010-10#1)(2012-3#1)
to identify the major##3##4##(1990-6#1)(1996-1#1)(2008-10#1)
to identify the mechanisms##2##4##(2008-1#1)(2009-9#1)
to identify the metabolites##2##4##(1990-11#1)(2008-10#1)
to identify the molecular##2##4##(1993-6#1)(2009-12#1)
to identify the most appropriate##5##5##(1996-1#1)(2006-10#1)(2006-11#1)(2007-11#1)(2011-2#1)
to identify the most##10##4##(1995-12#1)(1996-1#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-11#2)(2007-3#1)(2008-10#1)(2011-2#1)
to identify the nursing##2##4##(2007-2#1)(2012-3#1)
to identify the optimal##5##4##(2008-10#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-1#1)
to identify the physiological##2##4##(2007-8#1)(2013-1#1)
to identify the possibility of##2##5##(2004-9#1)(2010-8#1)
to identify the possible##2##4##(1996-2#1)(2013-8#1)
to identify the potential##4##4##(2007-4#1)(2008-10#1)(2009-10#1)(2012-11#1)
to identify the precise##2##4##(1993-12#1)(2012-12#1)
to identify the prevalence of##2##5##(2011-2#1)(2012-2#1)
to identify the prevalence##3##4##(2011-2#2)(2012-2#1)
to identify the primary##2##4##(1994-2#1)(2008-10#1)
to identify the relationship between##2##5##(2010-12#1)(2012-3#1)
to identify the relative##4##4##(1993-12#1)(2007-1#1)(2007-11#1)(2008-10#1)
to identify the risk##3##4##(2008-4#1)(2008-7#1)(2013-7#1)
to identify the role of##4##5##(1992-9#1)(1997-8#1)(2007-11#1)(2013-1#1)
to identify the species of##3##5##(2007-12#1)(2007-8#1)(2008-10#1)
to identify the specific##3##4##(1994-8#1)(1997-4#1)(2008-11#1)
to identify the structural requirements##2##5##(1994-5#1)(2006-12#1)
to identify the types of##2##5##(1991-12#1)(2011-2#1)
to identify the##379##3##(1990-10#1)(1990-11#5)(1990-12#1)(1990-2#2)(1990-4#2)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#4)(1991-7#2)(1992-1#1)(1992-10#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1997-2#2)(1997-4#2)(1997-8#1)(2004-9#1)(2005-10#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#6)(2006-11#3)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#8)(2007-12#6)(2007-2#5)(2007-3#5)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#9)(2008-10#30)(2008-11#9)(2008-12#5)(2008-2#5)(2008-3#3)(2008-4#9)(2008-5#9)(2008-6#6)(2008-7#3)(2008-8#4)(2008-9#6)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#4)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#2)(2010-1#2)(2010-10#6)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#6)(2011-2#19)(2011-3#2)(2012-1#3)(2012-11#4)(2012-12#2)(2012-2#12)(2012-3#8)(2013-1#16)(2013-7#5)(2013-8#9)
to identify their##6##3##(1995-3#1)(2007-8#1)(2008-11#1)(2010-2#1)(2011-1#1)(2012-1#1)
to identify these##11##3##(1991-10#1)(1992-12#1)(1992-7#1)(1996-6#1)(2007-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2011-1#1)
to identify this##2##3##(1996-11#1)(2010-11#1)
to identify those patients who are##2##6##(2006-9#1)(2010-12#1)
to identify those patients who##4##5##(2006-9#1)(2008-1#1)(2010-12#1)(2012-1#1)
to identify those patients##5##4##(2006-9#1)(2008-1#1)(2010-12#1)(2012-1#2)
to identify those that##2##4##(2007-8#1)(2008-9#1)
to identify those with##2##4##(2010-8#1)(2012-2#1)
to identify those##22##3##(1990-7#1)(1991-4#1)(1993-3#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2013-8#1)
to identify two##4##3##(2008-10#3)(2008-9#1)
to identify unique##2##3##(2009-8#1)(2013-8#1)
to identify unknown##3##3##(1991-12#1)(2008-10#1)(2009-9#1)
to identify variables##4##3##(2007-10#1)(2007-12#1)(2008-8#1)(2012-2#1)
to identify variation##2##3##(1994-12#1)(2008-10#1)
to identify various##2##3##(2009-1#1)(2012-12#1)
to identify wellbeing with##2##4##(2008-10#2)
to identify what##4##3##(2006-10#1)(2008-12#1)(2010-11#1)(2011-2#1)
to identify where##2##3##(2005-12#1)(2008-10#1)
to identify whether##5##3##(1995-11#1)(2008-10#1)(2011-2#3)
to identify which of##3##4##(1994-9#1)(2008-4#1)(2008-9#1)
to identify which patients##2##4##(2007-5#1)(2010-12#1)
to identify which##14##3##(1994-9#1)(1995-5#1)(1995-6#1)(1996-3#1)(2006-10#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-12#1)
to identify who##2##3##(2007-3#1)(2009-10#1)
to identify##1699##2##(1990-10#3)(1990-11#8)(1990-12#5)(1990-2#5)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#4)(1990-8#3)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#11)(1991-2#7)(1991-3#2)(1991-4#3)(1991-5#7)(1991-6#2)(1991-7#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#3)(1992-2#7)(1992-3#4)(1992-5#3)(1992-6#3)(1992-7#4)(1992-8#2)(1992-9#3)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#7)(1993-2#6)(1993-3#7)(1993-4#1)(1993-5#1)(1993-6#7)(1993-8#2)(1993-9#2)(1994-1#2)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#8)(1994-3#4)(1994-5#3)(1994-6#4)(1994-8#6)(1994-9#11)(1995-1#13)(1995-10#3)(1995-11#5)(1995-12#8)(1995-2#8)(1995-3#7)(1995-5#5)(1995-6#3)(1995-8#2)(1996-1#6)(1996-11#3)(1996-12#11)(1996-2#5)(1996-3#7)(1996-4#1)(1996-5#7)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#7)(1997-2#7)(1997-3#3)(1997-4#7)(1997-5#3)(1997-7#4)(1997-8#5)(2004-1#1)(2004-10#1)(2004-11#1)(2004-2#1)(2004-3#1)(2004-4#1)(2004-9#1)(2005-10#5)(2005-11#6)(2005-12#4)(2005-2#1)(2005-5#2)(2005-7#1)(2005-8#5)(2005-9#4)(2006-1#1)(2006-10#31)(2006-11#5)(2006-12#10)(2006-2#11)(2006-3#2)(2006-4#3)(2006-5#3)(2006-6#2)(2006-7#6)(2006-8#9)(2006-9#3)(2007-1#3)(2007-10#15)(2007-11#19)(2007-12#25)(2007-2#13)(2007-3#8)(2007-4#7)(2007-5#5)(2007-6#7)(2007-7#15)(2007-8#21)(2007-9#8)(2008-1#24)(2008-10#124)(2008-11#49)(2008-12#27)(2008-2#24)(2008-3#21)(2008-4#57)(2008-5#28)(2008-6#19)(2008-7#47)(2008-8#26)(2008-9#37)(2009-1#2)(2009-10#12)(2009-11#5)(2009-12#12)(2009-2#5)(2009-3#10)(2009-4#9)(2009-5#7)(2009-6#9)(2009-7#5)(2009-8#9)(2009-9#4)(2010-1#2)(2010-10#10)(2010-11#18)(2010-12#19)(2010-2#9)(2010-3#9)(2010-4#9)(2010-5#6)(2010-6#6)(2010-7#4)(2010-8#6)(2010-9#7)(2011-1#32)(2011-12#2)(2011-2#65)(2011-3#4)(2011-8#1)(2012-1#14)(2012-11#7)(2012-12#39)(2012-2#42)(2012-3#58)(2012-7#1)(2012-8#1)(2013-1#100)(2013-7#15)(2013-8#44)
to identifying an##2##3##(2008-9#1)(2011-1#1)
to identifying and##2##3##(1990-5#1)(2011-2#1)
to identifying patients##2##3##(1997-8#1)(2006-2#1)
to identifying the##3##3##(1994-11#1)(2006-10#1)(2008-5#1)
to identifying##21##2##(1990-5#1)(1994-11#1)(1994-3#1)(1995-2#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-3#1)
to identity##5##2##(2007-3#1)(2010-1#1)(2010-10#1)(2010-2#1)(2013-8#1)
to idiopathic##2##2##(2006-12#1)(2009-10#1)
to idiosyncratic##2##2##(1994-11#1)(2008-10#1)
to ignore the##4##3##(1990-6#1)(2008-10#1)(2008-3#1)(2008-7#1)
to ignore##9##2##(1990-6#1)(1995-5#1)(2007-1#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-7#1)(2011-1#1)
to ill##2##2##(2010-7#1)(2012-2#1)
to illicit drug use##3##4##(2009-7#2)(2010-4#1)
to illicit##6##2##(1996-10#1)(2008-10#1)(2008-5#1)(2009-7#2)(2010-4#1)
to illness and##2##3##(1992-12#1)(2008-1#1)
to illness##8##2##(1992-12#1)(1993-1#1)(1994-4#1)(1995-2#1)(2008-1#1)(2009-5#1)(2012-1#1)(2012-12#1)
to illuminate and##2##3##(2008-3#2)
to illuminate the##4##3##(1997-3#1)(2008-11#1)(2008-9#1)(2012-12#1)
to illuminate##14##2##(1997-3#1)(2005-7#1)(2007-11#1)(2007-9#1)(2008-11#2)(2008-2#2)(2008-3#3)(2008-9#1)(2009-7#1)(2012-12#1)
to illumination from below##2##4##(1991-2#2)
to illumination##6##2##(1991-2#2)(1993-3#1)(1995-8#2)(2008-3#1)
to illusory contours##2##3##(2008-8#2)
to illusory##3##2##(2007-12#1)(2008-8#2)
to illustrate an##2##3##(1994-7#1)(2008-4#1)
to illustrate and##6##3##(1992-1#1)(1996-3#1)(2008-2#1)(2008-7#1)(2009-9#1)(2010-9#1)
to illustrate how it##2##4##(1994-3#1)(2008-2#1)
to illustrate how the##3##4##(2007-12#1)(2008-11#1)(2008-8#1)
to illustrate how this##2##4##(2007-12#1)(2010-6#1)
to illustrate how##15##3##(1994-3#1)(1995-2#1)(1995-3#1)(1997-4#1)(1997-8#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-6#1)
to illustrate its##3##3##(2006-10#1)(2010-3#1)(2012-3#1)
to illustrate our##2##3##(2008-2#1)(2009-5#1)
to illustrate some of the##2##5##(2006-10#1)(2008-4#1)
to illustrate some of##3##4##(2006-10#1)(2008-4#1)(2012-2#1)
to illustrate that the##2##4##(2008-2#1)(2009-2#1)
to illustrate that##5##3##(2005-8#1)(2008-2#1)(2009-2#1)(2013-1#2)
to illustrate the author's##2##4##(2011-2#1)(2013-7#1)
to illustrate the effects##2##4##(2008-12#1)(2009-4#1)
to illustrate the performance of the algorithm##2##7##(2008-2#1)(2008-3#1)
to illustrate the performance of the##3##6##(2008-2#1)(2008-3#2)
to illustrate the performance of##4##5##(2008-2#1)(2008-3#3)
to illustrate the performances of##2##5##(1993-1#1)(2009-12#1)
to illustrate the potential##2##4##(1990-8#1)(2008-11#1)
to illustrate the proposed##3##4##(1996-12#1)(2008-3#1)(2010-2#1)
to illustrate the usefulness of##2##5##(2010-2#1)(2012-2#1)
to illustrate the usefulness##3##4##(2008-10#1)(2010-2#1)(2012-2#1)
to illustrate the##87##3##(1990-8#1)(1991-1#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-4#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-9#1)(1997-7#1)(1997-8#1)(2005-2#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#8)(2008-4#3)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#1)(2010-2#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#7)(2013-1#4)(2013-7#1)(2013-8#1)
to illustrate their##3##3##(2007-4#1)(2010-1#1)(2010-4#1)
to illustrate these##2##3##(2007-12#1)(2012-1#1)
to illustrate this##4##3##(2006-10#1)(2008-10#1)(2008-3#1)(2011-1#1)
to illustrate what##2##3##(2008-2#1)(2012-2#1)
to illustrate##164##2##(1990-8#1)(1991-1#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-4#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#4)(1996-3#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#4)(2005-2#1)(2005-8#1)(2006-10#5)(2006-2#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-4#2)(2007-7#1)(2008-1#1)(2008-10#12)(2008-11#6)(2008-12#1)(2008-2#10)(2008-3#9)(2008-4#6)(2008-6#2)(2008-7#9)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#2)(2009-2#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-1#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#3)(2012-1#2)(2012-2#11)(2012-3#2)(2013-1#10)(2013-7#2)(2013-8#2)
to image a##4##3##(1990-11#1)(2008-2#1)(2008-3#1)(2011-1#1)
to image an##3##3##(2007-12#1)(2007-9#1)(2008-3#1)
to image analysis##2##3##(2007-9#1)(2008-5#1)
to image and##2##3##(2006-12#1)(2010-7#1)
to image blood flow##2##4##(2007-12#1)(2011-1#1)
to image noise##2##3##(2008-2#2)
to image processing##2##3##(2008-2#1)(2008-3#1)
to image the spatial distribution of##2##6##(2007-12#1)(2008-2#1)
to image the##13##3##(2007-11#3)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#1)(2010-12#1)(2011-1#1)(2011-7#1)
to image these##2##3##(1996-5#1)(2008-2#1)
to image through##2##3##(1997-4#1)(2008-3#1)
to image##74##2##(1990-11#1)(1995-12#1)(1996-5#1)(1997-4#1)(2006-12#1)(2007-11#4)(2007-12#8)(2007-9#2)(2008-1#1)(2008-10#2)(2008-2#26)(2008-3#13)(2008-5#1)(2009-12#1)(2010-1#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#5)(2011-7#1)(2012-2#1)
to images of##3##3##(1995-8#1)(1997-8#1)(2007-12#1)
to images##6##2##(1995-8#1)(1997-8#1)(2007-11#1)(2007-12#2)(2012-2#1)
to imaging of##3##3##(1997-8#1)(2007-11#1)(2010-8#1)
to imaging##15##2##(1991-1#1)(1997-4#1)(1997-8#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#1)(2009-5#1)(2010-8#1)(2012-2#1)
to imatinib##11##2##(2007-12#2)(2008-6#3)(2009-3#3)(2012-12#3)
to imipenem##6##2##(2005-8#1)(2006-8#1)(2007-7#1)(2008-12#1)(2012-12#1)(2012-2#1)
to imitate##4##2##(2005-10#1)(2008-2#1)(2008-6#1)(2010-6#1)
to immature##3##2##(1990-5#1)(1991-3#1)(2007-11#1)
to immediate##10##2##(1990-9#1)(1996-11#1)(2008-11#2)(2008-4#1)(2008-5#1)(2009-10#1)(2012-2#1)(2013-1#2)
to immediately post-UVD##2##3##(1996-9#2)
to immediately##8##2##(1990-11#1)(1996-9#2)(2006-10#1)(2008-4#1)(2009-8#1)(2010-6#1)(2011-2#1)
to immobilised##4##2##(1990-12#1)(1994-12#1)(2013-7#2)
to immobility##3##2##(2008-11#2)(2013-1#1)
to immobilization of##2##3##(2006-8#1)(2008-4#1)
to immobilization stress##2##3##(1995-12#1)(2012-1#1)
to immobilization##4##2##(1995-12#1)(2006-8#1)(2008-4#1)(2012-1#1)
to immobilize DNA##2##3##(2008-10#2)
to immobilize a##4##3##(1991-5#2)(1995-3#1)(2008-10#1)
to immobilize##17##2##(1991-5#2)(1995-3#1)(2006-12#1)(2007-8#2)(2008-10#5)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-4#1)
to immobilized factor##2##3##(1993-11#1)(1994-3#1)
to immobilized protein##2##3##(1994-3#1)(2008-2#1)
to immobilized##28##2##(1990-4#1)(1991-12#1)(1992-11#1)(1992-12#3)(1992-4#1)(1992-7#1)(1993-11#1)(1993-7#1)(1994-2#1)(1994-3#2)(1995-1#2)(1995-3#1)(1996-3#1)(1997-2#1)(1997-4#1)(2008-10#4)(2008-2#1)(2008-4#3)(2008-7#1)
to immortalize primary##2##3##(2008-11#1)(2008-2#1)
to immortalize##4##2##(2008-11#3)(2008-2#1)
to immune cells##2##3##(2008-9#1)(2012-2#1)
to immune complexes##3##3##(1995-8#1)(2005-12#2)
to immune responses##2##3##(1995-12#1)(2008-5#1)
to immune##18##2##(1990-12#1)(1993-8#1)(1995-12#1)(1995-8#1)(2005-12#2)(2007-11#2)(2007-3#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-8#1)(2009-9#1)(2012-2#2)(2012-3#1)
to immunise##2##2##(2007-11#2)
to immunity##4##2##(1997-3#1)(2006-10#2)(2008-10#1)
to immunization##8##2##(1991-11#1)(1991-5#1)(1996-10#1)(2006-10#1)(2008-4#1)(2010-9#1)(2013-7#2)
to immunize##6##2##(1993-8#1)(1994-3#1)(2008-3#1)(2008-4#1)(2011-1#1)(2011-2#1)
to immunoassays##2##2##(2008-10#2)
to immunoblotting##2##2##(1993-2#1)(1993-6#1)
to immunogenetic##2##2##(2006-2#1)(2013-1#1)
to immunoglobulin##2##2##(1990-11#2)
to immunohistochemistry##2##2##(1991-6#1)(2007-8#1)
to immunological##6##2##(1991-5#1)(1996-12#1)(2008-10#1)(2008-4#3)
to immunologists##2##2##(2007-11#1)(2008-4#1)
to immunomodulatory##2##2##(1995-2#1)(2013-8#1)
to immunoprecipitate##5##2##(1990-11#2)(1992-12#1)(1992-2#1)(1992-9#1)
to immunoreact with##2##3##(1997-1#1)(2008-9#1)
to immunoreactive##2##2##(1992-6#1)(1995-8#1)
to immunostimulatory##2##2##(1993-7#1)(1995-12#1)
to immunosuppression##4##2##(2007-11#1)(2008-10#1)(2008-5#1)(2010-5#1)
to immunosuppressive therapy##3##3##(2006-10#1)(2007-7#1)(2007-8#1)
to immunosuppressive##7##2##(1992-3#1)(1995-5#1)(2006-10#3)(2007-7#1)(2007-8#1)
to immunotherapy of##2##3##(1994-5#1)(2007-11#1)
to immunotherapy##4##2##(1994-5#1)(2007-11#1)(2010-12#1)(2013-1#1)
to impact on##5##3##(1996-8#1)(2006-10#2)(2008-3#1)(2012-3#1)
to impact the##6##3##(2006-1#1)(2006-11#1)(2006-8#1)(2008-3#1)(2010-6#1)(2010-9#1)
to impact##28##2##(1996-8#2)(1997-1#1)(2005-10#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-4#3)(2008-10#1)(2008-3#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-3#2)(2013-7#1)
to impacts##3##2##(1992-1#1)(1997-5#1)(2006-11#1)
to impair the##4##3##(1990-6#1)(1992-10#1)(1994-8#1)(2008-4#1)
to impair##19##2##(1990-6#1)(1992-10#2)(1993-9#1)(1994-3#1)(1994-8#1)(1996-5#2)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-10#1)(2012-12#1)(2012-3#1)
to impaired##23##2##(1992-2#1)(1995-8#1)(1997-8#1)(2004-11#1)(2006-9#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2009-3#1)(2009-5#1)(2009-8#1)(2010-5#1)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
to impairment of##5##3##(1996-12#1)(2005-10#1)(2008-7#1)(2012-1#1)(2012-12#1)
to impairment##6##2##(1993-11#1)(1996-12#1)(2005-10#1)(2008-7#1)(2012-1#1)(2012-12#1)
to impairments in##2##3##(2008-11#1)(2008-7#1)
to impart##4##2##(2005-7#1)(2009-12#1)(2010-12#1)(2010-4#1)
to impede the##3##3##(1995-3#1)(2008-4#2)
to impede##7##2##(1995-3#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#2)
to impersonal##2##2##(2008-11#1)(2009-4#1)
to implant an##2##3##(1997-1#1)(2008-9#1)
to implant and##2##3##(2007-8#1)(2012-3#1)
to implant in##3##3##(2007-7#1)(2008-9#1)(2012-3#1)
to implant loosening##2##3##(2008-11#2)
to implant the catheter into the##2##6##(2007-7#2)
to implant the##3##3##(2006-10#1)(2007-7#2)
to implant##23##2##(1992-12#1)(1992-5#1)(1994-9#1)(1997-1#1)(2004-9#2)(2006-10#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-11#3)(2008-9#4)(2010-6#1)(2012-12#1)(2012-3#2)
to implantable##2##2##(2008-11#1)(2010-5#1)
to implantation##7##2##(1991-12#1)(1995-7#1)(2005-10#2)(2008-9#2)(2012-1#1)
to implanted##2##2##(2010-9#1)(2011-1#1)
to implement CQI##2##3##(1993-12#1)(1994-12#1)
to implement a new##3##4##(1994-9#1)(2007-11#1)(2012-2#1)
to implement a##22##3##(1993-12#1)(1994-12#1)(1994-9#1)(1995-12#1)(1997-1#2)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-6#2)(2010-4#1)(2012-1#1)(2012-2#1)(2013-1#2)
to implement an##9##3##(2007-11#2)(2007-3#1)(2008-10#1)(2008-3#3)(2010-4#1)(2011-1#1)
to implement and##7##3##(1995-2#1)(2007-7#1)(2008-2#2)(2008-6#1)(2008-8#1)(2013-1#1)
to implement as##2##3##(2008-2#1)(2011-12#1)
to implement continuous quality improvement##2##5##(1994-3#2)
to implement in##4##3##(2008-2#1)(2011-12#1)(2013-1#2)
to implement more##2##3##(2008-10#1)(2008-3#1)
to implement policy##2##3##(1992-1#1)(2010-11#1)
to implement some##2##3##(2008-10#1)(2008-4#1)
to implement strategies##2##3##(2008-11#1)(2012-3#1)
to implement such a##3##4##(1994-9#1)(2005-11#1)(2012-12#1)
to implement such##8##3##(1991-12#1)(1991-2#1)(1994-9#1)(2005-11#1)(2008-3#1)(2012-12#3)
to implement the method##2##4##(1993-6#1)(2010-2#1)
to implement the multicommutation approach##2##5##(2008-10#2)
to implement the new##2##4##(2007-4#1)(2008-11#1)
to implement the##36##3##(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-2#1)(1997-3#1)(1997-7#1)(2005-5#1)(2006-12#2)(2006-2#1)(2007-1#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#2)(2008-2#5)(2008-3#3)(2008-4#2)(2008-7#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-9#1)(2011-1#2)
to implement these##7##3##(1996-1#1)(2007-1#1)(2008-11#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
to implement this##2##3##(2008-10#1)(2010-11#1)
to implement total quality management (TQM)##2##6##(1993-12#1)(1994-1#1)
to implement##218##2##(1990-5#1)(1991-12#1)(1991-2#1)(1992-1#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-7#1)(1994-9#2)(1995-12#1)(1995-2#2)(1995-3#1)(1996-1#2)(1997-1#3)(1997-3#1)(1997-7#3)(2004-12#1)(2005-10#3)(2005-11#1)(2005-12#1)(2005-5#2)(2006-12#2)(2006-2#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#8)(2007-12#7)(2007-2#2)(2007-3#1)(2007-4#3)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#14)(2008-11#10)(2008-2#22)(2008-3#17)(2008-4#6)(2008-5#1)(2008-6#4)(2008-7#2)(2008-8#2)(2009-10#2)(2009-6#1)(2010-11#3)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#3)(2011-1#5)(2011-12#3)(2011-2#2)(2012-1#4)(2012-11#3)(2012-12#4)(2012-2#6)(2012-3#6)(2013-1#11)(2013-8#2)
to implementation of the##2##4##(1994-3#1)(1996-2#1)
to implementation of##7##3##(1993-3#1)(1994-3#1)(1995-3#1)(1996-2#1)(2008-2#1)(2013-1#2)
to implementation##20##2##(1993-3#3)(1994-3#1)(1995-3#1)(1996-1#1)(1996-2#1)(2005-10#1)(2006-2#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-6#1)(2010-12#1)(2011-12#1)(2013-1#4)
to implementing the##2##3##(2007-1#1)(2007-10#1)
to implementing##16##2##(1990-12#1)(1994-1#2)(1995-11#1)(1995-12#1)(1995-3#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-11#1)(2008-12#1)(2011-12#2)(2013-1#2)
to implicate##2##2##(1995-7#1)(1995-8#1)
to imply that##3##3##(2006-10#1)(2007-12#1)(2008-10#1)
to imply##5##2##(1997-5#1)(2006-10#1)(2007-12#1)(2008-10#1)(2012-1#1)
to import##2##2##(2008-10#1)(2008-4#1)
to important clinical##2##3##(1996-2#1)(2007-8#1)
to important risk##2##3##(2011-2#2)
to important##24##2##(1994-11#1)(1994-5#1)(1996-2#1)(1997-2#1)(2005-7#1)(2006-10#1)(2006-3#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-2#1)(2008-3#1)(2009-1#1)(2009-10#2)(2009-12#1)(2009-5#1)(2009-9#1)(2011-1#1)(2011-2#2)(2013-1#1)
to impose##5##2##(1995-9#1)(1996-8#1)(1997-5#1)(2007-1#1)(2012-1#1)
to impression##3##2##(2007-12#1)(2008-6#2)
to improve access to##4##4##(2008-7#1)(2010-12#2)(2010-8#1)
to improve access##5##3##(1994-3#1)(2008-7#1)(2010-12#2)(2010-8#1)
to improve accuracy of##5##4##(2010-7#1)(2013-1#4)
to improve accuracy##11##3##(2009-5#1)(2010-12#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#6)
to improve acute##2##3##(2008-8#1)(2010-5#1)
to improve adherence to##3##4##(2008-3#1)(2008-4#1)(2013-1#1)
to improve adherence##9##3##(2008-3#1)(2008-4#1)(2011-1#3)(2012-1#1)(2013-1#3)
to improve aerobic fitness##2##4##(2012-2#1)(2013-7#1)
to improve air quality##2##4##(1996-8#1)(2010-5#1)
to improve and develop##2##4##(2009-8#2)
to improve and maintain the##2##5##(1997-3#1)(2005-3#1)
to improve and##10##3##(1997-2#1)(1997-3#2)(2005-3#1)(2005-7#1)(2007-11#1)(2008-2#1)(2009-8#2)(2012-3#1)
to improve antibiotic##2##3##(1993-11#1)(2010-4#1)
to improve as##2##3##(1994-9#1)(2013-1#1)
to improve blood pressure control##2##5##(2008-8#1)(2013-1#1)
to improve body esteem and global self-esteem and##2##8##(2006-6#2)
to improve body##3##3##(2006-6#2)(2006-7#1)
to improve both##3##3##(1997-6#1)(2009-10#1)(2013-1#1)
to improve care and##3##4##(1997-3#1)(2007-8#1)(2012-12#1)
to improve care for##4##4##(2008-3#1)(2010-8#1)(2011-1#1)(2013-1#1)
to improve care##19##3##(1994-2#1)(1996-1#1)(1997-3#1)(2006-1#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-10#1)(2010-8#2)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
to improve cell##2##3##(2008-11#1)(2008-5#1)
to improve children's##2##3##(2006-10#1)(2012-2#1)
to improve clinical outcomes##2##4##(2008-11#1)(2012-3#1)
to improve clinical##8##3##(1996-12#1)(2006-10#1)(2008-11#1)(2008-3#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
to improve cognition##2##3##(2009-8#2)
to improve communication and##2##4##(2011-1#2)
to improve communication with##2##4##(1994-11#1)(2012-2#1)
to improve communication##6##3##(1994-11#1)(1996-11#1)(2010-4#1)(2011-1#2)(2012-2#1)
to improve community##3##3##(1996-1#1)(2006-10#1)(2007-9#1)
to improve compliance##4##3##(2006-1#1)(2006-5#1)(2007-2#1)(2007-4#1)
to improve conditions##2##3##(2008-1#1)(2008-12#1)
to improve consumer##2##3##(1995-2#1)(2013-1#1)
to improve control##2##3##(1993-9#1)(2010-1#1)
to improve crop##3##3##(2010-10#1)(2011-12#1)(2012-2#1)
to improve decision-making##3##3##(1992-2#1)(2008-8#1)(2013-7#1)
to improve delivery##2##3##(1996-1#1)(2006-8#1)
to improve detection##3##3##(2007-8#1)(2008-10#1)(2008-7#1)
to improve diagnosis##2##3##(2007-1#1)(2011-2#1)
to improve diagnostic accuracy of##3##5##(2010-12#1)(2013-1#2)
to improve diagnostic accuracy##4##4##(1991-3#1)(2010-12#1)(2013-1#2)
to improve diagnostic##7##3##(1991-3#1)(2008-10#1)(2009-10#2)(2010-12#1)(2013-1#2)
to improve drug##2##3##(2005-8#1)(2007-11#1)
to improve during##2##3##(2007-9#1)(2013-1#1)
to improve dyspnea##2##3##(2013-8#2)
to improve efficiency##3##3##(1995-3#1)(2008-2#1)(2008-7#1)
to improve estimates of##3##4##(2007-5#1)(2008-10#1)(2008-11#1)
to improve food##3##3##(2006-4#1)(2008-1#1)(2012-2#1)
to improve functional recovery##2##4##(2008-8#2)
to improve functional##5##3##(2008-5#1)(2008-6#1)(2008-8#2)(2013-1#1)
to improve functioning##3##3##(2007-11#1)(2012-1#1)(2012-2#1)
to improve future##3##3##(2011-1#1)(2013-1#2)
to improve gait##2##3##(2008-11#1)(2012-1#1)
to improve growth##2##3##(2008-10#1)(2009-5#1)
to improve health care delivery and##2##6##(2008-6#1)(2008-8#1)
to improve health care delivery##3##5##(2007-7#1)(2008-6#1)(2008-8#1)
to improve health care quality##2##5##(1996-3#1)(2007-4#1)
to improve health care##10##4##(1993-3#1)(1995-3#1)(1996-3#1)(2007-4#1)(2007-7#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-8#1)
to improve health outcomes##3##4##(1996-12#1)(2008-4#1)(2009-4#1)
to improve health##20##3##(1993-3#1)(1995-3#1)(1996-12#1)(1996-3#2)(1997-3#1)(2007-4#1)(2007-7#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#2)(2011-1#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#2)
to improve healthcare##2##3##(1997-3#1)(2013-1#1)
to improve her##2##3##(2006-10#1)(2007-9#1)
to improve his##2##3##(2006-2#1)(2007-2#1)
to improve homework##2##3##(2008-6#1)(2009-11#1)
to improve hospital##4##3##(1991-1#1)(1997-8#1)(2007-8#1)(2008-11#1)
to improve human health##2##4##(2007-11#1)(2012-2#1)
to improve hydrolysis##2##3##(2008-5#1)(2011-2#1)
to improve image##3##3##(2008-2#1)(2008-3#1)(2009-10#1)
to improve immunization##2##3##(1996-12#2)
to improve in##5##3##(1994-11#1)(2009-4#1)(2011-2#1)(2013-1#1)(2013-7#1)
to improve insulin resistance and##2##5##(2010-12#2)
to improve insulin sensitivity##3##4##(2008-11#1)(2008-3#2)
to improve insulin##6##3##(1990-1#1)(2008-11#1)(2008-3#2)(2010-12#2)
to improve it##4##3##(2006-12#1)(2007-12#1)(2007-3#1)(2008-2#1)
to improve its##8##3##(1992-3#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-7#1)
to improve knowledge of##2##4##(2010-4#1)(2010-7#1)
to improve knowledge##5##3##(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-8#1)
to improve living conditions##2##4##(2010-1#1)(2012-2#1)
to improve long-term##2##3##(2008-1#1)(2008-3#1)
to improve many##2##3##(2008-11#1)(2009-9#1)
to improve maternal##2##3##(2010-5#1)(2012-3#1)
to improve measurement##2##3##(2007-11#1)(2008-2#1)
to improve medical##3##3##(1994-3#1)(1996-3#1)(2006-6#1)
to improve mental##3##3##(2007-9#1)(2009-3#1)(2012-2#1)
to improve nursing##2##3##(1991-1#1)(1991-7#1)
to improve nutritional status##2##4##(2006-2#1)(2010-4#1)
to improve nutritional##4##3##(2006-2#1)(2010-4#1)(2012-1#1)(2012-2#1)
to improve on the##2##4##(2006-8#1)(2010-8#1)
to improve on##8##3##(1991-4#1)(2006-8#1)(2006-9#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-7#1)
to improve or##4##3##(2006-10#1)(2007-11#2)(2008-11#1)
to improve oral health##2##4##(1995-12#1)(2006-2#1)
to improve our knowledge of the efficacy and toxicity of cancer therapeutics in older adults##2##15##(2011-1#2)
to improve our knowledge##3##4##(2010-12#1)(2011-1#2)
to improve our understanding of the##5##6##(1990-8#1)(2008-10#1)(2008-11#1)(2012-1#2)
to improve our understanding of##11##5##(1990-8#1)(1993-12#1)(1996-4#1)(2008-10#1)(2008-11#1)(2012-1#2)(2012-12#2)(2013-1#2)
to improve our##17##3##(1990-8#1)(1992-2#1)(1993-12#1)(1996-10#1)(1996-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-12#1)(2011-1#2)(2012-1#2)(2012-12#2)(2013-1#2)
to improve outcome##5##3##(2006-10#1)(2006-2#1)(2009-4#1)(2012-12#2)
to improve outcomes and##2##4##(2007-8#1)(2007-9#1)
to improve outcomes for##2##4##(2007-10#1)(2013-1#1)
to improve outcomes in##3##4##(1997-1#1)(2008-6#1)(2010-2#1)
to improve outcomes##18##3##(1993-7#1)(1997-1#1)(2006-10#1)(2007-10#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-5#1)(2008-6#1)(2010-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
to improve overall##6##3##(2006-10#1)(2006-5#1)(2008-3#1)(2008-8#1)(2010-1#1)(2010-12#1)
to improve oxygenation and##2##4##(1994-6#1)(2006-10#1)
to improve oxygenation##3##3##(1994-6#1)(2006-10#1)(2007-9#1)
to improve pain management##2##4##(2007-12#1)(2007-8#1)
to improve pain##3##3##(2007-12#1)(2007-8#1)(2010-3#1)
to improve patient care##7##4##(1996-12#1)(2007-4#1)(2007-6#1)(2007-9#1)(2010-12#1)(2010-3#1)(2013-1#1)
to improve patient outcome##2##4##(2006-10#1)(2011-2#1)
to improve patient outcomes##5##4##(2008-9#1)(2010-2#2)(2011-1#1)(2011-2#1)
to improve patient safety by##3##5##(2007-4#1)(2013-1#2)
to improve patient safety##8##4##(2007-12#1)(2007-4#1)(2008-7#1)(2008-8#1)(2011-2#2)(2013-1#2)
to improve patient##32##3##(1994-2#1)(1996-12#1)(1996-3#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-4#2)(2007-6#1)(2007-9#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-2#1)(2013-1#3)
to improve patients'##5##3##(2007-7#1)(2009-1#1)(2009-7#1)(2011-2#1)(2013-8#1)
to improve performance and##3##4##(2006-10#1)(2013-1#2)
to improve performance of##2##4##(2008-2#1)(2013-8#1)
to improve performance##7##3##(1995-1#1)(2006-10#1)(2008-2#1)(2008-7#1)(2013-1#2)(2013-8#1)
to improve post-operative##2##3##(2007-8#1)(2008-11#1)
to improve postoperative##2##3##(2006-10#2)
to improve practice##4##3##(2007-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
to improve precision##4##3##(2008-10#1)(2008-9#1)(2013-1#2)
to improve predictive##2##3##(2006-9#1)(2011-2#1)
to improve processes##2##3##(1993-3#1)(1995-1#1)
to improve productivity##2##3##(2008-10#1)(2008-11#1)
to improve prostate cancer##2##4##(2007-12#1)(2009-5#1)
to improve public health##2##4##(1996-2#1)(2013-1#1)
to improve quality and##4##4##(1994-2#1)(1994-3#1)(2010-11#1)(2010-8#1)
to improve quality in##2##4##(1992-11#1)(1995-5#1)
to improve quality of care##3##5##(2006-8#1)(2008-3#2)
to improve quality of life##3##5##(2005-8#1)(2010-10#1)(2012-2#1)
to improve quality of##10##4##(1993-12#1)(2005-8#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-3#2)(2010-10#1)(2012-2#1)(2012-3#1)
to improve quality##23##3##(1992-11#1)(1993-12#1)(1994-2#2)(1994-3#1)(1995-3#1)(1995-5#1)(1996-2#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-3#2)(2010-10#1)(2010-11#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#3)
to improve rehabilitation##2##3##(1991-12#1)(2012-1#1)
to improve reliability##2##3##(2004-4#1)(2011-1#1)
to improve reporting##2##3##(2008-1#1)(2008-10#1)
to improve reproductive##3##3##(2008-7#1)(2012-3#1)(2013-7#1)
to improve research##2##3##(2007-12#1)(2010-5#1)
to improve resistance##2##3##(2008-10#1)(2012-5#1)
to improve respiratory##2##3##(2005-8#1)(2013-1#1)
to improve results##2##3##(2007-9#1)(2008-10#1)
to improve satisfaction with##2##4##(2008-11#1)(2008-9#1)
to improve screening##2##3##(1991-6#1)(2009-9#1)
to improve selectivity##2##3##(2008-10#1)(2008-11#1)
to improve sensitivity##3##3##(1996-12#1)(2008-10#2)
to improve service##2##3##(1993-12#1)(2012-3#1)
to improve services##2##3##(1991-3#1)(2008-6#1)
to improve stroke##2##3##(2007-9#1)(2010-12#1)
to improve survival and##2##4##(1994-6#1)(2011-3#1)
to improve survival in##3##4##(2006-10#1)(2008-5#1)(2010-5#1)
to improve survival##11##3##(1994-6#1)(2004-1#1)(2004-11#1)(2006-10#3)(2008-5#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-3#1)
to improve symptoms and##2##4##(2009-6#1)(2010-6#1)
to improve symptoms##4##3##(2005-10#1)(2005-6#1)(2009-6#1)(2010-6#1)
to improve the QOL##2##4##(1994-12#1)(2012-2#1)
to improve the accuracy of the##3##6##(2008-3#2)(2008-6#1)
to improve the accuracy of##11##5##(2005-11#1)(2008-10#2)(2008-2#3)(2008-3#4)(2008-6#1)
to improve the accuracy##14##4##(2005-11#1)(2008-10#3)(2008-2#4)(2008-3#5)(2008-6#1)
to improve the analysis of##2##5##(1994-9#1)(2008-10#1)
to improve the analytical##2##4##(2007-8#1)(2008-10#1)
to improve the assessment of##2##5##(2006-10#1)(2013-8#1)
to improve the axial##2##4##(2007-11#1)(2008-6#1)
to improve the biocompatibility##2##4##(2008-5#1)(2008-7#1)
to improve the care##3##4##(1994-2#1)(2006-12#1)(2006-9#1)
to improve the chance that##2##5##(1995-1#1)(2007-2#1)
to improve the chances of##3##5##(1993-11#1)(2006-11#1)(2008-2#1)
to improve the clarity of##2##5##(2008-2#1)(2009-3#1)
to improve the clinical##3##4##(2006-10#1)(2008-3#1)(2013-8#1)
to improve the delivery##2##4##(1996-2#1)(2008-12#1)
to improve the design##2##4##(1993-12#1)(2008-2#1)
to improve the detection limit##2##5##(2008-3#1)(2010-2#1)
to improve the detection of##3##5##(2005-8#1)(2008-10#1)(2012-3#1)
to improve the detection##8##4##(2005-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-2#1)(2012-3#1)(2013-8#1)
to improve the determination of##3##5##(1996-9#1)(2007-8#2)
to improve the diagnosis and##3##5##(2006-10#1)(2008-7#1)(2013-1#1)
to improve the diagnostic##2##4##(2006-10#1)(2009-8#1)
to improve the discrimination##2##4##(2007-12#1)(2012-3#1)
to improve the documentation of##2##5##(2007-7#1)(2010-5#1)
to improve the economics of##2##5##(2008-11#1)(2008-5#1)
to improve the effectiveness of##3##5##(1994-2#1)(1995-2#1)(2008-3#1)
to improve the efficacy of##3##5##(2008-1#1)(2010-3#1)(2012-3#1)
to improve the efficiency of gene##2##6##(1990-11#1)(2005-6#1)
to improve the efficiency of the##3##6##(1996-12#1)(2008-2#1)(2010-8#1)
to improve the efficiency of##9##5##(1990-11#1)(1996-12#1)(2005-6#1)(2007-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-8#1)(2011-2#1)
to improve the efficiency##11##4##(1990-11#1)(1995-3#1)(1996-12#1)(2004-4#1)(2005-6#1)(2007-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-8#1)(2011-2#1)
to improve the estimation of##2##5##(2008-7#1)(2011-2#1)
to improve the evaluation of##2##5##(2009-8#1)(2011-2#1)
to improve the extraction##2##4##(2008-10#2)
to improve the function##2##4##(2008-9#1)(2010-2#1)
to improve the health of children##2##6##(1995-1#1)(2009-8#1)
to improve the health of individuals and##2##7##(1993-3#1)(2012-12#1)
to improve the health of the##3##6##(1991-6#1)(2006-10#1)(2013-1#1)
to improve the health of##9##5##(1991-6#1)(1993-3#1)(1995-1#1)(2006-10#1)(2009-8#1)(2012-12#1)(2012-3#1)(2013-1#2)
to improve the health status of the##2##7##(1995-2#1)(2008-1#1)
to improve the health##13##4##(1991-6#1)(1993-3#1)(1995-1#1)(1995-2#1)(2006-10#1)(2008-1#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
to improve the identification##2##4##(2009-6#1)(2011-1#1)
to improve the long-term##3##4##(2006-7#1)(2008-11#1)(2011-2#1)
to improve the management of##2##5##(2006-1#1)(2008-1#1)
to improve the management##3##4##(2006-1#1)(2008-1#1)(2009-4#1)
to improve the medical##2##4##(1996-3#1)(2005-11#1)
to improve the method##2##4##(2008-10#1)(2008-11#1)
to improve the nutritional value of##3##6##(2006-4#1)(2008-6#1)(2010-4#1)
to improve the outcome of##2##5##(2006-2#1)(2008-11#1)
to improve the outcome##4##4##(2006-10#1)(2006-2#1)(2008-11#1)(2008-5#1)
to improve the outcomes in##2##5##(2010-12#1)(2011-2#1)
to improve the overall##4##4##(2007-2#1)(2008-2#2)(2008-3#1)
to improve the patient's quality of life##2##7##(2007-11#1)(2009-9#1)
to improve the performance and##2##5##(2008-4#1)(2013-1#1)
to improve the performance of a##2##6##(1993-12#1)(2008-3#1)
to improve the performance of the##2##6##(2008-2#1)(2012-1#1)
to improve the performance of##10##5##(1993-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2012-1#1)
to improve the performance##13##4##(1993-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-8#1)(2012-1#1)(2013-1#1)
to improve the power##2##4##(1993-6#1)(2012-3#1)
to improve the practice##2##4##(2006-1#1)(2007-12#1)
to improve the prediction##3##4##(2008-10#1)(2012-3#1)(2013-1#1)
to improve the process of##3##5##(1993-3#1)(2008-3#1)(2012-12#1)
to improve the production of##2##5##(1994-2#1)(2008-11#1)
to improve the production##3##4##(1994-2#1)(2008-11#2)
to improve the prognosis##3##4##(2006-2#1)(2010-3#1)(2011-2#1)
to improve the quality and##4##5##(1993-3#1)(1994-2#1)(2007-10#1)(2008-10#1)
to improve the quality of care provided##2##7##(2008-12#1)(2008-3#1)
to improve the quality of care##5##6##(1996-1#1)(1996-12#1)(2008-12#1)(2008-3#2)
to improve the quality of life and##3##7##(2007-7#1)(2008-5#1)(2009-8#1)
to improve the quality of life for##3##7##(2006-7#1)(2009-11#1)(2012-1#1)
to improve the quality of life##10##6##(1990-2#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-5#1)(2009-11#1)(2009-5#1)(2009-8#1)(2012-1#1)
to improve the quality of patient care##2##7##(1993-3#1)(2009-8#1)
to improve the quality of the##3##6##(1992-3#1)(2008-10#1)(2008-3#1)
to improve the quality of their##2##6##(1992-2#1)(2008-1#1)
to improve the quality of##37##5##(1990-2#1)(1992-2#2)(1992-3#2)(1993-3#1)(1994-3#1)(1996-1#1)(1996-12#1)(1997-3#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#2)(2008-3#4)(2008-5#2)(2009-11#1)(2009-5#1)(2009-8#2)(2010-4#1)(2010-8#1)(2010-9#1)(2012-1#1)(2012-11#1)(2013-1#1)(2013-8#1)
to improve the quality##41##4##(1990-2#1)(1992-2#2)(1992-3#2)(1993-3#2)(1994-2#1)(1994-3#1)(1996-1#1)(1996-12#1)(1997-3#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-12#2)(2008-3#4)(2008-5#2)(2009-11#1)(2009-5#1)(2009-8#2)(2010-4#1)(2010-8#1)(2010-9#1)(2012-1#1)(2012-11#1)(2013-1#1)(2013-8#1)
to improve the quantitative##2##4##(2006-4#1)(2008-10#1)
to improve the rate of##3##5##(2006-9#1)(2008-2#1)(2008-7#1)
to improve the recovery of##2##5##(2008-9#1)(2012-2#1)
to improve the resolution of##2##5##(1996-12#1)(2008-3#1)
to improve the resolution##3##4##(1996-12#1)(2006-5#1)(2008-3#1)
to improve the results##3##4##(2007-8#1)(2008-10#1)(2011-2#1)
to improve the safety and##2##5##(2006-10#1)(2006-12#1)
to improve the safety of##3##5##(2005-5#1)(2006-10#1)(2013-8#1)
to improve the safety##6##4##(2005-5#1)(2006-10#2)(2006-12#1)(2007-8#1)(2013-8#1)
to improve the scientific##2##4##(2005-8#1)(2012-12#1)
to improve the scope and accuracy of predictions##2##8##(2013-1#2)
to improve the sensitivity and##2##5##(2008-10#1)(2008-3#1)
to improve the sensitivity of the##2##6##(2008-10#2)
to improve the sensitivity of##6##5##(2005-12#1)(2007-12#1)(2008-10#4)
to improve the sensitivity##10##4##(1993-2#1)(2005-12#1)(2007-12#1)(2008-10#5)(2008-3#1)(2012-12#1)
to improve the separation and##2##5##(2008-10#2)
to improve the separation between##3##5##(2005-12#2)(2008-10#1)
to improve the separation##5##4##(2005-12#2)(2008-10#3)
to improve the signal-to-noise ratio##4##5##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
to improve the signal-to-noise##5##4##(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
to improve the situation##3##4##(2008-2#1)(2009-6#1)(2010-8#1)
to improve the spectral resolution##2##5##(2007-12#2)
to improve the speed and##2##5##(2008-7#1)(2010-12#1)
to improve the speed##3##4##(2008-7#1)(2008-9#1)(2010-12#1)
to improve the stability of the##2##6##(2008-10#2)
to improve the stability of##4##5##(2008-10#2)(2008-6#1)(2013-1#1)
to improve the strength##2##4##(2008-5#1)(2010-4#1)
to improve the success##2##4##(2007-5#1)(2008-12#1)
to improve the survival##2##4##(2008-11#1)(2010-12#1)
to improve the treatment##3##4##(2006-8#1)(2007-11#1)(2010-12#1)
to improve the understanding of the##2##6##(2006-7#1)(2008-11#1)
to improve the understanding of##3##5##(2006-7#1)(2007-9#1)(2008-11#1)
to improve the use of##2##5##(2012-11#1)(2012-12#1)
to improve the use##3##4##(2012-11#1)(2012-12#1)(2013-1#1)
to improve the##493##3##(1990-11#2)(1990-12#1)(1990-2#2)(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-2#2)(1992-3#2)(1992-5#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#5)(1993-4#1)(1993-6#3)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#2)(1994-9#2)(1995-1#2)(1995-2#2)(1995-3#2)(1995-6#1)(1995-9#1)(1996-1#2)(1996-12#5)(1996-2#3)(1996-3#1)(1996-9#3)(1997-1#2)(1997-3#1)(1997-4#1)(2004-4#2)(2004-9#1)(2005-11#4)(2005-12#4)(2005-5#2)(2005-6#1)(2005-8#3)(2006-1#3)(2006-10#13)(2006-11#4)(2006-12#2)(2006-2#4)(2006-4#4)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#2)(2006-9#2)(2007-10#1)(2007-11#8)(2007-12#10)(2007-2#4)(2007-3#2)(2007-5#1)(2007-7#5)(2007-8#12)(2007-9#2)(2008-1#6)(2008-10#52)(2008-11#17)(2008-12#6)(2008-2#26)(2008-3#31)(2008-4#3)(2008-5#12)(2008-6#7)(2008-7#7)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#5)(2009-9#2)(2010-1#3)(2010-11#1)(2010-12#7)(2010-2#4)(2010-3#2)(2010-4#5)(2010-5#5)(2010-8#6)(2010-9#3)(2011-1#7)(2011-2#13)(2012-1#4)(2012-11#5)(2012-12#9)(2012-2#7)(2012-3#9)(2012-8#1)(2013-1#29)(2013-7#1)(2013-8#11)
to improve their ability to##5##5##(2009-3#1)(2010-5#1)(2010-8#1)(2012-1#1)(2013-1#1)
to improve their performance##5##4##(1993-12#1)(1993-3#1)(2008-10#1)(2010-8#1)(2012-1#1)
to improve their##48##3##(1991-9#1)(1992-10#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-1#2)(1994-2#1)(1995-8#1)(1996-1#1)(1996-12#2)(2006-1#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-7#2)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#3)(2011-12#1)(2011-2#4)(2012-1#2)(2012-11#2)(2012-2#2)(2012-3#1)(2013-1#1)
to improve them##2##3##(1994-3#1)(2008-12#1)
to improve these##3##3##(1991-12#1)(2013-1#2)
to improve this##2##3##(1992-7#1)(2008-3#1)
to improve total##2##3##(1993-1#1)(2010-12#1)
to improve treatment##8##3##(2006-1#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2010-3#1)(2012-2#1)
to improve understanding of the##2##5##(1993-8#1)(2007-11#1)
to improve understanding of##4##4##(1993-8#1)(2007-11#1)(2008-10#1)(2011-2#1)
to improve understanding##6##3##(1990-8#1)(1993-8#1)(2007-11#1)(2008-10#1)(2008-7#1)(2011-2#1)
to improve upon##2##3##(2010-1#1)(2013-7#1)
to improve utilization##2##3##(1990-12#1)(1995-2#1)
to improve visualization##2##3##(2006-9#1)(2010-8#1)
to improve with##3##3##(1994-12#1)(2006-8#1)(2008-3#1)
to improve your##3##3##(1995-2#1)(1996-2#1)(2008-9#1)
to improve##1385##2##(1990-1#1)(1990-11#2)(1990-12#2)(1990-2#2)(1990-5#1)(1990-6#1)(1990-8#2)(1991-1#3)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#2)(1991-4#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#4)(1992-3#3)(1992-5#1)(1992-7#1)(1993-1#3)(1993-10#1)(1993-11#2)(1993-12#9)(1993-2#3)(1993-3#11)(1993-4#1)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#3)(1994-11#3)(1994-12#3)(1994-2#13)(1994-3#5)(1994-5#2)(1994-6#4)(1994-8#1)(1994-9#3)(1995-1#4)(1995-11#1)(1995-12#1)(1995-2#8)(1995-3#5)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#7)(1996-10#1)(1996-11#1)(1996-12#19)(1996-2#9)(1996-3#12)(1996-4#2)(1996-8#1)(1996-9#5)(1997-1#4)(1997-2#3)(1997-3#8)(1997-4#1)(1997-6#2)(1997-8#1)(2004-1#1)(2004-11#1)(2004-4#3)(2004-9#2)(2005-10#3)(2005-11#5)(2005-12#4)(2005-2#1)(2005-3#2)(2005-5#2)(2005-6#2)(2005-7#3)(2005-8#7)(2005-9#1)(2006-1#7)(2006-10#42)(2006-11#5)(2006-12#7)(2006-2#8)(2006-3#1)(2006-4#9)(2006-5#6)(2006-6#7)(2006-7#7)(2006-8#12)(2006-9#7)(2007-1#1)(2007-10#9)(2007-11#26)(2007-12#18)(2007-2#10)(2007-3#3)(2007-4#4)(2007-5#2)(2007-6#3)(2007-7#13)(2007-8#29)(2007-9#13)(2008-1#14)(2008-10#83)(2008-11#50)(2008-12#12)(2008-2#46)(2008-3#56)(2008-4#7)(2008-5#33)(2008-6#19)(2008-7#23)(2008-8#17)(2008-9#10)(2009-1#1)(2009-10#5)(2009-11#3)(2009-12#4)(2009-2#3)(2009-3#5)(2009-4#10)(2009-5#8)(2009-6#3)(2009-7#9)(2009-8#11)(2009-9#4)(2010-1#8)(2010-10#7)(2010-11#4)(2010-12#23)(2010-2#10)(2010-3#7)(2010-4#14)(2010-5#14)(2010-6#3)(2010-7#5)(2010-8#19)(2010-9#7)(2011-1#28)(2011-12#4)(2011-2#47)(2011-3#1)(2011-9#1)(2012-1#18)(2012-11#9)(2012-12#24)(2012-2#29)(2012-3#27)(2012-5#1)(2012-8#1)(2013-1#99)(2013-7#13)(2013-8#26)
to improved clinical outcomes##2##4##(2008-3#1)(2010-6#1)
to improved clinical##3##3##(2006-10#1)(2008-3#1)(2010-6#1)
to improved methods##2##3##(2006-2#1)(2007-6#1)
to improved outcomes##2##3##(2008-1#1)(2008-12#1)
to improved patient outcomes##4##4##(1996-1#1)(2008-3#1)(2010-6#1)(2011-2#1)
to improved patient##5##3##(1996-1#1)(2006-10#1)(2008-3#1)(2010-6#1)(2011-2#1)
to improved survival in patients with##2##6##(2006-10#1)(2009-12#1)
to improved survival##3##3##(2006-10#1)(2009-12#1)(2012-12#1)
to improved##73##2##(1990-9#1)(1991-12#1)(1994-5#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-8#1)(2005-2#1)(2006-10#5)(2006-11#1)(2006-2#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-10#1)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#1)
to improvement and##2##3##(2008-5#1)(2008-8#1)
to improvement in the##3##4##(1995-3#1)(2006-10#1)(2006-8#1)
to improvement in##8##3##(1995-3#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-2#1)(2008-4#1)(2009-7#1)(2010-8#1)
to improvement of the##2##4##(1990-8#1)(1997-8#1)
to improvement of##7##3##(1990-8#1)(1997-8#1)(2005-1#1)(2007-8#1)(2008-12#1)(2010-12#1)(2011-2#1)
to improvement##20##2##(1990-8#1)(1993-3#1)(1995-3#1)(1997-2#1)(1997-8#1)(2005-1#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#1)
to improvements in the##2##4##(1993-3#1)(2008-4#1)
to improvements in##10##3##(1993-3#1)(2006-6#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-3#1)(2011-2#1)
to improvements##12##2##(1993-3#1)(2006-6#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-3#1)(2011-2#1)
to improving cardiac##2##3##(2005-10#1)(2008-1#1)
to improving health##4##3##(1995-2#1)(1996-1#1)(2008-7#1)(2012-2#1)
to improving outcomes for##2##4##(2008-6#1)(2010-3#1)
to improving outcomes##3##3##(2008-6#1)(2008-7#1)(2010-3#1)
to improving patient##4##3##(1993-2#2)(2007-12#1)(2011-2#1)
to improving the efficiency##2##4##(1994-5#1)(2008-2#1)
to improving the##16##3##(1993-3#1)(1994-5#1)(1995-12#1)(1996-2#1)(1996-3#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-9#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
to improving their##2##3##(2007-6#1)(2008-12#1)
to improving treatment##2##3##(2005-7#1)(2006-1#1)
to improving##54##2##(1991-2#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-9#1)(1994-2#2)(1994-5#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-1#1)(2005-10#1)(2005-7#1)(2006-1#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#2)
to impulse##2##2##(2006-7#1)(2012-1#1)
to impulsive##2##2##(2009-10#1)(2013-1#1)
to impute##3##2##(2008-9#1)(2012-1#2)
to in situ##10##3##(1991-9#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-4#1)(2013-8#3)
to in the##5##3##(1993-10#1)(1994-2#1)(2008-10#1)(2008-2#1)(2011-1#1)
to in vitro##22##3##(1992-1#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-6#1)(1994-7#1)(1995-1#1)(1995-10#1)(1995-3#1)(1996-2#1)(1996-6#1)(2004-12#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-9#1)(2010-5#1)(2010-9#1)(2011-1#1)(2013-1#2)
to in vivo studies##3##4##(2010-7#1)(2011-1#1)(2012-1#1)
to in vivo##19##3##(1994-11#1)(1994-3#1)(1996-12#1)(1996-2#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-9#1)(2009-9#1)(2010-7#1)(2011-1#2)(2012-1#1)
to in##64##2##(1991-9#1)(1992-1#1)(1992-11#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-6#1)(1997-7#1)(2004-12#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#3)(2008-9#3)(2009-9#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#5)(2012-1#1)(2013-1#3)(2013-8#3)
to in-class variations##2##3##(2008-2#2)
to in-class##3##2##(2008-2#3)
to in-situ##2##2##(2008-10#1)(2013-8#1)
to inaccurate##5##2##(1996-12#1)(1996-5#1)(2006-7#1)(2008-10#1)(2008-9#1)
to inactivate 95% of the sporangia##2##6##(2008-10#2)
to inactivate or##2##3##(2008-6#1)(2013-1#1)
to inactivate the##6##3##(1990-8#1)(1993-11#1)(1993-3#1)(1994-10#1)(1995-2#1)(2008-10#1)
to inactivate##27##2##(1990-8#1)(1991-9#1)(1992-2#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-10#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-10#1)(1997-3#1)(1997-4#1)(2005-7#1)(2006-12#1)(2008-10#6)(2008-6#1)(2008-8#1)(2011-1#1)(2012-2#2)(2013-1#1)
to inactivation by##4##3##(1992-9#1)(1993-4#1)(1995-7#1)(2007-12#1)
to inactivation of the##2##4##(1996-1#1)(2008-1#1)
to inactivation of##4##3##(1990-5#1)(1995-6#1)(1996-1#1)(2008-1#1)
to inactivation##9##2##(1990-5#1)(1992-9#1)(1993-4#1)(1995-6#1)(1995-7#1)(1996-1#1)(1997-2#1)(2007-12#1)(2008-1#1)
to inactive##3##2##(1994-11#1)(2007-11#2)
to inadequate care##2##3##(1992-2#1)(2008-10#1)
to inadequate power##2##3##(2010-8#1)(2012-3#1)
to inadequate##17##2##(1992-2#1)(1992-4#1)(1993-11#1)(1993-5#1)(1993-9#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#2)(2010-8#1)(2012-2#1)(2012-3#2)
to inappropriate##11##2##(1994-9#1)(1997-1#1)(2006-10#1)(2006-11#1)(2006-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-4#1)(2010-11#1)
to incarceration##2##2##(2009-11#1)(2010-6#1)
to incidence of##5##3##(1997-3#1)(2006-10#1)(2008-10#3)
to incidence##9##2##(1991-11#1)(1994-2#1)(1997-3#1)(2006-10#1)(2008-10#4)(2008-8#1)
to incident##4##2##(2007-2#1)(2008-11#1)(2008-2#1)(2008-3#1)
to incisional##4##2##(2006-10#1)(2011-2#2)(2012-12#1)
to include a##19##3##(1994-8#1)(1997-2#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-3#1)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
to include additional##4##3##(1991-12#1)(1995-1#1)(2008-11#1)(2012-1#1)
to include all##3##3##(1997-3#1)(2006-10#1)(2012-2#1)
to include an##2##3##(2005-7#1)(2006-10#1)
to include both##2##3##(2007-12#1)(2008-9#1)
to include cases##2##3##(1991-9#1)(2013-7#1)
to include data##3##3##(2006-10#1)(2008-1#1)(2008-2#1)
to include fungal##2##3##(2007-12#1)(2013-1#1)
to include in##3##3##(2004-10#1)(2007-8#1)(2011-2#1)
to include information on##2##4##(1993-5#1)(2008-4#1)
to include more##7##3##(1993-12#1)(2006-10#2)(2007-3#1)(2007-7#1)(2008-12#1)(2008-3#1)
to include only the##2##4##(1995-8#1)(2008-2#1)
to include only##3##3##(1995-8#1)(2006-7#1)(2008-2#1)
to include other##4##3##(1991-3#1)(1995-12#1)(2008-12#1)(2008-3#1)
to include social##3##3##(2006-7#1)(2008-8#1)(2011-1#1)
to include such##2##3##(1992-1#1)(2010-8#1)
to include the effect of##2##5##(2008-2#1)(2008-3#1)
to include the##32##3##(1990-12#1)(1991-1#1)(1991-7#1)(1992-12#1)(1992-8#1)(1993-2#1)(1994-1#1)(1997-4#2)(1997-5#1)(2005-10#1)(2005-12#1)(2006-6#1)(2007-1#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2008-9#1)(2009-2#1)(2009-5#1)(2010-2#1)(2011-1#2)(2012-2#1)
to include three##2##3##(1993-2#1)(2012-2#1)
to include##216##2##(1990-11#1)(1990-12#4)(1990-2#1)(1991-1#1)(1991-12#1)(1991-3#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#4)(1992-8#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-5#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-12#3)(1995-2#1)(1995-8#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#3)(1997-5#1)(1997-8#1)(2004-1#1)(2004-10#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#2)(2006-10#7)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#2)(2007-1#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#3)(2007-7#2)(2007-8#2)(2008-1#5)(2008-10#10)(2008-11#6)(2008-12#4)(2008-2#11)(2008-3#9)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#3)(2008-8#2)(2008-9#4)(2009-12#1)(2009-2#3)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#4)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#4)(2010-8#4)(2010-9#1)(2011-1#7)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#5)(2013-7#1)
to inclusion in##2##3##(1995-9#1)(2008-6#1)
to inclusion of##3##3##(1992-1#1)(2007-1#1)(2007-11#1)
to inclusion##5##2##(1992-1#1)(1995-9#1)(2007-1#1)(2007-11#1)(2008-6#1)
to incoherent optical##3##3##(2007-12#3)
to incoherent##4##2##(2007-12#4)
to income##4##2##(1994-4#1)(2007-6#1)(2011-2#1)(2012-12#1)
to incoming##3##2##(2008-3#1)(2008-7#1)(2012-12#1)
to incomplete data##2##3##(2007-2#1)(2008-11#1)
to incomplete##14##2##(1996-2#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-7#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-1#1)
to incongruent##5##2##(2008-9#1)(2012-1#4)
to inconsistent##5##2##(2008-3#1)(2009-10#1)(2009-4#1)(2012-12#2)
to incorporate a##9##3##(1994-12#1)(1995-5#1)(2005-11#1)(2007-4#1)(2008-3#1)(2008-5#1)(2008-8#1)(2013-1#2)
to incorporate both##4##3##(1992-3#1)(1997-6#1)(2012-12#1)(2012-2#1)
to incorporate into the##2##4##(1995-8#1)(2007-2#1)
to incorporate into##3##3##(1995-8#1)(2004-9#1)(2007-2#1)
to incorporate more##2##3##(2008-12#1)(2012-3#1)
to incorporate new##2##3##(1992-1#1)(2008-10#1)
to incorporate short term event time information##2##7##(2013-1#2)
to incorporate the##12##3##(1993-5#1)(1993-6#1)(1995-1#1)(1995-11#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-10#1)(2011-1#1)
to incorporate##85##2##(1990-8#1)(1992-1#1)(1992-3#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-7#2)(1996-8#2)(1997-1#2)(1997-2#1)(1997-6#1)(2004-9#1)(2005-11#1)(2006-12#2)(2006-2#1)(2006-5#2)(2006-7#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#3)(2008-12#5)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#4)(2008-8#1)(2009-10#1)(2009-11#2)(2009-12#1)(2010-10#1)(2010-7#1)(2011-1#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#7)
to incorporation of##2##3##(1991-5#1)(2013-1#1)
to incorporation##3##2##(1991-5#1)(2008-5#1)(2013-1#1)
to incorrect##4##2##(1991-6#1)(1992-7#1)(2008-10#1)(2008-3#1)
to increase (P##2##3##(2008-10#1)(2010-2#1)
to increase D*##2##3##(2008-3#2)
to increase IP3##2##3##(1995-11#2)
to increase [Ca2+]i##2##3##(1992-7#1)(1994-6#1)
to increase access to##2##4##(1997-1#1)(2007-4#1)
to increase activity##3##3##(1992-6#1)(1997-6#1)(2009-10#1)
to increase after the##2##4##(1995-3#1)(2008-10#1)
to increase after##4##3##(1995-3#1)(2008-10#1)(2008-4#1)(2009-10#1)
to increase and##4##3##(2007-12#1)(2007-8#1)(2010-6#1)(2012-3#1)
to increase as a function of##2##6##(1994-9#1)(2008-8#1)
to increase as the##5##4##(1995-3#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-7#1)
to increase as##11##3##(1990-10#1)(1991-3#1)(1994-9#1)(1995-3#1)(2006-5#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-12#1)
to increase at##6##3##(1992-11#3)(2006-8#1)(2008-5#2)
to increase awareness about the##2##5##(2009-1#1)(2009-9#1)
to increase awareness and##3##4##(2006-8#1)(2007-3#1)(2008-3#1)
to increase awareness of##7##4##(1990-10#1)(1991-2#1)(2005-10#1)(2007-2#1)(2008-1#1)(2008-7#1)(2010-12#1)
to increase awareness##13##3##(1990-10#1)(1991-2#1)(2005-10#1)(2006-8#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-9#1)(2010-12#1)
to increase blood##2##3##(2006-4#1)(2008-12#1)
to increase both##4##3##(1993-6#1)(2008-10#1)(2008-7#1)(2009-3#1)
to increase by##7##3##(1992-12#1)(2004-9#1)(2008-5#1)(2008-6#1)(2013-1#2)(2013-7#1)
to increase compliance##2##3##(2005-8#1)(2008-8#1)
to increase condom use in##2##5##(2005-10#1)(2012-3#1)
to increase condom use with##2##5##(2012-3#2)
to increase condom use##4##4##(2005-10#1)(2012-3#3)
to increase confidence##2##3##(2008-10#1)(2010-11#1)
to increase discrimination##2##3##(2008-12#1)(2012-2#1)
to increase dramatically##2##3##(1995-3#1)(2008-2#1)
to increase drug##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
to increase due to the increased##2##6##(1997-6#1)(2009-3#1)
to increase during the##2##4##(2008-10#1)(2008-3#1)
to increase during##5##3##(1994-6#2)(2008-10#1)(2008-3#1)(2010-4#1)
to increase efficiency and##3##4##(1990-12#1)(1994-2#1)(2008-12#1)
to increase efficiency##6##3##(1990-12#1)(1994-2#1)(2008-11#1)(2008-12#1)(2008-2#1)(2013-1#1)
to increase folate##2##3##(2004-10#1)(2012-12#1)
to increase following##2##3##(1992-7#1)(1996-5#1)
to increase for##2##3##(1991-12#1)(2008-10#1)
to increase from 0##2##4##(2008-2#1)(2009-6#1)
to increase from##6##3##(1994-9#1)(2007-1#1)(2007-12#1)(2007-7#1)(2008-2#1)(2009-6#1)
to increase fruit##2##3##(2010-3#1)(2012-12#1)
to increase hemoglobin##2##3##(1990-10#1)(2010-9#1)
to increase in a##2##4##(1995-3#1)(2008-4#1)
to increase in incidence##2##4##(2006-12#1)(2010-8#1)
to increase in response to##2##5##(1992-6#1)(2009-6#1)
to increase in the future##3##5##(1990-12#1)(2006-10#1)(2010-5#1)
to increase in the##13##4##(1990-12#1)(1990-3#1)(1990-4#1)(1994-6#1)(2006-10#1)(2008-5#2)(2008-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-1#1)
to increase in##41##3##(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-1#1)(1992-6#1)(1993-4#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-3#2)(2004-4#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
to increase insulin sensitivity##2##4##(2007-8#1)(2012-3#1)
to increase insulin##3##3##(2007-8#1)(2008-7#1)(2012-3#1)
to increase intracellular##2##3##(1997-6#1)(2006-10#1)
to increase its##6##3##(1996-5#1)(2005-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)
to increase knowledge##4##3##(2010-4#1)(2010-7#1)(2013-1#2)
to increase metal##3##3##(2008-10#1)(2008-2#1)(2010-5#1)
to increase of##4##3##(1990-7#1)(2008-11#1)(2008-12#1)(2011-2#1)
to increase our understanding of the##3##6##(2006-10#2)(2006-5#1)
to increase our understanding of##8##5##(2005-11#1)(2006-10#3)(2006-5#1)(2008-8#1)(2010-8#1)(2013-1#1)
to increase our understanding##9##4##(2005-11#1)(2006-10#3)(2006-5#1)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
to increase our##10##3##(2005-11#1)(2006-10#3)(2006-5#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
to increase over the next##2##5##(1990-11#1)(2010-12#1)
to increase over##3##3##(1990-11#1)(2007-7#1)(2010-12#1)
to increase oxygen delivery##2##4##(1996-3#1)(2010-7#1)
to increase physical##2##3##(1993-2#1)(2008-5#1)
to increase predictability##2##3##(2006-12#1)(2013-7#1)
to increase productivity and##3##4##(1993-3#1)(2008-11#1)(2008-7#1)
to increase productivity##4##3##(1993-3#1)(1994-1#1)(2008-11#1)(2008-7#1)
to increase proportionally##2##3##(2008-10#1)(2012-2#1)
to increase public awareness of the##2##6##(2004-10#1)(2008-10#1)
to increase rapidly##2##3##(2010-12#1)(2012-12#1)
to increase recombinant protein production in##2##6##(2008-11#1)(2011-2#1)
to increase risk of##2##4##(1990-8#1)(2008-11#1)
to increase risk##3##3##(1990-8#1)(2008-11#1)(2010-4#1)
to increase sample##5##3##(2007-6#2)(2008-10#3)
to increase sensitivity and##2##4##(2008-10#2)
to increase sensitivity##8##3##(2007-11#1)(2008-10#5)(2008-4#2)
to increase services##3##3##(2010-10#3)
to increase significantly as##2##4##(1997-7#1)(2012-3#1)
to increase significantly the##2##4##(2008-10#1)(2012-12#1)
to increase significantly##7##3##(1992-11#1)(1997-7#1)(2008-10#2)(2011-2#1)(2012-12#1)(2012-3#1)
to increase skill##2##3##(1995-12#1)(2012-1#1)
to increase symptom##2##3##(2008-10#1)(2008-7#1)
to increase the accuracy of##2##5##(2010-4#1)(2013-7#1)
to increase the accuracy##3##4##(2008-3#1)(2010-4#1)(2013-7#1)
to increase the amount##2##4##(1997-3#1)(2006-4#1)
to increase the availability of##3##5##(1997-1#1)(2011-1#1)(2012-12#1)
to increase the awareness of this disease in##2##8##(2007-3#1)(2013-8#1)
to increase the awareness of##5##5##(2006-6#1)(2007-2#1)(2007-3#1)(2011-2#1)(2013-8#1)
to increase the awareness##8##4##(2006-6#1)(2007-12#1)(2007-2#1)(2007-3#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
to increase the complexity of##2##5##(2007-11#1)(2011-2#1)
to increase the concentration##2##4##(1995-1#1)(2008-5#1)
to increase the degree of##2##5##(1995-12#1)(2010-10#1)
to increase the effective##2##4##(2007-12#1)(2008-7#1)
to increase the effectiveness of##3##5##(1991-11#1)(2008-5#1)(2012-1#1)
to increase the efficacy##2##4##(2007-8#1)(2010-9#1)
to increase the efficiency of##7##5##(2005-6#1)(2008-7#2)(2009-9#1)(2011-1#1)(2011-12#1)(2012-1#1)
to increase the efficiency##9##4##(1993-3#1)(2005-6#1)(2008-7#2)(2009-9#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)
to increase the expression of##3##5##(2008-4#1)(2009-4#1)(2011-1#1)
to increase the expression##5##4##(1996-2#1)(2008-4#1)(2009-4#1)(2010-2#1)(2011-1#1)
to increase the incidence of##2##5##(1992-2#1)(2006-10#1)
to increase the incidence##4##4##(1992-2#1)(2006-10#1)(2007-10#1)(2012-3#1)
to increase the intensity of##2##5##(2008-12#1)(2013-8#1)
to increase the knowledge##2##4##(2007-10#1)(2013-1#1)
to increase the level of##6##5##(1995-10#1)(2006-2#2)(2008-10#1)(2008-5#1)(2009-6#1)
to increase the likelihood of##2##5##(2008-9#1)(2010-10#1)
to increase the likelihood##3##4##(2008-9#1)(2010-10#2)
to increase the number of##9##5##(1993-2#1)(2007-3#1)(2007-7#1)(2008-2#2)(2008-3#3)(2008-4#1)
to increase the number##10##4##(1993-2#1)(2007-3#1)(2007-7#1)(2008-2#2)(2008-3#3)(2008-4#1)(2010-11#1)
to increase the physical activity of healthcare workers in a public hospital in South Africa##2##15##(2013-1#2)
to increase the power of##2##5##(2008-2#1)(2008-4#1)
to increase the power##3##4##(2008-2#1)(2008-4#1)(2012-3#1)
to increase the precision of##3##5##(2006-6#1)(2007-8#1)(2008-10#1)
to increase the probability of##5##5##(1995-12#1)(2007-10#1)(2008-3#1)(2008-7#2)
to increase the production of##2##5##(1992-8#1)(2006-10#1)
to increase the production##3##4##(1992-8#1)(2006-10#1)(2006-12#1)
to increase the protein##2##4##(1995-5#1)(2006-12#1)
to increase the quality of##2##5##(2006-2#1)(2011-1#1)
to increase the rate of##2##5##(1991-6#1)(2008-4#1)
to increase the relative##2##4##(1990-7#1)(1994-2#1)
to increase the resistance##2##4##(1993-3#1)(1994-6#1)
to increase the resolution##2##4##(2007-12#1)(2008-3#1)
to increase the risk of##4##5##(2008-1#1)(2009-8#1)(2010-2#1)(2010-9#1)
to increase the risk##7##4##(2008-1#1)(2009-8#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#1)(2013-1#1)
to increase the safety and##2##5##(1995-7#1)(2013-1#1)
to increase the safety##3##4##(1995-7#1)(2007-11#1)(2013-1#1)
to increase the sensitivity and##2##5##(2008-10#2)
to increase the sensitivity of the method##2##7##(2008-10#1)(2008-5#1)
to increase the sensitivity of the##3##6##(1995-11#1)(2008-10#1)(2008-5#1)
to increase the sensitivity of##5##5##(1990-8#1)(1995-11#1)(2008-10#1)(2008-5#1)(2010-5#1)
to increase the sensitivity##12##4##(1990-8#1)(1995-11#1)(2008-10#6)(2008-2#2)(2008-5#1)(2010-5#1)
to increase the size of the##2##6##(2007-7#1)(2008-3#1)
to increase the stability of##3##5##(1991-1#1)(2008-2#1)(2011-2#1)
to increase the understanding of the##3##6##(1995-1#1)(1995-5#1)(1997-4#1)
to increase the yield of##4##5##(1996-1#1)(2006-5#1)(2008-2#1)(2008-4#1)
to increase the##283##3##(1990-10#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#2)(1992-1#1)(1992-10#1)(1992-2#1)(1992-8#2)(1992-9#1)(1993-10#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#2)(1995-7#1)(1995-9#1)(1996-1#3)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#3)(1997-3#5)(1997-4#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-4#1)(2005-6#1)(2006-10#4)(2006-12#2)(2006-2#3)(2006-4#1)(2006-5#1)(2006-6#4)(2006-7#1)(2006-8#1)(2007-10#4)(2007-11#9)(2007-12#7)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#5)(2008-10#15)(2008-11#6)(2008-12#2)(2008-2#14)(2008-3#20)(2008-4#7)(2008-5#10)(2008-6#2)(2008-7#6)(2008-9#1)(2009-4#5)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#9)(2011-12#1)(2011-2#5)(2012-1#4)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#7)(2013-1#6)(2013-7#4)(2013-8#7)
to increase their knowledge and##2##5##(2005-8#1)(2011-7#1)
to increase their##21##3##(1990-12#1)(1992-12#2)(1995-12#1)(1996-3#1)(1996-6#1)(1997-1#1)(2005-8#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-8#1)(2011-12#1)(2011-7#1)(2012-2#1)
to increase this##2##3##(2008-10#1)(2011-1#1)
to increase throughout the##2##4##(1996-2#1)(2008-1#1)
to increase to##4##3##(1995-2#1)(2007-11#1)(2008-6#1)(2008-7#1)
to increase tracheal##2##3##(1997-1#1)(2006-10#1)
to increase treatment##2##3##(2008-6#1)(2012-3#1)
to increase tyrosine phosphorylation##2##4##(1995-5#1)(1997-1#1)
to increase understanding of##3##4##(1995-6#1)(2008-12#1)(2008-2#1)
to increase understanding##4##3##(1995-6#1)(2008-12#2)(2008-2#1)
to increase with age##6##4##(1994-10#1)(1995-3#1)(1997-7#1)(2006-4#1)(2009-2#1)(2012-2#1)
to increase with an increase in##2##6##(2008-5#1)(2012-2#1)
to increase with increasing##9##4##(1990-12#1)(1995-6#1)(1996-6#1)(2004-9#1)(2005-11#2)(2008-3#1)(2008-7#1)(2008-9#1)
to increase with the increasing##2##5##(2008-8#1)(2012-2#1)
to increase with the##6##4##(2008-10#1)(2008-8#1)(2008-9#1)(2009-11#1)(2012-2#1)(2013-7#1)
to increase with time##5##4##(1991-2#1)(2006-9#1)(2008-10#2)(2010-5#1)
to increase with##39##3##(1990-12#1)(1991-2#1)(1994-10#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-6#1)(1997-7#1)(2004-9#1)(2005-11#4)(2006-4#1)(2006-9#1)(2007-1#1)(2007-12#2)(2007-5#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2010-5#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-7#1)
to increase##900##2##(1990-10#6)(1990-11#1)(1990-12#5)(1990-2#4)(1990-3#2)(1990-4#2)(1990-6#1)(1990-7#4)(1990-8#2)(1991-1#2)(1991-11#1)(1991-12#3)(1991-2#4)(1991-3#5)(1991-4#1)(1991-5#2)(1991-6#3)(1991-7#1)(1992-1#3)(1992-10#1)(1992-11#6)(1992-12#4)(1992-2#2)(1992-3#3)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#4)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#4)(1993-8#2)(1993-9#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#3)(1994-3#4)(1994-6#6)(1994-8#2)(1994-9#2)(1995-1#4)(1995-10#1)(1995-11#3)(1995-12#6)(1995-2#4)(1995-3#12)(1995-5#6)(1995-6#2)(1995-7#2)(1995-8#1)(1995-9#2)(1996-1#5)(1996-10#2)(1996-11#4)(1996-12#2)(1996-2#3)(1996-3#4)(1996-4#1)(1996-5#6)(1996-6#2)(1996-8#5)(1996-9#1)(1997-1#10)(1997-2#1)(1997-3#6)(1997-4#4)(1997-6#5)(1997-7#3)(1997-8#2)(2004-10#2)(2004-11#2)(2004-12#2)(2004-4#1)(2004-9#3)(2005-10#5)(2005-11#11)(2005-12#1)(2005-3#2)(2005-4#1)(2005-5#1)(2005-6#1)(2005-7#1)(2005-8#5)(2006-10#18)(2006-12#5)(2006-2#4)(2006-4#5)(2006-5#3)(2006-6#5)(2006-7#1)(2006-8#5)(2006-9#3)(2007-1#3)(2007-10#7)(2007-11#16)(2007-12#18)(2007-2#8)(2007-3#3)(2007-4#2)(2007-5#3)(2007-6#4)(2007-7#8)(2007-8#8)(2007-9#2)(2008-1#12)(2008-10#61)(2008-11#19)(2008-12#13)(2008-2#24)(2008-3#35)(2008-4#18)(2008-5#26)(2008-6#6)(2008-7#24)(2008-8#13)(2008-9#9)(2009-1#1)(2009-10#4)(2009-11#3)(2009-2#1)(2009-3#4)(2009-4#6)(2009-5#2)(2009-6#5)(2009-7#5)(2009-8#4)(2009-9#2)(2010-10#7)(2010-11#6)(2010-12#9)(2010-2#8)(2010-3#2)(2010-4#9)(2010-5#4)(2010-6#2)(2010-7#4)(2010-8#9)(2010-9#3)(2011-1#17)(2011-12#3)(2011-2#14)(2011-3#1)(2011-7#1)(2012-1#8)(2012-11#1)(2012-12#19)(2012-2#18)(2012-3#18)(2012-6#1)(2013-1#26)(2013-7#8)(2013-8#8)
to increased activation##2##3##(2008-11#1)(2013-1#1)
to increased activity##2##3##(2005-10#1)(2008-10#1)
to increased and##2##3##(1994-6#1)(1994-8#1)
to increased body##2##3##(2006-2#1)(2007-12#1)
to increased cell##3##3##(1990-8#1)(2010-4#1)(2012-5#1)
to increased drug##2##3##(1997-3#1)(2013-1#1)
to increased interest##2##3##(1995-2#1)(2007-9#1)
to increased levels of##3##4##(1994-11#1)(2007-1#1)(2012-2#1)
to increased metabolic##2##3##(1994-8#1)(2008-9#1)
to increased metabolism of##2##4##(2005-7#1)(2009-3#1)
to increased mortality##2##3##(2008-10#1)(2008-8#1)
to increased reactive##2##3##(2008-1#2)
to increased risk of##8##4##(2006-12#1)(2008-3#2)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
to increased risk##9##3##(2006-12#1)(2008-3#2)(2008-8#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
to increased susceptibility##2##3##(2008-10#1)(2013-7#1)
to increased toxicity##2##3##(2007-11#1)(2010-11#1)
to increased##209##2##(1990-11#4)(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-4#1)(1992-4#1)(1992-9#2)(1993-12#2)(1993-7#2)(1994-11#2)(1994-3#2)(1994-6#2)(1994-8#2)(1994-9#1)(1995-10#2)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#1)(2005-10#3)(2005-7#2)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-5#1)(2006-7#2)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#4)(2007-2#2)(2007-4#1)(2007-7#1)(2007-9#4)(2008-1#3)(2008-10#13)(2008-11#5)(2008-2#1)(2008-3#4)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#7)(2008-9#2)(2009-1#2)(2009-10#3)(2009-11#1)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#2)(2012-5#2)(2013-1#11)(2013-7#3)(2013-8#2)
to increases in the##4##4##(1991-2#1)(2006-5#1)(2007-4#1)(2008-7#1)
to increases in##16##3##(1990-4#1)(1991-2#1)(1994-5#1)(2005-12#1)(2006-12#2)(2006-5#1)(2006-6#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2009-12#1)
to increases##19##2##(1990-4#1)(1991-2#1)(1992-6#1)(1993-12#1)(1994-5#1)(1995-12#1)(2005-12#1)(2006-12#2)(2006-5#1)(2006-6#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2009-12#1)
to increasethe##2##2##(2008-11#2)
to increasing age##2##3##(1996-6#1)(2007-11#1)
to increasing concentrations of##5##4##(1990-2#2)(1990-7#1)(1995-5#1)(2008-11#1)
to increasing consumption of##2##4##(2011-2#1)(2012-2#1)
to increasing the##8##3##(1990-2#1)(1996-9#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-2#1)
to increasing##50##2##(1990-2#3)(1990-7#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(2004-4#1)(2005-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-2#2)(2010-3#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#1)
to increments in##3##3##(1993-7#2)(2010-2#1)
to incriminate##2##2##(2007-2#1)(2013-1#1)
to incubate##3##2##(1990-12#1)(2004-4#1)(2008-8#1)
to incubation##6##2##(1990-12#1)(1993-9#2)(1994-8#1)(2008-10#1)(2008-5#1)
to independent living##3##3##(2008-12#1)(2009-10#1)(2013-1#1)
to independent##12##2##(1996-9#1)(1997-6#1)(1997-7#1)(2006-11#1)(2008-11#1)(2008-12#1)(2009-10#1)(2009-3#1)(2013-1#4)
to independently test##3##3##(2008-11#1)(2008-5#1)(2010-3#1)
to independently##12##2##(1992-11#1)(1992-6#1)(1994-9#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-8#1)(2010-3#1)(2011-2#1)(2012-2#1)
to index##6##2##(1996-6#1)(2008-3#2)(2008-4#1)(2013-1#2)
to indicate a possible##2##4##(1994-8#1)(2004-11#1)
to indicate a##10##3##(1994-8#1)(1997-6#1)(2004-11#1)(2006-5#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
to indicate how##3##3##(1997-8#1)(2008-4#1)(2011-2#1)
to indicate that the##5##4##(1994-2#1)(2007-8#1)(2008-3#1)(2008-4#1)(2009-12#1)
to indicate that##33##3##(1990-10#1)(1990-12#1)(1991-11#1)(1991-6#1)(1994-2#1)(1994-9#1)(1996-6#1)(1997-8#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-3#1)(2007-8#3)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-8#1)(2013-1#3)
to indicate the presence of##3##5##(1992-8#1)(1994-2#1)(2007-9#1)
to indicate the probability of##2##5##(1996-5#1)(2008-12#1)
to indicate the##19##3##(1992-6#1)(1992-8#1)(1994-2#1)(1996-5#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#4)(2008-5#1)(2012-3#1)(2013-1#1)(2013-8#2)
to indicate whether a##2##4##(2008-11#1)(2008-3#1)
to indicate whether##3##3##(1992-9#1)(2008-11#1)(2008-3#1)
to indicate##97##2##(1990-10#1)(1990-12#1)(1991-11#1)(1991-6#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#2)(1993-3#1)(1994-2#2)(1994-8#1)(1994-9#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2005-8#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#3)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#4)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#3)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#2)(2010-8#2)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
to indication##2##2##(2007-11#1)(2008-1#1)
to indigenous##3##2##(2005-11#1)(2013-1#2)
to indirect effects##2##3##(2008-11#1)(2012-2#1)
to indirect##4##2##(2006-10#1)(2008-11#2)(2012-2#1)
to indirectly##5##2##(2006-11#1)(2007-5#1)(2008-10#1)(2008-4#1)(2013-7#1)
to individual and##2##3##(2008-8#1)(2012-1#1)
to individual differences in##2##4##(1990-1#1)(1997-8#1)
to individual differences##3##3##(1990-1#1)(1997-8#1)(2008-7#1)
to individual patients##3##3##(1997-4#1)(2010-10#1)(2010-12#1)
to individual risk factors##2##4##(2012-1#1)(2012-12#1)
to individual treatment##3##3##(1995-6#1)(1997-8#1)(2010-12#1)
to individual##72##2##(1990-1#1)(1991-1#1)(1991-4#1)(1992-4#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-6#2)(1996-9#2)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-7#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2009-4#1)(2009-8#1)(2010-10#2)(2010-12#5)(2011-2#2)(2012-1#3)(2012-12#5)(2012-2#1)
to individual-based##2##2##(2007-9#1)(2012-3#1)
to individualise##2##2##(2008-6#1)(2008-8#1)
to individualize the##5##3##(1991-1#1)(1997-4#1)(2008-6#1)(2009-1#1)(2011-1#1)
to individualize their##2##3##(2009-5#1)(2010-10#1)
to individualize##11##2##(1991-1#1)(1992-8#1)(1997-4#1)(2005-10#1)(2006-1#1)(2008-6#1)(2009-1#1)(2009-5#1)(2010-10#1)(2011-1#1)(2012-2#1)
to individualized##2##2##(1992-3#1)(2011-2#1)
to individuals of##3##3##(2006-1#1)(2007-3#1)(2010-8#1)
to individuals who##4##3##(2006-10#1)(2007-12#1)(2007-8#1)(2011-1#1)
to individuals with disabilities##2##4##(2005-11#2)
to individuals with##13##3##(1992-12#1)(1994-2#1)(2005-11#2)(2006-7#1)(2007-12#1)(2008-8#1)(2009-4#2)(2009-7#1)(2010-8#2)(2011-2#1)
to individuals##28##2##(1992-12#1)(1994-2#1)(2005-11#2)(2006-1#1)(2006-10#1)(2006-7#1)(2007-12#3)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#2)(2009-7#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
to individuate the##2##3##(2009-4#1)(2011-2#1)
to individuate##4##2##(2009-4#1)(2011-2#1)(2013-1#1)(2013-7#1)
to indomethacin##4##2##(1991-7#1)(2006-10#1)(2008-6#1)(2010-6#1)
to indoor air##2##3##(1992-4#2)
to indoor##6##2##(1992-4#2)(1993-6#2)(2005-8#1)(2008-10#1)
to induce Ca2+##2##3##(1991-3#1)(2010-11#1)
to induce DNA ISC##2##4##(2008-11#2)
to induce DNA damage##2##4##(1993-12#1)(2008-5#1)
to induce DNA single-strand breaks##2##5##(1996-2#1)(2008-3#1)
to induce DNA synthesis##3##4##(1990-10#1)(1992-2#1)(1995-11#1)
to induce DNA##10##3##(1990-10#1)(1992-2#1)(1993-12#1)(1995-11#1)(1996-2#1)(2008-11#3)(2008-3#1)(2008-5#1)
to induce IL-12##2##3##(1996-10#1)(2008-8#1)
to induce T-cell##2##3##(2006-10#1)(2006-6#1)
to induce TGFbeta2 and TbetaRII##2##5##(2007-11#2)
to induce a delayed##2##4##(1995-12#1)(2008-11#1)
to induce a hypersensitive##2##4##(2008-10#2)
to induce a sensitization response was predicted by##2##8##(2008-10#2)
to induce a state of##2##5##(2008-7#1)(2011-1#1)
to induce a##46##3##(1990-12#1)(1990-4#1)(1990-8#1)(1991-8#1)(1992-5#2)(1993-2#1)(1994-12#3)(1994-6#2)(1994-8#1)(1995-12#1)(1995-8#1)(1996-10#2)(1996-12#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-9#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#1)
to induce an increase in##3##5##(1990-10#1)(2007-8#1)(2008-5#1)
to induce an##15##3##(1990-10#1)(1990-2#1)(1992-9#1)(1993-3#1)(1994-3#1)(1995-12#1)(1997-4#1)(2006-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)
to induce analgesia##2##3##(1996-8#1)(1997-1#1)
to induce and maintain##3##4##(1992-8#1)(2007-10#1)(2012-3#1)
to induce and##5##3##(1992-8#1)(2007-10#1)(2008-8#1)(2012-3#1)(2013-1#1)
to induce antibody##3##3##(1990-5#1)(1995-5#1)(2008-11#1)
to induce antigen-specific##2##3##(1992-1#1)(2008-11#1)
to induce any##3##3##(1991-2#1)(1991-8#1)(1997-4#1)
to induce apoptosis in##5##4##(1993-4#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-8#1)
to induce apoptosis of##2##4##(1996-1#1)(2009-8#1)
to induce apoptosis through##2##4##(2009-3#1)(2013-1#1)
to induce apoptosis##13##3##(1993-4#1)(1994-9#1)(1996-1#1)(1996-12#1)(1997-3#1)(2008-10#2)(2008-8#2)(2009-12#1)(2009-3#1)(2009-8#1)(2013-1#1)
to induce autoimmune##2##3##(1997-4#1)(2008-4#1)
to induce autoimmunity##4##3##(2006-10#1)(2006-5#2)(2008-4#1)
to induce bilayer##2##3##(1991-9#1)(2005-11#1)
to induce both##3##3##(1992-8#1)(2006-1#1)(2008-10#1)
to induce c-fos expression##2##4##(1994-12#2)
to induce c-fos##4##3##(1994-12#2)(1997-5#2)
to induce cAMP in LC##2##5##(1995-8#2)
to induce cancer##2##3##(1990-11#1)(2011-2#1)
to induce catalepsy in the##2##5##(1992-12#1)(1993-11#1)
to induce cell##7##3##(1991-2#1)(1992-2#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
to induce changes in##3##4##(1996-5#1)(2011-12#1)(2012-2#1)
to induce complete##2##3##(1992-3#1)(2011-2#1)
to induce conformational changes##2##4##(1992-5#1)(2006-10#1)
to induce cyclic##2##3##(1993-6#1)(1995-11#1)
to induce differentiation of##4##4##(1995-3#1)(2008-11#1)(2008-9#1)(2012-12#1)
to induce differentiation##6##3##(1995-3#2)(1997-3#1)(2008-11#1)(2008-9#1)(2012-12#1)
to induce ectopic##2##3##(2008-4#1)(2011-2#1)
to induce expression##2##3##(2008-10#1)(2008-11#1)
to induce fluorescence##3##3##(2007-12#1)(2008-10#2)
to induce formation of the##2##5##(1990-5#1)(2008-10#1)
to induce functional##2##3##(1990-7#1)(2011-1#1)
to induce fusion##2##3##(2006-10#1)(2009-12#1)
to induce immunologic##2##3##(2008-1#1)(2009-5#1)
to induce in vitro##2##4##(1990-4#1)(2012-12#1)
to induce intrinsic##2##3##(1997-7#1)(2011-2#1)
to induce labour in##2##4##(1995-4#1)(2006-6#1)
to induce liver##2##3##(2009-3#1)(2013-1#1)
to induce lysosomal storage of##2##5##(1993-12#2)
to induce lysosomal##3##3##(1993-12#3)
to induce maximal##2##3##(2008-3#1)(2011-12#1)
to induce models##4##3##(2013-1#4)
to induce monocytic differentiation##2##4##(1994-8#1)(1997-7#1)
to induce or##3##3##(1996-4#1)(2007-8#1)(2008-8#1)
to induce oxidative##3##3##(1993-7#1)(1995-6#1)(2008-11#1)
to induce plastic changes##2##4##(2008-3#1)(2008-9#1)
to induce platelet activation##2##4##(2006-6#2)
to induce proliferation of##2##4##(1993-6#1)(2009-4#1)
to induce proliferation##4##3##(1993-6#1)(2008-4#2)(2009-4#1)
to induce protective immunity to##2##5##(2007-11#2)
to induce protective##4##3##(2006-10#1)(2006-12#1)(2007-11#2)
to induce resistance in##3##4##(2008-10#3)
to induce resistance##6##3##(2008-10#5)(2008-5#1)
to induce reversible##2##3##(1994-11#1)(2009-12#1)
to induce second-order nonlinearity##2##4##(2007-11#1)(2007-12#1)
to induce severe symptoms in##2##5##(2008-10#2)
to induce severe##3##3##(2008-10#2)(2011-1#1)
to induce significant##3##3##(2007-12#1)(2009-6#1)(2010-6#1)
to induce similar##3##3##(2006-11#1)(2007-9#1)(2008-10#1)
to induce specific##3##3##(1997-4#1)(1997-6#1)(2005-10#1)
to induce stable##2##3##(1993-11#1)(2008-10#1)
to induce systemic resistance in tobacco##2##6##(2008-10#2)
to induce systemic resistance in##5##5##(2008-10#5)
to induce systemic resistance##7##4##(2008-10#7)
to induce systemic##8##3##(2008-10#8)
to induce the conformational change in##2##6##(1992-12#1)(1994-11#1)
to induce the expression of##3##5##(1996-12#1)(2008-10#1)(2008-8#1)
to induce the production of##3##5##(1992-6#1)(2008-1#1)(2013-8#1)
to induce the tyrosine phosphorylation of##2##6##(1992-8#1)(1995-3#1)
to induce the##35##3##(1990-11#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-3#2)(1996-12#1)(1997-8#1)(2005-11#1)(2006-9#1)(2007-5#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-7#1)(2012-2#1)(2013-8#1)
to induce these##3##3##(1990-2#1)(2008-10#1)(2012-12#1)
to induce this##2##3##(1997-4#1)(2008-10#1)
to induce tissue##2##3##(1997-1#1)(2012-1#1)
to induce tolerance##2##3##(2006-10#1)(2008-10#1)
to induce transcription of the##2##5##(1995-10#1)(1995-3#1)
to induce transcription##3##3##(1994-3#1)(1995-10#1)(1995-3#1)
to induce transdifferentiation##3##3##(2012-12#2)(2012-7#1)
to induce tumor##2##3##(2008-3#1)(2013-8#1)
to induce tumor-specific##2##3##(2006-10#1)(2011-1#1)
to induce tumors in##2##4##(2008-10#1)(2008-12#1)
to induce weight loss##2##4##(2006-10#1)(2006-2#1)
to induce##575##2##(1990-10#2)(1990-11#4)(1990-12#2)(1990-2#5)(1990-4#3)(1990-5#3)(1990-7#1)(1990-8#1)(1990-9#3)(1991-1#1)(1991-12#1)(1991-2#7)(1991-3#1)(1991-5#8)(1991-8#3)(1991-9#5)(1992-1#1)(1992-12#2)(1992-2#3)(1992-3#5)(1992-5#7)(1992-6#3)(1992-8#5)(1992-9#3)(1993-11#2)(1993-12#6)(1993-2#1)(1993-3#2)(1993-4#2)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#2)(1994-12#8)(1994-2#5)(1994-3#4)(1994-5#3)(1994-6#4)(1994-8#6)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#10)(1995-2#1)(1995-3#9)(1995-4#1)(1995-5#3)(1995-6#3)(1995-8#5)(1995-9#3)(1996-1#1)(1996-10#5)(1996-11#2)(1996-12#3)(1996-2#3)(1996-4#3)(1996-5#4)(1996-8#4)(1996-9#1)(1997-1#4)(1997-2#5)(1997-3#6)(1997-4#8)(1997-5#3)(1997-6#4)(1997-7#6)(1997-8#2)(2003-11#1)(2004-11#1)(2005-10#3)(2005-11#4)(2005-6#1)(2005-8#1)(2006-1#1)(2006-10#14)(2006-11#2)(2006-12#3)(2006-2#2)(2006-5#4)(2006-6#4)(2006-7#1)(2006-8#3)(2006-9#2)(2007-10#4)(2007-11#11)(2007-12#8)(2007-2#3)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#7)(2008-10#63)(2008-11#20)(2008-12#3)(2008-2#4)(2008-3#12)(2008-4#15)(2008-5#12)(2008-6#1)(2008-7#8)(2008-8#12)(2008-9#8)(2009-10#2)(2009-12#6)(2009-3#3)(2009-4#3)(2009-5#1)(2009-6#2)(2009-8#4)(2010-11#3)(2010-12#2)(2010-4#1)(2010-6#2)(2010-7#4)(2011-1#5)(2011-12#2)(2011-2#12)(2012-1#2)(2012-11#1)(2012-12#9)(2012-2#4)(2012-3#1)(2012-7#1)(2013-1#13)(2013-7#1)(2013-8#5)
to induced##11##2##(1990-5#1)(1990-8#1)(1994-2#1)(1994-5#1)(2005-11#1)(2008-10#1)(2008-7#2)(2008-9#1)(2012-12#1)(2013-1#1)
to inducers##2##2##(1990-7#1)(2010-2#1)
to inducing##3##2##(1991-9#1)(1997-3#1)(2008-10#1)
to induction of apoptosis in##2##5##(2008-11#1)(2008-9#1)
to induction of apoptosis##4##4##(1994-5#1)(1996-5#1)(2008-11#1)(2008-9#1)
to induction of neuronal differentiation##2##5##(1992-3#1)(1996-5#1)
to induction of the##2##4##(1994-2#1)(2012-1#1)
to induction of##22##3##(1992-3#1)(1992-6#2)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-8#1)(1996-1#1)(1996-5#2)(1997-2#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-10#1)(2012-1#2)(2013-7#1)
to induction##26##2##(1991-7#1)(1992-3#1)(1992-6#2)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-8#1)(1996-1#1)(1996-5#2)(1997-2#1)(2007-2#2)(2008-10#4)(2008-11#1)(2008-9#1)(2009-10#1)(2012-1#2)(2013-7#1)
to inductively coupled plasma mass spectrometry##3##6##(2007-8#2)(2008-10#1)
to inductively coupled plasma##7##4##(2007-8#2)(2008-10#5)
to inductively##8##2##(2007-8#2)(2008-10#5)(2013-7#1)
to industrial##7##2##(1995-2#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-12#1)
to industry##5##2##(1994-5#1)(2007-1#1)(2008-7#1)(2013-1#2)
to ineffective##2##2##(1991-3#1)(2012-12#1)
to inefficient##4##2##(1991-7#1)(1994-8#1)(2008-2#1)(2009-11#1)
to inequality##2##2##(2012-1#1)(2013-1#1)
to infant##12##2##(1990-12#1)(1992-6#1)(1994-6#1)(2006-10#1)(2007-9#1)(2009-9#1)(2010-6#1)(2011-1#4)(2012-2#1)
to infant's##2##2##(1990-12#2)
to infants and##2##3##(1995-3#1)(1996-8#1)
to infants##10##2##(1991-8#1)(1992-2#1)(1994-2#1)(1995-3#1)(1995-6#1)(1996-8#1)(2006-10#2)(2007-8#1)(2008-12#1)
to infarction##3##2##(1996-7#1)(1997-8#1)(2007-10#1)
to infect a novel host##2##5##(2013-1#2)
to infect a##4##3##(2008-10#2)(2013-1#2)
to infect and##2##3##(2006-10#1)(2008-10#1)
to infect different hosts##2##4##(2006-5#1)(2008-10#1)
to infect different##3##3##(2006-5#1)(2008-10#2)
to infect insect##2##3##(1991-1#1)(2008-7#1)
to infect its host##2##4##(2008-10#2)
to infect plants of##2##4##(2008-10#2)
to infect sclerotia##2##3##(2008-10#2)
to infect susceptible##2##3##(2007-6#1)(2007-9#1)
to infect the##8##3##(1991-6#1)(1992-3#1)(2008-10#3)(2008-11#1)(2008-8#1)(2013-1#1)
to infect##74##2##(1990-4#1)(1991-1#1)(1991-6#2)(1992-3#2)(1994-5#1)(1995-1#1)(1995-5#1)(1995-9#1)(1996-11#1)(1997-1#2)(1997-4#1)(2006-10#1)(2006-5#1)(2007-6#1)(2007-7#3)(2007-9#1)(2008-10#39)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2012-12#2)(2012-2#1)(2013-1#3)
to infected children##2##3##(2013-1#2)
to infected##13##2##(1990-9#1)(1996-12#1)(1996-3#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2012-3#1)(2013-1#2)
to infection and##11##3##(1990-8#1)(1994-2#1)(1997-4#1)(2006-10#3)(2007-8#1)(2008-10#3)(2012-2#1)
to infection as##2##3##(2006-10#1)(2008-10#1)
to infection at##3##3##(2008-10#2)(2013-1#1)
to infection by M##2##4##(2008-10#2)
to infection by P##2##4##(2008-10#2)
to infection by##25##3##(2007-7#1)(2008-10#16)(2009-3#2)(2009-5#5)(2010-7#1)
to infection control##2##3##(2008-1#1)(2012-3#1)
to infection from##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
to infection in the##4##4##(1994-2#2)(2008-10#1)(2011-2#1)
to infection in##8##3##(1994-2#2)(2005-7#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2011-2#1)
to infection is##3##3##(1997-7#1)(2008-10#1)(2010-12#1)
to infection of##4##3##(2008-10#1)(2008-2#1)(2009-6#1)(2010-12#1)
to infection was##3##3##(2008-10#3)
to infection when##2##3##(1993-5#1)(1994-2#1)
to infection with the##2##4##(2007-9#1)(2008-10#1)
to infection with##19##3##(1991-11#1)(1991-4#1)(1994-9#1)(1995-5#1)(1997-4#1)(2005-9#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#1)
to infection##151##2##(1990-6#1)(1990-8#1)(1991-11#1)(1991-4#1)(1993-12#1)(1993-5#1)(1994-2#8)(1994-9#1)(1995-5#1)(1997-4#2)(1997-7#1)(2005-7#1)(2005-9#1)(2006-10#6)(2006-7#3)(2006-8#1)(2007-1#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#60)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#2)(2008-9#2)(2009-12#1)(2009-3#2)(2009-5#6)(2009-6#2)(2009-8#1)(2010-12#4)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#9)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
to infections and##3##3##(2006-8#1)(2007-2#1)(2012-3#1)
to infections in##3##3##(1990-9#1)(2008-10#1)(2008-9#1)
to infections observed in##2##4##(1991-9#1)(2008-7#1)
to infections##24##2##(1990-9#1)(1991-6#1)(1991-9#1)(1997-5#1)(2006-8#3)(2007-1#1)(2007-2#5)(2007-8#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
to infectious agents##2##3##(1995-7#1)(2006-10#1)
to infectious and parasitic##2##4##(2007-2#2)
to infectious and##3##3##(2007-11#1)(2007-2#2)
to infectious bronchitis virus##2##4##(2007-6#1)(2008-5#1)
to infectious bronchitis##3##3##(1997-3#1)(2007-6#1)(2008-5#1)
to infectious complications##2##3##(1993-2#1)(1997-8#1)
to infectious diseases##7##3##(1990-6#1)(1997-8#1)(2007-7#1)(2008-10#3)(2012-2#1)
to infectious##23##2##(1990-6#1)(1993-2#1)(1995-7#1)(1997-3#1)(1997-8#2)(2006-10#1)(2006-11#1)(2007-11#1)(2007-2#2)(2007-6#1)(2007-7#1)(2008-10#4)(2008-4#1)(2008-5#3)(2008-8#1)(2012-2#1)
to infer a##2##3##(1997-4#1)(2008-4#1)
to infer climate##2##3##(2008-10#1)(2012-7#1)
to infer that##2##3##(2008-10#1)(2013-1#1)
to infer the##22##3##(1992-1#1)(1992-12#1)(1994-3#1)(1995-5#1)(1997-2#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-12#2)(2008-1#2)(2008-11#1)(2008-3#3)(2008-8#1)(2008-9#1)(2010-8#2)(2012-3#1)(2013-1#1)
to infer##47##2##(1992-1#1)(1992-12#1)(1994-3#1)(1995-5#1)(1997-2#1)(1997-4#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-12#2)(2008-1#3)(2008-10#4)(2008-11#1)(2008-3#5)(2008-4#4)(2008-8#1)(2008-9#1)(2010-3#1)(2010-7#1)(2010-8#3)(2011-1#3)(2012-1#1)(2012-3#2)(2012-7#1)(2012-9#1)(2013-1#3)(2013-8#1)
to inferences##2##2##(1993-1#1)(1997-4#1)
to inferior##2##2##(2009-5#1)(2012-11#1)
to inferring##2##2##(2008-4#1)(2008-7#1)
to infertility##4##2##(1994-11#1)(1995-2#1)(2011-2#1)(2012-11#1)
to infestation with##3##3##(1996-12#1)(2008-10#2)
to infestation##4##2##(1996-12#1)(2008-10#3)
to infiltrate##4##2##(2007-11#1)(2008-10#1)(2010-12#1)(2010-4#1)
to infiltration of##3##3##(2008-10#2)(2009-5#1)
to infiltration##6##2##(2005-11#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-5#1)
to infinity##4##2##(2007-12#1)(2008-12#1)(2008-2#1)(2010-12#1)
to inflamed tissues##2##3##(2008-3#2)
to inflamed##4##2##(1991-2#1)(1997-8#1)(2008-3#2)
to inflammation and##4##3##(1990-5#2)(1995-8#1)(2009-8#1)
to inflammation in##2##3##(1992-6#1)(2012-1#1)
to inflammation##13##2##(1990-5#2)(1992-6#1)(1995-1#1)(1995-8#1)(2005-11#2)(2008-2#1)(2009-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
to inflammatory and##4##3##(2007-8#1)(2008-4#1)(2010-12#1)(2011-2#1)
to inflammatory bowel disease##3##4##(2004-11#1)(2006-10#1)(2008-12#1)
to inflammatory bowel##4##3##(2004-11#1)(2006-10#1)(2008-12#1)(2012-11#1)
to inflammatory reactions##2##3##(2008-5#1)(2010-2#1)
to inflammatory stimuli##3##3##(2006-2#1)(2006-5#1)(2009-12#1)
to inflammatory##27##2##(1993-8#1)(1994-8#1)(1995-12#2)(1996-6#1)(2004-11#1)(2006-10#2)(2006-2#2)(2006-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2009-12#1)(2009-5#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)
to infliximab##7##2##(2006-10#1)(2007-11#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
to influence a##2##3##(2008-6#1)(2008-9#1)
to influence and##2##3##(2006-10#1)(2011-1#1)
to influence basal##2##3##(1991-2#1)(1993-11#1)
to influence both innate and##2##5##(2006-10#2)
to influence both##3##3##(2005-10#1)(2006-10#2)
to influence cell##2##3##(1993-6#1)(2008-5#1)
to influence eating habits##2##4##(2010-1#2)
to influence on the##2##4##(2006-8#1)(2013-1#1)
to influence on##3##3##(1994-3#1)(2006-8#1)(2013-1#1)
to influence overall##2##3##(1993-5#1)(2006-6#1)
to influence survival##2##3##(2007-8#1)(2008-6#1)
to influence the degree##2##4##(2008-7#1)(2009-7#1)
to influence the differentiation##2##4##(1995-1#1)(1996-10#1)
to influence the evolution of##2##5##(2006-10#1)(2008-8#1)
to influence the risk of##2##5##(1994-4#1)(2009-10#1)
to influence the##59##3##(1990-11#1)(1990-9#1)(1991-2#1)(1991-3#2)(1991-8#1)(1992-10#1)(1994-4#1)(1995-1#1)(1995-11#1)(1995-12#3)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-5#1)(2006-10#3)(2006-11#1)(2006-8#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
to influence their##3##3##(1997-1#1)(2008-8#1)(2010-3#1)
to influence them##2##3##(2008-12#1)(2008-2#1)
to influence##176##2##(1990-11#1)(1990-3#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-3#2)(1991-6#1)(1991-8#1)(1992-10#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#2)(1994-3#2)(1994-4#1)(1994-6#2)(1995-1#1)(1995-11#1)(1995-12#5)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#2)(1997-5#1)(1997-6#2)(2005-10#2)(2006-1#1)(2006-10#9)(2006-11#2)(2006-2#1)(2006-6#1)(2006-8#4)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#3)(2008-2#4)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#6)(2008-8#4)(2008-9#2)(2009-10#2)(2009-3#4)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#4)(2011-2#3)(2012-1#3)(2012-12#4)(2012-2#3)(2013-1#7)(2013-7#3)(2013-8#1)
to influenza and##4##3##(1997-8#3)(2011-2#1)
to influenza in##2##3##(1997-8#1)(2009-12#1)
to influenza vaccination##2##3##(1997-6#1)(2011-2#1)
to influenza virus##2##3##(1993-12#1)(2005-7#1)
to influenza##25##2##(1992-6#2)(1993-12#1)(1994-6#1)(1997-6#1)(1997-8#5)(2004-11#1)(2005-11#1)(2005-7#1)(2007-11#1)(2007-12#1)(2008-5#2)(2009-12#1)(2010-12#1)(2010-4#1)(2011-2#3)(2012-3#1)(2013-1#1)
to inform about##3##3##(1995-11#1)(2005-10#1)(2006-2#1)
to inform and##2##3##(1994-1#1)(2012-3#1)
to inform clinical##2##3##(2007-7#1)(2011-10#1)
to inform decision making##2##4##(1992-12#1)(2011-1#1)
to inform future##2##3##(2012-12#1)(2013-1#1)
to inform health policy##2##4##(1996-1#1)(2012-12#1)
to inform health##3##3##(1996-1#1)(2012-12#2)
to inform management##2##3##(1996-1#1)(2010-10#1)
to inform on the##2##4##(2009-8#1)(2013-1#1)
to inform policy##3##3##(2010-11#1)(2010-8#1)(2011-1#1)
to inform practice##2##3##(2007-10#1)(2009-8#1)
to inform public##3##3##(1996-1#1)(2008-1#1)(2011-1#1)
to inform research##2##3##(2007-12#1)(2008-12#1)
to inform the development of appropriate##2##6##(2007-10#1)(2011-2#1)
to inform the public about##2##5##(1992-1#1)(1996-2#1)
to inform the public##4##4##(1992-1#1)(1994-3#1)(1996-2#1)(2008-3#1)
to inform the##14##3##(1990-4#1)(1991-9#1)(1992-1#1)(1994-3#1)(1996-2#1)(2005-11#1)(2007-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-12#2)(2012-2#2)
to inform their patients##2##4##(1991-11#1)(1997-6#1)
to inform their##3##3##(1991-11#1)(1997-6#1)(2012-3#1)
to inform them##2##3##(1996-6#1)(2012-3#1)
to inform treatment##2##3##(2008-7#1)(2013-8#1)
to inform us##3##3##(2007-12#1)(2013-1#2)
to inform##104##2##(1990-4#1)(1991-11#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-12#2)(1994-1#1)(1994-3#1)(1995-11#1)(1996-1#3)(1996-2#1)(1996-6#1)(1997-3#1)(1997-6#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-2#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#6)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#5)(2011-10#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#4)(2012-3#6)(2013-1#13)(2013-8#1)
to informal##2##2##(2004-12#1)(2013-1#1)
to information on##2##3##(1995-3#1)(2008-4#1)
to information##18##2##(1990-12#1)(1995-3#1)(2006-7#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-11#1)(2010-8#2)(2013-1#1)(2013-8#1)
to informed consent##6##3##(2006-10#1)(2007-11#1)(2009-6#1)(2012-12#3)
to informed##8##2##(2006-1#1)(2006-10#1)(2007-11#1)(2009-6#1)(2011-2#1)(2012-12#3)
to infrared (IR)##2##3##(2007-12#1)(2011-2#1)
to infrared##5##2##(1996-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2011-2#1)
to infuse##4##2##(1992-1#1)(1997-3#1)(2008-8#1)(2009-5#1)
to infusion##2##2##(1991-12#1)(2008-1#1)
to ingest##6##2##(1990-2#1)(1995-5#1)(2008-1#1)(2008-4#1)(2008-5#2)
to ingestion of##5##3##(2009-4#1)(2009-9#1)(2011-2#1)(2012-2#2)
to inhalant##2##2##(2007-2#1)(2007-7#1)
to inhalation of##4##3##(1990-9#1)(1994-6#2)(1995-11#1)
to inhalation##7##2##(1990-9#1)(1994-3#1)(1994-6#2)(1995-11#1)(2006-6#1)(2007-1#1)
to inhale##2##2##(1992-3#1)(1997-4#1)
to inhaled##7##2##(1992-4#1)(1994-2#1)(2005-10#1)(2005-8#1)(2008-3#1)(2009-6#1)(2012-1#1)
to inherent##5##2##(1996-11#1)(2008-10#2)(2008-7#1)(2012-2#1)
to inherit##5##2##(2008-7#1)(2008-8#4)
to inheritance of##2##3##(2008-10#1)(2010-10#1)
to inherited##2##2##(2006-10#1)(2006-4#1)
to inhibin##2##2##(1994-3#1)(1996-8#1)
to inhibit Ca2+##2##3##(1990-11#1)(1991-5#1)
to inhibit Cat##2##3##(1992-1#1)(1994-12#1)
to inhibit DNA##2##3##(1991-7#1)(1997-3#1)
to inhibit HIV-1##2##3##(1994-6#1)(2011-3#1)
to inhibit HSV##2##3##(2008-5#1)(2009-12#1)
to inhibit PKC##2##3##(1991-10#1)(2008-8#1)
to inhibit a##3##3##(1992-5#1)(2008-11#1)(2013-8#1)
to inhibit binding of the##2##5##(1992-5#1)(2009-7#1)
to inhibit binding of##3##4##(1992-5#1)(1995-1#1)(2009-7#1)
to inhibit both##4##3##(1994-11#1)(1997-6#1)(2008-1#1)(2008-4#1)
to inhibit carcinogenesis##2##3##(1995-9#1)(2009-2#1)
to inhibit cell##3##3##(1991-2#1)(1994-6#1)(1994-8#1)
to inhibit cholesterol##2##3##(1994-9#1)(1996-8#1)
to inhibit cytokine##2##3##(2012-1#1)(2013-7#1)
to inhibit either##2##3##(1994-3#1)(2005-10#1)
to inhibit elastase##2##3##(2008-5#2)
to inhibit electrically evoked##2##4##(1995-12#1)(1995-6#1)
to inhibit gastric acid secretion##2##5##(1992-6#1)(1997-6#1)
to inhibit growth of##6##4##(1990-9#1)(1993-1#1)(2008-10#1)(2010-11#1)(2010-12#1)(2011-2#1)
to inhibit growth##10##3##(1990-2#1)(1990-9#1)(1993-1#1)(1995-1#1)(1995-2#1)(2005-11#1)(2008-10#1)(2010-11#1)(2010-12#1)(2011-2#1)
to inhibit human##2##3##(1992-8#1)(2008-10#1)
to inhibit in vitro##2##4##(1993-5#1)(2008-10#1)
to inhibit insulin##2##3##(1995-1#1)(1996-5#1)
to inhibit its##2##3##(1994-6#1)(1995-2#1)
to inhibit lipid peroxidation##4##4##(1992-8#1)(1993-8#1)(1995-1#1)(2011-2#1)
to inhibit platelet aggregation##2##4##(1995-5#1)(2006-10#1)
to inhibit platelet##3##3##(1994-10#1)(1995-5#1)(2006-10#1)
to inhibit proliferation of##2##4##(1991-8#1)(1997-3#1)
to inhibit proliferation##3##3##(1991-8#1)(1997-3#1)(2013-7#1)
to inhibit protein##2##3##(1990-9#1)(1994-2#1)
to inhibit replication of##3##4##(1993-9#1)(1994-6#1)(1996-1#1)
to inhibit rotavirus binding##2##4##(2012-1#2)
to inhibit some##3##3##(1995-2#1)(1996-8#1)(2007-11#1)
to inhibit the activity of the##2##6##(1995-11#1)(1996-5#1)
to inhibit the activity##3##4##(1990-6#1)(1995-11#1)(1996-5#1)
to inhibit the binding of 125I-IGF-II to the##2##8##(1990-5#2)
to inhibit the binding of##10##5##(1990-12#1)(1990-5#2)(1992-9#1)(1994-8#1)(1995-11#1)(1997-1#1)(2008-4#2)(2009-2#1)
to inhibit the conversion of##2##5##(1992-6#1)(1995-11#1)
to inhibit the development of##2##5##(2005-3#1)(2009-4#1)
to inhibit the differentiation of##2##5##(1993-6#1)(2006-1#1)
to inhibit the enzyme##2##4##(1990-4#1)(1992-5#1)
to inhibit the expression of the##2##6##(1997-5#1)(2011-12#1)
to inhibit the expression of##8##5##(1995-11#1)(1997-5#1)(1997-6#1)(2006-12#1)(2008-5#1)(2008-9#1)(2010-1#1)(2011-12#1)
to inhibit the expression##9##4##(1993-6#1)(1995-11#1)(1997-5#1)(1997-6#1)(2006-12#1)(2008-5#1)(2008-9#1)(2010-1#1)(2011-12#1)
to inhibit the formation of##5##5##(1994-5#1)(1996-3#1)(1997-8#1)(2010-12#1)(2011-12#1)
to inhibit the function of##2##5##(1992-8#1)(2008-8#1)
to inhibit the growth of a##2##6##(2008-10#1)(2010-9#1)
to inhibit the growth of##15##5##(1991-10#1)(1992-6#1)(1993-11#1)(1994-3#1)(1996-2#1)(2008-10#5)(2008-3#1)(2008-5#1)(2009-2#1)(2010-9#1)(2011-1#1)
to inhibit the growth##16##4##(1991-10#1)(1992-6#1)(1993-11#1)(1994-3#1)(1996-2#1)(2008-10#5)(2008-3#1)(2008-5#2)(2009-2#1)(2010-9#1)(2011-1#1)
to inhibit the##125##3##(1990-11#1)(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#3)(1990-9#3)(1991-10#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-5#2)(1992-6#4)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-4#1)(1993-6#3)(1993-8#2)(1994-10#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#2)(1995-1#1)(1995-11#6)(1995-3#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#4)(1997-5#1)(1997-6#1)(1997-8#1)(2005-3#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-2#1)(2007-8#2)(2008-10#8)(2008-11#2)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-2#2)(2009-4#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-11#3)
to inhibit this##3##3##(1991-7#1)(1995-11#1)(2008-11#1)
to inhibit thrombin formation##2##4##(1994-5#2)
to inhibit thrombin##4##3##(1990-7#1)(1991-9#1)(1994-5#2)
to inhibit tumor cell growth##3##5##(1991-8#1)(2008-1#1)(2008-11#1)
to inhibit tumor##7##3##(1991-8#1)(1994-9#1)(2008-1#1)(2008-11#2)(2008-9#1)(2010-12#1)
to inhibit##407##2##(1990-10#2)(1990-11#3)(1990-12#4)(1990-2#5)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#5)(1990-8#2)(1990-9#6)(1991-10#3)(1991-11#3)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#3)(1991-7#2)(1991-8#5)(1991-9#6)(1992-1#2)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#7)(1992-6#7)(1992-7#3)(1992-8#4)(1992-9#4)(1993-1#1)(1993-11#2)(1993-12#2)(1993-4#3)(1993-5#1)(1993-6#3)(1993-8#3)(1993-9#3)(1994-10#3)(1994-11#5)(1994-12#2)(1994-2#5)(1994-3#6)(1994-5#5)(1994-6#10)(1994-8#9)(1994-9#9)(1995-1#8)(1995-10#1)(1995-11#10)(1995-12#7)(1995-2#5)(1995-3#5)(1995-5#2)(1995-6#4)(1995-8#4)(1995-9#1)(1996-1#2)(1996-10#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#2)(1997-1#5)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#4)(1997-6#5)(1997-7#1)(1997-8#2)(2005-10#1)(2005-11#2)(2005-3#1)(2005-7#3)(2005-8#2)(2006-1#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-4#1)(2006-8#5)(2007-11#5)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#18)(2008-11#8)(2008-3#2)(2008-4#5)(2008-5#11)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#3)(2009-10#2)(2009-11#2)(2009-12#3)(2009-2#3)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#3)(2010-2#5)(2010-4#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#6)(2011-3#1)(2012-1#4)(2012-11#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#2)
to inhibited##2##2##(1996-5#1)(2008-7#1)
to inhibition by malonyl-CoA##3##4##(1991-6#2)(1997-4#1)
to inhibition by the##2##4##(1992-3#1)(1994-9#1)
to inhibition by##25##3##(1990-7#1)(1991-12#1)(1991-6#2)(1992-3#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-11#2)(1995-3#1)(1995-5#1)(1995-8#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-4#1)(2008-5#1)(2010-2#1)(2013-7#1)
to inhibition of 5-HT##2##4##(2008-7#2)
to inhibition of the##9##4##(1990-7#1)(1991-7#1)(1993-4#1)(1993-6#1)(1994-6#1)(1996-1#1)(1996-2#1)(2008-10#1)(2013-1#1)
to inhibition of vital cellular functions##2##6##(2008-9#2)
to inhibition of##50##3##(1990-12#1)(1990-3#1)(1990-7#1)(1991-10#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#2)(1994-12#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#2)(2007-11#2)(2007-7#1)(2008-10#1)(2008-7#2)(2008-9#2)(2009-1#1)(2009-8#1)(2009-9#1)(2011-1#3)(2012-11#1)(2012-2#1)(2013-1#2)(2013-8#1)
to inhibition##85##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#2)(1991-10#1)(1991-12#1)(1991-5#1)(1991-6#3)(1991-7#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#3)(1996-1#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#2)(2007-11#3)(2007-7#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-1#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-1#3)(2012-11#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
to inhibitor##2##2##(1990-12#1)(1994-2#1)
to inhibitors of cell wall synthesis##2##6##(2006-11#2)
to inhibitors of##9##3##(1990-7#1)(1991-7#1)(1993-9#1)(1996-12#1)(2005-7#1)(2006-11#2)(2007-11#1)(2013-1#1)
to inhibitors##14##2##(1990-7#1)(1991-7#1)(1992-12#1)(1993-11#1)(1993-9#1)(1994-2#1)(1996-12#1)(2005-7#1)(2006-11#2)(2007-11#1)(2008-10#1)(2012-2#1)(2013-1#1)
to inhibitory##8##2##(1991-9#1)(1994-5#1)(2007-12#1)(2008-5#2)(2008-6#1)(2013-1#1)(2013-8#1)
to initial success##2##3##(2006-3#1)(2007-7#1)
to initial therapy##2##3##(1993-2#1)(2010-11#1)
to initial treatment with##2##4##(2007-11#1)(2010-12#1)
to initial##23##2##(1993-2#1)(1996-1#1)(2006-10#1)(2006-3#1)(2006-7#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#6)(2008-2#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-2#1)(2010-11#1)(2010-12#1)(2013-1#1)
to initially##4##2##(2008-10#1)(2010-3#1)(2012-1#1)(2012-12#1)
to initiate a biological weapons program##2##6##(1992-12#2)
to initiate a biological weapons##3##5##(1992-12#3)
to initiate a##13##3##(1991-1#1)(1992-12#3)(1995-1#1)(1995-11#1)(2006-10#1)(2007-2#2)(2008-10#1)(2009-4#1)(2009-9#1)(2012-2#1)
to initiate and##3##3##(1991-9#1)(1997-6#1)(2012-3#1)
to initiate early##2##3##(1990-3#1)(1996-8#1)
to initiate more playful contacts##2##5##(1992-9#2)
to initiate or##2##3##(2007-8#1)(2008-11#1)
to initiate the consent process for##2##6##(2008-8#2)
to initiate the consent process##3##5##(2008-8#3)
to initiate the##20##3##(1992-7#1)(1993-2#1)(1994-11#1)(1995-12#1)(1995-2#1)(1997-2#1)(2005-7#1)(2006-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#3)(2011-1#1)(2012-12#1)
to initiate this##2##3##(2006-10#1)(2006-12#1)
to initiate transcription##4##3##(1993-11#1)(1995-2#2)(1996-2#1)
to initiate treatment##4##3##(2007-2#1)(2008-6#1)(2010-12#1)(2013-8#1)
to initiate##118##2##(1990-11#1)(1990-12#1)(1990-3#1)(1991-1#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#3)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#5)(1995-3#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-2#2)(1996-8#1)(1997-2#1)(1997-6#2)(2005-10#1)(2005-7#1)(2006-10#3)(2006-12#2)(2006-2#1)(2007-10#1)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#6)(2008-11#8)(2008-12#1)(2008-2#3)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#6)(2009-11#1)(2009-4#2)(2009-8#1)(2009-9#2)(2010-12#3)(2010-2#1)(2011-1#2)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-7#1)(2013-8#1)
to initiating##7##2##(1997-2#1)(2006-10#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
to initiation of the##2##4##(1991-11#1)(2008-4#1)
to initiation of##13##3##(1991-11#1)(1993-5#1)(1995-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2009-2#1)(2009-3#1)(2010-2#1)(2011-1#2)
to initiation##16##2##(1991-11#1)(1993-5#1)(1995-9#1)(2005-10#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2009-2#1)(2009-3#1)(2010-2#1)(2011-1#3)(2013-8#1)
to inject##10##2##(1990-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2013-8#1)
to injection of##4##3##(1993-2#1)(2006-8#1)(2007-11#1)(2010-12#1)
to injection##11##2##(1993-11#1)(1993-2#1)(1995-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-5#1)(2010-12#1)(2013-1#1)
to injure##3##2##(1994-2#2)(2008-7#1)
to injured tissues##3##3##(2007-11#1)(2008-9#1)(2012-12#1)
to injured##7##2##(1996-9#1)(2007-11#1)(2007-4#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
to injuries##3##2##(1990-6#1)(2006-11#1)(2007-1#1)
to injury and##5##3##(1994-11#1)(2006-8#2)(2008-7#1)(2008-9#1)
to injury in##3##3##(1995-1#1)(2006-11#1)(2013-1#1)
to injury of the##2##4##(2007-8#1)(2013-1#1)
to injury of##3##3##(1992-7#1)(2007-8#1)(2013-1#1)
to injury or##3##3##(2006-10#1)(2007-1#1)(2008-1#1)
to injury##47##2##(1990-7#2)(1991-2#1)(1991-9#1)(1992-7#1)(1992-9#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-11#2)(1995-12#1)(1996-3#1)(1997-8#1)(2005-10#2)(2005-7#1)(2006-10#3)(2006-11#3)(2006-8#3)(2007-1#2)(2007-11#1)(2007-8#1)(2008-1#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
to innate immune##2##3##(2006-10#1)(2009-6#1)
to innate##3##2##(2006-10#1)(2008-5#1)(2009-6#1)
to inner##5##2##(1995-12#1)(1995-3#1)(2006-10#1)(2007-8#1)(2008-1#1)
to innocuous##3##2##(1996-12#2)(2004-4#1)
to innovate##4##2##(2008-7#1)(2011-2#1)(2013-1#2)
to innovations##2##2##(2005-7#1)(2008-3#1)
to innovative##3##2##(1994-2#1)(2011-2#2)
to inoculate a##2##3##(2008-10#1)(2008-11#1)
to inoculate##11##2##(2008-10#7)(2008-11#1)(2008-4#1)(2008-9#2)
to inoculation with the##4##4##(2008-10#3)(2012-11#1)
to inoculation with##9##3##(2008-10#7)(2012-11#2)
to inoculation##19##2##(1991-12#1)(2008-10#14)(2008-8#1)(2012-11#2)(2013-1#1)
to inoculum or##2##3##(2008-10#2)
to inoculum##8##2##(2008-10#8)
to inorganic mercury##3##3##(2008-10#3)
to inorganic phosphate##2##3##(1993-4#1)(2008-10#1)
to inorganic##10##2##(1990-5#1)(1993-4#2)(2007-9#1)(2008-10#4)(2008-3#1)(2008-5#1)
to inosine##4##2##(1991-11#1)(1995-8#1)(1997-4#1)(2010-9#1)
to inositol 1##2##3##(1993-8#2)
to inositol##9##2##(1991-2#1)(1992-11#1)(1993-8#2)(1996-1#1)(2006-10#1)(2008-8#3)
to inpatient beds##2##3##(2008-3#2)
to inpatient rehabilitation##2##3##(2006-10#1)(2007-10#1)
to inpatient##10##2##(1996-3#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-3#3)(2009-8#1)(2012-3#1)
to inpatients##3##2##(1992-1#1)(1993-12#1)(2011-2#1)
to input##2##2##(2005-11#1)(2008-1#1)
to inquire about##2##3##(1997-2#1)(2011-2#1)
to inquire into the##2##4##(2006-10#1)(2006-4#1)
to inquire##4##2##(1997-2#1)(2006-10#1)(2006-4#1)(2011-2#1)
to insect feeding##4##3##(2009-8#4)
to insect flight muscle fibrils##2##5##(1990-4#2)
to insect##10##2##(1990-4#2)(2006-12#1)(2009-8#4)(2010-12#1)(2011-1#1)(2011-2#1)
to insecticides##7##2##(1992-2#1)(2007-10#1)(2007-6#1)(2011-2#1)(2012-12#2)(2013-7#1)
to insects##3##2##(2007-3#1)(2008-5#1)(2009-8#1)
to inseminate##3##2##(2005-9#1)(2012-12#2)
to insert a##2##3##(1996-2#1)(2012-12#1)
to insert in##2##3##(2008-10#1)(2013-1#1)
to insert the##3##3##(1993-11#1)(2008-11#1)(2011-2#1)
to insert##12##2##(1990-11#1)(1990-9#1)(1993-11#1)(1996-2#1)(2007-5#1)(2008-10#1)(2008-11#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#2)
to insertion##5##2##(1996-10#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-5#1)
to insist on##2##3##(1995-12#1)(2009-7#1)
to insomnia##4##2##(2007-6#1)(2012-1#1)(2012-11#1)(2012-2#1)
to inspect the##3##3##(1995-4#1)(2007-12#1)(2008-7#1)
to inspect##6##2##(1995-4#1)(1995-6#1)(1997-5#1)(2007-12#1)(2008-6#1)(2008-7#1)
to inspection##2##2##(2007-12#1)(2008-10#1)
to inspiratory and expiratory##2##4##(1991-11#1)(1994-10#1)
to instability and##2##3##(2007-11#1)(2012-2#1)
to instability##4##2##(2007-11#1)(2008-6#1)(2009-5#1)(2012-2#1)
to install and use##2##4##(2008-3#1)(2008-4#1)
to install and##3##3##(2007-9#1)(2008-3#1)(2008-4#1)
to install the##2##3##(1991-1#1)(2009-9#1)
to install##8##2##(1991-1#1)(1996-2#1)(2005-12#1)(2007-9#1)(2008-3#1)(2008-4#1)(2009-9#1)(2012-12#1)
to instill##2##2##(2008-12#2)
to institute and implement##2##4##(2006-10#1)(2012-3#1)
to institute##4##2##(2006-10#1)(2008-2#1)(2011-12#1)(2012-3#1)
to institutional care##2##3##(1993-3#1)(1995-3#1)
to institutional##4##2##(1993-3#1)(1995-3#1)(2008-2#1)(2013-8#1)
to institutions##2##2##(1992-3#1)(1995-3#1)
to instruct##2##2##(1995-4#1)(2010-7#1)
to instruction##5##2##(2007-10#1)(2009-11#3)(2011-2#1)
to instrumental##3##2##(1991-6#1)(2007-6#1)(2008-3#1)
to instruments##2##2##(1997-4#1)(2006-6#1)
to insufficient##15##2##(1990-3#1)(1990-5#1)(1993-11#1)(1994-12#1)(1995-9#1)(1996-1#1)(2007-7#1)(2008-10#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
to insulate##4##2##(1991-3#2)(1992-2#1)(1994-5#1)
to insulin in##3##3##(1996-2#1)(2008-3#1)(2010-11#1)
to insulin resistance and##2##4##(2006-1#1)(2011-1#1)
to insulin resistance in##2##4##(1990-9#1)(2011-12#1)
to insulin resistance##14##3##(1990-9#1)(1996-2#1)(2006-1#2)(2006-9#1)(2008-1#2)(2008-3#2)(2010-4#1)(2011-1#1)(2011-12#1)(2012-5#1)(2013-1#1)
to insulin sensitivity##3##3##(1996-11#1)(2008-3#2)
to insulin treatment##2##3##(1994-2#1)(2010-4#1)
to insulin##54##2##(1990-7#1)(1990-9#1)(1991-10#2)(1991-7#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-8#1)(1996-11#2)(1996-2#3)(1996-8#2)(1997-8#1)(2005-8#1)(2006-1#2)(2006-2#1)(2006-9#1)(2008-1#5)(2008-3#6)(2008-9#1)(2010-10#1)(2010-11#2)(2010-4#3)(2011-1#2)(2011-12#1)(2012-5#1)(2013-1#3)(2013-8#1)
to insults##3##2##(2008-8#2)(2012-1#1)
to insurance##5##2##(1992-2#2)(1996-12#1)(1997-5#1)(2010-4#1)
to insure##5##2##(1993-3#1)(1994-3#1)(1997-2#1)(2008-10#1)(2008-9#1)
to intact animals##2##3##(1995-7#1)(2008-4#1)
to intact cells##4##3##(1991-8#1)(1994-11#1)(1995-3#1)(1997-1#1)
to intact fibrin was 0##2##5##(1991-7#2)
to intact human erythrocytes##2##4##(1990-12#1)(1994-8#1)
to intact##28##2##(1990-12#1)(1990-7#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-1#1)(1992-3#1)(1993-2#1)(1994-11#1)(1994-8#2)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-7#2)(1996-3#1)(1997-1#1)(1997-4#1)(2008-10#2)(2008-4#2)(2008-8#1)(2009-5#1)
to intake##2##2##(1993-12#1)(1997-8#1)
to integrate a##2##3##(1992-2#1)(2008-3#1)
to integrate and##4##3##(1993-2#1)(1994-12#1)(1995-1#1)(2010-9#1)
to integrate clinical and##3##4##(2006-11#1)(2013-1#2)
to integrate many##2##3##(2007-9#1)(2009-10#1)
to integrate public health and medicine##2##6##(1995-2#2)
to integrate public health and##3##5##(1995-2#3)
to integrate research##2##3##(2006-5#2)
to integrate results##2##3##(2007-6#1)(2008-4#1)
to integrate some##2##3##(1995-3#1)(2009-4#1)
to integrate the new##2##4##(1993-2#1)(2009-9#1)
to integrate the##10##3##(1993-2#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-8#1)(2009-9#1)(2012-3#1)
to integrate their##3##3##(1995-5#1)(1996-2#1)(2008-11#1)
to integrate these##3##3##(2006-1#1)(2008-7#1)(2012-12#1)
to integrate this##5##3##(1997-2#1)(2008-10#1)(2008-7#1)(2010-12#1)(2013-8#1)
to integrate##101##2##(1990-3#1)(1991-2#1)(1991-6#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#3)(1993-3#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-2#3)(1995-3#2)(1995-5#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-1#2)(2006-11#2)(2006-2#1)(2006-5#3)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-10#5)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#10)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#1)(2009-4#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-12#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#4)(2013-8#1)
to integrated health##3##3##(1997-2#1)(1997-3#1)(2006-9#1)
to integrated treatment at 12 months##2##6##(2012-3#2)
to integrated treatment##4##3##(2012-3#4)
to integrated##12##2##(1994-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-2#1)(2012-3#4)
to integrating##7##2##(1994-1#1)(1994-2#1)(2007-5#1)(2008-10#1)(2008-11#1)(2009-2#1)(2009-6#1)
to integration##7##2##(1992-12#1)(1992-2#1)(1994-3#1)(1997-3#1)(1997-5#1)(2008-11#1)(2012-2#1)
to integrative##2##2##(2008-12#1)(2008-5#1)
to intense and prolonged##2##4##(1996-7#1)(2007-5#1)
to intense##8##2##(1996-7#1)(2006-10#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-1#1)(2013-7#1)
to intensified##2##2##(1995-12#1)(2007-5#1)
to intensify the##3##3##(2007-2#1)(2008-1#1)(2008-11#1)
to intensify##8##2##(1991-10#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-11#2)(2010-10#1)(2010-3#1)
to intensities of##2##3##(2007-12#1)(2008-2#1)
to intensity##6##2##(2007-12#2)(2008-3#2)(2008-7#1)(2011-1#1)
to intensive care unit and##2##5##(2012-3#1)(2013-1#1)
to intensive care units##4##4##(2007-12#1)(2008-11#1)(2013-7#2)
to intensive care##10##3##(2006-4#2)(2007-12#2)(2008-11#1)(2012-3#1)(2013-1#2)(2013-7#2)
to intensive program##2##3##(2012-3#2)
to intensive##19##2##(2006-4#2)(2006-7#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-6#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#2)
to inter-individual##2##2##(1997-3#1)(2009-5#1)
to interact directly with the##3##5##(1995-6#2)(1997-4#1)
to interact directly with##5##4##(1995-3#1)(1995-6#2)(1996-1#1)(1997-4#1)
to interact directly##6##3##(1995-3#1)(1995-6#2)(1996-1#1)(1997-4#1)(2008-4#1)
to interact in##3##3##(1993-6#1)(1994-5#1)(1996-6#1)
to interact strongly with##2##4##(2007-12#1)(2009-3#1)
to interact with DNA##3##4##(1992-6#1)(2006-10#1)(2008-3#1)
to interact with TBP##2##4##(1992-5#1)(1993-8#1)
to interact with a##8##4##(1991-5#1)(1992-11#2)(1995-2#1)(2007-5#1)(2008-10#1)(2009-3#1)(2012-2#1)
to interact with all of##2##5##(2005-11#1)(2008-8#1)
to interact with each other and##2##6##(1997-6#1)(2008-10#1)
to interact with each other##3##5##(1996-5#1)(1997-6#1)(2008-10#1)
to interact with either the##2##5##(1995-11#1)(1995-8#1)
to interact with proteins##2##4##(2008-10#1)(2009-8#1)
to interact with the environment##2##5##(2010-5#1)(2012-1#1)
to interact with the##29##4##(1990-12#1)(1990-3#1)(1991-2#1)(1993-6#2)(1993-8#1)(1994-5#1)(1994-9#1)(1995-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(2005-8#1)(2007-6#1)(2008-10#2)(2008-5#3)(2009-12#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-3#2)(2013-1#1)
to interact with them##2##4##(2009-3#1)(2009-9#1)
to interact with##113##3##(1990-12#1)(1990-3#1)(1991-2#1)(1991-5#1)(1991-8#2)(1992-11#3)(1992-2#3)(1992-5#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#2)(1994-12#2)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#3)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-2#1)(1996-5#2)(1996-6#1)(1996-8#2)(1997-1#1)(1997-4#2)(1997-6#2)(2005-10#1)(2005-11#2)(2005-8#1)(2006-1#1)(2006-10#4)(2007-11#1)(2007-5#1)(2007-6#1)(2008-10#12)(2008-11#1)(2008-3#4)(2008-5#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#2)(2009-3#2)(2009-7#2)(2009-8#3)(2009-9#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)
to interact##136##2##(1990-12#1)(1990-3#1)(1990-4#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#2)(1992-11#3)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#3)(1993-8#2)(1994-12#3)(1994-5#4)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#4)(1995-8#2)(1996-1#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#2)(1997-1#1)(1997-4#3)(1997-6#3)(2005-10#1)(2005-11#2)(2005-8#1)(2006-1#1)(2006-10#4)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-10#12)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#4)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#2)(2009-3#3)(2009-7#2)(2009-8#3)(2009-9#1)(2010-5#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)
to interacting##3##2##(2004-4#1)(2006-5#1)(2009-7#1)
to interaction between##2##3##(1994-11#1)(2008-10#1)
to interaction with##2##3##(1996-6#1)(2008-3#1)
to interaction##8##2##(1994-11#1)(1994-2#1)(1996-6#1)(2008-10#1)(2008-3#1)(2012-1#1)(2012-6#2)
to interactions between##6##3##(1994-7#1)(1996-6#1)(2005-11#1)(2009-4#1)(2011-1#1)(2012-2#1)
to interactions with##3##3##(1991-8#1)(1995-3#1)(2009-11#1)
to interactions##15##2##(1991-3#1)(1991-8#1)(1994-7#1)(1995-3#1)(1996-1#1)(1996-6#1)(1996-8#1)(2005-11#1)(2008-10#1)(2008-4#1)(2009-11#1)(2009-4#1)(2009-6#1)(2011-1#1)(2012-2#1)
to intercalate##7##2##(1991-6#1)(1995-1#1)(2005-11#1)(2006-12#1)(2008-10#2)(2008-6#1)
to intercalation##2##2##(1991-2#1)(1997-8#1)
to intercellular junctions##2##3##(2009-10#2)
to intercellular##5##2##(1994-2#1)(2007-12#1)(2008-10#1)(2009-10#2)
to interchannel##2##2##(2007-12#1)(2008-3#1)
to interconvert##2##2##(1995-11#1)(1997-7#1)
to interdisciplinary##2##2##(1992-11#1)(1993-2#1)
to interest in testing##2##4##(2006-10#2)
to interest in##4##3##(1994-12#1)(2006-10#2)(2008-10#1)
to interest##8##2##(1993-1#1)(1994-12#1)(2006-10#3)(2006-5#1)(2008-10#1)(2010-3#1)
to interesting##2##2##(2008-7#1)(2013-8#1)
to interface with##3##3##(2008-10#2)(2010-2#1)
to interface##6##2##(2008-10#3)(2008-11#1)(2009-12#1)(2010-2#1)
to interfere with the##11##4##(1993-12#1)(1994-10#1)(1994-6#1)(2004-12#1)(2005-11#1)(2008-10#1)(2008-5#1)(2009-12#1)(2009-3#1)(2009-8#1)(2013-8#1)
to interfere with##31##3##(1991-10#1)(1993-12#1)(1994-10#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(1997-1#1)(2004-11#1)(2004-12#1)(2005-11#1)(2005-9#1)(2006-5#1)(2006-6#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-7#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-2#1)(2013-1#1)(2013-8#1)
to interfere##38##2##(1991-10#1)(1993-12#1)(1994-10#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-4#1)(1997-1#1)(2004-11#1)(2004-12#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-5#1)(2006-6#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-5#2)(2008-7#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-2#1)(2013-1#1)(2013-8#1)
to interference effects##2##3##(1994-6#1)(2008-1#1)
to interference from##5##3##(1990-8#1)(2008-10#3)(2008-3#1)
to interference with the##3##4##(1990-12#1)(1991-2#1)(2007-11#1)
to interference with##5##3##(1990-12#1)(1991-2#1)(1991-9#1)(1995-12#1)(2007-11#1)
to interference##14##2##(1990-12#1)(1990-8#1)(1991-2#1)(1991-9#1)(1994-6#1)(1995-12#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#1)
to interferences##8##2##(1990-11#1)(1991-7#1)(2005-11#1)(2008-10#5)
to interfering substances##2##3##(2008-10#1)(2013-1#1)
to interferometric##2##2##(2008-1#1)(2008-3#1)
to interferon##6##2##(2006-10#3)(2007-11#2)(2009-8#1)
to interferon-alpha-n1##2##2##(2007-11#2)
to interindividual differences in##2##4##(2007-10#1)(2008-10#1)
to interindividual##4##2##(1995-11#1)(2007-10#1)(2008-10#1)(2008-8#1)
to interleukin 2##2##3##(1992-6#1)(2008-11#1)
to interleukin##3##2##(1992-6#1)(2007-11#1)(2008-11#1)
to interleukin-1##2##2##(1990-10#1)(1992-6#1)
to interleukin-2##7##2##(1990-6#1)(1991-12#1)(1994-12#4)(1996-7#1)
to intermediate##10##2##(1990-5#1)(1991-1#1)(1992-3#1)(1992-8#1)(1993-9#2)(2006-1#1)(2006-10#1)(2008-6#1)(2012-11#1)
to intermittent##6##2##(1997-4#1)(2006-8#1)(2006-9#1)(2008-12#1)(2011-12#1)(2012-2#1)
to intermolecular##2##2##(1991-5#1)(2008-10#1)
to internal membranes##2##3##(1990-5#2)
to internal##22##2##(1990-2#1)(1990-5#2)(1992-12#1)(1993-3#1)(1993-9#1)(1995-10#1)(1995-8#1)(1996-8#1)(2006-7#3)(2007-12#2)(2008-11#2)(2008-4#2)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#1)
to internalize##3##2##(1992-12#1)(2006-7#1)(2009-7#1)
to internally##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
to international standards##3##3##(1990-7#1)(2005-5#1)(2010-9#1)
to international##18##2##(1990-7#1)(1991-12#1)(1992-12#1)(2005-5#3)(2006-10#1)(2006-2#1)(2007-2#2)(2007-4#1)(2008-1#1)(2008-8#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#2)
to interpersonal##4##2##(2007-3#1)(2008-1#1)(2010-12#1)(2010-2#1)
to interpolate##2##2##(1997-8#1)(2008-2#1)
to interpret and##4##3##(2006-10#1)(2007-10#1)(2008-10#1)(2008-5#1)
to interpret both##2##3##(2005-10#1)(2008-2#1)
to interpret data##2##3##(2008-8#1)(2009-3#1)
to interpret results##2##3##(1991-3#1)(2008-10#1)
to interpret the data##5##4##(2008-7#1)(2008-9#2)(2009-4#1)(2012-3#1)
to interpret the experimental results##2##5##(2005-11#1)(2009-7#1)
to interpret the experimental##4##4##(2005-11#2)(2008-3#1)(2009-7#1)
to interpret the results##2##4##(1990-8#1)(1995-4#1)
to interpret the##37##3##(1990-8#1)(1991-10#1)(1993-4#1)(1995-3#2)(1995-4#1)(1997-1#2)(1997-6#1)(2005-11#4)(2006-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#3)(2008-9#4)(2009-10#1)(2009-4#1)(2009-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
to interpret##82##2##(1990-2#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-3#1)(1992-2#1)(1992-8#1)(1993-2#1)(1993-4#1)(1995-12#1)(1995-3#2)(1995-4#2)(1997-1#2)(1997-6#3)(2005-10#1)(2005-11#5)(2006-10#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#5)(2009-1#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)
to interpretation of##2##3##(1994-6#1)(2009-4#1)
to interpretation##4##2##(1994-6#1)(2008-12#1)(2009-4#1)(2012-12#1)
to interpreting##4##2##(2006-2#1)(2008-2#1)(2013-1#2)
to interrogate multiple##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
to interrogate the##3##3##(2008-11#1)(2008-2#1)(2011-2#1)
to interrogate##11##2##(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-2#1)
to interrupt##5##2##(1992-3#1)(1995-8#1)(1996-7#1)(1997-6#1)(2011-2#1)
to intersect##2##2##(2007-12#1)(2008-2#1)
to intersexual##2##2##(2006-7#1)(2010-5#1)
to interspecific interactions##2##3##(2008-8#2)
to interspecific##4##2##(2008-10#1)(2008-5#1)(2008-8#2)
to interstitial##2##2##(2008-7#1)(2013-1#1)
to intervene at##2##3##(2006-6#1)(2008-1#1)
to intervene in a##2##4##(2008-9#1)(2009-4#1)
to intervene in the##3##4##(1995-6#1)(2007-10#1)(2013-1#1)
to intervene in##7##3##(1993-3#1)(1995-6#1)(2007-10#2)(2008-9#1)(2009-4#1)(2013-1#1)
to intervene##22##2##(1993-3#1)(1994-4#1)(1995-6#1)(2005-8#1)(2006-6#1)(2007-10#2)(2007-8#2)(2008-1#1)(2008-12#3)(2008-2#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-1#1)
to intervention and##2##3##(2008-5#1)(2012-3#1)
to intervention for##2##3##(2005-7#1)(2006-9#1)
to intervention##12##2##(2004-10#1)(2005-7#1)(2006-9#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-3#2)(2013-7#1)
to interventional##4##2##(2006-8#2)(2008-4#1)(2013-1#1)
to interventions to##3##3##(2007-10#1)(2009-9#1)(2011-1#1)
to interventions##10##2##(1992-3#1)(2007-10#1)(2008-1#1)(2008-6#1)(2009-12#1)(2009-9#1)(2010-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
to interview a##2##3##(2006-12#1)(2007-11#1)
to interview##7##2##(2006-12#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-7#1)(2010-3#1)(2010-8#1)
to intestinal malrotation##2##3##(2010-1#1)(2011-2#1)
to intestinal##13##2##(1990-9#1)(1994-3#1)(2006-10#2)(2006-2#2)(2008-12#1)(2010-1#2)(2010-5#1)(2011-2#2)(2012-2#1)
to intracavity##2##2##(2007-11#1)(2007-12#1)
to intracellular Ca2+##2##3##(1995-8#1)(2013-1#1)
to intracellular calcium##2##3##(1996-2#1)(2006-10#1)
to intracellular signalling##2##3##(1993-6#1)(2009-1#1)
to intracellular##15##2##(1992-2#1)(1993-6#1)(1995-8#1)(1996-2#1)(1996-9#1)(1997-5#1)(2004-11#1)(2006-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2009-1#1)(2012-12#1)(2013-1#1)
to intracerebral##3##2##(2007-9#2)(2011-1#1)
to intracranial##4##2##(1997-6#1)(2006-11#1)(2007-10#1)(2010-8#1)
to intractable##2##2##(1997-4#1)(2008-1#1)
to intracytoplasmic##2##2##(1995-8#1)(2006-2#1)
to intramolecular##4##2##(1993-8#1)(1994-12#1)(1995-8#1)(2008-5#1)
to intramuscular##2##2##(1991-3#1)(1993-8#1)
to intraperitoneal##2##2##(2007-2#1)(2008-10#1)
to intrathecal##5##2##(1991-4#1)(2009-6#1)(2011-2#3)
to intrauterine##2##2##(1992-5#1)(2006-9#1)
to intravascular##2##2##(2009-10#1)(2009-4#1)
to intravenous administration##2##3##(1992-2#1)(1992-8#1)
to intravenous immunoglobulin##2##3##(2006-10#1)(2007-9#1)
to intravenous##22##2##(1990-12#1)(1992-11#1)(1992-2#2)(1992-8#2)(1995-12#1)(1997-2#1)(1997-6#1)(2006-10#6)(2006-4#1)(2007-11#2)(2007-8#1)(2007-9#1)(2009-3#1)(2010-2#1)
to intravenously administered##2##3##(2007-5#1)(2008-7#1)
to intraventricular##3##2##(1991-8#1)(2006-5#1)(2008-10#1)
to intrinsic##11##2##(1990-10#1)(1990-6#1)(2006-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-1#1)(2013-1#3)
to introduce 20 mul volumes into the##2##7##(2008-10#2)
to introduce a variety of##2##5##(2005-11#1)(2008-4#1)
to introduce a##16##3##(1991-4#1)(1995-2#1)(1996-7#1)(1997-8#1)(2005-11#1)(2005-9#1)(2007-10#1)(2008-3#1)(2008-4#1)(2009-6#1)(2009-8#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
to introduce an##5##3##(1995-2#1)(1996-8#1)(2008-11#1)(2008-2#1)(2009-9#1)
to introduce foreign##2##3##(2005-8#1)(2008-11#1)
to introduce investigators to the types of##2##7##(2008-4#2)
to introduce new##2##3##(2005-8#1)(2007-5#1)
to introduce the concept of##2##5##(2008-11#1)(2012-12#1)
to introduce the##18##3##(1991-7#1)(1993-2#1)(1996-11#1)(2006-10#1)(2006-2#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-6#1)(2009-1#1)(2011-2#1)(2012-12#1)
to introduce##101##2##(1991-4#1)(1991-7#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-5#2)(1995-2#2)(1996-11#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-4#2)(1997-8#1)(2004-10#1)(2004-2#1)(2005-11#1)(2005-8#2)(2005-9#2)(2006-10#1)(2006-12#2)(2006-2#2)(2006-6#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#7)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#2)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
to introducing##6##2##(2005-10#1)(2007-8#1)(2008-11#1)(2008-12#1)(2011-3#1)(2012-1#1)
to introduction of the##2##4##(2008-10#2)
to introduction of##6##3##(1990-2#2)(1997-5#1)(2008-10#2)(2008-3#1)
to introduction##10##2##(1990-2#2)(1997-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2009-2#1)(2011-1#1)
to introgress##3##2##(2008-10#2)(2010-10#1)
to intubation##2##2##(1997-4#2)
to intussusception##2##2##(1993-9#1)(2007-11#1)
to invade a##4##3##(1991-12#1)(2008-10#1)(2008-9#1)(2013-8#1)
to invade the##5##3##(1996-5#1)(2007-12#1)(2008-10#2)(2009-5#1)
to invade##19##2##(1991-12#1)(1996-5#1)(2007-12#2)(2008-10#5)(2008-5#1)(2008-9#2)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
to invalidate##2##2##(1995-6#1)(1997-8#1)
to invasion##6##2##(2007-7#2)(2008-10#3)(2008-8#1)
to invasive ALM over a##2##5##(2010-6#2)
to invasive and##2##3##(2006-10#1)(2008-1#1)
to invasive carcinoma##2##3##(2008-1#1)(2011-2#1)
to invasive disease##2##3##(2010-8#1)(2012-2#1)
to invasive##23##2##(1994-6#1)(1995-8#1)(2004-1#1)(2006-10#1)(2006-2#2)(2007-12#1)(2007-6#3)(2007-7#1)(2008-1#2)(2009-9#1)(2010-6#3)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#2)
to invent new##2##3##(2008-1#1)(2011-2#1)
to inverse problems##2##3##(1997-6#1)(2008-3#1)
to inverse##4##2##(1996-1#1)(1997-6#1)(2007-12#1)(2008-3#1)
to invert the##3##3##(2008-2#1)(2008-3#2)
to invert##7##2##(2008-2#2)(2008-3#4)(2009-3#1)
to invest in##4##3##(1993-12#1)(2006-6#1)(2007-8#2)
to invest##8##2##(1992-8#1)(1993-12#1)(2006-6#1)(2007-6#1)(2007-8#2)(2008-2#1)(2008-6#1)
to investigate a possible##3##4##(1995-9#1)(2005-11#1)(2013-1#1)
to investigate a##10##3##(1995-9#1)(2005-11#1)(2006-12#3)(2008-11#2)(2008-7#1)(2012-3#1)(2013-1#1)
to investigate alterations in##2##4##(2006-12#1)(2012-3#1)
to investigate and##4##3##(1993-5#2)(2006-2#1)(2011-2#1)
to investigate any##3##3##(2008-11#1)(2010-5#1)(2010-8#1)
to investigate aspects of##2##4##(2007-9#1)(2011-1#1)
to investigate association of##2##4##(2008-10#1)(2010-12#1)
to investigate associations##2##3##(2011-2#1)(2013-1#1)
to investigate basic##2##3##(2008-3#1)(2009-1#1)
to investigate both the##2##4##(1990-5#1)(2012-1#1)
to investigate cellular##2##3##(2008-1#1)(2013-1#1)
to investigate changes in##3##4##(1994-8#1)(2007-8#1)(2012-2#1)
to investigate changes##4##3##(1994-8#1)(2006-5#1)(2007-8#1)(2012-2#1)
to investigate differences##2##3##(2007-12#1)(2010-5#1)
to investigate factors associated with##2##5##(2007-10#1)(2007-2#1)
to investigate factors##5##3##(2007-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2013-1#1)
to investigate further the##2##4##(1990-11#1)(1996-5#1)
to investigate further##3##3##(1990-11#1)(1996-5#1)(2012-2#1)
to investigate gene##2##3##(2006-12#1)(2013-8#1)
to investigate genetic##2##3##(1996-5#1)(2008-10#1)
to investigate how the##4##4##(1995-10#1)(2008-11#1)(2010-2#1)(2011-2#1)
to investigate how##26##3##(1993-3#1)(1994-12#1)(1994-6#1)(1995-10#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-4#1)(2006-9#1)(2007-2#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#2)(2013-7#2)
to investigate if the##4##4##(1996-6#1)(1997-2#1)(2008-10#1)(2008-6#1)
to investigate if##11##3##(1990-12#1)(1990-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-5#1)(2005-10#1)(2007-10#1)(2008-10#1)(2008-6#1)(2012-2#1)
to investigate impacts on##2##4##(2008-10#1)(2008-8#1)
to investigate in vitro##2##4##(1990-12#1)(2008-10#1)
to investigate in##4##3##(1990-12#1)(1990-4#1)(1995-1#1)(2008-10#1)
to investigate its potential##2##4##(2008-5#1)(2013-1#1)
to investigate its##14##3##(1991-12#1)(1995-8#1)(1997-6#1)(1997-7#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#2)(2013-1#2)
to investigate key##2##3##(1993-8#1)(2008-11#1)
to investigate mechanisms of##2##4##(2005-8#1)(2008-11#1)
to investigate mechanisms##5##3##(1996-4#1)(2005-8#1)(2006-2#1)(2008-11#1)(2009-11#1)
to investigate molecular##2##3##(1990-11#1)(1996-8#1)
to investigate new##5##3##(1994-2#1)(2006-11#1)(2008-7#1)(2010-6#1)(2012-2#1)
to investigate other##2##3##(2006-2#1)(2008-4#1)
to investigate possible##11##3##(1995-12#1)(1997-4#1)(2006-6#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-10#1)(2010-12#1)(2010-6#1)(2012-2#1)
to investigate potential##3##3##(1994-12#1)(2006-9#1)(2013-1#1)
to investigate protein##2##3##(2008-4#1)(2008-9#1)
to investigate several##2##3##(2008-2#1)(2008-3#1)
to investigate short-term##2##3##(1995-11#1)(1997-3#1)
to investigate some of the##2##5##(1993-8#1)(2007-9#1)
to investigate some##5##3##(1993-8#1)(2007-1#1)(2007-9#1)(2008-11#1)(2012-1#1)
to investigate subunit compositions##2##4##(2008-2#1)(2008-4#1)
to investigate such##2##3##(2007-9#1)(2012-2#1)
to investigate the ability of##2##5##(1994-6#1)(2009-5#1)
to investigate the actual##2##4##(1993-3#1)(2008-11#1)
to investigate the anti-proliferative##2##4##(2008-10#1)(2009-9#1)
to investigate the antimicrobial##2##4##(2006-8#1)(2012-2#1)
to investigate the association between the##3##6##(2008-3#2)(2011-2#1)
to investigate the association between##6##5##(2008-10#1)(2008-3#2)(2011-2#2)(2013-1#1)
to investigate the association##7##4##(2007-10#1)(2008-10#1)(2008-3#2)(2011-2#2)(2013-1#1)
to investigate the behaviour of##2##5##(1991-5#1)(2008-3#1)
to investigate the biological##2##4##(1990-7#1)(1995-2#1)
to investigate the cellular##4##4##(1993-12#1)(1994-8#1)(2008-4#1)(2011-2#1)
to investigate the changes in##4##5##(1993-11#1)(2010-2#1)(2010-4#1)(2012-12#1)
to investigate the changes##5##4##(1993-11#1)(2006-12#1)(2010-2#1)(2010-4#1)(2012-12#1)
to investigate the characteristics of##4##5##(1990-11#1)(2008-3#2)(2011-3#1)
to investigate the clinical##3##4##(2006-8#1)(2011-1#1)(2013-1#1)
to investigate the compatibility of##2##5##(2011-2#1)(2012-12#1)
to investigate the contribution of##4##5##(1995-12#1)(2009-4#1)(2009-6#1)(2012-3#1)
to investigate the correlation between##2##5##(2007-10#1)(2008-5#1)
to investigate the distribution of the##2##6##(1991-9#1)(1992-11#1)
to investigate the distribution of##5##5##(1991-9#1)(1992-11#1)(2006-8#1)(2008-10#1)(2008-4#1)
to investigate the dynamics of##3##5##(2008-11#1)(2008-2#1)(2009-6#1)
to investigate the effect of a##4##6##(1997-8#1)(2007-11#1)(2009-12#1)(2011-12#1)
to investigate the effect of aging on##2##7##(1994-6#1)(2008-7#1)
to investigate the effect of different##3##6##(2008-12#3)
to investigate the effect of the##7##6##(1991-11#1)(1996-3#1)(2007-8#1)(2008-12#1)(2008-3#1)(2011-2#1)(2013-7#1)
to investigate the effect of##72##5##(1991-11#1)(1991-8#1)(1992-8#1)(1993-3#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-8#1)(2005-8#1)(2006-11#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-12#6)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
to investigate the effect##73##4##(1991-11#1)(1991-8#1)(1992-8#1)(1993-3#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-8#1)(2005-8#1)(2006-11#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-12#6)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
to investigate the effectiveness of the##2##6##(2008-2#1)(2013-1#1)
to investigate the effectiveness of##9##5##(2006-10#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2013-1#2)
to investigate the effects and##2##5##(2008-3#1)(2011-3#1)
to investigate the effects of a##2##6##(1990-9#1)(2008-7#1)
to investigate the effects of different##4##6##(2008-8#1)(2013-1#1)(2013-8#2)
to investigate the effects of solvents and molecular structure upon acidity##2##11##(2007-11#2)
to investigate the effects of the##3##6##(2005-11#1)(2008-5#1)(2010-4#1)
to investigate the effects of##48##5##(1990-3#2)(1990-7#1)(1990-8#1)(1990-9#1)(1992-2#1)(1995-10#1)(1995-12#1)(1997-3#1)(1997-8#1)(2005-11#2)(2006-11#1)(2006-12#1)(2007-11#3)(2007-2#1)(2007-9#2)(2008-10#5)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#3)
to investigate the effects##50##4##(1990-3#2)(1990-7#1)(1990-8#1)(1990-9#1)(1992-2#1)(1995-10#1)(1995-12#1)(1997-3#1)(1997-8#1)(2005-11#2)(2006-11#1)(2006-12#1)(2007-11#3)(2007-2#1)(2007-9#2)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#3)
to investigate the efficacy of##4##5##(2008-10#1)(2008-3#1)(2009-8#1)(2013-1#1)
to investigate the efficacy##5##4##(1996-4#1)(2008-10#1)(2008-3#1)(2009-8#1)(2013-1#1)
to investigate the electrical##2##4##(2005-11#1)(2009-3#1)
to investigate the expression of##3##5##(1991-2#1)(1992-8#1)(2008-10#1)
to investigate the expression##7##4##(1991-2#1)(1992-8#1)(1994-12#1)(2008-10#2)(2008-9#1)(2012-1#1)
to investigate the extent to which##2##6##(2006-12#1)(2007-11#1)
to investigate the extent##3##4##(2006-12#1)(2007-11#1)(2012-3#1)
to investigate the factors##2##4##(1994-12#1)(2008-7#1)
to investigate the feasibility of the##2##6##(2008-2#1)(2008-3#1)
to investigate the feasibility of##6##5##(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)(2010-5#1)(2010-9#1)
to investigate the feasibility##7##4##(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)
to investigate the formation of##3##5##(1996-3#1)(2007-12#1)(2010-7#1)
to investigate the function of##2##5##(2005-11#1)(2008-9#1)
to investigate the functional##3##4##(1993-3#1)(1994-5#1)(1995-8#1)
to investigate the genetic diversity##3##5##(2008-10#2)(2013-8#1)
to investigate the genetic##4##4##(2007-10#1)(2008-10#2)(2013-8#1)
to investigate the hemodynamic##2##4##(2007-8#1)(2008-7#1)
to investigate the impact of##6##5##(2005-10#1)(2008-5#1)(2010-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
to investigate the impact##7##4##(2005-10#1)(2006-10#1)(2008-5#1)(2010-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
to investigate the importance of##4##5##(1992-12#1)(1992-5#1)(1995-5#1)(2012-3#1)
to investigate the incidence of##4##5##(2004-7#1)(2006-8#1)(2008-2#1)(2008-9#1)
to investigate the incidence##5##4##(2004-7#1)(2006-10#1)(2006-8#1)(2008-2#1)(2008-9#1)
to investigate the influence of the##5##6##(1996-11#1)(2008-10#2)(2009-12#1)(2011-2#1)
to investigate the influence of##24##5##(1991-11#1)(1993-11#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-12#1)(2004-11#1)(2006-4#1)(2007-2#2)(2008-10#3)(2008-11#2)(2008-12#1)(2009-12#1)(2009-6#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-1#1)
to investigate the interaction of##2##5##(1993-3#1)(2007-11#1)
to investigate the interaction##3##4##(1993-3#1)(1993-6#1)(2007-11#1)
to investigate the interactions between genetic##2##6##(2008-3#2)
to investigate the interactions between##3##5##(2005-11#1)(2008-3#2)
to investigate the kinetics of##2##5##(2008-10#1)(2008-8#1)
to investigate the level of##2##5##(2008-8#1)(2011-2#1)
to investigate the local##3##4##(1995-10#1)(2007-5#1)(2008-1#1)
to investigate the long-term effects of##2##6##(2008-7#1)(2009-1#1)
to investigate the long-term##3##4##(2008-7#1)(2009-1#1)(2010-2#1)
to investigate the mechanism by which##2##6##(1991-11#1)(2012-12#1)
to investigate the mechanism of action##2##6##(2008-7#1)(2011-2#1)
to investigate the mechanism of##9##5##(1990-9#1)(1992-8#1)(1994-8#1)(1995-6#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
to investigate the mechanism##15##4##(1990-9#1)(1991-11#1)(1992-8#1)(1994-10#1)(1994-8#1)(1995-6#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
to investigate the mechanisms of##3##5##(1990-4#1)(1992-7#1)(2007-4#1)
to investigate the mechanisms underlying##2##5##(2009-5#1)(2012-3#1)
to investigate the mechanisms##10##4##(1990-4#1)(1991-4#1)(1992-7#1)(1992-8#1)(1997-5#1)(2007-4#1)(2008-11#1)(2008-6#1)(2009-5#1)(2012-3#1)
to investigate the mode of##2##5##(1994-3#1)(2010-7#1)
to investigate the molecular basis of the##2##7##(1990-8#1)(1995-5#1)
to investigate the molecular basis of##4##6##(1990-8#1)(1995-5#1)(1996-12#1)(1996-2#1)
to investigate the molecular##13##4##(1990-8#2)(1992-3#1)(1994-11#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(2008-5#1)(2008-9#1)(2010-12#1)(2012-1#1)(2013-8#1)
to investigate the morphological##2##4##(2007-12#1)(2008-10#1)
to investigate the nature of the##2##6##(1991-7#1)(1995-3#1)
to investigate the nature of##3##5##(1991-7#1)(1995-3#1)(2008-1#1)
to investigate the nature##4##4##(1991-7#1)(1995-3#1)(1997-8#1)(2008-1#1)
to investigate the neural##3##4##(2008-11#1)(2008-9#1)(2012-2#1)
to investigate the occurrence of##3##5##(1997-3#1)(2008-7#1)(2013-1#1)
to investigate the origin of the##2##6##(1997-8#1)(2006-10#1)
to investigate the origin of##3##5##(1997-8#1)(2006-10#1)(2008-10#1)
to investigate the origin##4##4##(1997-8#1)(2006-10#1)(2008-10#2)
to investigate the pathogenesis##2##4##(1997-2#1)(2013-8#1)
to investigate the perception##2##4##(2008-1#1)(2008-9#1)
to investigate the performance of##2##5##(2006-12#1)(2012-3#1)
to investigate the physiological##4##4##(1997-2#1)(2008-8#1)(2010-7#1)(2013-1#1)
to investigate the possibility of##8##5##(1994-8#1)(1996-6#1)(1996-9#1)(2005-11#1)(2006-8#1)(2008-11#1)(2012-3#1)(2013-7#1)
to investigate the possibility that the##2##6##(1994-6#1)(1994-8#1)
to investigate the possibility##10##4##(1994-6#1)(1994-8#2)(1996-6#1)(1996-9#1)(2005-11#1)(2006-8#1)(2008-11#1)(2012-3#1)(2013-7#1)
to investigate the possible association##2##5##(1992-12#1)(2005-10#1)
to investigate the possible mechanism underlying##2##6##(1993-12#1)(2009-5#1)
to investigate the possible role of##2##6##(1995-11#1)(2009-9#1)
to investigate the possible##14##4##(1991-7#1)(1992-12#1)(1993-12#1)(1993-4#1)(1993-9#1)(1995-11#1)(2005-10#1)(2006-5#1)(2008-5#2)(2009-5#1)(2009-9#1)(2012-2#1)(2013-1#1)
to investigate the potential biological##2##5##(2010-10#1)(2012-3#1)
to investigate the potential effect of##2##6##(2010-12#1)(2013-1#1)
to investigate the potential of##2##5##(1992-9#1)(2008-7#1)
to investigate the potential use of##2##6##(2004-9#1)(2008-6#1)
to investigate the potential##12##4##(1992-9#2)(2004-9#1)(2008-6#1)(2008-7#2)(2010-10#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
to investigate the predictive value of##2##6##(2009-6#1)(2012-3#1)
to investigate the presence of##7##5##(1993-11#1)(1993-12#1)(1995-12#1)(1995-2#1)(2008-2#1)(2008-4#1)(2010-8#1)
to investigate the prevalence and##2##5##(2007-2#1)(2013-4#1)
to investigate the prevalence of##5##5##(2006-1#1)(2007-8#1)(2008-7#1)(2010-6#1)(2011-1#1)
to investigate the prevalence##8##4##(2006-1#1)(2007-2#1)(2007-8#1)(2008-7#1)(2010-6#1)(2011-1#1)(2012-1#1)(2013-4#1)
to investigate the process##2##4##(2008-10#1)(2008-3#1)
to investigate the production of##2##5##(2012-3#1)(2013-1#1)
to investigate the properties of the##2##6##(1990-5#1)(2006-11#1)
to investigate the properties of##3##5##(1990-5#1)(2006-11#1)(2008-10#1)
to investigate the protective##2##4##(2008-8#1)(2013-8#1)
to investigate the putative##2##4##(2008-10#1)(2008-11#1)
to investigate the reaction of##2##5##(1991-10#1)(2008-5#1)
to investigate the reaction##3##4##(1991-10#1)(2008-10#1)(2008-5#1)
to investigate the relation between##2##5##(1991-8#1)(2007-1#1)
to investigate the relations##2##4##(1992-9#1)(2009-10#1)
to investigate the relationship between the##11##6##(1991-2#1)(2005-11#1)(2008-10#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-1#1)
to investigate the relationship between##36##5##(1991-10#1)(1991-2#1)(1991-9#2)(1994-3#2)(1994-6#1)(1996-12#1)(1997-2#1)(2005-11#2)(2006-10#1)(2006-5#1)(2006-7#1)(2007-4#1)(2008-10#3)(2008-5#2)(2008-8#1)(2008-9#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#2)
to investigate the relationship of##2##5##(1993-6#1)(2008-10#1)
to investigate the relationship##39##4##(1991-10#1)(1991-2#1)(1991-9#2)(1993-6#1)(1994-3#2)(1994-6#1)(1996-12#1)(1997-2#1)(2005-11#2)(2006-10#1)(2006-5#1)(2006-7#1)(2007-4#1)(2008-10#4)(2008-5#2)(2008-8#1)(2008-9#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#2)
to investigate the relationships between##7##5##(1992-1#1)(2008-10#1)(2008-9#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-1#1)
to investigate the relationships##9##4##(1992-1#1)(2007-12#1)(2008-10#2)(2008-9#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-1#1)
to investigate the relative contribution of##2##6##(1992-12#1)(2011-2#1)
to investigate the relative##3##4##(1992-12#1)(2010-2#1)(2011-2#1)
to investigate the response of##2##5##(1993-9#1)(2013-1#1)
to investigate the response##6##4##(1993-11#1)(1993-9#1)(2006-12#1)(2008-9#1)(2010-3#1)(2013-1#1)
to investigate the role of the##5##6##(1994-2#1)(1995-3#1)(2008-10#2)(2009-2#1)
to investigate the role of##35##5##(1993-11#3)(1993-2#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-10#1)(1996-12#1)(2006-9#1)(2007-11#1)(2007-3#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-12#1)
to investigate the role##36##4##(1993-11#3)(1993-12#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-10#1)(1996-12#1)(2006-9#1)(2007-11#1)(2007-3#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-12#1)
to investigate the roles of##3##5##(1992-2#1)(2008-12#1)(2009-8#1)
to investigate the specific##2##4##(2005-11#1)(2013-1#1)
to investigate the structure and dynamics of##2##7##(2008-2#1)(2008-4#1)
to investigate the structure and##3##5##(2006-12#1)(2008-2#1)(2008-4#1)
to investigate the structure##4##4##(2006-12#1)(2008-2#1)(2008-4#1)(2008-5#1)
to investigate the suitability of##2##5##(2012-2#1)(2013-1#1)
to investigate the underlying##2##4##(2007-10#1)(2008-10#1)
to investigate the value of##2##5##(2004-1#1)(2007-2#1)
to investigate the##775##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#4)(1990-9#2)(1991-10#3)(1991-11#3)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#4)(1992-2#3)(1992-3#2)(1992-5#1)(1992-7#1)(1992-8#4)(1992-9#4)(1993-11#9)(1993-12#7)(1993-2#1)(1993-3#5)(1993-4#1)(1993-6#3)(1993-9#3)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#3)(1994-3#7)(1994-5#2)(1994-6#6)(1994-8#6)(1994-9#3)(1995-10#3)(1995-11#4)(1995-12#7)(1995-2#4)(1995-3#3)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#2)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#7)(1996-2#2)(1996-3#4)(1996-4#2)(1996-5#3)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-5#1)(1997-6#2)(1997-8#4)(2004-1#1)(2004-10#1)(2004-11#1)(2004-7#1)(2004-9#1)(2005-10#2)(2005-11#17)(2005-12#1)(2005-4#1)(2005-8#3)(2006-1#2)(2006-10#7)(2006-11#4)(2006-12#7)(2006-4#1)(2006-5#2)(2006-7#2)(2006-8#8)(2006-9#3)(2007-1#3)(2007-10#9)(2007-11#13)(2007-12#10)(2007-2#7)(2007-3#4)(2007-4#5)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#11)(2007-9#5)(2008-1#5)(2008-10#64)(2008-11#14)(2008-12#10)(2008-2#12)(2008-3#18)(2008-4#10)(2008-5#20)(2008-6#8)(2008-7#17)(2008-8#16)(2008-9#14)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#3)(2009-2#3)(2009-3#2)(2009-4#5)(2009-5#4)(2009-6#8)(2009-7#5)(2009-8#4)(2009-9#4)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#13)(2010-2#9)(2010-3#2)(2010-4#5)(2010-5#3)(2010-6#3)(2010-7#5)(2010-8#10)(2010-9#2)(2011-1#11)(2011-11#1)(2011-12#3)(2011-2#24)(2011-3#4)(2012-1#7)(2012-11#2)(2012-12#9)(2012-2#15)(2012-3#18)(2013-1#23)(2013-4#1)(2013-7#4)(2013-8#16)
to investigate their effects on##2##5##(1994-11#1)(2010-5#1)
to investigate their##25##3##(1990-12#1)(1992-1#1)(1994-11#1)(1996-8#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-11#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
to investigate these##9##3##(1992-3#2)(1993-5#1)(2006-10#1)(2007-1#1)(2008-2#1)(2008-4#1)(2008-7#1)(2011-1#1)
to investigate this important##2##4##(2006-10#1)(2008-5#1)
to investigate this##9##3##(1995-10#1)(1996-1#1)(1996-5#1)(1997-7#1)(2006-10#2)(2007-11#1)(2008-11#1)(2008-5#1)
to investigate trends in##2##4##(2006-11#1)(2012-2#1)
to investigate two##2##3##(2007-12#1)(2012-1#1)
to investigate variation in##2##4##(2007-12#1)(2008-10#1)
to investigate whether age is associated with use of osteoporosis drugs in a##2##13##(2010-3#2)
to investigate whether an##2##4##(2005-9#1)(2010-7#1)
to investigate whether the##16##4##(1991-5#1)(1991-9#1)(1995-3#1)(1995-4#1)(1997-7#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
to investigate whether there is##5##5##(1992-12#1)(1996-12#1)(2011-1#1)(2011-2#1)(2012-1#1)
to investigate whether this##5##4##(1994-12#1)(1997-8#1)(2007-5#1)(2008-6#1)(2012-2#1)
to investigate whether##79##3##(1991-5#1)(1991-9#2)(1992-12#1)(1992-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-7#2)(1997-8#2)(2005-9#1)(2006-5#1)(2007-10#2)(2007-12#2)(2007-5#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2010-10#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#5)(2013-7#2)(2013-8#1)
to investigate which##4##3##(1995-1#1)(1995-12#1)(1996-8#1)(2010-3#1)
to investigate##1251##2##(1990-10#1)(1990-11#3)(1990-12#4)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#4)(1990-7#3)(1990-8#5)(1990-9#2)(1991-10#3)(1991-11#3)(1991-12#3)(1991-2#3)(1991-3#3)(1991-4#2)(1991-5#2)(1991-6#4)(1991-7#3)(1991-8#2)(1991-9#7)(1992-1#2)(1992-11#2)(1992-12#5)(1992-2#4)(1992-3#5)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#5)(1992-9#4)(1993-11#9)(1993-12#8)(1993-2#2)(1993-3#6)(1993-4#1)(1993-5#3)(1993-6#3)(1993-8#2)(1993-9#4)(1994-10#1)(1994-11#5)(1994-12#8)(1994-2#5)(1994-3#8)(1994-5#2)(1994-6#9)(1994-8#8)(1994-9#4)(1995-1#3)(1995-10#5)(1995-11#6)(1995-12#13)(1995-2#4)(1995-3#4)(1995-4#1)(1995-5#4)(1995-6#4)(1995-7#2)(1995-8#3)(1995-9#2)(1996-1#4)(1996-10#2)(1996-11#2)(1996-12#8)(1996-2#2)(1996-3#4)(1996-4#3)(1996-5#7)(1996-6#4)(1996-7#3)(1996-8#5)(1996-9#2)(1997-1#1)(1997-2#7)(1997-3#3)(1997-4#4)(1997-5#4)(1997-6#5)(1997-7#4)(1997-8#10)(2004-1#1)(2004-10#2)(2004-11#1)(2004-7#1)(2004-9#1)(2005-10#5)(2005-11#20)(2005-12#1)(2005-4#1)(2005-8#4)(2005-9#1)(2006-1#2)(2006-10#13)(2006-11#8)(2006-12#13)(2006-2#3)(2006-4#3)(2006-5#4)(2006-6#1)(2006-7#2)(2006-8#13)(2006-9#5)(2007-1#7)(2007-10#15)(2007-11#17)(2007-12#18)(2007-2#13)(2007-3#4)(2007-4#7)(2007-5#3)(2007-6#2)(2007-7#1)(2007-8#14)(2007-9#13)(2008-1#8)(2008-10#89)(2008-11#42)(2008-12#16)(2008-2#17)(2008-3#26)(2008-4#20)(2008-5#30)(2008-6#11)(2008-7#27)(2008-8#21)(2008-9#21)(2009-1#2)(2009-10#3)(2009-11#4)(2009-12#4)(2009-2#3)(2009-3#3)(2009-4#6)(2009-5#5)(2009-6#9)(2009-7#5)(2009-8#7)(2009-9#5)(2010-1#2)(2010-10#5)(2010-11#4)(2010-12#16)(2010-2#17)(2010-3#7)(2010-4#7)(2010-5#9)(2010-6#6)(2010-7#8)(2010-8#15)(2010-9#2)(2011-1#21)(2011-11#1)(2011-12#6)(2011-2#42)(2011-3#4)(2012-1#14)(2012-11#3)(2012-12#18)(2012-2#27)(2012-3#26)(2012-5#1)(2013-1#42)(2013-4#1)(2013-7#8)(2013-8#21)
to investigated##2##2##(2008-7#1)(2012-3#1)
to investigating the##2##3##(1991-1#1)(2008-2#1)
to investigating##6##2##(1991-1#1)(1991-3#1)(1993-2#1)(1996-5#1)(2008-2#1)(2013-1#1)
to investigation and##4##3##(2008-11#3)(2009-10#1)
to investigation of##2##3##(1993-2#1)(2005-7#1)
to investigation##11##2##(1993-2#1)(2005-7#1)(2006-9#1)(2008-10#1)(2008-11#4)(2008-7#1)(2009-10#1)(2010-10#1)
to investigations##2##2##(1995-2#1)(2008-11#1)
to investigators interested in##2##4##(1993-3#1)(2008-4#1)
to investigators##4##2##(1993-3#1)(2007-8#1)(2008-4#1)(2012-2#1)
to investing in##2##3##(2007-4#1)(2010-12#1)
to investment##2##2##(1994-2#1)(2008-5#1)
to invite##2##2##(1994-2#1)(2010-12#1)
to invoke the##3##3##(2008-1#1)(2013-1#2)
to invoke##6##2##(1994-11#1)(2008-1#1)(2008-3#1)(2008-7#1)(2013-1#2)
to involve a##7##3##(1991-1#1)(1992-9#1)(1994-5#1)(1996-6#1)(2006-12#1)(2006-7#1)(2007-12#1)
to involve all##3##3##(1996-10#1)(1996-2#1)(2009-10#1)
to involve an##4##3##(1991-12#1)(1996-12#1)(2008-4#1)(2013-8#1)
to involve both##4##3##(1993-9#1)(1997-5#1)(2007-11#1)(2008-2#1)
to involve changes in the##2##5##(2007-11#1)(2008-9#1)
to involve changes in##3##4##(2006-5#1)(2007-11#1)(2008-9#1)
to involve in##3##3##(2007-2#1)(2008-11#1)(2012-12#1)
to involve staff##2##3##(1994-12#2)
to involve the activation of##2##5##(1994-3#1)(1996-8#1)
to involve the##26##3##(1990-7#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-11#2)(1994-3#1)(1995-1#1)(1995-6#1)(1996-8#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-4#1)(2009-3#1)(2009-4#1)(2009-8#1)(2011-2#2)(2012-12#2)(2013-8#1)
to involve##98##2##(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#2)(1992-9#1)(1993-3#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#2)(1995-3#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#2)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-7#1)(2006-10#3)(2006-12#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#4)(2007-12#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-11#1)(2012-12#6)(2012-3#2)(2013-8#2)
to involvement in##2##3##(2007-12#1)(2009-7#1)
to involvement of the##2##4##(2007-9#1)(2010-11#1)
to involvement of##5##3##(1997-1#1)(2007-9#1)(2010-11#1)(2012-3#2)
to involvement##10##2##(1997-1#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-9#1)(2009-7#1)(2010-11#1)(2012-3#2)
to involving##2##2##(1994-2#1)(1996-12#1)
to iodate##3##2##(2008-10#3)
to iodide##4##2##(1992-12#1)(1992-6#1)(1996-9#1)(2007-8#1)
to iodine##8##2##(1996-8#1)(2008-10#5)(2009-3#1)(2011-1#1)
to iodized##2##2##(1990-3#1)(2013-1#1)
to ion and##2##3##(1997-4#1)(2008-7#1)
to ion chromatographic##2##3##(2008-10#2)
to ion chromatography##2##3##(1991-2#1)(2008-10#1)
to ion##10##2##(1991-2#1)(1997-4#1)(2008-10#5)(2008-7#1)(2009-3#1)(2012-3#1)
to ion-exchange##2##2##(1997-2#1)(2006-10#1)
to ion-pair##2##2##(2008-10#2)
to ionic##2##2##(1990-11#1)(1992-11#1)
to ionising radiation##3##3##(2008-7#1)(2008-8#1)(2009-5#1)
to ionising##4##2##(1994-4#1)(2008-7#1)(2008-8#1)(2009-5#1)
to ionization##2##2##(2006-10#1)(2009-3#1)
to ionizing radiation in##2##4##(1995-6#1)(1997-4#1)
to ionizing radiation is##3##4##(1997-4#1)(2006-8#1)(2008-7#1)
to ionizing radiation or##2##4##(1992-7#1)(2008-7#1)
to ionizing radiation##17##3##(1992-7#1)(1994-8#1)(1995-12#1)(1995-6#2)(1996-6#1)(1997-4#2)(1997-7#1)(2006-8#1)(2008-11#1)(2008-7#4)(2008-9#2)
to ionizing##20##2##(1992-7#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#2)(1996-6#1)(1997-4#2)(1997-7#2)(2006-8#1)(2008-11#1)(2008-7#5)(2008-9#2)
to ions##4##2##(1990-5#1)(2008-3#1)(2008-8#1)(2011-1#1)
to iontophoretically applied gamma-aminobutyric acid##2##5##(1995-7#2)
to iontophoretically applied##3##3##(1995-7#3)
to iprodione##6##2##(2008-10#6)
to iron deficiency##4##3##(2006-10#1)(2009-8#3)
to iron##11##2##(1991-11#1)(1992-6#1)(1996-7#1)(2005-10#1)(2006-10#1)(2008-10#1)(2008-11#1)(2009-8#4)
to iron(II)##2##2##(2008-10#2)
to iron(III) by##2##3##(2008-10#2)
to iron(III)##5##2##(1996-2#1)(1997-7#1)(2008-10#3)
to irradiate the##2##3##(2008-3#1)(2008-5#1)
to irradiate##8##2##(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-1#2)
to irradiated##2##2##(1995-2#1)(2008-12#1)
to irradiation and##2##3##(1997-1#2)
to irradiation or##2##3##(1992-10#1)(1996-10#1)
to irradiation##9##2##(1992-10#1)(1992-2#1)(1994-12#1)(1996-10#1)(1997-1#2)(1997-4#1)(2007-9#1)(2008-7#1)
to irreversible##6##2##(1993-11#1)(2008-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2012-1#1)
to irreversibly inhibit##2##3##(1994-8#1)(2011-1#1)
to irreversibly##4##2##(1991-4#1)(1991-9#1)(1994-8#1)(2011-1#1)
to irritant##2##2##(1992-4#1)(2008-5#1)
to ischaemia##3##2##(2006-10#1)(2008-7#1)(2011-1#1)
to ischaemic heart disease and##2##5##(2005-10#1)(2008-8#1)
to ischaemic heart disease##3##4##(1993-8#1)(2005-10#1)(2008-8#1)
to ischaemic##6##2##(1993-8#1)(1996-1#1)(2005-10#1)(2008-5#1)(2008-8#1)(2009-2#1)
to ischemia and##2##3##(1996-12#1)(2006-10#1)
to ischemia##25##2##(1990-6#1)(1991-11#1)(1991-6#1)(1996-12#1)(1996-9#6)(1997-5#1)(1997-8#1)(2006-10#1)(2007-10#3)(2008-10#1)(2008-4#1)(2008-8#2)(2009-3#1)(2010-1#1)(2011-1#1)(2011-2#2)
to ischemia-reperfusion injury##3##3##(1991-9#1)(1996-9#1)(2008-1#1)
to ischemia-reperfusion##6##2##(1991-9#1)(1996-9#1)(2008-1#1)(2012-3#2)(2013-7#1)
to ischemic damages##2##3##(1994-3#2)
to ischemic injury##3##3##(2006-10#1)(2009-10#1)(2013-1#1)
to ischemic##20##2##(1991-11#1)(1993-4#1)(1994-3#2)(1996-10#1)(1996-12#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-4#2)(2009-10#2)(2010-7#1)(2013-1#2)(2013-7#1)(2013-8#1)
to islet antigens##2##3##(2007-5#2)
to islet##6##2##(1997-8#1)(2007-5#2)(2010-10#1)(2010-11#2)
to isocyanate##2##2##(2008-10#1)(2013-8#1)
to isolate C##2##3##(2005-9#1)(2008-5#1)
to isolate MG2##3##3##(2008-10#3)
to isolate MG96-36##3##3##(2008-10#3)
to isolate a full-length##2##4##(1993-7#1)(1995-1#1)
to isolate a##17##3##(1991-2#1)(1991-5#2)(1992-1#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-7#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-2#1)(1996-5#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-5#1)
to isolate all##2##3##(1994-6#1)(2008-2#1)
to isolate an##3##3##(1990-9#1)(1996-10#1)(1997-4#1)
to isolate and characterize##6##4##(1990-2#1)(1990-5#1)(2004-9#1)(2008-2#1)(2008-4#1)(2008-7#1)
to isolate and identify##5##4##(1990-2#2)(2006-8#1)(2007-8#1)(2010-4#1)
to isolate and propagate##2##4##(1992-9#1)(2008-9#1)
to isolate and quantify##3##4##(1997-2#1)(2008-10#2)
to isolate and##22##3##(1990-2#3)(1990-5#1)(1992-9#1)(1993-8#1)(1997-2#1)(2004-9#1)(2006-8#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-4#1)
to isolate cDNA##3##3##(1991-11#1)(2008-2#1)(2008-4#1)
to isolate cDNAs encoding##3##4##(1993-6#1)(1994-11#1)(2008-2#1)
to isolate cDNAs##4##3##(1993-12#1)(1993-6#1)(1994-11#1)(2008-2#1)
to isolate cells##2##3##(1996-1#1)(2008-11#1)
to isolate fungi##2##3##(2008-10#1)(2013-8#1)
to isolate hemicelluloses from process water from a thermomechanical pulp mill##2##11##(2008-5#2)
to isolate other##2##3##(1994-12#1)(2008-11#1)
to isolate pure rotational Raman spectra##2##6##(2008-3#2)
to isolate pure##5##3##(1990-12#1)(1990-8#1)(2008-3#2)(2008-4#1)
to isolate specific##2##3##(2008-4#1)(2008-7#1)
to isolate such##2##3##(1990-5#1)(2008-10#1)
to isolate the active##2##4##(2008-12#2)
to isolate the##35##3##(1990-10#1)(1990-11#1)(1990-7#1)(1991-5#1)(1992-11#1)(1992-6#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-7#1)(1997-2#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-8#1)(2008-9#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-2#1)
to isolate them##2##3##(2008-2#1)(2012-2#1)
to isolate##196##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#3)(1990-5#3)(1990-7#1)(1990-8#1)(1990-9#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-7#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-2#3)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-2#4)(1997-4#4)(1997-7#2)(2004-11#1)(2004-9#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-8#2)(2007-11#2)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#25)(2008-11#11)(2008-12#3)(2008-2#9)(2008-3#5)(2008-4#13)(2008-5#6)(2008-7#3)(2008-8#2)(2008-9#5)(2009-10#1)(2009-12#2)(2009-4#1)(2009-6#1)(2010-2#2)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
to isolated##23##2##(1991-7#1)(1992-10#1)(1992-3#5)(1992-8#1)(1994-11#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-5#1)(2006-12#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
to isolates from##3##3##(2008-10#3)
to isolates of the##2##4##(2008-10#2)
to isolates of##7##3##(2008-10#6)(2008-5#1)
to isolates##14##2##(2008-10#13)(2008-5#1)
to isolating the##2##3##(2008-10#1)(2008-8#1)
to isolating##3##2##(2008-10#1)(2008-4#1)(2008-8#1)
to isolation##3##2##(1991-8#1)(1994-5#1)(1996-7#1)
to isomerize##2##2##(1997-2#1)(2007-11#1)
to isoprenaline##3##2##(1990-9#1)(1995-12#1)(1997-2#1)
to isoproterenol##5##2##(1991-2#1)(1992-6#1)(1994-12#1)(1995-6#2)
to isotonic##2##2##(1995-8#1)(2005-10#1)
to issue a##3##3##(1991-4#1)(2010-9#1)(2011-12#1)
to issue##9##2##(1991-4#1)(1992-8#1)(2005-8#1)(2006-8#1)(2008-4#2)(2010-9#1)(2011-12#1)(2011-2#1)
to issues of##7##3##(1991-12#1)(2006-11#1)(2006-5#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-7#1)
to issues related to##2##4##(2008-10#1)(2008-11#1)
to issues that##3##3##(1997-2#1)(2008-11#1)(2013-8#1)
to issues##16##2##(1991-12#1)(1997-2#2)(2006-11#1)(2006-5#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-7#1)(2008-8#1)(2010-7#1)(2013-8#1)
to it and##3##3##(1994-6#1)(2006-10#1)(2011-2#1)
to it being##3##3##(2008-4#1)(2013-1#2)
to it by##2##3##(1993-1#1)(2009-2#1)
to it in vivo##2##4##(1992-9#1)(2006-10#1)
to it in##4##3##(1992-9#1)(1995-6#2)(2006-10#1)
to it##65##2##(1991-2#1)(1991-7#1)(1992-12#1)(1992-9#1)(1993-1#1)(1994-6#2)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-2#1)(1996-6#2)(1996-8#1)(1997-8#1)(2005-10#1)(2006-10#5)(2006-12#1)(2006-7#1)(2006-8#1)(2007-9#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)
to items##2##2##(2008-9#1)(2012-2#1)
to iterative##2##2##(2008-10#2)
to iteratively improve##2##3##(2008-10#1)(2009-9#1)
to iteratively##3##2##(2008-10#1)(2008-2#1)(2009-9#1)
to itraconazole##2##2##(1993-8#1)(2008-5#1)
to its 5'-triphosphate##2##3##(1990-12#2)
to its DNA##2##3##(1992-12#1)(1997-5#1)
to its ability to##21##4##(1990-2#1)(1991-12#1)(1992-8#2)(1993-3#1)(1994-11#1)(1994-3#2)(1995-12#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#2)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)
to its ability##22##3##(1990-2#1)(1991-12#1)(1992-8#2)(1993-3#1)(1994-11#1)(1994-3#2)(1995-12#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)
to its active metabolite##3##4##(1995-5#1)(2008-8#1)(2010-9#1)
to its active##6##3##(1990-11#1)(1995-5#1)(1997-4#1)(2005-9#1)(2008-8#1)(2010-9#1)
to its activities in##2##4##(2008-10#1)(2009-6#1)
to its activities##3##3##(2008-10#1)(2009-2#1)(2009-6#1)
to its advantage of##2##4##(2008-2#1)(2012-2#1)
to its affinity for##2##4##(1992-12#1)(1993-3#1)
to its affinity##3##3##(1992-12#1)(1993-3#1)(2008-5#1)
to its analgesic##2##3##(1990-6#1)(2009-12#1)
to its antioxidant property##2##4##(1993-2#1)(2012-3#1)
to its antioxidant##3##3##(1993-2#1)(2010-4#1)(2012-3#1)
to its application##3##3##(1997-6#1)(2011-1#1)(2013-8#1)
to its association with##2##4##(1992-4#1)(2011-1#1)
to its biological function##2##4##(1991-11#1)(2007-12#1)
to its biological##3##3##(1991-11#1)(1992-6#1)(2007-12#1)
to its cell##2##3##(1992-9#1)(2008-9#1)
to its cellular##2##3##(1991-8#1)(2008-4#1)
to its central##2##3##(2008-10#1)(2011-2#1)
to its chemical##2##3##(1993-6#1)(2006-6#1)
to its clinical##2##3##(2007-11#1)(2008-11#1)
to its cognate##2##3##(1992-7#1)(1997-5#1)
to its complexity and##3##4##(2007-12#1)(2007-8#1)(2012-1#1)
to its consistency##2##3##(2008-10#1)(2012-2#1)
to its corresponding##5##3##(2007-6#1)(2008-10#1)(2008-5#2)(2010-5#1)
to its current##2##3##(2007-9#1)(2008-1#1)
to its detection##2##3##(2008-4#1)(2012-2#1)
to its determination by##5##4##(2008-10#5)
to its determination in##2##4##(2008-10#2)
to its determination##7##3##(2008-10#7)
to its detrimental##2##3##(2008-10#1)(2008-7#1)
to its development in##3##4##(2006-10#1)(2011-1#1)(2011-2#1)
to its development##9##3##(2006-10#1)(2008-7#1)(2010-3#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
to its diagnosis##3##3##(1990-9#1)(2010-2#2)
to its diagnostic accuracy##2##4##(1996-12#1)(2011-2#1)
to its direct##2##3##(1992-8#1)(2008-11#1)
to its dissociation##2##3##(2006-10#1)(2007-8#1)
to its downstream##2##3##(1997-6#1)(2008-12#1)
to its effect on the##2##5##(1993-6#1)(1993-8#1)
to its effect on##7##4##(1991-5#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-11#1)(2008-10#1)(2010-4#1)
to its effect##9##3##(1991-5#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-11#1)(2008-10#2)(2010-4#1)(2013-8#1)
to its effects on##2##4##(1990-2#1)(1990-3#1)
to its effects##4##3##(1990-2#1)(1990-3#1)(2007-6#1)(2008-10#1)
to its end##2##3##(1996-2#1)(2007-9#1)
to its environment##2##3##(1992-10#1)(2007-9#1)
to its excellent##2##3##(1991-5#1)(2010-12#1)
to its execution##2##3##(2011-2#2)
to its exposure##2##3##(2008-11#1)(2011-1#1)
to its expression##3##3##(1993-12#1)(1993-5#1)(1996-5#1)
to its favorable##2##3##(1994-8#1)(2010-11#1)
to its final##2##3##(1993-3#1)(1995-1#1)
to its formation##2##3##(1996-8#1)(2012-2#1)
to its functional##2##3##(2011-2#2)
to its goals##2##3##(2006-3#1)(2007-4#1)
to its good##2##3##(1993-2#1)(2008-10#1)
to its high content of##2##5##(2008-12#1)(2011-2#1)
to its high incidence and##2##5##(2008-10#1)(2008-8#1)
to its high incidence##4##4##(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
to its high porosity##2##4##(2008-11#1)(2009-12#1)
to its high sensitivity##3##4##(2007-8#1)(2008-10#1)(2008-3#1)
to its high##30##3##(1992-11#1)(1993-3#1)(1994-9#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-2#1)(2010-4#3)(2011-1#1)(2011-2#3)(2013-1#1)
to its higher##2##3##(2008-5#1)(2011-2#1)
to its highly##3##3##(2007-11#1)(2008-10#1)(2008-7#1)
to its host cell##2##4##(1993-12#1)(1996-8#1)
to its host##3##3##(1993-12#1)(1996-8#1)(2008-4#1)
to its human##4##3##(1993-3#1)(1994-9#1)(1996-10#1)(2013-7#1)
to its immunosuppressive##2##3##(1991-12#1)(1996-8#1)
to its implementation##3##3##(1992-1#1)(1995-3#1)(2008-3#1)
to its importance in##3##4##(2008-10#1)(2010-2#1)(2013-1#1)
to its importance##5##3##(1995-8#1)(2008-10#1)(2008-5#1)(2010-2#1)(2013-1#1)
to its important##2##3##(2006-2#1)(2012-12#1)
to its incorporation into the##2##5##(1992-6#1)(2008-3#1)
to its incorporation into##3##4##(1991-1#1)(1992-6#1)(2008-3#1)
to its increasing##2##3##(1991-6#1)(2006-10#1)
to its influence##3##3##(1991-9#1)(2006-6#1)(2008-10#1)
to its inhibition of##2##4##(1992-9#1)(1993-8#1)
to its inhibition##3##3##(1990-11#1)(1992-9#1)(1993-8#1)
to its initial##5##3##(1990-3#1)(2007-12#1)(2008-2#1)(2008-9#1)(2011-2#1)
to its integration##2##3##(2008-5#2)
to its large size##2##4##(2009-11#1)(2013-7#1)
to its local##2##3##(1993-12#1)(2006-2#1)
to its location and##2##4##(1993-3#1)(2011-2#1)
to its location##5##3##(1993-3#1)(2009-2#1)(2011-2#1)(2013-1#2)
to its low##10##3##(1993-8#1)(1993-9#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-5#1)(2010-1#1)(2012-1#1)
to its maximum##3##3##(2008-1#1)(2008-12#1)(2008-7#1)
to its measurement##2##3##(2008-10#1)(2012-2#1)
to its mechanism of action##2##5##(2006-10#1)(2010-3#1)
to its mechanism##3##3##(1990-12#1)(2006-10#1)(2010-3#1)
to its membrane receptor##2##4##(1993-3#1)(2006-10#1)
to its membrane##3##3##(1993-3#1)(1994-6#1)(2006-10#1)
to its molecular##3##3##(1991-2#1)(1992-3#1)(2008-4#1)
to its more##3##3##(2007-8#1)(2008-5#1)(2009-8#1)
to its morphology##2##3##(2006-6#1)(2009-2#1)
to its most##2##3##(1994-12#1)(2012-3#1)
to its native##4##3##(1992-6#1)(2008-10#2)(2008-9#1)
to its natural##4##3##(1993-3#1)(2008-1#1)(2008-10#1)(2008-8#1)
to its new##3##3##(1990-12#1)(1992-12#1)(2008-8#1)
to its nuclear receptor##2##4##(1992-12#1)(1994-5#1)
to its original##3##3##(2006-3#1)(2006-6#1)(2008-5#1)
to its own##7##3##(1991-2#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)
to its particular##2##3##(1995-11#1)(2007-8#1)
to its poor##3##3##(2007-11#1)(2010-12#1)(2013-7#1)
to its population##2##3##(2012-2#1)(2012-3#1)
to its possible##3##3##(1993-4#1)(2007-2#1)(2010-11#1)
to its potential##3##3##(1997-4#1)(2008-12#1)(2010-12#1)
to its presence##3##3##(1995-11#1)(1996-9#1)(2012-2#1)
to its promoter##2##3##(1993-3#1)(2013-1#1)
to its rapid##2##3##(2008-10#1)(2012-12#1)
to its rarity and##2##4##(2011-2#2)
to its rarity##6##3##(2007-7#1)(2008-10#1)(2010-2#1)(2011-2#3)
to its receptor in##2##4##(1995-11#1)(2009-2#1)
to its receptor on##2##4##(1994-12#1)(2008-1#1)
to its receptor with##2##4##(1990-12#1)(1990-3#1)
to its receptor##19##3##(1990-12#1)(1990-3#1)(1991-12#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-6#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)
to its recognition##3##3##(1995-1#1)(1995-8#1)(2006-12#1)
to its reliability##2##3##(1990-5#1)(2008-10#1)
to its response##2##3##(1993-6#1)(2008-2#1)
to its role in the##2##5##(1997-6#1)(2007-12#1)
to its role in##11##4##(1997-6#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-12#2)(2011-12#1)(2012-1#1)(2012-12#1)
to its role##13##3##(1992-6#1)(1997-6#1)(2003-11#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-12#2)(2011-12#1)(2012-1#1)(2012-12#1)
to its safety##3##3##(2010-12#1)(2012-1#1)(2012-2#1)
to its second##2##3##(2008-2#1)(2008-8#1)
to its sensitivity##2##3##(1990-3#1)(1994-3#1)
to its simplicity##8##3##(1991-10#1)(2007-10#1)(2008-10#1)(2008-11#1)(2010-7#1)(2012-12#2)(2013-1#1)
to its site of##2##4##(1990-12#1)(2006-10#1)
to its site##4##3##(1990-12#1)(1997-2#1)(1997-4#1)(2006-10#1)
to its sites##2##3##(1990-11#1)(1991-11#1)
to its specific##5##3##(1996-5#1)(2007-7#1)(2008-5#1)(2011-2#1)(2013-8#1)
to its status##2##3##(2007-9#1)(2011-2#1)
to its stimulation##2##3##(2008-7#1)(2012-12#1)
to its success##3##3##(1994-2#1)(1994-3#1)(2006-8#1)
to its suitability##2##3##(2008-10#1)(2008-11#1)
to its superior##2##3##(2008-3#1)(2011-2#1)
to its surface##4##3##(1995-5#1)(2007-12#1)(2008-10#1)(2008-3#1)
to its target##4##3##(2007-11#1)(2009-2#1)(2010-12#1)(2011-2#1)
to its tremendous##2##3##(2008-4#1)(2008-7#1)
to its triphosphate##2##3##(1991-4#1)(2008-4#1)
to its unique##6##3##(1995-4#1)(1996-5#1)(1997-5#1)(2006-10#1)(2008-1#1)(2013-8#1)
to its unparalleled##2##3##(2010-7#1)(2013-1#1)
to its use as##2##4##(2008-10#1)(2008-2#1)
to its use in##3##4##(2008-11#1)(2008-8#1)(2011-12#1)
to its use##9##3##(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2011-12#1)
to its usefulness for##2##4##(1992-11#1)(2008-3#1)
to its usefulness##3##3##(1992-11#1)(1995-7#1)(2008-3#1)
to its versatility and##3##4##(2007-12#1)(2009-10#2)
to its versatility##4##3##(2007-12#1)(2009-10#2)(2011-2#1)
to its weak##3##3##(1995-8#1)(1996-7#1)(2010-6#1)
to its wide availability and its##2##6##(2009-1#2)
to its wide##3##3##(2008-10#1)(2009-1#2)
to its##917##2##(1990-10#3)(1990-11#4)(1990-12#12)(1990-2#4)(1990-3#6)(1990-4#5)(1990-5#5)(1990-6#4)(1990-7#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#7)(1991-2#4)(1991-3#2)(1991-4#2)(1991-5#3)(1991-6#4)(1991-7#2)(1991-8#3)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#9)(1992-2#4)(1992-3#3)(1992-4#2)(1992-5#2)(1992-6#6)(1992-7#1)(1992-8#3)(1992-9#5)(1993-11#3)(1993-12#4)(1993-2#2)(1993-3#15)(1993-4#1)(1993-5#1)(1993-6#6)(1993-8#5)(1993-9#2)(1994-1#1)(1994-10#2)(1994-11#3)(1994-12#3)(1994-2#3)(1994-3#12)(1994-5#3)(1994-6#2)(1994-8#3)(1994-9#3)(1995-1#5)(1995-10#1)(1995-11#6)(1995-12#4)(1995-2#7)(1995-3#6)(1995-4#1)(1995-5#3)(1995-6#2)(1995-7#2)(1995-8#5)(1996-1#2)(1996-10#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#5)(1996-6#3)(1996-7#2)(1996-8#6)(1996-9#1)(1997-1#5)(1997-2#6)(1997-3#2)(1997-4#5)(1997-5#4)(1997-6#5)(1997-7#3)(2003-11#1)(2004-1#1)(2004-3#1)(2004-4#1)(2005-1#1)(2005-10#1)(2005-11#6)(2005-12#2)(2005-5#1)(2005-7#4)(2005-8#3)(2005-9#1)(2006-10#15)(2006-11#1)(2006-12#3)(2006-2#3)(2006-3#3)(2006-4#1)(2006-5#2)(2006-6#6)(2006-7#1)(2006-8#4)(2006-9#1)(2007-1#4)(2007-10#3)(2007-11#11)(2007-12#18)(2007-2#2)(2007-3#3)(2007-4#4)(2007-5#1)(2007-6#2)(2007-7#6)(2007-8#10)(2007-9#6)(2008-1#13)(2008-10#77)(2008-11#19)(2008-12#9)(2008-2#18)(2008-3#13)(2008-4#20)(2008-5#32)(2008-6#1)(2008-7#18)(2008-8#18)(2008-9#7)(2009-1#2)(2009-10#4)(2009-11#1)(2009-12#6)(2009-2#8)(2009-3#2)(2009-4#5)(2009-5#2)(2009-6#2)(2009-8#4)(2009-9#1)(2010-1#2)(2010-11#3)(2010-12#13)(2010-2#8)(2010-3#3)(2010-4#6)(2010-5#3)(2010-6#2)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#16)(2011-10#1)(2011-12#3)(2011-2#37)(2012-1#7)(2012-11#5)(2012-12#14)(2012-2#16)(2012-3#5)(2013-1#25)(2013-7#6)(2013-8#23)
to itself##5##2##(1993-6#1)(1995-2#1)(1995-6#1)(2008-3#1)(2010-4#1)
to jasmonic acid##2##3##(2008-5#1)(2012-2#1)
to jasmonic##3##2##(2008-5#1)(2009-6#1)(2012-2#1)
to job satisfaction##2##3##(1994-1#1)(2007-4#1)
to job##5##2##(1994-1#1)(1996-2#1)(2004-9#1)(2007-4#1)(2009-10#1)
to join the##8##3##(1990-4#1)(2006-4#1)(2007-4#1)(2007-7#1)(2007-8#1)(2009-6#1)(2010-3#1)(2011-1#1)
to join this##2##3##(2008-1#1)(2010-11#1)
to join##24##2##(1990-4#1)(1996-2#1)(1996-9#1)(1997-1#1)(2006-10#1)(2006-4#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#2)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#2)
to joint attention##2##3##(2009-4#1)(2013-1#1)
to joint destruction and##2##4##(2011-2#1)(2012-3#1)
to joint destruction##3##3##(2007-11#1)(2011-2#1)(2012-3#1)
to joint##13##2##(2006-11#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-3#1)(2009-4#1)(2009-5#3)(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
to jointly##2##2##(1992-12#1)(2011-1#1)
to journal##4##2##(1991-12#1)(1993-12#1)(2005-7#1)(2012-3#1)
to journey##2##2##(1996-2#1)(2008-9#1)
to judge the##7##3##(1990-12#1)(1996-4#1)(2006-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#1)
to judge whether##3##3##(1994-8#1)(1996-2#1)(2008-8#1)
to judge##19##2##(1990-12#1)(1993-9#1)(1994-8#1)(1996-2#1)(1996-4#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)
to judicial##2##2##(1993-5#1)(2006-3#1)
to juggle##2##2##(1991-3#1)(2006-10#1)
to junior##2##2##(1993-1#1)(2012-2#1)
to just a few##2##4##(1992-9#1)(2007-10#1)
to just the##2##3##(1992-3#1)(2008-10#1)
to just##7##2##(1992-3#1)(1992-9#1)(2007-1#1)(2007-10#1)(2008-10#2)(2010-12#1)
to justify and##2##3##(2007-5#1)(2011-12#1)
to justify the##14##3##(1992-6#1)(1995-1#1)(1997-1#1)(2005-10#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-2#1)
to justify use of##3##4##(1995-5#1)(2008-11#1)(2008-7#1)
to justify##35##2##(1992-6#1)(1995-1#1)(1995-5#1)(1997-1#1)(1997-8#1)(2005-10#1)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-3#3)(2007-4#1)(2007-5#2)(2007-7#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#2)(2008-7#2)(2009-2#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)
to juvenile rats##2##3##(1993-7#2)
to juvenile##5##2##(1993-7#2)(2007-5#1)(2008-5#1)(2012-11#1)
to k##2##2##(1992-9#1)(1995-3#1)
to kainic acid##4##3##(1992-8#1)(1993-2#2)(2010-10#1)
to kallikrein##2##2##(1991-8#2)
to kanamycin##3##2##(1992-6#1)(1994-12#1)(2008-10#1)
to kappa-opioid##2##2##(1996-12#1)(1997-2#1)
to karyotyping##3##2##(1993-1#1)(2008-10#1)(2012-12#1)
to keep a##5##3##(1992-11#1)(1992-3#1)(1993-1#1)(2006-10#1)(2011-1#1)
to keep his##2##3##(1993-11#1)(2007-8#1)
to keep in mind that##3##5##(1992-3#1)(2007-8#1)(2009-12#1)
to keep in mind the##2##5##(2009-1#1)(2009-6#1)
to keep in mind##6##4##(1992-3#1)(2007-7#1)(2007-8#1)(2009-1#1)(2009-12#1)(2009-6#1)
to keep in##10##3##(1991-1#1)(1992-3#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2009-1#1)(2009-12#1)(2009-6#1)
to keep on working##2##4##(2007-2#1)(2012-12#1)
to keep on##3##3##(1990-3#1)(2007-2#1)(2012-12#1)
to keep pace with##3##4##(1996-2#2)(2006-2#1)
to keep pace##5##3##(1995-1#1)(1996-2#2)(2006-2#1)(2009-6#1)
to keep the##30##3##(1990-11#1)(1991-1#1)(1991-4#1)(1992-1#1)(1992-3#1)(1994-3#1)(1996-8#1)(1997-2#1)(2004-8#1)(2006-4#1)(2007-7#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-7#2)(2010-12#1)(2010-8#1)(2011-2#3)(2012-1#2)(2012-2#1)(2013-8#1)
to keep their##4##3##(1993-1#1)(1996-3#1)(2009-10#1)(2010-7#1)
to keep them##4##3##(1993-6#1)(2008-10#1)(2010-4#1)(2010-9#1)
to keep this##2##3##(1996-3#1)(2012-2#1)
to keep track of##2##4##(2007-9#1)(2008-12#1)
to keep up with the##2##5##(2007-8#1)(2008-3#1)
to keep up with##4##4##(2007-8#2)(2008-3#1)(2008-4#1)
to keep up##5##3##(2005-11#1)(2007-8#2)(2008-3#1)(2008-4#1)
to keep##115##2##(1990-11#1)(1990-2#1)(1990-3#1)(1991-1#4)(1991-4#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-3#3)(1992-9#1)(1993-1#2)(1993-11#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#2)(1996-3#4)(1996-8#1)(1997-2#1)(1997-3#1)(2004-8#1)(2005-11#1)(2005-3#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#6)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#3)(2008-7#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-6#3)(2009-7#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#3)(2013-8#2)
to keloid##2##2##(2007-7#1)(2012-2#1)
to keratinocytes in vitro##3##4##(2008-8#3)
to keratinocytes in##4##3##(2008-8#3)(2012-2#1)
to keratinocytes##11##2##(1996-2#1)(2007-7#1)(2008-8#6)(2011-2#1)(2012-2#2)
to kernel##3##2##(2008-10#1)(2008-3#2)
to ketamine##6##2##(2007-2#2)(2009-5#2)(2011-12#1)(2012-12#1)
to ketoconazole##7##2##(2007-7#2)(2008-5#4)(2012-2#1)
to key##9##2##(2007-1#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-11#1)
to keyhole limpet hemocyanin (KLH)##2##5##(2008-10#2)
to keyhole limpet hemocyanin##3##4##(2008-10#2)(2010-12#1)
to keyhole limpet##4##3##(1993-11#1)(2008-10#2)(2010-12#1)
to kidney and##2##3##(1993-8#1)(2012-2#1)
to kidney injury##2##3##(2007-8#1)(2008-8#1)
to kidney transplantation##6##3##(1995-12#2)(2006-10#1)(2010-4#2)(2010-8#1)
to kidney##19##2##(1992-3#1)(1992-5#1)(1993-8#1)(1995-12#2)(1995-8#1)(2006-10#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-8#2)(2010-4#2)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
to kidney-type-alpha 2u-globulin##2##3##(1992-11#2)
to kidneys##2##2##(1990-3#1)(2007-7#1)
to kill S##2##3##(1995-8#1)(2009-6#1)
to kill cells##2##3##(2008-11#1)(2008-4#1)
to kill the##3##3##(2006-7#1)(2010-4#1)(2010-8#1)
to kill##34##2##(1990-7#2)(1995-2#3)(1995-8#1)(1995-9#1)(1996-3#1)(1997-5#1)(2006-7#1)(2006-8#1)(2007-11#3)(2007-9#1)(2008-10#4)(2008-11#2)(2008-4#3)(2008-5#1)(2009-3#2)(2009-6#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
to killing by##10##3##(1991-9#1)(1994-5#1)(1995-8#1)(1997-2#1)(2006-8#2)(2008-5#3)(2012-2#1)
to killing of##2##3##(2008-5#1)(2010-9#1)
to killing##14##2##(1991-9#1)(1994-5#1)(1994-6#1)(1995-8#1)(1997-2#1)(2006-7#1)(2006-8#2)(2008-5#4)(2010-9#1)(2012-2#1)
to kinase##3##2##(1994-3#1)(2008-1#1)(2009-4#1)
to kinetic data##2##3##(2008-10#1)(2008-4#1)
to kinetic##5##2##(1991-5#1)(1996-1#1)(2008-10#2)(2008-4#1)
to knee##5##2##(1997-2#1)(2007-11#1)(2007-4#1)(2011-2#1)(2012-2#1)
to knock down the expression of##2##6##(2008-4#1)(2010-12#1)
to knock down##5##3##(2008-11#1)(2008-4#1)(2010-12#1)(2011-1#1)(2012-11#1)
to knock##7##2##(2007-9#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-12#1)(2011-1#1)(2012-11#1)
to knockout##3##2##(2010-2#2)(2013-1#1)
to know about the##3##4##(2006-2#1)(2007-10#1)(2012-2#1)
to know about##9##3##(1995-1#1)(1996-8#1)(2006-2#1)(2007-10#1)(2008-10#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-2#1)
to know and##3##3##(1995-3#1)(2007-7#1)(2013-8#1)
to know how the##2##4##(2008-2#1)(2010-7#1)
to know how##6##3##(1992-12#1)(2008-2#1)(2010-7#1)(2010-9#1)(2012-12#1)(2013-8#1)
to know if the##2##4##(1993-3#1)(2008-3#1)
to know if##3##3##(1993-3#1)(2008-11#1)(2008-3#1)
to know more##2##3##(1996-3#1)(2010-8#1)
to know that##6##3##(1995-9#1)(1996-11#1)(1997-5#1)(2006-12#1)(2007-4#1)(2011-2#1)
to know the fetal sex as part of##3##8##(2013-1#3)
to know the fetal sex##6##5##(2013-1#6)
to know the incidence of##2##5##(2008-11#1)(2013-8#1)
to know the prevalence##2##4##(2007-7#1)(2008-1#1)
to know the##58##3##(1991-9#1)(1993-5#1)(1997-8#1)(2006-10#1)(2006-12#2)(2007-11#3)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#3)(2013-1#8)(2013-8#4)
to know their##2##3##(1996-11#1)(2013-1#1)
to know what##9##3##(1997-8#1)(2006-10#1)(2006-7#1)(2007-5#1)(2007-7#2)(2008-11#1)(2008-4#1)(2012-1#1)
to know when to##2##4##(2004-12#1)(2008-7#1)
to know when##3##3##(2004-12#1)(2008-7#1)(2013-7#1)
to know where to##2##4##(1996-12#1)(1997-8#1)
to know whether or not##3##5##(1993-12#1)(2007-11#1)(2008-11#1)
to know whether##11##3##(1992-7#1)(1993-12#1)(1994-12#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2012-2#1)(2012-3#1)
to know which##3##3##(2007-9#1)(2012-2#1)(2013-8#1)
to know##154##2##(1990-3#1)(1990-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-12#2)(1995-1#1)(1995-3#1)(1995-9#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-5#1)(1997-6#1)(1997-8#3)(2004-12#1)(2005-11#1)(2006-10#2)(2006-12#3)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-4#7)(2007-5#2)(2007-6#1)(2007-7#7)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#9)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#3)(2009-5#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#8)(2012-3#1)(2013-1#13)(2013-7#2)(2013-8#7)
to knowledge development##2##3##(2010-10#1)(2012-12#1)
to knowledge in##2##3##(2008-11#1)(2013-8#1)
to knowledge##16##2##(1993-1#1)(1993-10#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
to known genes##8##3##(1995-12#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-6#1)(1997-8#2)
to known inhibitors of##2##4##(1996-12#1)(2012-2#1)
to known proteins##8##3##(1990-11#1)(1991-11#1)(1995-12#1)(1995-9#1)(1996-8#1)(1997-4#2)(1997-7#1)
to known##65##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-11#2)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-6#2)(1995-11#1)(1995-12#2)(1995-7#1)(1995-8#1)(1995-9#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#2)(2005-11#1)(2006-10#1)(2006-12#2)(2006-6#1)(2007-12#2)(2007-8#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
to label and##2##3##(2007-8#1)(2012-12#1)
to label cells##4##3##(1996-11#1)(2008-4#1)(2009-6#1)(2012-2#1)
to label the##8##3##(1990-4#1)(1991-9#1)(2008-1#1)(2008-11#2)(2008-7#1)(2008-9#2)
to label##35##2##(1990-4#1)(1991-9#1)(1992-1#2)(1994-5#1)(1994-6#1)(1994-9#1)(1996-11#1)(1997-4#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#4)(2008-7#1)(2008-9#6)(2009-6#1)(2010-4#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)
to labeled##3##2##(1991-3#1)(1993-9#1)(2008-8#1)
to labelled##2##2##(1990-11#1)(2010-4#1)
to laboratories##2##2##(1995-12#1)(2008-9#1)
to laboratory automation for high throughput screening##2##7##(2008-10#2)
to laboratory automation##3##3##(2008-10#3)
to laboratory tests##2##3##(2008-5#1)(2009-8#1)
to laboratory##15##2##(1992-11#1)(1996-2#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
to lacZ##6##2##(1990-3#2)(1990-9#1)(1994-3#1)(1995-8#1)(1997-5#1)
to lack of a##2##4##(1993-12#1)(1993-2#1)
to lack of data##2##4##(2006-2#1)(2008-3#1)
to lack of resources##2##4##(2007-6#1)(2010-12#1)
to lack of##54##3##(1990-1#1)(1990-10#1)(1992-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-4#1)(1995-5#1)(1996-11#1)(2005-8#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#2)(2007-7#2)(2008-1#1)(2008-10#1)(2008-12#3)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
to lack##65##2##(1990-1#1)(1990-10#1)(1991-5#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-4#1)(1994-9#1)(1995-5#1)(1996-11#1)(1997-4#1)(1997-7#1)(2005-8#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#3)(2007-7#2)(2008-1#1)(2008-10#3)(2008-12#3)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
to lactate dehydrogenase##3##3##(1997-4#1)(1997-8#1)(2010-4#1)
to lactation##2##2##(2007-2#1)(2012-12#1)
to lactic acid by##2##4##(1990-12#1)(2008-5#1)
to lactic acid##5##3##(1990-12#1)(2004-9#1)(2008-5#2)(2013-8#1)
to lag behind##4##3##(2008-12#1)(2008-9#1)(2011-1#2)
to lag##5##2##(2008-12#1)(2008-9#1)(2010-8#1)(2011-1#2)
to lamb##2##2##(2007-10#1)(2008-9#1)
to lambda-cyhalothrin##2##2##(2007-10#2)
to lamin A##2##3##(1990-11#1)(2011-2#1)
to lamin##3##2##(1990-11#1)(2008-8#1)(2011-2#1)
to laminin and fibronectin##2##4##(1993-5#1)(1995-12#1)
to laminin and##3##3##(1992-9#1)(1993-5#1)(1995-12#1)
to laminin##5##2##(1991-5#1)(1992-9#1)(1993-5#1)(1994-5#1)(1995-12#1)
to land##3##2##(1997-4#1)(2007-9#1)(2008-10#1)
to landscape##4##2##(2006-5#1)(2008-8#2)(2013-1#1)
to language##7##2##(2006-11#1)(2008-11#1)(2008-2#1)(2009-1#1)(2010-2#2)(2012-3#1)
to lanthanide##2##2##(2008-10#1)(2008-3#1)
to laparoscopic surgery##3##3##(2009-8#1)(2010-1#1)(2013-1#1)
to laparoscopic##11##2##(1994-2#1)(2008-3#1)(2009-8#1)(2010-1#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-7#1)
to laparoscopy##2##2##(2004-2#1)(2011-1#1)
to laparotomy##7##2##(1993-3#1)(1994-2#1)(1994-9#1)(1995-3#1)(1996-1#1)(2008-8#1)(2012-3#1)
to large changes in##3##4##(1990-9#1)(2008-10#1)(2008-7#1)
to large earthquakes##2##3##(1996-4#2)
to large numbers of##4##4##(1997-8#1)(2008-10#1)(2008-4#1)(2009-6#1)
to large populations##3##3##(1992-2#1)(2008-7#1)(2013-1#1)
to large scale##5##3##(2005-7#1)(2008-11#1)(2008-7#2)(2009-3#1)
to large unilamellar vesicles##2##4##(1991-9#1)(1992-12#1)
to large urban##2##3##(1990-12#1)(2012-12#1)
to large##81##2##(1990-12#2)(1990-3#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1993-8#1)(1995-12#1)(1996-12#1)(1996-4#4)(1997-7#1)(1997-8#1)(2005-12#1)(2005-7#1)(2006-11#1)(2006-2#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-5#2)(2007-8#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#7)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#4)
to large-scale##12##2##(1990-5#1)(1996-12#1)(1996-4#1)(2006-6#1)(2007-9#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2012-2#1)
to larger##8##2##(1993-3#1)(1995-6#1)(1996-3#1)(2007-6#1)(2008-10#2)(2008-2#1)(2008-4#1)
to larvae##3##2##(2007-3#2)(2008-11#1)
to larval tracks##2##3##(2011-12#2)
to larval##4##2##(2007-11#1)(2008-8#1)(2011-12#2)
to lase##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
to laser light##4##3##(2007-12#1)(2008-2#1)(2012-12#2)
to laser##18##2##(1992-9#1)(1993-3#1)(1994-3#1)(2005-8#1)(2007-12#2)(2008-1#2)(2008-2#3)(2008-3#2)(2009-2#1)(2011-1#1)(2012-12#2)(2013-1#1)
to last for##2##3##(2008-7#1)(2012-2#1)
to last##7##2##(2008-12#1)(2008-7#1)(2009-12#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
to late adolescence##3##3##(2007-3#1)(2009-7#2)
to late blight##3##3##(2008-10#3)
to late restenosis##2##3##(1994-10#1)(2006-6#1)
to late##42##2##(1990-11#1)(1991-2#1)(1992-6#1)(1993-2#1)(1994-10#1)(1994-2#1)(1996-8#1)(1997-6#1)(2006-10#1)(2006-6#1)(2007-3#1)(2007-8#1)(2008-10#9)(2008-3#1)(2008-5#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
to latent infection##4##3##(2008-10#4)
to latent##7##2##(2008-10#5)(2008-9#1)(2012-11#1)
to later##11##2##(1991-9#1)(1995-6#1)(2005-6#1)(2006-7#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-11#1)(2011-1#1)
to lateral##14##2##(1991-11#1)(1992-11#1)(1996-8#1)(2006-11#2)(2007-12#2)(2007-4#3)(2007-9#1)(2008-4#1)(2009-4#1)(2010-12#1)
to latex##2##2##(1990-7#1)(1991-12#1)
to launch a##2##3##(1996-2#1)(2007-9#1)
to launch the##4##3##(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)
to launch##11##2##(1996-2#1)(2005-6#1)(2005-9#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)
to lay out##2##3##(2008-1#1)(2008-9#1)
to lay the foundation for##4##5##(2007-4#1)(2008-4#1)(2012-12#1)(2013-8#1)
to lay the##5##3##(2007-4#1)(2008-4#1)(2009-4#1)(2012-12#1)(2013-8#1)
to lay##15##2##(1993-1#1)(1994-1#1)(2004-4#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-12#2)(2013-8#1)
to layer##6##2##(1991-3#2)(1995-2#1)(2005-11#1)(2008-11#1)(2008-7#1)
to layers##3##2##(2004-4#1)(2008-3#1)(2010-2#1)
to leaching##2##2##(2008-10#1)(2009-6#1)
to lead a##3##3##(1994-9#1)(2011-2#1)(2013-8#1)
to lead from##2##3##(2008-3#1)(2012-12#1)
to lead in petrol##2##4##(2006-5#2)
to lead in##4##3##(2006-5#3)(2012-12#1)
to lead poisoning##3##3##(2012-1#2)(2013-1#1)
to lead the##5##3##(1990-12#1)(2007-8#1)(2009-6#1)(2009-7#2)
to lead to a##7##4##(1993-11#1)(1996-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2010-2#1)(2012-2#1)
to lead to an increase in##2##6##(1994-3#1)(1995-4#1)
to lead to an##4##4##(1994-3#1)(1995-4#1)(2008-3#1)(2010-2#1)
to lead to greater##2##4##(2009-7#1)(2011-2#1)
to lead to improved##2##4##(2008-3#1)(2008-4#1)
to lead to more##2##4##(1995-5#1)(1996-12#1)
to lead to new##2##4##(1991-11#1)(2008-1#1)
to lead to the##13##4##(1990-6#1)(1994-3#2)(2006-9#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-8#1)(2011-2#3)
to lead to##61##3##(1990-5#1)(1990-6#1)(1991-11#1)(1993-11#1)(1993-3#1)(1994-3#3)(1994-6#1)(1995-4#1)(1995-5#1)(1996-11#1)(1996-12#2)(1996-6#1)(2005-11#1)(2006-10#4)(2006-2#2)(2006-9#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-2#2)(2010-9#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)
to lead##106##2##(1990-12#1)(1990-5#2)(1990-6#1)(1991-11#2)(1993-11#1)(1993-2#1)(1993-3#1)(1994-3#3)(1994-6#1)(1994-9#1)(1995-4#1)(1995-5#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-4#2)(2005-11#2)(2006-10#4)(2006-2#2)(2006-5#4)(2006-9#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#2)(2007-9#6)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-6#1)(2009-7#3)(2009-8#1)(2010-2#2)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#4)(2013-8#1)
to leadership##3##2##(1995-1#1)(1996-3#1)(2007-4#1)
to leading##2##2##(1993-3#1)(2008-2#1)
to leaf blast##3##3##(2008-10#3)
to leaf rust and##4##4##(2008-10#4)
to leaf rust##12##3##(2008-10#12)
to leaf spot disease##2##4##(2008-10#2)
to leaf spot##3##3##(2008-10#3)
to leaf##33##2##(2007-6#1)(2008-10#30)(2008-12#1)(2012-9#1)
to leaky##2##2##(2008-10#1)(2008-7#1)
to lean##5##2##(1991-3#1)(1997-5#2)(2008-9#1)(2012-3#1)
to learn a##3##3##(2008-1#1)(2009-3#1)(2012-2#1)
to learn about the##3##4##(2009-3#2)(2011-12#1)
to learn about their##3##4##(2007-2#1)(2011-2#1)(2012-2#1)
to learn about##16##3##(1994-1#1)(1994-2#2)(2007-2#1)(2007-8#1)(2008-11#2)(2008-2#1)(2009-3#2)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
to learn and practice##2##4##(2006-6#1)(2007-2#1)
to learn and to##3##4##(1995-4#1)(2006-7#1)(2009-2#1)
to learn and##14##3##(1994-3#1)(1995-4#1)(2006-6#1)(2006-7#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-2#1)(2010-11#1)(2010-5#1)(2011-1#1)(2013-1#1)
to learn from the##3##4##(1992-3#1)(2006-10#1)(2007-4#1)
to learn from their experiences##2##5##(2005-7#1)(2012-12#1)
to learn from##13##3##(1990-5#1)(1992-3#1)(2005-7#1)(2006-10#2)(2007-10#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-12#1)
to learn how to be##2##5##(1994-3#1)(2007-8#1)
to learn how to##9##4##(1991-3#1)(1994-1#1)(1994-3#1)(1995-9#1)(2007-8#1)(2008-10#1)(2009-4#1)(2010-12#2)
to learn how##10##3##(1991-3#1)(1994-1#1)(1994-3#1)(1995-9#1)(2007-8#1)(2008-10#1)(2009-4#1)(2010-12#2)(2012-2#1)
to learn more about the##5##5##(1993-11#1)(2006-10#1)(2009-11#1)(2009-4#1)(2010-11#1)
to learn more about##8##4##(1993-11#1)(1995-2#1)(1995-3#1)(2006-10#1)(2008-7#1)(2009-11#1)(2009-4#1)(2010-11#1)
to learn more##9##3##(1993-11#1)(1995-2#1)(1995-3#1)(2006-10#1)(2008-7#1)(2009-11#1)(2009-4#1)(2010-11#1)(2013-8#1)
to learn of##2##3##(1993-12#1)(1996-5#1)
to learn that##4##3##(1992-12#1)(2007-9#1)(2011-1#1)(2012-3#1)
to learn the fetal sex##2##5##(2013-1#2)
to learn the##17##3##(1992-9#1)(1993-3#1)(1993-5#1)(1994-12#1)(1996-5#1)(1997-3#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-1#2)(2013-1#3)
to learn to##4##3##(1991-2#1)(1994-2#1)(1996-12#1)(2008-8#1)
to learn whether##2##3##(1990-12#1)(1990-6#1)
to learn##133##2##(1990-12#1)(1990-5#1)(1990-6#1)(1991-2#2)(1991-3#1)(1992-12#1)(1992-3#3)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#2)(1994-1#2)(1994-12#1)(1994-2#3)(1994-3#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-3#1)(2005-7#1)(2006-10#4)(2006-2#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#6)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#2)(2009-11#1)(2009-2#2)(2009-3#5)(2009-4#2)(2010-11#3)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#14)(2013-7#1)(2013-8#3)
to learning and memory##2##4##(1994-5#1)(1996-5#1)
to learning and##4##3##(1994-5#1)(1996-5#1)(2011-1#2)
to learning in a##2##4##(2008-11#1)(2011-1#1)
to learning in##5##3##(2008-11#4)(2011-1#1)
to learning##29##2##(1992-8#1)(1994-2#1)(1994-5#1)(1996-5#1)(2006-7#1)(2006-8#1)(2007-5#1)(2007-7#1)(2008-11#9)(2009-3#1)(2011-1#9)(2011-2#1)(2012-1#1)
to least##3##2##(2008-5#1)(2008-9#1)(2013-8#1)
to leave a##2##3##(2008-4#1)(2008-9#1)
to leave the nest##2##4##(2008-8#2)
to leave the##10##3##(1993-5#1)(1995-6#1)(2006-10#1)(2007-10#1)(2008-8#2)(2008-9#2)(2011-1#1)(2011-12#1)
to leave their practices##2##4##(2008-9#2)
to leave their##4##3##(2008-9#3)(2011-1#1)
to leave##27##2##(1993-5#1)(1993-6#1)(1995-6#1)(1996-11#1)(1997-5#1)(2004-3#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-9#1)(2008-4#1)(2008-8#3)(2008-9#6)(2009-10#1)(2011-1#2)(2011-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
to leaves##9##2##(1995-1#1)(2008-10#7)(2010-5#1)
to lectin##2##2##(2008-4#1)(2011-2#1)
to lectins##2##2##(1995-11#1)(1997-7#1)
to left anterior descending##3##4##(2007-8#3)
to left ventricular diastolic##2##4##(2006-2#1)(2010-12#1)
to left ventricular hypertrophy##2##4##(1992-8#1)(2013-1#1)
to left ventricular##9##3##(1992-8#1)(1997-8#1)(2006-2#1)(2006-6#1)(2007-8#1)(2007-9#1)(2010-12#1)(2012-2#1)(2013-1#1)
to left##37##2##(1992-8#1)(1997-8#1)(2006-2#1)(2006-3#1)(2006-6#2)(2007-10#1)(2007-12#1)(2007-6#1)(2007-8#9)(2007-9#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-3#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#2)
to left-handed##3##2##(1991-5#2)(1995-10#1)
to legal##4##2##(1990-12#1)(2008-11#1)(2011-12#1)(2012-11#1)
to leishmaniasis##2##2##(2008-12#1)(2008-4#1)
to lend##2##2##(2007-10#1)(2008-6#1)
to length of##4##3##(2007-2#2)(2010-12#1)(2012-2#1)
to lengthen##4##2##(1991-8#1)(2007-11#1)(2007-8#2)
to lens##6##2##(1995-3#1)(1997-1#1)(2007-12#3)(2008-3#1)
to lenses##2##2##(2006-6#1)(2008-3#1)
to lenticels##2##2##(2008-10#2)
to leprosis##3##2##(2008-10#3)
to lesion##5##2##(1994-10#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-5#1)
to lesions##5##2##(1991-2#1)(2006-10#1)(2007-8#1)(2008-10#1)(2010-3#1)
to less common##2##3##(2006-10#1)(2012-3#1)
to less invasive##2##3##(2006-10#1)(2006-2#1)
to less positive values##2##4##(2008-10#2)
to less than 0##6##4##(1991-6#1)(1995-1#1)(2007-12#1)(2008-10#1)(2008-3#2)
to less than 1##4##4##(1991-10#1)(1994-12#1)(2008-9#1)(2012-12#1)
to less than 1%##3##4##(1992-3#1)(2007-11#2)
to less than 10% of##2##5##(1990-11#1)(1991-2#1)
to less than 10%##5##4##(1990-11#1)(1991-2#1)(1993-6#1)(2007-7#1)(2008-12#1)
to less than 100##2##4##(1990-5#1)(2008-3#1)
to less than 16 years##2##5##(2013-1#2)
to less than 2%##2##4##(1992-8#1)(2006-10#1)
to less than 20##4##4##(1996-7#1)(1997-3#1)(2006-5#1)(2008-2#1)
to less than 4##4##4##(2008-2#1)(2013-1#3)
to less than 5##3##4##(1996-7#1)(2008-3#1)(2013-1#1)
to less than 5%##3##4##(2007-11#1)(2008-7#1)(2012-2#1)
to less than 50% of##2##5##(1994-3#1)(2009-10#1)
to less than 50%##3##4##(1994-3#1)(2008-5#1)(2009-10#1)
to less than half##2##4##(1994-2#1)(2011-1#1)
to less than##71##3##(1990-11#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-2#3)(1991-6#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1996-7#2)(1997-3#1)(2006-10#1)(2006-5#1)(2006-8#2)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#5)(2008-3#8)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#12)
to less##99##2##(1990-11#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-2#3)(1991-6#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1996-12#1)(1996-7#2)(1997-3#1)(1997-8#1)(2006-10#3)(2006-12#3)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#5)(2008-3#8)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#14)
to lessen the##6##3##(1991-3#1)(1997-2#1)(2006-10#1)(2007-2#1)(2009-7#1)(2012-2#1)
to lessen##10##2##(1991-3#1)(1994-2#1)(1994-8#1)(1997-2#1)(2006-10#1)(2006-5#1)(2007-2#1)(2009-7#1)(2009-9#1)(2012-2#1)
to lesser extents##2##3##(1991-4#1)(1995-6#1)
to lesser##6##2##(1991-4#1)(1993-8#2)(1995-6#1)(2007-8#1)(2008-4#1)
to let the##4##3##(1994-1#1)(1995-6#1)(2008-2#1)(2008-3#1)
to let##6##2##(1994-1#1)(1994-2#1)(1995-6#1)(2008-2#2)(2008-3#1)
to lethal##8##2##(1991-1#1)(1992-6#1)(1994-11#1)(1995-12#1)(2006-9#1)(2012-2#1)(2013-1#1)(2013-7#1)
to lettuce##4##2##(2008-10#4)
to leucine##5##2##(1991-2#1)(1992-1#1)(1996-2#1)(1997-5#1)(2008-3#1)
to leukemia##4##2##(1991-3#1)(1995-1#1)(2008-3#1)(2008-4#1)
to leukotrienes##2##2##(1997-5#1)(2008-3#1)
to levamisole##4##2##(1990-11#1)(2007-7#1)(2008-1#2)
to level of##2##3##(1992-9#1)(1993-8#1)
to level off##3##3##(1994-9#1)(2005-11#1)(2008-4#1)
to level##8##2##(1992-6#1)(1992-9#1)(1993-8#1)(1994-9#1)(2005-11#1)(2008-10#1)(2008-4#1)(2010-2#1)
to levels above##2##3##(2006-7#1)(2009-6#1)
to levels below##3##3##(1991-11#1)(1991-12#1)(2008-7#1)
to levels comparable to those##2##5##(1990-2#1)(1995-10#1)
to levels comparable to##5##4##(1990-2#1)(1993-12#1)(1995-10#1)(2009-5#1)(2012-2#1)
to levels comparable##6##3##(1990-2#1)(1993-12#1)(1995-10#1)(2009-5#1)(2012-2#2)
to levels in##3##3##(1991-2#1)(1992-12#1)(2013-1#1)
to levels of##11##3##(1992-6#1)(1992-9#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-2#1)(1997-8#1)(2005-10#2)(2008-10#1)
to levels significantly lower than##2##5##(2008-10#1)(2008-8#1)
to levels significantly##3##3##(1994-2#1)(2008-10#1)(2008-8#1)
to levels that##2##3##(2007-8#1)(2008-5#1)
to levels##46##2##(1990-2#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-4#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-8#2)(1996-2#1)(1997-4#1)(1997-8#2)(2005-10#2)(2006-7#1)(2007-11#3)(2007-6#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#2)(2009-6#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#1)
to leverage##8##2##(2006-5#1)(2008-2#1)(2011-1#1)(2012-3#1)(2013-1#4)
to levodopa in advanced##2##4##(1997-7#1)(2008-5#1)
to levodopa in##3##3##(1997-7#1)(2005-7#1)(2008-5#1)
to levodopa##7##2##(1994-10#1)(1997-7#1)(2005-7#1)(2008-11#1)(2008-5#1)(2008-7#2)
to liability##2##2##(1992-12#1)(1994-1#1)
to liberate##9##2##(1992-6#1)(1994-10#1)(2005-11#1)(2008-10#3)(2008-4#2)(2008-6#1)
to lidar##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
to lidocaine##3##2##(1996-10#2)(2006-8#1)
to lie in the##4##4##(1995-8#1)(1996-2#1)(2008-10#1)(2008-8#1)
to lie in##6##3##(1995-8#1)(1996-2#1)(2008-10#1)(2008-8#1)(2009-8#1)(2012-2#1)
to lie on##3##3##(1995-6#1)(2007-12#1)(2008-11#1)
to lie with##2##3##(1993-3#1)(2007-8#1)
to lie##19##2##(1991-7#1)(1993-3#1)(1994-5#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-2#1)(2004-12#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-2#1)
to life and##7##3##(1993-11#1)(1996-12#1)(1997-1#1)(2011-2#4)
to life in##3##3##(1990-2#1)(2009-8#1)(2011-2#1)
to life threatening##4##3##(2006-4#1)(2007-4#1)(2007-9#1)(2012-12#1)
to life##40##2##(1990-12#1)(1990-2#1)(1991-12#1)(1993-11#1)(1993-6#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-1#1)(1997-8#2)(2006-10#1)(2006-4#1)(2007-10#1)(2007-4#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#6)(2012-1#1)(2012-11#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
to life&quot##4##2##(2007-6#3)(2008-10#1)
to life-threatening infections##2##3##(2005-8#1)(2007-12#1)
to life-threatening##10##2##(1996-12#1)(2005-8#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
to lifestyle changes##4##3##(2007-5#1)(2008-3#2)(2010-8#1)
to lifestyle##10##2##(1996-1#1)(2006-8#1)(2007-5#1)(2008-1#1)(2008-3#3)(2010-8#1)(2011-1#1)(2012-2#1)
to lifetime##2##2##(2012-1#1)(2013-1#1)
to lift##3##2##(1994-2#1)(1997-3#1)(2008-11#1)
to ligand##10##2##(1991-8#1)(1993-12#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(2008-10#3)(2008-5#1)
to ligands##8##2##(1992-8#1)(1994-11#2)(2008-10#1)(2008-4#3)(2010-2#1)
to ligation##3##2##(2006-10#1)(2008-11#1)(2010-12#1)
to light and##2##3##(2008-10#1)(2012-2#1)
to light during the##2##4##(1994-2#1)(2010-12#1)
to light in##4##3##(2006-9#2)(2007-5#1)(2009-4#1)
to light is##2##3##(1997-6#1)(2008-12#1)
to light onset##2##3##(1995-3#1)(1996-9#1)
to light scattering by##2##4##(2007-12#1)(2008-3#1)
to light scattering##3##3##(2007-12#1)(2008-3#2)
to light the##4##3##(2007-2#1)(2008-5#1)(2008-9#1)(2010-12#1)
to light through##2##3##(2007-12#1)(2008-6#1)
to light##63##2##(1991-10#1)(1991-9#2)(1992-6#1)(1992-7#2)(1992-9#1)(1993-7#1)(1994-2#1)(1994-4#1)(1994-6#1)(1995-3#1)(1996-9#1)(1997-4#1)(1997-6#2)(2006-1#1)(2006-10#1)(2006-9#2)(2007-1#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-4#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-12#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
to light-induced##2##2##(2007-12#1)(2008-7#1)
to lignin##2##2##(2012-2#1)(2013-1#1)
to like her##2##3##(2007-12#2)
to limb##4##2##(1991-1#1)(1992-11#2)(1997-4#1)
to limit family size##2##4##(1996-8#2)
to limit or##2##3##(1995-1#1)(2006-10#1)
to limit patient##2##3##(2008-3#2)
to limit the damage##2##4##(2008-10#1)(2010-12#1)
to limit the progression of##2##5##(2007-8#1)(2008-10#1)
to limit the risk of##3##5##(2008-11#1)(2008-8#1)(2011-3#1)
to limit the spread of##2##5##(1990-6#1)(2011-2#1)
to limit the##48##3##(1990-12#1)(1990-6#2)(1991-1#2)(1992-5#1)(1993-3#2)(1994-2#1)(1994-3#1)(1997-6#1)(2006-10#1)(2006-11#3)(2006-7#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-4#2)(2009-8#1)(2010-12#1)(2011-12#1)(2011-2#3)(2011-3#1)(2012-12#1)(2013-8#1)
to limit their##4##3##(1996-11#1)(2006-10#1)(2007-11#1)(2008-3#1)
to limit##101##2##(1990-12#1)(1990-4#1)(1990-6#3)(1991-1#2)(1991-10#1)(1991-8#1)(1992-5#1)(1993-3#2)(1993-9#1)(1994-2#1)(1994-3#1)(1995-1#1)(1996-11#1)(1996-2#1)(1996-8#2)(1996-9#1)(1997-3#1)(1997-6#1)(2006-10#7)(2006-11#3)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#6)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#6)(2011-3#1)(2012-12#3)(2012-2#4)(2013-1#2)(2013-8#1)
to limitations in##4##3##(1993-9#1)(2006-10#1)(2008-12#1)(2012-2#1)
to limitations of##3##3##(2007-2#1)(2008-11#1)(2010-3#1)
to limitations such as##2##4##(1997-8#1)(2006-1#1)
to limitations##11##2##(1993-9#1)(1997-8#1)(2006-1#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-3#2)(2012-2#1)
to limited joint mobility##2##4##(2008-1#2)
to limited##17##2##(1991-11#1)(1991-7#1)(1995-10#1)(1995-12#1)(1996-8#1)(2005-10#1)(2005-8#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2010-12#1)(2010-7#1)(2013-8#1)
to limiting##2##2##(2008-8#1)(2011-2#1)
to limits of detection##2##4##(2008-10#1)(2012-1#1)
to lindane##3##2##(1991-3#1)(1997-3#2)
to linear and##2##3##(1994-12#1)(2007-11#1)
to linear regression##2##3##(1992-8#1)(2007-11#1)
to linear##15##2##(1991-10#1)(1992-8#1)(1994-12#1)(1995-1#1)(1996-6#1)(1997-5#1)(2006-11#1)(2007-11#2)(2007-12#1)(2008-3#2)(2008-9#1)(2011-1#1)(2012-2#1)
to linearize the##2##3##(2008-2#1)(2010-2#1)
to link population##2##3##(1994-9#1)(2008-10#1)
to link the##10##3##(1993-4#1)(1994-12#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-8#1)(2013-7#2)
to link them##2##3##(1993-2#1)(2008-6#1)
to link theory##2##3##(2008-11#1)(2008-12#1)
to link##62##2##(1990-9#1)(1991-2#1)(1992-12#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-9#1)(1995-2#1)(1995-6#1)(1996-10#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-7#1)(2010-11#1)(2010-5#1)(2010-9#1)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#5)
to linkage group##3##3##(1997-4#1)(2008-10#2)
to linkage##6##2##(1990-8#1)(1996-5#1)(1997-4#1)(2008-10#2)(2012-3#1)
to linking##2##2##(2008-5#1)(2008-7#1)
to linoleate##2##2##(1995-2#2)
to lipase##2##2##(1994-3#1)(1995-2#1)
to lipid bilayer##2##3##(1996-1#1)(2012-2#1)
to lipid bilayers##3##3##(1990-11#1)(1993-6#1)(1994-9#1)
to lipid peroxidation (LPO)##2##4##(2008-7#1)(2010-7#1)
to lipid peroxidation##7##3##(1994-5#1)(2005-8#1)(2008-10#1)(2008-7#1)(2010-7#1)(2011-1#1)(2013-8#1)
to lipid vesicles##2##3##(1992-6#1)(1993-3#1)
to lipid##35##2##(1990-11#2)(1990-3#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-6#2)(1992-9#2)(1993-10#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-8#1)(1996-1#1)(1997-1#1)(2004-11#1)(2005-10#1)(2005-8#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-7#1)(2009-12#1)(2010-7#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
to lipid-free##2##2##(1991-8#1)(1993-6#1)
to lipids##4##2##(1993-6#1)(2008-10#1)(2008-11#1)(2013-7#1)
to lipofection##2##2##(2008-7#2)
to lipopolysaccharide##6##2##(1990-5#2)(1991-5#1)(1992-7#1)(1997-1#1)(1997-5#1)
to lipoprotein lipase##2##3##(1991-10#1)(1991-12#1)
to lipoprotein receptors##2##3##(1992-2#1)(1994-9#1)
to lipoprotein##7##2##(1990-7#1)(1991-10#1)(1991-12#1)(1992-2#1)(1994-9#1)(1995-2#1)(2010-10#1)
to lipoproteins##3##2##(1995-5#2)(1997-2#1)
to liposomal##2##2##(2006-10#1)(2008-7#1)
to liposomes that contained cardiolipin or phosphatidylserine##2##7##(1990-6#2)
to liposomes that contained cardiolipin##3##5##(1990-6#3)
to liposomes##6##2##(1990-2#1)(1990-6#3)(2005-11#1)(2009-7#1)
to liquid chromatography (LC)##2##4##(2008-10#2)
to liquid chromatography##3##3##(1994-9#1)(2008-10#2)
to liquid##16##2##(1994-3#1)(1994-9#1)(1995-11#1)(2006-10#2)(2006-12#2)(2008-10#4)(2008-5#1)(2008-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
to list##3##2##(2007-8#1)(2008-4#1)(2011-1#1)
to listen attentively to##2##4##(1990-12#1)(1995-5#1)
to listen to##2##3##(2007-3#1)(2008-5#1)
to listen##6##2##(1990-12#1)(1995-5#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-5#1)
to literature data##2##3##(1991-6#1)(2005-11#1)
to literature values##2##3##(2008-10#1)(2008-7#1)
to literature##10##2##(1991-6#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#1)(2011-2#1)(2013-1#2)
to lithium in##2##3##(1997-4#1)(2009-8#1)
to lithium##11##2##(1992-2#1)(1992-8#1)(1997-4#1)(2004-11#3)(2007-12#1)(2008-10#3)(2009-8#1)
to litigation##3##2##(1992-2#1)(2006-8#1)(2007-4#1)
to littermates##2##2##(2008-4#1)(2013-8#1)
to little##4##2##(2005-8#1)(2007-8#1)(2008-10#1)(2012-1#1)
to live and##2##3##(2008-10#1)(2009-8#1)
to live at home##2##4##(2006-7#2)
to live in##6##3##(1997-2#1)(2007-12#1)(2009-7#1)(2011-2#2)(2012-12#1)
to live longer##3##3##(2006-2#1)(2007-1#1)(2010-5#1)
to live with##7##3##(1992-3#1)(1993-6#1)(1994-2#1)(1995-9#1)(2006-4#1)(2007-8#1)(2008-8#1)
to live##35##2##(1992-3#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-9#1)(1997-2#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-8#2)(2008-9#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
to live&quot##2##2##(2008-5#1)(2011-2#1)
to liver and##4##3##(1993-12#1)(1993-9#1)(2006-6#1)(2010-2#1)
to liver cirrhosis and hepatocellular carcinoma##2##6##(2007-11#1)(2008-8#1)
to liver cirrhosis##3##3##(2007-11#1)(2007-12#1)(2008-8#1)
to liver diseases##2##3##(1991-12#1)(2011-2#1)
to liver fibrosis##3##3##(1996-8#1)(2011-2#1)(2012-12#1)
to liver function tests##2##4##(1990-4#1)(1992-6#1)
to liver function##3##3##(1990-4#1)(1992-6#1)(2007-8#1)
to liver injury##2##3##(1996-5#1)(2006-2#1)
to liver resection##2##3##(2006-6#1)(2010-11#1)
to liver transplant##2##3##(1993-9#1)(2013-1#1)
to liver transplantation##5##3##(1995-4#1)(1995-7#1)(2006-10#1)(2008-11#1)(2013-1#1)
to liver##51##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-6#1)(1993-12#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-4#1)(1995-7#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-7#1)(2006-10#2)(2006-2#1)(2006-6#2)(2007-11#3)(2007-12#1)(2007-8#1)(2008-11#1)(2008-8#1)(2009-10#1)(2010-1#1)(2010-11#1)(2010-2#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)
to livestock and##3##3##(1991-7#1)(2008-10#2)
to livestock##8##2##(1991-7#1)(1997-7#1)(2007-11#1)(2008-10#3)(2008-12#1)(2013-1#1)
to living##8##2##(1991-12#1)(1992-8#1)(1995-7#1)(1995-8#1)(2007-7#1)(2010-10#1)(2011-1#1)(2012-2#1)
to load a##3##3##(1994-9#1)(2006-11#1)(2007-5#1)
to load and##2##3##(2011-1#1)(2012-1#1)
to load the##2##3##(1993-11#1)(2004-11#1)
to load##10##2##(1993-11#1)(1994-9#1)(2004-11#1)(2006-11#1)(2007-5#1)(2007-7#1)(2007-9#1)(2009-7#1)(2011-1#1)(2012-1#1)
to loading##6##2##(1993-12#1)(2008-2#1)(2009-5#1)(2009-7#1)(2010-12#1)(2012-2#1)
to lobby##2##2##(1992-5#1)(2008-10#1)
to lobectomy##2##2##(2007-8#2)
to local and systemic##2##4##(1990-8#1)(2008-10#1)
to local and##3##3##(1990-8#1)(1996-12#1)(2008-10#1)
to local circumstances##2##3##(1990-4#1)(2013-1#1)
to local conditions##3##3##(2005-9#1)(2008-1#1)(2011-2#1)
to local failure##3##3##(2007-4#1)(2008-6#2)
to local mechanical##2##3##(2009-8#1)(2013-1#1)
to local recurrence##3##3##(2008-6#1)(2010-3#1)(2011-1#1)
to local recurrences##2##3##(2008-6#1)(2009-4#1)
to local treatment##2##3##(1990-11#1)(1994-2#1)
to local variations in##2##4##(1992-9#1)(2008-2#1)
to local##81##2##(1990-11#1)(1990-4#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-9#2)(1993-2#1)(1994-1#1)(1994-2#2)(1994-6#1)(1995-1#1)(1995-12#1)(1995-4#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-9#1)(1997-3#2)(1997-6#1)(1997-7#1)(2005-11#3)(2005-9#1)(2006-10#3)(2006-12#1)(2006-5#1)(2006-7#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#2)(2008-8#2)(2008-9#2)(2009-1#1)(2009-11#1)(2009-4#2)(2009-8#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#1)(2013-1#6)(2013-7#1)
to localise##2##2##(2008-11#1)(2012-2#1)
to localised##2##2##(2008-11#1)(2012-2#1)
to localization of##2##3##(2006-2#1)(2010-11#1)
to localization##4##2##(2006-2#1)(2007-12#1)(2010-11#1)(2011-2#1)
to localize a##2##3##(1990-2#1)(1993-11#1)
to localize and identify##2##4##(1994-9#1)(2007-11#1)
to localize and##5##3##(1994-9#1)(2007-11#1)(2008-10#1)(2009-8#1)(2011-2#1)
to localize homocysteate-like immunoreactivity in human##2##6##(1994-2#1)(1995-12#1)
to localize in##2##3##(2006-5#1)(2007-12#1)
to localize targets##2##3##(1995-8#1)(2008-11#1)
to localize the protein##2##4##(1992-3#1)(2008-1#1)
to localize the##20##3##(1990-11#1)(1990-12#1)(1990-7#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-5#1)(1993-8#1)(1995-2#1)(1996-12#1)(1996-5#1)(2006-8#1)(2008-1#1)(2008-5#2)(2010-2#1)(2013-1#2)(2013-8#1)
to localize to##2##3##(2012-12#2)
to localize##72##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#2)(1991-11#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-4#1)(1997-6#2)(1997-8#1)(2006-5#1)(2006-8#2)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#4)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
to localized##4##2##(1993-3#1)(2008-10#1)(2012-12#2)
to locally##6##2##(1995-2#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-3#1)(2011-2#1)
to locate and attack##2##4##(2011-12#2)
to locate and##5##3##(1996-1#1)(2008-3#1)(2009-5#1)(2011-12#2)
to locate objects##2##3##(2008-2#2)
to locate the##19##3##(1990-3#1)(1990-4#1)(1990-7#2)(1992-11#1)(1992-9#1)(1994-2#1)(1994-9#1)(1995-5#1)(2006-10#1)(2006-4#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2011-1#1)(2011-2#1)
to locate their##4##3##(1990-11#1)(1994-8#1)(2007-1#1)(2007-12#1)
to locate them##2##3##(2008-10#1)(2008-11#1)
to locate##61##2##(1990-11#2)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#2)(1992-11#2)(1992-3#1)(1992-9#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-5#1)(1996-1#1)(2006-10#1)(2006-12#2)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-5#3)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#1)(2008-7#1)(2009-12#1)(2009-5#1)(2011-1#1)(2011-12#3)(2011-2#2)(2012-12#1)(2013-7#1)
to location of the##2##4##(2008-10#1)(2008-5#1)
to location##7##2##(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2011-1#1)(2012-12#1)
to locations##2##2##(1991-11#1)(2013-8#1)
to loci that##2##3##(1991-12#1)(2008-10#1)
to lock a##2##3##(2007-11#1)(2007-12#1)
to lock the##7##3##(1990-8#1)(2008-2#3)(2011-1#2)(2012-12#1)
to lock##11##2##(1990-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-2#3)(2011-1#2)(2012-12#1)
to locomotion##2##2##(2007-7#1)(2008-2#1)
to locus##2##2##(1996-6#1)(2011-2#1)
to log K(ex)##2##3##(2008-10#2)
to log##5##2##(1996-5#1)(2008-10#3)(2008-5#1)
to logistic regression##2##3##(1993-6#1)(2012-12#1)
to logistic##3##2##(1991-12#1)(1993-6#1)(2012-12#1)
to long term care##2##4##(1995-1#1)(2006-7#1)
to long term##6##3##(1990-2#1)(1990-4#1)(1995-1#1)(2006-7#1)(2007-11#2)
to long##16##2##(1990-2#1)(1990-4#1)(1991-9#1)(1995-1#1)(1997-8#1)(2005-4#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#3)(2008-5#1)(2008-9#1)(2009-8#1)(2010-6#1)
to long-distance##3##2##(1995-11#1)(2008-10#1)(2011-2#1)
to long-lasting##4##2##(1992-3#1)(1993-9#1)(1996-10#1)(2012-2#1)
to long-lived##2##2##(2008-11#1)(2009-6#1)
to long-range##2##2##(1997-5#1)(2008-10#1)
to long-term alterations##2##3##(1996-10#2)
to long-term care##3##3##(1990-12#1)(1996-2#1)(2013-1#1)
to long-term recovery##2##3##(2006-10#1)(2010-2#1)
to long-term survival##2##3##(1991-12#1)(2007-1#1)
to long-term therapy##2##3##(2005-1#1)(2012-3#1)
to long-term##44##2##(1990-12#1)(1991-12#1)(1991-5#1)(1993-3#1)(1994-5#1)(1995-12#1)(1996-10#3)(1996-2#1)(1997-2#1)(1997-4#3)(2005-1#1)(2005-10#2)(2006-10#2)(2007-1#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-9#1)(2012-2#2)(2012-3#2)(2013-1#2)
to longer than##2##3##(2007-12#1)(2008-10#1)
to longer wavelengths##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
to longer##15##2##(1996-1#1)(1996-3#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-7#1)(2009-9#1)(2010-2#1)
to longitudinal and##2##3##(1996-11#1)(2008-2#1)
to longitudinal##8##2##(1991-6#1)(1991-7#1)(1993-12#1)(1996-11#1)(1996-9#1)(1997-2#1)(2008-10#1)(2008-2#1)
to look at the pattern of##2##6##(1991-11#1)(1992-12#1)
to look at the##13##4##(1991-11#1)(1991-4#1)(1992-12#1)(1995-11#1)(1996-3#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-6#1)(2008-7#1)(2009-4#1)
to look at##25##3##(1991-11#1)(1991-4#1)(1992-12#1)(1993-2#1)(1994-2#1)(1995-11#1)(1996-3#1)(1997-3#1)(1997-4#1)(2004-10#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-6#2)(2007-8#1)(2008-1#1)(2008-6#1)(2008-7#1)(2009-4#2)(2010-10#1)(2011-2#1)(2012-3#2)
to look beyond##2##3##(2007-11#1)(2008-6#1)
to look for &quot##2##4##(1993-11#1)(1996-3#1)
to look for a##3##4##(1996-4#1)(2008-10#1)(2011-2#1)
to look for in##2##4##(1992-12#1)(1996-3#1)
to look for the##2##4##(2008-12#1)(2008-5#1)
to look for##29##3##(1990-2#1)(1991-11#1)(1992-12#1)(1992-5#1)(1993-11#1)(1994-2#1)(1994-3#1)(1996-12#1)(1996-3#2)(1996-4#1)(1997-6#1)(1997-8#1)(2006-12#1)(2006-8#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-12#1)(2011-2#1)(2013-8#1)
to look into the##5##4##(1990-8#1)(2007-2#1)(2009-4#1)(2010-12#1)(2012-2#1)
to look into##8##3##(1990-8#1)(2007-2#1)(2008-10#3)(2009-4#1)(2010-12#1)(2012-2#1)
to look up##4##3##(1992-3#1)(2006-10#1)(2008-5#1)(2008-6#1)
to look##77##2##(1990-2#1)(1990-8#1)(1991-11#2)(1991-4#1)(1992-12#2)(1992-3#1)(1992-5#1)(1993-11#1)(1993-2#1)(1994-2#2)(1994-3#1)(1995-11#1)(1996-12#1)(1996-3#3)(1996-4#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#2)(2004-10#1)(2004-3#1)(2006-10#2)(2006-12#3)(2006-8#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#1)(2009-12#1)(2009-4#3)(2009-5#1)(2010-10#1)(2010-12#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-8#1)
to loop##3##2##(1993-8#1)(1995-2#1)(1996-8#1)
to loose##5##2##(1992-4#1)(1993-12#1)(2005-4#1)(2012-12#1)(2013-1#1)
to loosen the##2##3##(1995-2#1)(2007-9#1)
to loosen##4##2##(1992-4#1)(1995-2#1)(2007-9#1)(2010-1#1)
to lose its##2##3##(1997-8#1)(2007-9#1)
to lose the ability to##3##5##(2008-10#2)(2008-4#1)
to lose the##4##3##(1994-3#1)(2008-10#2)(2008-4#1)
to lose weight and##2##4##(2007-12#1)(2013-7#1)
to lose weight##17##3##(1993-1#1)(1997-3#1)(2006-7#1)(2007-12#4)(2008-7#1)(2009-2#6)(2010-7#1)(2010-8#1)(2013-7#1)
to lose##35##2##(1991-8#1)(1993-1#1)(1994-3#1)(1996-6#1)(1997-3#1)(1997-8#1)(2006-5#1)(2006-7#1)(2007-12#5)(2007-9#2)(2008-10#3)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#7)(2009-4#1)(2010-7#1)(2010-8#1)(2013-7#1)
to loss of a##2##4##(1993-12#1)(1993-9#1)
to loss of##37##3##(1990-4#1)(1990-5#1)(1991-1#1)(1991-12#1)(1992-1#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-10#1)(1994-5#1)(1995-10#1)(1995-3#1)(1996-8#1)(1997-2#1)(1997-4#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
to loss the graft in##2##5##(2011-2#2)
to loss##41##2##(1990-4#1)(1990-5#1)(1991-1#1)(1991-12#1)(1992-1#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-10#1)(1994-5#1)(1995-10#1)(1995-3#1)(1996-8#1)(1997-2#1)(1997-4#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-2#4)(2012-3#3)(2013-1#2)(2013-8#1)
to lovastatin##5##2##(1990-7#1)(1991-7#1)(1992-11#1)(1994-8#1)(2005-8#1)
to low P##2##3##(2012-3#2)
to low and##2##3##(2008-10#1)(2011-1#1)
to low bone##2##3##(2007-9#1)(2008-3#1)
to low concentrations of##4##4##(1991-1#1)(1996-10#1)(1996-12#1)(2013-1#1)
to low contrast##2##3##(1996-5#1)(2010-2#1)
to low dose##4##3##(2008-7#4)
to low dose-rates of ionizing radiation##2##6##(2013-1#2)
to low doses of ionizing radiation##2##6##(2008-7#1)(2011-1#1)
to low doses of low-LET radiation##2##6##(2008-7#2)
to low doses of radiation##4##5##(2008-7#3)(2010-4#1)
to low doses of##15##4##(1994-2#1)(1995-10#1)(2008-10#1)(2008-7#10)(2010-4#1)(2011-1#1)
to low doses##18##3##(1994-2#1)(1995-10#1)(1996-6#1)(2008-10#1)(2008-5#1)(2008-7#11)(2010-4#1)(2011-1#1)
to low levels of##9##4##(1992-9#1)(1994-12#1)(1995-10#1)(1997-8#1)(2007-12#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-9#1)
to low levels##11##3##(1992-9#1)(1994-12#1)(1995-10#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-9#1)(2012-12#1)
to low light##2##3##(2009-10#1)(2009-8#1)
to low molecular weight##7##4##(1990-2#1)(1997-2#1)(2004-9#1)(2006-12#1)(2006-8#1)(2008-10#2)
to low molecular##8##3##(1990-2#1)(1996-3#1)(1997-2#1)(2004-9#1)(2006-12#1)(2006-8#1)(2008-10#2)
to low numbers of##2##4##(1992-12#1)(2005-8#1)
to low pH##2##3##(1991-5#1)(1992-11#1)
to low radiation doses##2##4##(1996-6#1)(2013-1#1)
to low temperature##6##3##(2005-12#1)(2008-11#2)(2008-5#1)(2011-1#2)
to low to##2##3##(1997-4#1)(2007-11#1)
to low values##2##3##(1990-3#1)(2008-5#1)
to low##136##2##(1990-2#2)(1990-3#1)(1990-5#1)(1991-1#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-10#3)(1996-10#2)(1996-12#1)(1996-3#1)(1996-5#3)(1996-6#3)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-8#1)(2004-4#1)(2004-9#1)(2005-12#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-3#2)(2007-6#1)(2007-9#2)(2008-10#11)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#19)(2008-8#1)(2008-9#2)(2009-10#2)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#5)
to low-##3##2##(2007-12#1)(2007-4#1)(2008-10#1)
to low-density##2##2##(2008-2#1)(2008-3#1)
to low-dose##5##2##(1990-12#1)(2008-7#1)(2009-5#1)(2011-1#1)(2013-1#1)
to low-frequency vibration##2##3##(2008-2#1)(2008-3#1)
to low-frequency##4##2##(1990-12#1)(1991-7#1)(2008-2#1)(2008-3#1)
to low-grade##4##2##(1990-3#1)(2007-3#1)(2008-10#1)(2008-7#1)
to low-income##3##2##(1996-12#1)(2011-2#1)(2013-1#1)
to low-level##2##2##(1992-4#1)(2008-7#1)
to low-molecular weight##2##3##(1991-12#1)(2008-10#1)
to low-molecular##4##2##(1990-5#1)(1991-12#1)(2008-10#2)
to lower LDL##2##3##(2005-10#1)(2013-1#1)
to lower blepharoplasty##2##3##(2010-12#2)
to lower blood pressure##4##4##(1993-2#1)(1996-9#2)(2005-10#1)
to lower blood##5##3##(1993-2#1)(1996-9#2)(2004-11#1)(2005-10#1)
to lower breast cancer risk##2##5##(2009-12#2)
to lower concentrations##2##3##(1996-12#1)(2008-10#1)
to lower levels of##3##4##(2009-5#1)(2009-7#2)
to lower plasma##2##3##(1992-5#1)(1995-8#1)
to lower temperature##2##3##(1992-8#1)(2008-10#1)
to lower the pH##2##4##(2008-5#2)
to lower the serum##3##4##(2004-11#1)(2005-3#1)(2006-10#1)
to lower the##16##3##(1992-8#1)(1993-12#1)(1993-6#1)(1994-12#1)(2004-11#1)(2005-3#1)(2006-10#1)(2006-3#1)(2007-12#1)(2008-5#3)(2008-6#1)(2008-7#1)(2010-11#1)(2011-1#1)
to lower##100##2##(1990-12#1)(1991-2#1)(1992-12#1)(1992-5#2)(1992-8#2)(1993-12#1)(1993-2#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-7#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-4#1)(1996-8#1)(1996-9#2)(1997-2#1)(2004-11#2)(2005-10#2)(2005-12#1)(2005-3#1)(2005-4#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-3#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#2)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-5#2)(2009-7#2)(2010-11#2)(2010-12#2)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)
to lowering##3##2##(2005-10#1)(2008-7#1)(2009-11#1)
to lowest##4##2##(2007-7#1)(2008-10#2)(2008-5#1)
to lubrication##2##2##(2009-6#2)
to lumbar disc herniation##2##4##(1992-11#1)(2007-7#1)
to lumbar##9##2##(1992-11#1)(1995-9#1)(1996-2#1)(2006-8#3)(2007-7#1)(2010-11#1)(2011-1#1)
to luminal##3##2##(1997-8#2)(2006-10#1)
to lunar##2##2##(2008-2#2)
to lung cancer in##2##4##(1996-9#1)(2010-12#1)
to lung cancer##14##3##(1996-3#1)(1996-9#1)(1997-3#1)(2004-1#1)(2006-10#1)(2008-11#1)(2009-12#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2011-3#1)(2013-1#1)
to lung function##2##3##(2005-11#1)(2007-11#1)
to lung injury##3##3##(1994-3#1)(2007-8#1)(2012-12#1)
to lung tissue##2##3##(2011-2#1)(2013-8#1)
to lung transplant##2##3##(2011-3#2)
to lung transplantation##3##3##(2006-10#1)(2012-12#2)
to lung##42##2##(1990-3#2)(1991-5#1)(1991-6#1)(1994-2#1)(1994-3#1)(1996-3#1)(1996-9#1)(1997-3#1)(2004-1#1)(2004-4#1)(2005-11#1)(2006-10#4)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-8#2)(2009-12#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#4)(2011-3#3)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
to lungs and##2##3##(2008-5#1)(2012-2#1)
to lungs##4##2##(1994-5#1)(2004-4#1)(2008-5#1)(2012-2#1)
to lure##2##2##(1992-1#1)(2007-9#1)
to lymph node metastasis##2##4##(2008-5#1)(2011-2#1)
to lymph node##5##3##(1994-6#1)(2004-2#1)(2007-3#1)(2008-5#1)(2011-2#1)
to lymph nodes and##2##4##(2007-11#1)(2007-9#1)
to lymph nodes##9##3##(1991-12#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-4#2)(2012-3#1)(2013-1#2)
to lymph##15##2##(1991-12#1)(1994-6#1)(2004-2#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-4#3)(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
to lymphatic##2##2##(2006-10#1)(2007-11#1)
to lymphoid##2##2##(1995-2#1)(2008-11#1)
to lymphokine-activated killer##2##3##(1993-11#2)
to lyophilized##2##2##(1997-8#1)(2008-7#1)
to lyse the##4##3##(1994-2#1)(1996-9#1)(2008-4#2)
to lyse tumor##2##3##(2008-4#2)
to lyse##15##2##(1990-11#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-2#1)(1996-9#1)(2008-4#5)(2009-6#1)(2010-3#1)(2013-1#1)
to lysine##4##2##(1990-12#1)(2008-4#1)(2008-5#1)(2009-9#1)
to lysis by##3##3##(1992-2#2)(2008-9#1)
to lysis##13##2##(1990-11#4)(1990-12#1)(1992-1#1)(1992-2#2)(1997-6#1)(2005-12#1)(2008-9#2)(2013-1#1)
to lyso##2##2##(1996-5#2)
to lysosomal##3##2##(1991-8#1)(1992-2#1)(1992-4#1)
to lysosomes##11##2##(1990-9#2)(1991-7#3)(1997-7#1)(2008-1#3)(2012-12#1)(2013-1#1)
to lysozyme##5##2##(1992-8#1)(1996-7#1)(1997-5#2)(2009-3#1)
to lysyl##4##2##(1991-1#1)(1995-3#1)(2004-11#1)(2008-11#1)
to lytic##2##2##(1997-3#1)(2013-1#1)
to mRNA is##2##3##(1992-11#1)(2006-12#1)
to mRNA##14##2##(1990-7#1)(1991-3#1)(1991-9#2)(1992-11#1)(1995-4#1)(1996-7#1)(2006-10#1)(2006-12#2)(2010-4#1)(2012-12#2)(2012-2#1)
to mRNAs##2##2##(1994-12#1)(2008-2#1)
to macrolides##3##2##(1993-5#1)(2006-10#1)(2010-4#1)
to macromolecular##4##2##(2008-10#1)(2010-7#1)(2012-1#1)(2012-2#1)
to macromolecules##5##2##(1991-9#1)(1995-12#1)(1995-7#1)(1996-5#1)(2008-7#1)
to macrophage##6##2##(1992-12#1)(1992-8#1)(1994-9#1)(1995-6#1)(1996-10#1)(2013-1#1)
to macrophage-like##2##2##(1991-12#1)(1993-4#1)
to macrophages by##2##3##(1990-4#1)(1996-4#1)
to macrophages##10##2##(1990-12#1)(1990-4#1)(1992-7#1)(1995-2#1)(1996-4#3)(2008-11#1)(2008-4#2)
to macroporous alginate cryogel##2##4##(2012-1#2)
to macroporous alginate##3##3##(2012-1#3)
to macroscopic##7##2##(1991-4#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-3#1)
to macular##5##2##(2011-2#1)(2012-12#2)(2013-1#2)
to made##2##2##(2008-10#1)(2011-2#1)
to magnesium##4##2##(1990-9#1)(2006-2#1)(2008-10#2)
to magnetic resonance imaging##2##4##(1992-3#1)(2006-6#1)
to magnetic resonance##5##3##(1992-3#1)(1996-5#1)(2006-6#1)(2009-12#1)(2009-2#1)
to magnetic##10##2##(1992-3#1)(1996-5#2)(2005-11#1)(2006-6#1)(2007-9#1)(2009-12#1)(2009-2#1)(2011-2#2)
to main##5##2##(1995-5#1)(2006-10#1)(2008-10#3)
to mainly##5##2##(1990-6#1)(1994-5#1)(2010-11#1)(2010-7#1)(2012-1#1)
to maintain a constant##2##4##(1990-10#1)(2008-2#1)
to maintain a fixed##2##4##(2008-2#2)
to maintain a high index of suspicion##3##7##(2005-10#1)(2006-10#1)(2011-2#1)
to maintain a high##5##4##(1991-6#1)(2005-10#1)(2006-10#1)(2007-9#1)(2011-2#1)
to maintain a relatively##2##4##(1993-11#1)(2012-3#1)
to maintain a stable##2##4##(2012-1#1)(2013-8#1)
to maintain a##48##3##(1990-10#1)(1990-12#1)(1990-4#1)(1991-1#1)(1991-6#2)(1992-6#1)(1993-11#1)(1993-12#1)(1997-4#1)(1997-7#1)(2004-10#1)(2005-10#1)(2005-12#2)(2006-10#1)(2006-11#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-2#1)(2011-11#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
to maintain accurate##2##3##(1992-11#1)(2008-7#1)
to maintain adequate##4##3##(2006-4#1)(2008-7#1)(2010-7#1)(2012-2#1)
to maintain an average##2##4##(2008-11#1)(2010-8#1)
to maintain an##13##3##(1995-4#1)(2005-9#1)(2006-10#1)(2007-2#1)(2008-11#1)(2008-6#1)(2010-7#2)(2010-8#1)(2011-2#2)(2012-3#1)(2013-8#1)
to maintain and improve##3##4##(2008-4#1)(2010-2#1)(2011-2#1)
to maintain and##4##3##(2007-12#1)(2008-4#1)(2010-2#1)(2011-2#1)
to maintain blood##2##3##(2005-10#1)(2008-7#1)
to maintain cell##3##3##(2011-2#2)(2013-1#1)
to maintain confidentiality##2##3##(2005-7#1)(2008-5#1)
to maintain constant##3##3##(2005-11#1)(2010-11#1)(2011-2#1)
to maintain control of##3##4##(2006-10#1)(2008-3#1)(2008-7#1)
to maintain control##4##3##(2006-10#1)(2008-3#1)(2008-7#1)(2013-7#1)
to maintain damage##2##3##(2008-10#1)(2011-2#1)
to maintain desired##2##3##(1995-6#1)(2008-11#1)
to maintain high##3##3##(1996-4#1)(1997-2#1)(2008-2#1)
to maintain homeostasis##2##3##(1995-12#1)(2012-1#1)
to maintain its##5##3##(2008-11#2)(2008-7#1)(2009-10#1)(2009-8#1)
to maintain long-term##3##3##(2007-7#1)(2008-11#1)(2013-1#1)
to maintain normal body##2##4##(2006-6#1)(2011-2#1)
to maintain normal cell##2##4##(1990-11#1)(2011-1#1)
to maintain normal##12##3##(1990-11#1)(1992-1#1)(2006-6#1)(2006-7#1)(2008-1#1)(2008-3#2)(2010-2#2)(2011-1#1)(2011-2#1)(2012-12#1)
to maintain optimal##2##3##(2010-11#1)(2013-1#1)
to maintain pH##2##3##(1992-10#1)(2008-10#1)
to maintain spermatogenesis##3##3##(1992-12#2)(2012-2#1)
to maintain stable##2##3##(1996-8#1)(2008-8#1)
to maintain such##3##3##(2008-8#1)(2013-1#2)
to maintain sufficient##2##3##(2005-11#1)(2010-4#1)
to maintain the delicate balance between##2##6##(2008-9#2)
to maintain the healthy##2##4##(2010-4#1)(2012-11#1)
to maintain the highest##2##4##(1994-2#1)(1995-12#1)
to maintain the integrity of the##3##6##(1996-8#1)(2008-12#1)(2012-3#1)
to maintain the integrity of##5##5##(1995-8#1)(1996-8#1)(2008-1#1)(2008-12#1)(2012-3#1)
to maintain the normal##2##4##(2008-11#1)(2008-9#1)
to maintain the quality of##2##5##(1994-12#1)(2008-11#1)
to maintain the same##3##4##(2008-11#1)(2008-3#1)(2011-2#1)
to maintain the structure##2##4##(2006-12#1)(2008-11#1)
to maintain the##89##3##(1990-10#1)(1990-11#1)(1990-3#1)(1991-9#1)(1993-8#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-8#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-12#2)(2006-7#1)(2007-11#1)(2007-4#3)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#6)(2008-11#6)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#4)(2008-9#3)(2009-10#2)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-2#4)(2011-3#1)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#5)
to maintain their##8##3##(1991-12#1)(1992-9#1)(1997-6#1)(2004-12#1)(2007-11#1)(2009-6#1)(2011-2#1)(2013-1#1)
to maintain this##5##3##(1995-1#1)(2004-2#1)(2006-10#1)(2012-1#2)
to maintain viability##3##3##(1993-4#1)(2006-5#2)
to maintain##376##2##(1990-10#3)(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1991-1#1)(1991-12#3)(1991-2#2)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#1)(1993-4#1)(1993-7#1)(1993-8#2)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#2)(1994-5#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#3)(2004-10#1)(2004-12#2)(2004-2#1)(2005-10#4)(2005-11#3)(2005-12#3)(2005-3#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#9)(2006-11#1)(2006-12#3)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#5)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#3)(2007-5#1)(2007-7#6)(2007-8#4)(2007-9#3)(2008-1#7)(2008-10#12)(2008-11#16)(2008-12#3)(2008-2#10)(2008-3#8)(2008-4#5)(2008-5#7)(2008-6#5)(2008-7#12)(2008-8#8)(2008-9#9)(2009-1#1)(2009-10#3)(2009-4#2)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#4)(2010-2#6)(2010-3#1)(2010-4#2)(2010-6#2)(2010-7#3)(2010-8#3)(2010-9#3)(2011-1#2)(2011-11#1)(2011-2#20)(2011-3#1)(2012-1#6)(2012-11#1)(2012-12#4)(2012-2#9)(2012-3#5)(2013-1#15)(2013-7#3)(2013-8#9)
to maintaining a##2##3##(2010-7#1)(2011-2#1)
to maintaining the##2##3##(2007-4#1)(2008-3#1)
to maintaining##12##2##(1994-3#1)(1994-5#1)(2007-2#1)(2007-4#1)(2008-3#1)(2010-2#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#1)
to maintenance of##2##3##(2005-11#1)(2008-9#1)
to maintenance##5##2##(2005-11#1)(2007-7#1)(2008-10#1)(2008-9#1)(2011-12#1)
to maize leaves##2##3##(2008-10#2)
to maize##9##2##(1991-10#1)(1991-12#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)
to major histocompatibility complex (MHC) class II molecules##2##8##(1995-8#1)(1996-4#1)
to major histocompatibility complex (MHC)##5##5##(1995-8#2)(1996-4#1)(2006-11#1)(2010-12#1)
to major histocompatibility complex##6##4##(1995-8#2)(1996-4#1)(1997-4#1)(2006-11#1)(2010-12#1)
to major histocompatibility##7##3##(1995-8#2)(1996-4#1)(1997-4#2)(2006-11#1)(2010-12#1)
to major resistance genes in##2##5##(2008-10#2)
to major resistance genes##3##4##(2008-10#3)
to major structural##2##3##(1996-10#1)(2007-9#1)
to major surgery##2##3##(2005-10#1)(2007-9#1)
to major##38##2##(1991-9#1)(1993-1#1)(1994-12#1)(1994-6#1)(1995-3#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-4#1)(1997-4#2)(1997-8#2)(2005-10#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-9#2)(2008-10#5)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2011-1#1)(2011-3#1)(2012-3#1)
to make a correct diagnosis##2##5##(1990-5#1)(2013-7#1)
to make a correct##3##4##(1990-5#1)(2012-12#1)(2013-7#1)
to make a decision##2##4##(2008-7#1)(2013-1#1)
to make a definite diagnosis##2##5##(2010-1#1)(2013-7#1)
to make a definite##3##4##(2008-7#1)(2010-1#1)(2013-7#1)
to make a diagnosis of##3##5##(1997-8#1)(2012-2#1)(2013-8#1)
to make a diagnosis##6##4##(1997-8#1)(2006-8#1)(2007-11#2)(2012-2#1)(2013-8#1)
to make a difference##4##4##(2006-8#1)(2008-1#1)(2008-11#1)(2011-2#1)
to make a differential diagnosis##3##5##(2008-4#1)(2011-2#1)(2013-1#1)
to make a major##3##4##(1992-12#1)(1993-3#1)(2006-4#1)
to make a profit##2##4##(1994-2#1)(2007-4#1)
to make a significant contribution##2##5##(1997-8#1)(2013-8#1)
to make a significant##3##4##(1997-8#1)(2008-5#1)(2013-8#1)
to make a##93##3##(1990-12#1)(1990-5#1)(1991-1#1)(1992-12#3)(1992-3#1)(1993-3#1)(1993-5#1)(1994-1#4)(1994-11#1)(1994-2#2)(1995-4#1)(1995-5#2)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#3)(2006-10#2)(2006-11#2)(2006-12#1)(2006-4#1)(2006-8#2)(2007-11#3)(2007-12#1)(2007-3#2)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-12#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#4)(2013-7#2)(2013-8#3)
to make accurate predictions##2##4##(1992-6#1)(2008-2#1)
to make accurate##4##3##(1992-6#1)(2008-2#1)(2008-3#1)(2012-2#1)
to make an appropriate referral##2##5##(2009-10#1)(2013-1#1)
to make an early diagnosis of##2##6##(2007-11#1)(2010-9#1)
to make an early diagnosis##5##5##(1995-8#1)(2006-4#1)(2007-11#1)(2010-12#1)(2010-9#1)
to make an##25##3##(1992-3#1)(1995-8#1)(1996-11#1)(2006-4#1)(2007-11#3)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-7#2)(2009-10#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
to make appropriate decisions##2##4##(1994-12#1)(2006-9#1)
to make appropriate##6##3##(1994-12#1)(2006-9#1)(2008-11#1)(2009-8#1)(2013-1#1)(2013-8#1)
to make artificial##3##3##(2008-6#1)(2009-7#1)(2013-8#1)
to make better decisions##2##4##(2004-12#1)(2008-2#1)
to make better##4##3##(2004-12#1)(2008-2#1)(2008-3#1)(2010-9#1)
to make changes in##3##4##(1997-3#1)(2007-9#1)(2009-10#1)
to make changes##5##3##(1997-3#1)(2007-2#1)(2007-9#1)(2009-10#1)(2009-6#1)
to make claims##2##3##(2008-5#1)(2009-4#1)
to make clear##2##3##(2005-11#1)(2008-6#1)
to make communication##2##3##(1995-12#1)(1996-1#1)
to make comparisons##3##3##(1991-12#1)(2008-10#1)(2011-1#1)
to make data##2##3##(1996-1#1)(2012-3#1)
to make decisions##8##3##(1992-2#1)(1993-2#1)(1994-9#1)(1995-9#1)(2008-1#1)(2009-7#1)(2010-8#1)(2011-8#1)
to make dentists aware of the##2##6##(2012-12#1)(2012-2#1)
to make diagnosis of##2##4##(2008-1#1)(2011-12#1)
to make direct##2##3##(2008-7#1)(2008-9#1)
to make evidence-based##2##3##(2008-2#1)(2012-12#1)
to make in##3##3##(1992-2#1)(2006-10#1)(2008-3#1)
to make inferences about##2##4##(2008-4#1)(2012-1#1)
to make inferences##4##3##(2006-5#1)(2008-4#1)(2008-8#1)(2012-1#1)
to make information accessible##2##4##(1995-12#1)(1996-1#1)
to make informed choices##2##4##(2008-3#1)(2010-4#1)
to make informed decisions about##2##5##(2008-1#1)(2008-9#1)
to make informed decisions##6##4##(1991-2#1)(2008-1#1)(2008-12#1)(2008-9#2)(2012-2#1)
to make informed##8##3##(1991-2#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-9#2)(2010-4#1)(2012-2#1)
to make it possible to##4##5##(2005-11#1)(2008-3#1)(2009-11#1)(2009-6#1)
to make it##24##3##(1990-5#1)(1991-7#1)(1993-9#1)(1994-9#1)(2005-11#2)(2006-3#1)(2006-5#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-11#1)(2009-6#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)
to make its##3##3##(1995-11#1)(2008-2#1)(2008-4#1)
to make judgements##2##3##(2007-10#1)(2008-12#1)
to make meaningful##2##3##(1995-1#1)(2006-5#1)
to make medical##2##3##(1995-12#1)(2010-8#1)
to make more##8##3##(1997-3#2)(1997-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-3#2)
to make new##2##3##(2008-5#1)(2011-2#1)
to make on##2##3##(2009-8#1)(2013-8#1)
to make our##3##3##(2007-8#1)(2007-9#1)(2013-8#1)
to make possible##2##3##(2007-8#1)(2008-2#1)
to make predictions##3##3##(1991-1#1)(2008-10#1)(2008-7#1)
to make progress in##2##4##(2008-5#1)(2010-3#1)
to make progress##4##3##(2006-10#1)(2008-5#1)(2008-7#1)(2010-3#1)
to make rapid##3##3##(2008-3#1)(2008-7#1)(2008-9#1)
to make recommendations for##3##4##(2006-10#1)(2009-11#1)(2010-11#1)
to make recommendations##5##3##(2006-10#1)(2007-12#1)(2009-11#1)(2010-11#1)(2012-12#1)
to make room for##2##4##(2006-3#1)(2007-9#1)
to make screening##2##3##(2005-11#1)(2012-2#1)
to make sense of the##3##5##(2007-7#1)(2012-11#1)(2012-12#1)
to make sense of their##2##5##(2007-11#1)(2009-5#1)
to make sense of##5##4##(2007-11#1)(2007-7#1)(2009-5#1)(2012-11#1)(2012-12#1)
to make sense##6##3##(1997-7#1)(2007-11#1)(2007-7#1)(2009-5#1)(2012-11#1)(2012-12#1)
to make smart##2##3##(1996-3#1)(2010-12#1)
to make some##5##3##(1991-10#1)(1995-2#1)(1996-5#1)(2006-5#1)(2007-9#1)
to make spatially##2##3##(2007-12#1)(2008-11#1)
to make substantial improvements in##2##5##(1994-12#1)(2006-6#1)
to make substantial##4##3##(1993-12#1)(1994-12#1)(1997-7#1)(2006-6#1)
to make such a##2##4##(2007-6#1)(2008-10#1)
to make such##4##3##(1991-1#1)(2007-6#1)(2008-10#1)(2008-2#1)
to make sure that the##3##5##(1993-1#1)(1995-9#1)(2008-10#1)
to make sure that##5##4##(1993-1#2)(1993-3#1)(1995-9#1)(2008-10#1)
to make sure the##2##4##(1995-6#1)(2008-10#1)
to make sure##9##3##(1993-1#2)(1993-3#1)(1995-6#1)(1995-9#1)(2005-7#1)(2008-10#2)(2009-10#1)
to make the best##2##4##(2008-10#1)(2013-1#1)
to make the correct##2##4##(1996-6#1)(2012-2#1)
to make the decision##2##4##(2007-8#1)(2008-12#1)
to make the diagnosis##4##4##(2004-1#1)(2007-12#1)(2007-7#1)(2008-3#1)
to make the first##2##4##(2007-8#1)(2010-5#1)
to make the model##2##4##(1992-9#1)(2006-11#1)
to make the most##3##4##(1993-12#1)(2006-9#1)(2012-2#1)
to make the necessary##2##4##(1994-12#1)(2006-10#1)
to make the procedure##2##4##(2008-10#1)(2010-7#1)
to make the system##2##4##(2008-10#2)
to make the##73##3##(1990-12#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-6#1)(1997-3#1)(2004-1#1)(2004-8#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#7)
to make their##2##3##(2004-5#1)(2005-9#1)
to make them more accessible##2##5##(1995-7#1)(2008-2#1)
to make them more##3##4##(1995-7#1)(1996-3#1)(2008-2#1)
to make them##13##3##(1991-1#1)(1993-5#1)(1995-7#1)(1996-3#1)(2004-4#1)(2006-10#1)(2007-5#1)(2008-11#2)(2008-2#1)(2008-6#1)(2010-1#1)(2012-2#1)
to make these##8##3##(1993-9#1)(2006-12#1)(2008-11#1)(2008-5#1)(2010-11#1)(2010-7#1)(2011-1#1)(2012-3#1)
to make this assumption##2##4##(1990-8#1)(2009-11#1)
to make this diagnosis##2##4##(1997-8#1)(2008-5#1)
to make this##12##3##(1990-8#1)(1996-12#1)(1996-8#1)(1997-8#2)(2006-6#1)(2006-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)
to make those##3##3##(1995-12#1)(2005-4#1)(2013-7#1)
to make treatment comparisons##2##4##(1995-8#1)(1997-4#1)
to make treatment decisions##3##4##(2007-12#1)(2007-2#1)(2009-4#1)
to make treatment##6##3##(1995-8#1)(1997-4#1)(2006-10#1)(2007-12#1)(2007-2#1)(2009-4#1)
to make two##2##3##(1990-4#1)(2008-3#1)
to make up for##2##4##(1993-5#1)(2009-7#1)
to make up##3##3##(1993-5#1)(2009-7#1)(2012-3#1)
to make use of the##2##5##(2006-11#1)(2008-10#1)
to make use of##8##4##(1995-4#1)(1996-3#1)(2006-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2012-3#1)
to make useful##2##3##(1992-3#1)(2008-7#1)
to make##621##2##(1990-12#3)(1990-3#1)(1990-4#2)(1990-5#3)(1990-8#1)(1990-9#1)(1991-1#5)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#2)(1991-4#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#3)(1992-2#2)(1992-3#3)(1992-5#2)(1992-6#1)(1992-9#1)(1993-1#3)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#3)(1993-5#3)(1993-8#1)(1993-9#2)(1994-1#6)(1994-11#1)(1994-12#5)(1994-2#2)(1994-3#2)(1994-9#3)(1995-1#2)(1995-11#2)(1995-12#6)(1995-2#4)(1995-4#2)(1995-5#2)(1995-6#2)(1995-7#2)(1995-8#3)(1995-9#3)(1996-1#4)(1996-11#3)(1996-12#3)(1996-2#3)(1996-3#4)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#6)(1997-4#2)(1997-7#2)(1997-8#8)(2004-1#1)(2004-12#2)(2004-4#1)(2004-5#1)(2004-8#1)(2005-10#2)(2005-11#4)(2005-4#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#14)(2006-11#5)(2006-12#4)(2006-3#2)(2006-4#3)(2006-5#6)(2006-6#3)(2006-8#4)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#11)(2007-12#11)(2007-2#7)(2007-3#2)(2007-4#5)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#15)(2007-9#8)(2008-1#9)(2008-10#26)(2008-11#21)(2008-12#6)(2008-2#26)(2008-3#22)(2008-4#10)(2008-5#14)(2008-6#6)(2008-7#23)(2008-8#9)(2008-9#7)(2009-10#4)(2009-11#3)(2009-2#1)(2009-4#4)(2009-5#2)(2009-6#2)(2009-7#5)(2009-8#6)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#4)(2010-3#1)(2010-4#4)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#5)(2010-9#4)(2011-1#8)(2011-12#1)(2011-2#15)(2011-3#1)(2011-8#1)(2012-1#4)(2012-11#2)(2012-12#9)(2012-2#17)(2012-3#9)(2013-1#19)(2013-7#3)(2013-8#11)
to making the##3##3##(2008-5#1)(2011-1#1)(2012-2#1)
to making##17##2##(1993-3#1)(1995-9#1)(1996-1#1)(2006-10#1)(2006-7#1)(2007-3#1)(2007-6#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
to malaria and##3##3##(2006-10#1)(2006-4#1)(2007-11#1)
to malaria in##2##3##(1995-12#1)(2010-1#1)
to malaria##16##2##(1994-11#1)(1995-12#1)(2006-10#1)(2006-4#2)(2007-11#1)(2007-2#2)(2008-11#1)(2008-8#1)(2009-6#1)(2010-1#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
to malathion##5##2##(2005-8#3)(2012-2#1)(2013-1#1)
to male Wistar rats##2##4##(1995-3#1)(2007-8#1)
to male and female rats##2##5##(1993-2#1)(1996-10#1)
to male and female##3##4##(1993-2#1)(1996-10#1)(2008-5#1)
to male patients##3##3##(2006-10#1)(2012-2#1)(2012-3#1)
to male rats##2##3##(1995-3#1)(2008-6#1)
to male##47##2##(1990-3#1)(1990-5#1)(1992-6#1)(1992-9#1)(1993-2#2)(1995-3#2)(1995-5#1)(1996-10#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-3#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#5)(2008-6#2)(2008-8#2)(2008-9#4)(2009-2#1)(2011-1#1)(2011-12#1)(2012-2#2)(2012-3#3)
to males and approximately##2##4##(2008-9#2)
to males and##14##3##(2008-4#1)(2008-8#3)(2008-9#10)
to males##29##2##(1991-3#1)(1996-10#1)(1997-8#1)(2007-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#4)(2008-9#12)(2009-9#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-7#1)(2013-8#1)
to males)##2##2##(1992-4#1)(1997-4#1)
to malignancies##2##2##(2009-12#1)(2010-12#1)
to malignancy##8##2##(1990-12#1)(1990-2#1)(1992-11#1)(2005-3#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-12#1)
to malignant cells##2##3##(2007-10#1)(2013-8#1)
to malignant hyperthermia##2##3##(1997-3#1)(2010-9#1)
to malignant progression##2##3##(2008-6#2)
to malignant transformation##4##3##(1991-9#1)(2006-10#1)(2008-11#1)(2012-1#1)
to malignant##26##2##(1990-10#1)(1990-2#1)(1991-9#2)(1993-2#1)(1993-5#1)(1995-4#1)(1997-3#1)(1997-8#1)(2005-3#1)(2006-10#2)(2007-10#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-8#2)
to malnutrition and##2##3##(2008-12#2)
to malnutrition##7##2##(1991-12#1)(1993-12#1)(1996-3#1)(2008-10#1)(2008-12#2)(2012-2#1)
to mammalian GnRH##2##3##(1995-5#2)
to mammalian aldo/keto reductases##2##4##(1990-5#2)
to mammalian cells##5##3##(1994-5#1)(2006-6#1)(2007-8#1)(2008-4#1)(2008-9#1)
to mammalian##46##2##(1990-12#1)(1990-5#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-4#1)(1992-5#1)(1993-11#1)(1993-2#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#3)(1996-8#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-11#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-11#2)(2008-4#2)(2008-9#1)
to mammals##7##2##(1990-12#1)(1991-9#1)(1996-2#1)(2007-12#1)(2008-7#1)(2009-6#1)(2009-8#1)
to mammary##3##2##(1996-3#1)(2010-9#1)(2012-1#1)
to mammography screening##2##3##(2006-10#2)
to mammography##6##2##(1990-10#1)(1995-2#1)(2004-2#1)(2006-10#3)
to man and##3##3##(1995-11#1)(1997-1#1)(2007-7#1)
to man##17##2##(1994-2#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-10#1)(1997-1#2)(1997-3#1)(2005-7#1)(2005-9#1)(2006-12#1)(2007-7#1)(2008-5#1)(2009-6#1)(2010-7#1)
to manage a##2##3##(2007-2#1)(2013-1#1)
to manage and##3##3##(2011-2#1)(2013-1#2)
to manage clinical##2##3##(1997-5#1)(2007-10#1)
to manage complex##3##3##(2006-10#1)(2008-1#1)(2008-2#1)
to manage difficult##2##3##(2010-12#1)(2011-2#1)
to manage in##2##3##(2007-2#1)(2007-7#1)
to manage it##2##3##(2007-9#1)(2010-11#1)
to manage pain##4##3##(1996-7#1)(2007-2#1)(2010-8#1)(2013-1#1)
to manage patients with##3##4##(1996-7#1)(2006-10#1)(2009-3#1)
to manage patients##4##3##(1996-7#1)(2006-10#1)(2008-3#1)(2009-3#1)
to manage the consequences of##2##5##(2006-10#1)(2007-12#1)
to manage the disease##2##4##(2008-10#1)(2008-8#1)
to manage the##29##3##(1993-12#1)(1994-2#1)(1994-3#2)(1995-3#1)(1996-2#1)(1997-1#1)(2006-10#2)(2007-12#1)(2007-5#3)(2008-10#3)(2008-11#2)(2008-6#1)(2008-8#1)(2010-11#1)(2010-7#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
to manage their child's asthma##2##5##(2010-9#2)
to manage their##9##3##(1992-2#1)(1994-1#2)(2006-9#1)(2010-2#1)(2010-9#2)(2013-1#1)(2013-7#1)
to manage these##5##3##(1996-1#1)(2006-4#1)(2006-9#1)(2007-12#1)(2008-4#1)
to manage this problem##5##4##(1994-3#2)(2007-4#1)(2013-1#1)(2013-8#1)
to manage this risk##2##4##(2007-12#1)(2008-10#1)
to manage this##11##3##(1994-3#2)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
to manage type##2##3##(2008-7#1)(2009-11#1)
to manage##172##2##(1990-3#1)(1991-8#1)(1992-2#1)(1993-12#2)(1993-9#1)(1994-1#2)(1994-2#3)(1994-3#4)(1994-7#1)(1994-9#1)(1995-12#4)(1995-3#2)(1996-1#1)(1996-2#4)(1996-3#3)(1996-7#2)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-4#3)(2006-7#1)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#3)(2007-3#1)(2007-4#2)(2007-5#3)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#5)(2008-2#1)(2008-3#3)(2008-4#2)(2008-6#3)(2008-7#7)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#3)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#2)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#12)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#14)(2013-7#2)(2013-8#4)
to managed care in##2##4##(1995-12#1)(1996-2#1)
to managed care organizations##2##4##(1996-2#1)(2007-1#1)
to managed care##13##3##(1991-12#1)(1991-2#1)(1993-3#1)(1994-12#1)(1994-3#2)(1995-12#2)(1996-2#2)(1997-2#1)(2007-1#2)
to managed##15##2##(1991-12#1)(1991-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-12#2)(1996-2#2)(1997-2#1)(2007-1#2)(2011-2#1)
to management of##9##3##(2007-12#1)(2007-6#1)(2008-1#1)(2008-7#3)(2009-4#1)(2010-12#1)(2012-12#1)
to management##30##2##(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1994-2#1)(1995-3#1)(2006-10#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-6#2)(2008-7#4)(2008-9#1)(2009-4#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#1)
to managing the##2##3##(2008-12#1)(2008-3#1)
to managing##12##2##(1991-12#1)(1992-1#1)(1993-2#1)(1994-2#1)(1995-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2009-3#1)(2009-7#1)
to mandate and##3##3##(1991-12#1)(2008-3#2)
to mandate##7##2##(1991-12#1)(1996-1#1)(1997-3#1)(2008-3#2)(2010-2#1)(2012-1#1)
to maneuver the##2##3##(2006-11#1)(2008-11#1)
to manic-depressive disease##2##3##(1997-5#2)
to manifest##6##2##(2006-1#1)(2007-7#1)(2008-3#2)(2009-3#1)(2009-9#1)
to manifestation of##2##3##(1990-7#1)(2007-5#1)
to manipulate a##3##3##(2008-11#2)(2012-1#1)
to manipulate and##3##3##(2007-9#1)(2009-12#1)(2013-7#1)
to manipulate host##2##3##(2008-8#1)(2010-12#1)
to manipulate objects##2##3##(2008-11#1)(2012-2#1)
to manipulate the##13##3##(1990-2#1)(1995-5#1)(2004-4#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-12#1)(2009-5#1)(2010-2#1)(2011-7#1)(2013-8#1)
to manipulate##56##2##(1990-2#1)(1992-6#1)(1994-8#1)(1995-5#1)(1997-4#1)(2004-4#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-8#1)(2007-9#2)(2008-11#10)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#2)(2010-12#1)(2010-2#2)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-7#2)(2013-8#2)
to manipulating the##2##3##(2008-12#1)(2013-1#1)
to manipulating##3##2##(2008-11#1)(2008-12#1)(2013-1#1)
to manipulation##2##2##(2008-11#1)(2011-2#1)
to manipulations##2##2##(2008-4#1)(2008-7#1)
to mankind##2##2##(1994-5#1)(2008-10#1)
to manual##9##2##(1994-6#1)(2006-2#2)(2007-8#1)(2008-10#1)(2010-8#1)(2012-2#1)(2013-1#2)
to manufacture##8##2##(2007-11#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#2)(2010-9#1)
to manufacturers##2##2##(2008-8#1)(2010-5#1)
to many aspects of##2##4##(2008-9#1)(2011-1#1)
to many biological##2##3##(2009-12#1)(2010-12#1)
to many countries##2##3##(2008-1#1)(2010-7#1)
to many details##2##3##(2006-12#1)(2008-9#1)
to many different cell types##2##5##(1994-5#1)(2008-9#1)
to many different##6##3##(1994-5#1)(1997-6#1)(2008-11#1)(2008-3#1)(2008-9#1)(2013-8#1)
to many diseases##2##3##(2010-12#1)(2011-10#1)
to many factors##2##3##(2009-11#1)(2009-3#1)
to many health##2##3##(1995-12#1)(1995-2#1)
to many human##3##3##(2004-4#1)(2008-2#1)(2008-4#1)
to many isolates of##2##4##(2008-10#2)
to many of the##6##4##(1992-2#1)(2007-11#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-12#1)
to many of##9##3##(1991-3#1)(1992-2#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)
to many other##9##3##(1996-12#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-5#1)(2010-1#1)(2010-3#1)(2011-2#1)
to many patients##4##3##(1993-11#1)(2006-12#2)(2006-2#1)
to many processes##2##3##(2008-7#2)
to many types of##5##4##(1992-2#1)(1994-3#1)(2008-4#1)(2009-1#1)(2010-1#1)
to many##133##2##(1990-8#1)(1991-3#1)(1992-12#1)(1992-2#3)(1992-3#1)(1993-11#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#4)(1996-12#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(2004-2#1)(2004-4#1)(2005-10#3)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#3)(2006-2#2)(2006-5#1)(2006-6#1)(2006-8#2)(2007-11#4)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#4)(2008-2#5)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#7)(2009-1#1)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-8#2)(2010-1#2)(2010-11#1)(2010-12#5)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#3)(2012-2#4)(2013-1#1)(2013-8#2)
to map cell##2##3##(2008-11#2)
to map genes for##3##4##(1994-8#1)(1996-5#2)
to map genes##5##3##(1994-8#1)(1996-5#2)(2008-10#1)(2008-12#1)
to map out##3##3##(1991-8#1)(2007-7#1)(2008-8#1)
to map the gene##3##4##(1995-2#1)(2008-10#2)
to map the location of##2##5##(1993-12#1)(1996-5#1)
to map the##37##3##(1990-11#1)(1990-2#1)(1990-7#1)(1992-11#1)(1992-7#1)(1993-11#2)(1993-12#1)(1993-7#1)(1994-5#1)(1995-2#1)(1995-4#1)(1996-5#1)(1997-2#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#2)(2008-9#2)(2010-2#2)(2010-8#1)(2012-2#1)
to map##87##2##(1990-11#2)(1990-2#1)(1990-7#1)(1990-9#1)(1991-8#1)(1992-11#1)(1992-7#1)(1993-11#2)(1993-12#1)(1993-7#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-4#1)(1996-4#1)(1996-5#4)(1997-2#1)(1997-4#1)(2006-4#1)(2007-12#3)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-8#1)(2009-9#1)(2010-2#3)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#5)
to marginal##4##2##(2007-1#1)(2008-3#1)(2012-1#1)(2012-2#1)
to marijuana##3##2##(1991-1#1)(1991-4#1)(2006-8#1)
to marine##3##2##(2007-5#1)(2008-9#1)(2010-5#1)
to mark the##3##3##(1994-3#1)(2008-4#1)(2012-5#1)
to mark their##2##3##(2009-2#1)(2009-3#1)
to mark##10##2##(1994-3#1)(2007-9#1)(2008-10#1)(2008-4#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-2#1)(2012-5#1)(2013-1#1)
to marked improvement##2##3##(2006-10#1)(2007-12#1)
to marked##9##2##(2006-10#1)(2007-12#1)(2008-10#2)(2008-5#1)(2009-3#1)(2012-2#2)(2013-1#1)
to markedly affect the##2##4##(1991-5#1)(1996-2#1)
to markedly affect##3##3##(1991-5#1)(1996-2#1)(2012-11#1)
to markedly improve##2##3##(2005-7#1)(2008-3#1)
to markedly influence##2##3##(2007-12#1)(2013-8#1)
to markedly##9##2##(1991-5#1)(1996-2#1)(2005-7#1)(2007-12#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-11#1)(2013-8#1)
to markers##2##2##(1997-5#1)(2008-11#1)
to market a##2##3##(1990-9#1)(1997-2#1)
to market and##2##3##(2007-7#1)(2008-5#1)
to market##20##2##(1990-12#1)(1990-5#1)(1990-9#1)(1992-8#1)(1995-1#1)(1995-3#1)(1996-2#1)(1997-2#1)(2005-7#1)(2005-9#1)(2006-10#2)(2007-7#1)(2008-11#1)(2008-5#2)(2008-6#1)(2009-11#1)(2009-9#1)(2011-2#1)
to markets##2##2##(2011-2#1)(2013-1#1)
to marry##6##2##(1992-10#1)(1996-11#1)(1996-3#1)(1996-6#1)(2009-11#1)(2012-3#1)
to mash##2##2##(1997-4#2)
to mask the##3##3##(2008-10#1)(2008-12#1)(2010-5#1)
to mask##10##2##(1995-6#1)(1997-5#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-5#1)
to mass spectrometric analysis and##3##5##(1990-7#1)(2008-4#1)(2008-5#1)
to mass spectrometry##5##3##(2008-10#2)(2010-7#1)(2012-12#1)(2012-3#1)
to mass transfer##2##3##(2005-11#1)(2013-8#1)
to mass##18##2##(1990-7#1)(2005-11#1)(2006-10#1)(2007-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-7#1)(2012-12#1)(2012-3#2)(2013-8#1)
to mass-produce##2##2##(2008-10#1)(2008-11#1)
to massage##3##2##(2008-10#1)(2008-5#1)(2009-1#1)
to massive##10##2##(1995-10#1)(1996-11#1)(1997-4#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-8#1)(2009-4#1)(2011-2#1)(2013-1#1)
to mastectomy##3##2##(1990-12#1)(2004-1#1)(2007-11#1)
to master the##2##3##(1997-3#1)(2007-5#1)
to master##3##2##(1992-1#1)(1997-3#1)(2007-5#1)
to match a##4##3##(1997-8#1)(2007-12#1)(2008-9#1)(2012-1#1)
to match that of##2##4##(1993-3#1)(2009-4#1)
to match the##20##3##(1990-3#1)(1991-3#1)(1991-8#1)(1994-8#1)(1995-11#1)(1996-1#1)(1996-3#1)(1996-4#1)(2005-8#1)(2006-10#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2010-10#1)
to match those##2##3##(2007-8#1)(2009-7#1)
to match##51##2##(1990-3#1)(1991-3#1)(1991-8#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-8#1)(1995-11#2)(1996-1#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-8#2)(2005-8#1)(2006-10#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-4#2)(2009-7#1)(2010-10#2)(2011-1#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-8#2)
to matched control##2##3##(2006-8#1)(2009-10#1)
to matched##6##2##(1992-2#1)(1992-6#1)(2006-8#1)(2007-8#1)(2009-10#1)(2012-1#1)
to mate and##2##3##(2008-9#1)(2009-9#1)
to mate##8##2##(2006-5#1)(2008-8#1)(2008-9#1)(2009-9#2)(2011-2#1)(2012-12#2)
to material##6##2##(2006-11#1)(2008-3#3)(2009-9#1)(2010-12#1)
to materialize##2##2##(1995-2#1)(2013-1#1)
to materials science##2##3##(1997-4#1)(2006-5#1)
to materials##5##2##(1991-12#1)(1997-4#1)(2006-5#1)(2008-7#2)
to maternal autoimmune##3##3##(2006-9#2)(2008-4#1)
to maternal##17##2##(1992-10#1)(1993-6#1)(1995-8#2)(1996-5#1)(1996-7#1)(2006-9#2)(2007-4#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-4#1)(2010-11#1)(2011-1#1)(2011-2#1)
to maternity##3##2##(1992-4#1)(2013-1#1)(2013-8#1)
to mathematical##2##2##(2007-11#1)(2008-10#1)
to mating pheromone##2##3##(1991-5#1)(1994-12#1)
to mating##6##2##(1991-5#1)(1992-1#1)(1994-12#1)(1997-6#1)(2007-12#1)(2008-10#1)
to matrix interference##2##3##(2008-10#2)
to matrix##10##2##(1992-4#1)(1993-4#2)(1995-2#1)(2008-10#3)(2008-5#1)(2008-8#1)(2013-1#1)
to matrix-bound##2##2##(1995-8#2)
to maturation of##2##3##(1992-7#1)(2007-7#1)
to maturation##9##2##(1992-7#1)(1994-8#1)(1996-3#1)(2006-11#1)(2006-5#1)(2007-7#1)(2008-10#1)(2012-11#2)
to mature##26##2##(1990-12#2)(1990-7#1)(1991-1#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-4#1)(1993-12#1)(1994-11#1)(1995-1#4)(1995-12#1)(1995-5#1)(1995-6#1)(1997-7#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-5#2)(2008-6#1)(2009-3#1)(2013-8#1)
to maturity##5##2##(1991-12#1)(2008-11#1)(2008-9#1)(2011-1#1)(2013-7#1)
to maxillary##2##2##(2007-3#1)(2009-7#1)
to maximal##11##2##(1990-11#1)(1994-12#1)(1995-7#1)(1996-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-3#1)
to maximally##6##2##(1994-12#1)(1995-11#1)(2006-7#1)(2008-2#1)(2008-5#1)(2009-10#1)
to maximise the##5##3##(2005-7#1)(2006-2#1)(2008-11#1)(2010-3#1)(2012-2#1)
to maximise##15##2##(2005-7#1)(2006-2#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-12#1)(2010-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
to maximize opportunities##2##3##(1997-1#1)(2011-1#1)
to maximize quality of##2##4##(1993-3#1)(2013-1#1)
to maximize survival##2##3##(2007-5#1)(2008-5#1)
to maximize the benefits##2##4##(1994-3#1)(2011-1#1)
to maximize the likelihood##2##4##(1997-2#1)(2008-9#1)
to maximize the number of##2##5##(2013-7#1)(2013-8#1)
to maximize the##46##3##(1992-2#1)(1993-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1997-2#1)(2005-11#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-12#3)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-10#1)(2010-8#2)(2010-9#2)(2011-1#1)(2012-1#1)(2012-12#1)(2013-7#2)(2013-8#1)
to maximize their##4##3##(2008-11#1)(2008-9#2)(2011-2#1)
to maximize##121##2##(1992-12#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2004-1#1)(2004-8#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#2)(2007-12#4)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2008-1#2)(2008-10#9)(2008-11#6)(2008-2#5)(2008-3#7)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#11)(2009-4#1)(2009-9#1)(2010-10#1)(2010-2#2)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
to maximizing##2##2##(2007-4#1)(2008-11#1)
to maximum##19##2##(1991-2#1)(1992-11#1)(1993-5#1)(1994-3#1)(1995-6#1)(2004-10#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-4#1)(2012-3#1)
to me##5##2##(1993-8#1)(1996-12#1)(2007-9#1)(2008-10#1)(2009-9#1)
to meals##2##2##(1995-4#1)(2007-10#1)
to mean arterial pressure##2##4##(1990-12#1)(2007-7#1)
to mean that a##2##4##(1993-5#1)(2006-10#1)
to mean that the##2##4##(2008-10#1)(2010-3#1)
to mean that##7##3##(1993-5#1)(1994-9#1)(2006-10#1)(2007-11#1)(2008-10#2)(2010-3#1)
to mean the##3##3##(1995-2#1)(1996-5#1)(2013-1#1)
to mean##17##2##(1990-12#1)(1993-5#1)(1994-9#1)(1995-2#1)(1996-5#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-3#1)(2013-1#2)
to meaningful##2##2##(1997-3#1)(2008-4#1)
to meaningfully##2##2##(1991-12#1)(2011-2#1)
to measurable##3##2##(2008-11#1)(2008-8#1)(2010-12#1)
to measure MT##2##3##(2008-10#2)
to measure a##8##3##(1997-6#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-12#1)(2010-8#1)(2011-2#1)
to measure absorption##3##3##(2006-5#1)(2008-3#2)
to measure adherence##2##3##(2007-7#1)(2008-3#1)
to measure agreement##2##3##(2008-7#1)(2013-1#1)
to measure airway##2##3##(1997-1#1)(2005-10#1)
to measure all##3##3##(2008-10#1)(2008-4#1)(2010-9#1)
to measure an##4##3##(1993-9#1)(2008-2#2)(2008-3#1)
to measure and observe##2##4##(2008-10#1)(2008-11#1)
to measure and##12##3##(1996-3#1)(1997-2#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-11#1)(2012-3#1)(2013-1#3)
to measure antibodies##2##3##(1994-9#1)(2005-8#1)
to measure anxiety and##3##4##(1996-1#1)(2008-6#1)(2013-7#1)
to measure any##2##3##(1997-5#1)(2012-1#1)
to measure at##2##3##(1990-2#1)(2008-2#1)
to measure atmospheric##3##3##(2008-2#1)(2008-3#2)
to measure blood flow##2##4##(1994-4#1)(2008-10#1)
to measure blood##8##3##(1994-4#1)(2007-8#2)(2008-1#1)(2008-10#3)(2010-11#1)
to measure body dissatisfaction##2##4##(2007-12#2)
to measure body##3##3##(1991-8#1)(2007-12#2)
to measure bone##2##3##(1993-11#1)(2009-4#1)
to measure both##7##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)
to measure cardiac##3##3##(2006-10#2)(2008-10#1)
to measure cellular##2##3##(2008-11#2)
to measure changes in the##4##5##(1991-5#1)(1993-6#1)(2004-9#1)(2008-3#1)
to measure changes in##12##4##(1990-4#1)(1991-5#1)(1993-6#1)(1997-6#1)(2004-9#1)(2007-10#1)(2008-3#2)(2008-7#1)(2009-4#1)(2011-2#1)(2012-3#1)
to measure chemotaxis of LGL##2##5##(1990-12#2)
to measure circulating##3##3##(1994-9#1)(2005-3#1)(2006-10#1)
to measure compliance##2##3##(1996-12#1)(2011-2#1)
to measure depth##2##3##(1995-11#1)(2012-2#1)
to measure differences##2##3##(1997-8#1)(2007-12#1)
to measure directly the##2##4##(2008-2#2)
to measure directly##4##3##(1997-3#1)(2008-2#3)
to measure disease##3##3##(2008-10#2)(2008-7#1)
to measure dopamine##2##3##(1990-1#1)(1993-6#1)
to measure economic##2##3##(1994-12#1)(1995-9#1)
to measure exocytosis##2##3##(2008-1#1)(2008-11#1)
to measure fluid##2##3##(2007-11#1)(2008-2#1)
to measure fluorescence##2##3##(2008-2#1)(2008-4#1)
to measure health-related##2##3##(2011-1#1)(2013-8#1)
to measure human##7##3##(1992-7#1)(1992-8#1)(1993-6#1)(2006-5#1)(2008-4#2)(2011-2#1)
to measure in situ the##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
to measure in situ##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
to measure in##7##3##(1992-4#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-11#1)
to measure intracellular calcium##2##4##(2008-4#2)
to measure its##3##3##(2008-10#1)(2008-5#1)(2012-1#1)
to measure large##2##3##(2008-2#1)(2008-9#1)
to measure lumbar##2##3##(2006-7#1)(2013-1#1)
to measure optical##3##3##(2007-11#1)(2007-12#1)(2011-7#1)
to measure other##2##3##(1996-12#1)(2012-2#1)
to measure outcomes##3##3##(1996-2#1)(1997-1#1)(2012-12#1)
to measure patient satisfaction##2##4##(1997-1#1)(2011-2#1)
to measure phase##3##3##(2008-2#2)(2009-4#1)
to measure physical morbidity in##2##5##(2012-12#2)
to measure positive##2##3##(2007-10#1)(2010-6#1)
to measure precisely the##2##4##(2012-1#1)(2012-2#1)
to measure profiles of##2##4##(2008-3#2)
to measure progress##3##3##(1996-1#1)(2008-10#1)(2012-12#1)
to measure protein##5##3##(1990-12#1)(1991-3#1)(1991-5#1)(2008-1#1)(2008-4#1)
to measure quality of life##2##5##(2006-10#1)(2011-2#1)
to measure quality##4##3##(1997-1#1)(2006-10#1)(2011-2#2)
to measure satisfaction##2##3##(1996-3#1)(2008-11#1)
to measure sensitivity##2##3##(2008-10#2)
to measure serum levels of##2##5##(2006-10#1)(2008-10#1)
to measure serum levels##3##4##(1994-10#1)(2006-10#1)(2008-10#1)
to measure serum##5##3##(1990-8#1)(1992-11#1)(1994-10#1)(2006-10#1)(2008-10#1)
to measure simultaneously and##2##4##(2007-12#1)(2008-11#1)
to measure simultaneously##4##3##(2007-12#2)(2008-11#1)(2008-3#1)
to measure small##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
to measure spatial variation##2##4##(2008-10#1)(2011-2#1)
to measure temperature##3##3##(2008-3#3)
to measure the ability of##4##5##(2008-1#1)(2008-4#2)(2010-2#1)
to measure the ability##5##4##(2008-1#1)(2008-4#2)(2010-2#1)(2012-3#1)
to measure the absolute##3##4##(2008-2#2)(2008-3#1)
to measure the amplitude of##2##5##(2007-12#1)(2008-3#1)
to measure the amplitude##3##4##(2007-12#2)(2008-3#1)
to measure the binding##3##4##(1995-3#1)(2008-10#1)(2008-4#1)
to measure the biological##2##4##(2008-11#1)(2008-4#1)
to measure the changes in##3##5##(2006-7#1)(2008-12#1)(2008-3#1)
to measure the changes##4##4##(2004-9#1)(2006-7#1)(2008-12#1)(2008-3#1)
to measure the concentration of##8##5##(1991-10#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)
to measure the concentrations of##3##5##(2008-4#2)(2011-1#1)
to measure the density##2##4##(1995-12#1)(2006-10#1)
to measure the distance##2##4##(2007-4#1)(2008-2#1)
to measure the effect of##3##5##(2008-11#1)(2008-4#1)(2012-12#1)
to measure the effect##4##4##(2008-11#1)(2008-4#1)(2008-5#1)(2012-12#1)
to measure the effectiveness of an##2##6##(1995-2#1)(2011-1#1)
to measure the effectiveness of##4##5##(1991-1#1)(1995-2#1)(2010-10#1)(2011-1#1)
to measure the effects of##4##5##(1993-7#1)(1995-12#1)(2006-12#1)(2008-9#1)
to measure the elastic modulus##2##5##(1996-12#1)(2004-9#1)
to measure the evolution of##2##5##(2007-2#1)(2010-7#1)
to measure the extent of##3##5##(1994-5#1)(2008-10#1)(2008-4#1)
to measure the free concentration of##2##6##(2008-10#2)
to measure the free##3##4##(1992-6#1)(2008-10#2)
to measure the fringe##2##4##(2008-2#1)(2008-3#1)
to measure the functional##2##4##(1996-5#1)(2008-12#1)
to measure the impact of these##2##6##(2008-9#1)(2013-1#1)
to measure the impact of##4##5##(1992-12#1)(2008-7#1)(2008-9#1)(2013-1#1)
to measure the in##2##4##(1994-5#1)(2008-3#1)
to measure the intrinsic fluorescence emission of a sample solution##2##10##(2008-1#1)(2008-2#1)
to measure the kinetics of##2##5##(2008-3#1)(2008-8#1)
to measure the levels of##2##5##(1991-12#1)(2008-4#1)
to measure the modified##2##4##(1997-2#1)(2007-7#1)
to measure the nonlinear##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
to measure the optical##4##4##(2007-12#1)(2008-3#3)
to measure the orientation of##2##5##(2008-3#1)(2010-5#1)
to measure the prevalence of##2##5##(2007-2#1)(2011-1#1)
to measure the rate##5##4##(1993-11#1)(1997-4#1)(2008-4#1)(2009-12#1)(2010-12#1)
to measure the refractive indices##2##5##(2008-3#2)
to measure the refractive##3##4##(2008-3#3)
to measure the relative##2##4##(2007-4#1)(2008-10#1)
to measure the same##2##4##(1997-8#1)(2008-10#1)
to measure the scattering##2##4##(2008-3#2)
to measure the spatial##2##4##(2008-2#1)(2008-3#1)
to measure the spectral##2##4##(2008-2#1)(2008-3#1)
to measure the surface profile of a##2##7##(1992-7#1)(2007-12#1)
to measure the surface##6##4##(1992-7#1)(2007-12#1)(2008-2#2)(2008-3#2)
to measure the thermal##3##4##(2008-3#3)
to measure the total##2##4##(2008-10#1)(2008-3#1)
to measure the true##2##4##(2008-3#1)(2009-11#1)
to measure the uptake of##2##5##(1990-1#1)(1997-8#1)
to measure the velocity difference##2##5##(2008-2#1)(2008-3#1)
to measure the velocity field in##2##6##(2008-2#2)
to measure the velocity##5##4##(2008-2#4)(2008-3#1)
to measure the volume of##2##5##(1996-7#1)(2011-2#1)
to measure the##319##3##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-7#2)(1993-8#1)(1994-3#4)(1994-5#2)(1994-9#2)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-5#1)(1996-7#2)(1997-1#2)(1997-2#1)(1997-4#2)(1997-8#2)(2004-9#2)(2005-11#4)(2006-10#4)(2006-12#2)(2006-5#1)(2006-6#1)(2006-7#2)(2007-1#1)(2007-11#7)(2007-12#16)(2007-2#4)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#4)(2008-10#15)(2008-11#3)(2008-12#4)(2008-2#40)(2008-3#47)(2008-4#17)(2008-5#9)(2008-7#6)(2008-8#2)(2008-9#7)(2009-11#2)(2009-12#3)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#3)(2010-5#3)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#2)
to measure their##11##3##(1996-5#1)(1997-3#2)(2007-9#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-7#1)
to measure them##3##3##(2006-10#1)(2008-3#1)(2012-2#1)
to measure these parameters##2##4##(2008-2#1)(2011-1#1)
to measure these##8##3##(1993-2#1)(1995-1#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-9#1)(2010-11#1)(2011-1#1)
to measure tissue##3##3##(2006-10#1)(2008-2#1)(2012-2#1)
to measure total##5##3##(2008-3#1)(2008-9#2)(2012-12#1)(2013-1#1)
to measure transmittance##2##3##(2007-3#1)(2008-3#1)
to measure tropospheric##2##3##(2008-3#2)
to measure two-dimensional##4##3##(2008-2#1)(2008-3#2)(2008-4#1)
to measure urinary##2##3##(1994-6#1)(2013-1#1)
to measure various##2##3##(2007-12#1)(2008-10#1)
to measure visual fatigue##2##4##(2013-7#2)
to measure visual##3##3##(2010-8#1)(2013-7#2)
to measure##903##2##(1990-1#2)(1990-11#3)(1990-12#4)(1990-2#5)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#4)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#3)(1991-4#1)(1991-5#4)(1991-6#1)(1991-8#2)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#3)(1992-4#2)(1992-6#1)(1992-7#3)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-6#3)(1993-7#3)(1993-8#1)(1993-9#3)(1994-10#2)(1994-12#2)(1994-3#6)(1994-4#1)(1994-5#3)(1994-6#1)(1994-9#4)(1995-1#3)(1995-11#2)(1995-12#11)(1995-2#2)(1995-3#3)(1995-5#3)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#10)(1996-2#2)(1996-3#5)(1996-5#3)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#6)(1997-2#2)(1997-3#4)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#6)(2004-11#2)(2004-4#1)(2004-9#3)(2005-10#1)(2005-11#9)(2005-3#1)(2005-4#1)(2005-8#2)(2006-10#13)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#2)(2006-5#6)(2006-6#4)(2006-7#6)(2006-9#3)(2007-1#1)(2007-10#3)(2007-11#13)(2007-12#46)(2007-2#5)(2007-3#3)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#10)(2007-9#4)(2008-1#10)(2008-10#55)(2008-11#13)(2008-12#10)(2008-2#73)(2008-3#107)(2008-4#45)(2008-5#23)(2008-6#5)(2008-7#17)(2008-8#6)(2008-9#19)(2009-1#1)(2009-10#1)(2009-11#5)(2009-12#3)(2009-4#5)(2009-6#1)(2009-7#5)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#8)(2010-2#6)(2010-3#2)(2010-4#5)(2010-5#6)(2010-6#2)(2010-7#6)(2010-8#4)(2010-9#3)(2011-1#12)(2011-2#22)(2011-3#1)(2011-7#1)(2012-1#8)(2012-11#1)(2012-12#12)(2012-2#11)(2012-3#8)(2013-1#25)(2013-7#5)(2013-8#5)
to measured##6##2##(1991-5#1)(2007-12#1)(2008-6#1)(2008-7#1)(2009-8#1)(2013-1#1)
to measurement and##2##3##(2008-3#1)(2010-1#1)
to measurement errors##2##3##(2008-11#1)(2008-2#1)
to measurement of the##4##4##(1995-12#1)(2007-11#1)(2007-12#1)(2008-3#1)
to measurement of##9##3##(1995-12#1)(1996-8#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)
to measurement##16##2##(1995-12#1)(1996-8#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#5)(2010-1#1)
to measurements of##7##3##(1993-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-2#1)
to measurements##13##2##(1993-2#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#4)(2009-5#1)(2011-2#1)(2012-1#1)
to measures of##4##3##(2008-10#1)(2010-3#1)(2011-1#1)(2013-8#1)
to measures##6##2##(1996-3#1)(2008-10#1)(2008-11#1)(2010-3#1)(2011-1#1)(2013-8#1)
to measuring an##2##3##(1992-3#1)(2008-2#1)
to measuring the##5##3##(1990-5#1)(2007-1#1)(2008-3#3)
to measuring##19##2##(1990-5#1)(1992-3#1)(1996-2#1)(2007-1#1)(2007-12#1)(2007-4#2)(2008-2#1)(2008-3#5)(2008-4#2)(2010-2#1)(2011-1#1)(2012-12#2)
to meat##4##2##(2005-5#1)(2010-4#3)
to mechanical damage##2##3##(2006-5#1)(2007-7#1)
to mechanical drifts##2##3##(2008-3#1)(2011-1#1)
to mechanical injury##2##3##(1993-2#1)(2007-1#1)
to mechanical stimulation##5##3##(2008-11#1)(2008-12#1)(2009-12#1)(2009-8#2)
to mechanical stimuli##3##3##(1993-12#1)(1997-3#1)(2008-4#1)
to mechanical stress##3##3##(2007-7#1)(2007-9#1)(2012-3#1)
to mechanical ventilation##2##3##(2005-8#1)(2006-10#1)
to mechanical##47##2##(1990-8#1)(1991-12#1)(1992-5#1)(1993-12#1)(1993-2#1)(1995-7#1)(1995-8#1)(1997-3#1)(2004-9#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-2#2)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-7#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-7#1)(2009-8#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#2)
to mechanically##2##2##(1994-12#1)(2008-8#1)
to mechanisms of##2##3##(2007-7#1)(2010-11#1)
to mechanisms##7##2##(1996-12#1)(1996-4#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-8#1)(2010-11#1)
to media##7##2##(1991-3#1)(2006-5#1)(2007-12#2)(2008-3#1)(2008-7#1)(2012-12#1)
to medial##4##2##(1993-12#1)(1993-5#1)(2006-8#1)(2013-1#1)
to median nerve##2##3##(2008-9#1)(2012-2#1)
to median##4##2##(2006-2#1)(2008-9#1)(2012-1#1)(2012-2#1)
to mediate a variety of##2##5##(2008-4#1)(2010-6#1)
to mediate a##3##3##(1997-4#1)(2008-4#1)(2010-6#1)
to mediate in vivo##2##4##(1994-5#1)(2008-4#1)
to mediate interactions between##2##4##(1990-6#1)(2008-7#1)
to mediate many##2##3##(1991-8#1)(2009-8#1)
to mediate responses##2##3##(1994-2#1)(2008-8#1)
to mediate the relationship between##2##5##(2009-10#1)(2010-3#1)
to mediate the##20##3##(1992-3#1)(1992-7#1)(1992-8#1)(1993-5#1)(1993-8#1)(1994-5#1)(1996-1#1)(1997-4#2)(1997-5#1)(2007-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-2#1)(2010-3#1)(2011-12#1)(2012-12#1)
to mediate their##3##3##(1990-8#1)(1994-12#1)(1996-4#1)
to mediate##93##2##(1990-11#1)(1990-3#1)(1990-6#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-3#2)(1992-7#1)(1992-8#1)(1993-12#1)(1993-5#1)(1993-8#1)(1993-9#4)(1994-12#2)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-6#1)(1997-2#1)(1997-4#6)(1997-5#1)(1997-6#2)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#1)(2009-10#1)(2009-8#6)(2010-11#2)(2010-2#2)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
to medical care##12##3##(1992-12#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-3#1)(2005-10#1)(2006-8#1)(2007-9#3)(2008-8#1)(2009-4#1)
to medical doctors##2##3##(2006-10#2)
to medical education##2##3##(2009-7#1)(2010-11#1)
to medical errors##2##3##(2004-5#1)(2007-12#1)
to medical literature##2##3##(1991-3#1)(2013-1#1)
to medical practice##2##3##(1992-12#1)(2008-3#1)
to medical procedures##3##3##(1996-2#1)(2008-10#2)
to medical research##2##3##(2007-4#1)(2012-11#1)
to medical school##6##3##(1994-4#3)(2009-3#1)(2012-11#1)(2012-3#1)
to medical staff##3##3##(1992-1#1)(1993-1#1)(2013-1#1)
to medical students##7##3##(1994-12#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-1#3)
to medical therapy or##2##4##(1993-3#1)(2013-1#1)
to medical therapy##10##3##(1992-5#1)(1993-3#1)(1994-2#1)(1996-11#1)(2006-2#1)(2006-9#1)(2007-8#1)(2010-12#1)(2012-12#1)(2013-1#1)
to medical treatment##17##3##(1990-4#1)(1991-11#1)(1992-5#1)(1995-4#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-3#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)
to medical##114##2##(1990-10#2)(1990-12#1)(1990-4#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-1#1)(1992-12#2)(1992-5#2)(1993-1#1)(1993-3#3)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-4#3)(1994-8#1)(1995-2#1)(1995-4#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-11#1)(2004-5#1)(2004-7#1)(2005-10#2)(2006-10#3)(2006-2#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#4)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#3)(2012-11#2)(2012-12#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
to medically##2##2##(1995-1#1)(2006-1#1)
to medication adherence##2##3##(1992-12#1)(2011-1#1)
to medication among##2##3##(2012-1#2)
to medication in##2##3##(1990-4#1)(2012-1#1)
to medication management##2##3##(2008-11#2)
to medication regimens##2##3##(1992-12#2)
to medication##22##2##(1990-4#2)(1992-12#3)(1992-3#1)(1993-9#1)(2006-3#1)(2007-9#1)(2008-11#2)(2008-3#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#6)
to medications##7##2##(2005-7#1)(2006-3#1)(2008-1#1)(2008-6#1)(2010-4#1)(2011-2#1)(2013-1#1)
to medicine##13##2##(1991-2#1)(1993-1#1)(1995-6#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-7#1)(2012-1#1)(2012-11#2)(2013-1#2)
to medicines##2##2##(2012-12#1)(2013-1#1)
to medium and##3##3##(1993-8#1)(2007-2#1)(2008-12#1)
to medium##14##2##(1993-8#1)(1996-2#2)(1996-5#1)(2004-11#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)
to medium-sized##2##2##(1990-8#1)(2008-2#1)
to medullary##2##2##(1992-6#1)(2008-5#1)
to meet a##3##3##(1995-12#1)(2009-11#1)(2013-7#1)
to meet all##2##3##(2007-11#1)(2008-5#1)
to meet an##2##3##(2008-7#1)(2010-2#1)
to meet and##3##3##(1991-6#1)(1994-2#1)(1995-3#1)
to meet both##2##3##(2008-2#1)(2012-1#1)
to meet changing##2##3##(1995-1#1)(1995-5#1)
to meet current##2##3##(1994-2#1)(2009-3#1)
to meet emerging##2##3##(1997-3#2)
to meet in##2##3##(1992-1#1)(2008-11#1)
to meet its##7##3##(1990-10#1)(1990-5#1)(1993-1#1)(1995-12#1)(1995-3#1)(2008-10#1)(2008-3#1)
to meet or exceed##2##4##(1995-1#1)(2010-2#1)
to meet service##2##3##(1995-1#1)(1995-2#1)
to meet specific##2##3##(1994-1#1)(2006-10#1)
to meet target##2##3##(2008-5#1)(2012-2#1)
to meet the challenges of the##3##6##(1993-2#1)(1994-2#1)(2008-5#1)
to meet the challenges of##5##5##(1993-2#1)(1994-2#1)(2008-5#1)(2010-9#1)(2011-1#1)
to meet the changing##2##4##(2004-3#1)(2007-4#1)
to meet the claims##2##4##(1993-3#1)(2012-3#1)
to meet the demand##2##4##(2008-11#1)(2008-9#1)
to meet the demands of the##3##6##(1994-2#1)(2008-7#1)(2012-3#1)
to meet the demands of##7##5##(1994-2#1)(1995-2#1)(2007-7#1)(2008-10#1)(2008-7#1)(2012-3#2)
to meet the increasing demand for##2##6##(2007-4#1)(2010-4#1)
to meet the increasing##3##4##(2006-6#1)(2007-4#1)(2010-4#1)
to meet the national##2##4##(2008-11#1)(2009-12#1)
to meet the need for##3##5##(1997-7#1)(2008-10#1)(2010-11#1)
to meet the needs of a##2##6##(1991-3#1)(2008-10#1)
to meet the needs of the clientele##2##7##(2008-2#2)
to meet the needs of the##9##6##(1994-2#1)(1995-2#2)(1997-1#1)(2008-2#2)(2009-3#1)(2009-7#1)(2013-8#1)
to meet the needs of their##3##6##(1993-1#1)(2008-1#1)(2010-3#1)
to meet the needs of##33##5##(1991-3#1)(1992-2#1)(1993-1#1)(1993-12#1)(1994-1#2)(1994-2#2)(1994-3#1)(1994-9#1)(1995-2#2)(1996-2#1)(1996-3#1)(1997-1#2)(2005-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-6#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-8#1)
to meet the needs##35##4##(1991-3#1)(1992-2#1)(1993-1#1)(1993-12#1)(1994-1#2)(1994-2#2)(1994-3#1)(1994-9#1)(1995-2#2)(1996-2#1)(1996-3#1)(1997-1#2)(2005-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-6#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#1)(2013-8#1)
to meet the new##2##4##(1994-1#1)(2010-7#1)
to meet the requirements of##3##5##(2008-11#1)(2008-2#2)
to meet the requirements##4##4##(2008-11#1)(2008-2#3)
to meet the specific##2##4##(2010-11#1)(2012-3#1)
to meet the standards##2##4##(1991-8#1)(2011-2#1)
to meet the##118##3##(1990-12#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-2#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#3)(1994-12#2)(1994-2#4)(1994-3#3)(1994-9#1)(1995-2#3)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-4#1)(1997-7#1)(2004-3#1)(2005-12#1)(2005-5#1)(2005-9#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-2#2)(2007-4#2)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#7)(2008-11#9)(2008-12#1)(2008-2#5)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-11#3)(2010-12#1)(2010-3#1)(2010-4#3)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#2)(2013-8#1)
to meet their financial##2##4##(2008-11#1)(2008-7#1)
to meet their needs##3##4##(1994-1#1)(2008-11#1)(2008-9#1)
to meet their##10##3##(1994-1#1)(2005-5#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-11#3)(2008-7#1)(2008-9#1)
to meet them##2##3##(2008-10#1)(2012-1#1)
to meet these challenges##4##4##(2006-2#1)(2008-10#1)(2008-11#1)(2009-12#1)
to meet these goals##2##4##(1993-5#1)(2008-10#1)
to meet these needs##4##4##(1993-3#1)(2005-12#1)(2013-1#2)
to meet these requirements##2##4##(1992-12#1)(2008-3#1)
to meet these##15##3##(1992-12#1)(1993-3#1)(1993-5#1)(2005-12#1)(2006-2#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-12#1)(2010-4#1)(2012-2#1)(2013-1#2)
to meet this challenge##2##4##(2006-10#1)(2007-4#1)
to meet this##4##3##(2005-11#1)(2006-10#1)(2007-4#1)(2009-8#1)
to meet those needs##3##4##(2006-1#1)(2007-4#1)(2011-1#1)
to meet those##4##3##(1990-12#1)(2006-1#1)(2007-4#1)(2011-1#1)
to meet with##3##3##(2005-7#1)(2005-8#1)(2010-8#1)
to meet your##2##3##(1992-1#1)(1995-2#1)
to meet##242##2##(1990-10#1)(1990-12#3)(1990-5#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#3)(1992-12#2)(1992-2#1)(1993-1#3)(1993-10#1)(1993-12#2)(1993-2#2)(1993-3#3)(1993-5#1)(1994-1#5)(1994-11#1)(1994-12#2)(1994-2#6)(1994-3#4)(1994-9#1)(1995-1#3)(1995-12#2)(1995-2#5)(1995-3#4)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#2)(1997-3#3)(1997-4#1)(1997-7#1)(2004-3#1)(2005-11#1)(2005-12#2)(2005-5#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#3)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#3)(2007-4#4)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#4)(2008-10#12)(2008-11#18)(2008-12#2)(2008-2#8)(2008-3#7)(2008-5#4)(2008-6#1)(2008-7#7)(2008-9#2)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#4)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#5)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#3)(2012-1#3)(2012-12#4)(2012-2#5)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#3)
to meeting the##3##3##(1990-12#1)(1993-1#1)(1995-3#1)
to meeting##4##2##(1990-12#1)(1993-1#1)(1995-3#1)(2013-1#1)
to mefenoxam##5##2##(2008-10#5)
to mefloquine##2##2##(2008-7#1)(2009-6#1)
to meiotic##2##2##(1995-8#1)(2012-2#1)
to melanin##2##2##(2008-3#2)
to melanoma cells##2##3##(1991-3#1)(2012-3#1)
to melanoma##9##2##(1991-3#1)(1995-4#1)(1997-7#1)(2007-11#1)(2009-3#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-7#1)
to melatonin##3##2##(1991-12#1)(1991-2#1)(1995-7#1)
to melt##2##2##(2008-11#1)(2010-5#1)
to members of the##10##4##(1993-12#1)(1994-12#1)(1994-3#1)(1996-1#1)(1997-8#1)(2005-7#1)(2006-12#1)(2008-10#2)(2009-5#1)
to members of##13##3##(1993-12#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-1#1)(1997-8#1)(2005-7#1)(2006-12#1)(2008-10#2)(2008-11#1)(2009-5#1)
to members##14##2##(1993-12#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-1#1)(1997-8#1)(2004-3#1)(2005-7#1)(2006-12#1)(2008-10#2)(2008-11#1)(2009-5#1)
to membrane depolarization##2##3##(1992-3#1)(2008-8#1)
to membrane electrodes##2##3##(2007-8#1)(2008-10#1)
to membrane fractions##2##3##(1993-3#1)(1996-5#1)
to membrane fusion##3##3##(2008-8#1)(2009-12#1)(2012-2#1)
to membrane lipids##2##3##(1994-11#1)(1997-1#1)
to membrane potential##3##3##(1994-12#1)(2008-8#2)
to membrane receptors##2##3##(1991-8#1)(2008-7#1)
to membrane sites##2##3##(1994-11#1)(1994-12#1)
to membrane##38##2##(1990-11#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-3#1)(1995-8#1)(1996-5#2)(1997-1#1)(1997-5#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-7#2)(2008-8#4)(2009-12#1)(2009-8#1)(2011-1#1)(2012-2#1)
to membrane-bound polysomes##2##3##(2008-11#2)
to membrane-bound proteins##2##3##(1994-11#1)(1994-12#1)
to membrane-bound##5##2##(1994-11#1)(1994-12#1)(1995-6#1)(2008-11#2)
to membranes and##3##3##(1995-6#1)(1997-5#1)(2008-7#1)
to membranes from##3##3##(1990-10#1)(1992-6#1)(1995-6#1)
to membranes of##5##3##(1991-8#1)(1993-11#1)(1994-10#1)(1995-6#1)(2008-7#1)
to membranes where##2##3##(1990-7#1)(1995-5#1)
to membranes##27##2##(1990-10#1)(1990-4#1)(1990-7#2)(1991-11#1)(1991-8#1)(1991-9#1)(1992-6#1)(1993-11#1)(1994-10#1)(1994-12#3)(1995-11#2)(1995-5#1)(1995-6#3)(1997-5#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2012-2#1)
to memorize##3##2##(2008-6#3)
to memory and##2##3##(1991-3#1)(1993-12#1)
to memory formation##2##3##(1997-2#1)(2008-11#1)
to memory##12##2##(1991-3#1)(1991-5#1)(1993-12#1)(1993-9#1)(1995-12#1)(1997-2#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-12#1)(2011-2#1)
to men and##2##3##(2005-10#1)(2009-5#1)
to men##18##2##(1990-10#1)(1991-8#1)(1994-6#2)(1996-11#1)(1997-7#1)(2005-10#1)(2007-12#2)(2007-8#1)(2008-2#1)(2009-5#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#2)
to men's##2##2##(1995-3#1)(2007-12#1)
to menadione##2##2##(1995-8#1)(2009-10#1)
to mend##2##2##(1995-2#1)(2008-7#1)
to meningioma##2##2##(1997-7#1)(2007-12#1)
to meningococcal##2##2##(1991-8#1)(1995-9#1)
to meningovascular neurosyphilis##2##3##(1997-5#1)(2012-12#1)
to menopausal status##2##3##(1991-12#1)(2010-10#1)
to mental and##2##3##(2008-2#1)(2013-8#1)
to mental health and well-being##2##5##(2007-6#1)(2011-2#1)
to mental health and##3##4##(2007-6#1)(2010-2#1)(2011-2#1)
to mental health services##5##4##(1996-3#2)(1997-2#1)(2008-12#1)(2008-2#1)
to mental health##18##3##(1992-6#1)(1996-3#2)(1997-2#1)(2006-9#1)(2007-6#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#2)
to mental illness##4##3##(1996-8#1)(2006-9#1)(2011-1#2)
to mental stress##2##3##(1991-12#1)(2008-10#1)
to mental##32##2##(1991-1#1)(1991-12#1)(1992-6#1)(1996-3#2)(1996-6#1)(1996-8#1)(1997-2#2)(2006-9#2)(2007-6#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#2)(2008-7#1)(2009-10#1)(2010-2#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#2)(2013-8#2)
to mentally##3##2##(1991-6#1)(2009-8#1)(2010-6#1)
to mention new##2##3##(2008-4#1)(2011-2#1)
to mention that##3##3##(1997-6#1)(2008-10#1)(2008-5#1)
to mention the##2##3##(2008-10#1)(2008-8#1)
to mention##13##2##(1991-10#1)(1996-11#1)(1997-6#1)(2005-11#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-4#1)(2011-2#1)
to mentor##2##2##(2008-9#1)(2012-3#1)
to mercury##4##2##(1993-6#1)(1996-3#1)(2005-11#1)(2013-1#1)
to merge in##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
to merge with the##2##4##(1997-4#1)(2009-9#1)
to merge with##3##3##(1995-11#1)(1997-4#1)(2009-9#1)
to merge##15##2##(1992-8#1)(1995-11#3)(1995-7#1)(1995-8#1)(1997-4#1)(1997-7#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-9#1)
to merit##3##2##(1995-11#1)(1995-5#1)(2006-7#1)
to mesenchymal##3##2##(2008-6#1)(2012-12#2)
to mesenteric##3##2##(1996-2#3)
to mesh##2##2##(2005-8#1)(2011-2#1)
to messages##2##2##(1990-8#1)(2008-7#1)
to meta I##2##3##(1994-11#2)
to meta-analysis##2##2##(1994-7#1)(1996-3#1)
to metabolic abnormalities##3##3##(2005-10#1)(2006-9#1)(2010-2#1)
to metabolic acidosis##2##3##(2006-10#1)(2009-8#1)
to metabolic and##3##3##(2005-8#1)(2007-10#1)(2008-7#1)
to metabolic changes##2##3##(1996-12#1)(2004-11#1)
to metabolic derangements##2##3##(1990-6#1)(2010-10#1)
to metabolic syndrome##4##3##(2008-1#1)(2008-3#3)
to metabolic##27##2##(1990-3#1)(1990-6#1)(1990-7#1)(1991-6#1)(1996-12#1)(2004-11#1)(2005-10#2)(2005-8#1)(2006-10#1)(2006-9#1)(2007-10#1)(2008-1#1)(2008-3#3)(2008-6#1)(2008-7#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-4#1)(2012-3#1)(2013-8#2)
to metabolically##4##2##(1990-3#1)(1993-9#1)(1994-11#1)(2013-1#1)
to metabolise##3##2##(1990-11#2)(2008-7#1)
to metabolism##4##2##(2008-10#1)(2008-5#1)(2008-7#1)(2010-2#1)
to metabolites##2##2##(2013-8#2)
to metabolize epicatechin showed##2##4##(2008-10#2)
to metabolize##8##2##(2006-10#1)(2008-10#2)(2008-5#1)(2009-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
to metal ion##2##3##(1991-5#1)(2004-9#1)
to metal##22##2##(1991-5#1)(1996-2#1)(1997-7#1)(2004-9#2)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-3#2)(2008-5#1)(2010-12#1)(2011-1#1)(2012-12#2)
to metalaxyl##10##2##(2008-10#10)
to metallic##6##2##(1994-6#1)(1996-2#1)(2004-9#1)(2008-10#1)(2008-7#1)(2010-12#1)
to metallothionein##2##2##(1995-3#1)(2008-5#1)
to metals##10##2##(2007-12#1)(2008-3#4)(2010-8#1)(2011-1#3)(2013-1#1)
to metaphase##4##2##(2008-1#2)(2008-4#1)(2013-1#1)
to metastases##3##2##(1991-6#1)(2008-6#1)(2009-5#1)
to metastasis##7##2##(1992-7#1)(1997-3#1)(2007-11#1)(2007-9#1)(2008-1#2)(2012-2#1)
to metastasize to##3##3##(2007-4#1)(2010-7#1)(2012-3#1)
to metastasize##7##2##(2004-1#1)(2007-4#1)(2009-3#1)(2010-3#2)(2010-7#1)(2012-3#1)
to metastatic disease##3##3##(2007-8#1)(2008-6#1)(2009-8#1)
to metastatic##13##2##(1996-2#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-6#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-2#2)
to methacholine##3##2##(1994-6#1)(2008-1#2)
to methadone maintenance##2##3##(2011-1#2)
to methadone##3##2##(2007-12#1)(2011-1#2)
to methamphetamine##6##2##(1993-3#3)(1996-10#1)(1997-8#2)
to methane##3##2##(1991-1#1)(2008-10#1)(2008-6#1)
to methanol in whole embryo culture##2##6##(1995-3#2)
to methanol##5##2##(1995-3#3)(2011-2#2)
to methicillin##5##2##(1991-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-7#1)
to methiocarb##2##2##(2011-2#2)
to methionine sulfoxide##2##3##(1995-5#1)(2009-10#1)
to methionine##6##2##(1995-3#1)(1995-5#1)(2008-1#1)(2009-10#1)(2010-8#1)(2012-2#1)
to methodological##5##2##(2007-10#1)(2008-1#1)(2008-10#1)(2008-9#1)(2012-1#1)
to methods of##2##3##(2010-8#1)(2012-1#1)
to methods that##4##3##(1994-2#1)(1994-5#1)(2008-2#1)(2010-6#1)
to methods##10##2##(1993-9#1)(1994-2#1)(1994-5#1)(1997-3#1)(2006-3#1)(2008-2#1)(2008-3#1)(2010-6#1)(2010-8#1)(2012-1#1)
to methotrexate (MTX)##3##3##(1991-4#1)(1994-3#1)(2008-8#1)
to methotrexate##10##2##(1990-8#1)(1991-2#1)(1991-4#1)(1994-3#2)(1995-7#1)(2007-11#1)(2008-8#1)(2013-1#2)
to methyl##12##2##(1991-8#1)(1992-3#1)(2005-10#1)(2007-10#1)(2007-11#1)(2008-10#5)(2010-12#1)(2013-8#1)
to methylate##5##2##(1992-11#2)(1992-3#1)(1994-8#1)(1995-8#1)
to methylated##2##2##(1996-10#1)(2007-10#1)
to methylation##3##2##(1990-3#1)(1992-3#1)(2010-2#1)
to methylene##2##2##(2005-12#1)(2008-11#1)
to methylphenidate##2##2##(2006-12#1)(2011-2#1)
to metronidazole and amoxicillin##2##4##(2006-8#2)
to metronidazole and##3##3##(2006-8#2)(2008-12#1)
to metronidazole##9##2##(2006-10#1)(2006-6#1)(2006-8#4)(2007-7#1)(2008-12#2)
to mevalonate##2##2##(1993-8#1)(1996-7#1)
to mice and##3##3##(1995-12#1)(1997-8#1)(2009-12#1)
to mice by the##2##4##(1996-1#1)(1997-8#1)
to mice in##3##3##(1991-11#1)(1995-11#1)(1997-7#1)
to mice##33##2##(1990-3#1)(1990-4#1)(1990-6#1)(1991-11#1)(1991-9#1)(1993-3#1)(1994-5#1)(1995-11#1)(1995-12#2)(1995-6#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#2)(2007-11#1)(2008-11#2)(2008-4#4)(2008-5#1)(2009-12#1)(2010-12#1)(2012-12#1)(2013-1#2)
to micelle##2##2##(1990-2#1)(2008-10#1)
to micelles##3##2##(1994-11#1)(1994-2#1)(2008-10#1)
to micro##4##2##(2009-7#1)(2013-1#2)(2013-8#1)
to microarray analysis##2##3##(2008-7#1)(2010-12#1)
to microarray##5##2##(2008-4#1)(2008-7#2)(2010-10#1)(2010-12#1)
to microbes##2##2##(2005-11#1)(2007-11#1)
to microbial##12##2##(1993-11#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-5#1)(2011-2#2)(2012-2#1)(2013-1#3)
to microbiological##2##2##(2007-1#1)(2007-7#1)
to microbiology##3##2##(2008-4#1)(2008-9#2)
to microdamage##2##2##(2008-6#1)(2013-7#1)
to microelectrodes##2##2##(2009-12#1)(2012-1#1)
to microencapsulated##2##2##(2010-11#1)(2011-2#1)
to micromanipulate##2##2##(2005-11#1)(2008-3#1)
to micromolar concentrations##2##3##(2008-10#1)(2008-4#1)
to micromolar##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
to microorganisms and##3##3##(1990-11#1)(2008-4#1)(2008-5#1)
to microorganisms##5##2##(1990-11#1)(2005-11#1)(2008-4#1)(2008-5#1)(2010-9#1)
to microparticles##3##2##(1992-12#3)
to microsatellite##2##2##(2008-10#1)(2008-5#1)
to microsclerotia##3##2##(2008-10#3)
to microscopy##3##2##(1990-3#1)(2007-12#1)(2008-3#1)
to microsomal##3##2##(1993-8#1)(1994-5#1)(1995-6#1)
to microsomes##2##2##(1990-7#1)(1994-11#1)
to microspheres and##2##3##(2008-9#2)
to microspheres##3##2##(2008-9#3)
to microstructure##3##2##(2006-2#1)(2007-12#1)(2008-3#1)
to microtubules##10##2##(1990-10#2)(1991-9#2)(1992-8#1)(1995-2#1)(1995-3#1)(1997-4#1)(2004-12#1)(2008-5#1)
to microwave radiation##3##3##(2008-10#2)(2012-1#1)
to mid##4##2##(1991-3#1)(1992-9#1)(2007-12#1)(2008-12#1)
to mid-1994##2##2##(1995-9#1)(2008-2#1)
to mid-latitudes##2##2##(1996-5#1)(2008-2#1)
to midbrain dopaminergic neurons in##2##5##(2008-7#2)
to midbrain##3##2##(1997-5#1)(2008-7#2)
to middle cerebral artery##3##4##(1996-3#1)(1997-2#1)(2006-11#1)
to middle school##3##3##(2009-4#1)(2009-7#2)
to middle##15##2##(1991-6#1)(1995-1#1)(1995-9#1)(1996-3#1)(1997-2#1)(2006-11#1)(2008-3#1)(2008-9#1)(2009-4#1)(2009-7#4)(2010-1#1)(2013-8#1)
to midwifery##3##2##(2008-9#1)(2009-2#1)(2011-2#1)
to midwives##2##2##(1993-5#1)(2011-2#1)
to migraine##2##2##(2007-10#1)(2012-2#1)
to migrate from the##2##4##(1995-5#1)(2006-10#1)
to migrate in##2##3##(1994-11#1)(2012-1#1)
to migrate into##3##3##(1997-8#1)(2008-5#1)(2010-12#1)
to migrate to##4##3##(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
to migrate towards##2##3##(2008-5#1)(2013-1#1)
to migrate##21##2##(1994-11#1)(1995-5#1)(1997-8#1)(2005-10#1)(2006-10#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-12#1)(2010-2#2)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
to migration##5##2##(2007-8#1)(2007-9#1)(2008-10#1)(2011-2#1)(2012-2#1)
to migratory##2##2##(2008-3#2)
to mild in##2##3##(1992-7#1)(1997-8#1)
to mild##17##2##(1991-1#1)(1992-7#1)(1993-3#1)(1994-11#1)(1996-8#1)(1997-8#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
to milder##2##2##(1997-8#1)(2007-2#1)
to mildly##4##2##(2008-10#1)(2008-5#1)(2011-2#1)(2012-1#1)
to military##4##2##(1991-11#1)(1992-3#1)(1995-6#1)(2007-8#1)
to milk##3##2##(1991-2#1)(1993-8#1)(2007-8#1)
to millions of##6##3##(1997-6#1)(2006-5#1)(2007-12#1)(2007-4#1)(2008-12#1)(2012-12#1)
to mimic the dimensions of##2##5##(1991-9#1)(2007-8#1)
to mimic the##33##3##(1990-7#1)(1991-1#1)(1991-11#1)(1991-9#1)(1992-4#1)(1993-9#1)(1994-12#1)(1994-9#2)(1995-1#2)(1995-12#2)(1996-2#1)(1997-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2009-12#2)(2009-2#1)(2009-7#1)(2010-4#1)(2010-6#1)(2010-8#2)(2010-9#1)(2012-11#1)(2012-3#1)(2012-4#1)
to mimic those##4##3##(1990-12#1)(1992-1#1)(1994-5#1)(2012-2#1)
to mimic##62##2##(1990-12#1)(1990-7#2)(1991-1#1)(1991-10#1)(1991-11#2)(1991-9#2)(1992-1#1)(1992-4#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-5#2)(1994-9#2)(1995-1#2)(1995-12#2)(1996-2#1)(1996-5#1)(1997-4#3)(1997-5#1)(2006-7#1)(2007-1#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#1)(2008-9#1)(2009-12#3)(2009-2#1)(2009-7#1)(2010-4#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-2#1)(2012-1#2)(2012-11#1)(2012-2#2)(2012-3#1)(2012-4#1)(2012-8#1)
to mind##4##2##(2006-4#1)(2008-9#1)(2009-9#1)(2013-8#1)
to mine##3##2##(2010-7#1)(2013-1#2)
to mineral##4##2##(1995-8#1)(2008-10#2)(2008-3#1)
to mineralized##3##2##(1993-9#1)(2008-10#1)(2013-8#1)
to miniaturization##2##2##(2007-8#1)(2008-10#1)
to minimal##6##2##(2006-6#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-11#1)(2011-1#1)
to minimise any##2##3##(1994-6#1)(2005-10#1)
to minimise risk##2##3##(2007-11#1)(2008-8#1)
to minimise the high##2##4##(1997-7#1)(2008-10#1)
to minimise the risk of##2##5##(2008-6#1)(2010-4#1)
to minimise the##13##3##(1996-8#1)(1997-7#1)(2005-12#1)(2005-7#2)(2007-7#1)(2008-10#1)(2008-12#1)(2008-6#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)
to minimise their##2##3##(2008-1#1)(2011-2#1)
to minimise##34##2##(1992-7#1)(1994-6#1)(1996-8#1)(1997-7#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-7#2)(2005-8#1)(2007-11#4)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
to minimize additional##3##3##(2007-7#1)(2012-2#2)
to minimize deleterious effects of##2##5##(2007-1#1)(2010-9#1)
to minimize diagnostic##2##3##(1996-3#1)(2013-1#1)
to minimize errors##2##3##(2008-2#1)(2012-3#1)
to minimize inertial effects##2##4##(2006-11#2)
to minimize injury##2##3##(2006-10#2)
to minimize its##2##3##(2006-10#2)
to minimize long-term##3##3##(2006-10#1)(2007-11#2)
to minimize matrix##2##3##(2008-10#2)
to minimize non-specific##3##3##(1995-2#1)(2005-7#1)(2008-10#1)
to minimize or##3##3##(2010-9#1)(2013-1#2)
to minimize risk##2##3##(2008-6#1)(2013-1#1)
to minimize the approximation error##2##5##(2008-2#2)
to minimize the bias##2##4##(2007-8#1)(2008-10#1)
to minimize the difference between##2##5##(2007-11#1)(2008-2#1)
to minimize the effect of##3##5##(1995-3#1)(2008-10#1)(2008-3#1)
to minimize the effects of##3##5##(1993-1#1)(2008-3#1)(2008-9#1)
to minimize the incidence##2##4##(2006-10#1)(2010-6#1)
to minimize the interference##2##4##(2008-10#2)
to minimize the potential##3##4##(1995-12#1)(2012-2#1)(2013-8#1)
to minimize the risk of##14##5##(1992-3#1)(1993-1#1)(1995-8#1)(1996-3#1)(1996-9#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2010-12#1)(2010-7#1)(2011-11#1)(2013-1#1)(2013-8#1)
to minimize the risks##3##4##(1997-5#1)(2008-8#1)(2013-1#1)
to minimize the side-effects##2##4##(1997-6#1)(2007-7#1)
to minimize the##83##3##(1991-9#1)(1992-12#1)(1992-3#1)(1993-1#2)(1993-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-3#1)(1996-9#3)(1997-5#1)(1997-6#1)(2005-12#1)(2005-7#1)(2006-10#4)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#2)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#9)(2008-11#3)(2008-2#6)(2008-3#6)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#2)(2010-12#1)(2010-6#1)(2010-7#1)(2011-11#1)(2011-2#2)(2012-1#3)(2012-2#1)(2013-1#3)(2013-8#2)
to minimize their##3##3##(2004-9#1)(2008-7#1)(2010-2#1)
to minimize these##3##3##(2008-11#1)(2008-3#1)(2010-9#1)
to minimize this##3##3##(1992-3#1)(2008-2#1)(2009-7#1)
to minimize##194##2##(1991-12#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-1#2)(1993-10#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-9#3)(1997-3#1)(1997-5#1)(1997-6#1)(2004-9#1)(2005-10#1)(2005-12#2)(2005-7#2)(2006-10#10)(2006-11#3)(2006-8#2)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#2)(2007-4#2)(2007-7#3)(2007-8#4)(2008-1#2)(2008-10#21)(2008-11#5)(2008-12#1)(2008-2#12)(2008-3#9)(2008-4#1)(2008-5#5)(2008-6#6)(2008-7#5)(2008-8#2)(2008-9#4)(2009-10#1)(2009-3#1)(2009-6#2)(2009-7#1)(2010-12#3)(2010-2#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#3)(2011-11#1)(2011-2#4)(2012-1#5)(2012-11#2)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#3)
to minimizing the##2##3##(2007-11#1)(2008-2#1)
to minimizing##9##2##(1995-12#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-2#2)(2008-7#1)(2013-7#1)
to minimum##4##2##(2007-12#1)(2008-10#2)(2008-5#1)
to minor complications##2##3##(1990-8#1)(2007-7#1)
to minor##14##2##(1990-11#1)(1990-8#1)(1992-6#1)(1997-5#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#2)(2008-4#1)(2011-12#1)(2011-2#1)(2013-8#1)
to minors##3##2##(1996-1#1)(1996-11#2)
to minute asymmetric##2##3##(2006-10#2)
to minute##3##2##(1996-5#1)(2006-10#2)
to mirror##2##2##(2006-6#1)(2008-5#1)
to misalignement##2##2##(2008-3#2)
to misalignment##8##2##(2007-11#1)(2008-2#3)(2008-3#4)
to misalignments##2##2##(2007-11#1)(2008-2#1)
to misidentification##2##2##(2011-2#2)
to misinterpretation##4##2##(1990-2#1)(1992-1#1)(2006-10#1)(2007-8#1)
to misleading##7##2##(1997-2#1)(2007-12#1)(2008-12#1)(2009-3#2)(2011-2#1)(2012-2#1)
to misperceptions##2##2##(2008-7#1)(2010-4#1)
to miss##5##2##(1991-1#1)(1993-8#1)(2007-1#1)(2012-2#2)
to missing data##2##3##(1994-9#1)(2012-12#1)
to missing##3##2##(1994-9#1)(1997-2#1)(2012-12#1)
to mistakes##2##2##(2008-3#1)(2009-8#1)
to misunderstandings##2##2##(2006-10#1)(2012-2#1)
to misuse##3##2##(1994-2#1)(2007-11#1)(2012-2#1)
to mitigate its##2##3##(2007-7#1)(2007-9#1)
to mitigate the effects of##3##5##(2007-2#1)(2008-12#1)(2008-2#1)
to mitigate the##15##3##(2007-11#1)(2007-2#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-4#1)(2009-5#1)(2012-11#4)(2013-1#1)(2013-8#1)
to mitigate these##2##3##(2009-5#1)(2012-12#1)
to mitigate this##2##3##(2007-1#1)(2011-2#1)
to mitigate##36##2##(1992-1#1)(1994-3#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#2)(2007-9#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-4#1)(2009-5#2)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#2)(2012-11#4)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
to mitochondria and##4##3##(1994-3#1)(2005-8#1)(2006-2#1)(2011-2#1)
to mitochondria##15##2##(1992-6#1)(1992-7#1)(1992-9#1)(1994-3#1)(1994-5#1)(2005-8#2)(2006-2#1)(2007-9#1)(2008-7#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#2)
to mitochondrial dysfunction##4##3##(1995-5#1)(1997-6#1)(2007-9#1)(2008-1#1)
to mitochondrial##11##2##(1991-2#1)(1991-7#1)(1992-11#1)(1994-12#1)(1995-3#1)(1995-5#1)(1997-6#1)(2005-8#1)(2007-9#1)(2008-1#1)(2009-4#1)
to mitogen stimulation##2##3##(1990-10#1)(1991-8#1)
to mitogen##3##2##(1990-10#1)(1991-8#1)(2008-5#1)
to mitogenic or##3##3##(1990-9#1)(2007-2#1)(2008-4#1)
to mitogenic##7##2##(1990-9#1)(1991-5#1)(1992-6#1)(1996-10#1)(1996-2#1)(2007-2#1)(2008-4#1)
to mitogens##8##2##(1991-12#1)(1992-12#3)(1992-2#1)(1994-12#1)(1995-2#1)(2008-4#1)
to mitomycin C (MMC)##2##4##(1992-12#1)(1997-1#1)
to mitomycin C##3##3##(1992-12#1)(1997-1#1)(1997-7#1)
to mitosis##2##2##(2008-9#1)(2009-10#1)
to mitoxantrone##2##2##(1991-6#2)
to mixed##5##2##(1994-9#1)(1996-2#1)(2007-12#1)(2008-10#1)(2010-10#1)
to mixing##2##2##(2007-10#1)(2008-10#1)
to mixtures of##4##3##(2007-11#1)(2008-10#2)(2011-2#1)
to mobile##6##2##(1990-9#1)(1994-8#1)(2008-2#1)(2011-2#3)
to mobilise##2##2##(2007-12#1)(2008-11#1)
to mobility in older individuals##3##5##(2010-9#3)
to mobility##4##2##(2008-7#1)(2010-9#3)
to mobilization##2##2##(1995-12#1)(2006-7#1)
to mobilize a##2##3##(1997-4#1)(2006-2#1)
to mobilize the##5##3##(1996-2#1)(2006-8#1)(2008-2#1)(2008-9#1)(2013-8#1)
to mobilize##21##2##(1992-8#1)(1992-9#1)(1994-2#1)(1996-2#1)(1996-3#2)(1997-4#1)(2006-2#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
to mode##5##2##(2007-12#1)(2008-3#1)(2010-12#1)(2012-11#2)
to model a##5##3##(2008-2#1)(2013-1#4)
to model and simulate##2##4##(2008-2#1)(2008-7#1)
to model and##8##3##(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-7#1)(2010-4#1)(2010-7#1)
to model different##3##3##(2012-2#1)(2013-1#2)
to model individual##2##3##(2007-6#1)(2011-2#1)
to model predictions##2##3##(2008-10#1)(2008-9#1)
to model relative##2##3##(1992-6#1)(2013-7#1)
to model the behavior of##2##5##(2004-3#1)(2007-9#1)
to model the effects of##2##5##(1995-2#1)(2008-2#1)
to model the overall##2##4##(2007-4#1)(2011-2#1)
to model the system##2##4##(2008-10#1)(2008-2#1)
to model the##60##3##(1991-11#1)(1991-2#1)(1992-12#1)(1993-11#1)(1993-5#1)(1994-10#1)(1994-5#1)(1994-8#1)(1995-2#1)(1997-1#1)(2004-3#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-2#4)(2008-3#9)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#3)(2009-11#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-5#2)(2011-2#1)
to model this##4##3##(1991-11#1)(2008-3#1)(2008-5#1)(2008-7#1)
to model##155##2##(1991-11#2)(1991-2#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-4#1)(1993-5#1)(1994-10#1)(1994-5#3)(1994-8#1)(1995-1#1)(1995-2#1)(1995-8#2)(1996-12#2)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2004-3#1)(2005-11#2)(2006-10#2)(2006-11#2)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-4#2)(2007-6#1)(2007-8#1)(2007-9#3)(2008-10#11)(2008-11#3)(2008-2#10)(2008-3#20)(2008-4#6)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#9)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-7#1)(2009-9#2)(2010-1#2)(2010-2#3)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#3)(2013-1#8)(2013-7#2)
to model-based##2##2##(2011-1#2)
to modeling the##3##3##(2008-2#1)(2008-3#2)
to modeling##17##2##(2006-5#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#4)(2008-4#2)(2008-8#1)(2010-2#1)(2010-7#1)(2010-9#1)(2013-8#1)
to modelling##2##2##(2008-7#1)(2010-11#1)
to models that##4##3##(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
to models##8##2##(1994-12#1)(2007-4#1)(2008-10#1)(2008-8#2)(2008-9#1)(2011-1#1)(2011-2#1)
to moderate and##2##3##(2005-10#1)(2008-8#1)
to moderate climate##2##3##(2012-5#2)
to moderate cognitive impairment##2##4##(2008-2#1)(2011-2#1)
to moderate in##5##3##(1995-10#1)(2007-11#1)(2008-3#1)(2010-12#1)(2010-4#1)
to moderate intensity##2##3##(1994-6#1)(2012-2#1)
to moderate levels of##3##4##(1992-6#1)(2008-10#2)
to moderate the##5##3##(2007-12#1)(2009-10#1)(2009-7#2)(2010-2#1)
to moderate##96##2##(1990-12#1)(1991-9#2)(1992-10#1)(1992-4#1)(1992-6#1)(1993-2#1)(1994-11#2)(1994-12#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-9#2)(1996-1#1)(1996-3#1)(1997-6#1)(1997-8#2)(2004-11#1)(2005-10#3)(2005-6#1)(2006-10#1)(2006-4#1)(2007-11#5)(2007-12#2)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#2)(2009-4#1)(2009-7#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#1)(2011-12#1)(2011-2#2)(2012-2#3)(2012-5#3)(2013-1#3)(2013-8#1)
to moderately severe##7##3##(1994-9#1)(1996-7#1)(2006-2#1)(2006-6#2)(2007-4#1)(2008-5#1)
to moderately##14##2##(1992-3#1)(1993-9#1)(1994-9#1)(1996-7#1)(2006-2#1)(2006-6#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-5#1)(2010-12#1)(2012-1#1)(2013-8#1)
to modern humans##3##3##(1997-4#2)(2006-7#1)
to modern##20##2##(1990-6#1)(1991-5#1)(1993-3#1)(1997-2#1)(1997-4#2)(2005-10#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-1#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-8#1)(2010-9#1)(2012-12#1)(2012-3#2)
to modernize the##3##3##(2007-12#2)(2010-12#1)
to modernize##4##2##(2006-12#1)(2007-12#2)(2010-12#1)
to modes of##2##3##(1992-6#1)(2008-2#1)
to modest##3##2##(1995-4#1)(2007-8#1)(2012-2#1)
to modification by##3##3##(1993-3#1)(1996-3#1)(1996-9#1)
to modification of##2##3##(1997-1#2)
to modification##8##2##(1991-2#1)(1993-3#1)(1996-3#1)(1996-9#1)(1997-1#2)(1997-8#1)(2008-12#1)
to modified##4##2##(1994-10#1)(1997-2#1)(2008-5#1)(2011-2#1)
to modify a##4##3##(2005-11#1)(2006-5#1)(2008-10#1)(2008-11#1)
to modify disease##2##3##(2008-4#1)(2011-2#1)
to modify such##2##3##(1991-3#1)(2008-4#1)
to modify the activity of##2##5##(2008-5#1)(2010-5#1)
to modify the disease##2##4##(2008-12#1)(2009-9#1)
to modify the surface morphology##2##5##(2005-11#1)(2009-7#1)
to modify the surface##3##4##(2005-11#1)(2008-10#1)(2009-7#1)
to modify the##58##3##(1990-4#1)(1990-6#2)(1991-12#1)(1991-6#2)(1992-1#1)(1992-9#1)(1995-1#1)(1997-5#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-11#4)(2007-12#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-7#2)(2009-9#2)(2010-4#3)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
to modify their function##2##4##(2007-12#1)(2012-2#1)
to modify their##5##3##(1997-6#1)(2006-8#1)(2007-12#1)(2007-8#1)(2012-2#1)
to modify##121##2##(1990-4#1)(1990-6#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-8#2)(1992-1#1)(1992-10#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-4#2)(1993-6#1)(1994-10#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#2)(1997-5#1)(1997-6#1)(1997-8#3)(2004-9#1)(2005-11#2)(2006-10#3)(2006-12#3)(2006-5#2)(2006-6#1)(2006-8#3)(2006-9#1)(2007-11#5)(2007-12#2)(2007-4#1)(2007-8#3)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#2)(2009-4#2)(2009-7#2)(2009-9#2)(2010-12#1)(2010-4#3)(2010-5#1)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#2)
to modulate a##2##3##(2008-2#1)(2011-1#1)
to modulate and##3##3##(2009-10#2)(2009-8#1)
to modulate cell##3##3##(1995-8#1)(1996-2#1)(2008-11#1)
to modulate cellular##4##3##(1993-3#1)(2008-8#1)(2012-11#2)
to modulate continuous-wave pseudorandom noise lidar##2##6##(2008-2#2)
to modulate dendritic##2##3##(1990-7#1)(2008-4#1)
to modulate isotype switching in##2##5##(2010-12#2)
to modulate neuronal##2##3##(2008-5#1)(2008-7#1)
to modulate some##2##3##(1991-5#1)(2008-7#1)
to modulate the activity of##3##5##(1992-12#1)(2007-11#1)(2008-4#1)
to modulate the binding of##2##5##(1990-5#1)(1995-3#1)
to modulate the blood lipid metabolism##2##6##(2013-1#2)
to modulate the expression of##7##5##(1992-9#1)(1994-11#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)
to modulate the fate of##2##5##(2007-8#1)(2009-8#1)
to modulate the laser light passing through the ultrasonic beam inside the tissue##2##13##(2007-12#1)(2008-3#1)
to modulate the laser light passing through##3##7##(2007-12#2)(2008-3#1)
to modulate the production of##2##5##(1994-11#1)(2009-9#1)
to modulate the##50##3##(1990-5#1)(1990-7#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-8#1)(1994-10#1)(1994-11#2)(1995-3#1)(1996-1#1)(1996-5#2)(2005-7#2)(2006-10#1)(2007-11#5)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#6)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-4#1)(2011-1#1)(2013-1#2)(2013-7#1)
to modulate their function##2##4##(1996-10#1)(2012-2#1)
to modulate their##6##3##(1990-6#1)(1996-10#1)(1997-6#1)(2008-5#1)(2009-6#1)(2012-2#1)
to modulate this##3##3##(1994-9#1)(1995-6#1)(2008-8#1)
to modulate##140##2##(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-3#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#2)(1997-4#1)(1997-5#1)(1997-6#2)(2004-9#1)(2005-7#2)(2005-9#1)(2006-1#1)(2006-10#2)(2006-11#1)(2007-11#5)(2007-12#3)(2007-8#1)(2008-10#3)(2008-11#11)(2008-2#5)(2008-3#4)(2008-4#6)(2008-5#6)(2008-7#5)(2008-8#3)(2009-10#2)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#3)(2009-9#2)(2010-1#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#2)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
to modulating##3##2##(1991-7#1)(2006-10#1)(2008-11#1)
to modulation by##3##3##(1990-2#1)(2006-10#1)(2011-1#1)
to modulation of the##4##4##(1991-2#1)(1995-7#1)(2006-10#1)(2010-12#1)
to modulation of##8##3##(1991-2#1)(1994-6#1)(1995-7#1)(1995-8#1)(2006-10#1)(2008-8#1)(2009-3#1)(2010-12#1)
to modulation##11##2##(1990-2#1)(1991-2#1)(1994-6#1)(1995-7#1)(1995-8#1)(2006-10#2)(2008-8#1)(2009-3#1)(2010-12#1)(2011-1#1)
to moisture##5##2##(1996-5#1)(2008-10#3)(2010-4#1)
to molar region##2##3##(2010-10#1)(2013-1#1)
to molecular biology##3##3##(1996-6#1)(2008-4#1)(2013-8#1)
to molecular##38##2##(1991-9#1)(1992-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-7#1)(1996-6#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-9#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-3#1)(2011-1#4)(2012-11#1)(2013-1#4)(2013-8#1)
to monitor HIV##2##3##(1991-6#1)(1997-4#1)
to monitor and control##6##4##(1991-1#1)(2006-10#1)(2008-11#2)(2008-2#1)(2011-1#1)
to monitor and evaluate##2##4##(1994-1#1)(2009-4#1)
to monitor and##20##3##(1991-1#1)(1992-3#1)(1994-1#2)(1997-2#1)(2006-10#1)(2007-11#2)(2008-10#2)(2008-11#2)(2008-2#2)(2009-11#1)(2009-4#1)(2011-1#2)(2012-2#1)(2013-1#1)
to monitor blending##2##3##(2008-10#2)
to monitor cell##2##3##(2008-3#1)(2012-3#1)
to monitor changes in##3##4##(1996-12#1)(2010-4#1)(2012-2#1)
to monitor changes##5##3##(1996-12#1)(2007-3#1)(2008-7#1)(2010-4#1)(2012-2#1)
to monitor disease progression##2##4##(2008-4#1)(2008-8#1)
to monitor for##5##3##(2006-10#1)(2007-9#1)(2008-10#1)(2008-4#1)(2010-12#1)
to monitor gene expression##2##4##(1992-8#1)(2008-9#1)
to monitor glucose##2##3##(1996-7#1)(2008-10#1)
to monitor growth##2##3##(2008-10#1)(2009-8#1)
to monitor in##2##3##(2008-3#1)(2011-2#1)
to monitor its##3##3##(1992-9#1)(2007-11#1)(2007-3#1)
to monitor lymphocyte migration##2##4##(2008-4#2)
to monitor patients##4##3##(1990-2#1)(1993-12#1)(2006-9#1)(2008-10#1)
to monitor populations of##2##4##(2011-12#1)(2011-2#1)
to monitor progress##2##3##(1995-1#1)(2008-8#1)
to monitor quality of##2##4##(1995-9#1)(2009-4#1)
to monitor the activity of##4##5##(2007-12#1)(2008-4#1)(2011-1#1)(2012-2#1)
to monitor the binding##2##4##(1997-2#2)
to monitor the changes in##2##5##(2008-10#2)
to monitor the concentration of l-cysteine##2##6##(2008-10#2)
to monitor the concentration of##3##5##(2008-10#2)(2008-11#1)
to monitor the concentrations of##2##5##(2008-10#2)
to monitor the conformational##2##4##(1992-6#1)(2008-10#1)
to monitor the effect of##4##5##(1992-3#1)(1992-5#1)(2008-5#1)(2013-8#1)
to monitor the effectiveness of##2##5##(2007-8#1)(2007-9#1)
to monitor the effects of##4##5##(1993-2#1)(2008-10#1)(2010-5#1)(2013-8#1)
to monitor the efficacy##3##4##(1993-6#1)(2012-12#2)
to monitor the environmental##2##4##(2010-5#1)(2010-9#1)
to monitor the level of##3##5##(1993-3#1)(2006-10#1)(2008-10#1)
to monitor the population##2##4##(2007-8#1)(2008-10#1)
to monitor the progress of##2##5##(1997-5#1)(2008-9#1)
to monitor the rate of##2##5##(1994-9#1)(2008-8#1)
to monitor the success of##2##5##(1994-2#1)(2012-3#1)
to monitor the success##3##4##(1994-2#1)(2005-8#1)(2012-3#1)
to monitor the treatment##2##4##(2008-1#1)(2008-10#1)
to monitor the##136##3##(1990-11#1)(1990-2#1)(1990-9#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#3)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#3)(1995-11#1)(1995-12#1)(1995-4#1)(1995-9#1)(1996-11#2)(1996-6#1)(1997-2#3)(1997-4#1)(1997-5#2)(1997-6#1)(2004-9#1)(2005-11#2)(2005-12#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-3#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#31)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#8)(2008-4#5)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#4)
to monitor their##7##3##(1997-3#2)(2006-2#1)(2007-11#1)(2008-11#1)(2008-9#1)(2013-1#1)
to monitor these##3##3##(1996-12#1)(2007-12#1)(2008-3#1)
to monitor treatment##2##3##(2007-11#1)(2012-2#1)
to monitor##366##2##(1990-11#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-4#2)(1994-5#1)(1994-9#3)(1995-1#2)(1995-11#3)(1995-12#2)(1995-4#3)(1995-5#1)(1995-9#2)(1996-11#3)(1996-12#3)(1996-5#1)(1996-6#2)(1996-7#2)(1997-2#6)(1997-3#2)(1997-4#3)(1997-5#4)(1997-6#2)(1997-7#1)(2004-4#1)(2004-9#1)(2005-11#4)(2005-12#1)(2005-8#1)(2006-10#5)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#3)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#10)(2007-12#8)(2007-3#2)(2007-4#2)(2007-7#1)(2007-8#8)(2007-9#4)(2008-1#2)(2008-10#59)(2008-11#12)(2008-12#1)(2008-2#16)(2008-3#11)(2008-4#12)(2008-5#5)(2008-7#6)(2008-8#7)(2008-9#6)(2009-10#2)(2009-11#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#4)(2010-5#4)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#6)(2012-1#3)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#8)
to monitoring##12##2##(1996-12#1)(1997-6#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2010-10#1)(2011-1#1)
to monoamine##2##2##(1994-2#2)
to monoclonal antibodies##2##3##(1992-7#1)(2008-9#1)
to monocrotaline##2##2##(1993-3#2)
to monocyte##2##2##(2006-10#1)(2007-11#1)
to monocytes or##2##3##(1996-8#1)(2008-4#1)
to monocytes##5##2##(1992-12#1)(1995-12#2)(1996-8#1)(2008-4#1)
to monocytic##2##2##(1996-11#1)(1997-7#1)
to monolayer cell cultures##5##4##(2008-1#1)(2008-2#1)(2008-4#2)(2008-5#1)
to monomer##4##2##(1994-6#1)(1996-2#1)(1997-1#1)(2007-12#1)
to monomeric sugars##3##3##(2004-8#2)(2008-5#1)
to monomeric##5##2##(1993-9#1)(2004-8#2)(2008-4#1)(2008-5#1)
to monomers##4##2##(1991-12#1)(1995-2#1)(1997-2#1)(2009-12#1)
to monotherapy##3##2##(1991-2#1)(1997-3#1)(2010-5#1)
to monotone##2##2##(2008-11#2)
to monovalent##6##2##(1990-3#1)(1990-7#1)(2008-10#4)
to monthly##2##2##(1997-3#1)(2013-7#1)
to months##3##2##(1993-2#1)(2006-11#1)(2008-11#1)
to mood##4##2##(1996-1#1)(2008-4#1)(2008-7#1)(2010-2#1)
to moral##2##2##(2007-4#1)(2008-11#1)
to morbid##2##2##(2005-10#1)(2006-5#1)
to morbidity and mortality##3##4##(2006-10#2)(2006-5#1)
to morbidity and##5##3##(2005-8#1)(2006-10#2)(2006-5#1)(2007-8#1)
to more accurate##6##3##(2006-10#1)(2006-9#1)(2008-10#1)(2010-12#1)(2013-1#2)
to more accurately##6##3##(2005-8#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-9#1)(2012-2#1)
to more aggressive##3##3##(2006-10#1)(2010-12#1)(2012-2#1)
to more appropriate##3##3##(2007-4#1)(2008-7#1)(2009-12#1)
to more complex##7##3##(2007-9#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-10#1)
to more complicated##2##3##(2008-2#1)(2008-3#1)
to more conservative##2##3##(1993-6#1)(2006-10#1)
to more conventional##2##3##(2008-10#1)(2010-11#1)
to more effective##7##3##(1994-3#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)
to more effectively##3##3##(1996-3#1)(2006-10#1)(2009-4#1)
to more efficient##4##3##(1996-1#1)(2010-7#1)(2011-2#1)(2012-3#1)
to more established##2##3##(2008-10#1)(2013-1#1)
to more favorable##2##3##(2008-10#1)(2013-8#1)
to more fully explore##2##4##(2010-3#1)(2010-4#1)
to more fully understand##2##4##(2010-4#1)(2012-2#1)
to more fully##6##3##(1993-11#1)(1996-4#1)(2010-3#1)(2010-4#2)(2012-2#1)
to more internal##2##3##(1994-11#2)
to more negative values##2##4##(1996-1#1)(2008-10#1)
to more negative##6##3##(1994-9#1)(1995-12#1)(1996-1#1)(1997-5#1)(2008-10#2)
to more patients##2##3##(2006-7#1)(2008-1#1)
to more positive values##3##4##(1993-12#1)(2008-10#2)
to more positive##5##3##(1993-12#1)(2006-6#1)(2007-8#1)(2008-10#2)
to more radical##3##3##(2008-6#1)(2011-1#1)(2012-3#1)
to more rational##3##3##(2007-6#1)(2008-11#1)(2011-2#1)
to more readily##2##3##(2005-10#1)(2013-8#1)
to more serious##4##3##(1991-2#1)(2007-7#1)(2013-1#2)
to more severe##5##3##(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-12#1)
to more specific##4##3##(1991-12#1)(1994-6#1)(1996-12#1)(2010-3#1)
to more specifically##3##3##(1992-8#1)(1996-5#1)(2008-6#1)
to more than 1##2##4##(2008-10#1)(2008-9#1)
to more than 10##5##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-11#1)
to more than 100##2##4##(2007-12#1)(2010-4#1)
to more than 15 mg##2##5##(2013-8#2)
to more than 15##3##4##(2006-2#1)(2013-8#2)
to more than 50%##3##4##(1994-11#1)(1995-11#1)(2006-10#1)
to more than 600 mg##2##5##(2013-8#2)
to more than a single##2##5##(2008-2#1)(2008-3#1)
to more than a##5##4##(1994-12#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)
to more than one##5##4##(1995-1#1)(1995-5#1)(2007-2#1)(2007-8#1)(2011-2#1)
to more than two##2##4##(2006-5#2)
to more than##59##3##(1990-2#1)(1990-9#1)(1992-3#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-2#1)(2006-5#2)(2007-1#1)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#5)(2008-3#1)(2008-5#1)(2008-9#1)(2009-11#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#4)
to more traditional##4##3##(2008-8#1)(2009-4#1)(2010-1#1)(2013-8#1)
to more widespread use of##2##5##(2007-9#1)(2008-11#1)
to more##264##2##(1990-11#1)(1990-2#2)(1990-5#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-9#2)(1994-11#3)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#3)(1996-1#2)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#3)(1996-4#2)(1996-5#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-1#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-10#8)(2006-2#1)(2006-5#4)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#3)(2007-1#3)(2007-11#2)(2007-12#7)(2007-2#3)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#3)(2008-1#4)(2008-10#24)(2008-11#7)(2008-12#2)(2008-2#10)(2008-3#5)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#7)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#3)(2010-4#4)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#3)(2012-7#1)(2013-1#11)(2013-7#1)(2013-8#8)
to morphine in the##3##4##(1993-2#2)(2008-3#1)
to morphine in##4##3##(1993-2#2)(2008-1#1)(2008-3#1)
to morphine##18##2##(1991-1#1)(1991-6#1)(1993-2#3)(1994-10#2)(1994-2#1)(1995-12#3)(1996-12#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-3#1)(2013-7#1)
to morphological changes##2##3##(2006-6#2)
to morphological##6##2##(1992-6#1)(1994-8#1)(2006-10#1)(2006-6#2)(2008-6#1)
to morphologically##4##2##(2008-11#1)(2008-5#2)(2010-3#1)
to morphology##4##2##(1995-9#1)(2007-12#1)(2008-5#2)
to mortality and##2##3##(2007-12#1)(2008-3#1)
to mortality in##3##3##(1991-2#1)(2005-10#1)(2008-11#1)
to mortality##18##2##(1991-2#1)(2005-10#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
to mosquito##6##2##(1991-5#1)(2011-1#5)
to mosquitoes##2##2##(2006-10#1)(2007-2#1)
to most accurately##2##3##(1995-1#1)(2009-3#1)
to most biological##2##3##(2008-7#1)(2009-3#1)
to most effectively##2##3##(1992-3#1)(2008-9#1)
to most of the##9##4##(1990-10#1)(1996-2#1)(2005-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2013-1#1)
to most of##11##3##(1990-10#1)(1991-3#1)(1996-2#1)(2005-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2013-1#1)
to most people##2##3##(1993-2#1)(1996-5#1)
to most##78##2##(1990-10#1)(1990-5#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-11#1)(1994-6#2)(1995-1#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#2)(2006-11#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#3)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#2)(2009-5#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#7)
to mother and##3##3##(2006-12#1)(2009-3#1)(2012-2#1)
to mother##4##2##(2006-12#1)(2009-3#1)(2012-2#1)(2013-8#1)
to mothers and##3##3##(2011-2#1)(2013-1#2)
to mothers from the control##2##5##(2006-8#1)(2011-1#1)
to mothers from the##3##4##(2006-8#2)(2011-1#1)
to mothers from##4##3##(1990-2#1)(2006-8#2)(2011-1#1)
to mothers of##2##3##(2008-7#1)(2011-1#1)
to mothers with##2##3##(1990-10#1)(2008-4#1)
to mothers##21##2##(1990-10#1)(1990-2#1)(1991-7#1)(1992-2#1)(1992-5#1)(1995-1#1)(2006-8#2)(2007-2#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#2)
to mothers'##3##2##(2008-11#1)(2009-10#1)(2010-10#1)
to motion##3##2##(1992-2#1)(2007-12#1)(2008-11#1)
to motivate patients to##2##4##(1993-11#1)(2008-3#1)
to motivate the##5##3##(1996-3#1)(2008-3#1)(2008-8#1)(2010-5#1)(2011-2#1)
to motivate##12##2##(1993-11#1)(1996-3#1)(2006-1#1)(2006-2#1)(2006-5#1)(2007-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-5#1)(2011-2#1)
to motivation##2##2##(2008-10#1)(2008-4#1)
to motor##16##2##(1991-1#1)(1992-11#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-1#1)(2006-10#2)(2007-12#1)(2007-8#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-2#1)
to mount a##5##3##(1997-6#1)(2006-10#2)(2008-10#1)(2009-12#1)
to mount an##2##3##(1997-6#1)(2008-4#1)
to mount the##2##3##(1993-7#1)(2008-2#1)
to mount##16##2##(1991-10#1)(1993-7#1)(1994-12#1)(1997-6#2)(2006-10#4)(2008-10#1)(2008-2#1)(2008-4#2)(2008-9#1)(2009-12#1)(2009-9#1)
to mouse and human##3##4##(1991-12#1)(2010-7#1)(2013-8#1)
to mouse and##5##3##(1991-12#1)(1994-12#1)(1994-9#1)(2010-7#1)(2013-8#1)
to mouse brain##2##3##(1990-2#1)(2010-2#1)
to mouse macrophages##2##3##(1995-2#1)(2008-4#1)
to mouse##41##2##(1990-11#1)(1990-2#1)(1990-3#2)(1991-1#1)(1991-12#1)(1992-4#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-12#5)(1994-5#1)(1994-9#3)(1995-2#2)(1995-7#1)(1996-10#1)(1997-9#1)(2008-11#2)(2008-4#4)(2008-7#1)(2008-9#1)(2010-1#1)(2010-2#1)(2010-7#1)(2013-8#1)
to mouth##6##2##(2006-10#5)(2008-11#1)
to move a##2##3##(1997-6#1)(2008-9#1)
to move about##2##3##(1993-4#1)(2007-7#1)
to move beyond the##2##4##(1992-2#1)(1993-12#1)
to move beyond##5##3##(1992-2#1)(1993-12#1)(1994-1#1)(2009-8#1)(2013-1#1)
to move forward##2##3##(1996-1#1)(2011-1#1)
to move freely##2##3##(1996-1#1)(2008-8#1)
to move from the##2##4##(1991-7#1)(2008-10#1)
to move from##7##3##(1991-7#1)(1995-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-3#1)
to move in##3##3##(1991-11#1)(2007-12#1)(2009-8#1)
to move into##3##3##(1994-5#1)(2008-1#1)(2008-8#1)
to move the##8##3##(2006-6#2)(2008-12#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-2#1)
to move to a##2##4##(2008-7#1)(2010-10#1)
to move to##3##3##(2008-7#1)(2010-10#1)(2012-2#1)
to move toward the##3##4##(2007-10#1)(2008-10#1)(2011-2#1)
to move toward##5##3##(1994-1#1)(1995-2#1)(2007-10#1)(2008-10#1)(2011-2#1)
to move towards##2##3##(2008-10#1)(2008-3#1)
to move##78##2##(1990-12#1)(1991-11#1)(1991-6#1)(1991-7#1)(1992-10#1)(1992-2#1)(1992-7#1)(1993-12#1)(1993-4#1)(1994-1#2)(1994-12#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#2)(1997-1#2)(1997-4#2)(1997-6#2)(2005-8#1)(2006-12#1)(2006-6#2)(2007-10#2)(2007-11#2)(2007-12#4)(2007-2#1)(2007-4#2)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-8#2)(2010-10#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
to movement disorders##2##3##(2008-11#2)
to movement##10##2##(1991-1#1)(1996-8#1)(2006-7#2)(2008-10#1)(2008-11#2)(2008-6#1)(2008-8#1)(2011-2#1)
to movements##2##2##(1995-5#1)(2012-1#1)
to moving##7##2##(1990-4#1)(2008-2#1)(2008-8#3)(2009-5#1)(2011-1#1)
to moxidectin##2##2##(1993-10#2)
to mu 1 and mu 2 opiate##2##7##(1996-8#2)
to mu 1 and mu 2##3##6##(1996-8#3)
to mu 1##4##3##(1996-8#4)
to mu##5##2##(1992-9#1)(1996-8#4)
to much higher##2##3##(1994-3#1)(1995-2#1)
to much of##2##3##(2005-7#1)(2009-4#1)
to much##10##2##(1994-3#1)(1995-2#1)(1996-8#1)(2005-7#1)(2006-4#1)(2008-11#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-9#1)
to mucosa##2##2##(1990-9#1)(2008-5#1)
to mucosal##3##2##(2006-12#1)(2008-4#1)(2008-5#1)
to mud##2##2##(2007-5#1)(2008-3#1)
to multi-organ failure##2##3##(1993-2#1)(2012-12#1)
to multi-organ##3##2##(1993-2#1)(2007-11#1)(2012-12#1)
to multilayer##3##2##(2007-11#1)(2008-2#2)
to multimorbidity##4##2##(2013-1#4)
to multiorgan##3##2##(1996-8#1)(2008-10#1)(2012-12#1)
to multiple antibiotics##2##3##(2007-8#1)(2011-2#1)
to multiple components of##2##4##(1995-1#1)(2013-8#1)
to multiple components##3##3##(1995-1#1)(1996-2#1)(2013-8#1)
to multiple infections##2##3##(2008-10#1)(2008-4#1)
to multiple myeloma##2##3##(2006-12#2)
to multiple organ##2##3##(2006-10#1)(2012-1#1)
to multiple sclerosis##3##3##(1991-7#1)(2008-11#1)(2010-12#1)
to multiple targets##2##3##(2008-10#1)(2009-8#1)
to multiple##99##2##(1990-10#1)(1990-12#1)(1990-4#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-8#2)(1992-11#1)(1992-3#2)(1994-12#1)(1994-3#1)(1995-1#2)(1995-2#1)(1995-8#1)(1996-2#2)(1997-4#2)(2005-11#1)(2005-8#2)(2006-10#3)(2006-12#4)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-11#4)(2007-12#2)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#3)(2010-12#1)(2010-2#3)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
to multiplex##3##2##(2008-2#2)(2008-3#1)
to multiplexing##2##2##(2008-4#1)(2012-2#1)
to multiply and##2##3##(2008-10#1)(2012-12#1)
to multiply in the##2##4##(1995-2#1)(2006-8#1)
to multiply in##5##3##(1995-2#1)(2006-8#1)(2008-10#2)(2013-8#1)
to multiply the##3##3##(1996-6#1)(2008-3#1)(2009-10#1)
to multiply##16##2##(1993-2#1)(1995-2#1)(1996-6#1)(2006-4#1)(2006-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#1)(2012-12#1)(2013-8#1)
to multisystem##2##2##(2009-6#1)(2012-3#1)
to multivariate analyses##2##3##(2006-4#1)(2008-10#1)
to multivariate analysis##4##3##(1995-9#1)(2008-10#1)(2008-7#1)(2009-6#1)
to multivariate##11##2##(1995-9#1)(2006-4#1)(2008-10#6)(2008-7#1)(2009-4#1)(2009-6#1)
to multiwavelength##2##2##(2006-5#1)(2008-2#1)
to murine cyclin D3##2##4##(1997-4#2)
to murine##16##2##(1991-3#1)(1992-12#1)(1993-4#1)(1995-2#2)(1995-5#1)(1996-10#1)(1997-1#1)(1997-4#2)(1997-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)
to muscarinic receptor##2##3##(1996-6#1)(1997-5#1)
to muscarinic receptors in##3##4##(1995-11#1)(1997-5#1)(2008-3#1)
to muscarinic receptors##4##3##(1995-11#1)(1997-5#1)(2007-1#1)(2008-3#1)
to muscarinic##10##2##(1990-10#1)(1990-2#1)(1990-7#1)(1995-11#1)(1996-2#1)(1996-6#1)(1997-5#2)(2007-1#1)(2008-3#1)
to muscle and##2##3##(2010-8#1)(2010-9#1)
to muscle contraction##2##3##(1996-10#1)(2008-6#1)
to muscle fiber##2##3##(2010-4#2)
to muscle##21##2##(1991-10#1)(1991-11#1)(1993-2#1)(1996-10#1)(1996-5#1)(1997-8#1)(2005-10#1)(2007-8#1)(2008-1#1)(2008-4#2)(2008-6#1)(2008-7#2)(2009-10#1)(2010-4#2)(2010-8#2)(2010-9#1)(2012-1#1)
to muscular and##3##3##(2007-12#2)(2007-7#1)
to muscular##6##2##(2007-12#5)(2007-7#1)
to musculoskeletal##2##2##(1992-9#1)(2006-10#1)
to music after implantation##2##4##(2008-9#2)
to music##12##2##(1991-12#1)(2007-6#6)(2008-9#3)(2010-3#1)(2010-8#1)
to mustard##2##2##(2007-2#1)(2011-12#1)
to mutagenic##6##2##(1990-6#2)(1993-11#1)(1996-6#1)(2008-7#1)(2011-1#1)
to mutagens##2##2##(1993-4#1)(1993-9#1)
to mutant##4##2##(1991-8#1)(1994-8#1)(1996-6#1)(2011-2#1)
to mutants##2##2##(1995-5#1)(2008-9#1)
to mutation##12##2##(1990-8#1)(1991-4#2)(1994-5#1)(1997-3#3)(2008-9#1)(2012-2#3)(2013-1#1)
to mutations in the##5##4##(1994-11#1)(2008-11#1)(2009-11#1)(2011-1#1)(2012-2#1)
to mutations in##11##3##(1994-11#1)(1994-12#1)(1996-2#1)(2008-11#2)(2008-7#1)(2009-11#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
to mutations or##2##3##(2006-9#1)(2008-10#1)
to mutations##20##2##(1994-11#1)(1994-12#1)(1996-11#1)(1996-2#1)(2006-12#1)(2006-2#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#2)(2009-11#1)(2009-3#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
to mutual##4##2##(1992-11#1)(1997-7#1)(2008-3#1)(2010-4#1)
to my knowledge##4##3##(2008-2#3)(2008-3#1)
to my##11##2##(1997-2#2)(1997-3#1)(2007-2#1)(2008-2#3)(2008-3#1)(2011-2#1)(2013-7#1)(2013-8#1)
to mycobacteria##3##2##(2005-7#1)(2007-7#1)(2011-2#1)
to mycobacterial##6##2##(1990-5#2)(1994-11#1)(2006-8#1)(2011-2#1)(2013-8#1)
to mycophenolate mofetil##2##3##(1996-8#1)(2008-1#1)
to mycotic##2##2##(2006-1#1)(2010-2#1)
to myelin##4##2##(1991-12#1)(1995-12#1)(1995-6#1)(2012-2#1)
to myoblasts##2##2##(1990-10#1)(2009-9#1)
to myocardial infarction##3##3##(1991-6#1)(1993-12#1)(2012-2#1)
to myocardial ischemia and##2##4##(1995-6#1)(2007-8#1)
to myocardial ischemia##4##3##(1995-6#1)(2007-8#1)(2008-7#1)(2010-5#1)
to myocardial##14##2##(1991-6#1)(1993-12#1)(1995-6#1)(1996-3#1)(1996-9#1)(2006-10#1)(2007-8#3)(2008-7#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
to myofibroblasts##3##2##(2006-10#1)(2009-8#1)(2012-12#1)
to myosin light chains##5##4##(2008-4#5)
to myosin light##6##3##(1990-11#1)(2008-4#5)
to myotubes##2##2##(1996-4#2)
to n =##2##3##(2005-11#1)(2009-9#1)
to n##4##2##(1994-6#1)(2005-11#1)(2007-11#1)(2009-9#1)
to n-3##2##2##(2013-1#2)
to naive and##2##3##(1996-9#1)(2010-12#1)
to naive##11##2##(1991-12#1)(1994-3#1)(1995-12#2)(1996-9#1)(2008-10#3)(2010-12#1)(2011-2#2)
to naked##3##2##(1992-12#1)(2010-5#1)(2013-1#1)
to nalidixic acid##2##3##(1995-8#1)(2012-3#1)
to name a few##5##4##(2006-10#1)(2006-6#1)(2008-7#1)(2008-9#1)(2009-3#1)
to name a new##2##4##(1996-12#1)(2008-4#1)
to name a##8##3##(1996-12#1)(2006-10#2)(2006-6#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)
to name the##3##3##(1991-4#1)(1995-11#1)(2007-12#1)
to name##18##2##(1991-4#1)(1994-12#1)(1994-8#1)(1995-11#1)(1996-12#1)(2005-8#1)(2006-10#2)(2006-6#1)(2007-12#2)(2008-4#3)(2008-7#1)(2008-9#1)(2009-3#1)(2012-12#1)
to nanomolar concentrations of##4##4##(1990-12#1)(1994-12#1)(1994-3#1)(1994-6#1)
to nanomolar##5##2##(1990-12#1)(1994-12#1)(1994-3#1)(1994-6#1)(1996-5#1)
to nanoparticles##2##2##(2008-9#1)(2013-1#1)
to nanoscale##2##2##(2006-6#1)(2010-11#1)
to nanotechnology##3##2##(2010-12#2)(2010-7#1)
to narcotic##2##2##(1991-2#1)(2012-3#1)
to naringenin##3##2##(2008-11#3)
to narrate##2##2##(2008-1#1)(2013-1#1)
to narrow down the##2##4##(2008-8#1)(2011-2#1)
to narrow the spectral##2##4##(2007-12#1)(2008-2#1)
to narrow the##7##3##(1993-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)
to narrow##14##2##(1993-12#1)(1997-1#2)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-8#1)(2011-2#1)
to nasal##7##2##(1990-7#1)(1990-9#1)(1995-11#1)(1997-4#1)(2007-12#1)(2009-6#1)(2009-9#1)
to nascent##2##2##(1993-3#1)(2011-2#1)
to national norms and##2##4##(1996-2#1)(2010-3#1)
to national norms##4##3##(1994-3#2)(1996-2#1)(2010-3#1)
to national standards##3##3##(1993-1#1)(1994-3#2)
to national##20##2##(1993-1#1)(1994-3#4)(1995-1#1)(1996-2#1)(2005-5#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#1)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
to native uPA##3##3##(2008-11#3)
to native##30##2##(1990-4#1)(1990-5#1)(1990-7#2)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-6#2)(1995-11#1)(1995-8#1)(1996-5#1)(1997-8#2)(2006-10#1)(2007-2#1)(2007-8#1)(2008-11#3)(2008-5#2)(2009-8#1)(2009-9#2)(2010-11#1)(2010-4#1)(2012-2#1)
to natural and##7##3##(1992-6#1)(1993-6#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-8#1)(2012-3#1)
to natural enemies##2##3##(2008-9#1)(2011-12#1)
to natural selection##3##3##(1997-4#1)(2008-10#1)(2008-8#1)
to natural stimuli##4##3##(1991-11#1)(2007-1#1)(2008-7#2)
to natural water samples##2##4##(2008-10#2)
to natural##48##2##(1990-12#1)(1991-11#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-9#2)(1996-5#1)(1997-4#1)(2005-9#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-2#2)(2007-5#1)(2008-10#10)(2008-2#1)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#1)(2010-12#1)(2011-12#1)(2012-12#4)(2012-3#1)(2013-1#4)(2013-8#1)
to naturally occurring##5##3##(1991-10#1)(2005-11#1)(2008-4#1)(2008-7#2)
to naturally##7##2##(1991-10#1)(1991-9#1)(2005-11#1)(2008-3#1)(2008-4#1)(2008-7#2)
to nature##4##2##(1996-2#1)(2007-3#1)(2008-8#2)
to navigate the##2##3##(2006-1#1)(2007-12#1)
to navigate##9##2##(1995-1#1)(1997-3#1)(2006-1#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-4#2)(2008-9#1)
to near control levels##2##4##(1994-12#1)(2011-2#1)
to near control##3##3##(1994-12#1)(1995-3#1)(2011-2#1)
to near homogeneity from the##2##5##(1990-8#1)(1996-5#1)
to near homogeneity from##5##4##(1990-5#2)(1990-8#1)(1993-11#1)(1996-5#1)
to near homogeneity##20##3##(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#2)(1991-5#1)(1992-11#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-3#2)(1994-8#1)(1996-10#1)(1996-5#1)(1997-1#1)(2008-4#1)(2012-2#1)
to near normal##2##3##(1990-5#1)(2011-2#1)
to near zero##3##3##(2008-10#2)(2008-9#1)
to near##41##2##(1990-5#3)(1990-7#1)(1990-8#1)(1991-1#2)(1991-2#3)(1991-5#1)(1992-11#1)(1993-11#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-3#1)(1996-10#1)(1996-5#1)(1997-1#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-2#1)(2011-2#2)(2012-2#1)(2013-1#2)
to near-infrared##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
to near-ultraviolet radiation##2##3##(1990-5#1)(1990-9#1)
to nearby##4##2##(1990-2#1)(1991-2#1)(1993-9#1)(2008-8#1)
to nearly 1##2##3##(2007-11#1)(2007-12#1)
to nearly##15##2##(1990-4#1)(1996-5#2)(2006-10#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2010-3#1)(2011-1#1)
to neck##2##2##(1995-6#1)(2007-6#1)
to necrosis##7##2##(1996-5#1)(2007-9#1)(2008-10#3)(2008-2#1)(2012-2#1)
to necrotic##3##2##(2008-10#1)(2008-6#1)(2012-2#1)
to necrotrophic##2##2##(2008-10#2)
to nectar##2##2##(1992-3#1)(2013-8#1)
to need##5##2##(1990-10#1)(2005-7#1)(2007-12#1)(2010-10#1)(2012-2#1)
to needed##3##2##(2007-12#1)(2007-5#1)(2009-12#1)
to needs##3##2##(1996-3#1)(2007-3#1)(2011-1#1)
to negate##3##2##(1994-9#1)(2004-3#1)(2013-1#1)
to negative effects##2##3##(2011-1#1)(2013-1#1)
to negative stimuli##2##3##(2008-4#1)(2010-3#1)
to negative##32##2##(1990-11#1)(1990-8#1)(1992-6#1)(1994-6#1)(1996-2#2)(1996-7#1)(1997-4#1)(2006-10#1)(2007-12#3)(2007-2#1)(2007-7#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#4)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#2)
to negatively charged##5##3##(1992-12#1)(1993-3#3)(2008-10#1)
to negatively impact##2##3##(2006-1#1)(2008-12#1)
to negatively influence##2##3##(2006-10#1)(2007-9#1)
to negatively regulate##3##3##(1995-6#1)(1997-7#1)(2013-1#1)
to negatively##15##2##(1992-12#1)(1993-3#3)(1995-6#1)(1997-7#1)(2006-1#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-9#1)(2011-1#1)(2012-1#1)(2013-1#1)
to neglect##3##2##(2005-11#1)(2006-2#1)(2008-1#1)
to negligible##4##2##(1992-8#1)(2006-10#1)(2008-11#1)(2010-8#1)
to negotiate##6##2##(1990-12#1)(1994-1#1)(1996-5#1)(2006-1#1)(2008-9#1)(2009-3#1)
to neighboring cells##3##3##(2008-10#2)(2008-4#1)
to neighboring##9##2##(1995-11#1)(2007-9#2)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)
to neighbors##5##2##(2008-1#1)(2008-8#4)
to neither##3##2##(1996-9#1)(2008-4#1)(2008-5#1)
to nematode##2##2##(2007-12#1)(2008-7#1)
to nematodes##2##2##(2006-10#1)(2008-10#1)
to neoadjuvant chemotherapy##5##3##(1993-11#1)(2004-2#1)(2008-12#1)(2008-9#1)(2010-12#1)
to neoadjuvant therapy##3##3##(2007-8#1)(2008-12#1)(2010-12#1)
to neoadjuvant##15##2##(1993-11#1)(2004-2#3)(2007-8#1)(2008-12#2)(2008-9#1)(2010-12#2)(2010-7#1)(2013-8#4)
to neocortical##2##2##(1991-9#1)(1997-6#1)
to neonatal intensive care unit##2##5##(1991-2#1)(2008-11#1)
to neonatal intensive care##4##4##(1991-2#1)(1993-5#1)(2008-11#1)(2013-1#1)
to neonatal##14##2##(1991-2#1)(1993-5#1)(1996-10#1)(1997-2#1)(2008-11#3)(2011-1#2)(2012-12#2)(2013-1#3)
to neoplasia##3##2##(1992-9#1)(1997-3#1)(2011-1#1)
to neoplastic transformation##2##3##(1992-2#1)(2010-3#1)
to neoplastic##5##2##(1991-3#1)(1992-2#1)(2006-2#1)(2010-3#1)(2013-1#1)
to nephrologists##2##2##(2007-7#1)(2008-4#1)
to nephrology##3##2##(2008-1#2)(2012-1#1)
to nephropathy##2##2##(2007-8#1)(2008-1#1)
to nerve cell##2##3##(1994-12#1)(2008-6#1)
to nerve growth factor (NGF)##6##5##(1991-11#1)(1996-5#2)(1997-2#1)(1997-8#1)(2008-11#1)
to nerve growth factor##9##4##(1991-11#1)(1996-5#2)(1997-2#1)(1997-6#1)(1997-8#1)(2008-11#1)(2010-12#2)
to nerve##27##2##(1990-10#2)(1991-11#1)(1991-3#1)(1993-11#1)(1993-7#3)(1994-12#1)(1995-11#1)(1996-5#2)(1997-2#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-11#1)(2006-8#1)(2007-11#2)(2008-11#2)(2008-6#1)(2010-12#2)(2010-2#1)(2012-1#1)
to nerves##2##2##(2006-12#1)(2010-7#1)
to nervous control##2##3##(1995-12#2)
to nervous##4##2##(1990-7#1)(1995-12#2)(2010-12#1)
to nest##3##2##(2008-8#2)(2008-9#1)
to net##6##2##(1990-3#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-9#1)
to network##4##2##(2008-2#1)(2008-3#1)(2010-1#1)(2013-1#1)
to neural and##3##3##(1991-1#1)(2007-8#1)(2013-8#1)
to neural coding##2##3##(1991-6#1)(2008-1#1)
to neural stem cell##2##4##(2008-1#1)(2009-10#1)
to neural##21##2##(1990-5#2)(1990-9#1)(1991-1#1)(1991-6#1)(1992-8#1)(1993-6#1)(1996-12#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-6#1)(2009-10#1)(2009-8#1)(2012-12#2)(2012-2#1)(2013-8#2)
to neurite##4##2##(1992-6#1)(1995-11#2)(2007-10#1)
to neuroblastoma cells##2##3##(1991-9#1)(1992-11#1)
to neurodegeneration in##3##3##(2007-12#1)(2008-11#1)(2008-7#1)
to neurodegenerative disorders##3##3##(2008-7#1)(2009-8#1)(2010-11#1)
to neurodegenerative##6##2##(1996-6#1)(2008-7#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)
to neurodevelopmental##2##2##(2008-6#1)(2011-12#1)
to neurofilament##2##2##(1991-1#1)(1996-5#1)
to neurogenic##2##2##(2007-10#1)(2011-12#1)
to neuroleptic##2##2##(2008-1#1)(2008-2#1)
to neuroleptics##2##2##(1993-8#1)(2008-9#1)
to neurologic##2##2##(2006-10#1)(2008-7#1)
to neurological diseases##2##3##(1993-2#1)(2011-2#1)
to neurological impairment##2##3##(1997-6#1)(2009-4#1)
to neurological##10##2##(1992-11#1)(1993-2#1)(1997-6#1)(2007-11#1)(2009-4#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-11#1)(2013-7#1)
to neuromuscular blocking agents##3##4##(1996-9#2)(2013-1#1)
to neuromuscular##4##2##(1996-9#2)(1997-4#1)(2013-1#1)
to neuron##2##2##(2008-3#1)(2008-5#1)
to neuronal cell death##5##4##(1995-11#1)(1995-12#1)(2008-11#1)(2009-12#1)(2012-12#1)
to neuronal cell##6##3##(1995-11#1)(1995-12#1)(2004-12#1)(2008-11#1)(2009-12#1)(2012-12#1)
to neuronal cells##2##3##(1995-12#1)(2005-8#1)
to neuronal damage##4##3##(2004-12#1)(2006-3#1)(2007-11#1)(2011-1#1)
to neuronal death##2##3##(1991-1#1)(1994-11#1)
to neuronal##27##2##(1991-1#1)(1993-11#2)(1993-2#1)(1994-11#1)(1995-11#1)(1995-12#2)(1995-5#1)(1995-8#1)(1997-6#1)(2004-12#2)(2005-8#1)(2006-3#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-7#2)(2009-12#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
to neurons and oligodendrocytes##2##4##(1995-7#1)(2008-11#1)
to neurons and##3##3##(1990-11#1)(1995-7#1)(2008-11#1)
to neurons of the central##2##5##(1994-11#1)(2008-4#1)
to neurons of the##3##4##(1993-2#1)(1994-11#1)(2008-4#1)
to neurons of##4##3##(1991-11#1)(1993-2#1)(1994-11#1)(2008-4#1)
to neurons##18##2##(1990-11#1)(1991-11#1)(1993-2#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-6#1)(1995-7#1)(2007-12#1)(2008-11#3)(2008-4#1)(2010-12#1)(2012-12#3)
to neuropathic pain##2##3##(2008-12#1)(2010-4#1)
to neuropathic##3##2##(2008-12#1)(2010-3#1)(2010-4#1)
to neuropeptide Y Y1 and##2##5##(1996-12#2)
to neuropeptide Y##3##3##(1996-12#2)(1997-5#1)
to neuropsychological##2##2##(1996-3#1)(2011-2#1)
to neuroscience##2##2##(1990-8#1)(2007-10#1)
to neurosurgeons##3##2##(2006-7#1)(2008-7#1)(2013-1#1)
to neurosurgery##3##2##(2007-5#1)(2009-8#1)(2011-1#1)
to neurosurgical##2##2##(2005-10#1)(2007-10#1)
to neurotrophins##2##2##(1995-11#1)(1996-5#1)
to neutral hydrolysis##2##3##(1996-8#1)(2010-2#1)
to neutral##20##2##(1991-3#1)(1992-6#1)(1993-11#1)(1994-9#1)(1996-8#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2009-11#1)(2009-3#2)(2010-12#1)(2010-2#1)(2010-8#1)(2012-12#2)(2012-3#1)(2013-8#1)
to neutralise##4##2##(2006-4#2)(2007-11#2)
to neutralize HF in the microwave-assisted acid dissolution of ceramic glazes for their chemical analysis##2##15##(2008-10#2)
to neutralize the##6##3##(1994-9#1)(1995-11#1)(1996-7#1)(2008-5#2)(2011-12#1)
to neutralize##14##2##(1993-11#1)(1994-9#1)(1995-11#1)(1996-7#1)(2007-12#1)(2008-10#3)(2008-5#3)(2010-8#1)(2011-12#1)(2012-12#1)
to never##2##2##(2007-8#1)(2008-11#1)
to never-smokers##2##2##(2010-2#1)(2013-4#1)
to new and##4##3##(1992-6#1)(2006-12#1)(2009-12#1)(2011-1#1)
to new applications in##2##4##(2007-8#1)(2008-3#1)
to new applications##3##3##(2007-8#1)(2008-3#1)(2008-9#1)
to new approaches##3##3##(2006-10#1)(2007-10#1)(2008-5#1)
to new areas##2##3##(2008-10#1)(2011-1#1)
to new cases##2##3##(2008-1#1)(2012-3#1)
to new environmental conditions##2##4##(2008-11#1)(2010-8#1)
to new forms of##3##4##(1993-8#1)(2006-10#1)(2007-6#1)
to new heterocyclic##2##3##(2007-11#1)(2012-3#1)
to new problems##2##3##(1996-3#1)(2006-10#1)
to new realities##2##3##(1995-3#1)(2008-9#1)
to new strategies for the##2##5##(2006-10#1)(2008-4#1)
to new strategies##3##3##(2006-10#1)(2008-11#1)(2008-4#1)
to new technologies##2##3##(2008-10#1)(2008-6#1)
to new therapeutic##5##3##(2006-10#1)(2008-1#1)(2010-5#1)(2011-2#1)(2012-2#1)
to new therapies##4##3##(2008-11#1)(2008-6#2)(2010-12#1)
to new treatment##2##3##(2006-10#1)(2006-9#1)
to new ways##2##3##(1996-4#1)(2012-2#1)
to new##137##2##(1990-3#1)(1990-6#1)(1991-11#2)(1992-1#1)(1992-6#2)(1993-2#1)(1993-8#1)(1995-2#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-3#4)(1996-4#1)(1996-6#1)(1996-7#1)(1997-3#2)(2005-11#2)(2005-7#2)(2005-8#1)(2006-1#2)(2006-10#11)(2006-12#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#6)(2008-10#9)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#3)(2008-8#2)(2008-9#3)(2009-12#2)(2009-4#1)(2009-5#1)(2009-8#2)(2010-12#4)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#3)(2013-1#4)(2013-8#3)
to newborn##3##2##(2008-10#1)(2011-1#1)(2012-3#1)
to newly##4##2##(1996-6#1)(2004-8#1)(2007-12#1)(2013-7#1)
to ng/mL##2##2##(1993-1#1)(2012-12#1)
to nickel##3##2##(2008-10#3)
to nicotine (0##2##3##(1994-2#1)(1996-10#1)
to nicotine and##5##3##(1990-7#1)(1996-10#1)(2008-5#1)(2009-6#1)(2011-2#1)
to nicotine##17##2##(1990-7#1)(1994-2#2)(1994-3#1)(1995-12#3)(1996-10#3)(2007-2#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-8#1)(2011-2#1)(2013-1#1)
to nicotinic acid##2##3##(2008-5#1)(2013-1#1)
to nicotinic receptors##3##3##(1996-12#3)
to nicotinic##6##2##(1996-12#3)(2008-5#1)(2012-2#1)(2013-1#1)
to night temperatures##2##3##(2012-5#2)
to nil##2##2##(2008-10#1)(2008-12#1)
to nine years##2##3##(1994-12#1)(2013-1#1)
to nine##28##2##(1991-5#1)(1994-12#1)(1994-9#1)(1995-9#1)(1996-12#2)(1996-9#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-11#2)(2008-5#3)(2008-7#1)(2008-9#1)(2009-12#1)(2010-9#1)(2012-2#1)(2013-1#1)
to nipple feeding##4##3##(2010-5#4)
to nitrate##9##2##(1992-6#2)(2007-11#1)(2008-10#5)(2010-5#1)
to nitric acid##2##3##(2008-10#2)
to nitric oxide (NO) and##2##5##(1993-6#1)(2008-10#1)
to nitric oxide (NO)##3##4##(1993-6#1)(2008-10#2)
to nitric oxide##14##3##(1991-9#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1996-3#1)(2005-7#1)(2007-11#1)(2008-10#3)
to nitric##16##2##(1991-9#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1996-3#1)(2005-7#1)(2007-11#1)(2008-10#5)
to nitrite and dioxygen##2##4##(2010-5#2)
to nitrite and##4##3##(2005-11#1)(2008-10#1)(2010-5#2)
to nitrite in##2##3##(1993-11#1)(2008-10#1)
to nitrite##17##2##(1993-11#1)(2005-11#1)(2007-2#1)(2008-10#12)(2010-5#2)
to nitrocellulose membranes##2##3##(1990-12#1)(2005-7#1)
to nitrocellulose##10##2##(1990-11#1)(1990-12#1)(1990-7#2)(1990-9#1)(1991-6#1)(1993-12#1)(1996-11#1)(2005-7#1)(2008-4#1)
to nitrogen dioxide##2##3##(2008-10#2)
to nitrogen##10##2##(1990-2#1)(1991-7#1)(1996-4#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2010-12#1)
to nitroglycerin##3##2##(1996-12#3)
to no longer##2##3##(2004-3#1)(2013-8#1)
to no response##2##3##(1992-6#1)(2007-7#1)
to no##29##2##(1990-5#1)(1991-1#1)(1991-6#1)(1992-6#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-7#1)(2004-3#1)(2005-10#1)(2006-3#1)(2007-1#1)(2007-12#1)(2007-6#2)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-6#1)(2010-2#1)(2010-5#2)(2012-3#1)(2013-7#1)(2013-8#1)
to nociceptive##3##2##(1993-5#1)(2008-7#1)(2013-8#1)
to noise and##9##3##(2007-12#1)(2008-2#4)(2008-3#3)(2009-4#1)
to noise is##2##3##(2008-2#1)(2008-9#1)
to noise level##2##3##(2008-10#1)(2010-8#1)
to noise ratio of##5##4##(2007-8#1)(2008-10#2)(2008-7#1)(2011-1#1)
to noise ratio##15##3##(2005-4#2)(2007-1#1)(2007-8#1)(2008-10#7)(2008-7#1)(2008-9#1)(2011-1#2)
to noise##49##2##(2005-11#1)(2005-4#2)(2007-1#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-2#10)(2008-3#6)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-4#1)(2010-2#1)(2010-8#2)(2011-1#2)(2013-1#1)
to noise-induced hearing loss##3##4##(2007-4#3)
to non##8##2##(1992-7#1)(1993-9#1)(1996-12#1)(2007-1#1)(2008-10#1)(2011-1#2)(2013-1#1)
to non- or weakly adherent##2##5##(2006-8#2)
to non-B##3##2##(2006-8#3)
to non-NMDA##2##2##(1991-3#1)(1994-8#1)
to non-availability of##2##3##(2008-7#1)(2010-10#1)
to non-compliance##2##2##(1996-3#1)(2011-2#1)
to non-destructive##2##2##(2008-10#1)(2011-1#1)
to non-endemic areas##2##3##(2007-1#1)(2011-1#1)
to non-endemic##4##2##(2007-1#2)(2007-2#1)(2011-1#1)
to non-hospital sites##2##3##(1996-1#2)
to non-host##2##2##(2007-12#1)(2009-6#1)
to non-infected##2##2##(2005-7#1)(2008-12#1)
to non-invasively image##2##3##(2009-12#1)(2012-3#1)
to non-invasively##6##2##(1997-8#1)(2008-7#1)(2009-12#1)(2010-12#2)(2012-3#1)
to non-linear##2##2##(2008-10#1)(2008-11#1)
to non-liver##2##2##(1991-3#1)(2010-12#1)
to non-peptide##2##2##(1994-6#1)(1997-2#1)
to non-polar##5##2##(1993-2#2)(2008-10#1)(2009-12#1)(2009-7#1)
to non-pregnant##2##2##(1993-12#1)(2007-2#1)
to non-specific##8##2##(1993-12#1)(1994-2#1)(1994-9#1)(1997-5#1)(2005-9#1)(2007-12#1)(2008-10#1)(2012-2#1)
to non-steroidal anti-inflammatory drugs##2##4##(2006-10#1)(2007-4#1)
to non-target##2##2##(2006-12#1)(2011-12#1)
to noncontact##2##2##(2006-3#1)(2007-12#1)
to nondiabetics##2##2##(2006-6#1)(2011-2#1)
to none##2##2##(1997-7#1)(2013-8#1)
to nonhuman primates##2##3##(2006-10#1)(2007-8#1)
to nonhuman##3##2##(2006-10#1)(2007-8#1)(2009-2#1)
to nonignorable crossover##2##3##(2005-11#2)
to noninvasive##4##2##(1997-4#1)(2008-2#1)(2008-3#1)(2013-1#1)
to noninvasively##6##2##(1993-4#1)(2007-11#1)(2007-4#1)(2010-8#1)(2012-2#2)
to nonionic##3##2##(2008-10#2)(2008-11#1)
to nonlinear##9##2##(2007-12#1)(2008-10#1)(2008-3#4)(2008-7#1)(2009-10#1)(2012-12#1)
to nonlinearities##2##2##(2006-6#1)(2007-11#1)
to nonpermissive temperature##2##3##(1990-5#1)(1995-3#1)
to nonprofit##2##2##(1993-1#1)(1996-2#1)
to nonspecific##7##2##(1991-9#1)(1993-8#1)(1994-9#1)(1995-8#1)(2005-8#1)(2008-2#1)(2009-5#1)
to nonspherical##2##2##(2008-2#1)(2008-7#1)
to nonsteroidal antiinflammatory##2##3##(2006-10#1)(2008-3#1)
to nonsurgical##2##2##(2007-12#1)(2008-1#1)
to nontexture features##2##3##(2008-2#2)
to nontransgenic##2##2##(1995-2#1)(2008-10#1)
to noradrenaline##13##2##(1990-10#1)(1990-5#1)(1993-11#4)(1995-9#1)(1996-12#1)(1997-4#1)(2009-5#4)
to norepinephrine##8##2##(1992-1#1)(1992-6#1)(1993-7#1)(1994-12#1)(1994-8#2)(1995-7#1)(2005-10#1)
to normal after##4##3##(1990-7#1)(2005-12#1)(2006-10#1)(2013-1#1)
to normal aging##2##3##(1992-10#1)(1996-2#1)
to normal and##8##3##(1994-9#1)(1995-12#1)(2006-10#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
to normal at 120 days##2##5##(1996-5#2)
to normal at##3##3##(1990-7#1)(1996-5#2)
to normal breast##2##3##(1990-12#1)(1993-11#1)
to normal by##2##3##(1992-4#1)(2008-9#1)
to normal cats##2##3##(1990-4#2)
to normal cells##5##3##(1990-7#1)(1995-1#1)(2005-7#1)(2009-10#1)(2012-3#1)
to normal controls##7##3##(1990-12#1)(1995-12#2)(1996-4#1)(2008-11#1)(2008-8#2)
to normal epithelium##2##3##(1991-7#1)(2007-5#1)
to normal fibroblasts##2##3##(1992-8#2)
to normal from the third##2##5##(1997-2#1)(2007-1#1)
to normal from##3##3##(1992-8#1)(1997-2#1)(2007-1#1)
to normal human##4##3##(1994-8#1)(2008-11#1)(2008-5#1)(2010-3#1)
to normal in##9##3##(1990-11#1)(1991-3#1)(1991-5#1)(1993-11#1)(1993-3#1)(2006-10#1)(2006-4#1)(2006-9#1)(2008-4#1)
to normal islets##2##3##(1990-8#2)
to normal levels following##2##4##(2010-2#2)
to normal levels##15##3##(1991-10#1)(1991-5#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-6#1)(1995-12#1)(1996-5#1)(2006-9#1)(2008-7#1)(2010-2#2)(2010-4#1)(2011-2#2)
to normal mice##3##3##(1990-11#1)(1993-7#1)(2010-12#1)
to normal or##2##3##(2007-8#1)(2012-2#1)
to normal saline##2##3##(2008-9#1)(2012-12#1)
to normal skin##3##3##(2008-5#3)
to normal subjects##5##3##(1990-8#1)(1994-11#1)(1995-11#1)(2007-8#1)(2008-5#1)
to normal tissue##5##3##(2005-12#1)(2007-12#1)(2008-2#1)(2010-3#1)(2012-2#1)
to normal tissues##3##3##(2007-4#1)(2008-1#1)(2010-9#1)
to normal values after##2##4##(1996-3#1)(2013-1#1)
to normal values##9##3##(1993-11#1)(1993-6#1)(1994-3#1)(1996-3#1)(1997-7#1)(2005-12#1)(2007-8#1)(2008-12#1)(2013-1#1)
to normal when##2##3##(1992-11#1)(2008-6#1)
to normal with##3##3##(2006-1#2)(2008-5#1)
to normal within##7##3##(1991-7#1)(1991-8#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#1)(1996-6#1)
to normal##233##2##(1990-10#5)(1990-11#2)(1990-12#4)(1990-2#2)(1990-3#2)(1990-4#3)(1990-7#3)(1990-8#3)(1990-9#1)(1991-10#1)(1991-3#1)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#2)(1992-3#3)(1992-4#2)(1992-5#1)(1992-8#3)(1993-1#1)(1993-11#6)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#2)(1993-7#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-3#2)(1994-4#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-5#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#3)(1996-6#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-1#1)(2004-9#2)(2005-12#3)(2005-7#1)(2006-1#3)(2006-10#4)(2006-4#1)(2006-6#2)(2006-9#2)(2007-1#2)(2007-11#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#7)(2008-12#2)(2008-2#3)(2008-4#4)(2008-5#11)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#5)(2009-1#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#2)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-1#3)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#6)(2013-8#1)
to normalise##3##2##(1991-5#1)(1995-3#1)(2010-10#1)
to normalization of the##2##4##(2010-12#1)(2012-1#1)
to normalization of##3##3##(2010-12#1)(2012-1#1)(2013-1#1)
to normalization##5##2##(1991-7#1)(2008-7#1)(2010-12#1)(2012-1#1)(2013-1#1)
to normalize blood pressure##2##4##(1990-1#1)(2006-10#1)
to normalize the results##2##4##(2008-10#1)(2008-3#1)
to normalize the##6##3##(1990-2#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#1)
to normalize##18##2##(1990-1#1)(1990-2#1)(1991-7#1)(1993-1#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#2)(2010-11#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
to normals##4##2##(1992-9#1)(1995-6#1)(1997-2#1)(2006-11#1)
to normotensives##3##2##(2007-1#1)(2009-5#1)(2012-2#1)
to normothermic##4##2##(1994-2#1)(1994-5#2)(1996-9#1)
to normoxia##3##2##(1994-5#1)(1996-12#1)(2010-8#1)
to norms##2##2##(1995-2#1)(2011-12#1)
to northern##2##2##(1996-4#1)(2008-10#1)
to not only##8##3##(1997-6#1)(2007-7#1)(2008-2#1)(2008-7#1)(2011-12#1)(2012-1#1)(2013-1#2)
to not##21##2##(1990-2#1)(1993-8#1)(1994-11#1)(1995-5#2)(1997-6#1)(2006-10#1)(2007-1#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-4#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#2)
to note that the##6##4##(1995-11#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-4#1)(2011-2#1)
to note that##17##3##(1994-3#1)(1995-11#1)(1996-12#1)(1996-9#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-4#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-2#1)
to note the##3##3##(2007-7#1)(2008-6#1)(2013-8#1)
to note##25##2##(1992-2#1)(1994-3#1)(1995-11#1)(1996-12#1)(1996-9#1)(1997-7#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-8#1)
to notice##2##2##(1990-7#1)(2009-4#1)
to notify##5##2##(1991-10#1)(2006-7#1)(2008-1#1)(2010-3#1)(2010-8#1)
to novel and##2##3##(1995-12#1)(2008-7#1)
to novel approaches##2##3##(2007-11#1)(2011-2#1)
to novel methods##2##3##(2007-12#1)(2008-10#1)
to novel##38##2##(1991-11#1)(1991-9#1)(1992-4#1)(1993-6#2)(1994-2#1)(1995-12#2)(1995-7#1)(1997-6#1)(1997-7#1)(2005-7#2)(2006-10#3)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-2#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
to novelty in##2##3##(1993-6#1)(1994-2#1)
to novelty##10##2##(1993-5#2)(1993-6#6)(1994-2#2)
to now##36##2##(1990-8#1)(1991-10#1)(1991-6#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-5#1)(1993-7#1)(1994-4#1)(1995-9#1)(1996-11#1)(2006-10#1)(2006-2#2)(2006-6#1)(2007-3#1)(2007-7#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-7#1)(2011-1#2)(2011-2#3)(2013-8#1)
to noxious heat##4##3##(1991-11#1)(2006-10#1)(2008-7#1)(2009-3#1)
to noxious stimuli##7##3##(1990-4#1)(1993-2#1)(1996-3#1)(1997-2#1)(2006-10#1)(2008-4#1)(2012-1#1)
to noxious##16##2##(1990-4#1)(1991-11#1)(1993-2#1)(1996-3#1)(1997-2#2)(2005-11#1)(2006-10#2)(2008-4#1)(2008-5#2)(2008-7#2)(2009-3#1)(2012-1#1)
to nuclear extracts##2##3##(1991-1#1)(1995-6#1)
to nuclear medicine##2##3##(1993-2#1)(2008-2#1)
to nuclear##23##2##(1991-1#1)(1991-5#1)(1992-4#1)(1992-5#1)(1993-2#1)(1994-9#3)(1995-6#3)(1995-8#1)(1997-4#1)(2005-7#1)(2007-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#2)(2012-2#1)
to nucleases##3##2##(2008-11#1)(2008-4#2)
to nucleate##2##2##(1997-2#1)(2007-12#1)
to nuclei##3##2##(1990-2#1)(1990-8#1)(1993-6#1)
to nucleic acid##6##3##(2006-10#1)(2007-11#1)(2008-4#2)(2008-9#1)(2011-1#1)
to nucleic acids##4##3##(1991-8#1)(1997-6#1)(2008-4#2)
to nucleic##10##2##(1991-8#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-4#4)(2008-9#1)(2011-1#1)
to nucleoside monophosphates##2##3##(1991-5#1)(2008-4#1)
to nucleoside##5##2##(1991-5#1)(1994-8#1)(1996-2#1)(2008-1#1)(2008-4#1)
to nucleotide sequencing##2##3##(1996-12#1)(2006-10#1)
to nucleotide##11##2##(1992-11#1)(1993-11#2)(1996-11#1)(1996-12#1)(1997-1#1)(1997-8#1)(2006-10#1)(2007-6#1)(2008-10#1)(2008-9#1)
to nucleotides##2##2##(1995-3#1)(2008-4#1)
to nucleus##10##2##(1991-2#2)(1992-8#2)(2007-11#1)(2008-7#1)(2008-8#1)(2008-9#3)
to nude mice##2##3##(1994-11#2)
to nude mouse##2##3##(2012-3#2)
to nude##4##2##(1994-11#2)(2012-3#2)
to null##2##2##(2007-11#1)(2008-3#1)
to nulliparous women##2##3##(1996-7#1)(1997-7#1)
to number of##5##3##(1995-9#1)(2006-5#1)(2008-10#2)(2008-5#1)
to number##8##2##(1991-7#1)(1995-9#1)(2006-5#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-5#1)
to numerical##3##2##(2007-11#1)(2008-3#1)(2008-8#1)
to numerous##23##2##(1994-8#1)(1997-1#1)(2005-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-4#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
to nurse education##2##3##(2008-11#1)(2008-12#1)
to nurse##10##2##(1994-2#1)(2006-5#1)(2008-11#2)(2008-12#1)(2011-2#2)(2012-3#1)(2013-8#2)
to nurse-delivered screening##2##3##(2012-11#2)
to nurses and##4##3##(2007-10#1)(2008-7#1)(2013-1#2)
to nurses in##2##3##(2004-9#1)(2005-7#1)
to nurses##10##2##(2004-9#1)(2005-12#1)(2005-7#1)(2007-10#1)(2008-1#1)(2008-12#1)(2008-7#1)(2010-8#1)(2013-1#2)
to nursing education##3##3##(1996-3#1)(2008-1#1)(2010-3#1)
to nursing home##2##3##(1993-12#1)(2008-11#1)
to nursing homes is##2##4##(1990-12#2)
to nursing homes##8##3##(1990-12#4)(1994-12#2)(1994-2#1)(1995-1#1)
to nursing practice and##2##4##(1990-8#1)(2009-8#1)
to nursing practice##3##3##(1990-8#1)(2009-8#1)(2013-8#1)
to nursing##35##2##(1990-12#4)(1990-8#1)(1993-12#1)(1994-12#2)(1994-2#1)(1994-3#2)(1995-1#1)(1995-9#1)(1996-3#1)(2005-6#1)(2007-10#3)(2008-1#2)(2008-11#4)(2008-12#4)(2009-8#1)(2010-3#3)(2011-2#2)(2013-8#1)
to nurture##2##2##(2008-3#1)(2008-8#1)
to nutrient##11##2##(1991-11#1)(2004-2#1)(2007-3#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2010-7#1)(2012-12#1)
to nutrients##2##2##(2008-10#1)(2008-9#1)
to nutrition and##2##3##(2011-2#1)(2013-8#1)
to nutrition##9##2##(1990-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-2#2)(2013-8#1)
to nutritional##7##2##(1991-11#1)(1992-2#1)(1993-9#1)(2010-7#2)(2012-12#1)(2012-2#1)
to nylon##2##2##(1994-6#1)(2008-4#1)
to nystatin##3##2##(2007-7#1)(2008-5#2)
to obese##4##2##(2007-12#3)(2010-10#1)
to obesity and the##2##4##(2008-10#1)(2008-9#1)
to obesity or##2##3##(2009-12#1)(2011-2#1)
to obesity##16##2##(1990-5#1)(2006-1#1)(2006-2#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-2#1)(2011-1#2)(2011-2#1)
to obey##4##2##(1997-1#1)(2006-10#1)(2008-10#2)
to object recognition##3##3##(1995-8#2)(1997-8#1)
to object##10##2##(1992-10#1)(1995-8#3)(1997-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2012-1#1)
to objectify##2##2##(1990-9#1)(2010-3#1)
to objective##5##2##(1991-11#1)(2006-10#1)(2007-3#1)(2007-7#1)(2012-12#1)
to objectively assess patients'##2##4##(2008-11#1)(2009-1#1)
to objectively assess the##2##4##(2008-2#1)(2011-1#1)
to objectively assess##5##3##(2008-11#1)(2008-2#1)(2009-1#1)(2010-11#1)(2011-1#1)
to objectively quantify##4##3##(2008-11#1)(2010-7#1)(2012-1#2)
to objectively##17##2##(2006-12#1)(2007-10#1)(2007-3#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2009-1#1)(2010-11#1)(2010-7#1)(2011-1#1)(2012-1#4)(2012-3#1)
to objects##6##2##(1992-5#1)(1995-8#3)(2008-2#1)(2011-2#1)
to obliterate##2##2##(2007-8#1)(2008-7#1)
to obscure##4##2##(2006-7#1)(2008-10#1)(2009-10#1)(2012-3#1)
to observation##3##2##(1991-10#1)(2008-10#1)(2008-8#1)
to observations of##2##3##(1990-3#1)(2009-12#1)
to observations##3##2##(1990-3#1)(1991-5#1)(2009-12#1)
to observe a##7##3##(1992-5#1)(1995-8#1)(1996-3#1)(1997-2#1)(1997-4#1)(2008-3#1)(2008-8#1)
to observe and##6##3##(2006-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-6#1)(2011-1#1)
to observe living##2##3##(2008-1#1)(2008-11#1)
to observe that##4##3##(1992-6#1)(2008-11#1)(2012-12#1)(2013-1#1)
to observe the effect of##2##5##(2008-12#1)(2008-4#1)
to observe the effect##4##4##(2008-10#1)(2008-12#1)(2008-4#1)(2011-2#1)
to observe the effects of##3##5##(2008-9#1)(2011-2#2)
to observe the formation of##2##5##(1995-8#1)(2008-10#1)
to observe the presence##2##4##(2007-10#1)(2008-10#1)
to observe the##50##3##(1991-8#1)(1994-8#1)(1995-11#1)(1995-8#1)(1997-8#1)(2006-12#1)(2007-10#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#9)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#3)(2009-3#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#2)
to observe their##2##3##(2009-10#1)(2009-4#1)
to observe##122##2##(1991-8#1)(1991-9#1)(1992-5#1)(1992-6#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-8#2)(1996-11#1)(1996-3#1)(1996-8#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-8#1)(2006-1#1)(2006-12#3)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#2)(2007-10#3)(2007-11#3)(2007-12#4)(2007-3#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#19)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#3)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-3#1)(2009-4#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#6)
to observed weather patterns##2##4##(2008-10#2)
to observed##16##2##(1995-10#1)(1995-3#1)(1995-6#1)(1996-4#1)(2005-8#1)(2006-9#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-6#1)
to observing##3##2##(1996-8#1)(2006-12#1)(2008-2#1)
to obstetrics##2##2##(2007-5#1)(2012-12#1)
to obstruction of the##3##4##(1991-11#1)(2006-5#1)(2008-1#1)
to obstruction of##4##3##(1991-11#1)(2006-5#1)(2008-1#1)(2012-12#1)
to obstruction##8##2##(1991-11#1)(1997-1#1)(2006-5#1)(2008-1#1)(2008-10#1)(2010-12#1)(2011-2#1)(2012-12#1)
to obstructive##3##2##(2005-11#1)(2008-10#1)(2012-2#1)
to obtain 0##3##3##(1992-11#1)(2008-10#1)(2008-2#1)
to obtain PCR##2##3##(1993-6#1)(2008-10#1)
to obtain a better##2##4##(1996-3#1)(2007-6#1)
to obtain a complete##3##4##(2007-11#1)(2008-7#1)(2013-8#1)
to obtain a comprehensive##2##4##(1993-1#1)(2008-4#1)
to obtain a correct##2##4##(2008-2#1)(2008-5#1)
to obtain a deeper##2##4##(1993-2#1)(2008-8#1)
to obtain a definitive##2##4##(1997-3#1)(2006-10#1)
to obtain a direct##3##4##(1993-1#1)(2008-7#1)(2009-12#1)
to obtain a final##3##4##(2008-3#1)(2013-1#2)
to obtain a full##2##4##(1991-5#1)(2010-5#1)
to obtain a given##2##4##(1995-9#1)(2008-10#1)
to obtain a good##6##4##(2008-2#1)(2008-9#1)(2010-5#1)(2012-12#2)(2013-1#1)
to obtain a high##5##4##(2007-7#1)(2008-11#1)(2008-3#1)(2012-12#1)(2012-2#1)
to obtain a highly##2##4##(2007-12#1)(2008-4#1)
to obtain a homogeneous##3##4##(2008-10#2)(2009-7#1)
to obtain a large##2##4##(2008-3#1)(2010-5#1)
to obtain a more##4##4##(2004-9#1)(2008-10#1)(2008-2#1)(2011-1#1)
to obtain a quantitative##3##4##(2008-10#1)(2008-3#1)(2008-4#1)
to obtain a reliable##2##4##(2008-10#2)
to obtain a result##3##4##(1991-3#3)
to obtain a single##2##4##(2008-3#1)(2010-5#1)
to obtain a stable##4##4##(2007-11#1)(2008-10#1)(2008-5#1)(2008-9#1)
to obtain a suitable sensitivity##2##5##(1993-2#1)(2008-10#1)
to obtain a suitable##3##4##(1993-2#1)(2008-10#2)
to obtain a three-dimensional##2##4##(2008-3#1)(2013-1#1)
to obtain a tissue sample##2##5##(2006-6#1)(2008-5#1)
to obtain a two-dimensional##2##4##(2007-11#1)(2008-2#1)
to obtain a unique solution##2##5##(1997-8#1)(2008-3#1)
to obtain a##182##3##(1990-4#1)(1991-2#2)(1991-3#3)(1991-4#1)(1991-5#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-2#2)(1994-3#2)(1994-5#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-9#2)(1996-12#3)(1996-3#1)(1997-3#1)(1997-8#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-12#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-11#5)(2007-12#3)(2007-4#2)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#24)(2008-11#2)(2008-2#12)(2008-3#12)(2008-4#5)(2008-5#11)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-4#1)(2010-5#5)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#5)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#9)(2013-8#3)
to obtain accurate and precise##2##5##(2008-10#1)(2008-3#1)
to obtain accurate estimates##2##4##(2008-10#1)(2008-4#1)
to obtain accurate results##3##4##(2008-10#3)
to obtain accurate##12##3##(1990-8#1)(2006-5#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2012-12#1)(2013-8#1)
to obtain adequate##4##3##(1994-9#1)(2006-6#1)(2009-1#1)(2011-2#1)
to obtain an accurate##2##4##(2006-6#1)(2008-4#1)
to obtain an adequate##2##4##(2010-12#1)(2012-2#1)
to obtain an appropriate##2##4##(2008-10#1)(2011-2#1)
to obtain an efficient##2##4##(2008-3#1)(2008-9#1)
to obtain an estimate##2##4##(2009-3#1)(2011-2#1)
to obtain an improvement##2##4##(1991-2#1)(2008-10#1)
to obtain an optimal##2##4##(2007-11#1)(2008-2#1)
to obtain an optimum##2##4##(2008-2#1)(2011-12#1)
to obtain an overall##2##4##(1995-6#1)(2006-6#1)
to obtain an##42##3##(1991-2#1)(1992-5#1)(1993-12#1)(1994-5#1)(1995-6#1)(1996-12#1)(1997-3#1)(2006-10#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#6)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#3)(2008-9#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-2#1)(2013-1#1)
to obtain and##3##3##(1996-3#1)(2008-5#1)(2013-8#1)
to obtain any##2##3##(2008-8#1)(2013-8#1)
to obtain appropriate##3##3##(2006-2#1)(2006-3#1)(2007-4#1)
to obtain approval##2##3##(2008-8#1)(2008-9#1)
to obtain baseline##3##3##(2004-9#1)(2006-8#1)(2007-3#1)
to obtain basic##2##3##(1995-1#1)(2011-2#1)
to obtain better results##2##4##(2008-10#1)(2010-12#1)
to obtain better##7##3##(1997-7#1)(2008-10#3)(2008-7#1)(2010-12#1)(2012-3#1)
to obtain both##6##3##(1997-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-8#1)(2010-12#1)
to obtain by##3##3##(1991-2#1)(2008-10#1)(2008-2#1)
to obtain cDNA##2##3##(1995-8#1)(2006-12#1)
to obtain catalytic##2##3##(1994-8#1)(2007-11#1)
to obtain complete##2##3##(2007-8#1)(2008-2#1)
to obtain confidence intervals##2##4##(1997-7#1)(2008-10#1)
to obtain correct##3##3##(2007-2#1)(2008-7#1)(2011-2#1)
to obtain data on##2##4##(1993-8#1)(2006-11#1)
to obtain data##6##3##(1993-8#1)(1994-5#1)(2006-10#1)(2006-11#1)(2007-2#1)(2008-2#1)
to obtain definitive##2##3##(1992-12#1)(2011-2#1)
to obtain different##2##3##(2005-11#1)(2008-10#1)
to obtain directly##3##3##(1990-9#1)(2007-12#1)(2008-2#1)
to obtain effective##2##3##(1993-11#1)(2008-3#1)
to obtain enough##2##3##(1996-2#1)(2008-11#1)
to obtain estimates for the##2##5##(1992-8#1)(2008-7#1)
to obtain estimates##4##3##(1991-4#1)(1992-8#1)(1995-6#1)(2008-7#1)
to obtain extract##3##3##(2008-11#3)
to obtain feedback from##4##4##(2013-1#4)
to obtain free##2##3##(2008-10#1)(2008-4#1)
to obtain full##3##3##(2008-10#1)(2008-5#1)(2008-6#1)
to obtain good##8##3##(1990-5#1)(1991-4#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-7#1)
to obtain high##10##3##(1997-5#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-9#1)(2011-2#1)(2013-1#1)
to obtain high-contrast##2##3##(2007-4#1)(2008-7#1)
to obtain high-quality##2##3##(2007-12#1)(2008-2#1)
to obtain higher##2##3##(2008-10#1)(2008-2#1)
to obtain highly purified##2##4##(1991-11#1)(1994-12#1)
to obtain highly##7##3##(1991-11#1)(1994-12#1)(1994-3#1)(1996-9#1)(2008-4#1)(2010-12#1)(2010-4#1)
to obtain human##2##3##(2008-11#1)(2010-12#1)
to obtain information about the##5##5##(1993-8#1)(1996-4#1)(2005-11#1)(2008-3#1)(2008-7#1)
to obtain information about##9##4##(1993-8#1)(1994-11#1)(1996-4#1)(2005-11#1)(2006-4#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-12#1)
to obtain information on the##8##5##(1993-12#1)(1993-3#1)(1995-2#1)(1997-3#1)(2006-12#1)(2008-3#1)(2008-4#1)(2011-2#1)
to obtain information on##11##4##(1991-1#1)(1993-12#1)(1993-3#1)(1995-2#1)(1997-3#1)(2006-12#1)(2006-6#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)
to obtain information##23##3##(1991-1#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-2#1)(1996-3#1)(1996-4#1)(1997-3#1)(2005-11#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2011-2#1)(2012-12#1)
to obtain informed consent##2##4##(2006-10#1)(2007-3#1)
to obtain insight into##2##4##(1995-12#1)(1995-6#1)
to obtain insight##3##3##(1995-12#1)(1995-6#1)(2010-3#1)
to obtain insights into the##3##5##(2008-7#1)(2011-1#1)(2011-2#1)
to obtain it##2##3##(1997-3#1)(2006-8#1)
to obtain its##2##3##(1991-2#1)(2009-3#1)
to obtain large##3##3##(1990-11#1)(2008-4#1)(2008-5#1)
to obtain low##2##3##(2007-12#1)(2010-4#1)
to obtain maximal##2##3##(2007-11#1)(2007-12#1)
to obtain maximum sensitivity##2##4##(2008-10#2)
to obtain maximum##8##3##(1994-6#1)(2006-8#1)(2008-10#3)(2008-4#2)(2008-9#1)
to obtain meaningful##2##3##(2008-2#1)(2012-3#1)
to obtain milligram amounts of enzymatically active##2##7##(2008-4#2)
to obtain monoclonal##3##3##(2007-10#1)(2008-4#1)(2008-9#1)
to obtain more accurate##2##4##(1993-12#1)(1996-2#1)
to obtain more information about##3##5##(1995-5#1)(2008-6#1)(2012-12#1)
to obtain more##9##3##(1993-12#1)(1995-5#1)(1996-10#1)(1996-2#1)(2007-8#1)(2008-6#1)(2009-4#1)(2010-1#1)(2012-12#1)
to obtain multiple##2##3##(2008-2#2)
to obtain new##5##3##(1991-4#1)(2007-11#1)(2008-8#1)(2010-12#1)(2011-3#1)
to obtain optical##2##3##(2008-1#1)(2008-2#1)
to obtain optimal##5##3##(1992-12#1)(2006-1#1)(2009-4#1)(2010-2#1)(2011-2#1)
to obtain optimum##2##3##(2008-10#1)(2008-3#1)
to obtain particular##2##3##(2008-10#1)(2008-4#1)
to obtain precise##2##3##(1996-5#1)(2009-9#1)
to obtain preliminary##2##3##(2013-7#2)
to obtain pure##4##3##(1995-6#1)(2005-10#1)(2008-10#1)(2008-11#1)
to obtain qualitative##2##3##(2007-11#1)(2008-10#1)
to obtain quantitative data##2##4##(1990-5#1)(2007-11#1)
to obtain quantitative##7##3##(1990-5#1)(2007-11#1)(2008-10#5)
to obtain quantities of##2##4##(1991-8#1)(2008-4#1)
to obtain relevant##2##3##(1993-3#1)(1997-6#1)
to obtain reliable and##2##4##(2006-10#1)(2010-12#1)
to obtain reliable##8##3##(1996-6#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-9#1)(2010-12#2)
to obtain results similar to##2##5##(1997-1#1)(2008-3#1)
to obtain several##3##3##(1992-6#1)(1996-5#1)(2007-12#1)
to obtain some##7##3##(1995-5#1)(2004-12#1)(2005-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2013-1#1)
to obtain stable##2##3##(2008-10#1)(2009-3#1)
to obtain such##2##3##(2007-12#1)(2008-3#1)
to obtain suitable##2##3##(2005-11#1)(2010-5#1)
to obtain the Raman##2##4##(2008-2#1)(2008-3#1)
to obtain the absorption##2##4##(2008-3#1)(2012-2#1)
to obtain the analytical##3##4##(2007-11#1)(2008-10#2)
to obtain the average##2##4##(2008-2#1)(2008-7#1)
to obtain the best##4##4##(1990-10#1)(2008-10#2)(2012-12#1)
to obtain the better##3##4##(2008-10#2)(2010-8#1)
to obtain the calibration##2##4##(2008-10#1)(2008-5#1)
to obtain the corresponding##2##4##(2008-10#1)(2010-7#1)
to obtain the desired##2##4##(1995-8#1)(2008-2#1)
to obtain the entire##2##4##(2006-5#1)(2008-5#1)
to obtain the free##2##4##(2005-11#1)(2008-10#1)
to obtain the ideal##2##4##(2007-5#1)(2008-10#1)
to obtain the maximum##5##4##(1991-12#1)(2008-10#4)
to obtain the most##4##4##(2005-9#1)(2007-8#1)(2008-10#1)(2008-2#1)
to obtain the optimal##2##4##(2008-5#1)(2013-1#1)
to obtain the optimum##7##4##(2007-12#1)(2008-10#3)(2008-2#1)(2010-12#1)(2013-1#1)
to obtain the relevant##2##4##(1995-5#1)(2008-9#1)
to obtain the required##2##4##(1993-12#1)(2008-2#1)
to obtain the##142##3##(1990-10#1)(1991-12#1)(1993-12#1)(1993-8#2)(1994-12#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-8#1)(1997-4#1)(1997-5#1)(2005-11#3)(2005-6#1)(2005-9#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-10#2)(2007-11#4)(2007-12#5)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#36)(2008-11#1)(2008-12#1)(2008-2#18)(2008-3#11)(2008-4#3)(2008-5#7)(2008-7#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
to obtain their##4##3##(1994-1#1)(2007-3#1)(2007-8#1)(2008-10#1)
to obtain three-dimensional##4##3##(1996-12#1)(2007-12#1)(2012-12#2)
to obtain tissue##2##3##(1992-12#1)(2008-3#1)
to obtain total##2##3##(1992-11#1)(2008-10#1)
to obtain training##2##3##(2008-2#1)(2012-2#1)
to obtain useful##2##3##(2008-2#1)(2008-4#1)
to obtain valuable information##2##4##(1990-12#1)(2008-10#1)
to obtain valuable##4##3##(1990-12#1)(2007-8#1)(2008-10#1)(2013-1#1)
to obtain##951##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-4#3)(1990-5#4)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#5)(1991-2#5)(1991-3#4)(1991-4#5)(1991-5#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#5)(1992-2#2)(1992-5#3)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#5)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#5)(1994-1#1)(1994-11#4)(1994-12#4)(1994-2#1)(1994-3#8)(1994-5#3)(1994-6#3)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#2)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#1)(1995-5#5)(1995-6#5)(1995-8#4)(1995-9#2)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#6)(1996-2#4)(1996-3#5)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#4)(1997-4#7)(1997-5#2)(1997-6#3)(1997-7#3)(1997-8#5)(2004-11#2)(2004-12#3)(2004-9#4)(2005-10#3)(2005-11#15)(2005-12#2)(2005-6#1)(2005-9#1)(2006-1#1)(2006-10#11)(2006-11#2)(2006-12#12)(2006-2#1)(2006-3#2)(2006-4#2)(2006-5#6)(2006-6#8)(2006-7#1)(2006-8#6)(2007-1#3)(2007-10#6)(2007-11#22)(2007-12#29)(2007-2#3)(2007-3#5)(2007-4#5)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#9)(2007-9#4)(2008-1#6)(2008-10#136)(2008-11#20)(2008-12#9)(2008-2#67)(2008-3#54)(2008-4#30)(2008-5#36)(2008-6#6)(2008-7#16)(2008-8#10)(2008-9#19)(2009-1#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#5)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#3)(2010-1#1)(2010-11#1)(2010-12#10)(2010-2#2)(2010-3#1)(2010-4#6)(2010-5#9)(2010-6#1)(2010-7#3)(2010-8#7)(2010-9#2)(2011-1#7)(2011-12#1)(2011-2#24)(2011-3#1)(2012-1#4)(2012-12#16)(2012-2#13)(2012-3#11)(2013-1#23)(2013-7#3)(2013-8#9)
to obtaining positive samples from the##2##6##(2010-6#2)
to obtaining the##2##3##(2007-1#1)(2012-2#1)
to obtaining##14##2##(2007-1#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-8#1)(2008-4#2)(2008-6#1)(2009-12#1)(2010-6#2)(2012-2#1)
to obviate##2##2##(1991-3#1)(2011-2#1)
to occasional##3##2##(1995-5#1)(2007-7#1)(2010-9#1)
to occlude##6##2##(1994-10#2)(1997-3#1)(2006-12#1)(2008-7#1)(2010-5#1)
to occupational##6##2##(1995-1#1)(1995-3#1)(1997-5#1)(2009-4#1)(2010-9#1)(2013-1#1)
to occupy a##5##3##(1992-7#1)(1994-2#1)(2006-10#1)(2008-9#1)(2013-7#1)
to occupy##11##2##(1992-7#1)(1994-2#1)(2006-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-2#2)(2011-2#1)(2013-7#1)
to occur after##2##3##(1990-7#1)(2009-3#1)
to occur among##2##3##(2009-5#1)(2010-6#1)
to occur and##4##3##(1994-11#1)(1997-1#1)(2007-10#1)(2008-10#1)
to occur as a result of##2##6##(2006-10#1)(2012-2#1)
to occur as a##3##4##(2006-10#1)(2008-11#1)(2012-2#1)
to occur as##5##3##(1997-3#1)(2006-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
to occur at a##3##4##(1994-12#1)(1995-3#1)(2008-5#1)
to occur at an##3##4##(1992-12#1)(2007-11#1)(2007-4#1)
to occur at approximately##2##4##(1996-4#1)(2007-4#1)
to occur at the##4##4##(1990-3#1)(1993-11#1)(1996-7#1)(1996-8#1)
to occur at##17##3##(1990-3#1)(1990-4#1)(1990-5#1)(1992-12#1)(1993-11#1)(1994-12#1)(1995-3#1)(1996-4#1)(1996-7#1)(1996-8#1)(2005-11#1)(2006-11#1)(2007-11#1)(2007-4#2)(2008-5#1)(2009-3#1)
to occur between the##2##4##(1990-3#1)(1993-12#1)
to occur between##4##3##(1990-2#1)(1990-3#1)(1993-12#1)(1996-8#1)
to occur by##5##3##(1993-9#1)(1994-12#1)(1994-2#1)(1996-5#1)(2008-7#1)
to occur during##6##3##(1995-2#1)(2006-7#1)(2007-9#1)(2008-5#1)(2009-2#1)(2013-7#1)
to occur earlier##2##3##(1995-7#1)(2007-6#1)
to occur following##4##3##(1992-2#1)(1992-9#1)(2008-11#1)(2013-1#1)
to occur for##5##3##(1991-2#1)(1994-9#1)(2007-12#1)(2007-2#1)(2013-8#1)
to occur if##3##3##(2006-2#1)(2008-10#1)(2008-8#1)
to occur in a##10##4##(1991-6#1)(1994-6#1)(1994-9#1)(1997-7#1)(2006-10#1)(2007-8#2)(2008-10#2)(2009-8#1)
to occur in many##2##4##(2006-10#1)(2008-8#1)
to occur in patients with##3##5##(1991-2#1)(1994-8#1)(2011-2#1)
to occur in the presence of##3##6##(1992-12#1)(1994-8#1)(1995-3#1)
to occur in the##16##4##(1992-12#1)(1993-12#1)(1994-8#1)(1995-10#1)(1995-3#1)(2006-11#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-3#1)(2011-1#1)(2013-1#1)
to occur in this##2##4##(1995-6#1)(2010-3#1)
to occur in up to##2##5##(2004-12#1)(2007-11#1)
to occur in##74##3##(1990-11#2)(1990-6#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-12#1)(1993-12#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-12#1)(2005-12#1)(2005-8#1)(2006-10#4)(2006-11#2)(2006-8#1)(2007-11#1)(2007-8#3)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#4)(2009-10#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#2)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#2)
to occur more##2##3##(1995-10#1)(2012-2#1)
to occur only##3##3##(1991-12#1)(1994-5#1)(1994-9#1)
to occur over##3##3##(2007-12#1)(2013-1#2)
to occur predominantly##2##3##(1994-8#1)(1995-10#1)
to occur through##7##3##(1990-7#1)(1992-8#1)(1994-12#1)(1994-8#1)(2007-10#1)(2008-10#1)(2009-3#1)
to occur throughout the##2##4##(2008-10#2)
to occur via an##3##4##(1994-12#1)(2013-1#2)
to occur via##6##3##(1990-5#1)(1993-7#1)(1994-12#1)(2008-4#1)(2013-1#2)
to occur when the##2##4##(1996-11#1)(2008-7#1)
to occur when##10##3##(1991-6#1)(1995-3#2)(1996-11#1)(2005-11#1)(2006-10#1)(2008-5#1)(2008-7#1)(2012-12#2)
to occur with##11##3##(1990-11#2)(1993-3#1)(1993-6#1)(2007-7#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-1#1)(2011-1#1)
to occur within##4##3##(1991-10#1)(1993-12#1)(1994-12#1)(2012-12#1)
to occur without##2##3##(1994-2#1)(2008-10#1)
to occur##282##2##(1990-11#4)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-6#2)(1992-1#1)(1992-12#3)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#5)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#5)(1994-9#4)(1995-1#2)(1995-10#4)(1995-2#1)(1995-3#4)(1995-4#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-4#3)(1996-5#2)(1996-7#1)(1996-8#2)(1997-1#3)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#1)(2004-12#1)(2005-11#3)(2005-12#3)(2005-5#1)(2005-8#2)(2006-10#8)(2006-11#4)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#5)(2007-2#1)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#3)(2008-10#14)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#9)(2008-6#2)(2008-7#10)(2008-8#7)(2008-9#2)(2009-10#1)(2009-2#2)(2009-3#4)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#2)(2010-3#2)(2010-6#1)(2010-7#1)(2011-1#2)(2011-12#3)(2011-2#6)(2012-12#6)(2012-2#5)(2013-1#6)(2013-7#3)(2013-8#2)
to occurrence of##6##3##(1990-9#1)(1997-4#1)(1997-8#1)(2008-7#2)(2010-3#1)
to ocean##2##2##(2007-9#1)(2008-3#1)
to oceanographic##3##2##(2007-5#1)(2008-2#1)(2012-2#1)
to octopamine##2##2##(2008-7#2)
to ocular##6##2##(1991-8#1)(2007-1#2)(2008-4#2)(2010-12#1)
to odorants##2##2##(1994-5#1)(2006-12#1)
to off##2##2##(2008-11#1)(2013-1#1)
to off-axis##2##2##(2007-12#1)(2008-3#1)
to off-pump##3##2##(2007-8#3)
to offenders##3##2##(2008-11#1)(2010-12#1)(2010-6#1)
to offer a more##2##4##(2008-11#1)(2010-12#1)
to offer a solution to##2##5##(2007-2#1)(2008-12#1)
to offer a##15##3##(1991-3#1)(1993-2#1)(1993-6#1)(2006-10#1)(2006-2#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-2#3)
to offer all##2##3##(2007-7#1)(2010-9#1)
to offer an excellent##2##4##(2008-1#1)(2009-3#1)
to offer an improvement##2##4##(1994-9#1)(1995-8#1)
to offer an##7##3##(1994-12#1)(1994-9#1)(1995-8#1)(2007-4#1)(2008-1#1)(2009-3#1)(2010-11#1)
to offer effective##3##3##(2006-10#1)(2008-3#1)(2008-7#1)
to offer in the##2##4##(2006-7#1)(2008-12#1)
to offer in##3##3##(2005-9#1)(2006-7#1)(2008-12#1)
to offer information that##2##4##(2005-11#1)(2009-3#1)
to offer new##2##3##(2007-11#1)(2008-7#1)
to offer no##2##3##(2005-11#1)(2008-10#1)
to offer significant advantages##2##4##(1997-4#1)(2006-7#1)
to offer significant##3##3##(1997-4#1)(2005-7#1)(2006-7#1)
to offer some##3##3##(2005-7#1)(2010-8#1)(2011-3#1)
to offer students##2##3##(1993-12#1)(2008-11#1)
to offer such##2##3##(2005-7#1)(2012-2#1)
to offer the most##3##4##(1995-3#1)(2006-10#1)(2011-2#1)
to offer the##12##3##(1991-4#1)(1992-2#1)(1995-3#1)(1996-6#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-4#1)(2008-2#1)(2009-12#1)(2010-8#1)(2011-2#1)
to offer this##2##3##(1992-9#1)(1997-8#1)
to offer to the##2##4##(1991-6#1)(2008-7#1)
to offer to##3##3##(1991-6#1)(2008-7#1)(2009-5#1)
to offer##124##2##(1990-12#2)(1990-5#1)(1990-8#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-6#3)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-6#3)(1996-9#1)(1997-4#1)(1997-8#1)(2005-11#4)(2005-7#4)(2005-8#2)(2005-9#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#2)(2007-11#2)(2007-2#3)(2007-4#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#9)(2008-8#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-11#1)(2012-2#3)(2012-3#3)(2013-1#4)
to offering##2##2##(1996-2#1)(2006-3#1)
to official##2##2##(2008-10#1)(2010-12#1)
to offset a##2##3##(1992-12#1)(1994-3#1)
to offset the##7##3##(1997-3#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-12#1)(2012-12#1)
to offset##10##2##(1992-12#1)(1994-3#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-12#1)(2012-12#1)
to offspring##4##2##(2007-12#1)(2008-9#2)(2012-2#1)
to ofloxacin##4##2##(2007-7#1)(2008-5#1)(2009-5#1)(2011-2#1)
to oil palm##2##3##(1996-7#2)
to oil##4##2##(1996-7#2)(2008-10#2)
to okadaic acid##2##3##(1993-12#1)(1995-3#1)
to olanzapine##2##2##(2010-2#2)
to old age##3##3##(1993-1#1)(1996-3#1)(2008-4#1)
to old##9##2##(1993-1#1)(1993-10#1)(1996-3#1)(2006-6#1)(2008-10#2)(2008-4#1)(2012-1#1)(2013-7#1)
to older ages##2##3##(2009-7#2)
to older people##5##3##(2008-5#1)(2008-6#1)(2010-10#2)(2013-8#1)
to older persons##2##3##(1990-12#1)(1995-1#1)
to older##21##2##(1990-12#1)(1991-12#1)(1992-1#1)(1995-1#1)(1996-12#1)(2006-4#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-2#1)(2009-7#2)(2010-10#2)(2011-1#1)(2011-2#1)(2013-8#1)
to oleate##2##2##(1990-8#1)(1994-8#1)
to oleic acid##2##3##(2004-11#1)(2008-8#1)
to oligodendrocytes##2##2##(1996-8#1)(2013-8#1)
to oligonucleotides##5##2##(1992-2#1)(1994-11#1)(1994-6#1)(1995-2#1)(2008-4#1)
to oligosaccharides containing##2##3##(1990-12#1)(1995-3#1)
to oligosaccharides##3##2##(1990-12#1)(1992-9#1)(1995-3#1)
to olive##2##2##(2008-10#2)
to omega-3##2##2##(2010-4#1)(2013-7#1)
to omega-conotoxin##3##2##(1990-7#2)(1996-5#1)
to omeprazole##2##2##(2006-10#1)(2010-12#1)
to omit the##2##3##(2007-3#1)(2008-10#1)
to on the##3##3##(1996-12#1)(2008-5#1)(2012-12#1)
to on##6##2##(1996-12#1)(2007-8#1)(2008-11#1)(2008-5#1)(2012-1#1)(2012-12#1)
to on-line##7##2##(2008-10#6)(2010-5#1)
to once weekly##2##3##(2007-12#1)(2008-7#1)
to once-daily##2##2##(1992-8#1)(2010-4#1)
to oncogenic##2##2##(1992-11#1)(2010-3#1)
to oncology##3##2##(1996-4#1)(2007-11#1)(2013-7#1)
to one another in##3##4##(1997-8#1)(2007-12#1)(2008-10#1)
to one another##22##3##(1990-11#1)(1992-9#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-8#1)(2006-5#1)(2007-12#2)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-6#1)(2011-12#1)
to one class##2##3##(1993-1#1)(2006-12#1)
to one end##2##3##(2006-11#1)(2008-10#1)
to one for##3##3##(1990-11#1)(1991-10#1)(2008-10#1)
to one half##3##3##(1991-4#1)(2005-10#1)(2008-3#1)
to one hour##2##3##(1994-8#1)(2012-3#1)
to one hundred##2##3##(1991-12#1)(2008-11#1)
to one in which they##2##5##(1995-8#1)(2008-8#1)
to one in which##4##4##(1991-9#1)(1995-8#1)(2008-8#1)(2010-7#1)
to one in##6##3##(1991-9#1)(1993-8#1)(1995-8#1)(2005-7#1)(2008-8#1)(2010-7#1)
to one major##2##3##(2008-5#1)(2008-6#1)
to one molecule##2##3##(1990-9#1)(2008-8#1)
to one month##3##3##(2007-2#1)(2012-2#2)
to one of a##2##4##(2006-5#1)(2013-1#1)
to one of five##2##4##(2008-9#1)(2010-12#1)
to one of four groups##3##5##(1992-1#1)(2011-2#2)
to one of four##8##4##(1991-3#1)(1992-1#1)(1995-9#1)(2008-9#1)(2011-2#2)(2012-2#1)(2012-9#1)
to one of its##3##4##(1991-3#1)(1992-12#1)(1996-11#1)
to one of the following##3##5##(1992-8#1)(1995-2#1)(2007-5#1)
to one of the four groups##2##6##(2007-2#1)(2008-7#1)
to one of the four##3##5##(2004-4#1)(2007-2#1)(2008-7#1)
to one of the three groups##3##6##(2007-6#1)(2008-12#1)(2013-8#1)
to one of the two##7##5##(1990-5#1)(1991-3#1)(2007-8#1)(2008-12#1)(2008-5#1)(2009-6#1)(2010-4#1)
to one of the##40##4##(1990-5#1)(1990-7#1)(1991-3#1)(1991-7#1)(1992-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-4#1)(1997-4#1)(2004-4#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#2)(2009-6#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-7#1)(2012-3#1)(2013-7#1)(2013-8#1)
to one of three groups##4##5##(1991-1#1)(2006-9#1)(2008-4#1)(2009-5#1)
to one of three##11##4##(1991-1#1)(1994-3#1)(2006-11#1)(2006-12#1)(2006-9#1)(2008-4#2)(2009-5#1)(2010-11#1)(2012-12#1)(2013-1#1)
to one of two##6##4##(1996-8#1)(2007-12#1)(2008-9#1)(2009-2#1)(2010-4#1)(2011-1#1)
to one of##84##3##(1990-5#1)(1990-7#1)(1991-1#1)(1991-3#3)(1991-7#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-8#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-9#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-4#1)(2004-4#1)(2006-11#1)(2006-12#2)(2006-4#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#6)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#3)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2012-9#1)(2013-1#2)(2013-7#2)(2013-8#1)
to one or both##2##4##(2008-10#2)
to one or more of the##6##6##(1992-5#1)(1995-2#1)(2006-10#2)(2007-11#1)(2008-10#1)
to one or more of##7##5##(1992-5#1)(1995-2#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-7#1)
to one or more##17##4##(1992-5#1)(1993-4#1)(1994-5#1)(1995-2#1)(1995-8#1)(2006-10#2)(2007-11#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2013-1#2)(2013-8#2)
to one or several##2##4##(1992-8#1)(2008-4#1)
to one or the other##3##5##(1990-5#1)(1996-9#1)(2008-5#1)
to one or two##2##4##(1994-3#1)(2007-10#1)
to one or##28##3##(1990-5#1)(1991-8#1)(1992-5#1)(1992-8#1)(1993-4#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-8#1)(1996-9#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-6#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2013-1#2)(2013-8#2)
to one patient##3##3##(1993-5#1)(2008-5#1)(2010-5#1)
to one side of the##2##5##(2008-10#1)(2008-2#1)
to one side of##4##4##(1995-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
to one that##3##3##(2006-6#1)(2007-12#1)(2008-7#1)
to one third of##5##4##(1993-6#1)(2006-9#1)(2007-5#1)(2007-7#1)(2008-12#1)
to one third##7##3##(1993-6#1)(2006-1#1)(2006-9#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-12#1)
to one used##2##3##(2009-12#1)(2013-7#1)
to one week after##2##4##(2008-7#1)(2008-8#1)
to one week##3##3##(2008-7#1)(2008-8#1)(2013-1#1)
to one where##2##3##(2008-7#1)(2010-10#1)
to one year##5##3##(1991-9#1)(1996-1#1)(1997-5#1)(2007-4#1)(2009-6#1)
to one##277##2##(1990-11#2)(1990-12#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#4)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#3)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#3)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-10#2)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-11#2)(2006-12#5)(2006-4#2)(2006-5#3)(2006-6#1)(2006-9#2)(2007-10#1)(2007-11#4)(2007-12#7)(2007-2#3)(2007-3#1)(2007-4#2)(2007-5#3)(2007-6#2)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#26)(2008-11#4)(2008-12#3)(2008-2#6)(2008-3#8)(2008-4#6)(2008-5#7)(2008-6#1)(2008-7#8)(2008-8#5)(2008-9#7)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#2)(2012-9#1)(2013-1#5)(2013-7#4)(2013-8#3)
to one's own##2##3##(2008-11#1)(2008-2#1)
to one's##4##2##(1994-12#1)(2008-11#1)(2008-2#1)(2008-5#1)
to one-fourth of##2##3##(1990-5#1)(2008-6#1)
to one-half of the##2##4##(2007-2#1)(2008-10#1)
to one-half of##4##3##(2007-2#1)(2008-10#1)(2008-4#1)(2010-11#1)
to one-third of##5##3##(1993-6#1)(1996-2#1)(2007-5#1)(2009-9#1)(2012-2#1)
to ongoing##7##2##(1993-8#1)(1995-5#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2009-7#1)
to onion##3##2##(2008-10#3)
to online##4##2##(1996-6#1)(2008-10#1)(2008-7#1)(2010-8#1)
to only 24##2##3##(2007-8#1)(2008-10#1)
to only 5##3##3##(2007-12#1)(2008-10#1)(2011-2#1)
to only a few##3##4##(2008-10#1)(2008-3#1)(2008-6#1)
to only a##8##3##(1992-10#1)(1994-9#1)(1995-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)
to only one of the two##2##6##(2008-7#1)(2010-5#1)
to only one of the##4##5##(2008-10#1)(2008-7#2)(2010-5#1)
to only one of##6##4##(1991-2#1)(2008-10#1)(2008-5#1)(2008-7#2)(2010-5#1)
to only one##13##3##(1990-8#1)(1991-2#1)(1992-9#1)(1994-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#3)(2008-9#1)(2010-5#1)
to only partially##2##3##(1994-6#1)(2010-3#1)
to only the##2##3##(1996-9#1)(2008-10#1)
to only two##2##3##(1995-11#1)(2008-2#1)
to only##67##2##(1990-4#1)(1990-6#1)(1990-8#1)(1991-2#2)(1992-10#1)(1992-2#1)(1992-7#1)(1992-9#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-12#3)(2007-2#1)(2007-8#3)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#4)(2008-9#1)(2009-4#1)(2010-3#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
to onset and##3##3##(1991-7#1)(1993-2#2)
to onset of##15##3##(1992-6#1)(1993-10#1)(1993-11#2)(1993-12#2)(1997-2#1)(2005-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2012-12#1)(2012-3#1)(2013-1#1)
to onset##21##2##(1991-7#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#2)(1994-2#1)(1997-2#1)(2004-3#1)(2005-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2012-12#1)(2012-3#1)(2013-1#1)
to oocyte##2##2##(2012-2#1)(2012-3#1)
to oocytes##2##2##(2008-4#1)(2009-7#1)
to opaque##2##2##(2008-3#1)(2012-2#1)
to open in##2##3##(2007-12#1)(2011-12#1)
to open surgery##5##3##(2006-6#1)(2006-9#1)(2007-8#1)(2007-9#1)(2008-12#1)
to open the##7##3##(1994-11#1)(2005-11#1)(2006-12#1)(2007-8#2)(2007-9#1)(2008-11#1)
to open up the##2##4##(1996-2#1)(2010-8#1)
to open up##4##3##(1996-2#1)(2010-8#1)(2011-2#1)(2012-1#1)
to open##57##2##(1992-5#1)(1994-11#1)(1994-3#2)(1994-8#1)(1995-9#1)(1996-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-3#1)(2005-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#2)(2007-8#8)(2007-9#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-7#2)(2009-6#1)(2010-8#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#2)
to open-label##2##2##(2008-7#1)(2009-9#1)
to opening##4##2##(2006-6#1)(2007-10#1)(2008-11#1)(2010-11#1)
to operate -##2##3##(2007-11#1)(2009-4#1)
to operate a##2##3##(1995-1#1)(1996-4#1)
to operate and##6##3##(1993-10#1)(1996-2#1)(2008-10#3)(2008-11#1)
to operate at the##3##4##(1991-12#1)(2006-4#1)(2012-2#1)
to operate at##9##3##(1991-12#1)(2004-4#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-8#1)(2012-2#1)
to operate in a##3##4##(1992-12#1)(1997-1#1)(2007-8#1)
to operate in all##2##4##(2010-4#1)(2012-3#1)
to operate in the##2##4##(2008-2#1)(2008-4#1)
to operate in##14##3##(1992-12#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)
to operate on##3##3##(1997-8#1)(2007-7#1)(2008-7#1)
to operate simultaneously in##2##4##(1995-6#1)(2005-10#1)
to operate the BFNF##2##4##(2008-3#2)
to operate to##2##3##(1994-3#1)(2008-10#1)
to operate under##3##3##(2008-1#1)(2008-11#1)(2008-3#1)
to operate with##4##3##(1993-9#1)(2007-5#1)(2008-3#2)
to operate##80##2##(1991-12#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-10#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-10#1)(2006-4#1)(2007-11#2)(2007-12#4)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-2#6)(2008-3#7)(2008-4#2)(2008-7#3)(2008-8#2)(2009-4#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)
to operating##4##2##(2007-11#2)(2007-7#1)(2008-2#1)
to operation in##2##3##(1990-3#1)(2008-2#1)
to operation##6##2##(1990-3#1)(1990-4#1)(1996-2#1)(2008-11#1)(2008-2#1)(2008-7#1)
to operational##3##2##(1991-1#1)(1994-3#1)(2004-9#1)
to operationalize##3##2##(1991-12#1)(1996-1#1)(2008-1#1)
to operative##4##2##(2006-7#1)(2007-11#1)(2009-2#1)(2009-3#1)
to ophthalmologists and##2##3##(2007-11#1)(2007-2#1)
to opiate##2##2##(1991-1#1)(1994-8#1)
to opioid receptors##4##3##(1996-7#1)(2009-12#1)(2009-7#2)
to opioid##8##2##(1991-1#1)(1991-2#1)(1993-8#1)(1996-7#1)(2008-6#1)(2009-12#1)(2009-7#2)
to opioids##3##2##(2006-10#1)(2007-12#1)(2009-7#1)
to opium poppy##4##3##(2008-10#4)
to opium##5##2##(2008-10#4)(2008-3#1)
to opportunistic infections or##2##4##(1990-3#1)(1993-1#1)
to opportunistic infections##4##3##(1990-3#1)(1993-1#1)(2007-10#1)(2007-12#1)
to opportunistic##6##2##(1990-3#1)(1993-1#1)(2007-10#1)(2007-12#1)(2007-2#2)
to oppose##4##2##(1997-6#1)(2008-11#1)(2012-3#1)(2013-7#1)
to opposite##2##2##(1994-11#1)(1997-7#1)
to opt##2##2##(2010-8#1)(2013-1#1)
to optic##5##2##(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#2)
to optical communications##2##3##(2007-12#2)
to optical correlation##2##3##(2008-2#2)
to optical damage##2##3##(2007-12#1)(2008-2#1)
to optical feedback from##2##4##(2007-12#1)(2008-3#1)
to optical feedback##4##3##(2007-12#3)(2008-3#1)
to optical##33##2##(1997-6#1)(2006-4#1)(2007-11#2)(2007-12#11)(2008-2#13)(2008-3#3)(2008-7#1)(2009-5#1)
to optically##7##2##(1995-3#1)(2007-12#3)(2008-10#1)(2008-3#1)(2011-1#1)
to optics##2##2##(2007-11#1)(2008-3#1)
to optimal conditions for##2##4##(2008-10#2)
to optimal##13##2##(2004-1#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2010-7#1)(2013-1#1)(2013-8#1)
to optimally##11##2##(1993-11#1)(1993-12#1)(2006-1#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-1#1)
to optimise the reaction conditions##2##5##(2008-10#2)
to optimise the##10##3##(1993-2#1)(1996-12#1)(2007-11#1)(2008-10#5)(2008-3#1)(2012-11#1)
to optimise these##2##3##(2008-10#1)(2008-11#1)
to optimise##25##2##(1990-3#1)(1993-2#1)(1996-12#1)(2007-11#3)(2007-7#1)(2008-10#9)(2008-11#3)(2008-3#2)(2008-7#1)(2012-11#2)(2012-12#1)
to optimization of##6##3##(1991-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)
to optimization##7##2##(1991-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#1)
to optimize a##5##3##(2004-12#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-7#1)
to optimize and##2##3##(2008-10#1)(2009-1#1)
to optimize care##3##3##(2006-2#1)(2008-3#1)(2010-12#1)
to optimize conditions for##2##4##(2008-11#1)(2008-4#1)
to optimize conditions##4##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)
to optimize free fatty##2##4##(2008-5#2)
to optimize its##3##3##(2007-11#1)(2008-10#1)(2012-2#1)
to optimize long-term outcomes##2##4##(2009-8#2)
to optimize management##2##3##(2008-10#1)(2013-1#1)
to optimize the assay##2##4##(2008-4#1)(2010-12#1)
to optimize the care##2##4##(2008-1#1)(2010-8#1)
to optimize the conditions for the##4##6##(2007-10#1)(2008-10#3)
to optimize the conditions for##11##5##(2007-10#1)(2008-10#10)
to optimize the conditions##12##4##(2007-10#1)(2008-10#11)
to optimize the culture##2##4##(1997-2#1)(2008-5#1)
to optimize the design of##2##5##(2008-8#1)(2011-2#1)
to optimize the design##4##4##(2008-3#1)(2008-8#1)(2011-2#1)(2013-7#1)
to optimize the detection##2##4##(1996-5#1)(2008-3#1)
to optimize the enzymatic##2##4##(2008-5#2)
to optimize the extraction##3##4##(2008-10#3)
to optimize the method##2##4##(1997-2#1)(2008-10#1)
to optimize the reaction##2##4##(2008-10#1)(2008-4#1)
to optimize the system##2##4##(2008-10#1)(2008-9#1)
to optimize the use of##2##5##(2007-3#1)(2011-2#1)
to optimize the##116##3##(1991-11#1)(1992-2#1)(1993-11#1)(1993-5#1)(1995-1#1)(1996-5#1)(1997-2#3)(1997-4#1)(2004-11#1)(2004-8#1)(2005-10#1)(2005-11#2)(2005-12#1)(2006-11#1)(2006-12#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#33)(2008-11#1)(2008-2#7)(2008-3#9)(2008-4#4)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#3)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#5)(2012-2#1)(2013-1#3)(2013-7#2)
to optimize their##6##3##(1990-7#1)(1992-10#1)(1993-5#1)(2008-11#1)(2013-1#2)
to optimize this##2##3##(2008-5#1)(2012-2#1)
to optimize treatment##4##3##(2006-10#1)(2008-5#2)(2010-5#1)
to optimize##244##2##(1990-3#1)(1990-7#1)(1991-11#2)(1992-10#1)(1992-2#1)(1993-11#1)(1993-5#2)(1995-1#2)(1995-2#1)(1996-10#1)(1996-5#1)(1997-2#3)(1997-4#1)(1997-7#1)(2004-11#1)(2004-12#1)(2004-8#1)(2005-10#2)(2005-11#2)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-10#3)(2007-11#3)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2008-1#2)(2008-10#48)(2008-11#6)(2008-12#1)(2008-2#16)(2008-3#17)(2008-4#6)(2008-5#16)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#4)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#10)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#11)(2013-7#2)(2013-8#3)
to optimizing the##3##3##(2008-3#1)(2012-1#1)(2013-1#1)
to optimizing transfection##2##3##(2008-1#2)
to optimizing##11##2##(1992-8#1)(1993-3#1)(2008-1#2)(2008-2#2)(2008-3#2)(2008-4#1)(2012-1#1)(2013-1#1)
to or above##3##3##(1991-7#1)(1997-7#1)(2008-1#1)
to or better than##3##4##(2006-9#1)(2007-11#1)(2008-5#1)
to or better##4##3##(2006-9#1)(2007-11#1)(2008-10#1)(2008-5#1)
to or from##3##3##(1993-12#1)(2008-11#1)(2008-2#1)
to or greater than that of##2##6##(1991-12#1)(2008-10#1)
to or greater than that##3##5##(1990-12#1)(1991-12#1)(2008-10#1)
to or greater than##6##4##(1990-12#1)(1991-12#1)(1991-2#1)(1997-6#1)(2008-10#1)(2008-8#1)
to or greater##7##3##(1990-12#1)(1991-12#1)(1991-2#1)(1996-8#1)(1997-6#1)(2008-10#1)(2008-8#1)
to or higher than##2##4##(1992-9#1)(2008-11#1)
to or intolerant of##3##4##(2007-8#1)(2012-1#1)(2012-3#1)
to or larger than##3##4##(1995-9#1)(2007-11#1)(2008-8#1)
to or less than##3##4##(1995-1#1)(2008-10#1)(2008-2#1)
to or near the##2##4##(2008-10#1)(2008-5#1)
to or smaller##2##3##(2007-11#1)(2013-1#1)
to or##72##2##(1990-12#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-4#1)(1994-12#1)(1994-7#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-9#1)(1996-3#1)(1996-8#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-3#2)(2007-4#2)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#4)(2008-2#2)(2008-5#5)(2008-7#1)(2008-8#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
to oral and##3##3##(1994-12#1)(2007-12#2)
to oral cancer##2##3##(2008-4#1)(2012-2#1)
to oral corticosteroids##2##3##(2006-10#1)(2008-11#1)
to oral health care##2##4##(2008-1#1)(2008-4#1)
to oral health##6##3##(2005-9#1)(2008-1#1)(2008-4#1)(2012-12#1)(2012-2#1)(2012-3#1)
to oral hygiene##2##3##(2011-1#2)
to oral##44##2##(1992-11#1)(1992-2#1)(1993-1#1)(1994-12#1)(1996-3#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#3)(2007-12#4)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#3)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
to orange##2##2##(2007-8#1)(2008-9#1)
to orchestrate##9##2##(1995-5#1)(2007-12#1)(2008-1#2)(2008-9#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)
to orchiectomy##2##2##(1990-3#1)(2008-10#1)
to order##12##2##(1994-3#1)(1995-12#1)(1995-6#1)(1996-11#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2011-1#1)
to ordered##2##2##(1995-6#1)(2011-1#1)
to orders##3##2##(2007-11#1)(2013-1#2)
to ordinary##6##2##(1995-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-5#1)
to organ##11##2##(1991-12#1)(1992-1#1)(1992-3#2)(2008-6#1)(2009-8#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#2)
to organ-specific##5##2##(1991-5#1)(1994-5#1)(1996-11#1)(2008-4#1)(2012-1#1)
to organelle##3##2##(1997-6#1)(2008-2#1)(2011-2#1)
to organic acids##2##3##(1995-5#1)(2006-1#1)
to organic amine##2##3##(2008-10#2)
to organic dusts##2##3##(2005-8#1)(2008-11#1)
to organic matter and##2##4##(2008-10#1)(2011-2#1)
to organic matter##4##3##(2008-10#3)(2011-2#1)
to organic solvents##5##3##(1990-4#1)(1990-8#2)(2008-10#1)(2011-1#1)
to organic##28##2##(1990-4#1)(1990-8#2)(1993-6#1)(1994-3#1)(1995-5#1)(2005-11#2)(2005-8#1)(2006-1#1)(2007-11#1)(2008-10#9)(2008-11#2)(2008-5#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#2)
to organisms that##3##3##(1992-5#1)(2006-12#1)(2008-8#1)
to organisms##5##2##(1992-5#1)(1992-8#1)(2006-12#1)(2008-11#1)(2008-8#1)
to organizational and##2##3##(1992-1#1)(1993-2#1)
to organizational##9##2##(1992-1#1)(1993-2#2)(1994-12#2)(1994-2#1)(1995-1#1)(1996-2#1)(2007-5#1)
to organize a##3##3##(1992-1#1)(2011-12#1)(2013-8#1)
to organize and##5##3##(1991-5#1)(1996-2#1)(2009-9#1)(2013-1#2)
to organize the##7##3##(1997-7#1)(1997-8#1)(2008-1#1)(2009-4#1)(2010-11#1)(2012-3#1)(2013-1#1)
to organize their##2##3##(1991-3#1)(2009-4#1)
to organize##29##2##(1991-3#1)(1991-5#1)(1992-1#1)(1993-12#1)(1994-3#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-4#2)(2009-9#1)(2010-11#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
to organizing##4##2##(1997-1#1)(2007-4#1)(2008-12#1)(2010-8#1)
to organophosphate##3##2##(2005-11#1)(2007-10#1)(2012-1#1)
to organophosphorus##3##2##(1996-12#1)(2008-4#1)(2010-12#1)
to organs##3##2##(2009-5#1)(2012-3#1)(2013-1#1)
to oriP##2##2##(1994-3#2)
to orient the##5##3##(1990-7#1)(1991-1#1)(1993-3#1)(1995-10#1)(2008-11#1)
to orient to##2##3##(2011-2#2)
to orient##9##2##(1990-7#1)(1991-1#1)(1993-3#1)(1995-10#1)(2006-5#1)(2008-11#1)(2009-4#1)(2011-2#2)
to orientation##4##2##(1990-10#1)(1992-3#1)(1995-12#1)(2007-11#1)
to original##3##2##(1990-5#1)(2005-7#1)(2007-2#1)
to originate from the spinal##2##5##(2007-11#1)(2008-7#1)
to originate from##10##3##(1993-4#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-7#1)(2011-2#1)
to originate in the##2##4##(1997-4#1)(2008-3#1)
to originate##13##2##(1993-3#1)(1993-4#1)(1997-4#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-3#1)(2008-7#1)(2011-2#1)
to orphan##2##2##(1995-12#1)(2008-4#1)
to orthodontic forces##2##3##(2010-3#1)(2011-12#1)
to orthodontic##3##2##(2010-3#1)(2011-12#1)(2013-7#1)
to orthology##2##2##(2010-6#2)
to orthopaedic##2##2##(2004-9#1)(2012-2#1)
to orthopedic##2##2##(2010-3#1)(2012-2#1)
to orthopedics##2##2##(2006-10#1)(2007-11#1)
to oscillate in##2##3##(1990-2#1)(2007-12#1)
to oscillate##6##2##(1990-2#1)(1994-12#1)(2007-12#3)(2008-3#1)
to oscillations in##2##3##(1990-8#1)(2006-10#1)
to oscillations##3##2##(1990-8#1)(1991-5#1)(2006-10#1)
to oscillatory##2##2##(2007-12#1)(2008-1#1)
to osmotic stress##5##3##(1997-8#1)(2006-5#1)(2008-7#2)(2009-8#1)
to osmotic##8##2##(1995-12#1)(1997-8#1)(2006-5#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-8#1)
to osteoarthritis##5##2##(2007-7#2)(2007-8#1)(2010-4#1)(2010-9#1)
to osteochondral##2##2##(2007-11#1)(2008-6#1)
to osteogenic cells##2##3##(2008-11#1)(2010-2#1)
to osteogenic##3##2##(2008-1#1)(2008-11#1)(2010-2#1)
to osteomyelitis##3##2##(2008-1#1)(2010-6#2)
to osteonecrosis##2##2##(2009-3#1)(2012-12#1)
to osteopontin##2##2##(1992-4#1)(2010-2#1)
to osteoporosis##8##2##(1992-2#1)(1993-11#1)(2006-8#1)(2007-11#2)(2008-12#1)(2008-7#1)(2008-8#1)
to other CARICOMP sites##4##4##(2008-5#1)(2011-2#3)
to other E##2##3##(1995-6#1)(1997-2#1)
to other European countries##4##4##(2006-10#2)(2007-8#1)(2008-7#1)
to other agents##2##3##(1991-12#1)(2010-12#1)
to other animals##2##3##(1993-2#1)(2012-1#1)
to other anions##2##3##(2008-10#2)
to other antibiotics##3##3##(2005-7#1)(2007-4#2)
to other antigens##2##3##(1995-5#1)(2012-12#1)
to other antihypertensive drugs##2##4##(2008-3#1)(2008-8#1)
to other antioxidants##2##3##(2008-10#1)(2013-8#1)
to other applications##3##3##(2007-11#1)(2008-2#1)(2009-11#1)
to other approaches##2##3##(1995-1#1)(2008-3#1)
to other areas##3##3##(2007-5#1)(2008-3#1)(2009-9#1)
to other aspects of##3##4##(1991-11#1)(1992-5#1)(2008-2#1)
to other available##3##3##(1991-12#1)(2008-2#1)(2008-7#1)
to other cardiac##2##3##(1993-12#1)(2007-8#1)
to other causes##5##3##(1993-6#1)(1993-9#1)(1995-9#1)(2008-8#1)(2013-1#1)
to other cell##2##3##(1996-4#1)(2012-3#1)
to other cells##3##3##(1995-3#1)(2006-4#1)(2008-2#1)
to other clinical##3##3##(1995-6#1)(2008-7#1)(2010-12#1)
to other communities##2##3##(2007-10#1)(2008-2#1)
to other countries in##2##4##(2007-9#1)(2008-12#1)
to other countries##9##3##(1996-12#1)(2006-10#1)(2006-8#2)(2007-6#1)(2007-9#1)(2008-12#2)(2010-11#1)
to other cytokines##2##3##(1992-8#1)(2008-4#1)
to other databases##2##3##(2008-4#1)(2008-8#1)
to other disciplines##4##3##(1994-12#1)(2005-10#1)(2008-12#1)(2008-5#1)
to other diseases##9##3##(1990-3#1)(1990-5#1)(1990-6#1)(1991-5#1)(2007-11#1)(2009-4#1)(2012-3#1)(2013-1#2)
to other domains##3##3##(2011-2#1)(2013-1#2)
to other drugs##2##3##(2006-10#1)(2008-8#1)
to other elements##2##3##(1994-6#1)(2007-8#1)
to other ethnic groups##2##4##(2008-1#1)(2008-3#1)
to other eukaryotic##2##3##(1997-6#1)(2008-9#1)
to other existing##2##3##(2008-3#1)(2012-3#1)
to other factors##4##3##(2005-10#1)(2007-8#1)(2012-12#1)(2013-7#1)
to other forms of##5##4##(1993-9#1)(2007-4#1)(2008-11#1)(2008-2#1)(2012-3#1)
to other fungal##2##3##(1997-6#1)(2007-7#1)
to other genotypes##2##3##(2008-10#1)(2008-5#1)
to other groups of##2##4##(2012-1#1)(2013-7#1)
to other groups##9##3##(1992-3#1)(1992-5#1)(2006-5#1)(2007-3#1)(2008-10#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-7#1)
to other health##3##3##(1990-5#1)(1994-3#1)(1996-12#1)
to other imaging##2##3##(2008-8#1)(2011-2#1)
to other important##2##3##(1992-3#1)(2008-10#1)
to other infectious diseases##2##4##(1993-7#1)(2006-10#1)
to other infectious##3##3##(1993-7#1)(2006-10#1)(2010-2#1)
to other invertebrate##2##3##(2008-7#1)(2008-8#1)
to other known proteins##4##4##(1990-10#1)(1993-6#1)(1995-2#1)(1997-2#1)
to other known##13##3##(1990-10#1)(1991-5#1)(1993-11#1)(1993-6#1)(1995-2#3)(1995-8#1)(1996-12#2)(1996-6#1)(1997-2#1)(1997-4#1)
to other medical##3##3##(1996-1#1)(2008-5#1)(2013-8#1)
to other medications in the##2##5##(2006-10#2)
to other members of the##3##5##(1995-8#1)(1996-10#1)(2008-4#1)
to other members of this family##3##6##(1995-3#1)(1996-12#1)(2010-3#1)
to other members of##7##4##(1995-3#1)(1995-8#1)(1996-10#1)(1996-12#1)(2008-4#2)(2010-3#1)
to other metal cations##2##4##(2008-10#2)
to other methods##6##3##(1996-9#1)(2006-8#1)(2007-11#1)(2008-10#1)(2010-2#1)(2010-4#1)
to other modalities of treatment##2##5##(2006-8#2)
to other modalities of##3##4##(2006-8#3)
to other modalities##6##3##(1993-5#1)(2006-10#1)(2006-8#3)(2008-1#1)
to other models##2##3##(2008-10#1)(2009-6#1)
to other neurological##2##3##(2006-10#1)(2010-8#1)
to other organic##2##3##(2007-12#1)(2009-11#1)
to other organisms##6##3##(1994-12#1)(2008-1#1)(2008-5#1)(2008-8#1)(2009-9#1)(2012-2#1)
to other organs##6##3##(1992-9#1)(1993-10#1)(2008-3#1)(2008-5#2)(2008-7#1)
to other parts of##6##4##(2007-12#1)(2008-12#1)(2009-2#1)(2010-11#1)(2011-1#2)
to other physical##2##3##(1996-6#1)(2008-10#1)
to other plant PyrDC##2##4##(1990-12#2)
to other plant##5##3##(1990-12#2)(2008-10#1)(2008-9#1)(2010-5#1)
to other plants##3##3##(2013-1#2)(2013-8#1)
to other plasma##2##3##(1992-4#1)(1996-3#1)
to other populations##5##3##(2006-5#1)(2007-2#1)(2008-11#1)(2008-8#1)(2009-5#1)
to other previously described##2##4##(1990-5#1)(2007-1#1)
to other previously##3##3##(1990-5#1)(2007-1#1)(2008-2#1)
to other problems in##2##4##(1993-7#1)(2008-7#1)
to other problems##4##3##(1993-7#1)(2006-10#1)(2008-2#1)(2008-7#1)
to other protein##3##3##(1995-3#1)(2008-10#1)(2013-1#1)
to other proteins and##2##4##(1992-4#1)(2008-5#1)
to other proteins##8##3##(1991-4#1)(1992-4#1)(1994-9#1)(1995-1#1)(1996-10#2)(2008-4#1)(2008-5#1)
to other published##3##3##(1997-8#1)(2006-11#1)(2008-11#1)
to other regions in the##2##5##(1992-8#1)(2008-1#1)
to other regions of the brain##2##6##(1993-7#1)(2009-9#1)
to other regions of the##3##5##(1990-5#1)(1993-7#1)(2009-9#1)
to other regions of##4##4##(1990-5#1)(1993-7#1)(2007-3#1)(2009-9#1)
to other regions##6##3##(1990-5#1)(1992-8#1)(1993-7#1)(2007-3#1)(2008-1#1)(2009-9#1)
to other relevant##2##3##(1991-4#1)(2008-3#1)
to other reported##4##3##(1990-7#1)(1992-8#1)(2007-2#1)(2008-10#1)
to other reports##5##3##(1995-10#1)(2006-12#1)(2007-3#1)(2009-8#1)(2011-2#1)
to other serine##2##3##(1990-5#1)(1995-6#1)
to other sites##2##3##(2009-3#1)(2013-8#1)
to other sources of##2##4##(2008-10#1)(2010-12#1)
to other sources##3##3##(2008-10#1)(2010-12#2)
to other species of##2##4##(2008-10#1)(2010-3#1)
to other species##10##3##(1993-6#1)(1996-4#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-11#1)(2010-3#1)(2010-8#1)
to other standard##2##3##(1993-2#1)(2008-7#1)
to other statins##2##3##(2008-5#2)
to other strains##3##3##(1991-10#1)(1993-2#1)(2008-10#1)
to other studies##6##3##(1993-11#1)(2006-10#1)(2008-5#1)(2008-9#1)(2013-1#1)(2013-7#1)
to other systems##3##3##(1991-2#1)(2005-11#1)(2006-12#1)
to other taste stimuli##2##4##(1995-11#2)
to other techniques for##2##4##(2008-2#1)(2008-9#1)
to other techniques##4##3##(1990-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
to other therapeutic##2##3##(2007-8#1)(2008-5#1)
to other therapies##3##3##(1990-5#1)(2006-12#1)(2008-5#1)
to other tissues##2##3##(1991-12#1)(2007-8#1)
to other traditional##2##3##(2006-10#1)(2006-11#1)
to other treatment##2##3##(2010-5#1)(2011-2#1)
to other treatments##4##3##(2004-10#1)(2007-1#1)(2008-10#1)(2012-3#1)
to other two groups##3##4##(2010-7#1)(2011-12#1)(2011-2#1)
to other two##5##3##(2008-5#2)(2010-7#1)(2011-12#1)(2011-2#1)
to other types of##14##4##(1990-11#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-9#1)(2010-8#2)(2011-2#1)
to other vertebrate##2##3##(1996-7#1)(2008-8#1)
to other viruses##3##3##(1997-6#1)(2008-10#2)
to other well-established##2##3##(2006-10#1)(2008-5#1)
to other##742##2##(1990-10#2)(1990-11#3)(1990-12#4)(1990-2#1)(1990-3#1)(1990-5#8)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-10#3)(1991-11#2)(1991-12#6)(1991-2#1)(1991-3#1)(1991-4#4)(1991-5#4)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#2)(1992-7#3)(1992-8#3)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#4)(1993-12#3)(1993-2#4)(1993-5#2)(1993-6#5)(1993-7#3)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#5)(1994-2#3)(1994-3#3)(1994-5#7)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#5)(1995-10#2)(1995-11#3)(1995-12#1)(1995-2#4)(1995-3#5)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#4)(1995-9#2)(1996-1#3)(1996-10#5)(1996-12#8)(1996-2#1)(1996-3#7)(1996-4#3)(1996-5#1)(1996-6#5)(1996-7#4)(1996-8#2)(1996-9#2)(1997-2#3)(1997-3#7)(1997-4#5)(1997-6#3)(1997-7#1)(1997-8#3)(2004-10#1)(2005-10#3)(2005-11#2)(2005-7#2)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#18)(2006-11#4)(2006-12#7)(2006-2#1)(2006-4#2)(2006-5#3)(2006-6#4)(2006-8#9)(2007-1#2)(2007-10#3)(2007-11#13)(2007-12#11)(2007-2#7)(2007-3#7)(2007-4#4)(2007-5#2)(2007-6#3)(2007-7#5)(2007-8#12)(2007-9#4)(2008-1#14)(2008-10#57)(2008-11#15)(2008-12#9)(2008-2#22)(2008-3#20)(2008-4#16)(2008-5#33)(2008-6#2)(2008-7#17)(2008-8#17)(2008-9#10)(2009-10#2)(2009-11#5)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#5)(2010-1#2)(2010-10#2)(2010-11#7)(2010-12#10)(2010-2#4)(2010-3#4)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#14)(2010-9#1)(2011-1#8)(2011-12#3)(2011-2#18)(2011-7#1)(2012-1#2)(2012-11#2)(2012-12#6)(2012-2#9)(2012-3#8)(2013-1#18)(2013-7#6)(2013-8#8)
to others and##2##3##(2008-2#1)(2013-7#1)
to others reported in the literature##2##6##(2006-10#1)(2008-2#1)
to others that are##2##4##(1991-8#1)(2005-9#1)
to others that##3##3##(1991-8#1)(2005-9#1)(2012-12#1)
to others was##2##3##(2012-1#1)(2012-12#1)
to others##41##2##(1990-2#1)(1991-7#1)(1991-8#1)(1994-6#1)(1995-5#1)(1996-8#1)(1997-3#1)(2003-11#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)
to ouabain##2##2##(1992-11#1)(1992-12#1)
to our Department for##2##4##(2007-11#1)(2012-3#1)
to our Department##4##3##(2007-11#1)(2007-7#1)(2007-8#1)(2012-3#1)
to our attention##3##3##(1991-3#1)(2008-10#1)(2011-1#1)
to our calculations##2##3##(1993-12#1)(2006-8#1)
to our center##5##3##(1991-10#1)(2006-7#1)(2007-2#1)(2007-7#1)(2008-4#1)
to our centre##2##3##(2010-10#1)(2011-1#1)
to our clinic with##3##4##(2005-12#1)(2007-8#1)(2010-2#1)
to our clinic##11##3##(2005-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
to our criteria##2##3##(2007-8#1)(2008-10#1)
to our current##2##3##(2005-10#1)(2013-1#1)
to our department for##2##4##(2012-3#1)(2013-7#1)
to our department with a##3##5##(2007-10#1)(2011-2#2)
to our department with##4##4##(2007-10#1)(2007-8#1)(2011-2#2)
to our department##18##3##(1991-8#1)(1992-2#1)(1993-8#1)(1997-8#1)(2007-10#1)(2007-8#2)(2008-12#1)(2009-6#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
to our earlier##3##3##(1997-2#1)(2006-8#2)
to our emergency department##2##4##(2007-3#1)(2008-3#1)
to our expectation##3##3##(1994-11#1)(1994-12#1)(1995-1#1)
to our experience as##2##4##(1994-2#1)(2009-2#1)
to our experience##8##3##(1993-10#1)(1994-2#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2009-2#1)
to our facility##5##3##(1992-6#2)(1994-12#1)(2013-8#2)
to our findings##3##3##(1995-12#1)(1996-9#1)(2007-8#1)
to our hospital after##2##4##(2007-8#1)(2010-2#1)
to our hospital and##2##4##(2007-8#1)(2012-2#1)
to our hospital because of##5##5##(2007-12#1)(2008-1#1)(2008-7#1)(2012-2#2)
to our hospital because##6##4##(2007-12#1)(2008-1#2)(2008-7#1)(2012-2#2)
to our hospital for evaluation of##2##6##(2008-1#1)(2010-12#1)
to our hospital for evaluation##3##5##(2008-1#1)(2010-12#2)
to our hospital for further##2##5##(2011-2#1)(2012-2#1)
to our hospital for##15##4##(1991-12#1)(2006-4#1)(2007-8#1)(2008-1#2)(2009-3#1)(2010-12#2)(2011-2#2)(2012-2#2)(2013-8#3)
to our hospital with abdominal pain##2##6##(1993-6#1)(2012-12#1)
to our hospital with##12##4##(1993-6#1)(2005-12#1)(2006-10#1)(2006-4#1)(2007-10#2)(2007-12#1)(2008-1#1)(2011-2#1)(2012-12#2)(2013-7#1)
to our hospital##49##3##(1990-9#1)(1991-12#1)(1993-6#1)(2005-12#1)(2006-10#1)(2006-4#3)(2007-10#3)(2007-12#2)(2007-3#1)(2007-8#3)(2008-1#5)(2008-7#1)(2009-3#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#7)(2013-1#2)(2013-7#1)(2013-8#4)
to our hypothesis##4##3##(1995-11#1)(1995-5#1)(1997-8#1)(2006-3#1)
to our institution for##2##4##(2008-12#1)(2012-2#1)
to our institution with a##3##5##(2012-2#1)(2013-1#2)
to our institution with##6##4##(2006-10#1)(2007-9#1)(2008-8#1)(2012-2#1)(2013-1#2)
to our institution##12##3##(2005-6#1)(2006-10#1)(2006-12#1)(2007-9#1)(2008-12#1)(2008-6#1)(2008-8#1)(2012-2#3)(2013-1#2)
to our knowledge are the first##2##6##(2008-2#2)
to our knowledge for the first time##3##7##(2008-10#1)(2008-2#1)(2008-3#1)
to our knowledge in##4##4##(2006-10#1)(2007-11#1)(2007-12#1)(2008-3#1)
to our knowledge is##9##4##(2007-12#1)(2008-2#2)(2008-3#6)
to our knowledge of the##2##5##(1995-5#1)(2006-10#1)
to our knowledge of##5##4##(1995-5#1)(2006-10#1)(2009-2#1)(2009-8#1)(2010-6#1)
to our knowledge represents the##2##5##(1995-2#1)(1997-2#1)
to our knowledge the first observation##5##6##(2007-11#3)(2007-12#2)
to our knowledge the first##52##5##(2007-11#13)(2007-12#27)(2008-1#5)(2008-10#1)(2008-2#3)(2008-3#3)
to our knowledge the highest##6##5##(2007-11#2)(2007-12#3)(2008-1#1)
to our knowledge the shortest##2##5##(2007-12#2)
to our knowledge the##68##4##(2007-11#17)(2007-12#37)(2008-1#6)(2008-10#1)(2008-2#4)(2008-3#3)
to our knowledge this is the first report of##2##9##(2008-9#1)(2013-8#1)
to our knowledge this is the first##4##7##(1990-12#1)(1997-8#1)(2008-9#1)(2013-8#1)
to our knowledge##290##3##(1990-12#1)(1991-11#1)(1992-6#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-4#1)(1997-1#2)(1997-2#2)(1997-8#2)(2006-10#2)(2006-9#1)(2007-10#1)(2007-11#30)(2007-12#70)(2007-6#2)(2007-8#1)(2008-1#8)(2008-10#4)(2008-11#3)(2008-2#46)(2008-3#87)(2008-7#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
to our laboratory##2##3##(2007-5#1)(2008-5#1)
to our medical##5##3##(1992-9#1)(2005-1#1)(2008-3#2)(2012-12#1)
to our method##2##3##(2008-2#1)(2008-5#1)
to our new##2##3##(1991-9#1)(2008-10#1)
to our outpatient clinic##2##4##(1996-1#1)(2013-8#1)
to our own##2##3##(1990-6#1)(1997-7#1)
to our patients and##2##4##(2007-5#1)(2007-8#1)
to our patients##5##3##(1997-3#1)(2007-5#1)(2007-8#1)(2008-3#1)(2008-7#1)
to our predictions##2##3##(1996-9#1)(2010-2#1)
to our previous##5##3##(1991-4#1)(2006-8#1)(2008-10#1)(2008-6#1)(2008-7#1)
to our previously##3##3##(1990-12#1)(1992-1#1)(2008-2#1)
to our readers##2##3##(2008-8#1)(2009-9#1)
to our results##6##3##(1991-8#1)(1993-2#1)(1995-1#1)(2008-2#1)(2008-8#1)(2009-2#1)
to our stroke unit##2##4##(2007-10#2)
to our stroke##4##3##(2007-10#3)(2007-9#1)
to our study##6##3##(2007-11#1)(2007-5#1)(2008-5#1)(2011-7#2)(2012-12#1)
to our systems##2##3##(2006-10#1)(2010-2#1)
to our understanding of the development##2##6##(1991-3#1)(2008-7#1)
to our understanding of the##12##5##(1991-3#1)(1994-2#1)(2005-11#1)(2006-10#2)(2006-12#1)(2008-1#1)(2008-11#2)(2008-7#2)(2010-5#1)
to our understanding of##28##4##(1991-3#1)(1994-11#1)(1994-2#1)(1995-11#1)(1996-2#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-11#2)(2008-1#1)(2008-11#2)(2008-4#1)(2008-7#4)(2008-8#2)(2009-11#1)(2010-11#1)(2010-5#1)(2011-12#1)(2012-1#1)(2012-2#1)
to our understanding##29##3##(1991-3#1)(1994-11#1)(1994-2#1)(1995-11#1)(1996-2#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-11#2)(2008-1#1)(2008-11#2)(2008-4#1)(2008-7#4)(2008-8#2)(2009-11#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-12#1)(2012-1#1)(2012-2#1)
to our##616##2##(1990-11#1)(1990-12#3)(1990-6#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-6#3)(1992-9#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1996-1#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-9#2)(1997-1#3)(1997-2#3)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#4)(2004-11#1)(2005-1#1)(2005-10#1)(2005-11#2)(2005-12#3)(2005-6#1)(2005-7#1)(2006-10#10)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#3)(2006-7#1)(2006-8#4)(2006-9#2)(2007-10#10)(2007-11#34)(2007-12#74)(2007-2#2)(2007-3#3)(2007-4#2)(2007-5#5)(2007-6#3)(2007-7#7)(2007-8#17)(2007-9#3)(2008-1#14)(2008-10#15)(2008-11#9)(2008-12#2)(2008-2#53)(2008-3#92)(2008-4#4)(2008-5#6)(2008-6#4)(2008-7#13)(2008-8#7)(2008-9#2)(2009-10#2)(2009-11#1)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#3)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#4)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#9)(2011-3#1)(2011-7#2)(2012-1#2)(2012-11#1)(2012-12#7)(2012-2#17)(2012-3#5)(2013-1#20)(2013-7#2)(2013-8#14)
to out##2##2##(1997-3#1)(2008-8#1)
to out-of-plane##2##2##(2008-2#1)(2008-3#1)
to outbreaks of##2##3##(2007-12#1)(2007-7#1)
to outbreaks##4##2##(1995-3#1)(2007-12#1)(2007-7#1)(2011-2#1)
to outcome##9##2##(1994-6#1)(1995-5#1)(1997-1#1)(2006-10#1)(2006-12#1)(2007-10#1)(2008-11#1)(2011-1#1)(2012-11#1)
to outcomes in##2##3##(2005-7#1)(2012-2#1)
to outcomes##12##2##(1997-6#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-4#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#3)
to outdoor##4##2##(1996-3#2)(2008-10#1)(2012-3#1)
to outer membrane##3##3##(2008-1#1)(2012-11#2)
to outer##9##2##(1994-2#2)(1995-9#1)(2006-10#2)(2008-1#1)(2012-11#2)(2013-1#1)
to outline a##3##3##(2008-6#1)(2010-2#1)(2010-4#1)
to outline the current##2##4##(2008-8#1)(2013-1#1)
to outline the##18##3##(1992-12#1)(1993-5#1)(1995-11#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
to outline##28##2##(1992-12#1)(1993-5#1)(1994-5#1)(1995-11#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-4#1)(2012-12#2)(2012-2#1)(2013-1#1)
to outpatient care##3##3##(1991-1#1)(1993-12#1)(1995-5#1)
to outpatient##14##2##(1991-1#2)(1991-12#1)(1992-2#1)(1993-1#1)(1993-12#2)(1995-5#1)(1996-2#1)(2006-3#1)(2006-5#1)(2008-3#1)(2010-9#1)(2012-2#1)
to outperform the##3##3##(2008-2#1)(2010-3#1)(2012-3#1)
to outperform##5##2##(1991-8#1)(2008-2#2)(2010-3#1)(2012-3#1)
to output##5##2##(1996-2#1)(2008-2#2)(2008-3#2)
to outside agencies##2##3##(2007-2#2)
to outside##4##2##(1997-4#1)(2007-2#2)(2008-8#1)
to outsource##2##2##(1994-2#1)(2009-12#1)
to outweigh the##3##3##(1992-3#1)(2006-12#1)(2009-3#1)
to outweigh##5##2##(1992-3#1)(2006-12#1)(2009-3#1)(2009-6#1)(2012-1#1)
to ovalbumin and##3##3##(1990-5#1)(1995-2#1)(1995-6#1)
to ovalbumin##4##2##(1990-5#1)(1995-2#1)(1995-6#1)(2012-1#1)
to ovarian##6##2##(2006-4#1)(2007-11#1)(2008-4#1)(2008-9#1)(2010-12#1)(2012-12#1)
to ovariectomized (OVX)##2##3##(2009-3#1)(2013-1#1)
to ovariectomized##3##2##(2007-8#1)(2009-3#1)(2013-1#1)
to over 200##2##3##(1991-12#1)(2007-11#1)
to over 50##2##3##(2006-5#1)(2008-3#1)
to over 50%##2##3##(2005-7#1)(2012-3#1)
to over a##2##3##(1993-12#1)(2007-12#1)
to over##37##2##(1990-8#1)(1991-12#1)(1991-7#2)(1992-2#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1996-3#2)(1997-1#3)(1997-2#1)(1997-4#1)(2005-11#1)(2005-7#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-5#1)(2009-9#1)(2010-7#1)(2012-2#1)(2012-3#3)(2013-8#1)
to over-serve##3##2##(2007-12#3)
to over-the-counter##2##2##(1990-4#1)(2006-5#1)
to overall##18##2##(1991-6#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-12#1)(1995-6#1)(1996-11#1)(2005-11#1)(2006-2#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-9#1)(2011-1#1)(2013-1#1)
to overcome a##2##3##(2008-7#2)
to overcome current##2##3##(2008-11#1)(2010-5#1)
to overcome differences##2##3##(1996-1#1)(2012-2#1)
to overcome in##2##3##(1994-5#1)(2006-10#1)
to overcome it##2##3##(2007-9#1)(2008-5#1)
to overcome limitations##2##3##(2006-7#1)(2008-1#1)
to overcome many of##2##4##(2008-9#1)(2010-8#1)
to overcome obstacles to##2##4##(1996-2#2)
to overcome resistance##4##3##(2008-10#2)(2008-11#1)(2012-12#1)
to overcome some of##2##4##(2008-1#1)(2008-5#1)
to overcome some##4##3##(2006-9#1)(2008-1#1)(2008-5#1)(2009-12#1)
to overcome such##2##3##(2008-2#1)(2008-8#1)
to overcome the current##4##4##(1991-2#1)(2007-11#1)(2013-1#1)(2013-7#1)
to overcome the difficulties##2##4##(1995-6#1)(2012-12#1)
to overcome the effects##2##4##(2008-10#1)(2008-6#1)
to overcome the gastrointestinal##2##4##(2010-1#1)(2012-3#1)
to overcome the limitations of##3##5##(2007-8#1)(2008-10#1)(2008-7#1)
to overcome the limited##2##4##(1992-5#1)(2007-12#1)
to overcome the potential##2##4##(1995-5#1)(1996-4#1)
to overcome the problem of##2##5##(2008-2#1)(2008-3#1)
to overcome the problem##4##4##(2006-12#1)(2008-2#1)(2008-3#2)
to overcome the problems##2##4##(2006-10#1)(2008-7#1)
to overcome the skin##2##4##(2010-7#1)(2012-12#1)
to overcome the##77##3##(1991-11#2)(1991-2#2)(1991-5#1)(1992-3#1)(1992-5#1)(1995-5#1)(1995-6#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-11#5)(2007-12#6)(2007-8#1)(2008-10#10)(2008-2#3)(2008-3#6)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-11#1)(2009-2#1)(2010-1#1)(2010-10#1)(2010-7#1)(2010-8#2)(2011-1#1)(2012-12#5)(2012-3#2)(2013-1#3)(2013-7#2)
to overcome their##2##3##(2007-8#1)(2008-2#1)
to overcome them##4##3##(2008-1#1)(2009-4#1)(2010-10#1)(2010-12#1)
to overcome these barriers##4##4##(2013-1#4)
to overcome these challenges##3##4##(2007-5#1)(2011-2#1)(2013-8#1)
to overcome these drawbacks##2##4##(2010-5#1)(2010-6#1)
to overcome these limitations##6##4##(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-6#1)
to overcome these problems##5##4##(1996-3#1)(2007-7#1)(2008-1#1)(2008-11#1)(2009-11#1)
to overcome these two problems##2##5##(2008-2#1)(2008-5#1)
to overcome these##28##3##(1996-3#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-5#1)(2010-6#1)(2011-2#1)(2011-7#1)(2013-1#4)(2013-8#1)
to overcome this limitation##6##4##(2006-12#1)(2007-11#1)(2008-1#1)(2008-7#1)(2010-11#1)(2010-7#1)
to overcome this problem##2##4##(2008-6#1)(2012-2#1)
to overcome this##21##3##(1994-6#1)(2006-12#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-11#2)(2010-11#1)(2010-12#1)(2010-7#1)(2012-12#2)(2012-2#1)(2013-1#1)
to overcome those##3##3##(2007-5#1)(2008-2#1)(2013-7#1)
to overcome##225##2##(1990-12#1)(1991-11#3)(1991-2#2)(1991-5#1)(1991-7#1)(1992-3#1)(1992-5#1)(1994-3#2)(1994-5#1)(1994-6#2)(1995-5#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-3#2)(2004-2#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#2)(2006-6#1)(2006-7#3)(2006-8#1)(2006-9#1)(2007-11#8)(2007-12#8)(2007-5#3)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#6)(2008-10#21)(2008-11#7)(2008-12#1)(2008-2#8)(2008-3#8)(2008-4#1)(2008-5#7)(2008-6#6)(2008-7#7)(2008-8#6)(2008-9#2)(2009-10#1)(2009-11#6)(2009-12#2)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#3)(2011-7#1)(2012-1#2)(2012-12#11)(2012-2#5)(2012-3#3)(2013-1#10)(2013-7#3)(2013-8#1)
to overcrowding of the##2##4##(2008-8#1)(2008-9#1)
to overdose##2##2##(1991-1#1)(1991-2#1)
to overestimate disease##2##3##(2008-10#2)
to overestimate the##3##3##(1992-6#1)(1993-2#1)(2008-7#1)
to overestimate##6##2##(1992-6#1)(1993-2#1)(2008-10#2)(2008-7#1)(2012-11#1)
to overestimation of##2##3##(1992-9#1)(1994-4#1)
to overestimation##3##2##(1992-9#1)(1994-4#1)(2008-10#1)
to overexpress##6##2##(1993-1#1)(1994-8#1)(1995-2#1)(2007-9#2)(2008-11#1)
to overexpression of the##2##4##(2006-12#1)(2008-6#1)
to overexpression of##3##3##(2006-12#1)(2007-11#1)(2008-6#1)
to overfishing##2##2##(2007-5#2)
to overhaul the##2##3##(1994-12#1)(1995-3#1)
to overhaul##3##2##(1994-12#1)(1995-3#1)(1996-7#1)
to overlap##4##2##(1994-3#1)(2006-10#1)(2006-5#1)(2007-12#1)
to overlapping##5##2##(1994-5#1)(2008-10#2)(2008-3#1)(2009-5#1)
to overloading##2##2##(1990-6#1)(2007-11#1)
to overlook##3##2##(2010-4#1)(2011-1#1)(2012-12#1)
to overlying##3##2##(2008-2#1)(2010-3#1)(2011-2#1)
to override##2##2##(2008-5#1)(2012-12#1)
to oversee##2##2##(1994-3#1)(2010-3#1)
to overt##3##2##(1995-2#1)(2008-1#1)(2008-5#1)
to overturn##3##2##(1992-11#1)(1995-6#1)(1996-11#1)
to overuse##4##2##(2006-1#1)(2008-11#2)(2011-2#1)
to overweight and obesity##7##4##(2011-2#2)(2013-8#5)
to overweight in California adolescents##2##5##(2010-11#2)
to overweight##12##2##(2008-5#1)(2010-11#3)(2011-2#2)(2012-3#1)(2013-8#5)
to overwhelming##2##2##(1993-6#1)(2007-11#1)
to ovine##2##2##(1992-3#1)(1995-11#1)
to oviposit##5##2##(2007-6#2)(2008-5#1)(2008-9#1)(2009-4#1)
to ovoid##2##2##(2004-2#1)(2012-1#1)
to ovulate##3##2##(2006-5#1)(2012-12#2)
to oxacillin##2##2##(2006-10#2)
to oxalate##4##2##(1994-12#2)(2008-10#2)
to oxidant stress##2##3##(2010-8#2)
to oxidation in##2##3##(1995-12#1)(2004-11#1)
to oxidation of the##4##4##(1995-6#1)(2007-12#1)(2008-10#1)(2009-9#1)
to oxidation of##6##3##(1995-6#1)(2007-12#1)(2008-10#2)(2009-9#1)(2012-2#1)
to oxidation than those##2##4##(2004-11#1)(2008-10#1)
to oxidation##23##2##(1991-12#1)(1995-12#2)(1995-6#1)(1996-3#1)(1997-2#1)(2004-11#3)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-9#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
to oxidative and##2##3##(2008-11#1)(2008-7#1)
to oxidative damage##3##3##(1995-6#1)(2005-11#1)(2006-12#1)
to oxidative insults##2##3##(1997-5#1)(2009-3#1)
to oxidative modification##4##3##(1991-2#1)(1991-5#1)(1995-12#2)
to oxidative stress and##6##4##(2005-10#1)(2006-8#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-1#1)
to oxidative stress as##3##4##(2004-11#1)(2007-1#1)(2008-5#1)
to oxidative stress caused by##2##5##(1997-6#1)(2008-10#1)
to oxidative stress in the##2##5##(1997-6#1)(2008-7#1)
to oxidative stress in##8##4##(1994-3#1)(1995-1#1)(1996-9#1)(1997-6#1)(2004-11#1)(2008-7#1)(2011-1#1)(2012-12#1)
to oxidative stress induced##2##4##(2012-3#1)(2013-1#1)
to oxidative stress is##2##4##(2006-8#1)(2009-10#1)
to oxidative stress##60##3##(1990-6#2)(1991-2#1)(1994-3#3)(1995-1#1)(1995-9#1)(1996-9#1)(1997-5#1)(1997-6#3)(2004-11#2)(2005-10#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-8#2)(2006-9#3)(2007-1#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-3#3)(2008-4#5)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#3)(2009-5#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-12#1)(2012-12#1)(2012-3#1)(2013-1#2)
to oxidative##85##2##(1990-6#2)(1991-2#3)(1991-5#1)(1991-8#1)(1992-3#1)(1994-3#3)(1995-1#2)(1995-12#2)(1995-6#1)(1995-9#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-5#2)(1997-6#3)(2004-11#3)(2005-10#1)(2005-11#2)(2005-8#2)(2006-12#2)(2006-8#2)(2006-9#3)(2007-1#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-3#3)(2008-4#5)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#3)(2009-3#2)(2009-5#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
to oxidise##3##2##(1997-2#1)(2008-10#1)(2012-3#1)
to oxidize the##2##3##(1994-8#1)(2009-11#1)
to oxidize##24##2##(1990-10#1)(1992-3#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-8#1)(1997-1#1)(1997-7#2)(2004-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-3#1)(2010-7#1)(2010-9#1)(2011-2#2)(2013-1#2)
to oxidized LDL##2##3##(1996-2#1)(2013-7#1)
to oxidized##4##2##(1993-6#1)(1994-5#1)(1996-2#1)(2013-7#1)
to oxygen and hydrogen peroxide##2##5##(1996-1#1)(1996-10#1)
to oxygen and##3##3##(1993-12#1)(1996-1#1)(1996-10#1)
to oxygen deficiency##2##3##(1995-11#1)(2007-12#1)
to oxygen in##2##3##(1994-6#1)(2008-9#1)
to oxygen radicals##2##3##(1990-5#1)(2010-7#1)
to oxygen##29##2##(1990-12#2)(1990-5#1)(1990-8#1)(1991-10#2)(1991-9#1)(1992-12#1)(1993-12#2)(1994-6#1)(1994-8#1)(1995-11#2)(1995-5#1)(1996-1#1)(1996-10#1)(1996-9#1)(2005-11#1)(2005-8#1)(2007-12#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-4#1)(2010-7#1)
to oxygen-glucose deprivation##2##3##(1994-2#1)(1996-6#1)
to oxygenate##2##2##(2005-9#1)(2007-8#1)
to ozone depletion and##2##4##(1991-6#1)(1996-1#1)
to ozone##8##2##(1991-6#1)(1992-3#1)(1996-1#1)(2006-12#1)(2008-10#1)(2009-4#1)(2010-12#1)(2011-2#1)
to p##4##2##(2005-10#2)(2008-10#1)(2008-11#1)
to p&lt##4##2##(2007-2#2)(2010-6#1)(2010-9#1)
to p-aminophenol##3##2##(2008-10#2)(2010-4#1)
to p100##2##2##(1994-6#2)
to p185erbB2##2##2##(1990-9#2)
to p21##2##2##(1995-6#1)(1996-5#1)
to p33##2##2##(1996-5#2)
to p46-61##2##2##(1995-2#2)
to p53##3##2##(1993-9#1)(1994-12#2)
to p75R##5##2##(1994-2#5)
to pH 10##3##3##(1991-2#1)(2008-3#1)(2013-1#1)
to pH 2##6##3##(1996-5#1)(2006-10#1)(2008-10#4)
to pH 3##7##3##(1994-8#1)(1996-5#1)(2008-10#4)(2010-3#1)
to pH 4##4##3##(2008-10#2)(2008-5#2)
to pH 5##5##3##(2004-8#1)(2008-10#3)(2008-11#1)
to pH 6##3##3##(2008-10#2)(2008-7#1)
to pH 7##2##3##(1990-3#1)(2008-10#1)
to pH 8##2##3##(2008-10#2)
to pH 9##4##3##(1992-6#1)(1994-8#1)(1997-3#1)(2008-10#1)
to pH of##2##3##(1997-8#1)(2008-10#1)
to pH##63##2##(1990-3#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-2#2)(1992-6#1)(1993-12#1)(1994-8#2)(1995-2#1)(1996-5#2)(1997-1#1)(1997-3#1)(1997-8#1)(2004-8#1)(2005-12#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-10#29)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2013-1#1)(2013-8#1)
to pR490##2##2##(1991-7#2)
to package and##2##3##(2008-10#1)(2012-1#1)
to package##4##2##(1993-6#1)(2008-10#1)(2008-3#1)(2012-1#1)
to paclitaxel in##2##3##(2007-10#1)(2013-7#1)
to paclitaxel##6##2##(2007-10#1)(2008-6#1)(2008-8#1)(2010-11#2)(2013-7#1)
to paediatric##2##2##(2007-9#1)(2008-11#1)
to paid##2##2##(1993-6#1)(2008-7#1)
to pain and##6##3##(2004-3#1)(2006-3#1)(2010-3#1)(2012-12#2)(2013-1#1)
to pain assessment##2##3##(2008-7#1)(2010-7#1)
to pain management among##2##4##(2009-12#1)(2010-11#1)
to pain management##7##3##(2007-12#1)(2007-8#1)(2008-3#1)(2008-8#1)(2009-12#1)(2010-11#2)
to pain or##3##3##(1996-12#1)(2008-4#1)(2011-2#1)
to pain relief##6##3##(1996-7#1)(2006-10#1)(2006-12#1)(2006-9#1)(2008-9#1)(2009-12#1)
to pain treatment##2##3##(2009-12#1)(2009-3#1)
to pain with anhydrosis##2##4##(2012-2#2)
to pain with##3##3##(2012-12#1)(2012-2#2)
to pain##60##2##(1991-4#1)(1993-10#1)(1993-7#1)(1996-12#1)(1996-7#3)(2004-3#1)(2006-10#5)(2006-12#2)(2006-3#2)(2006-8#1)(2006-9#1)(2007-12#2)(2007-8#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-12#4)(2009-3#1)(2009-9#4)(2010-11#2)(2010-3#1)(2010-7#1)(2011-2#1)(2012-12#3)(2012-2#5)(2013-1#4)
to painful and##2##3##(1995-9#1)(2009-11#1)
to painful stimuli##2##3##(2011-2#2)
to painful##6##2##(1995-9#1)(2008-1#1)(2008-7#1)(2009-11#1)(2011-2#2)
to paint##2##2##(2008-10#1)(2009-8#1)
to pair##5##2##(1995-12#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)
to paired-pulse##2##2##(1997-5#2)
to pairs of##4##3##(1991-1#1)(1995-8#1)(2008-10#1)(2008-2#1)
to palladium##2##2##(2008-10#2)
to palliate##4##2##(2007-8#1)(2008-7#1)(2012-12#1)(2013-1#1)
to palliative care##2##3##(2007-12#1)(2012-2#1)
to palliative##6##2##(1990-12#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-7#1)(2012-2#1)
to palmitate##2##2##(1990-10#1)(2010-10#1)
to pancreatic cancer##4##3##(2006-10#1)(2006-6#1)(2007-6#1)(2011-2#1)
to pancreatic islets##2##3##(2008-11#1)(2010-10#1)
to pancreatic lipase##2##3##(1992-3#1)(1995-5#1)
to pancreatic##25##2##(1990-4#1)(1990-8#1)(1992-3#1)(1995-5#1)(1995-7#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-6#1)(2007-5#1)(2007-6#1)(2008-11#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2011-1#2)(2011-2#2)(2013-1#2)
to pancreatitis##3##2##(1992-9#1)(2006-10#1)(2013-8#1)
to pandemic##6##2##(2010-9#2)(2011-2#2)(2012-1#1)(2013-1#1)
to panel##2##2##(1994-4#1)(2008-2#1)
to panic##2##2##(2008-11#1)(2013-8#1)
to panicle blast##3##3##(2008-10#3)
to papaverine##3##2##(1996-12#1)(2007-9#1)(2008-10#1)
to paper##2##2##(2008-3#1)(2011-2#1)
to papillary##2##2##(1991-10#1)(2007-10#1)
to paracetamol##3##2##(1990-10#1)(2006-2#1)(2008-10#1)
to parallel the##3##3##(1992-11#1)(1993-11#1)(1995-2#1)
to parallel##7##2##(1992-11#1)(1993-11#1)(1994-6#1)(1995-2#1)(1996-3#1)(1997-7#1)(2007-12#1)
to parameterize the##3##3##(2007-12#1)(2008-3#1)(2009-11#1)
to parameterize##4##2##(2007-12#1)(2008-3#1)(2008-8#1)(2009-11#1)
to parameters##3##2##(2008-2#2)(2009-10#1)
to parametric##2##2##(1991-12#1)(2007-12#1)
to parasite antigen##2##3##(2006-10#1)(2007-2#1)
to parasite##7##2##(1996-10#1)(1997-7#1)(2006-10#1)(2006-4#1)(2007-2#1)(2008-4#1)(2012-2#1)
to parasites##5##2##(2008-10#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#1)
to parasitism##4##2##(2008-8#4)
to parasitize##6##2##(2008-10#5)(2008-8#1)
to parathyroid hormone##3##3##(1992-3#1)(2010-6#1)(2013-7#1)
to parathyroid##6##2##(1990-9#1)(1992-3#1)(2010-2#1)(2010-6#1)(2013-1#1)(2013-7#1)
to parent reports##2##3##(2008-11#1)(2008-12#1)
to parent##10##2##(1990-12#1)(1991-12#1)(1991-4#1)(1995-1#1)(1995-3#1)(2008-11#1)(2008-12#2)(2008-4#1)(2010-7#1)
to parental cells##3##3##(1994-8#1)(1996-6#2)
to parental##12##2##(1990-12#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-8#1)(1996-3#1)(1996-6#3)(2006-7#1)(2009-7#1)(2010-1#1)
to parenteral and oral aluminum##2##5##(1992-11#2)
to parenteral##7##2##(1992-11#3)(1996-8#2)(2006-11#1)(2012-2#1)
to parenthood##8##2##(2007-2#5)(2009-11#1)(2009-4#2)
to parenting##2##2##(1991-7#1)(2009-11#1)
to parents and##4##3##(1990-12#1)(1997-7#1)(2013-1#2)
to parents of children##4##4##(2005-12#1)(2009-4#2)(2009-8#1)
to parents of##5##3##(1995-2#1)(2005-12#1)(2009-4#2)(2009-8#1)
to parents who##3##3##(1996-5#1)(2007-7#1)(2010-6#1)
to parents##26##2##(1990-12#1)(1991-8#1)(1992-12#1)(1993-5#1)(1995-1#1)(1995-2#1)(1996-5#1)(1997-7#1)(2005-10#1)(2005-12#1)(2007-2#1)(2007-7#1)(2008-8#2)(2009-4#3)(2009-8#1)(2010-11#1)(2010-2#2)(2010-6#1)(2011-1#2)(2013-1#2)
to parents'##2##2##(2006-8#1)(2010-1#1)
to parents?##2##2##(1996-4#1)(2009-9#1)
to parietal##4##2##(1990-3#1)(1990-9#1)(1995-11#1)(2006-10#1)
to part of##5##3##(1990-5#1)(1990-6#1)(1992-12#1)(1993-6#1)(2010-8#1)
to parthenogenetic##3##2##(2007-12#1)(2008-9#2)
to partial or##2##3##(2008-8#1)(2009-7#1)
to partial##14##2##(1991-12#1)(1992-7#1)(1992-8#1)(1994-6#1)(1995-1#1)(1996-9#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-7#1)
to partially coherent##2##3##(2007-11#2)
to partially overcome##3##3##(1994-6#1)(2008-11#1)(2008-5#1)
to partially purified##4##3##(1990-8#1)(1991-6#1)(1993-12#1)(1994-11#1)
to partially##31##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#3)(1991-12#1)(1991-5#1)(1991-6#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-7#1)(1996-3#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-2#1)
to participants and##3##3##(1995-2#1)(2012-3#1)(2013-1#1)
to participants in##3##3##(2009-11#2)(2011-1#1)
to participants##13##2##(1995-2#1)(2008-1#2)(2008-11#1)(2008-5#1)(2009-11#2)(2009-4#1)(2009-6#1)(2010-11#1)(2011-1#1)(2012-3#1)(2013-1#1)
to participate actively##2##3##(2007-4#2)
to participate and##2##3##(2008-11#1)(2009-6#1)
to participate in a##11##4##(1995-5#1)(2007-11#1)(2007-2#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
to participate in and##2##4##(1995-1#1)(2013-1#1)
to participate in clinical trials##3##5##(2009-6#1)(2010-12#1)(2013-1#1)
to participate in faculty##2##4##(2005-12#1)(2010-3#1)
to participate in health##2##4##(2006-2#1)(2009-6#1)
to participate in nucleotide##2##4##(1995-8#2)
to participate in regulating##2##4##(2008-3#1)(2008-4#1)
to participate in research##5##4##(1992-6#1)(2009-6#1)(2010-11#1)(2012-2#1)(2012-3#1)
to participate in society##2##4##(2009-6#1)(2012-3#1)
to participate in the study##5##5##(1994-12#1)(2008-11#1)(2010-1#1)(2010-6#1)(2012-2#1)
to participate in the##35##4##(1991-4#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-12#1)(1994-2#2)(1996-1#1)(1996-2#1)(1996-5#1)(1996-8#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-10#3)(2007-4#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-6#1)(2012-11#1)(2012-2#2)(2013-1#1)(2013-8#2)
to participate in these##3##4##(2012-2#1)(2013-1#2)
to participate in this study##2##5##(1991-2#1)(2007-10#1)
to participate in this##6##4##(1991-2#1)(2007-10#1)(2008-1#1)(2008-11#1)(2009-7#1)(2010-4#1)
to participate in##121##3##(1990-8#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-11#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-7#1)(2005-12#1)(2005-7#1)(2006-10#3)(2006-2#2)(2006-4#1)(2006-5#1)(2007-1#1)(2007-10#5)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#5)(2008-11#6)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#2)(2009-6#6)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#7)(2013-8#2)
to participate##153##2##(1990-2#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-11#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-7#1)(2004-2#1)(2005-12#1)(2005-7#1)(2006-10#4)(2006-2#2)(2006-4#1)(2006-5#2)(2007-1#1)(2007-10#7)(2007-11#1)(2007-2#1)(2007-4#4)(2007-7#1)(2007-8#2)(2008-1#6)(2008-11#8)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#2)(2009-6#8)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#1)(2011-1#4)(2011-12#1)(2011-2#1)(2012-1#5)(2012-11#1)(2012-12#4)(2012-2#7)(2012-3#2)(2013-1#12)(2013-7#2)(2013-8#2)
to participating in##2##3##(2006-9#1)(2007-6#1)
to participation in##4##3##(2007-5#1)(2009-4#1)(2010-9#1)(2011-2#1)
to participation##8##2##(1994-12#1)(1995-5#1)(2007-5#1)(2009-4#1)(2010-9#1)(2011-2#1)(2011-9#1)(2012-1#1)
to particle size##4##3##(1997-2#1)(2008-10#1)(2008-3#1)(2010-2#1)
to particle##11##2##(1997-2#2)(2005-11#1)(2008-10#2)(2008-3#4)(2008-8#1)(2010-2#1)
to particles with sharp edges##2##5##(2008-3#2)
to particles##3##2##(1996-12#1)(2008-3#2)
to particular regions##3##3##(1995-12#1)(2007-3#2)
to particular##22##2##(1994-3#1)(1995-11#1)(1995-12#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-4#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-7#1)(2010-2#1)(2010-7#1)(2012-3#1)(2013-1#1)(2013-7#1)
to particularly##3##2##(2008-2#1)(2008-3#1)(2012-3#1)
to particulate fractions##2##3##(1994-12#1)(1997-4#1)
to particulate matter##5##3##(2008-10#1)(2008-9#1)(2010-2#1)(2010-5#1)(2013-8#1)
to particulate##8##2##(1990-7#1)(1994-12#1)(1997-4#1)(2008-10#1)(2008-9#1)(2010-2#1)(2010-5#1)(2013-8#1)
to partition##4##2##(1991-7#1)(1995-11#1)(2008-3#1)(2008-7#1)
to partly##2##2##(2008-3#1)(2012-1#1)
to partner with##2##3##(2010-10#1)(2012-2#1)
to partner##6##2##(1994-12#1)(2008-6#1)(2009-4#2)(2010-10#1)(2012-2#1)
to partnership##2##2##(2008-11#1)(2009-5#1)
to parts of the##3##4##(1994-12#1)(2009-10#1)(2011-2#1)
to parts of##4##3##(1990-6#1)(1994-12#1)(2009-10#1)(2011-2#1)
to pass an examination##2##4##(2012-3#2)
to pass on##2##3##(1991-11#1)(2007-1#1)
to pass the##6##3##(1996-7#1)(2006-12#2)(2008-2#1)(2008-4#1)(2010-5#1)
to pass through the##4##4##(2007-5#1)(2008-10#1)(2010-12#1)(2011-2#1)
to pass through##13##3##(1990-11#1)(1993-10#1)(1993-12#1)(1993-3#1)(1996-12#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-12#1)(2011-2#2)
to pass##34##2##(1990-11#1)(1991-11#1)(1993-10#1)(1993-12#1)(1993-3#1)(1994-2#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-7#1)(2005-10#1)(2005-8#1)(2006-12#2)(2006-6#1)(2007-1#1)(2007-5#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-9#2)(2010-12#1)(2010-5#1)(2011-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
to passing##3##2##(1993-12#1)(2008-10#1)(2008-3#1)
to passive movements##2##3##(1996-9#2)
to passive smoking##4##3##(2011-12#1)(2012-1#3)
to passive##10##2##(1992-12#1)(1996-9#2)(2011-12#1)(2011-2#1)(2012-1#4)(2012-9#1)
to passively##3##2##(1991-9#1)(2008-3#1)(2012-3#1)
to past##2##2##(2007-2#1)(2012-12#1)
to pastoral##2##2##(2009-10#1)(2010-1#1)
to pasture##2##2##(1994-1#1)(2010-4#1)
to pastures##2##2##(2008-5#1)(2012-12#1)
to patch##2##2##(2008-3#1)(2008-8#1)
to patents on##3##3##(2005-11#1)(2008-6#1)(2010-7#1)
to patents##5##2##(2005-11#1)(2005-8#1)(2008-5#1)(2008-6#1)(2010-7#1)
to pathogen attack##2##3##(2008-10#2)
to pathogen control##2##3##(2008-10#2)
to pathogen infection##3##3##(1997-2#1)(2008-10#1)(2009-2#1)
to pathogen##17##2##(1997-2#1)(2008-10#14)(2009-2#1)(2012-1#1)
to pathogenesis and##2##3##(2008-3#1)(2008-8#1)
to pathogenesis##7##2##(2006-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2012-10#1)
to pathogenic##9##2##(1996-4#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-7#2)(2011-2#2)(2013-1#1)
to pathogenicity##3##2##(1996-7#1)(2008-10#2)
to pathogens and##2##3##(2012-2#1)(2013-1#1)
to pathogens by##2##3##(2013-1#2)
to pathogens##13##2##(1997-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-12#1)(2010-4#2)(2012-12#1)(2012-2#1)(2013-1#3)
to pathological##9##2##(1994-11#1)(1995-8#1)(2005-11#1)(2007-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2012-11#1)
to pathology##5##2##(1996-12#1)(2006-12#1)(2008-10#1)(2008-8#1)(2011-2#1)
to pathotype 1##3##3##(2008-10#3)
to pathotype 2##2##3##(2008-10#2)
to pathotype##6##2##(2008-10#6)
to pathways##2##2##(1996-5#1)(2010-7#1)
to patient care##16##3##(1993-2#1)(1993-9#1)(1995-2#1)(1997-1#1)(1997-2#1)(2006-10#1)(2007-10#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-12#1)(2012-12#1)(2013-1#2)
to patient management##3##3##(2011-2#1)(2012-2#2)
to patient safety##4##3##(2006-10#1)(2007-1#1)(2008-9#1)(2013-8#1)
to patient satisfaction##4##3##(1993-12#1)(1993-4#1)(1995-12#1)(2008-9#1)
to patient survival##2##3##(2011-2#2)
to patient##80##2##(1991-12#1)(1992-1#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-9#1)(1994-2#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(2005-6#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-11#3)(2008-3#2)(2008-4#1)(2008-6#4)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#6)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#8)(2013-8#1)
to patient's##7##2##(2006-2#1)(2007-10#1)(2007-7#1)(2008-7#1)(2008-8#1)(2013-1#1)(2013-8#1)
to patients and the##2##4##(2007-3#1)(2007-9#1)
to patients and their families##2##5##(1992-3#1)(2007-12#1)
to patients and their##3##4##(1992-3#1)(2007-12#1)(2010-3#1)
to patients and##14##3##(1990-11#1)(1992-12#1)(1992-3#1)(1993-10#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-9#1)(2008-2#1)(2010-3#1)(2011-2#1)(2012-1#1)
to patients at the##2##4##(2007-1#1)(2007-7#1)
to patients at##5##3##(2006-2#1)(2007-1#1)(2007-7#1)(2013-1#2)
to patients in##6##3##(1993-12#1)(1995-12#2)(2005-12#1)(2010-7#1)(2012-2#1)
to patients is##4##3##(1992-12#1)(1995-2#1)(2008-3#1)(2010-2#1)
to patients not##2##3##(1995-5#1)(2012-11#1)
to patients of##3##3##(1994-3#1)(2012-3#1)(2013-8#1)
to patients receiving##3##3##(2005-7#1)(2007-12#1)(2010-9#1)
to patients suffering from##5##4##(1996-4#1)(1997-3#1)(2006-2#1)(2006-9#1)(2010-5#1)
to patients the##2##3##(1996-3#1)(2012-2#1)
to patients treated with##3##4##(1992-10#1)(2006-5#1)(2007-6#1)
to patients undergoing##5##3##(1994-3#1)(2007-8#3)(2008-8#1)
to patients using##2##3##(2008-8#1)(2008-9#1)
to patients who had##2##4##(2007-3#1)(2008-11#1)
to patients who have##3##4##(1992-3#1)(2007-8#2)
to patients who##16##3##(1990-12#1)(1992-3#1)(2006-10#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#4)(2008-11#1)(2008-7#1)(2010-4#1)(2010-9#1)(2011-1#1)(2013-1#1)
to patients whose##3##3##(2004-11#1)(2008-11#1)(2012-12#1)
to patients with advanced cancer##2##5##(2007-11#1)(2007-6#1)
to patients with advanced##4##4##(2006-10#1)(2007-11#1)(2007-6#1)(2010-9#1)
to patients with established##2##4##(1993-11#1)(2007-11#1)
to patients with left##2##4##(2007-8#1)(2008-7#1)
to patients with severe##2##4##(1997-1#1)(2007-12#1)
to patients with the##3##4##(1997-1#1)(2008-1#1)(2011-2#1)
to patients with##102##3##(1991-11#1)(1991-5#2)(1991-8#1)(1993-1#1)(1993-11#1)(1994-11#1)(1994-3#1)(1995-6#1)(1997-1#2)(2004-3#1)(2005-10#1)(2005-6#1)(2005-7#1)(2005-8#2)(2006-10#4)(2006-11#1)(2006-6#2)(2007-11#5)(2007-12#2)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#9)(2007-9#3)(2008-1#3)(2008-10#5)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#14)(2012-2#2)(2013-1#5)(2013-8#4)
to patients##253##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#3)(1991-11#1)(1991-2#1)(1991-5#3)(1991-8#1)(1992-10#1)(1992-12#4)(1992-3#2)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#1)(1994-11#1)(1994-2#2)(1994-3#4)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-1#2)(1997-3#1)(2004-11#1)(2004-2#1)(2004-3#2)(2005-10#1)(2005-11#1)(2005-12#2)(2005-6#2)(2005-7#2)(2005-8#2)(2006-10#6)(2006-11#1)(2006-12#1)(2006-2#3)(2006-5#1)(2006-6#2)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#6)(2007-2#3)(2007-3#4)(2007-4#6)(2007-6#2)(2007-7#6)(2007-8#18)(2007-9#5)(2008-1#5)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#7)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-2#3)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#4)(2011-1#9)(2011-2#23)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#11)(2013-8#6)
to patients' overall##2##3##(1991-3#1)(2012-12#1)
to patients'##15##2##(1990-10#1)(1991-3#1)(1991-8#1)(1995-9#1)(1996-3#1)(2006-3#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-6#2)(2010-12#1)(2012-12#1)(2013-1#2)
to pattern recognition##2##3##(2008-10#1)(2008-2#1)
to pattern##10##2##(2006-5#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-4#2)
to patterns of##2##3##(1991-11#1)(2008-11#1)
to patterns##4##2##(1991-11#1)(2005-10#1)(2008-11#1)(2008-9#1)
to pause##2##2##(1997-5#1)(2009-10#1)
to paw##2##2##(1996-12#1)(2008-7#1)
to pay $1 million to##2##5##(1995-12#2)
to pay $1##3##3##(1995-12#2)(2007-7#1)
to pay and##3##3##(1992-2#1)(2008-1#1)(2012-12#1)
to pay attention to the##2##5##(2007-10#1)(2013-7#1)
to pay attention to##5##4##(2007-10#1)(2007-11#1)(2008-8#1)(2013-1#1)(2013-7#1)
to pay attention##6##3##(2005-3#1)(2007-10#1)(2007-11#1)(2008-8#1)(2013-1#1)(2013-7#1)
to pay close attention to##2##5##(1995-2#1)(2012-2#1)
to pay for a reduction in##2##6##(2006-12#2)
to pay for it##2##4##(1995-1#1)(2011-12#1)
to pay for the##5##4##(1996-6#1)(2006-10#1)(2007-7#2)(2012-12#1)
to pay for treatment##2##4##(2007-7#1)(2009-10#1)
to pay for##29##3##(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#2)(1995-12#1)(1995-2#1)(1996-2#1)(1996-6#2)(2006-10#1)(2006-12#3)(2007-11#1)(2007-2#1)(2007-7#4)(2007-8#1)(2008-10#1)(2009-10#1)(2010-12#2)(2011-12#1)(2012-12#1)(2012-3#1)(2013-8#1)
to pay in##4##3##(1997-5#1)(2006-10#1)(2006-5#1)(2012-12#1)
to pay more attention to the##2##6##(2007-9#1)(2008-1#1)
to pay more attention to##5##5##(1995-1#1)(2007-9#1)(2008-1#1)(2010-2#1)(2010-4#1)
to pay more##6##3##(1995-1#1)(2006-12#1)(2007-9#1)(2008-1#1)(2010-2#1)(2010-4#1)
to pay##84##2##(1992-2#1)(1992-6#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#3)(1995-1#3)(1995-12#4)(1995-2#2)(1995-6#1)(1996-11#2)(1996-2#2)(1996-5#2)(1996-6#3)(1997-2#1)(1997-5#1)(2005-3#1)(2005-8#1)(2006-10#2)(2006-12#5)(2006-5#2)(2006-8#2)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#11)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-6#2)(2008-8#1)(2009-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
to peak at##2##3##(1994-5#1)(2007-1#1)
to peak plasma##2##3##(1992-4#1)(1993-7#1)
to peak serum level##2##4##(1993-11#2)
to peak##29##2##(1990-2#1)(1990-5#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-4#1)(1992-8#1)(1993-11#2)(1993-2#1)(1993-7#1)(1994-5#1)(1997-7#1)(2005-11#1)(2007-1#2)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-1#1)(2010-9#1)(2012-12#1)
to peak)##3##2##(2007-12#1)(2007-4#2)
to peanut##7##2##(1996-11#4)(2008-10#2)(2012-11#1)
to pear and##2##3##(2008-10#2)
to pear##5##2##(2008-10#5)
to pedestrians##2##2##(2006-11#1)(2011-2#1)
to pediatric medical##2##3##(1994-3#1)(2009-6#1)
to pediatric##8##2##(1994-1#1)(1994-3#1)(2006-8#1)(2006-9#1)(2008-12#1)(2008-9#1)(2009-6#1)(2010-5#1)
to pediatricians##2##2##(2007-11#1)(2007-12#1)
to peer pressure##2##3##(2009-7#1)(2013-7#1)
to peer##8##2##(2005-7#1)(2007-9#1)(2009-7#2)(2012-2#3)(2013-7#1)
to peers##3##2##(2008-12#1)(2010-4#1)(2012-1#1)
to pegylated##2##2##(2011-2#2)
to pelvic##3##2##(1995-4#1)(2006-2#1)(2011-2#1)
to penetrate into the##3##4##(1994-3#2)(2008-7#1)
to penetrate into##4##3##(1994-3#2)(2008-3#1)(2008-7#1)
to penetrate the cuticle##3##4##(2008-10#2)(2011-1#1)
to penetrate the##15##3##(1992-12#1)(1993-11#1)(1996-9#1)(1997-1#1)(2005-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#2)(2011-1#2)(2012-3#1)(2013-1#1)
to penetrate through the##3##4##(1995-12#1)(2008-7#1)(2012-1#1)
to penetrate through##5##3##(1995-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-1#1)
to penetrate to the##2##4##(2008-10#1)(2008-6#1)
to penetrate##34##2##(1992-12#1)(1993-11#1)(1994-3#2)(1995-12#1)(1996-3#1)(1996-9#1)(1997-1#1)(2005-11#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2009-10#1)(2010-12#1)(2011-1#2)(2012-1#1)(2012-3#1)(2013-1#1)
to penetrating##2##2##(2006-2#1)(2011-2#1)
to penetration##3##2##(2008-10#2)(2012-2#1)
to penicillin G##3##3##(2008-10#1)(2010-4#1)(2013-8#1)
to penicillin among##2##3##(2006-8#1)(2007-12#1)
to penicillin and##4##3##(1992-8#1)(2006-10#1)(2008-12#1)(2011-2#1)
to penicillin##27##2##(1990-12#1)(1992-8#1)(1993-3#1)(1995-3#2)(2006-10#1)(2006-8#2)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-12#3)(2008-8#1)(2009-5#1)(2010-4#2)(2011-1#1)(2011-2#3)(2013-8#1)
to pentachlorophenol##2##2##(1997-7#1)(2006-3#1)
to people aged##2##3##(2012-3#1)(2013-1#1)
to people in##3##3##(1993-1#1)(2005-9#1)(2012-2#1)
to people living##2##3##(2005-10#1)(2009-5#1)
to people who##4##3##(1995-6#1)(1996-12#1)(2007-8#1)(2008-2#1)
to people with disabilities##3##4##(1996-1#1)(2009-6#1)(2011-2#1)
to people with mental illness##3##5##(2011-1#3)
to people with mental##5##4##(2008-2#1)(2011-1#3)(2012-12#1)
to people with##20##3##(1993-1#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-1#1)(2006-2#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-6#1)(2011-1#4)(2011-2#2)(2012-12#1)(2013-1#1)
to people##43##2##(1993-1#2)(1995-12#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-5#1)(2005-10#1)(2005-9#1)(2006-2#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)(2009-6#1)(2011-1#5)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
to people's##6##2##(1996-1#1)(2008-1#1)(2010-2#3)(2010-4#1)
to pepper##4##2##(2008-10#4)
to peptide##13##2##(1991-7#1)(1993-5#2)(1994-6#2)(1994-9#1)(1995-1#1)(1996-3#1)(2007-6#1)(2008-2#1)(2008-4#2)(2010-1#1)
to peptides of##2##3##(1990-2#1)(1993-12#1)
to peptides##10##2##(1990-2#1)(1990-7#1)(1993-12#1)(1995-1#1)(1995-2#1)(2005-7#1)(2007-11#1)(2008-11#1)(2008-4#1)(2010-2#1)
to perceive and##2##3##(2008-7#1)(2011-10#1)
to perceive the##2##3##(2012-1#1)(2012-3#1)
to perceive##13##2##(1996-1#1)(1996-7#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-8#2)(2010-3#1)(2011-10#1)(2012-1#1)(2012-3#1)(2013-1#1)
to perceived barriers to##2##4##(2007-12#1)(2011-2#1)
to perceived benefits##2##3##(2007-12#1)(2009-4#1)
to perceived##11##2##(2006-10#1)(2007-12#5)(2009-4#1)(2009-9#1)(2010-10#1)(2011-2#2)
to percent##3##2##(2008-10#2)(2008-7#1)
to perception of##3##3##(2005-7#1)(2007-3#1)(2009-1#1)
to perception##4##2##(2005-7#1)(2007-3#1)(2009-1#1)(2010-9#1)
to perceptions of##5##3##(1994-3#1)(2010-12#1)(2010-4#1)(2010-9#1)(2012-3#1)
to perceptions##6##2##(1994-3#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-3#1)
to perchlorate##2##2##(2007-8#1)(2008-10#1)
to percutaneous coronary intervention##2##4##(2009-5#1)(2010-7#1)
to percutaneous drainage##2##3##(2007-8#1)(2010-12#1)
to percutaneous##14##2##(1991-9#1)(1994-11#1)(2006-11#1)(2006-6#1)(2007-7#1)(2007-8#2)(2008-3#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-1#1)
to perforation##4##2##(1993-6#1)(2006-10#1)(2006-7#1)(2009-8#1)
to perform a biopsy for##2##5##(2012-2#2)
to perform a biopsy##3##4##(2012-2#2)(2013-8#1)
to perform a complex##2##4##(2007-7#1)(2013-7#1)
to perform a comprehensive##2##4##(2010-2#1)(2011-2#1)
to perform a genetic##2##4##(2006-2#1)(2008-1#1)
to perform a number of##2##5##(2008-11#1)(2008-3#1)
to perform a variety of##2##5##(2008-2#2)
to perform a##57##3##(1993-11#1)(1996-11#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-12#2)(2007-7#4)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#3)(2008-9#2)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-8#2)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
to perform accurate##5##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2013-1#1)
to perform activities of daily living (ADL)##2##7##(2004-3#1)(2012-1#1)
to perform activities of daily living##4##6##(2004-3#1)(2006-8#1)(2007-7#1)(2012-1#1)
to perform an##11##3##(2006-6#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-2#1)(2010-11#1)(2010-3#1)(2012-3#1)
to perform and can be##2##5##(2011-12#1)(2012-1#1)
to perform and##16##3##(1990-12#1)(1990-2#1)(1991-4#1)(1997-6#1)(2004-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-5#1)(2011-12#1)(2011-2#2)(2012-1#1)
to perform biopsies of##2##4##(2007-8#1)(2011-2#1)
to perform both##3##3##(2008-10#1)(2008-2#1)(2008-6#1)
to perform certain##3##3##(1990-4#1)(2006-3#1)(2006-8#1)
to perform chest compressions##2##4##(2006-10#2)
to perform complex##2##3##(2008-7#1)(2013-1#1)
to perform diagnostic##2##3##(2006-10#1)(2008-11#1)
to perform different##2##3##(1993-6#2)
to perform each##3##3##(2006-6#1)(2010-2#2)
to perform electrochemical##2##3##(2008-10#1)(2010-2#1)
to perform fast##2##3##(2011-1#1)(2013-1#1)
to perform high##2##3##(2008-10#1)(2010-5#1)
to perform in situ##2##4##(2008-10#1)(2008-2#1)
to perform in##7##3##(2006-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-8#1)(2012-12#1)
to perform its##2##3##(1994-12#1)(1997-5#1)
to perform laparoscopic surgery##2##4##(2004-2#2)
to perform more##5##3##(1993-2#1)(2008-4#1)(2009-4#1)(2010-7#1)(2010-8#1)
to perform poorly on##2##4##(1995-1#1)(2012-3#1)
to perform quantitative analyses##2##4##(1997-2#1)(2013-7#1)
to perform quantitative analysis of##2##5##(2013-1#1)(2013-8#1)
to perform quantitative##8##3##(1997-2#2)(2008-10#2)(2008-7#1)(2013-1#1)(2013-7#1)(2013-8#1)
to perform repeated##2##3##(1995-9#1)(2006-6#1)
to perform routine living##2##4##(2008-1#2)
to perform routine##3##3##(2006-8#1)(2008-1#2)
to perform several##2##3##(1991-3#1)(2008-10#1)
to perform simultaneous##2##3##(2008-10#1)(2008-2#1)
to perform such##3##3##(2006-3#1)(2007-12#1)(2010-12#1)
to perform surgical##2##3##(2004-2#1)(2006-6#1)
to perform tasks##3##3##(2006-8#1)(2007-9#1)(2008-7#1)
to perform than the##2##4##(2008-4#2)
to perform than##3##3##(2008-4#2)(2008-6#1)
to perform the analysis##2##4##(2008-10#1)(2009-4#1)
to perform the calculations##3##4##(2008-10#2)(2008-2#1)
to perform the calibration##3##4##(2008-10#3)
to perform the test##2##4##(2010-4#1)(2012-1#1)
to perform the##56##3##(1990-8#1)(1991-8#1)(1993-9#1)(1994-3#1)(1997-7#1)(2006-3#1)(2006-5#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#3)(2013-8#2)
to perform their##4##3##(1991-3#1)(2007-12#1)(2008-7#1)(2011-2#1)
to perform these##5##3##(1990-12#2)(2006-6#1)(2008-3#1)(2010-6#1)
to perform this##5##3##(1995-8#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-9#1)
to perform titration and standard addition in##2##7##(2008-10#2)
to perform two##2##3##(2008-3#2)
to perform well in both##2##5##(1992-9#1)(1997-3#1)
to perform well##5##3##(1992-9#1)(1997-3#1)(2008-10#1)(2010-8#1)(2012-3#1)
to perform with##2##3##(1996-4#1)(2006-10#1)
to perform##484##2##(1990-12#4)(1990-2#1)(1990-3#2)(1990-4#3)(1990-6#1)(1990-8#3)(1991-2#1)(1991-3#2)(1991-4#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#4)(1993-5#1)(1993-6#3)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#3)(1995-1#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#4)(1996-4#1)(1996-7#1)(1996-8#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-2#3)(2004-3#1)(2004-8#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-9#1)(2006-10#12)(2006-12#3)(2006-2#3)(2006-3#3)(2006-4#1)(2006-5#2)(2006-6#11)(2006-7#1)(2006-8#11)(2006-9#3)(2007-10#1)(2007-11#5)(2007-12#10)(2007-2#1)(2007-4#2)(2007-5#3)(2007-6#1)(2007-7#9)(2007-8#5)(2007-9#2)(2008-1#12)(2008-10#60)(2008-11#10)(2008-12#3)(2008-2#21)(2008-3#27)(2008-4#19)(2008-5#6)(2008-6#4)(2008-7#12)(2008-8#1)(2008-9#6)(2009-10#2)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#3)(2009-5#3)(2009-8#3)(2010-11#1)(2010-12#3)(2010-2#8)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#6)(2010-9#3)(2011-1#4)(2011-12#3)(2011-2#15)(2011-3#1)(2012-1#7)(2012-11#1)(2012-12#4)(2012-2#9)(2012-3#6)(2013-1#13)(2013-7#8)(2013-8#11)
to performance in##5##3##(1992-9#1)(1996-3#1)(2006-6#1)(2006-8#1)(2007-8#1)
to performance measures##2##3##(1996-2#1)(2008-3#1)
to performance##20##2##(1992-9#1)(1995-3#1)(1996-2#1)(1996-3#2)(1996-6#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#1)(2011-1#1)(2012-1#2)(2012-12#1)
to performing the##2##3##(2008-2#1)(2012-12#1)
to performing##14##2##(1992-8#1)(1996-5#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-2#1)(2009-8#1)(2010-11#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
to perinatal##4##2##(1994-6#1)(1996-3#1)(2007-2#1)(2008-9#1)
to periodic or##2##3##(2008-2#1)(2008-9#1)
to periodic##6##2##(1990-8#1)(2006-10#1)(2007-12#2)(2008-2#1)(2008-9#1)
to periodontal##4##2##(1997-4#1)(2006-2#2)(2012-3#1)
to perioperative##6##2##(2006-10#2)(2010-2#1)(2012-2#1)(2013-1#2)
to peripheral and cortical stimulation in##2##6##(1990-4#2)
to peripheral blood ratios##2##4##(2013-7#2)
to peripheral blood##7##3##(1996-3#1)(2007-2#1)(2010-8#1)(2013-1#1)(2013-7#3)
to peripheral nerve injury##2##4##(1995-7#2)
to peripheral nerves##3##3##(1994-11#1)(2007-7#1)(2013-8#1)
to peripheral pulmonary##2##3##(2007-8#1)(2010-8#1)
to peripheral##27##2##(1990-4#2)(1991-3#1)(1994-11#2)(1995-12#1)(1995-7#4)(1996-3#1)(1997-3#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-4#2)(2008-7#1)(2010-8#2)(2012-2#1)(2013-1#1)(2013-7#3)(2013-8#1)
to peritoneal dialysis##2##3##(1996-8#1)(2011-2#1)
to peritoneal##7##2##(1995-12#1)(1996-8#1)(2006-6#2)(2011-2#2)(2012-2#1)
to peritonitis##3##2##(2005-8#1)(2011-2#1)(2012-2#1)
to perivascular nerve stimulation##2##4##(1990-10#2)
to permanent##12##2##(1990-10#1)(1992-7#1)(1997-6#1)(2006-1#1)(2007-7#2)(2007-9#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-12#1)(2013-1#1)
to permanently##5##2##(1993-11#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-5#1)
to permeabilize##4##2##(1992-10#1)(1992-9#2)(2008-4#1)
to permeate the cell membrane##2##5##(2008-9#1)(2009-5#1)
to permethrin residues##2##3##(2011-2#2)
to permethrin##5##2##(2010-2#1)(2011-2#2)(2012-2#2)
to permit a##2##3##(1996-12#1)(2007-8#1)
to permit any##2##3##(1991-9#1)(1993-11#1)
to permit its##2##3##(1991-8#1)(2006-10#1)
to permit monitoring of##2##4##(1990-12#1)(2007-12#1)
to permit more##2##3##(2008-3#2)
to permit the direct##2##4##(1993-12#1)(2008-3#1)
to permit the rapid##2##4##(1992-8#1)(2007-12#1)
to permit the use of##3##5##(1993-9#1)(2007-11#1)(2007-12#1)
to permit the##19##3##(1992-8#1)(1993-12#1)(1993-9#1)(1994-9#1)(1995-1#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-9#2)(2009-8#1)(2012-12#1)
to permit##79##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-6#1)(1992-8#2)(1993-11#2)(1993-12#1)(1993-9#1)(1994-10#1)(1994-9#3)(1995-1#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-7#1)(2005-6#1)(2005-7#1)(2006-10#1)(2007-11#4)(2007-12#12)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#6)(2008-3#10)(2008-4#4)(2008-9#3)(2009-8#1)(2009-9#1)(2010-3#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)
to peroxidation##5##2##(1990-11#3)(2009-5#1)(2012-2#1)
to peroxidative##2##2##(1995-7#1)(2009-5#1)
to peroxide-induced haemolysis##2##3##(1991-12#2)
to peroxiredoxin hyperoxidation##2##3##(2010-4#2)
to peroxisome proliferators##2##3##(1992-8#1)(1994-8#1)
to peroxisome##4##2##(1992-8#1)(1994-8#1)(1995-6#1)(2009-8#1)
to peroxisomes and##2##3##(1993-9#1)(2009-10#1)
to peroxisomes##4##2##(1992-7#1)(1993-9#1)(2009-10#2)
to perpetuate##2##2##(2006-12#1)(2008-9#1)
to persist in the##2##4##(1992-3#1)(2007-7#1)
to persist in##8##3##(1990-11#1)(1992-3#1)(2004-4#1)(2007-7#1)(2008-2#1)(2008-7#1)(2008-8#2)
to persist##26##2##(1990-11#1)(1991-2#1)(1991-8#1)(1992-3#1)(1997-6#1)(2004-4#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-3#1)(2011-1#1)(2011-3#1)(2013-1#1)(2013-7#1)
to persistence of##2##3##(2007-12#1)(2008-8#1)
to persistent infection##2##3##(2006-10#1)(2011-2#1)
to persistent spectral holes in##2##5##(2007-12#2)
to persistent##14##2##(1991-12#1)(1992-9#1)(1996-11#1)(1996-9#1)(2006-10#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-8#3)(2011-2#2)
to persisting##2##2##(2009-4#1)(2012-2#1)
to personal and##2##3##(1993-12#1)(2012-1#1)
to personal health information##3##4##(2007-12#1)(2013-1#2)
to personal##13##2##(1990-8#1)(1993-12#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-5#1)(2009-5#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)
to personality characteristics##2##3##(2007-10#1)(2008-11#1)
to personality disorder##2##3##(2007-3#2)
to personality##5##2##(2007-10#1)(2007-3#2)(2008-1#1)(2008-11#1)
to personalized##2##2##(2009-4#1)(2013-1#1)
to personnel##2##2##(1996-2#1)(1997-8#1)
to persons with##6##3##(1992-8#1)(1993-9#1)(1996-1#1)(1996-2#1)(2009-7#1)(2013-7#1)
to persons##12##2##(1991-8#1)(1991-9#1)(1992-8#1)(1993-10#1)(1993-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(2005-7#1)(2007-12#1)(2009-7#1)(2013-7#1)
to persuade##6##2##(1995-6#1)(1996-1#1)(1996-11#1)(1997-8#1)(2009-4#1)(2012-12#1)
to perturb the##4##3##(1994-5#1)(1995-9#1)(2008-3#1)(2012-2#1)
to perturb##5##2##(1990-2#1)(1994-5#1)(1995-9#1)(2008-3#1)(2012-2#1)
to perturbations in##6##3##(1990-8#1)(1996-2#1)(1996-7#1)(2007-12#1)(2008-3#1)(2010-11#1)
to perturbations of##2##3##(2007-9#1)(2008-11#1)
to perturbations##10##2##(1990-8#1)(1996-2#1)(1996-7#1)(2007-12#2)(2007-9#1)(2008-11#2)(2008-3#1)(2010-11#1)
to pertussis toxin##2##3##(1993-8#1)(1994-11#1)
to pertussis toxin-sensitive G-proteins##2##4##(1990-3#1)(1997-2#1)
to pertussis toxin-sensitive##4##3##(1990-3#1)(1990-7#1)(1996-8#1)(1997-2#1)
to pertussis##10##2##(1990-3#1)(1990-7#1)(1993-8#1)(1994-11#2)(1995-5#2)(1996-8#1)(1997-2#1)(2010-12#1)
to pesticides##5##2##(1990-9#1)(2008-8#1)(2010-1#1)(2012-1#1)(2012-2#1)
to pests##3##2##(2008-10#2)(2011-2#1)
to petroleum products##2##3##(1992-10#1)(2006-5#1)
to petroleum##3##2##(1992-10#1)(2006-5#1)(2013-1#1)
to phage##4##2##(1995-2#1)(2008-4#1)(2010-4#1)(2012-2#1)
to phages##3##2##(2008-10#1)(2013-1#2)
to pharmaceutical formulations##4##3##(2008-10#4)
to pharmaceutical##13##2##(2005-11#1)(2006-2#2)(2008-10#5)(2008-7#1)(2009-5#1)(2010-8#1)(2012-11#1)(2012-2#1)
to pharmacies##2##2##(1990-5#1)(1995-1#1)
to pharmacokinetic studies##2##3##(1997-3#1)(2008-10#1)
to pharmacokinetic##3##2##(1997-3#1)(2008-10#1)(2011-1#1)
to pharmacokinetics##3##2##(1996-6#1)(2008-10#1)(2009-1#1)
to pharmacologic##5##2##(1990-8#1)(2004-3#1)(2006-10#2)(2007-6#1)
to pharmacological therapy##2##3##(2007-7#1)(2012-12#1)
to pharmacological treatment##3##3##(1990-11#1)(2011-12#1)(2012-3#1)
to pharmacological##11##2##(1990-11#1)(1995-6#1)(2004-12#1)(2005-8#1)(2006-9#1)(2007-7#1)(2008-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-3#1)
to pharmacology##2##2##(1997-2#1)(2008-12#1)
to pharmacotherapy##4##2##(2004-3#1)(2008-7#1)(2009-11#1)(2012-2#1)
to pharyngeal##2##2##(2011-2#1)(2012-12#1)
to phase I##2##3##(2008-1#1)(2008-5#1)
to phase II##2##3##(2005-8#1)(2007-2#1)
to phase matching##2##3##(2007-11#1)(2007-12#1)
to phase modulation##2##3##(2008-2#1)(2008-3#1)
to phase##29##2##(1991-6#1)(1994-2#1)(1994-5#1)(1996-1#2)(2005-8#2)(2007-11#4)(2007-12#3)(2007-2#1)(2008-1#1)(2008-2#5)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-1#1)(2013-8#1)
to phenol##4##2##(2008-10#4)
to phenolic##2##2##(2008-10#1)(2011-2#1)
to phenotype R(T)R(V)##2##3##(2008-10#2)
to phenotype##9##2##(1996-3#1)(2007-12#1)(2008-10#4)(2008-4#1)(2008-7#1)(2012-2#1)
to phenotypes##3##2##(1994-11#1)(2008-10#1)(2011-1#1)
to phenotypic diversity##2##3##(2008-7#1)(2009-8#1)
to phenotypic variation##3##3##(2009-2#2)(2012-3#1)
to phenotypic##10##2##(1991-12#1)(2006-10#1)(2008-7#1)(2008-8#2)(2009-2#2)(2009-8#1)(2012-3#1)(2013-1#1)
to phenotypically##3##2##(2008-9#2)(2010-4#1)
to phenylalanine##7##2##(1990-5#1)(1992-9#1)(1993-6#1)(1995-3#1)(1997-7#1)(2008-10#1)(2011-2#1)
to phenylamide fungicides##2##3##(2008-10#2)
to phenylephrine in##2##3##(1994-2#1)(2013-8#1)
to phenylephrine##6##2##(1994-2#4)(1995-12#1)(2013-8#1)
to phenytoin##3##2##(1994-2#2)(2008-8#1)
to pheromone##3##2##(1991-5#2)(2011-2#1)
to phonological##4##2##(2007-10#1)(2008-12#1)(2008-4#2)
to phorbol ester and##2##4##(1992-9#1)(1994-11#1)
to phorbol ester##8##3##(1990-7#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-8#1)
to phorbol esters##3##3##(1994-11#1)(1994-2#2)
to phorbol myristate acetate##2##4##(1992-7#1)(1997-8#1)
to phorbol##14##2##(1990-7#1)(1991-3#1)(1992-7#1)(1992-9#1)(1993-8#1)(1994-11#2)(1994-2#2)(1994-8#1)(1995-3#1)(1995-6#1)(1996-8#1)(1997-8#1)
to phosphatase##2##2##(1990-12#1)(1995-3#1)
to phosphate##5##2##(1994-11#1)(1994-6#1)(1996-8#1)(2008-10#1)(2010-2#1)
to phosphatidylethanolamine##2##2##(1991-3#1)(1992-8#1)
to phosphatidylinositol##4##2##(1995-6#1)(1997-8#1)(2009-10#1)(2009-7#1)
to phosphatidylinositol-specific phospholipase C-alpha##2##4##(1991-7#2)
to phosphatidylserine##3##2##(1995-10#1)(2008-11#1)(2011-1#1)
to phosphine##3##2##(1990-8#1)(2008-11#1)(2011-2#1)
to phosphoinositide##2##2##(1993-6#1)(1996-12#1)
to phosphoinositides##2##2##(1994-11#1)(1995-8#1)
to phospholipase C##3##3##(1990-9#1)(1994-12#1)(1994-3#1)
to phospholipase##5##2##(1990-9#1)(1992-1#1)(1994-12#1)(1994-3#1)(1997-7#1)
to phospholipid##8##2##(1990-11#1)(1990-3#1)(1992-12#1)(1994-3#1)(1994-9#2)(1995-8#1)(2008-9#1)
to phospholipids in##2##3##(1994-12#1)(1994-5#1)
to phospholipids##6##2##(1990-2#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-5#1)
to phosphorylate and##2##3##(2010-7#1)(2012-12#1)
to phosphorylate the##2##3##(1991-10#1)(1997-7#1)
to phosphorylate##12##2##(1990-9#1)(1991-10#1)(1991-4#2)(1993-5#1)(1994-5#1)(1995-11#1)(1996-11#1)(1997-7#1)(2008-7#1)(2010-7#1)(2012-12#1)
to phosphorylated##2##2##(1990-2#1)(1997-7#1)
to phosphorylation of##4##3##(1997-1#2)(2008-8#1)(2010-12#1)
to phosphorylation##7##2##(1996-8#1)(1997-1#2)(1997-2#1)(2008-8#1)(2010-12#1)(2013-1#1)
to phosphoserine##2##2##(1996-8#1)(2012-2#1)
to photo-symbiotic clams##2##3##(2008-5#2)
to photoactivated##3##2##(1991-12#2)(2008-1#1)
to photoactivation##2##2##(1990-5#2)
to photobleaching##4##2##(2008-3#2)(2008-9#1)(2011-1#1)
to photochemotherapy##5##2##(1991-12#1)(2007-7#4)
to photodegradation##2##2##(2008-1#1)(2008-3#1)
to photodiode##2##2##(2007-1#1)(2007-11#1)
to photographic##2##2##(2008-3#2)
to photon##4##2##(2007-12#1)(2008-3#2)(2010-5#1)
to photonic##3##2##(2007-12#1)(2010-4#2)
to photoreceptor##3##2##(1994-3#1)(1995-1#1)(1997-4#1)
to photosensitize##2##2##(1994-12#1)(2006-12#1)
to phylogenetic##5##2##(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)
to phylogeny##3##2##(1991-6#1)(2008-4#2)
to physical and mental##2##4##(2008-12#1)(2009-11#1)
to physical and##8##3##(1990-8#1)(2005-1#1)(2005-11#1)(2006-11#1)(2008-11#1)(2008-12#1)(2009-11#1)(2011-1#1)
to physical attractiveness##2##3##(2006-7#1)(2009-4#1)
to physical health##3##3##(2010-3#1)(2011-1#1)(2011-2#1)
to physical therapy##6##3##(1996-1#1)(2008-12#1)(2008-7#2)(2010-7#1)(2012-2#1)
to physical##45##2##(1990-8#1)(1991-7#1)(1992-12#1)(1994-9#1)(1996-1#1)(2005-1#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-7#2)(2009-11#1)(2009-12#1)(2009-4#2)(2009-7#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#5)(2012-2#2)(2012-3#1)
to physically and##2##3##(1995-11#1)(1997-1#1)
to physically##8##2##(1995-11#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)
to physician##11##2##(1993-3#2)(1994-1#1)(1996-12#1)(1996-3#1)(2006-8#2)(2007-9#1)(2008-8#1)(2009-11#2)
to physicians and##7##3##(1992-1#1)(1993-3#1)(1994-12#2)(1994-3#1)(2011-1#1)(2013-1#1)
to physicians as##2##3##(1993-3#1)(2008-12#1)
to physicians in the##2##4##(1992-6#1)(2010-7#1)
to physicians in##3##3##(1992-6#1)(2010-7#1)(2011-2#1)
to physicians##37##2##(1991-1#1)(1991-3#1)(1992-1#3)(1992-3#1)(1992-6#1)(1993-3#3)(1993-9#1)(1994-1#1)(1994-12#3)(1994-3#2)(1995-12#1)(1996-1#1)(2006-8#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-7#2)(2011-1#2)(2011-2#1)(2013-1#1)
to physico-chemical##2##2##(2008-10#2)
to physiologic##4##2##(1997-2#1)(2008-10#1)(2008-7#1)(2010-10#1)
to physiological changes##2##3##(1995-3#1)(2009-3#1)
to physiological conditions##3##3##(1996-1#1)(1997-7#1)(2009-2#1)
to physiological levels of##2##4##(2005-12#1)(2010-1#1)
to physiological##21##2##(1990-5#1)(1994-11#1)(1995-3#1)(1996-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(2005-12#1)(2006-7#1)(2007-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-2#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-1#1)(2011-1#1)(2012-2#1)
to physiologically relevant##2##3##(1997-8#1)(2009-12#1)
to physiologically##3##2##(1997-8#1)(2009-12#1)(2009-6#1)
to physiotherapy##3##2##(1992-2#1)(1995-3#1)(2011-2#1)
to phytochrome##2##2##(1995-2#1)(1996-8#1)
to phytohemagglutinin##3##2##(1992-12#1)(1994-2#1)(2011-2#1)
to pi##2##2##(1997-4#1)(2007-12#1)
to pick up##2##3##(2005-7#1)(2012-2#1)
to pick##5##2##(1992-2#1)(1995-12#1)(2005-7#1)(2012-1#1)(2012-2#1)
to picture##4##2##(1995-2#1)(1997-8#1)(2009-2#1)(2009-9#1)
to pictures##4##2##(2007-12#1)(2010-2#1)(2013-1#2)
to pigeon delta##2##3##(1993-4#2)
to pigmentation##2##2##(2007-9#1)(2008-7#1)
to pigs##2##2##(2008-12#1)(2010-4#1)
to pilot##6##2##(1994-3#3)(2007-10#1)(2008-1#1)(2008-10#1)
to pin##2##2##(2009-3#1)(2012-3#1)
to pinch##2##2##(1991-6#1)(2008-12#1)
to pinpoint the##7##3##(1990-12#1)(2006-3#1)(2008-10#1)(2008-7#1)(2009-6#1)(2013-1#2)
to pinpoint##12##2##(1990-12#1)(2006-3#1)(2007-9#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-6#1)(2012-3#2)(2013-1#2)
to pirimicarb##2##2##(2007-8#2)
to pistachio##3##2##(2008-10#3)
to pitch canker##2##3##(2008-10#2)
to pitch##5##2##(1995-11#1)(1996-1#1)(2008-10#2)(2011-2#1)
to pituitary adenomas##3##3##(1990-12#1)(2011-2#1)(2013-1#1)
to pituitary##4##2##(1990-11#1)(1990-12#1)(2011-2#1)(2013-1#1)
to place a##7##3##(1990-12#1)(1995-12#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-11#1)(2013-1#1)
to place and##3##3##(2007-8#1)(2008-2#1)(2012-2#1)
to place it##3##3##(2006-10#1)(2009-7#1)(2012-1#1)
to place the##12##3##(1992-11#1)(2006-12#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#1)(2012-3#1)
to place them in the context of the##2##8##(2008-12#1)(2010-7#1)
to place them in##4##4##(1993-9#1)(1995-1#1)(2008-12#1)(2010-7#1)
to place##60##2##(1990-12#1)(1991-11#1)(1991-12#1)(1992-11#1)(1992-6#1)(1993-1#1)(1993-9#1)(1995-1#1)(1995-12#1)(1995-9#1)(1996-12#1)(2004-9#1)(2005-11#2)(2006-10#2)(2006-12#1)(2006-5#1)(2006-7#1)(2007-12#1)(2007-5#2)(2007-8#3)(2008-1#4)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-7#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
to placebo (p &lt##3##4##(1993-11#1)(2006-10#1)(2007-7#1)
to placebo for treatment of##2##5##(2008-5#1)(2013-8#1)
to placebo for##3##3##(2008-3#1)(2008-5#1)(2013-8#1)
to placebo in##3##3##(2007-11#1)(2007-7#1)(2008-3#1)
to placebo or##2##3##(2005-10#1)(2008-3#1)
to placebo##39##2##(1990-3#1)(1991-11#1)(1991-3#1)(1992-8#1)(1993-11#1)(1996-9#1)(1997-6#1)(1997-7#1)(2004-1#1)(2005-10#1)(2005-7#3)(2005-8#3)(2006-10#2)(2007-10#1)(2007-11#3)(2007-7#2)(2008-10#1)(2008-3#5)(2008-5#2)(2008-7#2)(2009-11#1)(2010-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
to placement in##3##3##(2007-8#2)(2008-10#1)
to placement of##3##3##(2006-5#1)(2007-7#1)(2010-10#1)
to placement##9##2##(1994-6#1)(2006-5#1)(2006-8#1)(2007-7#2)(2007-8#2)(2008-10#1)(2010-10#1)
to placental##4##2##(1991-12#1)(1991-4#1)(1993-4#1)(2007-3#1)
to plague##4##2##(2007-11#1)(2008-3#1)(2008-8#1)(2010-8#1)
to plan a##2##3##(1992-1#1)(2012-3#1)
to plan and implement##2##4##(1996-3#1)(2008-11#1)
to plan and##6##3##(1994-2#1)(1996-3#1)(2007-7#1)(2008-11#1)(2008-6#1)(2011-2#1)
to plan for a##2##4##(2007-2#1)(2008-2#1)
to plan for the##3##4##(1992-2#1)(1992-4#1)(1993-1#1)
to plan for##11##3##(1992-12#1)(1992-2#1)(1992-4#1)(1993-1#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-6#2)(2010-3#1)(2013-1#1)
to plan surgical##2##3##(2005-9#1)(2008-6#1)
to plan the best##2##4##(2008-7#1)(2009-4#1)
to plan the##7##3##(1990-6#1)(2007-5#1)(2008-10#1)(2008-7#1)(2009-11#1)(2009-4#1)(2013-8#1)
to plan their##2##3##(1995-12#1)(2013-8#1)
to plan to##2##3##(2008-6#1)(2008-7#1)
to plan##57##2##(1990-12#1)(1990-6#2)(1991-12#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-1#1)(1994-2#2)(1995-11#1)(1995-12#1)(1996-3#1)(1997-8#1)(2003-11#1)(2005-5#1)(2005-9#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-6#5)(2008-7#2)(2008-9#1)(2009-11#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#5)(2013-8#2)
to planar##2##2##(1997-7#1)(2009-2#1)
to planning##6##2##(1993-3#1)(1994-2#2)(1995-2#1)(2008-6#1)(2012-12#1)
to plant cells##3##3##(1992-5#1)(2008-10#1)(2009-8#1)
to plant disease##4##3##(2008-10#4)
to plant##39##2##(1990-4#1)(1991-12#1)(1992-5#1)(1994-12#1)(1994-3#1)(2006-12#1)(2008-10#14)(2008-7#1)(2008-8#4)(2008-9#2)(2009-8#5)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
to planting##6##2##(2008-10#6)
to plants in##3##3##(2004-4#1)(2012-2#1)(2013-8#1)
to plants##36##2##(1990-11#1)(1992-3#1)(1992-5#2)(1992-7#1)(1993-2#1)(1994-6#1)(1997-3#1)(1997-4#1)(2004-4#2)(2006-3#1)(2006-5#1)(2007-10#1)(2008-10#9)(2008-11#1)(2009-8#1)(2011-1#2)(2011-12#2)(2011-2#1)(2012-1#1)(2012-2#2)(2013-7#1)(2013-8#2)
to plaque##5##2##(1993-9#1)(2006-2#1)(2011-12#1)(2012-2#1)(2013-7#1)
to plasma TG levels alone##2##5##(2008-3#2)
to plasma clotting##2##3##(1995-10#1)(2011-2#1)
to plasma concentration##2##3##(2007-11#1)(2008-7#1)
to plasma exchange##2##3##(2006-10#1)(2007-12#1)
to plasma from##2##3##(1995-12#1)(1996-5#1)
to plasma membrane rich fractions##2##5##(1991-12#2)
to plasma membrane##7##3##(1991-12#2)(1992-11#1)(1994-3#2)(2008-11#1)(2009-8#1)
to plasma membranes in##2##4##(1992-3#1)(1995-8#1)
to plasma membranes##3##3##(1990-10#1)(1992-3#1)(1995-8#1)
to plasma proteins##3##3##(1990-11#1)(1994-10#1)(1997-8#1)
to plasma##54##2##(1990-1#1)(1990-10#1)(1990-11#3)(1990-12#1)(1990-5#1)(1990-6#1)(1991-12#2)(1991-9#1)(1992-11#1)(1992-3#1)(1993-2#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-4#1)(1995-1#2)(1995-10#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-8#1)(2004-11#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#2)(2008-8#1)(2009-6#1)(2009-8#1)(2010-12#2)(2011-1#1)(2011-2#1)
to plasmid DNA##2##3##(2007-11#2)
to plasmid##6##2##(1990-3#1)(1996-7#1)(2007-11#2)(2008-10#1)(2008-4#1)
to plasmin##2##2##(1990-11#1)(1990-9#1)
to plasminogen and##3##3##(1995-6#1)(1996-5#1)(1997-2#1)
to plasminogen##5##2##(1995-6#1)(1996-5#2)(1996-8#1)(1997-2#1)
to plastic##5##2##(2008-10#1)(2008-11#1)(2008-4#1)(2009-6#1)(2012-4#1)
to plate##2##2##(1991-8#1)(1994-6#1)
to plateau##2##2##(2005-7#1)(2008-10#1)
to platelet activation##2##3##(1994-6#1)(2008-11#1)
to platelet aggregation##5##3##(1991-8#1)(1991-9#1)(2007-11#1)(2008-11#1)(2008-4#1)
to platelet glycoprotein##2##3##(1993-3#1)(2009-12#1)
to platelet##20##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-7#2)(1991-12#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-3#1)(1994-6#1)(1995-2#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-6#1)(2009-12#1)(2011-2#1)
to platelet-derived microparticles##3##3##(1992-12#3)
to platelet-derived##4##2##(1992-12#3)(1993-8#1)
to platelets and##2##3##(2007-11#1)(2009-3#1)
to platelets of##2##3##(2008-3#2)
to platelets##13##2##(1991-7#1)(1991-8#1)(1992-6#1)(1993-3#1)(1996-5#1)(2006-6#2)(2007-11#1)(2008-3#4)(2009-3#1)
to platinum##3##2##(2008-10#1)(2008-4#2)
to platinum-based chemotherapy##2##3##(2009-5#1)(2010-8#1)
to platinum-based##3##2##(2008-11#1)(2009-5#1)(2010-8#1)
to play a central role in this process##2##8##(1992-9#1)(1993-4#1)
to play a central role in##8##6##(1992-9#1)(1993-11#1)(1993-4#1)(2006-2#1)(2008-7#1)(2008-8#2)(2013-8#1)
to play a critical role in the##2##7##(1990-11#1)(2012-3#1)
to play a critical role in##11##6##(1990-11#1)(1994-2#1)(1994-9#1)(1995-11#1)(1997-4#1)(2006-6#1)(2011-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
to play a critical role##13##5##(1990-11#1)(1994-2#1)(1994-9#1)(1995-11#1)(1997-4#1)(2006-6#1)(2008-11#1)(2009-3#1)(2011-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
to play a crucial role in##4##6##(1993-8#1)(2008-6#1)(2010-10#1)(2013-8#1)
to play a crucial role##5##5##(1992-10#1)(1993-8#1)(2008-6#1)(2010-10#1)(2013-8#1)
to play a crucial##6##4##(1992-10#1)(1993-8#1)(2008-10#1)(2008-6#1)(2010-10#1)(2013-8#1)
to play a dominant role in##2##6##(2007-12#1)(2008-1#1)
to play a fundamental role##2##5##(2004-12#1)(2008-1#1)
to play a key role in the##5##7##(1994-9#1)(1995-12#1)(2005-8#1)(2006-10#1)(2011-2#1)
to play a key role in##16##6##(1993-6#2)(1994-9#1)(1995-12#1)(1997-3#1)(2005-8#1)(2006-10#1)(2007-7#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
to play a key role##17##5##(1993-6#2)(1994-9#1)(1995-12#1)(1997-3#1)(2005-8#1)(2006-10#1)(2007-7#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
to play a major role in the development of##2##9##(1994-6#1)(2010-3#1)
to play a major role in the##8##7##(1992-12#1)(1992-4#1)(1992-8#1)(1994-12#1)(1994-6#1)(2008-4#1)(2010-2#1)(2010-3#1)
to play a major role in##12##6##(1992-12#1)(1992-4#1)(1992-8#1)(1994-12#2)(1994-6#1)(2007-11#1)(2008-10#1)(2008-4#1)(2010-2#1)(2010-3#1)(2013-1#1)
to play a major role##13##5##(1992-12#1)(1992-4#1)(1992-8#1)(1994-12#2)(1994-6#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-4#1)(2010-2#1)(2010-3#1)(2013-1#1)
to play a major##14##4##(1992-12#1)(1992-4#1)(1992-8#1)(1994-12#2)(1994-6#1)(1996-4#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-4#1)(2010-2#1)(2010-3#1)(2013-1#1)
to play a minor role##2##5##(2005-11#1)(2010-12#1)
to play a more##2##4##(1995-1#1)(2011-1#1)
to play a pivotal role in the##2##7##(2008-1#1)(2008-11#1)
to play a pivotal role in##5##6##(2008-1#1)(2008-11#2)(2008-3#1)(2012-2#1)
to play a pivotal role##7##5##(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2012-2#1)
to play a primary##2##4##(2006-8#1)(2009-4#1)
to play a role in the development of##2##8##(1994-2#1)(1997-2#1)
to play a role in the pathogenesis of##2##8##(1994-8#1)(2008-4#1)
to play a role in the regulation of##4##8##(1991-9#1)(1992-6#1)(1995-8#1)(2008-4#1)
to play a role in the##18##6##(1990-12#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-6#1)(1994-2#1)(1994-8#1)(1995-8#1)(1997-2#1)(2008-1#1)(2008-4#2)(2008-8#1)(2010-12#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
to play a role in this##2##6##(2008-1#1)(2008-12#1)
to play a role in##61##5##(1990-12#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-9#2)(1992-1#1)(1992-12#1)(1992-6#2)(1992-8#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-2#1)(1996-8#1)(1997-2#1)(1997-4#1)(2003-11#1)(2005-9#1)(2006-10#3)(2006-2#1)(2006-4#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#3)(2008-8#2)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-7#2)(2012-12#1)(2012-2#1)(2012-7#1)(2013-1#2)
to play a role##65##4##(1990-12#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-9#2)(1992-1#1)(1992-12#1)(1992-6#2)(1992-8#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-2#2)(1996-8#1)(1997-2#1)(1997-4#1)(2003-11#1)(2005-9#1)(2006-10#3)(2006-2#1)(2006-4#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#3)(2008-7#1)(2008-8#2)(2009-8#3)(2009-9#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-7#2)(2012-12#1)(2012-2#1)(2012-7#1)(2013-1#3)
to play a significant role in both##2##7##(2006-12#1)(2011-1#1)
to play a significant role in the##6##7##(1990-7#1)(2008-10#1)(2009-8#1)(2011-1#1)(2012-2#2)
to play a significant role in##14##6##(1990-7#1)(1996-7#1)(1997-4#1)(2006-12#1)(2008-10#3)(2008-7#1)(2009-8#1)(2011-1#2)(2012-2#2)(2013-8#1)
to play a significant role##16##5##(1990-7#1)(1996-7#1)(1997-4#1)(2005-11#1)(2006-12#1)(2008-10#3)(2008-7#1)(2009-8#1)(2011-1#3)(2012-2#2)(2013-8#1)
to play a##175##3##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#2)(1992-3#2)(1992-4#2)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-8#2)(1996-2#2)(1996-4#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-7#1)(2003-11#1)(2004-12#1)(2005-11#2)(2005-8#1)(2005-9#1)(2006-10#5)(2006-12#1)(2006-2#2)(2006-4#1)(2006-6#1)(2006-8#2)(2007-11#2)(2007-12#1)(2007-7#3)(2007-8#1)(2008-1#5)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#4)(2009-9#1)(2010-10#4)(2010-12#3)(2010-2#2)(2010-3#2)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#6)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#2)(2012-7#1)(2013-1#4)(2013-7#1)(2013-8#5)
to play after##2##3##(2009-5#2)
to play an active role##4##5##(1996-11#1)(1996-8#1)(2007-2#1)(2008-11#1)
to play an essential role in##2##6##(1992-9#1)(2005-10#1)
to play an important and##2##5##(1994-10#1)(2006-2#1)
to play an important role for##3##6##(1994-12#1)(2008-3#1)(2010-7#1)
to play an important role in regulating##2##7##(1996-5#1)(2010-11#1)
to play an important role in the pathogenesis of##4##9##(2006-10#1)(2006-9#1)(2007-1#1)(2011-1#1)
to play an important role in the##19##7##(1990-4#1)(1991-3#1)(1992-11#1)(1993-9#1)(1994-2#1)(1994-4#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-6#1)(2006-10#1)(2006-9#1)(2007-1#1)(2008-3#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)
to play an important role in this##2##7##(2008-7#1)(2010-8#1)
to play an important role in##60##6##(1990-4#1)(1991-3#1)(1992-11#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-4#1)(1994-8#1)(1995-12#2)(1995-3#1)(1995-8#1)(1996-10#1)(1996-12#3)(1996-2#2)(1996-5#1)(1996-6#1)(1997-3#1)(1997-6#1)(1997-8#2)(2004-1#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#3)(2009-2#1)(2009-4#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-8#2)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
to play an important role##67##5##(1990-4#1)(1991-3#1)(1992-11#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-8#1)(1995-12#2)(1995-3#1)(1995-8#1)(1996-10#1)(1996-12#3)(1996-2#2)(1996-5#1)(1996-6#1)(1997-3#1)(1997-6#1)(1997-8#3)(2004-1#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#3)(2009-2#1)(2009-4#1)(2009-8#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
to play an important##70##4##(1990-4#1)(1991-3#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-8#1)(1995-12#2)(1995-3#1)(1995-8#1)(1996-10#1)(1996-12#3)(1996-2#2)(1996-5#1)(1996-6#1)(1997-3#1)(1997-6#1)(1997-8#3)(2004-1#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#3)(2009-2#1)(2009-4#1)(2009-8#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
to play an##80##3##(1990-11#1)(1990-4#1)(1991-12#1)(1991-3#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-8#1)(1995-12#2)(1995-3#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-8#3)(2004-1#1)(2005-10#2)(2006-10#2)(2006-2#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#3)(2008-9#3)(2009-2#1)(2009-4#1)(2009-8#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
to play central roles in##2##5##(1996-9#1)(2012-2#1)
to play critical roles in##2##5##(2009-10#1)(2011-1#1)
to play critical##3##3##(2009-10#1)(2011-1#2)
to play important roles in the##2##6##(1996-10#1)(2011-2#1)
to play important roles in##15##5##(1996-10#1)(1997-7#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#1)
to play important roles##17##4##(1996-10#1)(1997-7#1)(2006-12#1)(2006-8#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#1)
to play important##19##3##(1996-10#1)(1997-7#1)(2006-12#1)(2006-8#1)(2007-11#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#1)
to play in this##2##4##(1997-2#1)(2008-7#1)
to play in##20##3##(1992-3#1)(1997-2#1)(2006-5#1)(2007-2#1)(2007-6#1)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
to play key roles in##2##5##(2007-8#1)(2009-8#1)
to play little##2##3##(1996-8#1)(2008-7#1)
to play no##2##3##(1991-1#1)(2007-3#1)
to play roles in##4##4##(2007-12#1)(2008-8#1)(2009-10#1)(2009-8#1)
to play some##2##3##(2006-4#1)(2012-2#1)
to play the role of##2##5##(1990-12#1)(1993-12#1)
to play the##3##3##(1990-12#1)(1993-12#1)(1997-4#1)
to play their##2##3##(2010-3#1)(2010-8#1)
to play with##2##3##(2008-4#1)(2011-1#1)
to play##341##2##(1990-11#2)(1990-12#3)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#3)(1992-4#2)(1992-6#2)(1992-8#3)(1992-9#3)(1993-11#2)(1993-12#3)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#3)(1994-4#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-8#3)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#4)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#5)(1997-6#1)(1997-7#2)(1997-8#3)(2003-11#1)(2004-1#1)(2004-12#1)(2005-10#2)(2005-11#2)(2005-8#1)(2005-9#1)(2006-10#8)(2006-12#2)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#9)(2008-11#11)(2008-12#2)(2008-2#4)(2008-3#6)(2008-4#12)(2008-5#4)(2008-6#2)(2008-7#10)(2008-8#6)(2008-9#6)(2009-10#3)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#2)(2009-8#8)(2009-9#1)(2010-10#5)(2010-11#3)(2010-12#9)(2010-2#3)(2010-3#4)(2010-4#1)(2010-5#1)(2010-7#3)(2010-8#5)(2011-1#10)(2011-2#7)(2012-1#2)(2012-12#3)(2012-2#6)(2012-3#2)(2012-7#1)(2013-1#9)(2013-7#2)(2013-8#6)
to please patients##2##3##(1996-3#1)(2012-3#1)
to please##4##2##(1996-3#1)(2008-12#1)(2010-8#1)(2012-3#1)
to plot##3##2##(1995-8#1)(2008-10#2)
to plots##2##2##(1990-11#1)(2008-10#1)
to pneumococcal##2##2##(2011-2#2)
to pneumonia##3##2##(1992-6#1)(2011-12#1)(2013-8#1)
to point at##2##3##(1993-7#1)(2009-2#1)
to point out the##3##4##(1996-12#1)(2007-10#1)(2009-4#1)
to point out##6##3##(1996-12#1)(2007-10#1)(2008-10#1)(2008-6#1)(2009-4#1)(2009-7#1)
to point to##3##3##(1997-1#1)(2010-5#1)(2012-3#1)
to point towards##2##3##(2006-2#1)(2011-2#1)
to point##18##2##(1991-8#1)(1993-7#1)(1996-12#1)(1997-1#1)(2006-2#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-7#2)
to poison##2##2##(2007-6#1)(2007-8#1)
to poisoning##4##2##(1995-1#1)(1997-3#2)(2012-12#1)
to polar##2##2##(2007-12#1)(2008-11#1)
to polarization self-modulation##3##3##(2007-11#3)
to polarization##11##2##(2006-7#1)(2007-11#3)(2007-12#2)(2008-1#2)(2008-2#1)(2008-3#2)
to polarize##3##2##(1993-8#2)(2009-10#1)
to polarized light##2##3##(2007-12#2)
to polarized##6##2##(2007-12#2)(2008-7#2)(2009-8#2)
to pole##2##2##(2007-12#1)(2007-9#1)
to police##2##2##(1993-2#1)(2005-9#1)
to policy makers and##2##4##(1997-2#1)(2013-1#1)
to policy makers##6##3##(1994-1#2)(1997-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
to policy##11##2##(1991-2#1)(1993-3#1)(1994-1#2)(1997-2#1)(2005-11#1)(2008-1#1)(2008-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
to policy-makers##3##2##(2007-7#1)(2012-12#2)
to polio##2##2##(2007-10#1)(2012-12#1)
to pollen tube##2##3##(2009-12#1)(2009-8#1)
to pollen##5##2##(2009-10#1)(2009-12#1)(2009-8#1)(2011-2#1)(2013-1#1)
to pollutant##3##2##(1992-4#1)(2005-11#1)(2008-10#1)
to polluted water##2##3##(2012-2#2)
to polluted##4##2##(1991-4#1)(2010-5#1)(2012-2#2)
to pollution##2##2##(2007-10#1)(2008-8#1)
to poly##3##2##(1990-10#1)(1991-12#1)(2007-11#1)
to poly(dA)##3##2##(1997-2#1)(2010-5#2)
to poly(dAdT)##2##2##(1995-2#2)
to poly(dG)##2##2##(1992-6#1)(1997-2#1)
to poly(dT) as##2##3##(1991-2#1)(1997-2#1)
to poly-L-lysine##2##2##(1990-8#1)(2005-7#1)
to polyarteritis nodosa##2##3##(1990-6#1)(2007-8#1)
to polychlorinated biphenyls##2##3##(1995-12#1)(2008-11#1)
to polyclonal##4##2##(1990-6#1)(1994-3#1)(2007-2#1)(2008-10#1)
to polycyclic aromatic hydrocarbons##3##4##(1992-3#2)(1995-11#1)
to polycyclic aromatic##4##3##(1992-3#2)(1995-11#1)(2012-2#1)
to polyethylene glycol##2##3##(1990-9#1)(2007-11#1)
to polyethylene##4##2##(1990-9#1)(2004-9#1)(2007-11#1)(2008-8#1)
to polymer##10##2##(1991-10#1)(1992-11#1)(1994-9#1)(1996-6#1)(2005-11#1)(2008-10#1)(2008-2#1)(2010-12#1)(2011-1#1)(2011-2#1)
to polymerase chain reaction (PCR)##2##5##(2008-10#1)(2011-2#1)
to polymerase chain reaction##5##4##(1991-9#1)(1994-2#1)(1994-6#1)(2008-10#1)(2011-2#1)
to polymerase##8##2##(1991-9#1)(1994-2#1)(1994-6#1)(1994-8#1)(1996-4#1)(2008-10#1)(2011-2#1)(2012-2#1)
to polymerization##2##2##(1994-9#1)(2008-10#1)
to polymers##2##2##(2006-2#2)
to polypeptide##2##2##(1991-8#1)(2005-10#1)
to polypharmacy##3##2##(2008-12#1)(2011-1#1)(2011-2#1)
to polystyrene##3##2##(1992-8#1)(1995-3#1)(2010-12#1)
to polyvinyl##2##2##(1992-7#1)(1996-11#1)
to pool##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
to poor health##2##3##(2008-7#1)(2011-2#1)
to poor palatability##2##3##(2008-9#2)
to poor prognosis##4##3##(1994-6#1)(2004-1#1)(2007-9#1)(2013-8#1)
to poor response##2##3##(2010-12#1)(2013-1#1)
to poor##53##2##(1990-6#1)(1991-12#1)(1992-7#1)(1993-3#1)(1994-6#1)(1997-6#1)(2004-1#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#3)(2008-3#1)(2008-6#2)(2008-7#1)(2008-9#6)(2009-12#1)(2009-4#2)(2009-7#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
to poorer##3##2##(2005-9#1)(2007-12#1)(2008-6#1)
to poorly##3##2##(2007-3#1)(2008-10#1)(2008-7#1)
to popular belief##5##3##(1993-1#1)(1997-3#1)(2008-5#1)(2009-9#1)(2012-3#1)
to popular##7##2##(1993-1#1)(1997-3#1)(2007-2#1)(2008-5#1)(2009-9#1)(2011-1#1)(2012-3#1)
to populate##5##2##(1992-5#1)(1993-6#1)(1995-11#1)(1995-2#1)(2006-7#1)
to population health##2##3##(2008-1#1)(2010-11#1)
to population##23##2##(1996-3#1)(1997-2#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-8#3)(2008-9#4)(2010-11#1)(2010-2#1)(2011-1#3)(2011-2#1)(2013-1#2)
to population-based surveys##2##3##(2008-12#1)(2010-2#1)
to populations in##3##3##(1992-3#1)(2005-7#1)(2012-3#1)
to populations of##2##3##(2012-2#2)
to populations##11##2##(1992-3#1)(1997-1#1)(2005-7#1)(2008-10#2)(2009-5#1)(2010-5#1)(2012-1#1)(2012-2#2)(2012-3#1)
to porcine##6##2##(1992-12#1)(1993-9#1)(1996-12#1)(1997-5#1)(2007-4#1)(2008-5#1)
to porous##3##2##(2008-11#1)(2008-5#1)(2010-9#1)
to portal hypertension##3##3##(2006-10#2)(2009-8#1)
to portal##6##2##(1993-12#3)(2006-10#2)(2009-8#1)
to portions of the##2##4##(1993-6#1)(1995-11#1)
to portions of##3##3##(1992-2#1)(1993-6#1)(1995-11#1)
to portray the##2##3##(1993-2#1)(2009-10#1)
to portray##5##2##(1993-2#1)(1996-3#1)(2006-7#1)(2007-6#1)(2009-10#1)
to pose a##9##3##(1994-6#1)(1994-7#1)(2007-11#1)(2007-12#1)(2008-11#1)(2009-4#1)(2009-9#1)(2010-6#1)(2010-9#1)
to pose questions##2##3##(1995-6#1)(2010-2#1)
to pose##20##2##(1991-12#1)(1994-6#1)(1994-7#1)(1995-6#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-6#2)(2010-9#1)
to position 6 of##2##4##(1991-7#1)(2008-4#1)
to position a##3##3##(1994-3#1)(2007-5#1)(2008-2#1)
to position the##6##3##(1990-10#1)(1993-8#1)(1995-5#1)(2006-3#1)(2007-8#1)(2008-9#1)
to position themselves for##2##4##(1992-6#1)(1997-1#1)
to position themselves##3##3##(1992-6#1)(1994-12#1)(1997-1#1)
to position##28##2##(1990-10#1)(1991-7#1)(1992-11#2)(1992-6#1)(1993-8#1)(1994-12#1)(1994-3#3)(1995-5#2)(1996-1#1)(1996-10#1)(1997-1#2)(1997-3#1)(1997-4#1)(2006-11#1)(2006-3#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-7#1)(2011-1#1)
to positions##5##2##(1990-7#1)(1997-9#1)(2006-11#1)(2007-10#1)(2008-3#1)
to positive and negative##2##4##(2010-3#1)(2013-8#1)
to positive and##3##3##(2009-4#1)(2010-3#1)(2013-8#1)
to positive or negative##2##4##(2008-10#2)
to positive outcomes##2##3##(2005-10#1)(2010-6#1)
to positive stimuli##2##3##(2008-4#1)(2010-3#1)
to positive##34##2##(1990-10#1)(1992-3#1)(1992-5#1)(2004-2#2)(2005-10#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-4#2)(2008-9#1)(2009-11#1)(2009-4#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2012-12#3)(2013-1#3)(2013-8#3)
to positively affect##2##3##(1995-12#1)(2007-9#1)
to positively##8##2##(1995-12#1)(2007-4#1)(2007-9#1)(2008-10#3)(2008-5#1)(2008-7#1)
to posses##3##2##(2007-1#1)(2008-12#1)(2008-5#1)
to possess a##7##3##(1997-5#1)(2007-12#1)(2008-5#2)(2009-2#1)(2011-12#1)(2013-1#1)
to possess an##6##3##(1996-9#1)(1997-1#2)(2008-5#1)(2009-8#1)(2010-10#1)
to possess both##2##3##(1990-5#1)(2008-10#1)
to possess greater##3##3##(2005-11#1)(2006-9#1)(2009-4#1)
to possess high##2##3##(1993-4#1)(2010-12#1)
to possess more##3##3##(2008-5#2)(2008-8#1)
to possess neuroprotective##2##3##(2008-1#1)(2008-11#1)
to possess remarkable##2##3##(1992-2#1)(2008-5#1)
to possess the##5##3##(1993-8#1)(2008-10#3)(2008-11#1)
to possess##93##2##(1990-5#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-2#2)(1992-3#4)(1992-6#1)(1992-7#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-8#2)(1994-12#1)(1994-5#2)(1995-1#3)(1995-5#1)(1995-8#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-5#1)(1997-6#1)(2004-9#1)(2005-11#1)(2005-7#1)(2006-12#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#9)(2008-8#2)(2009-11#1)(2009-12#2)(2009-2#2)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#3)
to possible mechanisms##2##3##(1991-12#1)(2005-7#1)
to possible##29##2##(1990-3#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-2#1)(1993-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1996-4#1)(1996-6#1)(1996-8#1)(2005-7#1)(2006-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
to possibly##3##2##(1992-7#1)(2008-11#1)(2009-12#1)
to post##7##2##(1996-11#1)(2006-8#1)(2007-4#1)(2007-9#1)(2008-5#1)(2009-6#1)(2013-8#1)
to post-test and##2##3##(2008-12#1)(2010-2#1)
to post-traumatic##2##2##(1991-2#1)(2007-11#1)
to posterior##12##2##(1997-8#1)(2006-12#1)(2006-7#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
to postmenopausal##3##2##(1991-4#1)(2008-4#1)(2012-3#1)
to postnatal day##8##3##(1991-7#1)(1993-3#1)(1996-1#1)(1996-3#1)(1996-4#1)(1997-7#1)(2005-7#1)(2008-7#1)
to postnatal##9##2##(1991-7#1)(1993-3#1)(1996-1#1)(1996-3#1)(1996-4#1)(1997-7#1)(2005-7#1)(2008-7#1)(2009-2#1)
to postoperative complications##2##3##(1992-8#2)
to postoperative##15##2##(1992-8#2)(1993-9#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-10#1)(2011-2#2)(2013-1#1)(2013-8#1)
to postoperatively##2##2##(1994-2#1)(2007-11#1)
to postpartum##2##2##(2008-10#1)(2013-1#1)
to postpone or##2##3##(2011-2#2)
to postpone##6##2##(1997-7#1)(2007-9#1)(2008-6#1)(2011-2#2)(2012-2#1)
to posttest##2##2##(2008-12#1)(2010-10#1)
to posttranscriptional##3##2##(1994-8#1)(1995-2#1)(1996-12#1)
to posttraumatic stress disorder (PTSD)##2##5##(2008-8#1)(2013-1#1)
to postulate that##3##3##(1996-12#1)(1996-9#1)(2008-12#1)
to postulate##11##2##(1990-8#2)(1992-6#1)(1993-6#1)(1995-3#1)(1996-12#1)(1996-9#1)(2006-11#1)(2008-10#1)(2008-12#1)(2013-1#1)
to potassium##5##2##(1993-9#1)(1996-3#1)(2007-9#1)(2008-10#1)(2008-2#1)
to potato and tomato##2##4##(2008-10#2)
to potato and##3##3##(2008-10#3)
to potato late blight of##2##5##(2008-10#2)
to potato##12##2##(2008-10#12)
to potent##5##2##(1992-9#1)(1995-5#1)(1996-8#1)(2007-11#1)(2008-1#1)
to potential mechanisms of##2##4##(2008-11#1)(2008-5#1)
to potential participants##2##3##(2007-7#1)(2012-2#1)
to potential therapeutic##2##3##(1990-7#1)(2006-10#1)
to potential##36##2##(1990-7#1)(1993-1#1)(1994-1#1)(1997-7#1)(2006-10#2)(2007-11#1)(2007-2#1)(2007-7#2)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#5)(2008-9#1)(2009-7#1)(2010-5#1)(2010-9#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
to potentially enhance##2##3##(2008-5#1)(2008-7#1)
to potentially##22##2##(1990-8#1)(1993-1#1)(1994-3#1)(1995-9#1)(1996-12#1)(2004-10#1)(2005-7#1)(2006-6#1)(2007-10#1)(2007-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
to potentials more negative than##2##5##(1993-3#1)(1996-5#1)
to potentials more positive than##2##5##(1993-3#1)(1996-5#1)
to potentials more##4##3##(1993-3#2)(1996-5#2)
to potentiate the release of##2##5##(1990-12#1)(2012-12#1)
to potentiate the##11##3##(1990-12#1)(1990-8#2)(1991-4#1)(1993-6#1)(1995-12#1)(1996-11#1)(1996-5#1)(2006-10#1)(2012-1#1)(2012-12#1)
to potentiate##21##2##(1990-12#1)(1990-8#2)(1991-3#1)(1991-4#1)(1993-6#3)(1994-8#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-4#1)(2006-10#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-12#1)(2012-1#1)(2012-12#1)
to potentiometric##2##2##(2008-10#2)
to potently##2##2##(1994-5#1)(1994-8#1)
to poultry##2##2##(2008-5#1)(2011-2#1)
to poverty##3##2##(1993-1#1)(1995-9#1)(2007-6#1)
to powdery mildew in##4##4##(2008-10#4)
to powdery mildew##18##3##(2006-9#1)(2008-10#17)
to power##12##2##(1994-4#1)(2004-4#1)(2008-3#4)(2008-4#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
to practical applications of##2##4##(2008-10#1)(2012-2#1)
to practical applications##5##3##(2007-8#1)(2008-10#1)(2008-2#2)(2012-2#1)
to practical approaches for##2##4##(2009-8#1)(2011-2#1)
to practical issues##2##3##(1992-9#1)(2005-10#1)
to practical##17##2##(1990-9#1)(1992-9#1)(1996-1#1)(2005-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2009-2#1)(2009-8#1)(2011-2#1)(2012-2#1)
to practically any##2##3##(1993-3#1)(1994-12#1)
to practice and##3##3##(2006-3#1)(2008-12#1)(2010-10#1)
to practice in this##2##4##(2008-12#1)(2010-1#1)
to practice in##8##3##(2008-11#3)(2008-12#1)(2008-8#1)(2009-9#1)(2010-1#1)(2010-11#1)
to practice it##2##3##(2008-10#1)(2008-11#1)
to practice medicine##3##3##(1992-2#1)(2006-10#1)(2011-1#1)
to practice the##3##3##(2008-10#1)(2009-4#1)(2012-3#1)
to practice##79##2##(1992-2#1)(1993-1#1)(1993-12#2)(1993-3#1)(1996-2#2)(2004-10#1)(2005-12#1)(2005-7#2)(2005-9#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-10#3)(2008-11#14)(2008-12#5)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#3)(2013-1#6)(2013-8#2)
to practice'##2##2##(2008-11#1)(2008-12#1)
to practices##3##2##(2010-9#1)(2011-1#2)
to practicing##3##2##(2007-4#1)(2007-7#1)(2008-11#1)
to practise in a##2##4##(2006-8#1)(2011-2#1)
to practise in##3##3##(1997-5#1)(2006-8#1)(2011-2#1)
to practise##10##2##(1990-4#1)(1997-5#1)(2005-8#1)(2006-8#1)(2011-2#4)(2013-8#2)
to practising##2##2##(1995-11#1)(2005-9#1)
to practitioners working##2##3##(2006-11#1)(2012-12#1)
to practitioners##5##2##(2006-11#1)(2008-10#1)(2008-11#1)(2009-8#1)(2012-12#1)
to pray##4##2##(2010-2#4)
to praziquantel##6##2##(2006-10#2)(2012-3#4)
to pre-existing##4##2##(2007-11#1)(2008-7#1)(2012-12#1)(2012-5#1)
to pre-mRNA##2##2##(1991-9#2)
to pre-translational##2##2##(1995-3#2)
to pre-treat##2##2##(2008-10#2)
to pre-treatment##4##2##(1990-12#1)(2006-4#1)(2008-3#1)(2011-1#1)
to precede the##3##3##(1994-11#1)(1994-3#1)(2013-8#1)
to precede##5##2##(1994-11#1)(1994-3#1)(2006-2#1)(2009-10#1)(2013-8#1)
to precipitate and##2##3##(2008-5#1)(2008-9#1)
to precipitate the##7##3##(1993-8#1)(1996-6#1)(2004-9#1)(2008-2#1)(2008-4#1)(2009-2#1)(2013-8#1)
to precipitate##16##2##(1992-12#1)(1993-8#1)(1996-2#1)(1996-6#1)(2004-9#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-4#3)(2008-5#1)(2008-9#1)(2009-2#1)(2013-8#1)
to precipitation of##3##3##(1991-12#1)(2008-2#1)(2011-1#1)
to precipitation##5##2##(1991-12#1)(2008-2#1)(2008-8#1)(2011-1#1)(2011-12#1)
to precise##5##2##(2005-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)
to precisely define the##2##4##(2010-6#1)(2012-12#1)
to precisely evaluate the##2##4##(2008-10#1)(2012-2#1)
to precisely predict##2##3##(2004-2#1)(2008-10#1)
to precisely##23##2##(1997-1#1)(2004-1#1)(2004-2#1)(2006-7#1)(2007-11#1)(2007-5#1)(2008-10#3)(2008-3#2)(2008-7#2)(2009-5#1)(2009-8#2)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
to preclude##2##2##(2007-4#1)(2009-3#1)
to precocious and##2##3##(2007-12#1)(2010-5#1)
to precocious##3##2##(1994-11#1)(2007-12#1)(2010-5#1)
to preconcentrate##8##2##(2008-10#8)
to preconcentration##2##2##(2008-10#2)
to predation risk##2##3##(2008-9#1)(2010-8#1)
to predation##5##2##(2008-9#1)(2010-8#3)(2012-3#1)
to predator##3##2##(2008-4#2)(2008-9#1)
to predators and##2##3##(2008-4#1)(2008-8#1)
to predators##5##2##(2008-4#1)(2008-8#2)(2008-9#1)(2013-1#1)
to predefined##5##2##(1995-4#1)(2007-9#1)(2008-10#1)(2009-11#1)(2013-8#1)
to predict Fusarium##2##3##(2008-10#2)
to predict a##9##3##(1990-8#2)(1994-10#1)(2004-4#1)(2006-6#1)(2007-9#1)(2008-10#1)(2009-4#1)(2010-2#1)
to predict accurately##2##3##(2007-12#1)(2008-5#1)
to predict and compare the##2##5##(2011-2#1)(2013-1#1)
to predict and compare##3##4##(1996-1#1)(2011-2#1)(2013-1#1)
to predict and##7##3##(1996-1#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
to predict anger and aggression##2##5##(2009-4#2)
to predict bacterial pneumonia##2##4##(2010-12#2)
to predict because##2##3##(1996-8#1)(2005-8#1)
to predict both##4##3##(2004-12#1)(2007-4#1)(2008-2#1)(2009-6#1)
to predict carcinogenicity##2##3##(1995-6#2)
to predict changes##2##3##(2008-2#1)(2008-8#1)
to predict chemical##2##3##(2010-4#2)
to predict clinical##2##3##(2005-8#1)(2012-12#1)
to predict disease severity##2##4##(2008-10#2)
to predict disease##6##3##(2005-8#1)(2008-10#2)(2008-6#1)(2010-12#1)(2011-1#1)
to predict future##3##3##(1990-11#1)(1991-2#1)(2008-11#1)
to predict globe rupture##2##4##(2006-11#2)
to predict how##4##3##(2007-3#1)(2008-5#1)(2011-2#1)(2012-2#1)
to predict in vivo##3##4##(1995-7#1)(2008-11#1)(2008-5#1)
to predict in##5##3##(1995-7#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-8#1)
to predict long-term##2##3##(1994-7#1)(1995-11#1)
to predict meat##2##3##(2010-4#2)
to predict mortality##3##3##(2006-10#1)(2008-3#1)(2009-4#1)
to predict or##2##3##(2008-2#1)(2009-12#1)
to predict positive##2##3##(2006-2#1)(2008-10#1)
to predict postoperative##2##3##(2007-8#1)(2012-2#1)
to predict potential##2##3##(2008-8#1)(2012-12#1)
to predict protein##2##3##(2008-7#1)(2013-8#1)
to predict radiological##3##3##(1996-11#1)(2013-1#2)
to predict renal##2##3##(2006-10#1)(2006-8#1)
to predict response##3##3##(1992-3#1)(1995-10#1)(2012-2#1)
to predict responses##2##3##(1993-11#1)(2010-12#1)
to predict risk##3##3##(2010-7#1)(2012-1#1)(2013-1#1)
to predict severity##2##3##(2008-10#2)
to predict success in##2##4##(1992-2#1)(2013-7#1)
to predict that a##2##4##(1996-1#1)(2009-5#1)
to predict that##5##3##(1995-8#1)(1996-1#1)(2007-12#1)(2008-7#1)(2009-5#1)
to predict the accuracy of##2##5##(2008-2#1)(2010-2#1)
to predict the average##2##4##(2005-11#1)(2008-7#1)
to predict the clinical course##2##5##(2008-7#1)(2010-7#1)
to predict the clinical##4##4##(1995-4#1)(2008-7#1)(2010-7#1)(2012-1#1)
to predict the concentration##2##4##(2008-10#1)(2010-4#1)
to predict the consequences of##3##5##(1992-3#1)(2008-7#1)(2010-9#1)
to predict the distribution and##2##5##(2008-8#2)
to predict the effect of##5##5##(2008-3#2)(2008-7#2)(2012-2#1)
to predict the effects of##2##5##(2008-2#1)(2010-9#1)
to predict the efficacy of##2##5##(1996-12#1)(2008-5#1)
to predict the exact##2##4##(1995-11#1)(2008-10#1)
to predict the existence of##2##5##(1997-9#1)(2007-12#1)
to predict the extent and##2##5##(1997-2#1)(2012-12#1)
to predict the flow##2##4##(2008-11#1)(2008-7#1)
to predict the function of newly##2##6##(2008-4#1)(2009-5#1)
to predict the function of##3##5##(2008-4#1)(2009-5#1)(2010-2#1)
to predict the future##2##4##(1993-2#1)(2007-11#1)
to predict the immune##2##4##(2008-10#2)
to predict the impact of##2##5##(2008-10#1)(2008-8#1)
to predict the impact##3##4##(1997-3#1)(2008-10#1)(2008-8#1)
to predict the incidence of##2##5##(2008-10#1)(2009-3#1)
to predict the intensity statistics of the light##2##8##(2007-12#1)(2008-2#1)
to predict the intensity##3##4##(2007-12#1)(2008-2#2)
to predict the likelihood of##3##5##(2009-6#1)(2011-2#1)(2012-12#1)
to predict the most##2##4##(2010-8#1)(2013-8#1)
to predict the number##2##4##(2008-11#1)(2012-12#1)
to predict the onset of##2##5##(1992-1#1)(2008-10#1)
to predict the outcome of##3##5##(1990-8#1)(1994-2#1)(2007-7#1)
to predict the outcome##4##4##(1990-8#1)(1994-2#1)(2007-7#1)(2012-1#1)
to predict the potential##2##4##(1996-3#1)(2013-8#1)
to predict the presence of##4##5##(2007-10#1)(2008-10#1)(2012-3#2)
to predict the prognosis of##2##5##(2010-6#1)(2010-8#1)
to predict the response##2##4##(2005-10#1)(2012-2#1)
to predict the risk of##3##5##(2006-9#1)(2011-2#1)(2013-1#1)
to predict the severity of##2##5##(2008-10#1)(2010-8#1)
to predict the shape and##2##5##(2008-10#1)(2008-2#1)
to predict the stability of##2##5##(1996-4#1)(2008-6#1)
to predict the value of##2##5##(2008-3#1)(2008-8#1)
to predict the##192##3##(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-4#1)(1995-6#1)(1995-8#2)(1996-12#3)(1996-3#1)(1996-4#3)(1997-2#2)(1997-3#3)(1997-4#2)(1997-7#1)(1997-8#1)(1997-9#1)(2005-10#1)(2005-11#6)(2005-8#1)(2006-11#1)(2006-5#1)(2006-9#2)(2007-10#2)(2007-11#2)(2007-12#5)(2007-4#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#21)(2008-11#2)(2008-2#12)(2008-3#13)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#11)(2008-8#10)(2008-9#1)(2009-11#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-12#1)(2010-2#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#2)(2011-2#5)(2012-1#3)(2012-11#3)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#2)
to predict their##2##3##(2007-11#1)(2008-11#1)
to predict this##2##3##(1995-4#1)(2007-11#1)
to predict vaccine equivalence##2##4##(1995-5#2)
to predict violent##2##3##(1996-2#1)(2009-7#1)
to predict whether##4##3##(2008-10#1)(2010-5#1)(2010-8#2)
to predict which##6##3##(1994-2#1)(2007-11#1)(2008-10#1)(2012-1#1)(2013-1#2)
to predict who will##2##4##(2008-3#1)(2008-7#1)
to predict##493##2##(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-12#2)(1991-2#2)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#1)(1993-11#1)(1993-2#2)(1993-5#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-7#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-4#2)(1995-5#2)(1995-6#5)(1995-7#1)(1995-8#4)(1996-1#3)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-4#4)(1996-5#1)(1996-8#3)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#3)(1997-5#1)(1997-7#1)(1997-8#2)(1997-9#1)(2004-10#1)(2004-12#2)(2004-2#1)(2004-4#1)(2005-10#2)(2005-11#7)(2005-8#4)(2006-10#6)(2006-11#3)(2006-12#4)(2006-2#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#3)(2007-1#1)(2007-10#5)(2007-11#6)(2007-12#10)(2007-3#2)(2007-4#5)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#7)(2007-9#1)(2008-1#3)(2008-10#49)(2008-11#6)(2008-12#2)(2008-2#20)(2008-3#20)(2008-4#5)(2008-5#10)(2008-6#7)(2008-7#18)(2008-8#21)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#3)(2009-4#6)(2009-5#3)(2009-6#3)(2009-7#4)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#6)(2010-2#6)(2010-3#1)(2010-4#12)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#8)(2010-9#2)(2011-1#5)(2011-12#2)(2011-2#14)(2012-1#5)(2012-11#4)(2012-12#8)(2012-2#11)(2012-3#9)(2013-1#20)(2013-7#4)(2013-8#5)
to predicted##4##2##(1991-10#1)(1992-3#1)(1996-10#1)(2008-12#1)
to predicting##7##2##(1995-5#2)(2004-4#1)(2008-11#1)(2010-1#1)(2011-12#1)(2013-8#1)
to prediction of##3##3##(2008-5#1)(2008-7#1)(2009-10#1)
to prediction##4##2##(2006-11#1)(2008-5#1)(2008-7#1)(2009-10#1)
to predictions of the##2##4##(2008-9#1)(2011-1#1)
to predictions of##3##3##(2008-9#1)(2009-9#1)(2011-1#1)
to predictions##6##2##(2008-10#1)(2008-9#1)(2009-9#1)(2010-7#1)(2011-1#1)(2012-2#1)
to predispose to##2##3##(1993-10#1)(2007-8#1)
to prednisone therapy##2##3##(2005-8#1)(2006-10#1)
to prednisone##3##2##(2005-8#1)(2006-10#2)
to predominant##2##2##(2012-1#1)(2012-2#1)
to predominantly##3##2##(1992-11#1)(1992-4#1)(2008-8#1)
to predominate in##2##3##(2008-10#2)
to predominate##3##2##(2006-10#1)(2008-10#2)
to prefer##9##2##(2005-11#1)(2007-4#1)(2007-6#1)(2008-11#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-12#1)
to preferential##3##2##(1997-7#1)(2005-8#1)(2012-12#1)
to preferentially##12##2##(1993-6#1)(1993-7#1)(1993-9#1)(1995-12#1)(1995-5#1)(1997-1#1)(1997-5#1)(2008-10#1)(2008-7#1)(2009-11#1)(2012-1#1)(2013-1#1)
to preformed##3##2##(1990-11#2)(1992-3#1)
to pregnancy (e##2##3##(2007-9#2)
to pregnancy and##5##3##(1990-4#1)(2008-10#1)(2009-1#1)(2009-4#1)(2012-12#1)
to pregnancy outcome##2##3##(2007-3#1)(2008-11#1)
to pregnancy##24##2##(1990-4#1)(1992-5#2)(1992-7#1)(1994-4#1)(1995-2#1)(1996-11#1)(2006-10#2)(2007-12#1)(2007-3#1)(2007-7#1)(2007-9#3)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-1#1)(2009-4#1)(2012-1#1)(2012-12#1)(2013-1#1)
to pregnant rats##4##3##(1994-11#1)(1996-4#1)(2008-3#1)(2008-4#1)
to pregnant women is##2##4##(1992-11#1)(2013-1#1)
to pregnant women##7##3##(1992-11#1)(1996-6#1)(2007-2#2)(2009-1#1)(2009-10#1)(2013-1#1)
to pregnant##16##2##(1992-11#1)(1993-4#1)(1994-11#1)(1996-4#2)(1996-6#1)(2007-2#4)(2008-3#1)(2008-4#1)(2008-8#1)(2009-1#1)(2009-10#1)(2013-1#1)
to pregnenolone##2##2##(1990-3#1)(1991-10#1)
to prejudice##2##2##(1996-12#1)(2012-3#1)
to preliminary##3##2##(1992-11#1)(2005-8#1)(2008-10#1)
to premature death##3##3##(2012-12#3)
to premature##15##2##(1990-3#1)(1994-3#1)(1996-1#1)(2005-10#3)(2007-11#1)(2008-4#2)(2008-5#1)(2010-11#1)(2010-5#1)(2012-12#3)
to prematurely##4##2##(1997-4#2)(2011-2#1)(2012-3#1)
to premenopausal##4##2##(1991-4#1)(1991-8#1)(2004-2#1)(2008-3#1)
to prenatal care##4##3##(2008-10#1)(2008-11#1)(2009-7#2)
to prenatal##8##2##(1997-3#1)(2008-10#2)(2008-11#1)(2009-7#2)(2011-1#1)(2011-2#1)
to preoperative chemotherapy was##3##4##(2008-1#1)(2010-3#2)
to preoperative chemotherapy##4##3##(2008-1#1)(2010-3#3)
to preoperative planning##2##3##(2008-7#1)(2011-1#1)
to preoperative values##3##3##(1991-2#1)(2011-1#1)(2013-1#1)
to preoperative##24##2##(1991-2#1)(1995-4#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-7#3)(2009-10#1)(2009-12#1)(2009-2#1)(2010-3#3)(2010-7#1)(2011-1#2)(2011-2#3)(2013-1#1)(2013-7#1)
to preoperatively##2##2##(2011-1#1)(2013-7#1)
to preparation and##2##3##(2007-9#1)(2008-9#1)
to preparation of the##2##4##(2008-10#1)(2008-4#1)
to preparation of##5##3##(2005-10#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-4#1)
to preparation##9##2##(2005-10#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-9#1)(2013-1#2)
to preparations##2##2##(1990-3#1)(1995-1#1)
to preparative##2##2##(2008-10#2)
to prepare &quot##2##3##(1990-12#1)(1991-12#1)
to prepare a new##2##4##(2012-12#1)(2013-8#1)
to prepare a##24##3##(1990-11#1)(1993-12#1)(1993-3#1)(1993-7#1)(1995-2#1)(2006-5#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#2)(2008-9#1)(2010-7#1)(2012-12#2)(2013-7#1)(2013-8#2)
to prepare an##4##3##(1994-12#1)(2006-10#1)(2008-10#2)
to prepare and##10##3##(1993-11#1)(1997-6#1)(2008-10#3)(2008-4#1)(2008-5#1)(2010-12#1)(2010-7#1)(2012-12#1)
to prepare for a##3##4##(1993-7#1)(2012-2#2)
to prepare for the##3##4##(2006-4#1)(2007-12#1)(2012-3#1)
to prepare for##12##3##(1993-2#1)(1993-7#1)(2005-9#1)(2006-4#1)(2007-12#1)(2007-2#2)(2012-2#4)(2012-3#1)
to prepare inorganic##2##3##(2008-10#1)(2010-4#1)
to prepare magnetic##2##3##(2010-12#2)
to prepare new##3##3##(1997-7#1)(2010-5#1)(2012-3#1)
to prepare nurses##3##3##(2005-12#1)(2008-11#2)
to prepare patients for surgery##2##5##(2006-10#2)
to prepare taste##2##3##(2008-10#1)(2012-3#1)
to prepare the##26##3##(1990-8#1)(1991-12#1)(1994-9#1)(1995-8#1)(1997-2#1)(2005-11#2)(2005-12#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2009-4#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-7#1)
to prepare them for the##2##5##(2008-12#1)(2010-3#1)
to prepare them for##4##4##(2008-12#2)(2010-3#1)(2013-1#1)
to prepare them##7##3##(1991-11#1)(1993-3#1)(2008-12#2)(2008-4#1)(2010-3#1)(2013-1#1)
to prepare##184##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-8#1)(1992-12#2)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-7#2)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#4)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#3)(2005-12#3)(2005-7#1)(2005-9#1)(2006-10#3)(2006-12#3)(2006-4#1)(2006-5#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#26)(2008-11#7)(2008-12#5)(2008-2#4)(2008-3#1)(2008-4#6)(2008-5#8)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#3)(2009-4#2)(2009-5#3)(2009-8#1)(2010-10#1)(2010-12#4)(2010-3#1)(2010-4#3)(2010-5#2)(2010-7#5)(2011-1#2)(2011-2#1)(2011-3#2)(2012-1#1)(2012-10#1)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#1)(2013-7#2)(2013-8#3)
to preparing##3##2##(2008-11#1)(2008-12#1)(2008-4#1)
to prescribe a##3##3##(1990-5#1)(1994-4#1)(1996-11#1)
to prescribe antibiotics##3##3##(1997-4#2)(2006-10#1)
to prescribe than##2##3##(2006-12#1)(2009-7#1)
to prescribe##20##2##(1990-12#1)(1990-5#1)(1992-2#1)(1993-2#1)(1994-4#1)(1996-11#1)(1996-8#1)(1997-4#2)(2006-10#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-7#1)(2009-9#1)(2011-1#1)
to prescribed##2##2##(1993-9#1)(2010-12#1)
to prescribers##2##2##(2008-8#1)(2009-3#1)
to prescribing##2##2##(2008-8#1)(2011-2#1)
to prescription##3##2##(1995-11#1)(2008-8#1)(2010-3#1)
to presence of##3##3##(2007-5#1)(2008-10#1)(2008-7#1)
to presence##4##2##(2007-5#1)(2008-10#2)(2008-7#1)
to present a case of##4##5##(2011-2#1)(2012-12#2)(2012-2#1)
to present a case##6##4##(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#2)
to present a clinical##2##4##(2008-6#1)(2013-1#1)
to present a comprehensive review of the literature##2##8##(2011-1#1)(2012-2#1)
to present a comprehensive##3##4##(2005-8#1)(2011-1#1)(2012-2#1)
to present a major challenge to##2##6##(2008-10#1)(2010-1#1)
to present a new##2##4##(2008-10#1)(2008-11#1)
to present a perspective##2##4##(2008-12#1)(2012-2#1)
to present a##35##3##(1992-10#1)(1993-12#1)(1994-6#1)(2005-8#1)(2006-10#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#1)
to present an overview of the##2##6##(2007-1#1)(2013-1#1)
to present an overview of##4##5##(2007-1#1)(2008-1#1)(2010-5#1)(2013-1#1)
to present an overview##5##4##(2007-1#1)(2008-1#1)(2010-10#1)(2010-5#1)(2013-1#1)
to present an unusual case of##2##6##(2011-1#1)(2013-1#1)
to present an##12##3##(1997-3#1)(2007-1#1)(2007-3#1)(2007-7#1)(2008-1#1)(2009-6#1)(2010-10#1)(2010-5#1)(2011-1#2)(2013-1#2)
to present and analyse##2##4##(2008-10#1)(2008-11#1)
to present and discuss##3##4##(2005-7#1)(2008-5#1)(2013-1#1)
to present and##7##3##(2005-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#1)
to present antigen##2##3##(1992-8#1)(1995-8#1)
to present evidence##2##3##(1990-5#1)(2008-6#1)
to present our##2##3##(2007-8#1)(2012-12#1)
to present results##3##3##(2006-5#1)(2008-12#1)(2011-2#1)
to present some of the##2##5##(2008-12#1)(2013-1#1)
to present some##4##3##(2006-10#1)(2008-12#1)(2009-4#1)(2013-1#1)
to present the case of a##2##6##(2008-5#1)(2012-3#1)
to present the current##2##4##(2007-11#1)(2008-5#1)
to present the most##3##4##(2005-10#1)(2011-2#1)(2012-2#1)
to present the results of##2##5##(2007-11#1)(2011-2#1)
to present the results##3##4##(2007-11#1)(2011-2#1)(2013-8#1)
to present the technique##2##4##(2007-8#1)(2008-10#1)
to present the##43##3##(1996-3#1)(1997-3#1)(2005-10#1)(2006-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-5#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
to present their##2##3##(2007-8#1)(2012-2#1)
to present this##3##3##(2007-7#1)(2008-6#1)(2013-1#1)
to present to##4##3##(1996-6#1)(2009-9#1)(2010-8#1)(2012-2#1)
to present various##2##3##(1997-6#1)(2007-8#1)
to present with##7##3##(2006-1#1)(2007-12#1)(2008-4#1)(2008-6#1)(2009-11#1)(2011-2#1)(2012-2#1)
to present##202##2##(1990-5#2)(1991-4#1)(1992-1#1)(1992-10#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-2#2)(1994-6#1)(1994-8#1)(1995-8#3)(1996-1#1)(1996-11#1)(1996-3#2)(1996-6#1)(1997-3#2)(1997-6#1)(1997-8#1)(2005-10#1)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#13)(2006-12#1)(2006-4#1)(2006-5#2)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#2)(2007-7#5)(2007-8#9)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#7)(2008-6#4)(2008-7#4)(2008-9#4)(2009-11#2)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#14)(2012-12#11)(2012-2#9)(2012-3#3)(2013-1#8)(2013-7#2)(2013-8#3)
to presentation##10##2##(1991-12#1)(2005-8#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-3#1)(2012-11#1)(2013-1#1)
to presentations##2##2##(2008-5#1)(2008-7#1)
to presenting##4##2##(2008-12#1)(2008-2#1)(2013-1#2)
to preserve a##3##3##(1996-8#1)(2008-3#1)(2009-10#1)
to preserve edges that##2##4##(2008-2#2)
to preserve fertility##3##3##(2008-5#1)(2009-2#1)(2012-3#1)
to preserve or##3##3##(1993-3#1)(2004-10#1)(2008-5#1)
to preserve perfusion##4##3##(2012-12#4)
to preserve renal function##2##4##(1996-9#1)(2011-2#1)
to preserve renal##3##3##(1996-9#1)(2007-7#1)(2011-2#1)
to preserve the##27##3##(1991-9#1)(1993-5#1)(1993-7#1)(1997-5#1)(2006-10#1)(2006-6#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#4)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#3)(2010-1#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)
to preserve their##6##3##(2007-11#1)(2008-3#1)(2009-7#1)(2010-4#1)(2012-2#1)(2013-1#1)
to preserve these##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)
to preserve##91##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-9#1)(1993-3#1)(1993-5#1)(1993-7#1)(1994-2#1)(1995-12#1)(1995-4#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-5#1)(2004-10#1)(2005-1#1)(2006-10#2)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#5)(2007-7#2)(2007-8#1)(2007-9#2)(2008-10#5)(2008-2#5)(2008-3#5)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-7#2)(2010-1#1)(2010-12#1)(2010-3#3)(2010-4#2)(2010-8#1)(2011-2#5)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#3)
to preserved##6##2##(1992-8#1)(2008-10#1)(2011-2#1)(2012-1#1)(2013-1#2)
to preserving the##2##3##(1991-3#1)(1997-8#1)
to preserving##5##2##(1991-3#2)(1997-8#1)(2010-5#1)(2012-1#1)
to press a##3##3##(1992-11#1)(1992-9#1)(1993-5#1)
to press##9##2##(1992-11#1)(1992-3#1)(1992-9#1)(1993-5#1)(2006-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-8#1)
to pressure and##2##3##(1992-1#1)(1995-1#1)
to pressure on the##2##4##(1996-8#1)(2009-1#1)
to pressure symptoms##2##3##(2008-6#1)(2010-2#1)
to pressure##21##2##(1990-3#1)(1991-9#1)(1992-1#2)(1995-1#1)(1995-4#1)(1996-8#1)(1997-3#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-1#1)(2010-2#1)(2010-4#1)(2012-3#1)
to pressures##3##2##(1995-2#1)(2005-12#1)(2008-2#1)
to presumed##2##2##(1995-8#1)(2010-5#1)
to presynaptic##2##2##(1993-6#1)(2008-7#1)
to preterm##4##2##(2006-10#1)(2007-2#1)(2008-11#1)(2013-1#1)
to pretreatment levels of##2##4##(1996-2#1)(2007-10#1)
to pretreatment levels##4##3##(1995-12#1)(1996-2#1)(2007-10#1)(2008-8#1)
to pretreatment##7##2##(1995-12#1)(1996-2#1)(2007-10#2)(2007-9#1)(2008-6#1)(2008-8#1)
to prevail in##2##3##(1997-1#1)(2009-2#1)
to prevail##3##2##(1995-3#1)(1997-1#1)(2009-2#1)
to prevailing##2##2##(2007-12#1)(2011-12#1)
to prevalence of##3##3##(2006-8#1)(2009-12#1)(2010-4#1)
to prevalence##4##2##(2006-8#1)(2008-9#1)(2009-12#1)(2010-4#1)
to prevalent##2##2##(2006-2#1)(2008-8#1)
to preveneered and stainless steel crowns##2##6##(2012-12#2)
to preveneered##3##2##(2012-12#3)
to prevent HIV infection##3##4##(1991-12#1)(2007-7#1)(2008-10#1)
to prevent HIV transmission##2##4##(2008-10#1)(2013-8#1)
to prevent HIV##8##3##(1991-12#1)(1996-11#1)(1997-6#1)(2007-7#1)(2008-10#2)(2012-3#1)(2013-8#1)
to prevent a &quot##2##4##(1993-1#1)(1995-2#1)
to prevent a##11##3##(1993-1#1)(1995-2#1)(1996-6#1)(1997-5#1)(2007-9#1)(2008-10#1)(2008-3#1)(2009-5#1)(2010-12#1)(2011-2#1)(2013-8#1)
to prevent abuse##2##3##(1997-7#1)(2012-3#1)
to prevent acute##3##3##(2007-8#1)(2013-1#2)
to prevent adhesion##3##3##(2006-10#1)(2008-7#2)
to prevent adverse##3##3##(2006-2#1)(2008-4#1)(2010-7#1)
to prevent an episode of##2##5##(2007-8#2)
to prevent an##5##3##(2007-8#3)(2013-1#2)
to prevent and control##7##4##(2006-2#1)(2007-12#1)(2008-1#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
to prevent and cure##4##4##(2008-10#1)(2008-5#1)(2008-8#1)(2013-8#1)
to prevent and detect##2##4##(1993-3#1)(2009-3#1)
to prevent and inhibit##2##4##(2004-12#1)(2006-1#1)
to prevent and manage##3##4##(2012-1#1)(2012-3#1)(2013-1#1)
to prevent and relieve##2##4##(2008-11#1)(2012-3#1)
to prevent and treat##16##4##(1993-5#1)(2006-10#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2009-12#1)(2009-5#1)(2010-3#1)(2010-4#1)(2013-1#2)(2013-8#1)
to prevent and##44##3##(1992-2#1)(1993-3#1)(1993-5#1)(2004-12#1)(2006-1#1)(2006-10#2)(2006-2#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#3)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#2)(2009-3#1)(2009-5#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#3)
to prevent any##2##3##(2011-12#1)(2013-8#1)
to prevent apoptosis##2##3##(1994-10#1)(1995-3#1)
to prevent aspiration##2##3##(1991-11#1)(2010-7#1)
to prevent bacterial##3##3##(2004-9#1)(2006-2#1)(2008-4#1)
to prevent biofilm formation##2##4##(2008-1#1)(2013-1#1)
to prevent bleeding##3##3##(1992-11#1)(2007-8#1)(2009-8#1)
to prevent cancer##6##3##(1997-1#1)(2006-10#1)(2006-2#1)(2009-3#1)(2011-12#1)(2013-7#1)
to prevent caries##2##3##(1991-6#1)(2006-10#1)
to prevent cell##2##3##(1994-9#1)(2008-11#1)
to prevent childhood##2##3##(2010-8#1)(2012-2#1)
to prevent chronic##2##3##(2009-11#1)(2011-2#1)
to prevent complications##6##3##(2007-12#1)(2007-8#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
to prevent contamination by##3##4##(2008-10#1)(2008-2#1)(2012-2#1)
to prevent contamination##6##3##(1991-6#1)(2008-10#2)(2008-2#1)(2008-8#1)(2012-2#1)
to prevent damage to the##2##5##(2008-11#1)(2008-3#1)
to prevent damage to##3##4##(2007-11#1)(2008-11#1)(2008-3#1)
to prevent damage##5##3##(1992-9#1)(2007-11#1)(2008-11#1)(2008-3#1)(2013-8#1)
to prevent development of##2##4##(1991-6#1)(1994-11#1)
to prevent direct##2##3##(1997-5#1)(2008-4#1)
to prevent disease and##2##4##(2006-2#1)(2013-7#1)
to prevent disease##5##3##(2006-10#1)(2006-2#1)(2008-7#1)(2013-7#2)
to prevent dissemination##2##3##(2008-10#1)(2012-2#1)
to prevent early##4##3##(2007-12#1)(2009-7#1)(2013-1#1)(2013-8#1)
to prevent exposure to##3##4##(2007-12#1)(2010-5#1)(2013-1#1)
to prevent fraud##2##3##(2006-8#1)(2009-6#1)
to prevent further##9##3##(1994-12#1)(1995-12#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-5#1)(2008-7#1)(2012-2#1)
to prevent germination##2##3##(2008-7#1)(2011-2#1)
to prevent glycation##2##3##(1994-8#1)(2008-5#1)
to prevent graft##2##3##(2007-8#1)(2011-2#1)
to prevent hemorrhage##2##3##(2008-12#1)(2010-8#1)
to prevent hepatitis B##2##4##(2007-11#1)(2009-6#1)
to prevent hepatitis##4##3##(1990-9#1)(2006-2#1)(2007-11#1)(2009-6#1)
to prevent hypertensive##2##3##(1992-8#1)(2008-8#1)
to prevent iatrogenic##4##3##(1996-3#1)(2006-6#2)(2010-8#1)
to prevent infection##3##3##(2010-12#2)(2013-1#1)
to prevent infections##8##3##(2007-11#1)(2008-4#1)(2008-5#1)(2011-2#5)
to prevent injury##2##3##(1997-3#1)(2007-6#1)
to prevent interference from##2##4##(2008-10#1)(2008-3#1)
to prevent interference##3##3##(2008-10#2)(2008-3#1)
to prevent invasive##2##3##(2007-8#1)(2013-1#1)
to prevent irreversible##2##3##(2007-2#1)(2008-10#1)
to prevent it##6##3##(1995-5#1)(1996-8#1)(2007-9#1)(2008-11#1)(2012-2#2)
to prevent its##7##3##(1990-11#1)(2005-7#2)(2008-1#1)(2008-3#1)(2011-2#1)(2012-12#1)
to prevent liver##2##3##(2009-9#1)(2011-2#1)
to prevent local##2##3##(2009-10#1)(2011-2#1)
to prevent long-term complications##2##4##(2008-1#2)
to prevent long-term##4##3##(2008-1#2)(2010-2#1)(2013-1#1)
to prevent low birth weight##2##5##(1995-12#1)(2010-6#1)
to prevent low##3##3##(1995-12#1)(1997-7#1)(2010-6#1)
to prevent major##2##3##(2005-12#1)(2010-9#1)
to prevent minors from##2##4##(1996-11#1)(1996-5#1)
to prevent morbidity##2##3##(2006-10#1)(2008-1#1)
to prevent not only##2##4##(1991-6#1)(2008-5#1)
to prevent obesity##2##3##(2007-12#1)(2012-2#1)
to prevent one##2##3##(2007-8#2)
to prevent onset of##2##4##(2008-1#1)(2010-10#1)
to prevent or arrest##3##4##(1992-6#1)(2008-1#1)(2012-12#1)
to prevent or delay the##2##5##(2007-11#1)(2008-1#1)
to prevent or delay##6##4##(2005-11#1)(2007-11#1)(2008-1#2)(2010-10#2)
to prevent or relieve the##2##5##(2008-9#1)(2010-9#1)
to prevent or reverse the##2##5##(1994-2#1)(2011-1#1)
to prevent or reverse##4##4##(1991-9#1)(1994-2#1)(2008-3#1)(2011-1#1)
to prevent or treat##6##4##(1993-11#1)(2007-11#1)(2008-10#2)(2008-7#1)(2013-8#1)
to prevent or##32##3##(1991-9#1)(1992-6#1)(1993-11#1)(1994-2#1)(1994-4#1)(2005-11#1)(2006-9#1)(2007-11#3)(2008-1#4)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-10#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-8#1)
to prevent organ##2##3##(2006-10#1)(2007-11#1)
to prevent osteoporosis##2##3##(1996-6#1)(2005-3#1)
to prevent pain##2##3##(2007-12#1)(2008-4#1)
to prevent permanent##2##3##(2007-7#1)(2012-11#1)
to prevent possible##4##3##(1990-11#1)(1990-5#1)(2010-4#1)(2012-12#1)
to prevent postoperative##6##3##(1990-12#1)(1992-3#1)(2005-12#1)(2006-10#2)(2010-7#1)
to prevent pregnancy##2##3##(1990-6#1)(1995-5#1)
to prevent premature##2##3##(1991-6#1)(2011-3#1)
to prevent progression to##2##4##(2010-12#1)(2011-12#1)
to prevent psychosocial##2##3##(2010-12#1)(2013-1#1)
to prevent pulmonary##3##3##(1991-9#1)(1992-12#1)(2007-8#1)
to prevent radial artery occlusion and radial artery spasm##2##9##(2011-2#2)
to prevent recurrence and##4##4##(1995-4#1)(2007-11#1)(2007-8#1)(2010-7#1)
to prevent recurrence of##2##4##(2007-8#1)(2012-2#1)
to prevent recurrence##8##3##(1991-11#1)(1995-4#1)(2007-11#1)(2007-8#2)(2008-3#1)(2010-7#1)(2012-2#1)
to prevent recurrent##5##3##(1991-11#1)(1991-3#1)(2006-10#2)(2012-1#1)
to prevent rejection##2##3##(2007-11#1)(2007-8#1)
to prevent relapse##3##3##(2006-10#1)(2010-2#1)(2012-12#1)
to prevent renal##3##3##(2007-8#1)(2009-5#1)(2010-7#1)
to prevent respiratory##2##3##(2006-10#2)
to prevent secondary##5##3##(1993-9#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-4#1)
to prevent serious##3##3##(2008-10#1)(2010-1#1)(2010-10#1)
to prevent severe##4##3##(2007-11#1)(2007-8#1)(2008-3#1)(2010-1#1)
to prevent skin cancer##2##4##(1991-11#1)(2010-9#1)
to prevent skin##3##3##(1991-11#1)(2008-5#1)(2010-9#1)
to prevent spread of HIV##2##5##(1996-11#1)(2008-8#1)
to prevent spread##3##3##(1996-11#1)(2005-8#1)(2008-8#1)
to prevent such a##2##4##(2008-5#1)(2009-3#1)
to prevent such##6##3##(2006-10#1)(2006-7#1)(2007-12#1)(2008-5#1)(2009-3#1)(2013-8#1)
to prevent sudden##2##3##(2006-7#1)(2012-2#1)
to prevent suicide##2##3##(1990-3#1)(1991-2#1)
to prevent the accumulation##2##4##(1995-8#1)(2008-10#1)
to prevent the binding of##2##5##(1990-11#1)(1990-5#1)
to prevent the development of##11##5##(1991-9#1)(2006-12#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-12#1)(2010-9#1)
to prevent the disease##2##4##(1994-9#1)(1996-6#1)
to prevent the effect##2##4##(1994-3#1)(2008-9#1)
to prevent the formation of##3##5##(1997-8#1)(2006-3#1)(2011-2#1)
to prevent the neurotoxic##2##4##(1991-8#1)(1995-5#1)
to prevent the onset of##4##5##(2008-3#1)(2008-7#1)(2012-1#1)(2013-1#1)
to prevent the onset##5##4##(2008-3#1)(2008-7#1)(2009-7#1)(2012-1#1)(2013-1#1)
to prevent the patient from##2##5##(1994-11#1)(2006-10#1)
to prevent the progression##3##4##(2006-2#1)(2008-7#1)(2013-1#1)
to prevent the spread of HIV##2##6##(1997-6#1)(2007-7#1)
to prevent the spread of##6##5##(1993-8#1)(1997-6#2)(2007-7#1)(2008-10#1)(2011-1#1)
to prevent the##107##3##(1990-1#1)(1990-11#2)(1990-5#1)(1990-9#1)(1991-10#2)(1991-12#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-5#1)(1992-7#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-6#2)(1997-8#2)(2004-12#1)(2005-3#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#4)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#3)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2013-1#3)(2013-7#1)
to prevent their occurrence##2##4##(1991-5#1)(2012-2#1)
to prevent their##5##3##(1991-5#1)(2008-1#1)(2008-5#1)(2008-6#1)(2012-2#1)
to prevent them from##2##4##(2010-11#1)(2011-1#1)
to prevent them##8##3##(2007-11#1)(2007-9#1)(2008-11#1)(2010-11#1)(2011-1#1)(2013-1#3)
to prevent these##9##3##(1990-11#1)(1992-8#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-5#1)(2008-7#1)(2010-9#1)
to prevent this##11##3##(1992-1#1)(1993-11#1)(1994-7#1)(1995-6#1)(1995-8#1)(1996-3#1)(2006-6#1)(2007-8#1)(2009-10#1)(2009-9#1)(2013-1#1)
to prevent trade barriers##2##4##(2012-12#2)
to prevent transmission##2##3##(1997-5#1)(2011-2#1)
to prevent type 1 diabetes##2##5##(2007-5#2)
to prevent unnecessary##4##3##(1995-10#1)(2008-1#1)(2008-10#1)(2011-2#1)
to prevent viral##2##3##(2008-11#1)(2011-1#1)
to prevent weight gain in##2##5##(2008-10#1)(2012-2#1)
to prevent##786##2##(1990-1#1)(1990-11#8)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-9#2)(1991-10#2)(1991-11#5)(1991-12#2)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#5)(1991-7#1)(1991-8#3)(1991-9#5)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-10#2)(1993-11#5)(1993-12#4)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#2)(1994-11#4)(1994-12#2)(1994-2#3)(1994-3#1)(1994-4#1)(1994-5#3)(1994-7#1)(1994-8#4)(1994-9#4)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#7)(1995-6#2)(1995-8#3)(1995-9#1)(1996-1#1)(1996-10#2)(1996-11#6)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#4)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#4)(1997-7#3)(1997-8#2)(2004-11#1)(2004-12#2)(2004-9#2)(2005-10#1)(2005-11#4)(2005-12#2)(2005-3#2)(2005-7#3)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#24)(2006-11#1)(2006-12#1)(2006-2#11)(2006-3#4)(2006-4#1)(2006-5#2)(2006-6#6)(2006-7#4)(2006-8#4)(2006-9#3)(2007-1#1)(2007-10#4)(2007-11#20)(2007-12#15)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#5)(2007-7#8)(2007-8#31)(2007-9#7)(2008-1#25)(2008-10#41)(2008-11#17)(2008-12#4)(2008-2#2)(2008-3#22)(2008-4#17)(2008-5#21)(2008-6#5)(2008-7#17)(2008-8#8)(2008-9#4)(2009-1#1)(2009-10#5)(2009-11#3)(2009-12#7)(2009-3#6)(2009-5#3)(2009-6#3)(2009-7#3)(2009-8#3)(2009-9#3)(2010-1#2)(2010-10#5)(2010-11#3)(2010-12#10)(2010-2#4)(2010-3#1)(2010-4#4)(2010-5#2)(2010-6#2)(2010-7#8)(2010-8#10)(2010-9#5)(2011-1#10)(2011-12#7)(2011-2#34)(2011-3#2)(2012-1#6)(2012-11#1)(2012-12#16)(2012-2#19)(2012-3#8)(2013-1#34)(2013-7#6)(2013-8#14)
to preventing the##3##3##(2007-8#1)(2008-8#1)(2008-9#1)
to preventing##8##2##(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-11#1)
to prevention and intervention##2##4##(2009-7#1)(2010-12#1)
to prevention and treatment##2##4##(1996-3#1)(2012-2#1)
to prevention and##8##3##(1996-3#1)(1997-2#1)(2009-7#1)(2010-12#1)(2011-1#2)(2012-1#1)(2012-2#1)
to prevention of##3##3##(1995-9#1)(1996-4#1)(2006-1#1)
to prevention##22##2##(1990-12#1)(1995-9#1)(1996-3#1)(1996-4#1)(1997-2#1)(2005-8#1)(2006-1#1)(2006-7#1)(2007-7#1)(2008-5#1)(2008-7#1)(2009-7#2)(2010-12#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#1)(2013-7#1)
to preventive health##3##3##(2008-4#3)
to preventive measures##3##3##(1990-12#1)(1992-3#1)(2009-1#1)
to preventive##9##2##(1990-12#1)(1992-3#1)(1992-4#1)(2006-5#1)(2008-4#3)(2009-1#1)(2012-2#1)
to previous experience##2##3##(2005-8#1)(2008-5#1)
to previous findings##3##3##(1993-5#1)(1996-5#1)(1997-1#1)
to previous reports##15##3##(1990-11#1)(1992-11#1)(1992-3#1)(1993-6#2)(1994-2#1)(1996-9#1)(2006-10#1)(2007-1#1)(2007-9#1)(2008-10#1)(2008-9#1)(2011-1#2)(2011-2#1)
to previous research##3##3##(1994-2#1)(1994-3#1)(2008-12#1)
to previous results for##2##4##(1991-8#1)(1997-5#1)
to previous results##5##3##(1991-8#1)(1992-3#1)(1997-5#1)(2008-6#1)(2011-2#1)
to previous studies##10##3##(1992-6#1)(1996-7#2)(2007-12#1)(2007-5#1)(2008-2#1)(2008-3#1)(2009-2#1)(2009-6#1)(2012-12#1)
to previous versions of##2##4##(2011-2#1)(2012-1#1)
to previous##76##2##(1990-11#1)(1990-9#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-3#2)(1992-6#2)(1993-2#1)(1993-5#1)(1993-6#2)(1993-8#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-3#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-5#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#3)
to previously characterized##3##3##(2008-10#2)(2013-1#1)
to previously described##3##3##(1995-3#1)(1995-9#1)(2008-10#1)
to previously established##2##3##(2007-1#1)(2008-11#1)
to previously identified genes##2##4##(1995-4#1)(1997-8#1)
to previously identified##6##3##(1994-8#1)(1995-4#1)(1996-10#1)(1996-6#1)(1997-8#1)(2008-10#1)
to previously known##2##3##(1992-8#1)(1997-3#1)
to previously proposed##2##3##(1996-11#1)(2009-10#1)
to previously published data and##2##5##(1991-9#1)(2012-11#1)
to previously published##10##3##(1991-9#1)(1995-4#1)(1995-6#1)(1996-5#1)(2007-12#1)(2008-11#1)(2008-3#1)(2012-1#1)(2012-11#1)(2012-2#1)
to previously reported##9##3##(1991-1#1)(1991-9#1)(1993-1#1)(2008-10#1)(2008-2#1)(2009-12#1)(2009-4#1)(2012-12#1)(2013-1#1)
to previously##47##2##(1990-2#1)(1991-1#1)(1991-9#3)(1992-8#1)(1993-1#1)(1994-8#1)(1995-3#1)(1995-4#2)(1995-6#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-1#1)(2007-11#2)(2007-12#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-12#3)(2009-4#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)
to price##3##2##(1993-2#1)(1994-12#1)(2011-1#1)
to primarily##3##2##(2007-10#1)(2008-2#1)(2012-1#1)
to primary aldosteronism##2##3##(1990-11#1)(2006-9#1)
to primary and##5##3##(1994-12#1)(1997-7#1)(2005-10#1)(2008-3#1)(2010-3#1)
to primary care physicians##3##4##(2004-3#2)(2008-6#1)
to primary care##9##3##(1997-3#1)(2004-3#2)(2007-11#1)(2008-6#1)(2008-7#3)(2010-7#1)
to primary dentin##2##3##(2008-5#2)
to primary health care##2##4##(2008-6#1)(2010-8#1)
to primary human osteoblasts##2##4##(2006-5#2)
to primary human##3##3##(1992-3#1)(2006-5#2)
to primary infection##2##3##(2006-10#1)(2008-10#1)
to primary open angle glaucoma##2##5##(2011-2#2)
to primary prevention##3##3##(1995-3#1)(1995-5#1)(1997-1#1)
to primary##72##2##(1990-11#1)(1990-7#1)(1991-1#1)(1991-8#1)(1992-3#1)(1993-10#2)(1993-8#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2004-3#2)(2005-10#1)(2005-3#1)(2006-10#4)(2006-4#1)(2006-5#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#3)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#2)
to primate##2##2##(1995-2#2)
to primates##3##2##(1991-11#1)(1995-8#1)(2012-3#1)
to prime the##2##3##(1992-7#1)(1993-9#1)
to prime##9##2##(1992-7#1)(1993-9#1)(1994-12#1)(1995-2#2)(1997-5#1)(2007-7#1)(2008-11#1)(2008-4#1)
to priming##2##2##(1990-9#1)(1993-2#1)
to principal components##2##3##(2008-10#2)
to principal##4##2##(2008-10#2)(2008-11#1)(2010-1#1)
to prior findings##3##3##(2007-9#1)(2008-9#1)(2009-11#1)
to prior##6##2##(2007-9#1)(2008-1#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-3#1)
to prioritize##20##2##(1994-3#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-9#2)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#4)(2013-8#1)
to privacy##10##2##(1990-5#1)(1993-9#1)(1996-12#1)(1996-9#1)(1997-5#1)(2008-12#1)(2010-5#2)(2013-1#2)
to private##12##2##(1990-7#2)(1992-11#1)(1993-3#1)(1995-3#1)(1996-3#1)(1997-8#1)(2007-9#1)(2008-11#2)(2008-7#1)(2008-8#1)
to proactively##4##2##(1992-1#1)(2010-10#1)(2013-1#2)
to probe DNA##2##3##(1992-4#1)(2008-10#1)
to probe RNA##2##3##(1991-12#1)(2008-4#1)
to probe a##5##3##(1994-8#1)(1995-8#1)(2007-12#1)(2008-3#2)
to probe its##2##3##(1995-5#1)(2006-12#1)
to probe the molecular##2##4##(2006-10#1)(2008-10#1)
to probe the structural##5##4##(1994-5#1)(1994-9#1)(1996-9#1)(2006-3#1)(2006-6#1)
to probe the structure##2##4##(2006-10#1)(2008-4#1)
to probe the##54##3##(1990-10#1)(1990-7#1)(1990-8#1)(1991-3#1)(1991-4#3)(1992-6#2)(1993-11#1)(1993-5#2)(1993-6#1)(1993-7#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-6#1)(2006-10#3)(2006-3#1)(2006-6#1)(2007-11#4)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
to probe their##3##3##(2006-12#1)(2008-10#1)(2012-2#1)
to probe##112##2##(1990-10#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-3#1)(1991-4#5)(1991-9#1)(1992-4#1)(1992-6#2)(1993-11#1)(1993-5#2)(1993-6#1)(1993-7#1)(1994-12#2)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#2)(1995-10#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#2)(1995-9#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-6#1)(2005-10#1)(2005-11#2)(2006-10#3)(2006-12#2)(2006-3#1)(2006-6#1)(2007-11#7)(2007-12#6)(2008-1#2)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-4#2)(2009-9#2)(2010-7#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
to probes##2##2##(1991-5#1)(1996-11#1)
to probiotics##2##2##(2007-12#1)(2011-2#1)
to problem use##3##3##(2013-1#3)
to problem##5##2##(2008-12#1)(2010-11#1)(2013-1#3)
to problem-solve##2##2##(2004-3#1)(2012-2#1)
to problems in the##2##4##(1993-6#1)(1997-8#1)
to problems in##6##3##(1991-11#1)(1993-6#1)(1997-8#1)(2006-10#1)(2006-4#1)(2009-3#1)
to problems of##5##3##(1991-6#1)(2007-12#1)(2008-2#1)(2008-8#1)(2010-8#1)
to problems related to##2##4##(1992-10#1)(2008-9#1)
to problems##23##2##(1991-11#1)(1991-6#1)(1992-10#1)(1993-2#1)(1993-6#1)(1994-6#2)(1994-9#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-2#1)(2010-8#1)(2013-1#1)
to procedural##3##2##(2009-6#1)(2010-12#1)(2012-2#1)
to proceed by##6##3##(1990-12#2)(1990-8#1)(1995-1#1)(1996-2#1)(1997-1#1)
to proceed in a##2##4##(1996-7#1)(2008-3#1)
to proceed in##3##3##(1996-7#1)(2008-11#1)(2008-3#1)
to proceed to##3##3##(1995-1#1)(2006-3#1)(2011-2#1)
to proceed with a##3##4##(1993-2#1)(1996-11#1)(2010-12#1)
to proceed with##12##3##(1990-8#1)(1993-2#1)(1993-4#2)(1996-11#1)(1996-12#1)(1996-5#1)(2005-8#1)(2008-10#1)(2008-2#1)(2010-12#1)(2013-1#1)
to proceed##45##2##(1990-11#1)(1990-12#4)(1990-8#2)(1991-3#1)(1993-2#1)(1993-4#2)(1993-8#1)(1995-1#2)(1995-3#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-5#1)(1996-7#1)(1997-1#1)(2004-9#1)(2005-8#1)(2006-3#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-12#3)(2010-9#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
to process a##5##3##(2008-5#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-11#1)
to process and##5##3##(1995-3#1)(2007-12#1)(2008-1#1)(2008-4#1)(2010-9#1)
to process information##2##3##(1996-1#1)(2008-7#1)
to process large##2##3##(2008-10#1)(2008-7#1)
to process monitoring##2##3##(2008-10#2)
to process the##16##3##(1995-12#1)(2007-12#1)(2007-4#1)(2007-5#2)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-8#1)
to process##69##2##(1990-12#1)(1994-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1996-1#3)(1996-2#1)(1996-5#1)(1997-2#1)(2005-10#1)(2006-12#1)(2007-12#3)(2007-4#2)(2007-5#2)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#10)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-7#2)(2010-11#1)(2010-2#1)(2010-9#2)(2011-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
to processed##2##2##(2008-7#1)(2010-4#1)
to processes of##2##3##(2007-9#1)(2008-8#1)
to processes##5##2##(1993-5#1)(2004-4#1)(2007-9#1)(2008-8#1)(2009-10#1)
to processing##10##2##(1993-12#3)(1996-10#1)(2007-12#1)(2008-10#2)(2008-3#1)(2010-2#1)(2011-12#1)
to procreate##3##2##(1996-11#1)(2006-3#1)(2012-3#1)
to procure##3##2##(1997-7#1)(2006-10#1)(2007-11#1)
to produce &quot##2##3##(1992-7#1)(2009-12#1)
to produce 1##2##3##(2006-4#1)(2010-4#1)
to produce NO##4##3##(1993-6#1)(2006-8#3)
to produce SA##3##3##(2008-10#3)
to produce T##2##3##(1990-6#1)(1994-2#1)
to produce a 2##2##4##(2006-8#1)(2009-5#1)
to produce a PCR##2##4##(1991-6#1)(2005-11#1)
to produce a continuous##2##4##(2008-10#1)(2008-5#1)
to produce a functional##2##4##(2008-8#1)(2009-6#1)
to produce a high##3##4##(1993-9#1)(2010-4#1)(2013-7#1)
to produce a large##3##4##(1992-9#1)(2008-10#2)
to produce a larger##2##4##(1994-9#1)(2008-2#1)
to produce a more##2##4##(2008-10#1)(2008-11#1)
to produce a range of##2##5##(2009-12#1)(2013-1#1)
to produce a red complex##2##5##(2008-10#2)
to produce a significant##2##4##(2006-8#1)(2007-11#1)
to produce a##148##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-6#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-9#2)(1994-11#2)(1994-2#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-10#1)(1995-12#1)(1995-5#2)(1996-7#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-9#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-1#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-11#7)(2007-12#7)(2007-2#1)(2007-9#1)(2008-10#24)(2008-11#3)(2008-12#1)(2008-2#11)(2008-3#8)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#3)(2013-1#1)(2013-7#2)
to produce accurate##2##3##(2008-3#1)(2013-1#1)
to produce active##3##3##(1994-3#1)(2012-1#1)(2012-2#1)
to produce alcohols from##2##4##(2008-6#2)
to produce an optimal##3##4##(2007-12#1)(2008-11#1)(2008-2#1)
to produce an##38##3##(1990-12#2)(1990-8#1)(1992-9#1)(1994-3#1)(1995-9#1)(1996-5#2)(1997-1#1)(2005-11#2)(2005-7#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#3)(2008-5#3)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-7#1)(2011-2#1)(2012-2#1)
to produce analgesia##3##3##(2006-10#1)(2009-12#1)(2011-2#1)
to produce and secrete##2##4##(1995-2#1)(2008-10#1)
to produce and##10##3##(1993-2#1)(1993-7#1)(1995-2#1)(1997-4#1)(2005-7#1)(2006-2#1)(2007-11#2)(2008-1#1)(2008-10#1)
to produce antibodies##2##3##(1992-4#1)(1993-9#1)
to produce any##3##3##(1993-2#1)(2005-9#1)(2006-8#1)
to produce apothecia##2##3##(2008-10#2)
to produce ascites##2##3##(1991-12#2)
to produce bone##2##3##(2008-11#1)(2012-12#1)
to produce both##6##3##(1991-1#1)(1991-5#1)(2007-12#1)(2008-10#1)(2008-4#1)(2010-6#1)
to produce chemiluminescence##2##3##(2007-8#1)(2008-10#1)
to produce continuous##2##3##(2007-5#1)(2008-7#1)
to produce cytokines##2##3##(2004-9#1)(2006-7#1)
to produce data##2##3##(2008-7#1)(2010-9#1)
to produce different##4##3##(1991-10#1)(2008-2#2)(2008-5#1)
to produce effector##2##3##(1997-1#1)(2012-3#1)
to produce extracellular##2##3##(2008-10#1)(2008-9#1)
to produce fluorescent##2##3##(2008-10#2)
to produce free radicals##2##4##(1995-3#1)(2007-11#1)
to produce full##2##3##(1990-2#1)(1996-6#1)
to produce good##4##3##(1996-3#1)(2007-12#1)(2009-3#1)(2011-1#1)
to produce greater##3##3##(1991-7#1)(2010-5#1)(2012-3#1)
to produce high levels of##3##5##(1997-4#1)(2007-11#1)(2008-5#1)
to produce high##6##3##(1992-1#1)(1997-4#1)(2005-11#1)(2007-11#1)(2008-5#1)(2009-5#1)
to produce high-resolution##2##3##(2006-6#1)(2008-2#1)
to produce highly##2##3##(2008-5#1)(2008-9#1)
to produce homozygous##2##3##(1995-8#1)(2008-10#1)
to produce hormones##2##3##(2009-5#1)(2012-1#1)
to produce infectious##2##3##(1990-5#1)(2008-10#1)
to produce inositol phosphates##3##4##(1993-5#3)
to produce insoluble##2##3##(1993-5#1)(2008-6#1)
to produce interferon-gamma##2##3##(1996-10#1)(2008-11#1)
to produce interleukin##2##3##(1990-2#1)(2008-4#1)
to produce its##2##3##(1994-8#1)(2008-1#1)
to produce large amounts of##3##5##(2008-10#1)(2008-11#1)(2008-7#1)
to produce large quantities of##2##5##(2008-10#1)(2008-11#1)
to produce large##8##3##(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)
to produce light emission##2##4##(2008-10#2)
to produce light##3##3##(2008-10#2)(2010-12#1)
to produce lipid##2##3##(1996-8#1)(2012-12#1)
to produce local##2##3##(2008-2#2)
to produce many##2##3##(1993-1#1)(2006-10#1)
to produce maps of##2##4##(2008-3#1)(2008-8#1)
to produce mature##2##3##(1990-12#1)(2010-8#1)
to produce monochromatic##2##3##(2008-2#2)
to produce monoclonal##2##3##(1990-5#1)(2008-1#1)
to produce more##5##3##(1993-11#1)(1994-2#1)(2005-11#1)(2007-12#1)(2008-8#1)
to produce multilayered##2##3##(2005-11#1)(2008-2#1)
to produce nanoscale##2##3##(2008-7#1)(2011-1#1)
to produce new##2##3##(2008-11#1)(2012-2#1)
to produce nitric oxide resided on the membranous fragment of##2##10##(1993-4#1)(1994-6#1)
to produce nitric oxide##7##4##(1993-4#4)(1994-6#2)(2006-8#1)
to produce novel##3##3##(1992-2#1)(2008-7#1)(2009-11#1)
to produce one-dimensional##2##3##(2008-2#1)(2008-3#1)
to produce oospores in potato tuber tissue##2##7##(2008-10#2)
to produce oospores in##3##4##(2008-10#3)
to produce oospores##6##3##(2008-10#6)
to produce optical##2##3##(2008-2#2)
to produce or##2##3##(2008-2#1)(2009-5#1)
to produce recombinant##7##3##(1994-2#1)(1995-5#1)(1996-5#1)(2006-12#1)(2007-6#1)(2008-11#1)(2008-2#1)
to produce reliable##2##3##(2008-10#1)(2008-7#1)
to produce results##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
to produce secondary##3##3##(2008-10#3)
to produce sharp##2##3##(2008-2#1)(2008-3#1)
to produce siderophores##2##3##(1996-8#1)(2013-1#1)
to produce significant##3##3##(1997-1#1)(2006-8#1)(2007-12#1)
to produce significantly##2##3##(2007-12#1)(2008-3#1)
to produce similar##3##3##(1992-10#1)(2008-12#2)
to produce smooth##2##3##(2008-2#1)(2008-8#1)
to produce solid##2##3##(2008-5#2)
to produce specific##4##3##(1994-3#1)(2005-6#1)(2007-4#1)(2008-11#1)
to produce stable##3##3##(2007-12#1)(2007-4#1)(2008-5#1)
to produce substantial##2##3##(1990-4#1)(2008-6#1)
to produce such##3##3##(2008-3#1)(2009-4#1)(2010-7#1)
to produce sufficient##2##3##(1997-7#1)(2008-11#1)
to produce the corresponding##2##4##(1995-5#1)(2008-10#1)
to produce the desired##3##4##(2007-12#2)(2009-9#1)
to produce the observed##2##4##(2005-11#1)(2008-11#1)
to produce the##56##3##(1990-12#1)(1991-2#1)(1991-7#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-8#1)(1995-10#1)(1995-5#1)(1995-7#1)(1996-11#1)(1996-8#1)(2005-11#2)(2006-12#1)(2006-3#1)(2006-4#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-9#1)(2008-10#6)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#3)(2013-1#1)(2013-8#1)
to produce therapeutic##2##3##(2006-11#1)(2008-11#1)
to produce these##4##3##(1992-9#1)(1993-11#1)(2005-12#1)(2011-1#1)
to produce this##3##3##(1992-2#1)(2008-10#1)(2008-8#1)
to produce two##4##3##(1997-4#1)(2007-9#1)(2008-1#1)(2008-9#1)
to produce valid##2##3##(1991-12#1)(2008-12#1)
to produce various##4##3##(1992-7#1)(2008-10#1)(2008-5#1)(2008-7#1)
to produce vomiting##2##3##(1997-7#2)
to produce##883##2##(1990-10#2)(1990-11#2)(1990-12#9)(1990-2#4)(1990-3#2)(1990-4#3)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#4)(1990-9#1)(1991-1#4)(1991-10#3)(1991-12#4)(1991-2#4)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#2)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#2)(1992-2#3)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#6)(1993-1#1)(1993-11#5)(1993-12#1)(1993-2#3)(1993-3#3)(1993-4#8)(1993-5#6)(1993-6#4)(1993-7#2)(1993-8#1)(1993-9#5)(1994-11#3)(1994-12#1)(1994-2#6)(1994-3#5)(1994-5#3)(1994-6#5)(1994-8#5)(1994-9#3)(1995-10#2)(1995-12#3)(1995-2#2)(1995-3#4)(1995-5#6)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-10#1)(1996-11#3)(1996-12#4)(1996-2#3)(1996-3#3)(1996-5#4)(1996-6#3)(1996-7#1)(1996-8#3)(1996-9#3)(1997-1#4)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#2)(1997-7#4)(1997-8#1)(2004-12#3)(2004-9#4)(2005-10#1)(2005-11#9)(2005-12#3)(2005-4#1)(2005-6#1)(2005-7#6)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#4)(2006-11#3)(2006-12#7)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#4)(2006-6#3)(2006-7#2)(2006-8#8)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#25)(2007-12#37)(2007-2#2)(2007-4#3)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#10)(2008-10#110)(2008-11#32)(2008-12#7)(2008-2#54)(2008-3#28)(2008-4#25)(2008-5#28)(2008-6#13)(2008-7#24)(2008-8#15)(2008-9#10)(2009-10#2)(2009-11#4)(2009-12#4)(2009-2#3)(2009-3#3)(2009-4#3)(2009-5#5)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-12#8)(2010-2#8)(2010-3#4)(2010-4#8)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#5)(2010-9#3)(2011-1#8)(2011-12#2)(2011-2#9)(2011-3#1)(2012-1#9)(2012-11#2)(2012-12#13)(2012-2#11)(2012-3#8)(2013-1#11)(2013-7#5)(2013-8#2)
to produce)##2##2##(2008-9#2)
to producing a##2##3##(2008-7#1)(2009-10#1)
to producing##5##2##(1992-5#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)
to product##10##2##(1996-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-9#1)(2009-10#1)(2011-2#2)
to production and##2##3##(2008-3#1)(2012-2#1)
to production in##2##3##(2008-10#1)(2008-7#1)
to production of sporangia##2##4##(2008-10#2)
to production of##12##3##(1993-6#1)(1996-1#1)(1997-4#2)(2007-7#1)(2008-10#3)(2008-11#3)(2008-6#1)
to production##19##2##(1992-12#1)(1993-6#1)(1996-1#1)(1997-4#2)(2006-9#1)(2007-7#1)(2008-10#4)(2008-11#4)(2008-3#1)(2008-6#1)(2008-7#1)(2012-2#1)
to productive##2##2##(1993-11#1)(2005-4#1)
to productivity##2##2##(2007-11#1)(2008-9#1)
to products##6##2##(1990-12#1)(1995-1#1)(1997-1#1)(2008-10#1)(2008-4#1)(2010-4#1)
to professional work##2##3##(2007-11#1)(2011-2#1)
to professional##15##2##(1991-12#1)(1993-1#1)(1996-1#1)(1996-3#1)(1997-3#1)(2006-2#1)(2006-3#1)(2007-11#1)(2008-1#1)(2008-12#1)(2009-7#1)(2011-2#2)(2012-12#1)(2012-2#1)
to proficiency##3##2##(2007-12#1)(2008-1#1)(2010-4#1)
to profile##8##2##(1993-5#1)(1995-3#1)(2008-10#1)(2008-2#1)(2008-9#1)(2011-2#2)(2013-1#1)
to profit from##2##3##(1994-10#1)(2008-3#1)
to proflavine##2##2##(1991-12#2)
to profound##6##2##(1995-2#1)(1995-8#1)(2007-1#1)(2008-4#1)(2008-9#2)
to progesterone and##2##3##(1995-4#1)(2008-7#1)
to progesterone##9##2##(1990-3#3)(1991-9#1)(1995-10#1)(1995-11#1)(1995-4#1)(2008-7#1)(2012-2#1)
to progestin therapy##2##3##(1990-2#1)(2007-10#1)
to progestin##3##2##(1990-2#1)(1992-2#1)(2007-10#1)
to prognosis##5##2##(1990-4#2)(1990-8#1)(1993-9#1)(2010-11#1)
to program##9##2##(1995-12#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-7#1)(2011-2#1)
to programmed##3##2##(1992-2#1)(1994-6#1)(2009-9#1)
to progress beyond##2##3##(2012-12#1)(2013-8#1)
to progress in##5##3##(1996-11#1)(2007-8#1)(2008-11#1)(2009-4#1)(2011-1#1)
to progress into##2##3##(2011-12#1)(2013-7#1)
to progress the##2##3##(2012-12#2)
to progress through the cell cycle##3##6##(1990-8#1)(1993-11#1)(1996-1#1)
to progress through the##4##4##(1990-8#1)(1993-11#1)(1996-1#1)(2009-3#1)
to progress to##3##3##(1995-7#1)(2005-10#1)(2008-5#1)
to progress##34##2##(1990-8#1)(1993-11#1)(1995-7#1)(1996-1#1)(1996-11#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-6#2)(2006-8#1)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2011-1#2)(2011-12#1)(2012-12#3)(2012-3#1)(2013-7#1)(2013-8#2)
to progression from##2##3##(1995-2#1)(2007-5#1)
to progression of the##2##4##(1992-6#1)(2010-6#1)
to progression of##6##3##(1992-6#1)(1997-3#1)(2007-11#1)(2008-1#1)(2010-6#1)(2011-1#1)
to progression##28##2##(1990-10#1)(1990-2#1)(1991-10#1)(1991-2#2)(1991-4#1)(1992-6#1)(1993-1#1)(1995-2#1)(1997-3#1)(2004-1#1)(2006-12#2)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#1)(2010-12#2)(2010-6#1)(2011-1#1)(2012-1#2)(2013-1#1)
to progressive deterioration##2##3##(2005-10#1)(2012-12#1)
to progressive loss of##3##4##(2007-1#1)(2008-7#1)(2012-3#1)
to progressive renal##2##3##(2006-10#2)
to progressive##21##2##(1991-5#1)(1994-3#2)(1995-10#1)(2004-11#1)(2005-10#1)(2006-10#2)(2007-1#1)(2007-8#2)(2008-11#1)(2008-7#4)(2009-9#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-3#1)
to progressively##2##2##(1995-10#1)(2004-11#1)
to prohibit the##3##3##(2006-8#1)(2007-6#2)
to prohibit##4##2##(2005-11#1)(2006-8#1)(2007-6#2)
to project the##4##3##(2007-1#1)(2008-2#1)(2009-8#1)(2012-2#1)
to project to the##3##4##(1995-7#1)(1996-5#1)(1997-3#1)
to project to##4##3##(1994-10#1)(1995-7#1)(1996-5#1)(1997-3#1)
to project##12##2##(1990-10#1)(1994-10#1)(1995-7#1)(1996-5#1)(1997-3#1)(2006-5#1)(2007-1#1)(2008-2#2)(2009-8#2)(2012-2#1)
to prokaryotes##2##2##(1990-12#1)(2008-11#1)
to prokaryotic##3##2##(1992-12#1)(1994-2#1)(2010-10#1)
to prolactin##3##2##(1990-11#1)(2006-9#1)(2008-4#1)
to proliferate and migrate##2##4##(2008-11#1)(2008-7#1)
to proliferate and##9##3##(1996-11#1)(1997-6#1)(2007-11#1)(2008-11#3)(2008-4#1)(2008-7#1)(2009-5#1)
to proliferate at##2##3##(1996-7#1)(2008-11#1)
to proliferate in##3##3##(1990-12#1)(2008-10#1)(2008-11#1)
to proliferate##30##2##(1990-12#2)(1990-6#1)(1992-12#1)(1992-2#1)(1992-8#1)(1996-11#1)(1996-7#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-11#8)(2008-4#3)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
to proliferation##6##2##(1991-10#1)(1991-3#1)(2008-10#1)(2008-11#1)(2012-12#2)
to proline##5##2##(1991-12#1)(1993-12#1)(1993-4#1)(1997-4#1)(2008-10#1)
to prolong its##2##3##(1991-5#1)(2012-2#1)
to prolong survival and##2##4##(1990-12#1)(2007-8#1)
to prolong survival##3##3##(1990-12#1)(2006-8#1)(2007-8#1)
to prolong the duration of##2##5##(2006-7#1)(2011-12#1)
to prolong the##12##3##(1990-12#1)(1991-3#1)(1992-6#2)(2005-7#1)(2006-7#1)(2007-11#2)(2007-12#1)(2008-5#1)(2011-12#1)(2013-8#1)
to prolong##34##2##(1990-12#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-6#2)(1993-11#1)(1994-2#1)(2005-7#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-12#2)(2012-2#1)(2013-8#1)
to prolongation of##3##3##(1990-11#1)(1990-7#1)(2008-11#1)
to prolonged survival##2##3##(1993-8#1)(2011-12#1)
to prolonged##11##2##(1991-12#1)(1991-4#1)(1993-8#1)(1997-1#1)(2008-10#1)(2008-7#2)(2011-12#1)(2011-2#1)(2013-1#2)
to prominent##4##2##(2006-10#1)(2006-3#1)(2008-4#1)(2011-1#1)
to promising##2##2##(2007-7#1)(2012-2#1)
to promote a##6##3##(2006-9#1)(2007-1#1)(2008-10#2)(2008-4#1)(2011-1#1)
to promote active learning##3##4##(2005-10#1)(2005-12#1)(2006-5#1)
to promote adherence##3##3##(1992-6#1)(2013-1#2)
to promote an##2##3##(1991-2#1)(2007-4#1)
to promote and evaluate critical thinking##2##6##(2008-12#2)
to promote and##12##3##(1995-9#1)(1996-2#1)(2007-2#2)(2007-9#1)(2008-12#2)(2008-5#1)(2008-7#1)(2012-1#1)(2012-2#1)(2012-3#1)
to promote bone##2##3##(1996-5#1)(2004-9#1)
to promote both the maintenance and enrichment of glioblastoma stem-like cells (GSCs) and confer resistance to chemo- and radiotherapy##2##19##(2012-12#2)
to promote cell adhesion##2##4##(1990-11#1)(1995-5#1)
to promote cell attachment##2##4##(1994-9#1)(1995-6#1)
to promote cell growth##2##4##(2008-7#1)(2013-1#1)
to promote cell##8##3##(1990-11#1)(1994-9#1)(1995-5#1)(1995-6#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)
to promote children's##2##3##(2012-2#1)(2013-1#1)
to promote cholesterol efflux##2##4##(1990-12#1)(2008-10#1)
to promote culturally##2##3##(1997-2#1)(2013-8#1)
to promote dissemination of psychiatric research conducted in low and middle income countries##2##13##(2011-1#2)
to promote early##5##3##(2006-3#1)(2008-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
to promote greater##5##3##(1997-1#1)(2005-5#1)(2007-10#1)(2010-4#1)(2011-2#1)
to promote healing##2##3##(2010-12#1)(2010-2#1)
to promote health##5##3##(2007-10#1)(2008-1#1)(2008-7#1)(2010-12#1)(2012-3#1)
to promote healthy##3##3##(2008-12#1)(2012-1#2)
to promote local##2##3##(2007-5#1)(2008-7#1)
to promote more##2##3##(2011-1#1)(2012-2#1)
to promote neurite##2##3##(1995-1#1)(1995-3#1)
to promote normal birth##2##4##(2007-2#1)(2008-6#1)
to promote normal##3##3##(2007-2#1)(2008-6#1)(2009-9#1)
to promote or##2##3##(2013-1#2)
to promote physical activity and healthy eating##2##7##(2013-1#2)
to promote physical activity or healthy eating##2##7##(2013-1#2)
to promote physical activity##6##4##(2007-10#1)(2010-2#1)(2013-1#4)
to promote professional##2##3##(2008-12#1)(2009-11#1)
to promote quality improvement##2##4##(1996-2#1)(1997-1#1)
to promote quality##6##3##(1996-2#1)(1997-1#1)(2008-3#1)(2008-9#1)(2011-12#2)
to promote recovery##2##3##(2006-7#1)(2011-2#1)
to promote research##2##3##(2008-6#1)(2013-1#1)
to promote smoking cessation##3##4##(1991-12#1)(1994-11#1)(1994-7#1)
to promote smoking##4##3##(1991-12#1)(1994-11#1)(1994-7#1)(2012-12#1)
to promote the activation of##2##5##(2008-1#1)(2008-4#1)
to promote the adoption of##2##5##(2008-4#1)(2010-11#1)
to promote the degradation of##2##5##(2008-3#2)
to promote the development of##4##5##(1996-4#1)(2008-11#1)(2009-4#1)(2011-2#1)
to promote the establishment of##2##5##(2008-11#1)(2012-12#1)
to promote the expression of##2##5##(1995-8#1)(2006-12#1)
to promote the formation of##3##5##(1995-2#2)(2008-9#1)
to promote the health##2##4##(2009-4#1)(2012-2#1)
to promote the quality of##2##5##(2007-10#2)
to promote the safe##2##4##(2007-11#1)(2007-4#1)
to promote the##75##3##(1990-2#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-3#1)(1994-3#1)(1995-2#3)(1995-3#1)(1995-8#2)(1996-1#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-4#2)(2007-6#1)(2008-1#5)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
to promote weight##2##3##(2005-10#1)(2008-5#1)
to promote##340##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-3#1)(1992-5#2)(1992-6#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#2)(1995-8#3)(1995-9#1)(1996-1#4)(1996-11#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#2)(1997-7#1)(1997-8#1)(2004-2#1)(2004-9#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-5#3)(2005-7#1)(2005-8#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-3#2)(2006-5#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#7)(2007-11#5)(2007-12#4)(2007-2#5)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#9)(2008-10#17)(2008-11#9)(2008-12#8)(2008-2#2)(2008-3#7)(2008-4#5)(2008-5#4)(2008-6#3)(2008-7#6)(2008-8#7)(2008-9#4)(2009-11#2)(2009-12#1)(2009-3#2)(2009-4#5)(2009-6#1)(2009-8#2)(2009-9#3)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#5)(2010-4#1)(2010-5#2)(2011-1#7)(2011-12#3)(2011-2#17)(2012-1#3)(2012-11#1)(2012-12#11)(2012-2#12)(2012-3#10)(2013-1#21)(2013-7#6)(2013-8#4)
to promoter##2##2##(1994-3#1)(2007-12#1)
to promoters##3##2##(1992-5#1)(1994-3#1)(2012-3#1)
to promoting the##2##3##(1996-10#1)(2007-12#1)
to promoting##13##2##(1993-12#1)(1994-3#1)(1996-1#1)(1996-10#1)(2007-12#1)(2008-11#1)(2008-5#1)(2009-2#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
to promotion of##3##3##(1991-12#1)(1994-12#1)(2007-12#1)
to prompt##8##2##(1995-2#1)(2007-10#1)(2008-11#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
to promptly##4##2##(2006-10#1)(2008-8#1)(2010-6#1)(2012-1#1)
to pronounced##3##2##(1996-11#1)(1997-7#1)(2008-3#1)
to propagate in##2##3##(2006-10#1)(2008-2#1)
to propagate##16##2##(1990-1#1)(1990-3#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2010-12#1)(2012-2#1)
to propagation##2##2##(2007-12#1)(2009-12#1)
to propel##2##2##(1994-9#1)(2008-10#1)
to proper##9##2##(1993-6#1)(2006-10#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-7#1)(2012-3#1)
to properly address##2##3##(2008-7#1)(2010-2#1)
to properly diagnose##2##3##(2007-5#1)(2008-10#1)
to properly evaluate and##2##4##(2007-7#1)(2008-3#1)
to properly evaluate##3##3##(2007-7#1)(2008-3#1)(2011-12#1)
to properly manage##2##3##(1993-2#1)(2012-12#1)
to properly##22##2##(1990-8#1)(1991-12#1)(1993-2#1)(1997-1#1)(2005-5#1)(2006-11#1)(2006-5#1)(2007-5#2)(2007-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#2)(2010-2#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
to properties of##4##3##(2007-12#1)(2009-8#2)(2013-1#1)
to prophylaxis##2##2##(2006-2#1)(2007-2#1)
to propiconazole##5##2##(2008-10#5)
to propofol##2##2##(2006-10#1)(2013-7#1)
to propolis##2##2##(2006-8#1)(2008-10#1)
to proportional##2##2##(2008-10#1)(2009-11#1)
to propose a method for##2##5##(2008-3#1)(2010-3#1)
to propose a new##5##4##(2005-10#1)(2006-6#1)(2007-8#1)(2008-3#1)(2010-8#1)
to propose a##22##3##(1990-7#1)(1991-3#1)(1991-8#1)(1993-11#1)(1993-3#1)(1994-12#1)(1995-3#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2010-3#1)(2010-8#1)(2011-2#2)(2012-1#1)
to propose an##5##3##(2006-12#2)(2008-10#1)(2008-11#1)(2013-1#1)
to propose and##2##3##(1991-3#1)(2010-8#1)
to propose that the##3##4##(2006-10#1)(2007-12#1)(2008-10#1)
to propose that##9##3##(1990-9#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)
to propose the##6##3##(2008-1#1)(2008-9#1)(2010-12#1)(2011-1#1)(2013-7#2)
to propose##59##2##(1990-7#1)(1990-9#1)(1991-3#2)(1991-8#1)(1992-8#1)(1993-11#2)(1993-3#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-3#1)(1997-5#1)(2005-10#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-4#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#3)(2013-7#2)
to proposed##2##2##(1991-10#1)(2007-7#1)
to propranolol##2##2##(1992-8#1)(2008-4#1)
to prospective payment##2##3##(1991-1#1)(1992-1#1)
to prospective##6##2##(1991-1#1)(1992-1#1)(2005-10#1)(2008-11#1)(2008-12#2)
to prospectively evaluate##2##3##(2006-6#1)(2008-7#1)
to prospectively##10##2##(2005-10#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-9#1)(2008-4#1)(2008-7#1)(2012-12#2)(2012-2#1)
to prosper##2##2##(1997-2#1)(2008-11#1)
to prostate cancer##7##3##(2007-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-5#1)(2011-2#1)
to prostate##9##2##(1993-4#1)(2006-6#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-5#1)(2011-2#1)
to prostate-specific antigen##2##3##(2012-12#2)
to prostatic adenoma in##2##4##(1991-6#1)(1994-3#1)
to prostatic##3##2##(1990-12#1)(1991-6#1)(1994-3#1)
to prosthetic##3##2##(2007-11#1)(2007-12#1)(2011-2#1)
to protease##6##2##(1990-10#1)(1993-6#1)(1995-1#1)(1995-9#1)(2007-12#1)(2008-1#1)
to proteases##4##2##(1992-6#1)(1993-3#1)(2008-10#2)
to protect DNA##2##3##(1995-6#1)(2006-2#1)
to protect a##2##3##(2011-2#1)(2012-11#1)
to protect against the##3##4##(1996-4#1)(2008-5#1)(2013-1#1)
to protect against##30##3##(1991-6#3)(1991-9#1)(1992-10#1)(1993-3#1)(1995-12#1)(1996-12#1)(1996-4#1)(2005-7#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-5#5)(2010-8#1)(2011-2#3)(2011-9#1)(2012-12#1)(2013-1#4)(2013-8#1)
to protect all##3##3##(1995-3#1)(2008-5#1)(2009-12#1)
to protect and##3##3##(1995-6#1)(2010-4#1)(2011-2#1)
to protect assets##2##3##(1992-12#2)
to protect both##4##3##(2010-4#1)(2012-1#1)(2012-11#2)
to protect cells##5##3##(1991-10#1)(1994-11#1)(1997-2#1)(2006-10#1)(2007-2#1)
to protect from##3##3##(1990-3#1)(1993-3#1)(2007-11#1)
to protect human subjects##4##4##(2005-11#1)(2007-11#2)(2009-4#1)
to protect human##6##3##(2005-11#1)(2006-7#1)(2007-11#2)(2009-4#1)(2010-7#1)
to protect immunodeficient##3##3##(2008-5#3)
to protect in##2##3##(1996-4#1)(2004-12#1)
to protect its##2##3##(1996-12#1)(2012-11#1)
to protect itself##2##3##(1992-9#1)(2012-2#1)
to protect neurons from##3##4##(1995-10#1)(2008-4#1)(2008-7#1)
to protect neurons##5##3##(1995-10#1)(2007-11#1)(2008-4#1)(2008-5#1)(2008-7#1)
to protect oral##2##3##(2008-7#1)(2012-2#1)
to protect public health##2##4##(2008-11#1)(2008-8#1)
to protect squalene##2##3##(2008-5#2)
to protect the artificial##2##4##(2008-5#2)
to protect the cells##2##4##(1992-11#1)(2008-11#1)
to protect the environment##3##4##(2007-5#1)(2008-3#1)(2010-9#1)
to protect the heart##4##4##(2006-10#1)(2007-8#1)(2008-1#1)(2011-2#1)
to protect the liver from ethanol-induced injury##2##7##(1995-3#2)
to protect the myocardium##2##4##(1993-7#1)(1996-9#1)
to protect the skin from##3##5##(2006-12#1)(2008-3#1)(2011-2#1)
to protect the skin##4##4##(2006-12#1)(2008-3#1)(2008-5#1)(2011-2#1)
to protect the##73##3##(1990-2#1)(1991-9#1)(1992-11#1)(1992-5#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-3#2)(1995-8#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-5#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-11#5)(2008-3#2)(2008-4#2)(2008-5#8)(2008-8#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#4)
to protect their##8##3##(1991-9#1)(1992-3#2)(1994-6#1)(2007-12#1)(2007-2#1)(2009-10#1)(2009-2#1)
to protect them against##2##4##(1994-3#1)(2013-1#1)
to protect them##4##3##(1994-3#1)(2007-12#1)(2011-2#1)(2013-1#1)
to protect themselves against##2##4##(1997-7#1)(2006-10#1)
to protect themselves and their##2##5##(1991-6#1)(2008-12#1)
to protect themselves and##3##4##(1991-6#1)(2008-12#1)(2010-3#1)
to protect themselves from##3##4##(2007-2#1)(2007-7#1)(2011-2#1)
to protect themselves##9##3##(1991-6#1)(1997-7#1)(2006-10#1)(2007-2#1)(2007-7#2)(2008-12#1)(2010-3#1)(2011-2#1)
to protect wheat##2##3##(2008-10#1)(2011-2#1)
to protect women##3##3##(1990-2#2)(2004-10#1)
to protect##263##2##(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-6#5)(1991-9#3)(1992-10#2)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#3)(1993-12#2)(1993-3#3)(1993-4#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-6#2)(1995-8#2)(1996-1#3)(1996-12#3)(1996-3#1)(1996-4#2)(1996-5#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-6#3)(1997-7#2)(2004-10#1)(2004-12#2)(2004-2#1)(2005-11#2)(2005-5#1)(2005-7#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-6#2)(2006-7#2)(2007-11#7)(2007-12#5)(2007-2#4)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#7)(2008-1#4)(2008-10#6)(2008-11#9)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#6)(2008-5#21)(2008-7#3)(2008-8#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-11#1)(2010-12#6)(2010-2#2)(2010-3#1)(2010-4#2)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#2)(2011-10#1)(2011-12#2)(2011-2#13)(2011-9#1)(2012-1#2)(2012-11#4)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#10)(2013-8#3)
to protecting##4##2##(1992-1#1)(1996-2#1)(2006-10#1)(2013-1#1)
to protection against##2##3##(1992-8#1)(1995-5#1)
to protection##8##2##(1992-8#2)(1995-5#2)(2005-9#1)(2006-10#2)(2013-7#1)
to protein A##3##3##(1991-11#2)(1992-7#1)
to protein adsorption##2##3##(2009-7#1)(2010-4#1)
to protein antigens##2##3##(2008-4#1)(2010-12#1)
to protein denaturation##2##3##(2006-10#1)(2011-2#1)
to protein kinase C activation##3##5##(1990-9#1)(1992-6#1)(1994-8#1)
to protein kinase C##8##4##(1990-7#1)(1990-9#1)(1991-6#1)(1992-6#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-3#1)
to protein kinase##9##3##(1990-7#1)(1990-9#1)(1991-6#1)(1992-6#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-3#1)(2008-2#1)
to protein phosphorylation##3##3##(1994-3#1)(1994-5#1)(1994-9#1)
to protein stability##2##3##(1992-5#1)(1993-3#1)
to protein synthesis##4##3##(1990-5#1)(1991-2#1)(1993-3#1)(2009-3#1)
to protein##87##2##(1990-5#3)(1990-7#2)(1990-9#1)(1991-1#1)(1991-11#3)(1991-2#2)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#2)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1994-11#2)(1994-12#2)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-8#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-12#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#2)(2008-9#2)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#2)(2010-6#1)(2011-2#2)(2012-1#1)(2012-3#2)
to protein-bound carbohydrate sulfate##2##4##(1990-3#2)
to protein-free##2##2##(2008-11#2)
to proteinase K##2##3##(1990-5#1)(1996-12#1)
to proteinases##2##2##(1990-4#1)(2008-11#1)
to proteins and##6##3##(1994-12#1)(1995-3#1)(1996-12#1)(2008-10#1)(2008-4#1)(2010-2#1)
to proteins from##3##3##(1991-12#1)(1992-8#1)(1995-6#1)
to proteins in##4##3##(1991-1#1)(1995-7#1)(2008-10#1)(2008-7#1)
to proteins that##4##3##(1992-10#1)(1997-3#1)(2010-12#1)(2012-1#1)
to proteins to##2##3##(1996-10#1)(2008-10#1)
to proteins##45##2##(1990-9#1)(1991-1#1)(1991-12#1)(1992-10#1)(1992-2#1)(1992-8#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-3#1)(1995-6#2)(1995-7#2)(1995-8#1)(1996-10#2)(1996-12#1)(1997-3#2)(1997-7#1)(2006-10#1)(2008-1#1)(2008-10#5)(2008-4#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2012-1#1)
to proteoglycan in##2##3##(1992-6#2)
to proteoglycan##4##2##(1990-5#1)(1992-6#3)
to proteolysis and##3##3##(1995-8#1)(2010-6#1)(2011-1#1)
to proteolysis by trypsin##2##4##(1991-2#1)(1992-11#1)
to proteolysis by##3##3##(1991-2#1)(1992-11#2)
to proteolysis##21##2##(1990-5#4)(1991-10#1)(1991-2#1)(1992-11#3)(1992-3#1)(1992-9#1)(1994-5#2)(1995-6#1)(1995-8#1)(1996-7#1)(1996-8#1)(1997-7#1)(2008-1#1)(2010-6#1)(2011-1#1)
to proteolytic degradation##6##3##(1995-8#1)(1997-4#1)(2006-12#4)
to proteolytic digestion##4##3##(1992-9#2)(1993-8#1)(1995-8#1)
to proteolytic enzymes##2##3##(1994-11#1)(2008-10#1)
to proteolytic##16##2##(1992-9#2)(1993-8#1)(1994-11#2)(1995-8#2)(1996-4#1)(1996-9#1)(1997-4#1)(2006-12#4)(2007-11#1)(2008-10#1)
to proteomics##2##2##(2007-8#1)(2009-4#1)
to protocols##3##2##(1991-8#1)(2012-12#2)
to proton##7##2##(1992-6#1)(1994-11#1)(1996-12#1)(1997-3#1)(1997-4#1)(2008-6#1)(2012-2#1)
to protonated##2##2##(2008-10#1)(2009-11#1)
to protonation of the##3##4##(1991-8#1)(2005-11#1)(2006-10#1)
to protonation of##4##3##(1991-8#1)(1992-6#1)(2005-11#1)(2006-10#1)
to protoporphyrin IX##2##3##(1992-8#1)(2008-5#1)
to protoporphyrin##3##2##(1991-10#1)(1992-8#1)(2008-5#1)
to prove a##5##3##(2008-10#3)(2008-3#1)(2009-9#1)
to prove it##2##3##(2008-10#1)(2008-7#1)
to prove that the##3##4##(1996-12#1)(2008-10#1)(2009-9#1)
to prove that##11##3##(1991-7#1)(1996-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-2#1)
to prove the efficacy of##2##5##(2007-11#1)(2007-8#1)
to prove the##21##3##(1993-11#1)(1994-6#1)(1995-9#1)(2007-10#1)(2007-11#3)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2009-2#1)(2009-8#1)(2011-1#1)(2013-8#1)
to prove whether##2##3##(2008-5#1)(2011-12#1)
to prove##62##2##(1991-7#1)(1993-11#1)(1993-5#1)(1994-6#1)(1995-11#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-2#1)(2007-7#1)(2007-8#4)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-2#1)(2009-8#2)(2009-9#2)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-11#1)(2012-12#1)(2013-7#1)(2013-8#1)
to provide &quot##2##3##(1992-4#1)(2012-11#1)
to provide EC within 24 hours##2##6##(2013-1#2)
to provide EC##3##3##(2006-2#1)(2013-1#2)
to provide a basis for##2##5##(1991-11#1)(1996-4#1)
to provide a better##3##4##(2007-8#1)(2010-3#1)(2011-12#1)
to provide a brief##5##4##(1996-2#1)(2010-10#1)(2012-12#2)(2013-1#1)
to provide a broader understanding of the##2##7##(1993-10#1)(2008-7#1)
to provide a broader##3##4##(1993-10#1)(2008-11#1)(2008-7#1)
to provide a clearer##2##4##(2012-1#1)(2012-12#1)
to provide a complete##2##4##(2008-2#1)(2008-6#1)
to provide a comprehensive##7##4##(1993-12#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-6#1)(2011-2#1)(2013-8#1)
to provide a cure##3##4##(1994-6#1)(2008-7#1)(2011-2#1)
to provide a description of the##2##6##(2006-2#1)(2009-7#1)
to provide a description of##3##5##(1991-12#1)(2006-2#1)(2009-7#1)
to provide a fast##3##4##(2007-12#1)(2008-7#1)(2012-2#1)
to provide a forum for##2##5##(2007-12#1)(2008-5#1)
to provide a foundation##2##4##(1996-2#1)(2008-12#1)
to provide a framework for the##2##6##(2008-7#1)(2012-12#1)
to provide a framework for##5##5##(1992-6#1)(2008-6#1)(2008-7#1)(2012-12#1)(2012-2#1)
to provide a functional##2##4##(1994-8#1)(2008-11#1)
to provide a fundamental##2##4##(2008-11#1)(2008-5#1)
to provide a general##4##4##(1997-3#1)(2007-1#1)(2008-4#1)(2008-6#1)
to provide a good##6##4##(1994-12#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#1)
to provide a guide##2##4##(2008-4#2)
to provide a literature review##2##5##(2007-12#1)(2010-6#1)
to provide a method for##2##5##(2008-1#1)(2012-1#1)
to provide a method##3##4##(2008-1#1)(2008-4#1)(2012-1#1)
to provide a model##2##4##(1992-6#1)(2006-8#1)
to provide a more detailed##2##5##(1991-4#1)(1992-6#1)
to provide a more##7##4##(1991-4#1)(1992-6#1)(1994-12#1)(2004-2#1)(2006-10#2)(2008-10#1)
to provide a powerful##2##4##(2006-12#1)(2008-2#1)
to provide a profile of##2##5##(1991-12#1)(1995-2#1)
to provide a rational approach to the##2##7##(1996-3#1)(2011-2#1)
to provide a rational basis for##2##6##(1996-10#1)(2008-1#1)
to provide a rational##4##4##(1996-10#1)(1996-3#1)(2008-1#1)(2011-2#1)
to provide a relatively##2##4##(2008-10#1)(2008-7#1)
to provide a reliable##2##4##(2011-7#1)(2012-2#1)
to provide a robust##3##4##(2008-1#1)(2008-3#1)(2008-4#1)
to provide a safe##3##4##(1995-2#1)(2008-10#1)(2008-11#1)
to provide a significant##2##4##(2004-12#1)(2007-7#1)
to provide a single##2##4##(2007-12#1)(2008-7#1)
to provide a specific##3##4##(1997-8#1)(2008-3#1)(2009-9#1)
to provide a standard##3##4##(2004-9#1)(2006-8#1)(2010-8#1)
to provide a theoretical##2##4##(1992-3#1)(1996-12#1)
to provide a unified##2##4##(2007-11#1)(2013-7#1)
to provide a##240##3##(1990-3#1)(1990-5#2)(1991-11#1)(1991-12#2)(1991-4#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-8#1)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-2#3)(1995-3#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#3)(1996-3#2)(1996-4#1)(1997-3#1)(1997-8#1)(2004-12#1)(2004-2#1)(2004-9#1)(2005-11#1)(2005-7#1)(2006-10#7)(2006-11#2)(2006-12#3)(2006-2#4)(2006-3#1)(2006-4#1)(2006-8#2)(2007-1#2)(2007-10#2)(2007-11#1)(2007-12#9)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#3)(2008-10#13)(2008-11#10)(2008-12#3)(2008-2#11)(2008-3#10)(2008-4#13)(2008-5#5)(2008-6#4)(2008-7#9)(2008-8#2)(2008-9#3)(2009-10#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#6)(2011-7#2)(2012-1#3)(2012-12#10)(2012-2#7)(2012-3#3)(2013-1#1)(2013-7#2)(2013-8#3)
to provide absolute##2##3##(2008-2#2)
to provide access to##3##4##(1991-12#1)(2006-9#1)(2008-11#1)
to provide accurate and##4##4##(1993-12#1)(2006-2#1)(2008-7#1)(2012-2#1)
to provide accurate##5##3##(1993-12#1)(2006-2#1)(2008-7#1)(2010-3#1)(2012-2#1)
to provide additional support##3##4##(2008-12#1)(2011-1#1)(2013-1#1)
to provide additional##10##3##(2007-12#1)(2008-10#2)(2008-12#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-3#1)(2013-1#1)
to provide adequate##17##3##(1991-12#1)(1992-4#1)(1996-5#1)(1997-3#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-5#1)(2008-11#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)
to provide an account of the##2##6##(2007-10#1)(2008-10#1)
to provide an adequate##2##4##(1996-1#1)(1996-2#1)
to provide an assessment of##2##5##(2008-1#1)(2010-5#1)
to provide an efficient and effective##2##6##(1994-2#1)(2005-5#1)
to provide an important##2##4##(1991-11#1)(2006-5#1)
to provide an insight##2##4##(2008-7#1)(2011-1#1)
to provide an objective##3##4##(1996-7#1)(2007-3#1)(2013-7#1)
to provide an overview of the##10##6##(2004-7#1)(2008-10#2)(2008-6#1)(2008-9#1)(2009-6#2)(2011-12#1)(2011-2#2)
to provide an overview of this##2##6##(2011-2#1)(2013-8#1)
to provide an overview of##20##5##(1995-3#1)(2004-7#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-5#1)(2009-6#2)(2010-11#1)(2010-12#1)(2011-12#1)(2011-2#3)(2012-12#1)(2013-8#1)
to provide an overview##22##4##(1995-3#1)(2004-7#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-6#1)(2008-9#1)(2009-5#1)(2009-6#2)(2010-11#1)(2010-12#1)(2011-12#1)(2011-2#3)(2012-12#1)(2013-8#1)
to provide an update on##2##5##(2008-8#1)(2009-3#1)
to provide an update##3##4##(2008-5#1)(2008-8#1)(2009-3#1)
to provide an##79##3##(1990-12#1)(1991-11#1)(1993-1#1)(1994-2#1)(1994-5#1)(1995-3#1)(1995-6#1)(1996-1#2)(1996-2#1)(1996-7#2)(1997-8#2)(2004-7#1)(2005-5#1)(2006-1#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#1)(2009-6#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#5)(2013-1#1)(2013-7#1)(2013-8#3)
to provide anaesthesia for##2##4##(2006-10#2)
to provide and##3##3##(2009-5#1)(2012-2#2)
to provide any significant##2##4##(1991-2#1)(2008-2#1)
to provide any##3##3##(1991-2#1)(1995-11#1)(2008-2#1)
to provide appropriate care##2##4##(2007-12#1)(2011-2#1)
to provide appropriate##7##3##(1993-3#1)(1995-9#1)(1997-7#1)(2006-10#1)(2007-12#1)(2011-2#1)(2012-12#1)
to provide assistance to##2##4##(2006-5#1)(2012-1#1)
to provide assistance##3##3##(1996-3#1)(2006-5#1)(2012-1#1)
to provide basic##3##3##(2008-7#1)(2012-1#1)(2013-7#1)
to provide better information on##3##5##(1992-3#1)(2007-2#1)(2008-3#1)
to provide better information##4##4##(1992-3#1)(2006-10#1)(2007-2#1)(2008-3#1)
to provide better services##2##4##(1993-12#1)(2012-2#1)
to provide better##11##3##(1992-3#1)(1993-12#1)(2006-10#1)(2007-2#1)(2008-3#2)(2008-9#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
to provide both##5##3##(2006-11#1)(2007-11#1)(2007-12#1)(2008-8#1)(2011-2#1)
to provide care##7##3##(1993-12#1)(2005-11#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2010-3#1)
to provide clinically##4##3##(2008-10#1)(2008-3#1)(2013-1#2)
to provide clinicians with a##2##5##(2006-10#1)(2007-11#1)
to provide clues to##2##4##(2008-11#1)(2012-3#1)
to provide clues##5##3##(2008-11#1)(2008-7#2)(2012-3#1)(2013-8#1)
to provide complete##4##3##(2008-10#1)(2008-12#1)(2008-8#1)(2012-11#1)
to provide comprehensive care##2##4##(2008-12#1)(2010-3#1)
to provide comprehensive##6##3##(1993-2#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-12#1)(2010-3#1)
to provide continuous##2##3##(2011-1#1)(2012-2#1)
to provide critical##2##3##(2006-10#1)(2012-2#1)
to provide data for##2##4##(1990-2#1)(2010-7#1)
to provide data to support##2##5##(2008-5#1)(2010-12#1)
to provide data to##3##4##(2008-5#1)(2010-12#1)(2012-12#1)
to provide data##7##3##(1990-2#1)(2004-3#1)(2008-5#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)
to provide diagnostic information##2##4##(2006-6#1)(2007-4#1)
to provide direct##3##3##(2008-11#1)(2013-1#2)
to provide early intervention##2##4##(2006-7#1)(2009-6#1)
to provide effective treatment##2##4##(2007-7#1)(2010-12#1)
to provide effective##4##3##(2006-4#1)(2007-7#1)(2008-5#1)(2010-12#1)
to provide efficient##2##3##(2007-12#1)(2008-3#1)
to provide environmental##2##3##(2008-10#1)(2012-2#1)
to provide equivalent##2##3##(1996-2#1)(2007-11#1)
to provide essential##2##3##(2012-12#1)(2012-2#1)
to provide estimates of##6##4##(1995-2#1)(1996-8#1)(1997-3#1)(1997-6#1)(2008-10#1)(2009-3#1)
to provide evidence for the##3##5##(2006-10#1)(2006-12#1)(2007-11#1)
to provide evidence for##6##4##(1996-12#1)(1996-9#1)(2006-10#1)(2006-12#1)(2007-11#1)(2010-12#1)
to provide evidence of##3##4##(1995-5#1)(2008-12#1)(2012-12#1)
to provide evidence##14##3##(1995-5#1)(1996-12#1)(1996-9#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-11#2)(2008-12#1)(2010-12#1)(2012-12#2)
to provide excellent##2##3##(2008-10#1)(2008-2#1)
to provide for a##3##4##(2008-10#1)(2008-6#1)(2013-1#1)
to provide for##10##3##(1991-3#1)(1992-3#1)(1995-3#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-6#1)(2013-1#2)
to provide fully##2##3##(1995-9#1)(2009-7#1)
to provide fundamental information##2##4##(1996-2#1)(2005-11#1)
to provide good##4##3##(2007-3#1)(2008-3#1)(2008-6#1)(2012-12#1)
to provide greater##7##3##(2007-9#1)(2008-2#3)(2008-3#1)(2008-6#1)(2010-6#1)
to provide guidance for##4##4##(2006-12#1)(2006-8#1)(2013-1#1)(2013-8#1)
to provide guidance on##3##4##(2006-10#1)(2008-11#1)(2009-2#1)
to provide guidance##10##3##(1992-2#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-4#1)(2008-11#1)(2008-3#1)(2009-2#1)(2013-1#1)(2013-8#1)
to provide guidelines to##3##4##(1992-3#1)(2006-2#1)(2009-9#1)
to provide guidelines##4##3##(1992-3#1)(2006-2#1)(2008-10#1)(2009-9#1)
to provide health care##2##4##(1994-12#1)(1997-3#1)
to provide health##5##3##(1994-12#1)(1997-3#1)(2007-5#1)(2008-11#1)(2010-12#1)
to provide high##6##3##(1991-12#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
to provide high-quality##3##3##(1991-2#1)(1997-1#1)(2008-1#1)
to provide high-speed##2##3##(2005-7#1)(2007-12#1)
to provide holistic care##2##4##(2007-8#1)(2008-11#1)
to provide immediate##4##3##(2007-7#1)(2008-4#1)(2012-12#2)
to provide improved##3##3##(2006-7#1)(2007-1#1)(2008-2#1)
to provide in the##2##4##(2009-7#1)(2010-10#1)
to provide in##3##3##(2006-11#1)(2009-7#1)(2010-10#1)
to provide increased##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
to provide independent##3##3##(2008-10#1)(2008-6#1)(2008-9#1)
to provide information about the##4##5##(1993-12#1)(2007-12#1)(2008-10#1)(2008-4#1)
to provide information about##9##4##(1992-2#1)(1993-12#1)(2007-12#1)(2008-10#2)(2008-4#1)(2009-5#1)(2009-9#1)(2011-3#1)
to provide information and##2##4##(2009-5#1)(2012-3#1)
to provide information for##4##4##(1996-12#1)(1996-9#1)(2008-12#1)(2011-1#1)
to provide information on the##2##5##(2006-2#1)(2007-11#1)
to provide information on##7##4##(1991-5#1)(1995-6#1)(1996-6#1)(2006-2#1)(2007-11#1)(2007-2#1)(2012-2#1)
to provide information to the##2##5##(2007-2#1)(2007-3#1)
to provide information to##5##4##(1996-2#1)(2007-2#1)(2007-3#1)(2010-8#1)(2012-1#1)
to provide information##32##3##(1991-5#1)(1992-2#1)(1993-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-9#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-5#2)(2009-9#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)
to provide initial##2##3##(2007-10#1)(2008-5#1)
to provide insight into the##4##5##(1994-3#1)(2007-11#2)(2008-2#1)
to provide insight into##11##4##(1991-2#1)(1994-3#1)(1996-12#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2009-5#1)(2009-9#1)(2012-3#1)
to provide insight##12##3##(1991-2#1)(1994-3#1)(1996-12#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2009-5#1)(2009-9#1)(2012-3#1)(2013-1#1)
to provide insights into the##4##5##(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
to provide insights into##6##4##(2007-9#1)(2008-10#2)(2008-11#1)(2012-2#1)(2013-1#1)
to provide insights##7##3##(2007-9#1)(2008-10#2)(2008-11#1)(2010-10#1)(2012-2#1)(2013-1#1)
to provide insurance##2##3##(1991-2#2)
to provide integrated##2##3##(2008-7#1)(2010-10#1)
to provide knowledge##2##3##(2009-6#1)(2012-3#1)
to provide long-term##4##3##(2008-11#1)(2008-4#1)(2011-1#1)(2012-2#1)
to provide mechanical##3##3##(1995-3#1)(1996-4#1)(2008-5#1)
to provide mechanistic##2##3##(2008-11#1)(2011-1#1)
to provide medium##2##3##(2007-11#1)(2008-3#1)
to provide mental health##2##4##(1991-1#1)(2013-1#1)
to provide mental##3##3##(1991-1#1)(2010-1#1)(2013-1#1)
to provide more information##2##4##(2007-3#1)(2007-4#1)
to provide more##13##3##(1990-3#1)(1992-3#1)(1996-10#1)(1997-1#1)(2006-11#1)(2007-3#1)(2007-4#1)(2007-6#1)(2008-10#1)(2009-7#1)(2011-2#1)(2013-1#2)
to provide much##3##3##(2004-11#1)(2008-2#1)(2008-4#1)
to provide new information on the##2##6##(1990-4#1)(2006-6#1)
to provide new information on##3##5##(1990-4#1)(2006-6#1)(2008-3#1)
to provide new information##5##4##(1990-4#1)(2006-6#1)(2008-2#1)(2008-3#1)(2012-1#1)
to provide new##14##3##(1990-4#1)(1996-1#1)(1996-8#1)(2006-6#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-11#1)(2010-7#1)(2012-1#1)(2013-8#1)
to provide normal##2##3##(2008-7#1)(2013-3#1)
to provide nutrition##2##3##(1991-12#1)(1991-3#1)
to provide one of the##2##5##(2008-10#1)(2012-2#1)
to provide one##3##3##(2006-8#1)(2008-10#1)(2012-2#1)
to provide opportunities for##3##4##(1993-6#1)(2006-5#1)(2009-11#1)
to provide opportunities##4##3##(1993-6#1)(2006-5#1)(2009-11#1)(2013-1#1)
to provide optimal##5##3##(2007-11#1)(2008-2#1)(2010-4#1)(2011-3#1)(2012-1#1)
to provide patient##2##3##(2010-5#1)(2013-1#1)
to provide patients with##2##4##(2007-8#1)(2008-7#1)
to provide physicians with##2##4##(2006-12#1)(2008-3#1)
to provide physicians##3##3##(2006-12#1)(2008-3#2)
to provide practical##3##3##(1991-2#1)(2006-8#1)(2011-2#1)
to provide primary care physicians##2##5##(2007-10#1)(2010-8#1)
to provide prolonged##3##3##(2006-10#1)(2008-5#1)(2008-8#1)
to provide protection##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
to provide quality care##3##4##(2007-9#1)(2008-11#1)(2011-1#1)
to provide quality health care##2##5##(1994-3#1)(2008-11#1)
to provide quality patient care##2##5##(1997-1#1)(2006-1#1)
to provide quality##8##3##(1994-3#1)(1997-1#1)(2006-1#1)(2007-9#1)(2008-11#2)(2011-1#2)
to provide quantitative information##3##4##(2008-2#1)(2008-7#1)(2013-7#1)
to provide quantitative##5##3##(2008-10#2)(2008-2#1)(2008-7#1)(2013-7#1)
to provide rapid##4##3##(2008-10#1)(2011-1#1)(2011-12#1)(2011-2#1)
to provide real-time##3##3##(2008-2#1)(2013-1#2)
to provide recommendations for##2##4##(2008-11#1)(2012-3#1)
to provide relevant##2##3##(2006-10#1)(2007-2#1)
to provide reliable##3##3##(2008-10#1)(2008-7#1)(2012-1#1)
to provide relief##2##3##(2007-11#1)(2008-9#1)
to provide robust##2##3##(2008-2#1)(2013-1#1)
to provide safe##5##3##(1994-3#1)(2007-12#2)(2008-10#1)(2008-6#1)
to provide sensitive##2##3##(1992-4#1)(2008-10#1)
to provide services##4##3##(1992-3#1)(1994-1#2)(2008-11#1)
to provide significant clinical##2##4##(2006-10#1)(2008-7#1)
to provide significant##4##3##(2006-10#1)(2007-3#1)(2008-7#1)(2012-3#1)
to provide significantly##2##3##(2006-5#1)(2008-3#1)
to provide similar##2##3##(2007-7#1)(2008-4#1)
to provide smoking cessation##3##4##(2011-2#1)(2012-3#2)
to provide soft tissue##2##4##(2007-7#1)(2008-9#1)
to provide solid##2##3##(2005-8#1)(2013-8#1)
to provide some##12##3##(1991-3#1)(1996-12#1)(1996-2#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-11#1)
to provide sound##2##3##(2010-5#2)
to provide spatial##3##3##(2008-3#1)(2008-7#1)(2012-2#1)
to provide specific##2##3##(1991-2#1)(1996-12#1)
to provide stability##2##3##(2005-7#1)(2006-8#1)
to provide structural##2##3##(2006-12#1)(2007-8#1)
to provide students with##3##4##(2006-5#1)(2008-11#1)(2011-1#1)
to provide students##4##3##(1995-1#1)(2006-5#1)(2008-11#1)(2011-1#1)
to provide substantial##3##3##(2008-3#1)(2010-12#1)(2011-1#1)
to provide such a##2##4##(2006-10#1)(2008-3#1)
to provide such services##2##4##(1993-1#1)(2005-11#1)
to provide such##7##3##(1993-1#1)(1996-3#1)(2005-11#1)(2006-10#1)(2008-11#1)(2008-3#1)(2013-8#1)
to provide sufficient##7##3##(1994-12#1)(2005-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2013-1#2)
to provide support##4##3##(2007-2#1)(2008-11#1)(2008-4#1)(2012-12#1)
to provide sustained##2##3##(2008-11#1)(2012-2#1)
to provide systemic##3##3##(2005-8#1)(2008-10#1)(2008-6#1)
to provide that##2##3##(1996-1#1)(1996-3#1)
to provide the basic information##2##5##(1990-12#1)(2008-7#1)
to provide the best##11##4##(2004-12#1)(2006-10#1)(2007-2#1)(2008-10#3)(2008-4#1)(2008-5#1)(2010-11#1)(2012-2#1)(2013-7#1)
to provide the desired##2##4##(1990-5#1)(2010-8#1)
to provide the first##4##4##(1995-5#1)(2005-11#1)(2007-11#1)(2008-5#1)
to provide the greatest##2##4##(1993-6#1)(1995-12#1)
to provide the maximum##2##4##(2008-10#1)(2008-3#1)
to provide the most##2##4##(1997-2#1)(2011-2#1)
to provide the necessary##3##4##(2007-12#1)(2008-3#1)(2011-1#1)
to provide the reader with an understanding of the##2##9##(2007-7#1)(2008-10#1)
to provide the reader with##4##5##(2007-7#1)(2008-10#1)(2008-5#1)(2010-9#1)
to provide the same##2##4##(2007-2#1)(2008-2#1)
to provide the##99##3##(1990-11#1)(1990-12#1)(1990-5#1)(1991-1#1)(1992-6#1)(1993-6#1)(1994-2#1)(1995-12#3)(1995-5#1)(1997-1#2)(1997-2#1)(1997-4#1)(2004-12#1)(2005-11#1)(2005-12#1)(2005-5#1)(2006-10#1)(2006-12#2)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#4)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#6)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-11#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
to provide their##5##3##(1997-2#1)(2008-9#1)(2010-8#1)(2013-1#2)
to provide them with##3##4##(2007-7#1)(2013-8#2)
to provide these patients with##2##5##(2007-2#1)(2011-2#1)
to provide these##4##3##(1997-1#1)(2007-2#1)(2011-2#1)(2013-8#1)
to provide timely and##2##4##(1992-12#1)(2012-12#1)
to provide timely##3##3##(1992-12#1)(2008-8#1)(2012-12#1)
to provide tissue##2##3##(2006-10#1)(2009-9#1)
to provide to##2##3##(2010-8#1)(2013-1#1)
to provide unique##2##3##(1990-7#1)(2008-1#1)
to provide updated information##2##4##(2011-2#1)(2012-2#1)
to provide useful information for##2##5##(1996-3#1)(2012-12#1)
to provide useful information##4##4##(1996-3#1)(2008-9#1)(2009-5#1)(2012-12#1)
to provide useful##12##3##(1994-3#1)(1996-3#1)(2004-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-11#1)(2012-12#1)(2012-2#3)
to provide valid##3##3##(1995-2#1)(1995-8#1)(2007-4#1)
to provide valuable information##2##4##(2005-11#1)(2009-5#1)
to provide##1238##2##(1990-10#1)(1990-11#4)(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#3)(1990-7#1)(1990-8#1)(1991-1#2)(1991-11#2)(1991-12#8)(1991-2#9)(1991-3#3)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#5)(1992-3#7)(1992-4#3)(1992-5#1)(1992-6#5)(1992-8#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#7)(1993-2#2)(1993-3#2)(1993-6#3)(1993-9#1)(1994-1#3)(1994-12#8)(1994-2#4)(1994-3#5)(1994-5#1)(1994-6#4)(1994-8#2)(1994-9#2)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#10)(1995-3#8)(1995-5#3)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#5)(1996-10#2)(1996-11#1)(1996-12#10)(1996-2#8)(1996-3#8)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#3)(1997-1#6)(1997-2#2)(1997-3#5)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#6)(2004-10#1)(2004-11#2)(2004-12#2)(2004-2#1)(2004-3#1)(2004-7#1)(2004-9#3)(2005-10#1)(2005-11#9)(2005-12#2)(2005-3#1)(2005-5#2)(2005-7#4)(2005-8#3)(2005-9#1)(2006-1#4)(2006-10#33)(2006-11#9)(2006-12#14)(2006-2#8)(2006-3#1)(2006-4#3)(2006-5#9)(2006-6#3)(2006-7#6)(2006-8#8)(2006-9#2)(2007-1#6)(2007-10#6)(2007-11#23)(2007-12#28)(2007-2#15)(2007-3#6)(2007-4#11)(2007-5#5)(2007-6#5)(2007-7#10)(2007-8#12)(2007-9#8)(2008-1#13)(2008-10#70)(2008-11#47)(2008-12#12)(2008-2#47)(2008-3#48)(2008-4#26)(2008-5#20)(2008-6#16)(2008-7#43)(2008-8#13)(2008-9#17)(2009-1#1)(2009-10#3)(2009-11#3)(2009-12#2)(2009-2#4)(2009-3#3)(2009-4#1)(2009-5#11)(2009-6#5)(2009-7#6)(2009-8#1)(2009-9#11)(2010-1#2)(2010-10#8)(2010-11#11)(2010-12#9)(2010-2#1)(2010-3#4)(2010-4#3)(2010-5#7)(2010-6#5)(2010-7#7)(2010-8#11)(2010-9#2)(2011-1#24)(2011-12#5)(2011-2#35)(2011-3#3)(2011-7#2)(2012-1#17)(2012-11#3)(2012-12#32)(2012-2#45)(2012-3#16)(2013-1#34)(2013-3#1)(2013-7#8)(2013-8#25)
to provider##5##2##(1994-2#1)(1995-2#1)(1996-1#1)(1997-1#1)(2012-1#1)
to providers##10##2##(1992-12#1)(1996-3#1)(2005-8#1)(2006-8#1)(2007-3#1)(2008-6#1)(2008-7#2)(2013-1#2)
to providing information##2##3##(2008-9#1)(2009-9#1)
to providing##30##2##(1993-3#1)(1995-3#1)(1996-3#1)(2005-11#1)(2006-4#1)(2007-12#1)(2007-4#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-9#3)(2009-11#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
to provincial##3##2##(2010-8#1)(2012-12#2)
to provision##3##2##(2008-9#1)(2009-10#1)(2009-7#1)
to provoke a##3##3##(1990-10#1)(1993-3#1)(2008-4#1)
to provoke##9##2##(1990-10#1)(1993-3#1)(1996-11#1)(2004-11#1)(2006-10#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
to provoked cerebral##2##3##(2004-12#2)
to provoked##3##2##(2004-12#3)
to proximal##8##2##(1997-7#1)(2007-11#2)(2007-7#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-3#1)
to proximity##2##2##(1990-12#1)(2010-12#1)
to pruritus##3##2##(2008-1#1)(2013-7#2)
to psychiatric care##2##3##(1993-12#1)(2008-2#1)
to psychiatric departments##2##3##(1991-9#1)(1993-8#1)
to psychiatric disorders##2##3##(2009-8#1)(2012-2#1)
to psychiatric##18##2##(1991-9#1)(1993-12#2)(1993-8#1)(1995-1#1)(1997-3#1)(1997-8#2)(2005-6#1)(2007-9#2)(2008-2#1)(2008-4#1)(2009-8#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#1)
to psychiatrists##2##2##(1996-6#1)(2011-1#1)
to psychiatry##4##2##(1991-3#1)(2008-8#1)(2009-8#1)(2013-8#1)
to psychoactive substances##3##3##(2011-1#1)(2013-7#2)
to psychoactive##5##2##(2011-1#1)(2013-7#4)
to psychoeducation##2##2##(2007-12#1)(2012-2#1)
to psychological factors##2##3##(1990-6#1)(2006-10#1)
to psychological##10##2##(1990-6#1)(1991-12#1)(1992-5#1)(1995-1#1)(1995-4#1)(2006-10#1)(2008-12#1)(2009-10#1)(2009-4#1)(2010-2#1)
to psychopathology##3##2##(1997-8#1)(2008-1#1)(2012-1#1)
to psychopharmacology##2##2##(2005-7#1)(2008-4#1)
to psychosis##3##2##(1991-6#1)(2005-10#1)(2012-1#1)
to psychosocial##5##2##(1995-1#1)(1995-12#2)(2011-2#2)
to psychostimulants##3##2##(1995-12#1)(1996-10#2)
to psychotherapy##5##2##(2008-3#1)(2009-10#1)(2009-9#2)(2013-1#1)
to psychotic##2##2##(1996-7#1)(2011-1#1)
to psychotropic##2##2##(2004-3#1)(2009-7#1)
to puberty##4##2##(1993-4#1)(2006-5#1)(2007-2#1)(2008-4#1)
to public and##3##3##(1994-3#1)(2008-7#1)(2011-1#1)
to public health and##2##4##(2007-2#1)(2012-2#1)
to public health emergencies##3##4##(2008-8#1)(2012-2#2)
to public health practice##5##4##(1996-1#1)(1996-12#1)(1996-3#1)(2007-11#1)(2012-2#1)
to public health research##2##4##(2007-11#1)(2011-1#1)
to public health surveillance systems##2##5##(2008-7#2)
to public health surveillance##3##4##(1997-3#1)(2008-7#2)
to public health##48##3##(1993-12#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-3#4)(2006-10#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-7#3)(2008-8#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#7)(2013-1#5)
to public health's##2##3##(1996-2#1)(1996-3#1)
to public##71##2##(1992-11#1)(1992-12#1)(1993-12#1)(1994-3#2)(1995-9#1)(1996-1#1)(1996-12#3)(1996-2#3)(1996-3#2)(1997-3#4)(2006-10#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#2)(2008-10#2)(2008-12#3)(2008-5#1)(2008-7#5)(2008-8#1)(2010-12#2)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#8)(2013-1#5)(2013-7#2)(2013-8#1)
to publication bias##2##3##(1993-12#1)(2006-10#1)
to publication##4##2##(1993-12#1)(2006-10#1)(2006-5#1)(2007-8#1)
to publicize the##2##3##(1992-12#1)(2008-7#1)
to publish in##2##3##(2005-7#1)(2011-2#1)
to publish##15##2##(1991-12#1)(1991-2#1)(1993-12#1)(1993-8#1)(2005-7#2)(2007-4#1)(2008-10#1)(2008-7#2)(2009-11#1)(2010-12#3)(2011-2#1)
to published data##4##3##(1996-1#1)(2006-8#1)(2007-12#1)(2008-10#1)
to published results##2##3##(2008-9#1)(2013-1#1)
to published##12##2##(1993-12#1)(1996-1#1)(1996-9#1)(2006-10#1)(2006-8#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-9#1)(2013-1#2)
to pull out the##2##4##(2007-7#1)(2008-7#1)
to pull the plug##2##4##(1994-3#1)(2007-9#1)
to pull the##3##3##(1994-3#1)(2007-9#1)(2008-11#1)
to pull##9##2##(1994-3#1)(2006-7#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-5#1)
to pulmonary fibrosis##2##3##(1995-8#1)(2005-8#1)
to pulmonary hypertension##3##3##(2005-11#1)(2006-4#1)(2010-12#1)
to pulmonary tuberculosis##3##3##(2011-1#2)(2013-1#1)
to pulmonary##32##2##(1991-4#1)(1994-5#1)(1994-6#1)(1995-8#1)(1996-12#2)(2005-10#1)(2005-11#1)(2005-8#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-12#2)(2008-7#1)(2010-10#1)(2010-12#1)(2010-9#2)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
to pulse##3##2##(1990-10#1)(2007-12#1)(2008-10#1)
to pulsed##3##2##(2007-3#1)(2008-9#1)(2009-4#1)
to pulses of##2##3##(1990-11#1)(2007-11#1)
to pulses##3##2##(1990-11#1)(2007-11#1)(2007-12#1)
to pump a##2##3##(2007-12#2)
to pump the##2##3##(1994-8#1)(2008-11#1)
to pump##8##2##(1994-8#1)(1997-1#1)(2007-12#3)(2008-11#2)(2008-2#1)
to pumps##2##2##(2007-9#1)(2008-3#1)
to puncture the##2##3##(2010-8#1)(2011-2#1)
to pups##2##2##(1991-1#2)
to purchase and##2##3##(2006-10#1)(2008-3#1)
to purchase the##2##3##(2004-2#1)(2007-7#1)
to purchase##19##2##(1990-12#1)(1992-12#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-3#1)(1996-11#2)(1997-3#1)(2004-2#1)(2006-10#2)(2006-7#1)(2007-12#1)(2007-7#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-12#1)
to pure water##2##3##(2005-11#1)(2008-10#1)
to pure##26##2##(1990-12#1)(1990-5#2)(1992-11#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-5#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-11#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-2#4)(2008-7#1)(2012-12#1)(2013-1#1)
to purely##2##2##(1995-5#1)(2007-4#1)
to purge##2##2##(1990-11#1)(2008-10#1)
to purification##2##2##(2010-5#1)(2011-2#1)
to purified##13##2##(1991-2#1)(1991-3#1)(1992-6#2)(1993-3#1)(1993-4#1)(1994-9#1)(1995-7#1)(2007-6#1)(2008-1#1)(2008-9#1)(2011-1#1)(2011-2#1)
to purify the##8##3##(1990-11#1)(1991-7#1)(1994-12#1)(1994-5#1)(1997-7#1)(2006-7#1)(2008-4#1)(2010-4#1)
to purify this##2##3##(1994-11#1)(1997-7#1)
to purify##39##2##(1990-11#1)(1990-7#1)(1991-12#2)(1991-7#1)(1992-12#2)(1993-4#1)(1994-11#1)(1994-12#2)(1994-5#1)(1997-4#1)(1997-7#2)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#5)(2008-5#1)(2008-6#1)(2010-4#2)(2012-12#3)(2013-1#1)(2013-8#1)
to purine##2##2##(1993-8#1)(1995-12#1)
to purple##3##2##(1994-5#1)(2008-2#1)(2008-4#1)
to purposefully##2##2##(2008-1#1)(2009-10#1)
to pursue a##6##3##(1990-10#1)(1992-1#1)(2007-4#1)(2008-10#1)(2009-5#1)(2012-3#1)
to pursue graduate studies in nursing education##2##7##(2012-2#2)
to pursue the##4##3##(1992-3#1)(1993-3#1)(2008-11#1)(2008-9#1)
to pursue##37##2##(1990-10#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-3#1)(1994-5#1)(1995-1#1)(1995-6#1)(1996-3#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#2)
to purulent##2##2##(1992-3#1)(2010-2#1)
to push the##2##3##(2007-12#1)(2010-12#1)
to push##7##2##(1992-3#1)(2006-10#1)(2007-12#1)(2008-4#1)(2008-6#1)(2010-12#1)(2010-8#1)
to put a##2##3##(2007-9#1)(2010-5#1)
to put in place##4##4##(1995-12#1)(2007-7#1)(2008-7#1)(2012-3#1)
to put into##4##3##(1990-11#1)(2006-10#1)(2008-2#1)(2012-12#1)
to put it into a##2##5##(2007-8#1)(2012-1#1)
to put it##3##3##(1990-5#1)(2007-8#1)(2012-1#1)
to put more##4##3##(1997-2#1)(2007-3#1)(2007-7#1)(2008-10#1)
to put the##5##3##(1991-11#1)(1992-1#1)(1995-6#1)(2007-8#1)(2013-8#1)
to put them in##2##4##(1997-6#1)(2011-2#1)
to put##33##2##(1990-11#1)(1990-3#1)(1990-5#1)(1991-11#1)(1991-3#1)(1992-1#1)(1993-6#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-2#1)(1997-6#1)(2006-10#1)(2006-8#1)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-2#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#2)
to putative##3##2##(1990-5#1)(2007-8#1)(2012-1#1)
to putting##2##2##(2010-6#1)(2010-8#1)
to pyramidal cells##2##3##(1991-6#1)(1995-5#1)
to pyrethroids##2##2##(1997-5#1)(2005-8#1)
to pyridoxine##3##2##(1990-10#1)(2007-3#1)(2008-7#1)
to pyrimethamine##2##2##(2008-10#1)(2010-12#1)
to pyrimidine bases##2##3##(1991-12#1)(1992-6#1)
to pyrolysis##2##2##(2008-10#2)
to pyruvate were##2##3##(1993-11#1)(1994-9#1)
to pyruvate##4##2##(1990-12#1)(1993-11#1)(1994-9#1)(2008-7#1)
to quadrat size##2##3##(2008-10#2)
to qualify as##2##3##(2007-11#1)(2008-3#1)
to qualify for##4##3##(1990-4#1)(1991-10#1)(1993-3#1)(1994-2#1)
to qualify##6##2##(1990-4#1)(1991-10#1)(1993-3#1)(1994-2#1)(2007-11#1)(2008-3#1)
to qualitative##4##2##(2008-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
to qualitatively##7##2##(1992-9#1)(2006-10#1)(2008-10#2)(2008-8#1)(2013-1#2)
to quality and##4##3##(1997-5#1)(2006-12#1)(2007-4#1)(2007-8#1)
to quality care##3##3##(1991-1#1)(1993-12#1)(2007-4#1)
to quality control##3##3##(1992-9#1)(2007-8#1)(2008-10#1)
to quality improvement of##2##4##(1997-8#1)(2008-1#1)
to quality improvement##6##3##(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-8#1)(2008-1#1)
to quality in##2##3##(1994-1#1)(1996-2#1)
to quality of life##2##4##(1996-12#1)(2006-2#1)
to quality of##5##3##(1995-3#1)(1996-12#1)(2006-2#1)(2012-3#1)(2013-1#1)
to quality##38##2##(1991-1#1)(1991-3#1)(1992-9#1)(1993-12#2)(1994-1#2)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#3)(1996-12#1)(1996-2#1)(1997-2#1)(1997-5#1)(1997-8#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-8#2)(2008-1#1)(2008-10#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)
to quantify analytes##2##3##(2008-10#1)(2011-1#1)
to quantify and stage##2##4##(2012-2#2)
to quantify and##11##3##(2006-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-2#1)(2010-4#1)(2010-5#1)(2012-2#2)
to quantify both the##2##4##(2007-12#1)(2008-8#1)
to quantify changes in##2##4##(2009-7#1)(2011-1#1)
to quantify the amount of##2##5##(2008-10#1)(2011-1#1)
to quantify the degree of##4##5##(2008-10#1)(2008-2#1)(2010-3#1)(2012-1#1)
to quantify the degree##5##4##(2007-5#1)(2008-10#1)(2008-2#1)(2010-3#1)(2012-1#1)
to quantify the effect of##7##5##(2007-8#2)(2008-10#2)(2008-7#1)(2013-1#2)
to quantify the effects of##7##5##(1991-11#1)(2007-1#1)(2008-10#2)(2008-11#1)(2010-2#1)(2012-1#1)
to quantify the extent of##2##5##(1994-11#1)(2013-1#1)
to quantify the hydrolysis##2##4##(2008-10#1)(2013-1#1)
to quantify the influence of##2##5##(2008-10#1)(2008-9#1)
to quantify the performance of the##2##6##(2008-2#1)(2008-3#1)
to quantify the size##3##4##(2007-12#1)(2008-7#1)(2010-10#1)
to quantify the total##2##4##(2008-1#1)(2008-10#1)
to quantify the##117##3##(1990-11#1)(1990-5#1)(1990-7#1)(1991-11#1)(1992-5#1)(1992-7#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-12#1)(1996-7#1)(1997-6#1)(1997-8#1)(2005-1#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-1#3)(2007-10#1)(2007-12#5)(2007-4#3)(2007-5#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-2#6)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-3#2)(2010-8#2)(2011-1#3)(2011-2#3)(2012-1#3)(2012-2#2)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#2)
to quantify total##2##3##(2008-1#1)(2008-12#1)
to quantify##255##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#1)(1992-5#1)(1992-7#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-2#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-12#2)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-3#2)(1997-6#1)(1997-8#1)(2005-1#1)(2006-10#3)(2006-11#1)(2006-12#3)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#2)(2007-12#7)(2007-3#1)(2007-4#3)(2007-5#2)(2007-8#8)(2007-9#3)(2008-1#3)(2008-10#53)(2008-11#7)(2008-12#3)(2008-2#7)(2008-3#9)(2008-4#11)(2008-5#5)(2008-6#1)(2008-7#11)(2008-8#4)(2008-9#3)(2009-2#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#7)(2012-1#3)(2012-12#2)(2012-2#7)(2012-3#3)(2013-1#14)(2013-7#2)(2013-8#2)
to quantifying##4##2##(2005-11#1)(2008-10#1)(2008-11#1)(2008-8#1)
to quantitate enantiomeric mixtures##2##4##(2008-10#2)
to quantitate the##15##3##(1990-12#1)(1991-9#1)(1992-12#1)(1992-6#1)(1996-11#1)(1996-8#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#1)(2009-10#1)
to quantitate total protein##2##4##(2008-2#1)(2008-9#1)
to quantitate##54##2##(1990-12#4)(1990-2#1)(1991-9#2)(1992-12#2)(1992-6#1)(1992-8#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-5#2)(1996-1#1)(1996-11#3)(1996-12#1)(1996-8#1)(1997-3#1)(1997-5#1)(2006-5#1)(2007-1#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-4#9)(2008-6#1)(2008-9#6)(2009-10#1)(2012-2#1)
to quantitation##3##2##(1991-5#1)(2008-10#1)(2008-4#1)
to quantitative analysis of##3##4##(2007-8#1)(2008-2#1)(2008-9#1)
to quantitative analysis##6##3##(1997-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)
to quantitative##15##2##(1997-5#1)(1997-8#1)(2006-2#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-4#2)(2008-9#1)(2011-1#1)(2012-2#1)
to quantitatively analyze the##2##4##(2008-2#1)(2009-7#1)
to quantitatively analyze##4##3##(2008-2#1)(2008-4#1)(2009-7#1)(2010-6#1)
to quantitatively assess##5##3##(2007-8#1)(2008-10#2)(2011-1#1)(2013-1#1)
to quantitatively determine the##2##4##(1994-3#1)(2007-5#1)
to quantitatively determine##4##3##(1994-3#1)(2007-5#1)(2008-10#2)
to quantitatively measure GTP gamma S binding to specific G proteins in##2##12##(1992-6#2)
to quantitatively measure##10##3##(1992-6#2)(1994-9#1)(2008-10#1)(2008-8#1)(2009-9#1)(2012-12#2)(2013-1#2)
to quantitatively##41##2##(1991-8#1)(1992-6#2)(1993-3#1)(1994-3#1)(1994-9#1)(1995-12#1)(1997-4#1)(2005-11#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-2#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-7#1)(2012-12#2)(2013-1#3)(2013-8#1)
to quantization##3##2##(2008-2#3)
to quantum Hall##2##3##(1993-8#1)(2012-2#1)
to quantum##3##2##(1993-8#1)(2010-12#1)(2012-2#1)
to quartz surfaces##2##3##(2008-10#2)
to quartz##4##2##(2005-11#1)(2007-8#1)(2008-10#2)
to quench the fluorescence of##2##5##(1997-4#1)(2008-9#1)
to quench the##5##3##(1996-2#1)(1997-4#1)(2006-10#2)(2008-9#1)
to quench##10##2##(1992-9#1)(1996-2#1)(1997-4#1)(2006-10#3)(2007-4#1)(2008-5#1)(2008-8#1)(2008-9#1)
to quenching by##2##3##(1997-7#1)(2006-10#1)
to quenching of the##2##4##(2007-12#1)(2008-4#1)
to quenching of##3##3##(2007-12#1)(2008-4#1)(2013-1#1)
to quenching##5##2##(1997-7#1)(2006-10#1)(2007-12#1)(2008-4#1)(2013-1#1)
to query##6##2##(2007-6#1)(2008-1#1)(2008-10#1)(2008-4#2)(2012-2#1)
to question the##4##3##(1993-2#1)(2008-12#1)(2008-9#1)(2010-6#1)
to question##12##2##(1991-12#1)(1993-2#1)(1996-5#1)(2005-10#2)(2008-12#1)(2008-4#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-6#1)
to questionnaires##3##2##(1992-6#1)(2008-2#1)(2013-7#1)
to questions about the##3##4##(2004-12#1)(2008-8#1)(2008-9#1)
to questions about##6##3##(1991-2#1)(1992-12#1)(2004-12#1)(2008-8#1)(2008-9#1)(2013-1#1)
to questions of##4##3##(1990-5#1)(1997-8#1)(2008-10#1)(2011-1#1)
to questions regarding##2##3##(1994-12#1)(2008-7#1)
to questions that##2##3##(1995-1#1)(2008-11#1)
to questions##20##2##(1990-5#1)(1991-2#1)(1992-12#1)(1994-12#1)(1995-1#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-1#1)
to quick##3##2##(2006-6#1)(2008-10#1)(2011-2#1)
to quickly and##4##3##(1992-9#1)(2008-10#1)(2008-11#1)(2013-7#1)
to quickly identify##2##3##(1997-6#1)(2011-2#1)
to quickly##17##2##(1990-12#1)(1992-9#1)(1995-9#1)(1997-6#1)(2006-10#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-9#1)(2011-2#2)(2013-1#2)(2013-7#1)
to quiescent cells##2##3##(1993-6#1)(1993-8#1)
to quiescent##4##2##(1990-3#1)(1993-6#1)(1993-8#1)(1995-3#1)
to quinine##4##2##(1996-8#1)(1996-9#1)(2006-4#1)(2009-6#1)
to quinolone##2##2##(2008-5#1)(2012-3#1)
to quisqualate##2##2##(1990-2#1)(1993-12#1)
to quit and##2##3##(2012-1#1)(2013-1#1)
to quit smoking were##2##4##(2012-2#1)(2013-8#1)
to quit smoking##8##3##(2007-9#1)(2008-8#1)(2012-2#2)(2013-8#4)
to quit using##2##3##(2008-4#2)
to quit##31##2##(1991-12#1)(1991-5#1)(1994-7#2)(2006-2#2)(2007-9#1)(2008-4#2)(2008-8#1)(2010-2#3)(2011-2#2)(2012-1#2)(2012-2#5)(2013-1#3)(2013-8#6)
to r = 0##3##4##(1991-5#1)(1995-2#1)(1996-11#1)
to r =##5##3##(1990-2#1)(1991-3#1)(1991-5#1)(1995-2#1)(1996-11#1)
to r-hu IFN-gamma##2##3##(1993-9#2)
to rTMS and##2##3##(2010-6#2)
to rTMS##3##2##(2010-6#2)(2013-1#1)
to rabbit##8##2##(1990-12#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-11#1)(1995-2#1)(2007-1#1)(2010-4#1)
to rabbits##3##2##(1991-5#1)(2005-10#1)(2008-4#1)
to race 1 isolates##2##4##(2008-10#2)
to race 1##8##3##(2008-10#8)
to race 2##6##3##(2008-10#6)
to race 3##3##3##(2008-10#3)
to race 4##2##3##(2008-10#2)
to race##26##2##(1992-10#1)(2007-10#1)(2008-10#22)(2011-2#1)(2012-11#1)
to races 1 and 4 was##2##6##(2008-10#2)
to races 1 and 4##4##5##(2008-10#4)
to races 1 and 8##2##5##(2008-10#2)
to races 1 and##10##4##(2008-10#9)(2012-11#1)
to races 1##12##3##(2008-10#11)(2012-11#1)
to races##15##2##(2008-10#14)(2012-11#1)
to radial artery##4##3##(2007-8#4)
to radial##7##2##(1997-3#1)(2007-8#4)(2009-3#1)(2011-2#1)
to radiant heat##2##3##(2006-6#1)(2008-5#1)
to radiate##2##2##(1995-3#1)(2008-7#1)
to radiation in##2##3##(2007-10#1)(2008-7#1)
to radiation sensitive##2##3##(1993-9#2)
to radiation therapy##5##3##(1994-12#1)(1997-3#1)(2010-12#1)(2012-1#1)(2012-2#1)
to radiation were##2##3##(2006-12#1)(2008-6#1)
to radiation##33##2##(1991-7#2)(1993-12#1)(1993-2#1)(1993-9#2)(1994-12#1)(1994-8#1)(1997-3#1)(2006-12#4)(2007-10#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
to radiation-induced##3##2##(1994-8#1)(2009-12#1)(2012-2#1)
to radical##5##2##(1992-8#1)(2006-10#1)(2008-11#1)(2010-11#1)(2011-1#1)
to radioactive##5##2##(1993-11#1)(1997-3#1)(2005-7#1)(2008-5#1)(2009-12#1)
to radiofrequency##2##2##(1996-4#1)(2006-7#1)
to radiographic##2##2##(2012-12#1)(2013-1#1)
to radiolabel the##2##3##(1991-3#1)(2008-4#1)
to radiolabel##4##2##(1991-3#1)(1996-2#1)(2008-11#1)(2008-4#1)
to radiological##5##2##(1993-5#1)(2007-11#1)(2008-4#1)(2008-6#1)(2010-9#1)
to radiologists##3##2##(1997-8#1)(2007-4#2)
to radiology##6##2##(1991-2#1)(1992-3#1)(1994-1#1)(1996-2#1)(2007-4#2)
to radiopharmaceuticals##2##2##(2008-2#2)
to radiotherapy and chemotherapy##2##4##(1990-10#1)(2010-12#1)
to radiotherapy and##4##3##(1990-10#1)(2005-11#1)(2007-4#1)(2010-12#1)
to radiotherapy of##2##3##(2006-12#1)(2011-1#1)
to radiotherapy##21##2##(1990-10#1)(1993-5#1)(1994-8#1)(2005-11#1)(2006-12#2)(2006-8#1)(2007-4#1)(2007-6#1)(2008-6#3)(2010-12#1)(2010-3#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)
to radon##5##2##(1991-11#2)(1996-3#1)(1996-6#1)(2008-7#1)
to rain##3##2##(2007-11#1)(2008-3#1)(2010-2#1)
to raindrop##2##2##(2008-3#2)
to raise a##2##3##(1996-11#1)(2007-8#1)
to raise an##2##3##(1990-2#1)(2008-6#1)
to raise awareness of##3##4##(2006-10#1)(2007-3#1)(2007-9#1)
to raise awareness##5##3##(2006-10#2)(2007-10#1)(2007-3#1)(2007-9#1)
to raise intracellular cAMP##2##4##(1995-11#1)(1995-6#1)
to raise intracellular##3##3##(1992-8#1)(1995-11#1)(1995-6#1)
to raise questions about##2##4##(1993-1#1)(2007-5#1)
to raise some##2##3##(2007-5#1)(2009-5#1)
to raise the awareness of##3##5##(2006-6#1)(2008-9#1)(2013-1#1)
to raise the awareness##4##4##(2006-6#1)(2008-9#1)(2011-2#1)(2013-1#1)
to raise the level of##2##5##(1995-9#1)(2004-10#1)
to raise the possibility##2##4##(2008-7#1)(2008-8#1)
to raise the##20##3##(1990-3#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-5#1)(1993-5#1)(1995-9#1)(1996-12#1)(2004-10#1)(2005-6#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#2)(2013-1#1)
to raise##57##2##(1990-11#2)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-5#1)(1992-8#1)(1993-1#1)(1993-5#1)(1993-9#1)(1995-11#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-7#1)(1996-8#1)(1997-2#1)(1997-9#1)(2004-10#1)(2005-6#1)(2006-10#4)(2006-6#1)(2007-10#1)(2007-3#1)(2007-5#2)(2007-8#2)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
to raised##2##2##(1993-12#1)(1997-4#1)
to raising##3##2##(2007-11#1)(2007-9#1)(2011-2#1)
to random distributions of##2##4##(2007-12#1)(2008-7#1)
to random errors##3##3##(2008-2#1)(2010-12#1)(2010-4#1)
to random##21##2##(1993-6#1)(1993-9#1)(1995-12#1)(1995-6#1)(2004-11#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-7#2)(2010-12#1)(2010-4#1)(2010-8#2)(2012-12#1)
to randomized##3##2##(2006-8#2)(2010-11#1)
to randomly##4##2##(2004-1#1)(2005-11#1)(2008-9#1)(2012-2#1)
to range between##4##3##(1995-1#1)(2005-11#1)(2008-2#1)(2010-3#1)
to range from 0##3##4##(1995-5#1)(2008-10#1)(2008-2#1)
to range from 1##3##4##(1994-8#1)(2008-10#1)(2013-1#1)
to range from##16##3##(1993-4#1)(1994-10#1)(1994-8#1)(1995-5#1)(2005-11#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
to range##23##2##(1991-4#1)(1993-4#1)(1994-10#1)(1994-8#1)(1995-1#1)(1995-5#1)(2005-11#2)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
to ranges of##2##3##(2008-3#2)
to rank the##6##3##(1991-2#1)(1992-11#1)(2007-8#1)(2008-5#1)(2011-2#1)(2013-8#1)
to rank##15##2##(1991-2#1)(1992-11#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
to rapid and##3##3##(1990-5#1)(2010-4#1)(2012-12#1)
to rapid changes in the##2##5##(2007-3#1)(2009-5#1)
to rapid changes in##4##4##(1990-2#1)(2007-3#1)(2009-5#1)(2011-2#1)
to rapid water##2##3##(2013-8#2)
to rapid##38##2##(1990-2#1)(1990-5#1)(1990-6#2)(1991-2#2)(1991-3#1)(1992-9#1)(1994-2#2)(1995-11#1)(2006-5#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-8#2)(2008-9#2)(2009-5#1)(2010-11#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
to rapidly acquire##2##3##(2011-1#2)
to rapidly adapt to##2##4##(1996-10#1)(2008-9#1)
to rapidly assess##3##3##(2006-5#1)(2008-4#1)(2011-2#1)
to rapidly detect the##2##4##(2008-10#1)(2008-4#1)
to rapidly detect##4##3##(2008-10#1)(2008-4#1)(2012-2#2)
to rapidly generate##5##3##(1991-5#1)(1992-7#1)(2007-10#1)(2008-11#1)(2008-6#1)
to rapidly identify##3##3##(2004-4#1)(2008-2#1)(2013-1#1)
to rapidly produce##2##3##(2007-1#1)(2008-11#1)
to rapidly screen large##2##4##(2008-10#1)(2008-9#1)
to rapidly screen##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#1)
to rapidly##61##2##(1991-5#1)(1991-8#1)(1992-10#1)(1992-7#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-9#1)(1997-1#1)(2004-4#1)(2005-11#1)(2006-1#1)(2006-5#1)(2007-1#1)(2007-10#4)(2007-12#1)(2008-10#6)(2008-11#6)(2008-2#2)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-5#1)(2009-9#1)(2010-3#2)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#4)(2013-1#1)
to rare variants##5##3##(2012-3#5)
to rare##13##2##(1991-9#1)(1996-3#1)(1997-1#1)(2006-10#2)(2008-11#1)(2012-2#1)(2012-3#6)
to rarely##2##2##(1996-2#1)(2008-7#1)
to rat LH##2##3##(1994-12#2)
to rat and mouse##2##4##(1997-2#2)
to rat and##6##3##(1992-3#1)(1994-2#1)(1996-5#1)(1997-2#2)(1997-8#1)
to rat brain membranes##2##4##(1990-10#1)(1993-11#1)
to rat brain##5##3##(1990-10#1)(1992-3#1)(1993-11#1)(1994-12#1)(1996-2#1)
to rat cortex/hippocampal membranes##2##4##(1993-11#2)
to rat liver mitochondria##2##4##(1991-5#1)(1994-12#1)
to rat liver##4##3##(1991-11#1)(1991-5#1)(1992-6#1)(1994-12#1)
to rat olfactory bulb##2##4##(1995-5#2)
to rat##52##2##(1990-10#2)(1990-11#1)(1990-3#1)(1990-5#1)(1990-7#4)(1990-8#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-3#2)(1992-6#4)(1993-11#5)(1993-12#1)(1993-2#1)(1994-12#4)(1994-2#1)(1994-6#1)(1994-9#2)(1995-12#1)(1995-3#1)(1995-5#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-2#2)(1997-3#1)(1997-8#1)(2008-4#1)
to rate how##2##3##(2009-10#2)
to rate the importance of##2##5##(1993-12#1)(1995-3#1)
to rate the##9##3##(1993-12#1)(1995-3#1)(1996-2#1)(1997-8#1)(2007-4#1)(2007-8#1)(2008-10#1)(2012-3#1)(2013-8#1)
to rate##29##2##(1991-2#1)(1991-6#1)(1993-1#1)(1993-12#1)(1993-2#1)(1995-1#1)(1995-3#1)(1996-2#1)(1997-8#1)(2007-12#2)(2007-4#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-12#1)(2008-7#2)(2008-9#1)(2009-10#2)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#2)
to rates##2##2##(1993-12#1)(2009-8#1)
to rather than##3##3##(1990-10#1)(1994-9#1)(2008-5#1)
to rather##4##2##(1990-10#1)(1991-6#1)(1994-9#1)(2008-5#1)
to ratio##3##2##(2006-12#1)(2007-8#1)(2012-2#1)
to rational design##2##3##(1997-4#1)(2008-4#1)
to rational##6##2##(1990-12#1)(1991-7#1)(1997-4#1)(1997-8#1)(2008-4#1)(2011-1#1)
to rationalize the##9##3##(1996-5#1)(1996-8#1)(1997-7#1)(2006-10#2)(2008-10#2)(2008-7#1)(2013-7#1)
to rationalize##13##2##(1990-12#1)(1990-8#1)(1995-3#1)(1996-5#1)(1996-8#1)(1997-7#1)(2006-10#2)(2008-10#2)(2008-7#1)(2010-12#1)(2013-7#1)
to rationally design##3##3##(2008-10#1)(2008-4#1)(2011-1#1)
to rationally##7##2##(1996-7#2)(2008-10#1)(2008-12#1)(2008-4#1)(2011-1#1)(2013-7#1)
to ratios of##2##3##(2008-10#2)
to rats and##4##3##(1993-9#1)(1995-11#1)(1996-12#1)(2008-4#1)
to rats at##3##3##(1992-2#1)(1994-3#1)(2013-1#1)
to rats causes##2##3##(1990-5#1)(2006-9#1)
to rats for##3##3##(1990-5#1)(1993-7#1)(2008-6#1)
to rats is##2##3##(1992-7#1)(1995-3#1)
to rats pretreated with##3##4##(1991-5#1)(2008-6#2)
to rats produced##2##3##(1996-12#1)(2012-2#1)
to rats resulted in##2##4##(1991-8#1)(2009-4#1)
to rats with##4##3##(1992-7#1)(1993-4#1)(1993-6#1)(2010-12#1)
to rats##56##2##(1990-2#1)(1990-5#2)(1991-5#2)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-7#2)(1993-12#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-10#1)(1996-12#2)(1996-8#1)(1997-2#1)(1997-5#1)(1997-8#2)(2006-6#1)(2006-9#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#4)(2009-4#1)(2010-12#2)(2012-1#2)(2012-2#2)(2013-1#2)
to raw##2##2##(2008-3#1)(2010-4#1)
to re-associate##2##2##(1995-3#1)(1996-9#1)
to re-engineer##2##2##(1996-2#1)(2007-12#1)
to re-establish##3##2##(2006-6#1)(2007-5#1)(2008-1#1)
to re-estimate the sample size##3##5##(2012-2#3)
to re-evaluate the##5##3##(1995-6#1)(1995-7#1)(2008-11#1)(2008-4#1)(2009-5#1)
to re-evaluate##8##2##(1995-6#1)(1995-7#1)(2006-8#1)(2008-11#1)(2008-4#2)(2008-7#1)(2009-5#1)
to re-examine the##2##3##(2008-11#1)(2010-12#1)
to re-examine##9##2##(1992-12#1)(1994-6#1)(1996-3#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-7#1)(2010-12#1)
to re-think##3##2##(1990-2#1)(1991-6#1)(2005-8#1)
to reach 1##2##3##(1993-9#1)(2008-11#1)
to reach 50% of##2##4##(2008-10#1)(2011-2#1)
to reach a better##2##4##(2006-2#1)(2007-11#1)
to reach a conclusion regarding the potential for##2##8##(2005-7#2)
to reach a conclusion##5##4##(1993-3#1)(2005-7#3)(2007-6#1)
to reach a critical##2##4##(2008-7#1)(2008-8#1)
to reach a definitive diagnosis##2##5##(1993-8#1)(2006-2#1)
to reach a maximum value##2##5##(2008-5#2)
to reach a maximum##5##4##(1990-7#1)(1992-11#1)(2006-7#1)(2008-5#2)
to reach a peak at##2##5##(1992-9#1)(1993-12#1)
to reach a plateau##2##4##(1993-9#1)(2008-10#1)
to reach a##40##3##(1990-7#1)(1992-11#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-6#1)(2005-10#1)(2005-7#3)(2006-10#1)(2006-2#2)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#1)(2009-2#1)(2012-3#1)
to reach an##3##3##(1992-12#1)(1996-3#1)(2008-8#1)
to reach and grasp##2##4##(1996-1#2)
to reach and##3##3##(1996-1#2)(2008-4#1)
to reach as##2##3##(2008-2#1)(2011-1#1)
to reach clinical##2##3##(2008-11#1)(2008-5#1)
to reach conclusions##2##3##(1992-11#1)(2005-5#1)
to reach criterion##2##3##(1993-12#1)(1993-7#1)
to reach equilibrium##2##3##(2006-6#1)(2008-10#1)
to reach its full potential##2##5##(2008-11#1)(2012-2#1)
to reach its##6##3##(1992-11#1)(1992-3#1)(1994-3#1)(2008-11#1)(2008-3#1)(2012-2#1)
to reach maximum temperature##2##4##(2012-12#2)
to reach steady state##2##4##(2008-10#2)
to reach such##2##3##(2007-10#1)(2007-12#1)
to reach the highest level##2##5##(2008-10#1)(2008-8#1)
to reach the##47##3##(1990-12#1)(1990-5#1)(1992-5#1)(1994-10#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-11#1)(1996-1#1)(1996-10#1)(1996-5#1)(1997-1#1)(1997-3#2)(2006-10#1)(2006-4#1)(2006-5#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#2)(2013-1#2)(2013-8#1)
to reach their targets##2##4##(1991-3#1)(2008-1#1)
to reach their##6##3##(1991-3#1)(2008-1#2)(2008-6#1)(2009-4#1)(2010-5#1)
to reach them##2##3##(2009-6#1)(2013-7#1)
to reach this goal##3##4##(1997-3#1)(2007-7#1)(2011-2#1)
to reach this##8##3##(1997-3#1)(2006-2#1)(2007-7#1)(2008-10#1)(2011-2#1)(2012-11#1)(2012-12#2)
to reach##212##2##(1990-11#1)(1990-12#1)(1990-5#3)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-11#4)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-12#1)(1994-3#5)(1994-8#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-1#4)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-3#3)(1997-5#1)(1997-8#1)(2004-12#1)(2004-3#1)(2005-10#1)(2005-5#2)(2005-7#3)(2005-9#1)(2006-10#4)(2006-12#1)(2006-2#4)(2006-4#2)(2006-5#1)(2006-6#2)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#4)(2007-12#2)(2007-3#1)(2007-6#1)(2007-7#2)(2007-9#2)(2008-1#7)(2008-10#22)(2008-11#6)(2008-12#2)(2008-2#6)(2008-3#2)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#4)(2008-8#5)(2009-12#1)(2009-2#3)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-12#3)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#8)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
to react against##2##3##(1990-11#1)(2006-5#1)
to react in##2##3##(1991-12#1)(2006-2#1)
to react specifically with the##2##5##(1993-6#1)(2008-5#1)
to react to##2##3##(1990-3#1)(2006-10#1)
to react with a specific monoclonal antibody##2##7##(1990-11#1)(2008-10#1)
to react with a##5##4##(1990-11#1)(1991-7#1)(2005-9#1)(2006-8#1)(2008-10#1)
to react with o-phthalaldehyde (OPA)##2##5##(2008-10#2)
to react with the##6##4##(1993-11#1)(1993-9#1)(2008-10#3)(2009-9#1)
to react with##30##3##(1990-11#1)(1991-7#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-6#2)(1993-9#1)(1995-5#1)(1997-4#1)(2005-9#1)(2006-8#1)(2008-10#13)(2008-8#1)(2009-9#1)(2010-4#1)
to react##49##2##(1990-11#3)(1990-3#1)(1991-12#1)(1991-7#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-6#3)(1993-9#1)(1994-9#2)(1995-5#1)(1997-4#1)(2005-5#1)(2005-9#2)(2006-10#1)(2006-2#1)(2006-5#1)(2006-8#1)(2008-10#16)(2008-11#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2012-1#1)
to reaction 2##2##3##(1992-6#2)
to reaction with##2##3##(1992-12#1)(2008-10#1)
to reaction##12##2##(1991-6#1)(1992-12#1)(1992-6#2)(1996-5#1)(2007-8#1)(2008-10#2)(2008-7#1)(2010-5#1)(2011-2#2)
to reactions##2##2##(1993-4#1)(2008-11#1)
to reactivate the##4##3##(1990-5#1)(1992-7#1)(1995-6#1)(2008-5#1)
to reactivate##8##2##(1990-5#1)(1992-7#1)(1995-6#1)(1997-4#1)(1997-7#1)(2008-5#2)(2011-2#1)
to reactivation##2##2##(1993-11#1)(2012-12#1)
to reactive intermediates##4##3##(1991-9#1)(1995-7#2)(2008-10#1)
to reactive oxygen species (ROS)##2##5##(2008-10#1)(2011-10#1)
to reactive oxygen species##4##4##(1994-12#1)(1997-8#1)(2008-10#1)(2011-10#1)
to reactive##17##2##(1990-11#1)(1991-11#1)(1991-5#1)(1991-9#1)(1994-12#1)(1995-12#2)(1995-7#2)(1996-6#1)(1997-8#1)(2008-10#2)(2008-3#1)(2009-8#1)(2011-10#1)(2013-7#1)
to read and##2##3##(2007-9#1)(2011-2#1)
to read in##2##3##(2007-9#1)(2010-2#1)
to read out the##2##4##(2008-3#2)
to read the##8##3##(2006-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-12#1)(2010-4#1)(2011-1#1)
to read these##2##3##(2010-4#1)(2012-2#1)
to read##30##2##(1990-12#1)(1990-3#1)(1995-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-9#2)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#1)(2009-11#1)(2009-12#2)(2010-2#1)(2010-4#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#2)
to readapt##2##2##(2011-2#1)(2012-1#1)
to readers##2##2##(2007-2#1)(2008-12#1)
to readily##7##2##(1997-3#1)(2007-3#1)(2008-1#1)(2008-4#1)(2009-2#1)(2011-2#1)(2013-8#1)
to reading fluency##2##3##(2010-3#2)
to reading##4##2##(2008-12#1)(2010-3#3)
to real data##6##3##(1991-12#1)(2007-10#1)(2008-2#1)(2009-10#1)(2011-2#1)(2013-8#1)
to real samples##12##3##(2008-10#11)(2012-11#1)
to real world##2##3##(2007-4#1)(2008-10#1)
to real##41##2##(1991-12#1)(1992-1#1)(1996-5#1)(1997-3#1)(2006-10#1)(2006-2#2)(2006-6#1)(2007-10#1)(2007-4#1)(2008-10#19)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
to real-time##7##2##(2006-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#1)(2013-8#1)
to real-world##3##2##(2006-5#1)(2008-10#1)(2011-2#1)
to realign##2##2##(1995-3#1)(2007-12#1)
to realise the##3##3##(2008-11#2)(2008-12#1)
to realise##10##2##(1991-5#1)(2006-2#2)(2007-12#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#1)
to reality##5##2##(1991-8#1)(1992-2#1)(1995-12#1)(2007-12#1)(2009-2#1)
to realize a##9##3##(2007-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-5#1)(2011-2#1)(2013-8#1)
to realize an##2##3##(2008-2#1)(2012-3#1)
to realize that##7##3##(1991-2#1)(1994-9#1)(2008-1#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-2#1)
to realize the##15##3##(1996-3#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#2)
to realize their##3##3##(2006-4#1)(2008-10#1)(2010-12#1)
to realize this##6##3##(1995-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-6#1)(2010-8#1)
to realize##70##2##(1991-2#1)(1994-12#1)(1994-9#1)(1995-1#1)(1996-3#2)(2006-10#1)(2006-4#1)(2007-12#5)(2007-8#2)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#11)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#2)(2009-6#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-12#2)(2011-2#4)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
to realizing##4##2##(2008-3#3)(2009-10#1)
to reallocate their##2##3##(1990-12#1)(2013-8#1)
to reap the##3##3##(1996-1#1)(2006-11#1)(2008-10#1)
to reap##4##2##(1996-1#1)(2006-11#1)(2008-10#1)(2008-11#1)
to rear##3##2##(1996-11#1)(2006-11#1)(2007-4#1)
to rearing##2##2##(2008-11#1)(2008-9#1)
to rearranged##2##2##(1995-2#1)(2008-4#1)
to reason about##2##3##(2008-11#1)(2008-9#1)
to reason##4##2##(2006-3#1)(2008-11#1)(2008-7#1)(2008-9#1)
to reasonably##2##2##(2008-7#1)(2011-2#1)
to reassess their##2##3##(1991-3#1)(2007-11#1)
to reassess##7##2##(1991-3#1)(1996-3#1)(2007-11#1)(2008-5#1)(2009-8#1)(2012-2#1)(2013-1#1)
to rebuild##4##2##(1992-2#1)(2007-11#2)(2009-11#1)
to recalculate##2##2##(2006-10#1)(2009-5#1)
to recall##2##2##(2006-3#1)(2011-2#1)
to recanalize##2##2##(1991-3#1)(2011-2#1)
to recapitulate the##3##3##(1997-4#1)(2012-1#1)(2013-1#1)
to recapitulate##6##2##(1997-4#1)(2008-1#1)(2008-2#1)(2008-5#1)(2012-1#1)(2013-1#1)
to receive 20##3##3##(2011-12#1)(2012-2#2)
to receive a##11##3##(1990-4#1)(1994-3#1)(1995-12#1)(1996-5#1)(2005-8#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-12#1)(2012-3#1)
to receive an##4##3##(1990-3#1)(2008-9#1)(2013-1#1)(2013-8#1)
to receive and##3##3##(2004-9#1)(2008-7#1)(2013-8#1)
to receive attention##3##3##(2006-10#1)(2008-1#1)(2012-3#1)
to receive care##5##3##(1996-12#1)(2008-7#1)(2012-12#3)
to receive either a##2##4##(2006-10#1)(2008-8#1)
to receive either the##3##4##(2006-10#1)(2007-8#1)(2013-1#1)
to receive either##21##3##(1990-9#1)(1992-4#1)(1993-4#1)(1996-2#1)(2006-10#2)(2007-10#1)(2007-2#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-7#1)(2010-8#1)(2013-1#2)(2013-7#1)
to receive influenza##3##3##(2012-3#3)
to receive information##3##3##(1995-8#1)(1996-1#1)(2009-5#1)
to receive inputs##2##3##(1993-2#1)(2008-4#1)
to receive multimodal##2##3##(1991-8#1)(2012-3#1)
to receive placebo##3##3##(2007-8#1)(2008-7#1)(2011-2#1)
to receive the same##2##4##(1991-10#1)(2008-5#1)
to receive the##13##3##(1990-2#1)(1991-10#1)(1994-12#1)(1994-9#1)(1997-3#1)(2007-2#1)(2008-1#1)(2008-4#1)(2008-5#1)(2011-2#4)
to receive treatment with##2##4##(2007-11#1)(2010-8#1)
to receive treatment##4##3##(2007-11#1)(2008-7#1)(2010-8#1)(2013-1#1)
to receive##179##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-10#2)(1992-4#1)(1992-8#1)(1993-1#1)(1993-2#2)(1993-4#1)(1993-7#2)(1994-1#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-5#1)(2004-1#1)(2004-2#1)(2004-9#2)(2005-8#1)(2006-10#3)(2006-2#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-10#5)(2007-11#1)(2007-12#1)(2007-2#4)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#3)(2008-1#3)(2008-10#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#3)(2008-7#6)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#3)(2010-3#2)(2010-4#1)(2010-7#3)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#13)(2012-1#4)(2012-12#6)(2012-2#6)(2012-3#6)(2013-1#10)(2013-7#4)(2013-8#3)
to receiving##5##2##(2008-9#1)(2009-1#1)(2009-4#1)(2010-2#1)(2010-9#1)
to recent data##2##3##(2005-9#1)(2011-2#1)
to recent experiments##2##3##(1991-11#1)(2007-12#1)
to recent findings##4##3##(1990-2#1)(2008-1#1)(2008-11#2)
to recent reports##2##3##(2007-8#1)(2008-11#1)
to recent##32##2##(1990-2#1)(1990-5#1)(1991-11#1)(1991-7#1)(1992-3#1)(1993-6#1)(1997-7#2)(2005-8#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#4)(2013-8#2)
to recently##6##2##(1990-5#1)(2006-8#1)(2007-11#1)(2008-9#1)(2011-2#2)
to receptor##9##2##(1990-4#1)(1993-6#3)(1994-6#1)(1995-3#1)(1996-2#1)(1996-8#1)(1997-5#1)
to receptors in##2##3##(1993-11#1)(1994-5#1)
to receptors of the##2##4##(1996-2#1)(2007-11#1)
to receptors##8##2##(1993-11#1)(1994-5#1)(1995-3#1)(1996-12#1)(1996-2#1)(2006-10#1)(2007-11#1)(2011-1#1)
to recipient##10##2##(1995-2#1)(2006-5#3)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)
to reclaim##2##2##(2008-1#1)(2008-6#1)
to recognise and##3##3##(2008-6#1)(2012-12#1)(2012-2#1)
to recognise the##3##3##(1995-10#1)(2008-1#1)(2008-7#1)
to recognise this##2##3##(2007-7#1)(2013-8#1)
to recognise##21##2##(1994-2#1)(1995-10#2)(1996-8#1)(1997-7#1)(2006-2#1)(2006-3#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
to recognition of##4##3##(1996-5#1)(2008-1#1)(2008-3#1)(2012-2#1)
to recognition##10##2##(1994-9#1)(1996-5#1)(1996-7#1)(2008-1#2)(2008-3#1)(2009-4#1)(2012-2#2)(2012-3#1)
to recognize a previously seen##2##5##(1991-2#1)(2010-2#1)
to recognize a##10##3##(1990-10#1)(1991-2#1)(1992-1#1)(1992-8#1)(1997-1#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-7#1)(2010-2#1)
to recognize and react##2##4##(2006-10#1)(2013-7#1)
to recognize and respond to##2##5##(2007-2#1)(2009-9#1)
to recognize and treat##2##4##(1995-11#1)(2004-3#1)
to recognize and##23##3##(1993-1#1)(1994-1#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-5#1)(2004-3#1)(2006-10#2)(2006-4#1)(2007-2#1)(2008-10#1)(2008-11#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
to recognize differences in##3##4##(1994-3#1)(2012-12#2)
to recognize it##2##3##(1995-5#1)(2008-11#1)
to recognize sexual abuse##2##4##(2009-9#2)
to recognize target##3##3##(1995-8#1)(2007-8#1)(2008-10#1)
to recognize that the##3##4##(1996-6#1)(2006-2#1)(2008-7#1)
to recognize that##12##3##(1992-8#1)(1995-11#1)(1996-6#1)(2006-10#1)(2006-2#2)(2007-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-8#1)
to recognize the most##2##4##(2008-2#1)(2012-3#1)
to recognize the possibility of##2##5##(2008-12#1)(2011-2#1)
to recognize the##40##3##(1990-2#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-12#1)(1993-2#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1997-5#1)(2005-11#1)(2005-8#1)(2006-5#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-4#1)(2009-9#2)(2010-11#1)(2010-5#1)(2010-6#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
to recognize their##2##3##(1993-2#1)(2006-1#1)
to recognize them##2##3##(2007-5#1)(2008-1#1)
to recognize these##2##3##(2008-11#1)(2010-1#1)
to recognize this##5##3##(1991-5#1)(1991-8#1)(2008-9#1)(2011-2#1)(2013-7#1)
to recognize##174##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-8#2)(1993-1#1)(1993-2#2)(1993-7#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-4#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#2)(1997-1#2)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-8#2)(2006-1#1)(2006-10#8)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#2)(2007-11#1)(2007-12#1)(2007-2#4)(2007-3#2)(2007-5#3)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#8)(2009-10#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#7)(2010-1#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#2)(2010-6#2)(2010-8#3)(2010-9#4)(2011-1#1)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#2)
to recognized##2##2##(1992-7#1)(1996-12#1)
to recognizing the##2##3##(2008-3#1)(2009-4#1)
to recognizing##4##2##(2008-12#1)(2008-3#1)(2008-4#1)(2009-4#1)
to recombinant hepatitis B##3##4##(1997-4#2)(2007-11#1)
to recombinant human##3##3##(1992-1#1)(1993-12#1)(2007-11#1)
to recombinant##22##2##(1990-9#1)(1991-12#1)(1992-1#2)(1992-8#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-5#1)(1994-9#2)(1996-12#1)(1996-5#1)(1997-4#2)(2007-11#3)(2008-10#1)(2008-11#1)(2011-2#1)(2012-1#1)
to recombination events##2##3##(1993-11#1)(2008-12#1)
to recombination##4##2##(1990-11#1)(1993-11#1)(2008-10#1)(2008-12#1)
to recombine##3##2##(1991-3#1)(1992-12#1)(2008-4#1)
to recommend a##3##3##(2007-8#1)(2007-9#1)(2008-9#1)
to recommend it##3##3##(1992-12#1)(1996-2#1)(2008-7#1)
to recommend that##3##3##(1997-2#1)(2007-2#1)(2010-9#1)
to recommend the##9##3##(1993-12#3)(1994-2#1)(1995-4#1)(2008-10#1)(2010-5#1)(2011-2#1)(2012-1#1)
to recommend this##2##3##(1995-4#1)(2007-11#1)
to recommend##48##2##(1990-11#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-12#3)(1994-2#1)(1995-4#2)(1996-11#1)(1996-2#1)(1996-3#1)(1997-2#1)(2005-1#1)(2005-11#1)(2006-10#2)(2006-2#1)(2007-11#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#5)(2008-9#1)(2009-10#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#1)(2013-8#1)
to recommended##3##2##(2008-3#1)(2008-8#1)(2011-2#1)
to recommending the##2##3##(2008-10#1)(2009-4#1)
to recommending##3##2##(2008-10#1)(2009-4#1)(2009-5#1)
to reconcile the different##2##4##(2005-11#1)(2009-3#1)
to reconcile the discrepancy between##2##5##(1993-11#1)(2008-11#1)
to reconcile the##10##3##(1992-3#1)(1993-11#1)(2005-11#1)(2006-2#1)(2006-5#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-3#1)(2011-1#1)
to reconcile these##2##3##(2008-11#1)(2013-8#1)
to reconcile##19##2##(1992-3#1)(1993-11#1)(1995-5#1)(1996-10#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-5#2)(2008-8#1)(2009-3#1)(2011-1#1)(2013-8#1)
to reconsider the##5##3##(1991-1#1)(2006-4#1)(2008-12#1)(2008-2#1)(2009-12#1)
to reconsider##8##2##(1991-1#1)(2005-11#1)(2006-4#1)(2007-2#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-12#1)
to reconstitute the##8##3##(1990-2#1)(1990-3#1)(1992-3#1)(1995-12#1)(2006-3#1)(2007-8#3)
to reconstitute##16##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-2#1)(1992-3#1)(1993-6#2)(1994-9#1)(1995-12#1)(1997-4#1)(2006-3#1)(2007-8#3)(2009-2#1)(2012-2#1)
to reconstituted##2##2##(1990-12#1)(1995-5#1)
to reconstruct a##7##3##(2006-11#1)(2007-4#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-6#1)(2011-1#1)
to reconstruct an##3##3##(2007-12#1)(2008-3#1)(2012-3#1)
to reconstruct ancestral##2##3##(2008-8#1)(2010-6#1)
to reconstruct large##2##3##(1994-6#1)(2010-6#1)
to reconstruct the##35##3##(2006-3#1)(2007-11#1)(2007-12#10)(2007-8#2)(2008-1#1)(2008-12#1)(2008-2#2)(2008-3#6)(2008-8#1)(2008-9#1)(2009-2#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
to reconstruct their##2##3##(2008-8#1)(2009-2#1)
to reconstruct##82##2##(1992-1#1)(1994-6#1)(1995-5#1)(2006-11#1)(2006-3#1)(2007-11#5)(2007-12#14)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-12#1)(2008-2#4)(2008-3#13)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-2#2)(2009-5#1)(2009-8#1)(2010-6#3)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#1)
to reconstruction##4##2##(2008-2#1)(2008-3#3)
to reconstructive##2##2##(2008-9#1)(2011-2#1)
to record a##2##3##(1994-2#1)(2008-3#1)
to record high-resolution##2##3##(2008-2#1)(2008-3#1)
to record information on##2##4##(2008-4#1)(2008-7#1)
to record the##26##3##(1994-2#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#5)(2008-8#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-6#1)(2010-8#1)(2011-3#1)(2012-1#1)(2013-1#2)(2013-8#1)
to record three positive and three negative characteristics about themselves##2##10##(2006-6#2)
to record##79##2##(1991-6#1)(1993-5#1)(1994-12#1)(1994-2#2)(1994-3#1)(1996-12#1)(1996-5#1)(1996-9#1)(2006-12#1)(2006-6#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-12#6)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#8)(2008-3#15)(2008-4#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#1)
to records##2##2##(2008-5#1)(2013-1#1)
to recover and##3##3##(1996-11#1)(2013-1#2)
to recover from injury##2##4##(1991-3#1)(2008-1#1)
to recover from##8##3##(1991-3#1)(2005-10#1)(2006-10#1)(2007-5#2)(2008-1#1)(2008-10#1)(2008-2#1)
to recover image structure##2##4##(1997-8#2)
to recover in##2##3##(2008-5#2)
to recover the correct##3##4##(2008-2#1)(2013-1#2)
to recover the image##2##4##(2007-11#1)(2011-1#1)
to recover the##22##3##(1991-2#1)(1995-12#1)(1997-4#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#4)(2008-3#3)(2008-4#2)(2009-5#1)(2010-9#1)(2011-1#1)(2013-1#2)
to recover tocopherols##2##3##(2008-6#2)
to recover##78##2##(1991-12#1)(1991-2#1)(1991-3#1)(1993-12#1)(1993-5#1)(1995-12#2)(1995-8#1)(1996-11#3)(1997-4#2)(1997-8#2)(2005-10#1)(2005-8#1)(2006-10#1)(2006-3#1)(2006-7#1)(2007-11#1)(2007-12#5)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-2#8)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#2)(2010-4#1)(2010-9#1)(2011-1#1)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#5)
to recovery of##2##3##(1992-10#1)(2008-9#1)
to recovery##15##2##(1990-12#1)(1992-10#1)(1993-7#1)(1997-3#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-3#1)
to recreate the##3##3##(2009-10#1)(2012-1#2)
to recreate##4##2##(2007-1#1)(2009-10#1)(2012-1#2)
to recreational##2##2##(2009-5#1)(2013-1#1)
to recruit a##2##3##(1993-2#1)(2010-9#1)
to recruit and retain##3##4##(1991-3#1)(2007-4#1)(2008-5#1)
to recruit and##5##3##(1991-3#1)(2007-4#1)(2007-8#1)(2008-5#2)
to recruit host effector functions##2##5##(2007-11#1)(2009-2#1)
to recruit the##4##3##(2007-12#1)(2008-9#1)(2012-2#1)(2013-1#1)
to recruit##34##2##(1991-3#1)(1993-1#1)(1993-2#1)(1993-6#1)(1995-2#1)(1997-4#1)(1997-7#1)(2005-10#1)(2006-10#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#2)(2008-11#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-9#1)(2012-2#2)(2012-3#1)(2013-1#1)
to recruitment##6##2##(1990-2#1)(1995-1#1)(2005-9#1)(2008-11#1)(2008-8#1)(2010-10#1)
to rectal cancer##3##3##(1993-6#1)(2008-10#1)(2009-9#1)
to rectal##6##2##(1991-7#1)(1993-6#1)(1996-3#1)(2008-10#1)(2008-5#1)(2009-9#1)
to rectify##4##2##(1996-1#1)(2008-1#1)(2008-3#1)(2012-12#1)
to recur##5##2##(1990-8#1)(1993-11#1)(2008-7#1)(2010-12#1)(2013-1#1)
to recurrence and##2##3##(2007-8#1)(2008-7#1)
to recurrence##8##2##(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
to recurrent episodes of##2##4##(1990-12#1)(2006-1#1)
to recurrent##16##2##(1990-12#1)(1990-6#1)(1992-12#1)(1992-9#2)(2006-1#1)(2007-11#3)(2007-2#1)(2008-11#1)(2008-8#1)(2009-3#1)(2011-2#1)(2013-1#2)
to recycle##5##2##(1994-9#1)(1995-6#1)(2005-8#1)(2006-12#1)(2009-9#1)
to red blood cells##2##4##(1990-1#1)(1995-5#1)
to red light##2##3##(1992-6#1)(2008-8#1)
to red##16##2##(1990-1#1)(1990-12#1)(1992-6#1)(1995-5#1)(2008-10#3)(2008-12#1)(2008-8#1)(2010-5#1)(2011-12#2)(2012-2#2)(2012-3#1)(2013-7#1)
to redefine the##4##3##(1994-3#1)(1996-1#1)(2011-2#1)(2012-12#1)
to redefine##7##2##(1994-3#1)(1995-2#1)(1996-1#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-12#1)
to redesign##6##2##(1992-12#1)(1995-2#1)(1996-1#1)(1997-1#1)(1997-2#1)(2008-1#1)
to redirect the##2##3##(2008-2#2)
to redirect##7##2##(1997-7#1)(2005-10#1)(2007-4#1)(2007-6#1)(2008-2#2)(2012-2#1)
to redistribution of the##2##4##(1997-3#1)(2007-9#1)
to redistribution of##3##3##(1993-11#1)(1997-3#1)(2007-9#1)
to redox##9##2##(1991-4#1)(1995-6#1)(2008-10#3)(2008-7#1)(2010-4#2)(2011-2#1)
to redress the##6##3##(2005-8#1)(2006-12#1)(2008-11#1)(2008-5#1)(2009-12#1)(2011-2#1)
to redress this##2##3##(2008-4#1)(2010-12#1)
to redress##9##2##(2005-8#1)(2006-12#1)(2006-4#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-12#1)(2011-2#1)
to reduce CBF##2##3##(1997-6#1)(2008-7#1)
to reduce CVD##2##3##(2010-12#1)(2012-12#1)
to reduce DNA##2##3##(1992-4#1)(1997-4#1)
to reduce a##7##3##(1993-1#1)(2008-10#2)(2008-8#1)(2012-1#1)(2013-1#2)
to reduce adverse effects##2##4##(2006-10#1)(2013-1#1)
to reduce adverse##4##3##(2006-10#1)(2013-1#3)
to reduce air pollution##3##4##(2008-6#1)(2010-9#1)(2011-2#1)
to reduce alcohol##2##3##(2008-1#1)(2012-12#1)
to reduce and##3##3##(1993-8#1)(2007-10#1)(2012-3#1)
to reduce attrition##2##3##(2010-5#1)(2012-3#1)
to reduce bacterial##3##3##(2008-10#1)(2008-3#1)(2013-8#1)
to reduce beam-hardening##2##3##(2012-12#2)
to reduce bleeding##2##3##(2005-10#1)(2006-10#1)
to reduce blood pressure adequately##2##5##(1990-11#1)(1995-2#1)
to reduce blood pressure##3##4##(1990-11#1)(1995-2#1)(2008-8#1)
to reduce blood##4##3##(1990-11#1)(1995-2#1)(1996-9#1)(2008-8#1)
to reduce brain##2##3##(1996-9#1)(2010-2#1)
to reduce cardiovascular morbidity##2##4##(1993-11#1)(1996-9#1)
to reduce cardiovascular risk##3##4##(2008-6#1)(2009-11#1)(2010-12#1)
to reduce cardiovascular##5##3##(1993-11#1)(1996-9#1)(2008-6#1)(2009-11#1)(2010-12#1)
to reduce cervical##2##3##(2011-2#1)(2013-1#1)
to reduce contamination##2##3##(2008-10#1)(2013-1#1)
to reduce cost##3##3##(2007-8#1)(2008-7#1)(2012-2#1)
to reduce costs and##4##4##(1997-1#1)(2006-6#1)(2010-9#1)(2012-1#1)
to reduce costs##15##3##(1990-4#1)(1991-12#1)(1994-3#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-1#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-10#1)(2010-9#1)(2011-1#1)(2012-1#1)
to reduce damage and##2##4##(2006-6#1)(2008-10#1)
to reduce damage##3##3##(2006-6#1)(2008-10#1)(2012-11#1)
to reduce development##3##3##(1994-6#1)(2008-11#1)(2011-2#1)
to reduce dietary salt##2##4##(2013-1#2)
to reduce disease##3##3##(2008-10#2)(2011-2#1)
to reduce disparities##3##3##(2009-5#1)(2012-3#1)(2013-1#1)
to reduce drastically the##3##4##(2008-10#2)(2008-3#1)
to reduce errors##2##3##(2007-4#1)(2010-10#1)
to reduce expenses and improve##2##5##(1991-4#2)
to reduce expenses and##3##4##(1991-4#2)(1995-3#1)
to reduce exposure to##2##4##(2008-11#1)(2010-9#1)
to reduce false-positive##2##3##(2008-4#1)(2012-2#1)
to reduce financial##2##3##(1991-2#1)(2010-8#1)
to reduce further the##2##4##(2006-10#1)(2006-8#1)
to reduce further##3##3##(2006-10#1)(2006-8#1)(2013-1#1)
to reduce health inequalities##2##4##(1994-4#1)(2012-1#1)
to reduce health##4##3##(1994-12#1)(1994-4#1)(2010-5#1)(2012-1#1)
to reduce high##3##3##(2010-8#1)(2013-1#2)
to reduce infection rates##2##4##(2007-8#1)(2012-12#1)
to reduce inflammation and##4##4##(1992-11#1)(2007-11#1)(2011-2#1)(2013-1#1)
to reduce insecticide use##2##4##(2004-11#1)(2008-10#1)
to reduce interference##2##3##(1993-2#1)(1995-1#1)
to reduce its mortality##2##4##(2007-9#1)(2012-12#1)
to reduce its##4##3##(1991-7#1)(2007-9#1)(2008-7#1)(2012-12#1)
to reduce length of stay and##2##6##(1993-3#1)(1995-3#1)
to reduce length of stay##4##5##(1993-3#1)(1995-3#1)(2006-10#1)(2010-11#1)
to reduce levels##2##3##(2008-1#1)(2008-9#1)
to reduce local##2##3##(2004-4#1)(2007-11#1)
to reduce maternal mortality##3##4##(1994-3#1)(2008-11#1)(2013-1#1)
to reduce maternal##5##3##(1994-3#1)(2006-10#1)(2008-11#1)(2013-1#2)
to reduce medical errors##2##4##(2008-3#1)(2008-7#1)
to reduce microbial loads##2##4##(1997-4#1)(2010-4#1)
to reduce mitochondrial##2##3##(2008-1#1)(2010-3#1)
to reduce morbidity and mortality##7##5##(1990-2#1)(2006-10#1)(2006-4#1)(2008-1#1)(2011-1#1)(2011-2#1)(2013-1#1)
to reduce morbidity and##8##4##(1990-2#1)(2006-10#2)(2006-4#1)(2008-1#1)(2011-1#1)(2011-2#1)(2013-1#1)
to reduce mortality and##3##4##(2006-10#2)(2006-2#1)
to reduce mortality##10##3##(2006-10#2)(2006-2#2)(2007-11#1)(2008-3#1)(2008-8#1)(2010-5#1)(2010-8#1)(2012-3#1)
to reduce negative##2##3##(2006-6#1)(2012-12#1)
to reduce noise##2##3##(2008-1#1)(2013-1#1)
to reduce or eliminate the##2##5##(1992-2#1)(2006-2#1)
to reduce or eliminate##5##4##(1992-2#1)(2006-2#1)(2006-3#1)(2007-11#1)(2008-2#1)
to reduce or prevent##2##4##(2010-1#1)(2010-5#1)
to reduce or##16##3##(1992-2#1)(2006-2#1)(2006-3#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-5#1)(2012-3#1)(2013-1#2)
to reduce overall##2##3##(2006-2#1)(2011-2#1)
to reduce pain##8##3##(2006-10#1)(2006-8#1)(2007-2#1)(2007-7#1)(2009-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
to reduce patient##4##3##(1996-2#2)(2008-3#1)(2010-12#1)
to reduce peak##2##3##(1992-5#1)(1997-3#1)
to reduce plasma cholesterol levels##2##5##(2005-9#2)
to reduce post-operative##2##3##(2007-8#2)
to reduce postoperative##4##3##(2006-10#1)(2007-9#1)(2008-10#1)(2008-8#1)
to reduce poverty##2##3##(2007-7#1)(2008-7#1)
to reduce recurrence rates##3##4##(1997-6#1)(2006-11#1)(2007-8#1)
to reduce recurrence##4##3##(1997-6#1)(2006-11#1)(2007-8#1)(2011-2#1)
to reduce risk of##3##4##(2008-10#1)(2009-5#1)(2013-8#1)
to reduce risk##6##3##(2005-9#1)(2007-6#1)(2008-10#1)(2008-3#1)(2009-5#1)(2013-8#1)
to reduce risks##3##3##(1991-3#2)(2006-10#1)
to reduce salt##4##3##(2012-2#3)(2013-1#1)
to reduce secondary##2##3##(1996-9#1)(2006-4#1)
to reduce serum cholesterol##2##4##(1991-6#1)(1994-9#1)
to reduce serum##4##3##(1991-6#1)(1994-9#1)(2005-8#1)(2010-12#1)
to reduce significantly the##6##4##(1993-11#1)(1996-6#1)(2007-12#1)(2008-2#2)(2013-8#1)
to reduce significantly##7##3##(1993-11#1)(1996-6#1)(2007-12#1)(2008-2#2)(2013-1#1)(2013-8#1)
to reduce sodium intake##2##4##(2011-1#1)(2013-1#1)
to reduce sodium##3##3##(2011-1#1)(2013-1#2)
to reduce stigma##2##3##(2011-1#1)(2012-12#1)
to reduce stress##2##3##(2008-8#1)(2011-12#1)
to reduce substantially the##2##4##(1994-9#1)(2007-12#1)
to reduce surface##2##3##(2007-12#1)(2008-6#1)
to reduce sweating##2##3##(2008-5#2)
to reduce sympathetic##2##3##(2005-10#1)(2008-10#1)
to reduce symptoms and##2##4##(2006-9#1)(2010-10#1)
to reduce symptoms##3##3##(2006-9#1)(2010-10#1)(2011-2#1)
to reduce the amount of##4##5##(2008-10#1)(2008-11#2)(2011-2#1)
to reduce the burden of##5##5##(2006-11#1)(2007-10#1)(2007-12#1)(2011-2#1)(2012-3#1)
to reduce the chance of##2##5##(1995-6#1)(2006-9#1)
to reduce the chance##3##4##(1995-6#1)(2006-9#1)(2008-7#1)
to reduce the clinical##2##4##(2008-8#1)(2013-1#1)
to reduce the computation##2##4##(2008-2#1)(2008-3#1)
to reduce the consequences##2##4##(2008-12#1)(2011-2#1)
to reduce the cost of##4##5##(1997-4#1)(2006-10#1)(2008-2#1)(2013-1#1)
to reduce the cost##7##4##(1996-12#1)(1997-4#1)(2006-10#1)(2008-2#2)(2008-7#1)(2013-1#1)
to reduce the deleterious##2##4##(1996-11#1)(2007-3#1)
to reduce the dose##3##4##(2005-9#1)(2008-7#1)(2013-1#1)
to reduce the effect of##3##5##(2007-8#1)(2008-2#1)(2009-5#1)
to reduce the effects of##5##5##(1997-6#1)(2008-2#1)(2008-3#2)(2009-7#1)
to reduce the effects##6##4##(1997-6#1)(2004-7#1)(2008-2#1)(2008-3#2)(2009-7#1)
to reduce the extent of##2##5##(2008-5#1)(2012-11#1)
to reduce the frequency of##2##5##(2006-5#1)(2007-4#1)
to reduce the frequency##4##4##(2005-7#1)(2006-5#1)(2007-4#1)(2010-2#1)
to reduce the harm##2##4##(2008-11#1)(2013-8#1)
to reduce the high mortality##2##5##(2007-11#1)(2011-12#1)
to reduce the high##4##4##(2007-11#1)(2008-12#1)(2011-1#1)(2011-12#1)
to reduce the impact of##6##5##(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#2)
to reduce the impact##7##4##(2008-10#1)(2008-11#1)(2008-5#1)(2010-8#1)(2011-1#1)(2011-2#2)
to reduce the incidence of stroke##2##6##(1993-12#1)(2008-1#1)
to reduce the incidence of##34##5##(1990-6#1)(1991-12#1)(1992-12#2)(1993-12#1)(1993-3#1)(1996-1#1)(1997-8#1)(2004-12#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-8#3)(2008-1#1)(2008-10#2)(2008-6#1)(2008-8#3)(2009-3#1)(2009-6#1)(2010-12#1)(2011-12#2)(2011-2#1)(2013-1#1)
to reduce the incidence##36##4##(1990-6#1)(1991-12#1)(1992-12#2)(1993-12#1)(1993-3#1)(1996-1#1)(1997-8#1)(2004-12#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-6#1)(2008-8#3)(2009-3#1)(2009-6#1)(2010-12#1)(2011-12#2)(2011-2#1)(2013-1#1)
to reduce the influence of##2##5##(2008-2#2)
to reduce the influence##3##4##(2008-10#1)(2008-2#2)
to reduce the interference##2##4##(2008-10#2)
to reduce the level of##4##5##(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#1)
to reduce the likelihood of##2##5##(2008-3#1)(2010-9#1)
to reduce the loss of##2##5##(2008-2#1)(2010-5#1)
to reduce the morbidity and mortality##3##6##(1996-9#1)(2009-4#1)(2012-12#1)
to reduce the morbidity##4##4##(1996-9#1)(2007-3#1)(2009-4#1)(2012-12#1)
to reduce the mortality##3##4##(1993-10#1)(1993-8#1)(2013-1#1)
to reduce the neck##2##4##(2007-4#2)
to reduce the need for##2##5##(2007-7#1)(2008-6#1)
to reduce the negative consequences of##2##6##(1990-6#1)(2007-8#1)
to reduce the number and##2##5##(2007-12#1)(2012-12#1)
to reduce the number of##24##5##(1990-11#1)(1992-8#1)(1994-3#1)(1994-5#1)(1995-7#1)(1996-6#1)(2006-10#2)(2007-11#2)(2007-4#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-5#1)(2011-2#1)(2012-2#2)(2013-8#1)
to reduce the number##26##4##(1990-11#1)(1992-8#1)(1994-3#1)(1994-5#1)(1995-7#1)(1996-6#1)(2006-10#2)(2007-11#2)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
to reduce the occurrence of##3##5##(1995-11#1)(2008-12#1)(2010-7#1)
to reduce the potential for##2##5##(1993-10#1)(2008-10#1)
to reduce the potential##4##4##(1993-10#1)(2006-2#1)(2008-10#1)(2013-8#1)
to reduce the prevalence of##4##5##(2006-4#1)(2007-6#1)(2008-3#1)(2012-12#1)
to reduce the production of##5##5##(2007-11#1)(2008-1#1)(2008-10#1)(2008-9#1)(2011-1#1)
to reduce the proportion of##3##5##(1993-9#1)(2005-7#1)(2008-10#1)
to reduce the rate of complications##2##6##(2010-7#1)(2013-1#1)
to reduce the rate of##6##5##(1994-12#1)(2008-2#1)(2008-5#1)(2010-7#1)(2010-8#1)(2013-1#1)
to reduce the rate##7##4##(1992-1#1)(1994-12#1)(2008-2#1)(2008-5#1)(2010-7#1)(2010-8#1)(2013-1#1)
to reduce the required##3##4##(2006-11#1)(2008-2#1)(2008-3#1)
to reduce the risk of cardiovascular##2##6##(2008-3#1)(2012-2#1)
to reduce the risk of premature cardiovascular disease##2##8##(2009-11#2)
to reduce the risk of transmission##2##6##(1994-12#1)(2006-10#1)
to reduce the risk of##46##5##(1990-2#1)(1993-11#1)(1993-7#1)(1994-12#1)(1996-2#1)(1996-3#1)(2006-10#3)(2006-11#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#3)(2008-10#3)(2008-11#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#2)(2009-6#2)(2009-7#1)(2010-1#1)(2010-12#2)(2010-4#1)(2011-2#1)(2012-2#2)(2013-8#4)
to reduce the risk##47##4##(1990-2#1)(1993-11#1)(1993-7#1)(1994-12#1)(1996-2#1)(1996-3#1)(2006-10#4)(2006-11#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#3)(2008-10#3)(2008-11#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#2)(2009-6#2)(2009-7#1)(2010-1#1)(2010-12#2)(2010-4#1)(2011-2#1)(2012-2#2)(2013-8#4)
to reduce the risks in##2##5##(2008-11#1)(2008-4#1)
to reduce the risks of##2##5##(2008-12#1)(2008-9#1)
to reduce the risks##5##4##(2006-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)
to reduce the severity of##2##5##(1991-3#1)(2010-1#1)
to reduce the size of the##2##6##(1996-3#1)(2010-10#1)
to reduce the size of##3##5##(1994-11#1)(1996-3#1)(2010-10#1)
to reduce the spatial##2##4##(1994-5#1)(2009-5#1)
to reduce the spread of the disease##2##7##(2007-7#2)
to reduce the spread of##3##5##(2007-7#2)(2010-12#1)
to reduce the stress##2##4##(2009-9#1)(2010-12#1)
to reduce the surface roughness of a##2##7##(2007-12#1)(2008-2#1)
to reduce the surface##5##4##(2004-9#1)(2005-11#1)(2007-12#1)(2008-2#1)(2010-4#1)
to reduce the time##3##4##(2008-10#1)(2008-3#1)(2008-4#1)
to reduce the variability of##2##5##(2008-10#1)(2008-2#1)
to reduce the variance of##2##5##(2008-2#1)(2009-3#1)
to reduce the##413##3##(1990-11#1)(1990-2#1)(1990-6#2)(1991-10#1)(1991-12#3)(1991-3#1)(1991-4#1)(1991-6#3)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#3)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-3#1)(1995-5#1)(1995-6#3)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-6#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2004-12#1)(2004-7#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-7#3)(2005-9#1)(2006-10#11)(2006-11#4)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#2)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#12)(2007-12#9)(2007-2#1)(2007-3#4)(2007-4#5)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#15)(2008-1#5)(2008-10#27)(2008-11#11)(2008-12#4)(2008-2#26)(2008-3#22)(2008-4#5)(2008-5#10)(2008-6#4)(2008-7#9)(2008-8#6)(2008-9#4)(2009-10#3)(2009-11#2)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#3)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#3)(2010-10#1)(2010-12#8)(2010-2#2)(2010-4#5)(2010-5#1)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#7)(2011-11#1)(2011-12#4)(2011-2#11)(2011-7#1)(2012-1#3)(2012-11#1)(2012-12#8)(2012-2#6)(2012-3#1)(2013-1#13)(2013-7#1)(2013-8#10)
to reduce their risk##2##4##(1996-8#1)(2011-2#1)
to reduce their##8##3##(1991-6#1)(1996-8#1)(1996-9#1)(2006-11#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
to reduce thermal##2##3##(1991-2#1)(2007-12#1)
to reduce these##5##3##(1993-1#1)(2008-11#1)(2008-8#1)(2010-4#1)(2011-1#1)
to reduce thiosulfate##2##3##(2006-8#1)(2011-2#1)
to reduce this risk##3##4##(1994-12#1)(2008-1#1)(2009-11#1)
to reduce this##9##3##(1994-12#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-7#1)(2009-11#1)(2011-1#1)(2013-8#1)
to reduce tissue##2##3##(2008-10#1)(2009-4#1)
to reduce to##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
to reduce total##3##3##(1990-7#1)(2007-8#1)(2011-2#1)
to reduce toughness of##2##4##(2013-1#2)
to reduce uncertainties in##2##4##(2008-2#1)(2008-5#1)
to reduce variation##3##3##(1993-3#1)(1996-1#1)(1996-12#1)
to reduce vertical##4##3##(1995-3#3)(2007-12#1)
to reduce violence##4##3##(1994-2#1)(2012-12#1)(2012-3#2)
to reduce waiting##2##3##(2006-12#1)(2008-11#1)
to reduce##1040##2##(1990-1#1)(1990-10#1)(1990-11#2)(1990-2#2)(1990-4#1)(1990-6#2)(1990-7#2)(1990-9#2)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#4)(1991-4#3)(1991-6#5)(1991-7#3)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-4#2)(1992-5#3)(1992-6#2)(1992-8#1)(1992-9#3)(1993-1#2)(1993-10#2)(1993-11#4)(1993-12#1)(1993-2#3)(1993-3#5)(1993-4#1)(1993-5#2)(1993-7#2)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#4)(1994-4#2)(1994-5#3)(1994-6#3)(1994-7#2)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#5)(1995-2#4)(1995-3#7)(1995-5#2)(1995-6#4)(1995-7#3)(1995-8#1)(1996-1#5)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#4)(1996-3#3)(1996-4#1)(1996-6#4)(1996-7#1)(1996-8#2)(1996-9#6)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#4)(1997-7#1)(1997-8#3)(2004-11#2)(2004-12#2)(2004-4#1)(2004-7#1)(2004-9#2)(2005-1#1)(2005-10#4)(2005-11#4)(2005-5#1)(2005-7#3)(2005-8#2)(2005-9#5)(2006-10#32)(2006-11#7)(2006-12#7)(2006-2#5)(2006-3#3)(2006-4#5)(2006-5#3)(2006-6#6)(2006-7#2)(2006-8#8)(2006-9#3)(2007-1#2)(2007-10#4)(2007-11#30)(2007-12#22)(2007-2#6)(2007-3#4)(2007-4#8)(2007-5#1)(2007-6#2)(2007-7#6)(2007-8#30)(2007-9#3)(2008-1#18)(2008-10#67)(2008-11#26)(2008-12#5)(2008-2#44)(2008-3#44)(2008-4#9)(2008-5#25)(2008-6#9)(2008-7#22)(2008-8#18)(2008-9#9)(2009-10#4)(2009-11#5)(2009-2#1)(2009-3#5)(2009-4#4)(2009-5#7)(2009-6#5)(2009-7#3)(2009-8#4)(2009-9#3)(2010-1#7)(2010-10#5)(2010-11#3)(2010-12#14)(2010-2#3)(2010-3#3)(2010-4#11)(2010-5#5)(2010-6#1)(2010-7#4)(2010-8#9)(2010-9#9)(2011-1#20)(2011-11#2)(2011-12#6)(2011-2#33)(2011-7#1)(2012-1#10)(2012-11#2)(2012-12#23)(2012-2#20)(2012-3#13)(2013-1#60)(2013-7#2)(2013-8#19)
to reduced activity##2##3##(1995-2#1)(2006-9#1)
to reduced bacterial##2##3##(2008-10#2)
to reduced melanogenesis##2##3##(2008-5#2)
to reduced##55##2##(1990-2#1)(1991-6#1)(1991-9#1)(1992-9#1)(1993-1#1)(1993-12#1)(1995-2#1)(1995-5#1)(1996-8#1)(1997-2#1)(1997-3#1)(2004-11#1)(2005-8#1)(2006-10#2)(2006-9#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#2)
to reducing the number of##3##5##(1995-5#1)(2008-2#1)(2008-3#1)
to reducing the##12##3##(1992-12#1)(1995-5#1)(1996-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2012-3#1)
to reducing##31##2##(1992-12#1)(1992-3#1)(1992-6#1)(1995-12#1)(1995-5#1)(1996-12#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-7#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
to reduction in##5##3##(1990-4#1)(1992-3#1)(2008-1#2)(2010-6#1)
to reduction of the##3##4##(1994-11#1)(2007-11#1)(2007-6#1)
to reduction of##15##3##(1990-7#1)(1991-8#1)(1992-1#1)(1994-11#1)(1995-6#1)(2005-8#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-2#1)(2011-1#1)(2011-2#2)(2013-1#1)
to reduction##25##2##(1990-4#1)(1990-7#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-3#1)(1994-11#1)(1994-12#1)(1995-5#1)(1995-6#1)(2005-8#1)(2006-1#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#1)(2010-6#1)(2011-1#1)(2011-2#2)(2013-1#1)
to reductions in dietary##2##4##(2012-2#2)
to reductions in the##3##4##(2008-10#1)(2008-4#1)(2011-2#1)
to reductions in##14##3##(1995-2#1)(1997-5#1)(2005-11#1)(2005-7#1)(2008-10#1)(2008-4#2)(2008-5#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#1)
to redundant##2##2##(1994-8#1)(2009-5#1)
to reengineer the##2##3##(1996-1#1)(2011-7#1)
to reengineer##3##2##(1996-1#1)(2011-7#1)(2012-2#1)
to reestablish##4##2##(2009-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
to reevaluate##3##2##(2005-8#1)(2008-11#1)(2008-9#1)
to reexamine their##2##3##(1990-12#1)(1996-12#1)
to reexamine##4##2##(1990-12#1)(1990-5#1)(1996-12#1)(2008-9#1)
to refer patients##3##3##(1993-3#1)(2007-6#1)(2010-9#1)
to refer them to##2##4##(1991-11#1)(2008-10#1)
to refer to##9##3##(2006-10#1)(2006-8#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
to refer##19##2##(1991-11#1)(1993-3#1)(1995-9#1)(2006-10#1)(2006-8#1)(2007-6#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
to reference##15##2##(1990-12#1)(1992-12#1)(1994-10#1)(1994-12#1)(1996-2#1)(1996-3#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
to referral##4##2##(2006-10#1)(2007-8#1)(2008-6#1)(2012-2#1)
to referring physicians##3##3##(1993-12#1)(2007-4#1)(2011-2#1)
to referring##4##2##(1993-12#1)(1996-3#1)(2007-4#1)(2011-2#1)
to refine the model##2##4##(1994-8#1)(2007-10#1)
to refine the treatment##2##4##(2011-2#1)(2013-1#1)
to refine the##20##3##(1994-8#1)(1996-3#1)(2005-11#1)(2006-10#2)(2007-10#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
to refine this##2##3##(2006-10#1)(2008-4#1)
to refine##31##2##(1994-7#1)(1994-8#1)(1996-3#1)(2005-11#1)(2006-10#7)(2007-10#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
to reflect a##6##3##(1992-1#1)(1993-4#1)(1996-5#1)(1996-6#1)(1997-8#1)(2006-3#1)
to reflect an##2##3##(1990-11#1)(1997-2#1)
to reflect changes in##2##4##(1991-7#1)(2013-1#1)
to reflect current##3##3##(1997-2#1)(2010-4#1)(2011-2#1)
to reflect differences in##2##4##(1994-3#1)(1995-12#1)
to reflect on the##5##4##(2006-4#1)(2006-9#1)(2012-3#3)
to reflect on##12##3##(1990-12#1)(1994-9#1)(1995-1#1)(2005-7#1)(2006-4#1)(2006-9#1)(2008-11#1)(2009-9#1)(2012-3#4)
to reflect that##3##3##(2008-11#1)(2008-12#1)(2008-7#1)
to reflect the effects of##2##5##(2008-2#1)(2011-1#1)
to reflect the impact of##2##5##(2008-2#1)(2011-1#1)
to reflect the presence##2##4##(1997-1#1)(2008-7#1)
to reflect the transient##2##4##(1994-2#1)(2008-10#1)
to reflect the##40##3##(1990-12#1)(1991-2#1)(1991-3#1)(1993-2#2)(1993-3#1)(1994-2#1)(1995-2#1)(1996-3#1)(1997-1#1)(2006-9#1)(2007-11#2)(2007-5#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-1#1)(2010-3#1)(2011-1#2)(2011-2#3)(2012-3#2)
to reflect##115##2##(1990-11#1)(1990-12#3)(1990-2#2)(1991-2#2)(1991-3#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-7#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-5#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-8#1)(2005-7#1)(2005-8#2)(2006-3#1)(2006-4#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#4)(2007-5#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-2#1)(2010-3#1)(2010-4#2)(2011-1#4)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#7)(2013-1#2)
to reflectance##2##2##(2008-2#2)
to reflected##3##2##(2008-3#3)
to reflection##2##2##(2008-12#1)(2013-1#1)
to reflections##2##2##(1996-9#1)(2008-3#1)
to reflective##2##2##(1990-5#1)(2013-1#1)
to reflux##2##2##(1993-2#1)(2012-3#1)
to refold##2##2##(1995-3#1)(1995-4#1)
to reform Medicare##2##3##(1997-3#1)(2008-6#1)
to reform the delivery of health care##2##7##(1994-12#1)(1997-1#1)
to reform the##4##3##(1992-5#1)(1994-12#1)(1997-1#1)(2008-4#1)
to reform##11##2##(1992-5#1)(1994-12#1)(1995-2#2)(1997-1#1)(1997-3#1)(2008-4#1)(2008-6#1)(2010-5#1)(2010-9#1)(2013-8#1)
to reformulate the##2##3##(1994-11#1)(2007-8#1)
to refractive-index##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
to refractory retrograde ejaculation##3##4##(2011-2#3)
to refractory##4##2##(2011-2#3)(2012-2#1)
to refrain from##2##3##(2006-7#1)(2012-12#1)
to reframe the##2##3##(2007-3#1)(2013-1#1)
to refuse medication##3##3##(1990-12#1)(1992-12#2)
to refuse treatment##7##3##(1990-5#1)(1995-12#2)(1995-2#1)(2006-5#1)(2007-12#2)
to refuse##17##2##(1990-11#1)(1990-12#1)(1990-5#1)(1992-12#2)(1994-12#1)(1995-12#2)(1995-2#1)(2004-12#1)(2006-5#1)(2007-12#2)(2008-11#1)(2008-9#1)(2009-6#2)
to refute##2##2##(2006-8#1)(2008-3#1)
to regain the##2##3##(2008-1#1)(2012-1#1)
to regain their former##3##4##(2012-3#1)(2013-1#2)
to regain##10##2##(1992-5#1)(1995-8#1)(2008-1#1)(2008-7#1)(2008-9#1)(2012-1#2)(2012-3#1)(2013-1#2)
to regard##6##2##(1991-2#1)(1995-6#1)(1997-7#1)(2008-11#1)(2008-5#1)(2013-8#1)
to regenerate after##2##3##(1994-2#1)(2012-12#1)
to regenerate the##7##3##(1995-10#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-5#2)(2013-1#1)
to regenerate##29##2##(1990-2#1)(1992-1#1)(1994-2#2)(1995-10#1)(1995-3#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#6)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
to regenerating##2##2##(2008-1#1)(2010-1#1)
to region##5##2##(1992-2#1)(2007-4#1)(2008-10#1)(2008-7#1)(2013-8#1)
to regional and##4##3##(2008-1#1)(2009-9#1)(2010-7#1)(2011-1#1)
to regional##20##2##(1992-12#1)(1994-12#1)(1994-5#1)(1996-2#1)(1997-7#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#2)(2009-6#1)(2009-9#2)(2010-11#1)(2010-7#1)(2011-1#1)(2013-7#1)
to regions of##2##3##(2012-1#1)(2012-12#1)
to regions##9##2##(1992-7#1)(1995-10#1)(1996-4#1)(2007-7#1)(2008-11#1)(2008-3#1)(2012-1#1)(2012-12#1)(2012-3#1)
to register a##3##3##(2008-11#1)(2008-3#1)(2013-7#1)
to register##11##2##(1990-11#1)(1991-2#1)(1996-11#1)(1996-7#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-2#1)(2013-7#1)
to registered##4##2##(1995-8#1)(2008-11#1)(2008-12#1)(2011-2#1)
to regress##3##2##(1992-5#1)(1995-4#1)(1996-10#1)
to regression of##3##3##(1992-12#1)(1996-9#1)(2006-6#1)
to regression##4##2##(1992-12#1)(1994-6#1)(1996-9#1)(2006-6#1)
to regrow##3##2##(1991-3#2)(2008-5#1)
to regular##7##2##(1997-2#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-5#1)(2010-9#1)
to regularity for##3##3##(2008-10#3)
to regularity##4##2##(2008-10#4)
to regularly##8##2##(1997-7#1)(2007-11#1)(2008-12#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#1)
to regulate a wide##3##4##(2005-7#1)(2008-11#1)(2008-9#1)
to regulate a##6##3##(1990-8#1)(1995-2#1)(2005-7#1)(2008-11#1)(2008-9#1)(2009-5#1)
to regulate actin polymerization##2##4##(1990-3#1)(1996-2#1)
to regulate actin##4##3##(1990-3#1)(1996-2#1)(2012-2#2)
to regulate all##2##3##(1991-12#1)(2012-1#1)
to regulate and##2##3##(1994-5#1)(2008-2#1)
to regulate both##3##3##(1995-6#1)(2008-10#1)(2012-2#1)
to regulate cell cycle##2##4##(2008-1#1)(2009-3#1)
to regulate cell growth##2##4##(2005-11#1)(2008-11#1)
to regulate cell##6##3##(1994-6#1)(2005-11#1)(2008-1#1)(2008-11#1)(2009-3#1)(2012-1#1)
to regulate development##2##3##(1993-3#1)(1994-12#1)
to regulate food intake##2##4##(2008-1#1)(2008-3#1)
to regulate gene expression##3##4##(1993-6#1)(2008-4#1)(2012-12#1)
to regulate gene##4##3##(1993-6#1)(2007-8#1)(2008-4#1)(2012-12#1)
to regulate insulin##2##3##(1997-4#1)(2011-1#1)
to regulate its##2##3##(1995-8#1)(2005-9#1)
to regulate neuronal##3##3##(1995-2#1)(2008-10#1)(2013-8#1)
to regulate telomere length##2##4##(2012-3#2)
to regulate the activity of##3##5##(1995-5#1)(1996-9#1)(2009-8#1)
to regulate the cell##2##4##(2008-11#1)(2012-3#1)
to regulate the expression of a number of##2##8##(2010-8#1)(2012-12#1)
to regulate the expression of the##4##6##(1992-6#1)(1993-12#1)(1994-5#1)(2008-11#1)
to regulate the expression of##15##5##(1992-6#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-9#1)(2008-11#1)(2008-4#1)(2010-8#1)(2011-2#2)(2012-12#3)
to regulate the##47##3##(1990-8#1)(1991-11#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-5#1)(1995-9#1)(1996-9#1)(2005-11#1)(2005-7#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-12#2)(2008-11#2)(2008-4#3)(2008-5#2)(2008-9#1)(2009-10#2)(2009-8#2)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#1)(2013-8#1)
to regulate their##2##3##(1995-8#1)(2012-12#1)
to regulate transcription##5##3##(1991-12#1)(1995-2#1)(1997-4#1)(2008-9#1)(2011-2#1)
to regulate##171##2##(1990-11#1)(1990-3#2)(1990-8#2)(1991-11#1)(1991-12#3)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#4)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#5)(1995-5#1)(1995-6#3)(1995-8#2)(1995-9#1)(1996-10#1)(1996-2#3)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#3)(2005-10#1)(2005-11#3)(2005-7#3)(2005-9#1)(2006-11#2)(2006-12#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#6)(2007-2#1)(2007-8#3)(2008-1#2)(2008-10#4)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#4)(2009-10#4)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#4)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#3)(2012-12#8)(2012-2#12)(2012-3#3)(2013-1#1)(2013-8#2)
to regulated##3##2##(2006-2#1)(2008-4#1)(2008-7#1)
to regulation at##2##3##(1990-8#1)(2007-12#1)
to regulation by##2##3##(1993-8#1)(1995-9#1)
to regulation of##7##3##(1994-11#1)(1994-8#1)(2007-12#1)(2007-8#1)(2008-8#1)(2009-8#1)(2013-1#1)
to regulation##12##2##(1990-8#1)(1993-8#2)(1994-11#1)(1994-8#1)(1995-9#1)(2007-12#2)(2007-8#1)(2008-8#1)(2009-8#1)(2013-1#1)
to regulatory and##3##3##(2007-5#1)(2012-3#1)(2013-7#1)
to regulatory effects##2##3##(1991-3#1)(1995-2#1)
to regulatory##15##2##(1991-3#1)(1993-6#1)(1995-2#1)(1995-6#1)(1996-3#1)(2005-8#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-11#1)(2010-9#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-7#1)
to rehabilitate##3##2##(1993-3#1)(2007-6#1)(2011-2#1)
to rehabilitation and##2##3##(2007-7#1)(2008-2#1)
to rehabilitation may##2##3##(2007-9#1)(2008-6#1)
to rehabilitation professionals##2##3##(1996-2#1)(2006-10#1)
to rehabilitation##15##2##(1995-9#1)(1996-2#1)(1996-6#1)(2006-10#2)(2007-7#1)(2007-9#2)(2008-10#1)(2008-2#2)(2008-6#1)(2008-9#1)(2010-3#1)(2012-2#1)
to reimburse##5##2##(1993-3#1)(1997-2#1)(1997-5#1)(2008-12#2)
to reimbursement##2##2##(2011-2#1)(2012-2#1)
to rein in##2##3##(1994-3#1)(2013-7#1)
to reinforce and##3##3##(1994-2#1)(2011-2#1)(2012-2#1)
to reinforce the abdominal wall##2##5##(1996-9#1)(2007-7#1)
to reinforce the##8##3##(1992-11#1)(1992-2#1)(1996-9#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-9#1)
to reinforce##25##2##(1992-11#1)(1992-2#1)(1993-12#1)(1994-2#1)(1996-9#1)(2004-2#1)(2005-5#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#3)(2009-11#1)(2009-9#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#2)
to reinforcement##3##2##(2008-10#1)(2008-5#1)(2009-11#1)
to reinforcing##2##2##(1993-6#1)(2006-11#1)
to reinterpret##2##2##(2008-2#1)(2012-2#1)
to reintroduce the##2##3##(1990-5#1)(2009-5#1)
to reintroduce##3##2##(1990-5#1)(1995-8#1)(2009-5#1)
to reinvent##2##2##(1994-12#1)(2006-5#1)
to reject the interference##2##4##(2008-10#2)
to reject the##4##3##(2008-10#2)(2008-3#1)(2008-7#1)
to reject##14##2##(1992-1#1)(1995-5#1)(2006-7#1)(2008-10#2)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#2)
to rejection##3##2##(2007-11#1)(2007-7#1)(2008-3#1)
to rejoin##4##2##(1997-1#3)(2008-8#1)
to rejuvenate##2##2##(2007-9#1)(2010-11#1)
to relapse in patients##2##4##(1994-5#1)(2004-1#1)
to relapse prevention##2##3##(2006-9#1)(2012-2#1)
to relapse##14##2##(1994-5#1)(1994-8#1)(2004-1#2)(2006-7#1)(2006-9#1)(2007-12#1)(2007-8#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-12#2)(2012-2#1)
to relate the apparent##2##4##(2006-10#1)(2008-3#1)
to relate the observed##2##4##(1997-2#1)(2008-10#1)
to relate the##18##3##(1990-3#1)(1995-4#1)(1997-2#1)(2006-10#1)(2007-9#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-5#3)(2008-9#1)(2012-2#1)
to relate their##2##3##(2008-11#1)(2008-7#1)
to relate them to##2##4##(1997-7#1)(2008-9#1)
to relate these##4##3##(2007-2#1)(2008-2#1)(2008-8#1)(2010-4#1)
to relate this##2##3##(1997-4#1)(2008-7#1)
to relate to the##2##4##(1996-8#1)(2011-1#1)
to relate to##10##3##(1993-2#1)(1994-1#1)(1996-8#1)(2006-10#1)(2006-7#1)(2008-11#1)(2009-8#2)(2011-1#1)(2012-12#1)
to relate##70##2##(1990-3#1)(1993-2#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-4#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-7#1)(2005-10#2)(2006-10#3)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-9#1)(2008-10#14)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#3)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-8#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
to related##7##2##(1994-3#1)(1995-3#1)(2007-2#1)(2008-11#1)(2008-4#1)(2009-12#1)(2010-2#1)
to relatedness##2##2##(2008-8#1)(2008-9#1)
to relative##3##2##(2008-2#1)(2008-4#1)(2008-7#1)
to relatively small##4##3##(2008-5#2)(2008-7#1)(2010-8#1)
to relatively##19##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-9#1)(1996-10#1)(1996-2#1)(1996-7#1)(1997-4#1)(2005-10#1)(2005-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2010-8#1)(2013-1#1)
to relatives##3##2##(1996-6#1)(2008-2#1)(2011-2#1)
to relax##9##2##(1992-7#1)(1996-10#1)(2005-7#1)(2006-6#1)(2007-12#1)(2008-2#1)(2008-7#2)(2010-6#1)
to relay##3##2##(1990-3#1)(2008-1#1)(2008-3#1)
to relearn##2##2##(1992-9#1)(1993-2#1)
to release NO##3##3##(1993-3#1)(1996-6#1)(2008-5#1)
to release cytokines and##2##4##(2006-2#1)(2007-11#1)
to release from##2##3##(1991-12#1)(2008-8#1)
to release nitric oxide##2##4##(1994-12#1)(2008-5#1)
to release of##4##3##(1990-11#1)(1997-2#1)(2006-10#1)(2007-7#1)
to release the##13##3##(1990-10#1)(1992-11#1)(1992-5#1)(1994-2#1)(1994-8#2)(1995-10#1)(2007-10#1)(2008-11#1)(2008-5#2)(2008-9#1)(2012-2#1)
to release their##2##3##(2008-4#1)(2011-1#1)
to release various##2##3##(1990-3#1)(2006-12#1)
to release##78##2##(1990-10#2)(1990-11#1)(1990-3#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-8#2)(1995-10#1)(1995-11#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-6#1)(2006-10#2)(2006-12#3)(2006-2#1)(2006-3#1)(2006-5#1)(2007-10#2)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-4#3)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-8#1)(2013-8#1)
to releasing##2##2##(1994-1#1)(2007-11#1)
to relegate##2##2##(2008-11#1)(2013-1#1)
to relevant data##2##3##(2008-11#1)(2008-7#1)
to relevant information##4##3##(2013-1#4)
to relevant##12##2##(1990-12#1)(2006-1#1)(2008-11#1)(2008-2#2)(2008-7#1)(2013-1#6)
to reliable##3##2##(1992-7#1)(1993-12#1)(2008-2#1)
to reliably detect##2##3##(2008-10#1)(2008-3#1)
to reliably predict##3##3##(1993-6#1)(2009-4#1)(2012-1#1)
to reliably##23##2##(1993-6#1)(1997-8#1)(2006-7#1)(2006-8#1)(2008-10#4)(2008-3#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-2#1)(2010-3#1)(2010-6#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#2)
to relief##2##2##(1996-2#1)(2011-2#1)
to relieve pain##10##3##(1990-5#1)(2006-3#1)(2006-6#1)(2007-11#1)(2008-9#1)(2009-12#1)(2010-7#1)(2011-1#2)(2013-8#1)
to relieve symptoms##2##3##(2007-11#1)(2011-1#1)
to relieve the##6##3##(1995-8#1)(2007-11#1)(2008-4#1)(2009-6#1)(2010-12#1)(2011-2#1)
to relieve##40##2##(1990-5#1)(1992-5#1)(1993-3#1)(1995-3#1)(1995-8#1)(1996-6#1)(1996-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-6#2)(2006-8#1)(2007-11#4)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-12#1)(2010-7#1)(2011-1#3)(2011-2#2)(2013-1#2)(2013-8#1)
to religion##3##2##(2008-4#1)(2009-11#1)(2009-7#1)
to religious##6##2##(1991-10#1)(2008-10#1)(2008-3#1)(2009-10#1)(2010-2#1)(2013-1#1)
to relocate the##2##3##(2008-10#1)(2009-4#1)
to rely in##2##3##(1994-3#1)(2010-4#1)
to rely on a##4##4##(1997-8#1)(2006-7#1)(2007-12#1)(2008-6#1)
to rely on the##2##4##(1996-10#1)(1997-7#1)
to rely on##18##3##(1990-1#1)(1991-9#1)(1993-12#1)(1994-5#1)(1995-2#1)(1996-10#1)(1997-7#1)(1997-8#1)(2006-5#1)(2006-7#1)(2007-12#1)(2008-2#1)(2008-6#2)(2008-7#1)(2011-2#2)(2013-1#1)
to rely##26##2##(1990-1#1)(1991-9#1)(1993-12#1)(1994-3#1)(1994-5#1)(1995-2#1)(1996-10#1)(1997-3#1)(1997-7#1)(1997-8#2)(2006-5#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-6#2)(2008-7#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-1#1)
to relying on##2##3##(2008-12#1)(2009-5#1)
to remain an##2##3##(2008-1#1)(2013-1#1)
to remain asymptomatic##2##3##(2008-10#1)(2008-4#1)
to remain financially##2##3##(2012-2#2)
to remain in solution##2##4##(1991-3#1)(2008-10#1)
to remain in their##3##4##(2008-3#1)(2008-9#1)(2010-10#1)
to remain in##10##3##(1991-3#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-3#1)(2010-10#1)
to remain intact##2##3##(1996-5#1)(1996-6#1)
to remain invisible##2##3##(1994-4#1)(2008-7#1)
to remain living at home##3##5##(2013-1#3)
to remain stable##4##3##(2008-10#1)(2008-7#1)(2010-9#1)(2012-12#1)
to remain susceptible to##2##4##(2008-10#2)
to remain the principal##2##4##(1997-6#1)(2005-11#1)
to remain the##5##3##(1993-1#1)(1997-6#1)(2005-11#1)(2006-10#1)(2008-10#1)
to remain viable##2##3##(1994-12#1)(1997-3#1)
to remain##74##2##(1990-7#1)(1991-1#2)(1991-3#1)(1991-4#1)(1992-8#1)(1993-1#1)(1994-12#1)(1994-3#2)(1994-4#2)(1994-5#2)(1996-5#3)(1996-6#1)(1997-3#1)(1997-6#1)(2005-10#4)(2005-11#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-3#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-5#1)(2013-1#7)(2013-8#1)
to remarkable##5##2##(2005-11#1)(2007-7#1)(2011-2#2)(2013-1#1)
to remediate##3##2##(2004-10#1)(2007-10#1)(2012-12#1)
to remedy the##3##3##(1994-11#1)(2008-11#1)(2010-11#1)
to remedy##7##2##(1994-11#1)(2006-3#1)(2007-11#1)(2007-4#1)(2008-11#1)(2010-11#1)(2012-2#1)
to remember that##4##3##(1991-11#1)(2007-11#1)(2008-5#1)(2013-1#1)
to remember the##4##3##(1995-3#1)(2005-10#1)(2009-11#1)(2009-2#1)
to remember##19##2##(1991-11#1)(1995-3#1)(1995-4#1)(2005-10#1)(2006-3#1)(2006-7#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-11#3)(2008-2#1)(2008-5#1)(2009-11#1)(2009-2#1)(2010-3#1)(2011-2#1)(2013-1#1)
to remind us##2##3##(1997-3#1)(2008-1#1)
to remind##8##2##(1991-4#1)(1997-3#1)(2006-8#2)(2007-11#2)(2008-1#1)(2008-3#1)
to remodel the##3##3##(2007-11#1)(2007-5#1)(2007-8#1)
to remote primary##2##3##(1997-4#1)(2008-10#1)
to remote sensing of##2##4##(2008-10#1)(2008-3#1)
to remote sensing##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
to remote##9##2##(1995-1#1)(1997-4#1)(2008-10#2)(2008-2#2)(2008-3#3)
to remotely##3##2##(2008-3#1)(2008-7#1)(2008-9#1)
to removal of the##3##4##(1997-3#1)(2005-11#1)(2008-7#1)
to removal of##6##3##(1992-6#1)(1996-2#1)(1997-3#1)(2005-11#1)(2008-10#1)(2008-7#1)
to removal##7##2##(1992-6#1)(1996-2#1)(1997-3#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-7#1)
to remove DNA##2##3##(2008-4#1)(2011-2#1)
to remove a##5##3##(1993-6#1)(1995-2#1)(2008-6#1)(2012-12#2)
to remove an##2##3##(2007-11#1)(2011-3#1)
to remove any##3##3##(1992-6#1)(1994-12#1)(2013-1#1)
to remove barriers##2##3##(1994-2#1)(1997-2#1)
to remove endocrine##2##3##(2005-11#1)(2013-1#1)
to remove excess##2##3##(2008-10#1)(2011-2#1)
to remove interference##2##3##(2008-10#2)
to remove only##2##3##(2008-7#2)
to remove residual##7##3##(2008-10#1)(2008-3#1)(2008-4#2)(2008-8#3)
to remove silicon##2##3##(2008-10#2)
to remove the device##3##4##(2008-11#3)
to remove the mass##2##4##(2008-2#1)(2013-8#1)
to remove the most##2##4##(1993-3#1)(2008-10#1)
to remove the same##3##4##(1993-10#2)(2011-2#1)
to remove the##67##3##(1990-11#1)(1990-2#1)(1991-1#1)(1992-3#1)(1993-10#2)(1993-3#1)(1994-8#1)(1995-12#1)(1996-1#1)(1996-5#1)(1997-6#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#18)(2008-11#4)(2008-2#4)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-4#2)(2011-12#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
to remove them##2##3##(2007-8#1)(2008-5#1)
to remove this##2##3##(2007-6#1)(2010-6#1)
to remove traces of##4##4##(2007-6#1)(2008-10#3)
to remove water##3##3##(2007-10#1)(2008-10#1)(2009-11#1)
to remove##216##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-6#1)(1992-11#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-10#4)(1993-3#1)(1993-6#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-6#1)(2005-11#2)(2005-12#1)(2005-4#1)(2005-5#1)(2005-9#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#3)(2007-10#3)(2007-11#5)(2007-12#4)(2007-6#2)(2007-8#6)(2007-9#3)(2008-1#1)(2008-10#37)(2008-11#4)(2008-12#1)(2008-2#8)(2008-3#8)(2008-4#9)(2008-5#6)(2008-6#6)(2008-7#4)(2008-8#3)(2008-9#4)(2009-11#1)(2009-4#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#4)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#8)(2011-3#1)(2012-12#6)(2012-3#1)(2013-1#7)(2013-7#4)(2013-8#3)
to removing##2##2##(2008-5#1)(2010-3#1)
to remyelinate##2##2##(2006-6#1)(2008-7#1)
to renal and##2##3##(1991-12#1)(2007-8#1)
to renal cell carcinoma##2##4##(2006-8#1)(2007-7#1)
to renal failure in##3##4##(2006-8#1)(2008-4#1)(2011-12#1)
to renal failure##9##3##(2005-12#1)(2005-7#1)(2006-8#1)(2007-6#1)(2008-1#1)(2008-4#2)(2010-9#1)(2011-12#1)
to renal function##4##3##(1996-3#1)(2007-11#1)(2007-6#1)(2008-7#1)
to renal replacement##2##3##(2007-11#1)(2007-7#1)
to renal##36##2##(1990-11#1)(1991-12#1)(1995-11#1)(1996-12#1)(1996-3#1)(1996-8#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-8#2)(2007-11#2)(2007-2#1)(2007-3#1)(2007-6#2)(2007-7#2)(2007-8#3)(2008-1#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
to render the##8##3##(1990-5#1)(1995-8#1)(1996-11#1)(1997-6#1)(2008-10#1)(2010-8#1)(2011-1#1)(2012-1#1)
to render##22##2##(1990-5#1)(1990-8#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-11#1)(1997-5#2)(1997-6#2)(2005-11#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-7#1)
to renew##3##2##(1992-6#1)(1995-6#1)(2008-3#1)
to renin##3##2##(1990-8#2)(2008-1#1)
to reopen##2##2##(2008-8#1)(2010-12#1)
to reorganize##2##2##(1992-2#1)(2008-2#1)
to reorient##2##2##(1992-11#1)(2008-1#1)
to repair a##3##3##(1994-5#1)(2007-8#1)(2013-7#1)
to repair and##3##3##(1994-5#1)(2008-10#1)(2009-3#1)
to repair both##2##3##(1995-1#1)(2009-9#1)
to repair damaged##2##3##(2007-11#1)(2008-8#1)
to repair methylated DNA##2##4##(1995-5#2)
to repair or##2##3##(2008-11#1)(2009-9#1)
to repair structural integrity of tissues at the ocular surface##2##10##(2012-11#2)
to repair the##10##3##(1990-11#1)(1991-10#1)(1992-9#1)(2004-9#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-5#1)(2009-10#1)(2013-8#1)
to repair##48##2##(1990-11#1)(1991-10#1)(1992-2#1)(1992-9#1)(1994-5#3)(1995-1#1)(1995-5#3)(1995-8#1)(1997-4#1)(2004-9#1)(2006-10#1)(2006-3#1)(2006-5#1)(2007-11#5)(2007-12#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-9#2)(2010-1#1)(2010-7#1)(2010-8#3)(2011-2#1)(2012-1#1)(2012-11#2)(2012-2#1)(2013-7#1)(2013-8#1)
to repeal##2##2##(1990-9#1)(2006-7#1)
to repeat the##3##3##(2007-1#2)(2008-2#1)
to repeat##7##2##(1997-5#1)(2006-10#1)(2007-1#2)(2008-2#1)(2008-5#1)(2009-6#1)
to repeated surgery in##2##4##(2007-7#2)
to repeated##32##2##(1992-7#2)(1992-8#1)(1994-8#1)(1995-12#1)(1996-10#1)(1997-4#2)(2005-11#2)(2007-10#2)(2007-3#2)(2007-7#3)(2007-8#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#3)(2009-9#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-3#2)(2013-1#1)
to repeatedly##3##2##(1995-3#1)(2012-1#1)(2013-1#1)
to reperfusion##4##2##(1995-6#1)(2007-10#2)(2008-3#1)
to repetitive##6##2##(2006-10#1)(2008-11#1)(2008-7#1)(2009-8#2)(2010-12#1)
to repetitively##2##2##(2007-12#1)(2008-7#1)
to replace Ca2+ in##2##4##(1995-11#2)
to replace a##8##3##(1991-9#1)(2006-12#1)(2007-7#1)(2009-10#1)(2009-5#1)(2010-2#1)(2013-7#2)
to replace damaged##2##3##(2008-11#1)(2009-4#1)
to replace each##2##3##(1991-4#1)(2008-10#1)
to replace the conventional##2##4##(2008-11#1)(2013-8#1)
to replace the##30##3##(1990-2#1)(1992-2#1)(1992-3#1)(1994-12#1)(1996-10#1)(2005-10#1)(2007-11#2)(2007-8#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-8#2)(2009-5#2)(2010-12#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
to replace this##4##3##(1993-7#1)(2006-12#1)(2006-7#1)(2008-10#1)
to replace##99##2##(1990-2#1)(1990-7#2)(1991-2#1)(1991-4#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-7#1)(1993-9#1)(1994-12#2)(1994-3#2)(1995-1#2)(1995-11#2)(1995-6#1)(1996-10#1)(1996-2#2)(2004-9#1)(2005-10#1)(2005-8#2)(2006-12#2)(2006-2#1)(2006-7#1)(2007-11#3)(2007-4#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#4)(2008-11#4)(2008-2#4)(2008-3#3)(2008-4#2)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#3)(2010-1#1)(2010-12#3)(2010-2#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#2)(2011-7#1)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#4)(2012-3#2)(2013-7#2)(2013-8#2)
to replacement of##4##3##(1990-6#2)(2013-1#2)
to replacement therapy##2##3##(2008-1#1)(2012-12#1)
to replacement##7##2##(1990-6#2)(2005-8#1)(2008-1#1)(2012-12#1)(2013-1#2)
to replenish##4##2##(1990-12#1)(1996-9#1)(2008-1#1)(2009-6#1)
to replicate and##4##3##(1990-11#1)(1994-5#1)(2010-6#1)(2012-2#1)
to replicate in##6##3##(1993-11#1)(1995-2#1)(1997-3#1)(2006-11#1)(2008-9#1)(2013-8#1)
to replicate the##5##3##(1992-11#1)(2008-2#1)(2008-5#1)(2010-12#1)(2012-3#1)
to replicate these findings##2##4##(1994-2#1)(2007-12#1)
to replicate##34##2##(1990-11#1)(1990-8#1)(1992-11#1)(1992-12#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-8#1)(1996-9#1)(1997-3#1)(1997-8#1)(2006-11#2)(2007-11#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-4#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
to replication of##2##3##(2008-5#1)(2012-2#1)
to replication##4##2##(1996-11#1)(2008-5#1)(2012-2#1)(2012-3#1)
to report a case of##7##5##(1993-10#1)(2006-10#2)(2006-4#1)(2007-12#1)(2011-1#1)(2013-8#1)
to report a case##9##4##(1993-10#1)(2006-10#2)(2006-4#1)(2007-12#1)(2008-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
to report a problem##2##4##(2006-10#1)(2010-3#1)
to report a##22##3##(1993-10#1)(1995-7#1)(2005-10#1)(2006-10#3)(2006-4#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-5#2)(2009-5#1)(2010-3#1)(2011-1#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
to report an##4##3##(2008-1#1)(2008-4#1)(2012-12#1)(2012-2#1)
to report and discuss the##2##5##(2008-9#1)(2009-10#1)
to report and##6##3##(1993-1#1)(1993-6#1)(1995-2#1)(2008-9#1)(2009-10#1)(2009-8#1)
to report on the##4##4##(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#1)
to report on##9##3##(1996-11#1)(2008-11#2)(2008-12#1)(2008-4#1)(2010-3#1)(2011-2#1)(2013-1#2)
to report or not##2##4##(1995-12#1)(2012-11#1)
to report outcome##2##3##(2012-1#1)(2012-3#1)
to report that they##2##4##(1995-6#1)(2007-9#1)
to report that##6##3##(1995-6#1)(1997-8#2)(2007-9#1)(2013-1#2)
to report the##18##3##(1996-12#1)(2006-11#1)(2006-6#1)(2007-11#1)(2008-5#2)(2008-7#2)(2008-9#1)(2010-3#1)(2010-6#1)(2011-2#3)(2012-3#1)(2013-1#3)
to report this case##3##4##(1992-10#1)(2008-7#2)
to report this##5##3##(1992-10#1)(2006-8#1)(2008-7#2)(2013-1#1)
to report##149##2##(1990-11#1)(1991-2#1)(1992-10#1)(1992-5#1)(1993-1#1)(1993-10#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-6#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-8#3)(2004-7#1)(2005-10#2)(2006-10#4)(2006-11#1)(2006-4#1)(2006-6#2)(2006-8#3)(2007-11#2)(2007-12#2)(2007-2#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#6)(2008-12#5)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#4)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#5)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#2)(2010-3#5)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#8)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#18)(2013-8#5)
to reported genes##2##3##(1995-8#1)(1996-6#1)
to reported in vivo##2##4##(1992-11#2)
to reported##10##2##(1992-11#2)(1995-8#1)(1996-10#1)(1996-6#2)(2008-10#1)(2008-6#1)(2011-1#2)
to reporter##3##2##(1990-8#1)(2008-10#1)(2008-7#1)
to reporting##3##2##(2010-11#1)(2011-2#2)
to reports in the##2##4##(1993-3#1)(1997-6#1)
to reports of##3##3##(2006-7#1)(2007-7#1)(2012-12#1)
to reports##8##2##(1993-3#1)(1997-6#1)(2006-7#1)(2007-3#1)(2007-7#2)(2008-5#1)(2012-12#1)
to reposition##2##2##(2007-7#1)(2009-8#1)
to represent a distinct##2##4##(1991-7#1)(1992-7#1)
to represent a new##2##4##(1991-2#1)(1993-3#1)
to represent a significant##3##4##(1994-5#1)(2008-10#1)(2010-6#1)
to represent a##37##3##(1991-11#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-4#1)(1992-7#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-4#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-5#1)(2008-7#2)(2008-8#1)(2010-3#1)(2010-6#1)(2011-2#3)(2013-8#1)
to represent alternative##2##3##(2007-9#1)(2012-3#1)
to represent an##8##3##(1997-4#1)(2005-7#1)(2007-12#1)(2007-8#1)(2008-7#2)(2010-12#1)(2013-8#1)
to represent data##3##3##(2008-7#1)(2013-1#2)
to represent early##2##3##(1991-12#1)(2008-9#1)
to represent multiple##3##3##(2009-4#1)(2013-1#2)
to represent the human##2##4##(1991-7#1)(2007-4#1)
to represent the spatial##2##4##(2008-11#2)
to represent the##43##3##(1990-4#1)(1990-7#3)(1991-7#1)(1996-12#3)(2006-11#1)(2006-2#1)(2007-2#1)(2007-4#2)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#3)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#4)
to represent them##4##3##(2010-5#1)(2013-1#2)(2013-8#1)
to represent two##2##3##(1994-8#1)(2010-3#1)
to represent##150##2##(1990-2#1)(1990-4#1)(1990-7#3)(1991-11#1)(1991-12#3)(1991-2#1)(1991-7#2)(1991-9#1)(1992-4#1)(1992-7#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#3)(1996-4#2)(1997-4#1)(2004-2#1)(2005-10#1)(2005-7#2)(2006-10#3)(2006-11#1)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-4#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#5)(2008-12#1)(2008-2#9)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#4)(2008-7#10)(2008-8#3)(2008-9#2)(2009-3#1)(2009-4#2)(2009-6#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-6#2)(2010-9#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#13)(2013-8#4)
to repress##8##2##(1996-1#1)(1996-7#1)(1997-1#1)(2007-12#2)(2008-11#1)(2008-4#1)(2008-7#1)
to reproduce a##3##3##(2008-11#1)(2010-6#1)(2013-8#1)
to reproduce the disease##2##4##(2008-10#1)(2008-5#1)
to reproduce the##20##3##(1993-11#2)(1997-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-8#1)
to reproduce##53##2##(1991-10#1)(1991-5#1)(1992-1#1)(1992-10#1)(1992-9#2)(1993-11#2)(1995-4#1)(1995-8#1)(1996-12#1)(1997-2#1)(2005-9#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-5#1)(2010-10#1)(2010-6#1)(2010-8#2)(2011-2#1)(2012-1#1)(2013-8#3)
to reproducible##3##2##(1996-1#1)(2009-8#1)(2012-12#1)
to reproducibly##3##2##(2008-11#2)(2009-8#1)
to reproduction##3##2##(2008-5#1)(2008-8#1)(2008-9#1)
to reproduction)##2##2##(2008-8#2)
to reproductive health##2##3##(1991-5#1)(2007-4#1)
to reproductive##8##2##(1991-5#1)(1992-12#1)(1993-7#1)(2006-4#1)(2007-4#1)(2008-9#1)(2009-4#1)(2013-1#1)
to reprogram##6##2##(1996-1#1)(2008-9#1)(2012-11#2)(2012-12#2)
to reprogramming##2##2##(2008-9#1)(2009-3#1)
to request##5##2##(1992-12#1)(1997-5#1)(2006-10#1)(2008-1#1)(2009-12#1)
to require a##6##3##(1990-7#1)(1991-9#1)(1992-10#1)(1996-8#1)(2006-3#1)(2008-7#1)
to require conventional##2##3##(2006-10#1)(2012-2#1)
to require that##2##3##(1992-1#1)(2009-4#1)
to require the##11##3##(1992-1#2)(1993-4#1)(1995-2#1)(1995-6#2)(2007-11#1)(2009-4#1)(2010-2#1)(2013-1#1)(2013-8#1)
to require##50##2##(1990-2#1)(1990-3#1)(1990-7#1)(1991-10#1)(1991-3#1)(1991-8#2)(1991-9#1)(1992-1#3)(1992-10#1)(1992-3#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-2#1)(1996-5#1)(1996-8#1)(2004-10#1)(2006-10#2)(2006-3#1)(2006-4#1)(2007-11#1)(2007-4#1)(2008-1#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-4#2)(2009-9#1)(2010-2#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#2)
to required##2##2##(2007-12#1)(2008-10#1)
to requirements##2##2##(1992-10#1)(2005-10#1)
to reschedule##2##2##(2012-3#2)
to rescue patients##2##3##(2007-11#1)(2013-8#1)
to rescue the patient##2##4##(2007-8#1)(2013-8#1)
to rescue the##8##3##(1993-9#1)(1995-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)(2013-8#1)
to rescue##23##2##(1991-3#1)(1993-9#1)(1995-11#1)(1995-3#1)(1996-6#1)(1997-4#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-2#2)(2013-1#1)(2013-8#2)
to research and##3##3##(2008-7#1)(2009-4#1)(2013-8#1)
to research in the##2##4##(2010-7#1)(2012-1#1)
to research in##5##3##(1992-3#1)(2007-8#1)(2010-1#1)(2010-7#1)(2012-1#1)
to research on##5##3##(1995-2#1)(2006-7#1)(2008-12#1)(2010-10#1)(2013-8#1)
to research participants##5##3##(2007-11#1)(2009-4#2)(2009-6#1)(2009-9#1)
to research participation##2##3##(2008-5#1)(2009-4#1)
to research the##3##3##(2007-11#1)(2010-1#1)(2013-8#1)
to research utilisation is##2##4##(2008-11#2)
to research##43##2##(1990-3#1)(1992-11#1)(1992-12#2)(1992-3#1)(1993-5#1)(1995-2#1)(1996-3#1)(1997-3#1)(2005-10#1)(2006-7#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-12#1)(2009-4#4)(2009-6#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-7#1)(2010-9#1)(2012-1#1)(2012-12#1)(2013-7#1)(2013-8#4)
to research-based##2##2##(2008-11#1)(2008-12#1)
to researchers in##2##3##(2008-5#1)(2008-9#1)
to researchers who##2##3##(2005-8#1)(2007-5#1)
to researchers##15##2##(2005-8#2)(2007-2#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-2#1)(2011-1#1)(2012-12#2)
to researching##2##2##(2009-5#1)(2010-1#1)
to resect the##2##3##(2006-8#1)(2008-5#1)
to resect##11##2##(1993-10#1)(2006-12#2)(2006-5#1)(2006-8#2)(2007-11#1)(2008-5#1)(2008-6#1)(2010-2#1)(2012-12#1)
to resection##3##2##(2007-11#1)(2008-5#2)
to resemble that##2##3##(1997-4#1)(2008-12#1)
to resemble##8##2##(1991-10#1)(1993-11#1)(1995-11#1)(1997-4#1)(2006-7#1)(2008-12#1)(2008-6#1)(2008-8#1)
to resequence##2##2##(2008-2#1)(2012-2#1)
to reset##4##2##(1991-3#1)(2008-5#2)(2009-9#1)
to reshape the##3##3##(1991-1#1)(1995-3#1)(2010-8#1)
to reshape##4##2##(1991-1#1)(1995-3#2)(2010-8#1)
to reside in a##3##4##(1990-7#1)(1994-5#1)(1994-8#1)
to reside##6##2##(1990-7#1)(1992-4#1)(1994-5#1)(1994-8#1)(1997-6#1)(2010-4#1)
to resident##2##2##(1993-11#1)(2011-2#1)
to residential##3##2##(1995-2#1)(2012-12#2)
to residents of##2##3##(2011-2#1)(2012-12#1)
to residents##5##2##(2007-12#1)(2007-2#1)(2010-7#1)(2011-2#1)(2012-12#1)
to residual##14##2##(1994-2#1)(1996-2#1)(1997-3#1)(2004-2#1)(2008-10#3)(2008-11#1)(2008-3#3)(2011-1#1)(2011-2#1)(2012-8#1)
to residues of##2##3##(1992-11#1)(1996-7#1)
to residues##30##2##(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-7#2)(1991-8#2)(1992-11#1)(1992-4#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#2)(1995-2#1)(1995-3#1)(1996-5#3)(1996-7#1)(2006-12#1)(2008-8#1)(2010-5#2)
to resist frosts##2##3##(2009-2#2)
to resist the##4##3##(1991-8#1)(2006-10#1)(2008-3#1)(2008-8#1)
to resist##26##2##(1991-8#1)(1992-9#1)(1996-9#1)(1997-2#1)(2004-9#1)(2006-10#5)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#2)(2009-2#2)(2009-3#1)(2010-4#1)(2012-12#2)(2013-1#2)
to resistance against##2##3##(2008-10#1)(2011-2#1)
to resistance genes##3##3##(2008-10#3)
to resistance in##3##3##(2008-10#3)
to resistance to apoptosis##2##4##(2005-10#1)(2009-8#1)
to resistance to##7##3##(1994-10#1)(2005-10#1)(2008-10#3)(2008-6#1)(2009-8#1)
to resistance##24##2##(1993-3#1)(1994-10#1)(2005-10#1)(2008-1#1)(2008-10#14)(2008-6#1)(2009-11#1)(2009-8#1)(2011-2#1)(2013-1#2)
to resistant cells##2##3##(1990-7#2)
to resistant##7##2##(1990-7#2)(1997-8#1)(2005-7#1)(2008-10#3)
to resolution of##3##3##(1991-6#1)(1995-9#1)(1996-6#1)
to resolve all##3##3##(1996-5#1)(2010-12#1)(2011-1#1)
to resolve ambiguities encountered##2##4##(1991-7#2)
to resolve and##3##3##(1990-11#1)(2008-10#1)(2008-9#1)
to resolve it##2##3##(2008-10#1)(2009-6#1)
to resolve such##3##3##(2008-3#1)(2009-5#1)(2010-12#1)
to resolve the complex##2##4##(1996-9#1)(2008-10#1)
to resolve the discrepant results##2##5##(1996-8#1)(1997-6#1)
to resolve the problem##2##4##(2008-10#1)(2008-11#1)
to resolve the##24##3##(1990-6#1)(1990-8#1)(1993-7#1)(1994-12#1)(1996-8#1)(1996-9#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-5#2)(2008-8#1)(2009-10#1)(2010-5#1)(2011-1#1)
to resolve these issues##2##4##(2007-4#1)(2013-1#1)
to resolve these##6##3##(1993-12#1)(2005-7#1)(2007-4#1)(2008-7#1)(2008-8#1)(2013-1#1)
to resolve this problem##2##4##(2011-1#1)(2013-8#1)
to resolve this serious##2##4##(1995-5#1)(2013-1#1)
to resolve this##9##3##(1995-5#1)(1996-3#1)(1997-4#1)(2006-12#1)(2007-9#1)(2011-1#1)(2013-1#2)(2013-8#1)
to resolve##118##2##(1990-11#1)(1990-12#2)(1990-6#1)(1990-8#2)(1991-7#2)(1992-3#1)(1993-12#1)(1993-7#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-5#2)(1995-9#1)(1996-3#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#2)(2005-10#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#8)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#5)(2009-10#1)(2009-2#3)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#3)(2010-5#1)(2011-1#5)(2011-2#1)(2013-1#3)(2013-7#2)(2013-8#1)
to resolving trade disputes##2##4##(2005-5#2)
to resolving##5##2##(2005-5#2)(2007-8#2)(2008-10#1)
to resonantly##2##2##(2007-12#2)
to resorb##3##2##(1991-11#1)(1993-9#1)(2005-3#1)
to resort to##6##3##(1990-5#1)(1993-12#1)(1996-8#1)(2007-12#1)(2008-8#1)(2009-12#1)
to resource##2##2##(2008-9#1)(2011-12#1)
to respect##4##2##(2005-7#2)(2006-9#1)(2007-2#1)
to respective##3##2##(2008-1#1)(2008-11#1)(2009-5#1)
to respectively##3##2##(1991-7#1)(1994-5#1)(2007-12#1)
to respiratory distress##4##3##(1993-5#1)(2012-2#2)(2013-1#1)
to respiratory insufficiency##2##3##(1995-7#1)(2010-12#1)
to respiratory##27##2##(1990-9#1)(1992-4#1)(1993-5#1)(1993-8#1)(1994-3#2)(1995-7#2)(1996-1#1)(1996-4#1)(1997-7#1)(2006-2#1)(2007-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2012-2#3)(2013-1#3)
to respond adequately##2##3##(1990-12#1)(2007-11#1)
to respond appropriately##2##3##(2007-2#1)(2008-12#1)
to respond at##2##3##(1995-8#1)(2010-4#1)
to respond better to##2##4##(1992-1#1)(2013-1#1)
to respond in##3##3##(1995-2#1)(2007-12#1)(2008-10#1)
to respond more to##2##4##(2008-11#2)
to respond positively##2##3##(1992-3#1)(2012-3#1)
to respond to a wide##2##5##(1995-2#1)(2008-7#1)
to respond to a##10##4##(1990-11#1)(1992-8#1)(1993-3#2)(1995-2#1)(2006-8#1)(2008-2#1)(2008-7#2)(2012-1#1)
to respond to antigen##3##4##(1992-5#1)(2007-3#1)(2008-3#1)
to respond to environmental##2##4##(2007-3#1)(2012-3#1)
to respond to growth##2##4##(1992-9#1)(2008-4#1)
to respond to mitogens##2##4##(1991-12#1)(1992-2#1)
to respond to new##3##4##(2008-1#1)(2011-2#1)(2012-12#1)
to respond to other modalities of##2##6##(2006-8#2)
to respond to other##4##4##(2006-8#3)(2007-12#1)
to respond to stress##2##4##(1994-11#1)(2008-8#1)
to respond to the needs of the##2##7##(1995-1#1)(2007-9#1)
to respond to the##21##4##(1991-12#1)(1991-3#1)(1994-12#1)(1995-1#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-3#2)(1997-4#1)(2006-10#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#1)
to respond to these##9##4##(1991-12#1)(1994-12#1)(1995-1#1)(1996-4#1)(2008-10#3)(2008-2#1)(2010-12#1)
to respond to this problem##2##5##(1992-9#1)(2006-10#1)
to respond to this##4##4##(1992-9#1)(2006-10#1)(2007-7#1)(2008-10#1)
to respond to##143##3##(1990-11#2)(1990-2#2)(1990-8#1)(1990-9#1)(1991-10#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-3#2)(1994-11#1)(1994-12#6)(1994-3#3)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-11#2)(1996-2#2)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(2005-5#1)(2006-10#4)(2006-2#1)(2006-6#1)(2006-8#7)(2007-10#1)(2007-12#2)(2007-3#3)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#6)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#3)(2010-12#2)(2010-3#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#2)
to respond with##3##3##(2008-9#1)(2009-8#1)(2010-2#1)
to respond without prejudice##2##4##(2008-11#2)
to respond##188##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-8#2)(1990-9#1)(1991-10#3)(1991-12#4)(1991-2#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-3#2)(1994-11#1)(1994-12#6)(1994-3#3)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-8#2)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(2005-5#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#8)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#3)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#7)(2008-11#7)(2008-12#4)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#4)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#3)(2012-12#6)(2012-2#4)(2012-3#3)(2013-1#1)
to response bias##2##3##(2007-9#1)(2012-2#1)
to response to##2##3##(2004-2#1)(2008-7#1)
to response##16##2##(1993-7#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-1#2)(1996-9#1)(2004-2#1)(2006-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2012-2#1)
to responses of##2##3##(1990-4#1)(1996-9#1)
to responses##5##2##(1990-4#1)(1991-5#1)(1996-9#1)(2006-6#1)(2008-8#1)
to responsiveness to##2##3##(1992-12#1)(1995-12#1)
to rest##7##2##(1993-12#1)(1996-1#1)(1997-7#1)(2005-10#1)(2008-9#1)(2013-1#2)
to restart##3##2##(2011-2#3)
to restenosis##2##2##(1996-8#1)(2006-10#1)
to resting##4##2##(1994-10#1)(1994-12#1)(1997-4#1)(1997-7#1)
to restoration of##5##3##(1993-8#1)(1995-8#1)(1997-5#1)(2008-2#1)(2012-3#1)
to restoration##7##2##(1993-8#1)(1995-8#1)(1997-5#1)(2008-2#1)(2011-2#1)(2012-3#1)(2013-7#1)
to restore a##3##3##(1993-9#1)(2007-11#1)(2008-3#1)
to restore and##4##3##(2007-12#1)(2008-4#1)(2008-5#1)(2010-12#1)
to restore brain##2##3##(2006-12#1)(2008-1#1)
to restore diploidy##2##3##(2008-9#2)
to restore elbow flexion##3##4##(2008-9#3)
to restore or##2##3##(1997-2#1)(2012-1#1)
to restore respiration##2##3##(1996-7#2)
to restore sinus rhythm##2##4##(2007-9#1)(2008-7#1)
to restore that order##2##4##(2007-1#2)
to restore the continuity##2##4##(1993-2#1)(2007-8#1)
to restore the##25##3##(1990-6#1)(1993-2#1)(1993-3#1)(1994-10#1)(1995-6#1)(2004-3#1)(2005-1#1)(2007-12#1)(2007-5#2)(2007-8#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-8#1)(2008-9#2)(2009-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
to restore vision##3##3##(1997-3#1)(2009-12#1)(2009-8#1)
to restore##97##2##(1990-11#1)(1990-2#1)(1990-6#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-9#1)(1995-6#2)(1996-3#2)(1996-7#2)(1997-2#1)(1997-3#1)(1997-8#1)(2004-3#1)(2005-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-1#3)(2007-11#6)(2007-12#2)(2007-3#1)(2007-5#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#7)(2009-12#1)(2009-3#1)(2009-7#2)(2009-8#2)(2010-12#1)(2010-2#1)(2011-2#5)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#1)
to restrain the##2##3##(2010-8#1)(2013-1#1)
to restrain##5##2##(1995-9#1)(1996-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
to restraint##5##2##(1993-12#1)(1993-2#1)(1995-12#2)(2008-7#1)
to restrict administration of##2##4##(1992-11#2)
to restrict the##6##3##(1992-9#1)(2006-10#1)(2008-10#1)(2008-11#1)(2010-2#1)(2012-2#1)
to restrict their##2##3##(1996-5#1)(2010-6#1)
to restrict##18##2##(1991-3#1)(1992-11#2)(1992-9#1)(1993-12#1)(1996-5#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2010-2#1)(2010-6#1)(2011-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
to restricted##2##2##(2008-10#1)(2010-4#1)
to restriction fragment length##2##4##(1994-11#1)(2008-10#1)
to restriction##5##2##(1994-11#1)(2007-7#1)(2008-10#1)(2008-12#1)(2009-5#1)
to restrictions on##2##3##(2007-2#1)(2008-5#1)
to restrictions##4##2##(1992-3#1)(2007-2#1)(2008-4#1)(2008-5#1)
to restructure the##2##3##(1994-1#1)(1995-1#1)
to restructure##6##2##(1994-1#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-3#1)
to restructuring##5##2##(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-3#1)
to result from a##7##4##(1994-3#1)(1994-8#1)(1995-11#1)(1995-8#1)(1997-1#1)(2007-8#1)(2010-12#1)
to result from the interaction of##3##6##(1994-3#1)(2005-8#1)(2008-9#1)
to result from the##18##4##(1990-11#1)(1990-2#1)(1992-3#1)(1994-3#1)(1997-4#1)(2005-12#1)(2005-8#1)(2005-9#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2013-8#1)
to result from##53##3##(1990-11#1)(1990-12#1)(1990-2#1)(1991-2#2)(1991-9#1)(1992-3#2)(1992-6#1)(1993-11#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#3)(2005-12#1)(2005-8#1)(2005-9#2)(2006-10#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-3#1)(2010-12#2)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
to result in a##13##4##(1993-7#1)(1994-11#1)(1994-3#1)(1994-9#1)(1997-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2009-6#1)(2009-9#1)
to result in an increase of##2##6##(1994-9#1)(2008-10#1)
to result in an##4##4##(1994-9#1)(1997-8#1)(2008-10#1)(2010-11#1)
to result in high##2##4##(2008-10#2)
to result in increased##2##4##(2006-6#1)(2012-3#1)
to result in the##12##4##(1990-7#1)(1992-3#1)(1993-6#1)(1995-8#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-12#1)(2009-10#1)(2009-2#1)
to result in##70##3##(1990-12#1)(1990-7#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-9#2)(1995-2#1)(1995-8#2)(1996-4#1)(1996-5#1)(1997-1#1)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#4)(2006-11#2)(2006-12#1)(2006-6#1)(2007-11#3)(2007-12#2)(2007-5#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
to result##132##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-7#1)(1991-2#2)(1991-3#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#3)(1992-6#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-7#1)(1994-11#2)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#3)(1995-11#1)(1995-2#2)(1995-6#2)(1995-8#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-4#5)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-8#1)(2005-9#2)(2006-10#5)(2006-11#2)(2006-12#1)(2006-6#1)(2007-11#3)(2007-12#3)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#11)(2008-11#5)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#2)(2009-6#1)(2009-9#2)(2010-10#2)(2010-11#1)(2010-12#3)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
to results from##6##3##(1996-3#1)(2007-12#1)(2008-1#1)(2008-7#1)(2010-4#1)(2012-3#1)
to results obtained##6##3##(1990-2#1)(2008-10#3)(2008-6#1)(2010-2#1)
to results of##4##3##(1990-6#1)(1991-6#1)(2006-10#1)(2008-6#1)
to results seen in##2##4##(1990-4#1)(2007-12#1)
to results that##4##3##(2008-10#1)(2008-3#2)(2013-8#1)
to results with##4##3##(1992-6#1)(1992-8#1)(1993-11#1)(2008-10#1)
to results##34##2##(1990-2#1)(1990-4#1)(1990-6#1)(1991-6#1)(1992-6#1)(1992-8#1)(1993-11#1)(1995-11#1)(1996-3#1)(2006-10#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#1)(2009-5#1)(2010-1#1)(2010-2#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
to resume the##3##3##(2006-10#1)(2013-1#2)
to resume tobacco use##2##4##(2007-12#2)
to resume tobacco##4##3##(2007-12#4)
to resume##16##2##(1990-2#1)(1994-8#1)(2005-10#1)(2006-10#1)(2007-12#4)(2008-5#2)(2010-1#1)(2011-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
to resuscitate##2##2##(2008-10#1)(2010-7#1)
to retain and##3##3##(1992-12#1)(2008-10#1)(2013-7#1)
to retain its##2##3##(1994-3#1)(2010-4#1)
to retain the##14##3##(1990-2#1)(1991-9#1)(1994-11#1)(1994-2#1)(1997-1#1)(1997-6#1)(1997-7#1)(2006-12#1)(2006-3#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-7#1)
to retain their##3##3##(1996-1#1)(2006-10#1)(2008-9#1)
to retain##49##2##(1990-2#1)(1990-6#1)(1991-9#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-11#2)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#1)(1995-2#1)(1995-9#1)(1996-1#1)(1997-1#1)(1997-6#1)(1997-7#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-3#1)(2013-1#3)(2013-7#1)
to retard the##3##3##(2005-11#1)(2008-5#1)(2010-12#1)
to retard##10##2##(1993-12#1)(1994-6#2)(2004-11#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2010-5#1)
to retarded##2##2##(1990-5#1)(1996-8#1)
to retention##4##2##(1996-12#1)(1996-9#1)(2008-10#1)(2008-8#1)
to rethink the##3##3##(1991-12#1)(2011-3#1)(2012-12#1)
to rethink##9##2##(1991-12#1)(2006-6#1)(2007-9#2)(2009-8#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-12#1)
to retinal##5##2##(1993-8#1)(2009-6#2)(2011-1#1)(2012-12#1)
to retinoic acid (RA)##3##4##(1991-9#1)(1995-10#1)(1996-5#1)
to retinoic acid##15##3##(1990-12#2)(1991-2#1)(1991-9#2)(1992-2#1)(1992-8#1)(1993-12#1)(1993-4#1)(1994-10#1)(1994-12#1)(1995-10#1)(1996-11#1)(1996-5#1)(2008-9#1)
to retinoids##4##2##(1993-12#1)(1994-8#1)(2006-12#2)
to retinol##3##2##(2008-5#2)(2008-8#1)
to retinyl##2##2##(1994-12#1)(2008-8#1)
to retract##2##2##(2010-9#1)(2013-1#1)
to retrieval of##3##3##(2006-3#1)(2009-3#1)(2010-8#1)
to retrieve a##4##3##(1995-6#1)(2008-2#2)(2008-8#1)
to retrieve aerosol properties from lidar backscatter measurements##2##8##(2008-3#2)
to retrieve all##2##3##(1990-12#1)(2010-6#1)
to retrieve an##2##3##(2008-2#2)
to retrieve narrow and broad terms within the Standard MedDRA Query (SMQ) related to 'anaphylactic shock' and the terms from the High Level Term (HLT) grouping related to 'anaphylaxis'##2##29##(2013-1#2)
to retrieve ozone##2##3##(2008-3#2)
to retrieve the optical##2##4##(2008-2#1)(2008-3#1)
to retrieve the particle##2##4##(2008-3#2)
to retrieve the##22##3##(1993-12#1)(1997-3#1)(2008-2#7)(2008-3#7)(2008-4#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
to retrieve vertical##2##3##(2008-3#2)
to retrieve##70##2##(1990-12#2)(1991-1#1)(1993-12#2)(1993-7#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-1#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#16)(2008-3#21)(2008-4#1)(2008-7#4)(2008-8#2)(2009-6#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#5)
to retrograde##3##2##(1991-5#1)(1992-10#1)(2007-8#1)
to retrospective##2##2##(2008-1#1)(2010-1#1)
to retrospectively##4##2##(1992-12#1)(2008-6#1)(2011-2#1)(2012-1#1)
to return for##5##3##(1993-6#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-9#1)
to return of##2##3##(2012-12#2)
to return the##7##3##(1994-8#1)(1995-5#1)(2006-3#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-5#1)
to return their##2##3##(1995-3#1)(2008-6#1)
to return to normal##4##4##(1993-11#1)(1993-2#1)(2006-6#1)(2012-12#1)
to return to the##4##4##(2008-10#1)(2008-5#1)(2009-10#1)(2010-7#1)
to return to their##6##4##(1990-8#1)(1992-5#1)(2005-7#1)(2008-7#1)(2010-3#1)(2011-2#1)
to return to work##4##4##(1993-12#1)(2008-1#1)(2009-3#1)(2012-12#1)
to return to##34##3##(1990-8#1)(1991-10#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-3#1)(2005-7#1)(2006-11#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#2)(2009-6#1)(2010-3#1)(2010-7#1)(2011-2#3)(2012-12#2)(2013-7#1)
to return##63##2##(1990-8#1)(1991-10#2)(1992-5#1)(1993-1#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#2)(2007-11#3)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-5#2)(2009-6#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#5)(2012-12#4)(2013-7#1)
to reuse##2##2##(2007-7#1)(2008-12#1)
to revamp##2##2##(1994-10#1)(1995-5#1)
to revascularization##4##2##(1995-10#1)(2006-10#1)(2007-8#1)(2009-7#1)
to revascularize##4##2##(1990-4#1)(2006-11#1)(2008-9#2)
to reveal a##7##3##(1997-2#1)(2006-6#1)(2007-11#1)(2007-5#1)(2008-3#1)(2008-7#1)(2013-1#1)
to reveal an##2##3##(2006-8#1)(2008-10#1)
to reveal any##11##3##(1993-5#1)(1995-3#1)(2007-10#1)(2007-7#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-6#1)(2012-12#1)(2012-3#1)
to reveal duodenal##2##3##(2008-4#1)(2011-2#1)
to reveal effects##2##3##(2008-10#1)(2008-9#1)
to reveal mechanisms##2##3##(2008-11#1)(2010-7#1)
to reveal optical##2##3##(2007-11#1)(2008-3#1)
to reveal some##3##3##(1990-8#1)(1993-5#1)(2009-3#1)
to reveal structural##2##3##(1990-4#1)(2007-12#1)
to reveal that the##2##4##(1995-11#1)(2013-8#1)
to reveal that##3##3##(1995-11#1)(2007-11#1)(2013-8#1)
to reveal the##32##3##(1990-2#1)(1991-11#1)(1991-8#1)(1994-6#1)(1995-5#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)
to reveal whether the##2##4##(2006-8#1)(2008-5#1)
to reveal whether##5##3##(2006-8#1)(2008-5#1)(2011-2#1)(2012-1#1)(2012-11#1)
to reveal##128##2##(1990-10#1)(1990-2#1)(1990-4#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-8#1)(1993-5#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-2#1)(1997-2#1)(1997-3#2)(1997-7#2)(1997-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#3)(2007-2#2)(2007-5#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#13)(2008-11#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#3)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#2)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#2)
to reverse the inhibitory effect of##2##6##(1992-6#1)(1996-8#1)
to reverse the transformed morphology of Rat1 cells##2##8##(1996-4#2)
to reverse the trend##2##4##(1991-3#1)(1992-8#1)
to reverse the##23##3##(1991-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1995-12#1)(1996-4#2)(1996-5#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-8#1)(2005-10#1)(2005-9#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
to reverse these##3##3##(2006-9#1)(2008-1#1)(2012-2#1)
to reverse this##3##3##(1991-3#1)(1991-6#1)(1997-5#1)
to reverse##65##2##(1990-2#1)(1990-9#1)(1991-3#2)(1991-6#1)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-4#2)(1996-5#2)(1996-7#1)(1996-8#2)(1996-9#2)(1997-3#1)(1997-5#2)(1997-8#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2008-1#3)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-11#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)
to reversed-phase##2##2##(1991-3#1)(2008-10#1)
to reversible##6##2##(1992-6#1)(1995-7#1)(2007-2#1)(2008-10#2)(2012-2#1)
to reversibly##3##2##(1992-4#1)(1996-12#1)(2008-11#1)
to revert##5##2##(1994-8#2)(2006-4#1)(2008-10#1)(2012-2#1)
to review a##3##3##(1996-12#1)(1997-3#1)(2008-11#1)
to review all##5##3##(2008-2#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
to review and discuss the##2##5##(1996-2#1)(2005-8#1)
to review and discuss##4##4##(1996-2#1)(2005-8#1)(2012-12#2)
to review and##10##3##(1996-2#1)(2005-8#1)(2007-7#1)(2008-1#1)(2012-12#3)(2012-2#1)(2013-1#2)
to review current knowledge##2##4##(2008-8#1)(2010-3#1)
to review current##7##3##(2005-10#1)(2005-8#1)(2008-3#1)(2008-8#1)(2010-3#1)(2011-2#1)(2012-1#1)
to review evidence on##2##4##(2007-8#1)(2008-3#1)
to review evidence##3##3##(2007-8#1)(2008-3#1)(2009-11#1)
to review how##2##3##(2009-3#1)(2010-12#1)
to review our##3##3##(2007-3#1)(2008-1#1)(2012-2#1)
to review recent##5##3##(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)
to review some of the current##2##6##(2008-11#1)(2009-4#1)
to review some of the##4##5##(1993-12#1)(2008-11#1)(2008-4#1)(2009-4#1)
to review some##6##3##(1990-12#1)(1993-12#1)(2008-11#1)(2008-4#1)(2009-4#1)(2012-11#1)
to review the available##2##4##(2006-9#1)(2011-1#1)
to review the clinical##2##4##(2008-9#1)(2011-2#1)
to review the current##3##4##(2006-8#1)(2008-8#1)(2012-2#1)
to review the different##3##4##(2007-11#1)(2007-12#1)(2007-8#1)
to review the evidence##5##4##(1994-11#1)(2008-1#1)(2008-8#1)(2009-10#1)(2010-5#1)
to review the incidence##2##4##(2006-10#1)(2007-5#1)
to review the literature on##6##5##(2006-2#1)(2007-6#3)(2010-3#1)(2013-1#1)
to review the literature##14##4##(1993-5#1)(1997-3#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-6#3)(2008-3#1)(2009-5#1)(2010-3#1)(2011-1#1)(2013-1#2)
to review the management of##2##5##(2008-10#1)(2011-2#1)
to review the progress##2##4##(2008-5#1)(2010-10#1)
to review the published##2##4##(2006-8#1)(2008-3#1)
to review the recent##3##4##(2008-4#1)(2009-1#1)(2013-1#1)
to review the role of##2##5##(2007-2#1)(2010-2#1)
to review the use##2##4##(2008-10#1)(2013-8#1)
to review the##98##3##(1991-12#1)(1991-2#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-3#1)(1997-3#1)(2004-1#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-2#3)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#3)(2007-5#1)(2007-6#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#3)(2009-1#1)(2009-10#2)(2009-5#3)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#2)(2011-7#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
to review their##2##3##(1994-3#1)(2008-3#1)
to review these##2##3##(2007-7#1)(2007-8#1)
to review##197##2##(1990-12#3)(1991-12#1)(1991-2#1)(1991-4#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-7#1)(1994-11#1)(1994-3#2)(1995-6#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-8#1)(1997-3#2)(2004-1#1)(2005-10#2)(2005-4#1)(2005-6#1)(2005-7#2)(2005-8#3)(2006-1#1)(2006-10#5)(2006-2#3)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-2#4)(2007-3#1)(2007-5#1)(2007-6#3)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#5)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#10)(2008-9#3)(2009-1#1)(2009-10#4)(2009-11#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#1)(2011-1#3)(2011-12#3)(2011-2#5)(2011-7#1)(2012-1#2)(2012-11#2)(2012-12#5)(2012-2#9)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#3)
to reviewers##4##2##(2010-11#1)(2010-12#2)(2013-8#1)
to reviewing##2##2##(2009-10#1)(2009-4#1)
to revise the##3##3##(2006-8#1)(2008-10#1)(2009-2#1)
to revise##7##2##(1993-2#1)(1996-6#1)(2005-12#1)(2006-8#1)(2008-10#1)(2009-2#1)(2012-3#1)
to revised##2##2##(2006-8#1)(2011-2#1)
to revision##4##2##(1993-1#1)(2007-11#1)(2008-8#2)
to revisit the##3##3##(2006-10#1)(2008-3#1)(2012-12#1)
to revisit##7##2##(1997-8#1)(2006-10#1)(2008-3#1)(2008-4#1)(2009-8#1)(2012-1#1)(2012-12#1)
to revive##3##2##(2006-7#1)(2011-12#1)(2012-3#1)
to revolutionize the study##2##4##(2008-4#1)(2011-11#1)
to revolutionize the##8##3##(2006-10#1)(2007-4#1)(2008-4#2)(2008-7#1)(2009-5#1)(2011-11#1)(2013-1#1)
to revolutionize##15##2##(2005-10#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-7#1)(2009-5#2)(2011-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
to reward and##2##3##(1991-3#1)(2007-8#1)
to reward##14##2##(1991-3#1)(1993-12#1)(1993-6#1)(1994-3#1)(1995-2#1)(2007-4#2)(2007-8#2)(2007-9#1)(2008-2#1)(2010-2#1)(2011-1#1)(2012-1#1)
to rewrite##2##2##(2008-7#1)(2009-8#1)
to rhabdomyolysis##2##2##(1997-5#1)(2006-5#1)
to rheumatoid arthritis patients##2##4##(2007-11#1)(2012-2#1)
to rheumatoid arthritis##5##3##(2007-11#1)(2007-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
to rhizosphere##2##2##(2008-10#2)
to rhodopsin##3##2##(1990-12#1)(2012-12#2)
to rhythm disturbances##2##3##(2010-12#2)
to rhythm##4##2##(2008-10#1)(2010-12#3)
to ribose##2##2##(1993-9#1)(1995-1#1)
to ribosomal proteins from other eukaryotes##4##6##(1992-5#1)(1992-8#1)(1994-5#2)
to ribosomal proteins##6##3##(1992-5#1)(1992-8#1)(1993-11#1)(1994-5#2)(1997-4#1)
to ribosomal##9##2##(1992-5#1)(1992-8#1)(1993-11#1)(1994-5#2)(1997-1#2)(1997-4#1)(2006-5#1)
to ribosomes##2##2##(1990-2#1)(1995-6#1)
to rice blast in##2##4##(2008-10#1)(2012-2#1)
to rice blast##7##3##(2008-10#6)(2012-2#1)
to rice telomeric##2##3##(2008-8#2)
to rice##17##2##(1997-4#1)(2005-11#1)(2008-10#10)(2008-8#2)(2009-10#1)(2012-11#1)(2012-2#1)
to rifampicin##5##2##(1990-7#1)(1993-5#1)(1997-2#1)(2008-2#1)(2010-4#1)
to right coronary##2##3##(2007-8#1)(2012-2#1)
to right heart##2##3##(2010-5#1)(2011-2#1)
to right hemisphere##2##3##(1996-2#1)(2012-2#1)
to right ventricular##3##3##(2005-9#1)(2007-8#1)(2011-2#1)
to right##26##2##(1993-7#1)(1995-4#1)(1996-2#2)(2005-9#2)(2006-2#1)(2007-2#1)(2007-8#3)(2007-9#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-1#3)(2011-2#2)(2012-2#4)(2013-1#1)(2013-8#1)
to right-handed##2##2##(1991-5#1)(1995-10#1)
to rigid##5##2##(1992-4#1)(2006-11#1)(2006-6#1)(2008-3#1)(2008-6#1)
to rigid-bar##2##2##(2007-4#2)
to rigidify##2##2##(1994-2#1)(2006-2#1)
to rigor##2##2##(1994-11#1)(1996-11#1)
to rigorous##5##2##(1992-1#1)(2006-10#1)(2008-9#1)(2012-3#2)
to ring##2##2##(2007-11#1)(2008-3#1)
to rise at##3##3##(1996-3#2)(2010-12#1)
to rise in the##2##4##(1995-3#1)(2010-12#1)
to rise in##5##3##(1990-12#1)(1995-3#1)(2010-12#1)(2012-2#1)(2013-8#1)
to rise to##2##3##(1996-11#1)(2013-1#1)
to rise with the##2##4##(1993-3#1)(2013-1#1)
to rise with##3##3##(1993-3#1)(1993-9#1)(2013-1#1)
to rise##35##2##(1990-12#1)(1992-2#1)(1993-3#1)(1993-9#1)(1994-12#2)(1995-10#1)(1995-3#1)(1996-11#1)(1996-3#2)(1996-5#1)(2004-8#1)(2005-8#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-9#1)(2010-12#2)(2010-3#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
to rising concern##2##3##(1997-2#1)(2010-11#1)
to rising##7##2##(1997-2#1)(2004-9#1)(2010-11#1)(2010-7#1)(2010-9#1)(2012-2#1)(2012-6#1)
to risk assessment##4##3##(1996-3#1)(2008-7#1)(2010-12#1)(2010-4#1)
to risk factors in##3##4##(2010-7#1)(2012-11#2)
to risk factors##9##3##(2006-10#1)(2007-12#1)(2008-5#1)(2008-9#1)(2010-7#1)(2010-8#1)(2012-11#2)(2012-2#1)
to risk of large bowel cancer##2##6##(1990-7#2)
to risk of##8##3##(1990-6#1)(1990-7#2)(1994-2#1)(2007-1#1)(2007-7#1)(2008-1#1)(2011-2#1)
to risk stratification##2##3##(2010-6#1)(2012-3#1)
to risk stratify patients##2##4##(2006-10#1)(2010-11#1)
to risk##36##2##(1990-6#2)(1990-7#2)(1991-11#1)(1992-12#1)(1992-3#1)(1994-2#1)(1996-2#1)(1996-3#2)(2006-10#2)(2007-1#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-11#2)(2012-2#1)(2012-3#2)(2013-1#1)
to risk-benefit##2##2##(2006-10#1)(2007-8#1)
to risks in##2##3##(2008-7#1)(2008-9#1)
to risks##5##2##(2007-11#1)(2008-7#2)(2008-9#1)(2012-2#1)
to river water samples##2##4##(2008-10#2)
to river water##3##3##(2008-10#3)
to road traffic accidents##3##4##(1996-11#1)(2007-3#1)(2013-7#1)
to road traffic##5##3##(1996-11#1)(2007-3#1)(2008-10#1)(2010-11#1)(2013-7#1)
to road##8##2##(1996-11#1)(2007-2#1)(2007-3#1)(2008-10#1)(2009-10#1)(2009-7#1)(2010-11#1)(2013-7#1)
to robert##2##2##(2008-3#1)(2011-1#1)
to robot##2##2##(2006-6#1)(2008-1#1)
to robotics##3##2##(2007-12#3)
to rodents##2##2##(1997-5#1)(2008-10#1)
to roles##2##2##(1996-6#1)(2008-12#1)
to roll out##2##3##(2008-11#1)(2012-3#1)
to roll##3##2##(2008-11#1)(2008-7#1)(2012-3#1)
to room temperature##2##3##(2007-12#1)(2008-3#1)
to room##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
to root coverage treatment##2##4##(2013-1#2)
to root##11##2##(1992-12#1)(2008-10#4)(2009-6#1)(2009-8#1)(2010-5#1)(2013-1#3)
to root-knot nematodes##2##3##(2008-10#2)
to roots of##3##3##(2008-10#2)(2011-1#1)
to roots##10##2##(1992-12#1)(2008-10#8)(2011-1#1)
to rosiglitazone##2##2##(2008-1#1)(2010-4#1)
to rotate about the##2##4##(2008-3#2)
to rotate about##3##3##(2008-3#3)
to rotate##10##2##(1991-2#1)(1995-8#1)(1996-1#1)(2007-12#1)(2008-2#1)(2008-3#3)(2008-7#1)(2010-12#1)
to rotation##2##2##(1994-11#1)(2007-11#1)
to roughly##2##2##(1993-3#1)(2012-3#1)
to round##3##2##(1992-4#1)(1997-4#1)(2012-12#1)
to roundabouts##4##2##(2012-12#4)
to route##4##2##(2008-2#3)(2013-7#1)
to routine analyses##4##3##(1995-2#1)(2008-10#2)(2010-5#1)
to routine analysis##2##3##(2008-10#2)
to routine clinical application##2##4##(2007-4#1)(2008-10#1)
to routine clinical##6##3##(1995-2#1)(2005-8#1)(2007-4#1)(2008-10#2)(2008-11#1)
to routine##26##2##(1990-12#1)(1990-3#1)(1992-8#1)(1995-2#2)(1996-2#1)(2004-2#1)(2005-10#1)(2005-8#1)(2007-4#1)(2007-7#3)(2007-9#1)(2008-10#7)(2008-11#1)(2008-7#1)(2010-12#1)(2010-5#1)(2012-2#1)
to routinely detect##2##3##(2007-9#1)(2011-1#1)
to routinely##4##2##(2007-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
to rubella##4##2##(1996-5#1)(2007-2#1)(2010-10#1)(2011-2#1)
to rubisco activase##2##3##(1991-9#2)
to rule on##4##3##(1993-6#1)(1996-5#1)(2007-9#1)(2012-2#1)
to rule out PE##2##4##(2012-2#2)
to rule out a##2##4##(2008-4#1)(2012-3#1)
to rule out any##2##4##(2008-5#1)(2012-2#1)
to rule out some##2##4##(2008-8#1)(2013-8#1)
to rule out the##5##4##(2008-2#1)(2010-5#1)(2011-2#2)(2012-12#1)
to rule out##30##3##(1995-5#1)(1996-12#1)(2005-11#1)(2005-8#1)(2006-2#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#2)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
to rule##37##2##(1993-6#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-4#1)(2005-11#1)(2005-8#1)(2006-2#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#2)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#2)
to rules##3##2##(2008-9#1)(2013-1#2)
to run a##2##3##(1991-9#1)(1993-12#1)
to run the##3##3##(2005-5#1)(2008-4#1)(2012-2#1)
to run##28##2##(1991-9#2)(1992-8#1)(1993-12#1)(1994-6#1)(1997-8#1)(2005-10#2)(2005-5#1)(2005-9#1)(2007-8#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-8#1)(2012-2#1)
to runoff##2##2##(2008-5#1)(2011-2#1)
to rupture and##3##3##(1992-12#1)(1996-9#1)(2012-2#1)
to rupture of the##3##4##(2007-4#1)(2007-8#1)(2013-7#1)
to rupture of##8##3##(1995-5#2)(1996-3#1)(2007-4#1)(2007-8#1)(2008-10#1)(2012-1#1)(2013-7#1)
to rupture##15##2##(1992-12#1)(1995-5#2)(1996-3#1)(1996-9#1)(2006-11#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#1)
to ruptured##3##2##(2006-7#1)(2007-10#1)(2008-7#1)
to rural communities##2##3##(2010-7#1)(2013-1#1)
to rural settings##2##3##(2007-3#1)(2008-8#1)
to rural##15##2##(1991-1#1)(1993-2#2)(1994-1#2)(1994-3#1)(1996-3#1)(2007-12#1)(2007-3#1)(2008-8#1)(2010-10#1)(2010-7#1)(2012-12#1)(2013-1#2)
to ryanodine##2##2##(1993-12#1)(1994-8#1)
to sacrifice the##3##3##(2008-12#1)(2008-2#1)(2008-4#1)
to sacrifice##10##2##(1992-11#1)(1995-2#1)(1995-7#1)(1996-2#1)(2004-9#1)(2006-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)
to safe and##2##3##(2008-8#1)(2012-11#1)
to safe##11##2##(1996-8#1)(2008-10#1)(2008-8#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-3#2)(2013-1#1)
to safeguard the##3##3##(1994-4#1)(2007-1#1)(2012-2#1)
to safeguard##10##2##(1994-2#1)(1994-4#1)(2005-11#1)(2006-11#1)(2006-9#1)(2007-1#1)(2007-9#1)(2008-11#1)(2011-1#1)(2012-2#1)
to safeguarding##2##2##(1991-12#1)(2009-10#1)
to safely and##2##3##(2010-10#1)(2011-2#1)
to safely exclude##2##3##(2005-10#2)
to safely##13##2##(1997-6#1)(2005-10#2)(2006-10#1)(2006-11#1)(2006-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-5#1)(2010-10#1)(2010-11#1)(2011-2#1)
to safer##2##2##(2008-5#1)(2012-2#1)
to safety and##3##3##(1991-3#1)(2010-4#1)(2011-2#1)
to safety in##2##3##(2006-6#1)(2008-8#1)
to safety##10##2##(1991-3#1)(1991-5#1)(1996-12#1)(2006-6#1)(2007-11#1)(2008-4#1)(2008-8#1)(2010-4#1)(2010-6#1)(2011-2#1)
to saikogenin E##2##3##(2008-11#2)
to salary##2##2##(1991-12#1)(1995-3#1)
to salbutamol##2##2##(1995-1#1)(2007-11#1)
to salicylic acid##3##3##(2006-10#1)(2008-5#1)(2008-8#1)
to saline controls##4##3##(1992-5#1)(1995-12#1)(2008-4#1)(2012-3#1)
to saline or##2##3##(1993-1#1)(1995-11#1)
to saline##12##2##(1992-5#1)(1993-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(2008-10#1)(2008-4#1)(2009-10#1)(2009-6#1)(2009-8#1)(2012-3#1)(2013-8#1)
to salinity##7##2##(1997-6#1)(2004-2#1)(2008-12#2)(2008-5#2)(2013-1#1)
to salivary gland##2##3##(1994-7#1)(2008-8#1)
to salt stress in bryophytes##2##5##(2009-6#2)
to salt stress##6##3##(1997-8#1)(2008-8#1)(2009-6#4)
to salt##15##2##(1993-8#1)(1993-9#1)(1996-5#1)(1997-8#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#5)(2013-1#2)
to salvage chemotherapy##2##3##(2008-1#1)(2008-6#1)
to salvage radiation therapy##2##4##(2006-9#2)
to salvage the##2##3##(2007-8#1)(2011-1#1)
to salvage##13##2##(2006-9#2)(2007-8#3)(2008-1#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-9#1)(2010-4#1)(2011-1#1)(2013-1#1)
to same##3##2##(1996-6#1)(2008-12#1)(2009-6#1)
to sample all##2##3##(2008-5#1)(2012-12#1)
to sample size##4##3##(2008-10#2)(2012-2#1)(2013-1#1)
to sample the##5##3##(2008-10#2)(2008-2#2)(2008-7#1)
to sample##52##2##(1990-10#1)(1991-11#1)(1994-2#1)(1995-2#1)(1995-5#2)(1995-9#1)(1996-1#1)(2006-10#1)(2007-8#2)(2008-1#1)(2008-10#16)(2008-11#2)(2008-2#4)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
to samples from##3##3##(1991-5#1)(1994-2#1)(2008-11#1)
to samples of##3##3##(1995-2#1)(2008-10#2)
to samples prepared in##2##4##(2008-10#2)
to samples with##2##3##(1991-9#1)(2008-10#1)
to samples##20##2##(1990-2#1)(1991-5#1)(1991-9#1)(1994-2#1)(1995-1#1)(1995-2#1)(2005-11#1)(2006-2#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-5#1)
to sampling##9##2##(1996-12#2)(2008-10#5)(2008-3#1)(2013-7#1)
to sap-sucking insects##2##3##(2006-12#2)
to sap-sucking##3##2##(2006-12#2)(2013-7#1)
to saponin##2##2##(1997-2#1)(2005-10#1)
to satellite##2##2##(2005-11#1)(2013-8#1)
to satisfaction with##3##3##(2006-1#1)(2007-12#2)
to satisfactorily##3##2##(2007-12#1)(2008-10#2)
to satisfactory results##2##3##(2005-11#1)(2008-2#1)
to satisfactory##6##2##(1996-8#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-2#1)
to satisfy the needs of##3##5##(1995-1#1)(2008-2#1)(2013-7#1)
to satisfy the##18##3##(1991-4#1)(1994-2#1)(1995-1#1)(1996-1#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
to satisfy##40##2##(1991-4#1)(1993-1#1)(1994-2#2)(1994-3#1)(1995-1#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-3#1)(2005-12#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)
to saturate the##4##3##(1991-2#1)(1991-5#1)(2008-3#1)(2009-11#1)
to saturate##7##2##(1991-2#1)(1991-5#1)(1991-8#1)(2008-10#1)(2008-3#2)(2009-11#1)
to saturated fat##2##3##(2010-4#2)
to saturated fatty acid##2##4##(2008-12#1)(2010-4#1)
to saturated fatty##4##3##(1997-7#1)(2008-12#1)(2010-4#2)
to saturated##9##2##(1995-7#1)(1996-5#1)(1997-7#1)(2008-12#1)(2010-4#4)(2011-1#1)
to saturation##2##2##(1992-4#1)(1993-7#1)
to save lives and##2##4##(1993-9#1)(2010-8#1)
to save lives##6##3##(1991-3#1)(1993-9#1)(2006-10#1)(2010-11#1)(2010-8#1)(2013-1#1)
to save the##6##3##(1990-5#1)(1994-7#1)(1997-7#1)(2007-2#1)(2008-9#1)(2010-8#1)
to save time and##2##4##(2008-10#1)(2008-5#1)
to save time##5##3##(1993-10#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)
to save##39##2##(1990-2#1)(1990-4#1)(1990-5#1)(1991-3#1)(1991-8#1)(1992-10#1)(1992-11#1)(1993-10#1)(1993-9#1)(1994-2#2)(1994-7#1)(1996-11#1)(1996-12#2)(1997-4#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-9#1)(2010-11#1)(2010-8#2)(2011-2#1)(2012-11#1)(2013-1#3)
to say about##2##3##(1992-8#1)(2012-2#1)
to say that the##2##4##(2008-7#1)(2009-6#1)
to say that##5##3##(1991-3#1)(1996-11#1)(2007-9#1)(2008-7#1)(2009-6#1)
to say the##3##3##(1993-5#1)(2008-10#1)(2011-2#1)
to say they would##2##4##(2010-2#2)
to say##23##2##(1990-4#1)(1991-3#1)(1992-8#1)(1993-5#1)(1994-11#1)(1994-7#1)(1996-11#1)(2006-1#1)(2006-10#2)(2006-4#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#2)(2009-6#1)(2010-2#2)(2011-2#1)(2012-2#1)
to scab##4##2##(2008-10#4)
to scale and summarize the enormous amount of data collected and to visualize the degradations or improvements in multiple organ systems in real time##2##24##(2013-1#2)
to scale and##3##3##(2008-2#1)(2013-1#2)
to scale the##2##3##(2007-12#1)(2008-3#1)
to scale up##3##3##(2008-11#2)(2008-7#1)
to scale##16##2##(1991-1#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-2#2)(2008-3#3)(2008-7#1)(2010-2#1)(2010-8#1)(2013-1#2)
to scale-up the##2##3##(2008-11#2)
to scale-up##4##2##(2008-11#2)(2009-2#1)(2013-1#1)
to scaling up##2##3##(2008-4#2)
to scaling##5##2##(2008-3#1)(2008-4#2)(2008-8#1)(2013-7#1)
to scan##11##2##(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-7#3)(2008-9#1)
to scanning##2##2##(2008-11#1)(2011-7#1)
to scaphoid##2##2##(2006-3#1)(2008-9#1)
to scar formation##2##3##(2006-7#1)(2012-12#1)
to scarce##3##2##(1996-2#1)(2007-7#1)(2011-2#1)
to scattered light##2##3##(2008-3#1)(2008-4#1)
to scattering##10##2##(2007-12#2)(2008-2#3)(2008-3#4)(2011-1#1)
to scavenge##11##2##(1992-5#1)(1993-4#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-8#1)(2005-7#1)(2009-8#1)(2012-12#1)
to schedule patient##2##3##(1996-1#1)(2013-1#1)
to schedule##8##2##(1995-6#1)(1996-1#2)(2006-10#1)(2008-5#1)(2010-2#1)(2013-1#2)
to scheduled##2##2##(2010-4#1)(2013-1#1)
to schistosomiasis##4##2##(1994-3#1)(1996-12#2)(2006-10#1)
to schizophrenia##10##2##(1995-11#2)(1996-7#1)(1997-5#2)(1997-8#2)(2010-12#1)(2012-1#1)(2012-3#1)
to school##16##2##(1996-1#1)(1996-8#1)(2004-8#1)(2005-10#1)(2006-5#1)(2007-1#1)(2007-2#1)(2008-1#1)(2008-7#1)(2009-9#1)(2010-5#2)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
to schools and##2##3##(2008-9#1)(2010-5#1)
to schools##3##2##(2008-10#1)(2008-9#1)(2010-5#1)
to science and##2##3##(2005-7#1)(2007-8#1)
to science##12##2##(1990-8#1)(2005-7#1)(2006-10#1)(2006-4#2)(2007-3#1)(2007-8#1)(2007-9#2)(2009-4#1)(2011-2#1)(2013-1#1)
to scientific##15##2##(1992-5#1)(1992-6#1)(1993-1#1)(1994-6#1)(1997-6#1)(2006-7#1)(2007-10#1)(2007-4#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
to scientists and##3##3##(1997-8#1)(2005-7#1)(2008-10#1)
to scientists##8##2##(1997-8#1)(2005-7#1)(2005-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2013-7#1)
to scoliosis##2##2##(2007-8#2)
to score##4##2##(1997-3#1)(2008-7#1)(2008-8#1)(2013-7#1)
to scoring##2##2##(1995-2#1)(2008-1#1)
to scrapie infection##4##3##(2006-8#4)
to screen a human##4##4##(1993-11#1)(1993-7#1)(1994-12#1)(1997-4#1)
to screen a##14##3##(1990-2#1)(1990-4#1)(1990-6#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-7#1)(1994-12#1)(1994-6#1)(1997-4#1)(2007-2#1)(2008-4#1)(2010-2#1)(2013-1#1)
to screen an##3##3##(1996-6#1)(2008-8#1)(2013-1#1)
to screen and##3##3##(2008-10#1)(2008-12#1)(2011-1#1)
to screen blood##3##3##(2008-1#2)(2013-1#1)
to screen cDNA libraries##3##4##(2008-2#2)(2008-4#1)
to screen for CYP2D6##2##4##(2010-12#2)
to screen for depression among##2##5##(2006-10#1)(2007-9#1)
to screen for mutations##2##4##(2005-12#1)(2006-10#1)
to screen for such##2##4##(1991-11#1)(2012-2#1)
to screen for##39##3##(1991-11#1)(1991-3#1)(1992-11#1)(1994-7#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-2#1)(2005-12#1)(2006-10#2)(2007-2#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#1)(2010-12#2)(2010-5#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#1)
to screen patients for##2##4##(1993-9#1)(2006-12#1)
to screen patients##3##3##(1993-9#1)(1994-8#1)(2006-12#1)
to screen the##9##3##(1996-8#1)(1996-9#1)(1997-8#1)(2005-11#1)(2007-5#1)(2007-7#1)(2008-8#2)(2010-12#1)
to screen those##3##3##(2008-3#1)(2010-12#1)(2013-8#1)
to screen##127##2##(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1991-11#1)(1991-3#1)(1992-11#2)(1992-8#1)(1993-11#3)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-3#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-8#1)(2005-11#3)(2005-12#1)(2006-10#3)(2006-12#1)(2007-2#2)(2007-5#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#11)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#8)(2008-7#2)(2008-8#6)(2008-9#6)(2009-11#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#2)
to screening and##3##3##(2008-4#1)(2009-7#1)(2011-1#1)
to screening delays among AAW##2##5##(2008-4#2)
to screening delays##3##3##(2008-4#3)
to screening for##2##3##(2008-4#1)(2011-2#1)
to screening is##2##3##(1995-9#1)(2008-10#1)
to screening the##2##3##(1990-11#1)(2008-10#1)
to screening##23##2##(1990-11#1)(1994-4#1)(1995-9#1)(1997-1#2)(2007-4#1)(2008-10#2)(2008-11#3)(2008-4#6)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
to scrutinise the##2##3##(2005-7#1)(2011-1#1)
to scrutinise##3##2##(1997-6#1)(2005-7#1)(2011-1#1)
to scrutiny##2##2##(2008-11#2)
to sea water##3##3##(2008-10#2)(2008-5#1)
to sea##8##2##(1995-3#1)(1995-7#1)(2007-9#1)(2008-10#2)(2008-5#2)(2012-2#1)
to seal the##3##3##(2008-10#1)(2012-3#1)(2013-8#1)
to seal##5##2##(1997-4#1)(2008-10#1)(2010-8#1)(2012-3#1)(2013-8#1)
to search a##3##3##(2008-12#1)(2008-9#2)
to search engines##2##3##(2007-2#2)
to search for a##2##4##(1995-10#1)(2008-4#1)
to search for new##5##4##(1991-12#1)(2007-11#1)(2008-10#1)(2009-11#1)(2013-1#1)
to search for the presence of##2##6##(1996-2#1)(2008-7#1)
to search for the##12##4##(1996-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-12#2)(2010-4#1)(2011-1#1)(2012-12#1)(2013-8#1)
to search for##54##3##(1991-1#1)(1991-12#1)(1992-2#1)(1992-6#1)(1995-10#1)(1995-6#1)(1996-2#1)(1997-1#1)(1997-6#1)(2005-3#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#2)(2009-3#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#4)(2013-8#2)
to search the database##3##4##(1991-12#1)(1993-8#1)(2008-4#1)
to search the##10##3##(1991-12#2)(1993-8#1)(1997-6#1)(2008-4#3)(2008-8#1)(2009-12#1)(2013-1#1)
to search##95##2##(1991-1#1)(1991-12#3)(1991-2#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-6#1)(1993-8#1)(1994-3#2)(1995-10#1)(1995-6#1)(1996-2#1)(1997-1#1)(1997-6#2)(2005-3#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#5)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#9)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#5)(2009-11#1)(2009-12#3)(2009-3#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#7)(2013-8#3)
to season##3##2##(1996-8#1)(2007-6#1)(2008-10#1)
to seasonal##9##2##(2008-10#2)(2008-5#2)(2008-8#1)(2011-1#1)(2012-2#2)(2013-8#1)
to seasonality##3##2##(2008-5#1)(2009-4#1)(2011-2#1)
to seawater##6##2##(2008-10#2)(2008-3#1)(2008-5#1)(2010-4#1)(2011-1#1)
to second order in##2##4##(2008-3#2)
to second order##6##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)
to second##16##2##(1995-6#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2011-12#1)(2012-12#1)(2013-1#2)
to second-order##3##2##(2007-11#1)(2007-12#1)(2008-1#1)
to secondary infection##3##3##(2008-1#1)(2008-10#2)
to secondary##24##2##(1990-7#1)(1993-12#1)(1995-4#1)(1997-6#2)(2006-10#1)(2006-11#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-7#1)(2011-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
to secrete human##3##3##(2008-11#1)(2008-5#2)
to secrete insulin##3##3##(1990-8#1)(2008-1#1)(2010-10#1)
to secrete##34##2##(1990-11#1)(1990-8#1)(1992-3#1)(1992-8#1)(1993-9#1)(1994-5#1)(1995-8#1)(1996-10#1)(1996-4#1)(1997-4#2)(2006-12#1)(2006-7#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-5#2)(2008-8#3)(2008-9#1)(2009-2#1)(2009-7#1)(2010-10#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
to secreted##4##2##(1991-12#1)(1996-11#1)(2006-10#1)(2008-4#1)
to secretion of cytokines##2##4##(1997-4#1)(2010-9#1)
to secretion of##5##3##(1990-6#1)(1992-3#1)(1997-4#1)(2010-9#1)(2013-7#1)
to secretion##6##2##(1990-6#1)(1992-3#1)(1997-4#1)(2010-9#1)(2011-1#1)(2013-7#1)
to secretory granules##2##3##(1996-4#2)
to secretory vesicles##2##3##(1991-1#2)
to secretory##7##2##(1991-1#2)(1996-4#2)(1997-6#1)(2009-10#1)(2010-4#1)
to section##3##2##(1991-8#2)(2008-3#1)
to secure a##2##3##(2006-6#1)(2011-2#1)
to secure an##2##3##(2008-10#1)(2010-2#1)
to secure the wheelchair##2##4##(2013-1#2)
to secure the##7##3##(1996-12#1)(2008-10#1)(2009-3#1)(2012-12#1)(2012-3#1)(2013-1#2)
to secure their##2##3##(2008-5#1)(2012-11#1)
to secure##25##2##(1990-8#1)(1992-1#1)(1994-11#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-2#1)(2005-11#1)(2006-6#1)(2006-7#1)(2007-11#1)(2008-10#2)(2008-5#2)(2009-3#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#3)
to security##4##2##(1991-6#1)(1994-2#1)(2007-8#1)(2009-4#1)
to sedentary##4##2##(2008-1#1)(2008-3#2)(2011-1#1)
to sediment##4##2##(1996-3#1)(2007-5#1)(2008-10#2)
to sediments##3##2##(2006-6#1)(2007-5#1)(2007-8#1)
to see a physician##2##4##(1994-2#1)(2006-2#1)
to see a##6##3##(1994-2#1)(2006-2#3)(2010-12#1)(2011-12#1)
to see an increase in##2##5##(1995-12#1)(2008-3#1)
to see an##5##3##(1992-1#1)(1995-12#1)(1997-4#1)(2008-3#1)(2011-1#1)
to see for##3##3##(1992-3#1)(2006-4#1)(2008-2#1)
to see how##9##3##(1992-4#1)(2005-7#1)(2006-10#1)(2006-3#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-8#1)(2011-2#1)
to see if any##2##4##(2007-12#1)(2012-12#1)
to see if the##7##4##(1991-9#1)(1993-3#1)(1995-9#1)(1996-2#1)(2007-10#1)(2008-11#1)(2012-1#1)
to see if there##3##4##(1994-9#1)(1995-12#1)(2008-6#1)
to see if##23##3##(1991-9#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-9#2)(1995-12#1)(1995-9#1)(1996-2#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#2)(2010-12#1)(2012-1#1)(2012-12#1)
to see its##2##3##(1995-4#1)(2007-12#1)
to see more##2##3##(1996-2#1)(2008-1#1)
to see patients##2##3##(2009-4#1)(2011-2#1)
to see that##6##3##(1991-4#1)(1994-12#1)(1994-9#1)(2005-7#1)(2007-8#1)(2012-1#1)
to see the incidence##2##4##(2012-3#2)
to see the pattern of##2##5##(2006-4#1)(2012-2#1)
to see the##25##3##(1991-12#1)(1992-3#1)(1994-2#1)(2006-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-4#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
to see their##2##3##(1993-8#1)(2004-10#1)
to see these##2##3##(1991-2#1)(2007-6#1)
to see this##2##3##(1992-3#1)(2009-10#1)
to see whether the##3##4##(2007-8#1)(2010-10#1)(2012-12#1)
to see whether##15##3##(1993-7#1)(1995-5#1)(1997-1#1)(1997-8#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2010-10#1)(2011-1#1)(2012-12#1)
to see##131##2##(1991-12#1)(1991-2#1)(1991-4#2)(1991-9#1)(1992-1#1)(1992-3#4)(1992-4#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-9#3)(1995-1#1)(1995-12#2)(1995-4#1)(1995-5#1)(1995-9#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-10#1)(2005-10#1)(2005-7#2)(2006-10#1)(2006-2#3)(2006-3#1)(2006-4#3)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#2)(2007-6#1)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#3)(2008-11#4)(2008-12#4)(2008-2#3)(2008-3#3)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#2)
to seed the MEF plate##2##5##(2008-8#2)
to seed##14##2##(1995-3#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#4)(2008-9#2)(2009-2#1)(2012-11#1)(2013-1#1)
to seedling##2##2##(2008-10#1)(2008-12#1)
to seedlings of##2##3##(2008-10#2)
to seedlings##5##2##(2008-10#5)
to seek a second##2##4##(1997-7#1)(2011-12#1)
to seek a solution##2##4##(2006-12#1)(2012-3#1)
to seek a##9##3##(1992-3#1)(1997-7#1)(2005-7#1)(2006-12#1)(2008-10#1)(2010-4#1)(2010-7#1)(2011-12#1)(2012-3#1)
to seek collaborative solutions##2##4##(1992-1#1)(2005-8#1)
to seek help##2##3##(2012-1#1)(2012-3#1)
to seek medical advice##2##4##(1994-12#1)(2007-2#1)
to seek medical attention##4##4##(2007-7#1)(2008-7#1)(2012-12#2)
to seek medical##7##3##(1994-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-7#1)(2012-12#2)
to seek more information##3##4##(1996-1#1)(2008-12#2)
to seek out##7##3##(1991-11#1)(1996-3#1)(2005-10#1)(2008-10#1)(2012-3#1)(2013-1#2)
to seek treatment##4##3##(2006-10#1)(2006-2#1)(2008-11#1)(2008-9#1)
to seek##76##2##(1990-12#1)(1990-6#1)(1991-11#1)(1991-2#1)(1992-1#1)(1992-3#1)(1992-4#1)(1993-1#1)(1994-1#1)(1994-12#2)(1994-3#1)(1995-12#1)(1996-1#2)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-7#1)(2004-12#1)(2004-9#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#2)(2007-10#2)(2007-2#3)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#4)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#2)(2012-1#1)(2012-12#3)(2012-3#4)(2013-1#2)
to seeking##5##2##(2008-10#1)(2008-7#1)(2009-9#1)(2012-12#1)(2012-3#1)
to segment and##4##3##(1994-3#1)(2008-2#1)(2011-12#1)(2012-3#1)
to segment the##4##3##(1992-7#1)(1992-9#1)(2008-2#1)(2009-4#1)
to segment##19##2##(1992-7#1)(1992-9#1)(1994-2#1)(1994-3#1)(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#1)(2009-4#1)(2011-12#1)(2012-3#5)
to segmental##3##2##(1992-5#1)(1994-2#1)(2008-4#1)
to segments of##5##3##(1990-8#1)(1991-3#1)(1991-6#1)(1993-6#1)(1994-2#1)
to segregate##7##2##(1997-4#1)(2007-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-4#1)
to seize##2##2##(1997-8#1)(2008-12#1)
to seizure generation##3##3##(2008-12#1)(2009-8#2)
to seizure##6##2##(1993-4#1)(1996-10#1)(2004-11#1)(2008-12#1)(2009-8#2)
to seizures induced by##3##4##(1996-10#3)
to seizures##4##2##(1996-1#1)(1996-10#3)
to select a##8##3##(2004-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-9#1)(2010-8#1)(2012-2#1)
to select an appropriate##3##4##(1993-3#1)(1997-2#1)(2009-10#1)
to select an##4##3##(1993-3#1)(1997-2#1)(2008-2#1)(2009-10#1)
to select appropriate##2##3##(1991-2#1)(2010-5#1)
to select for##11##3##(1994-3#1)(1994-5#1)(1997-4#1)(1997-7#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2012-3#1)
to select important##2##3##(2008-10#1)(2010-7#1)
to select one##3##3##(1996-2#1)(2008-10#1)(2008-11#1)
to select optimum##3##3##(2008-2#3)
to select patients##3##3##(1991-8#1)(1994-8#1)(2007-9#1)
to select study##2##3##(2012-12#2)
to select the appropriate##3##4##(1996-6#1)(1997-7#1)(2007-10#1)
to select the best##6##4##(2006-10#1)(2008-10#1)(2008-5#2)(2010-8#1)(2012-3#1)
to select the most appropriate##5##5##(1992-8#1)(2007-8#1)(2008-10#2)(2008-3#1)
to select the most##9##4##(1990-12#1)(1992-8#1)(1993-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2011-1#1)(2013-1#1)
to select the number of##5##5##(2008-10#4)(2012-3#1)
to select the optimum##3##4##(2008-10#2)(2008-8#1)
to select the##48##3##(1990-12#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-12#2)(1994-6#1)(1995-4#1)(1996-12#1)(1996-6#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-6#1)(2006-10#1)(2006-2#2)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-12#1)(2010-8#1)(2011-1#1)(2012-3#3)(2013-1#2)
to select their##2##3##(1997-7#1)(2013-1#1)
to select this##2##3##(1993-4#1)(2008-10#1)
to select those##3##3##(2008-10#1)(2009-7#1)(2013-8#1)
to select variables##2##3##(1995-2#2)
to select women##2##3##(2011-2#2)
to select##170##2##(1990-10#2)(1990-12#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-4#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-6#2)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#4)(2004-9#1)(2005-10#2)(2005-11#1)(2005-6#1)(2005-7#2)(2005-8#1)(2006-10#2)(2006-2#2)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-6#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#32)(2008-11#4)(2008-2#8)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#2)(2009-12#2)(2009-3#1)(2009-7#1)(2009-9#2)(2010-12#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#2)(2012-3#6)(2013-1#3)(2013-8#2)
to selected features of the##2##5##(1993-12#1)(2008-10#1)
to selected patients##2##3##(2006-10#1)(2013-7#1)
to selected##22##2##(1992-8#1)(1993-12#1)(1996-9#1)(1997-8#1)(2005-5#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#5)
to selection and##2##3##(1994-2#1)(2008-10#1)
to selection bias##2##3##(2004-1#1)(2006-12#1)
to selection for##5##3##(1991-1#1)(2008-7#1)(2008-8#1)(2008-9#2)
to selection in the##2##4##(2008-8#1)(2012-2#1)
to selection in##3##3##(2008-8#2)(2012-2#1)
to selection of the##3##4##(1996-2#1)(2006-10#1)(2008-10#1)
to selection of##9##3##(1990-11#1)(1995-5#1)(1996-2#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)
to selection on##2##3##(2008-10#1)(2012-3#1)
to selection was##2##3##(2008-8#1)(2008-9#1)
to selection##39##2##(1990-11#1)(1991-1#1)(1994-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(2004-1#1)(2006-10#1)(2006-12#1)(2007-7#1)(2008-10#7)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#10)(2008-9#4)(2009-2#1)(2012-2#1)(2012-3#3)
to selective serotonin reuptake inhibitors##2##5##(2008-6#1)(2012-3#1)
to selective##20##2##(1991-2#1)(1991-3#1)(1991-8#1)(1995-5#1)(1997-5#1)(1997-6#1)(2005-1#1)(2005-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#2)
to selectively amplify and##2##4##(1991-9#1)(2007-11#1)
to selectively amplify##4##3##(1991-9#1)(2007-11#2)(2010-9#1)
to selectively destroy##2##3##(1992-8#1)(2007-11#1)
to selectively detect##2##3##(2008-10#2)
to selectively inhibit##3##3##(1992-3#1)(1993-11#1)(1995-3#1)
to selectively label##2##3##(1994-12#1)(1997-7#1)
to selectively remove##3##3##(1994-6#1)(2008-10#2)
to selectively separate##4##3##(2008-10#2)(2009-2#1)(2011-1#1)
to selectively##57##2##(1990-2#1)(1990-8#1)(1991-9#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-12#2)(1994-6#1)(1995-1#1)(1995-3#1)(1997-7#2)(2005-7#1)(2005-8#1)(2006-12#1)(2006-7#1)(2007-11#6)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#10)(2008-12#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-6#1)(2010-9#1)(2011-1#2)(2012-2#3)(2013-1#1)
to selectivity##3##2##(1995-3#1)(1997-5#1)(2008-10#1)
to selenate##2##2##(2008-10#2)
to selenite##5##2##(1992-7#3)(2008-10#2)
to selenium##3##2##(2005-7#1)(2008-10#1)(2008-7#1)
to self and##2##3##(2007-7#1)(2008-11#1)
to self##16##2##(1990-11#1)(1991-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1996-3#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#2)(2013-1#1)
to self-administer##2##2##(1993-4#1)(1996-5#1)
to self-assemble into##4##3##(1995-5#1)(2008-7#1)(2009-2#1)(2010-5#1)
to self-assembly##2##2##(2008-7#1)(2009-11#1)
to self-care##4##2##(2006-1#1)(2009-7#1)(2011-1#1)(2011-2#1)
to self-degrade##3##2##(1997-4#1)(2007-12#2)
to self-determination##6##2##(1991-2#2)(1997-8#3)(2010-2#1)
to self-focusing##2##2##(2007-12#1)(2008-3#1)
to self-harm##7##2##(2006-7#6)(2012-11#1)
to self-medicate##2##2##(2008-8#1)(2013-8#1)
to self-medication##2##2##(2011-2#1)(2013-8#1)
to self-monitor their daily pedometer-determined step count##2##7##(2010-2#2)
to self-phase modulation##5##3##(2007-11#1)(2007-12#3)(2008-2#1)
to self-renew and differentiate into##2##5##(2008-11#1)(2012-12#1)
to self-renew and##3##3##(2008-1#1)(2008-11#1)(2012-12#1)
to self-renew##4##2##(2008-1#1)(2008-11#1)(2009-3#1)(2012-12#1)
to self-reported##2##2##(2009-11#1)(2013-1#1)
to self-stimulation##2##2##(1993-6#1)(1996-1#1)
to sell the##2##3##(1997-7#1)(2005-7#1)
to sell##7##2##(1991-9#1)(1992-9#1)(1995-2#1)(1997-7#1)(2005-7#1)(2007-9#1)(2009-4#1)
to semantic##3##2##(1990-8#1)(2007-10#1)(2008-5#1)
to semi-structured interviews##2##3##(1996-1#1)(2008-1#1)
to semiconductor systems##2##3##(2006-12#1)(2010-4#1)
to send##8##2##(1990-4#1)(1990-7#1)(1991-3#1)(1993-7#1)(1994-12#1)(2004-9#1)(2006-10#1)(2008-1#1)
to senescence##5##2##(1991-1#1)(1991-6#1)(1991-8#1)(1995-8#1)(1996-9#1)
to sense and##5##3##(2009-8#2)(2010-11#1)(2013-1#1)(2013-8#1)
to sense the##4##3##(2008-10#1)(2008-9#1)(2009-11#1)(2009-7#1)
to sense##26##2##(1991-2#1)(1991-4#1)(1995-3#1)(1996-3#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-9#1)(2009-11#1)(2009-7#1)(2009-8#6)(2010-11#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
to sensitise##2##2##(2007-7#1)(2011-2#1)
to sensitive##9##2##(2007-12#2)(2008-10#3)(2008-3#1)(2009-3#1)(2011-2#1)(2012-2#1)
to sensitivity##5##2##(1994-6#1)(1996-9#1)(2006-11#1)(2008-10#1)(2009-12#1)
to sensitization##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
to sensitize##2##2##(1993-9#1)(2009-4#1)
to sensor##5##2##(1997-4#1)(2007-9#1)(2008-10#1)(2008-2#1)(2009-11#1)
to sensorimotor##2##2##(1992-10#1)(2007-12#1)
to sensors##2##2##(2008-10#2)
to sensory stimulation##3##3##(1992-7#1)(1993-6#1)(1995-5#1)
to sensory##15##2##(1992-5#1)(1992-7#1)(1993-6#1)(1995-5#1)(1996-3#1)(1996-5#1)(1997-3#2)(1997-8#1)(2008-4#1)(2008-7#1)(2010-4#2)(2011-1#1)(2013-1#1)
to sentinel##2##2##(2008-11#1)(2012-2#1)
to separate DNA fragments##2##4##(1996-6#1)(2008-10#1)
to separate DNA##3##3##(1991-8#1)(1996-6#1)(2008-10#1)
to separate a##3##3##(1990-8#1)(2005-11#1)(2006-7#1)
to separate all the##2##4##(2011-2#1)(2013-7#1)
to separate amino acids##2##4##(1991-8#1)(2005-12#1)
to separate and identify##3##4##(1996-5#1)(2008-10#2)
to separate and purify##3##4##(2008-10#1)(2012-12#1)(2013-7#1)
to separate and to##2##4##(2008-10#1)(2008-5#1)
to separate and##9##3##(1990-10#1)(1996-5#1)(2008-10#4)(2008-5#1)(2012-12#1)(2013-7#1)
to separate it from##2##4##(2008-4#2)
to separate it##3##3##(2008-4#2)(2008-7#1)
to separate the effects of##2##5##(1997-5#1)(2010-2#1)
to separate the species##2##4##(2008-10#2)
to separate the##31##3##(1995-1#1)(1996-4#1)(1997-2#2)(1997-5#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-2#2)(2008-3#1)(2008-5#1)(2009-10#2)(2010-12#1)(2010-2#2)(2011-1#2)(2011-2#1)(2013-7#1)
to separate them##2##3##(2008-10#2)
to separate these compounds##2##4##(2008-10#2)
to separate this##2##3##(2006-10#1)(2007-10#1)
to separate tissue##2##3##(1995-7#1)(2007-12#1)
to separate two##2##3##(2008-10#1)(2008-5#1)
to separate##144##2##(1990-10#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-5#1)(1995-7#1)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-5#2)(1997-6#1)(2004-8#1)(2005-11#1)(2005-12#1)(2005-4#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#48)(2008-11#3)(2008-2#5)(2008-3#4)(2008-4#6)(2008-5#4)(2008-7#3)(2008-9#1)(2009-10#2)(2009-12#1)(2010-12#1)(2010-2#3)(2010-5#2)(2011-1#3)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#3)
to separately##6##2##(1997-3#1)(2007-11#1)(2008-10#1)(2008-4#1)(2011-1#1)(2012-3#1)
to separating and detecting##2##4##(1990-12#1)(2008-10#1)
to separation##6##2##(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-5#1)
to sepsis and##4##3##(2007-11#1)(2008-4#1)(2008-8#1)(2013-1#1)
to sepsis##9##2##(1990-6#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-4#1)(2008-8#1)(2010-5#1)(2012-12#1)(2013-1#1)
to septic shock##3##3##(2007-11#1)(2007-7#1)(2013-1#1)
to septoria##4##2##(2008-10#4)
to sequence analysis##3##3##(1994-12#1)(2008-10#1)(2012-2#1)
to sequence specific##2##3##(1990-11#1)(1991-2#1)
to sequence##11##2##(1990-11#1)(1991-2#1)(1991-7#1)(1994-12#1)(1995-11#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-2#1)(2013-1#1)
to sequences found in##2##4##(2007-6#1)(2008-10#1)
to sequences of##2##3##(1997-8#1)(2006-8#1)
to sequences##10##2##(1994-5#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-8#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-7#1)
to sequencing##5##2##(2007-9#1)(2008-4#1)(2012-2#2)(2013-8#1)
to sequential##3##2##(1996-8#1)(2007-6#1)(2008-10#1)
to sequentially##4##2##(2007-11#1)(2007-12#1)(2008-4#2)
to sequester and##2##3##(2010-6#1)(2012-1#1)
to sequester the##4##3##(1990-7#1)(1996-7#1)(2008-10#1)(2009-12#1)
to sequester##10##2##(1990-7#1)(1994-2#1)(1994-8#1)(1996-7#1)(2008-10#2)(2008-5#1)(2009-12#1)(2010-6#1)(2012-1#1)
to serial##2##2##(1992-8#1)(1996-11#1)
to serine or##2##3##(1993-3#1)(2008-11#1)
to serine##15##2##(1991-2#1)(1992-12#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-9#1)
to serious errors##2##3##(2008-10#1)(2010-7#1)
to serious##23##2##(1990-3#1)(1993-12#1)(1997-1#1)(2006-1#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-9#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#4)(2013-1#1)
to seroconvert##2##2##(2007-2#1)(2008-5#1)
to serogroup##3##2##(2008-12#1)(2012-12#2)
to serogroups A##2##3##(2009-9#1)(2010-10#1)
to serotonergic##2##2##(2007-7#1)(2008-6#1)
to serotonin (5-hydroxytryptamine##2##3##(1995-12#1)(1996-3#1)
to serotonin##8##2##(1990-5#1)(1995-12#1)(1996-3#1)(1996-8#1)(1997-6#1)(2006-12#2)(2011-2#1)
to serotype##3##2##(1991-3#1)(1996-12#1)(2008-5#1)
to serotypes 1##2##3##(1996-12#2)
to serovar##2##2##(2007-8#1)(2013-1#1)
to serum albumin##4##3##(1990-8#1)(1996-11#1)(1996-12#1)(2008-7#1)
to serum and##2##3##(1990-12#1)(2008-4#1)
to serum samples was##2##4##(1995-2#1)(2008-10#1)
to serum samples##3##3##(1992-5#1)(1995-2#1)(2008-10#1)
to serum starvation##4##3##(1995-5#1)(1996-2#1)(2008-9#1)(2012-2#1)
to serum##40##2##(1990-10#1)(1990-12#1)(1990-8#2)(1991-10#1)(1991-8#4)(1992-2#1)(1992-5#1)(1993-11#1)(1993-3#2)(1993-8#1)(1994-11#1)(1995-2#2)(1995-4#2)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-2#1)(2005-7#1)(2006-10#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-11#1)(2011-2#1)(2012-2#1)
to serum-free conditions##2##3##(2008-11#2)
to serum-free culture##2##3##(1991-12#1)(1994-6#1)
to serum-free medium##3##3##(2008-11#2)(2012-3#1)
to serum-free##8##2##(1991-12#1)(1994-6#1)(2008-11#5)(2012-3#1)
to serum-sensitized DH5α##2##3##(2011-1#2)
to serum-starved##2##2##(1991-10#1)(1993-8#1)
to serve a##2##3##(2008-5#1)(2012-2#1)
to serve as a guide for##2##6##(1991-12#1)(2007-2#1)
to serve as a low-cost##2##5##(2004-8#1)(2008-10#1)
to serve as a model##2##5##(1990-5#1)(2006-10#1)
to serve as a universal##2##5##(1993-2#1)(2008-8#1)
to serve as a##31##4##(1990-3#1)(1990-5#1)(1991-12#1)(1992-3#2)(1993-2#1)(1994-6#1)(1995-5#1)(2004-8#1)(2006-10#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#6)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-8#1)(2010-9#1)(2012-11#2)(2013-7#1)(2013-8#1)
to serve as an##5##4##(1995-6#1)(2008-10#1)(2008-5#1)(2009-8#1)(2013-8#1)
to serve as the##6##4##(1995-12#1)(1995-3#1)(1997-8#1)(2006-12#1)(2006-5#1)(2008-5#1)
to serve as##71##3##(1990-11#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-3#2)(1992-9#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-9#1)(1997-2#1)(1997-8#1)(2004-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2007-2#2)(2007-5#1)(2007-8#1)(2008-10#13)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-8#3)(2008-9#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-11#2)(2013-1#2)(2013-7#1)(2013-8#2)
to serve in##3##3##(2008-2#1)(2008-5#1)(2010-12#1)
to serve more##2##3##(1993-12#1)(2012-2#1)
to serve the community##2##4##(1997-1#1)(2008-1#1)
to serve the##9##3##(1997-1#1)(1997-3#1)(2005-8#1)(2006-4#1)(2006-5#1)(2007-4#1)(2008-1#1)(2010-2#1)(2012-3#1)
to serve##107##2##(1990-11#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-3#2)(1992-9#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#2)(1995-12#1)(1995-3#2)(1995-5#2)(1995-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-8#2)(2004-8#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#2)(2006-5#2)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#13)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#1)(2008-8#3)(2008-9#2)(2009-4#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#2)
to service users##3##3##(2008-12#1)(2012-11#1)(2012-3#1)
to service##13##2##(1993-1#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1996-12#1)(2007-4#1)(2008-11#2)(2008-12#1)(2008-2#1)(2012-11#1)(2012-3#1)
to services and##5##3##(1991-1#1)(1993-1#1)(1996-1#1)(1997-5#1)(2007-7#1)
to services that##3##3##(2008-5#1)(2013-1#2)
to services##18##2##(1991-1#1)(1992-3#1)(1992-8#1)(1993-1#1)(1994-1#1)(1994-12#1)(1996-1#1)(1997-5#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-5#1)(2009-6#1)(2010-10#1)(2011-1#1)(2013-1#2)
to set a##2##3##(2012-2#1)(2013-7#1)
to set an##2##3##(1994-10#1)(2007-12#1)
to set aside##2##3##(1995-2#1)(2007-9#1)
to set the##11##3##(1997-6#1)(2006-2#1)(2007-11#2)(2007-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2012-2#1)(2013-7#1)
to set up a##12##4##(1993-11#1)(1993-3#1)(1996-5#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-2#1)
to set up and##5##4##(1996-1#1)(2007-9#1)(2008-11#1)(2008-4#1)(2013-8#1)
to set up##25##3##(1991-3#1)(1992-6#1)(1993-11#1)(1993-3#1)(1996-1#1)(1996-5#1)(1997-4#1)(2005-5#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-9#2)(2012-2#1)(2013-8#1)
to set##60##2##(1991-2#1)(1991-3#1)(1992-1#2)(1992-2#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-10#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-5#2)(2006-2#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-11#2)(2009-6#1)(2010-10#1)(2012-2#3)(2013-1#1)(2013-7#2)(2013-8#2)
to sets of##2##3##(2007-12#1)(2012-3#1)
to setting##2##2##(1994-1#1)(2011-2#1)
to settle a##2##3##(1996-11#1)(1997-5#1)
to settle##12##2##(1990-6#1)(1992-6#1)(1995-6#1)(1996-11#1)(1997-5#2)(2005-11#1)(2007-9#1)(2008-11#1)(2008-5#1)(2013-1#1)(2013-8#1)
to seven days##3##3##(2004-9#1)(2006-6#1)(2013-7#1)
to seven##26##2##(1991-12#1)(1991-6#1)(1993-10#1)(1993-8#1)(1994-9#1)(1995-2#1)(1995-8#1)(1997-5#1)(2004-9#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-5#3)(2009-12#1)(2010-12#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
to sevenfold##2##2##(2006-9#1)(2007-11#1)
to seventeen##2##2##(1992-2#1)(1992-3#1)
to seventh##2##2##(2008-1#2)
to sever##2##2##(2006-3#1)(2007-8#1)
to several biological##2##3##(2008-10#1)(2008-7#1)
to several different##4##3##(1997-2#1)(1997-6#1)(2008-1#1)(2008-4#1)
to several difficulties##2##3##(2006-6#1)(2012-2#1)
to several diseases##3##3##(2008-10#1)(2009-5#1)(2013-1#1)
to several factors including##2##4##(2007-5#1)(2008-5#1)
to several factors##3##3##(1992-4#1)(2007-5#1)(2008-5#1)
to several functions of##2##4##(1992-3#1)(2011-1#1)
to several hours##4##3##(1991-2#1)(1997-6#1)(2008-10#1)(2011-1#1)
to several hundred##6##3##(2008-2#2)(2008-4#1)(2009-11#1)(2009-4#1)(2012-2#1)
to several important##2##3##(2008-8#1)(2010-12#1)
to several meters##2##3##(2008-3#2)
to several micrometers##2##3##(2005-11#1)(2008-3#1)
to several months##5##3##(1991-8#1)(1995-2#1)(2006-10#1)(2007-11#1)(2012-2#1)
to several of the##3##4##(1996-5#1)(1997-4#1)(2009-9#1)
to several of##4##3##(1996-5#1)(1997-4#1)(2009-9#1)(2012-11#1)
to several other studies##2##4##(2008-5#1)(2008-6#1)
to several other##7##3##(1990-2#1)(1990-6#1)(1992-7#1)(2008-5#1)(2008-6#1)(2009-8#1)(2012-2#1)
to several pharmaceutical##2##3##(2008-10#1)(2012-12#1)
to several risk##2##3##(2008-5#1)(2013-1#1)
to several stimuli##2##3##(1995-12#1)(1995-8#1)
to several stresses##2##3##(1995-12#1)(2011-2#1)
to several studies##2##3##(1990-6#1)(2013-1#1)
to several tens of##2##4##(2005-11#1)(2008-1#1)
to several tens##3##3##(2005-11#1)(2008-1#1)(2008-10#1)
to several types of diseases##2##5##(2008-4#1)(2012-11#1)
to several types of##3##4##(2008-4#1)(2008-7#1)(2012-11#1)
to several years##2##3##(1990-3#1)(2008-4#1)
to several##172##2##(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-4#1)(1993-5#1)(1993-7#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-7#1)(1995-8#2)(1996-12#1)(1996-5#1)(1996-8#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#2)(2005-11#2)(2005-8#1)(2006-10#2)(2006-11#2)(2006-2#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#26)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#7)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-11#2)(2012-12#2)(2012-2#7)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#1)
to severe acute##4##3##(1996-8#1)(2007-11#1)(2011-1#2)
to severe cases##2##3##(1995-5#1)(2007-11#1)
to severe chronic##4##3##(2006-10#2)(2008-5#1)(2012-2#1)
to severe cognitive impairment##2##4##(2008-2#1)(2010-2#1)
to severe complications##4##3##(1992-12#1)(2007-8#1)(2011-1#1)(2011-2#1)
to severe depression##2##3##(2007-7#1)(2011-2#1)
to severe hypertension##2##3##(1991-2#1)(2009-5#1)
to severe in##2##3##(1995-6#1)(2007-10#1)
to severe malnutrition##2##3##(2006-2#1)(2013-8#1)
to severe pain##3##3##(2007-2#1)(2012-1#1)(2013-1#1)
to severe##135##2##(1990-10#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-12#1)(1993-11#1)(1993-8#2)(1994-5#2)(1995-10#1)(1995-5#1)(1995-6#2)(1996-3#1)(1996-8#1)(1997-3#1)(1997-6#1)(2004-12#1)(2005-11#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-11#2)(2006-12#2)(2006-2#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#6)(2007-2#3)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#5)(2008-5#10)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#3)(2009-7#2)(2009-8#2)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#5)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#3)(2012-7#1)(2013-1#4)(2013-8#1)
to severely##6##2##(1994-6#1)(1996-10#1)(2006-10#2)(2008-10#1)(2008-3#1)
to severity of the##2##4##(1997-3#1)(2011-12#1)
to severity of##8##3##(1994-2#1)(1997-3#1)(2007-9#1)(2008-12#1)(2008-5#1)(2011-1#1)(2011-12#1)(2013-1#1)
to severity##9##2##(1994-2#1)(1997-3#1)(2007-9#1)(2008-12#1)(2008-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)
to sewage##5##2##(1993-8#1)(2008-10#2)(2008-5#1)(2013-1#1)
to sex and##3##3##(2008-5#1)(2008-7#1)(2011-1#1)
to sex differences in##2##4##(1993-4#1)(2009-7#1)
to sex hormones##2##3##(2006-8#1)(2010-5#1)
to sex##28##2##(1990-12#1)(1993-10#1)(1993-3#1)(1993-4#1)(1994-6#1)(2006-12#1)(2006-7#1)(2006-8#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-1#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-5#3)(2010-6#1)(2010-8#2)(2011-1#1)(2011-12#1)(2012-2#1)(2012-3#2)
to sexual and reproductive health##3##5##(2012-3#3)
to sexual changes##3##3##(2008-7#3)
to sexual##23##2##(1992-10#1)(1993-12#2)(1996-12#1)(1997-8#1)(2005-9#1)(2008-12#3)(2008-7#3)(2008-9#2)(2010-4#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#4)(2013-1#1)
to sexually receptive female rats##3##5##(1993-7#2)(2013-8#1)
to sexually receptive##4##3##(1993-7#3)(2013-8#1)
to sexually transmitted diseases##2##4##(1993-3#1)(2007-7#1)
to sexually transmitted##4##3##(1993-3#1)(2007-7#1)(2012-2#1)(2012-3#1)
to sexually##9##2##(1993-3#1)(1993-7#3)(2007-7#1)(2012-2#1)(2012-3#2)(2013-8#1)
to shade##4##2##(2007-3#2)(2007-8#1)(2008-9#1)
to shake the##2##3##(1996-12#1)(2008-10#1)
to shake##3##2##(1996-12#1)(2008-10#1)(2013-7#1)
to sham##11##2##(1993-5#1)(1993-6#1)(1995-11#2)(1995-12#1)(1996-12#1)(1996-9#1)(1997-3#1)(2008-7#1)(2010-5#1)(2012-2#1)
to sham-operated animals and##3##4##(1990-10#1)(1993-2#1)(2012-1#1)
to shape the future of##4##5##(1991-1#1)(2005-10#1)(2008-1#2)
to shape the##11##3##(1991-1#1)(1995-1#1)(2005-10#1)(2006-10#1)(2007-11#1)(2008-1#2)(2008-12#1)(2008-2#2)(2009-8#1)
to shape##28##2##(1991-1#1)(1991-3#1)(1995-1#1)(1995-7#1)(2005-10#1)(2005-11#2)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-12#2)(2008-2#3)(2008-3#2)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
to share a similar##2##4##(1996-6#1)(2008-1#1)
to share a##4##3##(1996-6#1)(1997-1#1)(2008-1#1)(2010-11#1)
to share important##2##3##(1990-4#1)(2008-2#1)
to share in the##3##4##(1996-3#1)(2008-9#2)
to share information##3##3##(1996-2#1)(1996-3#1)(2008-11#1)
to share the burden##2##4##(1995-1#1)(2006-6#1)
to share the##7##3##(1992-6#1)(1994-2#1)(1995-1#1)(2006-6#1)(2007-7#1)(2009-8#1)(2013-1#1)
to share their##8##3##(1992-3#2)(2007-8#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-2#1)
to share with##2##3##(2008-6#1)(2010-9#1)
to share##61##2##(1990-11#1)(1990-4#1)(1992-1#1)(1992-2#1)(1992-3#3)(1992-6#1)(1993-12#1)(1994-1#1)(1994-2#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-6#1)(1997-1#1)(1997-3#1)(1997-6#1)(2006-1#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-8#1)(2010-11#3)(2010-9#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
to shared##5##2##(1990-7#2)(1993-2#1)(1997-7#1)(2009-7#1)
to sharing##2##2##(2007-3#1)(2008-6#1)
to sharp##3##2##(2007-8#1)(2008-2#1)(2012-12#1)
to shear stress##6##3##(1993-11#1)(2008-11#1)(2010-1#2)(2012-12#2)
to shear##11##2##(1993-11#1)(2007-4#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-1#2)(2012-12#2)(2012-2#1)
to sheath blight##2##3##(2008-10#2)
to shed light on the##5##5##(1995-3#1)(1997-9#1)(2008-8#1)(2009-3#1)(2009-5#1)
to shed light on##12##4##(1995-3#1)(1997-2#1)(1997-9#1)(2006-2#1)(2007-12#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#2)(2013-1#2)
to shed some light on the##2##6##(1993-12#1)(2008-11#1)
to shed some light on##3##5##(1993-12#1)(2006-8#1)(2008-11#1)
to shed some light##4##4##(1993-12#1)(2006-8#1)(2008-11#1)(2012-12#1)
to shed##21##2##(1993-12#1)(1994-11#1)(1995-3#1)(1997-2#1)(1997-9#1)(2006-2#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#2)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#2)
to sheep red blood cells (SRBC)##2##6##(1991-12#1)(2008-10#1)
to sheep red blood cells##8##5##(1991-12#1)(1993-12#1)(1995-2#1)(2008-10#5)
to sheep##12##2##(1991-12#1)(1993-12#1)(1993-8#1)(1995-2#1)(1996-12#1)(2008-10#6)(2008-4#1)
to shell##2##2##(2008-5#1)(2008-8#1)
to shield the##3##3##(1991-2#1)(2006-5#1)(2009-10#1)
to shield##4##2##(1990-5#1)(1991-2#1)(2006-5#1)(2009-10#1)
to shift from##4##3##(1990-5#1)(1995-6#1)(2008-10#1)(2008-11#1)
to shift resources##2##3##(1995-1#1)(1995-2#1)
to shift the##6##3##(1991-5#1)(1991-8#1)(1997-2#1)(2007-12#1)(2008-3#1)(2013-8#1)
to shift their##2##3##(1997-1#1)(2008-10#1)
to shift to##4##3##(2006-10#2)(2008-10#1)(2008-5#1)
to shift##31##2##(1990-5#1)(1991-5#1)(1991-8#1)(1992-9#1)(1995-1#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1997-1#1)(1997-2#1)(1997-6#1)(2005-11#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
to shock##3##2##(2008-2#1)(2009-10#1)(2011-12#1)
to short duration##2##3##(2011-2#1)(2012-2#1)
to short term##2##3##(1996-5#1)(2013-8#1)
to short##22##2##(1990-11#1)(1991-9#1)(1992-3#1)(1996-2#1)(1996-5#1)(2006-10#2)(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-8#1)
to short-##3##2##(2007-8#1)(2011-2#1)(2012-2#1)
to short-lived##2##2##(1996-3#2)
to short-term##7##2##(1992-4#1)(1994-11#2)(2008-10#2)(2008-12#1)(2010-3#1)
to shortage of##4##3##(1990-3#1)(2007-4#2)(2008-1#1)
to shorten the duration of##2##5##(1992-6#1)(2005-10#1)
to shorten the time##3##4##(2011-2#1)(2013-1#2)
to shorten the##14##3##(1992-11#1)(1992-6#1)(2005-10#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-7#1)(2009-8#1)(2011-2#1)(2012-8#1)(2013-1#2)
to shorten##19##2##(1992-1#1)(1992-11#1)(1992-6#1)(2005-10#1)(2006-12#1)(2006-6#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-8#1)(2013-1#2)
to shortening of##2##3##(1997-8#1)(2006-6#1)
to shortening##3##2##(1997-8#1)(2006-6#1)(2007-11#1)
to shorter wavelengths with##2##4##(1990-3#1)(2007-12#1)
to shorter wavelengths##3##3##(1990-3#1)(2007-12#1)(2008-3#1)
to shorter##12##2##(1990-3#1)(1992-7#1)(1992-9#1)(1993-9#1)(1996-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)
to shoulder edge)##2##3##(2007-4#2)
to shoulder##8##2##(2007-11#3)(2007-4#2)(2007-7#1)(2007-8#2)
to show a clear##2##4##(2008-1#1)(2008-3#1)
to show a difference in##2##5##(1996-6#1)(2007-11#1)
to show a relationship between##2##5##(2009-10#1)(2012-3#1)
to show a significant##2##4##(2008-5#1)(2011-12#1)
to show a statistical##2##4##(2005-7#1)(2008-5#1)
to show a##35##3##(1990-2#1)(1994-2#3)(1994-3#1)(1995-10#1)(1995-12#2)(1996-10#1)(1996-6#1)(1997-1#1)(1997-3#1)(2005-11#1)(2005-7#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#3)(2008-8#1)(2009-10#1)(2010-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
to show an effect of##2##5##(2007-12#1)(2009-10#1)
to show an effect##3##4##(1994-2#1)(2007-12#1)(2009-10#1)
to show an increase##2##4##(1996-3#1)(2008-3#1)
to show an interaction##2##4##(2009-8#1)(2013-8#1)
to show an##12##3##(1992-5#1)(1993-1#1)(1994-2#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-10#1)(2009-8#1)(2013-8#1)
to show any##11##3##(1990-5#1)(1991-9#1)(1997-6#1)(2005-10#2)(2006-10#1)(2006-2#1)(2007-5#1)(2008-5#1)(2010-2#1)(2010-4#1)
to show clinical##3##3##(2006-10#1)(2011-2#1)(2012-12#1)
to show excellent##2##3##(2008-10#1)(2011-2#1)
to show good##3##3##(1992-7#1)(2007-9#1)(2008-3#1)
to show how the proposed##2##5##(2008-10#1)(2008-2#1)
to show how the##6##4##(2007-10#1)(2007-8#1)(2008-10#2)(2008-2#1)(2012-2#1)
to show how##21##3##(1993-2#1)(2006-12#1)(2006-3#2)(2007-10#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#3)(2008-8#1)(2009-2#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-2#2)
to show in##2##3##(1990-10#1)(1997-4#1)
to show its robustness##2##4##(2008-2#2)
to show promise##2##3##(1996-5#1)(2010-2#1)
to show significant##3##3##(1994-11#1)(1995-12#1)(2007-8#1)
to show signs of##2##4##(2006-10#1)(2006-8#1)
to show similar##2##3##(1997-6#1)(2009-4#1)
to show some of##2##4##(2008-11#1)(2009-10#1)
to show some##3##3##(2008-11#1)(2009-10#1)(2013-1#1)
to show strict##2##3##(1994-11#1)(2005-8#1)
to show that a##5##4##(1994-2#1)(1995-11#1)(2008-3#1)(2008-8#1)(2012-12#1)
to show that human##3##4##(1995-8#1)(2009-12#1)(2009-4#1)
to show that it##3##4##(1990-6#1)(1993-7#1)(2008-2#1)
to show that the##29##4##(1990-8#3)(1991-12#1)(1992-2#1)(1993-6#2)(1993-9#1)(1995-5#1)(1996-1#1)(1996-5#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-1#1)(2012-2#1)(2013-8#1)
to show that there is##2##5##(2008-3#1)(2012-2#1)
to show that there##3##4##(2008-3#1)(2009-10#1)(2012-2#1)
to show that these##3##4##(1995-4#1)(1996-5#1)(2008-10#1)
to show that this##5##4##(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
to show that##119##3##(1990-6#1)(1990-8#4)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-6#4)(1993-7#1)(1993-9#1)(1994-2#3)(1994-9#1)(1995-11#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-5#4)(1997-1#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#2)(2005-8#1)(2006-10#4)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#5)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-5#2)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#3)
to show the capability of##2##5##(2009-5#1)(2013-1#1)
to show the feasibility of##2##5##(2008-10#1)(2010-5#1)
to show the importance of##2##5##(2008-7#1)(2009-4#1)
to show the influence of##2##5##(2008-8#1)(2012-3#1)
to show the most##3##4##(2005-7#2)(2008-5#1)
to show the performance##2##4##(2008-10#1)(2008-2#1)
to show the role of##2##5##(1991-6#1)(2011-1#1)
to show the##69##3##(1990-5#2)(1991-6#1)(1992-1#1)(1992-10#1)(1992-2#1)(1993-1#1)(1993-3#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-4#1)(1997-7#1)(1997-8#2)(2005-11#1)(2005-7#2)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#8)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-3#1)
to show this##3##3##(1996-7#1)(2012-11#2)
to show whether##4##3##(1992-2#1)(1995-7#1)(2006-6#1)(2012-1#1)
to show##373##2##(1990-10#1)(1990-2#1)(1990-5#5)(1990-6#1)(1990-8#4)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#3)(1992-3#1)(1992-5#1)(1992-7#2)(1992-9#2)(1993-1#2)(1993-2#1)(1993-3#2)(1993-6#4)(1993-7#1)(1993-9#1)(1994-11#2)(1994-2#7)(1994-3#3)(1994-6#1)(1994-9#1)(1995-10#2)(1995-11#1)(1995-12#5)(1995-2#1)(1995-4#2)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#5)(1996-6#1)(1996-7#1)(1997-1#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#3)(2004-4#1)(2005-10#2)(2005-11#4)(2005-7#3)(2005-8#3)(2006-10#9)(2006-12#4)(2006-2#1)(2006-3#3)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#9)(2007-12#6)(2007-3#2)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#3)(2007-9#5)(2008-1#7)(2008-10#23)(2008-11#6)(2008-12#3)(2008-2#14)(2008-3#11)(2008-4#7)(2008-5#14)(2008-7#4)(2008-8#12)(2008-9#3)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#4)(2009-5#2)(2009-6#2)(2009-8#3)(2009-9#1)(2010-1#2)(2010-12#4)(2010-2#2)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#11)(2012-1#1)(2012-11#3)(2012-12#6)(2012-2#8)(2012-3#4)(2013-1#10)(2013-3#1)(2013-7#1)(2013-8#5)
to showing##2##2##(1997-8#1)(2009-9#1)
to shrink##5##2##(1994-8#1)(1994-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
to shut down##2##3##(1996-10#1)(2007-9#1)
to shuttle##3##2##(1990-2#1)(2008-10#2)
to sick##2##2##(1992-3#1)(2009-7#1)
to sickle cell##2##3##(1996-6#1)(2009-6#1)
to side effects##6##3##(1990-5#1)(1991-7#1)(1996-1#1)(2005-11#1)(2008-3#1)(2011-1#1)
to side##13##2##(1990-5#2)(1991-7#1)(1996-1#1)(2005-11#1)(2007-4#1)(2008-3#1)(2008-4#1)(2009-9#3)(2011-1#1)(2011-12#1)
to sigma receptors##2##3##(1990-2#2)
to sigma sites##3##3##(1992-12#1)(1994-3#1)(1995-12#1)
to sigma##7##2##(1990-2#4)(1992-12#1)(1994-3#1)(1995-12#1)
to signal the##2##3##(1990-3#1)(2006-10#1)
to signal to##2##3##(1994-6#1)(2008-2#1)
to signal transduction##5##3##(1990-11#1)(1990-3#1)(1991-10#1)(1996-10#1)(2012-2#1)
to signal##26##2##(1990-11#2)(1990-3#2)(1991-10#1)(1992-12#1)(1994-2#1)(1994-6#1)(1995-3#1)(1995-6#1)(1996-10#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#4)(2008-8#2)(2009-5#1)(2012-2#1)
to signaling##3##2##(1995-3#1)(2005-10#1)(2009-9#1)
to signalling pathways##2##3##(1992-7#1)(2008-7#1)
to signalling##4##2##(1992-7#1)(1993-7#1)(2008-7#1)(2010-2#1)
to signals from##2##3##(2007-5#1)(2009-8#1)
to signals that##3##3##(1995-5#1)(1997-4#1)(2006-10#1)
to signals##6##2##(1995-5#1)(1997-4#1)(2006-10#1)(2007-5#1)(2009-8#1)(2011-12#1)
to significant changes in the##2##5##(2006-4#1)(2008-10#1)
to significant changes in##5##4##(2006-4#1)(2008-10#1)(2008-7#1)(2012-12#2)
to significant differences in##2##4##(1990-8#1)(2013-8#1)
to significant differences##3##3##(1990-8#1)(1993-1#1)(2013-8#1)
to significant economic losses##2##4##(2008-10#1)(2010-4#1)
to significant enhancement of the##2##5##(2007-12#1)(2011-1#1)
to significant enhancement of##3##4##(1995-8#1)(2007-12#1)(2011-1#1)
to significant improvement in##2##4##(2011-2#1)(2013-8#1)
to significant improvement##4##3##(2005-1#1)(2008-2#1)(2011-2#1)(2013-8#1)
to significant improvements in the##2##5##(2008-2#1)(2009-9#1)
to significant improvements in##4##4##(1994-8#1)(2008-2#1)(2008-5#1)(2009-9#1)
to significant increase in##2##4##(2007-1#1)(2011-1#1)
to significant increase##3##3##(2007-1#1)(2008-10#1)(2011-1#1)
to significant increases in##2##4##(2008-8#1)(2012-1#1)
to significant levels##2##3##(2008-10#1)(2010-4#1)
to significant morbidity including##2##4##(2008-7#1)(2012-2#1)
to significant morbidity##4##3##(1993-7#1)(2008-7#1)(2008-8#1)(2012-2#1)
to significant##84##2##(1990-8#1)(1993-1#1)(1993-11#1)(1993-7#1)(1994-1#1)(1994-11#1)(1994-8#1)(1995-3#1)(1995-8#1)(1995-9#1)(1997-2#1)(1997-4#1)(2004-11#1)(2005-1#1)(2005-11#1)(2005-5#1)(2006-10#2)(2006-4#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#3)(2008-7#4)(2008-8#3)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-9#1)(2010-4#2)(2010-5#1)(2011-1#4)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#3)
to significantly affect the##2##4##(2009-4#1)(2009-9#1)
to significantly affect##5##3##(1994-11#1)(2006-10#1)(2008-8#1)(2009-4#1)(2009-9#1)
to significantly alter##3##3##(1995-6#1)(1997-2#1)(2011-2#1)
to significantly decrease##6##3##(1990-12#1)(1991-9#1)(1994-12#1)(2007-11#1)(2008-8#1)(2010-2#1)
to significantly enhance the##2##4##(2008-10#1)(2008-11#1)
to significantly enhance##7##3##(1994-10#1)(2008-10#1)(2008-11#2)(2011-2#1)(2013-1#2)
to significantly higher##7##3##(1992-2#1)(2006-8#1)(2007-12#1)(2008-10#2)(2010-12#1)(2012-5#1)
to significantly improve the##3##4##(1993-7#1)(2010-12#1)(2013-1#1)
to significantly improve##7##3##(1993-7#1)(1997-5#1)(2008-1#1)(2008-5#1)(2010-12#2)(2013-1#1)
to significantly increase the##3##4##(1996-5#1)(2006-5#1)(2009-7#1)
to significantly increase##6##3##(1991-12#1)(1995-1#1)(1996-5#1)(2006-5#1)(2008-11#1)(2009-7#1)
to significantly increased##2##3##(2004-1#1)(2010-4#1)
to significantly influence the##3##4##(2007-1#1)(2008-7#1)(2008-9#1)
to significantly influence##4##3##(1991-2#1)(2007-1#1)(2008-7#1)(2008-9#1)
to significantly inhibit the##2##4##(1996-10#1)(2008-5#1)
to significantly inhibit##4##3##(1992-3#1)(1992-8#1)(1996-10#1)(2008-5#1)
to significantly reduce mortality##3##4##(2006-4#1)(2008-10#1)(2011-1#1)
to significantly reduce the##6##4##(1992-8#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-5#1)
to significantly reduce##19##3##(1992-8#1)(1994-9#1)(1996-3#1)(2006-10#1)(2006-4#1)(2007-2#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#1)(2011-1#1)(2012-12#1)
to significantly stimulate##2##3##(1991-10#1)(2006-6#1)
to significantly suppress##2##3##(2008-10#1)(2008-4#1)
to significantly##98##2##(1990-12#1)(1990-3#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-8#2)(1993-7#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-5#1)(2004-1#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-9#2)(2008-1#2)(2008-10#9)(2008-11#7)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-4#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2012-5#1)(2013-1#5)
to signing##2##2##(1996-1#1)(2008-1#1)
to signs and symptoms of##2##5##(2007-8#1)(2008-3#1)
to signs and symptoms##3##4##(1997-2#1)(2007-8#1)(2008-3#1)
to signs of##2##3##(1996-10#1)(2008-7#1)
to signs##5##2##(1996-10#1)(1997-2#1)(2007-8#1)(2008-3#1)(2008-7#1)
to silence##4##2##(2008-2#1)(2008-9#1)(2011-1#1)(2012-2#1)
to silica and##2##3##(2008-10#1)(2009-12#1)
to silica gel##3##3##(2008-10#3)
to silica##9##2##(2005-11#2)(2008-10#5)(2008-8#1)(2009-12#1)
to silicon##2##2##(2006-12#1)(2008-5#1)
to silicone##2##2##(1996-12#1)(1997-2#1)
to silver##3##2##(2005-11#2)(2008-10#1)
to silver(I) ion over alkali##2##5##(2008-10#2)
to similar levels##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
to similar studies##2##3##(2006-8#1)(2008-10#1)
to similar##25##2##(1990-7#1)(1992-11#1)(1993-7#1)(1994-9#1)(1995-12#1)(1995-2#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-6#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-3#1)
to similarly##2##2##(1997-2#1)(2008-10#1)
to simple##21##2##(1991-12#1)(1992-2#1)(1997-3#1)(1997-4#1)(2006-2#1)(2007-1#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-7#2)(2009-6#1)(2010-5#1)(2012-2#1)
to simplicity##4##2##(2008-10#3)(2008-11#1)
to simplify and##2##3##(2006-10#1)(2008-10#1)
to simplify the problem##2##4##(2008-2#1)(2008-3#1)
to simplify the procedure##2##4##(2006-10#1)(2013-1#1)
to simplify the##20##3##(1991-2#1)(1991-7#1)(1992-2#1)(1995-1#1)(1996-4#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-2#1)(2008-10#2)(2008-2#4)(2008-3#2)(2010-8#1)(2012-3#1)(2013-1#1)
to simplify their##2##3##(1992-3#1)(1994-6#1)
to simplify##39##2##(1991-2#1)(1991-7#1)(1992-2#1)(1992-3#1)(1993-12#1)(1994-6#1)(1995-1#2)(1996-12#1)(1996-4#1)(1996-9#1)(1997-4#1)(2005-11#1)(2006-10#3)(2006-2#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#6)(2008-3#2)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
to simply##2##2##(2008-6#1)(2011-1#1)
to simulate a##5##3##(1995-6#1)(2007-12#1)(2008-9#1)(2009-7#1)(2010-1#1)
to simulate different##2##3##(1995-3#1)(2006-11#1)
to simulate in##2##3##(1997-4#1)(2008-6#1)
to simulate radiances##2##3##(2008-3#2)
to simulate the behavior of##3##5##(2008-11#1)(2008-3#2)
to simulate the effects of##3##5##(2008-3#2)(2012-1#1)
to simulate the performance of##2##5##(2007-12#1)(2008-3#1)
to simulate the##52##3##(1994-5#1)(1995-8#1)(1996-12#1)(1997-7#1)(2005-12#1)(2007-11#2)(2007-12#2)(2007-4#3)(2008-10#4)(2008-11#4)(2008-2#4)(2008-3#15)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#2)(2009-8#1)(2010-2#1)(2012-1#1)
to simulate##115##2##(1990-11#1)(1994-12#1)(1994-5#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-11#2)(2007-12#3)(2007-4#7)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#8)(2008-2#8)(2008-3#22)(2008-5#1)(2008-6#6)(2008-7#4)(2008-8#2)(2008-9#3)(2009-11#2)(2009-4#3)(2009-7#1)(2009-8#1)(2010-1#1)(2010-2#3)(2010-5#1)(2011-1#2)(2011-2#3)(2012-1#3)(2013-8#1)
to simulated microgravity##2##3##(2008-9#1)(2009-7#1)
to simulated solar light##2##4##(2008-8#2)
to simulated solar##3##3##(2008-11#1)(2008-8#2)
to simulated##20##2##(1994-2#1)(1996-12#1)(2007-4#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#3)(2008-9#1)(2009-6#1)(2009-7#1)(2013-7#1)
to simulating##2##2##(2008-10#1)(2010-5#1)
to simulation##3##2##(2008-11#1)(2008-2#1)(2009-8#1)
to simulations##5##2##(2007-9#1)(2010-2#2)(2013-1#2)
to simultaneous determination of##5##4##(2005-4#1)(2008-10#4)
to simultaneous determination##6##3##(2005-4#1)(2008-10#5)
to simultaneous##15##2##(1996-5#1)(2005-4#2)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#7)(2008-5#1)(2013-8#1)
to simultaneously assess##2##3##(2008-12#1)(2008-9#1)
to simultaneously detect##4##3##(2007-8#1)(2008-10#1)(2008-9#1)(2013-8#1)
to simultaneously determine the apparent binding constants and thermodynamic parameters##2##10##(2008-10#2)
to simultaneously determine the##4##4##(1996-3#1)(1997-8#1)(2008-10#2)
to simultaneously determine##6##3##(1996-3#1)(1997-8#1)(2008-10#3)(2011-1#1)
to simultaneously measure##3##3##(1994-2#1)(2008-9#2)
to simultaneously monitor##3##3##(1996-12#1)(1997-2#1)(2008-2#1)
to simultaneously##55##2##(1990-4#1)(1990-6#1)(1993-11#1)(1994-2#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-3#2)(1997-2#1)(1997-4#1)(1997-8#2)(2004-11#1)(2006-6#1)(2006-7#2)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#2)(2008-10#7)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#4)(2009-12#1)(2009-9#1)(2010-1#1)(2011-1#2)(2012-2#3)(2012-3#2)(2013-8#2)
to simvastatin##2##2##(2006-5#1)(2012-2#1)
to sing##3##2##(1991-8#1)(2008-2#1)(2013-8#1)
to single agent##2##3##(2007-11#1)(2009-8#1)
to single and##3##3##(1995-5#1)(1996-12#1)(2007-1#1)
to single crystalline##2##3##(2006-4#1)(2009-11#1)
to single modality##2##3##(2008-12#1)(2008-6#1)
to single neurons##2##3##(1995-11#1)(1995-8#1)
to single out##3##3##(2008-11#1)(2008-3#1)(2011-1#1)
to single##44##2##(1990-2#1)(1990-4#1)(1990-9#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-6#1)(1993-1#1)(1994-2#2)(1994-3#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#2)(1996-12#1)(1996-6#1)(1996-7#2)(2006-10#1)(2006-4#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-3#1)(2011-1#1)(2012-3#1)(2013-1#3)
to single-crystal##2##2##(2006-5#1)(2008-7#1)
to single-dose##3##2##(1990-6#1)(1995-5#1)(2007-3#1)
to single-mode fiber coupling##2##4##(2008-2#2)
to single-mode fiber with##2##4##(2008-2#1)(2008-3#1)
to single-mode fiber##6##3##(2008-2#5)(2008-3#1)
to single-mode##8##2##(2007-12#1)(2008-2#5)(2008-3#2)
to single-stranded DNA and to##2##5##(1991-5#1)(1994-12#1)
to single-stranded DNA##4##3##(1990-5#2)(1991-5#1)(1994-12#1)
to single-stranded##7##2##(1990-5#2)(1991-5#1)(1992-12#1)(1994-12#1)(1996-10#1)(1997-2#1)
to singlet oxygen##2##3##(1991-2#1)(2008-5#1)
to sink##3##2##(1993-2#1)(1997-2#1)(2008-8#1)
to sinks planted##2##3##(2008-10#2)
to sinus rhythm##9##3##(1990-9#1)(1994-3#1)(1997-1#3)(2007-9#1)(2011-2#2)(2013-1#1)
to sirolimus##2##2##(2011-2#2)
to sit in##2##3##(2006-8#1)(2011-7#1)
to sit##4##2##(2006-8#1)(2007-7#1)(2011-7#1)(2012-2#1)
to site and##2##3##(2008-10#1)(2008-6#1)
to site of##2##3##(2006-8#1)(2008-7#1)
to site##8##2##(2006-8#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#1)
to sites of DNA damage##2##5##(2012-12#1)(2013-1#1)
to sites of##11##3##(1992-12#2)(1992-9#1)(1994-12#1)(2006-9#1)(2007-11#1)(2008-1#1)(2009-6#1)(2009-7#1)(2012-12#1)(2013-1#1)
to sites##21##2##(1991-9#1)(1992-12#2)(1992-9#1)(1994-11#1)(1994-12#1)(1995-1#3)(1995-8#1)(1997-4#1)(2006-9#1)(2007-11#1)(2008-1#2)(2008-10#2)(2009-6#1)(2009-7#1)(2012-12#1)(2013-1#1)
to sitting##2##2##(2010-3#1)(2011-2#1)
to situations in which##2##4##(2008-8#1)(2008-9#1)
to situations where##5##3##(1994-11#1)(2006-12#1)(2006-4#1)(2008-10#1)(2009-11#1)
to situations##14##2##(1993-9#1)(1994-11#1)(2006-12#1)(2006-4#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2012-3#1)(2013-1#2)
to six different##5##3##(1990-4#1)(1996-2#1)(2008-10#3)
to six months##7##3##(1992-10#1)(1993-6#1)(1997-3#1)(2008-10#1)(2011-1#1)(2012-2#2)
to six species##2##3##(2007-3#1)(2008-10#1)
to six times##4##3##(2008-1#2)(2008-11#1)(2010-12#1)
to six weeks of##2##4##(2007-8#1)(2008-10#1)
to six weeks##5##3##(2006-9#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-4#1)
to six years##2##3##(2009-2#1)(2011-1#1)
to six##69##2##(1990-4#1)(1990-6#1)(1991-2#1)(1992-10#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-10#2)(1995-6#1)(1996-2#1)(1996-3#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#2)(2007-8#2)(2008-1#2)(2008-10#13)(2008-11#3)(2008-5#5)(2008-6#1)(2008-8#2)(2009-12#1)(2009-2#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#2)(2012-12#2)(2012-2#3)(2013-7#1)
to sixfold##4##2##(1993-3#1)(2006-10#1)(2006-12#1)(2010-2#1)
to sixteen##3##2##(1993-7#1)(2006-2#1)(2008-6#1)
to sixth##2##2##(2007-12#1)(2009-5#1)
to size and##3##3##(2006-9#1)(2007-11#1)(2009-5#1)
to size##18##2##(1993-8#1)(1996-12#1)(2005-11#1)(2006-9#1)(2007-11#1)(2007-9#2)(2008-10#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-6#1)(2011-1#1)(2012-3#1)
to size-asymmetric competition##2##3##(2008-8#2)
to skeletal muscle in##2##4##(1993-2#1)(2007-6#1)
to skeletal muscle is##2##4##(1990-8#1)(2011-1#1)
to skeletal muscle##8##3##(1990-8#1)(1991-7#1)(1993-2#1)(2007-6#1)(2008-3#1)(2008-4#1)(2011-1#1)(2012-12#1)
to skeletal##12##2##(1990-5#1)(1990-8#1)(1991-7#1)(1993-2#1)(1996-9#1)(2007-6#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-12#1)
to skilled nursing facility##2##4##(1991-1#2)
to skilled nursing##3##3##(1991-1#2)(1991-2#1)
to skilled##4##2##(1991-1#3)(1991-2#1)
to skin a cat##2##4##(1995-1#1)(2006-3#1)
to skin and##3##3##(2008-5#2)(2013-8#1)
to skin cancer##3##3##(2007-12#3)
to skin prick##2##3##(2007-2#1)(2013-1#1)
to skin sensitization##2##3##(2007-8#1)(2008-5#1)
to skin tumor##3##3##(1990-6#1)(1992-8#2)
to skin##42##2##(1990-6#2)(1992-8#2)(1993-9#1)(1994-6#1)(1995-1#1)(1996-3#1)(1997-2#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-8#2)(2008-5#10)(2008-9#2)(2009-5#1)(2009-9#1)(2010-8#2)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#2)
to skull##4##2##(2005-9#1)(2006-11#1)(2007-1#2)
to slaughter##3##2##(1997-3#1)(2010-4#1)(2011-1#1)
to sleep##16##2##(1990-5#1)(1992-10#1)(1994-4#1)(1996-9#1)(2004-3#1)(2006-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-2#1)(2010-8#2)(2011-1#2)(2012-3#1)(2013-1#1)
to sliding##3##2##(2006-11#1)(2010-10#2)
to slightly##4##2##(1990-12#1)(1992-7#1)(2008-10#1)(2008-11#1)
to slip##3##2##(1996-4#2)(2004-9#1)
to slow down##3##3##(2008-7#1)(2011-1#1)(2011-2#1)
to slow the growth##2##4##(1992-2#2)
to slow the progression of chronic renal##2##7##(2006-8#1)(2006-9#1)
to slow the progression of myopia##2##6##(2012-12#2)
to slow the progression of##11##5##(1993-12#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-11#1)(2012-12#2)(2013-8#2)
to slow the##17##3##(1992-2#2)(1993-12#1)(1997-4#1)(2004-12#1)(2005-11#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-11#1)(2012-12#2)(2013-8#2)
to slow##33##2##(1991-7#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#2)(1993-12#1)(1993-2#1)(1995-5#1)(1995-9#1)(1997-4#1)(2004-12#1)(2005-11#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-3#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#3)(2013-8#2)
to slower##4##2##(1990-3#1)(2008-10#2)(2008-8#1)
to slowly##2##2##(2008-8#1)(2009-11#1)
to small areas##2##3##(2008-10#1)(2008-3#1)
to small bowel##5##3##(1992-5#1)(2006-10#1)(2008-6#1)(2011-2#1)(2013-1#1)
to small changes in the##3##5##(2008-3#2)(2013-1#1)
to small changes in##5##4##(1996-7#1)(2008-3#3)(2013-1#1)
to small grains##2##3##(2008-10#1)(2008-9#1)
to small molecules##4##3##(1993-7#1)(1994-2#1)(2012-11#2)
to small organic molecules##2##4##(1997-6#1)(2010-11#1)
to small variations in the##3##5##(1994-12#1)(2008-2#2)
to small variations in##4##4##(1994-12#1)(2008-2#2)(2013-8#1)
to small variations##5##3##(1994-12#1)(2007-12#1)(2008-2#2)(2013-8#1)
to small##63##2##(1990-11#1)(1990-3#1)(1990-4#1)(1991-11#1)(1991-9#1)(1992-10#1)(1992-5#1)(1992-7#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-5#2)(1996-7#2)(1997-6#1)(2005-10#1)(2006-10#3)(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#10)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-7#1)(2010-10#2)(2010-11#1)(2011-2#2)(2012-11#2)(2013-1#2)(2013-8#1)
to small-diameter##2##2##(1991-8#1)(2013-1#1)
to smaller##15##2##(1990-12#3)(1991-9#1)(1996-5#1)(1996-8#1)(2005-11#1)(2006-6#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-7#1)
to smoke##11##2##(1991-11#1)(1997-1#1)(2006-10#1)(2006-2#1)(2006-7#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-2#2)
to smoking cessation##2##3##(2005-12#1)(2012-3#1)
to smoking##24##2##(1990-6#1)(1991-9#1)(1994-3#1)(1994-6#1)(2005-12#1)(2006-7#2)(2007-2#2)(2007-7#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#1)(2010-2#2)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#2)
to smooth muscle##2##3##(1990-7#1)(1993-9#1)
to smooth the##2##3##(2008-10#1)(2011-2#1)
to smooth##9##2##(1990-7#1)(1992-7#1)(1993-9#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2011-2#1)
to snakebite##2##2##(2009-6#1)(2012-2#1)
to so-called##3##2##(2003-11#1)(2006-11#1)(2010-12#1)
to social and economic##2##4##(1991-3#1)(2008-5#1)
to social and##7##3##(1990-3#1)(1991-3#1)(2005-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-12#1)
to social capital##2##3##(2008-2#1)(2012-12#1)
to social isolation##2##3##(2012-2#2)
to social phobia##3##3##(2008-4#3)
to social welfare##2##3##(2008-9#2)
to social##49##2##(1990-3#1)(1990-9#1)(1991-3#1)(1994-4#1)(1996-1#1)(1996-3#1)(1997-5#2)(2004-11#1)(2005-10#1)(2006-7#1)(2006-9#1)(2007-3#1)(2008-11#1)(2008-2#5)(2008-4#4)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-4#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#1)
to socialize##3##2##(1992-3#1)(2006-9#1)(2010-2#1)
to socially marginalized groups##3##4##(2012-11#3)
to socially##4##2##(2012-11#3)(2013-1#1)
to society of##3##3##(1997-4#1)(2007-7#1)(2008-2#1)
to society##14##2##(1990-9#1)(1994-3#1)(1995-11#2)(1995-2#1)(1996-2#1)(1997-4#1)(2006-2#1)(2007-7#1)(2008-11#2)(2008-2#1)(2008-7#1)(2009-7#1)
to socio-economic development##2##3##(2006-10#1)(2010-9#1)
to socio-economic status##2##3##(1991-5#1)(2011-2#1)
to socio-economic##5##2##(1991-5#1)(2006-10#1)(2008-12#1)(2010-9#1)(2011-2#1)
to socio-professional integration of people with severe mental disorders##2##9##(2008-2#2)
to socio-professional integration##4##3##(2008-2#4)
to sociocultural factors##2##3##(2007-12#1)(2010-12#1)
to sociocultural##3##2##(2007-12#1)(2010-12#1)(2013-1#1)
to sociodemographic##2##2##(2011-2#2)
to socioeconomic status##2##3##(1991-6#1)(1994-6#1)
to socioeconomic##5##2##(1991-6#1)(1994-6#2)(2006-10#1)(2008-1#1)
to sodium azide and##2##4##(1994-3#1)(2008-12#1)
to sodium azide##4##3##(1994-3#1)(1995-8#1)(2008-12#1)(2011-2#1)
to sodium bromate in##2##4##(2008-9#2)
to sodium bromate##4##3##(2008-9#4)
to sodium chloride##4##3##(1990-9#1)(1992-11#1)(2004-4#1)(2012-2#1)
to sodium depletion##3##3##(1993-12#2)(1995-9#1)
to sodium dodecyl##2##3##(2008-10#2)
to sodium fluoride##2##3##(2008-12#2)
to sodium##34##2##(1990-9#2)(1992-11#1)(1992-3#1)(1993-12#2)(1994-3#1)(1995-11#1)(1995-12#1)(1995-8#2)(1995-9#1)(1996-12#1)(2004-4#1)(2005-11#1)(2007-12#1)(2008-10#7)(2008-12#3)(2008-5#1)(2008-9#4)(2010-12#1)(2011-2#1)(2012-2#1)
to soft dough##2##3##(2008-10#2)
to soft tissue##8##3##(2006-6#1)(2007-4#1)(2008-10#1)(2008-6#2)(2009-8#1)(2010-11#1)(2012-2#1)
to soft##15##2##(2004-9#1)(2006-6#1)(2007-11#1)(2007-4#1)(2008-10#5)(2008-6#2)(2009-11#1)(2009-8#1)(2010-11#1)(2012-2#1)
to soil at##4##3##(2008-10#4)
to soil drought##3##3##(2012-5#1)(2012-6#1)(2012-8#1)
to soil##28##2##(2004-4#1)(2006-3#1)(2008-10#19)(2010-3#1)(2010-5#1)(2011-12#1)(2012-5#1)(2012-6#1)(2012-8#1)(2013-7#1)
to solar ultraviolet radiation##3##4##(2006-12#2)(2011-2#1)
to solar ultraviolet##4##3##(2006-12#2)(2011-2#2)
to solar##9##2##(1990-9#1)(2006-12#2)(2007-7#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#2)
to solely##3##2##(1993-10#1)(2008-2#1)(2012-2#1)
to solicit##2##2##(2006-8#1)(2007-12#1)
to solid phase##2##3##(1997-4#1)(2008-10#1)
to solid substrates##2##3##(1994-11#1)(2008-4#1)
to solid##13##2##(1992-4#1)(1993-9#1)(1994-11#1)(1997-4#1)(2005-11#2)(2007-7#1)(2008-10#3)(2008-2#1)(2008-4#1)(2009-8#1)
to solid-phase extraction##2##3##(1993-2#1)(2008-10#1)
to solid-phase##3##2##(1993-2#1)(2008-10#1)(2008-4#1)
to solidify##3##2##(2009-4#1)(2013-1#2)
to solitary##3##2##(1991-3#1)(2006-10#1)(2007-8#1)
to solubility##3##2##(2008-2#1)(2008-4#1)(2008-5#1)
to solubilization##2##2##(2005-11#1)(2008-4#1)
to solubilize and##2##3##(2005-11#1)(2012-2#1)
to solubilize carbon nanotubes##2##4##(2009-10#2)
to solubilize the##3##3##(1992-12#1)(2005-11#1)(2008-4#1)
to solubilize##12##2##(1992-12#1)(1993-5#1)(1994-9#1)(1996-5#1)(2005-11#3)(2008-4#1)(2009-10#2)(2012-2#1)(2013-1#1)
to solubilized##3##2##(1990-7#1)(1994-11#1)(1994-12#1)
to soluble##10##2##(1991-9#1)(1992-5#1)(1992-7#1)(1993-4#1)(1994-6#1)(2008-4#2)(2008-5#1)(2008-7#1)(2012-4#1)
to solution##4##2##(1991-11#1)(2004-2#1)(2008-10#2)
to solutions##5##2##(1990-11#1)(2007-7#1)(2007-9#1)(2008-10#1)(2009-11#1)
to solve a##7##3##(1991-10#1)(2008-3#1)(2008-6#1)(2008-7#2)(2010-7#1)(2011-2#1)
to solve for the##2##4##(2008-3#1)(2011-1#1)
to solve for##4##3##(2007-12#1)(2008-3#2)(2011-1#1)
to solve it##3##3##(2007-2#1)(2009-6#2)
to solve many##2##3##(2008-2#1)(2008-3#1)
to solve problems##5##3##(2006-4#1)(2008-3#1)(2008-5#1)(2010-5#1)(2012-3#1)
to solve some##3##3##(2008-10#1)(2008-2#1)(2010-7#1)
to solve specific##3##3##(2006-11#1)(2008-5#1)(2010-6#1)
to solve the heat##2##4##(2009-4#1)(2011-2#1)
to solve the problem of##2##5##(2008-3#2)
to solve the problem that##2##5##(2008-10#1)(2008-3#1)
to solve the problem##7##4##(1997-8#1)(2007-12#1)(2008-10#2)(2008-3#3)
to solve the problems##2##4##(1994-6#1)(2012-2#1)
to solve the radiative transfer equation##2##6##(2008-3#2)
to solve the radiative transfer##3##5##(2008-3#3)
to solve the##40##3##(1991-4#1)(1992-9#1)(1994-6#1)(1997-8#1)(2005-7#1)(2007-11#1)(2007-12#3)(2008-10#5)(2008-2#4)(2008-3#8)(2008-7#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)
to solve these problems##5##4##(2006-2#1)(2006-6#1)(2008-10#2)(2010-12#1)
to solve these##6##3##(2006-2#1)(2006-6#1)(2008-10#2)(2009-2#1)(2010-12#1)
to solve this problem##11##4##(1997-1#1)(2006-8#1)(2007-8#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-10#1)(2010-11#1)(2010-2#1)(2013-1#1)
to solve##109##2##(1990-12#1)(1991-10#1)(1991-4#1)(1992-9#1)(1994-6#1)(1996-12#1)(1997-1#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-11#1)(2006-2#2)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#11)(2008-3#15)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-6#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#3)(2011-2#3)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#3)
to solvent effects##2##3##(1994-8#1)(2008-3#1)
to solvent extraction##5##3##(1992-3#1)(2008-10#3)(2008-5#1)
to solvent##16##2##(1990-8#2)(1992-3#1)(1992-9#1)(1994-8#1)(1995-10#1)(1995-3#1)(1995-5#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-3#1)
to solving the##2##3##(2008-12#1)(2008-2#1)
to solving##3##2##(2008-12#1)(2008-2#2)
to somatic##10##2##(1994-8#2)(1995-9#1)(2007-7#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)(2013-8#1)
to somatosensory stimulation##3##3##(1991-3#2)(1993-6#1)
to somatosensory##5##2##(1991-10#1)(1991-3#3)(1993-6#1)
to somatostatin##4##2##(1992-6#1)(1994-11#2)(2006-10#1)
to some authors##2##3##(1992-2#1)(2009-10#1)
to some basic##2##3##(1990-8#1)(2004-10#1)
to some common##2##3##(2008-10#1)(2008-2#1)
to some degree##12##3##(1992-2#1)(1993-12#1)(1995-6#1)(2004-4#1)(2006-10#1)(2006-12#1)(2006-5#1)(2008-10#1)(2008-8#1)(2010-12#1)(2012-1#1)(2012-12#1)
to some extent by the##2##5##(2008-6#1)(2008-9#1)
to some extent by##6##4##(2004-4#1)(2005-7#1)(2006-10#1)(2008-3#1)(2008-6#1)(2008-9#1)
to some extent for##2##4##(2008-10#1)(2008-5#1)
to some extent on##2##4##(2008-12#1)(2013-1#1)
to some extent the##4##4##(1990-4#1)(1993-12#1)(1993-9#1)(2008-5#1)
to some extent to##2##4##(1996-6#1)(2006-11#1)
to some extent##54##3##(1990-10#1)(1990-4#1)(1990-5#1)(1992-11#1)(1993-1#1)(1993-12#1)(1993-4#1)(1993-8#1)(1993-9#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-6#1)(2004-4#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-10#1)(2007-2#1)(2007-6#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-9#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
to some form of##2##4##(2009-6#1)(2012-3#1)
to some kind of##2##4##(2007-3#1)(2008-4#1)
to some known##4##3##(1994-8#1)(2007-1#1)(2012-3#1)(2013-1#1)
to some new##2##3##(2008-10#1)(2008-3#1)
to some of the issues##2##5##(2009-6#1)(2010-8#1)
to some of the key##2##5##(1992-12#1)(2010-5#1)
to some of the more##3##5##(2006-10#1)(2008-4#2)
to some of the##24##4##(1992-12#1)(1992-3#1)(1993-7#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-7#1)(1995-8#1)(1996-12#1)(2006-10#3)(2006-6#1)(2008-10#2)(2008-4#2)(2009-6#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
to some of##26##3##(1992-12#1)(1992-3#1)(1993-7#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-7#1)(1995-8#1)(1996-12#1)(2006-10#3)(2006-6#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#1)(2009-6#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
to some other##4##3##(1991-12#1)(1997-8#1)(2006-6#1)(2008-5#1)
to some patients##3##3##(2005-8#1)(2008-9#1)(2010-8#1)
to some strains##2##3##(1991-3#1)(2008-10#1)
to some##213##2##(1990-10#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-3#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#4)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#3)(1995-9#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#2)(1997-6#2)(1997-8#1)(2004-10#1)(2004-4#2)(2005-10#2)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#9)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#3)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#3)(2007-3#1)(2007-4#1)(2007-6#3)(2008-10#25)(2008-11#4)(2008-12#2)(2008-2#6)(2008-3#6)(2008-4#5)(2008-5#8)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#7)(2009-10#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-8#4)(2010-9#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#4)(2013-1#4)(2013-8#1)
to someone##2##2##(1996-11#1)(2012-1#1)
to sophisticated##6##2##(1996-1#1)(2008-2#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
to sort out the##2##4##(1990-10#1)(1996-6#1)
to sort out##4##3##(1990-10#1)(1991-12#1)(1996-6#1)(2008-2#1)
to sort##12##2##(1990-10#1)(1991-12#1)(1996-4#1)(1996-6#1)(2005-8#1)(2006-6#1)(2008-2#1)(2008-6#1)(2011-2#3)(2012-2#1)
to sound##5##2##(1991-1#1)(1991-5#1)(1992-3#1)(2007-5#1)(2009-5#1)
to source##2##2##(2007-4#1)(2011-1#1)
to sources##2##2##(1990-12#1)(2008-11#1)
to southern##6##2##(2008-10#6)
to soybean oil##2##3##(2004-8#1)(2008-5#1)
to soybean production in the##2##5##(2008-10#2)
to soybean##9##2##(2004-8#1)(2008-10#6)(2008-5#1)(2012-11#1)
to space group##7##3##(1991-12#2)(1992-11#1)(1994-9#1)(1995-3#1)(1996-9#1)(2008-8#1)
to space##12##2##(1991-12#2)(1992-1#1)(1992-11#1)(1994-9#1)(1995-3#1)(1996-9#1)(2008-10#1)(2008-4#1)(2008-8#2)(2012-3#1)
to span the##4##3##(1991-9#1)(1993-8#1)(2007-7#1)(2008-4#1)
to spare the##3##3##(2008-10#1)(2009-5#1)(2010-12#1)
to spare##5##2##(2006-9#1)(2008-10#1)(2009-4#1)(2009-5#1)(2010-12#1)
to spark##2##2##(2008-10#1)(2008-7#1)
to spatial heterogeneity##2##3##(2008-8#2)
to spatial##23##2##(1993-5#2)(1996-11#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-2#4)(2008-3#2)(2008-8#4)(2008-9#1)(2009-5#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-3#1)
to spatially direct##2##3##(2010-4#1)(2010-9#1)
to spatially variable##2##3##(2008-8#2)
to spatially##14##2##(1995-12#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-8#2)(2009-8#2)(2010-4#2)(2010-9#1)(2011-1#1)(2013-8#1)
to spawn##2##2##(2006-4#1)(2008-8#1)
to speak of##2##3##(1996-3#1)(2007-10#1)
to speak##11##2##(1991-2#1)(1996-3#2)(2007-10#1)(2007-7#1)(2008-7#2)(2009-11#1)(2010-4#1)(2011-2#1)(2012-3#1)
to speakers##2##2##(2008-4#1)(2008-5#1)
to special##8##2##(1993-2#1)(1993-8#1)(1995-2#1)(2008-3#1)(2008-6#1)(2009-2#1)(2009-4#1)(2012-12#1)
to specialist##5##2##(2008-11#2)(2008-8#1)(2009-4#1)(2009-8#1)
to specialists in##2##3##(2007-1#1)(2008-11#1)
to specialists##3##2##(2007-1#1)(2007-6#1)(2008-11#1)
to specialized##7##2##(1992-6#1)(1992-9#1)(2007-9#1)(2008-9#1)(2013-1#3)
to specialty##7##2##(1994-3#1)(1997-2#1)(2006-10#2)(2008-4#1)(2010-10#1)(2010-12#1)
to speciate##5##2##(1994-6#1)(2007-7#1)(2007-8#1)(2008-10#2)
to speciation##6##2##(1996-6#1)(2008-10#1)(2008-8#2)(2010-6#2)
to species and##2##3##(1991-3#1)(2013-7#1)
to species composition##2##3##(2007-3#1)(2008-5#1)
to species differences##2##3##(1994-3#1)(2006-10#1)
to species level##6##3##(2007-3#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-2#2)
to species status##2##3##(2008-1#1)(2008-10#1)
to species##36##2##(1991-3#1)(1992-9#1)(1994-3#1)(1997-2#1)(2006-10#1)(2006-4#1)(2006-7#2)(2007-12#2)(2007-3#2)(2007-8#1)(2008-1#2)(2008-10#5)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-9#1)(2010-6#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
to specific DNA sequences##2##4##(1993-9#1)(2006-12#1)
to specific DNA##5##3##(1991-4#1)(1993-9#1)(1997-6#1)(2005-12#1)(2006-12#1)
to specific and non-specific##2##4##(1997-5#1)(2005-8#1)
to specific antibodies##2##3##(1992-8#1)(2012-7#1)
to specific behaviors##2##3##(1997-6#1)(2012-12#1)
to specific cell surface receptors##4##5##(1990-2#2)(1994-10#1)(2008-7#1)
to specific cell surface##5##4##(1990-2#2)(1994-10#1)(2006-6#1)(2008-7#1)
to specific cell##6##3##(1990-2#2)(1992-9#1)(1994-10#1)(2006-6#1)(2008-7#1)
to specific components of the##3##5##(2006-10#1)(2009-4#2)
to specific diseases##2##3##(2008-8#1)(2009-5#1)
to specific environmental signals##2##4##(1994-3#1)(2011-1#1)
to specific membrane##2##3##(1991-4#1)(2008-8#1)
to specific methodology##2##3##(2008-10#1)(2009-7#1)
to specific modules of an evaluation##2##6##(2013-1#2)
to specific morphological and##2##4##(1994-11#1)(2008-9#1)
to specific peptide##2##3##(1990-10#1)(2008-4#1)
to specific proteins##3##3##(1997-1#1)(2007-8#1)(2009-12#1)
to specific regions##2##3##(1993-6#1)(2011-2#1)
to specific sites in##2##4##(1994-12#1)(2009-3#1)
to specific sites on##2##4##(1991-8#1)(1997-7#1)
to specific sites##5##3##(1991-11#1)(1991-8#1)(1994-12#1)(1997-7#1)(2009-3#1)
to specific stages##2##3##(2010-5#1)(2012-2#1)
to specific treatment for##2##4##(2005-7#1)(2008-6#1)
to specific treatment##4##3##(2005-7#1)(2008-6#1)(2010-11#1)(2012-2#1)
to specific types of##3##4##(1995-5#1)(2005-7#1)(2009-4#1)
to specific##168##2##(1990-10#1)(1990-12#1)(1990-2#4)(1990-8#2)(1991-11#4)(1991-4#3)(1991-6#2)(1991-8#4)(1992-3#1)(1992-5#1)(1992-6#4)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-3#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#3)(2004-4#1)(2005-11#2)(2005-12#1)(2005-7#3)(2005-8#2)(2006-10#4)(2006-12#3)(2006-6#1)(2007-11#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#16)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#7)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#2)(2009-12#1)(2009-3#2)(2009-4#4)(2009-5#2)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#3)(2011-7#1)(2012-12#2)(2012-2#4)(2012-3#1)(2012-7#1)(2013-1#6)(2013-7#1)(2013-8#1)
to specifically affect the##2##4##(1993-8#1)(1995-8#1)
to specifically bind##5##3##(1990-7#1)(1994-8#1)(1994-9#1)(1996-8#1)(2008-10#1)
to specifically detect##3##3##(2008-10#3)
to specifically identify##2##3##(2007-11#1)(2009-6#1)
to specifically inhibit the##2##4##(1991-7#1)(1993-3#1)
to specifically measure##2##3##(2008-10#1)(2008-5#1)
to specifically target##3##3##(2008-12#1)(2010-5#1)(2010-8#1)
to specifically##41##2##(1990-12#1)(1990-6#1)(1990-7#1)(1991-7#1)(1991-9#1)(1992-5#1)(1993-3#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-3#1)(1996-8#1)(2004-12#1)(2006-7#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)
to specificity##3##2##(1992-3#1)(1997-2#1)(2012-12#1)
to specified##4##2##(1991-2#1)(2008-10#1)(2008-2#1)(2008-5#1)
to specify a single##2##4##(1995-6#1)(2008-7#1)
to specify a##4##3##(1994-5#1)(1995-6#1)(2008-7#1)(2011-1#1)
to specify the##23##3##(1994-12#1)(1996-7#1)(2005-11#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#2)(2009-10#2)(2010-11#1)(2010-12#1)(2011-1#2)(2013-1#1)(2013-8#1)
to specify which##3##3##(2008-10#1)(2013-1#2)
to specify##41##2##(1990-8#1)(1991-5#1)(1992-1#1)(1994-12#1)(1994-5#1)(1995-6#2)(1996-7#1)(2005-11#1)(2006-10#1)(2007-4#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#3)(2009-10#3)(2009-6#1)(2010-11#1)(2010-12#1)(2011-1#3)(2013-1#3)(2013-8#1)
to specimen##2##2##(2007-8#1)(2008-3#1)
to specimens##3##2##(2008-10#1)(2011-1#1)(2013-1#1)
to spectral analysis##2##3##(2007-12#1)(2008-7#1)
to spectral resolution##2##3##(2007-12#1)(2008-2#1)
to spectral##10##2##(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#1)(2008-7#1)(2012-7#1)
to spectrally##7##2##(1995-3#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2009-9#1)
to spectrophotometric determination of##4##4##(2008-10#4)
to spectrophotometric##6##2##(2008-10#6)
to spectroscopic##5##2##(1996-11#1)(1997-5#1)(2007-11#1)(2008-2#1)(2008-5#1)
to spectroscopy##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
to speculate about##2##3##(1996-4#1)(2006-5#1)
to speculate on##2##3##(1994-2#1)(2006-10#1)
to speculate that##5##3##(1990-5#1)(1994-2#1)(2008-11#1)(2008-4#1)(2013-8#1)
to speculate##12##2##(1990-5#1)(1994-2#2)(1996-4#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-11#1)(2008-4#1)(2011-3#1)(2013-8#1)
to speculation that##3##3##(1996-1#1)(1997-5#1)(2008-4#1)
to speech and##2##3##(2007-9#1)(2009-2#1)
to speech##7##2##(2007-9#1)(2008-4#1)(2008-9#2)(2009-2#1)(2012-1#1)(2012-12#1)
to speed up computations##2##4##(2008-3#2)
to speed up the##6##4##(1997-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)
to speed up##13##3##(1990-11#1)(1992-8#1)(1997-2#1)(2007-2#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-7#1)
to speed##22##2##(1990-11#1)(1990-3#1)(1990-4#1)(1992-8#1)(1993-12#1)(1997-1#1)(1997-2#2)(2007-2#1)(2008-10#5)(2008-2#1)(2008-3#4)(2008-7#1)(2012-11#1)(2012-3#1)
to spelling##2##2##(2009-7#2)
to spend in##2##3##(2008-11#1)(2011-2#1)
to spend more time on##2##5##(1993-1#1)(2008-1#1)
to spend more time##3##4##(1993-1#1)(2008-1#1)(2012-2#1)
to spend time##3##3##(1991-2#1)(2005-7#1)(2013-8#1)
to spend##16##2##(1991-2#1)(1992-9#1)(1993-1#1)(1994-12#1)(1996-12#1)(2005-7#1)(2006-7#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-8#1)
to sperm##11##2##(1997-6#3)(1997-8#3)(2006-5#2)(2007-12#1)(2008-5#1)(2010-8#1)
to spermatogenesis##2##2##(2009-10#1)(2012-2#1)
to spermatozoa##3##2##(2006-5#2)(2012-2#1)
to spermine##3##2##(1993-12#1)(1997-8#1)(2008-8#1)
to spherical##2##2##(2008-10#1)(2013-1#1)
to spike##4##2##(1995-12#1)(1996-9#1)(2008-10#1)(2009-4#1)
to spill over into##2##4##(2006-6#1)(2009-7#1)
to spin##5##2##(1990-5#1)(1993-3#1)(2006-12#1)(2006-7#1)(2008-2#1)
to spinal cord injury##3##4##(1993-12#1)(2007-11#1)(2008-2#1)
to spinal cord##5##3##(1993-12#1)(2007-11#1)(2008-2#1)(2008-5#1)(2012-1#1)
to spinal metastases##3##3##(2006-2#2)(2008-7#1)
to spinal##15##2##(1990-11#1)(1993-12#2)(1996-12#1)(1996-2#1)(1997-8#1)(2006-2#2)(2006-5#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-5#1)(2008-7#1)(2012-1#1)
to spindle##3##2##(2008-6#1)(2012-12#2)
to spine##2##2##(2006-7#1)(2007-3#1)
to splanchnic##2##2##(1997-5#1)(2006-8#1)
to spleen and##2##3##(1990-4#1)(2008-4#1)
to spleen##3##2##(1990-4#1)(2008-11#1)(2008-4#1)
to splice##4##2##(1991-5#1)(1991-9#1)(1993-5#1)(1996-12#1)
to splicing##3##2##(1992-12#1)(1995-1#1)(1996-7#1)
to split##10##2##(1995-12#1)(1996-6#1)(1997-6#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-4#1)(2009-11#1)(2009-2#1)
to sponsor##10##2##(2006-10#8)(2007-4#1)(2008-6#1)
to spontaneous healing##2##3##(1991-12#1)(2007-8#1)
to spontaneous##19##2##(1990-2#1)(1990-5#1)(1991-12#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-10#1)(1997-4#1)(1997-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-3#1)(2011-1#1)
to spontaneously##6##2##(1990-2#1)(1996-11#1)(1997-6#1)(2007-1#1)(2008-10#1)(2011-1#1)
to sporadic##2##2##(2009-10#1)(2012-2#1)
to spore germination##2##3##(2008-10#1)(2011-2#1)
to spore##5##2##(2008-10#2)(2010-10#1)(2010-2#1)(2011-2#1)
to sport##5##2##(1993-3#1)(2008-12#1)(2008-2#1)(2011-1#1)(2013-7#1)
to sports and occupational##2##4##(2009-3#2)
to sports and##3##3##(2009-3#2)(2013-7#1)
to sports##8##2##(2008-9#1)(2009-3#2)(2009-5#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
to sporulate and##2##3##(1991-8#1)(2008-10#1)
to sporulate##6##2##(1991-8#1)(1995-9#1)(2008-10#3)(2012-3#1)
to sporulation##3##2##(1997-3#1)(2008-10#2)
to spot##4##2##(2008-11#1)(2010-4#1)(2011-1#1)(2013-1#1)
to spouses##2##2##(2009-4#1)(2012-12#1)
to spread and##4##3##(2006-10#1)(2008-1#1)(2008-5#1)(2011-2#1)
to spread awareness##2##3##(2007-7#1)(2011-1#1)
to spread from##4##3##(2008-10#1)(2008-9#1)(2009-9#1)(2010-10#1)
to spread in##2##3##(2008-10#2)
to spread into##3##3##(2008-10#2)(2013-1#1)
to spread of scab within##3##5##(2008-10#3)
to spread over##2##3##(1994-6#1)(1996-5#1)
to spread the##3##3##(1997-6#1)(2007-7#1)(2010-12#1)
to spread to##4##3##(2007-11#1)(2007-9#1)(2008-11#1)(2010-12#1)
to spread##38##2##(1993-3#1)(1994-6#1)(1995-5#1)(1996-5#1)(1997-6#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-12#2)(2011-1#2)(2011-2#1)(2013-1#1)
to spreading##3##2##(2007-12#1)(2007-7#1)(2010-12#1)
to spring##2##2##(2008-12#1)(2009-4#1)
to sprout##3##2##(1990-2#1)(1992-7#1)(1997-3#1)
to spurious##4##2##(2006-4#1)(2006-5#1)(2008-3#2)
to squamous cell carcinoma##3##4##(1996-11#1)(2005-11#1)(2010-5#1)
to squamous##4##2##(1993-11#1)(1996-11#1)(2005-11#1)(2010-5#1)
to ssDNA##2##2##(1995-8#1)(1996-7#1)
to stabilise the##2##3##(1991-6#1)(2007-8#1)
to stabilise##4##2##(1991-6#1)(2007-8#1)(2008-10#1)(2008-4#1)
to stability and##2##3##(1997-4#1)(2012-2#1)
to stability##3##2##(1997-4#1)(2005-11#1)(2012-2#1)
to stabilization of the##3##4##(1992-3#1)(2008-4#1)(2012-2#1)
to stabilization of##4##3##(1992-3#1)(2007-8#1)(2008-4#1)(2012-2#1)
to stabilization##6##2##(1992-3#1)(2007-8#1)(2008-10#1)(2008-4#1)(2012-2#1)(2013-1#1)
to stabilize a##3##3##(1992-6#1)(1995-10#1)(2008-3#1)
to stabilize the##31##3##(1990-12#1)(1990-8#1)(1991-2#1)(1991-8#1)(1992-3#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-5#1)(1995-1#1)(1996-9#1)(1997-2#1)(1997-6#1)(2005-11#3)(2006-10#1)(2006-12#1)(2006-3#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-12#1)(2010-8#1)(2012-3#1)(2013-8#1)
to stabilize##68##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-10#2)(1996-11#1)(1996-5#2)(1996-9#1)(1997-2#2)(1997-6#2)(2005-11#5)(2006-10#1)(2006-12#1)(2006-3#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#2)(2008-8#2)(2009-8#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
to stable##12##2##(1990-5#1)(1994-11#1)(1995-3#2)(1997-3#1)(2006-12#1)(2007-12#3)(2008-8#1)(2012-2#1)(2013-7#1)
to stably express##3##3##(2006-12#1)(2007-6#1)(2008-11#1)
to stably##5##2##(2005-7#1)(2006-12#1)(2007-6#1)(2008-11#1)(2008-8#1)
to staff and##2##3##(1991-2#1)(1996-3#1)
to staff##15##2##(1991-2#1)(1991-4#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-3#1)(1997-1#1)(2008-11#2)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
to staffing##2##2##(2006-2#1)(2008-11#1)
to stage I##3##3##(1991-8#1)(2011-2#2)
to stage of##2##3##(1991-8#1)(2008-11#1)
to stage##19##2##(1991-8#2)(2006-10#2)(2007-11#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-7#2)(2008-8#1)(2009-9#1)(2011-2#2)(2012-3#1)
to stages##4##2##(1995-1#1)(2004-11#1)(2007-8#1)(2008-10#1)
to stain the##3##3##(1991-12#1)(1992-8#1)(2013-7#1)
to stain##11##2##(1991-12#1)(1992-8#1)(1994-10#1)(1995-9#1)(2006-5#1)(2007-12#1)(2008-4#1)(2008-8#1)(2008-9#2)(2013-7#1)
to staining intensity##2##3##(1991-11#1)(2011-2#1)
to staining of##2##3##(2005-9#1)(2008-2#1)
to staining##7##2##(1990-12#1)(1991-11#1)(2005-9#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-2#1)
to stakeholders##2##2##(2012-3#1)(2013-8#1)
to stall##2##2##(1991-9#1)(1997-3#1)
to stand for##3##3##(2007-4#1)(2008-10#1)(2008-5#1)
to stand up and##2##4##(2007-8#1)(2012-12#1)
to stand up for##2##4##(1995-9#1)(2010-5#1)
to stand up##5##3##(1995-9#1)(2007-8#1)(2008-5#1)(2010-5#1)(2012-12#1)
to stand##16##2##(1993-2#1)(1994-12#1)(1995-9#1)(2006-10#1)(2007-2#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-5#2)(2009-7#1)(2010-5#1)(2012-12#1)(2012-3#1)
to standard doses of##2##4##(2009-5#1)(2010-3#1)
to standard laboratory##2##3##(2007-3#1)(2008-10#1)
to standard methods of##2##4##(2008-10#1)(2011-2#1)
to standard methods##6##3##(2008-10#1)(2008-12#1)(2008-3#2)(2011-2#1)(2013-1#1)
to standard solutions##3##3##(2008-10#3)
to standard surgical##2##3##(2006-11#1)(2009-4#1)
to standard techniques##2##3##(2008-2#1)(2010-7#1)
to standard therapy##5##3##(2006-10#1)(2007-2#1)(2011-2#1)(2013-1#1)(2013-7#1)
to standard treatment##2##3##(2008-5#1)(2012-11#1)
to standard wound care##2##4##(2011-2#2)
to standard##98##2##(1990-12#2)(1990-8#1)(1991-8#1)(1992-2#1)(1992-5#1)(1993-6#2)(1993-9#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-5#1)(1997-2#1)(1997-8#1)(2005-12#1)(2005-7#1)(2006-10#4)(2006-11#3)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#12)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#2)(2008-5#2)(2008-6#3)(2008-7#4)(2008-9#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#7)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#2)
to standardise the##4##3##(1990-4#1)(1991-10#1)(2008-1#1)(2008-10#1)
to standardise##7##2##(1990-4#1)(1991-10#1)(1996-2#1)(2006-8#1)(2008-1#2)(2008-10#1)
to standardize and##3##3##(2007-10#1)(2008-9#1)(2013-1#1)
to standardize the##5##3##(1990-4#1)(2005-8#1)(2010-4#1)(2011-2#1)(2012-2#1)
to standardize##20##2##(1990-4#1)(1992-4#1)(1995-12#1)(1996-1#1)(1996-12#1)(2005-8#1)(2006-5#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
to standardized##6##2##(1993-10#1)(2004-12#1)(2006-10#1)(2007-10#1)(2008-10#1)(2013-1#1)
to standards##6##2##(1992-3#1)(1994-3#1)(2009-2#1)(2011-2#1)(2012-12#2)
to standing and##3##3##(2006-6#1)(2008-7#2)
to standing##9##2##(2006-6#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-7#3)(2013-1#2)
to start a##6##3##(1990-2#1)(1995-12#1)(1996-3#1)(2007-2#2)(2012-12#1)
to start and##3##3##(2008-1#1)(2008-6#1)(2013-8#1)
to start any##2##3##(2007-11#2)
to start at##3##3##(1995-12#1)(2007-12#1)(2010-9#1)
to start of##2##3##(2008-10#1)(2010-10#1)
to start the##6##3##(1996-1#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-6#1)(2010-12#1)
to start therapy##2##3##(1994-9#1)(2008-5#1)
to start treatment##2##3##(1992-2#1)(1995-10#1)
to start with##4##3##(1993-12#1)(1994-12#1)(2007-11#1)(2010-6#1)
to start##65##2##(1990-2#2)(1990-4#1)(1991-11#1)(1992-2#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-7#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-4#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-3#1)(2006-8#1)(2007-11#6)(2007-12#1)(2007-2#2)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#3)(2008-5#2)(2008-6#2)(2008-8#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-9#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
to starting##7##2##(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-4#1)(2010-8#1)(2013-1#1)
to starvation##3##2##(1996-5#1)(2007-12#1)(2008-10#1)
to state and local##3##4##(2008-6#1)(2013-1#2)
to state anxiety level##2##4##(1990-8#2)
to state that the##2##4##(2006-12#1)(2011-1#1)
to state that##8##3##(1994-2#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-7#1)(2011-1#1)(2013-1#2)
to state##26##2##(1990-4#1)(1990-8#2)(1994-2#1)(1995-11#1)(1995-3#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-6#2)(2008-7#1)(2009-12#1)(2009-7#1)(2010-8#3)(2011-1#2)(2013-1#5)
to state-of-the-art##3##2##(2008-2#1)(2009-5#1)(2009-9#1)
to states##4##2##(1994-2#2)(1995-9#1)(2009-11#1)
to static##11##2##(1991-5#4)(1997-1#1)(2006-10#1)(2008-3#1)(2008-4#1)(2009-7#1)(2013-8#2)
to statin therapy in##4##4##(1997-2#2)(2008-7#1)(2009-12#1)
to statin therapy##5##3##(1997-2#2)(2008-7#1)(2009-12#1)(2013-8#1)
to statins##2##2##(2010-9#2)
to stationary##4##2##(1993-2#1)(2007-12#2)(2009-6#1)
to statistical analysis##3##3##(1990-7#1)(1994-6#1)(2008-1#1)
to statistical##9##2##(1990-6#1)(1990-7#1)(1994-6#1)(2005-11#1)(2008-1#2)(2008-10#1)(2012-3#1)(2013-7#1)
to statistically##7##2##(2007-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-3#1)
to stay and##3##3##(2006-8#1)(2008-10#1)(2009-6#1)
to stay at##2##3##(2004-7#1)(2007-4#1)
to stay healthy##2##3##(1994-12#1)(2011-2#1)
to stay in the##3##4##(2007-1#1)(2007-12#1)(2008-3#1)
to stay in##4##3##(2007-1#1)(2007-12#1)(2008-3#1)(2011-2#1)
to stay on##3##3##(1995-1#1)(1997-2#1)(2008-7#1)
to stay open##2##3##(1996-12#1)(2008-3#1)
to stay##33##2##(1991-4#1)(1992-9#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-2#1)(2004-4#1)(2004-7#1)(2006-10#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-5#1)(2011-2#2)
to steady state##2##3##(1994-11#1)(2009-6#1)
to steady##3##2##(1994-11#1)(2008-11#1)(2009-6#1)
to steady-state##2##2##(1992-6#1)(2007-12#1)
to steal##2##2##(1991-7#1)(2007-9#1)
to steer the nutrition transition into a more positive direction##2##10##(2012-1#2)
to steer the##3##3##(2007-11#1)(2012-1#2)
to steer##5##2##(2007-11#1)(2007-8#1)(2012-1#2)(2013-7#1)
to stem cell##5##3##(2009-3#3)(2012-11#2)
to stem cells##3##3##(1990-12#1)(2008-11#1)(2012-12#1)
to stem from the##2##4##(2005-10#1)(2007-12#1)
to stem from##3##3##(2005-10#1)(2007-12#1)(2008-4#1)
to stem##17##2##(1990-12#1)(1994-3#1)(1997-3#1)(2005-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-9#1)(2009-3#3)(2012-11#2)(2012-12#1)
to stenosis##4##2##(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#1)
to stent occlusion##2##3##(1990-8#1)(2013-1#1)
to stent##4##2##(1990-8#1)(2011-2#2)(2013-1#1)
to step##3##2##(1993-1#1)(2010-5#1)(2011-2#1)
to stepwise##2##2##(1990-10#1)(2007-8#1)
to stereoselective##3##2##(1993-2#1)(1994-5#1)(2008-10#1)
to stereotype##2##2##(1993-5#1)(2008-5#1)
to steric hindrance##4##3##(1994-9#1)(2006-12#1)(2008-10#2)
to steric##8##2##(1994-9#1)(1997-7#1)(2006-12#1)(2008-10#4)(2010-12#1)
to sterility##2##2##(2012-2#1)(2013-8#1)
to sterilization##3##2##(1993-1#1)(2009-7#1)(2010-1#1)
to sterilize##2##2##(2005-12#1)(2008-9#1)
to steroid therapy##4##3##(1994-6#1)(2007-7#1)(2008-4#1)(2013-1#1)
to steroid##9##2##(1991-8#1)(1994-6#1)(1996-2#1)(2005-8#1)(2007-7#1)(2008-4#2)(2012-2#1)(2013-1#1)
to steroids##7##2##(1994-5#1)(1997-8#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-11#1)(2013-1#1)
to still##3##2##(1993-12#1)(2008-7#1)(2012-12#1)
to stimulants##2##2##(2008-6#1)(2008-8#1)
to stimulate DNA synthesis in##2##5##(1990-11#1)(1990-9#1)
to stimulate DNA synthesis##7##4##(1990-11#1)(1990-9#1)(1992-3#1)(1992-9#1)(1995-1#1)(1995-5#1)(1997-7#1)
to stimulate ET release##2##4##(1990-12#2)
to stimulate PI turnover##2##4##(1991-5#1)(1993-9#1)
to stimulate PI##3##3##(1991-5#1)(1993-9#1)(1994-9#1)
to stimulate a##6##3##(1990-9#1)(1993-6#1)(1996-5#1)(2006-7#1)(2008-10#1)(2010-9#1)
to stimulate an##4##3##(1996-11#1)(2008-12#1)(2009-5#1)(2010-1#1)
to stimulate bone formation##2##4##(2012-11#2)
to stimulate bone resorption##2##4##(1990-9#1)(1991-3#1)
to stimulate bone##5##3##(1990-9#1)(1991-3#1)(2008-8#1)(2012-11#2)
to stimulate both##2##3##(1992-3#1)(1997-1#1)
to stimulate discussion and##2##4##(2010-8#1)(2013-8#1)
to stimulate discussion##3##3##(2009-9#1)(2010-8#1)(2013-8#1)
to stimulate endothelial##2##3##(1995-8#2)
to stimulate formation of##2##4##(1994-2#1)(1997-6#1)
to stimulate glucose##3##3##(1994-8#1)(1997-7#1)(2008-11#1)
to stimulate insulin release##2##4##(1990-8#1)(2004-11#1)
to stimulate insulin##4##3##(1990-8#1)(1992-4#1)(1995-8#1)(2004-11#1)
to stimulate its##2##3##(1990-5#1)(1993-8#1)
to stimulate macrophages to produce nitric oxide##2##7##(1993-4#2)
to stimulate or inhibit##3##4##(1994-8#1)(2006-10#1)(2008-9#1)
to stimulate phosphoinositide##3##3##(1990-11#1)(1992-10#1)(1993-7#1)
to stimulate production of##4##4##(1991-12#2)(2008-10#1)(2012-2#1)
to stimulate proliferation of##5##4##(1995-10#1)(2008-4#4)
to stimulate proliferation##6##3##(1995-10#1)(1996-11#1)(2008-4#4)
to stimulate sustained##2##3##(2008-10#1)(2009-12#1)
to stimulate the development of##2##5##(1990-10#1)(1995-4#1)
to stimulate the growth of##2##5##(2006-10#1)(2008-4#1)
to stimulate the phosphorylation of##2##5##(1990-3#1)(1991-5#1)
to stimulate the production of##3##5##(2008-11#1)(2008-6#1)(2012-12#1)
to stimulate the proliferation##3##4##(1996-10#1)(2008-4#2)
to stimulate the spermiation##2##4##(2007-3#2)
to stimulate the synthesis of##2##5##(1993-12#1)(1994-2#1)
to stimulate the##44##3##(1990-10#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-5#1)(1993-12#2)(1993-8#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-9#1)(1995-3#1)(1995-4#1)(1996-10#1)(1997-1#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-3#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-6#1)(2010-7#1)(2012-1#1)(2012-12#1)
to stimulate their##3##3##(2004-3#1)(2008-7#1)(2008-8#1)
to stimulate transcription in##2##4##(1993-8#1)(2011-1#1)
to stimulate transcription when##2##4##(1994-2#1)(1996-8#1)
to stimulate transcription##4##3##(1993-8#1)(1994-2#1)(1996-8#1)(2011-1#1)
to stimulate##239##2##(1990-10#3)(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#7)(1991-1#2)(1991-10#1)(1991-12#5)(1991-2#1)(1991-3#2)(1991-5#3)(1991-6#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-12#3)(1993-4#2)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#8)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#5)(1994-9#4)(1995-1#3)(1995-10#2)(1995-12#1)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#3)(1996-10#1)(1996-11#2)(1996-12#3)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#4)(1997-1#4)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#2)(2004-11#2)(2004-3#1)(2005-11#1)(2006-1#1)(2006-10#4)(2006-3#1)(2006-7#3)(2007-11#2)(2007-12#2)(2007-3#2)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#4)(2008-12#1)(2008-3#3)(2008-4#12)(2008-5#10)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#3)
to stimulated##3##2##(1992-8#1)(1995-3#1)(2007-12#1)
to stimulating sound-pulses##2##3##(2008-8#2)
to stimulating##4##2##(2007-11#1)(2008-1#1)(2008-8#2)
to stimulation by##8##3##(1990-5#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-7#1)(1992-3#1)(1994-3#1)(1995-12#1)
to stimulation of both##2##4##(1991-1#1)(1993-12#1)
to stimulation of only##2##4##(1990-4#1)(2007-10#1)
to stimulation of the##5##4##(1990-10#1)(1991-4#1)(1992-7#1)(1992-8#1)(1995-11#1)
to stimulation of##26##3##(1990-10#1)(1990-4#2)(1991-1#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-8#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1994-8#1)(1995-11#2)(1996-1#1)(2007-10#1)(2007-2#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2011-1#1)
to stimulation with##10##3##(1991-10#1)(1991-2#1)(1992-1#1)(1994-12#1)(1995-2#1)(1996-12#3)(2007-2#1)(2008-6#1)
to stimulation##59##2##(1990-10#1)(1990-4#2)(1990-5#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#2)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-12#2)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-10#1)(1996-12#3)(1997-8#1)(2007-10#2)(2007-12#1)(2007-2#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-12#1)(2011-1#3)
to stimulatory molecules##2##3##(1995-12#2)
to stimuli that##4##3##(1991-8#1)(1995-12#1)(1996-10#1)(2009-10#1)
to stimuli##17##2##(1991-8#1)(1993-12#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-8#1)(2007-9#2)(2009-10#1)(2009-4#1)(2010-1#1)(2013-1#2)
to stimulus##4##2##(1995-12#1)(1997-1#2)(2009-8#1)
to stochastic fluctuations##2##3##(2013-8#2)
to stochastic##9##2##(2007-9#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-7#2)(2013-8#2)
to stop and##3##3##(1994-7#1)(1996-2#1)(2010-9#1)
to stop bleeding##3##3##(2005-10#1)(2008-3#2)
to stop codon##2##3##(1991-6#1)(1995-10#1)
to stop driving##2##3##(2006-8#2)
to stop or##4##3##(2006-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
to stop selling##2##3##(2007-2#1)(2009-6#1)
to stop smoking##2##3##(2011-1#1)(2012-2#1)
to stop the rapid increase##2##5##(2012-2#2)
to stop the reaction##2##4##(2006-5#1)(2008-11#1)
to stop the##16##3##(1995-6#1)(1996-9#1)(1997-6#1)(2006-1#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-2#1)(2012-2#3)(2013-1#1)
to stop##60##2##(1991-12#1)(1991-6#2)(1992-6#1)(1994-2#1)(1994-7#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-6#3)(1996-2#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-6#1)(1997-8#1)(2004-5#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#1)(2010-1#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#2)(2013-8#1)
to storage##5##2##(1991-3#1)(1994-3#2)(2008-8#2)
to store and##4##3##(2007-12#1)(2007-9#1)(2008-7#1)(2012-1#1)
to store the##4##3##(1996-11#1)(2006-6#1)(2008-2#1)(2008-3#1)
to store##28##2##(1993-3#1)(1996-11#1)(1997-6#1)(2006-6#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#5)(2008-5#2)(2008-7#4)(2012-1#1)(2012-11#2)
to strain##11##2##(1993-9#1)(2005-11#1)(2006-9#2)(2008-10#4)(2008-3#1)(2009-3#1)(2012-1#1)
to strains##3##2##(2008-1#1)(2008-10#1)(2010-7#1)
to strategic planning##5##3##(1994-2#2)(1994-3#1)(1995-1#1)(2012-3#1)
to strategic##6##2##(1994-2#2)(1994-3#1)(1995-1#1)(1997-1#1)(2012-3#1)
to strategically##4##2##(1996-1#1)(1996-2#1)(1996-3#2)
to strategies for##3##3##(1991-12#1)(2008-10#1)(2008-6#1)
to strategies that##2##3##(2008-8#1)(2012-3#1)
to strategies##6##2##(1991-12#1)(1991-6#1)(2008-10#1)(2008-6#1)(2008-8#1)(2012-3#1)
to stratify patients##3##3##(1996-4#1)(2007-12#1)(2012-2#1)
to stratify the##2##3##(1997-6#1)(2008-10#1)
to stratify##7##2##(1996-4#1)(1997-6#1)(2007-12#1)(2008-10#2)(2012-2#2)
to stratum corneum##3##3##(1996-5#1)(2007-7#1)(2008-5#1)
to stratum##4##2##(1996-5#1)(2007-7#1)(2008-5#1)(2012-12#1)
to strawberry fields##3##3##(2008-10#3)
to strawberry##7##2##(2008-10#7)
to stray light##2##3##(2008-2#1)(2008-3#1)
to stray##3##2##(2008-2#1)(2008-3#1)(2010-9#1)
to streamline and##2##3##(1997-3#1)(2008-10#1)
to streamline##7##2##(1994-3#1)(1997-3#1)(2008-10#1)(2008-8#1)(2010-9#1)(2012-1#1)(2012-3#1)
to strength##2##2##(1994-8#1)(2008-7#1)
to strengthen and##2##3##(1992-3#1)(2008-7#1)
to strengthen public##2##3##(2007-12#1)(2011-2#1)
to strengthen the hypothesis that##3##5##(1995-5#1)(2012-2#1)(2013-1#1)
to strengthen the public health##2##5##(1996-2#1)(1997-2#1)
to strengthen the##21##3##(1992-6#1)(1993-12#1)(1995-5#1)(1996-2#1)(1997-2#1)(2004-12#1)(2006-10#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-6#1)(2010-3#1)(2011-12#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
to strengthen their##3##3##(1992-3#1)(1997-2#1)(2012-12#1)
to strengthen these##2##3##(2007-10#1)(2009-10#1)
to strengthen##47##2##(1990-4#1)(1992-3#2)(1992-6#1)(1993-12#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-2#2)(2004-12#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#2)(2008-7#1)(2009-10#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
to strengthening##2##2##(1992-1#1)(2013-1#1)
to streptavidin##3##2##(1994-3#1)(1994-9#1)(1997-2#1)
to streptococcus##2##2##(2009-5#1)(2011-12#1)
to streptokinase##2##2##(2007-11#2)
to streptomycin##6##2##(1993-8#1)(2008-10#2)(2008-5#1)(2009-6#1)(2010-2#1)
to stress and##14##3##(1993-12#1)(1994-11#1)(1994-6#1)(1995-12#2)(1996-2#1)(2006-9#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)
to stress at##2##3##(1995-12#1)(2007-2#1)
to stress conditions##4##3##(2008-2#1)(2009-8#1)(2012-12#1)(2013-7#1)
to stress in the##2##4##(1994-11#1)(2008-11#1)
to stress in##8##3##(1994-11#1)(1995-12#1)(1995-8#1)(2004-2#1)(2008-10#1)(2008-11#2)(2008-7#1)
to stress is##3##3##(1991-8#1)(2012-2#1)(2013-1#1)
to stress of##2##3##(2006-10#1)(2008-5#1)
to stress response##2##3##(1996-9#1)(2011-1#1)
to stress the importance of##2##5##(2007-10#1)(2008-3#1)
to stress the##5##3##(1990-8#1)(1990-9#1)(2007-10#1)(2008-3#1)(2008-7#1)
to stress##93##2##(1990-8#1)(1990-9#1)(1991-8#1)(1993-12#3)(1993-7#1)(1994-11#6)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#13)(1995-8#1)(1996-2#3)(1996-5#1)(1996-9#2)(1997-4#1)(1997-5#2)(1997-7#1)(2004-2#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-6#1)(2008-10#2)(2008-11#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#1)(2009-10#1)(2009-2#1)(2009-6#1)(2009-8#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
to stressed##3##2##(2008-2#1)(2009-8#1)(2013-1#1)
to stressful stimuli##4##3##(1990-12#1)(1994-2#2)(2013-1#1)
to stressful##6##2##(1990-12#1)(1994-2#2)(2006-8#1)(2013-1#2)
to stressors##6##2##(1995-12#2)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
to stretch##4##2##(1996-9#1)(1997-5#1)(2010-5#2)
to stretching##3##2##(2008-10#2)(2009-3#1)
to striatal##5##2##(1991-12#2)(1996-3#1)(2007-11#1)(2008-11#1)
to striate cortex##2##3##(1995-5#1)(1995-8#1)
to strict##3##2##(1996-8#1)(2007-4#1)(2008-4#1)
to striga emergence##2##3##(2008-10#2)
to strike a##2##3##(1997-6#1)(2008-4#1)
to strike the##2##3##(1996-5#1)(2006-8#1)
to strike##6##2##(1996-5#2)(1997-6#1)(2006-8#1)(2007-12#1)(2008-4#1)
to striking##2##2##(1990-4#1)(2011-12#1)
to stripe rust##10##3##(2008-10#10)
to strive for##2##3##(2007-11#1)(2009-7#1)
to strive##3##2##(2007-11#1)(2009-7#1)(2010-12#1)
to stroke##18##2##(1995-9#2)(2007-10#5)(2007-7#2)(2007-9#3)(2008-3#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
to stromal##2##2##(1997-7#1)(2011-1#1)
to strong light##2##3##(1991-12#1)(2008-9#1)
to strong selective##2##3##(2008-7#1)(2013-1#1)
to strong##21##2##(1991-12#1)(1992-9#1)(1994-10#1)(1994-8#1)(1996-7#1)(1997-5#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#1)
to stronger##3##2##(2008-6#1)(2011-2#1)(2013-8#1)
to strongly depend on the##2##5##(1993-11#1)(2009-2#1)
to strongly enhance the##2##4##(2008-10#2)
to strongly influence the##2##4##(2008-10#1)(2008-9#1)
to strongly##27##2##(1990-11#1)(1990-12#1)(1992-5#2)(1993-11#1)(1993-12#2)(1994-11#1)(1994-8#1)(1995-6#1)(2005-11#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-12#2)(2008-10#5)(2008-3#1)(2008-4#1)(2008-9#1)(2009-2#1)(2009-4#1)(2012-12#1)
to structural and functional##2##4##(2008-7#1)(2010-8#1)
to structural and##3##3##(2006-5#1)(2008-7#1)(2010-8#1)
to structural changes in the##2##5##(1996-3#1)(1997-4#1)
to structural changes##5##3##(1991-5#1)(1993-8#1)(1994-5#1)(1996-3#1)(1997-4#1)
to structural characterization##2##3##(1994-12#1)(2009-9#1)
to structural##37##2##(1991-5#1)(1991-9#1)(1992-12#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-4#2)(1997-7#1)(2005-11#1)(2006-10#2)(2006-5#1)(2006-9#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-1#1)
to structurally##4##2##(1997-2#1)(2006-12#1)(2008-1#1)(2008-11#1)
to structure and##3##3##(1993-4#1)(2004-2#1)(2008-7#1)
to structure the##2##3##(2008-8#1)(2010-2#1)
to structure##16##2##(1992-12#1)(1993-4#1)(1995-2#1)(1997-1#1)(2004-2#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-12#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-1#2)(2012-2#2)
to structured##2##2##(2008-2#1)(2008-9#1)
to structures##6##2##(1990-11#1)(1991-11#1)(1992-11#1)(1995-3#1)(2008-4#1)(2011-2#1)
to struggle with##2##3##(2007-2#1)(2008-10#1)
to struggle##3##2##(2006-10#1)(2007-2#1)(2008-10#1)
to student nurses##2##3##(2008-11#1)(2008-12#1)
to student##10##2##(2008-11#3)(2008-12#4)(2008-2#1)(2013-1#2)
to students from##2##3##(2008-11#1)(2011-2#1)
to students of##2##3##(1991-11#1)(2004-12#1)
to students##17##2##(1991-11#1)(1996-1#1)(2004-12#1)(2007-1#1)(2007-12#1)(2008-11#3)(2008-12#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
to students'##5##2##(2004-12#1)(2008-12#2)(2013-1#2)
to studies in##3##3##(2008-5#1)(2010-4#1)(2010-6#1)
to studies of##7##3##(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-2#1)(2012-3#1)
to studies on the##2##4##(1995-5#1)(2009-10#1)
to studies on##3##3##(1995-5#1)(2009-10#1)(2010-12#1)
to studies with##2##3##(2006-10#1)(2008-8#1)
to studies##23##2##(1993-11#1)(1995-5#2)(1996-5#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#2)(2010-4#2)(2010-6#1)(2012-2#1)(2012-3#1)
to study (1)##3##3##(2008-3#1)(2008-4#1)(2008-9#1)
to study a large##3##4##(1991-11#1)(1993-11#1)(2006-8#1)
to study a##10##3##(1991-11#1)(1993-11#1)(1996-6#1)(1996-8#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-6#1)
to study age##2##3##(1990-9#1)(2008-8#1)
to study aging##2##3##(1993-11#1)(1994-5#1)
to study and characterize##2##4##(2007-11#1)(2008-2#1)
to study and compare##2##4##(1992-3#1)(2007-7#1)
to study and##12##3##(1992-3#1)(1995-1#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-1#2)(2012-3#1)(2013-8#1)
to study any##3##3##(1997-6#1)(2007-10#1)(2008-4#1)
to study bacterial##2##3##(1990-9#1)(2008-11#1)
to study basic##3##3##(2008-4#1)(2008-9#1)(2010-7#1)
to study biological##3##3##(2007-12#1)(2008-5#1)(2008-9#1)
to study bone##2##3##(1992-5#1)(2004-9#1)
to study both the##6##4##(1993-6#1)(1994-10#1)(1997-8#1)(2009-4#1)(2013-1#2)
to study both##8##3##(1993-6#1)(1994-10#1)(1997-8#1)(2008-3#1)(2009-4#1)(2010-6#1)(2013-1#2)
to study brain##2##3##(2008-11#1)(2008-8#1)
to study cancer##2##3##(1995-9#1)(2008-11#1)
to study cell##4##3##(2008-10#1)(2008-4#2)(2009-12#1)
to study clinical##2##3##(2007-8#1)(2012-3#1)
to study competition for nutrients##2##5##(2008-10#2)
to study different##3##3##(2007-10#1)(2008-2#1)(2010-5#1)
to study dynamic##3##3##(1997-4#1)(2011-1#2)
to study early##2##3##(2008-7#1)(2012-12#1)
to study effects of##4##4##(2008-11#1)(2008-2#1)(2010-10#1)(2010-2#1)
to study effects##5##3##(2006-12#1)(2008-11#1)(2008-2#1)(2010-10#1)(2010-2#1)
to study factors##2##3##(1990-3#1)(2008-8#1)
to study fast biological reactions involving O2##2##7##(1995-8#2)
to study further##2##3##(1994-8#1)(2008-5#1)
to study gene expression##2##4##(2008-10#1)(2008-8#1)
to study gene function##2##4##(2008-2#1)(2008-4#1)
to study gene##5##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)
to study glucose##2##3##(1990-11#1)(2004-9#1)
to study how##9##3##(1995-11#1)(1996-11#1)(2007-12#1)(2008-10#1)(2008-5#2)(2008-8#1)(2010-4#1)(2010-8#1)
to study human##4##3##(1995-10#1)(1996-5#1)(2006-12#1)(2008-10#1)
to study immunological aspects of##2##5##(1991-8#1)(2008-4#1)
to study in detail the##2##5##(1991-3#1)(2008-2#1)
to study in vitro##2##4##(2008-4#1)(2008-9#1)
to study in##9##3##(1991-3#1)(1996-4#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-4#1)(2008-9#1)(2012-12#1)
to study individual##3##3##(2006-12#1)(2008-5#1)(2012-3#1)
to study its effects on##3##5##(1995-2#1)(1995-8#1)(2013-7#1)
to study its##14##3##(1995-2#1)(1995-8#1)(1996-2#1)(1997-6#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-5#1)(2010-2#2)(2012-12#1)(2013-7#1)(2013-8#1)
to study mechanisms of##6##4##(1992-11#1)(1996-10#1)(2008-10#1)(2008-4#1)(2013-1#2)
to study mechanisms##7##3##(1991-11#1)(1992-11#1)(1996-10#1)(2008-10#1)(2008-4#1)(2013-1#2)
to study methylation##2##3##(2008-4#2)
to study morphological changes##2##4##(2006-5#1)(2011-1#1)
to study of##4##3##(1996-8#1)(2008-10#2)(2011-2#1)
to study patients with##2##4##(1992-7#1)(2013-1#1)
to study patterns of gene expression##2##6##(1997-6#1)(2008-7#1)
to study patterns of##3##4##(1997-6#1)(2008-7#1)(2009-2#1)
to study photon migration##2##4##(2008-2#1)(2008-3#1)
to study plant##2##3##(2009-10#1)(2013-8#1)
to study prevalence of##2##4##(2006-6#1)(2008-12#1)
to study prevalence##3##3##(2006-6#1)(2007-7#1)(2008-12#1)
to study processes##2##3##(2007-9#1)(2008-11#1)
to study protein##3##3##(2007-6#1)(2008-4#1)(2012-2#1)
to study protein-protein##2##3##(2007-8#2)
to study several##2##3##(1990-12#1)(2008-10#1)
to study some##2##3##(1990-3#1)(2006-10#1)
to study specifically##2##3##(1992-11#1)(2006-10#1)
to study structure-activity relationships##2##4##(1994-9#1)(1996-10#1)
to study surface##2##3##(2008-10#1)(2008-4#1)
to study synaptic function##2##4##(2007-12#2)
to study the actions of##3##5##(1990-5#1)(1996-1#1)(2008-2#1)
to study the activity of##2##5##(1991-5#1)(2013-1#1)
to study the adsorption of##2##5##(2008-10#2)
to study the adsorption##3##4##(2008-10#3)
to study the antioxidant##2##4##(1993-2#1)(2011-2#1)
to study the behavior##3##4##(1991-3#1)(2008-2#1)(2008-3#1)
to study the binding##4##4##(1991-8#1)(1993-11#1)(2006-10#1)(2008-11#1)
to study the biological##2##4##(1995-6#1)(2013-8#1)
to study the cellular and##2##5##(1990-4#1)(1994-6#1)
to study the cellular##5##4##(1990-4#1)(1994-6#1)(2008-11#1)(2009-12#1)(2010-12#1)
to study the characteristics of##2##5##(2006-12#1)(2008-5#1)
to study the chemical##2##4##(2006-12#1)(2008-10#1)
to study the clinical##2##4##(1993-5#1)(2008-5#1)
to study the conformational##2##4##(1994-8#1)(2008-4#1)
to study the contribution of##2##5##(1997-1#1)(2010-9#1)
to study the correlation of##2##5##(2005-12#1)(2006-1#1)
to study the distribution of##10##5##(1990-7#1)(1991-5#1)(1992-8#1)(1994-8#1)(1995-12#1)(1995-5#1)(1997-1#1)(2008-10#1)(2008-11#1)(2010-9#1)
to study the dynamics of the##4##6##(2008-1#2)(2008-3#1)(2010-11#1)
to study the dynamics of##7##5##(2005-11#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-7#1)(2010-11#1)
to study the effect of a##2##6##(1991-6#1)(2008-7#1)
to study the effect of the##8##6##(1994-10#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-3#1)(2013-7#2)
to study the effect of##54##5##(1990-11#1)(1990-2#1)(1991-6#1)(1991-7#2)(1992-3#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-5#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-5#1)(1997-1#1)(1997-2#2)(2004-9#1)(2006-11#1)(2007-10#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-10#5)(2008-12#2)(2008-2#2)(2008-5#1)(2008-7#3)(2008-8#2)(2009-3#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#1)(2013-7#2)(2013-8#1)
to study the effect on##2##5##(1996-9#2)
to study the effect##57##4##(1990-11#1)(1990-2#1)(1991-6#1)(1991-7#2)(1992-3#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-5#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-5#1)(1996-9#2)(1997-1#1)(1997-2#2)(2004-9#1)(2006-11#1)(2007-10#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-10#5)(2008-12#2)(2008-2#2)(2008-5#2)(2008-7#3)(2008-8#2)(2009-3#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#1)(2013-7#2)(2013-8#1)
to study the effects of different##2##6##(2012-11#1)(2013-8#1)
to study the effects of initial##2##6##(2008-10#2)
to study the effects of these##2##6##(1997-7#1)(2006-8#1)
to study the effects of##41##5##(1992-6#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1995-12#1)(1997-3#2)(1997-5#1)(1997-7#2)(2005-11#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2008-10#4)(2008-12#1)(2008-2#4)(2008-4#1)(2008-5#1)(2009-8#1)(2010-4#2)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
to study the effects on##2##5##(1993-12#1)(2008-5#1)
to study the effects##43##4##(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1995-12#1)(1997-3#2)(1997-5#1)(1997-7#2)(2005-11#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2008-10#4)(2008-12#1)(2008-2#4)(2008-4#1)(2008-5#2)(2009-8#1)(2010-4#2)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
to study the efficacy of##2##5##(1991-11#1)(2008-5#1)
to study the epidemiological##2##4##(2007-2#1)(2008-5#1)
to study the evolution of##3##5##(2008-2#1)(2008-7#1)(2008-8#1)
to study the expression of##3##5##(1991-9#1)(1992-3#1)(2008-9#1)
to study the expression##4##4##(1990-9#1)(1991-9#1)(1992-3#1)(2008-9#1)
to study the factors##2##4##(2008-7#1)(2011-2#1)
to study the feasibility##2##4##(2008-3#1)(2008-8#1)
to study the formation of the##2##6##(1990-3#1)(2008-4#1)
to study the formation of##3##5##(1990-3#1)(2008-4#1)(2008-6#1)
to study the function of##5##5##(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
to study the functional##4##4##(1992-11#1)(2006-6#1)(2007-12#1)(2008-10#1)
to study the genetic basis##2##5##(2008-4#1)(2010-4#1)
to study the genetic##4##4##(2008-10#1)(2008-4#1)(2008-7#1)(2010-4#1)
to study the growth##3##4##(2008-3#1)(2013-8#2)
to study the immunogenicity of##2##5##(1997-6#1)(2007-2#1)
to study the impact of##4##5##(2008-10#1)(2008-4#1)(2010-2#1)(2011-1#1)
to study the impact##5##4##(2006-11#1)(2008-10#1)(2008-4#1)(2010-2#1)(2011-1#1)
to study the in vivo##5##5##(1994-9#1)(1995-8#1)(2004-9#2)(2011-1#1)
to study the in##6##4##(1994-9#1)(1995-8#1)(2004-9#2)(2008-1#1)(2011-1#1)
to study the influence of cell shape##2##7##(1994-8#1)(2008-2#1)
to study the influence of the##4##6##(2005-11#1)(2007-9#1)(2008-10#1)(2008-2#1)
to study the influence of##19##5##(1992-6#1)(1993-9#1)(1994-8#1)(1997-8#1)(2004-11#1)(2005-11#1)(2006-10#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#3)(2010-4#1)(2012-2#1)(2013-8#1)
to study the inheritance of##2##5##(2008-10#2)
to study the interaction between##7##5##(1997-6#1)(2005-11#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-6#1)(2011-1#1)
to study the interaction of##5##5##(1990-4#1)(1994-2#1)(2007-5#1)(2008-5#1)(2008-9#1)
to study the interaction##13##4##(1990-4#1)(1994-2#1)(1997-6#1)(2005-11#1)(2007-5#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-1#1)
to study the interactions of##3##5##(2008-9#2)(2010-12#1)
to study the interactions##4##4##(2008-9#2)(2010-12#1)(2011-2#1)
to study the involvement of##3##5##(1996-3#1)(2008-11#1)(2012-3#1)
to study the joint##2##4##(2012-3#2)
to study the kinetic##3##4##(2008-10#2)(2008-11#1)
to study the kinetics of##4##5##(1990-12#1)(2008-11#1)(2008-2#1)(2008-4#1)
to study the mechanism by which##2##6##(1992-3#1)(1994-6#1)
to study the mechanism of##7##5##(1991-1#1)(1992-8#1)(1996-8#1)(2007-4#1)(2008-1#1)(2008-11#1)(2009-7#1)
to study the mechanism##9##4##(1991-1#1)(1992-3#1)(1992-8#1)(1994-6#1)(1996-8#1)(2007-4#1)(2008-1#1)(2008-11#1)(2009-7#1)
to study the mechanisms of##5##5##(2008-11#1)(2008-8#1)(2009-11#1)(2010-12#1)(2013-8#1)
to study the mechanisms##8##4##(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#2)(2009-11#1)(2010-12#1)(2013-8#1)
to study the metal##2##4##(1992-4#1)(2008-10#1)
to study the mode of##2##5##(1996-3#1)(2005-10#1)
to study the modulation##2##4##(2010-3#1)(2010-5#1)
to study the molecular basis of the##2##7##(1997-2#1)(2008-10#1)
to study the molecular basis of##3##6##(1990-7#1)(1997-2#1)(2008-10#1)
to study the molecular interactions between##2##6##(1995-10#1)(2008-10#1)
to study the molecular mechanisms##2##5##(1991-7#1)(2013-1#1)
to study the molecular##9##4##(1990-7#1)(1991-7#1)(1992-8#1)(1995-10#1)(1995-2#1)(1997-2#1)(2008-10#2)(2013-1#1)
to study the mononuclear phagocytic system##2##6##(2007-11#2)
to study the occurrence of##3##5##(1990-6#1)(1991-9#1)(2007-10#1)
to study the pattern of##3##5##(1997-4#1)(2006-12#1)(2008-7#1)
to study the performance of##2##5##(2009-9#1)(2010-5#1)
to study the pharmacokinetics of##2##5##(1996-6#1)(2008-10#1)
to study the physiological##2##4##(2005-7#1)(2008-10#1)
to study the population##3##4##(2008-10#2)(2008-8#1)
to study the possible##3##4##(1992-12#1)(1997-1#1)(2008-10#1)
to study the prevalence of##7##5##(1990-9#1)(1997-2#1)(2006-7#1)(2007-10#1)(2007-3#1)(2011-1#1)(2011-12#1)
to study the process of##4##5##(2008-11#1)(2008-4#1)(2008-8#1)(2009-12#1)
to study the process##5##4##(1997-1#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-12#1)
to study the processes of##2##5##(2007-8#1)(2008-11#1)
to study the processes##5##4##(2007-11#1)(2007-8#1)(2008-11#3)
to study the regulation of##4##5##(1992-12#1)(1994-8#1)(1994-9#1)(2008-4#1)
to study the regulatory##2##4##(1993-6#1)(1995-12#1)
to study the relation between##2##5##(1992-3#1)(2010-2#1)
to study the relationship between the##5##6##(1991-1#1)(2008-10#1)(2008-5#1)(2011-1#1)(2013-8#1)
to study the relationship between##12##5##(1991-1#1)(1991-11#1)(2006-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-8#2)
to study the relationship of the SSCT##2##7##(2008-9#2)
to study the relationship of##4##5##(2008-7#1)(2008-9#2)(2012-2#1)
to study the relationship##16##4##(1991-1#1)(1991-11#1)(2006-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-9#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#2)
to study the relative##2##4##(2008-3#1)(2008-4#1)
to study the role of the##2##6##(2006-10#1)(2008-11#1)
to study the role of##20##5##(1990-4#2)(1990-5#1)(1992-9#1)(1993-12#1)(1996-11#1)(1996-3#1)(1997-4#1)(2005-8#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-2#1)
to study the roles of##2##5##(2007-8#1)(2012-2#1)
to study the separation##2##4##(2008-10#2)
to study the spread of##2##5##(2008-10#2)
to study the stability of##2##5##(1997-3#1)(2005-11#1)
to study the stability##3##4##(1995-1#1)(1997-3#1)(2005-11#1)
to study the structure and activity##2##6##(2008-5#1)(2013-1#1)
to study the structure and##3##5##(1997-4#1)(2008-5#1)(2013-1#1)
to study the structure##6##4##(1991-1#1)(1993-3#1)(1997-4#1)(2008-5#1)(2010-5#1)(2013-1#1)
to study the structures of##2##5##(2005-11#1)(2008-10#1)
to study the susceptibility##2##4##(1992-9#1)(2008-5#1)
to study the thermal##2##4##(1996-11#1)(1997-7#1)
to study the topography of the##2##6##(1991-2#1)(1995-12#1)
to study the variability of##2##5##(2008-10#1)(2010-4#1)
to study the variability##3##4##(2008-10#2)(2010-4#1)
to study the variations in##2##5##(2009-7#1)(2013-8#1)
to study the variations##3##4##(2007-12#1)(2009-7#1)(2013-8#1)
to study the vibrational structure##2##5##(2006-4#2)
to study the##658##3##(1990-11#1)(1990-12#5)(1990-2#2)(1990-3#1)(1990-4#5)(1990-5#2)(1990-6#1)(1990-7#2)(1990-9#2)(1991-1#3)(1991-10#1)(1991-11#3)(1991-12#3)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#3)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#4)(1992-9#3)(1993-1#2)(1993-11#3)(1993-12#5)(1993-2#2)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#3)(1993-8#3)(1993-9#2)(1994-10#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#4)(1994-6#4)(1994-8#5)(1994-9#2)(1995-1#3)(1995-10#1)(1995-12#5)(1995-2#2)(1995-3#2)(1995-5#4)(1995-6#1)(1995-8#3)(1996-1#3)(1996-11#3)(1996-3#5)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#6)(1997-2#4)(1997-3#4)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#7)(1997-8#3)(2004-11#1)(2004-9#3)(2005-10#2)(2005-11#9)(2005-12#2)(2005-4#1)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#4)(2006-11#5)(2006-12#4)(2006-2#1)(2006-4#2)(2006-5#3)(2006-6#2)(2006-7#3)(2006-8#1)(2007-1#1)(2007-10#6)(2007-11#11)(2007-12#10)(2007-2#5)(2007-3#2)(2007-4#3)(2007-5#1)(2007-7#2)(2007-8#9)(2007-9#3)(2008-1#6)(2008-10#79)(2008-11#21)(2008-12#6)(2008-2#24)(2008-3#11)(2008-4#18)(2008-5#25)(2008-6#2)(2008-7#16)(2008-8#16)(2008-9#12)(2009-1#1)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#2)(2009-9#3)(2010-10#1)(2010-11#2)(2010-12#7)(2010-2#4)(2010-3#1)(2010-4#9)(2010-5#3)(2010-6#2)(2010-7#2)(2010-9#2)(2011-1#11)(2011-10#1)(2011-12#2)(2011-2#12)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#10)(2012-3#6)(2013-1#9)(2013-7#5)(2013-8#18)
to study their effects on##2##5##(1991-5#1)(2010-7#1)
to study their effects##3##4##(1991-5#1)(2008-10#1)(2010-7#1)
to study their performance##2##4##(2008-10#1)(2008-8#1)
to study their##16##3##(1991-5#1)(1992-1#1)(1994-12#1)(1994-6#1)(1995-12#1)(2005-12#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-10#3)(2008-8#1)(2010-7#1)(2011-2#1)(2013-7#1)
to study them##2##3##(2006-4#1)(2012-2#1)
to study these##6##3##(2007-11#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-7#1)(2010-11#1)
to study this effect##2##4##(1997-4#1)(2008-10#1)
to study this process##2##4##(1993-4#1)(1994-9#1)
to study this##15##3##(1991-12#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-9#1)(1997-4#1)(2006-2#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-9#2)(2012-12#1)(2013-8#1)
to study tumor##2##3##(1992-11#1)(2010-7#1)
to study two##2##3##(1990-3#1)(2011-1#1)
to study various aspects of##3##5##(1990-9#1)(2009-10#1)(2010-10#1)
to study various aspects##4##4##(1990-9#1)(2009-10#1)(2010-10#1)(2010-6#1)
to study various##5##3##(1990-9#1)(2009-10#1)(2010-10#1)(2010-6#1)(2012-2#1)
to study viroid replication##2##4##(2008-9#2)
to study whether the##2##4##(1996-8#1)(2011-2#1)
to study whether##4##3##(1991-9#1)(1993-9#1)(1996-8#1)(2011-2#1)
to study##1215##2##(1990-11#3)(1990-12#7)(1990-2#4)(1990-3#4)(1990-4#5)(1990-5#3)(1990-6#2)(1990-7#4)(1990-8#1)(1990-9#6)(1991-1#3)(1991-10#1)(1991-11#5)(1991-12#5)(1991-2#3)(1991-3#3)(1991-4#2)(1991-5#4)(1991-6#2)(1991-7#5)(1991-8#4)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#4)(1992-12#3)(1992-3#6)(1992-4#1)(1992-5#2)(1992-6#5)(1992-7#1)(1992-8#8)(1992-9#3)(1993-1#2)(1993-11#5)(1993-12#7)(1993-2#2)(1993-3#5)(1993-4#4)(1993-5#2)(1993-6#5)(1993-8#3)(1993-9#4)(1994-10#3)(1994-11#3)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#5)(1994-6#7)(1994-8#7)(1994-9#4)(1995-1#5)(1995-10#4)(1995-11#2)(1995-12#8)(1995-2#4)(1995-3#2)(1995-5#6)(1995-6#1)(1995-7#2)(1995-8#8)(1995-9#1)(1996-1#5)(1996-10#2)(1996-11#4)(1996-12#1)(1996-2#1)(1996-3#6)(1996-4#3)(1996-5#3)(1996-6#4)(1996-7#2)(1996-8#4)(1996-9#4)(1997-1#6)(1997-2#7)(1997-3#4)(1997-4#6)(1997-5#2)(1997-6#8)(1997-7#7)(1997-8#6)(2004-11#1)(2004-9#5)(2005-10#2)(2005-11#13)(2005-12#3)(2005-4#2)(2005-7#1)(2005-8#2)(2006-1#2)(2006-10#16)(2006-11#7)(2006-12#8)(2006-2#3)(2006-3#1)(2006-4#3)(2006-5#6)(2006-6#4)(2006-7#3)(2006-8#4)(2007-1#4)(2007-10#10)(2007-11#18)(2007-12#26)(2007-2#6)(2007-3#4)(2007-4#3)(2007-5#3)(2007-6#1)(2007-7#6)(2007-8#14)(2007-9#6)(2008-1#11)(2008-10#128)(2008-11#45)(2008-12#13)(2008-2#42)(2008-3#26)(2008-4#47)(2008-5#36)(2008-6#4)(2008-7#33)(2008-8#26)(2008-9#28)(2009-1#1)(2009-10#4)(2009-11#4)(2009-12#6)(2009-2#4)(2009-3#3)(2009-4#4)(2009-5#3)(2009-6#3)(2009-7#4)(2009-8#4)(2009-9#7)(2010-1#1)(2010-10#3)(2010-11#5)(2010-12#10)(2010-2#8)(2010-3#3)(2010-4#12)(2010-5#5)(2010-6#6)(2010-7#5)(2010-8#2)(2010-9#6)(2011-1#22)(2011-10#1)(2011-12#2)(2011-2#22)(2011-3#1)(2012-1#7)(2012-11#1)(2012-12#12)(2012-2#21)(2012-3#13)(2012-9#1)(2013-1#19)(2013-7#11)(2013-8#26)
to studying the##5##3##(1993-11#1)(2008-5#1)(2008-9#1)(2009-2#1)(2013-8#1)
to studying##13##2##(1993-11#1)(1993-3#1)(2005-11#1)(2007-10#1)(2008-10#1)(2008-5#2)(2008-9#1)(2009-2#2)(2010-2#1)(2012-2#1)(2013-8#1)
to styrene##2##2##(1997-8#1)(2008-5#1)
to sub-Doppler lines of##2##4##(2008-2#2)
to sub-lethal levels##2##3##(1992-5#1)(1996-12#1)
to sub-lethal##3##2##(1992-5#1)(1996-12#1)(2013-1#1)
to sub-ppb##2##2##(2008-10#2)
to subcellular##3##2##(1993-6#1)(1997-7#1)(2008-1#1)
to subclinical##4##2##(2006-10#1)(2012-2#1)(2013-1#2)
to subcortical##2##2##(1993-9#1)(2009-10#1)
to subcutaneous##5##2##(1992-5#1)(2004-1#1)(2007-7#1)(2008-8#1)(2012-2#1)
to subdivide the##2##3##(2007-11#1)(2012-2#1)
to subgroup I##3##3##(2008-10#3)
to subgroup##7##2##(2008-10#7)
to subgroups##4##2##(1994-9#1)(1996-2#1)(1997-8#1)(2008-10#1)
to subject##6##2##(1997-5#1)(2006-10#1)(2007-4#1)(2008-4#1)(2009-3#1)(2009-6#1)
to subjective and objective##2##4##(2008-10#1)(2008-4#1)
to subjective##10##2##(1990-3#1)(1991-8#1)(1992-5#1)(1995-11#1)(1996-12#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-9#1)
to subjects in##2##3##(2006-5#1)(2008-4#1)
to subjects with##4##3##(1991-6#1)(1995-11#2)(2009-10#1)
to subjects##15##2##(1991-6#1)(1995-11#2)(1996-2#1)(1997-7#1)(2005-1#1)(2006-5#1)(2007-5#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-3#1)
to sublethal concentrations##2##3##(1991-12#1)(2008-5#1)
to sublethal##5##2##(1991-12#1)(1994-2#1)(1995-8#1)(2008-10#1)(2008-5#1)
to submicrometer##4##2##(2007-12#1)(2008-2#3)
to submit an##2##3##(2006-8#1)(2008-7#1)
to submit their##2##3##(2008-11#1)(2008-7#1)
to submit##14##2##(1990-4#1)(1992-1#1)(1996-5#1)(2006-7#1)(2006-8#1)(2007-2#1)(2008-11#1)(2008-5#2)(2008-7#3)(2008-8#1)(2012-2#1)
to submitochondrial particles##3##3##(1990-5#1)(1992-11#1)(1995-1#1)
to suboptimal##4##2##(2007-6#1)(2007-9#1)(2008-3#1)(2010-12#1)
to subsequent pathogen##2##3##(2008-10#1)(2009-8#1)
to subsequent##22##2##(1991-12#1)(1992-6#1)(1994-11#1)(1996-4#1)(1997-1#1)(2008-10#3)(2008-2#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-2#2)(2013-1#1)(2013-7#1)
to subsequently##4##2##(1997-6#1)(2008-1#1)(2008-4#1)(2009-11#1)
to subserve##2##2##(1993-6#1)(2010-12#1)
to subside##2##2##(1995-6#1)(2007-7#1)
to subsidize##3##2##(1996-3#1)(2011-12#1)(2012-12#1)
to subsist##2##2##(1991-11#1)(2008-11#1)
to substance P##5##3##(1990-11#1)(1993-11#1)(1996-12#2)(2007-8#1)
to substance abuse##5##3##(1994-2#3)(2008-2#1)(2008-3#1)
to substance use##4##3##(2010-10#1)(2010-12#1)(2010-6#1)(2013-1#1)
to substance##15##2##(1990-11#1)(1993-11#1)(1994-2#3)(1996-12#2)(2007-8#1)(2008-2#1)(2008-3#1)(2010-10#1)(2010-12#1)(2010-6#1)(2013-1#1)(2013-8#1)
to substantial##14##2##(1992-4#1)(1997-8#3)(2007-4#1)(2007-7#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-11#1)(2013-1#2)
to substantially improve##3##3##(2006-10#1)(2006-6#1)(2008-10#1)
to substantially reduce the##5##4##(1992-8#1)(1994-11#1)(2008-3#2)(2008-6#1)
to substantially reduce##7##3##(1992-8#1)(1994-11#1)(1994-12#1)(2006-4#1)(2008-3#2)(2008-6#1)
to substantially##18##2##(1992-8#1)(1994-11#1)(1994-12#1)(1995-1#1)(1996-3#1)(1997-1#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-6#1)(2008-8#1)(2012-2#1)
to substantiate the##5##3##(1993-3#1)(2008-11#2)(2008-7#1)(2009-9#1)
to substantiate these##2##3##(1992-7#1)(2007-11#1)
to substantiate##12##2##(1992-7#1)(1993-3#1)(1995-12#1)(2007-11#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)(2012-12#1)
to substitute for the##4##4##(1993-3#1)(1993-9#1)(1995-2#1)(2008-10#1)
to substitute for##9##3##(1991-4#1)(1993-3#1)(1993-9#1)(1995-2#2)(1996-10#1)(1996-3#1)(2008-10#2)
to substitute the##4##3##(2008-11#2)(2008-8#1)(2010-11#1)
to substitute##19##2##(1991-4#1)(1993-3#1)(1993-9#1)(1995-2#2)(1996-10#1)(1996-3#1)(1997-1#1)(1997-5#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-8#1)(2008-9#1)(2010-11#1)(2013-1#1)
to substituted##5##2##(2008-10#1)(2008-8#1)(2009-3#1)(2010-2#1)(2011-1#1)
to substitution of##3##3##(1991-7#1)(2011-1#1)(2011-2#1)
to substitution##7##2##(1991-7#2)(1996-2#2)(1996-8#1)(2011-1#1)(2011-2#1)
to substitutions at position##2##4##(1994-8#2)
to substrate and##2##3##(1994-11#1)(2008-6#1)
to substrate##9##2##(1990-10#1)(1991-7#1)(1993-7#1)(1994-11#2)(1995-8#1)(1996-6#1)(2008-6#1)(2008-7#1)
to substrates##2##2##(1991-2#1)(1995-1#1)
to subtle##2##2##(2007-12#1)(2008-3#1)
to subtoxic levels of##2##4##(1993-12#1)(2008-10#1)
to subtract##3##2##(2007-12#2)(2008-3#1)
to subunit##5##2##(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#1)(1995-2#1)
to succeed in##3##3##(2008-1#1)(2008-4#1)(2011-2#1)
to succeed##9##2##(1997-2#1)(1997-3#1)(2006-10#1)(2008-1#1)(2008-4#1)(2008-8#2)(2009-12#1)(2011-2#1)
to success in##7##3##(1996-12#1)(1997-1#1)(2005-8#1)(2006-5#1)(2008-11#1)(2008-4#1)(2011-1#1)
to successful treatment##3##3##(2006-10#1)(2007-4#1)(2012-2#1)
to successful##32##2##(1991-12#1)(1994-12#1)(1994-2#3)(1994-3#1)(1995-1#1)(1995-12#1)(1997-1#1)(2005-7#2)(2006-10#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
to successfully demonstrate the##2##4##(1995-12#1)(2008-10#1)
to successfully implement##2##3##(1994-1#1)(2012-1#1)
to successfully manage##2##3##(1994-12#1)(2012-3#1)
to successfully meet the##3##4##(1991-1#1)(1997-1#1)(2012-12#1)
to successfully prevent##2##3##(2009-5#1)(2010-12#1)
to successfully treat##3##3##(1991-3#1)(2008-11#1)(2008-7#1)
to successfully##56##2##(1991-1#1)(1991-3#1)(1992-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#2)(1995-12#1)(1997-1#1)(1997-2#1)(2004-1#1)(2004-12#1)(2004-4#1)(2005-10#2)(2006-6#1)(2006-8#2)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-12#1)(2009-4#1)(2009-5#2)(2010-12#2)(2010-4#1)(2010-7#1)(2011-12#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
to successive##4##2##(1995-3#1)(2008-10#1)(2008-2#2)
to successively##3##2##(2008-2#1)(2009-3#1)(2013-1#1)
to such a signal##2##4##(1993-3#1)(2008-2#1)
to such a##14##3##(1993-12#1)(1993-3#1)(1993-4#1)(1995-1#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#2)(2009-5#1)(2009-9#1)
to such an extent that##3##5##(1990-11#1)(2007-12#1)(2009-9#1)
to such an##6##3##(1990-11#1)(1993-1#1)(2007-12#1)(2007-8#1)(2008-2#1)(2009-9#1)
to such behaviour##2##3##(2008-11#1)(2011-2#1)
to such conditions##2##3##(2008-11#1)(2008-7#1)
to such diseases##3##3##(1995-12#1)(2008-1#1)(2013-7#1)
to such environments##3##3##(2007-9#1)(2013-1#2)
to such modifications##2##3##(1993-6#1)(1997-6#1)
to such problems##3##3##(1994-6#1)(2009-10#1)(2010-12#1)
to such processes##3##3##(2008-7#1)(2013-1#2)
to such treatment##2##3##(1994-11#1)(2008-9#1)
to such##111##2##(1990-11#1)(1990-2#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-4#2)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#3)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-6#1)(2004-4#1)(2004-9#1)(2005-11#3)(2005-12#1)(2005-7#2)(2005-9#1)(2006-10#2)(2006-7#1)(2006-9#1)(2007-12#3)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#4)(2008-4#2)(2008-5#1)(2008-7#6)(2008-9#2)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#3)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#8)(2013-7#1)
to suck##2##2##(1990-8#1)(2009-6#1)
to sucrose##3##2##(1992-11#1)(1992-7#1)(2008-8#1)
to sudden cardiac death##7##4##(1994-5#1)(1995-2#1)(1996-9#1)(2007-2#1)(2008-10#1)(2008-8#1)(2009-5#1)
to sudden##12##2##(1994-5#1)(1995-2#1)(1996-9#1)(2006-10#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-8#1)(2009-2#1)(2009-5#1)(2010-11#1)
to sue the##2##3##(1995-12#1)(1996-5#1)
to sue##6##2##(1995-12#1)(1996-12#1)(1996-5#3)(1997-5#1)
to suffer any##2##3##(2009-4#1)(2013-8#1)
to suffer from a##6##4##(1990-10#1)(1991-10#1)(2008-3#1)(2008-7#1)(2009-4#1)(2009-6#1)
to suffer from##14##3##(1990-10#1)(1991-10#1)(1996-8#1)(1996-9#1)(2008-1#2)(2008-3#2)(2008-7#2)(2009-4#1)(2009-6#1)(2011-12#1)(2012-3#1)
to suffer pain##2##3##(1991-2#1)(1996-7#1)
to suffer##26##2##(1990-10#1)(1991-10#1)(1991-2#1)(1991-8#1)(1992-4#1)(1993-3#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-8#1)(2007-10#1)(2008-1#2)(2008-3#2)(2008-7#2)(2009-4#2)(2009-6#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-8#2)
to suffice##2##2##(1997-5#1)(2013-1#1)
to sufficient##4##2##(1992-6#1)(1995-2#1)(2009-8#1)(2011-2#1)
to sufficiently##2##2##(1994-6#1)(1997-1#1)
to sugar beet##3##3##(2008-10#3)
to sugar##4##2##(2007-3#1)(2008-10#3)
to sugarcane mosaic virus##2##4##(2008-10#1)(2008-9#1)
to sugarcane##6##2##(2008-10#3)(2008-9#1)(2013-1#2)
to sugars##2##2##(2011-2#2)
to suggest a functional role##2##5##(1993-6#1)(1994-5#1)
to suggest a##8##3##(1990-11#1)(1991-2#1)(1993-6#1)(1994-5#1)(2006-12#1)(2007-12#1)(2008-11#1)(2012-2#1)
to suggest an##3##3##(1992-10#1)(2007-12#1)(2008-5#1)
to suggest more##2##3##(1993-3#1)(2010-12#1)
to suggest that a##3##4##(2008-7#1)(2012-2#1)(2013-1#1)
to suggest that it is##2##5##(1996-3#1)(2006-10#1)
to suggest that the##21##4##(1990-11#1)(1991-2#1)(1992-11#1)(1993-3#1)(1994-12#1)(1994-2#1)(1996-7#1)(2006-2#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-1#1)(2012-12#1)
to suggest that their##2##4##(1995-3#1)(2008-10#1)
to suggest that this##2##4##(2005-9#1)(2008-3#1)
to suggest that##66##3##(1990-11#1)(1991-2#1)(1991-4#1)(1992-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-3#1)(1997-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-1#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-3#1)(2009-7#2)(2009-9#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)
to suggest the use of##2##5##(2008-3#1)(2008-8#1)
to suggest the##12##3##(1991-2#1)(1992-12#1)(2006-10#1)(2006-12#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#1)
to suggest##119##2##(1990-11#2)(1990-7#1)(1991-2#3)(1991-3#1)(1991-4#1)(1992-10#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-3#2)(1997-7#1)(1997-8#1)(2004-4#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#3)(2006-2#1)(2006-7#1)(2007-1#2)(2007-12#4)(2007-2#1)(2007-7#2)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#5)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#3)(2009-3#1)(2009-4#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
to suggestions##4##2##(1992-2#1)(2006-4#1)(2008-2#1)(2008-4#1)
to suicidal ideation##2##3##(1992-1#1)(2010-8#1)
to suicidal##5##2##(1992-1#1)(2010-8#1)(2012-12#2)(2013-8#1)
to suicide##10##2##(1993-3#1)(1996-1#2)(1997-3#1)(2006-12#1)(2008-8#1)(2010-5#1)(2010-6#1)(2013-1#2)
to suit different##3##3##(2008-2#2)(2010-4#1)
to suit the##7##3##(1991-5#1)(1996-12#1)(1996-6#1)(2010-3#2)(2012-12#1)(2013-1#1)
to suit##17##2##(1991-5#1)(1993-12#1)(1994-3#1)(1996-12#1)(1996-6#1)(2005-7#1)(2005-9#1)(2008-10#1)(2008-2#3)(2010-3#2)(2010-4#1)(2010-7#1)(2012-12#1)(2013-1#1)
to suitable##2##2##(2008-10#2)
to suitably##2##2##(2006-10#1)(2013-7#1)
to sulfate and##3##3##(2008-10#2)(2011-2#1)
to sulfate##6##2##(2008-10#4)(2008-6#1)(2011-2#1)
to sulfide##6##2##(1993-8#1)(2006-8#1)(2008-10#3)(2011-2#1)
to sulfite##5##2##(1990-3#1)(1991-8#1)(2007-8#2)(2008-10#1)
to sulphide##2##2##(2008-10#2)
to sum the##2##3##(2006-5#1)(2008-10#1)
to sum up the##2##4##(2007-8#1)(2008-3#1)
to sum##5##2##(2006-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
to sumatriptan##3##2##(1993-8#1)(2005-7#1)(2008-6#1)
to summarise the##7##3##(1996-11#1)(2007-11#2)(2008-8#2)(2011-1#1)(2012-12#1)
to summarise##9##2##(1996-11#1)(2007-11#2)(2008-8#2)(2008-9#1)(2011-1#1)(2012-12#2)
to summarize our##2##3##(2007-12#1)(2008-11#1)
to summarize recent##5##3##(2006-10#1)(2006-12#1)(2008-10#1)(2008-7#1)(2012-12#1)
to summarize some##2##3##(2008-4#1)(2009-10#1)
to summarize the current knowledge of##2##6##(2012-12#1)(2013-7#1)
to summarize the current##5##4##(1996-10#1)(2010-2#1)(2011-12#1)(2012-12#1)(2013-7#1)
to summarize the key##2##4##(1997-8#2)
to summarize the##30##3##(1994-5#1)(1996-10#1)(1997-8#2)(2005-9#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-1#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-2#1)(2010-9#2)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#2)
to summarize##59##2##(1993-3#1)(1994-5#1)(1995-12#1)(1996-10#1)(1996-12#1)(1997-8#2)(2005-9#1)(2006-10#4)(2006-12#2)(2006-4#1)(2007-1#1)(2007-12#2)(2008-1#1)(2008-10#6)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-2#1)(2010-9#2)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#4)(2012-2#1)(2013-1#6)(2013-7#2)(2013-8#1)
to sun##7##2##(1991-6#1)(2007-2#1)(2007-3#1)(2008-5#1)(2011-2#2)(2013-8#1)
to sunburn##3##2##(2007-1#2)(2008-4#1)
to sunlight##13##2##(1991-9#1)(2005-12#1)(2006-3#1)(2007-11#1)(2008-5#3)(2008-8#1)(2011-2#4)(2012-1#1)
to super##2##2##(2004-8#1)(2008-9#1)
to supercritical##3##2##(1996-11#2)(2008-10#1)
to superficial##2##2##(2008-6#1)(2013-1#1)
to superimposition##2##2##(2008-6#1)(2008-8#1)
to superior vena cava##3##4##(2007-8#2)(2008-11#1)
to superior##6##2##(1992-3#1)(2007-8#2)(2008-11#1)(2008-2#1)(2009-4#1)
to superoxide dismutase##2##3##(1993-1#1)(1995-3#1)
to superoxide##3##2##(1993-1#1)(1994-3#1)(1995-3#1)
to supersede##4##2##(1993-12#1)(2007-8#1)(2010-12#1)(2013-1#1)
to supplement the clinical##3##4##(1997-2#1)(2008-3#1)(2008-4#1)
to supplement the##13##3##(1996-3#1)(1996-7#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-7#1)(2013-8#1)
to supplement their##3##3##(2008-1#1)(2008-5#1)(2010-2#1)
to supplement##27##2##(1991-5#1)(1992-3#1)(1996-3#1)(1996-7#1)(1997-2#2)(1997-8#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#2)(2010-7#1)(2010-8#2)(2011-2#1)(2012-1#1)(2013-8#1)
to supplementation##2##2##(2007-11#2)
to supply an##2##3##(1995-12#1)(2008-8#1)
to supply nutrients and oxygen##2##5##(2008-11#1)(2009-11#1)
to supply the##8##3##(1997-1#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-3#1)
to supply##31##2##(1991-11#1)(1992-3#1)(1993-6#1)(1994-4#1)(1995-12#2)(1997-1#1)(2005-9#1)(2006-10#1)(2007-12#3)(2008-1#1)(2008-11#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
to support CQI##2##3##(1994-2#1)(1994-3#1)
to support a relationship between##3##5##(1993-11#1)(1996-9#1)(2006-2#1)
to support a role for##3##5##(1991-10#1)(2006-10#1)(2008-2#1)
to support a##28##3##(1991-10#1)(1991-5#1)(1993-11#1)(1993-12#1)(1994-1#2)(1995-5#1)(1996-3#1)(1996-9#1)(2005-5#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
to support activities##2##3##(1992-2#1)(2008-7#1)
to support an approach##2##4##(1994-3#1)(2006-2#1)
to support an##8##3##(1994-3#1)(2005-9#1)(2006-10#2)(2006-2#1)(2008-10#1)(2008-8#1)(2009-8#1)
to support and enhance##2##4##(2008-5#1)(2011-2#1)
to support and##7##3##(1995-1#1)(2005-12#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-2#1)
to support any##3##3##(2007-8#1)(2008-10#1)(2009-4#1)
to support appropriate##2##3##(1997-1#1)(2007-8#1)
to support both##3##3##(2009-9#1)(2010-3#1)(2010-4#1)
to support cell growth##5##4##(2006-8#1)(2008-11#2)(2008-5#1)(2012-8#1)
to support cell##6##3##(2006-8#1)(2008-11#2)(2008-5#1)(2009-7#1)(2012-8#1)
to support children's##2##3##(1992-3#1)(2010-5#1)
to support claims##2##3##(2008-5#2)
to support communication with teachers##2##5##(2012-12#2)
to support communication with##3##4##(2012-12#3)
to support data##3##3##(1997-3#1)(2013-1#2)
to support decision making##2##4##(2006-5#1)(2008-12#1)
to support dialysis##3##3##(2007-8#3)
to support each##2##3##(2007-2#1)(2010-11#1)
to support environmental##2##3##(2008-11#2)
to support extensive##2##3##(2007-4#1)(2008-10#1)
to support future##2##3##(1995-12#1)(1996-2#1)
to support growth of##3##4##(2006-5#1)(2008-4#1)(2011-2#1)
to support growth##4##3##(1994-2#1)(2006-5#1)(2008-4#1)(2011-2#1)
to support its##6##3##(2007-10#1)(2007-7#1)(2009-8#1)(2010-11#1)(2010-3#1)(2013-8#1)
to support key##3##3##(2008-3#1)(2013-1#2)
to support learning in practice##2##5##(2008-11#2)
to support long-term##2##3##(2008-11#1)(2009-6#1)
to support many##2##3##(2005-10#1)(2008-7#1)
to support multiple##3##3##(2007-12#1)(2008-2#1)(2012-1#1)
to support new##4##3##(1996-12#1)(1997-1#1)(2006-6#1)(2008-7#1)
to support or refute the##3##5##(1996-3#1)(2007-6#2)
to support or##4##3##(1996-3#1)(2006-10#1)(2007-6#2)
to support our##3##3##(2008-10#1)(2008-7#1)(2012-5#1)
to support patient care##3##4##(2008-11#1)(2013-1#2)
to support patient##5##3##(2006-4#1)(2008-11#1)(2013-1#3)
to support patients##4##3##(1995-2#1)(2008-1#1)(2010-3#1)(2011-1#1)
to support population-based##2##3##(2010-11#2)
to support primary healthcare##2##4##(2010-11#2)
to support primary##3##3##(2010-11#2)(2012-12#1)
to support quality##2##3##(2010-11#1)(2011-2#1)
to support such a##2##4##(2007-9#1)(2008-10#1)
to support such##9##3##(1997-1#1)(2005-10#1)(2007-9#1)(2008-10#2)(2008-11#1)(2011-1#1)(2012-1#1)(2013-8#1)
to support teaching##2##3##(2008-11#1)(2012-3#1)
to support that##4##3##(1997-4#1)(2006-10#1)(2007-12#1)(2008-10#1)
to support the clinical findings##2##5##(2010-8#2)
to support the clinical##3##4##(2009-4#1)(2010-8#2)
to support the concept that##3##5##(2006-10#1)(2008-3#2)
to support the development and##2##5##(1994-2#1)(2013-1#1)
to support the development of##4##5##(2010-2#1)(2012-11#1)(2012-2#1)(2012-3#1)
to support the development##6##4##(1994-2#1)(2010-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
to support the diagnosis of##2##5##(1997-3#1)(2010-9#1)
to support the existence of##2##5##(2007-4#1)(2008-7#1)
to support the growth of##2##5##(2008-11#1)(2008-5#1)
to support the growth##3##4##(2008-11#2)(2008-5#1)
to support the hypothesis of a##2##6##(1993-9#1)(1996-2#1)
to support the hypothesis of##3##5##(1993-9#1)(1996-2#1)(2006-12#1)
to support the hypothesis that##6##5##(1996-1#1)(2006-4#1)(2008-10#1)(2009-12#1)(2011-2#1)(2013-1#1)
to support the hypothesis##9##4##(1993-9#1)(1996-1#1)(1996-2#1)(2006-12#1)(2006-4#1)(2008-10#1)(2009-12#1)(2011-2#1)(2013-1#1)
to support the idea of##2##5##(2008-8#1)(2008-9#1)
to support the idea##3##4##(1993-12#1)(2008-8#1)(2008-9#1)
to support the production of##2##5##(1997-4#1)(2008-11#1)
to support the role of##3##5##(1996-10#1)(2008-7#1)(2012-2#1)
to support the role##4##4##(1996-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
to support the use of##11##5##(2007-12#1)(2007-7#1)(2007-8#2)(2008-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2012-12#1)(2013-1#2)
to support the##128##3##(1990-2#1)(1990-5#1)(1991-1#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#2)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-2#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-7#1)(1997-3#1)(1997-4#2)(2004-3#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-4#2)(2006-7#1)(2007-11#2)(2007-12#4)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#11)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#5)(2008-7#5)(2008-8#3)(2008-9#3)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#6)(2013-8#1)
to support their##7##3##(1993-12#1)(2008-3#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-12#2)
to support these##3##3##(1995-2#1)(2005-11#1)(2010-11#1)
to support this hypothesis##4##4##(2008-1#1)(2008-7#1)(2008-8#1)(2012-11#1)
to support this view##2##4##(2008-10#1)(2012-3#1)
to support this##17##3##(1993-3#1)(2004-10#1)(2005-5#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)
to support two##3##3##(2007-11#1)(2013-1#2)
to support young##2##3##(2006-2#1)(2009-5#1)
to support##483##2##(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#3)(1991-1#1)(1991-10#1)(1991-2#1)(1991-5#2)(1991-8#1)(1992-12#2)(1992-2#3)(1992-3#1)(1992-9#1)(1993-11#2)(1993-12#4)(1993-3#2)(1993-8#1)(1993-9#1)(1994-1#3)(1994-10#1)(1994-12#2)(1994-2#5)(1994-3#4)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#3)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-8#3)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-7#2)(1996-9#1)(1997-1#6)(1997-2#1)(1997-3#3)(1997-4#3)(1997-5#3)(2004-10#2)(2004-3#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-5#2)(2005-9#1)(2006-10#11)(2006-12#2)(2006-2#5)(2006-4#3)(2006-5#3)(2006-6#1)(2006-7#2)(2006-8#4)(2007-10#3)(2007-11#4)(2007-12#9)(2007-2#8)(2007-3#1)(2007-4#3)(2007-6#3)(2007-7#2)(2007-8#12)(2007-9#5)(2008-1#5)(2008-10#23)(2008-11#30)(2008-12#5)(2008-2#7)(2008-3#8)(2008-4#10)(2008-5#13)(2008-6#2)(2008-7#18)(2008-8#7)(2008-9#7)(2009-10#1)(2009-11#3)(2009-12#3)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#15)(2010-12#2)(2010-2#4)(2010-3#4)(2010-4#1)(2010-5#5)(2010-6#2)(2010-7#3)(2010-8#9)(2010-9#1)(2011-1#5)(2011-12#3)(2011-2#11)(2011-9#1)(2012-1#4)(2012-11#4)(2012-12#13)(2012-2#9)(2012-3#9)(2012-5#1)(2012-8#1)(2013-1#34)(2013-7#3)(2013-8#6)
to supporting the##2##3##(1995-12#1)(2007-6#1)
to supporting##5##2##(1995-12#1)(2007-11#1)(2007-6#1)(2008-11#1)(2012-12#1)
to supportive##3##2##(2008-3#1)(2012-12#1)(2012-2#1)
to suppose that##5##3##(1990-5#1)(1994-6#1)(2008-10#1)(2009-8#1)(2010-2#1)
to suppress Fusarium wilt##2##4##(2008-10#2)
to suppress disease##3##3##(2008-10#3)
to suppress experimental##2##3##(1991-3#1)(2010-12#1)
to suppress in##2##3##(1995-1#1)(2007-7#1)
to suppress or##5##3##(1993-6#1)(2006-10#1)(2008-7#1)(2010-12#1)(2011-2#1)
to suppress populations##2##3##(2008-10#2)
to suppress the development of##2##5##(1993-3#1)(2009-2#1)
to suppress the disease##4##4##(2008-10#2)(2008-7#1)(2012-2#1)
to suppress the interference##2##4##(2008-10#1)(2008-2#1)
to suppress the##44##3##(1990-2#1)(1990-5#1)(1992-12#1)(1992-4#1)(1992-7#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-6#1)(1997-7#1)(2006-12#1)(2006-4#1)(2007-6#1)(2008-10#6)(2008-11#4)(2008-2#6)(2008-3#3)(2008-5#1)(2008-7#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-2#1)
to suppress transformation##3##3##(1990-8#1)(1993-12#1)(1995-2#1)
to suppress##143##2##(1990-11#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-4#1)(1992-7#1)(1992-8#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-5#1)(1997-6#2)(1997-7#2)(2004-11#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#4)(2007-12#5)(2007-3#1)(2007-6#1)(2007-7#1)(2008-10#34)(2008-11#5)(2008-12#1)(2008-2#8)(2008-3#10)(2008-4#1)(2008-5#2)(2008-7#4)(2008-9#1)(2009-2#1)(2009-5#1)(2009-8#2)(2010-12#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-2#1)
to suppression of##6##3##(1994-6#1)(2008-10#2)(2008-11#1)(2009-3#1)(2013-1#1)
to supraconducive##3##2##(2008-10#3)
to surface plasmons##2##3##(2007-12#1)(2008-2#1)
to surface roughness##2##3##(2008-2#1)(2008-3#1)
to surface water##2##3##(2007-10#1)(2009-6#1)
to surface##46##2##(1990-12#1)(1991-3#1)(1992-8#1)(1995-10#1)(1996-12#1)(1997-6#1)(2004-9#1)(2007-10#2)(2007-11#1)(2007-12#6)(2007-5#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-2#8)(2008-3#3)(2008-6#2)(2009-6#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
to surfaces and##3##3##(1990-2#1)(2008-3#1)(2011-11#1)
to surfaces##13##2##(1990-2#2)(2005-11#1)(2008-10#2)(2008-3#2)(2008-6#1)(2009-12#1)(2010-4#1)(2011-11#1)(2013-1#1)(2013-8#1)
to surfactant##2##2##(2005-11#2)
to surfactants##2##2##(1996-2#1)(2008-5#1)
to surgeon##2##2##(2011-12#1)(2012-2#1)
to surgeons for##2##3##(2009-8#1)(2010-8#1)
to surgeons##6##2##(2006-6#1)(2007-8#2)(2008-4#1)(2009-8#1)(2010-8#1)
to surgery and##8##3##(1991-2#1)(1993-1#1)(1995-9#1)(1997-2#1)(2007-5#1)(2008-9#1)(2009-10#1)(2010-7#1)
to surgery for##9##3##(1993-9#1)(1994-9#1)(1995-9#1)(2005-10#1)(2006-10#1)(2008-11#1)(2008-9#1)(2012-12#1)(2012-3#1)
to surgery in##5##3##(1991-10#1)(1992-5#1)(2004-1#1)(2006-6#1)(2008-10#1)
to surgery may##2##3##(2006-3#1)(2012-12#1)
to surgery of##2##3##(1996-12#1)(2007-12#1)
to surgery or##5##3##(1990-10#1)(2008-10#1)(2008-7#2)(2008-9#1)
to surgery should##2##3##(1996-8#1)(1997-8#1)
to surgery were##2##3##(2008-7#1)(2012-3#1)
to surgery##86##2##(1990-10#2)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-5#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-9#2)(1995-9#3)(1996-12#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-1#1)(2005-10#1)(2006-10#1)(2006-3#2)(2006-6#3)(2006-7#2)(2007-11#2)(2007-12#4)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#2)(2009-4#1)(2010-12#2)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#3)(2012-3#5)(2013-1#3)
to surgical biopsy##2##3##(1996-9#1)(2007-4#1)
to surgical castration##2##3##(1991-4#1)(2010-4#1)
to surgical correction##2##3##(2006-11#1)(2006-7#1)
to surgical drainage and##2##4##(2007-7#2)
to surgical education##2##3##(2007-3#1)(2012-3#1)
to surgical excision##3##3##(2007-7#1)(2009-4#1)(2012-3#1)
to surgical intervention##6##3##(1993-10#1)(2006-10#1)(2011-1#1)(2011-12#2)(2012-12#1)
to surgical management##4##3##(1991-3#1)(2008-9#1)(2010-12#1)(2013-1#1)
to surgical procedure##2##3##(1993-10#1)(2011-2#1)
to surgical procedures##4##3##(1990-3#1)(2005-11#1)(2006-5#1)(2007-11#1)
to surgical repair of##2##4##(1993-1#1)(1996-6#1)
to surgical resection##5##3##(1997-6#1)(2006-6#1)(2008-3#1)(2010-11#1)(2012-12#1)
to surgical stimuli##2##3##(2011-2#2)
to surgical stress##6##3##(1993-9#2)(2006-10#2)(2007-11#1)(2013-1#1)
to surgical tracheostomy##2##3##(2008-2#1)(2012-12#1)
to surgical trauma##6##3##(2006-10#1)(2008-1#1)(2008-12#1)(2010-7#1)(2012-12#2)
to surgical treatment for##2##4##(2004-1#1)(2010-1#1)
to surgical treatment##7##3##(1990-10#1)(1997-8#1)(2004-1#1)(2007-11#1)(2007-8#1)(2010-1#1)(2011-2#1)
to surgical##96##2##(1990-10#1)(1990-12#1)(1990-3#2)(1991-3#1)(1991-4#1)(1992-10#1)(1993-1#1)(1993-10#3)(1993-9#2)(1994-2#1)(1996-6#1)(1996-9#1)(1997-6#1)(1997-8#2)(2004-1#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#3)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#8)(2012-1#1)(2012-12#5)(2012-3#3)(2013-1#2)
to surgically##6##2##(2006-12#1)(2007-8#1)(2008-7#1)(2009-5#1)(2009-8#1)(2011-1#1)
to surmount the##2##3##(2008-3#1)(2011-2#1)
to surmount##3##2##(2008-11#1)(2008-3#1)(2011-2#1)
to surrogate##3##2##(1996-6#1)(2006-10#1)(2012-2#1)
to surrounding##7##2##(1991-2#1)(1995-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)
to surveillance and##2##3##(1997-1#1)(2013-1#1)
to surveillance##5##2##(1997-1#1)(2006-11#1)(2011-2#1)(2013-1#2)
to survey for##2##3##(2008-10#2)
to survey the##10##3##(1994-9#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#1)(2009-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
to survey##27##2##(1992-12#1)(1993-12#2)(1994-9#1)(1995-12#1)(1996-1#2)(1996-3#2)(1996-7#1)(1997-1#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2009-12#1)(2011-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
to surveys##2##2##(2010-2#1)(2013-7#1)
to survival analysis##2##3##(1997-2#1)(2008-10#1)
to survival of##3##3##(2006-8#1)(2011-12#1)(2013-1#1)
to survival with##2##3##(1990-8#1)(1992-2#1)
to survival##28##2##(1990-8#1)(1992-2#1)(1992-9#2)(1993-4#1)(1994-12#1)(1994-2#1)(1995-4#1)(1997-2#1)(2006-10#2)(2006-7#1)(2006-8#3)(2007-8#1)(2008-10#3)(2008-5#2)(2008-7#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-1#2)
to survive a##3##3##(2006-8#1)(2010-3#1)(2011-2#1)
to survive and grow##2##4##(2006-10#1)(2008-5#1)
to survive and##7##3##(1992-3#1)(1997-4#1)(2004-4#1)(2006-10#1)(2007-12#1)(2008-5#1)(2013-1#1)
to survive at##2##3##(1991-4#1)(1995-1#1)
to survive for##3##3##(1996-5#1)(2008-7#1)(2008-8#1)
to survive in gastric##2##4##(2011-1#1)(2012-2#1)
to survive in the##3##4##(2008-10#1)(2011-2#1)(2012-12#1)
to survive in##11##3##(1993-2#1)(1996-12#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-7#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
to survive the##4##3##(2010-4#1)(2011-2#1)(2013-8#2)
to survive under##2##3##(1995-3#1)(2006-12#1)
to survive##72##2##(1991-12#1)(1991-3#2)(1991-4#1)(1992-3#2)(1993-11#1)(1993-2#1)(1993-7#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#2)(1997-3#1)(1997-4#1)(2004-4#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-6#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-7#4)(2008-8#2)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
to survivorship##2##2##(2008-7#1)(2011-2#1)
to susceptibility to##2##3##(2007-7#1)(2008-4#1)
to susceptibility##5##2##(2006-11#1)(2007-7#1)(2008-10#1)(2008-4#1)(2010-12#1)
to susceptible##6##2##(2006-10#1)(2007-2#1)(2008-10#3)(2008-7#1)
to suspect a##2##3##(2008-10#1)(2011-2#1)
to suspect the##2##3##(1991-4#1)(2010-5#1)
to suspect##11##2##(1991-4#1)(1996-9#1)(2006-10#1)(2007-9#1)(2008-10#1)(2009-2#1)(2010-5#2)(2010-7#1)(2011-2#1)(2013-8#1)
to suspected##2##2##(1990-3#1)(2006-10#1)
to suspend##3##2##(1993-3#1)(1997-2#1)(2008-7#1)
to suspicion of##3##3##(1992-3#1)(1995-5#1)(2008-1#1)
to sustain a##3##3##(1994-12#1)(2008-2#1)(2013-7#1)
to sustain an##4##3##(2007-1#2)(2008-1#1)(2008-2#1)
to sustain that##2##3##(2013-1#2)
to sustain the##9##3##(1990-2#1)(2006-7#1)(2007-8#1)(2008-5#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)
to sustain##42##2##(1990-11#1)(1990-2#1)(1991-2#1)(1991-3#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-6#1)(1995-9#1)(1997-5#1)(2005-7#1)(2006-11#1)(2006-7#1)(2007-1#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-5#1)(2009-4#1)(2010-10#3)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
to sustainable##4##2##(1992-5#1)(2007-11#1)(2009-8#1)(2012-3#1)
to sustained##9##2##(2005-8#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
to swallow##3##2##(1990-6#1)(1997-4#1)(2007-8#1)
to sweeteners##3##2##(2008-2#3)
to swell in##2##3##(2008-5#1)(2008-9#1)
to swell##5##2##(2005-11#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-2#1)
to swim##3##2##(2007-7#1)(2008-5#1)(2013-8#1)
to swing##2##2##(1994-2#1)(2007-12#1)
to switch between##2##3##(1996-7#1)(2007-12#1)
to switch from##7##3##(1992-9#1)(1995-4#1)(1996-6#1)(1997-6#1)(2008-6#1)(2009-4#1)(2011-1#1)
to switch on##2##3##(2009-11#1)(2011-2#1)
to switch to a##2##4##(2006-10#1)(2007-9#1)
to switch##27##2##(1992-9#1)(1995-10#1)(1995-4#1)(1996-11#1)(1996-6#1)(1996-7#1)(1997-6#1)(2006-10#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-2#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-11#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
to switching##3##2##(1993-2#1)(2008-11#1)(2008-3#1)
to symbiosis##2##2##(2008-5#1)(2010-6#1)
to symmetric##3##2##(2008-11#1)(2008-3#1)(2008-9#1)
to sympathetic activation##2##3##(1997-5#1)(2005-10#1)
to sympathetic preganglionic##2##3##(1992-1#2)
to sympathetic stimulation##2##3##(2006-10#1)(2007-10#1)
to sympathetic##9##2##(1991-3#1)(1992-1#2)(1992-8#1)(1997-5#1)(2005-10#1)(2006-10#1)(2007-10#1)(2008-1#1)
to sympathovagal##2##2##(2009-11#1)(2012-2#1)
to symptom onset##2##3##(2006-12#1)(2007-6#1)
to symptom severity##2##3##(2007-12#1)(2008-10#1)
to symptom##9##2##(1995-2#1)(1996-5#1)(1996-8#1)(2006-12#1)(2007-12#1)(2007-6#1)(2008-10#1)(2009-9#1)(2010-5#1)
to symptomatic##7##2##(1993-7#1)(2007-5#1)(2007-7#2)(2009-5#1)(2011-2#1)(2012-2#1)
to symptoms and##2##3##(2006-10#1)(2008-7#1)
to symptoms from##2##3##(2008-10#1)(2008-3#1)
to symptoms of##5##3##(1992-12#1)(2006-10#1)(2008-3#1)(2008-6#1)(2013-8#1)
to symptoms that##2##3##(2010-8#1)(2013-1#1)
to symptoms##18##2##(1991-3#1)(1992-1#1)(1992-12#1)(1993-5#1)(1997-2#1)(1997-3#1)(2006-10#2)(2008-10#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2010-8#1)(2013-1#1)(2013-7#1)(2013-8#1)
to synapse formation##2##3##(1995-12#1)(1996-8#1)
to synapse##4##2##(1995-12#1)(1996-8#1)(2007-10#1)(2010-2#1)
to synaptic plasticity##2##3##(1996-6#1)(2009-8#1)
to synaptic##11##2##(1994-2#1)(1996-12#2)(1996-4#1)(1996-6#1)(1997-6#1)(2007-11#1)(2008-4#2)(2009-8#2)
to synchronize the##3##3##(2008-11#1)(2008-3#1)(2009-10#1)
to synchronize##8##2##(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-10#1)(2009-8#1)(2011-1#1)
to synchronous##3##2##(1991-5#1)(1996-8#1)(2008-10#1)
to syndromic##2##2##(1994-10#1)(2010-12#1)
to synergistically##2##2##(1992-12#1)(2007-11#1)
to synergize with##3##3##(1993-12#1)(1996-10#1)(2009-12#1)
to syngeneic##3##2##(1995-2#1)(1997-4#1)(2008-4#1)
to synovial##4##2##(2006-10#1)(2008-6#2)(2012-3#1)
to synthesis of##5##3##(1991-7#1)(1992-1#1)(1997-4#1)(2007-11#1)(2010-3#1)
to synthesis##8##2##(1991-7#1)(1992-1#1)(1995-3#1)(1997-4#1)(2006-12#1)(2007-11#1)(2008-10#1)(2010-3#1)
to synthesise##8##2##(1992-11#1)(1995-6#1)(1997-1#1)(2007-11#2)(2008-10#1)(2010-12#1)(2012-12#1)
to synthesize DNA##3##3##(1992-12#1)(1993-6#1)(1994-9#1)
to synthesize a##9##3##(1990-3#1)(1991-2#1)(1991-7#1)(1993-3#1)(2006-11#1)(2008-2#1)(2008-3#1)(2009-3#1)(2010-2#1)
to synthesize and secrete##3##4##(1993-3#1)(1994-5#1)(1997-8#1)
to synthesize and##13##3##(1991-4#1)(1991-8#1)(1993-3#1)(1994-5#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-6#1)(2010-4#1)(2012-1#1)(2012-11#2)(2013-8#1)
to synthesize hemoglobin by##2##4##(1992-1#1)(1995-11#1)
to synthesize primers##2##3##(1993-3#2)
to synthesize serotonin##2##3##(1995-7#2)
to synthesize the##8##3##(1993-3#1)(2006-12#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-2#1)
to synthesize two##2##3##(1990-2#1)(2006-8#1)
to synthesize vitamin C##2##4##(2012-2#2)
to synthesize##107##2##(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-1#3)(1992-12#4)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#5)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-7#2)(1996-1#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-8#1)(2006-11#1)(2006-12#2)(2006-8#1)(2007-11#5)(2007-8#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#3)(2008-9#5)(2009-10#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-2#2)(2010-4#1)(2011-1#1)(2012-1#1)(2012-11#3)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
to synthetic and##2##3##(2008-10#1)(2008-2#1)
to synthetic peptides##3##3##(1991-8#1)(1994-11#1)(1995-1#1)
to synthetic##23##2##(1990-12#1)(1991-2#1)(1991-8#1)(1992-2#1)(1993-3#1)(1994-11#1)(1995-1#1)(1996-4#1)(2004-2#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2009-5#1)(2010-8#1)(2012-12#1)
to system##2##2##(2008-1#1)(2008-7#1)
to systematic errors##3##3##(2008-2#1)(2008-3#2)
to systematic##9##2##(1990-4#1)(2007-10#1)(2008-2#1)(2008-3#2)(2008-9#1)(2010-12#1)(2013-1#2)
to systematically collect##2##3##(1993-2#1)(2010-9#1)
to systematically evaluate##3##3##(2008-4#1)(2009-4#1)(2011-2#1)
to systematically review##2##3##(2005-10#1)(2013-1#1)
to systematically study##2##3##(1994-7#1)(2008-6#1)
to systematically##28##2##(1993-2#1)(1994-7#1)(1995-9#1)(1996-2#1)(1997-2#1)(2005-10#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-4#2)(2009-9#1)(2010-12#1)(2010-9#2)(2011-2#1)(2013-1#2)
to systematize the##3##3##(2007-7#1)(2008-10#1)(2009-4#1)
to systemic chemotherapy##2##3##(1994-12#1)(2008-6#1)
to systemic##30##2##(1990-8#1)(1991-1#1)(1994-12#2)(1995-3#1)(1996-3#1)(1997-5#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-6#1)(2008-7#1)(2009-2#1)(2009-8#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#2)
to systemically##4##2##(2008-10#4)
to systems of##3##3##(2006-10#1)(2007-11#1)(2008-11#1)
to systems##7##2##(1995-1#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-7#1)(2012-2#1)
to systolic##2##2##(2006-10#1)(2007-8#1)
to t-PA##2##2##(1990-11#1)(1990-12#1)
to tRNA##4##2##(1991-4#1)(1997-5#1)(1997-6#1)(2006-12#1)
to tRNA(Cys)##2##2##(2006-12#2)
to tachykinin##2##2##(1993-12#2)
to tackle a##2##3##(2008-1#1)(2009-11#1)
to tackle it##2##3##(2012-12#1)(2012-3#1)
to tackle the##3##3##(2007-8#1)(2007-9#1)(2012-3#1)
to tackle this##5##3##(1995-5#1)(2007-7#1)(2009-10#1)(2009-5#1)(2011-2#1)
to tackle##28##2##(1991-11#1)(1994-3#1)(1995-5#1)(2005-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)
to tacrolimus##2##2##(2005-8#1)(2007-8#1)
to tactile stimulation##2##3##(1991-3#1)(1997-2#1)
to tag##9##2##(1997-8#1)(2004-4#1)(2007-9#1)(2008-10#2)(2008-9#2)(2012-3#2)
to tailor the##8##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2013-1#1)
to tailor therapy##2##3##(2006-10#1)(2013-1#1)
to tailor##20##2##(1993-2#1)(1994-3#1)(2006-10#2)(2007-11#2)(2007-12#2)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#1)(2010-4#1)(2011-2#1)(2013-1#3)
to take a##17##3##(1990-6#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-3#1)(1993-2#1)(1994-10#1)(2004-12#1)(2006-8#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-7#1)
to take account of the##2##5##(2008-3#1)(2012-3#1)
to take account of##8##4##(1994-8#1)(1996-11#1)(2005-10#1)(2008-3#1)(2008-7#1)(2010-10#1)(2012-1#1)(2012-3#1)
to take account##9##3##(1994-8#1)(1996-11#1)(2005-10#1)(2008-3#1)(2008-7#1)(2010-10#1)(2012-1#1)(2012-3#1)(2013-8#1)
to take action##5##3##(1991-7#1)(2008-11#1)(2008-6#1)(2011-1#1)(2012-2#1)
to take actions##2##3##(2008-10#1)(2012-3#1)
to take advantage of a##3##5##(2007-11#1)(2008-10#1)(2008-3#1)
to take advantage of the##9##5##(1994-3#2)(2007-10#1)(2007-12#1)(2008-2#2)(2008-4#1)(2009-2#1)(2012-2#1)
to take advantage of these##3##5##(2004-10#1)(2008-10#1)(2008-4#1)
to take advantage of this##4##5##(1993-12#1)(2006-5#1)(2008-7#1)(2008-9#1)
to take advantage of two##2##5##(1996-1#1)(2008-3#1)
to take advantage of##34##4##(1990-11#1)(1993-12#1)(1994-3#2)(1995-5#1)(1995-6#1)(1996-1#1)(2004-10#1)(2004-2#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-7#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#1)(2010-4#1)(2012-2#1)(2013-1#2)
to take an active##2##4##(2006-1#1)(2007-7#1)
to take an##4##3##(2006-1#1)(2007-2#1)(2007-7#1)(2008-5#1)
to take appropriate##2##3##(2012-1#1)(2012-2#1)
to take care of##7##4##(1990-10#1)(1992-10#1)(1992-12#1)(2004-9#1)(2006-6#1)(2008-10#1)(2012-2#1)
to take care##11##3##(1990-10#1)(1992-10#1)(1992-12#1)(2004-9#1)(2006-6#1)(2008-10#1)(2011-2#4)(2012-2#1)
to take full advantage of the##4##6##(1996-4#1)(2006-4#1)(2006-5#1)(2008-7#1)
to take full advantage of##6##5##(1994-2#1)(1996-4#1)(2006-4#1)(2006-5#1)(2008-2#1)(2008-7#1)
to take into account the actual three-dimensional geometry##2##8##(2008-3#2)
to take into account the##20##5##(1993-2#1)(1994-2#1)(1995-12#1)(1995-5#2)(1997-2#1)(2006-8#1)(2008-10#5)(2008-11#1)(2008-3#2)(2010-2#1)(2010-9#1)(2012-3#3)
to take into account##28##4##(1990-7#1)(1993-2#1)(1994-2#1)(1995-12#1)(1995-5#2)(1997-2#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#3)(2010-2#1)(2010-9#1)(2012-1#1)(2012-3#3)
to take into consideration##3##4##(1995-12#1)(2006-10#1)(2006-5#1)
to take into##31##3##(1990-7#1)(1993-2#1)(1994-2#1)(1995-12#2)(1995-5#2)(1997-2#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-11#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#3)(2010-2#1)(2010-9#1)(2012-1#1)(2012-3#3)
to take measures##2##3##(2008-12#1)(2010-5#1)
to take more##2##3##(1993-12#1)(2008-11#1)
to take note of##2##4##(2008-8#1)(2008-9#1)
to take note##3##3##(1990-9#1)(2008-8#1)(2008-9#1)
to take on the##2##4##(1990-4#1)(2007-12#1)
to take on##6##3##(1990-4#1)(1997-6#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-11#1)
to take over##2##3##(2007-4#1)(2007-8#1)
to take part in research projects##2##6##(1992-3#1)(2009-6#1)
to take part in research##3##5##(1992-3#1)(2009-6#2)
to take part in the##3##5##(1993-3#1)(1997-6#1)(2011-1#1)
to take part in##16##4##(1990-11#1)(1992-3#1)(1993-3#1)(1996-11#1)(1997-6#1)(2006-3#1)(2007-11#1)(2008-10#1)(2009-6#6)(2011-1#1)(2013-8#1)
to take part##20##3##(1990-10#1)(1990-11#1)(1992-3#1)(1993-3#1)(1996-11#1)(1997-6#1)(2006-3#1)(2007-11#1)(2008-10#2)(2008-11#2)(2009-6#6)(2011-1#1)(2013-8#1)
to take place at##2##4##(1996-2#1)(2008-10#1)
to take place during the##2##5##(1990-2#1)(2009-9#1)
to take place in a##2##5##(2008-10#1)(2008-11#1)
to take place in the##3##5##(1992-3#1)(2008-7#2)
to take place in##12##4##(1992-3#1)(1993-11#1)(2008-10#2)(2008-11#1)(2008-7#2)(2010-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
to take place via##2##4##(1996-2#1)(2010-4#1)
to take place##30##3##(1990-2#1)(1990-5#1)(1990-8#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-6#1)(1996-2#2)(2006-8#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-7#3)(2009-9#1)(2010-4#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
to take precautions##2##3##(1996-5#2)
to take preventive##2##3##(2010-9#1)(2011-2#1)
to take shape##2##3##(2009-3#1)(2011-2#1)
to take some##2##3##(2006-9#1)(2007-6#1)
to take steps to##3##4##(1993-1#1)(2007-11#1)(2008-11#1)
to take steps##5##3##(1993-1#1)(2007-11#2)(2008-11#1)(2010-9#1)
to take such##2##3##(2006-6#1)(2008-1#1)
to take the lead##3##4##(1995-12#2)(1995-2#1)
to take the opportunity to##2##5##(2006-10#1)(2013-8#1)
to take the place of##2##5##(2007-10#1)(2008-11#1)
to take the##20##3##(1992-9#1)(1995-12#2)(1995-2#1)(2005-9#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-2#2)(2013-7#1)(2013-8#2)
to take their medication##2##4##(1990-8#1)(1993-11#1)
to take them into account##2##5##(2011-1#1)(2012-2#1)
to take this##2##3##(1992-6#1)(2012-12#1)
to take up##8##3##(1991-11#1)(1991-7#1)(2008-1#2)(2008-2#1)(2008-9#1)(2009-12#1)(2011-1#1)
to take##290##2##(1990-10#2)(1990-11#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#4)(1993-3#2)(1993-6#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#1)(1995-12#5)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#1)(1995-9#1)(1996-1#2)(1996-11#2)(1996-2#2)(1996-4#1)(1996-5#3)(1997-2#2)(1997-5#1)(1997-6#3)(2004-10#1)(2004-12#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-9#1)(2006-1#1)(2006-10#7)(2006-12#1)(2006-3#2)(2006-4#1)(2006-5#3)(2006-6#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#3)(2007-2#3)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#17)(2008-11#14)(2008-12#2)(2008-2#9)(2008-3#7)(2008-4#4)(2008-5#3)(2008-6#4)(2008-7#8)(2008-8#2)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#6)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#6)(2011-2#8)(2012-1#3)(2012-12#2)(2012-2#6)(2012-3#6)(2013-1#3)(2013-7#2)(2013-8#7)
to take-all##3##2##(2008-10#3)
to talin##2##2##(1993-4#2)
to talk about##5##3##(1995-7#1)(2008-6#1)(2012-3#3)
to talk openly##2##3##(2007-9#1)(2012-3#1)
to talk to##5##3##(1997-1#1)(2007-7#1)(2009-7#1)(2012-3#1)(2013-1#1)
to talk##16##2##(1995-7#1)(1997-1#1)(2007-7#1)(2007-9#2)(2008-6#1)(2009-11#1)(2009-7#1)(2012-12#2)(2012-3#5)(2013-1#1)
to tall fescue##2##3##(2008-10#2)
to tall##3##2##(2008-10#2)(2013-1#1)
to tame the##2##3##(1997-1#1)(2008-10#1)
to tamoxifen therapy##2##3##(1993-11#1)(1994-6#1)
to tamoxifen##10##2##(1990-2#1)(1991-8#2)(1992-8#1)(1993-1#2)(1993-11#1)(1994-6#1)(2008-10#2)
to tandem mass spectrometry##2##4##(2008-4#1)(2010-9#1)
to tap water and##4##4##(2008-10#3)(2009-5#1)
to tap water##7##3##(2007-1#1)(2008-10#5)(2009-5#1)
to tap##14##2##(1994-11#1)(2006-4#2)(2007-1#1)(2008-10#6)(2008-8#2)(2009-5#1)(2012-2#1)
to taper##2##2##(2009-10#1)(2013-1#1)
to tardive dyskinesia##4##3##(1997-8#1)(2007-6#1)(2010-12#1)(2012-1#1)
to tardive##5##2##(1997-8#2)(2007-6#1)(2010-12#1)(2012-1#1)
to target a##2##3##(1991-12#1)(2010-5#1)
to target and kill##3##4##(2011-2#1)(2012-12#2)
to target and##4##3##(2005-7#1)(2011-2#1)(2012-12#2)
to target antigens##2##3##(2005-11#1)(2006-12#1)
to target cells##8##3##(2005-7#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-9#2)(2011-2#1)
to target different##3##3##(1993-2#1)(1997-4#1)(2005-7#1)
to target human##2##3##(2008-10#1)(2010-1#1)
to target more##2##3##(2008-1#1)(2008-2#1)
to target promoters##2##3##(1994-6#1)(2007-12#1)
to target proteins##5##3##(2007-12#2)(2011-2#1)(2012-3#2)
to target stimulus##2##3##(2013-7#2)
to target the##10##3##(2005-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-8#1)(2009-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
to target their##4##3##(1994-9#1)(1997-3#1)(2007-1#1)(2009-4#1)
to target this##2##3##(2007-11#1)(2011-2#1)
to target treatment##3##3##(1996-12#1)(2008-7#1)(2010-3#1)
to target tumor##2##3##(1995-1#1)(2007-8#1)
to target##134##2##(1990-12#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-6#1)(1992-12#1)(1993-11#1)(1993-2#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-5#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(2005-10#1)(2005-11#2)(2005-7#4)(2005-8#1)(2006-12#2)(2007-1#2)(2007-11#2)(2007-12#5)(2007-8#4)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#2)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#10)(2012-12#5)(2012-2#2)(2012-3#5)(2013-1#6)(2013-7#4)(2013-8#2)
to targeted##7##2##(1996-11#1)(2005-10#1)(2007-12#1)(2008-6#1)(2008-9#1)(2012-12#1)(2013-7#1)
to targeting##2##2##(1993-2#1)(2008-12#1)
to targets defined by proximity##2##5##(2008-9#2)
to targets defined by##3##4##(2008-9#3)
to targets presented##3##3##(1995-8#1)(1996-6#2)
to targets##11##2##(1992-9#1)(1995-8#1)(1996-6#2)(2008-9#3)(2009-9#1)(2010-2#1)(2010-5#1)(2011-2#1)
to task##11##2##(1992-9#1)(1995-11#1)(1995-12#1)(2005-10#1)(2008-7#2)(2012-12#2)(2012-3#1)(2013-1#2)
to tasks##5##2##(1990-4#1)(2008-11#1)(2009-7#1)(2009-8#1)(2013-7#1)
to taste stimuli##7##3##(1996-8#2)(2012-12#3)(2013-1#2)
to taste##8##2##(1996-8#3)(2012-12#3)(2013-1#2)
to tau##3##2##(1992-12#1)(1995-10#1)(2004-12#1)
to taxol##5##2##(1992-8#2)(1994-9#1)(1996-4#1)(2008-5#1)
to taxonomic##3##2##(1992-5#1)(2008-10#1)(2013-7#1)
to tea##2##2##(2005-11#1)(2008-11#1)
to teach and##2##3##(2008-11#1)(2008-12#1)
to teach for##2##3##(2005-12#2)
to teach students##2##3##(1995-12#1)(2010-3#1)
to teach the##3##3##(1996-1#1)(2009-4#1)(2012-1#1)
to teach their##2##3##(1992-4#1)(2012-12#1)
to teach##39##2##(1992-4#1)(1993-12#2)(1995-12#1)(1996-1#1)(1996-3#1)(2005-10#1)(2005-12#3)(2006-12#1)(2006-5#2)(2007-3#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#5)(2008-12#3)(2008-3#1)(2008-7#1)(2009-11#1)(2009-4#2)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#1)
to teachers##2##2##(2007-4#1)(2011-2#1)
to teaching and##3##3##(2006-5#1)(2008-11#1)(2011-2#1)
to teaching##19##2##(1994-12#1)(1995-1#1)(2005-12#2)(2006-5#1)(2007-10#1)(2008-1#1)(2008-11#5)(2008-12#1)(2009-8#1)(2011-2#3)(2013-1#1)(2013-8#1)
to teams##2##2##(1997-2#2)
to tear##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
to technical##19##2##(1991-12#1)(1993-10#2)(1996-2#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-8#1)(2011-2#1)(2012-2#2)
to techniques and##2##3##(1991-3#1)(2009-9#1)
to techniques##3##2##(1991-3#1)(2009-9#1)(2012-12#1)
to technology and##2##3##(2006-6#1)(2007-4#1)
to technology##3##2##(2006-6#1)(2007-4#1)(2008-11#1)
to teenagers who##2##3##(2007-7#2)
to teenagers##3##2##(1996-9#1)(2007-7#2)
to teeth##2##2##(2008-6#2)
to teleosts##2##2##(1991-9#1)(2008-5#1)
to telephone##2##2##(1995-12#1)(2006-11#1)
to television##2##2##(2007-3#1)(2008-2#1)
to tell the story of##2##5##(2008-3#1)(2011-2#1)
to tell the##3##3##(2008-3#1)(2011-2#1)(2012-12#1)
to tell##14##2##(1991-2#1)(1993-7#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-12#2)(2013-1#4)(2013-8#1)
to temephos##2##2##(2012-2#2)
to temperature and hydrostatic pressure##4##5##(2008-2#3)(2008-3#1)
to temperature and pressure##2##4##(2008-3#2)
to temperature and relative humidity##2##5##(2008-10#2)
to temperature and##12##3##(1994-8#1)(2008-10#3)(2008-2#3)(2008-3#4)(2012-2#1)
to temperature changes##2##3##(1994-10#1)(2008-1#1)
to temperature effects##2##3##(2008-11#1)(2008-8#1)
to temperature fluctuations##2##3##(2008-10#1)(2008-3#1)
to temperature variation##2##3##(2007-11#1)(2011-1#1)
to temperature variations##2##3##(1994-12#1)(2011-12#1)
to temperature##51##2##(1990-11#1)(1990-2#1)(1991-2#1)(1991-9#1)(1994-10#1)(1994-12#1)(1994-8#1)(1996-2#1)(2005-11#1)(2006-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#4)(2008-3#5)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#3)(2012-6#2)(2013-8#1)
to temperatures &gt##2##3##(1995-6#1)(2008-10#1)
to temperatures above##2##3##(2010-4#1)(2011-12#1)
to temperatures##10##2##(1995-6#1)(2007-12#2)(2008-10#4)(2008-6#1)(2010-4#1)(2011-12#1)
to templates##3##2##(2008-6#2)(2008-7#1)
to temporal##5##2##(2006-12#1)(2008-1#1)(2008-2#2)(2011-1#1)
to temporally##2##2##(2007-11#1)(2007-12#1)
to temporarily##3##2##(2007-9#2)(2009-7#1)
to temporary##3##2##(2006-12#1)(2008-5#1)(2012-5#1)
to ten days##3##3##(1991-8#1)(1992-5#1)(2007-7#1)
to ten times##8##3##(1992-1#1)(1993-3#1)(1994-9#2)(1996-6#1)(2005-8#1)(2008-10#1)(2013-8#1)
to ten years##3##3##(2006-4#1)(2007-7#1)(2010-8#1)
to ten##32##2##(1990-10#2)(1991-7#1)(1991-8#1)(1992-1#2)(1992-5#1)(1993-3#2)(1994-5#1)(1994-9#2)(1996-11#1)(1996-2#1)(1996-6#1)(1997-8#2)(2005-8#1)(2006-4#1)(2007-7#2)(2008-10#5)(2008-4#1)(2008-5#2)(2008-8#1)(2010-8#1)(2013-8#1)
to ten-fold##3##2##(1990-2#1)(1992-8#1)(1996-11#1)
to tenfold##2##2##(1992-7#1)(1993-6#1)
to tenofovir##2##2##(2013-1#2)
to tens of thousands of##2##5##(2007-11#1)(2008-2#1)
to tens of##8##3##(1991-2#1)(2007-11#1)(2007-12#2)(2008-2#4)
to tensile loading##3##3##(2006-11#2)(2007-4#1)
to tensile##5##2##(2004-9#1)(2006-11#2)(2007-4#1)(2012-1#1)
to tension##4##2##(2006-11#1)(2009-1#1)(2009-8#1)(2011-1#1)
to tentatively##2##2##(1996-5#1)(2008-7#1)
to terbinafine##2##2##(1993-8#1)(2008-5#1)
to term##11##2##(1990-5#2)(1992-12#1)(1994-2#1)(1994-4#1)(1997-4#1)(2005-8#1)(2006-12#1)(2008-3#1)(2010-8#1)(2011-1#1)
to terminal differentiation##4##3##(1995-1#3)(2009-3#1)
to terminal##8##2##(1990-11#1)(1993-8#1)(1995-1#3)(2005-2#1)(2008-10#1)(2009-3#1)
to terminate a pregnancy##2##4##(2007-3#2)
to terminate her pregnancy##2##4##(2006-4#2)
to terminate the cardiopulmonary bypass##2##5##(2007-9#2)
to terminate the##7##3##(1991-3#1)(1991-8#1)(1992-6#1)(1994-11#1)(2007-9#2)(2008-11#1)
to terminate treatment##2##3##(2005-7#1)(2007-3#1)
to terminate##29##2##(1990-10#1)(1991-3#1)(1991-8#1)(1992-2#1)(1992-6#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-4#2)(1995-8#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-5#1)(2005-7#1)(2006-4#2)(2007-12#1)(2007-3#3)(2007-9#2)(2008-11#1)(2009-8#1)(2013-1#2)
to termination of##2##3##(1997-2#1)(2008-1#1)
to termination##4##2##(1997-2#1)(2008-1#1)(2009-12#1)(2009-2#1)
to terminations##2##2##(2008-9#1)(2011-1#1)
to terms with the##3##4##(1994-1#1)(1995-11#1)(1997-2#1)
to terms with##6##3##(1994-1#1)(1995-1#1)(1995-11#1)(1997-2#1)(2008-11#1)(2012-3#1)
to terrestrial##3##2##(2004-4#1)(2006-5#1)(2012-3#1)
to terror##3##2##(1990-8#1)(2009-7#2)
to terrorism##3##2##(2007-9#1)(2008-4#1)(2008-9#1)
to tertiary##2##2##(1992-8#1)(2010-8#1)
to test a hypothesis about##2##5##(2008-10#1)(2013-1#1)
to test a model##2##4##(2008-12#1)(2012-3#1)
to test a new##2##4##(1996-6#1)(2008-3#1)
to test a##15##3##(1991-12#1)(1993-12#1)(1994-11#1)(1994-7#1)(1996-6#1)(1997-8#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-9#1)(2012-3#1)(2013-1#1)
to test an##5##3##(1993-9#1)(1997-3#1)(2008-3#1)(2008-6#1)(2009-3#1)
to test and verify the##2##5##(2007-11#1)(2008-3#1)
to test and verify##3##4##(2007-11#1)(2008-3#2)
to test and##7##3##(2007-11#1)(2008-11#1)(2008-3#2)(2010-8#1)(2011-2#1)(2013-7#1)
to test associations between##2##4##(1997-5#1)(2012-3#1)
to test current##2##3##(1993-5#1)(1997-6#1)
to test different##3##3##(2008-9#1)(2011-2#1)(2012-1#1)
to test directly##2##3##(2005-7#1)(2006-8#1)
to test for a##2##4##(1993-1#1)(2008-4#1)
to test for differences in##2##5##(1994-2#1)(2008-9#1)
to test for differences##3##4##(1994-2#1)(2008-5#1)(2008-9#1)
to test for the##3##4##(1994-8#1)(2008-11#1)(2010-8#1)
to test for##52##3##(1992-11#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-1#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-4#1)(1996-1#1)(1996-2#1)(1997-5#1)(2006-10#1)(2006-2#2)(2006-7#1)(2006-8#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-4#8)(2008-5#1)(2008-7#1)(2008-9#3)(2009-4#2)(2010-2#1)(2010-8#1)(2011-1#1)(2012-2#3)(2012-3#2)(2013-1#2)
to test hypotheses about the##3##5##(1994-6#1)(2008-10#1)(2008-8#1)
to test hypotheses about##4##4##(1994-6#1)(2008-10#1)(2008-8#1)(2012-3#1)
to test hypotheses concerning the##2##5##(1993-12#1)(2008-10#1)
to test hypotheses##6##3##(1993-12#1)(1994-6#1)(2008-10#2)(2008-8#1)(2012-3#1)
to test if the##2##4##(2007-10#1)(2007-12#1)
to test if these##2##4##(2008-10#1)(2012-1#1)
to test if##13##3##(1991-11#1)(1993-11#1)(1994-12#1)(2004-2#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-1#1)(2012-3#1)
to test in##3##3##(1991-11#1)(2008-11#1)(2008-5#1)
to test its##4##3##(1997-1#1)(2006-12#1)(2007-3#1)(2008-12#1)
to test new##2##3##(2008-10#1)(2009-5#1)
to test samples##2##3##(1991-9#1)(2006-5#1)
to test such##2##3##(1992-9#1)(2011-2#1)
to test the accuracy of this##2##6##(1990-12#1)(2008-2#1)
to test the accuracy##3##4##(1990-12#1)(2008-2#1)(2008-3#1)
to test the activity of##2##5##(2008-4#1)(2008-5#1)
to test the applicability of##2##5##(2007-10#1)(2010-12#1)
to test the application##2##4##(1991-5#1)(2012-3#1)
to test the assumption##2##4##(2006-8#1)(2010-2#1)
to test the biological##2##4##(1992-6#1)(2009-4#1)
to test the effect of##5##5##(1991-8#1)(1995-2#1)(1995-8#1)(2008-10#1)(2012-2#1)
to test the effectiveness of##3##5##(2008-2#1)(2009-3#1)(2010-10#1)
to test the effects of##15##5##(1990-10#1)(1992-1#2)(1994-12#1)(1996-1#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-5#1)(2010-11#1)(2012-12#1)(2012-2#1)
to test the effects##16##4##(1990-10#1)(1992-1#2)(1994-12#1)(1996-1#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-5#1)(2010-11#1)(2012-12#1)(2012-2#1)
to test the efficacy of##2##5##(2008-7#1)(2010-8#1)
to test the feasibility of the##2##6##(2005-11#1)(2011-2#1)
to test the feasibility of##6##5##(1990-12#1)(1996-2#1)(1997-8#1)(2005-11#1)(2011-2#1)(2012-1#1)
to test the feasibility##7##4##(1990-12#1)(1996-2#1)(1997-8#1)(2005-11#1)(2008-11#1)(2011-2#1)(2012-1#1)
to test the function of##4##5##(1990-11#1)(1995-2#1)(2006-10#1)(2008-1#1)
to test the hypothesis of##3##5##(1991-2#1)(2008-10#1)(2009-2#1)
to test the hypothesis that the##7##6##(1994-6#1)(2007-1#1)(2007-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-7#1)
to test the hypothesis that##40##5##(1990-1#1)(1990-8#2)(1992-9#1)(1993-12#1)(1994-10#2)(1994-6#1)(1995-4#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-7#1)(2004-11#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-5#1)
to test the hypothesis##43##4##(1990-1#1)(1990-8#2)(1991-2#1)(1992-9#1)(1993-12#1)(1994-10#2)(1994-6#1)(1995-4#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-7#1)(2004-11#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-5#1)
to test the impact of##2##5##(1991-11#1)(2013-8#1)
to test the model##3##4##(1996-9#1)(2008-3#1)(2008-6#1)
to test the null hypothesis##2##5##(1995-5#1)(2008-10#1)
to test the possibility##2##4##(1991-6#1)(2009-2#1)
to test the prediction that##2##5##(2008-5#1)(2008-8#1)
to test the prediction##3##4##(2008-12#1)(2008-5#1)(2008-8#1)
to test the predictions of##2##5##(2004-2#1)(2008-8#1)
to test the presence of##2##5##(2006-7#1)(2013-7#1)
to test the response of##2##5##(2006-11#1)(2008-1#1)
to test the role of##4##5##(1994-3#1)(1995-8#1)(2008-5#1)(2008-8#1)
to test the sensitivity of the##2##6##(1990-12#1)(1996-7#1)
to test the sensitivity of##3##5##(1990-12#1)(1996-7#1)(2008-5#1)
to test the significance of##2##5##(1994-5#1)(2008-10#1)
to test the stability of the##2##6##(2008-3#2)
to test the suitability of##2##5##(2008-10#1)(2009-10#1)
to test the system##2##4##(2007-12#1)(2008-11#1)
to test the utility of the##2##6##(1994-2#1)(2004-9#1)
to test the validity of the##4##6##(1997-2#1)(1997-4#1)(2005-11#1)(2008-10#1)
to test the validity of##7##5##(1990-9#1)(1997-2#1)(1997-4#1)(2005-11#1)(2008-10#1)(2008-3#1)(2010-12#1)
to test the##205##3##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#3)(1990-8#2)(1990-9#1)(1991-11#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-10#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-2#2)(1995-4#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-7#1)(1996-9#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#18)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#14)(2008-4#3)(2008-5#9)(2008-6#2)(2008-7#5)(2008-8#8)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#4)(2012-2#4)(2012-3#1)(2012-5#2)(2013-1#3)(2013-7#1)(2013-8#1)
to test their##10##3##(1990-8#1)(1997-1#1)(1997-5#1)(1997-7#1)(2006-2#1)(2008-10#2)(2009-5#1)(2010-6#1)(2013-8#1)
to test them##3##3##(2007-3#1)(2008-10#1)(2010-3#1)
to test these hypotheses##2##4##(2008-8#1)(2009-2#1)
to test these##10##3##(1991-5#1)(1994-12#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#2)(2009-2#1)
to test this hypothesis##8##4##(1994-10#1)(1995-5#1)(1997-7#1)(2006-7#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-3#1)
to test this##15##3##(1993-11#1)(1994-10#1)(1995-5#1)(1996-3#1)(1996-7#1)(1997-7#1)(1997-8#1)(2006-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-5#1)(2012-3#1)
to test two##3##3##(1993-12#1)(2008-6#1)(2008-9#1)
to test visual##2##3##(1992-7#1)(2007-6#1)
to test whether a##5##4##(1990-11#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-2#1)
to test whether the##6##4##(1994-3#1)(2005-11#1)(2009-10#1)(2009-2#1)(2009-5#1)(2013-1#1)
to test whether these##2##4##(2008-10#1)(2009-5#1)
to test whether this##3##4##(1997-5#1)(2008-9#1)(2012-3#1)
to test whether##37##3##(1990-11#1)(1992-8#2)(1994-3#1)(1995-11#1)(1995-3#1)(1996-7#1)(1997-2#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#2)(2010-11#1)(2010-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
to test which##2##3##(2008-8#1)(2009-8#1)
to test##485##2##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#4)(1990-3#1)(1990-5#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#2)(1991-2#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-6#2)(1992-7#2)(1992-8#4)(1992-9#3)(1993-1#1)(1993-10#2)(1993-11#2)(1993-12#4)(1993-3#1)(1993-4#1)(1993-5#1)(1993-9#3)(1994-1#1)(1994-10#3)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#2)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-2#3)(1995-3#2)(1995-4#2)(1995-5#2)(1995-6#1)(1995-8#2)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-4#1)(1996-6#1)(1996-7#3)(1996-9#2)(1997-1#2)(1997-2#4)(1997-3#4)(1997-4#2)(1997-5#5)(1997-6#2)(1997-7#4)(1997-8#4)(2004-11#1)(2004-12#1)(2004-2#2)(2004-4#1)(2004-9#2)(2005-10#2)(2005-11#3)(2005-7#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#3)(2006-3#1)(2006-5#1)(2006-7#3)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#3)(2007-12#5)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#4)(2008-1#6)(2008-10#43)(2008-11#17)(2008-12#4)(2008-2#11)(2008-3#21)(2008-4#13)(2008-5#13)(2008-6#4)(2008-7#10)(2008-8#17)(2008-9#12)(2009-1#1)(2009-10#2)(2009-11#1)(2009-2#5)(2009-3#2)(2009-4#3)(2009-5#6)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#6)(2010-3#5)(2010-5#2)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#9)(2011-3#1)(2012-1#6)(2012-12#5)(2012-2#7)(2012-3#9)(2012-5#2)(2012-6#1)(2013-1#9)(2013-7#2)(2013-8#4)
to testicular##3##2##(2008-10#1)(2008-6#1)(2010-1#1)
to testify##5##2##(1996-12#1)(2008-10#1)(2008-11#1)(2009-2#1)(2011-12#1)
to testing##16##2##(1993-7#1)(1994-2#1)(1996-12#1)(1997-2#1)(2004-9#1)(2006-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#2)(2011-2#1)(2012-12#1)(2012-2#2)
to testosterone##7##2##(1990-11#1)(1992-9#1)(1995-5#1)(1996-11#1)(2006-9#1)(2008-5#1)(2012-12#1)
to tests of##3##3##(2008-3#1)(2011-7#1)(2012-1#1)
to tetanus toxoid in##2##4##(1995-2#1)(2009-5#1)
to tetanus toxoid##4##3##(1995-2#1)(2009-5#1)(2011-2#2)
to tetanus##8##2##(1994-8#1)(1995-12#1)(1995-2#1)(2008-5#1)(2009-5#1)(2009-9#1)(2011-2#2)
to tether##3##2##(1990-2#1)(1996-5#1)(2007-10#1)
to tetracycline and##2##3##(2007-10#1)(2012-2#1)
to tetracycline##9##2##(1995-5#1)(2005-10#1)(2006-5#1)(2006-8#1)(2007-10#1)(2008-10#2)(2010-9#1)(2012-2#1)
to tetrahydroaminoacridine and##2##3##(1992-8#2)
to texture##3##2##(2008-2#2)(2008-6#1)
to thalidomide##2##2##(2006-10#1)(2011-2#1)
to thank##2##2##(2011-2#1)(2013-8#1)
to thapsigargin##2##2##(1990-10#1)(1997-2#1)
to that achieved in##2##4##(1995-12#1)(2008-10#1)
to that achieved with##5##4##(1993-2#1)(1996-9#1)(2006-9#1)(2007-11#1)(2008-7#1)
to that achieved##9##3##(1993-2#1)(1995-12#1)(1996-9#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-12#1)
to that among##2##3##(2007-11#1)(2008-5#1)
to that area##2##3##(1996-2#1)(2008-8#1)
to that associated with the##2##5##(1993-12#1)(2008-2#1)
to that associated with##4##4##(1993-12#2)(2008-10#1)(2008-2#1)
to that at the##3##4##(2007-11#1)(2008-3#1)(2010-8#1)
to that at##8##3##(1996-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-12#1)(2010-8#1)(2013-1#1)
to that before##3##3##(1995-5#1)(2013-1#2)
to that by##10##3##(1990-1#1)(1990-4#1)(2008-8#2)(2008-9#6)
to that caused by##7##4##(1990-11#1)(1991-10#1)(1992-6#1)(1992-8#1)(1993-11#1)(2008-2#1)(2010-4#1)
to that commonly##2##3##(2010-12#1)(2010-2#1)
to that derived from##2##4##(1992-12#1)(1994-5#1)
to that derived##3##3##(1992-12#1)(1994-5#1)(1997-5#1)
to that described for##7##4##(1990-5#1)(1992-9#1)(2007-12#1)(2008-10#1)(2009-12#1)(2012-11#2)
to that described in##2##4##(2006-7#1)(2007-2#1)
to that described##9##3##(1990-5#1)(1992-9#1)(2006-7#1)(2007-12#1)(2007-2#1)(2008-10#1)(2009-12#1)(2012-11#2)
to that developed for##2##4##(1992-9#2)
to that during##2##3##(1991-4#1)(1997-5#1)
to that environment##2##3##(2007-3#2)
to that estimated from##2##4##(1997-5#1)(2008-2#1)
to that exhibited by##4##4##(1992-12#1)(1994-12#1)(2008-10#1)(2008-3#1)
to that expected from##2##4##(1994-12#1)(2008-10#1)
to that expected##3##3##(1994-12#1)(1996-8#1)(2008-10#1)
to that for the picrate one##2##6##(2008-10#2)
to that for the##9##4##(1992-12#1)(1994-9#1)(1995-11#1)(1996-5#2)(2008-10#3)(2010-9#1)
to that for##25##3##(1990-4#1)(1991-7#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-5#1)(1994-9#2)(1995-11#1)(1996-5#2)(1996-8#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-3#1)(2008-9#1)(2010-10#1)(2010-9#1)(2011-1#1)
to that found for##4##4##(1994-9#1)(1995-8#2)(2007-11#1)
to that found in liver##2##5##(1996-5#1)(2010-10#1)
to that found in the##5##5##(1995-1#1)(1995-6#1)(1996-5#1)(2008-11#1)(2012-12#1)
to that found in##23##4##(1991-5#1)(1991-6#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-5#2)(1997-4#1)(1997-5#1)(1997-8#1)(2006-3#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-11#1)(2008-5#1)(2008-7#2)(2010-10#1)(2010-4#1)(2012-12#1)
to that found with##2##4##(1990-12#1)(1991-3#1)
to that found##32##3##(1990-12#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-6#1)(1995-8#2)(1996-5#2)(1997-4#1)(1997-5#1)(1997-8#1)(2006-3#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-11#1)(2008-5#1)(2008-7#2)(2010-10#1)(2010-4#1)(2012-12#1)
to that from##9##3##(1992-12#1)(1992-5#1)(1995-2#1)(1996-2#1)(2004-12#1)(2004-4#1)(2008-6#1)(2009-12#1)(2013-1#1)
to that habitat##2##3##(2008-8#2)
to that in 2009##2##4##(2012-3#2)
to that in a##2##4##(2008-10#1)(2008-11#1)
to that in control##6##4##(1992-4#1)(1993-2#1)(1994-2#1)(1994-3#1)(2008-10#1)(2008-7#1)
to that in controls##2##4##(1994-2#1)(1996-10#1)
to that in infected##2##4##(2008-10#2)
to that in normal##3##4##(1996-5#1)(1996-8#1)(2012-1#1)
to that in the general population##2##6##(2006-2#1)(2010-2#1)
to that in the##27##4##(1990-10#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-2#1)(1994-11#2)(1994-2#1)(1995-5#2)(1996-10#1)(1997-8#1)(2006-2#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2010-10#1)(2010-2#1)
to that in water##3##4##(2008-10#2)(2008-7#1)
to that in young##2##4##(2008-7#1)(2013-7#1)
to that in##100##3##(1990-10#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-11#4)(1991-12#1)(1991-5#1)(1991-7#1)(1991-8#3)(1992-12#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-2#2)(1994-11#2)(1994-2#3)(1994-3#1)(1995-11#1)(1995-5#4)(1995-7#1)(1995-9#1)(1996-10#2)(1996-12#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-4#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#12)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2012-1#3)(2012-3#2)(2013-1#3)(2013-7#1)
to that induced by the##3##5##(1993-3#1)(2008-10#1)(2012-1#1)
to that induced by##11##4##(1991-6#1)(1993-3#1)(1994-2#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-8#1)(2008-10#1)(2009-10#1)(2012-1#2)
to that known as##2##4##(1996-2#1)(2006-10#1)
to that known##4##3##(1996-2#1)(1997-4#2)(2006-10#1)
to that measured in##2##4##(1990-2#1)(2013-1#1)
to that measured##6##3##(1990-2#1)(1992-9#2)(1995-7#1)(2007-8#1)(2013-1#1)
to that observed following##2##4##(2006-10#1)(2007-12#1)
to that observed for the##3##5##(1991-3#1)(1993-5#1)(1996-7#1)
to that observed for##16##4##(1990-2#1)(1991-10#1)(1991-3#1)(1991-4#1)(1993-5#1)(1994-11#1)(1994-3#1)(1996-5#2)(1996-7#1)(2008-10#2)(2008-7#1)(2009-2#1)(2009-3#1)(2011-2#1)
to that observed in the##7##5##(1991-6#1)(1991-8#1)(1994-9#1)(1995-12#1)(1996-6#1)(2008-10#1)(2009-12#1)
to that observed in##39##4##(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-12#1)(1996-5#2)(1996-6#2)(1997-2#1)(1997-3#1)(2005-11#1)(2006-10#1)(2008-10#4)(2008-7#2)(2009-12#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#2)
to that observed on##2##4##(1994-10#1)(2007-12#1)
to that observed with other##2##5##(1990-6#1)(1993-11#1)
to that observed with##12##4##(1990-6#1)(1993-11#1)(1994-8#1)(1996-6#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-7#1)
to that observed##77##3##(1990-11#1)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#1)(1993-11#2)(1993-5#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#3)(1996-12#1)(1996-5#4)(1996-6#3)(1996-7#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-10#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#11)(2008-5#1)(2008-7#4)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-10#1)(2011-2#2)(2012-2#1)(2013-1#2)
to that obtained at##2##4##(2008-10#1)(2008-11#1)
to that obtained by##2##4##(2008-10#1)(2012-2#1)
to that obtained for the##2##5##(1990-7#1)(1992-12#1)
to that obtained for##4##4##(1990-7#1)(1992-12#1)(1995-8#1)(2008-5#1)
to that obtained from the##2##5##(1991-2#1)(2007-12#1)
to that obtained from##7##4##(1991-2#1)(1992-6#1)(1993-12#1)(1994-9#1)(2007-11#1)(2007-12#1)(2010-4#1)
to that obtained in##8##4##(1990-12#1)(1992-12#1)(1993-6#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-11#2)
to that obtained with a##3##5##(2007-12#1)(2008-10#1)(2008-3#1)
to that obtained with##13##4##(1991-2#1)(1994-2#1)(1995-1#1)(1995-12#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2010-2#1)(2013-7#1)
to that obtained##39##3##(1990-12#1)(1990-7#1)(1991-2#2)(1992-12#2)(1992-6#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-2#1)(2010-4#1)(2012-2#1)(2013-7#1)
to that of 1##3##4##(1991-1#1)(2010-12#1)(2010-8#1)
to that of D##2##4##(1993-12#1)(2006-8#1)
to that of M##2##4##(2008-10#1)(2011-2#1)
to that of S##2##4##(1995-3#1)(2008-8#1)
to that of a conventional##2##5##(1997-5#1)(2008-10#1)
to that of a single##2##5##(2006-5#1)(2013-1#1)
to that of a standard##3##5##(2007-11#1)(2007-3#1)(2011-1#1)
to that of a##39##4##(1990-2#1)(1991-1#1)(1992-5#1)(1992-8#1)(1993-11#1)(1995-10#1)(1996-12#1)(1996-4#1)(1997-4#1)(1997-5#1)(2006-5#1)(2006-8#1)(2007-11#3)(2007-3#3)(2007-9#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2011-1#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
to that of all##2##4##(2006-8#1)(2007-7#1)
to that of an##6##4##(1991-9#1)(1997-4#1)(1997-6#1)(2006-8#1)(2007-12#1)(2008-2#1)
to that of control##10##4##(1990-1#1)(1991-9#1)(1992-10#1)(1992-3#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-9#2)(2010-4#1)
to that of controls##6##4##(1990-11#1)(1992-9#1)(2006-5#1)(2008-11#1)(2008-6#1)(2011-12#1)
to that of conventional##4##4##(2007-12#1)(2010-12#1)(2012-12#1)(2012-2#1)
to that of free rhuMAbHER2-Fab'##2##5##(1995-2#2)
to that of free##3##4##(1995-2#2)(1997-7#1)
to that of human##11##4##(1990-7#1)(1990-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1995-2#1)(1996-4#1)(1997-4#1)(1997-7#1)(2008-4#1)(2008-6#1)
to that of indomethacin at a dose of 10 mg/kg##2##10##(2010-2#2)
to that of insulin##3##4##(1992-10#1)(1994-3#1)(2008-8#1)
to that of its##7##4##(1990-5#1)(1990-7#1)(1991-10#1)(1991-7#1)(1996-10#1)(1997-7#1)(2008-9#1)
to that of mammalian##3##4##(1991-1#1)(1992-11#1)(1997-8#1)
to that of mature##3##4##(1990-12#1)(1992-12#1)(2008-5#1)
to that of native##7##4##(1991-4#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-3#1)(1994-6#1)(1994-8#1)
to that of normal##4##4##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)
to that of other centres##2##5##(2006-8#2)
to that of other known##2##5##(1990-9#1)(2008-5#1)
to that of other##31##4##(1990-10#1)(1990-11#1)(1990-12#1)(1990-8#1)(1990-9#1)(1991-2#1)(1992-2#1)(1993-2#1)(1993-3#1)(1994-5#1)(1995-1#1)(1997-3#1)(2005-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-5#2)(2008-7#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)
to that of patients##2##4##(2010-3#1)(2011-2#1)
to that of previously##2##4##(1996-10#1)(2010-12#1)
to that of pure##2##4##(2005-11#1)(2008-3#1)
to that of purified##2##4##(1992-2#1)(1995-8#1)
to that of rat##6##4##(1990-5#1)(1992-6#1)(1993-12#1)(1996-12#1)(2008-11#2)
to that of stems##2##4##(2008-12#2)
to that of the 1918 pandemic##2##6##(2011-1#2)
to that of the activated##2##5##(1994-5#1)(2005-11#1)
to that of the alpha##2##5##(1991-1#1)(2007-9#1)
to that of the cells##2##5##(2008-11#1)(2012-12#1)
to that of the control##12##5##(1993-11#1)(1994-8#1)(1997-2#1)(2008-8#1)(2008-9#6)(2011-12#1)(2011-2#1)
to that of the conventional##3##5##(1995-1#1)(2008-12#1)(2012-12#1)
to that of the general population##2##6##(2006-10#1)(2010-12#1)
to that of the host##2##5##(1994-2#1)(2013-8#1)
to that of the human##6##5##(1990-12#1)(1993-5#1)(2007-7#1)(2008-4#1)(2010-12#1)(2011-1#1)
to that of the intact##3##5##(1990-2#1)(1993-6#1)(1995-5#1)
to that of the mature##2##5##(1991-9#1)(1994-9#1)
to that of the most##2##5##(1991-3#1)(1996-4#1)
to that of the native##2##5##(1995-11#1)(2008-11#1)
to that of the normal##2##5##(1990-4#1)(2008-9#1)
to that of the original##3##5##(2008-11#1)(2008-2#1)(2010-2#1)
to that of the other##2##5##(1991-2#1)(1994-6#1)
to that of the parent##2##5##(1997-5#1)(1997-7#1)
to that of the previously##3##5##(1991-2#1)(1994-9#1)(2011-1#1)
to that of the rat gene##2##6##(1991-7#1)(1994-11#1)
to that of the rat##5##5##(1991-7#1)(1993-4#1)(1994-11#1)(1994-8#1)(2011-2#1)
to that of the reference##3##5##(1995-3#1)(2008-3#1)(2008-5#1)
to that of the skin##2##5##(1992-8#1)(2008-5#1)
to that of the standard##2##5##(1997-3#1)(2008-8#1)
to that of the wild type##5##6##(1990-5#1)(1991-8#1)(1992-8#1)(1993-3#1)(1995-1#1)
to that of the wild-type enzyme##5##6##(1992-6#1)(1994-11#1)(1994-5#1)(1995-1#1)(1996-11#1)
to that of the wild-type##11##5##(1992-4#1)(1992-6#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-11#1)(1997-2#2)
to that of the yeast##3##5##(1991-6#1)(1996-2#1)(1997-8#1)
to that of the##264##4##(1990-10#1)(1990-12#5)(1990-2#3)(1990-3#1)(1990-4#3)(1990-5#5)(1990-7#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#5)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#2)(1992-2#1)(1992-3#2)(1992-4#2)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#3)(1993-11#2)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#4)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#2)(1994-6#3)(1994-8#4)(1994-9#3)(1995-1#6)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#4)(1995-6#1)(1995-7#1)(1995-8#3)(1996-10#1)(1996-11#1)(1996-2#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#2)(1997-1#1)(1997-2#8)(1997-3#1)(1997-4#3)(1997-5#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-11#2)(2005-9#1)(2006-10#1)(2006-11#2)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#3)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#4)(2007-12#7)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#9)(2008-11#5)(2008-12#1)(2008-2#7)(2008-3#4)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#3)(2008-8#7)(2008-9#12)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#5)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
to that of their##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
to that of total##2##4##(1990-4#1)(1995-3#1)
to that of wild-type##5##4##(1994-11#1)(1994-8#1)(1995-11#1)(1996-11#1)(2010-10#1)
to that of young##3##4##(1992-1#1)(1993-1#1)(2008-5#1)
to that of##783##3##(1990-1#3)(1990-10#5)(1990-11#3)(1990-12#12)(1990-2#8)(1990-3#1)(1990-4#7)(1990-5#9)(1990-6#1)(1990-7#4)(1990-8#3)(1990-9#4)(1991-1#5)(1991-10#3)(1991-11#1)(1991-12#1)(1991-2#6)(1991-3#4)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#9)(1991-8#2)(1991-9#5)(1992-1#3)(1992-10#2)(1992-11#4)(1992-12#3)(1992-2#5)(1992-3#5)(1992-4#2)(1992-5#2)(1992-6#7)(1992-7#2)(1992-8#7)(1992-9#6)(1993-1#1)(1993-11#8)(1993-12#6)(1993-2#4)(1993-3#6)(1993-4#3)(1993-5#1)(1993-6#8)(1993-7#1)(1993-8#5)(1993-9#1)(1994-11#6)(1994-12#7)(1994-2#3)(1994-3#6)(1994-5#3)(1994-6#9)(1994-7#1)(1994-8#8)(1994-9#5)(1995-1#9)(1995-10#2)(1995-11#4)(1995-12#2)(1995-2#7)(1995-3#8)(1995-5#6)(1995-6#4)(1995-7#1)(1995-8#7)(1996-1#1)(1996-10#3)(1996-11#3)(1996-12#8)(1996-2#4)(1996-3#4)(1996-4#4)(1996-5#7)(1996-6#2)(1996-7#4)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#11)(1997-3#5)(1997-4#9)(1997-5#3)(1997-6#2)(1997-7#8)(1997-8#5)(2004-11#1)(2004-12#1)(2005-10#2)(2005-11#9)(2005-7#1)(2005-9#1)(2006-10#10)(2006-11#3)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#5)(2006-6#1)(2006-8#10)(2006-9#1)(2007-10#4)(2007-11#17)(2007-12#17)(2007-2#4)(2007-3#3)(2007-4#1)(2007-6#2)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#55)(2008-11#16)(2008-12#6)(2008-2#18)(2008-3#11)(2008-4#5)(2008-5#27)(2008-6#6)(2008-7#9)(2008-8#12)(2008-9#19)(2009-10#3)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#3)(2010-10#1)(2010-11#3)(2010-12#6)(2010-2#3)(2010-3#3)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#4)(2011-1#7)(2011-10#1)(2011-12#3)(2011-2#14)(2012-1#1)(2012-11#3)(2012-12#9)(2012-2#5)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#9)
to that offered##2##3##(1991-2#1)(1995-11#1)
to that on##6##3##(1991-12#1)(1991-5#1)(1996-2#1)(2005-11#1)(2008-10#2)
to that point##2##3##(2012-12#1)(2012-2#1)
to that population##2##3##(1995-12#1)(2008-8#1)
to that previously observed##2##4##(1996-5#1)(2010-8#1)
to that previously reported for##2##5##(1990-1#1)(2006-5#1)
to that previously##8##3##(1990-1#1)(1990-2#1)(1991-4#1)(1995-5#1)(1996-5#1)(2005-9#1)(2006-5#1)(2010-8#1)
to that produced by the##2##5##(1994-3#1)(1996-5#1)
to that produced by##6##4##(1993-3#1)(1994-3#1)(1996-5#1)(2006-10#1)(2008-3#1)(2009-5#1)
to that provided by the##3##5##(2008-10#2)(2011-1#1)
to that provided by##5##4##(1992-5#1)(2007-10#1)(2008-10#2)(2011-1#1)
to that published##2##3##(2008-1#1)(2008-7#1)
to that reported by##2##4##(1990-7#1)(2008-6#1)
to that reported for other##3##5##(1993-6#1)(2004-11#1)(2007-12#1)
to that reported for##13##4##(1991-6#1)(1991-7#1)(1992-12#1)(1993-6#1)(1993-9#1)(1994-2#1)(1995-1#1)(1995-12#1)(2004-11#1)(2007-12#1)(2008-11#1)(2008-7#1)(2011-11#1)
to that reported from##2##4##(1990-12#1)(2007-2#1)
to that reported previously##2##4##(1990-2#1)(1997-8#1)
to that reported with the standard##2##6##(1991-10#1)(2007-11#1)
to that reported##25##3##(1990-12#1)(1990-2#1)(1990-7#1)(1991-10#1)(1991-6#1)(1991-7#1)(1992-12#1)(1993-6#1)(1993-9#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-9#1)(1997-8#1)(2004-11#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-6#2)(2008-7#1)(2011-11#1)(2012-12#1)
to that required for##2##4##(1996-7#1)(2006-9#1)
to that resulting from##2##4##(1990-4#1)(1995-12#1)
to that seen for##2##4##(1994-12#1)(2013-1#1)
to that seen in the##4##5##(1994-8#1)(1995-1#1)(2007-12#1)(2012-2#1)
to that seen in##16##4##(1992-12#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-5#1)(1996-4#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
to that seen with##7##4##(1990-5#1)(1992-4#1)(1993-8#2)(1995-1#1)(1997-3#1)(2007-11#1)
to that seen##27##3##(1990-5#1)(1992-12#1)(1992-4#1)(1993-8#2)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#2)(1995-5#1)(1996-4#1)(1997-3#1)(1997-6#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
to that shown by##2##4##(1993-2#1)(1995-5#1)
to that the##2##3##(1990-7#1)(2007-10#1)
to that used in##2##4##(2005-8#1)(2010-10#1)
to that used##4##3##(2005-8#1)(2008-10#2)(2010-10#1)
to that which##6##3##(1990-4#1)(1993-9#1)(1994-5#1)(2007-11#1)(2009-11#1)(2012-12#1)
to that with##9##3##(1991-2#1)(1992-5#1)(1993-11#1)(1996-7#1)(2007-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-8#1)
to that without##3##3##(1994-5#1)(2008-10#1)(2010-4#1)
to that##1368##2##(1990-1#6)(1990-10#6)(1990-11#5)(1990-12#15)(1990-2#14)(1990-3#2)(1990-4#11)(1990-5#11)(1990-6#2)(1990-7#9)(1990-8#5)(1990-9#4)(1991-1#5)(1991-10#6)(1991-11#5)(1991-12#7)(1991-2#14)(1991-3#8)(1991-4#5)(1991-5#9)(1991-6#5)(1991-7#12)(1991-8#7)(1991-9#5)(1992-1#3)(1992-10#3)(1992-11#4)(1992-12#13)(1992-2#6)(1992-3#6)(1992-4#5)(1992-5#5)(1992-6#9)(1992-7#2)(1992-8#8)(1992-9#12)(1993-1#1)(1993-11#12)(1993-12#11)(1993-2#9)(1993-3#9)(1993-4#3)(1993-5#2)(1993-6#10)(1993-7#2)(1993-8#9)(1993-9#4)(1994-10#1)(1994-11#11)(1994-12#13)(1994-2#9)(1994-3#12)(1994-5#9)(1994-6#9)(1994-7#1)(1994-8#11)(1994-9#10)(1995-1#14)(1995-10#3)(1995-11#8)(1995-12#9)(1995-2#10)(1995-3#9)(1995-5#15)(1995-6#5)(1995-7#3)(1995-8#15)(1995-9#2)(1996-1#1)(1996-10#5)(1996-11#3)(1996-12#14)(1996-2#8)(1996-3#5)(1996-4#5)(1996-5#22)(1996-6#6)(1996-7#8)(1996-8#7)(1996-9#5)(1997-1#2)(1997-2#14)(1997-3#8)(1997-4#14)(1997-5#7)(1997-6#3)(1997-7#11)(1997-8#8)(2004-11#2)(2004-12#2)(2004-4#1)(2005-10#3)(2005-11#13)(2005-4#1)(2005-7#1)(2005-8#2)(2005-9#2)(2006-10#16)(2006-11#4)(2006-12#4)(2006-2#2)(2006-3#2)(2006-4#2)(2006-5#6)(2006-6#1)(2006-7#1)(2006-8#10)(2006-9#3)(2007-1#4)(2007-10#7)(2007-11#28)(2007-12#28)(2007-2#9)(2007-3#6)(2007-4#1)(2007-6#2)(2007-7#5)(2007-8#6)(2007-9#3)(2008-1#7)(2008-10#113)(2008-11#30)(2008-12#10)(2008-2#22)(2008-3#18)(2008-4#7)(2008-5#34)(2008-6#10)(2008-7#25)(2008-8#24)(2008-9#32)(2009-10#5)(2009-11#4)(2009-12#5)(2009-2#1)(2009-3#3)(2009-4#3)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#3)(2010-1#1)(2010-10#6)(2010-11#4)(2010-12#10)(2010-2#6)(2010-3#5)(2010-4#8)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#6)(2010-9#1)(2011-1#9)(2011-10#1)(2011-11#1)(2011-12#3)(2011-2#16)(2012-1#7)(2012-11#5)(2012-12#13)(2012-2#13)(2012-3#7)(2013-1#17)(2013-7#6)(2013-8#12)
to the &quot##54##3##(1990-10#1)(1990-11#1)(1991-4#1)(1991-5#1)(1991-8#2)(1992-12#1)(1993-11#1)(1993-3#2)(1993-8#1)(1994-6#1)(1994-9#1)(1995-2#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-8#1)(2004-4#1)(2005-11#1)(2006-10#1)(2007-3#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#2)
to the +4 oxidation state in##2##6##(2008-5#2)
to the 0##5##3##(1992-2#1)(1994-12#1)(1996-8#1)(2007-1#1)(2008-10#1)
to the 1##11##3##(1991-10#2)(1991-4#1)(1992-12#1)(1992-6#1)(1993-11#1)(2005-3#1)(2006-12#1)(2008-10#3)
to the 10 patients##2##4##(1997-3#1)(2004-11#1)
to the 10##4##3##(1992-11#1)(1997-3#1)(2004-11#1)(2012-12#1)
to the 10th##2##3##(1996-6#1)(2013-8#1)
to the 11##2##3##(2007-8#1)(2008-10#1)
to the 12##6##3##(1996-11#1)(1996-6#2)(2008-7#1)(2011-2#1)(2012-12#1)
to the 133 bp insertion##2##5##(1993-9#2)
to the 14th day##2##4##(1990-12#1)(1991-4#1)
to the 14th##3##3##(1990-12#1)(1991-4#2)
to the 16##3##3##(1991-10#1)(1997-6#1)(2008-2#1)
to the 16S##2##3##(2006-8#1)(2010-12#1)
to the 18S rRNA##4##4##(1997-2#1)(2006-11#3)
to the 18S##5##3##(1997-2#1)(2006-11#3)(2008-10#1)
to the 1918##2##3##(2009-4#1)(2011-1#1)
to the 1970s##3##3##(2007-12#1)(2009-2#1)(2010-5#1)
to the 1985##2##3##(1996-2#1)(2011-2#1)
to the 1990##2##3##(2009-6#1)(2011-1#1)
to the 1992##2##3##(2008-5#2)
to the 1995##2##3##(1996-4#1)(2012-3#1)
to the 1st##3##3##(1992-10#1)(1996-11#1)(2008-10#1)
to the 2##4##3##(1995-5#1)(1996-6#1)(2007-10#1)(2008-10#1)
to the 20##3##3##(1993-1#1)(2008-10#2)
to the 20-kDa##2##3##(1990-2#1)(1993-12#1)
to the 2000##2##3##(2010-4#1)(2011-1#1)
to the 2000s##2##3##(2007-12#1)(2012-3#1)
to the 2001##2##3##(2008-11#1)(2012-12#1)
to the 2009##2##3##(2011-1#1)(2011-2#1)
to the 2010##2##3##(2013-1#1)(2013-7#1)
to the 21##3##3##(1993-6#1)(1996-9#1)(1997-5#1)
to the 21st##2##3##(2005-8#1)(2006-10#1)
to the 23##2##3##(1996-5#1)(1996-7#1)
to the 23S##2##3##(1993-12#1)(1995-8#1)
to the 3' and 5'##2##5##(1994-11#1)(2008-2#1)
to the 3' end of a##2##6##(1991-7#1)(1994-9#1)
to the 3' end of the##8##6##(1991-7#1)(1992-3#1)(1992-6#1)(1993-5#1)(1994-3#1)(1997-2#1)(1997-4#1)(2008-11#1)
to the 3' end of##11##5##(1991-7#2)(1992-3#1)(1992-6#1)(1993-5#1)(1994-3#1)(1994-9#1)(1997-2#1)(1997-4#1)(2008-11#1)(2008-8#1)
to the 3' end##12##4##(1991-7#2)(1992-3#1)(1992-6#1)(1993-5#1)(1994-3#1)(1994-9#1)(1996-4#1)(1997-2#1)(1997-4#1)(2008-11#1)(2008-8#1)
to the 3' untranslated region##2##5##(2008-7#1)(2009-5#1)
to the 3'##24##3##(1990-4#1)(1991-7#2)(1992-2#1)(1992-3#1)(1992-6#1)(1993-5#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-4#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-11#1)(2012-1#1)
to the 3'-UTR##2##3##(2008-1#2)
to the 3'-end of##2##4##(1991-6#1)(1994-8#1)
to the 3'-end##3##3##(1991-6#1)(1994-8#1)(2006-12#1)
to the 3'-side of the##3##5##(1995-1#3)
to the 3'-terminal##2##3##(1992-6#1)(1993-8#1)
to the 30th##2##3##(2006-2#1)(2008-5#1)
to the 3D##4##3##(1995-11#1)(1996-2#1)(2008-10#1)(2008-5#1)
to the 4-position of##2##4##(1993-4#1)(1997-2#1)
to the 40##4##3##(1996-12#3)(1997-3#1)
to the 43##2##3##(2007-7#1)(2007-9#1)
to the 45##2##3##(1996-12#1)(2008-7#1)
to the 5##4##3##(1992-3#1)(2008-4#2)(2011-2#1)
to the 5' end of the##4##6##(1990-12#1)(1993-6#1)(1996-1#1)(2006-12#1)
to the 5' end of##6##5##(1990-12#1)(1993-6#1)(1994-12#1)(1994-5#1)(1996-1#1)(2006-12#1)
to the 5' region of the##2##6##(1990-3#1)(1995-8#1)
to the 5' terminus of the##3##6##(1996-5#1)(2005-11#1)(2008-4#1)
to the 5' terminus of##4##5##(1996-5#1)(2005-11#1)(2008-4#2)
to the 5'##22##3##(1990-12#2)(1990-3#1)(1991-11#1)(1991-5#2)(1991-9#1)(1993-6#1)(1994-12#1)(1994-5#1)(1995-8#1)(1996-1#1)(1996-5#1)(1997-2#1)(2005-11#1)(2006-12#1)(2008-10#2)(2008-4#3)(2012-2#1)
to the 5'-end##3##3##(2006-12#2)(2008-10#1)
to the 5'-terminus of##2##4##(2008-4#2)
to the 5'-untranslated region##3##4##(1990-2#2)(1996-7#1)
to the 50%##3##3##(2009-5#1)(2012-2#1)(2013-1#1)
to the 5S(1/2) ?##2##4##(2007-12#2)
to the 6##3##3##(1992-2#1)(2013-8#2)
to the 6th##2##3##(1996-4#1)(2008-7#1)
to the 7th##3##3##(1997-7#1)(2006-8#1)(2013-7#1)
to the 9th##5##3##(1991-9#1)(1993-3#1)(1994-3#1)(2008-11#1)(2008-7#1)
to the A##6##3##(1990-11#1)(1992-9#1)(1993-3#1)(1994-5#1)(1996-6#1)(2008-10#1)
to the A-site of the ribosome##2##6##(2006-12#2)
to the A-site##3##3##(1992-8#1)(2006-12#2)
to the A1##3##3##(1993-3#1)(1994-5#1)(2011-2#1)
to the A2##2##3##(2008-10#1)(2011-2#1)
to the ACL##3##3##(1997-8#1)(2007-8#1)(2013-1#1)
to the ADHD##2##3##(2006-10#1)(2012-1#1)
to the AGL2 gene family##2##5##(1997-2#2)
to the AGL2##4##3##(1997-2#3)(1997-8#1)
to the AIDS##5##3##(1990-3#1)(1991-2#1)(1992-12#1)(1993-3#1)(2007-12#1)
to the AP##2##3##(1994-5#1)(2007-8#1)
to the AP-1##2##3##(1995-12#1)(1996-5#1)
to the APOE##2##3##(1996-5#2)
to the AT##2##3##(1992-3#1)(1993-3#1)
to the ATP##2##3##(1991-4#1)(1995-6#1)
to the ATP-induced##2##3##(1992-11#1)(1995-3#1)
to the AVM##2##3##(1997-6#1)(2008-7#1)
to the Acute##2##3##(2007-9#1)(2008-7#1)
to the Ag surface##2##4##(2013-1#2)
to the Ag##3##3##(2013-1#3)
to the Alu##2##3##(1990-11#1)(1993-12#1)
to the Alzheimer's##2##3##(1991-10#1)(1995-8#1)
to the American##7##3##(1992-7#1)(2006-10#1)(2007-4#1)(2008-3#1)(2009-4#1)(2010-6#1)(2011-1#1)
to the Americas##2##3##(2008-10#1)(2012-1#1)
to the Andean##2##3##(2008-10#2)
to the Ar1##2##3##(1990-7#2)
to the Arabidopsis##4##3##(1996-5#1)(2006-12#1)(2008-7#2)
to the Aspergillus##2##3##(1994-9#1)(1997-4#1)
to the Avahan program##3##4##(2012-3#3)
to the B##7##3##(1991-3#1)(1992-6#2)(1994-5#1)(2008-10#2)(2010-5#1)
to the B-form##2##3##(1992-5#1)(2006-10#1)
to the BTB##2##3##(2012-2#2)
to the Bacillus##3##3##(2010-10#1)(2011-2#2)
to the Benes network##2##4##(2008-2#2)
to the Bragg##2##3##(2007-12#1)(2008-2#1)
to the British##2##3##(1995-8#1)(2008-10#1)
to the C domain##2##4##(1995-5#2)
to the C terminus of the##3##6##(1994-8#1)(1995-2#1)(1995-3#1)
to the C terminus of##4##5##(1994-8#1)(1995-2#1)(1995-3#1)(1997-2#1)
to the C terminus##5##4##(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1997-2#1)
to the C##13##3##(1994-3#2)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#2)(1997-2#1)(2008-10#3)(2012-12#1)
to the C-C##2##3##(1996-5#1)(2005-9#1)
to the C-terminal domain##2##4##(1991-4#1)(1996-1#1)
to the C-terminal of##2##4##(2008-6#1)(2008-9#1)
to the C-terminal region of##2##5##(1990-7#1)(2006-10#1)
to the C-terminal side of##2##5##(1995-6#1)(1996-5#1)
to the C-terminal##19##3##(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-4#1)(1992-1#1)(1992-9#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-5#1)(1996-7#1)(1996-9#1)(2006-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-6#1)
to the C-terminus of the##4##5##(1992-3#1)(1993-12#1)(1995-5#1)(1997-2#1)
to the C-terminus of##7##4##(1991-8#1)(1992-3#1)(1993-12#1)(1995-5#1)(1997-2#1)(1997-6#1)(2012-3#1)
to the C-terminus##8##3##(1991-8#1)(1992-3#1)(1993-12#1)(1994-3#1)(1995-5#1)(1997-2#1)(1997-6#1)(2012-3#1)
to the C1-C2##2##3##(2007-11#1)(2011-2#1)
to the C10##2##3##(1990-8#1)(1993-11#1)
to the CD spectrum in##2##5##(1994-11#2)
to the CD spectrum##4##4##(1993-6#2)(1994-11#2)
to the CD##5##3##(1993-6#2)(1994-11#2)(2010-4#1)
to the CD4 receptor##2##4##(1992-5#1)(2005-7#1)
to the CD4##3##3##(1992-5#1)(1997-4#1)(2005-7#1)
to the CDC##2##3##(1996-5#1)(2006-7#1)
to the CF0##4##3##(1992-6#4)
to the CL intensity##3##4##(2008-10#3)
to the CL##4##3##(2008-10#4)
to the CNS##8##3##(1990-11#1)(1990-4#2)(1994-10#1)(2007-11#2)(2008-2#1)(2010-12#1)
to the COOH-terminal##4##3##(1992-9#1)(1995-6#1)(1996-5#2)
to the CRE##2##3##(2013-1#2)
to the CS##2##3##(1995-11#1)(2012-2#1)
to the CSF##2##3##(1993-12#1)(2012-3#1)
to the Ca2+##6##3##(1991-8#1)(1992-9#1)(1994-12#2)(1995-12#1)(2008-8#1)
to the Canadian health##2##4##(1994-2#1)(2007-7#1)
to the Canadian##7##3##(1994-2#1)(1996-1#1)(2006-5#1)(2007-3#1)(2007-7#1)(2009-4#1)(2010-4#1)
to the Cardiothoracic##2##3##(2007-8#1)(2011-2#1)
to the Catholic##2##3##(1991-3#1)(1996-12#1)
to the Center##3##3##(1994-3#1)(2011-2#1)(2013-8#1)
to the Child-Pugh##2##3##(2007-8#1)(2009-9#1)
to the Chinese##2##3##(2008-10#1)(2011-1#1)
to the Clinic##4##3##(1994-12#1)(1995-9#1)(2007-8#1)(2011-2#1)
to the Co-4##2##3##(2008-10#2)
to the Connecticut##2##3##(1995-5#1)(1997-3#1)
to the Convention have##2##4##(1990-2#1)(1992-12#1)
to the Convention##4##3##(1990-2#1)(1992-12#2)(2005-11#1)
to the Court of##2##4##(1995-12#1)(1997-5#1)
to the CrkSH3(N) domain##2##4##(1994-12#2)
to the D##5##3##(1990-4#1)(1995-2#1)(2008-10#3)
to the D2##3##3##(1990-5#1)(1993-9#1)(2005-8#1)
to the DNA backbone##2##4##(1994-5#1)(1996-11#1)
to the DNA binding##4##4##(1995-6#1)(2008-2#2)(2012-12#1)
to the DNA substrate##2##4##(1994-11#1)(1997-3#1)
to the DNA##23##3##(1991-10#1)(1991-5#1)(1991-7#1)(1992-12#1)(1993-5#1)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-6#2)(1995-8#1)(1996-11#1)(1997-3#1)(2006-10#2)(2008-12#1)(2008-2#2)(2008-9#1)(2010-2#1)(2012-12#1)(2013-1#1)
to the DNA-binding domain of##2##5##(1994-9#1)(1997-1#1)
to the DNA-binding##6##3##(1991-11#1)(1994-9#1)(1995-3#1)(1995-8#1)(1997-1#1)(2009-3#1)
to the DNC diet resulted in##2##6##(2010-2#2)
to the Danish##2##3##(1993-3#1)(1993-8#1)
to the Department of##13##4##(1990-10#1)(1992-3#1)(1993-5#1)(1995-11#1)(1995-6#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-6#1)(2012-12#2)(2012-2#1)(2013-8#1)
to the Department##14##3##(1990-10#1)(1992-3#1)(1993-5#1)(1995-11#1)(1995-6#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-6#1)(2012-12#2)(2012-2#1)(2013-8#1)
to the Donnan##2##3##(2005-11#1)(2011-2#1)
to the Drosophila segment polarity gene##3##6##(1990-8#1)(1993-12#2)
to the Drosophila##6##3##(1990-11#2)(1990-8#1)(1993-12#2)(1997-1#1)
to the E##5##3##(1990-11#1)(1991-4#1)(1995-12#1)(1995-3#1)(1996-9#1)
to the E2##3##3##(1991-2#1)(1997-1#1)(2008-10#1)
to the ECR##2##3##(1995-11#1)(2008-10#1)
to the ED##7##3##(2007-7#2)(2009-8#1)(2011-12#1)(2013-1#3)
to the EDP##2##3##(2008-7#2)
to the EGR-1##2##3##(1990-11#1)(1991-10#1)
to the ELISA##3##3##(2008-10#2)(2012-12#1)
to the ER gene##2##4##(1996-11#1)(1997-7#1)
to the ER##10##3##(1990-5#1)(1990-6#1)(1994-12#2)(1996-11#1)(1997-7#1)(2008-11#3)(2012-2#1)
to the Editor##8##3##(2005-9#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-10#1)(2010-4#1)(2011-2#1)(2013-1#1)
to the Emergency Department (ED)##2##5##(2008-3#1)(2012-2#1)
to the Emergency Department of##2##5##(2006-8#1)(2013-1#1)
to the Emergency Department##5##4##(2006-8#1)(2008-3#1)(2009-10#1)(2012-2#1)(2013-1#1)
to the Emergency Room##2##4##(2007-11#1)(2007-2#1)
to the Emergency##7##3##(2006-8#1)(2007-11#1)(2007-2#1)(2008-3#1)(2009-10#1)(2012-2#1)(2013-1#1)
to the Escherichia coli enzyme##2##5##(1991-4#1)(1995-8#1)
to the Escherichia coli##8##4##(1990-5#1)(1991-4#1)(1993-12#1)(1995-8#1)(1996-10#1)(1996-3#2)(1997-6#1)
to the European##9##3##(1993-5#1)(2006-11#1)(2007-8#1)(2008-10#3)(2010-4#1)(2011-1#1)(2011-2#1)
to the FA##4##3##(2008-10#2)(2009-1#2)
to the FDA##4##3##(2005-6#2)(2005-8#1)(2008-5#1)
to the FI system##2##4##(2008-10#2)
to the FS##3##3##(1991-12#2)(2005-11#1)
to the Family##2##3##(1997-1#1)(2008-10#1)
to the Fc portion of##2##5##(1990-12#1)(2008-4#1)
to the Fc region of##2##5##(2008-11#1)(2009-2#1)
to the Fc region##3##4##(2008-11#2)(2009-2#1)
to the Fc##6##3##(1990-12#2)(2008-11#2)(2008-4#1)(2009-2#1)
to the Federal##2##3##(1992-1#1)(1993-6#1)
to the First##3##3##(1995-1#1)(2007-7#1)(2011-2#1)
to the Food##3##3##(2008-5#1)(2008-9#1)(2012-1#1)
to the Fourier##2##3##(1995-8#1)(2007-12#1)
to the Future##2##3##(2008-10#1)(2013-1#1)
to the G##7##3##(1991-2#1)(1992-5#1)(1993-7#1)(1994-12#1)(1994-8#1)(2008-10#1)(2008-6#1)
to the GCN4 motif##2##4##(2008-9#2)
to the GI##2##3##(2008-4#1)(2010-2#1)
to the GO##2##3##(2008-4#1)(2008-9#1)
to the Genetic Analysis Workshop 17##5##6##(2012-3#5)
to the German##3##3##(2006-6#1)(2011-2#1)(2013-8#1)
to the Golgi apparatus##5##4##(1990-7#2)(1992-12#1)(1992-7#1)(2012-2#1)
to the Golgi##14##3##(1990-7#2)(1992-12#1)(1992-7#1)(1994-12#1)(1994-9#1)(1995-2#1)(1997-6#1)(2006-10#2)(2008-4#1)(2009-8#1)(2012-2#2)
to the Gulf##2##3##(2004-7#2)
to the H2O2##2##3##(1990-1#1)(1997-1#1)
to the HA##2##3##(1992-12#1)(2008-5#1)
to the HBV##2##3##(1997-4#1)(2008-10#1)
to the HIV epidemic##5##4##(1990-6#1)(1993-12#1)(2007-12#1)(2009-7#1)(2011-2#1)
to the HIV##6##3##(1990-6#1)(1992-7#1)(1993-12#1)(2007-12#1)(2009-7#1)(2011-2#1)
to the HIV-1##3##3##(1997-3#1)(2008-4#1)(2013-1#1)
to the HIV/AIDS##3##3##(2007-7#1)(2013-7#2)
to the HLA##3##3##(1991-11#2)(2008-10#1)
to the HPLC##2##3##(2008-10#2)
to the HPV##2##3##(1991-2#2)
to the Health##4##3##(1991-2#1)(1992-2#1)(2006-8#1)(2010-11#1)
to the High##3##3##(1992-12#1)(2008-11#1)(2009-6#1)
to the Homo sapiens##2##4##(2011-1#1)(2012-2#1)
to the IC##2##3##(2008-10#2)
to the ICP-MS##2##3##(2008-10#2)
to the ICRP##2##3##(1997-8#1)(2013-1#1)
to the ICU between 1970 and the end of 1999##2##10##(2006-10#2)
to the ICU##9##3##(2004-1#1)(2006-10#3)(2009-6#2)(2010-5#1)(2012-3#1)(2013-1#1)
to the IGF-1 receptor##2##4##(1990-11#1)(1994-11#1)
to the IGF-I receptor##4##4##(1990-9#2)(1993-9#2)
to the Icelandic##3##3##(2006-8#3)
to the IgG##2##3##(1994-12#1)(1994-9#1)
to the Ile##2##3##(1990-8#1)(1993-7#1)
to the Institute of##4##4##(1991-11#1)(1991-6#1)(2011-2#1)(2013-1#1)
to the Intensive##2##3##(1990-9#1)(2012-3#1)
to the Internal##2##3##(2008-5#1)(2009-8#1)
to the International Classification of##3##5##(1990-12#1)(2007-8#1)(2008-11#1)
to the International##13##3##(1990-12#1)(1994-9#1)(1997-6#1)(2004-3#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-3#1)(2013-7#1)
to the Internet##8##3##(1994-12#1)(1994-3#1)(1996-2#1)(2006-6#1)(2007-4#1)(2008-2#1)(2008-9#1)(2010-12#1)
to the Iranian oil industry##2##5##(2006-2#2)
to the Israeli-Palestinian##2##3##(2012-12#2)
to the Italian##5##3##(1991-12#1)(1994-2#1)(2008-10#1)(2009-5#1)(2011-1#1)
to the K+ equilibrium##3##4##(1990-7#1)(1994-2#1)(1997-1#1)
to the L5##2##3##(1992-5#1)(1993-4#1)
to the LAD##3##3##(2006-12#1)(2007-8#2)
to the LC##2##3##(2008-10#2)
to the LIP##2##3##(1990-12#1)(1991-8#1)
to the LNN##2##3##(2008-2#1)(2008-3#1)
to the Laser##2##3##(2008-3#2)
to the Leptosphaeria maculans-Brassica napus##2##5##(2008-10#2)
to the Lewis##2##3##(1991-3#1)(2005-11#1)
to the M##6##3##(1992-3#1)(1993-3#1)(1994-11#1)(1997-3#1)(2008-10#1)(2008-7#1)
to the MHC class I##2##5##(1992-4#1)(1996-2#1)
to the MHC##4##3##(1992-4#1)(1995-5#1)(1996-2#1)(2008-4#1)
to the MMSE##2##3##(2008-7#1)(2013-1#1)
to the MSH##2##3##(1993-5#1)(1995-12#1)
to the Massachusetts##2##3##(2007-10#1)(2008-12#1)
to the Medicare##8##3##(1991-1#1)(1992-1#1)(1992-12#2)(1992-2#1)(1995-2#1)(1996-12#1)(2007-4#1)
to the Mediterranean region##2##4##(2010-12#1)(2013-1#1)
to the Mediterranean##3##3##(2010-12#1)(2011-2#1)(2013-1#1)
to the Meth-paired chamber##3##4##(2012-2#3)
to the Meth-paired##4##3##(2012-2#4)
to the Middle Ages##2##4##(2009-10#1)(2013-8#1)
to the Middle##3##3##(2009-10#1)(2009-2#1)(2013-8#1)
to the Minister of Health##2##5##(2006-10#1)(2009-5#1)
to the Ministry##2##3##(1991-2#1)(2004-7#1)
to the Mn cluster##2##4##(1995-8#2)
to the N and##2##4##(1994-9#1)(1995-5#1)
to the N domain##2##4##(1995-5#2)
to the N terminus##2##4##(1994-3#1)(1995-6#1)
to the N##11##3##(1994-3#1)(1994-9#1)(1995-5#3)(1995-6#1)(1996-2#1)(1997-4#1)(2008-10#2)(2011-2#1)
to the N- and C-terminal##2##5##(1990-7#1)(1992-3#1)
to the N- and##3##4##(1990-7#1)(1992-3#1)(1997-6#1)
to the N-terminal domain of the##2##6##(1991-7#1)(1997-5#1)
to the N-terminal domain of##5##5##(1991-7#1)(1993-11#1)(1997-5#1)(2006-5#1)(2006-6#1)
to the N-terminal half of the##2##6##(1992-7#1)(2011-1#1)
to the N-terminal##22##3##(1990-4#1)(1990-7#4)(1991-5#1)(1991-7#3)(1992-7#1)(1992-8#1)(1993-11#1)(1994-11#2)(1995-3#1)(1996-5#1)(1997-5#1)(2006-5#1)(2006-6#1)(2008-11#1)(2010-4#1)(2011-1#1)
to the N-termini of the##2##5##(1991-8#1)(1995-11#1)
to the N-terminus of the##2##5##(1991-1#1)(2008-10#1)
to the N-terminus of##4##4##(1990-7#1)(1991-1#1)(1994-2#1)(2008-10#1)
to the N2##2##3##(1996-7#1)(2008-11#1)
to the NADH oxidase##2##4##(1994-12#1)(1995-4#1)
to the NADH##4##3##(1993-6#1)(1994-12#1)(1995-4#1)(2008-10#1)
to the NE##2##3##(1996-7#1)(2004-4#1)
to the NF-kappa B##3##4##(1995-1#1)(1995-12#1)(1997-3#1)
to the NF-kappa##4##3##(1993-6#1)(1995-1#1)(1995-12#1)(1997-3#1)
to the NH2 terminal sequence##2##5##(1991-3#1)(1991-7#1)
to the NH2 terminus of##2##5##(1995-6#1)(1996-5#1)
to the NH2##4##3##(1991-3#1)(1991-7#1)(1995-6#1)(1996-5#1)
to the NH2-terminal region##2##4##(1994-11#1)(1994-12#1)
to the NH2-terminal sequence of the##2##6##(1995-6#1)(1997-6#1)
to the NH2-terminal##6##3##(1990-10#1)(1990-7#1)(1994-11#1)(1994-12#1)(1995-6#1)(1997-6#1)
to the NHS##2##3##(2012-12#1)(2013-8#1)
to the NICU##2##3##(1991-1#1)(1993-5#1)
to the NMDA R1/R2C##2##4##(1994-9#2)
to the NMDA##4##3##(1992-6#1)(1992-8#1)(1994-9#2)
to the NMR##3##3##(1997-4#1)(1997-5#1)(2010-7#1)
to the NOS reaction mixture##2##5##(2008-5#2)
to the NOS##3##3##(1997-6#1)(2008-5#2)
to the NTS##2##3##(1991-8#1)(2013-1#1)
to the NZ##2##3##(2008-11#1)(2008-8#1)
to the National Health Accounts##2##5##(1991-2#1)(2005-9#1)
to the National Health##4##4##(1991-2#1)(1994-11#1)(1996-8#1)(2005-9#1)
to the National Institute of##3##5##(1992-12#1)(2008-10#1)(2008-3#1)
to the National Institute##4##4##(1992-12#1)(2008-10#1)(2008-3#1)(2012-12#1)
to the National Insurance##2##4##(1990-4#1)(1997-6#1)
to the National##24##3##(1990-4#1)(1991-2#1)(1992-12#1)(1992-3#1)(1994-11#1)(1996-5#2)(1996-8#1)(1997-6#1)(2005-9#1)(2006-2#1)(2006-5#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-8#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#2)(2012-12#1)
to the Nd##2##3##(2007-12#1)(2008-3#1)
to the Netherlands##2##3##(1992-2#1)(2008-10#1)
to the New Zealand##2##4##(2008-1#1)(2008-11#1)
to the New##4##3##(1990-6#1)(2008-1#1)(2008-11#1)(2012-1#1)
to the North##3##3##(1992-5#1)(1993-1#1)(1994-12#1)
to the Northern##2##3##(2008-7#1)(2012-2#1)
to the Norwegian##6##3##(1993-10#1)(1994-9#1)(1995-5#1)(1996-3#1)(1997-8#1)(2011-2#1)
to the Nyquist##2##3##(2007-11#1)(2008-3#1)
to the OPO cavity##2##4##(2007-12#1)(2008-3#1)
to the Ontario##4##3##(1991-2#1)(1994-1#1)(1996-1#1)(2007-6#1)
to the Oxford Colposcopy##2##4##(1994-2#1)(2004-10#1)
to the P site##2##4##(1993-11#1)(2006-11#1)
to the P##8##3##(1990-2#1)(1990-5#1)(1991-5#1)(1993-11#1)(2006-11#1)(2007-3#1)(2008-10#2)
to the P1##2##3##(1991-4#1)(2008-8#1)
to the P450##2##3##(1994-8#1)(1995-3#1)
to the PACS##2##3##(2004-9#2)
to the PBN##2##3##(1992-10#1)(2009-10#1)
to the PCR##4##3##(1990-2#1)(2005-9#1)(2008-10#1)(2008-4#1)
to the PFC##2##3##(1996-5#1)(1997-2#1)
to the PIHCP##2##3##(2008-1#2)
to the POM##2##3##(2010-6#2)
to the PRDII domain##3##4##(1990-3#3)
to the PSD##2##3##(1996-12#1)(2008-3#1)
to the PTV##4##3##(2008-11#1)(2008-2#1)(2008-6#2)
to the Pacific##2##3##(2008-1#2)
to the Panel Study of Income Dynamics##2##7##(2010-2#2)
to the Pediatric##4##3##(2006-10#1)(2011-2#1)(2013-1#2)
to the Pseudomonas syringae##2##4##(1996-4#1)(2008-10#1)
to the R##3##3##(2005-7#1)(2008-10#1)(2008-5#1)
to the R-state##2##3##(1990-9#1)(1995-2#1)
to the RNA##5##3##(1992-6#1)(1994-2#1)(2004-1#1)(2008-10#1)(2012-3#1)
to the RNA-dependent RNA polymerase##2##5##(2008-10#2)
to the RP##2##3##(1996-4#1)(2010-12#1)
to the RRE with##2##4##(1993-8#2)
to the RRE##3##3##(1993-8#3)
to the Rev-responsive##2##3##(1991-7#2)
to the Royal College of##2##5##(2012-12#1)(2012-3#1)
to the Royal##3##3##(2008-6#1)(2012-12#1)(2012-3#1)
to the Ryan White CARE Act##2##6##(1996-6#2)
to the S phase##2##4##(1992-8#1)(1994-12#1)
to the S##9##3##(1991-9#1)(1992-8#1)(1994-12#1)(1996-6#1)(2008-10#4)(2008-11#1)
to the S2 multiline##2##4##(1994-12#1)(1997-7#1)
to the S2##3##3##(1994-12#1)(1997-7#2)
to the SH2 domain of##2##5##(1995-3#1)(1995-6#1)
to the SH2##4##3##(1995-3#1)(1995-6#2)(1996-5#1)
to the SI##4##3##(2008-10#1)(2012-2#3)
to the SIMD array##2##4##(2008-2#2)
to the SL2##2##3##(2007-12#2)
to the SNT##2##3##(2005-9#2)
to the SPE##3##3##(2007-8#1)(2008-10#2)
to the SV40##3##3##(1992-5#1)(1994-12#1)(2008-11#1)
to the Second##3##3##(1990-4#1)(1995-4#1)(2011-1#1)
to the Sellmeier dispersion function##2##5##(2008-2#1)(2008-3#1)
to the Senate##2##3##(1995-6#2)
to the Slump Test##2##4##(2008-12#2)
to the Sm##2##3##(1994-8#1)(1997-9#1)
to the South##3##3##(2005-7#1)(2011-2#2)
to the Special##2##3##(2006-2#1)(2009-4#1)
to the State of##2##4##(2011-1#1)(2011-2#1)
to the State##3##3##(1992-1#1)(2011-1#1)(2011-2#1)
to the Study of##2##4##(2008-10#1)(2012-1#1)
to the T cell##4##4##(1991-12#1)(1992-12#1)(1995-6#1)(1997-6#1)
to the T state is##2##5##(1990-8#1)(2008-11#1)
to the T state##3##4##(1990-8#2)(2008-11#1)
to the T##8##3##(1990-8#3)(1991-12#1)(1992-12#1)(1995-6#1)(1997-6#1)(2008-11#1)
to the T-state##2##3##(1990-9#1)(1992-7#1)
to the TATA box##5##4##(1990-6#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-3#1)
to the TATA##8##3##(1990-6#2)(1993-5#1)(1993-6#1)(1993-8#1)(1994-3#1)(1995-2#1)(1997-2#1)
to the TCR##2##3##(1992-5#1)(2008-4#1)
to the TCRAC##2##3##(1997-9#2)
to the TGF-beta 1##2##4##(1990-9#2)
to the TGF-beta##3##3##(1990-9#2)(2008-9#1)
to the TH##2##3##(1995-12#1)(2007-12#1)
to the Ti##3##3##(2004-9#2)(2008-8#1)
to the TiO2##2##3##(2010-4#2)
to the Type I benzodiazepine receptor##2##6##(1994-12#1)(1994-5#1)
to the Type##3##3##(1992-9#1)(1994-12#1)(1994-5#1)
to the U##11##3##(1993-12#1)(1993-3#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-4#1)(2009-5#1)(2012-1#1)(2013-1#1)(2013-8#1)
to the UK National Patient Safety Agency##2##7##(2009-2#2)
to the UK##8##3##(2006-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2009-2#2)(2012-2#1)(2013-8#1)
to the US FDA##2##4##(2005-9#1)(2008-5#1)
to the US Food and Drug Administration##3##7##(1995-8#1)(2007-7#1)(2012-12#1)
to the US##12##3##(1993-7#1)(1995-6#1)(1995-8#1)(1996-6#2)(1997-2#1)(2005-9#1)(2007-7#1)(2008-5#1)(2008-8#1)(2012-12#1)(2012-2#1)
to the USA##3##3##(2006-2#1)(2009-4#2)
to the UV##6##3##(2007-12#2)(2008-10#2)(2008-3#1)(2011-2#1)
to the United Nations##3##4##(1992-10#1)(1992-6#1)(1996-1#1)
to the United States##12##4##(1995-1#1)(1996-7#1)(2005-10#2)(2007-10#1)(2008-10#2)(2008-11#1)(2010-5#3)(2012-12#1)
to the United##20##3##(1992-10#1)(1992-6#2)(1995-1#1)(1996-1#1)(1996-2#1)(1996-7#1)(2005-10#2)(2007-10#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-5#3)(2012-12#1)
to the University of##5##4##(1991-3#1)(1996-1#1)(2008-10#1)(2011-2#2)
to the University##7##3##(1991-3#1)(1993-1#1)(1996-1#1)(2008-10#1)(2011-2#3)
to the VLDL receptor##2##4##(1995-6#2)
to the VMH##3##3##(1993-2#3)
to the VSCC##2##3##(2007-9#2)
to the VTA##3##3##(1993-12#1)(1993-2#2)
to the Veterinary##3##3##(1992-2#1)(2005-5#1)(2007-2#1)
to the WHO##11##3##(1990-12#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-9#1)(2011-2#4)
to the Washington##2##3##(1997-8#1)(2007-2#1)
to the West##2##3##(2009-7#1)(2011-2#1)
to the Western##2##3##(2007-5#1)(2008-10#1)
to the Women's Health##2##4##(1991-10#1)(2013-8#1)
to the World Health Organization (WHO)##7##6##(1995-5#1)(1997-6#1)(2008-12#1)(2008-3#1)(2009-8#1)(2010-6#1)(2011-2#1)
to the World Health Organization##11##5##(1990-3#1)(1993-6#1)(1995-5#1)(1997-6#2)(2008-12#1)(2008-3#1)(2009-5#1)(2009-8#1)(2010-6#1)(2011-2#1)
to the World Health##12##4##(1990-3#1)(1993-6#1)(1995-5#1)(1997-6#2)(2008-12#1)(2008-3#1)(2009-5#1)(2009-8#1)(2010-5#1)(2010-6#1)(2011-2#1)
to the World##16##3##(1990-3#1)(1993-6#1)(1995-5#1)(1997-6#2)(2007-2#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-5#1)(2009-8#1)(2010-5#1)(2010-6#1)(2011-2#2)
to the X chromosome##3##4##(1994-9#2)(2008-8#1)
to the X##9##3##(1991-5#1)(1994-9#2)(1995-11#1)(2007-12#1)(2008-10#2)(2008-8#2)
to the X-chromosome##2##3##(1990-8#1)(2008-12#1)
to the X-ray##6##3##(1990-4#1)(1991-4#2)(1991-5#1)(1996-6#1)(2012-12#1)
to the Y chromosome##4##4##(1990-11#1)(1996-5#2)(2008-8#1)
to the Y##6##3##(1990-11#1)(1993-9#1)(1996-5#2)(2007-12#1)(2008-8#1)
to the Z line##3##4##(2008-6#3)
to the Z##4##3##(2008-3#1)(2008-6#3)
to the aa##2##3##(1995-8#1)(1997-2#1)
to the abdomen##5##3##(1991-5#1)(1997-3#1)(2008-9#2)(2013-8#1)
to the abdominal##2##3##(2007-11#1)(2013-1#1)
to the aberrant##2##3##(2007-12#1)(2007-8#1)
to the ability of the##5##5##(1992-12#1)(1996-10#1)(2006-11#1)(2008-10#2)
to the ability of these##3##5##(1991-2#1)(2007-11#1)(2007-12#1)
to the ability of##19##4##(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1995-10#1)(1996-10#1)(1996-12#1)(1997-3#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-10#1)(2010-3#1)(2013-8#1)
to the ability to##11##4##(1994-3#1)(1995-12#1)(1996-12#1)(1996-8#1)(2006-10#2)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-12#1)
to the ability##30##3##(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1994-3#1)(1995-10#1)(1995-12#1)(1996-10#1)(1996-12#2)(1996-8#1)(1997-3#1)(2006-10#2)(2006-11#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-5#2)(2008-9#1)(2009-12#1)(2010-10#1)(2010-3#1)(2013-8#1)
to the abnormal##2##3##(2005-11#1)(2007-7#1)
to the abortion##2##3##(2006-7#1)(2008-8#1)
to the above mentioned##2##4##(1994-9#1)(2012-3#1)
to the above results##2##4##(1994-3#1)(1994-8#1)
to the above##16##3##(1990-12#1)(1991-1#1)(1993-12#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-4#1)(1995-8#1)(1997-3#1)(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)(2013-8#2)
to the above-mentioned##3##3##(2008-10#2)(2008-7#1)
to the absence of##26##4##(1990-12#1)(1990-5#1)(1991-6#1)(1991-9#1)(1995-5#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-7#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
to the absence##27##3##(1990-12#1)(1990-5#1)(1991-6#1)(1991-9#1)(1995-5#1)(1997-3#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-7#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
to the absolute##5##3##(1991-9#1)(2008-10#2)(2008-4#1)(2008-8#1)
to the absorbed pump power##6##5##(2007-11#2)(2007-12#3)(2008-3#1)
to the absorbed##8##3##(2007-11#2)(2007-12#4)(2008-3#1)(2011-1#1)
to the absorption and##2##4##(2008-2#1)(2008-3#1)
to the absorption coefficient of the##2##6##(2008-3#2)
to the absorption coefficient##3##4##(2008-2#1)(2008-3#2)
to the absorption maximum##2##4##(1994-5#1)(2008-10#1)
to the absorption of##2##4##(2008-3#1)(2008-5#1)
to the absorption spectra##2##4##(2008-10#1)(2008-2#1)
to the absorption##20##3##(1994-5#1)(2006-4#1)(2007-12#1)(2008-10#5)(2008-2#5)(2008-3#5)(2008-5#1)(2013-8#1)
to the abundance of##2##4##(2008-7#1)(2008-9#1)
to the abundant##2##3##(2009-8#1)(2010-4#1)
to the academic##2##3##(2007-8#1)(2009-11#1)
to the acceptor dye##2##4##(2008-10#1)(2009-2#1)
to the acceptor##4##3##(1990-12#1)(2008-10#2)(2009-2#1)
to the accessibility##2##3##(2008-4#1)(2013-7#1)
to the accident##2##3##(2006-12#1)(2007-11#1)
to the accumulated##3##3##(2005-11#1)(2008-3#1)(2008-7#1)
to the accumulation of the##2##5##(1996-10#1)(2008-7#1)
to the accumulation of these##2##5##(1994-3#1)(2011-1#1)
to the accumulation of##30##4##(1990-5#2)(1993-12#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-7#1)(1996-8#1)(2006-3#1)(2006-5#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-6#1)(2008-7#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#2)(2012-3#1)(2013-1#1)
to the accumulation##31##3##(1990-5#2)(1993-12#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-7#1)(1996-8#1)(2006-3#1)(2006-5#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-6#1)(2008-7#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#2)(2012-3#1)(2013-1#1)
to the accuracy of the##3##5##(1991-4#1)(2008-10#1)(2008-3#1)
to the accuracy##5##3##(1991-4#1)(2008-10#2)(2008-2#1)(2008-3#1)
to the accurate##2##3##(1991-11#1)(2008-10#1)
to the achievement of##2##4##(2006-5#1)(2008-11#1)
to the acid##5##3##(1996-5#1)(2007-6#1)(2008-10#2)(2011-1#1)
to the acid-base##2##3##(1994-5#1)(2005-12#1)
to the acoustic##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
to the acquired data##2##4##(1997-6#1)(2011-1#1)
to the acquired##5##3##(1990-9#1)(1997-6#1)(2006-5#1)(2008-5#1)(2011-1#1)
to the acquisition of the##2##5##(1991-1#1)(2009-3#1)
to the acquisition of##6##4##(1990-7#1)(1991-1#1)(2008-2#1)(2008-5#1)(2009-3#1)(2010-11#1)
to the acquisition##8##3##(1990-7#1)(1991-1#1)(1994-8#1)(2006-11#1)(2008-2#1)(2008-5#1)(2009-3#1)(2010-11#1)
to the act##2##3##(1990-12#2)
to the actin cytoskeleton##5##4##(1993-9#1)(2009-12#3)(2009-7#1)
to the actin##6##3##(1993-9#1)(1994-8#1)(2009-12#3)(2009-7#1)
to the action of##20##4##(1992-11#1)(1994-11#2)(1994-5#1)(1994-8#2)(1995-12#2)(1995-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2011-1#2)(2011-2#2)(2012-2#1)
to the action##22##3##(1992-1#1)(1992-11#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-8#2)(1995-12#2)(1995-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2011-1#2)(2011-2#2)(2012-2#1)
to the actions of##4##4##(1990-10#1)(1990-5#1)(1992-10#1)(2008-4#1)
to the actions##5##3##(1990-10#1)(1990-5#1)(1992-1#1)(1992-10#1)(2008-4#1)
to the activated##5##3##(1994-3#1)(1997-7#1)(2007-11#1)(2008-10#1)(2009-10#1)
to the activation of a series of##2##7##(1996-10#1)(1996-5#1)
to the activation of a##5##5##(1991-1#1)(1994-8#1)(1995-12#1)(1996-10#1)(1996-5#1)
to the activation of the##2##5##(2006-12#1)(2009-1#1)
to the activation of##25##4##(1991-1#1)(1991-2#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#2)(1994-6#1)(1994-8#1)(1995-12#2)(1995-3#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-5#1)(2006-12#1)(2008-6#2)(2008-8#1)(2009-1#1)(2009-8#1)(2010-11#1)
to the activation##29##3##(1991-1#1)(1991-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#2)(1993-8#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-3#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-5#1)(1996-7#1)(1997-7#1)(2006-12#1)(2008-6#2)(2008-8#1)(2009-1#1)(2009-8#1)(2010-11#1)
to the activator##2##3##(1992-5#1)(2008-9#1)
to the active site of PLA2##2##6##(1993-6#2)
to the active site of the enzyme##3##7##(1991-5#1)(1992-11#1)(1994-5#1)
to the active site of the##4##6##(1991-5#1)(1992-11#1)(1994-5#1)(2008-8#1)
to the active site of##11##5##(1990-5#1)(1991-5#1)(1992-11#1)(1993-6#2)(1994-5#2)(1994-8#1)(1995-11#1)(2008-8#1)(2010-2#1)
to the active site##24##4##(1990-12#1)(1990-3#1)(1990-5#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-3#2)(1992-6#1)(1993-6#2)(1994-5#2)(1994-8#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-7#2)(2006-12#1)(2008-8#1)(2009-12#1)(2010-2#1)(2012-2#1)
to the active##40##3##(1990-12#1)(1990-3#1)(1990-5#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-3#2)(1992-6#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-8#1)(1995-11#2)(1995-6#1)(1995-8#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-4#1)(2005-1#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-2#1)(2012-2#1)
to the active-site##2##3##(1993-11#1)(1994-2#1)
to the activities of##2##4##(2008-4#1)(2013-8#1)
to the activity of the##3##5##(1995-11#1)(2006-10#1)(2007-12#1)
to the activity of##11##4##(1992-12#1)(1994-8#2)(1995-11#1)(1997-4#1)(2005-1#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-4#1)
to the activity##16##3##(1991-8#1)(1992-12#1)(1994-8#2)(1994-9#1)(1995-11#1)(1997-4#1)(1997-8#1)(2005-1#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-4#1)(2013-1#1)
to the actual##12##3##(1993-12#1)(2005-1#1)(2006-8#2)(2007-10#1)(2007-11#1)(2008-10#1)(2008-6#1)(2010-3#1)(2011-1#1)(2011-12#1)(2013-7#1)
to the acute##8##3##(1990-8#1)(1994-2#1)(1995-6#1)(1996-9#1)(1997-2#1)(2006-11#1)(2008-3#1)(2009-3#1)
to the acyl##3##3##(1993-9#1)(1995-8#1)(1996-5#1)
to the acylation##2##3##(1990-8#1)(1997-4#1)
to the addition of the##3##5##(1990-1#1)(2007-3#1)(2008-10#1)
to the addition of##16##4##(1990-1#1)(1992-8#1)(1993-6#1)(1993-9#1)(1996-1#1)(1996-3#1)(1996-9#1)(2006-10#1)(2007-3#1)(2008-10#4)(2008-11#1)(2008-5#1)(2010-10#1)
to the addition or##2##4##(2006-6#1)(2009-8#1)
to the addition##18##3##(1990-1#1)(1992-8#1)(1993-6#1)(1993-9#1)(1996-1#1)(1996-3#1)(1996-9#1)(2006-10#1)(2006-6#1)(2007-3#1)(2008-10#4)(2008-11#1)(2008-5#1)(2009-8#1)(2010-10#1)
to the additional##5##3##(2006-8#1)(2007-12#1)(2007-3#1)(2008-7#1)(2009-5#1)
to the adenosine##2##3##(1993-12#1)(1994-5#1)
to the adjacent##9##3##(1990-6#1)(1991-5#1)(1994-11#1)(1995-11#1)(1996-2#1)(2008-2#1)(2010-8#1)(2012-12#1)(2013-1#1)
to the adjustment##2##3##(1992-12#1)(2007-12#1)
to the administration of##12##4##(1994-6#1)(1995-12#1)(1995-3#1)(1997-3#1)(2007-10#1)(2007-11#2)(2007-5#2)(2008-5#1)(2008-9#2)
to the administrative##2##3##(1996-2#1)(2007-2#1)
to the administrators##2##3##(2008-5#1)(2009-6#1)
to the adolescents'##3##3##(1990-5#1)(2007-2#1)(2009-7#1)
to the adoption of a##3##5##(1997-4#1)(2007-12#1)(2009-9#1)
to the adoption of the##3##5##(1991-7#1)(2008-1#1)(2008-8#1)
to the adoption of##17##4##(1991-7#1)(1997-4#1)(2005-10#1)(2007-10#1)(2007-12#6)(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-9#1)(2013-8#1)
to the adsorption of##3##4##(2005-11#1)(2006-10#1)(2008-6#1)
to the adsorption##6##3##(2005-11#2)(2006-10#1)(2008-10#2)(2008-6#1)
to the adult##12##3##(1991-3#1)(1991-4#1)(1996-8#1)(1997-2#1)(1997-6#1)(2007-12#1)(2007-4#1)(2008-10#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
to the advanced##2##3##(1991-9#1)(2007-8#1)
to the advancement of##4##4##(1995-9#1)(2008-10#1)(2008-4#1)(2010-5#1)
to the advantage##2##3##(1990-10#1)(2010-5#1)
to the advantages of##3##4##(1993-12#1)(2010-4#1)(2012-2#1)
to the advantages##5##3##(1993-12#1)(2008-10#2)(2010-4#1)(2012-2#1)
to the advent of##5##4##(1996-12#1)(2006-8#1)(2007-11#1)(2010-11#1)(2011-1#1)
to the adverse effects of##2##5##(2005-10#1)(2007-7#1)
to the adverse effects##3##4##(1992-3#1)(2005-10#1)(2007-7#1)
to the adverse##7##3##(1992-3#1)(1996-8#1)(1997-5#1)(2005-10#1)(2007-7#1)(2009-4#1)(2009-9#1)
to the aerosol##3##3##(1996-3#1)(2008-2#1)(2008-3#1)
to the aetiology and##2##4##(2009-5#1)(2011-2#1)
to the aetiology of##7##4##(1990-8#1)(1996-11#1)(1997-1#1)(2008-5#1)(2008-9#1)(2011-2#2)
to the aetiology##9##3##(1990-8#1)(1996-11#1)(1997-1#1)(2008-5#1)(2008-9#1)(2009-5#1)(2011-2#3)
to the affected tissue##2##4##(1993-3#1)(2007-11#1)
to the affected##13##3##(1993-3#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
to the affinity##3##3##(1991-10#1)(1995-1#1)(1996-11#1)
to the aforementioned##4##3##(1993-2#1)(2007-4#1)(2008-10#2)
to the agar##3##3##(2006-8#1)(2008-10#2)
to the age and##2##4##(1994-12#1)(2012-3#1)
to the age group##3##4##(2007-8#1)(2008-3#1)(2012-3#1)
to the age groups##2##4##(1991-5#1)(1992-6#1)
to the age of 50##3##5##(1990-4#1)(1992-3#1)(2009-3#1)
to the age of hamsters##2##5##(1996-9#2)
to the age of the patient##2##6##(2004-2#1)(2010-2#1)
to the age of the##7##5##(1993-9#1)(1994-11#1)(1995-6#1)(2004-2#1)(2008-10#1)(2010-2#1)(2011-1#1)
to the age of##19##4##(1990-4#1)(1990-6#1)(1991-3#1)(1992-3#1)(1993-9#1)(1994-11#1)(1995-1#1)(1995-6#1)(1996-9#2)(2004-2#1)(2008-10#1)(2008-4#1)(2009-3#1)(2010-2#1)(2011-1#1)(2012-1#2)(2013-7#1)
to the age##32##3##(1990-4#1)(1990-6#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-6#1)(1993-10#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-6#1)(1996-9#2)(2004-2#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-3#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-3#2)(2013-7#1)
to the aged##2##3##(1990-12#1)(1990-5#1)
to the agent chosen##2##4##(2009-11#1)(2009-8#1)
to the agent##4##3##(1991-3#1)(2008-10#1)(2009-11#1)(2009-8#1)
to the agents##4##3##(1991-12#2)(2008-5#1)(2011-1#1)
to the aggressive##2##3##(2008-10#1)(2012-1#1)
to the aging##4##3##(1991-12#1)(1992-1#1)(2010-3#1)(2013-1#1)
to the air##5##3##(2006-11#1)(2008-10#2)(2008-11#1)(2010-2#1)
to the airway##4##3##(1994-3#1)(1997-1#1)(2006-10#1)(2010-7#1)
to the airways##4##3##(1992-3#1)(1994-5#1)(1996-12#1)(2007-11#1)
to the aldehyde##3##3##(1991-5#1)(1994-8#1)(1995-7#1)
to the aldo-keto reductase##2##4##(1994-3#1)(1994-6#1)
to the alfalfa biomass##2##4##(2008-10#2)
to the alfalfa##3##3##(2008-10#2)(2009-4#1)
to the algorithm of##2##4##(1996-4#1)(2005-1#1)
to the allergen##2##3##(2008-10#1)(2010-5#1)
to the alleviation of##2##4##(2005-8#1)(2011-1#1)
to the allosteric##2##3##(1992-6#1)(1997-1#1)
to the alpha and beta##2##5##(1992-11#1)(1996-10#1)
to the alpha subunit##4##4##(1991-5#1)(1994-3#1)(1994-8#1)(1995-9#1)
to the alpha subunits##2##4##(1992-2#1)(1995-8#1)
to the alpha##22##3##(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#3)(1992-11#1)(1992-2#1)(1992-5#1)(1993-8#3)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)
to the alpha-amino##2##3##(1992-8#1)(2005-11#1)
to the alpha-subunit of##3##4##(1995-3#1)(1996-5#1)(2008-5#1)
to the already##5##3##(1994-6#1)(2006-12#1)(2008-2#1)(2009-6#1)(2011-2#1)
to the altered##3##3##(2006-2#1)(2008-3#1)(2012-2#1)
to the alternative##6##3##(1990-4#1)(1991-5#1)(1994-12#1)(1994-9#1)(2008-8#1)(2012-12#1)
to the ambient##3##3##(1992-8#1)(2008-3#1)(2010-8#1)
to the ambulatory##3##3##(1996-2#1)(2006-1#1)(2008-3#1)
to the amino acid sequence##2##5##(1992-6#1)(1996-12#1)
to the amino acid##5##4##(1992-6#1)(1994-3#1)(1995-5#1)(1996-12#1)(1996-5#1)
to the amino terminus of the##2##6##(1991-5#1)(1995-2#1)
to the amino terminus of##6##5##(1991-10#1)(1991-2#1)(1991-5#1)(1994-9#1)(1995-2#1)(1996-5#1)
to the amino terminus##7##4##(1991-10#1)(1991-2#1)(1991-5#1)(1994-9#1)(1995-2#1)(1996-5#1)(1996-7#1)
to the amino##16##3##(1991-10#1)(1991-2#1)(1991-5#1)(1992-6#2)(1994-3#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-5#2)(1996-7#1)(2006-4#1)(2007-10#1)(2008-10#1)
to the amino-acid sequence##2##4##(1997-3#1)(1997-5#1)
to the amino-terminal##3##3##(1992-6#1)(1995-11#1)(1996-5#1)
to the ammonia##2##3##(1994-5#1)(1997-7#1)
to the amount of food##2##5##(2008-5#1)(2013-8#1)
to the amount of protein##4##5##(1992-7#1)(2008-2#1)(2008-3#1)(2010-12#1)
to the amount of##46##4##(1990-2#1)(1990-4#1)(1991-10#1)(1991-9#1)(1992-6#1)(1992-7#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-10#1)(1995-3#1)(1997-8#1)(2006-12#1)(2006-5#1)(2007-6#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#2)(2008-8#1)(2009-8#1)(2010-12#2)(2010-7#1)(2011-2#1)(2012-2#2)(2013-8#1)
to the amount##48##3##(1990-2#1)(1990-4#1)(1991-10#1)(1991-9#1)(1992-6#1)(1992-7#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-10#1)(1995-3#1)(1997-8#1)(2006-12#1)(2006-5#1)(2007-6#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#2)(2008-8#1)(2009-8#1)(2010-12#2)(2010-7#1)(2011-2#1)(2012-2#3)(2013-8#1)
to the amounts of##2##4##(2008-10#1)(2013-1#1)
to the amounts##3##3##(2006-3#1)(2008-10#1)(2013-1#1)
to the amplification of##2##4##(1994-3#1)(2007-11#1)
to the amplification##4##3##(1994-3#1)(2007-11#3)
to the amplitude of the##2##5##(1994-6#1)(2008-3#1)
to the amygdala and##2##4##(1990-7#2)
to the amygdala##7##3##(1990-7#2)(1992-7#1)(2008-4#2)(2009-2#1)(2011-2#1)
to the amyloid##4##3##(1991-9#1)(1992-12#2)(1997-7#1)
to the anaemia of##2##4##(1995-3#2)
to the anal##2##3##(2011-2#1)(2013-7#1)
to the analgesic##5##3##(1994-2#1)(1996-2#1)(1997-2#1)(2007-2#1)(2008-3#1)
to the analogous##3##3##(1992-3#1)(2006-8#1)(2008-2#1)
to the analyses of##5##4##(2008-10#5)
to the analyses##6##3##(2008-10#6)
to the analysis of longitudinal data##3##6##(1993-9#1)(1996-12#1)(1997-8#1)
to the analysis of metabolites##2##5##(2008-10#1)(2010-5#1)
to the analysis of natural water samples##3##7##(1991-8#1)(2008-10#2)
to the analysis of natural water##4##6##(1991-8#1)(2008-10#3)
to the analysis of natural##5##5##(1991-8#1)(2008-10#4)
to the analysis of pharmaceutical##2##5##(2008-10#2)
to the analysis of phenolic compounds##2##6##(2008-10#2)
to the analysis of real##4##5##(2008-10#3)(2008-2#1)
to the analysis of river##2##5##(2008-10#2)
to the analysis of several##2##5##(2008-10#1)(2009-10#1)
to the analysis of some##4##5##(2008-10#4)
to the analysis of the##16##5##(1992-12#1)(1995-5#1)(1995-8#1)(1997-8#1)(2005-4#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-4#1)(2008-6#1)(2011-2#1)
to the analysis of these herbicides in##2##7##(2008-10#2)
to the analysis of these##5##5##(1995-1#1)(2008-10#4)
to the analysis of two##3##5##(2006-11#1)(2008-10#1)(2008-3#1)
to the analysis of various##2##5##(1992-2#1)(2008-10#1)
to the analysis of##169##4##(1990-3#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#3)(1994-4#1)(1995-1#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-8#3)(2005-4#4)(2006-10#3)(2006-11#1)(2007-12#1)(2007-8#8)(2007-9#1)(2008-10#95)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-12#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)
to the analysis##175##3##(1990-3#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#3)(1994-4#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-8#3)(2005-4#4)(2006-10#3)(2006-11#1)(2006-5#1)(2007-12#1)(2007-8#8)(2007-9#1)(2008-10#98)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-12#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)
to the analyte##4##3##(2008-10#4)
to the analytes##2##3##(2008-10#2)
to the analytical column##3##4##(1997-3#1)(2008-10#2)
to the analytical##7##3##(1997-3#1)(2008-10#6)
to the anastomosis##2##3##(2006-6#1)(2007-8#1)
to the anatomic##2##3##(1992-4#1)(2012-11#1)
to the anatomical##4##3##(2007-11#1)(2012-2#2)(2013-1#1)
to the anesthesiologist##4##3##(2006-10#2)(2012-12#1)(2013-8#1)
to the angle of incidence##3##5##(2008-3#3)
to the angle of##5##4##(2008-3#5)
to the angle##8##3##(2008-2#1)(2008-3#7)
to the animal##8##3##(1991-11#1)(1992-7#1)(1993-6#1)(2007-8#1)(2008-4#4)
to the animal's##4##3##(1993-12#1)(1993-2#1)(1995-8#1)(2011-2#1)
to the animals##8##3##(2004-11#1)(2008-12#1)(2008-5#1)(2010-1#1)(2011-2#2)(2013-8#2)
to the ankle joint##2##4##(2007-1#1)(2007-8#1)
to the annual##5##3##(1990-4#1)(1995-3#1)(1996-6#2)(2006-10#1)
to the antagonistic##3##3##(1991-7#1)(2008-10#1)(2008-12#1)
to the anterior and##2##4##(2008-7#1)(2012-2#1)
to the anterior cruciate ligament (ACL)##3##6##(2007-8#1)(2008-4#1)(2013-1#1)
to the anterior cruciate ligament##7##5##(2007-8#5)(2008-4#1)(2013-1#1)
to the anterior wall of the maxillary sinus##2##8##(2011-1#1)(2011-7#1)
to the anterior##33##3##(1990-12#1)(1991-3#1)(1991-4#1)(1993-12#1)(1994-3#1)(1996-9#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#4)(2007-8#5)(2008-4#1)(2008-5#1)(2008-7#2)(2009-1#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#2)(2013-1#2)
to the anteroventral and anterodorsal thalamic nuclei of##2##8##(1992-8#1)(1993-11#1)
to the anteroventral and anterodorsal thalamic nuclei##3##7##(1992-8#2)(1993-11#1)
to the anteroventral and anterodorsal##4##5##(1992-8#2)(1993-11#2)
to the anti-inflammatory effects of##3##5##(2006-9#1)(2009-1#1)(2010-1#1)
to the anti-inflammatory##4##3##(2006-9#1)(2008-10#1)(2009-1#1)(2010-1#1)
to the antibiotic##6##3##(1993-2#1)(1993-5#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-6#1)
to the antibiotics##5##3##(2010-8#1)(2012-12#2)(2012-3#1)(2013-8#1)
to the antibody##5##3##(1990-2#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-6#1)
to the anticancer drug##2##4##(1990-7#1)(1994-10#1)
to the anticipated##3##3##(2006-9#1)(2008-10#1)(2008-3#1)
to the anticoagulant##2##3##(1997-2#1)(2009-11#1)
to the antidepressant##2##3##(2010-12#1)(2011-2#1)
to the antiestrogen binding site##3##5##(1990-2#3)
to the antiestrogen##5##3##(1990-2#3)(1993-1#1)(2008-11#1)
to the antigenic##2##3##(1993-7#1)(1995-6#1)
to the antigens##3##3##(1995-5#1)(1996-2#1)(2009-5#1)
to the antihypertensive##3##3##(1991-5#1)(2009-4#1)(2012-3#1)
to the antimicrobial##3##3##(2007-7#1)(2008-7#1)(2013-8#1)
to the antioxidant activity of##2##5##(2009-6#1)(2013-1#1)
to the antiproliferative effects of interferon##2##6##(1996-5#2)
to the antiproliferative effects of##4##5##(1994-10#1)(1996-5#2)(1996-8#1)
to the antiproliferative##5##3##(1991-8#1)(1994-10#1)(1996-5#2)(1996-8#1)
to the antisense##4##3##(1992-8#3)(1995-3#1)
to the antitumor activity##2##4##(1995-11#1)(2008-5#1)
to the antitumor##4##3##(1994-9#1)(1995-11#1)(1996-10#1)(2008-5#1)
to the antiviral activity##2##4##(1992-5#1)(1997-2#1)
to the aortic##3##3##(2006-1#1)(2007-8#1)(2010-12#1)
to the aperture##3##3##(2007-12#1)(2008-2#2)
to the apex of the##2##5##(2007-7#1)(2009-5#1)
to the apex##4##3##(2007-7#1)(2009-2#1)(2009-5#1)(2013-1#1)
to the apical cell surface##2##5##(1993-6#2)
to the apical cell##3##4##(1993-6#2)(2008-9#1)
to the apical stem loop##2##5##(2009-7#2)
to the apical surface##2##4##(1991-12#1)(2008-1#1)
to the apical##16##3##(1991-12#1)(1993-6#2)(1997-6#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-10#2)(2009-7#2)(2012-2#1)
to the apolipoprotein##2##3##(1990-7#1)(1996-5#1)
to the apoprotein##3##3##(1990-2#1)(1990-8#1)(1992-10#1)
to the apoptotic##2##3##(1995-2#1)(2011-2#1)
to the apparent##4##3##(1990-12#1)(1991-12#1)(1993-2#1)(2008-10#1)
to the appearance of a##3##5##(1992-8#1)(2005-11#1)(2008-4#1)
to the appearance of large##2##5##(1992-6#1)(1992-8#1)
to the appearance of the##5##5##(1991-6#1)(1996-6#1)(2008-5#1)(2010-2#1)(2012-2#1)
to the appearance of##20##4##(1991-6#1)(1992-12#1)(1992-6#1)(1992-8#2)(1994-12#1)(1996-6#1)(2005-11#1)(2008-1#1)(2008-4#1)(2008-5#1)(2010-1#1)(2010-2#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)
to the appearance##21##3##(1991-6#1)(1992-12#1)(1992-6#1)(1992-8#2)(1994-12#2)(1996-6#1)(2005-11#1)(2008-1#1)(2008-4#1)(2008-5#1)(2010-1#1)(2010-2#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)
to the appendix##2##3##(2009-7#1)(2011-2#1)
to the application of a##2##5##(1995-5#1)(2008-10#1)
to the application of the##3##5##(2007-8#1)(2008-1#1)(2010-11#1)
to the application of##19##4##(1992-12#1)(1995-5#1)(1996-1#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2009-12#1)(2010-11#1)(2010-3#1)(2011-1#2)(2012-12#1)
to the application##23##3##(1992-12#1)(1995-5#1)(1996-1#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2009-11#1)(2009-12#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-1#2)(2012-12#1)
to the applications in##2##4##(2006-6#1)(2008-5#1)
to the applied##5##3##(2008-10#2)(2008-3#1)(2008-5#1)(2009-12#1)
to the approach to##2##4##(2006-10#1)(2012-2#1)
to the approach##6##3##(1993-12#1)(2006-10#1)(2010-3#1)(2012-2#1)(2013-1#2)
to the appropriate conditions##2##4##(2008-1#1)(2010-10#1)
to the appropriate##15##3##(1994-12#1)(2004-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-10#1)(2012-12#1)(2013-1#2)(2013-8#1)
to the approval of the##3##5##(2005-5#1)(2007-9#1)(2010-11#1)
to the approval of##5##4##(2005-5#1)(2007-9#1)(2008-8#1)(2009-9#1)(2010-11#1)
to the approximately##2##3##(1990-5#1)(1993-9#1)
to the aquatic##2##3##(2011-12#1)(2012-11#1)
to the aqueous phase##9##4##(1990-5#1)(1994-2#1)(1995-1#1)(2008-10#3)(2008-5#1)(2010-5#2)
to the aqueous solution was##2##5##(2005-11#1)(2008-10#1)
to the aqueous subphase##2##4##(1992-12#1)(2005-11#1)
to the aqueous##19##3##(1990-5#1)(1991-2#1)(1992-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(2005-11#2)(2008-10#7)(2008-5#1)(2010-4#1)(2010-5#2)
to the archetypal##2##3##(1993-2#1)(1997-1#1)
to the arcuate##3##3##(2008-7#1)(2010-10#2)
to the area of the##2##5##(1995-8#1)(2006-9#1)
to the area of##12##4##(1992-3#1)(1992-8#1)(1994-11#1)(1995-8#1)(2004-9#1)(2006-10#1)(2006-3#1)(2006-7#1)(2006-9#1)(2009-1#1)(2012-1#1)(2013-7#1)
to the area under##3##4##(1997-3#1)(2008-10#2)
to the area##22##3##(1992-2#1)(1992-3#1)(1992-8#1)(1994-11#2)(1995-8#1)(1997-3#1)(2004-9#1)(2006-10#1)(2006-3#1)(2006-7#1)(2006-9#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-1#1)(2012-1#1)(2013-7#1)
to the areas of##2##4##(1993-8#1)(2008-4#1)
to the areas##3##3##(1993-8#1)(2008-10#1)(2008-4#1)
to the argument##3##3##(1996-1#1)(1996-12#1)(2012-12#1)
to the aromatic ring##3##4##(1993-12#1)(1997-2#1)(2007-11#1)
to the arrangement of##2##4##(2008-7#2)
to the array##3##3##(2008-10#2)(2009-6#1)
to the arsenic##2##3##(2013-1#2)
to the arterial##2##3##(1990-12#1)(2010-6#1)
to the artery##2##3##(2006-6#1)(2009-6#1)
to the articular surface##2##4##(1991-10#1)(2006-3#1)
to the articular##3##3##(1991-10#1)(2006-3#1)(2008-1#1)
to the artificial##2##3##(1990-2#1)(2008-5#1)
to the ascending aorta##2##4##(2007-8#1)(2008-11#1)
to the asialoglycoprotein receptor##2##4##(1993-11#1)(1995-2#1)
to the asparagine##3##3##(1990-4#1)(1997-7#1)(2009-12#1)
to the assay medium##2##4##(1990-12#1)(1996-5#1)
to the assay of##6##4##(1991-5#1)(1991-8#1)(1992-11#1)(2008-10#3)
to the assay##13##3##(1990-12#1)(1991-10#1)(1991-5#1)(1991-8#1)(1992-11#1)(1993-12#1)(1993-7#1)(1996-5#2)(2008-10#3)(2012-1#1)
to the assembly of##8##4##(1993-6#1)(1995-4#1)(1995-8#1)(2007-11#1)(2008-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
to the assembly##10##3##(1993-6#1)(1995-4#1)(1995-8#1)(2007-11#1)(2008-11#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
to the assessment and management of##2##6##(1996-12#1)(2007-10#1)
to the assessment and##3##4##(1996-12#1)(2007-10#1)(2009-4#1)
to the assessment of##16##4##(1990-3#1)(1992-10#1)(1992-3#1)(1992-7#1)(1993-6#1)(1996-3#1)(1997-8#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-4#2)(2008-5#1)(2009-1#1)(2010-5#1)(2012-1#1)
to the assessment##20##3##(1990-3#1)(1992-10#1)(1992-3#1)(1992-7#1)(1993-6#1)(1996-12#1)(1996-3#1)(1997-8#1)(2006-6#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2009-1#1)(2009-4#1)(2010-5#1)(2012-1#1)
to the assignment of a##2##5##(1997-2#1)(2008-10#1)
to the assignment##3##3##(1997-2#1)(2008-10#1)(2008-11#1)
to the associated##7##3##(1994-5#1)(1995-3#1)(1997-5#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)
to the association of##2##4##(1994-11#1)(1995-3#1)
to the association##3##3##(1994-11#1)(1995-3#1)(2012-3#1)
to the assumption that the##3##5##(2009-2#1)(2009-8#1)(2012-2#1)
to the assumption that##6##4##(1990-5#1)(2008-2#1)(2009-2#1)(2009-8#1)(2010-2#1)(2012-2#1)
to the assumption##7##3##(1990-5#1)(1993-5#1)(2008-2#1)(2009-2#1)(2009-8#1)(2010-2#1)(2012-2#1)
to the assumptions##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
to the asymmetric##2##3##(2008-9#1)(2010-3#1)
to the asymptotic##2##3##(1994-3#1)(2008-2#1)
to the atherosclerotic##2##3##(1993-6#1)(2012-11#1)
to the atmosphere##10##3##(1991-3#1)(1995-3#1)(1996-8#3)(2006-3#1)(2008-10#1)(2008-3#2)(2009-3#1)
to the atomic##4##3##(1990-12#1)(1992-1#1)(2004-11#1)(2010-7#1)
to the atrophy##2##3##(1992-12#1)(2009-2#1)
to the attached##2##3##(2005-10#1)(2008-11#1)
to the attachment##2##3##(1994-10#1)(1995-8#1)
to the attacker##3##3##(2008-2#1)(2009-6#1)(2009-8#1)
to the attendees##2##3##(2008-10#1)(2013-1#1)
to the attention of##9##4##(1990-3#1)(1997-2#1)(2005-12#1)(2006-3#1)(2007-1#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#1)
to the author##15##3##(1991-1#2)(1991-12#1)(1991-3#2)(1992-1#1)(1992-8#1)(1993-2#2)(2006-10#1)(2007-6#1)(2008-11#1)(2008-12#1)(2008-2#2)
to the author's knowledge##7##4##(2007-12#3)(2008-2#4)
to the author's##10##3##(2007-11#1)(2007-12#3)(2008-2#4)(2011-2#1)(2013-1#1)
to the authors##3##3##(2006-7#1)(2008-2#1)(2008-7#1)
to the authors' attention##3##4##(1990-4#1)(1993-10#1)(1993-3#1)
to the authors' knowledge that##2##5##(2007-11#1)(2008-1#1)
to the authors' knowledge##30##4##(2007-10#1)(2007-11#3)(2007-12#18)(2008-1#1)(2008-2#3)(2008-3#3)(2012-12#1)
to the authors'##35##3##(1990-4#1)(1993-10#1)(1993-3#1)(2006-2#1)(2007-10#1)(2007-11#3)(2007-12#18)(2007-7#1)(2008-1#1)(2008-2#3)(2008-3#3)(2012-12#1)
to the availability of more##2##5##(1992-2#1)(2011-2#1)
to the availability of##15##4##(1992-2#1)(1994-3#1)(1996-6#1)(2004-3#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-6#1)(2008-10#1)(2009-5#1)(2010-11#1)(2011-2#2)(2012-1#1)(2012-2#1)
to the availability##17##3##(1992-2#1)(1993-10#1)(1994-3#1)(1996-6#2)(2004-3#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-6#1)(2008-10#1)(2009-5#1)(2010-11#1)(2011-2#2)(2012-1#1)(2012-2#1)
to the available data on##3##5##(2010-8#1)(2012-12#2)
to the available data##5##4##(2006-2#1)(2008-8#1)(2010-8#1)(2012-12#2)
to the available##11##3##(1990-9#1)(1991-4#1)(1994-3#1)(2006-2#1)(2006-8#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)
to the average of##4##4##(1992-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
to the average temperature##2##4##(2008-8#2)
to the average##24##3##(1992-2#1)(1992-6#1)(1993-1#1)(1994-9#1)(1996-4#1)(1997-5#1)(2006-11#1)(2007-12#1)(2008-10#4)(2008-6#1)(2008-8#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)
to the averaged##2##3##(1996-11#1)(2010-8#1)
to the avian##3##3##(1994-2#1)(1994-9#1)(2013-8#1)
to the avidin##2##3##(1991-10#1)(2008-10#1)
to the avirulence gene##3##4##(2008-10#3)
to the avirulence##4##3##(2008-10#4)
to the axes of the##2##5##(2005-11#1)(2008-10#1)
to the axial skeleton##2##4##(1996-6#1)(2011-2#1)
to the axial##6##3##(1991-6#1)(1996-6#1)(1997-7#1)(2007-12#1)(2008-10#1)(2011-2#1)
to the axis of the##5##5##(2006-11#1)(2008-2#3)(2008-3#1)
to the axis##7##3##(2006-11#1)(2006-9#1)(2008-11#1)(2008-2#3)(2008-3#1)
to the axon##3##3##(1995-2#1)(1996-1#1)(1996-2#1)
to the axonal membrane##2##4##(2008-7#1)(2012-2#1)
to the axonal##3##3##(2008-7#1)(2010-12#1)(2012-2#1)
to the back of the##3##5##(2008-9#1)(2012-1#1)(2012-2#1)
to the back##12##3##(1995-12#1)(1997-7#1)(2007-11#1)(2008-3#1)(2008-9#1)(2009-4#1)(2012-1#1)(2012-2#1)(2013-1#4)
to the background##9##3##(2007-12#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-8#1)(2011-2#1)
to the backscattering##2##3##(2008-3#2)
to the bacteria##3##3##(2006-8#1)(2008-5#1)(2012-12#1)
to the bacterial##12##3##(1990-11#2)(1990-12#1)(1990-3#1)(1994-12#1)(1997-5#1)(2008-10#1)(2009-6#1)(2009-8#1)(2010-10#1)(2012-2#1)(2013-8#1)
to the bacteriophage##2##3##(1991-5#1)(1993-12#1)
to the balance of##3##4##(1994-11#1)(2008-5#1)(2009-8#1)
to the balance##4##3##(1994-11#1)(2006-10#1)(2008-5#1)(2009-8#1)
to the bands##2##3##(1993-9#1)(2008-10#1)
to the bare##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
to the basal ganglia##2##4##(1995-8#1)(2008-7#1)
to the basal lamina##2##4##(2008-12#1)(2009-10#1)
to the basal level at 10##2##6##(1991-7#1)(1994-2#1)
to the basal level at##3##5##(1990-2#1)(1991-7#1)(1994-2#1)
to the basal level##5##4##(1990-2#1)(1991-7#1)(1994-2#1)(1997-7#1)(2010-12#1)
to the basal##20##3##(1990-2#1)(1991-7#1)(1994-2#2)(1995-8#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-6#1)(1997-7#1)(2006-5#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-11#1)(2010-12#1)
to the base of##2##4##(2006-5#1)(2008-11#1)
to the base##7##3##(1991-6#1)(1995-11#1)(2005-4#1)(2006-5#1)(2007-7#1)(2008-10#1)(2008-11#1)
to the baseline level##2##4##(1997-6#1)(2008-10#1)
to the baseline##8##3##(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-3#1)(2011-2#2)(2013-1#1)
to the basement membrane##3##4##(1995-12#1)(2007-9#1)(2009-3#1)
to the basic##22##3##(1992-1#1)(1992-10#1)(1992-9#1)(1993-2#1)(1994-11#1)(1994-12#1)(1995-11#1)(1996-10#1)(1996-5#1)(2005-10#1)(2006-10#2)(2006-2#1)(2007-1#1)(2007-3#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)
to the basilar artery##5##4##(1997-6#1)(2006-12#1)(2007-9#3)
to the basis##2##3##(1995-1#1)(2007-12#1)
to the basolateral##5##3##(1991-12#1)(1993-6#1)(1994-3#1)(1995-12#1)(2008-1#1)
to the batch##2##3##(2008-10#1)(2008-11#1)
to the bath solution##2##4##(1994-5#1)(1997-7#1)
to the bath##5##3##(1991-5#1)(1994-5#1)(1997-4#1)(1997-7#1)(2008-12#1)
to the bathing medium##2##4##(1990-7#1)(1992-8#1)
to the bathing##3##3##(1990-7#1)(1992-8#1)(1996-7#1)
to the beam##5##3##(2006-4#1)(2008-2#3)(2008-3#1)
to the bedside##5##3##(2005-10#1)(2005-2#1)(2008-1#1)(2008-9#1)(2009-4#1)
to the beet##2##3##(2008-10#1)(2008-12#1)
to the beginning of the##8##5##(1994-5#1)(1994-9#1)(1996-12#2)(1997-6#1)(2008-11#1)(2008-5#1)(2008-6#1)
to the beginning of##9##4##(1994-5#1)(1994-9#1)(1996-12#2)(1997-6#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)
to the beginning##10##3##(1994-5#1)(1994-9#1)(1996-12#2)(1997-6#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-3#1)
to the behavior observed##2##4##(2008-10#1)(2008-7#1)
to the behavior of##4##4##(2007-12#1)(2008-3#1)(2008-8#1)(2010-2#1)
to the behavior##6##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-2#1)
to the behavioral##3##3##(1991-8#1)(2008-8#1)(2009-9#1)
to the behaviour of##2##4##(1990-2#1)(2008-5#1)
to the behavioural##4##3##(1990-10#1)(1990-2#1)(1992-9#1)(1995-12#1)
to the belief that##2##4##(1990-5#1)(1996-2#1)
to the bench##2##3##(2005-10#1)(2008-11#1)
to the beneficial effects of##2##5##(2008-7#1)(2011-2#1)
to the beneficial##4##3##(1997-7#1)(2008-7#1)(2010-1#1)(2011-2#1)
to the benefit of##9##4##(2005-10#1)(2006-10#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-11#3)(2011-1#1)
to the benefit##10##3##(2005-10#1)(2006-10#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#1)(2011-1#1)
to the benefits##2##3##(2006-12#1)(2008-11#1)
to the benign##2##3##(1997-3#1)(2007-11#1)
to the benzodiazepine##4##3##(1991-11#1)(1994-5#1)(1995-11#1)(1996-11#1)
to the benzyl##3##3##(1992-8#2)(2005-11#1)
to the best available##3##4##(2006-2#1)(2007-4#1)(2008-2#1)
to the best of our knowledge##19##6##(1995-5#1)(1996-7#1)(2007-11#3)(2007-12#1)(2007-7#2)(2008-1#1)(2008-2#4)(2008-3#3)(2008-6#1)(2010-2#1)(2013-1#1)
to the best of our##20##5##(1995-5#1)(1996-7#1)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-2#4)(2008-3#3)(2008-6#1)(2010-2#1)(2013-1#1)
to the best##36##3##(1995-5#1)(1996-5#1)(1996-7#1)(1997-8#1)(2006-2#1)(2006-5#1)(2007-11#3)(2007-12#1)(2007-4#3)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#7)(2008-3#3)(2008-6#1)(2008-9#1)(2010-2#1)(2011-2#1)(2013-1#3)
to the beta##5##3##(1990-7#1)(1993-8#1)(1994-9#1)(1995-5#1)(1995-6#1)
to the beta-lactams##2##3##(1991-12#1)(1996-3#1)
to the better##6##3##(1994-4#1)(2007-7#1)(2008-10#1)(2013-1#1)(2013-8#2)
to the biceps##2##3##(2006-3#1)(2007-12#1)
to the bifurcation##2##3##(2007-8#1)(2008-3#1)
to the bilayer##7##3##(1990-4#1)(1990-7#1)(1993-3#1)(1994-12#1)(1995-10#2)(1996-1#1)
to the bile##3##3##(1995-4#1)(2004-11#1)(2008-5#1)
to the biliary##4##3##(1996-4#1)(2006-10#1)(2008-3#1)(2010-9#1)
to the binary##3##3##(1997-4#1)(2008-10#1)(2008-2#1)
to the binding affinity##3##4##(1996-4#1)(1997-2#1)(2009-12#1)
to the binding domain##2##4##(1991-5#1)(2008-8#1)
to the binding energy##2##4##(1994-9#1)(2006-1#1)
to the binding of the##2##5##(1990-11#1)(1990-12#1)
to the binding of##10##4##(1990-11#1)(1990-12#2)(1990-7#1)(1991-2#1)(1995-1#1)(1995-8#1)(1997-6#1)(2008-3#1)(2011-1#1)
to the binding sites##2##4##(1993-3#1)(1995-12#1)
to the binding to##2##4##(2005-8#1)(2009-8#1)
to the binding##29##3##(1990-11#1)(1990-12#2)(1990-4#1)(1990-7#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-8#1)(2006-1#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-8#1)(2011-1#1)(2012-2#1)
to the binuclear center##2##4##(1995-1#1)(1995-2#1)
to the binuclear##3##3##(1995-1#1)(1995-2#1)(1997-7#1)
to the bioactive##2##3##(1992-12#1)(2006-12#1)
to the biological and##2##4##(1991-1#1)(2006-10#1)
to the biological function of##3##5##(1994-11#1)(1995-1#1)(2009-5#1)
to the biological##25##3##(1990-2#1)(1991-1#1)(1993-2#1)(1994-11#1)(1995-1#1)(1995-3#1)(1995-6#1)(1997-2#2)(1997-8#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-12#1)(2012-2#1)(2012-3#1)
to the biologically active##2##4##(1990-12#1)(1995-3#1)
to the biologically##4##3##(1990-12#1)(1991-2#1)(1995-3#1)(2012-3#1)
to the biology of the##2##5##(1991-6#1)(2008-1#1)
to the biology##3##3##(1991-6#1)(2008-1#1)(2011-2#1)
to the biomedical##3##3##(2008-5#1)(2008-7#1)(2013-1#1)
to the biosynthesis of##2##4##(1990-6#1)(2009-10#1)
to the biotransformation##2##3##(2008-11#1)(2008-5#1)
to the birth##2##3##(1993-10#1)(2013-7#1)
to the bladder and##4##4##(1995-12#2)(2007-4#1)(2011-2#1)
to the bladder is##3##4##(2006-6#1)(2013-1#2)
to the bladder##11##3##(1992-2#1)(1995-12#2)(2005-10#1)(2006-1#1)(2006-6#1)(2007-4#1)(2008-10#1)(2011-2#1)(2013-1#2)
to the blastocyst stage in##2##5##(2006-5#1)(2008-11#1)
to the blastocyst stage was##2##5##(2006-5#2)
to the blastocyst stage##11##4##(1995-11#1)(1995-2#1)(2006-5#8)(2008-11#1)
to the block##2##3##(2008-2#1)(2010-4#1)
to the blockage of##2##4##(2004-9#1)(2011-3#1)
to the blood pressure##3##4##(1991-12#1)(1991-2#1)(2007-2#1)
to the blood vessels of##2##5##(2006-11#1)(2008-11#1)
to the blood##13##3##(1991-12#1)(1991-2#1)(1996-6#1)(2006-10#1)(2006-11#1)(2007-2#2)(2008-11#1)(2008-3#2)(2008-7#1)(2010-5#1)(2013-8#1)
to the bloodstream##3##3##(2007-11#1)(2008-7#1)(2012-3#1)
to the blue##2##3##(2008-10#1)(2008-2#1)
to the body axes##4##4##(2012-12#4)
to the body mass index##3##5##(2008-9#1)(2011-1#1)(2012-11#1)
to the body of knowledge##2##5##(1995-12#1)(2011-2#1)
to the body of##6##4##(1995-12#1)(1997-2#1)(2008-6#1)(2009-4#1)(2010-9#1)(2011-2#1)
to the body##30##3##(1992-11#1)(1995-12#1)(1995-5#2)(1995-8#1)(1997-2#1)(2004-9#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#2)(2008-9#2)(2009-4#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#5)
to the body's##2##3##(2006-10#1)(2007-12#1)
to the bone marrow##4##4##(2006-10#1)(2008-7#1)(2009-3#1)(2011-1#1)
to the bone##13##3##(1992-8#1)(1993-9#1)(1996-11#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-7#2)(2008-9#1)(2009-3#1)(2011-1#1)(2013-8#2)
to the bones##3##3##(2009-10#1)(2009-3#1)(2010-12#1)
to the bony##4##3##(2006-8#1)(2008-7#1)(2008-9#1)(2010-12#1)
to the borders##2##3##(2008-2#1)(2012-11#1)
to the both##4##3##(1992-9#1)(2007-8#2)(2008-4#1)
to the bottom layer##2##4##(2008-9#1)(2009-9#1)
to the bottom of the##2##5##(2007-1#1)(2008-4#1)
to the bottom of##3##4##(2007-1#1)(2008-4#1)(2011-1#1)
to the bottom##8##3##(2007-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-9#1)(2011-1#1)
to the bound right-handed form##3##5##(2006-10#3)
to the bound##5##3##(1994-8#1)(2005-10#1)(2006-10#3)
to the boundary##2##3##(2008-2#1)(2010-10#1)
to the bovine##6##3##(1990-2#1)(1991-10#1)(1991-4#1)(1992-8#1)(1993-4#1)(1994-12#1)
to the brain and spinal cord##3##6##(2006-10#2)(2007-11#1)
to the brain by##2##4##(2008-5#1)(2010-5#1)
to the brain cannabinoid receptor##3##5##(1996-1#1)(1997-2#2)
to the brain slice##2##4##(2008-11#2)
to the brain stem##2##4##(1995-12#1)(2006-12#1)
to the brain surface##2##4##(1990-2#2)
to the brain tissue##3##4##(1996-9#1)(2006-11#1)(2012-1#1)
to the brain##47##3##(1990-2#2)(1992-10#1)(1993-10#1)(1994-2#1)(1994-5#1)(1995-12#2)(1995-4#1)(1995-5#2)(1995-7#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-2#2)(1997-4#1)(2006-10#3)(2006-11#2)(2006-12#1)(2006-7#1)(2007-11#2)(2007-12#2)(2007-8#3)(2008-1#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-5#2)(2012-1#3)(2013-1#1)
to the brainstem##2##3##(1993-8#1)(2012-1#1)
to the breast are##2##4##(1993-12#1)(2012-12#1)
to the breast##13##3##(1993-12#1)(1993-2#1)(2004-1#1)(2007-2#1)(2007-4#3)(2007-5#1)(2009-5#2)(2009-8#1)(2011-2#1)(2012-12#1)
to the broad##5##3##(1991-10#1)(2006-12#1)(2008-12#1)(2008-7#1)(2012-2#1)
to the broader##4##3##(1993-1#1)(2008-1#1)(2009-9#1)(2010-11#1)
to the bronchial##2##3##(2007-8#1)(2010-8#1)
to the brush##2##3##(1991-12#1)(1993-6#1)
to the bud##2##3##(1997-4#1)(2009-8#1)
to the buffer solution##2##4##(1994-3#1)(2008-8#1)
to the buffer##6##3##(1991-5#1)(1994-2#1)(1994-3#2)(2008-10#1)(2008-8#1)
to the bulk of##2##4##(2006-8#1)(2012-2#1)
to the bulk##10##3##(1991-7#1)(1991-8#1)(2005-11#1)(2005-12#1)(2006-8#1)(2008-10#1)(2008-3#1)(2009-4#1)(2010-4#1)(2012-2#1)
to the burden of##2##4##(2012-12#1)(2012-2#1)
to the burden##3##3##(2006-9#1)(2012-12#1)(2012-2#1)
to the business##2##3##(1993-3#1)(2007-9#1)
to the c##4##3##(1990-4#1)(1996-2#2)(1997-7#1)
to the cAMP##2##3##(1995-3#1)(1997-2#1)
to the cDNA##8##3##(1991-10#1)(1991-5#1)(1991-6#1)(1993-8#2)(1996-2#1)(2008-4#1)(2008-7#1)
to the cDNAs##2##3##(1993-2#1)(1994-12#1)
to the calamus scriptorius)##2##4##(1993-7#1)(1994-10#1)
to the calcium##3##3##(1997-2#1)(2007-12#1)(2011-2#1)
to the calculated##5##3##(1990-10#1)(1992-6#1)(1995-12#1)(1996-6#1)(2008-3#1)
to the calculation of the##2##5##(2006-10#1)(2008-3#1)
to the calculation of##5##4##(2006-10#1)(2007-11#2)(2008-3#1)(2009-11#1)
to the calculation##6##3##(2006-10#1)(2007-11#2)(2008-3#2)(2009-11#1)
to the calf##2##3##(1997-3#1)(2008-5#1)
to the calibration##2##3##(2008-10#2)
to the calmodulin##4##3##(1991-7#1)(1992-12#1)(1992-3#1)(1992-9#1)
to the cancer cells##2##4##(1990-5#1)(1997-4#1)
to the cancer##6##3##(1990-5#1)(1997-4#1)(2008-7#1)(2009-3#1)(2010-11#1)(2013-1#1)
to the cap site##2##4##(1991-4#1)(1992-11#1)
to the cap##3##3##(1991-4#1)(1992-11#1)(2008-10#1)
to the capability of##2##4##(2008-3#2)
to the capacity assignment##2##4##(2008-2#2)
to the capacity of the##4##5##(1996-5#1)(2005-8#1)(2013-1#1)(2013-7#1)
to the capacity of##7##4##(1994-3#1)(1995-3#1)(1996-5#1)(2005-8#1)(2008-5#1)(2013-1#1)(2013-7#1)
to the capacity##9##3##(1994-3#1)(1995-3#1)(1996-5#1)(2005-8#1)(2008-2#2)(2008-5#1)(2013-1#1)(2013-7#1)
to the capillary##5##3##(1996-5#1)(2005-11#1)(2008-10#2)(2008-4#1)
to the capsid##2##3##(1994-8#1)(1995-1#1)
to the capture of##2##4##(2006-11#1)(2008-2#1)
to the carbohydrate##4##3##(1990-11#1)(1996-5#1)(1996-6#1)(2008-11#1)
to the carbon atom##2##4##(1991-3#1)(2005-3#1)
to the carbon paste##2##4##(2008-10#2)
to the carbon##9##3##(1991-3#1)(2005-3#1)(2006-12#1)(2007-8#1)(2008-10#3)(2010-3#1)(2010-5#1)
to the carbonyl oxygen atom##2##5##(1992-9#2)
to the carbonyl oxygen of##2##5##(1991-3#1)(1992-6#1)
to the carbonyl oxygen##4##4##(1991-3#1)(1992-6#1)(1992-9#2)
to the carbonyl##5##3##(1991-3#1)(1992-6#1)(1992-9#2)(1997-2#1)
to the carboxyl##2##3##(2005-12#1)(2012-2#1)
to the cardiac##7##3##(1990-3#1)(1990-6#1)(2007-9#2)(2008-12#1)(2008-7#1)(2012-2#1)
to the cardiologists##2##3##(2008-11#1)(2011-2#1)
to the cardiovascular##5##3##(1991-2#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#1)
to the care of older people##2##6##(2010-10#2)
to the care of older##3##5##(2010-10#2)(2010-6#1)
to the care of their##2##5##(2005-7#1)(2008-12#1)
to the care of##11##4##(1997-1#1)(2005-7#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-7#1)(2010-10#2)(2010-6#1)(2011-2#1)
to the care##20##3##(1991-10#1)(1992-2#1)(1994-12#1)(1997-1#1)(1997-6#1)(2005-7#1)(2006-10#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-7#1)(2010-10#2)(2010-6#1)(2011-2#1)(2013-1#3)
to the career##4##3##(1997-2#1)(2007-12#2)(2008-5#1)
to the carotid arteries##2##4##(2007-10#1)(2008-7#1)
to the carotid body stimulation##2##5##(1994-10#2)
to the carotid##10##3##(1993-12#2)(1994-10#2)(1994-2#1)(1996-5#1)(2007-10#1)(2007-9#1)(2008-7#1)(2012-3#1)
to the carrier##3##3##(2008-10#3)
to the case manager##2##4##(2006-1#2)
to the case of a##2##5##(2008-3#2)
to the case of##12##4##(1992-6#1)(1993-3#1)(1993-5#1)(2005-11#1)(2008-2#3)(2008-3#3)(2009-9#1)(2010-3#1)
to the case where the##3##5##(2005-11#1)(2006-10#1)(2008-2#1)
to the case where##5##4##(2005-11#1)(2006-10#1)(2008-2#1)(2008-6#1)(2010-2#1)
to the case##25##3##(1992-6#1)(1993-3#1)(1993-5#1)(2005-11#2)(2006-1#2)(2006-10#1)(2007-11#1)(2008-2#4)(2008-3#5)(2008-6#1)(2008-8#1)(2009-9#1)(2010-2#2)(2010-3#1)(2012-3#1)
to the case-control##2##3##(1997-6#1)(2012-3#1)
to the catalytic core##2##4##(1991-11#1)(2011-1#1)
to the catalytic domains of##2##5##(1991-6#1)(1994-8#1)
to the catalytic pocket of the enzyme##2##7##(1993-3#2)
to the catalytic residues##2##4##(1994-8#1)(1994-9#1)
to the catalytic site of the##2##6##(1994-5#2)
to the catalytic site of##3##5##(1993-6#1)(1994-5#2)
to the catalytic site##8##4##(1990-3#1)(1991-11#1)(1991-6#1)(1992-6#1)(1993-6#1)(1994-5#2)(2009-7#1)
to the catalytic subunits##2##4##(1992-6#1)(1995-2#1)
to the catalytic##30##3##(1990-3#1)(1991-11#2)(1991-6#2)(1992-3#1)(1992-6#2)(1993-3#2)(1993-6#1)(1994-5#2)(1994-8#2)(1994-9#2)(1995-10#1)(1995-11#1)(1995-2#2)(1995-6#2)(1996-4#1)(2007-10#1)(2008-10#1)(2008-4#1)(2009-7#1)(2011-1#1)(2012-2#1)
to the catalytically##2##3##(1992-12#1)(1995-8#1)
to the category of##3##4##(2005-8#1)(2006-9#1)(2008-7#1)
to the category##5##3##(2005-8#1)(2006-9#1)(2008-10#1)(2008-7#1)(2008-9#1)
to the catheterization laboratory##2##4##(2008-3#2)
to the cationic##2##3##(2010-2#1)(2011-1#1)
to the caudal##2##3##(1993-3#1)(1996-5#1)
to the causal##2##3##(2012-2#1)(2012-3#1)
to the causative##3##3##(1992-5#1)(1996-8#1)(2006-4#1)
to the cause of##6##4##(2007-6#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-1#1)(2013-1#1)
to the cavity##5##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-7#1)
to the cell body##4##4##(1994-10#1)(2008-7#3)
to the cell cortex##3##4##(1997-6#1)(2009-10#2)
to the cell culture##3##4##(2009-10#2)(2010-4#1)
to the cell cycle##2##4##(1995-3#1)(2003-11#1)
to the cell membrane##14##4##(1990-2#1)(1990-9#2)(1993-12#2)(1993-9#1)(1994-8#1)(1997-1#1)(1997-4#1)(2007-8#1)(2008-11#2)(2008-9#1)(2010-8#1)
to the cell membranes##2##4##(1991-12#1)(1994-9#1)
to the cell of##2##4##(2009-2#1)(2010-3#1)
to the cell periphery##2##4##(2008-11#1)(2009-2#1)
to the cell surface and##2##5##(1990-12#1)(2010-11#1)
to the cell surface is##2##5##(1993-6#1)(2008-11#1)
to the cell surface of Colo201 cells##2##7##(2008-11#2)
to the cell surface of##4##5##(1992-6#1)(1993-8#1)(2008-11#2)
to the cell surface##32##4##(1990-12#1)(1990-5#1)(1991-1#1)(1991-9#3)(1992-5#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-11#2)(1995-7#1)(1995-8#1)(1996-8#1)(1997-1#1)(2005-7#1)(2007-8#1)(2008-1#2)(2008-11#3)(2008-2#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-11#1)(2011-1#1)
to the cell wall##5##4##(1992-8#1)(1997-4#1)(2006-12#1)(2008-4#1)(2008-6#1)
to the cell##99##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-7#1)(1991-9#3)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-8#1)(1997-1#3)(1997-4#3)(1997-5#1)(1997-6#1)(2003-11#1)(2005-7#2)(2006-12#1)(2007-12#1)(2007-4#1)(2007-8#2)(2008-1#3)(2008-11#7)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#5)(2008-9#1)(2009-10#4)(2009-2#3)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
to the cell's##2##3##(1996-12#1)(2006-10#1)
to the cells##34##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#3)(1991-9#1)(1992-8#2)(1993-12#1)(1993-3#1)(1993-4#1)(1994-5#1)(1994-8#1)(1995-1#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-7#1)(2006-2#1)(2006-5#1)(2007-6#1)(2008-1#2)(2008-11#4)(2008-6#1)(2009-4#1)(2010-11#1)(2010-12#1)(2012-12#2)
to the cells' ability to##2##5##(1992-3#1)(1994-12#1)
to the cells'##3##3##(1992-3#1)(1994-12#1)(1995-4#1)
to the cellular##8##3##(1992-8#1)(1993-12#1)(1994-11#1)(1994-2#1)(2005-11#1)(2006-10#1)(2007-2#1)(2010-10#1)
to the center of the##5##5##(1993-3#1)(2006-10#1)(2007-12#1)(2008-2#2)
to the center##8##3##(1993-3#1)(1996-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-2#2)(2013-1#1)
to the central amygdaloid nucleus##2##5##(1996-1#2)
to the central canal##4##4##(1991-5#1)(1995-5#2)(1996-5#1)
to the central core##2##4##(1991-4#1)(2007-9#1)
to the central nervous system (CNS)##4##6##(1996-5#1)(2007-11#1)(2008-11#1)(2008-5#1)
to the central nervous system##11##5##(1994-12#1)(1995-4#1)(1996-5#1)(2006-10#2)(2007-11#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-10#1)(2013-8#1)
to the central nucleus##3##4##(1992-6#1)(1993-12#1)(1996-9#1)
to the central or peripheral nervous system##2##7##(2008-7#1)(2010-7#1)
to the central or##3##4##(1994-12#1)(2008-7#1)(2010-7#1)
to the central##44##3##(1990-2#1)(1990-3#1)(1991-10#2)(1991-11#2)(1991-4#1)(1991-5#1)(1991-7#1)(1992-6#1)(1993-12#1)(1994-12#2)(1994-3#1)(1994-5#1)(1995-4#1)(1995-5#2)(1996-1#2)(1996-5#2)(1996-9#2)(1997-1#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#2)(2010-7#1)(2013-8#1)
to the centre of##2##4##(1995-12#1)(2008-9#1)
to the centre##5##3##(1991-11#1)(1995-12#1)(2007-3#1)(2008-1#1)(2008-9#1)
to the centromeric region of chromosome##2##6##(1996-8#1)(2008-10#1)
to the centrosome##3##3##(1991-5#1)(2012-12#2)
to the cerebellar##5##3##(1993-12#1)(1993-7#1)(1996-10#2)(1996-5#1)
to the cerebellum##5##3##(1991-6#1)(1994-3#1)(1995-11#2)(1997-6#1)
to the cerebral cortex of##2##5##(1993-12#1)(1995-6#1)
to the cerebral cortex##6##4##(1990-7#1)(1993-12#1)(1995-6#1)(1997-6#1)(2008-11#1)(2008-9#1)
to the cerebral##9##3##(1990-7#1)(1993-12#1)(1995-6#1)(1997-6#1)(1997-8#1)(2006-3#1)(2008-11#1)(2008-7#1)(2008-9#1)
to the cervical spinal cord##2##5##(2010-5#2)
to the cervical spine and##2##5##(2007-11#2)
to the cervical spine##14##4##(2007-11#14)
to the cervical##21##3##(1992-1#1)(2007-11#16)(2007-8#1)(2010-5#2)(2013-1#1)
to the cessation of##2##4##(2006-10#1)(2008-4#1)
to the challenge of##5##4##(1994-7#1)(2005-8#1)(2008-10#2)(2008-3#1)
to the challenge##8##3##(1994-7#2)(2005-8#1)(2008-10#2)(2008-3#1)(2013-1#2)
to the challenges of##3##4##(1995-1#1)(2006-10#1)(2009-11#1)
to the challenges##6##3##(1995-1#1)(1996-1#1)(1996-2#1)(2006-10#1)(2009-11#1)(2012-12#1)
to the chance##2##3##(2008-2#1)(2008-8#1)
to the change in the##2##5##(2008-4#1)(2011-2#1)
to the change in##13##4##(1991-2#1)(2005-3#1)(2006-10#1)(2006-11#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-12#1)(2011-1#1)(2011-2#1)
to the change of##7##4##(1991-5#1)(1991-8#1)(1992-6#1)(2005-4#1)(2008-3#1)(2008-8#1)(2010-8#1)
to the change##21##3##(1990-8#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-6#1)(2005-3#1)(2005-4#1)(2006-10#1)(2006-11#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-8#2)(2009-12#1)(2010-8#1)(2011-1#1)(2011-2#1)
to the changes in the##7##5##(1990-12#1)(1993-9#1)(1994-10#1)(1995-3#1)(2008-10#1)(2008-5#1)(2011-1#1)
to the changes in##13##4##(1990-12#1)(1990-7#1)(1992-3#1)(1993-9#1)(1994-10#1)(1995-3#1)(1996-5#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-1#1)
to the changes of##5##4##(2007-12#1)(2008-10#1)(2008-9#1)(2009-4#1)(2011-1#1)
to the changes that##2##4##(2007-12#1)(2008-12#1)
to the changes##24##3##(1990-12#1)(1990-7#1)(1992-3#1)(1993-9#1)(1994-10#2)(1994-6#1)(1995-3#1)(1996-5#1)(2007-12#2)(2007-2#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2011-1#2)
to the changing##6##3##(1994-2#1)(1996-2#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
to the channel##6##3##(1993-12#1)(1995-10#1)(2006-4#1)(2007-12#1)(2008-2#1)(2008-8#1)
to the character##2##3##(2007-10#1)(2012-2#1)
to the characterisation of##2##4##(2008-11#1)(2008-4#1)
to the characterisation##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
to the characteristic##10##3##(1990-11#1)(1997-4#1)(2006-10#1)(2008-2#1)(2008-5#2)(2008-9#1)(2009-2#1)(2010-10#1)(2010-6#1)
to the characteristics of the##6##5##(1993-10#1)(1996-9#2)(2008-10#1)(2008-2#1)(2009-7#1)
to the characteristics of##8##4##(1993-10#1)(1996-9#2)(2006-11#1)(2008-10#1)(2008-2#1)(2009-7#1)(2012-1#1)
to the characteristics##9##3##(1993-10#1)(1996-9#2)(2006-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-7#1)(2012-1#1)
to the characterization of the##2##5##(1991-2#1)(2011-1#1)
to the characterization of##10##4##(1991-2#2)(1994-3#1)(1994-8#1)(2006-12#1)(2008-10#1)(2008-3#2)(2011-1#2)
to the characterization##11##3##(1991-2#2)(1993-5#1)(1994-3#1)(1994-8#1)(2006-12#1)(2008-10#1)(2008-3#2)(2011-1#2)
to the charges##2##3##(1990-7#1)(1991-3#1)
to the chemical composition of the##2##6##(2011-1#1)(2013-8#1)
to the chemical##18##3##(1991-6#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-8#2)(2008-10#5)(2008-3#1)(2008-5#1)(2010-1#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
to the chemotherapy##5##3##(1991-8#1)(2008-11#1)(2008-8#1)(2010-3#1)(2012-12#1)
to the chest wall##2##4##(1992-2#1)(2009-1#1)
to the chest##8##3##(1992-2#1)(2005-12#1)(2006-11#1)(2006-6#1)(2007-4#1)(2007-7#1)(2009-1#1)(2012-2#1)
to the chick##2##3##(1992-12#1)(2006-4#1)
to the chicken##2##3##(1991-3#1)(2010-3#1)
to the child and the##2##5##(2009-4#1)(2009-8#1)
to the child and##5##4##(2009-10#1)(2009-4#1)(2009-8#1)(2012-12#1)(2012-2#1)
to the child during##2##4##(1993-3#1)(2012-12#1)
to the child##26##3##(1992-4#1)(1993-3#1)(1997-8#1)(2006-4#1)(2006-5#5)(2007-4#1)(2007-7#1)(2008-11#1)(2008-4#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-9#1)(2011-1#1)(2012-12#2)(2012-2#2)(2013-8#1)
to the children and##2##4##(1995-6#1)(2012-12#1)
to the children##9##3##(1990-11#1)(1994-4#1)(1995-6#1)(1996-1#1)(1996-12#1)(2007-11#1)(2008-3#1)(2012-12#1)(2013-8#1)
to the children's##5##3##(1991-2#1)(2005-10#1)(2006-2#1)(2008-2#1)(2011-2#1)
to the chip##2##3##(2008-3#1)(2008-4#1)
to the chiral##2##3##(2006-12#1)(2008-10#1)
to the chloramphenicol acetyl transferase (CAT) reporter gene##2##8##(1992-12#1)(1994-8#1)
to the chloramphenicol acetyl transferase (CAT)##3##6##(1992-12#1)(1992-8#1)(1994-8#1)
to the chloramphenicol##10##3##(1990-8#1)(1991-2#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-4#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-8#1)
to the choice of the##3##5##(1991-11#1)(2005-11#1)(2013-1#1)
to the choice of##13##4##(1991-11#1)(1991-9#1)(2005-11#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#1)(2012-12#1)(2013-1#2)
to the cholinergic##4##3##(1994-3#1)(1997-2#1)(2008-7#1)(2010-8#1)
to the chondrocytes##2##3##(1994-11#1)(1994-12#1)
to the choroid plexus##2##4##(1994-10#1)(2008-7#1)
to the chromatographic##3##3##(2008-10#3)
to the chromophore##2##3##(1991-7#1)(1994-11#1)
to the chromosome##2##3##(1996-7#1)(1997-6#1)
to the chronic##5##3##(1992-2#1)(1996-12#1)(1996-4#1)(1997-8#1)(2006-10#1)
to the circadian##2##3##(1997-5#1)(2008-3#1)
to the circular muscle of the guinea-pig##2##7##(1997-4#2)
to the circular muscle of##3##5##(1997-4#3)
to the circular##5##3##(1994-11#1)(1997-4#3)(2008-3#1)
to the circulation of##2##4##(2009-10#1)(2012-2#1)
to the circulation##5##3##(1993-6#1)(2008-7#1)(2009-10#1)(2010-12#1)(2012-2#1)
to the cis##2##3##(1990-8#1)(1992-12#1)
to the citizens##2##3##(2009-3#1)(2012-3#1)
to the claim##2##3##(2007-4#1)(2008-8#1)
to the claims##2##3##(2007-9#1)(2008-1#1)
to the class I##3##4##(1990-11#1)(1995-1#1)(2008-4#1)
to the class of##11##4##(1991-12#1)(1994-5#1)(1995-12#1)(1996-5#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-5#1)(2009-12#1)(2010-8#1)
to the class##22##3##(1990-10#1)(1990-11#1)(1991-12#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-5#1)(1997-7#3)(2006-6#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-12#1)(2010-8#1)(2011-2#1)
to the classes##2##3##(2008-10#1)(2008-2#1)
to the classic##11##3##(1990-8#1)(1993-10#1)(2006-2#1)(2006-8#1)(2007-12#1)(2008-3#1)(2009-1#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-1#1)
to the classical##20##3##(1995-12#1)(1996-11#1)(2005-11#2)(2005-8#1)(2006-6#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-6#1)(2009-8#1)(2013-8#1)
to the classification of##9##4##(1990-3#1)(1994-2#1)(2008-10#1)(2008-7#2)(2010-12#1)(2010-7#1)(2012-11#1)(2012-2#1)
to the classification##12##3##(1990-3#1)(1994-2#1)(2008-10#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-7#1)(2011-2#2)(2012-11#1)(2012-2#1)
to the clean##2##3##(2005-11#1)(2010-4#1)
to the clearance of##2##4##(1990-2#1)(1990-9#1)
to the cleavage furrow##3##4##(2009-8#3)
to the cleavage of##2##4##(1995-6#1)(2008-10#1)
to the cleavage##5##3##(1995-6#1)(2008-10#1)(2009-8#3)
to the cleft##2##3##(1991-4#1)(1996-7#1)
to the client with hypertension##2##5##(2012-3#2)
to the client##5##3##(2008-2#2)(2010-8#1)(2012-3#2)
to the climate##2##3##(2012-5#1)(2012-9#1)
to the clinic##17##3##(1993-2#1)(1995-9#1)(1996-12#1)(1996-6#1)(2005-6#1)(2006-10#1)(2007-4#2)(2007-8#1)(2008-1#2)(2008-11#2)(2010-3#2)(2010-8#1)(2011-7#1)
to the clinical and##2##4##(2006-8#1)(2012-3#1)
to the clinical course##2##4##(1991-5#1)(2007-12#1)
to the clinical laboratory##2##4##(1996-6#1)(2008-7#1)
to the clinical management of##3##5##(2006-10#2)(2009-3#1)
to the clinical management##4##4##(2006-10#3)(2009-3#1)
to the clinical picture##2##4##(1997-7#1)(2007-6#1)
to the clinical practice##4##4##(2007-5#1)(2008-5#1)(2012-2#1)(2013-8#1)
to the clinical setting##2##4##(2005-7#1)(2010-12#1)
to the clinical severity of##2##5##(1997-6#1)(2007-6#1)
to the clinical severity##4##4##(1997-6#1)(2007-6#1)(2009-6#2)
to the clinical situation##3##4##(2008-10#1)(2008-11#1)(2008-4#1)
to the clinical status##2##4##(2006-10#1)(2006-4#1)
to the clinical##61##3##(1990-5#1)(1990-9#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-2#1)(1993-11#1)(1993-2#1)(1994-2#1)(1996-11#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-7#1)(2005-9#1)(2006-10#5)(2006-4#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#3)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-3#1)(2009-6#2)(2010-10#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
to the clinically##2##3##(1995-3#1)(2012-3#1)
to the clinician##10##3##(1993-12#1)(1996-12#1)(2006-10#1)(2006-12#1)(2009-12#1)(2009-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
to the clinicians##2##3##(2008-1#1)(2008-7#1)
to the cloaca##2##3##(2007-12#1)(2007-2#1)
to the clonal##2##3##(1991-10#1)(2008-10#1)
to the cloned##5##3##(1991-12#1)(1992-6#1)(1993-9#1)(1995-8#1)(1996-12#1)
to the close##4##3##(2008-10#2)(2009-9#1)(2012-2#1)
to the closure of##2##4##(2007-8#1)(2012-1#1)
to the cluster##5##3##(1996-2#1)(1997-4#1)(1997-8#2)(2008-10#1)
to the clustering##2##3##(1990-5#1)(2012-1#1)
to the coating##2##3##(2008-3#1)(2009-11#1)
to the coding region of the##2##6##(1990-11#1)(1994-8#1)
to the coding region of##3##5##(1990-11#1)(1991-8#1)(1994-8#1)
to the coding region##4##4##(1990-11#1)(1991-12#1)(1991-8#1)(1994-8#1)
to the coding##8##3##(1990-11#1)(1991-12#1)(1991-8#1)(1994-12#1)(1994-5#2)(1994-8#1)(1997-2#1)
to the cofactor##5##3##(1992-12#1)(1995-7#1)(1997-4#1)(1997-7#1)(2009-3#1)
to the cognitive##5##3##(1995-12#1)(2008-11#1)(2008-4#1)(2009-10#1)(2010-10#1)
to the coherent##3##3##(2007-11#1)(2008-1#1)(2008-3#1)
to the cohort##2##3##(2008-6#1)(2008-8#1)
to the cold##3##3##(1991-2#1)(2008-7#1)(2012-12#1)
to the collagenase##2##3##(1994-2#1)(1996-8#1)
to the collapse of the##2##5##(1992-5#1)(2008-10#1)
to the collection of##2##4##(2008-6#1)(2010-3#1)
to the collection##4##3##(2008-10#2)(2008-6#1)(2010-3#1)
to the collective##2##3##(2008-4#1)(2008-9#1)
to the collisional##2##3##(1995-8#1)(1997-2#1)
to the colon##2##3##(2009-12#1)(2012-1#1)
to the colonial##2##3##(2006-7#1)(2008-8#1)
to the color##4##3##(1993-3#2)(1997-1#1)(2010-4#1)
to the colorectal##2##3##(1991-5#1)(2008-10#1)
to the column##9##3##(1990-12#1)(1991-11#1)(1992-5#1)(1992-6#1)(1996-8#1)(1997-1#1)(2008-10#2)(2010-11#1)
to the combination of##12##4##(1990-2#1)(1991-10#1)(1991-9#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-7#1)(2012-12#1)(2013-1#1)
to the combination##16##3##(1990-2#1)(1991-10#1)(1991-12#1)(1991-9#1)(1992-8#1)(1995-5#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-7#1)(2012-12#1)(2013-1#1)
to the combinations##2##3##(1995-9#1)(2008-9#1)
to the combined action of##2##5##(2007-12#1)(2008-11#1)
to the combined effect of##3##5##(1990-2#1)(2007-12#1)(2008-3#1)
to the combined effects of##3##5##(2005-11#1)(2007-11#1)(2008-10#1)
to the combined##15##3##(1990-11#1)(1990-2#1)(1997-8#1)(2005-11#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)
to the commercial##5##3##(2006-5#1)(2007-4#1)(2007-6#1)(2008-5#1)(2010-4#1)
to the commercially available##3##4##(1997-3#1)(2007-8#1)(2010-4#1)
to the common assumption that##2##5##(1992-12#1)(2010-12#1)
to the common bile duct##2##5##(1990-9#1)(1993-9#1)
to the common disease/rare##2##4##(2012-3#2)
to the common peroneal nerve##3##5##(2006-8#1)(2007-7#2)
to the common##26##3##(1990-9#1)(1991-6#1)(1992-12#1)(1992-8#1)(1993-9#1)(1994-9#1)(2006-8#1)(2007-7#2)(2008-10#6)(2008-3#1)(2008-7#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-11#1)(2012-3#2)
to the commonly used##4##4##(2006-12#1)(2007-8#1)(2012-1#1)(2012-12#1)
to the commonly##6##3##(2006-12#1)(2006-4#1)(2007-8#1)(2012-1#1)(2012-12#2)
to the communication of##2##4##(2007-9#1)(2010-4#1)
to the communication##3##3##(2007-9#1)(2009-2#1)(2010-4#1)
to the communities##2##3##(2008-1#1)(2009-4#1)
to the community and to##2##5##(2006-5#1)(2013-8#1)
to the community that##2##4##(2007-9#1)(2008-8#1)
to the community##29##3##(1991-12#1)(1992-5#2)(1993-7#1)(1994-1#1)(1995-1#1)(1996-3#1)(1997-8#1)(2004-12#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-7#4)(2008-8#2)(2009-10#1)(2011-1#2)(2011-2#3)(2013-8#1)
to the comparison##3##3##(1996-1#2)(2008-3#1)
to the competitive effect of##2##5##(1996-5#1)(2008-11#1)
to the complement##2##3##(1990-6#1)(2010-12#1)
to the complementary##2##3##(1995-1#1)(2006-12#1)
to the complete##9##3##(1992-3#1)(1995-1#1)(2005-8#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-2#1)
to the completion of the##2##5##(1992-3#1)(2008-11#1)
to the completion of##5##4##(1991-6#1)(1992-3#1)(1993-9#1)(2008-11#1)(2008-3#1)
to the complex nature of##3##5##(1993-6#1)(2008-10#1)(2008-6#1)
to the complex##32##3##(1990-12#2)(1990-5#1)(1993-6#1)(1994-5#1)(2006-10#2)(2007-11#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
to the complexation##4##3##(2007-8#1)(2008-10#2)(2013-1#1)
to the complexes##2##3##(1995-8#1)(1996-2#1)
to the complexities##2##3##(2006-7#1)(2008-8#1)
to the complexity of the##8##5##(1997-3#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-9#1)(2010-9#1)(2011-2#1)
to the complexity of##13##4##(1996-8#1)(1997-3#1)(2004-4#1)(2005-7#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-9#1)(2009-8#1)(2010-9#1)(2011-2#1)
to the complexity##14##3##(1996-8#1)(1997-3#1)(2004-4#1)(2005-7#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-9#1)(2009-8#1)(2010-9#1)(2011-2#2)
to the complications of##4##4##(1991-10#1)(2006-8#1)(2008-8#1)(2012-2#1)
to the components of##2##4##(1993-11#1)(2007-2#1)
to the composition of the##2##5##(1990-10#1)(2011-1#1)
to the composition##4##3##(1990-10#1)(2007-8#1)(2008-10#1)(2011-1#1)
to the compound stimulus##5##4##(1997-8#5)
to the compound##10##3##(1996-2#1)(1997-8#5)(2005-9#1)(2008-1#1)(2008-10#2)
to the compounds##3##3##(1997-3#1)(1997-4#1)(2008-10#1)
to the comprehension##2##3##(1994-11#1)(2007-9#1)
to the comprehensive##2##3##(1992-8#1)(1993-2#1)
to the compression of##2##4##(2008-2#2)
to the compression##4##3##(1993-3#1)(2008-2#2)(2013-8#1)
to the computation of##2##4##(2007-12#1)(2008-3#1)
to the computation##3##3##(2007-12#1)(2008-3#1)(2011-1#1)
to the computer screen##2##4##(2008-10#1)(2012-1#1)
to the computer##8##3##(1992-4#1)(1992-8#1)(2008-10#3)(2008-11#1)(2009-10#1)(2012-1#1)
to the concave side of##2##5##(2012-2#2)
to the concentration of formaldehyde##2##5##(2008-10#2)
to the concentration of nucleic acids in the range##2##9##(2008-10#2)
to the concentration of nucleic acids##3##6##(2008-10#3)
to the concentration of the##6##5##(1996-12#1)(2008-10#4)(2010-3#1)
to the concentration of tryptophan and histidine##2##7##(2007-8#2)
to the concentration of vanadium##2##5##(2008-10#2)
to the concentration of##79##4##(1990-1#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-8#2)(1994-12#1)(1994-8#1)(1996-12#2)(1997-7#1)(2005-12#1)(2006-12#1)(2006-3#1)(2007-8#4)(2008-1#1)(2008-10#51)(2008-12#1)(2008-5#2)(2010-3#1)(2010-5#1)(2012-11#1)(2012-2#1)
to the concentration##87##3##(1990-1#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-8#3)(1994-12#1)(1994-8#1)(1996-12#2)(1997-7#1)(2005-12#1)(2006-12#1)(2006-3#1)(2007-1#1)(2007-8#4)(2008-1#1)(2008-10#56)(2008-12#1)(2008-5#3)(2010-3#1)(2010-5#1)(2012-11#1)(2012-2#1)
to the concentrations of both##2##5##(1994-12#1)(2008-10#1)
to the concentrations of##3##4##(1994-12#1)(2008-10#2)
to the concentrations##4##3##(1994-12#1)(2008-10#2)(2008-11#1)
to the concept of##13##4##(1990-2#1)(1990-6#1)(1993-6#1)(1996-1#1)(2007-4#1)(2008-2#2)(2008-6#1)(2008-9#1)(2010-8#1)(2012-11#1)(2012-12#1)(2013-1#1)
to the concept that the##2##5##(1995-11#1)(1995-5#1)
to the concept that##7##4##(1993-11#1)(1993-9#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-5#1)(2008-7#1)
to the concept##21##3##(1990-2#1)(1990-6#1)(1993-11#1)(1993-6#1)(1993-9#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-5#1)(2006-10#1)(2007-4#1)(2008-2#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-11#1)(2012-12#1)(2013-1#1)
to the concepts of##2##4##(1993-6#1)(2010-7#1)
to the concepts##5##3##(1992-1#1)(1993-6#1)(1995-1#1)(2007-3#1)(2010-7#1)
to the conceptual##3##3##(2008-11#1)(2010-2#1)(2013-1#1)
to the concerns of##2##4##(1993-12#1)(2006-4#1)
to the conclusion that in##2##5##(1990-11#1)(1992-5#1)
to the conclusion that the##13##5##(1991-8#1)(1992-9#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-3#2)(2009-3#1)(2011-1#2)(2013-8#2)
to the conclusion that this##2##5##(1995-3#1)(1995-4#1)
to the conclusion that##47##4##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1991-8#1)(1992-3#1)(1992-5#1)(1992-9#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-9#1)(2006-10#2)(2006-2#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#3)(2009-3#1)(2011-1#3)(2011-2#1)(2012-12#1)(2013-8#2)
to the conclusion##48##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1991-8#1)(1992-3#2)(1992-5#1)(1992-9#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-9#1)(2006-10#2)(2006-2#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#3)(2009-3#1)(2011-1#3)(2011-2#1)(2012-12#1)(2013-8#2)
to the condition##4##3##(2006-10#1)(2006-4#1)(2009-4#1)(2011-2#1)
to the conditional##2##3##(1992-6#1)(2008-5#1)
to the conditioned medium##2##4##(1991-4#1)(1993-12#1)
to the conditioned stimulus##2##4##(1997-7#1)(2009-2#1)
to the conditioned##4##3##(1991-4#1)(1993-12#1)(1997-7#1)(2009-2#1)
to the conditions##3##3##(1995-1#1)(2008-10#1)(2008-2#1)
to the conduction band of TiO(2)##3##6##(2005-11#3)
to the condylar##2##3##(1996-9#1)(2006-3#1)
to the configuration##4##3##(1995-11#1)(1996-6#1)(2008-10#1)(2008-8#1)
to the conformation##2##3##(1995-11#1)(2008-10#1)
to the conformational##4##3##(1997-4#1)(2006-12#2)(2008-11#1)
to the conjunctiva and cornea##2##5##(2006-11#1)(2007-1#1)
to the connection##3##3##(1990-10#1)(2008-11#1)(2010-9#1)
to the connective##2##3##(2007-12#1)(2012-11#1)
to the consensus sequence of##2##5##(1996-6#1)(1997-4#1)
to the consensus sequence##3##4##(1995-2#1)(1996-6#1)(1997-4#1)
to the consensus##11##3##(1990-12#1)(1990-2#1)(1991-11#1)(1991-2#1)(1991-5#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-6#1)(1997-4#1)(2008-10#1)
to the conservation of##3##4##(2007-2#1)(2007-3#1)(2008-5#1)
to the conserved region of##2##5##(1992-11#1)(2008-8#1)
to the conserved region##3##4##(1992-11#1)(1992-6#1)(2008-8#1)
to the conserved##13##3##(1991-2#1)(1992-11#1)(1992-6#1)(1994-9#1)(1995-8#1)(1996-7#1)(1996-8#1)(2005-11#1)(2006-8#1)(2008-10#1)(2008-8#1)(2012-12#1)(2013-8#1)
to the considerable##2##3##(2008-1#1)(2008-10#1)
to the constant##2##3##(1990-5#1)(2010-4#1)
to the constraints##2##3##(2012-2#1)(2013-8#1)
to the construct##2##3##(2008-2#1)(2013-7#1)
to the construction of a##2##5##(1990-12#1)(2008-4#1)
to the construction of the##2##5##(2006-12#1)(2013-8#1)
to the construction of##13##4##(1990-12#1)(1990-5#1)(1991-3#1)(1994-8#1)(1995-6#1)(1997-4#1)(2006-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2013-8#1)
to the construction##14##3##(1990-12#1)(1990-5#1)(1991-3#1)(1994-8#1)(1995-6#1)(1997-4#1)(2006-12#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#1)(2013-8#1)
to the consumer##5##3##(1992-12#1)(2007-7#1)(2008-5#2)(2010-4#1)
to the consumption of##4##4##(1992-8#1)(2008-4#1)(2011-2#1)(2012-2#1)
to the contact##3##3##(2006-11#1)(2006-12#1)(2013-1#1)
to the contamination of##3##4##(1994-3#1)(1997-6#1)(2008-10#1)
to the contamination##5##3##(1994-3#1)(1997-6#1)(2008-10#2)(2012-2#1)
to the contemporary##3##3##(2006-8#1)(2007-11#1)(2008-9#1)
to the content of the##2##5##(1993-4#1)(2008-10#1)
to the content of##7##4##(1991-10#1)(1993-4#1)(1993-6#1)(2008-10#2)(2008-11#1)(2011-2#1)
to the content##9##3##(1991-10#1)(1993-4#1)(1993-6#1)(2007-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)
to the context##2##3##(2007-11#1)(2008-2#1)
to the continued##5##3##(1991-10#1)(1993-12#1)(1995-7#1)(2011-2#1)(2012-1#1)
to the continuous##2##3##(2008-10#1)(2008-2#1)
to the contraction##3##3##(1991-8#1)(2005-11#1)(2009-4#1)
to the contralateral side##5##4##(1993-7#1)(1994-2#1)(1995-7#1)(2007-12#1)(2007-7#1)
to the contralateral##11##3##(1990-4#1)(1993-7#1)(1994-2#1)(1995-7#1)(1997-1#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-9#1)(2010-2#1)(2012-2#1)
to the contrary##10##3##(1991-4#1)(1991-6#1)(1993-4#1)(1993-6#1)(1995-2#1)(1997-5#1)(2006-7#1)(2009-4#1)(2010-8#1)(2012-2#1)
to the contrast##5##3##(1991-1#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)
to the contribution##3##3##(2005-11#1)(2008-3#1)(2010-4#1)
to the contributions of##3##4##(2008-10#1)(2008-2#1)(2009-6#1)
to the contributory##2##3##(2011-2#1)(2013-1#1)
to the control and##3##4##(2007-8#1)(2008-4#1)(2010-4#1)
to the control group and##2##5##(1991-12#1)(2008-12#1)
to the control group in##3##5##(2006-8#1)(2007-10#1)(2007-2#1)
to the control group##42##4##(1991-10#1)(1991-12#1)(1993-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1997-2#1)(1997-3#2)(2006-5#1)(2006-8#2)(2007-10#1)(2007-2#2)(2008-10#1)(2008-12#1)(2008-4#1)(2009-12#1)(2009-5#3)(2009-6#2)(2009-8#1)(2010-10#1)(2010-2#1)(2010-7#1)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#1)
to the control groups##2##4##(2008-12#1)(2008-7#1)
to the control level##8##4##(1992-1#1)(1992-4#1)(1993-2#1)(1996-5#1)(2008-11#1)(2008-6#2)(2012-1#1)
to the control of##15##4##(1990-7#1)(1992-12#1)(1992-8#1)(1995-2#1)(1997-7#1)(2005-11#1)(2006-10#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#1)(2010-8#1)(2013-8#1)
to the control values##2##4##(1996-2#1)(2011-2#1)
to the control##135##3##(1990-11#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#2)(1993-2#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#2)(1997-7#1)(2005-10#2)(2005-11#1)(2006-10#2)(2006-5#1)(2006-8#2)(2007-10#1)(2007-2#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#8)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#5)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#3)(2009-12#1)(2009-3#1)(2009-5#3)(2009-6#3)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-4#3)(2010-7#2)(2010-8#1)(2011-12#1)(2011-2#6)(2012-1#3)(2012-12#3)(2012-2#5)(2012-3#1)(2012-6#2)(2013-1#2)(2013-7#2)(2013-8#2)
to the controlled##3##3##(1994-9#1)(2007-11#1)(2009-8#1)
to the controls##21##3##(1990-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1994-11#1)(1994-5#1)(1995-9#1)(1996-11#1)(1996-4#1)(1997-2#1)(2006-10#1)(2006-12#2)(2007-2#1)(2008-7#2)(2008-8#1)(2010-4#1)(2010-5#1)(2013-1#1)(2013-8#1)
to the controversial##3##3##(2010-6#2)(2012-2#1)
to the controversy##2##3##(1990-12#1)(1991-11#1)
to the convenience##2##3##(2007-4#1)(2007-8#1)
to the conventional method##3##4##(2008-11#2)(2008-2#1)
to the conventional technique##2##4##(2011-2#1)(2011-7#1)
to the conventional treatment##3##4##(2010-4#1)(2012-12#1)(2012-2#1)
to the conventional##49##3##(1990-12#1)(1997-8#1)(2004-1#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#3)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#6)(2008-3#2)(2008-4#2)(2008-5#2)(2009-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
to the conventionally##2##3##(1993-4#1)(2012-12#1)
to the conversion of##5##4##(1990-12#1)(1991-6#1)(1996-5#1)(2007-1#1)(2008-3#1)
to the convulsant##2##3##(1990-10#1)(1991-11#1)
to the cooperation##3##3##(1990-4#2)(2011-1#1)
to the cooperative##2##3##(1995-1#1)(2008-10#1)
to the copper##4##3##(1993-9#1)(2006-10#1)(2009-3#1)(2012-2#1)
to the core matrix##2##4##(2008-4#1)(2009-11#1)
to the core region##2##4##(1991-4#1)(2008-5#1)
to the core##10##3##(1990-10#2)(1991-4#1)(1997-1#1)(1997-7#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-11#1)
to the corneal##2##3##(2008-11#1)(2009-7#1)
to the coronary artery##2##4##(2006-6#1)(2008-10#1)
to the coronary care unit##2##5##(1990-3#1)(2008-3#1)
to the coronary##8##3##(1990-3#1)(2006-6#1)(2008-10#2)(2008-3#1)(2012-3#1)(2013-2#2)
to the corpus##2##3##(1996-5#1)(2006-5#1)
to the correct##10##3##(1990-8#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-12#1)(2011-2#2)
to the correction##2##3##(2006-6#1)(2008-3#1)
to the correlation##2##3##(1996-6#1)(2007-8#1)
to the corresponding amines##3##4##(1995-6#1)(1996-10#1)(2005-8#1)
to the corresponding diphosphates##2##4##(1994-8#1)(2008-4#1)
to the corresponding parameters##2##4##(2007-11#1)(2010-12#1)
to the corresponding pure##2##4##(2006-8#1)(2012-2#1)
to the corresponding rat##2##4##(1991-1#1)(2008-7#1)
to the corresponding values##3##4##(1990-7#1)(1991-2#1)(2008-10#1)
to the corresponding##102##3##(1990-12#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#2)(1992-2#2)(1992-5#1)(1992-9#2)(1993-3#1)(1993-9#2)(1994-12#1)(1994-5#2)(1994-6#1)(1994-8#4)(1995-11#1)(1995-2#1)(1995-3#3)(1995-6#1)(1995-8#2)(1996-10#2)(1996-3#1)(1996-5#3)(1996-6#2)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#1)(2005-11#1)(2005-8#2)(2006-12#2)(2006-8#1)(2007-10#2)(2007-11#7)(2007-2#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
to the cortex and##2##4##(1991-9#1)(2007-9#1)
to the cortex##7##3##(1991-9#1)(1996-3#1)(2007-9#1)(2008-11#4)
to the cortical##4##3##(1990-9#2)(2008-7#1)(2012-12#1)
to the cost of the##3##5##(1993-1#1)(2008-10#1)(2008-2#1)
to the cost of##5##4##(1993-1#1)(1995-6#1)(2008-10#1)(2008-2#1)(2010-8#1)
to the cost##7##3##(1993-1#1)(1995-6#1)(2008-10#1)(2008-2#1)(2010-8#2)(2013-1#1)
to the costs of##2##4##(2008-7#1)(2008-8#1)
to the costs##3##3##(2007-2#1)(2008-7#1)(2008-8#1)
to the country##4##3##(2005-10#1)(2007-9#2)(2010-1#1)
to the coupling of##3##4##(1991-12#1)(2007-12#1)(2008-5#1)
to the coupling##6##3##(1991-12#1)(2005-4#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
to the course of##5##4##(1992-3#1)(1993-1#1)(1994-6#1)(1996-8#1)(2011-2#1)
to the court##2##3##(1995-6#1)(2005-8#1)
to the covalent##2##3##(1991-3#1)(1997-4#1)
to the cover glass##2##4##(2008-11#2)
to the craniocervical junction##4##4##(2011-2#4)
to the cranium##3##3##(2007-12#1)(2007-5#1)(2008-11#1)
to the cream##2##3##(2008-5#2)
to the creation of a##4##5##(1991-3#1)(2007-11#1)(2008-3#1)(2009-11#1)
to the creation of##17##4##(1991-3#1)(1992-1#1)(1997-1#1)(1997-3#1)(2006-6#1)(2006-7#1)(2007-11#2)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#2)(2009-11#1)(2010-1#1)
to the creation##18##3##(1991-3#1)(1992-1#1)(1997-1#1)(1997-3#2)(2006-6#1)(2006-7#1)(2007-11#2)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#2)(2009-11#1)(2010-1#1)
to the criteria##15##3##(1991-11#1)(1992-4#1)(1997-2#1)(2004-1#1)(2005-7#1)(2006-6#1)(2007-7#2)(2008-1#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
to the critical##10##3##(1994-4#1)(2005-5#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-10#1)(2010-9#1)
to the cross-linking##2##3##(1995-6#1)(2012-3#1)
to the cross-reactivity##2##3##(1990-12#1)(2008-10#1)
to the crude##2##3##(1992-2#1)(2007-6#1)
to the crystal##5##3##(1996-8#1)(2006-4#1)(2008-1#1)(2008-2#1)(2008-3#1)
to the crystallite##2##3##(2005-11#1)(2008-10#1)
to the crystals##2##3##(1993-6#1)(2009-8#1)
to the cube##2##3##(2007-12#1)(2008-10#1)
to the cue##3##3##(1996-6#3)
to the cultivation##3##3##(1994-11#1)(2008-5#1)(2008-6#1)
to the culture media##4##4##(1995-10#1)(2008-11#3)
to the culture medium at##2##5##(1995-11#1)(2004-8#1)
to the culture medium of##4##5##(1992-6#1)(1993-9#1)(1994-8#1)(2009-3#1)
to the culture medium##36##4##(1990-10#1)(1990-11#1)(1991-10#1)(1991-2#1)(1991-5#1)(1992-6#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-9#1)(1997-2#1)(2004-8#2)(2006-11#1)(2006-12#1)(2008-1#1)(2008-11#9)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2011-1#1)
to the culture of##4##4##(1993-12#1)(2007-2#1)(2008-11#1)(2008-9#1)
to the culture##60##3##(1990-10#1)(1990-11#1)(1990-2#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-4#2)(1992-6#1)(1993-12#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-9#1)(1997-2#1)(2004-8#2)(2006-10#1)(2006-11#1)(2006-12#1)(2007-2#1)(2008-1#1)(2008-11#19)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2011-1#1)
to the cultured human##2##4##(1993-6#1)(2006-8#1)
to the cultured##3##3##(1993-6#1)(1995-12#1)(2006-8#1)
to the cultures##4##3##(1991-2#1)(1995-2#1)(1997-1#1)(1997-6#1)
to the cumulative##2##3##(1994-5#1)(2008-7#1)
to the current nursing##2##4##(1991-2#1)(2008-12#1)
to the current practice##2##4##(2008-10#1)(2010-10#1)
to the current standard##2##4##(2008-4#1)(2010-12#1)
to the current system##3##4##(1990-10#1)(1991-3#1)(2006-10#1)
to the current understanding of##2##5##(2009-4#1)(2012-11#1)
to the current view##2##4##(1990-2#1)(2011-1#1)
to the current##60##3##(1990-10#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#1)(1993-6#1)(1996-1#1)(1996-12#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#5)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)
to the currently accepted##2##4##(1995-3#1)(2008-1#1)
to the currently available##2##4##(2006-10#1)(2007-7#1)
to the currently##6##3##(1995-3#1)(2005-7#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-7#1)
to the customary##2##3##(1990-7#1)(2008-1#1)
to the cutaneous##3##3##(1996-8#1)(2006-8#1)(2012-3#1)
to the cuticle##5##3##(2007-12#3)(2008-8#2)
to the cyanide##2##3##(1990-4#1)(2008-10#1)
to the cytokine##3##3##(1995-3#1)(1996-10#1)(2012-1#1)
to the cytopathic effect##2##4##(2008-4#2)
to the cytoplasm at##2##4##(1992-3#1)(1994-3#1)
to the cytoplasm of##3##4##(1995-12#1)(1997-4#1)(2008-1#1)
to the cytoplasm##19##3##(1991-11#1)(1991-7#1)(1992-3#1)(1992-8#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-2#3)(1995-3#1)(1997-2#1)(1997-4#1)(2006-12#1)(2008-1#2)(2008-5#1)(2009-8#1)(2011-2#1)
to the cytoplasmic domain of the##3##6##(1992-5#1)(1994-9#1)(1995-3#1)
to the cytoplasmic membrane##2##4##(1992-7#1)(2008-5#1)
to the cytoplasmic tail##3##4##(1991-11#1)(1992-5#1)(2008-9#1)
to the cytoplasmic##11##3##(1991-11#1)(1992-5#2)(1992-6#1)(1992-7#1)(1994-2#1)(1994-9#1)(1995-3#1)(2008-10#1)(2008-5#1)(2008-9#1)
to the cytoskeleton##8##3##(1992-6#1)(1994-12#2)(1994-9#1)(1997-6#1)(2008-11#1)(2012-12#2)
to the cytosol and##2##4##(1997-4#1)(2009-10#1)
to the cytosol##8##3##(1990-3#1)(1991-10#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-1#1)(2009-10#1)(2011-1#1)
to the cytosolic##11##3##(1990-12#1)(1990-3#1)(1993-6#1)(1994-9#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(2005-8#1)(2007-12#1)
to the cytotoxic action##2##4##(1995-3#1)(1996-3#1)
to the cytotoxic activity of##2##5##(1991-3#1)(1995-8#1)
to the cytotoxic effects of##3##5##(1990-2#1)(1995-3#1)(1996-9#1)
to the cytotoxic##10##3##(1990-2#1)(1991-3#1)(1994-11#1)(1995-3#2)(1995-8#1)(1996-3#1)(1996-9#1)(2006-9#1)(2010-12#1)
to the cytotoxicity of##3##4##(1992-8#1)(2012-12#1)(2013-1#1)
to the cytotoxicity##4##3##(1992-8#1)(2008-11#1)(2012-12#1)(2013-1#1)
to the daily##7##3##(1992-9#1)(1993-3#1)(1996-1#1)(2006-2#1)(2008-10#1)(2010-5#1)(2011-1#1)
to the damaged##5##3##(1990-11#1)(1990-2#1)(1993-5#1)(2009-6#1)(2012-1#1)
to the danger of##2##4##(2008-12#1)(2012-2#1)
to the danger##3##3##(2007-9#1)(2008-12#1)(2012-2#1)
to the data acquisition##2##4##(2007-3#1)(2008-2#1)
to the data and##3##4##(1995-4#1)(2006-9#1)(2012-12#1)
to the data obtained at##2##5##(1994-8#1)(2011-1#1)
to the data obtained##5##4##(1994-8#1)(1996-5#1)(2008-10#1)(2008-5#1)(2011-1#1)
to the data of##2##4##(1996-12#1)(2007-8#1)
to the data on##3##4##(1990-6#1)(2008-1#1)(2008-10#1)
to the data##47##3##(1990-6#1)(1994-8#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-5#1)(2005-4#1)(2006-12#1)(2006-9#1)(2007-12#5)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#3)(2008-7#2)(2009-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
to the database as##2##4##(2006-10#1)(2008-7#1)
to the database##5##3##(2006-10#1)(2008-4#2)(2008-7#1)(2009-4#1)
to the death of##10##4##(1995-7#1)(1996-6#1)(2007-11#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2012-12#1)
to the death##11##3##(1995-7#1)(1996-6#1)(2007-11#2)(2008-11#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-12#1)(2012-12#1)
to the debate##7##3##(1993-12#1)(1994-6#1)(1996-8#1)(2005-7#1)(2007-4#1)(2008-6#1)(2012-3#1)
to the decision of##2##4##(2012-12#1)(2013-1#1)
to the decision to##5##4##(1993-3#1)(1995-4#1)(1996-12#1)(2009-12#1)(2011-2#1)
to the decision##9##3##(1993-3#1)(1995-4#1)(1996-12#1)(2007-8#1)(2008-10#1)(2009-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
to the decline of##4##4##(1994-8#1)(2008-6#1)(2008-7#1)(2012-3#1)
to the decline##5##3##(1994-8#1)(2008-6#1)(2008-7#1)(2010-12#1)(2012-3#1)
to the decrease in the##4##5##(1996-11#1)(2007-12#1)(2008-3#1)(2008-7#1)
to the decrease in##9##4##(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(2004-9#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-7#1)
to the decrease of##7##4##(1994-2#1)(1995-11#1)(2005-11#1)(2008-10#2)(2008-3#1)(2008-5#1)
to the decrease##17##3##(1994-2#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(2004-9#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)
to the decreased##6##3##(1990-8#1)(1991-9#1)(2008-1#1)(2008-11#1)(2010-7#2)
to the decreases in##2##4##(1996-10#1)(1997-2#1)
to the deduced aa sequence of##2##6##(1995-2#1)(1997-1#1)
to the deduced aa##3##4##(1993-2#1)(1995-2#1)(1997-1#1)
to the deep##6##3##(1990-8#3)(1993-7#2)(2009-12#1)
to the defect##2##3##(2008-3#1)(2010-6#1)
to the defined##2##3##(1996-1#1)(2008-2#1)
to the definition of a##2##5##(1993-4#1)(2007-11#1)
to the definition of the##3##5##(1991-4#1)(2006-2#1)(2008-2#1)
to the definition of##12##4##(1991-4#1)(1993-4#2)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-1#1)
to the definition##13##3##(1991-4#1)(1992-11#1)(1993-4#2)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-1#1)
to the deformation of##2##4##(2005-11#1)(2008-3#1)
to the degradation by the##2##5##(1990-2#1)(1991-4#1)
to the degradation by##3##4##(1990-2#1)(1991-4#1)(1996-9#1)
to the degradation of the##2##5##(2008-2#1)(2008-7#1)
to the degradation of##4##4##(1990-2#1)(2008-2#1)(2008-4#1)(2008-7#1)
to the degradation##8##3##(1990-2#2)(1991-4#1)(1996-5#1)(1996-9#1)(2008-2#1)(2008-4#1)(2008-7#1)
to the degree of##38##4##(1990-3#1)(1990-5#1)(1991-1#1)(1991-2#1)(1991-7#2)(1991-9#1)(1992-2#1)(1992-8#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-3#1)(1997-1#1)(2004-11#1)(2005-8#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#2)(2009-5#1)(2010-11#1)(2011-2#1)(2013-7#1)
to the degree to which##2##5##(1997-8#1)(2008-4#1)
to the degree##41##3##(1990-3#1)(1990-5#1)(1991-1#1)(1991-2#1)(1991-7#2)(1991-9#1)(1992-2#1)(1992-8#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-3#1)(1997-1#1)(1997-8#1)(2004-11#1)(2005-8#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-5#1)(2010-11#1)(2011-2#1)(2013-7#1)
to the delay in##3##4##(1991-2#1)(2005-7#1)(2009-11#1)
to the delay##7##3##(1990-7#1)(1991-2#1)(1997-6#1)(2005-7#1)(2009-11#2)(2012-12#1)
to the deleterious effects of##3##5##(2008-1#1)(2008-4#1)(2008-7#1)
to the deletion##2##3##(1995-5#1)(1996-10#1)
to the delivery of##4##4##(1994-1#1)(2008-4#1)(2008-7#1)(2013-1#1)
to the delivery##5##3##(1994-1#1)(1994-3#1)(2008-4#1)(2008-7#1)(2013-1#1)
to the demands of##3##4##(1990-12#1)(2008-2#1)(2011-2#1)
to the demands placed##2##4##(1995-12#2)
to the demands##7##3##(1990-12#1)(1995-12#2)(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#1)
to the demodulation##2##3##(2008-3#2)
to the demonstration of##2##4##(1993-10#1)(2008-7#1)
to the denaturation##2##3##(2006-10#1)(2013-1#1)
to the density of the##2##5##(2008-10#1)(2008-3#1)
to the density of##5##4##(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-11#1)
to the density##6##3##(1990-2#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-11#1)
to the dental team##2##4##(2012-2#2)
to the dental##5##3##(2008-6#2)(2008-7#1)(2012-2#2)
to the dentate##2##3##(1996-2#1)(1996-3#1)
to the department of##3##4##(2008-6#1)(2012-2#1)(2013-1#1)
to the department##8##3##(1990-12#1)(1993-8#1)(1994-8#1)(1997-4#1)(2008-11#1)(2008-6#1)(2012-2#1)(2013-1#1)
to the dependence of##2##4##(2007-12#1)(2008-1#1)
to the deposition of##4##4##(1990-8#1)(2008-10#1)(2008-7#1)(2011-12#1)
to the deposition##7##3##(1990-8#1)(2005-11#1)(2008-10#3)(2008-7#1)(2011-12#1)
to the deprotonation of the##2##5##(1993-3#1)(1994-2#1)
to the depth of the##2##5##(2008-3#1)(2010-12#1)
to the depth of##5##4##(1994-9#1)(2008-3#2)(2010-12#1)(2011-2#1)
to the depth##7##3##(1994-9#1)(2008-3#3)(2008-8#1)(2010-12#1)(2011-2#1)
to the descending aorta##4##4##(2007-8#3)(2008-11#1)
to the descending##5##3##(2007-8#3)(2008-11#1)(2011-2#1)
to the described##3##3##(1995-6#1)(2007-6#1)(2007-7#1)
to the description of##4##4##(1991-2#1)(1993-9#1)(2008-1#1)(2009-2#1)
to the design and##6##4##(2005-5#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-9#1)(2011-2#1)
to the design of a##3##5##(2008-2#1)(2008-3#1)(2010-2#1)
to the design of novel##3##5##(1991-7#1)(1992-6#1)(2011-1#1)
to the design of the##4##5##(2008-11#1)(2008-3#1)(2008-5#1)(2012-1#1)
to the design of this##2##5##(2008-12#1)(2008-3#1)
to the design of##38##4##(1991-7#1)(1992-6#1)(1994-8#1)(1995-7#1)(1997-1#1)(1997-2#1)(2005-11#1)(2007-11#4)(2007-12#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#5)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-2#1)
to the design##48##3##(1991-7#1)(1992-6#1)(1994-8#1)(1995-7#1)(1996-1#1)(1997-1#1)(1997-2#2)(2005-11#1)(2005-5#1)(2007-11#4)(2007-12#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#7)(2008-5#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-2#1)(2013-1#1)
to the desire to##3##4##(2009-5#1)(2010-12#1)(2012-2#1)
to the desired##12##3##(1993-2#1)(1994-9#1)(1997-4#1)(1997-5#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-4#1)(2010-5#1)
to the destruction of the##3##5##(1992-9#1)(2007-7#1)(2009-10#1)
to the details of the##2##5##(2007-12#2)
to the details##3##3##(1994-12#1)(2007-12#2)
to the detected signal##2##4##(2008-3#2)
to the detected##7##3##(1993-7#1)(2007-11#1)(2008-3#3)(2008-6#1)(2012-11#1)
to the detection and##3##4##(2006-11#1)(2008-5#1)(2010-2#1)
to the detection limit##2##4##(2008-10#1)(2008-2#1)
to the detection limits of##2##5##(2008-10#2)
to the detection of low##2##5##(2008-10#1)(2008-5#1)
to the detection of the##2##5##(1990-11#1)(2008-10#1)
to the detection of##27##4##(1990-11#1)(1994-2#1)(1994-9#1)(1996-12#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-8#2)(2008-10#8)(2008-2#3)(2008-3#1)(2008-5#2)(2012-11#2)(2013-1#1)
to the detection##40##3##(1990-11#1)(1994-2#1)(1994-9#1)(1996-12#1)(1997-6#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#13)(2008-2#5)(2008-3#2)(2008-5#3)(2010-2#1)(2012-11#2)(2012-2#1)(2013-1#1)
to the detector##11##3##(1993-12#1)(1996-5#1)(2008-10#5)(2008-2#2)(2008-3#2)
to the determination of Captopril##3##5##(2008-10#3)
to the determination of Cr(III) and Cr(VI) in##2##8##(2008-10#2)
to the determination of Cr(III) and##3##6##(2008-10#3)
to the determination of Fe and##2##6##(2008-10#1)(2013-8#1)
to the determination of Pb and Zn in tapwater and human hair##2##12##(2008-10#2)
to the determination of Se(IV)##2##5##(2008-10#2)
to the determination of ammonia in##2##6##(2008-10#2)
to the determination of ammonium##2##5##(2008-10#2)
to the determination of benzoyl peroxide in wheat flour##2##9##(2008-10#2)
to the determination of chromium in##4##6##(2008-10#4)
to the determination of chromium##5##5##(2008-10#5)
to the determination of dopamine in##3##6##(2008-10#2)(2010-5#1)
to the determination of free##3##5##(1990-1#1)(2008-10#2)
to the determination of glucose in##4##6##(2008-10#3)(2010-5#1)
to the determination of iodate and##2##6##(2008-10#2)
to the determination of iron in##4##6##(2008-10#4)
to the determination of iron##5##5##(2008-10#5)
to the determination of low##4##5##(2008-10#3)(2008-2#1)
to the determination of manganese in##2##6##(2008-10#2)
to the determination of nitrite in##4##6##(2008-10#4)
to the determination of palladium in##2##6##(2008-10#2)
to the determination of perchlorate in##2##6##(2008-10#2)
to the determination of perchlorate##3##5##(2007-8#1)(2008-10#2)
to the determination of protein##2##5##(1991-11#1)(2008-10#1)
to the determination of sodium##2##5##(2008-10#2)
to the determination of sulfide in##3##6##(2008-10#3)
to the determination of sulfide##4##5##(2007-8#1)(2008-10#3)
to the determination of the##24##5##(1995-4#1)(2005-4#1)(2008-10#18)(2008-2#1)(2009-8#1)(2010-12#1)(2011-1#1)
to the determination of these compounds in##5##7##(2008-10#5)
to the determination of these##17##5##(2007-8#1)(2008-10#16)
to the determination of this##2##5##(1992-11#1)(2008-10#1)
to the determination of trace amount of##4##7##(2008-10#4)
to the determination of trace amounts of##7##7##(2005-4#1)(2008-10#6)
to the determination of trace##32##5##(2005-4#3)(2008-10#29)
to the determination of vanadium in##6##6##(2008-10#6)
to the determination of zinc##2##5##(2008-10#2)
to the determination of##412##4##(1990-1#1)(1990-8#3)(1990-9#1)(1991-11#1)(1991-9#1)(1992-1#1)(1992-11#1)(1994-8#1)(1994-9#2)(1995-4#1)(1996-5#2)(1997-2#1)(2005-4#6)(2007-11#1)(2007-8#9)(2007-9#1)(2008-10#363)(2008-2#2)(2008-3#5)(2008-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-5#2)(2011-1#1)(2012-4#1)(2013-8#1)
to the determination##420##3##(1990-1#1)(1990-8#3)(1990-9#1)(1991-11#1)(1991-9#1)(1992-1#1)(1992-11#1)(1994-8#1)(1994-9#2)(1995-4#1)(1996-5#2)(1997-2#1)(2005-4#6)(2007-11#1)(2007-8#9)(2007-9#1)(2008-10#371)(2008-2#2)(2008-3#5)(2008-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-5#2)(2011-1#1)(2012-4#1)(2013-8#1)
to the determined##2##3##(1994-8#1)(2010-12#1)
to the detriment of##3##4##(2007-11#1)(2008-12#1)(2012-12#1)
to the developing##8##3##(1995-6#1)(2005-8#1)(2006-11#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#1)(2012-1#1)
to the development and evaluation of##2##6##(2006-5#1)(2008-11#1)
to the development and evolution of##2##6##(1993-4#1)(2007-9#1)
to the development and maintenance of##2##6##(2008-12#1)(2008-4#1)
to the development and progression of##5##6##(2008-10#1)(2011-2#2)(2012-12#1)(2013-1#1)
to the development and use of##2##6##(1995-8#1)(2005-7#1)
to the development and##25##4##(1992-12#1)(1992-2#1)(1993-4#1)(1995-8#1)(1996-9#1)(1997-4#1)(1997-5#1)(2005-7#1)(2006-5#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-8#2)(2009-8#2)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)
to the development of Wilms' tumor##2##6##(1990-6#2)
to the development of a new##5##6##(1992-6#1)(2006-10#1)(2006-4#1)(2008-10#1)(2012-3#1)
to the development of a##32##5##(1991-9#1)(1992-3#1)(1992-6#1)(1994-12#1)(1995-1#1)(1996-1#1)(1997-6#2)(2005-5#1)(2005-8#1)(2006-10#2)(2006-4#1)(2008-10#8)(2008-3#1)(2008-4#1)(2009-11#1)(2010-7#1)(2011-2#3)(2012-12#2)(2012-3#2)
to the development of alternative##2##5##(1994-12#1)(2007-8#1)
to the development of an##5##5##(1995-12#1)(2006-8#1)(2008-3#1)(2010-7#1)(2011-2#1)
to the development of atherosclerosis##2##5##(1991-11#1)(2008-1#1)
to the development of cardiovascular disease##3##6##(1996-9#1)(1997-8#1)(2008-1#1)
to the development of central##2##5##(1991-11#1)(2008-9#1)
to the development of chronic##2##5##(2006-10#1)(2013-1#1)
to the development of clinical##2##5##(2010-5#1)(2011-2#1)
to the development of diabetic##4##5##(1996-12#1)(2008-1#2)(2012-2#1)
to the development of diseases##2##5##(1992-12#1)(2008-7#1)
to the development of drug resistance##2##6##(1997-6#1)(2007-11#1)
to the development of emphysema##2##5##(1994-11#1)(2006-9#1)
to the development of gene therapy##2##6##(2005-7#1)(2008-11#1)
to the development of highly##2##5##(2009-11#1)(2010-7#1)
to the development of human##2##5##(1994-5#1)(1994-6#1)
to the development of hypertension in##2##6##(1997-6#1)(2006-1#1)
to the development of hypertension##3##5##(1997-6#2)(2006-1#1)
to the development of improved##2##5##(2005-7#1)(2011-2#1)
to the development of insulin resistance##5##6##(2008-3#1)(2008-9#1)(2012-2#2)(2012-5#1)
to the development of limb ischaemia##2##6##(2007-9#2)
to the development of medical##2##5##(1993-2#1)(2010-8#1)
to the development of new strategies##2##6##(2010-5#1)(2011-10#1)
to the development of new therapeutic##2##6##(2005-11#1)(2007-11#1)
to the development of new##11##5##(2005-11#1)(2007-11#1)(2008-2#1)(2008-7#1)(2009-4#1)(2010-12#2)(2010-5#1)(2011-1#2)(2011-10#1)
to the development of novel therapeutic##3##6##(2008-1#1)(2008-6#1)(2012-12#1)
to the development of novel##10##5##(2005-7#1)(2006-10#1)(2006-11#1)(2008-1#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-8#1)(2012-12#1)
to the development of nursing##2##5##(1997-7#1)(2008-12#1)
to the development of premature##2##5##(1997-2#1)(2008-1#1)
to the development of resistance##3##5##(1994-8#1)(2006-11#1)(2011-3#1)
to the development of restrictive lung function##2##7##(1991-12#2)
to the development of several##2##5##(2008-1#1)(2008-5#1)
to the development of specific##5##5##(1994-1#1)(2008-10#1)(2008-3#1)(2012-11#1)(2012-2#1)
to the development of synthetic##2##5##(2008-7#1)(2009-3#1)
to the development of the disease##2##6##(1997-3#1)(2010-9#1)
to the development of the first##2##6##(2006-6#1)(2011-12#1)
to the development of the##25##5##(1993-11#1)(1994-2#1)(1997-3#1)(1997-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2009-12#1)(2009-4#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#1)(2013-8#2)
to the development of these##2##5##(2008-5#1)(2013-8#1)
to the development of this type of##2##7##(1997-8#1)(2011-2#1)
to the development of this##6##5##(1995-9#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-5#1)(2011-2#1)
to the development of##325##4##(1990-4#2)(1990-6#2)(1991-11#2)(1991-12#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#3)(1993-4#1)(1993-5#1)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-9#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#2)(1997-6#5)(1997-7#1)(1997-8#3)(2005-10#1)(2005-11#1)(2005-12#1)(2005-5#1)(2005-7#4)(2005-8#3)(2006-1#1)(2006-10#9)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#3)(2006-6#4)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#9)(2007-12#4)(2007-2#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#3)(2007-9#3)(2008-1#12)(2008-10#15)(2008-11#9)(2008-12#7)(2008-2#3)(2008-3#8)(2008-4#6)(2008-5#8)(2008-6#3)(2008-7#7)(2008-8#2)(2008-9#5)(2009-11#4)(2009-12#1)(2009-2#1)(2009-3#5)(2009-4#3)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#3)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#3)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#6)(2011-10#1)(2011-12#2)(2011-2#20)(2011-3#2)(2012-1#1)(2012-11#2)(2012-12#8)(2012-2#7)(2012-3#4)(2012-4#1)(2012-5#1)(2013-1#3)(2013-7#1)(2013-8#6)
to the development##355##3##(1990-4#2)(1990-6#2)(1991-11#2)(1991-12#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#3)(1993-4#2)(1993-5#1)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#5)(1997-7#1)(1997-8#3)(2005-10#1)(2005-11#1)(2005-12#1)(2005-5#2)(2005-7#5)(2005-8#3)(2006-1#1)(2006-10#9)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#4)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#10)(2007-12#4)(2007-2#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#3)(2007-9#4)(2008-1#12)(2008-10#18)(2008-11#10)(2008-12#9)(2008-2#3)(2008-3#8)(2008-4#7)(2008-5#8)(2008-6#3)(2008-7#7)(2008-8#4)(2008-9#6)(2009-11#4)(2009-12#1)(2009-2#1)(2009-3#5)(2009-4#3)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#3)(2010-1#3)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#3)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#6)(2011-10#1)(2011-12#2)(2011-2#22)(2011-3#2)(2012-1#1)(2012-11#2)(2012-12#9)(2012-2#7)(2012-3#4)(2012-4#1)(2012-5#1)(2013-1#5)(2013-7#2)(2013-8#6)
to the developmental stage of##2##5##(2008-10#1)(2008-9#1)
to the developmental stage##4##4##(1996-11#1)(2008-10#1)(2008-6#1)(2008-9#1)
to the developmental##5##3##(1995-2#1)(1996-11#1)(2008-10#1)(2008-6#1)(2008-9#1)
to the developmentally##2##3##(1995-1#1)(2008-12#1)
to the device##9##3##(2007-11#1)(2007-8#1)(2008-11#3)(2008-2#1)(2008-3#1)(2010-8#1)(2012-1#1)
to the diabetes##2##3##(1992-5#1)(2008-1#1)
to the diabetic##2##3##(2008-1#1)(2011-2#1)
to the diagnosis and management of##4##6##(2006-9#1)(2008-4#1)(2008-7#1)(2011-2#1)
to the diagnosis and treatment of##9##6##(1992-5#1)(1993-5#1)(2006-2#1)(2008-1#1)(2010-11#1)(2010-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
to the diagnosis and##18##4##(1992-5#2)(1992-8#1)(1993-5#1)(2006-10#2)(2006-2#1)(2006-9#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
to the diagnosis of a##2##5##(2007-7#1)(2009-9#1)
to the diagnosis of chronic##2##5##(1992-5#1)(1994-7#1)
to the diagnosis of the##3##5##(2006-9#1)(2007-7#1)(2008-2#1)
to the diagnosis of this##2##5##(2007-9#1)(2009-9#1)
to the diagnosis of##32##4##(1990-3#1)(1990-6#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-5#1)(1993-1#1)(1994-7#1)(1995-9#1)(1996-2#1)(1996-3#1)(1997-7#1)(2006-10#2)(2006-8#1)(2006-9#1)(2007-12#2)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-3#1)(2009-9#3)(2011-1#1)(2013-1#1)
to the diagnosis##61##3##(1990-3#1)(1990-6#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-5#3)(1992-8#1)(1993-1#1)(1993-5#1)(1993-7#1)(1994-7#1)(1995-9#1)(1996-2#1)(1996-3#2)(1997-7#1)(2006-10#4)(2006-2#1)(2006-8#2)(2006-9#2)(2007-10#1)(2007-12#3)(2007-7#3)(2007-9#1)(2008-1#2)(2008-10#2)(2008-2#2)(2008-4#1)(2008-6#2)(2008-7#1)(2009-2#1)(2009-3#1)(2009-9#3)(2010-11#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#2)
to the diagnosis-related##2##3##(1991-3#1)(1993-1#1)
to the diagnostic armamentarium##2##4##(1996-1#1)(2007-8#1)
to the diagnostic##5##3##(1996-1#1)(2007-8#1)(2009-4#1)(2012-2#1)(2013-1#1)
to the diagonal##2##3##(1997-7#1)(2008-12#1)
to the diaphragm and##2##4##(1990-2#1)(2010-9#1)
to the diet of##4##4##(1994-8#1)(2004-11#1)(2008-5#1)(2012-2#1)
to the diet##12##3##(1991-2#1)(1991-6#1)(1993-9#1)(1994-8#1)(1994-9#1)(2004-11#1)(2005-10#1)(2007-2#1)(2007-3#1)(2008-12#1)(2008-5#1)(2012-2#1)
to the difference between the##2##5##(2008-3#1)(2011-1#1)
to the difference between##3##4##(2008-3#1)(2011-1#1)(2011-2#1)
to the difference in the##7##5##(1990-8#1)(1995-3#1)(2004-11#1)(2008-10#1)(2008-5#1)(2008-9#1)(2012-11#1)
to the difference in##16##4##(1990-8#1)(1993-12#1)(1994-6#1)(1995-3#1)(1997-6#1)(2004-11#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2012-11#1)(2012-2#1)(2012-3#1)
to the difference##26##3##(1990-8#2)(1993-12#1)(1994-6#1)(1995-3#1)(1996-7#1)(1997-6#1)(2004-11#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#2)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#5)(2012-3#1)
to the differences between##3##4##(1995-12#1)(2008-2#1)(2010-8#1)
to the differences in the##3##5##(1994-3#1)(2008-10#1)(2009-11#1)
to the differences in##8##4##(1994-3#1)(2005-11#1)(2005-12#1)(2006-10#1)(2008-10#1)(2008-4#1)(2009-11#1)(2009-12#1)
to the differences##12##3##(1994-3#1)(1995-12#1)(1997-2#1)(2005-11#1)(2005-12#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-11#1)(2009-12#1)(2010-8#1)
to the different sizes of the##2##6##(2005-11#1)(2008-10#1)
to the different types##2##4##(1991-9#1)(1997-2#1)
to the different##49##3##(1990-3#1)(1990-7#1)(1991-3#1)(1991-9#1)(1992-3#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-9#2)(1996-4#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-7#2)(2005-11#2)(2005-7#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-2#1)(2010-8#1)(2011-12#1)(2012-12#2)(2013-8#1)
to the differential diagnosis of##3##5##(1992-2#1)(2006-8#1)(2011-2#1)
to the differential diagnosis##7##4##(1992-2#1)(2006-8#1)(2008-9#1)(2010-12#1)(2011-2#2)(2012-2#1)
to the differential##16##3##(1991-2#1)(1992-2#1)(1992-3#1)(1993-11#1)(1995-5#1)(1996-6#1)(2006-8#1)(2007-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)
to the differentiation of##3##4##(1995-8#1)(2008-10#1)(2013-7#1)
to the differentiation##6##3##(1995-8#1)(1996-3#1)(2007-12#1)(2008-10#2)(2013-7#1)
to the differing##5##3##(1996-2#1)(2006-11#1)(2008-10#1)(2008-2#1)(2011-2#1)
to the difficulties in##3##4##(2007-6#1)(2012-11#1)(2013-8#1)
to the difficulties of##2##4##(2008-2#1)(2012-3#1)
to the difficulties##9##3##(1995-1#1)(2007-12#1)(2007-6#1)(2008-11#1)(2008-2#1)(2009-9#1)(2012-11#1)(2012-3#1)(2013-8#1)
to the difficulty in obtaining##2##5##(2008-10#1)(2008-9#1)
to the difficulty in##7##4##(1996-6#1)(2005-10#1)(2007-7#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-2#1)
to the difficulty of##3##4##(2006-2#1)(2008-11#1)(2008-8#1)
to the difficulty##12##3##(1996-6#1)(2005-10#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-2#1)
to the diffraction limit##5##4##(2007-11#1)(2007-12#2)(2008-3#2)
to the diffuse##2##3##(2008-3#1)(2012-12#1)
to the diffusion of##3##4##(1993-8#1)(2006-12#1)(2012-2#1)
to the diffusion##7##3##(1993-8#1)(2006-12#1)(2008-2#1)(2008-3#3)(2012-2#1)
to the digital##2##3##(2008-10#1)(2008-7#1)
to the digits##2##3##(2008-6#2)
to the dihydropyridine##2##3##(1991-7#1)(1996-5#1)
to the dimension##2##3##(1993-5#1)(2009-9#1)
to the dimer##3##3##(1990-4#1)(1990-9#1)(1993-4#1)
to the dimethyl sulfonium ion##2##5##(1994-8#2)
to the dimethyl##3##3##(1994-8#2)(2007-10#1)
to the diminished##2##3##(1990-11#1)(1990-3#1)
to the dipole##3##3##(1993-3#1)(2006-12#1)(2007-12#1)
to the direct action##2##4##(1991-12#1)(1991-7#1)
to the direct analysis of##2##5##(2008-10#1)(2008-7#1)
to the direct determination of##13##5##(1992-4#1)(2005-4#1)(2007-8#1)(2008-10#9)(2008-2#1)
to the direct determination##15##4##(1992-4#1)(2005-4#1)(2007-8#1)(2008-10#11)(2008-2#1)
to the direct##39##3##(1991-12#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-4#1)(1995-1#1)(2005-4#1)(2006-12#1)(2007-8#1)(2008-10#15)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-4#1)(2011-1#1)(2013-1#3)
to the direction of the##4##5##(1993-12#1)(1994-2#1)(1996-6#1)(2008-3#1)
to the direction of##12##4##(1993-12#1)(1993-5#1)(1994-2#1)(1996-6#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2013-8#1)
to the direction##14##3##(1993-12#1)(1993-5#1)(1994-2#1)(1996-6#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2013-8#1)
to the directional##2##3##(2009-8#1)(2009-9#1)
to the directive 93/42 EEC##2##5##(2006-6#2)
to the disabled##2##3##(1997-2#1)(2009-6#1)
to the disadvantages##2##3##(1994-3#1)(2009-6#1)
to the disappearance of##3##4##(1990-3#1)(1992-6#1)(1995-3#1)
to the disc##5##3##(1996-6#1)(2006-7#2)(2006-8#1)(2008-5#1)
to the discipline of##2##4##(1991-3#1)(2008-10#1)
to the disclosure##2##3##(2005-8#1)(2013-1#1)
to the discovery and##4##4##(1997-4#1)(2005-4#1)(2008-7#1)(2010-8#1)
to the discovery of a##7##5##(1994-11#1)(1996-11#1)(2005-8#1)(2008-4#2)(2012-2#2)
to the discovery of the##5##5##(2008-11#1)(2010-7#1)(2011-1#1)(2011-3#1)(2013-8#1)
to the discovery of##30##4##(1994-11#1)(1995-8#1)(1996-11#1)(1997-4#1)(2004-12#1)(2005-8#1)(2006-12#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#1)(2010-12#2)(2010-3#2)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#3)(2013-8#1)
to the discovery##38##3##(1994-11#1)(1995-8#1)(1996-11#1)(1997-4#2)(2004-12#1)(2005-4#1)(2005-8#1)(2006-12#1)(2006-6#1)(2008-11#1)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#1)(2010-12#2)(2010-3#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
to the discussion of the##2##5##(1994-3#1)(2008-10#1)
to the discussion of##6##4##(1993-3#1)(1994-3#1)(2005-8#1)(2007-12#1)(2008-10#1)(2011-2#1)
to the discussion##9##3##(1993-3#1)(1994-3#1)(1994-4#1)(2005-8#1)(2007-12#1)(2008-10#1)(2009-4#1)(2011-2#2)
to the disease and##3##4##(1996-3#1)(2008-10#1)(2008-6#1)
to the disease process##2##4##(1991-9#1)(1997-8#1)
to the disease##35##3##(1990-6#1)(1991-2#1)(1991-9#1)(1993-1#1)(1995-7#1)(1996-3#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-10#8)(2008-12#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-3#1)(2010-7#1)(2012-2#1)(2012-3#1)
to the dish##2##3##(2008-11#2)
to the disorder##6##3##(1991-12#1)(2008-10#1)(2010-11#1)(2012-12#1)(2012-2#1)(2013-8#1)
to the dispersion##3##3##(2007-12#1)(2008-1#1)(2011-2#1)
to the display of##2##4##(1993-6#1)(1994-12#1)
to the disposal of##2##4##(1991-4#1)(2009-10#1)
to the disruption of the##4##5##(1992-5#1)(1994-3#1)(2007-11#1)(2007-12#1)
to the dissection##2##3##(1990-7#1)(2012-1#1)
to the dissociation of##3##4##(1992-3#1)(1993-3#1)(1995-6#1)
to the dissociation##5##3##(1992-3#1)(1993-3#1)(1993-8#1)(1995-6#1)(2006-4#1)
to the dissolution##2##3##(2008-10#1)(2011-2#1)
to the distal end of the##2##6##(2008-10#1)(2008-5#1)
to the distal end of##4##5##(1997-1#1)(2008-10#1)(2008-5#1)(2008-8#1)
to the distal end##5##4##(1997-1#1)(2008-10#1)(2008-5#2)(2008-8#1)
to the distal femur##2##4##(2006-11#1)(2008-2#1)
to the distal part of the##2##6##(2009-4#1)(2011-2#1)
to the distal##22##3##(1990-4#1)(1992-9#1)(1997-1#2)(2005-8#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
to the distance between the##2##5##(2007-4#1)(2008-2#1)
to the distance between##4##4##(2007-4#1)(2008-10#2)(2008-2#1)
to the distance##5##3##(2007-4#1)(2008-10#2)(2008-2#1)(2008-3#1)
to the distant##4##3##(1992-8#1)(1997-1#1)(2007-12#1)(2009-2#1)
to the distinct##5##3##(1994-2#1)(1996-2#1)(1997-4#1)(2008-10#1)(2009-8#1)
to the distinction between##2##4##(1997-3#1)(2012-12#1)
to the distinction##3##3##(1997-3#1)(1997-5#1)(2012-12#1)
to the distribution of##7##4##(1990-12#1)(1990-7#1)(1991-6#1)(1995-4#1)(1996-1#1)(2010-11#1)(2010-6#1)
to the distribution pattern of##2##5##(2007-1#1)(2008-5#1)
to the distribution##13##3##(1990-12#1)(1990-7#1)(1991-6#1)(1992-3#1)(1992-9#1)(1995-4#1)(1996-1#1)(1997-2#1)(2006-5#1)(2007-1#1)(2008-5#1)(2010-11#1)(2010-6#1)
to the disulfide##2##3##(1992-1#1)(1996-7#1)
to the divalent##2##3##(1996-7#1)(2008-10#1)
to the diverse range of##2##5##(2010-5#1)(2011-3#1)
to the diverse##6##3##(1995-12#1)(2008-10#1)(2010-5#2)(2011-3#1)(2012-12#1)
to the diversity of##5##4##(2008-10#3)(2009-5#1)(2012-12#1)
to the diversity##7##3##(2008-1#1)(2008-10#4)(2009-5#1)(2012-12#1)
to the division of##2##4##(2005-11#1)(2009-10#1)
to the doctor's role##2##4##(1992-6#2)
to the doctors##4##3##(1990-5#1)(1992-6#1)(1997-4#1)(1997-6#1)
to the domain of##2##4##(2007-12#1)(2007-5#1)
to the domains of##2##4##(1994-11#1)(2008-8#1)
to the dominant##2##3##(2008-7#1)(2010-6#1)
to the donor##9##3##(1992-3#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-10#1)(2011-2#1)(2011-3#1)
to the dopamine transporter##2##4##(1994-12#1)(1994-9#1)
to the dopamine##5##3##(1994-12#1)(1994-9#1)(1995-11#1)(1996-12#1)(1996-2#1)
to the dopaminergic##3##3##(1990-2#1)(1991-3#1)(1996-10#1)
to the dorsal horn##3##4##(1996-7#1)(2006-12#2)
to the dorsal nucleus of the lateral lemniscus##2##8##(1996-9#1)(1997-3#1)
to the dorsal premotor cortex##3##5##(1995-12#3)
to the dorsal premotor##4##4##(1995-12#3)(1995-5#1)
to the dorsal protocerebrum##2##4##(2007-12#2)
to the dorsal root ganglion##5##5##(1993-4#1)(1996-3#1)(1996-7#1)(2006-12#2)
to the dorsal surface of the##2##6##(1997-5#1)(2008-4#1)
to the dorsal##28##3##(1990-11#1)(1991-3#1)(1991-5#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-8#1)(1995-12#3)(1995-5#1)(1996-3#1)(1996-7#2)(1996-9#1)(1997-3#1)(1997-5#1)(2006-12#4)(2007-12#3)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)
to the dorsolateral prefrontal cortex##2##5##(1995-1#1)(2010-7#1)
to the dosage##2##3##(2006-6#1)(2008-11#1)
to the dose at##2##4##(2010-9#2)
to the dose of##5##4##(1992-12#1)(1993-3#1)(1995-12#1)(2013-1#2)
to the dose##13##3##(1992-12#1)(1993-3#1)(1993-6#1)(1995-12#1)(2008-3#1)(2009-10#1)(2009-8#1)(2010-2#1)(2010-9#2)(2011-1#1)(2013-1#2)
to the double layer of iridophores in the##2##8##(2008-5#2)
to the double##8##3##(1992-12#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#3)
to the double-stranded##2##3##(2008-10#2)
to the downstream##6##3##(1991-5#1)(1993-3#1)(1994-2#1)(1995-1#1)(1997-3#1)(2008-9#1)
to the draining##2##3##(2008-4#1)(2008-7#1)
to the draw direction##2##4##(2010-4#2)
to the drawing##2##3##(2007-10#1)(2008-3#1)
to the drinking##2##3##(2005-10#1)(2008-10#1)
to the droplet##2##3##(2005-11#1)(2008-3#1)
to the drug and##2##4##(1990-3#1)(1995-4#1)
to the drug in##2##4##(2007-11#1)(2008-10#1)
to the drug##19##3##(1990-3#1)(1990-5#1)(1992-5#1)(1994-12#1)(1995-12#1)(1995-4#1)(1995-6#1)(2005-8#1)(2006-10#1)(2007-11#2)(2008-10#3)(2008-5#3)(2010-12#2)
to the drug's##2##3##(1991-2#1)(2004-3#1)
to the drugs##4##3##(1990-1#1)(2006-7#1)(2008-8#1)(2009-6#1)
to the dual##2##3##(1995-12#1)(2012-12#1)
to the duplex##6##3##(1991-7#1)(1992-9#1)(1995-3#1)(2008-5#3)
to the dural sleeve##3##4##(2006-11#1)(2006-12#2)
to the duration of the##3##5##(2007-12#1)(2008-10#1)(2011-2#1)
to the duration of##11##4##(1996-5#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)
to the duration##13##3##(1996-5#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-7#1)(2010-9#1)(2011-2#1)(2013-1#1)
to the dye##4##3##(1996-1#1)(2007-12#1)(2008-10#2)
to the dying##2##3##(1990-10#1)(2011-2#1)
to the dynamic nature of healthcare##2##6##(2013-1#2)
to the dynamic nature of##4##5##(2013-1#4)
to the dynamic##6##3##(2008-10#2)(2013-1#4)
to the dynamical##2##3##(2007-12#1)(2010-10#1)
to the dynamics of the##3##5##(1995-11#1)(2005-10#1)(2007-12#1)
to the dynamics of##8##4##(1995-11#1)(1996-1#1)(2005-10#1)(2006-10#1)(2007-12#1)(2008-3#1)(2008-8#1)(2008-9#1)
to the dysfunction of##2##4##(2009-6#1)(2012-2#1)
to the ear##6##3##(1996-11#1)(1996-5#1)(2006-10#1)(2008-2#1)(2008-9#2)
to the earlier##8##3##(1991-1#1)(1993-3#1)(1997-3#1)(1997-8#1)(2007-2#1)(2007-8#1)(2008-7#1)(2009-2#1)
to the early 1970s##2##4##(2006-10#1)(2007-8#1)
to the early 1980s##2##4##(2008-5#1)(2010-5#1)
to the early detection of metastatic##2##6##(1992-10#1)(1994-12#1)
to the early detection of##5##5##(1992-10#2)(1994-12#1)(1994-7#1)(2008-5#1)
to the early diagnosis##2##4##(1992-10#1)(2005-11#1)
to the early phase of##4##5##(1990-6#1)(1995-9#1)(1997-6#1)(2008-3#1)
to the early stages of##3##5##(2006-8#1)(2008-11#1)(2008-7#1)
to the early twentieth century##2##5##(2008-7#1)(2010-1#1)
to the early##37##3##(1990-6#1)(1991-12#1)(1992-10#3)(1993-6#1)(1994-12#1)(1994-6#1)(1994-7#1)(1995-11#2)(1995-6#1)(1995-9#1)(1997-3#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
to the earth (earthing)##2##4##(2008-12#1)(2009-6#1)
to the earthquake##2##3##(1996-4#2)
to the ease of##5##4##(1991-12#1)(2008-11#1)(2010-12#1)(2010-7#1)(2012-2#1)
to the east##2##3##(1992-5#1)(2007-5#1)
to the easy##3##3##(2008-4#1)(2009-2#1)(2012-12#1)
to the ecological##3##3##(2008-10#2)(2008-8#1)
to the economic##2##3##(2010-3#1)(2010-8#1)
to the ectopic##3##3##(1990-12#1)(1995-4#1)(2009-5#1)
to the edge of a##3##5##(1991-3#1)(2008-3#1)(2013-7#1)
to the edge of##5##4##(1991-3#1)(2008-2#1)(2008-3#2)(2013-7#1)
to the edge##9##3##(1991-3#1)(2007-12#1)(2008-2#2)(2008-3#2)(2008-6#1)(2013-7#2)
to the edges##2##3##(2006-10#1)(2006-6#1)
to the editor##30##3##(1995-8#1)(1995-9#1)(1996-9#1)(1997-3#1)(2006-10#2)(2007-10#1)(2007-2#1)(2007-9#1)(2008-11#3)(2008-12#8)(2008-4#1)(2008-6#1)(2008-9#2)(2010-2#1)(2011-2#1)(2013-1#4)
to the education and##2##4##(1996-6#1)(2008-8#1)
to the education of##3##4##(2008-11#1)(2008-12#1)(2010-2#1)
to the education##7##3##(1996-6#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)
to the educational##2##3##(2006-10#1)(2008-12#1)
to the effect of the##9##5##(1991-8#1)(1993-9#1)(1995-11#1)(2005-11#2)(2007-7#1)(2008-2#1)(2008-8#1)(2010-11#1)
to the effect of##33##4##(1990-3#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-9#1)(1995-1#1)(1995-11#1)(1996-5#2)(1997-4#1)(2005-11#2)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-11#1)(2012-1#1)(2013-8#1)
to the effect on##2##4##(1991-12#1)(1992-11#1)
to the effect that##3##4##(2006-3#1)(2006-6#2)
to the effect##39##3##(1990-3#2)(1990-4#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-9#1)(1995-1#1)(1995-11#1)(1996-5#2)(1997-4#1)(2005-11#2)(2006-3#1)(2006-6#2)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-11#1)(2012-1#1)(2013-8#1)
to the effective implementation of##2##5##(2008-1#1)(2008-10#1)
to the effective particle##2##4##(2005-11#1)(2008-3#1)
to the effective treatment of##2##5##(2005-10#1)(2013-7#1)
to the effective##19##3##(1990-2#1)(1991-9#1)(1993-12#1)(1995-7#1)(1997-1#1)(2005-10#1)(2005-11#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2009-4#1)(2010-8#1)(2012-3#1)(2013-7#1)
to the effectiveness of the##3##5##(1992-7#1)(2007-7#1)(2008-3#1)
to the effectiveness of##5##4##(1992-7#1)(2007-11#1)(2007-7#1)(2008-3#1)(2008-5#1)
to the effects of a##2##5##(2008-10#1)(2012-3#1)
to the effects of other##2##5##(2008-10#1)(2008-3#1)
to the effects of the##4##5##(1992-8#1)(1996-9#1)(2005-11#1)(2008-11#1)
to the effects of##53##4##(1990-3#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-8#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-7#1)(2005-11#2)(2006-10#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-5#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-2#1)(2010-9#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
to the effects##57##3##(1990-3#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-8#1)(1993-6#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-7#1)(2005-11#2)(2006-10#2)(2006-2#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-5#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-2#1)(2010-9#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
to the efficacy and##2##4##(2010-3#1)(2011-2#1)
to the efficacy of the##2##5##(2007-2#1)(2013-1#1)
to the efficacy of##7##4##(2007-11#1)(2007-2#1)(2007-6#1)(2008-5#1)(2008-7#1)(2010-8#1)(2013-1#1)
to the efficacy##12##3##(2007-11#1)(2007-2#1)(2007-6#4)(2008-5#1)(2008-7#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
to the efficiency of the##2##5##(1994-9#1)(2007-2#1)
to the efficiency of##4##4##(1994-9#1)(2007-2#1)(2008-5#1)(2012-3#1)
to the efficiency##6##3##(1994-9#1)(1997-2#1)(2007-2#1)(2008-10#1)(2008-5#1)(2012-3#1)
to the efficient##3##3##(2008-10#3)
to the egg##3##3##(1992-8#1)(2008-6#1)(2008-9#1)
to the eighth##2##3##(2007-9#1)(2008-1#1)
to the ejection##2##3##(1990-9#2)
to the elaboration of##3##4##(2005-10#1)(2008-11#1)(2008-8#1)
to the elbow##2##3##(2008-4#1)(2012-1#1)
to the elderly and##2##4##(1991-3#1)(1996-1#1)
to the elderly##13##3##(1991-3#1)(1994-1#2)(1996-1#1)(1996-5#1)(2006-7#1)(2008-2#2)(2008-5#1)(2009-7#1)(2009-9#1)(2011-2#1)(2013-1#1)
to the electric field##4##4##(1996-1#1)(2006-12#1)(2006-2#1)(2008-3#1)
to the electrochemical##4##3##(2006-12#1)(2008-10#3)
to the electrode surface##3##4##(2008-10#3)
to the electrode##8##3##(1994-2#1)(1995-6#1)(2005-11#1)(2007-11#1)(2008-10#3)(2008-3#1)
to the electron injection##2##4##(2008-10#2)
to the electron##5##3##(1995-5#1)(2008-10#3)(2011-1#1)
to the electronic##6##3##(2006-10#1)(2007-5#1)(2008-10#1)(2010-4#1)(2013-1#2)
to the electrophoretic mobility##2##4##(1991-11#1)(2008-10#1)
to the electrophoretic##3##3##(1990-3#1)(1991-11#1)(2008-10#1)
to the electrostatic interactions##2##4##(1990-12#1)(2008-10#1)
to the electrostatic##6##3##(1990-12#1)(2005-11#1)(2008-10#3)(2008-5#1)
to the elemental##2##3##(2006-10#1)(2008-10#1)
to the elements of##2##4##(1994-3#2)
to the elements##3##3##(1994-3#2)(2008-10#1)
to the elevated plus-maze##2##4##(1993-7#1)(2013-1#1)
to the elevated##5##3##(1992-4#1)(1993-7#2)(2007-10#1)(2013-1#1)
to the elevation of##4##4##(1996-4#1)(2006-4#1)(2007-9#1)(2009-7#1)
to the elevation##6##3##(1996-4#1)(2004-11#1)(2006-4#1)(2007-9#1)(2008-10#1)(2009-7#1)
to the elimination of##6##4##(1990-11#1)(1992-3#1)(1993-12#1)(1996-3#1)(2008-2#1)(2009-7#1)
to the elongation##4##3##(1992-7#2)(1994-12#2)
to the eluate##2##3##(1991-5#1)(1992-9#1)
to the elucidation of the##4##5##(1996-11#1)(2007-8#1)(2008-8#1)(2011-2#1)
to the elucidation of##8##4##(1996-11#1)(1997-8#1)(2007-8#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-4#1)(2011-2#1)
to the elution##2##3##(1990-5#1)(1992-6#1)
to the embryo##5##3##(2008-10#1)(2008-11#2)(2012-11#2)
to the emergence of a##3##5##(2006-10#1)(2008-9#1)(2009-5#1)
to the emergence of drug-resistant##3##5##(2006-11#1)(2011-3#1)(2013-1#1)
to the emergence of new##2##5##(1995-12#1)(2008-2#1)
to the emergence of##19##4##(1995-12#1)(2005-5#1)(2006-10#2)(2006-11#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-12#1)(2009-5#1)(2011-12#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
to the emergence or##2##4##(2006-10#1)(2010-4#1)
to the emergence##23##3##(1995-12#1)(2005-5#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-3#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-4#1)(2011-12#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
to the emergency department (ED)##5##5##(2007-7#2)(2008-3#1)(2010-2#1)(2012-2#1)
to the emergency department complaining of##2##6##(2007-7#1)(2011-2#1)
to the emergency department with a##3##6##(2007-10#1)(2013-1#2)
to the emergency department with##19##5##(2006-4#2)(2007-10#1)(2007-3#1)(2007-5#2)(2008-3#4)(2009-6#1)(2009-9#2)(2010-7#1)(2011-2#2)(2013-1#3)
to the emergency department##41##4##(2006-4#2)(2007-10#4)(2007-3#1)(2007-5#2)(2007-7#4)(2008-11#1)(2008-3#7)(2009-6#1)(2009-9#2)(2010-11#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)
to the emergency room with##6##5##(2007-9#1)(2008-3#1)(2009-3#2)(2010-12#1)(2013-1#1)
to the emergency room##14##4##(2005-10#1)(2007-12#3)(2007-3#1)(2007-8#2)(2007-9#1)(2008-3#1)(2009-3#2)(2010-12#1)(2013-1#2)
to the emergency service##3##4##(1996-9#1)(2007-8#1)(2011-2#1)
to the emergency##64##3##(1991-2#1)(1992-1#1)(1993-2#1)(1996-9#1)(2005-10#1)(2006-4#2)(2007-10#4)(2007-12#3)(2007-3#2)(2007-5#2)(2007-7#4)(2007-8#3)(2007-9#2)(2008-11#1)(2008-3#9)(2009-3#2)(2009-6#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#8)(2013-7#1)
to the emerging field of##3##5##(2006-2#1)(2008-4#1)(2009-5#1)
to the emerging##9##3##(2006-2#1)(2007-12#1)(2008-11#1)(2008-4#1)(2009-5#1)(2009-8#2)(2010-12#1)(2013-7#1)
to the emission of##3##4##(2007-12#1)(2008-10#1)(2012-2#1)
to the emission##8##3##(2007-12#1)(2008-10#5)(2010-7#1)(2012-2#1)
to the empirical##3##3##(1996-2#1)(2007-12#1)(2013-1#1)
to the encapsulation##2##3##(2008-10#1)(2008-5#1)
to the end of August##2##5##(2008-2#1)(2008-5#1)
to the end of the growth period##2##7##(2007-7#1)(2007-8#1)
to the end of the study##12##6##(2008-9#11)(2012-2#1)
to the end of the##28##5##(1990-10#1)(1990-9#1)(1993-9#1)(2006-9#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#12)(2009-3#1)(2011-2#1)(2012-2#1)
to the end of##41##4##(1990-10#1)(1990-9#1)(1992-12#1)(1993-9#2)(1995-1#1)(1997-1#1)(1997-5#1)(2006-9#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#12)(2009-3#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
to the end##44##3##(1990-10#1)(1990-9#1)(1992-12#1)(1993-9#2)(1995-1#1)(1997-1#1)(1997-5#1)(2006-9#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-9#12)(2009-3#1)(2009-7#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
to the endocrine##2##3##(2008-7#1)(2008-9#1)
to the endogenous##4##3##(2008-11#1)(2008-7#1)(2009-12#1)(2012-12#1)
to the endometrium##3##3##(1991-12#1)(2009-6#1)(2011-2#1)
to the endoplasmic reticulum (ER)##3##5##(1993-3#1)(1994-12#1)(2009-2#1)
to the endoplasmic reticulum##16##4##(1993-3#1)(1993-6#1)(1994-12#2)(1995-3#1)(1995-6#1)(1996-8#2)(1997-7#1)(2008-11#3)(2009-2#1)(2009-7#1)(2011-1#1)(2012-12#1)
to the endoproteinase Glu-C##2##4##(1992-7#2)
to the endothelial##4##3##(1995-12#2)(1996-8#1)(2010-10#1)
to the endothelium##3##3##(1990-12#1)(1996-2#1)(2008-5#1)
to the endothelium-dependent##2##3##(1996-12#1)(2007-9#1)
to the ends of##4##4##(1994-6#1)(1994-9#1)(1997-4#1)(2008-4#1)
to the ends##5##3##(1994-6#1)(1994-9#1)(1996-3#1)(1997-4#1)(2008-4#1)
to the energetic##4##3##(1991-9#1)(2006-12#1)(2008-10#1)(2013-1#1)
to the energy transfer##4##4##(2008-10#2)(2008-8#2)
to the energy##15##3##(1995-11#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2012-2#1)(2012-3#1)(2013-1#1)
to the enhanced##9##3##(1994-5#1)(1996-12#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-10#1)(2009-8#1)(2013-1#1)
to the enhancement of##7##4##(1990-6#1)(1992-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-9#1)
to the enhancer##3##3##(1992-10#1)(1994-8#1)(1996-10#1)
to the enormous##2##3##(2008-7#1)(2012-3#1)
to the enriched##3##3##(1992-11#1)(1993-7#1)(1997-4#1)
to the enrichment of##3##4##(1995-10#1)(2010-1#1)(2013-7#1)
to the enrichment##6##3##(1991-2#1)(1995-10#1)(2008-10#1)(2010-1#1)(2013-7#2)
to the enthalpy of##2##4##(1992-5#2)
to the entire##16##3##(1990-7#1)(1991-3#1)(1991-8#1)(1992-2#1)(1994-11#1)(1994-6#1)(2006-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#1)(2011-2#2)(2012-2#2)
to the entorhinal cortex##3##4##(1991-9#1)(1997-5#1)(1997-7#1)
to the entorhinal##5##3##(1991-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)
to the entry of the##2##5##(1997-6#1)(2005-11#1)
to the entry of##4##4##(1992-2#1)(1993-3#1)(1997-6#1)(2005-11#1)
to the entry##7##3##(1992-2#1)(1992-9#1)(1993-11#1)(1993-3#1)(1997-6#1)(2005-11#1)(2012-1#1)
to the envelope##2##3##(1992-8#1)(2007-12#1)
to the environment and##4##4##(2007-1#1)(2008-10#1)(2008-5#1)(2012-2#1)
to the environment in the##2##5##(1996-7#1)(2008-8#1)
to the environment##24##3##(1994-12#1)(1994-6#1)(1995-2#1)(1996-7#1)(2007-1#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#4)(2008-8#1)(2009-4#1)(2011-1#1)(2012-1#2)(2012-2#1)(2013-1#2)
to the environmental conditions##2##4##(2006-10#1)(2010-10#1)
to the environmental##7##3##(1991-12#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-5#1)(2010-10#1)(2010-7#1)
to the enzymatic##2##3##(1992-7#1)(1994-11#1)
to the enzyme active site##2##5##(1990-12#1)(1995-6#1)
to the enzyme and##3##4##(1993-11#1)(1995-1#1)(2008-10#1)
to the enzyme in the##3##5##(1993-6#3)
to the enzyme in##5##4##(1993-6#3)(1996-6#1)(2008-10#1)
to the enzyme purified from##2##5##(1993-8#1)(1997-8#1)
to the enzyme through##2##4##(1994-8#1)(2008-10#1)
to the enzyme with a##2##5##(1993-4#1)(1994-5#1)
to the enzyme##57##3##(1990-12#1)(1990-3#3)(1990-8#1)(1991-1#3)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-11#3)(1993-2#2)(1993-4#1)(1993-6#3)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-1#2)(1995-10#1)(1995-6#1)(1996-6#3)(1996-7#2)(1996-8#1)(1997-4#1)(1997-8#1)(2005-11#1)(2007-8#1)(2008-10#8)(2008-7#1)(2009-8#1)
to the enzyme-substrate##2##3##(1990-9#1)(1994-5#1)
to the epidemic##4##3##(1995-12#1)(2008-10#1)(2008-3#1)(2011-1#1)
to the epidemiological##2##3##(2008-3#1)(2013-1#1)
to the epidemiology of##3##4##(2006-4#1)(2008-9#1)(2011-2#1)
to the epidemiology##5##3##(2006-10#1)(2006-4#1)(2007-11#1)(2008-9#1)(2011-2#1)
to the epidermal growth factor receptor (EGFR)##2##7##(1990-9#1)(2010-5#1)
to the epidermal growth##3##4##(1990-9#1)(1991-10#1)(2010-5#1)
to the epidermal##5##3##(1990-9#1)(1991-10#1)(1994-5#1)(2007-12#1)(2010-5#1)
to the epidermis and##5##4##(2008-10#4)(2008-5#1)
to the epidermis##8##3##(2007-12#1)(2008-10#4)(2008-5#2)(2012-12#1)
to the epithelial##2##3##(1992-1#1)(1997-6#1)
to the epithelium##2##3##(2011-1#1)(2013-1#1)
to the equation##6##3##(2005-11#3)(2006-10#1)(2008-10#2)
to the equilibrium##4##3##(2005-11#1)(2008-10#2)(2008-4#1)
to the equivalent##8##3##(1994-12#1)(1995-3#2)(1995-8#1)(1997-6#1)(2004-11#1)(2008-2#1)(2010-4#1)
to the eradication##3##3##(2008-11#1)(2010-5#1)(2012-12#1)
to the erosion##2##3##(2008-1#1)(2010-4#1)
to the error##2##3##(2008-10#1)(2008-2#1)
to the erythrocyte##2##3##(1990-12#1)(2012-12#1)
to the essential##4##3##(1994-12#1)(2009-4#1)(2010-12#1)(2013-8#1)
to the established##7##3##(1990-3#1)(2005-7#1)(2007-11#2)(2008-1#1)(2008-7#1)(2012-2#1)
to the establishment of a##5##5##(1993-9#1)(2008-10#1)(2008-2#1)(2009-10#1)(2011-2#1)
to the establishment of an##2##5##(2006-10#1)(2012-12#1)
to the establishment of the##5##5##(1991-3#1)(1991-6#1)(1994-5#1)(1996-9#1)(1997-2#1)
to the establishment of##21##4##(1991-3#1)(1991-6#1)(1993-9#1)(1994-5#1)(1996-9#1)(1997-2#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-2#1)(2008-5#1)(2008-6#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
to the establishment##23##3##(1991-3#1)(1991-6#1)(1993-9#1)(1994-12#1)(1994-5#1)(1996-9#1)(1997-2#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-2#1)(2008-5#1)(2008-6#1)(2009-10#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
to the estimated##4##3##(1992-3#1)(1994-2#1)(1995-12#1)(1995-3#1)
to the estimation##2##3##(1997-3#1)(2008-7#1)
to the estrogen receptor##3##4##(2008-11#3)
to the estrogen##5##3##(1992-6#1)(2008-11#4)
to the estrogenic##2##3##(1990-8#1)(2010-5#1)
to the ethical##4##3##(1994-12#1)(2006-1#1)(2007-12#1)(2008-2#1)
to the ethics of##2##4##(1991-3#1)(2005-11#1)
to the ethnic##2##3##(2008-3#1)(2010-8#1)
to the etiology and##2##4##(2008-11#1)(2011-1#1)
to the etiology of##3##4##(1996-1#1)(2007-7#1)(2009-4#1)
to the etiology##8##3##(1990-6#1)(1996-1#1)(2006-12#1)(2007-7#1)(2008-11#1)(2008-5#1)(2009-4#1)(2011-1#1)
to the eukaryotic##3##3##(1991-4#1)(1993-11#1)(1995-8#1)
to the evaluation and management of##2##6##(2006-5#1)(2006-9#1)
to the evaluation and##4##4##(2006-5#1)(2006-9#1)(2009-3#1)(2012-3#1)
to the evaluation of the##3##5##(1996-12#1)(2007-9#1)(2013-1#1)
to the evaluation of##15##4##(1991-12#1)(1993-12#1)(1995-2#1)(1996-12#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-5#1)(2013-1#1)
to the evaluation##20##3##(1991-12#1)(1993-12#1)(1995-2#1)(1996-12#1)(2006-10#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-3#1)(2012-3#1)(2013-1#1)
to the event##2##3##(2008-2#2)
to the evidence##4##3##(1995-12#1)(2008-4#1)(2008-8#1)(2011-2#1)
to the evolution of new traits##2##6##(2010-4#2)
to the evolution of the##4##5##(1993-8#1)(2008-4#1)(2012-12#1)(2012-3#1)
to the evolution of##25##4##(1993-8#1)(2006-12#1)(2007-10#1)(2007-12#1)(2008-3#1)(2008-4#2)(2008-8#6)(2009-3#1)(2010-4#2)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#1)
to the evolutionary##4##3##(1994-12#1)(2008-6#1)(2009-6#1)(2013-1#1)
to the evolving##4##3##(1997-2#1)(2008-12#1)(2009-9#1)(2010-7#1)
to the exact solutions##2##4##(1992-9#1)(2008-3#1)
to the exact##9##3##(1990-8#1)(1992-6#1)(1992-9#1)(1994-12#1)(2007-11#1)(2007-5#1)(2008-2#1)(2008-3#1)(2009-12#1)
to the exaggerated##2##3##(1993-3#1)(2005-10#1)
to the examination of##3##4##(2008-3#1)(2011-12#1)(2012-12#1)
to the examination##5##3##(2004-2#1)(2006-6#1)(2008-3#1)(2011-12#1)(2012-12#1)
to the examiner's##2##3##(2008-12#1)(2008-9#1)
to the excellent##3##3##(2008-10#1)(2008-2#1)(2008-7#1)
to the excessive##2##3##(1992-10#1)(2008-11#1)
to the exchange of knowledge##2##5##(2008-9#1)(2013-1#1)
to the exchange of##5##4##(1990-2#1)(2008-10#1)(2008-9#2)(2013-1#1)
to the exchange##6##3##(1990-2#1)(1997-7#1)(2008-10#1)(2008-9#2)(2013-1#1)
to the excited##2##3##(2006-10#1)(2007-12#1)
to the exclusion of##6##4##(1995-11#1)(2008-10#1)(2008-9#1)(2009-10#1)(2009-4#1)(2013-7#1)
to the executive suite##2##4##(2008-1#2)
to the executive##3##3##(2008-1#2)(2008-8#1)
to the existence of##18##4##(1992-12#1)(1993-9#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-2#1)(2005-11#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-8#1)(2013-1#1)
to the existing##16##3##(1994-1#1)(1994-7#1)(1996-1#2)(1996-11#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#3)(2008-8#1)(2010-6#1)(2010-7#1)(2011-1#1)
to the exon##4##3##(1990-12#1)(1991-9#1)(1993-12#1)(1994-12#1)
to the expectation that##2##4##(2006-7#1)(2012-12#1)
to the expectations of##2##4##(2007-3#1)(2008-9#1)
to the expected##21##3##(1990-12#1)(1990-8#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-7#1)(1993-8#1)(1994-12#1)(1994-5#2)(1997-6#1)(1997-7#1)(2005-9#1)(2006-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2012-2#1)
to the experience of##6##4##(1993-6#1)(2006-3#1)(2008-12#1)(2010-5#1)(2012-11#1)(2012-3#1)
to the experiences of men##2##5##(2009-5#2)
to the experiment##4##3##(1996-10#1)(2006-4#1)(2007-12#1)(2007-8#1)
to the experimental data##3##4##(2005-11#1)(2006-11#1)(2008-7#1)
to the experimental results##2##4##(2005-11#1)(2008-2#1)
to the experimental##17##3##(1995-3#1)(1995-7#1)(2005-11#2)(2006-10#1)(2006-11#1)(2007-2#1)(2008-11#2)(2008-2#3)(2008-3#3)(2008-7#2)
to the experts##2##3##(1996-2#1)(1996-3#1)
to the explicit##2##3##(2008-7#1)(2012-12#1)
to the exploration of the##2##5##(1994-2#1)(2010-8#1)
to the exponential phase##2##4##(1997-2#1)(2011-2#1)
to the exponential##8##3##(1993-12#1)(1997-2#1)(2005-11#1)(2008-6#2)(2009-11#1)(2010-4#1)(2011-2#1)
to the exposed##2##3##(2005-7#1)(2006-12#1)
to the exposure of##2##4##(1995-6#1)(2006-10#1)
to the exposure##5##3##(1991-12#1)(1994-6#1)(1995-6#1)(2006-10#1)(2011-2#1)
to the expression of a##5##5##(1991-11#1)(1991-3#1)(1992-6#1)(1995-11#1)(1996-2#1)
to the expression of##22##4##(1991-11#1)(1991-3#1)(1992-3#1)(1992-5#1)(1992-6#1)(1994-5#1)(1994-9#1)(1995-11#1)(1996-12#1)(1996-2#1)(1997-5#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#2)(2012-3#1)
to the expression##29##3##(1991-11#1)(1991-3#1)(1992-3#1)(1992-5#1)(1992-6#2)(1994-5#1)(1994-9#1)(1995-11#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#2)(2012-3#1)
to the extended##3##3##(1991-3#1)(1997-7#1)(2007-11#1)
to the extension of the##3##5##(2008-10#1)(2010-5#1)(2013-7#1)
to the extension of##4##4##(2007-11#1)(2008-10#1)(2010-5#1)(2013-7#1)
to the extensive##4##3##(2007-8#1)(2008-8#1)(2012-2#1)(2012-3#1)
to the extent of the##4##5##(1994-6#1)(2008-10#1)(2008-3#1)(2008-8#1)
to the extent of their##2##5##(2008-10#1)(2010-8#1)
to the extent of##21##4##(1991-2#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-6#1)(1992-9#1)(1994-6#1)(1996-1#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-8#1)
to the extent possible##2##4##(1995-1#1)(1997-5#1)
to the extent that it##3##5##(2008-6#1)(2009-7#1)(2012-11#1)
to the extent that the##4##5##(1991-4#1)(2005-9#1)(2007-10#1)(2007-6#1)
to the extent that##15##4##(1990-4#1)(1991-10#1)(1991-4#1)(1993-1#1)(2005-9#1)(2006-2#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-10#1)(2009-7#1)(2012-11#1)
to the extent to which##2##5##(1992-3#1)(2006-1#1)
to the extent##44##3##(1990-4#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-7#2)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1994-6#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-5#1)(2005-7#2)(2005-9#1)(2006-1#1)(2006-2#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-7#1)(2010-8#1)(2012-11#1)
to the external environment##4##4##(1995-3#2)(1995-5#1)(2008-5#1)
to the external##21##3##(1990-3#1)(1990-8#1)(1991-5#1)(1994-11#1)(1995-3#2)(1995-5#1)(1996-2#1)(1996-8#1)(2007-12#2)(2008-10#1)(2008-11#3)(2008-2#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-12#1)
to the extracellular domain of the##2##6##(1997-2#1)(2008-4#1)
to the extracellular domain of##4##5##(1994-9#1)(1996-5#1)(1997-2#1)(2008-4#1)
to the extracellular domain##6##4##(1993-8#1)(1994-9#1)(1995-5#1)(1996-5#1)(1997-2#1)(2008-4#1)
to the extracellular domains of##2##5##(1991-6#1)(1994-5#1)
to the extracellular matrix##7##4##(1993-2#1)(1996-5#1)(1997-3#1)(2007-8#1)(2008-1#1)(2011-1#1)(2012-12#1)
to the extracellular medium##2##4##(1996-2#1)(2012-11#1)
to the extracellular space##4##4##(2008-4#1)(2009-8#1)(2009-9#1)(2012-2#1)
to the extracellular##29##3##(1991-6#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-5#3)(1994-9#2)(1995-2#1)(1995-5#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-4#3)(2009-8#1)(2009-9#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#1)
to the extracorporeal##2##3##(1992-1#1)(2007-7#1)
to the extraction of##6##4##(2006-5#1)(2006-8#1)(2008-10#3)(2012-1#1)
to the extraction##19##3##(2006-5#1)(2006-8#1)(2008-10#15)(2012-1#2)
to the extreme##3##3##(1997-7#1)(2008-2#1)(2008-5#1)
to the extremely##3##3##(2008-8#1)(2008-9#1)(2010-4#1)
to the extremities##2##3##(1992-6#1)(2009-3#1)
to the eye##11##3##(1995-9#3)(2007-1#1)(2007-12#1)(2008-4#1)(2008-5#1)(2010-1#1)(2010-8#1)(2011-1#1)(2012-12#1)
to the eyes##2##3##(2006-10#1)(2009-4#1)
to the fabrication of##3##4##(2007-12#1)(2008-3#1)(2009-3#1)
to the fabrication##4##3##(2007-12#1)(2008-3#2)(2009-3#1)
to the face##6##3##(1996-2#1)(1996-5#1)(2006-4#1)(2008-2#1)(2008-3#1)(2008-5#1)
to the facial nucleus##2##4##(1993-12#1)(1996-5#1)
to the facial##6##3##(1992-4#1)(1993-12#1)(1996-5#1)(2006-11#1)(2007-11#1)(2008-9#1)
to the facilitation of##3##4##(2008-11#2)(2008-5#1)
to the facilitation##4##3##(1997-5#1)(2008-11#2)(2008-5#1)
to the fact that a##2##5##(1990-11#1)(2008-3#1)
to the fact that it is##2##6##(1994-9#1)(2008-10#1)
to the fact that it##4##5##(1994-9#1)(2008-10#1)(2008-5#1)(2012-2#1)
to the fact that most##2##5##(2008-1#1)(2008-10#1)
to the fact that some##2##5##(1992-10#1)(2007-2#1)
to the fact that the##14##5##(1990-8#1)(1991-11#1)(1991-2#1)(1992-3#1)(1994-4#1)(2006-11#1)(2006-5#1)(2007-12#2)(2008-11#2)(2008-2#1)(2010-4#1)(2012-3#1)
to the fact that these##2##5##(1990-2#1)(2009-2#1)
to the fact that they##4##5##(2007-5#1)(2011-12#1)(2012-2#1)(2012-3#1)
to the fact that this##2##5##(2007-8#1)(2008-3#1)
to the fact that##60##4##(1990-11#1)(1990-2#1)(1990-3#1)(1990-8#2)(1991-11#1)(1991-2#1)(1991-6#1)(1992-10#1)(1992-3#1)(1993-9#1)(1994-4#1)(1994-9#1)(1995-11#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-2#2)(2009-4#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-8#1)
to the fact##61##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-8#2)(1991-11#1)(1991-2#1)(1991-6#1)(1992-10#1)(1992-3#1)(1993-9#1)(1994-4#1)(1994-9#1)(1995-11#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-2#2)(2009-4#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-8#1)
to the factor##2##3##(1991-12#1)(1996-2#1)
to the factors affecting the##2##5##(1996-7#1)(2008-10#1)
to the factors influencing##2##4##(2008-2#1)(2008-4#1)
to the factors that##3##4##(2007-8#1)(2009-4#1)(2011-1#1)
to the factors##9##3##(1996-7#1)(1996-9#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-4#1)(2011-1#1)
to the facts that##2##4##(2008-10#1)(2010-7#1)
to the failure of the##2##5##(1996-2#1)(2007-11#1)
to the failure of##8##4##(1994-3#1)(1996-2#1)(2004-9#1)(2007-11#1)(2011-2#1)(2011-3#1)(2013-1#2)
to the failure##9##3##(1994-3#1)(1996-2#1)(2004-9#1)(2007-11#1)(2010-8#1)(2011-2#1)(2011-3#1)(2013-1#2)
to the familial##2##3##(2012-3#1)(2013-1#1)
to the families##5##3##(2008-10#2)(2008-5#1)(2008-6#1)(2013-8#1)
to the family of receptors##3##5##(1991-2#2)(1996-5#1)
to the family of ubiquitin-protein ligases##2##6##(1995-6#2)
to the family of##25##4##(1990-10#1)(1990-4#1)(1991-12#1)(1991-2#2)(1993-2#1)(1993-6#1)(1994-10#1)(1994-8#1)(1995-1#1)(1995-6#3)(1996-5#1)(1997-7#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-2#1)(2008-4#1)(2009-7#1)(2012-12#1)(2012-2#1)
to the family##52##3##(1990-10#1)(1990-4#1)(1990-8#1)(1991-12#1)(1991-2#2)(1993-2#1)(1993-5#1)(1993-6#1)(1994-10#1)(1994-8#1)(1995-1#1)(1995-6#3)(1996-5#1)(1997-7#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-3#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#5)(2012-12#3)(2012-2#2)(2013-7#1)(2013-8#1)
to the far field##3##4##(2007-12#3)
to the far infrared##3##4##(2008-1#1)(2008-3#2)
to the far##7##3##(2007-12#4)(2008-1#1)(2008-3#2)
to the fascia##2##3##(2008-6#1)(2009-1#1)
to the fast##7##3##(2005-10#1)(2007-3#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#1)
to the fatty##4##3##(1991-12#1)(1992-11#1)(1994-5#1)(1996-5#1)
to the favorable##2##3##(1993-9#1)(2011-2#1)
to the favourable##2##3##(1990-8#1)(2007-8#1)
to the fear of##3##4##(1994-4#1)(2006-9#1)(2011-1#1)
to the feature##13##3##(2008-2#7)(2008-3#6)
to the features##4##3##(1992-9#1)(1993-12#1)(2008-3#1)(2008-7#1)
to the federal##3##3##(1991-10#1)(2009-4#2)
to the feeding effect of##2##5##(1990-2#2)
to the female genital##2##4##(2007-12#1)(2008-7#1)
to the female##9##3##(1990-11#1)(1990-8#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-7#2)(2009-10#2)
to the femoral head##2##4##(2004-9#1)(2007-7#1)
to the femoral shaft##2##4##(2006-11#2)
to the femoral##7##3##(2004-9#1)(2006-11#2)(2007-7#1)(2008-7#1)(2011-2#2)
to the femur##2##3##(2007-1#1)(2007-4#1)
to the fetus##9##3##(1995-8#3)(2005-10#1)(2006-8#2)(2008-3#1)(2009-5#1)(2009-9#1)
to the few##2##3##(2006-10#1)(2007-3#1)
to the fiber axis##5##4##(1994-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
to the fiber expansion##2##4##(2008-10#2)
to the fiber##14##3##(1994-11#1)(2007-12#3)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#3)
to the fibers##2##3##(2007-12#1)(2008-2#1)
to the fibrinogen-recognition site##2##4##(1993-3#2)
to the field of##14##4##(1990-10#1)(1992-3#1)(2005-7#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-4#2)(2009-4#1)(2012-1#1)(2012-2#1)
to the field results##2##4##(2008-10#1)(2010-8#1)
to the field##28##3##(1990-10#1)(1992-3#1)(1992-6#1)(1993-6#1)(1996-2#2)(2005-6#1)(2005-7#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2009-4#1)(2010-1#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#2)
to the fields of##2##4##(2007-9#1)(2010-5#1)
to the fields##4##3##(2007-9#1)(2010-5#1)(2012-2#1)(2013-8#1)
to the fifth##3##3##(1996-11#1)(2007-12#1)(2008-6#1)
to the fight##2##3##(1993-12#1)(2008-10#1)
to the film##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#1)
to the filter##3##3##(1991-12#1)(2008-2#1)(2008-3#1)
to the final diagnosis of##2##5##(2008-5#1)(2010-6#1)
to the final diagnosis##3##4##(2008-5#1)(2010-6#1)(2011-2#1)
to the final outcome of##2##5##(1994-11#1)(2008-7#1)
to the final step of##2##5##(2008-12#1)(2008-4#1)
to the final##22##3##(1993-9#1)(1994-11#1)(1994-3#1)(1995-11#1)(1996-5#1)(1997-8#1)(2005-11#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2010-6#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
to the financial and##2##4##(2006-5#1)(2012-2#1)
to the financial##3##3##(1995-1#1)(2006-5#1)(2012-2#1)
to the finding of##3##4##(1996-5#1)(2007-1#1)(2010-12#1)
to the finding##6##3##(1994-8#1)(1996-5#1)(2007-1#1)(2010-12#1)(2010-7#1)(2012-2#1)
to the findings from##2##4##(1991-4#1)(2007-8#1)
to the findings in##3##4##(1991-8#1)(1996-7#1)(2010-9#1)
to the findings of##5##4##(1993-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
to the findings##13##3##(1991-4#1)(1991-8#1)(1993-5#1)(1996-7#1)(2006-6#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-9#1)(2013-8#1)
to the fine##3##3##(1993-5#1)(2007-11#1)(2012-1#1)
to the fingers and##2##4##(2008-6#1)(2012-1#1)
to the fingers##4##3##(2006-3#2)(2008-6#1)(2012-1#1)
to the finite##2##3##(2007-12#1)(2009-6#1)
to the fire##3##3##(1996-12#1)(2008-10#1)(2010-3#1)
to the firing##2##3##(1994-10#1)(2009-3#1)
to the first Stokes##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
to the first coding exon##2##5##(1990-8#2)
to the first derivative of the##2##6##(2008-10#1)(2008-2#1)
to the first issue##2##4##(1997-2#1)(2008-10#1)
to the first order##3##4##(2006-4#1)(2008-2#1)(2008-3#1)
to the first year##2##4##(1994-6#1)(2013-8#1)
to the first##80##3##(1990-12#2)(1990-8#2)(1991-12#1)(1991-6#1)(1991-7#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-5#2)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-6#2)(1997-8#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-4#1)(2006-5#1)(2007-11#4)(2007-12#4)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#3)(2008-4#2)(2008-5#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
to the first-order##2##3##(1991-4#1)(2007-12#1)
to the fish##3##3##(2008-7#2)(2009-6#1)
to the fishery##2##3##(2007-3#1)(2013-7#1)
to the fitness of##3##4##(1993-5#1)(2006-3#1)(2008-8#1)
to the five##5##3##(1990-12#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
to the fixation##2##3##(2006-8#1)(2012-3#1)
to the fixed##2##3##(1997-2#1)(2009-6#1)
to the flagellar switch protein FliM##2##6##(1994-8#2)
to the flexor##3##3##(2006-3#1)(2008-9#2)
to the floor of the##2##5##(2008-7#1)(2009-9#1)
to the floor##5##3##(1995-6#1)(2006-8#2)(2008-7#1)(2009-9#1)
to the flow cell##4##4##(2008-10#4)
to the flow of a##2##5##(1991-9#1)(2008-11#1)
to the flow of##4##4##(1991-9#1)(1997-1#1)(2008-10#1)(2008-11#1)
to the flow##15##3##(1991-9#1)(1996-10#1)(1997-1#1)(2006-12#1)(2008-10#8)(2008-11#1)(2008-4#1)(2011-2#1)
to the flow-injection determination of##2##5##(2008-10#2)
to the flower##3##3##(2006-12#1)(2008-10#1)(2011-10#1)
to the fluorescence##6##3##(1991-5#1)(1991-9#1)(1992-9#1)(1993-9#1)(2006-10#1)(2008-3#1)
to the fluorescent##2##3##(1990-9#1)(2007-8#1)
to the fluorophore##2##3##(1997-6#1)(2008-2#1)
to the fluoroquinolone class##2##4##(2006-10#1)(2008-3#1)
to the fluoroquinolone##3##3##(2006-10#1)(2007-2#1)(2008-3#1)
to the fly##2##3##(2008-10#1)(2008-11#1)
to the focal point##4##4##(2006-5#1)(2008-3#3)
to the focal region##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
to the focal##9##3##(2006-5#1)(2007-12#1)(2008-2#1)(2008-3#6)
to the focus of##2##4##(1994-3#1)(2007-9#1)
to the focus##5##3##(1994-3#1)(2007-9#1)(2008-2#1)(2011-2#1)(2012-1#1)
to the folding intermediate##2##4##(1997-4#2)
to the folding##3##3##(1995-1#1)(1997-4#2)
to the foliage##2##3##(2008-10#2)
to the follow-up under treatment or to the detection of exacerbations##2##11##(2012-11#2)
to the follow-up##3##3##(2008-11#1)(2012-11#2)
to the following clinical##2##4##(2010-6#1)(2011-2#1)
to the following conclusions##3##4##(1990-2#1)(2008-10#1)(2012-12#1)
to the following variables##2##4##(2006-6#1)(2008-3#1)
to the following##33##3##(1990-12#1)(1990-2#1)(1993-5#1)(1993-8#1)(1994-12#1)(1995-1#1)(1995-11#1)(1996-1#1)(1996-5#1)(2005-12#1)(2006-5#2)(2006-6#2)(2007-1#1)(2007-12#2)(2007-8#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
to the food supply##2##4##(2006-10#1)(2013-1#1)
to the food##8##3##(1994-2#1)(1994-3#1)(2006-10#1)(2006-4#1)(2007-3#1)(2008-10#1)(2011-2#1)(2013-1#1)
to the foot##3##3##(2007-7#1)(2009-10#2)
to the foramen ovale##2##4##(2005-9#1)(2007-8#1)
to the foramen##5##3##(2005-9#2)(2006-12#1)(2007-8#1)(2008-9#1)
to the force field##2##4##(1995-8#1)(2010-2#1)
to the force##4##3##(1995-8#1)(2010-12#1)(2010-2#1)(2012-1#1)
to the fore in##2##4##(2006-10#1)(2008-7#1)
to the fore##4##3##(2006-10#1)(2008-2#1)(2008-7#1)(2010-2#1)
to the forearm##4##3##(1996-9#1)(2007-7#1)(2008-5#1)(2009-9#1)
to the forebrain##2##3##(1993-6#1)(2007-1#1)
to the forefront in##2##4##(1992-5#1)(2007-8#1)
to the forefront of##3##4##(1994-1#1)(2006-10#2)
to the forefront##9##3##(1992-5#1)(1994-1#1)(1995-9#1)(1997-8#1)(2006-10#2)(2007-8#1)(2008-5#1)(2012-1#1)
to the foreign##3##3##(1990-3#1)(2007-9#1)(2011-2#1)
to the forest##2##3##(2008-5#1)(2013-8#1)
to the form##2##3##(1990-5#1)(2005-11#1)
to the formal##4##3##(1995-2#1)(2004-12#1)(2010-7#1)(2012-3#1)
to the formation and##7##4##(1990-3#1)(1991-7#1)(2007-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2012-2#1)
to the formation of a##25##5##(1990-3#1)(1991-9#2)(1992-12#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-7#1)(1997-2#2)(2005-11#3)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2010-2#1)(2010-3#1)(2011-1#1)
to the formation of additional##3##5##(1995-7#1)(2007-12#1)(2008-10#1)
to the formation of an##4##5##(1995-5#1)(2005-11#2)(2008-10#1)
to the formation of cross links##2##6##(1991-8#1)(1994-8#1)
to the formation of reactive##3##5##(1992-6#1)(2008-11#1)(2010-7#1)
to the formation of secondary##2##5##(1991-10#1)(2008-11#1)
to the formation of the corresponding##2##6##(2007-11#2)
to the formation of the##22##5##(1991-1#1)(1992-12#1)(1992-9#1)(1994-2#1)(1994-8#1)(1996-12#1)(1996-5#2)(1997-4#1)(1997-8#1)(2005-11#1)(2007-11#3)(2008-10#3)(2008-3#1)(2009-3#1)(2009-8#1)(2010-5#1)(2011-1#1)
to the formation of##159##4##(1990-3#1)(1990-4#2)(1990-5#1)(1991-1#1)(1991-10#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#2)(1992-6#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-2#5)(1994-3#1)(1994-8#4)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#4)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#3)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#1)(2005-11#12)(2005-7#1)(2006-10#2)(2006-11#1)(2007-11#6)(2007-12#6)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#26)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#5)(2008-7#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#7)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#2)(2013-8#1)
to the formation##168##3##(1990-3#2)(1990-4#2)(1990-5#1)(1991-1#1)(1991-10#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-12#2)(1992-6#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-2#5)(1994-3#1)(1994-8#4)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#4)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#3)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#1)(2005-11#12)(2005-7#1)(2006-10#2)(2006-11#1)(2007-1#1)(2007-11#6)(2007-12#6)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#27)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#5)(2008-7#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#7)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-2#1)(2013-8#1)
to the former compounds##2##4##(1997-4#1)(2007-11#1)
to the former##7##3##(1992-4#1)(1994-11#1)(1997-4#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#1)
to the formula##4##3##(2006-10#1)(2008-4#1)(2012-12#1)(2012-3#1)
to the formulation of##3##4##(2008-5#1)(2010-1#1)(2011-3#1)
to the formulation##4##3##(2008-5#1)(2008-8#1)(2010-1#1)(2011-3#1)
to the foundation of##2##4##(1994-1#1)(2009-2#1)
to the four categories of the QOL-ACE##2##7##(1994-12#2)
to the four##9##3##(1992-3#1)(1994-12#2)(1995-8#1)(2007-8#1)(2008-10#3)(2008-7#1)
to the fourth order##4##4##(2007-12#1)(2008-3#3)
to the fourth##10##3##(1995-3#1)(2007-12#2)(2008-10#2)(2008-3#3)(2008-9#1)(2012-2#1)
to the fraction##2##3##(1991-2#1)(2011-12#1)
to the fracture##3##3##(1991-6#1)(2006-11#1)(2009-3#1)
to the fragment##3##3##(1997-6#1)(2008-2#2)
to the framework of##2##4##(1990-8#1)(1997-6#1)
to the framework##6##3##(1990-8#1)(1997-6#1)(2008-4#2)(2012-1#1)(2012-2#1)
to the free energy difference##2##5##(2006-12#1)(2010-7#1)
to the free energy of##3##5##(1990-11#1)(1991-7#1)(1992-12#1)
to the free energy##7##4##(1990-11#1)(1991-7#1)(1992-12#1)(1994-11#1)(1995-11#1)(2006-12#1)(2010-7#1)
to the free##24##3##(1990-11#1)(1991-7#1)(1992-12#2)(1994-11#1)(1995-11#1)(1995-2#1)(1995-5#2)(1995-7#1)(1996-12#2)(1996-7#1)(2006-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-7#2)(2009-10#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-7#1)
to the frequencies of##2##4##(1991-1#1)(1997-7#1)
to the frequency of##7##4##(1991-4#1)(1991-5#1)(1994-6#1)(2006-11#1)(2008-10#2)(2009-10#1)
to the frequency##13##3##(1991-4#1)(1991-5#1)(1994-6#1)(1996-2#1)(2006-11#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-10#1)
to the frequent occurrence of##3##5##(1990-2#1)(2008-6#1)(2012-3#1)
to the frequent##7##3##(1990-2#1)(1992-10#1)(1996-12#1)(2006-10#1)(2008-6#1)(2012-3#2)
to the frequently##3##3##(1991-4#1)(1997-4#1)(2009-10#1)
to the freshly##2##3##(1997-1#1)(2011-2#1)
to the fringe##2##3##(2008-2#1)(2008-3#1)
to the frontal##3##3##(1997-5#1)(2005-11#1)(2007-4#1)
to the fruit##5##3##(2008-10#4)(2008-7#1)
to the full width##2##4##(2007-12#1)(2008-2#1)
to the full##19##3##(1990-3#1)(1991-12#1)(1992-1#1)(1993-9#1)(1995-12#2)(1996-12#1)(1996-6#1)(2007-12#2)(2008-2#1)(2008-3#2)(2008-7#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#2)
to the full-length##6##3##(1993-8#1)(1995-2#1)(1995-5#1)(1997-6#1)(2008-10#1)(2008-7#1)
to the function of the##7##5##(1991-6#1)(1994-11#1)(1996-10#1)(2008-4#1)(2008-7#1)(2010-12#1)(2012-3#1)
to the function of##14##4##(1991-6#1)(1993-6#1)(1994-11#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-8#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-12#1)(2012-3#1)
to the function##16##3##(1991-6#1)(1993-6#1)(1994-11#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-8#1)(2006-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2012-3#1)
to the functional and##2##4##(2005-7#1)(2011-2#1)
to the functional diversity of##2##5##(1992-2#1)(2008-4#1)
to the functional role of##2##5##(1994-8#1)(2011-2#1)
to the functional##18##3##(1990-12#1)(1992-2#1)(1993-12#1)(1993-6#1)(1994-5#1)(1994-6#1)(1994-8#1)(1997-4#1)(2005-7#1)(2006-6#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#3)(2012-11#2)
to the functionally##2##3##(2007-9#1)(2009-2#1)
to the functioning##2##3##(2008-7#2)
to the functions of##4##4##(1991-7#1)(1994-11#1)(2006-12#1)(2009-8#1)
to the fundamental laser##2##4##(2008-2#1)(2008-3#1)
to the fundamental understanding of##2##5##(2008-3#1)(2008-4#1)
to the fundamental understanding##3##4##(2008-3#1)(2008-4#1)(2012-3#1)
to the fundamental##16##3##(1992-6#1)(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#3)(2008-4#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
to the funding of##2##4##(1997-7#1)(2006-5#1)
to the fungal##4##3##(2008-10#3)(2010-10#1)
to the fungicide metalaxyl##2##4##(2008-10#2)
to the fungicide##6##3##(2006-5#1)(2008-10#5)
to the fungicides##8##3##(2008-10#8)
to the fungus##5##3##(2008-10#4)(2011-10#1)
to the further development of##2##5##(2005-7#1)(2010-12#1)
to the further##4##3##(2005-7#1)(2008-9#1)(2010-10#1)(2010-12#1)
to the fusion##2##3##(1991-3#1)(2008-10#1)
to the future development of##2##5##(2008-11#1)(2011-2#1)
to the future of##2##4##(2007-10#1)(2007-4#1)
to the future##28##3##(1991-1#2)(1991-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-2#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#2)(2008-10#1)(2008-11#1)(2008-3#1)(2009-12#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
to the gallbladder and the##3##5##(2007-4#3)
to the gallbladder##6##3##(2007-4#3)(2008-3#2)(2010-9#1)
to the gamma##3##3##(1990-9#1)(1992-9#1)(1994-11#1)
to the ganglioside##2##3##(1995-1#1)(1996-4#1)
to the gap between##2##4##(1991-1#1)(2013-1#1)
to the gap width between##2##5##(2005-11#1)(2007-12#1)
to the gap##4##3##(1991-1#1)(2005-11#1)(2007-12#1)(2013-1#1)
to the gas phase##3##4##(2008-10#2)(2008-7#1)
to the gas##6##3##(1991-9#1)(1995-11#1)(1996-12#1)(2008-10#2)(2008-7#1)
to the gastric##5##3##(1997-6#1)(2006-10#1)(2009-8#1)(2011-2#1)(2012-2#1)
to the gastrointestinal tract##4##4##(2007-2#1)(2008-7#1)(2013-1#2)
to the gastrointestinal##6##3##(1997-3#1)(2006-8#1)(2007-2#1)(2008-7#1)(2013-1#2)
to the gate##2##3##(2007-11#1)(2009-5#1)
to the gel phase##2##4##(2006-10#1)(2010-5#1)
to the gel##8##3##(1990-4#2)(2006-10#1)(2008-2#1)(2008-7#1)(2010-5#2)(2011-1#1)
to the gender##3##3##(2009-4#2)(2012-12#1)
to the gene encoding##7##4##(1991-12#1)(1991-6#1)(1992-7#1)(1995-3#1)(1996-2#1)(2006-11#1)(2012-1#1)
to the gene##24##3##(1991-12#1)(1991-6#1)(1992-3#2)(1992-7#1)(1994-5#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-11#2)(2006-12#1)(2006-8#1)(2008-1#2)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-1#1)
to the genera##10##3##(2007-7#1)(2008-10#4)(2008-5#1)(2008-7#1)(2013-7#2)(2013-8#1)
to the general population##11##4##(1991-9#1)(1994-2#1)(1997-3#1)(2006-7#1)(2007-4#1)(2008-11#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-12#1)
to the general practitioner##3##4##(1992-5#2)(2011-2#1)
to the general ward##2##4##(1990-3#1)(2007-8#1)
to the general##39##3##(1990-1#1)(1990-3#1)(1991-9#1)(1992-5#2)(1992-8#1)(1993-6#1)(1994-2#1)(1995-6#1)(1997-3#1)(2006-10#2)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)
to the generalization of##2##4##(2008-2#1)(2009-9#1)
to the generalized##2##3##(1990-8#1)(2008-3#1)
to the generally##2##3##(2008-11#1)(2008-2#1)
to the generated##2##3##(2008-2#1)(2010-12#1)
to the generation of a##4##5##(1993-3#1)(1997-8#1)(2010-12#1)(2011-1#1)
to the generation of the##2##5##(2007-12#1)(2010-2#1)
to the generation of##32##4##(1990-8#1)(1992-7#1)(1993-2#1)(1993-3#1)(1993-6#1)(1995-11#1)(1995-9#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-8#1)(1997-9#1)(2004-11#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2009-2#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-9#1)(2012-1#1)
to the generation##35##3##(1990-8#1)(1992-7#1)(1993-2#1)(1993-3#1)(1993-6#1)(1995-11#1)(1995-9#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-8#1)(1997-9#1)(2004-11#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#2)(2009-2#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-9#1)(2012-1#1)(2012-3#1)
to the generic##2##3##(2010-8#1)(2013-7#1)
to the genes of##2##4##(1995-12#1)(2008-8#1)
to the genes##6##3##(1995-12#1)(1995-8#1)(1996-6#1)(1997-3#1)(2008-1#1)(2008-8#1)
to the genesis and##2##4##(1994-3#1)(2008-10#1)
to the genesis##4##3##(1991-12#1)(1994-3#1)(2008-10#2)
to the genetic diversity of##2##5##(2008-10#1)(2012-12#1)
to the genetic diversity##4##4##(2008-10#3)(2012-12#1)
to the genetic regression##2##4##(2008-9#2)
to the genetic risk of##2##5##(2008-1#2)
to the genetic structure of##2##5##(2008-10#2)
to the genetic##25##3##(1990-3#1)(1995-3#1)(1996-5#1)(1997-2#2)(2007-12#1)(2008-1#2)(2008-10#5)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#2)(2010-12#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
to the genome##5##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2011-1#1)
to the genomic##2##3##(1997-1#1)(2008-10#1)
to the genotype##3##3##(2008-8#1)(2011-12#1)(2011-2#1)
to the genotypes of##2##4##(1995-6#1)(1996-3#1)
to the genus Flavobacterium##2##4##(2012-2#2)
to the genus Streptomyces##2##4##(1991-12#1)(2005-11#1)
to the genus Tospovirus##2##4##(2008-10#2)
to the genus##23##3##(1991-12#1)(1997-4#1)(2005-11#2)(2006-10#1)(2006-8#1)(2007-7#1)(2008-10#7)(2008-5#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)
to the geographic##3##3##(1991-12#1)(2008-10#1)(2013-1#1)
to the geographical##4##3##(2007-8#1)(2008-1#1)(2008-4#1)(2011-2#1)
to the geological##3##3##(1996-6#1)(2005-11#1)(2013-8#1)
to the geometric##3##3##(1992-12#1)(2008-10#1)(2008-3#1)
to the geometry of the##4##5##(1990-12#1)(1990-5#1)(2007-12#1)(2008-2#1)
to the geometry of##5##4##(1990-12#1)(1990-5#1)(2007-12#1)(2008-10#1)(2008-2#1)
to the geometry##6##3##(1990-12#1)(1990-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
to the geriatric##2##3##(1990-5#1)(2010-8#1)
to the germ line##3##4##(2007-12#2)(2009-3#1)
to the germ##4##3##(2006-6#1)(2007-12#2)(2009-3#1)
to the germline##2##3##(2012-12#2)
to the gestational age##4##4##(2004-10#1)(2008-7#1)(2011-1#2)
to the given##3##3##(2008-7#1)(2009-6#1)(2012-1#1)
to the glandular##2##3##(1997-1#1)(2007-12#1)
to the glass fibers)##2##4##(2010-9#2)
to the glass##10##3##(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-3#2)(2010-9#3)
to the glassy carbon electrode##3##5##(2008-10#3)
to the global##13##3##(1991-12#1)(1993-3#1)(1995-5#1)(1996-4#1)(2006-8#1)(2008-10#1)(2008-8#1)(2009-11#1)(2009-4#1)(2010-2#1)(2010-4#1)(2011-2#2)
to the glucokinase locus##2##4##(1992-5#2)
to the glucokinase##3##3##(1992-5#3)
to the glucose##7##3##(1995-1#1)(2008-10#5)(2008-5#1)
to the glutamate##2##3##(1990-11#1)(1995-6#1)
to the glycine##2##3##(1991-9#1)(2010-7#1)
to the glycoprotein IIb-IIIa receptor##2##5##(1990-5#1)(2005-7#1)
to the goal##4##3##(1993-2#1)(1995-3#1)(2008-5#1)(2012-2#1)
to the gold standard##3##4##(2004-1#1)(2007-11#1)(2012-3#1)
to the good##2##3##(1995-5#1)(2007-12#1)
to the gradual##4##3##(1991-11#1)(1995-9#1)(1996-9#1)(2008-7#1)
to the graduate##2##3##(2008-9#1)(2011-2#1)
to the graft##3##3##(1996-2#1)(2006-3#1)(2010-3#1)
to the granule cells##2##4##(1990-5#1)(1991-6#1)
to the granule##4##3##(1990-5#1)(1991-6#1)(1992-2#1)(1992-7#1)
to the graphite##3##3##(1992-2#1)(1992-7#1)(2008-10#1)
to the grating##12##3##(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#5)
to the gravity##2##3##(2007-7#1)(2008-11#1)
to the great amount of##3##5##(2008-10#1)(2008-7#1)(2009-8#1)
to the great##10##3##(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-8#1)(2010-10#1)(2012-11#1)
to the greater##12##3##(1990-5#1)(1991-2#1)(1993-11#1)(1994-5#1)(2007-2#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-2#1)(2011-12#1)(2012-2#1)
to the greatest extent##2##4##(2005-12#1)(2006-6#1)
to the greatest##4##3##(2005-12#1)(2006-6#1)(2008-10#1)(2012-12#1)
to the green##4##3##(1991-9#1)(1994-11#1)(1995-5#1)(2009-10#1)
to the gross##2##3##(2007-11#1)(2008-10#1)
to the ground##7##3##(1994-11#1)(1997-1#1)(2008-10#1)(2008-3#3)(2008-6#1)
to the group of the##2##5##(2008-11#1)(2012-12#1)
to the group of##16##4##(1991-9#1)(1993-11#1)(1995-5#1)(1996-5#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)(2009-2#1)(2012-1#1)(2012-12#1)(2013-8#3)
to the group##28##3##(1991-11#1)(1991-6#1)(1991-9#2)(1992-3#2)(1993-11#1)(1993-5#1)(1993-9#1)(1995-5#1)(1996-5#1)(1996-8#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-3#1)(2012-1#1)(2012-12#1)(2013-7#1)(2013-8#4)
to the groups##4##3##(1993-7#1)(2005-12#1)(2006-8#1)(2008-4#1)
to the growing body of evidence##6##6##(1993-6#1)(1993-7#1)(2009-2#1)(2010-5#1)(2013-1#2)
to the growing body of##8##5##(1993-1#1)(1993-6#1)(1993-7#1)(2006-10#1)(2009-2#1)(2010-5#1)(2013-1#2)
to the growing evidence##2##4##(2007-9#1)(2008-7#1)
to the growing interest in##4##5##(2006-10#1)(2007-11#1)(2008-2#1)(2009-7#1)
to the growing number of##3##5##(1991-1#1)(2009-10#1)(2012-1#1)
to the growing recognition##2##4##(2007-11#1)(2011-1#1)
to the growing use of##2##5##(2009-11#1)(2013-8#1)
to the growing##29##3##(1990-10#1)(1991-1#1)(1993-1#1)(1993-12#1)(1993-6#1)(1993-7#1)(1997-1#1)(2006-10#2)(2007-11#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-1#1)(2013-1#3)(2013-8#1)
to the growth and survival of##2##6##(2012-12#1)(2013-8#1)
to the growth inhibitory and##2##5##(1991-1#1)(1992-3#1)
to the growth inhibitory effects of##2##6##(1996-4#1)(2008-11#1)
to the growth inhibitory##5##4##(1991-1#1)(1992-3#1)(1995-2#1)(1996-4#1)(2008-11#1)
to the growth medium##2##4##(1997-1#1)(1997-6#1)
to the growth of the##4##5##(1996-9#1)(2006-7#1)(2008-10#1)(2013-1#1)
to the growth of##8##4##(1996-9#1)(2004-4#1)(2006-7#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-10#1)(2013-1#1)
to the growth##31##3##(1990-12#1)(1991-1#1)(1991-7#1)(1992-3#1)(1992-4#1)(1993-12#1)(1994-5#1)(1995-2#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-6#1)(2004-4#2)(2006-7#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-3#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
to the growth-inhibitory effect of 12-O-tetradecanoylphorbol 13-acetate (TPA) and##2##9##(1991-7#2)
to the guidance of the##3##5##(2008-7#1)(2009-3#1)(2009-8#1)
to the guidelines for##2##4##(2007-8#1)(2008-12#1)
to the guidelines##5##3##(1991-4#1)(2007-8#1)(2008-10#1)(2008-12#1)(2012-2#1)
to the gut##3##3##(1992-6#1)(2006-10#1)(2006-5#1)
to the habit##2##3##(1991-9#1)(2010-12#1)
to the hair##4##3##(2006-12#2)(2008-5#2)
to the hamster##2##3##(1995-8#1)(1996-8#1)
to the hand and##3##4##(2007-7#1)(2008-6#1)(2011-2#1)
to the hand##19##3##(1993-1#1)(1996-1#1)(1997-8#1)(2006-4#1)(2007-3#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#2)(2011-2#3)(2012-2#5)
to the hands##3##3##(1997-1#1)(2009-9#1)(2012-3#1)
to the head and##3##4##(2007-4#1)(2010-7#1)(2012-2#1)
to the head of the##2##5##(2007-9#1)(2008-12#1)
to the head of##5##4##(2006-11#1)(2007-9#1)(2008-12#1)(2008-3#2)
to the head##15##3##(1995-11#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-3#2)(2008-5#1)(2010-7#1)(2012-1#2)(2012-2#1)
to the headspace##2##3##(2008-10#2)
to the healing of##2##4##(2006-8#1)(2008-9#1)
to the healing##4##3##(2006-8#1)(2008-9#1)(2009-10#1)(2012-12#1)
to the health and##2##4##(2005-7#1)(2007-2#1)
to the health authorities##2##4##(1993-5#1)(1996-1#1)
to the health care field##2##5##(1996-3#1)(1997-1#1)
to the health care system##3##5##(1993-3#1)(1997-1#1)(2011-1#1)
to the health care##15##4##(1991-2#1)(1993-12#3)(1993-3#1)(1993-6#1)(1995-1#2)(1996-3#1)(1997-1#2)(2008-11#1)(2011-1#1)(2013-1#1)(2013-8#1)
to the health of##7##4##(1991-1#1)(1994-6#1)(1995-3#1)(2007-1#1)(2007-8#1)(2010-6#1)(2013-8#1)
to the health services##2##4##(1996-11#2)
to the health system##2##4##(2008-1#1)(2009-10#1)
to the health##37##3##(1991-1#1)(1991-2#1)(1991-6#1)(1993-12#3)(1993-3#1)(1993-5#1)(1993-6#1)(1994-5#2)(1994-6#1)(1995-1#2)(1995-3#1)(1996-1#1)(1996-11#2)(1996-3#1)(1997-1#2)(1997-2#1)(2005-7#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2009-10#1)(2009-3#1)(2010-6#1)(2011-1#2)(2013-1#1)(2013-8#2)
to the healthcare system##3##4##(2007-11#1)(2010-2#1)(2013-1#1)
to the healthcare##7##3##(1997-3#1)(2007-11#1)(2008-11#1)(2010-2#1)(2011-2#2)(2013-1#1)
to the healthy tissue##2##4##(2013-1#2)
to the healthy##6##3##(2008-11#1)(2010-12#2)(2013-1#3)
to the hearing##3##3##(2008-4#1)(2008-9#1)(2013-1#1)
to the heart and##4##4##(1994-2#1)(1997-1#1)(2007-8#1)(2010-2#1)
to the heart of it##2##5##(1996-3#1)(2004-4#1)
to the heart##20##3##(1991-3#1)(1993-1#1)(1993-2#1)(1994-2#1)(1996-3#1)(1997-1#1)(1997-4#1)(2004-11#1)(2004-4#1)(2006-6#1)(2007-12#1)(2007-8#2)(2008-12#1)(2008-7#1)(2010-12#2)(2010-2#1)(2011-2#2)
to the heat-shock protein##2##4##(1994-12#1)(1995-4#1)
to the heat-shock##3##3##(1991-10#1)(1994-12#1)(1995-4#1)
to the heavy##2##3##(1997-2#1)(1997-4#1)
to the helical##2##3##(1992-6#1)(1993-9#1)
to the helix axis##3##4##(1993-3#1)(2006-12#2)
to the helix##8##3##(1993-3#2)(1994-5#1)(1994-9#1)(1995-5#1)(1997-7#1)(2006-12#2)
to the helminth##2##3##(1994-6#1)(2007-7#1)
to the hematopoietic system##2##4##(2008-9#1)(2011-1#1)
to the heme iron##4##4##(1991-9#1)(1994-5#1)(1997-7#1)(2008-10#1)
to the heme##11##3##(1990-8#1)(1991-9#1)(1994-12#1)(1994-5#3)(1994-8#1)(1996-2#1)(1997-7#1)(2008-10#1)(2009-9#1)
to the heparin##2##3##(1993-6#1)(1994-10#1)
to the hepatic##2##3##(1996-12#1)(2012-2#1)
to the hepatitis##2##3##(1996-12#1)(2006-10#1)
to the hepatobiliary system##2##4##(2010-9#1)(2013-8#1)
to the hepatocytes##2##3##(1991-1#1)(1994-11#1)
to the herbicide##4##3##(2006-12#2)(2007-5#1)(2009-6#1)
to the heterocyclic##2##3##(1996-11#1)(2010-2#1)
to the heterogeneity of the##3##5##(1996-10#1)(1996-8#1)(2010-4#1)
to the heterogeneity of##6##4##(1996-10#1)(1996-8#1)(1997-4#1)(2010-12#1)(2010-4#1)(2010-7#1)
to the heterogeneous##3##3##(1993-8#1)(1994-3#1)(2008-7#1)
to the heterologous##6##3##(1993-8#1)(1994-8#1)(1995-3#1)(1997-7#1)(2008-10#2)
to the high affinity##2##4##(1994-12#1)(1994-8#1)
to the high complexity##2##4##(2008-10#1)(2010-11#1)
to the high degree of##2##5##(1994-8#1)(2012-2#1)
to the high expression of##2##5##(2008-5#1)(2009-9#1)
to the high level of##2##5##(2008-7#1)(2013-1#1)
to the high morbidity and mortality##2##6##(2010-12#1)(2012-3#1)
to the high number of##3##5##(1993-6#1)(2008-6#1)(2008-7#1)
to the high prevalence of##2##5##(1992-5#1)(2007-7#1)
to the high prevalence##3##4##(1992-5#1)(2007-7#1)(2008-8#1)
to the high rate of##5##5##(1993-1#1)(2005-1#1)(2007-12#1)(2008-6#1)(2013-8#1)
to the high rate##6##4##(1993-1#1)(2005-1#1)(2007-1#1)(2007-12#1)(2008-6#1)(2013-8#1)
to the high rates of##3##5##(2009-5#1)(2010-2#1)(2011-2#1)
to the high sensitivity of this##2##6##(2008-10#1)(2013-8#1)
to the high sensitivity of##3##5##(2008-10#2)(2013-8#1)
to the high##76##3##(1990-5#1)(1990-7#1)(1990-9#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-8#3)(1994-9#1)(1995-2#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#1)(2004-9#1)(2005-1#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#13)(2008-11#1)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#1)(2009-11#1)(2009-5#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#3)
to the high-affinity receptor##3##4##(1995-10#2)(1996-8#1)
to the high-affinity##7##3##(1990-7#1)(1995-10#2)(1996-10#1)(1996-8#1)(1997-1#1)(2008-4#1)
to the higher affinity##2##4##(1991-7#1)(1992-8#1)
to the higher incidence of##2##5##(2007-10#1)(2011-12#1)
to the higher##26##3##(1991-5#1)(1991-7#2)(1992-8#1)(1994-2#1)(1997-2#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-10#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)
to the highest concentration##2##4##(1995-3#1)(1997-2#1)
to the highest levels##2##4##(1995-10#1)(2013-1#1)
to the highest##25##3##(1990-3#1)(1990-6#1)(1995-10#1)(1995-3#1)(1996-1#1)(1996-11#1)(1997-2#1)(2004-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
to the highly conserved##3##4##(1994-11#1)(1994-5#1)(1996-8#1)
to the highly##13##3##(1994-11#1)(1994-5#1)(1996-5#1)(1996-8#1)(2006-12#2)(2007-12#1)(2008-10#1)(2008-11#1)(2009-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
to the hip##9##3##(1990-2#1)(2006-11#1)(2007-10#1)(2007-11#3)(2007-7#1)(2008-4#2)
to the hippocampal##3##3##(1992-9#1)(1995-12#1)(1997-7#1)
to the hippocampus##6##3##(1993-11#1)(1993-12#1)(2008-11#1)(2010-12#1)(2013-8#2)
to the histologic##2##3##(1991-12#1)(1997-7#1)
to the histological##4##3##(1994-6#1)(1994-9#1)(2007-11#1)(2010-4#1)
to the histopathological##2##3##(2007-8#1)(2011-2#1)
to the historical##4##3##(1996-3#1)(2008-10#1)(2008-4#1)(2009-10#1)
to the history and##4##4##(2008-8#1)(2009-10#2)(2010-2#1)
to the history of##2##4##(2007-5#1)(2010-1#1)
to the history##7##3##(2006-8#1)(2007-5#1)(2008-8#1)(2009-10#2)(2010-1#1)(2010-2#1)
to the holoenzyme and##2##4##(1990-2#1)(1992-6#1)
to the home##6##3##(1990-11#1)(1990-12#1)(1991-1#1)(1996-2#1)(2006-10#1)(2007-9#1)
to the homeodomain##3##3##(1997-5#3)
to the homologous##8##3##(1990-2#1)(1993-12#1)(1996-7#1)(1997-2#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-5#1)
to the hormonal##2##3##(1994-11#1)(2008-11#1)
to the hormone response##2##4##(1991-2#1)(1997-7#1)
to the hormone##5##3##(1990-8#1)(1991-2#1)(1994-9#1)(1997-1#1)(1997-7#1)
to the hospital and the##2##5##(1993-8#1)(2011-2#1)
to the hospital and##4##4##(1993-8#1)(2006-10#1)(2011-2#2)
to the hospital due to##3##5##(2008-7#1)(2011-1#1)(2013-8#1)
to the hospital for##5##4##(2005-6#1)(2007-7#1)(2009-8#1)(2013-1#2)
to the hospital with a##3##5##(2010-7#1)(2012-12#1)(2013-1#1)
to the hospital with##8##4##(2007-10#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-7#1)(2012-12#1)(2013-1#1)
to the hospital within##2##4##(1993-9#1)(2012-2#1)
to the hospital##78##3##(1990-12#1)(1990-3#1)(1990-9#1)(1991-11#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-9#1)(1996-2#1)(1996-5#1)(1997-7#1)(2005-6#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#2)(2007-12#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#3)(2009-10#2)(2009-3#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#12)(2013-8#1)
to the hospital's##2##3##(1996-3#2)
to the hospitals##2##3##(1992-12#1)(2009-5#1)
to the host by##2##4##(1995-12#1)(2008-1#1)
to the host cells##3##4##(1991-3#1)(1997-1#1)(2012-12#1)
to the host##26##3##(1991-10#1)(1991-3#1)(1991-9#1)(1992-3#1)(1993-6#1)(1995-12#1)(1996-4#1)(1997-1#1)(2005-11#1)(2005-7#1)(2006-10#1)(2008-1#2)(2008-10#4)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-9#1)(2011-1#1)(2012-12#1)
to the hot plate##2##4##(1994-2#1)(2010-5#1)
to the house dust##2##4##(2007-2#1)(2008-3#1)
to the human and##2##4##(1991-10#1)(1992-12#1)
to the human body##2##4##(2007-8#1)(2008-5#1)
to the human brain##2##4##(2006-11#1)(2009-5#1)
to the human cDNA##2##4##(1991-6#1)(1994-3#1)
to the human gene##4##4##(1991-6#1)(1993-9#1)(1997-6#1)(2009-2#1)
to the human genome##3##4##(1997-6#1)(2007-10#2)
to the human hsp27##2##4##(1993-6#2)
to the human immunodeficiency virus (HIV)##2##6##(1990-6#1)(1993-8#1)
to the human immunodeficiency virus##4##5##(1990-6#1)(1993-12#1)(1993-8#1)(1996-1#1)
to the human lysosomal alpha-mannosidase##2##5##(1997-8#2)
to the human organism##2##4##(1996-6#1)(2004-9#1)
to the human population##2##4##(2005-12#1)(2006-10#1)
to the human##86##3##(1990-11#1)(1990-12#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-6#2)(1991-8#3)(1991-9#1)(1992-11#3)(1992-12#4)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-9#3)(1995-10#1)(1995-11#1)(1995-3#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-6#3)(1997-7#1)(1997-8#2)(1997-9#1)(2004-9#1)(2005-12#1)(2006-10#1)(2006-11#5)(2007-10#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-5#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
to the human-performance data##2##4##(1995-12#2)
to the hybrid##3##3##(1995-8#2)(2008-3#1)
to the hydrodynamic##4##3##(1994-9#1)(2005-11#1)(2008-2#1)(2008-5#1)
to the hydrogen##2##3##(1992-6#1)(2008-10#1)
to the hydrolysis of##2##4##(1991-3#1)(2008-4#1)
to the hydrolysis##3##3##(1991-3#1)(2005-11#1)(2008-4#1)
to the hydrophilic##2##3##(1995-10#1)(1996-10#1)
to the hydrophobic##8##3##(1993-9#1)(1994-12#1)(1994-6#1)(1996-1#1)(2004-8#1)(2008-10#2)(2008-12#1)
to the hydrophobicity of the##3##5##(1992-3#1)(1995-5#1)(1997-5#1)
to the hydroxyl group of##3##5##(1992-12#1)(1996-5#1)(2008-4#1)
to the hydroxyl group##5##4##(1992-12#1)(1995-5#1)(1996-5#1)(2007-8#1)(2008-4#1)
to the hydroxyl##10##3##(1992-12#1)(1995-2#1)(1995-5#1)(1996-5#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#2)
to the hypothalamic structures##2##4##(1996-3#2)
to the hypothalamic##3##3##(1996-3#2)(2009-2#1)
to the hypothalamus##6##3##(1993-2#1)(1995-12#1)(1996-9#1)(1997-5#1)(2010-10#1)(2010-12#1)
to the hypothesis of##3##4##(1995-3#1)(2006-2#1)(2012-1#1)
to the hypothesis that rapid##2##5##(2008-5#1)(2008-8#1)
to the hypothesis that the##4##5##(2007-11#1)(2008-3#1)(2010-2#2)
to the hypothesis that##25##4##(1991-12#1)(1991-6#1)(1992-8#1)(1993-2#1)(1994-12#1)(1996-1#1)(1997-2#2)(1997-6#1)(2006-5#1)(2007-1#1)(2007-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
to the hypothesis##31##3##(1990-11#1)(1991-12#1)(1991-6#1)(1992-8#1)(1993-2#1)(1994-12#1)(1995-3#1)(1996-1#1)(1997-2#2)(1997-6#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-2#2)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#1)
to the hypothesized##2##3##(1993-6#1)(2008-12#1)
to the hypothetical##2##3##(1996-6#1)(2008-9#1)
to the idea of##2##4##(2006-4#1)(2011-1#1)
to the idea that##4##4##(1992-3#1)(2008-2#1)(2012-12#1)(2012-2#1)
to the idea##6##3##(1992-3#1)(2006-4#1)(2008-2#1)(2011-1#1)(2012-12#1)(2012-2#1)
to the ideal or##2##4##(2009-5#1)(2010-2#1)
to the ideal##8##3##(1995-6#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-2#1)(2012-12#1)
to the identification and##2##4##(1991-8#1)(2008-7#1)
to the identification of a##5##5##(1991-9#1)(1993-6#1)(2007-1#1)(2009-5#1)(2012-3#1)
to the identification of genes involved in##2##7##(1997-8#1)(2009-12#1)
to the identification of novel##6##5##(2008-1#1)(2008-7#2)(2009-10#1)(2012-1#1)(2012-12#1)
to the identification of the##8##5##(1990-8#1)(2007-1#1)(2008-10#2)(2008-11#1)(2010-8#1)(2012-12#2)
to the identification of three##2##5##(1996-9#1)(2009-4#1)
to the identification of##60##4##(1990-5#1)(1990-8#2)(1991-9#2)(1993-6#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1996-9#1)(1997-8#1)(2005-8#1)(2006-10#1)(2007-1#2)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-4#2)(2008-7#5)(2009-10#2)(2009-12#2)(2009-4#1)(2009-5#2)(2010-10#1)(2010-12#1)(2010-8#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#4)(2012-3#2)(2013-1#2)
to the identification##62##3##(1990-5#1)(1990-8#2)(1991-8#1)(1991-9#2)(1993-6#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1996-9#1)(1997-8#1)(2005-8#1)(2006-10#1)(2007-1#2)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-4#2)(2008-7#6)(2009-10#2)(2009-12#2)(2009-4#1)(2009-5#2)(2010-10#1)(2010-12#1)(2010-8#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#4)(2012-3#2)(2013-1#2)
to the ideological##2##3##(2008-7#1)(2010-1#1)
to the iliac##2##3##(2007-4#1)(2009-9#1)
to the illness##2##3##(1997-8#1)(2008-6#1)
to the illuminated##2##3##(2007-8#1)(2008-2#1)
to the illumination##2##3##(2008-2#1)(2008-3#1)
to the image of the##2##5##(2008-12#1)(2008-5#1)
to the image of##3##4##(2008-12#2)(2008-5#1)
to the image##9##3##(2008-12#3)(2008-2#2)(2008-5#1)(2008-6#1)(2010-5#1)(2011-1#1)
to the imaging##3##3##(2008-2#2)(2012-12#1)
to the immaturity of##2##4##(1995-8#1)(2007-1#1)
to the immediate##7##3##(1992-4#1)(1994-12#1)(1996-10#1)(1996-3#1)(2005-10#1)(2008-11#1)(2013-1#1)
to the immobilised##2##3##(2008-10#1)(2013-7#1)
to the immobilized GST-G2 fusion protein##2##6##(1994-3#2)
to the immobilized##6##3##(1994-3#2)(1996-2#1)(1997-3#1)(1997-4#1)(2008-8#1)
to the immune response##3##4##(2006-10#2)(2009-10#1)
to the immune system##7##4##(1997-3#1)(2007-11#1)(2008-10#3)(2008-7#1)(2012-1#1)
to the immune##10##3##(1997-3#1)(2006-10#2)(2007-11#1)(2008-10#3)(2008-7#1)(2009-10#1)(2012-1#1)
to the immunoglobulin superfamily##3##4##(1996-8#1)(1997-7#1)(2006-10#1)
to the immunoglobulin##4##3##(1996-8#1)(1997-6#1)(1997-7#1)(2006-10#1)
to the immunological##3##3##(1990-12#1)(1997-7#1)(2012-1#1)
to the immunosuppressant##3##3##(1992-6#1)(1994-12#1)(2010-12#1)
to the immunosuppressive treatment##2##4##(1992-5#1)(2007-8#1)
to the immunosuppressive##4##3##(1992-5#1)(1995-2#1)(2007-11#1)(2007-8#1)
to the impact of##9##4##(2007-12#2)(2008-1#1)(2008-12#1)(2008-2#1)(2008-8#1)(2012-2#1)(2013-1#2)
to the impact##11##3##(2007-12#2)(2008-1#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-11#1)(2012-2#1)(2013-1#3)
to the impairment of##2##4##(1994-11#1)(1995-3#1)
to the imperative of##2##4##(1997-1#1)(2009-4#1)
to the implant##2##3##(2005-5#1)(2007-5#1)
to the implantation of##2##4##(2006-9#1)(2007-8#1)
to the implantation##4##3##(1995-11#2)(2006-9#1)(2007-8#1)
to the implants##2##3##(2004-9#1)(2013-1#1)
to the implementation of a##2##5##(2007-11#1)(2008-2#1)
to the implementation of critical thinking teaching strategies##2##8##(2005-12#2)
to the implementation of the##5##5##(1994-3#1)(1997-3#1)(2008-10#1)(2008-2#1)(2010-5#1)
to the implementation of this##3##5##(2007-4#1)(2008-2#1)(2010-10#1)
to the implementation of##20##4##(1993-9#1)(1994-3#1)(1997-3#1)(2005-12#2)(2007-11#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-2#4)(2008-7#1)(2009-11#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-11#1)(2013-1#1)
to the implications of##2##4##(1993-12#1)(2009-4#1)
to the implications##3##3##(1993-12#1)(2009-4#1)(2011-1#1)
to the importance of the##4##5##(1995-2#1)(2009-7#1)(2012-1#1)(2012-12#1)
to the importance of this##3##5##(2008-9#1)(2011-2#1)(2013-1#1)
to the importance of##22##4##(1991-6#1)(1992-3#1)(1995-2#1)(1996-3#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-7#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#1)
to the importance##24##3##(1991-6#1)(1991-9#1)(1992-3#1)(1995-2#1)(1996-3#1)(2007-11#1)(2007-12#2)(2008-1#3)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-7#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#1)
to the important role of##2##5##(2008-10#1)(2013-7#1)
to the important##3##3##(2008-10#2)(2013-7#1)
to the impossibility of##3##4##(1992-10#1)(2009-4#1)(2012-2#1)
to the improved##5##3##(1993-11#1)(2008-10#1)(2008-11#2)(2011-2#1)
to the improvement of##10##4##(1991-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-9#1)(2011-1#1)(2012-2#2)
to the improvement##13##3##(1991-5#1)(1991-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-9#1)(2009-9#1)(2011-1#1)(2012-2#2)(2013-8#1)
to the in situ##3##4##(2008-10#1)(2008-3#2)
to the in vitro##2##4##(1992-8#1)(2008-10#1)
to the in vivo##7##4##(1991-1#1)(1991-4#1)(1994-12#1)(1996-1#1)(1997-1#1)(2008-10#1)(2008-5#1)
to the in##13##3##(1990-2#1)(1991-1#1)(1991-4#1)(1992-8#1)(1994-12#1)(1996-1#1)(1997-1#1)(2008-10#3)(2008-3#2)(2008-5#1)
to the in-vitro##2##3##(1990-12#1)(2008-4#1)
to the inability of the##2##5##(2006-10#1)(2013-1#1)
to the inability of##5##4##(1997-1#1)(2006-10#1)(2008-4#1)(2012-3#1)(2013-1#1)
to the inability##8##3##(1997-1#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-5#1)(2012-3#1)(2013-1#1)
to the inaccuracy##2##3##(1991-10#1)(2008-1#1)
to the inactivation of##3##4##(1997-2#1)(1997-6#1)(2005-7#1)
to the inactive##3##3##(1991-11#1)(1992-6#1)(1993-11#1)
to the inappropriate##3##3##(1993-12#1)(2008-10#2)
to the incentives##2##3##(1992-2#1)(1995-3#1)
to the incidence and##6##4##(1990-6#1)(1997-6#1)(2006-10#1)(2006-2#1)(2007-11#1)(2009-12#1)
to the incidence of##9##4##(1990-5#1)(1990-8#1)(1995-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-8#1)(2012-12#1)
to the incidence##16##3##(1990-5#1)(1990-6#1)(1990-8#1)(1995-12#1)(1997-6#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2012-12#1)
to the incident beam##5##4##(2007-12#1)(2008-2#2)(2008-3#2)
to the incident light##2##4##(2008-2#1)(2008-3#1)
to the incident radiation##2##4##(2008-3#2)
to the incident##15##3##(1996-12#1)(2007-12#3)(2008-2#4)(2008-3#7)
to the inclusion of##4##4##(2005-11#1)(2008-10#1)(2008-9#1)(2011-1#1)
to the inclusion##6##3##(2005-11#1)(2008-10#2)(2008-9#1)(2009-8#1)(2011-1#1)
to the incoming##4##3##(1996-4#1)(2008-10#1)(2008-2#1)(2008-3#1)
to the incorporation of##6##4##(1990-12#1)(1990-2#1)(1994-10#1)(2005-9#1)(2007-9#1)(2008-2#1)
to the incorporation##7##3##(1990-12#1)(1990-2#1)(1994-10#1)(2005-9#1)(2007-9#1)(2008-11#1)(2008-2#1)
to the increase in the##5##5##(1994-5#1)(1997-2#1)(2005-7#1)(2006-5#1)(2008-10#1)
to the increase in##29##4##(1991-2#1)(1992-2#1)(1992-6#1)(1993-3#1)(1994-5#2)(1994-8#1)(1995-3#1)(1996-10#1)(1997-2#2)(2005-7#1)(2006-10#1)(2006-5#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2010-4#2)(2010-8#1)(2012-12#1)(2012-2#1)
to the increase of##11##4##(1993-10#1)(2005-3#1)(2006-1#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-12#1)(2009-3#1)(2010-12#1)
to the increase##43##3##(1991-2#1)(1992-2#1)(1992-6#1)(1993-10#1)(1993-3#1)(1994-5#2)(1994-8#1)(1995-3#1)(1996-10#1)(1996-9#1)(1997-2#2)(2005-3#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-5#1)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2009-3#1)(2010-12#1)(2010-4#2)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
to the increased expression of##2##5##(1992-6#1)(1997-7#1)
to the increased number##5##4##(1991-12#1)(1991-2#1)(1991-3#1)(1994-6#1)(2008-1#1)
to the increased risk of##3##5##(1991-8#1)(2005-10#1)(2011-2#1)
to the increased##45##3##(1990-3#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-10#1)(1996-8#1)(1996-9#1)(1997-6#1)(1997-7#1)(2004-3#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-6#2)(2009-2#1)(2009-3#2)(2009-5#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
to the increasing number of##2##5##(2010-8#1)(2012-3#1)
to the increasing prevalence of##2##5##(2010-8#1)(2011-2#1)
to the increasing prevalence##3##4##(2006-10#1)(2010-8#1)(2011-2#1)
to the increasing trend##2##4##(2008-1#1)(2013-1#1)
to the increasing##21##3##(1995-8#1)(1996-6#1)(1997-3#1)(2005-5#1)(2006-10#1)(2007-1#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
to the incubation medium##5##4##(1990-4#1)(1994-8#1)(1995-11#1)(2008-5#1)(2008-8#1)
to the incubation##9##3##(1990-4#1)(1993-11#1)(1993-6#1)(1994-8#1)(1995-11#1)(1997-1#1)(2008-5#1)(2008-8#1)(2011-2#1)
to the index##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
to the indications##5##3##(1990-3#1)(1993-1#1)(2006-3#1)(2007-11#1)(2008-8#1)
to the indicator##2##3##(2008-10#1)(2013-8#1)
to the indium##2##3##(2008-10#1)(2009-3#1)
to the individual and##6##4##(1997-4#3)(2007-3#1)(2008-4#1)(2009-9#1)
to the individual gratings##2##4##(1997-8#2)
to the individual level##2##4##(2011-2#1)(2012-2#1)
to the individual patient##13##4##(1990-4#1)(1996-8#1)(2005-12#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-4#1)(2008-7#1)(2010-12#2)(2010-6#1)
to the individual##41##3##(1990-4#1)(1992-8#1)(1993-2#1)(1994-1#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-4#3)(1997-8#2)(2005-12#1)(2006-10#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-10#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
to the individual's##2##3##(2008-1#1)(2008-4#1)
to the individuals##3##3##(2007-11#1)(2007-5#1)(2008-3#1)
to the indole##2##3##(2008-5#2)
to the induced##3##3##(1991-10#1)(1993-2#1)(2007-11#1)
to the induction of DNA##2##5##(1997-4#1)(2008-7#1)
to the induction of the##2##5##(1991-12#1)(1994-9#1)
to the induction of these##2##5##(1994-6#1)(1996-3#1)
to the induction of##23##4##(1990-11#1)(1990-4#1)(1991-12#1)(1991-2#1)(1992-4#1)(1994-10#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1996-3#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-4#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#1)
to the induction##24##3##(1990-11#1)(1990-4#1)(1991-12#1)(1991-2#1)(1992-4#1)(1994-10#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1996-3#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-4#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#1)
to the inductive##2##3##(1991-12#1)(1995-5#1)
to the inductively coupled plasma-mass##2##5##(2008-10#2)
to the industry##2##3##(2005-10#1)(2008-11#1)
to the infant##7##3##(1992-2#1)(1995-3#1)(1995-6#1)(2006-5#1)(2007-1#1)(2007-7#1)(2010-7#1)
to the infection by##2##4##(2009-8#1)(2011-2#1)
to the infection control##2##4##(2005-9#1)(2008-1#1)
to the infection##14##3##(1992-8#1)(1993-6#1)(2005-9#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-1#1)
to the infectious##3##3##(1990-7#1)(2005-9#1)(2010-7#1)
to the infective##3##3##(2006-10#1)(2008-4#1)(2011-2#1)
to the inferior alveolar nerve##2##5##(2007-12#2)
to the inferior border of the##3##6##(1994-3#1)(2004-9#1)(2010-12#1)
to the inferior colliculus##3##4##(1990-7#2)(1997-3#1)
to the inferior surface of the##2##6##(2007-8#1)(2013-1#1)
to the inferior vena cava##2##5##(2006-6#1)(2011-2#1)
to the inferior##18##3##(1990-7#2)(1994-3#1)(1995-11#1)(1995-5#1)(1997-3#1)(2004-9#1)(2006-10#1)(2006-6#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
to the inflammation##3##3##(1991-9#1)(2008-5#1)(2012-12#1)
to the inflammatory changes##2##4##(2008-1#1)(2010-2#1)
to the inflammatory response##2##4##(2006-3#1)(2011-1#1)
to the inflammatory##8##3##(1994-2#1)(1995-3#1)(2006-3#1)(2008-1#1)(2008-9#1)(2010-2#1)(2011-1#1)(2012-12#1)
to the influence of a##2##5##(1993-12#1)(2008-7#1)
to the influence of the##4##5##(2004-4#1)(2008-10#1)(2008-9#1)(2010-3#1)
to the influence of##15##4##(1990-2#1)(1991-12#1)(1993-12#1)(1995-5#1)(2004-4#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2012-9#1)
to the influence##16##3##(1990-2#1)(1991-12#1)(1993-12#1)(1995-5#1)(2004-4#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2012-9#1)
to the influx of##2##4##(1997-8#1)(2010-9#1)
to the information##6##3##(1996-3#1)(2006-2#1)(2007-5#1)(2008-5#1)(2012-12#1)(2013-8#1)
to the inherent##10##3##(1994-3#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2013-1#2)
to the inheritance of##2##4##(1994-9#1)(2007-1#1)
to the inhibition by##2##4##(1996-9#1)(1997-3#1)
to the inhibition of adenylate cyclase##2##6##(1993-6#1)(1995-6#1)
to the inhibition of the##6##5##(1992-9#1)(1993-8#1)(1994-6#1)(1997-4#1)(2008-8#1)(2008-9#1)
to the inhibition of ubiquitin-proteasome pathway##3##6##(2008-9#3)
to the inhibition of##35##4##(1990-2#1)(1990-5#1)(1991-2#1)(1991-5#1)(1991-8#2)(1992-11#3)(1992-6#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-5#1)(2005-8#1)(2006-2#1)(2008-10#2)(2008-11#1)(2008-8#2)(2008-9#4)(2010-2#1)(2010-3#1)(2012-1#1)(2012-2#1)
to the inhibition##40##3##(1990-2#1)(1990-5#1)(1991-2#1)(1991-5#1)(1991-8#2)(1992-11#3)(1992-6#1)(1992-7#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-6#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(2005-8#1)(2006-2#1)(2008-10#2)(2008-11#1)(2008-8#2)(2008-9#5)(2010-2#1)(2010-3#1)(2012-1#1)(2012-2#1)
to the inhibitor##6##3##(1992-12#1)(1994-6#1)(1994-9#1)(1995-11#1)(1996-5#1)(1996-7#1)
to the inhibitory effect of##7##5##(1992-5#1)(1994-6#1)(1995-5#1)(1996-2#1)(2006-10#1)(2008-10#1)(2008-7#1)
to the inhibitory##13##3##(1991-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1994-6#1)(1995-5#1)(1996-2#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-7#1)
to the inhomogeneity of##2##4##(1990-9#1)(2008-3#1)
to the initial clinical##2##4##(2008-7#1)(2010-12#1)
to the initial concentration of##2##5##(2007-10#1)(2008-10#1)
to the initial diagnosis of##3##5##(2007-8#1)(2012-11#2)
to the initial rate##2##4##(2008-5#2)
to the initial stages of##2##5##(2007-10#1)(2007-12#1)
to the initial values##2##4##(1990-7#1)(2007-9#1)
to the initial##50##3##(1990-11#1)(1990-7#1)(1991-10#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-9#1)(1993-6#1)(1994-7#1)(1995-11#1)(1996-8#1)(1996-9#1)(2004-12#1)(2005-12#1)(2005-7#1)(2006-11#1)(2006-3#2)(2007-10#4)(2007-11#3)(2007-12#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-1#2)(2012-11#2)
to the initially##2##3##(1994-11#1)(2008-12#1)
to the initiation and development of##4##6##(1997-4#1)(2008-10#1)(2010-4#1)(2012-3#1)
to the initiation and##7##4##(1993-3#1)(1997-4#1)(2008-10#1)(2008-7#1)(2010-4#1)(2012-2#1)(2012-3#1)
to the initiation of##8##4##(1993-9#1)(1997-4#1)(2006-12#1)(2006-5#1)(2008-1#1)(2008-8#1)(2010-3#1)(2012-12#1)
to the initiation##20##3##(1991-10#1)(1993-3#1)(1993-6#1)(1993-9#1)(1997-4#2)(1997-5#1)(2006-12#1)(2006-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-4#1)(2012-12#1)(2012-2#2)(2012-3#1)
to the injected##2##3##(1995-12#2)
to the injection of##2##4##(1993-6#1)(1994-2#1)
to the injection site##3##4##(1996-1#1)(1996-7#1)(1997-3#1)
to the injection##8##3##(1990-8#1)(1993-6#1)(1994-2#1)(1996-1#1)(1996-7#1)(1997-3#1)(2008-1#1)(2011-2#1)
to the injections##3##3##(1994-8#1)(1997-3#2)
to the injured##4##3##(1993-5#1)(2005-8#1)(2006-11#1)(2011-2#1)
to the injury##3##3##(1991-10#1)(2007-4#1)(2013-7#1)
to the innate immune##2##4##(2008-11#1)(2010-9#1)
to the inner membrane##3##4##(1991-10#1)(1992-7#1)(1993-3#1)
to the inner mitochondrial membrane##3##5##(1993-6#1)(1996-2#1)(2012-2#1)
to the inner##19##3##(1990-4#1)(1991-10#2)(1991-4#1)(1992-7#1)(1993-3#2)(1993-6#1)(1996-2#1)(1997-1#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-5#3)(2008-9#1)(2012-2#1)
to the innervated##2##3##(1990-11#1)(1995-3#1)
to the inoculated##3##3##(2008-10#2)(2008-9#1)
to the inoculation##4##3##(2008-10#2)(2008-11#1)(2008-8#1)
to the input variables##2##4##(2008-10#2)
to the input##16##3##(1991-3#1)(1991-6#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-2#7)(2008-3#1)(2008-6#1)
to the insect##2##3##(2008-10#1)(2008-9#1)
to the insect's##2##3##(2008-10#1)(2012-12#1)
to the insensitivity##2##3##(2008-10#1)(2008-7#1)
to the insertion of##4##4##(1991-5#1)(2007-3#1)(2008-11#1)(2008-9#1)
to the inside of the##2##5##(2008-2#1)(2009-8#1)
to the inside##3##3##(2008-12#1)(2008-2#1)(2009-8#1)
to the insoluble##2##3##(2008-10#1)(2009-7#1)
to the instability of##3##4##(1997-8#1)(2010-4#1)(2011-2#1)
to the instability##4##3##(1997-8#1)(2008-8#1)(2010-4#1)(2011-2#1)
to the institution##3##3##(1993-2#1)(1994-1#1)(2007-7#1)
to the instrument##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
to the instruments##2##3##(1996-12#1)(2006-6#1)
to the insufficient##2##3##(2006-2#1)(2008-10#1)
to the insulin receptor##3##4##(1993-7#1)(2006-10#1)(2007-8#1)
to the insulin##6##3##(1993-7#1)(1996-10#1)(2006-10#1)(2007-8#1)(2008-6#1)(2010-11#1)
to the intact##11##3##(1993-4#1)(1993-9#1)(1994-12#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-11#1)(2013-8#1)
to the intake of##3##4##(2006-10#2)(2008-1#1)
to the integrated##4##3##(1997-7#1)(2005-11#1)(2008-6#1)(2012-3#1)
to the integration of##3##4##(1993-2#1)(1996-10#1)(2008-3#1)
to the integrity of the##2##5##(1992-11#1)(1992-3#1)
to the intensity of the##6##5##(2007-10#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-5#1)(2009-8#1)
to the intensity of##8##4##(1996-1#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-5#1)(2009-8#1)
to the intensity##13##3##(1990-3#1)(1991-12#1)(1996-1#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-5#1)(2009-8#1)
to the intensive care unit (ICU)##2##6##(2009-6#1)(2012-2#1)
to the intensive care unit for##2##6##(2006-4#1)(2009-6#1)
to the intensive care unit##8##5##(2006-10#1)(2006-4#3)(2009-6#2)(2012-2#1)(2013-1#1)
to the intensive care##9##4##(1993-12#1)(2006-10#1)(2006-4#3)(2009-6#2)(2012-2#1)(2013-1#1)
to the intensive##11##3##(1993-12#1)(2006-10#2)(2006-4#3)(2007-7#1)(2009-6#2)(2012-2#1)(2013-1#1)
to the intent of the##2##5##(2007-4#1)(2009-4#1)
to the intentional##2##3##(2007-12#1)(2012-1#1)
to the interaction between the##2##5##(2008-10#1)(2012-2#1)
to the interaction between##5##4##(2008-10#2)(2008-7#1)(2008-8#1)(2012-2#1)
to the interaction of the##4##5##(1994-2#1)(1994-9#1)(2005-11#1)(2008-10#1)
to the interaction of##13##4##(1993-8#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-8#1)(2005-11#1)(2008-10#4)(2008-4#1)(2009-7#1)(2010-4#1)
to the interaction with the ectosymbiotic bacteria##2##7##(2008-4#2)
to the interaction with the##3##5##(2008-3#1)(2008-4#2)
to the interaction with##5##4##(1994-5#1)(2008-3#1)(2008-4#2)(2012-12#1)
to the interaction##24##3##(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-8#1)(2005-11#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#1)(2009-7#1)(2010-4#1)(2012-12#1)(2012-2#1)
to the interactions##2##3##(2007-11#1)(2008-10#1)
to the intercellular##2##3##(2008-10#2)
to the interests and##2##4##(1992-1#1)(2008-2#1)
to the interface is##2##4##(1993-6#2)
to the interface##6##3##(1993-6#2)(1994-11#1)(1995-5#1)(1995-8#1)(2008-3#1)
to the interfacial##5##3##(2005-11#2)(2006-12#1)(2009-5#1)(2010-4#1)
to the interference of##3##4##(2005-4#1)(2008-10#1)(2008-5#1)
to the interference##6##3##(2005-4#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-8#1)
to the interferences##3##3##(1990-6#1)(2008-10#2)
to the interferon##3##3##(1992-6#1)(1997-1#1)(2007-11#1)
to the intergenic##2##3##(1991-12#1)(2008-5#1)
to the interior of the##4##5##(2007-11#1)(2007-8#1)(2009-7#1)(2013-1#1)
to the interior##5##3##(1990-12#1)(2007-11#1)(2007-8#1)(2009-7#1)(2013-1#1)
to the interlayer##2##3##(2005-11#2)
to the intermediate##3##3##(1992-9#1)(2008-2#1)(2009-2#1)
to the internal carotid##2##4##(2006-12#2)
to the internal mammary##2##4##(2005-12#1)(2013-1#1)
to the internal surfaces of the porous silica##2##8##(1990-8#1)(2012-12#1)
to the internal##27##3##(1990-10#1)(1990-8#1)(1991-3#2)(1991-7#1)(1991-9#2)(1994-3#1)(1996-5#1)(1996-8#1)(2005-12#1)(2006-12#2)(2006-3#1)(2007-7#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
to the international##9##3##(1992-8#1)(1997-7#1)(2006-10#1)(2006-11#1)(2008-11#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
to the interpretation of##6##4##(1997-8#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#1)
to the intervention group##4##4##(1991-10#1)(2007-5#1)(2008-12#1)(2008-9#1)
to the intervention##12##3##(1991-10#1)(1991-9#1)(1992-9#1)(2007-5#1)(2008-12#2)(2008-2#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
to the interview##3##3##(1991-9#1)(2007-9#1)(2008-5#1)
to the intestinal mucosa##2##4##(1992-12#1)(2005-10#1)
to the intestinal##8##3##(1992-12#1)(1997-2#1)(2005-10#1)(2007-2#1)(2007-8#1)(2008-4#1)(2009-6#1)(2010-2#1)
to the intracellular##12##3##(1990-7#1)(1991-12#1)(1992-6#1)(1992-8#2)(1994-12#1)(1994-9#1)(1995-5#1)(2008-8#1)(2011-2#1)(2013-8#2)
to the intracerebral##2##3##(1996-1#1)(2008-7#1)
to the intraocular tissues##2##4##(1996-2#1)(2008-3#1)
to the intraoperative##2##3##(2006-6#1)(2007-12#1)
to the intravenous##3##3##(2006-10#1)(2011-2#2)
to the intrinsic##10##3##(1994-2#1)(1995-10#1)(1997-1#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2009-11#1)(2011-1#1)
to the introduction of a##2##5##(1996-11#1)(2007-11#1)
to the introduction of effective##2##5##(2008-5#1)(2010-3#1)
to the introduction of##16##4##(1991-12#1)(1996-11#1)(2005-5#1)(2006-10#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-12#1)(2008-5#2)(2009-11#1)(2010-3#1)(2010-4#1)(2012-12#1)(2012-2#1)
to the introduction##17##3##(1991-12#1)(1996-11#1)(2005-5#1)(2006-10#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-12#2)(2008-5#2)(2009-11#1)(2010-3#1)(2010-4#1)(2012-12#1)(2012-2#1)
to the intron##2##3##(1991-9#1)(1995-1#1)
to the invariant##2##3##(2006-11#2)
to the inverse##8##3##(1997-8#1)(2007-12#1)(2008-2#3)(2008-5#1)(2008-8#1)(2009-12#1)
to the inversion of##3##4##(2008-2#1)(2008-3#2)
to the inversion##4##3##(2008-2#1)(2008-3#2)(2013-1#1)
to the inverted##3##3##(1990-5#1)(1994-3#1)(2007-12#1)
to the investigation of the##2##5##(2006-5#1)(2008-10#1)
to the investigation of##14##4##(1991-12#1)(1991-2#1)(1995-3#1)(1995-6#1)(1997-1#1)(2005-9#1)(2006-5#1)(2007-6#1)(2008-10#3)(2008-12#1)(2008-8#1)(2010-3#1)
to the investigation##15##3##(1991-12#1)(1991-2#1)(1995-3#1)(1995-6#1)(1997-1#1)(2005-9#1)(2006-5#1)(2007-6#1)(2008-10#4)(2008-12#1)(2008-8#1)(2010-3#1)
to the investigations##2##3##(1997-7#1)(2008-10#1)
to the involved##2##3##(1990-8#1)(2006-10#1)
to the involvement of a##2##5##(2008-10#1)(2008-4#1)
to the involvement of##11##4##(1994-12#1)(1994-3#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2010-10#1)(2013-8#1)
to the ion##2##3##(2008-10#2)
to the ion-exchange chromatography##2##4##(1996-6#1)(1997-2#1)
to the ion-exchange##5##3##(1996-6#1)(1996-8#2)(1997-2#1)(1997-8#1)
to the ionic strength##3##4##(1995-2#1)(2008-10#1)(2008-5#1)
to the ionic##6##3##(1990-10#1)(1995-2#1)(1997-7#1)(2008-10#2)(2008-5#1)
to the ionization##4##3##(1993-3#1)(2008-10#2)(2013-8#1)
to the ionophore##2##3##(2008-10#2)
to the ipsilateral breast##2##4##(1994-12#1)(1995-10#1)
to the ipsilateral representation##2##4##(1995-11#2)
to the ipsilateral side##2##4##(1996-9#1)(1997-8#1)
to the ipsilateral##10##3##(1994-12#1)(1995-10#1)(1995-11#2)(1995-7#1)(1996-9#1)(1997-8#1)(2006-7#1)(2012-12#2)
to the iris##2##3##(1996-5#2)
to the iron##4##3##(1990-3#1)(1994-8#1)(2008-5#1)(2012-2#1)
to the irradiation##3##3##(1994-3#1)(1997-6#1)(2008-3#1)
to the irreversible##5##3##(1993-12#1)(1994-10#1)(1994-12#1)(1995-8#1)(2006-10#1)
to the ischemic##4##3##(1996-12#1)(1997-2#1)(2008-8#1)(2010-12#1)
to the island##2##3##(1993-7#1)(2008-10#1)
to the isoelectric##2##3##(2005-11#1)(2008-11#1)
to the isolate##4##3##(2008-10#4)
to the isolated##2##3##(1991-6#1)(1996-5#1)
to the isolates##2##3##(2008-10#2)
to the isolation of a##6##5##(1991-2#1)(1994-6#1)(2007-1#2)(2009-10#1)(2011-1#1)
to the isolation of the##2##5##(1991-8#1)(2006-12#1)
to the isolation of two##3##5##(2006-12#1)(2007-1#1)(2010-5#1)
to the isolation of##20##4##(1991-11#1)(1991-2#2)(1991-8#1)(1992-8#1)(1994-6#1)(2006-12#3)(2007-1#4)(2008-1#1)(2008-10#1)(2008-5#1)(2009-10#1)(2010-2#1)(2010-5#1)(2011-1#1)
to the isolation##24##3##(1991-11#1)(1991-2#2)(1991-8#1)(1992-8#1)(1994-6#1)(2006-12#3)(2007-1#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2010-2#2)(2010-5#1)(2011-1#1)(2013-1#2)
to the isomerization##2##3##(1995-3#1)(2008-10#1)
to the issue of the##2##5##(2007-11#1)(2008-3#1)
to the issue of##4##4##(1995-3#1)(2007-11#1)(2007-12#1)(2008-3#1)
to the issue##8##3##(1992-5#1)(1995-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-3#1)(2009-7#1)
to the issues##3##3##(1992-2#1)(2006-4#1)(2013-1#1)
to the iterative Fourier transform algorithm##2##6##(2008-2#1)(2008-3#1)
to the iterative##3##3##(2008-2#1)(2008-3#2)
to the job##2##3##(1993-12#1)(2008-2#1)
to the joint##7##3##(1995-4#1)(2007-4#1)(2007-7#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-11#1)
to the journal##2##3##(1996-9#1)(2008-11#1)
to the jugular vein##2##4##(1990-2#1)(2009-6#1)
to the junction##2##3##(1996-8#1)(2007-8#1)
to the junctional##4##3##(1990-2#1)(1992-7#1)(1996-12#1)(2012-11#1)
to the juvenile##2##3##(2007-5#1)(2009-8#1)
to the key##4##3##(1995-6#1)(2008-9#1)(2010-8#1)(2011-1#1)
to the kidney##10##3##(1990-4#1)(1993-9#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-11#1)(2011-2#1)
to the kinase##2##3##(1993-6#1)(1996-5#1)
to the kinetic##3##3##(1992-4#1)(1994-11#1)(2008-10#1)
to the kinetics of the##2##5##(1997-3#1)(2008-10#1)
to the kinetics of##3##4##(1997-3#1)(2008-10#2)
to the knee joint##3##4##(2007-11#2)(2007-8#1)
to the knee##7##3##(2006-11#1)(2007-11#4)(2007-8#1)(2008-12#1)
to the knowledge of the##3##5##(1993-11#1)(2012-2#1)(2013-8#1)
to the knowledge of##6##4##(1990-5#1)(1993-11#1)(2005-1#1)(2010-12#1)(2012-2#1)(2013-8#1)
to the knowledge that##2##4##(1997-8#1)(2007-8#1)
to the knowledge##9##3##(1990-5#1)(1993-11#1)(1997-8#1)(2005-1#1)(2007-2#1)(2007-8#1)(2010-12#1)(2012-2#1)(2013-8#1)
to the known sequence]##2##4##(2008-4#2)
to the known sequences##2##4##(1991-10#1)(1997-4#1)
to the known##28##3##(1990-11#1)(1991-10#1)(1991-11#1)(1992-1#1)(1992-3#1)(1995-1#1)(1995-12#1)(1996-10#2)(1996-12#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#2)(2010-2#1)(2012-2#1)
to the lab##5##3##(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#2)
to the labeled carbon##2##4##(1992-3#2)
to the labeled##3##3##(1992-3#3)
to the labeling##2##3##(1997-2#1)(2010-8#1)
to the lability of the##2##5##(1993-11#1)(1994-11#1)
to the laboratory##16##3##(1991-6#1)(2006-2#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#4)(2008-8#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)
to the labyrinth##2##3##(2012-2#2)
to the lac operon##2##4##(1991-7#1)(1995-3#1)
to the lac##3##3##(1991-7#1)(1995-3#1)(1997-6#1)
to the lacZ reporter gene##2##5##(1993-3#1)(1997-5#1)
to the lacZ##4##3##(1993-3#1)(1994-3#1)(1997-5#1)(2013-1#1)
to the lack of a##6##5##(1991-10#1)(1996-11#1)(2006-2#1)(2007-11#1)(2008-10#1)(2012-2#1)
to the lack of adequate##4##5##(2008-10#1)(2008-9#1)(2010-2#1)(2010-5#1)
to the lack of appropriate##2##5##(2008-9#1)(2011-1#1)
to the lack of proper##2##5##(2008-10#1)(2011-2#1)
to the lack of reliable##2##5##(1994-8#1)(2006-10#1)
to the lack of the##2##5##(2010-5#1)(2011-2#1)
to the lack of##61##4##(1990-5#1)(1990-9#1)(1991-10#1)(1991-11#1)(1992-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-9#1)(1996-11#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-11#2)(2006-2#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2010-12#1)(2010-2#2)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#2)
to the lack##62##3##(1990-5#1)(1990-9#1)(1991-10#1)(1991-11#1)(1992-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-9#1)(1996-11#1)(1997-6#2)(2005-11#1)(2006-10#1)(2006-11#2)(2006-2#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2010-12#1)(2010-2#2)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#2)
to the lamellar##2##3##(1994-12#1)(2008-8#1)
to the lamina##2##3##(2007-8#1)(2008-7#1)
to the large amount of##2##5##(1992-2#1)(2008-5#1)
to the large difference##2##4##(1994-6#1)(2008-11#1)
to the large number of##3##5##(1996-2#1)(2007-9#1)(2010-11#1)
to the large numbers##2##4##(1996-9#1)(2008-11#1)
to the large sample##2##4##(2010-2#2)
to the large subunit of##2##5##(1994-12#1)(1995-1#1)
to the large subunit##3##4##(1992-3#1)(1994-12#1)(1995-1#1)
to the large##37##3##(1992-2#1)(1992-3#2)(1994-12#3)(1994-6#1)(1995-1#1)(1995-5#1)(1996-2#2)(1996-9#1)(1997-2#1)(2005-12#1)(2006-10#1)(2006-2#1)(2007-12#3)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-11#1)(2010-2#2)(2010-8#1)(2012-2#1)
to the large-scale##2##3##(2008-10#1)(2012-2#1)
to the larger##6##3##(1993-3#1)(1996-5#1)(2007-12#1)(2008-9#1)(2009-8#1)(2012-5#1)
to the largest##3##3##(1994-12#1)(2009-7#1)(2013-8#1)
to the larvae##2##3##(2009-8#1)(2011-2#1)
to the larynx##3##3##(1994-7#1)(2006-4#2)
to the laser beam##2##4##(2007-12#1)(2008-9#1)
to the laser frequency##2##4##(2007-12#1)(2008-3#1)
to the laser##13##3##(1990-12#1)(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#3)(2008-9#1)(2010-11#1)
to the last 20 amino acids of the##2##8##(1992-6#1)(1996-8#1)
to the last##9##3##(1990-11#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-6#1)(1996-8#1)(2006-11#1)(2006-2#1)(2009-4#1)
to the late##5##3##(1990-11#1)(1996-9#1)(1997-8#1)(2008-8#1)(2012-1#1)
to the late-onset##2##3##(1990-5#1)(1991-3#1)
to the latent##2##3##(2006-10#1)(2010-4#1)
to the later##2##3##(2008-1#1)(2012-11#1)
to the lateral amygdaloid nucleus##2##5##(1991-9#2)
to the lateral canthus##2##4##(2010-12#2)
to the lateral ventricles##2##4##(2006-5#2)
to the lateral##17##3##(1991-9#2)(1992-7#1)(1993-12#2)(1996-6#1)(1997-7#1)(2006-12#1)(2006-5#3)(2007-12#1)(2007-4#1)(2008-3#1)(2010-12#2)(2012-3#1)
to the latest##10##3##(1990-2#1)(1991-6#1)(1997-8#1)(2004-10#1)(2006-5#1)(2007-8#3)(2008-3#1)(2008-9#1)
to the latter##12##3##(1991-2#1)(1991-9#1)(1994-11#1)(1995-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-2#1)(2012-6#1)(2013-8#1)
to the launched##3##3##(2007-12#2)(2008-3#1)
to the law##6##3##(1991-10#1)(1996-5#1)(1997-8#1)(2006-8#1)(2011-2#2)
to the layout of##2##4##(2007-7#1)(2012-2#1)
to the lead##3##3##(1995-3#1)(2008-3#1)(2013-8#1)
to the leaf surface##3##4##(1994-11#1)(2008-10#2)
to the leaf##6##3##(1994-11#1)(2008-10#5)
to the learning##5##3##(2006-6#1)(2006-8#1)(2008-11#1)(2009-4#1)(2011-2#1)
to the least##5##3##(2010-10#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
to the leaves##3##3##(2008-10#2)(2009-8#1)
to the lectin##2##3##(1992-9#1)(2008-10#1)
to the left adrenal##2##4##(1997-8#1)(2007-9#1)
to the left and right##4##5##(1996-6#1)(2008-9#1)(2009-2#2)
to the left anterior descending (LAD) coronary artery##2##8##(2005-12#1)(2006-12#1)
to the left anterior descending (LAD)##3##6##(2005-12#1)(2006-12#1)(2007-8#1)
to the left anterior descending artery##4##6##(2006-10#1)(2007-8#3)
to the left anterior descending##7##5##(2005-12#1)(2006-10#1)(2006-12#1)(2007-8#4)
to the left atrial##2##4##(1997-1#1)(1997-8#1)
to the left kidney##2##4##(1997-3#1)(2013-1#1)
to the left of the falciform ligament##2##7##(2008-3#2)
to the left of the##4##5##(1997-4#1)(2008-3#2)(2009-6#1)
to the left of##6##4##(1990-10#1)(1997-4#1)(2008-3#2)(2009-2#1)(2009-6#1)
to the left or to the right##2##7##(2007-4#1)(2013-1#1)
to the left or##3##4##(2007-4#2)(2013-1#1)
to the left pulmonary artery##3##5##(2007-8#1)(2012-12#2)
to the left side##4##4##(2010-4#1)(2010-9#1)(2012-12#2)
to the left##75##3##(1990-10#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-6#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#2)(2005-12#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#10)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-2#4)(2009-6#1)(2009-7#1)(2010-4#1)(2010-9#1)(2011-2#3)(2012-12#6)(2012-2#1)(2012-7#1)(2013-1#2)
to the legal##3##3##(1991-7#1)(2011-1#1)(2011-2#1)
to the length and##4##4##(2007-8#1)(2008-5#1)(2008-9#1)(2010-7#1)
to the length of the##5##5##(1991-10#1)(1993-11#1)(1996-4#1)(2008-10#1)(2008-9#1)
to the length of##7##4##(1990-8#1)(1991-10#1)(1993-11#1)(1996-4#1)(1997-3#1)(2008-10#1)(2008-9#1)
to the length##14##3##(1990-8#1)(1991-10#1)(1993-11#1)(1996-4#1)(1997-3#1)(2005-11#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-9#2)(2010-7#1)
to the lens and##2##4##(1993-9#1)(1995-8#1)
to the lens##6##3##(1993-9#1)(1995-8#1)(2008-3#3)(2013-8#1)
to the lesion##19##3##(1991-9#1)(1993-3#1)(1994-12#1)(1994-2#1)(1996-2#2)(1996-5#4)(1997-3#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-7#2)(2012-2#1)
to the lesions##3##3##(2008-7#1)(2011-1#1)(2012-2#1)
to the less##7##3##(1991-3#1)(1995-11#1)(1996-8#1)(2008-10#1)(2008-4#1)(2009-12#1)(2011-2#1)
to the lethal effects of##2##5##(1995-12#1)(2007-11#1)
to the lethal##3##3##(1995-12#1)(2007-11#1)(2008-10#1)
to the letter to the##2##5##(2008-4#1)(2010-2#1)
to the leucine##2##3##(1991-12#1)(1992-3#1)
to the level and##3##4##(1990-5#1)(1992-6#1)(2008-11#1)
to the level observed in##2##5##(1993-8#1)(2011-2#1)
to the level observed##3##4##(1993-8#1)(1995-3#1)(2011-2#1)
to the level of available##2##5##(1993-6#1)(2008-11#1)
to the level of control##2##5##(1997-3#1)(2010-5#1)
to the level of expression of the##2##7##(2006-8#1)(2008-11#1)
to the level of expression of##3##6##(1995-2#1)(2006-8#1)(2008-11#1)
to the level of the##5##5##(1990-7#1)(1992-3#1)(2006-7#1)(2008-10#1)(2009-9#1)
to the level of##43##4##(1990-12#1)(1990-4#1)(1990-6#1)(1990-7#1)(1992-3#1)(1993-11#1)(1993-6#1)(1994-3#1)(1995-2#2)(1996-7#1)(1997-3#1)(1997-7#1)(2006-2#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-6#1)(2009-9#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-2#3)(2013-7#1)
to the level##61##3##(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-11#1)(1993-6#1)(1993-8#2)(1994-3#1)(1995-2#2)(1995-3#1)(1996-2#1)(1996-7#1)(1997-3#1)(1997-7#1)(2006-2#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-6#1)(2009-9#1)(2010-5#1)(2011-12#1)(2011-2#3)(2012-2#3)(2013-7#1)
to the levels of##9##4##(1990-5#1)(1991-5#1)(1991-9#1)(1992-4#1)(1992-8#1)(1997-8#1)(2006-12#1)(2008-10#1)(2011-2#1)
to the levels required##2##4##(1990-6#1)(2010-7#1)
to the levels##15##3##(1990-5#1)(1990-6#1)(1991-5#1)(1991-9#1)(1992-4#1)(1992-8#1)(1995-9#1)(1997-8#1)(2006-12#1)(2008-10#1)(2009-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)
to the liberation of##2##4##(1990-8#1)(2007-1#1)
to the life##4##3##(2008-2#1)(2008-5#1)(2009-5#1)(2013-8#1)
to the ligament of Treitz##3##5##(2006-8#1)(2008-6#1)(2013-1#1)
to the ligament##4##3##(2006-8#1)(2008-6#1)(2013-1#2)
to the ligand##8##3##(1990-2#1)(1994-11#1)(1994-12#1)(1994-8#1)(1996-6#1)(2008-4#3)
to the ligand-binding##2##3##(1995-11#1)(1995-8#1)
to the light beam##2##4##(2007-12#1)(2007-3#1)
to the light##7##3##(1994-2#1)(1997-2#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-12#1)(2010-8#1)
to the likelihood of##3##4##(1992-2#1)(2007-4#1)(2008-12#1)
to the likelihood##5##3##(1992-2#1)(2007-4#1)(2008-12#1)(2008-8#1)(2012-12#1)
to the limb##2##3##(1990-8#1)(1995-8#1)
to the limited##16##3##(1994-5#1)(2006-11#1)(2007-4#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-10#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
to the line of##2##4##(2008-2#1)(2008-6#1)
to the line##4##3##(2008-2#1)(2008-3#2)(2008-6#1)
to the linear##9##3##(1996-7#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2013-7#1)
to the lines of the grating##3##6##(2008-3#3)
to the lines##4##3##(2008-3#4)
to the link between##3##4##(2012-2#1)(2013-1#2)
to the link##4##3##(2008-3#1)(2012-2#1)(2013-1#2)
to the lipid bilayer##2##4##(1995-11#1)(2009-2#1)
to the lipid membrane##2##4##(1994-5#1)(2005-11#1)
to the lipid monolayers##2##4##(1990-5#1)(1995-5#1)
to the lipid##11##3##(1990-2#1)(1990-5#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-5#1)(2005-11#1)(2008-5#1)(2009-2#1)
to the lipophilic##2##3##(1992-9#1)(2008-10#1)
to the liposomal surface##2##4##(2008-10#2)
to the liposomal##3##3##(2008-10#3)
to the liposome##3##3##(1990-11#1)(1990-5#1)(1994-5#1)
to the liposomes##4##3##(1990-4#1)(1994-3#1)(1996-1#2)
to the liquid##8##3##(1992-9#1)(1994-2#1)(2006-10#1)(2006-2#1)(2008-10#3)(2008-2#1)
to the list of##13##4##(1994-6#1)(1995-12#1)(2006-10#3)(2007-10#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-1#1)(2009-3#1)
to the list##14##3##(1991-11#1)(1994-6#1)(1995-12#1)(2006-10#3)(2007-10#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-1#1)(2009-3#1)
to the literature on##2##4##(2006-9#1)(2008-11#1)
to the literature review##2##4##(2008-11#1)(2012-12#1)
to the literature values##2##4##(2008-10#2)
to the literature##28##3##(1990-6#1)(1991-12#1)(1994-8#1)(1996-3#2)(1996-6#2)(1997-4#1)(1997-6#1)(2006-2#1)(2006-3#1)(2006-9#2)(2007-10#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-6#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-12#1)
to the little##2##3##(2007-5#1)(2009-2#1)
to the liver and the lung##2##6##(1994-7#1)(2010-11#1)
to the liver and##4##4##(1991-4#1)(1992-6#1)(1994-7#1)(2010-11#1)
to the liver##34##3##(1990-2#2)(1990-3#1)(1990-5#1)(1990-8#1)(1991-4#2)(1991-7#1)(1992-11#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-2#1)(1994-7#1)(1995-10#1)(1996-6#1)(1997-3#1)(1997-4#1)(2007-2#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-5#1)(2012-1#1)(2012-2#2)(2013-1#2)
to the living##3##3##(2008-10#1)(2008-12#1)(2013-8#1)
to the load##3##3##(2005-10#1)(2006-11#1)(2013-7#1)
to the loaded##2##3##(2008-10#1)(2009-4#1)
to the local population##2##4##(2008-9#1)(2011-2#1)
to the local##37##3##(1992-1#1)(1993-11#1)(1993-8#1)(1995-5#1)(1995-9#1)(1996-6#1)(1996-8#1)(1997-8#1)(2005-12#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
to the localization of the##2##5##(1991-12#1)(2007-9#1)
to the locally##2##3##(2009-7#1)(2010-4#1)
to the location of the##7##5##(1990-5#1)(1991-6#1)(1993-5#1)(1994-10#1)(2007-8#1)(2008-10#1)(2008-11#1)
to the location of##12##4##(1990-5#1)(1991-6#1)(1993-5#1)(1994-10#1)(1995-11#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-9#1)
to the location##17##3##(1990-5#1)(1991-1#1)(1991-6#1)(1993-5#1)(1994-10#1)(1995-11#1)(1997-3#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2010-9#1)(2012-12#1)
to the locomotor system##2##4##(2007-11#1)(2007-8#1)
to the locomotor##3##3##(1993-3#1)(2007-11#1)(2007-8#1)
to the locus coeruleus##2##4##(1991-9#1)(1996-5#1)
to the locus##3##3##(1991-9#1)(1996-5#1)(2008-10#1)
to the logarithm of the##3##5##(1990-2#1)(2008-10#2)
to the logarithm of##5##4##(1990-2#1)(2008-10#3)(2009-7#1)
to the logistic##3##3##(2007-8#1)(2008-10#1)(2008-3#1)
to the long arm of##2##5##(1995-11#1)(1996-4#1)
to the long axis of the##3##6##(2004-11#1)(2006-11#1)(2009-10#1)
to the long latency##2##4##(1995-2#1)(2010-9#1)
to the long term##2##4##(1992-1#1)(1992-6#1)
to the long##15##3##(1991-3#1)(1992-1#1)(1992-6#1)(1995-11#1)(1995-2#1)(1996-4#1)(1997-7#1)(2004-11#1)(2006-11#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-9#1)(2012-12#1)(2012-2#1)
to the long-term##8##3##(1993-11#1)(1994-6#1)(2007-4#1)(2008-10#1)(2008-4#1)(2010-2#1)(2010-3#1)(2012-3#1)
to the longitudinal axis of the forearm##2##7##(2006-11#2)
to the longitudinal axis of the##4##6##(2006-11#2)(2006-3#1)(2007-12#1)
to the longitudinal##7##3##(1992-12#1)(2004-9#1)(2006-11#2)(2006-3#1)(2007-12#2)
to the loss of a##2##5##(1993-3#1)(2007-7#1)
to the loss of the##6##5##(1991-7#1)(1995-11#1)(1997-4#1)(2008-2#1)(2011-1#1)(2013-8#1)
to the loss of##19##4##(1990-11#1)(1991-11#1)(1991-7#1)(1992-11#1)(1993-3#1)(1995-11#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-7#1)(2007-7#1)(2008-1#1)(2008-2#2)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
to the loss##22##3##(1990-11#1)(1991-11#1)(1991-7#1)(1992-11#1)(1993-3#1)(1995-11#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-2#2)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
to the low affinity##2##4##(1991-5#1)(1996-10#1)
to the low concentrations##2##4##(1992-4#1)(2008-10#1)
to the low content##2##4##(1997-2#1)(2008-10#1)
to the low density lipoprotein receptor##3##6##(1990-11#1)(1994-9#1)(1995-2#1)
to the low density##4##4##(1990-11#1)(1994-9#1)(1995-2#1)(2012-2#1)
to the low level of##2##5##(1994-3#1)(2008-10#1)
to the low level##3##4##(1991-7#1)(1994-3#1)(2008-10#1)
to the low oral##2##4##(2008-8#2)
to the low prevalence of##2##5##(2008-10#1)(2008-3#1)
to the low##52##3##(1990-11#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-4#1)(1994-3#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-4#2)(1996-5#1)(1997-2#2)(2005-11#1)(2006-4#1)(2007-3#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-4#1)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#1)
to the low-affinity##3##3##(1990-11#1)(1990-7#1)(1997-4#1)
to the lower limbs##4##4##(1991-3#1)(2006-10#1)(2012-12#2)
to the lower lobe##2##4##(2007-8#2)
to the lower##38##3##(1990-12#1)(1991-3#1)(1992-3#1)(1992-6#1)(1992-7#1)(1994-11#1)(1996-10#1)(1997-7#1)(2004-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#1)(2009-5#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2012-12#3)(2012-2#1)
to the lower-affinity##2##3##(1992-6#2)
to the lowered##2##3##(2005-9#1)(2008-7#1)
to the lowest level##4##4##(2006-7#1)(2008-10#1)(2008-8#1)(2009-3#1)
to the lowest##9##3##(1991-5#1)(2006-7#1)(2007-11#1)(2008-10#4)(2008-8#1)(2009-3#1)
to the lum and the lux operons in##2##8##(1996-2#2)
to the lum and##3##4##(1996-2#3)
to the lumbar spinal cord##3##5##(1990-4#1)(1990-5#2)
to the lumbar##6##3##(1990-4#1)(1990-5#2)(2006-7#1)(2007-6#1)(2012-2#1)
to the lumen of##2##4##(1994-9#1)(2010-12#1)
to the lumen##5##3##(1994-9#1)(2007-12#1)(2007-9#1)(2008-10#1)(2010-12#1)
to the luminal##3##3##(1990-6#1)(1991-2#1)(1991-9#1)
to the lung##18##3##(1990-12#1)(1990-3#1)(1992-2#2)(1992-9#1)(1996-3#1)(1997-1#1)(2005-11#1)(2007-8#1)(2008-10#3)(2008-7#3)(2010-3#1)(2012-1#1)(2013-8#1)
to the lungfish and caiman calcitonins##2##6##(2008-5#2)
to the lungs and##4##4##(1994-5#1)(1997-1#1)(2007-11#1)(2008-5#1)
to the lungs in##2##4##(1994-9#1)(2008-5#1)
to the lungs of##2##4##(2007-11#1)(2008-6#1)
to the lungs##20##3##(1990-10#1)(1993-3#1)(1994-5#1)(1994-9#1)(1996-3#1)(1997-1#1)(2005-11#1)(2005-8#1)(2006-10#2)(2007-11#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-5#2)(2008-6#1)(2009-3#1)
to the lymph nodes##2##4##(1990-4#1)(2012-3#1)
to the lymph##3##3##(1990-4#1)(1997-6#1)(2012-3#1)
to the lysis##3##3##(1997-4#1)(2006-8#1)(2008-2#1)
to the lysosomal##3##3##(1997-8#1)(2012-12#2)
to the lysosome via transferrin##2##5##(1993-11#2)
to the lytic##2##3##(2008-10#1)(2008-11#1)
to the mRNA for##2##4##(1990-12#1)(1996-12#1)
to the mRNA of##2##4##(1990-3#1)(2011-2#1)
to the mRNA##6##3##(1990-12#1)(1990-3#1)(1994-8#1)(1996-12#2)(2011-2#1)
to the mRNAs##2##3##(1993-11#1)(2008-4#1)
to the macromolecular##2##3##(1993-6#1)(1996-2#1)
to the macromolecule##2##3##(1993-2#1)(2005-11#1)
to the magnetic##5##3##(1990-9#1)(1996-7#1)(2006-11#1)(2009-5#1)(2013-1#1)
to the magnitude of the##6##5##(1990-11#1)(1990-5#1)(1994-12#1)(2007-12#1)(2008-10#1)(2013-8#1)
to the magnitude of##12##4##(1990-11#2)(1990-5#1)(1990-8#1)(1993-12#1)(1993-2#1)(1994-12#1)(2007-12#1)(2008-10#2)(2010-5#1)(2013-8#1)
to the magnitude##13##3##(1990-11#2)(1990-5#1)(1990-8#1)(1993-12#1)(1993-2#1)(1994-12#1)(2007-12#1)(2008-10#2)(2010-5#1)(2012-12#1)(2013-8#1)
to the main chain##2##4##(1991-7#1)(1997-1#1)
to the main##21##3##(1990-4#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-5#1)(1994-6#1)(1997-1#1)(1997-5#1)(1997-6#1)(2004-9#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2010-7#1)
to the maintenance of the##6##5##(1991-10#1)(1992-3#1)(1995-12#1)(1996-1#1)(2006-2#1)(2012-1#1)
to the maintenance of##16##4##(1990-12#1)(1991-10#1)(1992-3#1)(1994-3#1)(1995-12#1)(1996-1#1)(2006-2#1)(2007-5#1)(2008-10#1)(2008-5#2)(2009-6#2)(2012-1#1)(2012-2#1)(2013-8#1)
to the maintenance##19##3##(1990-12#1)(1990-9#1)(1991-10#1)(1992-3#1)(1994-3#1)(1995-12#1)(1996-1#1)(1996-11#1)(2006-2#1)(2007-5#1)(2008-10#1)(2008-5#2)(2009-6#2)(2011-1#1)(2012-1#1)(2012-2#1)(2013-8#1)
to the major groove##4##4##(1991-4#1)(1992-4#1)(1995-10#1)(1996-4#1)
to the major##23##3##(1990-12#1)(1991-4#1)(1992-4#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-8#1)(1996-11#1)(1996-4#1)(1997-9#1)(2005-7#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-4#1)(2010-12#1)(2010-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
to the majority of##6##4##(1991-10#1)(1992-7#1)(1995-10#1)(2007-3#1)(2007-9#1)(2013-8#1)
to the majority##7##3##(1991-10#1)(1992-7#1)(1995-10#1)(2007-3#1)(2007-9#1)(2008-10#1)(2013-8#1)
to the male rat##2##4##(1996-10#1)(1996-9#1)
to the male##8##3##(1993-6#3)(1994-6#1)(1995-8#1)(1996-10#1)(1996-9#1)(2010-2#1)
to the malignant##4##3##(1991-9#1)(2008-4#1)(2008-5#1)(2010-9#1)
to the mammalian bone##2##4##(1990-11#2)
to the mammalian##14##3##(1990-11#2)(1993-5#1)(1993-6#1)(1994-12#1)(1994-5#1)(1995-6#1)(1997-3#1)(2005-9#1)(2008-1#1)(2008-4#2)(2010-12#1)(2010-3#1)
to the mammary gland##2##4##(1993-2#1)(2013-8#1)
to the managed care##2##4##(1994-3#1)(1995-3#1)
to the management of this##4##5##(2008-8#1)(2008-9#1)(2013-1#2)
to the management of##49##4##(1995-12#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-3#3)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-2#2)(2006-5#1)(2007-1#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#2)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#5)(2013-8#1)
to the management##52##3##(1992-9#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-3#3)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-2#2)(2006-5#1)(2007-1#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#2)(2010-12#1)(2010-3#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#2)(2013-1#5)(2013-8#1)
to the managing##2##3##(2011-2#1)(2013-1#1)
to the mandibular##2##3##(2007-12#1)(2013-8#1)
to the manganese##2##3##(1995-8#1)(2008-5#1)
to the manifestation of##2##4##(1993-11#1)(2008-10#1)
to the mannose##2##3##(1995-6#1)(2008-10#1)
to the manual##3##3##(2004-10#1)(2008-10#2)
to the many##9##3##(1990-12#1)(1993-3#1)(2007-7#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-7#1)(2012-2#1)
to the map##2##3##(1990-10#1)(2008-7#1)
to the mapping of##2##4##(1990-5#1)(2012-1#1)
to the marked##4##3##(2005-1#1)(2006-5#1)(2007-8#1)(2008-1#1)
to the markers##3##3##(1997-5#2)(2010-11#1)
to the market##7##3##(1991-12#1)(1997-1#1)(2006-10#1)(2008-10#1)(2008-7#1)(2009-8#1)(2011-2#1)
to the marketplace##3##3##(1994-1#1)(2007-4#1)(2008-11#1)
to the mask##3##3##(2008-2#1)(2008-3#1)(2010-5#1)
to the mass of##3##4##(1990-8#1)(1996-3#1)(2007-8#1)
to the mass##10##3##(1990-8#1)(1992-6#1)(1996-3#1)(2007-12#1)(2007-8#2)(2008-4#1)(2008-6#1)(2009-5#1)(2013-7#1)
to the material##2##3##(2008-10#1)(2010-8#1)
to the maternal##3##3##(2008-5#1)(2009-2#1)(2011-2#1)
to the mathematical##3##3##(2008-10#1)(2008-6#1)(2013-8#1)
to the mating##2##3##(1994-12#1)(2008-9#1)
to the matrix effect##2##4##(2008-10#2)
to the matrix##11##3##(2006-12#1)(2007-4#1)(2008-10#6)(2008-4#1)(2008-5#1)(2013-7#1)
to the maturation##2##3##(1991-9#1)(2006-5#1)
to the mature form##2##4##(1996-7#1)(1997-1#1)
to the mature size##2##4##(1994-2#1)(1996-2#1)
to the mature##14##3##(1990-11#1)(1990-9#1)(1991-11#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#1)(1994-2#1)(1995-2#1)(1996-2#1)(1996-7#1)(1997-1#1)(2006-5#1)(2007-12#1)
to the maximal##3##3##(1994-11#1)(2008-6#1)(2011-2#1)
to the maximization of##2##4##(2008-3#1)(2008-7#1)
to the maximum of##2##4##(1996-5#1)(2008-10#1)
to the maximum##18##3##(1990-7#1)(1991-10#1)(1991-5#1)(1994-5#1)(1995-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(2006-7#1)(2008-10#6)(2008-2#1)(2008-5#1)(2011-2#1)
to the maze##2##3##(1990-7#1)(1993-6#1)
to the mean##18##3##(1994-4#2)(1996-1#1)(1996-12#1)(1997-2#1)(2006-11#2)(2007-12#2)(2008-10#4)(2009-10#1)(2009-8#1)(2011-12#1)(2011-2#1)(2013-8#1)
to the measured data##2##4##(2007-11#1)(2008-2#1)
to the measured##16##3##(1994-12#1)(2005-11#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#5)(2008-3#3)
to the measurement of the##3##5##(2007-12#1)(2008-3#2)
to the measurement of##22##4##(1990-8#1)(1993-1#1)(2006-10#1)(2006-3#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-2#6)(2008-3#4)(2009-7#1)
to the measurement##29##3##(1990-8#1)(1993-1#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-2#7)(2008-3#6)(2009-7#1)(2010-3#1)(2012-3#1)(2013-1#1)
to the measurements##3##3##(2008-2#1)(2008-3#2)
to the mechanical##10##3##(1993-12#1)(1996-11#1)(2006-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-5#1)(2009-7#1)(2009-8#1)
to the mechanism of action of##2##6##(1990-3#1)(2006-10#1)
to the mechanism of##12##4##(1990-2#1)(1990-3#1)(1991-5#1)(1993-4#1)(1994-3#1)(1995-3#1)(1995-8#1)(2005-11#1)(2006-10#1)(2008-7#1)(2012-2#1)(2013-1#1)
to the mechanism##18##3##(1990-2#1)(1990-3#1)(1991-5#1)(1991-8#1)(1992-6#1)(1993-4#1)(1993-6#1)(1994-3#1)(1995-3#1)(1995-8#1)(2005-11#1)(2006-1#1)(2006-10#1)(2008-7#1)(2009-6#1)(2012-12#1)(2012-2#1)(2013-1#1)
to the mechanisms of##4##4##(2006-10#1)(2006-8#1)(2010-12#1)(2011-1#1)
to the mechanisms##8##3##(1996-3#1)(2006-10#1)(2006-8#1)(2007-4#1)(2008-1#1)(2008-7#1)(2010-12#1)(2011-1#1)
to the media noise in##2##5##(2008-2#1)(2008-3#1)
to the media##7##3##(2007-12#2)(2008-11#3)(2008-2#1)(2008-3#1)
to the medial##15##3##(1992-9#1)(1996-9#1)(1997-3#1)(1997-7#1)(2006-12#1)(2008-11#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-2#2)(2010-12#2)(2011-2#1)
to the median##7##3##(1992-4#1)(1995-8#1)(1997-5#1)(2007-7#1)(2008-10#1)(2008-5#2)
to the mediastinum##4##3##(2008-11#1)(2008-6#2)(2012-2#1)
to the medical care system##2##5##(1995-12#2)
to the medical department##2##4##(1990-10#1)(1990-8#1)
to the medical staff##3##4##(1994-2#1)(2007-11#1)(2008-8#1)
to the medical treatment##2##4##(1993-3#1)(2006-10#1)
to the medical##25##3##(1990-10#2)(1990-6#1)(1990-8#1)(1992-3#1)(1992-5#1)(1993-3#1)(1994-2#1)(1995-12#2)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
to the medication##5##3##(1995-2#1)(2006-12#1)(2008-11#2)(2012-12#1)
to the medium containing##2##4##(1997-8#1)(2008-5#1)
to the medium of##4##4##(1991-1#1)(1992-6#2)(1996-9#1)
to the medium was##4##4##(1991-12#1)(1993-12#1)(1993-3#1)(2007-8#1)
to the medium with##2##4##(1993-12#1)(2008-7#1)
to the medium##33##3##(1991-1#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-6#2)(1993-12#3)(1993-3#2)(1993-6#1)(1994-12#1)(1994-6#1)(1995-12#1)(1996-5#1)(1996-9#1)(1997-7#1)(1997-8#1)(2006-4#1)(2006-5#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)
to the medullary##2##3##(1991-3#1)(2008-1#1)
to the membrane and##4##4##(1992-3#1)(2008-2#1)(2008-7#1)(2009-8#1)
to the membrane during##2##4##(1996-5#1)(2013-7#1)
to the membrane fraction##6##4##(1991-2#1)(1991-4#1)(1992-3#1)(1993-8#1)(1995-11#1)(1996-5#1)
to the membrane of##4##4##(1992-12#1)(1993-8#1)(2008-8#1)(2009-2#1)
to the membrane plane##3##4##(1993-8#1)(1997-4#1)(2008-10#1)
to the membrane support##2##4##(1991-5#2)
to the membrane##57##3##(1990-12#1)(1990-2#1)(1990-4#2)(1990-5#1)(1990-7#2)(1990-9#1)(1991-2#1)(1991-3#1)(1991-4#3)(1991-5#2)(1991-7#1)(1992-12#2)(1992-3#2)(1992-7#1)(1993-4#2)(1993-8#6)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#2)(1996-2#1)(1996-3#2)(1996-5#3)(1997-4#1)(1997-6#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-4#1)(2013-7#1)(2013-8#1)
to the membrane-associated##3##3##(1990-5#1)(1992-11#1)(1992-4#1)
to the membrane-bound##2##3##(2005-12#1)(2009-7#1)
to the membranes##9##3##(1990-11#1)(1991-4#1)(1992-3#2)(1992-6#1)(1993-4#1)(1994-11#1)(1996-2#1)(2008-10#1)
to the memory of##2##4##(2011-1#1)(2011-2#1)
to the memory##4##3##(1990-11#1)(2008-11#1)(2011-1#1)(2011-2#1)
to the meningococcal##2##3##(2010-10#2)
to the mental health of##2##5##(2007-3#1)(2012-12#1)
to the mental health##5##4##(2007-3#1)(2008-11#3)(2012-12#1)
to the mental##7##3##(2007-3#1)(2007-8#1)(2008-11#3)(2011-1#1)(2012-12#1)
to the mentally ill##2##4##(2006-9#1)(2008-4#1)
to the mentally##3##3##(1997-2#1)(2006-9#1)(2008-4#1)
to the mentioned##2##3##(2008-11#1)(2008-5#1)
to the metabolic syndrome##5##4##(2008-3#5)
to the metabolic##7##3##(1990-2#1)(2008-3#5)(2013-1#1)
to the metabolism of##2##4##(1995-1#1)(2008-11#1)
to the metal cations##2##4##(2008-10#2)
to the metal##20##3##(1992-7#1)(1993-6#1)(1994-6#2)(1997-2#1)(2006-3#1)(2006-6#2)(2008-10#7)(2008-3#1)(2008-5#2)(2008-7#1)(2010-4#1)
to the metallic state##2##4##(2008-10#1)(2011-1#1)
to the metastasis##2##3##(1991-3#1)(2009-5#1)
to the metastatic##5##3##(1990-8#1)(1991-3#1)(2006-2#1)(2007-6#1)(2010-3#1)
to the method of##8##4##(1993-12#1)(1997-6#1)(1997-7#1)(2007-8#2)(2008-1#1)(2008-10#2)
to the method used##3##4##(1997-3#1)(2008-10#1)(2013-1#1)
to the method##17##3##(1992-4#1)(1993-12#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-10#2)(2007-10#1)(2007-8#2)(2008-1#1)(2008-10#5)(2013-1#1)
to the methodology##4##3##(2006-10#1)(2008-10#1)(2008-11#1)(2011-12#1)
to the methods of##2##4##(1994-3#1)(2012-12#1)
to the methods we##2##4##(1994-6#1)(1996-12#1)
to the methods##4##3##(1994-3#1)(1994-6#1)(1996-12#1)(2012-12#1)
to the methyl group##2##4##(1990-2#1)(1997-2#1)
to the methyl##4##3##(1990-2#1)(1991-2#1)(1994-8#1)(1997-2#1)
to the micellar##2##3##(1997-2#1)(2005-11#1)
to the microbial##3##3##(2006-8#1)(2008-5#1)(2011-12#1)
to the microchip##2##3##(2008-10#2)
to the microorganisms##2##3##(2006-12#1)(2013-8#1)
to the microscopic##2##3##(1995-3#1)(1997-3#1)
to the microsomal binding site##2##5##(1990-2#2)
to the microsomal##3##3##(1990-2#2)(1994-3#1)
to the microstructure##2##3##(2008-3#1)(2009-7#1)
to the microtubule organizing center##2##5##(2008-9#1)(2013-1#1)
to the microtubule##3##3##(1995-1#1)(2008-9#1)(2013-1#1)
to the mid##2##3##(2007-12#1)(2008-12#1)
to the middle cerebral artery (MCA)##3##6##(1996-5#1)(2007-10#1)(2008-7#1)
to the middle third of the##2##6##(1991-4#1)(1993-2#1)
to the middle##9##3##(1991-4#1)(1993-2#1)(1995-5#1)(1996-5#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-7#1)
to the midgut##2##3##(1992-3#1)(2013-7#1)
to the midline##2##3##(1990-8#1)(2005-9#1)
to the mild##2##3##(1993-12#1)(2008-10#1)
to the military##2##3##(2008-7#1)(2009-6#1)
to the miniature##2##3##(2008-10#1)(2009-10#1)
to the minimal##7##3##(1992-2#1)(1996-8#1)(1997-7#1)(2005-5#1)(2006-12#1)(2008-10#1)(2009-4#1)
to the minimization of##2##4##(2008-2#1)(2008-3#1)
to the minimum##8##3##(1990-11#1)(1990-4#1)(1991-3#1)(1992-3#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-7#1)
to the minor##3##3##(1991-11#1)(1991-8#1)(2006-12#1)
to the missing##2##3##(1993-3#1)(2008-2#1)
to the mitochondria and##2##4##(2008-11#1)(2011-2#1)
to the mitochondria##6##3##(1992-6#1)(1994-8#1)(2008-10#1)(2008-11#2)(2011-2#1)
to the mitochondrial##4##3##(1995-2#1)(1995-6#1)(1997-2#1)(2009-8#1)
to the mitogenic##2##3##(1991-1#1)(1992-9#1)
to the mitral valve##2##4##(2008-4#1)(2012-12#1)
to the mixed##2##3##(1993-12#1)(1997-8#1)
to the mixture of##2##4##(2008-10#1)(2008-6#1)
to the mixture##4##3##(1995-8#1)(2005-11#1)(2008-10#1)(2008-6#1)
to the mobile phase##5##4##(1993-12#1)(1995-6#1)(2008-10#2)(2011-1#1)
to the mobilization of##2##4##(1992-3#1)(1996-8#1)
to the model##21##3##(2005-11#1)(2006-10#2)(2006-11#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2009-2#1)(2009-9#1)(2010-5#1)(2012-1#1)(2012-3#2)
to the models##2##3##(2006-11#1)(2009-4#1)
to the modification of##5##4##(1990-8#1)(1991-8#1)(2007-11#1)(2008-1#1)(2010-2#1)
to the modified base##2##4##(1991-1#1)(1991-7#1)
to the modified##10##3##(1990-8#1)(1991-1#1)(1991-7#1)(1993-2#1)(1995-11#1)(2008-10#2)(2008-2#1)(2008-4#1)(2010-10#1)
to the modulation of##2##4##(2010-12#1)(2010-2#1)
to the modulation##3##3##(2008-3#1)(2010-12#1)(2010-2#1)
to the modulator##2##3##(2007-12#1)(2008-2#1)
to the modulatory##2##3##(1991-9#1)(1993-3#1)
to the moisture##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
to the molecular basis of##2##5##(1993-3#1)(2011-1#1)
to the molecular mechanisms of##2##5##(1997-4#1)(2005-7#1)
to the molecular structure of##2##5##(2008-10#1)(2012-2#1)
to the molecular structure##3##4##(2008-10#1)(2008-4#1)(2012-2#1)
to the molecular##20##3##(1991-6#1)(1992-2#1)(1993-3#1)(1996-5#2)(1997-4#1)(2005-7#1)(2006-10#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-4#1)(2010-1#1)(2011-1#1)(2012-2#3)
to the monitoring of##9##4##(1992-3#1)(1996-8#1)(2008-10#5)(2008-2#1)(2010-5#1)
to the monitoring##11##3##(1992-3#1)(1996-8#1)(2008-10#5)(2008-2#1)(2008-6#1)(2010-4#1)(2010-5#1)
to the monoclonal antibody##5##4##(1990-12#1)(1995-12#1)(1996-5#1)(2005-11#1)(2008-10#1)
to the monoclonal##6##3##(1990-12#2)(1995-12#1)(1996-5#1)(2005-11#1)(2008-10#1)
to the monolayer##2##3##(1992-6#1)(1996-1#1)
to the monomer##5##3##(1990-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#1)
to the morbidity and mortality associated with##3##7##(2007-8#1)(2008-1#1)(2012-12#1)
to the morbidity and mortality##6##5##(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2012-12#1)
to the morbidity and##7##4##(1997-8#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2012-12#1)
to the more common##2##4##(2006-8#1)(2009-5#1)
to the more commonly used##3##5##(1991-12#1)(1997-4#1)(2008-1#1)
to the more severe##3##4##(2006-11#1)(2008-4#1)(2013-8#1)
to the more##35##3##(1990-5#1)(1991-12#1)(1993-4#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-11#1)(1996-2#1)(1996-5#2)(1997-4#1)(1997-7#2)(2005-12#1)(2006-10#2)(2006-11#2)(2006-8#1)(2007-10#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2011-12#1)(2011-2#1)(2013-8#2)
to the morphological and##2##4##(1992-6#1)(2012-9#1)
to the morphological##7##3##(1992-6#1)(2006-6#1)(2008-10#1)(2008-6#1)(2009-8#1)(2010-4#1)(2012-9#1)
to the morphology and##2##4##(2006-10#1)(2009-7#1)
to the morphology of the##2##5##(1992-6#1)(2006-5#1)
to the morphology of##4##4##(1992-6#1)(2006-5#2)(2007-5#1)
to the morphology##6##3##(1992-6#1)(2006-10#1)(2006-5#2)(2007-5#1)(2009-7#1)
to the mortality##3##3##(1990-10#1)(2008-8#1)(2008-9#1)
to the most common##5##4##(2006-6#1)(2008-10#1)(2009-2#1)(2010-8#1)(2012-2#1)
to the most important##3##4##(2007-11#1)(2011-2#1)(2013-8#1)
to the most modern##2##4##(1990-9#1)(2008-10#1)
to the most potent##3##4##(1995-5#1)(2006-9#1)(2013-1#1)
to the most recent data##2##5##(2008-4#1)(2011-3#1)
to the most recent findings##3##5##(2006-2#1)(2007-9#1)(2013-8#1)
to the most recent##8##4##(2006-2#1)(2007-9#1)(2008-4#1)(2008-8#1)(2010-7#1)(2011-3#1)(2012-2#1)(2013-8#1)
to the most suitable##3##4##(1990-10#1)(1994-2#1)(1996-12#1)
to the most##53##3##(1990-10#1)(1990-9#1)(1992-12#1)(1993-8#1)(1994-2#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-2#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#3)(2013-1#1)(2013-8#2)
to the mother##5##3##(2006-2#1)(2008-8#1)(2008-9#1)(2010-9#1)(2013-1#1)
to the motion##2##3##(2008-2#1)(2008-6#1)
to the motor##4##3##(2006-12#1)(2007-7#1)(2012-1#1)(2013-7#1)
to the mouse and human SCFs##2##6##(1993-5#2)
to the mouse and human##5##5##(1990-3#3)(1993-5#2)
to the mouse and##6##4##(1990-3#3)(1992-11#1)(1993-5#2)
to the mouse##22##3##(1990-2#1)(1990-3#4)(1991-11#2)(1991-8#1)(1992-11#1)(1993-2#1)(1993-4#1)(1993-5#2)(1994-12#2)(1994-5#1)(1994-9#1)(1997-4#1)(1997-9#1)(2008-11#1)(2008-4#1)(2012-3#1)
to the mouth##3##3##(1991-1#1)(2009-10#1)(2011-2#1)
to the movement##3##3##(2008-10#1)(2012-1#1)(2013-1#1)
to the moving##2##3##(1996-1#1)(2009-6#1)
to the much##6##3##(1991-11#1)(1994-1#1)(1994-11#1)(2008-10#2)(2013-7#1)
to the mucosa##4##3##(2006-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
to the mucosal##2##3##(2006-10#1)(2008-1#1)
to the multidisciplinary team##3##4##(2010-3#1)(2012-12#1)(2012-2#1)
to the multifunctional##2##3##(1996-5#1)(2008-11#1)
to the multiple##3##3##(1996-2#1)(2008-7#1)(2011-1#1)
to the murine##3##3##(1990-5#1)(1991-12#1)(1996-5#1)
to the muscle and##2##4##(2008-5#1)(2012-3#1)
to the muscle cell##2##4##(1996-3#2)
to the muscle##10##3##(1991-6#1)(1994-8#1)(1996-3#2)(2005-10#1)(2008-2#1)(2008-5#1)(2010-4#1)(2012-12#1)(2012-3#1)
to the musculotendinous junction##2##4##(2009-3#1)(2013-1#1)
to the musculotendinous##3##3##(2007-8#1)(2009-3#1)(2013-1#1)
to the mutant##3##3##(2008-10#1)(2008-8#2)
to the mutation##3##3##(1990-12#1)(2008-10#1)(2012-11#1)
to the mutations##2##3##(2011-1#1)(2012-12#1)
to the mutual##3##3##(2007-10#1)(2007-12#1)(2008-10#1)
to the mycelium##2##3##(2008-10#1)(2008-4#1)
to the myocardium##8##3##(2004-11#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-8#1)(2012-1#1)(2013-1#1)
to the myosin##2##3##(1996-11#1)(1997-4#1)
to the nail##4##3##(2008-5#3)(2013-8#1)
to the naked##2##3##(2007-12#1)(2008-8#1)
to the nanometer##2##3##(2007-9#1)(2008-2#1)
to the nasal##3##3##(1997-1#1)(2007-4#1)(2007-5#1)
to the nation##2##3##(2006-10#1)(2006-7#1)
to the national##8##3##(1993-5#1)(1995-12#1)(2006-4#1)(2008-8#1)(2010-8#1)(2011-1#1)(2013-7#1)(2013-8#1)
to the native enzyme##3##4##(1995-1#1)(1995-2#1)(1995-8#1)
to the native protein##4##4##(1993-6#1)(1994-8#1)(1995-1#1)(1995-2#1)
to the native state##2##4##(1995-3#1)(1997-4#1)
to the native structure##3##4##(1991-5#1)(1995-1#1)(1995-4#1)
to the native##32##3##(1990-11#1)(1990-2#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-2#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-8#2)(1995-1#3)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-8#1)(1997-2#2)(1997-4#2)(2008-10#2)(2008-6#1)(2008-7#1)(2010-5#1)
to the natural history model for patient survival##2##8##(2004-11#2)
to the natural history##3##4##(1996-3#1)(2004-11#2)
to the natural product##2##4##(2009-5#2)
to the natural##14##3##(1994-11#1)(1995-10#1)(1996-3#1)(1997-4#1)(2004-11#2)(2006-10#1)(2006-12#1)(2008-2#2)(2008-5#1)(2009-5#2)(2012-3#1)
to the naturally occurring##2##4##(1991-9#1)(2008-10#1)
to the naturally##3##3##(1991-9#1)(2008-1#1)(2008-10#1)
to the nature and extent of##2##6##(2011-1#1)(2012-2#1)
to the nature and##4##4##(1994-3#1)(2006-10#1)(2011-1#1)(2012-2#1)
to the nature of the##17##5##(1991-10#1)(1991-4#1)(1992-3#1)(1993-10#1)(1996-8#1)(2004-3#1)(2005-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2011-2#1)(2013-1#2)
to the nature of##28##4##(1991-10#1)(1991-4#1)(1992-3#1)(1993-10#1)(1996-4#1)(1996-8#1)(2004-10#1)(2004-3#1)(2004-4#1)(2005-11#1)(2005-9#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#3)
to the nature##32##3##(1991-10#1)(1991-4#1)(1992-3#1)(1993-10#1)(1994-3#1)(1996-4#1)(1996-8#1)(2004-10#1)(2004-3#1)(2004-4#1)(2005-11#1)(2005-9#1)(2006-10#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)
to the near infrared##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
to the near##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
to the near-infrared##2##3##(2007-8#1)(2008-5#1)
to the nearby##2##3##(1990-11#1)(1991-8#1)
to the nearest##8##3##(1992-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2012-1#1)
to the nebulizer##2##3##(2008-10#2)
to the necessity of##5##4##(1997-4#1)(2005-8#1)(2007-12#1)(2009-5#1)(2010-4#1)
to the necessity to##2##4##(2007-11#1)(2012-2#1)
to the necessity##7##3##(1997-4#1)(2005-8#1)(2007-11#1)(2007-12#1)(2009-5#1)(2010-4#1)(2012-2#1)
to the neck##6##3##(1992-6#1)(1996-4#1)(2007-4#3)(2008-10#1)
to the need for a better##2##6##(1991-6#1)(2011-2#1)
to the need for a##4##5##(1991-6#1)(2008-12#1)(2008-2#1)(2011-2#1)
to the need for##25##4##(1990-12#1)(1991-3#1)(1991-6#1)(1994-2#1)(1995-5#1)(1995-8#1)(2004-10#1)(2006-10#2)(2006-5#1)(2006-6#1)(2006-7#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#1)
to the need of##5##4##(1996-5#1)(2007-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
to the need to##14##4##(1997-2#1)(2006-10#2)(2006-3#1)(2007-10#1)(2007-12#1)(2008-3#1)(2008-6#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#1)
to the need##45##3##(1990-12#1)(1991-3#1)(1991-6#1)(1994-2#1)(1995-5#1)(1995-8#1)(1996-5#1)(1997-2#1)(2004-10#1)(2006-10#4)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2009-2#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-4#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
to the needle##2##3##(1996-9#1)(2008-3#1)
to the needs and##3##4##(2007-8#1)(2008-7#2)
to the needs of children##2##5##(2010-7#1)(2012-2#1)
to the needs of each##2##5##(2007-12#1)(2008-6#1)
to the needs of the individual##2##6##(2008-8#1)(2013-8#1)
to the needs of the patient##2##6##(2006-10#1)(2006-3#1)
to the needs of the people##2##6##(2007-3#1)(2009-12#1)
to the needs of the##15##5##(1995-1#1)(1996-3#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-8#1)(2009-12#1)(2009-6#1)(2013-8#2)
to the needs of##30##4##(1994-1#1)(1995-1#2)(1996-2#1)(1996-3#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-6#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-8#2)
to the needs##34##3##(1994-1#1)(1995-1#2)(1996-2#1)(1996-3#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-6#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-8#2)
to the negative consequences of##2##5##(2010-2#1)(2013-7#1)
to the negative control##3##4##(1990-6#1)(2006-10#1)(2006-12#1)
to the negative element##2##4##(2008-11#2)
to the negative regulatory##2##4##(1991-12#1)(2008-11#1)
to the negative##21##3##(1990-6#1)(1991-12#1)(1992-6#1)(1994-2#1)(1995-3#1)(1996-11#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-4#1)(2009-12#1)(2009-8#1)(2010-2#1)(2013-7#1)
to the negligible##2##3##(1995-11#1)(2007-11#1)
to the nematode##4##3##(1997-2#1)(2007-12#1)(2008-10#2)
to the nematodes##2##3##(2008-10#1)(2008-12#1)
to the neocortex##3##3##(1990-7#1)(1991-3#1)(1992-10#1)
to the neonatal intensive care unit (NICU)##2##7##(1993-3#1)(1993-5#1)
to the neonatal intensive care unit##3##6##(1993-3#1)(1993-5#1)(2007-3#1)
to the neonatal##5##3##(1993-3#1)(1993-5#1)(2006-8#2)(2007-3#1)
to the nerve##2##3##(1995-8#1)(2006-3#1)
to the nerves of the##2##5##(1993-2#1)(2007-7#1)
to the nerves##4##3##(1993-2#1)(2007-7#2)(2008-1#1)
to the nervous system##5##4##(1991-6#1)(1994-5#1)(2007-11#1)(2008-1#1)(2008-4#1)
to the nest of a##2##5##(2008-9#2)
to the net##4##3##(1991-4#1)(1996-7#1)(1996-8#1)(1997-7#1)
to the network##3##3##(2005-10#1)(2008-11#1)(2008-3#1)
to the neural##5##3##(1991-3#1)(2007-12#2)(2011-2#2)
to the neurological##5##3##(2005-12#1)(2007-8#1)(2007-9#1)(2011-2#1)(2013-8#1)
to the neuron-specific##2##3##(1991-9#1)(1994-3#1)
to the neuronal cell bodies##2##5##(1991-12#1)(1997-7#1)
to the neuronal voltage-dependent sodium channel##2##6##(1994-9#2)
to the neuronal##9##3##(1990-12#1)(1991-12#2)(1991-3#1)(1994-9#2)(1996-11#1)(1996-12#1)(1997-7#1)
to the neuroprotective##2##3##(2006-7#1)(2007-10#1)
to the neurosurgical##2##3##(2006-7#1)(2012-3#1)
to the neurotoxic effects of##2##5##(1993-4#1)(1996-12#1)
to the neurotoxic effects##3##4##(1993-4#1)(1996-12#1)(2008-7#1)
to the neurotoxic##6##3##(1990-11#1)(1993-4#1)(1996-12#1)(1997-8#1)(2007-12#1)(2008-7#1)
to the neurotoxicity##2##3##(1993-7#1)(2007-7#1)
to the neutral##3##3##(2007-1#1)(2008-10#1)(2008-4#1)
to the neutralization##2##3##(2006-10#1)(2012-11#1)
to the new environment##2##4##(2009-4#1)(2012-2#1)
to the new##30##3##(1991-1#1)(1991-10#1)(1991-3#1)(1992-9#1)(1994-1#1)(1994-12#1)(1994-9#1)(1997-2#2)(1997-4#1)(2004-9#1)(2005-11#1)(2006-6#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#2)
to the newborn##2##3##(1995-9#1)(2011-2#1)
to the newer##3##3##(1996-1#1)(2007-11#1)(2008-8#1)
to the newly developed##3##4##(1996-2#1)(1997-4#1)(2006-4#1)
to the newly##7##3##(1991-5#1)(1996-2#1)(1997-4#1)(1997-6#1)(2004-9#1)(2006-4#1)(2008-3#1)
to the next generation of##3##5##(2007-11#1)(2010-10#1)(2012-12#1)
to the next generation##6##4##(1997-8#1)(2007-11#1)(2008-8#1)(2010-10#2)(2012-12#1)
to the next in##3##4##(1990-5#1)(1994-9#1)(2008-11#1)
to the next level##3##4##(2009-4#1)(2011-1#1)(2013-8#1)
to the next stage##3##4##(1997-4#1)(2007-11#1)(2008-3#1)
to the next step##2##4##(1994-11#1)(2007-4#1)
to the next##41##3##(1990-10#1)(1990-5#1)(1993-6#1)(1994-11#1)(1994-9#1)(1996-3#1)(1997-4#1)(1997-8#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-7#3)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#3)(2008-8#3)(2008-9#1)(2009-4#1)(2010-10#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
to the niche##3##3##(2008-1#1)(2009-3#2)
to the nicotinic##2##3##(1990-2#1)(2008-4#1)
to the ninth##3##3##(2007-12#2)(2008-3#1)
to the nipple##2##3##(1994-12#1)(1996-6#1)
to the nitrite##2##3##(2008-10#2)
to the nitro group##2##4##(1995-6#1)(2007-11#1)
to the nociceptive##4##3##(1992-7#2)(1993-9#1)(2009-7#1)
to the nodule##2##3##(2008-7#1)(2013-8#1)
to the noise level##2##4##(2009-8#1)(2012-2#1)
to the noise##4##3##(2008-2#1)(2008-3#1)(2009-8#1)(2012-2#1)
to the nominal##5##3##(1992-2#1)(2006-7#1)(2007-5#1)(2012-3#2)
to the non-permissive temperature##2##4##(1995-3#1)(1995-6#1)
to the non-treated##2##3##(2004-4#1)(2008-11#1)
to the nonlinear##10##3##(1991-8#1)(2005-4#1)(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#1)
to the norm##2##3##(2008-11#2)
to the normal level##7##4##(1991-2#1)(1996-9#1)(1997-2#1)(2008-11#1)(2008-6#1)(2010-12#1)(2012-1#1)
to the normal range##2##4##(2006-7#1)(2008-7#1)
to the normal values##2##4##(2008-7#1)(2010-12#1)
to the normal##36##3##(1990-3#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-7#2)(1992-3#1)(1994-12#2)(1994-9#1)(1995-11#1)(1996-9#1)(1997-2#1)(2006-10#1)(2006-7#1)(2007-2#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#1)
to the normotensive state##2##4##(2013-8#2)
to the north##6##3##(2007-5#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-10#1)
to the nose and##2##4##(2007-4#1)(2010-5#1)
to the nose##3##3##(2007-4#2)(2010-5#1)
to the notion of##2##4##(2006-3#1)(2012-1#1)
to the notion that the##2##5##(1997-7#1)(2008-3#1)
to the notion that##5##4##(1997-7#1)(2006-2#1)(2008-3#1)(2008-5#1)(2012-1#1)
to the notion##7##3##(1997-7#1)(2006-2#1)(2006-3#1)(2008-3#1)(2008-5#1)(2012-1#2)
to the novel##6##3##(1990-8#1)(2008-5#1)(2008-7#1)(2008-8#2)(2013-7#1)
to the nozzle##2##3##(2006-4#1)(2010-9#1)
to the nuclear envelope and##2##5##(2008-9#1)(2011-2#1)
to the nuclear envelope##4##4##(2008-9#1)(2011-2#2)(2012-2#1)
to the nuclear matrix##4##4##(1990-8#1)(1991-8#1)(1994-9#1)(1996-11#1)
to the nuclear##17##3##(1990-8#1)(1991-8#2)(1994-9#1)(1995-1#1)(1995-6#1)(1996-11#1)(1997-4#1)(2007-8#1)(2008-7#1)(2008-9#1)(2011-2#4)(2012-2#1)(2013-8#1)
to the nucleolus##2##3##(1994-9#2)
to the nucleotide##6##3##(1990-12#1)(1994-5#1)(2008-10#2)(2013-1#1)(2013-8#1)
to the nucleus and##7##4##(1990-8#1)(1994-9#1)(1995-8#1)(1997-6#1)(2006-10#1)(2008-7#2)
to the nucleus as##2##4##(1991-1#1)(1994-6#1)
to the nucleus by##2##4##(2008-1#1)(2008-10#1)
to the nucleus follows##2##4##(1991-5#2)
to the nucleus in##2##4##(1997-6#1)(2011-2#1)
to the nucleus of the solitary tract##2##7##(1996-5#1)(2013-1#1)
to the nucleus of##4##4##(1996-5#1)(1997-6#1)(2009-10#1)(2013-1#1)
to the nucleus tractus##3##4##(1991-8#2)(1997-5#1)
to the nucleus##51##3##(1990-11#1)(1990-12#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-5#4)(1991-8#2)(1993-12#1)(1993-6#1)(1993-7#1)(1994-6#2)(1994-9#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-10#2)(1996-2#1)(1996-5#1)(1997-1#1)(1997-5#1)(1997-6#4)(2005-11#1)(2006-10#2)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
to the null##3##3##(1992-1#1)(2008-3#1)(2008-8#1)
to the number and##2##4##(2006-8#1)(2008-3#1)
to the number of cells##2##5##(2006-12#1)(2008-11#1)
to the number of maxima in the ACE strategy##2##9##(2008-9#2)
to the number of##69##4##(1990-10#1)(1990-5#2)(1990-8#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-8#2)(1996-12#1)(1997-3#1)(1997-6#1)(2004-12#1)(2006-10#2)(2006-12#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#6)(2009-10#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-1#1)(2013-8#2)
to the number##75##3##(1990-10#1)(1990-5#2)(1990-8#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-8#2)(1996-12#1)(1996-4#1)(1997-3#1)(1997-6#1)(2004-12#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#3)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#4)(2008-9#6)(2009-10#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-1#1)(2013-8#3)
to the numbers##2##3##(2012-2#1)(2013-1#1)
to the numerous##2##3##(2006-11#1)(2008-10#1)
to the nursing home##2##4##(1992-1#1)(2010-10#1)
to the nursing profession##2##4##(2013-8#2)
to the nursing##6##3##(1992-1#1)(2005-10#1)(2008-11#1)(2010-10#1)(2013-8#2)
to the nutritional##5##3##(2005-10#1)(2007-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
to the object##6##3##(1993-7#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-9#1)
to the observation of##2##4##(2008-10#1)(2011-1#1)
to the observation that the##2##5##(2008-5#1)(2011-1#1)
to the observation that##3##4##(2005-9#1)(2008-5#1)(2011-1#1)
to the observation##6##3##(2005-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-1#2)
to the observed data##4##4##(2008-10#2)(2008-7#1)(2008-8#1)
to the observed##31##3##(1990-8#1)(1991-1#1)(1991-10#1)(1991-7#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-8#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-10#1)(2010-12#1)(2011-2#1)
to the observer##3##3##(2007-12#1)(2012-2#2)
to the obstruction##2##3##(2008-3#1)(2010-6#1)
to the obtained##2##3##(2011-2#2)
to the occipital##4##3##(1996-9#1)(2006-5#1)(2008-7#1)(2011-1#1)
to the occiput##2##3##(2006-12#1)(2006-9#1)
to the occupational##2##3##(2007-3#1)(2008-7#1)
to the occurrence of the##3##5##(1991-3#1)(2008-10#1)(2011-2#1)
to the occurrence of##29##4##(1991-3#1)(1994-9#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(2007-10#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-2#1)
to the occurrence##30##3##(1991-3#1)(1994-9#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(2006-10#1)(2007-10#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-2#1)
to the ocular##2##3##(1992-2#1)(2009-8#1)
to the odor of##3##4##(1994-8#1)(2006-12#1)(2009-8#1)
to the official##3##3##(1991-9#1)(2008-10#2)
to the offspring##2##3##(2007-2#1)(2012-1#1)
to the oh8Gua##3##3##(1997-1#3)
to the oil/water interface##2##4##(2005-11#2)
to the old##3##3##(2007-7#1)(2008-8#1)(2012-3#1)
to the older##3##3##(1992-7#1)(1994-4#1)(2010-10#1)
to the olfactory bulb##2##4##(2007-5#1)(2008-1#1)
to the olfactory##4##3##(2006-12#1)(2007-5#1)(2008-1#1)(2012-2#1)
to the oligosaccharide##2##3##(1992-10#1)(1993-7#1)
to the on-axis##2##3##(2007-11#1)(2008-2#1)
to the oncogenic##2##3##(1991-7#1)(2006-10#1)
to the oncologist##3##3##(2008-10#1)(2008-5#1)(2008-6#1)
to the one of##2##4##(2009-11#1)(2011-2#1)
to the one used##2##4##(1992-1#1)(2010-2#1)
to the one##14##3##(1992-1#1)(1995-4#1)(1995-5#1)(1996-2#1)(1996-9#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-4#1)(2009-11#1)(2010-2#1)(2010-7#1)(2011-2#1)
to the ones##7##3##(1992-9#1)(1994-6#1)(2007-1#1)(2008-11#2)(2008-2#1)(2008-4#1)
to the ongoing debate##3##4##(2006-10#1)(2007-7#1)(2009-10#1)
to the ongoing##5##3##(2006-10#1)(2007-7#1)(2008-1#1)(2009-10#1)(2012-6#1)
to the only##3##3##(1993-3#1)(1995-3#1)(2008-8#1)
to the onset and progression of##2##6##(1993-9#1)(2011-2#1)
to the onset and##4##4##(1993-9#1)(2008-3#1)(2010-12#1)(2011-2#1)
to the onset of AD##2##5##(1996-6#1)(2009-10#1)
to the onset of organ##3##5##(2013-1#3)
to the onset of symptoms##3##5##(2004-11#1)(2006-8#1)(2009-8#1)
to the onset of the disease##2##6##(2009-3#1)(2009-8#1)
to the onset of the##4##5##(1991-11#1)(1993-2#1)(2009-3#1)(2009-8#1)
to the onset of##34##4##(1990-7#1)(1991-1#1)(1991-11#1)(1991-5#1)(1991-8#1)(1991-9#1)(1993-2#1)(1994-2#1)(1994-4#1)(1996-2#1)(1996-6#1)(2004-11#2)(2006-8#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-8#2)(2010-10#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#3)
to the onset##39##3##(1990-7#1)(1991-1#1)(1991-11#1)(1991-5#1)(1991-8#1)(1991-9#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-4#1)(1996-2#1)(1996-6#1)(2004-11#2)(2006-8#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#3)
to the oocyte##3##3##(1991-12#1)(2007-12#1)(2008-10#1)
to the open reading##2##4##(1993-4#1)(2013-8#1)
to the open##8##3##(1991-5#1)(1993-4#1)(1993-5#1)(1994-6#1)(2007-3#1)(2010-12#1)(2012-12#1)(2013-8#1)
to the opening##4##3##(1991-8#1)(1993-12#1)(1995-2#1)(2007-4#1)
to the operated side##2##4##(1995-8#1)(2008-6#1)
to the operated##3##3##(1995-8#1)(2007-8#1)(2008-6#1)
to the operating room##6##4##(2006-9#1)(2009-3#1)(2009-6#1)(2010-12#1)(2011-12#1)(2012-3#1)
to the operating##11##3##(1991-8#1)(2006-5#1)(2006-6#1)(2006-9#1)(2008-7#1)(2009-3#1)(2009-6#1)(2010-12#1)(2011-12#1)(2012-3#1)(2013-8#1)
to the operation of the##2##5##(1995-12#1)(2007-12#1)
to the operation of##4##4##(1995-12#1)(2007-12#1)(2008-2#1)(2008-3#1)
to the operation##9##3##(1995-12#1)(1996-12#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2013-1#1)
to the operative##3##3##(1996-1#1)(1997-8#1)(2008-10#1)
to the ophthalmic artery##3##4##(2005-5#1)(2008-7#1)(2009-8#1)
to the opinion##3##3##(1995-5#1)(1995-6#1)(1997-3#1)
to the opposite##10##3##(1990-8#1)(1991-10#1)(1992-9#1)(1994-12#1)(1995-2#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
to the optic nerve##3##4##(1995-9#1)(2011-1#1)(2011-2#1)
to the optic##4##3##(1995-9#1)(2008-3#1)(2011-1#1)(2011-2#1)
to the optical axis of the##2##6##(2008-3#2)
to the optical axis##5##4##(2008-2#2)(2008-3#3)
to the optical##28##3##(1990-8#1)(2007-11#2)(2007-12#6)(2008-2#5)(2008-3#11)(2008-9#1)(2010-1#1)(2012-2#1)
to the optically pure##2##4##(1995-3#2)
to the optimal combination of multiple tests##2##7##(2010-2#2)
to the optimal##14##3##(1995-4#2)(1997-8#1)(2004-10#1)(2005-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-3#1)(2010-2#2)(2012-12#1)(2012-2#2)
to the optimization of the##2##5##(2008-10#1)(2008-3#1)
to the optimization of##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
to the optimization##5##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-2#1)
to the optimized##2##3##(2008-10#1)(2008-2#1)
to the optimum##9##3##(1991-11#1)(1992-5#1)(1997-6#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
to the oral##11##3##(1990-12#1)(1991-8#1)(1994-11#1)(1996-10#1)(2005-8#1)(2007-12#3)(2011-1#1)(2012-2#1)(2013-8#1)
to the orbit##3##3##(2006-12#2)(2013-7#1)
to the orbital##3##3##(2006-12#1)(2009-2#1)(2010-12#1)
to the order of##4##4##(2005-11#1)(2005-4#1)(2007-12#1)(2008-10#1)
to the order##10##3##(2005-11#1)(2005-12#1)(2005-4#1)(2007-12#2)(2008-10#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
to the ordinary##6##3##(1991-6#1)(2007-12#1)(2008-2#2)(2008-6#1)(2008-7#1)
to the organ##3##3##(1991-5#1)(2008-7#1)(2009-2#1)
to the organic layer##2##4##(2008-10#1)(2010-4#1)
to the organic##7##3##(1990-9#1)(2008-10#4)(2008-5#1)(2010-4#1)
to the organism##5##3##(2006-10#1)(2009-8#1)(2010-4#1)(2011-2#1)(2013-1#1)
to the organization of the##2##5##(1991-5#1)(1993-9#1)
to the organization of##4##4##(1991-5#1)(1993-9#1)(1994-2#1)(2009-7#1)
to the organization##13##3##(1991-5#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-2#2)(1996-2#1)(2007-1#1)(2009-7#1)(2010-7#1)(2011-1#3)
to the orientation of the##4##5##(1992-6#1)(2007-11#1)(2007-12#1)(2009-12#1)
to the orientation##5##3##(1990-3#1)(1992-6#1)(2007-11#1)(2007-12#1)(2009-12#1)
to the origin of replication##2##5##(1995-3#2)
to the origin of the##7##5##(1993-3#1)(2004-3#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-5#1)
to the origin of##11##4##(1993-3#1)(1994-12#1)(1994-3#1)(1995-3#2)(2004-3#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-5#1)
to the origin##12##3##(1993-3#1)(1994-12#1)(1994-3#1)(1995-3#2)(1997-8#1)(2004-3#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-5#1)
to the original concentration##2##4##(2008-10#2)
to the original level##3##4##(1990-2#1)(1992-9#1)(1994-5#1)
to the original location##2##4##(2008-10#1)(2009-4#1)
to the original##50##3##(1990-2#2)(1990-9#1)(1991-2#1)(1991-5#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-1#1)(2004-9#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-6#1)(2008-8#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
to the origins of##3##4##(2006-7#1)(2007-12#1)(2008-6#1)
to the orthogonal##2##3##(2008-1#1)(2008-2#1)
to the orthopedic surgeon##2##4##(2008-8#1)(2009-8#1)
to the orthopedic##4##3##(2007-11#1)(2007-8#1)(2008-8#1)(2009-8#1)
to the orthorhombic space group##3##5##(1992-8#1)(1994-9#1)(1997-6#1)
to the orthorhombic system##2##4##(1992-12#1)(1997-7#1)
to the orthorhombic##6##3##(1992-12#1)(1992-8#1)(1994-9#1)(1997-6#1)(1997-7#1)(2013-8#1)
to the osteopathic##2##3##(1991-12#1)(2008-3#1)
to the other drugs##2##4##(2008-10#1)(2008-8#1)
to the other five##3##4##(2007-2#1)(2007-8#1)(2008-5#1)
to the other groups##5##4##(1996-8#1)(1997-2#1)(2008-1#1)(2008-4#1)(2008-8#1)
to the other in##3##4##(1994-9#1)(2008-10#1)(2008-3#1)
to the other metal##4##4##(1991-4#1)(1997-2#2)(2008-10#1)
to the other ones##2##4##(2008-5#1)(2012-12#1)
to the other three##6##4##(1990-3#1)(1997-1#1)(2008-10#2)(2008-7#1)(2009-11#1)
to the other two##10##4##(1993-2#1)(1995-10#1)(1996-12#1)(2006-12#1)(2007-10#1)(2007-2#1)(2008-10#2)(2010-2#1)(2010-7#1)
to the other##126##3##(1990-12#3)(1990-3#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-1#2)(1992-3#1)(1993-10#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#2)(1994-9#2)(1995-1#2)(1995-10#1)(1995-2#2)(1996-12#3)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-5#1)(2006-12#2)(2007-10#3)(2007-11#4)(2007-12#3)(2007-2#2)(2007-4#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#23)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#7)(2008-7#2)(2008-8#2)(2009-11#2)(2009-4#1)(2009-8#1)(2010-2#2)(2010-3#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
to the others##9##3##(1994-5#1)(2008-10#2)(2008-7#1)(2010-4#1)(2012-12#1)(2013-1#3)
to the otic##3##3##(1993-12#1)(1996-4#2)
to the otolaryngologist##2##3##(2008-8#1)(2009-9#1)
to the outbreak##2##3##(1997-5#1)(2012-1#1)
to the outcome of##7##4##(1997-4#1)(2005-10#1)(2006-10#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-8#1)
to the outcome##10##3##(1991-12#1)(1997-4#1)(2005-10#1)(2006-10#1)(2008-10#1)(2008-6#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
to the outcomes##4##3##(2007-12#1)(2007-7#1)(2008-4#2)
to the outer nuclear membrane##2##5##(2008-9#2)
to the outer surface of the##4##6##(1991-9#1)(2007-11#1)(2008-11#1)(2008-7#1)
to the outer surface##5##4##(1991-9#1)(1994-5#1)(2007-11#1)(2008-11#1)(2008-7#1)
to the outer##15##3##(1990-11#1)(1991-9#1)(1992-1#1)(1992-6#1)(1992-7#1)(1994-5#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#2)
to the outlet##2##3##(2006-8#1)(2008-11#1)
to the outpatient setting##2##4##(1993-12#2)
to the outpatient##6##3##(1993-12#2)(1995-12#1)(2006-10#1)(2008-1#1)(2011-2#1)
to the output##4##3##(1997-7#1)(2008-2#1)(2008-3#2)
to the outside of the##2##5##(2008-10#1)(2008-8#1)
to the outside##7##3##(2005-10#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-8#1)
to the ovaries##2##3##(2010-12#1)(2013-8#1)
to the ovary and##2##4##(1990-11#1)(2008-12#1)
to the ovary##8##3##(1990-10#1)(1990-11#1)(1996-2#1)(1997-3#1)(2008-1#1)(2008-12#1)(2009-12#1)(2013-8#1)
to the overall toxicity of##2##5##(1997-4#1)(2004-2#1)
to the overall##45##3##(1990-11#1)(1990-2#1)(1990-3#2)(1991-5#1)(1991-8#1)(1991-9#1)(1993-3#1)(1993-9#1)(1994-12#2)(1995-3#1)(1996-5#1)(1997-4#1)(2004-2#1)(2005-11#1)(2007-11#1)(2007-5#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2010-12#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
to the overlap##2##3##(2007-3#1)(2009-8#1)
to the overlying##2##3##(2008-10#1)(2009-1#1)
to the oxidation of##6##4##(1990-12#1)(1990-4#1)(1990-5#1)(2008-10#2)(2010-5#1)
to the oxidation##7##3##(1990-12#1)(1990-4#1)(1990-5#1)(1993-4#1)(2008-10#2)(2010-5#1)
to the oxidative stress##2##4##(1992-6#1)(2008-11#1)
to the oxidative##7##3##(1992-6#1)(1995-6#1)(1997-8#1)(2007-11#1)(2008-11#1)(2009-8#1)(2011-1#1)
to the oxidized##4##3##(1992-12#1)(1994-5#1)(2006-12#1)(2008-11#1)
to the oxygen##4##3##(1994-5#1)(2007-11#1)(2008-10#1)(2009-12#1)
to the p##2##3##(2008-3#1)(2010-3#1)
to the p85##2##3##(1994-3#2)
to the pH##2##3##(1994-11#1)(2008-10#1)
to the packing##2##3##(2007-11#1)(2013-1#1)
to the paediatric##6##3##(1996-9#1)(2005-11#1)(2006-2#1)(2008-11#1)(2010-7#1)(2013-1#1)
to the painful##3##3##(2008-3#1)(2010-7#1)(2011-2#1)
to the pancreas##8##3##(2008-1#1)(2008-3#3)(2008-7#1)(2008-8#1)(2009-5#1)(2013-1#1)
to the pancreatic##3##3##(1994-12#1)(1996-12#1)(2008-11#1)
to the pandemic##2##3##(2007-2#1)(2012-12#1)
to the panel##3##3##(1993-12#1)(2005-7#2)
to the paper##3##3##(1996-1#1)(2008-10#1)(2009-8#1)
to the parameter##2##3##(2008-10#1)(2008-6#1)
to the parameters of the##3##5##(1994-8#1)(2008-2#1)(2010-6#1)
to the parameters of##4##4##(1994-8#1)(2008-2#1)(2008-3#1)(2010-6#1)
to the parameters##5##3##(1994-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-6#1)
to the parametric##2##3##(1993-5#1)(2011-1#1)
to the parasite##6##3##(1992-8#1)(2006-10#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-3#1)
to the paraxial##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
to the parent compound##4##4##(1990-3#1)(1991-5#1)(1997-2#1)(2008-5#1)
to the parent drug##3##4##(1993-2#1)(2008-5#1)(2010-12#1)
to the parent##15##3##(1990-3#1)(1990-9#1)(1991-5#1)(1993-2#1)(1996-9#1)(1997-2#1)(1997-4#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2010-12#1)(2011-1#1)
to the parent's##2##3##(1995-9#1)(2009-7#1)
to the parental cells##2##4##(1993-4#1)(1996-6#1)
to the parental##9##3##(1991-12#1)(1993-3#1)(1993-4#1)(1995-7#1)(1996-6#1)(2008-10#1)(2009-4#1)(2011-1#1)(2013-1#1)
to the participant##2##3##(2008-12#1)(2010-2#1)
to the participants##2##3##(1991-10#1)(2008-3#1)
to the participating##2##3##(2008-3#1)(2008-7#1)
to the particle##4##3##(2004-9#1)(2007-12#1)(2008-3#2)
to the particles##3##3##(1990-3#1)(1991-7#1)(1995-2#1)
to the particular##12##3##(1990-3#1)(1993-3#1)(1995-8#1)(2005-10#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-8#1)(2010-10#1)(2010-6#1)
to the particulate fraction##3##4##(1992-11#1)(1995-3#1)(1996-11#1)
to the particulate##5##3##(1992-11#1)(1995-3#2)(1996-11#1)(1996-12#1)
to the passive##3##3##(1992-1#1)(1995-8#1)(2007-11#1)
to the patellar##2##3##(1995-8#1)(2008-9#1)
to the patellofemoral joint##2##4##(2007-8#1)(2008-12#1)
to the pathogen##13##3##(2008-10#10)(2008-8#1)(2009-8#1)(2012-3#1)
to the pathogenesis and treatment of##2##6##(2008-4#1)(2011-1#1)
to the pathogenesis and##4##4##(2006-10#1)(2008-4#1)(2009-9#1)(2011-1#1)
to the pathogenesis of several##2##5##(1997-8#1)(2010-5#1)
to the pathogenesis of the##3##5##(2007-12#1)(2008-11#1)(2012-1#1)
to the pathogenesis of##30##4##(1991-8#1)(1996-12#1)(1997-4#1)(1997-7#1)(1997-8#2)(2005-8#1)(2006-10#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-7#2)(2009-6#1)(2009-9#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
to the pathogenesis##37##3##(1991-8#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2005-8#1)(2006-10#4)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-6#1)(2009-9#2)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
to the pathogenetic##2##3##(1997-8#1)(2008-3#1)
to the pathogenic##4##3##(1996-2#1)(2008-1#1)(2008-4#1)(2010-6#1)
to the pathogens##2##3##(1991-11#1)(2008-10#1)
to the pathological##2##3##(2008-1#1)(2008-6#1)
to the pathology of##4##4##(2008-4#1)(2010-11#1)(2011-2#1)(2013-8#1)
to the pathology##7##3##(1992-12#1)(2008-4#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-8#1)
to the pathophysiology and treatment of##2##6##(2006-9#1)(2008-5#1)
to the pathophysiology of renal##2##5##(2005-7#2)
to the pathophysiology of##11##4##(1992-7#1)(1996-3#1)(2005-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-8#1)(2012-2#1)
to the pathophysiology##14##3##(1992-3#1)(1992-7#1)(1996-3#1)(2005-7#2)(2006-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-8#1)(2012-2#1)
to the pathways##2##3##(2010-12#1)(2012-12#1)
to the patient and the##2##5##(2010-4#1)(2013-8#1)
to the patient and##16##4##(1990-2#1)(1991-7#1)(1997-2#1)(2005-12#1)(2006-6#1)(2007-6#2)(2008-10#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-3#1)(2010-4#1)(2012-12#1)(2012-3#1)(2013-8#1)
to the patient but##2##4##(2006-12#1)(2009-3#1)
to the patient during##2##4##(2006-8#1)(2008-10#1)
to the patient in##4##4##(2006-2#1)(2006-9#1)(2007-8#1)(2011-2#1)
to the patient is##2##4##(2007-7#1)(2012-12#1)
to the patient population##2##4##(1992-3#1)(2010-11#1)
to the patient than##2##4##(1994-4#1)(1997-4#1)
to the patient with##7##4##(1992-5#1)(1993-2#1)(2007-10#1)(2008-10#1)(2008-4#1)(2012-3#1)(2013-1#1)
to the patient##93##3##(1990-10#1)(1990-2#2)(1991-11#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-4#2)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1995-10#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-12#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#4)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#4)(2008-3#2)(2008-4#3)(2008-6#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
to the patient's clinical##2##4##(1996-9#1)(2006-2#1)
to the patient's life##2##4##(2010-8#1)(2011-2#1)
to the patient's##40##3##(1990-5#1)(1990-8#1)(1991-2#1)(1992-12#1)(1993-10#1)(1993-9#1)(1994-4#1)(1994-5#2)(1994-6#1)(1994-7#1)(1996-9#1)(1997-2#2)(2005-12#1)(2006-1#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#1)
to the patients and##7##4##(1993-2#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-2#1)(2009-6#1)(2012-2#1)
to the patients in##3##4##(2007-11#1)(2009-12#1)(2009-6#1)
to the patients who##2##4##(1992-3#1)(2008-10#1)
to the patients with##10##4##(1995-8#1)(1997-3#1)(2005-10#1)(2006-12#1)(2006-7#1)(2007-7#1)(2008-10#2)(2013-1#1)(2013-8#1)
to the patients##45##3##(1990-2#1)(1992-3#1)(1993-2#1)(1994-5#1)(1995-8#1)(1995-9#2)(1997-3#1)(2005-10#2)(2006-10#1)(2006-12#2)(2006-2#1)(2006-7#1)(2007-11#2)(2007-2#1)(2007-7#3)(2007-9#2)(2008-10#3)(2008-3#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-6#2)(2010-3#1)(2010-8#3)(2011-1#1)(2011-12#2)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
to the patients'##10##3##(1990-2#1)(1990-7#1)(1995-9#1)(1996-3#1)(2006-1#1)(2008-1#1)(2008-5#1)(2008-6#1)(2010-8#1)(2013-1#1)
to the pattern of##6##4##(1991-1#1)(1995-11#1)(2005-10#1)(2005-9#1)(2008-9#1)(2009-10#1)
to the pattern##12##3##(1990-2#1)(1991-1#1)(1991-11#1)(1995-11#1)(1995-5#1)(1996-6#1)(2005-10#1)(2005-9#1)(2007-12#1)(2007-5#1)(2008-9#1)(2009-10#1)
to the peak of##4##4##(1994-5#1)(2007-9#1)(2008-2#1)(2008-6#1)
to the peak##8##3##(1994-5#1)(2007-1#1)(2007-9#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#2)
to the peaks##2##3##(1996-7#1)(2005-11#1)
to the pediatric##2##3##(2007-2#1)(2012-12#1)
to the pelvic##4##3##(2005-10#1)(2006-9#1)(2007-4#2)
to the pelvis##7##3##(1991-2#1)(2008-8#2)(2010-3#1)(2012-1#3)
to the penetration##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
to the people##4##3##(1991-1#1)(2007-5#1)(2008-1#1)(2012-12#1)
to the peptide##16##3##(1990-8#2)(1991-10#1)(1992-5#1)(1994-12#2)(1994-8#1)(1995-2#1)(1995-8#1)(1996-5#1)(1997-4#1)(2008-4#3)(2009-12#1)(2010-11#1)
to the peptides##3##3##(1990-8#1)(1991-7#1)(1992-8#1)
to the perceived##3##3##(1990-5#1)(2007-12#1)(2012-2#1)
to the percentage of##2##4##(1990-6#1)(2011-2#1)
to the perception of##5##4##(2006-10#1)(2007-8#1)(2009-4#1)(2013-8#2)
to the perception##7##3##(2006-10#1)(2007-8#1)(2008-4#2)(2009-4#1)(2013-8#2)
to the perceptions of##2##4##(2009-9#1)(2010-5#1)
to the performance of the##3##5##(1996-7#1)(2008-10#1)(2008-2#1)
to the performance of##12##4##(1990-11#1)(1992-10#1)(1992-9#1)(1993-7#1)(1995-1#1)(1996-7#1)(2006-10#1)(2008-10#1)(2008-2#2)(2008-6#1)(2013-1#1)
to the performance##13##3##(1990-11#1)(1992-10#1)(1992-9#1)(1993-7#1)(1995-1#1)(1996-7#1)(2006-10#1)(2008-10#1)(2008-2#3)(2008-6#1)(2013-1#1)
to the perfusate##3##3##(1991-9#1)(1993-3#1)(1997-8#1)
to the perfusion##3##3##(1995-12#1)(1997-8#1)(2008-11#1)
to the perineum##2##3##(1992-9#1)(2008-10#1)
to the period of the##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
to the period##6##3##(1990-11#1)(1993-10#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
to the periodic##3##3##(1990-5#1)(1993-6#1)(2007-12#1)
to the periodontal##2##3##(1990-3#1)(2012-12#1)
to the perioperative##3##3##(2008-7#1)(2008-8#2)
to the peripheral parts of the##2##6##(1994-12#1)(1996-3#1)
to the peripheral##11##3##(1993-9#1)(1994-12#1)(1996-3#1)(2007-11#1)(2008-3#1)(2009-10#2)(2012-1#1)(2012-3#1)(2013-1#2)
to the periphery of the##5##5##(1997-8#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-7#1)
to the periphery of##7##4##(1990-8#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-7#1)(2008-8#1)
to the periphery##10##3##(1990-8#1)(1997-8#1)(2006-10#2)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-2#1)
to the periplasm##3##3##(1994-2#1)(1997-6#1)(2008-7#1)
to the peritoneal cavity##6##4##(1990-2#1)(1990-5#2)(2007-12#2)(2013-1#1)
to the peritoneal##8##3##(1990-2#1)(1990-4#1)(1990-5#2)(2007-12#2)(2007-8#1)(2013-1#1)
to the peritoneum##2##3##(1990-10#2)
to the peroxisome##2##3##(1995-3#1)(2008-5#1)
to the persistence of the##3##5##(2008-5#1)(2010-6#1)(2013-8#1)
to the persistence of##5##4##(2008-5#1)(2008-8#1)(2010-6#1)(2013-1#1)(2013-8#1)
to the persistence##6##3##(2008-5#1)(2008-8#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
to the persistent##3##3##(2008-11#2)(2010-2#1)
to the personal##3##3##(1995-12#1)(2007-7#1)(2008-8#1)
to the perturbation of##3##4##(1994-6#1)(1997-4#1)(2008-10#1)
to the perturbation##4##3##(1992-9#1)(1994-6#1)(1997-4#1)(2008-10#1)
to the pesticide##3##3##(1997-3#1)(2008-10#1)(2008-7#1)
to the petrous apex##2##4##(2006-12#2)
to the phage##4##3##(1994-12#1)(2008-10#1)(2009-5#1)(2012-2#1)
to the pharmaceutical business##2##4##(2008-10#2)
to the pharmaceutical industry and##2##5##(2006-2#1)(2011-2#1)
to the pharmaceutical##7##3##(2005-7#1)(2006-2#1)(2008-10#3)(2011-2#1)(2012-2#1)
to the pharmacokinetic study of##3##5##(1996-8#1)(2008-10#2)
to the pharmacokinetics study##2##4##(2011-2#2)
to the pharmacological##4##3##(1990-5#1)(2006-6#1)(2008-7#1)(2010-8#1)
to the phase change##2##4##(2008-2#2)
to the phase of the##3##5##(2007-12#2)(2008-2#1)
to the phase##11##3##(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-5#1)
to the phenol##2##3##(1994-5#1)(2010-8#1)
to the phenomenon of##3##4##(2006-10#1)(2006-11#1)(2007-11#1)
to the phenomenon##7##3##(2006-10#1)(2006-11#1)(2007-11#1)(2008-1#1)(2008-10#1)(2009-10#1)(2012-2#1)
to the phenotype##6##3##(1994-3#1)(2004-11#1)(2008-12#1)(2011-1#1)(2012-12#1)(2012-3#1)
to the phenotypic##2##3##(2008-11#1)(2009-8#1)
to the pheromone##2##3##(2008-6#2)
to the phosphate##2##3##(1990-8#1)(1997-5#1)
to the phospholipid##3##3##(1990-12#1)(1994-12#1)(1995-8#1)
to the phosphorylated##2##3##(1991-3#1)(1994-11#1)
to the phosphorylation of##3##4##(1994-5#1)(1994-8#1)(2008-9#1)
to the photoaging process##2##4##(2008-5#2)
to the photochemical##2##3##(1991-4#1)(1992-8#1)
to the photocycle of##2##4##(1994-5#1)(2006-10#1)
to the phrenic##3##3##(1990-7#3)
to the phylogenetically##2##3##(1996-8#1)(2008-10#1)
to the physical and chemical##2##5##(2011-1#1)(2011-2#1)
to the physical and##5##4##(2008-2#1)(2008-3#1)(2011-1#1)(2011-2#2)
to the physical##13##3##(1991-5#1)(1992-5#1)(1993-2#1)(1996-4#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2011-1#2)(2011-2#2)
to the physician##14##3##(1991-1#1)(1992-12#1)(1993-1#1)(1993-3#1)(1997-4#1)(2004-1#1)(2006-10#1)(2006-8#3)(2010-3#1)(2010-6#1)(2011-1#2)
to the physician's##3##3##(1990-12#1)(1991-7#1)(2011-2#1)
to the physicochemical characteristics of##2##5##(2008-5#1)(2010-4#1)
to the physiologic##2##3##(2006-10#1)(2010-12#1)
to the physiological##8##3##(1990-11#1)(1992-1#1)(1997-2#1)(2007-2#1)(2008-1#1)(2008-4#1)(2010-10#1)(2012-1#1)
to the pig##3##3##(1990-2#1)(1990-9#1)(2011-1#1)
to the pigment##2##3##(1992-2#1)(2008-8#1)
to the pineal##2##3##(1994-5#1)(1995-3#1)
to the pipette##2##3##(1994-5#1)(2008-11#1)
to the pituitary and##2##4##(1990-3#1)(1995-8#1)
to the pituitary gland##4##4##(1993-9#1)(1995-7#1)(2008-5#1)(2012-3#1)
to the pituitary##9##3##(1990-3#1)(1990-9#1)(1993-9#1)(1995-7#1)(1995-8#1)(2008-5#1)(2012-1#1)(2012-3#1)(2013-1#1)
to the place of##2##4##(2008-12#1)(2012-12#1)
to the placebo group##6##4##(1997-7#2)(2004-1#1)(2008-3#1)(2010-5#1)(2012-12#1)
to the placebo##9##3##(1997-7#2)(2004-1#1)(2008-3#1)(2008-5#3)(2010-5#1)(2012-12#1)
to the placement##2##3##(2008-11#1)(2008-12#1)
to the placental##2##3##(1990-9#1)(1992-8#1)
to the planar##2##3##(1995-2#1)(2013-8#1)
to the plane of the bilayer##2##6##(1991-5#1)(1994-12#1)
to the plane of the##6##5##(1991-5#1)(1994-12#1)(1995-5#1)(2006-11#1)(2008-2#1)(2008-3#1)
to the plane of##12##4##(1991-5#1)(1994-12#1)(1995-5#1)(2006-11#1)(2008-2#2)(2008-3#6)
to the plane##13##3##(1991-5#1)(1994-12#1)(1995-5#1)(2006-11#1)(2007-11#1)(2008-2#2)(2008-3#6)
to the planned##5##3##(1992-9#2)(2006-12#1)(2007-8#1)(2012-2#1)
to the planning treatment volume (PTV)##2##6##(2008-11#1)(2008-6#1)
to the planning##4##3##(1994-6#1)(2008-11#1)(2008-6#1)(2009-5#1)
to the plant##12##3##(1992-3#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#1)(2011-10#1)
to the plantar##2##3##(2009-12#1)(2010-11#1)
to the plants##3##3##(2008-10#2)(2011-2#1)
to the plasma and##2##4##(1995-1#1)(2005-12#1)
to the plasma membrane and##3##5##(1994-11#1)(1995-6#1)(2008-1#1)
to the plasma membrane by a non-Golgi pathway##2##8##(1994-3#2)
to the plasma membrane by a##3##6##(1992-3#1)(1994-3#2)
to the plasma membrane by##7##5##(1992-3#1)(1994-3#2)(1995-6#1)(2008-4#1)(2010-11#2)
to the plasma membrane of##4##5##(1990-12#1)(1990-2#1)(1990-9#1)(1994-5#1)
to the plasma membrane through##2##5##(1996-3#1)(2009-7#1)
to the plasma membrane##45##4##(1990-12#1)(1990-2#1)(1990-7#1)(1990-9#1)(1992-3#1)(1992-7#1)(1993-4#2)(1994-11#2)(1994-12#1)(1994-3#5)(1994-5#1)(1994-8#1)(1995-11#1)(1995-6#2)(1996-3#1)(1996-8#2)(1997-3#1)(1997-4#1)(1997-6#5)(2005-8#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-8#1)(2009-10#2)(2009-7#1)(2010-11#2)(2012-12#1)
to the plasma membranes##2##4##(1994-5#1)(2008-5#1)
to the plasma##58##3##(1990-12#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-2#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-4#2)(1993-6#1)(1994-11#2)(1994-12#1)(1994-3#5)(1994-5#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-6#2)(1996-3#1)(1996-8#2)(1997-3#1)(1997-4#2)(1997-6#5)(1997-7#1)(2005-12#1)(2005-4#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-10#2)(2009-7#1)(2010-11#2)(2012-12#1)
to the plasmalemma##3##3##(1993-3#1)(1996-9#1)(1997-7#1)
to the plate##2##3##(1990-4#1)(2013-1#1)
to the platelet##3##3##(1991-6#1)(1995-11#1)(2008-1#1)
to the platelet-derived growth factor receptor##2##6##(1994-3#1)(1996-8#1)
to the pleckstrin homology domain of RAC protein kinase##2##9##(1994-12#2)
to the plethora of##2##4##(2008-5#1)(2009-6#1)
to the point of##9##4##(1991-3#1)(1992-12#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-7#1)(2010-8#1)
to the point that##3##4##(2008-5#1)(2009-7#1)(2013-1#1)
to the point where##5##4##(1990-12#1)(1991-2#1)(1992-3#1)(1995-8#1)(2009-12#1)
to the point##21##3##(1990-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-3#1)(1995-8#1)(1996-1#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#3)(2008-5#1)(2008-7#2)(2009-12#1)(2009-4#1)(2009-7#1)(2010-8#1)(2013-1#1)
to the polar head##3##4##(1990-2#1)(1996-6#1)(1997-7#1)
to the polar##6##3##(1990-2#1)(1991-5#1)(1996-6#1)(1996-9#1)(1997-7#1)(2007-5#1)
to the polarity of the##2##5##(2005-11#1)(2006-12#1)
to the polarity##3##3##(2005-11#1)(2006-12#1)(2008-10#1)
to the polarization of the##2##5##(2008-2#1)(2008-3#1)
to the polarization properties##2##4##(2008-1#1)(2008-3#1)
to the polarization##7##3##(2007-11#1)(2008-1#1)(2008-2#2)(2008-3#3)
to the police##4##3##(1993-3#1)(1994-4#1)(1997-8#1)(2007-3#1)
to the political##2##3##(2008-9#1)(2011-1#1)
to the poly(A) tail##3##4##(1990-4#1)(1991-9#1)(2008-4#1)
to the polymer matrix##2##4##(2008-10#1)(2008-3#1)
to the polymer##6##3##(1991-3#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-7#1)
to the polymerization##5##3##(1990-7#1)(1993-6#1)(2007-8#1)(2008-3#1)(2010-10#1)
to the polypeptide##3##3##(1994-10#1)(1994-9#1)(1996-8#1)
to the polypurine tract##2##4##(1996-4#2)
to the polysaccharide##3##3##(1992-8#1)(2005-8#1)(2010-12#1)
to the poor##10##3##(1992-4#1)(1994-7#1)(1996-1#1)(2006-8#1)(2007-5#1)(2008-10#2)(2008-8#1)(2009-4#1)(2010-2#1)
to the poorest##2##3##(1992-2#1)(1992-5#1)
to the popliteal artery##2##4##(1991-3#1)(2007-11#1)
to the popular##4##3##(1996-4#1)(1997-2#1)(2007-9#1)(2008-5#1)
to the population at##2##4##(1994-4#1)(2011-2#1)
to the population in##2##4##(2011-1#1)(2011-2#1)
to the population of##4##4##(1995-1#1)(2008-6#1)(2010-12#1)(2013-8#1)
to the population##20##3##(1992-2#1)(1992-6#1)(1993-6#1)(1994-4#1)(1995-1#1)(2006-8#1)(2007-3#1)(2008-6#1)(2010-12#1)(2011-1#1)(2011-2#6)(2012-3#1)(2013-1#1)(2013-8#2)
to the pores##2##3##(2008-7#1)(2013-8#1)
to the porphyrin core##2##4##(2008-10#1)(2010-6#1)
to the porphyrin##5##3##(1997-6#2)(2008-10#2)(2010-6#1)
to the portion of the##2##5##(1997-9#1)(2009-1#1)
to the portion of##3##4##(1997-9#2)(2009-1#1)
to the position of the##4##5##(2007-12#1)(2007-7#1)(2008-3#2)
to the position of##6##4##(2007-12#1)(2007-7#1)(2008-3#3)(2010-12#1)
to the position##8##3##(2007-12#1)(2007-7#1)(2008-2#1)(2008-3#3)(2009-10#1)(2010-12#1)
to the positional##2##3##(1996-6#1)(1996-8#1)
to the positioning##2##3##(1995-10#1)(2008-3#1)
to the positions and##2##4##(1997-2#1)(2008-3#1)
to the positive##10##3##(1990-12#1)(1990-9#1)(1991-9#1)(1992-6#1)(1997-7#1)(2008-11#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-8#1)
to the possibility of a##2##5##(2010-10#1)(2010-3#1)
to the possibility of##22##4##(1991-8#1)(1992-2#1)(1993-12#1)(1994-6#1)(1995-1#1)(1996-12#1)(1996-7#1)(2006-4#1)(2007-11#3)(2007-8#1)(2008-7#2)(2008-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2012-1#1)(2012-2#2)(2012-3#1)
to the possibility that the##3##5##(1991-5#1)(2010-2#1)(2011-1#1)
to the possibility that##13##4##(1991-5#1)(1993-2#1)(1995-1#1)(2006-10#2)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-2#1)(2011-1#1)
to the possibility##36##3##(1991-5#1)(1991-8#1)(1992-2#1)(1993-12#1)(1993-2#1)(1994-6#1)(1995-1#2)(1996-12#1)(1996-7#1)(2006-10#2)(2006-4#1)(2007-11#3)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#1)
to the possible complications of##2##5##(1993-9#1)(2006-3#1)
to the possible complications##3##4##(1993-9#1)(2006-3#1)(2008-7#1)
to the possible role of##2##5##(2008-10#1)(2008-4#1)
to the possible role##3##4##(2006-10#1)(2008-10#1)(2008-4#1)
to the possible##23##3##(1990-2#1)(1992-2#1)(1992-7#1)(1993-1#1)(1993-9#1)(1994-6#1)(1997-6#1)(1997-7#1)(2005-1#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-4#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2013-1#1)
to the possibly##2##3##(1994-12#1)(2008-3#1)
to the posterior segment##2##4##(2009-3#1)(2009-4#1)
to the posterior##15##3##(1990-12#1)(1996-11#2)(1996-9#1)(2007-1#2)(2007-7#1)(2007-8#2)(2009-10#1)(2009-3#1)(2009-4#1)(2011-1#1)(2013-1#1)(2013-7#1)
to the postoperative##2##3##(2007-8#1)(2010-12#1)
to the potent##5##3##(1991-2#1)(1992-11#1)(1996-9#1)(2008-10#1)(2008-5#1)
to the potential for##5##4##(2005-6#1)(2006-10#1)(2008-3#1)(2012-11#1)(2012-3#1)
to the potential occurrence of##2##5##(2007-7#1)(2013-1#1)
to the potential of the##2##5##(2005-11#1)(2008-10#1)
to the potential of##6##4##(2005-11#1)(2005-8#1)(2008-10#2)(2012-12#1)(2012-2#1)
to the potential##27##3##(1992-6#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-5#1)(2005-11#1)(2005-6#1)(2005-8#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#6)(2008-3#1)(2010-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
to the potentially##2##3##(1990-10#1)(1992-5#1)
to the potting##2##3##(2008-10#2)
to the power of the##3##5##(2009-10#1)(2012-3#2)
to the power##10##3##(2004-4#1)(2005-11#1)(2007-12#2)(2008-10#2)(2009-10#1)(2011-2#1)(2012-3#2)
to the practical##3##3##(1994-12#1)(2008-10#1)(2008-11#1)
to the practice of##10##4##(1992-1#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-12#1)(2010-11#1)(2012-1#1)(2012-12#1)(2012-3#2)
to the practice##12##3##(1992-1#1)(2007-12#1)(2007-4#2)(2007-6#1)(2008-11#1)(2008-12#1)(2010-11#1)(2012-1#1)(2012-12#1)(2012-3#2)
to the practicing clinician##2##4##(2009-9#1)(2011-2#1)
to the practicing##5##3##(1996-3#1)(2009-9#1)(2010-2#1)(2011-2#1)(2013-1#1)
to the practitioner##2##3##(2006-10#1)(2008-3#1)
to the preceding##3##3##(1993-2#1)(2008-10#1)(2008-7#1)
to the precipitation##4##3##(1991-7#1)(2005-11#1)(2008-10#1)(2012-2#1)
to the precise##3##3##(1994-1#1)(2007-3#1)(2008-11#1)
to the precision of##2##4##(2008-10#1)(2008-7#1)
to the precision##3##3##(1990-6#1)(2008-10#1)(2008-7#1)
to the precolumn##2##3##(1990-8#1)(2008-10#1)
to the preconcentration of##4##4##(2008-10#4)
to the preconcentration##7##3##(2008-10#7)
to the predicted##9##3##(1992-12#1)(1992-3#1)(1992-4#1)(1993-7#1)(1996-4#1)(2004-12#1)(2008-10#1)(2009-12#1)(2009-8#1)
to the prediction of##4##4##(2008-2#1)(2009-4#1)(2009-7#2)
to the prediction##5##3##(1995-3#1)(2008-2#1)(2009-4#1)(2009-7#2)
to the predictions of##3##4##(1995-3#1)(2008-2#1)(2008-8#1)
to the predictive value of##2##5##(1995-3#1)(2005-10#1)
to the predictive##3##3##(1995-3#1)(2005-10#1)(2012-12#1)
to the predominance of##5##4##(1992-6#1)(1997-2#1)(2007-7#1)(2008-1#1)(2008-6#1)
to the predominant##2##3##(1991-10#1)(1991-7#1)
to the preferential##4##3##(1991-2#1)(2007-12#1)(2008-11#2)
to the preferred##2##3##(1993-9#1)(2007-12#1)
to the prefrontal cortex##2##4##(2009-10#1)(2012-1#1)
to the prefrontal##3##3##(2009-10#1)(2011-2#1)(2012-1#1)
to the pregnancy##4##3##(2006-5#1)(2007-2#2)(2009-10#1)
to the pregnant state##2##4##(1994-6#1)(2008-4#1)
to the premature##2##3##(1994-8#1)(2007-11#1)
to the preparation of##13##4##(1991-8#1)(1993-9#1)(1994-5#1)(1996-5#2)(2007-11#2)(2008-10#1)(2008-2#1)(2009-12#1)(2009-2#1)(2010-12#1)(2012-2#1)
to the preparation##14##3##(1991-8#1)(1993-9#1)(1994-5#1)(1996-5#2)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2009-12#1)(2009-2#1)(2010-12#1)(2012-2#1)
to the prescribing##3##3##(1993-12#1)(2006-10#1)(2008-11#1)
to the presence of a##13##5##(1990-3#1)(1993-12#1)(1993-8#1)(1994-6#1)(1995-1#2)(1997-6#1)(2006-12#1)(2007-2#1)(2011-1#2)(2012-12#1)(2012-2#1)
to the presence of an extra##2##6##(1990-12#1)(2010-4#1)
to the presence of an##7##5##(1990-12#1)(1991-2#1)(1997-3#1)(2008-10#1)(2009-9#1)(2010-10#1)(2010-4#1)
to the presence of endogenous##2##5##(1996-12#1)(2010-11#1)
to the presence of heparin##2##5##(1990-12#1)(1994-10#1)
to the presence of local##2##5##(1991-9#1)(2008-10#1)
to the presence of other##3##5##(1992-8#1)(2008-10#2)
to the presence of the##16##5##(1990-10#1)(1994-11#1)(1994-3#1)(1996-6#1)(2006-10#1)(2006-12#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-11#1)(2010-2#2)(2011-2#1)
to the presence of two##2##5##(1991-2#1)(2013-7#1)
to the presence of##149##4##(1990-10#1)(1990-12#4)(1990-3#1)(1991-11#1)(1991-2#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#2)(1993-10#1)(1993-11#2)(1993-12#1)(1993-8#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-12#1)(1995-4#1)(1996-12#3)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#3)(2004-9#1)(2005-11#3)(2005-8#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#3)(2006-8#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#24)(2008-11#4)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#4)(2011-12#2)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#2)
to the presence or absence of##4##6##(2006-7#1)(2007-7#1)(2008-10#2)
to the presence or##5##4##(1991-4#1)(2006-7#1)(2007-7#1)(2008-10#2)
to the presence##158##3##(1990-10#1)(1990-12#4)(1990-3#1)(1991-11#1)(1991-2#2)(1991-4#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#2)(1993-10#1)(1993-11#2)(1993-12#1)(1993-8#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-12#1)(1995-4#1)(1996-12#3)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#3)(2004-9#1)(2005-11#3)(2005-8#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#26)(2008-11#4)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#4)(2011-12#2)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#2)
to the present day##5##4##(1990-4#1)(2007-5#1)(2008-10#1)(2008-4#1)(2012-3#1)
to the present study to##2##5##(2006-8#1)(2008-2#1)
to the present study##3##4##(2006-8#1)(2007-8#1)(2008-2#1)
to the present time##5##4##(1994-2#1)(1997-8#1)(2006-1#1)(2007-7#1)(2008-12#1)
to the present##40##3##(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1992-5#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-12#2)(1997-8#1)(2006-1#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#2)
to the preservation of the##2##5##(2008-10#1)(2010-9#1)
to the preservation of##6##4##(2006-7#1)(2007-5#1)(2008-10#1)(2010-8#1)(2010-9#1)(2011-2#1)
to the preservation##7##3##(2006-7#1)(2007-5#2)(2008-10#1)(2010-8#1)(2010-9#1)(2011-2#1)
to the presumed##3##3##(1994-8#1)(1995-3#1)(2008-10#1)
to the prevailing##6##3##(1992-3#2)(1996-9#1)(2006-4#1)(2011-12#1)(2011-9#1)
to the prevalence of##9##4##(1996-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2009-5#1)(2011-1#2)(2012-3#1)(2013-8#1)
to the prevalence##13##3##(1996-12#2)(2006-7#1)(2007-2#1)(2008-10#1)(2008-12#1)(2009-5#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-8#1)
to the prevention of dental##2##5##(2006-2#1)(2008-7#1)
to the prevention of##16##4##(1991-1#1)(1991-2#2)(1991-5#1)(1993-9#1)(2006-10#2)(2006-2#1)(2006-6#1)(2007-1#1)(2007-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#1)(2012-12#1)
to the prevention##18##3##(1990-12#1)(1991-1#1)(1991-2#2)(1991-5#2)(1993-9#1)(2006-10#2)(2006-2#1)(2006-6#1)(2007-1#1)(2007-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#1)(2012-12#1)
to the previous reports##2##4##(1994-3#1)(2012-12#1)
to the previous##16##3##(1990-11#1)(1994-3#1)(1995-6#1)(1997-7#1)(2006-8#1)(2007-2#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-5#3)(2008-6#2)(2010-5#1)(2012-12#1)
to the previously characterized##2##4##(1990-5#1)(1997-4#1)
to the previously cloned##2##4##(1992-5#1)(1994-8#1)
to the previously described##10##4##(1991-2#1)(1991-3#1)(1991-9#1)(1993-4#1)(1996-1#1)(2008-10#4)(2012-1#1)
to the previously documented##3##4##(1993-12#1)(1994-11#1)(2009-5#1)
to the previously identified##5##4##(1994-9#1)(1996-12#1)(1996-3#1)(2008-10#1)(2009-4#1)
to the previously mentioned##2##4##(2006-10#1)(2009-8#1)
to the previously reported##13##4##(1991-1#1)(1991-6#1)(1992-10#1)(1992-5#1)(1992-9#1)(1993-12#1)(1997-2#1)(2007-1#1)(2007-11#1)(2007-12#2)(2008-10#1)(2011-2#1)
to the previously##49##3##(1990-4#1)(1990-5#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-9#1)(1993-12#2)(1993-4#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-6#1)(1994-8#1)(1994-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#8)(2009-4#1)(2009-5#1)(2009-8#2)(2011-2#1)(2012-1#1)
to the price##2##3##(2007-8#1)(2011-2#1)
to the primary care##2##4##(1996-12#1)(2008-7#1)
to the primary structure of##2##5##(1990-4#1)(1992-3#1)
to the primary structure##3##4##(1990-3#1)(1990-4#1)(1992-3#1)
to the primary tumor##4##4##(1991-4#1)(2006-10#1)(2008-6#1)(2010-12#1)
to the primary tumour##2##4##(1997-3#1)(2011-2#1)
to the primary##39##3##(1990-3#1)(1990-4#1)(1991-11#1)(1991-4#2)(1991-8#1)(1992-3#1)(1992-6#1)(1993-5#1)(1993-9#1)(1996-12#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-2#2)(2007-1#1)(2007-12#1)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
to the primer##2##3##(1990-5#1)(2009-7#1)
to the principal##5##3##(2008-2#2)(2008-3#3)
to the principle of the##2##5##(2007-8#1)(2008-5#1)
to the principles of##7##4##(1992-6#1)(1994-2#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-9#1)(2011-2#1)
to the principles##8##3##(1992-6#1)(1994-2#1)(2005-5#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-9#1)(2011-2#1)
to the pristine##2##3##(2009-11#1)(2010-8#1)
to the private##2##3##(2008-10#1)(2012-2#1)
to the probability of##4##4##(2007-4#1)(2008-3#1)(2008-4#1)(2009-10#1)
to the probability that##3##4##(2008-2#1)(2008-8#1)(2008-9#1)
to the probability##8##3##(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)
to the probable##2##3##(1991-11#1)(2010-5#1)
to the probe##8##3##(1990-10#1)(1996-7#1)(2007-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-1#1)
to the probing##2##3##(2007-11#1)(2008-2#1)
to the problem is##2##4##(1992-8#1)(2012-12#1)
to the problem of classifying compounds##2##6##(2008-7#2)
to the problem of##34##4##(1990-12#1)(1990-6#1)(1991-6#2)(1991-9#1)(1994-6#1)(1994-8#1)(2004-7#1)(2005-11#1)(2005-8#1)(2005-9#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-11#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-10#1)
to the problem##51##3##(1990-12#1)(1990-6#1)(1991-6#2)(1991-9#1)(1992-8#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1997-3#1)(1997-5#1)(2004-7#1)(2005-11#1)(2005-8#1)(2005-9#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-2#8)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2012-12#1)
to the problems of##3##4##(1990-11#1)(2006-10#1)(2008-5#1)
to the problems that##2##4##(1991-12#1)(2008-2#1)
to the problems##12##3##(1990-11#1)(1991-12#1)(1991-3#1)(1992-10#1)(2006-10#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2010-6#1)(2011-2#1)
to the procedure used##2##4##(1996-1#1)(2007-11#1)
to the procedure##12##3##(1996-1#1)(2006-12#2)(2007-11#1)(2007-8#2)(2007-9#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
to the process by##2##4##(1996-6#1)(2008-4#1)
to the process of##17##4##(1993-12#1)(1994-11#1)(1995-12#1)(1996-2#1)(2005-11#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-2#1)(2008-11#2)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
to the process##33##3##(1993-12#1)(1994-11#1)(1994-3#1)(1995-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(2004-3#1)(2005-10#1)(2005-11#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)
to the processes of##3##4##(1991-3#1)(1991-9#1)(2008-10#1)
to the processes##6##3##(1991-3#1)(1991-9#1)(2008-10#2)(2010-5#1)(2012-11#1)
to the processing of##6##4##(1990-12#1)(1992-12#1)(1993-6#1)(2008-1#1)(2008-3#1)(2009-8#1)
to the processing##8##3##(1990-12#1)(1992-12#1)(1993-6#1)(1994-11#1)(2008-1#1)(2008-3#1)(2008-9#1)(2009-8#1)
to the procurement of vascular stents in interventional radiology##2##9##(2012-2#2)
to the producer##2##3##(1992-2#1)(2008-10#1)
to the product of the##3##5##(1990-11#1)(2008-3#2)
to the product of##6##4##(1990-11#1)(1995-8#1)(1996-8#1)(2008-3#2)(2008-5#1)
to the product##10##3##(1990-11#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-8#1)(1996-8#1)(2008-2#1)(2008-3#2)(2008-5#1)
to the production of a##2##5##(2008-4#1)(2008-5#1)
to the production of an##2##5##(1991-6#1)(2007-11#1)
to the production of the##5##5##(2007-11#1)(2008-10#3)(2009-2#1)
to the production of##35##4##(1990-7#1)(1991-6#1)(1992-4#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#2)(1997-4#1)(2005-11#1)(2005-5#1)(2005-8#1)(2007-11#2)(2007-4#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-2#1)(2009-3#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
to the production##38##3##(1990-7#1)(1991-6#1)(1992-4#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#2)(1997-4#1)(2005-11#1)(2005-5#1)(2005-8#1)(2006-10#1)(2007-11#2)(2007-4#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#1)(2009-2#1)(2009-3#1)(2009-6#1)(2011-2#1)(2012-3#2)(2013-8#1)
to the products of the##2##5##(1994-8#1)(2006-3#1)
to the products##3##3##(1994-8#1)(2006-3#1)(2010-12#1)
to the profession##4##3##(1992-12#1)(2008-12#1)(2009-4#1)(2012-3#1)
to the professional##3##3##(2006-2#1)(2013-1#1)(2013-8#1)
to the profile##2##3##(1992-1#1)(2008-1#1)
to the profiles of the##2##5##(2008-2#1)(2008-7#1)
to the prognosis##2##3##(1990-8#1)(1992-6#1)
to the program in##2##4##(1992-3#1)(1995-1#1)
to the program of##2##4##(2007-11#1)(2007-8#1)
to the program##5##3##(1992-3#1)(1995-1#1)(2007-11#1)(2007-8#1)(2009-4#1)
to the programme##3##3##(1993-6#1)(2007-7#1)(2012-3#1)
to the progress of##4##4##(1996-4#1)(2009-7#1)(2010-8#1)(2012-2#1)
to the progress##5##3##(1996-4#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
to the progression of the##2##5##(1993-12#1)(2009-8#1)
to the progression of##14##4##(1993-12#1)(1994-6#1)(1996-3#1)(1997-7#2)(2005-7#1)(2008-1#1)(2008-7#1)(2008-9#2)(2009-7#1)(2009-8#1)(2011-1#1)(2012-1#1)
to the progression##16##3##(1993-12#1)(1994-6#1)(1996-3#1)(1997-7#2)(2005-11#1)(2005-7#1)(2008-1#1)(2008-7#1)(2008-9#2)(2009-7#1)(2009-8#1)(2010-2#1)(2011-1#1)(2012-1#1)
to the progressive##5##3##(1991-10#1)(1992-12#1)(1995-5#1)(2007-7#1)(2008-3#1)
to the project##3##3##(2008-11#1)(2008-7#2)
to the projection##3##3##(1997-6#1)(2008-2#1)(2013-7#1)
to the proliferation of##2##4##(2008-8#1)(2008-9#1)
to the proliferation##3##3##(2008-8#1)(2008-9#1)(2011-2#1)
to the prolongation of##2##4##(1991-3#1)(1991-4#1)
to the prolonged##3##3##(1991-9#1)(2008-9#1)(2009-6#1)
to the promoter and##2##4##(1991-2#1)(1991-5#1)
to the promoter of##3##4##(1990-11#1)(1990-9#1)(2009-8#1)
to the promoter region of##3##5##(1991-6#1)(1992-11#1)(1992-12#1)
to the promoter##14##3##(1990-11#1)(1990-3#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1996-4#1)(1997-4#2)(1997-5#1)(2009-8#2)
to the promoters##3##3##(1992-11#1)(1993-12#1)(1997-2#1)
to the propagating##2##3##(2007-12#1)(2008-2#1)
to the propagation of##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
to the propagation##6##3##(2007-11#2)(2007-12#2)(2008-3#2)
to the propensity for##2##4##(1993-6#1)(2012-12#1)
to the propensity of##2##4##(2008-5#1)(2012-2#1)
to the propensity##4##3##(1993-6#1)(2008-5#1)(2012-12#1)(2012-2#1)
to the proper##3##3##(1996-12#1)(2008-11#1)(2009-8#1)
to the properties of a##2##5##(2008-11#1)(2008-2#1)
to the properties of the##5##5##(1991-12#1)(1992-3#1)(2008-2#1)(2008-5#1)(2009-5#1)
to the properties of##9##4##(1991-12#1)(1992-3#1)(1997-1#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-5#1)(2009-5#1)
to the proportion of##6##4##(2008-7#2)(2008-8#1)(2009-7#1)(2011-1#1)(2012-3#1)
to the proportion##7##3##(2006-7#1)(2008-7#2)(2008-8#1)(2009-7#1)(2011-1#1)(2012-3#1)
to the proposal that the##4##5##(1990-8#1)(1991-1#1)(1991-2#1)(1995-8#1)
to the proposal that##6##4##(1990-8#1)(1991-1#1)(1991-2#1)(1991-7#1)(1994-8#1)(1995-8#1)
to the proposal##7##3##(1990-8#1)(1991-1#1)(1991-2#1)(1991-7#1)(1994-8#1)(1995-8#1)(2010-2#1)
to the proposed##7##3##(2007-11#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-5#1)
to the prospective##3##3##(1991-2#1)(1991-3#1)(2006-9#1)
to the prostate##3##3##(1990-9#1)(1993-8#1)(2007-5#1)
to the prosthetic##2##3##(2006-12#1)(2008-5#1)
to the protease##4##3##(1991-9#1)(1992-11#1)(1992-6#1)(1993-8#1)
to the proteasome##4##3##(1997-7#1)(2007-8#2)(2008-8#1)
to the protected##2##3##(1992-12#1)(2005-8#1)
to the protection of the##2##5##(2006-6#1)(2008-10#1)
to the protection of##5##4##(2005-11#1)(2006-6#1)(2008-10#2)(2010-5#1)
to the protective effect of##2##5##(2005-10#1)(2012-2#1)
to the protective##7##3##(1991-1#1)(1993-12#1)(1995-5#1)(1996-2#1)(2005-10#1)(2007-12#1)(2012-2#1)
to the protein composition of the##2##6##(1991-2#1)(1991-8#1)
to the protein in##2##4##(1995-10#1)(1995-8#1)
to the protein therapeutic##2##4##(2008-10#1)(2008-11#1)
to the protein##36##3##(1990-10#1)(1990-5#1)(1991-1#1)(1991-2#2)(1991-8#2)(1991-9#1)(1992-12#2)(1992-3#1)(1992-8#1)(1994-12#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-4#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2009-6#1)(2009-8#1)(2012-2#1)(2013-8#1)
to the proteins##6##3##(1990-10#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-5#1)(2009-10#1)
to the proteolytic##2##3##(1996-2#1)(2008-5#1)
to the protocol##3##3##(2010-3#1)(2011-2#2)
to the protonation of##5##4##(1990-10#1)(1991-8#1)(1997-1#1)(1997-4#1)(2008-10#1)
to the provider##2##3##(1995-2#1)(2007-12#1)
to the provincial##2##3##(1991-1#1)(1997-5#1)
to the provision of health care##2##6##(1992-3#1)(1996-3#1)
to the provision of##6##4##(1992-3#1)(1996-3#1)(2006-10#1)(2006-5#1)(2008-1#1)(2012-2#1)
to the proximal end of##2##5##(1997-7#1)(2007-8#1)
to the proximal femur##2##4##(2007-11#1)(2007-7#1)
to the proximal##15##3##(1991-12#1)(1993-2#1)(1994-12#1)(1995-4#1)(1996-10#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-4#1)(2008-9#1)
to the proximity of the##2##5##(1990-12#1)(2006-12#1)
to the proximity of##3##4##(1990-12#1)(2006-12#1)(2008-6#1)
to the psoas muscle##2##4##(2008-10#1)(2009-2#1)
to the psychiatric##3##3##(1991-9#1)(2006-2#1)(2009-7#1)
to the psychological##3##3##(1994-12#1)(1994-9#1)(1996-1#1)
to the public and##2##4##(1993-1#1)(2012-3#1)
to the public as##2##4##(1997-3#1)(2007-2#1)
to the public health##2##4##(1991-4#1)(2010-5#1)
to the public##27##3##(1991-4#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#1)(1994-3#1)(1996-11#1)(1996-12#1)(1996-4#2)(1997-3#1)(2007-10#1)(2007-2#2)(2008-10#1)(2008-5#3)(2008-7#2)(2008-9#1)(2010-12#2)(2010-5#1)(2011-1#1)(2012-3#1)(2013-7#1)
to the public's##2##3##(1995-12#1)(2010-7#1)
to the publication of##2##4##(1996-2#1)(2005-7#1)
to the published##12##3##(1990-7#1)(1992-4#1)(1993-5#1)(1995-1#1)(2007-4#1)(2007-7#2)(2008-3#3)(2008-9#1)(2012-2#1)
to the pulmonary artery##2##4##(2007-8#2)
to the pulmonary##12##3##(1992-3#1)(1993-3#1)(1997-1#1)(2005-8#1)(2007-2#1)(2007-3#1)(2007-8#3)(2008-4#1)(2010-1#1)(2011-2#1)
to the pulp##2##3##(2005-10#1)(2008-5#1)
to the pulse width##3##4##(2008-3#3)
to the pulse##8##3##(2007-12#2)(2007-7#2)(2008-3#3)(2008-5#1)
to the pump##5##3##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)
to the pure liquid phase are##2##6##(1991-4#1)(1992-5#1)
to the pure liquid phase##3##5##(1991-4#2)(1992-5#1)
to the pure##6##3##(1991-4#2)(1992-5#1)(2008-10#1)(2010-10#1)(2012-1#1)
to the purification of##5##4##(1990-11#1)(1996-3#3)(2008-4#1)
to the purified##6##3##(1990-7#2)(1991-2#1)(1991-3#1)(1994-11#1)(2010-11#1)
to the purine##4##3##(1994-9#1)(1995-3#1)(1997-7#1)(2010-2#1)
to the purpose##2##3##(1996-9#1)(2007-11#1)
to the pursuit of##2##4##(2008-7#1)(2009-5#1)
to the putative##15##3##(1990-11#1)(1990-8#1)(1991-9#1)(1993-2#1)(1994-5#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-8#2)(1997-4#1)(2008-10#1)(2008-5#1)(2008-6#1)(2012-2#1)
to the pyrimidine ring##3##4##(1991-4#1)(1994-7#1)(1996-5#1)
to the pyrimidine##4##3##(1991-4#1)(1992-8#1)(1994-7#1)(1996-5#1)
to the pyrrole##2##3##(1991-7#1)(1994-5#1)
to the quadratic##2##3##(2008-10#1)(2008-3#1)
to the quadrature##2##3##(2008-2#1)(2008-3#1)
to the qualitative method##2##4##(2007-11#1)(2010-10#1)
to the qualitative##3##3##(2007-11#1)(2010-10#1)(2013-7#1)
to the quality assurance##4##4##(2007-8#1)(2008-10#2)(2008-11#1)
to the quality control of##3##5##(2007-8#1)(2008-10#2)
to the quality of the##5##5##(1995-11#1)(2007-1#1)(2007-8#1)(2008-2#1)(2008-3#1)
to the quality of##14##4##(1993-4#1)(1994-6#1)(1995-11#1)(1996-2#2)(2005-11#1)(2007-1#1)(2007-12#1)(2007-8#2)(2008-2#1)(2008-3#1)(2009-11#1)(2010-1#1)
to the quality##23##3##(1993-4#1)(1994-6#1)(1995-11#1)(1996-2#2)(2005-10#1)(2005-11#1)(2007-1#1)(2007-12#1)(2007-5#1)(2007-8#4)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2009-11#1)(2010-1#1)
to the quantitation##4##3##(2007-8#1)(2008-10#3)
to the quantitative determination of##2##5##(1992-2#1)(2008-10#1)
to the quantitative##6##3##(1991-8#1)(1992-2#1)(1997-3#1)(2008-10#2)(2009-10#1)
to the quantity of##2##4##(1997-2#1)(2008-10#1)
to the quantity##3##3##(1997-2#1)(2008-10#1)(2008-5#1)
to the quantized##2##3##(2007-12#1)(2008-10#1)
to the quartz##3##3##(2008-10#2)(2013-8#1)
to the quaternary##2##3##(1994-8#2)
to the quencher##3##3##(1990-8#1)(1992-12#1)(2006-10#1)
to the quenching##2##3##(1994-12#1)(2005-11#1)
to the quest for##3##4##(2004-10#1)(2008-9#1)(2013-1#1)
to the question of the##3##5##(1996-3#1)(2008-9#1)(2010-7#1)
to the question of whether##2##5##(2006-10#1)(2011-2#1)
to the question of##11##4##(1993-2#1)(1996-3#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-5#1)(2008-9#2)(2009-7#1)(2010-7#1)(2011-2#1)
to the question##13##3##(1993-2#1)(1995-3#1)(1996-3#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-2#1)(2008-5#1)(2008-9#2)(2009-7#1)(2010-7#1)(2011-2#1)
to the questionnaire##6##3##(1992-8#1)(1993-11#1)(2006-10#1)(2007-3#1)(2011-1#1)(2012-1#1)
to the questions##4##3##(2006-7#1)(2008-3#1)(2010-4#1)(2013-8#1)
to the radial##2##3##(2006-4#1)(2008-9#1)
to the radiation##7##3##(2006-12#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-10#1)
to the radiative##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2010-4#1)
to the radiology##3##3##(1995-2#1)(1996-3#1)(2007-4#1)
to the radius of##2##4##(2005-11#1)(2008-3#1)
to the radius##4##3##(2005-11#2)(2008-3#2)
to the rainy season##3##4##(2008-5#1)(2013-7#1)(2013-8#1)
to the random##5##3##(1990-7#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-11#1)
to the range of physical##2##5##(2010-4#1)(2012-2#1)
to the range of##9##4##(1993-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-4#1)(2010-4#1)(2012-2#1)(2013-1#1)
to the range##11##3##(1991-5#1)(1993-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-4#1)(2010-4#1)(2012-2#1)(2013-1#1)
to the rank of species##4##5##(2008-10#4)
to the rank##6##3##(2005-11#1)(2008-10#5)
to the rapid death##2##4##(2007-6#1)(2012-12#1)
to the rapid development of##3##5##(2006-10#1)(2008-10#2)
to the rapid development##4##4##(2006-10#1)(2008-10#2)(2010-2#1)
to the rapid growth of the##2##6##(2006-6#1)(2009-5#1)
to the rapid growth of##3##5##(2006-6#1)(2007-11#1)(2009-5#1)
to the rapid growth##4##4##(2006-6#1)(2007-11#1)(2009-3#1)(2009-5#1)
to the rapid increase##2##4##(1996-9#1)(2011-1#1)
to the rapid##33##3##(1993-9#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-6#1)(2006-10#2)(2006-6#1)(2007-11#2)(2007-5#1)(2007-6#1)(2008-10#6)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-2#1)(2011-1#1)(2012-11#1)(2012-12#2)
to the rapidly##2##3##(1996-10#1)(2013-1#1)
to the rarity of this##4##5##(2007-9#1)(2010-12#1)(2010-5#1)(2011-2#1)
to the rarity of##12##4##(2006-7#1)(2007-9#1)(2008-6#1)(2010-12#2)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
to the rat and human##3##5##(1993-12#1)(1994-8#2)
to the rat and##4##4##(1993-12#1)(1994-11#1)(1994-8#2)
to the rat liver##3##4##(1991-1#1)(1993-7#1)(1994-11#1)
to the rat rDNA promoter##2##5##(1993-3#2)
to the rat##27##3##(1991-1#1)(1991-7#1)(1993-12#3)(1993-2#1)(1993-3#3)(1993-4#2)(1993-7#1)(1994-11#2)(1994-3#1)(1994-8#3)(1995-12#1)(1995-3#1)(1996-10#1)(1996-2#1)(1997-2#1)(1997-5#1)(2006-6#1)(2007-3#1)(2007-9#1)
to the rate of the##2##5##(1992-1#1)(1997-4#1)
to the rate of##8##4##(1990-12#1)(1991-12#1)(1991-7#1)(1992-1#1)(1993-9#1)(1997-4#1)(2008-10#1)(2008-8#1)
to the rate##9##3##(1990-12#1)(1990-7#1)(1991-12#1)(1991-7#1)(1992-1#1)(1993-9#1)(1997-4#1)(2008-10#1)(2008-8#1)
to the rates of##2##4##(1992-12#1)(1994-11#1)
to the rates##3##3##(1992-12#2)(1994-11#1)
to the rather##4##3##(1991-5#1)(1993-8#1)(1997-8#1)(2008-11#1)
to the ratio of the##2##5##(2004-12#1)(2007-12#1)
to the ratio of##6##4##(1996-3#1)(2004-12#1)(2005-10#1)(2007-12#1)(2008-10#2)
to the ratio##7##3##(1996-3#1)(2004-12#1)(2005-10#1)(2007-12#1)(2008-10#2)(2008-5#1)
to the rational##2##3##(2006-2#1)(2007-6#1)
to the rats in the##2##5##(2011-2#2)
to the rats##6##3##(1992-7#1)(1993-4#1)(1996-10#1)(2011-2#2)(2012-2#1)
to the raw##2##3##(2010-10#1)(2013-1#1)
to the reaction medium##4##4##(1991-7#1)(2008-10#1)(2008-7#1)(2010-5#1)
to the reaction mixture##4##4##(1991-3#1)(2007-8#1)(2013-8#2)
to the reaction##20##3##(1990-7#1)(1991-3#1)(1991-7#1)(1992-2#1)(1994-8#1)(1995-1#1)(1997-2#1)(2004-9#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-7#1)(2010-12#1)(2010-5#1)(2013-8#2)
to the reactive##7##3##(1995-6#1)(1996-2#1)(2008-10#1)(2012-2#2)(2013-1#2)
to the reactor##3##3##(2007-8#1)(2008-11#1)(2009-2#1)
to the reading of##2##4##(2007-5#1)(2008-1#1)
to the reading##3##3##(2007-5#1)(2008-1#1)(2008-3#1)
to the reagent##2##3##(2008-10#2)
to the reagents##3##3##(1995-10#1)(2008-10#2)
to the real world##2##4##(1997-1#1)(2006-2#1)
to the real##14##3##(1997-1#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-1#1)(2013-1#1)
to the realization of##5##4##(2007-11#1)(2007-12#1)(2008-11#1)(2008-7#1)(2009-11#1)
to the realization##8##3##(1993-11#1)(2005-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-11#1)
to the reasonable##2##3##(1994-6#1)(2008-3#1)
to the received##3##3##(2008-2#2)(2009-7#1)
to the receiver##3##3##(2008-10#1)(2008-2#2)
to the receiving phase##2##4##(2008-10#2)
to the recent##16##3##(1990-6#1)(1996-3#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-7#1)(2011-2#1)
to the recently described##4##4##(1992-8#1)(1992-9#1)(2012-2#1)(2013-7#1)
to the recently reported##5##4##(1993-12#1)(1994-3#1)(1997-1#1)(2008-10#1)(2010-7#1)
to the recently##14##3##(1992-8#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-3#1)(1997-1#1)(2008-10#3)(2008-6#1)(2010-7#1)(2010-9#1)(2012-2#1)(2013-7#1)
to the receptor and##4##4##(1991-3#1)(1993-6#1)(1994-9#1)(1996-2#1)
to the receptor for##2##4##(1990-2#1)(1994-3#1)
to the receptor##26##3##(1990-2#1)(1990-4#1)(1990-5#3)(1991-3#1)(1991-7#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-6#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-3#1)(2008-4#1)(2013-8#1)
to the receptors##3##3##(1991-7#1)(1995-11#1)(2007-1#1)
to the recipient##5##3##(2005-12#1)(2007-12#1)(2008-5#1)(2011-2#1)(2013-8#1)
to the reciprocal##2##3##(1995-12#1)(2012-12#1)
to the recognition of##10##4##(1997-8#1)(2005-7#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-7#1)(2010-4#1)
to the recognition##14##3##(1991-8#1)(1997-8#1)(2005-7#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#2)(2008-4#2)(2008-7#1)(2008-8#1)(2010-4#1)(2012-3#1)
to the recombinant protein##2##4##(1993-9#1)(1994-12#1)
to the recombinant##7##3##(1993-9#1)(1994-12#1)(1994-6#1)(1995-3#1)(1995-5#1)(1996-5#1)(2005-8#1)
to the recombination##2##3##(1997-2#1)(2008-7#1)
to the recommendations of the International##3##6##(2009-11#1)(2013-1#2)
to the recommendations of the##7##5##(1990-3#1)(2008-1#1)(2009-11#1)(2012-12#1)(2012-3#1)(2013-1#2)
to the recommendations of##8##4##(1990-3#1)(2008-1#1)(2009-11#1)(2010-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
to the recommendations##9##3##(1990-3#1)(2007-11#1)(2008-1#1)(2009-11#1)(2010-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
to the recommended##2##3##(2006-6#1)(2013-1#1)
to the reconstruction of##3##4##(2008-2#1)(2008-7#1)(2009-3#1)
to the recording and##2##4##(1993-12#1)(2008-2#1)
to the recording of##2##4##(2007-11#2)
to the recording##5##3##(1993-12#1)(1995-7#1)(2007-11#2)(2008-2#1)
to the recovery and##4##4##(1991-6#1)(2008-10#3)
to the recovery of##7##4##(2007-12#1)(2008-10#3)(2008-9#1)(2011-1#1)(2012-1#1)
to the recovery##12##3##(1991-6#1)(2007-12#1)(2008-10#6)(2008-9#1)(2011-1#1)(2012-1#1)(2012-12#1)
to the recruitment##3##3##(1996-2#1)(2008-5#1)(2012-2#1)
to the rectal##2##3##(1991-9#1)(2008-7#1)
to the rectum##7##3##(1990-4#1)(1993-9#1)(2007-12#1)(2008-7#1)(2011-11#1)(2011-2#1)(2013-1#1)
to the red##3##3##(1994-5#1)(2006-5#1)(2006-6#1)
to the redox##5##3##(2008-10#2)(2008-11#1)(2008-5#1)(2010-7#1)
to the reduced weight gain following##2##6##(1994-6#2)
to the reduced##13##3##(1990-12#1)(1990-2#1)(1993-9#1)(1994-6#2)(1995-9#1)(1997-6#1)(2006-12#1)(2006-7#1)(2008-10#1)(2008-2#1)(2010-5#1)(2012-2#1)
to the reduction in##11##4##(1991-1#1)(1991-4#1)(1992-9#1)(1996-9#2)(2004-9#1)(2007-11#2)(2007-9#1)(2008-10#1)(2008-8#1)
to the reduction of the##6##5##(1995-12#1)(2008-10#4)(2009-5#1)
to the reduction of##30##4##(1990-5#1)(1992-9#1)(1995-12#1)(1996-2#1)(2005-10#1)(2006-2#1)(2008-10#12)(2008-3#2)(2008-4#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#4)
to the reduction##43##3##(1990-5#1)(1991-1#1)(1991-4#1)(1992-9#2)(1994-9#1)(1995-12#1)(1996-2#1)(1996-9#2)(2004-9#1)(2005-10#1)(2006-2#1)(2007-11#2)(2007-9#1)(2008-10#13)(2008-3#3)(2008-4#1)(2008-8#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#4)
to the reference genome##2##4##(2008-2#1)(2012-2#1)
to the reference method##3##4##(2008-10#3)
to the reference spectrophotometer##2##4##(2008-3#2)
to the reference strain##2##4##(2008-10#1)(2013-8#1)
to the reference##28##3##(1991-12#1)(1994-6#1)(2006-10#1)(2006-7#3)(2007-12#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
to the referral##2##3##(1997-3#1)(2006-2#1)
to the reflecting##2##3##(2008-3#1)(2009-8#1)
to the refractive index##3##4##(2008-3#3)
to the regimen##3##3##(1994-2#1)(2007-8#1)(2012-3#1)
to the region around the##2##5##(1995-7#1)(2006-2#1)
to the region between##2##4##(1993-11#1)(1995-10#1)
to the region from nt##2##5##(1996-10#2)
to the region from##3##4##(1996-10#2)(1996-6#1)
to the region of the##3##5##(1992-12#1)(1993-11#1)(1994-8#1)
to the region of##6##4##(1992-12#1)(1993-11#1)(1994-8#1)(2008-2#1)(2008-5#1)(2008-6#1)
to the region##19##3##(1990-2#1)(1991-12#1)(1992-12#1)(1993-11#2)(1994-8#2)(1995-10#1)(1995-7#1)(1996-10#2)(1996-5#1)(1996-6#1)(2005-8#1)(2006-2#1)(2008-2#1)(2008-5#1)(2008-6#1)(2013-1#1)
to the regional lymph nodes##2##5##(2008-6#2)
to the regional##10##3##(1992-8#1)(1994-6#1)(2007-5#1)(2008-1#1)(2008-2#1)(2008-6#3)(2012-12#1)(2013-8#1)
to the regression##2##3##(1996-2#1)(2008-10#1)
to the regular##5##3##(1992-10#1)(1997-6#2)(2007-12#1)(2008-10#1)
to the regulated secretory pathway##3##5##(1990-5#1)(1994-11#1)(1996-4#1)
to the regulated##6##3##(1990-5#2)(1994-11#1)(1995-2#1)(1996-4#1)(2008-4#1)
to the regulation of food intake##2##6##(1993-7#1)(2006-1#1)
to the regulation of the##3##5##(1994-3#1)(1995-5#1)(2011-2#1)
to the regulation of##25##4##(1990-2#1)(1990-5#1)(1991-10#1)(1991-5#1)(1991-8#1)(1993-7#1)(1994-12#1)(1994-3#1)(1995-5#1)(2006-1#1)(2006-11#1)(2007-8#1)(2008-1#1)(2008-4#2)(2008-5#2)(2009-3#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-1#1)
to the regulation##28##3##(1990-2#1)(1990-5#1)(1991-10#1)(1991-5#1)(1991-8#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-5#1)(2006-1#1)(2006-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#3)(2009-3#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-1#1)
to the regulatory##7##3##(1990-8#1)(1991-2#1)(1997-2#1)(1997-5#1)(1997-7#1)(2008-11#1)(2013-8#1)
to the rehabilitation unit##2##4##(1991-6#1)(2007-9#1)
to the rehabilitation##6##3##(1991-6#1)(1995-5#1)(2007-8#2)(2007-9#1)(2012-1#1)
to the relationship between the##2##5##(2007-11#1)(2008-9#1)
to the relationship between##8##4##(1992-3#1)(1995-2#1)(2005-11#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)
to the relationship##11##3##(1992-3#1)(1995-2#1)(1997-7#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#2)(2008-9#1)
to the relationships##2##3##(2008-11#1)(2011-2#1)
to the relative efficiency of##2##5##(1990-10#1)(1992-3#1)
to the relative merits of##2##5##(2006-2#1)(2008-3#1)
to the relative##24##3##(1990-10#1)(1990-7#1)(1992-3#1)(1996-11#1)(1997-8#1)(2006-2#1)(2006-5#1)(2007-12#2)(2007-2#1)(2008-1#3)(2008-10#4)(2008-2#2)(2008-3#2)(2008-9#1)(2009-12#1)(2010-4#1)
to the relatively high##3##4##(1990-12#1)(1994-12#1)(2008-3#1)
to the relatively low##2##4##(1995-2#1)(2009-9#1)
to the relatively##10##3##(1990-12#1)(1992-6#1)(1994-12#1)(1995-2#1)(1997-4#1)(2008-10#1)(2008-3#2)(2009-10#1)(2009-9#1)
to the release of##13##4##(1990-2#1)(1991-7#1)(1992-11#1)(1996-2#1)(2004-9#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#1)(2010-3#1)(2011-2#1)
to the release##16##3##(1990-2#1)(1991-7#1)(1992-11#1)(1992-12#1)(1996-2#1)(1997-2#1)(2004-9#1)(2006-8#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-5#1)(2010-3#1)(2011-2#1)
to the relevance of##4##4##(1994-6#1)(2003-11#1)(2008-12#1)(2011-12#1)
to the relevance##5##3##(1994-6#1)(1997-1#1)(2003-11#1)(2008-12#1)(2011-12#1)
to the relevant##10##3##(1991-12#2)(1992-8#1)(1995-12#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-3#1)(2013-8#1)
to the remainder of the##4##5##(1994-9#1)(1996-1#1)(2005-8#1)(2007-11#1)
to the remaining eye##2##4##(1992-10#2)
to the remaining##11##3##(1992-10#2)(1995-10#1)(1996-2#1)(1997-3#1)(2007-10#1)(2008-10#1)(2012-11#2)(2013-1#1)(2013-8#1)
to the remission##2##3##(1991-2#1)(2008-5#1)
to the remote##2##3##(1993-3#1)(2013-8#1)
to the removal of##7##4##(1996-10#1)(1996-11#1)(2005-11#1)(2007-10#1)(2007-9#1)(2009-12#1)(2012-12#1)
to the renal##6##3##(1996-2#1)(2007-8#1)(2008-11#1)(2010-12#1)(2011-2#1)(2012-11#1)
to the renin-angiotensin system##2##4##(1993-11#2)
to the reorganisation of the##2##5##(1990-5#1)(2011-2#1)
to the reorganization of##2##4##(1993-6#1)(1995-12#1)
to the repair##2##3##(1994-2#1)(2007-12#1)
to the repeat##2##3##(1997-4#1)(2009-3#1)
to the repeated##3##3##(1996-12#2)(2008-8#1)
to the repertoire of##2##4##(1991-2#1)(2007-3#1)
to the replacement of the##3##5##(2008-2#1)(2009-3#1)(2012-12#1)
to the replacement of##5##4##(1990-5#1)(1993-8#1)(2008-2#1)(2009-3#1)(2012-12#1)
to the replication of##2##4##(2008-10#1)(2010-2#1)
to the replication##3##3##(1994-9#1)(2008-10#1)(2010-2#1)
to the report##2##3##(2008-5#1)(2013-8#1)
to the reported##7##3##(1990-10#1)(1990-4#1)(1992-1#1)(1997-2#1)(2007-1#1)(2012-3#1)(2013-8#1)
to the reporter##4##3##(1991-7#1)(1996-11#1)(2005-9#1)(2009-5#1)
to the repression of##3##4##(1995-12#1)(2008-1#1)(2008-10#1)
to the reproductive##3##3##(1994-10#1)(2007-3#1)(2008-5#1)
to the requesting##2##3##(2010-3#1)(2011-2#1)
to the required##5##3##(1990-2#1)(2007-11#1)(2008-3#1)(2008-8#1)(2012-12#1)
to the requirement for##2##4##(2006-2#1)(2007-5#1)
to the requirement##4##3##(2006-2#1)(2007-5#1)(2008-10#1)(2008-3#1)
to the requirements for##2##4##(2004-9#1)(2008-10#1)
to the requirements of the individual##2##6##(2007-8#1)(2013-1#1)
to the requirements of the##4##5##(1993-10#1)(2007-8#1)(2008-4#1)(2013-1#1)
to the requirements of##7##4##(1991-3#1)(1993-10#1)(2007-8#1)(2008-2#1)(2008-4#1)(2013-1#2)
to the requirements##9##3##(1991-3#1)(1993-10#1)(2004-9#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2013-1#2)
to the rescue##3##3##(1992-3#1)(1995-2#1)(2009-4#1)
to the research##9##3##(2008-11#2)(2008-2#1)(2008-6#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-12#1)
to the resection##3##3##(1990-11#1)(2007-8#2)
to the reservoir##4##3##(1996-2#1)(2007-12#1)(2008-10#2)
to the residual##4##3##(2008-2#2)(2008-3#1)(2008-8#1)
to the resilience of##3##4##(2007-3#1)(2009-7#2)
to the resistance gene##2##4##(2008-10#2)
to the resistance of##3##4##(2008-10#1)(2008-5#1)(2012-2#1)
to the resistance##8##3##(2006-11#1)(2008-10#5)(2008-5#1)(2012-2#1)
to the resistant##3##3##(1990-12#1)(2008-10#2)
to the resolution of##9##4##(2006-12#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-8#1)(2011-1#1)
to the resolution##11##3##(2006-12#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-8#1)(2011-1#1)
to the resonance##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
to the resonant##3##3##(2007-11#1)(2008-3#1)(2010-1#1)
to the resonator##2##3##(2007-11#1)(2007-12#1)
to the respective##11##3##(1997-2#1)(2005-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-1#1)(2012-2#1)
to the respiratory chain##2##4##(1994-11#1)(1997-7#1)
to the respiratory system##2##4##(1996-3#1)(2012-1#1)
to the respiratory tract##6##4##(1994-12#1)(1996-1#1)(1996-3#1)(2007-10#1)(2008-5#1)(2012-2#1)
to the respiratory##14##3##(1994-11#1)(1994-12#1)(1996-1#1)(1996-3#2)(1997-7#1)(2007-10#1)(2007-7#2)(2008-5#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-2#1)
to the response of##5##4##(1994-10#1)(2007-4#2)(2007-8#1)(2008-10#1)
to the response##10##3##(1992-6#1)(1994-10#1)(1994-2#1)(2006-8#1)(2007-11#1)(2007-4#2)(2007-8#1)(2008-10#2)
to the responses of##2##4##(1994-10#1)(2007-11#1)
to the responses##4##3##(1994-10#1)(2007-11#1)(2008-7#1)(2012-12#1)
to the rest of the body##4##6##(1992-3#1)(2008-1#1)(2013-1#2)
to the rest of the population##3##6##(2008-2#2)(2011-2#1)
to the rest of the##15##5##(1992-10#1)(1992-3#1)(1993-2#1)(1993-5#1)(1994-3#1)(1995-1#1)(2006-10#1)(2008-1#1)(2008-2#2)(2008-3#1)(2011-2#1)(2012-1#1)(2013-1#2)
to the rest of##18##4##(1992-10#1)(1992-3#1)(1993-2#1)(1993-5#1)(1994-3#1)(1995-1#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)(2011-2#2)(2012-1#1)(2013-1#2)
to the rest##19##3##(1992-10#1)(1992-3#1)(1993-2#1)(1993-5#1)(1994-3#1)(1995-1#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)(2010-4#1)(2011-2#2)(2012-1#1)(2013-1#2)
to the resting##2##3##(1996-4#1)(2008-4#1)
to the restoration of##3##4##(2007-11#1)(2007-7#1)(2008-11#1)
to the restoration##4##3##(2007-11#1)(2007-7#1)(2008-11#1)(2011-2#1)
to the restriction of##2##4##(1991-7#1)(2008-11#1)
to the restriction##3##3##(1990-4#1)(1991-7#1)(2008-11#1)
to the resulting##9##3##(1992-8#1)(1995-3#1)(2007-12#1)(2008-2#1)(2008-4#1)(2009-5#1)(2010-5#1)(2013-8#2)
to the results from the##3##5##(2006-10#1)(2007-2#1)(2008-1#1)
to the results from##6##4##(2006-10#1)(2006-6#1)(2007-2#1)(2008-1#1)(2008-3#1)(2012-3#1)
to the results in##3##4##(1995-3#1)(2007-5#1)(2012-2#1)
to the results obtained##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
to the results of a##2##5##(1995-6#1)(1996-8#1)
to the results of the most recent##2##7##(1995-6#1)(2006-6#1)
to the results of the##11##5##(1993-1#1)(1995-6#1)(1996-6#1)(2005-11#1)(2005-12#1)(2006-6#1)(2007-11#2)(2008-2#1)(2008-3#1)(2012-2#1)
to the results of##29##4##(1990-6#1)(1991-3#1)(1992-11#1)(1993-1#1)(1994-2#2)(1995-6#2)(1996-6#2)(1996-8#1)(2005-11#1)(2005-12#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-11#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-8#1)(2010-2#2)(2012-2#1)
to the results##69##3##(1990-6#2)(1990-9#1)(1991-2#1)(1991-3#1)(1992-11#1)(1993-1#1)(1993-10#1)(1993-11#1)(1994-2#2)(1995-3#1)(1995-6#2)(1996-6#2)(1996-8#1)(1997-4#1)(2004-9#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#3)(2007-2#1)(2007-5#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-2#3)(2010-8#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
to the retained##2##3##(2004-10#1)(2012-1#1)
to the retention times of##2##5##(1991-5#1)(1992-7#1)
to the retention##6##3##(1990-8#1)(1991-5#1)(1992-7#1)(1993-7#1)(1994-8#1)(1995-12#1)
to the retina##10##3##(1994-2#1)(1996-2#2)(1997-8#1)(2007-12#1)(2008-4#2)(2008-7#1)(2012-12#1)(2013-1#1)
to the retinal##2##3##(1996-2#1)(2006-4#1)
to the retrieval##2##3##(2008-3#1)(2010-8#1)
to the reverse##3##3##(1994-12#1)(1997-6#1)(2011-2#1)
to the review##2##3##(1995-6#1)(2012-2#1)
to the reward##2##3##(1993-2#1)(1997-6#1)
to the rhabdom##2##3##(2007-12#1)(2009-10#1)
to the rho##2##3##(1991-2#1)(1992-5#1)
to the rhythm of##2##4##(2012-2#2)
to the ribose##2##3##(1990-5#1)(1996-7#1)
to the ribosome during##2##4##(1994-6#1)(1994-9#1)
to the ribosome##5##3##(1994-6#1)(1994-9#1)(1995-4#1)(2005-7#1)(2006-12#1)
to the right adrenal gland##2##5##(2008-5#2)
to the right and##3##4##(1993-11#1)(1995-12#1)(2008-3#1)
to the right arm of chromosome##3##6##(1995-6#3)
to the right atrium##2##4##(1992-8#1)(2007-8#1)
to the right coronary artery##2##5##(1990-3#1)(2007-8#1)
to the right in a parallel##2##6##(1995-12#1)(1996-10#1)
to the right in the##4##5##(1997-5#1)(2004-12#1)(2008-4#1)(2009-5#1)
to the right in##8##4##(1994-2#1)(1995-12#1)(1995-3#1)(1996-10#1)(1997-5#1)(2004-12#1)(2008-4#1)(2009-5#1)
to the right kidney##2##4##(1990-9#1)(2007-2#1)
to the right of the##2##5##(1990-12#1)(2008-4#1)
to the right of##4##4##(1990-12#1)(1995-12#1)(2008-4#1)(2009-5#1)
to the right patient at the right time##2##8##(1993-12#1)(2012-2#1)
to the right side of the##2##6##(1996-3#1)(2011-2#1)
to the right side##3##4##(1996-3#1)(2007-8#1)(2011-2#1)
to the right ventricle##2##4##(1997-1#1)(2008-10#1)
to the right with##2##4##(1990-5#1)(1994-11#1)
to the right##82##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-9#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-5#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-12#6)(1995-3#1)(1995-6#3)(1996-10#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-5#1)(2004-12#1)(2006-1#1)(2006-2#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#5)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#4)(2009-10#1)(2009-12#1)(2009-2#4)(2009-5#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#4)
to the rigorous##3##3##(2006-10#1)(2007-2#1)(2008-4#1)
to the ring##4##3##(1994-9#1)(2005-11#1)(2007-10#1)(2008-2#1)
to the rise in##3##4##(2007-9#1)(2008-11#2)
to the rise of the##2##5##(2005-11#1)(2008-11#1)
to the rise of##3##4##(2005-11#1)(2007-8#1)(2008-11#1)
to the rise##7##3##(1994-2#1)(2005-11#1)(2007-8#1)(2007-9#1)(2008-11#3)
to the rising incidence of##2##5##(2006-10#1)(2009-3#1)
to the rising##6##3##(2006-10#1)(2007-12#1)(2008-3#1)(2009-3#1)(2010-9#1)(2011-12#1)
to the risk for##2##4##(2007-7#1)(2008-10#1)
to the risk group##2##4##(2011-2#2)
to the risk in##2##4##(2005-10#1)(2010-12#1)
to the risk of##24##4##(1990-7#1)(1991-4#1)(1991-9#1)(1992-3#1)(1994-3#1)(1994-4#1)(1995-11#1)(1996-6#1)(2005-10#1)(2006-10#2)(2007-6#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-1#1)(2011-1#2)(2011-12#2)(2012-1#1)(2013-1#1)
to the risk##37##3##(1990-12#1)(1990-7#1)(1991-4#1)(1991-9#1)(1992-3#1)(1993-2#1)(1994-3#1)(1994-4#1)(1995-11#1)(1996-6#1)(1997-3#1)(2005-10#2)(2006-10#2)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-1#1)(2010-12#1)(2011-1#3)(2011-12#2)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#1)
to the robustness of##2##4##(1997-3#1)(2008-10#1)
to the rock##2##3##(1996-4#1)(2008-10#1)
to the role of the nurse##2##6##(2011-1#2)
to the role of the##5##5##(2005-1#1)(2010-10#1)(2010-3#1)(2011-1#2)
to the role of##29##4##(1991-7#1)(1993-8#1)(1994-2#1)(1997-4#1)(2005-1#1)(2006-11#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-7#1)(2011-1#4)(2012-12#1)(2013-1#1)
to the role played by##2##5##(2008-1#1)(2008-10#1)
to the role##32##3##(1991-7#1)(1993-8#1)(1994-2#1)(1997-4#1)(2005-1#1)(2006-11#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-7#1)(2011-1#4)(2012-12#1)(2013-1#1)
to the roles of##3##4##(1992-3#1)(2005-10#1)(2010-5#1)
to the root##4##3##(2008-10#1)(2008-7#1)(2009-8#1)(2011-1#1)
to the root-knot nematode##2##4##(2008-10#1)(2009-3#1)
to the roots of##3##4##(1991-1#1)(2008-10#1)(2010-4#1)
to the roots##6##3##(1991-1#1)(2008-10#3)(2010-4#1)(2011-2#1)
to the rostral##3##3##(1993-12#1)(1996-4#1)(1997-5#1)
to the rotational##2##3##(2007-12#1)(2008-10#1)
to the route of administration##3##5##(1992-11#3)
to the route of##4##4##(1992-11#3)(2006-10#1)
to the routine use of##2##5##(2005-12#1)(2008-6#1)
to the routine##7##3##(1994-3#1)(2005-12#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2013-1#1)
to the running##2##3##(2007-8#1)(2010-7#1)
to the rupture of##3##4##(1991-5#2)(2009-2#1)
to the rural areas##2##4##(2008-3#1)(2011-2#1)
to the rural##4##3##(1991-1#1)(2008-3#1)(2011-2#1)(2012-12#1)
to the sacrum##4##3##(2006-10#2)(2008-8#1)(2013-8#1)
to the safety##4##3##(1994-11#1)(2009-10#1)(2011-2#1)(2012-1#1)
to the sagittal sinus##2##4##(2013-8#2)
to the sagittal##3##3##(2006-3#1)(2013-8#2)
to the saline##2##3##(1995-12#1)(2013-1#1)
to the salivary glands##2##4##(2008-10#2)
to the salivary##3##3##(2008-10#2)(2009-1#1)
to the same DNA##3##4##(1991-10#1)(1994-12#1)(1995-1#1)
to the same antibody##2##4##(1996-7#1)(2008-7#1)
to the same degree in##2##5##(1995-7#1)(1996-9#1)
to the same degree##8##4##(1990-2#1)(1993-6#1)(1995-5#1)(1995-7#1)(1996-9#2)(2007-10#1)(2008-10#1)
to the same extent as the##2##6##(2008-10#2)
to the same extent as##11##5##(1990-11#1)(1992-11#2)(1993-6#1)(2008-10#3)(2008-3#1)(2008-4#1)(2012-12#1)(2013-8#1)
to the same extent by##4##5##(1991-1#1)(1993-2#1)(1995-4#1)(2012-3#1)
to the same extent in##6##5##(1994-12#1)(1996-5#1)(2007-9#1)(2008-10#2)(2008-2#1)
to the same extent##33##4##(1990-11#1)(1991-1#1)(1991-5#1)(1991-7#1)(1991-8#2)(1992-11#2)(1993-2#1)(1993-4#1)(1993-6#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-2#1)(1996-5#1)(2006-8#1)(2007-9#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-8#1)
to the same family##2##4##(1994-8#1)(2009-4#1)
to the same final##2##4##(1990-2#1)(2010-7#1)
to the same gene##4##4##(1995-8#1)(1996-4#1)(2008-10#1)(2010-7#1)
to the same hospital##2##4##(1991-2#1)(1991-3#1)
to the same level found in##2##6##(1996-9#1)(2006-4#1)
to the same level##3##4##(1996-9#1)(2006-4#1)(2013-1#1)
to the same protein##2##4##(1997-6#1)(2011-1#1)
to the same region of the##2##6##(1990-12#1)(1994-8#1)
to the same region##6##4##(1990-12#1)(1993-8#2)(1994-11#1)(1994-8#1)(2008-10#1)
to the same selective##2##4##(2008-8#2)
to the same species##3##4##(2008-10#1)(2008-5#1)(2013-7#1)
to the same subjects##3##4##(1996-3#1)(2007-1#1)(2012-3#1)
to the same vision##2##4##(1996-1#2)
to the same##184##3##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#1)(1991-1#2)(1991-10#1)(1991-2#2)(1991-3#2)(1991-5#5)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#4)(1992-12#1)(1992-2#1)(1992-4#2)(1992-8#1)(1993-2#1)(1993-4#1)(1993-6#3)(1993-7#1)(1993-8#3)(1994-11#2)(1994-12#3)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1995-1#2)(1995-11#1)(1995-2#5)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#3)(1996-1#2)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#3)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(2005-11#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#32)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#4)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-7#2)(2011-1#4)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#1)
to the sample and by##2##5##(2007-12#1)(2008-1#1)
to the sample in##2##4##(1991-2#1)(2008-10#1)
to the sample solution##4##4##(2008-10#4)
to the sample surface##4##4##(2005-11#1)(2008-10#1)(2008-2#1)(2012-2#1)
to the sample##28##3##(1991-2#1)(1992-12#1)(1995-2#1)(1996-12#1)(2005-11#1)(2007-12#2)(2007-9#2)(2008-1#1)(2008-10#13)(2008-2#2)(2012-2#2)(2013-8#1)
to the sampled##2##3##(2008-10#1)(2008-2#1)
to the samples##7##3##(1995-2#1)(2006-10#1)(2008-10#5)
to the sampling##2##3##(1996-12#1)(2010-2#1)
to the sandbar opening and##3##5##(2013-7#3)
to the sandbar opening##4##4##(2013-7#4)
to the sarcolemma##2##3##(2007-9#2)
to the satellite##2##3##(2008-2#1)(2008-3#1)
to the saturable mechanism of heparin clearance##2##7##(1990-12#2)
to the saturable mechanism##3##4##(1990-12#3)
to the scale##4##3##(2008-11#1)(2008-8#1)(2008-9#1)(2012-11#1)
to the scalp and##2##4##(2005-11#1)(2013-8#1)
to the scalp##7##3##(2005-11#2)(2008-5#2)(2010-6#2)(2013-8#1)
to the scanning##2##3##(2005-12#1)(2008-2#1)
to the scattered##3##3##(2008-3#3)
to the scattering##6##3##(2008-2#2)(2008-3#4)
to the scavenging##2##3##(1995-12#1)(2009-6#1)
to the scene##3##3##(2004-7#1)(2008-1#1)(2012-12#1)
to the scheduled##2##3##(1996-1#1)(2007-8#1)
to the scheme##3##3##(1991-7#1)(2007-11#1)(2008-10#1)
to the sciatic nerve##5##4##(1991-3#1)(1991-6#2)(1995-12#2)
to the scientific community##2##4##(2005-7#1)(2010-2#1)
to the scientific##5##3##(2005-7#1)(2007-2#1)(2007-8#1)(2010-2#1)(2011-1#1)
to the score equation##2##4##(1993-9#2)
to the screening of##2##4##(2007-12#1)(2008-10#1)
to the screening##4##3##(1993-1#1)(1996-5#1)(2007-12#1)(2008-10#1)
to the sea##2##3##(2007-3#1)(2008-3#1)
to the search for##4##4##(2006-5#1)(2008-10#1)(2012-12#1)(2012-3#1)
to the search of##2##4##(2008-10#1)(2011-2#1)
to the search##8##3##(2006-5#1)(2008-10#2)(2008-9#1)(2009-11#1)(2011-2#1)(2012-12#1)(2012-3#1)
to the seasonal##2##3##(2007-8#1)(2008-10#1)
to the second harmonic##2##4##(2007-12#1)(2008-1#1)
to the second order##2##4##(2006-4#1)(2008-3#1)
to the second##39##3##(1990-12#1)(1990-8#1)(1991-12#1)(1991-6#3)(1992-7#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-3#1)(1996-5#1)(2005-10#1)(2006-3#2)(2006-4#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-8#2)(2010-3#1)(2010-6#2)(2013-7#1)(2013-8#1)
to the second-order##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
to the secondary##8##3##(1993-6#1)(1994-9#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#3)
to the secretion of##4##4##(2006-9#1)(2008-4#1)(2008-6#1)(2008-8#1)
to the section##2##3##(2007-8#1)(2008-10#1)
to the security##2##3##(1993-2#1)(1997-2#1)
to the seed##7##3##(2006-12#1)(2008-10#5)(2008-8#1)
to the segmental##2##3##(2007-12#2)
to the segmentation of##2##4##(2008-2#2)
to the segmentation##3##3##(2008-2#2)(2008-3#1)
to the segregation of the##2##5##(2005-11#1)(2012-11#1)
to the segregation of##3##4##(2005-11#2)(2012-11#1)
to the selection of resistant##2##5##(2008-10#1)(2012-1#1)
to the selection of##8##4##(1997-1#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-9#1)(2010-2#1)(2012-1#1)
to the selection##10##3##(1991-8#1)(1997-1#1)(2006-9#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-9#1)(2010-2#1)(2012-1#1)
to the selective determination of##3##5##(2007-8#1)(2008-10#2)
to the selective##13##3##(1990-2#1)(1994-8#1)(1995-3#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-7#1)(2008-8#1)(2013-1#2)
to the sella##2##3##(1991-6#1)(2011-2#1)
to the sensing interface##2##4##(2008-10#2)
to the sensing##7##3##(2008-10#3)(2008-3#1)(2008-4#1)(2008-9#1)(2009-5#1)
to the sensitive##3##3##(1994-3#1)(2008-10#1)(2011-2#1)
to the sensitivity of the##3##5##(1990-6#1)(2008-4#1)(2008-5#1)
to the sensitivity of##5##4##(1990-5#1)(1990-6#1)(2008-10#1)(2008-4#1)(2008-5#1)
to the sensitivity##11##3##(1990-12#1)(1990-5#1)(1990-6#1)(1995-11#1)(2006-3#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-5#1)
to the sensor##7##3##(1997-4#1)(2004-9#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-11#1)(2009-3#1)
to the sensory##4##3##(1993-12#1)(2007-1#1)(2008-7#1)(2008-8#1)
to the separate##2##3##(1990-5#1)(2008-10#1)
to the separated##2##3##(2008-8#1)(2010-7#1)
to the separately##2##3##(1995-5#2)
to the separation and preconcentration of##2##6##(2008-10#2)
to the separation and##4##4##(1991-8#1)(2008-10#3)
to the separation of the##2##5##(1991-9#1)(2008-10#1)
to the separation of##14##4##(1991-11#1)(1991-9#1)(1996-5#2)(2006-10#1)(2008-10#5)(2008-11#1)(2008-7#2)(2013-8#1)
to the separation##19##3##(1991-11#1)(1991-8#1)(1991-9#1)(1996-5#2)(2006-10#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-7#2)(2013-8#1)
to the septum##3##3##(1991-5#1)(2008-2#1)(2013-1#1)
to the sequence of a##3##5##(1990-2#1)(1993-6#1)(1994-6#1)
to the sequence of the first two##3##7##(1991-4#1)(2012-12#2)
to the sequence of the##9##5##(1990-4#1)(1991-4#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-12#2)
to the sequence of##17##4##(1990-11#1)(1990-2#2)(1990-4#1)(1991-12#1)(1991-4#1)(1993-6#1)(1994-6#1)(1995-2#1)(1997-5#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2012-12#2)
to the sequence##27##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-4#1)(1991-12#1)(1991-4#1)(1992-4#1)(1992-9#1)(1993-6#1)(1994-6#1)(1995-2#1)(1996-8#1)(1997-5#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2009-8#1)(2012-12#2)(2013-1#1)
to the sequences of the##3##5##(1993-6#1)(1994-9#1)(2010-5#1)
to the sequences of##5##4##(1991-6#1)(1993-6#1)(1994-8#1)(1994-9#1)(2010-5#1)
to the sequences##9##3##(1990-7#1)(1990-8#1)(1991-5#1)(1991-6#1)(1993-6#1)(1994-8#2)(1994-9#1)(2010-5#1)
to the sequencing##2##3##(1990-9#1)(2010-8#1)
to the sequential##2##3##(1994-8#1)(2008-10#1)
to the series##2##3##(1995-5#1)(1995-8#1)
to the serine proteinase##2##4##(1990-5#1)(1996-5#1)
to the serine##4##3##(1990-5#1)(1991-8#1)(1994-5#1)(1996-5#1)
to the serious##5##3##(1995-8#1)(2005-11#1)(2007-11#1)(2007-5#1)(2013-1#1)
to the serosal side##2##4##(1994-3#1)(1994-9#1)
to the serum##8##3##(1991-2#1)(1991-3#1)(1991-6#1)(1992-3#1)(1995-12#1)(1996-8#1)(2007-7#1)(2013-8#1)
to the service##2##3##(2004-9#1)(2010-8#1)
to the services##2##3##(1993-3#1)(1995-3#1)
to the set of##3##4##(2008-11#1)(2008-3#1)(2013-1#1)
to the set##5##3##(2008-11#1)(2008-3#3)(2013-1#1)
to the severe##7##3##(1996-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2013-1#1)(2013-7#1)(2013-8#1)
to the severity and##2##4##(1990-12#1)(2009-5#1)
to the severity of hypertension##2##5##(2010-12#1)(2013-1#1)
to the severity of the disease##2##6##(1993-11#1)(2010-12#1)
to the severity of the##8##5##(1993-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-12#1)(2013-7#1)
to the severity of their##2##5##(2007-6#1)(2008-11#1)
to the severity of##26##4##(1992-3#1)(1993-11#1)(1996-3#1)(1997-8#1)(2004-12#1)(2005-11#1)(2006-4#1)(2007-11#1)(2007-6#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
to the severity##30##3##(1990-12#1)(1992-3#1)(1993-11#1)(1996-3#1)(1997-8#1)(2004-12#1)(2005-11#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-6#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
to the sexual##3##3##(1991-6#1)(2009-9#1)(2012-12#1)
to the shape of the##8##5##(1996-1#1)(2008-1#1)(2008-2#2)(2008-3#1)(2009-10#1)(2009-2#1)(2013-7#1)
to the shape of##9##4##(1996-1#1)(2008-1#1)(2008-2#2)(2008-3#2)(2009-10#1)(2009-2#1)(2013-7#1)
to the shape##11##3##(1996-1#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-2#2)(2008-3#2)(2009-10#1)(2009-2#1)(2013-7#1)
to the shear##3##3##(2006-11#2)(2007-4#1)
to the shearing plates##2##4##(1993-7#2)
to the shearing##3##3##(1993-7#2)(2008-3#1)
to the shoot##2##3##(2008-10#1)(2012-2#1)
to the short arm of##5##5##(1990-4#1)(2008-10#4)
to the short##15##3##(1990-4#1)(1994-8#1)(1995-2#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#1)(2013-7#1)
to the short-chain##2##3##(2005-11#1)(2008-5#1)
to the shorter##4##3##(1990-2#1)(1997-7#1)(2007-11#1)(2008-5#1)
to the shot##3##3##(1997-8#1)(2007-12#1)(2008-3#1)
to the shot-noise limit##2##4##(2007-11#1)(2008-1#1)
to the shoulder girdle##2##4##(2006-9#1)(2009-3#1)
to the shoulder##7##3##(2006-11#1)(2006-9#1)(2007-4#2)(2008-7#1)(2009-3#1)(2011-12#1)
to the side effects##3##4##(1992-12#1)(1997-3#1)(2008-4#1)
to the side of the##4##5##(2007-12#1)(2008-3#1)(2008-6#1)(2008-7#1)
to the side of##5##4##(2007-12#2)(2008-3#1)(2008-6#1)(2008-7#1)
to the side position##2##4##(1992-4#1)(2007-1#1)
to the side##14##3##(1992-12#1)(1992-4#1)(1997-3#1)(2007-1#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2013-1#2)
to the sidewall##2##3##(2006-6#1)(2008-3#1)
to the sight of objects##2##5##(1993-6#2)
to the sight or ingestion of food##2##7##(1991-5#2)
to the sight##6##3##(1991-5#4)(1993-6#2)
to the sigma##2##3##(1995-2#1)(1995-6#1)
to the signal of##2##4##(2008-10#1)(2008-2#1)
to the signal##16##3##(1995-3#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#5)(2008-7#1)(2009-3#1)(2009-9#1)(2010-7#1)
to the significance of the##2##5##(1997-8#1)(2013-1#1)
to the significance of##5##4##(1997-8#1)(2005-8#1)(2009-4#1)(2011-2#1)(2013-1#1)
to the significance##6##3##(1997-8#1)(2005-8#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
to the significant increase in##3##5##(2008-5#1)(2009-8#1)(2012-11#1)
to the significant##13##3##(1994-2#1)(2005-1#2)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)
to the silencing##2##3##(2008-9#1)(2011-2#1)
to the silica surface##3##4##(2005-11#1)(2007-11#1)(2008-10#1)
to the silica##4##3##(2005-11#1)(2007-11#1)(2008-10#2)
to the siloxy bilayer##2##4##(2008-10#2)
to the similar##7##3##(1991-7#1)(1994-11#1)(1994-2#1)(1997-6#1)(2008-3#1)(2012-3#1)(2013-8#1)
to the similarity of the##2##5##(2008-10#1)(2012-12#1)
to the similarity of##3##4##(2005-11#1)(2008-10#1)(2012-12#1)
to the similarity##4##3##(2005-11#1)(2008-10#1)(2008-2#1)(2012-12#1)
to the simple##9##3##(1990-6#1)(1996-3#1)(2007-5#1)(2007-8#3)(2008-10#2)(2012-1#1)
to the simplest##2##3##(1990-10#1)(2008-9#1)
to the simulated##6##3##(2008-10#2)(2012-3#4)
to the simulation##3##3##(2007-5#1)(2008-10#1)(2012-3#1)
to the simultaneous analysis of##2##5##(2008-10#2)
to the simultaneous determination of##28##5##(2008-10#27)(2012-12#1)
to the simultaneous##44##3##(2007-8#1)(2008-1#1)(2008-10#36)(2008-2#1)(2008-3#1)(2008-5#1)(2012-12#1)(2013-1#2)
to the single##10##3##(1990-5#1)(1992-4#1)(2007-11#1)(2008-10#2)(2008-2#1)(2009-2#1)(2012-6#1)(2013-1#1)(2013-8#1)
to the sinonasal##2##3##(2010-7#1)(2011-2#1)
to the site of exocytosis##2##5##(1997-4#1)(1997-6#1)
to the site of infection##2##5##(1997-1#1)(2012-12#1)
to the site of injury##2##5##(2007-11#1)(2012-12#1)
to the site of the primary##2##6##(2008-6#1)(2013-1#1)
to the site of the##9##5##(1990-8#1)(1991-1#1)(1995-6#1)(2005-9#1)(2008-4#2)(2008-6#1)(2013-1#2)
to the site of##34##4##(1990-2#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-3#1)(1991-9#1)(1994-9#1)(1995-6#2)(1996-5#2)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-9#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2012-12#2)(2013-1#2)
to the site##41##3##(1990-2#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-3#1)(1991-9#1)(1994-9#1)(1995-6#3)(1996-5#2)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#2)(2005-11#1)(2005-9#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2012-12#2)(2012-2#1)(2013-1#3)
to the site-specific##3##3##(1995-12#1)(2006-12#1)(2007-12#1)
to the sites##3##3##(1990-12#1)(1992-1#1)(2012-12#1)
to the situation in pterygote insects##2##6##(2007-12#2)
to the situation in the##2##5##(1990-6#1)(2008-5#1)
to the situation in##7##4##(1990-6#1)(1997-4#1)(2007-12#2)(2008-2#1)(2008-5#1)(2008-7#1)
to the situation of##2##4##(2007-11#1)(2013-1#1)
to the situation##18##3##(1990-4#1)(1990-6#1)(1991-5#1)(1994-2#1)(1995-6#1)(1996-3#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-7#1)(2013-1#1)
to the six##3##3##(1997-2#1)(2006-10#1)(2008-1#1)
to the sixth##3##3##(1990-12#1)(2005-10#1)(2008-2#1)
to the size and the##2##5##(2008-10#1)(2008-3#1)
to the size and##4##4##(1996-3#1)(2008-10#1)(2008-2#1)(2008-3#1)
to the size of the target##2##6##(1991-4#1)(1996-3#1)
to the size of the##10##5##(1990-7#1)(1991-11#1)(1991-4#1)(1996-12#1)(1996-3#1)(2006-10#1)(2007-12#1)(2008-10#1)(2010-8#1)(2011-2#1)
to the size of##22##4##(1990-7#1)(1991-11#1)(1991-4#1)(1992-5#1)(1993-10#1)(1993-2#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-6#1)(2006-10#2)(2007-12#1)(2008-10#1)(2008-3#2)(2010-2#1)(2010-8#2)(2011-12#1)(2011-2#1)(2013-8#1)
to the size##30##3##(1990-7#1)(1991-11#1)(1991-4#1)(1992-5#1)(1993-10#1)(1993-2#2)(1996-12#1)(1996-3#2)(1997-1#1)(1997-6#1)(2006-10#3)(2006-4#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#4)(2010-2#1)(2010-8#2)(2011-12#1)(2011-2#1)(2013-8#1)
to the skeletal muscle##3##4##(1992-5#1)(1993-12#1)(2008-8#1)
to the skeletal##4##3##(1992-5#1)(1993-12#1)(2007-11#1)(2008-8#1)
to the skeleton##3##3##(1996-9#1)(2008-1#2)
to the skills##2##3##(1995-4#1)(2007-12#1)
to the skin but##2##4##(1991-6#1)(2012-3#1)
to the skin in##3##4##(2008-5#2)(2013-8#1)
to the skin surface##4##4##(2008-10#1)(2008-5#3)
to the skin##41##3##(1991-11#1)(1991-6#1)(1991-8#1)(1992-8#2)(1993-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(2008-10#3)(2008-4#1)(2008-5#15)(2008-7#1)(2008-9#1)(2009-6#1)(2010-5#1)(2010-6#2)(2010-7#1)(2011-2#2)(2012-3#1)(2013-7#1)(2013-8#2)
to the skipping of##2##4##(1996-7#1)(1997-7#1)
to the skull base##2##4##(2006-12#1)(2008-1#1)
to the skull##5##3##(2006-11#1)(2006-12#1)(2007-4#1)(2008-1#1)(2012-12#1)
to the slide##2##3##(2008-11#1)(2008-8#1)
to the slow##10##3##(1994-11#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#2)
to the small difference##2##4##(2007-1#1)(2007-12#1)
to the small intestine##3##4##(2008-3#1)(2011-2#1)(2012-1#1)
to the small number of##7##5##(1991-5#1)(1993-5#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-2#1)(2010-5#1)
to the small sample##3##4##(2008-7#1)(2011-2#1)(2013-1#1)
to the small##36##3##(1991-12#1)(1991-5#1)(1992-3#1)(1993-5#1)(1993-6#1)(1994-9#1)(1996-9#1)(1997-5#1)(2006-10#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-2#1)(2010-5#1)(2011-2#3)(2012-1#1)(2013-1#1)
to the small-signal##2##3##(2008-2#2)
to the smooth##2##3##(1993-7#1)(2012-2#1)
to the so-called##7##3##(1990-5#1)(1992-1#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-7#1)(2012-2#1)
to the social and cultural##2##5##(2006-10#1)(2008-9#1)
to the social and##3##4##(2006-10#1)(2008-11#1)(2008-9#1)
to the social##12##3##(1995-12#1)(1997-3#1)(1997-5#1)(2006-10#1)(2008-11#1)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#1)(2011-2#2)(2013-1#1)
to the sociological##2##3##(2007-6#1)(2009-7#1)
to the sodium channel##2##4##(1994-9#2)
to the sodium##3##3##(1994-9#2)(2008-10#1)
to the soft##3##3##(2006-9#1)(2008-2#1)(2010-11#1)
to the soil##8##3##(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2011-12#2)
to the soils##2##3##(2008-10#2)
to the solid phase##3##4##(1994-8#1)(2008-10#1)(2008-4#1)
to the solid##5##3##(1994-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)
to the soluble##4##3##(1992-11#1)(1992-6#1)(1994-12#1)(1997-8#1)
to the solution containing##2##4##(2005-11#1)(2008-10#1)
to the solution of a##3##5##(2008-2#2)(2009-10#1)
to the solution of the##4##5##(2007-12#1)(2008-2#3)
to the solution of##8##4##(2007-12#1)(2008-2#5)(2008-7#1)(2009-10#1)
to the solution##27##3##(1992-8#1)(2005-11#5)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-2#6)(2008-7#1)(2009-10#1)(2011-2#1)(2011-3#1)
to the solutions##2##3##(2008-10#2)
to the solvent##10##3##(1990-7#1)(1991-4#1)(1995-2#2)(2007-10#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-2#1)(2013-1#1)
to the sound##3##3##(2008-10#1)(2008-2#1)(2012-2#1)
to the source of##6##4##(1993-3#1)(1994-9#1)(2007-5#2)(2007-6#1)(2012-1#1)
to the source##13##3##(1993-3#1)(1994-9#1)(2007-12#1)(2007-5#2)(2007-6#1)(2008-10#1)(2008-3#3)(2008-5#1)(2011-1#1)(2012-1#1)
to the south##4##3##(2007-5#1)(2008-10#2)(2008-11#1)
to the soybean##2##3##(1990-11#1)(2012-11#1)
to the space group P2(1)2(1)2(1)##2##5##(1991-4#1)(2009-3#1)
to the space group##4##4##(1991-4#1)(1996-6#1)(2008-8#1)(2009-3#1)
to the space##6##3##(1991-4#1)(1996-6#1)(2005-8#1)(2008-8#1)(2009-3#1)(2011-1#1)
to the sparse literature on##2##5##(2009-5#1)(2011-2#1)
to the spatial##13##3##(1993-2#1)(1994-9#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
to the special needs of##3##5##(1991-2#1)(1997-8#1)(2012-12#1)
to the special##15##3##(1991-2#1)(1991-8#1)(1997-8#1)(2005-3#1)(2005-5#1)(2008-4#1)(2008-6#1)(2009-10#1)(2010-12#1)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
to the specialist##2##3##(2008-3#1)(2013-1#1)
to the specialty of##2##4##(2007-4#2)
to the specialty##3##3##(2007-4#3)
to the speciation analysis of##2##5##(2005-4#1)(2008-10#1)
to the speciation analysis##3##4##(2005-4#1)(2008-10#2)
to the speciation of##9##4##(1996-8#1)(2008-10#8)
to the speciation##13##3##(1996-8#1)(2005-4#1)(2008-10#11)
to the species P##2##4##(2006-8#1)(2008-7#1)
to the species level##2##4##(2008-5#1)(2008-8#1)
to the species##10##3##(1994-3#2)(2006-8#1)(2007-1#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)(2013-7#1)
to the specific binding of##2##5##(1995-1#1)(2008-7#1)
to the specific energy dissipation rate##4##6##(2008-7#4)
to the specific needs of##2##5##(1996-3#1)(2012-2#1)
to the specific requirements of##2##5##(1995-5#1)(2008-4#1)
to the specific##48##3##(1991-2#1)(1992-1#1)(1992-4#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-6#1)(2005-11#1)(2006-10#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#5)(2009-3#1)(2009-5#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#1)(2013-7#1)
to the specificity of the##2##5##(1994-9#1)(2008-10#1)
to the specificity of##3##4##(1994-9#2)(2008-10#1)
to the specificity##5##3##(1994-9#2)(1997-2#1)(2008-10#2)
to the spectra##3##3##(2008-10#2)(2008-2#1)
to the spectral data##2##4##(2008-10#1)(2012-12#1)
to the spectral##11##3##(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#6)(2012-12#1)(2013-8#1)
to the spectrophotometric determination of##5##5##(2007-10#1)(2008-10#4)
to the spectrophotometric method##2##4##(2008-10#1)(2008-5#1)
to the spectrophotometric##9##3##(2007-10#1)(2007-8#1)(2008-10#6)(2008-5#1)
to the spectrum of##4##4##(2005-4#1)(2008-10#1)(2011-2#1)(2012-1#1)
to the speed##2##3##(2008-10#1)(2012-1#1)
to the sperm nuclear matrix##2##5##(1990-11#2)
to the sperm##6##3##(1990-11#3)(1995-5#1)(2006-5#1)(2008-7#1)
to the sphere##3##3##(1991-6#1)(2008-2#1)(2008-3#1)
to the spherical##2##3##(2007-12#1)(2012-2#1)
to the spider##2##3##(2006-12#1)(2007-6#1)
to the spinal cord and##2##5##(1994-8#1)(2007-11#1)
to the spinal cord in##2##5##(1996-5#1)(2007-11#1)
to the spinal cord##15##4##(1992-8#1)(1994-8#2)(1996-5#2)(2006-2#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#1)(2008-4#1)(2008-7#1)(2012-1#1)
to the spinal##19##3##(1992-8#1)(1994-8#2)(1996-5#2)(2006-2#1)(2006-8#4)(2007-1#1)(2007-11#3)(2007-12#1)(2008-4#1)(2008-7#2)(2012-1#1)
to the spine and##2##4##(2007-11#1)(2008-3#1)
to the spine are##2##4##(2006-2#2)
to the spine##8##3##(2006-2#2)(2007-11#4)(2007-7#1)(2008-3#1)
to the spleen and##2##4##(2010-12#1)(2012-1#1)
to the spleen##7##3##(1991-12#1)(2007-2#1)(2008-10#1)(2010-12#1)(2012-1#1)(2012-2#2)
to the spontaneous firing rate##2##5##(1997-8#2)
to the spontaneous firing##3##4##(1997-8#3)
to the spontaneous##7##3##(1994-2#1)(1997-8#3)(2007-12#1)(2008-1#1)(2008-11#1)
to the spread of take-all##2##5##(2008-10#2)
to the spread of##6##4##(1995-5#1)(2008-10#2)(2008-12#1)(2010-12#1)(2011-2#1)
to the spring##2##3##(2011-2#1)(2012-1#1)
to the squamous##2##3##(2007-11#1)(2012-12#1)
to the square root of the##3##6##(2007-12#1)(2008-10#1)(2008-3#1)
to the square root of##5##5##(2005-11#1)(2007-12#2)(2008-10#1)(2008-3#1)
to the square##12##3##(2005-11#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-3#6)
to the stability of the native state##2##7##(1991-4#1)(1992-6#1)
to the stability of the##8##5##(1990-8#1)(1991-4#2)(1992-6#3)(2008-10#1)(2011-2#1)
to the stability of##12##4##(1990-8#1)(1991-4#2)(1991-7#1)(1992-6#4)(1995-1#1)(2008-10#2)(2011-2#1)
to the stability##13##3##(1990-8#1)(1991-4#2)(1991-7#1)(1992-6#4)(1994-8#1)(1995-1#1)(2008-10#2)(2011-2#1)
to the stabilization of##4##4##(1994-12#1)(2007-12#1)(2009-9#1)(2012-12#1)
to the stabilization##7##3##(1990-8#1)(1994-11#1)(1994-12#1)(1997-2#1)(2007-12#1)(2009-9#1)(2012-12#1)
to the staff##2##3##(1991-1#1)(2010-12#1)
to the stage of##6##4##(1992-2#1)(1995-12#1)(2008-11#1)(2010-12#1)(2010-8#1)(2013-1#1)
to the stage##7##3##(1992-2#1)(1995-12#1)(2008-11#1)(2010-12#1)(2010-8#1)(2013-1#1)(2013-8#1)
to the stages of##3##4##(2008-12#1)(2009-2#1)(2012-1#1)
to the standard technique##2##4##(2007-7#1)(2011-7#1)
to the standard thermodynamic##2##4##(1996-11#2)
to the standard##56##3##(1991-6#1)(1992-5#1)(1992-7#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-6#1)(1996-11#2)(1996-3#1)(1996-5#1)(1996-7#1)(1997-6#1)(1997-8#1)(2005-11#3)(2006-1#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-2#2)(2009-4#1)(2009-5#1)(2010-1#1)(2010-5#1)(2011-1#3)(2011-7#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
to the standardization of##2##4##(1996-3#1)(2013-7#1)
to the standards of##2##4##(1991-3#1)(2011-2#1)
to the standards##5##3##(1991-3#1)(1996-1#1)(2005-5#1)(2008-5#1)(2011-2#1)
to the start of mechanical ventilation##2##6##(2005-8#2)
to the start of the##3##5##(2008-10#1)(2010-11#1)(2011-2#1)
to the start of##7##4##(2005-8#2)(2008-10#1)(2008-3#1)(2010-11#1)(2011-2#1)(2013-8#1)
to the start site of##2##5##(1992-3#1)(1992-8#1)
to the start##11##3##(1992-3#1)(1992-8#1)(1997-4#1)(2005-8#2)(2008-10#1)(2008-3#1)(2008-6#1)(2010-11#1)(2011-2#1)(2013-8#1)
to the startle##2##3##(1991-11#1)(2008-11#1)
to the state of##4##4##(1990-10#1)(1991-5#1)(2008-10#1)(2012-2#1)
to the state##12##3##(1990-10#1)(1991-5#1)(1992-1#1)(1993-6#1)(1996-3#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-6#1)(2011-2#2)(2012-2#1)
to the states##3##3##(1994-6#1)(1997-3#1)(1997-8#1)
to the static##3##3##(1994-8#1)(2008-11#1)(2013-8#1)
to the stationary phase##4##4##(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
to the stationary##6##3##(1996-5#1)(2007-12#1)(2008-10#1)(2008-7#2)(2011-2#1)
to the statistic##2##3##(1997-3#2)
to the statistical##3##3##(1994-6#1)(1997-3#1)(2008-12#1)
to the stem cell##2##4##(2007-10#1)(2009-3#1)
to the stem##5##3##(2007-10#1)(2008-10#2)(2009-3#1)(2011-12#1)
to the stenosis##2##3##(2007-10#1)(2007-9#1)
to the stent##2##3##(1990-8#1)(2007-8#1)
to the step##3##3##(1991-9#1)(2008-3#1)(2011-2#1)
to the steroid##2##3##(1994-9#1)(1996-5#1)
to the sterol##3##3##(1996-5#1)(2008-10#2)
to the stimulated##3##3##(1995-8#1)(1996-1#1)(1997-6#1)
to the stimulation by##3##4##(1991-9#1)(1992-11#1)(1994-6#1)
to the stimulation of##10##4##(1992-12#1)(1993-7#3)(1994-11#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-6#1)
to the stimulation##17##3##(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-7#3)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-6#1)
to the stimuli##5##3##(1993-12#1)(1997-2#1)(2007-1#1)(2007-5#1)(2009-6#1)
to the stimulus flicker at each electrode##2##7##(2007-9#2)
to the stimulus##6##3##(1991-9#1)(1994-2#1)(1994-6#1)(2006-7#1)(2007-9#2)
to the stomach##8##3##(1990-3#1)(1992-6#1)(1993-11#1)(1996-11#1)(2006-10#2)(2007-8#1)(2008-5#1)
to the storage##4##3##(2007-8#1)(2008-11#1)(2008-3#2)
to the strain##4##3##(2007-7#1)(2008-10#2)(2008-2#1)
to the stratospheric aerosol##2##4##(2008-2#2)
to the stratum corneum##3##4##(2008-5#3)
to the stratum##4##3##(2007-10#1)(2008-5#3)
to the strength of the##4##5##(1990-4#1)(2007-12#1)(2008-5#1)(2010-10#1)
to the strength of##8##4##(1990-4#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-8#3)(2010-10#1)
to the strength##10##3##(1990-4#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#3)(2010-10#1)
to the stress of##5##4##(1991-4#1)(1995-11#1)(2006-10#1)(2008-11#1)(2008-7#1)
to the stress regimen##2##4##(2008-11#2)
to the stress##11##3##(1991-4#1)(1995-11#1)(1996-4#1)(2006-10#1)(2008-11#3)(2008-6#1)(2008-7#1)(2009-8#1)(2012-12#1)
to the striatum##4##3##(1994-10#1)(1995-7#1)(2008-11#1)(2008-7#1)
to the strict##3##3##(1990-4#1)(2005-11#1)(2008-11#1)
to the striking##2##3##(1994-3#1)(2009-10#1)
to the stroke##3##3##(2007-10#1)(2008-11#1)(2012-2#1)
to the stroma##2##3##(1992-12#1)(2009-2#1)
to the strong##15##3##(1990-8#1)(1993-8#1)(1996-5#1)(2005-11#1)(2007-11#1)(2008-10#3)(2008-2#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-7#1)
to the strongest##2##3##(1990-11#1)(2006-2#1)
to the structural organization of##2##5##(2009-8#1)(2010-8#1)
to the structural##13##3##(1990-12#1)(1995-12#1)(1995-8#1)(2006-11#1)(2006-12#1)(2008-10#2)(2008-5#1)(2009-8#1)(2010-8#2)(2012-2#1)(2013-1#1)
to the structurally related##3##4##(1994-12#1)(1994-9#1)(2011-2#1)
to the structure and##2##4##(2008-1#1)(2008-11#1)
to the structure of the##5##5##(1990-7#1)(1992-3#1)(2005-11#1)(2006-11#1)(2008-10#1)
to the structure of##8##4##(1990-5#1)(1990-7#1)(1992-3#1)(1993-6#1)(2005-11#1)(2006-11#1)(2008-10#2)
to the structure##17##3##(1990-5#1)(1990-7#1)(1992-3#2)(1993-6#1)(1995-8#1)(1997-3#1)(2005-11#1)(2005-4#1)(2006-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)(2010-7#1)
to the structures of##2##4##(2008-10#1)(2009-2#1)
to the structures##4##3##(1997-3#1)(2004-9#1)(2008-10#1)(2009-2#1)
to the structuring of##2##4##(1993-12#1)(2008-10#1)
to the structuring##3##3##(1993-12#1)(2008-10#1)(2008-9#1)
to the student##2##3##(2008-11#1)(2012-3#1)
to the students##4##3##(2008-11#1)(2011-2#1)(2013-8#2)
to the students'##2##3##(2012-3#2)
to the studied##4##3##(2006-10#1)(2008-12#1)(2009-1#1)(2010-3#1)
to the studies##4##3##(1994-3#1)(1996-2#1)(2006-10#1)(2008-10#1)
to the study group##2##4##(1991-12#1)(2007-7#1)
to the study of a##2##5##(2007-12#1)(2012-1#1)
to the study of bacterial##2##5##(2006-10#1)(2006-8#1)
to the study of cell##2##5##(2007-12#1)(2008-9#1)
to the study of cellular##2##5##(1992-9#1)(1996-12#1)
to the study of human##3##5##(2006-10#1)(2006-3#1)(2008-2#1)
to the study of the optical##2##6##(2008-3#2)
to the study of the##12##5##(1997-2#1)(2005-11#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#3)(2009-9#1)
to the study of these##3##5##(2006-10#1)(2008-8#1)(2009-8#1)
to the study of two##2##5##(1990-3#1)(2011-1#1)
to the study of##88##4##(1990-12#1)(1990-3#1)(1990-4#1)(1991-5#3)(1991-9#1)(1992-6#1)(1992-9#1)(1994-6#1)(1994-8#1)(1995-1#1)(1996-12#1)(1997-2#1)(1997-7#1)(2005-11#1)(2005-9#1)(2006-10#4)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#6)(2007-4#2)(2007-6#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#4)(2008-3#7)(2008-4#6)(2008-5#1)(2008-8#5)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#2)(2012-1#2)(2013-1#1)(2013-8#2)
to the study was##3##4##(2006-10#2)(2007-7#1)
to the study##114##3##(1990-12#3)(1990-3#1)(1990-4#1)(1991-12#1)(1991-5#3)(1991-9#1)(1992-1#1)(1992-6#1)(1992-9#1)(1994-6#1)(1994-8#1)(1995-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-5#1)(1997-7#1)(2005-11#1)(2005-9#1)(2006-10#7)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#7)(2007-2#1)(2007-4#2)(2007-6#1)(2007-7#3)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#4)(2008-3#7)(2008-4#6)(2008-5#3)(2008-7#2)(2008-8#5)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#3)(2013-1#1)(2013-8#2)
to the sub##2##3##(2008-10#1)(2008-12#1)
to the subchondral layer##2##4##(2007-11#2)
to the subclass##2##3##(1993-6#1)(2009-9#1)
to the subcutaneous##2##3##(2009-6#1)(2012-12#1)
to the subject##5##3##(2008-5#1)(2009-4#1)(2009-6#1)(2013-7#1)(2013-8#1)
to the subjective##2##3##(2008-5#1)(2012-1#1)
to the subjects##5##3##(1992-3#1)(1995-5#1)(2006-11#1)(2008-9#1)(2010-2#1)
to the submandibular##2##3##(1995-11#1)(2005-7#1)
to the suboccipital craniotomy##2##4##(2006-5#2)
to the subodontoblastic##2##3##(1994-5#2)
to the subsequent##7##3##(1992-7#1)(1994-3#1)(2007-2#1)(2008-11#1)(2009-11#1)(2011-2#1)(2012-3#1)
to the subset##2##3##(2007-12#1)(2008-8#1)
to the substance##2##3##(2005-10#1)(2008-5#1)
to the substantia nigra##3##4##(1991-2#1)(1997-3#1)(2009-10#1)
to the substantia##4##3##(1991-2#1)(1997-2#1)(1997-3#1)(2009-10#1)
to the substitution of##3##4##(1991-7#1)(2010-5#1)(2011-1#1)
to the substitution##7##3##(1991-7#1)(2008-10#2)(2008-5#1)(2008-6#1)(2010-5#1)(2011-1#1)
to the substrate and##5##4##(1994-6#1)(2007-12#1)(2008-3#1)(2008-7#1)(2012-2#1)
to the substrate surface##4##4##(2005-4#1)(2008-10#1)(2008-3#1)(2010-4#1)
to the substrate##29##3##(1991-4#2)(1991-5#1)(1992-12#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-5#1)(2005-11#1)(2005-4#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#3)(2008-7#2)(2010-4#1)(2010-7#1)(2012-2#1)
to the substratum##2##3##(2007-5#1)(2008-11#1)
to the subtle##2##3##(2010-10#1)(2010-11#1)
to the subunit interface##2##4##(1993-6#1)(1995-2#1)
to the subunit##4##3##(1992-2#1)(1993-6#1)(1995-2#1)(1997-2#1)
to the success of an##3##5##(2007-4#1)(2008-4#1)(2013-1#1)
to the success of any##2##5##(2008-11#2)
to the success of both##2##5##(1990-12#1)(2008-9#1)
to the success of this##3##5##(2007-12#1)(2008-1#1)(2013-8#1)
to the success of##33##4##(1990-12#1)(1991-8#1)(1993-3#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-3#2)(2006-12#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-9#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
to the success or failure of##2##6##(2008-12#1)(2012-2#1)
to the success##37##3##(1990-12#1)(1991-8#1)(1992-8#1)(1993-3#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-3#2)(2006-12#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#3)(2008-4#1)(2008-9#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#1)
to the successful management of##2##5##(2007-12#1)(2011-2#1)
to the successful##14##3##(1992-2#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-6#1)(2010-9#1)(2011-2#1)
to the sudden##2##3##(1996-11#1)(2010-12#1)
to the sugar##3##3##(2006-10#1)(2007-3#1)(2008-10#1)
to the suggestion of##2##4##(2006-8#1)(2011-2#1)
to the suggestion that##7##4##(1990-8#1)(1991-10#1)(1992-1#1)(1992-6#1)(1992-7#1)(1997-4#1)(2009-4#1)
to the suggestion##9##3##(1990-8#1)(1991-10#1)(1992-1#1)(1992-6#1)(1992-7#1)(1997-4#1)(2006-8#1)(2009-4#1)(2011-2#1)
to the sulfate ion##2##4##(1995-11#1)(2008-10#1)
to the sum of the##4##5##(1997-2#1)(2008-10#2)(2008-2#1)
to the sum of two##2##5##(1997-8#1)(2005-11#1)
to the sum of##10##4##(1997-2#1)(1997-8#1)(2005-11#1)(2006-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2010-12#1)
to the summation##2##3##(2008-10#1)(2008-4#1)
to the summer##2##3##(1997-3#1)(2006-8#1)
to the sun##3##3##(2008-2#1)(2011-2#2)
to the superfamily of##3##4##(1993-12#1)(1996-9#1)(1997-7#1)
to the superior##9##3##(1995-7#1)(1996-12#1)(2005-5#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-7#1)(2009-4#1)(2013-1#1)
to the support##5##3##(1990-7#2)(1991-7#1)(2008-4#1)(2009-5#1)
to the supported##2##3##(1994-11#1)(2008-7#1)
to the supportive##2##3##(2013-1#2)
to the suppression of##9##4##(1991-6#1)(1992-8#1)(1994-12#1)(1995-2#1)(1995-7#1)(2006-1#1)(2008-10#1)(2008-11#1)(2008-5#1)
to the suppression##11##3##(1991-6#1)(1992-8#1)(1993-12#1)(1994-12#1)(1995-2#1)(1995-7#1)(1995-8#1)(2006-1#1)(2008-10#1)(2008-11#1)(2008-5#1)
to the suppressive effects of##2##5##(1994-10#1)(2008-10#1)
to the suprascapular nerve and##2##5##(2008-9#2)
to the surface and##4##4##(2004-9#1)(2008-3#1)(2008-5#1)(2008-9#1)
to the surface area of##2##5##(2008-9#1)(2012-2#1)
to the surface of a metal##2##6##(2005-11#1)(2008-2#1)
to the surface of a##6##5##(2005-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2010-4#1)
to the surface of activated platelets##2##6##(1992-12#1)(1993-3#1)
to the surface of liposomes##2##5##(2005-11#2)
to the surface of the membrane##4##6##(1994-2#1)(2008-2#1)(2008-4#2)
to the surface of the##18##5##(1994-11#2)(1994-2#1)(1994-9#2)(1995-5#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2010-2#1)(2010-3#1)(2010-7#1)(2013-1#1)
to the surface of##42##4##(1992-12#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-9#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-3#1)(2005-11#3)(2006-1#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2013-1#1)
to the surface profile##2##4##(2007-12#1)(2008-2#1)
to the surface##86##3##(1990-8#1)(1991-3#2)(1992-12#1)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-9#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-3#1)(2004-9#2)(2005-11#6)(2006-1#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#3)(2007-6#1)(2008-10#6)(2008-11#2)(2008-2#8)(2008-3#6)(2008-4#4)(2008-5#7)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-2#2)(2010-3#1)(2010-4#3)(2010-7#1)(2012-2#2)(2013-1#1)
to the surfaces##5##3##(2006-12#1)(2006-8#1)(2007-11#1)(2013-8#2)
to the surfactant-rich phase##3##4##(2008-10#3)
to the surgeon##11##3##(1993-1#1)(2007-11#1)(2007-12#2)(2007-5#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-8#1)
to the surgeons##2##3##(2006-6#1)(2008-7#1)
to the surgery##4##3##(2008-3#1)(2008-5#1)(2008-7#1)(2011-3#1)
to the surgical procedure##4##4##(2004-2#1)(2006-8#1)(2007-8#1)(2008-7#1)
to the surgical resection##2##4##(2006-6#1)(2011-2#1)
to the surgical##21##3##(1993-6#1)(1995-8#1)(1996-9#1)(2004-2#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#2)(2009-6#1)(2010-3#1)(2011-2#1)
to the surrounding structures##2##4##(1993-6#1)(2012-2#1)
to the surrounding tissues##3##4##(1990-6#1)(2006-6#1)(2007-12#1)
to the surrounding##20##3##(1990-6#1)(1991-3#1)(1993-6#1)(1994-6#1)(1996-7#1)(1997-4#1)(2005-8#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-7#1)(2009-2#1)(2010-7#1)(2011-1#1)(2012-11#1)(2012-2#2)
to the survey##14##3##(1991-2#1)(1995-1#1)(1995-12#1)(1995-3#1)(2005-11#1)(2007-9#1)(2008-12#1)(2008-9#1)(2010-1#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
to the survival and##2##4##(2008-10#1)(2012-12#1)
to the survival of##6##4##(1992-8#1)(1995-3#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-8#1)
to the survival##10##3##(1992-7#1)(1992-8#1)(1995-3#1)(2006-8#1)(2007-2#1)(2008-10#2)(2008-8#1)(2009-10#1)(2012-12#1)
to the susceptibility of##5##4##(1994-11#1)(1995-12#1)(2006-10#1)(2008-10#1)(2012-3#1)
to the susceptibility to##2##4##(2008-7#1)(2009-7#1)
to the susceptibility##8##3##(1994-11#1)(1995-12#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-7#1)(2012-3#1)
to the susceptible##5##3##(2008-10#2)(2008-5#1)(2009-8#2)
to the sustained##3##3##(1990-4#1)(1991-9#2)
to the suture##3##3##(2007-5#3)
to the symmetric##3##3##(2005-4#1)(2008-5#1)(2008-7#1)
to the sympathetic nervous system##3##5##(2005-10#1)(2006-12#1)(2009-10#1)
to the sympathetic##5##3##(1993-1#1)(2005-10#1)(2006-12#1)(2006-8#1)(2009-10#1)
to the symptoms of##3##4##(1993-12#1)(2011-1#1)(2011-12#1)
to the symptoms##6##3##(1993-12#1)(2008-2#1)(2008-4#1)(2010-5#1)(2011-1#1)(2011-12#1)
to the synaptic##3##3##(1997-5#1)(2008-5#1)(2009-8#1)
to the syndrome##3##3##(1993-9#1)(2008-3#1)(2009-10#1)
to the synthesis of a##2##5##(1996-4#1)(2009-9#1)
to the synthesis of an##2##5##(1992-7#1)(2009-5#1)
to the synthesis of some##2##5##(1992-7#1)(2008-5#1)
to the synthesis of##29##4##(1990-8#1)(1992-7#2)(1992-9#1)(1994-10#1)(1996-4#1)(1997-4#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-11#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-6#1)(2010-7#1)(2011-2#1)
to the synthesis##33##3##(1990-8#1)(1992-7#2)(1992-9#1)(1994-10#1)(1996-4#1)(1996-8#1)(1997-4#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-11#4)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-6#1)(2010-7#1)(2011-2#1)(2012-3#1)
to the synthetic##5##3##(1991-10#1)(1992-7#1)(2008-10#1)(2008-11#1)(2008-3#1)
to the system of##3##4##(1990-5#1)(2006-10#1)(2012-3#1)
to the system using a multisyringe burette coupled with##2##9##(2008-10#2)
to the system##24##3##(1990-5#1)(1995-3#1)(1997-8#1)(2006-10#1)(2007-12#2)(2007-5#1)(2008-10#6)(2008-11#3)(2008-2#2)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2012-3#1)
to the systematic##3##3##(2006-10#1)(2009-10#1)(2013-1#1)
to the systemic circulation##2##4##(2008-3#1)(2011-2#1)
to the systemic##6##3##(2005-11#1)(2007-11#1)(2008-3#1)(2011-2#1)(2012-1#1)(2012-2#1)
to the systems##3##3##(2008-10#1)(2008-5#1)(2012-1#1)
to the table##3##3##(2008-1#1)(2010-12#1)(2013-1#1)
to the tail##3##3##(1990-5#1)(2011-1#2)
to the tails##2##3##(1994-3#1)(1997-4#1)
to the talo-crural joint##2##4##(2007-11#2)
to the target DNA##2##4##(2008-4#2)
to the target in the##2##5##(2008-11#1)(2009-8#1)
to the target population##2##4##(2008-3#1)(2012-3#1)
to the target sequence##3##4##(2008-4#2)(2008-9#1)
to the target sequences of##2##5##(2008-10#1)(2009-8#1)
to the target##48##3##(1992-5#1)(1996-6#2)(1997-2#1)(2005-10#1)(2006-11#1)(2006-5#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#6)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-8#4)(2010-2#1)(2010-9#1)(2011-1#2)(2012-1#2)(2012-2#2)(2012-3#1)
to the targeted##2##3##(2008-10#1)(2008-4#1)
to the targets##3##3##(1996-2#1)(2007-8#1)(2008-3#1)
to the task of##4##4##(2008-10#1)(2008-3#1)(2012-3#1)(2013-1#1)
to the task##9##3##(1994-3#1)(2007-9#1)(2008-10#1)(2008-3#1)(2009-4#1)(2010-5#1)(2012-1#1)(2012-3#1)(2013-1#1)
to the taste panel test##2##5##(2008-10#2)
to the taste##4##3##(1991-3#1)(2008-10#2)(2010-5#1)
to the teaching##3##3##(1997-7#1)(2007-2#1)(2011-2#1)
to the team were##2##4##(2006-8#1)(2013-7#1)
to the team##7##3##(1993-3#1)(2006-8#2)(2008-10#1)(2009-8#1)(2013-7#2)
to the technical##4##3##(2006-10#1)(2006-6#1)(2009-8#1)(2012-1#1)
to the technique##10##3##(1997-3#2)(2005-8#1)(2006-5#1)(2007-11#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-12#2)
to the techniques##2##3##(2008-10#1)(2012-12#1)
to the technological##3##3##(2008-2#1)(2009-9#1)(2010-9#1)
to the technology##2##3##(2007-10#1)(2008-7#1)
to the telencephalon##2##3##(1996-5#2)
to the temperature##6##3##(1997-7#1)(2006-6#1)(2007-12#1)(2008-2#1)(2008-3#2)
to the template##5##3##(1990-5#1)(1991-7#1)(1994-12#1)(1994-9#1)(2008-2#1)
to the temporal##5##3##(2006-12#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-7#1)
to the tendency##2##3##(1997-4#1)(2009-4#1)
to the tendon##2##3##(2006-3#1)(2008-11#1)
to the tension##2##3##(1990-8#1)(2005-11#1)
to the term##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
to the terminal##3##3##(1990-12#1)(1997-2#1)(2012-12#1)
to the termination of##2##4##(2007-8#1)(2008-9#1)
to the test of##2##4##(2008-10#1)(2011-2#1)
to the test word##2##4##(2008-10#2)
to the test##14##3##(1992-9#1)(2005-10#1)(2006-5#1)(2008-10#7)(2008-5#1)(2009-12#1)(2010-7#1)(2011-2#1)
to the tested##2##3##(2006-11#1)(2008-10#1)
to the testing##2##3##(2007-5#1)(2008-7#1)
to the testis##4##3##(2007-6#1)(2008-11#1)(2009-10#1)(2012-2#1)
to the tests##2##3##(1996-1#1)(2010-2#1)
to the thalamus and the##2##5##(1996-7#1)(1997-3#1)
to the thalamus and##3##4##(1996-7#2)(1997-3#1)
to the thalamus##5##3##(1991-5#1)(1996-7#2)(1997-3#1)(2012-2#1)
to the theoretical limit##2##4##(2007-12#1)(2008-2#1)
to the theoretical prediction##2##4##(2005-11#1)(2007-12#1)
to the theoretical value##2##4##(2007-12#1)(2008-3#1)
to the theoretical##13##3##(2005-11#1)(2007-12#3)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#1)(2010-1#1)(2013-1#1)
to the theory of##7##4##(1996-4#1)(2005-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2012-12#1)(2013-7#1)
to the theory that##2##4##(2008-1#1)(2009-8#1)
to the theory##10##3##(1996-4#1)(2005-11#1)(2005-4#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-8#1)(2012-12#1)(2013-7#1)
to the therapeutic armamentarium for##2##5##(2010-11#1)(2012-12#1)
to the therapeutic armamentarium##3##4##(2008-7#1)(2010-11#1)(2012-12#1)
to the therapeutic##16##3##(1993-2#1)(1994-8#1)(1996-10#1)(1996-11#1)(2005-7#2)(2007-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-8#2)
to the therapist##3##3##(1991-4#1)(2006-2#1)(2012-2#1)
to the therapy of##2##4##(1995-1#1)(2008-10#1)
to the therapy##7##3##(1994-2#1)(1995-1#1)(1995-10#1)(2008-10#1)(2009-8#1)(2010-4#1)(2011-1#1)
to the thermal##4##3##(1992-7#1)(1993-6#1)(2008-3#1)(2011-12#1)
to the thermodynamics of##4##4##(1991-4#1)(1992-5#1)(1996-11#2)
to the thick##3##3##(1996-11#1)(2008-6#2)
to the thickness##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
to the thigh##4##3##(2006-6#1)(2007-6#1)(2008-6#1)(2009-3#1)
to the thin filament##2##4##(1996-5#2)
to the thin##5##3##(1996-5#2)(1997-4#1)(2007-12#1)(2008-11#1)
to the third##15##3##(1991-6#1)(1995-5#2)(1996-5#1)(2007-12#3)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-11#1)(2011-1#1)(2013-8#2)
to the third-order nonlinear optical susceptibilities of##2##7##(2007-12#2)
to the third-order##3##3##(2007-12#3)
to the thoracic spine##2##4##(2008-12#1)(2008-8#1)
to the thoracic##4##3##(2006-12#1)(2008-12#1)(2008-8#1)(2008-9#1)
to the thoroughness and##2##4##(1996-9#1)(1997-3#1)
to the thread##2##3##(2007-11#1)(2007-7#1)
to the threat of##2##4##(2006-5#1)(2008-5#1)
to the threat##3##3##(2006-5#1)(2008-5#1)(2011-2#1)
to the three major##2##4##(1994-2#1)(2008-10#1)
to the three##35##3##(1991-2#2)(1992-2#1)(1992-8#1)(1994-12#2)(1994-2#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-8#1)(1997-2#1)(1997-4#1)(2007-1#1)(2007-2#1)(2008-10#10)(2008-11#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-8#1)(2012-12#2)
to the three-dimensional##4##3##(2007-12#2)(2008-3#1)(2008-6#1)
to the threshold##2##3##(1991-4#1)(2006-11#1)
to the thrombin##2##3##(1990-7#1)(1995-3#1)
to the thyroid gland##5##4##(2006-2#2)(2007-10#2)(2008-12#1)
to the thyroid##9##3##(1990-5#1)(2006-2#2)(2007-10#3)(2007-8#1)(2008-12#1)(2011-2#1)
to the tibia##2##3##(2007-8#1)(2008-6#1)
to the tidal##2##3##(2007-5#1)(2008-5#1)
to the tiles##2##3##(2007-5#2)
to the tilt##2##3##(2008-2#1)(2008-3#1)
to the time of the##3##5##(2008-1#1)(2008-3#1)(2011-1#1)
to the time of##14##4##(1992-3#1)(1995-1#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-5#1)
to the time when the##2##5##(2008-10#2)
to the time when##4##4##(2008-10#3)(2008-9#1)
to the time##24##3##(1992-2#1)(1992-3#1)(1995-1#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-5#1)
to the time-resolved##2##3##(2006-5#1)(2008-2#1)
to the timing of##3##4##(2007-9#1)(2008-6#1)(2008-7#1)
to the timing##5##3##(2007-12#1)(2007-9#1)(2008-6#1)(2008-7#1)(2012-1#1)
to the tip of the##5##5##(1991-12#1)(1996-7#1)(2008-10#1)(2010-4#1)(2010-6#1)
to the tip of##6##4##(1991-12#1)(1996-7#1)(2008-10#2)(2010-4#1)(2010-6#1)
to the tissue##12##3##(1991-10#1)(1994-9#1)(1996-9#1)(1997-4#1)(2006-10#1)(2006-6#1)(2008-3#3)(2008-6#1)(2010-4#1)(2013-1#1)
to the tissues##5##3##(1996-3#1)(1997-2#1)(2008-10#1)(2010-7#1)(2012-12#1)
to the titanium##5##3##(2004-9#1)(2008-5#2)(2009-11#1)(2013-1#1)
to the title##3##3##(2010-12#2)(2013-1#1)
to the titration##4##3##(1992-7#1)(1997-2#1)(2006-6#1)(2008-10#1)
to the tobacco sesquiterpene cyclase##2##5##(1995-3#2)
to the tobacco##3##3##(1995-3#2)(2006-10#1)
to the tonic##3##3##(2007-1#1)(2008-1#1)(2008-8#1)
to the top of the##2##5##(1996-4#1)(2008-2#1)
to the top of##8##4##(1990-8#1)(1994-9#1)(1996-4#1)(2007-9#1)(2008-2#2)(2008-3#1)(2008-4#1)
to the top##14##3##(1990-8#1)(1994-9#1)(1996-4#1)(2005-5#1)(2007-9#1)(2008-1#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2010-11#1)(2013-8#1)
to the topic##2##3##(2008-5#1)(2013-8#1)
to the topics##3##3##(1990-5#1)(2011-1#2)
to the topography of##2##4##(1993-10#1)(2004-11#1)
to the topography##4##3##(1993-10#1)(2004-11#1)(2008-3#1)(2011-2#1)
to the topoisomerase II##2##4##(1994-6#1)(1994-8#1)
to the total amount of food in the sets##2##9##(2009-5#2)
to the total amount of##5##5##(2006-10#1)(2008-10#1)(2008-6#1)(2009-5#2)
to the total concentration##2##4##(1994-2#1)(2008-10#1)
to the total energy##2##4##(2006-10#1)(2008-9#1)
to the total number of##5##5##(1993-3#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-6#1)
to the total of##3##4##(2008-10#1)(2010-8#1)(2011-1#1)
to the total##73##3##(1990-3#1)(1990-5#1)(1991-12#2)(1991-3#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#2)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#2)(2005-12#1)(2006-10#5)(2006-12#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#2)(2009-9#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
to the town##2##3##(1995-1#1)(2008-7#1)
to the toxic effect of##2##5##(1992-6#1)(1993-12#1)
to the toxic##8##3##(1992-6#1)(1992-8#1)(1993-12#1)(2006-8#1)(2008-10#2)(2008-5#1)(2013-7#1)
to the toxicity of##5##4##(1990-3#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)
to the toxicity##7##3##(1990-3#1)(2007-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)
to the toxin##14##3##(1991-12#1)(1991-9#1)(1995-2#1)(2008-10#11)
to the trace analysis of##2##5##(2008-10#1)(2008-3#1)
to the trace##3##3##(2008-10#2)(2008-3#1)
to the track##2##3##(2008-3#2)
to the traditional criteria of##2##5##(1997-8#1)(2005-8#1)
to the traditional methods##2##4##(1991-4#1)(2006-10#1)
to the traditional risk factors##2##5##(2008-4#1)(2011-2#1)
to the traditional##38##3##(1991-4#1)(1992-1#1)(1996-1#1)(1997-8#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-8#1)(2007-5#1)(2007-8#4)(2008-1#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#4)(2008-8#1)(2008-9#1)(2009-12#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)
to the trained##3##3##(1995-1#1)(2008-4#1)(2012-2#1)
to the training##4##3##(1991-12#1)(2008-2#1)(2012-1#2)
to the traits##2##3##(2008-8#1)(2008-9#1)
to the trajectory##2##3##(1996-6#1)(2008-3#1)
to the trans##2##3##(1993-6#1)(1994-3#1)
to the trans-Golgi network##2##4##(2008-1#1)(2012-12#1)
to the transcribed##2##3##(1993-6#1)(1994-8#1)
to the transcription initiation##3##4##(1992-12#1)(1992-5#1)(1995-6#1)
to the transcription start point##5##5##(1990-11#1)(1991-5#1)(1993-12#1)(1993-3#1)(1997-6#1)
to the transcription start site##2##5##(1995-2#2)
to the transcription start##7##4##(1990-11#1)(1991-5#1)(1993-12#1)(1993-3#1)(1995-2#2)(1997-6#1)
to the transcription##12##3##(1990-10#1)(1990-11#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-3#1)(1995-2#2)(1995-6#1)(1997-6#1)
to the transcriptional start##2##4##(1991-2#1)(1996-12#1)
to the transcriptional##5##3##(1990-3#1)(1991-2#1)(1993-12#1)(1996-12#1)(2011-1#1)
to the transcriptionally active##2##4##(1994-12#1)(1994-3#1)
to the transduction##2##3##(1990-5#1)(1992-9#1)
to the transfected##2##3##(1996-6#2)
to the transfer of##3##4##(1992-10#1)(2008-10#1)(2012-3#1)
to the transfer##6##3##(1992-10#1)(1994-11#1)(1997-6#1)(2008-10#2)(2012-3#1)
to the transformation of##2##4##(2005-11#1)(2011-1#1)
to the transformation##3##3##(2005-11#1)(2008-2#1)(2011-1#1)
to the transformed##4##3##(1995-6#1)(2007-1#1)(2008-7#1)(2012-12#1)
to the transient##3##3##(2008-10#1)(2008-2#1)(2010-3#1)
to the transit##2##3##(2006-12#1)(2008-10#1)
to the transition from the##2##5##(1992-7#1)(2005-11#1)
to the transition##7##3##(1992-7#1)(2005-11#1)(2007-2#1)(2008-9#2)(2009-6#1)(2010-12#1)
to the translation start##2##4##(1997-8#1)(2012-2#1)
to the translation##3##3##(1996-5#1)(1997-8#1)(2012-2#1)
to the translocation of##2##4##(1990-12#1)(1994-9#1)
to the translocation##3##3##(1990-12#1)(1994-3#1)(1994-9#1)
to the transmembrane domain##3##4##(1995-2#1)(2008-11#1)(2009-10#1)
to the transmembrane##7##3##(1992-3#1)(1994-3#1)(1995-2#1)(1995-3#2)(2008-11#1)(2009-10#1)
to the transmission of##7##4##(1993-1#1)(2006-10#1)(2008-10#1)(2008-11#1)(2010-1#1)(2010-12#1)(2011-1#1)
to the transmission##11##3##(1993-1#1)(2006-10#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2010-1#1)(2010-12#1)(2011-1#1)
to the transplantation##3##3##(2012-12#2)(2013-1#1)
to the transport of##5##4##(1990-8#1)(1996-6#1)(2007-8#2)(2008-6#1)
to the transport##8##3##(1990-8#1)(1996-6#1)(1996-9#1)(2007-12#1)(2007-8#2)(2008-2#1)(2008-6#1)
to the transposase##2##3##(1994-9#1)(1995-8#1)
to the trauma patient##2##4##(2006-10#2)
to the trauma##4##3##(2006-10#2)(2008-10#1)(2009-9#1)
to the travel##2##3##(2006-10#1)(2007-2#1)
to the travelling##2##3##(2007-7#1)(2011-2#1)
to the treated##2##3##(1992-5#1)(2008-10#1)
to the treating physician##2##4##(1996-3#1)(2008-7#1)
to the treating surgeon##4##4##(2009-10#1)(2009-9#1)(2010-3#1)(2013-1#1)
to the treating##7##3##(1996-3#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-3#1)(2013-1#1)(2013-8#1)
to the treatise##2##3##(1995-4#1)(2007-5#1)
to the treatment and##5##4##(2006-4#1)(2007-8#1)(2010-12#1)(2011-2#2)
to the treatment group##2##4##(2006-4#1)(2010-7#1)
to the treatment groups##2##4##(2007-8#1)(2012-2#1)
to the treatment of colon and rectal cancer##2##8##(2011-2#2)
to the treatment of patients with##3##6##(1993-1#1)(2006-10#1)(2010-2#1)
to the treatment of the##2##5##(2005-3#1)(2010-3#1)
to the treatment of this##3##5##(2007-12#1)(2008-8#1)(2010-12#1)
to the treatment of##62##4##(1990-9#1)(1991-11#1)(1991-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-1#1)(1996-3#2)(1996-4#1)(1996-7#1)(2005-10#1)(2005-11#1)(2005-3#1)(2005-7#3)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2007-11#5)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#2)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)
to the treatment regimen##3##4##(1991-2#1)(1994-12#1)(2007-12#1)
to the treatment with##4##4##(1991-6#1)(2007-7#1)(2008-10#1)(2008-5#1)
to the treatment##101##3##(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-9#1)(1994-12#1)(1994-3#1)(1996-3#2)(1996-4#2)(1996-7#1)(2005-10#1)(2005-11#1)(2005-3#1)(2005-7#3)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#2)(2006-6#1)(2007-11#5)(2007-12#3)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#4)(2008-3#3)(2008-5#3)(2008-7#7)(2008-8#1)(2008-9#2)(2009-7#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#3)(2013-8#1)
to the treatments##4##3##(1995-8#1)(2008-10#1)(2010-2#1)(2012-9#1)
to the trend##2##3##(2007-7#1)(2008-8#1)
to the trends in##2##4##(1992-7#1)(2007-11#1)
to the tricyclic##2##3##(1996-5#1)(2006-12#1)
to the trigeminal nerve##2##4##(2006-11#1)(2006-12#1)
to the trigeminal##4##3##(1996-9#2)(2006-11#1)(2006-12#1)
to the triggering of##2##4##(2013-1#2)
to the triggering##3##3##(2007-11#1)(2013-1#2)
to the trivalent state##4##4##(2008-10#4)
to the tropics and##2##4##(2010-12#1)(2011-2#1)
to the tropics##5##3##(1995-12#1)(2007-2#1)(2010-12#1)(2010-6#1)(2011-2#1)
to the trp##2##3##(1990-9#1)(1992-8#1)
to the true##7##3##(1995-9#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-7#1)
to the trunk##3##3##(2007-3#1)(2008-10#1)(2013-8#1)
to the tryptic##2##3##(1990-2#1)(1990-5#1)
to the tumor and##2##4##(2006-10#1)(2006-11#1)
to the tumor cells##2##4##(2008-6#2)
to the tumor##15##3##(1995-10#1)(1996-3#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-6#1)(2008-12#1)(2008-6#2)(2008-9#1)(2010-12#1)(2012-11#1)(2012-12#1)
to the tumorigenesis##5##3##(2011-2#1)(2013-8#4)
to the tumorigenic process##2##4##(1990-11#1)(1994-12#1)
to the tumors##2##3##(2004-9#1)(2007-11#1)
to the tumour##5##3##(1995-12#1)(2006-6#1)(2007-8#1)(2011-1#2)
to the two Mn ions##2##5##(2008-8#2)
to the two drug##2##4##(1993-6#1)(2010-3#1)
to the two##57##3##(1990-10#1)(1991-4#1)(1991-5#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-3#1)(1993-6#1)(1994-11#3)(1994-2#1)(1995-11#1)(1995-3#2)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-5#1)(1996-6#1)(1996-9#2)(1997-2#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#11)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-3#1)(2011-2#1)(2013-7#1)
to the two-dimensional##5##3##(2008-2#2)(2008-3#1)(2011-1#1)(2013-8#1)
to the two-photon##2##3##(2008-3#1)(2009-11#1)
to the type 2##2##4##(2012-12#1)(2013-1#1)
to the type and##4##4##(2006-5#1)(2007-11#1)(2008-11#1)(2012-2#1)
to the type of operation##2##5##(1990-3#2)
to the type of opioid##2##5##(1995-7#2)
to the type of the##2##5##(1992-3#1)(2008-3#1)
to the type of treatment##2##5##(1993-11#1)(1993-6#1)
to the type of##36##4##(1990-10#1)(1990-3#2)(1992-3#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-3#1)(1995-7#2)(2006-1#1)(2006-12#1)(2006-9#2)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-9#2)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
to the type##49##3##(1990-10#1)(1990-3#2)(1991-8#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-3#1)(1995-3#1)(1995-7#2)(1996-5#1)(1997-2#1)(1997-6#1)(2006-1#1)(2006-12#1)(2006-5#1)(2006-9#2)(2007-11#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-9#2)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
to the types of##5##4##(1996-4#1)(2007-12#1)(2008-4#2)(2013-8#1)
to the typical##6##3##(1993-3#1)(1996-4#1)(2007-1#1)(2010-10#1)(2010-6#1)(2011-2#1)
to the typically##3##3##(1991-4#1)(2009-4#1)(2011-1#1)
to the tyrosine kinase##2##4##(1993-6#1)(2013-8#1)
to the tyrosine phosphorylation and##2##5##(1995-3#1)(1995-6#1)
to the tyrosine phosphorylation of##2##5##(1995-3#1)(1996-5#1)
to the tyrosine phosphorylation##4##4##(1995-3#2)(1995-6#1)(1996-5#1)
to the tyrosine##9##3##(1993-6#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-5#1)(1996-9#1)(2006-6#1)(2013-8#1)
to the ubiquitously##2##3##(1995-1#1)(2006-6#1)
to the ulnar##2##3##(1997-3#1)(2007-6#1)
to the ultimate fate of##2##5##(2006-2#1)(2008-10#1)
to the ultimate##3##3##(2006-2#1)(2007-4#1)(2008-10#1)
to the ultrasonic##2##3##(2007-12#2)
to the ultrastructural##2##3##(2008-7#1)(2011-2#1)
to the umbilical##2##3##(1996-12#1)(2013-1#1)
to the uncertainty##6##3##(1991-2#1)(1996-12#1)(2007-11#1)(2008-10#1)(2011-12#1)(2012-12#1)
to the uncoupling##3##3##(1991-3#1)(1997-7#1)(2010-5#1)
to the underlying disease##4##4##(2006-6#1)(2008-7#2)(2010-12#1)
to the underlying##19##3##(1991-11#1)(1991-2#1)(1995-2#1)(1995-3#1)(1996-1#1)(1997-3#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-12#1)
to the understanding and##2##4##(2006-9#1)(2009-12#1)
to the understanding of gene##3##5##(2008-7#1)(2010-10#1)(2012-3#1)
to the understanding of its##2##5##(2006-2#1)(2008-4#1)
to the understanding of the##17##5##(1991-9#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-3#1)(1995-2#1)(1997-8#1)(2006-11#1)(2007-9#1)(2008-10#1)(2008-12#1)(2009-6#1)(2009-7#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
to the understanding of##39##4##(1991-12#1)(1991-9#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-3#1)(1995-2#1)(1997-8#1)(2004-2#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#2)(2009-12#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-2#3)(2012-3#2)
to the understanding##42##3##(1991-12#1)(1991-9#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-3#1)(1995-2#1)(1997-8#1)(2004-2#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-9#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#2)(2009-12#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#2)
to the undertreatment of pain##2##5##(1996-7#2)
to the unexposed##3##3##(2008-3#1)(2008-9#1)(2009-5#1)
to the unfolded protein##2##4##(1997-1#1)(1997-2#1)
to the unique iron-binding##2##4##(1996-5#2)
to the unique nature of##2##5##(2008-4#1)(2013-8#1)
to the unique##19##3##(1991-10#1)(1991-5#1)(1991-9#1)(1993-2#1)(1995-3#1)(1996-2#1)(1996-5#2)(1996-7#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-11#1)(2012-2#1)(2013-1#1)(2013-8#2)
to the uniqueness of##2##4##(2008-11#1)(2008-9#1)
to the universal##2##3##(1997-8#1)(2008-8#1)
to the university##2##3##(1993-2#1)(2006-8#1)
to the unmodified##3##3##(1995-2#1)(2006-10#1)(2010-4#1)
to the unpaired##3##3##(1994-6#1)(2007-10#1)(2012-2#1)
to the unproteolyzed##2##3##(1995-11#2)
to the unrelated##2##3##(2012-3#2)
to the untreated##10##3##(1990-3#1)(1995-12#1)(1995-9#1)(2005-11#2)(2007-7#1)(2008-4#1)(2008-5#2)(2011-12#1)
to the unusual##2##3##(1997-6#1)(2011-2#1)
to the up-regulation of##2##4##(1995-10#1)(1995-2#1)
to the upper##21##3##(1992-12#1)(1992-3#1)(1992-6#1)(1996-4#1)(1996-9#1)(2006-11#2)(2007-10#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#4)(2012-1#1)(2013-1#1)
to the upper-half of the face##2##6##(2010-1#2)
to the upregulation of##4##4##(1993-3#1)(2009-8#1)(2010-11#1)(2012-12#1)
to the upstream##3##3##(1993-3#1)(1994-10#1)(1997-7#1)
to the uptake of##3##4##(1991-10#1)(1997-1#1)(2007-5#1)
to the uptake##4##3##(1991-10#1)(1997-1#1)(2007-5#1)(2012-1#1)
to the uracil##2##3##(1996-6#1)(1996-7#1)
to the urban##3##3##(1991-6#1)(2008-10#1)(2008-4#1)
to the ureter##2##3##(1997-3#1)(2007-10#1)
to the urgency of##2##4##(1996-1#1)(2007-7#1)
to the urgency##3##3##(1996-1#1)(2007-7#1)(2008-10#1)
to the urinary bladder and##2##5##(1996-11#2)
to the urinary bladder##4##4##(1996-11#2)(2004-2#1)(2009-7#1)
to the urinary##6##3##(1996-11#2)(1996-12#1)(2004-2#1)(2007-12#1)(2009-7#1)
to the urine##4##3##(1994-6#1)(1995-2#1)(2008-10#1)(2008-4#1)
to the urological##2##3##(2006-7#1)(2008-10#1)
to the use of a##4##5##(2007-7#2)(2008-10#1)(2008-5#1)
to the use of embryonic stem cells for medical purposes##2##10##(2006-7#1)(2006-8#1)
to the use of embryonic stem cells for##5##8##(2006-7#1)(2006-8#4)
to the use of geospatial data##2##6##(2008-8#2)
to the use of herbal##2##5##(2006-8#2)
to the use of the##10##5##(1993-9#1)(2006-10#2)(2006-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2012-2#1)(2013-8#1)
to the use of these##5##5##(2006-10#1)(2007-8#1)(2008-2#1)(2008-7#1)(2012-3#1)
to the use of this##2##5##(1990-4#1)(2010-12#1)
to the use of##135##4##(1990-2#1)(1990-4#1)(1991-2#1)(1992-6#2)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-3#1)(1995-4#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-8#1)(2004-1#1)(2005-10#3)(2005-7#2)(2005-8#2)(2006-10#9)(2006-2#2)(2006-4#1)(2006-6#1)(2006-7#3)(2006-8#7)(2006-9#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-10#8)(2008-11#4)(2008-12#3)(2008-2#6)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#3)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-6#2)(2010-8#2)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#2)
to the use##136##3##(1990-2#1)(1990-4#1)(1991-2#1)(1992-6#2)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-3#1)(1995-4#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-8#1)(2004-1#1)(2005-10#3)(2005-7#2)(2005-8#2)(2006-10#9)(2006-2#2)(2006-4#1)(2006-6#1)(2006-7#3)(2006-8#7)(2006-9#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-10#8)(2008-11#4)(2008-12#3)(2008-2#6)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#3)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-6#2)(2010-8#2)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#2)
to the usefulness##2##3##(2006-10#1)(2007-3#1)
to the user##5##3##(2006-6#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-5#1)
to the user's motion##2##4##(2012-1#2)
to the user's##5##3##(1993-9#1)(2012-1#4)
to the usual##21##3##(1990-8#1)(1991-4#1)(1993-5#1)(1994-8#1)(1997-2#1)(1997-8#1)(2005-11#1)(2005-3#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-9#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)
to the uterine##2##3##(1992-8#1)(2011-2#1)
to the uterus##4##3##(1992-2#1)(1994-9#1)(2009-8#2)
to the utility of##2##4##(2008-2#1)(2008-6#1)
to the utilization of##3##4##(2008-11#1)(2011-1#1)(2011-2#1)
to the utilization##5##3##(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#2)
to the vaccine##12##3##(1990-3#1)(1991-12#1)(2005-7#1)(2005-9#1)(2007-11#2)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#2)(2013-8#1)
to the vacuole##8##3##(1997-6#3)(2009-10#5)
to the vaginal##2##3##(1992-9#1)(2009-2#1)
to the validity of the##2##5##(2008-7#2)
to the validity of##4##4##(1990-10#1)(2008-11#1)(2008-7#2)
to the value of 0##2##5##(1990-5#1)(1996-7#1)
to the value of##10##4##(1990-5#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-7#1)(2007-2#1)(2008-3#1)(2008-8#2)(2013-7#1)
to the value##16##3##(1990-5#1)(1990-8#1)(1991-7#1)(1992-3#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-6#1)(1996-7#1)(2007-2#1)(2008-3#1)(2008-8#2)(2011-1#1)(2013-7#1)
to the values obtained from the##2##6##(1992-2#1)(2012-3#1)
to the values obtained from##3##5##(1992-2#1)(2008-10#1)(2012-3#1)
to the values obtained##6##4##(1992-2#1)(1992-6#1)(2006-1#1)(2008-10#1)(2008-5#1)(2012-3#1)
to the values of the##4##5##(2005-11#1)(2008-10#2)(2010-8#1)
to the values of##6##4##(2005-11#1)(2008-10#2)(2008-2#1)(2010-3#1)(2010-8#1)
to the values##19##3##(1991-2#1)(1992-2#1)(1992-3#1)(1992-6#1)(2005-11#1)(2006-1#1)(2007-2#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-5#2)(2008-8#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-3#1)
to the valve##2##3##(1997-5#1)(2012-12#1)
to the var##2##3##(2008-5#2)
to the variability in##2##4##(2007-9#1)(2009-4#1)
to the variability##5##3##(2007-9#1)(2009-4#1)(2009-7#1)(2012-2#1)(2013-1#1)
to the variance##3##3##(2008-2#1)(2008-8#1)(2008-9#1)
to the variant##5##3##(1991-12#1)(1991-3#1)(1992-7#1)(1993-7#1)(2010-2#1)
to the variation in the##2##5##(2008-10#1)(2013-1#1)
to the variation in##3##4##(2008-10#1)(2011-1#1)(2013-1#1)
to the variation of the##2##5##(2008-2#2)
to the variation of##5##4##(2004-9#1)(2008-2#2)(2011-1#1)(2012-3#1)
to the variation##9##3##(2004-9#1)(2008-10#1)(2008-2#2)(2009-12#1)(2011-1#2)(2012-3#1)(2013-1#1)
to the variations##2##3##(1992-3#1)(2008-3#1)
to the variety of##2##4##(1990-8#1)(1994-8#1)
to the variety##3##3##(1990-6#1)(1990-8#1)(1994-8#1)
to the various##18##3##(1990-5#1)(1994-8#1)(1996-9#1)(2006-10#1)(2006-3#1)(2007-12#1)(2008-10#3)(2008-2#1)(2009-7#1)(2011-1#1)(2012-2#1)(2013-1#5)
to the varying##2##3##(1993-8#1)(2008-10#1)
to the vascular endothelium##2##4##(2008-1#1)(2008-3#1)
to the vascular tissues##2##4##(2008-10#2)
to the vascular##15##3##(1991-6#2)(1992-6#1)(1997-5#1)(2006-4#1)(2007-10#1)(2007-3#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-8#1)(2009-3#1)
to the vasodilatory##2##3##(1995-2#1)(1997-5#1)
to the vast##2##3##(2006-1#1)(2007-2#1)
to the vector##5##3##(1990-5#1)(1990-9#1)(1997-4#1)(2008-10#1)(2011-2#1)
to the vehicle controls##4##4##(2008-9#4)
to the vehicle##7##3##(1991-2#1)(2007-11#1)(2008-5#1)(2008-9#4)
to the vein##4##3##(2006-12#1)(2007-7#2)(2007-8#1)
to the venous##3##3##(1994-9#1)(2006-3#1)(2008-2#1)
to the ventilated##2##3##(1992-6#1)(2006-10#1)
to the ventral striatum##2##4##(1993-6#2)
to the ventral##7##3##(1993-6#2)(1997-3#1)(1997-7#1)(2005-5#1)(2007-12#1)(2012-2#1)
to the ventricular##4##3##(1991-4#1)(1993-3#1)(2006-4#1)(2006-5#1)
to the ventrolateral##3##3##(1992-11#1)(1993-3#1)(1996-6#1)
to the venture##2##3##(2007-1#2)
to the vertebral canal##2##4##(2007-11#1)(2007-7#1)
to the vertebral column##3##4##(2006-8#1)(2007-11#1)(2008-4#1)
to the vertebral##8##3##(2006-12#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-7#1)(2008-3#1)(2008-4#1)
to the vertebrates##2##3##(1992-5#1)(2008-7#1)
to the very low##2##4##(1995-6#1)(1996-8#1)
to the very virulent##2##4##(2013-8#2)
to the very##13##3##(1995-5#1)(1995-6#1)(1996-8#1)(2005-11#1)(2007-11#1)(2008-7#1)(2008-9#2)(2009-12#1)(2010-7#1)(2012-2#1)(2013-8#2)
to the vesicle##2##3##(1994-8#1)(1995-10#1)
to the vesicles##6##3##(1990-12#1)(1992-6#1)(1994-12#2)(1994-8#1)(1995-5#1)
to the vessel##4##3##(1993-9#1)(2008-10#1)(2008-7#1)(2012-1#1)
to the veterinary##2##3##(2011-1#1)(2013-1#1)
to the victims of##4##4##(1993-3#1)(2007-3#1)(2011-2#2)
to the victims##6##3##(1993-3#1)(2005-8#1)(2007-3#2)(2011-2#2)
to the view of##2##4##(2012-3#1)(2013-8#1)
to the view that##3##4##(1995-1#1)(2013-7#1)(2013-8#1)
to the view##5##3##(1995-1#1)(2012-3#1)(2013-7#1)(2013-8#2)
to the vinyl group or##2##5##(1994-9#1)(2008-10#1)
to the vinyl##3##3##(1994-9#1)(2008-10#2)
to the viral replication##2##4##(1994-8#1)(2008-10#1)
to the viral##9##3##(1990-7#1)(1990-8#1)(1992-6#1)(1994-8#1)(2008-10#2)(2008-3#1)(2008-9#1)(2013-1#1)
to the virulence of##2##4##(1995-1#1)(2005-8#1)
to the virus is##2##4##(2011-1#1)(2012-2#1)
to the virus##20##3##(1993-8#1)(1995-12#1)(2006-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#3)(2011-1#3)(2012-2#2)(2013-1#2)
to the visible##5##3##(2007-11#2)(2008-3#2)(2013-1#1)
to the visual cortex##2##4##(1995-11#1)(1997-3#1)
to the visual##7##3##(1992-12#1)(1995-11#1)(1997-3#1)(2007-5#2)(2008-3#1)(2009-12#1)
to the visualization##2##3##(2008-2#1)(2012-3#1)
to the vitamin D##2##4##(1994-11#1)(1995-2#1)
to the voice of##2##4##(2008-11#1)(2009-5#1)
to the volatility##2##3##(2008-2#1)(2013-7#1)
to the voltammetric##2##3##(2008-10#2)
to the volume of##6##4##(1997-8#1)(2008-10#4)(2011-12#1)
to the volume##8##3##(1997-8#1)(2006-10#1)(2007-8#1)(2008-10#4)(2011-12#1)
to the waiting##2##3##(2011-3#1)(2012-12#1)
to the wall of the##2##5##(1990-11#1)(2013-1#1)
to the wall##5##3##(1990-11#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-1#1)
to the ward##2##3##(2007-11#1)(2012-2#1)
to the wards##2##3##(2007-8#1)(2011-2#1)
to the water##12##3##(2006-3#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-5#2)(2012-3#1)
to the wave fronts##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
to the wave##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
to the waveguide##2##3##(2008-10#1)(2008-3#1)
to the wavelength of##4##4##(2008-1#1)(2008-10#1)(2008-2#2)
to the wavelength##9##3##(2008-1#2)(2008-10#1)(2008-2#3)(2008-3#3)
to the way in which the##2##6##(2008-11#1)(2012-3#1)
to the way in which##3##5##(2008-11#1)(2012-1#1)(2012-3#1)
to the way##10##3##(1995-5#1)(2004-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-3#1)(2012-1#1)(2012-3#1)(2013-1#2)
to the ways##2##3##(1994-3#1)(2007-4#1)
to the weak##5##3##(2005-11#1)(2006-6#1)(2008-3#1)(2008-8#1)(2012-3#1)
to the weaker##2##3##(1994-6#1)(1996-6#1)
to the weight of the##2##5##(1991-12#1)(2009-1#1)
to the weight of##3##4##(1991-12#1)(2008-10#1)(2009-1#1)
to the weight##4##3##(1991-12#1)(1996-3#1)(2008-10#1)(2009-1#1)
to the welfare##2##3##(2005-7#1)(2011-2#1)
to the well##5##3##(1991-2#1)(1995-12#1)(2006-10#1)(2006-4#1)(2008-5#1)
to the well-known##15##3##(1994-5#1)(1994-9#1)(1995-12#1)(2005-11#1)(2007-12#2)(2008-2#3)(2008-3#1)(2008-5#2)(2008-8#1)(2009-8#1)(2012-3#1)
to the well-studied##3##3##(1995-8#1)(1997-7#1)(2008-9#1)
to the wells##2##3##(1990-12#1)(1994-9#1)
to the wheat stripe rust##2##5##(2008-10#2)
to the whole##14##3##(1991-10#1)(1993-12#1)(1995-6#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-11#1)(2012-2#1)
to the wide variation in##2##5##(1996-12#1)(2012-3#1)
to the wide variety of##2##5##(2007-2#1)(2010-2#1)
to the wide##10##3##(1991-2#1)(1991-3#1)(1996-12#1)(2007-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-2#1)(2012-3#1)
to the widely distributed##2##4##(1992-8#1)(1997-4#1)
to the widely used##3##4##(2010-11#1)(2010-8#1)(2012-2#1)
to the widely##6##3##(1990-6#1)(1992-8#1)(1997-4#1)(2010-11#1)(2010-8#1)(2012-2#1)
to the wider##2##3##(2005-7#1)(2011-2#1)
to the widespread use of these compounds##2##7##(1991-4#1)(2012-1#1)
to the widespread use of##9##5##(1991-4#1)(1993-12#1)(2005-9#1)(2006-8#1)(2007-8#1)(2008-7#1)(2012-1#1)(2012-2#1)(2013-8#1)
to the widespread##12##3##(1991-4#1)(1993-12#1)(1995-8#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-7#1)(2012-1#1)(2012-2#1)(2013-8#1)
to the width of the##2##5##(1993-9#1)(2007-11#1)
to the width of##3##4##(1993-9#1)(2007-11#1)(2013-1#1)
to the wild type protein##2##5##(1996-11#1)(2008-11#1)
to the wild type##14##4##(1990-10#1)(1990-11#1)(1991-4#1)(1991-7#1)(1994-11#1)(1995-11#1)(1996-11#2)(1997-8#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)
to the wild##15##3##(1990-10#1)(1990-11#1)(1991-4#1)(1991-7#1)(1994-11#1)(1995-11#1)(1996-11#2)(1997-8#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)
to the wild-type enzyme##7##4##(1990-10#1)(1992-3#1)(1993-6#2)(1995-2#1)(1996-2#1)(1997-4#1)
to the wild-type protein##2##4##(1991-4#1)(1992-3#1)
to the wild-type strain##3##4##(1993-2#1)(2006-8#1)(2006-9#1)
to the wild-type##26##3##(1990-10#1)(1991-4#1)(1992-3#2)(1993-2#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-9#1)(1995-10#1)(1995-2#2)(1996-12#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#2)(2006-8#1)(2006-9#1)(2008-10#2)(2009-6#1)(2009-8#1)
to the wind direction##2##4##(2008-10#1)(2008-5#1)
to the wind##5##3##(2008-10#3)(2008-11#1)(2008-5#1)
to the word##2##3##(1994-1#1)(2009-11#1)
to the work force##2##4##(1991-7#1)(1992-12#1)
to the work of##4##4##(2008-11#1)(2008-12#1)(2010-5#1)(2010-9#1)
to the work piece##2##4##(2008-3#2)
to the work##10##3##(1991-7#1)(1992-12#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-3#2)(2010-5#1)(2010-9#1)(2012-3#1)
to the workforce##2##3##(2007-2#1)(2011-1#1)
to the working##3##3##(1993-11#1)(2008-10#1)(2008-3#1)
to the workshop##2##3##(1992-5#1)(2008-10#1)
to the world of##5##4##(1995-3#1)(1995-5#1)(1996-12#1)(2006-10#1)(2008-8#1)
to the world##7##3##(1995-3#1)(1995-5#1)(1996-12#1)(1997-6#1)(2006-10#1)(2007-9#1)(2008-8#1)
to the wound surface##2##4##(2007-8#1)(2010-12#1)
to the wound was##2##4##(1991-6#1)(2011-1#1)
to the wound##5##3##(1991-6#1)(2007-8#1)(2008-10#1)(2010-12#1)(2011-1#1)
to the writing-beam polarization##2##4##(2007-11#2)
to the written examination##2##4##(2012-1#2)
to the wrong##2##3##(2010-12#1)(2012-3#1)
to the year 2018##2##4##(2008-11#2)
to the year##5##3##(2006-8#2)(2008-11#2)(2009-7#1)
to the yeast and##2##4##(1994-8#1)(1996-5#1)
to the yeast##10##3##(1991-2#1)(1991-6#1)(1993-6#1)(1994-8#1)(1995-4#1)(1996-5#1)(1997-1#1)(2008-10#1)(2009-12#1)(2010-1#1)
to the yellow##2##3##(1997-1#1)(2007-12#1)
to the young group##2##4##(1992-10#1)(1996-8#1)
to the young##5##3##(1992-10#1)(1996-8#1)(2008-10#1)(2008-7#1)(2008-9#1)
to the younger age##2##4##(2008-9#1)(2012-12#1)
to the younger##6##3##(2006-12#1)(2006-7#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-12#1)
to the z axis##2##4##(2008-3#2)
to the zero##5##3##(1990-10#1)(1994-8#1)(2007-11#1)(2008-10#1)(2008-11#1)
to the zinc finger##3##4##(1991-10#1)(1991-2#2)
to the zinc##5##3##(1991-10#1)(1991-2#2)(1991-5#1)(1995-11#1)
to the zona##2##3##(1995-12#1)(2008-4#1)
to the zwitterionic##2##3##(2007-11#1)(2008-10#1)
to the##29357##2##(1990-1#9)(1990-10#67)(1990-11#110)(1990-12#177)(1990-2#126)(1990-3#107)(1990-4#88)(1990-5#134)(1990-6#56)(1990-7#98)(1990-8#127)(1990-9#59)(1991-1#74)(1991-10#85)(1991-11#77)(1991-12#137)(1991-2#140)(1991-3#119)(1991-4#91)(1991-5#134)(1991-6#101)(1991-7#104)(1991-8#96)(1991-9#124)(1992-1#69)(1992-10#40)(1992-11#63)(1992-12#129)(1992-2#85)(1992-3#151)(1992-4#52)(1992-5#80)(1992-6#143)(1992-7#77)(1992-8#116)(1992-9#92)(1993-1#45)(1993-10#28)(1993-11#77)(1993-12#170)(1993-2#95)(1993-3#131)(1993-4#49)(1993-5#52)(1993-6#154)(1993-7#43)(1993-8#80)(1993-9#101)(1994-1#24)(1994-10#34)(1994-11#149)(1994-12#211)(1994-2#112)(1994-3#162)(1994-4#17)(1994-5#125)(1994-6#114)(1994-7#15)(1994-8#170)(1994-9#165)(1995-1#115)(1995-10#50)(1995-11#119)(1995-12#155)(1995-2#154)(1995-3#178)(1995-4#40)(1995-5#108)(1995-6#139)(1995-7#33)(1995-8#154)(1995-9#44)(1996-1#102)(1996-10#60)(1996-11#74)(1996-12#153)(1996-2#149)(1996-3#129)(1996-4#84)(1996-5#213)(1996-6#116)(1996-7#84)(1996-8#101)(1996-9#103)(1997-1#120)(1997-2#191)(1997-3#134)(1997-4#180)(1997-5#73)(1997-6#158)(1997-7#163)(1997-8#138)(1997-9#9)(2003-11#2)(2004-1#12)(2004-10#12)(2004-11#23)(2004-12#18)(2004-2#11)(2004-3#7)(2004-4#16)(2004-7#5)(2004-8#3)(2004-9#44)(2005-1#12)(2005-10#79)(2005-11#260)(2005-12#42)(2005-2#1)(2005-3#9)(2005-4#32)(2005-5#27)(2005-6#7)(2005-7#69)(2005-8#72)(2005-9#34)(2006-1#25)(2006-10#433)(2006-11#128)(2006-12#209)(2006-2#94)(2006-3#63)(2006-4#72)(2006-5#115)(2006-6#123)(2006-7#70)(2006-8#166)(2006-9#60)(2007-1#86)(2007-10#122)(2007-11#499)(2007-12#679)(2007-2#132)(2007-3#74)(2007-4#132)(2007-5#111)(2007-6#74)(2007-7#238)(2007-8#429)(2007-9#157)(2008-1#312)(2008-10#3043)(2008-11#651)(2008-12#225)(2008-2#779)(2008-3#933)(2008-4#432)(2008-5#663)(2008-6#243)(2008-7#559)(2008-8#377)(2008-9#376)(2009-1#22)(2009-10#150)(2009-11#57)(2009-12#74)(2009-2#103)(2009-3#91)(2009-4#131)(2009-5#107)(2009-6#101)(2009-7#107)(2009-8#166)(2009-9#81)(2010-1#39)(2010-10#70)(2010-11#67)(2010-12#198)(2010-2#143)(2010-3#91)(2010-4#139)(2010-5#146)(2010-6#64)(2010-7#93)(2010-8#147)(2010-9#64)(2011-1#335)(2011-10#5)(2011-11#1)(2011-12#70)(2011-2#652)(2011-3#23)(2011-7#4)(2011-9#2)(2012-1#200)(2012-11#76)(2012-12#401)(2012-2#463)(2012-3#280)(2012-4#2)(2012-5#5)(2012-6#5)(2012-7#2)(2012-9#4)(2013-1#561)(2013-2#2)(2013-7#116)(2013-8#333)
to their UV##2##3##(2008-10#1)(2010-4#1)
to their ability to selectively##2##5##(2009-2#1)(2012-2#1)
to their ability to##18##4##(1990-11#1)(1994-11#3)(1996-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-2#1)(2009-8#1)(2010-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
to their actual##3##3##(2007-11#1)(2007-12#1)(2007-5#1)
to their adult##2##3##(1995-1#1)(2008-9#1)
to their affected##2##3##(2007-8#1)(2010-2#1)
to their age##5##3##(1990-8#1)(1994-2#1)(1994-3#1)(2008-3#1)(2011-2#1)
to their almost##2##3##(1994-3#1)(2006-1#1)
to their antimicrobial##2##3##(2008-10#1)(2010-9#1)
to their antioxidant##2##3##(2008-10#1)(2008-11#1)
to their antiproliferative##2##3##(1991-8#1)(1995-2#1)
to their appearance##2##3##(2005-8#1)(2013-1#1)
to their application##2##3##(2008-2#1)(2008-8#1)
to their applications##3##3##(2005-11#1)(2006-12#1)(2010-7#1)
to their associated##2##3##(2008-2#1)(2009-2#1)
to their attention##3##3##(1990-10#1)(2005-10#1)(2006-2#1)
to their behavior##2##3##(1991-2#2)
to their benefit##2##3##(1994-3#1)(2012-2#1)
to their biocompatibility##2##3##(2008-7#1)(2012-12#1)
to their biological##5##3##(2006-11#1)(2006-12#1)(2007-6#1)(2010-10#1)(2011-2#1)
to their body##2##3##(2008-5#1)(2011-12#1)
to their capacity##2##3##(2006-6#1)(2006-7#1)
to their cell##3##3##(1994-3#1)(2007-12#1)(2008-6#1)
to their chemical structure##2##4##(2006-12#1)(2010-8#1)
to their chemical##3##3##(2006-12#1)(2008-10#1)(2010-8#1)
to their child##3##3##(1993-12#1)(2012-12#1)(2012-2#1)
to their child's##2##3##(1995-1#1)(2007-12#1)
to their children and##2##4##(2010-10#1)(2012-12#1)
to their children##9##3##(1990-2#1)(1995-1#1)(2007-11#1)(2010-10#2)(2012-12#2)(2013-1#1)(2013-7#1)
to their children's##3##3##(1994-3#1)(1995-1#2)
to their clients##2##3##(2008-5#1)(2011-2#1)
to their clinical##6##3##(1992-10#1)(1993-9#1)(2007-7#1)(2008-10#1)(2010-11#1)(2011-2#1)
to their cognate##4##3##(1993-6#1)(1996-5#1)(1997-2#1)(2011-12#1)
to their communities##3##3##(1995-3#1)(2004-12#1)(2008-12#1)
to their complexity##2##3##(2008-10#1)(2011-2#1)
to their controls##3##3##(2006-8#1)(2008-10#1)(2008-7#1)
to their corresponding##7##3##(1993-11#1)(1993-7#1)(1997-6#1)(2007-11#1)(2008-9#1)(2009-7#2)
to their counterparts in the##2##5##(1997-7#1)(2008-7#1)
to their counterparts in##3##4##(1995-10#1)(1997-7#1)(2008-7#1)
to their counterparts##5##3##(1995-10#1)(1997-7#1)(2008-7#1)(2009-6#1)(2012-12#1)
to their current##3##3##(2007-10#1)(2008-12#1)(2009-1#1)
to their cytotoxic potential##2##4##(1992-11#1)(2008-4#1)
to their daily##3##3##(2005-9#1)(2006-6#1)(2008-11#1)
to their death##3##3##(2008-10#2)(2011-2#1)
to their deaths##2##3##(1995-1#1)(2007-2#1)
to their density##2##3##(1992-3#1)(1995-1#1)
to their destinations##2##3##(1995-2#1)(1996-5#1)
to their determination##15##3##(2006-12#1)(2008-10#14)
to their different##5##3##(1994-12#1)(2007-11#1)(2008-10#1)(2008-8#1)(2011-1#1)
to their disease##3##3##(2008-1#1)(2008-10#1)(2010-3#1)
to their distribution##2##3##(1995-12#1)(2012-5#1)
to their effect on##4##4##(2007-1#1)(2008-10#1)(2008-5#1)(2008-8#1)
to their effectiveness##4##3##(2005-1#1)(2008-5#1)(2008-7#1)(2010-1#1)
to their effector##2##3##(1990-3#1)(1996-5#1)
to their effects on the##3##5##(1993-6#1)(1993-9#1)(2008-5#1)
to their effects on##4##4##(1993-6#2)(1993-9#1)(2008-5#1)
to their effects##5##3##(1993-6#2)(1993-9#1)(2008-10#1)(2008-5#1)
to their efficacy and##2##4##(2006-10#1)(2011-12#1)
to their efficacy##3##3##(2006-10#2)(2011-12#1)
to their efficiency##3##3##(2008-10#1)(2008-2#2)
to their employees##3##3##(1990-12#1)(1992-3#1)(2006-1#1)
to their environment##6##3##(1996-12#2)(1997-4#2)(2007-8#1)(2009-6#1)
to their evaluation##2##3##(1994-9#1)(2008-7#1)
to their excellent##2##3##(1997-8#1)(2009-7#1)
to their experience##2##3##(2006-6#1)(2013-1#1)
to their experiences##2##3##(2008-12#1)(2011-1#1)
to their expression##2##3##(1995-12#1)(1996-4#1)
to their extracellular##2##3##(1995-3#1)(1997-1#1)
to their family##2##3##(1994-12#1)(2012-2#1)
to their financial##2##3##(2010-10#2)
to their free##3##3##(1991-2#1)(2008-11#1)(2013-7#1)
to their full##2##3##(2006-10#1)(2011-2#1)
to their function##5##3##(1991-2#1)(1992-7#1)(2007-8#1)(2008-4#1)(2011-2#1)
to their health##5##3##(2005-7#1)(2006-10#2)(2008-12#1)(2008-4#1)
to their high##13##3##(1990-12#1)(1995-11#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-11#1)(2013-1#1)(2013-7#1)
to their home##2##3##(2008-8#1)(2010-8#1)
to their homes for terminal care##2##6##(1993-3#2)
to their homes##6##3##(1990-12#1)(1990-8#2)(1993-3#2)(2011-2#1)
to their host plants##2##4##(2008-10#1)(2008-9#1)
to their host##3##3##(2008-10#2)(2008-9#1)
to their illness##2##3##(1992-12#1)(2007-7#1)
to their implementation##2##3##(2005-5#1)(2011-2#1)
to their importance in##2##4##(2009-12#1)(2013-1#1)
to their importance##3##3##(2009-12#1)(2013-1#2)
to their incorporation into the##2##5##(1991-2#1)(2008-10#1)
to their incorporation##3##3##(1991-2#1)(2008-10#2)
to their increased##4##3##(1994-12#1)(2012-12#1)(2012-2#2)
to their increasing##3##3##(2005-3#1)(2006-10#1)(2008-3#1)
to their individual##3##3##(1992-1#1)(1995-3#1)(2010-9#1)
to their influence on##2##4##(2007-6#1)(2008-10#1)
to their inherent##6##3##(1995-1#1)(2007-12#1)(2008-10#1)(2008-4#1)(2012-11#1)(2012-2#1)
to their inhibitory##2##3##(1991-10#1)(1994-5#1)
to their interaction with##3##4##(1990-12#1)(1990-4#1)(2008-10#1)
to their jobs##3##3##(1995-3#1)(1996-1#1)(1997-3#1)
to their knowledge##2##3##(2007-3#1)(2008-11#1)
to their large##2##3##(1991-11#1)(2009-11#1)
to their learning##2##3##(2008-11#2)
to their length##2##3##(2008-9#2)
to their lives##3##3##(2007-2#2)(2008-12#1)
to their location##3##3##(1991-2#1)(1997-2#1)(2010-6#1)
to their long-term##2##3##(2007-2#1)(2007-4#1)
to their low##7##3##(1996-1#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-4#1)(2011-1#1)
to their main##2##3##(2007-6#1)(2008-12#1)
to their malignancy##2##3##(2011-2#1)(2013-8#1)
to their mature form##2##4##(1992-6#2)
to their mature##4##3##(1991-3#1)(1992-6#2)(1995-2#1)
to their means##2##3##(1992-4#1)(1993-6#1)
to their mode of##2##4##(1994-11#1)(2011-1#1)
to their molecular##2##3##(2008-5#1)(2008-7#1)
to their native##2##3##(1995-4#1)(2012-2#1)
to their natural##4##3##(2008-10#1)(2008-7#1)(2008-8#1)(2009-12#1)
to their nature##2##3##(1990-7#1)(2012-2#1)
to their need##2##3##(1992-3#1)(2010-2#1)
to their needs##3##3##(2005-7#2)(2010-8#1)
to their new##2##3##(1991-3#1)(2008-2#1)
to their normal counterparts##2##4##(1993-6#1)(2010-7#1)
to their normal##6##3##(1993-6#1)(2005-7#1)(2008-10#1)(2008-7#1)(2010-7#1)(2012-2#1)
to their nursing practice##2##4##(2008-12#1)(2013-8#1)
to their offspring##2##3##(2008-2#1)(2008-7#1)
to their optimum##2##3##(2008-10#1)(2009-11#1)
to their origin##4##3##(1994-6#1)(1995-12#1)(2010-7#1)(2011-1#1)
to their original##10##3##(1992-5#1)(1997-4#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-4#1)(2011-1#1)
to their own##16##3##(1990-12#1)(1993-1#1)(1993-2#1)(1995-7#1)(1997-8#1)(2006-12#1)(2006-5#1)(2006-7#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-4#1)(2009-7#3)(2012-12#1)
to their parent##2##3##(1990-5#1)(2013-8#1)
to their partners##2##3##(2007-12#1)(2008-9#1)
to their pathophysiological##2##3##(1995-6#1)(2011-1#1)
to their patients and##2##4##(1992-2#1)(2009-9#1)
to their patients##14##3##(1990-2#1)(1991-6#1)(1992-12#1)(1992-2#1)(1994-1#2)(1994-7#1)(1997-1#1)(2005-10#1)(2006-8#1)(2008-11#1)(2008-9#1)(2009-9#1)(2012-3#1)
to their patients'##3##3##(2006-2#1)(2008-7#1)(2008-8#1)
to their perceived##2##3##(2008-11#1)(2013-7#1)
to their perceptions of##2##4##(2012-2#1)(2012-3#1)
to their performance##2##3##(2008-10#1)(2012-2#1)
to their potency##3##3##(1990-12#1)(1993-4#1)(1996-6#1)
to their potential##5##3##(2006-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-9#1)
to their previous##2##3##(2008-7#1)(2008-9#1)
to their primary##2##3##(1995-2#1)(2013-1#1)
to their professional##2##3##(2008-9#1)(2013-8#1)
to their rapid##2##3##(1992-2#1)(1996-6#1)
to their reduced##2##3##(2008-10#1)(2012-2#1)
to their reduction##2##3##(2007-11#1)(2008-10#1)
to their relationship with##2##4##(1994-8#1)(2008-10#1)
to their relative##4##3##(1994-9#1)(1997-2#1)(2006-10#1)(2007-5#1)
to their relatively high##3##4##(1997-2#1)(2008-5#1)(2009-4#1)
to their respective##30##3##(1991-3#1)(1992-1#2)(1992-3#1)(1992-4#1)(1993-12#1)(1993-9#2)(1994-2#1)(1995-7#1)(1996-9#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-4#1)(2007-7#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-5#1)(2010-6#1)(2012-3#1)
to their response##3##3##(1996-3#1)(2008-10#1)(2013-1#1)
to their responsiveness to##2##4##(1993-2#1)(2004-11#1)
to their role in##6##4##(2008-10#1)(2008-5#1)(2008-7#2)(2010-3#1)(2012-3#1)
to their roles##3##3##(2007-12#1)(2011-1#1)(2012-12#1)
to their sensitivity##2##3##(1990-11#1)(2006-8#1)
to their sequence##3##3##(1992-7#1)(1996-6#1)(2008-6#1)
to their sexual##2##3##(2009-7#1)(2012-3#1)
to their side##2##3##(2007-6#1)(2010-10#1)
to their simple##2##3##(2008-10#1)(2009-10#1)
to their size and##2##4##(1994-9#1)(2011-2#1)
to their skin##2##3##(1996-6#1)(2008-5#1)
to their small size##4##4##(1993-4#1)(2008-1#1)(2008-10#1)(2009-5#1)
to their social##2##3##(2007-8#1)(2009-7#1)
to their species##3##3##(2007-7#1)(2008-10#1)(2008-5#1)
to their specific needs##2##4##(1992-2#1)(2006-2#1)
to their specific##8##3##(1990-4#1)(1991-4#1)(1992-2#1)(1997-2#1)(2005-11#1)(2006-2#1)(2008-10#1)(2008-11#1)
to their spouse##2##3##(2007-12#1)(2012-11#1)
to their stroke##2##3##(2008-4#1)(2008-8#1)
to their structural##3##3##(1991-9#1)(2009-12#1)(2009-5#1)
to their structure##2##3##(2005-8#1)(2009-8#1)
to their success##3##3##(1992-1#1)(2008-10#1)(2012-3#1)
to their successful##2##3##(1996-2#1)(2007-11#1)
to their survival##2##3##(2008-10#1)(2008-7#1)
to their synaptic##2##3##(1990-12#1)(2007-8#1)
to their target##5##3##(1997-1#1)(2006-10#1)(2006-12#1)(2007-12#1)(2009-12#1)
to their targets##2##3##(1991-3#1)(2007-12#1)
to their terminal velocity##2##4##(2008-5#2)
to their therapeutic##2##3##(2008-4#1)(2012-2#1)
to their treatment##2##3##(2006-8#1)(2008-3#1)
to their trophic hormone##2##4##(1991-10#2)
to their ubiquitous##3##3##(2007-8#1)(2012-12#2)
to their unique##6##3##(1992-1#1)(1993-3#1)(2008-5#1)(2010-10#1)(2010-5#1)(2012-2#1)
to their use as##4##4##(1997-5#1)(2008-4#1)(2008-7#1)(2011-1#1)
to their use in##3##4##(2004-9#1)(2006-10#1)(2013-1#1)
to their use##15##3##(1996-7#1)(1997-5#1)(2004-9#1)(2006-10#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
to their work##3##3##(1996-9#1)(2007-8#1)(2008-9#1)
to their##1204##2##(1990-10#1)(1990-11#4)(1990-12#11)(1990-2#4)(1990-3#3)(1990-4#4)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#3)(1991-1#2)(1991-10#3)(1991-11#1)(1991-12#3)(1991-2#10)(1991-3#7)(1991-4#2)(1991-5#4)(1991-6#2)(1991-8#1)(1991-9#3)(1992-1#6)(1992-10#2)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#6)(1992-4#2)(1992-5#1)(1992-6#4)(1992-7#4)(1992-8#3)(1992-9#2)(1993-1#3)(1993-10#1)(1993-11#5)(1993-12#7)(1993-2#5)(1993-3#4)(1993-4#2)(1993-5#2)(1993-6#7)(1993-7#2)(1993-9#7)(1994-1#2)(1994-10#1)(1994-11#9)(1994-12#5)(1994-2#7)(1994-3#6)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#3)(1994-9#3)(1995-1#11)(1995-10#2)(1995-11#3)(1995-12#7)(1995-2#8)(1995-3#10)(1995-4#2)(1995-5#3)(1995-6#1)(1995-7#2)(1995-8#3)(1996-1#4)(1996-10#1)(1996-11#2)(1996-12#5)(1996-2#4)(1996-3#1)(1996-4#5)(1996-5#5)(1996-6#4)(1996-7#2)(1996-9#5)(1997-1#6)(1997-2#9)(1997-3#4)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#5)(2004-10#1)(2004-11#2)(2004-12#3)(2004-3#1)(2004-9#2)(2005-1#1)(2005-10#3)(2005-11#6)(2005-3#1)(2005-5#2)(2005-7#6)(2005-8#3)(2005-9#1)(2006-1#2)(2006-10#17)(2006-11#4)(2006-12#8)(2006-2#5)(2006-4#1)(2006-5#7)(2006-6#4)(2006-7#2)(2006-8#9)(2007-1#2)(2007-10#5)(2007-11#14)(2007-12#24)(2007-2#12)(2007-3#4)(2007-4#3)(2007-5#7)(2007-6#5)(2007-7#10)(2007-8#15)(2007-9#3)(2008-1#8)(2008-10#130)(2008-11#31)(2008-12#21)(2008-2#19)(2008-3#20)(2008-4#20)(2008-5#39)(2008-6#6)(2008-7#25)(2008-8#20)(2008-9#23)(2009-1#1)(2009-10#4)(2009-11#5)(2009-12#6)(2009-2#6)(2009-3#4)(2009-4#3)(2009-5#5)(2009-6#4)(2009-7#12)(2009-8#6)(2009-9#3)(2010-1#2)(2010-10#9)(2010-11#3)(2010-12#3)(2010-2#3)(2010-3#5)(2010-4#3)(2010-5#8)(2010-6#2)(2010-7#6)(2010-8#15)(2010-9#2)(2011-1#17)(2011-12#4)(2011-2#39)(2011-9#1)(2012-1#2)(2012-11#4)(2012-12#27)(2012-2#39)(2012-3#19)(2012-5#1)(2013-1#34)(2013-7#7)(2013-8#10)
to them and##3##3##(2008-12#1)(2008-8#1)(2008-9#1)
to them by##2##3##(1995-1#1)(2012-12#1)
to them in##5##3##(1993-10#1)(1993-11#1)(1996-12#1)(2010-11#1)(2010-9#1)
to them of##2##3##(2008-10#1)(2012-3#1)
to them while##2##3##(2010-10#1)(2012-1#1)
to them with##2##3##(2007-2#1)(2008-10#1)
to them##78##2##(1990-12#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-12#2)(1992-3#3)(1993-10#1)(1993-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-9#1)(1996-12#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-8#2)(2004-11#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#2)(2009-8#1)(2010-10#3)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
to thematic##2##2##(2008-11#2)
to themselves##7##2##(1990-12#1)(1990-6#1)(1991-12#1)(2005-7#1)(2008-11#1)(2008-4#1)(2010-10#1)
to then##2##2##(1996-10#1)(2011-1#1)
to theophylline##2##2##(1994-8#1)(2008-1#1)
to theoretical predictions##2##3##(2008-3#1)(2008-9#1)
to theoretical##12##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#1)(2010-3#1)(2011-2#1)
to theoretically##3##2##(2008-3#1)(2010-12#1)(2010-8#1)
to theories##2##2##(1997-8#1)(2008-8#1)
to theory building##2##3##(1995-3#1)(2008-5#1)
to theory development##2##3##(2008-8#1)(2009-8#1)
to theory##6##2##(1993-3#1)(1995-3#1)(2008-5#1)(2008-8#1)(2009-7#1)(2009-8#1)
to therapeutic agents and##2##4##(2008-6#1)(2009-11#1)
to therapeutic agents##3##3##(2006-10#1)(2008-6#1)(2009-11#1)
to therapeutic cloning##2##3##(2006-8#1)(2007-1#1)
to therapeutic##31##2##(1992-3#1)(1993-1#1)(1993-11#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-2#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-5#3)(2007-9#1)(2008-11#2)(2008-6#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-12#1)(2011-1#2)(2012-12#3)(2012-2#1)(2013-7#1)
to therapeutical##2##2##(1992-9#1)(2008-1#1)
to therapies for##2##3##(2006-10#1)(2008-8#1)
to therapies that##2##3##(2012-2#1)(2012-3#1)
to therapies##8##2##(2006-10#1)(2006-8#1)(2008-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
to therapists##3##2##(2006-11#1)(2012-2#2)
to therapy and##12##3##(1995-10#1)(2005-8#1)(2005-9#1)(2007-3#1)(2007-7#1)(2008-9#1)(2009-3#1)(2011-1#3)(2011-2#1)(2012-2#1)
to therapy in patients with##2##5##(1995-1#1)(2011-2#1)
to therapy in##9##3##(1993-11#3)(1995-1#2)(2007-3#1)(2007-7#1)(2010-11#1)(2011-2#1)
to therapy is##3##3##(1993-9#1)(1995-2#1)(2008-8#1)
to therapy of##3##3##(2004-2#1)(2006-8#1)(2008-3#1)
to therapy or##2##3##(2007-12#1)(2010-6#1)
to therapy with##4##3##(2006-9#1)(2011-1#2)(2012-2#1)
to therapy##101##2##(1990-10#1)(1990-5#1)(1991-2#2)(1991-7#1)(1992-8#1)(1993-11#3)(1993-9#2)(1994-7#2)(1995-1#2)(1995-10#1)(1995-12#1)(1995-2#1)(1997-2#1)(1997-3#1)(2004-1#1)(2004-2#2)(2005-10#1)(2005-8#5)(2005-9#1)(2006-10#2)(2006-12#3)(2006-8#2)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#2)(2007-7#6)(2008-1#3)(2008-11#4)(2008-3#2)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#3)(2010-7#1)(2011-1#6)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
to there##2##2##(1996-7#1)(2007-7#1)
to thermal and chemical##2##4##(2006-10#1)(2009-6#1)
to thermal and##5##3##(2006-10#1)(2008-3#1)(2008-7#1)(2009-6#1)(2011-2#1)
to thermal cycling##2##3##(2008-4#1)(2013-8#1)
to thermal stress##2##3##(1992-1#1)(2012-2#1)
to thermal##24##2##(1992-1#1)(1994-5#1)(1995-2#1)(1996-8#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-12#1)(2009-6#3)(2010-4#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
to thermally##3##2##(1997-4#1)(2008-2#1)(2009-12#1)
to thermodynamic##2##2##(1992-5#1)(2008-10#1)
to thermographic results##3##3##(1993-11#3)
to these agents##12##3##(1990-2#2)(1991-12#1)(1996-9#1)(2007-2#1)(2007-8#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-8#1)(2011-1#1)
to these and other##7##4##(1992-12#1)(1997-5#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-9#1)(2013-1#1)
to these antibiotics##2##3##(2007-7#1)(2013-8#1)
to these approaches##2##3##(2010-9#1)(2013-8#1)
to these cell##3##3##(1992-4#1)(1997-2#1)(2008-11#1)
to these cells##7##3##(1993-8#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-6#1)(1997-1#1)(2010-4#1)
to these challenges by##2##4##(1995-1#1)(2008-6#1)
to these challenges##4##3##(1994-12#1)(1995-1#1)(2008-11#1)(2008-6#1)
to these changes##5##3##(1994-8#1)(1997-4#1)(2007-3#1)(2009-4#1)(2009-5#1)
to these clients##2##3##(2011-1#1)(2011-2#1)
to these common##2##3##(2009-6#1)(2010-9#1)
to these compounds##11##3##(1990-7#2)(1991-6#1)(1992-8#1)(1993-6#1)(1994-3#1)(1997-3#1)(2008-10#2)(2008-4#1)(2008-8#1)
to these concerns##4##3##(1994-12#1)(2007-12#1)(2012-3#1)(2013-1#1)
to these conclusions##2##3##(2007-8#1)(2009-11#1)
to these data##4##3##(1990-6#1)(1997-8#1)(2008-4#2)
to these demographic##2##3##(1995-1#1)(2009-4#1)
to these different##3##3##(1994-3#1)(2005-12#1)(2008-2#1)
to these diseases##2##3##(2008-8#1)(2009-4#1)
to these disorders##2##3##(1991-4#1)(2006-10#1)
to these drugs##11##3##(1992-8#1)(1993-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1997-4#1)(2006-12#1)(2007-11#1)(2008-8#1)(2012-3#1)(2013-8#1)
to these effects##5##3##(1996-9#1)(2007-12#1)(2008-2#1)(2008-9#1)(2009-11#1)
to these elements##3##3##(1995-3#1)(1995-6#1)(2008-10#1)
to these entities##2##3##(2006-10#1)(2013-8#1)
to these factors##4##3##(1990-12#1)(2006-12#1)(2008-2#1)(2011-2#1)
to these findings are##2##4##(1993-9#1)(2008-9#1)
to these findings##10##3##(1993-4#1)(1993-9#1)(1994-5#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2011-1#1)(2013-1#2)
to these four##2##3##(1994-3#1)(2008-6#1)
to these functions##3##3##(2008-11#1)(2008-4#1)(2013-8#1)
to these fundamental##2##3##(1990-10#1)(2006-10#1)
to these groups##2##3##(2006-12#1)(2011-3#1)
to these guidelines##3##3##(1992-12#1)(2006-8#1)(2010-8#1)
to these high##2##3##(2007-7#1)(2012-12#1)
to these hormones##2##3##(1996-4#1)(2008-2#1)
to these in##2##3##(1994-9#1)(2009-11#1)
to these individuals##2##3##(2011-1#1)(2011-2#1)
to these methods##4##3##(2008-2#1)(2008-4#1)(2009-3#1)(2010-12#1)
to these microorganisms##2##3##(2007-12#1)(2011-2#1)
to these new##4##3##(1997-3#1)(2007-9#1)(2008-10#1)(2010-12#1)
to these parameters##3##3##(1992-12#1)(1995-11#1)(2008-10#1)
to these pathogens##4##3##(2008-10#2)(2009-10#1)(2009-3#1)
to these patients with##2##4##(2006-10#1)(2013-1#1)
to these patients##13##3##(1994-3#1)(1994-6#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-1#1)(2009-2#1)(2010-12#1)(2010-7#1)(2010-8#1)(2013-1#1)
to these physiological##2##3##(2008-5#1)(2008-9#1)
to these problems##6##3##(1991-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-8#1)
to these procedures##4##3##(1993-3#1)(2007-12#1)(2008-3#1)(2009-5#1)
to these processes##5##3##(1993-12#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-3#1)
to these properties##3##3##(1996-6#1)(2008-7#1)(2010-1#1)
to these proteins##3##3##(1990-9#1)(1995-2#2)
to these questions##3##3##(1996-6#1)(1997-8#1)(2008-7#1)
to these receptors##5##3##(1991-12#1)(1993-6#1)(2008-4#1)(2009-12#2)
to these residues##2##3##(1990-10#1)(1994-12#1)
to these results##9##3##(1992-7#1)(1993-4#1)(1995-7#1)(1996-8#1)(2004-9#1)(2006-9#1)(2008-10#1)(2008-12#1)(2008-5#1)
to these risk factors##2##4##(2007-10#1)(2011-1#1)
to these risks##2##3##(2008-3#2)
to these same##2##3##(2007-11#1)(2009-4#1)
to these services##4##3##(1995-2#1)(2006-8#1)(2012-11#1)(2013-1#1)
to these signals##2##3##(1995-12#1)(2008-9#1)
to these sources##2##3##(1992-6#1)(2007-2#1)
to these species##2##3##(2008-10#1)(2008-8#1)
to these stimuli##3##3##(1990-12#1)(1996-8#1)(2012-7#1)
to these studies##3##3##(2007-8#1)(2008-11#1)(2008-8#1)
to these surfaces##2##3##(1997-4#1)(2012-11#1)
to these symptoms##3##3##(1992-4#1)(2007-12#1)(2009-5#1)
to these tests##2##3##(2008-10#1)(2008-12#1)
to these three##2##3##(1996-5#1)(2008-10#1)
to these two parameters##2##4##(2007-10#1)(2008-3#1)
to these two##19##3##(1993-12#1)(1994-8#1)(1996-3#1)(1996-7#2)(2006-10#2)(2007-10#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)
to these types of##3##4##(2006-11#1)(2008-3#1)(2010-9#1)
to these variables##2##3##(2008-8#1)(2013-8#1)
to these##503##2##(1990-1#1)(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#3)(1990-5#1)(1990-6#3)(1990-7#2)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#3)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#3)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#3)(1993-4#5)(1993-6#3)(1993-8#1)(1993-9#2)(1994-12#5)(1994-2#1)(1994-3#6)(1994-4#1)(1994-5#3)(1994-6#1)(1994-8#4)(1994-9#3)(1995-1#4)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#7)(1995-3#2)(1995-6#2)(1995-7#2)(1995-8#2)(1995-9#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#4)(1996-7#3)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#4)(1997-5#3)(1997-7#1)(1997-8#4)(2004-12#1)(2004-9#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-5#1)(2005-8#1)(2006-10#11)(2006-11#3)(2006-12#5)(2006-2#3)(2006-6#1)(2006-7#1)(2006-8#5)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#7)(2007-12#6)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#4)(2007-7#7)(2007-8#4)(2007-9#2)(2008-1#5)(2008-10#36)(2008-11#13)(2008-12#5)(2008-2#12)(2008-3#12)(2008-4#20)(2008-5#10)(2008-6#3)(2008-7#6)(2008-8#15)(2008-9#9)(2009-1#2)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#7)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#4)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#3)(2010-7#3)(2010-8#4)(2010-9#4)(2011-1#7)(2011-2#11)(2011-3#1)(2012-1#3)(2012-11#2)(2012-12#7)(2012-2#2)(2012-3#5)(2012-7#1)(2013-1#12)(2013-7#1)(2013-8#8)
to theta##2##2##(1993-12#1)(2005-11#1)
to thiamin##3##2##(1990-2#1)(1995-10#1)(2010-4#1)
to thickening##2##2##(2012-1#2)
to thickness##2##2##(2006-10#1)(2008-2#1)
to thin media images##2##4##(2007-12#2)
to thin##6##2##(1995-2#1)(1997-6#1)(2007-12#4)
to think about the##3##4##(2008-4#1)(2009-5#1)(2009-8#1)
to think about their##2##4##(2008-6#1)(2013-8#1)
to think about##10##3##(2004-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-8#1)(2013-8#1)
to think of##2##3##(1991-1#1)(1996-11#1)
to think that##3##3##(2007-11#1)(2008-5#1)(2012-11#1)
to think##29##2##(1991-1#1)(1991-11#1)(1993-2#1)(1995-3#1)(1996-11#1)(1996-4#1)(2004-12#1)(2005-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-8#2)(2012-1#2)(2012-11#1)(2012-12#1)(2012-3#2)(2013-8#1)
to thinking##4##2##(1995-12#1)(1995-2#1)(2008-6#2)
to thinning##2##2##(2007-7#1)(2008-10#1)
to thiocyanate##2##2##(2008-10#2)
to thiol##3##2##(1997-8#1)(2008-5#2)
to thiophanate-methy1 and##3##3##(2008-10#3)
to thiophanate-methy1##4##2##(2008-10#4)
to thiophanate-methyl but##2##3##(2008-10#2)
to thiophanate-methyl##4##2##(2008-10#4)
to thioredoxin##5##2##(1990-12#1)(1991-2#2)(1991-7#1)(1993-4#1)
to third parties##4##3##(1991-1#1)(1992-1#1)(2013-1#2)
to third##9##2##(1991-1#1)(1992-1#1)(1993-4#1)(2007-7#1)(2008-10#2)(2012-2#1)(2013-1#2)
to third-order##2##2##(2007-12#1)(2008-3#1)
to thirteen##2##2##(2008-4#1)(2008-6#1)
to this accuracy##2##3##(2005-11#1)(2008-3#1)
to this agent##2##3##(2006-8#1)(2008-7#1)
to this analysis##3##3##(1990-11#1)(1991-7#1)(2007-12#1)
to this and other##2##4##(1995-1#1)(2008-11#1)
to this and##3##3##(1993-12#1)(1995-1#1)(2008-11#1)
to this approach is##3##4##(2008-10#1)(2008-4#1)(2008-7#1)
to this approach##6##3##(1994-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-9#1)
to this area of##2##4##(1990-12#1)(2006-10#1)
to this area##4##3##(1990-12#1)(1990-5#1)(1993-11#1)(2006-10#1)
to this axis##3##3##(2006-11#1)(2008-2#1)(2008-5#1)
to this case##2##3##(1991-3#1)(2012-12#1)
to this challenge##4##3##(1993-12#1)(1994-12#1)(2007-12#1)(2009-9#1)
to this class of##3##4##(2008-11#1)(2008-7#1)(2011-2#1)
to this class##4##3##(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#1)
to this classification##2##3##(1992-3#1)(1997-8#1)
to this client group##2##4##(1997-7#1)(2008-11#1)
to this combination##2##3##(1994-11#1)(2006-10#1)
to this common##2##3##(2005-8#1)(2010-11#1)
to this complex##2##3##(1992-5#1)(2006-2#1)
to this compound##3##3##(1991-3#1)(1991-8#1)(2008-10#1)
to this condition is##2##4##(2005-9#1)(2011-2#1)
to this condition##7##3##(1996-9#1)(2005-9#1)(2006-10#1)(2007-11#1)(2008-11#1)(2011-1#1)(2011-2#1)
to this decision##3##3##(1993-3#1)(1997-1#1)(2005-8#1)
to this disease##8##3##(1995-3#1)(2008-10#1)(2008-5#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-8#1)(2013-1#1)
to this domain##2##3##(1997-5#1)(2008-10#1)
to this drug##2##3##(1997-4#1)(2012-12#1)
to this effect##10##3##(1991-1#1)(1991-3#1)(1992-5#1)(1993-12#1)(1995-12#1)(2006-10#1)(2006-3#1)(2008-3#1)(2008-7#1)(2010-4#1)
to this end##3##3##(2008-1#1)(2008-10#1)(2013-8#1)
to this enzyme is##2##4##(1992-9#1)(1996-6#1)
to this enzyme##5##3##(1990-12#1)(1990-7#1)(1992-9#1)(1995-3#1)(1996-6#1)
to this experiment##2##3##(1992-1#1)(2008-12#1)
to this factor##2##3##(1994-6#1)(2008-4#1)
to this family##3##3##(1992-12#1)(1992-5#1)(2008-5#1)
to this field##3##3##(2006-10#1)(2008-1#1)(2009-12#1)
to this gathering##2##3##(1996-6#1)(2009-9#1)
to this group of##4##4##(1991-10#1)(1992-11#1)(1996-1#1)(2007-3#1)
to this group##7##3##(1991-10#1)(1992-11#1)(1995-6#1)(1996-1#1)(2007-3#1)(2008-12#1)(2008-6#1)
to this growth##2##3##(1990-7#1)(2006-2#1)
to this hypothesis##4##3##(1990-3#1)(2006-10#1)(2008-9#1)(2009-11#1)
to this increased##2##3##(1991-3#1)(2006-10#1)
to this inhibitor##2##3##(1994-10#1)(2010-2#1)
to this interpretation##2##3##(1990-7#1)(2009-10#1)
to this is the##3##4##(2008-11#1)(2008-2#1)(2011-2#1)
to this is##5##3##(1995-7#1)(2006-10#1)(2008-11#1)(2008-2#1)(2011-2#1)
to this issue##4##3##(2005-10#1)(2008-1#1)(2008-2#1)(2010-12#1)
to this kind of treatment##2##5##(2008-12#1)(2008-4#1)
to this kind of##4##4##(2007-7#2)(2008-12#1)(2008-4#1)
to this mechanism##3##3##(1992-9#1)(2005-11#1)(2009-3#1)
to this method##4##3##(2008-11#1)(2008-2#1)(2009-2#1)(2013-1#1)
to this model##8##3##(1991-8#1)(1995-2#1)(1997-1#1)(2005-11#1)(2006-4#1)(2007-9#1)(2008-3#1)(2008-5#1)
to this new##8##3##(1996-12#1)(2007-3#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
to this objective##2##3##(2006-10#1)(2008-5#1)
to this particular##2##3##(2006-10#1)(2011-2#1)
to this pathogen##4##3##(2007-7#1)(2008-10#2)(2010-12#1)
to this patient##2##3##(2010-12#1)(2010-8#1)
to this peptide##2##3##(1990-2#1)(1992-6#1)
to this phenomenon##5##3##(1995-11#1)(1995-6#1)(1997-7#1)(2008-8#1)(2012-2#1)
to this population##5##3##(2006-1#1)(2008-12#1)(2008-9#1)(2009-5#1)(2011-12#1)
to this possibility##2##3##(2007-5#1)(2012-2#1)
to this problem and##2##4##(2007-2#1)(2011-2#1)
to this problem by##2##4##(1994-3#1)(2006-10#1)
to this problem in##2##4##(1992-9#1)(2007-11#1)
to this problem is##5##4##(1991-5#1)(1996-12#1)(1996-9#1)(2008-7#1)(2010-11#1)
to this problem##27##3##(1990-11#1)(1991-5#1)(1992-9#1)(1994-3#1)(1994-9#1)(1996-12#1)(1996-9#1)(1997-3#1)(2004-4#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-11#1)(2011-2#2)(2012-2#1)(2013-1#1)
to this procedure##3##3##(1994-3#1)(2008-10#1)(2010-6#1)
to this process##6##3##(1991-10#1)(1994-6#1)(1995-1#1)(2011-2#2)(2012-12#1)
to this progress##2##3##(1990-11#1)(2008-3#1)
to this protein##6##3##(1992-11#1)(1992-8#1)(1993-12#1)(1994-6#1)(1996-4#1)(1997-6#1)
to this question##9##3##(1993-3#1)(1993-5#1)(1994-3#1)(2004-3#1)(2007-1#1)(2007-10#1)(2007-8#1)(2013-1#2)
to this rare##4##3##(1990-10#1)(2007-8#2)(2012-12#1)
to this reaction##2##3##(2007-11#1)(2008-5#1)
to this receptor##6##3##(1990-2#1)(1992-9#1)(1997-7#1)(1997-8#1)(2008-8#1)(2009-4#1)
to this region of##2##4##(1994-5#1)(2008-10#1)
to this region##10##3##(1991-12#1)(1991-7#1)(1994-5#1)(1994-6#1)(1995-10#1)(1996-3#1)(2008-10#2)(2008-11#1)(2011-2#1)
to this resource##2##3##(2008-7#1)(2013-1#1)
to this response##2##3##(1993-6#1)(2008-7#1)
to this review##4##3##(1990-1#1)(2006-10#1)(2008-5#1)(2011-1#1)
to this risk##2##3##(1992-9#1)(2009-10#1)
to this rule##3##3##(1992-1#1)(1996-5#1)(2007-8#1)
to this sequence##2##3##(1990-2#1)(1991-11#1)
to this series##3##3##(2006-10#2)(2010-9#1)
to this service##2##3##(1990-8#1)(2007-8#1)
to this setting##2##3##(2005-9#1)(2012-12#1)
to this site is##2##4##(1990-5#1)(1995-3#1)
to this site##3##3##(1990-5#2)(1995-3#1)
to this special##3##3##(1990-12#1)(1991-4#1)(2010-7#1)
to this species##3##3##(1991-9#1)(1992-12#1)(2007-3#1)
to this strategy##2##3##(2005-11#1)(2008-6#1)
to this stress##2##3##(2006-10#1)(2011-1#1)
to this study##10##3##(1991-12#1)(1994-12#1)(2004-11#1)(2005-9#1)(2007-5#1)(2007-7#1)(2008-12#1)(2009-10#1)(2010-8#1)(2011-2#1)
to this success##2##3##(2008-10#1)(2009-5#1)
to this system##5##3##(1990-9#1)(2008-10#1)(2008-6#1)(2008-8#1)(2012-3#1)
to this task##3##3##(2006-6#1)(2008-5#1)(2012-12#1)
to this technique##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
to this theory##2##3##(2008-10#1)(2008-6#1)
to this topic##3##3##(2008-12#1)(2009-8#1)(2013-7#1)
to this toxin##3##3##(1997-4#1)(2008-10#2)
to this treatment##4##3##(1991-12#1)(1997-5#1)(2006-12#1)(2008-10#1)
to this trend##2##3##(2011-2#1)(2012-2#1)
to this type of##10##4##(1990-4#1)(1996-3#1)(2006-2#1)(2006-3#1)(2008-10#2)(2008-8#1)(2009-3#1)(2009-6#1)(2010-5#1)
to this type##11##3##(1990-4#1)(1996-3#1)(2006-2#1)(2006-3#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-5#1)
to this variation##2##3##(1995-3#1)(2008-10#1)
to this view##3##3##(1991-6#1)(1995-2#1)(2008-5#1)
to this vital##2##3##(2006-8#1)(2012-1#1)
to this vulnerable##2##3##(2007-1#1)(2009-9#1)
to this work##3##3##(2007-4#1)(2007-5#1)(2013-1#1)
to this##696##2##(1990-1#1)(1990-10#1)(1990-11#5)(1990-12#5)(1990-2#3)(1990-3#4)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#6)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#8)(1991-4#2)(1991-5#3)(1991-6#3)(1991-7#3)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#3)(1992-4#1)(1992-5#4)(1992-6#2)(1992-8#1)(1992-9#5)(1993-11#2)(1993-12#5)(1993-2#1)(1993-3#5)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-10#3)(1994-11#3)(1994-12#3)(1994-2#3)(1994-3#6)(1994-5#3)(1994-6#6)(1994-8#2)(1994-9#3)(1995-1#4)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#7)(1995-6#5)(1995-7#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-12#4)(1996-2#3)(1996-3#3)(1996-4#3)(1996-5#3)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#3)(1997-2#2)(1997-3#3)(1997-4#6)(1997-5#3)(1997-6#3)(1997-7#5)(1997-8#3)(2004-11#1)(2004-12#2)(2004-2#1)(2004-3#1)(2004-4#2)(2004-7#1)(2005-10#2)(2005-11#6)(2005-7#2)(2005-8#3)(2005-9#3)(2006-1#2)(2006-10#29)(2006-11#5)(2006-12#3)(2006-2#4)(2006-3#3)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#4)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#11)(2007-12#10)(2007-2#4)(2007-3#4)(2007-4#2)(2007-5#3)(2007-6#1)(2007-7#9)(2007-8#9)(2007-9#2)(2008-1#5)(2008-10#47)(2008-11#16)(2008-12#10)(2008-2#17)(2008-3#17)(2008-4#8)(2008-5#16)(2008-6#6)(2008-7#13)(2008-8#15)(2008-9#11)(2009-10#3)(2009-11#3)(2009-12#3)(2009-2#5)(2009-3#4)(2009-4#6)(2009-5#6)(2009-6#1)(2009-8#2)(2009-9#5)(2010-11#5)(2010-12#8)(2010-2#3)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#5)(2010-9#2)(2011-1#11)(2011-10#1)(2011-12#2)(2011-2#19)(2012-1#4)(2012-12#9)(2012-2#7)(2012-3#6)(2013-1#13)(2013-7#4)(2013-8#4)
to thoracic disc##2##3##(2006-3#1)(2006-7#1)
to thoracic##8##2##(1992-8#1)(2006-2#1)(2006-3#1)(2006-7#2)(2007-1#1)(2012-3#2)
to thoroughly##3##2##(1993-11#1)(2010-12#1)(2011-2#1)
to those achieved by the##2##5##(1993-6#1)(2008-12#1)
to those achieved by##5##4##(1993-6#1)(1997-8#1)(2007-6#1)(2008-10#1)(2008-12#1)
to those achieved using##2##4##(1991-3#1)(2008-10#1)
to those achieved with##4##4##(2007-7#2)(2008-10#2)
to those achieved##14##3##(1991-3#1)(1993-6#1)(1997-8#1)(2007-6#1)(2007-7#4)(2008-10#4)(2008-12#1)(2008-8#1)
to those afforded by##2##4##(2008-10#1)(2013-8#1)
to those areas##2##3##(2005-7#1)(2005-9#1)
to those associated with the##2##5##(2005-12#1)(2008-2#1)
to those associated with##5##4##(1993-7#1)(2005-12#2)(2008-2#1)(2011-2#1)
to those at the##2##4##(1994-12#1)(2008-9#1)
to those at##8##3##(1992-11#1)(1994-12#1)(1995-9#1)(2006-8#1)(2008-11#1)(2008-9#1)(2009-3#1)(2012-12#1)
to those born in the##2##5##(1992-2#1)(2005-10#1)
to those by##2##3##(2005-3#1)(2008-10#1)
to those calculated##5##3##(2008-2#1)(2008-5#1)(2008-8#1)(2012-12#2)
to those caused by##7##4##(1990-11#1)(2006-10#1)(2008-10#2)(2008-3#1)(2008-5#1)(2012-2#1)
to those cells##2##3##(1996-5#1)(1996-9#1)
to those currently##2##3##(2006-4#1)(2008-10#1)
to those described for##3##4##(1994-11#1)(2008-4#2)
to those described in##6##4##(1997-1#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-6#1)(2011-2#1)
to those described##13##3##(1990-5#1)(1993-12#1)(1994-11#1)(1994-3#1)(1997-1#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-4#2)(2008-6#1)(2011-2#1)
to those determined using##2##4##(2008-10#2)
to those determined##5##3##(1994-8#1)(1996-2#1)(2008-10#3)
to those during##2##3##(1994-11#1)(2010-12#1)
to those elicited by##2##4##(1997-3#1)(2008-5#1)
to those employed##3##3##(1993-3#1)(2008-2#1)(2008-8#1)
to those estimated##3##3##(2008-10#2)(2011-1#1)
to those expected in##2##4##(1996-10#1)(2008-11#1)
to those expected##4##3##(1991-8#1)(1996-10#1)(2008-11#1)(2008-9#1)
to those exposed##2##3##(1995-5#1)(2011-2#1)
to those expressing the##2##4##(2006-11#1)(2008-10#1)
to those faced##2##3##(2007-4#1)(2008-7#1)
to those fed ration T1##2##5##(2007-8#2)
to those fed##4##3##(2006-12#1)(2007-8#2)(2008-7#1)
to those for the##6##4##(1991-8#1)(1995-6#1)(1997-6#1)(1997-8#1)(2006-3#1)(2008-10#1)
to those for##21##3##(1990-3#1)(1991-7#1)(1991-8#1)(1991-9#1)(1993-12#1)(1994-11#1)(1995-1#1)(1995-6#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-3#1)(2008-10#1)(2008-3#1)(2011-1#1)(2012-1#1)
to those found for##4##4##(1994-3#1)(1997-6#1)(2004-4#1)(2011-12#1)
to those found in the##6##5##(1991-9#1)(1993-12#1)(1994-9#1)(1996-10#1)(2008-4#1)(2008-7#1)
to those found in##25##4##(1990-2#1)(1991-5#1)(1991-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-9#2)(1995-8#1)(1996-10#1)(1996-2#1)(1997-5#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#1)
to those found on##2##4##(2008-10#2)
to those found using##2##4##(1996-3#1)(2010-9#1)
to those found##35##3##(1990-2#1)(1991-5#1)(1991-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-3#1)(1994-9#2)(1995-8#1)(1996-10#1)(1996-2#1)(1996-3#1)(1997-5#1)(1997-6#1)(2004-4#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#1)
to those from conventional##2##4##(2008-10#2)
to those from other##2##4##(1993-9#1)(1995-4#1)
to those from the##3##4##(1994-3#1)(2008-10#1)(2012-12#1)
to those from##22##3##(1993-12#1)(1993-5#1)(1993-9#1)(1994-3#1)(1995-4#1)(1997-5#1)(2007-12#1)(2007-3#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2009-5#1)(2010-6#1)(2012-12#2)(2012-2#1)(2012-3#1)
to those generally##2##3##(1994-7#1)(2008-5#1)
to those given##2##3##(2006-2#1)(2008-10#1)
to those grown in##2##4##(2008-10#2)
to those grown##3##3##(1993-6#1)(2008-10#2)
to those having##2##3##(1995-3#1)(2013-1#1)
to those identified##3##3##(1994-2#1)(2008-10#1)(2010-4#1)
to those in Group##3##4##(1992-11#1)(2011-1#1)(2011-2#1)
to those in mammals##3##4##(1992-1#1)(2008-7#1)(2009-5#1)
to those in other##2##4##(1990-5#1)(2008-10#1)
to those in plasma##3##4##(1994-11#1)(1995-7#2)
to those in the control##6##5##(1996-3#1)(2011-1#1)(2013-8#4)
to those in the##31##4##(1990-2#1)(1990-8#1)(1991-2#1)(1993-12#1)(1994-3#1)(1996-3#1)(1997-3#1)(2006-4#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-5#1)(2013-7#1)(2013-8#8)
to those in which##2##4##(1992-10#1)(1996-12#1)
to those in##90##3##(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#1)(1993-12#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-7#2)(1996-12#3)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-8#1)(2007-9#2)(2008-10#9)(2008-11#1)(2008-3#4)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#2)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#2)(2013-7#1)(2013-8#8)
to those induced by the##3##5##(1992-3#1)(2008-10#1)(2008-5#1)
to those induced by##11##4##(1990-7#1)(1991-6#1)(1992-3#1)(1996-12#1)(1997-6#1)(2008-10#3)(2008-12#1)(2008-5#1)(2011-2#1)
to those observed for##6##4##(1993-3#1)(1995-8#1)(2008-5#2)(2009-11#1)(2009-2#1)
to those observed in response to##2##6##(1994-12#1)(2008-10#1)
to those observed in the field##4##6##(2008-10#4)
to those observed in the##11##5##(1990-7#1)(1996-10#1)(1996-2#1)(1996-8#1)(1997-8#1)(2006-11#1)(2008-10#4)(2008-2#1)
to those observed in##37##4##(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-2#1)(1993-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-6#1)(1996-10#2)(1996-2#1)(1996-8#1)(1997-8#2)(2004-4#1)(2006-1#1)(2006-11#1)(2007-9#1)(2008-10#9)(2008-2#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-12#1)(2011-2#1)
to those observed with##5##4##(1992-12#1)(1992-3#1)(2005-7#1)(2008-10#1)(2012-3#1)
to those observed##57##3##(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-2#1)(1992-12#2)(1992-3#1)(1993-11#2)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-6#1)(1995-8#1)(1996-10#2)(1996-2#1)(1996-8#1)(1997-2#1)(1997-8#2)(2004-4#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-9#1)(2008-10#10)(2008-2#1)(2008-5#3)(2008-7#3)(2008-9#1)(2009-11#1)(2009-2#1)(2010-10#1)(2011-12#1)(2011-2#1)(2012-3#1)
to those obtained at##3##4##(2007-11#1)(2008-10#2)
to those obtained by a##2##5##(2008-5#2)
to those obtained by the##6##5##(2008-10#5)(2012-2#1)
to those obtained by using##3##5##(2008-10#2)(2010-4#1)
to those obtained by##21##4##(1994-12#1)(1996-7#1)(2008-10#15)(2008-5#2)(2010-4#1)(2012-2#1)
to those obtained for##4##4##(1993-8#1)(1995-5#1)(2007-11#1)(2008-10#1)
to those obtained from corresponding##2##5##(2005-11#1)(2009-8#1)
to those obtained from##7##4##(1992-12#1)(1995-10#1)(2005-11#1)(2006-9#1)(2008-10#1)(2009-8#1)(2013-1#1)
to those obtained in the##4##5##(1990-4#1)(2008-10#2)(2008-5#1)
to those obtained in##16##4##(1990-4#1)(1990-5#2)(1990-8#1)(1992-7#1)(1994-2#1)(1997-8#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#5)(2008-5#1)
to those obtained previously##3##4##(1992-3#1)(1993-11#1)(2006-12#1)
to those obtained using the##4##5##(1993-1#1)(2008-10#2)(2008-5#1)
to those obtained using##8##4##(1992-2#1)(1993-1#1)(2008-10#4)(2008-5#1)(2009-5#1)
to those obtained with conventional##2##5##(1996-8#1)(2008-10#1)
to those obtained with the##6##5##(1994-3#1)(2008-10#3)(2008-11#1)(2012-12#1)
to those obtained with##23##4##(1992-6#1)(1994-3#1)(1994-9#1)(1996-8#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-5#1)(2010-1#1)(2012-12#1)
to those obtained##89##3##(1990-4#1)(1990-5#2)(1990-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-5#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-9#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-11#4)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#40)(2008-11#1)(2008-5#5)(2009-11#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
to those occurring##2##3##(2006-7#1)(2008-10#1)
to those of a control##3##5##(1997-8#1)(2008-10#1)(2011-2#1)
to those of a##5##4##(1997-8#1)(2008-10#3)(2011-2#1)
to those of acute##2##4##(2008-7#1)(2009-8#1)
to those of an##5##4##(1993-1#1)(2006-6#1)(2007-1#1)(2008-10#2)
to those of blood##2##4##(1992-1#1)(2008-10#1)
to those of bovine##2##4##(1993-11#1)(1994-8#1)
to those of cells##2##4##(1997-1#1)(2008-5#1)
to those of control##4##4##(1993-1#1)(1994-8#1)(1995-1#1)(2008-4#1)
to those of conventional##5##4##(1992-10#1)(1992-3#1)(2007-12#1)(2007-8#1)(2008-10#1)
to those of human##7##4##(1991-10#1)(1992-6#1)(1993-5#1)(1994-12#1)(1994-8#1)(1997-5#1)(2007-4#1)
to those of natural##3##4##(1994-3#1)(2006-6#1)(2008-7#1)
to those of negative##2##4##(1997-8#1)(2007-12#1)
to those of normal##5##4##(1990-2#1)(1991-3#1)(1992-12#1)(1994-12#1)(1996-12#1)
to those of other fungal##2##5##(1997-2#2)
to those of other##15##4##(1991-2#1)(1991-8#1)(1994-5#1)(1996-1#1)(1997-1#1)(1997-2#2)(2006-6#1)(2007-2#1)(2008-10#3)(2008-5#1)(2009-4#1)(2013-1#1)
to those of previously##2##4##(1996-7#1)(2007-11#1)
to those of purified##2##4##(1991-3#1)(1995-8#1)
to those of similar##2##4##(1990-12#1)(1992-9#1)
to those of the CYP3A probe drug midazolam##2##8##(2011-2#2)
to those of the average##2##5##(1996-11#1)(2008-3#1)
to those of the classical##2##5##(1997-2#1)(2008-3#1)
to those of the control##4##5##(2008-9#1)(2012-2#1)(2013-8#2)
to those of the controls##4##5##(1992-9#1)(2006-1#1)(2008-8#1)(2012-12#1)
to those of the human##3##5##(1993-9#1)(1997-7#1)(2008-3#1)
to those of the native##5##5##(1992-3#1)(1994-8#1)(1995-10#1)(1995-12#1)(1997-2#1)
to those of the parental##3##5##(1991-1#1)(1991-12#1)(2013-1#1)
to those of the patients with##2##6##(1991-7#1)(2005-10#1)
to those of the patients##3##5##(1991-7#1)(2005-10#1)(2007-8#1)
to those of the primary##2##5##(1997-3#1)(2013-7#1)
to those of the respective##3##5##(1995-5#2)(2007-11#1)
to those of the wild-type enzyme##3##6##(1990-10#1)(1995-2#1)(1995-5#1)
to those of the wild-type protein##3##6##(1992-3#1)(1994-9#1)(1997-5#1)
to those of the wild-type##12##5##(1990-10#1)(1992-3#1)(1993-6#1)(1993-8#1)(1994-9#1)(1995-10#1)(1995-2#2)(1995-5#1)(1996-7#1)(1997-5#1)(2006-12#1)
to those of the##136##4##(1990-10#2)(1990-2#1)(1990-3#1)(1990-5#3)(1991-1#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#3)(1992-11#1)(1992-2#1)(1992-3#3)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#4)(1996-11#1)(1996-2#2)(1996-4#1)(1996-6#1)(1996-7#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(2005-10#1)(2005-11#2)(2005-9#1)(2006-1#1)(2006-10#1)(2006-11#4)(2006-12#2)(2006-5#1)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#12)(2009-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#4)
to those of two##3##4##(1997-4#1)(2008-4#1)(2013-1#1)
to those of wild-type##6##4##(1992-6#1)(1993-11#1)(1994-11#2)(1995-2#1)(2008-10#1)
to those of young##3##4##(1990-5#1)(1990-7#1)(1992-12#1)
to those of##415##3##(1990-1#1)(1990-10#2)(1990-12#3)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#4)(1990-7#4)(1990-8#1)(1990-9#1)(1991-1#3)(1991-10#2)(1991-12#2)(1991-2#3)(1991-3#3)(1991-4#2)(1991-5#5)(1991-6#1)(1991-7#4)(1991-8#3)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#5)(1992-12#4)(1992-2#3)(1992-3#6)(1992-4#1)(1992-6#3)(1992-7#3)(1992-8#4)(1992-9#2)(1993-1#2)(1993-11#3)(1993-12#1)(1993-2#3)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#4)(1994-10#1)(1994-11#3)(1994-12#4)(1994-2#2)(1994-3#4)(1994-5#3)(1994-6#1)(1994-7#1)(1994-8#5)(1994-9#2)(1995-1#3)(1995-10#2)(1995-11#2)(1995-12#2)(1995-2#5)(1995-3#2)(1995-5#7)(1995-6#2)(1995-8#3)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#3)(1996-8#1)(1997-1#5)(1997-2#5)(1997-3#2)(1997-4#4)(1997-5#2)(1997-6#2)(1997-7#4)(1997-8#3)(2004-4#1)(2005-10#1)(2005-11#4)(2005-4#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-11#5)(2006-12#5)(2006-3#1)(2006-5#1)(2006-6#3)(2007-1#1)(2007-10#2)(2007-11#11)(2007-12#11)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#35)(2008-11#2)(2008-12#3)(2008-2#5)(2008-3#12)(2008-4#6)(2008-5#8)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#16)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#2)(2010-12#1)(2010-2#2)(2010-4#7)(2010-5#1)(2011-1#5)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#6)
to those on##2##3##(1997-3#1)(2008-11#1)
to those patients##2##3##(2005-12#1)(2006-10#1)
to those predicted##3##3##(2005-11#1)(2008-8#1)(2013-1#1)
to those prepared##2##3##(2008-10#2)
to those present in##2##4##(1991-9#1)(1993-11#1)
to those present##3##3##(1991-9#1)(1993-11#1)(2012-11#1)
to those previously described##5##4##(1991-6#1)(1992-2#1)(1995-3#1)(2011-2#1)(2012-3#1)
to those previously observed in##2##5##(1991-7#1)(2012-2#1)
to those previously published##2##4##(2004-9#1)(2005-11#1)
to those previously reported for##3##5##(1990-2#1)(1991-4#1)(2007-1#1)
to those previously reported##6##4##(1990-2#1)(1991-4#1)(1996-4#1)(2007-1#1)(2008-10#2)
to those previously##21##3##(1990-2#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-2#1)(1995-3#1)(1995-6#1)(1996-4#1)(2004-9#1)(2005-11#1)(2006-12#1)(2007-1#1)(2007-4#1)(2008-10#3)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
to those produced by##5##4##(1990-10#2)(1997-7#1)(2008-11#1)(2008-4#1)
to those produced in##2##4##(1994-9#1)(2008-10#1)
to those produced##7##3##(1990-10#2)(1994-9#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#1)
to those provided by the##3##5##(2008-10#1)(2008-4#2)
to those recorded at##2##4##(1994-8#1)(2008-10#1)
to those regions##2##3##(1995-6#1)(2012-1#1)
to those registered##2##3##(2008-6#1)(2010-4#1)
to those reported for the##3##5##(1994-2#1)(1995-11#1)(2008-10#1)
to those reported for##10##4##(1990-2#1)(1990-3#1)(1991-6#1)(1994-2#1)(1995-11#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-6#1)
to those reported in other##2##5##(2007-12#1)(2007-3#1)
to those reported in the literature##2##6##(2007-12#1)(2008-10#1)
to those reported in##10##4##(1991-2#1)(1995-12#1)(1997-2#2)(2007-12#2)(2007-3#1)(2008-10#3)
to those reported previously for##2##5##(1996-2#1)(2008-5#1)
to those reported##30##3##(1990-2#1)(1990-3#1)(1991-2#1)(1991-6#1)(1992-10#1)(1993-4#1)(1994-2#1)(1995-10#1)(1995-11#1)(1995-12#1)(1996-2#1)(1997-2#2)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-10#1)(2010-6#1)(2013-1#1)
to those seen in the##3##5##(1996-12#1)(1997-2#1)(2012-3#1)
to those seen in##10##4##(1992-9#1)(1995-11#1)(1995-12#1)(1995-7#1)(1996-12#1)(1997-2#1)(2007-4#1)(2008-2#1)(2012-12#1)(2012-3#1)
to those seen with##5##4##(2006-10#1)(2007-11#1)(2008-5#1)(2011-2#1)(2012-3#1)
to those seen##19##3##(1991-6#1)(1992-9#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-7#1)(1996-12#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-2#1)(2008-5#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-3#2)
to those shown##2##3##(1995-3#1)(1997-4#1)
to those taken by##2##4##(2007-10#1)(2010-7#1)
to those that are##3##4##(1994-8#1)(2007-11#1)(2007-12#1)
to those that were##3##4##(1995-9#1)(2008-10#1)(2008-9#1)
to those that##15##3##(1991-11#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-9#1)(2006-9#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#1)(2008-9#1)(2009-5#1)(2012-2#1)
to those treated with##3##4##(1991-3#1)(1993-11#1)(2008-11#1)
to those treated##4##3##(1991-3#1)(1993-11#1)(2008-11#1)(2009-6#1)
to those under##2##3##(2006-10#1)(2012-12#1)
to those used in##6##4##(1993-2#1)(2007-12#1)(2008-6#1)(2008-7#1)(2009-4#1)(2011-2#1)
to those used##10##3##(1990-11#1)(1993-2#1)(1994-11#1)(2007-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-4#1)(2011-2#2)
to those using##2##3##(2010-4#1)(2010-6#1)
to those which are##2##4##(2005-7#1)(2013-8#1)
to those which##4##3##(1995-6#1)(2005-7#1)(2007-4#1)(2013-8#1)
to those who are##2##4##(1995-12#1)(2011-1#1)
to those who did not have##2##6##(1996-12#1)(2012-3#1)
to those who did not##3##5##(1991-8#1)(1996-12#1)(2012-3#1)
to those who had not##2##5##(2006-10#1)(2012-3#1)
to those who had##4##4##(1996-12#1)(2006-10#1)(2007-2#1)(2012-3#1)
to those who have##3##4##(1993-12#1)(2006-5#1)(2010-2#1)
to those who need##2##4##(1993-2#1)(1995-1#1)
to those who received##2##4##(2008-6#1)(2013-8#1)
to those who were##2##4##(1991-8#1)(1991-9#1)
to those who##28##3##(1991-5#1)(1991-8#2)(1991-9#1)(1993-12#1)(1993-2#1)(1994-1#1)(1995-1#1)(1995-12#1)(1996-12#2)(1997-4#1)(2006-10#1)(2006-5#1)(2007-2#2)(2007-4#1)(2007-7#1)(2008-10#1)(2008-6#2)(2009-10#1)(2010-2#1)(2011-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
to those whose##2##3##(1992-3#1)(2008-1#1)
to those with &lt##2##4##(2010-3#1)(2011-1#1)
to those with strong physician examiner systems##2##7##(1993-12#2)
to those with##31##3##(1990-9#1)(1991-5#1)(1992-8#1)(1993-12#2)(1995-10#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-3#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#3)(2009-2#1)(2009-7#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)
to those without##16##3##(1995-6#1)(2007-10#1)(2008-3#2)(2008-9#2)(2009-11#1)(2009-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
to those##1201##2##(1990-1#1)(1990-10#4)(1990-11#3)(1990-12#5)(1990-2#7)(1990-3#5)(1990-4#4)(1990-5#9)(1990-7#6)(1990-8#4)(1990-9#3)(1991-1#4)(1991-10#2)(1991-11#2)(1991-12#3)(1991-2#6)(1991-3#7)(1991-4#4)(1991-5#8)(1991-6#5)(1991-7#7)(1991-8#7)(1991-9#5)(1992-1#3)(1992-10#3)(1992-11#8)(1992-12#7)(1992-2#7)(1992-3#10)(1992-4#4)(1992-6#6)(1992-7#4)(1992-8#5)(1992-9#3)(1993-1#4)(1993-11#8)(1993-12#9)(1993-2#7)(1993-3#5)(1993-4#3)(1993-5#3)(1993-6#5)(1993-7#4)(1993-8#3)(1993-9#6)(1994-1#1)(1994-10#1)(1994-11#9)(1994-12#8)(1994-2#8)(1994-3#10)(1994-5#5)(1994-6#2)(1994-7#2)(1994-8#11)(1994-9#8)(1995-1#7)(1995-10#7)(1995-11#7)(1995-12#9)(1995-2#7)(1995-3#7)(1995-4#2)(1995-5#9)(1995-6#8)(1995-7#3)(1995-8#5)(1995-9#2)(1996-1#2)(1996-10#4)(1996-11#2)(1996-12#13)(1996-2#9)(1996-3#2)(1996-4#2)(1996-5#2)(1996-6#3)(1996-7#5)(1996-8#3)(1996-9#2)(1997-1#8)(1997-2#13)(1997-3#9)(1997-4#8)(1997-5#5)(1997-6#7)(1997-7#7)(1997-8#10)(2004-4#3)(2004-9#1)(2005-10#2)(2005-11#9)(2005-12#3)(2005-3#1)(2005-4#1)(2005-7#5)(2005-8#2)(2005-9#3)(2006-1#2)(2006-10#15)(2006-11#8)(2006-12#8)(2006-2#2)(2006-3#2)(2006-4#2)(2006-5#4)(2006-6#3)(2006-7#2)(2006-8#3)(2006-9#2)(2007-1#3)(2007-10#5)(2007-11#22)(2007-12#19)(2007-2#5)(2007-3#5)(2007-4#8)(2007-5#3)(2007-6#1)(2007-7#10)(2007-8#9)(2007-9#5)(2008-1#4)(2008-10#158)(2008-11#12)(2008-12#5)(2008-2#17)(2008-3#26)(2008-4#19)(2008-5#30)(2008-6#9)(2008-7#24)(2008-8#11)(2008-9#26)(2009-10#2)(2009-11#4)(2009-12#2)(2009-2#4)(2009-3#5)(2009-4#7)(2009-5#7)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#3)(2010-12#4)(2010-2#5)(2010-3#1)(2010-4#13)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#17)(2011-12#2)(2011-2#24)(2012-1#5)(2012-11#1)(2012-12#14)(2012-2#11)(2012-3#15)(2012-5#1)(2013-1#15)(2013-7#2)(2013-8#19)
to thousands of##6##3##(1991-2#1)(1996-12#1)(2007-8#1)(2008-10#1)(2008-4#2)
to threat##2##2##(2012-2#1)(2013-1#1)
to three basic##2##3##(1992-4#1)(2013-1#1)
to three consecutive##2##3##(2008-10#1)(2011-2#1)
to three copies of##2##4##(2008-10#1)(2009-7#1)
to three different##14##3##(1991-6#1)(1991-7#1)(1992-2#1)(1997-2#1)(2008-10#5)(2008-3#1)(2008-4#1)(2012-3#1)(2013-1#1)(2013-7#1)
to three dimensions##2##3##(2008-3#1)(2012-12#1)
to three distinct##5##3##(1994-12#1)(1994-6#1)(2008-10#1)(2010-10#1)(2011-1#1)
to three general##2##3##(1993-4#1)(2013-8#1)
to three groups of##3##4##(1993-1#1)(2008-10#1)(2009-5#1)
to three groups##7##3##(1993-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-3#1)(2009-5#1)(2011-2#1)
to three hours##2##3##(1993-12#1)(2008-11#1)
to three major##3##3##(1997-8#1)(2008-7#1)(2011-1#1)
to three months##7##3##(1991-12#1)(2006-10#1)(2006-7#2)(2011-1#1)(2012-2#1)(2013-1#1)
to three of the##2##4##(1997-8#1)(2008-11#1)
to three of##4##3##(1991-12#1)(1997-8#1)(2008-11#1)(2011-1#1)
to three or more##3##4##(1997-2#1)(2011-2#1)(2012-3#1)
to three other##3##3##(1990-9#1)(1995-8#1)(1996-11#1)
to three parameters##3##3##(1991-10#1)(2007-11#1)(2007-9#1)
to three patients##2##3##(1993-3#1)(2006-3#1)
to three regions of##2##4##(1994-12#1)(2011-2#1)
to three regions##4##3##(1994-12#1)(1996-3#1)(2008-9#1)(2011-2#1)
to three target##2##3##(1994-8#1)(2008-12#1)
to three times the standard deviation of the blank##6##9##(2008-10#6)
to three times the standard deviation of the##7##8##(2008-10#7)
to three times the standard deviation of##8##7##(2008-10#8)
to three times the##11##4##(1992-3#1)(2006-9#1)(2008-1#1)(2008-10#8)
to three times##28##3##(1992-3#1)(1995-6#1)(1996-3#1)(2006-10#1)(2006-9#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-2#3)(2008-5#1)(2008-6#1)(2010-5#1)(2011-11#1)(2011-2#2)(2012-2#1)
to three weeks##4##3##(1991-3#1)(1995-2#1)(2007-12#1)(2007-7#1)
to three years##9##3##(1990-12#1)(1992-1#1)(1993-10#1)(2006-10#2)(2006-8#1)(2007-7#1)(2008-1#1)(2011-1#1)
to three##219##2##(1990-12#1)(1990-2#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#2)(1995-4#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-7#1)(1997-8#2)(2004-11#1)(2005-7#1)(2006-10#4)(2006-11#1)(2006-3#1)(2006-4#2)(2006-6#2)(2006-7#3)(2006-8#4)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#42)(2008-11#3)(2008-12#6)(2008-2#5)(2008-3#4)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#5)(2011-11#1)(2011-12#1)(2011-2#8)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#5)(2013-7#4)(2013-8#2)
to three-##2##2##(1997-3#1)(2007-12#1)
to three-dimensional##10##2##(1992-9#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-3#4)(2008-7#1)(2009-3#1)
to three-fold##5##2##(1996-3#1)(1996-4#1)(1997-8#2)(2007-8#1)
to three-way##2##2##(2008-10#1)(2011-1#1)
to threefold higher##3##3##(2006-12#2)(2008-5#1)
to threefold##7##2##(1992-11#2)(2006-12#2)(2008-10#1)(2008-5#1)(2010-4#1)
to threonine##2##2##(1993-3#1)(1994-9#1)
to threshold##2##2##(1992-9#1)(2008-2#1)
to thrips feeding##2##3##(2009-8#2)
to thrips##4##2##(2006-12#1)(2008-10#1)(2009-8#2)
to thrive and##4##3##(2007-2#1)(2007-3#1)(2008-1#1)(2012-3#1)
to thrive under##2##3##(2012-12#1)(2012-2#1)
to thrive was##2##3##(2007-2#1)(2009-8#1)
to thrive##19##2##(1992-3#1)(1993-1#1)(1994-3#1)(2007-2#2)(2007-3#2)(2007-7#1)(2008-1#1)(2008-4#1)(2008-9#1)(2009-8#1)(2010-5#1)(2010-6#2)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
to thrombi##2##2##(2008-10#1)(2008-5#1)
to thrombin##11##2##(1990-5#1)(1991-6#2)(1993-3#2)(1994-3#1)(1996-8#2)(1997-1#1)(2007-10#1)(2013-8#1)
to thromboembolic complications##2##3##(2012-1#1)(2013-1#1)
to thromboembolic##4##2##(2009-8#1)(2012-1#1)(2013-1#2)
to thrombolysis##5##2##(1990-12#1)(2007-11#3)(2007-9#1)
to thrombolytic therapy##3##3##(2007-10#1)(2007-11#2)
to thrombosis and##4##3##(1997-8#1)(2007-7#1)(2009-11#1)(2011-3#1)
to thrombosis##10##2##(1993-5#2)(1997-8#1)(2004-10#1)(2007-7#3)(2008-7#1)(2009-11#1)(2011-3#1)
to thrombotic##6##2##(1991-7#1)(2006-4#1)(2008-1#1)(2008-10#1)(2009-7#1)(2010-4#1)
to thromboxane##2##2##(1990-12#1)(1995-3#1)
to thrombus formation##2##3##(1995-3#1)(2012-2#1)
to throw light on##2##4##(2008-1#1)(2010-3#1)
to throw##5##2##(2006-10#1)(2008-1#1)(2008-11#1)(2010-3#1)(2013-8#1)
to thylakoid##2##2##(1992-6#1)(1994-12#1)
to thymine and##2##3##(1993-3#1)(2007-8#1)
to thymine##5##2##(1992-1#1)(1992-8#1)(1993-3#1)(2007-8#1)(2012-2#1)
to thyroid hormone analogues##2##4##(1992-11#1)(1992-4#1)
to thyroid hormone##10##3##(1991-9#1)(1992-11#1)(1992-4#1)(1995-10#2)(1995-8#3)(2006-9#1)(2009-5#1)
to thyroid##18##2##(1991-3#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-4#1)(1994-11#1)(1995-10#2)(1995-8#3)(2006-6#1)(2006-9#1)(2007-1#1)(2008-1#1)(2009-5#1)(2010-11#1)(2011-2#1)
to thyrotropin##6##2##(1990-9#2)(1992-2#1)(1994-11#1)(1994-6#1)(2006-1#1)
to thyrotropin-releasing hormone (TRH)##2##4##(1996-11#1)(2008-4#1)
to thyrotropin-releasing hormone##3##3##(1994-2#1)(1996-11#1)(2008-4#1)
to tibial##2##2##(2008-6#1)(2009-3#1)
to ticks##2##2##(1991-11#1)(2008-8#1)
to tie##4##2##(1995-1#1)(1996-2#1)(2007-9#1)(2012-12#1)
to tight##5##2##(1997-3#1)(2006-6#1)(2009-11#1)(2011-2#1)(2013-8#1)
to tightly##2##2##(1995-1#1)(2009-8#1)
to tilt##5##2##(2008-2#2)(2008-3#2)(2013-7#1)
to time and##3##3##(1992-11#1)(2008-10#1)(2008-3#1)
to time of##5##3##(1994-11#1)(2006-11#1)(2008-10#1)(2008-2#1)(2008-7#1)
to time to##3##3##(1997-8#1)(2007-8#1)(2008-2#1)
to time##35##2##(1992-11#1)(1994-11#1)(1997-7#1)(1997-8#1)(2004-1#1)(2006-10#1)(2006-11#1)(2006-8#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#3)(2011-7#1)(2012-1#1)(2012-2#1)(2013-8#2)
to time-consuming##4##2##(1994-12#1)(2007-12#1)(2008-10#2)
to time-domain##3##2##(2007-12#1)(2008-1#1)(2011-7#1)
to time-resolved##2##2##(2007-12#1)(2008-7#1)
to time-varying##2##2##(2008-2#1)(2008-3#1)
to timing##3##2##(2007-12#2)(2009-3#1)
to tissue culture##2##3##(1992-2#1)(2004-9#1)
to tissue destruction##2##3##(2012-3#1)(2013-7#1)
to tissue diagnosis##2##3##(2008-3#1)(2010-7#1)
to tissue engineering##2##3##(2008-11#2)
to tissue mass##3##3##(2008-4#1)(2013-1#2)
to tissue##37##2##(1990-11#1)(1991-10#1)(1992-2#1)(1993-4#1)(1994-5#2)(1994-9#1)(1995-2#1)(1995-7#1)(1995-8#1)(1996-7#1)(2004-9#1)(2005-10#1)(2006-10#2)(2007-8#1)(2008-1#1)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
to tissue-specific##3##2##(1996-10#1)(2006-6#1)(2008-4#1)
to tissues and##2##3##(1994-3#1)(2010-10#1)
to tissues##8##2##(1994-3#1)(2005-7#1)(2006-7#1)(2006-8#1)(2010-10#1)(2010-9#1)(2012-2#1)(2013-1#1)
to titanium##2##2##(2005-12#1)(2013-1#1)
to titrate##4##2##(1991-4#1)(2005-10#1)(2008-10#1)(2009-11#1)
to to##3##2##(1993-6#1)(1995-2#1)(2012-2#1)
to tobacco and##4##3##(1994-11#1)(1996-1#1)(1997-1#1)(2009-6#1)
to tobacco smoke##8##3##(1991-12#2)(1991-4#1)(1994-2#2)(2008-11#1)(2009-11#1)(2013-1#1)
to tobacco use##4##3##(1997-1#2)(2008-6#1)(2010-9#1)
to tobacco##33##2##(1990-8#1)(1991-11#1)(1991-12#3)(1991-4#1)(1991-5#2)(1992-2#1)(1992-6#2)(1993-6#1)(1994-11#1)(1994-2#2)(1996-1#1)(1997-1#3)(2007-2#1)(2008-10#5)(2008-11#1)(2008-6#1)(2009-11#1)(2009-6#1)(2010-9#1)(2013-1#3)
to tobamoviruses##2##2##(1997-6#1)(2008-10#1)
to today##5##2##(2006-8#2)(2009-6#1)(2012-11#2)
to today's##8##2##(1991-3#1)(1994-8#1)(2006-6#1)(2007-5#1)(2007-9#1)(2009-3#1)(2009-4#1)(2012-12#1)
to toe##2##2##(2006-11#1)(2010-10#1)
to tolerance##7##2##(1995-12#1)(1995-3#1)(2006-10#1)(2007-11#1)(2008-4#1)(2008-5#1)(2009-10#1)
to tolerate a##3##3##(1993-2#1)(2008-11#2)
to tolerate salt##2##3##(2009-6#2)
to tolerate##24##2##(1993-2#1)(1995-8#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#3)(2009-6#3)(2009-8#1)(2010-2#1)(2011-1#1)(2013-1#1)
to toluene##6##2##(2005-12#1)(2008-10#1)(2008-7#1)(2011-2#3)
to tomato and##4##3##(1997-1#1)(2008-10#3)
to tomato plants##4##3##(2008-10#4)
to tomato spotted wilt virus##2##5##(2008-10#2)
to tomato##23##2##(1997-1#1)(2006-12#1)(2008-10#16)(2008-8#4)(2013-8#1)
to tone##4##2##(1996-9#2)(2008-8#1)(2008-9#1)
to tongue##3##2##(2006-2#1)(2007-3#1)(2012-12#1)
to tooth brushing##2##3##(2012-11#1)(2012-12#1)
to tooth##5##2##(1995-11#1)(2008-6#1)(2012-11#1)(2012-12#1)(2013-1#1)
to topical agents##2##3##(2007-8#1)(2008-5#1)
to topical application of##2##4##(2007-8#1)(2013-1#1)
to topical application##4##3##(2007-8#1)(2008-12#2)(2013-1#1)
to topical drug delivery##2##4##(2012-2#2)
to topical treatment##2##3##(2005-11#1)(2011-2#1)
to topical use##2##3##(1997-5#1)(2008-5#1)
to topical##24##2##(1997-5#2)(2005-11#1)(2005-7#2)(2006-10#1)(2007-7#2)(2007-8#2)(2008-12#2)(2008-5#2)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)
to torsional##3##2##(1991-4#1)(1991-7#1)(2008-7#1)
to torture##2##2##(2008-7#1)(2013-1#1)
to total and##2##3##(1991-10#1)(1992-3#1)
to total body##3##3##(1993-12#1)(2006-8#1)(2010-12#1)
to total cavopulmonary connection##2##4##(2007-8#2)
to total cholesterol##3##3##(1996-4#1)(2008-8#1)(2012-2#1)
to total glutathione##2##3##(1995-12#1)(1996-8#1)
to total hip##3##3##(1995-4#1)(2007-11#1)(2013-1#1)
to total nitrogen##2##3##(2008-10#1)(2013-8#1)
to total phosphorus##2##3##(2013-8#2)
to total quality management##2##4##(1994-2#1)(1994-3#1)
to total##77##2##(1990-3#1)(1990-4#2)(1990-8#1)(1991-10#2)(1991-11#1)(1991-5#1)(1991-6#1)(1992-3#1)(1993-10#1)(1993-12#2)(1993-6#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-4#2)(1996-2#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-1#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-8#3)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-4#1)(2013-7#1)(2013-8#6)
to totally##2##2##(1990-4#1)(1993-9#1)
to touch##3##2##(1990-10#1)(1996-2#1)(2008-11#1)
to toughness##2##2##(2010-2#2)
to town##2##2##(2007-12#1)(2009-10#1)
to toxic accumulation of##2##4##(1992-11#1)(2007-12#1)
to toxic agents##2##3##(1991-9#1)(1995-4#1)
to toxic chemicals##2##3##(1997-3#1)(2006-7#1)
to toxic##17##2##(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1995-4#1)(1997-3#2)(2005-8#1)(2006-12#1)(2006-7#1)(2007-12#1)(2008-10#1)(2010-4#1)(2010-9#1)(2011-1#1)(2012-2#1)
to toxicant exposure##2##3##(2008-10#1)(2012-12#1)
to toxicants##4##2##(2008-9#1)(2012-12#2)(2012-2#1)
to toxicity and##3##3##(1997-2#1)(2007-11#2)
to toxicity##9##2##(1994-8#1)(1997-2#1)(2007-11#2)(2008-5#2)(2011-1#1)(2012-12#1)(2013-1#1)
to toxin##4##2##(1991-8#1)(1994-5#1)(2008-10#1)(2008-7#1)
to toxins##2##2##(2008-9#1)(2013-8#1)
to trace the##5##3##(1997-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2012-2#1)
to trace##17##2##(1990-12#1)(1994-6#1)(1997-3#1)(2006-10#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
to track a moving target##3##5##(2008-11#3)
to track a##4##3##(2008-11#3)(2008-4#1)
to track changes in##2##4##(2008-6#1)(2011-1#1)
to track the##21##3##(1994-3#1)(1996-5#1)(2004-4#1)(2005-11#1)(2006-6#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-3#3)(2008-8#1)(2009-11#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#1)
to track##47##2##(1992-6#1)(1994-3#1)(1995-12#1)(1996-5#1)(1997-2#1)(2004-4#1)(2005-11#1)(2006-6#1)(2007-11#2)(2007-12#3)(2008-10#4)(2008-11#4)(2008-2#3)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-11#1)(2010-3#1)(2011-1#4)(2011-12#1)(2011-2#3)(2012-2#3)
to tracking##4##2##(1995-12#1)(2010-6#1)(2013-1#2)
to traction##2##2##(1992-1#1)(2005-10#1)
to trade off between##2##4##(2007-12#1)(2008-2#1)
to trade off##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
to trade##8##2##(2007-12#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-5#1)(2011-2#1)
to trade-offs##2##2##(2008-8#1)(2009-6#1)
to traditional health##2##3##(1992-1#1)(1996-12#1)
to traditional masculine norms##2##4##(2009-5#2)
to traditional methods of##2##4##(1990-9#1)(2011-2#1)
to traditional methods##5##3##(1990-9#1)(2006-8#1)(2008-10#1)(2009-9#1)(2011-2#1)
to traditional nonsteroidal##2##3##(2006-10#2)
to traditional surgery##2##3##(1990-4#1)(2013-8#1)
to traditional##81##2##(1990-10#1)(1990-4#1)(1990-5#1)(1990-9#1)(1992-1#2)(1992-2#1)(1992-5#1)(1993-12#1)(1993-8#1)(1994-9#1)(1996-12#1)(1996-8#1)(2004-3#2)(2005-12#1)(2005-8#1)(2006-10#4)(2006-5#1)(2006-6#1)(2006-8#3)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#3)
to traffic accidents##2##3##(2012-11#1)(2013-8#1)
to traffic into##2##3##(2008-1#1)(2008-9#1)
to traffic##8##2##(2008-1#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-2#1)(2010-11#1)(2012-11#1)(2013-8#1)
to train a##2##3##(1994-8#1)(2007-5#1)
to train and##2##3##(2007-12#1)(2012-3#1)
to train nurses##2##3##(1995-2#1)(2012-12#1)
to train physicians##2##3##(1997-3#1)(2012-2#1)
to train the##4##3##(1993-3#1)(2008-10#1)(2008-3#1)(2012-1#1)
to train##41##2##(1992-12#1)(1993-3#1)(1993-7#1)(1994-6#1)(1994-8#1)(1995-2#2)(1996-1#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#2)(2007-6#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-8#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-1#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)
to training##17##2##(1991-1#1)(1996-3#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2011-2#3)(2012-1#2)(2012-2#1)
to traits such as##2##4##(2008-8#1)(2010-12#1)
to trans-2##2##2##(1994-8#2)
to trans-replicate##2##2##(2008-10#2)
to transactivate the human##2##4##(1997-7#2)
to transactivate##3##2##(1997-7#3)
to transactivation##2##2##(1992-7#1)(2008-10#1)
to transcend##2##2##(2007-9#1)(2009-10#1)
to transcranial##2##2##(2006-11#1)(2011-2#1)
to transcribe##2##2##(1992-1#1)(1993-3#1)
to transcript##2##2##(1995-1#1)(2008-9#1)
to transcription factors##3##3##(1997-2#1)(2008-10#1)(2010-11#1)
to transcription##12##2##(1994-9#1)(1995-1#1)(1995-3#3)(1995-6#1)(1997-2#2)(2007-12#1)(2008-10#1)(2010-11#1)(2011-2#1)
to transcriptional activation##2##3##(1992-12#1)(2013-1#1)
to transcriptional changes in##2##4##(1996-12#1)(2008-10#1)
to transcriptional##9##2##(1990-7#1)(1992-12#1)(1993-3#1)(1996-10#1)(1996-12#1)(2006-10#1)(2008-10#1)(2008-4#1)(2013-1#1)
to transduce signals from##2##4##(2007-12#1)(2009-8#1)
to transduce signals##3##3##(2007-12#1)(2009-8#1)(2012-2#1)
to transduce##12##2##(1992-12#1)(1994-5#1)(1995-1#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-8#1)(2009-8#1)(2012-2#1)
to transducin##2##2##(1990-2#2)
to transfect##8##2##(1990-8#1)(1993-8#1)(2008-11#2)(2008-4#2)(2010-9#1)(2013-1#1)
to transfer a##5##3##(1993-1#1)(1993-2#1)(2006-5#1)(2010-7#1)(2011-1#1)
to transfer energy##2##3##(1990-7#1)(2007-12#1)
to transfer from the BPP calibration set to the RPP calibration set##2##12##(2007-12#2)
to transfer genes into cells from##2##6##(1990-5#2)
to transfer genes to##3##4##(1994-11#1)(1994-5#1)(2008-10#1)
to transfer genes##5##3##(1990-5#2)(1994-11#1)(1994-5#1)(2008-10#1)
to transfer the##8##3##(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#1)
to transfer to##2##3##(2006-4#1)(2009-10#1)
to transfer##52##2##(1990-5#3)(1990-7#1)(1990-9#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-5#1)(1996-5#4)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-5#2)(2006-6#1)(2007-11#1)(2007-12#4)(2007-6#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
to transferrin and##2##3##(1995-6#1)(2008-5#1)
to transferrin##7##2##(1993-11#1)(1995-6#1)(1996-8#1)(2008-10#2)(2008-5#2)
to transform Escherichia coli##2##4##(1990-5#1)(2008-4#1)
to transform cells##2##3##(1995-2#1)(1997-4#1)
to transform into##2##3##(1997-8#1)(2008-5#1)
to transform the##14##3##(1992-12#1)(1995-3#1)(2005-11#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2009-3#1)(2009-4#1)(2011-1#1)(2012-2#1)
to transform##48##2##(1990-1#1)(1990-5#2)(1991-10#1)(1991-7#1)(1992-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-3#1)(1996-7#1)(1997-4#2)(1997-7#1)(1997-8#1)(2005-11#2)(2005-12#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#5)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
to transformation by##3##3##(1993-11#1)(2008-10#1)(2008-6#1)
to transformation##10##2##(1993-11#1)(1994-12#1)(2006-10#1)(2008-10#1)(2008-6#1)(2010-3#1)(2012-11#2)(2012-12#1)(2013-8#1)
to transforming growth factor##2##4##(1995-2#1)(2011-1#1)
to transforming growth factor-beta##4##4##(1992-2#1)(1992-3#2)(1996-5#1)
to transforming growth##6##3##(1992-2#1)(1992-3#2)(1995-2#1)(1996-5#1)(2011-1#1)
to transforming##7##2##(1992-2#1)(1992-3#2)(1995-2#1)(1996-5#1)(2007-9#1)(2011-1#1)
to transfuse##2##2##(2006-10#1)(2010-11#1)
to transgenic plants##3##3##(1995-6#1)(2008-11#1)(2013-8#1)
to transient changes##2##3##(2008-7#1)(2009-6#1)
to transient##16##2##(1992-10#1)(1992-7#2)(1992-8#1)(1993-2#1)(1994-5#1)(1995-3#1)(1997-4#1)(2006-10#1)(2008-7#1)(2009-3#1)(2009-6#1)(2011-1#1)(2012-2#2)(2013-7#1)
to transiently and selectably transform##2##5##(1997-4#2)
to transiently express##2##3##(1995-2#1)(2010-5#1)
to transiently##7##2##(1990-6#1)(1995-2#2)(1997-4#2)(2010-3#1)(2010-5#1)
to transistor mismatch##2##3##(2008-2#1)(2009-5#1)
to transition to##2##3##(2007-11#1)(2008-5#1)
to transition##6##2##(1995-3#1)(2007-11#1)(2008-5#1)(2010-12#2)(2011-2#1)
to transitional##2##2##(2010-7#1)(2012-2#1)
to translate and##3##3##(2006-10#1)(2007-12#1)(2010-1#1)
to translate into a##2##4##(2009-5#1)(2009-9#1)
to translate into##4##3##(2006-10#1)(2009-5#1)(2009-9#1)(2010-2#1)
to translate the##3##3##(2006-7#1)(2010-12#1)(2011-1#1)
to translate##23##2##(1993-2#1)(1997-2#1)(2006-10#2)(2006-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#2)(2008-9#1)(2009-3#2)(2009-5#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-3#1)
to translation##3##2##(1990-7#1)(2008-4#1)(2011-1#1)
to translational##4##2##(2008-1#1)(2008-8#1)(2011-1#1)(2012-12#1)
to translocate a##2##3##(1991-9#1)(2008-11#1)
to translocate to the##2##4##(1994-5#1)(2006-10#1)
to translocate##11##2##(1991-9#1)(1992-3#1)(1994-3#1)(1994-5#1)(1995-7#1)(2006-10#1)(2007-12#2)(2008-11#1)(2009-10#1)(2010-6#1)
to transmembrane##3##2##(1994-3#1)(1994-9#1)(2011-1#1)
to transmission##4##2##(2007-6#1)(2008-4#1)(2009-7#1)(2012-2#1)
to transmit TSWV##3##3##(2008-10#3)
to transmit Tomato##2##3##(2008-10#2)
to transmit a##3##3##(1990-9#1)(2008-3#2)
to transmit and##4##3##(2007-12#1)(2007-9#1)(2008-1#1)(2009-5#1)
to transmit both##2##3##(2008-10#2)
to transmit the virus##2##4##(2008-10#2)
to transmit the##7##3##(1991-8#1)(2008-10#4)(2008-3#1)(2008-8#1)
to transmit virus##2##3##(2008-10#2)
to transmit##54##2##(1990-5#1)(1990-9#1)(1991-8#1)(1993-3#1)(1995-4#1)(2004-11#1)(2005-7#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-9#1)(2008-1#1)(2008-10#21)(2008-11#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-8#1)(2009-5#1)(2012-12#1)(2013-1#1)
to transmitter release##2##3##(1990-2#1)(1997-8#1)
to transmitter##3##2##(1990-2#1)(1997-6#1)(1997-8#1)
to transplant##10##2##(1995-12#1)(2006-10#1)(2007-5#1)(2008-11#1)(2009-10#1)(2010-6#1)(2011-2#1)(2013-1#2)(2013-8#1)
to transplantation and##2##3##(2007-11#1)(2011-2#1)
to transplantation##17##2##(1995-12#2)(1995-2#1)(1995-7#1)(2006-10#2)(2007-11#2)(2007-8#1)(2008-1#1)(2008-11#1)(2010-6#1)(2011-2#4)(2012-1#1)
to transport and##2##3##(1993-3#1)(1996-9#1)
to transport##27##2##(1990-2#1)(1991-10#1)(1992-7#1)(1993-3#1)(1995-11#1)(1996-1#1)(1996-9#1)(1997-6#2)(2005-11#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#2)(2012-2#2)(2013-1#2)
to transport)##2##2##(1995-11#1)(2008-10#1)
to transportation##3##2##(2011-2#1)(2013-1#2)
to transposon##2##2##(2008-10#1)(2010-5#1)
to transradial##2##2##(2011-2#1)(2012-1#1)
to transthyretin##2##2##(1992-4#2)
to transurethral resection##2##3##(1991-9#1)(2008-1#1)
to transversal and##2##3##(2008-2#1)(2008-9#1)
to transverse##2##2##(1990-5#1)(2008-1#1)
to trap and##2##3##(2005-11#1)(2007-11#1)
to trap the##4##3##(1995-2#1)(1997-1#1)(2007-8#1)(2010-12#1)
to trap##15##2##(1993-6#1)(1995-2#1)(1995-3#1)(1997-1#1)(2005-11#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-2#2)(2010-12#1)(2011-2#1)
to trapping##2##2##(2007-12#1)(2009-12#1)
to trastuzumab and##2##3##(2012-3#1)(2013-1#1)
to trastuzumab##7##2##(2008-5#1)(2012-3#3)(2013-1#3)
to trauma and##3##3##(2005-10#1)(2009-3#1)(2011-2#1)
to trauma is##2##3##(1992-4#1)(2012-3#1)
to trauma or surgery##2##4##(1991-2#1)(2008-7#1)
to trauma or##5##3##(1991-2#1)(2008-5#1)(2008-7#2)(2009-3#1)
to trauma##26##2##(1991-10#1)(1991-2#1)(1992-3#1)(1992-4#1)(2005-10#1)(2006-10#2)(2006-8#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-3#2)(2010-12#1)(2011-12#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)
to traumatic##10##2##(2007-7#1)(2007-8#1)(2008-4#1)(2008-6#1)(2009-3#3)(2009-7#1)(2011-1#1)(2012-3#1)
to travel are##2##3##(2006-10#1)(2007-2#1)
to travel clinics##2##3##(2007-2#2)
to travel##14##2##(1992-11#1)(1992-12#1)(1996-1#1)(2006-10#1)(2007-2#6)(2007-7#1)(2008-2#1)(2008-8#1)(2008-9#1)
to travellers##6##2##(2007-2#6)
to travelling##2##2##(1992-2#1)(2009-7#1)
to traverse the##2##3##(1990-5#1)(2008-10#1)
to traverse##3##2##(1990-5#1)(2006-12#1)(2008-10#1)
to treat FM##2##3##(2009-7#1)(2010-6#1)
to treat HIV-positive patients##4##4##(1996-11#2)(2006-8#1)(2007-1#1)
to treat HIV-positive##5##3##(1996-11#3)(2006-8#1)(2007-1#1)
to treat PD##2##3##(2008-11#1)(2008-7#1)
to treat RA##2##3##(2006-10#1)(2010-8#1)
to treat a variety of##3##5##(1992-1#1)(2006-6#1)(2006-9#1)
to treat a wide variety of##2##6##(2006-8#1)(2010-2#1)
to treat a wide##4##4##(2006-8#1)(2008-10#1)(2008-8#1)(2010-2#1)
to treat a##18##3##(1992-1#1)(1993-1#1)(1993-2#2)(2006-6#1)(2006-8#3)(2006-9#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-8#2)(2010-2#1)(2011-2#1)(2013-1#1)
to treat acute renal failure##2##5##(2007-8#2)
to treat acute##9##3##(1997-8#1)(2007-11#2)(2007-8#2)(2007-9#2)(2008-11#1)(2013-8#1)
to treat an##2##3##(2008-3#1)(2008-6#1)
to treat and prevent##3##4##(2006-10#1)(2007-11#1)(2009-3#1)
to treat and##10##3##(2006-10#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2008-7#1)(2009-3#1)(2010-8#1)(2011-2#1)
to treat angina##2##3##(2009-2#1)(2010-12#1)
to treat anxiety disorders##2##4##(2008-7#1)(2013-8#1)
to treat bacterial infections##3##4##(2008-4#1)(2011-1#1)(2012-2#1)
to treat bacterial##4##3##(1993-2#1)(2008-4#1)(2011-1#1)(2012-2#1)
to treat bipolar disorder##2##4##(2008-8#2)
to treat but##2##3##(1993-5#1)(2012-2#1)
to treat cancer patients##2##4##(2005-10#1)(2011-2#1)
to treat cancer##8##3##(1994-5#1)(2005-10#1)(2008-1#2)(2008-9#1)(2010-2#1)(2011-2#1)(2013-1#1)
to treat cardiac##2##3##(1990-3#1)(2008-9#1)
to treat chronic lung##2##4##(2007-11#1)(2008-9#1)
to treat chronic##11##3##(2005-7#1)(2006-12#2)(2006-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-9#1)(2012-12#1)(2012-3#1)
to treat diabetes mellitus##2##4##(2009-3#1)(2011-2#1)
to treat diabetes##5##3##(2007-11#1)(2008-1#1)(2009-3#2)(2011-2#1)
to treat disease##2##3##(2008-5#1)(2013-8#1)
to treat diseases##3##3##(1994-8#1)(2006-8#1)(2009-8#1)
to treat disorders of##3##4##(2006-4#1)(2006-7#1)(2013-1#1)
to treat disorders##4##3##(2006-4#1)(2006-7#1)(2008-1#1)(2013-1#1)
to treat gastric varices##2##4##(2013-1#2)
to treat gastric##3##3##(2005-12#1)(2013-1#2)
to treat genital##2##3##(1991-6#1)(2007-11#1)
to treat human##3##3##(2006-6#1)(2010-4#1)(2012-2#1)
to treat hypertension and##2##4##(2005-10#1)(2008-5#1)
to treat hypertension##10##3##(1996-6#1)(1996-9#1)(2005-10#2)(2007-7#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-12#1)(2010-4#1)
to treat in##2##3##(2008-5#1)(2010-6#1)
to treat infants##2##3##(1997-1#1)(2006-7#1)
to treat inflammatory diseases##3##4##(2008-10#1)(2008-11#1)(2012-1#1)
to treat inflammatory disorders##2##4##(2007-8#1)(2008-3#1)
to treat inflammatory##6##3##(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#1)(2012-1#1)
to treat it##3##3##(1992-5#1)(2007-9#1)(2008-1#1)
to treat many##4##3##(1996-6#1)(2007-10#1)(2007-6#1)(2010-12#1)
to treat most##2##3##(1997-6#1)(2010-3#1)
to treat neck##2##3##(2009-5#2)
to treat obesity##2##3##(2008-1#1)(2011-2#1)
to treat or not to treat##2##6##(1995-5#1)(2008-8#1)
to treat or not to treat?##2##6##(2008-8#1)(2012-12#1)
to treat or not to##4##5##(1995-5#1)(2008-8#2)(2012-12#1)
to treat or prevent##2##4##(2007-12#1)(2008-1#1)
to treat or##8##3##(1995-5#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-8#2)(2012-12#1)
to treat orthopoxvirus##2##3##(2009-9#2)
to treat other##2##3##(2005-10#1)(2009-4#1)
to treat pain##3##3##(2006-10#1)(2007-2#1)(2008-7#1)
to treat painful##3##3##(2006-8#2)(2010-3#1)
to treat patients in##2##4##(1994-11#1)(2012-2#1)
to treat patients suffering from##3##5##(2006-8#1)(2008-3#1)(2009-6#1)
to treat patients with acute##2##5##(2007-9#1)(2012-12#1)
to treat patients with type 2 diabetes##2##7##(2008-1#1)(2008-3#1)
to treat patients with##17##4##(2005-9#1)(2006-2#1)(2006-3#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-5#1)(2009-8#1)(2012-12#2)(2013-1#1)
to treat patients##25##3##(1994-1#1)(1994-11#1)(1997-1#1)(2005-9#1)(2006-2#1)(2006-3#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-3#2)(2008-5#1)(2009-6#1)(2009-8#1)(2012-12#2)(2012-2#1)(2013-1#1)
to treat people with HIV##2##5##(1995-6#2)
to treat people with##4##4##(1995-6#2)(1996-1#1)(1996-11#1)
to treat prostate cancer##3##4##(2007-5#1)(2008-1#1)(2008-7#1)
to treat retinal degenerative disease##3##5##(2012-12#3)
to treat rheumatoid arthritis##2##4##(1992-10#1)(2007-11#1)
to treat schizophrenia##4##3##(2005-8#1)(2007-7#1)(2008-4#1)(2012-2#1)
to treat severe##2##3##(2006-10#1)(2012-2#1)
to treat some##2##3##(2008-4#1)(2011-1#1)
to treat spasticity##2##3##(2006-4#1)(2007-7#1)
to treat stress##2##3##(2006-9#1)(2008-10#1)
to treat such##2##3##(2008-3#1)(2010-3#1)
to treat the disease##3##4##(2007-10#1)(2007-11#1)(2010-5#1)
to treat the pain##2##4##(2008-8#1)(2010-1#1)
to treat the problem##2##4##(1997-6#1)(2007-11#1)
to treat the##46##3##(1993-12#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-6#2)(2004-1#1)(2006-10#1)(2006-12#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#3)(2012-2#1)(2013-1#2)
to treat them##5##3##(1993-10#1)(2011-7#1)(2013-1#2)(2013-7#1)
to treat these disorders##3##4##(2007-8#1)(2008-8#1)(2010-5#1)
to treat these patients##2##4##(1991-11#1)(2012-2#1)
to treat these##12##3##(1991-11#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-7#1)(2008-8#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2012-2#1)
to treat this condition##2##4##(2006-10#1)(2013-8#1)
to treat this type of##3##5##(2005-8#1)(2008-1#1)(2012-12#1)
to treat this##14##3##(2005-8#1)(2006-10#2)(2007-11#1)(2008-1#2)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
to treat thoracic##2##3##(2006-7#1)(2006-8#1)
to treat tuberculosis##2##3##(2009-4#1)(2012-3#1)
to treat type##2##3##(1994-4#1)(2007-8#1)
to treat upper##2##3##(2008-2#1)(2012-1#1)
to treat various##5##3##(2008-10#1)(2008-7#1)(2009-8#1)(2010-5#1)(2010-7#1)
to treat when##2##3##(2006-9#1)(2012-12#1)
to treat with##6##3##(1997-4#1)(2006-10#1)(2007-11#1)(2007-8#1)(2011-1#1)(2013-1#1)
to treat##596##2##(1990-12#1)(1990-3#4)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#3)(1992-2#1)(1992-5#4)(1992-8#1)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#4)(1993-5#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-4#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-4#1)(1995-5#3)(1995-6#3)(1995-8#1)(1995-9#2)(1996-1#1)(1996-11#5)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#4)(1997-8#1)(2004-1#1)(2004-3#1)(2004-9#1)(2005-10#7)(2005-11#4)(2005-12#1)(2005-5#1)(2005-6#2)(2005-7#3)(2005-8#5)(2005-9#1)(2006-1#1)(2006-10#18)(2006-12#14)(2006-2#4)(2006-3#2)(2006-4#2)(2006-5#1)(2006-6#5)(2006-7#8)(2006-8#17)(2006-9#7)(2007-1#2)(2007-10#5)(2007-11#27)(2007-12#8)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#10)(2007-8#20)(2007-9#6)(2008-1#18)(2008-10#14)(2008-11#8)(2008-12#5)(2008-2#4)(2008-3#9)(2008-4#8)(2008-5#19)(2008-6#7)(2008-7#17)(2008-8#19)(2008-9#5)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#7)(2009-4#3)(2009-5#4)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#4)(2010-1#1)(2010-11#1)(2010-12#10)(2010-2#6)(2010-3#5)(2010-4#2)(2010-5#3)(2010-6#4)(2010-7#2)(2010-8#5)(2011-1#8)(2011-2#24)(2011-3#1)(2011-7#1)(2012-1#5)(2012-11#2)(2012-12#21)(2012-2#13)(2012-3#7)(2013-1#23)(2013-7#2)(2013-8#9)
to treat?]##2##2##(2006-8#1)(2013-8#1)
to treated##4##2##(2006-10#1)(2008-10#1)(2008-4#2)
to treating##12##2##(1997-1#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-8#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-7#1)(2010-8#1)
to treatment allocation##2##3##(2007-11#1)(2008-10#1)
to treatment and the##2##4##(2008-9#1)(2011-2#1)
to treatment and##21##3##(1991-3#1)(1996-12#1)(1997-3#1)(2004-11#1)(2006-10#1)(2006-12#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-2#1)(2010-12#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
to treatment are also##2##4##(2007-11#1)(2008-6#1)
to treatment are##4##3##(1996-8#1)(2007-11#1)(2008-6#1)(2013-8#1)
to treatment by##5##3##(1993-3#1)(2005-7#1)(2008-10#1)(2008-3#1)(2010-12#1)
to treatment can##3##3##(2006-1#1)(2006-8#1)(2008-5#1)
to treatment failure##6##3##(2006-6#2)(2006-8#1)(2008-5#1)(2009-7#1)(2013-8#1)
to treatment for##8##3##(1997-2#1)(2007-10#1)(2008-10#2)(2008-7#1)(2012-11#1)(2012-2#1)(2013-7#1)
to treatment has##2##3##(2006-10#1)(2007-12#1)
to treatment have been investigated##2##5##(2007-10#1)(2013-1#1)
to treatment in##9##3##(1993-2#1)(2007-2#1)(2007-3#2)(2007-8#1)(2008-3#1)(2009-4#1)(2012-12#1)(2012-2#1)
to treatment is a##2##4##(2009-5#1)(2012-2#1)
to treatment is##9##3##(1991-6#1)(1997-2#1)(2006-1#1)(2008-1#1)(2008-3#1)(2008-5#1)(2009-5#1)(2011-12#1)(2012-2#1)
to treatment may##2##3##(2004-7#1)(2012-3#1)
to treatment of the##2##4##(1990-11#1)(1994-5#1)
to treatment of##17##3##(1990-11#1)(1993-8#1)(1994-5#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-3#1)(2010-3#1)(2011-7#1)(2012-1#1)(2013-8#1)
to treatment or##2##3##(2007-11#1)(2012-2#1)
to treatment outcomes##2##3##(2009-8#1)(2010-10#1)
to treatment regimens##2##3##(2008-7#1)(2012-1#1)
to treatment was##12##3##(1991-8#1)(1996-6#1)(1996-9#1)(2007-7#2)(2008-6#3)(2008-7#1)(2009-8#1)(2013-1#2)
to treatment which can##2##4##(2005-7#1)(2008-1#1)
to treatment which##3##3##(2005-11#1)(2005-7#1)(2008-1#1)
to treatment with antibiotic##2##4##(2008-7#1)(2008-9#1)
to treatment with antibiotics##2##4##(2007-8#1)(2012-2#1)
to treatment with corticosteroids##2##4##(2006-10#2)
to treatment with drugs##2##4##(1994-6#1)(1994-9#1)
to treatment with either##3##4##(1992-8#1)(1995-5#1)(2010-12#1)
to treatment with the##5##4##(2006-11#1)(2007-11#1)(2008-10#1)(2008-8#1)(2011-2#1)
to treatment with##61##3##(1990-2#1)(1990-3#1)(1990-9#1)(1992-1#2)(1992-2#1)(1992-6#2)(1992-8#2)(1993-3#2)(1994-6#2)(1994-9#1)(1995-1#1)(1995-5#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#1)(2004-11#1)(2005-7#1)(2006-10#4)(2006-11#1)(2007-1#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#3)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
to treatment##321##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#1)(1990-9#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#3)(1992-8#2)(1993-1#1)(1993-2#1)(1993-3#3)(1993-5#1)(1993-8#2)(1994-4#1)(1994-5#1)(1994-6#3)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#2)(1996-12#3)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#5)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#1)(2004-11#3)(2004-3#1)(2004-7#1)(2005-11#1)(2005-7#3)(2005-8#1)(2005-9#1)(2006-1#3)(2006-10#12)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#3)(2006-7#2)(2006-8#3)(2007-1#2)(2007-10#2)(2007-11#11)(2007-12#2)(2007-2#5)(2007-3#2)(2007-4#2)(2007-5#1)(2007-7#10)(2007-8#7)(2007-9#1)(2008-1#5)(2008-10#11)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#9)(2008-4#4)(2008-5#4)(2008-6#7)(2008-7#9)(2008-8#4)(2008-9#3)(2009-10#1)(2009-2#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#7)(2010-3#3)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#16)(2011-3#1)(2011-7#1)(2012-1#4)(2012-11#2)(2012-12#9)(2012-2#10)(2012-3#3)(2013-1#12)(2013-7#4)(2013-8#9)
to treatment)##2##2##(1990-12#1)(2007-8#1)
to treatments##8##2##(1993-9#1)(2004-4#1)(2008-10#1)(2008-7#2)(2008-8#1)(2010-2#1)(2010-6#1)
to tree##2##2##(2008-5#2)
to trees##6##2##(2007-2#1)(2008-10#4)(2010-4#1)
to tremolite##2##2##(1991-12#2)
to tremor##2##2##(1993-9#1)(2008-11#1)
to trends in##2##3##(1995-1#1)(2008-4#1)
to triage patients##3##3##(2006-10#1)(2008-7#1)(2009-10#1)
to triage##6##2##(2006-10#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-8#1)
to trial##7##2##(1995-12#1)(1995-6#1)(1996-12#1)(2005-8#1)(2007-7#1)(2008-11#1)(2012-1#1)
to trials##3##2##(2008-5#1)(2012-3#2)
to trifluoperizine##2##2##(1995-11#2)
to trigeminal anesthesia##2##3##(2007-3#2)
to trigeminal##3##2##(2006-8#1)(2007-3#2)
to trigger a##3##3##(1991-4#1)(2008-10#1)(2009-9#1)
to trigger an##2##3##(1992-1#1)(2006-7#1)
to trigger and##2##3##(1994-8#1)(2007-11#1)
to trigger or##2##3##(1992-8#1)(2006-10#1)
to trigger the##5##3##(1991-10#1)(1993-3#1)(1997-4#1)(2008-10#1)(2013-8#1)
to trigger##33##2##(1991-10#1)(1991-4#1)(1992-1#1)(1992-8#1)(1993-3#1)(1994-2#1)(1994-8#1)(1994-9#1)(1996-10#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-9#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
to triggering of the##2##4##(2008-8#2)
to triggering##3##2##(2008-8#2)(2009-8#1)
to trim##7##2##(1992-8#1)(1993-5#1)(1993-6#1)(2007-12#1)(2010-12#3)
to trimers##2##2##(1991-10#1)(2007-11#1)
to trimethoprim-sulfamethoxazole##2##2##(2009-2#1)(2013-8#1)
to triple##4##2##(1996-8#1)(2007-11#1)(2008-9#1)(2011-1#1)
to tritiated##2##2##(1994-5#1)(2008-11#1)
to trivalent##2##2##(1997-7#1)(2008-10#1)
to trochanteric##2##2##(2006-10#1)(2008-7#1)
to trolox##2##2##(2008-10#2)
to tropical##5##2##(2007-3#1)(2007-7#1)(2008-5#1)(2010-12#1)(2012-2#1)
to troponin C##8##3##(1991-2#1)(1995-6#1)(1997-2#5)(2010-5#1)
to true biological##2##3##(2008-10#1)(2010-7#1)
to true##7##2##(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-7#1)
to truly##2##2##(1995-12#1)(2009-6#1)
to truncate the##2##3##(1993-2#1)(2008-3#1)
to truncated##4##2##(1993-11#1)(1994-12#1)(1996-8#1)(1997-2#1)
to trust##3##2##(2007-2#1)(2013-1#1)(2013-8#1)
to try and##4##3##(2006-10#1)(2008-1#1)(2008-3#1)(2010-12#1)
to try to find##2##4##(2006-10#1)(2009-4#1)
to try to##17##3##(1993-7#1)(1994-8#1)(1997-5#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-1#1)(2009-4#1)(2009-6#1)(2010-5#1)(2011-2#2)(2013-1#1)
to try##24##2##(1992-1#1)(1993-7#1)(1994-8#1)(1996-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2006-10#2)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-9#1)(2009-1#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-2#2)(2013-1#1)
to trypsin and##3##3##(1990-11#1)(1994-2#1)(2005-8#1)
to trypsin##10##2##(1990-11#1)(1990-3#2)(1991-12#1)(1991-8#1)(1992-3#1)(1993-3#1)(1994-2#1)(1996-2#1)(2005-8#1)
to trypsinolysis##2##2##(1991-3#2)
to tryptic cleavage##2##3##(1990-3#2)
to tryptic digestion##3##3##(1993-8#1)(1995-1#1)(2009-4#1)
to tryptic##6##2##(1990-3#2)(1993-8#1)(1995-1#1)(1995-6#1)(2009-4#1)
to tryptophan##2##2##(1993-11#1)(2012-1#1)
to tuberculin##4##2##(1990-6#2)(2006-6#1)(2010-4#1)
to tuberculosis and##2##3##(2008-7#1)(2010-12#1)
to tuberculosis##16##2##(1991-11#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-12#1)(2008-7#1)(2009-7#1)(2010-12#2)(2011-1#3)(2012-2#2)(2013-1#2)
to tubing##2##2##(1991-3#1)(2013-8#1)
to tubulin and##2##3##(1990-10#1)(1997-4#1)
to tubulin was##2##3##(1990-10#1)(1997-4#1)
to tubulin##10##2##(1990-10#4)(1992-9#1)(1994-9#1)(1997-4#3)(2008-6#1)
to tumor antigens##3##3##(1991-12#1)(2008-5#2)
to tumor cells##8##3##(1990-5#1)(1993-11#1)(1995-6#1)(1997-2#2)(2006-10#1)(2008-9#2)
to tumor formation##2##3##(2008-10#1)(2013-1#1)
to tumor growth in##2##4##(1991-9#1)(2008-7#1)
to tumor growth##4##3##(1991-9#1)(1993-11#1)(2008-7#1)(2011-2#1)
to tumor necrosis factor alpha##2##5##(1990-10#1)(1996-5#1)
to tumor necrosis factor##3##4##(1990-10#1)(1995-3#1)(1996-5#1)
to tumor necrosis factor-alpha (TNF-alpha)##2##5##(2006-10#1)(2009-9#1)
to tumor necrosis factor-alpha##4##4##(2006-10#1)(2009-9#2)(2010-7#1)
to tumor necrosis##7##3##(1990-10#1)(1995-3#1)(1996-5#1)(2006-10#1)(2009-9#2)(2010-7#1)
to tumor progression##2##3##(1991-7#1)(2006-12#1)
to tumor promoters##2##3##(1991-7#1)(1992-5#1)
to tumor sites##3##3##(2011-1#1)(2012-11#2)
to tumor tissue##3##3##(1993-11#1)(1997-7#1)(2009-4#1)
to tumor##72##2##(1990-10#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-7#2)(1991-9#1)(1992-5#1)(1993-11#3)(1994-3#1)(1994-9#2)(1995-1#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-5#1)(1997-2#2)(1997-7#4)(2005-10#1)(2005-5#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-4#2)(2009-9#3)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-11#2)(2013-1#4)(2013-8#3)
to tumor-bearing mice##2##3##(2008-11#1)(2012-11#1)
to tumoral##2##2##(2005-11#1)(2007-9#1)
to tumorigenesis##5##2##(1994-12#1)(2008-6#1)(2011-2#2)(2012-12#1)
to tumors of##2##3##(2006-8#1)(2011-1#1)
to tumors##21##2##(1993-10#1)(1993-11#2)(1994-8#1)(1995-2#1)(1995-5#1)(1996-4#1)(2005-7#1)(2006-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-10#1)(2011-1#3)(2011-2#1)(2012-12#1)(2013-8#2)
to tumour formation##2##3##(2009-4#1)(2012-12#1)
to tumour growth##2##3##(1991-5#1)(2007-11#1)
to tumour##12##2##(1990-10#1)(1991-5#1)(1997-4#1)(2007-11#1)(2007-5#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#2)(2012-12#1)(2013-1#1)
to tumours##3##2##(1994-9#1)(2004-2#1)(2007-11#1)
to tune the##12##3##(1992-3#1)(2005-10#1)(2006-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2010-2#1)(2013-7#1)
to tune##17##2##(1992-3#1)(2005-10#1)(2006-11#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2010-2#2)(2012-12#1)(2013-7#1)
to tungsten##2##2##(1992-8#1)(1994-6#1)
to tunneling##4##2##(1992-12#1)(1993-3#1)(1993-8#1)(2008-2#1)
to turbulent##2##2##(2008-3#1)(2013-1#1)
to turn off##2##3##(2006-10#1)(2007-12#1)
to turn our##2##3##(2006-12#1)(2007-6#1)
to turn over##2##3##(1993-6#1)(2008-8#1)
to turn the##3##3##(2007-9#1)(2009-7#1)(2012-1#1)
to turn##20##2##(1992-6#1)(1993-6#1)(1994-3#3)(1995-5#1)(1996-8#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-8#2)(2009-7#1)(2011-1#1)(2012-1#1)
to twelve##9##2##(1990-12#1)(1990-8#1)(1994-8#1)(1996-11#1)(2006-12#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-1#1)
to twenty##2##2##(2007-1#1)(2008-4#1)
to twice the##7##3##(1990-10#1)(1994-2#1)(1996-12#1)(2008-2#2)(2008-3#1)(2008-7#1)
to twice##12##2##(1990-10#1)(1992-2#1)(1994-2#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-7#1)(2010-9#1)
to twins##2##2##(1997-7#1)(2011-2#1)
to two cases##2##3##(1996-2#1)(2008-10#1)
to two community##2##3##(2008-12#1)(2008-2#1)
to two consecutive##3##3##(2008-12#2)(2010-4#1)
to two decades##3##3##(2005-8#1)(2008-10#1)(2012-2#1)
to two different##19##3##(1992-1#1)(1992-9#1)(1993-2#1)(1996-5#1)(2004-1#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2011-2#1)
to two distinct##5##3##(1991-10#1)(1993-3#1)(1994-8#2)(2008-10#1)
to two groups of##3##4##(2006-2#1)(2008-11#1)(2012-2#1)
to two groups##11##3##(2004-11#1)(2006-2#1)(2007-9#2)(2008-10#1)(2008-11#2)(2008-5#1)(2012-2#2)(2013-8#1)
to two highly##2##3##(1993-11#1)(2010-8#1)
to two major##4##3##(1990-5#1)(1995-5#1)(1997-1#1)(2008-10#1)
to two methods for##2##4##(2008-10#2)
to two months##2##3##(1995-11#1)(2009-3#1)
to two or more##4##4##(1994-3#1)(2006-3#1)(2008-10#1)(2008-4#1)
to two or three##2##4##(1990-10#1)(2005-7#1)
to two or##6##3##(1990-10#1)(1994-3#1)(2005-7#1)(2006-3#1)(2008-10#1)(2008-4#1)
to two other##5##3##(2006-4#1)(2008-2#1)(2008-4#1)(2010-10#1)(2011-2#1)
to two possible##2##3##(1992-4#1)(2008-10#1)
to two sets of##2##4##(2008-10#1)(2008-3#1)
to two sites##2##3##(1995-1#1)(2008-8#1)
to two types##2##3##(1991-9#1)(1996-4#1)
to two very different##2##4##(1992-7#1)(2008-7#1)
to two years##9##3##(1992-11#1)(1996-11#1)(1997-5#2)(2005-9#1)(2006-10#1)(2007-1#1)(2008-11#1)(2010-8#1)
to two##252##2##(1990-10#2)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-1#2)(1991-10#1)(1991-11#3)(1991-3#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#4)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-7#2)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#3)(1997-6#2)(1997-7#2)(1997-9#1)(2004-1#1)(2004-11#2)(2005-11#1)(2005-4#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#1)(2006-8#3)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#9)(2007-3#1)(2007-7#4)(2007-9#6)(2008-10#44)(2008-11#6)(2008-12#4)(2008-2#5)(2008-3#16)(2008-4#6)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
to two-dimensional##14##2##(1993-11#1)(2006-10#1)(2007-11#3)(2007-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-9#1)
to two-way##2##2##(1993-6#1)(2008-12#1)
to tylosin##3##2##(2008-5#3)
to type 1##8##3##(1990-12#1)(1993-6#1)(1997-2#1)(2006-10#1)(2007-5#2)(2008-1#1)(2008-2#1)
to type 2 diabetes##5##4##(2008-1#1)(2008-3#2)(2011-1#1)(2012-2#1)
to type 2##6##3##(1994-4#1)(2008-1#1)(2008-3#2)(2011-1#1)(2012-2#1)
to type I##6##3##(2005-3#1)(2007-7#1)(2007-9#1)(2008-11#2)(2010-5#1)
to type II##3##3##(1991-9#1)(1993-9#1)(2006-2#1)
to type of##7##3##(1991-3#1)(2006-11#1)(2008-10#1)(2009-7#1)(2010-6#1)(2011-2#1)(2012-1#1)
to type##46##2##(1990-12#1)(1990-8#1)(1991-3#1)(1991-8#1)(1991-9#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-4#1)(1995-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(2005-3#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-5#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2009-7#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#1)
to types of##3##3##(1993-12#1)(2007-6#1)(2008-2#1)
to typhoid##2##2##(2007-2#2)
to typical##6##2##(1993-3#1)(1994-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2012-2#1)
to typically developing adolescents##2##4##(2012-2#2)
to typically developing##4##3##(2010-9#1)(2012-2#2)(2013-7#1)
to typically##5##2##(2007-1#1)(2010-9#1)(2012-2#2)(2013-7#1)
to tyrosine hydroxylase##3##3##(1994-5#1)(1995-11#1)(1997-6#1)
to tyrosine kinase##2##3##(2010-4#1)(2013-1#1)
to tyrosine phosphorylation of##2##4##(1996-8#1)(1997-7#1)
to tyrosine phosphorylation##3##3##(1994-12#1)(1996-8#1)(1997-7#1)
to tyrosine##14##2##(1990-5#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-3#1)(1996-8#1)(1996-9#1)(1997-6#1)(1997-7#1)(2005-8#1)(2008-1#1)(2008-3#1)(2010-4#1)(2013-1#1)
to tyrosine-phosphorylated##2##2##(1995-3#1)(2012-12#1)
to u-100##2##2##(1990-5#2)
to ubiquinone##4##2##(1990-8#2)(1996-7#1)(2011-1#1)
to ubiquitin##4##2##(1991-1#1)(1993-8#1)(2007-8#1)(2009-7#1)
to ultimate carcinogens##2##3##(1991-5#1)(1992-3#1)
to ultimate##3##2##(1991-5#1)(1992-3#2)
to ultimately##5##2##(1997-6#1)(2004-12#1)(2006-10#1)(2008-7#1)(2010-8#1)
to ultrafast##3##2##(2007-12#1)(2008-3#1)(2012-8#1)
to ultrashort##2##2##(2007-12#2)
to ultrasound disruption##2##3##(2008-6#2)
to ultrasound guidance##2##3##(2007-7#1)(2010-12#1)
to ultrasound##14##2##(1991-8#1)(1993-8#1)(2007-7#2)(2008-3#1)(2008-6#2)(2008-8#1)(2009-5#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
to ultraviolet (UV) radiation##2##4##(2005-11#1)(2008-10#1)
to ultraviolet B (UVB) radiation##2##5##(1996-6#1)(2011-2#1)
to ultraviolet irradiation##2##3##(1993-3#1)(2010-8#1)
to ultraviolet light##6##3##(1990-5#1)(1997-1#1)(1997-4#1)(2007-11#1)(2011-2#1)(2013-8#1)
to ultraviolet radiation##6##3##(1990-5#1)(2007-11#3)(2007-8#1)(2011-2#1)
to ultraviolet##21##2##(1990-5#2)(1990-9#1)(1993-3#1)(1996-6#1)(1997-1#1)(1997-4#1)(2005-11#1)(2007-11#4)(2007-8#1)(2008-10#2)(2010-7#1)(2010-8#1)(2011-2#3)(2013-8#1)
to un-substituted control aptamer##2##4##(2009-3#2)
to unacceptable##2##2##(1990-2#1)(2013-1#1)
to unambiguously##3##2##(2008-10#1)(2010-12#1)(2013-8#1)
to unanticipated##2##2##(1996-2#1)(2011-1#1)
to unavoidable##2##2##(2007-12#1)(2008-5#1)
to unbalanced##4##2##(1994-8#1)(2008-11#1)(2008-3#1)(2010-11#1)
to unbound##2##2##(1993-6#1)(1996-11#1)
to uncertainties in the##2##4##(2008-3#2)
to uncertainty##2##2##(1992-12#1)(1992-9#1)
to uncontrolled##4##2##(1994-11#1)(1996-4#1)(1996-7#1)(2009-3#1)
to uncouple##3##2##(1990-7#1)(1991-7#1)(2009-8#1)
to uncover behaviors and benefits from voluntary use##2##8##(2013-1#2)
to uncover the##12##3##(2006-7#1)(2006-9#1)(2007-8#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2011-12#1)(2012-12#1)(2013-1#1)
to uncover##25##2##(2006-7#1)(2006-9#1)(2007-8#1)(2008-4#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-12#2)(2011-12#1)(2011-9#1)(2012-11#1)(2012-12#2)(2013-1#5)
to under##5##2##(1994-9#1)(2007-12#1)(2008-10#2)(2008-5#1)
to underestimate##5##2##(1991-3#1)(1992-6#1)(2005-10#1)(2006-9#1)(2008-6#1)
to undergo HIV-antibody testing##2##4##(1996-5#2)
to undergo a##13##3##(1992-12#1)(1992-7#1)(1993-8#1)(1996-12#1)(2006-5#1)(2006-6#2)(2007-12#2)(2007-8#1)(2008-10#1)(2008-7#1)(2012-1#1)
to undergo an##4##3##(1992-9#1)(1997-3#1)(2007-12#1)(2010-4#1)
to undergo apoptosis in##3##4##(1995-2#1)(1997-2#1)(2008-10#1)
to undergo apoptosis##9##3##(1994-5#1)(1995-2#3)(1997-2#1)(2008-10#1)(2008-9#1)(2009-8#1)(2010-6#1)
to undergo cardiac##2##3##(1995-12#1)(2010-2#1)
to undergo further##2##3##(2006-4#1)(2006-7#1)
to undergo medical##2##3##(1990-6#1)(2008-2#1)
to undergo rapid##3##3##(1996-5#1)(2009-9#1)(2010-5#1)
to undergo spontaneous##2##3##(1993-3#1)(2008-8#1)
to undergo surgery##3##3##(2006-12#1)(2013-1#2)
to undergo surgical##2##3##(2008-8#1)(2009-4#1)
to undergo terminal maturation##2##4##(1994-8#2)
to undergo the##5##3##(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#2)
to undergo this##2##3##(1994-12#1)(2008-7#1)
to undergo##130##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-12#2)(1992-6#1)(1992-7#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#2)(1994-12#2)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#3)(1995-12#1)(1995-2#3)(1995-6#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-5#4)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(2004-2#1)(2004-3#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#2)(2006-5#2)(2006-6#4)(2006-7#1)(2007-10#1)(2007-12#3)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#4)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#6)(2013-7#1)
to undergoing##2##2##(1991-1#1)(2008-12#1)
to undergraduate and graduate##2##4##(2006-5#2)
to undergraduate dental students##2##4##(2009-2#1)(2012-1#1)
to undergraduate nursing students##2##4##(2007-8#1)(2008-11#1)
to undergraduate##8##2##(1993-3#1)(2006-5#2)(2007-8#1)(2008-11#2)(2009-2#1)(2012-1#1)
to underlie the##7##3##(1995-3#1)(1995-8#1)(1996-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2013-1#1)
to underlie this##2##3##(2007-5#1)(2009-8#1)
to underlie##20##2##(1990-11#1)(1994-5#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-9#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-11#1)(2009-8#1)(2010-2#1)(2011-1#1)(2013-1#1)(2013-8#1)
to underline that##4##3##(2006-12#1)(2006-2#2)(2012-12#1)
to underline the##2##3##(2007-10#1)(2011-1#1)
to underline##6##2##(2006-12#1)(2006-2#2)(2007-10#1)(2011-1#1)(2012-12#1)
to underlying##14##2##(1996-11#1)(1996-3#1)(1997-6#1)(2005-8#1)(2006-10#1)(2007-8#2)(2008-7#1)(2010-2#1)(2010-5#2)(2011-1#1)(2012-11#1)(2012-2#1)
to undermine the##2##3##(2007-8#1)(2012-2#1)
to undermine##4##2##(2007-8#1)(2007-9#1)(2009-11#1)(2012-2#1)
to underpin##4##2##(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
to underscore the##2##3##(2008-10#1)(2011-2#1)
to underserved##3##2##(2008-4#1)(2010-11#1)(2010-5#1)
to understand a##2##3##(2006-7#1)(2009-11#1)
to understand and control##3##4##(2008-5#1)(2010-7#1)(2011-1#1)
to understand and##25##3##(1991-9#1)(1994-2#1)(1994-3#1)(1996-1#1)(1997-3#1)(1997-4#1)(2006-5#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-11#2)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
to understand better the##3##4##(1994-9#1)(2007-12#1)(2009-12#1)
to understand better##5##3##(1994-3#1)(1994-9#1)(2007-12#1)(2009-12#1)(2010-2#1)
to understand group##2##3##(2008-8#1)(2010-4#1)
to understand how best to##2##5##(2007-9#1)(2012-3#1)
to understand how such##2##4##(2008-11#1)(2010-5#1)
to understand how the##10##4##(1992-3#1)(1993-6#1)(1997-6#1)(2006-10#1)(2008-12#1)(2008-3#1)(2009-10#1)(2010-4#1)(2010-6#1)(2011-2#1)
to understand how these##2##4##(1993-5#1)(2009-7#1)
to understand how##38##3##(1992-3#1)(1993-5#1)(1993-6#1)(1994-11#1)(1996-4#1)(1997-6#1)(2006-10#3)(2007-12#1)(2007-9#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
to understand its##3##3##(2008-5#2)(2010-4#1)
to understand mechanisms##2##3##(2008-11#1)(2008-9#1)
to understand more about the##2##5##(2008-11#1)(2009-6#1)
to understand more about##3##4##(2008-11#2)(2009-6#1)
to understand more##4##3##(2006-10#1)(2008-11#2)(2009-6#1)
to understand patients'##2##3##(2010-4#1)(2013-8#1)
to understand that the##2##4##(2006-10#1)(2009-9#1)
to understand that##9##3##(1991-1#1)(2005-10#1)(2005-9#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-11#1)(2009-9#1)(2010-8#1)
to understand the advantages and disadvantages##2##6##(2004-2#1)(2009-3#1)
to understand the basis##2##4##(1997-2#1)(1997-7#1)
to understand the behavior of##2##5##(2008-3#1)(2012-12#1)
to understand the biological##2##4##(2011-1#1)(2012-3#1)
to understand the characteristics of##2##5##(2007-3#1)(2010-8#1)
to understand the clinical##3##4##(2006-8#1)(2013-1#2)
to understand the complex##6##4##(2008-11#1)(2008-4#1)(2010-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
to understand the consequences of##4##5##(1994-2#1)(2008-2#1)(2008-4#2)
to understand the context##2##4##(2008-6#1)(2012-12#1)
to understand the dynamics of##2##5##(2007-9#1)(2008-2#1)
to understand the dynamics##3##4##(2007-9#1)(2008-2#1)(2012-1#1)
to understand the effects of##3##5##(1990-10#1)(1996-11#1)(2013-8#1)
to understand the evolution##2##4##(2008-10#1)(2009-2#1)
to understand the evolutionary##2##4##(2008-11#1)(2013-7#1)
to understand the experiences##2##4##(2007-11#1)(2012-12#1)
to understand the factors which##3##5##(2007-10#1)(2013-1#2)
to understand the factors##7##4##(2006-12#1)(2007-10#1)(2008-10#1)(2011-1#1)(2012-2#1)(2013-1#2)
to understand the function of##4##5##(1997-8#1)(2006-12#1)(2008-9#1)(2009-6#1)
to understand the functional##3##4##(1992-4#1)(2007-12#1)(2009-9#1)
to understand the genetic##3##4##(2008-10#1)(2008-8#1)(2012-1#1)
to understand the immune##2##4##(2006-8#1)(2013-1#1)
to understand the impact of##2##5##(2007-12#1)(2008-10#1)
to understand the influence of##2##5##(2004-9#1)(2006-11#1)
to understand the interaction##2##4##(2008-5#1)(2008-8#1)
to understand the mechanism of##3##5##(1994-11#1)(2008-8#1)(2013-8#1)
to understand the mechanism##5##4##(1994-11#1)(2008-11#1)(2008-8#2)(2013-8#1)
to understand the mechanisms of##4##5##(1993-12#1)(2007-10#1)(2007-11#1)(2008-10#1)
to understand the mechanisms##7##4##(1993-12#1)(1994-10#1)(1995-2#1)(2007-10#1)(2007-11#1)(2008-10#2)
to understand the molecular basis of this##2##7##(1997-2#1)(2011-1#1)
to understand the molecular basis of##5##6##(1997-1#1)(1997-2#1)(2008-4#1)(2011-1#1)(2012-2#1)
to understand the molecular basis##6##5##(1997-1#1)(1997-2#1)(2008-4#1)(2008-9#1)(2011-1#1)(2012-2#1)
to understand the molecular mechanisms##3##5##(2008-10#1)(2008-4#1)(2011-1#1)
to understand the molecular##13##4##(1994-11#1)(1995-5#1)(1997-1#1)(1997-2#1)(2005-8#1)(2007-7#1)(2008-10#1)(2008-4#2)(2008-9#1)(2011-1#2)(2012-2#1)
to understand the nature and##4##5##(2006-10#1)(2008-10#1)(2008-5#1)(2012-12#1)
to understand the nature of##3##5##(2008-10#1)(2009-8#1)(2010-7#1)
to understand the nature##7##4##(2006-10#1)(2008-10#2)(2008-5#1)(2009-8#1)(2010-7#1)(2012-12#1)
to understand the origin of##2##5##(1996-4#1)(2010-5#1)
to understand the pathogenesis of##2##5##(1994-4#1)(2006-10#1)
to understand the pathogenesis##3##4##(1994-4#1)(2006-10#1)(2012-2#1)
to understand the pathophysiology of##3##5##(1996-12#1)(2008-10#1)(2008-7#1)
to understand the physical##3##4##(2008-1#1)(2008-5#1)(2008-7#1)
to understand the physiology##3##4##(1996-11#1)(2007-11#1)(2009-9#1)
to understand the potential##3##4##(1994-5#1)(2008-10#1)(2012-2#1)
to understand the process of##2##5##(2006-11#1)(2011-2#1)
to understand the relationship between##7##5##(2007-10#1)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#2)
to understand the relationship##8##4##(2007-10#1)(2007-4#1)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#2)
to understand the role of##8##5##(1994-11#1)(1997-2#1)(2008-6#1)(2009-12#1)(2009-5#1)(2009-7#2)(2012-3#1)
to understand the underlying##2##4##(2011-1#1)(2012-2#1)
to understand the way##2##4##(2009-5#1)(2009-8#1)
to understand the##259##3##(1990-10#1)(1990-4#1)(1990-5#1)(1990-7#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#1)(1995-2#1)(1995-5#2)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#2)(2004-2#1)(2004-9#1)(2005-3#1)(2005-8#1)(2006-10#6)(2006-11#3)(2006-12#2)(2006-2#2)(2006-5#1)(2006-7#2)(2006-8#2)(2007-1#1)(2007-10#4)(2007-11#3)(2007-12#5)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#6)(2008-5#7)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#3)(2009-3#3)(2009-5#2)(2009-6#1)(2009-7#4)(2009-8#4)(2009-9#3)(2010-12#4)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#7)(2011-12#1)(2011-2#4)(2012-1#3)(2012-12#9)(2012-2#10)(2012-3#10)(2013-1#13)(2013-7#2)(2013-8#7)
to understand their biological##2##4##(2008-7#1)(2009-2#1)
to understand their role##2##4##(2008-3#1)(2008-5#1)
to understand their##25##3##(1993-1#1)(1993-2#1)(1994-3#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-5#1)(2010-8#1)(2011-12#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
to understand these##9##3##(1994-11#1)(2004-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#1)
to understand this phenomenon##4##4##(2006-7#1)(2009-9#1)(2013-1#1)(2013-8#1)
to understand this##10##3##(1994-2#1)(1996-12#1)(2006-7#1)(2007-7#1)(2009-9#1)(2010-5#1)(2011-1#1)(2013-1#1)(2013-8#2)
to understand what##6##3##(1996-6#1)(2006-10#1)(2006-7#1)(2009-10#1)(2012-1#1)(2013-8#1)
to understand whether##2##3##(2008-5#1)(2013-1#1)
to understand why##7##3##(1997-6#1)(2010-2#2)(2010-4#1)(2010-8#1)(2012-3#1)(2013-8#1)
to understand##518##2##(1990-10#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-11#5)(1994-12#1)(1994-2#3)(1994-3#6)(1994-4#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#2)(1996-1#2)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#3)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#4)(1997-6#4)(1997-7#1)(1997-8#2)(2004-12#1)(2004-2#2)(2004-9#1)(2005-10#1)(2005-3#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#15)(2006-11#3)(2006-12#4)(2006-2#2)(2006-5#3)(2006-7#5)(2006-8#4)(2007-1#1)(2007-10#6)(2007-11#3)(2007-12#9)(2007-3#3)(2007-4#4)(2007-5#2)(2007-6#3)(2007-7#4)(2007-8#3)(2007-9#6)(2008-1#3)(2008-10#24)(2008-11#19)(2008-12#3)(2008-2#6)(2008-3#10)(2008-4#7)(2008-5#16)(2008-6#5)(2008-7#12)(2008-8#10)(2008-9#10)(2009-10#4)(2009-11#2)(2009-12#4)(2009-2#6)(2009-3#4)(2009-4#2)(2009-5#4)(2009-6#6)(2009-7#6)(2009-8#5)(2009-9#6)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#6)(2010-2#6)(2010-3#4)(2010-4#5)(2010-5#6)(2010-6#3)(2010-7#4)(2010-8#5)(2010-9#3)(2011-1#11)(2011-10#1)(2011-12#2)(2011-2#10)(2012-1#9)(2012-12#13)(2012-2#16)(2012-3#17)(2013-1#25)(2013-7#4)(2013-8#15)
to understanding a##2##3##(2008-7#1)(2011-12#1)
to understanding and##2##3##(2006-9#1)(2012-12#1)
to understanding how##3##3##(2008-1#1)(2009-10#1)(2009-5#1)
to understanding interactions##2##3##(2007-11#1)(2008-8#1)
to understanding of##3##3##(1992-12#1)(2008-9#2)
to understanding the##29##3##(1993-12#1)(1996-3#1)(2006-2#1)(2006-3#1)(2007-1#2)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2010-12#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
to understanding these##2##3##(1995-8#1)(2007-4#1)
to understanding this##3##3##(2006-7#1)(2011-1#1)(2011-2#1)
to understanding##80##2##(1990-5#1)(1992-12#1)(1992-2#1)(1993-12#1)(1995-8#1)(1996-3#1)(1996-7#1)(2006-10#3)(2006-2#1)(2006-3#1)(2006-7#1)(2006-9#1)(2007-1#2)(2007-11#2)(2007-12#3)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#6)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-6#2)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#3)(2012-9#1)(2013-1#2)
to undertake a##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
to undertake further##2##3##(2008-11#1)(2008-12#1)
to undertake such an##2##4##(1995-4#1)(2012-3#1)
to undertake such##4##3##(1995-4#1)(2006-7#1)(2008-4#1)(2012-3#1)
to undertake the##5##3##(2007-10#1)(2007-11#1)(2008-11#1)(2008-8#1)(2012-3#1)
to undertake this##2##3##(2007-10#1)(2008-11#1)
to undertake##33##2##(1991-3#1)(1992-1#1)(1992-9#1)(1994-1#1)(1995-4#1)(1996-2#1)(1996-7#1)(2006-4#1)(2006-5#1)(2006-7#2)(2007-10#2)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-2#1)(2008-4#1)(2008-8#1)(2010-11#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#3)
to undetectable levels##11##3##(1990-2#1)(1991-5#1)(1994-12#1)(2005-11#1)(2006-10#1)(2006-9#1)(2008-10#3)(2008-5#1)(2011-1#1)
to undetectable##13##2##(1990-2#1)(1991-5#1)(1994-12#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-10#4)(2008-5#1)(2011-1#1)
to undetected##2##2##(2007-9#1)(2008-9#1)
to undifferentiated##3##2##(1992-9#1)(2009-6#1)(2010-9#1)
to undo##2##2##(1990-4#1)(1991-1#1)
to unequal##4##2##(1991-12#1)(2008-10#2)(2009-12#1)
to unequivocally##3##2##(1997-6#1)(2008-6#1)(2008-7#1)
to uneven##2##2##(2008-10#1)(2013-1#1)
to unexpected##2##2##(1994-11#1)(2012-2#1)
to unexposed##2##2##(2008-10#1)(2008-3#1)
to unfamiliar##4##2##(2008-11#1)(2008-12#1)(2010-2#1)(2013-7#1)
to unfolded##3##2##(1994-8#1)(1997-4#1)(2008-10#1)
to unfractionated##2##2##(1997-2#1)(2010-6#1)
to unhealthy##3##2##(1993-2#1)(2012-1#1)(2013-1#1)
to unidentified##2##2##(1994-8#1)(1995-7#1)
to uniform##2##2##(1996-6#1)(2008-3#1)
to unify the##4##3##(2007-8#1)(2008-1#1)(2008-6#1)(2008-7#1)
to unify##10##2##(2007-11#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)
to unilateral##9##2##(1990-4#1)(1991-2#1)(1993-10#1)(1993-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1996-1#1)(2013-8#1)
to uninfected cells##3##3##(1992-7#2)(1997-2#1)
to uninfected##9##2##(1991-5#1)(1992-7#2)(1994-9#1)(1995-2#1)(1997-2#1)(2008-4#1)(2008-8#1)(2012-3#1)
to uninsured##2##2##(1995-1#1)(1995-12#1)
to unintended##2##2##(2007-11#1)(2008-12#1)
to unipolar##2##2##(1996-3#1)(2007-8#1)
to unique##6##2##(1995-12#1)(1997-2#1)(1997-4#1)(2006-11#1)(2007-11#1)(2012-1#1)
to uniquely##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
to unitary##2##2##(2007-11#1)(2008-9#1)
to unite the##2##3##(2008-10#1)(2010-12#1)
to unite##4##2##(2007-6#1)(2008-10#1)(2008-9#1)(2010-12#1)
to units of##2##3##(1997-3#1)(2008-2#1)
to units##3##2##(1997-3#1)(2008-2#1)(2008-9#1)
to universal precautions##3##3##(2007-7#1)(2010-3#2)
to universal##7##2##(1994-2#1)(2007-7#1)(2008-10#1)(2008-11#2)(2010-3#2)
to universities##5##2##(1994-12#1)(1997-5#1)(2006-9#1)(2007-9#1)(2008-11#1)
to university##3##2##(1990-9#1)(2007-8#1)(2011-2#1)
to unknown sequences##2##3##(2007-8#1)(2008-7#1)
to unknown##10##2##(1995-12#1)(1996-9#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-7#2)
to unlabeled##3##2##(1992-3#1)(1995-11#1)(1997-8#1)
to unlinked##2##2##(1995-6#1)(1996-3#1)
to unnecessarily##2##2##(2006-2#1)(2010-12#1)
to unnecessary##5##2##(1990-12#1)(1991-11#1)(2007-5#1)(2007-9#1)(2008-10#1)
to unravel the##16##3##(1993-9#1)(1994-8#2)(1997-4#1)(2005-10#1)(2006-10#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2012-12#2)(2013-8#1)
to unravel##26##2##(1993-2#1)(1993-9#1)(1994-8#2)(1995-11#1)(1997-4#1)(1997-7#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-2#1)(2012-12#2)(2013-8#1)
to unrelated##4##2##(2007-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
to unroof the##2##3##(2008-7#2)
to unsafe##3##2##(2008-11#2)(2012-12#1)
to unstable##2##2##(1996-4#1)(2008-5#1)
to unstimulated cells##2##3##(1993-8#1)(2008-11#1)
to unstimulated##3##2##(1993-8#1)(1996-1#1)(2008-11#1)
to unsuccessful##3##2##(2007-9#1)(2008-11#1)(2008-4#1)
to untrained##4##2##(1993-2#1)(2007-4#2)(2010-12#1)
to untreated cells##3##3##(1991-7#1)(1992-5#1)(1995-3#1)
to untreated control##3##3##(1997-4#1)(2007-6#1)(2008-11#1)
to untreated controls##2##3##(1995-3#1)(2012-12#1)
to untreated##19##2##(1991-7#1)(1992-5#1)(1992-8#1)(1994-2#1)(1994-8#1)(1995-3#2)(1997-3#1)(1997-4#1)(1997-8#1)(2007-6#1)(2007-8#2)(2008-10#1)(2008-11#2)(2012-12#2)(2013-1#1)
to unusual sites##2##3##(2009-5#1)(2012-2#1)
to unusual##5##2##(2007-7#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
to unwanted diffraction orders##2##4##(2007-12#1)(2008-2#1)
to unwanted##5##2##(1997-5#1)(2007-12#2)(2008-10#1)(2008-2#1)
to unwind##3##2##(1993-3#1)(2012-1#2)
to up to##9##3##(1995-2#1)(2008-10#3)(2008-7#1)(2009-4#1)(2009-7#1)(2010-8#1)(2011-1#1)
to up##10##2##(1994-3#1)(1995-2#1)(2008-10#3)(2008-7#1)(2009-4#1)(2009-7#1)(2010-8#1)(2011-1#1)
to up-regulate##4##2##(1994-10#1)(1995-12#1)(1995-7#1)(2011-1#1)
to up-regulation of##3##3##(1995-12#1)(1997-7#2)
to update and##2##3##(2007-12#1)(2011-1#1)
to update our knowledge on##2##5##(1991-3#1)(2013-1#1)
to update the##11##3##(1993-9#1)(1994-1#1)(1995-5#1)(2005-11#1)(2008-3#2)(2008-6#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-12#1)
to update their##6##3##(2006-6#1)(2008-10#1)(2010-4#1)(2010-5#1)(2012-11#1)(2012-12#1)
to update##30##2##(1991-3#1)(1993-9#1)(1994-1#1)(1995-5#1)(2005-11#1)(2006-6#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#2)(2013-1#2)
to updating##2##2##(1992-12#1)(2006-10#1)
to upgrade##3##2##(2008-11#1)(2008-9#2)
to uphold##3##2##(1995-3#1)(2007-11#1)(2012-3#1)
to upper##8##2##(2005-8#1)(2006-11#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-9#1)(2012-3#1)
to upregulate##5##2##(1993-4#2)(2006-10#1)(2010-3#1)(2013-1#1)
to upright##2##2##(2008-11#1)(2008-7#1)
to upstream##3##2##(1991-8#1)(2008-11#1)(2008-9#1)
to uptake of##2##3##(2006-10#1)(2008-10#1)
to uptake sites##2##3##(1995-7#1)(2008-7#1)
to uptake##7##2##(1993-9#1)(1995-7#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-2#1)
to upward##2##2##(2007-10#1)(2008-10#1)
to uracil##4##2##(1994-9#3)(2007-11#1)
to uranium##2##2##(2008-10#1)(2013-1#1)
to uranyl##3##2##(1997-2#2)(2008-10#1)
to urban stressor##2##3##(2008-6#2)
to urban##7##2##(1996-3#1)(2007-8#1)(2008-6#2)(2012-12#1)(2013-1#2)
to urea##4##2##(1995-2#2)(2008-10#2)
to ureteral##2##2##(1993-12#1)(2006-9#1)
to uric acid was##2##4##(2008-10#2)
to uric acid##4##3##(1993-12#1)(2008-10#3)
to uridine phosphorylase##2##3##(1996-6#2)
to uridine##5##2##(1990-7#1)(1991-4#1)(1993-9#1)(1996-6#2)
to urinary catheters##2##3##(1996-12#2)
to urinary tract infection##3##4##(2007-8#1)(2008-1#1)(2011-2#1)
to urinary##13##2##(1991-9#1)(1992-2#1)(1993-12#1)(1993-8#1)(1996-12#2)(1996-9#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-7#1)(2010-5#1)(2011-2#1)
to urine from##2##3##(2004-11#2)
to urine samples##5##3##(1993-1#1)(1996-6#1)(1996-8#1)(2008-10#2)
to urine##10##2##(1991-8#1)(1993-1#1)(1996-12#1)(1996-6#1)(1996-8#1)(2004-11#3)(2008-10#2)
to urology##2##2##(2007-5#1)(2010-2#1)
to urothelial##2##2##(1990-6#1)(2008-10#1)
to us for##3##3##(1992-10#1)(2008-11#1)(2008-8#1)
to us that##3##3##(2007-2#1)(2008-11#1)(2013-8#1)
to us to##2##3##(2006-3#1)(2009-6#1)
to us with a##2##4##(2007-7#1)(2012-2#1)
to us with##14##3##(2007-7#4)(2008-9#1)(2011-1#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
to us##46##2##(1992-1#1)(1992-10#1)(1995-11#1)(1996-11#1)(2005-11#1)(2006-3#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-7#5)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-6#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
to use HI##2##3##(1997-3#1)(2008-3#1)
to use a combination of##2##5##(2007-6#1)(2008-4#1)
to use a strategy##2##4##(2008-2#1)(2010-7#1)
to use a system##2##4##(1990-5#1)(1996-9#1)
to use a##49##3##(1990-3#1)(1990-5#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-8#1)(1993-6#1)(1995-1#1)(1995-12#1)(1996-9#1)(2004-12#1)(2005-8#1)(2006-10#1)(2006-7#2)(2007-12#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#2)(2008-6#1)(2008-7#2)(2009-9#1)(2010-2#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)
to use all##2##3##(2012-3#1)(2013-7#1)
to use an##16##3##(1991-6#1)(1993-10#1)(1994-3#1)(1995-1#1)(2004-3#1)(2005-5#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2012-3#1)
to use and##13##3##(2006-8#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#1)(2010-4#1)(2010-5#1)(2012-1#1)(2012-2#1)
to use appropriate##2##3##(2011-2#1)(2013-8#1)
to use as a##3##4##(1990-9#1)(2007-11#1)(2008-12#1)
to use as an##2##4##(1996-2#1)(2008-2#1)
to use as##8##3##(1990-9#1)(1996-2#1)(1997-8#1)(2007-11#1)(2008-12#1)(2008-2#1)(2009-9#1)(2010-12#1)
to use because the##2##4##(2008-11#2)
to use by##2##3##(1997-1#1)(2010-8#1)
to use cell phones##2##4##(2010-12#2)
to use chemotherapy##2##3##(1994-6#1)(2008-6#1)
to use condoms in##2##4##(2006-7#1)(2007-7#1)
to use condoms##13##3##(1990-6#1)(1997-7#1)(2006-7#1)(2007-6#3)(2007-7#2)(2008-4#3)(2009-5#1)(2012-3#1)
to use data##3##3##(2008-3#1)(2013-1#2)
to use different##7##3##(1991-8#1)(1993-6#1)(1995-3#1)(1997-6#1)(2007-1#1)(2008-6#1)(2013-1#1)
to use drugs##4##3##(1990-3#1)(1991-7#1)(2007-11#1)(2009-9#1)
to use either##2##3##(2005-12#1)(2012-2#1)
to use electrical##2##3##(2006-4#1)(2011-2#1)
to use evidence-based##2##3##(2008-9#1)(2010-11#1)
to use family##2##3##(2010-8#1)(2011-1#1)
to use for##4##3##(2006-10#1)(2008-10#2)(2013-7#1)
to use genetic##2##3##(1997-3#1)(2011-12#1)
to use good##3##3##(2007-2#1)(2008-4#1)(2008-9#1)
to use government##2##3##(2012-3#2)
to use health##2##3##(1991-6#1)(2008-3#1)
to use high##2##3##(1997-8#1)(2008-5#1)
to use in a##3##4##(1991-1#1)(2012-12#2)
to use in the assessment of##2##6##(2008-6#1)(2011-1#1)
to use in the##5##4##(2006-10#1)(2007-12#1)(2007-4#1)(2008-6#1)(2011-1#1)
to use in##21##3##(1990-12#2)(1991-1#2)(1993-12#1)(1993-8#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-6#1)(2010-11#1)(2011-1#1)(2012-12#2)(2012-3#2)
to use insulin##2##3##(1993-12#1)(1994-4#1)
to use it for the##2##5##(1997-3#1)(2008-11#1)
to use it for##3##4##(1997-3#1)(2008-11#2)
to use it to##3##4##(1996-8#1)(2007-11#1)(2007-4#1)
to use it##14##3##(1992-11#1)(1992-4#1)(1996-8#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-11#2)(2009-10#1)(2009-3#1)(2009-7#1)(2010-4#1)
to use its##2##3##(2007-1#1)(2008-5#1)
to use less##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
to use measurements of##2##4##(1990-2#1)(2008-5#1)
to use methods##2##3##(1994-7#1)(2008-4#1)
to use molecular##2##3##(2005-8#1)(2008-11#1)
to use multiple##3##3##(2008-10#1)(2008-4#1)(2010-11#1)
to use of a##6##4##(1994-11#1)(1995-4#1)(2007-7#1)(2008-3#1)(2011-12#1)(2012-3#1)
to use of the##2##4##(2008-3#1)(2012-2#1)
to use of these##2##4##(1990-4#1)(2013-1#1)
to use of##21##3##(1990-4#1)(1992-11#1)(1993-9#1)(1994-11#1)(1995-4#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-8#1)(2008-9#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
to use only##3##3##(1991-3#1)(2006-2#1)(2008-6#1)
to use or##2##3##(2008-12#1)(2010-11#1)
to use other##2##3##(1996-6#1)(2007-11#1)
to use outcomes##2##3##(1994-1#1)(1996-1#1)
to use positive##2##3##(2008-7#1)(2012-12#1)
to use research in##4##4##(2008-11#1)(2009-3#1)(2010-5#1)(2010-8#1)
to use resources##2##3##(1993-12#1)(2009-1#1)
to use results from##2##4##(1992-6#1)(2012-1#1)
to use several##2##3##(2008-1#1)(2008-5#1)
to use simple##2##3##(1993-9#1)(2008-11#1)
to use such##4##3##(1997-4#1)(2008-3#1)(2009-9#1)(2013-1#1)
to use than##4##3##(1992-3#1)(2008-7#1)(2009-6#1)(2012-2#1)
to use the Internet##3##4##(2007-12#1)(2007-7#1)(2007-9#1)
to use the data##2##4##(1995-3#1)(1996-7#1)
to use the drug##2##4##(1990-2#1)(1993-8#1)
to use the model##2##4##(2007-7#1)(2008-11#1)
to use the same##4##4##(2007-8#1)(2008-11#1)(2008-2#1)(2008-8#1)
to use the term##2##4##(1990-11#1)(2004-11#1)
to use the##94##3##(1990-11#1)(1990-2#2)(1990-3#1)(1991-1#1)(1992-11#1)(1992-4#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-2#1)(1994-3#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-4#1)(2004-11#1)(2004-9#1)(2006-10#2)(2006-2#1)(2006-3#1)(2007-11#2)(2007-12#4)(2007-7#2)(2007-8#2)(2007-9#2)(2008-10#3)(2008-11#4)(2008-2#3)(2008-3#4)(2008-4#10)(2008-7#3)(2008-8#1)(2008-9#2)(2009-4#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-8#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
to use their own ventilators or##2##6##(2011-1#2)
to use their own##3##4##(2005-12#1)(2011-1#2)
to use their##7##3##(1994-12#1)(2005-12#1)(2011-1#2)(2012-1#1)(2012-2#1)(2013-1#1)
to use them to##4##4##(1993-12#1)(2005-11#1)(2008-10#1)(2013-7#1)
to use these methods to##2##5##(1994-8#1)(1995-6#1)
to use these tests##2##4##(1990-12#1)(2009-4#1)
to use these##14##3##(1990-12#1)(1991-1#1)(1994-2#1)(1994-8#1)(1995-6#1)(1996-2#1)(2006-10#2)(2008-10#2)(2009-4#1)(2010-10#1)(2010-3#1)(2012-1#1)
to use thin##2##3##(2007-11#1)(2008-3#1)
to use this method##2##4##(2008-10#1)(2008-2#1)
to use this##18##3##(1993-9#2)(2006-10#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-5#1)(2012-3#1)
to use to##6##3##(2007-3#1)(2007-4#1)(2008-4#1)(2009-10#1)(2012-12#1)(2013-8#1)
to use two##3##3##(2008-5#1)(2013-1#2)
to use when##5##3##(1997-3#1)(2008-9#2)(2010-10#1)(2011-2#1)
to use##703##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#4)(1990-3#4)(1990-4#2)(1990-5#1)(1990-6#1)(1990-9#2)(1991-1#4)(1991-11#1)(1991-3#2)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#3)(1992-12#1)(1992-3#3)(1992-4#2)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#5)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#6)(1994-1#3)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#6)(1994-4#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#2)(1995-1#2)(1995-12#2)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#2)(1996-1#3)(1996-12#2)(1996-2#3)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#3)(1997-3#7)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#3)(2004-11#1)(2004-12#2)(2004-3#1)(2004-9#2)(2005-10#1)(2005-11#2)(2005-12#3)(2005-5#1)(2005-7#2)(2005-8#3)(2006-10#15)(2006-11#2)(2006-12#1)(2006-2#4)(2006-3#3)(2006-4#1)(2006-5#4)(2006-6#1)(2006-7#5)(2006-8#8)(2007-1#3)(2007-10#1)(2007-11#15)(2007-12#20)(2007-2#8)(2007-3#4)(2007-4#6)(2007-5#1)(2007-6#4)(2007-7#10)(2007-8#8)(2007-9#8)(2008-1#6)(2008-10#35)(2008-11#28)(2008-12#10)(2008-2#13)(2008-3#31)(2008-4#40)(2008-5#15)(2008-6#7)(2008-7#14)(2008-8#9)(2008-9#18)(2009-1#1)(2009-10#4)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#4)(2009-6#4)(2009-7#1)(2009-8#1)(2009-9#6)(2010-1#2)(2010-10#2)(2010-11#5)(2010-12#8)(2010-2#4)(2010-3#2)(2010-4#2)(2010-5#8)(2010-7#2)(2010-8#11)(2010-9#1)(2011-1#7)(2011-12#4)(2011-2#14)(2011-3#1)(2012-1#7)(2012-11#1)(2012-12#13)(2012-2#14)(2012-3#14)(2013-1#24)(2013-7#5)(2013-8#9)
to use]##2##2##(1993-10#1)(1994-8#1)
to useful##5##2##(2007-11#1)(2008-1#1)(2008-10#1)(2008-8#1)(2013-1#1)
to user##4##2##(2008-10#1)(2011-1#1)(2011-2#2)
to users of##2##3##(2012-12#1)(2013-8#1)
to users##5##2##(1990-9#1)(2008-11#1)(2008-3#1)(2012-12#1)(2013-8#1)
to using a##5##3##(1997-8#1)(2006-10#1)(2008-7#1)(2012-1#1)(2013-1#1)
to using mice##2##3##(2008-6#2)
to using the##5##3##(2006-5#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)
to using##23##2##(1992-2#1)(1992-5#1)(1994-12#1)(1997-8#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-7#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2009-10#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
to usual care##3##3##(2005-12#1)(2008-11#1)(2008-4#1)
to usual##8##2##(1995-12#1)(2005-12#1)(2007-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-2#1)
to uterine##4##2##(1994-9#1)(2006-5#1)(2011-2#2)
to utilise##7##2##(1997-6#1)(2006-10#1)(2006-6#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-7#1)
to utilization of##3##3##(1991-12#1)(1996-2#1)(2008-8#1)
to utilization##4##2##(1991-12#1)(1995-12#1)(1996-2#1)(2008-8#1)
to utilize a##6##3##(1994-2#1)(1995-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
to utilize the##10##3##(1993-3#1)(1995-2#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#1)(2011-2#1)
to utilize this##4##3##(1994-3#1)(2008-1#1)(2008-4#1)(2008-5#1)
to utilize xylose##2##3##(2008-6#1)(2012-3#1)
to utilize##59##2##(1990-3#1)(1991-3#1)(1991-6#1)(1992-3#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-8#1)(1997-1#2)(1997-4#1)(2006-5#2)(2006-8#1)(2007-12#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
to vacate##2##2##(1991-7#2)
to vaccinate their daughters##4##4##(2011-1#4)
to vaccination against hepatitis B##2##5##(1993-6#1)(2013-1#1)
to vaccination in##2##3##(2010-4#1)(2011-2#1)
to vaccination with##2##3##(1997-3#1)(2005-9#1)
to vaccination##14##2##(1990-11#1)(1993-6#1)(1997-3#1)(2005-9#2)(2009-5#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)
to vaccine##5##2##(1995-5#1)(2005-11#1)(2011-2#2)(2012-12#1)
to vaccine-preventable##2##2##(2010-9#2)
to vaccines##6##2##(2007-11#3)(2008-8#1)(2009-4#1)(2013-1#1)
to vagal##2##2##(1997-7#1)(2010-2#1)
to vaginal##2##2##(1993-12#1)(2011-12#1)
to validate a##10##3##(1996-2#1)(2007-12#1)(2008-10#3)(2008-7#1)(2012-1#1)(2013-1#2)(2013-8#1)
to validate and##2##3##(2008-3#1)(2009-11#1)
to validate our##3##3##(2007-10#1)(2008-1#1)(2012-3#1)
to validate the developed##2##4##(2008-10#1)(2011-2#1)
to validate the impact of##2##5##(2011-2#1)(2013-1#1)
to validate the model##10##4##(2007-4#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2010-2#1)(2011-2#1)(2013-8#1)
to validate the proposed##2##4##(2008-2#1)(2008-7#1)
to validate the technique##4##4##(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)
to validate the use of##2##5##(2010-7#1)(2011-2#1)
to validate the##65##3##(1991-5#1)(1995-3#1)(1996-3#1)(1997-2#1)(2006-5#1)(2006-8#1)(2007-4#2)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#8)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#2)(2010-2#1)(2010-7#1)(2011-1#2)(2011-2#9)(2012-2#1)(2013-1#1)(2013-8#1)
to validate these##3##3##(2007-11#1)(2010-12#1)(2010-2#1)
to validate this##6##3##(1994-2#1)(1995-1#1)(1995-3#1)(1995-5#1)(2008-1#1)(2013-1#1)
to validate##113##2##(1991-5#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-7#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-6#1)(2007-8#5)(2008-1#3)(2008-10#21)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#10)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#9)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#3)
to validated##2##2##(2007-1#1)(2011-2#1)
to validation##2##2##(2008-10#1)(2010-11#1)
to valine##4##2##(1992-9#2)(1993-11#1)(2007-5#1)
to value the##3##3##(1990-12#1)(2006-12#1)(2006-8#1)
to value##8##2##(1990-12#1)(1991-5#1)(1994-12#1)(1995-12#1)(2005-7#1)(2006-12#1)(2006-7#1)(2006-8#1)
to values below##3##3##(1992-4#1)(2008-10#1)(2012-3#1)
to values greater than##2##4##(1990-5#1)(2008-3#1)
to values observed in##2##4##(2008-10#1)(2010-12#1)
to values of##2##3##(1991-2#1)(2007-12#1)
to values##32##2##(1990-12#2)(1990-3#1)(1990-5#2)(1990-9#1)(1991-2#1)(1992-2#1)(1992-4#2)(1993-3#1)(1993-4#1)(1994-2#1)(1994-4#1)(1994-6#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-7#1)(2004-4#1)(2006-2#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-8#1)(2012-3#1)
to valve##3##2##(2006-8#1)(2007-8#1)(2010-12#1)
to vanadium##2##2##(1992-4#1)(2008-10#1)
to vancomycin and##2##3##(1991-6#1)(2010-8#1)
to vancomycin##19##2##(1991-6#1)(1995-2#1)(2005-8#1)(2006-10#1)(2007-12#2)(2007-7#4)(2008-5#2)(2010-8#2)(2011-2#3)(2012-12#2)
to vanish##3##2##(1990-5#1)(2007-9#1)(2009-2#1)
to vapor##3##2##(2005-11#1)(2008-10#2)
to vaporize##2##2##(2008-3#1)(2010-8#1)
to variable expression of##2##4##(1996-12#1)(2011-2#1)
to variable##6##2##(1990-12#1)(1994-9#1)(1996-12#1)(2008-1#1)(2008-8#1)(2011-2#1)
to variables##2##2##(2007-8#1)(2013-1#1)
to variance in##2##3##(2009-9#1)(2011-2#1)
to variances in##2##3##(2008-11#1)(2008-9#1)
to variation in the##5##4##(1990-1#1)(2006-10#1)(2008-10#1)(2010-1#1)(2010-8#1)
to variation in##18##3##(1990-1#1)(1996-2#1)(2006-10#1)(2008-1#1)(2008-10#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#1)(2010-1#1)(2010-8#1)(2011-2#1)(2013-1#1)
to variation of##3##3##(1990-11#1)(2006-12#1)(2012-3#1)
to variation##25##2##(1990-1#1)(1990-11#1)(1996-2#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-10#5)(2008-6#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-2#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
to variations in the##15##4##(1991-10#1)(1992-3#1)(1993-3#1)(2005-10#1)(2007-11#2)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-2#1)
to variations in##23##3##(1990-12#1)(1990-2#2)(1991-10#1)(1992-3#1)(1993-3#1)(2005-10#1)(2007-11#2)(2008-10#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-1#1)
to variations##24##2##(1990-12#1)(1990-2#2)(1991-10#1)(1992-3#1)(1993-3#1)(2005-10#1)(2007-11#2)(2008-10#2)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-1#1)
to variceal##4##2##(2006-10#4)
to varicella zoster virus##2##4##(1992-11#1)(2007-11#1)
to varied##2##2##(2004-3#1)(2006-12#1)
to various adverse##2##3##(1993-12#1)(2009-5#1)
to various antibiotics##2##3##(2008-12#1)(2011-1#1)
to various antimicrobial agents##2##4##(2006-5#1)(2008-10#1)
to various aspects of##4##4##(1994-5#1)(1997-2#1)(2006-10#1)(2012-3#1)
to various concentrations of##3##4##(1990-4#1)(1992-11#1)(1997-2#1)
to various concentrations##5##3##(1990-4#1)(1992-11#1)(1997-2#1)(1997-3#1)(2011-12#1)
to various degrees##5##3##(1991-12#1)(1993-3#1)(1995-6#1)(2007-11#1)(2007-4#1)
to various diseases##3##3##(2011-1#1)(2012-12#2)
to various doses of##2##4##(2008-7#2)
to various drugs##3##3##(1991-12#1)(1994-8#1)(2008-10#1)
to various extents##4##3##(1990-5#1)(1992-9#1)(1994-2#1)(1996-7#1)
to various forms of##2##4##(1993-9#1)(2008-3#1)
to various groups of##3##4##(2006-8#1)(2007-7#1)(2008-8#1)
to various human##2##3##(1992-3#1)(1992-4#1)
to various infectious##2##3##(2007-1#1)(2007-2#1)
to various optical##2##3##(2008-2#1)(2008-3#1)
to various other##2##3##(2006-6#1)(2007-12#1)
to various problems in##2##4##(1990-9#1)(2009-12#1)
to various stimulants##2##3##(1990-3#1)(2007-2#1)
to various stimuli##8##3##(1991-2#1)(1995-8#2)(2008-4#3)(2009-3#1)(2010-12#1)
to various toxic##2##3##(1997-4#1)(2009-6#1)
to various types of##4##4##(1992-9#1)(1996-12#1)(2009-10#1)(2012-1#1)
to various water samples##3##4##(2008-10#3)
to various##222##2##(1990-12#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-9#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#2)(1996-12#2)(1996-3#1)(1996-5#2)(1996-7#1)(1996-9#2)(1997-2#3)(1997-3#2)(1997-4#3)(1997-7#1)(2004-11#1)(2004-9#1)(2005-12#1)(2005-8#2)(2005-9#1)(2006-10#2)(2006-12#2)(2006-5#1)(2006-6#3)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#20)(2008-11#3)(2008-12#2)(2008-2#7)(2008-3#6)(2008-4#7)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#5)(2009-10#2)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-5#1)(2010-7#1)(2011-1#6)(2011-12#5)(2011-2#1)(2012-1#1)(2012-11#3)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#8)(2013-7#2)(2013-8#1)
to vary according to the##2##5##(1996-11#1)(2010-2#1)
to vary according to##4##4##(1992-11#1)(1996-11#1)(2007-10#1)(2010-2#1)
to vary from##7##3##(1992-11#1)(1992-3#1)(2005-11#1)(2007-12#1)(2007-9#1)(2008-2#1)(2010-12#1)
to vary in a##2##4##(1995-8#1)(2007-10#1)
to vary in##5##3##(1995-8#1)(2007-10#1)(2008-10#3)
to vary little##2##3##(2008-10#2)
to vary significantly##3##3##(2008-10#1)(2008-3#1)(2009-7#1)
to vary the shape of##2##5##(2008-2#2)
to vary the##8##3##(2007-4#1)(2008-1#1)(2008-11#1)(2008-2#3)(2008-3#1)(2010-4#1)
to vary with the##2##4##(1990-12#1)(2005-11#1)
to vary with##6##3##(1990-12#1)(1991-4#1)(1997-3#2)(2005-11#1)(2008-8#1)
to vary##54##2##(1990-12#1)(1991-4#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-9#1)(1993-5#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-11#1)(1997-3#2)(2005-11#3)(2007-10#2)(2007-12#3)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#6)(2008-3#5)(2008-4#1)(2008-8#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-4#1)(2012-3#1)(2013-1#2)
to varying concentrations of##4##4##(1995-5#2)(2008-10#1)(2009-11#1)
to varying conditions##2##3##(2006-10#1)(2009-5#1)
to varying degrees by##2##4##(2008-4#1)(2008-9#1)
to varying degrees##8##3##(1991-8#1)(1993-1#1)(1996-11#1)(2006-7#1)(2007-2#1)(2008-4#1)(2008-9#1)(2013-8#1)
to varying extents##5##3##(1992-11#1)(1994-11#1)(1995-4#1)(2008-10#1)(2010-12#1)
to varying levels of##2##4##(1996-2#1)(2010-2#1)
to varying levels##3##3##(1996-2#1)(2007-10#1)(2010-2#1)
to varying##30##2##(1990-11#1)(1991-8#1)(1992-11#1)(1993-1#1)(1994-11#1)(1995-4#1)(1995-5#2)(1996-11#1)(1996-2#1)(2006-10#1)(2006-7#1)(2007-10#2)(2007-2#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
to vascular endothelial cells##3##4##(1992-12#1)(1994-2#1)(1997-1#1)
to vascular endothelial growth factor##4##5##(2008-8#2)(2010-1#1)(2011-12#1)
to vascular endothelial##8##3##(1992-12#1)(1994-2#1)(1997-1#1)(2008-8#2)(2010-1#1)(2011-12#1)(2013-8#1)
to vascular endothelium##3##3##(1992-12#1)(1996-2#1)(1996-3#1)
to vascular muscle##3##3##(1991-6#3)
to vascular smooth muscle cells##2##5##(1994-6#1)(2008-5#1)
to vascular##35##2##(1991-6#3)(1992-12#3)(1993-7#1)(1994-2#1)(1994-6#1)(1995-2#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(2006-10#2)(2007-7#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-6#1)(2010-1#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2013-8#1)
to vasoactive intestinal##2##3##(1991-2#1)(1994-3#1)
to vasoactive##4##2##(1991-2#1)(1994-3#1)(2006-12#1)(2010-12#1)
to vasodilatation##4##2##(2005-11#1)(2006-10#3)
to vasopressin##4##2##(1990-12#1)(1995-5#1)(2007-9#1)(2013-1#1)
to vector control##2##3##(2006-4#1)(2013-1#1)
to vector##7##2##(2006-4#1)(2008-11#3)(2010-1#1)(2011-2#1)(2013-1#1)
to vectorial##2##2##(2007-11#1)(2009-10#1)
to vectors##2##2##(2008-10#1)(2011-2#1)
to vegetative##4##2##(2008-10#1)(2008-8#1)(2011-2#2)
to vehicle control##5##3##(1994-9#1)(1996-11#1)(2008-10#1)(2008-5#1)(2010-5#1)
to vehicle controls##2##3##(1990-7#1)(1993-3#1)
to vehicle treatment##2##3##(1991-10#1)(2009-8#1)
to vehicle##15##2##(1990-7#1)(1991-10#1)(1993-3#1)(1994-9#1)(1996-11#1)(1996-12#1)(2007-4#1)(2008-10#1)(2008-5#1)(2009-3#1)(2009-8#3)(2010-5#1)(2012-12#1)
to vehicle-injected controls##2##3##(1990-7#1)(1993-9#1)
to vehicle-injected##3##2##(1990-7#1)(1993-9#1)(1997-2#1)
to vehicle-treated controls##2##3##(1992-10#1)(1993-4#1)
to vehicle-treated##5##2##(1990-7#1)(1992-10#1)(1993-3#1)(1993-4#1)(2008-5#1)
to velocity##2##2##(2008-2#1)(2008-3#1)
to venous thromboembolism##2##3##(2007-10#1)(2008-3#1)
to venous##7##2##(1996-9#1)(1997-1#1)(2007-10#1)(2007-8#1)(2008-3#1)(2011-2#1)(2012-1#1)
to ventilate##2##2##(1997-4#1)(2006-10#1)
to ventilatory##5##2##(1997-4#1)(2005-10#1)(2005-8#2)(2012-3#1)
to ventral##3##2##(1993-3#1)(2006-12#1)(2009-2#1)
to ventricular##7##2##(2006-4#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-8#1)(2009-10#1)(2010-11#1)
to ventromedial##3##2##(1991-5#1)(1994-6#1)(2008-11#1)
to verapamil##2##2##(1993-7#1)(1997-1#1)
to verb##2##2##(2012-11#2)
to verbal##2##2##(2007-11#1)(2012-3#1)
to verbs##2##2##(1991-2#1)(2008-11#1)
to verify a##3##3##(1996-3#1)(2006-10#1)(2008-12#1)
to verify and##3##3##(1997-3#1)(2008-10#1)(2010-3#1)
to verify if the##6##4##(2006-11#1)(2007-7#1)(2008-10#1)(2010-3#1)(2011-12#1)(2012-2#1)
to verify if##9##3##(2006-11#1)(2007-7#1)(2008-10#3)(2008-9#1)(2010-3#1)(2011-12#1)(2012-2#1)
to verify its feasibility##2##4##(2008-10#2)
to verify its##7##3##(2007-7#2)(2008-1#1)(2008-10#2)(2008-2#1)(2013-1#1)
to verify our##3##3##(1993-11#1)(2007-12#1)(2011-2#1)
to verify that the##4##4##(1997-3#1)(2006-7#1)(2008-3#1)(2011-2#1)
to verify that##13##3##(1993-7#1)(1993-9#1)(1997-3#1)(2006-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2011-2#1)
to verify the accuracy of##2##5##(2008-2#1)(2012-12#1)
to verify the accuracy##3##4##(2008-10#1)(2008-2#1)(2012-12#1)
to verify the clinical##2##4##(2007-8#1)(2008-3#1)
to verify the effect of##2##5##(1997-2#1)(2008-7#1)
to verify the effectiveness of##2##5##(1991-6#1)(2008-2#1)
to verify the effectiveness##3##4##(1991-6#1)(2008-2#1)(2008-5#1)
to verify the influence of##2##5##(2008-7#1)(2013-7#1)
to verify the numerical##2##4##(2006-10#1)(2008-9#1)
to verify the position of the##2##6##(2007-7#2)
to verify the theoretical##2##4##(2008-2#1)(2010-5#1)
to verify the utility##2##4##(2006-8#1)(2008-6#1)
to verify the##84##3##(1990-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-3#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-12#4)(2007-2#1)(2007-7#5)(2007-8#4)(2008-1#2)(2008-10#9)(2008-11#1)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#6)(2008-9#2)(2009-2#1)(2009-3#1)(2009-7#1)(2010-12#2)(2010-5#2)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#2)
to verify their##2##3##(2008-10#1)(2013-7#1)
to verify these findings##2##4##(2005-11#1)(2010-12#1)
to verify these##4##3##(2005-11#1)(2007-1#1)(2008-10#1)(2010-12#1)
to verify this proposition##2##4##(2007-11#2)
to verify whether##5##3##(1997-1#1)(2007-3#1)(2008-11#1)(2010-9#1)(2011-2#1)
to verify##160##2##(1990-5#1)(1990-6#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-7#1)(1993-9#1)(1994-3#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#2)(2005-9#1)(2006-10#2)(2006-11#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#4)(2007-12#5)(2007-2#1)(2007-3#1)(2007-7#8)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#20)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#9)(2008-4#3)(2008-5#3)(2008-6#5)(2008-7#8)(2008-9#5)(2009-2#1)(2009-3#1)(2009-7#1)(2010-12#3)(2010-3#2)(2010-5#2)(2010-6#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#5)(2013-7#3)(2013-8#2)
to vertebral##5##2##(1993-11#1)(2006-8#1)(2008-7#1)(2009-3#1)(2009-4#1)
to vertebrate##8##2##(1991-10#1)(1993-9#1)(1995-2#1)(1996-5#1)(1997-2#1)(2008-7#1)(2008-9#1)(2012-12#1)
to vertebrates##5##2##(1991-3#1)(2007-12#1)(2008-12#1)(2012-12#1)(2012-3#1)
to very few##2##3##(2007-5#1)(2008-10#1)
to very good##6##3##(1990-9#1)(1991-3#1)(2007-7#1)(2008-4#2)(2012-12#1)
to very high levels of##3##5##(2005-12#1)(2008-4#1)(2010-6#1)
to very high levels##4##4##(1996-8#1)(2005-12#1)(2008-4#1)(2010-6#1)
to very high##10##3##(1996-8#1)(1997-6#1)(2005-12#1)(2006-12#1)(2007-6#1)(2008-11#1)(2008-4#1)(2008-5#2)(2010-6#1)
to very large##3##3##(2006-6#1)(2007-12#1)(2008-10#1)
to very low concentrations##2##4##(2006-10#1)(2007-12#1)
to very low doses of##2##5##(2008-7#1)(2009-7#1)
to very low levels##4##4##(1993-3#2)(2005-8#1)(2010-7#1)
to very low##14##3##(1991-6#1)(1993-3#2)(1996-5#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-2#1)(2008-7#1)(2009-7#1)(2010-7#1)(2012-2#1)(2013-8#1)
to very small##3##3##(1993-7#1)(2008-7#1)(2011-2#1)
to very stable##2##3##(2008-10#2)
to very##60##2##(1990-9#1)(1991-3#1)(1991-6#1)(1993-3#3)(1993-7#1)(1994-8#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-6#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-12#3)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-7#1)(2010-6#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#2)
to vesicle##7##2##(1992-6#2)(1995-10#1)(1997-1#1)(1997-7#1)(2008-11#1)(2008-3#1)
to vesicles containing##3##3##(1992-12#3)
to vesicles formed from mixtures of PC and##2##8##(1992-12#2)
to vesicles##8##2##(1990-11#1)(1991-9#1)(1992-12#5)(2008-10#1)
to vessels and##2##3##(1997-4#1)(2008-2#1)
to vessels##5##2##(1997-4#1)(2005-12#1)(2006-6#1)(2008-2#1)(2013-1#1)
to viability##2##2##(2008-11#1)(2008-9#1)
to viable##6##2##(1991-11#1)(2007-7#1)(2008-11#3)(2011-1#1)
to vibration##2##2##(1991-12#1)(2008-2#1)
to vibrational##2##2##(1992-2#1)(1992-9#1)
to vibrations##2##2##(2008-2#2)
to victims of domestic violence##2##5##(1995-12#1)(2007-2#1)
to victims of##6##3##(1995-12#1)(2007-2#1)(2008-8#1)(2011-2#2)(2012-12#1)
to victims##8##2##(1995-12#1)(2007-2#1)(2008-2#1)(2008-8#1)(2011-2#2)(2012-1#1)(2012-12#1)
to video##3##2##(2008-11#1)(2008-3#1)(2009-6#1)
to view the##12##3##(1993-1#1)(2006-11#2)(2007-5#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2011-2#1)(2013-8#1)
to view this##2##3##(2008-6#1)(2012-3#1)
to view##33##2##(1992-3#1)(1993-1#2)(1994-8#1)(1995-1#1)(1996-2#2)(1996-5#1)(2004-12#1)(2004-2#1)(2005-9#1)(2006-11#2)(2007-2#1)(2007-5#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-9#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-8#1)
to viewing##3##2##(2004-12#1)(2006-7#1)(2007-12#1)
to vinblastine##3##2##(1991-7#1)(1994-11#2)
to vinca##3##2##(1995-5#2)(2008-5#1)
to vinclozolin (S(T)R(V))##4##3##(2008-10#4)
to vinclozolin##10##2##(2008-10#10)
to vincristine and##2##3##(1993-8#2)
to vincristine plus##2##3##(1993-8#2)
to vincristine##6##2##(1993-8#4)(1993-9#1)(2011-2#1)
to vinyl carbamate##2##3##(1994-2#2)
to vinyl chloride##3##3##(1992-1#1)(2010-12#1)(2012-2#1)
to vinyl##5##2##(1992-1#1)(1994-2#2)(2010-12#1)(2012-2#1)
to violate the##3##3##(1990-12#1)(1995-8#1)(2012-2#1)
to violate##4##2##(1990-12#1)(1995-8#1)(1997-1#1)(2012-2#1)
to violations of the##2##4##(1994-9#1)(2010-2#1)
to violations of##4##3##(1994-9#2)(2008-8#1)(2010-2#1)
to violence and##4##3##(1995-8#1)(2008-11#1)(2009-7#1)(2009-9#1)
to violence##14##2##(1991-4#1)(1995-8#1)(2008-11#1)(2008-9#1)(2009-5#1)(2009-7#4)(2009-9#4)(2013-7#1)
to violent##7##2##(2007-10#1)(2009-3#1)(2009-7#3)(2010-6#1)(2011-1#1)
to viral RNA##4##3##(1994-9#1)(1996-11#1)(2008-10#2)
to viral infection##5##3##(1991-2#1)(2007-10#2)(2007-11#1)(2007-8#1)
to viral infections##3##3##(2008-1#1)(2008-7#1)(2013-1#1)
to viral##28##2##(1990-5#1)(1991-2#1)(1994-9#1)(1995-2#1)(1996-11#1)(1996-4#1)(2005-12#4)(2007-10#2)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
to virtual##2##2##(2008-4#1)(2008-6#1)
to virtually any##5##3##(1996-12#1)(2006-8#1)(2007-4#1)(2008-3#1)(2010-4#1)
to virtually##6##2##(1996-12#1)(2006-8#1)(2007-4#1)(2008-3#1)(2010-10#1)(2010-4#1)
to virulence to##2##3##(2008-10#2)
to virulence##8##2##(1990-8#1)(1997-6#2)(2007-7#1)(2008-10#4)
to virulences in group##2##4##(2008-10#2)
to virulences in##3##3##(2008-10#3)
to virulent##3##2##(2008-10#2)(2013-8#1)
to virus infection##3##3##(2008-10#2)(2008-11#1)
to virus transmission##2##3##(2008-10#2)
to virus##10##2##(1997-1#1)(1997-3#1)(2008-10#7)(2008-11#1)
to viruses in##2##3##(2007-11#1)(2008-10#1)
to viruses##5##2##(2006-5#1)(2007-11#1)(2008-10#2)(2011-1#1)
to visceral fat accumulation##2##4##(2006-6#1)(2008-1#1)
to visceral leishmaniasis##2##3##(2008-7#2)
to visceral##8##2##(2006-10#1)(2006-6#1)(2006-9#1)(2008-1#1)(2008-7#2)(2009-2#1)(2013-8#1)
to visible##5##2##(2007-12#1)(2008-3#1)(2010-12#1)(2010-5#1)(2012-1#1)
to vision##3##2##(1993-3#1)(2008-4#1)(2009-10#1)
to visit a##3##3##(1993-8#1)(1996-11#1)(1996-8#1)
to visit##15##2##(1990-7#2)(1992-12#1)(1993-8#1)(1995-6#1)(1996-11#1)(1996-8#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
to visiting##2##2##(2008-1#1)(2010-5#1)
to visual loss##2##3##(2009-8#1)(2013-7#1)
to visual stimuli##3##3##(1990-4#1)(1993-2#1)(2008-8#1)
to visual targets##2##3##(1995-8#1)(2009-8#1)
to visual word##2##3##(1995-12#1)(2008-4#1)
to visual##25##2##(1990-4#1)(1990-6#1)(1993-2#2)(1995-12#1)(1995-8#2)(1996-2#1)(1996-9#2)(1997-7#1)(2004-7#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-4#1)(2009-8#2)(2012-2#1)(2012-3#1)(2013-7#2)
to visualise the##3##3##(1996-5#1)(2012-2#2)
to visualise##6##2##(1996-5#1)(2008-11#1)(2008-8#1)(2012-2#3)
to visualize and quantify##2##4##(2007-8#1)(2012-2#1)
to visualize and##5##3##(1992-10#1)(2006-9#1)(2007-8#1)(2008-11#1)(2012-2#1)
to visualize antibodies by##2##4##(2008-4#2)
to visualize the arterial##2##4##(1990-5#1)(2013-8#1)
to visualize the##30##3##(1990-5#1)(1991-12#1)(1992-12#1)(1993-4#1)(1994-5#1)(1996-11#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-8#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-11#2)(2013-1#2)(2013-8#2)
to visualize##71##2##(1990-10#1)(1990-5#1)(1991-12#1)(1992-10#1)(1992-12#1)(1993-4#1)(1994-5#1)(1996-11#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#1)(2005-11#2)(2006-6#2)(2006-9#2)(2007-1#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#8)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#2)(2012-11#2)(2012-2#3)(2013-1#2)(2013-8#3)
to visually perceived##2##3##(1995-5#2)
to visually##5##2##(1990-12#1)(1992-10#1)(1995-5#2)(2007-8#1)
to vital##3##2##(2007-9#1)(2012-1#1)(2012-12#1)
to vitamin A deficiency##2##4##(1991-8#1)(2007-1#1)
to vitamin A##4##3##(1991-8#1)(1992-8#1)(2007-1#1)(2008-11#1)
to vitamin C##3##3##(2008-5#1)(2010-12#1)(2012-2#1)
to vitamin D deficiency##2##4##(2010-3#1)(2011-2#1)
to vitamin D response elements##2##5##(1995-8#1)(2008-1#1)
to vitamin D##6##3##(1995-8#1)(2005-1#1)(2008-1#2)(2010-3#1)(2011-2#1)
to vitamin E##2##3##(1994-5#1)(1996-3#1)
to vitamin##20##2##(1990-11#1)(1991-8#1)(1992-8#1)(1994-5#1)(1995-8#1)(1996-3#1)(1997-3#1)(2005-1#1)(2007-1#1)(2007-11#1)(2008-1#2)(2008-11#1)(2008-5#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
to vocal##2##2##(2007-6#2)
to vocational##3##2##(2006-8#2)(2011-2#1)
to voice##4##2##(1992-3#1)(1993-1#1)(1996-11#1)(2009-4#1)
to void##2##2##(1991-4#1)(2007-1#1)
to volatile##4##2##(2006-10#1)(2008-10#1)(2008-5#1)(2010-8#1)
to voltammetric##2##2##(2008-10#2)
to volume##9##2##(1991-2#1)(2005-11#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-9#1)(2013-1#1)
to voluntarily##2##2##(2012-12#2)
to voluntary##3##2##(1990-10#1)(2007-2#1)(2007-7#1)
to volunteer##5##2##(1994-2#2)(1994-3#1)(1995-2#1)(2006-11#1)
to von Frey##2##3##(1997-2#1)(2009-12#1)
to von##3##2##(1993-3#1)(1997-2#1)(2009-12#1)
to voriconazole##2##2##(2008-4#1)(2009-8#1)
to vortex##2##2##(1995-10#1)(2008-6#1)
to vulnerable##3##2##(1993-2#1)(2007-11#1)(2012-12#1)
to waist circumference##2##3##(2010-12#1)(2011-2#1)
to wait for##4##3##(1994-1#1)(2007-7#1)(2007-9#1)(2009-1#1)
to wait##13##2##(1992-2#1)(1994-1#1)(1995-12#1)(1995-9#2)(2006-2#3)(2007-7#1)(2007-9#1)(2009-1#1)(2012-3#1)(2013-7#1)
to waiting##3##2##(1997-1#1)(2008-12#1)(2008-5#1)
to wake##2##2##(2006-4#1)(2007-9#1)
to waking##2##2##(1994-12#1)(2013-1#1)
to walk on the##2##4##(2009-9#1)(2012-1#1)
to walk or##2##3##(2008-6#1)(2010-2#1)
to walk unassisted##2##3##(2007-10#1)(2007-2#1)
to walk with##2##3##(2007-7#1)(2011-12#1)
to walk##31##2##(1991-9#1)(1995-5#1)(1995-9#1)(1996-9#3)(2005-7#1)(2006-7#1)(2007-10#3)(2007-11#2)(2007-2#1)(2007-7#2)(2008-11#1)(2008-6#1)(2009-3#2)(2009-9#1)(2010-12#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)
to walking##3##2##(2007-5#1)(2012-1#2)
to war##3##2##(1992-3#1)(1993-9#1)(1994-9#1)
to ward off##2##3##(2012-12#1)(2012-2#1)
to ward##3##2##(2005-1#1)(2012-12#1)(2012-2#1)
to warfarin##8##2##(1995-9#1)(2007-8#3)(2010-12#1)(2011-1#1)(2012-12#2)
to warm##3##2##(1993-3#1)(2005-11#1)(2008-10#1)
to warn##5##2##(1993-4#1)(1997-1#1)(2007-9#1)(2008-7#1)(2011-2#1)
to warrant a##2##3##(2006-9#1)(2010-8#1)
to warrant consideration##2##3##(2010-2#1)(2011-2#1)
to warrant the##2##3##(2008-10#1)(2012-12#1)
to warrant##17##2##(1994-3#3)(1994-9#1)(2006-2#1)(2006-9#2)(2007-7#1)(2008-1#1)(2008-10#3)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
to wash##2##2##(1993-3#1)(2008-4#1)
to waste##7##2##(1993-1#1)(1993-2#1)(1997-3#1)(2008-10#3)(2011-2#1)
to wastewater##2##2##(2008-10#2)
to watch over##2##3##(2007-12#1)(2011-2#1)
to watch##7##2##(1995-12#1)(1997-2#1)(2005-12#1)(2007-12#1)(2008-10#1)(2009-12#1)(2011-2#1)
to water analysis##4##3##(2008-10#4)
to water and salt##2##4##(2010-3#1)(2012-1#1)
to water and##10##3##(1995-2#1)(1996-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2010-3#1)(2012-1#1)
to water deficit##3##3##(2009-8#3)
to water immersion##2##3##(2005-8#1)(2008-5#1)
to water samples and##2##4##(2008-10#2)
to water samples##10##3##(2008-10#9)(2010-5#1)
to water stress##4##3##(2009-8#2)(2012-7#2)
to water vapor##4##3##(1997-1#1)(2008-10#2)(2009-3#1)
to water##79##2##(1990-2#1)(1991-2#1)(1991-5#1)(1992-7#1)(1993-11#1)(1994-10#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-8#1)(1997-1#2)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#3)(2007-3#1)(2008-10#22)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#6)(2009-9#1)(2010-3#2)(2010-5#3)(2010-8#1)(2011-1#2)(2012-1#3)(2012-11#1)(2012-12#3)(2012-7#2)(2013-1#1)
to water-leaving##2##2##(2008-3#2)
to water-soluble chromium##2##3##(1994-5#2)
to water-soluble proteins##2##3##(1990-9#2)
to water-soluble##5##2##(1990-9#2)(1992-3#1)(1994-5#2)
to waterborne cadmium##2##3##(2004-4#2)
to wave##2##2##(2006-6#1)(2007-12#1)
to waveguide##3##2##(2007-12#2)(2008-2#1)
to wavelengths##2##2##(2007-8#1)(2008-2#1)
to waves##2##2##(2006-6#1)(2012-3#1)
to ways of##3##3##(1993-6#1)(2008-2#1)(2008-9#1)
to ways##4##2##(1993-6#1)(2008-11#1)(2008-2#1)(2008-9#1)
to weak##5##2##(1990-5#1)(1992-12#1)(1993-11#1)(1995-5#1)(2006-10#1)
to weaken##2##2##(1995-2#1)(2008-9#1)
to wean from##2##3##(2010-8#1)(2013-1#1)
to wean##5##2##(1997-4#2)(2007-11#1)(2010-8#1)(2013-1#1)
to weanling##2##2##(1990-5#1)(1992-5#1)
to wear a##3##3##(2008-12#1)(2012-12#1)(2013-8#1)
to wear the##3##3##(2005-11#1)(2009-10#1)(2012-12#1)
to wear##10##2##(1997-7#1)(2005-11#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-12#2)(2013-8#1)
to weather variables##3##3##(2008-10#3)
to weather##7##2##(2008-10#6)(2013-8#1)
to web##2##2##(2010-4#1)(2011-2#1)
to week 12##2##3##(1992-12#1)(2008-7#1)
to week##6##2##(1992-12#2)(2007-2#1)(2008-7#2)(2009-9#1)
to weeks##5##2##(1997-1#1)(2007-11#1)(2008-9#1)(2009-12#1)(2013-8#1)
to weigh the##2##3##(2008-10#1)(2012-2#1)
to weigh##8##2##(1991-9#1)(2006-10#2)(2007-9#1)(2008-10#1)(2012-12#1)(2012-2#2)
to weight loss##5##3##(1995-12#1)(2006-2#1)(2008-3#1)(2010-8#1)(2012-2#1)
to weight the##2##3##(1996-2#1)(2012-2#1)
to weight##14##2##(1995-12#1)(1996-2#1)(2004-3#1)(2006-2#1)(2008-2#2)(2008-3#1)(2008-4#3)(2010-8#1)(2012-2#2)(2013-1#1)
to welfare##2##2##(1990-11#1)(2008-2#1)
to well##10##2##(2005-11#1)(2006-2#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-1#2)(2013-8#1)
to well-being##2##2##(2010-2#1)(2010-4#1)
to well-established##3##2##(2008-7#1)(2010-10#1)(2012-11#1)
to western##2##2##(2008-10#1)(2011-2#1)
to wet digestion##2##3##(2008-10#2)
to wet heat at##2##4##(2008-5#1)(2011-2#1)
to wet##5##2##(2008-10#3)(2008-5#1)(2011-2#1)
to what can be##2##4##(2008-11#1)(2012-3#1)
to what degree the##2##4##(2008-2#1)(2013-8#1)
to what degree##11##3##(1991-12#1)(1993-12#1)(1994-8#1)(1995-6#2)(2007-2#1)(2007-5#1)(2008-2#1)(2010-3#1)(2010-9#1)(2013-8#1)
to what extent the intended##2##5##(1995-6#2)
to what extent the##20##4##(1991-2#1)(1995-6#2)(1995-8#1)(1996-4#1)(1997-8#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)
to what extent##46##3##(1991-2#1)(1992-1#1)(1992-12#1)(1993-12#1)(1993-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-8#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-2#3)(2013-1#2)(2013-7#1)
to what has been reported in##3##6##(1995-1#1)(2007-12#1)(2010-4#1)
to what has been reported##7##5##(1994-9#1)(1995-1#1)(2006-10#2)(2007-12#1)(2007-2#1)(2010-4#1)
to what has been shown##2##5##(2008-10#1)(2008-7#1)
to what has been##12##4##(1994-9#1)(1995-1#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-4#1)
to what has##14##3##(1994-9#1)(1995-1#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-5#1)(2010-4#1)(2010-9#1)
to what is actually##2##4##(1992-9#1)(2008-5#1)
to what is expected##2##4##(2008-8#1)(2008-9#1)
to what is generally##2##4##(1990-2#1)(2008-5#1)
to what is known about the##2##6##(2007-9#1)(2008-11#1)
to what is known##3##4##(2005-11#1)(2007-9#1)(2008-11#1)
to what is observed in##3##5##(1995-12#1)(1995-3#1)(2012-2#1)
to what is seen in##2##5##(1990-10#1)(1993-11#1)
to what is##20##3##(1990-10#1)(1990-2#1)(1992-9#1)(1993-11#1)(1995-12#1)(1995-3#1)(2005-11#2)(2007-9#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
to what was observed##4##4##(1990-10#1)(1993-12#1)(2008-11#1)(2012-3#1)
to what was##10##3##(1990-10#1)(1991-2#1)(1993-12#1)(1996-6#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2012-3#1)
to what we##2##3##(2008-5#1)(2010-2#1)
to what would be##2##4##(1993-12#1)(2011-1#1)
to what##140##2##(1990-10#2)(1990-2#1)(1991-12#1)(1991-2#2)(1992-1#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-3#1)(1993-5#1)(1994-12#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#4)(1995-8#1)(1996-12#2)(1996-4#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-8#1)(2005-11#2)(2005-7#1)(2006-10#3)(2006-2#1)(2006-6#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#3)(2007-2#4)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-12#5)(2008-2#3)(2008-3#3)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#6)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#1)
to wheat (Triticum aestivum)##2##4##(2008-10#2)
to wheat chromosomes 7A and 7D##2##6##(2008-5#2)
to wheat leaf rust##2##4##(2008-10#2)
to wheat or##2##3##(2008-10#2)
to wheat stripe rust##2##4##(2008-10#2)
to wheat##19##2##(1990-3#1)(2008-10#13)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#1)
to wheelchair##3##2##(2007-7#2)(2007-8#1)
to when the##5##3##(1992-6#1)(1994-5#1)(1997-8#1)(2007-2#1)(2011-2#1)
to when##12##2##(1992-6#1)(1994-5#1)(1995-12#1)(1997-7#1)(1997-8#1)(2007-2#1)(2007-9#1)(2008-8#1)(2009-3#2)(2011-1#1)(2011-2#1)
to where##3##2##(1996-1#1)(2008-3#1)(2012-2#1)
to whether it is##3##4##(1995-11#1)(1996-12#1)(2008-10#1)
to whether or not##6##4##(1990-3#1)(1994-11#1)(2006-12#1)(2007-11#1)(2009-5#1)(2013-1#1)
to whether the##15##3##(1990-6#1)(1991-1#1)(1993-5#1)(1994-12#1)(1996-4#1)(2005-8#1)(2007-10#1)(2007-11#1)(2008-11#2)(2008-12#1)(2008-2#1)(2010-2#1)(2013-1#2)
to whether this##3##3##(1992-12#1)(1993-9#1)(1994-2#1)
to whether##66##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#2)(1991-1#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-4#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-11#2)(1996-12#1)(1996-4#1)(1996-8#1)(1997-5#1)(2005-12#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-7#2)(2006-8#3)(2007-10#2)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-5#2)(2010-12#2)(2010-2#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#6)
to which 1##2##3##(1995-5#1)(1996-2#1)
to which a different toxicity and therefore##2##7##(2008-10#2)
to which a##14##3##(1990-11#1)(1993-9#1)(1997-8#1)(2006-5#1)(2007-11#1)(2008-10#4)(2008-11#1)(2010-3#1)(2012-2#1)(2013-1#2)
to which an##6##3##(1996-11#1)(2007-12#1)(2007-6#1)(2008-10#1)(2009-12#1)(2010-2#1)
to which both##2##3##(2007-12#1)(2008-11#1)
to which each##3##3##(1995-2#1)(2009-10#1)(2009-5#1)
to which existing##2##3##(2010-11#1)(2012-12#1)
to which extent##3##3##(2006-10#1)(2008-11#1)(2011-2#1)
to which flow##2##3##(2006-8#1)(2008-9#1)
to which individual##2##3##(1990-2#1)(2006-5#1)
to which is##4##3##(1990-8#1)(1990-9#1)(2006-6#1)(2010-12#1)
to which it binds##2##4##(1996-7#1)(2010-10#1)
to which it is less##2##5##(1993-10#1)(1997-2#1)
to which it is##15##4##(1990-5#1)(1992-3#1)(1993-10#2)(1994-12#1)(1995-4#1)(1996-9#1)(1997-2#2)(2005-9#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-12#1)(2011-1#1)
to which it##22##3##(1990-5#1)(1992-3#1)(1993-10#2)(1994-12#1)(1995-4#1)(1996-7#1)(1996-9#1)(1997-2#2)(2005-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-10#1)(2011-1#1)(2011-12#1)(2011-2#1)
to which of##3##3##(1991-9#1)(1993-11#1)(2007-3#1)
to which other##3##3##(1995-2#1)(2006-7#1)(2009-9#1)
to which patients##4##3##(1994-2#1)(2006-10#1)(2008-11#1)(2012-2#1)
to which people##2##3##(2009-5#1)(2010-4#1)
to which research##2##3##(2010-8#1)(2013-8#1)
to which such##4##3##(2004-4#1)(2006-5#1)(2009-12#1)(2010-7#1)
to which the data##2##4##(2008-10#1)(2008-5#1)
to which the maximum##2##4##(2007-10#1)(2008-2#1)
to which the most##2##4##(1994-11#1)(1996-2#1)
to which the patient is##2##5##(1991-4#1)(2007-7#1)
to which the patient##3##4##(1991-4#1)(2007-7#1)(2011-2#1)
to which the test product is##2##6##(2008-5#2)
to which the##86##3##(1990-10#1)(1991-12#2)(1991-4#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-3#2)(1993-5#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-3#3)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-8#2)(2007-10#2)(2007-12#2)(2007-6#1)(2007-7#2)(2008-1#3)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#6)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-7#2)(2009-9#2)(2010-12#1)(2010-6#1)(2010-8#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#1)(2013-1#2)
to which their##3##3##(1990-5#1)(2008-9#1)(2009-7#1)
to which there##3##3##(1993-8#1)(1994-11#1)(1997-8#1)
to which these##13##3##(1990-2#1)(1990-3#1)(1992-2#1)(1996-8#1)(1997-7#1)(2006-10#2)(2008-10#1)(2008-3#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-9#1)
to which they are##4##4##(1994-3#1)(1996-1#1)(2009-6#1)(2010-2#1)
to which they belong##4##4##(2008-9#1)(2009-5#1)(2011-2#1)(2012-3#1)
to which they had##2##4##(2008-8#1)(2010-4#1)
to which they have been##2##5##(1991-12#1)(2011-2#1)
to which they have##4##4##(1991-12#1)(2005-7#1)(2008-8#1)(2011-2#1)
to which they##26##3##(1991-12#1)(1991-4#1)(1992-11#1)(1994-3#1)(1996-1#1)(1996-2#2)(1997-1#1)(2005-7#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-5#1)(2009-6#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)
to which this##5##3##(1995-1#1)(1995-2#1)(1997-3#1)(2006-10#1)(2008-6#1)
to which various##3##3##(1991-11#1)(1993-9#1)(2007-11#1)
to which we##4##3##(2006-1#1)(2007-12#1)(2007-6#1)(2008-5#1)
to which##411##2##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#3)(1990-8#3)(1990-9#1)(1991-11#1)(1991-12#4)(1991-4#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-6#3)(1992-8#1)(1992-9#2)(1993-10#2)(1993-11#2)(1993-2#1)(1993-3#4)(1993-5#2)(1993-6#2)(1993-8#2)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#4)(1994-3#3)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#5)(1995-4#1)(1995-5#3)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#4)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#4)(1997-3#2)(1997-5#1)(1997-6#3)(1997-7#5)(1997-8#4)(2004-12#1)(2004-4#2)(2005-10#2)(2005-11#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#7)(2006-11#1)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#2)(2006-8#5)(2007-10#2)(2007-11#3)(2007-12#9)(2007-3#1)(2007-4#2)(2007-6#3)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#29)(2008-11#14)(2008-12#3)(2008-2#4)(2008-3#7)(2008-4#8)(2008-5#18)(2008-6#1)(2008-7#6)(2008-8#10)(2008-9#10)(2009-10#1)(2009-11#2)(2009-12#3)(2009-2#1)(2009-4#4)(2009-5#5)(2009-6#1)(2009-7#4)(2009-8#1)(2009-9#5)(2010-10#1)(2010-11#3)(2010-12#4)(2010-2#6)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#2)(2011-12#3)(2011-2#13)(2012-1#3)(2012-12#4)(2012-2#7)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#3)
to whispering-gallery modes##3##3##(2007-12#3)
to white matter##2##3##(1995-8#1)(2005-10#1)
to white##13##2##(1991-12#1)(1993-5#1)(1995-8#1)(2005-10#1)(2008-10#8)(2010-11#1)
to whole blood##3##3##(1992-4#1)(2008-2#1)(2009-4#1)
to whole tissue##2##3##(2010-9#2)
to whole##13##2##(1992-4#1)(1995-1#1)(1995-5#1)(1997-7#1)(2005-10#1)(2006-2#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-4#1)(2010-9#2)(2012-12#1)
to whole-body##2##2##(1992-3#1)(1995-1#1)
to whom the##4##3##(1994-3#1)(2007-4#1)(2007-8#1)(2011-2#1)
to whom##13##2##(1994-3#1)(1996-2#1)(1997-6#1)(2007-4#1)(2007-8#1)(2008-5#1)(2009-6#1)(2010-2#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-12#2)
to wide local excision##2##4##(2008-6#1)(2010-8#1)
to wide##10##2##(2004-1#1)(2007-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-12#1)(2010-8#1)(2011-2#2)
to widen the##6##3##(2008-10#1)(2008-12#1)(2008-5#1)(2010-12#1)(2010-2#1)(2010-4#1)
to widen##7##2##(2006-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-12#1)(2010-2#1)(2010-4#1)
to widespread adoption##4##3##(2012-12#4)
to widespread##11##2##(1997-6#1)(2004-2#1)(2005-7#1)(2006-8#1)(2007-9#1)(2008-10#1)(2011-3#1)(2012-12#4)
to wild type cerebellum##2##4##(1994-10#2)
to wild type##19##3##(1990-8#1)(1991-7#2)(1992-6#1)(1994-10#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#1)(1997-4#1)(1997-7#1)(2008-8#1)(2009-8#1)(2010-4#2)(2011-1#1)(2012-2#2)
to wild##26##2##(1990-8#1)(1991-7#2)(1991-9#1)(1992-6#1)(1992-9#1)(1993-7#1)(1994-10#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#1)(1997-4#1)(1997-7#1)(2005-9#1)(2008-8#1)(2009-8#1)(2010-4#2)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)
to wild-type Mb##2##3##(1994-5#2)
to wild-type cells##3##3##(1995-4#1)(1996-3#1)(2007-12#1)
to wild-type enzyme##3##3##(1994-11#2)(1995-5#1)
to wild-type hIK1##2##3##(2008-8#2)
to wild-type protein##2##3##(1990-8#1)(1994-2#1)
to wild-type##41##2##(1990-8#1)(1993-8#2)(1994-11#4)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-5#2)(1996-10#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-4#1)(1997-6#2)(2006-12#1)(2006-9#1)(2007-12#1)(2008-8#2)(2008-9#1)(2009-10#1)(2011-2#2)(2012-3#1)(2013-1#3)
to wildlife##2##2##(1990-3#1)(2006-7#1)
to win over##2##3##(2007-9#1)(2009-10#1)
to win##11##2##(1992-2#1)(1994-10#1)(1995-10#1)(1996-1#1)(2007-9#2)(2008-8#1)(2009-10#1)(2010-8#1)(2012-1#1)(2013-7#1)
to wind##3##2##(2008-3#1)(2008-8#1)(2013-7#1)
to wine##4##2##(2005-10#1)(2008-10#3)
to winter##4##2##(2008-10#3)(2010-7#1)
to withdraw from##2##3##(2010-12#1)(2010-2#1)
to withdraw##14##2##(1991-7#2)(1992-1#1)(1993-2#1)(1994-2#1)(1995-12#1)(2006-10#2)(2007-8#1)(2007-9#1)(2008-10#1)(2010-12#1)(2010-2#1)(2012-3#1)
to withdrawal of the##2##4##(1990-6#1)(1997-1#1)
to withdrawal of##5##3##(1990-6#1)(1994-11#1)(1997-1#1)(2007-11#1)(2007-7#1)
to withdrawal##8##2##(1990-6#1)(1993-2#1)(1994-11#1)(1997-1#1)(2007-11#2)(2007-7#1)(2008-2#1)
to withhold##7##2##(1993-7#5)(2007-2#1)(2009-10#1)
to within +/-0##4##3##(2008-3#4)
to within +/-5%##3##3##(2005-11#1)(2008-2#1)(2008-3#1)
to within 0##6##3##(1993-2#1)(1995-8#1)(2008-2#1)(2008-3#3)
to within 1##3##3##(1995-6#1)(2007-12#1)(2008-2#1)
to within 1%##3##3##(2008-1#1)(2008-3#2)
to within 10% of##2##4##(2007-12#1)(2011-2#1)
to within 10%##4##3##(2007-12#2)(2008-3#1)(2011-2#1)
to within 3##3##3##(2007-12#1)(2008-3#2)
to within 4##2##3##(1995-3#1)(2013-1#1)
to within 4%##2##3##(2008-2#1)(2008-3#1)
to within a few##5##4##(1997-4#1)(2008-1#1)(2008-3#3)
to within a##10##3##(1997-4#1)(2008-1#1)(2008-2#1)(2008-3#7)
to within an##2##3##(2008-2#1)(2008-3#1)
to within approximately##2##3##(2007-11#1)(2008-2#1)
to within normal range##2##4##(2007-6#1)(2013-1#1)
to within the normal range##3##5##(2006-7#1)(2008-3#1)(2011-1#1)
to within the normal##4##4##(1993-9#1)(2006-7#1)(2008-3#1)(2011-1#1)
to within the##8##3##(1991-2#1)(1993-9#1)(1996-4#1)(2006-7#2)(2008-10#1)(2008-3#1)(2011-1#1)
to within##84##2##(1990-7#1)(1991-2#1)(1991-5#1)(1993-11#1)(1993-2#1)(1993-9#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-4#1)(1997-4#1)(1997-8#1)(2005-11#2)(2006-7#2)(2007-11#2)(2007-12#5)(2007-6#1)(2008-1#3)(2008-10#3)(2008-2#10)(2008-3#35)(2008-8#2)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#2)
to withstand high##2##3##(2008-10#1)(2008-7#1)
to withstand##15##2##(1993-12#1)(2006-10#2)(2007-12#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-7#1)(2009-2#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-3#2)
to women in the##2##4##(1993-6#1)(2004-1#1)
to women in##5##3##(1990-12#1)(1991-3#1)(1993-6#1)(2004-1#1)(2007-2#1)
to women postpartum##2##3##(2007-11#2)
to women who are##2##4##(1997-1#1)(2012-3#1)
to women who##6##3##(1994-4#1)(1997-1#1)(2006-10#1)(2007-2#2)(2012-3#1)
to women with a##2##4##(2007-2#1)(2008-4#1)
to women with##8##3##(1992-4#1)(2004-2#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-3#1)(2008-4#1)(2011-2#1)
to women##47##2##(1990-12#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-4#1)(1993-6#1)(1994-2#2)(1994-4#1)(1996-9#1)(1997-1#1)(2004-1#2)(2004-2#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-12#4)(2007-2#5)(2007-4#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-12#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
to women's health##3##3##(1994-9#1)(1996-11#1)(2008-11#1)
to women's##12##2##(1994-9#1)(1995-1#1)(1995-12#1)(1996-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-11#1)(2009-3#1)(2009-4#1)(2010-8#1)(2011-2#1)
to wood##5##2##(1990-6#1)(1992-10#1)(2008-10#1)(2008-5#1)(2010-4#1)
to word##4##2##(2008-11#1)(2012-11#1)(2013-1#2)
to work after##3##3##(1996-12#1)(2007-10#1)(2012-12#1)
to work and##9##3##(1993-2#1)(1994-3#1)(2006-7#1)(2008-10#1)(2008-11#1)(2009-6#1)(2010-2#1)(2012-12#1)(2013-1#1)
to work as a##4##4##(2007-5#1)(2008-10#2)(2008-11#1)
to work as##7##3##(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2010-12#1)
to work at##6##3##(1993-7#1)(1996-12#1)(2006-10#1)(2007-4#1)(2008-10#1)(2010-11#1)
to work because##2##3##(1997-5#1)(2006-8#1)
to work collaboratively with##4##4##(2006-5#1)(2007-12#1)(2008-12#1)(2011-1#1)
to work collaboratively##6##3##(2006-10#1)(2006-5#1)(2007-12#1)(2008-12#1)(2011-1#1)(2013-1#1)
to work cooperatively##2##3##(2008-1#1)(2010-2#1)
to work differently##2##3##(1991-1#1)(1995-1#1)
to work effectively with##3##4##(2007-12#1)(2007-3#1)(2008-12#1)
to work for the##3##4##(1992-11#1)(2008-1#1)(2012-1#1)
to work for##6##3##(1992-11#1)(1996-1#1)(2007-11#1)(2008-1#1)(2012-1#2)
to work in a##2##4##(2008-2#1)(2011-2#1)
to work in partnership to##2##5##(1996-2#1)(2008-11#1)
to work in partnership with##3##5##(2008-11#1)(2008-12#2)
to work in partnership##5##4##(1996-2#1)(2008-11#2)(2008-12#2)
to work in the##2##4##(2005-7#1)(2008-10#1)
to work in##20##3##(1990-5#1)(1994-11#1)(1996-2#1)(1997-1#1)(2004-10#1)(2005-7#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#1)(2009-4#2)(2010-5#1)(2011-2#1)
to work mainly##2##3##(2008-4#1)(2013-1#1)
to work on the##2##4##(1992-12#1)(2008-10#1)
to work on##10##3##(1992-12#1)(1993-12#1)(1995-3#1)(1996-2#1)(2008-10#1)(2008-2#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-7#1)
to work out##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)
to work rates and##2##4##(2007-11#1)(2012-12#1)
to work rates##3##3##(2007-11#2)(2012-12#1)
to work to##2##3##(2007-2#1)(2008-7#1)
to work together in##2##4##(1996-12#1)(2007-5#1)
to work together to##6##4##(1991-3#1)(2006-4#1)(2007-1#1)(2010-10#1)(2010-2#1)(2012-2#1)
to work together##11##3##(1991-12#1)(1991-3#1)(1993-7#1)(1996-12#1)(2004-7#1)(2006-4#1)(2007-1#1)(2007-5#1)(2010-10#1)(2010-2#1)(2012-2#1)
to work well when##2##4##(2007-12#1)(2008-3#1)
to work well##5##3##(1994-2#1)(2007-12#1)(2008-10#2)(2008-3#1)
to work with the##2##4##(1997-2#1)(2009-10#1)
to work with these##2##4##(1991-2#1)(2008-9#1)
to work with##30##3##(1990-11#1)(1991-2#1)(1992-12#1)(1994-1#1)(1994-4#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-5#1)(1997-6#1)(2005-10#1)(2005-5#1)(2006-10#1)(2006-6#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-12#1)(2013-8#1)
to work within##3##3##(1992-5#1)(2006-6#1)(2007-10#1)
to work##203##2##(1990-11#1)(1990-5#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#2)(1993-2#1)(1993-7#2)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-4#2)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#4)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#2)(1997-5#2)(1997-6#2)(2004-10#1)(2004-7#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-7#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-4#2)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#6)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-8#2)(2008-1#7)(2008-10#11)(2008-11#8)(2008-12#5)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#3)(2009-10#2)(2009-3#2)(2009-4#4)(2009-6#2)(2009-8#1)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-5#2)(2010-6#2)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#7)(2012-1#3)(2012-12#10)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
to workers in the##3##4##(1995-1#1)(2008-7#1)(2011-2#1)
to workers##4##2##(1995-1#1)(2006-2#1)(2008-7#1)(2011-2#1)
to working##5##2##(2006-7#1)(2006-8#1)(2007-2#1)(2007-8#1)(2007-9#1)
to workplace##3##2##(2007-3#1)(2008-7#1)(2011-2#1)
to worldwide##2##2##(1992-3#1)(2005-8#1)
to worry?##2##2##(2007-9#1)(2011-2#1)
to worse##3##2##(2007-6#1)(2008-10#1)(2012-12#1)
to worsen##2##2##(2006-9#1)(2008-8#1)
to worsening of##3##3##(2005-10#1)(2008-3#1)(2008-9#1)
to worsening##6##2##(2005-10#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-3#1)(2009-4#1)
to wound closure##4##3##(2008-7#3)(2012-12#1)
to wound healing in##2##4##(2009-12#1)(2011-2#1)
to wound healing##3##3##(2009-12#1)(2011-2#1)(2013-1#1)
to wound##8##2##(2008-7#3)(2009-12#1)(2011-2#1)(2012-10#1)(2012-12#1)(2013-1#1)
to wounding##3##2##(1996-7#1)(2008-10#1)(2009-8#1)
to wounds##2##2##(2008-10#1)(2012-10#1)
to wrist##2##2##(2007-7#1)(2008-9#1)
to write a##2##3##(2008-3#1)(2010-7#1)
to write the##3##3##(2008-3#1)(2008-6#1)(2009-4#1)
to write##16##2##(1996-2#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-6#1)(2009-4#2)(2010-7#1)(2013-1#1)(2013-7#1)(2013-8#1)
to writing##2##2##(1995-11#1)(1996-6#1)
to wrong##2##2##(2008-4#1)(2009-9#1)
to x-ray##4##2##(1990-7#1)(1992-6#1)(1996-6#1)(2008-10#1)
to xanthine##3##2##(1991-9#2)(1993-12#1)
to xenobiotic##3##2##(2007-6#1)(2009-3#1)(2013-1#1)
to xenobiotics##2##2##(1990-3#1)(2008-7#1)
to xenotransplantation##4##2##(1995-11#3)(2007-11#1)
to xylem##2##2##(2008-10#1)(2008-11#1)
to year and##4##3##(2008-10#3)(2013-1#1)
to year##15##2##(1993-2#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-8#3)(2010-9#1)(2011-2#2)(2013-1#1)
to years##5##2##(1991-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
to yeast cells##4##3##(1990-2#1)(1990-3#1)(2006-2#1)(2008-10#1)
to yeast##29##2##(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-8#1)(1993-3#1)(1993-4#2)(1994-6#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-6#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-2#1)(2007-8#1)(2008-10#4)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)
to yeasts##2##2##(2008-7#1)(2011-2#1)
to yellow rust##3##3##(2008-10#3)
to yellow##7##2##(1992-2#1)(2008-10#4)(2008-3#1)(2008-7#1)
to yield a colored precipitate##2##5##(2008-4#1)(2008-9#1)
to yield a detection limit of##2##6##(2008-10#2)
to yield a high##3##4##(2007-11#1)(2008-10#1)(2008-7#1)
to yield a two-dimensional##2##4##(2007-12#1)(2008-3#1)
to yield a variety of##2##5##(1994-11#1)(2007-11#1)
to yield a##50##3##(1990-11#1)(1994-11#1)(1995-2#1)(1995-8#2)(1996-5#1)(1997-5#1)(2007-11#4)(2007-12#3)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-4#3)(2010-8#1)(2013-1#1)
to yield an accurate##2##4##(2007-11#1)(2012-1#1)
to yield an##10##3##(1993-12#1)(1995-8#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#2)(2012-1#1)
to yield deconvolution##3##3##(2008-10#3)
to yield estimates of##2##4##(2006-10#1)(2008-3#1)
to yield good##2##3##(2007-8#1)(2007-9#1)
to yield highly##2##3##(2007-12#1)(2008-4#1)
to yield important##2##3##(2007-10#1)(2009-4#1)
to yield maximal##2##3##(2006-1#1)(2008-5#1)
to yield new##2##3##(2009-5#1)(2012-2#1)
to yield similar##2##3##(1990-8#1)(1991-3#1)
to yield the desired##2##4##(2007-12#2)
to yield the##37##3##(1990-8#1)(1991-9#1)(1993-11#2)(1994-5#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-5#1)(1997-4#1)(2005-11#1)(2006-7#1)(2007-11#4)(2007-12#4)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#5)(2008-4#1)(2008-8#1)(2008-9#1)
to yield##244##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#3)(1990-8#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#3)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-7#1)(1992-9#2)(1993-11#3)(1993-12#2)(1993-2#1)(1993-5#1)(1994-11#5)(1994-5#3)(1994-6#1)(1994-8#4)(1995-11#1)(1995-2#1)(1995-3#3)(1995-6#2)(1995-7#1)(1995-8#3)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#3)(1997-8#3)(2004-9#1)(2005-11#3)(2005-6#1)(2006-1#1)(2006-10#3)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#12)(2007-12#13)(2007-8#4)(2007-9#3)(2008-1#3)(2008-10#19)(2008-11#5)(2008-12#3)(2008-2#19)(2008-3#21)(2008-4#14)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#3)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#6)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#2)(2013-8#2)
to yoga##2##2##(2004-8#1)(2011-12#1)
to young adult##2##3##(1995-6#1)(2006-7#1)
to young adulthood##2##3##(1996-5#1)(2006-9#1)
to young adults##2##3##(1990-4#1)(2012-1#1)
to young adults'##2##3##(2010-10#1)(2010-3#1)
to young and##5##3##(1997-3#1)(2006-10#1)(2007-2#1)(2008-9#1)(2013-7#1)
to young women##2##3##(1997-1#1)(2010-2#1)
to young##35##2##(1990-4#1)(1991-12#2)(1992-3#1)(1993-7#1)(1995-6#1)(1995-9#2)(1996-1#1)(1996-5#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-3#1)(1997-5#1)(1997-6#1)(2006-10#1)(2006-7#1)(2006-9#2)(2007-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-10#1)(2010-2#1)(2010-3#1)(2012-1#1)(2013-1#2)(2013-7#1)
to younger adults##2##3##(2010-2#1)(2012-1#1)
to younger patients##2##3##(1991-12#1)(2008-7#1)
to younger##10##2##(1990-12#1)(1991-12#1)(1996-2#1)(2006-9#1)(2008-2#1)(2008-7#1)(2009-4#1)(2010-2#1)(2012-1#1)(2012-2#1)
to your clinical##2##3##(1997-2#1)(2011-2#1)
to your heart##2##3##(2005-9#1)(2007-2#1)
to your##16##2##(1992-3#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-1#1)(1997-2#1)(2005-9#1)(2006-2#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-6#1)(2011-12#1)(2011-2#1)(2013-7#1)
to youth##4##2##(2008-7#1)(2009-4#1)(2010-1#1)(2012-1#1)
to youth's time in##2##4##(2009-7#2)
to zearalenone##3##2##(2008-10#1)(2013-1#2)
to zero after##2##3##(1993-2#1)(1994-5#1)
to zero at an##2##4##(1991-11#1)(2008-10#1)
to zero at##3##3##(1990-11#1)(1991-11#1)(2008-10#1)
to zero for##4##3##(1996-7#1)(2008-2#1)(2008-3#2)
to zero in the##2##4##(2008-1#1)(2008-2#1)
to zero in##5##3##(1992-6#1)(2008-1#1)(2008-11#1)(2008-2#1)(2010-5#1)
to zero or##2##3##(1990-8#1)(1997-7#1)
to zero##52##2##(1990-11#1)(1990-8#1)(1991-11#1)(1991-4#1)(1992-10#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-5#1)(1995-10#1)(1996-12#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-7#2)(2005-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#4)(2008-3#6)(2008-5#1)(2008-7#2)(2008-9#2)(2010-5#2)(2012-2#1)(2012-3#1)(2013-8#2)
to zeta##2##2##(1995-6#1)(2008-6#1)
to zidovudine##3##2##(1995-9#1)(2006-11#1)(2009-4#1)
to zidovudine) from replicating with EC50##2##6##(2011-3#2)
to zinc in the##2##4##(1996-3#1)(2004-4#1)
to zinc in##4##3##(1996-3#1)(2004-4#3)
to zinc##19##2##(1990-9#1)(1991-2#1)(1992-6#2)(1995-5#1)(1996-3#1)(1996-7#4)(2004-11#1)(2004-4#4)(2008-1#1)(2008-12#1)(2010-11#1)(2012-12#1)
to zirconia and##2##3##(2010-12#1)(2011-1#1)
to zone##2##2##(2006-3#1)(2008-7#1)
to ~0##4##2##(2007-12#2)(2008-2#1)(2012-12#1)
to ~1##2##2##(2007-11#1)(2008-3#1)
to ~2%##2##2##(2007-11#1)(2008-2#1)
to α-synuclein##2##2##(2012-1#2)
to β-cell##3##2##(2010-11#3)
to##223394##1##(1990-1#60)(1990-10#478)(1990-11#795)(1990-12#1092)(1990-2#813)(1990-3#605)(1990-4#495)(1990-5#878)(1990-6#424)(1990-7#608)(1990-8#707)(1990-9#427)(1991-1#479)(1991-10#465)(1991-11#479)(1991-12#992)(1991-2#939)(1991-3#699)(1991-4#486)(1991-5#744)(1991-6#581)(1991-7#613)(1991-8#623)(1991-9#729)(1992-1#520)(1992-10#286)(1992-11#556)(1992-12#925)(1992-2#642)(1992-3#924)(1992-4#343)(1992-5#500)(1992-6#808)(1992-7#467)(1992-8#748)(1992-9#689)(1993-1#359)(1993-10#186)(1993-11#745)(1993-12#1177)(1993-2#693)(1993-3#945)(1993-4#371)(1993-5#351)(1993-6#799)(1993-7#330)(1993-8#582)(1993-9#754)(1994-1#237)(1994-10#256)(1994-11#925)(1994-12#1207)(1994-2#1096)(1994-3#1237)(1994-4#141)(1994-5#767)(1994-6#879)(1994-7#125)(1994-8#929)(1994-9#1019)(1995-1#939)(1995-10#383)(1995-11#706)(1995-12#1187)(1995-2#1246)(1995-3#1189)(1995-4#254)(1995-5#838)(1995-6#863)(1995-7#262)(1995-8#924)(1995-9#345)(1996-1#686)(1996-10#410)(1996-11#590)(1996-12#1172)(1996-2#1013)(1996-3#925)(1996-4#466)(1996-5#1087)(1996-6#610)(1996-7#542)(1996-8#743)(1996-9#600)(1997-1#919)(1997-2#1255)(1997-3#945)(1997-4#1131)(1997-5#632)(1997-6#894)(1997-7#978)(1997-8#1041)(1997-9#24)(2003-11#19)(2004-1#99)(2004-10#114)(2004-11#244)(2004-12#197)(2004-2#136)(2004-3#115)(2004-4#174)(2004-5#6)(2004-7#25)(2004-8#36)(2004-9#302)(2005-1#63)(2005-10#694)(2005-11#1457)(2005-12#329)(2005-2#8)(2005-3#57)(2005-4#106)(2005-5#158)(2005-6#63)(2005-7#632)(2005-8#721)(2005-9#275)(2006-1#242)(2006-10#3721)(2006-11#680)(2006-12#1425)(2006-2#801)(2006-3#400)(2006-4#519)(2006-5#873)(2006-6#828)(2006-7#696)(2006-8#1500)(2006-9#494)(2007-1#627)(2007-10#1245)(2007-11#3785)(2007-12#4699)(2007-2#1473)(2007-3#738)(2007-4#1010)(2007-5#720)(2007-6#625)(2007-7#2108)(2007-8#3336)(2007-9#1467)(2008-1#2600)(2008-10#21061)(2008-11#5624)(2008-12#2030)(2008-2#5247)(2008-3#6142)(2008-4#3904)(2008-5#5142)(2008-6#1922)(2008-7#4708)(2008-8#3418)(2008-9#3090)(2009-1#141)(2009-10#965)(2009-11#591)(2009-12#722)(2009-2#706)(2009-3#846)(2009-4#1135)(2009-5#959)(2009-6#765)(2009-7#835)(2009-8#1129)(2009-9#735)(2010-1#377)(2010-10#657)(2010-11#754)(2010-12#1928)(2010-2#1243)(2010-3#748)(2010-4#1225)(2010-5#1063)(2010-6#540)(2010-7#811)(2010-8#1370)(2010-9#733)(2011-1#3056)(2011-10#41)(2011-11#28)(2011-12#722)(2011-2#5758)(2011-3#146)(2011-4#2)(2011-6#1)(2011-7#49)(2011-8#3)(2011-9#21)(2012-1#1698)(2012-10#7)(2012-11#692)(2012-12#3401)(2012-2#4250)(2012-3#2728)(2012-4#16)(2012-5#49)(2012-6#30)(2012-7#38)(2012-8#29)(2012-9#22)(2013-1#6159)(2013-2#2)(2013-3#5)(2013-4#5)(2013-7#1147)(2013-8#2853)
to&quot##2##1##(2007-8#1)(2008-4#1)
to)##5##1##(1991-7#1)(2008-8#1)(2009-7#1)(2010-7#1)(2013-1#1)
to-be-remembered##2##1##(2008-9#1)(2011-2#1)
to/from##2##1##(2009-12#1)(2009-7#1)
toad (Bufo##2##2##(1995-8#1)(2008-5#1)
toad - Bufo regularis##2##4##(2007-1#2)
toad -##3##2##(2007-1#3)
toad##19##1##(1990-11#1)(1992-11#1)(1993-5#2)(1994-5#1)(1995-8#1)(2007-1#5)(2008-12#2)(2008-5#4)(2008-6#1)(2013-1#1)
toadfish##3##1##(1993-12#1)(2010-8#2)
toads (Bufo##2##2##(2008-6#1)(2013-1#1)
toads##7##1##(2008-5#1)(2008-6#4)(2013-1#2)
toast##2##1##(2007-9#1)(2008-11#1)
toasted bread##3##2##(1997-3#3)
toasted##4##1##(1997-3#3)(2012-12#1)
tobacco (Nicotiana tabacum cv##2##4##(2006-12#1)(2008-10#1)
tobacco (Nicotiana tabacum)##3##3##(2008-10#2)(2008-9#1)
tobacco (Nicotiana##7##2##(2006-12#1)(2008-10#3)(2008-9#1)(2011-12#1)(2011-2#1)
tobacco addiction##2##2##(2011-2#1)(2012-12#1)
tobacco and alcohol use##3##4##(2007-6#1)(2008-1#1)(2011-1#1)
tobacco and alcohol##11##3##(1996-1#1)(2007-6#1)(2008-1#1)(2008-10#1)(2009-12#2)(2009-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
tobacco and tomato##2##3##(2008-10#2)
tobacco and##39##2##(1993-11#1)(1994-11#1)(1994-3#1)(1994-4#1)(1994-8#1)(1995-3#1)(1996-1#2)(1996-10#1)(1996-3#1)(1997-1#1)(2005-10#1)(2006-11#1)(2006-12#1)(2007-6#1)(2008-1#1)(2008-10#11)(2008-3#1)(2008-9#1)(2009-12#2)(2009-6#1)(2009-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#1)
tobacco as##3##2##(1990-8#1)(1991-4#1)(2006-12#1)
tobacco blue mold##3##3##(2008-10#3)
tobacco by##3##2##(2006-11#1)(2008-10#1)(2008-6#1)
tobacco can##2##2##(1992-6#1)(2008-9#1)
tobacco cells exhibited##2##3##(2009-6#2)
tobacco cells##8##2##(1996-4#1)(1997-4#1)(2008-10#1)(2009-6#5)
tobacco cessation intervention##2##3##(2008-4#2)
tobacco cessation##11##2##(2006-2#1)(2007-12#3)(2008-4#3)(2009-9#1)(2012-2#2)(2013-1#1)
tobacco chewing##4##2##(2005-11#1)(2008-10#1)(2013-1#2)
tobacco chloroplasts##3##2##(2006-12#3)
tobacco consumption##6##2##(1994-6#2)(1996-12#2)(2008-3#1)(2009-11#1)
tobacco control legislation##2##3##(2012-1#2)
tobacco control##14##2##(1996-1#1)(2008-1#1)(2009-12#4)(2010-2#1)(2011-2#1)(2012-1#5)(2012-12#1)
tobacco cyst nematode##2##3##(2009-3#2)
tobacco cyst##3##2##(2009-3#3)
tobacco dependence##7##2##(1994-7#1)(1997-3#1)(2008-8#2)(2010-11#2)(2013-7#1)
tobacco exhibiting##2##2##(2008-10#2)
tobacco exposed##2##2##(2013-1#2)
tobacco exposure##5##2##(1991-12#2)(1993-4#1)(2012-12#1)(2013-1#1)
tobacco extract##3##2##(2011-2#3)
tobacco habit in##2##3##(1991-6#1)(1993-9#1)
tobacco harm##2##2##(2008-8#2)
tobacco hornworm (Manduca sexta)##2##4##(2006-12#1)(2008-7#1)
tobacco hornworm##5##2##(1991-12#1)(1992-3#1)(2006-12#1)(2008-7#2)
tobacco in the most recent previous growing season##2##8##(2011-2#2)
tobacco in the##3##3##(2008-1#1)(2011-2#2)
tobacco in##9##2##(1992-6#1)(2005-9#1)(2008-1#2)(2008-10#2)(2011-2#2)(2012-2#1)
tobacco industry##3##2##(2009-12#1)(2009-7#2)
tobacco ingredients##2##2##(2009-7#2)
tobacco intervention##4##2##(2006-2#1)(2008-7#1)(2013-1#2)
tobacco is##4##2##(1997-2#1)(2006-12#1)(2006-8#1)(2011-2#1)
tobacco leaf##2##2##(2008-10#2)
tobacco leaves was##2##3##(2008-10#1)(2009-6#1)
tobacco leaves##8##2##(2006-12#1)(2008-10#4)(2008-7#1)(2009-6#1)(2010-4#1)
tobacco markets and##2##3##(2009-7#2)
tobacco mosaic virus isolated from##2##5##(2008-8#1)(2008-9#1)
tobacco mosaic virus##19##3##(1990-5#2)(1991-8#1)(1993-5#1)(1994-3#1)(1997-3#1)(1997-6#1)(2008-10#4)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)
tobacco mosaic##21##2##(1990-5#2)(1991-8#2)(1993-5#1)(1994-3#1)(1997-3#1)(1997-6#1)(2008-10#5)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)
tobacco nuclear##2##2##(1995-2#1)(1996-4#1)
tobacco peroxidase##3##2##(2006-10#3)
tobacco plant##6##2##(1990-5#1)(1997-2#1)(1997-8#1)(2006-12#1)(2008-10#1)(2008-9#1)
tobacco plants and##3##3##(1997-6#1)(2006-12#1)(2011-10#1)
tobacco plants expressing##5##3##(1994-3#1)(1997-6#1)(2006-12#1)(2008-10#1)(2008-8#1)
tobacco plants in##2##3##(2008-10#2)
tobacco plants were##2##3##(2008-10#2)
tobacco plants with##3##3##(2006-12#1)(2008-10#2)
tobacco plants##44##2##(1991-7#3)(1994-3#1)(1995-8#1)(1997-2#3)(1997-6#4)(2006-12#3)(2008-10#22)(2008-8#2)(2008-9#2)(2009-8#2)(2011-10#1)
tobacco product##3##2##(1991-5#1)(1993-4#1)(2009-7#1)
tobacco products to##2##3##(1996-11#2)
tobacco products##9##2##(1991-5#1)(1996-11#3)(2008-4#2)(2009-7#1)(2011-2#1)(2012-1#1)
tobacco protoplasts##10##2##(1994-2#1)(2008-10#4)(2008-11#1)(2008-8#4)
tobacco related##3##2##(1990-4#1)(2005-10#1)(2011-2#1)
tobacco sales to##2##3##(1996-11#1)(2012-1#1)
tobacco sales##3##2##(1991-5#1)(1996-11#1)(2012-1#1)
tobacco samples##2##2##(2008-10#2)
tobacco seeds##2##2##(1994-3#1)(2006-12#1)
tobacco shows##2##2##(2008-10#1)(2008-9#1)
tobacco smoke and lung cancer##2##5##(1993-2#1)(1996-3#1)
tobacco smoke and##5##3##(1993-2#1)(1994-2#1)(1996-3#1)(2008-1#1)(2008-10#1)
tobacco smoke components##2##3##(2013-1#2)
tobacco smoke in##2##3##(1991-12#1)(2005-10#1)
tobacco smoke##31##2##(1990-9#1)(1991-12#2)(1991-3#1)(1991-4#2)(1992-9#1)(1993-11#1)(1993-2#2)(1993-6#1)(1994-2#2)(1995-6#1)(1996-3#2)(2005-10#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-11#1)(2010-2#1)(2010-9#1)(2011-1#1)(2012-11#1)(2013-1#3)
tobacco smoking and##5##3##(1991-9#1)(2009-5#1)(2011-1#1)(2012-12#1)(2013-1#1)
tobacco smoking##15##2##(1991-9#3)(1992-5#1)(1994-2#1)(2008-12#1)(2009-5#1)(2011-1#2)(2012-11#1)(2012-12#1)(2013-1#4)
tobacco snuff addicts##2##3##(2008-4#2)
tobacco snuff##4##2##(2008-4#4)
tobacco suspension cell##2##3##(2008-10#2)
tobacco suspension##3##2##(2008-10#2)(2008-8#1)
tobacco to##2##2##(1991-5#1)(1996-1#1)
tobacco types##2##2##(2007-8#2)
tobacco usage##2##2##(1993-4#1)(2013-1#1)
tobacco use and##4##3##(1997-1#1)(2007-5#1)(2008-4#1)(2011-2#1)
tobacco use control##2##3##(1997-1#2)
tobacco use in Mississippi##2##4##(2010-9#2)
tobacco use in##6##3##(2006-2#1)(2008-6#1)(2009-12#2)(2010-9#2)
tobacco use is##2##3##(2006-2#2)
tobacco use research##2##3##(2008-8#2)
tobacco use was significantly higher among##2##6##(2006-2#2)
tobacco use was##3##3##(2006-2#3)
tobacco use##52##2##(1991-5#2)(1994-3#1)(1996-9#1)(1997-1#6)(2005-11#1)(2006-10#1)(2006-2#9)(2007-12#2)(2007-5#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#2)(2008-8#3)(2008-9#1)(2009-12#4)(2010-7#1)(2010-9#4)(2011-2#3)(2012-1#2)(2013-1#3)
tobacco users##6##2##(2006-2#2)(2007-12#2)(2008-4#1)(2010-9#1)
tobacco was##6##2##(1991-5#1)(1991-8#1)(1994-12#1)(2006-11#1)(2006-12#1)(2008-9#1)
tobacco were##3##2##(1991-8#1)(2008-10#2)
tobacco with##6##2##(2006-12#1)(2007-12#1)(2008-10#2)(2011-2#1)(2012-2#1)
tobacco##630##1##(1990-10#2)(1990-2#1)(1990-4#3)(1990-5#3)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#5)(1991-3#1)(1991-4#4)(1991-5#9)(1991-6#2)(1991-7#3)(1991-8#9)(1991-9#3)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#8)(1992-7#2)(1992-8#4)(1992-9#2)(1993-10#1)(1993-11#2)(1993-2#2)(1993-4#4)(1993-5#2)(1993-6#3)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#6)(1994-4#1)(1994-6#2)(1994-7#1)(1994-8#1)(1995-2#1)(1995-3#3)(1995-6#1)(1995-8#3)(1996-1#6)(1996-10#3)(1996-11#5)(1996-12#2)(1996-3#7)(1996-4#4)(1996-8#2)(1996-9#1)(1997-1#8)(1997-2#9)(1997-3#2)(1997-4#3)(1997-6#5)(1997-8#1)(2005-10#4)(2005-11#2)(2005-6#1)(2005-9#1)(2006-10#5)(2006-11#3)(2006-12#23)(2006-2#17)(2006-8#2)(2007-10#2)(2007-11#3)(2007-12#10)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#7)(2008-1#7)(2008-10#133)(2008-11#6)(2008-12#1)(2008-3#3)(2008-4#15)(2008-5#2)(2008-6#3)(2008-7#7)(2008-8#21)(2008-9#22)(2009-10#1)(2009-11#2)(2009-12#17)(2009-3#5)(2009-5#1)(2009-6#8)(2009-7#10)(2009-8#6)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#3)(2010-4#1)(2010-7#1)(2010-9#8)(2011-1#7)(2011-10#2)(2011-12#2)(2011-2#21)(2012-1#11)(2012-11#3)(2012-12#5)(2012-2#6)(2013-1#28)(2013-7#2)
tobacco-free##6##1##(2006-2#1)(2008-6#5)
tobacco-related morbidity and mortality##2##4##(1997-1#1)(2008-6#1)
tobacco-related neoplasms##3##2##(1990-10#1)(1990-4#2)
tobacco-related##10##1##(1990-10#2)(1990-4#2)(1997-1#2)(2006-2#1)(2008-6#1)(2008-8#2)
tobacco-specific nitrosamine##2##2##(1993-11#1)(1996-11#1)
tobacco-specific nitrosamines##2##2##(1991-5#1)(2013-8#1)
tobacco-specific##4##1##(1991-5#1)(1993-11#1)(1996-11#1)(2013-8#1)
tobaccos##6##1##(2006-11#1)(2008-8#2)(2008-9#2)(2013-1#1)
tobamovirus##9##1##(1995-2#1)(1997-3#1)(1997-6#1)(2008-10#6)
tobamoviruses##4##1##(1997-3#1)(1997-6#1)(2008-10#2)
tobe##5##1##(2008-11#3)(2008-2#2)
tobianus##2##1##(2010-8#2)
toborinone##5##1##(2008-5#5)
tobramycin and##5##2##(1991-3#1)(2007-7#2)(2007-8#1)(2011-1#1)
tobramycin##19##1##(1991-3#1)(2006-10#1)(2007-7#2)(2007-8#11)(2008-7#1)(2009-3#1)(2011-1#1)(2011-2#1)
toceranib##3##1##(2012-1#3)
tocilizumab##5##1##(2008-5#3)(2013-1#2)
tocochromanol##2##1##(2008-11#2)
tocolysis in##2##2##(2012-3#1)(2013-1#1)
tocolysis##5##1##(2006-1#2)(2012-3#1)(2013-1#2)
tocolytic drug##2##2##(1991-4#2)
tocolytic drugs##2##2##(1994-2#1)(1996-11#1)
tocolytic##9##1##(1991-4#2)(1992-12#1)(1993-4#1)(1994-2#1)(1996-11#1)(2006-10#1)(2007-3#1)(2009-1#1)
tocopherol acetate into SLN##3##4##(2008-5#3)
tocopherol acetate##6##2##(2008-5#5)(2012-1#1)
tocopherol and##2##2##(2005-12#1)(2008-5#1)
tocopherol concentration##5##2##(2008-5#3)(2008-6#1)(2009-8#1)
tocopherol in##2##2##(1990-11#1)(2012-2#1)
tocopherol##32##1##(1990-11#1)(1991-9#1)(1992-9#1)(1995-5#1)(2005-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#14)(2008-6#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#3)
tocopherols from##2##2##(2008-10#1)(2008-6#1)
tocopherols in##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
tocopherols were##2##2##(1990-2#1)(2012-2#1)
tocopherols##20##1##(1990-2#2)(1992-9#1)(2007-8#1)(2008-10#3)(2008-5#5)(2008-6#4)(2012-2#4)
tocopheroxyl##2##1##(1992-9#2)
tocopheryl O-glycosides##2##2##(2009-8#2)
tocopheryl##3##1##(2008-12#1)(2009-8#2)
tocoretinate on lichen##2##3##(2011-1#2)
tocoretinate##5##1##(2011-1#5)
tocotrienols##3##1##(1992-9#2)(2008-11#1)
todF##2##1##(1991-7#2)
today a##2##2##(2007-11#1)(2012-12#1)
today an##2##2##(2006-8#1)(2010-9#1)
today and in the future##2##5##(2008-12#1)(2008-4#1)
today and to##2##3##(1994-5#1)(2013-8#1)
today and tomorrow##5##3##(2007-1#1)(2007-12#1)(2007-4#1)(2011-2#1)(2011-3#1)
today and##20##2##(1992-7#1)(1994-5#1)(1995-12#2)(1995-9#1)(1996-12#1)(1996-3#1)(2005-8#1)(2007-1#1)(2007-12#1)(2007-4#1)(2008-11#2)(2008-12#1)(2008-4#1)(2009-6#1)(2011-2#1)(2011-3#1)(2012-9#1)(2013-8#1)
today are##9##2##(1992-3#1)(1995-1#1)(2006-11#1)(2006-6#1)(2007-2#1)(2008-12#1)(2010-10#1)(2010-3#1)(2011-2#1)
today as a##3##3##(1997-3#1)(2006-1#1)(2006-6#1)
today as##7##2##(1992-5#1)(1997-3#1)(2006-1#1)(2006-2#1)(2006-6#1)(2008-7#1)(2011-1#1)
today for##6##2##(1992-10#1)(1995-10#1)(2007-11#1)(2012-11#2)(2012-2#1)
today has##4##2##(1995-4#1)(2007-7#1)(2008-11#1)(2009-12#1)
today in the##3##3##(1992-6#1)(2008-1#1)(2010-6#1)
today in##9##2##(1992-6#1)(1995-3#1)(2005-10#1)(2005-8#1)(2006-7#1)(2008-1#1)(2010-6#1)(2011-2#2)
today is to##2##3##(1990-10#1)(2007-2#1)
today is##16##2##(1990-10#1)(1991-1#1)(1991-11#1)(1991-2#2)(1993-6#1)(1994-1#1)(1994-6#1)(2006-10#1)(2007-2#1)(2007-4#1)(2008-1#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
today it is##2##3##(2005-11#1)(2008-1#1)
today it##3##2##(2005-11#1)(2008-1#1)(2009-8#1)
today of##2##2##(1994-2#1)(2008-9#1)
today one##2##2##(2007-8#1)(2008-10#1)
today than##2##2##(2008-11#1)(2008-5#1)
today that##5##2##(1990-8#1)(1993-6#1)(1997-2#1)(2007-11#1)(2008-1#1)
today the##7##2##(1991-9#1)(1995-11#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-10#1)
today to##3##2##(1994-1#1)(2007-12#1)(2008-5#1)
today we##2##2##(2008-10#1)(2009-9#1)
today with##2##2##(2007-12#1)(2008-12#1)
today##320##1##(1990-10#2)(1990-12#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#1)(1991-2#4)(1991-3#3)(1991-6#2)(1991-9#1)(1992-10#1)(1992-2#1)(1992-3#4)(1992-5#1)(1992-6#2)(1992-7#1)(1993-10#1)(1993-11#3)(1993-2#4)(1993-3#3)(1993-6#3)(1993-9#1)(1994-1#3)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#4)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#5)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#4)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-8#3)(2004-8#1)(2005-10#4)(2005-11#1)(2005-4#1)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#8)(2006-11#2)(2006-12#1)(2006-2#3)(2006-4#1)(2006-6#4)(2006-7#1)(2006-8#8)(2006-9#4)(2007-1#2)(2007-11#7)(2007-12#6)(2007-2#2)(2007-3#2)(2007-4#7)(2007-5#1)(2007-7#4)(2007-8#3)(2007-9#2)(2008-1#9)(2008-10#15)(2008-11#11)(2008-12#3)(2008-3#2)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#2)(2009-4#4)(2009-5#1)(2009-6#3)(2009-8#2)(2009-9#4)(2010-10#3)(2010-12#6)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#4)(2011-2#8)(2011-3#3)(2011-7#1)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#7)(2012-3#2)(2012-9#1)(2013-1#8)(2013-7#2)(2013-8#1)
today's &quot##3##2##(1997-1#1)(2007-8#1)(2010-3#1)
today's changing##2##2##(1994-3#1)(1997-1#1)
today's competitive##5##2##(1990-12#1)(1991-2#1)(1991-3#1)(1994-12#1)(2008-12#1)
today's environment##2##2##(1991-3#1)(1995-12#1)
today's health care##10##3##(1991-12#1)(1991-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-8#1)(2008-1#3)(2008-11#1)
today's health##11##2##(1991-12#1)(1991-3#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-8#1)(2008-1#3)(2008-11#1)
today's healthcare##3##2##(1993-2#1)(1997-1#1)(2008-10#1)
today's hospitals##2##2##(1994-2#1)(2007-9#1)
today's market##3##2##(1991-3#1)(2007-5#1)(2008-12#1)
today's most##2##2##(2006-6#1)(2008-10#1)
today's practice##2##2##(2008-7#1)(2011-2#1)
today's problems##2##2##(2007-5#1)(2011-2#1)
today's radiology##2##2##(2007-4#2)
today's##122##1##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#1)(1991-12#1)(1991-2#2)(1991-3#5)(1992-10#1)(1992-12#1)(1992-2#5)(1993-1#1)(1993-2#1)(1993-3#2)(1994-1#2)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#4)(1997-2#1)(1997-3#2)(2004-3#1)(2005-8#4)(2006-10#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#2)(2007-4#6)(2007-5#3)(2007-8#4)(2007-9#5)(2008-1#5)(2008-10#6)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#3)(2011-7#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#4)
today?##2##1##(1997-5#1)(2006-10#1)
today?]##3##1##(1997-3#1)(1997-4#1)(2008-4#1)
today]##3##1##(1995-5#1)(2006-4#1)(2009-4#1)
toddler##8##1##(2006-10#1)(2006-8#1)(2007-8#1)(2008-11#1)(2012-2#4)
toddlers and##2##2##(2011-1#1)(2012-12#1)
toddlers had##2##2##(1995-3#1)(2008-4#1)
toddlers in the##2##3##(2012-1#1)(2012-2#1)
toddlers with autism spectrum disorders##2##5##(2009-4#1)(2012-2#1)
toddlers with##5##2##(2007-9#1)(2009-4#1)(2012-2#3)
toddlers##31##1##(1991-8#1)(1992-12#2)(1995-3#1)(2005-2#1)(2006-10#3)(2006-3#1)(2007-9#2)(2008-4#4)(2009-4#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#6)
toddlers' fear##2##2##(2012-12#2)
toddlers'##3##1##(2010-2#1)(2012-12#2)
toddlers’ manual search for an occluded object##2##7##(2012-1#2)
todorokite-type manganese##4##2##(2007-2#4)
toe deformity##2##2##(2010-11#1)(2010-3#1)
toe nails##10##2##(1994-6#5)(2007-7#1)(2008-5#2)(2009-2#2)
toe or##2##2##(2006-11#1)(2009-10#1)
toe transfer for##2##3##(2006-6#1)(2009-6#1)
toe transfer##3##2##(2006-6#1)(2009-6#2)
toe##54##1##(1990-9#2)(1992-3#4)(1992-7#1)(1993-12#1)(1994-6#5)(1996-8#1)(2006-11#1)(2006-4#1)(2006-6#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-12#2)(2008-5#3)(2008-7#3)(2009-10#1)(2009-2#2)(2009-6#2)(2009-8#1)(2010-10#1)(2010-11#4)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-9#3)(2012-12#1)(2012-3#1)(2013-1#1)
toenail##3##1##(1990-9#1)(2004-9#1)(2007-5#1)
toenails##7##1##(1994-6#1)(1995-4#1)(2005-11#1)(2008-5#3)(2008-9#1)
toes and##3##2##(1997-1#1)(2008-1#1)(2008-11#1)
toes with##2##2##(1997-3#1)(2011-2#1)
toes##25##1##(1997-1#2)(1997-3#2)(2006-10#3)(2006-3#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#2)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
toes)##2##1##(2008-11#1)(2008-8#1)
toffee##2##1##(2008-10#2)
together a number of##3##4##(1994-12#1)(2008-12#1)(2008-4#1)
together a##7##2##(1994-12#2)(2008-12#1)(2008-4#1)(2011-1#2)(2011-2#1)
together accounted for##2##3##(1995-7#1)(1997-3#1)
together after##3##2##(2007-2#1)(2008-6#1)(2013-8#1)
together all the##2##3##(2008-1#1)(2008-3#1)
together all##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
together along##3##2##(2007-12#1)(2008-11#1)(2008-9#1)
together an##3##2##(2006-4#1)(2008-5#1)(2011-2#1)
together and are##2##3##(1996-3#1)(2008-12#1)
together and form a##2##4##(2007-12#1)(2008-10#1)
together and form##3##3##(2006-12#1)(2007-12#1)(2008-10#1)
together and that##2##3##(2008-10#1)(2008-7#1)
together and were##3##3##(2006-10#1)(2008-10#2)
together and##20##2##(1993-1#1)(1996-1#2)(1996-3#1)(1996-7#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#7)(2008-12#1)(2008-7#1)(2010-4#1)(2012-2#1)
together are##6##2##(1995-2#1)(1997-2#1)(2007-10#1)(2007-4#1)(2008-10#1)(2011-2#1)
together as a##2##3##(1997-4#1)(2005-8#1)
together as##9##2##(1990-12#1)(1995-1#1)(1997-4#1)(2005-8#1)(2006-12#1)(2008-11#2)(2009-10#1)(2010-3#1)
together at##6##2##(2006-10#1)(2007-9#2)(2008-10#2)(2008-7#1)
together based on##3##3##(2008-10#1)(2008-2#1)(2013-1#1)
together basic##3##2##(2005-8#1)(2007-11#1)(2008-4#1)
together because##2##2##(2007-11#1)(2008-10#1)
together but##3##2##(1993-7#1)(2008-10#1)(2010-2#1)
together by a##3##3##(1997-1#1)(2008-4#1)(2008-8#1)
together by an##2##3##(2008-3#1)(2008-4#1)
together by##12##2##(1996-11#1)(1996-6#1)(1997-1#1)(1997-7#1)(2005-10#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-8#1)(2013-1#1)
together can##2##2##(1995-3#1)(2012-2#1)
together clinical##2##2##(1990-3#1)(2007-12#1)
together constitute##3##2##(2007-11#1)(2008-4#1)(2008-8#1)
together could##2##2##(2006-9#1)(2008-9#1)
together different##2##2##(2008-11#1)(2010-3#1)
together explained##2##2##(2011-2#1)(2012-3#1)
together for##14##2##(1996-1#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#2)(2008-6#2)(2008-8#1)(2013-1#1)
together form a##2##3##(2008-3#1)(2010-5#1)
together form the##3##3##(1993-10#1)(1994-3#1)(2009-9#1)
together form##5##2##(1993-10#1)(1994-3#1)(2008-3#1)(2009-9#1)(2010-5#1)
together had##2##2##(2012-2#1)(2013-1#1)
together have##2##2##(2012-12#2)
together health##2##2##(2008-1#1)(2011-9#1)
together in a##16##3##(1991-3#1)(1992-2#1)(1993-12#1)(1996-12#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#1)(2010-4#1)(2013-1#2)
together in the same##3##4##(1992-6#1)(1993-9#1)(1997-4#1)
together in the##10##3##(1991-12#1)(1992-6#1)(1993-9#1)(1995-11#1)(1997-4#1)(2008-10#1)(2009-9#2)(2012-7#1)(2013-7#1)
together in time##2##3##(1994-8#1)(2008-6#1)
together in##52##2##(1991-12#1)(1991-3#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-11#1)(1996-12#2)(1997-4#2)(1997-5#1)(1997-6#2)(2006-12#1)(2006-4#2)(2007-11#1)(2007-12#2)(2007-4#1)(2007-5#2)(2008-10#5)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#2)(2009-10#3)(2009-5#1)(2009-9#2)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-7#1)(2013-1#3)(2013-7#1)
together indicate that##3##3##(1990-7#1)(1996-12#1)(2008-7#1)
together into a##3##3##(2008-10#2)(2008-5#1)
together into##6##2##(1996-12#1)(2007-11#1)(2008-10#2)(2008-5#1)(2012-2#1)
together make up##2##3##(2008-9#1)(2009-10#1)
together make##3##2##(2008-9#1)(2009-10#1)(2011-2#1)
together many##2##2##(2008-5#1)(2008-9#1)
together of##2##2##(2007-8#1)(2013-1#1)
together on the##2##3##(1991-12#1)(1995-2#1)
together on##3##2##(1991-12#1)(1995-2#1)(2006-3#1)
together or##6##2##(1990-8#1)(2006-5#1)(2008-10#1)(2008-9#1)(2009-2#1)(2011-12#1)
together over##2##2##(2009-9#1)(2013-1#1)
together provide##2##2##(2008-2#1)(2011-1#1)
together researchers##2##2##(2005-7#1)(2007-9#1)
together some of##2##3##(2010-5#1)(2012-12#1)
together some##4##2##(2007-5#1)(2008-8#1)(2010-5#1)(2012-12#1)
together suggest that##5##3##(1990-12#1)(1994-5#1)(2008-3#1)(2008-5#1)(2012-1#1)
together suggest##6##2##(1990-12#1)(1994-5#1)(1995-6#1)(2008-3#1)(2008-5#1)(2012-1#1)
together the main##2##3##(2008-2#1)(2010-4#1)
together the most common##2##4##(2006-10#1)(2008-9#1)
together the##24##2##(1991-5#1)(1996-1#1)(1996-4#1)(1997-3#1)(1997-6#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-8#1)
together their##2##2##(1990-12#1)(2008-8#1)
together these data suggest##4##4##(1990-8#1)(2009-9#1)(2012-11#2)
together these##17##2##(1990-8#1)(1991-1#1)(1992-2#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-7#1)(1994-9#1)(1995-3#1)(1997-1#1)(1997-6#1)(2008-7#1)(2009-9#1)(2010-2#1)(2012-11#2)(2012-12#1)
together through##2##2##(1996-5#1)(2005-11#1)
together throughout the##2##3##(2008-7#1)(2010-5#1)
together to address##4##3##(1991-3#1)(1994-2#1)(2006-1#1)(2013-8#1)
together to develop a##2##4##(1997-2#1)(2010-7#1)
together to develop##4##3##(1997-2#1)(2010-2#1)(2010-7#1)(2010-8#1)
together to form a##2##4##(1992-6#1)(2008-2#1)
together to form##5##3##(1992-6#1)(1995-2#1)(2007-2#1)(2008-11#1)(2008-2#1)
together to identify##2##3##(1995-1#1)(2005-8#1)
together to make##3##3##(2008-11#1)(2008-3#1)(2010-11#1)
together to produce##2##3##(2010-4#1)(2011-1#1)
together to share their##2##4##(2008-7#1)(2010-11#1)
together to##52##2##(1991-2#1)(1991-3#1)(1992-11#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-1#1)(1995-2#4)(1996-2#1)(1996-3#1)(1997-2#1)(2005-8#1)(2006-1#1)(2006-12#1)(2006-4#1)(2006-9#1)(2007-1#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-12#2)(2009-2#1)(2010-10#1)(2010-11#5)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-8#2)
together via##2##2##(1990-8#1)(2008-7#1)
together was##3##2##(1997-4#1)(2006-10#1)(2007-12#1)
together were##5##2##(1997-3#1)(2004-11#1)(2007-8#1)(2010-2#1)(2011-12#1)
together with H+/K(+)-ATPase are##2##4##(1994-2#2)
together with a 3##2##4##(1990-11#1)(1992-3#1)
together with a brief##3##4##(1994-4#1)(2008-3#1)(2008-6#1)
together with a decrease in##2##5##(1995-10#1)(1996-9#1)
together with a discussion on the##2##6##(2008-1#1)(2008-11#1)
together with a discussion on##3##5##(2008-1#1)(2008-11#1)(2008-8#1)
together with a discussion##4##4##(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)
together with a highly##2##4##(1993-2#1)(1994-12#1)
together with a method##2##4##(2008-2#1)(2008-4#1)
together with a new##2##4##(1993-6#1)(2009-7#1)
together with a reduction of##2##5##(1993-12#1)(2008-10#1)
together with a review of the literature##3##7##(1996-3#1)(2011-2#1)(2012-2#1)
together with a review of the##4##6##(1991-2#1)(1996-3#1)(2011-2#1)(2012-2#1)
together with a review of##5##5##(1991-2#1)(1996-3#1)(2008-2#1)(2011-2#1)(2012-2#1)
together with a series of##3##5##(1991-12#1)(2007-11#1)(2009-12#1)
together with a short##2##4##(1993-12#1)(1994-8#1)
together with a unique##2##4##(1997-8#1)(2008-5#1)
together with a##111##3##(1990-11#2)(1990-12#2)(1991-12#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-4#2)(1994-5#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-12#2)(1995-5#1)(1995-9#1)(1996-12#2)(1996-3#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#4)(1997-8#3)(2004-2#1)(2005-8#1)(2006-11#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
together with an excellent discussion of the##2##7##(2008-9#2)
together with an increase in##4##5##(1991-9#1)(1993-11#1)(1994-12#1)(2008-5#1)
together with an increase##5##4##(1991-5#1)(1991-9#1)(1993-11#1)(1994-12#1)(2008-5#1)
together with an##26##3##(1991-5#1)(1991-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-3#1)(1996-4#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-5#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-7#1)(2011-2#1)(2012-3#1)
together with analysis of##2##4##(1994-12#1)(2010-12#1)
together with changes in##2##4##(2006-6#1)(2008-7#1)
together with chemical##3##3##(2004-4#1)(2008-10#1)(2012-2#1)
together with collagen##2##3##(2007-11#1)(2008-5#1)
together with computer##2##3##(2008-3#2)
together with control##2##3##(2005-11#1)(2008-10#1)
together with copper##2##3##(2008-10#1)(2008-5#1)
together with data##3##3##(1996-4#1)(1997-4#1)(2008-6#1)
together with discussion of##2##4##(2007-11#1)(2011-12#1)
together with elevated##3##3##(1996-11#1)(2006-6#1)(2008-5#1)
together with evidence##4##3##(1994-6#1)(1996-4#1)(2005-7#1)(2011-1#1)
together with examples that##2##4##(2009-12#1)(2010-10#1)
together with examples##3##3##(2007-12#1)(2009-12#1)(2010-10#1)
together with experimental results##2##4##(2007-11#1)(2008-2#1)
together with experimental##3##3##(2007-11#1)(2008-2#1)(2008-4#1)
together with genetic##2##3##(2008-5#1)(2013-8#1)
together with high##3##3##(1991-2#1)(2007-8#1)(2013-8#1)
together with improved##2##3##(1997-1#1)(2008-7#1)
together with in##3##3##(1997-1#1)(2004-9#1)(2008-3#1)
together with increased##2##3##(2008-10#1)(2012-12#1)
together with information on the##2##5##(1997-2#1)(2010-12#1)
together with its##13##3##(1990-7#1)(1993-8#1)(1996-10#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-5#1)(2010-5#1)(2011-1#1)(2013-1#1)
together with known##2##3##(2007-1#1)(2008-8#1)
together with lack of##2##4##(2008-3#1)(2008-9#1)
together with limited##2##3##(2006-8#1)(2011-3#1)
together with low##3##3##(2007-11#1)(2008-10#1)(2008-7#1)
together with machine learning technologies##2##5##(2013-1#2)
together with maternal##2##3##(1995-8#1)(2008-1#1)
together with multiple##2##3##(2007-12#1)(2008-5#1)
together with oral##2##3##(2007-11#1)(2007-7#1)
together with other clinical##3##4##(1996-5#1)(2012-11#2)
together with other factors##2##4##(2005-7#1)(2008-4#1)
together with other##26##3##(1990-11#1)(1990-8#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-8#1)(1993-6#1)(1993-9#1)(1996-5#1)(1996-6#1)(2004-4#1)(2005-7#1)(2006-2#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#2)(2012-11#2)(2013-7#1)(2013-8#1)
together with others##2##3##(1991-8#1)(1995-9#1)
together with our observation##2##4##(1992-3#1)(1996-6#1)
together with our previous results##2##5##(1992-4#1)(1996-10#1)
together with our previous##5##4##(1991-4#1)(1992-4#1)(1994-11#1)(1996-10#1)(1996-6#1)
together with our recent##2##4##(1992-5#1)(2012-2#1)
together with our##10##3##(1991-4#1)(1992-3#1)(1992-4#1)(1992-5#1)(1994-11#1)(1996-10#1)(1996-6#2)(2008-4#1)(2012-2#1)
together with oxygen##2##3##(2008-10#2)
together with partial##2##3##(2007-11#1)(2008-10#1)
together with potassium##2##3##(1997-7#1)(2008-10#1)
together with previous findings##4##4##(1991-11#2)(1994-12#1)(2008-8#1)
together with previous observations##3##4##(1991-9#1)(1993-12#1)(2008-6#1)
together with previous results##2##4##(1993-3#1)(2008-11#1)
together with previous studies##2##4##(1991-10#1)(2012-3#1)
together with previous##14##3##(1990-9#1)(1991-10#1)(1991-11#2)(1991-3#1)(1991-9#1)(1993-12#1)(1993-3#1)(1994-12#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-3#1)
together with previously##3##3##(1996-3#1)(1996-5#1)(2012-2#1)
together with published data##2##4##(1990-3#1)(1992-7#1)
together with published##3##3##(1990-3#1)(1992-7#1)(2007-8#1)
together with recent##4##3##(1993-12#1)(1996-6#1)(2012-2#1)(2013-7#1)
together with recommendations##2##3##(2005-11#1)(2007-7#1)
together with safety##2##3##(2008-4#1)(2008-8#1)
together with serum##3##3##(1991-12#1)(1995-3#1)(1996-3#1)
together with several##7##3##(1993-8#1)(1994-6#1)(1997-5#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
together with small##2##3##(1991-12#1)(2008-3#1)
together with some##8##3##(1993-12#1)(1995-6#1)(2006-6#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-12#1)(2009-10#1)
together with the appearance of##3##5##(1995-3#1)(2008-7#1)(2009-2#1)
together with the application of##3##5##(2007-2#1)(2008-10#1)(2010-11#1)
together with the complete genome sequence and annotation##14##8##(2011-2#14)
together with the complete genome sequence##23##6##(2011-2#23)
together with the complete##24##4##(2011-2#24)
together with the fact that##2##5##(1992-7#1)(1993-11#1)
together with the known##6##4##(1990-3#1)(1991-2#1)(2007-1#4)
together with the long##2##4##(2007-11#1)(2013-8#1)
together with the observation that##2##5##(1997-5#1)(2005-8#1)
together with the observation##3##4##(1997-5#1)(2005-8#1)(2010-5#1)
together with the outcome##2##4##(2009-5#1)(2010-12#1)
together with the predicted##2##4##(1991-8#1)(1996-8#1)
together with the previous##2##4##(1992-2#1)(2012-2#1)
together with the results of##5##5##(1994-3#1)(1996-11#1)(2006-7#1)(2008-3#1)(2008-5#1)
together with the results##6##4##(1994-3#1)(1996-11#1)(2006-7#1)(2008-3#1)(2008-5#1)(2008-9#1)
together with the two##2##4##(2006-12#1)(2007-1#1)
together with the use##2##4##(1996-5#1)(2008-8#1)
together with the##251##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-2#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-2#2)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#2)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#5)(1997-5#4)(1997-6#1)(1997-7#2)(2004-9#1)(2005-10#1)(2005-11#2)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#4)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#7)(2007-11#4)(2007-12#4)(2007-2#3)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#21)(2008-11#5)(2008-2#9)(2008-3#12)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#5)(2009-5#1)(2009-6#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#34)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#5)
together with their implications##2##4##(1990-6#1)(1997-7#1)
together with their respective##2##4##(2006-6#1)(2008-10#1)
together with their##23##3##(1990-6#1)(1991-1#1)(1991-9#1)(1992-12#1)(1995-8#1)(1997-7#1)(2006-6#1)(2007-12#1)(2008-10#5)(2008-5#2)(2008-8#1)(2008-9#2)(2009-2#1)(2010-6#1)(2012-4#1)(2013-1#1)(2013-8#1)
together with theoretical##4##3##(2008-10#1)(2008-3#1)(2008-9#1)(2013-1#1)
together with those of the##2##5##(1997-7#1)(2008-4#1)
together with those of##3##4##(1997-7#1)(2008-4#2)
together with those reported previously##2##5##(1996-4#1)(2006-10#1)
together with those##9##3##(1994-11#1)(1996-4#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-4#2)(2011-1#1)(2011-2#1)
together with three known##3##4##(2006-12#3)
together with three##4##3##(2006-12#3)(2008-3#1)
together with two##7##3##(1994-11#1)(2007-1#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-3#1)(2012-2#1)
together with##931##2##(1990-10#1)(1990-11#5)(1990-12#4)(1990-2#4)(1990-3#3)(1990-4#3)(1990-5#2)(1990-6#2)(1990-7#5)(1990-8#4)(1990-9#2)(1991-1#3)(1991-10#2)(1991-11#4)(1991-12#6)(1991-2#8)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#3)(1991-9#8)(1992-1#1)(1992-11#4)(1992-12#1)(1992-2#3)(1992-3#2)(1992-4#2)(1992-5#3)(1992-7#3)(1992-8#5)(1992-9#1)(1993-1#3)(1993-10#2)(1993-11#3)(1993-12#7)(1993-2#4)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#4)(1993-9#2)(1994-10#2)(1994-11#6)(1994-12#9)(1994-2#2)(1994-3#3)(1994-4#3)(1994-5#2)(1994-6#3)(1994-8#4)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#5)(1995-3#2)(1995-4#1)(1995-5#4)(1995-6#2)(1995-8#3)(1995-9#2)(1996-1#1)(1996-10#4)(1996-11#2)(1996-12#3)(1996-2#5)(1996-3#6)(1996-4#5)(1996-5#6)(1996-6#6)(1996-7#2)(1996-8#3)(1996-9#2)(1997-1#4)(1997-2#8)(1997-3#3)(1997-4#12)(1997-5#5)(1997-6#2)(1997-7#6)(1997-8#7)(2004-2#1)(2004-4#2)(2004-9#2)(2005-10#3)(2005-11#5)(2005-12#1)(2005-7#3)(2005-8#2)(2005-9#1)(2006-10#6)(2006-11#3)(2006-12#11)(2006-2#5)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#10)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#16)(2007-11#22)(2007-12#14)(2007-2#7)(2007-3#1)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#6)(2007-8#11)(2007-9#5)(2008-1#9)(2008-10#92)(2008-11#19)(2008-12#3)(2008-2#22)(2008-3#34)(2008-4#17)(2008-5#36)(2008-6#9)(2008-7#17)(2008-8#9)(2008-9#15)(2009-10#2)(2009-11#1)(2009-12#5)(2009-2#9)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#7)(2010-12#5)(2010-2#2)(2010-3#3)(2010-5#8)(2010-6#2)(2010-7#2)(2010-8#5)(2010-9#2)(2011-1#12)(2011-12#6)(2011-2#47)(2011-3#2)(2012-1#4)(2012-11#3)(2012-12#11)(2012-2#16)(2012-3#7)(2012-4#1)(2012-9#1)(2013-1#10)(2013-7#5)(2013-8#13)
together within the##3##3##(1990-12#1)(1991-12#1)(1991-5#1)
together within##5##2##(1990-12#1)(1991-12#1)(1991-5#1)(1992-6#1)(2005-5#1)
together##1712##1##(1990-10#2)(1990-11#6)(1990-12#10)(1990-2#4)(1990-3#5)(1990-4#3)(1990-5#3)(1990-6#3)(1990-7#6)(1990-8#8)(1990-9#3)(1991-1#4)(1991-10#5)(1991-11#4)(1991-12#13)(1991-2#9)(1991-3#7)(1991-4#3)(1991-5#5)(1991-6#3)(1991-7#4)(1991-8#5)(1991-9#9)(1992-1#4)(1992-11#7)(1992-12#2)(1992-2#5)(1992-3#3)(1992-4#2)(1992-5#4)(1992-6#3)(1992-7#4)(1992-8#9)(1992-9#1)(1993-1#5)(1993-10#3)(1993-11#7)(1993-12#13)(1993-2#6)(1993-3#9)(1993-4#2)(1993-5#1)(1993-6#8)(1993-7#2)(1993-8#5)(1993-9#5)(1994-10#2)(1994-11#8)(1994-12#15)(1994-2#3)(1994-3#8)(1994-4#3)(1994-5#5)(1994-6#6)(1994-7#1)(1994-8#6)(1994-9#7)(1995-1#8)(1995-10#2)(1995-11#5)(1995-12#7)(1995-2#13)(1995-3#7)(1995-4#1)(1995-5#6)(1995-6#9)(1995-7#3)(1995-8#6)(1995-9#3)(1996-1#8)(1996-10#6)(1996-11#4)(1996-12#8)(1996-2#6)(1996-3#9)(1996-4#7)(1996-5#12)(1996-6#7)(1996-7#3)(1996-8#5)(1996-9#3)(1997-1#9)(1997-2#17)(1997-3#7)(1997-4#18)(1997-5#8)(1997-6#10)(1997-7#16)(1997-8#10)(2003-11#2)(2004-10#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-4#2)(2004-7#1)(2004-9#2)(2005-10#8)(2005-11#10)(2005-12#1)(2005-5#1)(2005-7#4)(2005-8#9)(2005-9#3)(2006-1#2)(2006-10#11)(2006-11#4)(2006-12#16)(2006-2#7)(2006-3#3)(2006-4#6)(2006-5#4)(2006-6#12)(2006-7#2)(2006-8#3)(2006-9#4)(2007-1#19)(2007-10#4)(2007-11#33)(2007-12#30)(2007-2#11)(2007-3#3)(2007-4#6)(2007-5#7)(2007-6#2)(2007-7#7)(2007-8#21)(2007-9#11)(2008-1#14)(2008-10#154)(2008-11#41)(2008-12#12)(2008-2#37)(2008-3#46)(2008-4#31)(2008-5#58)(2008-6#17)(2008-7#35)(2008-8#21)(2008-9#30)(2009-1#1)(2009-10#10)(2009-11#2)(2009-12#9)(2009-2#11)(2009-3#5)(2009-4#3)(2009-5#8)(2009-6#4)(2009-7#2)(2009-8#5)(2009-9#7)(2010-1#1)(2010-10#2)(2010-11#14)(2010-12#9)(2010-2#9)(2010-3#5)(2010-4#4)(2010-5#12)(2010-6#2)(2010-7#4)(2010-8#8)(2010-9#2)(2011-1#23)(2011-10#1)(2011-12#8)(2011-2#63)(2011-3#2)(2011-9#1)(2012-1#7)(2012-11#6)(2012-12#25)(2012-2#34)(2012-3#16)(2012-4#1)(2012-7#2)(2012-9#1)(2013-1#35)(2013-7#7)(2013-8#29)
toilet and##2##2##(2008-1#1)(2011-12#1)
toilet##14##1##(1996-9#3)(2006-4#1)(2007-12#1)(2008-1#4)(2008-10#1)(2009-9#1)(2010-10#1)(2010-11#1)(2011-12#1)
toileting##3##1##(1991-8#3)
toiletry##2##1##(2008-5#2)
toilets##2##1##(1994-4#1)(2008-10#1)
tokamak edge##2##2##(1990-7#1)(1992-8#1)
tokamak##9##1##(1990-2#1)(1990-4#1)(1990-7#1)(1990-9#1)(1992-8#1)(1993-5#1)(1994-10#1)(1994-2#1)(2013-8#1)
tokarensis##2##1##(2008-6#2)
token##4##1##(1991-2#1)(1992-6#1)(2007-8#1)(2013-1#1)
tokens##7##1##(2008-7#1)(2013-1#6)
tolB##2##1##(1996-10#2)
tolQ##2##1##(1996-10#2)
tolQRABP6##2##1##(1996-10#2)
tolbutamide##14##1##(1991-1#1)(1991-12#6)(1991-3#4)(1995-3#1)(2007-10#2)
tolcapone##6##1##(1993-11#2)(1995-5#3)(2008-11#1)
told a##2##2##(1990-6#1)(2008-11#1)
told about the##2##3##(2008-10#1)(2013-1#1)
told by##3##2##(1993-12#1)(1993-9#1)(2009-10#1)
told me##4##2##(2007-8#1)(2007-9#1)(2009-10#1)(2013-7#1)
told that they##2##3##(1995-6#1)(2006-4#1)
told that##6##2##(1995-6#1)(2005-9#2)(2006-4#1)(2010-4#1)(2010-9#1)
told the##3##2##(1996-6#1)(2007-8#1)(2008-3#1)
told to be##3##3##(2006-12#1)(2012-12#2)
told to##7##2##(1991-8#1)(1992-8#1)(1995-5#1)(2006-12#1)(2008-11#1)(2012-12#2)
told what operation they##2##4##(2007-2#2)
told you##2##2##(2008-10#1)(2011-2#1)
told##44##1##(1990-6#1)(1991-4#1)(1991-8#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-1#1)(1995-5#2)(1995-6#2)(1996-11#1)(1996-6#1)(2005-9#2)(2006-12#1)(2006-4#1)(2007-2#3)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-9#1)(2009-10#2)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
tolerability and efficacy of##5##4##(1990-7#1)(2005-8#1)(2008-10#1)(2008-2#1)(2010-12#1)
tolerability and immunogenicity of##2##4##(2007-11#1)(2013-1#1)
tolerability and safety##3##3##(1996-1#1)(2006-6#1)(2009-11#1)
tolerability and##25##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-3#1)(1992-11#1)(1996-1#2)(1997-8#1)(2005-8#1)(2005-9#1)(2006-6#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-5#2)(2008-6#1)(2009-11#2)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
tolerability are##3##2##(1990-3#1)(2008-1#1)(2008-5#1)
tolerability compared with##2##3##(2007-1#1)(2008-3#1)
tolerability data##2##2##(2005-8#1)(2007-11#1)
tolerability for##2##2##(2005-7#1)(2006-10#1)
tolerability in##2##2##(2011-1#1)(2013-7#1)
tolerability of an##5##3##(1991-2#1)(1992-11#1)(1992-4#1)(2008-3#1)(2011-2#1)
tolerability of exenatide in##2##4##(2012-3#2)
tolerability of the##10##3##(1990-10#1)(1990-2#1)(1990-7#1)(1991-2#1)(1992-10#2)(1996-1#2)(2008-3#1)(2010-12#1)
tolerability of this##3##3##(1996-4#1)(2006-6#1)(2008-5#1)
tolerability of##64##2##(1990-10#3)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-2#3)(1991-7#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-4#2)(1994-12#1)(1994-6#1)(1996-1#2)(1996-4#1)(1996-9#1)(1997-8#3)(2005-7#1)(2006-10#2)(2006-2#2)(2006-6#1)(2007-11#4)(2007-7#2)(2008-3#8)(2008-5#2)(2009-11#1)(2009-12#1)(2009-8#2)(2009-9#1)(2010-12#2)(2011-2#2)(2012-2#1)(2012-3#4)(2013-1#1)
tolerability profile of##5##3##(2007-11#3)(2009-8#1)(2010-11#1)
tolerability profile##11##2##(1990-1#1)(2005-8#1)(2006-10#1)(2007-11#3)(2008-3#1)(2009-8#1)(2010-11#2)(2010-12#1)
tolerability profiles of##2##3##(2008-10#1)(2008-3#1)
tolerability to##4##2##(2005-7#1)(2008-5#1)(2013-1#2)
tolerability was##4##2##(1990-7#1)(1992-11#1)(2006-10#1)(2011-2#1)
tolerability with##2##2##(2008-5#1)(2009-8#1)
tolerability##176##1##(1990-1#1)(1990-10#3)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#2)(1990-6#1)(1990-7#4)(1991-2#4)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-10#2)(1992-11#3)(1992-4#2)(1993-9#1)(1994-12#1)(1994-6#2)(1996-1#4)(1996-4#2)(1996-9#1)(1997-1#2)(1997-3#1)(1997-8#5)(2004-12#1)(2004-3#1)(2005-7#4)(2005-8#3)(2005-9#1)(2006-10#6)(2006-2#2)(2006-6#3)(2007-1#1)(2007-10#3)(2007-11#17)(2007-7#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#17)(2008-4#1)(2008-5#11)(2008-6#1)(2008-8#1)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#4)(2009-9#1)(2010-11#5)(2010-12#4)(2011-1#3)(2011-2#4)(2012-2#2)(2012-3#6)(2013-1#5)(2013-7#1)(2013-8#1)
tolerable daily##2##2##(2011-2#1)(2013-8#1)
tolerable in the##2##3##(2008-10#1)(2008-6#1)
tolerable levels##3##2##(2005-9#1)(2007-11#1)(2008-10#1)
tolerable limit##3##2##(2013-1#1)(2013-8#2)
tolerable to##2##2##(2010-12#1)(2010-8#1)
tolerable upper intake levels##2##4##(2005-3#2)
tolerable##54##1##(1991-12#1)(1992-12#1)(1992-2#1)(1992-7#1)(1994-4#2)(2004-1#1)(2005-3#2)(2005-9#1)(2006-10#1)(2006-6#1)(2007-10#3)(2007-11#3)(2007-12#3)(2007-2#1)(2007-8#1)(2008-10#11)(2008-2#4)(2008-3#1)(2008-6#1)(2008-8#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#4)
tolerance (in##2##2##(2007-9#1)(2011-2#1)
tolerance against##3##2##(2006-11#1)(2007-5#1)(2008-6#1)
tolerance among##2##2##(2008-10#1)(2011-1#1)
tolerance analysis##3##2##(2008-3#3)
tolerance and a##2##3##(2008-1#1)(2008-3#1)
tolerance and adaptation##2##3##(2013-1#2)
tolerance and dependence##7##3##(1991-1#2)(1996-10#2)(2005-8#1)(2006-10#1)(2007-10#1)
tolerance and its##2##3##(2008-10#2)
tolerance and quality of life##2##5##(2008-7#1)(2010-8#1)
tolerance and resistance##2##3##(1996-2#1)(2008-5#1)
tolerance and response##2##3##(2007-1#1)(2013-1#1)
tolerance and sensitization##2##3##(2009-9#2)
tolerance and the##3##3##(1991-3#1)(2008-2#1)(2008-5#1)
tolerance and##68##2##(1991-1#2)(1991-3#1)(1992-7#1)(1993-12#1)(1993-2#1)(1995-10#1)(1995-2#2)(1996-10#2)(1996-12#1)(1996-2#1)(1996-4#1)(2005-1#1)(2005-12#1)(2005-8#1)(2006-10#6)(2006-12#2)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-3#2)(2013-1#5)(2013-8#1)
tolerance at##4##2##(2006-6#1)(2008-10#1)(2008-12#1)(2012-3#1)
tolerance between##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
tolerance breaking##2##2##(2008-10#2)
tolerance but##2##2##(2009-8#1)(2012-1#1)
tolerance by##10##2##(1994-11#1)(1996-10#1)(1997-1#1)(2007-11#1)(2008-3#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
tolerance can##2##2##(1995-2#1)(2008-2#1)
tolerance compared to the##2##4##(1997-4#1)(2006-9#1)
tolerance compared##3##2##(1997-4#1)(2006-9#1)(2008-10#1)
tolerance criterion##3##2##(2006-11#1)(2007-1#1)(2008-2#1)
tolerance data for the##2##4##(2006-11#1)(2007-4#1)
tolerance data##3##2##(2006-11#1)(2007-4#2)
tolerance development##2##2##(1991-1#1)(2005-9#1)
tolerance develops##2##2##(1995-10#1)(1995-2#1)
tolerance distribution function##2##3##(1995-4#2)
tolerance distribution##4##2##(1995-4#4)
tolerance during##4##2##(1990-8#1)(1996-12#1)(2005-1#1)(2012-3#1)
tolerance following##2##2##(1995-2#1)(2008-5#1)
tolerance for most##2##3##(2008-10#2)
tolerance for the##3##3##(2006-11#1)(2008-2#2)
tolerance for##15##2##(1995-12#1)(1997-1#1)(1997-3#1)(2006-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#2)(2010-2#1)
tolerance from##2##2##(2007-4#1)(2013-1#1)
tolerance has been##4##3##(1991-9#1)(1992-6#1)(2008-1#2)
tolerance has##5##2##(1991-9#1)(1992-6#1)(2007-11#1)(2008-1#2)
tolerance have##2##2##(2008-11#1)(2008-7#1)
tolerance in plants##4##3##(2006-11#1)(2008-9#1)(2011-2#2)
tolerance in rats##4##3##(1991-8#1)(1996-2#1)(2007-8#2)
tolerance in seeds of##2##4##(2013-7#2)
tolerance in the##4##3##(1991-1#1)(2008-10#1)(2008-5#1)(2009-9#1)
tolerance in vivo##2##3##(1991-9#1)(2006-10#1)
tolerance in##53##2##(1991-1#1)(1991-8#1)(1991-9#1)(1993-11#1)(1995-11#1)(1995-12#1)(1995-9#1)(1996-10#1)(1996-2#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-8#2)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-1#1)(2013-1#2)(2013-7#4)(2013-8#2)
tolerance induced by##3##3##(1990-8#1)(1991-12#1)(1992-6#1)
tolerance induction by##2##3##(2007-11#1)(2008-1#1)
tolerance induction##13##2##(1991-12#1)(2005-8#1)(2006-11#1)(2007-11#3)(2007-5#1)(2008-1#1)(2008-11#2)(2010-7#2)(2011-3#1)
tolerance interval##2##2##(2008-10#2)
tolerance into##2##2##(1991-12#1)(2008-1#1)
tolerance is an##2##3##(1997-4#1)(2012-11#1)
tolerance is defined as##2##4##(2007-11#1)(2008-5#1)
tolerance is the##4##3##(2006-10#1)(2008-11#1)(2012-1#1)(2013-8#1)
tolerance is##21##2##(1991-8#1)(1991-9#1)(1992-5#1)(1993-12#1)(1995-8#1)(1996-9#1)(1997-4#1)(2006-10#2)(2006-11#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-8#1)
tolerance level##2##2##(2008-10#1)(2008-2#1)
tolerance levels##2##2##(2008-10#1)(2009-2#1)
tolerance limit of##5##3##(2008-10#2)(2009-6#3)
tolerance limit##8##2##(1991-3#1)(2008-10#3)(2008-12#1)(2009-6#3)
tolerance limits for##3##3##(2008-10#3)
tolerance limits of##6##3##(2008-10#6)
tolerance limits##11##2##(2008-10#11)
tolerance may##5##2##(1992-2#1)(2006-4#1)(2006-6#1)(2007-11#1)(2008-1#1)
tolerance mechanisms##2##2##(2008-10#1)(2012-1#1)
tolerance might##2##2##(1997-8#1)(2008-10#1)
tolerance of L##2##3##(2010-4#1)(2011-1#1)
tolerance of a##2##3##(2008-3#1)(2008-6#1)
tolerance of deviance##4##3##(2011-12#4)
tolerance of different##2##3##(2004-4#1)(2011-2#1)
tolerance of enteral##2##3##(2006-4#1)(2012-2#1)
tolerance of fabrication errors##2##4##(2008-2#2)
tolerance of the hip##4##4##(2006-11#4)
tolerance of the human hip##2##5##(2006-11#2)
tolerance of the human##6##4##(2006-11#4)(2007-1#1)(2007-4#1)
tolerance of the knee##3##4##(2006-11#1)(2007-4#2)
tolerance of the spinal cord##2##5##(2006-2#1)(2007-11#1)
tolerance of the##45##3##(1990-11#1)(1992-2#1)(1993-9#1)(1996-5#1)(1997-6#1)(2004-4#1)(2006-11#18)(2006-2#1)(2007-1#2)(2007-11#1)(2007-4#6)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
tolerance of this##2##3##(2005-11#1)(2008-5#1)
tolerance of##132##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-6#1)(1992-1#1)(1992-2#3)(1993-11#1)(1993-5#1)(1993-9#1)(1994-11#2)(1995-4#1)(1995-8#1)(1996-5#3)(1997-1#2)(1997-3#1)(1997-6#1)(2004-4#5)(2005-11#1)(2006-10#1)(2006-11#20)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-4#9)(2007-7#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#5)(2008-6#2)(2008-8#1)(2009-2#1)(2009-7#1)(2010-12#2)(2010-3#1)(2010-4#3)(2011-1#4)(2011-12#7)(2011-2#5)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
tolerance on##3##2##(1991-12#1)(1996-10#1)(2008-3#1)
tolerance or##3##2##(1994-12#1)(2010-7#1)(2011-2#1)
tolerance phenomenon##2##2##(1996-10#1)(2008-10#1)
tolerance response##2##2##(2008-10#1)(2011-2#1)
tolerance target##2##2##(2009-7#2)
tolerance test##40##2##(1990-8#1)(1992-8#1)(1994-12#1)(1995-7#1)(1997-3#1)(2005-10#1)(2005-8#2)(2006-6#3)(2006-9#1)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2009-3#1)(2009-6#1)(2011-1#4)(2011-2#2)(2012-12#1)(2012-3#2)(2012-7#3)
tolerance tests##5##2##(2006-11#3)(2007-11#1)(2010-11#1)
tolerance than##2##2##(2008-7#1)(2012-5#1)
tolerance to ANA##2##3##(1995-10#2)
tolerance to BYDV##2##3##(2008-10#2)
tolerance to SbDV in the field##3##6##(2012-11#3)
tolerance to a##6##3##(1991-9#1)(1996-9#1)(2006-4#1)(2006-6#1)(2008-2#1)(2009-8#1)
tolerance to abiotic##2##3##(2009-6#1)(2009-8#1)
tolerance to barley yellow dwarf virus##2##6##(2008-10#2)
tolerance to cadmium cytotoxicity##2##4##(1997-3#2)
tolerance to drought##2##3##(2012-5#1)(2012-7#1)
tolerance to ethanol##2##3##(1994-10#1)(2008-10#1)
tolerance to ischemia-reperfusion##2##3##(1996-9#1)(2012-3#1)
tolerance to morphine##2##3##(1996-2#1)(2008-1#1)
tolerance to opioids##2##3##(2006-10#1)(2009-7#1)
tolerance to salinity##2##3##(1997-6#1)(2008-12#1)
tolerance to salt stress##3##4##(2008-8#1)(2009-6#2)
tolerance to salt##4##3##(2008-7#1)(2008-8#1)(2009-6#2)
tolerance to the drug##2##4##(1990-3#1)(1990-5#1)
tolerance to the##17##3##(1990-3#1)(1990-5#2)(1992-3#1)(1995-2#2)(1997-2#2)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
tolerance to##134##2##(1990-3#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#3)(1991-9#1)(1992-3#1)(1993-11#1)(1994-10#2)(1994-11#2)(1994-3#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-2#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#2)(1997-2#2)(1997-3#2)(1997-6#1)(1997-8#2)(2004-1#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-11#5)(2006-12#1)(2006-4#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#4)(2007-7#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-12#3)(2008-2#4)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-6#3)(2009-7#2)(2009-8#4)(2011-1#3)(2011-10#2)(2011-12#1)(2011-2#4)(2012-11#5)(2012-12#2)(2012-3#1)(2012-5#3)(2012-7#2)(2013-1#4)
tolerance toward##3##2##(1995-12#1)(2008-3#1)(2008-4#1)
tolerance towards##2##2##(1991-8#1)(2008-10#1)
tolerance using##3##2##(2006-11#1)(2008-4#1)(2012-1#1)
tolerance values##5##2##(2006-11#2)(2007-4#3)
tolerance was excellent##2##3##(1990-7#1)(2011-2#1)
tolerance was not##3##3##(1991-12#1)(1992-3#1)(1995-10#1)
tolerance was##23##2##(1990-5#1)(1990-7#1)(1991-12#1)(1991-8#1)(1992-2#1)(1992-3#1)(1995-10#1)(1995-5#1)(1996-5#1)(1997-7#1)(2006-12#1)(2008-11#1)(2008-5#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-11#3)(2012-5#1)(2013-1#2)(2013-7#1)
tolerance were obtained##2##3##(2005-11#1)(2011-1#1)
tolerance were##5##2##(2005-11#1)(2006-11#1)(2008-3#1)(2011-1#1)(2012-7#1)
tolerance while##2##2##(2008-10#2)
tolerance will##2##2##(2006-11#1)(2012-1#1)
tolerance with##5##2##(1994-3#1)(1996-2#1)(2008-1#3)
tolerance##953##1##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#8)(1990-6#1)(1990-7#1)(1990-8#5)(1990-9#1)(1991-1#7)(1991-10#1)(1991-11#2)(1991-12#11)(1991-3#7)(1991-5#1)(1991-6#2)(1991-8#8)(1991-9#7)(1992-1#1)(1992-2#6)(1992-3#2)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#5)(1993-11#3)(1993-12#2)(1993-2#1)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#6)(1994-12#4)(1994-3#6)(1994-4#1)(1994-9#1)(1995-1#1)(1995-10#5)(1995-11#2)(1995-12#5)(1995-2#9)(1995-3#1)(1995-4#5)(1995-5#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-10#10)(1996-11#2)(1996-12#4)(1996-2#6)(1996-3#2)(1996-4#1)(1996-5#6)(1996-6#1)(1996-7#1)(1996-9#3)(1997-1#4)(1997-2#2)(1997-3#5)(1997-4#2)(1997-6#3)(1997-7#1)(1997-8#4)(2004-1#1)(2004-4#9)(2005-1#2)(2005-10#5)(2005-11#3)(2005-12#1)(2005-7#1)(2005-8#4)(2005-9#1)(2006-10#24)(2006-11#48)(2006-12#7)(2006-2#3)(2006-4#3)(2006-5#3)(2006-6#10)(2006-8#4)(2006-9#5)(2007-1#8)(2007-10#1)(2007-11#23)(2007-12#7)(2007-3#2)(2007-4#20)(2007-5#10)(2007-7#5)(2007-8#8)(2007-9#2)(2008-1#21)(2008-10#95)(2008-11#15)(2008-12#12)(2008-2#17)(2008-3#42)(2008-4#14)(2008-5#21)(2008-6#6)(2008-7#11)(2008-8#3)(2008-9#8)(2009-10#2)(2009-11#1)(2009-2#3)(2009-3#2)(2009-5#1)(2009-6#11)(2009-7#7)(2009-8#11)(2009-9#5)(2010-1#1)(2010-10#6)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#5)(2010-5#1)(2010-6#2)(2010-7#5)(2010-8#2)(2010-9#1)(2011-1#23)(2011-10#7)(2011-12#10)(2011-2#37)(2011-3#1)(2012-1#13)(2012-11#17)(2012-12#7)(2012-2#5)(2012-3#14)(2012-5#6)(2012-7#8)(2012-9#1)(2013-1#21)(2013-7#7)(2013-8#8)
tolerance) and##6##2##(1996-5#1)(2006-10#1)(2006-5#1)(2006-8#1)(2008-2#1)(2010-10#1)
tolerance)##12##1##(1990-5#1)(1996-5#1)(2006-10#1)(2006-5#1)(2006-8#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2009-2#1)(2010-10#1)
tolerance-inducing##2##1##(1993-11#1)(2010-7#1)
tolerance]##5##1##(1990-3#1)(1991-9#1)(1993-9#1)(2007-9#1)(2008-7#1)
tolerances are##6##2##(2008-2#3)(2008-3#3)
tolerances for phase plates##2##4##(2008-3#2)
tolerances for##5##2##(2008-2#2)(2008-3#3)
tolerances in##2##2##(2008-3#1)(2012-11#1)
tolerances of approximately##2##3##(2008-3#2)
tolerances of the##3##3##(1997-2#1)(2008-3#1)(2011-12#1)
tolerances of##7##2##(1997-2#1)(2007-12#1)(2008-2#1)(2008-3#3)(2011-12#1)
tolerances on the##2##3##(2006-11#1)(2008-3#1)
tolerances on##3##2##(2006-11#1)(2008-3#2)
tolerances to##3##2##(1994-8#1)(2007-11#1)(2010-2#1)
tolerances were##2##2##(2006-11#1)(2012-11#1)
tolerances##44##1##(1994-8#1)(1997-2#1)(2006-11#2)(2007-11#1)(2007-12#2)(2008-2#14)(2008-3#17)(2008-7#1)(2010-2#1)(2011-12#1)(2012-11#2)(2012-2#1)
tolerancing of##2##2##(2008-3#2)
tolerancing##6##1##(2008-2#1)(2008-3#5)
tolerant CD4 T cells##2##4##(2008-11#2)
tolerant cultivar##2##2##(2008-12#1)(2011-10#1)
tolerant cv##2##2##(2008-10#2)
tolerant host##2##2##(2008-10#2)
tolerant mice##4##2##(1994-3#3)(1996-10#1)
tolerant of UVB radiation##2##4##(2008-11#2)
tolerant of##13##2##(1994-9#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#2)(2009-7#1)
tolerant rats##4##2##(1996-2#3)(1997-2#1)
tolerant stage##3##2##(2011-2#2)(2012-2#1)
tolerant to high##2##3##(2008-10#1)(2008-5#1)
tolerant to the##3##3##(2008-10#1)(2009-8#1)(2012-9#1)
tolerant to##23##2##(1994-5#1)(1996-5#1)(1997-2#1)(2004-4#1)(2006-12#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-8#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-9#1)(2013-1#2)(2013-7#1)
tolerant zucchini##2##2##(2008-10#2)
tolerant##99##1##(1993-3#1)(1994-3#3)(1994-5#1)(1994-9#1)(1995-7#1)(1996-10#1)(1996-2#3)(1996-5#1)(1997-2#3)(2004-4#2)(2005-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#26)(2008-11#4)(2008-12#10)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2009-11#1)(2009-7#1)(2009-8#2)(2010-10#1)(2011-10#2)(2011-12#1)(2011-2#6)(2012-11#1)(2012-2#4)(2012-9#1)(2013-1#4)(2013-7#1)
tolerate a##4##2##(1993-2#1)(2007-11#1)(2008-11#2)
tolerate any##2##2##(2007-11#1)(2007-9#1)
tolerate salt##3##2##(2008-10#1)(2009-6#2)
tolerate the##10##2##(1992-11#1)(1992-3#1)(1996-9#1)(2005-10#1)(2006-10#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-3#1)(2012-3#1)
tolerate##63##1##(1990-5#1)(1990-7#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-6#2)(1995-1#1)(1995-3#1)(1995-8#1)(1996-4#1)(1996-9#1)(1997-4#1)(2004-1#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-7#1)(2006-8#1)(2007-11#3)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#1)(2008-8#3)(2009-6#3)(2009-8#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
tolerated across##2##2##(2008-5#1)(2012-3#1)
tolerated all##2##2##(2010-7#2)
tolerated and the##4##3##(2006-4#1)(2007-7#2)(2011-2#1)
tolerated and##44##2##(1990-10#1)(1990-5#1)(1991-3#1)(1992-10#1)(1993-5#1)(1995-10#1)(1996-1#1)(1996-9#1)(2005-10#1)(2005-7#1)(2005-8#2)(2006-2#1)(2006-4#1)(2006-6#1)(2007-11#6)(2007-6#1)(2007-7#3)(2007-9#1)(2008-10#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#3)(2009-3#1)(2010-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
tolerated as##3##2##(1997-1#1)(2007-11#1)(2012-2#1)
tolerated at##8##2##(1990-11#1)(1997-3#1)(2006-10#1)(2008-10#4)(2008-12#1)
tolerated by most##5##3##(1992-12#1)(1996-12#1)(2006-10#2)(2009-9#1)
tolerated by the enzyme##2##4##(1994-9#2)
tolerated by the patient##4##4##(1990-4#1)(2005-11#1)(2006-2#1)(2007-8#1)
tolerated by the##15##3##(1990-12#1)(1990-4#1)(1992-8#1)(1994-9#2)(1996-6#1)(2005-11#1)(2006-2#2)(2007-8#1)(2008-5#4)(2012-5#1)
tolerated by this##2##3##(1992-11#1)(2008-7#1)
tolerated by##38##2##(1990-12#2)(1990-4#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-5#1)(1994-9#2)(1995-6#1)(1996-12#1)(1996-6#1)(2005-11#1)(2006-10#3)(2006-2#2)(2007-11#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-2#1)(2008-5#5)(2008-6#1)(2008-7#1)(2009-4#1)(2009-9#1)(2010-6#1)(2012-3#1)(2012-5#1)
tolerated dose (MTD)##3##3##(2005-8#1)(2007-11#1)(2008-6#1)
tolerated dose of##5##3##(1994-6#1)(1994-9#1)(1997-1#1)(1997-7#1)(2005-7#1)
tolerated dose##12##2##(1992-10#1)(1994-6#1)(1994-9#1)(1996-11#1)(1997-1#1)(1997-7#1)(2005-7#1)(2005-8#1)(2007-11#1)(2008-6#1)(2008-7#2)
tolerated doses##4##2##(1994-11#1)(2006-8#1)(2007-11#1)(2012-2#1)
tolerated in a##3##3##(1992-3#1)(2008-10#1)(2009-3#1)
tolerated in considerable amounts##3##4##(2008-10#3)
tolerated in the##9##3##(1993-11#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2011-2#1)
tolerated in these##2##3##(2004-3#1)(2008-3#1)
tolerated in##41##2##(1992-3#1)(1993-11#1)(1996-1#1)(1996-8#1)(2004-3#1)(2005-7#1)(2007-1#1)(2007-11#7)(2007-3#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-3#7)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#2)(2012-12#1)
tolerated the treatment well##2##4##(2010-7#1)(2012-1#1)
tolerated the##10##2##(2006-6#1)(2007-1#1)(2007-8#1)(2010-12#1)(2010-7#1)(2011-12#2)(2012-1#1)(2013-1#2)
tolerated with##10##2##(1997-3#1)(2004-2#1)(2005-7#1)(2005-8#1)(2006-6#2)(2007-11#1)(2008-6#1)(2008-7#1)(2011-2#1)
tolerated without##2##2##(2008-10#1)(2012-12#1)
tolerated##347##1##(1990-10#2)(1990-11#1)(1990-12#4)(1990-3#1)(1990-4#6)(1990-5#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-3#2)(1991-4#4)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#4)(1992-11#1)(1992-12#2)(1992-3#1)(1992-8#2)(1993-11#1)(1993-2#1)(1993-5#2)(1993-6#1)(1994-11#3)(1994-12#2)(1994-2#2)(1994-6#1)(1994-9#5)(1995-10#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#2)(1996-6#1)(1996-8#3)(1996-9#3)(1997-1#3)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#2)(2004-1#2)(2004-2#1)(2004-3#1)(2005-1#3)(2005-10#2)(2005-11#1)(2005-7#7)(2005-8#5)(2006-10#9)(2006-12#3)(2006-2#4)(2006-4#3)(2006-6#4)(2006-7#1)(2006-8#1)(2007-1#3)(2007-10#3)(2007-11#28)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#4)(2007-8#8)(2007-9#4)(2008-1#4)(2008-10#20)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#22)(2008-4#1)(2008-5#15)(2008-6#10)(2008-7#15)(2008-8#9)(2008-9#1)(2009-3#3)(2009-4#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-12#2)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#3)(2012-5#1)(2012-6#1)(2013-1#8)(2013-7#2)
tolerates##6##1##(1991-4#1)(1995-11#1)(1997-2#1)(2008-10#3)
tolerating##6##1##(1991-9#1)(1997-1#1)(2007-8#1)(2008-2#1)(2008-5#1)(2010-6#1)
tolerization of##2##2##(1991-12#1)(1995-2#1)
tolerization##4##1##(1991-12#1)(1995-2#1)(2008-8#2)
tolerized##5##1##(1991-12#1)(1995-2#1)(1996-4#1)(2008-11#2)
tolerogenic dendritic cells##2##3##(2007-11#1)(2011-1#1)
tolerogenic##8##1##(2006-10#1)(2007-11#3)(2007-5#1)(2009-8#1)(2011-1#1)(2011-2#1)
toll of##3##2##(1996-11#1)(2006-1#1)(2012-2#1)
toll on the##4##3##(2007-3#1)(2008-7#1)(2013-1#2)
toll on##7##2##(1994-9#1)(1996-3#1)(2007-3#1)(2008-3#1)(2008-7#1)(2013-1#2)
toll##16##1##(1994-9#1)(1996-11#1)(1996-3#1)(1997-6#2)(2005-11#1)(2006-1#1)(2007-3#1)(2008-3#1)(2008-7#1)(2010-3#1)(2012-2#1)(2013-1#4)
toll-free##2##1##(2007-4#1)(2010-11#1)
toll-like receptor##7##2##(2008-3#1)(2009-8#1)(2012-3#2)(2013-7#1)(2013-8#2)
toll-like receptors##2##2##(2008-7#1)(2009-3#1)
toll-like##11##1##(2008-1#1)(2008-3#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-2#1)(2012-3#2)(2013-7#1)(2013-8#2)
tolmetin and furosemide##2##3##(1992-9#2)
tolmetin##10##1##(1992-3#5)(1992-9#5)
tolnaftate##4##1##(2008-10#4)
tolterodine and oxybutynin##2##3##(1997-5#1)(2006-9#1)
tolterodine in##3##2##(1997-5#1)(2008-3#2)
tolterodine##10##1##(1997-5#6)(2006-9#1)(2008-3#3)
toluene 2-monooxygenase from Burkholderia##2##4##(1995-10#2)
toluene 2-monooxygenase##3##2##(1995-10#3)
toluene and methyl methacrylate##2##4##(1994-8#2)
toluene and p-xylene were obtained##2##5##(2008-10#2)
toluene and p-xylene##3##3##(2008-10#3)
toluene and xylene##2##3##(2008-10#2)
toluene and##17##2##(1994-8#2)(1996-8#1)(2005-12#1)(2008-10#9)(2008-11#1)(2008-5#1)(2009-10#1)(2013-8#1)
toluene at##3##2##(2008-10#1)(2009-9#1)(2010-5#1)
toluene depletion##2##2##(2008-7#2)
toluene dioxygenase##2##2##(1992-5#2)
toluene exposure on##2##3##(1990-5#1)(1995-12#1)
toluene exposure##7##2##(1990-5#1)(1995-12#3)(2008-7#1)(2011-2#2)
toluene from##2##2##(1990-5#1)(2008-10#1)
toluene in the##3##3##(1990-1#1)(1990-5#1)(2005-11#1)
toluene in##8##2##(1990-1#1)(1990-5#1)(1991-8#1)(2005-11#1)(2008-10#1)(2008-7#2)(2011-2#1)
toluene or xylene##3##3##(2008-10#3)
toluene oxidation##2##2##(1995-10#2)
toluene solubility##2##2##(2008-10#2)
toluene solutions##2##2##(2007-9#1)(2008-10#1)
toluene to##4##2##(1995-10#1)(2008-10#1)(2008-7#1)(2009-9#1)
toluene was##2##2##(2007-9#1)(2008-10#1)
toluene with##2##2##(1995-10#1)(2005-11#1)
toluene##159##1##(1990-1#1)(1990-10#1)(1990-5#4)(1991-11#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-5#2)(1994-7#1)(1994-8#3)(1995-10#11)(1995-12#3)(1995-2#2)(1996-8#1)(1997-8#2)(2004-4#1)(2005-11#3)(2005-12#3)(2005-8#1)(2006-10#1)(2006-4#1)(2007-10#3)(2007-12#3)(2007-8#3)(2007-9#2)(2008-10#58)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#15)(2009-10#2)(2009-9#6)(2010-11#1)(2010-2#1)(2010-5#3)(2010-7#1)(2011-2#5)(2012-2#1)(2013-8#1)
toluene)##3##1##(2008-10#1)(2008-7#1)(2010-3#1)
toluene-3-monooxygenase##2##1##(1995-2#2)
toluene-bitumen mass ratios##2##3##(2005-11#2)
toluidine blue O##5##3##(2008-10#5)
toluidine blue and##3##3##(1992-12#1)(2008-10#1)(2008-5#1)
toluidine blue o##2##3##(2008-10#2)
toluidine blue staining##2##3##(2008-4#1)(2012-3#1)
toluidine blue##15##2##(1992-12#1)(2008-10#8)(2008-4#1)(2008-5#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)
toluidine##18##1##(1992-12#1)(1993-12#1)(2008-10#9)(2008-4#1)(2008-5#2)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)
tomatine##2##1##(2008-8#2)
tomato (Lycopersicon esculentum##4##3##(1997-2#2)(2008-10#1)(2013-8#1)
tomato (Lycopersicon esculentum) and##2##4##(2008-10#2)
tomato (Lycopersicon esculentum)##7##3##(2008-10#6)(2013-8#1)
tomato (Lycopersicon##11##2##(1997-2#2)(2008-10#7)(2013-8#2)
tomato (Solanum lycopersicum)##2##3##(2008-5#1)(2008-7#1)
tomato DC3000 hrp mutants##2##4##(2008-10#2)
tomato DC3000##7##2##(2007-12#1)(2008-10#5)(2009-6#1)
tomato and parsley##2##3##(1997-1#2)
tomato and potato crops##2##4##(2008-10#2)
tomato and potato##11##3##(2008-10#11)
tomato and##30##2##(1997-1#2)(2008-10#26)(2008-12#1)(2008-7#1)
tomato as a host##2##4##(2008-8#1)(2011-2#1)
tomato as a##3##3##(2008-7#1)(2008-8#1)(2011-2#1)
tomato bushy stunt virus (TBSV)##2##5##(2008-9#2)
tomato by##4##2##(2008-10#4)
tomato carotenoids##3##2##(2008-12#3)
tomato caused by Fusarium oxysporum f##2##6##(2008-10#2)
tomato caused by##3##3##(2008-10#3)
tomato chromosome##4##2##(2008-10#1)(2008-5#3)
tomato chromosomes##3##2##(2008-5#3)
tomato crops##5##2##(2008-10#5)
tomato cultivars##7##2##(2008-10#7)
tomato fields and##2##3##(2008-10#2)
tomato fields##4##2##(2008-10#4)
tomato fruit##2##2##(2006-12#2)
tomato fruits##4##2##(2008-10#2)(2011-2#2)
tomato genotypes that exhibit different levels of##2##7##(2008-10#2)
tomato genotypes##4##2##(2008-10#4)
tomato in the##3##3##(2007-12#1)(2008-10#2)
tomato in##13##2##(2007-12#1)(2008-10#12)
tomato isolate##2##2##(2008-10#2)
tomato isolates##5##2##(2008-10#5)
tomato juice agar##2##3##(2008-10#1)(2008-8#1)
tomato late blight##3##3##(2008-10#3)
tomato leaf curl virus##2##4##(2008-10#2)
tomato leaf tissue##2##3##(2008-10#2)
tomato leaf##8##2##(2008-10#7)(2013-8#1)
tomato leaves was##3##3##(2013-8#3)
tomato leaves##15##2##(1997-2#1)(2008-10#8)(2013-8#6)
tomato leaves)##2##2##(2008-10#2)
tomato lines##3##2##(2008-10#3)
tomato mottle##3##2##(2008-10#3)
tomato or##2##2##(2008-10#2)
tomato pathogens##4##2##(2008-10#4)
tomato plant##2##2##(2008-10#2)
tomato plants and##3##3##(2008-10#2)(2009-8#1)
tomato plants carrying##2##3##(2009-8#1)(2010-9#1)
tomato plants from##2##3##(2008-10#2)
tomato plants grown in##3##4##(2008-10#3)
tomato plants in the##2##4##(2008-10#2)
tomato plants in##5##3##(2008-10#5)
tomato plants to##2##3##(2008-10#1)(2013-8#1)
tomato plants treated with##2##4##(2008-10#2)
tomato plants##58##2##(1990-7#1)(2008-10#49)(2008-9#1)(2009-8#4)(2010-9#1)(2011-12#1)(2013-8#1)
tomato population##2##2##(2008-8#2)
tomato powder##3##2##(2008-12#3)
tomato processing waste##2##3##(2011-12#2)
tomato production areas##2##3##(2008-10#2)
tomato production##7##2##(2008-10#7)
tomato race 1 (T1)##2##4##(2008-10#2)
tomato race##5##2##(2008-10#5)
tomato resistance##2##2##(2008-10#2)
tomato root##3##2##(1997-4#1)(2008-10#1)(2008-11#1)
tomato roots was##2##3##(2008-10#2)
tomato roots##14##2##(2008-10#10)(2013-8#4)
tomato seedlings were##2##3##(2008-10#2)
tomato seedlings##5##2##(2008-10#4)(2013-8#1)
tomato seeds##2##2##(2008-10#2)
tomato spotted wilt virus (TSWV)##2##5##(2008-10#2)
tomato spotted wilt virus##4##4##(2008-10#4)
tomato spotted wilt##5##3##(2008-10#5)
tomato stem##2##2##(2008-10#2)
tomato than##3##2##(2008-10#1)(2008-8#2)
tomato that has##2##3##(1996-8#1)(2008-10#1)
tomato to##2##2##(1990-3#1)(2008-10#1)
tomato transplants##2##2##(2008-10#2)
tomato was##4##2##(2008-10#3)(2011-12#1)
tomato were tested for##2##4##(2008-10#2)
tomato were##7##2##(2008-10#7)
tomato yellow leaf curl virus##3##5##(2008-10#2)(2008-8#1)
tomato yellow leaf curl##4##4##(2008-10#3)(2008-8#1)
tomato##471##1##(1990-3#1)(1990-7#2)(1991-11#2)(1992-8#1)(1993-12#1)(1993-9#1)(1995-2#2)(1996-8#3)(1997-1#2)(1997-2#5)(1997-4#1)(1997-6#1)(2006-12#5)(2007-12#2)(2007-3#1)(2007-8#1)(2008-10#353)(2008-11#1)(2008-12#10)(2008-5#12)(2008-7#6)(2008-8#13)(2008-9#4)(2009-3#1)(2009-6#1)(2009-8#6)(2010-4#3)(2010-9#1)(2011-12#7)(2011-2#5)(2012-2#1)(2013-8#16)
tomato-growing areas##2##2##(2008-10#2)
tomato-growing##4##1##(2008-10#4)
tomato-infecting##3##1##(2008-10#3)
tomatoes and##3##2##(1997-4#1)(2008-10#2)
tomatoes are grown##3##3##(2008-10#3)
tomatoes##17##1##(1997-4#1)(2007-12#1)(2008-10#12)(2008-2#2)(2008-3#1)
tomatos##3##1##(2013-8#3)
tombstoning##2##1##(2010-11#2)
tombusvirus species and##2##3##(2008-10#2)
tombusvirus##6##1##(2008-10#5)(2008-9#1)
tomentosa##4##1##(2007-1#1)(2008-5#1)(2012-2#2)
tomogram##4##1##(2007-12#1)(2007-8#1)(2008-2#2)
tomograms (CT)##2##2##(2006-3#1)(2006-7#1)
tomograms of##3##2##(1996-11#1)(2009-2#1)(2013-1#1)
tomograms##9##1##(1996-11#1)(2006-3#1)(2006-7#1)(2007-7#1)(2008-1#1)(2008-2#1)(2009-2#1)(2013-1#2)
tomograph##4##1##(1991-9#1)(2008-3#2)(2008-4#1)
tomographic (CT) scans##6##3##(2005-8#1)(2006-4#1)(2008-1#4)
tomographic (CT)##18##2##(1996-3#1)(2005-8#1)(2006-4#1)(2007-5#1)(2008-1#7)(2008-7#5)(2011-2#1)(2012-3#1)
tomographic and##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
tomographic angiography##13##2##(2006-1#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-9#1)(2011-2#1)(2013-1#3)
tomographic data##2##2##(2008-2#2)
tomographic image reconstruction##2##3##(2008-3#1)(2009-5#1)
tomographic image##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2009-5#1)
tomographic images and##2##3##(1992-10#1)(2011-2#1)
tomographic images of##2##3##(2008-3#1)(2009-12#1)
tomographic images##5##2##(1992-10#1)(2008-3#1)(2009-12#1)(2011-2#1)(2013-1#1)
tomographic imaging of##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2009-5#1)
tomographic imaging##15##2##(2007-11#1)(2007-12#4)(2007-9#1)(2008-2#2)(2008-3#2)(2009-5#1)(2012-1#1)(2013-1#3)
tomographic inversion##2##2##(2008-3#2)
tomographic method##2##2##(2007-11#1)(2008-1#1)
tomographic microscope##2##2##(2008-3#2)
tomographic procedure##2##2##(2007-11#1)(2008-3#1)
tomographic reconstruction and##2##3##(2008-2#1)(2009-10#1)
tomographic reconstruction##7##2##(2008-2#4)(2009-10#2)(2009-12#1)
tomographic scan##3##2##(2007-8#1)(2008-7#1)(2010-8#1)
tomographic scanning##3##2##(2005-12#1)(2005-8#1)(2006-10#1)
tomographic scans have##2##3##(1993-6#1)(2008-9#1)
tomographic scans##8##2##(1992-2#1)(1993-6#1)(1995-12#1)(2005-8#1)(2007-4#1)(2007-9#1)(2008-9#1)(2011-2#1)
tomographic severity##2##2##(1990-3#1)(2009-8#1)
tomographic slit technique##2##3##(2008-2#2)
tomographic studies of##2##3##(1993-4#1)(2008-4#1)
tomographic technique##2##2##(2008-3#2)
tomographic techniques##2##2##(1992-5#1)(2008-2#1)
tomographic##152##1##(1990-3#1)(1991-2#1)(1991-3#1)(1992-10#1)(1992-2#1)(1992-5#2)(1993-4#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-3#2)(1996-5#2)(1997-5#1)(1997-8#1)(2005-12#1)(2005-8#4)(2006-1#1)(2006-10#2)(2006-4#1)(2007-10#2)(2007-11#8)(2007-12#8)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#9)(2008-10#1)(2008-12#1)(2008-2#20)(2008-3#13)(2008-4#1)(2008-6#1)(2008-7#12)(2008-9#2)(2009-10#5)(2009-12#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#11)(2013-7#1)(2013-8#1)
tomographically##3##1##(2007-10#2)(2008-2#1)
tomographs revealed##2##2##(1992-2#1)(1994-10#1)
tomographs##3##1##(1992-2#1)(1994-10#1)(2006-5#1)
tomography (CT##3##2##(2006-6#1)(2008-1#1)(2012-11#1)
tomography (CT) and magnetic resonance imaging##3##6##(2007-9#1)(2010-9#1)(2011-2#1)
tomography (CT) and magnetic resonance##5##5##(2007-9#1)(2010-9#1)(2011-2#3)
tomography (CT) and##18##3##(2007-7#1)(2007-9#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#4)(2013-1#1)
tomography (CT) are##3##3##(2006-6#1)(2008-2#1)(2012-2#1)
tomography (CT) cisternography##2##3##(2005-9#1)(2008-12#1)
tomography (CT) demonstrated##2##3##(2006-2#1)(2010-12#1)
tomography (CT) is##6##3##(2005-8#1)(2007-10#1)(2008-7#1)(2011-3#1)(2012-2#1)(2012-3#1)
tomography (CT) of the chest##2##5##(2007-6#2)
tomography (CT) of the##11##4##(1991-3#1)(2005-5#1)(2006-12#1)(2007-6#2)(2008-6#1)(2008-8#2)(2011-1#3)
tomography (CT) scan##19##3##(1996-9#1)(2007-10#2)(2007-9#1)(2008-12#1)(2008-7#6)(2009-8#1)(2010-1#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
tomography (CT) scans of the##3##5##(2007-1#1)(2008-5#1)(2013-8#1)
tomography (CT) scans were##2##4##(2007-10#1)(2008-5#1)
tomography (CT) scans with##2##4##(2006-12#1)(2012-12#1)
tomography (CT) scans##12##3##(2006-12#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-9#1)(2008-5#2)(2008-7#2)(2011-2#1)(2012-12#1)(2013-8#1)
tomography (CT) showed a##3##4##(2006-10#1)(2006-4#1)(2011-2#1)
tomography (CT) showed##4##3##(2006-10#1)(2006-4#1)(2007-12#1)(2011-2#1)
tomography (CT) was##2##3##(1990-3#1)(2008-9#1)
tomography (CT)##155##2##(1990-3#1)(1991-11#1)(1991-3#2)(1995-2#1)(1996-9#1)(2004-1#1)(2005-10#1)(2005-5#1)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-4#2)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#9)(2007-11#1)(2007-12#2)(2007-4#3)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#2)(2007-9#7)(2008-1#2)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#11)(2008-8#5)(2008-9#3)(2009-10#1)(2009-3#1)(2009-8#2)(2010-1#2)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#10)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#15)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#3)
tomography (HRCT) and##3##3##(2007-2#1)(2011-2#2)
tomography (HRCT)##14##2##(1991-12#2)(2005-8#6)(2007-2#1)(2007-8#1)(2008-7#1)(2011-2#2)(2012-1#1)
tomography (OCT)##46##2##(1997-4#1)(2007-11#3)(2007-12#9)(2008-1#2)(2008-2#1)(2008-3#5)(2008-5#2)(2010-12#2)(2010-2#1)(2011-1#3)(2011-2#1)(2011-7#8)(2012-12#2)(2012-2#3)(2013-1#3)
tomography (PET) scanning##3##3##(2006-10#1)(2006-7#1)(2007-9#1)
tomography (PET)##45##2##(1990-8#1)(1992-10#1)(1992-3#1)(1993-11#1)(1993-9#1)(1994-9#2)(1995-11#2)(1995-12#3)(1995-2#1)(1996-2#1)(1996-5#4)(1996-7#1)(1997-6#1)(2004-1#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#3)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
tomography (PET/CT)##2##2##(2009-2#1)(2012-12#1)
tomography (SPECT)##18##2##(1992-10#1)(1992-2#1)(1994-1#1)(1996-12#1)(1996-5#1)(1996-7#1)(2005-1#1)(2005-9#1)(2007-10#1)(2007-9#3)(2008-11#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-8#1)(2012-2#1)
tomography after##2##2##(1990-3#1)(2012-12#1)
tomography allows##3##2##(1990-9#1)(2007-11#1)(2008-4#1)
tomography and computed##2##3##(2005-8#1)(2007-4#1)
tomography and intravascular ultrasound##2##4##(2009-5#2)
tomography and magnetic resonance imaging scans##3##6##(2008-9#1)(2011-2#1)(2012-2#1)
tomography and magnetic resonance imaging showed##2##6##(2008-7#1)(2011-2#1)
tomography and magnetic resonance imaging##23##5##(1990-12#1)(1992-2#1)(1996-8#1)(1997-8#1)(2005-2#1)(2006-12#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-12#1)(2011-2#4)(2012-12#1)(2012-2#1)
tomography and magnetic resonance##28##4##(1990-12#1)(1992-2#1)(1996-8#1)(1997-8#1)(2005-2#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2008-2#1)(2008-7#2)(2008-9#1)(2009-2#2)(2010-12#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#1)
tomography and radiation##2##3##(2007-4#1)(2011-2#1)
tomography and##80##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-11#1)(1992-2#1)(1993-5#1)(1994-3#1)(1996-2#1)(1996-8#1)(1997-8#1)(2005-2#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#5)(2007-4#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-7#3)(2008-9#2)(2009-10#1)(2009-2#2)(2009-4#1)(2009-5#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#4)(2011-2#8)(2012-11#1)(2012-12#1)(2012-2#5)(2013-1#1)(2013-8#2)
tomography angiography##31##2##(2006-10#3)(2007-9#1)(2008-11#3)(2008-12#8)(2008-4#1)(2008-6#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#2)(2013-1#3)
tomography are discussed##2##3##(2007-3#1)(2008-2#1)
tomography are##9##2##(2006-10#2)(2006-4#1)(2007-12#2)(2007-3#1)(2008-2#1)(2008-7#1)(2012-2#1)
tomography as a##3##3##(2007-12#1)(2009-5#1)(2010-12#1)
tomography based on the##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
tomography based on##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
tomography can provide##2##3##(2010-12#1)(2013-1#1)
tomography coronary angiography##4##3##(2008-11#1)(2009-4#2)(2010-7#1)
tomography demonstrated a##2##3##(2011-2#1)(2013-8#1)
tomography demonstrated##6##2##(1991-11#1)(1992-2#1)(1995-3#1)(2009-3#1)(2011-2#1)(2013-8#1)
tomography diagnostic of the intervertebral disc degeneration and degenerative changes of the lumbo-sacral spine##2##14##(2007-11#2)
tomography evaluation of##3##3##(2007-7#1)(2008-12#1)(2008-5#1)
tomography examination##3##2##(2007-8#1)(2008-1#1)(2010-3#1)
tomography examinations##3##2##(2007-11#1)(2010-9#1)(2012-1#1)
tomography findings##8##2##(2005-8#2)(2007-9#2)(2008-1#1)(2008-7#1)(2009-5#1)(2013-8#1)
tomography for the##4##3##(1991-1#1)(2006-7#1)(2008-3#1)(2013-7#1)
tomography for##22##2##(1991-1#1)(1995-11#1)(1995-4#1)(2006-7#1)(2007-11#2)(2007-12#4)(2008-2#1)(2008-3#3)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-2#1)(2012-3#1)(2013-7#1)
tomography has been##2##3##(2008-3#2)
tomography has##9##2##(2006-4#1)(2008-3#3)(2008-7#2)(2010-10#1)(2012-12#2)
tomography have been##2##3##(2008-2#1)(2011-1#1)
tomography have##4##2##(2006-10#1)(2007-4#1)(2008-2#1)(2011-1#1)
tomography images of a##2##4##(2007-4#1)(2010-9#1)
tomography images of##7##3##(1994-9#1)(2007-4#1)(2010-9#1)(2011-1#1)(2013-1#2)(2013-8#1)
tomography images##12##2##(1994-9#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-3#1)(2010-9#1)(2011-1#2)(2012-3#1)(2013-1#2)(2013-8#1)
tomography imaging in##2##3##(2005-1#1)(2008-12#1)
tomography imaging##9##2##(2005-1#1)(2007-8#1)(2008-12#1)(2008-3#2)(2008-6#1)(2010-12#1)(2012-1#1)(2012-12#1)
tomography in patients with##4##4##(2008-12#1)(2009-10#1)(2009-5#1)(2012-2#1)
tomography in patients##5##3##(1991-3#1)(2008-12#1)(2009-10#1)(2009-5#1)(2012-2#1)
tomography in the diagnosis##4##4##(2005-8#1)(2011-7#2)(2012-2#1)
tomography in the evaluation of##3##5##(1995-2#1)(2011-2#1)(2013-7#1)
tomography in the##12##3##(1995-2#1)(2005-8#1)(2006-7#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)(2011-7#2)(2012-2#1)(2013-7#1)
tomography in##51##2##(1990-11#1)(1990-3#1)(1991-1#1)(1991-11#1)(1991-3#2)(1993-5#1)(1994-1#1)(1994-7#1)(1995-10#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-5#1)(2004-1#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#2)(2008-11#1)(2008-12#4)(2008-3#3)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-5#1)(2010-12#2)(2011-2#2)(2011-7#3)(2012-2#2)(2013-1#1)(2013-2#1)(2013-7#1)
tomography is a##2##3##(1997-6#1)(2007-11#1)
tomography is##15##2##(1997-4#1)(1997-6#1)(2007-11#2)(2007-12#2)(2007-7#2)(2008-1#1)(2008-2#2)(2008-3#3)(2011-2#1)
tomography may be##2##3##(2009-3#1)(2010-3#1)
tomography may##3##2##(2006-10#1)(2009-3#1)(2010-3#1)
tomography of both##2##3##(1996-11#1)(2012-1#1)
tomography of the chest##6##4##(2006-10#1)(2007-8#2)(2008-6#1)(2010-12#1)(2013-7#1)
tomography of the##13##3##(1990-5#1)(1992-10#1)(1997-8#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-8#2)(2008-6#1)(2008-8#1)(2009-2#1)(2010-12#1)(2013-7#1)
tomography of##31##2##(1990-5#1)(1992-10#1)(1993-11#1)(1996-11#2)(1997-8#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-12#6)(2007-8#2)(2008-1#1)(2008-2#2)(2008-6#1)(2008-8#1)(2009-2#2)(2010-12#3)(2011-1#1)(2012-1#1)(2012-2#1)(2013-7#1)
tomography or magnetic resonance imaging##6##5##(1990-5#1)(1994-7#1)(1997-8#1)(2008-1#1)(2010-12#1)(2013-1#1)
tomography or magnetic resonance##7##4##(1990-5#1)(1994-7#1)(1997-8#1)(2008-1#1)(2010-12#1)(2011-2#1)(2013-1#1)
tomography or##11##2##(1990-5#1)(1994-7#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-1#1)(2010-12#2)(2011-1#1)(2011-2#1)(2013-1#1)
tomography pattern##2##2##(2007-11#1)(2008-2#1)
tomography provides##2##2##(2007-12#1)(2012-3#1)
tomography reconstruction##2##2##(1997-6#1)(2007-12#1)
tomography revealed a##4##3##(2012-1#1)(2013-1#2)(2013-7#1)
tomography revealed##10##2##(2007-8#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#2)
tomography reveals##2##2##(2007-11#1)(2010-12#1)
tomography scan is helpful in##2##5##(2009-7#1)(2010-12#1)
tomography scan is##3##3##(2009-3#1)(2009-7#1)(2010-12#1)
tomography scan showed##5##3##(2010-10#1)(2011-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
tomography scan was##2##3##(2006-10#1)(2012-2#1)
tomography scan##36##2##(1993-9#1)(2006-10#1)(2007-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2009-3#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#7)(2013-7#2)(2013-8#3)
tomography scanning of the##2##4##(2007-11#1)(2013-7#1)
tomography scanning##10##2##(2005-12#1)(2006-10#2)(2006-5#3)(2006-8#1)(2007-11#1)(2008-3#1)(2013-7#1)
tomography scans and##3##3##(2006-10#1)(2008-11#1)(2013-7#1)
tomography scans of##4##3##(2004-11#1)(2007-8#1)(2010-10#1)(2012-2#1)
tomography scans revealed##2##3##(2008-11#1)(2010-2#1)
tomography scans were performed##2##4##(2007-7#1)(2008-7#1)
tomography scans were##4##3##(2007-4#1)(2007-7#1)(2008-7#2)
tomography scans##25##2##(2004-11#1)(2006-10#1)(2007-10#3)(2007-4#1)(2007-7#1)(2007-8#1)(2008-11#3)(2008-7#4)(2009-7#1)(2009-8#1)(2010-10#2)(2010-2#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#1)
tomography should be##3##3##(1990-11#1)(1991-8#1)(2007-11#1)
tomography should##4##2##(1990-11#1)(1990-9#1)(1991-8#1)(2007-11#1)
tomography showed a##5##3##(1990-3#1)(2007-5#1)(2008-12#1)(2013-1#1)(2013-8#1)
tomography showed bilateral##3##3##(1990-3#1)(1997-3#1)(2012-12#1)
tomography showed##17##2##(1990-3#2)(1993-3#1)(1997-3#1)(2006-10#1)(2007-5#1)(2008-12#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#3)
tomography shows##2##2##(2007-12#1)(2013-1#1)
tomography study##8##2##(1996-10#1)(1996-3#1)(2006-11#1)(2007-10#1)(2007-3#1)(2008-8#1)(2009-9#1)(2012-2#1)
tomography system##10##2##(2007-11#5)(2007-12#1)(2008-2#1)(2008-3#3)
tomography technique was##2##3##(1996-2#1)(2007-12#1)
tomography technique##4##2##(1996-2#1)(2007-11#1)(2007-12#2)
tomography that##3##2##(2007-11#1)(2007-12#1)(2008-1#1)
tomography to##9##2##(1990-6#1)(1995-1#1)(2007-11#1)(2008-10#1)(2009-10#1)(2011-1#2)(2012-1#1)(2013-8#1)
tomography using##4##2##(2007-12#1)(2008-3#1)(2011-1#1)(2013-1#1)
tomography was used to##3##4##(2007-11#1)(2008-2#1)(2009-4#1)
tomography was used##4##3##(2007-11#1)(2008-2#1)(2009-4#1)(2010-12#1)
tomography was##12##2##(1993-8#1)(2005-12#1)(2007-11#1)(2007-12#2)(2008-2#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#2)
tomography were##3##2##(2012-2#1)(2013-1#2)
tomography with a##2##3##(2007-12#1)(2008-3#1)
tomography with contrast##2##3##(2007-10#1)(2009-7#1)
tomography with##19##2##(1993-9#1)(1996-7#1)(1997-6#1)(1997-8#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-8#2)(2008-3#3)(2008-7#1)(2009-3#1)(2009-7#1)(2012-2#1)
tomography##1221##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#5)(1990-5#3)(1990-6#3)(1990-8#1)(1990-9#4)(1991-1#2)(1991-11#5)(1991-12#3)(1991-3#4)(1991-8#3)(1992-1#1)(1992-10#5)(1992-12#1)(1992-2#3)(1992-3#2)(1992-5#1)(1993-10#1)(1993-11#3)(1993-3#1)(1993-5#5)(1993-8#1)(1993-9#3)(1994-1#2)(1994-2#1)(1994-3#1)(1994-7#3)(1994-9#4)(1995-1#2)(1995-10#2)(1995-11#4)(1995-12#5)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#3)(1995-9#2)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#5)(1996-3#1)(1996-5#8)(1996-7#3)(1996-8#2)(1996-9#1)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#9)(1997-8#4)(2004-1#3)(2004-11#1)(2005-1#2)(2005-10#2)(2005-12#3)(2005-2#1)(2005-5#1)(2005-7#1)(2005-8#17)(2005-9#4)(2006-1#2)(2006-10#32)(2006-11#3)(2006-12#8)(2006-2#6)(2006-3#1)(2006-4#9)(2006-5#3)(2006-6#4)(2006-7#6)(2006-8#7)(2006-9#4)(2007-1#1)(2007-10#22)(2007-11#70)(2007-12#91)(2007-2#1)(2007-3#5)(2007-4#14)(2007-5#2)(2007-6#3)(2007-7#13)(2007-8#26)(2007-9#23)(2008-1#19)(2008-10#4)(2008-11#12)(2008-12#27)(2008-2#37)(2008-3#65)(2008-4#8)(2008-5#7)(2008-6#8)(2008-7#46)(2008-8#12)(2008-9#9)(2009-10#10)(2009-11#1)(2009-12#3)(2009-2#7)(2009-3#6)(2009-4#8)(2009-5#9)(2009-6#3)(2009-7#4)(2009-8#6)(2009-9#1)(2010-1#4)(2010-10#8)(2010-12#30)(2010-2#5)(2010-3#4)(2010-4#1)(2010-5#1)(2010-6#4)(2010-7#3)(2010-8#4)(2010-9#7)(2011-1#40)(2011-12#1)(2011-2#52)(2011-3#1)(2011-7#19)(2012-1#12)(2012-11#4)(2012-12#26)(2012-2#60)(2012-3#8)(2013-1#50)(2013-2#1)(2013-7#11)(2013-8#21)
tomography)##6##1##(1996-11#1)(2008-7#1)(2009-2#1)(2010-12#1)(2010-2#1)(2012-2#1)
tomography-based##2##1##(1993-4#1)(2009-2#1)
tomography-computed tomography##2##2##(2010-12#1)(2012-2#1)
tomography-guided##6##1##(2007-1#1)(2007-8#1)(2008-6#1)(2008-8#1)(2009-3#2)
tomography/magnetic resonance##2##2##(2007-10#2)
tomography]##7##1##(1990-3#1)(1994-2#1)(1997-6#1)(2007-8#1)(2013-1#1)(2013-7#2)
tomorrow##18##1##(1990-2#1)(1993-2#1)(1993-3#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-1#1)(2006-4#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-4#2)(2008-12#1)(2009-9#1)(2011-2#1)(2011-3#1)(2012-12#1)
tomorrow's health##2##2##(1994-1#1)(1997-3#1)
tomorrow's##7##1##(1993-3#2)(1994-1#1)(1995-3#1)(1996-1#1)(1997-3#1)(2004-3#1)
tomorrow]##3##1##(2008-11#1)(2012-11#2)
tomotherapy##2##1##(2008-11#2)
toms##3##1##(2013-1#3)
ton of##2##2##(1993-1#1)(2008-5#1)
ton/ha##2##1##(2008-10#2)
tonB##5##1##(1991-8#1)(1996-4#1)(1997-2#3)
tonal targets##3##2##(2013-8#3)
tonal##8##1##(1991-12#1)(2006-7#1)(2008-2#1)(2013-1#1)(2013-8#4)
tone and content related to their voices##2##7##(1997-8#2)
tone and##21##2##(1992-8#1)(1994-10#1)(1995-12#1)(1995-5#1)(1996-5#1)(1997-4#1)(1997-5#1)(1997-8#2)(2006-12#1)(2006-2#1)(2007-4#1)(2008-1#1)(2009-10#1)(2009-4#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#2)
tone are##2##2##(2006-1#1)(2008-5#1)
tone as##2##2##(1991-1#1)(1993-6#1)
tone at##2##2##(2009-5#1)(2011-2#1)
tone bursts##3##2##(1996-9#3)
tone characteristics##4##2##(2007-1#4)
tone conditioned stimulus##2##3##(1992-10#1)(2008-4#1)
tone discrimination##2##2##(1992-7#1)(2008-9#1)
tone during##2##2##(1991-10#1)(2008-3#1)
tone elicited by noradrenaline##2##4##(1995-12#1)(1997-4#1)
tone if the F0 peak is##2##6##(2013-8#2)
tone in the##3##3##(1996-1#1)(2004-1#1)(2008-2#1)
tone in##7##2##(1991-5#1)(1996-1#1)(1997-5#1)(2004-1#1)(2005-10#1)(2008-2#1)(2008-8#1)
tone is##2##2##(1992-9#1)(2007-11#1)
tone of the##7##3##(1991-10#1)(2006-6#1)(2007-9#1)(2008-5#2)(2009-5#1)(2013-8#1)
tone of##17##2##(1991-10#1)(1991-2#1)(1991-9#1)(1995-2#2)(2006-6#1)(2007-5#1)(2007-9#1)(2008-11#2)(2008-5#3)(2008-9#1)(2009-5#2)(2013-8#1)
tone or syllable##2##3##(2012-1#2)
tone or##5##2##(1997-4#2)(2008-7#1)(2012-1#2)
tone patterns##2##2##(1995-12#2)
tone perception##2##2##(2008-9#2)
tone under##2##2##(1995-2#1)(2007-12#1)
tone was assessed by##2##4##(1993-2#1)(2007-10#1)
tone was##6##2##(1993-2#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-5#1)(2007-10#1)
tone with##2##2##(2008-9#1)(2009-5#1)
tone##186##1##(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#2)(1991-10#2)(1991-12#1)(1991-2#1)(1991-5#3)(1991-9#1)(1992-10#1)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#3)(1993-2#3)(1993-6#1)(1993-8#1)(1994-10#2)(1994-6#1)(1995-12#9)(1995-2#12)(1995-5#2)(1996-1#1)(1996-10#1)(1996-5#9)(1996-6#2)(1996-9#3)(1997-4#4)(1997-5#4)(1997-7#1)(1997-8#2)(2004-1#2)(2005-10#4)(2006-1#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#2)(2007-1#4)(2007-10#3)(2007-11#3)(2007-12#3)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#8)(2008-12#2)(2008-2#5)(2008-3#2)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#8)(2009-1#1)(2009-10#2)(2009-4#1)(2009-5#4)(2010-10#2)(2010-12#2)(2010-8#1)(2011-2#3)(2012-1#3)(2012-12#1)(2012-3#1)(2012-4#1)(2013-1#1)(2013-8#8)
tone)##2##1##(2008-3#1)(2008-5#1)
tone-dependent##5##1##(2008-2#5)
toned##2##1##(2008-6#2)
toner##2##1##(1996-11#1)(2008-10#1)
toners##2##1##(2008-2#2)
tones and##5##2##(2008-11#1)(2008-9#3)(2011-1#1)
tones of##2##2##(2008-2#1)(2012-1#1)
tones on##2##2##(2012-1#2)
tones were##2##2##(1996-1#1)(1997-7#1)
tones##36##1##(1991-1#3)(1992-9#1)(1995-12#2)(1995-5#3)(1996-1#5)(1997-7#5)(2006-2#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#4)(2009-4#1)(2011-1#1)(2012-1#3)(2013-8#3)
tongue and##10##2##(1993-1#2)(1997-6#1)(2006-2#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-5#1)(2013-1#2)
tongue as a##2##3##(2006-2#1)(2008-10#1)
tongue based on##3##3##(2008-10#3)
tongue brushing##4##2##(2006-2#4)
tongue cancer##5##2##(1993-4#4)(2007-12#1)
tongue coating##2##2##(2006-2#2)
tongue dorsum##3##2##(2006-8#2)(2008-10#1)
tongue enlargement##4##2##(2012-12#4)
tongue from a##2##3##(2012-1#2)
tongue has##3##2##(2006-8#1)(2008-1#1)(2008-10#1)
tongue in a##2##3##(2010-9#1)(2011-12#1)
tongue in##5##2##(2007-3#1)(2010-9#1)(2011-12#1)(2013-1#1)(2013-7#1)
tongue is very rare##3##4##(2010-9#1)(2013-1#2)
tongue is##6##2##(2007-8#2)(2008-2#1)(2010-9#1)(2013-1#2)
tongue movements##3##2##(2008-10#2)(2012-1#1)
tongue on##2##2##(2006-2#1)(2010-12#1)
tongue protrusion##3##2##(2012-1#3)
tongue was##3##2##(1994-5#1)(2008-10#2)
tongue were##2##2##(1994-5#1)(1996-5#1)
tongue##157##1##(1990-1#1)(1992-11#1)(1993-1#3)(1993-12#2)(1993-4#4)(1993-9#1)(1994-5#4)(1994-6#1)(1995-8#1)(1995-9#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-4#2)(1997-6#3)(2006-11#1)(2006-2#17)(2006-8#5)(2007-11#4)(2007-12#3)(2007-2#1)(2007-3#4)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#20)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-12#1)(2009-4#2)(2010-1#1)(2010-12#2)(2010-4#1)(2010-6#2)(2010-7#3)(2010-9#3)(2011-12#3)(2011-2#1)(2012-1#10)(2012-12#5)(2012-3#5)(2013-1#15)(2013-7#2)(2013-8#2)
tongues##2##1##(1993-2#1)(2007-11#1)
tonic activity in the##2##4##(1992-8#1)(2008-7#1)
tonic activity##3##2##(1991-9#1)(1992-8#1)(2008-7#1)
tonic and##6##2##(1991-9#1)(1997-5#1)(2008-10#1)(2008-5#2)(2010-3#1)
tonic clonic##2##2##(2008-12#1)(2012-12#1)
tonic contraction##3##2##(2004-12#3)
tonic immobility##4##2##(1991-12#2)(1993-9#2)
tonic inhibition##3##2##(2008-1#1)(2011-2#2)
tonic inhibitory##3##2##(1994-6#1)(2006-10#1)(2008-4#1)
tonic neuronal activity##2##3##(1991-9#2)
tonic pain##2##2##(1991-1#1)(1997-5#1)
tonic seizure##2##2##(1996-3#1)(2004-11#1)
tonic stimulation##2##2##(1990-5#1)(2013-1#1)
tonic vibratory reflex##2##3##(1995-12#1)(2010-12#1)
tonic##73##1##(1990-11#1)(1990-12#1)(1990-5#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-3#3)(1991-6#1)(1991-8#1)(1991-9#6)(1992-8#1)(1993-4#1)(1993-9#2)(1994-2#1)(1994-6#3)(1995-12#5)(1996-2#2)(1996-3#1)(1997-3#1)(1997-5#2)(1997-7#1)(2004-11#1)(2004-12#5)(2005-10#1)(2006-10#3)(2007-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
tonic-clonic seizures##7##2##(1991-4#2)(1992-11#1)(2004-11#1)(2005-10#1)(2006-11#1)(2008-11#1)
tonic-clonic##12##1##(1991-4#2)(1992-11#4)(2004-11#1)(2005-10#1)(2006-11#1)(2007-2#1)(2008-11#1)(2011-12#1)
tonically##10##1##(1991-2#1)(1993-11#1)(1994-2#1)(1995-12#2)(1996-10#1)(1997-2#1)(2008-5#1)(2008-6#1)(2010-12#1)
tonicity##3##1##(1990-3#1)(2008-5#1)(2013-8#1)
tonnes##2##1##(2008-10#1)(2008-5#1)
tonometer and Goldmann tonometer readings was -1##2##7##(2010-8#2)
tonometer and Goldmann tonometer readings was 2##2##7##(2010-8#2)
tonometer and Goldmann tonometer readings was##4##6##(2010-8#4)
tonometer and Goldmann##5##3##(2010-8#4)(2013-7#1)
tonometer and##6##2##(2008-4#1)(2010-8#4)(2013-7#1)
tonometer were##2##2##(2010-8#2)
tonometer##29##1##(2008-4#1)(2010-8#25)(2013-7#2)(2013-8#1)
tonometers##2##1##(2008-3#1)(2010-1#1)
tonometric##2##1##(1996-3#1)(2008-7#1)
tonometry##16##1##(1996-9#1)(2006-7#1)(2007-9#2)(2008-7#1)(2010-1#4)(2012-3#4)(2013-1#1)(2013-3#1)(2013-8#1)
tonoplast##8##1##(1996-5#1)(2008-10#2)(2008-11#3)(2009-8#1)(2010-9#1)
tonotopic##2##1##(2008-11#1)(2008-2#1)
tons ha-1##2##2##(2011-12#2)
tons of##5##2##(2006-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)
tons##14##1##(1991-6#1)(1993-9#1)(2006-4#2)(2007-5#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-6#1)(2011-12#2)
tonsil##10##1##(1993-12#1)(1997-6#1)(2007-4#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-7#1)(2013-8#1)
tonsillar carcinoma##2##2##(1990-6#1)(1991-5#1)
tonsillar herniation##2##2##(2006-5#2)
tonsillar lymphocytes##3##2##(1991-1#2)(1995-12#1)
tonsillar##16##1##(1990-6#2)(1991-1#2)(1991-5#1)(1992-7#1)(1995-12#1)(1997-3#1)(2006-5#3)(2006-9#1)(2008-4#2)(2008-9#1)(2013-1#1)
tonsillectomies##2##1##(1993-1#1)(1994-4#1)
tonsillectomy##22##1##(1995-1#1)(1995-11#1)(1996-12#11)(2006-10#1)(2006-12#1)(2007-11#1)(2013-1#6)
tonsillitis##8##1##(1993-8#1)(1996-12#1)(1997-4#1)(2011-2#4)(2012-12#1)
tonsils and##2##2##(1993-5#1)(2010-4#1)
tonsils are##2##2##(2008-4#1)(2010-4#1)
tonsils of##3##2##(1991-8#1)(1997-6#1)(2010-4#1)
tonsils or##2##2##(1995-2#1)(2008-5#1)
tonsils were##2##2##(2010-4#2)
tonsils##17##1##(1991-8#1)(1993-5#1)(1995-2#1)(1996-1#1)(1997-6#1)(2006-12#1)(2006-9#1)(2008-4#2)(2008-5#1)(2010-4#7)
tonsurans was##2##2##(2008-5#2)
tonsurans##7##1##(2008-5#6)(2012-3#1)
tonus##4##1##(1992-3#1)(2005-1#1)(2007-7#1)(2008-4#1)
too are##4##2##(1991-7#1)(1996-1#1)(2007-8#1)(2008-5#1)
too close to##2##3##(2008-10#2)
too close##3##2##(2005-10#1)(2008-10#2)
too complex##2##2##(2005-10#1)(2012-1#1)
too complicated##3##2##(1995-6#1)(2007-2#1)(2012-3#1)
too conservative##3##2##(1991-9#1)(2008-6#1)(2010-2#1)
too costly to be##3##4##(2008-10#1)(2008-4#1)(2008-9#1)
too costly to##6##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#2)
too different##4##2##(2008-10#1)(2008-3#1)(2013-1#2)
too distant##3##2##(2007-11#1)(2007-9#1)(2008-4#1)
too early to##8##3##(1993-11#1)(1994-7#1)(1995-6#1)(2007-11#1)(2008-1#2)(2008-5#1)(2011-3#1)
too early##10##2##(1993-11#1)(1994-7#1)(1995-6#1)(2007-11#1)(2007-3#1)(2008-1#2)(2008-5#1)(2011-3#1)(2013-1#1)
too expensive for the##2##4##(1996-5#1)(2007-7#1)
too expensive##9##2##(1995-12#1)(1996-5#1)(1997-6#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-11#1)(2010-11#1)(2013-1#1)
too extensive##3##2##(2006-2#1)(2007-12#1)(2008-3#1)
too far away##2##3##(1996-4#1)(2011-2#1)
too far##4##2##(1993-3#1)(1995-12#1)(1996-4#1)(2011-2#1)
too few##5##2##(1997-5#1)(2008-4#1)(2011-2#1)(2012-11#1)(2013-8#1)
too good to be##2##4##(1995-2#1)(2013-8#1)
too good##3##2##(1990-6#1)(1995-2#1)(2013-8#1)
too great to##2##3##(1997-8#1)(2008-10#1)
too great##5##2##(1997-8#1)(2008-10#1)(2008-8#2)(2008-9#1)
too has##4##2##(2009-10#1)(2012-1#1)(2012-3#2)
too have##5##2##(1994-8#1)(1996-1#1)(2006-10#1)(2008-7#1)(2009-7#1)
too heavy##3##2##(2007-12#2)(2012-1#1)
too heterogeneous##2##2##(2007-8#1)(2009-7#1)
too high for##3##3##(2006-4#1)(2007-2#1)(2012-3#1)
too high to be##2##4##(2007-12#1)(2008-9#1)
too high to##3##3##(2007-12#1)(2008-7#1)(2008-9#1)
too high##18##2##(1990-8#1)(1991-6#1)(1992-12#1)(1993-3#1)(1995-7#1)(2006-11#1)(2006-4#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
too if##2##2##(2008-2#1)(2009-6#1)
too important to##2##3##(2007-9#1)(2011-1#1)
too important##3##2##(2007-2#1)(2007-9#1)(2011-1#1)
too is##2##2##(1995-4#1)(2008-7#1)
too large to be##2##4##(1992-5#1)(2008-12#1)
too large to##6##3##(1992-5#1)(1993-12#1)(2008-12#1)(2008-6#1)(2008-9#1)(2011-2#1)
too large##15##2##(1992-4#1)(1992-5#1)(1993-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
too late to##3##3##(1993-11#1)(2007-3#1)(2008-10#1)
too late##10##2##(1993-11#1)(1993-5#1)(1994-3#1)(1995-6#1)(1996-6#1)(1996-8#1)(1997-8#1)(2007-3#1)(2008-10#1)(2008-11#1)
too limited to##4##3##(1991-9#1)(1992-11#1)(1996-8#1)(2010-2#1)
too limited##9##2##(1991-11#1)(1991-6#1)(1991-9#1)(1992-11#1)(1994-3#1)(1996-2#1)(1996-8#1)(2008-7#1)(2010-2#1)
too little is##2##3##(2006-9#1)(2009-4#1)
too little##9##2##(1995-12#1)(1996-6#1)(1996-9#2)(2006-9#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-4#1)
too long to be##2##4##(2008-3#1)(2011-2#1)
too long##6##2##(2007-7#1)(2008-11#1)(2008-3#1)(2009-4#1)(2011-2#1)(2012-2#1)
too low and##3##3##(1993-3#1)(2007-6#1)(2012-2#1)
too low for##2##3##(1990-10#1)(2006-4#1)
too low to allow##3##4##(2007-1#1)(2008-8#1)(2012-3#1)
too low to be##3##4##(1995-1#1)(2008-10#1)(2011-1#1)
too low to support##2##4##(1994-9#1)(2009-4#1)
too low to##16##3##(1992-3#1)(1992-6#1)(1992-8#1)(1994-9#1)(1995-1#1)(1996-11#1)(1997-5#1)(2007-1#1)(2008-10#1)(2008-8#1)(2009-4#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
too low##37##2##(1990-10#1)(1990-2#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-9#1)(1995-1#1)(1996-11#1)(1997-5#1)(1997-6#1)(2006-11#1)(2006-4#1)(2007-1#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)
too many choices##2##3##(2008-11#1)(2013-8#1)
too many##21##2##(1991-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-8#1)(1996-1#1)(2005-10#1)(2007-11#2)(2007-2#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
too may##2##2##(2006-10#1)(2008-3#1)
too much to the##2##4##(2008-2#1)(2009-4#1)
too much to##3##3##(2008-2#1)(2009-4#1)(2011-1#1)
too much##24##2##(1992-2#1)(1993-1#1)(1995-12#1)(1997-2#1)(2005-3#1)(2006-7#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-12#1)(2009-3#2)(2009-4#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
too narrow to##3##3##(2005-7#1)(2012-3#1)(2013-1#1)
too narrow##6##2##(2005-7#2)(2007-12#1)(2008-11#1)(2012-3#1)(2013-1#1)
too often considered##2##3##(1996-12#1)(2010-12#1)
too often the##2##3##(1991-12#1)(2010-2#1)
too often##14##2##(1990-5#1)(1991-12#1)(1991-3#1)(1992-8#1)(1993-12#1)(1996-12#1)(1996-2#1)(1997-5#1)(1997-8#1)(2006-10#1)(2008-8#1)(2010-12#1)(2010-2#1)(2011-2#1)
too rigid##2##2##(1991-9#1)(1992-6#1)
too severe##2##2##(1990-9#1)(1996-5#1)
too short for##3##3##(1995-6#1)(1995-7#1)(2008-10#1)
too short to##2##3##(1992-9#1)(2006-2#1)
too short##9##2##(1992-6#1)(1992-9#1)(1995-6#1)(1995-7#1)(2006-12#1)(2006-2#1)(2007-12#1)(2008-10#1)(2012-1#1)
too simple##3##2##(2008-2#1)(2010-2#1)(2010-8#1)
too slow to##2##3##(1990-2#1)(2008-3#1)
too slow##5##2##(1990-2#1)(1997-8#1)(2007-3#1)(2008-3#1)(2008-9#1)
too small and##3##3##(1992-10#1)(1993-10#1)(2008-8#1)
too small for##2##3##(2007-2#1)(2008-3#1)
too small to be##6##4##(1990-8#1)(1991-3#2)(2007-9#1)(2008-3#1)(2011-2#1)
too small to cause##2##4##(1994-3#1)(2008-10#1)
too small to##20##3##(1990-8#1)(1991-2#1)(1991-3#2)(1991-7#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1996-9#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-3#1)(2011-2#2)(2012-3#1)
too small##30##2##(1990-8#1)(1991-2#1)(1991-3#2)(1991-7#1)(1992-10#1)(1993-10#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1996-9#1)(1997-8#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-3#3)(2008-8#1)(2008-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
too soon##3##2##(1992-11#1)(2006-12#1)(2008-11#1)
too strongly##2##2##(1991-11#2)
too time-consuming##2##2##(2008-8#1)(2011-2#1)
too vague##2##2##(2008-7#1)(2013-7#1)
too variable##3##2##(1996-3#1)(2008-10#1)(2011-2#1)
too weak to##3##3##(1992-10#1)(2007-9#1)(2011-1#1)
too were##2##2##(1997-6#1)(2013-1#1)
too wide##3##2##(1990-12#1)(2008-8#2)
too young##4##2##(2007-1#1)(2008-8#1)(2012-3#1)(2013-1#1)
too##494##1##(1990-10#1)(1990-12#3)(1990-2#4)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#1)(1991-11#4)(1991-12#3)(1991-2#2)(1991-3#3)(1991-4#1)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#4)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#4)(1992-9#1)(1993-1#2)(1993-10#3)(1993-11#4)(1993-12#2)(1993-2#2)(1993-3#5)(1993-5#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-3#6)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-12#5)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#5)(1995-7#2)(1995-8#1)(1995-9#1)(1996-1#4)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#3)(1996-8#2)(1996-9#5)(1997-2#1)(1997-3#2)(1997-5#3)(1997-6#4)(1997-7#1)(1997-8#6)(2005-1#1)(2005-10#3)(2005-11#1)(2005-3#1)(2005-7#3)(2005-8#1)(2006-10#4)(2006-11#2)(2006-12#4)(2006-2#3)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#8)(2007-12#8)(2007-2#9)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#10)(2007-8#10)(2007-9#6)(2008-1#3)(2008-10#24)(2008-11#13)(2008-12#3)(2008-2#6)(2008-3#13)(2008-4#5)(2008-5#6)(2008-6#5)(2008-7#8)(2008-8#16)(2008-9#9)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#4)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#5)(2010-3#1)(2010-4#5)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-11#1)(2011-2#17)(2011-3#2)(2012-1#7)(2012-11#2)(2012-12#6)(2012-2#9)(2012-3#13)(2013-1#12)(2013-7#3)(2013-8#7)
took 1##2##2##(1995-11#1)(2008-11#1)
took 15##2##2##(2006-12#1)(2012-2#1)
took AZA##2##2##(2006-10#2)
took a##13##2##(1995-4#1)(2005-11#1)(2006-8#1)(2007-9#2)(2008-10#3)(2008-3#1)(2009-2#1)(2011-2#1)(2013-1#1)(2013-7#1)
took about##3##2##(1992-11#1)(2007-1#1)(2012-12#1)
took account of##2##3##(2008-12#1)(2012-3#1)
took advantage of the##5##4##(1994-2#1)(1995-2#1)(2008-12#1)(2008-7#2)
took advantage of##12##3##(1994-2#1)(1995-2#1)(1996-5#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-9#1)(2011-1#1)(2012-3#1)
took an##5##2##(1996-4#1)(2006-4#1)(2006-8#1)(2008-1#1)(2009-9#1)
took for##2##2##(1991-11#1)(2010-9#1)
took into account##9##3##(1992-9#1)(1995-11#1)(1997-5#1)(2006-10#1)(2008-10#2)(2008-4#1)(2009-6#1)(2012-12#1)
took its##2##2##(2008-10#1)(2012-12#1)
took less than##2##3##(1993-1#1)(2007-7#1)
took longer than##2##3##(1993-2#1)(2008-8#1)
took longer to##6##3##(1992-11#1)(1993-7#1)(2006-10#1)(2008-10#1)(2008-2#1)(2012-1#1)
took longer##8##2##(1992-11#1)(1993-2#1)(1993-7#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-8#1)(2012-1#1)
took more##2##2##(2008-10#1)(2013-1#1)
took nearly##2##2##(2007-9#2)
took no##2##2##(1991-6#1)(2008-3#1)
took on average##2##3##(1991-8#2)
took on the##3##3##(2006-11#1)(2009-4#1)(2012-2#1)
took on##8##2##(1991-8#2)(1996-1#1)(2006-11#1)(2008-2#1)(2009-4#1)(2012-2#1)(2013-1#1)
took over##3##2##(1990-9#1)(2008-10#1)(2008-5#1)
took part in a##4##4##(1997-6#1)(2005-1#1)(2012-1#1)(2013-1#1)
took part in an##2##4##(1995-6#1)(2008-10#1)
took part in the research##2##5##(2007-9#1)(2011-2#1)
took part in the study##9##5##(1991-8#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-7#1)(2009-7#1)(2010-9#1)(2012-1#1)(2013-1#1)
took part in the##16##4##(1991-8#1)(1995-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-7#1)(2009-7#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
took part in this study##2##5##(2008-10#1)(2008-7#1)
took part in this##4##4##(1996-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
took part in##32##3##(1991-4#1)(1991-8#1)(1995-11#1)(1995-6#1)(1996-11#1)(1997-6#1)(2005-1#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-7#1)(2007-9#2)(2008-10#3)(2008-11#2)(2008-7#2)(2009-6#1)(2009-7#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-1#2)(2012-12#1)(2013-1#2)
took part##39##2##(1991-4#1)(1991-8#1)(1995-11#1)(1995-6#1)(1996-11#1)(1996-4#1)(1997-6#1)(2005-1#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-9#2)(2008-10#3)(2008-11#2)(2008-7#2)(2009-6#1)(2009-7#1)(2010-12#2)(2010-9#1)(2011-2#3)(2011-7#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
took place after the##2##4##(1993-3#1)(2010-8#1)
took place after##3##3##(1993-3#1)(1993-8#1)(2010-8#1)
took place as##2##3##(1992-1#1)(2008-6#1)
took place at the##3##4##(1996-1#1)(2007-12#1)(2008-5#1)
took place at##7##3##(1991-10#1)(1996-1#1)(2007-12#1)(2008-11#1)(2008-5#2)(2008-6#1)
took place between##3##3##(1997-3#1)(2008-9#1)(2010-3#1)
took place during the##3##4##(1994-3#1)(2006-10#1)(2008-3#1)
took place during##5##3##(1992-3#1)(1994-3#1)(2006-10#1)(2008-10#1)(2008-3#1)
took place from the##3##4##(1993-10#1)(2006-8#1)(2013-1#1)
took place from##9##3##(1993-10#1)(1996-10#1)(2005-8#1)(2006-12#1)(2006-8#1)(2009-2#1)(2009-4#1)(2009-6#1)(2013-1#1)
took place in a##6##4##(1991-6#1)(1992-8#1)(2007-2#1)(2008-10#1)(2008-2#1)(2012-12#1)
took place in the##14##4##(1991-10#1)(1992-1#1)(1993-3#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-2#1)(2010-10#1)(2011-12#1)
took place in##40##3##(1990-10#1)(1991-10#1)(1991-3#1)(1991-6#1)(1992-1#2)(1992-8#1)(1993-3#2)(1993-6#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-3#1)(1997-5#1)(1997-6#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-5#2)(2008-8#1)(2009-2#1)(2010-10#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
took place under##3##3##(2008-10#1)(2011-2#2)
took place with##2##3##(1992-6#1)(1996-7#1)
took place within##3##3##(1990-10#1)(1991-11#1)(2008-5#1)
took place##114##2##(1990-10#2)(1990-2#1)(1991-10#3)(1991-11#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#3)(1992-3#2)(1992-6#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-3#2)(1996-1#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-3#1)(1997-5#1)(1997-6#1)(2005-11#2)(2005-8#2)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#9)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#2)(2009-4#2)(2009-6#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-12#2)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
took samples##2##2##(2008-5#1)(2008-6#1)
took significantly longer to##2##4##(2009-9#1)(2012-2#1)
took significantly##3##2##(2008-8#1)(2009-9#1)(2012-2#1)
took the##12##2##(1990-10#1)(1992-9#1)(1995-12#1)(2005-10#2)(2005-11#2)(2007-10#2)(2008-10#1)(2012-3#2)
took their##2##2##(2009-5#1)(2012-2#1)
took this##2##2##(2008-7#1)(2011-2#1)
took two##3##2##(1991-3#1)(1992-3#1)(2008-7#1)
took up the##3##3##(1990-5#1)(2007-5#1)(2009-7#1)
took up##10##2##(1990-5#1)(1991-7#1)(1992-6#1)(1995-11#1)(2007-5#1)(2008-10#1)(2008-5#1)(2009-7#2)(2010-11#1)
took##340##1##(1990-10#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-10#3)(1991-11#2)(1991-3#3)(1991-4#1)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#4)(1992-11#2)(1992-3#3)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-3#4)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#2)(1995-11#4)(1995-12#3)(1995-2#1)(1995-3#3)(1995-4#1)(1995-6#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#3)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#3)(1997-3#1)(1997-5#2)(1997-6#2)(2005-1#2)(2005-10#4)(2005-11#5)(2005-8#2)(2006-10#7)(2006-11#1)(2006-12#2)(2006-4#2)(2006-7#2)(2006-8#3)(2007-1#1)(2007-10#6)(2007-12#8)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#5)(2007-9#8)(2008-1#2)(2008-10#25)(2008-11#10)(2008-12#4)(2008-2#4)(2008-3#7)(2008-4#4)(2008-5#13)(2008-6#3)(2008-7#6)(2008-8#3)(2008-9#4)(2009-1#1)(2009-10#2)(2009-12#1)(2009-2#3)(2009-4#4)(2009-5#3)(2009-6#3)(2009-7#3)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-3#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#2)(2011-2#12)(2011-7#1)(2012-1#4)(2012-12#7)(2012-2#9)(2012-3#7)(2013-1#9)(2013-7#2)(2013-8#3)
tool able to##2##3##(2007-9#1)(2010-6#1)
tool among##4##2##(2009-5#3)(2012-1#1)
tool and as a##3##4##(1996-1#1)(1997-4#1)(2008-1#1)
tool and new##2##3##(2008-7#1)(2011-1#1)
tool and the##2##3##(2007-12#1)(2008-3#1)
tool and##23##2##(1995-4#1)(1996-1#1)(1997-2#1)(1997-4#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-11#1)(2009-9#1)(2010-6#1)(2011-1#1)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#1)
tool are##3##2##(1997-1#1)(2006-12#1)(2008-10#1)
tool as a##3##3##(2007-9#1)(2008-11#2)
tool as##9##2##(1994-8#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-9#1)(2012-12#1)
tool at##2##2##(2007-2#1)(2008-3#1)
tool available##3##2##(2008-1#1)(2011-1#1)(2013-1#1)
tool based on##2##3##(1995-2#1)(2008-2#1)
tool between##2##2##(1996-1#1)(2008-11#1)
tool both##2##2##(1994-4#1)(2008-2#1)
tool box##2##2##(2006-4#1)(2010-11#1)
tool by which##2##3##(2006-10#1)(2006-5#1)
tool by##3##2##(2006-10#1)(2006-5#1)(2009-6#1)
tool called##3##2##(2007-4#1)(2008-1#1)(2008-7#1)
tool can be used##2##4##(2008-1#1)(2008-3#1)
tool can be##3##3##(2008-1#1)(2008-3#1)(2008-9#1)
tool can##7##2##(2008-1#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-3#1)(2011-12#1)
tool capable of##3##3##(2010-4#1)(2013-1#2)
tool commonly used##2##3##(2011-3#1)(2012-1#1)
tool currently available for##2##4##(1994-11#1)(2009-9#1)
tool developed to##2##3##(2008-12#1)(2013-1#1)
tool developed##5##2##(2008-12#1)(2010-5#1)(2013-1#3)
tool development##2##2##(2007-12#1)(2008-7#1)
tool during##3##2##(1996-1#1)(1996-2#1)(2009-6#1)
tool for PD##2##3##(2008-11#1)(2008-5#1)
tool for a##6##3##(1994-6#1)(1997-6#1)(2008-2#1)(2008-7#1)(2012-12#2)
tool for accelerating##2##3##(2010-11#1)(2013-8#1)
tool for accurate##2##3##(2008-10#1)(2008-7#1)
tool for analysis of##2##4##(2008-1#1)(2011-3#1)
tool for analyzing##4##3##(1997-3#1)(2007-11#2)(2008-3#1)
tool for assessing the##5##4##(2007-2#1)(2008-4#1)(2008-5#1)(2010-2#1)(2010-9#1)
tool for assessing##7##3##(2007-2#1)(2008-4#1)(2008-5#1)(2010-2#1)(2010-9#1)(2012-1#1)(2013-1#1)
tool for better##2##3##(1994-11#1)(2013-7#1)
tool for biomedical research##2##4##(2008-9#1)(2010-12#1)
tool for both##2##3##(1992-4#1)(2008-10#1)
tool for bringing together##2##4##(1996-4#1)(2013-8#1)
tool for cancer##4##3##(2006-4#1)(2008-7#1)(2009-12#1)(2009-5#1)
tool for characterizing##4##3##(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)
tool for clinical##3##3##(1997-3#1)(2004-11#1)(2012-3#1)
tool for continuous monitoring of##2##5##(2011-1#1)(2013-8#1)
tool for continuous##3##3##(2010-8#1)(2011-1#1)(2013-8#1)
tool for data##2##3##(2008-11#1)(2010-5#1)
tool for detecting##6##3##(1994-11#1)(1997-3#1)(2007-10#1)(2007-11#1)(2012-3#2)
tool for determining##4##3##(1993-9#1)(2007-12#2)(2008-8#1)
tool for diagnosing##3##3##(2006-4#1)(2007-9#1)(2008-5#1)
tool for diagnosis of##2##4##(2006-5#1)(2008-9#1)
tool for diagnosis##4##3##(2006-5#1)(2008-9#1)(2011-1#1)(2011-2#1)
tool for early detection of##2##5##(2007-9#1)(2011-12#1)
tool for early##4##3##(2007-9#1)(2008-10#1)(2010-9#1)(2011-12#1)
tool for elucidating##3##3##(2006-10#1)(2010-2#1)(2013-1#1)
tool for epidemiological##2##3##(2008-10#1)(2012-3#1)
tool for estimating the##2##4##(1994-7#1)(2008-10#1)
tool for evaluating##3##3##(1990-8#1)(2011-2#1)(2012-2#1)
tool for evaluation of##2##4##(2009-2#1)(2011-2#1)
tool for examining##2##3##(1995-11#1)(2008-9#1)
tool for forensic##2##3##(2008-12#1)(2008-6#1)
tool for functional genomics##2##4##(2008-7#1)(2010-12#1)
tool for functional##3##3##(2008-7#1)(2010-12#1)(2010-2#1)
tool for future##2##3##(2007-8#1)(2009-10#1)
tool for gene function##2##4##(2011-1#1)(2013-1#1)
tool for gene therapy##2##4##(1992-8#1)(2006-12#1)
tool for gene##6##3##(1992-8#1)(1995-7#1)(2006-12#1)(2007-11#1)(2011-1#1)(2013-1#1)
tool for general##2##3##(2008-10#1)(2012-1#1)
tool for guiding##2##3##(2007-1#1)(2008-1#1)
tool for health care##2##4##(1993-3#1)(2009-8#1)
tool for health##4##3##(1993-3#1)(1994-7#1)(1997-1#1)(2009-8#1)
tool for identification of##4##4##(1992-8#1)(2007-1#1)(2008-4#1)(2009-5#1)
tool for identifying##10##3##(1990-10#1)(1995-8#1)(1996-12#1)(2008-10#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-3#1)(2011-1#1)
tool for imaging##2##3##(2007-12#1)(2008-4#1)
tool for implementing##2##3##(2008-2#1)(2008-6#1)
tool for improving practice##2##4##(2007-11#1)(2010-11#1)
tool for improving the quality of##2##6##(2008-7#1)(2010-2#1)
tool for improving the##3##4##(1997-5#1)(2008-7#1)(2010-2#1)
tool for improving##8##3##(1994-8#1)(1997-5#1)(2007-11#1)(2008-7#1)(2010-11#1)(2010-2#1)(2013-1#2)
tool for in situ##2##4##(2008-10#1)(2010-2#1)
tool for in vivo##2##4##(2008-1#1)(2010-2#1)
tool for in##6##3##(2008-1#1)(2008-10#2)(2010-2#2)(2012-3#1)
tool for information##2##3##(1991-3#1)(2011-1#1)
tool for investigating the##4##4##(1994-2#1)(1994-6#1)(2008-4#1)(2012-12#1)
tool for investigating##8##3##(1994-2#1)(1994-6#1)(2006-4#1)(2006-5#1)(2007-12#1)(2008-4#1)(2008-7#1)(2012-12#1)
tool for laparoscopic##2##3##(1993-12#1)(2009-6#1)
tool for leaders##2##3##(1996-1#1)(1997-1#1)
tool for long-term##2##3##(2005-10#1)(2009-4#1)
tool for malaria##2##3##(2007-2#1)(2008-8#1)
tool for management##3##3##(2008-10#1)(2013-1#2)
tool for many##3##3##(2008-1#1)(2008-3#1)(2010-7#1)
tool for mapping##2##3##(2008-3#1)(2008-8#1)
tool for measurement of##2##4##(2007-11#2)
tool for measurements of##2##4##(2007-12#1)(2008-6#1)
tool for measuring##4##3##(2008-11#1)(2008-7#1)(2010-10#1)(2010-12#1)
tool for modeling##2##3##(2007-11#2)
tool for molecular##4##3##(1995-11#1)(2008-4#1)(2008-9#1)(2010-3#1)
tool for monitoring##6##3##(1997-6#1)(2006-2#1)(2008-3#1)(2008-7#1)(2009-12#1)(2011-2#1)
tool for obtaining##3##3##(2006-12#1)(2008-11#1)(2008-7#1)
tool for parents##2##3##(2006-7#2)
tool for performing##2##3##(2007-1#1)(2010-2#1)
tool for predicting##6##3##(2006-5#1)(2008-10#1)(2010-10#1)(2011-1#1)(2012-12#1)(2013-1#1)
tool for probing##2##3##(1991-3#1)(1992-12#1)
tool for processing the##2##4##(2008-5#1)(2010-8#1)
tool for professional development##2##4##(2008-11#1)(2008-6#1)
tool for quality assurance##3##4##(1992-11#1)(2007-5#1)(2008-3#1)
tool for quality##6##3##(1992-11#1)(2007-5#1)(2007-8#1)(2008-3#1)(2008-9#1)(2011-1#1)
tool for quantitative##2##3##(2007-8#1)(2008-3#1)
tool for quickly##3##3##(2008-4#1)(2013-1#2)
tool for rapid##2##3##(1993-12#1)(2012-3#1)
tool for rational##2##3##(2007-11#1)(2012-11#1)
tool for reducing##3##3##(2007-4#1)(2008-11#1)(2008-6#1)
tool for risk-selection in##2##4##(2008-7#2)
tool for routine##3##3##(2006-6#1)(2008-10#1)(2009-11#1)
tool for screening##4##3##(2006-10#1)(2007-2#1)(2008-10#1)(2013-1#1)
tool for selective##2##3##(2008-11#1)(2008-4#1)
tool for structural##3##3##(2006-5#1)(2008-4#1)(2008-9#1)
tool for studies of##2##4##(2008-10#1)(2008-11#1)
tool for studies##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
tool for studying the##10##4##(1991-5#1)(1991-6#1)(1991-8#1)(1993-3#1)(1994-3#1)(1994-8#2)(2007-12#1)(2007-3#1)(2008-8#1)
tool for studying##28##3##(1990-10#1)(1991-5#1)(1991-6#1)(1991-8#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-8#2)(1996-12#1)(1997-5#1)(2005-8#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-8#2)(2010-2#1)(2010-6#1)(2012-12#2)
tool for the analysis of##6##5##(1996-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-2#1)(2012-1#1)
tool for the assessment of##2##5##(2011-2#1)(2012-12#1)
tool for the design of##2##5##(2008-2#1)(2010-4#1)
tool for the detection and characterization of##2##7##(1995-7#1)(2008-10#1)
tool for the detection of##5##5##(2008-10#3)(2008-11#1)(2008-3#1)
tool for the detection##7##4##(1995-7#1)(2008-10#4)(2008-11#1)(2008-3#1)
tool for the determination of##2##5##(2008-10#1)(2010-11#1)
tool for the development of new##2##6##(2008-2#1)(2008-8#1)
tool for the development of##3##5##(2008-2#1)(2008-8#2)
tool for the diagnosis of##2##5##(2008-1#1)(2011-2#1)
tool for the evaluation of##3##5##(1996-12#1)(2008-10#1)(2009-1#1)
tool for the identification of##2##5##(1997-1#1)(2011-1#1)
tool for the identification##3##4##(1997-1#1)(2008-10#1)(2011-1#1)
tool for the investigation of##4##5##(1991-2#1)(2006-12#1)(2008-10#1)(2008-7#1)
tool for the management of##2##5##(2006-11#1)(2007-8#1)
tool for the manipulation of##4##5##(2006-12#1)(2008-11#2)(2009-8#1)
tool for the rapid##3##4##(1994-9#1)(2008-10#2)
tool for the study of##10##5##(1993-9#1)(1995-6#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-4#1)(2013-1#1)
tool for the treatment of##3##5##(1991-2#1)(2007-8#1)(2008-4#1)
tool for the##102##3##(1990-2#1)(1990-7#1)(1991-2#2)(1992-12#1)(1992-8#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-4#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#3)(2007-1#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#4)(2008-1#1)(2008-10#19)(2008-11#5)(2008-2#5)(2008-3#1)(2008-4#7)(2008-7#4)(2008-8#2)(2008-9#3)(2009-1#1)(2009-4#2)(2009-5#1)(2009-8#2)(2010-11#1)(2010-2#2)(2010-4#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#2)(2013-7#1)
tool for this purpose##3##4##(2007-10#1)(2008-2#1)(2012-3#1)
tool for this##6##3##(2007-10#1)(2007-6#1)(2007-7#1)(2008-2#1)(2008-7#1)(2012-3#1)
tool for treating##3##3##(1991-2#1)(2007-11#1)(2010-2#1)
tool for understanding##4##3##(1996-1#1)(2005-10#1)(2008-2#1)(2008-8#1)
tool for use##2##3##(2006-2#1)(2007-8#1)
tool for visualizing##2##3##(2010-3#1)(2011-2#1)
tool for##646##2##(1990-10#2)(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-5#2)(1991-6#1)(1991-8#2)(1992-11#2)(1992-12#2)(1992-4#1)(1992-7#1)(1992-8#3)(1993-12#5)(1993-2#2)(1993-3#5)(1993-5#1)(1993-6#1)(1993-9#2)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-7#2)(1994-8#3)(1994-9#1)(1995-11#2)(1995-12#1)(1995-6#1)(1995-7#3)(1995-8#1)(1996-1#2)(1996-10#2)(1996-12#6)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#1)(1997-1#4)(1997-3#5)(1997-4#2)(1997-5#2)(1997-6#3)(2004-11#1)(2005-10#2)(2005-11#1)(2005-7#1)(2005-8#3)(2006-10#7)(2006-11#1)(2006-12#5)(2006-2#2)(2006-3#1)(2006-4#4)(2006-5#5)(2006-6#3)(2006-7#5)(2006-8#4)(2007-1#8)(2007-10#4)(2007-11#13)(2007-12#13)(2007-2#6)(2007-3#1)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#13)(2007-9#3)(2008-1#11)(2008-10#65)(2008-11#25)(2008-12#4)(2008-2#28)(2008-3#22)(2008-4#30)(2008-5#8)(2008-6#7)(2008-7#23)(2008-8#12)(2008-9#14)(2009-1#1)(2009-10#4)(2009-11#2)(2009-12#6)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#5)(2009-6#2)(2009-8#4)(2010-10#2)(2010-11#6)(2010-12#6)(2010-2#13)(2010-3#3)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#5)(2011-1#11)(2011-12#4)(2011-2#15)(2011-3#1)(2011-7#1)(2012-1#4)(2012-11#3)(2012-12#11)(2012-2#3)(2012-3#14)(2013-1#28)(2013-7#3)(2013-8#5)
tool frequently used##2##3##(2007-8#1)(2008-10#1)
tool grinding##3##2##(1994-6#3)
tool guided##4##2##(2012-12#4)
tool has been##3##3##(2008-5#1)(2008-7#1)(2009-2#1)
tool has not been##2##4##(1994-1#1)(2008-11#1)
tool has##5##2##(1994-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-2#1)
tool in a##7##3##(2006-10#1)(2006-5#1)(2007-11#1)(2008-2#1)(2008-7#2)(2011-2#1)
tool in aquatic##2##3##(2008-10#1)(2011-2#1)
tool in assessing the##3##4##(1996-4#1)(2009-4#1)(2012-12#1)
tool in characterizing##2##3##(1995-11#1)(2009-3#1)
tool in clinical##3##3##(1992-3#1)(2008-12#1)(2008-9#1)
tool in epidemiological studies##2##4##(2012-3#1)(2013-8#1)
tool in molecular biology##3##4##(1995-7#1)(2008-2#1)(2008-4#1)
tool in molecular##4##3##(1995-7#1)(1997-4#1)(2008-2#1)(2008-4#1)
tool in order##2##3##(2007-8#1)(2008-11#1)
tool in our##3##3##(2007-7#1)(2008-2#1)(2012-3#1)
tool in patients with##5##4##(1993-7#1)(2006-10#2)(2006-7#1)(2008-9#1)
tool in predicting##2##3##(1991-11#1)(2007-8#1)
tool in skin##2##3##(2008-5#2)
tool in the clinical##2##4##(1993-11#1)(2008-9#1)
tool in the control of##2##5##(2007-10#1)(2009-5#1)
tool in the detection of##3##5##(1996-12#1)(1996-8#1)(2007-5#1)
tool in the diagnosis and treatment of##2##7##(1992-2#1)(2006-2#1)
tool in the diagnosis and##3##5##(1992-2#1)(2006-2#1)(2008-3#1)
tool in the diagnosis of##5##5##(1991-12#1)(2006-2#1)(2007-6#1)(2008-12#1)(2013-1#1)
tool in the diagnosis##9##4##(1991-12#1)(1992-2#1)(2006-2#2)(2007-6#1)(2008-12#1)(2008-3#1)(2012-12#1)(2013-1#1)
tool in the diagnostic##2##4##(1992-3#1)(2008-3#1)
tool in the evaluation of##6##5##(2008-12#2)(2008-2#1)(2008-8#1)(2008-9#1)(2011-12#1)
tool in the evaluation##7##4##(2008-10#1)(2008-12#2)(2008-2#1)(2008-8#1)(2008-9#1)(2011-12#1)
tool in the future##3##4##(2007-11#1)(2008-10#1)(2009-5#1)
tool in the management of patients with##2##7##(2007-8#1)(2013-1#1)
tool in the management of##6##5##(2006-10#1)(2007-8#1)(2008-10#1)(2008-12#1)(2011-1#1)(2013-1#1)
tool in the near future##2##5##(2006-6#2)
tool in the study of##4##5##(1990-4#1)(1994-3#1)(2008-11#1)(2008-3#1)
tool in the surgical##2##4##(2005-12#1)(2011-2#1)
tool in the treatment of##4##5##(1990-11#1)(1991-1#1)(1996-9#1)(2008-9#1)
tool in the##90##3##(1990-11#1)(1990-4#2)(1991-1#1)(1991-12#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-11#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-7#1)(2005-10#1)(2005-12#1)(2006-10#2)(2006-2#2)(2006-6#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#4)(2008-10#7)(2008-11#3)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-11#1)(2009-5#2)(2009-6#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
tool in this##4##3##(1993-5#1)(2008-2#1)(2009-7#1)(2010-5#1)
tool in##234##2##(1990-11#1)(1990-4#2)(1991-1#1)(1991-11#1)(1991-12#2)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-11#1)(1993-4#1)(1993-5#1)(1993-7#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#7)(2006-2#2)(2006-4#2)(2006-5#2)(2006-6#3)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#4)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#8)(2007-9#4)(2008-1#4)(2008-10#19)(2008-11#9)(2008-12#7)(2008-2#10)(2008-3#5)(2008-4#3)(2008-5#5)(2008-7#5)(2008-8#6)(2008-9#10)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#6)(2011-12#1)(2011-2#4)(2012-12#5)(2012-2#3)(2012-3#5)(2013-1#2)(2013-8#6)
tool is##14##2##(1990-12#1)(1993-12#1)(1993-5#1)(1995-3#1)(2005-10#1)(2006-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)
tool making##2##2##(1991-11#1)(1994-6#1)
tool may be##3##3##(2008-10#1)(2010-12#1)(2012-2#1)
tool may##4##2##(1993-12#1)(2008-10#1)(2010-12#1)(2012-2#1)
tool not only##2##3##(2006-10#1)(2008-11#1)
tool of##13##2##(1990-3#1)(1991-3#1)(1993-12#1)(1994-12#1)(2006-4#1)(2008-10#1)(2008-11#2)(2008-3#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-2#1)
tool or##2##2##(1997-1#1)(2006-6#1)
tool provides##4##2##(2006-7#2)(2009-7#1)(2012-2#1)
tool requires##2##2##(2008-4#1)(2009-2#1)
tool than##3##2##(2008-10#1)(2012-2#1)(2013-8#1)
tool that allows##2##3##(2009-4#1)(2012-2#1)
tool that can be used##4##5##(2005-11#1)(2006-10#2)(2010-10#1)
tool that can be##5##4##(2005-11#1)(2006-10#2)(2008-3#1)(2010-10#1)
tool that can help##2##4##(2007-4#1)(2008-5#1)
tool that can##10##3##(1996-2#1)(2005-11#1)(2006-10#2)(2007-4#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-10#1)
tool that has##2##3##(2009-12#1)(2012-2#1)
tool that is##4##3##(1997-1#1)(2008-4#1)(2008-9#1)(2011-2#1)
tool that may be##2##4##(2008-12#1)(2013-8#1)
tool that may##3##3##(2006-2#1)(2008-12#1)(2013-8#1)
tool that will##2##3##(2008-2#1)(2011-2#1)
tool that##44##2##(1992-1#1)(1992-12#1)(1993-3#1)(1995-2#2)(1996-2#1)(1997-1#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-6#1)(2006-7#1)(2007-4#1)(2007-5#1)(2007-9#2)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#4)(2013-8#1)
tool to achieve##2##3##(1996-1#1)(2011-1#1)
tool to address##2##3##(2012-12#1)(2012-2#1)
tool to aid in##2##4##(2010-8#1)(2012-2#1)
tool to aid##3##3##(2010-8#1)(2011-2#1)(2012-2#1)
tool to analyze the##2##4##(1997-5#1)(2007-12#1)
tool to analyze##3##3##(1997-5#1)(2007-12#1)(2008-2#1)
tool to assess the##4##4##(1997-8#1)(2008-12#1)(2010-12#1)(2013-1#1)
tool to assess##8##3##(1992-1#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-12#1)(2013-1#2)
tool to assist##2##3##(2004-2#1)(2008-12#1)
tool to be used##2##4##(2009-2#1)(2013-8#1)
tool to better understand the##2##5##(2007-12#1)(2008-4#1)
tool to better understand##3##4##(2007-12#1)(2008-4#1)(2008-7#1)
tool to capture##2##3##(1996-3#1)(2013-1#1)
tool to characterize##2##3##(1990-7#1)(2010-1#1)
tool to decrease##2##3##(2008-4#1)(2010-9#1)
tool to detect##6##3##(1993-4#1)(1997-4#1)(2007-8#1)(2008-10#1)(2009-5#1)(2011-1#1)
tool to determine the##3##4##(2008-3#1)(2008-4#1)(2008-5#1)
tool to determine##4##3##(1997-1#1)(2008-3#1)(2008-4#1)(2008-5#1)
tool to develop##3##3##(2008-10#1)(2008-5#1)(2011-1#1)
tool to differentiate##2##3##(2008-10#1)(2008-4#1)
tool to dissect##2##3##(2008-11#1)(2012-12#1)
tool to elucidate the##2##4##(1993-9#1)(2008-3#1)
tool to elucidate##4##3##(1993-9#1)(2008-10#1)(2008-11#1)(2008-3#1)
tool to estimate##2##3##(1997-4#1)(2012-12#1)
tool to evaluate the quality of##2##6##(2007-8#1)(2012-2#1)
tool to evaluate the##4##4##(2006-2#1)(2007-8#1)(2008-11#1)(2012-2#1)
tool to evaluate##10##3##(2006-2#1)(2007-8#1)(2008-11#2)(2008-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
tool to further##2##3##(2006-8#1)(2007-4#1)
tool to gain##3##3##(2008-5#1)(2008-7#1)(2012-2#1)
tool to guide##4##3##(2008-3#1)(2008-9#1)(2009-10#1)(2012-1#1)
tool to help improve the##2##5##(2008-2#1)(2013-7#1)
tool to help##8##3##(1992-12#1)(1995-12#1)(2006-2#1)(2007-10#1)(2008-2#2)(2011-1#1)(2013-7#1)
tool to identify##12##3##(1993-9#1)(2006-7#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-9#1)(2012-2#1)(2013-1#3)
tool to improve##5##3##(1996-12#1)(2010-12#1)(2012-1#1)(2013-1#1)(2013-7#1)
tool to investigate the##7##4##(1992-5#1)(1997-2#1)(2008-11#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-8#1)
tool to investigate##14##3##(1992-5#1)(1997-2#1)(2006-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-3#1)(2010-4#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-8#1)
tool to manage##3##3##(1992-2#1)(2010-3#1)(2011-12#1)
tool to measure the##3##4##(1990-4#1)(2008-3#1)(2010-12#1)
tool to measure##11##3##(1990-4#1)(1996-3#1)(1997-8#1)(2007-12#1)(2008-3#1)(2008-4#1)(2009-4#1)(2010-12#1)(2010-4#1)(2012-1#1)(2012-12#1)
tool to monitor##5##3##(1996-12#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-9#1)
tool to obtain##2##3##(1993-2#1)(2011-2#1)
tool to perform##2##3##(2008-10#1)(2008-3#1)
tool to predict the##2##4##(2008-5#1)(2008-8#1)
tool to predict##3##3##(2008-5#1)(2008-8#1)(2011-2#1)
tool to prevent##3##3##(2007-12#1)(2009-9#1)(2013-8#1)
tool to probe the##3##4##(2006-10#1)(2009-10#1)(2012-2#1)
tool to probe##4##3##(1996-8#1)(2006-10#1)(2009-10#1)(2012-2#1)
tool to produce##2##3##(2008-11#2)
tool to provide##3##3##(2006-10#1)(2007-2#1)(2008-7#1)
tool to quantify##4##3##(2008-10#2)(2008-7#1)(2012-2#1)
tool to reveal the##2##4##(2006-12#1)(2010-7#1)
tool to screen##2##3##(1996-8#1)(2010-2#1)
tool to study the##6##4##(1991-1#1)(1994-2#1)(1995-1#1)(2005-7#1)(2007-10#1)(2010-6#1)
tool to study##16##3##(1991-1#1)(1993-3#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-6#1)(2005-11#1)(2005-7#1)(2006-10#2)(2007-10#1)(2007-8#1)(2010-6#1)(2010-8#1)(2011-1#1)
tool to understand the##2##4##(2006-2#1)(2008-1#1)
tool to understand##4##3##(2006-2#1)(2008-1#1)(2011-2#1)(2012-2#1)
tool to##255##2##(1990-4#1)(1990-7#1)(1991-1#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-9#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#2)(1995-8#1)(1996-1#1)(1996-12#3)(1996-3#2)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#2)(1997-5#2)(1997-8#2)(2004-2#1)(2005-11#1)(2005-7#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#3)(2006-3#1)(2006-5#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#6)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#19)(2008-11#13)(2008-12#3)(2008-2#5)(2008-3#7)(2008-4#8)(2008-5#7)(2008-6#1)(2008-7#15)(2008-8#2)(2008-9#6)(2009-10#3)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#6)(2010-2#1)(2010-3#2)(2010-4#3)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#7)(2011-12#2)(2011-2#5)(2012-1#4)(2012-11#1)(2012-12#7)(2012-2#11)(2012-3#3)(2012-7#2)(2013-1#9)(2013-7#3)(2013-8#3)
tool use##7##2##(2006-10#1)(2008-9#2)(2009-2#4)
tool used to##4##3##(1994-2#1)(1997-3#1)(2008-10#1)(2008-9#1)
tool used##6##2##(1994-2#1)(1997-3#1)(2008-10#1)(2008-9#1)(2010-12#1)(2013-8#1)
tool was developed##2##3##(2008-12#1)(2012-12#1)
tool was used##2##3##(2007-12#1)(2013-8#1)
tool was##11##2##(2007-12#3)(2008-11#3)(2008-12#2)(2012-12#2)(2013-8#1)
tool were##5##2##(2007-10#1)(2013-1#4)
tool when##2##2##(2006-10#1)(2013-1#1)
tool which##4##2##(1996-1#1)(1997-3#1)(2007-7#1)(2013-8#1)
tool will##3##2##(2006-6#1)(2007-1#1)(2008-10#1)
tool with which to##6##4##(1994-5#1)(2006-3#1)(2007-12#1)(2008-3#2)(2012-12#1)
tool with##17##2##(1993-12#1)(1994-5#1)(2006-3#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2009-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
tool within a##2##3##(2008-12#1)(2008-9#1)
tool##1645##1##(1990-10#3)(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#4)(1990-5#1)(1990-7#2)(1990-8#4)(1990-9#1)(1991-1#2)(1991-11#3)(1991-12#3)(1991-2#4)(1991-3#3)(1991-5#3)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#4)(1992-11#3)(1992-12#7)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#3)(1993-10#2)(1993-11#2)(1993-12#11)(1993-2#6)(1993-3#7)(1993-4#2)(1993-5#3)(1993-6#1)(1993-7#1)(1993-9#4)(1994-1#1)(1994-11#3)(1994-12#6)(1994-2#5)(1994-3#9)(1994-4#1)(1994-5#2)(1994-6#8)(1994-7#2)(1994-8#4)(1994-9#2)(1995-1#1)(1995-11#4)(1995-12#5)(1995-2#7)(1995-3#3)(1995-4#2)(1995-5#1)(1995-6#2)(1995-7#4)(1995-8#3)(1995-9#1)(1996-1#9)(1996-10#2)(1996-11#1)(1996-12#11)(1996-2#4)(1996-3#5)(1996-4#3)(1996-5#3)(1996-6#2)(1996-8#3)(1996-9#1)(1997-1#9)(1997-2#2)(1997-3#8)(1997-4#7)(1997-5#4)(1997-6#4)(1997-7#1)(1997-8#2)(2004-11#1)(2004-2#1)(2005-10#5)(2005-11#6)(2005-12#2)(2005-5#2)(2005-7#3)(2005-8#3)(2006-10#31)(2006-11#3)(2006-12#9)(2006-2#9)(2006-3#4)(2006-4#9)(2006-5#11)(2006-6#11)(2006-7#14)(2006-8#5)(2006-9#3)(2007-1#11)(2007-10#11)(2007-11#26)(2007-12#36)(2007-2#10)(2007-3#2)(2007-4#9)(2007-5#7)(2007-6#3)(2007-7#11)(2007-8#30)(2007-9#17)(2008-1#25)(2008-10#131)(2008-11#69)(2008-12#25)(2008-2#53)(2008-3#59)(2008-4#50)(2008-5#22)(2008-6#9)(2008-7#60)(2008-8#25)(2008-9#43)(2009-1#1)(2009-10#10)(2009-11#4)(2009-12#9)(2009-2#11)(2009-3#7)(2009-4#8)(2009-5#12)(2009-6#5)(2009-7#2)(2009-8#5)(2009-9#6)(2010-1#1)(2010-10#6)(2010-11#10)(2010-12#20)(2010-2#15)(2010-3#9)(2010-4#10)(2010-5#9)(2010-6#6)(2010-7#5)(2010-8#16)(2010-9#9)(2011-1#34)(2011-12#9)(2011-2#31)(2011-3#2)(2011-7#1)(2012-1#17)(2012-11#5)(2012-12#33)(2012-2#34)(2012-3#29)(2012-7#2)(2013-1#75)(2013-7#9)(2013-8#27)
tool)##3##1##(2007-10#1)(2007-12#1)(2013-1#1)
tool?##5##1##(1995-12#1)(2005-12#1)(2006-10#1)(2007-11#1)(2013-1#1)
toolbox to##2##2##(2008-8#1)(2010-11#1)
toolbox##8##1##(2006-5#1)(2006-9#1)(2008-8#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-9#1)(2012-2#1)
toolkit has been##2##3##(2009-12#1)(2013-1#1)
toolkit is##5##2##(2008-7#1)(2009-12#1)(2013-1#3)
toolkit logic##4##2##(2013-1#4)
toolkit of##2##2##(2008-12#1)(2009-5#1)
toolkit that##2##2##(2008-10#1)(2008-7#1)
toolkit##29##1##(2005-7#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#3)(2009-12#3)(2009-5#1)(2013-1#17)(2013-8#1)
toolkits##2##1##(2008-12#1)(2012-2#1)
tools (the##2##2##(2005-4#1)(2006-8#1)
tools and a##2##3##(1996-1#1)(2008-10#1)
tools and analyses##2##3##(1994-3#1)(2010-10#1)
tools and approaches##2##3##(2006-10#1)(2008-4#1)
tools and lack of##2##4##(2011-1#1)(2012-1#1)
tools and map data developed in the ICD-10 map project##2##10##(2013-1#2)
tools and methods##3##3##(1993-2#1)(2008-12#1)(2010-12#1)
tools and perceived improvement##2##4##(1996-3#2)
tools and procedures##2##3##(2007-1#1)(2010-4#1)
tools and processes##2##3##(2008-8#1)(2010-7#1)
tools and strategies##3##3##(2006-10#2)(2012-12#1)
tools and techniques##3##3##(1994-2#1)(2011-1#1)(2011-11#1)
tools and the##6##3##(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-10#1)(2013-1#1)
tools and##89##2##(1990-5#1)(1993-2#1)(1993-3#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-3#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#5)(2008-6#1)(2008-7#5)(2008-8#2)(2009-10#1)(2009-12#2)(2009-4#1)(2009-9#1)(2010-10#3)(2010-12#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#4)(2011-11#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#1)(2013-1#8)
tools applied##2##2##(2008-10#1)(2009-10#1)
tools are available##5##3##(2008-10#1)(2008-2#2)(2008-4#1)(2008-6#1)
tools are essential##3##3##(2008-7#1)(2013-1#2)
tools are the##3##3##(1991-3#1)(1994-2#1)(2005-10#1)
tools are##31##2##(1991-3#1)(1994-1#1)(1994-2#1)(1994-6#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2010-11#2)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
tools as##3##2##(1996-1#1)(2006-10#1)(2008-10#1)
tools available for the##2##4##(2007-8#1)(2011-2#1)
tools available for##4##3##(1997-5#1)(2007-8#1)(2008-2#1)(2011-2#1)
tools available to the##2##4##(2006-10#1)(2008-7#1)
tools available to##6##3##(2006-10#1)(2007-12#1)(2008-7#1)(2012-2#1)(2013-1#2)
tools available##12##2##(1997-5#1)(2006-10#2)(2007-12#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
tools based on the##3##4##(1993-9#1)(2008-10#1)(2008-8#1)
tools based on##5##3##(1993-9#1)(2008-10#1)(2008-8#1)(2013-1#2)
tools but##2##2##(1993-10#1)(2005-7#1)
tools by##2##2##(1996-3#1)(2005-10#1)
tools can assist the##2##4##(1993-12#1)(2008-12#1)
tools can be##6##3##(2005-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-12#1)(2012-2#1)
tools can##12##2##(1993-12#1)(2005-10#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-12#2)(2010-8#1)(2012-12#1)(2012-2#1)
tools currently##2##2##(2007-11#1)(2008-4#1)
tools designed for##2##3##(2008-7#1)(2013-7#1)
tools designed##3##2##(2008-3#1)(2008-7#1)(2013-7#1)
tools developed##4##2##(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)
tools for assessing##2##3##(2009-11#1)(2011-2#1)
tools for both##2##3##(2006-10#1)(2011-2#1)
tools for cell##2##3##(2010-12#2)
tools for data##4##3##(2008-7#1)(2010-11#1)(2011-1#1)(2012-3#1)
tools for detection and quantification of##2##6##(2008-10#2)
tools for detection of##2##4##(2008-1#1)(2008-3#1)
tools for detection##5##3##(2006-12#1)(2008-1#1)(2008-10#2)(2008-3#1)
tools for diagnosis##2##3##(1990-9#1)(1994-4#1)
tools for early detection of##3##5##(2006-10#1)(2008-8#2)
tools for early detection##4##4##(2006-10#1)(2008-8#2)(2010-8#1)
tools for future##2##3##(2010-11#1)(2012-3#1)
tools for high-throughput##2##3##(2007-8#2)
tools for identifying##2##3##(2008-8#1)(2008-9#1)
tools for many##3##3##(2006-12#1)(2008-7#1)(2010-1#1)
tools for mapping##2##3##(1990-7#1)(2012-2#1)
tools for monitoring##3##3##(2008-10#1)(2008-11#2)
tools for oncology research##2##4##(2009-6#1)(2010-5#1)
tools for optimizing##2##3##(2006-10#1)(2007-11#1)
tools for pain##2##3##(2007-11#1)(2008-7#1)
tools for planning and##3##4##(1995-12#1)(2013-1#2)
tools for probing##3##3##(2011-1#1)(2012-12#2)
tools for quantitative##2##3##(1995-3#1)(2010-5#1)
tools for screening for##2##4##(2013-7#2)
tools for screening##4##3##(2007-8#1)(2008-10#1)(2013-7#2)
tools for studies##2##3##(1994-3#1)(2007-11#1)
tools for studying the##4##4##(1995-3#1)(2008-4#2)(2010-11#1)
tools for studying##7##3##(1995-3#1)(2008-4#2)(2008-7#1)(2008-8#2)(2010-11#1)
tools for tackling##2##3##(1993-6#1)(2006-4#1)
tools for teaching and##2##4##(1996-9#1)(2007-2#1)
tools for teaching##3##3##(1996-9#1)(2007-2#2)
tools for the improvement of##2##5##(1994-6#1)(2008-11#1)
tools for the##33##3##(1990-8#1)(1991-9#1)(1993-12#1)(1993-6#1)(1994-6#1)(2006-10#1)(2006-12#2)(2006-6#1)(2007-6#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-4#3)(2008-7#2)(2009-2#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
tools for their##2##3##(2008-6#1)(2010-12#1)
tools for this##2##3##(2008-5#1)(2010-10#1)
tools for understanding and##2##4##(1994-12#1)(2007-12#1)
tools for understanding##4##3##(1994-12#1)(1994-3#1)(2007-12#1)(2008-11#1)
tools for use in##3##4##(2006-10#1)(2007-2#1)(2013-7#1)
tools for##219##2##(1990-7#1)(1990-8#1)(1990-9#2)(1991-9#1)(1992-2#1)(1993-12#1)(1993-6#2)(1994-12#1)(1994-3#2)(1994-4#1)(1994-6#3)(1995-1#1)(1995-12#2)(1995-3#4)(1995-6#1)(1995-8#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-11#1)(2006-10#6)(2006-12#7)(2006-4#1)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#6)(2007-12#1)(2007-2#3)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#5)(2008-1#5)(2008-10#15)(2008-11#11)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#13)(2008-5#3)(2008-6#1)(2008-7#16)(2008-8#8)(2008-9#3)(2009-10#1)(2009-11#2)(2009-2#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#2)(2010-11#5)(2010-12#4)(2010-2#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#5)(2011-3#1)(2011-9#1)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#10)(2013-7#3)(2013-8#2)
tools from the##2##3##(2008-7#1)(2011-2#1)
tools from##4##2##(2006-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
tools has##3##2##(2005-12#1)(2008-10#1)(2008-7#1)
tools have become available##2##4##(2006-9#1)(2009-6#1)
tools have become##3##3##(2006-9#1)(2007-1#1)(2009-6#1)
tools have been developed to##2##5##(2008-11#1)(2008-7#1)
tools have been developed##4##4##(2008-11#1)(2008-7#2)(2009-5#1)
tools have been used to##2##5##(2006-7#1)(2008-10#1)
tools have been##9##3##(2006-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-5#1)
tools have##19##2##(1996-1#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-5#1)(2009-6#1)(2010-12#1)(2013-1#1)
tools in a##2##3##(2008-10#1)(2008-7#1)
tools in cell##2##3##(2008-11#1)(2008-4#1)
tools in patients with##2##4##(2007-2#1)(2010-7#1)
tools in studying##2##3##(2008-5#1)(2010-8#1)
tools in the diagnosis of##2##5##(2012-12#1)(2013-1#1)
tools in the treatment of##2##5##(2006-10#1)(2008-8#1)
tools in the##12##3##(1992-3#1)(1997-3#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#2)(2010-4#1)(2012-12#1)(2013-1#1)
tools in##66##2##(1990-6#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-5#1)(1995-3#1)(1997-3#1)(1997-5#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#3)(2009-4#2)(2010-10#1)(2010-11#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
tools include##4##2##(2005-10#1)(2007-9#1)(2008-11#1)(2008-7#1)
tools including##2##2##(2008-8#1)(2010-3#1)
tools into their##2##3##(1997-2#1)(2010-8#1)
tools into##3##2##(1995-2#1)(1997-2#1)(2010-8#1)
tools is demonstrated##2##3##(2007-12#1)(2013-1#1)
tools is##5##2##(1997-7#1)(2007-12#1)(2008-10#1)(2011-2#1)(2013-1#1)
tools like##6##2##(1994-1#1)(1996-12#1)(2008-7#1)(2012-12#1)(2013-1#2)
tools may be##4##3##(1993-12#1)(2006-5#1)(2008-3#1)(2013-8#1)
tools may##6##2##(1993-12#1)(2006-5#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
tools necessary##2##2##(2008-1#1)(2012-1#1)
tools now##2##2##(2008-7#1)(2008-8#1)
tools of TQM##2##3##(1993-12#1)(1994-1#1)
tools of##15##2##(1993-12#1)(1994-1#1)(2006-10#2)(2007-10#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-12#2)(2008-9#1)(2010-5#1)(2012-2#2)
tools on##2##2##(2008-9#1)(2011-2#1)
tools or##2##2##(2008-10#1)(2010-12#1)
tools provided by##3##3##(2007-6#1)(2008-3#1)(2012-2#1)
tools such as a##3##4##(2008-10#2)(2010-5#1)
tools such as the##2##4##(2008-6#1)(2013-7#1)
tools such as##16##3##(1990-3#1)(1997-3#1)(2005-9#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-5#1)(2010-9#1)(2012-12#1)(2013-7#1)
tools that are able to##2##5##(2006-7#1)(2008-7#1)
tools that are used to##2##5##(2007-2#1)(2008-2#1)
tools that are used##3##4##(1996-2#1)(2007-2#1)(2008-2#1)
tools that are##21##3##(1994-12#1)(1996-2#1)(2006-11#1)(2006-7#1)(2007-11#1)(2007-2#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-10#2)(2010-11#2)(2010-2#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
tools that can be used to##2##6##(1996-2#1)(2008-4#1)
tools that can be used##3##5##(1996-2#1)(2005-10#1)(2008-4#1)
tools that can be##4##4##(1996-2#1)(2005-10#1)(2008-4#1)(2013-1#1)
tools that can greatly##2##4##(2006-10#1)(2008-10#1)
tools that can help##3##4##(2007-9#1)(2008-12#1)(2008-7#1)
tools that can##12##3##(1996-2#1)(2005-10#1)(2005-9#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2013-1#1)
tools that enable##3##3##(2009-12#1)(2010-2#1)(2010-5#1)
tools that may be used##2##5##(2008-7#1)(2011-12#1)
tools that may be##3##4##(1993-12#1)(2008-7#1)(2011-12#1)
tools that may##7##3##(1992-4#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-4#1)(2011-12#1)
tools that provide##3##3##(1992-12#1)(2006-10#1)(2010-12#1)
tools that will##3##3##(1996-12#1)(2008-10#1)(2008-12#1)
tools that##68##2##(1992-12#1)(1992-4#1)(1993-12#1)(1993-6#1)(1994-12#1)(1996-12#1)(1996-2#2)(2005-10#1)(2005-5#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#2)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#6)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-5#1)(2011-1#1)(2011-12#2)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#6)
tools to accomplish this##2##4##(1996-12#1)(2007-4#1)
tools to analyze##2##3##(2008-5#1)(2010-8#1)
tools to assess##3##3##(2008-10#2)(2012-3#1)
tools to create##4##3##(1996-1#1)(2008-11#1)(2008-7#1)(2010-7#1)
tools to design##2##3##(1996-10#1)(2007-11#1)
tools to detect##3##3##(2008-10#1)(2008-9#1)(2010-10#1)
tools to determine##3##3##(1993-7#1)(1995-9#1)(2011-1#1)
tools to enhance##2##3##(1994-3#1)(2013-7#1)
tools to evaluate##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
tools to facilitate##3##3##(1995-2#1)(1996-3#1)(2009-10#1)
tools to further##3##3##(2008-11#1)(2008-6#1)(2011-1#1)
tools to help the##2##4##(1991-2#1)(2008-10#1)
tools to help##6##3##(1991-2#2)(2004-4#1)(2007-9#1)(2008-10#1)(2012-12#1)
tools to identify the##2##4##(2008-1#1)(2008-2#1)
tools to identify##6##3##(2008-1#1)(2008-2#1)(2008-7#1)(2010-5#1)(2012-1#1)(2012-12#1)
tools to implement##2##3##(2008-3#1)(2008-6#1)
tools to improve##4##3##(2006-6#1)(2009-7#1)(2012-3#1)(2013-8#1)
tools to investigate the##2##4##(2006-5#1)(2008-11#1)
tools to make##2##3##(2006-6#1)(2006-9#1)
tools to measure##3##3##(1992-12#1)(2007-12#1)(2008-9#1)
tools to monitor##2##3##(2008-4#1)(2010-12#1)
tools to probe##2##3##(2008-4#1)(2008-8#1)
tools to study the##2##4##(1994-6#1)(2008-10#1)
tools to study##7##3##(1994-6#1)(2005-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-12#2)
tools to support##2##3##(2008-7#2)
tools to translate##2##3##(2007-11#1)(2010-11#1)
tools to treat##2##3##(2006-10#1)(2012-1#1)
tools to##134##2##(1991-2#2)(1992-12#1)(1993-12#2)(1993-7#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-2#2)(1995-3#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-3#2)(2004-3#1)(2004-4#1)(2005-10#2)(2005-8#1)(2006-10#1)(2006-5#1)(2006-6#2)(2006-9#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#6)(2008-5#1)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#6)(2011-3#1)(2012-1#3)(2012-12#4)(2012-2#1)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#4)
tools used by##2##3##(1990-12#1)(2008-12#1)
tools used in##4##3##(1990-10#1)(1995-12#1)(2005-10#1)(2008-2#1)
tools used to##3##3##(1992-2#1)(2008-7#1)(2011-12#1)
tools used##14##2##(1990-10#1)(1990-12#1)(1992-2#1)(1995-12#1)(1996-3#1)(2005-10#1)(2006-6#1)(2007-2#1)(2008-12#1)(2008-2#2)(2008-7#1)(2011-12#1)(2011-2#1)
tools using a unique mix of methods based on the science of biomedical informatics##2##14##(2013-1#2)
tools using##3##2##(2012-1#1)(2013-1#2)
tools we##2##2##(2006-10#1)(2012-2#1)
tools were##4##2##(2005-10#1)(2008-10#3)
tools which##4##2##(1992-3#1)(2005-5#1)(2008-12#1)(2012-3#1)
tools will be##3##3##(2007-5#1)(2008-9#1)(2009-5#1)
tools will##4##2##(2007-5#1)(2008-9#1)(2009-5#1)(2012-3#1)
tools with##7##2##(1994-6#1)(2008-10#1)(2008-3#1)(2011-12#1)(2012-1#1)(2013-1#2)
tools##1091##1##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-2#3)(1991-3#2)(1991-4#1)(1991-9#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-4#1)(1992-9#1)(1993-10#2)(1993-11#1)(1993-12#7)(1993-2#2)(1993-3#3)(1993-6#4)(1993-7#1)(1993-9#1)(1994-1#5)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#6)(1994-4#1)(1994-5#1)(1994-6#13)(1995-1#2)(1995-12#3)(1995-2#4)(1995-3#6)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#10)(1996-10#1)(1996-12#5)(1996-2#5)(1996-3#10)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#7)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2004-3#1)(2004-4#1)(2005-10#11)(2005-11#4)(2005-12#1)(2005-4#1)(2005-5#3)(2005-7#1)(2005-8#4)(2005-9#2)(2006-1#1)(2006-10#30)(2006-11#1)(2006-12#8)(2006-4#1)(2006-5#2)(2006-6#12)(2006-7#6)(2006-8#4)(2006-9#2)(2007-1#4)(2007-10#6)(2007-11#16)(2007-12#12)(2007-2#9)(2007-3#2)(2007-4#6)(2007-5#5)(2007-6#6)(2007-7#4)(2007-8#15)(2007-9#3)(2008-1#15)(2008-10#82)(2008-11#42)(2008-12#18)(2008-2#24)(2008-3#19)(2008-4#50)(2008-5#10)(2008-6#6)(2008-7#68)(2008-8#27)(2008-9#17)(2009-10#8)(2009-11#2)(2009-12#5)(2009-2#5)(2009-3#3)(2009-4#8)(2009-5#5)(2009-6#2)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#9)(2010-11#15)(2010-12#14)(2010-2#7)(2010-3#2)(2010-4#6)(2010-5#9)(2010-7#6)(2010-8#10)(2010-9#8)(2011-1#20)(2011-11#1)(2011-12#7)(2011-2#34)(2011-3#3)(2011-9#1)(2012-1#11)(2012-12#19)(2012-2#23)(2012-3#21)(2013-1#78)(2013-7#9)(2013-8#16)
tools)##3##1##(1994-6#2)(2008-10#1)
toosendanin##3##1##(2008-11#3)
tooth agenesis in##2##3##(2013-1#2)
tooth agenesis##4##2##(2010-3#1)(2011-1#1)(2013-1#2)
tooth and##5##2##(1991-5#1)(1996-3#1)(2008-1#1)(2012-2#2)
tooth avulsion##3##2##(2008-12#3)
tooth brushing frequency and##2##4##(2012-2#2)
tooth brushing in##2##3##(2006-2#1)(2012-12#1)
tooth brushing##6##2##(2006-2#1)(2012-11#1)(2012-12#1)(2012-2#3)
tooth buds##2##2##(2008-5#2)
tooth decay in##2##3##(1997-8#1)(2005-11#1)
tooth decay##10##2##(1997-8#1)(2005-11#4)(2006-10#1)(2006-2#1)(2007-10#1)(2008-5#1)(2012-12#1)
tooth development##2##2##(2006-2#1)(2013-1#1)
tooth developmental##3##2##(2008-5#1)(2013-1#2)
tooth dosimetry##2##2##(2008-7#2)
tooth enamel##6##2##(2005-10#1)(2008-12#1)(2009-7#1)(2012-2#1)(2013-8#2)
tooth erosion around orthodontic brackets##2##5##(2013-1#2)
tooth eruption##2##2##(1995-11#1)(2013-1#1)
tooth extraction##10##2##(1991-5#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-12#5)(2007-8#1)
tooth geometry##2##2##(2008-7#1)(2009-7#1)
tooth germs##3##2##(2009-3#2)(2013-1#1)
tooth images##2##2##(2010-2#2)
tooth in the primary##2##4##(2008-5#2)
tooth in the##5##3##(2008-5#2)(2008-7#2)(2012-3#1)
tooth in##7##2##(2008-12#1)(2008-5#2)(2008-7#2)(2012-3#1)(2013-8#1)
tooth is##4##2##(2007-12#1)(2008-7#1)(2012-12#1)(2013-1#1)
tooth loss and##2##3##(2008-9#1)(2012-12#1)
tooth loss in diabetic##2##4##(2012-12#2)
tooth loss in##5##3##(2008-12#2)(2008-9#1)(2012-12#2)
tooth loss##16##2##(2005-11#2)(2008-12#2)(2008-6#2)(2008-9#3)(2010-4#1)(2012-12#5)(2013-1#1)
tooth movement##9##2##(2004-3#3)(2008-11#1)(2011-1#3)(2013-1#2)
tooth of##3##2##(2007-2#1)(2012-12#1)(2013-1#1)
tooth preparation and##2##3##(2007-9#1)(2011-2#1)
tooth preparation##4##2##(1991-2#1)(2007-9#1)(2011-2#1)(2013-1#1)
tooth pulp##4##2##(1994-5#3)(1996-2#1)
tooth removal##3##2##(2007-12#1)(2008-6#2)
tooth replacement##3##2##(2009-8#2)(2013-1#1)
tooth sensitivity##2##2##(2008-5#1)(2013-8#1)
tooth separation was##3##3##(2008-12#3)
tooth separation##5##2##(2008-12#5)
tooth size##3##2##(2010-12#1)(2010-2#1)(2013-1#1)
tooth stains##5##2##(2013-1#5)
tooth structure##11##2##(1990-3#1)(1991-2#2)(1997-4#1)(2008-7#3)(2008-9#1)(2010-10#1)(2013-8#2)
tooth structures##3##2##(1991-2#1)(1996-11#1)(2011-2#1)
tooth supported##2##2##(2013-1#2)
tooth supporting tissues##2##3##(2005-11#1)(2006-8#1)
tooth surfaces and##2##3##(2005-11#1)(2006-2#1)
tooth surfaces##5##2##(1993-9#1)(2005-11#1)(2006-10#1)(2006-2#1)(2013-1#1)
tooth tissue engineering##3##3##(2008-5#2)(2013-1#1)
tooth to##2##2##(2007-2#1)(2008-7#1)
tooth type##2##2##(2013-1#2)
tooth was##9##2##(2008-5#1)(2008-7#1)(2010-3#2)(2011-2#1)(2012-12#1)(2013-1#3)
tooth whitening##2##2##(2009-8#1)(2012-8#1)
tooth with a##3##3##(2008-6#1)(2009-8#1)(2011-2#1)
tooth with##8##2##(2008-6#1)(2008-7#1)(2009-8#1)(2010-2#1)(2010-6#2)(2011-2#1)(2013-1#1)
tooth##269##1##(1990-3#1)(1990-5#1)(1991-2#5)(1991-5#2)(1991-9#1)(1993-9#1)(1994-5#3)(1995-11#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-4#3)(1997-8#1)(2004-3#3)(2004-9#1)(2005-10#1)(2005-11#9)(2005-9#1)(2006-10#3)(2006-12#1)(2006-2#5)(2006-8#1)(2007-10#1)(2007-12#11)(2007-2#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#2)(2008-12#15)(2008-2#1)(2008-3#1)(2008-5#15)(2008-6#9)(2008-7#23)(2008-9#5)(2009-3#2)(2009-4#1)(2009-7#2)(2009-8#5)(2010-10#3)(2010-12#2)(2010-2#6)(2010-3#6)(2010-4#1)(2010-5#2)(2010-6#3)(2011-1#5)(2011-12#4)(2011-2#9)(2012-11#1)(2012-12#14)(2012-2#10)(2012-3#2)(2012-8#1)(2013-1#46)(2013-7#1)(2013-8#7)
tooth-colored##2##1##(2008-7#1)(2013-1#1)
tooth-row##2##1##(2008-8#2)
toothbrush is##2##2##(2006-2#2)
toothbrush##6##1##(1996-12#1)(2006-2#5)
toothbrushes##9##1##(2006-10#1)(2006-2#7)(2012-2#1)
toothbrushing##6##1##(2006-2#1)(2010-5#4)(2011-2#1)
toothless##3##1##(1996-3#1)(2013-1#2)
toothpaste and##4##2##(2006-2#1)(2011-2#1)(2012-2#2)
toothpaste containing##2##2##(2011-1#1)(2011-2#1)
toothpaste to##2##2##(2006-2#1)(2011-2#1)
toothpaste##31##1##(2006-2#5)(2008-10#1)(2008-5#4)(2011-1#4)(2011-2#7)(2012-2#10)
toothpastes are##2##2##(2006-2#2)
toothpastes containing##2##2##(2008-5#1)(2011-2#1)
toothpastes##17##1##(2006-2#4)(2008-5#8)(2011-1#1)(2011-2#2)(2012-2#2)
toothpick causing pseudotumor of the first metatarsal##2##7##(2008-12#2)
toothpick ingestion##2##2##(2011-2#2)
toothpick##12##1##(2008-10#1)(2008-12#5)(2011-2#4)(2013-7#2)
toothpicks##4##1##(2008-10#1)(2008-2#1)(2011-2#2)
top 10##5##2##(2005-11#1)(2008-7#2)(2009-9#1)(2013-8#1)
top and bottom##5##3##(2007-1#1)(2008-12#1)(2008-3#1)(2009-4#1)(2010-2#1)
top and##12##2##(2007-1#1)(2007-10#1)(2008-12#1)(2008-2#4)(2008-3#3)(2009-4#1)(2010-2#1)
top component of##2##3##(1992-8#1)(2008-9#1)
top component##3##2##(1992-8#2)(2008-9#1)
top down##2##2##(1996-12#1)(2013-1#1)
top execs##2##2##(1990-4#1)(1997-7#1)
top five##4##2##(2007-8#1)(2008-12#1)(2012-2#1)(2013-8#1)
top genes##2##2##(2012-3#2)
top halves of faces##2##4##(2009-4#2)
top halves##3##2##(2009-4#3)
top in##2##2##(1993-3#1)(2010-12#1)
top layer of the##2##4##(2007-12#1)(2010-5#1)
top layer of##3##3##(2007-12#1)(2008-3#1)(2010-5#1)
top layer##6##2##(1990-12#1)(2007-12#1)(2008-3#2)(2010-1#1)(2010-5#1)
top of a##6##3##(1995-5#1)(2007-8#1)(2008-2#1)(2008-3#3)
top of an##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)
top of the##36##3##(1990-7#1)(1992-12#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-6#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-2#1)(2006-11#1)(2006-12#4)(2006-6#1)(2007-10#2)(2007-12#1)(2007-7#2)(2008-10#3)(2008-11#3)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-6#1)
top of these##2##3##(1997-4#1)(2008-10#1)
top of##76##2##(1990-7#1)(1990-8#1)(1992-12#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-9#4)(1995-5#1)(1995-6#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-4#1)(2006-11#1)(2006-12#5)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-2#6)(2008-3#10)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-6#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
top phase##2##2##(1992-11#1)(2012-1#1)
top predators##3##2##(2007-5#1)(2013-1#2)
top priorities##2##2##(2007-10#1)(2011-2#1)
top priority##5##2##(1990-12#1)(2007-12#1)(2007-9#1)(2008-4#1)(2013-1#1)
top ranked##4##2##(1991-6#1)(2010-12#3)
top science##2##2##(2007-9#2)
top surface##5##2##(2007-12#1)(2008-12#1)(2008-3#1)(2008-7#1)(2013-8#1)
top ten##3##2##(2007-5#1)(2012-3#2)
top to##5##2##(1995-1#1)(2005-11#1)(2007-1#1)(2007-9#1)(2008-10#1)
top trophic levels##2##3##(2008-5#1)(2008-9#1)
top trophic##3##2##(2008-5#1)(2008-8#1)(2008-9#1)
top two##2##2##(2007-9#1)(2008-10#1)
top##305##1##(1990-12#3)(1990-4#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-8#3)(1993-12#3)(1993-3#2)(1993-7#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#6)(1995-1#2)(1995-10#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#1)(1996-12#3)(1996-3#1)(1996-4#1)(1996-6#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#4)(2004-3#1)(2005-11#2)(2005-4#1)(2005-5#1)(2006-11#1)(2006-12#6)(2006-4#1)(2006-6#3)(2006-7#1)(2007-1#3)(2007-10#7)(2007-11#3)(2007-12#9)(2007-3#1)(2007-5#2)(2007-7#4)(2007-8#3)(2007-9#6)(2008-1#3)(2008-10#38)(2008-11#9)(2008-12#4)(2008-2#22)(2008-3#21)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#4)(2009-10#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#5)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#6)(2010-2#3)(2010-4#4)(2010-5#1)(2010-6#1)(2011-1#4)(2011-2#4)(2012-1#4)(2012-12#3)(2012-2#3)(2012-3#7)(2013-1#8)(2013-7#2)(2013-8#7)
top-down and bottom-up##2##3##(2008-12#1)(2012-3#1)
top-down and##3##2##(1997-8#1)(2008-12#1)(2012-3#1)
top-down approach##4##2##(2008-12#2)(2009-8#1)(2013-1#1)
top-down control of##2##3##(2007-3#1)(2011-12#1)
top-down effects##4##2##(2013-8#4)
top-down knowledge##2##2##(1997-8#2)
top-down method##3##2##(2006-12#1)(2010-7#1)(2011-2#1)
top-down modulation of##3##3##(2008-11#1)(2013-8#2)
top-down regulation of##2##3##(2007-3#2)
top-down##46##1##(1995-2#1)(1997-8#9)(2006-12#1)(2007-3#3)(2007-8#1)(2008-11#3)(2008-12#5)(2008-7#1)(2009-4#1)(2009-8#2)(2010-3#1)(2010-7#3)(2011-1#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#6)
top-down&quot##2##1##(2007-4#1)(2010-7#1)
top-hat beam##7##2##(2007-12#2)(2008-3#5)
top-hat##12##1##(2007-12#4)(2008-2#1)(2008-3#7)
top-layer optical properties##3##3##(2008-2#1)(2008-3#2)
top-layer##4##1##(2008-2#1)(2008-3#3)
top-level##2##1##(1995-8#1)(2005-11#1)
top-managers and##2##2##(1990-12#2)
top-of-the-atmosphere##5##1##(2008-2#2)(2008-3#3)
top-up##6##1##(1993-4#1)(1993-7#2)(2006-10#2)(2008-12#1)
top1 cleavage##2##2##(1995-5#2)
top1##4##1##(1995-5#4)
top3 slow growth phenotype##3##4##(2010-2#3)
top3##8##1##(2010-2#8)
topa quinone##2##2##(1994-3#1)(1995-5#1)
tophaceous gout##9##2##(2006-10#7)(2010-4#2)
tophaceous##11##1##(2006-10#8)(2010-4#3)
tophi##4##1##(2006-10#1)(2007-11#2)(2013-1#1)
topic and##8##2##(2007-4#1)(2008-10#1)(2008-4#2)(2009-12#1)(2009-4#1)(2011-1#1)(2013-1#1)
topic for##6##2##(1992-2#1)(1992-4#1)(1994-8#1)(2005-10#1)(2005-8#1)(2006-10#1)
topic has been##2##3##(1996-12#1)(2012-1#1)
topic has##3##2##(1990-11#1)(1996-12#1)(2012-1#1)
topic in pediatric##2##3##(2007-8#1)(2008-10#1)
topic in the literature##2##4##(1991-1#1)(1993-5#1)
topic in the##7##3##(1991-1#1)(1993-5#1)(2006-10#1)(2006-2#1)(2008-3#1)(2009-5#1)(2013-1#1)
topic in##84##2##(1991-1#1)(1993-5#1)(1994-7#1)(2005-10#1)(2006-10#1)(2006-2#2)(2006-8#1)(2007-4#1)(2007-8#62)(2008-10#3)(2008-3#1)(2008-9#1)(2009-5#2)(2009-9#1)(2010-7#1)(2012-12#2)(2013-1#1)(2013-8#1)
topic is##13##2##(1992-4#1)(1994-2#1)(1996-2#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)
topic model and predicate-based query expansion for retrieving clinical documents##2##10##(2013-1#2)
topic model##4##2##(2013-1#4)
topic of debate##3##3##(1993-3#1)(1995-3#1)(2008-11#1)
topic of discussion##2##3##(1996-12#1)(2008-1#1)
topic of interest##4##3##(2006-10#1)(2007-8#1)(2009-10#1)(2009-5#1)
topic of the##4##3##(1990-10#1)(2008-12#2)(2011-2#1)
topic of this article##2##4##(2008-11#1)(2008-5#1)
topic of this##3##3##(2005-8#1)(2008-11#1)(2008-5#1)
topic of##55##2##(1990-10#1)(1990-4#1)(1991-1#1)(1992-1#2)(1993-3#1)(1993-4#1)(1995-3#1)(1995-5#1)(1996-12#1)(1997-6#1)(2005-8#2)(2006-10#4)(2006-11#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#3)(2009-10#1)(2009-12#1)(2009-4#4)(2009-5#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#1)
topic structure##4##2##(2013-1#4)
topic to##4##2##(2007-2#2)(2007-4#1)(2008-11#1)
topic was##3##2##(2008-10#1)(2012-3#1)(2013-7#1)
topic with##5##2##(1996-8#1)(2007-1#1)(2008-12#1)(2012-12#1)(2013-8#1)
topic within##2##2##(2012-2#2)
topic##298##1##(1990-10#1)(1990-11#1)(1990-4#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-2#1)(1992-4#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-2#4)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-6#1)(2004-10#1)(2004-12#1)(2005-10#2)(2005-8#5)(2006-10#15)(2006-11#1)(2006-2#3)(2006-6#2)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#3)(2007-3#1)(2007-4#4)(2007-5#2)(2007-6#1)(2007-8#76)(2008-1#5)(2008-10#10)(2008-11#9)(2008-12#4)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#2)(2009-4#5)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#3)(2012-12#4)(2012-2#7)(2012-3#2)(2013-1#27)(2013-7#4)(2013-8#5)
topic&quot##2##1##(2013-1#2)
topic'##2##1##(2008-11#1)(2011-2#1)
topic]##2##1##(1993-11#1)(2005-6#1)
topical 13-HODE##3##2##(1994-5#3)
topical ALA##2##2##(1992-8#2)
topical CAI##3##2##(2009-8#3)
topical PDT##2##2##(2006-12#2)
topical PUVA therapy##2##3##(2007-8#2)
topical acne##2##2##(2010-8#2)
topical administration of##4##3##(1997-5#1)(2008-5#1)(2010-4#1)(2011-2#1)
topical administration##6##2##(1997-5#1)(2007-11#1)(2008-5#1)(2010-12#1)(2010-4#1)(2011-2#1)
topical agent##4##2##(1994-2#1)(2006-12#1)(2008-5#1)(2009-8#1)
topical agents for##2##3##(2007-11#1)(2011-2#1)
topical agents##9##2##(2005-12#1)(2007-1#1)(2007-11#2)(2007-2#1)(2007-8#1)(2008-5#1)(2009-8#1)(2011-2#1)
topical and oral##3##3##(2005-8#1)(2007-12#1)(2007-8#1)
topical and systemic treatments for##2##5##(2008-5#1)(2013-8#1)
topical and systemic##7##3##(2006-2#1)(2007-8#1)(2008-4#1)(2008-5#3)(2013-8#1)
topical and##16##2##(2005-7#1)(2005-8#2)(2006-10#1)(2006-2#1)(2007-12#1)(2007-8#2)(2008-12#1)(2008-4#1)(2008-5#4)(2009-4#1)(2013-8#1)
topical anesthesia##2##2##(1992-2#1)(2008-5#1)
topical anti-inflammatory##2##2##(1992-11#1)(2006-12#1)
topical antibiotic##2##2##(2007-7#1)(2008-1#1)
topical antibiotics and##2##3##(2005-7#1)(2009-8#1)
topical antibiotics##4##2##(2005-7#1)(2007-7#1)(2009-8#1)(2013-8#1)
topical antifungal therapy##2##3##(2012-3#2)
topical antifungal##3##2##(2011-2#1)(2012-3#2)
topical antifungals##3##2##(2008-5#2)(2011-2#1)
topical application in melasma##3##4##(2007-7#3)
topical application in##4##3##(2007-7#4)
topical application of ALA##2##4##(1992-9#2)
topical application of a##3##4##(2008-5#2)(2010-12#1)
topical application of##42##3##(1990-11#1)(1990-2#1)(1991-12#1)(1991-8#1)(1992-6#1)(1992-8#3)(1992-9#3)(1994-3#1)(1996-10#1)(1996-5#1)(2005-8#1)(2006-12#2)(2006-8#2)(2007-7#3)(2007-8#1)(2008-4#1)(2008-5#8)(2008-8#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-7#1)
topical application##61##2##(1990-11#1)(1990-2#1)(1991-12#1)(1991-8#1)(1992-6#1)(1992-8#3)(1992-9#3)(1994-3#1)(1996-10#1)(1996-5#1)(2005-11#1)(2005-8#1)(2006-12#3)(2006-8#2)(2007-7#7)(2007-8#1)(2008-12#4)(2008-4#1)(2008-5#12)(2008-6#1)(2008-8#1)(2009-6#2)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#3)(2013-1#3)(2013-7#1)
topical applications of apigenin##3##4##(2013-1#3)
topical applications of##5##3##(2006-12#1)(2008-8#1)(2013-1#3)
topical applications##9##2##(1993-11#1)(2006-12#1)(2008-8#2)(2011-12#2)(2013-1#3)
topical calcineurin inhibitors has led to##2##6##(2010-8#2)
topical calcineurin inhibitors##8##3##(2008-3#2)(2010-8#6)
topical combination##2##2##(2008-5#1)(2012-3#1)
topical corticosteroid##3##2##(2007-11#1)(2011-1#1)(2012-3#1)
topical corticosteroids and##2##3##(2007-8#1)(2012-3#1)
topical corticosteroids##8##2##(2006-10#1)(2007-11#4)(2007-8#1)(2009-6#1)(2012-3#1)
topical creams##2##2##(2008-5#1)(2012-2#1)
topical delivery##3##2##(2010-2#1)(2012-2#2)
topical drug delivery systems currently##2##5##(2012-2#2)
topical drug delivery systems##3##4##(2012-2#3)
topical drug delivery##6##3##(1996-2#1)(2012-2#5)
topical drug products##2##3##(2012-2#2)
topical drug##8##2##(1996-2#1)(2012-2#7)
topical exposure##3##2##(1992-2#2)(1997-2#1)
topical form of the##2##4##(2005-8#1)(2006-10#1)
topical formulation##5##2##(2005-7#2)(2007-8#1)(2008-3#1)(2008-5#1)
topical formulations##3##2##(2005-7#1)(2008-5#2)
topical imiquimod##4##2##(2005-8#1)(2007-11#1)(2012-3#2)
topical interferon-beta##2##2##(2007-8#2)
topical metronidazole##2##2##(2006-10#2)
topical microbicides##2##2##(2005-8#1)(2009-6#1)
topical negative pressure##2##3##(2007-8#1)(2012-2#1)
topical nonsteroidal anti-inflammatory drugs##2##4##(1994-2#1)(2006-12#1)
topical phenytoin##2##2##(2011-2#1)(2013-8#1)
topical preparations##2##2##(2008-5#2)
topical products##3##2##(2008-5#3)
topical retinoids##4##2##(2007-10#3)(2008-5#1)
topical steroid##4##2##(2006-10#3)(2007-7#1)
topical steroids and##4##3##(2006-12#1)(2007-7#1)(2007-8#1)(2011-2#1)
topical steroids##7##2##(2005-8#1)(2006-12#2)(2007-11#1)(2007-7#1)(2007-8#1)(2011-2#1)
topical sunscreens##3##2##(2006-12#1)(2008-5#2)
topical tacrolimus##3##2##(2005-8#1)(2006-10#1)(2012-2#1)
topical therapy and##2##3##(2010-12#1)(2012-12#1)
topical therapy in##2##3##(2007-10#1)(2007-8#1)
topical therapy with tar##2##4##(2007-8#2)
topical therapy##12##2##(1991-8#1)(2007-10#1)(2007-8#5)(2008-5#1)(2010-12#1)(2010-8#1)(2012-12#2)
topical treatment for##3##3##(1993-11#1)(2007-11#1)(2008-10#1)
topical treatment of##12##3##(1990-6#2)(1992-10#1)(1992-8#1)(1997-8#1)(2006-12#3)(2007-11#2)(2008-5#1)(2010-8#1)
topical treatment with##2##3##(2006-8#1)(2012-2#1)
topical treatment##25##2##(1990-6#3)(1992-10#1)(1992-8#1)(1993-11#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-12#3)(2006-8#1)(2007-11#4)(2007-8#1)(2008-10#1)(2008-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)
topical tretinoin##2##2##(1996-8#1)(2005-8#1)
topical use of beta-blockers##2##4##(1997-5#2)
topical use of##3##3##(1997-5#2)(2007-8#1)
topical use##6##2##(1997-5#2)(2006-12#1)(2007-11#1)(2007-8#1)(2008-5#1)
topical vitamin##2##2##(2010-12#1)(2010-9#1)
topical##390##1##(1990-11#2)(1990-2#1)(1990-4#1)(1990-6#3)(1991-12#1)(1991-3#1)(1991-8#2)(1992-10#1)(1992-11#1)(1992-2#5)(1992-6#2)(1992-8#6)(1992-9#3)(1993-1#2)(1993-11#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-2#3)(1994-3#1)(1994-5#3)(1994-9#1)(1995-7#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-5#4)(1997-8#4)(2004-3#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-7#7)(2005-8#9)(2006-10#13)(2006-12#24)(2006-2#2)(2006-6#1)(2006-8#3)(2006-9#1)(2007-1#3)(2007-10#4)(2007-11#18)(2007-12#2)(2007-2#2)(2007-7#16)(2007-8#25)(2007-9#1)(2008-1#2)(2008-10#3)(2008-12#6)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#49)(2008-6#3)(2008-8#5)(2009-4#1)(2009-6#6)(2009-8#10)(2010-12#6)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#13)(2010-9#4)(2011-1#5)(2011-12#3)(2011-2#14)(2012-1#1)(2012-10#1)(2012-11#1)(2012-12#8)(2012-2#18)(2012-3#7)(2013-1#7)(2013-7#2)(2013-8#5)
topical/transdermal drug delivery##2##3##(2008-5#2)
topically active##2##2##(1993-1#1)(2008-5#1)
topically administered##2##2##(1994-6#1)(2008-5#1)
topically and##3##2##(1992-6#1)(2007-8#1)(2008-5#1)
topically applied cosmetic products##2##4##(2008-5#2)
topically applied##17##2##(1992-1#1)(2008-5#13)(2008-8#1)(2009-8#1)(2011-1#1)
topically to##4##2##(1996-8#1)(2006-10#1)(2007-2#1)(2008-5#1)
topically treated with##2##3##(2008-5#1)(2008-8#1)
topically##44##1##(1992-1#1)(1992-2#1)(1992-6#1)(1993-1#2)(1994-6#1)(1995-9#1)(1996-8#2)(2005-9#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-7#3)(2007-8#1)(2008-12#2)(2008-5#20)(2008-8#2)(2009-8#1)(2011-1#1)(2012-11#1)
topics about the##2##3##(2008-7#1)(2013-1#1)
topics addressed in this##2##4##(2006-10#1)(2008-4#1)
topics addressed##4##2##(1997-2#1)(2006-10#1)(2008-4#1)(2008-5#1)
topics and##5##2##(1990-7#1)(1993-3#1)(1995-3#1)(2005-8#1)(2008-11#1)
topics are considered##2##3##(1995-12#1)(2008-10#1)
topics are##12##2##(1995-12#1)(1996-2#2)(1996-9#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-11#1)(2010-7#1)
topics as the##2##3##(2008-11#1)(2008-9#1)
topics as##5##2##(1994-1#1)(2007-4#1)(2008-11#1)(2008-9#2)
topics covered in this review include##2##6##(2007-12#1)(2012-12#1)
topics covered in this review##3##5##(2006-10#1)(2007-12#1)(2012-12#1)
topics covered##6##2##(2005-7#1)(2005-8#1)(2006-10#2)(2007-12#1)(2012-12#1)
topics discussed##3##2##(1993-12#1)(1994-3#1)(2007-4#1)
topics for future##3##3##(2007-11#1)(2008-11#1)(2010-9#1)
topics for the##2##3##(2007-2#1)(2008-5#1)
topics for##9##2##(2005-8#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-9#1)(2010-9#1)(2013-1#1)
topics from##4##2##(2008-2#1)(2008-5#1)(2013-1#2)
topics in the field of##2##5##(1992-3#1)(2008-5#1)
topics in the##7##3##(1992-3#1)(1994-2#1)(1996-6#1)(2005-10#1)(2006-10#1)(2007-6#1)(2008-5#1)
topics in##24##2##(1992-3#1)(1993-3#1)(1994-2#1)(1996-6#1)(2004-12#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#3)(2009-5#1)(2009-9#1)(2010-4#1)(2011-1#2)(2013-1#1)(2013-7#1)
topics include##3##2##(2005-9#1)(2006-5#1)(2008-2#1)
topics including##2##2##(2006-10#1)(2008-7#1)
topics of interest to the##2##5##(2008-10#1)(2008-5#1)
topics of interest to##4##4##(2005-8#1)(2008-10#1)(2008-12#1)(2008-5#1)
topics of interest##5##3##(2005-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-5#1)
topics of the##8##3##(2007-2#1)(2007-4#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-11#1)(2012-3#1)
topics of##31##2##(1990-7#1)(1993-1#1)(1995-2#1)(1996-2#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
topics on##2##2##(1994-2#1)(2011-3#1)
topics ranged##2##2##(2006-11#1)(2008-5#1)
topics ranging from##4##3##(2005-8#1)(2006-10#1)(2008-7#1)(2008-8#1)
topics related to##4##3##(2007-5#1)(2008-5#1)(2009-2#1)(2012-2#1)
topics relating to##3##3##(1996-2#1)(2006-10#1)(2010-8#1)
topics such as##7##3##(1994-12#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
topics that are currently##2##4##(1997-2#1)(2012-12#1)
topics that are##4##3##(1997-2#1)(2008-3#1)(2012-12#1)(2013-1#1)
topics that were##3##3##(1994-2#1)(2013-1#2)
topics that##12##2##(1994-2#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
topics to##3##2##(1995-2#1)(2010-4#1)(2012-3#1)
topics were covered##2##3##(2005-8#1)(2008-5#1)
topics were##7##2##(1990-12#1)(2005-11#1)(2005-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2013-1#1)
topics will##2##2##(1992-9#1)(2008-10#1)
topics with##2##2##(2006-10#1)(2012-12#1)
topics##237##1##(1990-12#2)(1990-5#1)(1990-7#2)(1991-2#1)(1991-3#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#3)(1993-5#1)(1994-1#1)(1994-12#2)(1994-2#4)(1994-3#4)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#5)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(2004-12#1)(2005-10#1)(2005-11#1)(2005-7#4)(2005-8#11)(2005-9#4)(2006-10#12)(2006-11#1)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#3)(2007-4#5)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#11)(2008-11#5)(2008-12#4)(2008-2#5)(2008-3#3)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#10)(2008-8#1)(2008-9#4)(2009-10#1)(2009-2#3)(2009-4#2)(2009-5#1)(2009-7#1)(2009-9#2)(2010-11#2)(2010-12#4)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#5)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#5)(2013-1#15)(2013-7#2)(2013-8#2)
topics&quot##3##1##(2007-9#1)(2013-1#2)
topiramate and##3##2##(2008-7#1)(2008-8#1)(2011-1#1)
topiramate##13##1##(2006-10#1)(2006-12#1)(2006-7#1)(2008-7#7)(2008-8#1)(2011-1#1)(2013-1#1)
topogenic##2##1##(1995-3#1)(1997-7#1)
topographic Hox expression##4##3##(2012-12#4)
topographic anatomy of##2##3##(2006-7#1)(2011-1#1)
topographic and##5##2##(1992-1#1)(2007-11#1)(2011-1#1)(2012-1#1)(2013-1#1)
topographic changes##2##2##(2007-1#1)(2007-12#1)
topographic data##2##2##(1997-5#1)(2005-11#1)
topographic images##2##2##(2006-4#1)(2007-12#1)
topographic location##2##2##(1992-8#1)(2008-7#1)
topographic map##3##2##(1993-9#2)(2011-1#1)
topographic mapping##2##2##(1994-2#1)(1995-6#1)
topographic maps##2##2##(2007-1#1)(2007-3#1)
topographic relationship between##2##3##(2007-6#1)(2008-7#1)
topographic##63##1##(1991-1#1)(1991-3#1)(1992-1#1)(1992-10#1)(1992-3#2)(1992-8#1)(1993-9#2)(1994-2#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-5#2)(2005-11#1)(2005-12#1)(2006-4#2)(2006-6#1)(2006-7#1)(2007-1#2)(2007-11#4)(2007-12#4)(2007-3#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#5)(2008-5#1)(2008-7#3)(2010-8#1)(2011-1#4)(2012-1#1)(2012-12#4)(2013-1#1)(2013-7#1)
topographical distribution##2##2##(2007-9#1)(2011-2#1)
topographical features##6##2##(1995-8#1)(2008-2#2)(2008-7#1)(2012-11#2)
topographical images of##2##3##(2008-2#1)(2008-4#1)
topographical map of the##2##4##(1994-2#1)(2010-12#1)
topographical organization of the##2##4##(2010-12#2)
topographical organization of##3##3##(1994-2#1)(2010-12#2)
topographical organization##5##2##(1994-2#1)(2008-11#2)(2010-12#2)
topographical##39##1##(1991-9#1)(1992-5#1)(1992-7#1)(1993-4#1)(1994-2#2)(1995-8#1)(1997-2#1)(1997-7#1)(2005-11#1)(2006-3#1)(2007-11#1)(2007-9#1)(2008-11#2)(2008-2#5)(2008-3#4)(2008-4#2)(2008-7#1)(2009-4#1)(2009-9#1)(2010-12#3)(2011-2#2)(2012-1#1)(2012-11#2)(2013-1#1)(2013-8#1)
topographically distinct##2##2##(1991-7#1)(2012-1#1)
topographically##16##1##(1991-3#1)(1991-7#1)(1995-5#1)(1995-6#1)(1996-6#1)(2005-10#1)(2007-12#2)(2008-11#1)(2008-3#2)(2010-1#2)(2012-1#1)(2012-12#2)
topographies##4##1##(2004-9#1)(2006-11#1)(2010-4#2)
topographique##2##1##(2012-2#1)(2013-1#1)
topographs##3##1##(2006-4#2)(2006-5#1)
topography analysis##2##2##(1991-12#1)(2008-5#1)
topography and the##2##3##(2005-11#1)(2008-2#1)
topography and##10##2##(1994-5#1)(2004-11#1)(2005-11#2)(2006-4#1)(2007-10#1)(2007-5#1)(2008-2#2)(2012-1#1)
topography by##2##2##(1995-12#1)(2008-3#1)
topography changes##3##2##(2008-2#1)(2008-3#2)
topography has##2##2##(2006-4#1)(2008-3#1)
topography in a##2##3##(1993-2#1)(2004-9#1)
topography in##6##2##(1993-2#1)(1995-5#1)(2004-9#1)(2007-12#1)(2009-8#1)(2011-1#1)
topography of the##15##3##(1991-2#1)(1992-11#1)(1992-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#2)(2010-12#1)(2013-8#1)
topography of##35##2##(1990-11#1)(1991-2#1)(1991-7#1)(1992-11#2)(1992-9#1)(1993-10#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-6#1)(1997-1#1)(2004-11#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2010-12#1)(2013-8#1)
topography on the##3##3##(2008-5#1)(2013-7#2)
topography on##6##2##(2004-9#1)(2008-3#2)(2008-5#1)(2013-7#2)
topography using##2##2##(2007-9#1)(2008-3#1)
topography was##2##2##(1997-3#1)(2012-1#1)
topography with##3##2##(2006-5#1)(2008-3#2)
topography##136##1##(1990-11#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-11#2)(1992-9#1)(1993-10#1)(1993-2#1)(1994-2#1)(1994-5#3)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1997-1#1)(1997-3#1)(1997-7#1)(2004-11#2)(2004-9#4)(2005-11#2)(2005-8#1)(2006-10#1)(2006-4#5)(2006-5#3)(2006-6#1)(2006-7#1)(2007-1#3)(2007-10#2)(2007-11#3)(2007-12#5)(2007-3#1)(2007-5#2)(2007-6#1)(2007-9#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#9)(2008-3#24)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-11#2)(2012-2#1)(2013-7#4)(2013-8#2)
topoisomerase I and II##3##4##(1995-7#2)(2008-5#1)
topoisomerase I and topoisomerase##2##4##(1993-8#1)(1995-7#1)
topoisomerase I and##8##3##(1992-8#1)(1993-3#1)(1993-8#1)(1995-3#1)(1995-7#3)(2008-5#1)
topoisomerase I cleavable##2##3##(1995-3#1)(1995-5#1)
topoisomerase I in##2##3##(1996-7#1)(2008-11#1)
topoisomerase I inhibitor##2##3##(1993-8#1)(1995-3#1)
topoisomerase I inhibitors##2##3##(2008-11#1)(2008-5#1)
topoisomerase I or II##2##4##(1995-7#1)(1996-6#1)
topoisomerase I##43##2##(1990-7#2)(1992-8#2)(1993-3#2)(1993-8#7)(1994-8#2)(1995-3#5)(1995-5#2)(1995-7#4)(1996-10#1)(1996-6#1)(1996-7#2)(1997-4#1)(1997-5#1)(2005-8#4)(2008-11#4)(2008-5#2)(2008-8#1)
topoisomerase I-##2##2##(1996-6#2)
topoisomerase II activity in##2##4##(1990-2#2)
topoisomerase II activity##5##3##(1990-2#4)(1995-1#1)
topoisomerase II and glutathione-S-transferase-pi##2##4##(1992-6#2)
topoisomerase II and##5##3##(1990-8#1)(1992-6#2)(1992-8#1)(1995-1#1)
topoisomerase II beta##5##3##(1995-6#5)
topoisomerase II binding and reaction##2##5##(1991-5#2)
topoisomerase II from rat testis##2##5##(1996-7#2)
topoisomerase II from##5##3##(1991-4#1)(1996-7#4)
topoisomerase II in##8##3##(1991-11#1)(1993-8#2)(1994-12#1)(1995-1#2)(1996-7#2)
topoisomerase II inhibitor##3##3##(1994-6#1)(2005-8#1)(2008-11#1)
topoisomerase II inhibitors##2##3##(1994-9#1)(2006-12#1)
topoisomerase II is##3##3##(1990-7#1)(1993-8#1)(1996-7#1)
topoisomerase II was##2##3##(1990-7#1)(1996-7#1)
topoisomerase II##75##2##(1990-2#6)(1990-7#6)(1990-8#1)(1991-11#2)(1991-2#1)(1991-4#1)(1991-5#4)(1992-6#2)(1992-8#1)(1993-3#3)(1993-8#6)(1994-12#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#10)(1995-6#9)(1996-7#9)(2005-8#1)(2006-12#1)(2008-11#3)(2008-5#1)(2008-8#1)(2013-1#1)
topoisomerase II-mediated DNA##3##3##(1991-2#3)
topoisomerase II-mediated##4##2##(1991-2#4)
topoisomerase III##3##2##(1997-4#3)
topoisomerase inhibitors##2##2##(2008-5#1)(2008-9#1)
topoisomerase##151##1##(1990-2#6)(1990-7#8)(1990-8#1)(1991-11#2)(1991-2#5)(1991-4#3)(1991-5#4)(1992-6#2)(1992-8#3)(1993-3#5)(1993-8#13)(1994-12#1)(1994-6#2)(1994-8#3)(1994-9#2)(1995-1#11)(1995-3#6)(1995-5#2)(1995-6#10)(1995-7#6)(1996-10#2)(1996-5#1)(1996-6#3)(1996-7#12)(1996-8#1)(1997-4#8)(1997-5#1)(2005-8#5)(2006-12#1)(2008-11#7)(2008-5#6)(2008-8#2)(2008-9#1)(2009-8#2)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
topoisomerase-II##3##1##(1993-7#3)
topoisomerases I &amp##2##3##(1994-12#1)(2007-11#1)
topoisomerases I##3##2##(1994-12#1)(2007-11#1)(2012-12#1)
topoisomerases and##2##2##(2005-8#1)(2012-3#1)
topoisomerases##15##1##(1990-12#1)(1994-12#1)(1996-8#1)(1997-4#1)(2005-7#1)(2005-8#5)(2007-11#2)(2012-12#1)(2012-3#2)
topoisomers##5##1##(1990-11#3)(1992-11#1)(1997-4#1)
topological and##4##2##(1993-6#1)(2007-11#1)(2008-6#1)(2012-2#1)
topological charge##3##2##(2007-11#2)(2007-12#1)
topological charges##5##2##(2007-11#3)(2007-12#1)(2008-2#1)
topological constraints##3##2##(1994-5#1)(1995-5#1)(1997-1#1)
topological defects##5##2##(2008-7#4)(2009-11#1)
topological distance indices##5##3##(2007-11#5)
topological distance matrix##2##3##(2007-11#2)
topological distance##7##2##(2007-11#7)
topological features##3##2##(1994-6#1)(2008-10#1)(2008-7#1)
topological index##2##2##(2008-10#2)
topological indices for the##3##4##(2007-11#1)(2008-10#2)
topological indices##11##2##(2007-11#6)(2008-10#5)
topological map##2##2##(2008-3#2)
topological ordering##2##2##(2012-2#2)
topological phase##2##2##(1993-5#1)(2008-2#1)
topological properties of polarized light##2##5##(2007-12#2)
topological structure of##3##3##(1996-7#1)(2005-11#1)(2007-11#1)
topological structure##4##2##(1996-7#1)(2005-11#1)(2006-12#1)(2007-11#1)
topological##85##1##(1991-8#1)(1993-5#1)(1993-6#1)(1994-10#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-7#1)(1997-1#1)(2005-11#1)(2006-12#2)(2007-11#26)(2007-12#5)(2007-9#1)(2008-1#1)(2008-10#9)(2008-2#3)(2008-3#2)(2008-4#2)(2008-6#2)(2008-7#6)(2009-11#1)(2009-3#1)(2010-6#1)(2010-7#1)(2010-9#1)(2012-2#4)(2012-3#1)
topologically equivalent##2##2##(1991-9#1)(1997-1#1)
topologically##13##1##(1991-9#1)(1992-12#1)(1994-12#1)(1997-1#1)(1997-7#1)(2007-12#2)(2008-2#1)(2008-6#1)(2010-12#2)(2010-2#1)(2013-1#1)
topologies and##2##2##(2008-3#1)(2012-3#1)
topologies include##2##2##(2007-12#1)(2008-3#1)
topologies of##2##2##(1990-11#1)(1995-5#1)
topologies under##2##2##(2010-6#1)(2012-3#1)
topologies##26##1##(1990-11#1)(1995-5#2)(1997-4#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2009-2#1)(2010-10#1)(2010-5#1)(2010-6#3)(2012-2#1)(2012-3#2)(2013-7#1)
topology and function##2##3##(1991-1#1)(2013-8#1)
topology and##16##2##(1991-1#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#1)(2009-5#1)(2010-3#1)(2012-2#1)(2013-8#1)
topology as##2##2##(1997-4#1)(2008-2#1)
topology by##2##2##(2008-11#1)(2008-6#1)
topology change##2##2##(2006-10#2)
topology for##6##2##(1992-12#1)(1992-4#1)(2008-2#1)(2008-6#1)(2012-12#2)
topology in which##2##3##(1997-2#1)(2008-9#1)
topology is##4##2##(1992-4#1)(1996-7#1)(1997-7#1)(2007-12#1)
topology of microsomal cytochrome P-450##2##5##(1990-8#2)
topology of the##20##3##(1990-11#1)(1992-11#4)(1993-6#1)(1994-5#1)(1994-9#1)(1995-6#1)(1995-8#2)(1996-4#1)(1996-5#1)(2006-10#1)(2008-11#2)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
topology of##33##2##(1990-11#1)(1990-8#2)(1992-11#4)(1992-4#1)(1993-11#1)(1993-6#2)(1994-2#2)(1994-5#1)(1994-9#2)(1995-6#1)(1995-8#2)(1996-4#1)(1996-5#1)(1996-7#1)(1997-7#2)(2006-10#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
topology on the##2##3##(2008-10#1)(2012-2#1)
topology##126##1##(1990-11#1)(1990-8#2)(1990-9#1)(1991-1#1)(1992-1#1)(1992-11#5)(1992-12#2)(1992-4#4)(1992-7#1)(1993-11#2)(1993-6#2)(1994-2#2)(1994-5#3)(1994-6#1)(1994-8#2)(1994-9#5)(1995-1#1)(1995-3#1)(1995-4#2)(1995-6#1)(1995-8#2)(1996-4#1)(1996-5#2)(1996-7#4)(1996-8#1)(1997-2#2)(1997-4#1)(1997-7#8)(2005-10#1)(2005-11#1)(2006-10#3)(2006-5#1)(2007-11#1)(2007-12#5)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#6)(2008-2#8)(2008-3#2)(2008-4#1)(2008-6#5)(2008-7#3)(2008-9#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-5#3)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
topometry##4##1##(2007-12#1)(2008-2#1)(2008-3#2)
topotecan##7##1##(1995-3#1)(1995-5#2)(1997-3#1)(2005-8#1)(2007-7#1)(2008-5#1)
topped##3##1##(2007-12#1)(2007-8#1)(2008-4#1)
tops##5##1##(1991-5#1)(1992-7#1)(2007-10#1)(2009-4#1)(2010-4#1)
topsoil##6##1##(2008-10#3)(2012-2#3)
tora##2##1##(2008-11#2)
torasemide##3##1##(1996-1#3)
torch with##2##2##(2008-10#2)
torch##14##1##(2007-7#1)(2008-10#12)(2010-9#1)
tori##2##1##(1994-10#1)(2008-2#1)
toric intraocular lens##2##3##(2013-1#1)(2013-7#1)
tormogen##3##1##(2007-12#3)
torn anterior##2##2##(2009-3#1)(2009-9#1)
torn##9##1##(1992-1#1)(1992-4#1)(2006-11#1)(2007-8#1)(2009-3#1)(2009-9#1)(2010-4#1)(2012-12#1)(2013-1#1)
tornado##2##1##(1996-2#2)
toroidal uniform##2##2##(2008-3#1)(2013-8#1)
toroidal##17##1##(1992-6#1)(1993-6#1)(1995-5#1)(2008-2#3)(2008-3#8)(2008-7#1)(2013-8#2)
toroidally curved thallium##2##3##(2008-2#2)
toroidally##3##1##(2008-2#2)(2008-3#1)
toronto##2##1##(2010-5#1)(2010-9#1)
torpid##4##1##(1993-2#1)(1995-12#2)(2009-2#1)
torpor##5##1##(1996-11#3)(2011-2#1)(2013-8#1)
torquata) from##2##2##(2007-6#1)(2009-7#1)
torquata)##3##1##(2007-6#2)(2009-7#1)
torquatus##3##1##(2008-7#3)
torque and##5##2##(2006-2#1)(2007-10#1)(2012-1#2)(2013-1#1)
torque between##3##2##(2013-1#3)
torque in##3##2##(1993-12#1)(2008-12#1)(2010-3#1)
torque levels ranging from##2##4##(1993-12#2)
torque on the##3##3##(2006-2#1)(2006-3#1)(2008-3#1)
torque output##2##2##(2012-1#2)
torque present on##2##3##(2008-2#1)(2008-3#1)
torque sensor##3##2##(2007-5#1)(2012-1#2)
torque was increasing##3##3##(1993-12#3)
torque was##7##2##(1993-12#5)(2007-7#1)(2008-12#1)
torque were##2##2##(2009-7#1)(2011-1#1)
torque##80##1##(1993-12#11)(1995-12#1)(1995-8#1)(2006-2#3)(2006-3#1)(2007-10#6)(2007-11#1)(2007-12#1)(2007-4#3)(2007-5#2)(2007-7#1)(2008-12#5)(2008-2#3)(2008-3#5)(2009-7#4)(2010-3#2)(2010-7#3)(2011-1#1)(2012-1#17)(2012-2#1)(2013-1#7)(2013-8#1)
torquens##2##1##(2012-2#2)
torques are##2##2##(1993-9#1)(2005-11#1)
torques##19##1##(1993-9#1)(1995-12#1)(2005-11#1)(2006-11#1)(2006-2#2)(2007-4#1)(2008-3#1)(2011-2#1)(2012-1#9)(2013-1#1)
torridus##3##1##(2011-1#3)
torsade de pointes##5##3##(2006-9#1)(2008-7#2)(2008-8#1)(2009-8#1)
torsade de##6##2##(1990-11#1)(2006-9#1)(2008-7#2)(2008-8#1)(2009-8#1)
torsades de pointes##6##3##(1991-8#1)(1993-8#1)(1997-1#1)(2009-10#1)(2010-7#2)
torsinA##2##1##(2008-11#2)
torsion and##2##2##(2008-10#1)(2010-12#1)
torsion angle of##2##3##(1995-11#1)(2006-5#1)
torsion angle restraints##2##3##(1991-4#1)(1992-12#1)
torsion angle##13##2##(1990-12#1)(1991-10#4)(1991-4#1)(1992-12#1)(1994-11#1)(1995-1#1)(1995-11#1)(1996-7#1)(1996-8#1)(2006-5#1)
torsion angles about##2##3##(1990-9#1)(1995-8#1)
torsion angles and##2##3##(1994-9#1)(2006-5#1)
torsion angles for##2##3##(1991-9#1)(1995-10#1)
torsion angles of the##2##4##(1995-7#1)(2008-4#1)
torsion angles of##4##3##(1991-4#1)(1995-11#1)(1995-7#1)(2008-4#1)
torsion angles##10##2##(1990-9#1)(1991-4#1)(1991-9#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-7#1)(1995-8#1)(2006-5#1)(2008-4#1)
torsion dystonia##2##2##(2008-11#1)(2008-7#1)
torsion in a##2##3##(2010-2#1)(2012-2#1)
torsion in##5##2##(2008-10#1)(2009-5#1)(2010-2#1)(2011-1#1)(2012-2#1)
torsion is a##2##3##(2007-8#1)(2010-6#1)
torsion is##4##2##(2007-8#1)(2008-10#1)(2010-6#1)(2011-1#1)
torsion of the left##2##4##(1997-3#1)(2009-8#1)
torsion of the##6##3##(1990-6#1)(1992-10#1)(1997-3#2)(2005-12#1)(2009-8#1)
torsion of##11##2##(1990-6#1)(1992-10#1)(1997-3#2)(2005-12#2)(2009-8#1)(2010-2#1)(2011-2#1)(2012-2#2)
torsion##78##1##(1990-12#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#4)(1991-4#2)(1991-9#1)(1992-10#1)(1992-12#1)(1994-11#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-7#1)(1995-8#1)(1996-7#1)(1996-8#1)(1997-3#3)(2005-12#3)(2006-1#1)(2006-10#2)(2006-5#2)(2007-8#2)(2008-10#18)(2008-11#2)(2008-4#1)(2008-7#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-6#2)(2011-1#2)(2011-2#4)(2012-2#3)
torsional angle##2##2##(1991-4#1)(1994-5#1)
torsional angles##8##2##(1991-4#1)(1991-7#1)(1992-12#3)(1992-4#1)(1993-11#1)(1993-6#1)
torsional fluctuations about the##2##4##(1993-11#1)(1995-10#1)
torsional motions##2##2##(1991-7#1)(1992-9#1)
torsional rotation##3##2##(1991-4#2)(1994-11#1)
torsional spring##2##2##(2012-1#2)
torsional stiffness##2##2##(2011-2#1)(2012-1#1)
torsional strain in##3##3##(1995-2#1)(2008-7#2)
torsional strain##5##2##(1995-2#1)(2008-7#3)(2009-3#1)
torsional##38##1##(1991-4#4)(1991-7#2)(1992-12#3)(1992-4#1)(1992-9#1)(1993-11#3)(1993-6#1)(1994-11#1)(1994-5#1)(1995-10#1)(1995-2#2)(1996-2#1)(1996-5#1)(1996-8#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#3)(2009-3#1)(2011-2#2)(2012-1#3)(2013-7#1)
torso and##2##2##(2011-2#2)
torso are##2##2##(2007-4#1)(2008-7#1)
torso##17##1##(2006-10#1)(2006-11#3)(2007-1#1)(2007-10#1)(2007-4#3)(2008-7#3)(2010-8#1)(2011-2#2)(2012-1#1)(2013-1#1)
tort law##2##2##(1992-1#1)(1994-1#1)
tort liability##2##2##(1993-12#2)
tort malpractice system##3##3##(2007-4#3)
tort reform##10##2##(1991-1#3)(1993-12#1)(2007-10#1)(2007-4#2)(2007-9#1)(2008-4#2)
tort##25##1##(1991-1#3)(1992-1#1)(1993-12#3)(1994-1#3)(1996-11#1)(1996-6#1)(1997-5#1)(2005-12#1)(2007-10#1)(2007-4#6)(2007-9#1)(2008-4#3)
torted##2##1##(2008-10#2)
torticollis##8##1##(1990-10#2)(1992-8#2)(2006-9#1)(2007-8#1)(2008-2#1)(2009-9#1)
tortoise##5##1##(1993-2#1)(2007-12#1)(2007-2#2)(2007-3#1)
tortoises##2##1##(2007-3#1)(2013-1#1)
tortuosity of##3##2##(2006-9#1)(2007-10#1)(2007-9#1)
tortuosity##10##1##(2005-11#2)(2006-1#1)(2006-9#1)(2007-10#1)(2007-9#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-8#1)
tortuous##15##1##(1991-9#1)(1994-6#1)(1996-9#1)(1997-3#2)(2006-1#1)(2007-7#2)(2007-9#1)(2010-5#1)(2012-3#1)(2013-1#3)(2013-8#1)
torture##29##1##(1990-6#1)(1991-2#2)(1995-11#4)(1996-11#1)(1996-3#5)(2005-10#1)(2005-8#2)(2008-2#1)(2008-7#6)(2011-1#1)(2012-12#1)(2013-1#4)
tortured refugees##2##2##(2013-1#2)
tortured##6##1##(1995-11#1)(1996-9#1)(2006-12#1)(2013-1#3)
torturing##2##1##(2008-4#1)(2013-1#1)
torulosum##2##1##(2012-11#2)
torus##4##1##(1990-1#2)(1995-5#1)(1997-3#1)
tosilate##5##1##(1996-12#2)(2008-1#3)
tositumomab##9##1##(2007-11#9)
tospoviral##3##1##(2008-10#3)
tospovirus infections##2##2##(2008-10#2)
tospovirus species##9##2##(2008-10#9)
tospovirus##20##1##(2008-10#20)
tospoviruses from##2##2##(2008-10#2)
tospoviruses in##2##2##(2008-10#2)
tospoviruses##27##1##(2008-10#27)
toss##3##1##(2011-2#3)
tosylate (DAST)##4##2##(2007-12#4)
tosylate##9##1##(1992-11#1)(1994-9#1)(2005-11#2)(2007-12#4)(2008-4#1)
total (free plus##3##3##(1993-2#1)(1997-1#1)(1997-7#1)
total (sum of free and sulphate conjugated)##2##7##(1997-7#2)
total 22##2##2##(1993-9#1)(2011-1#1)
total A beta##2##3##(1994-11#1)(1994-12#1)
total A##3##2##(1994-11#1)(1994-12#1)(1995-3#1)
total APP##4##2##(1996-12#4)
total Al##2##2##(2008-10#1)(2010-5#1)
total As and Sb##2##4##(2008-10#2)
total As##7##2##(2008-10#7)
total BTs##2##2##(2008-11#2)
total C4BP and PS-C4BP complex levels##2##6##(1995-1#2)
total C4BP and PS-C4BP complex##3##5##(1995-1#3)
total C4BP##5##2##(1995-1#5)
total CAs##2##2##(2008-11#2)
total CK##2##2##(1992-10#2)
total CSF##3##2##(1991-2#1)(1997-8#1)(2008-7#1)
total Cd##2##2##(2005-4#1)(2008-10#1)
total Cr##4##2##(2008-10#4)
total DNA extracted from##3##4##(2008-10#2)(2008-4#1)
total DNA from##2##3##(1990-5#1)(2008-10#1)
total DNA of##2##3##(2008-10#1)(2008-9#1)
total DNA##18##2##(1990-5#1)(1991-7#2)(1994-8#1)(2006-3#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2011-12#1)(2012-3#1)
total EI score##2##3##(2013-1#2)
total FA content##4##3##(2012-1#4)
total FA)##3##2##(1996-11#2)(2007-8#1)
total FIM##3##2##(2007-9#3)
total Fe##2##2##(2008-10#2)
total GFAP##3##2##(1990-7#3)
total HRV##2##2##(1995-3#1)(2012-12#1)
total Hg##3##2##(2004-4#1)(2008-10#2)
total IGF-I##2##2##(2006-1#1)(2012-3#1)
total IGF-II##2##2##(1992-9#2)
total Ig##2##2##(1990-12#2)
total IgA##3##2##(1990-8#1)(1996-11#1)(2008-11#1)
total IgE and histamine levels##2##5##(2007-2#2)
total IgE and##3##3##(2007-2#2)(2009-5#1)
total IgE##11##2##(1990-12#2)(1992-9#1)(2006-8#1)(2007-11#1)(2007-2#4)(2009-5#1)(2011-1#1)
total IgG##3##2##(1990-8#1)(1993-12#1)(2007-2#1)
total Ins 1##5##3##(1997-1#5)
total Mallet score##2##3##(2013-1#2)
total Medicaid spending##2##3##(1994-1#2)
total Medicaid##5##2##(1991-3#1)(1992-3#2)(1994-1#2)
total Medicare##3##2##(1990-12#1)(1991-3#1)(1995-3#1)
total N (TN)##2##3##(2007-7#1)(2013-8#1)
total N##8##2##(2007-7#2)(2008-10#1)(2008-5#3)(2011-12#1)(2013-8#1)
total P##2##2##(2008-10#1)(2008-9#1)
total PKC##2##2##(1991-7#1)(1994-12#1)
total PSA##2##2##(2006-10#2)
total Pb##2##2##(2008-10#2)
total RNA by##2##3##(1994-12#1)(1994-9#1)
total RNA extracted from the##2##5##(1992-3#1)(2008-10#1)
total RNA extracted from##5##4##(1992-3#1)(1996-10#1)(2008-10#2)(2008-4#1)
total RNA from##4##3##(1993-2#1)(1996-10#1)(2009-12#1)(2010-2#1)
total RNA is extracted##2##4##(2008-4#1)(2008-9#1)
total RNA is##3##3##(2008-4#2)(2008-9#1)
total RNA of##2##3##(2005-11#1)(2008-10#1)
total RNA was##4##3##(2008-9#1)(2011-2#3)
total RNA##53##2##(1991-5#1)(1991-8#2)(1991-9#1)(1992-3#2)(1992-7#1)(1993-2#1)(1994-11#2)(1994-12#1)(1994-9#1)(1995-12#2)(1996-10#2)(2005-11#1)(2007-1#2)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#2)(2008-4#8)(2008-7#2)(2008-9#4)(2009-12#3)(2010-11#1)(2010-2#1)(2011-2#3)(2012-2#1)(2012-3#1)
total RNAs extracted from##2##4##(1992-6#1)(2008-10#1)
total RNAs from##2##3##(1990-12#1)(1992-6#1)
total RNAs##5##2##(1990-12#1)(1992-6#2)(1993-9#1)(2008-10#1)
total SA concentration##2##3##(2008-12#2)
total SA##3##2##(2008-12#3)
total Se determination##2##3##(2008-10#2)
total Se##4##2##(2008-10#4)
total T cell numbers and##2##5##(1991-11#1)(1992-2#1)
total T cell##3##3##(1991-11#1)(1992-2#1)(2008-4#1)
total T##6##2##(1991-11#1)(1991-6#1)(1992-2#1)(2007-12#1)(2007-5#1)(2008-4#1)
total T4##2##2##(1995-3#1)(2008-7#1)
total UV##3##2##(2004-4#2)(2008-5#1)
total WMSA##2##2##(2009-10#2)
total abdominal hysterectomy and vaginal hysterectomy##2##6##(1993-12#2)
total abdominal hysterectomy with bilateral##2##5##(2011-2#1)(2013-1#1)
total abdominal hysterectomy##11##3##(1993-12#2)(1994-2#1)(1996-12#1)(2007-2#3)(2011-2#1)(2013-1#2)(2013-8#1)
total abdominal##14##2##(1993-12#5)(1994-2#1)(1996-12#1)(2007-2#3)(2011-2#1)(2013-1#2)(2013-8#1)
total absence of activity##2##4##(1993-3#1)(2008-10#1)
total absence of##7##3##(1993-3#1)(1993-8#1)(1996-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)
total absence##9##2##(1992-9#1)(1993-3#1)(1993-8#1)(1996-12#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)
total absorptance##2##2##(2008-3#2)
total absorption coefficients##2##3##(2008-3#2)
total absorption##6##2##(2008-3#6)
total abundance##2##2##(2008-9#1)(2013-7#1)
total acidity in soft drinks##2##5##(2008-10#2)
total acidity##7##2##(2008-10#5)(2010-12#1)(2012-2#1)
total activities##2##2##(2006-8#1)(2008-4#1)
total activity of##3##3##(1992-3#1)(1994-9#1)(2009-8#1)
total activity##8##2##(1990-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1994-9#1)(1997-4#1)(2008-8#1)(2009-8#1)
total adenine##3##2##(1990-6#3)
total adenylate##2##2##(1995-12#1)(2008-11#1)
total aerobic energy##2##3##(2013-8#2)
total alcohol##2##2##(1994-2#1)(2005-10#1)
total alkaline phosphatase##4##3##(1990-11#1)(2006-6#1)(2007-9#2)
total alkalinity##4##2##(2007-10#1)(2007-8#2)(2008-1#1)
total alpha##4##2##(1990-7#1)(1993-12#2)(1994-3#1)
total amino acid##3##3##(1990-11#1)(1990-6#1)(2010-4#1)
total amino acids for 1##2##5##(1990-12#2)
total amino acids##7##3##(1990-12#3)(2008-5#3)(2010-4#1)
total amino##10##2##(1990-11#1)(1990-12#3)(1990-6#1)(2008-5#3)(2010-4#2)
total amount of food##4##4##(2009-5#3)(2011-2#1)
total amount of sterols##2##4##(2007-8#1)(2008-10#1)
total amount of##60##3##(1990-7#1)(1991-2#1)(1991-6#1)(1991-9#1)(1993-1#1)(1993-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#3)(1996-2#1)(1996-3#1)(1997-3#2)(2004-11#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-4#1)(2007-1#1)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#4)(2008-3#1)(2008-6#1)(2008-8#4)(2009-5#3)(2010-11#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-12#1)
total amount##67##2##(1990-7#1)(1991-2#1)(1991-6#1)(1991-9#1)(1993-1#1)(1993-9#2)(1994-10#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#2)(2004-11#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-4#1)(2007-1#1)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#14)(2008-11#5)(2008-3#1)(2008-6#1)(2008-8#4)(2009-5#3)(2010-11#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)
total amounts of##7##3##(1991-1#1)(1994-2#1)(2007-7#1)(2008-10#2)(2008-6#1)(2013-8#1)
total analgesic##2##2##(1993-12#1)(2010-7#1)
total analysis systems (muTAS)##2##4##(2008-10#2)
total analysis systems##3##3##(2008-10#2)(2010-11#1)
total analysis time of##4##4##(1990-12#1)(1991-5#1)(2008-10#2)
total analysis time per sample##2##5##(1990-6#1)(2008-10#1)
total analysis time##13##3##(1990-12#1)(1990-6#1)(1991-5#1)(1997-3#1)(2008-10#8)(2012-1#1)
total analysis##18##2##(1990-12#1)(1990-6#1)(1991-5#1)(1997-3#1)(2007-8#1)(2008-10#11)(2010-11#1)(2012-1#1)
total analyte##3##2##(2008-10#3)
total analytical##4##2##(1991-8#1)(2010-2#1)(2010-7#2)
total and LDL cholesterol as##2##5##(1992-11#1)(2012-2#1)
total and LDL cholesterol##5##4##(1992-11#1)(2005-10#3)(2012-2#1)
total and LDL-cholesterol##5##3##(1991-10#2)(1991-6#1)(1996-9#1)(2007-8#1)
total and MeHg##3##3##(2004-4#3)
total and differential##4##3##(1997-6#1)(2007-12#1)(2008-10#2)
total and free testosterone levels##2##5##(2011-2#2)
total and free testosterone##3##4##(2007-7#1)(2011-2#2)
total and free##12##3##(1990-1#1)(1992-6#1)(1995-1#1)(1995-12#2)(1996-4#1)(2004-11#1)(2006-8#2)(2007-7#1)(2011-2#2)
total and high-density lipoprotein##2##4##(2005-10#1)(2010-2#1)
total and individual##2##3##(1993-11#1)(2008-12#1)
total and low density lipoprotein##2##5##(1993-9#1)(2008-7#1)
total and mercury species determination in##2##6##(2008-10#2)
total and protein-bound homocysteine##4##4##(2008-10#4)
total and water-soluble trace metal##2##5##(2007-8#2)
total and##89##2##(1990-1#1)(1990-10#1)(1990-12#1)(1990-5#1)(1991-10#2)(1991-2#1)(1991-6#1)(1991-7#2)(1991-8#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-10#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-12#2)(1995-3#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-6#2)(2004-11#2)(2004-4#4)(2005-10#5)(2006-1#1)(2006-10#1)(2006-8#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#5)(2008-10#12)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-12#1)(2009-4#2)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
total anionic##3##2##(2008-10#3)
total ankle arthroplasty##2##3##(2009-10#2)
total ankle replacement##3##3##(2009-10#2)(2009-7#1)
total ankle replacements##2##3##(2009-7#2)
total ankle##7##2##(2009-10#4)(2009-7#3)
total annual##4##2##(2008-11#1)(2011-1#1)(2012-12#1)(2013-8#1)
total anomalous pulmonary venous connection##4##5##(2007-8#2)(2008-11#2)
total anomalous pulmonary venous##5##4##(2007-8#3)(2008-11#2)
total anomalous##6##2##(2007-8#3)(2008-11#2)(2010-5#1)
total anterior circulation syndrome (TACS)##2##5##(2007-9#2)
total antigen##2##2##(1992-6#1)(2010-12#1)
total antimony##2##2##(2008-10#2)
total antioxidant activity of##3##4##(2007-8#1)(2008-10#2)
total antioxidant activity##8##3##(2007-8#2)(2008-10#3)(2011-1#1)(2011-2#1)(2012-1#1)
total antioxidant capacity (TAC)##4##4##(2007-8#1)(2008-10#2)(2013-8#1)
total antioxidant capacity##13##3##(2007-8#1)(2008-10#7)(2009-6#1)(2010-5#1)(2013-1#1)(2013-8#2)
total antioxidant power##3##3##(2013-8#3)
total antioxidant status##2##3##(2009-8#1)(2013-8#1)
total antioxidant##26##2##(2007-8#3)(2008-10#10)(2009-6#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#6)
total antioxidative##2##2##(2011-1#2)
total apo B##2##3##(1990-8#2)
total architecture##2##2##(2008-5#2)
total area of##7##3##(1995-12#4)(2008-4#1)(2008-6#1)(2013-8#1)
total area under the##2##4##(2008-10#1)(2008-8#1)
total area##11##2##(1995-12#4)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2012-1#1)(2013-8#1)
total arsenic content##2##3##(2008-10#2)
total arsenic in##5##3##(2008-10#5)
total arsenic##21##2##(1995-11#1)(2007-8#1)(2008-10#19)
total arsenic) were##2##3##(2008-10#2)
total arsenic)##3##2##(2008-10#3)
total arterial revascularisation##2##3##(2005-12#2)
total arterial##3##2##(2005-12#2)(2007-8#1)
total arteriovenous diffusive shunt of oxygen&quot##2##6##(2008-2#2)
total arteriovenous diffusive shunt of##3##5##(2008-2#3)
total arthroplasty##2##2##(2007-7#1)(2013-1#1)
total artificial##2##2##(2004-9#1)(2010-8#1)
total ash##3##2##(2007-8#1)(2010-11#1)(2010-12#1)
total atmospheric##3##2##(1991-6#1)(2008-10#1)(2008-3#1)
total backscattering coefficient##3##3##(2008-2#2)(2008-3#1)
total backscattering##6##2##(2008-2#3)(2008-3#3)
total bacteria##4##2##(1997-4#1)(2008-10#2)(2009-4#1)
total bacterial concentrations##2##3##(2009-4#2)
total bacterial count##3##3##(1992-2#3)
total bacterial populations on##2##4##(2008-10#2)
total bacterial protein##2##3##(1992-12#1)(2005-11#1)
total bacterial proteins##2##3##(2008-4#1)(2008-8#1)
total bacterial##14##2##(1992-12#1)(1992-2#3)(2005-11#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-8#1)(2009-4#2)(2010-4#1)
total bacterioplankton and##2##3##(2008-5#2)
total bacterioplankton##4##2##(2008-5#4)
total base##2##2##(1991-7#1)(2010-7#1)
total bile acids##2##3##(1996-7#1)(2008-5#1)
total bilirubin in##2##3##(2008-10#1)(2012-3#1)
total bilirubin level##2##3##(2007-12#1)(2010-7#1)
total bilirubin were##3##3##(1992-5#1)(2009-4#1)(2013-1#1)
total bilirubin##20##2##(1992-5#1)(1995-7#1)(2007-11#1)(2007-12#1)(2008-10#3)(2009-4#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
total binding capacity##2##3##(1993-6#1)(1997-1#1)
total binding##7##2##(1991-3#1)(1993-6#3)(1996-2#1)(1997-1#1)(1997-2#1)
total biomass##8##2##(2006-12#1)(2007-3#3)(2008-10#1)(2008-7#3)
total blood volume##2##3##(2006-2#1)(2007-5#1)
total blood##5##2##(1990-11#1)(2006-2#1)(2007-5#1)(2008-10#1)(2013-1#1)
total body clearance##2##3##(1990-11#1)(2012-3#1)
total body fat##3##3##(2007-9#1)(2008-3#1)(2010-2#1)
total body irradiation##9##3##(1993-9#2)(1994-4#1)(1994-7#1)(1994-9#1)(1995-4#1)(1996-6#1)(2007-4#1)(2008-1#1)
total body surface area##4##4##(1993-12#1)(2006-7#1)(2008-8#2)
total body water and##3##4##(1997-8#2)(2008-7#1)
total body water##6##3##(1997-8#2)(2007-7#1)(2008-7#2)(2009-11#1)
total body weight##2##3##(2008-3#1)(2010-12#1)
total body##50##2##(1990-11#1)(1992-1#1)(1992-2#1)(1992-4#1)(1993-12#1)(1993-9#3)(1994-4#1)(1994-7#1)(1994-9#1)(1995-4#1)(1995-5#1)(1996-6#1)(1997-1#1)(1997-7#1)(1997-8#2)(2006-10#1)(2006-7#1)(2006-8#3)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#3)(2009-11#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2012-3#1)(2013-1#3)(2013-7#1)
total burnt area##2##3##(2013-8#2)
total cadmium##2##2##(2005-4#1)(2008-10#1)
total calcium content##2##3##(1997-4#1)(2008-10#1)
total calcium##5##2##(1997-4#1)(2007-2#1)(2007-9#1)(2008-10#2)
total calorie intake##3##3##(1991-11#2)(1993-9#1)
total cancer##3##2##(1990-10#1)(1990-4#1)(2010-11#1)
total carbohydrate##3##2##(1991-2#1)(2004-11#1)(2008-6#1)
total carbohydrates and##2##3##(2011-1#1)(2012-12#1)
total carbohydrates##4##2##(1993-9#1)(2011-1#2)(2012-12#1)
total carbon and##2##3##(2008-12#1)(2008-5#1)
total carbon##6##2##(2008-10#3)(2008-12#1)(2008-5#1)(2009-6#1)
total carbonate##3##2##(2006-11#1)(2008-10#2)
total cardiovascular##3##2##(1993-12#2)(2013-1#1)
total care of the patient##2##5##(2006-1#1)(2010-3#1)
total care of the##3##4##(2006-1#1)(2009-2#1)(2010-3#1)
total care of##4##3##(1992-2#1)(2006-1#1)(2009-2#1)(2010-3#1)
total care##6##2##(1992-2#1)(1996-4#1)(2006-1#1)(2009-2#1)(2010-3#1)(2012-2#1)
total carnitine levels##2##3##(1991-2#1)(1996-8#1)
total carnitine##6##2##(1990-1#2)(1991-2#2)(1996-8#1)(2011-2#1)
total carotenes##2##2##(2007-8#2)
total carotenoid##3##2##(2007-12#1)(2008-12#1)(2008-5#1)
total carotenoids and total antioxidants in##2##6##(2011-2#2)
total carotenoids##3##2##(2011-2#2)(2012-2#1)
total cases##3##2##(2005-10#1)(2008-4#1)(2011-2#1)
total catch##4##2##(2007-3#1)(2007-5#1)(2013-1#1)(2013-7#1)
total catheter thrombosis in##2##4##(2007-7#2)
total catheter##3##2##(2007-7#2)(2008-1#1)
total cationic and total anionic arsenic##2##6##(2008-10#2)
total cationic##3##2##(2008-10#3)
total cavity loss##2##3##(2007-11#1)(2008-3#1)
total cavo-pulmonary connection##3##3##(2007-8#3)
total cavopulmonary connection (TCPC)##3##4##(2007-8#3)
total cavopulmonary connection##5##3##(2007-8#5)
total cavopulmonary##6##2##(1996-12#1)(2007-8#5)
total celiprolol or##2##3##(1996-8#2)
total celiprolol##4##2##(1996-8#4)
total cell concentration##3##3##(1990-2#1)(1994-11#1)(2008-11#1)
total cell count##2##3##(1995-11#1)(2008-1#1)
total cell densities##2##3##(2008-11#1)(2008-7#1)
total cell number and##2##4##(2008-11#1)(2012-12#1)
total cell number##6##3##(2008-11#3)(2008-5#1)(2012-12#1)(2013-1#1)
total cell protein content##3##4##(1990-5#1)(1992-8#1)(2008-11#1)
total cell protein##7##3##(1990-5#1)(1992-8#2)(1994-12#1)(2008-11#3)
total cell proteins##2##3##(1994-3#1)(2008-12#1)
total cell volume##3##3##(1995-11#2)(2012-1#1)
total cell##34##2##(1990-2#1)(1990-5#1)(1992-8#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#3)(1996-5#1)(2008-1#1)(2008-10#1)(2008-11#9)(2008-12#1)(2008-5#1)(2008-7#2)(2009-3#1)(2012-1#1)(2012-12#1)(2013-1#1)
total cells##8##2##(1994-11#1)(1994-6#1)(2008-10#3)(2008-7#3)
total cellular Mg2+##2##3##(1990-8#1)(1997-1#1)
total cellular RNA##7##3##(1994-12#1)(1995-10#1)(1997-1#1)(2007-2#1)(2008-4#1)(2008-5#1)(2008-7#1)
total cellular protein##8##3##(1990-3#1)(1990-5#2)(1991-1#1)(1993-3#1)(1995-1#1)(1995-3#1)(2008-9#1)
total cellular proteins##3##3##(1994-8#1)(2005-7#1)(2008-4#1)
total cellular##34##2##(1990-3#2)(1990-5#2)(1990-8#2)(1991-1#1)(1992-11#1)(1992-4#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#2)(1996-1#2)(1996-5#2)(1996-8#1)(1997-1#2)(2005-7#1)(2007-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)
total cerebral##3##2##(1995-7#1)(1997-6#1)(2009-10#1)
total change##2##2##(2008-10#1)(2008-2#1)
total charge and##2##3##(1993-11#2)
total charge##3##2##(1993-11#2)(1994-9#1)
total chlorophyll##5##2##(2008-10#1)(2008-12#2)(2008-9#1)(2011-12#1)
total cholesterol (TC) levels##2##4##(1990-2#1)(2008-7#1)
total cholesterol (TC)##9##3##(1990-2#1)(1997-2#2)(2007-11#2)(2007-8#1)(2007-9#1)(2008-7#1)(2013-1#1)
total cholesterol (p&lt##2##3##(2008-10#2)
total cholesterol and LDL cholesterol##3##5##(1992-12#1)(1993-12#1)(2011-2#1)
total cholesterol and atherosclerosis-index levels##2##5##(2008-6#2)
total cholesterol and serum##2##4##(1991-10#1)(2012-2#1)
total cholesterol and triglycerides##4##4##(1990-8#2)(1991-11#1)(2013-1#1)
total cholesterol and##21##3##(1990-8#2)(1991-10#1)(1991-11#2)(1992-12#1)(1992-8#1)(1993-12#2)(2007-1#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
total cholesterol by##2##3##(1991-2#1)(2011-11#1)
total cholesterol concentration in##2##4##(1997-8#1)(2008-10#1)
total cholesterol concentration##4##3##(1995-4#1)(1997-1#1)(1997-8#1)(2008-10#1)
total cholesterol content##2##3##(1990-11#1)(1990-8#1)
total cholesterol in##6##3##(1990-12#1)(1995-1#1)(1995-4#1)(2009-7#1)(2011-1#1)(2012-2#1)
total cholesterol level##4##3##(1991-8#1)(2008-1#1)(2008-8#1)(2010-4#1)
total cholesterol levels was##2##4##(1993-12#1)(1994-3#1)
total cholesterol levels##6##3##(1990-2#1)(1993-12#2)(1994-3#1)(1996-11#1)(2005-10#1)
total cholesterol values##2##3##(1992-11#1)(1993-11#1)
total cholesterol was##5##3##(1991-6#1)(2007-7#2)(2012-2#1)(2013-1#1)
total cholesterol were##2##3##(1991-8#1)(2011-1#1)
total cholesterol##127##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#3)(1991-2#3)(1991-6#1)(1991-8#2)(1992-11#4)(1992-12#2)(1992-8#3)(1993-1#1)(1993-11#1)(1993-12#5)(1994-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-4#2)(1996-11#1)(1996-4#2)(1996-9#2)(1997-1#3)(1997-2#4)(1997-8#1)(2004-11#1)(2005-10#3)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#4)(2008-12#4)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2009-7#1)(2010-10#5)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-11#2)(2011-2#3)(2012-2#8)(2013-1#6)(2013-8#2)
total cholesterol/HDL ratio##2##3##(1990-12#1)(2008-5#1)
total cholesterol/HDL-cholesterol##2##2##(1995-11#1)(2009-8#1)
total cholesterolemia and##3##3##(1991-12#3)
total cholesterolemia##4##2##(1991-12#4)
total chromium in##5##3##(2008-10#5)
total chromium##8##2##(2008-10#8)
total chromosome##2##2##(1996-10#1)(2011-2#1)
total circulating##2##2##(1991-6#1)(2006-6#1)
total colectomy##4##2##(1990-4#1)(2006-2#1)(2009-5#2)
total coliforms and##3##3##(2011-1#2)(2011-2#1)
total coliforms##5##2##(2006-8#1)(2008-5#1)(2011-1#2)(2011-2#1)
total collagen content##2##3##(2010-4#2)
total collagen##5##2##(2008-5#1)(2010-4#4)
total colonic aganglionosis##2##3##(2006-10#1)(2007-7#1)
total colonic##4##2##(1995-9#2)(2006-10#1)(2007-7#1)
total colonoscopy##3##2##(1993-10#1)(2011-1#1)(2011-2#1)
total community##2##2##(2008-8#1)(2011-2#1)
total concentration of the##4##4##(2005-11#1)(2008-10#3)
total concentration of##18##3##(1994-2#1)(1994-9#1)(2005-11#2)(2008-10#11)(2012-1#1)(2012-2#1)(2013-1#1)
total concentration##23##2##(1994-2#1)(1994-9#1)(2005-11#2)(2008-10#14)(2008-11#1)(2011-10#1)(2012-1#1)(2012-2#1)(2013-1#1)
total concentrations of##6##3##(1995-2#1)(2007-5#1)(2008-10#3)(2008-7#1)
total concentrations##8##2##(1990-11#1)(1995-2#1)(2006-10#1)(2007-5#1)(2008-10#3)(2008-7#1)
total constituent backscattering##2##3##(2008-2#1)(2008-3#1)
total content of##9##3##(1992-6#1)(2004-2#2)(2007-1#1)(2008-10#4)(2010-12#1)
total content##11##2##(1992-6#1)(2004-2#2)(2007-1#1)(2008-10#6)(2010-12#1)
total conversion efficiency##2##3##(2007-12#2)
total coronary artery occlusion##4##4##(1996-9#3)(2007-5#1)
total coronary artery##5##3##(1996-9#4)(2007-5#1)
total coronary heart disease risk level##2##6##(1991-6#2)
total coronary##7##2##(1991-6#2)(1996-9#4)(2007-5#1)
total correction##2##2##(1997-1#1)(2007-8#1)
total cost of the##3##4##(2006-12#1)(2008-5#1)(2009-12#1)
total cost of##13##3##(1990-12#1)(1993-12#1)(1996-11#1)(2004-1#1)(2004-9#1)(2006-12#2)(2006-8#2)(2008-5#1)(2009-12#1)(2010-8#1)(2011-2#1)
total cost per##2##3##(1994-12#1)(2007-8#1)
total cost##24##2##(1990-12#1)(1992-12#2)(1992-2#2)(1993-12#1)(1994-12#1)(1996-11#1)(2004-1#1)(2004-9#1)(2006-10#1)(2006-12#4)(2006-8#2)(2007-8#1)(2008-5#1)(2009-12#1)(2010-8#1)(2011-2#3)
total costs##7##2##(1992-12#2)(2007-7#1)(2008-12#1)(2011-1#1)(2013-1#2)
total count of micro-organisms##2##4##(2006-8#2)
total counts##2##2##(1997-4#1)(2008-10#1)
total coverage##2##2##(1997-4#1)(2005-11#1)
total creatine##3##2##(1996-5#1)(2008-5#1)(2012-1#1)
total crude##2##2##(1990-10#1)(2011-2#1)
total cumulative##2##2##(1994-6#1)(1995-9#1)
total current##3##2##(2006-6#1)(2008-10#1)(2008-8#1)
total cystectomy for cancer infiltrating##2##5##(2011-2#2)
total cystectomy##4##2##(1992-11#1)(2011-2#3)
total cytoplasmic RNA##2##3##(2008-2#1)(2008-4#1)
total daily dose of##3##4##(1990-12#1)(2007-2#2)
total daily dose##7##3##(1990-12#1)(1992-4#1)(2006-12#3)(2007-2#2)
total daily##10##2##(1990-12#1)(1992-4#1)(1996-4#1)(2006-12#3)(2007-2#2)(2008-9#1)(2013-7#1)
total darkness##4##2##(1991-5#1)(2008-10#2)(2008-4#1)
total death rate##2##3##(1990-6#2)
total deaths##2##2##(2006-10#1)(2008-9#1)
total decomposition of soil##2##4##(2008-10#2)
total decomposition##4##2##(2008-10#4)
total delay time##2##3##(2008-3#1)(2009-9#1)
total delay##3##2##(1990-2#1)(2008-3#1)(2009-9#1)
total density dependence in##2##4##(2008-8#2)
total density##7##2##(2004-11#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-8#2)
total dentures for patients with##2##5##(2007-9#2)
total dentures##3##2##(2007-9#3)
total determination##2##2##(2008-10#2)
total diet and##2##3##(1994-3#1)(2008-10#1)
total dietary##3##2##(1990-8#1)(2012-2#2)
total digestion##2##2##(2008-10#1)(2008-5#1)
total disappearance of##2##3##(1993-9#1)(1995-5#1)
total disappearance##3##2##(1990-9#1)(1993-9#1)(1995-5#1)
total disc replacement and##2##4##(2006-8#2)
total disc##5##2##(2006-8#3)(2012-12#2)
total discharge##2##2##(1990-12#1)(1991-6#1)
total discomfort##3##2##(2006-8#1)(2008-12#2)
total disease incidence##2##3##(2008-10#2)
total disease##6##2##(2008-10#5)(2011-2#1)
total dissociation of##2##3##(2005-8#1)(2012-3#1)
total dissociation##3##2##(1994-11#1)(2005-8#1)(2012-3#1)
total dissolution of##3##3##(2008-10#3)
total dissolved solids (TDS)##3##4##(2007-10#2)(2009-6#1)
total dissolved solids##5##3##(2007-10#2)(2008-1#2)(2009-6#1)
total dissolved##17##2##(2007-10#2)(2008-1#2)(2008-10#11)(2008-5#1)(2009-6#1)
total distance from the aperture to the focal point##3##9##(2008-3#3)
total distance##5##2##(1991-5#1)(2007-4#1)(2008-3#3)
total district government##2##3##(2011-12#2)
total dose in##2##3##(2007-10#1)(2011-2#1)
total dose of##18##3##(1991-11#1)(1991-2#2)(1992-11#1)(1993-7#1)(1995-3#1)(1995-9#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-6#6)(2010-7#1)(2013-1#1)
total dose##39##2##(1991-11#1)(1991-2#2)(1992-10#2)(1992-11#1)(1992-8#1)(1993-7#1)(1995-3#1)(1995-9#1)(2006-12#1)(2006-7#1)(2007-10#2)(2007-4#3)(2007-9#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#8)(2008-7#2)(2010-7#2)(2011-2#2)(2013-1#3)
total dose)##3##2##(1991-3#1)(2007-11#1)(2013-1#1)
total doses of##2##3##(2008-6#1)(2013-1#1)
total drug concentrations##2##3##(2008-8#2)
total drug##5##2##(1993-4#1)(1995-2#1)(2007-6#1)(2008-8#2)
total dry matter and grain yield##2##6##(2008-12#2)
total dry matter##3##3##(2006-9#1)(2008-12#2)
total dry weight ha(-1)##2##4##(2008-12#2)
total dry##5##2##(2006-9#1)(2008-12#4)
total duration of##5##3##(2005-11#1)(2006-12#1)(2007-9#1)(2008-7#1)(2008-8#1)
total duration##7##2##(1993-2#1)(2005-11#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-7#1)(2008-8#1)
total edentulous patient##2##3##(2013-1#2)
total effect##3##2##(2007-11#1)(2008-1#1)(2008-10#1)
total elbow##2##2##(2006-4#1)(2011-2#1)
total embryo viability rate##3##4##(2006-5#3)
total energy intake##10##3##(1990-2#1)(1993-9#1)(1994-7#3)(2006-6#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-2#1)
total energy of##2##3##(2007-11#1)(2007-12#1)
total energy##27##2##(1990-2#1)(1993-9#2)(1994-7#3)(1995-12#1)(1996-11#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-12#2)(2012-2#1)
total episode##2##2##(1994-2#2)
total episodes of##2##3##(1994-2#1)(2013-1#1)
total eradication of##2##3##(2007-12#1)(2012-12#1)
total error##7##2##(2008-10#1)(2008-2#1)(2008-3#5)
total essential##2##2##(1990-12#1)(2010-12#1)
total evaporation technique##2##3##(2008-10#2)
total evaporation##5##2##(2008-10#3)(2008-5#2)
total evidence##3##2##(1996-11#2)(2007-12#1)
total excision of the cerebellar##2##5##(2012-3#1)(2013-1#1)
total excision of##3##3##(1996-12#1)(2012-3#1)(2013-1#1)
total exposure##2##2##(2006-8#1)(2011-1#1)
total extinction altitude profiles##2##4##(2008-2#1)(2008-3#1)
total extinction##3##2##(2006-7#1)(2008-2#1)(2008-3#1)
total extract was##2##3##(2007-6#1)(2008-10#1)
total extractable hydrocarbon content##2##4##(2006-12#2)
total extractable##3##2##(2006-12#2)(2010-3#1)
total extraction##2##2##(2008-10#2)
total eye scanning length##2##4##(2004-11#2)
total family##3##2##(1993-12#1)(2008-8#1)(2010-9#1)
total fat and##2##3##(1990-8#1)(2008-7#1)
total fat##8##2##(1990-8#1)(1993-9#1)(2008-10#2)(2008-3#1)(2008-7#1)(2013-8#2)
total fatty acid##4##3##(1997-2#1)(2007-11#1)(2008-12#1)(2008-7#1)
total fatty acids in the##2##5##(2010-4#2)
total fatty acids##5##3##(1991-7#1)(2005-12#2)(2010-4#2)
total fatty##10##2##(1991-7#1)(1997-2#1)(2005-12#2)(2007-11#1)(2008-12#1)(2008-7#1)(2010-4#2)(2012-11#1)
total fears##2##2##(2011-2#2)
total fecundity##2##2##(2008-12#1)(2008-9#1)
total fertility##3##2##(2006-10#2)(2008-5#1)
total fiber optic##2##3##(1990-8#2)
total fields##2##2##(2008-2#1)(2008-3#1)
total flavonoids##3##2##(2006-12#1)(2012-12#1)(2013-1#1)
total flavonols##2##2##(2011-2#2)
total flora##3##2##(2011-2#3)
total flow rate##3##3##(2007-12#1)(2008-10#1)(2010-11#1)
total flow##8##2##(1991-10#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-5#1)(2010-11#1)
total fluorine##4##2##(2008-10#4)
total force on a##2##4##(2007-12#2)
total force##3##2##(2007-12#2)(2008-3#1)
total free energy##3##3##(2005-11#1)(2006-10#1)(2010-2#1)
total free##6##2##(1991-12#1)(2005-11#1)(2006-10#1)(2007-3#1)(2008-12#1)(2010-2#1)
total frequency##5##2##(1992-9#1)(2005-10#1)(2005-11#1)(2007-6#1)(2008-7#1)
total fungal spore##2##3##(2008-5#2)
total fungal spores##2##3##(2008-5#2)
total fungal##5##2##(2007-3#1)(2008-5#4)
total gastrectomy with##2##3##(1995-11#1)(2013-8#1)
total gastrectomy##11##2##(1990-9#1)(1992-10#1)(1992-9#1)(1995-11#1)(2006-10#1)(2006-2#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
total gene diversity##2##3##(2008-10#1)(2012-5#1)
total gene##3##2##(2008-10#1)(2010-1#1)(2012-5#1)
total genetic diversity was##2##4##(2005-10#1)(2008-10#1)
total genetic variability##3##3##(2008-10#1)(2008-8#1)(2012-1#1)
total genetic##9##2##(2005-10#1)(2008-10#6)(2008-8#1)(2012-1#1)
total genome##2##2##(2007-11#1)(2008-5#1)
total genomic DNA##6##3##(2008-1#1)(2008-10#4)(2008-2#1)
total germination was##2##3##(2012-2#2)
total global##3##2##(2005-7#1)(2010-12#1)(2010-6#1)
total glossectomy##3##2##(2011-12#3)
total glutathione in##2##3##(1996-8#1)(1997-2#1)
total glutathione##11##2##(1991-7#2)(1995-12#1)(1995-3#1)(1996-8#1)(1997-2#2)(2008-11#2)(2008-4#1)(2013-1#1)
total glycoalkaloids##5##2##(2008-10#5)
total hPRL and##2##3##(2008-11#2)
total hardness##7##2##(2007-10#3)(2008-5#1)(2008-8#1)(2009-6#2)
total healing time##2##3##(2007-8#2)
total health care##4##3##(1993-12#1)(1994-2#1)(1995-2#1)(1997-2#1)
total health##7##2##(1992-11#1)(1992-2#1)(1993-12#1)(1994-2#1)(1995-2#1)(1997-2#1)(2006-2#1)
total healthcare expenditures##4##3##(2013-1#4)
total healthcare##6##2##(2005-8#1)(2011-2#1)(2013-1#4)
total hemoglobin concentration##4##3##(2008-2#1)(2008-3#1)(2011-12#1)(2013-1#1)
total hemoglobin##7##2##(1996-12#2)(2007-10#1)(2008-2#1)(2008-3#1)(2011-12#1)(2013-1#1)
total hepatic cyst volume##2##4##(2007-8#2)
total hepatic##4##2##(1995-3#1)(1996-9#1)(2007-8#2)
total hip and knee##2##4##(2011-2#1)(2013-7#1)
total hip and total knee##3##5##(1994-3#1)(2009-3#1)(2011-2#1)
total hip and total##4##4##(1994-3#1)(2006-8#1)(2009-3#1)(2011-2#1)
total hip and##7##3##(1994-3#1)(2006-8#2)(2009-3#1)(2011-2#2)(2013-7#1)
total hip arthroplasties##6##3##(1996-9#2)(2007-11#2)(2011-2#2)
total hip arthroplasty (THA) or total knee arthroplasty (TKA)##2##9##(1994-3#1)(2013-7#1)
total hip arthroplasty (THA)##13##4##(1994-3#1)(2005-3#1)(2008-11#1)(2008-8#1)(2009-3#4)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
total hip arthroplasty and total knee arthroplasty##3##7##(2011-2#3)
total hip arthroplasty and##5##4##(2007-8#1)(2008-6#1)(2011-2#3)
total hip arthroplasty are##2##4##(2007-5#2)
total hip arthroplasty in##2##4##(2007-8#1)(2013-1#1)
total hip arthroplasty is##3##4##(1997-6#1)(2007-11#1)(2007-5#1)
total hip arthroplasty using##3##4##(2008-8#1)(2009-12#1)(2009-4#1)
total hip arthroplasty##71##3##(1994-3#1)(1995-4#1)(1996-9#1)(1997-6#1)(2004-9#2)(2005-3#1)(2006-10#1)(2007-11#2)(2007-5#3)(2007-7#2)(2007-8#2)(2008-11#1)(2008-3#1)(2008-6#3)(2008-8#12)(2009-12#1)(2009-3#12)(2009-4#3)(2010-11#1)(2010-2#1)(2010-9#1)(2011-2#6)(2012-12#1)(2012-2#4)(2013-1#6)(2013-7#1)
total hip or knee arthroplasty##2##5##(2010-9#1)(2013-1#1)
total hip or knee##3##4##(2010-9#1)(2013-1#2)
total hip or total knee##2##5##(2007-10#1)(2013-1#1)
total hip or##5##3##(2007-10#1)(2010-9#1)(2013-1#3)
total hip plasty##2##3##(2007-11#2)
total hip prostheses##2##3##(2008-3#1)(2009-4#1)
total hip prosthesis##3##3##(2008-3#1)(2008-6#1)(2009-3#1)
total hip replacement (THR)##4##4##(2007-11#1)(2007-7#1)(2009-3#1)(2013-8#1)
total hip replacement and##2##4##(1996-1#1)(2010-10#1)
total hip replacement in##5##4##(1996-11#1)(2007-7#4)
total hip replacement##42##3##(1994-12#1)(1994-8#1)(1995-2#1)(1996-1#2)(1996-11#1)(2007-11#4)(2007-7#12)(2007-8#2)(2008-6#1)(2008-8#1)(2009-3#3)(2010-10#8)(2013-1#3)(2013-7#1)(2013-8#1)
total hip replacements##2##3##(2007-11#2)
total hip##156##2##(1994-12#1)(1994-3#2)(1994-8#1)(1995-2#1)(1995-4#1)(1996-1#2)(1996-11#1)(1996-6#1)(1996-9#3)(1997-6#1)(2004-9#2)(2005-3#1)(2006-10#1)(2006-12#1)(2006-8#4)(2007-10#1)(2007-11#14)(2007-5#4)(2007-7#14)(2007-8#4)(2008-11#1)(2008-3#3)(2008-6#5)(2008-8#15)(2009-12#2)(2009-3#17)(2009-4#4)(2010-1#1)(2010-10#8)(2010-11#1)(2010-2#1)(2010-3#2)(2010-9#2)(2011-12#1)(2011-2#11)(2012-12#1)(2012-2#4)(2013-1#13)(2013-7#3)(2013-8#1)
total homocysteine (Hcy)##2##3##(2006-10#1)(2006-2#1)
total homocysteine##10##2##(1992-4#1)(1992-9#1)(1996-11#1)(2006-10#1)(2006-2#1)(2008-8#4)(2010-12#1)
total hospital costs##2##3##(1992-2#1)(2012-3#1)
total hospital##7##2##(1991-12#1)(1992-2#1)(1993-1#2)(1995-1#1)(2007-8#1)(2012-3#1)
total hours of##3##3##(1994-3#1)(2008-10#2)
total hours##5##2##(1994-3#1)(2006-10#1)(2008-10#3)
total human DNA##3##3##(2008-12#3)
total human##6##2##(1994-9#1)(1995-2#1)(1997-2#1)(2008-12#3)
total hydrocarbon contents and##2##4##(2008-10#2)
total hydrocarbon##3##2##(2008-10#3)
total hydroxyproline in##2##3##(1995-2#2)
total hysterectomy for##2##3##(2004-10#1)(2006-10#1)
total hysterectomy##5##2##(2004-10#1)(2006-10#1)(2011-2#3)
total impact##3##2##(2006-12#2)(2010-9#1)
total implants##2##2##(2007-1#1)(2013-1#1)
total in##3##2##(1991-8#1)(1993-10#1)(1993-9#1)
total incidence of##4##3##(1991-11#1)(1992-2#1)(2006-8#1)(2007-8#1)
total incidence##5##2##(1991-11#1)(1992-2#1)(2006-8#1)(2007-8#1)(2011-2#1)
total increase##2##2##(1990-5#1)(1996-12#1)
total infection##2##2##(2008-10#2)
total inhibition##4##2##(1990-8#1)(1991-10#1)(1993-6#1)(2005-11#1)
total inorganic As##2##3##(2008-10#2)
total inorganic Se##2##3##(2008-10#2)
total inorganic arsenic##5##3##(2008-10#5)
total inorganic iron##3##3##(2008-10#3)
total inorganic phosphates##5##3##(2008-10#5)
total inorganic##23##2##(2008-10#23)
total insect survival##2##3##(2008-6#2)
total integrated scattering (TIS)##2##4##(2008-2#1)(2008-3#1)
total integrated scattering##4##3##(2008-2#1)(2008-3#3)
total integrated##6##2##(2008-2#2)(2008-3#4)
total intensity of##2##3##(1993-9#1)(2008-1#1)
total intensity##5##2##(1993-9#1)(2007-11#1)(2008-1#1)(2008-3#2)
total internal reflection (TIR)##4##4##(2007-12#1)(2007-8#1)(2008-3#2)
total internal reflection at the##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
total internal reflection fluorescence##2##4##(2007-10#1)(2008-1#1)
total internal reflection in##2##4##(2007-12#2)
total internal reflection microscopy##7##4##(2007-12#4)(2008-3#3)
total internal reflection##44##3##(2007-10#1)(2007-11#5)(2007-12#9)(2007-8#3)(2008-1#1)(2008-10#1)(2008-2#11)(2008-3#13)
total internal reflections##2##3##(2007-12#1)(2008-2#1)
total internal##49##2##(2007-10#1)(2007-11#5)(2007-12#10)(2007-8#3)(2008-1#2)(2008-10#1)(2008-2#13)(2008-3#13)(2011-2#1)
total intracellular##6##2##(1990-12#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-11#1)(2008-10#1)
total intravenous anaesthesia (TIVA)##2##4##(2008-5#1)(2010-7#1)
total intravenous anaesthesia##7##3##(2006-10#3)(2008-5#1)(2010-7#2)(2011-2#1)
total intravenous anesthesia (TIVA)##3##4##(2011-2#1)(2012-12#1)(2013-7#1)
total intravenous anesthesia##6##3##(2011-2#3)(2012-12#1)(2013-7#2)
total intravenous##14##2##(2006-10#4)(2008-5#1)(2010-7#2)(2011-2#4)(2012-12#1)(2013-7#2)
total ion current chromatograms##2##4##(2005-12#1)(2007-8#1)
total ion current##4##3##(1992-1#1)(2005-12#1)(2007-8#1)(2008-10#1)
total ion##6##2##(1992-1#1)(2005-12#1)(2007-8#1)(2008-10#2)(2010-12#1)
total ionic concentration##2##3##(2008-10#2)
total ionic##4##2##(2008-10#4)
total iron and vanadium##2##4##(2008-10#2)
total iron binding capacity##2##4##(2006-9#1)(2007-8#1)
total iron in##4##3##(2008-10#4)
total iron##16##2##(2006-9#1)(2007-8#1)(2008-10#14)
total isolates recovered)##2##3##(2008-10#2)
total isolates##4##2##(1991-3#1)(2008-10#3)
total joint arthroplasty##8##3##(2006-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-12#2)
total joint replacement##5##3##(1997-2#1)(2006-10#1)(2008-10#1)(2008-9#1)(2012-3#1)
total joint##17##2##(1997-2#1)(2006-10#2)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#4)(2009-3#1)(2011-2#2)(2012-12#2)(2012-3#2)
total kidney##3##2##(1994-8#2)(2008-1#1)
total knee arthroplasties##3##3##(2011-2#3)
total knee arthroplasty (TKA) with##2##5##(2009-3#2)
total knee arthroplasty (TKA)##16##4##(1994-3#1)(2007-5#1)(2008-8#2)(2009-3#2)(2011-2#4)(2013-1#5)(2013-7#1)
total knee arthroplasty in patients##2##5##(2008-8#1)(2011-2#1)
total knee arthroplasty in##3##4##(2007-11#1)(2008-8#1)(2011-2#1)
total knee arthroplasty with##2##4##(2008-8#1)(2012-12#1)
total knee arthroplasty##62##3##(1994-3#2)(2007-11#4)(2007-5#2)(2007-8#1)(2008-8#13)(2009-3#6)(2009-4#1)(2010-3#2)(2011-1#3)(2011-2#10)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#12)(2013-7#1)
total knee replacement (TKR)##4##4##(2007-8#1)(2008-8#2)(2013-1#1)
total knee replacement in##2##4##(2007-8#1)(2008-8#1)
total knee replacement##22##3##(1994-12#1)(1995-2#1)(1996-3#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#4)(2008-7#1)(2008-8#6)(2009-3#1)(2013-1#1)(2013-7#1)
total knee replacements##2##3##(2008-8#1)(2011-1#1)
total knee##96##2##(1994-12#1)(1994-3#2)(1995-2#1)(1996-3#1)(1996-9#1)(2007-10#2)(2007-11#6)(2007-2#1)(2007-5#2)(2007-7#2)(2007-8#5)(2008-7#1)(2008-8#22)(2009-3#7)(2009-4#1)(2010-3#2)(2011-1#4)(2011-2#13)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#15)(2013-7#2)
total knowledge score##3##3##(2007-7#1)(2011-2#2)
total laparoscopic hysterectomy##3##3##(1996-2#1)(2010-3#1)(2011-2#1)
total laparoscopic##4##2##(1996-2#1)(2010-3#1)(2011-2#2)
total laryngectomy##3##2##(2009-10#1)(2011-1#1)(2013-7#1)
total lead##2##2##(2012-12#2)
total leaf##2##2##(2007-1#1)(2008-9#1)
total length and##4##3##(2007-12#1)(2008-5#1)(2008-7#1)(2009-4#1)
total length of the##7##4##(1996-6#1)(1997-6#1)(1997-8#2)(2006-10#1)(2008-5#1)(2012-12#1)
total length of##15##3##(1996-6#1)(1997-2#2)(1997-6#1)(1997-8#2)(2006-10#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-5#2)(2012-12#1)(2013-8#2)
total length was##3##3##(2007-3#1)(2008-5#2)
total length##33##2##(1996-10#1)(1996-6#1)(1997-2#2)(1997-6#1)(1997-8#2)(2006-10#1)(2007-12#2)(2007-3#4)(2007-5#2)(2007-8#1)(2008-5#7)(2008-7#1)(2009-4#1)(2010-8#3)(2012-12#1)(2013-7#1)(2013-8#2)
total length)##3##2##(1996-4#2)(2007-3#1)
total leucocyte count was##2##4##(1994-6#2)
total leucocyte##3##2##(1994-6#3)
total leukocyte count##4##3##(1990-12#1)(2008-7#1)(2009-7#1)(2010-5#1)
total leukocyte##8##2##(1990-12#1)(1996-12#1)(2007-1#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-5#1)(2011-2#1)
total levels of##2##3##(1997-7#1)(2008-10#1)
total life##2##2##(1995-12#1)(2008-7#1)
total lifespan##3##2##(2009-12#3)
total light##5##2##(1991-8#1)(1993-9#1)(2007-12#1)(2008-1#1)(2010-9#1)
total limb##2##2##(1990-11#1)(2005-10#1)
total linear indices##3##3##(2007-11#3)
total linear##4##2##(1996-1#1)(2007-11#3)
total lipid concentration##2##3##(1990-2#2)
total lipid content##3##3##(2010-4#2)(2010-8#1)
total lipid of##2##3##(1996-1#1)(2008-12#1)
total lipid##19##2##(1990-2#2)(1990-5#1)(1991-10#2)(1994-3#1)(1995-10#1)(1995-12#1)(1996-1#3)(1997-2#1)(2007-3#1)(2008-12#1)(2008-5#1)(2010-4#2)(2010-8#1)(2013-1#1)
total lipids and serum##3##4##(2008-12#3)
total lipids and##6##3##(1997-3#1)(2008-12#5)
total lipids in##3##3##(2008-12#2)(2010-11#1)
total lipids##17##2##(1990-2#1)(1991-2#1)(1997-3#1)(2007-8#1)(2008-11#1)(2008-12#11)(2010-11#1)
total liver##3##2##(1991-2#2)(1995-3#1)
total load of##2##3##(2008-10#2)
total long-chain##2##2##(1996-11#2)
total loss of##6##3##(1993-4#1)(1995-8#1)(1996-9#1)(2006-12#1)(2007-9#1)(2010-3#1)
total loss##9##2##(1993-4#1)(1995-8#1)(1996-9#1)(2006-12#1)(2007-9#1)(2008-3#2)(2008-6#1)(2010-3#1)
total lung capacity##2##3##(1996-2#2)
total lung##3##2##(1996-2#2)(1996-3#1)
total lymphocyte count##2##3##(1990-9#1)(2011-1#1)
total mRNA rather than polysomal mRNA and##2##7##(2012-2#2)
total mRNA##6##2##(1990-3#1)(1993-5#1)(1994-8#1)(2012-2#3)
total major##2##2##(2006-8#1)(2009-3#1)
total matrix##2##2##(1990-2#1)(2011-2#1)
total mean##4##2##(1991-6#1)(2008-2#1)(2008-5#1)(2013-1#1)
total measurement time)##2##3##(2008-3#2)
total measurement##3##2##(2008-3#3)
total median count##2##3##(2006-8#2)
total membrane protein##2##3##(1990-2#1)(1992-7#1)
total membrane##8##2##(1990-2#1)(1991-3#1)(1992-3#1)(1992-7#2)(1993-3#2)(1994-5#1)
total membranes of##2##3##(1992-12#1)(1994-9#1)
total membranes##3##2##(1992-12#1)(1992-7#1)(1994-9#1)
total memory##3##2##(2006-4#1)(2008-12#1)(2008-3#1)
total mercury##19##2##(1993-9#1)(1996-7#1)(2004-4#1)(2007-5#1)(2008-10#15)
total mesna##6##2##(2008-10#6)
total mesorectal excision for##2##4##(2008-8#1)(2012-12#1)
total mesorectal excision##3##3##(2008-8#1)(2012-12#2)
total mesorectal##4##2##(2006-6#1)(2008-8#1)(2012-12#2)
total metal concentrations##2##3##(2008-10#1)(2011-2#1)
total metal contents##2##3##(2010-5#2)
total metal##5##2##(2008-10#2)(2010-5#2)(2011-2#1)
total metals##4##2##(2008-10#3)(2010-5#1)
total midface deficiency##2##3##(2007-12#2)
total mitochondrial##2##2##(1990-2#1)(1991-5#1)
total molecular##3##2##(1993-4#1)(2008-10#1)(2008-3#1)
total morbidity##2##2##(1993-5#1)(2007-8#1)
total mortality and##6##3##(2005-12#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-4#1)(2013-8#1)
total mortality in##2##3##(1990-2#1)(2005-10#1)
total mortality##17##2##(1990-2#1)(1992-2#1)(1993-9#1)(1995-4#1)(2005-10#2)(2005-12#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2013-8#3)
total muscle##3##2##(1996-12#1)(2006-11#1)(2008-5#1)
total n-3##4##2##(1996-7#1)(2007-8#2)(2010-4#1)
total nitrogen and##3##3##(2008-5#1)(2009-6#1)(2013-1#1)
total nitrogen determination in animal feed##2##6##(2008-10#2)
total nitrogen##22##2##(2007-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#2)(2009-6#1)(2013-1#1)(2013-8#11)
total nuclear##4##2##(1990-7#1)(1992-12#2)(2008-5#1)
total nucleated cell count##6##4##(2006-5#4)(2008-10#2)
total nucleated cells##3##3##(2008-11#1)(2008-8#1)(2011-2#1)
total nucleated##9##2##(2006-5#4)(2008-10#2)(2008-11#1)(2008-8#1)(2011-2#1)
total nucleic acid extracts##2##4##(1996-12#1)(2008-10#1)
total nucleic acids##2##3##(2008-4#1)(2008-9#1)
total nucleic##4##2##(1996-12#1)(2008-10#1)(2008-4#1)(2008-9#1)
total number in the##2##4##(1994-3#1)(2008-10#1)
total number of 5##2##4##(2005-10#1)(2008-11#1)
total number of WDM channels##2##5##(2007-11#2)
total number of cells in embryos at blastulation##2##8##(2006-5#2)
total number of cells in embryos##3##6##(2006-5#3)
total number of cells in##7##5##(1995-7#1)(2006-5#6)
total number of cells##9##4##(1995-7#1)(2006-5#7)(2008-1#1)
total number of eggs##3##4##(2007-12#1)(2008-3#1)(2008-4#1)
total number of papers##2##4##(2007-3#1)(2013-1#1)
total number of patients##7##4##(1990-8#1)(1991-4#1)(1992-6#1)(1993-1#1)(1995-2#1)(2007-7#1)(2009-3#1)
total number of protein##2##4##(2008-12#1)(2008-4#1)
total number of subjects##2##4##(2008-12#1)(2008-6#1)
total number of##176##3##(1990-12#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-3#1)(1991-4#2)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-7#1)(1995-9#1)(1996-5#1)(1996-7#2)(1997-1#1)(1997-3#1)(1997-6#3)(1997-7#1)(2004-11#2)(2005-10#2)(2005-11#1)(2005-8#1)(2005-9#2)(2006-10#4)(2006-11#1)(2006-12#1)(2006-4#2)(2006-5#8)(2006-6#2)(2007-10#1)(2007-11#3)(2007-12#3)(2007-3#3)(2007-4#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#15)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#5)(2008-5#3)(2008-6#4)(2008-7#2)(2008-8#4)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-1#4)(2011-2#7)(2011-3#1)(2012-2#2)(2012-3#4)(2013-1#8)(2013-8#1)
total number##183##2##(1990-12#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-3#1)(1991-4#2)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-7#1)(1995-9#1)(1996-5#1)(1996-7#2)(1997-1#1)(1997-3#1)(1997-6#3)(1997-7#1)(2004-11#2)(2005-10#2)(2005-11#1)(2005-8#1)(2005-9#2)(2006-10#4)(2006-11#1)(2006-12#1)(2006-4#2)(2006-5#8)(2006-6#3)(2007-10#1)(2007-11#3)(2007-12#3)(2007-3#3)(2007-4#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#16)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#5)(2008-5#4)(2008-6#4)(2008-7#2)(2008-8#4)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-1#4)(2011-2#7)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#4)(2013-1#8)(2013-8#1)
total numbers and##2##3##(2007-5#1)(2010-9#1)
total numbers of cells##2##4##(2004-9#1)(2006-5#1)
total numbers of##3##3##(2004-9#1)(2006-5#1)(2011-2#1)
total numbers##7##2##(1993-7#1)(1994-9#1)(2004-9#1)(2006-5#1)(2007-5#1)(2010-9#1)(2011-2#1)
total nutrient uptake##2##3##(2008-12#2)
total nutrient##3##2##(2008-12#2)(2013-7#1)
total nymphal##2##2##(2004-11#1)(2011-2#1)
total obliteration##3##2##(1997-6#1)(2008-7#2)
total occlusion of the left##2##5##(2008-1#1)(2010-3#1)
total occlusion of the##8##4##(1993-11#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-12#1)(2010-3#1)(2010-4#1)(2013-8#1)
total occlusion of##11##3##(1993-11#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-7#1)(2009-12#1)(2010-3#1)(2010-4#1)(2012-1#1)(2013-8#1)
total occlusion was##2##3##(1996-9#1)(2008-5#1)
total occlusion##23##2##(1993-11#1)(1996-9#1)(1997-3#1)(2007-8#2)(2008-1#1)(2008-11#3)(2008-12#2)(2008-5#3)(2008-7#1)(2009-12#1)(2010-3#1)(2010-4#1)(2012-1#1)(2012-2#3)(2013-8#1)
total occlusion)##2##2##(2008-7#2)
total occlusions##8##2##(1996-9#1)(1997-6#1)(2008-11#1)(2008-12#3)(2009-5#1)(2012-2#1)
total of 1##34##3##(1990-11#1)(1990-9#2)(1991-6#1)(1992-8#1)(1994-11#1)(1995-5#2)(1996-1#1)(1996-11#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-7#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-5#4)(2008-6#1)(2008-9#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-12#2)(2012-3#1)
total of 10 patients##3##4##(2007-7#1)(2007-8#1)(2010-10#1)
total of 10##18##3##(1990-3#1)(1991-5#1)(1993-12#1)(1993-9#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-5#1)(2010-10#1)(2010-11#1)(2012-2#1)(2013-1#1)
total of 100##7##3##(1995-2#1)(2006-10#1)(2007-3#1)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#1)
total of 101##5##3##(2006-8#1)(2007-8#1)(2008-12#1)(2008-5#1)(2013-8#1)
total of 103##4##3##(1990-4#1)(1995-11#1)(1996-1#1)(2007-3#1)
total of 104##5##3##(1994-2#1)(1997-3#1)(2011-2#2)(2013-7#1)
total of 106##3##3##(2006-6#1)(2008-10#1)(2008-6#1)
total of 11##13##3##(1993-8#1)(2006-4#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-7#1)
total of 111##4##3##(2007-7#1)(2012-2#2)(2013-1#1)
total of 115 patients##2##4##(1990-4#1)(2005-1#1)
total of 117##3##3##(1990-4#1)(2008-10#1)(2008-3#1)
total of 119##6##3##(2006-2#1)(2007-5#1)(2008-4#1)(2008-7#1)(2010-4#1)(2013-7#1)
total of 12##16##3##(1992-2#1)(2006-11#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#1)(2009-12#1)(2010-12#1)(2012-1#1)(2013-1#1)(2013-8#1)
total of 120##4##3##(2006-6#1)(2007-7#1)(2008-8#1)(2010-7#1)
total of 124##4##3##(1992-12#1)(1997-8#1)(2012-2#1)(2013-3#1)
total of 128##3##3##(1991-9#1)(1997-4#1)(2008-5#1)
total of 13##10##3##(1995-5#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-11#1)(2009-3#1)(2009-5#1)(2013-8#1)
total of 134##2##3##(1992-9#1)(1996-12#1)
total of 14##10##3##(1992-11#1)(1993-12#1)(1994-12#1)(1997-6#1)(2007-1#1)(2008-10#1)(2011-2#1)(2013-1#2)(2013-7#1)
total of 142##2##3##(2007-7#1)(2010-12#1)
total of 148##2##3##(2007-7#1)(2007-8#1)
total of 15##13##3##(2006-10#1)(2006-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-11#2)(2009-3#1)(2012-2#1)(2013-7#2)
total of 155##3##3##(1994-3#1)(2008-10#1)(2013-7#1)
total of 156##4##3##(2007-11#1)(2008-11#1)(2010-12#1)(2011-2#1)
total of 16##6##3##(1996-6#1)(2008-11#1)(2008-7#1)(2009-6#1)(2012-2#1)(2013-8#1)
total of 166##2##3##(2005-11#1)(2011-2#1)
total of 169##2##3##(2007-3#1)(2008-12#1)
total of 17##8##3##(1994-3#1)(1994-9#1)(2005-11#1)(2007-1#1)(2007-2#1)(2008-10#1)(2008-9#1)(2013-1#1)
total of 175##3##3##(1994-6#1)(2007-3#1)(2010-3#1)
total of 176##2##3##(2007-7#2)
total of 179##3##3##(1992-9#1)(2007-3#1)(2011-1#1)
total of 18##10##3##(1996-3#1)(2004-12#1)(2005-12#1)(2007-12#1)(2008-8#2)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#1)
total of 184##2##3##(2011-2#1)(2012-2#1)
total of 185##3##3##(2007-11#1)(2010-4#1)(2011-2#1)
total of 186##3##3##(2007-7#2)(2010-1#1)
total of 189##2##3##(2008-10#1)(2008-3#1)
total of 19 patients##2##4##(1996-6#1)(2011-2#1)
total of 19##13##3##(1991-11#1)(1994-8#1)(1996-6#1)(1997-4#1)(1997-8#1)(2008-5#2)(2010-4#1)(2010-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
total of 192##4##3##(1992-3#1)(2006-10#1)(2007-8#1)(2008-7#1)
total of 2##15##3##(1992-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(2007-4#1)(2007-9#1)(2008-10#1)(2010-10#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-7#2)
total of 20##15##3##(1990-8#1)(1992-4#1)(1992-6#1)(1995-6#1)(1997-6#1)(2005-10#1)(2007-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-6#1)(2010-12#1)(2011-1#1)(2013-1#1)
total of 200##9##3##(1994-12#1)(2006-1#1)(2007-10#1)(2007-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
total of 205##2##3##(2007-12#1)(2013-7#1)
total of 21 patients##2##4##(2007-11#1)(2008-5#1)
total of 21##9##3##(1990-3#1)(1990-8#1)(2004-2#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-5#1)(2010-5#1)
total of 22##7##3##(2006-12#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
total of 223 patients##2##4##(2010-3#1)(2011-1#1)
total of 223##4##3##(1994-3#1)(2010-3#1)(2011-1#1)(2013-8#1)
total of 225##2##3##(1997-8#1)(2008-10#1)
total of 23##5##3##(2007-5#1)(2007-7#1)(2010-5#1)(2013-1#2)
total of 230##2##3##(2007-8#1)(2008-1#1)
total of 234##2##3##(2008-10#1)(2011-1#1)
total of 236##3##3##(2007-9#1)(2011-1#1)(2011-2#1)
total of 237##3##3##(1991-9#1)(2008-10#1)(2012-3#1)
total of 239##2##3##(1997-4#1)(2008-10#1)
total of 24##10##3##(1990-12#1)(1993-1#1)(1997-8#1)(2005-9#1)(2008-12#1)(2008-9#1)(2009-1#1)(2009-7#1)(2011-2#1)(2013-8#1)
total of 240##4##3##(2007-7#1)(2008-5#1)(2008-6#1)(2012-2#1)
total of 244##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
total of 246##2##3##(2006-11#1)(2007-7#1)
total of 25 patients##2##4##(1990-10#1)(1990-8#1)
total of 25##9##3##(1990-10#1)(1990-11#1)(1990-8#1)(2007-5#1)(2008-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
total of 250##4##3##(2006-8#1)(2008-10#1)(2011-2#1)(2012-2#1)
total of 258##4##3##(2006-8#1)(2008-5#1)(2008-7#1)(2010-5#1)
total of 26##6##3##(1993-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#1)
total of 260##2##3##(2008-10#1)(2008-6#1)
total of 264##2##3##(1993-6#1)(2007-8#1)
total of 265##2##3##(2008-6#1)(2010-8#1)
total of 27##8##3##(1990-11#1)(2008-2#2)(2008-5#1)(2010-6#1)(2012-2#2)(2013-1#1)
total of 270##2##3##(2007-11#1)(2011-1#1)
total of 279##2##3##(2006-10#1)(2013-8#1)
total of 28##10##3##(1991-12#1)(1996-9#1)(1997-4#1)(2006-12#1)(2006-5#1)(2008-1#1)(2008-8#1)(2009-10#1)(2009-6#1)(2012-3#1)
total of 285##3##3##(2010-12#1)(2011-1#2)
total of 291##2##3##(1991-8#1)(2010-4#1)
total of 3##15##3##(1991-5#1)(1991-9#1)(1993-1#1)(1996-6#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-9#1)(2010-8#1)(2012-2#2)(2012-3#1)(2012-6#1)(2013-1#1)(2013-7#1)
total of 30##14##3##(2004-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#3)(2008-8#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#1)(2013-1#1)
total of 300 patients##3##4##(2006-7#1)(2006-8#1)(2008-11#1)
total of 300##7##3##(2006-7#1)(2006-8#1)(2007-3#1)(2008-10#1)(2008-11#1)(2012-1#1)(2013-1#1)
total of 31##5##3##(2007-3#1)(2007-8#1)(2008-2#1)(2008-7#1)(2011-2#1)
total of 32##7##3##(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)(2013-8#1)
total of 33##9##3##(1996-9#1)(2007-1#1)(2007-7#1)(2008-10#2)(2008-6#1)(2008-9#1)(2010-3#1)(2012-11#1)
total of 34##8##3##(1993-3#1)(1995-4#1)(2007-12#1)(2008-4#2)(2008-7#1)(2010-5#1)(2013-1#1)
total of 35##6##3##(2005-1#1)(2009-4#1)(2012-2#2)(2013-1#1)(2013-8#1)
total of 350##3##3##(2007-7#1)(2008-1#1)(2008-12#1)
total of 36##3##3##(1993-2#1)(2011-2#1)(2013-1#1)
total of 362##3##3##(1992-8#1)(1994-2#1)(2007-2#1)
total of 4##8##3##(1993-12#1)(1994-2#1)(2007-7#1)(2008-12#1)(2008-4#1)(2011-1#1)(2013-1#2)
total of 40 patients##2##4##(2008-5#1)(2013-1#1)
total of 40##8##3##(2008-10#1)(2008-5#1)(2008-8#1)(2009-8#1)(2012-3#1)(2013-1#3)
total of 43##7##3##(1995-10#1)(2007-10#1)(2008-10#2)(2008-6#1)(2010-12#1)(2012-3#1)
total of 436##2##3##(2007-10#1)(2008-4#1)
total of 44##6##3##(1995-3#1)(1997-6#1)(2006-4#1)(2007-7#1)(2007-9#1)(2008-6#1)
total of 47##2##3##(1995-3#1)(2006-2#1)
total of 470##3##3##(2005-8#1)(2008-8#1)(2013-7#1)
total of 5##9##3##(1995-8#1)(2005-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-5#1)(2013-1#1)(2013-8#1)
total of 50##6##3##(1994-12#1)(2006-12#1)(2006-9#1)(2008-11#1)(2008-8#1)(2013-8#1)
total of 502##2##3##(2006-6#1)(2008-12#1)
total of 51##3##3##(1996-12#1)(2007-8#1)(2008-10#1)
total of 52##3##3##(2008-4#1)(2008-7#1)(2013-7#1)
total of 535##2##3##(2007-3#1)(2008-3#1)
total of 539##2##3##(1994-11#1)(2006-2#1)
total of 54 different##2##4##(2006-8#1)(2008-10#1)
total of 54##6##3##(2006-10#1)(2006-8#1)(2007-10#1)(2007-3#1)(2008-10#1)(2012-2#1)
total of 543##2##3##(1996-5#1)(2008-10#1)
total of 55##3##3##(1990-10#1)(1995-3#1)(2007-2#1)
total of 58##5##3##(1994-7#1)(2006-12#1)(2007-10#1)(2008-12#1)(2012-12#1)
total of 59##5##3##(2006-10#1)(2007-10#1)(2007-7#1)(2008-10#1)(2013-1#1)
total of 6 patients##2##4##(2008-10#1)(2012-2#1)
total of 6##12##3##(1991-5#1)(1993-9#1)(2006-11#1)(2006-4#2)(2008-1#1)(2008-10#1)(2008-12#2)(2008-4#1)(2011-1#1)(2012-2#1)
total of 60##11##3##(2007-11#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
total of 600##3##3##(1992-5#1)(2008-5#1)(2012-3#1)
total of 605##2##3##(1991-11#1)(2008-10#1)
total of 61##3##3##(1996-8#1)(2004-11#1)(2007-2#1)
total of 62##3##3##(1991-2#1)(2007-4#1)(2012-1#1)
total of 63##4##3##(2007-9#1)(2008-10#1)(2008-4#1)(2013-1#1)
total of 64##4##3##(1994-2#1)(2008-10#1)(2008-5#1)(2011-2#1)
total of 66##2##3##(2006-10#1)(2008-3#1)
total of 68##5##3##(2006-3#1)(2006-8#1)(2007-4#1)(2008-10#1)(2008-5#1)
total of 7##7##3##(1991-9#1)(1993-11#1)(1997-3#1)(2006-8#1)(2007-7#1)(2008-6#1)(2008-7#1)
total of 70##4##3##(2008-3#1)(2009-4#1)(2012-2#1)(2013-8#1)
total of 700##2##3##(2006-12#1)(2013-1#1)
total of 72##5##3##(1992-5#1)(1996-8#1)(2007-3#1)(2008-10#1)(2013-1#1)
total of 727##2##3##(2006-8#1)(2013-1#1)
total of 73##2##3##(2008-5#1)(2012-11#1)
total of 751##2##3##(2006-8#1)(2007-7#1)
total of 77##2##3##(2008-1#1)(2008-8#1)
total of 78##3##3##(2005-12#1)(2008-10#1)(2012-2#1)
total of 8##7##3##(1990-2#1)(1991-7#1)(1993-6#1)(2007-8#1)(2008-6#1)(2012-2#1)(2013-7#1)
total of 80##8##3##(1991-11#1)(2008-10#3)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#1)
total of 805##2##3##(2008-11#1)(2013-1#1)
total of 82##3##3##(1995-6#1)(1996-12#1)(2008-6#1)
total of 83##2##3##(1991-4#1)(2008-10#1)
total of 87##4##3##(1991-6#1)(2007-3#1)(2009-4#1)(2013-7#1)
total of 9 cases##2##4##(2006-4#1)(2011-1#1)
total of 9##8##3##(1993-3#1)(1994-3#1)(1997-4#1)(2006-4#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)
total of 90##2##3##(1994-8#1)(2011-2#1)
total of 91##4##3##(1997-6#1)(2006-4#1)(2008-10#1)(2008-5#1)
total of 94##3##3##(2007-3#1)(2009-3#1)(2010-2#1)
total of 96##9##3##(2006-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-2#1)(2010-4#1)(2013-1#2)(2013-7#1)
total of 99 patients##5##4##(2006-12#1)(2007-8#1)(2008-1#1)(2008-5#1)(2013-8#1)
total of 99##8##3##(2006-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-8#1)
total of approximately##4##3##(2007-12#2)(2008-7#1)(2009-4#1)
total of five##3##3##(1993-2#1)(2008-10#1)(2008-5#1)
total of four##5##3##(1996-12#1)(2007-12#1)(2008-10#2)(2012-2#1)
total of nine##5##3##(1992-8#1)(1994-8#1)(1995-2#1)(2007-4#1)(2010-4#1)
total of seven##3##3##(1995-6#1)(2006-6#1)(2008-10#1)
total of six##3##3##(1995-6#1)(2008-4#1)(2011-3#1)
total of the##4##3##(1992-6#1)(2008-10#1)(2008-12#1)(2008-3#1)
total of three##2##3##(1994-9#1)(2011-2#1)
total of##1251##2##(1990-10#2)(1990-11#4)(1990-12#4)(1990-2#1)(1990-3#3)(1990-4#5)(1990-5#1)(1990-6#1)(1990-8#5)(1990-9#3)(1991-10#2)(1991-11#3)(1991-12#3)(1991-2#1)(1991-4#3)(1991-5#4)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#5)(1992-8#4)(1992-9#3)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#6)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#4)(1994-12#7)(1994-2#4)(1994-3#4)(1994-5#3)(1994-6#2)(1994-7#2)(1994-8#3)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#3)(1995-4#3)(1995-5#4)(1995-6#6)(1995-8#2)(1996-1#3)(1996-10#1)(1996-11#3)(1996-12#8)(1996-2#2)(1996-3#3)(1996-5#1)(1996-6#4)(1996-8#3)(1996-9#2)(1997-2#1)(1997-3#2)(1997-4#7)(1997-5#1)(1997-6#9)(1997-7#1)(1997-8#6)(2004-1#1)(2004-11#2)(2004-12#2)(2004-2#3)(2005-1#2)(2005-10#2)(2005-11#4)(2005-12#2)(2005-7#2)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#17)(2006-11#3)(2006-12#11)(2006-2#6)(2006-3#1)(2006-4#10)(2006-5#3)(2006-6#10)(2006-7#5)(2006-8#17)(2006-9#2)(2007-1#6)(2007-10#21)(2007-11#11)(2007-12#12)(2007-2#19)(2007-3#22)(2007-4#5)(2007-5#14)(2007-6#6)(2007-7#47)(2007-8#25)(2007-9#6)(2008-1#16)(2008-10#95)(2008-11#16)(2008-12#22)(2008-2#13)(2008-3#19)(2008-4#14)(2008-5#54)(2008-6#21)(2008-7#30)(2008-8#20)(2008-9#9)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#4)(2009-3#3)(2009-4#4)(2009-5#4)(2009-6#4)(2009-7#3)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#15)(2010-2#3)(2010-3#5)(2010-4#15)(2010-5#5)(2010-6#3)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#38)(2011-12#3)(2011-2#64)(2011-3#2)(2012-1#5)(2012-11#3)(2012-12#14)(2012-2#40)(2012-3#19)(2012-6#1)(2013-1#57)(2013-3#1)(2013-7#24)(2013-8#38)
total operative##2##2##(2009-6#1)(2010-2#1)
total ophthalmoplegia##2##2##(2010-10#1)(2013-7#1)
total opioid sites##3##3##(1991-5#3)
total opioid##5##2##(1991-5#4)(2007-2#1)
total optical properties calculated##2##4##(2008-3#2)
total optical##5##2##(2008-2#1)(2008-3#3)(2010-12#1)
total or partial##4##3##(2007-11#1)(2008-10#1)(2010-9#1)(2011-12#1)
total or##13##2##(1991-7#1)(1993-12#1)(1994-6#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-7#1)(2010-7#1)(2010-9#1)(2011-12#2)(2011-2#1)
total organic C##2##3##(2007-7#2)
total organic carbon (TOC)##3##4##(2007-8#1)(2008-10#1)(2011-1#1)
total organic carbon content##5##4##(2005-11#4)(2008-10#1)
total organic carbon##9##3##(2005-11#4)(2007-8#1)(2008-1#1)(2008-10#2)(2011-1#1)
total organic##15##2##(2005-11#4)(2006-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#5)(2011-1#1)
total output power##2##3##(2007-12#2)
total output##7##2##(1994-8#1)(2007-12#4)(2008-3#2)
total ozone abundances from##2##4##(2008-2#2)
total ozone##9##2##(2008-2#9)
total pain relief##2##3##(2005-10#1)(2008-9#1)
total pain##4##2##(1991-5#1)(2005-10#1)(2008-9#1)(2013-1#1)
total pancreatectomy for##2##3##(1990-9#1)(2008-3#1)
total pancreatectomy##6##2##(1990-9#1)(2006-10#1)(2006-6#1)(2008-3#1)(2010-12#1)(2013-7#1)
total parenteral nutrition (TPN)##4##4##(1992-9#2)(2006-7#1)(2008-10#1)
total parenteral nutrition and##2##4##(2006-10#1)(2008-8#1)
total parenteral nutrition##28##3##(1991-6#1)(1992-9#2)(1996-4#1)(2004-11#2)(2005-10#4)(2006-10#3)(2006-2#1)(2006-7#2)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-8#1)(2009-5#1)(2010-7#2)(2011-2#3)
total parenteral##29##2##(1991-6#1)(1992-9#2)(1996-4#1)(2004-11#2)(2005-10#4)(2006-10#3)(2006-2#1)(2006-7#2)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-7#2)(2011-2#3)
total parotidectomy##4##2##(2007-5#1)(2009-5#1)(2011-2#1)(2013-8#1)
total patient##2##2##(2007-12#1)(2012-3#1)
total pelvic##3##2##(1992-3#2)(2008-8#1)
total percentage##2##2##(2008-6#1)(2010-8#1)
total period of##4##3##(1993-5#1)(1996-7#1)(2007-7#1)(2008-6#1)
total peripheral##3##2##(1991-12#1)(2008-3#2)
total phenol##2##2##(2008-10#1)(2013-1#1)
total phenolic content of the##3##5##(2008-10#1)(2008-11#1)(2012-11#1)
total phenolic content of##4##4##(2008-10#2)(2008-11#1)(2012-11#1)
total phenolic content##9##3##(2004-2#1)(2008-10#4)(2008-11#1)(2009-6#1)(2012-11#1)(2012-12#1)
total phenolic contents##3##3##(2012-2#1)(2013-8#2)
total phenolic##12##2##(2004-2#1)(2008-10#4)(2008-11#1)(2009-6#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-8#2)
total phenolics##3##2##(2004-2#1)(2011-2#1)(2013-1#1)
total phenols##4##2##(2008-10#1)(2010-4#2)(2011-2#1)
total phenotypic variation for resistance##3##5##(2008-10#3)
total phenotypic variation##4##3##(2008-10#4)
total phenotypic##7##2##(2008-10#6)(2012-3#1)
total phospholipids##2##2##(1992-12#1)(1994-12#1)
total phosphorous##2##2##(2013-1#1)(2013-8#1)
total phosphorus in##4##3##(2008-10#4)
total phosphorus##12##2##(2008-10#8)(2013-8#4)
total phosphorylation 0##2##3##(2010-12#2)
total photocurrent##2##2##(2007-12#1)(2008-2#1)
total plaque area##2##3##(2008-8#2)
total plaque##3##2##(2008-7#1)(2008-8#2)
total plasma cholesterol levels##2##4##(1990-3#1)(1994-8#1)
total plasma cholesterol##5##3##(1990-3#2)(1994-8#1)(2008-4#1)(2008-5#1)
total plasma levels##2##3##(1993-11#2)
total plasma protein##2##3##(2008-1#1)(2013-1#1)
total plasma proteins##3##3##(2004-11#1)(2008-4#1)(2008-5#1)
total plasma volume##2##3##(2011-2#2)
total plasma##23##2##(1990-11#1)(1990-3#2)(1992-11#1)(1992-2#2)(1993-11#3)(1994-8#1)(1995-8#1)(2004-11#1)(2006-12#1)(2008-1#1)(2008-4#3)(2008-5#2)(2008-7#1)(2011-2#2)(2013-1#1)
total plastic strain##3##3##(2009-7#3)
total plate##2##2##(2007-2#1)(2010-4#1)
total pollen##2##2##(2008-5#2)
total polycyclic aromatic hydrocarbons##2##4##(2008-10#2)
total polyphenol index##2##3##(2008-10#2)
total polyphenol##4##2##(2008-10#3)(2010-2#1)
total polyphenols and##2##3##(2007-8#1)(2012-2#1)
total pool of##3##3##(1996-8#2)(2006-7#1)
total population median##2##3##(2010-2#2)
total population of##12##3##(1991-12#1)(1992-6#1)(1993-6#1)(1995-3#2)(1996-5#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-5#1)(2012-12#2)
total population size of questing##2##5##(2004-11#2)
total population size##4##3##(2004-11#3)(2008-8#1)
total population##40##2##(1991-12#1)(1992-6#1)(1993-10#2)(1993-6#1)(1994-2#1)(1994-3#1)(1995-3#2)(1996-5#1)(1996-6#1)(1997-3#1)(2004-11#3)(2007-3#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-2#2)(2012-12#2)(2013-1#1)(2013-8#4)
total populations##3##2##(2006-5#1)(2009-5#1)(2011-2#1)
total power of##2##3##(2008-10#1)(2010-8#1)
total power##12##2##(1991-5#1)(1993-5#1)(2006-6#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#1)(2010-12#1)(2010-8#1)(2013-7#1)
total precipitation##3##2##(2008-10#2)(2013-8#1)
total preconcentration time##4##3##(2008-10#4)
total pressure##5##2##(2007-12#2)(2008-2#1)(2008-3#1)(2008-7#1)
total prevalence##3##2##(2004-12#1)(2007-2#1)(2008-5#1)
total primary production/total##2##3##(2013-8#2)
total proctectomy with##2##3##(2007-8#2)
total product##2##2##(1995-10#1)(2012-2#1)
total production of##3##3##(1992-3#1)(2007-12#1)(2011-1#1)
total production##4##2##(1991-11#1)(1992-3#1)(2007-12#1)(2011-1#1)
total progeny##3##2##(2012-2#3)
total protein (TP)##3##3##(2008-10#1)(2012-2#1)(2013-1#1)
total protein (r =##2##4##(1993-2#1)(2011-2#1)
total protein amount##2##3##(2008-11#2)
total protein and##7##3##(1992-6#1)(1997-8#1)(2008-4#2)(2008-9#1)(2012-2#1)(2013-8#1)
total protein assay##2##3##(2008-10#2)
total protein content##4##3##(1991-12#1)(1991-4#1)(1995-2#1)(2008-10#1)
total protein excretion##2##3##(1993-12#1)(2008-5#1)
total protein in crude lysates and purified or partially purified protein##2##11##(2008-1#1)(2008-2#1)
total protein in human serum##5##5##(2008-10#5)
total protein in##9##3##(2006-12#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-4#1)
total protein intake##2##3##(1991-11#1)(2013-8#1)
total protein levels##4##3##(2008-10#1)(2008-6#1)(2010-12#1)(2013-8#1)
total protein of##4##3##(2007-2#1)(2008-12#2)(2010-12#1)
total protein synthesis##3##3##(1991-6#1)(1992-12#1)(2006-12#1)
total protein were##2##3##(2008-6#1)(2011-1#1)
total protein##109##2##(1990-10#1)(1990-11#1)(1990-4#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-9#1)(1994-5#1)(1995-2#1)(1996-2#1)(1997-6#1)(1997-8#2)(2004-11#2)(2006-12#3)(2006-5#1)(2007-11#1)(2007-2#2)(2007-7#1)(2008-1#4)(2008-10#14)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#7)(2008-5#8)(2008-6#6)(2008-7#1)(2008-8#1)(2008-9#3)(2010-12#3)(2010-2#1)(2010-3#1)(2011-1#3)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#7)(2013-1#2)(2013-8#4)
total protein) and##2##3##(1990-11#1)(2008-4#1)
total protein)##3##2##(1990-11#1)(2008-4#1)(2008-7#1)
total proteins and##4##3##(1994-8#1)(1995-12#1)(2011-1#1)(2012-2#1)
total proteins in##7##3##(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#3)(2011-1#1)
total proteins of##2##3##(2008-12#1)(2008-9#1)
total proteins##26##2##(1993-6#1)(1994-8#1)(1995-12#1)(1996-8#1)(2004-11#1)(2005-8#1)(2008-10#4)(2008-12#4)(2008-5#1)(2008-8#3)(2008-9#1)(2010-12#1)(2010-4#1)(2011-1#4)(2012-2#1)
total proteolysis##2##2##(1991-5#1)(2013-1#1)
total pulse width##2##3##(2008-10#2)
total pulse##4##2##(2007-12#2)(2008-10#2)
total quality management (TQM)##15##4##(1993-12#1)(1993-2#1)(1993-3#3)(1994-1#1)(1994-2#3)(1995-1#1)(1995-3#4)(1996-2#1)
total quality management process##3##4##(1994-1#1)(1994-2#2)
total quality management##42##3##(1992-12#1)(1993-12#1)(1993-2#2)(1993-3#4)(1994-1#7)(1994-2#10)(1994-3#1)(1995-1#2)(1995-12#1)(1995-3#8)(1996-12#1)(1996-2#3)(2008-12#1)
total quality##52##2##(1992-12#2)(1993-1#1)(1993-12#1)(1993-2#3)(1993-3#4)(1994-1#8)(1994-2#11)(1994-3#1)(1995-1#2)(1995-12#1)(1995-3#9)(1996-12#1)(1996-2#3)(2007-8#4)(2008-12#1)
total radiation dose##3##3##(1993-2#1)(2007-6#1)(2008-6#1)
total radiation##5##2##(1993-2#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-6#1)
total radioactivity##7##2##(1990-3#1)(1992-2#2)(1993-11#1)(1994-8#1)(1996-6#1)(1997-8#1)
total radiotherapy dose##2##3##(2007-10#1)(2012-1#1)
total rat##3##2##(1990-7#1)(1994-5#1)(2004-12#1)
total rate of##3##3##(1993-8#1)(2007-7#1)(2012-2#1)
total reaction time variance##2##4##(2008-8#2)
total reaction time##3##3##(2008-10#1)(2008-8#2)
total recovery of the##3##4##(2008-10#1)(2010-12#1)(2013-8#1)
total recovery of##5##3##(1993-2#1)(2008-10#2)(2010-12#1)(2013-8#1)
total recovery was##4##3##(1990-4#1)(2008-10#1)(2008-5#1)(2013-8#1)
total recovery##11##2##(1990-4#1)(1992-12#1)(1993-2#1)(1997-8#1)(2008-10#3)(2008-5#1)(2010-12#1)(2013-8#2)
total reduction of##3##3##(2006-6#1)(2008-3#1)(2013-1#1)
total reflectance infrared##3##3##(2008-10#3)
total reflectance##20##2##(1991-9#2)(1993-3#1)(2005-11#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-10#8)(2008-2#1)(2008-3#3)
total reflection (ATR)##4##3##(1990-2#1)(1993-9#1)(2008-10#2)
total reflection Fourier transform infrared (ATR FT-IR)##3##7##(2007-11#1)(2007-12#1)(2007-8#1)
total reflection Fourier transform infrared spectroscopy##3##6##(1992-9#1)(2006-3#1)(2008-10#1)
total reflection Fourier transform infrared##10##5##(1992-9#1)(1997-4#1)(2006-3#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#2)
total reflection Fourier transform##11##4##(1992-9#1)(1997-4#1)(2006-3#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#2)(2008-5#1)
total reflection Fourier##12##3##(1992-9#1)(1997-4#1)(2006-3#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#3)(2008-5#1)
total reflection geometry for##2##4##(2008-3#2)
total reflection infrared##3##3##(1995-8#1)(2007-12#1)(2008-10#1)
total reflection##43##2##(1990-2#1)(1992-9#1)(1993-9#1)(1995-8#1)(1997-4#1)(1997-8#1)(2004-9#1)(2006-12#3)(2006-3#2)(2007-11#2)(2007-12#5)(2007-8#2)(2008-10#11)(2008-2#2)(2008-3#6)(2008-5#2)(2013-1#1)
total refraction##2##2##(2007-11#2)
total relative standard error##2##4##(2008-10#2)
total remission of##2##3##(1991-8#1)(2010-9#1)
total remission##3##2##(1990-4#1)(1991-8#1)(2010-9#1)
total removal of the tumour##2##5##(2007-11#1)(2008-7#1)
total removal of the##6##4##(2006-6#1)(2007-11#1)(2007-5#1)(2008-12#1)(2008-7#2)
total removal of##8##3##(2006-6#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-7#3)
total removal##13##2##(2006-6#1)(2007-1#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-7#5)(2012-3#2)
total replacement of##2##3##(2006-10#1)(2008-11#1)
total reproductive success##2##3##(2008-8#2)
total reproductive##4##2##(2008-8#3)(2012-3#1)
total resection of a##2##4##(2006-12#1)(2008-7#1)
total resection of the##5##4##(1990-3#1)(2007-4#1)(2008-12#1)(2012-3#1)(2013-1#1)
total resection of##9##3##(1990-3#1)(2006-12#1)(2007-4#1)(2007-8#1)(2008-12#1)(2008-7#2)(2012-3#1)(2013-1#1)
total resection was##2##3##(2006-12#2)
total resection##21##2##(1990-3#1)(2005-5#1)(2006-11#1)(2006-12#4)(2007-1#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-12#1)(2008-7#5)(2012-2#1)(2012-3#1)(2013-1#1)
total respiration##3##2##(1990-4#1)(2008-7#1)(2008-9#1)
total retention of Embrace was 23##2##6##(2012-12#2)
total retention##3##2##(2012-12#2)(2013-8#1)
total retrieval##2##2##(2008-3#2)
total root tip##2##3##(2008-10#2)
total root##3##2##(2008-10#2)(2011-2#1)
total safranal##3##2##(2007-8#3)
total sample comprised##2##3##(2008-11#1)(2013-1#1)
total sample of##4##3##(1996-3#1)(2006-8#1)(2013-1#1)(2013-7#1)
total sample or##2##3##(1994-5#1)(2006-8#1)
total sample size##2##3##(2011-1#1)(2012-3#1)
total sample##21##2##(1993-8#1)(1994-3#1)(1994-5#1)(1996-3#1)(2006-6#1)(2006-8#3)(2008-10#1)(2008-11#1)(2008-5#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#2)
total samples##2##2##(2007-3#1)(2008-12#1)
total saponin##5##2##(2006-12#1)(2007-1#2)(2008-11#1)(2012-12#1)
total saturated##4##2##(2006-12#2)(2010-4#1)(2012-2#1)
total scale and subscales##2##4##(2007-12#2)
total scale##5##2##(2007-12#2)(2007-2#1)(2010-11#1)(2012-11#1)
total scattering##3##2##(2008-2#1)(2008-3#2)
total score and subscale scores were##2##6##(2007-12#2)
total score and##3##3##(2007-12#2)(2011-1#1)
total score for##2##3##(2006-10#1)(2006-9#1)
total score of DHI-I##2##4##(2011-1#2)
total score of the##2##4##(2004-3#1)(2006-7#1)
total score of##6##3##(2004-3#1)(2006-7#1)(2011-1#4)
total score was##4##3##(1991-12#1)(2007-11#1)(2011-2#1)(2012-12#1)
total score##29##2##(1991-12#1)(1991-9#1)(1996-8#1)(2004-3#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#4)(2008-4#1)(2010-10#1)(2010-2#1)(2011-1#6)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#4)
total scores##5##2##(2008-10#1)(2008-11#1)(2010-12#2)(2012-11#1)
total screen##2##2##(1991-6#1)(2008-11#1)
total screening##2##2##(1992-8#1)(2013-7#1)
total sebum lipids##2##3##(2010-5#2)
total secreted##2##2##(1990-1#1)(2009-2#1)
total seed sterol##2##3##(2006-12#2)
total seed##5##2##(2006-12#2)(2008-8#1)(2008-9#1)(2013-8#1)
total selenium##6##2##(2008-10#5)(2010-11#1)
total series##2##2##(1991-10#1)(1996-9#1)
total serum IgE##3##3##(2008-10#1)(2011-1#2)
total serum bilirubin##2##3##(2011-2#1)(2012-2#1)
total serum cholesterol and##4##4##(1990-11#1)(1991-6#1)(1993-5#1)(2007-1#1)
total serum cholesterol levels##4##4##(1991-11#1)(1993-9#2)(1995-12#1)
total serum cholesterol##16##3##(1990-11#1)(1991-11#1)(1991-12#1)(1991-6#1)(1993-12#1)(1993-5#1)(1993-9#2)(1995-12#1)(1995-8#1)(1996-3#1)(2007-1#2)(2008-3#1)(2010-3#1)(2011-1#1)
total serum protein##2##3##(1993-12#2)
total serum zinc##2##3##(1994-10#2)
total serum##35##2##(1990-11#1)(1990-2#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-4#1)(1993-12#3)(1993-2#1)(1993-5#1)(1993-9#2)(1994-10#3)(1994-5#1)(1995-12#1)(1995-8#1)(1996-3#1)(2006-6#1)(2007-1#2)(2007-2#1)(2008-10#1)(2008-3#2)(2010-12#1)(2010-3#1)(2011-1#3)(2011-2#1)(2012-2#1)
total shoulder arthroplasty##3##3##(2008-6#3)
total shoulder##4##2##(2008-6#3)(2011-2#1)
total sialic acid##3##3##(1995-12#1)(2008-12#2)
total sialic acids##3##3##(2008-11#3)
total sialic##6##2##(1995-12#1)(2008-11#3)(2008-12#2)
total signals##2##2##(1997-1#1)(2008-3#1)
total skin irradiation##2##3##(1995-4#1)(1995-9#1)
total skin##4##2##(1995-4#1)(1995-9#2)(2007-7#1)
total sleep time (TST)##2##4##(2012-12#2)
total sleep time##4##3##(1994-8#1)(2010-7#1)(2012-12#2)
total small##2##2##(1997-8#1)(2008-8#1)
total soil copper##2##3##(2004-4#2)
total soil##3##2##(2004-4#2)(2013-8#1)
total solar##2##2##(2008-3#1)(2010-12#1)
total soluble phenolic compounds##3##4##(2008-10#3)
total soluble protein in the##2##5##(1994-5#1)(2013-1#1)
total soluble protein in##4##4##(1993-9#1)(1994-5#1)(2006-12#1)(2013-1#1)
total soluble protein##9##3##(1993-12#1)(1993-6#1)(1993-9#1)(1994-5#1)(2006-11#1)(2006-12#2)(2008-9#1)(2013-1#1)
total soluble protein)##2##3##(2006-12#1)(2011-2#1)
total soluble proteins##2##3##(1993-3#1)(2008-5#1)
total soluble##23##2##(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-5#1)(1996-12#1)(2006-11#1)(2006-12#3)(2008-10#4)(2008-12#3)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
total spectral##3##2##(1995-3#1)(2008-10#1)(2008-3#1)
total sperm##2##2##(2008-4#1)(2011-2#1)
total splenectomy##2##2##(1997-8#1)(2007-2#1)
total sterols##2##2##(1997-1#2)
total striatal##2##2##(1991-12#1)(1997-8#1)
total students##2##2##(2011-1#2)
total sugar##4##2##(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
total sugar)##2##2##(2008-10#2)
total sulfide##2##2##(2008-10#2)
total sulfur##7##2##(2008-10#7)
total sulphur dioxide##5##3##(2008-10#5)
total sulphur##10##2##(2008-10#10)
total surface##5##2##(1997-1#1)(2008-10#1)(2008-3#1)(2010-10#1)(2011-12#1)
total surfactant##4##2##(2005-11#2)(2008-10#1)(2008-5#1)
total surgical excision##2##3##(2007-8#1)(2010-11#1)
total surgical##6##2##(1992-12#1)(1994-5#1)(2006-6#1)(2007-8#1)(2008-8#1)(2010-11#1)
total survival time##2##3##(1995-12#1)(2013-8#1)
total survival##3##2##(1995-12#1)(2007-2#1)(2013-8#1)
total suspended solids##3##3##(2007-10#1)(2008-10#1)(2013-1#1)
total suspended##6##2##(2007-10#1)(2008-10#2)(2013-1#1)(2013-8#2)
total syntheses of##3##3##(2009-12#1)(2009-3#1)(2013-1#1)
total synthesis and##2##3##(1995-3#1)(2013-1#1)
total synthesis of natural products##2##5##(2010-12#2)
total synthesis of the##4##4##(1995-6#1)(2008-7#1)(2009-11#1)(2010-2#1)
total synthesis of##14##3##(1995-4#1)(1995-6#1)(1996-4#1)(2006-12#1)(2007-11#1)(2008-7#2)(2009-11#2)(2009-5#1)(2010-12#2)(2010-2#2)
total synthesis##24##2##(1991-10#1)(1995-3#2)(1995-4#1)(1995-6#1)(1996-4#1)(1996-7#1)(2006-12#2)(2007-11#1)(2008-7#3)(2009-11#3)(2009-5#1)(2010-12#4)(2010-2#2)(2013-1#1)
total system##5##2##(2008-5#1)(2011-1#3)(2012-2#1)
total tRNA##3##2##(2008-4#3)
total temporal##2##2##(1996-7#1)(2007-12#1)
total testosterone##7##2##(1990-10#1)(2006-6#2)(2008-5#1)(2012-12#2)(2013-1#1)
total thiamine##2##2##(1995-1#2)
total thickness##3##2##(2007-12#2)(2009-8#1)
total thiol##3##2##(1997-2#1)(2008-7#1)(2010-4#1)
total thiols##4##2##(2010-4#1)(2010-8#3)
total thyroidectomy and##2##3##(2006-10#1)(2013-1#1)
total thyroidectomy is the##2##4##(1990-9#1)(1993-6#1)
total thyroidectomy was##2##3##(1992-5#1)(2011-1#1)
total thyroidectomy##15##2##(1990-9#2)(1992-5#1)(1993-6#1)(2006-10#1)(2009-3#1)(2011-1#1)(2011-2#5)(2013-1#2)(2013-7#1)
total thyroxine (T4)##2##3##(1991-3#1)(1994-12#1)
total thyroxine##3##2##(1991-3#2)(1994-12#1)
total time for##2##3##(2008-10#2)
total time interval##2##3##(1994-3#2)
total time of##7##3##(1997-3#1)(2007-8#2)(2008-10#4)
total time##22##2##(1991-2#1)(1993-9#1)(1994-3#3)(1994-4#2)(1997-3#1)(2007-8#2)(2008-10#9)(2008-12#1)(2008-5#1)(2011-1#1)
total tissue##4##2##(1991-10#1)(1992-11#1)(1994-5#1)(2008-7#1)
total trace##4##2##(2007-5#1)(2007-8#1)(2008-10#1)(2010-5#1)
total tract digestibility##2##3##(2009-4#1)(2010-2#1)
total transmission##2##2##(2007-11#1)(2007-12#1)
total transplant charges##2##3##(2009-2#2)
total treatment costs##2##3##(2007-7#1)(2009-10#1)
total treatment duration##4##3##(1996-11#1)(2011-2#3)
total treatment##11##2##(1991-12#1)(1993-9#2)(1996-11#1)(2006-12#1)(2007-7#1)(2009-10#1)(2009-9#1)(2011-2#3)
total triglycerides and##2##3##(2005-10#2)
total triglycerides##3##2##(1993-1#1)(2005-10#2)
total trivalent arsenic##2##3##(2008-10#2)
total tumor removal was achieved by a second##2##8##(2007-1#2)
total tumor resection##3##3##(2006-10#1)(2007-1#1)(2013-8#1)
total tumor##7##2##(1992-10#1)(1996-6#1)(2006-10#1)(2007-1#3)(2013-8#1)
total understanding of##2##3##(1992-1#1)(1995-11#1)
total uptake of##3##3##(1990-11#1)(1990-5#1)(1994-6#1)
total uptake##5##2##(1990-11#1)(1990-5#1)(1992-3#1)(1994-6#1)(2010-12#1)
total urinary##3##2##(1993-1#1)(1994-6#1)(2009-6#1)
total urine volume##2##3##(2007-6#1)(2012-2#1)
total urogenital sinus mobilization##2##4##(2008-10#2)
total value##3##2##(2007-5#1)(2008-10#2)
total vanadium##6##2##(1994-11#1)(2008-10#4)(2008-3#1)
total variance##23##2##(1993-8#1)(1997-5#1)(2007-10#1)(2008-10#11)(2008-11#1)(2008-5#1)(2008-8#1)(2010-12#2)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
total variation##10##2##(2008-10#4)(2008-2#2)(2008-8#1)(2010-12#2)(2013-1#1)
total version##2##2##(2011-2#2)
total viable count##2##3##(2010-4#2)
total viable counts##3##3##(1997-4#1)(1997-5#2)
total viable##7##2##(1997-4#1)(1997-5#2)(2006-5#1)(2007-6#1)(2010-4#2)
total vitamin E (P=0##2##4##(2008-10#2)
total volatile##2##2##(2009-6#1)(2012-2#1)
total volume of gastric juice and gastric acidity##2##8##(2009-5#2)
total volume of##12##3##(1990-5#1)(1992-12#1)(1996-6#1)(2007-11#1)(2007-9#2)(2008-10#1)(2009-5#2)(2012-12#2)(2013-7#1)
total volume##17##2##(1990-5#1)(1992-12#1)(1996-6#1)(2007-11#1)(2007-3#1)(2007-9#2)(2008-10#3)(2008-11#1)(2008-5#1)(2009-5#2)(2012-12#2)(2013-7#1)
total water##10##2##(2008-10#1)(2008-5#3)(2010-12#2)(2010-8#2)(2011-1#1)(2011-2#1)
total weight of##2##3##(2007-3#1)(2012-2#1)
total weight##9##2##(2007-3#2)(2008-7#2)(2011-1#2)(2012-2#1)(2013-1#1)(2013-7#1)
total weight)##2##2##(2007-11#1)(2008-6#1)
total white blood cell count##3##5##(2005-8#1)(2007-10#1)(2012-1#1)
total white blood cell##6##4##(1997-3#1)(2005-8#1)(2007-10#2)(2007-9#1)(2012-1#1)
total white blood##9##3##(1990-9#1)(1991-9#1)(1997-3#1)(2005-8#1)(2007-10#2)(2007-9#1)(2012-1#1)(2012-12#1)
total white##10##2##(1990-9#1)(1991-9#1)(1992-2#1)(1997-3#1)(2005-8#1)(2007-10#2)(2007-9#1)(2012-1#1)(2012-12#1)
total work##4##2##(1996-1#1)(2008-11#1)(2009-9#1)(2011-2#1)
total worm burden##2##3##(1996-12#2)
total worm##3##2##(1996-12#3)
total x-ray absorption coefficient##2##4##(2012-2#2)
total yield##3##2##(1995-7#1)(2008-10#1)(2008-6#1)
total zirconia##2##2##(2008-10#2)
total##6149##1##(1990-1#5)(1990-10#10)(1990-11#21)(1990-12#28)(1990-2#21)(1990-3#16)(1990-4#15)(1990-5#13)(1990-6#13)(1990-7#18)(1990-8#26)(1990-9#18)(1991-1#6)(1991-10#14)(1991-11#20)(1991-12#23)(1991-2#18)(1991-3#14)(1991-4#10)(1991-5#22)(1991-6#23)(1991-7#13)(1991-8#17)(1991-9#15)(1992-1#6)(1992-10#9)(1992-11#17)(1992-12#23)(1992-2#23)(1992-3#28)(1992-4#9)(1992-5#5)(1992-6#18)(1992-7#5)(1992-8#17)(1992-9#16)(1993-1#14)(1993-10#7)(1993-11#11)(1993-12#39)(1993-2#17)(1993-3#15)(1993-4#6)(1993-5#7)(1993-6#14)(1993-7#2)(1993-8#11)(1993-9#30)(1994-1#13)(1994-10#7)(1994-11#20)(1994-12#26)(1994-2#29)(1994-3#30)(1994-4#3)(1994-5#14)(1994-6#16)(1994-7#7)(1994-8#25)(1994-9#13)(1995-1#21)(1995-10#7)(1995-11#17)(1995-12#26)(1995-2#17)(1995-3#38)(1995-4#12)(1995-5#12)(1995-6#10)(1995-7#6)(1995-8#9)(1995-9#9)(1996-1#14)(1996-10#6)(1996-11#18)(1996-12#36)(1996-2#18)(1996-3#15)(1996-4#14)(1996-5#11)(1996-6#13)(1996-7#9)(1996-8#17)(1996-9#19)(1997-1#29)(1997-2#28)(1997-3#15)(1997-4#19)(1997-5#9)(1997-6#24)(1997-7#14)(1997-8#24)(2004-1#2)(2004-10#2)(2004-11#25)(2004-12#4)(2004-2#8)(2004-3#1)(2004-4#13)(2004-9#10)(2005-1#2)(2005-10#31)(2005-11#32)(2005-12#11)(2005-3#1)(2005-4#3)(2005-5#1)(2005-7#4)(2005-8#14)(2005-9#3)(2006-1#4)(2006-10#64)(2006-11#9)(2006-12#57)(2006-2#13)(2006-3#6)(2006-4#22)(2006-5#25)(2006-6#29)(2006-7#15)(2006-8#52)(2006-9#12)(2007-1#27)(2007-10#49)(2007-11#82)(2007-12#101)(2007-2#50)(2007-3#57)(2007-4#14)(2007-5#38)(2007-6#17)(2007-7#114)(2007-8#132)(2007-9#33)(2008-1#57)(2008-10#788)(2008-11#99)(2008-12#107)(2008-2#96)(2008-3#166)(2008-4#70)(2008-5#186)(2008-6#75)(2008-7#114)(2008-8#137)(2008-9#57)(2009-1#2)(2009-10#14)(2009-11#8)(2009-12#17)(2009-2#11)(2009-3#33)(2009-4#25)(2009-5#21)(2009-6#18)(2009-7#17)(2009-8#10)(2009-9#13)(2010-1#6)(2010-10#23)(2010-11#18)(2010-12#57)(2010-2#29)(2010-3#19)(2010-4#50)(2010-5#19)(2010-6#4)(2010-7#16)(2010-8#27)(2010-9#10)(2011-1#114)(2011-10#3)(2011-11#2)(2011-12#23)(2011-2#229)(2011-3#5)(2012-1#28)(2012-11#10)(2012-12#74)(2012-2#112)(2012-3#52)(2012-5#1)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#213)(2013-3#1)(2013-4#1)(2013-7#60)(2013-8#123)
total) developed##2##2##(2006-10#1)(2006-2#1)
total) were##5##2##(1996-11#1)(2008-10#3)(2013-1#1)
total)##34##1##(1991-12#1)(1992-12#1)(1994-6#1)(1995-11#1)(1996-11#3)(1997-3#1)(1997-8#1)(2006-10#1)(2006-12#2)(2006-2#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#11)(2008-8#1)(2009-2#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
total- and LDL-cholesterol##2##3##(2008-10#2)
total-Fe##3##1##(2008-10#3)
total-body##2##1##(2008-7#1)(2010-11#1)
total-etch technique##2##2##(2008-5#2)
total-order planning##2##2##(2008-9#2)
total-variation##2##1##(2012-1#2)
total/HDL cholesterol ratio##2##3##(2013-1#2)
total/HDL cholesterol##3##2##(2013-1#3)
totale de##2##2##(2008-5#1)(2012-2#1)
totale##5##1##(2008-5#3)(2012-2#2)
totaled##5##1##(1993-8#1)(2007-2#1)(2008-10#1)(2008-11#2)
totaling##5##1##(1993-11#1)(2011-2#1)(2013-8#3)
totality of##7##2##(1993-8#1)(1996-6#1)(2005-10#1)(2006-3#1)(2007-10#1)(2009-8#1)(2011-2#1)
totality##8##1##(1993-8#1)(1996-6#1)(2005-10#1)(2006-3#1)(2007-10#1)(2009-8#1)(2011-2#2)
totalled##2##1##(1997-4#1)(2007-12#1)
totalling##5##1##(1990-3#1)(1993-2#1)(1994-6#1)(2008-10#1)(2010-10#1)
totally abolished by##2##3##(1996-8#1)(2008-1#1)
totally abolished the##3##3##(1994-2#1)(1996-5#2)
totally abolished##11##2##(1990-2#1)(1991-10#1)(1992-8#1)(1994-2#1)(1995-5#1)(1996-11#1)(1996-5#2)(1996-8#1)(2008-1#1)(2009-8#1)
totally absent from##3##3##(1992-1#1)(2007-5#1)(2012-2#1)
totally absent##4##2##(1992-1#1)(1993-12#1)(2007-5#1)(2012-2#1)
totally blocked by##4##3##(1992-11#1)(1994-11#1)(1996-9#1)(2008-10#1)
totally blocked##7##2##(1991-3#1)(1992-11#1)(1994-11#1)(1994-2#1)(1995-10#1)(1996-9#1)(2008-10#1)
totally consumed leaves##3##3##(2007-3#3)
totally deaf##2##2##(2008-2#2)
totally dependent on##4##3##(1990-7#1)(1991-12#1)(1994-3#1)(2012-1#1)
totally dependent##5##2##(1990-7#1)(1991-12#1)(1994-3#1)(2009-10#1)(2012-1#1)
totally different from##3##3##(1992-7#1)(1996-7#1)(2008-3#1)
totally different##10##2##(1992-7#1)(1996-7#1)(1997-1#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-12#1)
totally disappeared##2##2##(2008-10#1)(2008-8#1)
totally effective##2##2##(2006-4#1)(2007-11#1)
totally eliminate##2##2##(1990-3#1)(2006-8#1)
totally endoscopic coronary artery bypass grafting##3##6##(2007-8#3)
totally endoscopic coronary artery bypass##6##5##(2006-6#1)(2007-8#5)
totally endoscopic single vessel##2##4##(2007-8#2)
totally endoscopic single##3##3##(2007-8#3)
totally endoscopic##12##2##(2006-6#1)(2007-8#11)
totally excluded##2##2##(1993-6#1)(2007-12#1)
totally fill the##2##3##(2008-2#1)(2012-1#1)
totally implantable systems##2##3##(1990-4#1)(2007-7#1)
totally implantable##4##2##(1990-4#1)(2007-7#2)(2008-9#1)
totally in##6##2##(1991-8#1)(2006-12#1)(2007-1#1)(2008-12#1)(2008-2#1)(2008-4#1)
totally incoherent light##3##3##(2007-12#2)(2008-3#1)
totally incoherent##5##2##(2007-12#4)(2008-3#1)
totally independent##2##2##(1991-9#1)(2008-10#1)
totally inhibited by##2##3##(1991-2#1)(1993-8#1)
totally inhibited##5##2##(1991-2#1)(1992-11#1)(1992-12#1)(1993-8#1)(2008-7#1)
totally inhibits##2##2##(1993-3#1)(1996-11#1)
totally new##2##2##(2008-10#1)(2012-1#1)
totally occluded##3##2##(1991-6#1)(1997-8#1)(2010-12#1)
totally prevented emesis in##2##4##(1992-3#2)
totally prevented##4##2##(1992-3#3)(2008-10#1)
totally quenched##2##2##(1994-9#2)
totally removed and the##3##4##(2008-7#2)(2013-7#1)
totally removed and##4##3##(2008-7#3)(2013-7#1)
totally removed##11##2##(1996-5#1)(2006-12#1)(2008-10#1)(2008-7#6)(2012-3#1)(2013-7#1)
totally reversible##2##2##(1990-2#1)(2008-10#1)
totally satisfied##2##2##(2004-11#1)(2008-8#1)
totally suppressed##4##2##(1992-1#1)(1993-7#1)(1995-7#1)(2008-5#1)
totally synthetic##4##2##(1990-9#2)(2012-11#2)
totally##221##1##(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#3)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#2)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#3)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#2)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-9#4)(1995-10#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-11#4)(1996-5#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-8#2)(2004-11#1)(2005-10#2)(2005-11#3)(2006-10#1)(2006-12#3)(2006-2#2)(2006-4#1)(2006-6#2)(2006-8#2)(2007-1#1)(2007-11#3)(2007-12#7)(2007-3#4)(2007-5#1)(2007-7#7)(2007-8#13)(2007-9#1)(2008-1#2)(2008-10#16)(2008-12#3)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#10)(2008-8#3)(2008-9#2)(2009-10#3)(2009-6#2)(2009-7#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#4)(2011-2#5)(2012-1#3)(2012-11#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)
totals##5##1##(1995-3#1)(2008-12#2)(2009-7#1)(2013-1#1)
tothe##4##1##(2008-11#3)(2008-2#1)
totipotent cells##2##2##(2008-11#1)(2008-12#1)
totipotent##3##1##(1993-2#1)(2008-11#1)(2008-12#1)
toucan##2##1##(2008-5#2)
touch and vestibular##2##3##(1995-8#2)
touch and##9##2##(1995-8#2)(2008-3#2)(2008-7#1)(2009-8#1)(2010-9#1)(2012-2#2)
touch by##3##2##(2007-5#1)(2008-12#1)(2008-9#1)
touch of##3##2##(1996-11#1)(1996-9#1)(2011-1#1)
touch or##2##2##(1990-4#1)(1996-2#1)
touch the##2##2##(2008-2#1)(2013-1#1)
touch therapy##3##2##(2008-1#1)(2013-1#2)
touch with current##3##3##(2007-10#1)(2007-12#1)(2008-11#1)
touch with##5##2##(1991-4#1)(1993-6#1)(2007-10#1)(2007-12#1)(2008-11#1)
touch##65##1##(1990-10#1)(1990-4#1)(1991-3#1)(1991-4#1)(1991-6#1)(1993-12#1)(1993-6#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-8#4)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-9#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-2#3)(2007-5#3)(2007-8#1)(2007-9#1)(2008-1#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-6#1)(2009-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
touch)##2##1##(1996-3#1)(2007-5#1)
touched by##2##2##(2008-1#1)(2008-2#1)
touched off a##2##3##(2007-8#1)(2007-9#1)
touched on##3##2##(2005-7#1)(2007-2#1)(2007-4#1)
touched upon##4##2##(1993-6#1)(1996-9#1)(2006-3#1)(2009-10#1)
touched##17##1##(1993-6#1)(1996-9#1)(1997-3#1)(2005-7#1)(2006-3#1)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-2#1)(2008-5#1)(2009-10#1)(2010-3#1)(2012-11#1)(2012-2#1)
touches##3##1##(1993-11#1)(1995-2#1)(2007-11#1)
touching##10##1##(1995-12#1)(1996-3#1)(2004-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-7#2)(2011-1#1)(2012-2#1)
touchscreen##4##1##(1994-2#1)(2011-2#2)(2012-1#1)
tough decisions##2##2##(1994-12#1)(1995-2#1)
tough##25##1##(1992-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-4#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(2005-10#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-9#2)(2008-10#1)(2008-6#2)(2008-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)
toughening of##2##2##(2007-8#1)(2009-6#1)
toughening##4##1##(2007-12#1)(2007-8#1)(2009-6#1)(2009-7#1)
toughness and defect-tolerance##3##3##(2012-2#3)
toughness and##7##2##(2004-9#3)(2012-2#3)(2013-1#1)
toughness as well as##2##4##(2004-9#1)(2009-6#1)
toughness by##3##2##(2004-9#1)(2008-8#1)(2009-7#1)
toughness in##4##2##(2004-9#1)(2008-8#1)(2010-2#1)(2010-4#1)
toughness of raw pork##2##4##(2010-2#2)
toughness of semitendinosus##3##3##(2013-1#3)
toughness of the##3##3##(2008-8#2)(2013-1#1)
toughness of##19##2##(1997-4#1)(2004-9#3)(2006-6#1)(2006-7#1)(2008-8#5)(2010-2#3)(2010-4#1)(2013-1#4)
toughness was##2##2##(2004-9#1)(2009-6#1)
toughness##54##1##(1997-4#2)(2004-9#15)(2005-10#2)(2005-11#1)(2006-6#1)(2006-7#1)(2008-8#7)(2009-6#3)(2009-7#3)(2010-2#4)(2010-4#4)(2012-2#5)(2013-1#6)
toujours##2##1##(2012-2#2)
tour##5##1##(1992-6#1)(2006-5#1)(2007-2#1)(2008-1#1)(2010-9#1)
tourism and##2##2##(2007-2#1)(2008-11#1)
tourism##11##1##(2007-12#1)(2007-2#4)(2008-11#3)(2011-1#2)(2013-1#1)
tourist destination##2##2##(2007-2#2)
tourist destinations##2##2##(2007-2#2)
tourist##14##1##(1991-12#1)(1996-9#1)(2007-2#6)(2008-5#3)(2009-4#1)(2011-2#2)
touristic##2##1##(2007-3#1)(2011-1#1)
tourists and##2##2##(1991-12#1)(2008-1#1)
tourists in##6##2##(2007-2#5)(2007-3#1)
tourists##28##1##(1991-12#1)(1997-6#1)(2007-2#23)(2007-3#1)(2008-1#1)(2009-10#1)
tournament##2##1##(1992-5#1)(2011-2#1)
tourniquet ischemia##5##2##(2006-12#5)
tourniquet time and##2##3##(2006-10#1)(2006-3#1)
tourniquet time##3##2##(2006-10#1)(2006-3#1)(2013-1#1)
tourniquet##17##1##(1992-6#2)(2006-10#1)(2006-12#6)(2006-3#1)(2008-1#1)(2008-10#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
tourniquets was##2##2##(1992-6#2)
tourniquets##3##1##(1992-6#3)
tours##6##1##(1992-12#4)(2007-2#1)(2009-6#1)
tout##3##1##(2005-7#1)(2011-2#1)(2012-2#1)
touted as##2##2##(2007-8#1)(2008-3#1)
touted##3##1##(2007-8#1)(2007-9#1)(2008-3#1)
toward B##2##2##(2008-10#2)
toward H(2)O(2)##4##2##(2008-10#1)(2010-5#1)(2013-1#2)
toward NADH##4##2##(2008-10#3)(2010-4#1)
toward Th1##2##2##(2006-10#1)(2013-7#1)
toward a common##2##3##(2005-11#1)(2009-4#1)
toward a comprehensive##2##3##(1994-2#1)(1994-6#1)
toward a global##2##3##(2008-9#1)(2010-7#1)
toward a less##2##3##(2008-2#1)(2011-1#1)
toward a model##2##3##(1996-2#1)(2006-5#1)
toward a more democratic##2##4##(2011-2#1)(2013-7#1)
toward a more rational##2##4##(1995-3#1)(2006-12#1)
toward a more##10##3##(1993-1#2)(1995-3#1)(1997-1#1)(2006-12#1)(2008-9#1)(2011-2#2)(2012-3#1)(2013-7#1)
toward a national##2##3##(1997-3#1)(2007-7#1)
toward a sociology of conflict of interest in medical research&quot##4##10##(2012-11#4)
toward a target##4##3##(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)
toward a##84##2##(1991-4#1)(1991-5#1)(1992-6#2)(1992-9#2)(1993-1#2)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-3#3)(1995-6#1)(1996-10#1)(1996-2#2)(1997-1#1)(1997-3#2)(2005-11#2)(2006-12#3)(2006-4#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-12#4)(2007-7#2)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#5)(2009-4#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-11#5)(2012-12#6)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)
toward achieving##2##2##(2006-1#1)(2008-10#1)
toward advertising##3##2##(2008-12#3)
toward an##12##2##(1994-3#1)(1995-5#1)(1996-11#1)(2007-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-2#1)
toward analysis of##2##3##(2006-6#1)(2008-10#1)
toward and##4##2##(2009-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
toward basal levels##2##3##(1990-7#1)(1995-2#1)
toward baseline##2##2##(1991-5#1)(2006-10#1)
toward better##6##2##(1990-6#1)(1995-11#1)(2006-10#1)(2008-11#1)(2009-3#1)(2012-2#1)
toward biomedical##2##2##(2006-5#1)(2008-12#1)
toward birth##2##2##(1992-5#1)(2008-7#1)
toward both##3##2##(1991-4#1)(2008-10#1)(2008-11#1)
toward breast cancer screening##2##4##(2013-1#2)
toward cancer##2##2##(2009-5#1)(2012-2#1)
toward characterizing##2##2##(1992-4#1)(2013-7#1)
toward collaborating with community pharmacists##2##5##(2011-1#2)
toward collaborating with##3##3##(2011-1#3)
toward collaboration##3##2##(2011-1#3)
toward competency##2##2##(1994-12#2)
toward complementary##2##2##(2009-1#1)(2010-4#1)
toward control##3##2##(1993-8#1)(2013-1#1)(2013-8#1)
toward copper(II)##2##2##(2005-11#1)(2008-10#1)
toward determining the##2##3##(2007-11#1)(2007-8#1)
toward developing a##2##3##(2008-10#1)(2008-6#1)
toward developing##9##2##(2007-2#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-1#1)
toward development of a##3##4##(1997-7#1)(2007-7#1)(2011-1#1)
toward development of##6##3##(1997-7#1)(2007-5#1)(2007-7#1)(2008-1#1)(2011-1#2)
toward earlier##3##2##(2006-10#1)(2006-7#1)(2006-9#1)
toward either##2##2##(2008-10#2)
toward ethnic##2##2##(2006-7#1)(2012-12#1)
toward explaining##3##2##(2007-8#1)(2007-9#2)
toward exploring##2##2##(1993-11#1)(2010-7#1)
toward extinction##2##2##(2008-8#2)
toward familiar##2##2##(2010-2#2)
toward fat##2##2##(1995-12#1)(2007-12#1)
toward female##2##2##(2008-8#1)(2009-4#1)
toward fibrinogen##2##2##(1994-6#1)(1997-2#1)
toward fluoride##4##2##(2008-10#4)
toward future##2##2##(2008-1#1)(2010-10#1)
toward global##2##2##(1997-1#1)(2008-11#1)
toward glucose##2##2##(2008-10#1)(2008-8#1)
toward greater##9##2##(1991-3#1)(1994-1#1)(1996-2#1)(1997-2#1)(2006-7#1)(2006-8#1)(2008-10#2)(2013-8#1)
toward health care##5##3##(1993-1#1)(1993-12#1)(1996-1#1)(2007-10#1)(2008-3#1)
toward health##10##2##(1993-1#1)(1993-12#1)(1996-1#1)(2007-10#1)(2008-3#1)(2009-5#1)(2012-12#1)(2012-2#1)(2013-1#2)
toward high##2##2##(1991-5#1)(2007-2#1)
toward higher##8##2##(2005-11#1)(2007-2#2)(2008-10#1)(2008-11#2)(2009-2#1)(2011-2#1)
toward homosexuals##4##2##(1993-1#3)(1995-12#1)
toward human##4##2##(1990-7#1)(1994-11#1)(2005-7#1)(2008-11#1)
toward identification of the##2##4##(2011-2#1)(2013-7#1)
toward identifying the##3##3##(1993-11#1)(1995-2#1)(1997-2#1)
toward identifying##6##2##(1990-11#1)(1993-11#1)(1995-2#1)(1997-2#1)(2006-10#1)(2008-11#1)
toward improvement in##2##3##(2006-7#1)(2008-7#1)
toward improving the##4##3##(2007-9#1)(2008-2#1)(2012-1#1)(2013-1#1)
toward improving##10##2##(1995-6#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-5#1)(2012-1#1)(2013-1#2)(2013-8#1)
toward increased##3##2##(1992-9#1)(1996-3#1)(2008-10#1)
toward inhibitors##3##2##(1993-4#1)(1994-12#1)(2008-10#1)
toward its##8##2##(1990-5#1)(1992-12#1)(1993-6#1)(2006-5#1)(2006-8#1)(2007-4#1)(2008-4#1)(2010-5#1)
toward less positive##2##3##(2008-10#2)
toward less##6##2##(1993-12#1)(1997-4#1)(2006-2#1)(2006-9#1)(2008-10#2)
toward low##2##2##(1991-5#1)(2008-11#1)
toward lower levels##2##3##(1996-3#1)(2013-1#1)
toward lower##7##2##(1995-2#1)(1996-3#1)(2005-11#1)(2008-10#1)(2008-3#1)(2011-12#1)(2013-1#1)
toward making##4##2##(1994-2#1)(1995-2#1)(1997-3#1)(2007-11#1)
toward managed care##2##3##(1995-1#1)(1997-3#1)
toward managed##3##2##(1995-1#1)(1996-1#1)(1997-3#1)
toward massage that##2##3##(2009-1#2)
toward massage##5##2##(2009-1#5)
toward more negative potentials##2##4##(1996-10#1)(2005-11#1)
toward more positive##3##3##(2005-11#1)(2008-10#1)(2009-9#1)
toward more##13##2##(1996-10#1)(2005-11#2)(2007-12#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-4#1)(2009-9#1)(2011-1#1)(2011-2#1)
toward nanotechnology##3##2##(2010-12#3)
toward natural##2##2##(1997-8#1)(2012-2#1)
toward new##5##2##(1990-11#1)(1991-3#1)(1992-6#1)(2011-2#1)(2012-11#1)
toward noninvasive##2##2##(2006-10#1)(2007-12#1)
toward normal##3##2##(1990-12#1)(1990-2#1)(2007-8#1)
toward one##2##2##(1991-3#1)(2008-10#1)
toward other##5##2##(2006-5#1)(2006-9#1)(2008-11#1)(2010-7#1)(2013-1#1)
toward outpatient##2##2##(1991-1#1)(2006-7#1)
toward parent participation##2##3##(1994-3#2)
toward partners##2##2##(2009-7#1)(2010-11#1)
toward patient##4##2##(2005-10#1)(2007-4#1)(2012-2#1)(2013-1#1)
toward personal characteristics of##2##4##(2011-2#2)
toward persons##2##2##(2006-9#1)(2007-1#1)
toward potassium##2##2##(2008-10#2)
toward preventive##2##2##(2006-5#1)(2008-11#1)
toward protein##2##2##(1993-11#1)(1994-12#1)
toward providing care##2##3##(1996-2#1)(2011-1#1)
toward providing##6##2##(1996-2#1)(2010-3#1)(2011-1#4)
toward rational##2##2##(1993-11#1)(2010-11#1)
toward real-time##2##2##(2011-7#2)
toward reducing the##2##3##(2006-10#1)(2007-7#1)
toward reducing##4##2##(2006-10#3)(2007-7#1)
toward resistance##3##2##(2008-10#3)
toward shorter##3##2##(1995-6#1)(2007-2#1)(2012-3#1)
toward some##2##2##(2007-11#1)(2010-2#1)
toward specific##4##2##(2008-10#1)(2008-7#1)(2013-7#2)
toward synthetic##2##2##(1992-11#1)(2010-7#1)
toward taking##2##2##(2009-7#1)(2011-1#1)
toward testosterone##2##2##(1992-8#1)(1994-8#1)
toward that of##2##3##(1993-6#1)(1995-6#1)
toward that##3##2##(1993-2#1)(1993-6#1)(1995-6#1)
toward the 5'-end of the modified strand##2##7##(1995-1#1)(1996-7#1)
toward the C-terminal##2##3##(1995-8#1)(2008-10#1)
toward the HCO and its services##2##6##(2011-2#2)
toward the KB cell line##2##5##(2006-12#2)
toward the application##2##3##(2008-3#1)(2012-1#1)
toward the base##2##3##(2006-5#1)(2009-2#1)
toward the cathode##2##3##(1997-8#2)
toward the cell##3##3##(1994-6#1)(1997-4#1)(2007-10#1)
toward the center of##2##4##(1996-2#1)(2013-7#1)
toward the center##3##3##(1996-2#1)(2007-1#1)(2013-7#1)
toward the creation of##2##4##(1997-2#1)(2010-7#1)
toward the development of##6##4##(2005-7#1)(2006-6#1)(2008-3#1)(2009-1#1)(2009-10#1)(2009-4#1)
toward the elderly##2##3##(1994-1#1)(2008-11#1)
toward the end of the season##3##6##(2008-10#2)(2008-8#1)
toward the end of the##6##5##(1992-12#1)(2007-11#1)(2008-10#3)(2008-8#1)
toward the end##7##3##(1992-12#1)(2007-11#1)(2008-10#3)(2008-5#1)(2008-8#1)
toward the ends of##2##4##(1996-4#1)(2008-8#1)
toward the focus##2##3##(2007-12#1)(2008-3#1)
toward the identification of##4##4##(1991-2#1)(2006-10#1)(2008-1#1)(2009-8#1)
toward the internal##2##3##(2007-12#1)(2011-2#1)
toward the major groove##2##4##(1994-5#1)(1996-7#1)
toward the nudes##2##3##(2007-5#2)
toward the oxidation of##2##4##(2008-10#2)
toward the right##3##3##(1995-4#1)(2007-8#1)(2009-2#1)
toward the substrate##2##3##(1996-7#1)(2009-9#1)
toward the synthesis of##2##4##(2008-4#1)(2008-6#1)
toward the synthesis##3##3##(2008-4#1)(2008-6#1)(2012-12#1)
toward the use of##2##4##(2007-11#1)(2007-12#1)
toward the##250##2##(1990-12#1)(1990-2#1)(1990-4#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#3)(1991-5#2)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-3#2)(1992-7#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-2#1)(1994-3#4)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#3)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-11#2)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#1)(1996-7#5)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#4)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#5)(2004-11#2)(2004-2#1)(2004-3#1)(2005-11#3)(2005-7#1)(2006-10#4)(2006-12#4)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#6)(2007-3#1)(2007-5#4)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#20)(2008-11#4)(2008-2#4)(2008-3#9)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#6)(2008-9#1)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-4#2)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#2)(2010-9#2)(2011-2#7)(2012-1#2)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#3)(2013-8#1)
toward their##15##2##(1991-3#1)(1992-12#1)(1994-3#1)(1996-2#2)(1996-7#1)(1997-4#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-3#1)
toward these##3##2##(1991-12#1)(1992-8#1)(2007-8#1)
toward thinness##2##2##(2006-7#1)(2007-12#1)
toward this goal##3##3##(1990-12#1)(2008-6#1)(2011-1#1)
toward this##11##2##(1990-12#1)(1991-1#1)(1991-3#1)(1993-4#1)(1994-1#1)(1996-1#1)(2007-8#1)(2008-3#1)(2008-6#1)(2008-9#1)(2011-1#1)
toward those##2##2##(2006-10#1)(2008-4#1)
toward three##2##2##(1992-8#1)(2013-1#1)
toward tissue##2##2##(2006-9#1)(2008-3#1)
toward treatment##3##2##(1992-1#1)(2006-10#1)(2011-1#1)
toward tumor##4##2##(2006-10#1)(2008-11#1)(2008-5#1)(2010-7#1)
toward understanding its##2##3##(1995-3#1)(2007-11#1)
toward understanding the mechanisms##3##4##(1991-12#1)(1997-6#1)(2007-11#1)
toward understanding the##9##3##(1991-12#1)(1992-11#1)(1996-7#1)(1997-1#1)(1997-6#1)(2007-11#1)(2009-7#1)(2011-2#1)(2012-2#1)
toward understanding##17##2##(1991-12#1)(1992-11#1)(1995-3#1)(1996-7#1)(1997-1#1)(1997-6#1)(2006-12#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-8#1)(2009-10#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
toward using##2##2##(2006-12#1)(2007-9#1)
toward worse##2##2##(2005-8#1)(2011-2#1)
toward younger##2##2##(1994-3#1)(1997-5#1)
toward##1195##1##(1990-10#4)(1990-11#4)(1990-12#7)(1990-2#5)(1990-3#2)(1990-4#2)(1990-5#3)(1990-6#2)(1990-7#2)(1991-1#4)(1991-11#2)(1991-12#6)(1991-2#5)(1991-3#11)(1991-4#10)(1991-5#8)(1991-6#3)(1991-7#1)(1991-9#3)(1992-1#6)(1992-10#1)(1992-11#7)(1992-12#6)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#8)(1992-9#7)(1993-1#7)(1993-11#6)(1993-12#4)(1993-2#4)(1993-3#6)(1993-4#3)(1993-6#3)(1993-8#2)(1993-9#1)(1994-1#6)(1994-11#8)(1994-12#8)(1994-2#8)(1994-3#14)(1994-5#4)(1994-6#5)(1994-8#5)(1994-9#5)(1995-1#6)(1995-10#2)(1995-11#1)(1995-12#4)(1995-2#9)(1995-3#20)(1995-4#1)(1995-5#7)(1995-6#7)(1995-8#2)(1996-1#9)(1996-10#2)(1996-11#5)(1996-12#2)(1996-2#14)(1996-3#5)(1996-4#2)(1996-5#5)(1996-7#8)(1996-8#4)(1996-9#2)(1997-1#9)(1997-2#6)(1997-3#7)(1997-4#9)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#6)(2004-11#2)(2004-2#1)(2004-3#1)(2005-10#2)(2005-11#23)(2005-7#2)(2005-8#5)(2005-9#1)(2006-1#1)(2006-10#23)(2006-11#1)(2006-12#10)(2006-2#1)(2006-3#1)(2006-4#5)(2006-5#7)(2006-6#5)(2006-7#11)(2006-8#4)(2006-9#8)(2007-1#4)(2007-10#3)(2007-11#19)(2007-12#32)(2007-2#9)(2007-3#2)(2007-4#5)(2007-5#10)(2007-7#6)(2007-8#17)(2007-9#13)(2008-1#8)(2008-10#113)(2008-11#25)(2008-12#9)(2008-2#13)(2008-3#20)(2008-4#9)(2008-5#9)(2008-6#7)(2008-7#19)(2008-8#19)(2008-9#12)(2009-1#7)(2009-10#6)(2009-11#5)(2009-12#6)(2009-2#5)(2009-3#2)(2009-4#7)(2009-5#9)(2009-6#1)(2009-7#12)(2009-8#4)(2009-9#6)(2010-1#2)(2010-10#5)(2010-11#5)(2010-12#12)(2010-2#8)(2010-3#3)(2010-4#4)(2010-5#6)(2010-6#1)(2010-7#11)(2010-8#5)(2010-9#6)(2011-1#23)(2011-12#3)(2011-2#30)(2011-3#1)(2011-7#2)(2012-1#6)(2012-11#10)(2012-12#19)(2012-2#17)(2012-3#7)(2013-1#31)(2013-7#10)(2013-8#11)
towards 2##2##2##(1997-7#1)(2008-10#1)
towards Cu(II)##3##2##(2008-10#3)
towards H(2)O(2)##2##2##(2008-10#2)
towards HIV infection##2##3##(1994-5#1)(1997-5#1)
towards HIV##5##2##(1994-4#1)(1994-5#1)(1997-5#1)(2006-2#1)(2008-1#1)
towards HIV/AIDS##2##2##(2006-8#1)(2010-8#1)
towards Hg(2+)##2##2##(2008-10#2)
towards Hg(II)##3##2##(2008-10#3)
towards V(V)##2##2##(2008-10#1)(2008-3#1)
towards a logical representation of clinical trial literature##2##8##(2013-1#2)
towards a more##5##3##(2006-10#1)(2007-11#1)(2013-1#3)
towards a new##2##3##(2007-11#1)(2013-7#1)
towards a positive##2##3##(2008-7#1)(2011-1#1)
towards a range of##2##4##(1992-9#1)(2008-1#1)
towards a##68##2##(1990-12#1)(1992-1#1)(1992-8#1)(1992-9#2)(1993-5#1)(1994-10#1)(1994-12#1)(1994-6#2)(1995-12#1)(1996-1#1)(1996-6#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#4)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-6#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#7)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
towards achieving a##2##3##(2006-11#1)(2009-7#1)
towards achieving this goal##2##4##(1994-11#1)(2008-7#1)
towards achieving##6##2##(1994-11#1)(2006-11#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-7#1)
towards acupuncture##2##2##(1993-3#1)(1997-6#1)
towards advertising##2##2##(1991-2#2)
towards alcohol##2##2##(1991-8#1)(2009-10#1)
towards all##2##2##(1994-4#1)(2006-9#1)
towards an increased##3##3##(1997-2#1)(1997-4#1)(2008-10#1)
towards an integrated##2##3##(2008-6#1)(2012-12#1)
towards an understanding of##2##4##(1993-1#1)(2005-7#1)
towards an##22##2##(1991-12#1)(1993-1#1)(1994-2#1)(1995-12#1)(1995-6#1)(1997-2#1)(1997-4#1)(2005-7#1)(2006-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#2)(2009-5#1)(2012-11#2)(2012-12#1)(2013-1#1)
towards and##5##2##(1993-12#1)(1997-6#1)(2007-7#1)(2010-4#1)(2013-1#1)
towards another##2##2##(1992-9#1)(2008-11#1)
towards autopsy##2##2##(1993-8#2)
towards better##3##2##(1991-2#1)(2008-8#1)(2010-11#1)
towards both##4##2##(1997-8#1)(2007-1#1)(2011-2#1)(2012-2#1)
towards bystander CPR##2##3##(2006-10#2)
towards cancer##3##2##(1991-2#1)(2011-12#1)(2013-8#1)
towards cell##2##2##(1996-10#1)(2011-2#1)
towards changes in##2##3##(1996-1#1)(2006-12#1)
towards clinical applications##2##3##(2008-5#1)(2010-2#1)
towards clinical##5##2##(2008-5#4)(2010-2#1)
towards common##3##2##(1995-7#1)(2008-8#1)(2010-4#1)
towards community##2##2##(2007-12#1)(2007-8#1)
towards control##2##2##(1996-9#1)(2006-10#1)
towards copper(II)##2##2##(2008-10#2)
towards critical##2##2##(2008-1#1)(2008-11#1)
towards death##3##2##(1996-6#1)(2005-12#1)(2010-7#1)
towards deeper##2##2##(2008-5#2)
towards developing a##3##3##(1994-12#1)(2009-7#1)(2012-2#1)
towards developing##7##2##(1994-12#1)(2008-10#1)(2008-11#1)(2009-4#1)(2009-7#1)(2011-1#1)(2012-2#1)
towards development of##3##3##(2006-12#1)(2008-11#1)(2008-2#1)
towards different##6##2##(1990-12#1)(1990-5#1)(2008-10#1)(2009-3#1)(2011-1#1)(2013-1#1)
towards digit sucking##2##3##(2008-10#2)
towards dissociation##2##2##(1994-9#1)(1995-11#1)
towards each##2##2##(1994-9#1)(2011-1#1)
towards early##2##2##(2006-10#1)(2010-5#1)
towards elimination of##2##3##(2008-11#1)(2011-1#1)
towards elimination##3##2##(2008-11#1)(2011-1#1)(2012-12#1)
towards equilibrium##2##2##(2008-1#1)(2008-7#1)
towards family planning##3##3##(1991-1#1)(2006-2#1)(2008-7#1)
towards further##3##2##(1991-6#1)(2005-8#1)(2012-2#1)
towards future##3##2##(1992-2#1)(2007-11#1)(2013-1#1)
towards heme##2##2##(2008-5#1)(2008-7#1)
towards high##2##2##(2008-10#1)(2008-12#1)
towards higher##6##2##(1990-2#1)(1993-9#1)(1994-6#1)(2008-5#1)(2011-2#2)
towards human##4##2##(2007-11#1)(2008-11#1)(2008-3#1)(2013-1#1)
towards hybrid molecular nanosomal compositions containing dextrazides##2##7##(2010-12#2)
towards hybrid molecular nanosomal compositions##3##5##(2010-12#3)
towards identification##2##2##(2007-7#1)(2010-12#1)
towards identifying##2##2##(2005-10#1)(2008-6#1)
towards implementing##2##2##(2011-2#1)(2012-12#1)
towards improved##4##2##(2007-11#1)(2008-6#2)(2010-3#1)
towards improvement in##3##3##(2008-3#1)(2009-3#1)(2011-2#1)
towards improvement##4##2##(2008-3#1)(2009-3#2)(2011-2#1)
towards improving##2##2##(2008-4#1)(2012-12#1)
towards in situ##2##3##(2008-10#2)
towards increase##3##2##(2008-1#1)(2012-12#1)(2013-8#1)
towards increased##3##2##(1990-10#1)(2008-10#1)(2012-6#1)
towards increasing##5##2##(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)
towards informing##2##2##(2011-2#1)(2013-8#1)
towards insulin##2##2##(1993-12#2)
towards iron supplementation in hemodialysis patients treated##2##7##(2008-1#2)
towards isolated##2##2##(1991-3#1)(1996-12#1)
towards its##4##2##(1990-4#1)(2008-9#1)(2011-2#1)(2012-3#1)
towards less##5##2##(2007-5#2)(2007-8#1)(2008-10#2)
towards lower##6##2##(1996-4#1)(1997-1#1)(1997-5#1)(2007-3#1)(2007-8#1)(2008-7#1)
towards many##2##2##(2008-10#1)(2008-11#1)
towards meeting the##2##3##(2008-12#1)(2008-5#1)
towards men##2##2##(2006-7#1)(2008-11#1)
towards mental illness and##2##4##(2008-2#1)(2011-2#1)
towards mental illness##7##3##(2008-2#1)(2008-4#2)(2011-2#4)
towards metal##2##2##(1995-12#1)(2008-10#1)
towards more##12##2##(1992-6#1)(1993-11#1)(1996-12#1)(2006-10#2)(2007-6#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-3#1)(2012-3#1)
towards neutrophils##3##2##(1991-1#3)
towards new##4##2##(1997-5#1)(2007-8#1)(2008-3#1)(2010-2#1)
towards nitrite##2##2##(2007-8#1)(2008-10#1)
towards normal##3##2##(1994-8#1)(1995-3#1)(2012-2#1)
towards novel##2##2##(1995-1#1)(2010-9#1)
towards nurses##2##2##(2013-8#2)
towards oral##2##2##(2006-2#1)(2012-2#1)
towards other##4##2##(2008-11#1)(2008-4#1)(2008-9#1)(2009-6#1)
towards our understanding of##2##4##(2011-1#1)(2013-1#1)
towards oxidation##5##2##(1990-12#4)(2006-12#1)
towards oxygen##2##2##(1993-8#1)(2008-8#1)
towards papain##2##2##(1990-2#1)(1994-12#1)
towards patients##4##2##(2007-3#1)(2008-12#1)(2010-12#1)(2011-2#1)
towards people with##3##3##(2009-11#1)(2011-2#2)
towards people##4##2##(2008-11#1)(2009-11#1)(2011-2#2)
towards performing##2##2##(2006-10#2)
towards peripheral targets##2##3##(1993-7#1)(1996-3#1)
towards personalized medicine##3##3##(2010-4#2)(2013-1#1)
towards practice##2##2##(2008-11#2)
towards prevention of##2##3##(1996-6#1)(2007-4#1)
towards prevention##3##2##(1993-11#1)(1996-6#1)(2007-4#1)
towards prostate cancer##2##3##(2008-12#1)(2008-7#1)
towards psychiatry##3##2##(1992-6#1)(2008-4#1)(2009-7#1)
towards risk##2##2##(2009-12#1)(2012-3#1)
towards scientific##2##2##(1995-6#1)(2010-2#1)
towards screening##3##2##(1992-2#2)(1994-11#1)
towards single-stranded DNA##2##3##(1992-12#1)(2008-7#1)
towards smoking##4##2##(1990-6#1)(1991-8#1)(1995-6#1)(2009-9#1)
towards some##3##2##(2007-11#1)(2008-10#2)
towards specific##2##2##(1993-8#1)(1995-8#1)
towards such##2##2##(2006-12#1)(2012-12#1)
towards surgical##3##2##(1996-12#1)(2006-10#1)(2010-11#1)
towards targeted##2##2##(2008-9#1)(2012-1#1)
towards targets##2##2##(1997-2#1)(2010-10#1)
towards the aggregation of##2##4##(1995-5#2)
towards the central##2##3##(2007-3#1)(2013-1#1)
towards the centre of the##2##5##(2007-12#1)(2010-8#1)
towards the creation of a##3##5##(2008-7#1)(2013-1#2)
towards the design of##2##4##(2006-12#1)(2007-6#1)
towards the detection of##3##4##(2008-10#2)(2008-11#1)
towards the development of a##4##5##(2005-8#1)(2006-10#1)(2008-10#1)(2008-7#1)
towards the development of##11##4##(1992-2#1)(2005-8#2)(2006-10#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)
towards the elucidation of##3##4##(1990-11#1)(1995-11#1)(2008-7#1)
towards the end of the##3##5##(1990-8#1)(1996-3#1)(2008-4#1)
towards the end of##10##4##(1990-8#1)(1995-6#1)(1996-3#1)(2006-8#1)(2008-12#1)(2008-4#1)(2009-2#1)(2009-6#1)(2013-1#2)
towards the end##11##3##(1990-8#1)(1995-6#1)(1996-3#1)(2005-9#1)(2006-8#1)(2008-12#1)(2008-4#1)(2009-2#1)(2009-6#1)(2013-1#2)
towards the goal of##5##4##(1994-9#1)(2008-10#1)(2009-4#1)(2009-9#1)(2012-2#1)
towards the identification of##3##4##(2005-7#1)(2011-2#1)(2013-1#1)
towards the identification##4##3##(1997-4#1)(2005-7#1)(2011-2#1)(2013-1#1)
towards the interpretation of##2##4##(1991-11#1)(1994-12#1)
towards the molecular##2##3##(1996-2#1)(2008-2#1)
towards the most##3##3##(1995-5#1)(1997-3#1)(2008-5#1)
towards the negative##2##3##(2008-10#1)(2009-12#1)
towards the next##2##3##(2009-10#1)(2012-2#1)
towards the oxidation of NO##2##5##(2008-10#2)
towards the oxidation of##5##4##(2008-10#5)
towards the oxidation##6##3##(2008-10#6)
towards the periphery##2##3##(1992-3#1)(2009-3#1)
towards the production of##2##4##(2005-7#1)(2011-1#1)
towards the provision of##2##4##(1992-2#1)(2008-1#1)
towards the reduction of##2##4##(2008-10#1)(2010-7#1)
towards the sacrum##2##3##(1991-8#1)(2011-2#1)
towards the side of the##2##5##(1993-5#1)(1995-12#1)
towards the study##2##3##(2009-6#1)(2010-3#1)
towards the synthesis of##3##4##(2007-11#1)(2009-5#1)(2012-2#1)
towards the two##3##3##(1993-7#1)(2008-10#1)(2008-5#1)
towards the use of##2##4##(2007-7#1)(2008-2#1)
towards the use##3##3##(2007-7#2)(2008-2#1)
towards the##294##2##(1990-11#2)(1990-3#2)(1990-4#2)(1990-5#2)(1990-6#1)(1990-8#2)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#4)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#3)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#3)(1994-3#1)(1994-6#2)(1994-8#4)(1994-9#3)(1995-11#3)(1995-12#3)(1995-3#2)(1995-5#4)(1995-6#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#3)(1997-4#1)(1997-7#1)(1997-8#1)(2005-7#3)(2005-8#2)(2005-9#1)(2006-10#3)(2006-12#5)(2006-2#2)(2006-4#2)(2006-5#1)(2006-8#4)(2007-10#1)(2007-11#4)(2007-12#8)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#27)(2008-11#7)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#3)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-3#3)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#11)(2012-1#4)(2012-11#2)(2012-12#6)(2012-2#6)(2012-3#3)(2013-1#14)(2013-7#1)(2013-8#7)
towards their children##2##3##(2004-12#1)(2009-10#1)
towards their stable body weight##2##5##(2008-3#2)
towards their##16##2##(1990-6#1)(1991-9#1)(1993-12#2)(2004-12#1)(2006-12#1)(2006-2#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-10#1)(2010-3#2)(2012-1#1)
towards them##8##2##(2006-12#1)(2008-11#1)(2011-2#5)(2012-2#1)
towards these products##2##3##(2006-8#2)
towards these##4##2##(1991-1#1)(1995-7#1)(2006-8#2)
towards thiol##2##2##(1993-3#1)(2008-10#1)
towards this antimicrobial class##2##4##(2010-11#2)
towards this direction##2##3##(2012-2#2)
towards this##14##2##(1991-5#1)(1992-9#1)(1995-7#1)(2005-7#1)(2007-7#1)(2007-8#1)(2008-11#1)(2010-11#2)(2012-12#1)(2012-2#3)(2013-8#1)
towards to##2##2##(1990-12#1)(2010-7#1)
towards training##2##2##(2007-11#2)
towards treatment##2##2##(1993-1#1)(1997-3#1)
towards tumor##2##2##(2007-1#1)(2010-2#1)
towards understanding the##4##3##(2006-10#1)(2009-2#1)(2009-5#1)(2012-11#1)
towards understanding##10##2##(1995-4#1)(1997-6#1)(2006-10#1)(2007-9#1)(2008-10#1)(2009-2#1)(2009-5#1)(2011-1#1)(2012-11#1)(2012-2#1)
towards using##2##2##(1996-4#1)(2007-11#1)
towards various##4##2##(1996-5#1)(1997-6#1)(2007-11#1)(2008-10#1)
towards working##2##2##(2006-10#1)(2007-8#1)
towards##1273##1##(1990-10#2)(1990-11#3)(1990-12#10)(1990-2#3)(1990-3#2)(1990-4#3)(1990-5#4)(1990-6#4)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#5)(1991-11#2)(1991-12#5)(1991-2#9)(1991-3#7)(1991-4#3)(1991-5#3)(1991-6#3)(1991-8#4)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#10)(1992-3#2)(1992-5#2)(1992-6#4)(1992-7#2)(1992-8#5)(1992-9#8)(1993-1#2)(1993-10#1)(1993-11#4)(1993-12#6)(1993-2#2)(1993-3#10)(1993-4#3)(1993-5#3)(1993-7#2)(1993-8#5)(1993-9#3)(1994-10#1)(1994-11#6)(1994-12#9)(1994-2#3)(1994-3#4)(1994-4#3)(1994-5#2)(1994-6#7)(1994-8#8)(1994-9#9)(1995-1#3)(1995-11#4)(1995-12#7)(1995-3#7)(1995-4#1)(1995-5#5)(1995-6#6)(1995-7#7)(1995-8#3)(1995-9#2)(1996-1#4)(1996-10#2)(1996-11#2)(1996-12#7)(1996-2#2)(1996-3#5)(1996-4#4)(1996-5#4)(1996-6#5)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#3)(1997-3#4)(1997-4#2)(1997-5#4)(1997-6#4)(1997-7#4)(1997-8#5)(2004-12#1)(2004-2#1)(2005-1#2)(2005-10#3)(2005-11#3)(2005-12#1)(2005-7#5)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#32)(2006-11#2)(2006-12#23)(2006-2#9)(2006-4#3)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#11)(2006-9#1)(2007-1#4)(2007-10#2)(2007-11#23)(2007-12#17)(2007-2#6)(2007-3#10)(2007-4#2)(2007-5#4)(2007-6#3)(2007-7#12)(2007-8#20)(2007-9#7)(2008-1#19)(2008-10#121)(2008-11#39)(2008-12#10)(2008-2#10)(2008-3#11)(2008-4#15)(2008-5#22)(2008-6#9)(2008-7#42)(2008-8#20)(2008-9#14)(2009-1#1)(2009-10#8)(2009-11#3)(2009-12#7)(2009-2#4)(2009-3#5)(2009-4#7)(2009-5#6)(2009-6#8)(2009-7#5)(2009-8#4)(2009-9#4)(2010-1#1)(2010-10#6)(2010-11#7)(2010-12#12)(2010-2#8)(2010-3#11)(2010-4#7)(2010-5#7)(2010-7#7)(2010-8#7)(2010-9#4)(2011-1#24)(2011-12#5)(2011-2#50)(2011-3#3)(2012-1#8)(2012-11#14)(2012-12#30)(2012-2#29)(2012-3#17)(2012-6#1)(2013-1#54)(2013-7#4)(2013-8#21)
towel##2##1##(1992-3#1)(2008-5#1)
towels##5##1##(1992-2#1)(2007-7#1)(2008-11#1)(2008-4#1)(2009-6#1)
tower##8##1##(2007-1#1)(2008-10#1)(2008-12#1)(2008-5#3)(2011-1#1)(2011-2#1)
towers##7##1##(2006-10#1)(2007-4#1)(2008-10#1)(2008-5#2)(2008-8#2)
towhees##4##1##(2013-1#4)
town and##2##2##(1990-2#1)(1996-8#1)
town from##2##2##(2008-11#1)(2011-2#1)
town in##4##2##(2006-4#1)(2007-10#1)(2008-4#1)(2008-7#1)
town of Cabar##6##3##(2011-2#6)
town of##23##2##(1994-11#1)(1995-1#1)(1995-11#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-11#1)(2011-2#8)(2012-12#1)
town##55##1##(1990-2#1)(1990-6#1)(1991-8#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-11#1)(1996-3#1)(1996-8#1)(2005-11#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-10#3)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#2)(2009-4#1)(2010-11#1)(2011-2#13)(2012-12#3)(2013-8#1)
towns and##5##2##(1992-8#2)(2007-2#1)(2008-11#1)(2008-5#1)
towns in##2##2##(2008-9#1)(2013-8#1)
towns or##2##2##(2007-5#1)(2012-3#1)
towns##22##1##(1992-8#2)(1993-10#1)(1993-2#1)(1994-2#1)(1994-9#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#2)(2009-7#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
township and##2##2##(2007-7#1)(2013-8#1)
township in##4##2##(2009-4#1)(2012-12#1)(2013-8#2)
township near##2##2##(1994-10#1)(2007-7#1)
township##13##1##(1994-10#1)(2007-2#1)(2007-7#3)(2008-7#1)(2009-4#3)(2012-12#1)(2013-8#3)
townships##6##1##(1993-7#1)(1997-4#1)(2007-7#2)(2011-1#2)
townsvillensis##3##1##(2004-11#3)
tows##2##1##(2011-2#2)
tox(-)##3##1##(2008-10#3)
toxA and utxA##2##3##(1990-11#2)
toxA and##3##2##(1990-11#3)
toxA transcription##3##2##(1995-2#3)
toxA##17##1##(1990-11#4)(1995-2#11)(1995-6#1)(2008-5#1)
toxaemia##3##1##(1996-3#1)(2004-10#1)(2013-1#1)
toxemia##2##1##(2007-9#1)(2008-12#1)
toxic accumulation of##4##3##(1990-5#1)(1992-11#1)(2007-12#1)(2008-4#1)
toxic action of##6##3##(1992-11#1)(1996-8#1)(2004-12#2)(2008-10#1)(2010-2#1)
toxic action##8##2##(1992-11#1)(1992-8#1)(1996-8#1)(2004-12#2)(2007-11#1)(2008-10#1)(2010-2#1)
toxic activities##5##2##(1994-12#3)(2008-10#1)(2008-5#1)
toxic activity of##2##3##(1994-2#1)(2008-12#1)
toxic activity##6##2##(1992-3#1)(1994-12#1)(1994-2#1)(2008-10#1)(2008-12#1)(2008-6#1)
toxic adenoma##4##2##(2006-11#4)
toxic against##2##2##(2010-12#1)(2012-2#1)
toxic agent##2##2##(2006-7#1)(2008-11#1)
toxic agents##9##2##(1990-4#1)(1991-9#1)(1994-5#1)(1995-4#1)(2006-7#1)(2007-7#1)(2008-11#1)(2008-5#1)(2011-1#1)
toxic air pollutants##2##3##(2008-11#1)(2010-9#1)
toxic alkaloids##2##2##(2004-2#1)(2007-8#1)
toxic and essential elements in paired##2##6##(2010-5#2)
toxic and essential elements##3##4##(2008-10#1)(2010-5#2)
toxic and persistent##2##3##(2008-10#1)(2011-12#1)
toxic and##27##2##(1990-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1994-11#1)(1994-12#1)(2005-8#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-5#2)(2008-8#1)(2008-9#1)(2009-2#1)(2010-5#2)(2011-12#1)(2012-11#1)
toxic arsenic##3##2##(2008-10#3)
toxic by-products##2##2##(2008-11#1)(2009-10#1)
toxic chemical##3##2##(2005-11#1)(2008-10#1)(2008-6#1)
toxic chemicals##7##2##(1994-8#1)(1997-3#1)(2006-7#1)(2008-11#3)(2011-1#1)
toxic compared##2##2##(1993-3#1)(2010-8#1)
toxic components##2##2##(1996-11#1)(2008-7#1)
toxic compounds having##2##3##(2008-11#2)
toxic compounds in##3##3##(2007-10#1)(2007-11#1)(2008-10#1)
toxic compounds##17##2##(1997-4#1)(2004-4#1)(2006-10#1)(2006-2#1)(2007-10#2)(2007-11#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-5#1)(2008-8#1)
toxic concentrations of##2##3##(2007-5#1)(2010-4#1)
toxic concentrations##3##2##(1993-9#1)(2007-5#1)(2010-4#1)
toxic contaminants##2##2##(2007-10#1)(2008-10#1)
toxic damage##2##2##(1992-4#1)(2010-8#1)
toxic deaths##4##2##(1991-9#1)(1992-6#1)(2004-1#1)(2008-6#1)
toxic doses##3##2##(1990-4#1)(1994-5#1)(1996-12#1)
toxic drug##2##2##(1992-1#1)(2008-3#1)
toxic drugs##3##2##(2006-12#1)(2007-9#1)(2012-12#1)
toxic effect in the##2##4##(2008-5#1)(2010-2#1)
toxic effect of##17##3##(1990-7#1)(1991-8#1)(1992-6#1)(1993-12#1)(1993-5#1)(1997-3#1)(1997-5#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-2#1)(2011-12#1)(2012-1#1)(2012-3#1)(2013-1#1)
toxic effect on##5##3##(2008-10#1)(2008-4#1)(2010-10#1)(2012-1#1)(2013-1#1)
toxic effect##30##2##(1990-11#1)(1990-7#1)(1991-12#1)(1991-8#1)(1992-6#1)(1993-12#1)(1993-5#1)(1997-3#1)(1997-5#1)(2005-10#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2010-10#1)(2010-12#2)(2010-2#2)(2011-12#1)(2012-1#3)(2012-3#1)(2013-1#2)
toxic effects and##3##3##(2006-10#1)(2006-4#1)(2008-8#1)
toxic effects are##2##3##(1997-3#1)(2008-6#1)
toxic effects caused by##2##4##(2008-7#1)(2010-4#1)
toxic effects in##4##3##(1991-2#1)(1991-6#1)(1992-3#1)(1997-8#1)
toxic effects of##37##3##(1990-4#1)(1990-5#2)(1991-9#2)(1992-8#1)(1993-9#2)(1994-5#2)(1995-11#1)(1995-12#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-8#1)(2005-10#1)(2005-8#1)(2006-12#1)(2006-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-6#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
toxic effects on the##5##4##(1993-12#1)(1994-6#1)(2004-2#1)(2012-12#1)(2013-1#1)
toxic effects on##11##3##(1992-2#1)(1993-12#1)(1994-6#1)(1995-5#1)(1996-3#1)(2004-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
toxic effects##93##2##(1990-4#1)(1990-5#2)(1991-2#1)(1991-6#1)(1991-9#2)(1992-2#1)(1992-3#3)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-9#2)(1994-5#2)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#2)(1995-5#1)(1995-6#1)(1995-8#3)(1996-1#1)(1996-10#3)(1996-3#1)(1996-8#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-2#1)(2005-10#2)(2005-8#1)(2006-10#1)(2006-12#2)(2006-2#2)(2006-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-6#1)(2010-12#2)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-6#1)(2013-1#3)
toxic elements##6##2##(2008-10#2)(2008-5#1)(2009-6#2)(2010-8#1)
toxic epidermal necrolysis (TEN)##2##4##(2007-7#1)(2007-8#1)
toxic epidermal necrolysis##7##3##(1991-10#1)(1992-2#1)(2007-7#2)(2007-8#2)(2010-12#1)
toxic epidermal##8##2##(1991-10#1)(1992-2#1)(2005-11#1)(2007-7#2)(2007-8#2)(2010-12#1)
toxic equivalent##2##2##(2008-10#2)
toxic equivalents (TEQ)##2##3##(2008-10#2)
toxic equivalents##3##2##(2008-10#3)
toxic for the##2##3##(1991-9#1)(2008-10#1)
toxic for##5##2##(1991-9#1)(1992-12#1)(2007-11#1)(2008-10#1)(2008-4#1)
toxic form of##3##3##(2008-10#2)(2012-3#1)
toxic fraction##3##2##(2008-10#3)
toxic free##2##2##(2008-10#1)(2009-10#1)
toxic function##2##2##(1990-11#1)(2013-8#1)
toxic gas##4##2##(1996-11#1)(1996-12#3)
toxic gases##6##2##(1996-12#6)
toxic gene##3##2##(1990-5#1)(1996-10#1)(2008-6#1)
toxic goitre##2##2##(1990-9#2)
toxic hepatitis##3##2##(2005-12#1)(2010-12#1)(2012-1#1)
toxic in the##2##3##(1990-6#1)(1996-8#1)
toxic in##7##2##(1990-6#1)(1991-8#1)(1995-7#1)(1995-8#1)(1996-8#1)(2005-10#1)(2010-11#1)
toxic insults##3##2##(1995-10#1)(2005-7#1)(2011-12#1)
toxic lesions##3##2##(2008-1#3)
toxic levels of##2##3##(1997-3#1)(2008-5#1)
toxic levels##4##2##(1997-3#1)(2008-11#1)(2008-3#1)(2008-5#1)
toxic metabolic##2##2##(2007-9#1)(2008-5#1)
toxic metabolite##6##2##(1991-9#1)(1997-3#1)(2008-10#4)
toxic metal##6##2##(2007-8#1)(2008-10#4)(2009-7#1)
toxic metals in##4##3##(1992-6#2)(2008-10#2)
toxic metals##14##2##(1992-6#3)(1997-4#1)(2007-9#1)(2008-10#4)(2008-5#1)(2010-11#1)(2010-5#1)(2011-1#2)
toxic microcystin##2##2##(2007-8#1)(2008-10#1)
toxic myopathy##2##2##(2006-10#2)
toxic nature of##3##3##(2006-9#1)(2008-10#1)(2013-7#1)
toxic neuropathy##2##2##(2008-2#1)(2011-1#1)
toxic of##2##2##(2007-11#1)(2008-10#1)
toxic oil syndrome (TOS)##2##4##(2008-10#2)
toxic oil syndrome##3##3##(2008-10#3)
toxic oil##4##2##(1995-5#1)(2008-10#3)
toxic only##3##2##(1992-12#1)(2008-10#1)(2009-2#1)
toxic or##11##2##(1992-1#1)(1997-3#1)(2004-2#1)(2004-4#1)(2005-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#2)(2010-2#1)
toxic organic compounds##2##3##(1993-4#1)(2008-7#1)
toxic organic##3##2##(1993-4#1)(2008-7#1)(2011-1#1)
toxic oxygen species##2##3##(1991-9#1)(1997-2#1)
toxic oxygen##4##2##(1991-9#2)(1992-12#1)(1997-2#1)
toxic phytoplankton##2##2##(1992-8#1)(2009-8#1)
toxic potency##5##2##(1996-12#5)
toxic products##4##2##(1995-3#1)(2007-11#2)(2008-10#1)
toxic protein isolated from##2##4##(1992-3#1)(1995-11#1)
toxic protein##4##2##(1992-3#2)(1995-11#1)(1995-12#1)
toxic residues##2##2##(2006-5#1)(2008-10#1)
toxic retinopathy##2##2##(2008-3#1)(2012-12#1)
toxic shock syndrome toxin-1##2##4##(1997-2#2)
toxic shock syndrome##17##3##(1993-6#1)(1995-2#1)(1997-2#2)(2006-10#4)(2006-12#1)(2006-4#3)(2007-12#1)(2009-9#1)(2011-1#1)(2011-2#2)
toxic shock##19##2##(1993-3#1)(1993-6#1)(1995-2#1)(1997-2#2)(2006-10#4)(2006-12#1)(2006-4#3)(2007-11#1)(2007-12#1)(2009-9#1)(2011-1#1)(2011-2#2)
toxic side effects##6##3##(1994-3#1)(1994-6#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-2#1)
toxic side##7##2##(1990-10#1)(1994-3#1)(1994-6#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-2#1)
toxic side-effects##2##2##(2008-1#1)(2008-3#1)
toxic solvents##2##2##(2007-11#1)(2010-4#1)
toxic species in##2##3##(2010-8#1)(2012-1#1)
toxic species of##2##3##(2008-10#1)(2011-2#1)
toxic species##6##2##(1996-12#1)(2008-10#2)(2010-8#1)(2011-2#1)(2012-1#1)
toxic substances in the##2##4##(2007-11#1)(2013-8#1)
toxic substances in##3##3##(2007-11#1)(2008-5#1)(2013-8#1)
toxic substances##21##2##(1992-2#1)(1992-6#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#8)(2008-5#1)(2010-7#1)(2011-1#1)(2013-8#1)
toxic than MC##2##3##(1996-6#2)
toxic than##22##2##(1990-10#1)(1990-5#1)(1990-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1994-5#2)(1996-4#1)(1996-6#2)(2004-2#1)(2007-11#2)(2007-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2013-1#1)
toxic therapies##2##2##(2005-8#1)(2010-5#1)
toxic thyroid##4##2##(2006-10#2)(2008-4#2)
toxic to a##2##3##(1996-9#1)(2008-10#1)
toxic to all##2##3##(2006-10#1)(2008-11#1)
toxic to bradyrhizobia##2##3##(2008-5#2)
toxic to cultured##3##3##(1990-7#1)(1997-2#1)(2012-3#1)
toxic to microsclerotia##2##3##(2008-10#2)
toxic to the host cells##2##5##(1991-3#1)(1997-1#1)
toxic to the host##3##4##(1991-3#1)(1991-9#1)(1997-1#1)
toxic to the##14##3##(1990-3#1)(1991-3#1)(1991-9#1)(1996-12#1)(1996-6#2)(1997-1#1)(2004-9#1)(2008-1#2)(2008-10#1)(2008-7#2)(2008-8#1)
toxic to##56##2##(1990-3#1)(1990-5#2)(1990-7#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-12#1)(1993-12#1)(1994-5#1)(1995-10#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-6#3)(1996-9#1)(1997-1#1)(1997-2#2)(2004-9#1)(2006-10#2)(2007-11#1)(2007-6#1)(2008-1#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-5#6)(2008-7#4)(2008-8#1)(2012-3#1)(2013-1#1)
toxic trace##3##2##(2008-10#2)(2008-6#1)
toxic waste##2##2##(2007-8#1)(2008-12#1)
toxic wastes##3##2##(1990-3#1)(1994-11#1)(2009-6#1)
toxic##769##1##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#3)(1990-5#9)(1990-6#2)(1990-7#2)(1990-9#2)(1991-10#1)(1991-11#2)(1991-12#5)(1991-2#1)(1991-3#4)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#6)(1991-9#11)(1992-1#4)(1992-10#1)(1992-11#3)(1992-12#5)(1992-2#3)(1992-3#8)(1992-4#1)(1992-5#1)(1992-6#6)(1992-7#1)(1992-8#5)(1993-11#3)(1993-12#4)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#3)(1994-11#3)(1994-12#5)(1994-2#3)(1994-3#3)(1994-5#7)(1994-6#5)(1994-8#2)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#1)(1995-7#2)(1995-8#6)(1995-9#1)(1996-1#1)(1996-10#6)(1996-11#3)(1996-12#23)(1996-3#4)(1996-4#2)(1996-5#1)(1996-6#5)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#6)(1997-3#10)(1997-4#6)(1997-5#1)(1997-7#1)(1997-8#1)(2004-1#1)(2004-12#2)(2004-2#5)(2004-4#2)(2004-9#1)(2005-10#5)(2005-11#5)(2005-12#1)(2005-6#1)(2005-7#1)(2005-8#9)(2006-10#15)(2006-11#4)(2006-12#12)(2006-2#4)(2006-4#6)(2006-5#2)(2006-6#2)(2006-7#4)(2006-8#3)(2006-9#2)(2007-1#3)(2007-10#5)(2007-11#18)(2007-12#3)(2007-3#2)(2007-5#3)(2007-6#4)(2007-7#6)(2007-8#13)(2007-9#5)(2008-1#10)(2008-10#109)(2008-11#27)(2008-12#9)(2008-2#3)(2008-3#6)(2008-4#8)(2008-5#27)(2008-6#8)(2008-7#21)(2008-8#11)(2008-9#4)(2009-10#2)(2009-12#1)(2009-2#2)(2009-6#4)(2009-7#1)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#8)(2010-2#5)(2010-4#5)(2010-5#5)(2010-7#6)(2010-8#5)(2010-9#1)(2011-1#12)(2011-12#6)(2011-2#14)(2012-1#5)(2012-11#2)(2012-12#7)(2012-2#6)(2012-3#4)(2012-6#1)(2013-1#15)(2013-7#2)(2013-8#3)
toxic&quot##2##1##(2006-10#1)(2008-7#1)
toxicant effects##2##2##(2008-9#1)(2012-12#1)
toxicant exposure##3##2##(2008-10#1)(2008-9#1)(2012-12#1)
toxicant suppressants##3##2##(1996-12#3)
toxicant to##2##2##(2008-9#1)(2011-1#1)
toxicant##24##1##(1993-3#1)(1993-4#1)(1993-7#1)(1996-12#3)(1997-2#1)(2005-7#1)(2008-10#5)(2008-9#4)(2010-2#2)(2011-1#1)(2012-12#4)
toxicants and##4##2##(1996-12#1)(1997-3#1)(2012-12#1)(2012-2#1)
toxicants are##3##2##(1996-12#2)(2008-11#1)
toxicants in##4##2##(2008-10#3)(2008-8#1)
toxicants##36##1##(1991-11#1)(1994-5#1)(1995-1#1)(1995-11#1)(1996-12#4)(1997-3#1)(2004-4#1)(2008-10#5)(2008-11#3)(2008-7#2)(2008-8#1)(2008-9#1)(2010-10#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-9#1)(2012-12#3)(2012-2#5)
toxicities and##9##2##(1991-12#1)(1993-12#1)(1994-5#1)(1995-1#1)(2007-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-3#1)
toxicities are##2##2##(2007-11#2)
toxicities associated with##4##3##(2009-11#1)(2009-3#1)(2011-2#1)(2013-1#1)
toxicities of chemotherapy##2##3##(2008-7#1)(2009-7#1)
toxicities of the##3##3##(2007-11#1)(2008-3#1)(2008-6#1)
toxicities of##15##2##(2005-7#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-2#1)(2009-7#1)(2010-1#1)(2011-2#1)(2012-12#1)
toxicities recorded during##2##3##(2008-10#2)
toxicities to##2##2##(1993-11#1)(2007-11#1)
toxicities were##13##2##(1990-12#1)(1991-4#1)(1995-1#1)(1997-2#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-6#2)(2008-7#2)(2011-2#2)
toxicities##105##1##(1990-12#1)(1990-5#1)(1991-12#4)(1991-4#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-7#2)(1997-2#2)(2004-1#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-11#8)(2007-12#2)(2007-2#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-3#3)(2008-5#6)(2008-6#9)(2008-7#11)(2008-8#5)(2009-11#2)(2009-2#2)(2009-3#2)(2009-7#1)(2010-1#1)(2010-12#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)
toxicity after##3##2##(1994-5#1)(2005-9#1)(2012-2#1)
toxicity against Aedes aegypti##2##4##(2006-12#1)(2008-5#1)
toxicity against dopaminergic##3##3##(2008-7#3)
toxicity against normal##3##3##(2012-12#3)
toxicity against##11##2##(1995-5#1)(2006-12#1)(2008-11#1)(2008-5#1)(2008-7#4)(2012-12#3)
toxicity and Ca depletion##2##4##(2009-6#2)
toxicity and a##2##3##(2008-5#1)(2013-1#1)
toxicity and benthic community condition##2##5##(2012-1#2)
toxicity and carcinogenicity##5##3##(1997-2#1)(1997-3#1)(2008-8#1)(2008-9#2)
toxicity and clearance##2##3##(2009-10#2)
toxicity and efficacy##2##3##(2007-2#1)(2013-1#1)
toxicity and high##2##3##(2011-2#1)(2012-2#1)
toxicity and lethality (LD(50))##2##4##(2010-12#2)
toxicity and mortality##2##3##(2006-6#1)(2008-7#1)
toxicity and no##2##3##(2006-6#1)(2010-2#1)
toxicity and pharmacokinetics##2##3##(1996-8#1)(2005-8#1)
toxicity and repellency##2##3##(2011-2#2)
toxicity and the##5##3##(2005-11#1)(2006-2#1)(2008-9#1)(2012-2#1)(2013-1#1)
toxicity and therapeutic efficacy##2##4##(1994-11#1)(2007-11#1)
toxicity and##106##2##(1991-3#1)(1992-4#1)(1994-11#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-8#2)(1997-2#4)(1997-3#1)(1997-6#1)(2004-2#1)(2004-4#2)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#6)(2007-2#2)(2008-10#5)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#6)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#2)(2009-6#2)(2009-8#1)(2010-12#4)(2010-2#2)(2010-4#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#8)
toxicity and/or##4##2##(1997-1#1)(2008-8#1)(2009-3#1)(2011-2#1)
toxicity are##9##2##(1990-12#1)(1991-2#1)(1996-8#2)(2005-10#1)(2006-6#1)(2008-4#1)(2008-8#1)(2011-2#1)
toxicity as##4##2##(1995-12#1)(2006-10#1)(2008-10#2)
toxicity assays##3##2##(2006-10#1)(2006-5#1)(2008-10#1)
toxicity assessment##12##2##(1996-12#2)(2007-8#2)(2008-10#5)(2008-12#1)(2008-5#1)(2013-8#1)
toxicity associated with##11##3##(1990-5#1)(1995-1#1)(2005-9#1)(2006-10#1)(2007-11#3)(2008-6#1)(2008-9#2)(2012-1#1)
toxicity at low##3##3##(2008-12#2)(2008-7#1)
toxicity at the##2##3##(1993-1#1)(2008-10#1)
toxicity at##8##2##(1993-1#1)(2008-10#1)(2008-12#2)(2008-7#1)(2010-10#1)(2013-1#2)
toxicity between##3##2##(2005-7#1)(2009-8#1)(2012-3#1)
toxicity but##6##2##(1990-11#1)(1993-6#1)(1994-3#1)(1994-5#1)(2008-8#1)(2009-12#1)
toxicity by##11##2##(1991-3#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-5#1)(1995-9#1)(1997-3#1)(2004-11#1)(2008-7#2)(2010-8#1)
toxicity can be##2##3##(2008-3#1)(2011-2#1)
toxicity can##4##2##(1995-1#1)(2006-4#1)(2008-3#1)(2011-2#1)
toxicity compared to##2##3##(1995-10#1)(1996-8#1)
toxicity concerns##3##2##(2008-5#2)(2008-7#1)
toxicity could be##2##3##(1992-11#1)(2008-8#1)
toxicity could##5##2##(1992-11#1)(1995-3#1)(2008-11#1)(2008-8#1)(2011-2#1)
toxicity data##5##2##(1993-3#1)(1997-6#1)(2007-5#1)(2008-12#1)(2008-5#1)
toxicity due to##5##3##(1992-2#1)(1992-5#1)(1996-7#1)(2012-2#1)(2012-7#1)
toxicity during induction##2##3##(2008-10#2)
toxicity during##5##2##(1993-6#1)(2008-10#4)
toxicity effect##2##2##(2006-5#1)(2008-12#1)
toxicity effects##2##2##(1994-11#1)(2008-3#1)
toxicity endpoints##2##2##(2008-10#2)
toxicity experiment##2##2##(1997-3#1)(1997-4#1)
toxicity following##2##2##(2004-10#1)(2010-1#1)
toxicity for##9##2##(1991-9#1)(1995-3#2)(1997-1#1)(1997-7#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-11#1)
toxicity from##6##2##(1991-9#1)(2006-10#1)(2008-7#1)(2010-2#1)(2011-1#1)(2012-11#1)
toxicity has been##5##3##(1991-12#1)(1993-12#1)(2006-10#1)(2010-1#1)(2011-2#1)
toxicity has##6##2##(1991-12#1)(1993-12#1)(1996-8#1)(2006-10#1)(2010-1#1)(2011-2#1)
toxicity in a##5##3##(1992-11#1)(2007-12#1)(2007-4#1)(2013-1#2)
toxicity in aquatic##2##3##(2008-7#1)(2011-12#1)
toxicity in cultured human##2##4##(1992-11#1)(2008-11#1)
toxicity in cultured##3##3##(1992-11#1)(1992-3#1)(2008-11#1)
toxicity in human##2##3##(2010-7#1)(2013-1#1)
toxicity in humans is##2##4##(2006-10#1)(2008-5#1)
toxicity in islet cells##2##4##(1994-3#2)
toxicity in male##2##3##(1993-12#1)(2011-2#1)
toxicity in mice##4##3##(1993-4#1)(1996-10#1)(2008-10#1)(2013-1#1)
toxicity in patients with##5##4##(1991-12#1)(2004-1#1)(2006-10#1)(2013-1#2)
toxicity in patients##7##3##(1991-10#1)(1991-12#1)(2004-1#1)(2006-10#1)(2008-10#1)(2013-1#2)
toxicity in rat##2##3##(1995-12#1)(2008-8#1)
toxicity in rats##6##3##(1993-12#1)(1995-3#2)(2008-10#1)(2011-2#2)
toxicity in the##17##3##(1991-9#1)(1992-11#1)(1993-12#1)(1994-3#2)(1995-7#1)(2005-7#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2009-5#1)(2009-6#1)(2010-8#1)(2011-12#1)(2011-2#1)(2013-1#1)
toxicity in vitro##6##3##(1995-10#1)(2006-5#1)(2006-7#1)(2008-5#1)(2013-1#1)(2013-8#1)
toxicity in##91##2##(1990-3#1)(1991-10#1)(1991-12#1)(1991-9#1)(1992-11#3)(1992-3#1)(1992-8#1)(1993-12#3)(1993-4#1)(1993-6#1)(1994-3#5)(1995-10#1)(1995-12#1)(1995-3#2)(1995-7#1)(1996-10#1)(1997-4#1)(2004-1#1)(2004-9#1)(2005-7#2)(2005-8#1)(2006-10#5)(2006-5#1)(2006-7#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-12#2)(2011-2#5)(2012-1#2)(2013-1#11)(2013-8#1)
toxicity induced by drugs##2##4##(2009-2#1)(2012-1#1)
toxicity induced by##11##3##(1992-8#1)(1994-5#1)(1997-4#1)(2009-2#3)(2009-4#2)(2010-12#1)(2012-1#1)(2013-1#1)
toxicity induced##12##2##(1992-8#1)(1994-5#1)(1997-4#1)(2008-10#1)(2009-2#3)(2009-4#2)(2010-12#1)(2012-1#1)(2013-1#1)
toxicity is a##4##3##(1996-12#1)(1996-8#1)(2007-9#1)(2008-6#1)
toxicity is an##2##3##(2005-10#1)(2009-8#1)
toxicity is not##3##3##(1995-8#1)(1996-8#1)(2010-5#1)
toxicity is the##3##3##(1995-1#1)(2013-1#2)
toxicity is##33##2##(1990-4#1)(1991-12#1)(1994-11#1)(1995-1#1)(1995-8#1)(1996-12#1)(1996-8#3)(2005-10#1)(2005-7#1)(2006-10#1)(2006-4#2)(2006-8#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#3)
toxicity level##5##2##(2008-10#4)(2013-7#1)
toxicity makes##3##2##(1994-6#1)(1997-1#1)(2008-7#1)
toxicity may##6##2##(1990-5#1)(1994-11#1)(1995-8#1)(1996-8#2)(2006-10#1)
toxicity normally##2##2##(1995-10#1)(2007-11#1)
toxicity occurred in##2##3##(2006-10#1)(2011-2#1)
toxicity of 2##2##3##(2006-5#1)(2008-5#1)
toxicity of HEPALIP FORTE in rats##2##6##(2005-10#2)
toxicity of MC##2##3##(1996-6#2)
toxicity of MTBE##2##3##(2008-12#2)
toxicity of PAHs to##2##4##(2004-4#2)
toxicity of PAHs##4##3##(2004-4#4)
toxicity of a novel##2##4##(1994-5#1)(2006-6#1)
toxicity of a weathered oil##2##5##(2008-11#2)
toxicity of a##14##3##(1990-2#1)(1991-8#1)(1992-3#1)(1993-11#1)(1994-5#1)(2006-5#1)(2006-6#2)(2007-10#1)(2008-10#1)(2008-11#2)(2008-12#1)(2011-2#1)
toxicity of acetaminophen##2##3##(1991-9#1)(2007-12#1)
toxicity of aromatic nitrocompounds##2##4##(1995-8#2)
toxicity of cadmium to##2##4##(2011-12#2)
toxicity of cadmium##5##3##(1993-12#1)(1993-4#1)(2008-7#1)(2011-12#2)
toxicity of cancer##4##3##(2005-11#1)(2006-10#1)(2011-1#2)
toxicity of capecitabine##2##3##(2008-7#2)
toxicity of certain##2##3##(2008-10#1)(2008-9#1)
toxicity of dental resin composite##2##5##(2013-1#2)
toxicity of docetaxel##3##3##(2008-10#1)(2008-6#2)
toxicity of gold##5##3##(1994-5#4)(2010-12#1)
toxicity of lead##2##3##(1997-2#1)(1997-4#1)
toxicity of nanoparticles##2##3##(2008-7#1)(2010-7#1)
toxicity of several##2##3##(1994-5#1)(2008-5#1)
toxicity of some##4##3##(1993-11#1)(1996-2#1)(1997-2#1)(2004-4#1)
toxicity of the herbicide##2##4##(1993-3#1)(2006-5#1)
toxicity of the pesticide methomyl on the topmouth gudgeon (Pseudorasbora parva)##2##11##(2008-7#2)
toxicity of the##36##3##(1990-6#1)(1991-8#1)(1992-11#1)(1993-3#1)(1995-3#1)(1995-5#3)(1996-10#1)(1996-12#2)(1997-2#1)(1997-3#1)(1997-4#1)(2004-4#1)(2006-5#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
toxicity of these compounds##3##4##(2008-10#1)(2008-5#1)(2008-8#1)
toxicity of these##11##3##(1993-6#1)(2006-12#1)(2006-5#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-2#1)
toxicity of this plant##2##4##(2008-12#1)(2010-12#1)
toxicity of this##8##3##(1990-12#1)(1991-10#1)(1995-2#1)(1996-7#1)(2008-10#1)(2008-12#1)(2010-12#1)(2011-1#1)
toxicity of##242##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#2)(1990-6#1)(1990-7#1)(1991-10#1)(1991-3#1)(1991-8#2)(1991-9#2)(1992-11#6)(1992-3#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#4)(1993-3#3)(1993-4#1)(1993-6#1)(1993-7#1)(1994-3#1)(1994-5#7)(1994-8#1)(1994-9#2)(1995-1#1)(1995-2#3)(1995-3#4)(1995-5#4)(1995-8#4)(1996-10#1)(1996-12#5)(1996-2#1)(1996-3#1)(1996-4#3)(1996-6#3)(1996-7#1)(1996-8#1)(1997-2#4)(1997-3#6)(1997-4#3)(2004-11#1)(2004-2#1)(2004-4#7)(2005-1#1)(2005-10#2)(2005-11#2)(2005-7#2)(2005-8#2)(2006-10#2)(2006-12#3)(2006-5#6)(2006-6#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#8)(2008-12#7)(2008-3#3)(2008-4#1)(2008-5#7)(2008-6#6)(2008-7#11)(2008-8#5)(2008-9#3)(2009-10#1)(2009-2#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#2)(2011-1#6)(2011-12#4)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#5)(2013-8#3)
toxicity on##7##2##(1995-5#1)(1996-4#1)(2008-11#1)(2008-6#1)(2009-8#1)(2011-12#1)(2013-8#1)
toxicity or the##2##3##(1990-1#1)(2005-8#1)
toxicity or##8##2##(1990-1#1)(1992-10#1)(1993-4#1)(2005-8#1)(2006-10#1)(2008-7#1)(2010-12#1)(2012-12#1)
toxicity outcomes##3##2##(2008-8#1)(2012-3#1)(2013-7#1)
toxicity presenting##3##2##(2006-4#2)(2012-2#1)
toxicity probabilities##3##2##(2012-3#3)
toxicity produced by##2##3##(2010-2#1)(2013-1#1)
toxicity profile of tacrolimus##2##4##(2007-11#2)
toxicity profile of##3##3##(2007-11#2)(2010-12#1)
toxicity profile##11##2##(1995-3#1)(2006-10#2)(2007-11#2)(2008-11#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-11#1)(2010-12#1)
toxicity profiles##3##2##(2007-11#1)(2008-5#2)
toxicity represents a##2##3##(2008-6#1)(2008-8#1)
toxicity resulting from##3##3##(1995-3#1)(2005-9#1)(2008-10#1)
toxicity secondary to##7##3##(1990-10#1)(2007-12#1)(2010-12#1)(2013-1#4)
toxicity studies in##2##3##(2008-5#1)(2009-11#1)
toxicity studies of##3##3##(2009-5#1)(2012-11#2)
toxicity studies##16##2##(1992-11#1)(1996-8#1)(1997-2#1)(2004-4#1)(2008-5#2)(2009-11#1)(2009-2#1)(2009-5#1)(2010-2#1)(2011-2#3)(2012-1#1)(2012-11#2)
toxicity study in##3##3##(1994-11#1)(2008-10#1)(2008-5#1)
toxicity study of##3##3##(2007-11#1)(2009-5#1)(2013-1#1)
toxicity study using##2##3##(1992-5#1)(2005-7#1)
toxicity study with##2##3##(1994-11#1)(2010-1#1)
toxicity study##11##2##(1992-5#1)(1994-11#2)(2005-10#1)(2005-7#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-5#1)(2010-1#1)(2013-1#1)
toxicity test##5##2##(1996-12#1)(2008-10#3)(2008-9#1)
toxicity testing of##3##3##(1992-3#1)(2005-10#1)(2008-11#1)
toxicity testing##15##2##(1992-3#1)(1996-12#2)(2005-10#2)(2005-8#1)(2008-10#2)(2008-11#2)(2011-1#3)(2012-12#2)
toxicity tests based on##2##4##(2008-10#2)
toxicity tests were##2##3##(2004-4#1)(2008-10#1)
toxicity tests##12##2##(1996-12#1)(2004-4#1)(2008-10#10)
toxicity than the##2##3##(1994-5#1)(1994-7#1)
toxicity than##10##2##(1991-12#1)(1994-5#1)(1994-7#1)(1995-3#1)(1995-4#1)(1996-12#1)(2007-7#1)(2008-3#2)(2012-3#1)
toxicity that##4##2##(2006-10#1)(2008-1#1)(2008-8#1)(2009-10#1)
toxicity to normal cells##2##4##(2005-7#1)(2012-3#1)
toxicity to the##5##3##(1993-3#1)(2005-7#1)(2008-10#1)(2008-2#1)(2008-9#1)
toxicity to##30##2##(1990-3#1)(1991-1#1)(1993-12#1)(1993-3#2)(2005-7#3)(2006-10#1)(2007-7#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
toxicity toward##2##2##(1996-11#1)(2008-4#1)
toxicity towards##2##2##(1996-12#1)(2011-1#1)
toxicity using##2##2##(2008-10#1)(2008-8#1)
toxicity values##2##2##(2004-4#1)(2008-10#1)
toxicity was also##3##3##(2006-6#1)(2008-12#1)(2009-3#1)
toxicity was assessed##2##3##(1996-3#1)(2008-5#1)
toxicity was determined##2##3##(1996-8#1)(1997-3#1)
toxicity was dose dependent##2##4##(1991-1#1)(1994-11#1)
toxicity was evaluated by##2##4##(1990-3#1)(2005-1#1)
toxicity was evaluated##5##3##(1990-3#1)(1992-11#1)(1993-4#1)(2005-1#1)(2008-4#1)
toxicity was noted##2##3##(1990-10#1)(2008-6#1)
toxicity was observed##5##3##(1992-5#1)(1997-1#1)(2007-11#1)(2008-12#2)
toxicity was recorded##2##3##(2006-6#2)
toxicity was seen##3##3##(1992-4#1)(1996-1#1)(2005-7#1)
toxicity was##68##2##(1990-10#1)(1990-2#2)(1990-3#1)(1990-6#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-10#2)(1992-11#2)(1992-4#1)(1992-5#1)(1992-8#2)(1993-3#2)(1993-4#2)(1993-7#1)(1994-11#1)(1994-8#1)(1995-5#1)(1996-1#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(2004-1#1)(2004-4#1)(2005-1#1)(2005-7#1)(2006-12#2)(2006-6#4)(2007-11#1)(2008-12#3)(2008-4#1)(2008-5#3)(2008-6#6)(2008-7#5)(2008-9#1)(2009-3#1)(2009-8#1)(2012-12#2)(2012-2#1)
toxicity were observed##2##3##(1990-10#1)(2008-5#1)
toxicity were##14##2##(1990-10#1)(1990-11#1)(1992-3#1)(1994-12#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#3)(2010-5#1)(2011-2#2)
toxicity which##2##2##(2006-6#1)(2008-3#1)
toxicity with##8##2##(1993-3#2)(1994-4#1)(2006-10#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)
toxicity within##2##2##(2011-2#1)(2013-1#1)
toxicity without affecting##2##3##(1997-1#1)(2007-11#1)
toxicity##1454##1##(1990-1#1)(1990-10#8)(1990-11#2)(1990-12#7)(1990-2#5)(1990-3#7)(1990-4#3)(1990-5#4)(1990-6#2)(1990-7#2)(1991-1#5)(1991-10#4)(1991-12#12)(1991-2#6)(1991-3#5)(1991-4#1)(1991-6#2)(1991-7#1)(1991-8#5)(1991-9#6)(1992-1#1)(1992-10#4)(1992-11#17)(1992-12#3)(1992-2#2)(1992-3#7)(1992-4#5)(1992-5#4)(1992-6#4)(1992-7#2)(1992-8#13)(1992-9#2)(1993-1#3)(1993-11#2)(1993-12#11)(1993-2#2)(1993-3#12)(1993-4#7)(1993-6#5)(1993-7#3)(1994-11#11)(1994-12#2)(1994-3#8)(1994-4#1)(1994-5#15)(1994-6#3)(1994-7#1)(1994-8#6)(1994-9#2)(1995-1#5)(1995-10#4)(1995-11#1)(1995-12#4)(1995-2#5)(1995-3#15)(1995-4#1)(1995-5#14)(1995-6#4)(1995-7#3)(1995-8#11)(1995-9#1)(1996-1#6)(1996-10#4)(1996-11#2)(1996-12#21)(1996-2#2)(1996-3#3)(1996-4#5)(1996-6#3)(1996-7#2)(1996-8#26)(1997-1#6)(1997-2#13)(1997-3#16)(1997-4#8)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#3)(2004-1#3)(2004-10#1)(2004-11#2)(2004-2#2)(2004-4#16)(2004-9#1)(2005-1#3)(2005-10#10)(2005-11#3)(2005-4#1)(2005-7#19)(2005-8#14)(2005-9#5)(2006-10#44)(2006-12#9)(2006-2#1)(2006-4#7)(2006-5#10)(2006-6#17)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#41)(2007-12#9)(2007-2#7)(2007-3#3)(2007-4#3)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#8)(2007-9#2)(2008-1#5)(2008-10#109)(2008-11#29)(2008-12#19)(2008-2#2)(2008-3#20)(2008-4#12)(2008-5#53)(2008-6#47)(2008-7#57)(2008-8#41)(2008-9#18)(2009-10#4)(2009-11#2)(2009-12#1)(2009-2#7)(2009-3#5)(2009-4#4)(2009-5#3)(2009-6#8)(2009-8#7)(2010-1#5)(2010-10#2)(2010-11#6)(2010-12#18)(2010-2#10)(2010-3#2)(2010-4#7)(2010-5#3)(2010-6#2)(2010-7#4)(2010-8#5)(2011-1#22)(2011-12#12)(2011-2#46)(2011-3#1)(2012-1#12)(2012-11#5)(2012-12#18)(2012-2#26)(2012-3#15)(2012-7#2)(2013-1#66)(2013-7#3)(2013-8#12)
toxicity&quot##2##1##(1997-5#1)(2013-7#1)
toxicity)##5##1##(1995-2#1)(2005-9#1)(2008-7#1)(2011-1#2)
toxicity-attenuated##2##1##(2012-3#2)
toxicity-based SQG approaches##2##3##(2012-1#2)
toxicity-based SQG##3##2##(2012-1#3)
toxicity-related##2##1##(1990-2#1)(2005-7#1)
toxicity?##3##1##(2006-10#1)(2008-3#1)(2010-12#1)
toxicity]##2##1##(1990-10#1)(1994-3#1)
toxicokinetic##4##1##(1990-11#1)(2004-4#1)(2008-10#1)(2010-2#1)
toxicokinetics##11##1##(1993-12#1)(1995-3#4)(1996-8#5)(2011-2#1)
toxicologic and##2##2##(2008-9#1)(2009-12#1)
toxicologic control rats##2##3##(2010-5#2)
toxicologic##10##1##(1990-9#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-12#1)(2010-5#3)(2012-1#1)
toxicological analysis##3##2##(1997-2#1)(1997-8#1)(2011-2#1)
toxicological and hematological characteristics of Siganus rivulatus##2##7##(2012-2#2)
toxicological and##7##2##(2008-11#1)(2008-12#1)(2008-7#1)(2010-9#1)(2012-2#2)(2013-1#1)
toxicological assessments##2##2##(1996-1#1)(2009-2#1)
toxicological characteristics##3##2##(2008-5#2)(2011-1#1)
toxicological data##2##2##(1996-3#1)(2008-11#1)
toxicological effect of##2##3##(2008-10#1)(2013-1#1)
toxicological effects of##2##3##(2006-5#1)(2012-1#1)
toxicological effects##5##2##(1992-2#1)(2006-5#1)(2007-8#1)(2010-4#1)(2012-1#1)
toxicological evaluation##2##2##(1996-1#1)(2005-10#1)
toxicological investigations##2##2##(2010-12#1)(2010-9#1)
toxicological profile##2##2##(2007-1#1)(2008-5#1)
toxicological properties##3##2##(1996-10#1)(2008-12#1)(2008-5#1)
toxicological screening##3##2##(2005-8#2)(2008-10#1)
toxicological studies in##2##3##(1990-4#1)(1992-6#1)
toxicological studies of##2##3##(2008-12#1)(2011-1#1)
toxicological studies##9##2##(1990-4#1)(1992-6#1)(1994-6#1)(1996-8#1)(2008-11#1)(2008-12#1)(2008-6#1)(2011-1#1)(2012-11#1)
toxicological study##2##2##(2008-10#2)
toxicological testing##2##2##(1996-5#1)(2005-10#1)
toxicological##88##1##(1990-4#2)(1990-8#1)(1991-5#1)(1992-2#2)(1992-6#1)(1994-5#1)(1994-6#1)(1996-1#2)(1996-10#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#2)(1997-2#1)(1997-8#1)(2005-10#2)(2005-8#3)(2006-5#1)(2007-1#2)(2007-11#1)(2007-8#4)(2008-1#1)(2008-10#12)(2008-11#5)(2008-12#3)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-9#2)(2011-1#2)(2011-2#1)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#2)(2013-1#4)
toxicologically relevant##4##2##(1996-8#1)(2008-10#2)(2008-3#1)
toxicologically##6##1##(1996-8#1)(2008-10#4)(2008-3#1)
toxicologists##4##1##(2007-8#1)(2008-8#2)(2010-12#1)
toxicology analysis##2##2##(2008-5#1)(2011-2#1)
toxicology and carcinogenesis##2##3##(2008-9#2)
toxicology and##15##2##(1994-12#1)(2007-12#4)(2007-7#1)(2008-10#1)(2008-11#1)(2008-9#3)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
toxicology in##3##2##(1996-7#1)(2005-8#2)
toxicology into cosmetic ingredient##2##4##(2008-5#2)
toxicology into##3##2##(2008-5#2)(2010-7#1)
toxicology is##3##2##(1991-9#1)(1996-12#1)(2010-12#1)
toxicology of##6##2##(1995-3#1)(1996-8#1)(2007-6#1)(2008-5#1)(2008-7#2)
toxicology studies of##4##3##(2008-8#1)(2008-9#3)
toxicology studies##16##2##(2005-10#1)(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#11)
toxicology study##5##2##(1995-2#3)(2008-10#2)
toxicology##110##1##(1990-5#1)(1991-6#1)(1991-9#2)(1994-12#1)(1995-11#2)(1995-2#3)(1995-3#1)(1996-1#1)(1996-12#13)(1996-5#2)(1996-7#1)(1996-8#3)(1997-2#1)(1997-3#1)(2005-10#1)(2005-8#3)(2006-4#3)(2007-12#8)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#3)(2008-5#9)(2008-7#3)(2008-8#2)(2008-9#15)(2010-12#1)(2010-2#1)(2010-4#4)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#2)
toxicoses##2##1##(2007-2#1)(2008-10#1)
toxicosis##5##1##(1996-8#2)(2007-4#1)(2010-2#1)(2013-1#1)
toxicus##5##1##(2008-10#4)(2008-5#1)
toxigenic C##8##2##(2006-8#3)(2007-11#1)(2011-2#4)
toxigenic Fusarium species associated to cereal grains##2##7##(2010-10#2)
toxigenic Fusarium##3##2##(2008-10#1)(2010-10#2)
toxigenic and atoxigenic##2##3##(2005-11#2)
toxigenic culture##2##2##(2006-8#2)
toxigenic fungi##2##2##(2010-7#2)
toxigenic in the duckling tests##3##5##(2008-10#3)
toxigenic potential##2##2##(2010-10#1)(2011-2#1)
toxigenic strains of##2##3##(2006-8#1)(2008-10#1)
toxigenic##28##1##(1990-9#1)(1996-11#1)(2005-11#3)(2006-8#6)(2007-11#1)(2008-10#6)(2010-10#3)(2010-7#2)(2011-2#5)
toxigenicity##3##1##(2006-8#1)(2008-10#1)(2011-2#1)
toxin (10##2##2##(1994-3#1)(1996-10#1)
toxin (100##3##2##(1994-12#1)(1996-5#1)(1997-7#1)
toxin (BT)##2##2##(2004-10#1)(2008-2#1)
toxin (CT) and##2##3##(1990-3#1)(2007-8#1)
toxin (CT)##7##2##(1990-3#1)(1991-12#1)(1994-2#1)(1995-6#1)(1996-11#1)(1997-6#1)(2007-8#1)
toxin 1-methyl-4-phenyl-1##3##2##(1991-3#1)(1992-11#1)(2009-10#1)
toxin 2##4##2##(2008-7#1)(2011-2#1)(2013-1#2)
toxin A enteritis##2##3##(1997-4#2)
toxin A for##2##3##(1997-5#1)(2008-12#1)
toxin A in the##2##4##(2006-8#1)(2007-11#1)
toxin A##24##2##(1990-11#1)(1992-8#1)(1993-12#1)(1995-4#1)(1997-4#5)(1997-5#1)(2006-10#4)(2006-8#2)(2007-11#2)(2007-12#5)(2008-12#1)
toxin A-III##3##2##(1994-2#3)
toxin B from##2##3##(2007-12#1)(2009-2#1)
toxin B subunit##13##3##(1990-4#2)(1996-10#1)(1996-4#1)(1997-4#1)(1997-7#1)(2006-12#1)(2008-11#3)(2008-8#1)(2008-9#1)(2009-2#1)
toxin B##27##2##(1990-4#2)(1996-10#1)(1996-4#1)(1996-5#1)(1997-4#1)(1997-7#2)(2006-12#1)(2006-8#1)(2007-12#5)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#6)
toxin abolished##3##2##(1990-12#1)(1991-7#1)(1996-8#1)
toxin action##2##2##(1994-9#2)
toxin affinity for##2##3##(1996-2#2)
toxin also##5##2##(1992-5#1)(1992-9#1)(1994-2#1)(2008-10#2)
toxin and its##2##3##(1993-9#1)(2011-1#1)
toxin and the##3##3##(1995-1#1)(1996-5#1)(1997-8#1)
toxin and##27##2##(1990-3#1)(1990-8#1)(1991-10#1)(1992-2#1)(1993-8#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-5#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-11#1)(2006-7#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-8#2)(2011-1#1)(2011-2#2)(2013-1#1)
toxin as##5##2##(1991-5#1)(1997-7#1)(2006-8#2)(2008-10#1)
toxin assay##4##2##(2006-8#2)(2008-10#2)
toxin binding and##2##3##(1994-3#1)(1997-7#1)
toxin binding##9##2##(1990-7#1)(1991-8#1)(1992-9#2)(1994-3#4)(1997-7#1)
toxin blocks##2##2##(1991-7#1)(1994-9#1)
toxin by##3##2##(1990-5#1)(1996-12#1)(1997-6#1)
toxin can##5##2##(1991-12#1)(1994-9#1)(1995-2#1)(2008-4#1)(2011-2#1)
toxin concentrations##3##2##(1997-4#1)(2008-10#1)(2008-5#1)
toxin did not alter##2##4##(1991-12#1)(1992-3#1)
toxin did not##4##3##(1991-12#2)(1992-3#1)(2008-10#1)
toxin family##2##2##(1994-2#1)(2008-10#1)
toxin for##4##2##(1990-5#1)(1994-9#1)(1997-2#1)(2006-9#1)
toxin formation##2##2##(2006-4#1)(2008-7#1)
toxin from##5##2##(1993-7#1)(2008-10#2)(2008-8#1)(2012-12#1)
toxin gene##2##2##(2011-2#1)(2013-1#1)
toxin genes were##2##3##(2013-1#2)
toxin genes##9##2##(2006-8#1)(2008-10#1)(2010-3#2)(2013-1#5)
toxin has a##2##3##(1990-9#1)(2008-10#1)
toxin has been used##2##4##(2008-8#1)(2011-2#1)
toxin has been##4##3##(2008-10#2)(2008-8#1)(2011-2#1)
toxin has##9##2##(1990-9#1)(1991-5#1)(2006-9#1)(2008-1#1)(2008-10#3)(2008-8#1)(2011-2#1)
toxin in the##4##3##(1990-2#1)(1990-9#1)(1997-8#1)(2008-8#1)
toxin in##15##2##(1990-2#1)(1990-5#1)(1990-9#1)(1994-12#1)(1997-8#1)(2007-6#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-9#1)(2012-2#1)
toxin infusion##3##2##(1991-9#1)(1995-5#1)(2008-5#1)
toxin inhibited##3##2##(1990-3#1)(1993-9#1)(2008-4#1)
toxin inhibits##3##2##(1990-3#1)(1991-12#1)(2010-1#1)
toxin injections##3##2##(2008-7#1)(2008-8#1)(2011-1#1)
toxin insensitivity##2##2##(2008-10#2)
toxin into##2##2##(1991-1#1)(1991-10#1)
toxin is a##2##3##(1992-12#1)(1994-9#1)
toxin is an##2##3##(1991-12#1)(1992-8#1)
toxin is##21##2##(1991-10#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-8#1)(1994-2#1)(1994-9#1)(1995-8#1)(2006-2#1)(2006-8#3)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2012-12#1)(2012-3#1)
toxin levels##3##2##(2007-11#1)(2011-2#2)
toxin molecule##2##2##(1994-2#1)(1997-6#1)
toxin of Clostridium##2##3##(2006-9#1)(2013-8#1)
toxin of##6##2##(1991-5#1)(1991-7#1)(2006-5#1)(2006-9#1)(2008-5#1)(2013-8#1)
toxin on##3##2##(1990-3#1)(2006-8#2)
toxin or##2##2##(2007-12#1)(2010-2#1)
toxin partially inhibited##2##3##(1995-3#1)(1996-8#1)
toxin pretreatment##3##2##(1993-11#2)(1997-2#1)
toxin producing##4##2##(2006-8#2)(2012-2#2)
toxin production##14##2##(1992-12#1)(1993-10#1)(2007-12#1)(2008-10#4)(2008-5#1)(2010-12#2)(2011-2#4)
toxin reaction##4##2##(2008-10#4)
toxin sensitivity of##2##3##(2008-10#1)(2008-4#1)
toxin sensitivity##5##2##(2008-10#4)(2008-4#1)
toxin showed##2##2##(1990-3#1)(2008-10#1)
toxin substrate##3##2##(1991-1#1)(1991-9#1)(1992-9#1)
toxin substrates##4##2##(1990-3#1)(1991-10#1)(1991-9#1)(1992-9#1)
toxin synthesis##5##2##(1995-2#1)(2008-10#2)(2011-2#2)
toxin that activates##2##3##(1995-1#2)
toxin that is##3##3##(1990-8#1)(2008-10#1)(2011-2#1)
toxin that##7##2##(1990-8#1)(1995-1#2)(2008-10#2)(2008-5#1)(2011-2#1)
toxin therapy##2##2##(2007-11#1)(2011-2#1)
toxin to the##2##3##(1994-9#1)(2006-12#1)
toxin to##5##2##(1993-9#1)(1994-2#1)(1994-9#1)(2006-12#1)(2008-8#1)
toxin treatment of##2##3##(1992-8#1)(1994-9#1)
toxin treatment##6##2##(1990-3#1)(1991-8#1)(1992-8#1)(1993-11#1)(1994-5#1)(1994-9#1)
toxin type##10##2##(1990-9#1)(2005-11#1)(2006-10#1)(2008-10#4)(2008-2#1)(2008-8#1)(2010-8#1)
toxin using##2##2##(1990-3#1)(2008-10#1)
toxin was found to##2##4##(1992-3#1)(2008-10#1)
toxin was##10##2##(1992-3#1)(1993-9#1)(1995-9#1)(1997-6#1)(2006-12#1)(2008-10#4)(2009-4#1)
toxin were##2##2##(1997-6#1)(2008-8#1)
toxin with##3##2##(1991-9#1)(1993-7#1)(1997-6#1)
toxin##665##1##(1990-10#3)(1990-11#3)(1990-12#1)(1990-2#7)(1990-3#21)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#4)(1990-8#3)(1990-9#7)(1991-1#2)(1991-10#12)(1991-12#12)(1991-3#4)(1991-4#1)(1991-5#7)(1991-7#3)(1991-8#2)(1991-9#6)(1992-11#4)(1992-12#2)(1992-2#3)(1992-3#6)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#4)(1992-9#8)(1993-10#1)(1993-11#5)(1993-12#6)(1993-3#3)(1993-6#1)(1993-7#3)(1993-8#4)(1993-9#9)(1994-11#1)(1994-12#6)(1994-2#18)(1994-3#6)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#12)(1995-1#7)(1995-10#2)(1995-12#2)(1995-2#7)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#3)(1995-7#4)(1995-8#3)(1995-9#1)(1996-10#3)(1996-11#2)(1996-12#1)(1996-2#7)(1996-4#2)(1996-5#4)(1996-6#1)(1996-8#4)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#3)(1997-4#14)(1997-5#1)(1997-6#13)(1997-7#7)(1997-8#2)(2004-10#2)(2004-11#2)(2005-11#4)(2006-10#7)(2006-12#7)(2006-2#1)(2006-4#1)(2006-5#6)(2006-7#2)(2006-8#23)(2006-9#4)(2007-11#4)(2007-12#15)(2007-6#1)(2007-7#3)(2007-8#4)(2008-1#2)(2008-10#99)(2008-11#5)(2008-12#2)(2008-2#3)(2008-4#14)(2008-5#15)(2008-7#4)(2008-8#17)(2008-9#2)(2009-10#3)(2009-2#8)(2009-3#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-1#3)(2010-10#3)(2010-12#5)(2010-2#1)(2010-3#2)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#25)(2012-11#5)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#14)(2013-8#1)
toxin&quot##2##1##(1995-7#1)(2005-6#1)
toxin)##5##1##(1991-12#1)(1994-3#1)(1995-5#1)(2008-7#1)(2008-9#1)
toxin-##3##1##(1991-5#1)(2013-1#2)
toxin-catalyzed ADP-ribosylation of##4##3##(1990-9#1)(1992-9#3)
toxin-catalyzed ADP-ribosylation##7##2##(1990-7#1)(1990-9#1)(1992-9#4)(1993-8#1)
toxin-channel interactions##2##2##(2008-8#2)
toxin-induced##9##1##(1994-2#1)(1994-9#2)(1995-7#1)(2006-10#1)(2008-10#1)(2011-2#1)(2013-8#2)
toxin-insensitive##6##1##(1994-3#1)(1995-2#1)(2008-10#3)(2008-4#1)
toxin-insensitivity##2##1##(1990-2#1)(2008-10#1)
toxin-mediated##2##1##(1990-3#1)(1991-7#1)
toxin-producing##4##1##(2008-10#1)(2009-8#1)(2010-9#2)
toxin-related##2##1##(1991-12#1)(1991-5#1)
toxin-resistant##3##1##(1993-3#1)(2007-12#1)(2008-8#1)
toxin-sensitive G##5##2##(1990-7#1)(1995-11#1)(1995-2#1)(1997-1#2)
toxin-sensitive G-proteins##3##2##(1990-3#1)(1990-7#1)(1997-2#1)
toxin-sensitive##23##1##(1990-12#1)(1990-3#1)(1990-7#4)(1990-9#2)(1991-7#1)(1992-11#2)(1993-11#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#1)(2008-10#2)(2011-1#1)
toxin-treated##5##1##(1991-12#1)(1992-4#3)(1994-9#1)
toxin/g of##2##2##(1997-4#2)
toxins A and B##3##4##(2006-8#1)(2007-12#2)
toxins A##4##2##(2006-8#1)(2007-12#3)
toxins act##2##2##(2011-1#1)(2011-2#1)
toxins against##3##2##(1994-3#1)(2004-11#1)(2008-10#1)
toxins and their##2##3##(1994-12#1)(2008-10#1)
toxins and##14##2##(1990-9#1)(1994-12#1)(1994-2#1)(1995-5#1)(1997-6#1)(2006-10#1)(2007-11#2)(2007-6#1)(2008-10#1)(2008-9#1)(2011-12#1)(2011-2#1)(2012-12#1)
toxins are##13##2##(1990-5#1)(1991-4#1)(1994-2#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#2)(2011-1#2)
toxins by##2##2##(1990-9#1)(1994-12#1)
toxins from##5##2##(1990-2#1)(1993-12#1)(1994-11#1)(2006-10#1)(2011-12#1)
toxins have##5##2##(1994-2#1)(2008-10#1)(2008-5#2)(2011-1#1)
toxins in##13##2##(1996-6#1)(1997-4#1)(1997-6#1)(2006-12#1)(2006-8#2)(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
toxins of##4##2##(1991-10#1)(1993-12#1)(1993-6#1)(1994-5#1)
toxins or##6##2##(1991-12#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
toxins produced by##3##3##(1997-4#1)(2008-10#1)(2011-1#1)
toxins produced##4##2##(1997-4#2)(2008-10#1)(2011-1#1)
toxins that are##2##3##(2006-10#1)(2007-2#1)
toxins that##5##2##(2006-10#1)(2007-12#1)(2007-2#1)(2008-5#1)(2008-7#1)
toxins to##7##2##(1991-12#1)(2007-11#1)(2008-11#1)(2008-5#1)(2009-2#1)(2012-11#2)
toxins was##4##2##(1992-8#1)(2006-12#1)(2008-10#2)
toxins were##6##2##(1993-12#1)(2006-8#2)(2007-12#1)(2008-10#1)(2008-11#1)
toxins##232##1##(1990-11#1)(1990-12#1)(1990-2#5)(1990-5#3)(1990-8#1)(1990-9#4)(1991-10#2)(1991-12#5)(1991-4#1)(1992-2#2)(1992-7#1)(1992-8#2)(1993-10#3)(1993-11#1)(1993-12#5)(1993-3#2)(1993-6#3)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#5)(1994-2#5)(1994-3#5)(1994-5#3)(1994-6#1)(1995-1#4)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-4#1)(1996-6#1)(1997-4#5)(1997-6#3)(2004-11#2)(2004-2#1)(2005-8#1)(2006-10#9)(2006-12#5)(2006-8#7)(2007-11#7)(2007-12#7)(2007-2#1)(2007-6#2)(2007-8#1)(2008-10#24)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#15)(2008-7#6)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#2)(2011-1#8)(2011-12#3)(2011-2#7)(2012-11#2)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#3)
toxins)##2##1##(2008-10#1)(2010-3#1)
toxocarosis##6##1##(2011-2#5)(2013-1#1)
toxoid and##3##2##(1992-2#1)(1994-2#1)(2007-11#1)
toxoid vaccine##2##2##(1995-5#1)(2007-11#1)
toxoid was##2##2##(1995-5#1)(2007-8#1)
toxoid##28##1##(1990-4#1)(1991-2#1)(1992-2#1)(1994-2#1)(1995-12#3)(1995-2#1)(1995-5#3)(2006-4#1)(2007-11#2)(2007-8#6)(2008-11#1)(2008-4#3)(2009-5#1)(2011-2#3)
toxoids##5##1##(1994-8#1)(1995-3#1)(1995-5#1)(2006-5#1)(2007-11#1)
toxoplasma##11##1##(1990-5#1)(1990-9#2)(1993-2#1)(1993-5#1)(1994-7#2)(2006-7#1)(2007-8#1)(2011-1#2)
toxoplasmic encephalitis##3##2##(1993-5#2)(2008-4#1)
toxoplasmic##4##1##(1993-5#2)(2008-4#2)
toxoplasmosis and##5##2##(1990-9#1)(2006-7#1)(2007-10#2)(2007-9#1)
toxoplasmosis during pregnancy##3##3##(1990-9#1)(2007-7#1)(2008-4#1)
toxoplasmosis in AIDS##2##3##(1993-5#1)(2007-12#1)
toxoplasmosis in patients with HIV##2##5##(1994-4#1)(1996-3#1)
toxoplasmosis in patients with##3##4##(1991-2#1)(1994-4#1)(1996-3#1)
toxoplasmosis in##15##2##(1991-2#1)(1992-2#1)(1993-10#1)(1993-5#1)(1994-4#1)(1996-3#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-7#2)(2008-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
toxoplasmosis is##2##2##(1990-9#1)(2007-2#1)
toxoplasmosis was##3##2##(1993-5#1)(2006-7#1)(2013-8#1)
toxoplasmosis with##2##2##(1990-3#1)(2007-2#1)
toxoplasmosis##71##1##(1990-3#1)(1990-6#1)(1990-9#10)(1991-2#1)(1991-6#1)(1992-2#2)(1992-4#1)(1993-10#1)(1993-5#2)(1994-2#1)(1994-4#1)(1995-9#1)(1996-11#3)(1996-3#1)(1997-3#1)(2006-10#1)(2006-5#1)(2006-7#4)(2007-10#3)(2007-12#3)(2007-2#6)(2007-3#1)(2007-7#3)(2007-9#5)(2008-4#7)(2009-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#3)
toy in##2##2##(2011-2#1)(2013-8#1)
toy##6##1##(1997-6#1)(2005-12#1)(2007-8#1)(2011-2#1)(2013-8#2)
toyocamycin##2##1##(1996-8#2)
toys##5##1##(2009-5#1)(2011-1#4)
tr-/-##4##1##(1996-8#4)
tra##2##1##(1990-11#1)(2007-12#1)
traC##3##1##(1990-11#3)
traI##4##1##(1991-7#4)
traX##5##1##(1991-7#5)
trabeculae in##2##2##(2009-7#1)(2011-2#1)
trabeculae were##3##2##(2009-7#1)(2013-1#2)
trabeculae##14##1##(2005-11#1)(2006-8#1)(2007-7#2)(2009-7#4)(2010-7#1)(2011-2#3)(2013-1#2)
trabecular adenoma##2##2##(1992-8#2)
trabecular and##2##2##(1993-11#1)(2008-5#1)
trabecular bone architecture##2##3##(2009-4#1)(2009-7#1)
trabecular bone loss##3##3##(1993-11#3)
trabecular bone##19##2##(1993-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-7#2)(2009-3#1)(2009-4#1)(2009-7#4)(2010-10#1)(2010-9#2)(2011-1#1)
trabecular meshwork##5##2##(1991-5#1)(2008-11#1)(2008-4#1)(2011-2#2)
trabecular pattern##3##2##(1994-12#1)(2006-10#1)(2007-11#1)
trabecular rod Buckling index##2##4##(2010-10#2)
trabecular rod##5##2##(2010-10#5)
trabecular separation##2##2##(2010-10#2)
trabecular##54##1##(1991-11#2)(1991-5#1)(1992-8#2)(1993-11#4)(1994-12#1)(1996-12#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-3#1)(2009-4#1)(2009-7#6)(2010-10#10)(2010-12#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
trabeculectomy##4##1##(2008-7#1)(2011-1#1)(2011-12#1)(2013-8#1)
trace Au(III)##2##2##(2008-10#2)
trace CS##4##2##(2008-5#4)
trace Cu(2+)##2##2##(2008-10#2)
trace DNA analysis##3##3##(2008-12#3)
trace Li in serum##2##4##(2005-4#2)
trace amount of##37##3##(1991-5#1)(2005-4#1)(2007-8#1)(2008-10#27)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2013-1#1)(2013-8#1)
trace amount##38##2##(1991-5#1)(2005-4#1)(2007-8#1)(2008-10#28)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2013-1#1)(2013-8#1)
trace amounts in##3##3##(1993-6#1)(2008-10#1)(2008-11#1)
trace amounts of 165##2##4##(1993-12#2)
trace amounts of copper##6##4##(2008-10#6)
trace amounts of copper(II)##3##4##(2008-10#3)
trace amounts of lead##4##4##(2008-10#4)
trace amounts of rare##2##4##(2005-4#2)
trace amounts of zinc##4##4##(2005-4#1)(2008-10#3)
trace amounts of##123##3##(1990-11#1)(1990-9#1)(1992-7#1)(1993-12#2)(1996-7#1)(2005-4#3)(2005-8#1)(2007-8#1)(2008-10#109)(2008-11#1)(2013-7#2)
trace amounts##135##2##(1990-11#1)(1990-9#1)(1991-9#1)(1992-7#1)(1993-12#2)(1993-6#1)(1995-3#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-3#1)(2005-4#3)(2005-8#1)(2007-8#1)(2008-10#112)(2008-11#2)(2008-3#1)(2008-5#1)(2013-7#2)
trace analysis of##10##3##(2008-10#7)(2008-3#1)(2012-12#1)(2013-7#1)
trace analysis##19##2##(2008-10#14)(2008-3#2)(2011-2#1)(2012-12#1)(2013-7#1)
trace analytes##2##2##(2008-10#2)
trace and rare earth elements in##2##6##(2008-10#2)
trace and ultra trace##2##4##(2008-10#2)
trace and ultratrace##4##3##(2007-8#1)(2008-10#3)
trace and##13##2##(1994-9#1)(1996-9#1)(2006-4#1)(2007-8#1)(2008-10#8)(2008-5#1)
trace back to##2##3##(2010-4#1)(2011-1#1)
trace back##3##2##(1994-6#1)(2010-4#1)(2011-1#1)
trace barium in biological samples##2##5##(2005-4#2)
trace chemical##3##2##(2008-2#3)
trace components##2##2##(2006-12#1)(2008-10#1)
trace concentration of##2##3##(2008-10#1)(2008-3#1)
trace concentration##5##2##(2008-10#4)(2008-3#1)
trace concentrations of##4##3##(1991-8#1)(2008-10#3)
trace concentrations##6##2##(1991-8#1)(2008-10#5)
trace constituents in##3##3##(2006-12#2)(2008-10#1)
trace constituents##6##2##(2006-12#2)(2008-10#3)(2008-2#1)
trace copper in river##2##4##(2008-10#2)
trace copper##10##2##(2005-4#4)(2007-8#1)(2008-10#5)
trace copper(II)##2##2##(2007-8#1)(2008-10#1)
trace criterion##2##2##(2007-12#2)
trace determination of##13##3##(2008-10#12)(2008-5#1)
trace determination##15##2##(2008-10#14)(2008-5#1)
trace element analysis##2##3##(2008-10#2)
trace element concentrations##2##3##(1993-2#1)(2008-10#1)
trace element determination##4##3##(2008-10#4)
trace element determinations##2##3##(2007-8#1)(2008-10#1)
trace element partitioning##2##3##(2008-10#2)
trace element status##3##3##(2005-7#3)
trace element##34##2##(1993-2#2)(1994-3#1)(1997-5#1)(2005-7#3)(2007-8#1)(2008-10#17)(2008-12#1)(2010-12#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#1)
trace elemental concentrations##2##3##(1996-9#1)(2008-10#1)
trace elemental##4##2##(1996-9#1)(2007-8#1)(2008-10#2)
trace elements (As##3##3##(2008-10#3)
trace elements and##6##3##(1990-2#1)(2008-1#1)(2008-10#1)(2010-12#2)(2010-5#1)
trace elements are##2##3##(2008-10#2)
trace elements bound to##2##4##(2008-10#1)(2010-5#1)
trace elements content##2##3##(2008-10#2)
trace elements determination in##2##4##(2008-10#2)
trace elements in environmental samples##2##5##(2006-12#1)(2008-10#1)
trace elements in rainwater##4##4##(2007-8#4)
trace elements in the##4##4##(2008-10#2)(2010-12#2)
trace elements in water##2##4##(2008-10#2)
trace elements in##36##3##(2006-12#1)(2007-8#7)(2008-10#23)(2010-12#2)(2011-2#1)(2013-8#2)
trace elements like##2##3##(2008-10#1)(2013-8#1)
trace elements of##4##3##(2008-10#2)(2008-12#1)(2013-8#1)
trace elements such as##2##4##(1996-7#1)(2008-10#1)
trace elements was##2##3##(2008-10#2)
trace elements were##4##3##(2008-10#4)
trace elements##104##2##(1990-2#1)(1992-6#1)(1996-7#1)(2004-4#1)(2005-11#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-8#11)(2008-1#1)(2008-10#65)(2008-12#2)(2008-5#1)(2010-11#1)(2010-12#5)(2010-5#2)(2011-1#1)(2011-2#1)(2013-8#6)
trace elements)##2##2##(2008-10#1)(2008-11#1)
trace enrichment of##5##3##(2008-10#5)
trace enrichment##8##2##(2008-10#8)
trace evidence analysis##2##3##(1996-6#1)(2008-10#1)
trace evidence##5##2##(1996-6#1)(2008-10#2)(2008-6#1)(2012-2#1)
trace fossil##3##2##(2013-1#3)
trace gas detection##3##3##(2008-2#1)(2013-8#2)
trace gas##8##2##(2008-10#2)(2008-2#2)(2008-3#2)(2013-8#2)
trace gases##17##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#8)
trace germanium in vegetables##2##4##(2005-4#2)
trace heavy metals##8##3##(2008-10#6)(2009-6#2)
trace impurities##3##2##(2005-4#1)(2008-10#2)
trace iron##4##2##(2005-4#1)(2008-10#3)
trace lead in water##6##4##(2008-10#5)(2013-8#1)
trace lead##14##2##(2005-4#2)(2008-10#9)(2013-8#3)
trace level determination of##3##4##(2008-10#3)
trace level in##2##3##(2008-1#1)(2008-10#1)
trace level##17##2##(1997-2#1)(1997-5#1)(2007-8#1)(2008-1#1)(2008-10#12)(2013-7#1)
trace levels in##6##3##(2008-10#6)
trace levels of dissolved##2##4##(2008-10#1)(2008-7#1)
trace levels of lead##2##4##(2008-10#2)
trace levels of##31##3##(1990-8#1)(1994-6#1)(1995-2#1)(2008-10#27)(2008-7#1)
trace levels##61##2##(1990-4#1)(1990-8#1)(1994-6#1)(1995-2#1)(2004-4#1)(2007-8#1)(2008-10#54)(2008-7#1)
trace measurement of##2##3##(2008-10#2)
trace mercury##14##2##(2008-10#14)
trace metal analysis##2##3##(2008-10#2)
trace metal concentrations of##2##4##(2007-5#1)(2008-10#1)
trace metal concentrations##4##3##(1993-12#1)(2007-5#1)(2007-8#1)(2008-10#1)
trace metal fraction##3##3##(2007-8#3)
trace metal in##2##3##(2008-10#1)(2008-5#1)
trace metal ion##2##3##(2008-10#2)
trace metal ions##7##3##(2008-10#7)
trace metal##38##2##(1993-12#1)(1995-3#1)(2004-4#1)(2007-5#3)(2007-8#5)(2008-10#22)(2008-5#2)(2008-6#1)(2012-2#2)
trace metals analysis##2##3##(2008-10#2)
trace metals from##3##3##(2008-10#1)(2012-2#2)
trace metals in seawater##2##4##(2008-10#2)
trace metals in water by##2##5##(2008-10#2)
trace metals in water##3##4##(2008-10#3)
trace metals in##25##3##(1994-6#1)(2007-5#1)(2008-10#22)(2008-3#1)
trace metals with##2##3##(2007-8#1)(2008-10#1)
trace metals##67##2##(1994-6#2)(1994-8#1)(2004-4#1)(2005-4#1)(2007-5#1)(2007-8#3)(2008-10#45)(2008-11#3)(2008-3#1)(2008-5#2)(2010-11#1)(2012-2#6)
trace molybdenum##4##2##(2008-10#4)
trace of an##2##3##(2007-11#1)(2007-9#1)
trace of##14##2##(2007-11#1)(2007-9#2)(2008-10#4)(2008-2#1)(2008-3#1)(2008-9#1)(2009-6#1)(2010-12#1)(2011-2#1)(2013-7#1)
trace or##4##2##(2008-10#3)(2008-5#1)
trace organophosphorus vapor##2##3##(2007-8#2)
trace quantities##5##2##(2008-10#2)(2008-2#1)(2010-5#1)(2010-7#1)
trace rare earth elements##2##4##(2008-10#2)
trace rare earth impurities in##3##5##(2005-4#3)
trace rare earth##5##3##(2005-4#3)(2008-10#2)
trace species retrievals##2##3##(2008-2#2)
trace species##4##2##(2008-2#3)(2008-3#1)
trace stimulus##2##2##(2008-5#2)
trace the development of##4##4##(1996-9#1)(1997-2#1)(2007-8#1)(2008-2#1)
trace the##14##2##(1995-4#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-3#1)(2006-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-2#2)
trace tin in##2##3##(2005-4#1)(2008-10#1)
trace water##4##2##(2008-10#4)
trace##958##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-6#1)(1992-7#1)(1993-12#3)(1993-2#2)(1993-6#1)(1994-3#1)(1994-6#4)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-4#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#3)(1997-2#2)(1997-3#2)(1997-5#2)(2004-4#4)(2005-11#2)(2005-4#42)(2005-7#3)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#4)(2006-4#2)(2006-7#2)(2007-11#4)(2007-12#8)(2007-2#1)(2007-5#4)(2007-7#2)(2007-8#34)(2007-9#5)(2008-1#3)(2008-10#604)(2008-11#15)(2008-12#6)(2008-2#21)(2008-3#34)(2008-5#19)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-3#1)(2009-5#1)(2009-6#3)(2010-11#2)(2010-12#7)(2010-4#2)(2010-5#3)(2010-7#1)(2011-1#3)(2011-2#7)(2012-12#3)(2012-2#16)(2013-1#10)(2013-7#5)(2013-8#16)
trace)##2##1##(2006-12#1)(2013-1#1)
trace-back##3##1##(1993-2#1)(2008-3#2)
trace-gas analysis##2##2##(2008-2#1)(2008-3#1)
trace-gas detection##3##2##(2007-12#2)(2008-3#1)
trace-gas monitoring##2##2##(2007-12#1)(2008-3#1)
trace-gas##11##1##(2007-12#3)(2008-2#2)(2008-3#6)
traceability of##3##2##(2008-10#1)(2008-3#1)(2012-2#1)
traceability##13##1##(2008-10#3)(2008-3#1)(2010-4#5)(2012-2#4)
traceability/authenticity##2##1##(2012-12#2)
traceable to##2##2##(2008-3#1)(2008-8#1)
traceable##6##1##(2008-10#1)(2008-3#1)(2008-8#1)(2010-4#1)(2010-7#1)(2011-1#1)
traced by##3##2##(2008-10#1)(2010-8#1)(2012-3#1)
traced from##3##2##(2007-10#1)(2008-10#1)(2011-1#1)
traced in##4##2##(2006-3#1)(2007-5#1)(2007-7#1)(2009-6#1)
traced over the##2##3##(2008-10#1)(2008-8#1)
traced through##2##2##(1995-10#1)(2010-4#1)
traced to the##5##3##(1995-2#1)(2008-10#2)(2012-2#2)
traced to##21##2##(1991-11#1)(1991-2#1)(1991-4#1)(1993-12#1)(1993-6#2)(1994-12#1)(1995-2#1)(1995-3#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-6#1)(2008-7#1)(2009-2#1)(2009-9#1)(2012-2#2)(2013-8#1)
traced using##2##2##(1996-12#1)(2008-10#1)
traced##62##1##(1991-11#1)(1991-2#1)(1991-4#1)(1992-2#1)(1993-12#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-2#1)(2004-12#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#13)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#2)(2009-6#1)(2009-9#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-1#2)(2012-2#3)(2012-3#1)(2013-8#1)
tracer Fluoro-Gold##3##2##(1990-11#1)(1994-2#1)(1995-12#1)
tracer aerosols##2##2##(1994-12#2)
tracer and driver##3##3##(2008-2#3)
tracer and##9##2##(1995-10#1)(1996-12#2)(2008-2#5)(2010-5#1)
tracer animals##2##2##(2008-5#2)
tracer distribution##3##2##(1990-12#1)(1993-11#1)(2010-12#1)
tracer dose##2##2##(1991-7#2)
tracer elements##2##2##(1997-5#1)(2008-7#1)
tracer for##4##2##(1997-7#1)(2007-8#1)(2008-11#1)(2008-2#1)
tracer horseradish peroxidase##2##3##(1997-7#1)(2006-5#1)
tracer imaging##2##2##(2009-12#1)(2013-1#1)
tracer in the##2##3##(1990-5#1)(2008-7#1)
tracer in##4##2##(1990-5#1)(2008-10#1)(2008-7#1)(2010-12#1)
tracer injections##2##2##(1993-12#1)(2008-11#1)
tracer into the##3##3##(2008-11#1)(2008-7#1)(2010-10#1)
tracer into##5##2##(1990-5#1)(1995-10#1)(2008-11#1)(2008-7#1)(2010-10#1)
tracer is##2##2##(1997-8#1)(2008-2#1)
tracer molecules##4##2##(1990-5#1)(1996-5#1)(2007-8#1)(2010-12#1)
tracer particles##2##2##(1994-2#1)(2008-2#1)
tracer technique##2##2##(1994-12#1)(1994-2#1)
tracer uptake in##2##3##(2010-12#1)(2010-2#1)
tracer uptake##4##2##(1997-8#1)(2010-12#2)(2010-2#1)
tracer were##2##2##(1990-12#1)(1990-5#1)
tracer##136##1##(1990-10#1)(1990-11#2)(1990-12#7)(1990-2#1)(1990-3#1)(1990-5#8)(1991-12#3)(1991-3#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-6#1)(1993-11#2)(1993-12#2)(1993-4#1)(1993-8#1)(1994-12#3)(1994-2#4)(1994-9#1)(1995-10#3)(1995-11#1)(1995-12#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#3)(1996-12#4)(1996-5#1)(1996-6#2)(1996-9#3)(1997-2#1)(1997-5#1)(1997-7#2)(1997-8#2)(2005-9#1)(2006-5#1)(2007-12#1)(2007-8#2)(2008-10#6)(2008-11#3)(2008-2#12)(2008-3#1)(2008-5#4)(2008-7#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2010-1#1)(2010-10#1)(2010-12#12)(2010-2#1)(2010-5#2)(2010-9#1)(2011-2#2)(2012-11#1)(2012-2#2)(2013-1#2)(2013-7#1)
tracers can be##2##3##(2010-12#1)(2010-6#1)
tracers for##6##2##(1994-8#1)(2008-1#1)(2008-11#2)(2010-6#2)
tracers have##2##2##(2006-5#1)(2008-5#1)
tracers in##3##2##(1997-7#1)(2008-5#1)(2008-7#1)
tracers of##2##2##(1993-2#1)(2008-11#1)
tracers through a##2##3##(2008-10#2)
tracers##50##1##(1990-5#4)(1992-3#1)(1992-8#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-11#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-5#1)(2008-1#2)(2008-10#3)(2008-11#5)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2010-12#2)(2010-6#3)(2010-7#1)(2011-1#1)(2012-2#1)
traces and##4##2##(2008-11#1)(2008-7#1)(2009-12#1)(2013-1#1)
traces are##3##2##(1993-9#1)(2007-12#1)(2008-3#1)
traces at the##2##3##(2008-10#1)(2008-3#1)
traces can be##2##3##(2007-12#1)(2008-10#1)
traces in the##3##3##(2008-5#1)(2013-1#2)
traces in##7##2##(2008-10#3)(2008-5#1)(2011-12#1)(2013-1#2)
traces of aluminium##2##3##(2008-10#2)
traces of nickel(II)##3##3##(2008-10#3)
traces of silver ions##3##4##(2008-10#3)
traces of the##2##3##(1990-5#1)(2007-11#1)
traces of##62##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-2#1)(1995-2#1)(1995-9#1)(1996-3#1)(1996-5#1)(2007-1#1)(2007-11#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#42)(2008-11#1)(2008-3#1)(2008-5#1)(2009-3#1)(2010-8#2)(2013-1#1)
traces the development##2##3##(1997-8#1)(2012-2#1)
traces the history of##3##4##(2005-7#1)(2008-2#1)(2010-3#1)
traces the##12##2##(1994-3#1)(1997-8#1)(2005-7#1)(2006-3#1)(2006-7#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-5#1)(2010-3#1)(2012-2#2)
traces to##2##2##(1992-10#1)(2008-10#1)
traces with##3##2##(2008-10#2)(2013-7#1)
traces##123##1##(1990-11#1)(1990-2#1)(1990-5#1)(1991-2#1)(1992-10#1)(1993-11#1)(1993-9#1)(1994-3#1)(1995-2#1)(1995-9#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-8#1)(2005-7#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-3#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#60)(2008-11#4)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-3#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-12#1)(2012-2#4)(2013-1#4)(2013-7#1)
trachea and esophagus##2##3##(2007-8#1)(2011-1#1)
trachea and lungs##2##3##(1993-8#1)(2011-1#1)
trachea and##17##2##(1993-3#1)(1993-8#1)(2007-11#1)(2007-6#1)(2007-8#3)(2008-5#1)(2008-9#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#3)
trachea in##2##2##(2010-7#1)(2011-1#1)
trachea is##2##2##(2007-8#1)(2008-11#1)
trachea or##2##2##(1993-3#1)(2008-5#1)
trachea were##2##2##(2008-9#1)(2013-1#1)
trachea##97##1##(1990-4#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-8#1)(1992-10#1)(1992-3#1)(1992-5#1)(1993-3#6)(1993-8#1)(1994-10#1)(1994-3#1)(1994-5#1)(1995-12#2)(1996-10#2)(1996-12#2)(1996-3#1)(1996-6#2)(1996-9#1)(1997-1#3)(1997-3#1)(1997-6#2)(2005-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-8#14)(2008-10#1)(2008-11#1)(2008-5#7)(2008-8#3)(2008-9#7)(2009-2#1)(2009-6#1)(2009-9#2)(2010-10#1)(2010-12#2)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#7)(2013-1#5)
tracheae and##2##2##(1993-8#1)(2007-12#1)
tracheae are of no importance for##2##6##(2007-12#2)
tracheae are##3##2##(2007-12#3)
tracheae in##2##2##(2007-12#2)
tracheae##22##1##(1993-8#1)(2007-12#21)
tracheal and##3##2##(1993-8#1)(2005-9#1)(2006-10#1)
tracheal branches##3##2##(2007-12#1)(2008-7#1)(2012-12#1)
tracheal bronchial vasculature##2##3##(1997-1#2)
tracheal bronchial##3##2##(1997-1#3)
tracheal compression and##2##3##(2007-8#1)(2010-7#1)
tracheal compression##3##2##(2007-8#1)(2008-4#1)(2010-7#1)
tracheal epithelial##3##2##(1993-3#1)(1995-8#2)
tracheal epithelium##7##2##(1990-4#2)(1991-9#1)(1994-6#1)(1995-11#2)(2008-1#1)
tracheal extubation of##3##3##(2006-10#1)(2007-9#1)(2010-7#1)
tracheal incisions##2##2##(2006-9#2)
tracheal injury##3##2##(2007-8#2)(2010-7#1)
tracheal intubation and mechanical ventilation##2##5##(1991-11#1)(1992-12#1)
tracheal intubation for##2##3##(2012-1#1)(2012-12#1)
tracheal intubation in##2##3##(1996-6#1)(2011-1#1)
tracheal intubation##13##2##(1991-11#1)(1992-12#1)(1996-6#1)(1997-4#1)(2006-10#2)(2007-8#1)(2009-2#1)(2009-4#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-8#1)
tracheal lumen##5##2##(1990-4#2)(2007-8#1)(2008-10#1)(2008-5#1)
tracheal mite##3##2##(1991-2#3)
tracheal mucosa##2##2##(1991-5#1)(2008-8#1)
tracheal mucous velocity##4##3##(1991-9#4)
tracheal obstruction##8##2##(2007-8#1)(2013-1#7)
tracheal pseudomembrane##4##2##(2012-12#4)
tracheal repair##2##2##(2007-8#2)
tracheal rings##4##2##(2008-5#3)(2013-1#1)
tracheal rupture##3##2##(2007-8#2)(2009-5#1)
tracheal smooth##2##2##(1997-7#2)
tracheal stenosis after##2##3##(2007-8#2)
tracheal stenosis with##2##3##(2007-8#1)(2013-1#1)
tracheal stenosis##13##2##(2006-9#1)(2007-8#6)(2007-9#1)(2008-9#1)(2009-9#2)(2013-1#2)
tracheal stents##2##2##(2012-12#1)(2013-1#1)
tracheal system of harvestmen##2##4##(2007-12#2)
tracheal system of##4##3##(2007-12#4)
tracheal system##6##2##(2007-12#6)
tracheal tube is##2##3##(1997-4#1)(2007-8#1)
tracheal tube##7##2##(1997-4#1)(2006-10#2)(2007-8#1)(2009-5#1)(2011-2#1)(2012-12#1)
tracheal wall##4##2##(1993-7#2)(2008-5#1)(2011-2#1)
tracheal walls##4##2##(2007-12#4)
tracheal wash##2##2##(2007-2#1)(2012-2#1)
tracheal##203##1##(1990-3#1)(1990-4#6)(1990-7#2)(1991-11#5)(1991-2#5)(1991-5#1)(1991-9#6)(1992-12#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-7#3)(1993-8#1)(1994-10#2)(1994-11#3)(1994-6#3)(1994-9#1)(1995-11#2)(1995-3#1)(1995-8#2)(1996-3#2)(1996-6#1)(1997-1#4)(1997-4#2)(1997-6#1)(1997-7#2)(2005-9#1)(2006-10#9)(2006-9#5)(2007-12#15)(2007-2#3)(2007-8#25)(2007-9#4)(2008-1#3)(2008-10#2)(2008-4#1)(2008-5#11)(2008-7#2)(2008-8#2)(2008-9#2)(2009-2#3)(2009-4#1)(2009-5#2)(2009-6#3)(2009-9#2)(2010-7#4)(2011-1#3)(2011-2#3)(2012-1#2)(2012-12#15)(2012-2#1)(2012-3#2)(2013-1#16)(2013-8#1)
trachealess##3##1##(1997-4#1)(2010-4#2)
tracheas##3##1##(1997-3#2)(2008-5#1)
tracheo-bronchial##4##1##(2007-8#2)(2008-5#1)(2009-4#1)
tracheo-oesophageal fistula##3##2##(2007-8#2)(2010-11#1)
tracheobronchial tree##8##2##(1991-4#1)(2007-8#2)(2007-9#1)(2008-5#3)(2010-12#1)
tracheobronchial##20##1##(1991-4#1)(1992-2#1)(1992-5#2)(1996-1#1)(1997-1#1)(2007-8#5)(2007-9#2)(2008-5#5)(2010-12#1)(2010-8#1)
tracheobronchomegaly##4##1##(2008-5#1)(2010-12#2)(2012-12#1)
tracheocele##3##1##(2007-8#3)
tracheoesophageal fistula and##3##3##(1996-6#1)(2008-11#1)(2010-12#1)
tracheoesophageal fistula##12##2##(1996-6#2)(1997-3#2)(2007-8#3)(2008-11#1)(2008-6#1)(2008-8#1)(2010-12#1)(2012-12#1)
tracheoesophageal##15##1##(1996-6#2)(1997-3#2)(2006-8#1)(2007-8#4)(2008-11#1)(2008-6#1)(2008-8#1)(2010-12#1)(2012-12#1)(2013-1#1)
tracheomalacia##3##1##(2007-8#1)(2011-1#1)(2013-1#1)
tracheomycosis of##2##2##(2008-10#2)
tracheostoma##2##1##(1997-4#1)(2007-8#1)
tracheostomy and ventilator##2##3##(2012-2#2)
tracheostomy and##7##2##(1995-2#1)(2006-10#1)(2006-4#1)(2009-2#1)(2012-2#2)(2013-8#1)
tracheostomy have##2##2##(2007-8#2)
tracheostomy in the intensive care##2##5##(2006-10#1)(2013-1#1)
tracheostomy in the##3##3##(1996-3#1)(2006-10#1)(2013-1#1)
tracheostomy in##6##2##(1996-3#1)(2006-10#3)(2008-2#1)(2013-1#1)
tracheostomy site##2##2##(2006-4#1)(2013-1#1)
tracheostomy tube was##2##3##(2009-6#2)
tracheostomy tube##6##2##(2006-4#1)(2009-6#3)(2009-9#1)(2011-2#1)
tracheostomy wound##2##2##(2008-2#2)
tracheostomy##66##1##(1990-4#1)(1991-11#1)(1995-2#1)(1996-3#1)(1996-9#1)(2006-10#7)(2006-4#4)(2006-9#2)(2007-12#1)(2007-8#5)(2008-2#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#3)(2009-3#1)(2009-6#3)(2009-9#1)(2011-1#5)(2011-2#1)(2012-12#8)(2012-2#6)(2013-1#2)(2013-8#2)
tracheosyringeal##2##1##(2008-8#2)
tracheotomies##2##1##(2006-9#2)
tracheotomy##12##1##(1990-4#1)(1990-7#2)(1997-4#1)(2006-9#1)(2008-10#1)(2008-2#2)(2008-9#1)(2011-2#1)(2013-1#2)
trachitis/bronchitis##2##1##(2010-12#2)
trachoma and##2##2##(2006-2#1)(2010-8#1)
trachoma cases##2##2##(2006-2#2)
trachoma control##4##2##(1995-9#1)(2007-5#2)(2010-8#1)
trachoma in##4##2##(2006-2#1)(2010-8#2)(2013-1#1)
trachoma##26##1##(1991-9#1)(1995-9#1)(2006-10#1)(2006-2#8)(2007-1#1)(2007-5#5)(2010-8#7)(2013-1#1)(2013-7#1)
trachomatis and##11##2##(1991-3#2)(1992-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-3#1)(2012-2#1)
trachomatis are##2##2##(2008-3#1)(2011-1#1)
trachomatis as##2##2##(1991-12#1)(2008-3#1)
trachomatis by PCR##3##3##(2008-3#3)
trachomatis by##4##2##(2008-3#4)
trachomatis in##6##2##(1990-6#1)(1995-6#1)(2007-7#1)(2008-9#1)(2010-8#1)(2011-1#1)
trachomatis infection in##3##3##(2007-8#2)(2008-3#1)
trachomatis infection##12##2##(1997-3#1)(2006-10#2)(2007-8#3)(2008-11#1)(2008-3#2)(2012-3#1)(2013-1#2)
trachomatis is##3##2##(2006-10#1)(2007-7#2)
trachomatis pneumonia in infants##2##4##(2007-7#2)
trachomatis pneumonia##4##2##(2007-7#4)
trachomatis serovars##3##2##(1993-9#3)
trachomatis strains##3##2##(2005-12#1)(2007-7#1)(2008-9#1)
trachomatis was detected in##3##4##(2007-7#1)(2008-3#2)
trachomatis was detected##4##3##(2007-7#1)(2008-3#2)(2012-3#1)
trachomatis was found##2##3##(2007-7#1)(2008-12#1)
trachomatis was##9##2##(2005-11#1)(2007-7#3)(2007-8#1)(2008-12#1)(2008-3#2)(2012-3#1)
trachomatis##121##1##(1990-12#2)(1990-2#2)(1990-5#2)(1990-6#2)(1991-12#1)(1991-3#2)(1991-4#1)(1991-9#2)(1992-2#1)(1992-5#2)(1993-9#5)(1994-3#2)(1995-11#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-3#2)(1997-6#3)(2005-11#3)(2005-12#1)(2006-10#11)(2006-8#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-7#17)(2007-8#10)(2008-11#1)(2008-12#5)(2008-3#12)(2008-9#4)(2009-8#1)(2010-8#3)(2011-1#4)(2012-2#1)(2012-3#5)(2013-1#3)(2013-8#1)
trachomatis)##3##1##(1997-3#1)(2007-8#1)(2012-3#1)
tracing and##10##2##(1990-5#1)(1993-9#1)(1994-12#1)(1997-3#1)(2007-10#1)(2008-2#3)(2008-3#1)(2008-7#1)
tracing from the##2##3##(1995-7#1)(2010-10#1)
tracing in##2##2##(1993-3#1)(2008-3#1)
tracing is##3##2##(2008-2#1)(2008-3#1)(2010-12#1)
tracing method##5##2##(1990-5#2)(2004-11#1)(2008-3#2)
tracing methods##4##2##(1990-4#1)(1991-9#1)(2008-4#1)(2010-12#1)
tracing of##5##2##(1993-10#1)(1995-7#1)(2007-9#1)(2008-3#1)(2010-12#1)
tracing study##2##2##(1993-12#1)(1995-11#1)
tracing technique##2##2##(1996-11#1)(1997-7#1)
tracing techniques##3##2##(1996-9#1)(2008-4#1)(2010-10#1)
tracing the##5##2##(1990-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-3#1)
tracing to investigate##2##3##(1995-11#1)(2008-2#1)
tracing to##4##2##(1995-11#1)(2008-2#2)(2010-12#1)
tracing was##3##2##(1994-3#1)(2004-11#1)(2008-2#1)
tracing with immunofluorescence##2##3##(1995-10#1)(1996-9#1)
tracing##105##1##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#3)(1991-8#1)(1991-9#2)(1992-5#1)(1993-10#1)(1993-12#2)(1993-3#1)(1993-9#3)(1994-12#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-10#1)(1995-11#2)(1995-2#1)(1995-7#2)(1996-11#1)(1996-9#2)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#3)(2005-7#1)(2006-5#2)(2007-10#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-2#26)(2008-3#14)(2008-4#3)(2008-5#1)(2008-7#1)(2010-10#2)(2010-12#7)(2010-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
tracings##3##1##(1994-3#1)(2008-4#1)(2011-1#1)
track and##3##2##(2007-9#1)(2008-3#1)(2011-2#1)
track cell##2##2##(2008-9#1)(2012-2#1)
track down##2##2##(2006-7#1)(2008-11#1)
track for##3##2##(1995-12#1)(1997-2#1)(2008-10#1)
track in the##2##3##(1992-6#1)(2010-9#1)
track in##5##2##(1992-6#1)(1996-2#1)(2008-10#1)(2010-7#1)(2010-9#1)
track of##5##2##(1994-7#1)(2007-9#1)(2008-12#2)(2008-8#1)
track offset##5##2##(2008-2#5)
track patients with diabetes and other##2##6##(2013-8#2)
track patients with diabetes##4##4##(2013-8#4)
track pitch and##2##3##(2008-2#1)(2008-3#1)
track pitch of##2##3##(2007-12#1)(2008-2#1)
track pitch##7##2##(2007-12#1)(2008-2#4)(2008-3#2)
track provides##2##2##(1992-3#2)
track record of##2##3##(2008-1#1)(2012-3#1)
track record##4##2##(2007-4#1)(2008-1#1)(2008-5#1)(2012-3#1)
track the change##2##3##(2007-12#1)(2008-10#1)
track the route to##2##4##(2007-12#1)(2008-6#1)
track the##34##2##(1994-3#1)(1996-5#1)(2004-4#1)(2005-11#1)(2005-8#1)(2006-6#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-8#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
track their##2##2##(1996-2#1)(2007-7#1)
track was##2##2##(1995-11#1)(2009-4#1)
track##168##1##(1992-1#1)(1992-3#2)(1992-5#1)(1992-6#2)(1993-12#1)(1994-3#1)(1994-7#1)(1995-11#1)(1995-12#3)(1996-12#1)(1996-2#2)(1996-5#1)(1996-9#1)(1997-2#2)(2004-4#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#2)(2006-2#1)(2006-6#2)(2006-7#1)(2007-11#3)(2007-12#4)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#6)(2008-1#2)(2008-10#7)(2008-11#6)(2008-12#2)(2008-2#18)(2008-3#12)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#1)(2009-11#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#5)(2010-2#5)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#8)(2012-3#1)(2013-1#3)(2013-8#4)
track-error##2##1##(2008-2#2)
track]##2##1##(1991-11#1)(2008-4#1)
trackball##2##1##(2010-4#2)
tracked by##5##2##(2005-11#1)(2008-10#1)(2008-2#1)(2011-1#1)(2012-12#1)
tracked from##2##2##(2008-2#1)(2011-1#1)
tracked points in##2##3##(2008-6#2)
tracked the##5##2##(1997-3#1)(2008-11#1)(2008-3#1)(2009-11#1)(2013-8#1)
tracked##47##1##(1992-11#1)(1994-3#1)(1997-3#1)(2005-11#1)(2005-8#1)(2007-1#2)(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#2)(2008-6#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-8#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#1)
tracker and##2##2##(2008-2#1)(2008-3#1)
tracker##8##1##(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2009-12#1)(2012-1#1)(2013-1#1)
trackers##4##1##(2009-12#3)(2012-2#1)
tracking ability and##2##3##(2008-3#1)(2012-1#1)
tracking and##12##2##(1995-12#1)(2008-2#7)(2008-3#1)(2009-4#1)(2010-5#1)(2013-1#1)
tracking behaviors##4##2##(2013-1#4)
tracking control##2##2##(2010-2#2)
tracking correlations##5##2##(1992-6#5)
tracking data##2##2##(2008-10#1)(2009-4#1)
tracking devices##3##2##(2009-12#3)
tracking error signal##3##3##(2008-2#3)
tracking error##4##2##(2008-2#4)
tracking in##8##2##(2007-12#1)(2007-9#2)(2008-2#2)(2008-9#1)(2012-12#1)(2013-1#1)
tracking noise##2##2##(2008-2#1)(2008-3#1)
tracking of the number and content of physician performance reports##2##10##(2013-1#2)
tracking of the##10##3##(1995-9#1)(2007-12#1)(2008-2#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
tracking of##28##2##(1991-12#1)(1994-12#1)(1995-9#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-6#1)(2009-10#2)(2010-11#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#3)(2013-1#5)(2013-8#2)
tracking offset##3##2##(2008-2#3)
tracking or##2##2##(2005-8#1)(2007-12#1)
tracking performance##5##2##(1997-8#2)(2008-3#1)(2012-1#2)
tracking software##3##2##(2009-12#1)(2013-1#2)
tracking studies##2##2##(2010-8#1)(2013-1#1)
tracking system##9##2##(2006-6#1)(2007-11#1)(2008-2#3)(2009-4#1)(2011-2#1)(2012-12#2)
tracking systems##5##2##(1995-12#1)(1996-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
tracking task##2##2##(1997-8#1)(2012-1#1)
tracking tasks##6##2##(1993-9#1)(2012-1#5)
tracking technique##3##2##(2008-11#1)(2008-7#1)(2012-1#1)
tracking the position##2##3##(2008-2#1)(2010-8#1)
tracking the##14##2##(1995-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-12#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-1#1)
tracking to the##2##3##(1996-6#1)(1996-8#1)
tracking was##3##2##(2012-2#1)(2013-1#2)
tracking with##3##2##(2008-11#1)(2009-10#1)(2012-1#1)
tracking##259##1##(1990-11#1)(1991-12#3)(1992-6#6)(1993-11#1)(1993-9#1)(1994-12#1)(1995-12#3)(1995-4#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-6#2)(1996-8#3)(1997-1#1)(1997-5#1)(1997-8#5)(2005-11#2)(2005-8#1)(2006-10#1)(2006-6#2)(2006-9#1)(2007-11#4)(2007-12#6)(2007-5#2)(2007-6#1)(2007-9#2)(2008-1#5)(2008-10#6)(2008-11#8)(2008-2#41)(2008-3#15)(2008-4#2)(2008-6#3)(2008-7#4)(2008-9#4)(2009-10#3)(2009-12#7)(2009-4#5)(2009-6#1)(2010-10#1)(2010-11#1)(2010-2#4)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#7)(2011-1#7)(2011-2#6)(2012-1#17)(2012-12#6)(2012-2#8)(2013-1#37)(2013-8#2)
tracking)##2##1##(2007-12#1)(2008-2#1)
tracking-error signal (TES)##2##3##(2008-2#1)(2008-3#1)
tracking-error signal##5##2##(2008-2#3)(2008-3#2)
tracks and##3##2##(2007-4#1)(2008-3#1)(2012-2#1)
tracks are##2##2##(2008-2#1)(2011-12#1)
tracks can be##2##3##(2008-4#1)(2011-12#1)
tracks for##2##2##(1992-3#1)(2008-11#1)
tracks in##3##2##(2007-3#1)(2008-2#1)(2008-4#1)
tracks the##7##2##(1996-12#1)(2006-5#1)(2008-1#1)(2008-5#1)(2009-10#1)(2009-4#1)(2009-5#1)
tracks to##3##2##(1994-9#1)(2007-10#1)(2010-12#1)
tracks##52##1##(1990-5#1)(1991-4#1)(1992-3#1)(1994-2#1)(1994-9#1)(1996-12#1)(1997-2#1)(2006-2#1)(2006-5#2)(2007-10#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#2)(2011-1#1)(2011-12#11)(2011-2#1)(2012-2#2)
tracks&quot##2##1##(2008-4#1)(2011-2#1)
tract TCC##2##2##(2006-9#2)
tract abnormalities##2##2##(1996-12#1)(2011-2#1)
tract after##2##2##(2007-8#1)(2008-10#1)
tract ailments##3##2##(2010-12#3)
tract among##2##2##(2007-3#1)(2008-11#1)
tract and a##2##3##(1995-8#1)(2008-11#1)
tract and from##2##3##(1996-2#1)(2008-5#1)
tract and is##2##3##(1995-4#1)(2008-10#1)
tract and may##3##3##(1992-4#1)(2011-2#1)(2013-1#1)
tract and the##11##3##(1992-9#1)(1994-5#1)(1996-8#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)
tract and##61##2##(1990-3#1)(1990-4#1)(1990-5#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-5#1)(1994-5#1)(1995-4#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-8#1)(2005-10#1)(2005-7#1)(2006-10#3)(2006-4#1)(2006-5#2)(2006-9#1)(2007-10#1)(2007-12#1)(2007-8#1)(2007-9#2)(2008-10#3)(2008-11#3)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#1)
tract appears to be##2##4##(1996-8#1)(2006-2#1)
tract are rare##2##3##(1993-1#1)(2007-8#1)
tract are##17##2##(1990-6#1)(1992-3#1)(1993-1#1)(1993-5#1)(1994-12#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#2)(2012-12#1)(2012-2#1)
tract as##3##2##(1995-5#1)(2008-5#1)(2010-11#1)
tract associated cells##6##3##(2007-12#6)
tract associated##8##2##(1991-2#1)(1992-9#1)(2007-12#6)
tract but##2##2##(1991-11#1)(2006-10#1)
tract by a##3##3##(1992-9#1)(1994-12#1)(2011-1#1)
tract by##6##2##(1991-11#1)(1992-9#1)(1994-12#1)(2007-5#1)(2009-1#1)(2011-1#1)
tract calculi##2##2##(2006-12#1)(2011-1#1)
tract can be successfully##2##4##(2009-5#1)(2013-8#1)
tract can be##7##3##(1991-9#1)(1992-9#1)(1994-6#1)(2006-2#1)(2009-5#1)(2013-1#1)(2013-8#1)
tract can##9##2##(1991-9#1)(1992-9#1)(1994-6#1)(1996-12#1)(2006-2#1)(2009-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
tract cancer and##2##3##(2006-10#1)(2013-1#1)
tract cancer##13##2##(2006-10#7)(2006-6#1)(2008-1#1)(2010-12#3)(2013-1#1)
tract cancers##7##2##(1991-12#1)(1991-9#1)(2006-2#1)(2006-6#2)(2010-8#1)(2012-3#1)
tract caused##3##2##(2006-4#1)(2006-6#1)(2007-11#1)
tract congestion##3##2##(1997-4#1)(2010-12#2)
tract disease in##3##3##(2010-2#1)(2011-2#2)
tract disease##16##2##(1996-9#2)(2006-10#6)(2008-3#1)(2009-3#1)(2010-12#1)(2010-2#1)(2011-2#4)
tract diseases##7##2##(1991-12#2)(1992-6#1)(2006-2#1)(2008-10#1)(2009-8#1)(2012-12#1)
tract disorder##3##2##(1991-5#2)(2009-12#1)
tract disorders##2##2##(1993-9#1)(2006-12#1)
tract epithelial##2##2##(1991-9#1)(1994-4#1)
tract for##3##2##(2009-3#1)(2010-5#1)(2011-2#1)
tract from the##2##3##(1990-11#1)(2005-3#1)
tract from##3##2##(1990-11#1)(2005-3#1)(2012-12#1)
tract has been##2##3##(2006-10#1)(2011-1#1)
tract has##4##2##(2005-8#1)(2006-10#1)(2007-12#1)(2011-1#1)
tract have been described##2##4##(1997-8#1)(2012-2#1)
tract have been##4##3##(1990-8#1)(1997-8#1)(2012-12#1)(2012-2#1)
tract have##7##2##(1990-8#1)(1997-8#1)(2006-10#1)(2007-11#1)(2008-8#1)(2012-12#1)(2012-2#1)
tract in a##4##3##(1991-11#1)(2007-10#1)(2012-1#1)(2013-8#1)
tract in the##2##3##(1991-10#1)(2006-9#1)
tract in##25##2##(1990-11#1)(1991-10#1)(1991-11#1)(1992-12#1)(1992-9#2)(1994-12#1)(2004-2#1)(2006-2#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-1#2)(2013-7#1)(2013-8#1)
tract infection (UTI) by##2##4##(2006-10#1)(2007-8#1)
tract infection (UTI)##14##3##(2006-10#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-5#3)(2011-2#2)(2012-11#1)
tract infection and##9##3##(2006-10#1)(2006-2#1)(2008-10#1)(2008-4#3)(2008-7#1)(2010-12#1)(2010-2#1)
tract infection in##12##3##(1992-9#1)(1993-10#2)(2006-4#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-1#1)(2010-10#1)(2011-2#1)(2013-1#1)
tract infection is the##3##4##(2006-10#1)(2012-3#1)(2013-1#1)
tract infection is##4##3##(1991-12#1)(2006-10#1)(2012-3#1)(2013-1#1)
tract infection were##2##3##(2013-1#1)(2013-8#1)
tract infection with##3##3##(2008-10#1)(2009-5#1)(2013-1#1)
tract infection##108##2##(1990-11#1)(1991-12#1)(1991-4#1)(1992-9#1)(1993-1#2)(1993-10#2)(1994-2#1)(1994-3#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-8#1)(2005-10#1)(2005-7#2)(2005-8#1)(2006-10#9)(2006-2#2)(2006-4#1)(2006-9#3)(2007-12#4)(2007-2#2)(2007-3#1)(2007-7#6)(2007-8#4)(2008-1#4)(2008-10#3)(2008-3#2)(2008-4#4)(2008-6#2)(2008-7#6)(2009-1#2)(2009-5#5)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
tract infections are##4##3##(1997-4#1)(2005-11#1)(2006-4#1)(2013-8#1)
tract infections caused by##2##4##(1992-4#1)(2006-10#1)
tract infections in children##3##4##(2006-9#1)(2009-5#1)(2012-12#1)
tract infections in infants##2##4##(2007-12#1)(2008-11#1)
tract infections in women##3##4##(1992-9#1)(1993-1#1)(2011-1#1)
tract infections in##22##3##(1991-11#1)(1992-9#1)(1993-1#1)(1993-2#1)(1996-12#1)(1997-2#2)(2006-4#1)(2006-9#1)(2007-10#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-2#1)(2009-5#1)(2010-11#1)(2011-1#1)(2012-12#2)
tract infections were##3##3##(1992-12#1)(1993-2#1)(2008-1#1)
tract infections##120##2##(1990-7#1)(1991-11#1)(1991-12#5)(1991-4#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-2#3)(1994-11#1)(1995-5#1)(1996-12#3)(1997-2#2)(1997-4#2)(2005-11#2)(2005-8#1)(2005-9#1)(2006-10#4)(2006-4#3)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-3#2)(2007-4#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-2#2)(2009-3#2)(2009-5#2)(2009-7#1)(2009-9#2)(2010-11#4)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#6)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#4)
tract infections]##4##2##(1993-11#1)(1995-6#1)(1997-5#1)(2013-8#1)
tract involvement##3##2##(2007-2#1)(2012-2#1)(2012-3#1)
tract is a##6##3##(1990-6#1)(1996-1#1)(2006-6#1)(2008-12#1)(2008-4#1)(2009-1#1)
tract is rare##2##3##(1990-8#2)
tract is the most common##2##5##(2006-10#1)(2009-8#1)
tract is the##4##3##(1996-12#1)(2006-10#1)(2009-8#1)(2012-12#1)
tract is##29##2##(1990-11#2)(1990-6#1)(1990-8#2)(1993-5#1)(1996-1#1)(1996-11#1)(1996-12#2)(2005-11#1)(2006-10#2)(2006-2#2)(2006-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-1#1)(2009-2#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)
tract lesions##4##2##(1996-12#1)(2008-5#3)
tract malignancies##4##2##(2007-4#1)(2009-10#1)(2009-5#1)(2010-7#1)
tract malignancy##2##2##(1990-2#1)(2007-3#1)
tract may be##2##3##(1991-12#1)(1992-12#1)
tract may##3##2##(1991-12#1)(1992-12#1)(2012-12#1)
tract neoplasms##3##2##(1991-5#1)(1992-12#1)(2010-12#1)
tract obstruction##12##2##(1992-9#1)(2005-1#1)(2006-4#1)(2007-8#4)(2007-9#1)(2011-1#1)(2011-2#1)(2012-2#2)
tract of animals##2##3##(1993-10#1)(2008-10#1)
tract of children##2##3##(2007-3#1)(2011-2#1)
tract of ruminants##2##3##(2006-8#1)(2013-1#1)
tract of the rat##2##4##(1996-11#1)(1996-9#1)
tract of the##16##3##(1990-9#1)(1991-10#1)(1991-11#2)(1994-11#1)(1996-11#1)(1996-3#1)(1996-5#2)(1996-9#1)(2006-5#1)(2007-2#1)(2008-5#1)(2011-2#2)(2013-1#1)
tract of##53##2##(1990-4#1)(1990-9#2)(1991-10#1)(1991-11#2)(1991-2#1)(1992-2#1)(1993-10#2)(1994-10#1)(1994-11#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-9#1)(1997-6#1)(2006-5#1)(2006-8#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#4)(2008-7#1)(2011-2#6)(2012-2#2)(2013-1#6)
tract or the##2##3##(1992-12#1)(2008-11#1)
tract or##5##2##(1990-6#1)(1992-12#1)(2008-11#1)(2008-5#1)(2012-1#1)
tract pathogens##3##2##(2010-3#1)(2013-1#1)(2013-8#1)
tract pathology##2##2##(2009-4#1)(2010-12#1)
tract reconstruction##5##2##(2006-10#1)(2007-8#1)(2008-10#1)(2011-12#1)(2012-1#1)
tract samples##2##2##(2008-7#1)(2009-3#1)
tract showed a##2##3##(2006-2#1)(2011-2#1)
tract surgery##2##2##(2009-8#1)(2011-2#1)
tract symptoms##12##2##(1995-8#1)(2006-9#5)(2008-1#1)(2008-10#1)(2008-6#2)(2013-1#1)(2013-8#1)
tract that##3##2##(2006-2#1)(2007-7#1)(2009-8#1)
tract throughout the##2##3##(2008-5#1)(2008-7#1)
tract tissue##2##2##(2006-9#1)(2008-5#1)
tract to the##3##3##(1996-7#1)(2007-12#1)(2008-9#1)
tract to##4##2##(1996-7#1)(2006-10#1)(2007-12#1)(2008-9#1)
tract tracing methods##2##3##(1990-4#1)(2008-4#1)
tract tracing##5##2##(1990-4#1)(1997-6#1)(2008-4#3)
tract transection in neonatal rats##2##5##(2013-1#2)
tract transection##4##2##(2013-1#4)
tract tumors##4##2##(2007-10#1)(2007-4#2)(2010-12#1)
tract was##11##2##(1990-4#1)(1990-6#1)(1992-2#1)(1995-11#1)(1996-3#1)(1996-5#1)(2007-8#1)(2008-1#1)(2010-12#1)(2011-1#1)(2013-1#1)
tract were##6##2##(1990-10#1)(1991-6#1)(2007-2#1)(2008-1#1)(2008-8#1)(2010-12#1)
tract will##2##2##(1994-9#1)(2008-11#1)
tract with##5##2##(1991-5#1)(2006-10#1)(2006-2#1)(2008-10#1)(2010-12#1)
tract without##2##2##(2005-9#1)(2011-2#1)
tract##1161##1##(1990-10#2)(1990-11#8)(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#6)(1990-5#2)(1990-6#7)(1990-7#1)(1990-8#10)(1990-9#3)(1991-1#1)(1991-10#2)(1991-11#11)(1991-12#16)(1991-2#4)(1991-4#4)(1991-5#7)(1991-6#3)(1991-8#1)(1991-9#7)(1992-1#2)(1992-11#1)(1992-12#11)(1992-2#4)(1992-3#7)(1992-4#4)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#5)(1992-9#19)(1993-1#7)(1993-10#8)(1993-11#1)(1993-12#3)(1993-2#6)(1993-5#6)(1993-6#1)(1993-8#2)(1993-9#3)(1994-1#3)(1994-10#4)(1994-11#2)(1994-12#4)(1994-2#3)(1994-3#4)(1994-4#1)(1994-5#1)(1994-6#3)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#2)(1995-3#1)(1995-4#1)(1995-5#6)(1995-6#4)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#5)(1996-10#2)(1996-11#2)(1996-12#18)(1996-2#2)(1996-3#4)(1996-4#2)(1996-5#11)(1996-6#1)(1996-7#3)(1996-8#5)(1996-9#5)(1997-1#5)(1997-2#4)(1997-3#3)(1997-4#5)(1997-5#2)(1997-6#6)(1997-8#3)(2004-12#1)(2004-2#3)(2005-1#2)(2005-10#3)(2005-11#7)(2005-3#4)(2005-7#4)(2005-8#4)(2005-9#2)(2006-10#62)(2006-12#2)(2006-2#18)(2006-4#7)(2006-5#6)(2006-6#8)(2006-7#1)(2006-8#3)(2006-9#18)(2007-1#1)(2007-10#7)(2007-11#11)(2007-12#24)(2007-2#9)(2007-3#6)(2007-4#5)(2007-5#6)(2007-6#2)(2007-7#14)(2007-8#19)(2007-9#5)(2008-1#14)(2008-10#39)(2008-11#12)(2008-12#4)(2008-3#9)(2008-4#23)(2008-5#43)(2008-6#12)(2008-7#21)(2008-8#9)(2008-9#8)(2009-1#5)(2009-10#2)(2009-12#2)(2009-2#7)(2009-3#6)(2009-4#4)(2009-5#14)(2009-6#4)(2009-7#4)(2009-8#7)(2009-9#4)(2010-10#2)(2010-11#6)(2010-12#28)(2010-2#7)(2010-3#3)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#6)(2010-9#2)(2011-1#23)(2011-12#6)(2011-2#54)(2012-1#14)(2012-11#2)(2012-12#22)(2012-2#28)(2012-3#11)(2013-1#53)(2013-2#1)(2013-7#6)(2013-8#28)
tract)##2##1##(1991-1#1)(2013-7#1)
tract-tracing##2##1##(1996-11#1)(2008-7#1)
tract]##7##1##(1994-3#1)(1994-4#1)(1995-11#1)(1995-6#1)(1995-8#1)(2007-5#1)(2013-7#1)
tractable in##2##2##(2008-11#1)(2012-3#1)
tractable model##2##2##(2006-11#1)(2007-12#1)
tractable##17##1##(2005-10#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-8#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
traction and##4##2##(2005-10#1)(2006-9#1)(2007-11#1)(2007-12#1)
traction before closed reduction##2##4##(2007-8#2)
traction before##4##2##(2005-10#1)(2007-8#3)
traction for##2##2##(2005-10#1)(2006-4#1)
traction force##2##2##(2008-10#1)(2012-2#1)
traction forces##4##2##(2008-11#4)
traction in##2##2##(2007-4#1)(2012-1#1)
traction mobilizations##3##2##(2008-10#3)
traction of the##2##3##(2007-11#1)(2008-7#1)
traction was##2##2##(2005-10#2)
traction##66##1##(1992-1#2)(1993-9#2)(1996-12#1)(2005-10#10)(2006-3#3)(2006-4#1)(2006-9#3)(2007-10#1)(2007-11#4)(2007-12#1)(2007-4#1)(2007-7#3)(2007-8#9)(2008-10#6)(2008-11#4)(2008-7#2)(2008-9#4)(2009-4#2)(2009-5#1)(2009-9#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#2)
tractional##2##1##(2008-1#1)(2013-1#1)
tractography##5##1##(2008-11#1)(2008-9#2)(2010-12#1)(2012-2#1)
tractor fatalities##2##2##(2012-12#2)
tractor##5##1##(2012-12#5)
tractors and##2##2##(2008-11#1)(2008-12#1)
tractors##4##1##(2008-11#1)(2008-12#2)(2012-12#1)
tracts and##12##2##(1990-7#1)(1993-3#1)(1996-1#1)(1996-4#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-7#1)(2009-3#1)(2009-4#1)
tracts are##4##2##(1990-5#1)(1993-9#1)(2005-10#1)(2005-11#1)
tracts as well as##2##4##(1996-4#1)(2008-5#1)
tracts as well##3##3##(1996-4#1)(2006-7#1)(2008-5#1)
tracts in the##4##3##(1995-3#1)(1997-1#2)(2006-11#1)
tracts in##9##2##(1995-3#1)(1997-1#2)(2006-11#1)(2006-7#1)(2009-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
tracts of TTAGGG repeats are##2##5##(1993-9#2)
tracts of the##2##3##(1996-7#1)(2007-12#1)
tracts of##13##2##(1993-9#3)(1996-7#1)(1997-4#1)(1997-7#1)(2006-8#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)(2013-1#1)
tracts to##2##2##(2007-12#1)(2009-9#1)
tracts##96##1##(1990-5#1)(1990-6#1)(1990-7#1)(1991-11#2)(1992-11#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-9#4)(1994-2#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-6#3)(1996-1#1)(1996-11#1)(1996-4#2)(1996-5#2)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-11#2)(2006-7#3)(2006-8#4)(2007-11#1)(2007-12#5)(2007-6#1)(2007-7#2)(2007-9#3)(2008-1#2)(2008-11#3)(2008-4#2)(2008-5#5)(2008-7#8)(2009-3#1)(2009-4#3)(2009-5#1)(2009-9#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#1)(2013-1#3)(2013-8#1)
tractus solitarius##19##2##(1990-9#1)(1991-3#1)(1993-7#3)(1994-10#2)(1994-2#1)(1995-11#1)(1997-2#2)(1997-5#6)(2007-10#2)
tractus##32##1##(1990-5#2)(1990-9#1)(1991-3#1)(1991-8#2)(1992-3#2)(1993-2#3)(1993-7#3)(1994-10#2)(1994-2#1)(1995-11#1)(1995-7#2)(1997-2#2)(1997-5#8)(2007-10#2)
trade agreements##3##2##(1996-12#1)(2008-1#2)
trade and##4##2##(2007-2#1)(2008-7#1)(2011-2#1)(2013-8#1)
trade associations##3##2##(1992-8#1)(1995-12#1)(2013-7#1)
trade between the##2##3##(1993-10#1)(2008-8#1)
trade between##3##2##(1993-10#1)(2008-8#1)(2011-2#1)
trade in animals and animal products##2##6##(2005-5#2)
trade in health services will##2##5##(2008-7#2)
trade in health services##4##4##(2008-7#3)(2011-1#1)
trade in medications##2##3##(2008-9#2)
trade in##17##2##(1994-3#1)(1997-7#1)(2005-5#3)(2007-12#1)(2007-5#3)(2007-8#1)(2008-10#1)(2008-7#3)(2008-9#2)(2011-1#1)
trade of##3##2##(2009-5#1)(2010-9#1)(2012-12#1)
trade off between accuracy and##2##5##(2007-12#1)(2008-3#1)
trade off between##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)
trade off##8##2##(1993-2#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-6#2)(2012-12#1)
trade or movement of##2##4##(2007-6#1)(2011-2#1)
trade practices##3##2##(2007-11#1)(2008-7#2)
trade publications##2##2##(1995-12#1)(2008-12#1)
trade routes##3##2##(2011-2#3)
trade##111##1##(1990-7#2)(1992-8#1)(1993-10#1)(1993-2#1)(1993-3#2)(1994-3#1)(1995-12#2)(1995-6#1)(1995-7#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-6#1)(1997-6#1)(1997-7#1)(2005-5#9)(2005-7#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#7)(2007-6#2)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#9)(2008-8#2)(2008-9#2)(2009-4#1)(2009-5#2)(2010-11#1)(2010-2#1)(2010-4#1)(2010-9#2)(2011-1#3)(2011-2#9)(2012-12#5)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#3)
trade-off among different##2##3##(1994-3#1)(2008-2#1)
trade-off among##3##2##(1994-3#2)(2008-2#1)
trade-off between competitive ability and##2##5##(2008-8#2)
trade-off between competitive##3##3##(2008-8#3)
trade-off between egg size and number##2##6##(1991-5#1)(2010-8#1)
trade-off between growth and##2##4##(2004-2#1)(2008-8#1)
trade-off between the##6##3##(2007-12#1)(2008-2#2)(2008-3#3)
trade-off between these two##2##4##(2007-3#1)(2008-2#1)
trade-off between these##3##3##(2007-3#1)(2008-2#1)(2008-9#1)
trade-off between##48##2##(1991-5#1)(1995-2#2)(2004-2#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-10#1)(2008-2#6)(2008-3#9)(2008-8#9)(2008-9#6)(2010-2#1)(2010-8#3)(2012-2#1)(2012-3#1)(2013-1#2)
trade-off can##2##2##(2008-8#2)
trade-off for##4##2##(2007-4#1)(2008-3#1)(2008-8#1)(2009-3#1)
trade-off in##5##2##(2008-10#1)(2008-8#2)(2008-9#1)(2011-1#1)
trade-off is##3##2##(2007-11#1)(2008-2#1)(2008-8#1)
trade-off to##2##2##(2008-8#2)
trade-off##95##1##(1990-10#1)(1991-5#1)(1994-3#2)(1995-2#2)(2004-2#2)(2007-1#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-4#3)(2008-10#3)(2008-2#9)(2008-3#11)(2008-5#1)(2008-8#29)(2008-9#8)(2009-3#1)(2009-4#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-8#4)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#3)
trade-off)##2##1##(2008-9#2)
trade-offs and##2##2##(2008-2#1)(2008-8#1)
trade-offs between the##2##3##(1996-1#1)(2008-9#1)
trade-offs between##13##2##(1994-2#1)(1996-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#3)(2008-9#2)(2009-6#1)(2012-3#1)(2013-8#1)
trade-offs for##2##2##(2008-2#1)(2008-9#1)
trade-offs in##4##2##(2008-10#1)(2008-8#1)(2008-9#2)
trade-offs that##4##2##(2008-2#1)(2008-3#1)(2008-8#1)(2010-3#1)
trade-offs##47##1##(1992-2#1)(1994-2#2)(1994-3#2)(1996-1#1)(2008-10#2)(2008-2#4)(2008-3#3)(2008-8#15)(2008-9#9)(2009-6#1)(2010-3#3)(2012-3#2)(2013-8#2)
traded##3##1##(1992-9#1)(2007-12#1)(2008-8#1)
trademark##5##1##(1992-7#1)(1995-3#1)(2007-9#2)(2008-10#1)
trademarks of##2##2##(2008-10#2)
tradeoff and##2##2##(2010-2#1)(2010-5#1)
tradeoff between##4##2##(2008-2#1)(2011-1#1)(2012-1#2)
tradeoff##11##1##(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-1#3)(2013-8#1)
tradeoffs##3##1##(2004-12#1)(2009-12#1)(2009-5#1)
traders##2##1##(1992-9#1)(2011-2#1)
trades##4##1##(2007-4#1)(2008-10#1)(2008-12#1)(2009-8#1)
trading partners##2##2##(2005-5#1)(2007-12#1)
trading##15##1##(1990-2#1)(1991-6#1)(1992-5#1)(2005-11#2)(2005-5#3)(2006-10#1)(2007-12#1)(2007-3#1)(2008-2#1)(2008-4#1)(2009-12#1)(2009-3#1)
tradition and##5##2##(1995-12#1)(2007-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
tradition in##2##2##(2008-4#1)(2011-2#1)
tradition of the##2##3##(2008-8#1)(2013-8#1)
tradition of##15##2##(1991-2#1)(1994-3#2)(1995-1#1)(2006-2#1)(2007-3#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-2#2)(2009-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
tradition that##2##2##(1996-12#1)(2007-12#1)
tradition##48##1##(1991-12#1)(1991-2#1)(1992-12#1)(1994-3#2)(1995-1#2)(1995-12#1)(1995-3#1)(1995-7#1)(1996-12#2)(1997-7#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-12#2)(2007-3#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-12#3)(2008-2#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#3)(2009-4#1)(2009-7#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
traditional &quot##7##2##(1991-3#1)(1995-8#1)(1996-3#1)(2007-10#1)(2007-5#2)(2012-2#1)
traditional 2D##2##2##(2011-7#1)(2013-1#1)
traditional Chinese herbs##2##3##(2005-8#1)(2008-10#1)
traditional Chinese medicinal##4##3##(1992-2#2)(2005-10#1)(2013-1#1)
traditional Chinese medicine (TCM)##2##4##(2007-8#1)(2012-2#1)
traditional Chinese medicine for treating##2##5##(1992-2#1)(2008-12#1)
traditional Chinese medicine for##3##4##(1992-2#1)(2008-10#1)(2008-12#1)
traditional Chinese medicine##28##3##(1992-2#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-12#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#1)
traditional Chinese medicine)##2##3##(2010-10#2)
traditional Chinese medicines with##3##4##(2007-8#1)(2011-3#2)
traditional Chinese medicines##9##3##(2007-8#2)(2008-10#2)(2008-3#1)(2011-2#1)(2011-3#3)
traditional Chinese##61##2##(1992-2#3)(1997-2#2)(2005-10#2)(2005-8#1)(2006-10#2)(2007-12#1)(2007-8#4)(2008-10#11)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-10#2)(2010-2#1)(2011-2#5)(2011-3#5)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#7)(2013-7#1)
traditional IIP##2##2##(2009-11#2)
traditional Japanese##2##2##(2008-10#1)(2013-1#1)
traditional LLE method##2##3##(2012-12#2)
traditional NSAIDs##7##2##(2006-10#1)(2007-12#1)(2007-7#3)(2008-3#2)
traditional RP-LC##2##2##(2008-10#2)
traditional RRFF flap##2##3##(2008-9#2)
traditional acrylates##2##2##(2008-3#2)
traditional agents##2##2##(2004-3#1)(2010-12#1)
traditional air##2##2##(2008-11#2)
traditional analysis##3##2##(1993-7#1)(2008-7#1)(2009-5#1)
traditional and non-traditional##2##3##(2006-10#2)
traditional and nontraditional##2##3##(2007-11#1)(2008-10#1)
traditional and##13##2##(1991-9#1)(1994-6#1)(2006-10#2)(2007-11#1)(2008-1#2)(2008-10#1)(2008-4#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
traditional antibiotics##2##2##(2008-1#1)(2008-5#1)
traditional approach##6##2##(1995-2#1)(2006-5#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-4#1)
traditional approaches to##6##3##(1997-3#1)(2005-12#1)(2008-5#1)(2010-12#1)(2013-1#2)
traditional approaches##14##2##(1997-3#1)(2004-2#1)(2005-12#1)(2006-10#2)(2008-10#2)(2008-5#1)(2009-3#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#2)
traditional areas of##2##3##(2010-7#1)(2011-2#1)
traditional arguments##2##2##(2005-10#1)(2006-7#1)
traditional assessment##4##2##(1993-6#1)(2008-11#1)(2011-2#2)
traditional barriers##2##2##(2005-11#1)(2008-11#1)
traditional behavioral##2##2##(2005-12#1)(2006-7#1)
traditional biological##3##2##(2008-8#1)(2010-8#1)(2012-2#1)
traditional birth attendants##3##3##(2010-8#2)(2011-1#1)
traditional birth attendants)##2##3##(2007-7#2)
traditional birth##6##2##(2007-7#3)(2010-8#2)(2011-1#1)
traditional blood##3##2##(2007-7#3)
traditional bone setter##2##3##(2009-3#2)
traditional bone##3##2##(2009-3#3)
traditional but##2##2##(2007-7#1)(2008-5#1)
traditional cardiovascular risk factors##8##4##(1990-5#1)(2007-10#2)(2007-7#1)(2008-3#1)(2008-9#1)(2011-1#2)
traditional cardiovascular##9##2##(1990-5#1)(1990-6#1)(2007-10#2)(2007-7#1)(2008-3#1)(2008-9#1)(2011-1#2)
traditional cell culture##2##3##(2008-11#1)(2008-5#1)
traditional chemical##2##2##(2008-3#1)(2013-1#1)
traditional clinical##8##2##(1994-1#1)(1996-1#2)(2005-9#1)(2008-1#1)(2010-11#1)(2012-3#1)(2013-8#1)
traditional concept of##5##3##(2006-5#1)(2008-1#1)(2008-6#1)(2008-7#1)(2012-2#1)
traditional concept##7##2##(2006-5#1)(2008-1#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-11#1)(2012-2#1)
traditional concepts##2##2##(1992-1#1)(1993-3#1)
traditional criteria##3##2##(1997-8#1)(2005-8#1)(2008-3#1)
traditional culture##3##2##(2008-5#3)
traditional cytotoxic##3##2##(2008-5#1)(2009-8#2)
traditional design##3##2##(1996-12#1)(2006-10#1)(2008-2#1)
traditional diagnostic##3##2##(1991-9#1)(1993-10#1)(2011-1#1)
traditional doctors##2##2##(1997-5#1)(2010-12#1)
traditional drugs##2##2##(2005-7#1)(2007-11#1)
traditional educational##2##2##(2006-5#1)(2007-7#1)
traditional engineering##2##2##(1997-8#1)(2011-2#1)
traditional epidemiological##2##2##(2008-7#2)
traditional evaluation##2##2##(1992-6#1)(2010-8#1)
traditional exercise##2##2##(1991-12#1)(2013-1#1)
traditional experimental##2##2##(2008-8#1)(2010-9#1)
traditional fee-for-service##2##2##(1995-1#1)(1997-2#1)
traditional fermented##5##2##(2009-11#2)(2010-2#2)(2010-4#1)
traditional flow##3##2##(2007-4#1)(2008-9#2)
traditional futon mattress##2##3##(2008-6#2)
traditional healer##2##2##(2007-2#1)(2012-12#1)
traditional healers for##2##3##(2008-10#1)(2009-6#1)
traditional healers##8##2##(2006-7#1)(2007-7#2)(2008-10#1)(2008-4#1)(2009-6#1)(2010-7#1)(2012-12#1)
traditional health care##4##3##(1991-1#1)(1992-12#1)(1995-1#1)(1996-12#1)
traditional health##8##2##(1990-11#1)(1991-1#1)(1992-1#1)(1992-12#1)(1993-6#1)(1995-1#2)(1996-12#1)
traditional herbalists##2##2##(2007-6#2)
traditional identification##2##2##(2007-11#1)(2008-5#1)
traditional inpatient##2##2##(1992-1#1)(2006-7#1)
traditional institutions##2##2##(1991-1#1)(1993-12#1)
traditional jazz##3##2##(1992-3#3)
traditional knowledge##5##2##(1997-7#1)(2007-11#2)(2012-12#2)
traditional laboratory##2##2##(2008-11#1)(2008-6#1)
traditional legal##2##2##(2006-7#1)(2007-12#1)
traditional linear##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
traditional lines##2##2##(1990-12#1)(2008-12#1)
traditional liquid-liquid extraction##2##3##(2008-10#1)(2012-12#1)
traditional liquid-liquid##4##2##(2008-10#3)(2012-12#1)
traditional long##2##2##(1991-9#1)(2009-12#1)
traditional masculine##3##2##(2009-5#2)(2010-8#1)
traditional masculinity##2##2##(2009-5#2)
traditional means##4##2##(2006-12#1)(2007-12#1)(2008-4#1)(2008-9#1)
traditional measures of##4##3##(2006-8#1)(2007-8#1)(2009-7#1)(2012-2#1)
traditional measures##5##2##(1997-1#1)(2006-8#1)(2007-8#1)(2009-7#1)(2012-2#1)
traditional medical##7##2##(1990-12#1)(1994-1#1)(1997-3#1)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
traditional medicinal plant##2##3##(1991-6#1)(2008-10#1)
traditional medicinal plants##2##3##(2011-2#1)(2013-1#1)
traditional medicinal##5##2##(1991-6#1)(2008-10#2)(2011-2#1)(2013-1#1)
traditional medicine in##5##3##(2007-4#1)(2008-10#2)(2008-4#1)(2011-1#1)
traditional medicine to##2##3##(2008-11#1)(2010-2#1)
traditional medicine##24##2##(1990-8#2)(1992-5#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-3#1)(2007-4#1)(2007-5#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2009-3#1)(2010-2#1)(2011-1#2)(2013-1#2)
traditional medicines for##2##3##(2013-7#1)(2013-8#1)
traditional medicines##4##2##(1992-5#1)(2013-7#1)(2013-8#2)
traditional mental health##3##3##(2006-4#1)(2008-12#1)(2008-2#1)
traditional method based on##3##4##(2007-8#1)(2008-10#1)(2012-1#1)
traditional method of##4##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)
traditional method##16##2##(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-8#1)(2012-1#1)(2013-1#1)
traditional methods for##3##3##(2008-10#2)(2010-8#1)
traditional methods of evaluating##2##4##(1991-12#1)(2008-6#1)
traditional methods of##12##3##(1990-9#1)(1991-12#1)(1992-8#1)(2006-10#1)(2007-8#2)(2008-10#2)(2008-6#1)(2010-11#1)(2010-7#1)(2011-2#1)
traditional methods##39##2##(1990-9#1)(1991-12#1)(1991-4#1)(1992-8#1)(1993-10#1)(2005-12#1)(2006-10#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-12#1)(2007-8#2)(2008-10#10)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-9#1)(2010-11#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#2)
traditional microbiological methods##2##3##(2008-6#1)(2013-8#1)
traditional microscopic##3##2##(1996-12#1)(2008-10#1)(2012-2#1)
traditional models##5##2##(2008-11#2)(2008-8#2)(2012-12#1)
traditional nonsteroidal anti-inflammatory drugs##2##4##(2006-10#1)(2007-7#1)
traditional nonsteroidal##3##2##(2006-10#2)(2007-7#1)
traditional null hypothesis testing##2##4##(2006-5#2)
traditional nursing##2##2##(2005-12#1)(2008-1#1)
traditional off-line live cell counting##2##5##(2008-11#2)
traditional open operation##2##3##(1997-8#1)(2006-5#1)
traditional open##4##2##(1997-8#1)(2006-5#1)(2006-6#1)(2008-10#1)
traditional optical##2##2##(2008-3#1)(2008-6#1)
traditional outcome##2##2##(1994-11#1)(2009-5#1)
traditional paper##2##2##(2007-4#1)(2009-11#1)
traditional paradigms##3##2##(1994-2#1)(1996-12#1)(2007-11#1)
traditional parametric##2##2##(2009-4#1)(2010-2#1)
traditional performance information to improve##2##5##(2008-7#1)(2008-8#1)
traditional positional enrichment analyses##2##4##(2009-5#2)
traditional practice##2##2##(2006-10#1)(2008-8#1)
traditional practices##6##2##(1992-1#1)(1997-7#3)(2006-10#1)(2007-1#1)
traditional preparations and##2##3##(2007-11#2)
traditional process##2##2##(1994-3#1)(2008-11#1)
traditional production system##2##3##(2010-4#2)
traditional psychiatric##2##2##(2004-3#1)(2008-2#1)
traditional public health##3##3##(2007-3#1)(2008-7#1)(2009-4#1)
traditional publishing##2##2##(1991-5#1)(2007-4#1)
traditional quality##2##2##(1995-1#1)(1996-12#1)
traditional radiology##3##2##(1993-9#1)(2008-7#2)
traditional rehabilitation##2##2##(2008-2#1)(2013-1#1)
traditional remedies##2##2##(1994-4#1)(2007-6#1)
traditional reversed-phase columns##2##3##(1996-5#1)(2005-12#1)
traditional risk factors and##3##4##(1993-12#2)(2007-7#1)
traditional risk factors for cardiovascular disease##2##6##(2006-10#1)(2013-7#1)
traditional risk factors for cardiovascular##3##5##(2006-10#1)(2006-2#1)(2013-7#1)
traditional risk factors for##4##4##(2006-10#1)(2006-2#1)(2011-2#1)(2013-7#1)
traditional risk factors such as##2##5##(2010-12#1)(2013-1#1)
traditional risk factors##14##3##(1993-12#2)(2005-10#1)(2006-10#1)(2006-2#1)(2007-7#1)(2008-3#1)(2008-4#1)(2010-12#1)(2011-2#1)(2013-1#3)(2013-7#1)
traditional risk##15##2##(1993-12#2)(2005-10#1)(2006-10#1)(2006-2#1)(2007-7#1)(2008-3#2)(2008-4#1)(2010-12#1)(2011-2#1)(2013-1#3)(2013-7#1)
traditional role of##2##3##(1991-2#1)(2009-12#1)
traditional role##3##2##(1991-2#1)(1996-1#1)(2009-12#1)
traditional screen-film mammography##2##3##(2007-4#2)
traditional sensory assessment##3##3##(2008-5#3)
traditional simple##2##2##(1992-8#1)(2012-3#1)
traditional social work practice##2##4##(2008-3#2)
traditional social work##3##3##(2008-3#3)
traditional stereotype##2##2##(1993-2#1)(2012-3#1)
traditional stroke risk factors for homocysteine testing##2##7##(2007-10#2)
traditional stroke risk factors##3##4##(2007-10#3)
traditional surgery##3##2##(1990-4#1)(2007-5#1)(2013-8#1)
traditional surgical treatment##4##3##(1991-12#1)(1996-12#1)(2006-5#1)(2010-6#1)
traditional surgical##7##2##(1991-12#1)(1993-3#1)(1996-12#1)(2006-5#1)(2008-6#1)(2010-6#1)(2011-2#1)
traditional survey methods##2##3##(2010-1#1)(2013-8#1)
traditional survey##3##2##(2010-1#1)(2010-8#1)(2013-8#1)
traditional technique##7##2##(2006-7#1)(2008-3#1)(2011-2#3)(2013-1#2)
traditional techniques##15##2##(1990-4#1)(1993-2#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#1)(2010-8#1)(2012-1#1)
traditional tests##3##2##(2008-10#1)(2012-2#1)(2012-3#1)
traditional therapeutic##4##2##(2005-7#1)(2006-10#1)(2007-5#1)(2008-5#1)
traditional therapies##5##2##(1993-2#1)(2005-8#1)(2006-12#1)(2008-5#1)(2009-8#1)
traditional therapy##7##2##(1990-10#2)(1997-2#2)(2010-10#1)(2010-3#1)(2012-2#1)
traditional total abdominal and vaginal hysterectomies##2##6##(1993-12#2)
traditional total abdominal and##3##4##(1993-12#3)
traditional training##2##2##(2006-6#1)(2007-4#1)
traditional treatment##9##2##(1994-9#1)(2006-8#1)(2007-11#2)(2007-8#1)(2008-11#1)(2009-2#1)(2011-2#2)
traditional treatments##4##2##(1991-2#1)(2008-10#1)(2008-5#1)(2010-6#1)
traditional tribal##2##2##(2006-12#2)
traditional types of##2##3##(1997-2#1)(2006-5#1)
traditional types##3##2##(1997-2#1)(2006-5#1)(2012-2#1)
traditional use##4##2##(2004-10#1)(2007-11#1)(2008-6#1)(2013-7#1)
traditional vaginal hysterectomy##2##3##(1993-12#1)(1993-2#1)
traditional values##2##2##(1994-4#1)(2012-3#1)
traditional varieties##3##2##(2008-12#3)
traditional view##5##2##(1993-11#1)(1995-12#1)(2007-8#1)(2008-10#1)(2012-12#1)
traditional way to##3##3##(2012-2#1)(2013-1#2)
traditional way##6##2##(1991-12#1)(2006-2#1)(2008-3#1)(2012-2#1)(2013-1#2)
traditional##1163##1##(1990-10#2)(1990-11#1)(1990-12#4)(1990-2#1)(1990-4#2)(1990-5#2)(1990-6#1)(1990-8#3)(1990-9#1)(1991-1#2)(1991-11#3)(1991-12#8)(1991-2#4)(1991-3#3)(1991-4#1)(1991-5#3)(1991-6#4)(1991-9#3)(1992-1#10)(1992-12#3)(1992-2#5)(1992-3#3)(1992-4#1)(1992-5#5)(1992-6#1)(1992-8#2)(1993-10#4)(1993-11#1)(1993-12#7)(1993-2#6)(1993-3#4)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-1#3)(1994-11#1)(1994-12#1)(1994-2#5)(1994-3#4)(1994-4#3)(1994-6#1)(1994-9#2)(1995-1#7)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#5)(1996-12#8)(1996-2#4)(1996-3#3)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#2)(1997-1#3)(1997-2#10)(1997-3#4)(1997-4#1)(1997-5#2)(1997-7#5)(1997-8#3)(2004-10#1)(2004-11#1)(2004-2#2)(2004-3#5)(2004-9#1)(2005-1#1)(2005-10#5)(2005-11#4)(2005-12#7)(2005-4#1)(2005-6#1)(2005-7#3)(2005-8#3)(2005-9#1)(2006-10#36)(2006-11#1)(2006-12#8)(2006-2#5)(2006-3#1)(2006-4#5)(2006-5#13)(2006-6#5)(2006-7#9)(2006-8#5)(2007-1#5)(2007-10#11)(2007-11#19)(2007-12#13)(2007-2#3)(2007-3#4)(2007-4#11)(2007-5#7)(2007-6#3)(2007-7#23)(2007-8#22)(2007-9#1)(2008-1#18)(2008-10#97)(2008-11#31)(2008-12#11)(2008-2#25)(2008-3#49)(2008-4#25)(2008-5#28)(2008-6#20)(2008-7#20)(2008-8#14)(2008-9#24)(2009-10#3)(2009-11#10)(2009-12#6)(2009-2#2)(2009-3#8)(2009-4#5)(2009-5#9)(2009-6#5)(2009-7#6)(2009-8#5)(2009-9#5)(2010-1#1)(2010-10#3)(2010-11#4)(2010-12#16)(2010-2#9)(2010-3#2)(2010-4#8)(2010-5#5)(2010-6#10)(2010-7#7)(2010-8#15)(2010-9#5)(2011-1#16)(2011-12#1)(2011-2#39)(2011-3#6)(2011-7#1)(2012-1#6)(2012-11#2)(2012-12#20)(2012-2#34)(2012-3#21)(2013-1#41)(2013-7#9)(2013-8#15)
traditional&quot##3##1##(1993-12#1)(2005-10#1)(2008-9#1)
traditionally a##2##2##(1992-12#1)(2008-7#1)
traditionally as##3##2##(1996-9#1)(2008-5#1)(2010-12#1)
traditionally associated with the##2##4##(1995-1#1)(2008-5#1)
traditionally associated with##8##3##(1990-10#1)(1995-1#1)(2006-10#1)(2007-5#1)(2008-5#1)(2008-9#1)(2010-4#1)(2012-1#1)
traditionally attributed to##2##3##(2008-5#2)
traditionally based on##3##3##(1994-3#1)(1994-9#1)(2010-2#1)
traditionally been classified as##2##4##(2008-1#1)(2010-6#1)
traditionally been classified##3##3##(2008-1#1)(2010-6#2)
traditionally been considered##2##3##(2006-10#1)(2008-1#1)
traditionally been limited##3##3##(2007-8#1)(2008-7#1)(2010-12#1)
traditionally been the##4##3##(1993-5#1)(2005-7#1)(2007-11#1)(2008-10#1)
traditionally been viewed as a##2##5##(2006-8#1)(2013-1#1)
traditionally been viewed as##4##4##(2006-11#1)(2006-8#1)(2008-5#1)(2013-1#1)
traditionally been##47##2##(1991-2#1)(1991-3#1)(1992-8#1)(1993-5#1)(1993-7#1)(1994-3#2)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-6#3)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
traditionally considered to be##2##4##(2008-11#1)(2008-6#1)
traditionally considered to##3##3##(2008-11#1)(2008-6#1)(2012-8#1)
traditionally considered##8##2##(2006-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2012-2#1)(2012-8#1)(2013-1#1)
traditionally evaluated##2##2##(1997-2#1)(2012-3#1)
traditionally has been##3##3##(1994-12#1)(2005-10#1)(2008-11#1)
traditionally has##4##2##(1994-12#1)(2005-10#1)(2007-8#1)(2008-11#1)
traditionally have##4##2##(1993-12#1)(2006-7#1)(2008-10#1)(2008-3#1)
traditionally in##2##2##(1996-4#1)(2011-2#1)
traditionally measured##2##2##(2006-12#1)(2009-1#1)
traditionally performed by##2##3##(1991-6#1)(2008-10#1)
traditionally provided##2##2##(1993-12#1)(2007-8#1)
traditionally reported##2##2##(2010-2#1)(2012-12#1)
traditionally trained##2##2##(2008-12#1)(2013-8#1)
traditionally treated by##2##3##(2007-5#1)(2008-5#1)
traditionally used for##4##3##(2007-6#1)(2008-10#1)(2008-11#1)(2011-2#1)
traditionally used to##2##3##(2008-10#1)(2008-3#1)
traditionally used##12##2##(2004-4#1)(2007-1#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
traditionally viewed as##3##3##(2006-5#1)(2009-2#1)(2009-4#1)
traditionally viewed##4##2##(1990-12#1)(2006-5#1)(2009-2#1)(2009-4#1)
traditionally##199##1##(1990-10#1)(1990-12#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-7#1)(1994-1#1)(1994-12#2)(1994-3#4)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1996-1#2)(1996-4#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-8#1)(2004-4#1)(2005-10#1)(2005-12#2)(2005-7#1)(2006-10#8)(2006-11#1)(2006-12#4)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#3)(2007-6#3)(2007-8#4)(2008-1#5)(2008-10#11)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#4)(2008-5#8)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#4)(2009-1#1)(2009-11#1)(2009-2#2)(2009-4#2)(2009-5#1)(2009-8#3)(2010-11#2)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-1#3)(2012-12#1)(2012-2#7)(2012-3#3)(2012-8#1)(2013-1#4)(2013-7#3)(2013-8#3)
traditions and a##2##3##(1991-8#1)(2009-2#1)
traditions and innovations in education##2##5##(2008-12#2)
traditions and##6##2##(1991-8#1)(2006-10#1)(2007-12#1)(2008-12#2)(2009-2#1)
traditions of science##2##3##(1993-9#1)(2009-6#1)
traditions of##5##2##(1993-9#1)(2008-2#1)(2009-10#1)(2009-6#1)(2009-7#1)
traditions##29##1##(1991-3#1)(1991-8#1)(1993-3#2)(1993-9#1)(2006-10#2)(2006-7#1)(2007-12#1)(2008-1#1)(2008-12#3)(2008-2#1)(2008-5#1)(2008-7#2)(2009-10#3)(2009-2#3)(2009-6#1)(2009-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
traffic accident had##2##3##(1997-2#1)(2012-2#1)
traffic accident##14##2##(1992-6#1)(1995-3#2)(1997-2#1)(1997-3#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-8#1)(2009-2#1)(2009-3#1)(2012-2#1)(2013-1#1)
traffic accidents in##2##3##(2006-11#1)(2013-7#1)
traffic accidents is##3##3##(1992-6#1)(2007-3#1)(2013-8#1)
traffic accidents##25##2##(1990-9#1)(1991-6#1)(1992-6#2)(1993-3#3)(1995-8#1)(1996-11#1)(1996-2#1)(1996-8#1)(2006-10#1)(2006-11#2)(2007-3#1)(2007-4#1)(2008-4#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-11#1)(2013-7#1)(2013-8#3)
traffic accidents]##2##2##(1992-2#1)(2011-1#1)
traffic and the##2##3##(2007-11#1)(2008-11#1)
traffic and##13##2##(1991-5#1)(1993-10#1)(1993-9#2)(2005-10#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-2#1)(2010-11#2)(2010-3#1)
traffic as well##2##3##(2008-3#1)(2010-11#1)
traffic between##3##2##(1995-12#1)(2011-2#1)(2012-2#1)
traffic conditions##3##2##(2008-2#2)(2013-7#1)
traffic control is##2##3##(2008-3#1)(2011-2#1)
traffic control##3##2##(2008-2#1)(2008-3#1)(2011-2#1)
traffic fatalities##2##2##(2006-11#1)(2010-11#1)
traffic from the##2##3##(1993-5#1)(2010-8#1)
traffic in the##4##3##(2004-4#1)(2008-10#1)(2008-11#1)(2009-4#1)
traffic in##9##2##(1991-9#1)(1994-6#1)(1997-6#2)(2004-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-4#1)
traffic injuries in##4##3##(2008-10#1)(2008-4#1)(2009-7#1)(2011-2#1)
traffic injuries##9##2##(1990-6#1)(1992-6#1)(2008-10#2)(2008-4#3)(2009-7#1)(2011-2#1)
traffic intensity##2##2##(2008-5#1)(2013-8#1)
traffic is##7##2##(1992-3#1)(1993-5#2)(2008-2#1)(2008-8#3)
traffic lights##4##2##(2011-2#4)
traffic of##3##2##(2008-7#1)(2008-8#1)(2013-1#1)
traffic police of Hyderabad##2##4##(2004-4#2)
traffic police officers compared##2##4##(2008-6#2)
traffic police officers##7##3##(2008-6#7)
traffic police##12##2##(2004-4#3)(2006-12#1)(2008-6#7)(2012-3#1)
traffic safety##10##2##(1996-11#1)(2008-8#3)(2010-11#2)(2012-12#4)
traffic volumes##2##2##(2012-12#2)
traffic##226##1##(1990-11#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#5)(1993-10#1)(1993-3#3)(1993-5#9)(1993-9#5)(1994-3#1)(1994-6#2)(1994-9#2)(1995-1#1)(1995-12#2)(1995-3#2)(1995-8#1)(1996-11#3)(1996-2#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#5)(2004-4#4)(2005-10#2)(2006-10#1)(2006-11#3)(2006-12#1)(2006-2#1)(2007-1#1)(2007-10#4)(2007-11#1)(2007-12#1)(2007-3#2)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#12)(2008-11#11)(2008-2#10)(2008-3#8)(2008-4#5)(2008-5#3)(2008-6#7)(2008-7#2)(2008-8#19)(2008-9#2)(2009-10#2)(2009-2#3)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#12)(2010-3#4)(2010-8#1)(2011-1#1)(2011-2#13)(2012-1#1)(2012-11#1)(2012-12#8)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#4)
traffic-related injuries##3##2##(2011-2#3)
traffic-related##6##1##(2008-5#1)(2011-2#5)
trafficking and processing##2##3##(1991-1#2)
trafficking and##21##2##(1991-1#2)(1994-8#1)(1995-2#1)(1996-8#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-7#1)(2009-8#1)(2012-12#2)(2012-3#1)(2013-1#1)
trafficking at##2##2##(2008-1#1)(2008-7#1)
trafficking events##2##2##(2012-2#1)(2013-1#1)
trafficking from the##2##3##(2009-7#1)(2012-2#1)
trafficking from##3##2##(2009-10#1)(2009-7#1)(2012-2#1)
trafficking in##9##2##(1995-11#1)(1995-9#1)(1996-5#1)(1997-6#1)(2005-7#1)(2006-3#2)(2008-1#1)(2010-12#1)
trafficking is##3##2##(1993-6#1)(2008-7#1)(2011-2#1)
trafficking of Math1 was##2##4##(2011-2#2)
trafficking of Math1##5##3##(2011-2#5)
trafficking of influenza##2##3##(2004-2#1)(2013-1#1)
trafficking of the##3##3##(1997-1#1)(2008-4#1)(2012-3#1)
trafficking of##30##2##(1990-2#1)(1995-11#1)(1996-5#1)(1996-8#1)(1997-1#1)(2004-2#1)(2006-3#1)(2007-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#2)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
trafficking patterns of liposomal##2##4##(1995-5#2)
trafficking patterns of##3##3##(1995-5#2)(2008-1#1)
trafficking route##2##2##(2009-8#1)(2012-2#1)
trafficking routes##3##2##(2009-8#1)(2013-7#2)
trafficking through the##2##3##(2009-2#1)(2009-8#1)
trafficking through##3##2##(2008-1#1)(2009-2#1)(2009-8#1)
trafficking to the##3##3##(2007-8#1)(2008-8#1)(2009-10#1)
trafficking##127##1##(1990-2#1)(1991-1#2)(1991-11#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-6#2)(1994-8#1)(1995-1#1)(1995-11#3)(1995-2#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-5#3)(1996-6#1)(1996-8#3)(1997-1#2)(1997-6#1)(2004-2#1)(2005-7#2)(2006-10#2)(2006-2#1)(2006-3#5)(2007-11#3)(2007-8#1)(2008-1#5)(2008-11#6)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#10)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#3)(2009-8#9)(2010-12#4)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#5)(2013-7#2)
tragedy of##4##2##(2007-6#1)(2007-8#1)(2009-4#1)(2010-1#1)
tragedy##16##1##(1991-11#1)(1991-12#1)(1992-2#2)(2004-7#1)(2006-3#1)(2006-4#3)(2007-6#1)(2007-8#1)(2008-11#1)(2009-4#1)(2010-1#2)(2011-2#1)
tragic##5##1##(2005-8#1)(2007-11#1)(2008-4#1)(2011-2#1)(2013-1#1)
tragus##2##1##(2008-7#1)(2012-2#1)
trail in two hatches##2##4##(2008-12#2)
trail in##3##2##(2004-11#1)(2008-12#2)
trail of##5##2##(1991-1#1)(1992-2#1)(1992-8#1)(2011-2#1)(2013-8#1)
trail##29##1##(1991-1#1)(1992-2#1)(1992-8#1)(1993-3#1)(1994-7#1)(1995-1#3)(1996-11#1)(2004-11#6)(2006-12#1)(2007-3#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-8#2)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#2)
trailer of##2##2##(2008-8#2)
trailer##7##1##(2008-7#1)(2008-8#6)
trailing edge of the##2##4##(2007-12#1)(2011-2#1)
trailing edge##4##2##(2005-10#1)(2007-12#1)(2008-3#1)(2011-2#1)
trailing##21##1##(1994-1#2)(1997-6#2)(2005-10#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-7#1)(2009-6#5)(2011-12#4)(2011-2#1)
trails to##2##2##(2007-7#1)(2008-8#1)
trails##17##1##(1993-2#4)(2007-7#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#5)(2008-8#2)
train and##12##2##(2007-12#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#2)(2009-3#1)(2011-1#1)(2012-2#1)(2012-3#1)
train at##5##2##(2007-11#1)(2007-12#2)(2008-1#1)(2008-9#1)
train in the##2##3##(2007-11#1)(2007-12#1)
train in##5##2##(2007-11#2)(2007-12#3)
train of action potentials##2##4##(1991-8#1)(1996-3#1)
train of pulses##5##3##(2006-5#2)(2007-12#3)
train of##23##2##(1991-8#1)(1994-12#1)(1995-3#1)(1996-3#1)(2006-5#3)(2007-11#4)(2007-12#6)(2008-1#1)(2008-2#3)(2008-3#2)
train physicians and##2##3##(1992-12#1)(2012-2#1)
train physicians##3##2##(1992-12#1)(1997-3#1)(2012-2#1)
train the##7##2##(1993-3#1)(2007-6#1)(2008-10#1)(2008-3#1)(2009-4#1)(2010-3#1)(2012-1#1)
train their##3##2##(1994-6#1)(2004-12#1)(2010-5#1)
train them##2##2##(1990-4#1)(1992-12#1)
train##175##1##(1990-12#1)(1990-4#1)(1991-2#1)(1991-3#2)(1991-6#2)(1991-8#1)(1992-12#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-7#3)(1994-12#1)(1994-6#1)(1994-8#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#1)(2004-12#1)(2005-10#1)(2005-9#1)(2006-5#7)(2007-11#17)(2007-12#33)(2007-2#2)(2007-5#2)(2007-6#2)(2008-1#8)(2008-10#5)(2008-11#7)(2008-2#8)(2008-3#6)(2008-4#1)(2008-7#2)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#4)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#5)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#1)
train)##2##1##(2006-5#1)(2009-8#1)
train-of-four stimulation##3##2##(1996-9#3)
train-of-four##4##1##(1996-9#3)(2006-8#1)
trained a##5##2##(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#2)
trained and certified##2##3##(2007-4#1)(2008-10#1)
trained and prepared for##2##4##(2006-7#1)(2013-1#1)
trained and tested in a##2##5##(1992-10#1)(1993-11#1)
trained and tested the model using data of 3##2##9##(2013-1#2)
trained and tested##10##3##(1992-10#1)(1993-10#1)(1993-11#1)(1993-2#1)(1994-3#1)(2010-8#1)(2013-1#4)
trained and untrained##2##3##(2007-4#1)(2013-1#1)
trained and##24##2##(1992-10#1)(1993-10#1)(1993-11#1)(1993-2#1)(1994-3#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-4#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-8#1)(2011-1#1)(2013-1#7)(2013-7#1)
trained as a##3##3##(2007-2#1)(2010-7#2)
trained as##4##2##(2007-2#1)(2009-2#1)(2010-7#2)
trained at the##2##3##(1995-12#1)(2005-1#1)
trained at##3##2##(1995-12#1)(2005-1#1)(2007-4#1)
trained by back-propagation##3##3##(2008-10#3)
trained by##12##2##(2008-10#8)(2008-6#2)(2010-8#1)(2012-2#1)
trained for##6##2##(1990-4#1)(2007-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2012-3#1)
trained forensic physicians##2##3##(2005-8#2)
trained general practitioners##3##3##(1993-11#1)(1994-4#1)(2011-12#1)
trained group##4##2##(2013-1#2)(2013-7#2)
trained health##3##2##(1994-3#2)(2007-6#1)
trained in a##6##3##(1991-2#1)(1993-2#1)(1993-9#1)(1994-5#1)(1994-6#1)(2006-12#1)
trained in the##6##3##(2007-6#1)(2008-11#1)(2008-7#1)(2012-2#1)(2013-1#2)
trained in##43##2##(1990-7#1)(1991-2#1)(1991-3#1)(1992-3#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-8#1)(2005-10#1)(2006-12#1)(2006-8#1)(2007-4#1)(2007-6#2)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#3)(2008-2#1)(2008-7#1)(2009-2#1)(2011-1#1)(2012-2#4)(2013-1#3)
trained males##2##2##(2008-5#1)(2013-1#1)
trained medical##3##2##(2007-4#1)(2012-12#1)(2012-2#1)
trained microscopists##2##2##(2007-2#1)(2012-2#1)
trained nurse##4##2##(1996-2#1)(2007-2#1)(2008-12#1)(2009-3#1)
trained nurses for##2##3##(2007-12#1)(2009-4#1)
trained nurses##6##2##(2006-10#1)(2007-12#1)(2008-2#1)(2009-4#2)(2011-2#1)
trained on a##11##3##(1991-3#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-5#1)(1994-2#1)(1994-5#1)(2006-5#1)(2011-2#1)
trained on diverse##2##3##(2009-3#2)
trained on the##10##3##(1992-10#1)(1993-12#1)(1997-2#1)(2005-1#1)(2007-8#1)(2008-2#1)(2009-3#2)(2010-8#2)
trained on##29##2##(1991-1#1)(1991-3#1)(1992-10#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-5#1)(1994-2#1)(1994-3#1)(1994-5#1)(1997-2#1)(2005-1#1)(2006-2#2)(2006-5#1)(2007-8#1)(2008-2#1)(2009-3#4)(2010-8#2)(2011-2#1)(2013-1#1)
trained panelists##2##2##(2010-4#2)
trained participants##2##2##(2008-11#1)(2013-8#1)
trained personnel##8##2##(1994-1#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-4#2)(2012-2#2)
trained physicians##2##2##(1993-11#1)(1994-3#1)
trained staff##3##2##(1996-12#1)(2009-7#1)(2011-2#1)
trained taste panel##2##3##(2010-4#2)
trained teachers##2##2##(1993-6#1)(2011-2#1)
trained to detect##3##3##(1992-11#1)(1994-2#1)(2008-2#1)
trained to discriminate between##2##4##(1994-6#1)(1996-10#1)
trained to discriminate##10##3##(1990-10#1)(1991-12#1)(1992-10#1)(1993-12#1)(1994-6#1)(1996-10#1)(1997-5#1)(1997-7#2)(2008-8#1)
trained to perform##2##3##(1993-5#1)(1995-12#1)
trained to press a lever##2##5##(1992-11#1)(1992-9#1)
trained to use the##2##4##(2012-12#1)(2013-1#1)
trained to use##4##3##(1994-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
trained to##41##2##(1990-10#1)(1991-12#1)(1992-10#1)(1992-11#2)(1992-3#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#2)(1994-2#1)(1994-6#1)(1994-7#1)(1995-12#2)(1996-10#1)(1997-5#1)(1997-7#3)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
trained two##2##2##(1995-8#1)(2009-6#1)
trained using a##2##3##(2008-10#1)(2012-3#1)
trained using##5##2##(2008-10#1)(2010-11#1)(2010-2#1)(2012-1#1)(2012-3#1)
trained violinists##2##2##(2013-8#2)
trained with the##6##3##(2008-10#2)(2010-8#1)(2012-2#1)(2012-3#2)
trained with##17##2##(1995-10#1)(1996-6#1)(2006-12#1)(2007-12#1)(2007-9#2)(2008-10#3)(2008-2#1)(2008-3#1)(2010-8#2)(2012-2#2)(2012-3#2)
trained##358##1##(1990-10#1)(1990-11#3)(1990-4#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-10#4)(1992-11#2)(1992-12#1)(1992-3#2)(1992-9#2)(1993-10#1)(1993-11#3)(1993-12#7)(1993-2#5)(1993-3#3)(1993-5#5)(1993-6#3)(1993-7#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#7)(1994-4#2)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-12#3)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#2)(1996-2#4)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-4#2)(1997-5#1)(1997-7#4)(1997-8#2)(2005-1#2)(2005-10#2)(2005-8#2)(2006-10#6)(2006-12#3)(2006-2#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#6)(2007-3#2)(2007-4#9)(2007-6#5)(2007-7#3)(2007-8#5)(2007-9#4)(2008-1#2)(2008-10#25)(2008-11#9)(2008-12#3)(2008-2#9)(2008-3#3)(2008-4#5)(2008-5#8)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-12#1)(2009-2#2)(2009-3#5)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2010-11#1)(2010-12#2)(2010-2#3)(2010-4#9)(2010-7#5)(2010-8#9)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#2)(2012-12#3)(2012-2#21)(2012-3#6)(2013-1#29)(2013-7#3)(2013-8#5)
trainee can##2##2##(1996-6#1)(2012-1#1)
trainee in difficulty##3##3##(2007-7#3)
trainee##22##1##(1990-4#1)(1992-1#1)(1992-12#1)(1992-6#1)(1994-12#1)(1996-6#2)(2006-8#1)(2007-2#1)(2007-4#1)(2007-7#3)(2008-12#1)(2008-5#1)(2008-6#1)(2010-2#1)(2010-3#1)(2012-1#2)(2013-1#2)
trainees and##4##2##(2007-11#1)(2011-2#1)(2012-1#1)(2012-12#1)
trainees at a##2##3##(2005-10#1)(2012-2#1)
trainees at the##2##3##(1992-6#1)(2007-8#1)
trainees at##4##2##(1992-6#1)(2005-10#1)(2007-8#1)(2012-2#1)
trainees in##2##2##(2006-8#1)(2007-4#1)
trainees to##4##2##(2006-6#1)(2007-7#1)(2008-12#1)(2012-1#1)
trainees##51##1##(1992-12#1)(1992-6#5)(1993-11#1)(1994-12#2)(1994-7#1)(1995-12#1)(1996-8#1)(2005-10#2)(2006-10#1)(2006-12#1)(2006-6#3)(2006-8#1)(2007-10#3)(2007-11#1)(2007-4#2)(2007-7#2)(2007-8#4)(2008-11#1)(2008-12#1)(2009-4#2)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#1)
trainer##14##1##(2006-3#3)(2007-8#4)(2009-6#1)(2010-3#3)(2012-1#1)(2012-2#1)(2012-3#1)
trainers##20##1##(1992-12#1)(1994-2#1)(1994-3#1)(2006-3#8)(2012-1#4)(2013-1#5)
training (i##3##2##(1991-2#1)(2011-2#1)(2013-1#1)
training (n = 30)##3##4##(2013-8#3)
training (n =##4##3##(2009-11#1)(2013-8#3)
training a##2##2##(1994-2#1)(2008-4#1)
training accuracy##4##2##(2008-8#4)
training activities##4##2##(1991-12#1)(2006-3#1)(2009-2#1)(2011-2#1)
training adaptations in##2##3##(2008-5#2)
training adaptations##6##2##(2008-5#6)
training aids##2##2##(1997-1#1)(2008-10#1)
training alone##2##2##(2013-1#1)(2013-8#1)
training also##3##2##(1991-5#1)(1992-9#1)(2008-8#1)
training and a##3##3##(2008-2#1)(2008-7#1)(2010-12#1)
training and assessment of##2##4##(2006-6#2)
training and at follow-up##2##4##(2012-1#1)(2013-8#1)
training and at##4##3##(1993-9#1)(2012-1#1)(2012-2#1)(2013-8#1)
training and certification##4##3##(2007-4#3)(2009-10#1)
training and competition##3##3##(2009-5#2)(2010-1#1)
training and continuing education##2##4##(2010-8#1)(2011-2#1)
training and development##6##3##(1993-3#1)(1997-3#1)(2008-12#2)(2011-1#2)
training and education in##2##4##(1995-3#1)(2008-11#1)
training and education of##2##4##(1995-5#1)(2008-11#1)
training and education##8##3##(1995-3#1)(1995-5#1)(1997-6#1)(2006-6#1)(2006-8#1)(2008-11#2)(2008-12#1)
training and evaluation##4##3##(2006-6#2)(2007-4#1)(2010-12#1)
training and experience in##2##4##(2007-7#1)(2013-8#1)
training and experience##3##3##(2007-7#1)(2010-5#1)(2013-8#1)
training and practice##3##3##(1996-1#1)(2007-5#1)(2012-1#1)
training and prediction##2##3##(2008-10#2)
training and professional##2##3##(2007-8#1)(2009-4#1)
training and re-training##2##3##(2007-5#1)(2011-1#1)
training and research##4##3##(1993-1#1)(1993-11#1)(2007-12#1)(2013-1#1)
training and scientific##2##3##(2005-5#1)(2009-9#1)
training and technical##2##3##(2007-4#1)(2008-1#1)
training and test##4##3##(2007-11#1)(2009-7#1)(2010-2#1)(2010-4#1)
training and testing##4##3##(2008-10#1)(2008-2#1)(2010-8#1)(2011-2#1)
training and the##7##3##(1990-4#1)(1995-8#1)(2006-10#1)(2007-11#1)(2008-10#1)(2009-3#1)(2010-8#1)
training and tools##2##3##(2008-8#1)(2009-3#1)
training and weight reduction##2##4##(1990-12#1)(1996-11#1)
training and##189##2##(1990-12#2)(1990-2#1)(1990-4#2)(1991-2#1)(1991-6#1)(1992-10#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#3)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-3#1)(1997-5#1)(1997-6#1)(2004-7#1)(2005-5#3)(2006-10#2)(2006-5#1)(2006-6#7)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#3)(2007-3#1)(2007-4#6)(2007-5#3)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#9)(2008-11#4)(2008-12#8)(2008-2#4)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#2)(2009-10#3)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#4)(2010-2#2)(2010-4#1)(2010-5#2)(2010-8#3)(2011-1#3)(2011-2#6)(2012-1#6)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#13)(2013-7#1)(2013-8#3)
training approach##2##2##(2004-3#1)(2013-1#1)
training approaches that##2##3##(2005-7#2)
training approaches##5##2##(2005-7#3)(2013-8#2)
training are noted##2##3##(2009-7#2)
training are##15##2##(1993-1#1)(1994-3#1)(1994-7#1)(1995-2#1)(1995-8#1)(1996-6#1)(1997-5#1)(2006-5#1)(2007-12#1)(2007-7#1)(2008-8#1)(2009-7#2)(2011-1#1)(2012-3#1)
training as part of##2##4##(2005-1#1)(2008-4#1)
training as well as##3##4##(1993-6#1)(1994-12#1)(2008-10#1)
training as##13##2##(1991-3#1)(1993-6#1)(1994-12#1)(2005-1#1)(2005-7#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-4#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-8#1)
training at a##3##3##(2006-8#2)(2011-2#1)
training at##10##2##(1990-11#1)(1993-12#1)(1993-9#1)(1995-10#1)(1997-2#1)(2006-8#2)(2007-2#1)(2008-11#1)(2011-2#1)
training available##2##2##(1991-1#1)(2008-9#1)
training became##2##2##(2010-2#1)(2011-2#1)
training by##6##2##(1996-1#1)(1996-3#2)(2006-10#1)(2007-11#1)(2008-11#1)
training can be##2##3##(1993-2#1)(2005-10#1)
training can##6##2##(1993-2#1)(2005-10#1)(2008-10#1)(2008-11#1)(2009-6#1)(2012-1#1)
training center for##2##3##(2008-11#1)(2008-8#1)
training center##3##2##(2007-5#1)(2008-11#1)(2008-8#1)
training conditions##3##2##(1993-7#1)(2009-6#1)(2012-1#1)
training content##3##2##(2007-12#1)(2008-9#1)(2010-10#1)
training course for##2##3##(2006-6#1)(2010-3#1)
training course in##4##3##(2006-6#1)(2008-11#3)
training course of##2##3##(1996-6#1)(2012-12#1)
training course on##3##3##(2008-11#1)(2012-12#1)(2013-1#1)
training course##17##2##(1996-6#1)(2006-6#2)(2008-11#5)(2010-2#1)(2010-3#2)(2010-8#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
training courses for##2##3##(2007-8#1)(2008-10#1)
training courses##8##2##(2007-1#1)(2007-8#1)(2008-10#1)(2008-12#2)(2010-3#1)(2011-2#1)(2012-12#1)
training currently##2##2##(1992-12#1)(1995-1#1)
training curricula##2##2##(2006-10#1)(2006-6#1)
training data set##4##3##(2008-10#3)(2008-2#1)
training data sets##2##3##(2008-2#1)(2008-3#1)
training data##18##2##(2008-10#5)(2008-2#2)(2008-3#1)(2010-2#1)(2010-9#1)(2013-1#7)(2013-8#1)
training did not##2##3##(1993-5#1)(2009-6#1)
training during##4##2##(1993-8#1)(2012-1#3)
training effort##3##2##(1993-2#1)(2011-2#1)(2012-1#1)
training environments##3##2##(2008-6#1)(2012-1#2)
training exercises##3##2##(2006-6#1)(2012-1#2)
training experience##4##2##(1992-8#1)(2004-3#2)(2009-4#1)
training for children##2##3##(2012-1#1)(2012-2#1)
training for health care##2##4##(2008-1#1)(2013-8#1)
training for health##3##3##(2008-1#1)(2012-3#1)(2013-8#1)
training for nurses##3##3##(2008-11#1)(2008-9#1)(2011-2#1)
training for patients##2##3##(2008-8#1)(2010-3#1)
training for physicians##2##3##(1991-2#1)(1991-3#1)
training for staff##2##3##(1995-3#1)(2012-3#1)
training for stroke##2##3##(2012-1#2)
training for the##6##3##(1991-3#1)(1994-2#1)(2006-3#1)(2008-7#1)(2010-3#1)(2011-2#1)
training for##63##2##(1990-3#1)(1991-2#1)(1991-3#2)(1992-12#1)(1992-2#2)(1993-1#2)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-4#1)(2004-12#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-2#1)(2006-3#1)(2007-2#1)(2007-4#1)(2007-9#2)(2008-1#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#4)(2011-1#2)(2011-2#2)(2012-1#5)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#2)
training future pain##2##3##(2006-12#2)
training future##3##2##(2006-12#2)(2011-2#1)
training given##2##2##(1991-5#1)(1993-2#1)
training group (n= 10)##3##4##(2013-1#3)
training group (β=##3##3##(2013-1#3)
training group##8##2##(2013-1#8)
training groups##4##2##(1997-2#2)(2012-1#1)(2013-8#1)
training has been##2##3##(1991-3#1)(1993-1#1)
training has##6##2##(1991-3#1)(1993-1#1)(1995-12#1)(2005-7#1)(2006-6#1)(2012-1#1)
training have##2##2##(2006-6#1)(2010-4#1)
training human resources##2##3##(2011-2#2)
training image##2##2##(2008-2#1)(2010-9#1)
training images##8##2##(2007-12#1)(2008-2#4)(2008-3#2)(2009-11#1)
training improves##2##2##(2011-2#1)(2013-1#1)
training in CPR##2##3##(1993-8#1)(2006-10#1)
training in Canada##2##3##(2007-12#1)(2007-7#1)
training in Hygiene and Preventive Medicine##2##6##(2007-1#2)
training in a##4##3##(2006-2#1)(2009-4#1)(2011-2#2)
training in blood pressure monitoring##2##5##(2008-1#2)
training in experimental##2##3##(2008-1#1)(2011-2#1)
training in family##2##3##(1996-11#1)(1997-6#1)
training in general##3##3##(1990-4#1)(1991-8#1)(1993-12#1)
training in patients with chronic heart failure##2##7##(2005-1#2)
training in patients with##6##4##(1996-2#1)(2005-1#4)(2008-6#1)
training in preventive##2##3##(1994-2#1)(2005-11#1)
training in public health##3##4##(1996-3#1)(2008-1#1)(2012-12#1)
training in the United##2##4##(2007-4#1)(2008-12#1)
training in the use of drugs##2##6##(1990-4#2)
training in the use of##4##5##(1990-4#2)(1993-3#1)(2008-11#1)
training in the##18##3##(1990-4#2)(1993-3#1)(2005-7#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-12#1)(2012-1#1)(2012-2#2)(2013-1#1)
training in these##5##3##(1992-9#1)(2006-10#3)(2008-11#1)
training in this field##2##4##(1997-8#1)(2005-10#1)
training in##142##2##(1990-12#2)(1990-4#4)(1991-1#2)(1991-5#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-8#2)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-12#1)(2005-1#4)(2005-10#1)(2005-11#1)(2005-7#4)(2005-8#2)(2006-10#7)(2006-2#1)(2006-6#1)(2007-1#2)(2007-10#1)(2007-12#1)(2007-2#2)(2007-4#3)(2007-6#6)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#5)(2008-10#1)(2008-11#5)(2008-12#7)(2008-2#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2009-2#1)(2009-4#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#4)(2011-7#1)(2012-1#7)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
training increased##2##2##(1990-12#1)(1992-8#1)
training induced##3##2##(1993-9#1)(2012-1#1)(2013-8#1)
training initiatives##2##2##(2007-4#1)(2008-11#1)
training inputs##2##2##(1992-1#1)(2012-12#1)
training intensity##3##2##(2010-1#2)(2013-1#1)
training is a##3##3##(2006-6#1)(2008-3#1)(2008-5#1)
training is effective in##2##4##(2009-6#1)(2012-1#1)
training is##26##2##(1990-4#1)(1991-5#1)(1992-11#1)(1993-1#1)(1994-12#2)(1994-6#1)(1996-2#1)(1996-9#1)(1997-2#1)(2006-6#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-6#1)(2010-9#1)(2012-1#1)(2012-2#3)(2013-1#1)(2013-8#1)
training issues##2##2##(1993-2#1)(2013-1#1)
training key##2##2##(1994-1#1)(2008-7#1)
training level##2##2##(2005-10#1)(2009-3#1)
training load##2##2##(2008-5#1)(2012-3#1)
training machine##2##2##(2010-1#2)
training manual##2##2##(2008-8#1)(2011-2#1)
training may##5##2##(2005-7#1)(2009-3#1)(2012-1#1)(2013-1#2)
training method##5##2##(1994-2#1)(2006-6#1)(2010-8#1)(2013-1#2)
training methods##6##2##(2004-8#1)(2006-6#2)(2008-12#3)
training modality##2##2##(2013-8#2)
training mode##2##2##(2008-4#1)(2012-1#1)
training model##2##2##(1995-2#1)(2006-6#1)
training models##2##2##(2008-10#1)(2008-12#1)
training must##2##2##(1994-12#1)(2013-1#1)
training need##2##2##(2007-5#1)(2008-4#1)
training needs and##2##3##(2007-9#1)(2011-2#1)
training needs of##3##3##(2008-1#1)(2008-11#1)(2011-2#1)
training needs##7##2##(1996-1#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-9#1)(2011-2#2)
training objectives##3##2##(2006-6#1)(2010-3#2)
training of a##2##3##(2008-2#1)(2008-3#1)
training of clinical biochemists##2##4##(1994-12#2)
training of clinical##3##3##(1994-12#3)
training of community health agents##2##5##(2011-2#2)
training of community##3##3##(1996-2#1)(2011-2#2)
training of general practitioners##2##4##(1993-10#1)(1994-3#1)
training of health care professionals##2##5##(1991-3#1)(2007-4#1)
training of health care##4##4##(1991-3#1)(2007-4#1)(2008-11#1)(2013-1#1)
training of health##6##3##(1991-3#1)(2006-9#1)(2007-4#1)(2008-11#1)(2011-2#1)(2013-1#1)
training of hospital security##2##4##(1991-12#1)(1996-12#1)
training of medical##10##3##(1992-1#2)(1994-12#3)(1994-6#1)(2007-8#1)(2008-7#1)(2009-10#1)(2012-3#1)
training of moderate intensity##2##4##(1995-10#1)(1995-8#1)
training of nurses##4##3##(2011-2#1)(2012-12#2)(2013-1#1)
training of personnel##2##3##(2006-6#1)(2011-1#1)
training of residents##3##3##(1993-3#1)(1996-9#1)(2007-4#1)
training of staff##2##3##(1994-7#1)(2008-12#1)
training of technical##2##3##(2006-6#1)(2007-9#1)
training of the neural##4##4##(2007-8#1)(2008-2#1)(2008-3#1)(2010-8#1)
training of the##13##3##(1994-12#2)(1995-6#1)(2006-6#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-8#1)(2012-2#1)
training of##109##2##(1990-2#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-1#2)(1992-3#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-3#1)(1994-12#9)(1994-3#3)(1994-6#1)(1994-7#1)(1995-10#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-9#2)(1997-2#1)(1997-7#1)(2005-10#1)(2006-6#3)(2006-9#3)(2007-1#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-4#1)(2009-6#1)(2010-3#1)(2010-8#2)(2011-1#2)(2011-2#7)(2012-1#6)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
training offers##2##2##(2008-4#1)(2010-4#1)
training on a##2##3##(2005-1#1)(2012-3#1)
training on gait performance##2##4##(2013-1#2)
training on gait##3##3##(2006-10#1)(2013-1#2)
training on medical or domiciliary dental care for the elderly in need of nursing care##2##15##(2013-8#2)
training on the##8##3##(1992-12#1)(1997-2#1)(2005-1#1)(2006-3#1)(2008-5#1)(2009-6#1)(2010-12#1)(2012-3#1)
training on##58##2##(1990-4#1)(1992-12#1)(1993-2#1)(1993-9#1)(1994-7#1)(1995-1#1)(1995-6#1)(1995-9#1)(1997-1#1)(1997-2#1)(2005-1#2)(2006-10#1)(2006-2#1)(2006-3#2)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-1#1)(2009-3#2)(2009-4#1)(2009-6#3)(2010-12#1)(2011-2#3)(2012-1#5)(2012-2#1)(2012-3#3)(2013-1#8)(2013-8#4)
training only##2##2##(2006-2#1)(2009-6#1)
training opportunities##2##2##(2008-7#1)(2011-1#1)
training or experience##2##3##(1994-1#1)(2007-2#1)
training or##12##2##(1992-9#1)(1994-1#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-3#1)(2013-1#3)
training parameters##2##2##(2008-10#1)(2008-11#1)
training period##7##2##(2005-1#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-12#1)
training procedure##2##2##(2008-4#1)(2010-7#1)
training procedures##4##2##(1990-11#1)(1994-3#1)(2008-7#1)(2011-2#1)
training processes##3##2##(1993-3#1)(2013-1#1)(2013-7#1)
training program and##2##3##(1991-2#1)(2007-4#1)
training program at##3##3##(1996-2#1)(1996-6#1)(2007-12#1)
training program for##5##3##(1991-12#1)(1993-12#1)(2008-4#1)(2008-7#1)(2010-8#1)
training program has##2##3##(2007-12#1)(2008-7#1)
training program in##4##3##(1992-2#1)(2007-3#1)(2007-7#1)(2008-7#1)
training program on##2##3##(2012-2#2)
training program over the##2##4##(1992-1#1)(2011-2#1)
training program that##2##3##(2007-7#1)(2009-10#1)
training program##57##2##(1990-12#1)(1991-12#3)(1991-2#2)(1991-3#1)(1992-1#1)(1992-2#2)(1993-12#1)(1996-2#1)(1996-6#2)(1997-2#1)(2007-11#1)(2007-12#5)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-9#1)(2009-10#2)(2009-11#1)(2010-3#3)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-7#1)
training programme for##3##3##(1992-3#1)(2008-12#1)(2013-8#1)
training programme on##3##3##(2008-12#2)(2013-8#1)
training programme to improve##2##4##(2011-2#2)
training programme##18##2##(1991-5#1)(1992-3#1)(1994-12#1)(1996-4#1)(2008-12#3)(2008-7#1)(2009-4#1)(2011-2#4)(2012-12#1)(2013-1#2)(2013-8#2)
training programmes and##3##3##(2007-6#1)(2009-4#1)(2013-7#1)
training programmes for##3##3##(1991-12#1)(1994-12#1)(2011-2#1)
training programmes##12##2##(1991-12#1)(1992-6#1)(1994-12#1)(2007-6#2)(2008-12#1)(2009-4#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-7#1)
training programs and##4##3##(1996-4#1)(2007-5#1)(2007-7#1)(2008-12#1)
training programs are##4##3##(1992-1#1)(2007-12#1)(2008-1#1)(2011-2#1)
training programs for clinical##2##4##(1994-12#1)(2008-12#1)
training programs for##4##3##(1992-12#1)(1993-1#1)(1994-12#1)(2008-12#1)
training programs that##3##3##(1996-3#1)(2007-12#1)(2008-11#1)
training programs to##4##3##(1997-2#1)(1997-6#1)(2006-6#1)(2008-12#1)
training programs##42##2##(1992-1#4)(1992-12#3)(1993-1#2)(1994-12#2)(1996-3#3)(1996-4#1)(1997-2#1)(1997-6#1)(2004-8#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-12#3)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#3)(2008-11#1)(2008-12#3)(2008-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#2)
training progressed##2##2##(1993-9#1)(2012-1#1)
training protocol##2##2##(1996-9#2)
training reduces metformin##2##3##(2012-3#2)
training reduces##3##2##(2012-1#1)(2012-3#2)
training regimen##3##2##(2008-5#1)(2010-12#1)(2013-1#1)
training required to##2##3##(1992-11#1)(2008-11#1)
training required##4##2##(1992-11#1)(1996-3#1)(2008-11#1)(2012-1#1)
training requirements##7##2##(1991-12#1)(1992-9#1)(1994-12#2)(1996-2#2)(2007-12#1)
training sample size##4##3##(2013-1#4)
training sample##9##2##(1994-5#1)(2010-5#1)(2013-1#6)(2013-8#1)
training schemes##4##2##(1990-3#1)(1992-2#1)(1996-8#2)
training services##2##2##(1996-3#1)(2006-3#1)
training session##7##2##(1994-8#1)(1995-10#1)(2009-1#1)(2010-7#2)(2012-1#1)(2013-1#1)
training sessions and##3##3##(2010-3#1)(2012-1#2)
training sessions##10##2##(1991-3#1)(1992-10#1)(1995-10#1)(2008-2#1)(2010-12#1)(2010-3#1)(2012-1#3)(2012-2#1)
training set and##5##3##(2008-10#2)(2008-2#2)(2008-4#1)
training set of##10##3##(1995-6#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-6#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#1)
training set was##2##3##(2008-10#1)(2010-4#1)
training set##34##2##(1995-6#2)(1995-9#1)(1997-2#1)(2007-8#1)(2008-10#11)(2008-2#5)(2008-3#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
training sets##3##2##(1994-6#1)(2006-12#1)(2008-12#1)
training should be##3##3##(1996-3#1)(2012-3#1)(2013-1#1)
training showed##2##2##(1994-6#1)(2013-8#1)
training skills##2##2##(2012-2#2)
training studies##3##2##(2013-1#2)(2013-8#1)
training study##3##2##(1991-8#1)(2006-2#1)(2013-1#1)
training subject##2##2##(2010-9#2)
training system for##2##3##(2007-5#1)(2012-1#1)
training system##7##2##(2006-6#1)(2007-5#1)(2010-12#1)(2010-8#1)(2012-1#3)
training systems##4##2##(2006-6#1)(2007-5#1)(2010-12#1)(2010-8#1)
training than##2##2##(1991-2#1)(1993-2#1)
training that##7##2##(2006-10#1)(2007-4#1)(2008-1#1)(2009-1#1)(2009-8#1)(2010-5#1)(2011-2#1)
training the next generation of##2##5##(2007-8#1)(2008-11#1)
training the##15##2##(1990-7#1)(1993-5#1)(1997-3#1)(2005-1#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-1#1)(2012-1#2)(2013-1#2)
training they##2##2##(2005-1#1)(2008-11#1)
training through a##2##3##(1994-12#2)
training through##3##2##(1993-2#1)(1994-12#2)
training time##5##2##(2008-2#2)(2013-8#3)
training to provide##2##3##(1994-3#1)(2008-4#1)
training to reduce##2##3##(2008-6#1)(2011-12#1)
training to the##2##3##(2012-12#1)(2013-7#1)
training to those##2##3##(1993-2#1)(2007-4#1)
training to##31##2##(1993-2#1)(1993-9#1)(1994-3#1)(1995-1#1)(1996-9#1)(2004-12#2)(2006-7#1)(2006-8#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2010-10#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#1)(2013-1#4)(2013-7#1)
training tool##3##2##(2006-6#1)(2008-11#1)(2012-3#1)
training trials##5##2##(1993-6#4)(2008-5#1)
training under##2##2##(1991-3#1)(2009-8#1)
training using##4##2##(2007-10#1)(2007-11#2)(2008-9#1)
training videos##2##2##(1997-1#1)(2011-2#1)
training was performed##2##3##(2012-1#1)(2013-1#1)
training was##16##2##(1990-12#2)(1995-2#1)(2006-10#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-12#1)(2009-1#1)(2010-2#1)(2011-2#1)(2012-1#3)(2013-1#1)
training were##2##2##(1993-9#1)(2013-1#1)
training while##2##2##(2008-11#1)(2012-1#1)
training with a##3##3##(1993-5#1)(2007-10#1)(2009-4#1)
training with metformin##2##3##(2012-3#2)
training with the##2##3##(2008-4#2)
training with##18##2##(1991-7#1)(1991-9#1)(1993-5#1)(2006-10#1)(2007-10#2)(2007-11#1)(2008-11#1)(2008-4#2)(2009-4#1)(2009-6#1)(2010-10#1)(2012-1#2)(2012-3#2)(2013-1#1)
training workshop##3##2##(1995-3#1)(2008-8#1)(2013-1#1)
training workshops##2##2##(2010-12#1)(2013-8#1)
training would##2##2##(2007-10#1)(2007-7#1)
training##1894##1##(1990-11#2)(1990-12#10)(1990-2#2)(1990-3#6)(1990-4#9)(1990-6#1)(1990-7#1)(1991-1#5)(1991-11#2)(1991-12#9)(1991-2#11)(1991-3#13)(1991-4#1)(1991-5#10)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#9)(1992-10#3)(1992-11#2)(1992-12#13)(1992-2#9)(1992-3#4)(1992-5#1)(1992-6#3)(1992-8#3)(1992-9#7)(1993-1#17)(1993-10#1)(1993-11#4)(1993-12#12)(1993-2#15)(1993-3#11)(1993-5#4)(1993-6#6)(1993-7#1)(1993-8#8)(1993-9#9)(1994-1#5)(1994-12#33)(1994-2#6)(1994-3#21)(1994-5#2)(1994-6#6)(1994-7#4)(1994-8#2)(1995-1#8)(1995-10#7)(1995-12#3)(1995-2#9)(1995-3#4)(1995-5#4)(1995-6#7)(1995-8#8)(1995-9#6)(1996-1#11)(1996-10#2)(1996-11#2)(1996-12#8)(1996-2#17)(1996-3#16)(1996-4#3)(1996-6#4)(1996-8#4)(1996-9#9)(1997-1#4)(1997-2#15)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#4)(1997-7#2)(1997-8#3)(2004-12#8)(2004-3#5)(2004-7#1)(2004-8#3)(2004-9#1)(2005-1#13)(2005-10#4)(2005-11#1)(2005-5#4)(2005-6#1)(2005-7#12)(2005-8#6)(2006-10#25)(2006-11#1)(2006-12#7)(2006-2#10)(2006-3#13)(2006-5#2)(2006-6#36)(2006-7#4)(2006-8#4)(2006-9#9)(2007-1#4)(2007-10#10)(2007-11#15)(2007-12#27)(2007-2#12)(2007-3#6)(2007-4#29)(2007-5#15)(2007-6#13)(2007-7#13)(2007-8#18)(2007-9#8)(2008-1#28)(2008-10#54)(2008-11#58)(2008-12#42)(2008-2#36)(2008-3#14)(2008-4#25)(2008-5#36)(2008-6#19)(2008-7#26)(2008-8#16)(2008-9#17)(2009-1#11)(2009-10#7)(2009-11#8)(2009-2#3)(2009-3#9)(2009-4#14)(2009-5#3)(2009-6#14)(2009-7#4)(2009-8#3)(2009-9#1)(2010-1#13)(2010-10#3)(2010-11#3)(2010-12#18)(2010-2#9)(2010-3#14)(2010-4#5)(2010-5#9)(2010-6#2)(2010-7#5)(2010-8#16)(2010-9#8)(2011-1#16)(2011-12#2)(2011-2#88)(2011-7#1)(2012-1#120)(2012-12#22)(2012-2#47)(2012-3#39)(2013-1#139)(2013-7#11)(2013-8#43)
training&quot##2##1##(2011-2#1)(2012-1#1)
training'##2##1##(1994-12#1)(2009-6#1)
training)##6##1##(2005-1#2)(2008-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
training-induced##2##1##(1991-8#1)(2008-11#1)
training-set##2##1##(2008-3#1)(2013-1#1)
training?##4##1##(1992-2#1)(2006-10#2)(2013-7#1)
training]##2##1##(1996-2#1)(2008-9#1)
trainings##5##1##(2010-8#1)(2011-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
trains and##2##2##(2007-11#1)(2007-12#1)
trains based on##2##3##(2007-12#1)(2009-8#1)
trains by##4##2##(2007-11#1)(2007-12#2)(2008-1#1)
trains from##5##2##(2007-11#1)(2007-12#2)(2008-3#1)(2012-2#1)
trains generated by##2##3##(2007-12#1)(2009-8#1)
trains have been##2##3##(2007-12#2)
trains in##3##2##(2007-11#1)(2007-12#2)
trains of##17##2##(1991-6#1)(1992-1#1)(1992-11#1)(1995-2#1)(1996-1#1)(2007-10#1)(2007-12#5)(2008-2#3)(2008-3#1)(2009-2#1)(2010-12#1)
trains was##2##2##(2007-11#2)
trains with##7##2##(1996-12#1)(2007-12#4)(2008-3#1)(2013-8#1)
trains##82##1##(1990-5#2)(1991-2#4)(1991-6#1)(1992-1#1)(1992-11#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-12#2)(1996-5#1)(2004-3#1)(2007-10#1)(2007-11#10)(2007-12#23)(2008-1#2)(2008-11#6)(2008-2#5)(2008-3#5)(2008-4#1)(2008-9#1)(2009-2#1)(2009-8#3)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#2)
trait Loci mapping##3##3##(2008-10#3)
trait Loci##10##2##(2008-10#9)(2010-2#1)
trait Q1##8##2##(2012-3#8)
trait Q2##2##2##(2012-3#2)
trait affects##2##2##(2008-8#2)
trait and the##3##3##(2008-9#1)(2009-4#1)(2012-3#1)
trait and##19##2##(1992-4#1)(1994-3#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-4#1)(2010-6#1)(2012-3#3)(2013-1#2)(2013-8#1)
trait anxiety##12##2##(1990-8#2)(1994-12#2)(1994-2#1)(1996-6#1)(2007-4#1)(2008-11#1)(2008-2#2)(2009-9#1)(2010-6#1)
trait associations##3##2##(2008-10#1)(2009-8#1)(2012-12#1)
trait but##2##2##(1996-7#1)(2009-4#1)
trait evolution##2##2##(2012-3#2)
trait expression##4##2##(2008-8#1)(2012-3#3)
trait factors##3##2##(1994-2#1)(1997-8#2)
trait for##2##2##(2008-10#1)(2012-1#1)
trait had##2##2##(2008-12#1)(2011-12#1)
trait in the##3##3##(1994-3#1)(2008-9#1)(2012-3#1)
trait in##11##2##(1994-3#1)(1996-2#1)(2008-5#2)(2008-8#1)(2008-9#2)(2012-1#1)(2012-3#1)(2013-1#2)
trait inferences##4##2##(2008-11#4)
trait is##7##2##(1994-3#1)(1997-7#1)(2008-4#1)(2008-9#2)(2010-2#1)(2012-3#1)
trait loci (QTL)##40##3##(2006-12#2)(2008-10#26)(2008-7#2)(2008-8#4)(2009-2#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-3#2)
trait loci (QTLs) were identified##2##5##(2008-10#1)(2008-4#1)
trait loci (QTLs) were##3##4##(2008-10#2)(2008-4#1)
trait loci (QTLs)##11##3##(2008-10#3)(2008-4#1)(2008-8#2)(2008-9#1)(2009-10#1)(2012-11#3)
trait loci##65##2##(2006-12#3)(2008-10#32)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#7)(2008-9#2)(2009-10#2)(2009-2#1)(2010-2#1)(2011-1#1)(2012-1#2)(2012-11#3)(2012-3#5)
trait locus (QTL) mapping##4##4##(2008-8#1)(2010-2#1)(2012-3#2)
trait locus (QTL)##17##3##(2008-10#9)(2008-8#2)(2010-2#1)(2012-11#2)(2012-3#2)(2013-8#1)
trait locus##28##2##(2008-10#16)(2008-5#1)(2008-8#2)(2010-2#1)(2010-4#1)(2012-11#4)(2012-3#2)(2013-8#1)
trait negative affect##4##3##(2009-12#4)
trait of##12##2##(1995-1#1)(1996-3#1)(2008-10#2)(2008-3#1)(2008-4#1)(2010-6#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
trait ratings##2##2##(2009-8#1)(2012-3#1)
trait resilience##3##2##(2009-8#3)
trait self-objectification##4##2##(2007-12#4)
trait self-objectified##2##2##(2007-12#2)
trait that is##3##3##(2008-10#1)(2012-2#1)(2012-3#1)
trait that##6##2##(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)(2012-2#1)(2012-3#1)
trait variance##4##2##(2008-10#1)(2008-12#1)(2009-4#2)
trait variation##2##2##(2010-8#1)(2012-11#1)
trait was##3##2##(1993-12#1)(2006-12#1)(2012-12#1)
trait with##5##2##(1996-3#1)(2006-5#1)(2007-2#1)(2007-7#1)(2008-4#1)
trait##381##1##(1990-12#1)(1990-8#2)(1992-4#1)(1993-12#2)(1993-4#1)(1993-5#1)(1993-9#1)(1994-12#2)(1994-2#3)(1994-3#4)(1994-9#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-3#2)(1996-6#3)(1996-7#1)(1997-1#1)(1997-2#1)(1997-7#3)(1997-8#4)(2005-7#1)(2006-11#2)(2006-12#5)(2006-5#2)(2007-10#1)(2007-12#9)(2007-2#2)(2007-3#2)(2007-4#1)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#70)(2008-11#14)(2008-12#6)(2008-2#3)(2008-3#2)(2008-4#7)(2008-5#6)(2008-7#5)(2008-8#40)(2008-9#23)(2009-10#3)(2009-12#6)(2009-2#1)(2009-4#5)(2009-6#1)(2009-7#1)(2009-8#6)(2009-9#1)(2010-1#1)(2010-2#5)(2010-3#1)(2010-4#1)(2010-6#5)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#4)(2012-1#5)(2012-11#10)(2012-12#2)(2012-2#2)(2012-3#58)(2013-1#6)(2013-7#2)(2013-8#3)
trait-disinhibition variables##2##2##(2010-2#2)
trait-disinhibition##3##1##(2010-2#3)
trait-mediated##3##1##(2008-9#3)
trait-related##4##1##(1996-1#4)
trait-specific##2##1##(2008-11#1)(2012-3#1)
traitement médical##2##2##(2011-2#2)
traitement par ľaciclovir injectable##2##4##(2013-1#2)
traitement par##3##2##(2012-2#1)(2013-1#2)
traitement pour##2##2##(2012-2#1)(2013-1#1)
traitement##20##1##(2011-2#5)(2012-2#10)(2013-1#5)
traits Q1 and##2##3##(2012-3#2)
traits Q1##5##2##(2012-3#5)
traits affecting##3##2##(2008-8#2)(2008-9#1)
traits among##2##2##(2012-2#2)
traits and growth##2##3##(2012-3#2)
traits and interpersonal##2##3##(2012-2#2)
traits and the##3##3##(2008-8#1)(2008-9#1)(2009-10#1)
traits and##40##2##(1995-6#1)(2006-7#1)(2006-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#3)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-2#3)(2010-4#4)(2011-1#1)(2012-2#3)(2012-3#6)
traits are##19##2##(1995-12#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#3)(2008-9#2)(2009-5#1)(2010-4#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-7#1)
traits as##4##2##(1997-4#1)(2008-12#1)(2008-4#1)(2011-1#1)
traits associated with##2##3##(2008-10#1)(2008-8#1)
traits at##3##2##(2008-8#1)(2009-2#1)(2010-10#1)
traits by##2##2##(2008-8#1)(2012-3#1)
traits can also be##3##4##(2010-4#2)(2012-2#1)
traits can be##4##3##(2006-9#1)(2008-10#1)(2012-3#1)(2013-1#1)
traits can##11##2##(2006-9#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-4#2)(2012-2#2)(2012-3#2)(2013-1#1)
traits could##3##2##(2008-2#1)(2010-10#1)(2010-4#1)
traits do not##2##3##(2008-10#1)(2011-1#1)
traits do##3##2##(2008-10#1)(2008-8#1)(2011-1#1)
traits examined##2##2##(2008-8#1)(2012-1#1)
traits for which##2##3##(2008-9#2)
traits for##12##2##(1995-6#1)(2008-10#1)(2008-8#2)(2008-9#3)(2012-1#1)(2012-11#3)(2012-2#1)
traits have##3##2##(2006-11#1)(2007-3#1)(2008-8#1)
traits in a##5##3##(2008-1#1)(2008-8#1)(2009-4#1)(2010-8#1)(2012-2#1)
traits in an##3##3##(2008-1#1)(2008-8#1)(2008-9#1)
traits in birds##2##3##(2008-9#1)(2009-5#1)
traits in different##3##3##(2008-8#1)(2012-1#2)
traits in domestic##2##3##(2012-1#2)
traits in response to##2##4##(2008-8#2)
traits in soybean##2##3##(2012-11#2)
traits in the##6##3##(2008-8#2)(2008-9#1)(2010-10#1)(2010-4#1)(2012-3#1)
traits in##64##2##(1997-8#1)(2007-12#1)(2008-1#3)(2008-10#4)(2008-12#2)(2008-3#1)(2008-6#1)(2008-8#17)(2008-9#4)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#3)(2010-8#1)(2011-1#1)(2011-4#1)(2012-1#8)(2012-11#4)(2012-2#1)(2012-3#5)(2013-7#1)
traits including##3##2##(1997-4#1)(2009-8#1)(2010-10#1)
traits involved in##4##3##(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)
traits is##10##2##(1997-4#1)(2008-8#4)(2010-3#1)(2010-8#1)(2012-3#3)
traits may##3##2##(2008-8#1)(2008-9#2)
traits of C24 and##2##4##(2012-3#2)
traits of interest##3##3##(1997-4#1)(2008-8#1)(2012-2#1)
traits of the##11##3##(1990-5#1)(1993-6#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-9#1)
traits of this##3##3##(1996-3#1)(2006-4#1)(2012-12#1)
traits of##55##2##(1990-5#1)(1993-3#1)(1993-6#1)(1996-11#1)(1996-3#1)(1997-4#1)(2006-4#1)(2007-10#1)(2007-3#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#4)(2008-9#4)(2009-10#1)(2009-2#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#4)(2012-7#1)(2012-9#1)(2013-1#1)(2013-7#2)(2013-8#1)
traits on the##4##3##(1996-2#1)(2008-8#2)(2008-9#1)
traits on##13##2##(1990-12#1)(1996-2#1)(2007-12#1)(2008-8#3)(2008-9#3)(2009-2#1)(2012-12#1)(2012-3#2)
traits or##2##2##(2006-12#1)(2011-1#1)
traits previously##2##2##(1997-3#1)(2009-8#1)
traits provided##2##2##(2008-8#1)(2012-3#1)
traits related to##3##3##(2009-4#1)(2012-1#1)(2013-7#1)
traits remains##3##2##(2008-8#2)(2010-4#1)
traits should##2##2##(2008-10#1)(2008-8#1)
traits such as##7##3##(2008-10#1)(2008-4#1)(2008-8#4)(2010-12#1)
traits that are##8##3##(1995-2#1)(2008-10#1)(2008-8#2)(2008-9#1)(2012-3#2)(2012-5#1)
traits that were##2##3##(2008-5#1)(2008-8#1)
traits that##25##2##(1991-12#1)(1993-2#1)(1995-2#1)(2006-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#7)(2008-9#1)(2010-8#2)(2012-11#1)(2012-3#4)(2012-5#1)
traits to the##2##3##(2008-8#1)(2012-3#1)
traits to##10##2##(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-5#1)(2012-3#2)(2013-1#1)(2013-8#1)
traits under##3##2##(1997-4#1)(2008-8#1)(2013-8#1)
traits using##2##2##(2012-3#2)
traits was##4##2##(2008-10#1)(2008-8#2)(2013-8#1)
traits we##2##2##(2006-12#1)(2012-2#1)
traits were analyzed##2##3##(2008-8#1)(2012-11#1)
traits were determined##2##3##(2008-10#1)(2010-4#1)
traits were significantly##2##3##(2008-10#1)(2008-8#1)
traits were##22##2##(1997-8#1)(2004-11#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-8#5)(2009-8#1)(2010-12#1)(2010-4#4)(2011-1#1)(2012-11#1)
traits when##4##2##(2007-12#1)(2008-5#1)(2008-9#1)(2011-12#1)
traits which##3##2##(2007-11#1)(2009-8#1)(2012-2#1)
traits whose##2##2##(2008-8#1)(2008-9#1)
traits will##2##2##(2008-8#1)(2010-3#1)
traits with##5##2##(2008-8#1)(2008-9#2)(2012-3#2)
traits within##2##2##(2007-12#1)(2009-8#1)
traits##637##1##(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-8#1)(1992-2#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-2#2)(1994-3#3)(1994-9#3)(1995-12#1)(1995-2#1)(1995-6#4)(1996-11#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-4#9)(1997-8#4)(2004-11#4)(2006-10#1)(2006-11#1)(2006-12#4)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#3)(2007-11#2)(2007-12#5)(2007-3#2)(2007-5#1)(2008-1#5)(2008-10#46)(2008-11#9)(2008-12#11)(2008-2#3)(2008-3#3)(2008-4#11)(2008-5#7)(2008-6#2)(2008-7#8)(2008-8#119)(2008-9#51)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#5)(2009-4#5)(2009-5#3)(2009-7#4)(2009-8#11)(2009-9#1)(2010-10#8)(2010-12#5)(2010-2#4)(2010-3#5)(2010-4#29)(2010-5#3)(2010-6#4)(2010-7#2)(2010-8#8)(2011-1#8)(2011-12#6)(2011-2#7)(2011-4#1)(2012-1#17)(2012-11#16)(2012-12#10)(2012-2#23)(2012-3#70)(2012-5#2)(2012-7#1)(2012-9#1)(2013-1#11)(2013-7#9)(2013-8#6)
traits?##2##1##(1995-6#1)(2012-3#1)
trajectories and##9##2##(2007-12#1)(2007-5#1)(2008-11#2)(2008-12#1)(2009-7#1)(2012-1#1)(2012-2#2)
trajectories are##7##2##(2006-4#1)(2007-9#1)(2008-2#1)(2009-12#2)(2010-2#1)(2012-1#1)
trajectories became##2##2##(2007-4#1)(2011-2#1)
trajectories for##4##2##(2008-7#1)(2009-8#2)(2012-12#1)
trajectories from##3##2##(2009-7#1)(2010-2#1)(2011-12#1)
trajectories in the##3##3##(1996-12#1)(2007-12#1)(2008-3#1)
trajectories in##6##2##(1992-8#1)(1996-12#1)(2007-12#2)(2008-3#1)(2009-12#1)
trajectories of a##2##3##(2008-12#1)(2012-2#1)
trajectories of substance use##2##4##(2009-7#2)
trajectories of the##8##3##(1993-12#1)(1994-3#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-6#1)(2010-8#1)(2013-7#1)
trajectories of##34##2##(1990-4#1)(1993-11#1)(1993-12#1)(1994-10#1)(1994-3#1)(1994-8#1)(1996-12#1)(1997-3#1)(2006-10#1)(2007-11#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#2)(2008-8#2)(2009-6#1)(2009-7#2)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
trajectories that##4##2##(2007-11#1)(2008-11#2)(2008-8#1)
trajectories to##3##2##(2008-11#1)(2008-8#1)(2012-1#1)
trajectories were##6##2##(1992-11#1)(1993-2#1)(2007-1#1)(2007-4#1)(2007-5#1)(2008-8#1)
trajectories with##2##2##(2008-2#1)(2008-9#1)
trajectories##148##1##(1990-4#1)(1992-11#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-5#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-8#4)(1996-12#2)(1997-3#2)(2005-11#2)(2006-10#3)(2006-11#1)(2006-3#1)(2006-4#1)(2007-1#1)(2007-11#2)(2007-12#5)(2007-4#3)(2007-5#3)(2007-7#1)(2007-9#3)(2008-11#13)(2008-12#6)(2008-2#6)(2008-3#2)(2008-4#1)(2008-6#4)(2008-7#7)(2008-8#9)(2008-9#1)(2009-12#5)(2009-4#1)(2009-6#1)(2009-7#5)(2009-8#3)(2009-9#1)(2010-2#6)(2010-4#2)(2010-8#5)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#9)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#1)
trajectory and##5##2##(1994-8#1)(2008-2#1)(2009-6#1)(2009-7#1)(2011-2#1)
trajectory at the##3##3##(1996-6#2)(2008-2#1)
trajectory errors##2##2##(2008-3#2)
trajectory estimation##3##2##(2008-3#3)
trajectory group##2##2##(2009-8#1)(2010-4#1)
trajectory groups##3##2##(2008-12#1)(2010-4#2)
trajectory in the##2##3##(2007-5#1)(2008-7#1)
trajectory in##5##2##(2007-11#1)(2007-4#1)(2007-5#1)(2008-7#1)(2009-9#1)
trajectory is##4##2##(1995-12#1)(2007-5#1)(2008-3#1)(2009-8#1)
trajectory of a##5##3##(1992-9#1)(2006-10#1)(2006-5#2)(2007-7#1)
trajectory of the##14##3##(1991-4#1)(1994-11#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)(2008-7#1)(2009-4#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)
trajectory of##30##2##(1991-4#1)(1992-9#1)(1994-11#1)(1994-2#1)(1996-11#1)(1996-12#1)(1997-2#1)(2006-10#1)(2006-5#2)(2007-11#1)(2007-12#2)(2007-7#2)(2008-2#2)(2008-3#4)(2008-7#1)(2009-4#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
trajectory patterns##2##2##(2013-1#2)
trajectory to##3##2##(1995-12#1)(1996-6#1)(2011-2#1)
trajectory was##4##2##(1991-4#1)(1994-8#1)(2012-1#2)
trajectory##115##1##(1991-4#2)(1992-6#1)(1992-9#1)(1994-11#1)(1994-2#1)(1994-8#3)(1995-12#2)(1996-11#1)(1996-12#1)(1996-6#3)(1997-2#1)(2005-11#2)(2006-10#1)(2006-3#1)(2006-5#3)(2006-8#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-4#1)(2007-5#2)(2007-7#2)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#7)(2008-3#11)(2008-4#1)(2008-7#2)(2009-10#1)(2009-12#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#3)(2010-1#1)(2010-12#1)(2010-4#3)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#5)(2011-7#1)(2012-1#8)(2012-12#3)(2012-2#2)(2013-1#4)
trajectory-specific##3##1##(1994-8#3)
tramadol 2mg##2##2##(2010-7#2)
tramadol ER has##2##3##(2008-5#2)
tramadol ER##3##2##(2008-5#3)
tramadol HCl##2##2##(1996-7#2)
tramadol and##6##2##(1993-2#2)(1997-8#1)(2007-2#2)(2008-10#1)
tramadol is an##2##3##(1996-7#1)(2008-5#1)
tramadol is##3##2##(1996-7#2)(2008-5#1)
tramadol##42##1##(1993-2#4)(1996-5#3)(1996-7#8)(1997-8#1)(2006-10#2)(2006-12#1)(2007-2#4)(2007-8#1)(2008-10#6)(2008-5#7)(2008-9#1)(2010-12#1)(2010-2#1)(2010-7#2)
trampling##2##1##(2007-9#1)(2009-3#1)
trance##5##1##(2009-10#5)
tranexamic acid##14##2##(1993-9#4)(2007-8#9)(2011-12#1)
tranilast##10##1##(1995-11#3)(1996-12#2)(2008-5#5)
tranquilizers##6##1##(1993-9#1)(2005-11#1)(2006-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
tranquillisers##3##1##(2008-7#3)
trans FA##3##2##(2007-8#3)
trans Golgi network##4##3##(1990-12#1)(1992-11#2)(1992-12#1)
trans Golgi##6##2##(1990-12#2)(1992-11#2)(1992-12#1)(1993-6#1)
trans addition##2##2##(1995-1#2)
trans and cis##2##3##(1990-9#1)(2007-12#1)
trans conformation##4##2##(1990-10#1)(2008-8#2)(2010-5#1)
trans fatty acids on##2##4##(1991-1#1)(1992-4#1)
trans fatty acids##15##3##(1991-1#1)(1992-4#2)(1995-4#1)(2006-7#9)(2011-2#1)(2012-2#1)
trans fatty##16##2##(1991-1#1)(1992-4#2)(1995-4#1)(2006-7#10)(2011-2#1)(2012-2#1)
trans isomers of##6##3##(1992-4#1)(2006-7#1)(2010-2#4)
trans isomers##12##2##(1990-9#1)(1992-4#1)(1995-6#1)(1996-5#3)(2006-7#1)(2010-2#4)(2013-1#1)
trans splicing##2##2##(1990-6#2)
trans to##7##2##(1990-8#1)(1995-6#1)(1996-2#2)(1996-9#1)(2008-10#1)(2008-5#1)
trans##124##1##(1990-10#2)(1990-12#2)(1990-3#1)(1990-6#3)(1990-8#1)(1990-9#3)(1991-1#1)(1991-12#1)(1991-4#3)(1991-5#7)(1992-11#2)(1992-12#2)(1992-2#1)(1992-4#3)(1993-12#1)(1993-6#1)(1994-3#1)(1994-5#1)(1995-1#2)(1995-11#1)(1995-2#2)(1995-4#1)(1995-6#3)(1996-11#1)(1996-2#3)(1996-5#5)(1996-6#1)(1996-9#2)(1997-4#2)(1997-7#1)(2005-12#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-7#12)(2007-10#1)(2007-12#3)(2007-8#4)(2008-10#4)(2008-12#1)(2008-5#7)(2008-7#2)(2008-8#2)(2009-4#1)(2009-5#1)(2010-12#2)(2010-2#6)(2010-4#1)(2010-5#2)(2011-2#5)(2012-11#3)(2012-2#2)(2013-1#1)
trans)##5##1##(1990-2#2)(1995-1#1)(1996-5#1)(2006-7#1)
trans- and cis-resveratrol##2##3##(2008-10#2)
trans- and##4##2##(2007-10#1)(2008-10#2)(2009-9#1)
trans-##11##1##(1993-2#1)(1996-5#1)(2007-10#2)(2007-11#1)(2008-10#2)(2008-5#1)(2009-9#1)(2010-8#1)(2012-3#1)
trans-(+/-)-ACPD##2##1##(1993-7#2)
trans-1##5##1##(1996-5#1)(2005-8#1)(2007-11#2)(2008-5#1)
trans-11##2##1##(2010-4#1)(2012-2#1)
trans-2##7##1##(1991-10#2)(1994-8#3)(2012-3#1)(2013-8#1)
trans-2-hydroxycinnamic##2##1##(2013-1#2)
trans-3##3##1##(1990-5#3)
trans-3'-hydroxycotinine##5##1##(1993-2#5)
trans-4-(N##2##1##(1990-2#2)
trans-4-dienoyl-CoA##2##1##(1994-8#2)
trans-5##2##1##(2007-10#2)
trans-BPIC##2##1##(2008-10#2)
trans-Caryophyllene##2##1##(2008-11#1)(2012-12#1)
trans-DDP##2##1##(1995-10#1)(2008-5#1)
trans-EE##5##1##(2008-5#5)
trans-Golgi network##16##2##(1992-11#1)(1992-12#1)(1993-6#1)(1996-4#2)(2007-12#1)(2008-1#4)(2009-10#1)(2010-2#1)(2012-12#3)(2012-2#1)
trans-Golgi##20##1##(1991-1#1)(1992-11#1)(1992-12#1)(1993-6#1)(1995-8#1)(1996-4#2)(1997-2#1)(2007-12#1)(2008-1#4)(2009-10#1)(2010-2#1)(2011-1#1)(2012-12#3)(2012-2#1)
trans-Resveratrol and##2##2##(1995-3#1)(2008-10#1)
trans-Resveratrol##4##1##(1995-3#2)(2008-10#2)
trans-[RuCl(4)##2##1##(2008-5#2)
trans-acting elements in##3##3##(1995-2#1)(1996-5#2)
trans-acting factor##3##2##(1991-12#1)(1993-12#2)
trans-acting factors that##2##3##(1995-1#1)(2013-8#1)
trans-acting factors##11##2##(1991-5#1)(1991-8#1)(1992-11#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(2013-8#1)
trans-acting regulation system was##2##4##(2008-9#2)
trans-acting regulation system##3##3##(2008-9#3)
trans-acting replication specificity##2##3##(2008-10#2)
trans-acting transcriptional activator##2##3##(1990-1#1)(1995-3#1)
trans-acting##34##1##(1990-1#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-12#3)(1993-6#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#2)(1996-8#1)(1996-9#2)(1997-6#1)(2008-10#2)(2008-9#3)(2010-12#1)(2010-5#1)(2013-8#1)
trans-activate##2##1##(1994-2#1)(1996-8#1)
trans-activated##2##1##(1994-2#1)(1996-8#1)
trans-activating factors##3##2##(2008-9#3)
trans-activating##8##1##(1994-5#1)(1995-3#1)(2008-2#1)(2008-9#4)(2010-10#1)
trans-activation of##4##2##(1994-2#1)(1994-8#1)(1995-5#1)(1996-12#1)
trans-activation##11##1##(1991-3#2)(1994-2#1)(1994-8#3)(1995-5#1)(1996-10#1)(1996-12#1)(1996-7#1)(1996-8#1)
trans-activator LAP/IL6-DBP##2##2##(1991-8#2)
trans-activator##5##1##(1990-5#1)(1991-8#2)(1997-1#2)
trans-anethole##7##1##(2007-1#7)
trans-azetidine-2##2##1##(1995-11#1)(1995-12#1)
trans-columella access##2##2##(1990-9#2)
trans-diamminedichloroplatinum(II)##2##1##(1990-2#2)
trans-dominant effect##2##2##(1990-5#2)
trans-dominant##5##1##(1990-12#1)(1990-5#3)(2008-10#1)
trans-facet##2##1##(2012-3#2)
trans-farnesyl diphosphate##2##2##(1995-2#2)
trans-flupenthixol##4##1##(1993-6#4)
trans-fused##2##1##(2005-8#1)(2009-8#1)
trans-isomers##2##1##(1997-3#1)(2009-9#1)
trans-lucens##2##1##(2008-10#2)
trans-membrane##5##1##(1991-10#1)(2006-10#1)(2006-2#1)(2008-11#1)(2008-8#1)
trans-nerolidol##2##1##(2007-1#2)
trans-platin##3##1##(1991-10#3)
trans-radial##2##1##(2008-11#1)(2011-2#1)
trans-rectal##3##1##(2007-5#1)(2008-10#2)
trans-replicate##4##1##(2008-10#4)
trans-resveratrol was able to##2##4##(2008-10#2)
trans-resveratrol##7##1##(1995-3#4)(2008-10#3)
trans-sialidase##2##1##(1994-2#1)(1995-3#1)
trans-sinusal frontal approach##5##3##(2006-12#5)
trans-sphenoidal##2##1##(1993-2#1)(2006-12#1)
trans-spliced##6##1##(1996-9#3)(2007-12#3)
trans-splicing##13##1##(1996-9#6)(2007-12#4)(2008-8#1)(2011-3#1)(2012-2#1)
trans-sternal thymectomy##3##2##(2007-9#3)
trans-stilbene oxide##2##2##(1994-9#1)(1995-1#1)
trans-stilbene##3##1##(1994-9#1)(1995-1#1)(2008-3#1)
trans-tamoxifen##6##1##(2008-11#6)
trans-thoracic##2##1##(2007-8#1)(2008-10#1)
trans-translation##2##1##(2006-11#2)
trans/cis##2##1##(1990-10#1)(2008-7#1)
transabdominal and##3##2##(1996-1#2)(2006-9#1)
transabdominal approach was##2##3##(2006-8#1)(2008-9#1)
transabdominal approach##5##2##(1992-8#1)(2006-8#1)(2008-5#1)(2008-9#2)
transabdominal pre-peritoneal##4##2##(2012-12#4)
transabdominal preperitoneal##2##2##(1996-9#1)(2011-2#1)
transabdominal sampling##2##2##(1993-10#2)
transabdominal ultrasound##4##2##(2008-3#1)(2008-7#1)(2010-12#1)(2013-1#1)
transabdominal##32##1##(1992-12#1)(1992-8#2)(1993-10#3)(1995-1#1)(1996-1#2)(1996-9#1)(2006-8#2)(2006-9#2)(2007-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#4)(2013-1#1)
transacceleration##2##1##(1991-5#1)(1992-4#1)
transacting factor##2##2##(1990-5#1)(2008-9#1)
transacting factors##2##2##(1992-2#1)(1995-3#1)
transacting##6##1##(1990-5#1)(1992-2#1)(1994-3#1)(1995-3#1)(2008-9#2)
transaction##16##1##(1991-4#1)(1992-12#1)(1993-1#1)(1993-3#1)(2006-7#2)(2006-8#6)(2008-10#1)(2008-11#3)
transactional sex##8##2##(2007-7#6)(2011-2#2)
transactional theory##2##2##(2006-3#2)
transactional##13##1##(2006-3#2)(2007-7#7)(2011-2#2)(2012-1#1)(2013-7#1)
transactions and##4##2##(2006-7#2)(2006-8#1)(2012-3#1)
transactions for##2##2##(2006-7#1)(2006-8#1)
transactions that##2##2##(1993-1#1)(2008-5#1)
transactions##30##1##(1990-12#1)(1993-1#2)(1994-12#1)(1994-3#1)(1994-8#1)(2006-12#1)(2006-7#6)(2006-8#7)(2007-4#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-2#1)(2010-5#1)(2012-3#1)
transactivate the human apoA-II promoter##2##5##(1997-7#2)
transactivate the human##3##3##(1997-7#3)
transactivate the##5##2##(1995-3#1)(1996-8#1)(1997-7#3)
transactivate##11##1##(1994-12#1)(1995-3#1)(1995-8#2)(1996-8#1)(1997-4#1)(1997-7#4)(2008-8#1)
transactivated by##2##2##(1994-11#1)(2008-11#1)
transactivated##5##1##(1991-1#1)(1992-2#1)(1994-11#1)(1995-3#1)(2008-11#1)
transactivates the human##2##3##(1993-8#1)(1995-3#1)
transactivates the##3##2##(1993-8#1)(1995-3#1)(1997-4#1)
transactivates##8##1##(1993-8#2)(1994-3#1)(1995-3#2)(1997-4#1)(2010-12#1)(2013-1#1)
transactivating domain##3##2##(1994-3#3)
transactivating factors##3##2##(1994-9#1)(2008-11#1)(2008-9#1)
transactivating##11##1##(1990-5#1)(1993-12#1)(1994-3#3)(1994-5#1)(1994-9#1)(1995-3#1)(2008-11#1)(2008-9#1)(2009-6#1)
transactivation and##3##2##(1993-8#2)(1994-3#1)
transactivation assays##2##2##(2008-10#1)(2013-1#1)
transactivation axis##2##2##(2008-11#2)
transactivation by TTF-1##2##3##(1997-2#2)
transactivation by##8##2##(1992-7#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-3#1)(1996-5#1)(1997-2#2)
transactivation domain of##2##3##(1995-2#1)(1995-3#1)
transactivation domain##9##2##(1993-8#1)(1995-2#2)(1995-3#2)(1997-1#1)(1997-4#1)(1997-7#1)(2012-12#1)
transactivation domains##2##2##(1995-3#1)(1995-6#1)
transactivation effects##2##2##(1992-7#1)(1993-12#1)
transactivation function of##3##3##(1993-11#1)(1993-12#1)(1995-8#1)
transactivation function##6##2##(1993-11#1)(1993-12#3)(1995-8#1)(1997-4#1)
transactivation in##3##2##(1994-3#1)(1995-2#1)(2012-12#1)
transactivation of a##3##3##(1991-9#1)(1995-3#1)(1997-4#1)
transactivation of the##6##3##(1991-7#1)(1992-7#1)(1994-9#1)(1997-7#2)(2008-10#1)
transactivation of##18##2##(1991-7#1)(1991-9#1)(1992-7#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-3#1)(1997-4#1)(1997-7#2)(2008-10#2)(2008-9#1)(2011-2#1)(2012-12#1)
transactivation potential of##4##3##(1995-10#1)(1995-6#1)(1995-8#1)(1996-5#1)
transactivation was##2##2##(1992-7#1)(1997-7#1)
transactivation##93##1##(1990-6#1)(1991-7#1)(1991-9#1)(1992-7#6)(1993-11#1)(1993-12#4)(1993-6#1)(1993-8#11)(1993-9#3)(1994-11#1)(1994-12#1)(1994-3#6)(1994-9#5)(1995-10#1)(1995-2#4)(1995-3#6)(1995-6#5)(1995-8#4)(1996-2#1)(1996-5#2)(1997-1#2)(1997-2#2)(1997-4#4)(1997-7#4)(2008-10#3)(2008-11#3)(2008-9#2)(2011-2#1)(2012-12#6)(2013-1#1)
transactivation-independent##3##1##(1997-4#3)
transactivator##17##1##(1990-6#1)(1991-8#1)(1992-9#1)(1993-11#1)(1994-11#1)(1995-3#1)(1997-4#1)(2008-1#3)(2008-2#3)(2008-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
transactivators##7##1##(1992-2#1)(1995-8#1)(1997-3#1)(2008-11#3)(2008-5#1)
transacylase (E2)##2##2##(1991-1#2)
transacylase##9##1##(1991-1#2)(1992-4#1)(1993-9#5)(1995-8#1)
transaldolase and##3##2##(1990-3#1)(2010-12#2)
transaldolase##12##1##(1990-3#8)(1992-12#2)(2010-12#2)
transamidation##3##1##(1994-8#1)(2006-12#2)
transaminase activities##2##2##(2012-2#2)
transaminase and alkaline phosphatase##2##4##(2011-2#1)(2013-1#1)
transaminase and##6##2##(1991-8#1)(1992-1#1)(1995-6#1)(2011-2#1)(2013-1#2)
transaminase elevations##2##2##(1991-7#1)(2009-3#1)
transaminase levels##4##2##(1992-5#1)(1995-2#1)(1997-3#1)(2010-4#1)
transaminase or ALP levels##2##4##(2013-1#2)
transaminase or##3##2##(1991-7#1)(2013-1#2)
transaminase##37##1##(1991-7#2)(1991-8#1)(1992-1#1)(1992-5#1)(1992-9#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-9#1)(1997-3#1)(2008-11#3)(2008-7#2)(2009-3#1)(2010-12#2)(2010-4#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-2#4)(2013-1#6)
transaminases and##2##2##(2012-12#1)(2012-2#1)
transaminases were##2##2##(2008-1#1)(2008-4#1)
transaminases##27##1##(1992-5#2)(1994-11#1)(1994-4#1)(1994-5#1)(1996-11#1)(1996-2#1)(2004-11#1)(2004-4#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-6#1)(2008-1#2)(2008-4#1)(2008-5#1)(2009-5#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-2#2)(2013-1#3)
transaminases)##2##1##(1995-12#1)(2011-2#1)
transamination of##7##2##(1990-3#1)(1991-7#2)(1992-8#1)(1995-12#1)(1996-7#1)(1997-1#1)
transamination##10##1##(1990-3#1)(1991-7#2)(1992-8#1)(1995-12#1)(1996-7#3)(1997-1#1)(2010-8#1)
transanal endoscopic surgery##2##3##(2006-6#2)
transanal endoscopic##4##2##(1992-6#1)(1993-10#1)(2006-6#2)
transanal stapled procedure##2##3##(2006-6#2)
transanal##11##1##(1992-6#1)(1993-10#2)(2006-6#4)(2008-8#2)(2008-9#1)(2009-12#1)
transannular##4##1##(2007-8#1)(2009-10#3)
transaortic##3##1##(1992-9#1)(2007-8#2)
transarterial chemoembolization##7##2##(2010-12#1)(2012-12#1)(2013-7#1)(2013-8#4)
transarterial embolization##2##2##(2006-10#1)(2008-7#1)
transarterial##17##1##(1996-3#1)(1996-9#1)(1997-3#2)(2006-10#1)(2006-11#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#5)
transarticular screw##3##2##(2006-7#1)(2008-12#1)(2008-5#1)
transarticular##5##1##(2006-7#3)(2008-12#1)(2008-5#1)
transaxial##2##1##(1995-5#1)(1997-8#1)
transaxillary single-port##2##2##(2007-8#2)
transaxillary##9##1##(1991-6#1)(2007-7#6)(2007-8#2)
transbilayer diffusion##2##2##(1990-2#1)(1995-11#1)
transbilayer distribution##3##2##(1992-6#1)(1997-1#2)
transbilayer lipid##4##2##(1990-11#1)(1990-5#1)(1997-1#2)
transbilayer movement##4##2##(1990-5#1)(1996-5#3)
transbilayer##16##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#2)(1992-6#1)(1995-11#1)(1996-5#5)(1997-1#4)
transbronchial biopsy or##2##3##(1996-9#1)(2011-2#1)
transbronchial biopsy##9##2##(1992-4#1)(1996-9#1)(2005-8#1)(2007-8#2)(2011-2#3)(2013-8#1)
transbronchial lung biopsy (TBLB)##2##4##(2008-1#1)(2012-12#1)
transbronchial lung biopsy##5##3##(2008-1#3)(2010-8#1)(2012-12#1)
transbronchial needle##2##2##(2009-4#1)(2009-7#1)
transbronchial##16##1##(1992-4#1)(1996-9#1)(2005-8#1)(2007-8#2)(2008-1#3)(2009-4#1)(2009-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-8#1)
transcallosal##6##1##(1996-10#2)(2006-5#3)(2013-1#1)
transcaltachia##5##1##(1992-12#4)(1994-5#1)
transcapillary##3##1##(1994-5#1)(2010-1#1)(2011-1#1)
transcarbamoylase##6##1##(1990-8#2)(1990-9#2)(1995-6#2)
transcarbamylase (OTC) deficiency##2##3##(1992-4#1)(2009-8#1)
transcarbamylase##10##1##(1990-8#2)(1990-9#1)(1991-6#1)(1992-4#1)(1997-2#1)(2009-8#2)(2010-11#2)
transcatheter aortic valve implantation##3##4##(2009-5#1)(2010-12#1)(2013-1#1)
transcatheter aortic valve##5##3##(2009-4#1)(2009-5#1)(2010-12#1)(2013-1#2)
transcatheter aortic##6##2##(2009-4#1)(2009-5#1)(2010-12#1)(2013-1#3)
transcatheter arterial embolization##2##3##(1992-7#1)(2010-12#1)
transcatheter arterial##3##2##(1992-7#1)(2010-12#2)
transcatheter closure of a##3##4##(1996-6#1)(2007-8#1)(2008-4#1)
transcatheter closure of##6##3##(1996-6#1)(2007-8#1)(2008-11#1)(2008-4#1)(2009-10#1)(2013-1#1)
transcatheter closure##9##2##(1996-6#2)(2007-8#2)(2008-11#1)(2008-4#2)(2009-10#1)(2013-1#1)
transcatheter coil##2##2##(2008-11#1)(2013-1#1)
transcatheter embolization##2##2##(2006-9#1)(2008-4#1)
transcatheter embolotherapy##2##2##(2007-8#2)
transcatheter intervention##2##2##(2007-8#1)(2009-10#1)
transcatheter interventions##3##2##(2008-12#1)(2009-10#2)
transcatheter occlusion of##3##3##(1992-10#1)(1993-2#1)(2008-4#1)
transcatheter##42##1##(1992-10#1)(1992-7#1)(1993-2#1)(1996-6#2)(1997-8#1)(2006-10#2)(2006-9#1)(2007-8#6)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#5)(2009-10#4)(2009-4#1)(2009-5#2)(2010-12#3)(2010-8#1)(2013-1#7)
transceiver##5##1##(2008-2#4)(2012-1#1)
transceivers##3##1##(2007-12#1)(2008-3#2)
transcellular transport of this amino acid##2##6##(1992-6#2)
transcellular transport of##3##3##(1992-6#3)
transcellular transport##7##2##(1992-6#3)(1995-1#1)(2007-11#1)(2007-9#1)(2008-10#1)
transcellular##14##1##(1992-3#1)(1992-6#3)(1993-12#1)(1994-10#1)(1995-1#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-9#2)(2008-10#1)
transcend##3##1##(2007-9#1)(2009-10#1)(2012-2#1)
transcendence##3##1##(2010-8#1)(2011-1#1)(2013-8#1)
transcendent##2##1##(2008-12#1)(2012-2#1)
transcendental##5##1##(1994-11#1)(2007-10#2)(2009-2#1)(2013-1#1)
transcends##5##1##(1995-1#1)(2006-10#1)(2006-12#1)(2009-5#1)(2011-2#1)
transcervical approach##3##2##(2006-12#2)(2011-2#1)
transcervical mediastinal drainage##3##3##(2007-8#3)
transcervical osteotomy##2##2##(2012-2#2)
transcervical##18##1##(1991-2#1)(1991-8#1)(1993-10#2)(2006-12#2)(2006-6#1)(2007-3#1)(2007-8#5)(2011-2#2)(2012-2#2)(2013-1#1)
transcobalamin II##3##2##(1991-12#2)(1991-8#1)
transcochlear##3##1##(2005-5#3)
transcoder##4##1##(2008-2#4)
transcoding##2##1##(2008-2#2)
transcolonic##3##1##(2010-12#3)
transconjugant##5##1##(2006-8#1)(2008-10#4)
transconjugants##2##1##(2008-10#2)
transcortical##3##1##(1993-8#1)(1995-6#1)(2008-7#1)
transcortin##2##1##(1990-12#2)
transcortin-bound##2##1##(1990-12#2)
transcranial Doppler (TCD)##6##3##(2006-11#1)(2007-8#1)(2007-9#2)(2008-7#1)(2008-8#1)
transcranial Doppler and##2##3##(1992-10#1)(2007-10#1)
transcranial Doppler sonography##2##3##(1996-6#1)(2006-10#1)
transcranial Doppler ultrasonography##3##3##(1996-2#1)(2007-8#1)(2008-7#1)
transcranial Doppler was used to monitor##2##6##(2007-8#2)
transcranial Doppler##26##2##(1992-10#1)(1996-2#1)(1996-6#1)(2006-10#2)(2006-11#2)(2007-10#7)(2007-8#5)(2007-9#2)(2008-6#1)(2008-7#2)(2008-8#1)(2012-3#1)
transcranial blood-flow##2##2##(2012-1#2)
transcranial color-coded duplex sonography##6##4##(2007-10#2)(2007-9#4)
transcranial color-coded##7##2##(2007-10#2)(2007-9#4)(2010-12#1)
transcranial direct current stimulation (tDCS)##3##5##(2010-6#1)(2010-7#1)(2012-2#1)
transcranial direct current stimulation##8##4##(2010-6#1)(2010-7#3)(2011-1#2)(2012-2#2)
transcranial direct current##9##3##(2010-6#1)(2010-7#4)(2011-1#2)(2012-2#2)
transcranial doppler##3##2##(1990-9#1)(2007-9#2)
transcranial duplex##3##2##(1996-3#1)(2013-1#2)
transcranial electrical##2##2##(1996-2#1)(2006-12#1)
transcranial magnetic stimulation (TMS)##4##4##(1997-7#1)(2008-11#2)(2011-2#1)
transcranial magnetic stimulation (rTMS)##13##4##(1996-1#1)(2008-10#1)(2008-4#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-2#2)(2013-1#2)
transcranial magnetic stimulation in##4##4##(1996-1#1)(2012-2#3)
transcranial magnetic stimulation##39##3##(1996-1#2)(1997-7#1)(2005-10#1)(2005-7#1)(2006-3#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-9#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#5)(2011-1#5)(2011-2#4)(2012-1#1)(2012-2#5)(2013-1#3)
transcranial magnetic##40##2##(1996-1#2)(1996-6#1)(1997-7#1)(2005-10#1)(2005-7#1)(2006-3#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-9#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#5)(2011-1#5)(2011-2#4)(2012-1#1)(2012-2#5)(2013-1#3)
transcranial resection of pituitary##2##4##(2011-2#2)
transcranial resection##3##2##(2011-2#3)
transcranial sonography##2##2##(2008-11#1)(2013-7#1)
transcranial stimulation##4##2##(1996-2#3)(2009-10#1)
transcranial surgery##2##2##(2007-1#1)(2007-12#1)
transcranial##116##1##(1990-9#1)(1992-10#1)(1996-1#2)(1996-2#5)(1996-3#2)(1996-6#2)(1997-7#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-11#2)(2006-12#2)(2006-3#1)(2007-1#1)(2007-10#9)(2007-12#2)(2007-8#5)(2007-9#8)(2008-10#2)(2008-11#3)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-3#1)(2010-5#8)(2010-6#2)(2010-7#9)(2010-8#1)(2011-1#7)(2011-2#9)(2012-1#4)(2012-2#7)(2012-3#1)(2013-1#5)(2013-7#1)
transcranially##2##1##(2010-5#2)
transcribe and##2##2##(1996-6#1)(1996-7#1)
transcribe##14##1##(1991-11#1)(1992-1#1)(1992-5#1)(1993-11#1)(1993-3#1)(1995-2#1)(1996-10#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-7#1)(2007-11#1)(2008-7#1)
transcribed DNA sequences##2##3##(1995-1#1)(2008-11#1)
transcribed DNA##3##2##(1995-1#1)(2008-11#1)(2008-8#1)
transcribed RNA##5##2##(1990-4#1)(1993-3#1)(1996-4#1)(1997-2#1)(2008-11#1)
transcribed and analysed##2##3##(2010-3#1)(2011-1#1)
transcribed and analyzed##4##3##(1995-1#1)(2008-4#2)(2012-12#1)
transcribed and nontranscribed##2##3##(1996-5#1)(1997-1#1)
transcribed and translated in##2##4##(1990-12#1)(1993-2#1)
transcribed and translated##3##3##(1990-12#1)(1993-2#1)(2009-10#1)
transcribed and##21##2##(1990-12#2)(1990-2#1)(1991-11#1)(1992-9#1)(1993-2#1)(1993-5#1)(1995-1#1)(1996-5#1)(1997-1#1)(1997-7#1)(2006-12#1)(2008-2#1)(2008-4#2)(2009-10#1)(2010-3#1)(2010-9#1)(2011-1#1)(2012-12#2)
transcribed as polycistronic##2##3##(2008-8#1)(2012-2#1)
transcribed as##3##2##(1994-12#1)(2008-8#1)(2012-2#1)
transcribed at##6##2##(1991-8#1)(1992-2#1)(1993-2#1)(1993-3#1)(1993-9#1)(1997-4#1)
transcribed but##2##2##(2006-12#1)(2008-8#1)
transcribed by RNA polymerase II##3##5##(1990-6#1)(1992-2#1)(2009-5#1)
transcribed by RNA polymerase##4##4##(1990-6#1)(1992-2#1)(1993-12#1)(2009-5#1)
transcribed by the##4##3##(1992-3#1)(1995-5#1)(1997-7#1)(2009-4#1)
transcribed by##10##2##(1990-6#1)(1992-2#1)(1992-3#1)(1993-12#1)(1995-5#2)(1997-2#1)(1997-7#1)(2009-4#1)(2009-5#1)
transcribed from a promoter##2##4##(1990-7#1)(2007-12#1)
transcribed from a##8##3##(1990-7#1)(1992-9#2)(1994-5#1)(1995-6#1)(1996-2#1)(2006-8#1)(2007-12#1)
transcribed from the gene##2##4##(1996-2#1)(2006-12#1)
transcribed from the same##2##4##(1995-3#1)(2008-7#1)
transcribed from the##10##3##(1990-3#1)(1995-1#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-8#1)(2006-12#1)(2008-7#1)(2008-8#1)
transcribed from##27##2##(1990-3#2)(1990-5#1)(1990-7#1)(1992-9#2)(1994-2#1)(1994-5#1)(1995-1#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#3)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-12#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-3#1)
transcribed gene##2##2##(1997-5#1)(2006-12#1)
transcribed genes in##2##3##(1993-12#1)(1996-5#1)
transcribed genes##4##2##(1993-12#1)(1996-5#1)(1997-1#1)(2009-10#1)
transcribed in a##2##3##(1995-8#1)(1997-2#1)
transcribed in opposite directions##2##4##(1990-4#1)(1991-2#1)
transcribed in the same direction##4##5##(1990-7#1)(1990-9#1)(1992-4#1)(1994-12#1)
transcribed in the same orientation##2##5##(1995-8#1)(1997-1#1)
transcribed in the same##6##4##(1990-7#1)(1990-9#1)(1992-4#1)(1994-12#1)(1995-8#1)(1997-1#1)
transcribed in the##9##3##(1990-7#1)(1990-9#1)(1992-4#1)(1994-12#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-2#1)(2012-3#1)
transcribed in vitro with##2##4##(1993-8#1)(2008-8#1)
transcribed in vitro##5##3##(1991-4#1)(1993-8#1)(1994-9#1)(1997-5#1)(2008-8#1)
transcribed in##39##2##(1990-4#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-2#1)(1991-4#1)(1992-11#1)(1992-4#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-8#2)(1996-2#1)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#1)(2006-12#2)(2008-8#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
transcribed into cDNA and##2##4##(2008-11#1)(2008-4#1)
transcribed into##4##2##(1993-2#1)(2008-11#1)(2008-4#1)(2010-4#1)
transcribed open reading frames##2##4##(1996-6#2)
transcribed or not##2##3##(2008-11#2)
transcribed or##3##2##(2008-11#2)(2012-2#1)
transcribed region of the##3##4##(1994-12#1)(1994-8#1)(1996-5#1)
transcribed region of##4##3##(1994-12#1)(1994-8#1)(1996-5#2)
transcribed region##5##2##(1994-12#1)(1994-8#1)(1995-10#1)(1996-5#2)
transcribed sequence##4##2##(1994-12#1)(1996-2#1)(1997-5#2)
transcribed spacer (ITS) region##17##4##(2008-10#16)(2008-5#1)
transcribed spacer (ITS) sequences##3##4##(2008-10#2)(2008-9#1)
transcribed spacer (ITS)##41##3##(2008-10#38)(2008-5#1)(2008-9#1)(2010-10#1)
transcribed spacer 2##2##3##(2007-3#1)(2008-10#1)
transcribed spacer region##15##3##(2008-10#14)(2008-9#1)
transcribed spacer regions of##4##4##(2008-10#4)
transcribed spacer regions##6##3##(2008-10#6)
transcribed spacer sequences##2##3##(2008-10#2)
transcribed spacer##94##2##(2005-9#1)(2006-3#1)(2007-3#1)(2008-10#81)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2010-10#3)
transcribed to##4##2##(1992-11#1)(1992-8#1)(1997-7#1)(2006-4#1)
transcribed verbatim and analysed by##2##5##(2006-2#1)(2012-3#1)
transcribed verbatim and analysed##4##4##(2006-2#1)(2008-11#1)(2012-12#1)(2012-3#1)
transcribed verbatim and analyzed using##2##5##(2008-11#1)(2010-7#1)
transcribed verbatim and analyzed##3##4##(2008-11#1)(2010-7#1)(2011-1#1)
transcribed verbatim and##9##3##(2006-2#1)(2007-11#1)(2008-11#2)(2010-7#1)(2011-1#1)(2012-12#2)(2012-3#1)
transcribed verbatim##10##2##(2006-2#1)(2007-11#1)(2008-11#2)(2010-7#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
transcribed with##2##2##(1991-7#1)(1992-9#1)
transcribed##311##1##(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-7#3)(1991-8#1)(1992-11#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-8#3)(1992-9#4)(1993-11#3)(1993-12#3)(1993-2#3)(1993-3#3)(1993-5#1)(1993-6#3)(1993-8#3)(1993-9#1)(1994-12#5)(1994-2#3)(1994-5#1)(1994-6#2)(1994-8#4)(1994-9#2)(1995-1#3)(1995-10#2)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#3)(1996-11#2)(1996-2#7)(1996-4#2)(1996-5#4)(1996-6#4)(1996-7#3)(1997-1#5)(1997-2#4)(1997-3#3)(1997-4#3)(1997-5#5)(1997-7#4)(1997-8#1)(2005-9#1)(2006-10#1)(2006-12#6)(2006-2#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#85)(2008-11#8)(2008-12#2)(2008-2#1)(2008-4#5)(2008-5#2)(2008-7#2)(2008-8#11)(2008-9#3)(2009-10#3)(2009-2#1)(2009-4#1)(2009-5#2)(2009-9#1)(2010-10#3)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-12#5)(2012-2#5)(2012-3#5)(2013-1#3)(2013-8#1)
transcribes##4##1##(1990-10#1)(1991-9#1)(1995-2#1)(2012-11#1)
transcribing##6##1##(1993-6#1)(1997-5#1)(2006-10#1)(2008-4#1)(2009-10#1)(2011-2#1)
transcript (1##2##2##(1994-11#1)(2008-5#1)
transcript abundance in##3##3##(1996-7#1)(2006-12#1)(2012-2#1)
transcript abundance##11##2##(1996-7#3)(2006-12#1)(2008-11#1)(2008-7#2)(2012-2#1)(2012-3#1)(2013-8#2)
transcript accumulation##2##2##(2008-10#1)(2008-9#1)
transcript and protein##2##3##(2012-12#1)(2013-8#1)
transcript and the##4##3##(1991-1#1)(1991-7#1)(1993-9#1)(1994-6#1)
transcript and##11##2##(1991-1#1)(1991-7#1)(1993-11#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-6#1)(1995-8#1)(2012-12#1)(2013-8#1)
transcript are##3##2##(1994-12#1)(1995-3#1)(1996-7#1)
transcript by##2##2##(1992-3#1)(1997-7#1)
transcript changes##2##2##(1994-5#1)(2009-4#1)
transcript cleavage##6##2##(1994-8#1)(1994-9#1)(1996-8#4)
transcript containing##2##2##(1996-5#1)(1996-7#1)
transcript derived##2##2##(1990-2#1)(2009-6#1)
transcript driven by the##2##4##(1991-9#1)(1993-9#1)
transcript expression were##2##3##(2010-2#1)(2011-2#1)
transcript expression##9##2##(1993-12#1)(1995-8#1)(2006-10#1)(2006-8#1)(2010-2#1)(2011-2#4)
transcript for the##2##3##(1990-12#1)(1990-9#1)
transcript from a##2##3##(2008-10#2)
transcript from the##2##3##(1994-12#1)(2008-10#1)
transcript from##4##2##(1994-12#1)(2008-10#3)
transcript gene##2##2##(1997-2#2)
transcript in rat##2##3##(1993-6#1)(1995-2#1)
transcript in the##7##3##(1994-9#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-7#1)(2008-4#1)(2008-9#1)
transcript in##18##2##(1990-11#1)(1991-10#1)(1991-7#1)(1991-9#1)(1993-6#2)(1994-12#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-7#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-4#1)(2008-9#1)
transcript is present in L1 larvae and at the##2##9##(1993-12#2)
transcript is##16##2##(1991-10#2)(1991-12#1)(1991-5#1)(1991-9#1)(1993-12#3)(1993-9#1)(1994-12#1)(1995-11#1)(1996-10#1)(1997-1#1)(2008-8#1)(2009-10#1)(2013-1#1)
transcript level is##2##3##(1997-2#2)
transcript level of##4##3##(1993-11#2)(1997-6#1)(1997-7#1)
transcript level was##4##3##(1991-6#1)(1993-11#1)(1997-6#1)(2009-5#1)
transcript level##14##2##(1990-5#1)(1991-6#1)(1992-9#1)(1993-11#3)(1997-2#3)(1997-6#2)(1997-7#1)(2009-5#1)(2010-8#1)
transcript levels as##2##3##(1996-4#1)(2008-7#1)
transcript levels by##2##3##(2007-12#1)(2008-7#1)
transcript levels in a##2##4##(1997-6#1)(2008-4#1)
transcript levels in##7##3##(1991-12#1)(1992-9#1)(1994-3#1)(1996-10#1)(1997-6#1)(2008-4#1)(2008-7#1)
transcript levels of the##3##4##(1997-5#1)(1997-6#1)(2011-1#1)
transcript levels of##9##3##(1997-5#2)(1997-6#1)(1997-7#1)(2008-10#3)(2011-1#1)(2012-1#1)
transcript levels were##4##3##(1993-9#1)(1997-4#2)(2006-12#1)
transcript levels##30##2##(1991-12#1)(1991-5#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-5#1)(1996-10#1)(1996-4#1)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#1)(2006-12#1)(2007-12#2)(2008-10#3)(2008-4#1)(2008-7#4)(2008-9#1)(2011-1#1)(2012-1#1)
transcript map##3##2##(1996-8#1)(1997-2#1)(2008-7#1)
transcript may##2##2##(1991-10#1)(1992-8#1)
transcript of 1##4##3##(1994-12#1)(1996-6#3)
transcript of H-FABP in##2##4##(1997-6#2)
transcript of approx##2##3##(1991-6#1)(1991-7#1)
transcript of the##4##3##(1992-7#1)(1996-2#2)(2008-10#1)
transcript of##35##2##(1991-5#1)(1991-6#3)(1991-7#1)(1992-12#2)(1992-7#1)(1992-8#2)(1993-2#1)(1993-6#1)(1994-12#2)(1995-8#2)(1996-2#2)(1996-6#3)(1997-2#2)(1997-6#3)(1997-8#1)(2008-10#1)(2008-6#1)(2008-8#3)(2009-8#1)(2010-7#1)(2011-2#1)
transcript overlaps##2##2##(1991-7#2)
transcript pattern##2##2##(1991-7#1)(2008-8#1)
transcript patterns##2##2##(2005-11#1)(2012-3#1)
transcript processing##2##2##(1992-11#1)(1995-6#1)
transcript profiles##3##2##(2008-2#1)(2008-7#1)(2009-4#1)
transcript profiling##5##2##(2005-8#1)(2008-2#1)(2008-7#2)(2010-5#1)
transcript release##2##2##(1997-5#1)(1997-6#1)
transcript stability##3##2##(1991-11#1)(1995-1#1)(2008-11#1)
transcript that is##2##3##(1990-10#1)(1991-5#1)
transcript that##3##2##(1990-10#1)(1990-12#1)(1991-5#1)
transcript to##3##2##(1995-2#1)(1995-4#1)(1996-5#1)
transcript was detected by##3##4##(2008-10#3)
transcript was detected##5##3##(1996-6#1)(1997-7#1)(2008-10#3)
transcript was expressed##2##3##(1995-6#1)(2008-9#1)
transcript was found in##2##4##(1990-5#1)(2011-2#1)
transcript was not##2##3##(2006-8#1)(2007-11#1)
transcript was observed in##2##4##(1993-9#1)(1994-12#1)
transcript was##25##2##(1990-5#1)(1991-1#1)(1991-10#2)(1991-12#1)(1991-7#1)(1993-9#2)(1994-11#1)(1994-12#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-7#1)(2006-8#1)(2007-11#1)(2008-10#3)(2008-9#1)(2009-10#1)(2011-2#1)
transcript were##3##2##(1990-12#1)(1994-11#1)(2008-10#1)
transcript which could##2##3##(1991-9#1)(1992-8#1)
transcript which##4##2##(1991-9#2)(1992-8#1)(1993-11#1)
transcript##376##1##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#4)(1990-9#4)(1991-1#2)(1991-10#8)(1991-11#6)(1991-12#3)(1991-4#1)(1991-5#6)(1991-6#5)(1991-7#9)(1991-9#5)(1992-1#1)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#10)(1992-9#3)(1993-11#6)(1993-12#6)(1993-2#1)(1993-6#4)(1993-8#1)(1993-9#8)(1994-11#7)(1994-12#15)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#7)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#5)(1995-3#1)(1995-4#3)(1995-5#1)(1995-6#4)(1995-8#6)(1996-10#7)(1996-11#2)(1996-12#2)(1996-2#3)(1996-4#2)(1996-5#4)(1996-6#5)(1996-7#6)(1996-8#5)(1997-1#2)(1997-2#14)(1997-4#2)(1997-5#6)(1997-6#9)(1997-7#10)(1997-8#2)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#5)(2006-8#2)(2007-11#3)(2007-12#4)(2008-1#2)(2008-10#16)(2008-11#3)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#17)(2008-8#7)(2008-9#6)(2009-10#3)(2009-4#4)(2009-5#2)(2009-6#2)(2009-8#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#9)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#7)(2013-1#1)(2013-8#6)
transcript)##3##1##(1992-1#1)(1995-8#1)(1997-2#1)
transcriptase (RT)##15##2##(1990-10#1)(1991-9#1)(1994-6#2)(1995-1#1)(1995-8#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-6#1)(2006-3#1)(2007-3#1)(2008-11#1)(2013-1#1)
transcriptase activity##7##2##(1991-12#2)(1992-11#1)(1993-9#1)(1994-6#2)(2008-11#1)
transcriptase and##7##2##(1991-2#2)(1993-9#1)(1997-6#1)(2005-7#1)(2008-1#1)(2011-3#1)
transcriptase polymerase chain reaction (RT-PCR)##8##5##(1994-11#1)(1996-12#1)(1997-4#1)(2008-1#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
transcriptase polymerase chain reaction and fluorescence##2##6##(2007-12#2)
transcriptase polymerase chain reaction and##6##5##(1995-2#1)(1997-3#1)(2007-12#2)(2011-2#1)(2012-12#1)
transcriptase polymerase chain reaction##23##4##(1993-9#2)(1994-11#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-12#2)(2007-4#1)(2007-6#1)(2008-1#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
transcriptase##167##1##(1990-10#2)(1990-2#3)(1990-3#1)(1990-9#2)(1991-10#2)(1991-12#4)(1991-2#5)(1991-9#1)(1992-11#3)(1992-3#2)(1992-6#1)(1992-9#2)(1993-3#3)(1993-6#1)(1993-9#12)(1994-11#1)(1994-12#2)(1994-6#6)(1994-8#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-8#3)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#2)(1996-7#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#4)(1997-7#1)(2005-7#3)(2006-11#2)(2006-3#1)(2007-11#2)(2007-12#5)(2007-3#1)(2007-4#1)(2007-6#2)(2008-1#5)(2008-10#1)(2008-11#8)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#1)(2009-11#2)(2009-12#2)(2009-4#5)(2009-7#2)(2009-8#1)(2010-3#1)(2011-2#8)(2011-3#9)(2012-11#2)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
transcriptase-PCR##4##1##(1995-1#1)(1997-4#1)(2009-6#1)(2009-7#1)
transcriptase-polymerase chain reaction (RT-PCR) and##2##5##(2005-10#1)(2008-5#1)
transcriptase-polymerase chain reaction (RT-PCR) using##2##5##(1997-6#2)
transcriptase-polymerase chain reaction (RT-PCR)##16##4##(1994-2#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-2#2)(1997-2#1)(1997-5#1)(1997-6#2)(1997-7#1)(2005-10#1)(2007-8#1)(2008-5#2)(2008-8#1)
transcriptase-polymerase chain reaction using specific primers for##2##7##(1994-11#1)(1996-2#1)
transcriptase-polymerase chain reaction##31##3##(1993-6#1)(1994-11#1)(1994-2#1)(1994-9#2)(1995-12#1)(1995-3#1)(1996-12#3)(1996-2#3)(1997-2#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-9#1)(2005-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#3)(2008-8#1)(2012-3#1)
transcriptase-polymerase chain##32##2##(1993-6#1)(1994-11#1)(1994-2#1)(1994-9#2)(1995-12#1)(1995-3#1)(1996-12#3)(1996-2#4)(1997-2#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-9#1)(2005-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#3)(2008-8#1)(2012-3#1)
transcription (RT)##5##2##(1992-9#1)(1994-9#1)(1995-2#1)(1996-4#1)(2008-4#1)
transcription (RT)-PCR##2##2##(1994-12#1)(2012-12#1)
transcription activating##2##2##(1990-8#1)(2008-9#1)
transcription activation units##2##3##(1995-3#2)
transcription activation##9##2##(1990-6#1)(1991-9#1)(1995-3#5)(1997-7#1)(2011-2#1)
transcription activator##8##2##(1990-6#1)(1990-7#1)(1991-5#1)(1993-9#1)(1995-6#1)(1997-4#1)(2008-7#1)(2008-9#1)
transcription activators##2##2##(1990-12#1)(2008-9#1)
transcription activity##5##2##(1994-12#1)(1996-10#1)(1997-6#2)(2010-5#1)
transcription after##3##2##(1991-12#1)(1994-11#1)(1995-3#1)
transcription also##3##2##(1991-7#1)(1994-3#1)(1996-7#1)
transcription analysis##2##2##(1990-1#1)(2009-10#1)
transcription and analysis of the##2##5##(1993-9#1)(1996-3#1)
transcription and cell##2##3##(1990-6#1)(2008-10#1)
transcription and expression##2##3##(1997-1#1)(2008-8#1)
transcription and mRNA##2##3##(2007-12#1)(2008-2#1)
transcription and protein expression of##2##5##(1996-5#1)(2008-8#1)
transcription and protein##4##3##(1995-11#1)(1995-12#1)(1996-5#1)(2008-8#1)
transcription and replication of the##3##5##(1993-5#1)(1997-1#1)(1997-4#1)
transcription and replication of##6##4##(1993-5#2)(1994-8#1)(1997-1#1)(1997-4#1)(2010-7#1)
transcription and replication##8##3##(1993-5#2)(1994-8#1)(1997-1#2)(1997-2#1)(1997-4#1)(2010-7#1)
transcription and the##2##3##(1991-11#1)(1991-7#1)
transcription and to##3##3##(1993-3#1)(1993-6#1)(1995-8#1)
transcription and translation in##4##4##(1993-2#1)(1994-3#1)(1994-6#1)(2012-2#1)
transcription and translation of##6##4##(1990-11#1)(1990-12#1)(1990-3#1)(1991-12#1)(2005-1#1)(2008-11#1)
transcription and translation##17##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-9#1)(1991-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-6#1)(1996-10#1)(2005-1#1)(2006-10#1)(2006-5#1)(2008-11#1)(2012-2#1)
transcription and##88##2##(1990-1#1)(1990-11#1)(1990-12#1)(1990-3#3)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-7#1)(1992-12#3)(1992-7#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#2)(1995-10#1)(1995-11#1)(1995-12#3)(1995-6#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-7#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#3)(2005-1#1)(2006-10#1)(2006-11#2)(2006-5#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)
transcription and/or##2##2##(1994-8#1)(1996-11#1)
transcription apparatus##2##2##(1990-6#1)(2007-12#1)
transcription are##8##2##(1990-10#1)(1991-7#1)(1996-11#1)(1996-7#1)(2007-12#3)(2008-11#1)
transcription as##2##2##(1991-5#1)(1995-11#1)
transcription assay##2##2##(1996-4#1)(2008-4#1)
transcription assays showed##2##3##(1994-8#1)(1997-5#1)
transcription assays##11##2##(1990-6#1)(1991-2#1)(1991-3#1)(1992-12#1)(1993-5#1)(1994-3#1)(1994-8#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-5#1)
transcription at or near the##2##5##(1994-11#1)(1995-8#1)
transcription at or near##3##4##(1994-11#2)(1995-8#1)
transcription at##6##2##(1990-6#1)(1994-11#2)(1995-2#1)(1995-6#1)(1995-8#1)
transcription both##2##2##(1995-10#1)(1995-8#1)
transcription bubble&quot##2##2##(1995-2#2)
transcription but##4##2##(1990-6#1)(1993-3#1)(1994-8#1)(1995-2#1)
transcription by RNA polymerase##3##4##(1994-9#1)(1995-6#1)(1996-8#1)
transcription by methylation##2##3##(1990-11#2)
transcription by the##4##3##(1993-6#1)(1995-6#1)(1996-7#1)(1997-1#1)
transcription by##45##2##(1990-11#3)(1990-5#2)(1990-8#2)(1991-12#1)(1991-5#1)(1992-8#3)(1993-6#2)(1994-11#1)(1994-12#1)(1994-7#1)(1994-9#2)(1995-10#1)(1995-3#1)(1995-6#3)(1995-8#1)(1996-2#2)(1996-4#1)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(2008-11#1)(2008-4#1)(2008-8#2)(2011-2#1)(2013-1#1)
transcription co-factors##2##2##(2007-12#2)
transcription complex##11##2##(1990-4#1)(1990-6#1)(1990-8#1)(1993-2#1)(1995-1#1)(1995-2#2)(1996-11#1)(1996-7#3)
transcription complexes stalled##2##3##(1995-2#1)(1996-8#1)
transcription complexes##7##2##(1990-4#1)(1995-2#1)(1995-6#1)(1996-8#2)(1997-5#2)
transcription control##2##2##(1993-3#1)(2009-8#1)
transcription cycle##6##2##(1990-8#4)(2013-1#2)
transcription during the cell cycle##2##5##(1991-8#1)(2012-2#1)
transcription during##4##2##(1991-8#1)(1992-11#1)(1997-2#1)(2012-2#1)
transcription efficiency##2##2##(1995-1#1)(1995-6#1)
transcription element##2##2##(1993-7#1)(1994-12#1)
transcription elements##3##2##(1993-4#2)(2010-5#1)
transcription elongation##7##2##(1995-3#3)(1996-11#1)(1996-4#1)(2012-12#2)
transcription factor (HSF)##4##3##(1991-10#1)(1991-7#1)(1995-11#1)(2009-8#1)
transcription factor (MITF)##3##3##(1996-2#1)(2009-4#1)(2013-1#1)
transcription factor 1##2##3##(2009-3#1)(2010-5#1)
transcription factor AP-1##3##3##(1992-4#1)(2008-5#1)(2008-9#1)
transcription factor CREB##2##3##(1996-10#1)(2008-11#1)
transcription factor FOXO1a and##2##4##(2010-11#2)
transcription factor Foxa2##2##3##(2010-11#1)(2012-12#1)
transcription factor GHF-1/Pit-1##2##3##(1997-1#1)(2008-3#1)
transcription factor IIA##4##3##(1992-2#4)
transcription factor IIB##2##3##(1995-3#1)(1997-6#1)
transcription factor IIIA##2##3##(1992-8#1)(1995-11#1)
transcription factor NF-kappa B and##2##5##(1994-8#1)(2008-9#1)
transcription factor NF-kappa B in##2##5##(1997-3#2)
transcription factor NF-kappa B##8##4##(1990-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-3#2)(2008-9#1)
transcription factor NF-kappaB##3##3##(1996-5#1)(2010-3#1)(2012-12#1)
transcription factor NGFI-A##2##3##(1996-8#2)
transcription factor Oct1##2##3##(1991-8#2)
transcription factor PTF1 is##2##4##(1991-11#2)
transcription factor STAT3##2##3##(1996-5#2)
transcription factor Sp1 is##2##4##(1992-12#1)(1994-12#1)
transcription factor Sp1##9##3##(1990-6#1)(1991-2#2)(1991-4#1)(1992-12#2)(1994-12#2)(1996-10#1)
transcription factor activity##2##3##(1996-4#1)(2008-6#1)
transcription factor and##4##3##(1993-8#1)(1996-8#1)(1997-6#1)(2006-12#1)
transcription factor binding sites##2##4##(1994-11#1)(2008-4#1)
transcription factor binding##8##3##(1992-9#1)(1994-11#1)(1994-8#1)(1995-2#1)(1997-6#1)(2008-4#1)(2008-9#1)(2009-4#1)
transcription factor controlling##2##3##(2012-2#2)
transcription factor family##2##3##(1995-2#1)(1997-4#1)
transcription factor for the##2##4##(1995-2#1)(1995-3#1)
transcription factor for##4##3##(1995-1#1)(1995-2#1)(1995-3#1)(2006-8#1)
transcription factor gene##2##3##(1996-2#1)(2008-10#1)
transcription factor genes##4##3##(1995-3#1)(2008-10#1)(2009-10#1)(2012-12#1)
transcription factor in##5##3##(1990-5#1)(1995-1#1)(2009-10#1)(2009-8#2)
transcription factor involved in##2##4##(1997-4#1)(2011-2#1)
transcription factor is a##2##4##(1993-6#1)(2003-11#1)
transcription factor is##8##3##(1990-6#1)(1993-6#1)(1995-1#1)(1996-7#1)(2003-11#1)(2006-10#1)(2010-11#1)(2011-2#1)
transcription factor nuclear factor##2##4##(2007-8#1)(2012-3#1)
transcription factor nuclear##4##3##(2006-9#1)(2007-8#1)(2012-3#1)(2013-1#1)
transcription factor of the##4##4##(2003-11#1)(2006-7#1)(2006-8#1)(2010-8#1)
transcription factor of##6##3##(2003-11#1)(2006-7#1)(2006-8#1)(2010-10#1)(2010-8#1)(2013-8#1)
transcription factor or##2##3##(1991-9#1)(2012-2#1)
transcription factor regulating##3##3##(1995-3#1)(1995-8#1)(2008-4#1)
transcription factor that has##2##4##(1992-5#1)(1996-12#1)
transcription factor that is##2##4##(1991-11#1)(1996-11#1)
transcription factor that##12##3##(1991-11#1)(1991-12#1)(1992-5#1)(1994-11#1)(1994-9#1)(1996-11#2)(1996-12#1)(1996-8#1)(2009-4#1)(2012-12#1)(2013-1#1)
transcription factor which is##2##4##(1996-5#1)(2009-2#1)
transcription factor which##4##3##(1994-11#1)(1996-5#1)(2009-2#1)(2012-3#1)
transcription factor##350##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#5)(1991-2#3)(1991-3#1)(1991-4#5)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#3)(1992-11#2)(1992-12#4)(1992-2#5)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#3)(1992-9#1)(1993-12#3)(1993-2#3)(1993-3#2)(1993-4#1)(1993-6#4)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#7)(1994-12#4)(1994-3#1)(1994-8#8)(1994-9#5)(1995-1#8)(1995-11#2)(1995-2#6)(1995-3#11)(1995-6#7)(1995-8#2)(1995-9#1)(1996-10#3)(1996-11#4)(1996-12#1)(1996-2#5)(1996-3#1)(1996-4#3)(1996-5#9)(1996-7#1)(1996-8#6)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#9)(1997-6#4)(1997-7#2)(2003-11#3)(2005-10#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-12#6)(2007-6#1)(2007-8#2)(2008-10#5)(2008-11#9)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#5)(2008-7#4)(2008-8#1)(2008-9#7)(2009-10#2)(2009-2#2)(2009-3#4)(2009-4#3)(2009-5#1)(2009-6#2)(2009-8#16)(2010-10#2)(2010-11#7)(2010-12#1)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#8)(2012-1#2)(2012-12#13)(2012-2#7)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#3)
transcription factor)##4##2##(1994-8#1)(1995-2#1)(2007-9#1)(2011-2#1)
transcription factor-binding##2##2##(1993-6#1)(1994-12#1)
transcription factors (TFs)##3##3##(2008-9#1)(2011-2#1)(2012-2#1)
transcription factors Myf5 and##2##4##(1996-2#1)(2009-3#1)
transcription factors and the##2##4##(1996-10#1)(2010-11#1)
transcription factors and their##3##4##(1995-3#1)(2011-2#1)(2012-12#1)
transcription factors and##25##3##(1992-2#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-10#1)(1997-3#1)(2005-7#1)(2006-10#1)(2006-12#1)(2009-10#1)(2009-8#1)(2010-11#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
transcription factors are##12##3##(1994-12#1)(1996-10#1)(1996-5#1)(1997-7#1)(2005-7#1)(2007-12#1)(2009-5#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
transcription factors as##3##3##(1994-8#1)(2011-12#1)(2012-1#1)
transcription factors bind##2##3##(1993-9#1)(2007-12#1)
transcription factors binding##4##3##(1990-5#1)(2008-7#1)(2008-9#2)
transcription factors by##4##3##(1996-11#1)(1997-6#1)(2008-11#1)(2009-8#1)
transcription factors can##2##3##(1994-3#1)(2011-1#1)
transcription factors controlling##2##3##(1994-8#1)(2012-12#1)
transcription factors for##2##3##(1996-11#1)(2011-2#1)
transcription factors from##2##3##(2008-7#2)
transcription factors have##3##3##(1996-12#1)(2006-10#1)(2008-7#1)
transcription factors in the##3##4##(1993-2#1)(2013-1#2)
transcription factors in##13##3##(1991-1#1)(1991-12#1)(1992-2#1)(1993-2#1)(1996-11#1)(2006-12#1)(2008-9#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#3)
transcription factors involved in##2##4##(1995-3#1)(1996-3#1)
transcription factors is##4##3##(2008-7#1)(2009-8#1)(2011-2#1)(2012-3#1)
transcription factors may be##2##4##(1991-8#1)(1995-2#1)
transcription factors may##3##3##(1991-8#1)(1995-12#1)(1995-2#1)
transcription factors of the##5##4##(1994-12#1)(1994-2#1)(1997-2#1)(2010-7#1)(2013-8#1)
transcription factors of##7##3##(1994-12#2)(1994-2#1)(1997-2#1)(2008-1#1)(2010-7#1)(2013-8#1)
transcription factors or##2##3##(1997-2#1)(2008-2#1)
transcription factors regulating##2##3##(2011-1#1)(2013-7#1)
transcription factors such as##3##4##(1992-5#1)(1994-8#1)(2012-3#1)
transcription factors that regulate##5##4##(1995-8#1)(2008-1#1)(2008-3#1)(2011-2#1)(2012-12#1)
transcription factors that##21##3##(1994-3#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-10#1)(2006-11#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#3)
transcription factors to##4##3##(1994-3#1)(1994-9#1)(1996-5#1)(2011-2#1)
transcription factors were##7##3##(1994-3#1)(1995-3#1)(1996-11#1)(1997-6#1)(2008-11#2)(2013-1#1)
transcription factors which bind to##2##5##(1991-12#1)(1997-7#1)
transcription factors which##5##3##(1991-12#1)(1993-3#1)(1993-9#1)(1997-7#1)(2008-7#1)
transcription factors whose##2##3##(1995-1#1)(2005-8#1)
transcription factors with a##2##4##(1994-10#1)(2005-8#1)
transcription factors with##7##3##(1994-10#1)(1995-6#1)(2005-8#1)(2008-4#1)(2008-7#1)(2012-12#1)(2012-3#1)
transcription factors##296##2##(1990-11#1)(1990-5#2)(1990-6#2)(1991-1#1)(1991-11#1)(1991-12#4)(1991-5#1)(1991-8#1)(1992-12#2)(1992-2#2)(1992-5#1)(1992-6#1)(1993-11#2)(1993-12#5)(1993-2#2)(1993-3#3)(1993-6#4)(1993-9#3)(1994-10#1)(1994-11#3)(1994-12#6)(1994-2#2)(1994-3#6)(1994-5#2)(1994-8#5)(1994-9#3)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#7)(1995-5#1)(1995-6#2)(1995-8#5)(1996-10#4)(1996-11#4)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#5)(1996-7#1)(1996-8#1)(1997-2#5)(1997-3#1)(1997-4#2)(1997-6#6)(1997-7#4)(2005-11#1)(2005-6#1)(2005-7#3)(2005-8#2)(2006-10#4)(2006-11#1)(2006-12#2)(2007-11#1)(2007-12#4)(2007-5#2)(2007-8#1)(2008-1#6)(2008-10#5)(2008-11#8)(2008-2#2)(2008-3#1)(2008-4#7)(2008-5#3)(2008-6#5)(2008-7#11)(2008-8#3)(2008-9#8)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#8)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-7#3)(2011-1#4)(2011-12#1)(2011-2#9)(2012-1#4)(2012-12#12)(2012-2#8)(2012-3#11)(2013-1#9)(2013-7#1)(2013-8#1)
transcription factors)##2##2##(1995-11#1)(2008-7#1)
transcription followed by##2##3##(1991-11#1)(1997-6#1)
transcription following##2##2##(1993-6#1)(2008-11#1)
transcription for##2##2##(1996-8#1)(2012-3#1)
transcription from a##5##3##(1990-11#1)(1991-12#1)(1992-7#1)(1993-6#1)(2008-9#1)
transcription from the HIV-1##2##4##(1996-10#1)(1997-6#1)
transcription from the##18##3##(1990-3#1)(1990-7#1)(1991-5#1)(1992-1#1)(1992-8#1)(1993-3#2)(1994-8#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-8#1)(1997-2#1)(1997-6#2)(2013-8#1)
transcription from##41##2##(1990-11#2)(1990-3#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-1#3)(1992-7#1)(1992-8#1)(1993-11#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-3#3)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#3)(1996-4#1)(1996-8#1)(1997-2#1)(1997-4#3)(1997-6#2)(2008-9#1)(2012-3#1)(2013-8#1)
transcription have##2##2##(1997-4#1)(2008-11#1)
transcription in a##7##3##(1990-6#1)(1991-12#1)(1991-2#1)(1994-2#1)(1994-3#1)(1996-10#1)(2008-4#1)
transcription in both##2##3##(1991-12#1)(1996-3#1)
transcription in oligodendrocytes##2##3##(1994-9#2)
transcription in response to##3##4##(1991-11#1)(1997-2#1)(2008-4#1)
transcription in the absence of##2##5##(1994-6#1)(1994-9#1)
transcription in the presence of##5##5##(1991-11#1)(1994-9#1)(1995-8#1)(1996-8#2)
transcription in the presence##6##4##(1991-11#1)(1994-9#1)(1995-8#1)(1996-7#1)(1996-8#2)
transcription in the##14##3##(1990-11#1)(1990-3#1)(1991-11#1)(1994-12#1)(1994-6#1)(1994-9#2)(1995-4#1)(1995-8#1)(1996-7#1)(1996-8#2)(2008-7#1)(2009-3#1)
transcription in this##2##3##(1990-8#1)(1993-2#1)
transcription in vitro##6##3##(1990-12#1)(1991-3#1)(1992-5#1)(1995-2#1)(1997-2#1)(2008-5#1)
transcription in vivo##3##3##(1992-12#1)(1994-11#1)(1997-4#1)
transcription in##81##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#2)(1991-11#2)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#3)(1994-9#4)(1995-1#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-8#2)(1996-10#1)(1996-12#1)(1996-3#2)(1996-4#2)(1996-5#1)(1996-7#2)(1996-8#2)(1997-1#1)(1997-2#3)(1997-4#5)(2007-12#2)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
transcription incentive##2##2##(1992-2#2)
transcription inhibitor##2##2##(1997-2#1)(2004-9#1)
transcription initiated at##2##3##(1991-12#1)(1995-2#1)
transcription initiation and##2##3##(2008-2#1)(2008-4#1)
transcription initiation at##3##3##(1991-11#1)(1993-9#1)(1995-2#1)
transcription initiation by##2##3##(1995-6#1)(1997-7#1)
transcription initiation complex##3##3##(1991-4#1)(1992-5#2)
transcription initiation factor##2##3##(1995-8#1)(1997-3#1)
transcription initiation from##2##3##(1991-4#1)(1991-9#1)
transcription initiation site##12##3##(1990-12#1)(1990-5#1)(1991-9#1)(1992-12#1)(1993-3#1)(1993-4#1)(1994-11#1)(1995-10#1)(1995-2#1)(1995-3#1)(1997-4#1)(1997-7#1)
transcription initiation site)##2##3##(1995-6#1)(1997-3#1)
transcription initiation sites were##3##4##(1994-8#1)(1996-5#1)(1996-7#1)
transcription initiation sites##9##3##(1991-4#1)(1992-4#1)(1992-5#1)(1994-8#2)(1995-10#1)(1996-5#2)(1996-7#1)
transcription initiation##54##2##(1990-12#1)(1990-5#1)(1990-6#1)(1991-11#2)(1991-4#3)(1991-9#2)(1992-12#1)(1992-4#2)(1992-5#5)(1992-6#1)(1993-3#1)(1993-4#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-8#2)(1994-9#1)(1995-10#2)(1995-2#3)(1995-3#3)(1995-6#2)(1995-8#1)(1996-11#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#2)(1997-8#1)(2008-2#1)(2008-4#1)(2011-1#1)
transcription into##2##2##(1991-7#1)(1994-12#1)
transcription is also##2##3##(1990-3#1)(2008-9#1)
transcription is regulated by##2##4##(1993-12#1)(1995-10#1)
transcription is regulated##3##3##(1993-12#1)(1995-10#1)(1997-1#1)
transcription is restricted to##2##4##(1991-5#1)(1995-10#1)
transcription is##38##2##(1990-3#2)(1991-5#1)(1991-7#1)(1991-9#2)(1993-12#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-10#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#3)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
transcription level in##2##3##(1993-11#1)(2012-1#1)
transcription level of the##3##4##(1991-7#1)(1997-6#1)(1997-8#1)
transcription level##9##2##(1990-3#1)(1991-7#1)(1993-11#1)(1995-3#1)(1997-6#1)(1997-8#1)(2008-11#1)(2008-8#1)(2012-1#1)
transcription levels of##3##3##(1996-2#1)(1997-7#1)(2008-10#1)
transcription levels##10##2##(1991-7#1)(1996-2#1)(1997-6#1)(1997-7#2)(2008-10#3)(2009-12#1)(2012-12#1)
transcription machinery##9##2##(1992-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(2006-11#2)(2009-3#1)(2013-1#1)
transcription may be##3##3##(1993-12#1)(1993-9#1)(1995-3#1)
transcription may##6##2##(1990-8#1)(1991-4#1)(1993-12#1)(1993-9#1)(1995-3#1)(2011-2#1)
transcription observed##2##2##(1992-8#1)(1995-6#1)
transcription occurred##4##2##(1990-12#1)(1991-5#1)(1997-1#1)(2009-6#1)
transcription occurs in the##2##4##(1992-8#1)(2008-2#1)
transcription occurs##3##2##(1991-1#1)(1992-8#1)(2008-2#1)
transcription of XBP1##2##3##(2011-2#2)
transcription of a number of##3##5##(1996-3#1)(2011-1#2)
transcription of a reporter gene##5##5##(1995-3#2)(1995-8#1)(1996-8#1)(1997-4#1)
transcription of a##16##3##(1991-8#1)(1994-9#2)(1995-3#2)(1995-8#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-4#2)(2008-10#1)(2011-1#2)(2012-12#1)
transcription of an##3##3##(1995-8#1)(1997-7#1)(2008-5#1)
transcription of atrA##2##3##(1997-4#2)
transcription of genes##6##3##(1990-8#1)(1991-9#1)(1995-6#1)(2008-4#1)(2008-7#1)(2008-9#1)
transcription of human##2##3##(1991-12#1)(1996-10#1)
transcription of several##3##3##(1992-9#1)(1996-2#1)(2008-10#1)
transcription of target genes##2##4##(1993-2#1)(2012-12#1)
transcription of the AR##2##4##(1996-5#2)
transcription of the PEPCK gene##2##5##(1995-6#1)(1996-2#1)
transcription of the Rex-1 gene##2##5##(1994-9#2)
transcription of the Xenopus##2##4##(1993-6#1)(1995-8#1)
transcription of the ada gene##3##5##(1991-9#3)
transcription of the c-myc##2##4##(1991-4#1)(1996-5#1)
transcription of the gene encoding##3##5##(1994-8#1)(1995-6#1)(1997-2#1)
transcription of the gene##5##4##(1991-11#1)(1994-2#1)(1994-8#1)(1995-6#1)(1997-2#1)
transcription of the genes##2##4##(1995-2#1)(1996-4#1)
transcription of the human##3##4##(1992-8#1)(1997-1#1)(1997-7#1)
transcription of the two genes##3##5##(1991-2#2)(1996-11#1)
transcription of the##101##3##(1990-11#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-4#1)(1991-7#3)(1991-8#1)(1991-9#3)(1992-1#1)(1992-12#3)(1992-4#1)(1992-8#2)(1993-3#1)(1993-6#1)(1994-11#2)(1994-12#3)(1994-2#4)(1994-8#6)(1994-9#3)(1995-10#3)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#2)(1995-6#4)(1995-8#4)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-4#3)(1996-5#4)(1996-7#1)(1997-1#4)(1997-2#5)(1997-7#2)(1997-8#2)(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-8#1)(2010-10#1)(2010-8#1)
transcription of these genes##3##4##(1990-5#1)(1990-7#1)(1997-4#1)
transcription of these##4##3##(1990-5#1)(1990-7#1)(1997-4#1)(2005-12#1)
transcription of this gene##2##4##(1991-7#1)(2008-9#1)
transcription of##226##2##(1990-11#3)(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#2)(1991-4#1)(1991-7#4)(1991-8#3)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-4#1)(1992-8#2)(1992-9#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#4)(1994-11#4)(1994-12#4)(1994-2#5)(1994-3#2)(1994-8#7)(1994-9#6)(1995-10#5)(1995-11#2)(1995-12#1)(1995-2#8)(1995-3#5)(1995-6#6)(1995-8#8)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#1)(1996-4#5)(1996-5#5)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#6)(1997-2#6)(1997-4#7)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#2)(2004-10#1)(2005-12#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#6)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#8)(2009-8#2)(2010-10#3)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#4)
transcription or##7##2##(1991-12#1)(1992-12#1)(1992-3#1)(1994-3#1)(1994-8#1)(2010-10#1)(2012-3#1)
transcription past##3##2##(1996-11#2)(1997-4#1)
transcription pattern##2##2##(1991-7#1)(1995-8#1)
transcription polymerase chain reaction (RT-PCR)##12##5##(1992-12#1)(1993-8#1)(1995-11#1)(1996-12#1)(2005-11#1)(2007-10#1)(2007-6#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)
transcription polymerase chain reaction and##3##5##(2008-10#2)(2008-8#1)
transcription polymerase chain reaction##21##4##(1992-12#1)(1993-8#1)(1995-11#1)(1996-12#1)(1997-7#1)(2005-11#1)(2007-10#2)(2007-12#1)(2007-6#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
transcription polymerase chain##22##3##(1992-12#1)(1993-8#1)(1995-11#1)(1996-12#1)(1997-7#1)(2005-11#1)(2007-10#2)(2007-12#1)(2007-6#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
transcription process##2##2##(1990-8#1)(2008-7#1)
transcription products##4##2##(1991-11#1)(1994-6#1)(1997-5#1)(2008-4#1)
transcription rate of the gene##2##5##(1991-2#1)(1992-9#1)
transcription rate of the##6##4##(1991-10#1)(1991-2#1)(1992-9#1)(1994-12#2)(1994-3#1)
transcription rate of##10##3##(1991-10#1)(1991-2#1)(1992-3#1)(1992-9#1)(1994-12#3)(1994-3#1)(2008-4#2)
transcription rate##12##2##(1991-10#1)(1991-2#1)(1992-3#1)(1992-9#1)(1994-12#3)(1994-3#1)(1996-11#1)(2008-11#1)(2008-4#2)
transcription rates of a##2##4##(1994-3#1)(2008-10#1)
transcription rates of the##2##4##(1994-12#1)(1994-3#1)
transcription rates of##7##3##(1994-12#1)(1994-3#4)(2008-10#2)
transcription rates##11##2##(1991-12#1)(1994-12#2)(1994-3#5)(1997-4#1)(2008-10#2)
transcription reaction##5##2##(1994-12#2)(1997-2#1)(1997-6#1)(2008-4#1)
transcription reactions##2##2##(1995-6#1)(2008-4#1)
transcription regulation##8##2##(1993-4#1)(1994-8#1)(1995-6#1)(1996-8#1)(2008-7#2)(2008-9#1)(2011-2#1)
transcription regulator##4##2##(2010-10#3)(2011-1#1)
transcription regulators##2##2##(2005-7#1)(2008-7#1)
transcription significantly##2##2##(1995-12#1)(1995-3#1)
transcription sites of rRNA genes##2##5##(2008-8#2)
transcription sites##4##2##(1997-4#1)(2008-8#3)
transcription start point (tsp) and##2##5##(1991-6#1)(1997-2#1)
transcription start point (tsp) is##2##5##(1993-11#1)(1993-12#1)
transcription start point (tsp) of##2##5##(1993-12#1)(1993-6#1)
transcription start point (tsp) was##2##5##(1993-11#1)(1994-12#1)
transcription start point (tsp)##18##4##(1991-12#1)(1991-6#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#3)(1995-2#1)(1995-8#1)(1996-8#1)(1997-2#1)
transcription start point of##2##4##(1993-9#1)(1997-4#1)
transcription start point was##2##4##(1991-6#1)(1993-4#1)
transcription start point##39##3##(1990-11#2)(1990-5#2)(1990-9#1)(1991-12#2)(1991-5#1)(1991-6#3)(1991-9#2)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-12#3)(1995-2#1)(1995-4#1)(1995-8#2)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)
transcription start points (tsp)##4##4##(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#1)
transcription start points##9##3##(1990-11#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1993-2#1)(1993-6#1)(1993-7#1)
transcription start site of the##3##5##(1994-5#1)(1997-5#1)(2006-12#1)
transcription start site of##4##4##(1994-5#1)(1997-5#1)(2006-12#1)(2008-9#1)
transcription start site was located##2##5##(1997-6#1)(2008-9#1)
transcription start site was##4##4##(1991-7#2)(1997-6#1)(2008-9#1)
transcription start site##29##3##(1990-5#1)(1991-11#1)(1991-3#2)(1991-7#2)(1992-12#1)(1992-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#2)(1996-4#1)(1996-8#4)(1997-2#1)(1997-5#2)(1997-6#1)(2006-12#1)(2008-7#1)(2008-9#2)
transcription start sites for##3##4##(1992-4#1)(1995-5#1)(1997-1#1)
transcription start sites in##2##4##(1991-4#1)(1996-5#1)
transcription start sites##10##3##(1991-4#1)(1992-4#1)(1993-8#1)(1994-11#1)(1995-5#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(2008-4#1)
transcription start##89##2##(1990-11#4)(1990-5#3)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#3)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#3)(1991-7#2)(1991-8#1)(1991-9#3)(1992-12#1)(1992-2#1)(1992-4#1)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#3)(1995-4#1)(1995-5#1)(1995-8#2)(1996-4#1)(1996-5#1)(1996-8#6)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#2)(1997-6#2)(2006-12#1)(2008-4#1)(2008-7#1)(2008-9#2)
transcription system##7##2##(1990-4#1)(1991-4#1)(1992-7#1)(1993-3#1)(1994-9#1)(1995-2#1)(1995-8#1)
transcription termination at T1##2##4##(1997-2#2)
transcription termination function##2##3##(1995-2#1)(1995-4#1)
transcription termination of the##2##4##(1991-7#1)(1997-2#1)
transcription termination##19##2##(1990-5#1)(1991-7#1)(1993-4#1)(1994-9#1)(1995-2#1)(1995-4#5)(1995-5#1)(1996-7#4)(1997-2#3)(2008-11#1)
transcription terminator##5##2##(1990-11#2)(1990-3#1)(1990-5#1)(1996-8#1)
transcription terminators##9##2##(1990-5#1)(1990-9#1)(1993-4#2)(1994-12#1)(1994-5#1)(1995-2#1)(1997-1#1)(2008-7#1)
transcription through the##2##3##(1990-11#1)(1996-8#1)
transcription through##5##2##(1990-11#1)(1994-12#1)(1995-2#1)(1995-6#1)(1996-8#1)
transcription to the same extent##2##5##(1995-8#1)(2012-12#1)
transcription to##8##2##(1991-12#1)(1995-8#1)(1997-2#1)(2008-7#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
transcription under##4##2##(1992-12#1)(1993-3#1)(1994-12#1)(1995-10#1)
transcription unit of the gene##2##5##(1991-12#1)(1993-5#1)
transcription unit##10##2##(1990-11#2)(1990-5#2)(1991-12#1)(1992-12#2)(1993-5#1)(1994-2#1)(1994-3#1)
transcription units##2##2##(1993-6#2)
transcription using##2##2##(1991-8#1)(1995-2#1)
transcription via##3##2##(1993-6#1)(1995-2#1)(1995-6#1)
transcription was induced by##2##4##(1997-2#1)(2008-10#1)
transcription was not##4##3##(1990-11#1)(1995-8#1)(2008-7#1)(2011-2#1)
transcription was##18##2##(1990-11#1)(1990-7#1)(1990-9#1)(1992-5#1)(1993-12#1)(1994-12#1)(1995-2#1)(1995-8#1)(1997-2#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-4#1)(2011-2#2)
transcription were##4##2##(1990-7#1)(1991-1#1)(1994-9#1)(1995-2#1)
transcription when##4##2##(1991-10#1)(1993-12#1)(1994-2#1)(1996-8#1)
transcription with T7##2##3##(1993-11#1)(2008-4#1)
transcription with##9##2##(1992-6#1)(1992-9#1)(1993-11#1)(1993-9#1)(1995-10#1)(1997-6#1)(2008-10#1)(2008-4#1)(2010-11#1)
transcription##2073##1##(1990-1#2)(1990-10#4)(1990-11#25)(1990-12#9)(1990-2#1)(1990-3#12)(1990-4#3)(1990-5#18)(1990-6#20)(1990-7#9)(1990-8#16)(1990-9#7)(1991-1#7)(1991-10#6)(1991-11#15)(1991-12#32)(1991-2#8)(1991-3#5)(1991-4#16)(1991-5#17)(1991-6#3)(1991-7#22)(1991-8#12)(1991-9#15)(1992-1#6)(1992-10#1)(1992-11#4)(1992-12#27)(1992-2#13)(1992-3#6)(1992-4#5)(1992-5#10)(1992-6#6)(1992-7#6)(1992-8#12)(1992-9#8)(1993-11#8)(1993-12#24)(1993-2#14)(1993-3#18)(1993-4#9)(1993-5#7)(1993-6#30)(1993-7#3)(1993-8#7)(1993-9#23)(1994-10#3)(1994-11#25)(1994-12#44)(1994-2#14)(1994-3#27)(1994-5#5)(1994-6#6)(1994-7#2)(1994-8#45)(1994-9#35)(1995-1#19)(1995-10#16)(1995-11#10)(1995-12#6)(1995-2#59)(1995-3#56)(1995-4#8)(1995-5#6)(1995-6#37)(1995-8#38)(1995-9#3)(1996-1#1)(1996-10#15)(1996-11#31)(1996-12#11)(1996-2#18)(1996-3#7)(1996-4#21)(1996-5#31)(1996-6#2)(1996-7#21)(1996-8#34)(1996-9#1)(1997-1#21)(1997-2#43)(1997-3#7)(1997-4#48)(1997-5#11)(1997-6#26)(1997-7#19)(1997-8#4)(1997-9#1)(2003-11#3)(2004-10#1)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#5)(2005-12#1)(2005-6#1)(2005-7#4)(2005-8#2)(2005-9#1)(2006-10#6)(2006-11#6)(2006-12#6)(2006-5#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#4)(2007-12#26)(2007-5#2)(2007-6#2)(2007-8#5)(2007-9#5)(2008-1#10)(2008-10#33)(2008-11#45)(2008-2#11)(2008-3#3)(2008-4#41)(2008-5#13)(2008-6#11)(2008-7#40)(2008-8#27)(2008-9#44)(2009-10#5)(2009-12#1)(2009-2#2)(2009-3#8)(2009-4#5)(2009-5#4)(2009-6#5)(2009-8#33)(2009-9#1)(2010-1#2)(2010-10#12)(2010-11#14)(2010-12#4)(2010-2#7)(2010-3#2)(2010-4#4)(2010-5#8)(2010-6#2)(2010-7#5)(2010-8#3)(2010-9#1)(2011-1#19)(2011-12#2)(2011-2#43)(2012-1#8)(2012-12#43)(2012-2#27)(2012-3#25)(2013-1#26)(2013-7#4)(2013-8#7)
transcription)##8##1##(1991-5#1)(1992-3#1)(1996-2#1)(1996-5#1)(1996-7#1)(2008-1#1)(2009-3#1)(2012-2#1)
transcription-##2##1##(1994-11#1)(1997-2#1)
transcription-3##2##1##(2013-1#2)
transcription-PCR##16##1##(1993-12#1)(1993-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-4#2)(1997-4#2)(2007-3#1)(2008-9#3)(2010-11#1)(2011-2#1)(2013-8#1)
transcription-activating##4##1##(1990-8#1)(1992-5#1)(1997-4#1)(2012-2#1)
transcription-coupled repair##5##2##(1994-8#1)(1997-4#1)(2008-11#2)(2012-12#1)
transcription-coupled##9##1##(1994-8#2)(1994-9#1)(1995-8#1)(1997-4#1)(2008-11#2)(2012-12#2)
transcription-dependent##3##1##(1996-5#1)(2009-9#1)(2012-12#1)
transcription-factor binding motifs##2##3##(2006-10#2)
transcription-factor##4##1##(1995-5#1)(2006-10#2)(2008-7#1)
transcription-independent##2##1##(1996-5#1)(2011-2#1)
transcription-polymerase chain reaction (RT-PCR) with##2##5##(1997-7#1)(2008-10#1)
transcription-polymerase chain reaction (RT-PCR)##41##4##(1992-11#1)(1992-8#1)(1993-12#1)(1993-4#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2006-4#1)(2008-10#13)(2008-11#1)(2008-5#1)(2008-9#1)(2010-1#1)(2010-12#1)
transcription-polymerase chain reaction and##6##4##(1995-12#1)(2006-9#1)(2008-10#3)(2009-9#1)
transcription-polymerase chain reaction using##4##4##(1997-7#1)(2008-10#2)(2008-7#1)
transcription-polymerase chain reaction##91##3##(1991-10#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-11#2)(1994-12#4)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-5#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#2)(2006-4#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#1)(2008-10#33)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-9#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#2)
transcription-polymerase chain reactions##3##3##(1995-3#1)(2008-10#2)
transcription-polymerase chain##96##2##(1991-10#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-11#2)(1994-12#4)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#2)(2006-4#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#1)(2008-10#35)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#3)(2009-9#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#2)
transcription-polymerase##97##1##(1991-10#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-11#2)(1994-12#4)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#2)(2006-4#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#1)(2008-10#35)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#3)(2009-9#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#2)
transcription-translation system##2##2##(1990-1#1)(1991-9#1)
transcription-translation##5##1##(1990-1#1)(1991-12#1)(1991-9#1)(1993-12#1)(1995-6#1)
transcription/translation system##4##2##(1994-12#1)(1996-4#1)(1997-2#1)(1997-4#1)
transcription/translation##8##1##(1990-9#1)(1994-12#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-4#1)
transcriptional activation and##2##3##(2011-2#2)
transcriptional activation are##2##3##(1990-2#1)(1995-12#1)
transcriptional activation assay##2##3##(1991-9#1)(1995-8#1)
transcriptional activation at##2##3##(1995-2#1)(2013-1#1)
transcriptional activation by##10##3##(1990-6#2)(1991-11#1)(1993-8#2)(1993-9#1)(1994-9#1)(1995-6#1)(1995-8#1)(1997-1#1)
transcriptional activation in the##2##4##(1995-8#1)(1997-2#1)
transcriptional activation in##6##3##(1991-7#1)(1994-11#1)(1995-3#1)(1995-8#1)(1997-2#2)
transcriptional activation induced by##2##4##(1995-6#1)(1995-8#1)
transcriptional activation is##2##3##(1994-11#2)
transcriptional activation of a reporter##2##5##(1990-8#1)(1993-3#1)
transcriptional activation of a##5##4##(1990-8#1)(1993-3#1)(1994-12#1)(1995-11#1)(1996-8#1)
transcriptional activation of ori lambda##2##5##(1994-11#2)
transcriptional activation of the##7##4##(1991-5#1)(1992-12#1)(1995-10#1)(1995-8#1)(1996-10#1)(2007-8#1)(2012-2#1)
transcriptional activation of##31##3##(1990-11#1)(1990-8#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-12#1)(1995-10#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-8#2)(1996-10#1)(1996-12#2)(1996-4#1)(1996-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2009-8#2)(2010-12#1)(2012-12#1)(2012-2#1)
transcriptional activation##80##2##(1990-11#2)(1990-2#2)(1990-6#3)(1990-8#1)(1991-11#2)(1991-5#1)(1991-7#1)(1991-9#2)(1992-12#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#6)(1994-12#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#4)(1995-6#2)(1995-8#7)(1996-10#1)(1996-12#2)(1996-4#2)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#2)(1997-7#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-8#3)(2010-12#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#1)
transcriptional activator (TAT)##2##3##(2009-6#1)(2010-10#1)
transcriptional activator of##4##3##(1990-11#1)(1991-12#1)(1996-10#1)(2008-11#1)
transcriptional activator which binds to##2##5##(1990-11#1)(1991-5#1)
transcriptional activator which##3##3##(1990-1#1)(1990-11#1)(1991-5#1)
transcriptional activator##33##2##(1990-1#1)(1990-11#3)(1991-12#1)(1991-5#2)(1991-7#1)(1992-12#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#2)(1996-3#1)(1996-5#1)(1997-3#1)(1997-7#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-10#1)(2012-3#2)(2013-1#1)
transcriptional activators of##2##3##(1991-12#1)(2008-7#1)
transcriptional activators##10##2##(1990-8#1)(1991-12#1)(1994-12#1)(1995-2#1)(1996-2#2)(1996-4#1)(2008-7#1)(2010-10#1)(2012-12#1)
transcriptional activity and##2##3##(1996-11#1)(2011-1#1)
transcriptional activity by##2##3##(1995-10#1)(1995-6#1)
transcriptional activity can##2##3##(1996-11#1)(2006-11#1)
transcriptional activity from##3##3##(1992-1#1)(1997-7#1)(2008-8#1)
transcriptional activity in##9##3##(1992-12#1)(1994-11#1)(1995-2#1)(1995-3#3)(1997-7#1)(2007-5#1)(2012-3#1)
transcriptional activity of ATP-citrate lyase gene##2##6##(1992-11#2)
transcriptional activity of MDV genes##2##5##(2005-9#2)
transcriptional activity of the##10##4##(1992-8#1)(1994-3#1)(1995-3#1)(1996-10#1)(1996-5#2)(1997-7#2)(2012-12#2)
transcriptional activity of##32##3##(1992-11#2)(1992-8#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#3)(1996-10#2)(1996-4#2)(1996-5#3)(1997-7#2)(2005-9#2)(2008-11#1)(2008-3#3)(2008-8#1)(2010-4#1)(2012-12#2)(2012-3#1)(2013-7#1)
transcriptional activity was##3##3##(1993-12#1)(2006-11#1)(2011-2#1)
transcriptional activity##81##2##(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#3)(1992-12#1)(1992-5#1)(1992-8#1)(1993-12#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-10#2)(1995-2#2)(1995-3#5)(1995-6#2)(1995-8#4)(1996-10#2)(1996-11#3)(1996-4#2)(1996-5#5)(1996-9#1)(1997-4#1)(1997-7#5)(2005-9#2)(2006-11#2)(2007-5#2)(2008-11#2)(2008-3#3)(2008-5#2)(2008-8#2)(2009-10#3)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#6)(2013-7#1)
transcriptional analyses##2##2##(2006-8#1)(2012-12#1)
transcriptional and post-transcriptional levels##4##4##(1991-6#1)(1992-11#1)(2008-4#1)(2009-8#1)
transcriptional and post-transcriptional mechanisms##2##4##(1995-3#1)(1995-6#1)
transcriptional and post-transcriptional##7##3##(1990-3#1)(1991-6#1)(1992-11#1)(1995-3#1)(1995-6#1)(2008-4#1)(2009-8#1)
transcriptional and posttranscriptional##3##3##(2006-10#1)(2008-11#1)(2012-12#1)
transcriptional and translational signals##2##4##(1990-3#1)(1991-8#1)
transcriptional and translational##8##3##(1990-3#1)(1990-5#1)(1991-8#1)(1993-2#1)(1993-8#1)(1997-4#1)(2005-9#1)(2008-5#1)
transcriptional and##25##2##(1990-3#2)(1990-5#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1993-2#1)(1993-8#1)(1994-11#1)(1995-3#2)(1995-6#1)(1995-8#1)(1997-4#1)(2005-9#1)(2006-10#1)(2007-12#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-12#1)
transcriptional antitermination##2##2##(1990-5#1)(1997-1#1)
transcriptional beta-cell##2##2##(2007-5#2)
transcriptional cascade##2##2##(1992-2#1)(2012-2#1)
transcriptional changes in##3##3##(1996-12#1)(2008-10#1)(2012-12#1)
transcriptional changes##9##2##(1996-12#1)(2008-10#1)(2008-4#1)(2009-8#1)(2010-1#1)(2010-11#1)(2012-12#1)(2012-2#2)
transcriptional co-activator##3##2##(2011-2#1)(2013-1#2)
transcriptional coactivator##4##2##(1997-4#3)(2008-1#1)
transcriptional complexes##2##2##(1995-3#1)(1995-8#1)
transcriptional control elements##4##3##(1993-12#1)(1993-2#1)(1993-3#1)(1997-4#1)
transcriptional control is##2##3##(1994-12#1)(1995-3#1)
transcriptional control of a##2##4##(1995-2#1)(2008-7#1)
transcriptional control of the##6##4##(1993-8#1)(1994-12#1)(1995-10#1)(1997-3#1)(1997-4#1)(2010-10#1)
transcriptional control of two##3##4##(2011-2#1)(2012-12#2)
transcriptional control of##17##3##(1992-9#1)(1993-12#1)(1993-8#1)(1994-12#2)(1995-10#1)(1995-2#1)(1995-3#1)(1997-3#1)(1997-4#1)(2006-10#1)(2008-7#2)(2010-10#1)(2011-2#1)(2012-12#2)
transcriptional control regions of##2##4##(1997-2#2)
transcriptional control##35##2##(1990-11#1)(1991-8#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#3)(1994-6#1)(1995-10#1)(1995-2#1)(1995-3#3)(1995-8#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-4#3)(2006-10#1)(2008-11#2)(2008-7#2)(2010-10#1)(2011-2#1)(2012-12#2)(2012-2#1)
transcriptional corepressor##3##2##(2012-12#3)
transcriptional effects##3##2##(1991-1#1)(1992-3#1)(1996-11#1)
transcriptional elements##3##2##(1991-12#1)(1992-12#1)(1994-2#1)
transcriptional enhancement##4##2##(1995-6#2)(1996-11#2)
transcriptional enhancer##7##2##(1991-8#1)(1992-12#1)(1992-5#1)(1993-11#1)(1995-1#1)(1996-11#1)(2007-3#1)
transcriptional enhancers##2##2##(2008-8#2)
transcriptional estrogen##2##2##(1991-1#2)
transcriptional events##4##2##(1993-6#1)(1995-11#1)(2009-8#1)(2010-1#1)
transcriptional expression of SM alpha-actin##2##5##(1995-3#2)
transcriptional expression of##4##3##(1991-8#1)(1995-3#2)(2010-10#1)
transcriptional expression##7##2##(1991-8#1)(1992-12#1)(1995-3#2)(1995-5#1)(2008-8#1)(2010-10#1)
transcriptional factor and##2##3##(2008-9#2)
transcriptional factor that##2##3##(2008-6#1)(2013-1#1)
transcriptional factor##15##2##(1993-2#1)(1993-3#2)(1996-10#1)(1996-4#1)(1997-6#1)(1997-8#1)(2008-6#1)(2008-9#4)(2012-1#1)(2012-2#1)(2013-1#1)
transcriptional factors such as##2##4##(1994-6#1)(2012-12#1)
transcriptional factors##19##2##(1991-5#1)(1992-7#1)(1994-6#1)(1996-10#1)(1996-4#3)(2006-12#1)(2008-1#2)(2008-5#2)(2008-9#3)(2012-11#1)(2012-12#1)(2012-2#2)
transcriptional fusion##5##2##(1993-12#1)(1994-12#1)(1995-8#1)(2008-10#2)
transcriptional fusions##7##2##(1990-5#1)(1994-3#2)(1995-1#1)(1995-8#2)(1997-2#1)
transcriptional hierarchy##2##2##(1992-2#2)
transcriptional induction of the##5##4##(1991-3#1)(1994-8#1)(1994-9#1)(2008-11#1)(2011-1#1)
transcriptional induction of##9##3##(1991-3#1)(1992-12#1)(1994-8#1)(1994-9#2)(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
transcriptional inhibition##2##2##(1991-2#1)(1992-12#1)
transcriptional initiation sites##2##3##(1993-3#1)(1993-8#1)
transcriptional initiation##11##2##(1991-4#1)(1992-12#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-2#1)(1995-6#2)(1996-2#1)(2008-4#1)(2008-9#1)
transcriptional interference##3##2##(1994-11#1)(1996-7#1)(2011-2#1)
transcriptional level and##3##3##(1993-6#1)(2008-9#1)(2012-12#1)
transcriptional level by##6##3##(1993-4#1)(1995-2#1)(2008-10#1)(2009-8#1)(2011-1#1)(2013-1#1)
transcriptional level in##4##3##(1994-3#1)(2008-5#1)(2008-8#1)(2013-1#1)
transcriptional level of##5##3##(1991-3#1)(1997-4#2)(2012-12#2)
transcriptional level##37##2##(1990-1#1)(1991-12#1)(1991-3#1)(1992-7#2)(1993-4#1)(1993-6#2)(1994-3#1)(1994-8#1)(1994-9#3)(1995-2#1)(1995-8#1)(1996-4#1)(1997-4#2)(2007-7#1)(2008-10#1)(2008-11#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#3)(2013-1#2)
transcriptional machinery##8##2##(1991-5#1)(1995-8#1)(1997-6#2)(2008-6#1)(2010-11#2)(2013-1#1)
transcriptional mechanisms##2##2##(1995-5#1)(2007-8#1)
transcriptional modules##4##2##(2010-2#4)
transcriptional network##2##2##(2009-8#2)
transcriptional networks and##3##3##(2012-12#2)(2013-7#1)
transcriptional networks##9##2##(2008-11#3)(2008-3#1)(2009-8#2)(2012-12#2)(2013-7#1)
transcriptional or translational##3##3##(1994-8#1)(1997-4#1)(2005-12#1)
transcriptional or##4##2##(1994-12#1)(1994-8#1)(1997-4#1)(2005-12#1)
transcriptional orientation##6##2##(1991-9#1)(1994-3#1)(1996-3#1)(1996-6#1)(1997-6#1)(2008-8#1)
transcriptional pause##2##2##(1994-8#1)(1996-8#1)
transcriptional preproinsulin II##2##3##(2007-5#2)
transcriptional process##4##2##(1993-11#1)(1996-12#1)(1997-4#1)(2011-3#1)
transcriptional profiles of##4##3##(2008-7#1)(2009-9#1)(2010-11#1)(2012-1#1)
transcriptional profiles##8##2##(2008-6#1)(2008-7#2)(2009-9#1)(2010-11#1)(2012-1#1)(2013-1#1)(2013-8#1)
transcriptional profiling##4##2##(2008-7#3)(2009-8#1)
transcriptional program##2##2##(2012-12#1)(2012-2#1)
transcriptional programs##3##2##(2008-4#1)(2010-2#1)(2013-1#1)
transcriptional rate##4##2##(1990-3#2)(1995-2#1)(1995-9#1)
transcriptional read-through##2##2##(1990-7#1)(2012-3#1)
transcriptional regulation and##6##3##(1995-2#1)(1996-10#1)(1996-7#1)(2008-10#1)(2008-7#1)(2011-1#1)
transcriptional regulation by##8##3##(1992-12#1)(1994-11#1)(1995-8#1)(1996-4#1)(1997-6#1)(2006-11#1)(2007-12#1)(2012-2#1)
transcriptional regulation in##2##3##(2006-10#1)(2012-3#1)
transcriptional regulation of human##2##4##(1991-12#1)(1993-8#1)
transcriptional regulation of some genes##2##5##(1995-6#1)(2012-12#1)
transcriptional regulation of the human##2##5##(1996-10#1)(2008-11#1)
transcriptional regulation of the##7##4##(1991-1#1)(1993-6#1)(1996-10#1)(1997-1#1)(2008-11#2)(2008-7#1)
transcriptional regulation of##27##3##(1991-1#1)(1991-12#1)(1993-6#1)(1993-8#1)(1994-3#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-12#1)(1997-1#1)(1997-2#1)(2005-11#1)(2006-2#1)(2008-1#1)(2008-11#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2011-2#2)(2012-12#1)
transcriptional regulation##69##2##(1990-5#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-7#2)(1997-1#2)(1997-2#1)(1997-6#2)(1997-7#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#6)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-12#1)(2010-10#2)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#2)
transcriptional regulator##14##2##(1990-5#1)(1993-7#1)(1994-10#2)(1995-6#2)(1997-1#2)(2005-6#1)(2008-11#1)(2009-8#1)(2012-12#1)(2012-2#2)
transcriptional regulators of##2##3##(2006-9#1)(2012-12#1)
transcriptional regulators##11##2##(1991-11#1)(1991-5#1)(1997-4#2)(2006-9#1)(2007-12#1)(2008-7#1)(2010-10#1)(2012-12#3)
transcriptional regulatory elements##3##3##(1993-12#2)(1993-6#1)
transcriptional regulatory networks and##2##4##(2006-10#1)(2008-7#1)
transcriptional regulatory proteins##3##3##(1990-8#1)(2006-9#1)(2008-9#1)
transcriptional regulatory strategy of the rat tissue kallikrein gene family##2##10##(2007-3#2)
transcriptional regulatory system of##2##4##(1997-2#2)
transcriptional regulatory##23##2##(1990-8#1)(1991-10#1)(1992-3#1)(1992-7#1)(1993-12#2)(1993-6#1)(1995-2#1)(1995-8#1)(1996-7#1)(1997-2#2)(1997-4#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2012-1#1)(2012-12#1)
transcriptional reporter gene assay for##2##5##(2010-2#2)
transcriptional repression of##2##3##(2007-12#1)(2009-9#1)
transcriptional repression##9##2##(1994-6#2)(1996-2#2)(1996-4#1)(2007-12#1)(2009-9#1)(2012-12#1)(2012-3#1)
transcriptional repressor##8##2##(1991-10#1)(1995-6#1)(1997-2#1)(2007-10#1)(2007-12#1)(2008-7#1)(2009-6#1)(2011-1#1)
transcriptional repressors##2##2##(1991-5#1)(2009-8#1)
transcriptional response of##2##3##(2008-5#1)(2011-2#1)
transcriptional response to##3##3##(1994-8#1)(2009-12#1)(2010-7#1)
transcriptional response##7##2##(1994-8#2)(2008-5#1)(2009-12#1)(2010-12#1)(2010-7#1)(2011-2#1)
transcriptional responses to cAMP##2##4##(1995-3#2)
transcriptional responses to##5##3##(1991-7#1)(1995-3#2)(2012-12#1)(2013-8#1)
transcriptional responses##8##2##(1991-7#1)(1995-3#2)(1997-7#1)(2012-12#2)(2012-2#1)(2013-8#1)
transcriptional silencing of##3##3##(2009-3#1)(2012-12#2)
transcriptional silencing##13##2##(1995-2#1)(2006-12#1)(2007-10#2)(2008-4#1)(2009-3#3)(2010-3#1)(2012-12#4)
transcriptional start site of the##2##5##(1995-6#1)(1997-2#1)
transcriptional start site##10##3##(1992-2#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-3#2)(1995-6#2)(1996-12#1)(1997-2#1)
transcriptional start sites##6##3##(1990-11#1)(1991-4#1)(1993-3#1)(1994-11#2)(2008-4#1)
transcriptional start##19##2##(1990-10#1)(1990-11#1)(1990-3#1)(1991-2#1)(1991-4#1)(1992-2#1)(1993-3#1)(1994-11#3)(1994-8#1)(1995-11#1)(1995-3#2)(1995-6#2)(1996-12#1)(1997-2#1)(2008-4#1)
transcriptional state##2##2##(1992-11#1)(2012-2#1)
transcriptional status##4##2##(1995-2#1)(1997-7#1)(2007-10#1)(2013-1#1)
transcriptional stimulation##2##2##(1995-3#1)(1996-12#1)
transcriptional targets##2##2##(2012-12#1)(2013-8#1)
transcriptional terminator##5##2##(1994-12#1)(1996-10#3)(1996-2#1)
transcriptional terminators##3##2##(1990-5#1)(1991-8#1)(1993-5#1)
transcriptional trans-activating factors##2##3##(2008-9#2)
transcriptional trans-activating##3##2##(2008-9#3)
transcriptional unit##7##2##(1991-11#1)(1992-1#2)(1993-2#1)(1996-2#1)(2008-10#2)
transcriptional units##3##2##(2008-5#1)(2008-7#2)
transcriptional variant originates##2##3##(1993-11#2)
transcriptional##805##1##(1990-1#2)(1990-10#1)(1990-11#8)(1990-2#2)(1990-3#7)(1990-5#7)(1990-6#4)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#5)(1991-10#2)(1991-11#4)(1991-12#5)(1991-2#3)(1991-3#2)(1991-4#2)(1991-5#9)(1991-6#2)(1991-7#3)(1991-8#5)(1991-9#5)(1992-1#4)(1992-11#5)(1992-12#11)(1992-2#6)(1992-3#2)(1992-5#3)(1992-7#4)(1992-8#4)(1992-9#1)(1993-11#4)(1993-12#9)(1993-2#4)(1993-3#7)(1993-4#1)(1993-5#1)(1993-6#6)(1993-7#1)(1993-8#8)(1993-9#2)(1994-10#3)(1994-11#14)(1994-12#10)(1994-2#2)(1994-3#9)(1994-6#6)(1994-8#12)(1994-9#9)(1995-1#4)(1995-10#5)(1995-11#4)(1995-12#1)(1995-2#13)(1995-3#26)(1995-5#3)(1995-6#16)(1995-8#23)(1995-9#1)(1996-10#12)(1996-11#10)(1996-12#7)(1996-2#9)(1996-3#3)(1996-4#14)(1996-5#7)(1996-6#2)(1996-7#7)(1996-8#2)(1996-9#1)(1997-1#6)(1997-2#13)(1997-3#2)(1997-4#20)(1997-6#8)(1997-7#13)(1997-8#1)(2005-11#2)(2005-12#1)(2005-6#1)(2005-9#3)(2006-10#4)(2006-11#4)(2006-12#3)(2006-2#1)(2006-8#1)(2006-9#2)(2007-10#4)(2007-11#1)(2007-12#8)(2007-3#3)(2007-5#6)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#8)(2008-11#23)(2008-2#2)(2008-3#4)(2008-4#6)(2008-5#14)(2008-6#5)(2008-7#20)(2008-8#9)(2008-9#19)(2009-10#3)(2009-12#2)(2009-3#3)(2009-5#1)(2009-6#4)(2009-8#15)(2009-9#2)(2010-1#2)(2010-10#9)(2010-11#4)(2010-12#5)(2010-2#9)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#6)(2011-2#14)(2011-3#1)(2012-1#3)(2012-11#2)(2012-12#41)(2012-2#18)(2012-3#13)(2013-1#12)(2013-7#2)(2013-8#3)
transcriptionally activated in##2##3##(1990-3#1)(1996-3#1)
transcriptionally activated##5##2##(1990-11#1)(1990-3#1)(1996-3#1)(1997-4#1)(2009-8#1)
transcriptionally active DNA##3##3##(1990-12#1)(1990-7#2)
transcriptionally active and##2##3##(1994-12#1)(1997-1#1)
transcriptionally active##28##2##(1990-12#4)(1990-6#1)(1990-7#3)(1990-8#2)(1991-12#1)(1992-5#2)(1992-8#1)(1994-12#3)(1994-3#1)(1994-9#1)(1995-3#2)(1995-6#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-2#1)(2011-1#1)(2011-2#1)
transcriptionally inactive##2##2##(1992-5#1)(1994-3#1)
transcriptionally regulated by##4##3##(1995-5#1)(1997-4#1)(2009-7#1)(2010-12#1)
transcriptionally regulated##10##2##(1993-6#1)(1995-1#1)(1995-3#2)(1995-4#1)(1995-5#1)(1997-4#1)(2008-4#1)(2009-7#1)(2010-12#1)
transcriptionally silent##2##2##(1993-2#1)(2007-12#1)
transcriptionally##69##1##(1990-11#2)(1990-12#4)(1990-3#1)(1990-6#1)(1990-7#3)(1990-8#2)(1991-12#1)(1991-3#1)(1991-9#1)(1992-2#2)(1992-5#3)(1992-8#1)(1993-2#1)(1993-6#1)(1994-11#2)(1994-12#3)(1994-3#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-4#5)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
transcriptions##5##1##(1994-3#1)(2008-1#1)(2008-4#1)(2012-1#1)(2013-1#1)
transcriptome analysis of##5##3##(2009-12#1)(2010-4#1)(2012-12#1)(2013-1#1)(2013-8#1)
transcriptome analysis##13##2##(2008-7#1)(2009-12#2)(2009-8#2)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
transcriptome and##4##2##(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
transcriptome assembly##3##2##(2012-3#2)(2013-8#1)
transcriptome level##3##2##(2011-2#2)(2012-2#1)
transcriptome meta-analysis##2##2##(2009-10#2)
transcriptome of##3##2##(2006-12#1)(2009-10#1)(2010-7#1)
transcriptome studies##3##2##(2008-7#1)(2011-1#1)(2013-1#1)
transcriptome study##2##2##(2012-3#1)(2013-8#1)
transcriptome##54##1##(2006-12#1)(2008-10#1)(2008-7#5)(2009-10#5)(2009-12#4)(2009-4#1)(2009-8#3)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#8)(2013-1#4)(2013-8#7)
transcriptomes in##2##2##(2008-7#1)(2012-2#1)
transcriptomes of##2##2##(2008-7#2)
transcriptomes##10##1##(2008-7#4)(2009-10#1)(2010-2#1)(2012-1#1)(2012-2#1)(2013-8#2)
transcriptomic##12##1##(2007-11#1)(2008-5#1)(2008-7#3)(2009-10#1)(2009-8#2)(2010-11#1)(2011-1#1)(2012-12#1)(2012-2#1)
transcriptomics and proteomics data##3##4##(2012-3#3)
transcriptomics and proteomics##7##3##(2008-5#1)(2008-7#1)(2010-12#1)(2012-3#4)
transcriptomics in##2##2##(2012-12#1)(2013-8#1)
transcriptomics##13##1##(2006-12#1)(2007-12#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#4)(2013-8#1)
transcripts (7##2##2##(1993-3#1)(1994-11#1)
transcripts accumulated##2##2##(2008-8#1)(2008-9#1)
transcripts and the##4##3##(1990-7#1)(1997-2#1)(1997-6#1)(1997-7#1)
transcripts and##22##2##(1990-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1995-10#1)(1997-2#2)(1997-6#4)(1997-7#1)(2006-12#1)(2007-4#1)(2008-10#1)(2008-4#1)(2008-7#2)(2009-10#1)(2011-2#1)(2012-12#2)
transcripts appear to##4##3##(1990-5#1)(1997-1#1)(2006-10#1)(2009-10#1)
transcripts are expressed in##2##4##(1994-11#1)(1997-2#1)
transcripts are expressed##3##3##(1994-11#1)(1995-11#1)(1997-2#1)
transcripts are present##2##3##(1992-2#1)(1995-3#1)
transcripts are##20##2##(1990-5#1)(1992-10#1)(1992-11#1)(1992-2#1)(1993-6#1)(1994-11#2)(1994-12#1)(1995-11#1)(1995-3#1)(1997-2#1)(1997-4#1)(2006-10#1)(2006-11#1)(2008-10#1)(2008-11#1)(2012-1#1)(2012-2#2)(2013-1#1)
transcripts by##5##2##(1990-12#1)(1992-4#1)(1993-6#1)(1995-6#1)(2006-4#1)
transcripts can be##2##3##(1996-2#1)(2012-2#1)
transcripts can##3##2##(1996-2#1)(2008-7#1)(2012-2#1)
transcripts coding for##2##3##(1997-6#1)(2006-12#1)
transcripts containing the##3##3##(1991-12#1)(1994-12#2)
transcripts containing##7##2##(1991-12#1)(1994-12#3)(1996-7#1)(2008-8#1)(2011-3#1)
transcripts could be##2##3##(1992-9#1)(1996-2#1)
transcripts derived from##3##3##(1997-2#1)(2008-10#2)
transcripts due to##3##3##(1991-7#1)(1991-9#1)(1996-4#1)
transcripts during##3##2##(1996-11#1)(2012-12#2)
transcripts encoding a##2##3##(1994-3#1)(2006-10#1)
transcripts encoding the##4##3##(1991-10#1)(1993-5#1)(2008-10#1)(2012-2#1)
transcripts encoding##8##2##(1991-10#1)(1993-5#1)(1994-3#1)(2006-10#1)(2008-10#2)(2009-4#1)(2012-2#1)
transcripts expressed in##2##3##(1997-1#1)(2008-10#1)
transcripts following##2##2##(1993-12#1)(2008-7#1)
transcripts for the##2##3##(1995-8#1)(2013-8#1)
transcripts for##13##2##(1991-12#1)(1991-9#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-8#3)(2008-10#1)(2008-4#1)(2012-3#1)(2013-8#1)
transcripts from the##4##3##(1994-11#1)(1997-6#2)(2011-1#1)
transcripts from##18##2##(1990-8#1)(1992-11#2)(1992-6#1)(1994-11#1)(1994-8#1)(1995-6#1)(1996-10#1)(1996-5#1)(1997-5#1)(1997-6#2)(2007-4#1)(2008-10#2)(2008-4#1)(2011-1#1)(2012-2#1)
transcripts have also been##2##4##(1995-11#1)(2010-4#1)
transcripts have##4##2##(1995-11#1)(1997-1#1)(2010-4#1)(2012-12#1)
transcripts hybridizing to FLO1 DNA##2##5##(1995-4#2)
transcripts in a##2##3##(1991-6#1)(1997-4#1)
transcripts in human##3##3##(1992-9#1)(2008-4#1)(2008-7#1)
transcripts in the##9##3##(1994-8#1)(1994-9#1)(1996-8#1)(2006-12#1)(2008-9#2)(2012-2#1)(2013-1#2)
transcripts in two##2##3##(1990-8#2)
transcripts in wild-type##2##3##(1990-5#1)(2012-3#1)
transcripts in##55##2##(1990-5#3)(1990-7#2)(1990-8#3)(1991-6#1)(1991-7#1)(1992-4#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#4)(1995-10#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#3)(1997-8#1)(2006-11#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
transcripts is##6##2##(1990-8#1)(1994-3#1)(1994-6#1)(1996-7#1)(2008-4#1)(2010-4#1)
transcripts may be##2##3##(1997-7#1)(2008-10#1)
transcripts may##3##2##(1997-7#1)(2008-10#1)(2008-7#1)
transcripts observed in the##2##4##(1992-9#1)(2008-10#1)
transcripts of 1##4##3##(1993-5#2)(1994-11#1)(1996-5#1)
transcripts of 4##3##3##(1992-6#1)(1994-5#1)(2008-11#1)
transcripts of 6##2##3##(1991-1#1)(1996-5#1)
transcripts of mrr##2##3##(2008-11#2)
transcripts of the HGF gene##2##5##(1990-11#2)
transcripts of the##20##3##(1990-11#2)(1990-2#1)(1990-8#2)(1991-10#1)(1991-11#1)(1991-6#1)(1992-5#1)(1993-11#1)(1995-3#2)(1997-2#1)(1997-6#1)(2006-12#1)(2008-10#2)(2008-6#1)(2008-8#2)
transcripts of##59##2##(1990-11#2)(1990-2#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-5#3)(1991-6#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-5#2)(1993-9#1)(1994-11#1)(1994-5#1)(1995-3#3)(1996-5#2)(1997-2#2)(1997-6#2)(1997-7#1)(2006-12#1)(2007-11#2)(2008-10#5)(2008-11#5)(2008-3#1)(2008-6#1)(2008-8#3)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#1)
transcripts per cell##3##3##(1997-1#3)
transcripts per##5##2##(1996-2#1)(1997-1#3)(1997-5#1)
transcripts present in##2##3##(1995-11#1)(2008-4#1)
transcripts produced##3##2##(1993-9#1)(1996-7#1)(2006-8#1)
transcripts represented##2##2##(1990-2#1)(2009-8#1)
transcripts revealed the##2##3##(1997-7#2)
transcripts revealed##4##2##(1997-7#2)(2008-9#1)(2009-5#1)
transcripts show##2##2##(1997-3#1)(2008-7#1)
transcripts showed##2##2##(1996-8#1)(2008-8#1)
transcripts that are expressed##2##4##(2006-12#1)(2008-4#1)
transcripts that are##5##3##(1994-9#1)(2006-12#2)(2008-4#1)(2009-8#1)
transcripts that were##2##3##(2008-10#1)(2010-5#1)
transcripts that##13##2##(1990-11#1)(1994-9#1)(1996-10#1)(1997-8#1)(2006-11#1)(2006-12#2)(2007-4#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-5#1)
transcripts to##4##2##(1993-3#1)(2008-10#1)(2008-11#1)(2008-4#1)
transcripts was observed##2##3##(1990-7#1)(2005-9#1)
transcripts was##11##2##(1990-12#2)(1990-7#1)(1991-9#1)(1997-2#1)(2005-9#1)(2008-10#2)(2008-8#1)(2013-1#2)
transcripts were also##2##3##(1990-11#1)(2008-10#1)
transcripts were analyzed##2##3##(1993-2#1)(2008-10#1)
transcripts were barely detectable##2##4##(1992-3#1)(1994-12#1)
transcripts were detectable##2##3##(1997-8#1)(2008-5#1)
transcripts were detected in the##2##5##(1992-9#1)(1997-4#1)
transcripts were detected in##6##4##(1992-9#1)(1993-12#1)(1997-1#1)(1997-4#1)(2008-11#1)(2011-2#1)
transcripts were detected##11##3##(1992-9#1)(1993-12#2)(1993-5#1)(1994-11#1)(1995-8#1)(1997-1#1)(1997-4#1)(2008-11#1)(2009-7#1)(2011-2#1)
transcripts were expressed in##4##4##(1991-11#1)(1996-10#1)(1997-7#1)(2009-9#1)
transcripts were expressed##5##3##(1991-11#1)(1996-10#1)(1996-5#1)(1997-7#1)(2009-9#1)
transcripts were first detected##2##4##(1993-3#1)(1995-11#1)
transcripts were localized##2##3##(1992-9#1)(1997-4#1)
transcripts were present in##2##4##(1991-5#1)(1995-4#1)
transcripts were##57##2##(1990-11#2)(1990-7#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-7#1)(1994-11#3)(1994-12#4)(1994-2#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-8#2)(1996-10#1)(1996-5#1)(1997-1#1)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#1)(2006-12#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-9#2)(2009-10#1)(2009-4#1)(2009-7#1)(2009-9#1)(2011-2#1)(2013-1#1)
transcripts which##2##2##(1993-12#1)(1995-6#1)
transcripts whose##2##2##(1991-8#1)(1995-2#1)
transcripts with the##6##3##(1990-8#1)(1996-2#1)(1997-2#1)(2008-11#1)(2008-8#1)(2012-12#1)
transcripts with##15##2##(1990-8#1)(1995-3#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-6#1)(2008-11#2)(2008-4#2)(2008-7#1)(2008-8#1)(2010-4#1)(2012-12#1)(2012-2#1)
transcripts within##3##2##(1992-8#1)(2006-6#1)(2008-4#1)
transcripts##559##1##(1990-11#5)(1990-12#3)(1990-2#4)(1990-4#1)(1990-5#6)(1990-7#6)(1990-8#9)(1991-1#1)(1991-10#2)(1991-11#6)(1991-12#5)(1991-2#2)(1991-5#5)(1991-6#2)(1991-7#7)(1991-8#1)(1991-9#9)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#3)(1992-3#1)(1992-4#3)(1992-5#1)(1992-6#2)(1992-8#4)(1992-9#9)(1993-11#2)(1993-12#8)(1993-2#1)(1993-3#5)(1993-4#1)(1993-5#5)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#4)(1994-10#2)(1994-11#12)(1994-12#13)(1994-2#3)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#12)(1995-1#1)(1995-10#2)(1995-11#5)(1995-12#4)(1995-2#1)(1995-3#8)(1995-4#4)(1995-5#1)(1995-6#6)(1995-8#8)(1996-10#4)(1996-11#1)(1996-12#1)(1996-2#7)(1996-4#2)(1996-5#8)(1996-7#4)(1996-8#2)(1997-1#7)(1997-2#14)(1997-3#2)(1997-4#5)(1997-5#5)(1997-6#12)(1997-7#15)(1997-8#4)(2005-9#1)(2006-10#3)(2006-11#9)(2006-12#11)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#4)(2007-12#1)(2007-4#6)(2007-5#1)(2008-1#1)(2008-10#36)(2008-11#11)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#16)(2008-5#3)(2008-6#1)(2008-7#16)(2008-8#11)(2008-9#8)(2009-10#6)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#7)(2009-9#2)(2010-11#1)(2010-2#1)(2010-4#5)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#3)(2011-2#7)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#10)(2012-2#13)(2012-3#9)(2013-1#10)(2013-8#4)
transcritical##3##1##(2008-2#1)(2008-8#2)
transcultural encounters##2##2##(2008-11#1)(2010-8#1)
transcultural psychiatric##2##2##(2008-2#2)
transcultural psychiatry##4##2##(2008-2#4)
transcultural##15##1##(2008-11#2)(2008-2#12)(2010-8#1)
transcutaneous electrical nerve stimulation##3##4##(1991-2#1)(1995-12#1)(2011-12#1)
transcutaneous electrical nerve##4##3##(1991-2#1)(1995-12#1)(2010-1#1)(2011-12#1)
transcutaneous electrical##5##2##(1991-2#1)(1995-12#1)(2010-1#1)(2011-12#1)(2012-3#1)
transcutaneous oxygen pressure##2##3##(2013-1#2)
transcutaneous oxygen##3##2##(1992-3#1)(2013-1#2)
transcutaneous##20##1##(1991-2#1)(1992-3#1)(1992-8#1)(1995-12#1)(1995-8#1)(2004-9#1)(2006-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2010-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
transcytosis of##4##2##(1992-1#3)(1994-5#1)
transcytosis##17##1##(1992-1#5)(1994-10#1)(1994-5#1)(1995-2#2)(2008-1#1)(2009-10#4)(2009-12#1)(2011-1#1)(2012-2#1)
transdermal administration of nicotine##3##4##(2008-3#3)
transdermal administration of##4##3##(1992-12#1)(2008-3#3)
transdermal and oral##4##3##(2005-9#1)(2010-12#3)
transdermal application##2##2##(2004-12#1)(2012-12#1)
transdermal delivery of##6##3##(2004-1#1)(2007-2#2)(2008-5#1)(2010-12#1)(2012-12#1)
transdermal delivery system for##2##4##(2006-12#1)(2012-12#1)
transdermal delivery system##3##3##(2006-12#1)(2010-12#1)(2012-12#1)
transdermal delivery##10##2##(2004-1#1)(2004-12#1)(2006-12#1)(2007-2#2)(2008-5#1)(2010-12#2)(2012-12#2)
transdermal drug delivery system##3##4##(2004-12#2)(2008-3#1)
transdermal drug delivery##6##3##(1992-8#1)(2004-12#2)(2007-2#1)(2008-3#1)(2011-1#1)
transdermal fentanyl##3##2##(2008-3#1)(2009-6#2)
transdermal granisetron##5##2##(2010-12#5)
transdermal patch##2##2##(2011-2#2)
transdermal sequential##2##2##(1992-12#2)
transdermal system##7##2##(2006-3#1)(2007-8#1)(2008-3#2)(2009-6#2)(2010-12#1)
transdermal therapeutic##2##2##(1992-8#1)(2004-12#1)
transdermal transport of##3##3##(1991-6#2)(2007-2#1)
transdermal transport##5##2##(1991-6#3)(2007-2#2)
transdermal##66##1##(1991-6#3)(1991-8#1)(1992-12#3)(1992-8#2)(1994-9#1)(2004-1#1)(2004-12#5)(2005-1#1)(2005-9#1)(2006-12#1)(2006-3#1)(2007-10#2)(2007-2#5)(2007-8#2)(2008-3#8)(2008-5#1)(2008-8#1)(2009-3#2)(2009-6#5)(2010-12#11)(2011-1#2)(2011-2#2)(2012-12#4)(2013-8#1)
transdiaphragmatic##5##1##(2006-10#1)(2008-10#1)(2008-5#1)(2009-8#1)(2012-3#1)
transdifferentiate into##2##2##(2006-10#1)(2008-1#1)
transdifferentiate to##2##2##(2008-1#1)(2011-2#1)
transdifferentiate##4##1##(2006-10#1)(2008-1#2)(2011-2#1)
transdifferentiation and cellular fusion##2##4##(2008-1#2)
transdifferentiation and##3##2##(2008-1#2)(2008-10#1)
transdifferentiation of##7##2##(2007-5#1)(2009-3#1)(2010-12#1)(2012-12#2)(2012-7#1)(2013-8#1)
transdifferentiation##14##1##(2007-5#1)(2008-1#3)(2008-10#1)(2009-3#1)(2010-12#1)(2012-12#5)(2012-7#1)(2013-8#1)
transdisciplinarity##2##1##(1994-6#1)(2012-3#1)
transdisciplinary research##4##2##(2008-8#3)(2010-2#1)
transdisciplinary##10##1##(1994-6#1)(2006-5#1)(2008-1#1)(2008-11#1)(2008-8#3)(2009-2#1)(2010-2#1)(2011-1#1)
transdominant##3##1##(1993-8#1)(1995-8#1)(2005-7#1)
transduce a signal##2##3##(1994-3#1)(2008-11#1)
transduce a##5##2##(1994-3#1)(1995-8#1)(2008-11#2)(2008-5#1)
transduce exogenous genepCEP-p21 ( WAF-1 ) into##2##7##(2008-8#2)
transduce signals from##3##3##(1992-2#1)(2007-12#1)(2009-8#1)
transduce signals##6##2##(1992-2#1)(1993-9#1)(2007-12#1)(2008-11#1)(2009-8#1)(2012-2#1)
transduce the##2##2##(1993-3#1)(1993-9#1)
transduce##27##1##(1992-12#1)(1992-2#1)(1993-3#1)(1993-9#2)(1994-3#1)(1994-5#1)(1995-1#1)(1995-8#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-11#3)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-8#3)(2010-4#1)(2011-1#1)(2012-2#1)
transduced by##5##2##(1990-3#1)(2006-12#1)(2008-2#1)(2008-4#2)
transduced cells##5##2##(1994-5#1)(2007-12#1)(2008-11#1)(2008-9#1)(2011-2#1)
transduced during##2##2##(1993-6#1)(1994-12#1)
transduced into##3##2##(1993-6#1)(1995-5#1)(2009-6#1)
transduced to the##2##3##(1994-5#1)(2011-2#1)
transduced to##4##2##(1994-5#1)(1996-5#1)(2008-11#1)(2011-2#1)
transduced using##2##2##(2008-5#1)(2012-12#1)
transduced with a##3##3##(2009-10#1)(2012-12#1)(2012-2#1)
transduced with the##5##3##(1991-7#1)(1994-11#1)(1996-5#1)(2006-12#1)(2008-9#1)
transduced with##14##2##(1991-7#1)(1994-11#1)(1994-5#3)(1996-10#1)(1996-5#1)(2006-12#1)(2007-3#1)(2008-9#2)(2009-10#1)(2012-12#1)(2012-2#1)
transduced##59##1##(1990-3#1)(1991-7#1)(1993-11#1)(1993-2#1)(1993-6#3)(1994-11#1)(1994-12#1)(1994-5#5)(1994-8#2)(1995-5#1)(1996-10#1)(1996-5#2)(1997-4#3)(1997-8#1)(2006-12#2)(2007-12#1)(2007-3#3)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#2)(2009-6#1)(2009-9#1)(2010-12#2)(2011-2#3)(2012-12#5)(2012-2#1)(2012-3#1)
transducer (LSST) for##2##3##(2008-10#2)
transducer and a##3##3##(2006-12#1)(2007-8#1)(2009-6#1)
transducer and activator of transcription 3 (STAT3)##2##7##(2009-9#1)(2013-1#1)
transducer and activator of transcription##5##5##(2008-10#1)(2008-8#1)(2009-9#1)(2012-3#1)(2013-1#1)
transducer and activator of##7##4##(2008-10#1)(2008-8#1)(2009-3#1)(2009-9#1)(2012-1#1)(2012-3#1)(2013-1#1)
transducer and the##2##3##(2008-10#2)
transducer and##18##2##(2006-12#1)(2007-12#3)(2007-8#1)(2008-10#4)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2009-9#1)(2012-1#1)(2012-3#1)(2013-1#1)
transducer array##2##2##(2007-12#1)(2008-3#1)
transducer based on##2##3##(2008-2#2)
transducer for##4##2##(1992-8#1)(2007-11#1)(2008-10#1)(2008-3#1)
transducer in the##2##3##(2007-12#1)(2009-8#1)
transducer in##3##2##(2007-12#1)(2008-3#1)(2009-8#1)
transducer of the##3##3##(1995-2#1)(2008-9#1)(2009-5#1)
transducer of##9##2##(1994-9#1)(1995-2#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-8#1)(2008-9#1)(2009-5#1)
transducer was##4##2##(2007-8#1)(2008-10#2)(2009-5#1)
transducer were used##2##3##(2007-5#1)(2011-2#1)
transducer##114##1##(1990-9#1)(1991-1#1)(1992-1#1)(1992-8#1)(1993-5#1)(1994-5#2)(1994-9#1)(1995-2#2)(1996-2#2)(1996-4#1)(1996-5#4)(1996-9#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-5#1)(2007-11#2)(2007-12#7)(2007-4#2)(2007-5#1)(2007-8#4)(2008-1#2)(2008-10#16)(2008-11#1)(2008-2#7)(2008-3#11)(2008-4#5)(2008-7#1)(2008-8#3)(2008-9#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-2#2)(2011-1#2)(2011-2#4)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
transducer's##2##1##(2007-5#1)(2013-1#1)
transducers and activators of transcription (STAT)##3##6##(2011-2#2)(2012-3#1)
transducers and activators of transcription##9##5##(1995-3#1)(1996-2#1)(1996-5#1)(2009-3#1)(2011-12#1)(2011-2#3)(2012-3#1)
transducers and activators of##12##4##(1995-3#1)(1996-2#1)(1996-5#2)(2008-1#1)(2009-3#1)(2011-12#1)(2011-2#3)(2012-3#1)(2013-1#1)
transducers and##13##2##(1995-3#1)(1996-2#1)(1996-5#2)(2008-1#1)(2009-1#1)(2009-3#1)(2011-12#1)(2011-2#3)(2012-3#1)(2013-1#1)
transducers at the nanoscale##2##4##(2006-12#2)
transducers for##2##2##(2008-10#1)(2009-5#1)
transducers in##6##2##(1996-12#2)(1997-4#2)(2009-8#1)(2012-1#1)
transducers of cold stimuli##2##4##(2008-8#2)
transducers of##6##2##(1991-5#1)(2007-9#1)(2008-10#1)(2008-8#2)(2013-1#1)
transducers that##3##2##(1993-12#1)(2008-7#1)(2010-4#1)
transducers were##3##2##(1996-9#1)(2007-5#1)(2008-10#1)
transducers##69##1##(1990-8#1)(1991-5#1)(1993-10#1)(1993-12#1)(1995-3#1)(1995-6#1)(1996-12#3)(1996-2#1)(1996-5#2)(1996-9#1)(1997-4#3)(2006-12#3)(2007-5#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#12)(2008-3#3)(2008-7#1)(2008-8#2)(2009-1#1)(2009-12#1)(2009-3#1)(2009-5#6)(2009-8#1)(2010-4#2)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
transduces the##4##2##(2008-9#2)(2010-10#1)(2012-2#1)
transduces##8##1##(1996-5#1)(2008-9#2)(2009-12#1)(2010-10#1)(2011-12#1)(2012-2#1)(2013-1#1)
transducible##4##1##(2008-1#2)(2008-11#1)(2008-5#1)
transducin (Gt)##4##2##(1994-9#1)(1996-5#2)(1997-7#1)
transducin activation##2##2##(1992-6#1)(1994-9#1)
transducin is##2##2##(1990-2#1)(1995-1#1)
transducin was##2##2##(1990-2#2)
transducin##28##1##(1990-2#6)(1990-7#4)(1992-6#4)(1992-9#1)(1993-3#1)(1994-11#1)(1994-9#4)(1995-1#1)(1996-5#4)(1997-7#1)(2008-10#1)
transducing material for##2##3##(2008-10#2)
transducing system##2##2##(1995-8#1)(2008-10#1)
transducing the##4##2##(1993-6#1)(1996-3#1)(1996-4#1)(2010-2#1)
transducing##26##1##(1990-9#1)(1991-6#1)(1993-6#2)(1993-8#2)(1994-11#1)(1994-12#2)(1995-8#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-2#1)
transduction and##31##2##(1990-5#1)(1991-9#1)(1992-8#1)(1994-8#1)(1995-2#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-5#1)(2003-11#1)(2005-7#2)(2006-10#1)(2006-12#1)(2006-4#1)(2007-3#1)(2008-1#1)(2008-11#3)(2008-9#2)(2009-10#1)(2010-11#1)(2010-4#1)(2011-12#1)(2012-1#3)(2012-2#1)
transduction at the##2##3##(1992-11#1)(2008-7#1)
transduction at##3##2##(1992-11#1)(2008-7#1)(2009-10#1)
transduction between##2##2##(1994-5#1)(2006-8#1)
transduction by the##3##3##(1992-2#1)(1995-9#1)(2010-2#1)
transduction by##17##2##(1992-12#1)(1992-2#4)(1993-8#1)(1994-12#2)(1995-12#1)(1995-9#1)(1996-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-2#1)
transduction cascade##3##2##(1992-9#1)(1993-12#1)(1995-12#1)
transduction chain for##2##3##(2008-3#1)(2008-4#1)
transduction chain##3##2##(2008-3#1)(2008-4#2)
transduction component##2##2##(1992-3#1)(2008-9#1)
transduction domain##2##2##(2008-1#1)(2008-2#1)
transduction during##3##2##(2008-4#1)(2008-8#1)(2008-9#1)
transduction efficiency##3##2##(2007-3#1)(2008-11#1)(2011-3#1)
transduction events##8##2##(1994-6#1)(1994-9#4)(2008-4#2)(2012-12#1)
transduction has been##2##3##(1991-2#2)
transduction has##4##2##(1991-2#2)(1996-10#1)(2008-4#1)
transduction in a##3##3##(1990-9#1)(2008-10#1)(2008-6#1)
transduction in##37##2##(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#2)(1991-9#1)(1993-6#3)(1993-7#2)(1994-10#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-8#2)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-4#2)(1997-7#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-5#1)(2011-3#1)(2013-1#1)
transduction is##4##2##(1993-6#1)(2008-2#1)(2010-5#1)(2011-12#1)
transduction mechanism##4##2##(1990-9#1)(1994-3#1)(1994-9#1)(2008-4#1)
transduction networks##7##2##(2006-10#1)(2009-5#1)(2010-1#3)(2011-3#2)
transduction of a##3##3##(2008-1#1)(2008-4#1)(2008-8#1)
transduction of growth##2##3##(1991-1#1)(2010-5#1)
transduction of insulin##2##3##(1991-12#1)(1994-11#1)
transduction of murine hematopoietic##2##4##(1994-3#1)(1997-4#1)
transduction of signals##4##3##(1991-5#1)(1992-3#1)(1995-2#1)(2008-8#1)
transduction of the##12##3##(1990-12#1)(1990-3#1)(1990-7#1)(1991-10#1)(1996-10#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-8#1)
transduction of##54##2##(1990-12#1)(1990-3#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-3#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-11#2)(1994-3#1)(1994-5#3)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-7#1)(1996-10#2)(1996-5#1)(1996-7#1)(1997-3#1)(1997-4#3)(1997-5#1)(2007-11#1)(2008-1#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-9#1)(2010-10#2)(2010-5#1)(2013-1#1)
transduction pathway##47##2##(1990-11#1)(1991-12#1)(1991-5#1)(1992-8#1)(1993-4#1)(1993-6#1)(1994-11#3)(1994-2#1)(1994-3#3)(1994-9#2)(1995-6#1)(1995-8#2)(1996-10#1)(1996-11#2)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#3)(1997-7#2)(2004-12#1)(2006-9#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-7#2)(2008-8#2)(2009-4#1)(2009-8#1)(2011-3#1)(2012-3#1)(2013-8#1)
transduction pathways are##3##3##(1991-3#1)(2006-10#1)(2009-5#1)
transduction pathways leading to##4##4##(1992-12#1)(1996-8#1)(2008-4#1)(2009-6#1)
transduction pathways of##3##3##(1996-12#1)(1996-5#1)(2008-10#1)
transduction pathways that##4##3##(1992-2#1)(1994-8#1)(1997-1#1)(2009-10#1)
transduction pathways##94##2##(1990-11#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-7#3)(1993-4#1)(1993-6#1)(1993-7#2)(1994-11#1)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#1)(1995-2#4)(1995-3#1)(1996-12#1)(1996-5#4)(1996-8#1)(1997-1#1)(1997-4#2)(1997-6#2)(2005-10#2)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#3)(2006-5#1)(2006-9#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#7)(2008-5#4)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#2)(2009-5#2)(2009-6#3)(2009-8#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)
transduction processes##2##2##(1991-7#1)(2006-12#1)
transduction system in##2##3##(1992-8#1)(1995-8#1)
transduction system which##2##3##(1990-4#1)(1994-6#1)
transduction system##9##2##(1990-4#1)(1992-11#1)(1992-12#1)(1992-8#1)(1994-6#1)(1995-3#1)(1995-8#1)(1995-9#1)(2009-8#1)
transduction techniques##2##2##(2007-8#2)
transduction to##5##2##(1991-8#1)(1997-4#1)(2005-8#1)(2010-11#1)(2012-2#1)
transduction was##4##2##(1996-9#1)(1997-2#1)(2005-8#1)(2008-9#1)
transduction with a reverse fragment to a cDNA encoding human 6A8 alpha-mannosidase##2##12##(2008-8#2)
transduction with##4##2##(1990-11#2)(2008-8#2)
transduction##586##1##(1990-10#1)(1990-11#7)(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#4)(1990-9#3)(1991-1#1)(1991-10#4)(1991-11#1)(1991-12#4)(1991-2#4)(1991-3#1)(1991-5#3)(1991-7#3)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#3)(1992-12#4)(1992-2#5)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#4)(1992-9#4)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#3)(1993-6#10)(1993-7#7)(1993-8#5)(1993-9#2)(1994-10#1)(1994-11#10)(1994-12#6)(1994-2#2)(1994-3#11)(1994-5#7)(1994-6#7)(1994-8#6)(1994-9#12)(1995-1#1)(1995-10#3)(1995-11#5)(1995-12#3)(1995-2#11)(1995-3#6)(1995-5#1)(1995-6#6)(1995-7#2)(1995-8#11)(1995-9#2)(1996-10#6)(1996-11#2)(1996-12#3)(1996-2#5)(1996-3#1)(1996-5#11)(1996-7#2)(1996-8#4)(1996-9#2)(1997-1#2)(1997-2#4)(1997-3#3)(1997-4#15)(1997-5#3)(1997-6#5)(1997-7#5)(1997-8#1)(2003-11#1)(2004-12#1)(2005-10#2)(2005-11#1)(2005-7#8)(2005-8#6)(2006-10#10)(2006-11#1)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#1)(2006-9#2)(2007-11#4)(2007-12#11)(2007-3#3)(2007-8#2)(2007-9#1)(2008-1#6)(2008-10#17)(2008-11#16)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#26)(2008-5#8)(2008-6#2)(2008-7#11)(2008-8#19)(2008-9#11)(2009-10#5)(2009-12#2)(2009-4#2)(2009-5#3)(2009-6#7)(2009-8#12)(2009-9#2)(2010-1#5)(2010-10#4)(2010-11#3)(2010-12#4)(2010-2#1)(2010-4#2)(2010-5#5)(2010-7#2)(2011-1#1)(2011-12#2)(2011-2#5)(2011-3#6)(2012-1#4)(2012-12#8)(2012-2#9)(2012-3#7)(2013-1#5)(2013-8#1)
transductional##3##1##(1992-3#1)(2008-11#1)(2008-6#1)
transduodenal##3##1##(1993-2#1)(2008-3#1)(2008-9#1)
transdural communicating arteries##2##3##(2006-11#2)
transdural##3##1##(2006-11#2)(2008-7#1)
transect from##2##2##(2008-10#1)(2008-2#1)
transect surveys##2##2##(2010-8#2)
transect##30##1##(1994-3#2)(2004-11#1)(2005-10#2)(2006-4#1)(2007-5#2)(2008-10#5)(2008-2#2)(2008-5#5)(2010-8#4)(2011-12#1)(2013-1#3)(2013-7#2)
transected axons##2##2##(1990-4#2)
transected in##2##2##(1991-8#1)(1997-4#1)
transected nerves##2##2##(1990-2#2)
transected through the midcollicular line##2##5##(1992-11#2)
transected through the##3##3##(1992-11#3)
transected to##2##2##(2005-9#1)(2006-9#1)
transected##26##1##(1990-2#2)(1990-4#3)(1990-5#1)(1990-6#1)(1991-3#1)(1991-8#1)(1992-11#3)(1992-8#1)(1994-4#1)(1995-3#1)(1997-4#1)(2005-9#1)(2006-9#2)(2007-2#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#2)
transecting the brain at the##2##5##(2007-1#2)
transecting the##3##2##(1992-7#1)(2007-1#2)
transection and##3##2##(1996-12#1)(1997-4#2)
transection in##4##2##(1991-10#1)(1993-9#1)(2013-1#2)
transection of the corpus callosum##2##5##(1993-7#2)
transection of the fornix##2##4##(1991-5#1)(1992-11#1)
transection of the left internal mammary artery##3##7##(2007-8#3)
transection of the##19##3##(1991-5#2)(1991-8#2)(1992-11#1)(1993-7#2)(1997-4#1)(1997-7#1)(2006-12#1)(2007-8#5)(2008-11#1)(2009-3#1)(2009-8#1)(2012-3#1)
transection of##20##2##(1991-5#2)(1991-8#2)(1992-11#1)(1993-3#1)(1993-7#2)(1997-4#1)(1997-7#1)(2006-12#1)(2007-8#5)(2008-11#1)(2009-3#1)(2009-8#1)(2012-3#1)
transection##60##1##(1990-2#2)(1990-7#1)(1991-10#2)(1991-2#1)(1991-5#3)(1991-8#2)(1991-9#3)(1992-11#1)(1993-3#2)(1993-7#2)(1993-9#2)(1996-12#5)(1997-4#4)(1997-7#1)(2006-12#1)(2006-9#4)(2007-11#1)(2007-8#5)(2008-10#2)(2008-11#1)(2008-3#2)(2008-9#2)(2009-2#1)(2009-3#1)(2009-8#1)(2012-3#3)(2013-1#5)
transections (n =##2##3##(1992-11#2)
transections##17##1##(1991-5#4)(1991-8#1)(1992-11#5)(1996-12#1)(1997-3#1)(2005-9#1)(2007-8#1)(2008-3#2)(2008-7#1)
transects and##2##2##(2007-3#1)(2011-2#1)
transects at##2##2##(2007-3#1)(2008-5#1)
transects from the##2##3##(2008-5#1)(2013-7#1)
transects in##4##2##(2007-5#2)(2008-11#1)(2008-9#1)
transects of##2##2##(2007-5#1)(2008-10#1)
transects were##3##2##(2007-3#1)(2008-10#1)(2013-7#1)
transects##37##1##(2005-10#4)(2007-3#8)(2007-5#7)(2008-10#3)(2008-11#1)(2008-5#5)(2008-9#1)(2010-8#1)(2011-12#1)(2011-2#1)(2013-7#5)
transendothelial migration by##2##3##(1995-2#1)(2008-5#1)
transendothelial migration##11##2##(1995-2#4)(2006-6#1)(2007-12#1)(2008-5#1)(2009-10#1)(2012-1#3)
transendothelial##14##1##(1991-11#1)(1995-2#4)(2006-10#1)(2006-6#1)(2007-12#1)(2008-5#1)(2009-10#1)(2012-1#3)(2013-8#1)
transepidermal water loss (TEWL) and##2##5##(2008-5#2)
transepidermal water loss (TEWL) were##2##5##(2008-5#1)(2012-2#1)
transepidermal water loss (TEWL)##10##4##(2008-5#9)(2012-2#1)
transepidermal water loss##17##3##(2006-12#1)(2008-5#13)(2012-2#1)(2013-1#1)(2013-7#1)
transepidermal water##18##2##(2006-12#1)(2008-5#13)(2012-2#1)(2013-1#1)(2013-7#2)
transepidermal##20##1##(2006-12#1)(2007-7#1)(2008-5#14)(2012-2#1)(2013-1#1)(2013-7#2)
transepithelial electrical resistance (TER)##2##4##(2008-11#2)
transepithelial electrical resistance##5##3##(1994-6#1)(2007-8#1)(2008-11#2)(2008-12#1)
transepithelial electrical##6##2##(1994-6#1)(2007-8#1)(2008-11#2)(2008-12#2)
transepithelial potential difference##3##3##(2008-12#1)(2008-5#1)(2008-6#1)
transepithelial potential##4##2##(1991-5#1)(2008-12#1)(2008-5#1)(2008-6#1)
transepithelial##15##1##(1991-5#1)(1994-6#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-12#3)(2008-5#2)(2008-6#2)(2011-2#1)
transesophageal echocardiogram##7##2##(2009-10#1)(2009-3#1)(2010-2#2)(2010-6#1)(2011-2#1)(2013-1#1)
transesophageal echocardiographic##2##2##(2007-10#1)(2008-5#1)
transesophageal echocardiography (TEE) is##2##4##(1995-9#1)(2007-10#1)
transesophageal echocardiography (TEE)##5##3##(1995-9#1)(2007-10#1)(2008-7#1)(2010-8#1)(2011-2#1)
transesophageal echocardiography and##2##3##(2007-8#1)(2008-7#1)
transesophageal echocardiography as a##2##4##(2007-2#1)(2007-9#1)
transesophageal echocardiography in the##2##4##(1996-6#1)(2006-10#1)
transesophageal echocardiography in##5##3##(1996-6#1)(2006-10#2)(2009-10#1)(2013-7#1)
transesophageal echocardiography probe insertion in a##2##6##(2008-10#1)(2008-4#1)
transesophageal echocardiography##39##2##(1995-9#1)(1996-6#1)(1997-1#1)(1997-8#2)(2006-10#2)(2006-12#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#3)(2009-10#3)(2010-12#1)(2010-7#2)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
transesophageal##58##1##(1993-10#1)(1995-9#2)(1996-6#1)(1997-1#1)(1997-8#2)(2006-10#2)(2006-12#1)(2007-10#2)(2007-2#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#3)(2009-10#4)(2009-3#1)(2010-12#1)(2010-2#2)(2010-6#1)(2010-7#3)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)
transesterification and##3##2##(1994-2#1)(2008-7#2)
transesterification of vegetable oils in excess methanol##3##7##(2013-1#3)
transesterification of##9##2##(1996-5#1)(2007-10#1)(2007-6#1)(2008-10#1)(2008-6#1)(2010-4#1)(2013-1#3)
transesterification reaction##5##2##(2004-9#1)(2008-10#2)(2008-5#1)(2013-1#1)
transesterification reactions##2##2##(2009-9#1)(2013-1#1)
transesterification##28##1##(1994-2#3)(1996-5#2)(2004-9#3)(2007-10#1)(2007-6#1)(2008-10#3)(2008-5#1)(2008-6#3)(2008-7#4)(2009-9#1)(2010-4#1)(2013-1#5)
transexuality##2##1##(2013-1#2)
transfect##10##1##(1990-8#1)(1993-4#1)(1993-8#1)(2005-7#1)(2008-11#2)(2008-4#2)(2010-9#1)(2013-1#1)
transfectable##4##1##(1994-5#1)(2008-11#2)(2008-4#1)
transfectant (p&lt##2##2##(2008-9#2)
transfectant##20##1##(1991-12#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-3#1)(1994-9#1)(1995-5#1)(1997-2#1)(2007-11#1)(2008-11#2)(2008-3#2)(2008-9#7)
transfectants and##2##2##(1993-1#1)(1994-8#1)
transfectants are##2##2##(1995-5#1)(2008-11#1)
transfectants expressing##4##2##(1991-9#1)(1996-2#1)(1996-5#1)(2008-11#1)
transfectants of##2##2##(1997-9#1)(2008-11#1)
transfectants secreted##2##2##(1991-12#1)(1993-3#1)
transfectants were##5##2##(1991-12#1)(1992-9#1)(1993-8#1)(1995-1#1)(1997-2#1)
transfectants with##2##2##(1992-9#1)(1993-4#1)
transfectants##47##1##(1991-12#4)(1991-9#1)(1992-5#1)(1992-9#2)(1993-1#5)(1993-11#1)(1993-3#2)(1993-4#1)(1993-8#3)(1994-10#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-5#2)(1996-2#1)(1996-5#2)(1997-2#1)(1997-9#1)(2008-11#10)(2008-2#1)(2008-4#2)(2008-6#1)(2010-2#1)
transfected 293##2##2##(1996-4#1)(1996-5#1)
transfected CHO cell##3##3##(1992-9#1)(1994-8#1)(2008-11#1)
transfected CHO cells##9##3##(1991-7#1)(1992-9#1)(1994-8#1)(1995-3#2)(1996-6#2)(2008-11#2)
transfected CHO##12##2##(1991-7#1)(1992-9#2)(1994-8#2)(1995-3#2)(1996-6#2)(2008-11#3)
transfected COS cells##4##3##(1994-6#1)(1995-3#2)(2008-2#1)
transfected COS-1 cells##3##3##(1991-6#1)(1992-3#1)(1994-12#1)
transfected COS-7 cells##7##3##(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-9#1)(1995-10#1)(1997-6#1)
transfected COS-7##8##2##(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-9#1)(1995-10#1)(1995-11#1)(1997-6#1)
transfected Chinese hamster ovary cells##3##5##(1995-12#1)(1995-2#1)(1996-4#1)
transfected Chinese hamster ovary##5##4##(1992-12#1)(1995-12#1)(1995-2#1)(1996-4#1)(1997-1#1)
transfected Chinese hamster##6##3##(1992-12#1)(1995-12#1)(1995-2#1)(1996-4#1)(1997-1#1)(2008-11#1)
transfected DNA##3##2##(1995-2#1)(2008-2#2)
transfected Drosophila S2 cells##2##4##(2008-11#2)
transfected Drosophila##3##2##(1994-8#1)(2008-11#2)
transfected IgE receptors##2##3##(1996-2#2)
transfected MSCs##6##2##(2008-5#6)
transfected PC12 cells##3##3##(1990-5#2)(1992-9#1)
transfected PC12##4##2##(1990-5#2)(1992-9#1)(1995-2#1)
transfected PG##2##2##(2008-8#2)
transfected alone or with T beta##2##6##(1995-3#2)
transfected alone##3##2##(1995-3#2)(2008-11#1)
transfected by electroporation##3##3##(1990-10#1)(1994-5#1)(2008-10#1)
transfected by##8##2##(1990-10#1)(1994-5#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-9#2)(2011-12#1)
transfected cell line##3##3##(1992-11#1)(2005-10#1)(2008-11#1)
transfected cell lines##7##3##(1994-2#1)(2008-1#1)(2008-11#2)(2008-2#2)(2013-8#1)
transfected cell##14##2##(1992-11#1)(1992-9#1)(1994-2#1)(2005-10#1)(2008-1#1)(2008-11#3)(2008-2#2)(2008-4#1)(2010-9#2)(2013-8#1)
transfected cells are##2##3##(1992-12#1)(2007-11#1)
transfected cells but##2##3##(1992-3#1)(1995-5#1)
transfected cells expressing##2##3##(1995-1#1)(1996-4#1)
transfected cells in##3##3##(1992-9#1)(2007-11#1)(2008-11#1)
transfected cells was##5##3##(1993-9#2)(1994-8#1)(2008-11#1)(2008-4#1)
transfected cells were##5##3##(1991-2#1)(1993-12#1)(1994-8#2)(2005-10#1)
transfected cells with##6##3##(1991-11#1)(1992-3#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-5#1)
transfected cells##85##2##(1990-10#1)(1990-8#1)(1991-11#1)(1991-2#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#3)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#2)(1993-9#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#6)(1994-9#2)(1995-1#1)(1995-10#3)(1995-11#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-10#1)(1996-12#1)(1996-4#2)(1996-5#4)(1997-4#1)(1997-5#1)(1997-7#1)(2005-10#1)(2007-11#2)(2007-6#1)(2008-11#10)(2008-2#2)(2008-4#1)(2008-5#4)(2008-8#2)(2008-9#1)(2010-5#1)(2012-12#2)
transfected clones##4##2##(1990-6#1)(1992-9#1)(1996-6#1)(1997-7#1)
transfected fibroblasts##4##2##(1991-8#1)(1995-2#1)(1996-5#1)(2013-1#1)
transfected human##11##2##(1991-2#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-6#1)(1995-12#1)(1995-8#1)(1997-7#1)(2008-8#1)
transfected in##3##2##(1990-9#1)(1991-2#1)(2008-11#1)
transfected into COS-7 cells##2##4##(1990-5#1)(1993-12#1)
transfected into Chinese hamster ovary (CHO) cells##2##7##(2008-11#1)(2008-4#1)
transfected into Chinese hamster ovary##4##5##(1993-9#1)(1996-6#1)(2008-11#1)(2008-4#1)
transfected into HeLa cells##2##4##(1992-4#1)(1993-3#1)
transfected into Vero cells##2##4##(2008-11#1)(2013-8#1)
transfected into a##3##3##(1991-2#1)(1991-6#1)(1994-6#1)
transfected into chinese hamster ovary (CHO) cells##2##7##(1991-5#1)(1992-8#1)
transfected into mouse##2##3##(1991-1#1)(1993-5#1)
transfected into the##2##3##(1991-12#1)(2008-8#1)
transfected into##50##2##(1990-11#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#1)(1993-9#1)(1994-12#2)(1994-6#2)(1995-1#2)(1995-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-11#4)(2008-3#1)(2008-4#2)(2008-8#4)(2008-9#2)(2011-2#2)(2012-2#1)(2013-8#1)
transfected lines was##2##3##(1995-8#1)(1996-6#1)
transfected mammalian cells##2##3##(2008-11#1)(2008-2#1)
transfected mouse##3##2##(1991-8#1)(1994-2#1)(1996-5#1)
transfected murine##2##2##(1994-5#2)
transfected neuronal cell lines##2##4##(1994-3#1)(1995-2#1)
transfected the##3##2##(1995-5#1)(2007-1#1)(2008-11#1)
transfected to express##2##3##(1992-9#1)(2012-12#1)
transfected to##6##2##(1992-9#1)(1995-2#1)(1996-2#1)(1997-7#1)(2008-9#1)(2012-12#1)
transfected with DNA##2##3##(2006-6#1)(2008-2#1)
transfected with PD-L1##2##3##(2012-3#2)
transfected with a cDNA encoding##2##5##(1995-2#1)(1997-7#1)
transfected with a plasmid containing##2##5##(1990-12#1)(1990-6#1)
transfected with a plasmid##4##4##(1990-12#1)(1990-6#1)(2008-11#1)(2010-11#1)
transfected with a vector expressing##2##5##(1994-5#1)(2008-7#1)
transfected with a vector##3##4##(1994-5#1)(2008-11#1)(2008-7#1)
transfected with a##16##3##(1990-12#1)(1990-6#1)(1992-9#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-9#1)(1997-2#1)(1997-7#1)(2008-11#3)(2008-7#1)(2008-8#1)(2010-11#1)
transfected with an expression##2##4##(1992-12#1)(1992-5#1)
transfected with cDNA##2##3##(1996-2#1)(1996-3#1)
transfected with cloned##2##3##(1994-12#1)(1994-9#1)
transfected with constructs##2##3##(1993-9#1)(2008-10#1)
transfected with expression vectors##2##4##(1997-1#1)(2008-11#1)
transfected with expression##3##3##(1995-6#1)(1997-1#1)(2008-11#1)
transfected with full-length cDNA##2##4##(1992-9#1)(1995-10#1)
transfected with full-length##3##3##(1992-9#1)(1993-1#1)(1995-10#1)
transfected with human##4##3##(1991-9#1)(1995-2#1)(1996-8#1)(2008-4#1)
transfected with pMx-Luc##2##3##(1996-11#2)
transfected with pcDNA3##3##3##(2005-10#1)(2005-6#1)(2007-1#1)
transfected with plasmids##3##3##(1993-12#1)(1994-8#1)(1996-11#1)
transfected with sense construct##2##4##(2008-8#2)
transfected with the 3##2##4##(1995-3#2)
transfected with the cDNA for##2##5##(1992-7#1)(1994-11#1)
transfected with the cDNA##5##4##(1992-7#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)
transfected with the cloned##3##4##(1991-7#1)(1991-9#1)(1992-6#1)
transfected with the gene##2##4##(1995-11#1)(2008-5#1)
transfected with the human TSH receptor##2##6##(1992-2#1)(1996-5#1)
transfected with the human##7##4##(1991-1#1)(1992-2#1)(1993-11#1)(1994-8#1)(1996-5#1)(2008-11#1)(2008-4#1)
transfected with the##51##3##(1990-11#1)(1991-1#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-5#3)(1992-6#1)(1992-7#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-5#2)(1993-7#1)(1993-8#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-6#1)(1996-5#2)(1997-2#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#4)(2008-8#2)(2013-1#1)(2013-8#1)
transfected with this##3##3##(1993-5#1)(1995-2#1)(1997-7#1)
transfected with troutCYP1A-CAT##2##3##(2008-11#2)
transfected with##196##2##(1990-11#3)(1990-12#2)(1990-6#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-7#1)(1991-9#4)(1992-1#1)(1992-11#3)(1992-12#4)(1992-2#1)(1992-5#5)(1992-6#1)(1992-7#1)(1992-9#4)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#3)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#6)(1994-12#5)(1994-2#3)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#6)(1995-3#6)(1995-4#1)(1995-5#1)(1995-6#6)(1995-7#1)(1995-8#4)(1996-1#1)(1996-10#1)(1996-11#4)(1996-2#1)(1996-3#1)(1996-5#5)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#2)(1997-6#1)(1997-7#4)(1997-9#1)(2005-10#1)(2005-6#1)(2006-6#1)(2007-1#1)(2008-10#3)(2008-11#19)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#4)(2008-7#2)(2008-8#6)(2008-9#4)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2011-12#1)(2011-2#3)(2012-3#3)(2013-1#3)(2013-8#3)
transfected##556##1##(1990-10#2)(1990-11#4)(1990-12#2)(1990-5#5)(1990-6#2)(1990-7#2)(1990-8#2)(1990-9#2)(1991-1#2)(1991-11#2)(1991-12#4)(1991-2#5)(1991-5#2)(1991-6#3)(1991-7#2)(1991-8#3)(1991-9#7)(1992-1#1)(1992-11#7)(1992-12#7)(1992-2#4)(1992-3#7)(1992-4#1)(1992-5#8)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#13)(1993-1#3)(1993-11#1)(1993-12#5)(1993-3#9)(1993-4#7)(1993-5#7)(1993-6#4)(1993-7#1)(1993-8#3)(1993-9#6)(1994-10#1)(1994-11#6)(1994-12#10)(1994-2#6)(1994-3#3)(1994-5#9)(1994-6#7)(1994-8#18)(1994-9#6)(1995-1#4)(1995-10#5)(1995-11#4)(1995-12#4)(1995-2#18)(1995-3#16)(1995-4#1)(1995-5#5)(1995-6#8)(1995-7#1)(1995-8#10)(1996-1#1)(1996-10#2)(1996-11#4)(1996-12#1)(1996-2#4)(1996-3#1)(1996-4#4)(1996-5#13)(1996-6#6)(1996-8#3)(1996-9#2)(1997-1#6)(1997-2#3)(1997-4#3)(1997-5#3)(1997-6#2)(1997-7#9)(1997-9#1)(2005-10#3)(2005-6#1)(2005-8#1)(2006-6#1)(2007-1#3)(2007-11#4)(2007-6#1)(2008-1#3)(2008-10#5)(2008-11#54)(2008-2#10)(2008-3#4)(2008-4#17)(2008-5#17)(2008-7#3)(2008-8#19)(2008-9#11)(2009-8#1)(2010-10#1)(2010-11#4)(2010-12#1)(2010-3#1)(2010-5#1)(2010-9#2)(2011-1#1)(2011-12#2)(2011-2#7)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#5)
transfecting##16##1##(1990-10#1)(1997-7#2)(2008-11#8)(2008-4#2)(2008-8#1)(2008-9#1)(2010-1#1)
transfection activity of the lipopolylysine##3##5##(1991-5#3)
transfection activity##4##2##(1991-5#4)
transfection agent##3##2##(2008-11#1)(2010-4#1)(2012-12#1)
transfection agents##2##2##(2012-12#2)
transfection and##10##2##(1990-9#1)(1996-4#1)(2008-1#1)(2008-11#4)(2008-2#1)(2008-9#1)(2012-3#1)
transfection assays were##2##3##(1995-2#1)(2008-3#1)
transfection assays with##5##3##(1992-8#1)(1993-6#1)(1994-8#1)(1995-8#1)(1997-7#1)
transfection assays##25##2##(1991-10#1)(1991-5#1)(1992-11#1)(1992-8#1)(1993-6#1)(1994-8#2)(1995-10#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#2)(1996-10#2)(1996-5#1)(1996-7#1)(1997-6#1)(1997-7#2)(2007-10#1)(2008-3#2)(2008-7#1)
transfection by the##2##3##(1994-9#1)(1997-5#1)
transfection by##4##2##(1992-5#1)(1994-9#1)(1997-5#1)(2008-9#1)
transfection can be##2##3##(2008-1#1)(2008-11#1)
transfection can##3##2##(1996-12#1)(2008-1#1)(2008-11#1)
transfection complexes were##2##3##(2008-11#2)
transfection conditions##2##2##(2008-1#1)(2008-2#1)
transfection efficacy##3##2##(2008-11#1)(2013-1#2)
transfection efficiencies of##4##3##(2008-11#3)(2010-9#1)
transfection efficiencies##9##2##(1990-10#1)(2008-11#5)(2008-7#1)(2010-9#1)(2011-2#1)
transfection efficiency and##7##3##(2008-11#2)(2011-2#1)(2012-11#4)
transfection efficiency in##2##3##(2008-11#2)
transfection efficiency of the##4##4##(2008-11#1)(2010-4#1)(2011-1#1)(2012-3#1)
transfection efficiency of##9##3##(2008-11#4)(2008-9#1)(2010-1#1)(2010-4#1)(2011-1#1)(2012-3#1)
transfection efficiency with##2##3##(2006-12#1)(2008-5#1)
transfection efficiency##36##2##(1990-10#1)(1996-10#1)(2006-12#1)(2008-1#3)(2008-11#14)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#2)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-11#4)(2012-3#1)(2013-1#1)
transfection experiments##12##2##(1992-11#1)(1992-12#1)(1992-9#1)(1993-3#1)(1994-12#1)(1995-8#1)(1996-5#1)(1996-6#1)(2008-1#1)(2008-11#1)(2008-6#2)
transfection fate##2##2##(2008-11#2)
transfection has been##2##3##(1996-2#1)(2011-1#1)
transfection has##3##2##(1996-2#1)(2008-9#1)(2011-1#1)
transfection in##10##2##(1991-5#2)(1991-8#1)(1991-9#1)(1996-12#1)(1996-2#1)(2008-11#1)(2009-12#1)(2010-1#1)(2010-4#1)
transfection into cells##3##3##(1990-7#1)(1991-11#1)(1994-11#1)
transfection into cultured cells##2##4##(1992-8#1)(1997-4#1)
transfection into the##2##3##(1994-8#1)(1995-2#1)
transfection into##15##2##(1990-12#1)(1990-7#1)(1991-11#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-5#1)(1997-3#1)(1997-4#2)(2008-11#1)(2008-4#1)
transfection is##8##2##(2008-1#1)(2008-11#3)(2008-2#1)(2008-4#2)(2011-1#1)
transfection method##3##2##(1995-2#1)(2008-11#1)(2008-9#1)
transfection methods##6##2##(1990-10#1)(1996-10#1)(2008-1#1)(2008-11#1)(2008-4#1)(2011-1#1)
transfection microarrays##2##2##(2008-7#2)
transfection of DNA##2##3##(1997-5#1)(2008-6#1)
transfection of NIH 3T3##2##4##(1992-7#1)(1995-2#1)
transfection of a##4##3##(1997-1#1)(2007-6#1)(2008-11#1)(2008-2#1)
transfection of adherent##4##3##(1994-9#1)(2008-1#2)(2008-2#1)
transfection of an##3##3##(1994-11#1)(1994-3#2)
transfection of cells##4##3##(1994-10#1)(2005-7#1)(2008-4#1)(2012-2#1)
transfection of cultured##2##3##(1996-4#1)(1997-2#1)
transfection of human##3##3##(1993-9#1)(1995-3#1)(1996-5#1)
transfection of mammalian cells##3##4##(1990-3#1)(1991-8#1)(1994-9#1)
transfection of murine##2##3##(1993-5#1)(1995-2#1)
transfection of the##12##3##(1990-5#2)(1991-2#1)(1991-5#1)(1993-11#1)(1994-3#1)(1994-8#1)(1995-6#1)(1995-8#1)(2008-11#1)(2012-2#1)(2012-3#1)
transfection of##80##2##(1990-10#1)(1990-3#1)(1990-5#3)(1990-9#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-4#1)(1992-7#1)(1993-11#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-3#4)(1994-5#2)(1994-8#3)(1994-9#2)(1995-2#4)(1995-3#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-4#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-5#1)(2005-7#1)(2007-11#1)(2007-6#1)(2008-1#4)(2008-11#9)(2008-2#3)(2008-4#2)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-8#2)
transfection or##2##2##(1993-4#1)(2008-11#1)
transfection procedures##2##2##(1996-10#1)(2008-2#1)
transfection protocol##2##2##(2008-11#2)
transfection reagent for##2##3##(2006-12#1)(2011-2#1)
transfection reagent##5##2##(2006-12#1)(2008-11#2)(2008-7#1)(2011-2#1)
transfection reagents##4##2##(2008-11#4)
transfection studies in##2##3##(1994-9#1)(1996-5#1)
transfection studies##8##2##(1991-3#1)(1992-6#1)(1992-7#1)(1994-9#1)(1995-10#1)(1996-5#1)(1996-9#1)(2009-5#1)
transfection system based on##2##4##(1995-2#1)(2008-11#1)
transfection system##10##2##(1995-2#1)(2008-11#5)(2011-1#4)
transfection techniques##4##2##(2008-11#3)(2009-5#1)
transfection using the##2##3##(2008-1#1)(2008-11#1)
transfection was##4##2##(1995-2#1)(2008-11#3)
transfection we##2##2##(2009-5#2)
transfection with the##2##3##(1994-10#1)(1997-4#1)
transfection with##16##2##(1990-8#1)(1991-2#1)(1991-4#1)(1991-9#1)(1994-10#1)(1994-12#1)(1994-5#1)(1997-4#1)(1997-7#1)(2006-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#2)(2009-5#1)
transfection##411##1##(1990-10#5)(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#3)(1990-7#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#10)(1991-8#2)(1991-9#2)(1992-11#2)(1992-12#2)(1992-2#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#2)(1993-11#2)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#2)(1993-9#1)(1994-10#2)(1994-11#3)(1994-12#4)(1994-3#4)(1994-5#3)(1994-8#7)(1994-9#5)(1995-1#1)(1995-10#2)(1995-2#15)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#6)(1996-10#5)(1996-12#7)(1996-2#3)(1996-4#2)(1996-5#5)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#5)(1997-6#1)(1997-7#5)(1997-8#1)(2005-11#4)(2005-7#1)(2006-10#3)(2006-12#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#20)(2008-11#92)(2008-2#13)(2008-3#2)(2008-4#13)(2008-5#2)(2008-6#4)(2008-7#7)(2008-8#6)(2008-9#11)(2009-12#1)(2009-5#6)(2010-1#2)(2010-2#1)(2010-4#4)(2010-8#1)(2010-9#1)(2011-1#13)(2011-2#8)(2012-11#5)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#3)(2013-8#3)
transfections and##2##2##(1994-6#1)(2008-9#1)
transfections of##3##2##(1994-5#1)(1995-3#1)(1995-8#1)
transfections using##2##2##(1994-3#1)(1995-2#1)
transfections##21##1##(1993-6#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-8#1)(2006-12#1)(2008-1#3)(2008-11#2)(2008-2#1)(2008-4#2)(2008-9#2)(2013-1#1)
transfemoral approach##4##2##(2011-2#4)
transfemoral prosthesis##3##2##(2012-1#3)
transfemoral##16##1##(1990-8#1)(2006-10#1)(2006-11#1)(2011-2#4)(2012-1#5)(2013-1#4)
transfer (IVF-ET)##2##2##(2007-11#1)(2012-3#1)
transfer (LRET)##2##2##(1997-1#1)(2010-5#1)
transfer CCD camera##2##3##(2007-12#1)(2008-3#1)
transfer CCD##4##2##(2007-12#1)(2008-3#3)
transfer DNA replication##2##3##(1996-5#2)
transfer RNA (tRNA)##3##3##(1992-2#1)(1992-3#1)(1995-3#1)
transfer RNA genes##2##3##(2008-9#1)(2009-5#1)
transfer RNA in##2##3##(1992-3#1)(1994-11#1)
transfer RNA##15##2##(1990-8#4)(1992-12#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-8#1)(1994-11#1)(1995-3#1)(2008-9#1)(2009-5#2)
transfer RNAs##3##2##(1991-10#1)(1991-11#1)(2007-11#1)
transfer a##6##2##(1993-1#1)(1993-2#1)(2006-5#1)(2010-7#1)(2011-1#1)(2013-8#1)
transfer ability##2##2##(2007-8#1)(2008-10#1)
transfer across the##4##3##(1991-5#1)(2008-10#1)(2009-4#1)(2010-5#1)
transfer across##5##2##(1991-5#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-5#1)
transfer activities##2##2##(2007-10#1)(2007-7#1)
transfer activity##11##2##(1991-3#1)(1991-8#1)(1992-11#1)(1993-11#1)(1995-2#1)(1995-5#3)(1996-4#2)(1997-2#1)
transfer agent##5##2##(2006-5#1)(2008-10#1)(2008-12#2)(2009-11#1)
transfer among##3##2##(2008-1#1)(2010-12#1)(2013-1#1)
transfer and expression of the##2##5##(1994-3#1)(2008-5#1)
transfer and expression of##5##4##(1994-3#1)(2004-2#1)(2008-5#1)(2008-8#1)(2008-9#1)
transfer and expression##7##3##(1994-3#1)(2004-2#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)
transfer and not##2##3##(1990-5#1)(1995-2#1)
transfer and substrate##2##3##(1994-11#1)(1995-8#1)
transfer and the##4##3##(1994-5#1)(2008-10#2)(2009-11#1)
transfer and##72##2##(1990-5#2)(1991-4#1)(1992-6#1)(1992-9#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#2)(1995-2#2)(1995-3#1)(1995-8#3)(1996-11#1)(1996-5#2)(1997-2#1)(1997-4#1)(1997-7#1)(2004-2#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-3#2)(2007-12#5)(2008-1#1)(2008-10#4)(2008-11#7)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-11#3)(2009-9#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
transfer are##8##2##(1991-4#1)(1992-12#1)(1994-5#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)
transfer as well as##2##4##(1991-4#1)(2008-10#1)
transfer as##4##2##(1991-4#1)(1993-6#1)(1994-8#1)(2008-10#1)
transfer assay##2##2##(1994-9#1)(1995-10#1)
transfer at the##3##3##(1992-11#2)(2007-7#1)
transfer at##8##2##(1990-8#1)(1992-11#2)(1992-6#1)(1995-5#1)(2005-11#1)(2007-12#1)(2007-7#1)
transfer based on the##2##4##(1996-7#1)(2007-8#1)
transfer based on##4##3##(1996-7#1)(2007-8#3)
transfer between the##12##3##(1994-8#2)(1995-2#1)(1995-5#1)(1995-6#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-3#1)(2009-11#1)(2013-1#1)
transfer between two##3##3##(1991-5#1)(2007-11#1)(2012-2#1)
transfer between##61##2##(1990-2#1)(1990-4#1)(1990-7#1)(1991-2#1)(1991-5#1)(1992-6#1)(1993-3#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-8#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#2)(1997-1#2)(1997-6#1)(2005-11#1)(2006-10#1)(2007-11#3)(2007-12#2)(2008-10#9)(2008-3#1)(2008-7#2)(2008-8#3)(2009-11#2)(2009-6#1)(2010-10#2)(2010-5#1)(2010-7#1)(2012-12#2)(2012-2#5)(2013-1#2)
transfer by the##2##3##(1993-8#1)(2008-10#1)
transfer by##13##2##(1991-11#1)(1991-3#1)(1993-8#1)(1996-5#2)(1997-4#1)(1997-7#1)(2008-10#2)(2009-10#1)(2009-8#1)(2011-2#1)(2012-12#1)
transfer can be##5##3##(2006-6#1)(2007-3#1)(2008-12#1)(2012-12#1)(2012-3#1)
transfer can occur##2##3##(1992-6#1)(1993-3#1)
transfer can potentially##2##3##(2008-3#1)(2010-7#1)
transfer can##14##2##(1992-6#1)(1993-3#1)(1995-12#1)(2005-10#1)(2006-3#1)(2006-6#1)(2007-3#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-9#1)(2010-7#1)(2012-12#1)(2012-3#1)
transfer cells##2##2##(2008-11#2)
transfer coefficient and##3##3##(2008-3#1)(2008-7#2)
transfer coefficient were##2##3##(2008-10#1)(2008-11#1)
transfer coefficient##19##2##(1991-5#1)(1994-6#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#3)(2008-7#8)
transfer coefficients##4##2##(1997-2#1)(1997-6#1)(2007-4#1)(2008-7#1)
transfer complex##7##2##(1992-3#1)(1994-8#1)(1996-7#1)(2008-10#4)
transfer complexes##4##2##(2007-11#1)(2008-10#2)(2008-9#1)
transfer current##2##2##(2008-10#1)(2010-5#1)
transfer data##2##2##(1991-11#1)(1992-5#1)
transfer depends##2##2##(2008-10#1)(2013-8#1)
transfer distance##2##2##(1994-8#1)(2008-12#1)
transfer effects##2##2##(1995-8#1)(2008-11#1)
transfer efficiency and##2##3##(1997-8#1)(2008-9#1)
transfer efficiency of##2##3##(2008-10#1)(2010-10#1)
transfer efficiency##13##2##(1991-5#1)(1997-8#1)(2005-11#1)(2005-6#1)(2008-10#1)(2008-3#1)(2008-9#2)(2010-10#3)(2013-7#2)
transfer either##2##2##(2006-3#1)(2008-4#1)
transfer electrons##3##2##(1992-6#1)(2008-10#1)(2008-11#1)
transfer energy to##2##3##(2005-4#1)(2008-3#1)
transfer energy##4##2##(1990-7#1)(2005-4#1)(2007-12#1)(2008-3#1)
transfer episodes##3##2##(1993-12#3)
transfer equation##19##2##(2007-12#2)(2008-2#10)(2008-3#5)(2008-7#1)(2010-4#1)
transfer events##2##2##(1995-8#1)(2008-7#1)
transfer excitor##2##2##(2008-5#2)
transfer experiments demonstrated that##2##4##(1991-12#1)(2008-8#1)
transfer experiments##12##2##(1991-12#2)(1995-10#1)(1995-11#1)(1995-12#1)(1996-10#1)(1996-6#1)(1997-4#1)(2008-11#2)(2008-4#1)(2008-8#1)
transfer factor##2##2##(1996-3#1)(2010-9#1)
transfer following##2##2##(1990-5#1)(2008-3#1)
transfer for restoration of##2##4##(2006-3#1)(2008-9#1)
transfer for the##3##3##(1994-5#2)(1995-8#1)
transfer for##24##2##(1994-5#2)(1995-8#1)(2006-3#2)(2006-4#2)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#2)(2008-9#1)(2009-6#1)(2010-5#2)(2012-12#1)(2013-7#1)
transfer free energies of native and unfolded protein from water to##2##11##(1997-7#2)
transfer free energies of##3##4##(1997-7#3)
transfer free energy##2##3##(1997-2#1)(1997-7#1)
transfer free##5##2##(1997-2#1)(1997-7#4)
transfer from NADPH to##3##4##(1990-5#2)(1991-2#1)
transfer from NADPH##4##3##(1990-5#2)(1991-2#1)(1996-2#1)
transfer from a##9##3##(1990-5#1)(2007-12#3)(2007-8#1)(2008-10#2)(2008-4#1)(2009-12#1)
transfer from an##2##3##(1994-2#1)(2005-11#1)
transfer from gas phase to##2##5##(2006-10#2)
transfer from melanocytes to keratinocytes##2##5##(2008-8#2)
transfer from one##3##3##(1994-6#1)(2010-5#1)(2012-2#1)
transfer from the##27##3##(1990-10#1)(1990-11#1)(1992-7#1)(1993-11#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-2#2)(1997-4#1)(1997-6#1)(2005-11#1)(2007-12#4)(2008-10#2)(2008-3#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-5#2)(2011-2#1)(2013-1#1)
transfer from##110##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#1)(1990-5#3)(1990-8#2)(1991-10#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#3)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-2#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-4#4)(1997-6#1)(1997-7#2)(2004-4#1)(2005-10#1)(2005-11#4)(2006-1#1)(2006-10#3)(2006-3#1)(2007-11#1)(2007-12#8)(2007-8#1)(2008-10#9)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-4#1)(2010-5#3)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)
transfer function and##2##3##(2008-2#1)(2013-7#1)
transfer function for##6##3##(2008-1#1)(2008-10#1)(2008-3#4)
transfer function in##2##3##(2007-12#1)(2008-10#1)
transfer function is##6##3##(2008-2#4)(2008-3#2)
transfer function measurements of##2##4##(2008-3#2)
transfer function of a##4##4##(2007-12#1)(2008-2#3)
transfer function of the##6##4##(2007-12#2)(2008-2#3)(2008-3#1)
transfer function of##15##3##(2007-12#3)(2008-2#8)(2008-3#4)
transfer function rather than##2##4##(2007-11#1)(2008-2#1)
transfer function that##2##3##(2008-2#1)(2008-3#1)
transfer function##78##2##(2007-1#1)(2007-11#1)(2007-12#8)(2008-1#1)(2008-10#2)(2008-2#38)(2008-3#22)(2008-8#1)(2008-9#1)(2011-2#2)(2013-7#1)
transfer function)##3##2##(2008-10#2)(2011-2#1)
transfer functions were used in the hidden and output layers##3##10##(2008-10#3)
transfer functions##17##2##(1996-2#1)(2007-12#4)(2008-10#3)(2008-2#3)(2008-3#5)(2011-2#1)
transfer groups##2##2##(1994-8#1)(1996-5#1)
transfer has been##2##3##(1994-5#1)(2006-3#1)
transfer has##5##2##(1994-5#1)(2006-3#1)(2010-7#2)(2012-12#1)
transfer hydrogenation##2##2##(2010-7#2)
transfer imaging##2##2##(2006-9#1)(2008-11#1)
transfer immunotherapy##5##2##(2005-10#5)
transfer in a##7##3##(1992-1#1)(1995-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-12#1)
transfer in an##3##3##(2006-10#1)(2008-11#1)(2008-2#1)
transfer in comparison to the##2##5##(1996-5#1)(2008-11#1)
transfer in native##2##3##(1991-5#1)(2012-2#1)
transfer in rat##2##3##(1991-9#1)(1997-2#1)
transfer in the##28##3##(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#4)(1992-6#2)(1993-11#2)(1995-1#1)(1996-2#1)(1996-7#1)(2007-7#1)(2008-10#4)(2008-2#3)(2008-3#1)(2008-5#1)(2008-8#2)(2009-3#1)(2009-6#1)
transfer in##99##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#6)(1991-8#1)(1991-9#3)(1992-1#1)(1992-6#4)(1992-8#1)(1993-11#2)(1993-9#2)(1994-11#1)(1994-5#2)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#2)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-4#2)(2005-4#1)(2006-10#1)(2006-12#1)(2006-4#2)(2007-7#3)(2007-8#3)(2008-10#9)(2008-11#3)(2008-2#8)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-6#2)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
transfer inhibitor##3##2##(2008-8#1)(2009-11#1)(2012-12#1)
transfer inhibitors effectively##2##3##(2009-11#2)
transfer into an##2##3##(2008-3#1)(2008-8#1)
transfer into hematopoietic cells##2##4##(1994-5#1)(1995-12#1)
transfer into hematopoietic##3##3##(1994-5#1)(1995-12#1)(2008-5#1)
transfer into human##3##3##(1993-9#2)(2010-7#1)
transfer into mammalian cells##2##4##(2008-8#1)(2009-3#1)
transfer into mammalian##3##3##(1991-9#1)(2008-8#1)(2009-3#1)
transfer into mouse##2##3##(1997-4#1)(2008-8#1)
transfer into primary rat hepatocytes##3##5##(2008-9#3)
transfer into##33##2##(1990-8#2)(1991-9#1)(1993-9#2)(1994-3#1)(1994-5#3)(1994-9#1)(1995-12#2)(1995-2#1)(1996-3#2)(1997-4#2)(2007-1#1)(2008-11#2)(2008-3#1)(2008-5#2)(2008-8#3)(2008-9#3)(2009-11#1)(2009-3#1)(2010-11#1)(2010-7#1)
transfer is a##2##3##(2008-4#1)(2012-2#1)
transfer is one of the##3##5##(2006-10#1)(2007-7#1)(2008-8#1)
transfer is##30##2##(1991-11#1)(1991-3#1)(1994-11#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-8#1)(1997-4#1)(1997-7#1)(2006-10#2)(2006-3#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#2)(2009-3#1)(2011-2#1)(2012-2#4)(2013-7#1)(2013-8#1)
transfer kinetics of##3##3##(1990-5#1)(1997-7#1)(2008-8#1)
transfer kinetics##5##2##(1990-5#1)(1991-8#1)(1994-11#1)(1997-7#1)(2008-8#1)
transfer latency in the##2##4##(1991-2#1)(1993-3#1)
transfer latency on##2##3##(1991-2#2)
transfer latency##5##2##(1991-2#4)(1993-3#1)
transfer matrices##3##2##(2008-2#1)(2008-3#2)
transfer matrix##4##2##(2006-10#1)(2007-12#1)(2008-2#1)(2009-11#1)
transfer may##3##2##(1994-5#1)(2008-10#1)(2010-8#1)
transfer mechanism is##2##3##(1991-5#1)(1997-7#1)
transfer mechanism##4##2##(1991-5#1)(1992-7#1)(1997-7#1)(2008-5#1)
transfer mechanisms##2##2##(2006-11#1)(2006-8#1)
transfer method##8##2##(1992-4#1)(1996-1#1)(2007-12#3)(2008-11#1)(2008-4#1)(2008-9#1)
transfer modalities##2##2##(2005-8#1)(2010-3#1)
transfer model in##2##3##(1993-11#1)(2009-11#1)
transfer model##21##2##(1993-11#1)(2008-2#7)(2008-3#11)(2009-11#1)(2009-8#1)
transfer models##4##2##(2008-2#1)(2008-3#3)
transfer occurred##6##2##(1992-3#1)(1993-9#1)(1995-11#1)(2008-10#2)(2008-3#1)
transfer occurs##6##2##(1993-11#1)(1996-7#1)(2005-4#1)(2006-12#1)(2008-10#2)
transfer of DNA from##3##4##(1992-5#1)(2008-4#2)
transfer of DNA##5##3##(1992-5#1)(2008-2#1)(2008-4#3)
transfer of PGCs##4##3##(2008-11#4)
transfer of T##2##3##(2008-4#1)(2012-2#1)
transfer of [3H]cholesteryl oleate##2##4##(1993-11#2)
transfer of [3H]cholesteryl##3##3##(1993-11#2)(1996-4#1)
transfer of a##15##3##(1992-10#1)(1994-12#1)(1994-9#1)(1995-6#1)(1996-7#1)(1997-6#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-7#1)
transfer of an electron##2##4##(1997-4#1)(2008-10#1)
transfer of an##7##3##(1992-5#1)(1994-5#1)(1997-4#1)(2008-10#3)(2008-11#1)
transfer of benzene from pure liquid phase into water##2##9##(2006-10#2)
transfer of bilirubin##2##3##(1992-3#2)
transfer of cholesterol##2##3##(1990-2#2)
transfer of contaminants##2##3##(2004-4#1)(2008-10#1)
transfer of correlations##2##3##(2012-2#2)
transfer of embryos##2##3##(1991-3#1)(2008-4#1)
transfer of energy from##2##4##(2007-12#1)(2008-1#1)
transfer of fatty acid##2##4##(1990-4#1)(1992-8#1)
transfer of free and pedicled flaps##2##6##(1997-6#2)
transfer of free##3##3##(1995-10#1)(1997-6#2)
transfer of genes##3##3##(1990-5#1)(2006-8#1)(2008-4#1)
transfer of information about##2##4##(2008-4#1)(2009-10#1)
transfer of information between##2##4##(2012-11#1)(2013-1#1)
transfer of information##8##3##(1997-2#1)(2007-9#1)(2008-4#1)(2009-10#1)(2012-11#1)(2012-12#2)(2013-1#1)
transfer of knowledge##2##3##(2008-11#1)(2010-10#1)
transfer of laterality cues##4##4##(2012-12#4)
transfer of lipids##2##3##(1991-11#1)(1994-11#1)
transfer of patient##3##3##(2011-1#1)(2013-1#2)
transfer of patients##2##3##(1993-8#1)(2007-9#1)
transfer of proteins##2##3##(1994-5#1)(1995-2#1)
transfer of reducing equivalents##2##4##(2006-8#1)(2009-9#1)
transfer of silver nanoparticles##2##4##(2005-11#2)
transfer of substances between the photoreceptors and the##2##8##(1990-6#2)
transfer of the##65##3##(1990-11#4)(1990-12#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-5#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-2#3)(1996-2#1)(1996-5#3)(1997-5#1)(2005-11#3)(2005-12#1)(2005-6#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-8#2)(2010-5#1)(2013-1#1)
transfer of their##2##3##(2006-10#1)(2013-1#1)
transfer of these##6##3##(1992-6#1)(1993-3#1)(1996-11#1)(2007-11#1)(2007-12#1)(2008-9#1)
transfer of this##4##3##(1991-12#1)(1994-6#1)(2008-10#1)(2009-10#1)
transfer of transposable elements##2##4##(2009-6#2)
transfer of two##4##3##(1991-9#1)(1996-10#1)(1997-4#1)(2006-12#1)
transfer of##350##2##(1990-11#4)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-10#3)(1991-11#5)(1991-12#5)(1991-2#1)(1991-3#1)(1991-4#3)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#4)(1992-5#4)(1992-6#2)(1992-8#5)(1993-11#4)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#2)(1994-11#2)(1994-12#7)(1994-2#1)(1994-5#4)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-6#2)(1995-7#1)(1995-8#2)(1996-10#2)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#5)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#3)(1997-4#7)(1997-5#1)(1997-6#3)(1997-7#1)(2004-4#2)(2005-11#7)(2005-12#1)(2005-6#1)(2006-10#8)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-6#2)(2006-7#2)(2006-8#4)(2007-11#6)(2007-12#6)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#3)(2008-10#31)(2008-11#17)(2008-12#2)(2008-2#4)(2008-3#5)(2008-4#17)(2008-5#4)(2008-7#2)(2008-8#5)(2008-9#3)(2009-10#5)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#2)(2011-1#2)(2011-2#7)(2012-11#2)(2012-12#9)(2012-2#6)(2012-3#2)(2013-1#11)(2013-7#1)(2013-8#3)
transfer on the##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
transfer on##5##2##(1991-12#1)(2007-12#1)(2008-10#2)(2008-2#1)
transfer only##2##2##(2008-10#1)(2009-4#1)
transfer over##5##2##(1991-8#1)(2007-11#3)(2007-12#1)
transfer pathway##6##2##(1994-5#2)(1995-1#1)(2006-10#1)(2008-10#2)
transfer pathways##2##2##(1993-8#1)(2007-8#1)
transfer patients##3##2##(1992-6#1)(1993-12#1)(2007-7#1)
transfer phenomena##2##2##(1991-5#1)(2009-2#1)
transfer plasmid##2##2##(2005-11#1)(2008-2#1)
transfer problem##3##2##(2008-2#1)(2008-3#2)
transfer procedure##2##2##(1996-5#1)(2008-11#1)
transfer procedures##3##2##(2006-3#1)(2008-10#1)(2008-9#1)
transfer process##14##2##(1992-3#2)(1995-10#1)(2005-11#1)(2006-10#2)(2007-12#2)(2008-10#1)(2008-3#1)(2008-8#1)(2010-5#1)(2012-12#2)
transfer processes are##2##3##(1990-8#1)(1991-3#1)
transfer processes in##4##3##(1993-8#1)(1995-11#2)(2008-8#1)
transfer processes of##2##3##(2005-4#1)(2008-10#1)
transfer processes##15##2##(1990-8#1)(1991-3#1)(1993-8#1)(1995-11#2)(2005-4#1)(2008-10#4)(2008-2#1)(2008-8#2)(2011-2#1)(2012-2#1)
transfer programmes##2##2##(1996-6#1)(1996-8#1)
transfer programs##7##2##(2008-3#2)(2008-9#5)
transfer protein (MTP)##2##3##(1995-1#1)(2005-7#1)
transfer protein in human##2##4##(1991-3#1)(1995-8#1)
transfer protein in##3##3##(1991-3#1)(1995-8#1)(2007-8#1)
transfer protein was##2##3##(1991-2#2)
transfer protein##35##2##(1990-4#2)(1991-10#1)(1991-11#2)(1991-2#5)(1991-3#2)(1992-7#1)(1993-11#1)(1995-1#1)(1995-5#3)(1995-8#1)(1996-4#1)(1996-8#1)(1997-2#2)(1997-6#1)(2005-7#1)(2007-8#2)(2008-10#1)(2008-12#6)(2008-4#1)
transfer proteins##5##2##(1991-5#1)(2006-2#1)(2008-3#1)(2008-6#1)(2009-8#1)
transfer protocols##2##2##(1996-2#1)(2008-11#1)
transfer radiometer##2##2##(2008-3#2)
transfer rate constant (k(s))##2##4##(2008-10#2)
transfer rate constant##6##3##(2008-10#6)
transfer rate constants##4##3##(1991-5#1)(1997-1#1)(2008-10#2)
transfer rate from##2##3##(1990-5#1)(1997-7#1)
transfer rate of##2##3##(1994-3#1)(2008-5#1)
transfer rate##22##2##(1990-5#1)(1991-5#1)(1991-8#1)(1993-11#1)(1994-11#1)(1994-3#1)(1997-1#1)(1997-7#1)(2006-10#1)(2008-10#10)(2008-5#1)(2008-7#1)(2008-8#1)
transfer rates##4##2##(1991-5#1)(1995-3#1)(2010-12#1)(2012-2#1)
transfer ratios##3##2##(2007-8#1)(2008-3#2)
transfer reaction##12##2##(1991-2#1)(1991-3#1)(1992-11#1)(1994-12#1)(1996-7#1)(1996-8#1)(2008-10#4)(2009-6#1)(2010-2#1)
transfer reactions of##3##3##(1990-5#2)(2007-8#1)
transfer reactions##10##2##(1990-5#2)(2006-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-9#1)(2011-1#1)(2011-2#1)
transfer region##2##2##(1990-8#1)(1991-7#1)
transfer resistance##3##2##(2008-10#1)(2012-2#2)
transfer ribonucleic acids##4##3##(1990-8#2)(2008-10#1)(2008-4#1)
transfer selectivity##2##2##(2006-10#1)(2008-10#1)
transfer set##4##2##(2007-12#3)(2008-10#1)
transfer standard##2##2##(2008-2#1)(2008-3#1)
transfer step##3##2##(1994-11#1)(1995-10#1)(2012-3#1)
transfer steps in##2##3##(1992-3#1)(1996-7#1)
transfer steps##4##2##(1992-3#1)(1996-7#2)(2010-5#1)
transfer studies##4##2##(1991-3#1)(1992-3#1)(1994-9#1)(2008-4#1)
transfer study##2##2##(2006-10#1)(2008-8#1)
transfer substrate##2##2##(2007-11#2)
transfer surgery for##2##3##(2006-3#1)(2008-8#1)
transfer system##6##2##(1994-5#1)(1995-3#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-4#1)
transfer systems##3##2##(1996-5#1)(2006-10#1)(2008-9#1)
transfer technique##6##2##(1995-12#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-10#1)(2011-12#1)
transfer that##2##2##(2007-12#1)(2012-12#1)
transfer the##14##2##(1994-8#1)(1996-2#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-8#1)(2011-2#1)(2012-2#1)
transfer theory##8##2##(2006-10#1)(2008-2#2)(2008-3#5)
transfer therapy##2##2##(1993-2#1)(1996-1#1)
transfer this##2##2##(1997-7#1)(2008-10#1)
transfer through a scattering##2##4##(2008-2#1)(2008-3#1)
transfer through a##5##3##(1990-5#1)(2007-3#1)(2008-2#2)(2008-3#1)
transfer through cirrus clouds##2##4##(2008-3#2)
transfer through the##3##3##(1992-3#1)(1994-2#1)(2008-10#1)
transfer through##14##2##(1990-5#1)(1992-3#1)(1994-2#1)(2007-3#1)(2008-10#3)(2008-2#3)(2008-3#3)(2010-12#1)
transfer to a##8##3##(1991-5#1)(2006-10#1)(2006-4#1)(2007-3#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-4#1)
transfer to form##2##3##(1995-10#1)(2006-3#1)
transfer to our facility##2##4##(1992-6#1)(2013-8#1)
transfer to recipient##3##3##(2006-5#2)(2008-10#1)
transfer to the##25##3##(1991-6#1)(1992-1#1)(1992-12#1)(1992-4#1)(1993-5#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-4#2)(2006-12#1)(2007-12#2)(2007-3#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-10#1)(2009-9#1)(2011-2#1)
transfer to##96##2##(1990-12#1)(1990-2#2)(1990-7#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#2)(1993-5#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-5#3)(1994-8#1)(1995-10#3)(1995-6#1)(1995-8#1)(1996-2#3)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(2005-12#1)(2006-10#3)(2006-12#1)(2006-3#3)(2006-4#1)(2006-5#3)(2007-11#1)(2007-12#4)(2007-3#2)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#3)(2009-10#2)(2009-11#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-4#1)(2013-8#1)
transfer treatment##2##2##(2008-10#2)
transfer using##3##2##(1994-9#1)(2005-6#1)(2008-4#1)
transfer varies##2##2##(2008-2#1)(2012-1#1)
transfer vector##5##2##(1997-3#2)(1997-4#1)(2008-2#1)(2008-8#1)
transfer vectors for##2##3##(2008-11#1)(2008-4#1)
transfer vectors##12##2##(1993-12#1)(1997-4#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2010-12#1)(2012-11#2)
transfer via##3##2##(1995-10#1)(2006-7#1)(2007-12#1)
transfer volume##2##2##(2006-10#2)
transfer was achieved##3##3##(1990-5#1)(1997-4#1)(2008-11#1)
transfer was observed##2##3##(1990-11#1)(1991-5#1)
transfer was##24##2##(1990-11#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1994-8#1)(1995-2#2)(1996-2#1)(1997-4#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-8#2)(2009-10#1)(2009-6#1)(2009-8#1)(2010-2#1)(2011-2#1)
transfer were##6##2##(1995-5#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-9#2)
transfer with a##4##3##(1996-7#1)(2006-3#2)(2008-2#1)
transfer with##13##2##(1996-7#2)(1997-4#1)(2006-3#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-10#1)(2013-8#1)
transfer within the##3##3##(1991-4#1)(1992-8#1)(2012-3#1)
transfer within##4##2##(1991-4#1)(1992-8#1)(1993-6#1)(2012-3#1)
transfer##2201##1##(1990-10#2)(1990-11#9)(1990-12#5)(1990-2#10)(1990-3#1)(1990-4#5)(1990-5#21)(1990-6#2)(1990-7#3)(1990-8#18)(1990-9#2)(1991-10#7)(1991-11#14)(1991-12#14)(1991-2#21)(1991-3#15)(1991-4#8)(1991-5#24)(1991-6#1)(1991-7#4)(1991-8#7)(1991-9#10)(1992-1#5)(1992-10#2)(1992-11#8)(1992-12#11)(1992-2#3)(1992-3#18)(1992-4#3)(1992-5#7)(1992-6#18)(1992-7#4)(1992-8#11)(1992-9#5)(1993-1#2)(1993-11#17)(1993-12#7)(1993-2#5)(1993-3#9)(1993-5#1)(1993-6#6)(1993-8#10)(1993-9#10)(1994-11#18)(1994-12#12)(1994-2#6)(1994-3#9)(1994-5#32)(1994-6#4)(1994-8#19)(1994-9#8)(1995-1#8)(1995-10#12)(1995-11#7)(1995-12#9)(1995-2#20)(1995-3#10)(1995-5#18)(1995-6#8)(1995-7#1)(1995-8#13)(1995-9#1)(1996-1#6)(1996-10#6)(1996-11#2)(1996-12#4)(1996-2#11)(1996-3#7)(1996-4#6)(1996-5#22)(1996-6#3)(1996-7#14)(1996-8#4)(1996-9#2)(1997-1#7)(1997-2#15)(1997-3#3)(1997-4#34)(1997-5#2)(1997-6#9)(1997-7#23)(1997-8#3)(2004-2#2)(2004-4#3)(2005-10#8)(2005-11#19)(2005-12#3)(2005-4#4)(2005-6#6)(2005-7#4)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#42)(2006-11#3)(2006-12#10)(2006-2#4)(2006-3#21)(2006-4#7)(2006-5#10)(2006-6#5)(2006-7#3)(2006-8#5)(2006-9#4)(2007-1#2)(2007-10#3)(2007-11#28)(2007-12#66)(2007-2#5)(2007-3#8)(2007-4#2)(2007-6#2)(2007-7#13)(2007-8#21)(2007-9#6)(2008-1#10)(2008-10#195)(2008-11#68)(2008-12#16)(2008-2#111)(2008-3#125)(2008-4#46)(2008-5#24)(2008-6#16)(2008-7#33)(2008-8#62)(2008-9#43)(2009-10#16)(2009-11#17)(2009-12#3)(2009-2#8)(2009-3#7)(2009-4#7)(2009-5#8)(2009-6#9)(2009-7#1)(2009-8#10)(2009-9#9)(2010-1#1)(2010-10#6)(2010-11#2)(2010-12#10)(2010-2#9)(2010-3#5)(2010-4#5)(2010-5#23)(2010-6#1)(2010-7#14)(2010-8#3)(2010-9#2)(2011-1#12)(2011-12#3)(2011-2#34)(2011-3#2)(2012-1#3)(2012-11#8)(2012-12#32)(2012-2#37)(2012-3#9)(2012-4#1)(2013-1#21)(2013-7#9)(2013-8#19)
transfer&quot##2##1##(2006-7#1)(2009-8#1)
transfer)##8##1##(1990-8#1)(1997-6#1)(2008-8#1)(2008-9#3)(2010-12#1)(2010-5#1)
transfer-matrix method##2##2##(2008-3#2)
transfer-matrix##3##1##(2008-3#3)
transfer-proof formulae##2##2##(2008-5#2)
transfer-to-orbit experiment##2##2##(2008-3#2)
transferability of##6##2##(1992-4#1)(2008-10#1)(2008-11#1)(2008-5#2)(2012-2#1)
transferability##10##1##(1992-4#1)(2008-10#2)(2008-11#2)(2008-5#2)(2011-12#2)(2012-2#1)
transferable agents in##2##3##(2009-3#2)
transferable quality embryos##2##3##(2006-5#2)
transferable to other##2##3##(1991-12#1)(2010-8#1)
transferable to##5##2##(1991-12#1)(1994-6#1)(1996-3#1)(2008-10#1)(2010-8#1)
transferable##17##1##(1991-12#1)(1992-1#1)(1992-12#1)(1994-6#1)(1996-3#1)(2006-5#3)(2008-10#3)(2008-2#1)(2009-3#3)(2010-8#1)(2011-2#1)
transferase activity and##2##3##(1995-5#1)(2006-6#1)
transferase activity in##2##3##(1992-8#1)(1994-2#1)
transferase activity##11##2##(1992-8#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-5#2)(1996-9#1)(2005-8#1)(2006-6#1)(2008-5#1)
transferase and##8##2##(1992-10#1)(1994-2#1)(1996-3#1)(1997-2#1)(2005-7#1)(2006-10#1)(2008-4#1)(2013-1#1)
transferase cDNA##3##2##(1992-8#1)(2008-11#2)
transferase inhibitor##3##2##(1991-5#1)(2008-3#1)(2010-12#1)
transferase inhibitors##2##2##(2005-7#1)(2005-8#1)
transferase is##5##2##(1990-12#1)(1993-11#1)(1993-3#1)(1995-10#1)(2005-8#1)
transferase reaction##2##2##(1995-5#2)
transferase to##2##2##(1991-10#1)(1996-8#1)
transferase was##3##2##(1993-6#1)(1994-5#1)(1995-7#1)
transferase with##2##2##(2008-11#1)(2013-8#1)
transferase##148##1##(1990-12#2)(1991-1#1)(1991-10#4)(1991-11#1)(1991-2#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#6)(1993-11#1)(1993-3#3)(1993-6#2)(1994-11#7)(1994-2#3)(1994-5#2)(1994-6#6)(1994-8#4)(1995-1#3)(1995-10#3)(1995-4#1)(1995-5#6)(1995-7#3)(1996-12#1)(1996-3#1)(1996-5#2)(1996-8#3)(1996-9#1)(1997-2#1)(1997-3#2)(1997-5#3)(1997-6#2)(1997-7#3)(1997-9#2)(2005-11#1)(2005-7#3)(2005-8#4)(2006-10#1)(2006-6#2)(2007-11#1)(2007-5#2)(2007-6#1)(2008-10#4)(2008-11#6)(2008-3#1)(2008-4#3)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#2)(2009-6#1)(2009-8#2)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#2)
transferase-mediated##4##1##(2006-11#1)(2007-10#1)(2008-10#1)(2008-8#1)
transferases##20##1##(1992-2#1)(1992-3#1)(1993-3#1)(1994-5#1)(1995-1#1)(1996-8#1)(1997-2#1)(1997-6#2)(2007-3#2)(2008-11#3)(2008-8#1)(2009-5#1)(2010-2#2)(2011-1#1)(2013-1#1)
transfered##3##1##(2007-10#1)(2007-11#1)(2008-2#1)
transference of theoretical knowledge of holistic care into##2##8##(2008-11#2)
transference of##3##2##(2008-10#1)(2008-11#2)
transference##12##1##(1994-9#1)(2006-4#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#1)(2009-9#1)(2010-4#1)
transfering##2##1##(2012-3#2)
transferrable##3##1##(1991-12#1)(1991-2#1)(2008-9#1)
transferral to##3##2##(1990-10#1)(1993-5#2)
transferred ADM##2##2##(2006-3#2)
transferred NOE##3##2##(1990-10#1)(2005-7#2)
transferred across##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
transferred and##3##2##(2008-11#1)(2008-9#2)
transferred as##2##2##(1993-8#1)(2009-1#1)
transferred between the##2##3##(1990-9#1)(1997-6#1)
transferred between##6##2##(1990-9#1)(1992-6#1)(1995-8#1)(1997-6#1)(2006-8#1)(2008-10#1)
transferred by a##2##3##(2006-5#1)(2007-8#1)
transferred by##8##2##(1995-3#1)(1997-4#1)(2005-11#1)(2006-5#1)(2006-6#1)(2007-8#1)(2008-10#2)
transferred cell##2##2##(1991-12#1)(2008-8#1)
transferred clones##2##2##(1996-11#2)
transferred directly into##2##3##(2008-11#1)(2008-2#1)
transferred directly to##3##3##(1994-12#1)(2008-9#1)(2012-12#1)
transferred directly##6##2##(1994-12#1)(2008-11#1)(2008-2#1)(2008-9#1)(2011-12#1)(2012-12#1)
transferred from a##4##3##(1993-3#1)(2008-10#1)(2008-7#1)(2009-2#1)
transferred from the##14##3##(1991-11#1)(1991-5#1)(1993-3#3)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2013-1#1)
transferred from##48##2##(1991-11#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-3#4)(1994-3#1)(1994-5#1)(1994-6#2)(1997-3#1)(1997-6#1)(1997-8#2)(2006-10#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-10#6)(2008-2#2)(2008-4#5)(2008-5#1)(2008-7#2)(2008-8#3)(2009-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
transferred in the##2##3##(2008-10#2)
transferred in##6##2##(2007-11#1)(2008-10#2)(2008-12#1)(2010-5#1)(2012-3#1)
transferred into a##4##3##(2006-7#1)(2008-10#2)(2012-12#1)
transferred into papaya##2##3##(2008-10#2)
transferred into the##9##3##(1992-9#1)(1993-8#1)(1996-5#1)(2004-4#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-12#1)
transferred into wheat##2##3##(2008-8#2)
transferred into##49##2##(1991-12#2)(1992-3#1)(1992-9#1)(1993-8#1)(1994-5#1)(1994-9#1)(1996-5#1)(2004-4#2)(2006-11#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-5#1)(2008-10#11)(2008-11#3)(2008-12#2)(2008-4#2)(2008-8#9)(2008-9#2)(2009-5#1)(2010-2#1)(2010-6#1)(2012-12#1)(2013-7#1)
transferred monolayer##2##2##(1993-3#2)
transferred nuclear Overhauser effect spectroscopy (TRNOESY)##3##6##(1993-11#2)(1994-11#1)
transferred nuclear Overhauser effects##4##4##(1990-10#1)(1991-4#1)(1991-7#1)(1993-11#1)
transferred nuclear Overhauser##7##3##(1990-10#1)(1991-4#1)(1991-7#1)(1993-11#3)(1994-11#1)
transferred numts##2##2##(2009-10#2)
transferred onto a##2##3##(1995-6#1)(1996-8#1)
transferred over##2##2##(1995-11#1)(1996-8#1)
transferred per##2##2##(1993-11#1)(2008-10#1)
transferred the##7##2##(1994-11#1)(1994-5#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-9#1)
transferred through the##2##3##(2007-8#1)(2012-2#1)
transferred to ICU##2##3##(2007-8#1)(2007-9#1)
transferred to a nitrocellulose##2##4##(1993-8#1)(2006-8#1)
transferred to a##28##3##(1990-10#2)(1992-2#1)(1993-8#1)(1995-3#1)(2005-10#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#2)(2011-12#2)(2012-12#1)(2013-1#1)(2013-8#2)
transferred to another##2##3##(2008-10#1)(2009-3#1)
transferred to greenhouse##2##3##(2007-3#1)(2008-10#1)
transferred to nitrocellulose##4##3##(1990-11#1)(1990-9#1)(1996-11#1)(2008-4#1)
transferred to other hexasaccharides##2##4##(1994-5#2)
transferred to our hospital##3##4##(2006-4#1)(2007-8#2)
transferred to our##5##3##(1990-9#1)(2006-4#1)(2007-8#2)(2012-2#1)
transferred to the female##2##4##(1997-4#1)(2008-7#1)
transferred to the laboratory##2##4##(2008-5#1)(2010-3#1)
transferred to the##45##3##(1991-11#1)(1992-1#1)(1992-4#1)(1993-3#1)(1993-5#1)(1994-11#1)(1995-10#2)(1995-6#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#6)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-6#3)(2009-7#1)(2009-9#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#4)
transferred to##152##2##(1990-10#2)(1990-11#1)(1990-9#2)(1991-11#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-5#3)(1994-6#1)(1994-8#1)(1995-10#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-11#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(2004-4#1)(2005-10#1)(2005-5#1)(2006-4#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-3#2)(2007-5#1)(2007-8#4)(2007-9#4)(2008-1#1)(2008-10#22)(2008-11#8)(2008-12#4)(2008-2#3)(2008-3#2)(2008-4#6)(2008-5#7)(2008-7#2)(2008-8#2)(2008-9#3)(2009-3#1)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#5)(2013-7#2)(2013-8#2)
transferred with##3##2##(1996-5#1)(2006-8#1)(2010-6#1)
transferred##391##1##(1990-10#4)(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#3)(1991-11#2)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-1#2)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#4)(1993-12#1)(1993-3#9)(1993-5#3)(1993-6#1)(1993-8#3)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#6)(1994-6#3)(1994-8#1)(1994-9#3)(1995-10#3)(1995-11#2)(1995-3#2)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#1)(1996-10#1)(1996-11#3)(1996-5#5)(1996-8#3)(1997-2#2)(1997-3#4)(1997-4#2)(1997-6#3)(1997-7#1)(1997-8#3)(2004-4#3)(2005-10#1)(2005-11#2)(2005-5#1)(2005-7#2)(2006-10#1)(2006-11#1)(2006-12#2)(2006-3#2)(2006-4#2)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#7)(2007-2#1)(2007-3#3)(2007-5#3)(2007-8#7)(2007-9#5)(2008-1#1)(2008-10#56)(2008-11#15)(2008-12#7)(2008-2#8)(2008-3#3)(2008-4#17)(2008-5#8)(2008-7#4)(2008-8#17)(2008-9#13)(2009-1#1)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#2)(2010-3#1)(2010-5#2)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#3)(2011-2#5)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#8)(2012-3#2)(2013-1#8)(2013-7#3)(2013-8#2)
transferrin (CDT)##3##2##(1993-8#1)(1996-9#1)(1997-2#1)
transferrin (Tf)##6##2##(1990-8#1)(1994-10#1)(1994-6#1)(2010-11#1)(2013-1#1)(2013-7#1)
transferrin and albumin##2##3##(1995-6#2)
transferrin and the##2##3##(2008-5#1)(2013-7#1)
transferrin and##12##2##(1992-12#1)(1992-8#1)(1994-10#1)(1995-11#1)(1995-6#3)(1996-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-7#1)
transferrin concentration##2##2##(1990-12#1)(1990-3#1)
transferrin from##2##2##(1992-8#1)(2008-10#1)
transferrin in##9##2##(1992-8#1)(1993-12#2)(1995-3#2)(2008-11#4)
transferrin into##2##2##(1994-5#1)(2008-11#1)
transferrin is##2##2##(1992-6#1)(1992-9#1)
transferrin receptor (TfR)##4##3##(1995-5#1)(1995-6#1)(1997-4#1)(1997-8#1)
transferrin receptor gene##2##3##(1992-2#2)
transferrin receptor in##2##3##(1994-3#1)(1994-6#1)
transferrin receptor mRNA##3##3##(1995-2#3)
transferrin receptor##35##2##(1990-11#1)(1990-8#5)(1991-6#4)(1992-2#2)(1992-4#1)(1992-8#1)(1993-11#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-2#3)(1995-5#2)(1995-6#1)(1996-7#1)(1997-4#3)(1997-8#1)(2006-10#1)(2013-1#1)
transferrin receptors and##3##3##(1992-4#1)(1993-11#1)(2008-4#1)
transferrin receptors##6##2##(1990-8#2)(1992-4#1)(1993-11#1)(1994-8#1)(2008-4#1)
transferrin reduction##2##2##(1994-3#2)
transferrin saturation##16##2##(1992-5#1)(1996-2#3)(2006-9#3)(2007-2#3)(2007-7#2)(2008-1#2)(2008-3#1)(2013-1#1)
transferrin sialylation##2##2##(1995-3#2)
transferrin was studied in##2##4##(1992-4#1)(1995-3#1)
transferrin was##4##2##(1990-12#1)(1992-4#1)(1995-3#1)(2008-10#1)
transferrin##187##1##(1990-11#2)(1990-12#2)(1990-3#1)(1990-7#3)(1990-8#9)(1991-6#4)(1991-7#3)(1992-1#3)(1992-12#1)(1992-2#2)(1992-4#7)(1992-5#1)(1992-6#2)(1992-8#6)(1992-9#1)(1993-11#10)(1993-12#3)(1993-8#8)(1994-10#2)(1994-12#3)(1994-3#9)(1994-5#3)(1994-6#2)(1994-8#3)(1994-9#3)(1995-11#4)(1995-2#3)(1995-3#7)(1995-5#2)(1995-6#4)(1996-11#2)(1996-2#3)(1996-5#4)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-4#3)(1997-7#1)(1997-8#1)(2006-10#1)(2006-8#1)(2006-9#3)(2007-2#3)(2007-7#2)(2008-1#3)(2008-10#9)(2008-11#15)(2008-3#1)(2008-4#1)(2008-5#6)(2008-7#1)(2010-11#1)(2010-12#2)(2012-12#1)(2013-1#3)(2013-7#2)
transferrin)##2##1##(1990-1#1)(2008-11#1)
transferrin-bound iron##4##2##(1992-4#2)(1996-6#2)
transferrin-bound##6##1##(1992-4#2)(1995-11#1)(1996-6#2)(2008-5#1)
transferrin-free##2##1##(1992-4#1)(1996-2#1)
transferrin/albumin##2##1##(1992-4#2)
transferring and##2##2##(2005-10#1)(2007-10#1)
transferring flavoenzymes##2##2##(2008-11#2)
transferring it to##2##3##(1992-12#1)(1997-4#1)
transferring on##2##2##(2008-10#1)(2008-3#1)
transferring the adductor hallucis tendon##2##5##(2009-10#2)
transferring the##8##2##(1990-12#1)(1990-3#1)(1991-12#1)(2006-10#1)(2008-9#1)(2009-10#3)
transferring them into##2##3##(2007-8#1)(2008-9#1)
transferring these##2##2##(2009-6#1)(2011-12#1)
transferring to##2##2##(2013-1#2)
transferring##58##1##(1990-12#1)(1990-3#1)(1990-8#1)(1991-12#2)(1992-12#1)(1993-11#1)(1994-10#1)(1994-2#1)(1994-8#1)(1996-11#1)(1996-7#1)(1997-2#1)(1997-4#2)(1997-8#2)(2005-10#2)(2005-8#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#5)(2008-11#2)(2008-3#2)(2008-4#4)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#3)(2009-6#1)(2010-12#2)(2010-5#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
transferrins##2##1##(1994-3#2)
transfers and##3##2##(1991-2#1)(1997-6#1)(2008-7#1)
transfers are##6##2##(1993-12#1)(1996-2#1)(2008-7#1)(2008-9#2)(2009-6#1)
transfers as##2##2##(2008-9#1)(2013-1#1)
transfers between##3##2##(1995-2#1)(1996-2#1)(2005-8#1)
transfers electrons##2##2##(1994-8#1)(2011-1#1)
transfers for##3##2##(2006-3#1)(2008-2#1)(2008-8#1)
transfers from##5##2##(1995-2#1)(1995-5#1)(1996-10#1)(2007-12#1)(2007-7#1)
transfers have been##2##3##(2006-3#1)(2008-9#1)
transfers have##3##2##(2006-3#1)(2008-9#2)
transfers in the##2##3##(2008-9#1)(2009-10#1)
transfers in##9##2##(2006-10#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-9#2)(2009-10#1)(2009-4#1)
transfers of##7##2##(1996-8#1)(2006-7#1)(2008-10#1)(2009-6#1)(2012-2#2)(2013-1#1)
transfers the##5##2##(1995-10#1)(1995-6#1)(2008-7#1)(2010-8#1)(2012-12#1)
transfers to##7##2##(1993-12#1)(2007-2#1)(2008-9#4)(2013-1#1)
transfers using##2##2##(1994-9#1)(1996-10#1)
transfers were##2##2##(1997-4#2)
transfers##115##1##(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-5#1)(1992-9#1)(1993-12#2)(1993-3#1)(1994-8#2)(1994-9#3)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1996-1#2)(1996-10#2)(1996-11#2)(1996-2#2)(1996-4#1)(1996-8#2)(1997-4#2)(1997-6#1)(2004-9#1)(2005-8#2)(2006-10#1)(2006-3#6)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#4)(2008-1#1)(2008-10#8)(2008-2#3)(2008-3#3)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#15)(2009-10#2)(2009-4#1)(2009-6#3)(2010-8#4)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#4)
transfersomal gel##3##2##(2012-12#3)
transfersomal##6##1##(2012-12#6)
transfersomes##2##1##(2010-12#1)(2012-12#1)
transfilter experiments##2##2##(2008-6#2)
transflectance spectra##4##2##(2007-11#1)(2007-8#3)
transflectance spectrum##2##2##(2007-11#2)
transflectance##7##1##(2007-11#4)(2007-8#3)
transforaminal epidural injections##13##3##(2006-7#3)(2006-8#7)(2009-5#3)
transforaminal epidural steroid injection##3##4##(2006-7#2)(2012-2#1)
transforaminal epidural steroid injections##2##4##(2006-8#2)
transforaminal epidural steroid##6##3##(2006-7#2)(2006-8#2)(2007-1#1)(2012-2#1)
transforaminal epidural##20##2##(2006-7#5)(2006-8#10)(2007-1#1)(2009-5#3)(2012-2#1)
transforaminal injection##4##2##(2006-7#1)(2006-8#3)
transforaminal##29##1##(2006-7#6)(2006-8#17)(2007-1#2)(2009-5#3)(2012-2#1)
transform IR spectrometers##2##3##(2008-3#2)
transform IR##6##2##(2008-2#3)(2008-3#2)(2010-4#1)
transform a##3##2##(1997-7#1)(2008-2#1)(2009-8#1)
transform algorithm and##2##3##(2008-10#1)(2008-3#1)
transform algorithm##8##2##(2008-10#1)(2008-2#2)(2008-3#5)
transform an##2##2##(1996-7#1)(2008-2#1)
transform and the##4##3##(2008-2#1)(2008-3#3)
transform and##13##2##(2008-1#2)(2008-2#6)(2008-3#5)
transform are##4##2##(2008-2#2)(2008-3#1)(2008-6#1)
transform can be used to##2##5##(2008-3#1)(2010-4#1)
transform can be##5##3##(2008-2#2)(2008-3#1)(2008-6#1)(2010-4#1)
transform coefficients##5##2##(2008-2#5)
transform correlator (JTC)##4##3##(2008-2#2)(2008-3#2)
transform correlator for optical##2##4##(2008-3#2)
transform correlator for##5##3##(2008-2#1)(2008-3#4)
transform correlator##61##2##(2007-12#1)(2008-2#42)(2008-3#18)
transform correlators##3##2##(2008-2#1)(2008-3#2)
transform domain##5##2##(2008-2#5)
transform for##5##2##(2007-11#1)(2008-2#3)(2008-3#1)
transform from##3##2##(2008-1#1)(2008-3#1)(2012-2#1)
transform image coding##2##3##(2008-2#2)
transform image##3##2##(2008-2#3)
transform in##3##2##(2008-2#2)(2012-1#1)
transform infrared (FTIR)##20##3##(1991-10#1)(1994-11#1)(2007-8#1)(2007-9#1)(2008-10#9)(2008-5#2)(2008-7#1)(2008-8#1)(2009-1#1)(2009-4#1)(2010-4#1)
transform infrared imaging##3##3##(1997-5#1)(2007-12#1)(2008-8#1)
transform infrared spectrometric determination of##2##5##(2008-10#2)
transform infrared spectrometric##4##3##(2008-10#4)
transform infrared spectrometry and##2##4##(1997-2#1)(2008-5#1)
transform infrared spectrometry##16##3##(1992-8#1)(1994-3#1)(1997-2#2)(2006-12#1)(2008-10#9)(2008-5#2)
transform infrared spectroscopy of##3##4##(1997-4#1)(2006-10#1)(2007-11#1)
transform infrared spectroscopy##53##3##(1992-1#1)(1992-12#1)(1992-4#1)(1992-9#2)(1993-3#2)(1994-9#1)(1995-10#1)(1997-4#2)(2004-9#1)(2005-11#3)(2005-12#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-3#2)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#17)(2008-5#3)(2009-10#1)(2010-5#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
transform infrared study of##2##4##(1997-4#1)(2008-10#1)
transform infrared##157##2##(1990-3#1)(1991-10#1)(1991-5#3)(1992-1#1)(1992-12#1)(1992-4#1)(1992-8#1)(1992-9#2)(1993-3#2)(1994-11#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-5#1)(1997-2#2)(1997-4#4)(1997-5#1)(2004-9#1)(2005-11#4)(2005-12#1)(2005-4#1)(2006-10#1)(2006-12#10)(2006-3#2)(2007-11#7)(2007-12#9)(2007-8#7)(2007-9#2)(2008-10#52)(2008-2#5)(2008-3#3)(2008-5#8)(2008-7#2)(2008-8#2)(2009-1#1)(2009-10#1)(2009-4#1)(2010-4#3)(2010-5#1)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#1)
transform interferometry##2##2##(2008-3#2)
transform into a##2##3##(2008-2#1)(2010-1#1)
transform into##8##2##(1997-8#1)(2006-11#1)(2006-6#1)(2008-2#1)(2008-5#1)(2010-1#1)(2010-11#1)(2013-1#1)
transform is a##4##3##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
transform is proposed##2##3##(2008-2#1)(2008-3#1)
transform is used to##2##4##(1996-11#1)(2007-11#1)
transform is##20##2##(1996-11#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#9)(2008-3#6)
transform it##2##2##(2007-12#1)(2008-12#1)
transform light##3##2##(2008-2#1)(2011-1#2)
transform limit##3##2##(2007-12#3)
transform limited##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
transform many different##2##3##(2008-3#1)(2008-4#1)
transform mid-infrared##2##2##(2008-10#1)(2010-4#1)
transform of a coherent##3##4##(2007-12#3)
transform of a##8##3##(2007-12#7)(2009-12#1)
transform of an image##2##4##(2008-3#1)(2012-1#1)
transform of an##5##3##(2007-12#2)(2008-3#2)(2012-1#1)
transform of the##18##3##(1992-9#1)(2006-5#1)(2007-11#1)(2007-12#8)(2008-2#5)(2008-3#2)
transform of##35##2##(1992-9#1)(1996-9#1)(2006-5#1)(2007-11#1)(2007-12#18)(2008-2#6)(2008-3#5)(2009-12#1)(2012-1#1)
transform optical correlator##2##3##(2008-3#2)
transform optical##3##2##(2008-3#3)
transform orders##2##2##(2007-12#1)(2008-2#1)
transform plane##3##2##(2007-1#1)(2008-3#2)
transform power spectrum##2##3##(2008-3#2)
transform power##3##2##(2008-2#1)(2008-3#2)
transform profilometry##3##2##(2008-2#1)(2008-3#2)
transform spectrometer based on##2##4##(2007-12#2)
transform spectrometer##14##2##(2007-12#3)(2008-2#4)(2008-3#7)
transform spectrometers##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
transform spectroscopy (DRIFTS) and the curve-fitting deconvolution method##2##8##(2006-12#2)
transform spectroscopy (DRIFTS) and##3##4##(2006-12#2)(2008-10#1)
transform spectroscopy (FTIR)##2##3##(2011-1#1)(2011-2#1)
transform spectroscopy##18##2##(2005-11#1)(2006-12#2)(2008-10#2)(2008-2#10)(2008-3#1)(2011-1#1)(2011-2#1)
transform spectrum##2##2##(2013-8#2)
transform technique##2##2##(2007-8#1)(2008-3#1)
transform techniques are##2##3##(2008-2#2)
transform that##4##2##(2007-12#1)(2008-2#3)
transform the##20##2##(1992-12#1)(1995-3#1)(1997-4#1)(2005-11#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-9#1)(2011-1#1)(2012-2#1)
transform them into##2##3##(1996-1#1)(2005-11#1)
transform to the##3##3##(2006-10#1)(2008-1#1)(2008-10#1)
transform to##18##2##(1996-3#1)(2005-11#1)(2006-10#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#7)(2008-3#2)(2013-8#1)
transform was##3##2##(2008-2#2)(2012-2#1)
transform with##6##2##(2007-12#1)(2008-2#3)(2008-3#2)
transform##706##1##(1990-1#1)(1990-10#1)(1990-3#1)(1990-5#3)(1991-10#2)(1991-2#1)(1991-5#4)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-4#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-3#2)(1994-11#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#2)(1997-4#8)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-9#1)(2005-11#9)(2005-12#2)(2005-4#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#13)(2006-3#2)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#17)(2007-12#62)(2007-3#1)(2007-7#1)(2007-8#11)(2007-9#4)(2008-1#13)(2008-10#82)(2008-11#5)(2008-12#1)(2008-2#203)(2008-3#123)(2008-4#6)(2008-5#12)(2008-6#4)(2008-7#7)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-4#7)(2010-5#1)(2011-1#6)(2011-2#1)(2012-1#3)(2012-2#6)(2013-1#8)(2013-7#1)(2013-8#7)
transform-based Fourier deconvolution##2##3##(2008-10#2)
transform-based##5##1##(2008-10#2)(2008-2#2)(2008-3#1)
transform-limited pedestal-free##2##2##(2007-11#2)
transform-limited pulse##4##2##(2007-12#2)(2008-1#1)(2008-2#1)
transform-limited pulses with##2##3##(2007-12#1)(2008-2#1)
transform-limited pulses##3##2##(2007-12#2)(2008-2#1)
transform-limited##29##1##(2007-11#6)(2007-12#16)(2008-1#1)(2008-2#2)(2008-3#2)(2012-11#2)
transformable##3##1##(1990-11#1)(2005-7#1)(2010-5#1)
transformant Inu-66##2##2##(2011-1#2)
transformant cells##4##2##(1995-12#4)
transformant induced by retTPC##2##4##(1991-9#2)
transformant with##2##2##(1993-3#1)(1996-7#1)
transformant##30##1##(1990-3#1)(1991-7#1)(1991-9#4)(1993-3#1)(1994-12#3)(1995-12#5)(1996-4#1)(1996-7#3)(2008-10#6)(2008-4#1)(2008-8#1)(2011-1#3)
transformants and the##3##3##(2008-10#3)
transformants and##4##2##(2008-10#4)
transformants containing##2##2##(2008-10#1)(2008-5#1)
transformants for##2##2##(1990-8#1)(1997-6#1)
transformants in##2##2##(1991-9#1)(2008-10#1)
transformants obtained with##4##3##(1991-7#1)(1996-7#1)(2008-10#2)
transformants obtained##5##2##(1991-7#1)(1993-11#1)(1996-7#1)(2008-10#2)
transformants of##6##2##(1992-4#2)(2008-10#4)
transformants per##2##2##(2008-10#2)
transformants revealed##2##2##(1997-4#1)(2008-8#1)
transformants showed##3##2##(2008-10#3)
transformants that##3##2##(1990-11#1)(2008-10#2)
transformants was##3##2##(1997-2#2)(2008-10#1)
transformants were capable of##2##4##(1993-12#1)(1997-1#1)
transformants were##11##2##(1990-5#2)(1991-9#1)(1993-12#1)(1997-1#1)(2006-12#1)(2008-10#4)(2008-4#1)
transformants with a##3##3##(1991-7#1)(1997-4#1)(2008-10#1)
transformants with##9##2##(1991-7#1)(1995-4#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-10#2)(2008-8#1)(2011-1#1)
transformants##108##1##(1990-11#1)(1990-4#1)(1990-5#4)(1990-8#1)(1991-7#3)(1991-8#1)(1991-9#2)(1992-4#2)(1993-11#1)(1993-12#3)(1994-12#2)(1994-8#1)(1994-9#1)(1995-3#1)(1995-4#1)(1995-8#2)(1996-2#1)(1996-7#1)(1997-1#2)(1997-2#3)(1997-4#4)(1997-6#3)(1997-8#2)(2006-11#2)(2006-12#2)(2008-1#1)(2008-10#45)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#6)(2008-9#1)(2011-1#1)(2012-2#2)(2013-1#1)
transformants/microgram##2##1##(1990-9#2)
transformation (DRIFT) spectroscopy##2##3##(2008-10#2)
transformation algorithm##2##2##(2007-11#1)(2008-2#1)
transformation and expression##3##3##(1996-6#1)(1996-7#1)(2008-4#1)
transformation and selection##2##3##(2007-6#1)(2012-1#1)
transformation and the##5##3##(1995-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
transformation and##51##2##(1991-12#1)(1993-4#1)(1993-7#4)(1993-9#2)(1994-2#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-3#2)(1996-6#1)(1996-7#1)(2005-4#1)(2007-11#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#3)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#1)(2013-8#1)
transformation approach##2##2##(2004-8#2)
transformation are##4##2##(1994-8#1)(1996-11#1)(2007-11#1)(2008-10#1)
transformation as##2##2##(1994-9#1)(2009-12#1)
transformation assay##2##2##(1992-2#1)(1993-7#1)
transformation assays##2##2##(1994-6#1)(1995-12#1)
transformation associated##2##2##(1991-8#1)(2008-2#1)
transformation at the##2##3##(1995-4#1)(2008-11#1)
transformation at##4##2##(1995-4#2)(2008-11#1)(2008-9#1)
transformation because the##2##3##(2012-1#1)(2012-12#1)
transformation between##4##2##(1993-12#1)(2008-4#1)(2008-6#1)(2009-11#1)
transformation by the##4##3##(1996-5#2)(2008-10#2)
transformation by##22##2##(1990-1#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-9#1)(1993-11#2)(1995-8#2)(1996-5#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#2)(2009-11#1)(2009-5#1)
transformation can be##2##3##(2008-2#1)(2010-7#1)
transformation can##4##2##(1995-1#1)(2008-2#2)(2010-7#1)
transformation competent##2##2##(1990-8#2)
transformation depends##2##2##(1991-8#1)(2008-11#1)
transformation efficiencies##3##2##(1996-7#1)(2008-4#2)
transformation efficiency between##2##3##(1996-4#2)
transformation efficiency##12##2##(1990-5#1)(1992-11#1)(1996-4#5)(1996-7#1)(2006-12#3)(2008-11#1)
transformation event##2##2##(2008-10#2)
transformation experiments##3##2##(2007-7#2)(2008-11#1)
transformation for##3##2##(2008-1#1)(2012-11#1)(2012-3#1)
transformation frequencies##4##2##(1990-7#1)(2008-10#2)(2008-9#1)
transformation frequency##6##2##(1991-7#1)(2008-10#2)(2008-7#3)
transformation from##8##2##(1996-8#1)(2004-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-2#1)(2013-8#1)
transformation has been reported##2##4##(2008-10#1)(2012-12#1)
transformation has been used##2##4##(2008-8#1)(2012-11#1)
transformation has been##8##3##(1994-10#1)(1994-12#1)(2006-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-11#1)(2012-12#1)
transformation has##10##2##(1994-10#1)(1994-12#1)(1997-1#1)(2006-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-1#1)(2012-11#1)(2012-12#1)
transformation in a##4##3##(1993-7#1)(2007-7#1)(2012-2#1)(2013-8#1)
transformation in the##7##3##(1990-5#1)(1991-10#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-7#1)(2012-1#1)
transformation in vitro##10##3##(1991-8#1)(2008-7#9)
transformation in##59##2##(1990-5#2)(1991-10#1)(1991-8#1)(1992-11#2)(1992-5#3)(1993-1#1)(1993-12#1)(1993-7#2)(1995-9#1)(1996-2#1)(1997-1#1)(2006-10#1)(2006-8#1)(2007-11#4)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#13)(2010-3#1)(2011-2#2)(2012-1#3)(2012-12#4)(2012-2#1)(2013-1#1)(2013-8#1)
transformation incidence##2##2##(1994-2#2)
transformation induced by##2##3##(1991-12#1)(1996-2#1)
transformation into a##2##3##(2007-4#1)(2009-2#1)
transformation into##13##2##(1992-12#1)(1992-5#1)(1994-9#1)(1996-11#1)(2007-4#1)(2008-3#1)(2008-5#1)(2009-2#1)(2009-8#1)(2010-4#1)(2010-5#1)(2012-12#1)(2013-1#1)
transformation is a##2##3##(1995-4#1)(2011-2#1)
transformation is used to##3##4##(2008-2#1)(2013-1#2)
transformation is##28##2##(1993-11#1)(1993-12#1)(1994-10#1)(1994-9#1)(1995-2#1)(1995-4#3)(1997-6#1)(2006-12#2)(2007-11#2)(2007-5#1)(2007-8#1)(2008-10#1)(2008-2#4)(2008-6#1)(2008-7#1)(2008-8#2)(2009-5#1)(2011-2#1)(2013-1#2)
transformation matrix##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
transformation may be##3##3##(1992-11#1)(2007-12#1)(2008-3#1)
transformation may##6##2##(1992-11#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-3#1)(2010-7#1)
transformation method##5##2##(1994-12#1)(2004-8#1)(2008-2#2)(2008-8#1)
transformation methods##2##2##(2012-1#1)(2012-11#1)
transformation model##2##2##(2008-2#1)(2008-7#1)
transformation occurs in the anolyte##2##5##(2013-1#2)
transformation occurs##3##2##(2012-12#1)(2013-1#2)
transformation of Escherichia coli##2##4##(1990-11#1)(1997-6#1)
transformation of Fr3T3 fibroblasts by##2##5##(1996-5#2)
transformation of Listeria monocytogenes##2##4##(1990-9#2)
transformation of a##10##3##(1992-9#1)(1997-2#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-1#1)(2010-4#1)
transformation of cells by##2##4##(1991-9#1)(2008-5#1)
transformation of cells##7##3##(1991-9#1)(2007-3#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-2#1)
transformation of epithelial##2##3##(2012-1#1)(2012-12#1)
transformation of human##3##3##(1990-5#1)(1992-8#1)(2008-4#1)
transformation of incidence##3##3##(2008-10#3)
transformation of mouse##2##3##(1994-2#1)(1997-7#1)
transformation of native##2##3##(2008-5#1)(2009-5#1)
transformation of normal rat kidney cells##2##6##(1991-12#1)(1991-8#1)
transformation of normal##4##3##(1990-4#1)(1991-12#1)(1991-8#1)(2012-12#1)
transformation of oral lichen##3##4##(2008-4#3)
transformation of phenotype and##2##4##(1991-9#2)
transformation of skeletal elements derived from##2##6##(1993-12#2)
transformation of systems##2##3##(2008-2#1)(2013-1#1)
transformation of the fluorescent pseudomonad##2##5##(2008-10#2)
transformation of the health##2##4##(1995-2#1)(2008-2#1)
transformation of the resulting##2##4##(2008-3#1)(2009-3#1)
transformation of the##41##3##(1990-12#1)(1993-12#2)(1993-8#1)(1994-9#1)(1995-2#1)(1995-4#2)(1995-9#1)(1996-12#1)(1996-2#1)(1996-7#2)(1997-2#1)(1997-4#1)(2005-11#2)(2005-12#2)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-2#5)(2008-3#4)(2008-6#1)(2009-3#1)(2010-12#2)
transformation of these##2##3##(1992-11#1)(1992-2#1)
transformation of##212##2##(1990-1#2)(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#4)(1990-7#2)(1990-9#4)(1991-12#3)(1991-2#1)(1991-7#2)(1991-8#2)(1991-9#3)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-5#4)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#5)(1993-2#1)(1993-7#1)(1993-8#1)(1994-2#1)(1994-9#2)(1995-2#1)(1995-3#2)(1995-4#2)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-7#2)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(2004-4#1)(2004-9#2)(2005-11#5)(2005-12#3)(2005-8#1)(2006-10#3)(2006-12#3)(2006-2#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#3)(2007-12#5)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#9)(2008-10#10)(2008-11#6)(2008-12#1)(2008-2#12)(2008-3#7)(2008-4#11)(2008-5#5)(2008-6#4)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-5#2)(2010-12#3)(2010-2#1)(2010-4#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#2)
transformation or##2##2##(1997-7#1)(2006-12#1)
transformation procedure##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
transformation process of phase##2##4##(2008-10#1)(2012-2#1)
transformation process##3##2##(2008-10#1)(2008-4#1)(2012-2#1)
transformation processes##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
transformation products##5##2##(2007-8#2)(2008-10#3)
transformation properties##2##2##(1991-8#1)(2008-3#1)
transformation protocols##2##2##(2006-11#1)(2006-12#1)
transformation rates are##2##3##(2008-7#1)(2013-1#1)
transformation rates##6##2##(1990-9#1)(2008-7#1)(2012-12#2)(2013-1#2)
transformation suppressor##3##2##(1997-2#1)(2012-12#2)
transformation system for##3##3##(2006-12#1)(2008-10#1)(2008-8#1)
transformation system##10##2##(1990-5#1)(1990-7#1)(1991-8#1)(1994-4#1)(1997-2#2)(2006-12#1)(2008-10#1)(2008-8#1)(2012-3#1)
transformation that##6##2##(2004-4#1)(2007-12#2)(2008-2#1)(2008-4#1)(2009-10#1)
transformation to a##3##3##(2008-2#1)(2008-6#1)(2008-7#1)
transformation to colorectal carcinoma##2##4##(2009-12#2)
transformation to recover##3##3##(1997-4#1)(2013-1#2)
transformation to##23##2##(1992-1#1)(1992-6#1)(1992-9#1)(1996-2#1)(1997-4#1)(2006-10#1)(2006-8#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-12#2)(2010-7#1)(2010-9#1)(2012-12#1)(2013-1#2)
transformation under##3##2##(2006-8#1)(2008-2#1)(2008-3#1)
transformation using##4##2##(1990-11#1)(1997-7#1)(2006-12#1)(2008-11#1)
transformation vector##2##2##(2008-10#1)(2013-1#1)
transformation was not##2##3##(1991-8#1)(2008-7#1)
transformation was used##2##3##(2010-5#1)(2011-1#1)
transformation was##12##2##(1991-8#2)(1993-2#1)(1993-9#1)(1997-1#1)(2006-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-5#1)(2011-1#1)
transformation which##2##2##(2009-7#1)(2012-2#1)
transformation with a##3##3##(1993-3#1)(1997-3#1)(2008-3#1)
transformation with genes encoding##2##4##(2006-12#1)(2008-10#1)
transformation with##16##2##(1992-9#1)(1993-2#1)(1993-3#1)(1997-3#1)(2006-12#1)(2007-1#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-2#1)(2008-3#1)(2012-11#1)
transformation zone in patients with##2##5##(1990-6#1)(2011-2#1)
transformation zone##10##2##(1990-6#1)(1991-2#1)(1994-12#1)(1994-2#2)(2006-10#2)(2011-2#1)(2012-3#2)
transformation##898##1##(1990-1#3)(1990-11#5)(1990-12#1)(1990-4#1)(1990-5#11)(1990-6#3)(1990-7#7)(1990-8#7)(1990-9#9)(1991-1#2)(1991-10#6)(1991-12#7)(1991-2#5)(1991-5#1)(1991-7#5)(1991-8#9)(1991-9#8)(1992-1#1)(1992-11#6)(1992-12#3)(1992-2#8)(1992-3#1)(1992-5#10)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#5)(1993-1#2)(1993-11#5)(1993-12#10)(1993-2#7)(1993-3#3)(1993-4#1)(1993-6#1)(1993-7#8)(1993-8#2)(1993-9#3)(1994-10#2)(1994-11#3)(1994-12#6)(1994-2#7)(1994-3#1)(1994-4#2)(1994-6#1)(1994-8#6)(1994-9#8)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#5)(1995-3#3)(1995-4#8)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#3)(1995-9#3)(1996-1#1)(1996-11#3)(1996-12#4)(1996-2#6)(1996-3#2)(1996-4#5)(1996-5#5)(1996-6#2)(1996-7#6)(1996-8#2)(1997-1#6)(1997-2#9)(1997-3#1)(1997-4#4)(1997-6#2)(1997-7#4)(2004-4#4)(2004-8#3)(2004-9#3)(2005-11#6)(2005-12#3)(2005-4#1)(2005-8#1)(2006-10#15)(2006-11#4)(2006-12#18)(2006-2#2)(2006-3#1)(2006-7#1)(2006-8#8)(2006-9#3)(2007-1#2)(2007-10#6)(2007-11#21)(2007-12#23)(2007-3#2)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#7)(2007-9#4)(2008-1#16)(2008-10#54)(2008-11#24)(2008-12#6)(2008-2#48)(2008-3#23)(2008-4#21)(2008-5#11)(2008-6#14)(2008-7#32)(2008-8#17)(2008-9#11)(2009-1#1)(2009-10#3)(2009-11#4)(2009-12#4)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#6)(2009-7#2)(2009-8#2)(2010-12#7)(2010-2#3)(2010-3#3)(2010-4#3)(2010-5#4)(2010-7#4)(2010-8#2)(2010-9#2)(2011-1#9)(2011-12#1)(2011-2#14)(2012-1#13)(2012-11#11)(2012-12#29)(2012-2#11)(2012-3#7)(2013-1#20)(2013-8#4)
transformation)##3##1##(1996-6#1)(2010-12#2)
transformation-associated##3##1##(1992-11#1)(1994-9#2)
transformational##6##1##(1992-1#1)(1997-8#2)(2008-11#2)(2008-2#1)
transformations and##6##2##(2004-4#1)(2008-11#1)(2008-2#2)(2010-5#1)(2013-7#1)
transformations are also##2##3##(2008-2#1)(2008-3#1)
transformations are##8##2##(2004-4#1)(2008-12#1)(2008-2#3)(2008-3#2)(2013-1#1)
transformations as##2##2##(1995-4#1)(1997-3#1)
transformations for##3##2##(2008-2#2)(2010-4#1)
transformations have been##2##3##(2008-10#2)
transformations have##3##2##(2008-10#3)
transformations in soil##2##3##(1990-9#1)(2008-10#1)
transformations in the##4##3##(2008-2#2)(2008-8#1)(2013-1#1)
transformations in##16##2##(1990-9#1)(1991-9#1)(1997-8#2)(2007-8#1)(2008-10#2)(2008-12#2)(2008-2#2)(2008-8#1)(2008-9#1)(2009-4#1)(2013-1#2)
transformations include thoracic##2##3##(1990-11#2)
transformations include##3##2##(1990-11#2)(2008-10#1)
transformations inevitably##2##2##(1995-2#1)(2012-12#1)
transformations is##3##2##(2008-2#2)(2010-12#1)
transformations of an##2##3##(2008-2#1)(2008-4#1)
transformations of the##7##3##(1995-11#1)(1997-2#1)(2006-12#1)(2008-10#1)(2010-1#1)(2010-4#1)(2013-1#1)
transformations of##24##2##(1994-11#1)(1995-11#1)(1995-8#2)(1997-2#1)(2006-12#1)(2006-8#1)(2007-11#3)(2007-6#2)(2007-8#1)(2008-10#4)(2008-2#1)(2008-4#1)(2010-1#1)(2010-4#1)(2010-6#1)(2012-1#1)(2013-1#1)
transformations such as##3##3##(2008-2#2)(2009-3#1)
transformations that are##3##3##(1990-11#1)(2004-4#2)
transformations that##8##2##(1990-11#1)(2004-4#2)(2007-9#1)(2009-4#2)(2010-1#1)(2010-12#1)
transformations were##3##2##(1996-5#1)(2008-1#1)(2010-4#1)
transformations##148##1##(1990-11#3)(1990-9#1)(1991-9#1)(1992-3#1)(1994-11#1)(1995-11#1)(1995-2#3)(1995-4#1)(1995-8#2)(1996-3#1)(1996-5#2)(1997-1#2)(1997-2#1)(1997-3#2)(1997-8#2)(2004-4#6)(2005-11#1)(2006-12#3)(2006-3#1)(2006-8#2)(2007-1#3)(2007-11#5)(2007-6#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-12#4)(2008-2#22)(2008-3#2)(2008-4#2)(2008-6#4)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#4)(2010-1#2)(2010-12#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#3)(2013-8#1)
transformative leadership##3##2##(1996-1#1)(2008-1#2)
transformative##12##1##(1996-1#1)(2008-1#2)(2008-12#2)(2010-11#1)(2010-12#1)(2010-8#4)(2013-1#1)
transformed B##3##2##(1994-3#1)(1995-1#2)
transformed E##2##2##(1993-12#1)(2013-1#1)
transformed Gibbs energies of formation##2##5##(1996-11#2)
transformed Gibbs##3##2##(1996-11#3)
transformed and untransformed cells##2##4##(1993-2#1)(2011-2#1)
transformed and##8##2##(1993-2#1)(1993-6#1)(1997-2#1)(2004-4#1)(2008-7#1)(2011-2#2)(2012-12#1)
transformed at a##2##3##(1993-12#1)(1996-8#1)
transformed at##4##2##(1993-12#1)(1996-8#1)(2008-12#1)(2013-7#1)
transformed back##2##2##(1990-4#1)(1992-6#1)
transformed bacteria##2##2##(1996-12#1)(2008-11#1)
transformed by a##3##3##(1993-12#1)(1994-9#1)(2006-12#1)
transformed by human##3##3##(1992-9#2)(2008-10#1)
transformed by the##8##3##(1991-5#1)(1991-8#1)(1997-7#1)(2006-5#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
transformed by this##2##3##(1991-2#1)(1991-7#1)
transformed by##32##2##(1990-10#1)(1990-11#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-4#1)(1994-9#2)(1996-8#1)(1997-7#1)(2006-12#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-3#1)(2013-8#2)
transformed cell line##2##3##(1996-4#1)(2008-11#1)
transformed cell lines derived from##2##5##(1991-2#1)(1995-12#1)
transformed cell lines##8##3##(1991-2#2)(1991-7#1)(1993-6#1)(1995-12#1)(1995-2#2)(2008-11#1)
transformed cell##19##2##(1991-2#2)(1991-7#1)(1993-6#1)(1994-11#3)(1995-12#1)(1995-2#2)(1996-2#1)(1996-4#1)(1997-1#1)(2008-11#3)(2008-7#1)(2008-8#1)(2011-2#1)
transformed cells and##3##3##(1994-8#1)(1996-2#1)(2012-1#1)
transformed cells can##2##3##(1995-1#1)(1996-4#1)
transformed cells did not##2##4##(1993-2#1)(1994-8#1)
transformed cells do not##2##4##(1992-2#1)(2012-12#1)
transformed cells in##3##3##(1993-8#1)(2007-2#1)(2008-7#1)
transformed cells of##2##3##(1994-12#1)(1994-5#1)
transformed cells with##2##3##(1995-6#1)(2007-9#1)
transformed cells##65##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-6#1)(1991-1#1)(1991-2#5)(1991-7#1)(1991-8#1)(1992-2#3)(1992-9#1)(1993-11#1)(1993-2#2)(1993-7#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#2)(1995-1#1)(1995-2#5)(1995-6#2)(1995-8#1)(1996-2#1)(1996-4#2)(1997-2#2)(1997-4#2)(1997-7#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-7#1)(2009-9#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#2)
transformed chicken##2##2##(2008-5#2)
transformed clones##2##2##(1993-2#1)(2008-9#1)
transformed data##4##2##(1994-11#1)(1996-12#1)(2008-10#1)(2008-7#1)
transformed epidermal##2##2##(1991-10#1)(2008-8#1)
transformed fibroblasts##2##2##(1990-7#1)(1996-5#1)
transformed foci##2##2##(1992-5#2)
transformed from a##3##3##(1990-11#1)(1994-12#1)(2008-3#1)
transformed from##7##2##(1990-11#1)(1994-12#1)(1995-5#1)(2005-11#2)(2007-12#1)(2008-3#1)
transformed human##9##2##(1990-9#1)(1992-3#2)(1993-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(2008-10#1)
transformed in##6##2##(1993-11#1)(1993-4#1)(2006-8#1)(2007-10#1)(2007-3#1)(2008-8#1)
transformed infrared##5##2##(2008-10#4)(2013-8#1)
transformed input variables##2##3##(2008-2#2)
transformed into E##2##3##(1994-12#1)(2005-11#1)
transformed into a##16##3##(1993-8#1)(1996-7#1)(2006-6#1)(2007-12#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-2#1)(2009-7#1)(2010-7#1)(2012-1#1)(2012-2#1)
transformed into an##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
transformed into the gaseous##2##4##(2008-10#2)
transformed into the##8##3##(1994-8#1)(1996-6#1)(1996-7#1)(2005-11#1)(2008-10#2)(2008-4#1)(2008-9#1)
transformed into##67##2##(1993-8#1)(1994-12#2)(1994-8#1)(1995-12#1)(1995-8#2)(1996-3#1)(1996-5#3)(1996-6#1)(1996-7#2)(1997-1#1)(2005-11#3)(2006-11#1)(2006-12#2)(2006-6#1)(2007-11#1)(2007-12#3)(2007-5#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-2#1)(2009-7#2)(2009-8#1)(2010-4#1)(2010-7#2)(2011-1#2)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
transformed kidney##2##2##(1993-8#1)(2008-11#1)
transformed migraine##3##2##(2004-12#1)(2008-9#2)
transformed mouse##3##2##(1991-2#1)(1994-2#1)(2008-11#1)
transformed neonatal rat##2##3##(1996-5#2)
transformed over##2##2##(1993-8#1)(2008-6#1)
transformed phenotype in##2##3##(1995-6#1)(2011-2#1)
transformed phenotype of##4##3##(1991-7#1)(1995-6#1)(1997-1#1)(2008-11#1)
transformed phenotype##15##2##(1990-7#1)(1991-7#1)(1991-8#1)(1994-9#1)(1995-6#2)(1995-9#1)(1997-1#2)(1997-2#1)(2008-11#1)(2008-4#1)(2008-8#2)(2011-2#1)
transformed phenotypes##2##2##(1991-9#1)(1993-11#1)
transformed plants##3##2##(1997-6#1)(2006-12#1)(2007-1#1)
transformed rat##4##2##(1990-5#1)(1990-6#1)(1991-8#1)(1993-3#1)
transformed rat-liver epithelial-cell line##2##4##(1992-9#2)
transformed rat-liver##4##2##(1992-9#4)
transformed respiratory epithelial cells##2##4##(2008-10#2)
transformed roots##2##2##(2007-1#2)
transformed seeds in##2##3##(2006-12#2)
transformed seeds##3##2##(2006-12#3)
transformed signals##3##2##(2008-10#3)
transformed space##2##2##(2006-10#1)(2007-12#1)
transformed strains##2##2##(1990-9#1)(2008-10#1)
transformed the prognosis of##2##4##(2008-3#1)(2010-12#1)
transformed the##7##2##(2007-7#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-8#2)(2010-12#1)
transformed through##2##2##(2006-2#1)(2007-11#1)
transformed to the##3##3##(1997-7#1)(2008-6#1)(2010-5#1)
transformed to##29##2##(1992-4#1)(1993-5#1)(1996-10#1)(1996-4#1)(1997-7#2)(2004-4#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-11#5)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-10#1)(2010-11#1)(2010-5#1)(2013-1#2)
transformed tobacco##3##2##(2006-12#3)
transformed with a plasmid##3##4##(1993-8#1)(2007-9#1)(2010-6#1)
transformed with a##14##3##(1990-12#1)(1990-7#1)(1993-2#1)(1993-8#1)(1995-11#1)(1995-6#1)(2007-9#1)(2008-10#6)(2010-6#1)
transformed with an##2##3##(1993-11#1)(1994-2#1)
transformed with different##2##3##(1990-11#1)(1992-5#1)
transformed with the coat protein (CP)##2##6##(2008-10#2)
transformed with the recombinant##2##4##(1991-4#1)(1992-12#1)
transformed with the##17##3##(1990-10#1)(1990-12#1)(1991-1#1)(1991-4#1)(1992-12#1)(1993-8#1)(1994-11#1)(1995-2#1)(2006-12#2)(2008-10#7)
transformed with two##2##3##(1997-7#1)(2008-10#1)
transformed with##53##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-7#1)(1991-1#1)(1991-4#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-2#2)(1995-6#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-10#1)(2006-12#2)(2007-9#1)(2008-10#19)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#2)
transformed yeast##5##2##(1990-10#2)(1990-12#1)(1990-8#1)(1995-2#1)
transformed##536##1##(1990-10#4)(1990-11#5)(1990-12#4)(1990-4#1)(1990-5#5)(1990-6#2)(1990-7#6)(1990-8#5)(1990-9#3)(1991-1#2)(1991-10#1)(1991-2#9)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#7)(1991-8#6)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#5)(1992-3#3)(1992-4#1)(1992-5#4)(1992-6#2)(1992-7#1)(1992-9#7)(1993-1#4)(1993-11#8)(1993-12#4)(1993-2#6)(1993-3#1)(1993-4#2)(1993-5#2)(1993-6#4)(1993-7#3)(1993-8#6)(1994-11#10)(1994-12#5)(1994-2#2)(1994-3#4)(1994-5#3)(1994-8#5)(1994-9#4)(1995-1#3)(1995-11#1)(1995-12#2)(1995-2#13)(1995-4#1)(1995-5#1)(1995-6#5)(1995-8#3)(1995-9#2)(1996-10#1)(1996-11#3)(1996-12#2)(1996-2#4)(1996-3#1)(1996-4#8)(1996-5#7)(1996-6#1)(1996-7#2)(1996-8#2)(1997-1#6)(1997-2#5)(1997-4#4)(1997-6#1)(1997-7#5)(2004-12#4)(2004-4#3)(2005-11#8)(2006-10#6)(2006-11#2)(2006-12#16)(2006-2#1)(2006-3#2)(2006-5#1)(2006-6#1)(2006-8#2)(2007-1#3)(2007-10#2)(2007-11#4)(2007-12#8)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-9#3)(2008-1#2)(2008-10#55)(2008-11#28)(2008-12#1)(2008-2#16)(2008-3#9)(2008-4#8)(2008-5#6)(2008-6#4)(2008-7#12)(2008-8#14)(2008-9#6)(2009-12#1)(2009-2#1)(2009-7#4)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#3)(2011-2#10)(2011-7#1)(2012-1#4)(2012-12#4)(2012-2#1)(2013-1#7)(2013-7#1)(2013-8#6)
transformed)##2##1##(1995-12#1)(2008-9#1)
transformer and##2##2##(2007-12#1)(2008-2#1)
transformer oil##5##2##(2008-10#5)
transformer##21##1##(1993-7#1)(2007-11#1)(2007-12#4)(2008-1#2)(2008-10#8)(2008-2#2)(2008-3#3)
transformer-2##5##1##(2007-12#5)
transforming DNA##6##2##(1990-5#1)(1993-11#2)(1997-2#1)(2008-10#2)
transforming a##5##2##(1991-7#1)(2007-11#2)(2008-10#1)(2008-3#1)
transforming activity##9##2##(1990-10#1)(1991-9#1)(1992-7#2)(1993-11#1)(1994-8#1)(1996-5#1)(2008-5#1)(2010-4#1)
transforming an##3##2##(2007-12#1)(2008-11#1)(2008-2#1)
transforming data##2##2##(2008-4#1)(2012-12#1)
transforming domain of##2##3##(1991-10#2)
transforming domains##2##2##(1991-10#2)
transforming factor##2##2##(1992-11#1)(2009-2#1)
transforming functions##2##2##(1991-10#1)(1993-9#1)
transforming gene##3##2##(1991-6#1)(1993-9#1)(1994-12#1)
transforming growth factor (TGF) beta##2##5##(1996-5#1)(2011-2#1)
transforming growth factor (TGF)##3##4##(1996-5#1)(2007-9#1)(2011-2#1)
transforming growth factor (TGF)-beta 1##2##5##(1993-9#1)(1995-3#1)
transforming growth factor (TGF)-beta##5##4##(1992-9#1)(1993-9#1)(1995-3#1)(2008-11#2)
transforming growth factor (TGF)-beta1##2##4##(2008-5#1)(2010-12#1)
transforming growth factor (TGF)-β##2##4##(2011-2#1)(2012-2#1)
transforming growth factor alpha (TGF alpha)##4##6##(1990-3#1)(1992-12#1)(1992-8#1)(1993-7#1)
transforming growth factor alpha (TGF##5##5##(1990-3#1)(1992-12#1)(1992-8#1)(1993-7#1)(1997-1#1)
transforming growth factor alpha in human##2##6##(1990-3#1)(1992-8#1)
transforming growth factor alpha##12##4##(1990-3#2)(1992-12#1)(1992-8#2)(1992-9#1)(1993-3#1)(1993-7#1)(1997-1#1)(2008-5#1)(2008-7#1)(2011-2#1)
transforming growth factor beta (TGF beta)##3##6##(1991-12#1)(1992-9#1)(1996-4#1)
transforming growth factor beta (TGF-beta) and##2##6##(1993-12#1)(2008-1#1)
transforming growth factor beta (TGF-beta) on##2##6##(1991-4#1)(2008-12#1)
transforming growth factor beta (TGF-beta)##11##5##(1991-4#2)(1993-12#1)(1995-2#1)(1995-8#1)(1996-11#1)(2008-1#2)(2008-11#2)(2008-12#1)
transforming growth factor beta 1 in##2##6##(1990-8#1)(1995-5#1)
transforming growth factor beta 1##5##5##(1990-8#2)(1993-9#1)(1995-5#1)(2011-1#1)
transforming growth factor beta##34##4##(1990-5#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#3)(1991-12#1)(1991-4#2)(1992-9#1)(1993-12#3)(1993-9#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-11#1)(1996-4#1)(2007-8#1)(2008-1#2)(2008-11#3)(2008-12#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)
transforming growth factor beta-1##3##4##(1993-7#1)(1995-2#1)(2009-4#1)
transforming growth factor beta1##2##4##(2008-5#1)(2008-8#1)
transforming growth factor type beta (TGF-beta)##2##6##(1991-1#2)
transforming growth factor type beta##3##5##(1991-1#2)(1992-8#1)
transforming growth factor type##4##4##(1990-8#1)(1991-1#2)(1992-8#1)
transforming growth factor##82##3##(1990-3#2)(1990-5#1)(1990-8#3)(1990-9#1)(1991-1#3)(1991-10#3)(1991-12#1)(1991-2#1)(1991-4#2)(1992-12#1)(1992-8#3)(1992-9#3)(1993-12#3)(1993-3#1)(1993-7#3)(1993-9#2)(1994-10#1)(1995-2#6)(1995-3#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-1#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#5)(2008-12#1)(2008-5#3)(2008-7#1)(2008-8#2)(2009-3#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#3)
transforming growth factor-alpha (TGF-alpha)##2##4##(1990-9#1)(1993-9#1)
transforming growth factor-alpha##6##3##(1990-7#1)(1990-9#1)(1992-8#1)(1993-9#1)(1994-10#1)(1997-7#1)
transforming growth factor-beta (TGF-beta) is a##2##6##(1991-10#1)(1992-11#1)
transforming growth factor-beta (TGF-beta) on##2##5##(1990-12#1)(2008-11#1)
transforming growth factor-beta (TGF-beta) type##2##5##(1992-11#1)(1993-3#1)
transforming growth factor-beta (TGF-beta)##15##4##(1990-10#1)(1990-12#1)(1990-2#1)(1991-10#1)(1992-11#2)(1993-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-5#1)(2006-10#1)(2008-11#2)(2009-3#1)
transforming growth factor-beta 1 (TGF-beta 1)##3##6##(1991-12#1)(1992-3#1)(1994-11#1)
transforming growth factor-beta 1##9##4##(1990-2#2)(1991-12#1)(1992-3#2)(1994-11#2)(1995-2#2)
transforming growth factor-beta and##2##4##(2006-10#1)(2008-9#1)
transforming growth factor-beta could##2##4##(1993-12#2)
transforming growth factor-beta receptor type II##3##6##(2007-12#3)
transforming growth factor-beta receptor##4##4##(1995-3#1)(2007-12#3)
transforming growth factor-beta type II receptor##2##6##(1993-3#1)(1996-5#1)
transforming growth factor-beta type##3##4##(1992-11#1)(1993-3#1)(1996-5#1)
transforming growth factor-beta##54##3##(1990-10#1)(1990-12#1)(1990-2#3)(1991-10#2)(1991-12#1)(1991-4#1)(1992-11#3)(1992-2#1)(1992-3#2)(1992-4#1)(1993-12#5)(1993-3#2)(1993-6#1)(1994-11#2)(1994-8#2)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#2)(1996-5#2)(1997-6#1)(2005-8#1)(2006-10#3)(2007-12#3)(2008-11#2)(2008-6#1)(2008-9#2)(2009-3#1)(2009-9#1)(2013-1#1)
transforming growth factor-beta1 (TGF-beta1) in##2##5##(1996-5#1)(2007-9#1)
transforming growth factor-beta1 (TGF-beta1)##3##4##(1996-5#1)(1997-6#1)(2007-9#1)
transforming growth factor-beta1##12##3##(1996-5#1)(1997-6#1)(2006-9#5)(2007-11#1)(2007-9#2)(2009-2#1)(2013-1#1)
transforming growth factor-β (TGF-β)##3##4##(2012-12#3)
transforming growth factor-β##7##3##(2012-1#1)(2012-12#6)
transforming growth##169##2##(1990-10#1)(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#3)(1991-10#5)(1991-12#2)(1991-2#1)(1991-4#3)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-8#4)(1992-9#3)(1993-12#8)(1993-3#3)(1993-6#1)(1993-7#3)(1993-9#3)(1994-10#2)(1994-11#2)(1994-2#1)(1994-8#2)(1995-11#2)(1995-12#2)(1995-2#8)(1995-3#3)(1995-5#1)(1995-8#1)(1996-11#1)(1996-4#1)(1996-5#4)(1996-8#1)(1997-1#1)(1997-6#2)(1997-7#1)(2005-8#1)(2006-10#5)(2006-9#6)(2007-11#2)(2007-12#3)(2007-8#1)(2007-9#3)(2008-1#2)(2008-11#7)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#8)(2012-2#3)(2013-1#3)
transforming plasmid##3##2##(2008-10#2)(2008-4#1)
transforming properties##2##2##(1992-9#1)(2008-2#1)
transforming the lives of##2##4##(2006-10#1)(2007-2#1)
transforming the##17##2##(1993-9#1)(1994-3#1)(1996-12#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-7#2)(2008-8#1)(2010-8#1)
transforming vectors##2##2##(2008-10#2)
transforming##283##1##(1990-10#2)(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#3)(1990-7#2)(1990-8#5)(1990-9#2)(1991-1#3)(1991-10#10)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#3)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#2)(1992-11#7)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-7#3)(1992-8#4)(1992-9#5)(1993-11#4)(1993-12#8)(1993-2#1)(1993-3#3)(1993-6#1)(1993-7#3)(1993-9#8)(1994-10#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#4)(1995-11#2)(1995-12#2)(1995-2#10)(1995-3#4)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#6)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#2)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#6)(2006-12#1)(2006-9#7)(2007-10#1)(2007-11#5)(2007-12#4)(2007-2#1)(2007-3#1)(2007-8#3)(2007-9#5)(2008-1#2)(2008-10#11)(2008-11#8)(2008-12#1)(2008-2#9)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#4)(2009-2#3)(2009-3#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#10)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
transforms a##4##2##(1992-8#1)(2007-8#1)(2008-3#1)(2008-9#1)
transforms and##8##2##(2008-2#6)(2008-3#1)(2008-7#1)
transforms for##3##2##(2008-2#1)(2008-7#2)
transforms in##2##2##(2008-3#1)(2012-1#1)
transforms into##3##2##(1993-6#1)(2007-12#1)(2008-8#1)
transforms of the##2##3##(2008-2#1)(2008-3#1)
transforms of##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2010-7#1)
transforms on##2##2##(2007-11#1)(2008-3#1)
transforms the##11##2##(1990-9#1)(1994-12#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-10#1)(2006-10#1)(2008-2#1)(2008-3#2)(2012-3#1)
transforms to the##2##3##(2008-10#1)(2008-2#1)
transforms to##3##2##(1995-6#1)(2008-10#1)(2008-2#1)
transforms with##3##2##(1996-11#1)(2008-2#2)
transforms##81##1##(1990-9#1)(1991-7#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-6#1)(1996-11#1)(1997-2#1)(1997-6#1)(1997-7#1)(2004-4#1)(2005-10#1)(2006-10#2)(2007-11#1)(2007-12#7)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#23)(2008-3#13)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2010-4#2)(2010-7#1)(2011-1#1)(2012-1#1)(2012-3#1)
transformylase-IMP cyclohydrolase##2##2##(1994-11#2)
transfrontal approach##2##2##(2006-12#2)
transfrontal##3##1##(2006-12#2)(2008-7#1)
transfrontier knowledge translation&quot##2##3##(2011-1#2)
transfrontier knowledge##3##2##(2011-1#3)
transfrontier##4##1##(2011-1#4)
transfuse##4##1##(1996-9#1)(2006-10#2)(2010-11#1)
transfused and##2##2##(2007-7#1)(2012-2#1)
transfused in the##4##3##(1994-9#1)(2007-9#2)(2011-2#1)
transfused patients##3##2##(1994-3#1)(2011-2#1)(2012-2#1)
transfused with##8##2##(1993-9#1)(1994-12#3)(1994-6#2)(1994-9#1)(2005-12#1)
transfused##40##1##(1990-12#1)(1991-8#2)(1992-3#1)(1992-6#3)(1993-2#1)(1993-9#3)(1994-12#4)(1994-3#1)(1994-6#2)(1994-9#5)(1996-3#1)(1996-9#1)(1997-5#1)(2005-12#2)(2006-10#1)(2007-12#1)(2007-7#1)(2007-9#2)(2011-12#1)(2011-2#2)(2012-2#3)(2013-1#1)
transfusion after##2##2##(2006-10#1)(2007-9#1)
transfusion and their##2##3##(2005-10#1)(2013-7#1)
transfusion and##18##2##(1996-3#1)(1996-9#1)(2004-10#1)(2005-10#1)(2006-7#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
transfusion associated##3##2##(1995-9#1)(2008-10#2)
transfusion at##2##2##(1995-6#1)(2005-12#1)
transfusion case##2##2##(1996-11#1)(1996-12#1)
transfusion dependent##2##2##(2005-12#2)
transfusion during##6##2##(2005-9#1)(2006-10#1)(2006-12#1)(2008-1#1)(2010-12#1)(2012-2#1)
transfusion events##2##2##(2005-12#1)(2011-2#1)
transfusion for##2##2##(1990-3#1)(2007-9#1)
transfusion in one##2##3##(2006-12#1)(2008-1#1)
transfusion in the##2##3##(1994-9#1)(2007-7#1)
transfusion in##19##2##(1990-2#1)(1990-8#1)(1994-9#1)(1995-12#1)(1996-9#2)(1997-5#1)(1997-8#1)(2006-12#1)(2007-2#1)(2007-7#3)(2008-1#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#2)
transfusion independence##2##2##(2008-5#2)
transfusion is an essential##2##4##(2006-10#1)(2011-1#1)
transfusion is often##3##3##(2013-1#3)
transfusion is##8##2##(1991-11#1)(1996-9#1)(2006-10#1)(2007-4#1)(2011-1#1)(2013-1#3)
transfusion medicine##4##2##(2006-10#1)(2008-10#1)(2010-11#1)(2011-1#1)
transfusion medicine]##2##2##(2008-10#2)
transfusion must be##2##3##(2007-7#1)(2010-12#1)
transfusion of blood products and##2##5##(2006-10#1)(2006-2#1)
transfusion of blood products##3##4##(2006-10#2)(2006-2#1)
transfusion of blood##6##3##(2006-10#2)(2006-2#1)(2007-11#1)(2007-9#1)(2008-12#1)
transfusion of##17##2##(1990-2#1)(1993-6#1)(1994-12#1)(1996-9#1)(2005-10#1)(2006-10#3)(2006-2#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-12#1)(2010-7#1)(2013-1#1)(2013-8#1)
transfusion or##4##2##(1993-2#1)(2006-10#1)(2009-5#1)(2011-2#1)
transfusion practice in##2##3##(2006-12#1)(2008-12#1)
transfusion practice##7##2##(2006-10#1)(2006-12#1)(2006-4#1)(2008-12#2)(2009-4#1)(2010-12#1)
transfusion protocols##2##2##(2012-2#1)(2012-3#1)
transfusion reaction##6##2##(1993-6#1)(1993-9#1)(1994-12#1)(1994-9#1)(2012-2#2)
transfusion reactions were##2##3##(1994-12#1)(2005-12#1)
transfusion reactions##7##2##(1993-9#1)(1994-12#2)(1994-3#1)(1997-1#1)(2005-12#1)(2012-12#1)
transfusion recipients##2##2##(1990-5#1)(2006-2#1)
transfusion requirements in##4##3##(1996-9#1)(2007-9#1)(2008-3#2)
transfusion requirements##14##2##(1996-9#1)(2007-2#3)(2007-8#2)(2007-9#1)(2008-3#2)(2008-7#2)(2009-5#1)(2013-8#2)
transfusion response##2##2##(2011-2#2)
transfusion strategy##2##2##(2006-10#1)(2012-2#1)
transfusion therapy and##2##3##(1990-11#1)(2012-3#1)
transfusion therapy##9##2##(1990-11#3)(2007-8#1)(2012-3#1)(2013-1#4)
transfusion to##2##2##(1996-6#1)(2006-10#1)
transfusion volume &gt##2##3##(2011-2#2)
transfusion was##3##2##(1992-3#1)(2011-2#1)(2012-2#1)
transfusion were##5##2##(1994-12#2)(2007-9#1)(2013-1#2)
transfusion##284##1##(1990-11#4)(1990-2#2)(1990-3#3)(1990-5#1)(1990-8#4)(1991-11#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#3)(1992-9#2)(1993-2#2)(1993-6#2)(1993-9#3)(1994-12#10)(1994-3#2)(1994-6#1)(1994-9#4)(1995-12#3)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-3#3)(1996-6#2)(1996-9#11)(1997-1#1)(1997-5#3)(1997-8#1)(2004-10#2)(2005-10#2)(2005-12#7)(2005-9#1)(2006-10#17)(2006-12#4)(2006-2#2)(2006-4#2)(2006-6#2)(2006-7#2)(2007-11#3)(2007-12#2)(2007-2#5)(2007-4#1)(2007-7#12)(2007-8#14)(2007-9#7)(2008-1#3)(2008-10#8)(2008-11#1)(2008-12#6)(2008-3#3)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#2)(2009-3#2)(2009-4#1)(2009-5#2)(2010-11#3)(2010-12#4)(2010-2#2)(2010-7#2)(2011-1#4)(2011-12#2)(2011-2#15)(2011-8#1)(2012-12#1)(2012-2#13)(2012-3#3)(2013-1#27)(2013-7#1)(2013-8#5)
transfusion)##2##1##(1994-12#1)(2008-7#1)
transfusion-associated non-A##2##2##(1992-12#1)(2009-2#1)
transfusion-associated##7##1##(1992-12#1)(1996-6#1)(2005-10#1)(2005-12#1)(2006-2#1)(2009-2#1)(2012-12#1)
transfusion-dependent##2##1##(2008-3#1)(2010-8#1)
transfusion-related##3##1##(2005-10#1)(2008-1#1)(2011-2#1)
transfusion-transmitted viral infections##2##3##(2005-10#1)(2009-3#1)
transfusion-transmitted viral##3##2##(2005-10#2)(2009-3#1)
transfusion-transmitted virus##3##2##(2006-10#2)(2006-2#1)
transfusion-transmitted##10##1##(2005-10#2)(2006-10#2)(2006-2#1)(2009-3#1)(2012-12#2)(2012-2#2)
transfusional##2##1##(1993-6#1)(2013-8#1)
transfusions after##2##2##(1992-6#1)(2007-8#1)
transfusions and the##2##3##(2008-1#1)(2012-2#1)
transfusions and##10##2##(1990-5#1)(2006-10#1)(2007-8#1)(2008-1#3)(2008-8#1)(2010-12#1)(2012-2#2)
transfusions are##3##2##(1991-11#1)(1996-3#1)(2007-4#1)
transfusions at##2##2##(1994-12#1)(2009-4#1)
transfusions during##3##2##(2008-1#1)(2008-7#2)
transfusions has##2##2##(1990-11#1)(1990-2#1)
transfusions in patients with##2##4##(2010-9#1)(2011-2#1)
transfusions in##6##2##(1990-3#1)(1990-5#1)(2008-10#1)(2010-4#1)(2010-9#1)(2011-2#1)
transfusions of packed red##2##4##(2010-8#1)(2013-1#1)
transfusions of##5##2##(1990-2#1)(2010-8#2)(2013-1#1)(2013-8#1)
transfusions on the##2##3##(1995-6#1)(2012-2#1)
transfusions on##3##2##(1995-6#1)(2009-4#1)(2012-2#1)
transfusions to##5##2##(1990-3#1)(1995-12#1)(2006-10#2)(2009-4#1)
transfusions were##4##2##(1992-12#1)(1994-9#1)(1996-3#1)(2011-2#1)
transfusions without##2##2##(1995-3#1)(2008-3#1)
transfusions##97##1##(1990-11#2)(1990-2#3)(1990-3#4)(1990-5#2)(1990-8#1)(1991-11#1)(1991-3#2)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#2)(1993-8#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-12#3)(1996-3#5)(1997-1#1)(2005-10#2)(2005-12#1)(2005-8#1)(2006-10#4)(2006-4#1)(2006-6#1)(2007-11#1)(2007-4#2)(2007-7#1)(2007-8#4)(2008-1#5)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-4#5)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-2#7)(2012-2#4)(2013-1#2)(2013-8#2)
transgastric peritoneoscopy##2##2##(2009-8#2)
transgastric##5##1##(2008-3#1)(2009-8#2)(2010-12#2)
transgender adults and their##2##4##(2008-12#2)
transgender communities##2##2##(2006-11#1)(2008-12#1)
transgender people##2##2##(2008-12#2)
transgender##13##1##(2006-11#2)(2008-12#9)(2009-7#1)(2012-3#1)
transgene and to##2##3##(1995-8#1)(2012-12#1)
transgene and##6##2##(1995-8#1)(2005-6#1)(2006-11#1)(2008-10#1)(2008-2#1)(2012-12#1)
transgene carried##2##2##(1995-5#1)(2006-12#1)
transgene could##2##2##(2005-6#1)(2008-9#1)
transgene expression and##4##3##(1997-8#1)(2005-7#1)(2006-12#1)(2007-12#1)
transgene expression by##3##3##(2006-12#1)(2007-12#1)(2010-4#1)
transgene expression from##5##3##(2007-12#4)(2009-10#1)
transgene expression in the##3##4##(2009-10#1)(2012-12#2)
transgene expression in##8##3##(1994-3#1)(2006-12#1)(2009-10#2)(2011-1#1)(2012-1#1)(2012-12#2)
transgene expression was##2##3##(1994-3#1)(2012-1#1)
transgene expression##46##2##(1993-2#1)(1994-3#4)(1995-2#1)(1997-1#1)(1997-4#1)(1997-8#1)(2005-7#1)(2006-12#4)(2007-12#7)(2008-11#2)(2008-2#4)(2008-4#2)(2008-5#1)(2009-10#7)(2010-4#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)
transgene flow##3##2##(2008-10#1)(2010-10#1)(2011-2#1)
transgene frequency##2##2##(2008-8#2)
transgene in a##2##3##(2006-12#1)(2008-8#1)
transgene in the##2##3##(1993-2#1)(2008-10#1)
transgene in##10##2##(1991-5#1)(1993-2#1)(1995-12#1)(1995-2#1)(1997-4#1)(2006-12#1)(2008-10#3)(2008-8#1)
transgene insertion##2##2##(1990-8#1)(2010-10#1)
transgene integration##4##2##(1995-2#1)(2008-11#3)
transgene is##2##2##(1996-12#1)(2008-10#1)
transgene loci##3##2##(1993-2#1)(1993-6#1)(2006-12#1)
transgene on##2##2##(2006-11#1)(2006-12#1)
transgene product in##2##3##(2008-10#1)(2009-10#1)
transgene product##3##2##(2008-10#2)(2009-10#1)
transgene silencing##2##2##(2006-12#2)
transgene transcript##2##2##(2008-10#2)
transgene transmission##2##2##(2008-12#2)
transgene was expressed##2##3##(1995-2#1)(2007-3#1)
transgene was##9##2##(1990-8#1)(1995-1#1)(1995-2#1)(2006-12#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-8#1)(2012-2#1)
transgene##180##1##(1990-12#1)(1990-8#2)(1991-11#2)(1991-5#1)(1992-5#1)(1993-2#4)(1993-6#2)(1994-3#6)(1994-8#1)(1995-1#2)(1995-11#4)(1995-12#2)(1995-2#5)(1995-5#1)(1995-8#3)(1996-10#1)(1996-12#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-4#6)(1997-6#1)(1997-8#1)(2004-1#1)(2005-6#2)(2005-7#1)(2006-11#3)(2006-12#16)(2007-11#1)(2007-12#7)(2007-3#1)(2008-10#26)(2008-11#10)(2008-12#3)(2008-2#5)(2008-4#3)(2008-5#1)(2008-8#8)(2008-9#1)(2009-10#10)(2009-6#1)(2009-8#2)(2010-10#3)(2010-12#2)(2010-4#2)(2011-1#2)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#2)
transgene-mediated##2##1##(2008-10#2)
transgene-transgene junctions##2##2##(1993-6#2)
transgenerational marking##2##2##(2010-8#2)
transgenerational##3##1##(2010-8#2)(2011-1#1)
transgenes and##4##2##(1994-5#1)(2008-11#1)(2008-9#2)
transgenes can##4##2##(1995-8#2)(2008-10#1)(2011-1#1)
transgenes could##2##2##(2008-8#1)(2008-9#1)
transgenes in the##3##3##(2006-12#3)
transgenes in##9##2##(1993-6#2)(1994-5#1)(2006-12#4)(2008-2#1)(2012-3#1)
transgenes into##2##2##(1994-3#1)(2008-4#1)
transgenes is##2##2##(1995-2#1)(2009-10#1)
transgenes to##4##2##(1995-8#1)(1996-10#1)(2006-12#1)(2008-4#1)
transgenes were##2##2##(2006-12#1)(2008-5#1)
transgenes##55##1##(1993-6#2)(1994-3#1)(1994-5#2)(1995-2#2)(1995-8#3)(1996-10#2)(1997-4#1)(2006-10#1)(2006-12#12)(2007-12#1)(2008-10#2)(2008-11#4)(2008-2#3)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#4)(2009-10#1)(2010-12#2)(2011-1#1)(2011-12#3)(2012-3#2)(2013-1#1)
transgenesis and##2##2##(2008-4#1)(2008-7#1)
transgenesis##10##1##(1993-2#1)(1995-8#1)(2008-11#1)(2008-4#3)(2008-7#1)(2012-3#3)
transgenic Arabidopsis##5##2##(1994-3#1)(1996-12#1)(2006-12#1)(2008-10#1)(2009-8#1)
transgenic Drosophila##4##2##(1993-12#1)(1995-8#1)(2008-9#1)(2013-1#1)
transgenic N##2##2##(2008-10#1)(2012-3#1)
transgenic Nicotiana##3##2##(1993-5#1)(2008-10#2)
transgenic analyses##2##2##(2008-8#1)(2009-8#1)
transgenic and##10##2##(1994-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-9#1)(2009-4#1)(2010-7#1)
transgenic animal models##2##3##(1993-11#1)(2007-11#1)
transgenic animals and##4##3##(2005-6#1)(2005-8#1)(2008-11#1)(2013-8#1)
transgenic animals are##2##3##(1993-2#1)(1994-5#1)
transgenic animals by##2##3##(1992-8#1)(1994-5#1)
transgenic animals##31##2##(1992-11#1)(1992-8#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-5#4)(1994-8#1)(1995-1#2)(1995-2#1)(1995-6#1)(1995-8#2)(2005-6#1)(2005-8#1)(2006-12#1)(2007-11#1)(2008-11#2)(2008-4#1)(2008-7#3)(2013-8#1)
transgenic approach to##2##3##(2006-12#1)(2009-8#1)
transgenic approach##5##2##(1996-3#1)(2006-12#1)(2008-4#2)(2009-8#1)
transgenic approaches##2##2##(2012-11#2)
transgenic cell##2##2##(1993-9#1)(2008-10#1)
transgenic chloroplasts##3##2##(2006-12#3)
transgenic common carp Cyprinus carpio##2##5##(2010-8#2)
transgenic control##2##2##(2008-10#1)(2008-8#1)
transgenic cotton##3##2##(2006-12#2)(2011-2#1)
transgenic embryos##2##2##(1994-12#1)(1994-3#1)
transgenic events##2##2##(2006-12#2)
transgenic expression of##2##3##(2008-10#1)(2008-8#1)
transgenic expression##5##2##(1993-9#1)(2005-6#1)(2008-10#1)(2008-7#1)(2008-8#1)
transgenic females##3##2##(1993-12#2)(1995-2#1)
transgenic flies##5##2##(1993-9#1)(1994-3#1)(1995-6#1)(1997-2#1)(2008-8#1)
transgenic for##5##2##(1991-8#1)(1993-11#1)(1995-2#1)(2006-11#1)(2008-8#1)
transgenic hybrids##2##2##(2008-10#2)
transgenic hypovirulent strain##2##3##(2008-10#2)
transgenic hypovirulent strains##4##3##(2008-10#4)
transgenic hypovirulent##6##2##(2008-10#6)
transgenic indica rice##2##3##(2006-12#2)
transgenic line##10##2##(1990-11#1)(2006-12#5)(2008-10#4)
transgenic lines compared##2##3##(2006-12#1)(2008-10#1)
transgenic lines expressing##2##3##(2006-12#1)(2008-10#1)
transgenic lines in the##2##4##(1994-8#1)(1995-10#1)
transgenic lines in##3##3##(1994-8#1)(1995-10#1)(2008-10#1)
transgenic lines that##2##3##(1995-10#1)(1995-8#1)
transgenic lines were obtained##2##4##(2008-10#1)(2008-8#1)
transgenic lines were##7##3##(2008-10#5)(2008-8#1)(2009-10#1)
transgenic lines with##2##3##(2008-10#1)(2008-8#1)
transgenic lines##41##2##(1994-8#1)(1995-10#2)(1995-8#1)(1996-3#1)(1996-6#2)(2006-12#7)(2008-10#18)(2008-12#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-8#2)(2012-3#1)
transgenic livestock##4##2##(1995-2#1)(2008-11#3)
transgenic maize plants##4##3##(2006-12#1)(2008-8#3)
transgenic maize##9##2##(1995-6#1)(2006-12#3)(2008-10#1)(2008-8#3)(2011-2#1)
transgenic mice and in##2##4##(2007-3#1)(2011-2#1)
transgenic mice and their##2##4##(1992-11#1)(1993-5#1)
transgenic mice and##13##3##(1990-8#1)(1992-11#1)(1993-5#1)(1995-6#1)(1995-8#2)(2007-10#1)(2007-3#1)(2008-11#1)(2008-4#1)(2009-4#1)(2011-2#1)(2013-1#1)
transgenic mice are##3##3##(1990-8#1)(1993-2#1)(2008-4#1)
transgenic mice bearing##2##3##(1990-5#1)(2007-3#1)
transgenic mice but not##2##4##(1995-2#1)(1995-8#1)
transgenic mice by##2##3##(1991-5#1)(2008-2#1)
transgenic mice carrying multiple copies of the human S100 beta gene##2##11##(1993-12#1)(1993-5#1)
transgenic mice carrying multiple copies of the human##3##8##(1993-12#1)(1993-5#2)
transgenic mice carrying the##2##4##(1992-7#1)(1994-2#1)
transgenic mice carrying##7##3##(1990-8#1)(1992-7#1)(1993-12#1)(1993-5#2)(1994-2#2)
transgenic mice expressing a##2##4##(1995-2#1)(2008-4#1)
transgenic mice expressing constitutively##2##4##(1996-2#1)(1997-7#1)
transgenic mice expressing##9##3##(1994-8#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-7#1)(2005-7#1)(2008-4#2)(2013-8#1)
transgenic mice for##3##3##(2008-11#1)(2008-4#1)(2009-8#1)
transgenic mice in##4##3##(1995-8#1)(1997-4#1)(2008-4#2)
transgenic mice is##2##3##(1995-1#1)(2009-9#1)
transgenic mice overexpressing the human##3##5##(1992-8#2)(2007-1#1)
transgenic mice overexpressing##5##3##(1992-8#2)(1997-7#1)(2007-1#1)(2007-12#1)
transgenic mice revealed##2##3##(1995-6#1)(2012-2#1)
transgenic mice showed##3##3##(1994-6#1)(1997-7#1)(2008-9#1)
transgenic mice that express##4##4##(1992-11#1)(1994-6#1)(1994-9#1)(1997-7#1)
transgenic mice that##11##3##(1991-11#1)(1992-11#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-4#1)(1997-7#1)
transgenic mice using##4##3##(1994-8#1)(1996-6#1)(1997-5#1)(2008-4#1)
transgenic mice was generated##2##4##(1990-5#1)(2007-10#1)
transgenic mice was##4##3##(1990-11#1)(1990-5#1)(1995-1#1)(2007-10#1)
transgenic mice were produced##2##4##(1991-8#1)(1996-12#1)
transgenic mice were##6##3##(1991-8#1)(1996-10#1)(1996-12#1)(2008-9#2)(2011-2#1)
transgenic mice with##5##3##(1993-2#1)(1995-8#1)(1997-4#1)(2008-11#1)(2012-2#1)
transgenic mice##220##2##(1990-11#3)(1990-12#1)(1990-5#3)(1990-8#5)(1991-11#1)(1991-5#4)(1991-8#1)(1992-11#4)(1992-12#1)(1992-7#3)(1992-8#2)(1993-11#2)(1993-12#4)(1993-2#5)(1993-4#3)(1993-5#4)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#6)(1994-5#1)(1994-6#4)(1994-8#4)(1994-9#5)(1995-1#5)(1995-10#2)(1995-11#2)(1995-12#3)(1995-2#9)(1995-6#6)(1995-8#12)(1996-10#4)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#2)(1996-8#1)(1996-9#3)(1997-4#7)(1997-5#5)(1997-7#6)(2005-11#1)(2005-7#1)(2007-1#1)(2007-10#5)(2007-11#1)(2007-12#1)(2007-3#2)(2008-10#1)(2008-11#6)(2008-2#2)(2008-4#16)(2008-9#6)(2009-10#2)(2009-4#1)(2009-8#3)(2009-9#1)(2010-11#2)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#3)
transgenic model##6##2##(1990-11#1)(1991-11#1)(1995-2#1)(2006-12#1)(2007-3#1)(2007-5#1)
transgenic models##2##2##(2008-4#1)(2008-7#1)
transgenic mosquitoes##3##2##(2008-11#3)
transgenic mouse embryos##5##3##(1992-5#1)(1996-3#2)(1997-6#2)
transgenic mouse model for##4##4##(1995-2#1)(1995-6#1)(1996-11#1)(1997-4#1)
transgenic mouse model of##4##4##(1995-8#1)(1996-5#1)(2008-10#1)(2013-8#1)
transgenic mouse model##12##3##(1994-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-5#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-8#1)(2013-8#1)
transgenic mouse models##3##3##(1996-10#1)(2005-8#1)(2008-9#1)
transgenic mouse##30##2##(1992-5#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-1#2)(1995-11#3)(1995-2#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-3#3)(1996-5#1)(1997-4#2)(1997-6#2)(2005-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-8#1)(2013-8#1)
transgenic or##3##2##(2008-4#2)(2011-2#1)
transgenic organisms##2##2##(2006-12#1)(2008-8#1)
transgenic overexpression##2##2##(2005-11#1)(2011-2#1)
transgenic plant lines##2##3##(2006-12#1)(2008-10#1)
transgenic plant was##2##3##(2007-1#1)(2008-9#1)
transgenic plant##13##2##(2006-12#1)(2007-1#1)(2007-11#1)(2008-10#4)(2008-5#1)(2008-7#2)(2008-9#3)
transgenic plantlets##4##2##(2006-12#1)(2008-9#3)
transgenic plants and##2##3##(2006-12#1)(2013-8#1)
transgenic plants are##2##3##(2008-10#1)(2013-8#1)
transgenic plants as##2##3##(2006-12#1)(2012-2#1)
transgenic plants carrying##2##3##(1997-4#1)(2006-12#1)
transgenic plants could be##2##4##(2008-10#1)(2008-8#1)
transgenic plants expressing a##4##4##(2006-12#1)(2008-10#2)(2009-8#1)
transgenic plants expressing the##3##4##(1997-6#1)(2008-10#2)
transgenic plants expressing##10##3##(1997-6#1)(2006-12#1)(2008-10#5)(2009-8#2)(2011-10#1)
transgenic plants for##2##3##(2006-11#1)(2006-12#1)
transgenic plants was##4##3##(2006-12#1)(2008-10#2)(2008-8#1)
transgenic plants with##3##3##(1997-2#1)(2006-12#1)(2008-10#1)
transgenic plants##76##2##(1991-7#1)(1994-3#3)(1995-6#1)(1995-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-11#1)(2006-12#15)(2006-4#1)(2007-1#1)(2007-11#2)(2007-12#1)(2008-10#19)(2008-11#1)(2008-2#1)(2008-7#2)(2008-8#7)(2008-9#5)(2009-6#1)(2009-8#3)(2011-10#1)(2011-2#2)(2012-2#2)(2013-8#2)
transgenic potato plants##3##3##(1997-4#1)(2008-10#1)(2008-8#1)
transgenic potato##6##2##(1997-4#2)(2008-10#1)(2008-8#3)
transgenic proteins from genetically modified crops##2##6##(2006-12#2)
transgenic proteins##3##2##(2006-12#3)
transgenic rabbit##2##2##(1995-8#1)(2008-11#1)
transgenic rabbits was##2##3##(1994-8#1)(2008-11#1)
transgenic rabbits##8##2##(1994-8#2)(1995-8#1)(2008-11#2)(2008-12#3)
transgenic rats##5##2##(1990-11#1)(1996-5#1)(1997-7#1)(2006-6#1)(2008-11#1)
transgenic release##2##2##(2008-8#2)
transgenic resistance to##2##3##(2008-10#2)
transgenic resistance##3##2##(2008-10#3)
transgenic rice plants were##2##4##(2006-11#1)(2008-10#1)
transgenic rice plants##5##3##(2006-11#1)(2006-12#2)(2008-10#1)(2008-9#1)
transgenic rice variety Zhong 8215##2##5##(2008-9#2)
transgenic rice##18##2##(2006-11#3)(2006-12#4)(2008-10#1)(2008-12#2)(2008-8#1)(2008-9#7)
transgenic seeds##3##2##(2006-12#3)
transgenic soybean plants##3##3##(2008-10#2)(2012-11#1)
transgenic soybean##6##2##(2006-12#3)(2008-10#2)(2012-11#1)
transgenic soybeans##3##2##(2006-12#2)(2009-10#1)
transgenic studies##3##2##(1994-2#1)(1995-12#1)(1996-6#1)
transgenic technology##2##2##(2006-11#1)(2006-12#1)
transgenic tobacco and##2##3##(2006-11#1)(2006-12#1)
transgenic tobacco plants expressing##4##4##(1994-3#1)(1997-6#1)(2008-10#1)(2008-8#1)
transgenic tobacco plants##12##3##(1991-7#1)(1994-3#1)(1995-8#1)(1997-6#2)(2008-10#3)(2008-8#2)(2008-9#1)(2011-10#1)
transgenic tobacco protoplasts was##2##4##(2008-8#2)
transgenic tobacco protoplasts##3##3##(2008-8#3)
transgenic tobacco without##2##3##(2008-9#2)
transgenic tobacco##34##2##(1991-7#1)(1994-3#1)(1995-8#3)(1997-6#2)(2006-11#1)(2006-12#7)(2008-10#5)(2008-8#6)(2008-9#6)(2011-10#2)
transgenic tobaccos##3##2##(2008-8#1)(2008-9#2)
transgenic tomato##5##2##(2008-10#4)(2010-9#1)
transgenic wheat##2##2##(2006-12#1)(2011-10#1)
transgenic##764##1##(1990-11#6)(1990-12#1)(1990-5#4)(1990-8#5)(1991-11#2)(1991-5#4)(1991-7#2)(1991-8#2)(1992-11#5)(1992-12#1)(1992-5#1)(1992-7#3)(1992-8#5)(1993-11#5)(1993-12#9)(1993-2#7)(1993-4#3)(1993-5#6)(1993-6#1)(1993-9#3)(1994-10#2)(1994-11#2)(1994-12#4)(1994-2#7)(1994-3#9)(1994-5#6)(1994-6#4)(1994-8#11)(1994-9#5)(1995-1#9)(1995-10#5)(1995-11#5)(1995-12#4)(1995-2#16)(1995-6#11)(1995-8#24)(1996-10#5)(1996-11#2)(1996-12#5)(1996-2#2)(1996-3#6)(1996-4#1)(1996-5#7)(1996-6#5)(1996-8#1)(1996-9#3)(1997-2#2)(1997-4#15)(1997-5#6)(1997-6#5)(1997-7#8)(2005-11#3)(2005-6#2)(2005-7#1)(2005-8#2)(2006-10#1)(2006-11#13)(2006-12#87)(2006-4#2)(2006-6#2)(2007-1#3)(2007-10#5)(2007-11#7)(2007-12#2)(2007-3#3)(2007-5#1)(2008-1#1)(2008-10#97)(2008-11#24)(2008-12#8)(2008-2#5)(2008-3#1)(2008-4#30)(2008-5#3)(2008-7#11)(2008-8#37)(2008-9#42)(2009-10#4)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#11)(2009-9#3)(2010-10#1)(2010-11#2)(2010-2#2)(2010-5#2)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#1)(2011-10#4)(2011-2#17)(2012-1#2)(2012-11#3)(2012-12#5)(2012-2#6)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#10)
transgenically##3##1##(1997-4#1)(2008-10#1)(2010-11#1)
transgenics##7##1##(1995-2#1)(1996-5#1)(1996-6#1)(2007-11#1)(2008-11#1)(2008-2#1)(2010-8#1)
transglutaminase (TGase) could be##2##4##(1991-11#1)(2008-5#1)
transglutaminase (TGase)##5##2##(1990-7#1)(1991-11#1)(1992-9#1)(2008-1#1)(2008-5#1)
transglutaminase activity##6##2##(1990-12#2)(1992-8#2)(1994-9#1)(2008-5#1)
transglutaminase and##2##2##(1994-12#1)(2008-5#1)
transglutaminase gene expression##2##3##(1991-2#1)(1992-8#1)
transglutaminase gene##5##2##(1991-2#1)(1992-8#1)(1997-4#3)
transglutaminase in##5##2##(1990-12#1)(1994-12#1)(1994-9#2)(2008-5#1)
transglutaminase mRNA levels##2##3##(1992-8#2)
transglutaminase mRNA##3##2##(1992-8#3)
transglutaminase substrates##2##2##(1992-8#1)(1994-9#1)
transglutaminase was##3##2##(1990-12#1)(1994-9#2)
transglutaminase##68##1##(1990-12#8)(1990-5#2)(1990-7#1)(1991-11#2)(1991-2#2)(1992-8#12)(1992-9#1)(1993-11#1)(1994-11#3)(1994-12#2)(1994-9#11)(1995-2#3)(1997-4#5)(2006-10#3)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#5)(2008-9#1)(2010-4#3)
transglutaminase-catalyzed reactions##3##2##(1990-12#3)
transglutaminase-catalyzed##5##1##(1990-12#3)(1992-9#1)(2008-10#1)
transglutaminase-mediated##4##1##(1990-5#1)(1995-2#1)(2008-5#2)
transglycosylation##6##1##(1994-5#2)(1994-8#1)(1996-2#2)(2006-12#1)
transgressive segregation##5##2##(2008-10#5)
transgressive##6##1##(2008-10#6)
transhepatic cholecystoscopic lithotomy##2##3##(2008-5#2)
transhepatic##10##1##(2005-12#1)(2008-5#4)(2009-8#1)(2010-12#1)(2013-1#3)
transhydrogenation and ionization of water##2##5##(1993-12#2)
transhydrogenation##3##1##(1993-12#3)
transient (less than##2##3##(1990-11#1)(1990-5#1)
transient CH##6##2##(2006-9#6)
transient Horner's syndrome##2##3##(2007-8#1)(2013-1#1)
transient Horner's##3##2##(2007-8#1)(2008-8#1)(2013-1#1)
transient RasGAP##3##2##(2006-10#3)
transient [Ca2+]i##2##2##(1992-7#1)(1996-2#1)
transient absorption spectra of the##2##5##(2008-10#1)(2008-9#1)
transient absorption spectra of##4##4##(2005-4#1)(2008-10#1)(2008-9#2)
transient absorption spectroscopy##5##3##(1995-11#1)(1996-7#1)(1997-4#1)(2007-12#1)(2008-10#1)
transient absorption spectrum of##2##4##(2006-10#1)(2008-8#1)
transient absorption##24##2##(1994-11#1)(1995-11#1)(1996-7#1)(1997-4#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-3#3)(2008-8#1)(2008-9#2)(2011-1#2)
transient activation of##4##3##(1991-2#1)(1994-6#1)(1995-2#1)(2008-4#1)
transient and sustained##3##3##(1997-1#3)
transient and##33##2##(1990-12#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-4#1)(1992-7#1)(1994-8#1)(1994-9#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-1#3)(2006-8#1)(2007-11#3)(2007-9#1)(2008-1#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-2#1)(2012-11#2)(2013-1#1)(2013-7#1)
transient anemia and hepatitis##3##4##(2010-6#3)
transient apical##2##2##(2013-1#1)(2013-7#1)
transient assay in##2##3##(1992-11#1)(2008-10#1)
transient assay##3##2##(1992-11#1)(2006-12#1)(2008-10#1)
transient attention##3##2##(1997-1#3)
transient behavior##3##2##(2007-9#1)(2008-3#1)(2008-7#1)
transient bilateral##2##2##(1990-4#1)(1993-9#1)
transient but##2##2##(2008-7#1)(2012-2#1)
transient cerebral ischemia in mice##3##5##(1993-3#2)(2008-11#1)
transient cerebral ischemia in##4##4##(1990-7#1)(1993-3#2)(2008-11#1)
transient cerebral ischemia##12##3##(1990-7#1)(1993-3#2)(2007-9#1)(2008-11#1)(2010-12#7)
transient cerebral##13##2##(1990-7#1)(1993-3#2)(2007-9#1)(2008-11#1)(2008-7#1)(2010-12#7)
transient changes in##2##3##(1994-12#1)(2008-7#1)
transient changes##3##2##(1994-12#1)(2008-7#1)(2009-6#1)
transient chaotic##2##2##(2008-2#2)
transient compared##2##2##(1992-7#1)(1992-8#1)
transient component##2##2##(1996-1#2)
transient contraction##2##2##(1991-12#1)(1996-12#1)
transient cotransfection assays##2##3##(1993-12#1)(1994-11#1)
transient cotransfection##5##2##(1991-1#1)(1993-12#1)(1994-11#1)(1994-8#1)(2008-9#1)
transient cues##2##2##(2007-5#2)
transient currents##3##2##(1993-12#1)(2007-11#1)(2008-3#1)
transient decrease in##4##3##(1990-9#1)(1992-6#1)(2008-2#1)(2010-12#1)
transient decrease##6##2##(1990-9#1)(1992-6#1)(1993-4#1)(1997-7#1)(2008-2#1)(2010-12#1)
transient deformation##3##2##(2008-2#3)
transient deformations##3##2##(2008-2#3)
transient depolarizations##2##2##(1991-3#2)
transient drop##2##2##(1992-5#1)(2005-11#1)
transient dynamics of the##2##4##(2007-11#1)(2008-8#1)
transient dynamics##3##2##(2007-11#1)(2008-8#1)(2009-5#1)
transient effect##2##2##(2008-3#1)(2008-7#1)
transient effects##2##2##(1991-2#1)(2010-1#1)
transient electric birefringence##4##3##(1990-7#1)(1991-4#1)(1995-3#2)
transient electric##5##2##(1990-7#1)(1991-4#1)(1995-3#2)(2008-6#1)
transient elevation of##4##3##(1991-12#1)(1991-5#1)(2006-10#1)(2008-7#1)
transient evoked otoacoustic##2##3##(2006-8#1)(2008-1#1)
transient exposure##2##2##(1992-8#1)(2012-3#1)
transient expression assay##7##3##(1992-12#1)(1992-5#1)(1994-8#1)(1995-6#1)(1997-2#1)(1997-4#1)(2008-11#1)
transient expression experiments in##2##4##(1997-6#1)(2008-8#1)
transient expression experiments##3##3##(1994-9#1)(1997-6#1)(2008-8#1)
transient expression in COS cells##2##5##(1992-12#1)(1992-9#1)
transient expression in##4##3##(1992-12#1)(1992-9#1)(2008-2#1)(2008-4#1)
transient expression level##2##3##(2008-11#1)(2008-9#1)
transient expression of the##5##4##(1991-3#1)(1992-4#1)(1994-11#1)(2008-11#1)(2008-4#1)
transient expression of##16##3##(1991-3#1)(1991-7#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-9#1)(1994-11#1)(1994-2#1)(1997-4#1)(1997-7#1)(2008-11#1)(2008-4#2)(2008-9#1)(2009-4#1)(2010-11#1)
transient expression system##7##3##(1994-11#1)(2006-12#2)(2008-11#1)(2008-4#1)(2011-2#2)
transient expression##54##2##(1991-3#1)(1991-7#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(2006-12#2)(2008-1#1)(2008-11#6)(2008-2#3)(2008-4#4)(2008-5#1)(2008-8#1)(2008-9#3)(2009-4#2)(2010-11#1)(2011-2#2)(2011-3#1)
transient fluorescence##4##2##(1996-9#1)(2005-11#2)(2008-2#1)
transient focal ischemia##2##3##(2007-10#2)
transient focal##4##2##(1992-7#1)(2007-10#2)(2011-2#1)
transient forebrain ischemia for 5##2##5##(1994-5#1)(1997-1#1)
transient forebrain ischemia in the rat##3##6##(1991-11#2)(1996-12#1)
transient forebrain ischemia##11##3##(1990-5#1)(1991-11#3)(1994-5#1)(1996-12#3)(1997-1#1)(1997-7#2)
transient forebrain##12##2##(1990-5#1)(1991-11#3)(1994-5#1)(1996-1#1)(1996-12#3)(1997-1#1)(1997-7#2)
transient formation of##4##3##(1990-12#1)(1997-7#1)(2008-10#2)
transient gene expression in##3##4##(2008-11#3)
transient gene expression##10##3##(1995-5#1)(2008-1#1)(2008-11#5)(2008-2#1)(2008-4#1)(2012-3#1)
transient gene##12##2##(1995-5#1)(2008-1#1)(2008-11#6)(2008-2#1)(2008-4#1)(2008-9#1)(2012-3#1)
transient global amnesia##4##3##(1996-9#1)(2007-9#2)(2009-6#1)
transient global ischemia##4##3##(1996-12#1)(2011-2#3)
transient global##9##2##(1996-12#1)(1996-9#1)(2007-9#2)(2009-12#1)(2009-6#1)(2011-2#3)
transient gratings in##2##3##(2007-12#2)
transient gratings##3##2##(2007-12#3)
transient growth##3##2##(1992-12#1)(1995-2#1)(2006-12#1)
transient hypotension##2##2##(1991-12#1)(2007-5#1)
transient impairment of##2##3##(1993-9#1)(2007-11#1)
transient impairment##3##2##(1993-9#1)(2007-11#1)(2010-9#1)
transient in##5##2##(1992-3#1)(2006-12#1)(2007-12#2)(2008-8#1)
transient increase in [Ca2+]i##5##4##(1991-10#3)(1993-3#1)(1995-3#1)
transient increase in intracellular calcium##2##5##(1997-5#1)(2011-2#1)
transient increase in intracellular##3##4##(1992-7#1)(1997-5#1)(2011-2#1)
transient increase in plasma##2##4##(1996-12#1)(2012-1#1)
transient increase in the##8##4##(1991-1#1)(1991-4#1)(1992-6#1)(1993-3#1)(1995-6#1)(2007-11#1)(2008-8#1)(2010-12#1)
transient increase in urinary taurine##2##5##(1997-3#2)
transient increase in##39##3##(1990-12#1)(1990-2#1)(1991-1#1)(1991-10#4)(1991-4#1)(1991-8#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-12#3)(1995-3#2)(1995-6#1)(1995-8#1)(1996-12#2)(1996-7#1)(1997-2#1)(1997-3#2)(1997-5#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
transient increase of##8##3##(1991-6#1)(1991-7#1)(1992-6#1)(1992-9#1)(1993-4#1)(1994-3#1)(1997-2#1)(2007-11#1)
transient increase##48##2##(1990-12#1)(1990-2#1)(1991-1#1)(1991-10#4)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-9#1)(1994-12#3)(1994-3#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-12#2)(1996-7#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-7#1)(2007-11#2)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
transient increases in##5##3##(1990-10#1)(1992-5#1)(1994-6#1)(1994-9#1)(2008-9#1)
transient increases of##3##3##(1990-12#1)(1995-11#1)(2013-1#1)
transient increases##8##2##(1990-10#1)(1990-12#1)(1992-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(2008-9#1)(2013-1#1)
transient inflammatory reaction##2##3##(1997-1#1)(2007-8#1)
transient infrared##2##2##(2008-1#1)(2008-10#1)
transient inhibition of##8##3##(1990-8#1)(1991-1#1)(1993-11#1)(1994-8#1)(1995-7#1)(1997-7#1)(2005-8#1)(2009-9#1)
transient inhibition##10##2##(1990-8#1)(1991-1#1)(1993-11#2)(1994-8#1)(1995-7#1)(1997-7#1)(2005-8#1)(2009-9#1)(2010-2#1)
transient initial##2##2##(1996-5#1)(2005-10#1)
transient interactions##2##2##(2008-8#1)(2012-2#1)
transient intermediate##4##2##(1996-5#2)(2009-11#1)(2009-7#1)
transient inward current##5##3##(1990-7#1)(1992-11#1)(1994-2#3)
transient inward##8##2##(1990-7#1)(1992-11#1)(1994-2#3)(1995-12#1)(1995-2#1)(2008-4#1)
transient is##3##2##(1992-1#2)(2008-3#1)
transient ischaemic attack (TIA) or minor stroke##2##7##(1991-11#1)(2008-8#1)
transient ischaemic attack (TIA)##3##4##(1991-11#1)(2008-8#1)(2011-2#1)
transient ischaemic attack##6##3##(1991-11#1)(1992-10#1)(2008-8#3)(2011-2#1)
transient ischaemic##7##2##(1991-11#1)(1992-10#1)(2008-8#3)(2011-2#1)(2012-2#1)
transient ischemia was##2##3##(1992-7#1)(1994-2#1)
transient ischemia##10##2##(1990-7#1)(1992-7#3)(1993-2#1)(1993-3#1)(1994-2#1)(1996-12#2)(2007-10#1)
transient ischemic attack (TIA)##6##4##(2007-10#3)(2007-9#2)(2008-8#1)
transient ischemic attack and##2##4##(2006-8#1)(2007-9#1)
transient ischemic attack or##3##4##(1991-10#1)(2007-10#1)(2008-8#1)
transient ischemic attack##32##3##(1991-10#1)(2006-8#1)(2007-10#13)(2007-7#1)(2007-9#11)(2008-8#2)(2010-12#1)(2011-2#1)(2013-8#1)
transient ischemic attacks (TIAs)##2##4##(2007-10#2)
transient ischemic attacks and##3##4##(1991-3#1)(1995-9#1)(2006-11#1)
transient ischemic attacks##12##3##(1991-3#1)(1994-6#1)(1995-9#1)(2006-11#2)(2007-10#3)(2007-7#1)(2007-8#1)(2007-9#1)(2012-3#1)
transient ischemic##49##2##(1991-10#1)(1991-3#1)(1992-3#1)(1994-6#1)(1995-7#1)(1995-9#1)(2006-11#2)(2006-8#1)(2007-10#17)(2007-7#2)(2007-8#1)(2007-9#12)(2008-8#3)(2010-12#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
transient kinetics of##4##3##(1994-8#1)(1996-7#1)(2006-10#2)
transient lower esophageal sphincter relaxation##2##5##(2006-10#1)(2012-3#1)
transient lower esophageal sphincter relaxations##2##5##(2006-10#2)
transient lower esophageal sphincter##4##4##(2006-10#3)(2012-3#1)
transient lower##5##2##(2006-10#3)(2006-12#1)(2012-3#1)
transient manner##3##2##(1992-3#1)(1996-5#1)(2008-10#1)
transient micelle fusions##2##3##(1993-11#2)
transient middle cerebral artery occlusion##4##5##(1996-9#1)(2007-10#1)(2007-9#2)
transient nature of##3##3##(1996-2#1)(2007-2#1)(2008-10#1)
transient nature##5##2##(1995-8#1)(1996-2#1)(2007-2#1)(2008-10#1)(2012-12#1)
transient neurological symptoms##5##3##(2006-10#3)(2006-11#1)(2006-12#1)
transient neurological##7##2##(2006-10#3)(2006-11#2)(2006-12#1)(2010-3#1)
transient occlusion##2##2##(1992-11#1)(2007-10#1)
transient of##3##2##(1996-4#1)(2007-12#1)(2008-8#1)
transient or permanent##4##3##(1991-10#1)(1996-12#1)(2011-1#1)(2013-1#1)
transient or##5##2##(1991-10#1)(1996-12#1)(2011-1#2)(2013-1#1)
transient outward current and a##2##5##(1990-5#1)(1994-2#1)
transient outward current and##3##4##(1990-5#1)(1994-2#2)
transient outward current##4##3##(1990-5#1)(1993-2#1)(1994-2#2)
transient outward##6##2##(1990-5#1)(1993-2#1)(1994-2#2)(2009-12#1)(2010-12#1)
transient paralysis was found in three##2##6##(2008-7#2)
transient paralysis##5##2##(2008-5#2)(2008-7#2)(2012-1#1)
transient parametric gratings##2##3##(2007-12#2)
transient peak##2##2##(1991-8#1)(1993-3#1)
transient phase##4##2##(1991-5#1)(1992-7#1)(1994-2#1)(2008-1#1)
transient photoelectromotive force effects##2##4##(2008-3#2)
transient potential change##4##3##(2008-10#4)
transient radiative transfer##2##3##(2008-3#2)
transient rapid##2##2##(1994-2#1)(2007-10#1)
transient receptor potential (TRP)##2##4##(2008-8#1)(2009-3#1)
transient receptor potential vanilloid##2##4##(2009-12#1)(2011-2#1)
transient receptor potential##6##3##(2008-8#1)(2009-12#1)(2009-3#1)(2009-9#1)(2011-2#1)(2013-1#1)
transient regime##4##2##(2005-11#2)(2007-12#2)
transient renal##2##2##(1990-9#1)(2006-10#1)
transient replication##2##2##(2008-10#1)(2008-9#1)
transient response of##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
transient response##11##2##(1996-5#1)(1997-3#1)(2007-11#1)(2007-9#1)(2008-2#3)(2008-3#3)(2012-2#1)
transient responses##3##2##(2008-10#1)(2008-2#1)(2008-9#1)
transient rise in [Ca2+]i##3##4##(1992-6#1)(1995-3#2)
transient rise in##9##3##(1990-3#1)(1991-2#1)(1992-2#1)(1992-6#1)(1995-3#2)(1997-1#1)(2007-10#1)(2007-8#1)
transient rise##10##2##(1990-3#1)(1990-8#1)(1991-2#1)(1992-2#1)(1992-6#1)(1995-3#2)(1997-1#1)(2007-10#1)(2007-8#1)
transient seropositivity##2##2##(2008-5#2)
transient severe##2##2##(1991-2#1)(1996-12#1)
transient shear experiments##2##3##(2005-11#2)
transient short-pulse##2##2##(2008-3#2)
transient side effects##2##3##(1992-8#1)(1993-9#1)
transient signal##3##2##(1996-2#1)(2007-12#1)(2008-10#1)
transient signals##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2010-8#1)
transient silencing##2##2##(2008-10#1)(2009-8#1)
transient species##6##2##(1993-6#1)(2005-4#1)(2006-12#1)(2008-10#1)(2009-7#1)(2012-1#1)
transient spectral##2##2##(1996-7#1)(2007-12#1)
transient state##3##2##(1996-4#1)(2008-2#1)(2010-6#1)
transient states##3##2##(1995-9#1)(2006-10#1)(2008-3#1)
transient stimulated Raman scattering in##2##5##(2007-12#2)
transient stimulated Raman scattering##3##4##(2007-12#3)
transient symptoms##2##2##(2007-10#1)(2008-7#1)
transient temperature##3##2##(2006-6#1)(2008-11#1)(2009-7#1)
transient transfection and##3##3##(1996-4#1)(2008-1#1)(2008-2#1)
transient transfection assays in##4##4##(1991-5#1)(1996-7#1)(1997-6#1)(2008-3#1)
transient transfection assays with##2##4##(1992-8#1)(1994-8#1)
transient transfection assays##13##3##(1991-10#1)(1991-5#1)(1992-8#1)(1994-8#1)(1995-3#2)(1996-10#2)(1996-5#1)(1996-7#1)(1997-6#1)(1997-7#1)(2008-3#1)
transient transfection experiments##5##3##(1992-11#1)(1992-12#1)(1992-9#1)(1993-3#1)(1996-5#1)
transient transfection of##9##3##(1990-9#1)(1991-5#1)(1994-12#1)(1994-8#1)(1997-2#1)(2007-6#1)(2008-11#1)(2012-2#1)(2013-8#1)
transient transfection system##2##3##(2008-11#2)
transient transfection with##2##3##(1994-12#1)(1997-7#1)
transient transfection##44##2##(1990-9#1)(1991-10#1)(1991-5#2)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-12#2)(1994-8#2)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#2)(1996-10#3)(1996-4#1)(1996-5#2)(1996-7#1)(1997-2#1)(1997-6#1)(1997-7#2)(2007-6#1)(2008-1#1)(2008-11#9)(2008-2#1)(2008-3#1)(2012-2#1)(2013-8#1)
transient transfections##5##2##(1993-6#1)(1994-6#1)(1995-3#1)(2008-1#2)
transient type K channel##2##4##(1992-11#2)
transient up-regulation##3##2##(1994-5#1)(1997-7#1)(2010-10#1)
transient variations in##2##3##(1995-11#1)(2008-2#1)
transient visual##2##2##(2008-3#1)(2008-7#1)
transient##1040##1##(1990-10#2)(1990-11#3)(1990-12#4)(1990-2#1)(1990-3#3)(1990-4#2)(1990-5#3)(1990-6#2)(1990-7#5)(1990-8#3)(1990-9#3)(1991-1#5)(1991-10#8)(1991-11#4)(1991-12#5)(1991-2#6)(1991-3#9)(1991-4#2)(1991-5#6)(1991-6#2)(1991-7#3)(1991-8#6)(1991-9#2)(1992-1#4)(1992-10#2)(1992-11#8)(1992-12#5)(1992-2#1)(1992-3#5)(1992-4#2)(1992-5#7)(1992-6#9)(1992-7#11)(1992-8#8)(1992-9#3)(1993-1#1)(1993-11#6)(1993-12#5)(1993-2#3)(1993-3#8)(1993-4#4)(1993-6#3)(1993-8#3)(1993-9#6)(1994-10#2)(1994-11#7)(1994-12#12)(1994-2#14)(1994-3#2)(1994-5#4)(1994-6#6)(1994-8#8)(1994-9#6)(1995-1#1)(1995-10#2)(1995-11#4)(1995-12#5)(1995-2#6)(1995-3#16)(1995-5#3)(1995-6#3)(1995-7#3)(1995-8#2)(1995-9#3)(1996-1#5)(1996-10#3)(1996-11#3)(1996-12#13)(1996-2#3)(1996-3#4)(1996-4#8)(1996-5#13)(1996-6#2)(1996-7#6)(1996-8#1)(1996-9#5)(1997-1#12)(1997-2#4)(1997-3#3)(1997-4#10)(1997-5#3)(1997-6#3)(1997-7#14)(2005-10#1)(2005-11#8)(2005-12#1)(2005-4#3)(2005-5#2)(2005-8#4)(2006-10#22)(2006-11#9)(2006-12#14)(2006-2#1)(2006-4#4)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#3)(2006-9#8)(2007-1#1)(2007-10#28)(2007-11#24)(2007-12#41)(2007-2#5)(2007-5#6)(2007-6#3)(2007-7#5)(2007-8#14)(2007-9#25)(2008-1#15)(2008-10#35)(2008-11#38)(2008-12#2)(2008-2#34)(2008-3#28)(2008-4#19)(2008-5#14)(2008-6#1)(2008-7#17)(2008-8#19)(2008-9#19)(2009-10#1)(2009-11#3)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#4)(2009-7#3)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#14)(2010-2#2)(2010-3#3)(2010-5#1)(2010-6#5)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#9)(2011-10#1)(2011-2#16)(2011-3#1)(2012-1#8)(2012-11#3)(2012-12#3)(2012-2#12)(2012-3#10)(2013-1#14)(2013-7#3)(2013-8#4)
transient)##2##1##(1993-11#1)(2007-9#1)
transient-grating##2##1##(2007-12#1)(2008-3#1)
transiently activated by##2##3##(1994-2#1)(1997-7#1)
transiently activated##3##2##(1994-2#1)(1997-5#1)(1997-7#1)
transiently activates##2##2##(1996-1#1)(1996-8#1)
transiently after##2##2##(1991-12#1)(1992-2#1)
transiently and##7##2##(1992-1#1)(1994-2#1)(1997-4#2)(2006-11#1)(2008-3#1)(2010-11#1)
transiently by##3##2##(1990-6#1)(1994-12#1)(2008-5#1)
transiently expressed in COS-7 cells##2##5##(1995-10#1)(1995-3#1)
transiently expressed in COS-7##3##4##(1995-10#1)(1995-3#1)(2008-4#1)
transiently expressed in the##3##4##(1990-8#1)(1996-2#1)(1997-4#1)
transiently expressed in##12##3##(1990-8#1)(1991-2#1)(1993-3#1)(1993-4#1)(1995-10#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-4#1)(2008-4#1)(2008-8#2)
transiently expressed##22##2##(1990-8#1)(1991-2#1)(1992-7#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-4#1)(2006-12#1)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-3#1)(2012-2#1)
transiently expresses##2##2##(1991-9#1)(2008-11#1)
transiently in the##3##3##(1990-7#1)(1992-12#1)(1996-6#1)
transiently in##9##2##(1990-7#1)(1992-10#1)(1992-12#1)(1992-9#1)(1994-9#1)(1995-6#1)(1996-6#1)(1996-8#1)(2008-4#1)
transiently increase##2##2##(1992-1#1)(2010-6#1)
transiently increased after##2##3##(1993-12#1)(1994-8#1)
transiently increased the##3##3##(1992-9#1)(1994-10#1)(1994-12#1)
transiently increased##11##2##(1990-5#1)(1992-9#2)(1993-12#1)(1994-10#1)(1994-12#1)(1994-8#1)(1995-8#1)(1996-11#1)(2004-2#1)(2008-10#1)
transiently induced##5##2##(1991-1#1)(1993-8#1)(1994-12#1)(1995-1#1)(2009-8#1)
transiently reduced##2##2##(1995-12#1)(2008-1#1)
transiently reduces the##2##3##(2005-8#1)(2008-11#1)
transiently suppressed##3##2##(1990-5#1)(1997-1#1)(2008-11#1)
transiently to##2##2##(1994-2#1)(1997-4#1)
transiently transfected cells##3##3##(1996-5#1)(1997-4#1)(2008-2#1)
transiently transfected with plasmids##2##4##(1994-8#1)(1996-11#1)
transiently transfected with the##6##4##(1991-7#1)(1991-9#1)(1994-11#2)(1996-5#1)(2008-5#1)
transiently transfected with##15##3##(1991-7#1)(1991-9#1)(1992-11#1)(1994-11#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-6#1)(1996-11#2)(1996-5#1)(1997-2#1)(2008-5#1)
transiently transfected##27##2##(1991-7#1)(1991-9#1)(1992-11#1)(1994-11#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#2)(1996-5#3)(1997-2#1)(1997-4#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)
transiently with##2##2##(1995-2#1)(1995-3#1)
transiently within##2##2##(1991-7#1)(1997-6#1)
transiently##170##1##(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#2)(1991-1#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-7#2)(1991-9#2)(1992-1#2)(1992-10#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-7#2)(1992-9#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#2)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#5)(1994-12#4)(1994-2#3)(1994-6#2)(1994-8#3)(1994-9#3)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#5)(1995-2#4)(1995-3#7)(1995-5#1)(1995-6#2)(1995-8#4)(1996-1#1)(1996-11#3)(1996-2#2)(1996-5#4)(1996-6#1)(1996-8#3)(1997-1#1)(1997-2#3)(1997-4#6)(1997-5#3)(1997-6#1)(1997-7#1)(2004-2#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#6)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#2)(2009-3#1)(2009-8#2)(2010-11#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-12#3)(2012-2#2)(2013-1#2)
transients and##4##2##(2007-9#1)(2008-11#1)(2008-3#1)(2008-8#1)
transients are##5##2##(1994-8#1)(1995-2#1)(2007-12#2)(2008-4#1)
transients by##3##2##(1990-5#1)(2007-12#1)(2008-2#1)
transients during the##3##3##(1997-7#2)(2010-8#1)
transients during##4##2##(1997-7#2)(2007-12#1)(2010-8#1)
transients in the##3##3##(1992-9#1)(2007-12#1)(2008-8#1)
transients in##11##2##(1992-9#2)(1993-7#1)(1994-12#2)(1997-7#1)(2007-12#1)(2008-3#1)(2008-8#1)(2009-6#1)(2010-2#1)
transients of##5##2##(1996-8#1)(1997-4#1)(2008-10#1)(2008-3#2)
transients significantly##2##2##(1997-7#2)
transients to##2##2##(2007-12#1)(2008-3#1)
transients were##4##2##(1991-12#1)(1994-12#1)(1997-7#2)
transients within the##3##3##(2008-2#2)(2010-8#1)
transients##68##1##(1990-5#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-8#2)(1992-9#2)(1993-6#2)(1993-7#3)(1994-12#5)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-8#2)(1997-4#1)(1997-7#8)(2007-12#7)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#9)(2008-4#2)(2008-8#2)(2009-12#1)(2009-5#1)(2009-6#1)(2010-2#2)(2010-8#2)
transiliac##2##1##(1993-7#1)(2007-8#1)
transillumination imaging of##3##3##(1997-5#1)(2008-2#1)(2011-1#1)
transillumination imaging##4##2##(1997-5#1)(2008-2#2)(2011-1#1)
transillumination measurements##3##2##(2008-2#1)(2008-3#2)
transillumination of##3##2##(2006-10#1)(2007-12#1)(2008-2#1)
transillumination##18##1##(1997-5#1)(2006-10#1)(2007-12#3)(2007-3#1)(2008-2#6)(2008-3#4)(2011-1#2)
transin##2##1##(1992-6#2)
transistor (ISFET)##3##2##(2008-10#3)
transistor characteristics##2##2##(2008-2#1)(2008-7#1)
transistor radio antenna##2##3##(2013-8#2)
transistor##40##1##(1991-5#2)(1992-9#1)(1995-8#1)(2005-4#1)(2006-12#3)(2006-2#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#8)(2008-2#2)(2008-7#3)(2009-11#3)(2009-5#5)(2009-6#1)(2010-4#1)(2010-8#1)(2013-7#1)(2013-8#2)
transistors and##3##2##(2007-9#1)(2008-10#1)(2008-7#1)
transistors for##2##2##(2008-10#1)(2008-7#1)
transistors in##2##2##(2008-2#1)(2008-7#1)
transistors##39##1##(1990-6#1)(2006-12#1)(2007-8#2)(2007-9#3)(2008-10#8)(2008-2#4)(2008-7#12)(2009-2#1)(2009-6#3)(2009-8#1)(2010-11#2)(2010-4#1)
transit after##2##2##(2006-10#1)(2013-8#1)
transit and##2##2##(1995-9#1)(2008-7#1)
transit as##2##2##(2005-11#2)
transit in##5##2##(2009-5#2)(2012-2#1)(2013-1#2)
transit into the##2##3##(1996-8#1)(1997-6#1)
transit into##3##2##(1996-8#1)(1997-6#1)(1997-7#1)
transit of##10##2##(1991-7#1)(1992-3#1)(1997-6#1)(1997-7#1)(2008-7#1)(2009-5#1)(2011-1#1)(2012-2#3)
transit peptide of##2##3##(1994-12#1)(1996-10#1)
transit peptide##10##2##(1992-12#1)(1994-12#5)(1996-10#3)(2006-12#1)
transit peptides##7##2##(1990-2#3)(1994-12#3)(2009-5#1)
transit sequence##2##2##(1992-3#1)(1993-3#1)
transit through the##3##3##(1994-9#1)(1995-12#1)(2008-4#1)
transit through##4##2##(1994-9#1)(1995-12#1)(2008-4#1)(2008-7#1)
transit time of##3##3##(2005-3#1)(2007-7#1)(2008-10#1)
transit time was##2##3##(1995-9#1)(2013-8#1)
transit time##21##2##(1995-9#4)(1997-8#2)(2005-3#1)(2007-10#2)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#3)(2013-7#1)(2013-8#2)
transit times##4##2##(1995-9#1)(2007-11#3)
transit were##3##2##(2009-5#1)(2013-1#1)(2013-8#1)
transit##103##1##(1990-2#3)(1990-6#1)(1991-7#1)(1992-12#1)(1992-3#3)(1992-4#1)(1992-9#1)(1993-3#1)(1994-12#8)(1994-7#1)(1994-9#2)(1995-12#1)(1995-2#2)(1995-9#6)(1996-10#3)(1996-5#1)(1996-8#1)(1997-6#2)(1997-7#2)(1997-8#2)(2005-11#2)(2005-3#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#1)(2007-10#2)(2007-11#5)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-7#4)(2009-4#1)(2009-5#6)(2011-1#1)(2012-2#6)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#4)
transit)##2##1##(2010-5#2)
transiting##2##1##(2007-11#1)(2012-2#1)
transition (EMT)##4##2##(2010-12#1)(2012-12#1)(2012-2#2)
transition (EndoMT)##2##2##(2012-12#2)
transition (PPT)##2##2##(2009-5#1)(2010-3#1)
transition and heavy metal ions##9##5##(2008-10#9)
transition and post-transition metal ions##2##5##(2007-6#1)(2008-10#1)
transition and the##8##3##(2006-10#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-3#1)(2012-12#1)(2012-2#1)
transition and##42##2##(1990-3#1)(1991-6#1)(1992-9#1)(1994-5#1)(1995-12#1)(1995-5#1)(1996-4#1)(1996-7#1)(1997-6#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#12)(2008-11#3)(2008-2#1)(2008-3#3)(2008-7#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-8#1)
transition are##5##2##(1995-1#1)(2006-12#1)(2007-12#1)(2008-2#1)(2008-3#1)
transition as##3##2##(1995-2#1)(2008-10#2)
transition at 1##2##3##(2008-3#2)
transition at nucleotide position##3##4##(1993-3#1)(1994-11#1)(2008-10#1)
transition at nucleotide##6##3##(1993-3#1)(1994-11#2)(1994-3#1)(1994-9#1)(2008-10#1)
transition at the##2##3##(1992-8#1)(2012-1#1)
transition at##32##2##(1991-7#1)(1992-12#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-9#1)(1996-6#1)(2006-10#2)(2007-12#8)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#8)(2012-1#1)
transition away from##2##3##(2010-6#1)(2012-12#1)
transition between the two##3##4##(1991-6#1)(1996-6#1)(2008-1#1)
transition between the##9##3##(1991-6#1)(1996-6#1)(2006-4#1)(2007-12#2)(2008-1#1)(2008-10#1)(2009-12#1)(2012-3#1)
transition between these##2##3##(1994-8#1)(2005-11#1)
transition between##29##2##(1990-6#1)(1991-6#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-6#1)(1997-1#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-3#1)
transition by using##2##3##(1996-6#1)(2007-11#1)
transition by##9##2##(1993-2#1)(1993-8#1)(1994-2#1)(1996-6#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-3#1)(2012-12#1)
transition can be##3##3##(1992-6#1)(2008-10#1)(2008-5#1)
transition curve##3##2##(1994-8#1)(1995-6#1)(2008-10#1)
transition curves for##2##3##(1992-9#1)(1995-5#1)
transition dipole moments##4##3##(1991-9#1)(2006-4#3)
transition dipole##5##2##(1991-9#1)(2006-4#3)(2007-11#1)
transition dipoles##2##2##(1990-4#1)(2007-11#1)
transition due to##2##3##(2008-5#1)(2010-5#1)
transition element##2##2##(2008-10#1)(2008-3#1)
transition exhibited##2##2##(1990-8#1)(1992-10#1)
transition for##11##2##(1990-7#1)(1992-1#1)(1993-6#1)(1995-2#1)(1995-5#1)(2007-11#2)(2008-11#1)(2011-1#1)(2012-12#2)
transition frequencies##2##2##(2007-11#1)(2008-10#1)
transition frequency##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
transition from A##2##3##(1991-1#1)(1996-2#1)
transition from a##12##3##(1992-12#1)(1993-3#1)(1995-3#1)(1996-1#1)(1996-3#1)(1997-1#1)(2005-11#1)(2006-12#1)(2007-12#2)(2007-3#1)(2010-12#1)
transition from an##2##3##(1996-12#1)(2008-5#1)
transition from coalescent to speciation##2##5##(2010-6#2)
transition from hospital to home##2##5##(1991-12#1)(2011-2#1)
transition from hospital to residential care##2##6##(2012-12#2)
transition from hospital to##4##4##(1991-12#1)(2011-2#1)(2012-12#2)
transition from one care##2##4##(2010-8#1)(2013-1#1)
transition from one##4##3##(2006-10#1)(2008-7#1)(2010-8#1)(2013-1#1)
transition from sexual to parthenogenetic##2##5##(2008-9#2)
transition from single##2##3##(1996-12#1)(2008-3#1)
transition from the R##2##4##(1992-7#1)(2008-11#1)
transition from the##18##3##(1990-12#1)(1992-7#1)(1995-1#1)(1996-2#1)(1996-4#1)(1996-6#1)(2005-11#2)(2007-12#1)(2007-8#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-7#1)(2009-12#1)(2011-1#1)
transition from##112##2##(1990-12#1)(1990-3#1)(1991-1#3)(1991-11#1)(1991-12#2)(1992-10#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-3#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#2)(1996-6#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-1#1)(2005-11#4)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-9#2)(2007-11#3)(2007-12#7)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#6)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-6#2)(2009-9#1)(2010-12#2)(2010-5#2)(2010-6#2)(2010-8#2)(2011-1#3)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)
transition has##2##2##(1995-2#1)(2008-3#1)
transition in a##7##3##(1990-12#1)(1990-7#2)(1991-6#1)(1994-10#1)(1995-2#1)(2007-12#1)
transition in an##2##3##(1990-7#1)(2008-3#1)
transition in both##2##3##(1990-2#1)(2008-5#1)
transition in solid##2##3##(1991-9#1)(1993-6#1)
transition in the##20##3##(1990-5#1)(1990-8#2)(1991-1#1)(1991-2#1)(1991-4#1)(1992-6#1)(1994-10#1)(1994-11#1)(1994-3#1)(1995-1#1)(1997-4#1)(1997-7#1)(2005-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2009-8#1)(2010-12#1)
transition in##68##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#3)(1990-8#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-6#2)(1992-7#1)(1993-6#1)(1993-8#1)(1994-10#2)(1994-11#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-5#2)(1996-2#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-12#7)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
transition increases with increasing##2##4##(1990-7#1)(2005-11#1)
transition into##7##2##(1990-11#1)(1991-12#2)(2008-1#1)(2012-1#2)(2013-1#1)
transition is##20##2##(1990-11#1)(1990-3#1)(1990-7#1)(1991-7#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-4#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-12#1)(2010-7#1)
transition leading to##2##3##(1990-11#1)(2007-9#1)
transition line##2##2##(2008-2#1)(2008-3#1)
transition losses##4##2##(2008-3#4)
transition matrices##3##2##(1990-9#1)(1991-12#1)(2008-1#1)
transition matrix##5##2##(1991-12#1)(2008-12#1)(2008-3#3)
transition metal and##3##3##(2008-10#1)(2010-11#1)(2010-12#1)
transition metal cations##3##3##(2008-10#3)
transition metal complexes##7##3##(1997-7#2)(2007-11#1)(2008-10#2)(2008-3#1)(2010-7#1)
transition metal ion##2##3##(2008-10#1)(2010-6#1)
transition metal ions and##3##4##(2008-10#3)
transition metal ions##20##3##(1990-9#1)(1996-2#1)(2008-10#14)(2008-12#1)(2010-11#1)(2011-1#1)(2012-2#1)
transition metal##50##2##(1990-9#2)(1991-9#1)(1996-2#3)(1997-2#1)(1997-4#1)(1997-7#2)(2006-4#1)(2007-11#1)(2008-10#24)(2008-12#1)(2008-3#1)(2008-5#1)(2009-12#1)(2010-11#2)(2010-12#1)(2010-5#3)(2010-6#1)(2010-7#1)(2011-1#1)(2012-2#1)
transition metal-catalyzed##2##2##(2006-4#1)(2009-7#1)
transition metals and##4##3##(2006-12#1)(2008-10#3)
transition metals are##2##3##(1991-4#1)(2008-10#1)
transition metals in##7##3##(1995-8#1)(2008-10#2)(2008-5#1)(2009-3#1)(2010-11#2)
transition metals such as##2##4##(2005-11#1)(2008-10#1)
transition metals##35##2##(1991-4#3)(1995-8#1)(2005-11#1)(2006-12#1)(2008-10#17)(2008-2#2)(2008-4#1)(2008-5#3)(2009-10#1)(2009-3#1)(2010-11#2)(2011-1#2)
transition midpoint##2##2##(1990-4#1)(1995-5#1)
transition model##3##2##(1992-10#1)(2008-3#1)(2012-12#1)
transition networks##4##2##(2008-7#2)(2010-6#2)
transition observed##3##2##(1994-5#1)(1995-1#1)(1995-4#1)
transition occurred at##2##3##(1992-9#1)(1993-9#1)
transition occurred##5##2##(1992-9#1)(1993-9#1)(2007-12#1)(2008-10#2)
transition occurs##3##2##(1990-7#1)(1996-2#1)(2011-2#1)
transition of Ce3+##2##3##(2005-4#1)(2013-8#1)
transition of a##7##3##(1993-11#1)(2005-11#2)(2008-11#1)(2008-2#2)(2010-7#1)
transition of atomic##4##3##(2008-1#1)(2008-2#2)(2008-3#1)
transition of lambda-DNA induced by cationic surfactant##2##7##(2008-8#2)
transition of the DLPE/POPC mixtures##2##5##(1994-3#2)
transition of the phospholipid##2##4##(1990-4#1)(1994-2#1)
transition of the##33##3##(1990-4#2)(1990-8#1)(1992-11#1)(1993-3#1)(1994-2#1)(1994-3#4)(1995-11#2)(1995-5#1)(1997-1#1)(1997-5#1)(1997-7#1)(2005-11#3)(2006-10#1)(2006-6#1)(2007-11#2)(2007-12#3)(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-10#1)(2012-12#1)
transition of these##3##3##(1991-9#1)(2005-4#1)(2008-3#1)
transition of##92##2##(1990-12#1)(1990-2#1)(1990-4#2)(1990-7#1)(1990-8#1)(1991-4#1)(1991-9#2)(1992-11#2)(1992-5#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-3#2)(1993-6#1)(1994-2#1)(1994-3#4)(1994-8#2)(1995-11#3)(1995-5#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-5#2)(1997-7#2)(2005-11#5)(2005-4#2)(2006-10#2)(2006-5#1)(2006-6#1)(2007-11#3)(2007-12#6)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#8)(2008-8#4)(2009-11#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
transition or##3##2##(1992-6#1)(1995-6#1)(2008-3#1)
transition peak at##2##3##(1992-10#2)
transition period##6##2##(1992-3#1)(1996-3#1)(1997-2#1)(2007-11#1)(2011-2#2)
transition point##3##2##(1991-6#1)(1995-2#1)(2008-2#1)
transition points and transition intervals of##3##6##(2008-10#3)
transition points##8##2##(1994-5#1)(1995-5#1)(2008-10#4)(2008-4#1)(2009-4#1)
transition probabilities are##2##3##(2007-9#1)(2008-2#1)
transition probabilities##5##2##(1990-9#1)(1991-12#1)(2007-9#1)(2008-2#1)(2008-3#1)
transition probability matrices##2##3##(2011-2#2)
transition probability matrix##2##3##(1991-12#1)(1994-12#1)
transition probability##5##2##(1991-12#1)(1994-12#1)(2008-3#1)(2011-2#2)
transition process##3##2##(2009-1#1)(2010-12#1)(2012-12#1)
transition profiles##2##2##(1995-6#2)
transition protein 2##5##3##(1993-11#3)(2012-12#2)
transition rates between grades of##2##5##(1993-6#2)
transition rates##6##2##(1993-6#2)(2008-2#2)(2008-7#1)(2012-1#1)
transition region and##2##3##(1990-4#1)(1991-2#1)
transition region at##2##3##(2005-11#1)(2007-4#1)
transition region in##2##3##(1990-4#1)(1993-11#1)
transition region##11##2##(1990-4#5)(1991-2#1)(1992-6#1)(1993-11#1)(1996-12#1)(2005-11#1)(2007-4#1)
transition shape##2##2##(2008-3#2)
transition state analogue##2##3##(1990-5#1)(1992-8#1)
transition state analogue&quot##2##3##(2009-9#2)
transition state are##2##3##(1990-5#1)(1994-2#1)
transition state for hydride transfer##2##5##(1995-2#1)(1996-7#1)
transition state for##13##3##(1991-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#2)(1995-4#1)(1996-11#2)(1996-7#2)(2009-5#1)
transition state of the##4##4##(1995-10#1)(1996-11#1)(2010-4#1)(2010-5#1)
transition state of##8##3##(1991-9#1)(1995-10#1)(1996-11#3)(1997-2#1)(2010-4#1)(2010-5#1)
transition state that is##2##4##(1991-7#1)(1994-8#1)
transition state that##3##3##(1991-7#1)(1994-8#1)(1996-11#1)
transition state with the##2##4##(1991-7#1)(1995-10#1)
transition state with##3##3##(1991-7#1)(1995-1#1)(1995-10#1)
transition state##67##2##(1990-5#5)(1991-2#1)(1991-5#1)(1991-7#4)(1991-8#1)(1991-9#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-2#1)(1994-8#3)(1994-9#3)(1995-1#3)(1995-10#4)(1995-2#2)(1995-4#2)(1996-11#9)(1996-5#1)(1996-7#2)(1997-2#1)(1997-4#3)(2006-3#2)(2007-11#2)(2008-4#1)(2008-9#1)(2009-5#1)(2009-9#2)(2010-12#2)(2010-4#1)(2010-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
transition states and##3##3##(1993-6#1)(1995-4#1)(2012-3#1)
transition states for##3##3##(1992-6#1)(1996-5#1)(1996-7#1)
transition states##17##2##(1991-6#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-8#1)(1995-1#1)(1995-4#2)(1996-11#1)(1996-5#3)(1996-7#1)(2006-3#1)(2006-5#1)(2012-12#1)(2012-3#1)
transition strengths and##2##3##(1993-3#1)(2008-3#1)
transition temperature T(c)##2##3##(1990-9#1)(1991-6#1)
transition temperature and##5##3##(1990-3#1)(1995-5#2)(2005-11#1)(2006-10#1)
transition temperature from##2##3##(2006-10#1)(2007-12#1)
transition temperature in model membranes##2##5##(1991-2#2)
transition temperature is##2##3##(1991-7#1)(2005-11#1)
transition temperature of the##5##4##(2008-10#1)(2008-3#3)(2010-5#1)
transition temperature of##9##3##(1991-9#1)(1994-12#1)(1995-10#1)(2008-10#1)(2008-3#3)(2009-10#1)(2010-5#1)
transition temperature was##3##3##(1990-3#1)(2008-3#1)(2012-12#1)
transition temperature##51##2##(1990-2#1)(1990-3#3)(1990-5#1)(1990-9#1)(1991-2#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-5#1)(1994-12#1)(1994-3#1)(1995-10#1)(1995-3#2)(1995-5#3)(1997-7#2)(2004-9#2)(2005-11#3)(2006-10#5)(2007-12#1)(2008-10#3)(2008-3#5)(2008-5#2)(2008-9#1)(2009-10#1)(2009-3#1)(2010-4#1)(2010-5#1)(2012-12#1)
transition temperatures at##2##3##(1997-7#2)
transition temperatures of the##2##4##(2004-9#1)(2006-7#1)
transition temperatures of##7##3##(1993-9#1)(2004-9#1)(2006-7#1)(2008-10#2)(2010-4#1)(2013-7#1)
transition temperatures##20##2##(1991-2#1)(1993-9#1)(1994-12#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-7#4)(2004-9#1)(2006-7#1)(2008-10#3)(2008-9#1)(2009-7#1)(2010-4#2)(2013-7#1)
transition test##3##2##(2008-8#3)
transition that results in##2##4##(1991-7#1)(1992-8#1)
transition that##5##2##(1991-12#1)(1991-7#1)(1992-8#1)(1994-9#1)(2007-12#1)
transition the##2##2##(1991-2#1)(2013-1#1)
transition time##5##2##(2007-2#1)(2008-11#1)(2009-6#2)(2010-5#1)
transition times between##2##3##(1994-4#1)(1995-9#1)
transition times##5##2##(1991-2#1)(1993-5#1)(1994-4#1)(1995-9#1)(2012-1#1)
transition to a speech recognition##2##5##(2004-9#2)
transition to a##6##3##(1994-8#1)(1997-7#1)(2004-9#2)(2005-11#1)(2008-11#1)
transition to more##3##3##(2006-5#1)(2007-4#1)(2013-1#1)
transition to parenthood##7##3##(2007-2#5)(2009-4#2)
transition to the##10##3##(1991-10#1)(1991-12#1)(1992-12#1)(1993-11#1)(1996-3#1)(2007-11#1)(2007-9#1)(2008-3#1)(2008-7#1)(2013-1#1)
transition to##75##2##(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-7#1)(1992-12#1)(1993-11#1)(1993-7#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#3)(1997-6#1)(1997-7#1)(2004-9#2)(2005-10#1)(2005-11#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#5)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#5)
transition type##4##2##(2012-12#4)
transition types##10##2##(2012-12#10)
transition was monitored##2##3##(1990-2#1)(2008-2#1)
transition was##14##2##(1990-2#1)(1991-6#1)(1992-11#1)(1992-9#2)(1994-8#1)(1996-11#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)
transition were##3##2##(1992-6#1)(2006-10#1)(2007-12#1)
transition when##3##2##(2008-11#1)(2008-6#1)(2008-7#1)
transition with a##6##3##(1992-6#1)(1995-6#1)(2007-12#3)(2008-1#1)
transition with##9##2##(1992-6#1)(1995-6#1)(2007-12#4)(2008-1#1)(2008-10#1)(2008-8#1)
transition zone##15##2##(1990-7#2)(1991-5#1)(1993-2#1)(1995-5#1)(2006-4#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-2#3)(2010-12#1)(2013-7#2)
transition##1311##1##(1990-11#4)(1990-12#6)(1990-2#8)(1990-3#8)(1990-4#11)(1990-5#10)(1990-6#2)(1990-7#10)(1990-8#8)(1990-9#5)(1991-1#4)(1991-10#2)(1991-11#5)(1991-12#13)(1991-2#11)(1991-4#6)(1991-5#7)(1991-6#7)(1991-7#12)(1991-8#1)(1991-9#11)(1992-1#1)(1992-10#5)(1992-11#5)(1992-12#7)(1992-3#2)(1992-5#3)(1992-6#17)(1992-7#3)(1992-8#5)(1992-9#15)(1993-11#8)(1993-12#2)(1993-2#3)(1993-3#8)(1993-5#2)(1993-6#6)(1993-7#1)(1993-8#5)(1993-9#2)(1994-1#1)(1994-10#3)(1994-11#7)(1994-12#9)(1994-2#6)(1994-3#10)(1994-4#1)(1994-5#6)(1994-8#19)(1994-9#5)(1995-1#11)(1995-10#5)(1995-11#8)(1995-12#2)(1995-2#10)(1995-3#12)(1995-4#6)(1995-5#13)(1995-6#7)(1995-7#2)(1995-8#2)(1995-9#1)(1996-1#3)(1996-11#12)(1996-12#5)(1996-2#9)(1996-3#5)(1996-4#5)(1996-5#8)(1996-6#5)(1996-7#4)(1996-8#1)(1997-1#5)(1997-2#10)(1997-3#2)(1997-4#6)(1997-5#2)(1997-6#6)(1997-7#17)(1997-8#1)(2004-1#1)(2004-9#6)(2005-10#1)(2005-11#31)(2005-4#5)(2005-7#1)(2005-8#2)(2006-1#2)(2006-10#23)(2006-12#3)(2006-2#1)(2006-3#4)(2006-4#9)(2006-5#5)(2006-6#3)(2006-7#3)(2006-9#4)(2007-10#4)(2007-11#24)(2007-12#67)(2007-2#9)(2007-3#3)(2007-4#6)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#4)(2007-9#4)(2008-1#16)(2008-10#108)(2008-11#28)(2008-12#7)(2008-2#36)(2008-3#69)(2008-4#10)(2008-5#15)(2008-6#6)(2008-7#19)(2008-8#13)(2008-9#12)(2009-1#1)(2009-10#4)(2009-11#2)(2009-12#6)(2009-2#5)(2009-3#2)(2009-4#3)(2009-5#3)(2009-6#5)(2009-7#5)(2009-8#4)(2009-9#5)(2010-10#3)(2010-11#6)(2010-12#14)(2010-3#4)(2010-4#8)(2010-5#12)(2010-6#8)(2010-7#4)(2010-8#5)(2010-9#2)(2011-1#10)(2011-10#1)(2011-12#1)(2011-2#18)(2012-1#11)(2012-11#1)(2012-12#38)(2012-2#11)(2012-3#9)(2013-1#15)(2013-7#6)(2013-8#7)
transition&quot##3##1##(1996-3#1)(1996-4#2)
transition)##4##1##(2007-5#2)(2009-8#1)(2011-1#1)
transition-metal oxides are##2##3##(2012-2#2)
transition-metal oxides##4##2##(2006-12#1)(2010-12#1)(2012-2#2)
transition-metal##7##1##(1993-8#1)(2006-12#1)(2006-5#1)(2010-12#2)(2012-2#2)
transition-metal-ion-doped waveguide##2##2##(2007-11#2)
transition-state analog##4##2##(1991-5#2)(1995-2#2)
transition-state entropy##2##2##(2006-4#2)
transition-state stabilization by##2##3##(1990-2#1)(1994-5#1)
transition-state stabilization##6##2##(1990-2#3)(1992-3#2)(1994-5#1)
transition-state##27##1##(1990-2#3)(1991-2#2)(1991-5#2)(1992-3#2)(1992-5#1)(1993-11#1)(1993-6#1)(1994-5#2)(1995-1#1)(1995-2#2)(1995-5#3)(1996-8#1)(2006-4#2)(2008-5#2)(2012-12#2)
transition-state-analog complex##2##2##(1994-11#2)
transition-state-like tetrahedral##2##2##(1992-12#1)(1993-11#1)
transition-state-like##3##1##(1992-12#2)(1993-11#1)
transitional ER##2##2##(2012-2#2)
transitional and##5##2##(1995-8#2)(2008-10#1)(2008-4#1)(2011-1#1)
transitional care##3##2##(2008-5#2)(2010-2#1)
transitional cell carcinoma (TCC) of the##2##6##(2008-10#1)(2008-9#1)
transitional cell carcinoma (TCC)##4##4##(2006-10#1)(2006-9#1)(2008-10#1)(2008-9#1)
transitional cell carcinoma of the bladder##8##6##(1992-6#2)(1997-4#1)(2006-10#1)(2006-6#2)(2006-8#1)(2007-10#1)
transitional cell carcinoma of the##13##5##(1991-12#2)(1992-6#2)(1997-4#1)(2006-10#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-10#1)(2008-1#1)(2008-9#1)
transitional cell carcinoma of##15##4##(1991-12#2)(1992-6#2)(1997-4#1)(2006-10#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-10#1)(2008-1#1)(2008-9#1)(2012-1#2)
transitional cell carcinoma##34##3##(1990-6#1)(1991-12#2)(1992-6#2)(1997-4#3)(2006-10#3)(2006-6#3)(2006-8#1)(2006-9#3)(2007-10#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#2)(2009-5#2)(2011-2#1)(2012-1#4)(2012-3#1)
transitional cell##36##2##(1990-6#1)(1991-12#2)(1992-6#2)(1997-4#3)(2006-10#3)(2006-6#3)(2006-8#1)(2006-9#3)(2007-10#2)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#2)(2009-5#2)(2011-2#2)(2012-1#4)(2012-3#1)
transitional cells##4##2##(2006-12#4)
transitional day hospital##2##3##(1993-2#2)
transitional funding##4##2##(1991-12#2)(1993-1#1)(1994-1#1)
transitional stage##3##2##(2008-5#1)(2009-10#1)(2009-7#1)
transitional##95##1##(1990-12#1)(1990-6#1)(1991-12#4)(1991-4#1)(1992-1#1)(1992-6#3)(1993-1#1)(1993-12#1)(1993-2#2)(1994-1#1)(1994-6#1)(1995-8#2)(1996-3#1)(1997-4#3)(2006-10#3)(2006-12#4)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#3)(2007-10#3)(2007-11#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-9#6)(2009-10#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#4)(2012-2#4)(2012-3#2)
transitional-cell##2##1##(1991-11#1)(1997-7#1)
transitionally##2##1##(1996-2#1)(2008-2#1)
transitioned to##2##2##(2008-1#1)(2010-12#1)
transitioned##3##1##(2008-1#1)(2010-12#1)(2011-2#1)
transitioning from##7##2##(1991-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2009-8#1)(2009-9#1)(2010-7#1)
transitioning out##2##2##(2009-11#1)(2011-2#1)
transitioning to##3##2##(2008-11#1)(2010-6#1)(2013-1#1)
transitioning##19##1##(1991-12#1)(1997-2#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#3)(2009-11#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#2)(2013-1#3)
transitions and##12##2##(1991-2#1)(1997-4#1)(2006-9#1)(2007-12#1)(2008-10#1)(2009-10#2)(2009-5#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-1#1)
transitions are##19##2##(1990-7#2)(1990-8#1)(1991-8#1)(1992-6#1)(1997-7#2)(2006-12#2)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2009-12#1)(2009-5#1)(2011-2#3)
transitions at##6##2##(1990-7#1)(1996-5#1)(1997-7#1)(2008-2#2)(2012-2#1)
transitions between different##2##3##(2006-10#1)(2009-8#1)
transitions between the##2##3##(1992-8#1)(2010-8#1)
transitions between them##2##3##(2007-9#1)(2013-7#1)
transitions between##23##2##(1990-3#1)(1992-8#1)(1993-2#1)(1994-12#1)(1995-1#1)(2006-10#2)(2007-9#1)(2008-11#2)(2008-2#2)(2008-5#1)(2008-8#1)(2009-8#1)(2010-3#1)(2010-8#3)(2013-7#1)(2013-8#3)
transitions can##2##2##(1991-2#1)(2008-2#1)
transitions during##2##2##(2006-12#1)(2009-8#1)
transitions for##9##2##(1991-2#2)(2007-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2010-10#1)
transitions from the metal d to the##2##7##(2010-5#2)
transitions from the##5##3##(1995-4#1)(1996-4#1)(2008-9#1)(2010-5#2)
transitions from##9##2##(1993-9#1)(1995-4#1)(1996-4#1)(2005-11#1)(2008-1#1)(2008-7#1)(2008-9#1)(2010-5#2)
transitions have been##2##3##(1991-2#1)(2008-3#1)
transitions have##5##2##(1991-2#1)(1994-8#1)(2008-11#1)(2008-3#1)(2010-8#1)
transitions in a##2##3##(2007-11#1)(2007-12#1)
transitions in each##2##3##(1992-9#1)(2006-12#1)
transitions in the##14##3##(1991-6#1)(1993-6#1)(1996-11#1)(2007-11#2)(2008-2#3)(2008-3#4)(2010-4#1)(2013-7#1)
transitions in##48##2##(1990-8#1)(1991-6#3)(1991-8#1)(1991-9#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#1)(1995-11#1)(1995-3#1)(1995-7#1)(1996-11#1)(2006-10#1)(2006-12#1)(2006-5#2)(2007-11#4)(2007-12#2)(2008-1#1)(2008-11#1)(2008-2#4)(2008-3#5)(2008-7#1)(2008-8#1)(2010-4#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
transitions increases##2##2##(1990-7#1)(2008-10#1)
transitions induced by##5##3##(1997-1#4)(2007-12#1)
transitions is##5##2##(1990-11#1)(1995-3#1)(2008-3#2)(2009-10#1)
transitions near##5##2##(2007-11#3)(2007-12#1)(2008-3#1)
transitions observed in##2##3##(1994-8#1)(2005-11#1)
transitions occurring##2##2##(1997-1#1)(2008-8#1)
transitions of a##2##3##(2006-10#2)
transitions of iodine##2##3##(2007-11#1)(2008-3#1)
transitions of the##9##3##(1994-3#1)(1994-8#1)(1997-4#1)(2005-7#1)(2007-11#1)(2008-2#1)(2008-3#2)(2009-11#1)
transitions of##36##2##(1990-2#1)(1990-4#1)(1994-3#1)(1994-8#1)(1995-5#1)(1995-7#1)(1996-11#1)(1996-5#2)(1997-4#1)(2005-11#1)(2005-7#2)(2006-10#3)(2007-11#3)(2007-12#4)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#5)(2008-7#1)(2008-9#1)(2009-11#1)(2010-11#1)
transitions on##2##2##(1993-2#1)(2011-2#1)
transitions or##2##2##(1995-3#1)(2007-12#1)
transitions that##3##2##(1990-8#1)(1995-3#1)(2007-12#1)
transitions to##7##2##(1990-5#1)(1995-6#1)(1997-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
transitions were also##2##3##(1994-3#1)(2008-11#1)
transitions were observed##4##3##(1992-9#1)(1996-11#1)(2007-12#2)
transitions were##12##2##(1992-9#1)(1994-3#2)(1994-8#1)(1996-11#2)(2007-12#2)(2008-10#1)(2008-11#1)(2009-2#1)(2010-4#1)
transitions which##3##2##(1992-6#1)(1992-9#1)(2012-2#1)
transitions##348##1##(1990-11#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#4)(1990-8#5)(1991-11#1)(1991-2#8)(1991-6#4)(1991-8#2)(1991-9#3)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#5)(1993-11#2)(1993-2#4)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-9#2)(1994-12#1)(1994-3#3)(1994-5#1)(1994-8#5)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#2)(1996-11#5)(1996-2#1)(1996-4#1)(1996-5#4)(1997-1#7)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#9)(2005-11#4)(2005-4#1)(2005-7#2)(2006-10#10)(2006-12#5)(2006-4#1)(2006-5#6)(2006-7#1)(2006-9#1)(2007-11#12)(2007-12#25)(2007-8#1)(2007-9#3)(2008-1#3)(2008-10#8)(2008-11#7)(2008-12#1)(2008-2#19)(2008-3#31)(2008-4#3)(2008-5#1)(2008-7#5)(2008-8#10)(2008-9#2)(2009-10#4)(2009-11#1)(2009-12#3)(2009-2#2)(2009-5#3)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#3)(2010-2#3)(2010-3#2)(2010-4#3)(2010-5#2)(2010-7#2)(2010-8#5)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#4)(2013-1#8)(2013-7#3)(2013-8#7)
transitive inference and##2##3##(2009-8#2)
transitive inference##4##2##(2009-8#4)
transitive reasoning##2##2##(2009-8#2)
transitive##12##1##(2008-2#2)(2009-8#7)(2010-2#2)(2012-11#1)
transitivity##3##1##(2006-7#1)(2012-11#2)
transitory increase##2##2##(2008-11#1)(2013-1#1)
transitory increases##2##2##(1996-11#1)(1996-3#1)
transitory ischemic##2##2##(1997-2#1)(2013-7#1)
transitory##20##1##(1990-9#1)(1991-3#1)(1992-4#1)(1996-11#1)(1996-3#1)(1996-4#1)(1997-2#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2010-6#1)(2010-9#1)(2011-1#1)(2013-1#1)(2013-7#1)
transjugular intrahepatic portosystemic shunt##2##4##(2009-8#1)(2009-9#1)
transjugular intrahepatic portosystemic##3##3##(2006-8#1)(2009-8#1)(2009-9#1)
transjugular##5##1##(1991-11#1)(2006-12#1)(2006-8#1)(2009-8#1)(2009-9#1)
transketolase abnormalities##2##2##(1990-10#2)
transketolase activity##4##2##(1990-11#2)(1992-12#1)(1995-1#1)
transketolase##22##1##(1990-10#4)(1990-11#2)(1992-12#6)(1992-3#4)(1995-1#2)(1996-2#3)(2008-7#1)
transketolase-catalyzed condensation##2##2##(2008-7#2)
transketolase-catalyzed##3##1##(2008-7#3)
translabyrinthine##7##1##(1991-12#1)(2005-5#1)(2006-11#1)(2006-12#1)(2008-9#1)(2011-2#2)
translatability of##2##2##(1995-3#1)(1997-3#1)
translatability##3##1##(1995-3#1)(1997-3#1)(2012-2#1)
translatable and##2##2##(1997-3#1)(2008-10#1)
translatable glutaminase##2##2##(1991-7#2)
translatable to##3##2##(2007-11#1)(2008-2#1)(2008-4#1)
translatable##12##1##(1991-12#1)(1991-7#2)(1995-6#1)(1996-7#1)(1997-3#2)(2006-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)
translate into a##4##3##(2006-8#1)(2007-11#1)(2009-5#1)(2009-9#1)
translate into better##2##3##(2005-7#1)(2010-8#1)
translate into clinical##2##3##(2006-7#1)(2009-4#1)
translate into higher##2##3##(2006-11#1)(2010-5#1)
translate into improved##2##3##(2007-11#1)(2009-3#1)
translate into##26##2##(1991-12#1)(1991-5#1)(2005-7#1)(2006-10#4)(2006-11#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-3#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#1)
translate the data##2##3##(1996-12#1)(2006-7#1)
translate the##9##2##(1996-12#1)(1996-7#1)(2006-7#1)(2008-1#1)(2008-2#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-1#1)
translate to##4##2##(2012-12#1)(2013-8#3)
translate##62##1##(1991-12#1)(1991-5#1)(1993-2#1)(1995-12#1)(1996-12#1)(1996-7#1)(1997-2#1)(2005-7#1)(2006-10#5)(2006-11#2)(2006-12#1)(2006-7#2)(2006-8#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-9#1)(2009-3#3)(2009-4#2)(2009-5#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#3)
translated amino acid sequence##2##4##(1995-5#1)(2007-1#1)
translated amino acid##3##3##(1995-5#1)(2007-1#1)(2009-12#1)
translated and##4##2##(1990-2#1)(1992-1#1)(2006-8#1)(2008-12#1)
translated as a##2##3##(1990-8#1)(1992-6#1)
translated as##3##2##(1990-8#1)(1992-6#1)(2012-2#1)
translated from the##2##3##(1992-2#1)(2008-12#1)
translated from##7##2##(1991-6#1)(1992-2#1)(1996-2#1)(2006-10#1)(2008-11#1)(2008-12#1)(2012-12#1)
translated gene##2##2##(1992-1#1)(1993-5#1)
translated in a rabbit reticulocyte lysate##2##6##(1991-7#1)(1994-9#1)
translated in a##4##3##(1990-11#1)(1991-7#1)(1994-9#1)(1995-6#1)
translated in reticulocyte lysates##2##4##(1993-2#1)(1994-12#1)
translated in the##2##3##(1997-2#1)(2008-2#1)
translated in vitro##8##3##(1990-11#2)(1990-12#1)(1992-9#1)(1994-8#1)(1995-3#1)(1995-8#1)(2008-5#1)
translated in##22##2##(1990-11#3)(1990-12#1)(1991-7#1)(1992-9#1)(1993-2#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-6#2)(1995-8#1)(1997-2#1)(2008-10#2)(2008-2#1)(2008-5#1)(2011-1#1)(2012-2#1)
translated into a protein of##2##5##(1990-11#1)(1996-10#1)
translated into a protein##3##4##(1990-11#1)(1995-12#1)(1996-10#1)
translated into a significant##2##4##(2007-7#1)(2008-6#1)
translated into a##13##3##(1990-10#1)(1990-11#1)(1994-7#1)(1995-12#1)(1996-10#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)
translated into amino acid##2##4##(2006-12#1)(2009-3#1)
translated into clinical practice##4##4##(2006-10#1)(2008-3#1)(2012-1#1)(2012-12#1)
translated into clinical##6##3##(2006-10#1)(2008-3#1)(2008-5#1)(2012-1#1)(2012-12#1)(2012-2#1)
translated into##60##2##(1990-10#1)(1990-11#1)(1990-7#1)(1991-12#1)(1992-8#1)(1993-11#1)(1994-7#1)(1995-12#2)(1995-3#1)(1996-10#1)(1997-3#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-11#1)(2007-3#1)(2007-5#3)(2007-7#2)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-11#2)(2012-12#6)(2012-2#2)(2013-1#2)
translated on the##2##3##(1997-2#1)(2013-1#1)
translated on##4##2##(1992-3#2)(1997-2#1)(2013-1#1)
translated over the##2##3##(2007-12#1)(2013-1#1)
translated protein##7##2##(1993-12#1)(1993-6#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-4#1)(2013-1#1)
translated sequence of##2##3##(1994-6#1)(1997-3#1)
translated sequence##3##2##(1993-12#1)(1994-6#1)(1997-3#1)
translated the##2##2##(1990-11#1)(2008-12#1)
translated to the##3##3##(2007-12#1)(2008-3#1)(2012-1#1)
translated to##7##2##(1990-10#1)(1992-1#1)(2007-12#1)(2008-3#1)(2009-4#1)(2012-1#1)(2012-12#1)
translated##166##1##(1990-10#2)(1990-11#5)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-6#1)(1991-7#2)(1992-1#3)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#2)(1995-8#2)(1996-10#1)(1996-2#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-7#1)(2005-7#1)(2006-10#3)(2006-12#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-5#3)(2007-7#2)(2007-8#1)(2008-10#8)(2008-11#2)(2008-12#3)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#2)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-11#3)(2012-12#8)(2012-2#6)(2013-1#8)
translates in the##3##3##(2012-12#1)(2012-2#2)
translates into##10##2##(1997-2#1)(2006-10#1)(2007-12#1)(2007-4#2)(2008-7#2)(2009-4#1)(2009-9#1)(2010-11#1)
translates the##2##2##(1994-1#1)(2007-11#1)
translates to a##2##3##(1995-5#1)(2007-5#1)
translates to##6##2##(1995-5#1)(2007-4#1)(2007-5#1)(2010-4#1)(2010-8#1)(2011-12#1)
translates##32##1##(1991-12#1)(1993-3#1)(1994-1#1)(1995-5#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-4#3)(2007-5#1)(2008-10#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-12#1)(2012-12#1)(2012-2#5)(2013-8#1)
translating evidence into policy##2##4##(2008-7#2)
translating evidence into##3##3##(2008-3#1)(2008-7#2)
translating into##2##2##(2008-2#1)(2013-1#1)
translating research to practice##3##4##(2006-9#1)(2013-1#2)
translating research##4##2##(2006-9#1)(2008-11#1)(2013-1#2)
translating ribosomes##2##2##(1995-6#1)(1996-4#1)
translating the##9##2##(2006-10#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-10#1)(2010-12#1)(2010-5#1)(2012-11#1)(2013-1#1)
translating##47##1##(1991-3#1)(1992-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-1#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2012-11#3)(2012-12#1)(2013-1#5)
translation (KT)##3##2##(2008-11#1)(2011-1#1)(2011-12#1)
translation and expression##2##3##(2008-1#2)
translation and the##2##3##(1990-7#1)(2009-9#1)
translation and##23##2##(1990-4#1)(1990-7#2)(1991-11#1)(1992-9#1)(1995-2#3)(2007-12#1)(2008-1#2)(2008-11#1)(2008-4#1)(2009-4#3)(2009-9#2)(2010-10#1)(2010-11#1)(2010-9#1)(2012-2#1)(2013-1#1)
translation apparatus##4##2##(1995-8#1)(2005-10#1)(2008-7#1)(2013-8#1)
translation are##5##2##(1993-12#1)(2008-4#2)(2009-4#1)(2012-12#1)
translation as well as##2##4##(2008-9#1)(2010-4#1)
translation as##3##2##(1993-12#1)(2008-9#1)(2010-4#1)
translation by##2##2##(1995-8#1)(2008-10#1)
translation coefficients##3##2##(2008-2#3)
translation control##3##2##(1990-9#1)(2009-9#1)(2013-8#1)
translation during##2##2##(1994-8#1)(2009-3#1)
translation efficiencies##2##2##(1992-2#1)(1996-7#1)
translation efficiency of##3##3##(1992-2#2)(2006-5#1)
translation efficiency##5##2##(1992-2#4)(2006-5#1)
translation elongation factor 1-alpha##2##4##(2008-10#2)
translation elongation factor 1alpha##4##4##(2008-10#4)
translation elongation factor##12##3##(1995-8#2)(1996-4#1)(2006-12#1)(2008-10#7)(2008-8#1)
translation elongation##15##2##(1995-6#2)(1995-8#2)(1996-4#1)(2006-12#1)(2008-10#8)(2008-8#1)
translation from##2##2##(2011-1#1)(2011-12#1)
translation function##3##2##(1992-9#1)(1995-3#1)(2008-8#1)
translation has##3##2##(2008-11#1)(2009-10#1)(2013-8#1)
translation in the##7##3##(1990-7#1)(1995-8#1)(1996-7#1)(2007-12#1)(2008-12#1)(2012-1#1)(2012-2#1)
translation in vitro##2##3##(1990-8#1)(1991-2#1)
translation in##27##2##(1990-7#3)(1990-8#1)(1991-2#1)(1993-2#1)(1994-3#1)(1994-6#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-7#1)(1997-2#1)(2005-10#1)(2006-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-11#1)(2011-12#1)(2012-1#1)(2012-10#1)(2012-2#3)
translation inhibitors##2##2##(1991-1#1)(2008-10#1)
translation inhibitory##3##2##(1991-4#1)(2010-4#2)
translation initiation codon for the##2##5##(1990-9#1)(1996-10#1)
translation initiation codon##10##3##(1990-5#1)(1990-9#1)(1992-11#2)(1993-3#1)(1996-10#1)(1996-7#1)(1997-1#1)(1997-6#2)
translation initiation factor eIF-4E##2##4##(1995-2#2)
translation initiation factor eIF2B##3##4##(1997-6#1)(2011-1#2)
translation initiation factor##12##3##(1990-7#1)(1993-12#1)(1994-6#1)(1995-2#2)(1997-1#1)(1997-6#1)(2008-7#1)(2010-12#1)(2011-1#2)(2013-7#1)
translation initiation signals##2##3##(1991-7#1)(1991-9#1)
translation initiation site##6##3##(1996-5#1)(1997-2#3)(1997-6#1)(1997-7#1)
translation initiation sites of##6##4##(1996-10#1)(1996-8#1)(1997-2#1)(1997-6#3)
translation initiation sites on the genome of Synechocystis sp##3##9##(1996-8#1)(1997-2#1)(1997-6#1)
translation initiation sites on##4##4##(1996-8#1)(1997-2#2)(1997-6#1)
translation initiation sites##17##3##(1996-10#2)(1996-8#4)(1997-2#5)(1997-6#6)
translation initiation##60##2##(1990-5#1)(1990-7#2)(1990-9#1)(1991-7#1)(1991-9#1)(1992-11#2)(1993-12#1)(1993-3#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-6#1)(1996-10#3)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#4)(1997-1#2)(1997-2#8)(1997-6#10)(1997-7#3)(2005-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#2)(2013-7#1)
translation into##6##2##(2007-11#1)(2008-1#1)(2008-9#1)(2011-2#1)(2013-1#2)
translation is##10##2##(1994-9#1)(1995-5#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-9#1)(2010-11#1)(2013-1#1)
translation machinery##3##2##(2007-11#1)(2008-9#1)(2009-3#1)
translation matrices are##2##3##(2008-3#2)
translation may##2##2##(2008-2#1)(2008-7#1)
translation occurred##2##2##(1990-9#1)(1995-3#1)
translation of a##3##3##(1991-12#1)(2008-2#1)(2008-4#1)
translation of an##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
translation of mRNA##2##3##(1992-12#1)(1995-12#1)
translation of optical imaging agents##2##5##(2013-1#2)
translation of such##5##3##(1992-8#1)(2007-11#1)(2012-12#3)
translation of the mRNA##6##4##(1990-10#1)(1993-4#3)(1994-5#2)
translation of the##37##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1992-10#1)(1992-12#1)(1992-3#1)(1993-4#3)(1993-5#1)(1993-6#1)(1994-5#2)(1995-3#1)(1995-6#2)(1997-1#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-11#2)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-11#1)(2012-2#2)
translation of these findings to##2##5##(2009-12#1)(2010-6#1)
translation of these##6##3##(2007-7#1)(2008-10#1)(2009-12#2)(2010-6#1)(2011-2#1)
translation of##127##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1991-1#1)(1991-12#3)(1991-3#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-8#2)(1993-10#1)(1993-4#4)(1993-5#1)(1993-6#1)(1993-9#1)(1994-5#2)(1995-12#2)(1995-2#1)(1995-3#4)(1995-6#2)(1995-9#1)(1996-1#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-8#1)(2005-1#1)(2005-2#1)(2005-8#1)(2006-10#1)(2007-11#5)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#3)(2009-4#1)(2010-11#3)(2010-12#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-9#2)(2011-1#3)(2011-2#2)(2012-1#3)(2012-12#5)(2012-2#4)(2013-1#5)(2013-8#1)
translation on##2##2##(2007-12#1)(2011-2#1)
translation or##4##2##(2007-11#1)(2008-1#1)(2008-11#1)(2010-8#1)
translation process and##2##3##(2008-2#1)(2012-12#1)
translation process##3##2##(1997-2#1)(2008-2#1)(2012-12#1)
translation product of##3##3##(1994-8#1)(1995-1#1)(2008-10#1)
translation product was##2##3##(1997-8#1)(2008-10#1)
translation product##12##2##(1991-5#1)(1994-8#2)(1995-1#1)(1995-5#1)(1995-6#1)(1997-3#1)(1997-8#1)(2008-10#3)(2008-4#1)
translation products and##2##3##(1994-11#1)(1995-6#1)
translation products##11##2##(1992-2#1)(1994-11#4)(1994-9#1)(1995-6#1)(1997-2#2)(1997-4#1)(2008-4#1)
translation reactions##2##2##(1994-9#1)(1995-6#1)
translation regulation##4##2##(1990-7#1)(2008-9#2)(2010-12#1)
translation research##2##2##(2008-9#1)(2011-1#1)
translation stage##3##2##(2007-12#1)(2008-2#2)
translation stages##2##2##(2006-4#1)(2008-3#1)
translation start site##7##3##(1992-6#1)(1997-2#2)(1997-7#1)(1997-8#1)(2008-11#1)(2008-9#1)
translation start##11##2##(1990-11#1)(1992-6#1)(1995-12#1)(1997-2#3)(1997-7#1)(1997-8#1)(2008-11#1)(2008-9#1)(2012-2#1)
translation stop##3##2##(1990-10#1)(1994-3#1)(1997-2#1)
translation strategies##2##2##(2011-2#1)(2012-3#1)
translation studies##2##2##(1994-9#1)(2008-9#1)
translation system with##2##3##(1994-12#1)(1994-2#1)
translation system##9##2##(1990-2#1)(1991-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-4#1)(1997-6#1)(2005-1#1)
translation technique##2##2##(2008-3#1)(2012-11#1)
translation termination codon##2##3##(1992-4#1)(1997-1#1)
translation termination##5##2##(1992-4#1)(1997-1#1)(2008-4#1)(2008-9#2)
translation to##7##2##(1991-12#1)(2008-1#1)(2009-10#1)(2009-12#1)(2011-1#1)(2012-12#1)(2012-2#1)
translation was##2##2##(1993-12#1)(2007-7#1)
translation with##2##2##(1992-6#1)(2006-12#1)
translation##594##1##(1990-10#3)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#2)(1990-5#3)(1990-7#9)(1990-8#1)(1990-9#5)(1991-1#5)(1991-10#1)(1991-11#3)(1991-12#7)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#4)(1992-12#4)(1992-2#6)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#3)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#5)(1993-2#2)(1993-3#1)(1993-4#4)(1993-5#1)(1993-6#1)(1993-9#2)(1994-11#6)(1994-12#3)(1994-2#2)(1994-3#4)(1994-5#3)(1994-6#3)(1994-8#5)(1994-9#5)(1995-1#1)(1995-10#1)(1995-12#3)(1995-2#10)(1995-3#8)(1995-5#7)(1995-6#9)(1995-8#6)(1995-9#1)(1996-1#1)(1996-10#4)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#3)(1996-7#4)(1996-8#4)(1996-9#2)(1997-1#6)(1997-2#18)(1997-3#6)(1997-4#2)(1997-6#12)(1997-7#5)(1997-8#3)(2005-1#2)(2005-10#5)(2005-2#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#5)(2006-3#1)(2006-4#1)(2006-5#2)(2006-8#1)(2007-11#11)(2007-12#10)(2007-2#2)(2007-4#1)(2007-7#5)(2007-8#4)(2008-1#9)(2008-10#23)(2008-11#18)(2008-12#5)(2008-2#17)(2008-3#10)(2008-4#14)(2008-5#6)(2008-6#2)(2008-7#7)(2008-8#6)(2008-9#21)(2009-10#4)(2009-11#1)(2009-12#6)(2009-3#2)(2009-4#5)(2009-5#1)(2009-8#1)(2009-9#6)(2010-1#1)(2010-10#2)(2010-11#8)(2010-12#3)(2010-2#2)(2010-4#4)(2010-5#4)(2010-6#2)(2010-7#3)(2010-8#3)(2010-9#3)(2011-1#14)(2011-12#4)(2011-2#9)(2012-1#6)(2012-10#1)(2012-11#1)(2012-12#13)(2012-2#15)(2012-3#6)(2013-1#12)(2013-7#1)(2013-8#6)
translation)##3##1##(1997-6#1)(2008-4#1)(2008-9#1)
translation-rotation encoder##2##2##(2008-2#2)
translation-rotation##3##1##(2008-2#2)(2012-12#1)
translational activity in##2##3##(1990-2#2)
translational activity##8##2##(1990-2#4)(1990-3#1)(1995-8#1)(1996-11#1)(2006-11#1)
translational and rotational acceleration##2##4##(2007-4#2)
translational and rotational##3##3##(1994-9#1)(2007-4#2)
translational and##10##2##(1994-9#1)(1995-11#1)(2007-12#1)(2007-4#2)(2008-3#1)(2008-5#1)(2009-3#1)(2012-12#1)(2013-1#1)
translational apparatus##2##2##(1990-5#1)(2006-12#1)
translational applications##2##2##(2010-9#1)(2012-12#1)
translational cancer research##2##3##(2007-4#1)(2010-5#1)
translational capacity##2##2##(1994-8#1)(2008-11#1)
translational control during##2##3##(1993-12#1)(1994-8#1)
translational control##12##2##(1991-7#1)(1993-12#1)(1994-8#1)(1997-1#2)(2007-12#1)(2008-9#1)(2009-3#1)(2013-8#4)
translational coupling to##2##3##(1990-3#1)(1993-6#1)
translational coupling##4##2##(1990-3#1)(1993-6#3)
translational diffusion##6##2##(1991-9#3)(1993-11#1)(1997-6#1)(2006-10#1)
translational efficiency##6##2##(1990-10#2)(2008-11#1)(2008-7#2)(2008-9#1)
translational fidelity##2##2##(1993-11#1)(2006-12#1)
translational fusion with##2##3##(2006-12#1)(2013-8#1)
translational fusion##3##2##(1995-8#1)(2006-12#1)(2013-8#1)
translational fusions##4##2##(1990-11#1)(1990-5#1)(1994-12#2)
translational initiation codon##3##3##(1993-3#1)(1994-11#1)(1994-8#1)
translational initiation##8##2##(1991-12#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-8#1)(2008-5#1)(2008-8#2)
translational level##12##2##(1990-4#1)(1991-12#2)(1991-5#1)(1992-5#1)(1992-8#1)(1995-5#1)(2006-12#1)(2007-8#1)(2008-8#3)
translational levels##3##2##(1993-8#1)(1994-8#1)(1997-4#1)
translational machinery is##2##3##(1994-8#1)(2013-8#1)
translational machinery##7##2##(1992-12#1)(1994-8#1)(2008-9#2)(2009-3#1)(2011-1#1)(2013-8#1)
translational motion##3##2##(2008-2#1)(2008-3#1)(2010-4#1)
translational negative feedback##2##3##(2010-10#2)
translational or post-translational##2##3##(1992-8#1)(1993-11#1)
translational potential of##2##3##(2010-5#1)(2012-12#1)
translational processing##2##2##(1990-10#1)(1993-2#1)
translational product was##2##3##(1990-11#1)(1991-12#1)
translational product##4##2##(1990-11#1)(1990-2#1)(1991-12#1)(1993-9#1)
translational regulation in##3##3##(2009-3#1)(2012-12#2)
translational regulation of##4##3##(1992-8#1)(2008-10#1)(2012-12#2)
translational regulation##15##2##(1992-8#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-3#2)(2012-12#8)
translational repression##2##2##(2011-2#1)(2012-12#1)
translational research in##7##3##(2008-7#1)(2010-10#2)(2010-11#1)(2011-1#2)(2012-3#1)
translational research of##2##3##(2011-1#1)(2012-3#1)
translational research##28##2##(2005-8#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-5#4)(2010-6#1)(2010-8#1)(2011-1#3)(2012-12#3)(2012-3#3)
translational science##6##2##(2009-8#2)(2010-5#1)(2012-12#1)(2013-1#2)
translational shifts##2##2##(2008-2#2)
translational start codon of the##2##5##(1990-3#1)(2006-8#1)
translational start codon##7##3##(1990-3#1)(1992-3#1)(1995-8#1)(1997-4#1)(1997-7#1)(2006-8#1)(2008-9#1)
translational start##13##2##(1990-11#1)(1990-3#2)(1990-5#1)(1991-11#1)(1992-10#1)(1992-3#1)(1995-8#1)(1997-4#1)(1997-7#1)(2006-8#1)(2008-4#1)(2008-9#1)
translational stop codon##3##3##(1990-7#1)(1993-12#1)(1996-10#1)
translational stop##4##2##(1990-7#1)(1993-12#1)(1994-12#1)(1996-10#1)
translational studies##2##2##(2008-6#1)(2010-5#1)
translational systems biology##2##3##(2010-9#2)
translational temperature and##2##3##(2008-2#1)(2008-3#1)
translational temperature##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
translational termination##3##2##(1990-1#1)(2008-10#1)(2008-4#1)
translational##262##1##(1990-1#1)(1990-10#3)(1990-11#3)(1990-2#6)(1990-3#8)(1990-4#1)(1990-5#3)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#4)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#4)(1992-10#1)(1992-12#2)(1992-3#2)(1992-5#2)(1992-8#3)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-5#2)(1994-8#6)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-8#4)(1995-9#1)(1996-10#1)(1996-11#2)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#4)(1997-6#1)(1997-7#1)(2005-11#2)(2005-12#1)(2005-8#3)(2005-9#1)(2006-10#1)(2006-11#2)(2006-12#5)(2006-8#1)(2007-11#2)(2007-12#6)(2007-4#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#4)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#9)(2009-12#2)(2009-3#6)(2009-4#1)(2009-8#2)(2010-10#4)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#9)(2010-6#1)(2010-8#2)(2010-9#7)(2011-1#4)(2011-2#2)(2012-12#22)(2012-2#2)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#7)
translationally coupled##3##2##(1993-11#1)(1993-9#1)(1997-4#1)
translationally regulated##2##2##(1992-11#1)(2009-3#1)
translationally repressed##2##2##(2012-12#2)
translationally##12##1##(1992-11#1)(1993-11#1)(1993-9#1)(1994-5#1)(1997-4#2)(2008-11#1)(2009-3#1)(2010-12#2)(2012-12#2)
translations are##4##2##(1994-3#1)(2008-12#1)(2008-2#1)(2008-3#1)
translations of the##3##3##(1994-3#1)(2008-3#1)(2012-2#1)
translations of##4##2##(1994-3#1)(2008-3#1)(2011-2#1)(2012-2#1)
translations##16##1##(1994-3#2)(2007-5#1)(2008-12#1)(2008-2#3)(2008-3#2)(2009-6#1)(2010-1#2)(2011-1#2)(2011-2#1)(2012-2#1)
translations)##2##1##(2013-1#2)
translator##7##1##(2006-7#1)(2008-2#1)(2012-2#1)(2013-1#3)(2013-7#1)
translators and##2##2##(2007-9#1)(2008-2#1)
translators##3##1##(2007-9#1)(2008-2#1)(2013-1#1)
translesion synthesis##2##2##(2009-8#2)
translocase activity was##3##3##(1992-11#3)
translocase activity##6##2##(1992-11#5)(2004-12#1)
translocase and##2##2##(1997-4#1)(2011-2#1)
translocase##15##1##(1990-8#2)(1992-11#6)(1995-2#1)(1997-4#1)(1997-7#1)(2004-12#1)(2006-10#1)(2011-2#1)(2012-2#1)
translocate PKC##2##2##(1992-3#1)(1993-6#1)
translocate across##2##2##(1997-1#1)(2007-12#1)
translocate into##2##2##(2010-6#1)(2011-2#1)
translocate to##3##2##(1994-5#1)(2006-10#1)(2007-10#1)
translocate##20##1##(1990-2#1)(1991-7#1)(1991-9#1)(1992-3#1)(1993-6#1)(1994-3#1)(1994-5#1)(1995-7#1)(1997-1#1)(2006-10#1)(2007-10#1)(2007-12#2)(2008-11#1)(2009-10#3)(2010-6#1)(2011-2#1)(2011-3#1)
translocated across the cytoplasmic membrane and##2##6##(1991-10#2)
translocated across the##6##3##(1991-10#3)(1994-2#1)(1996-10#1)(1997-4#1)
translocated by##2##2##(1994-12#1)(1995-7#1)
translocated from the cytosol to the membrane##3##7##(1991-4#1)(1992-7#1)(1996-5#1)
translocated from the cytosol to the##4##6##(1991-4#1)(1992-7#1)(1996-2#1)(1996-5#1)
translocated from the cytosol to##6##5##(1991-4#1)(1992-6#1)(1992-7#1)(1996-2#1)(1996-5#1)(2011-2#1)
translocated from the##8##3##(1991-12#1)(1991-4#1)(1992-6#1)(1992-7#1)(1995-2#1)(1996-2#1)(1996-5#1)(2011-2#1)
translocated into the nucleus##2##4##(1996-12#1)(2009-8#1)
translocated into the##3##3##(1990-12#1)(1996-12#1)(2009-8#1)
translocated into##5##2##(1990-12#1)(1996-12#1)(2009-10#1)(2009-8#1)(2013-8#1)
translocated onto##2##2##(1992-6#1)(2009-10#1)
translocated to the inner##2##4##(1993-3#2)
translocated to the nucleus##2##4##(1994-6#1)(1994-9#1)
translocated to the##11##3##(1990-11#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-6#1)(1994-9#1)(1996-8#1)(2008-10#1)(2011-1#1)(2011-2#1)
translocated to##12##2##(1990-11#1)(1992-7#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-6#1)(1994-9#1)(1996-8#1)(2008-10#1)(2011-1#1)(2011-2#1)
translocated##57##1##(1990-11#1)(1990-12#1)(1990-7#1)(1991-10#3)(1991-11#1)(1991-12#1)(1991-4#1)(1992-6#2)(1992-7#2)(1992-8#1)(1993-2#3)(1993-3#2)(1993-6#1)(1993-8#1)(1994-12#3)(1994-2#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-7#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-8#2)(1997-4#1)(2006-7#2)(2008-10#4)(2009-10#2)(2009-8#2)(2011-1#2)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#2)
translocates as##2##2##(2007-12#1)(2008-10#1)
translocates from the##2##3##(1992-12#1)(1994-12#1)
translocates##11##1##(1992-12#1)(1993-11#1)(1994-12#2)(1994-2#1)(1995-2#1)(2007-12#1)(2008-10#1)(2011-2#1)(2012-1#2)
translocating##9##1##(1990-5#1)(1992-11#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-9#1)(2010-6#1)(2011-1#1)(2012-2#1)
translocation ATPase activity##3##3##(1993-9#2)(1997-7#1)
translocation ATPase##5##2##(1993-9#4)(1997-7#1)
translocation across the mitochondrial##2##4##(1994-8#1)(1995-6#1)
translocation across the##7##3##(1993-6#1)(1993-8#2)(1994-2#1)(1994-8#1)(1995-6#1)(2012-2#1)
translocation activity of F(0)##3##4##(2008-8#3)
translocation activity of##6##3##(1991-3#1)(1997-8#1)(2008-8#4)
translocation activity##7##2##(1991-3#1)(1997-8#1)(2008-8#5)
translocation and activation of##4##4##(1994-12#1)(1995-3#1)(1996-5#1)(2006-10#1)
translocation and translocation-addition lines##2##4##(2008-8#2)
translocation and##19##2##(1991-9#1)(1993-3#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#2)(1996-5#1)(1997-7#2)(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#2)(2009-8#1)(2012-3#1)
translocation at the##2##3##(1990-3#1)(2007-11#1)
translocation between chromosomes##2##3##(2009-2#1)(2012-12#1)
translocation between the##2##3##(1990-9#1)(1995-12#1)
translocation between##6##2##(1990-9#1)(1995-12#1)(1997-3#1)(2008-8#1)(2009-2#1)(2012-12#1)
translocation breakpoint in##3##3##(1991-5#1)(1995-11#1)(1997-1#1)
translocation breakpoint##4##2##(1991-5#1)(1995-11#1)(1997-1#1)(2008-8#1)
translocation but##2##2##(1992-8#1)(2006-7#1)
translocation by the##2##3##(1994-11#1)(1994-8#1)
translocation by##10##2##(1992-6#1)(1994-11#1)(1994-8#1)(1996-2#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-10#2)
translocation events##3##2##(1994-8#1)(2008-6#1)(2008-7#1)
translocation from the##4##3##(1992-8#1)(1996-3#1)(2006-10#1)(2008-10#1)
translocation from##12##2##(1990-12#1)(1991-2#1)(1992-8#1)(1994-11#1)(1994-12#1)(1995-12#1)(1996-3#1)(1997-4#1)(2006-10#1)(2008-10#2)(2008-9#1)
translocation has##2##2##(1990-9#1)(2010-10#1)
translocation in##19##2##(1990-2#2)(1992-11#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-10#1)(1994-11#1)(1994-12#1)(1995-11#1)(1996-12#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-3#1)
translocation into the ER##3##4##(1991-2#1)(1995-3#1)(1997-6#1)
translocation into the endoplasmic reticulum##2##5##(1991-2#2)
translocation into the##7##3##(1991-2#3)(1995-3#1)(1997-6#1)(2012-12#2)
translocation into##12##2##(1991-2#3)(1994-9#1)(1995-12#1)(1995-3#1)(1997-6#1)(1997-8#1)(2005-8#1)(2012-12#2)(2013-1#1)
translocation is not##2##3##(1994-11#1)(1994-12#1)
translocation is##9##2##(1991-10#1)(1993-6#1)(1994-11#2)(1994-12#1)(2007-12#1)(2008-1#1)(2008-6#1)(2012-1#1)
translocation line##4##2##(2008-5#1)(2008-8#3)
translocation machinery##3##2##(1993-8#1)(1993-9#1)(1997-2#1)
translocation of Nrf2 and##2##4##(2010-12#2)
translocation of PKC alpha and##2##5##(1995-3#1)(1996-11#1)
translocation of PKC epsilon##2##4##(1995-3#2)
translocation of PKC##8##3##(1991-4#2)(1994-2#1)(1995-3#4)(1996-11#1)
translocation of PKC-alpha##2##3##(1994-12#1)(2008-8#1)
translocation of PKC-sigma and PKC-epsilon##2##5##(1995-11#2)
translocation of PKCalpha from both mitochondria and cytosol to nucleus##2##10##(2008-9#2)
translocation of PKCalpha##4##3##(1996-5#1)(2008-9#3)
translocation of a##6##3##(1991-4#1)(1992-4#1)(1997-8#2)(2008-10#1)(2011-2#1)
translocation of casein kinase##2##4##(1994-11#1)(1994-8#1)
translocation of glucose transporter 4##2##5##(2008-11#2)
translocation of glucose##3##3##(1990-2#1)(2008-11#2)
translocation of p190 GAP##2##4##(1996-2#2)
translocation of phospholipids##2##3##(1993-9#1)(2008-11#1)
translocation of protein kinase C (PKC)##3##6##(1990-6#1)(1993-8#1)(1994-12#1)
translocation of protein kinase C to the##3##7##(1990-4#1)(1991-5#1)(1991-8#1)
translocation of protein kinase C##10##5##(1990-4#2)(1990-6#1)(1991-5#2)(1991-7#1)(1991-8#1)(1993-8#1)(1994-12#1)(1996-5#1)
translocation of protein##11##3##(1990-4#2)(1990-6#1)(1991-5#2)(1991-7#1)(1991-8#1)(1993-8#1)(1994-12#1)(1996-5#1)(1997-2#1)
translocation of rac p21s##4##4##(1993-8#4)
translocation of rac##5##3##(1993-8#4)(1996-2#1)
translocation of secretory proteins across the##2##6##(1991-5#1)(1992-6#1)
translocation of substrates##2##3##(1992-8#1)(1993-11#1)
translocation of the activated##2##4##(1994-12#1)(1996-5#1)
translocation of the cytosolic##2##4##(1990-7#1)(2009-12#1)
translocation of the glucocorticoid receptor##2##5##(1990-12#1)(2008-7#1)
translocation of the##23##3##(1990-12#1)(1990-7#1)(1991-10#1)(1991-5#1)(1992-3#2)(1992-4#1)(1994-12#3)(1995-3#1)(1995-6#1)(1996-5#1)(2007-10#1)(2008-10#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#2)
translocation of##142##2##(1990-12#2)(1990-2#1)(1990-4#2)(1990-6#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-4#3)(1991-5#5)(1991-7#1)(1991-8#2)(1992-11#1)(1992-3#5)(1992-4#3)(1992-6#2)(1992-8#1)(1993-11#1)(1993-8#7)(1993-9#1)(1994-11#3)(1994-12#12)(1994-2#1)(1994-3#1)(1994-8#3)(1994-9#2)(1995-11#5)(1995-3#7)(1995-5#3)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-5#4)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-7#1)(2008-8#4)(2008-9#3)(2009-12#1)(2009-5#1)(2009-8#1)(2010-10#2)(2010-11#2)(2010-12#3)(2011-2#3)(2012-2#3)(2013-1#1)(2013-8#1)
translocation on##2##2##(1990-7#1)(1994-12#1)
translocation pathway##3##2##(1994-12#1)(1995-6#1)(2010-11#1)
translocation points##2##2##(1996-6#2)
translocation process##2##2##(1990-3#1)(2012-2#1)
translocation t(11##2##2##(2007-12#1)(2010-11#1)
translocation t(15##4##2##(1991-11#1)(1991-9#1)(2012-2#2)
translocation through the##2##3##(1996-1#1)(2008-4#1)
translocation through##4##2##(1991-5#1)(1996-1#1)(2008-4#1)(2009-7#1)
translocation to the##7##3##(1991-5#1)(1992-11#1)(1993-8#1)(2008-1#1)(2008-11#2)(2012-12#1)
translocation to##11##2##(1991-5#1)(1992-11#1)(1993-8#1)(1995-11#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2010-5#1)(2012-12#1)
translocation was observed##3##3##(1990-5#1)(1996-5#1)(2006-7#1)
translocation was##12##2##(1990-2#1)(1990-5#1)(1993-4#1)(1994-6#1)(1996-5#1)(1997-7#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-10#1)(2009-2#1)(2010-3#1)
translocation were##2##2##(2007-12#1)(2012-2#1)
translocation which##3##2##(1995-3#1)(2008-8#1)(2009-6#1)
translocation with##4##2##(1994-12#1)(2007-11#1)(2008-10#1)(2010-10#1)
translocation##440##1##(1990-12#4)(1990-2#8)(1990-3#2)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#2)(1990-9#3)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-4#3)(1991-5#11)(1991-7#1)(1991-8#3)(1991-9#2)(1992-11#5)(1992-2#1)(1992-3#6)(1992-4#3)(1992-6#5)(1992-8#3)(1993-11#1)(1993-2#3)(1993-3#3)(1993-4#2)(1993-6#5)(1993-8#14)(1993-9#8)(1994-10#3)(1994-11#11)(1994-12#24)(1994-2#4)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#9)(1994-9#4)(1995-10#1)(1995-11#8)(1995-12#6)(1995-3#11)(1995-5#3)(1995-6#7)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#4)(1996-3#2)(1996-5#9)(1996-6#4)(1996-8#3)(1997-1#3)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#3)(1997-7#9)(1997-8#5)(2005-8#1)(2006-10#4)(2006-12#3)(2006-2#1)(2006-7#3)(2007-10#2)(2007-11#7)(2007-12#10)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#17)(2008-11#7)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#3)(2008-8#19)(2008-9#6)(2009-12#1)(2009-2#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#9)(2010-11#7)(2010-12#3)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#2)(2012-1#7)(2012-12#7)(2012-2#9)(2012-3#7)(2013-1#2)(2013-8#1)
translocation-addition lines##3##2##(2008-8#3)
translocation-addition##4##1##(2008-8#4)
translocation-coupled##2##1##(1993-9#2)
translocational##2##1##(1994-12#1)(2008-9#1)
translocations and##4##2##(2007-11#1)(2008-1#1)(2012-1#2)
translocations are##6##2##(1994-4#1)(2008-6#1)(2009-8#1)(2011-1#2)(2012-3#1)
translocations associated with##3##3##(1997-7#1)(2008-6#1)(2008-7#1)
translocations in T-cell acute##2##4##(1994-8#2)
translocations in tumors##2##3##(2011-1#2)
translocations in##11##2##(1991-5#1)(1994-8#2)(1995-11#1)(1996-2#2)(2008-8#1)(2011-1#3)(2012-1#1)
translocations involving##2##2##(1994-4#1)(2007-11#1)
translocations is##2##2##(2008-5#1)(2008-6#1)
translocations##50##1##(1991-11#1)(1991-5#1)(1994-12#1)(1994-4#2)(1994-8#2)(1995-11#1)(1995-8#1)(1996-2#3)(1997-7#2)(2005-11#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#5)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-1#4)(2011-1#6)(2011-2#1)(2012-1#5)(2012-12#1)(2012-3#1)(2013-8#1)
translocator protein (TSPO)##5##3##(2012-2#5)
translocator protein##6##2##(1995-2#1)(2012-2#5)
translocator##15##1##(1992-1#1)(1994-9#1)(1995-2#5)(1997-4#1)(2008-7#1)(2012-12#1)(2012-2#5)
translocon##3##1##(1997-6#2)(2012-2#1)
translucency of##3##2##(2012-2#3)
translucency##19##1##(1991-11#1)(1995-8#2)(2008-11#2)(2009-4#4)(2010-9#2)(2012-2#5)(2013-1#3)
translucens and##3##2##(2008-10#3)
translucens population size##2##3##(2008-10#2)
translucens population##3##2##(2008-10#3)
translucens pv##15##2##(2008-10#15)
translucens strains##3##2##(2008-10#3)
translucens##40##1##(1990-3#1)(2008-10#39)
translucent protective##2##2##(2008-2#1)(2008-3#1)
translucent##19##1##(1990-12#1)(1991-12#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-4#1)(2009-8#1)(2012-2#2)(2013-8#2)
transluminal angioplasty (PTA) of##2##4##(1991-6#1)(2006-11#1)
transluminal angioplasty (PTA) was##2##4##(2008-1#1)(2011-2#1)
transluminal angioplasty (PTA)##8##3##(1991-6#1)(2005-10#1)(2006-11#1)(2007-7#1)(2008-1#1)(2008-7#1)(2011-2#2)
transluminal angioplasty and##2##3##(1997-1#1)(2007-10#1)
transluminal angioplasty##20##2##(1991-3#1)(1991-6#1)(1993-8#1)(1997-1#1)(1997-3#1)(2005-10#1)(2006-11#3)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-11#1)(2008-7#2)(2011-2#2)
transluminal balloon angioplasty (TBA)##2##4##(2006-11#2)
transluminal balloon angioplasty##4##3##(2006-11#4)
transluminal balloon##5##2##(1990-8#1)(2006-11#4)
transluminal coronary angioplasty (PTCA) is##2##5##(1992-9#1)(1993-12#1)
transluminal coronary angioplasty (PTCA)##17##4##(1991-3#1)(1992-4#1)(1992-9#1)(1993-12#1)(1994-11#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-3#1)(2008-5#2)(2008-7#1)(2013-8#1)
transluminal coronary angioplasty##32##3##(1991-3#1)(1992-4#1)(1992-9#1)(1993-12#1)(1994-11#3)(1995-2#1)(1995-8#1)(1996-12#2)(1997-8#1)(2006-10#2)(2006-8#1)(2007-10#2)(2007-11#2)(2007-5#1)(2007-8#4)(2008-11#2)(2008-3#1)(2008-5#3)(2008-7#1)(2013-8#1)
transluminal coronary##35##2##(1991-3#2)(1992-2#1)(1992-4#1)(1992-9#1)(1993-12#1)(1994-11#3)(1995-2#1)(1995-8#1)(1996-12#2)(1997-8#1)(2006-10#2)(2006-8#1)(2007-10#2)(2007-11#2)(2007-5#1)(2007-8#4)(2008-11#2)(2008-3#1)(2008-5#3)(2008-7#1)(2009-10#1)(2013-8#1)
transluminal renal##2##2##(1994-9#1)(2006-10#1)
transluminal##69##1##(1990-8#1)(1991-3#3)(1991-6#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-11#3)(1994-9#1)(1995-2#1)(1995-8#1)(1996-12#2)(1997-1#1)(1997-3#1)(1997-8#1)(2005-10#1)(2006-10#3)(2006-11#7)(2006-8#1)(2007-10#3)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#5)(2008-1#3)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#4)(2009-10#1)(2009-2#1)(2009-6#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
transmandibular##2##1##(2006-6#1)(2012-3#1)
transmastoid approach##3##2##(2005-5#1)(2011-2#2)
transmastoid##5##1##(2005-5#1)(2011-2#4)
transmaxillary##2##1##(2006-6#1)(2011-2#1)
transmediastinal contralateral##2##2##(2007-8#2)
transmembrane Ca2+##3##2##(1995-3#1)(1997-6#1)(1997-7#1)
transmembrane H+##3##2##(1994-6#3)
transmembrane Na+##3##2##(1990-8#1)(1992-11#1)(1996-9#1)
transmembrane alpha-helices##2##2##(1992-12#1)(1993-11#1)
transmembrane amyloid##2##2##(1990-9#1)(2008-8#1)
transmembrane and cytoplasmic domains##4##4##(1991-4#1)(1992-12#1)(1995-3#2)
transmembrane and cytoplasmic##6##3##(1991-4#1)(1992-12#1)(1995-3#2)(1997-2#1)(1997-4#1)
transmembrane and##14##2##(1990-9#1)(1991-4#1)(1992-11#1)(1992-12#1)(1993-12#1)(1995-3#2)(1997-2#1)(1997-4#2)(1997-7#1)(2005-8#1)(2011-1#1)(2012-2#1)
transmembrane conductance regulator (CFTR)##5##4##(1990-8#1)(1995-11#1)(1995-6#1)(2008-3#1)(2011-3#1)
transmembrane conductance regulator##11##3##(1990-8#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-6#1)(1997-2#1)(1997-6#1)(2006-10#2)(2008-3#1)(2011-3#1)
transmembrane diffusion##2##2##(1997-1#2)
transmembrane domain (TMD)##2##3##(2012-2#1)(2013-1#1)
transmembrane domain and a##2##4##(1992-11#1)(1994-12#1)
transmembrane domain and an##3##4##(1993-3#1)(2008-11#1)(2008-3#1)
transmembrane domain and cytoplasmic##2##4##(1992-12#1)(2008-8#1)
transmembrane domain and##11##3##(1992-11#1)(1992-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-6#1)(1996-5#1)(1997-4#1)(2008-11#1)(2008-3#1)(2008-8#1)
transmembrane domain of the##8##4##(1992-12#2)(1993-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)
transmembrane domain of##12##3##(1992-12#2)(1993-11#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1997-7#1)(2008-11#1)
transmembrane domain##52##2##(1990-7#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#4)(1993-11#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#4)(1995-1#1)(1995-11#2)(1995-2#1)(1995-6#1)(1996-11#1)(1996-5#3)(1996-8#2)(1997-2#1)(1997-4#2)(1997-7#1)(2008-11#2)(2008-3#1)(2008-4#3)(2008-8#1)(2009-10#2)(2012-2#2)(2013-1#1)
transmembrane domains and##3##3##(1992-5#1)(2008-11#1)(2011-1#1)
transmembrane domains of the##3##4##(1992-5#1)(1994-5#1)(2012-2#1)
transmembrane domains of##5##3##(1992-5#1)(1994-12#1)(1994-5#1)(1994-9#1)(2012-2#1)
transmembrane domains were##2##3##(1994-5#1)(1996-10#1)
transmembrane domains##35##2##(1991-10#1)(1991-9#1)(1992-12#1)(1992-5#2)(1994-12#2)(1994-2#1)(1994-5#2)(1994-9#2)(1995-1#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-6#1)(1997-7#1)(2008-11#2)(2008-4#7)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)
transmembrane electron##3##2##(1992-6#1)(1994-3#1)(2009-9#1)
transmembrane forms##2##2##(1995-1#1)(1995-3#1)
transmembrane glycoprotein that##2##3##(1995-2#1)(2005-12#1)
transmembrane glycoprotein##7##2##(1992-12#1)(1992-3#1)(1993-4#1)(1995-2#1)(1996-12#1)(2005-12#1)(2005-7#1)
transmembrane glycoproteins##2##2##(1992-4#1)(2008-1#1)
transmembrane gradients##2##2##(1996-1#1)(2008-7#1)
transmembrane helices of the##2##4##(1994-12#1)(1997-2#1)
transmembrane helices of##5##3##(1990-5#1)(1991-3#2)(1994-12#1)(1997-2#1)
transmembrane helices##14##2##(1990-5#1)(1991-3#2)(1992-12#1)(1992-6#1)(1993-11#1)(1993-3#2)(1994-12#1)(1997-2#1)(1997-4#1)(2008-4#2)(2012-2#1)
transmembrane helix of##3##3##(1992-12#1)(1994-12#1)(2008-8#1)
transmembrane helix##11##2##(1992-12#2)(1993-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-2#1)(1997-3#1)(2008-8#3)
transmembrane ionic##2##2##(1992-8#1)(2006-10#1)
transmembrane mechanism##2##2##(1990-7#1)(1990-9#1)
transmembrane potential and##2##3##(1990-3#1)(2008-1#1)
transmembrane potential in##2##3##(1996-1#1)(1997-1#1)
transmembrane potential##19##2##(1990-3#5)(1994-12#6)(1996-1#2)(1997-1#1)(1997-6#1)(2005-8#1)(2007-3#1)(2008-1#1)(2008-8#1)
transmembrane protein of the##2##4##(2011-12#1)(2011-2#1)
transmembrane protein of##3##3##(1991-11#1)(2011-12#1)(2011-2#1)
transmembrane protein that##3##3##(1991-11#1)(2006-10#1)(2007-7#1)
transmembrane protein##21##2##(1990-9#1)(1991-11#2)(1992-5#1)(1993-12#1)(1994-3#1)(1994-9#1)(1995-8#1)(1996-5#1)(1997-7#1)(2006-10#1)(2006-2#1)(2007-7#1)(2008-9#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
transmembrane proteins and##3##3##(1997-1#1)(2013-1#2)
transmembrane proteins are##3##3##(1994-12#1)(2012-2#1)(2013-1#1)
transmembrane proteins including##2##3##(2009-8#1)(2013-1#1)
transmembrane proteins that are##2##4##(2008-5#1)(2012-12#1)
transmembrane proteins that##6##3##(2008-5#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-3#2)
transmembrane proteins with##2##3##(2009-1#1)(2009-8#1)
transmembrane proteins##28##2##(1994-12#1)(1995-9#1)(1996-9#1)(1997-1#1)(2005-7#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-8#3)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#6)
transmembrane receptor##4##2##(1994-9#1)(1995-2#1)(1997-4#1)(2007-12#1)
transmembrane receptors##3##2##(1994-2#1)(1997-7#1)(2009-3#1)
transmembrane region##14##2##(1990-11#1)(1991-10#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-3#1)(1997-2#1)(1997-6#1)(2005-8#1)(2009-8#1)(2012-12#1)
transmembrane regions of the##2##4##(1993-3#1)(1997-2#1)
transmembrane regions of##3##3##(1993-3#1)(1997-2#1)(2012-2#1)
transmembrane regions##8##2##(1993-3#2)(1994-5#1)(1994-8#1)(1996-6#1)(1997-2#1)(2009-6#1)(2012-2#1)
transmembrane regulator (CFTR)##2##3##(1997-3#1)(2006-10#1)
transmembrane segment of the##2##4##(1993-8#1)(1997-2#1)
transmembrane segment of##3##3##(1990-12#1)(1993-8#1)(1997-2#1)
transmembrane segment##17##2##(1990-12#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-9#2)(1995-3#1)(1995-7#1)(1997-2#5)(2008-8#1)
transmembrane segments of##4##3##(1990-10#1)(1990-5#1)(1997-2#1)(2012-2#1)
transmembrane segments##17##2##(1990-10#1)(1990-5#1)(1991-3#2)(1991-5#1)(1994-12#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#2)(2012-2#1)
transmembrane segments)##2##2##(1996-2#2)
transmembrane signaling in##2##3##(2008-9#1)(2011-1#1)
transmembrane signaling##15##2##(1991-12#1)(1991-4#1)(1992-8#1)(1993-1#1)(1993-6#2)(1994-5#1)(1996-10#1)(1996-5#1)(2008-9#2)(2011-1#3)(2012-2#1)
transmembrane signalling##6##2##(1990-8#1)(1991-8#2)(1993-9#1)(1994-6#1)(2008-4#1)
transmembrane topology prediction##2##3##(2012-2#2)
transmembrane topology##5##2##(1992-11#2)(2012-2#3)
transmembrane transfer of##2##3##(1990-12#1)(1995-2#1)
transmembrane translocation##2##2##(1994-11#1)(1994-12#1)
transmembrane transport##4##2##(1992-6#1)(1995-12#1)(1995-2#1)(2008-10#1)
transmembrane##421##1##(1990-10#2)(1990-11#3)(1990-12#2)(1990-3#8)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#4)(1990-9#4)(1991-10#5)(1991-11#3)(1991-12#2)(1991-2#1)(1991-3#4)(1991-4#2)(1991-5#1)(1991-7#4)(1991-8#3)(1991-9#5)(1992-11#8)(1992-12#13)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#3)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#4)(1993-12#6)(1993-2#1)(1993-3#8)(1993-4#1)(1993-6#2)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#6)(1994-12#15)(1994-2#2)(1994-3#5)(1994-5#6)(1994-6#7)(1994-8#2)(1994-9#16)(1995-1#5)(1995-10#1)(1995-11#3)(1995-12#1)(1995-2#7)(1995-3#10)(1995-5#2)(1995-6#5)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#3)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#8)(1996-6#1)(1996-7#1)(1996-8#5)(1996-9#4)(1997-1#6)(1997-2#13)(1997-3#2)(1997-4#7)(1997-6#5)(1997-7#7)(2005-11#1)(2005-12#1)(2005-7#3)(2005-8#3)(2006-10#5)(2006-12#1)(2006-2#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-1#3)(2008-10#2)(2008-11#5)(2008-3#2)(2008-4#18)(2008-5#3)(2008-7#4)(2008-8#8)(2008-9#6)(2009-1#1)(2009-10#3)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#4)(2009-9#3)(2010-10#1)(2011-1#6)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#17)(2012-3#2)(2013-1#9)(2013-8#1)
transmembranous##2##1##(1992-12#1)(1997-6#1)
transmetallation of##2##2##(2006-9#1)(2010-5#1)
transmethylation##3##1##(1991-5#1)(1994-12#1)(2007-11#1)
transmigration of##4##2##(2007-11#1)(2008-10#2)(2011-12#1)
transmigration##10##1##(2007-11#5)(2008-10#3)(2010-9#1)(2011-12#1)
transmissibility of##3##2##(1996-12#1)(2008-10#2)
transmissibility##8##1##(1996-12#1)(2008-10#6)(2011-3#1)
transmissible and nontransmissible##2##3##(2008-10#2)
transmissible and##4##2##(1993-2#1)(2008-10#3)
transmissible by the whitefly vector##2##5##(2008-10#2)
transmissible by the##3##3##(2008-10#3)
transmissible cancers##4##2##(2009-12#4)
transmissible diseases##2##2##(2005-5#1)(2011-2#1)
transmissible from##3##2##(2007-12#1)(2008-10#2)
transmissible spongiform encephalopathies##4##3##(1996-5#1)(2006-10#1)(2008-4#1)(2009-5#1)
transmissible spongiform##5##2##(1996-5#1)(2006-10#1)(2008-4#1)(2008-5#1)(2009-5#1)
transmissible##40##1##(1993-2#1)(1993-8#1)(1996-5#1)(1996-8#1)(1997-3#1)(2005-10#1)(2005-5#1)(2006-10#3)(2007-12#1)(2007-8#1)(2008-10#11)(2008-4#1)(2008-5#2)(2009-12#5)(2009-5#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-8#2)
transmission (MTCT)##2##2##(2007-2#1)(2007-7#1)
transmission (PMTCT)##3##2##(2007-7#1)(2008-8#1)(2012-2#1)
transmission activity##2##2##(1996-2#2)
transmission among the##2##3##(2008-5#1)(2012-2#1)
transmission among##8##2##(1991-1#1)(2007-12#2)(2008-5#2)(2012-2#1)(2013-8#2)
transmission and in##2##3##(1994-12#1)(1996-1#1)
transmission and may##2##3##(1995-12#1)(2008-10#1)
transmission and prevention and##3##4##(2007-6#1)(2011-2#1)(2012-12#1)
transmission and prevention##6##3##(1992-2#1)(2007-6#1)(2011-2#2)(2012-12#2)
transmission and reflection##8##3##(2007-12#2)(2008-2#2)(2008-3#4)
transmission and solar aureole measurements##2##5##(2008-3#2)
transmission and the##9##3##(1997-7#1)(2006-3#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#1)
transmission and to##3##3##(1991-2#1)(2009-8#1)(2013-1#1)
transmission and##106##2##(1990-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-12#2)(1994-5#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#7)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#17)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#3)(2008-9#4)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#2)(2013-1#1)
transmission are not##2##3##(2007-7#1)(2008-10#1)
transmission are##10##2##(1991-6#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#1)(2012-3#1)(2013-1#1)
transmission areas##3##2##(2006-4#2)(2008-8#1)
transmission as a function of the##2##6##(2007-11#1)(2007-12#1)
transmission as a function of##4##5##(2007-11#1)(2007-12#2)(2012-2#1)
transmission at a maximum age-specific penetrance##2##6##(1997-5#2)
transmission at the##3##3##(1991-3#1)(2008-3#1)(2008-9#1)
transmission at wavelengths##2##3##(2006-7#1)(2007-12#1)
transmission at##25##2##(1991-3#1)(1992-7#2)(1995-12#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-5#2)(2006-7#1)(2007-12#3)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-5#1)(2012-2#1)
transmission bandwidth##2##2##(2007-12#1)(2008-3#1)
transmission based on##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
transmission because##2##2##(2008-2#1)(2012-3#1)
transmission between##6##2##(2007-11#1)(2007-12#1)(2007-4#1)(2008-7#2)(2011-2#1)
transmission but##6##2##(1991-6#1)(2006-2#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-8#1)
transmission by the##3##3##(2008-10#2)(2008-3#1)
transmission by##29##2##(1990-11#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-6#1)(1996-1#1)(2004-11#1)(2007-11#1)(2007-3#1)(2008-10#16)(2008-3#1)(2010-1#1)(2011-2#1)(2012-3#1)
transmission can be##6##3##(1996-7#1)(2005-7#1)(2007-12#1)(2008-10#1)(2008-3#2)
transmission can##9##2##(1994-10#1)(1996-7#1)(2005-7#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2010-12#1)
transmission changes##2##2##(2008-2#1)(2008-9#1)
transmission characteristics of##6##3##(2008-10#1)(2008-2#1)(2008-3#4)
transmission characteristics##7##2##(2008-10#1)(2008-2#1)(2008-3#5)
transmission classes##2##2##(2008-10#2)
transmission coefficient for##2##3##(2007-12#1)(2008-3#1)
transmission coefficient of##2##3##(2008-2#1)(2008-3#1)
transmission coefficient##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
transmission coefficients##6##2##(2007-12#2)(2008-2#2)(2008-3#1)(2011-2#1)
transmission control##2##2##(2011-12#2)
transmission cycle##3##2##(2008-9#1)(2010-6#2)
transmission data##6##2##(2008-2#5)(2012-2#1)
transmission delays##2##2##(1996-8#2)
transmission distance##5##2##(2007-11#3)(2007-12#2)
transmission distances##2##2##(2007-12#1)(2009-8#1)
transmission due to##3##3##(1991-5#1)(2008-3#1)(2013-1#1)
transmission during##6##2##(1993-9#1)(1996-5#1)(2007-7#3)(2008-8#1)
transmission dynamics##4##2##(1991-9#1)(1992-9#2)(1997-7#1)
transmission efficiency and##2##3##(2008-10#1)(2008-3#1)
transmission efficiency for##2##3##(2008-10#2)
transmission efficiency of the##2##4##(2008-10#2)
transmission efficiency of##5##3##(2008-10#4)(2008-3#1)
transmission efficiency was##2##3##(2008-10#1)(2008-3#1)
transmission efficiency##13##2##(2008-10#9)(2008-2#1)(2008-3#3)
transmission electron micrographs##2##3##(2009-11#1)(2009-2#1)
transmission electron microscope (TEM)##5##4##(2005-11#1)(2006-12#1)(2008-8#1)(2009-11#1)(2009-7#1)
transmission electron microscope and##2##4##(1991-12#1)(2005-11#1)
transmission electron microscope##14##3##(1991-12#1)(2005-11#2)(2006-12#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-7#1)
transmission electron microscopic images##2##4##(2010-4#1)(2013-8#1)
transmission electron microscopic##7##3##(2006-10#1)(2007-9#2)(2008-5#1)(2009-11#1)(2010-4#1)(2013-8#1)
transmission electron microscopy (TEM) and##2##5##(2006-12#1)(2010-7#1)
transmission electron microscopy (TEM)##30##4##(1995-11#1)(1996-3#1)(2005-11#3)(2006-12#2)(2007-5#1)(2007-9#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-4#1)(2010-7#3)(2010-8#1)(2011-2#2)(2012-3#1)(2013-8#1)
transmission electron microscopy and##11##4##(1995-8#1)(1997-6#1)(2005-11#1)(2007-12#1)(2008-10#4)(2008-5#1)(2009-11#1)(2009-2#1)
transmission electron microscopy images##2##4##(2006-12#2)
transmission electron microscopy of##4##4##(1992-12#1)(1994-2#1)(2007-5#1)(2008-10#1)
transmission electron microscopy reveal##2##4##(2007-12#1)(2008-2#1)
transmission electron microscopy revealed##2##4##(2004-9#1)(2013-8#1)
transmission electron microscopy showed##3##4##(2007-7#1)(2008-7#1)(2008-8#1)
transmission electron microscopy to##6##4##(2007-12#1)(2008-10#3)(2008-5#1)(2008-7#1)
transmission electron microscopy we##2##4##(2008-5#1)(2009-2#1)
transmission electron microscopy were##4##4##(2007-12#1)(2008-10#1)(2008-7#1)(2012-2#1)
transmission electron microscopy##153##3##(1990-4#1)(1992-11#1)(1992-12#2)(1994-12#1)(1994-2#1)(1995-11#1)(1995-8#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#3)(2004-9#1)(2005-11#7)(2006-10#1)(2006-12#8)(2006-7#1)(2007-12#16)(2007-4#1)(2007-5#6)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#25)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#10)(2008-7#11)(2008-8#2)(2009-11#2)(2009-12#1)(2009-2#7)(2009-7#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-4#4)(2010-7#4)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
transmission electron##181##2##(1990-4#1)(1991-12#1)(1992-11#1)(1992-12#2)(1994-12#1)(1994-2#1)(1995-11#1)(1995-8#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#3)(2004-9#1)(2005-11#9)(2005-12#1)(2006-10#2)(2006-12#9)(2006-7#1)(2007-11#1)(2007-12#18)(2007-4#1)(2007-5#6)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#5)(2008-10#26)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#12)(2008-7#14)(2008-8#3)(2009-11#5)(2009-12#1)(2009-2#8)(2009-7#4)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-4#5)(2010-7#4)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
transmission electronic microscopy##2##3##(2008-5#1)(2011-12#1)
transmission enhancement##2##2##(2007-12#2)
transmission experiment##3##2##(2007-11#1)(2008-1#1)(2008-10#1)
transmission experiments##6##2##(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-9#1)(2011-1#1)
transmission factor##5##2##(2008-2#3)(2008-3#2)
transmission fiber##3##2##(2007-11#2)(2008-1#1)
transmission for the##2##3##(2008-3#1)(2008-7#1)
transmission for##10##2##(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-7#1)(2009-3#1)
transmission from the##4##3##(1992-8#1)(1993-3#1)(2011-2#1)(2013-1#1)
transmission from##20##2##(1992-8#2)(1993-3#1)(1994-6#1)(1995-6#1)(1996-5#1)(1997-6#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-5#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-7#1)
transmission function##5##2##(2007-11#1)(2008-2#3)(2008-3#1)
transmission functions for##2##3##(2008-2#2)
transmission functions##4##2##(2007-11#1)(2008-2#3)
transmission geometry##2##2##(2007-12#1)(2008-3#1)
transmission grating##7##2##(2007-12#2)(2008-2#2)(2008-3#3)
transmission gratings##7##2##(2006-4#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
transmission has been##3##3##(1997-7#1)(2008-8#1)(2012-12#1)
transmission has##5##2##(1996-6#1)(1997-7#1)(2008-4#1)(2008-8#1)(2012-12#1)
transmission holograms##2##2##(2008-2#1)(2008-3#1)
transmission imaging of##2##3##(2007-12#1)(2008-3#1)
transmission in a##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2012-12#1)
transmission in dispersion-managed##2##3##(2007-12#2)
transmission in hippocampal##3##3##(1996-5#1)(2007-10#1)(2013-8#1)
transmission in the dentate##2##4##(1995-12#1)(1995-7#1)
transmission in the laboratory##2##4##(2008-10#2)
transmission in the mammalian brain##2##5##(1997-7#1)(2007-10#1)
transmission in the nucleus accumbens##2##5##(1993-6#2)
transmission in the##42##3##(1990-4#1)(1990-5#1)(1990-7#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#3)(1994-10#1)(1994-2#2)(1995-11#1)(1995-12#2)(1995-7#1)(1997-2#2)(1997-5#2)(1997-6#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-8#3)(2011-1#1)(2011-12#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-8#1)
transmission in##109##2##(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-2#2)(1991-5#2)(1991-6#3)(1992-3#2)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#3)(1994-10#1)(1994-2#2)(1994-4#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-7#2)(1996-12#2)(1996-5#1)(1997-2#3)(1997-5#2)(1997-6#2)(1997-7#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-10#2)(2007-11#2)(2007-12#11)(2007-2#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#6)(2008-9#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-3#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-8#5)
transmission intensity##6##2##(2006-10#1)(2006-4#1)(2008-1#2)(2008-10#1)(2008-8#1)
transmission interruption##2##2##(2011-12#2)
transmission into##2##2##(1993-12#1)(2009-6#1)
transmission is favored##2##3##(2008-9#2)
transmission is low##2##3##(2006-10#1)(2010-12#1)
transmission is not##3##3##(2008-8#1)(2011-3#1)(2012-3#1)
transmission is still##2##3##(2006-10#1)(2013-1#1)
transmission is the##3##3##(2006-10#1)(2007-7#1)(2008-10#1)
transmission is##39##2##(1991-11#1)(1992-12#1)(1993-6#1)(1993-9#1)(1997-6#1)(2005-8#1)(2006-10#3)(2006-4#2)(2007-11#1)(2007-12#7)(2007-2#1)(2007-7#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#4)(2010-12#1)(2011-3#1)(2012-3#1)(2013-1#1)
transmission laser micro-joining of thin##2##5##(2009-7#2)
transmission laser##3##2##(2009-7#3)
transmission light##2##2##(2007-11#1)(2008-10#1)
transmission limit##2##2##(2007-12#1)(2008-2#1)
transmission line with##2##3##(2007-11#1)(2007-9#1)
transmission line##12##2##(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2012-1#1)(2012-11#1)
transmission lines is##2##3##(2007-11#1)(2008-3#1)
transmission lines##13##2##(2005-12#1)(2007-11#4)(2007-12#1)(2008-3#2)(2012-11#4)(2012-2#1)
transmission loss##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
transmission matrix##2##2##(2008-3#1)(2013-8#1)
transmission may be##3##3##(1994-10#1)(1995-12#1)(2008-8#1)
transmission may##4##2##(1991-5#1)(1994-10#1)(1995-12#1)(2008-8#1)
transmission measurement##3##2##(2007-12#1)(2008-2#1)(2008-5#1)
transmission measurements at different##2##4##(2008-2#1)(2008-3#1)
transmission measurements in##2##3##(2008-2#1)(2008-3#1)
transmission measurements of##2##3##(1990-12#1)(2008-5#1)
transmission measurements with##2##3##(2008-3#1)(2008-5#1)
transmission measurements##20##2##(1990-12#1)(1997-6#1)(2005-11#1)(2007-11#1)(2008-2#5)(2008-3#9)(2008-5#2)
transmission mechanism##2##2##(2008-10#2)
transmission microscope##2##2##(2007-12#1)(2008-2#1)
transmission mode##7##2##(2006-4#1)(2008-2#2)(2008-3#1)(2008-9#2)(2012-11#1)
transmission model##5##2##(2008-10#3)(2008-2#1)(2008-3#1)
transmission near##2##2##(2008-2#1)(2008-3#1)
transmission network##2##2##(2013-1#2)
transmission occurred##2##2##(2008-10#2)
transmission of AIDS##3##3##(1996-2#1)(2004-10#1)(2004-9#1)
transmission of HCV infection in##2##5##(2007-7#2)
transmission of HIV and other sexually transmitted infections##2##8##(2012-3#2)
transmission of HIV and##4##4##(2006-10#1)(2007-7#1)(2012-3#2)
transmission of HIV in##4##4##(1994-4#1)(2009-4#1)(2012-2#1)(2013-1#1)
transmission of HIV infection in a##2##6##(2007-8#2)
transmission of HIV infection##3##4##(1993-3#1)(2007-8#2)
transmission of HIV##31##3##(1991-3#1)(1991-5#1)(1993-3#1)(1994-4#1)(1995-3#3)(1995-6#2)(1996-5#1)(2006-10#4)(2007-2#1)(2007-7#1)(2007-8#2)(2009-4#3)(2009-7#1)(2010-12#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
transmission of HIV-1##4##3##(1992-8#1)(1994-7#1)(2006-10#1)(2009-4#1)
transmission of Mycobacterium##2##3##(2005-7#1)(2007-12#1)
transmission of SIVs##2##3##(2013-1#1)(2013-8#1)
transmission of TSWV##2##3##(2008-10#2)
transmission of TYMV in##2##4##(2008-10#2)
transmission of a##10##3##(2005-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)(2009-2#1)
transmission of an##3##3##(2004-11#1)(2008-1#1)(2010-2#1)
transmission of black-pigmented##2##3##(2006-8#2)
transmission of bloodborne##2##3##(2007-12#1)(2012-1#1)
transmission of both##4##3##(1994-11#1)(1997-7#1)(2008-10#1)(2009-4#1)
transmission of extracellular signals##3##4##(2008-1#1)(2008-2#1)(2009-8#1)
transmission of food preference##2##4##(2008-4#2)
transmission of hepatitis C virus##2##5##(2007-7#2)
transmission of hepatitis C##4##4##(1995-9#1)(2007-7#2)(2008-1#1)
transmission of hepatitis##5##3##(1995-9#1)(1996-3#1)(2007-7#2)(2008-1#1)
transmission of human##5##3##(1992-2#1)(2006-10#1)(2007-7#2)(2008-8#1)
transmission of impulses##2##3##(2006-12#1)(2007-10#1)
transmission of infection and##3##4##(2006-10#1)(2006-8#1)(2009-5#1)
transmission of infection##9##3##(2006-10#2)(2006-8#1)(2007-11#1)(2007-7#1)(2009-5#1)(2010-5#2)(2013-8#1)
transmission of information##6##3##(1990-11#1)(2006-5#1)(2008-2#1)(2008-5#1)(2010-8#2)
transmission of laser##2##3##(2008-3#2)
transmission of light through##2##4##(2008-3#2)
transmission of light##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
transmission of nociceptive##2##3##(1993-7#1)(2006-12#1)
transmission of poliovirus##2##3##(1995-5#1)(2008-4#1)
transmission of prion diseases##2##4##(1997-3#1)(2006-10#1)
transmission of prion##3##3##(1997-3#1)(2006-10#1)(2008-11#1)
transmission of schistosomiasis##3##3##(2008-8#2)(2012-3#1)
transmission of sexually transmitted##3##4##(1997-7#2)(2007-12#1)
transmission of signals##2##3##(1996-10#1)(1996-7#1)
transmission of the signal##2##4##(1991-11#2)
transmission of the virus##3##4##(1996-11#1)(2008-10#1)(2010-12#1)
transmission of the##27##3##(1991-11#2)(1993-6#1)(1994-3#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-8#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-2#2)(2008-3#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-12#1)(2011-1#1)(2011-3#1)
transmission of these bacteria##2##4##(2006-10#1)(2006-8#1)
transmission of these##3##3##(1997-6#1)(2006-10#1)(2006-8#1)
transmission of this##5##3##(1996-9#1)(2008-10#2)(2013-1#2)
transmission of two##2##3##(2008-3#1)(2008-9#1)
transmission of virus##2##3##(2008-10#2)
transmission of x rays##2##4##(2007-11#1)(2008-3#1)
transmission of##321##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-10#1)(1991-11#3)(1991-3#2)(1991-5#3)(1991-8#1)(1992-11#1)(1992-2#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-4#1)(1994-7#1)(1994-8#1)(1995-3#3)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#4)(2004-10#1)(2004-11#4)(2004-9#1)(2005-12#1)(2005-7#2)(2005-8#2)(2006-10#14)(2006-11#1)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#6)(2007-10#1)(2007-11#8)(2007-12#14)(2007-2#3)(2007-7#10)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#37)(2008-11#3)(2008-12#3)(2008-2#14)(2008-3#19)(2008-4#6)(2008-5#6)(2008-7#1)(2008-8#7)(2008-9#4)(2009-2#5)(2009-4#5)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#4)(2010-12#2)(2010-2#4)(2010-4#1)(2010-5#2)(2010-8#4)(2010-9#1)(2011-1#6)(2011-2#4)(2011-3#2)(2012-1#2)(2012-12#6)(2012-2#3)(2012-3#4)(2013-1#12)(2013-8#5)
transmission on the##2##3##(1995-11#1)(2008-3#1)
transmission on##6##2##(1993-2#1)(1995-11#1)(2007-12#1)(2008-3#2)(2008-8#1)
transmission or by##2##3##(2006-4#1)(2007-9#1)
transmission or##12##2##(1995-12#1)(1995-2#1)(2006-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-12#5)
transmission over a##3##3##(2007-12#1)(2008-2#2)
transmission over standard fiber##2##4##(2007-12#2)
transmission over##12##2##(2007-12#6)(2008-2#5)(2008-9#1)
transmission parameters##2##2##(1991-2#1)(2008-10#1)
transmission patterns##3##2##(2007-6#1)(2008-3#1)(2013-1#1)
transmission peaks##2##2##(2006-4#1)(2007-12#1)
transmission per##3##2##(2007-12#1)(2008-3#1)(2011-3#1)
transmission performance##4##2##(2007-11#2)(2008-3#1)(2008-4#1)
transmission phase##2##2##(2006-4#1)(2007-12#1)
transmission potential##2##2##(2008-2#1)(2012-12#1)
transmission profile##2##2##(2008-2#1)(2008-5#1)
transmission properties of a##2##4##(2007-12#1)(2008-10#1)
transmission properties of the##2##4##(1995-11#1)(2007-11#1)
transmission properties of##8##3##(1995-11#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)
transmission properties##11##2##(1995-11#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#3)(2008-7#1)
transmission protocol##2##2##(2006-6#1)(2008-2#1)
transmission quality##2##2##(2007-12#2)
transmission rate by##2##3##(2008-10#1)(2008-3#1)
transmission rate of the##2##4##(2008-8#1)(2008-9#1)
transmission rate of##3##3##(2007-12#1)(2008-8#1)(2008-9#1)
transmission rate##15##2##(1996-1#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-5#2)(2008-8#2)(2008-9#1)
transmission rates in##2##3##(1990-6#1)(2008-10#1)
transmission rates to##2##3##(2006-10#1)(2013-8#1)
transmission rates##10##2##(1990-6#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2012-2#1)(2013-8#1)
transmission regions##2##2##(2012-12#1)(2012-3#1)
transmission resulting from the##2##4##(1990-6#1)(2008-3#1)
transmission risk##3##2##(1991-2#1)(2008-8#1)(2012-12#1)
transmission risks##3##2##(2005-10#1)(2007-2#1)(2008-3#1)
transmission route and##2##3##(1997-7#1)(2007-11#1)
transmission route##4##2##(1997-7#1)(2007-11#1)(2007-2#1)(2008-10#1)
transmission season##3##2##(2005-8#1)(2006-4#1)(2008-4#1)
transmission spectra and##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
transmission spectra are##2##3##(2007-12#2)
transmission spectra of the##3##4##(2007-11#2)(2008-3#1)
transmission spectra of##8##3##(2007-11#3)(2008-2#1)(2008-3#4)
transmission spectra with##2##3##(2006-5#1)(2008-3#1)
transmission spectra##28##2##(2006-5#1)(2007-11#8)(2007-12#4)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#7)(2013-8#1)
transmission spectrometry using excised human epidermis as the substrate##2##9##(2008-5#2)
transmission spectrometry##3##2##(2008-5#2)(2009-12#1)
transmission spectrophotometer##2##2##(2010-8#1)(2011-2#1)
transmission spectroscopy##5##2##(2006-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-4#1)
transmission spectrum of a##3##4##(2007-12#2)(2008-2#1)
transmission spectrum of an##2##4##(2008-2#1)(2008-3#1)
transmission spectrum of##8##3##(2007-12#3)(2008-2#3)(2008-3#2)
transmission spectrum##16##2##(2007-11#2)(2007-12#6)(2008-1#1)(2008-2#5)(2008-3#2)
transmission still##3##2##(1994-8#1)(2007-11#1)(2012-2#1)
transmission such##2##2##(1994-11#1)(2011-2#1)
transmission system is##2##3##(2007-12#1)(2008-3#1)
transmission system with##5##3##(2007-11#1)(2007-12#3)(2008-1#1)
transmission system##21##2##(2007-11#4)(2007-12#9)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#2)(2010-12#1)(2013-1#2)
transmission systems are##2##3##(2008-1#1)(2008-2#1)
transmission systems with##5##3##(2007-11#1)(2007-12#3)(2008-1#1)
transmission systems##17##2##(2007-11#5)(2007-12#8)(2008-1#2)(2008-2#2)
transmission that##7##2##(1993-12#1)(2006-4#1)(2007-12#1)(2008-1#1)(2008-3#2)(2010-2#1)
transmission through a thick dynamic distorter##2##6##(2007-12#2)
transmission through a##7##3##(2007-11#1)(2007-12#5)(2008-2#1)
transmission through an optical##2##4##(2007-12#1)(2008-3#1)
transmission through an##4##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
transmission through optical fibers##3##4##(2008-2#3)
transmission through seed was##2##4##(2008-10#2)
transmission through the##12##3##(1991-6#1)(1992-3#1)(2006-1#1)(2007-11#1)(2007-9#1)(2008-2#2)(2008-3#2)(2008-5#1)(2010-2#1)(2011-2#1)
transmission through##47##2##(1991-6#1)(1992-3#1)(2006-1#1)(2007-11#4)(2007-12#9)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-2#7)(2008-3#6)(2008-5#2)(2008-9#1)(2010-1#1)(2010-2#3)(2011-2#3)(2012-2#1)
transmission to humans##3##3##(2004-11#1)(2006-12#1)(2013-1#1)
transmission to patients is##2##4##(1992-12#1)(2008-3#1)
transmission to patients##3##3##(1992-12#2)(2008-3#1)
transmission to the##6##3##(1990-11#1)(1995-6#1)(1997-4#1)(2010-10#1)(2011-2#2)
transmission to uninfected##2##3##(2008-4#1)(2012-3#1)
transmission to##36##2##(1990-11#1)(1992-12#2)(1992-3#1)(1993-12#1)(1994-12#1)(1995-6#1)(1996-8#1)(1997-4#1)(2004-11#1)(2006-12#1)(2007-2#1)(2007-3#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#5)(2008-4#1)(2008-8#1)(2009-11#1)(2009-4#1)(2010-10#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
transmission via##3##2##(1994-10#1)(1997-7#1)(2008-9#1)
transmission was not##2##3##(2008-10#1)(2008-8#1)
transmission was##22##2##(1991-5#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-10#7)(2008-2#2)(2008-8#1)(2009-12#1)(2009-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
transmission were##8##2##(1990-7#1)(1993-12#1)(1995-3#1)(1996-5#1)(1997-5#2)(2008-2#1)(2009-10#1)
transmission window##2##2##(2007-12#2)
transmission with##8##2##(1996-12#1)(1996-5#1)(2007-11#2)(2007-12#2)(2008-3#2)
transmission within the##3##3##(2011-3#2)(2013-8#1)
transmission within##6##2##(1997-4#1)(2005-10#1)(2008-8#1)(2011-3#2)(2013-8#1)
transmission##1969##1##(1990-11#4)(1990-12#2)(1990-4#2)(1990-5#3)(1990-6#4)(1990-7#4)(1990-9#3)(1991-1#2)(1991-10#1)(1991-11#4)(1991-12#1)(1991-2#6)(1991-3#3)(1991-5#8)(1991-6#7)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#5)(1992-2#4)(1992-3#7)(1992-6#3)(1992-7#3)(1992-8#6)(1992-9#5)(1993-1#3)(1993-11#1)(1993-12#12)(1993-2#5)(1993-3#5)(1993-4#1)(1993-5#1)(1993-6#6)(1993-7#2)(1993-9#3)(1994-10#4)(1994-11#3)(1994-12#5)(1994-2#7)(1994-3#3)(1994-4#4)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#5)(1995-11#8)(1995-12#12)(1995-2#2)(1995-3#5)(1995-4#1)(1995-5#1)(1995-6#11)(1995-7#3)(1995-8#2)(1995-9#2)(1996-1#6)(1996-10#1)(1996-11#2)(1996-12#11)(1996-2#10)(1996-3#5)(1996-4#1)(1996-5#13)(1996-6#1)(1996-7#3)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#7)(1997-3#3)(1997-4#7)(1997-5#9)(1997-6#12)(1997-7#14)(1997-8#1)(2004-10#1)(2004-11#7)(2004-9#3)(2005-10#3)(2005-11#11)(2005-12#3)(2005-7#3)(2005-8#9)(2005-9#1)(2006-1#1)(2006-10#43)(2006-11#1)(2006-12#15)(2006-2#2)(2006-3#1)(2006-4#23)(2006-5#3)(2006-6#3)(2006-7#3)(2006-8#10)(2006-9#1)(2007-10#6)(2007-11#87)(2007-12#178)(2007-2#11)(2007-3#3)(2007-4#5)(2007-5#7)(2007-6#4)(2007-7#26)(2007-8#6)(2007-9#10)(2008-1#29)(2008-10#213)(2008-11#16)(2008-12#8)(2008-2#145)(2008-3#181)(2008-4#28)(2008-5#47)(2008-7#37)(2008-8#56)(2008-9#35)(2009-1#1)(2009-10#1)(2009-11#7)(2009-12#4)(2009-2#15)(2009-3#3)(2009-4#10)(2009-5#3)(2009-6#4)(2009-7#15)(2009-8#7)(2009-9#4)(2010-1#10)(2010-10#2)(2010-11#3)(2010-12#14)(2010-2#9)(2010-3#1)(2010-4#8)(2010-5#4)(2010-6#2)(2010-7#4)(2010-8#9)(2010-9#1)(2011-1#15)(2011-12#6)(2011-2#31)(2011-3#10)(2011-7#1)(2012-1#7)(2012-11#8)(2012-12#22)(2012-2#27)(2012-3#19)(2013-1#37)(2013-7#2)(2013-8#32)
transmission)##5##1##(1990-9#1)(1997-5#1)(2008-10#2)(2008-5#1)
transmission-blocking antibodies##3##2##(1991-5#3)
transmission-blocking##7##1##(1991-5#4)(2006-10#3)
transmission-interrupted provinces in##2##3##(2011-12#2)
transmission-type holographic##3##2##(2008-2#3)
transmission-type##6##1##(2007-12#1)(2008-2#4)(2008-3#1)
transmissions by##4##2##(2007-11#2)(2008-10#2)
transmissions of the##2##3##(2008-2#1)(2011-1#1)
transmissions of##4##2##(2008-2#1)(2010-12#1)(2011-1#1)(2013-1#1)
transmissions with##2##2##(2007-11#1)(2008-1#1)
transmissions##27##1##(1992-3#1)(1994-3#2)(1996-2#1)(1996-7#1)(2007-11#4)(2007-12#2)(2008-1#2)(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#2)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#2)
transmissive tilted##3##2##(2008-3#3)
transmissive##16##1##(2007-12#4)(2008-2#1)(2008-3#10)(2009-11#1)
transmissivity of a##2##3##(2008-1#1)(2008-2#1)
transmissivity of##6##2##(2007-11#1)(2008-1#2)(2008-2#1)(2008-3#1)(2013-8#1)
transmissivity##12##1##(2007-11#1)(2007-12#4)(2008-1#2)(2008-2#2)(2008-3#1)(2008-5#1)(2013-8#1)
transmissometer for##2##2##(2008-2#2)
transmit HIV##2##2##(1991-6#1)(1996-5#1)
transmit TSWV##4##2##(2008-10#4)
transmit and receive##2##3##(2008-1#1)(2008-3#1)
transmit and##6##2##(2007-12#1)(2007-9#1)(2008-1#1)(2008-3#1)(2009-5#1)(2012-2#1)
transmit information##2##2##(1990-5#1)(2007-9#1)
transmit signals to##2##3##(1996-7#1)(2010-9#1)
transmit signals##3##2##(1996-7#1)(2009-8#1)(2010-9#1)
transmit the virus##4##3##(2008-10#4)
transmit the##16##2##(1991-8#1)(2006-6#2)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-8#1)(2009-6#1)(2011-2#1)
transmit this##2##2##(1991-9#1)(2012-12#1)
transmit##89##1##(1990-5#1)(1990-9#1)(1991-6#1)(1991-8#1)(1991-9#1)(1993-3#1)(1995-4#1)(1995-7#1)(1996-11#1)(1996-5#1)(1996-7#1)(1996-9#1)(2004-11#1)(2005-7#1)(2006-10#2)(2006-6#3)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#4)(2007-9#2)(2008-1#1)(2008-10#28)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#2)(2008-8#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
transmitochondrial cell lines##2##3##(1996-5#2)
transmitochondrial##3##1##(1995-11#1)(1996-5#2)
transmits a##3##2##(1995-6#1)(2008-2#1)(2008-5#1)
transmits the##3##2##(2008-3#1)(2010-2#1)(2012-2#1)
transmits##20##1##(1994-12#1)(1995-6#1)(2005-11#1)(2007-12#2)(2008-1#2)(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-8#1)(2010-2#1)(2010-5#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-8#1)
transmittable##6##1##(2006-10#1)(2008-10#4)(2008-3#1)
transmittance and reflectance of a##2##5##(2008-2#2)
transmittance and reflectance##6##3##(2008-2#5)(2008-3#1)
transmittance and the##6##3##(2007-11#1)(2008-2#3)(2008-3#2)
transmittance and##17##2##(2007-11#2)(2008-2#8)(2008-3#7)
transmittance are##2##2##(2008-2#1)(2008-3#1)
transmittance as##2##2##(2008-2#1)(2008-3#1)
transmittance data##2##2##(2007-11#1)(2008-3#1)
transmittance in the##2##3##(2008-3#1)(2008-5#1)
transmittance in##3##2##(2008-2#1)(2008-3#1)(2008-5#1)
transmittance is##3##2##(2008-2#2)(2008-3#1)
transmittance measurements of##2##3##(2008-2#1)(2008-3#1)
transmittance measurements##15##2##(2007-11#1)(2008-2#9)(2008-3#5)
transmittance model##2##2##(2008-2#1)(2008-3#1)
transmittance of a##4##3##(2008-2#1)(2008-3#3)
transmittance of the##8##3##(2007-12#2)(2008-2#4)(2008-3#2)
transmittance of##23##2##(2007-11#3)(2007-12#2)(2008-2#8)(2008-3#10)
transmittance spectra of##3##3##(2008-3#3)
transmittance spectra##7##2##(2008-2#2)(2008-3#5)
transmittance was##2##2##(2008-3#1)(2008-5#1)
transmittance##142##1##(2006-8#1)(2007-11#9)(2007-12#4)(2007-3#1)(2008-10#4)(2008-2#61)(2008-3#55)(2008-5#5)(2009-2#1)(2012-12#1)
transmittance-detection readout##2##2##(2008-2#2)
transmittances##4##1##(2007-12#1)(2008-2#1)(2008-3#2)
transmitted HIV##2##2##(1996-5#1)(2006-10#1)
transmitted PPV to##2##3##(2008-10#2)
transmitted PPV##3##2##(2008-10#3)
transmitted along##2##2##(2006-11#1)(2008-2#1)
transmitted amplitude##2##2##(2007-11#1)(2008-1#1)
transmitted and reflected##3##3##(2007-11#1)(2008-3#2)
transmitted and##12##2##(2007-11#2)(2008-10#1)(2008-2#3)(2008-3#6)
transmitted as an##2##3##(2006-10#1)(2007-7#1)
transmitted as##4##2##(1996-3#1)(2006-10#1)(2007-7#1)(2008-1#1)
transmitted beam##9##2##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#3)
transmitted beams##2##2##(2008-2#2)
transmitted between##6##2##(1992-11#1)(2006-10#1)(2006-8#1)(2008-10#1)(2012-3#1)(2013-1#1)
transmitted by a##2##3##(2008-2#1)(2008-3#1)
transmitted by an##2##3##(2008-5#1)(2008-9#1)
transmitted by aphids##2##3##(2008-10#2)
transmitted by the fiber##2##4##(2008-2#1)(2008-3#1)
transmitted by the##24##3##(1994-8#2)(1996-1#1)(2006-4#1)(2007-11#1)(2007-2#1)(2008-10#10)(2008-2#2)(2008-3#2)(2009-12#1)(2010-1#1)(2011-2#2)
transmitted by whiteflies##2##3##(2008-10#2)
transmitted by##68##2##(1992-6#1)(1994-3#1)(1994-4#1)(1994-8#2)(1996-1#1)(1996-11#1)(1996-2#1)(2006-4#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-9#1)(2008-10#29)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#2)(2008-9#1)(2009-12#1)(2009-4#1)(2010-1#1)(2010-2#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)
transmitted disease (STD)##5##3##(1992-12#1)(1992-2#1)(1992-5#1)(1996-12#1)(2009-5#1)
transmitted disease and##3##3##(1991-10#1)(2008-4#1)(2011-2#1)
transmitted disease##15##2##(1991-10#1)(1992-12#1)(1992-2#1)(1992-5#1)(1995-4#1)(1996-12#2)(2007-11#1)(2008-4#2)(2009-5#1)(2011-2#2)(2012-1#1)(2012-3#1)
transmitted diseases (STD)##3##3##(1990-3#1)(1990-6#1)(2006-10#1)
transmitted diseases (STDs)##2##3##(1992-2#1)(2011-2#1)
transmitted diseases and##3##3##(1990-11#1)(2004-10#1)(2006-10#1)
transmitted diseases are##4##3##(2006-10#2)(2008-12#1)(2010-7#1)
transmitted diseases##55##2##(1990-11#1)(1990-3#1)(1990-6#1)(1991-12#3)(1991-5#1)(1991-6#1)(1992-2#2)(1992-4#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-6#1)(1995-9#2)(1996-11#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#2)(2004-10#1)(2005-11#1)(2006-10#5)(2007-2#1)(2007-7#4)(2008-12#1)(2009-10#1)(2009-12#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
transmitted efficiently##2##2##(1991-8#1)(2008-10#1)
transmitted field##6##2##(2007-11#1)(2007-12#1)(2008-3#4)
transmitted from one##3##3##(2006-10#1)(2008-10#1)(2008-3#1)
transmitted from the##6##3##(2006-8#1)(2008-11#1)(2008-2#1)(2008-7#3)
transmitted from##22##2##(1990-3#1)(1990-9#1)(1996-3#1)(1997-6#1)(2006-10#2)(2006-8#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#3)(2008-9#1)(2010-5#1)
transmitted in a##2##3##(2008-10#1)(2008-2#1)
transmitted in an##2##3##(1994-8#1)(2005-11#1)
transmitted in the##4##3##(1996-8#1)(2008-1#1)(2008-10#1)(2008-7#1)
transmitted in##14##2##(1994-8#1)(1996-8#1)(2005-11#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-7#1)
transmitted infection##9##2##(2007-12#3)(2007-7#2)(2008-11#1)(2008-12#1)(2009-5#2)
transmitted infections (STIs)##10##3##(2007-7#4)(2008-12#1)(2011-2#1)(2012-12#1)(2012-3#3)
transmitted infections##52##2##(1994-3#1)(2006-10#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-7#6)(2008-1#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-5#3)(2010-11#1)(2010-2#1)(2011-1#2)(2011-12#2)(2011-2#6)(2012-12#5)(2012-2#1)(2012-3#6)(2013-1#2)(2013-8#1)
transmitted laser beam##2##3##(2008-3#1)(2009-11#1)
transmitted laser light##3##3##(2007-12#2)(2008-3#1)
transmitted laser##5##2##(2007-12#2)(2008-3#2)(2009-11#1)
transmitted light intensity##2##3##(2008-2#1)(2008-3#1)
transmitted light##16##2##(1997-6#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#5)(2009-5#1)
transmitted only##3##2##(1994-3#1)(2008-10#2)
transmitted over a##2##3##(2007-12#1)(2008-2#1)
transmitted over##5##2##(1992-3#1)(2007-12#1)(2008-2#2)(2009-9#1)
transmitted primarily##2##2##(2009-10#1)(2012-12#1)
transmitted pulse##3##2##(2007-12#2)(2008-2#1)
transmitted pump##2##2##(2007-12#2)
transmitted sexually##2##2##(1996-8#1)(2011-2#1)
transmitted signal##2##2##(2008-3#2)
transmitted solar##2##2##(2008-2#1)(2008-3#1)
transmitted the##6##2##(1990-8#1)(1992-6#1)(2008-10#4)
transmitted through a##5##3##(2007-12#1)(2008-2#3)(2008-3#1)
transmitted through an##2##3##(2008-2#2)
transmitted through biting##2##3##(1996-12#1)(1996-5#1)
transmitted through blood transfusion##2##4##(2012-2#2)
transmitted through blood##3##3##(2012-2#3)
transmitted through the##14##3##(2007-11#1)(2007-12#4)(2008-1#1)(2008-2#3)(2008-3#4)(2009-4#1)
transmitted through##44##2##(1995-11#1)(1996-12#1)(1996-5#3)(1997-8#1)(2007-11#2)(2007-12#8)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#8)(2008-3#8)(2009-4#1)(2009-5#1)(2010-12#1)(2012-2#3)
transmitted to and##2##3##(1990-5#1)(2010-9#1)
transmitted to humans by##2##4##(2008-1#1)(2011-2#1)
transmitted to humans##3##3##(2008-1#1)(2011-2#1)(2013-8#1)
transmitted to the##13##3##(1992-11#1)(1992-2#1)(1992-6#1)(1993-3#1)(1993-9#1)(1994-5#2)(1995-5#1)(2006-11#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
transmitted to##30##2##(1990-5#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-3#1)(1993-9#1)(1994-5#2)(1995-11#1)(1995-5#1)(1995-9#1)(2005-7#2)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#3)(2009-8#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
transmitted vertically##2##2##(1995-9#1)(2007-12#1)
transmitted via##7##2##(1990-6#1)(1992-2#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-10#1)(2012-12#1)
transmitted viral##3##2##(2006-6#1)(2008-11#1)(2013-1#1)
transmitted with##3##2##(1997-6#1)(2008-10#1)(2009-10#1)
transmitted##539##1##(1990-11#1)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-10#2)(1991-12#3)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#8)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#3)(1993-1#3)(1993-2#2)(1993-3#2)(1993-6#2)(1993-9#2)(1994-11#1)(1994-12#2)(1994-3#4)(1994-4#1)(1994-5#2)(1994-7#1)(1994-8#3)(1995-1#1)(1995-11#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-9#4)(1996-1#1)(1996-11#2)(1996-12#4)(1996-2#1)(1996-3#3)(1996-5#4)(1996-6#2)(1996-8#2)(1996-9#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#1)(2004-10#1)(2004-11#2)(2004-4#3)(2004-9#1)(2005-11#2)(2005-7#3)(2006-10#14)(2006-11#3)(2006-12#1)(2006-2#2)(2006-4#2)(2006-6#1)(2006-8#2)(2007-11#13)(2007-12#38)(2007-2#7)(2007-3#2)(2007-4#1)(2007-7#18)(2007-9#4)(2008-1#10)(2008-10#82)(2008-11#5)(2008-12#6)(2008-2#39)(2008-3#46)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#3)(2009-10#4)(2009-11#1)(2009-12#3)(2009-4#2)(2009-5#8)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#3)(2010-2#3)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#21)(2012-1#2)(2012-11#1)(2012-12#11)(2012-2#9)(2012-3#10)(2013-1#10)(2013-8#6)
transmitter and a##2##3##(2008-3#2)
transmitter and receiver##6##3##(2007-11#1)(2008-2#1)(2008-3#3)(2010-12#1)
transmitter and##14##2##(2007-11#3)(2008-2#2)(2008-3#8)(2010-12#1)
transmitter for##2##2##(2008-2#1)(2009-10#1)
transmitter has##2##2##(2007-12#1)(2008-2#1)
transmitter in the##4##3##(1990-7#1)(1993-3#1)(1997-6#1)(2008-7#1)
transmitter in##7##2##(1990-11#1)(1990-7#1)(1993-3#1)(1997-6#1)(2008-3#1)(2008-7#2)
transmitter is##3##2##(2007-11#1)(2008-1#1)(2008-3#1)
transmitter laser##2##2##(2007-11#1)(2007-12#1)
transmitter levels in##2##3##(1993-12#1)(1996-12#1)
transmitter levels##3##2##(1993-12#1)(1996-12#1)(1996-5#1)
transmitter of the##2##3##(1990-7#1)(1994-2#1)
transmitter of##3##2##(1990-7#1)(1992-6#1)(1994-2#1)
transmitter on##3##2##(2007-12#1)(2013-8#2)
transmitter or##2##2##(2007-12#1)(2008-7#1)
transmitter power##3##2##(2007-12#1)(2008-3#1)(2010-12#1)
transmitter release in##3##3##(1990-2#1)(1990-5#1)(1996-1#1)
transmitter release##14##2##(1990-2#1)(1990-4#1)(1990-5#1)(1992-8#4)(1993-2#1)(1994-9#1)(1995-11#2)(1996-1#1)(1997-8#2)
transmitter source##2##2##(2007-12#2)
transmitter systems##3##2##(1993-12#1)(1993-3#1)(2008-11#1)
transmitter##111##1##(1990-11#1)(1990-2#3)(1990-4#1)(1990-5#1)(1990-7#4)(1991-3#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#5)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1994-2#3)(1994-9#1)(1995-11#3)(1995-12#3)(1995-6#1)(1995-7#2)(1996-1#1)(1996-12#3)(1996-5#1)(1997-4#1)(1997-6#2)(1997-8#2)(2005-8#1)(2006-1#1)(2007-11#6)(2007-12#11)(2007-9#1)(2008-1#1)(2008-11#2)(2008-2#10)(2008-3#16)(2008-5#1)(2008-7#3)(2009-10#1)(2010-12#2)(2012-2#2)(2013-7#2)(2013-8#2)
transmitter-receiver##3##1##(2007-12#1)(2008-2#2)
transmitters (up to##2##3##(2008-10#2)
transmitters and##5##2##(1991-5#1)(2006-12#1)(2008-2#2)(2008-8#1)
transmitters in the##2##3##(1992-8#1)(2013-8#1)
transmitters in##3##2##(1992-8#1)(2013-8#2)
transmitters to##2##2##(1997-4#1)(2006-10#1)
transmitters##30##1##(1991-5#1)(1992-6#1)(1992-8#1)(1993-9#1)(1994-2#1)(1995-11#2)(1995-12#1)(1997-2#1)(1997-4#1)(2006-10#2)(2006-12#1)(2007-10#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#1)(2009-12#1)(2013-8#3)
transmitting HIV##2##2##(1996-6#1)(2012-3#1)
transmitting light##2##2##(2008-10#1)(2008-2#1)
transmitting the virus##2##3##(2008-10#2)
transmitting the##7##2##(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2012-11#1)
transmitting##51##1##(1992-9#1)(1993-3#1)(1994-6#1)(1995-12#1)(1996-6#1)(1997-2#1)(1997-5#1)(2006-10#2)(2006-7#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#8)(2008-2#6)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#2)(2010-1#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-2#3)(2012-3#1)
transmittive filters##2##2##(2008-2#2)
transmittive##3##1##(2008-2#3)
transmittivity spectrum of##2##3##(2005-4#2)
transmittivity##5##1##(2005-4#4)(2008-2#1)
transmucosal fentanyl citrate##3##3##(2007-2#3)
transmucosal##8##1##(1997-2#2)(2007-2#3)(2010-5#1)(2011-12#1)(2011-2#1)
transmucous absorption##2##2##(1993-10#2)
transmural and##3##2##(2008-10#1)(2010-8#1)(2013-7#1)
transmural dispersion of repolarization and##2##5##(2009-8#1)(2010-8#1)
transmural dispersion of repolarization##4##4##(2007-9#2)(2009-8#1)(2010-8#1)
transmural pressure##3##2##(2006-10#1)(2007-8#1)(2007-9#1)
transmural##29##1##(1990-11#1)(1990-5#1)(1991-3#1)(1991-7#1)(1993-7#1)(2006-10#1)(2007-5#1)(2007-8#3)(2007-9#4)(2008-10#2)(2008-11#2)(2008-7#1)(2009-8#1)(2010-11#1)(2010-8#3)(2012-2#1)(2013-1#1)(2013-7#3)
transmurality and##2##2##(1993-10#1)(2010-6#1)
transmyocardial laser revascularization##2##3##(2007-8#2)
transmyocardial revascularisation##4##2##(2007-8#4)
transmyocardial##7##1##(2007-8#6)(2009-8#1)
transnasal approach to the##2##4##(2011-2#2)
transnasal approach##5##2##(2007-1#2)(2011-2#3)
transnasal endoscopic approach##2##3##(2007-9#1)(2011-2#1)
transnasal endoscopic##6##2##(2006-12#2)(2007-9#1)(2011-2#2)(2013-8#1)
transnasal sphenopalatine##2##2##(2006-7#1)(2008-8#1)
transnasal surgery##4##2##(2007-1#3)(2009-2#1)
transnasal##26##1##(1991-1#1)(2006-12#2)(2006-7#2)(2007-1#5)(2007-2#1)(2007-9#1)(2008-8#1)(2009-2#1)(2010-12#1)(2011-2#8)(2012-1#1)(2013-1#1)(2013-8#1)
transnational health##2##2##(2005-10#2)
transnational##8##1##(2005-10#4)(2010-5#1)(2012-3#3)
transneuronal labeling##6##2##(1993-7#2)(1995-7#4)
transneuronal##12##1##(1993-7#2)(1993-9#1)(1994-2#2)(1995-6#1)(1995-7#5)(1997-5#1)
transnitrosation reaction##3##2##(1995-5#3)
transoceanic##6##1##(2007-12#4)(2009-2#2)
transoesophageal echocardiography is##2##3##(1994-11#1)(2006-4#1)
transoesophageal echocardiography##12##2##(1993-12#1)(1994-11#1)(2006-10#2)(2006-4#2)(2007-8#1)(2007-9#3)(2012-2#1)(2012-3#1)
transoesophageal##14##1##(1993-12#1)(1994-11#1)(2006-10#2)(2006-4#3)(2007-8#1)(2007-9#3)(2008-8#1)(2012-2#1)(2012-3#1)
transoral and##2##2##(2006-9#1)(2011-2#1)
transoral laser surgery is##2##4##(1991-4#1)(2011-1#1)
transoral laser surgery##4##3##(1991-4#1)(2011-1#3)
transoral odontoidectomy##2##2##(2006-9#2)
transoral##19##1##(1991-4#1)(2006-6#2)(2006-9#6)(2008-12#1)(2008-2#1)(2011-1#4)(2011-2#3)(2012-2#1)
transovarial transmission##3##2##(2008-10#3)
transovarial##4##1##(2008-10#4)
transpalpebral##3##1##(2011-2#3)
transpapillary##6##1##(1990-3#2)(1991-3#1)(2007-5#1)(2013-1#2)
transparencies##6##1##(1995-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
transparency and##13##2##(1993-5#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-4#2)(2012-2#1)(2013-1#1)
transparency in clinical##3##3##(2008-8#1)(2013-1#2)
transparency in the##3##3##(2008-1#1)(2008-2#1)(2010-4#1)
transparency in##17##2##(2007-12#1)(2008-1#3)(2008-11#1)(2008-2#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-2#2)(2013-1#4)
transparency of the##7##3##(2008-4#1)(2008-5#1)(2008-7#2)(2010-2#1)(2011-1#1)(2013-8#1)
transparency of##10##2##(1990-4#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-2#1)(2011-1#1)(2013-7#1)(2013-8#1)
transparency range##2##2##(2007-12#1)(2008-3#1)
transparency that##2##2##(2005-5#1)(2007-3#1)
transparency window##2##2##(2007-12#1)(2009-4#1)
transparency##95##1##(1990-4#1)(1993-5#1)(2005-5#1)(2006-5#1)(2007-11#3)(2007-12#15)(2007-3#1)(2007-8#2)(2008-1#5)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#5)(2008-4#1)(2008-5#4)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#5)(2011-1#2)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#5)
transparent and turbid##2##3##(1994-3#1)(2007-11#1)
transparent and##18##2##(1994-3#1)(1995-5#1)(1995-6#1)(2005-5#1)(2007-11#1)(2007-12#5)(2008-11#1)(2008-7#2)(2009-12#1)(2009-9#2)(2011-2#1)(2013-7#1)
transparent at##2##2##(2006-12#1)(2008-2#1)
transparent birefringent##2##2##(2008-2#2)
transparent cap##2##2##(2008-5#2)
transparent ceramic##3##2##(2013-8#3)
transparent ceramics were##2##3##(2013-8#2)
transparent dielectric##2##2##(2007-12#1)(2008-2#1)
transparent elastomeric##2##2##(2008-3#2)
transparent electrodes##2##2##(2008-3#1)(2008-7#1)
transparent film##2##2##(2007-11#1)(2008-11#1)
transparent films##3##2##(2007-12#1)(2008-2#2)
transparent glass ceramic##2##3##(2008-3#2)
transparent glass##8##2##(2008-10#1)(2008-2#4)(2008-3#3)
transparent in the##5##3##(2007-12#4)(2013-1#1)
transparent in##6##2##(2007-12#4)(2008-4#1)(2013-1#1)
transparent indium tin oxide##2##4##(2008-11#1)(2009-12#1)
transparent liquid##3##2##(2008-2#1)(2008-3#1)(2013-8#1)
transparent materials##7##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)(2009-5#1)
transparent media##5##2##(2007-11#3)(2007-12#1)(2008-2#1)
transparent objects##2##2##(2007-12#1)(2008-2#1)
transparent or##6##2##(2008-2#2)(2008-3#4)
transparent particles##2##2##(2008-2#1)(2008-3#1)
transparent plastic##2##2##(2006-6#1)(2008-1#1)
transparent plate##3##2##(2007-12#1)(2008-2#2)
transparent plates##6##2##(2007-12#4)(2008-3#2)
transparent polymer##2##2##(2006-2#1)(2008-1#1)
transparent samples##4##2##(2007-12#2)(2008-3#2)
transparent substrate##4##2##(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
transparent substrates##3##2##(2008-2#3)
transparent thin##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
transparent to the##3##3##(2007-12#1)(2008-3#2)
transparent to##4##2##(2007-12#1)(2008-3#3)
transparent##212##1##(1991-6#1)(1994-3#1)(1995-5#1)(1995-6#1)(1997-4#1)(1997-6#1)(2005-11#1)(2005-5#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#9)(2007-12#30)(2007-3#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#11)(2008-11#7)(2008-2#43)(2008-3#32)(2008-4#1)(2008-5#12)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#7)(2009-5#1)(2009-9#4)(2010-1#1)(2010-11#1)(2010-3#2)(2010-4#5)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#7)
transpedicular approach##3##2##(2005-2#1)(2007-1#2)
transpedicular fixation##11##2##(2006-8#4)(2007-11#4)(2008-4#2)(2008-6#1)
transpedicular screw fixation##2##3##(2006-8#1)(2012-2#1)
transpedicular screw##5##2##(2006-8#1)(2007-11#3)(2012-2#1)
transpedicular screws##6##2##(2007-11#6)
transpedicular thoracic discectomy##2##3##(2006-7#1)(2007-1#1)
transpedicular##36##1##(2005-2#2)(2006-7#2)(2006-8#5)(2007-1#4)(2007-11#16)(2007-7#2)(2007-8#1)(2008-4#2)(2008-6#1)(2012-2#1)
transpediculate vertebroplasty##2##2##(2006-8#2)
transpediculate##3##1##(2006-8#3)
transpeptidase in##2##2##(1992-9#1)(2011-2#1)
transpeptidase##16##1##(1990-3#1)(1991-5#2)(1991-9#1)(1992-1#1)(1992-9#3)(1995-11#2)(2007-12#1)(2007-8#1)(2008-4#1)(2010-2#1)(2011-2#2)
transpeptidation and##2##2##(2006-12#2)
transperineal##2##1##(1995-4#1)(2010-11#1)
transperitoneal approach##2##2##(2007-7#1)(2012-12#1)
transperitoneal procedures##2##2##(1996-12#1)(2006-8#1)
transperitoneal##7##1##(1993-10#1)(1996-12#1)(2006-8#1)(2007-7#1)(2008-10#1)(2011-2#1)(2012-12#1)
transpetrosal approach##5##2##(2006-12#2)(2008-7#3)
transpetrosal##7##1##(2006-12#3)(2008-7#4)
transpharyngeal##3##1##(1993-4#1)(2006-9#1)(2007-11#1)
transphosphorylation of##2##2##(1995-2#2)
transphosphorylation##4##1##(1991-1#1)(1995-1#1)(1995-2#2)
transpiration##8##1##(2008-10#7)(2012-7#1)
transpired##2##1##(2006-8#1)(2008-10#1)
transpiring##2##1##(2008-11#1)(2008-7#1)
transplacental passage of##2##3##(1992-4#1)(2010-6#1)
transplacental##6##1##(1990-7#1)(1991-3#1)(1992-4#1)(2010-6#1)(2011-2#2)
transplant (LT)##2##2##(2011-3#1)(2013-1#1)
transplant after##3##2##(1994-6#1)(2012-1#1)(2013-7#1)
transplant and##4##2##(2006-10#1)(2007-10#1)(2007-7#1)(2008-1#1)
transplant are not##2##3##(2011-2#1)(2012-12#1)
transplant are##4##2##(2011-2#2)(2012-12#1)(2013-1#1)
transplant by##2##2##(2010-11#1)(2013-1#1)
transplant candidates##7##2##(2006-10#1)(2007-8#5)(2013-1#1)
transplant center in##2##3##(2007-2#1)(2008-1#1)
transplant center##5##2##(2007-2#1)(2008-1#1)(2009-2#3)
transplant centers in##3##3##(2008-1#3)
transplant centers##10##2##(2006-10#1)(2007-7#1)(2008-1#3)(2008-4#1)(2010-6#1)(2010-8#2)(2011-3#1)
transplant centres##2##2##(2007-11#2)
transplant complications##3##2##(2008-1#2)(2010-10#1)
transplant coronary artery disease##2##4##(1997-7#2)
transplant duration##2##2##(2007-8#1)(2008-1#1)
transplant experiment##4##2##(2004-2#1)(2008-8#1)(2008-9#2)
transplant failure##2##2##(1994-3#1)(2007-8#1)
transplant for##3##2##(1992-3#1)(1994-5#1)(2013-1#1)
transplant from a##2##3##(2010-10#1)(2011-2#1)
transplant from##3##2##(2010-10#1)(2011-2#2)
transplant has##4##2##(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)
transplant immunology##2##2##(1995-12#1)(2006-10#1)
transplant in the##2##3##(1991-11#1)(2005-7#1)
transplant in three##2##3##(2007-2#1)(2008-1#1)
transplant in##8##2##(1991-11#1)(1996-6#1)(2005-7#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-11#1)(2013-8#1)
transplant is the best##2##4##(2011-2#2)
transplant is##7##2##(2006-10#1)(2006-3#2)(2010-6#1)(2011-2#3)
transplant model##3##2##(1997-6#1)(2008-11#1)(2009-2#1)
transplant models##3##2##(2008-11#1)(2010-7#1)(2012-12#1)
transplant nephrectomy##2##2##(1995-2#2)
transplant of##2##2##(1994-3#2)
transplant or##3##2##(2007-7#1)(2007-8#1)(2008-3#1)
transplant outcome##6##2##(1997-8#1)(2007-8#4)(2010-5#1)
transplant patient##10##2##(1991-3#1)(2005-10#1)(2006-10#1)(2007-2#1)(2007-7#2)(2008-1#1)(2013-1#2)(2013-7#1)
transplant patients at##3##3##(2008-1#3)
transplant patients is##2##3##(1994-5#1)(2008-1#1)
transplant patients to##2##3##(2006-6#1)(2008-4#1)
transplant patients with##6##3##(1995-2#2)(2008-1#1)(2011-2#1)(2012-12#2)
transplant patients##60##2##(1990-3#1)(1991-3#1)(1994-5#3)(1995-2#10)(1996-8#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-11#3)(2007-8#4)(2008-1#18)(2008-10#3)(2008-3#1)(2008-4#2)(2008-8#1)(2009-10#2)(2010-11#1)(2010-7#1)(2011-2#1)(2012-12#3)(2013-1#1)
transplant physicians##2##2##(2007-5#1)(2008-4#1)
transplant population in Saudi Arabia##2##5##(2008-1#2)
transplant population##5##2##(2007-12#1)(2007-7#1)(2008-1#3)
transplant procedure##2##2##(2011-3#1)(2012-12#1)
transplant procedures##2##2##(2007-2#1)(2013-1#1)
transplant program at the##2##4##(2008-1#1)(2009-3#1)
transplant program at##3##3##(2008-1#2)(2009-3#1)
transplant program##8##2##(1996-6#1)(2007-7#1)(2008-1#3)(2009-3#1)(2011-2#1)(2013-8#1)
transplant programme##2##2##(2006-10#1)(2010-7#1)
transplant programs##2##2##(2008-4#1)(2011-2#1)
transplant recipient caused by##3##4##(2007-7#1)(2009-2#2)
transplant recipient who##4##3##(1996-12#1)(2008-1#1)(2010-12#1)(2012-3#1)
transplant recipient##29##2##(1995-2#1)(1996-12#1)(2006-10#4)(2007-7#3)(2008-1#5)(2008-6#1)(2009-2#2)(2009-8#1)(2010-12#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
transplant recipients and##7##3##(1990-10#1)(1991-12#1)(1992-10#1)(2007-5#1)(2008-4#1)(2010-12#1)(2012-12#1)
transplant recipients are##4##3##(2006-10#1)(2007-11#1)(2008-1#1)(2008-3#1)
transplant recipients have##2##3##(1995-12#1)(2007-11#1)
transplant recipients in##3##3##(1995-2#1)(2007-7#2)
transplant recipients is##6##3##(2007-11#3)(2008-3#2)(2010-9#1)
transplant recipients were##4##3##(1995-2#1)(2007-11#1)(2007-2#1)(2008-4#1)
transplant recipients who are##3##4##(2007-11#1)(2007-8#2)
transplant recipients who##4##3##(2007-11#1)(2007-8#2)(2008-4#1)
transplant recipients with##3##3##(1995-2#1)(2007-11#2)
transplant recipients##120##2##(1990-10#1)(1991-11#2)(1991-12#1)(1992-10#1)(1993-11#1)(1995-12#1)(1995-2#13)(1996-1#1)(1996-3#3)(1997-2#1)(2005-12#1)(2006-10#9)(2007-11#25)(2007-12#8)(2007-2#1)(2007-5#2)(2007-7#4)(2007-8#6)(2008-1#9)(2008-10#2)(2008-3#8)(2008-4#8)(2008-6#2)(2008-8#1)(2009-10#1)(2010-12#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#2)
transplant rejection and##2##3##(2005-7#1)(2008-11#1)
transplant rejection in##2##3##(2007-11#1)(2012-3#1)
transplant rejection##16##2##(1995-2#2)(1995-8#1)(2005-7#2)(2005-8#1)(2005-9#2)(2007-11#1)(2008-10#1)(2008-11#3)(2008-8#1)(2009-10#1)(2012-3#1)
transplant renal artery##3##3##(2008-1#2)(2008-4#1)
transplant renal##4##2##(2008-1#2)(2008-4#2)
transplant setting##4##2##(1995-2#1)(2006-10#1)(2008-3#1)(2010-4#1)
transplant should##3##2##(2007-8#1)(2011-2#1)(2012-12#1)
transplant study##2##2##(1997-4#1)(2008-4#1)
transplant surgeons##2##2##(2007-5#1)(2009-2#1)
transplant teams and##2##3##(1995-12#1)(2011-3#1)
transplant teams##3##2##(1995-12#1)(2011-2#1)(2011-3#1)
transplant tissues##2##2##(1991-5#1)(2008-1#1)
transplant unit##3##2##(1991-7#1)(1994-10#1)(2013-1#1)
transplant was performed in##3##4##(2008-1#2)(2010-11#1)
transplant was the##2##3##(1993-9#1)(2009-2#1)
transplant was##8##2##(1993-9#1)(1997-3#1)(2007-9#1)(2008-1#3)(2009-2#1)(2010-11#1)
transplant were##3##2##(2008-10#1)(2010-12#1)(2012-12#1)
transplant with##3##2##(2007-7#1)(2011-2#1)(2012-12#1)
transplant without##2##2##(2007-8#1)(2011-2#1)
transplant##589##1##(1990-10#2)(1990-3#1)(1990-8#1)(1991-11#4)(1991-12#2)(1991-3#3)(1991-5#1)(1991-7#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-10#1)(1994-3#5)(1994-5#4)(1994-6#1)(1995-1#1)(1995-12#8)(1995-2#38)(1995-8#1)(1995-9#3)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#4)(1996-6#2)(1996-8#3)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#2)(1997-7#3)(1997-8#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-7#6)(2005-8#2)(2005-9#2)(2006-10#30)(2006-2#1)(2006-3#3)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#37)(2007-12#11)(2007-2#8)(2007-5#5)(2007-7#23)(2007-8#33)(2007-9#1)(2008-1#67)(2008-10#10)(2008-11#8)(2008-3#11)(2008-4#20)(2008-5#4)(2008-6#5)(2008-7#2)(2008-8#10)(2008-9#4)(2009-10#6)(2009-2#12)(2009-3#1)(2009-4#1)(2009-8#1)(2010-10#7)(2010-11#4)(2010-12#13)(2010-4#3)(2010-5#4)(2010-6#3)(2010-7#4)(2010-8#3)(2010-9#2)(2011-1#2)(2011-2#31)(2011-3#8)(2012-1#2)(2012-12#13)(2012-2#4)(2012-3#6)(2013-1#23)(2013-7#5)(2013-8#11)
transplant-related morbidity##2##2##(2006-10#1)(2009-10#1)
transplant-related mortality##3##2##(2006-10#1)(2007-11#1)(2010-11#1)
transplant-related##7##1##(2006-10#2)(2007-11#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-11#1)
transplantability##2##1##(1990-6#1)(1995-12#1)
transplantable mouse##2##2##(2008-4#1)(2010-12#1)
transplantable organs##2##2##(1991-3#1)(1994-1#1)
transplantable##16##1##(1990-7#1)(1991-3#2)(1991-6#1)(1992-1#2)(1992-8#1)(1993-4#1)(1994-1#1)(1995-5#1)(2008-1#1)(2008-4#2)(2010-12#2)(2011-2#1)
transplantation (n = 1)##2##4##(1994-3#2)
transplantation after##3##2##(2005-11#1)(2009-5#1)(2012-12#1)
transplantation alone##3##2##(1995-2#1)(2007-11#2)
transplantation and has been shown to##2##6##(2007-11#2)
transplantation and its##4##3##(2007-10#1)(2011-2#1)(2012-2#2)
transplantation and the##3##3##(2006-10#1)(2008-10#1)(2013-8#1)
transplantation and##58##2##(1991-12#1)(1992-6#1)(1993-1#1)(1995-12#2)(1995-2#1)(2005-12#1)(2005-8#1)(2006-10#8)(2006-6#2)(2007-10#1)(2007-11#8)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#4)(2009-2#1)(2009-3#1)(2010-10#2)(2010-12#2)(2010-8#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-10#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
transplantation are at##2##3##(2006-10#1)(2006-8#1)
transplantation are based on##2##4##(1997-5#1)(2007-11#1)
transplantation are not well##2##4##(2007-8#1)(2011-2#1)
transplantation are##16##2##(1991-2#1)(1993-1#1)(1993-3#1)(1994-6#1)(1997-5#1)(2006-10#4)(2006-8#1)(2006-9#1)(2007-11#1)(2007-8#1)(2010-12#1)(2011-2#2)
transplantation as a##4##3##(1993-3#1)(1996-8#1)(2006-10#1)(2010-11#1)
transplantation as immunotherapy for##2##4##(2008-11#2)
transplantation as##11##2##(1993-3#1)(1995-7#1)(1996-8#1)(2004-11#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-11#2)(2010-11#1)
transplantation at the##4##3##(2007-11#1)(2007-2#1)(2008-1#1)(2011-2#1)
transplantation at##7##2##(1992-5#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#2)(2011-2#1)
transplantation based on##2##3##(2007-1#1)(2009-2#1)
transplantation because of##4##3##(1993-8#1)(2009-2#1)(2013-1#2)
transplantation but##5##2##(2006-10#1)(2008-11#1)(2010-12#1)(2011-2#1)(2012-12#1)
transplantation by##5##2##(1991-12#1)(2006-10#1)(2007-11#1)(2009-2#1)(2012-2#1)
transplantation can be##5##3##(2006-10#2)(2007-11#1)(2011-3#1)(2012-12#1)
transplantation can##11##2##(1997-3#1)(2005-11#1)(2006-10#3)(2007-11#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-8#2)
transplantation carries##2##2##(2008-1#1)(2010-12#1)
transplantation centres##2##2##(2008-7#1)(2008-8#1)
transplantation could be##2##3##(2008-9#1)(2010-10#1)
transplantation depends on##2##3##(2006-10#1)(2011-1#1)
transplantation due to##3##3##(2008-1#1)(2010-11#1)(2011-1#1)
transplantation for acute##3##3##(1997-5#1)(2010-10#1)(2012-2#1)
transplantation for chronic##2##3##(1990-12#1)(2012-2#1)
transplantation for metabolic##3##3##(2004-11#2)(2012-11#1)
transplantation for patients with##4##4##(1991-11#1)(2007-2#1)(2008-3#1)(2010-5#1)
transplantation for primary##2##3##(2006-10#1)(2012-12#1)
transplantation for the treatment of##4##5##(2007-11#1)(2009-3#1)(2010-12#1)(2013-1#1)
transplantation for the##7##3##(2007-11#1)(2008-3#1)(2009-3#1)(2010-12#2)(2010-6#1)(2013-1#1)
transplantation for##51##2##(1990-12#1)(1990-5#1)(1991-11#4)(1992-8#1)(1993-11#1)(1994-8#1)(1995-8#1)(1997-5#1)(2004-11#3)(2006-10#2)(2006-6#1)(2007-11#2)(2007-2#2)(2007-8#3)(2008-1#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-10#3)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#1)
transplantation from living##2##3##(2007-7#1)(2011-2#1)
transplantation from##11##2##(1992-12#1)(1995-12#1)(2007-11#2)(2007-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
transplantation has become an##2##4##(2007-2#1)(2011-3#1)
transplantation has become##4##3##(2006-10#2)(2007-2#1)(2011-3#1)
transplantation has been established as##2##5##(2006-10#1)(2007-8#1)
transplantation has been shown##2##4##(2010-11#2)
transplantation has been used##3##4##(2007-11#1)(2008-11#2)
transplantation has been##19##3##(1995-7#1)(2004-11#1)(2005-8#1)(2006-10#3)(2007-11#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#3)(2010-11#2)(2011-2#1)(2013-8#1)
transplantation has##36##2##(1990-10#1)(1991-2#1)(1995-7#1)(1996-8#1)(1997-6#1)(2004-11#1)(2005-8#1)(2006-10#9)(2007-11#3)(2007-2#2)(2007-8#1)(2007-9#1)(2008-1#3)(2008-11#3)(2010-11#3)(2011-2#1)(2011-3#1)(2012-7#1)(2013-8#1)
transplantation have been reported##2##4##(2005-11#1)(2013-8#1)
transplantation have been##5##3##(2005-11#1)(2007-11#1)(2008-11#1)(2009-6#1)(2013-8#1)
transplantation in Iran##4##3##(2007-7#1)(2008-7#2)(2009-4#1)
transplantation in Japan##2##3##(2006-10#1)(2007-12#1)
transplantation in a child##2##4##(2010-11#1)(2011-2#1)
transplantation in a patient with##4##5##(1992-12#1)(2006-10#1)(2010-4#1)(2011-2#1)
transplantation in a patient##5##4##(1992-12#1)(2006-10#1)(2010-4#1)(2011-2#1)(2012-12#1)
transplantation in a##13##3##(1991-11#1)(1992-12#1)(2004-11#1)(2005-10#1)(2006-1#1)(2006-10#1)(2007-4#1)(2010-11#1)(2010-4#1)(2011-2#3)(2012-12#1)
transplantation in acute##3##3##(1995-12#1)(1997-5#1)(2009-7#1)
transplantation in adults##2##3##(1994-4#1)(2006-10#1)
transplantation in an##2##3##(2005-10#1)(2012-12#1)
transplantation in childhood##3##3##(1995-9#1)(2008-10#1)(2012-10#1)
transplantation in children##2##3##(2006-10#1)(2007-11#1)
transplantation in diabetic patients##2##4##(2007-11#1)(2008-1#1)
transplantation in fulminant hepatic##2##4##(1990-10#1)(2006-10#1)
transplantation in mice##3##3##(2008-11#3)
transplantation in patients with##4##4##(1991-11#1)(2007-8#2)(2013-1#1)
transplantation in patients##5##3##(1991-11#1)(2004-12#1)(2007-8#2)(2013-1#1)
transplantation in the treatment of##2##5##(2011-2#2)
transplantation in the type##2##4##(2008-1#2)
transplantation in the##14##3##(1990-11#1)(1996-8#1)(2006-8#1)(2007-1#1)(2008-1#2)(2008-4#4)(2009-8#1)(2011-2#3)
transplantation in vivo##3##3##(2008-5#1)(2012-12#2)
transplantation in##106##2##(1990-10#1)(1990-11#1)(1991-10#1)(1991-11#2)(1991-8#1)(1992-12#1)(1992-6#2)(1993-10#1)(1993-3#1)(1994-3#1)(1994-4#1)(1995-12#1)(1995-9#1)(1996-6#1)(1996-8#2)(1997-5#2)(1997-6#2)(2004-11#1)(2004-12#1)(2005-10#2)(2005-12#1)(2006-1#1)(2006-10#7)(2006-8#2)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#7)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#4)(2008-5#1)(2008-7#3)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#3)(2010-4#4)(2011-1#1)(2011-2#9)(2012-1#1)(2012-10#2)(2012-12#6)(2013-1#1)(2013-8#3)
transplantation into the##5##3##(2008-7#1)(2011-2#1)(2012-12#2)(2012-2#1)
transplantation into##14##2##(1991-11#2)(1991-9#1)(1997-4#1)(2006-10#1)(2008-11#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-12#3)(2012-2#1)
transplantation is a promising##2##4##(2008-3#1)(2012-12#1)
transplantation is a##9##3##(1997-4#1)(2005-8#1)(2007-8#1)(2008-1#1)(2008-3#1)(2010-7#1)(2011-3#1)(2012-12#2)
transplantation is an##4##3##(1997-8#1)(2006-10#1)(2010-10#1)(2010-6#1)
transplantation is associated with##3##4##(2006-10#1)(2007-11#1)(2011-2#1)
transplantation is considered the##2##4##(2005-7#1)(2006-10#1)
transplantation is considered##5##3##(2005-7#1)(2006-10#1)(2008-1#1)(2010-4#1)(2011-2#1)
transplantation is essential##2##3##(1995-8#1)(2006-10#1)
transplantation is limited by##2##4##(2007-8#1)(2012-12#1)
transplantation is not##3##3##(2007-7#1)(2008-3#1)(2012-2#1)
transplantation is now##2##3##(2007-11#1)(2011-3#1)
transplantation is still##3##3##(1995-12#1)(2008-11#1)(2008-5#1)
transplantation is the only##4##4##(2006-10#1)(2006-2#1)(2006-8#1)(2010-12#1)
transplantation is the treatment of choice for most##2##8##(2006-10#1)(2007-7#1)
transplantation is the##13##3##(1995-5#1)(2005-7#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-1#1)(2007-7#1)(2008-5#1)(2010-12#1)(2010-6#1)(2011-2#1)
transplantation is to##2##3##(2006-10#1)(2010-11#1)
transplantation is##81##2##(1992-10#1)(1992-6#1)(1993-2#1)(1993-6#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-8#1)(1997-4#1)(1997-8#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-7#2)(2005-8#1)(2006-10#12)(2006-2#1)(2006-8#1)(2007-1#1)(2007-11#4)(2007-7#2)(2007-8#4)(2008-1#3)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2009-2#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#2)(2010-7#1)(2011-2#6)(2011-3#4)(2012-12#6)(2012-2#2)(2013-1#3)(2013-7#1)
transplantation may be##3##3##(2007-8#1)(2012-2#1)(2013-8#1)
transplantation may##7##2##(1991-5#1)(2006-10#1)(2007-8#2)(2012-12#1)(2012-2#1)(2013-8#1)
transplantation medicine##3##2##(2008-1#3)
transplantation model##5##2##(1991-7#1)(2006-10#1)(2008-11#1)(2008-7#1)(2009-3#1)
transplantation of a##2##3##(2008-11#1)(2010-2#1)
transplantation of autologous##3##3##(1991-12#1)(2012-1#1)(2012-2#1)
transplantation of dissociated##2##3##(1994-6#2)
transplantation of fetal##3##3##(1991-5#1)(1996-5#1)(2012-1#1)
transplantation of foetal islet cells##2##5##(1992-6#2)
transplantation of human##6##3##(2008-4#1)(2010-12#1)(2012-12#4)
transplantation of mesenchymal stem cells##8##5##(2010-12#2)(2010-2#1)(2012-1#4)(2012-7#1)
transplantation of mononuclear bone marrow cells##2##6##(2012-1#2)
transplantation of mononuclear##3##3##(2012-1#3)
transplantation of organs##2##3##(1997-6#1)(2005-11#1)
transplantation of the##3##3##(1992-1#1)(1992-6#1)(2008-9#1)
transplantation of##82##2##(1991-12#1)(1991-5#2)(1992-1#1)(1992-12#1)(1992-6#4)(1993-12#2)(1994-3#1)(1994-6#2)(1995-12#1)(1995-7#2)(1995-8#1)(1996-11#1)(1996-5#1)(1997-4#1)(1997-6#2)(2005-1#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2010-12#5)(2010-2#4)(2010-7#1)(2011-2#2)(2012-1#10)(2012-10#1)(2012-12#5)(2012-2#4)(2012-3#1)(2012-7#1)(2013-1#4)
transplantation offers##3##2##(2006-10#1)(2007-11#1)(2008-8#1)
transplantation on the##2##3##(2009-10#1)(2012-2#1)
transplantation on##6##2##(1991-10#1)(2008-4#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
transplantation or##12##2##(1991-5#1)(1993-2#1)(1996-12#1)(2005-1#1)(2007-7#1)(2007-8#1)(2008-11#2)(2010-5#1)(2012-1#2)(2013-7#1)
transplantation outcome##3##2##(1997-5#1)(2008-1#1)(2013-1#1)
transplantation outcomes##2##2##(2007-9#1)(2009-2#1)
transplantation patients##2##2##(2008-1#1)(2009-10#1)
transplantation procedures##3##2##(2008-1#1)(2011-2#1)(2012-12#1)
transplantation recipients##2##2##(1991-12#1)(2007-7#1)
transplantation remains the most##2##4##(1997-5#1)(2007-8#1)
transplantation remains the only effective treatment##2##6##(2006-10#2)
transplantation remains the only effective##4##5##(2004-11#1)(2006-10#3)
transplantation remains the##8##3##(1997-5#1)(2004-11#1)(2006-10#3)(2007-8#2)(2010-10#1)
transplantation remains##10##2##(1997-5#1)(2004-11#1)(2006-10#3)(2007-11#1)(2007-8#2)(2010-10#1)(2012-12#1)
transplantation research##2##2##(1992-5#1)(2009-8#1)
transplantation should be considered##2##4##(1995-7#1)(2012-2#1)
transplantation should be##5##3##(1995-7#1)(2006-10#1)(2008-5#1)(2010-12#1)(2012-2#1)
transplantation should##6##2##(1995-7#1)(2006-10#1)(2008-5#1)(2008-9#1)(2010-12#1)(2012-2#1)
transplantation showed a##2##3##(2011-2#1)(2012-7#1)
transplantation studies##3##2##(1990-5#1)(2008-11#1)(2012-10#1)
transplantation therapies##2##2##(2008-1#1)(2008-11#1)
transplantation therapy##5##2##(2008-11#1)(2008-3#1)(2009-10#1)(2010-9#1)(2013-8#1)
transplantation to##13##2##(1994-3#2)(1995-2#1)(1995-5#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-11#1)
transplantation using##2##2##(1995-12#1)(2010-10#1)
transplantation was done##2##3##(2007-2#1)(2007-7#1)
transplantation was estimated##2##3##(1991-9#1)(2008-4#1)
transplantation was performed in##2##4##(1992-8#1)(2012-12#1)
transplantation was performed##4##3##(1992-8#1)(2007-8#1)(2010-6#1)(2012-12#1)
transplantation was##22##2##(1991-11#1)(1991-5#1)(1991-9#2)(1992-8#1)(1995-2#1)(1997-3#1)(1997-4#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-4#2)(2008-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
transplantation were##6##2##(1991-8#1)(1993-1#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
transplantation will be##4##3##(1994-5#1)(2006-10#1)(2008-1#1)(2008-3#1)
transplantation will##8##2##(1992-6#1)(1993-11#1)(1994-5#1)(1995-12#1)(2006-10#1)(2008-1#1)(2008-12#1)(2008-3#1)
transplantation with a##2##3##(1994-3#1)(2008-1#1)
transplantation with the##2##3##(2008-4#1)(2012-2#1)
transplantation with##15##2##(1992-6#1)(1994-3#1)(1995-9#1)(2005-8#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
transplantation##1402##1##(1990-10#4)(1990-11#3)(1990-12#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#2)(1991-11#10)(1991-12#5)(1991-2#4)(1991-3#3)(1991-5#7)(1991-7#3)(1991-8#3)(1991-9#5)(1992-1#1)(1992-10#1)(1992-12#6)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#4)(1992-6#16)(1992-8#2)(1992-9#1)(1993-1#5)(1993-10#1)(1993-11#5)(1993-12#2)(1993-2#5)(1993-3#6)(1993-6#2)(1993-7#1)(1993-8#1)(1994-1#1)(1994-3#10)(1994-4#1)(1994-5#7)(1994-6#6)(1994-7#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-12#21)(1995-2#25)(1995-4#3)(1995-5#3)(1995-7#7)(1995-8#3)(1995-9#6)(1996-10#1)(1996-11#3)(1996-12#6)(1996-2#1)(1996-5#1)(1996-6#3)(1996-7#1)(1996-8#9)(1996-9#1)(1997-1#1)(1997-3#9)(1997-4#4)(1997-5#7)(1997-6#7)(1997-7#4)(1997-8#4)(2004-11#17)(2004-12#4)(2004-9#1)(2005-1#2)(2005-10#4)(2005-11#9)(2005-12#6)(2005-7#8)(2005-8#11)(2006-1#1)(2006-10#122)(2006-11#1)(2006-2#4)(2006-4#2)(2006-6#5)(2006-8#7)(2006-9#1)(2007-1#5)(2007-10#5)(2007-11#85)(2007-12#5)(2007-2#11)(2007-3#1)(2007-4#3)(2007-5#4)(2007-7#39)(2007-8#57)(2007-9#4)(2008-1#78)(2008-10#10)(2008-11#32)(2008-12#10)(2008-3#8)(2008-4#28)(2008-5#16)(2008-6#4)(2008-7#19)(2008-8#9)(2008-9#8)(2009-10#8)(2009-2#13)(2009-3#5)(2009-4#3)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#11)(2009-9#1)(2010-1#3)(2010-10#13)(2010-11#26)(2010-12#24)(2010-2#6)(2010-3#2)(2010-4#11)(2010-5#5)(2010-6#6)(2010-7#6)(2010-8#7)(2010-9#3)(2011-1#7)(2011-12#1)(2011-2#81)(2011-3#19)(2012-1#17)(2012-10#7)(2012-11#5)(2012-12#61)(2012-2#30)(2012-3#11)(2012-7#9)(2013-1#33)(2013-7#3)(2013-8#34)
transplantation&quot##4##1##(2005-10#1)(2009-10#3)
transplantation)##4##1##(1992-6#1)(2006-2#1)(2008-5#1)(2010-12#1)
transplantation--a##3##1##(1995-2#1)(2008-10#1)(2008-4#1)
transplantation?##2##1##(1997-5#1)(2012-12#1)
transplantation]##36##1##(1990-3#1)(1990-5#1)(1991-2#2)(1991-5#1)(1992-1#1)(1992-10#1)(1992-4#2)(1992-6#1)(1993-3#1)(1994-5#1)(1995-4#1)(1996-12#1)(1996-6#1)(1997-3#1)(2005-11#2)(2005-9#1)(2007-5#1)(2008-1#1)(2008-10#1)(2011-2#9)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
transplantations and##3##2##(2006-10#1)(2011-2#1)(2012-12#1)
transplantations are##3##2##(1995-4#1)(2011-3#2)
transplantations at our##2##3##(1996-8#1)(2008-1#1)
transplantations have been performed##2##4##(1995-2#1)(1997-5#1)
transplantations in##2##2##(1995-9#1)(1997-6#1)
transplantations performed in##4##3##(1993-9#1)(1996-12#1)(1996-6#1)(1997-6#1)
transplantations were performed##5##3##(2006-10#1)(2007-7#1)(2008-1#1)(2012-12#1)(2013-8#1)
transplantations##40##1##(1991-12#1)(1992-6#1)(1993-9#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-9#1)(1996-12#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-5#2)(1997-6#3)(2005-7#1)(2006-10#4)(2006-4#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#3)(2010-12#1)(2011-2#2)(2011-3#3)(2012-12#3)(2012-3#1)(2013-8#1)
transplanted DPSCs differentiated into astrocytes in preference to neurons##2##9##(2012-12#2)
transplanted F344##2##2##(2011-2#2)
transplanted after##2##2##(1991-9#1)(2007-8#1)
transplanted and##4##2##(1992-7#1)(1995-2#1)(2011-2#1)(2013-8#1)
transplanted animals##4##2##(1993-12#1)(1994-3#1)(1995-7#1)(2008-3#1)
transplanted at the##3##3##(1995-2#1)(1996-4#1)(2008-10#1)
transplanted at##4##2##(1995-2#1)(1996-4#1)(2007-10#1)(2008-10#1)
transplanted between January 1979 and November 1998##2##7##(2008-1#2)
transplanted between##4##2##(2007-7#1)(2008-1#2)(2008-4#1)
transplanted bone##4##2##(1995-8#1)(2008-4#1)(2010-11#2)
transplanted cells##8##2##(1993-12#1)(1996-1#1)(2008-3#1)(2008-4#1)(2010-11#1)(2012-12#3)
transplanted from##2##2##(2007-7#1)(2011-2#1)
transplanted hearts##2##2##(1991-3#1)(2009-3#1)
transplanted human##2##2##(2010-12#1)(2012-3#1)
transplanted in the##2##3##(1994-3#1)(1996-8#1)
transplanted in vivo##2##3##(2006-6#1)(2008-11#1)
transplanted in##9##2##(1994-3#1)(1994-5#1)(1996-8#1)(2005-7#1)(2006-10#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-8#1)
transplanted into an##3##3##(2006-10#2)(2006-6#1)
transplanted into the##9##3##(1992-1#1)(1992-8#1)(1995-11#1)(1996-1#1)(2008-10#1)(2008-4#1)(2010-11#1)(2010-12#1)(2010-2#1)
transplanted into##33##2##(1992-1#1)(1992-8#1)(1994-5#1)(1995-11#2)(1995-3#1)(1996-1#1)(2006-10#3)(2006-6#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-11#2)(2010-12#1)(2010-2#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-8#1)
transplanted islet##2##2##(2008-10#1)(2010-11#1)
transplanted islets##2##2##(2008-10#1)(2011-2#1)
transplanted kidney##7##2##(1992-2#2)(2007-7#4)(2012-12#1)
transplanted livers##2##2##(2006-10#1)(2007-11#1)
transplanted on##2##2##(1994-11#1)(2010-10#1)
transplanted organ##2##2##(1990-12#1)(2011-3#1)
transplanted patients##9##2##(2007-2#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-8#1)(2013-1#2)
transplanted peptide##3##2##(1995-3#3)
transplanted rats##2##2##(1996-1#1)(2009-3#1)
transplanted tissue##3##2##(1994-5#1)(2012-12#2)
transplanted tissues##2##2##(2009-10#1)(2010-7#1)
transplanted to the##2##3##(2006-10#1)(2013-8#1)
transplanted to##7##2##(1990-8#1)(1992-9#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-8#1)
transplanted tumor of##2##3##(2008-9#1)(2011-2#1)
transplanted tumor##6##2##(1992-9#1)(2007-11#1)(2008-9#3)(2011-2#1)
transplanted with human##2##3##(2008-11#2)
transplanted with##10##2##(1991-12#1)(1994-3#1)(1997-6#1)(2006-4#1)(2008-11#2)(2008-4#1)(2008-9#1)(2011-3#1)(2012-2#1)
transplanted##201##1##(1990-12#1)(1990-8#1)(1991-12#2)(1991-3#2)(1991-5#2)(1991-9#2)(1992-1#1)(1992-2#2)(1992-3#3)(1992-7#2)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#2)(1994-11#1)(1994-3#4)(1994-4#1)(1994-5#3)(1994-6#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#4)(1995-7#1)(1995-8#1)(1996-1#3)(1996-4#1)(1996-8#1)(1997-6#1)(2005-11#1)(2005-7#1)(2006-10#8)(2006-4#1)(2006-6#2)(2007-10#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-7#6)(2007-8#2)(2007-9#2)(2008-1#7)(2008-10#10)(2008-11#6)(2008-3#5)(2008-4#6)(2008-5#3)(2008-8#6)(2008-9#8)(2009-10#2)(2009-12#2)(2009-3#3)(2009-5#1)(2010-10#2)(2010-11#7)(2010-12#3)(2010-2#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#11)(2011-3#3)(2012-1#1)(2012-12#13)(2012-2#1)(2012-3#1)(2012-7#2)(2013-1#8)(2013-7#1)(2013-8#3)
transplanting##14##1##(1992-12#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#1)(2009-2#2)(2012-11#2)
transplantion##2##1##(2008-1#1)(2011-3#1)
transplants and##3##2##(2006-6#1)(2008-4#1)(2008-9#1)
transplants are##4##2##(1991-5#1)(1997-5#1)(2006-10#1)(2011-2#1)
transplants for the##2##3##(2007-11#1)(2007-4#1)
transplants for##4##2##(1991-2#1)(2007-11#1)(2007-4#1)(2008-11#1)
transplants from##2##2##(1995-9#1)(2009-8#1)
transplants has##2##2##(2008-5#1)(2011-2#1)
transplants have been##2##3##(2008-1#2)
transplants have##3##2##(2006-10#1)(2008-1#2)
transplants in the field##2##4##(2008-10#2)
transplants in the##5##3##(2007-8#1)(2008-1#1)(2008-10#2)(2010-6#1)
transplants in##7##2##(2007-8#1)(2008-1#1)(2008-10#2)(2008-7#1)(2010-6#1)(2013-8#1)
transplants of##5##2##(1990-5#1)(1993-12#2)(1994-3#1)(1994-5#1)
transplants performed##3##2##(2008-1#1)(2009-3#1)(2011-2#1)
transplants were carried out at##2##5##(2008-1#2)
transplants were performed##4##3##(2007-11#1)(2007-8#1)(2013-1#2)
transplants were##9##2##(1991-11#1)(1996-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2013-1#2)
transplants with##3##2##(2008-10#1)(2011-2#2)
transplants##119##1##(1990-11#2)(1990-12#1)(1990-5#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-5#1)(1991-7#1)(1992-1#1)(1993-12#2)(1994-3#1)(1994-5#2)(1995-12#1)(1995-2#4)(1995-3#1)(1995-7#1)(1995-9#2)(1996-1#2)(1996-11#1)(1996-4#1)(1996-5#1)(1996-8#3)(1997-5#2)(2005-7#2)(2005-8#1)(2006-10#3)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#9)(2007-2#2)(2007-4#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#13)(2008-10#6)(2008-11#1)(2008-4#3)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#3)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-2#7)(2013-1#4)(2013-8#3)
transplasma membrane electron transfer##2##4##(2009-9#2)
transplasma membrane electron transport##6##4##(1991-10#2)(1992-11#1)(1992-7#1)(1993-4#1)(1994-8#1)
transplasma membrane electron##8##3##(1991-10#2)(1992-11#1)(1992-7#1)(1993-4#1)(1994-8#1)(2009-9#2)
transplasma membrane##10##2##(1991-10#2)(1992-11#1)(1992-7#1)(1993-4#2)(1994-8#1)(2009-9#3)
transplastomic tobacco##2##2##(2006-12#1)(2011-2#1)
transplastomic##3##1##(2006-12#2)(2011-2#1)
transplatin##2##1##(1995-1#1)(1995-10#1)
transponder##4##1##(2008-4#2)(2010-12#1)(2010-8#1)
transponders##4##1##(1992-10#1)(2009-4#1)(2010-8#2)
transport a##2##2##(2008-7#1)(2011-2#1)
transport across the BBB##2##4##(1995-3#1)(2005-8#1)
transport across the plasma membrane##2##5##(1992-4#2)
transport across the##10##3##(1991-12#1)(1992-4#2)(1995-3#1)(1995-5#1)(1995-8#1)(1997-1#1)(1997-2#1)(2005-8#1)(2012-2#1)
transport across##17##2##(1991-12#1)(1991-6#1)(1992-4#2)(1994-6#1)(1995-3#1)(1995-5#1)(1995-8#1)(1997-1#1)(1997-2#1)(2005-8#1)(2008-10#2)(2008-6#1)(2010-2#1)(2011-2#1)(2012-2#1)
transport activities##4##2##(1991-12#1)(1996-9#1)(2006-2#1)(2008-11#1)
transport activity and##3##3##(1992-1#1)(1992-4#1)(1994-12#1)
transport activity for##3##3##(1990-11#1)(1991-9#2)
transport activity of##5##3##(1990-5#1)(1991-4#1)(2008-11#1)(2008-8#1)(2010-12#1)
transport activity was##3##3##(1991-4#1)(1994-8#1)(1996-4#1)
transport activity##34##2##(1990-11#3)(1990-5#2)(1991-12#1)(1991-4#2)(1991-9#2)(1992-1#2)(1992-4#4)(1994-12#2)(1994-2#1)(1994-8#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-1#2)(2008-11#1)(2008-5#1)(2008-8#2)(2010-12#2)(2011-2#2)
transport and binding##2##3##(1992-6#2)
transport and calcium##2##3##(1991-1#1)(2009-6#1)
transport and delivery##2##3##(2008-5#1)(2009-7#1)
transport and diffusion##2##3##(2008-7#1)(2010-7#1)
transport and expression##2##3##(1990-3#2)
transport and fate of##2##4##(1996-8#1)(2008-10#1)
transport and its##2##3##(1991-9#1)(2013-1#1)
transport and metabolism of##3##4##(1995-1#1)(2007-11#1)(2011-3#1)
transport and metabolism##5##3##(1993-9#1)(1995-1#1)(2006-10#1)(2007-11#1)(2011-3#1)
transport and redistribution##2##3##(1992-6#1)(1995-6#1)
transport and release##2##3##(2006-2#1)(2010-4#1)
transport and storage##2##3##(2008-10#1)(2008-5#1)
transport and the##10##3##(1990-11#1)(1990-12#1)(1991-3#1)(1992-6#1)(1995-5#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-9#1)(2013-1#1)
transport and##125##2##(1990-11#2)(1990-12#1)(1990-3#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-3#1)(1991-6#1)(1991-9#2)(1992-2#1)(1992-6#6)(1993-3#1)(1993-5#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-5#1)(1995-6#4)(1996-8#1)(1996-9#1)(1997-1#2)(1997-7#3)(2004-4#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-2#2)(2006-6#1)(2007-11#3)(2007-12#4)(2007-7#2)(2007-8#3)(2008-10#4)(2008-11#3)(2008-4#4)(2008-5#3)(2008-7#4)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#2)(2010-2#1)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#4)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
transport and/or##2##2##(1990-12#1)(2012-12#1)
transport are##4##2##(1994-8#1)(2006-10#1)(2006-5#1)(2012-12#1)
transport as##3##2##(1992-9#1)(1993-2#1)(1994-2#1)
transport assays##2##2##(1993-6#1)(2008-4#1)
transport at the##4##3##(1991-3#1)(1991-9#1)(1997-6#1)(2010-12#1)
transport at##8##2##(1991-3#1)(1991-9#1)(1992-6#2)(1995-7#1)(1997-6#1)(2010-12#1)(2010-8#1)
transport barges##2##2##(2010-8#2)
transport between##4##2##(1990-7#1)(1990-8#1)(1992-12#1)(1995-11#1)
transport but##3##2##(1990-12#1)(1993-11#1)(1995-12#1)
transport by PTHrP in##2##4##(1994-3#2)
transport by arachidonic acid##2##4##(1995-11#2)
transport by the##4##3##(1990-7#1)(1992-11#2)(1994-6#1)
transport by##34##2##(1990-11#1)(1990-7#1)(1991-5#1)(1992-11#4)(1992-6#1)(1994-11#1)(1994-2#1)(1994-3#4)(1994-6#1)(1994-8#1)(1995-11#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-7#1)(1997-2#2)(1997-7#1)(2005-11#1)(2006-10#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-2#1)(2011-1#1)(2011-2#1)
transport can be##3##3##(1997-6#1)(2008-10#1)(2008-6#1)
transport can##6##2##(1994-3#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-6#1)
transport capabilities##2##2##(2007-11#1)(2008-10#1)
transport capacity##3##2##(1995-6#1)(1996-2#1)(2008-10#1)
transport characteristics of##3##3##(1990-2#1)(2008-7#1)(2011-2#1)
transport characteristics##9##2##(1990-2#1)(1991-5#1)(1994-9#1)(2007-12#1)(2008-7#1)(2011-2#4)
transport coefficient##2##2##(2007-8#1)(2008-2#1)
transport coefficients##2##2##(2007-8#1)(2007-9#1)
transport competent##2##2##(1994-11#2)
transport complex##2##2##(1990-11#1)(1997-6#1)
transport defect##2##2##(1997-1#1)(2010-11#1)
transport distance##2##2##(2007-7#1)(2009-8#1)
transport during##4##2##(1991-1#1)(2006-8#1)(2009-8#1)(2012-1#1)
transport equation is applied to##2##5##(2008-2#1)(2008-3#1)
transport equation is##5##3##(2007-12#1)(2007-9#1)(2008-2#2)(2008-3#1)
transport equation##7##2##(2007-11#1)(2007-12#1)(2007-9#1)(2008-2#3)(2008-3#1)
transport experiments##3##2##(1990-2#1)(2008-10#1)(2011-2#1)
transport flux##2##2##(2008-7#2)
transport for##5##2##(1991-4#1)(2008-5#1)(2008-8#1)(2010-2#1)(2012-2#1)
transport from blood to##2##4##(1993-12#1)(1997-5#1)
transport from blood##3##3##(1993-12#1)(1994-9#1)(1997-5#1)
transport from the Golgi to the plasma membrane##2##8##(1997-6#1)(2008-11#1)
transport from the Golgi to the##3##6##(1997-6#2)(2008-11#1)
transport from the##14##3##(1995-8#1)(1996-2#1)(1997-6#2)(2007-11#1)(2008-11#2)(2008-3#2)(2008-7#2)(2009-3#1)(2009-8#1)(2012-12#1)
transport from##24##2##(1991-2#1)(1992-11#1)(1992-6#1)(1993-12#1)(1994-9#1)(1995-8#1)(1996-2#1)(1997-5#1)(1997-6#2)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-11#3)(2008-3#2)(2008-7#2)(2009-3#1)(2009-8#1)(2012-12#1)
transport function of##2##3##(1995-6#1)(2006-8#1)
transport function##3##2##(1993-9#1)(1995-6#1)(2006-8#1)
transport functions##3##2##(1994-10#1)(2010-9#1)(2012-2#1)
transport glycoproteins##3##2##(1990-11#3)
transport has been##2##3##(1996-4#1)(2008-10#1)
transport has##3##2##(1992-6#1)(1996-4#1)(2008-10#1)
transport in Walker 256##2##4##(1991-3#2)
transport in a##6##3##(1992-6#1)(1993-3#1)(2006-2#1)(2007-9#1)(2008-3#1)(2008-7#1)
transport in biological##2##3##(1993-3#1)(2011-1#1)
transport in blastocysts##2##3##(1991-9#2)
transport in cells and tissues##2##5##(2011-1#2)
transport in erythrocyte##2##3##(1990-3#1)(1990-4#1)
transport in human##3##3##(1991-1#1)(1992-4#1)(2008-1#1)
transport in isolated##2##3##(1996-5#1)(2008-11#1)
transport in large##2##3##(2009-8#1)(2013-1#1)
transport in rabbit##2##3##(1996-2#1)(2008-1#1)
transport in rat##4##3##(1990-4#2)(1991-3#1)(1991-5#1)
transport in renal##2##3##(1992-2#1)(1997-1#1)
transport in the CNT and CCD##2##6##(2012-12#2)
transport in the presence of##2##5##(1995-8#1)(1996-8#1)
transport in the rat##3##4##(1995-11#1)(1997-3#1)(2008-12#1)
transport in the small intestine##2##5##(2006-10#2)
transport in the##31##3##(1990-4#1)(1990-8#1)(1991-9#1)(1992-2#1)(1992-7#1)(1995-1#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-8#1)(1997-3#1)(1997-8#2)(2006-10#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-6#1)(2008-7#1)(2009-9#1)(2012-12#3)
transport in these##2##3##(2010-2#1)(2012-12#1)
transport in vitro##2##3##(1997-6#1)(2008-4#1)
transport in##137##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#3)(1990-4#5)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-12#2)(1991-3#5)(1991-5#3)(1991-6#1)(1991-9#4)(1992-1#2)(1992-2#3)(1992-4#1)(1992-6#3)(1992-7#2)(1993-11#1)(1993-2#1)(1993-3#3)(1994-12#3)(1994-8#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-2#2)(1996-5#3)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(2005-8#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#4)(2008-1#4)(2008-10#3)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#7)(2009-5#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-5#1)(2010-7#2)(2011-1#5)(2011-2#2)(2012-11#1)(2012-12#4)(2012-2#1)(2013-1#1)
transport inhibition##2##2##(1991-9#1)(1996-5#1)
transport inhibitor##8##2##(1991-8#1)(1993-8#1)(1994-12#2)(1995-1#1)(2008-7#2)(2009-6#1)
transport inhibitors##10##2##(1990-11#1)(1991-5#1)(1992-7#1)(1994-12#1)(1994-6#1)(1996-11#1)(2006-8#1)(2008-5#1)(2009-10#1)(2011-1#1)
transport inside##2##2##(2008-3#1)(2011-2#1)
transport into the myotubes##2##4##(1994-11#2)
transport into the nucleus##2##4##(1994-11#1)(2012-2#1)
transport into the##8##3##(1992-8#1)(1994-11#3)(1994-5#1)(1997-8#1)(2007-4#1)(2012-2#1)
transport into##19##2##(1991-1#1)(1992-12#1)(1992-8#1)(1993-6#1)(1994-11#6)(1994-5#1)(1996-11#1)(1997-8#1)(2007-4#1)(2008-1#2)(2008-3#1)(2012-2#2)
transport is a##4##3##(1994-3#1)(1995-11#1)(2012-12#1)(2012-2#1)
transport is critical##2##3##(2009-8#1)(2010-7#1)
transport is not##6##3##(1990-12#1)(1991-5#1)(2007-12#1)(2007-8#1)(2008-8#1)(2009-6#1)
transport is of##2##3##(1990-8#1)(1997-8#1)
transport is rate-limiting##2##3##(1991-5#1)(2006-10#1)
transport is##41##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-3#1)(1991-5#2)(1992-1#1)(1993-8#1)(1994-3#2)(1995-1#1)(1995-11#3)(1996-1#1)(1996-6#1)(1997-8#1)(2006-10#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#4)(2010-4#1)(2010-7#2)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
transport machinery is##3##3##(2009-10#1)(2011-2#2)
transport machinery##8##2##(1993-6#1)(2008-11#1)(2009-10#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-2#1)
transport may be##2##3##(2007-12#1)(2012-2#1)
transport may##5##2##(2007-12#1)(2011-2#1)(2012-2#2)(2013-1#1)
transport mean free path##9##4##(2007-12#2)(2008-2#3)(2008-3#4)
transport mean-free##2##2##(2008-2#2)
transport mechanism##8##2##(1990-12#1)(1990-8#1)(1995-10#1)(2008-10#4)(2010-4#1)
transport mechanisms##4##2##(1991-11#1)(1994-10#1)(1994-12#1)(2013-1#1)
transport medium and##2##3##(2007-1#1)(2007-8#1)
transport medium##4##2##(2007-1#1)(2007-8#1)(2009-4#2)
transport method##2##2##(2007-8#2)
transport model with##2##3##(2008-10#2)
transport model##7##2##(2007-8#2)(2008-10#2)(2008-2#1)(2010-10#1)(2013-1#1)
transport models are##2##3##(1997-6#1)(2007-8#1)
transport models##4##2##(1994-3#1)(1997-6#1)(2007-8#1)(2010-9#1)
transport modes##5##2##(1990-3#3)(1991-4#1)(2008-8#1)
transport molecules##2##2##(1994-12#1)(2008-11#1)
transport numbers##3##2##(1994-12#1)(2005-11#2)
transport of 5-methyltetrahydrofolate##3##3##(1994-6#3)
transport of AVP##3##3##(1992-9#3)
transport of Ca2+##2##3##(1990-8#1)(1994-2#1)
transport of a##6##3##(1992-6#1)(1993-12#1)(1994-11#1)(1997-8#1)(2008-4#1)(2008-5#1)
transport of acivicin across the BBB##2##6##(1995-3#2)
transport of all##2##3##(1991-3#1)(2008-11#1)
transport of amino acids##3##4##(1990-12#1)(1997-8#1)(2013-1#1)
transport of anionic amino acids in blastocysts##2##7##(1991-9#2)
transport of anionic amino acids in##3##6##(1990-12#1)(1991-9#2)
transport of anionic amino acids##4##5##(1990-12#1)(1991-9#3)
transport of cations##2##3##(1991-5#1)(2008-5#1)
transport of cholesterol##2##3##(1991-7#1)(1995-12#1)
transport of circulating##2##3##(1993-12#2)
transport of critically ill##2##4##(1993-5#1)(2006-10#1)
transport of cuticular lipids##2##4##(2009-8#2)
transport of cuticular##3##3##(2009-8#3)
transport of cystine##2##3##(2007-7#1)(2008-11#1)
transport of drugs##3##3##(1991-6#2)(2004-12#1)
transport of horseradish peroxidase##4##4##(1990-7#1)(1997-2#1)(2009-2#2)
transport of lithium##2##3##(2008-10#2)
transport of mRNAs##2##3##(1992-3#1)(2008-10#1)
transport of manure##2##3##(2008-5#2)
transport of nutrients##2##3##(1994-11#1)(2008-7#1)
transport of proteins##4##3##(1993-3#1)(2008-1#1)(2009-8#2)
transport of small solutes and proteins##2##6##(2011-2#2)
transport of sugar-coupled##2##3##(1994-9#2)
transport of sulfobromophthalein##2##3##(1990-3#2)
transport of the Eu(III)##2##4##(2008-10#2)
transport of the receptor to the##2##6##(1993-4#1)(1994-11#1)
transport of the##25##3##(1990-7#1)(1991-10#1)(1992-11#1)(1992-3#1)(1993-4#1)(1994-11#1)(1994-12#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-9#1)(1997-3#1)(1997-7#1)(2005-1#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-11#1)(2010-8#1)(2012-12#1)(2013-1#2)
transport of these##2##3##(1990-3#1)(1991-7#1)
transport of this amino acid##3##5##(1992-6#3)
transport of this##5##3##(1992-6#3)(2007-8#1)(2008-3#1)
transport of uric acid##2##4##(2011-2#2)
transport of various##2##3##(2008-1#1)(2011-2#1)
transport of β-actin mRNA##3##4##(2012-2#3)
transport of##272##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#4)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#4)(1991-4#2)(1991-5#3)(1991-6#4)(1991-7#2)(1991-8#2)(1991-9#5)(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#5)(1992-6#9)(1992-9#3)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#2)(1993-8#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#5)(1994-5#1)(1994-6#4)(1994-8#2)(1994-9#4)(1995-11#2)(1995-12#1)(1995-3#4)(1995-6#4)(1995-8#2)(1996-10#1)(1996-11#1)(1996-2#4)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#2)(1997-7#2)(1997-8#2)(2004-12#1)(2005-1#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-3#2)(2006-5#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-5#2)(2007-7#1)(2007-8#5)(2008-1#2)(2008-10#21)(2008-11#7)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#3)(2009-10#2)(2009-2#2)(2009-3#1)(2009-5#1)(2009-8#9)(2009-9#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#7)(2011-3#5)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#7)(2013-1#5)(2013-8#2)
transport on##3##2##(1997-2#2)(2005-7#1)
transport or##5##2##(1990-2#1)(1991-11#1)(1994-8#2)(1996-12#1)
transport parameters##4##2##(2005-11#2)(2011-2#1)(2011-3#1)
transport pathways##10##2##(1991-4#1)(1995-6#1)(1995-8#1)(1997-6#1)(2006-10#1)(2006-8#1)(2008-11#2)(2012-8#2)
transport phase##3##2##(1992-9#2)(2008-7#1)
transport phenomena##2##2##(2009-3#1)(2010-10#1)
transport play a##2##3##(2010-2#1)(2011-2#1)
transport problems in##2##3##(2006-10#1)(2009-9#1)
transport problems##8##2##(2006-10#1)(2008-6#1)(2009-9#6)
transport process in##2##3##(1992-6#2)
transport process##10##2##(1991-5#1)(1992-6#5)(1994-12#1)(1994-2#1)(2004-11#1)(2008-7#1)
transport processes in##2##3##(1991-3#1)(1993-4#1)
transport processes were##2##3##(1991-9#1)(1992-3#1)
transport processes##14##2##(1991-3#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-4#2)(1993-9#2)(1995-2#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-1#1)
transport properties and##2##3##(2010-2#2)
transport properties in##3##3##(1995-5#1)(2009-2#1)(2010-2#1)
transport properties##20##2##(1990-3#1)(1992-1#1)(1992-8#1)(1995-5#1)(1996-11#1)(1997-1#1)(1997-5#1)(2006-10#1)(2008-10#1)(2008-7#2)(2009-12#3)(2009-2#1)(2010-2#3)(2010-9#1)(2012-1#1)
transport protein##12##2##(1990-10#1)(1991-6#1)(1991-8#1)(1993-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-8#1)(2008-10#1)(2010-11#1)
transport proteins and##3##3##(2006-10#2)(2009-10#1)
transport proteins in##3##3##(2008-7#2)(2012-12#1)
transport proteins##26##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-8#2)(1991-3#1)(1994-6#1)(1995-11#1)(1995-3#1)(2006-10#2)(2008-11#1)(2008-3#1)(2008-7#3)(2008-9#1)(2009-10#2)(2009-6#1)(2011-2#4)(2012-12#1)(2012-2#1)
transport rate of##6##3##(1990-4#1)(1994-11#1)(1994-12#1)(2008-11#1)(2008-9#1)(2012-12#1)
transport rate##15##2##(1990-4#1)(1991-1#2)(1994-11#1)(1994-12#1)(1994-8#1)(1996-1#3)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
transport rates and##3##3##(1990-10#1)(1994-8#1)(2005-10#1)
transport rates##7##2##(1990-10#1)(1991-1#2)(1991-5#1)(1994-8#1)(1994-9#1)(2005-10#1)
transport reactions##3##2##(1995-8#1)(1996-9#2)
transport regime##2##2##(2007-12#1)(2009-4#1)
transport route##2##2##(1996-1#1)(2008-1#1)
transport scattering and##2##3##(2008-2#1)(2008-3#1)
transport scattering coefficient##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
transport scattering coefficients from##2##4##(2008-2#1)(2008-3#1)
transport scattering coefficients##3##3##(2008-2#2)(2008-3#1)
transport scattering##9##2##(2007-12#1)(2008-2#4)(2008-3#4)
transport services##2##2##(2005-8#2)
transport showed that##2##3##(1990-8#1)(2013-7#1)
transport showed##3##2##(1990-3#1)(1990-8#1)(2013-7#1)
transport site with##2##3##(1995-5#2)
transport site##4##2##(1995-5#4)
transport sites on band 3##2##5##(1994-5#2)
transport sites##4##2##(1990-5#1)(1994-5#2)(1996-9#1)
transport solution##2##2##(2008-2#2)
transport status in##2##3##(2007-8#1)(2011-2#1)
transport status##4##2##(2007-8#3)(2011-2#1)
transport studies##2##2##(1992-9#1)(2007-11#1)
transport study##2##2##(1991-11#1)(2008-10#1)
transport system and##4##3##(1990-2#1)(1992-1#1)(2008-11#1)(2013-1#1)
transport system for the##2##4##(1992-3#1)(1994-12#1)
transport system for##8##3##(1990-11#1)(1990-2#1)(1990-3#1)(1992-3#1)(1994-12#1)(1994-9#1)(1995-12#1)(2012-11#1)
transport system in##2##3##(1990-5#1)(2008-11#1)
transport system is##4##3##(1991-5#1)(1992-6#1)(1995-8#1)(2009-8#1)
transport system of##4##3##(1990-11#1)(1992-6#1)(1995-12#1)(2013-7#1)
transport system##54##2##(1990-11#3)(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-3#2)(1992-6#3)(1993-4#1)(1994-12#1)(1994-8#1)(1994-9#4)(1995-12#2)(1995-8#2)(1996-1#1)(1996-11#1)(1996-9#2)(1997-1#2)(2006-10#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#4)(2009-8#1)(2010-5#1)(2012-11#1)(2013-1#1)(2013-7#1)
transport system)##2##2##(1996-12#2)
transport systems in##4##3##(1990-8#2)(1992-11#2)
transport systems##22##2##(1990-11#1)(1990-3#1)(1990-8#6)(1991-3#1)(1991-9#1)(1992-11#3)(1994-3#1)(1994-9#1)(1995-8#1)(1997-2#1)(2006-10#2)(2007-11#2)(2011-2#1)
transport theory##2##2##(1994-5#1)(2007-8#1)
transport through a##3##3##(1996-1#1)(2008-10#1)(2010-7#1)
transport through the##12##3##(1990-6#1)(1994-11#2)(1994-12#1)(1995-2#1)(2006-12#2)(2007-12#1)(2008-10#2)(2009-8#2)
transport through##31##2##(1990-12#1)(1990-6#1)(1992-6#2)(1993-3#1)(1994-11#2)(1994-12#1)(1994-3#1)(1995-2#1)(1996-1#1)(2006-12#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-7#3)(2009-3#2)(2009-8#2)(2010-7#1)(2011-2#1)
transport time##2##2##(2008-3#2)
transport to lysosomes##2##3##(2008-1#2)
transport to the hospital##2##4##(1994-3#1)(2013-1#1)
transport to the plasma membrane##3##5##(1993-4#1)(1994-5#1)(1997-6#1)
transport to the##21##3##(1990-3#1)(1992-11#2)(1993-4#1)(1993-6#1)(1994-3#1)(1994-5#1)(1997-6#2)(2008-1#1)(2008-10#3)(2008-3#1)(2008-7#1)(2009-11#1)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#2)
transport to##45##2##(1990-3#1)(1991-9#1)(1992-11#2)(1993-4#1)(1993-6#1)(1994-3#1)(1994-5#1)(1997-6#2)(2006-10#1)(2007-12#2)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#3)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#4)(2009-11#1)(2010-4#1)(2012-1#2)(2012-12#1)(2012-2#3)(2012-5#1)(2013-1#2)(2013-8#1)
transport vesicles##3##2##(1992-11#1)(1997-6#1)(2008-1#1)
transport via a##2##3##(1992-6#1)(1994-3#1)
transport via##9##2##(1992-11#1)(1992-6#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-5#1)(2007-12#1)(2010-11#1)(2013-8#1)
transport was also##2##3##(1992-6#1)(1995-8#1)
transport was inhibited by##2##4##(1994-11#1)(1995-8#1)
transport was observed with##2##4##(2008-10#2)
transport was observed##6##3##(1996-4#1)(1997-7#1)(2006-7#1)(2008-10#2)(2011-2#1)
transport was similar##2##3##(1991-1#1)(1995-7#1)
transport was studied in##2##4##(1991-5#1)(1996-9#1)
transport was##34##2##(1990-2#1)(1990-3#2)(1991-1#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-6#1)(1992-7#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#2)(1995-7#1)(1995-8#2)(1996-4#1)(1996-9#1)(1997-1#1)(1997-6#1)(1997-7#2)(2006-7#1)(2007-5#1)(2008-10#3)(2008-4#1)(2011-2#2)
transport were investigated##2##3##(1992-6#1)(2008-10#1)
transport were studied in##2##4##(1992-11#1)(1992-6#1)
transport were studied##3##3##(1990-3#1)(1992-11#1)(1992-6#1)
transport were##11##2##(1990-3#3)(1992-11#1)(1992-6#2)(2006-10#1)(2008-10#2)(2008-4#1)(2013-1#1)
transport while##3##2##(1992-11#1)(1995-1#1)(1996-11#1)
transport with##9##2##(1990-3#1)(1991-3#1)(1991-9#1)(1996-5#1)(2006-12#1)(2007-9#1)(2008-7#2)(2012-2#1)
transport without##3##2##(1992-6#2)(2008-3#1)
transport##1805##1##(1990-10#6)(1990-11#19)(1990-12#13)(1990-2#13)(1990-3#30)(1990-4#9)(1990-5#8)(1990-6#4)(1990-7#8)(1990-8#24)(1990-9#3)(1991-1#12)(1991-10#4)(1991-11#5)(1991-12#9)(1991-2#10)(1991-3#17)(1991-4#10)(1991-5#20)(1991-6#9)(1991-7#5)(1991-8#4)(1991-9#25)(1992-1#10)(1992-11#27)(1992-12#4)(1992-2#4)(1992-3#11)(1992-4#9)(1992-5#1)(1992-6#53)(1992-7#5)(1992-8#6)(1992-9#7)(1993-11#4)(1993-12#7)(1993-2#5)(1993-3#9)(1993-4#6)(1993-5#5)(1993-6#7)(1993-7#1)(1993-8#5)(1993-9#5)(1994-10#2)(1994-11#21)(1994-12#23)(1994-2#5)(1994-3#23)(1994-4#1)(1994-5#9)(1994-6#14)(1994-7#1)(1994-8#24)(1994-9#16)(1995-1#8)(1995-10#4)(1995-11#16)(1995-12#6)(1995-2#14)(1995-3#8)(1995-5#13)(1995-6#17)(1995-7#2)(1995-8#19)(1996-1#10)(1996-10#1)(1996-11#16)(1996-12#10)(1996-2#10)(1996-3#4)(1996-4#4)(1996-5#12)(1996-6#3)(1996-7#3)(1996-8#10)(1996-9#15)(1997-1#27)(1997-2#11)(1997-3#2)(1997-4#5)(1997-5#3)(1997-6#18)(1997-7#14)(1997-8#6)(2004-11#1)(2004-12#2)(2004-4#2)(2005-1#1)(2005-10#5)(2005-11#11)(2005-5#1)(2005-7#3)(2005-8#10)(2006-10#37)(2006-11#1)(2006-12#3)(2006-2#6)(2006-3#2)(2006-5#5)(2006-6#3)(2006-7#1)(2006-8#7)(2007-1#2)(2007-10#2)(2007-11#19)(2007-12#34)(2007-2#3)(2007-4#1)(2007-5#10)(2007-6#4)(2007-7#7)(2007-8#33)(2007-9#13)(2008-1#21)(2008-10#80)(2008-11#42)(2008-12#3)(2008-2#21)(2008-3#34)(2008-4#19)(2008-5#24)(2008-6#12)(2008-7#48)(2008-8#17)(2008-9#11)(2009-10#17)(2009-11#2)(2009-12#3)(2009-2#6)(2009-3#7)(2009-4#3)(2009-5#3)(2009-6#7)(2009-7#3)(2009-8#29)(2009-9#15)(2010-1#1)(2010-10#2)(2010-11#7)(2010-12#9)(2010-2#10)(2010-3#1)(2010-4#12)(2010-5#3)(2010-6#1)(2010-7#9)(2010-8#7)(2010-9#6)(2011-1#15)(2011-12#3)(2011-2#54)(2011-3#8)(2012-1#9)(2012-11#5)(2012-12#27)(2012-2#31)(2012-3#3)(2012-5#1)(2012-8#2)(2013-1#26)(2013-7#3)(2013-8#6)
transport)##9##1##(1990-11#1)(1992-12#1)(1993-5#1)(1994-12#1)(1995-11#1)(1995-6#1)(2008-10#1)(2008-5#1)(2012-5#1)
transport-dependent##3##1##(1995-9#1)(2009-6#2)
transport-of-intensity equation##2##2##(2007-11#1)(2008-3#1)
transport-related##2##1##(2011-2#2)
transportability of##3##2##(2012-1#1)(2013-1#2)
transportability##5##1##(2010-8#1)(2012-1#2)(2013-1#2)
transportable system##3##2##(2006-12#1)(2008-2#1)(2008-3#1)
transportable##8##1##(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-8#1)(2012-2#1)(2013-8#1)
transportation and##12##2##(1993-8#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-7#1)(2008-9#2)(2010-12#1)(2012-3#1)(2013-1#3)
transportation by##4##2##(2008-5#1)(2013-1#3)
transportation facilities##2##2##(1992-5#1)(2013-7#1)
transportation for##2##2##(1994-3#1)(2010-4#1)
transportation is##2##2##(2013-1#2)
transportation networks##3##2##(2013-8#3)
transportation of the##3##3##(1994-9#1)(2008-5#2)
transportation of##14##2##(1991-11#1)(1994-9#1)(2005-8#1)(2007-8#1)(2008-10#1)(2008-5#3)(2009-10#2)(2010-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
transportation system##3##2##(1994-1#1)(1996-3#1)(2008-10#1)
transportation to##2##2##(1991-6#1)(1995-5#1)
transportation without##2##2##(2008-3#1)(2012-2#1)
transportation##95##1##(1990-10#1)(1991-11#1)(1991-6#1)(1992-5#1)(1993-5#2)(1993-8#1)(1994-1#1)(1994-3#1)(1994-9#1)(1995-5#1)(1996-3#1)(2005-2#1)(2005-5#1)(2005-8#2)(2006-10#1)(2006-5#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#8)(2008-3#3)(2008-5#5)(2008-6#1)(2008-7#2)(2008-9#3)(2009-10#4)(2009-12#1)(2009-4#1)(2010-12#4)(2010-2#1)(2010-4#3)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#17)(2013-7#1)(2013-8#5)
transported across the##2##3##(1993-6#1)(2008-8#1)
transported across##3##2##(1993-6#1)(2008-11#1)(2008-8#1)
transported along the##3##3##(1997-3#1)(2008-10#1)(2013-1#1)
transported along##4##2##(1997-3#1)(2007-8#1)(2008-10#1)(2013-1#1)
transported and##3##2##(1991-11#1)(1993-3#1)(2013-1#1)
transported away from the##2##4##(2007-3#1)(2007-5#1)
transported by Mobile Fire Medics##2##5##(2007-9#2)
transported by a##5##3##(1994-3#1)(1994-8#1)(2008-4#1)(2008-7#1)(2010-4#1)
transported by means of a nitrogen carrier into a##2##9##(2007-8#1)(2008-10#1)
transported by means of a##3##5##(2007-8#1)(2008-10#2)
transported by the##4##3##(1992-6#1)(1996-12#1)(2005-11#1)(2008-10#1)
transported by##20##2##(1991-11#1)(1992-6#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-12#1)(2005-11#1)(2007-8#1)(2007-9#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2010-4#1)(2012-2#1)(2013-1#1)
transported from the##11##3##(1990-8#1)(1992-12#1)(1993-7#1)(1994-9#1)(1997-6#3)(2008-10#1)(2008-4#1)(2008-5#1)(2009-8#1)
transported from##15##2##(1990-8#1)(1992-12#1)(1993-7#1)(1994-9#1)(1995-12#1)(1995-3#1)(1997-6#3)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)
transported in the##2##3##(1993-5#1)(1996-2#1)
transported in##8##2##(1993-5#1)(1994-12#1)(1994-2#1)(1994-8#1)(1996-2#1)(1996-3#1)(2005-10#1)(2011-1#1)
transported into mammalian microsomes##2##4##(1994-11#1)(1994-2#1)
transported into the brain by##2##5##(1995-3#1)(1996-12#1)
transported into the brain##3##4##(1993-12#1)(1995-3#1)(1996-12#1)
transported into the##9##3##(1992-3#1)(1993-12#1)(1994-8#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(2009-6#1)(2012-2#1)
transported into##18##2##(1992-3#1)(1993-12#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-8#1)(2006-11#1)(2008-1#1)(2008-10#1)(2009-6#1)(2012-2#1)
transported over##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
transported substrate##2##2##(1990-12#1)(1995-11#1)
transported through the##3##3##(1995-1#1)(1997-6#1)(2008-7#1)
transported through##4##2##(1990-5#1)(1995-1#1)(1997-6#1)(2008-7#1)
transported to a##4##3##(1997-7#1)(2007-9#1)(2012-1#2)
transported to an##2##3##(2008-10#2)
transported to the cell surface##2##5##(1990-5#1)(1992-5#1)
transported to the detector##3##4##(1993-12#1)(2008-10#2)
transported to the laboratory##2##4##(2008-10#1)(2008-5#1)
transported to the plasma membrane##2##5##(1994-3#1)(1995-6#1)
transported to the##25##3##(1990-5#1)(1991-12#2)(1992-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-6#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-6#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-5#1)(2010-11#1)(2013-1#1)
transported to##36##2##(1990-5#1)(1991-12#2)(1992-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-4#1)(1995-6#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-8#2)(2007-9#1)(2008-10#7)(2008-11#2)(2008-5#1)(2010-11#1)(2011-1#1)(2012-1#2)(2013-1#1)
transported via the##2##3##(1991-10#1)(1992-12#1)
transported via##3##2##(1991-10#1)(1992-12#1)(2009-9#1)
transported with##2##2##(1994-12#1)(2008-10#1)
transported##171##1##(1990-11#2)(1990-12#2)(1990-5#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-5#1)(1991-6#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#5)(1993-11#1)(1993-12#3)(1993-3#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#3)(1994-11#4)(1994-12#2)(1994-2#2)(1994-3#3)(1994-8#4)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#2)(1995-3#2)(1995-4#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#4)(1996-2#3)(1996-3#3)(1996-8#2)(1996-9#2)(1997-3#3)(1997-4#2)(1997-6#5)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-11#1)(2006-4#1)(2006-8#1)(2007-3#1)(2007-5#2)(2007-8#5)(2007-9#4)(2008-1#1)(2008-10#23)(2008-11#5)(2008-2#2)(2008-4#3)(2008-5#5)(2008-7#3)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-4#3)(2011-1#2)(2012-1#2)(2012-2#2)(2013-1#4)
transporter (5-HTT)##2##2##(1995-5#1)(1996-12#1)
transporter (DAT)##8##2##(1995-11#1)(1996-12#2)(1997-2#1)(1997-7#1)(2007-11#1)(2008-11#2)
transporter (SERT)##6##2##(1996-12#2)(1997-2#1)(2005-9#1)(2006-10#1)(2010-12#1)
transporter 1##5##2##(1993-8#2)(2009-8#1)(2009-9#1)(2013-1#1)
transporter 2 (GLUT 2)##2##4##(1994-2#2)
transporter GLUT1 mRNA##2##3##(1994-3#2)
transporter P-glycoprotein##3##2##(2007-8#1)(2008-11#1)(2009-4#1)
transporter activity##4##2##(1995-2#1)(2007-9#1)(2010-10#1)(2013-8#1)
transporter and##8##2##(1991-4#1)(1994-6#1)(1995-11#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-7#1)(2009-9#1)
transporter as judged##2##3##(1996-1#1)(1997-6#1)
transporter as##5##2##(1995-11#1)(1996-1#1)(1997-6#1)(2008-6#1)(2008-7#1)
transporter binding##3##2##(1995-12#1)(1997-1#1)(2006-9#1)
transporter by##2##2##(1995-11#1)(1995-8#1)
transporter containing##2##2##(1990-2#1)(1995-2#1)
transporter content##3##2##(1990-2#1)(1994-12#1)(1995-11#1)
transporter could##2##2##(1996-12#2)
transporter densities in##2##3##(1996-1#2)
transporter densities##5##2##(1996-1#5)
transporter expression##5##2##(1992-6#1)(1993-6#1)(1996-5#3)
transporter family##5##2##(1993-6#1)(1996-8#1)(2008-7#1)(2011-2#1)(2013-8#1)
transporter for##5##2##(1994-9#1)(1996-12#2)(2006-10#1)(2011-2#1)
transporter from mouse brain##2##4##(1992-6#1)(1995-11#1)
transporter from##4##2##(1992-6#1)(1995-11#1)(2006-10#1)(2008-5#1)
transporter gene##11##2##(1991-12#1)(1991-3#2)(1993-8#1)(1995-11#1)(2008-10#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-7#1)
transporter genes##2##2##(1991-12#1)(2006-10#1)
transporter in rat##2##3##(1992-7#1)(1992-8#1)
transporter in the##5##3##(1994-2#1)(1994-8#1)(1997-1#1)(1997-7#1)(2008-4#1)
transporter in##20##2##(1992-1#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-6#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-7#1)(2005-9#1)(2006-9#1)(2008-4#1)(2010-2#1)(2012-3#1)
transporter is encoded by##2##4##(1994-8#1)(1995-6#1)
transporter is more##2##3##(1996-5#2)
transporter is not##3##3##(1995-12#2)(1996-4#1)
transporter is##18##2##(1990-11#3)(1994-10#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#2)(1997-7#1)(2006-11#1)
transporter isoform##4##2##(1993-6#2)(1996-12#1)(2010-11#1)
transporter mRNA in the##3##4##(1994-2#2)(2012-2#1)
transporter mRNA##6##2##(1990-8#1)(1993-3#1)(1994-2#2)(2012-2#2)
transporter mRNAs##2##2##(1996-2#2)
transporter may##2##2##(1992-7#1)(1994-9#1)
transporter of the##3##3##(1992-2#1)(1996-12#2)
transporter of##10##2##(1991-6#1)(1992-2#1)(1992-6#1)(1993-6#1)(1995-6#1)(1995-8#1)(1996-12#2)(2010-2#1)(2011-1#1)
transporter previously##3##2##(1991-3#1)(1994-8#1)(1995-11#1)
transporter protein in##2##3##(1995-6#1)(2006-10#1)
transporter protein##12##2##(1990-8#1)(1992-7#1)(1992-8#1)(1993-6#1)(1995-11#1)(1995-6#2)(1996-12#1)(2006-10#2)(2009-8#1)(2012-3#1)
transporter proteins may##2##3##(1990-8#1)(1993-3#1)
transporter proteins##7##2##(1990-8#1)(1992-1#1)(1993-3#2)(1996-12#1)(2008-1#1)(2008-11#1)
transporter sites##2##2##(1995-5#1)(1996-12#1)
transporter that##3##2##(1995-2#1)(2004-11#1)(2011-2#1)
transporter type 2##3##3##(1995-10#1)(1995-12#1)(2008-11#1)
transporter was isolated##2##3##(1994-10#1)(1995-11#1)
transporter was##6##2##(1991-4#1)(1994-10#1)(1994-12#1)(1995-11#1)(1996-1#1)(1996-2#1)
transporter were##4##2##(1992-1#1)(1996-12#1)(1996-5#1)(2008-10#1)
transporter##360##1##(1990-11#4)(1990-2#4)(1990-8#5)(1991-1#1)(1991-12#7)(1991-3#6)(1991-4#5)(1991-5#2)(1991-6#1)(1992-1#5)(1992-11#1)(1992-2#2)(1992-3#1)(1992-6#7)(1992-7#4)(1992-8#2)(1993-12#2)(1993-3#4)(1993-6#8)(1993-8#4)(1994-10#5)(1994-11#2)(1994-12#5)(1994-2#7)(1994-3#2)(1994-6#5)(1994-8#6)(1994-9#4)(1995-1#1)(1995-10#2)(1995-11#13)(1995-12#7)(1995-2#8)(1995-5#2)(1995-6#7)(1995-8#6)(1996-1#10)(1996-10#5)(1996-12#28)(1996-2#9)(1996-4#6)(1996-5#8)(1996-6#6)(1996-7#1)(1996-8#4)(1996-9#2)(1997-1#4)(1997-2#2)(1997-4#1)(1997-6#2)(1997-7#8)(2004-11#1)(2005-9#2)(2006-10#9)(2006-11#1)(2006-12#2)(2006-9#3)(2007-11#1)(2007-12#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#14)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#1)(2009-10#1)(2009-4#3)(2009-5#1)(2009-8#6)(2009-9#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#5)(2010-7#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#1)(2013-8#2)
transporter-1##2##1##(2009-12#1)(2011-1#1)
transporter-deficient##2##1##(1997-4#1)(2011-2#1)
transporter-like##2##1##(1995-8#1)(1996-5#1)
transporter-mediated##3##1##(1996-12#1)(2004-11#1)(2008-10#1)
transporter-vesamicol receptor (AcChT-VR)##2##3##(1992-6#2)
transporter-vesamicol receptor##4##2##(1992-6#4)
transporters and the##2##3##(1990-2#1)(2013-1#1)
transporters and##12##2##(1990-2#1)(1994-9#1)(1995-6#1)(2007-11#1)(2008-1#1)(2009-8#2)(2010-12#1)(2012-12#1)(2013-1#2)(2013-8#1)
transporters are##9##2##(1990-2#1)(1993-3#1)(2005-8#1)(2006-11#2)(2006-12#1)(2008-7#1)(2009-8#1)(2013-1#1)
transporters but##2##2##(2008-8#1)(2009-8#1)
transporters for##4##2##(1993-3#1)(2008-7#1)(2009-5#1)(2011-2#1)
transporters from##3##2##(1990-10#1)(1995-11#1)(2008-8#1)
transporters have been##3##3##(2006-11#1)(2007-8#1)(2010-2#1)
transporters have##4##2##(2006-11#1)(2007-8#1)(2008-8#1)(2010-2#1)
transporters in rat##2##3##(1990-2#1)(1996-12#1)
transporters in the plasma membrane##2##5##(1990-10#1)(1990-2#1)
transporters in the plasma##3##4##(1990-10#1)(1990-2#1)(1996-9#1)
transporters in the##10##3##(1990-10#1)(1990-2#1)(1994-11#1)(1996-9#1)(2008-11#1)(2008-7#2)(2008-8#1)(2012-12#1)(2013-1#1)
transporters in these##2##3##(1990-2#2)
transporters in##25##2##(1990-10#2)(1990-11#1)(1990-2#4)(1994-11#1)(1994-12#2)(1996-12#1)(1996-9#1)(2006-11#1)(2008-11#1)(2008-4#1)(2008-7#4)(2008-8#2)(2009-12#1)(2012-12#2)(2013-1#1)
transporters of the##2##3##(2008-10#1)(2011-1#1)
transporters of##5##2##(1995-2#1)(2008-10#1)(2008-8#1)(2010-2#1)(2011-1#1)
transporters or##2##2##(2008-5#1)(2008-7#1)
transporters to##4##2##(1991-9#1)(1993-3#1)(1996-12#1)(2008-4#1)
transporters was##4##2##(1990-10#1)(1991-9#1)(1997-1#1)(2009-12#1)
transporters##183##1##(1990-10#7)(1990-11#2)(1990-2#9)(1990-8#1)(1991-2#2)(1991-3#1)(1991-9#4)(1992-3#1)(1992-6#3)(1992-8#1)(1993-12#2)(1993-3#4)(1993-6#1)(1994-1#1)(1994-10#3)(1994-11#1)(1994-12#6)(1994-2#2)(1994-3#1)(1994-9#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#4)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#1)(1997-4#4)(2005-8#3)(2006-10#2)(2006-11#4)(2006-12#2)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#8)(2008-4#2)(2008-5#1)(2008-7#21)(2008-8#11)(2009-12#2)(2009-5#1)(2009-8#5)(2009-9#1)(2010-12#4)(2010-2#5)(2011-1#1)(2011-2#1)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#8)(2013-8#4)
transporters)##2##1##(2005-8#1)(2012-3#1)
transporting a##2##2##(1994-2#1)(2013-1#1)
transporting and##2##2##(2008-2#1)(2009-10#1)
transporting biomass##2##2##(2008-5#2)
transporting critically ill##2##3##(2005-8#1)(2010-8#1)
transporting epithelia##2##2##(2006-10#1)(2007-12#1)
transporting proteins##2##2##(2008-8#1)(2013-8#1)
transporting the##3##2##(1996-3#1)(2010-12#1)(2012-2#1)
transporting##41##1##(1992-11#1)(1994-12#2)(1994-2#1)(1995-3#1)(1996-3#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-12#3)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-1#1)(2012-2#2)(2013-1#3)(2013-8#2)
transports to##2##2##(1995-5#1)(2008-1#1)
transports##20##1##(1990-5#1)(1992-6#1)(1993-5#1)(1995-2#1)(1995-5#2)(1997-4#1)(1997-7#2)(2005-8#1)(2006-10#2)(2008-1#1)(2008-11#1)(2008-9#1)(2009-4#2)(2010-12#1)(2013-1#2)
transposa and vacuma##4##3##(2008-10#4)
transposa and##5##2##(2008-10#5)
transposa isolates##3##2##(2008-10#3)
transposa##9##1##(2008-10#9)
transposable element in##4##3##(1991-11#1)(1997-4#1)(2008-10#1)(2012-3#1)
transposable element##24##2##(1991-11#1)(1991-12#2)(1994-3#1)(1995-8#2)(1997-1#2)(1997-4#3)(2008-10#5)(2008-11#2)(2008-8#1)(2008-9#1)(2012-3#3)(2013-1#1)
transposable elements (TEs)##2##3##(1994-6#1)(2009-3#1)
transposable elements and##3##3##(2009-10#1)(2009-6#2)
transposable elements in##5##3##(1994-6#1)(2008-7#1)(2009-6#2)(2010-5#1)
transposable elements##25##2##(1994-6#2)(1994-8#1)(2006-12#1)(2008-10#6)(2008-11#2)(2008-7#1)(2009-10#3)(2009-3#1)(2009-6#5)(2010-5#1)(2010-8#1)(2012-3#1)
transposable##56##1##(1991-11#1)(1991-12#2)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-12#2)(1995-8#3)(1997-1#2)(1997-4#4)(2006-12#1)(2008-10#12)(2008-11#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#3)(2009-3#1)(2009-6#5)(2010-5#1)(2010-8#2)(2012-3#4)(2013-1#1)
transposase and##3##2##(1990-3#1)(1995-8#1)(2011-12#1)
transposase to##2##2##(1990-3#1)(2012-3#1)
transposase##20##1##(1990-3#3)(1990-5#1)(1994-9#4)(1995-8#5)(1996-12#2)(1996-6#1)(2008-10#1)(2011-12#1)(2012-3#2)
transposase-induced cleavages##2##2##(1994-9#2)
transposases##2##1##(1996-4#1)(2012-3#1)
transpose##6##1##(1995-8#2)(2005-10#1)(2008-2#1)(2008-3#2)
transposed basilic vein fistula##5##4##(2007-7#5)
transposed basilic##6##2##(2007-7#6)
transposed into the##2##3##(1997-2#1)(2007-12#1)
transposed##16##1##(1991-11#1)(1992-9#1)(1995-11#1)(1997-2#1)(2007-12#1)(2007-7#6)(2008-10#1)(2008-6#1)(2008-9#2)(2013-8#1)
transposes##2##1##(1991-5#1)(2008-10#1)
transposing##8##1##(1993-1#1)(1994-3#1)(1995-8#2)(2008-10#1)(2008-2#3)
transposition activity##5##2##(1990-3#1)(1994-9#1)(1995-8#2)(2008-10#1)
transposition and transfection##2##3##(2005-11#2)
transposition and##4##2##(2005-11#2)(2008-10#1)(2008-9#1)
transposition frequency##6##2##(1995-8#1)(2012-3#4)(2013-8#1)
transposition immunity##4##2##(1990-3#4)
transposition in##5##2##(1991-5#2)(1997-7#1)(2008-10#1)(2009-10#1)
transposition is##6##2##(1991-7#1)(1995-1#1)(1995-8#3)(2010-12#1)
transposition of a latissimus dorsi##2##5##(1994-12#1)(2007-8#1)
transposition of a##3##3##(1994-12#1)(1995-2#1)(2007-8#1)
transposition of the great arteries##7##5##(2006-8#1)(2007-8#1)(2009-10#2)(2009-4#1)(2010-6#1)(2012-1#1)
transposition of the great##8##4##(1996-11#1)(2006-8#1)(2007-8#1)(2009-10#2)(2009-4#1)(2010-6#1)(2012-1#1)
transposition of the##17##3##(1990-9#1)(1996-11#1)(1996-7#1)(2006-3#1)(2006-8#1)(2007-2#1)(2007-8#2)(2008-3#1)(2009-10#2)(2009-4#1)(2010-12#2)(2010-6#1)(2011-2#1)(2012-1#1)
transposition of##30##2##(1990-9#1)(1994-12#1)(1995-2#1)(1995-8#2)(1996-11#1)(1996-7#1)(1997-4#1)(2006-3#2)(2006-8#2)(2007-2#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-10#2)(2009-4#1)(2010-12#2)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
transposition plasmid##2##2##(2005-11#2)
transposition properties of##2##3##(1991-9#1)(1997-4#1)
transposition properties##4##2##(1991-9#2)(1997-4#2)
transposition rates##2##2##(2012-3#2)
transposition##122##1##(1990-3#8)(1990-9#1)(1991-5#4)(1991-7#3)(1991-9#2)(1993-10#1)(1993-8#1)(1994-12#2)(1994-6#1)(1994-9#4)(1995-1#2)(1995-2#3)(1995-8#17)(1996-11#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#4)(1997-7#2)(2005-11#4)(2006-10#1)(2006-3#2)(2006-6#1)(2006-8#2)(2007-2#3)(2007-7#3)(2007-8#3)(2008-1#4)(2008-10#7)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-10#3)(2009-4#1)(2010-12#3)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#9)(2013-8#5)
transposon Tn3##2##2##(1990-3#1)(1996-12#1)
transposon Tn7##3##2##(1991-5#1)(1991-7#1)(1995-8#1)
transposon ends##2##2##(1991-5#1)(1995-8#1)
transposon family##2##2##(1994-8#1)(1997-1#1)
transposon in##2##2##(2008-10#2)
transposon insertion events##2##3##(2009-10#1)(2013-8#1)
transposon insertion mutants##2##3##(1993-9#1)(1995-8#1)
transposon insertion##6##2##(1993-9#1)(1995-8#1)(2006-8#1)(2008-10#1)(2009-10#1)(2013-8#1)
transposon insertions##4##2##(2008-7#3)(2009-10#1)
transposon mutagenesis##5##2##(2007-10#1)(2008-10#2)(2008-9#2)
transposon was##2##2##(1993-11#1)(1997-2#1)
transposon##59##1##(1990-3#1)(1990-9#1)(1991-5#3)(1991-7#2)(1991-9#1)(1993-11#2)(1993-12#1)(1993-9#1)(1994-8#2)(1995-2#1)(1995-8#6)(1995-9#1)(1996-10#1)(1996-12#1)(1997-1#1)(1997-2#5)(2006-8#1)(2007-10#1)(2008-10#11)(2008-7#3)(2008-9#3)(2009-10#2)(2009-3#2)(2009-5#1)(2010-4#1)(2010-5#3)(2013-8#1)
transposons and##2##2##(2010-12#1)(2010-5#1)
transposons##14##1##(1993-11#2)(1994-12#1)(1994-8#1)(1995-2#1)(1995-8#1)(2006-8#2)(2008-10#1)(2008-7#2)(2009-3#1)(2010-12#1)(2010-5#1)
transracial adoption##2##2##(2008-5#2)
transracial##4##1##(2008-5#4)
transradial access##3##2##(2011-2#3)
transradial approach for coronary##2##4##(2011-2#2)
transradial approach for percutaneous coronary##2##5##(2011-2#2)
transradial approach for##6##3##(2011-2#6)
transradial approach##16##2##(2008-11#3)(2011-2#13)
transradial coronary angiography##2##3##(2011-2#2)
transradial coronary##4##2##(2011-2#4)
transradial interventions##2##2##(2011-2#2)
transradial procedure##2##2##(2011-2#2)
transradial prosthesis##2##2##(2012-1#2)
transradial##40##1##(2006-11#1)(2008-11#3)(2011-2#33)(2012-1#3)
transrectal High-Intensity Focused Ultrasound (HIFU) treatment##2##6##(2013-1#2)
transrectal sonography##4##2##(1991-12#1)(2006-1#1)(2011-2#2)
transrectal ultrasonography##3##2##(1990-9#1)(1997-8#1)(2006-5#1)
transrectal##16##1##(1990-9#1)(1991-12#1)(1997-8#1)(2005-10#1)(2006-1#1)(2006-5#1)(2007-3#1)(2007-6#1)(2008-8#1)(2010-12#1)(2011-2#3)(2012-12#1)(2013-1#2)
transrepressing function##2##2##(1996-2#2)
transseptal##3##1##(2006-5#1)(2006-8#1)(2008-10#1)
transsexuals have##2##2##(2013-1#2)
transsexuals##7##1##(2007-10#1)(2009-10#1)(2013-1#5)
transshipment##2##1##(2008-5#1)(2012-3#1)
transsphenoidal approach to##2##3##(2011-2#2)
transsphenoidal approach##6##2##(2011-2#6)
transsphenoidal pituitary surgery##2##3##(1997-1#1)(2006-5#1)
transsphenoidal surgery##7##2##(1997-1#1)(2005-10#1)(2005-9#1)(2006-9#1)(2008-7#2)(2013-8#1)
transsphenoidal##19##1##(1991-6#1)(1997-1#2)(2005-10#1)(2005-9#1)(2006-5#1)(2006-9#1)(2008-7#2)(2009-2#1)(2011-2#8)(2013-8#1)
transsternal thymectomy for myasthenia gravis##2##5##(2007-8#2)
transsternal thymectomy##3##2##(2007-8#3)
transsynaptic##3##1##(1990-2#1)(1993-3#1)(1997-2#1)
transtemporal##2##1##(2007-9#1)(2011-2#1)
transtentorial##2##1##(2006-12#1)(2008-7#1)
transtheoretical model (TTM)##2##3##(2008-12#1)(2013-1#1)
transtheoretical model##5##2##(2008-12#1)(2008-3#1)(2008-9#1)(2013-1#2)
transtheoretical##6##1##(2008-12#1)(2008-3#1)(2008-9#1)(2012-2#1)(2013-1#2)
transthoracic and transesophageal##2##3##(2007-7#1)(2011-2#1)
transthoracic and##4##2##(2006-8#1)(2007-7#2)(2011-2#1)
transthoracic aortic clamping##3##3##(2007-8#3)
transthoracic approach##3##2##(2006-7#1)(2007-8#1)(2010-7#1)
transthoracic echocardiography and##2##3##(2008-12#1)(2011-2#1)
transthoracic echocardiography##12##2##(2006-4#1)(2007-11#1)(2007-8#4)(2008-11#1)(2008-12#1)(2008-4#1)(2010-7#1)(2011-2#1)(2012-2#1)
transthoracic mediastinal drainage##3##3##(2007-8#3)
transthoracic needle biopsy##2##3##(1996-12#1)(2010-12#1)
transthoracic pressure##2##2##(2005-11#2)
transthoracic ultrasonography##2##2##(2010-12#2)
transthoracic##43##1##(1993-3#1)(1996-12#1)(1997-1#1)(2005-11#2)(2006-10#1)(2006-4#1)(2006-7#3)(2006-8#1)(2007-11#1)(2007-7#3)(2007-8#12)(2008-11#1)(2008-12#1)(2008-4#1)(2009-10#1)(2009-3#1)(2010-12#3)(2010-2#1)(2010-7#2)(2011-2#3)(2012-2#1)(2013-1#1)
transthyretin (TTR) mRNA##2##3##(1993-12#1)(1994-10#1)
transthyretin (TTR)##5##2##(1992-4#1)(1992-8#2)(1993-12#1)(1994-10#1)
transthyretin (prealbumin) in human cerebrospinal fluid##2##6##(1991-2#2)
transthyretin and synthetic##2##3##(1991-3#2)
transthyretin and##6##2##(1991-3#4)(1993-11#1)(1994-8#1)
transthyretin gene##7##2##(1990-11#1)(1990-5#1)(1990-6#2)(1992-1#1)(1992-8#2)
transthyretin##42##1##(1990-11#2)(1990-5#2)(1990-6#6)(1991-2#7)(1991-3#6)(1992-1#2)(1992-4#2)(1992-8#5)(1993-11#1)(1993-12#1)(1994-10#3)(1994-8#2)(1995-2#1)(1995-3#1)(2013-1#1)
transthyrohyoid##2##1##(2012-2#2)
transtibial prostheses##3##2##(2013-1#3)
transtibial##7##1##(2007-10#1)(2007-7#1)(2011-2#1)(2013-1#4)
transtracheal##3##1##(1996-5#1)(1997-4#1)(2013-1#1)
transtrapezium approach##3##2##(2008-9#3)
transtympanic##5##1##(2008-4#4)(2008-9#1)
transudate##2##1##(1997-8#1)(2005-7#1)
transudates##4##1##(1997-8#4)
transumbilical incision##2##2##(2012-12#1)(2013-1#1)
transumbilical laparoendoscopic##2##2##(2012-12#2)
transumbilical thoracic##2##2##(2013-1#2)
transumbilical##7##1##(2012-12#3)(2013-1#4)
transurethral prostate##2##2##(1990-11#2)
transurethral resection of bladder tumor##2##5##(2006-10#1)(2008-10#1)
transurethral resection of the prostate (TURP)##2##6##(2006-12#1)(2006-8#1)
transurethral resection of the prostate##4##5##(2006-12#1)(2006-8#1)(2006-9#1)(2012-3#1)
transurethral resection of the##6##4##(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2012-12#1)(2012-3#1)
transurethral resection of##10##3##(2006-10#2)(2006-12#1)(2006-8#1)(2006-9#2)(2008-10#1)(2011-1#1)(2012-12#1)(2012-3#1)
transurethral resection was##2##3##(2011-12#1)(2012-12#1)
transurethral resection##18##2##(1991-9#1)(2006-10#2)(2006-12#1)(2006-8#1)(2006-9#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2009-5#1)(2011-1#1)(2011-12#1)(2012-12#2)(2012-3#1)(2013-7#1)
transurethral##28##1##(1990-11#2)(1990-4#1)(1991-9#1)(1996-1#2)(2006-10#2)(2006-12#1)(2006-8#1)(2006-9#3)(2007-3#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-5#1)(2010-2#1)(2011-1#1)(2011-12#1)(2012-12#2)(2012-3#1)(2013-7#1)
transvaginal color Doppler##4##3##(1995-3#4)
transvaginal hysterosonography##6##2##(2007-3#6)
transvaginal sonography##10##2##(1990-10#1)(1992-12#2)(1995-4#1)(2007-3#2)(2007-8#1)(2011-1#1)(2011-2#2)
transvaginal ultrasound##2##2##(1995-3#1)(2006-6#1)
transvaginal##37##1##(1990-10#1)(1991-11#2)(1992-12#3)(1995-3#5)(1995-4#2)(1996-1#2)(1996-12#1)(2004-10#1)(2006-6#1)(2007-2#2)(2007-3#8)(2007-8#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#1)
transvaginally##2##1##(1995-4#1)(1996-12#1)
transvenous##14##1##(1990-6#1)(1996-9#1)(2006-11#1)(2006-12#2)(2007-9#2)(2008-10#1)(2008-12#1)(2008-7#1)(2009-9#1)(2012-1#1)(2013-1#2)
transversal and##4##2##(2007-11#1)(2008-2#1)(2008-9#1)(2011-2#1)
transversal groove##2##2##(2006-4#2)
transversal study##2##2##(1992-5#1)(2012-3#1)
transversal##19##1##(1992-5#1)(1994-6#1)(2006-4#2)(2007-11#2)(2007-8#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#2)(2009-2#3)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#1)
transversally heated##2##2##(2008-10#2)
transversally into##2##2##(2008-12#1)(2013-1#1)
transversally##9##1##(1991-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2013-1#1)
transverse and longitudinal##6##3##(2005-11#1)(2006-5#1)(2007-12#2)(2008-2#1)(2012-11#1)
transverse and sagittal##2##3##(2012-2#2)
transverse and##16##2##(2005-11#1)(2006-5#1)(2007-12#5)(2008-2#1)(2008-3#3)(2009-3#1)(2010-1#1)(2012-11#1)(2012-2#2)
transverse beam profile##2##3##(2007-12#1)(2008-2#1)
transverse beam##3##2##(2007-12#1)(2008-2#2)
transverse carpal ligament##5##3##(2006-3#1)(2008-9#3)(2012-2#1)
transverse coherence##4##2##(2007-12#2)(2008-3#2)
transverse colon##8##2##(1990-5#1)(1991-6#1)(1993-9#2)(2005-12#1)(2008-11#1)(2008-9#1)(2010-2#1)
transverse cuts##2##2##(2007-3#1)(2008-5#1)
transverse diameter of the aberrant pancreatic tissue##2##7##(2012-2#2)
transverse diameter of the##5##4##(2008-4#1)(2011-2#2)(2012-2#2)
transverse dimension##2##2##(2007-12#2)
transverse dimensions##2##2##(2008-1#1)(2008-3#1)
transverse displacement##2##2##(2008-2#2)
transverse electro-optic effect in##2##4##(2008-3#2)
transverse flow velocity##2##3##(2007-11#1)(2008-3#1)
transverse fracture of##2##3##(2007-1#1)(2013-1#1)
transverse instability##2##2##(2007-12#2)
transverse intensity profile##3##3##(2007-11#1)(2007-12#2)
transverse intensity##5##2##(2007-11#1)(2007-12#4)
transverse laser##2##2##(2008-2#1)(2008-3#1)
transverse ligament##3##2##(2006-7#1)(2013-1#2)
transverse load##4##2##(2007-12#4)
transverse mode##9##2##(2007-12#3)(2008-2#1)(2008-3#5)
transverse modes in##2##3##(2007-12#1)(2008-2#1)
transverse modes##5##2##(2007-12#2)(2008-2#3)
transverse myelitis and neuromyelitis optica##2##5##(2012-3#2)
transverse myelitis and##3##3##(2012-3#3)
transverse myelitis##11##2##(2006-10#1)(2007-7#1)(2010-12#1)(2012-11#1)(2012-12#1)(2012-3#6)
transverse optical##2##2##(2007-12#1)(2008-1#1)
transverse or##2##2##(2008-2#1)(2008-3#1)
transverse plane##8##2##(2006-3#1)(2007-11#1)(2007-12#2)(2007-7#2)(2008-2#1)(2008-3#1)
transverse planes##2##2##(2007-11#1)(2008-3#1)
transverse process##2##2##(2006-8#1)(2011-12#1)
transverse processes##4##2##(2007-1#1)(2007-11#1)(2007-5#2)
transverse profile##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
transverse relaxation rates of##2##4##(1995-1#1)(1997-5#1)
transverse relaxation rates##7##3##(1995-1#6)(1997-5#1)
transverse relaxation times##2##3##(1997-5#1)(2011-1#1)
transverse relaxation##13##2##(1995-1#8)(1997-5#2)(2011-1#2)(2012-2#1)
transverse resolution of the##2##4##(2006-5#1)(2008-2#1)
transverse resolution of##7##3##(2006-5#1)(2007-12#5)(2008-2#1)
transverse resolution##12##2##(2006-5#1)(2007-12#9)(2008-2#1)(2008-3#1)
transverse scanning##2##2##(2007-12#1)(2008-3#1)
transverse section##2##2##(2007-12#1)(2008-7#1)
transverse sections##6##2##(1995-6#1)(2008-5#2)(2008-7#1)(2011-2#2)
transverse sinus in##2##3##(1996-6#1)(2012-1#1)
transverse sinus##9##2##(1996-6#2)(1996-9#2)(2006-12#1)(2008-7#3)(2012-1#1)
transverse spatial##8##2##(2007-11#2)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#1)
transverse the membrane##2##3##(1990-5#1)(1993-3#1)
transverse to the optical##2##4##(2007-11#1)(2007-12#1)
transverse to the##6##3##(2007-11#1)(2007-12#4)(2008-3#1)
transverse tubules##5##2##(1991-7#1)(1993-3#1)(1994-5#1)(2008-1#2)
transverse view##2##2##(1996-11#1)(2007-7#1)
transverse##311##1##(1990-5#2)(1991-2#1)(1991-3#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-2#2)(1993-12#1)(1993-3#3)(1993-4#1)(1993-9#2)(1994-5#1)(1995-1#8)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-11#1)(1996-5#2)(1996-6#2)(1996-9#2)(1997-5#2)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-4#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#2)(2006-5#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#4)(2007-11#25)(2007-12#72)(2007-3#2)(2007-5#2)(2007-7#4)(2007-8#2)(2008-1#5)(2008-10#4)(2008-11#1)(2008-2#26)(2008-3#39)(2008-4#1)(2008-5#3)(2008-7#5)(2008-9#6)(2009-3#2)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-12#4)(2010-2#2)(2010-4#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#3)(2012-12#2)(2012-2#10)(2012-3#6)(2013-1#6)(2013-7#1)
transverse-electric fundamental##2##2##(2007-12#2)
transverse-electric##3##1##(2007-12#2)(2008-3#1)
transverse-mode operation##2##2##(2007-12#2)
transverse-mode##5##1##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
transverse-sigmoid sinus DAVM##2##3##(2006-12#2)
transverse-sigmoid sinus dural arteriovenous malformations##3##5##(2006-12#1)(2008-7#2)
transverse-sigmoid sinus##7##2##(2006-12#4)(2007-10#1)(2008-7#2)
transversely heated graphite atomizer (THGA)##2##5##(2008-10#2)
transversely heated graphite atomizer##4##4##(2008-10#4)
transversely heated graphite##7##3##(2008-10#7)
transversely varying saturable gain##3##4##(2007-12#3)
transversely##19##1##(1993-3#1)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#9)(2008-3#1)(2009-7#1)
transversion at nucleotide##3##3##(1994-11#1)(1994-12#1)(1995-1#1)
transversion at position##2##3##(1996-6#1)(2008-10#1)
transversion at##7##2##(1991-10#1)(1993-4#1)(1994-11#1)(1994-12#1)(1995-1#1)(1996-6#1)(2008-10#1)
transversion##19##1##(1990-12#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-10#1)(1991-7#1)(1992-8#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-1#1)(1996-4#1)(1996-6#1)(2008-10#4)
transversions at the##2##3##(1992-2#1)(1993-9#1)
transversions##8##1##(1992-2#1)(1993-9#1)(1995-10#1)(1995-5#1)(1996-4#1)(1997-1#1)(1997-4#1)(2008-4#1)
transversostomy##2##1##(1992-8#2)
transversus abdominis##3##2##(2008-8#1)(2012-12#2)
transvesical##2##1##(2011-2#1)(2013-1#1)
transwell##4##1##(1992-9#1)(2007-12#1)(2008-4#1)(2012-3#1)
tranverse##2##1##(2007-11#1)(2007-12#1)
trap and the##2##3##(2007-3#1)(2008-10#1)
trap and##13##2##(2005-11#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#1)(2009-8#1)
trap as##2##2##(2008-8#1)(2013-8#1)
trap at##2##2##(2005-11#1)(2008-10#1)
trap can##2##2##(2008-2#1)(2013-8#1)
trap detector##3##2##(2007-8#1)(2008-2#2)
trap door##2##2##(2008-10#1)(2012-12#1)
trap for##6##2##(2007-12#3)(2008-10#2)(2008-2#1)
trap groups##2##2##(2013-7#2)
trap hydroxyl radicals and##2##4##(2008-1#1)(2008-10#1)
trap in the##2##3##(2008-5#1)(2013-8#1)
trap in##8##2##(2004-11#1)(2006-5#1)(2007-8#1)(2008-5#1)(2013-8#4)
trap is##2##2##(2007-12#1)(2008-3#1)
trap mass spectrometer##7##3##(2007-8#1)(2008-1#1)(2008-10#4)(2009-10#1)
trap mass spectrometry##14##3##(2007-8#1)(2008-10#7)(2008-8#2)(2010-11#1)(2011-1#1)(2012-12#1)(2012-2#1)
trap mass##22##2##(2007-8#2)(2008-1#1)(2008-10#12)(2008-8#2)(2009-10#1)(2010-11#1)(2011-1#1)(2012-12#1)(2012-2#1)
trap method##2##2##(1996-8#1)(2007-8#1)
trap one##2##2##(1990-10#1)(2006-2#1)
trap plants in##2##3##(2008-10#2)
trap plants##7##2##(2007-6#1)(2008-10#6)
trap plots##2##2##(2008-10#2)
trap state to P680##2##4##(1997-4#2)
trap system##4##2##(2008-10#3)(2008-9#1)
trap the##6##2##(1993-3#1)(1995-2#1)(1997-1#1)(1997-6#1)(2007-8#1)(2010-12#1)
trap trees for##2##3##(2011-2#2)
trap trees##8##2##(2011-2#8)
trap was##2##2##(2005-11#1)(2008-10#1)
trap##198##1##(1990-10#1)(1990-12#1)(1991-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-8#2)(1997-1#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-11#5)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#7)(2007-12#9)(2007-3#2)(2007-6#2)(2007-8#7)(2008-1#4)(2008-10#51)(2008-11#1)(2008-2#17)(2008-3#9)(2008-5#4)(2008-8#4)(2008-9#4)(2009-10#3)(2009-12#2)(2009-5#3)(2009-8#2)(2010-11#2)(2010-12#1)(2010-7#2)(2011-1#4)(2011-12#1)(2011-2#10)(2012-12#4)(2012-2#2)(2013-1#1)(2013-7#3)(2013-8#7)
trap&quot##2##1##(1997-4#1)(2009-11#1)
trap(-1)##2##1##(2008-5#2)
trap)##2##1##(1996-8#1)(2004-11#1)
trap-nests##2##1##(2007-3#2)
trap/two-hybrid system##3##2##(2008-2#2)(2008-9#1)
trapeziectomy##2##1##(2006-3#2)
trapeziometacarpal interposition arthroplasty##2##3##(2009-3#2)
trapeziometacarpal joint##2##2##(2006-3#1)(2008-9#1)
trapeziometacarpal##4##1##(2006-3#1)(2008-9#1)(2009-3#2)
trapezium##4##1##(2008-9#2)(2010-6#1)(2010-9#1)
trapezius and##2##2##(2010-9#2)
trapezius muscle##3##2##(2010-9#3)
trapezius##17##1##(2006-12#2)(2006-8#1)(2007-5#2)(2010-9#11)(2012-2#1)
trapezoidal apertures of##2##3##(2008-3#2)
trapezoidal##10##1##(1996-11#1)(2008-10#1)(2008-2#1)(2008-3#6)(2010-8#1)
trapped and##5##2##(2006-3#1)(2008-10#1)(2008-2#2)(2009-12#1)
trapped at##4##2##(1991-7#1)(1994-8#1)(1997-7#1)(2005-11#1)
trapped between##2##2##(2005-11#1)(2010-5#1)
trapped by a##2##3##(2007-11#1)(2008-10#1)
trapped by an##2##3##(1992-5#1)(1997-4#1)
trapped by##14##2##(1990-2#1)(1992-5#1)(1994-3#1)(1997-4#1)(1997-7#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#4)
trapped flow analysis system (ByT-FAS)##3##5##(2008-10#3)
trapped flow##4##2##(2008-10#4)
trapped from##4##2##(1991-4#2)(2007-6#1)(2007-8#1)
trapped in a##8##3##(2005-11#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-3#1)
trapped in the cavity##2##4##(2007-12#1)(2008-2#1)
trapped in the##18##3##(1996-4#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#10)(2008-2#1)(2008-5#2)
trapped in##38##2##(1990-5#1)(1996-4#1)(2005-11#1)(2007-11#2)(2007-12#5)(2007-9#1)(2008-1#1)(2008-10#18)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-2#1)
trapped metallic particle##2##3##(2008-1#1)(2008-2#1)
trapped near the##2##3##(1994-11#1)(2007-10#1)
trapped on##2##2##(1991-8#1)(2007-3#1)
trapped pulse##3##2##(2007-11#3)
trapped with##3##2##(1991-9#1)(1994-6#1)(2008-10#1)
trapped within the##2##3##(1991-9#1)(2007-12#1)
trapped within##6##2##(1990-11#1)(1991-9#1)(2007-11#1)(2007-12#1)(2008-3#1)(2012-2#1)
trapped##151##1##(1990-11#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-4#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-5#1)(1992-6#2)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-4#2)(1996-7#1)(1996-8#1)(1997-4#1)(1997-7#2)(2004-11#1)(2004-4#1)(2004-7#1)(2005-11#5)(2005-7#2)(2006-2#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#11)(2007-12#16)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#42)(2008-11#2)(2008-2#6)(2008-3#6)(2008-4#2)(2008-5#2)(2008-7#1)(2009-12#2)(2009-2#2)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#2)
trapped-flow analysis##3##2##(2008-10#3)
trapper##2##1##(1997-2#2)
trapping agent in vivo##2##4##(1990-4#2)
trapping agent##7##2##(1990-4#2)(1992-9#1)(1993-3#1)(1995-8#1)(1997-8#1)(2009-10#1)
trapping and atomisation efficiency##2##4##(2008-10#2)
trapping and atomisation temperatures##2##4##(2008-10#2)
trapping and atomisation##5##3##(2008-10#5)
trapping and release of the magnetic beads in the flow cell were controlled by##2##14##(2008-10#2)
trapping and##20##2##(1991-4#1)(1992-6#1)(2007-11#3)(2008-10#10)(2008-3#2)(2008-8#2)(2009-12#1)
trapping by the##3##3##(2007-11#1)(2008-10#1)(2010-7#1)
trapping by##5##2##(1993-3#1)(2007-11#2)(2008-10#1)(2010-7#1)
trapping conditions##2##2##(2007-11#1)(2007-12#1)
trapping efficiency##3##2##(2007-8#1)(2008-10#1)(2008-2#1)
trapping experiments##5##2##(1995-1#2)(1996-5#1)(2007-12#1)(2010-5#1)
trapping force on##2##3##(2008-2#2)
trapping force##4##2##(2008-2#4)
trapping forces##2##2##(2007-12#1)(2008-2#1)
trapping in##6##2##(1993-4#1)(2007-11#1)(2007-12#3)(2008-7#1)
trapping of mitochondria near plasma membrane##2##6##(2007-10#2)
trapping of mitochondria near##3##4##(2007-10#3)
trapping of nanoparticles and microparticles by a Gaussian standing wave##2##10##(2007-12#2)
trapping of nanoparticles##3##3##(2007-12#3)
trapping of nitric oxide##3##4##(1993-9#2)(1994-5#1)
trapping of the##5##3##(2007-12#1)(2008-10#1)(2008-7#1)(2012-11#2)
trapping of##37##2##(1990-2#1)(1991-6#1)(1991-9#1)(1992-3#1)(1993-9#3)(1994-5#1)(1995-5#1)(1996-5#2)(2005-11#1)(2007-10#3)(2007-11#1)(2007-12#8)(2008-10#6)(2008-3#2)(2008-7#1)(2010-12#1)(2011-12#1)(2012-11#2)
trapping on##2##2##(2005-8#1)(2007-12#1)
trapping properties of a##2##4##(2008-3#2)
trapping sites##3##2##(2007-3#3)
trapping solution##2##2##(2008-10#2)
trapping system##5##2##(1996-4#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)
trapping technique##4##2##(1990-2#1)(1996-2#1)(2008-10#1)(2008-2#1)
trapping theory##3##2##(2006-9#1)(2008-11#2)
trapping using##3##2##(1996-2#1)(2008-3#1)(2011-1#1)
trapping vector##2##2##(1996-10#1)(1996-4#1)
trapping was##3##2##(1993-12#1)(2008-10#1)(2010-11#1)
trapping with##7##2##(1994-12#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-7#1)
trapping##204##1##(1990-12#1)(1990-2#3)(1990-4#2)(1990-9#1)(1991-11#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-12#2)(1993-3#2)(1993-4#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-5#2)(1994-9#1)(1995-1#4)(1995-11#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-2#2)(1996-4#4)(1996-5#3)(1997-2#1)(1997-4#1)(1997-8#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-9#2)(2007-10#4)(2007-11#16)(2007-12#20)(2007-3#4)(2007-8#1)(2008-1#2)(2008-10#45)(2008-11#2)(2008-2#11)(2008-3#12)(2008-5#2)(2008-7#7)(2008-8#2)(2009-10#1)(2009-12#1)(2009-5#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-11#2)(2012-2#1)(2013-8#1)
traps and pitfalls in##2##4##(1992-1#1)(2012-2#1)
traps and pitfalls##5##3##(1992-1#2)(1994-3#1)(2012-2#2)
traps and##13##2##(1991-2#1)(1992-1#2)(1994-3#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-4#1)(2012-12#2)(2012-2#2)(2013-7#1)
traps baited with##3##3##(2011-2#1)(2012-2#1)(2013-7#1)
traps in##5##2##(1991-3#1)(2008-10#2)(2011-2#1)(2013-7#1)
traps of##3##2##(1997-8#1)(2011-12#2)
traps placed in##2##3##(2008-8#1)(2011-12#1)
traps the##2##2##(1997-6#1)(2007-12#1)
traps to##3##2##(2011-12#1)(2013-7#2)
traps was##4##2##(2004-11#1)(2007-12#1)(2013-7#2)
traps were placed##2##3##(2004-11#1)(2008-10#1)
traps were##4##2##(2004-11#1)(2008-10#1)(2010-8#1)(2012-12#1)
traps with##2##2##(2008-5#2)
traps##101##1##(1991-2#1)(1991-3#1)(1992-1#2)(1993-1#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-8#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#6)(2004-2#4)(2005-8#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-10#10)(2008-2#5)(2008-3#2)(2008-5#11)(2008-7#1)(2008-8#1)(2009-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#8)(2011-2#9)(2012-12#5)(2012-2#4)(2013-7#10)
trash##7##1##(1996-11#1)(2008-10#6)
trasnsthoracic##2##1##(2007-8#2)
trastuzumab (Herceptin)##4##2##(2007-10#1)(2008-10#1)(2008-5#1)(2011-1#1)
trastuzumab and##5##2##(2007-11#1)(2008-10#1)(2010-1#1)(2012-3#1)(2013-1#1)
trastuzumab in##3##2##(2007-11#1)(2008-5#1)(2012-3#1)
trastuzumab was##2##2##(2011-2#1)(2013-1#1)
trastuzumab were##2##2##(2011-2#2)
trastuzumab##46##1##(2007-10#1)(2007-11#5)(2008-10#2)(2008-11#1)(2008-5#6)(2008-7#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#6)(2012-12#5)(2012-3#6)(2013-1#10)
trastuzumab-resistant##2##1##(2012-3#2)
trastuzumab-sensitive##2##1##(2012-3#1)(2013-1#1)
trastuzumab-unresponsive##2##1##(2013-1#2)
trategies##2##1##(2008-11#2)
tratment##4##1##(2005-1#1)(2006-6#1)(2007-11#1)(2008-7#1)
trauma The##2##2##(2008-5#1)(2008-9#1)
trauma anaesthesia##3##2##(2006-10#3)
trauma and allows##3##3##(2008-9#1)(2012-12#2)
trauma and in##3##3##(1991-4#1)(2006-9#1)(2007-11#1)
trauma and is##4##3##(2006-9#1)(2007-3#1)(2007-9#1)(2008-7#1)
trauma and its##2##3##(2006-10#1)(2007-10#1)
trauma and mental health problems##2##5##(2009-8#2)
trauma and movement disorders##2##4##(2008-11#2)
trauma and surgery##3##3##(2007-11#1)(2008-4#1)(2008-5#1)
trauma and the##4##3##(1991-4#1)(2008-4#1)(2011-2#1)(2013-8#1)
trauma and##81##2##(1990-2#1)(1990-9#1)(1991-2#1)(1991-4#3)(1992-6#1)(2005-10#1)(2005-7#1)(2006-10#7)(2006-12#1)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#3)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#2)(2008-9#6)(2009-11#1)(2009-3#3)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#1)(2013-1#2)(2013-8#5)
trauma anesthesia##3##2##(2006-10#3)
trauma are##7##2##(1996-12#1)(2007-11#1)(2008-9#2)(2011-12#1)(2012-2#2)
trauma assessment##2##2##(2008-6#2)
trauma associated with##2##3##(1993-11#1)(2010-12#1)
trauma can be##2##3##(2006-8#1)(2013-8#1)
trauma can##7##2##(2006-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-3#1)(2013-8#1)
trauma care##15##2##(1991-12#1)(1992-2#1)(2006-10#10)(2007-11#1)(2007-7#1)(2012-2#1)
trauma cases##4##2##(2010-12#1)(2011-2#1)(2013-1#2)
trauma caused by the##2##4##(2008-1#1)(2012-2#1)
trauma caused by##4##3##(2007-8#2)(2008-1#1)(2012-2#1)
trauma center in##2##3##(2006-10#1)(2007-9#1)
trauma center##10##2##(2006-10#1)(2007-12#2)(2007-8#1)(2007-9#1)(2011-2#2)(2012-3#1)(2013-1#2)
trauma centers##5##2##(2006-2#1)(2008-11#2)(2008-6#1)(2011-2#1)
trauma critical care##3##3##(2013-1#2)(2013-8#1)
trauma due to##3##3##(2008-7#1)(2011-2#1)(2012-2#1)
trauma during##2##2##(2007-8#1)(2009-11#1)
trauma exposure##7##2##(2008-9#1)(2009-4#2)(2009-8#3)(2012-12#1)
trauma followed by##2##3##(1996-6#1)(2007-5#1)
trauma following##5##2##(1993-5#1)(2007-4#1)(2012-2#1)(2013-1#2)
trauma from##3##2##(1991-11#1)(2005-12#1)(2011-2#1)
trauma group##2##2##(2006-10#2)
trauma has a##2##3##(2006-10#1)(2012-2#1)
trauma has##7##2##(1992-2#1)(1996-9#1)(2006-10#1)(2007-1#1)(2007-11#1)(2010-12#1)(2012-2#1)
trauma history##2##2##(2008-9#1)(2013-8#1)
trauma in a##4##3##(2007-10#1)(2007-7#1)(2011-1#1)(2013-7#1)
trauma in an##2##3##(2007-3#1)(2008-5#1)
trauma in childhood##2##3##(2007-3#1)(2009-9#1)
trauma in children##6##3##(2007-11#2)(2007-3#3)(2011-1#1)
trauma in the##8##3##(1996-10#1)(2006-10#1)(2007-10#1)(2009-3#1)(2009-6#1)(2012-12#1)(2013-8#2)
trauma in##40##2##(1990-2#1)(1994-2#1)(1996-10#1)(1997-6#1)(2006-10#2)(2006-11#1)(2006-4#1)(2006-7#1)(2007-10#2)(2007-11#3)(2007-3#7)(2007-4#1)(2007-7#1)(2007-9#1)(2008-12#1)(2008-5#2)(2008-6#1)(2009-3#1)(2009-6#1)(2009-9#1)(2011-1#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
trauma is a major cause of##2##6##(2011-1#1)(2012-3#1)
trauma is a##5##3##(2006-10#1)(2007-12#1)(2010-3#1)(2011-1#1)(2012-3#1)
trauma is##23##2##(1992-4#1)(2005-8#1)(2006-10#4)(2006-2#1)(2007-12#1)(2007-8#2)(2007-9#2)(2008-10#1)(2008-5#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
trauma life support##7##3##(1992-5#2)(2006-10#4)(2009-3#1)
trauma management and##2##3##(2006-10#1)(2011-2#1)
trauma management##8##2##(2006-10#3)(2007-11#1)(2011-12#1)(2011-2#1)(2013-1#2)
trauma may be##2##3##(1992-2#1)(2007-12#1)
trauma may##4##2##(1992-2#2)(2005-8#1)(2007-12#1)
trauma model##2##2##(1997-7#1)(2008-4#1)
trauma of the##4##3##(1990-9#1)(2005-5#1)(2007-8#1)(2011-1#1)
trauma of##14##2##(1990-9#1)(1991-7#1)(1994-12#1)(1994-2#2)(2005-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-5#1)(2011-1#1)(2012-1#1)
trauma on##5##2##(2007-10#2)(2007-7#1)(2008-8#1)(2010-2#1)
trauma or##21##2##(1990-10#1)(1990-9#1)(1991-2#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-7#2)(2008-1#1)(2008-5#2)(2008-7#2)(2009-3#2)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
trauma patient##14##2##(2006-10#9)(2007-12#1)(2009-6#1)(2012-12#1)(2012-2#1)(2013-1#1)
trauma patients admitted to##2##4##(1992-3#1)(2006-2#1)
trauma patients have##2##3##(2007-1#1)(2010-7#1)
trauma patients should##2##3##(2006-10#1)(2008-11#1)
trauma patients with##2##3##(2005-10#1)(2006-10#1)
trauma patients##25##2##(1992-3#1)(2005-10#1)(2006-10#7)(2006-2#1)(2007-1#1)(2007-12#1)(2007-3#2)(2007-7#3)(2008-11#1)(2009-4#1)(2009-6#4)(2010-7#1)(2012-2#1)
trauma requires a##2##3##(2006-10#1)(2008-8#1)
trauma research##2##2##(2009-4#2)
trauma service##3##2##(2012-2#3)
trauma such as##2##3##(2006-10#1)(2011-1#1)
trauma surgeon involvement##2##3##(2006-2#2)
trauma surgeon##4##2##(2006-10#1)(2006-2#2)(2009-9#1)
trauma surgeons##3##2##(2006-2#2)(2009-4#1)
trauma surgery is##2##3##(2006-10#1)(2007-9#1)
trauma surgery##10##2##(1990-11#1)(2006-10#2)(2007-9#1)(2008-8#1)(2009-8#1)(2010-9#2)(2011-2#1)(2013-8#1)
trauma system##3##2##(2006-10#1)(2008-4#1)(2008-6#1)
trauma systems##4##2##(2006-10#3)(2007-11#1)
trauma team##2##2##(1992-3#1)(2007-11#1)
trauma that##2##2##(2007-4#1)(2008-9#1)
trauma there##2##2##(2007-11#1)(2008-8#1)
trauma to a##2##3##(2007-5#1)(2010-6#1)
trauma to the airway##2##4##(2006-10#1)(2010-7#1)
trauma to the anterior##2##4##(2006-4#1)(2013-1#1)
trauma to the pelvic##2##4##(2007-4#2)
trauma to the primary predecessors##2##5##(2013-1#2)
trauma to the##39##3##(1991-11#1)(1991-2#1)(1992-2#1)(1993-1#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-4#2)(2006-9#1)(2007-11#3)(2007-2#1)(2007-3#1)(2007-4#4)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-9#2)(2009-3#1)(2010-7#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-7#1)(2013-1#3)
trauma to##51##2##(1991-11#1)(1991-2#1)(1992-2#1)(1993-1#1)(1995-8#1)(2005-12#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-3#1)(2006-4#2)(2006-6#1)(2006-9#1)(2007-11#3)(2007-2#1)(2007-3#1)(2007-4#5)(2007-5#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-6#1)(2010-7#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-7#1)(2013-1#4)
trauma units##3##2##(1992-3#1)(1994-5#2)
trauma victims##6##2##(2006-10#3)(2006-12#1)(2007-7#1)(2008-3#1)
trauma was##6##2##(1991-11#1)(2008-12#1)(2008-7#1)(2010-7#1)(2011-12#1)(2013-8#1)
trauma were##2##2##(2011-1#1)(2011-2#1)
trauma with##15##2##(1991-11#1)(1991-6#1)(1995-5#1)(1996-1#1)(2006-10#2)(2006-9#1)(2008-1#1)(2008-12#1)(2010-1#1)(2011-1#3)(2013-1#1)(2013-8#1)
trauma##891##1##(1990-10#1)(1990-11#1)(1990-2#4)(1990-6#1)(1990-9#5)(1991-10#1)(1991-11#5)(1991-12#1)(1991-2#4)(1991-4#6)(1991-6#1)(1991-7#1)(1991-8#2)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#6)(1992-3#6)(1992-4#2)(1992-5#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-5#1)(1993-8#3)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-4#1)(1994-5#3)(1994-7#1)(1995-12#5)(1995-5#1)(1995-8#1)(1996-1#4)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-6#1)(1996-8#2)(1996-9#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-10#1)(2004-7#1)(2005-10#4)(2005-11#3)(2005-12#4)(2005-5#2)(2005-7#5)(2005-8#5)(2006-1#1)(2006-10#105)(2006-11#4)(2006-12#6)(2006-2#11)(2006-3#2)(2006-4#13)(2006-5#2)(2006-6#1)(2006-7#4)(2006-8#7)(2006-9#6)(2007-1#3)(2007-10#11)(2007-11#38)(2007-12#15)(2007-2#5)(2007-3#23)(2007-4#12)(2007-5#7)(2007-7#18)(2007-8#27)(2007-9#9)(2008-1#7)(2008-10#8)(2008-11#9)(2008-12#10)(2008-2#2)(2008-3#5)(2008-4#9)(2008-5#15)(2008-6#10)(2008-7#14)(2008-8#9)(2008-9#24)(2009-10#3)(2009-11#4)(2009-2#2)(2009-3#15)(2009-4#11)(2009-5#4)(2009-6#16)(2009-7#2)(2009-8#6)(2009-9#7)(2010-1#4)(2010-11#1)(2010-12#12)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#9)(2010-8#2)(2010-9#8)(2011-1#14)(2011-12#9)(2011-2#31)(2012-1#4)(2012-12#28)(2012-2#38)(2012-3#8)(2012-7#3)(2012-8#1)(2013-1#31)(2013-7#3)(2013-8#26)
trauma-focused research with##2##3##(2009-4#2)
trauma-focused research##6##2##(2009-4#6)
trauma-focused##7##1##(2009-4#7)
trauma-hemorrhage##4##1##(2013-1#4)
trauma-related##10##1##(2008-8#1)(2009-11#3)(2009-4#4)(2012-2#2)
trauma]##13##1##(1990-2#1)(1990-9#3)(1991-4#1)(1991-6#1)(1992-10#1)(1992-6#1)(1994-3#1)(1997-6#1)(2007-9#1)(2008-12#1)(2010-6#1)
traumas and##2##2##(1991-6#1)(2012-1#1)
traumas##13##1##(1991-3#1)(1991-6#1)(1993-5#2)(1996-3#1)(2004-12#1)(2007-10#2)(2008-8#1)(2009-3#1)(2009-4#1)(2012-1#2)
traumatic amputations after injuries##2##4##(1992-6#2)
traumatic amputations##3##2##(1992-6#3)
traumatic and##7##2##(1997-5#1)(2006-6#1)(2007-11#2)(2008-8#1)(2008-9#1)(2009-5#1)
traumatic aortic rupture##2##3##(2007-4#1)(2009-8#1)
traumatic aortic##3##2##(2006-4#1)(2007-4#1)(2009-8#1)
traumatic ascending aortic##2##3##(2007-8#2)
traumatic aspects of##2##3##(2009-7#2)
traumatic bone##2##2##(1990-7#1)(2004-3#1)
traumatic brachial plexus##2##3##(2008-8#2)
traumatic brain injuries##4##3##(1996-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
traumatic brain injury (TBI)##13##4##(1993-12#1)(2004-12#1)(2006-7#1)(2007-10#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
traumatic brain injury and##3##4##(2006-10#1)(2008-8#1)(2013-1#1)
traumatic brain injury has##3##4##(1994-12#1)(2006-10#2)
traumatic brain injury in rats##3##5##(1993-12#1)(1994-12#1)(2008-7#1)
traumatic brain injury in##4##4##(1993-12#1)(1994-12#1)(2008-7#1)(2012-2#1)
traumatic brain injury is##4##4##(1990-12#1)(1997-5#1)(2006-10#2)
traumatic brain injury may##2##4##(1997-5#1)(2008-7#1)
traumatic brain injury patients##3##4##(2012-2#1)(2013-1#2)
traumatic brain injury##89##3##(1990-12#3)(1991-12#3)(1993-12#2)(1994-12#4)(1995-12#1)(1995-4#1)(1996-1#1)(1997-2#3)(1997-5#3)(2004-12#1)(2006-10#9)(2006-11#1)(2006-3#2)(2006-4#5)(2006-7#3)(2007-1#1)(2007-10#1)(2007-11#2)(2007-4#2)(2007-8#2)(2008-10#1)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#2)(2009-10#3)(2010-1#2)(2010-5#2)(2010-9#2)(2011-1#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#3)
traumatic brain injury]##2##3##(2009-5#1)(2011-1#1)
traumatic brain##98##2##(1990-12#4)(1991-12#3)(1993-12#2)(1994-12#5)(1995-12#1)(1995-4#1)(1996-1#2)(1997-2#3)(1997-5#3)(2004-12#1)(2006-10#9)(2006-11#1)(2006-3#2)(2006-4#6)(2006-7#3)(2007-1#1)(2007-10#1)(2007-11#2)(2007-4#2)(2007-8#2)(2008-10#1)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#2)(2009-10#3)(2009-5#1)(2010-1#2)(2010-5#2)(2010-9#2)(2011-1#2)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#4)(2013-1#5)(2013-8#4)
traumatic carotid cavernous fistula##2##4##(2012-2#2)
traumatic cartilage lesions##2##3##(2007-7#2)
traumatic cartilage##3##2##(2007-7#3)
traumatic cataract##2##2##(2008-11#2)
traumatic event##9##2##(2005-10#1)(2006-12#1)(2007-9#1)(2008-10#1)(2008-6#2)(2008-9#1)(2009-3#1)(2012-12#1)
traumatic events##6##2##(1993-10#1)(1996-3#1)(2008-9#1)(2009-4#1)(2011-1#1)(2012-1#1)
traumatic hemorrhage##2##2##(2006-10#1)(2012-3#1)
traumatic hernia##2##2##(2009-8#1)(2011-2#1)
traumatic injuries to the cervical spine##3##6##(2007-11#3)
traumatic injuries to##4##3##(2007-11#3)(2007-7#1)
traumatic injuries##17##2##(1991-4#1)(2006-10#2)(2007-1#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-2#2)(2013-7#2)
traumatic injury is##2##3##(2006-10#1)(2012-2#1)
traumatic injury to the##4##4##(2006-10#1)(2006-4#1)(2006-5#1)(2007-11#1)
traumatic injury to##7##3##(2006-10#1)(2006-4#1)(2006-5#1)(2007-11#4)
traumatic injury##16##2##(2006-10#3)(2006-4#1)(2006-5#1)(2007-11#5)(2007-7#1)(2012-12#1)(2012-2#3)(2012-3#1)
traumatic leptomeningeal##2##2##(2013-8#2)
traumatic lesions of the##2##4##(1991-3#1)(2007-11#1)
traumatic lesions##7##2##(1990-6#1)(1991-3#1)(2007-11#2)(2007-7#1)(2008-8#1)(2010-4#1)
traumatic lung pseudocyst is##3##4##(2013-1#3)
traumatic lung pseudocyst##4##3##(2013-1#4)
traumatic lung##5##2##(2006-10#1)(2013-1#4)
traumatic macular hole##2##3##(2012-12#2)
traumatic macular##3##2##(2012-12#2)(2013-7#1)
traumatic middle cerebral artery occlusion##2##5##(2008-7#2)
traumatic neuronal injury##3##3##(1995-12#3)
traumatic or degenerative##3##3##(2007-11#1)(2013-1#2)
traumatic or##10##2##(1991-9#1)(2005-8#2)(2007-11#1)(2007-12#2)(2008-11#1)(2008-4#1)(2013-1#2)
traumatic patient##2##2##(2007-5#1)(2007-8#1)
traumatic pseudoaneurysm of the##3##4##(2008-12#2)(2008-8#1)
traumatic pseudoaneurysm##4##2##(2007-8#1)(2008-12#2)(2008-8#1)
traumatic reticuloperitonitis##3##2##(1993-1#3)
traumatic rupture of the pericardium##2##5##(2007-4#1)(2008-11#1)
traumatic rupture of the##4##4##(2007-4#1)(2008-11#1)(2010-8#1)(2012-1#1)
traumatic rupture of##5##3##(2007-4#1)(2008-11#1)(2008-12#1)(2010-8#1)(2012-1#1)
traumatic rupture##6##2##(2007-4#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-8#1)(2012-1#1)
traumatic soft tissue##2##3##(1995-3#1)(2009-5#1)
traumatic spinal cord##4##3##(1991-6#1)(1995-9#2)(2007-11#1)
traumatic spinal##5##2##(1991-6#1)(1995-9#2)(2007-11#1)(2011-2#1)
traumatic stress disorder (PTSD)##2##4##(2006-8#1)(2012-12#1)
traumatic stress disorder##7##3##(1991-2#1)(2006-8#2)(2007-12#1)(2008-11#1)(2012-12#1)(2013-8#1)
traumatic stress##11##2##(1991-2#1)(2006-8#2)(2007-12#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
traumatic subarachnoid haemorrhage##2##3##(2008-7#2)
traumatic surgery##2##2##(2007-11#1)(2008-6#1)
traumatic ulcers##4##2##(2008-5#4)
traumatic vascular injuries##2##3##(2008-9#1)(2011-2#1)
traumatic vascular##3##2##(2008-9#2)(2011-2#1)
traumatic##372##1##(1990-12#4)(1990-2#2)(1990-3#1)(1990-4#1)(1990-6#2)(1990-7#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-4#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-6#3)(1992-8#1)(1993-1#3)(1993-10#1)(1993-12#2)(1994-12#5)(1995-12#5)(1995-3#1)(1995-4#1)(1995-7#1)(1995-9#2)(1996-1#2)(1996-3#1)(1997-2#3)(1997-5#4)(2004-11#2)(2004-12#1)(2004-3#1)(2005-10#2)(2005-8#3)(2006-10#19)(2006-11#3)(2006-12#2)(2006-2#1)(2006-3#3)(2006-4#9)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#6)(2007-1#2)(2007-10#2)(2007-11#26)(2007-12#5)(2007-3#1)(2007-4#6)(2007-5#1)(2007-7#12)(2007-8#10)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#5)(2008-12#7)(2008-4#3)(2008-5#6)(2008-6#4)(2008-7#16)(2008-8#11)(2008-9#15)(2009-10#3)(2009-11#1)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#3)(2009-6#3)(2009-7#3)(2009-8#4)(2010-1#2)(2010-12#3)(2010-2#2)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#5)(2011-2#14)(2012-1#10)(2012-12#8)(2012-2#13)(2012-3#6)(2013-1#14)(2013-7#3)(2013-8#7)
traumatica##2##1##(1990-12#2)
traumatically##3##1##(1995-3#1)(1996-1#2)
traumatism in blood service##2##4##(2009-2#2)
traumatism##7##1##(2006-7#1)(2007-3#1)(2008-6#1)(2009-2#2)(2010-6#1)(2013-1#1)
traumatization##4##1##(1991-6#1)(1994-11#1)(2006-5#1)(2013-1#1)
traumatized##11##1##(1996-9#1)(2006-5#1)(2007-12#2)(2008-5#1)(2009-4#1)(2009-9#1)(2012-2#1)(2012-7#1)(2013-1#2)
traumatological##2##1##(1996-9#1)(2008-8#1)
traumatology and rehabilitation##2##3##(2007-11#2)
traumatology and##4##2##(1991-4#1)(2007-11#2)(2011-2#1)
traumatology##12##1##(1991-4#1)(2006-6#1)(2007-11#4)(2007-8#2)(2011-2#1)(2013-1#2)(2013-8#1)
traums##2##1##(2008-9#2)
travail##3##1##(2011-2#1)(2013-1#2)
travel abroad##4##2##(2007-2#2)(2008-1#1)(2010-3#1)
travel advice##2##2##(2007-2#2)
travel advisories##2##2##(2007-2#2)
travel along##2##2##(1993-3#1)(2007-2#1)
travel among##2##2##(2008-9#2)
travel and children##3##3##(2008-11#3)
travel and the##2##3##(2006-10#1)(2011-1#1)
travel and##20##2##(1992-11#1)(1993-2#1)(1993-8#1)(1995-2#1)(2005-11#1)(2006-10#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-2#1)(2011-1#1)(2012-12#1)(2013-8#1)
travel are##3##2##(1990-8#1)(2006-10#1)(2007-2#1)
travel between##2##2##(1997-4#1)(2009-7#1)
travel by##2##2##(2007-2#1)(2011-2#1)
travel direction##2##2##(2007-6#1)(2009-8#1)
travel health advice and##4##4##(2007-2#4)
travel health advice##13##3##(2007-2#13)
travel health associations##2##3##(2007-2#2)
travel health practitioners##4##3##(2007-2#4)
travel health##28##2##(2007-2#28)
travel healthcare professionals##2##3##(2007-2#2)
travel history to##2##3##(2007-12#1)(2011-2#1)
travel history##5##2##(2007-12#1)(2010-12#1)(2011-2#3)
travel in##4##2##(1992-12#1)(2006-7#1)(2011-2#1)(2012-12#1)
travel insurance##7##2##(2007-2#7)
travel is##4##2##(2011-2#1)(2012-2#1)(2013-8#2)
travel medicine and##3##3##(2007-2#3)
travel medicine in##2##3##(2007-2#2)
travel medicine##25##2##(1995-9#1)(2006-10#3)(2007-2#18)(2011-1#2)(2011-2#1)
travel of##4##2##(2007-12#1)(2007-8#1)(2008-10#1)(2010-12#1)
travel or##2##2##(1991-8#1)(2011-2#1)
travel related##3##2##(2007-2#2)(2011-2#1)
travel speed in##2##3##(2010-8#2)
travel speed##4##2##(2010-8#4)
travel through the##2##3##(1995-9#1)(2008-1#1)
travel through##4##2##(1995-9#1)(2008-1#1)(2012-3#2)
travel time and##2##3##(2008-9#1)(2010-9#1)
travel time to##2##3##(2007-6#1)(2012-12#1)
travel time##8##2##(1991-3#1)(1995-3#1)(2007-6#1)(2008-8#2)(2008-9#1)(2010-9#1)(2012-12#1)
travel times##4##2##(2008-1#2)(2008-8#2)
travel to an##2##3##(2006-12#1)(2007-2#1)
travel to##9##2##(1992-12#1)(2005-11#1)(2006-12#1)(2007-2#3)(2007-7#1)(2008-8#1)(2009-5#1)
travel was##3##2##(1997-6#1)(2007-2#1)(2011-2#1)
travel with##2##2##(1990-3#1)(2006-2#1)
travel##244##1##(1990-3#1)(1990-6#1)(1990-8#3)(1991-12#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-2#2)(1993-2#1)(1993-3#1)(1993-8#1)(1995-2#1)(1995-3#1)(1995-9#2)(1996-1#2)(1996-7#2)(1997-4#1)(1997-6#1)(2005-10#1)(2005-11#2)(2005-7#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-4#1)(2006-7#2)(2006-9#2)(2007-1#1)(2007-12#6)(2007-2#92)(2007-3#1)(2007-4#1)(2007-6#4)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#4)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-8#8)(2008-9#3)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#3)(2010-5#4)(2010-8#7)(2010-9#1)(2011-1#4)(2011-2#15)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#2)(2013-8#6)
travel-related diseases##2##2##(2007-2#2)
travel-related##5##1##(2007-2#4)(2011-2#1)
travel]##2##1##(1993-8#1)(2007-3#1)
traveled by##4##2##(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
traveled to##6##2##(1993-8#1)(2008-1#1)(2008-2#1)(2008-8#1)(2012-12#2)
traveled##24##1##(1993-8#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-2#1)(2004-11#2)(2005-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-7#1)(2008-8#2)(2009-10#1)(2010-12#1)(2011-2#1)(2012-12#3)(2012-2#1)
traveled)##2##1##(1991-5#1)(2008-5#1)
traveler is##2##2##(2007-2#1)(2010-12#1)
traveler who##2##2##(2007-2#2)
traveler##9##1##(1996-8#1)(2007-2#4)(2010-12#2)(2011-2#2)
traveler's diarrhea##3##2##(1993-3#1)(2006-10#1)(2008-8#1)
traveler's##4##1##(1992-2#1)(1993-3#1)(2006-10#1)(2008-8#1)
travelers after##2##2##(2007-2#1)(2011-2#1)
travelers and##2##2##(2011-2#2)
travelers should##3##2##(2007-2#3)
travelers to##4##2##(1993-8#1)(2007-2#1)(2008-1#1)(2011-2#1)
travelers with##3##2##(1992-12#1)(2007-2#1)(2011-2#1)
travelers##48##1##(1992-12#1)(1993-4#1)(1993-8#1)(1996-8#2)(2007-2#17)(2008-1#2)(2008-10#2)(2008-3#1)(2010-12#2)(2011-2#17)(2012-2#2)
travelers]##2##1##(2011-2#2)
traveling in##2##2##(1991-5#1)(2008-3#1)
traveling salesman##2##2##(1991-3#1)(1992-12#1)
traveling to the##2##3##(1995-2#1)(2012-1#1)
traveling to##8##2##(1993-9#1)(1995-2#1)(2006-10#2)(2011-2#2)(2012-1#1)(2012-2#1)
traveling wave##5##2##(2007-12#2)(2007-9#1)(2008-10#1)(2009-5#1)
traveling waves in##2##3##(2007-12#2)
traveling waves of##2##3##(2007-9#1)(2008-3#1)
traveling waves##10##2##(1990-3#2)(2007-11#2)(2007-12#2)(2007-9#1)(2008-3#1)(2009-5#2)
traveling##49##1##(1990-3#2)(1991-3#1)(1991-5#1)(1991-8#1)(1992-12#1)(1993-9#1)(1995-2#1)(2006-10#2)(2006-4#1)(2007-11#2)(2007-12#8)(2007-9#4)(2008-1#1)(2008-10#1)(2008-3#6)(2008-5#2)(2008-6#1)(2008-9#1)(2009-5#4)(2010-12#1)(2011-2#4)(2012-1#1)(2012-2#1)(2013-1#1)
traveling-wave electro-optic##2##2##(2007-11#1)(2007-12#1)
traveling-wave modulators##2##2##(2007-12#2)
traveling-wave optical parametric##4##3##(2007-12#3)(2008-3#1)
traveling-wave parametric##3##2##(2007-12#3)
traveling-wave##24##1##(2007-11#3)(2007-12#16)(2008-1#3)(2008-3#2)
travelled by##2##2##(2008-10#1)(2011-2#1)
travelled to the##3##3##(1997-7#1)(2008-7#1)(2010-12#1)
travelled to##5##2##(1997-7#1)(2007-12#1)(2008-7#1)(2010-12#2)
travelled##12##1##(1994-2#1)(1997-7#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-1#1)(2010-12#2)(2011-1#1)(2011-2#1)
traveller##24##1##(1993-8#2)(1994-7#1)(1995-5#1)(2005-8#1)(2007-2#14)(2008-10#2)(2008-11#1)(2009-7#1)(2012-10#1)
traveller's diarrhea##2##2##(1993-3#1)(1997-3#1)
traveller's##4##1##(1993-3#1)(1997-3#1)(2007-2#2)
traveller]##2##1##(2006-4#1)(2007-2#1)
travellers and##3##2##(1994-4#1)(2007-2#1)(2009-9#1)
travellers are##2##2##(2007-2#2)
travellers as##2##2##(2007-2#2)
travellers due to##3##3##(2007-2#2)(2009-5#1)
travellers for##2##2##(2007-2#2)
travellers from Australia##6##3##(2007-2#6)
travellers from##8##2##(2007-2#8)
travellers in##4##2##(2007-2#4)
travellers is##3##2##(2007-2#3)
travellers should##2##2##(2007-2#2)
travellers to distant##2##3##(1993-3#2)
travellers to endemic areas##2##4##(2007-2#1)(2008-10#1)
travellers to endemic##3##3##(2007-2#2)(2008-10#1)
travellers to##14##2##(1993-3#2)(1997-4#1)(2007-2#9)(2008-10#1)(2009-5#1)
travellers undertaking##2##2##(2007-2#2)
travellers##114##1##(1991-5#1)(1993-3#2)(1994-4#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-8#1)(1997-3#1)(1997-4#1)(2007-2#93)(2008-10#1)(2009-5#4)(2009-6#1)(2009-9#1)(2010-5#3)(2011-2#1)
travellers' diarrhoea##2##2##(1992-12#1)(2007-2#1)
travellers'##5##1##(1992-12#1)(2007-2#4)
travelling and##3##2##(1990-6#1)(1993-5#1)(2007-12#1)
travelling to Africa##2##3##(2007-2#2)
travelling to##9##2##(2005-11#1)(2007-2#6)(2008-10#1)(2008-4#1)
travelling wave##3##2##(1997-3#1)(2007-9#1)(2008-9#1)
travelling##35##1##(1990-6#1)(1991-11#1)(1991-12#1)(1992-2#1)(1993-5#1)(1996-12#1)(1997-3#1)(2005-11#1)(2006-4#2)(2007-12#1)(2007-2#8)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-7#1)(2010-8#1)(2011-2#3)(2012-11#1)(2012-12#1)(2013-8#1)
travels through the##3##3##(1995-1#1)(2007-9#1)(2010-10#1)
travels##10##1##(1990-6#1)(1995-1#1)(1996-8#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-1#1)(2010-10#1)
traveltime tomography##2##2##(2008-2#2)
travers##2##1##(2012-2#1)(2013-1#1)
traversal##4##1##(2008-6#1)(2008-8#3)
traverse the##7##2##(1990-5#1)(1996-5#1)(1997-6#1)(2007-12#1)(2008-10#2)(2009-10#1)
traverse##14##1##(1990-5#1)(1990-8#1)(1993-4#1)(1994-12#1)(1995-2#1)(1996-5#1)(1997-6#1)(2006-12#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-8#1)(2009-10#1)
traversed by the##2##3##(1996-6#1)(2008-3#1)
traversed the##2##2##(1993-4#1)(2011-2#1)
traversed##9##1##(1991-8#1)(1993-4#1)(1994-6#1)(1996-6#1)(2007-11#1)(2007-8#1)(2008-3#2)(2011-2#1)
traverses an##2##2##(1996-5#1)(2008-2#1)
traverses the##4##2##(1994-8#1)(2006-10#2)(2008-2#1)
traverses##8##1##(1994-8#2)(1996-5#1)(2006-10#2)(2008-2#2)(2011-2#1)
traversing the##5##2##(2006-10#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
traversing through##2##2##(2005-11#1)(2007-8#1)
traversing##13##1##(1996-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-2#2)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
travoprost##2##1##(2009-8#1)(2013-8#1)
trawl net##3##2##(2008-12#1)(2008-5#1)(2013-7#1)
trawl nets##2##2##(2008-5#1)(2013-7#1)
trawl##11##1##(2006-6#2)(2007-3#1)(2008-12#1)(2008-5#4)(2013-7#3)
trawling disturbance##4##2##(2006-6#4)
trawling##11##1##(2006-6#10)(2010-8#1)
tray and##2##2##(2007-10#1)(2012-3#1)
tray##11##1##(1993-2#1)(1997-3#1)(2005-9#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-12#1)(2012-3#1)
trays and##2##2##(2008-12#1)(2013-1#1)
trays of##2##2##(2011-12#1)(2013-8#1)
trays were##2##2##(2007-7#2)
trays##23##1##(1990-12#1)(1997-2#1)(2007-2#1)(2007-7#4)(2008-10#2)(2008-11#3)(2008-12#1)(2008-6#2)(2008-8#1)(2009-3#1)(2009-5#1)(2011-12#2)(2013-1#1)(2013-8#2)
trazodone metabolite##2##2##(1990-2#2)
trazodone##20##1##(1990-2#8)(1995-2#5)(2008-10#2)(2008-3#4)(2008-9#1)
trc promoter##3##2##(1993-6#1)(2006-12#2)
treacherous##2##1##(2006-9#1)(2009-10#1)
treadmill exercise##8##2##(1991-9#1)(2005-8#1)(2007-11#1)(2008-3#2)(2010-12#2)(2013-1#1)
treadmill running on##3##3##(2008-12#2)(2012-1#1)
treadmill running##9##2##(1997-7#1)(2008-12#3)(2012-1#3)(2013-1#2)
treadmill speed##4##2##(1990-4#1)(2012-1#2)(2013-8#1)
treadmill test##3##2##(2008-5#1)(2012-11#1)(2012-2#1)
treadmill tests##2##2##(1991-3#1)(2008-3#1)
treadmill training in##2##3##(2011-2#1)(2012-1#1)
treadmill training##3##2##(2011-2#1)(2012-1#2)
treadmill walking##4##2##(2007-10#1)(2012-1#3)
treadmill was##3##2##(1990-4#1)(1991-3#1)(2012-1#1)
treadmill##66##1##(1990-2#1)(1990-4#5)(1991-2#1)(1991-3#2)(1991-9#1)(1994-8#1)(1997-7#1)(2005-8#2)(2007-10#2)(2007-11#1)(2008-10#1)(2008-12#3)(2008-3#4)(2008-5#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#2)(2011-2#1)(2012-1#20)(2012-11#1)(2012-2#2)(2013-1#7)(2013-8#3)
treament##3##1##(1996-9#1)(2008-5#1)(2012-2#1)
treasure##4##1##(1993-1#1)(2008-6#1)(2009-7#1)(2012-12#1)
treat a##19##2##(1992-1#1)(1993-1#1)(1993-2#2)(1996-12#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-8#2)(2010-2#1)(2011-2#1)(2013-1#1)
treat acute##11##2##(1997-8#1)(2007-11#2)(2007-8#2)(2007-9#2)(2008-11#1)(2010-3#1)(2013-8#2)
treat alcohol##2##2##(2008-2#1)(2008-4#1)
treat all##4##2##(1990-12#1)(2011-2#1)(2013-1#2)
treat allergic##2##2##(2010-4#1)(2011-2#1)
treat an##3##2##(2007-8#1)(2008-3#1)(2008-6#1)
treat and prevent##4##3##(2006-10#2)(2007-11#1)(2009-3#1)
treat and##15##2##(1994-3#1)(2006-10#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-12#1)(2008-7#1)(2009-3#1)(2010-8#1)(2011-2#2)
treat atrial fibrillation##2##3##(2007-8#2)
treat both##5##2##(1997-3#1)(2006-10#1)(2006-7#1)(2011-2#1)(2013-8#1)
treat chronic##13##2##(2005-7#1)(2006-12#2)(2006-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-3#1)
treat epilepsy##2##2##(2006-10#1)(2008-2#1)
treat high-risk##2##2##(2008-11#1)(2012-3#1)
treat him##2##2##(1996-12#1)(2005-12#1)
treat human diseases##2##3##(2006-6#1)(2012-3#1)
treat human##4##2##(2006-6#1)(2010-4#1)(2012-2#1)(2012-3#1)
treat illness##2##2##(2008-10#1)(2010-12#1)
treat individuals##3##2##(2004-3#1)(2008-3#1)(2012-12#1)
treat infants with##2##3##(1992-11#1)(1992-3#1)
treat infants##4##2##(1992-11#1)(1992-3#1)(1997-1#1)(2006-7#1)
treat invasive##2##2##(2008-7#1)(2011-2#1)
treat it##8##2##(1992-5#1)(1993-10#1)(1995-5#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#1)(2012-3#1)
treat major##2##2##(1994-11#1)(2008-6#1)
treat many##5##2##(1996-6#1)(2007-10#1)(2007-6#1)(2010-12#1)(2011-2#1)
treat medically##2##2##(2007-8#1)(2010-12#1)
treat mental##2##2##(1991-1#1)(2008-4#1)
treat most##3##2##(1997-6#1)(1997-8#1)(2010-3#1)
treat multidrug-resistant##2##2##(2011-2#1)(2013-1#1)
treat obesity and##2##3##(2008-1#1)(2009-11#1)
treat obesity##3##2##(2008-1#1)(2009-11#1)(2011-2#1)
treat or not to treat##3##5##(1995-5#1)(2006-8#1)(2008-8#1)
treat or not to treat?##3##5##(1997-3#1)(2008-8#1)(2012-12#1)
treat or not to##6##4##(1995-5#1)(1997-3#1)(2006-8#1)(2008-8#2)(2012-12#1)
treat or prevent##3##3##(2004-11#1)(2007-12#1)(2008-1#1)
treat or##11##2##(1995-5#1)(1997-3#1)(2004-11#1)(2005-11#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-8#2)(2012-12#1)
treat osteoporosis##5##2##(1993-11#2)(2007-11#1)(2007-8#1)(2008-3#1)
treat patients with this##2##4##(2006-9#1)(2008-6#1)
treat patients with##23##3##(1993-2#1)(1995-12#1)(2005-7#1)(2005-9#1)(2006-2#1)(2006-3#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
treat patients##34##2##(1993-2#1)(1994-1#1)(1994-11#1)(1995-12#1)(1996-3#1)(1997-1#1)(2005-7#1)(2005-9#1)(2006-2#2)(2006-3#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
treat secondary##2##2##(1991-9#1)(2013-8#1)
treat small##2##2##(2004-1#1)(2006-6#1)
treat stress and##2##3##(2008-10#2)
treat stress##3##2##(2006-9#1)(2008-10#2)
treat such##3##2##(2008-3#1)(2010-2#1)(2010-3#1)
treat the disease##5##3##(2006-10#1)(2007-10#1)(2007-11#1)(2008-7#1)(2010-5#1)
treat the pain##3##3##(2008-5#1)(2008-8#1)(2010-1#1)
treat the underlying##3##3##(1996-7#1)(2006-11#1)(2008-1#1)
treat the##66##2##(1993-12#1)(1993-9#1)(1995-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-6#2)(2004-1#1)(2006-10#2)(2006-11#1)(2006-12#3)(2007-10#1)(2007-11#3)(2007-12#3)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#2)
treat their##3##2##(2007-3#1)(2013-1#2)
treat them##9##2##(1993-10#1)(2007-12#2)(2011-7#1)(2012-2#1)(2013-1#3)(2013-7#1)
treat these lesions##2##3##(2007-6#1)(2008-7#1)
treat these patients##6##3##(1991-11#1)(2005-8#1)(2006-2#1)(2006-7#1)(2012-2#1)(2013-8#1)
treat these##21##2##(1991-11#1)(2005-8#1)(2006-11#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2012-2#1)(2013-8#1)
treat this condition##3##3##(2006-10#1)(2011-1#1)(2013-8#1)
treat this infection##2##3##(2006-10#1)(2010-12#1)
treat this##22##2##(1995-5#1)(2005-8#1)(2006-10#4)(2006-8#1)(2007-11#1)(2008-1#2)(2008-3#2)(2009-10#1)(2010-12#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
treat tumors##3##2##(1991-5#1)(2006-2#1)(2010-2#1)
treat two##2##2##(1995-6#1)(2010-6#1)
treat with##7##2##(1997-4#1)(2004-3#1)(2006-10#1)(2007-11#1)(2007-8#1)(2011-1#1)(2013-1#1)
treat##776##1##(1990-12#2)(1990-3#4)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#3)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#4)(1992-6#1)(1992-8#1)(1993-1#2)(1993-10#2)(1993-11#3)(1993-12#2)(1993-2#5)(1993-5#2)(1993-9#4)(1994-1#1)(1994-11#2)(1994-3#1)(1994-4#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-4#1)(1995-5#5)(1995-6#3)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#5)(1996-12#3)(1996-2#2)(1996-3#3)(1996-4#1)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#4)(1997-8#2)(2004-1#2)(2004-11#1)(2004-3#3)(2004-9#1)(2005-10#7)(2005-11#4)(2005-12#2)(2005-5#1)(2005-6#2)(2005-7#4)(2005-8#6)(2005-9#1)(2006-1#1)(2006-10#27)(2006-11#2)(2006-12#16)(2006-2#6)(2006-3#2)(2006-4#2)(2006-5#1)(2006-6#5)(2006-7#10)(2006-8#19)(2006-9#7)(2007-1#2)(2007-10#7)(2007-11#29)(2007-12#13)(2007-2#4)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#4)(2007-7#11)(2007-8#23)(2007-9#6)(2008-1#21)(2008-10#20)(2008-11#13)(2008-12#7)(2008-2#8)(2008-3#17)(2008-4#14)(2008-5#23)(2008-6#12)(2008-7#23)(2008-8#22)(2008-9#5)(2009-10#5)(2009-11#4)(2009-12#3)(2009-2#1)(2009-3#7)(2009-4#3)(2009-5#6)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#5)(2010-1#1)(2010-11#1)(2010-12#11)(2010-2#8)(2010-3#6)(2010-4#3)(2010-5#3)(2010-6#5)(2010-7#2)(2010-8#6)(2011-1#11)(2011-12#2)(2011-2#29)(2011-3#1)(2011-7#1)(2012-1#6)(2012-11#3)(2012-12#23)(2012-2#18)(2012-3#11)(2013-1#32)(2013-7#3)(2013-8#15)
treat?]##3##1##(1993-6#1)(2006-8#1)(2013-8#1)
treatable and##2##2##(2008-7#1)(2012-12#1)
treatable by##5##2##(1990-3#1)(1995-8#1)(2005-7#1)(2006-8#1)(2008-11#1)
treatable causes##2##2##(2006-2#1)(2007-2#1)
treatable condition##2##2##(1991-2#1)(2008-1#1)
treatable disease of##2##3##(1997-2#1)(2013-8#1)
treatable disease##8##2##(1991-8#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-1#2)(2010-6#1)(2013-8#1)
treatable disorder##2##2##(2007-3#1)(2012-2#1)
treatable with##4##2##(2006-7#1)(2009-11#1)(2011-1#1)(2011-3#1)
treatable##57##1##(1990-3#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-2#1)(1993-5#1)(1993-7#1)(1994-4#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-8#1)(1997-2#1)(1997-3#2)(2004-3#1)(2005-7#1)(2006-10#4)(2006-2#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-3#1)(2008-1#3)(2008-11#2)(2008-7#3)(2008-9#1)(2009-11#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#3)(2012-2#2)(2013-7#1)(2013-8#2)
treated 14 patients##2##3##(2007-11#2)
treated 32##2##2##(1997-4#1)(2013-1#1)
treated 38##2##2##(1990-12#1)(1996-6#1)
treated HCC##4##2##(2008-10#4)
treated KU812 cells##5##3##(2008-11#5)
treated a##6##2##(1993-8#1)(2007-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#1)
treated according to the##4##4##(2006-10#1)(2008-9#1)(2010-3#1)(2011-2#1)
treated according to##11##3##(1992-8#1)(1993-11#1)(1997-7#1)(2006-10#1)(2008-9#1)(2010-3#1)(2011-2#4)(2012-3#1)
treated accordingly##4##2##(2005-5#1)(2008-7#1)(2010-2#1)(2012-2#1)
treated adult##2##2##(2007-3#1)(2008-7#1)
treated after##8##2##(1994-12#1)(1996-6#1)(2006-10#1)(2006-5#1)(2007-8#3)(2008-4#1)
treated and control animals##2##4##(1991-5#1)(2008-10#1)
treated and control cultures##2##4##(1995-8#1)(1996-3#1)
treated and control##8##3##(1991-5#1)(1995-8#1)(1996-3#1)(2007-10#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-10#1)
treated and the##3##3##(1996-8#1)(2005-6#1)(2006-12#1)
treated and their##2##3##(2007-12#1)(2009-6#1)
treated and untreated##8##3##(1990-2#1)(1993-12#1)(1995-6#1)(2006-8#1)(2007-10#1)(2008-10#2)(2008-3#1)
treated and##44##2##(1990-2#1)(1991-11#1)(1991-5#1)(1992-2#1)(1993-12#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-8#1)(1997-4#1)(2005-6#1)(2006-12#2)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
treated animals and##3##3##(1991-2#1)(1993-2#1)(2009-4#1)
treated animals had##2##3##(1993-2#1)(1997-2#1)
treated animals was##2##3##(1993-12#1)(1994-8#1)
treated animals were not##2##4##(2010-12#2)
treated animals were##3##3##(2010-12#3)
treated animals with##2##3##(1993-4#1)(1996-12#1)
treated animals##26##2##(1991-2#1)(1993-12#1)(1993-2#3)(1993-4#1)(1994-6#1)(1994-8#2)(1994-9#1)(1996-12#1)(1997-2#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-4#2)(2009-5#1)(2010-12#3)(2011-2#3)(2012-12#1)
treated appropriately##4##2##(1996-12#1)(2006-7#1)(2007-12#1)(2008-1#1)
treated are##3##2##(1991-9#1)(1993-9#1)(2009-3#1)
treated areas##4##2##(1993-9#1)(2006-12#1)(2006-4#1)(2008-8#1)
treated as a case of##2##5##(2011-12#1)(2012-3#1)
treated as a##23##3##(1992-5#1)(1993-11#1)(1996-9#1)(2006-10#1)(2006-12#2)(2006-6#1)(2007-10#1)(2007-3#1)(2007-9#1)(2008-2#2)(2008-3#3)(2008-9#2)(2010-12#1)(2011-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
treated as an##6##3##(1992-5#1)(2005-11#1)(2007-10#1)(2007-11#1)(2008-2#1)(2011-1#1)
treated as described above##2##4##(1996-8#1)(2008-5#1)
treated as outpatients##5##3##(2006-12#1)(2007-8#3)(2011-1#1)
treated as separate##2##3##(2007-2#1)(2008-6#1)
treated as such##2##3##(2005-10#1)(2006-7#1)
treated as the##3##3##(1990-5#1)(1993-7#1)(2012-2#1)
treated as two##3##3##(1997-1#1)(2008-2#1)(2008-3#1)
treated as well##2##3##(1991-9#1)(2010-7#1)
treated as##80##2##(1990-5#1)(1990-9#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-5#2)(1993-11#1)(1993-7#1)(1994-7#1)(1995-12#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-12#3)(2006-6#2)(2006-7#2)(2007-10#2)(2007-11#3)(2007-2#1)(2007-3#1)(2007-8#4)(2007-9#2)(2008-10#4)(2008-2#5)(2008-3#6)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#2)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#2)(2011-12#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)
treated at King##3##3##(2007-3#2)(2008-6#1)
treated at a##10##3##(1990-12#1)(1995-7#1)(2006-10#2)(2007-1#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
treated at an##2##3##(2006-8#1)(2008-10#1)
treated at our Institute##2##4##(2010-3#1)(2013-1#1)
treated at our institution##6##4##(2006-8#1)(2007-2#1)(2010-12#1)(2011-2#1)(2013-1#2)
treated at our##17##3##(1990-6#1)(1990-9#1)(1997-3#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-2#1)(2013-1#3)
treated at the Department of##3##5##(1995-5#1)(2006-6#1)(2011-12#1)
treated at the Marian Weiss Rehabilitation Center in Konstancin##2##9##(2007-11#2)
treated at the National##2##4##(2007-8#1)(2012-12#1)
treated at the Norwegian Radium Hospital##2##6##(1993-9#1)(1996-4#1)
treated at the##35##3##(1990-6#1)(1991-6#2)(1993-12#1)(1993-6#1)(1993-9#1)(1995-11#1)(1995-5#2)(1996-4#1)(1997-3#1)(2006-11#1)(2006-6#1)(2007-11#4)(2007-7#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-6#3)(2009-5#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
treated at their institution##2##4##(2006-11#1)(2006-9#1)
treated at##94##2##(1990-12#1)(1990-6#2)(1990-9#1)(1991-6#2)(1993-12#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-9#1)(1995-11#1)(1995-5#2)(1995-7#1)(1996-4#1)(1997-3#2)(1997-8#1)(2005-11#1)(2006-10#2)(2006-11#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#4)(2007-2#1)(2007-3#2)(2007-7#2)(2007-8#6)(2008-10#2)(2008-2#3)(2008-3#3)(2008-5#2)(2008-6#8)(2008-7#1)(2008-8#2)(2009-5#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#4)(2013-1#6)
treated because it##2##3##(2006-4#1)(2012-2#1)
treated because of##3##3##(1993-10#1)(1994-6#1)(2007-7#1)
treated because##5##2##(1993-10#1)(1994-6#1)(2006-4#1)(2007-7#1)(2012-2#1)
treated before##4##2##(2005-9#1)(2006-10#1)(2008-10#1)(2011-1#1)
treated between 1994 and##2##4##(2008-1#1)(2011-2#1)
treated between January##2##3##(2007-8#1)(2011-2#1)
treated between##17##2##(1991-6#1)(1992-6#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#2)(2008-7#1)(2009-2#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
treated both##2##2##(2005-6#1)(2012-12#1)
treated by Ilizarov method##2##4##(2007-11#1)(2007-8#1)
treated by Molndal technique##2##4##(2011-2#2)
treated by PDT##2##3##(2008-5#2)
treated by a combination of##3##5##(1990-12#1)(2007-10#1)(2007-2#1)
treated by a##22##3##(1990-12#1)(1990-9#1)(1992-2#1)(1994-3#1)(1996-11#1)(1997-3#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-10#2)(2008-9#2)(2009-3#1)(2009-4#1)(2011-2#2)(2012-12#1)(2012-2#1)
treated by administration of##2##4##(1997-6#1)(2008-5#1)
treated by bilateral##2##3##(1991-5#1)(1997-1#1)
treated by bisphosphonates##2##3##(2007-11#2)
treated by both##2##3##(2008-10#1)(2008-9#1)
treated by chemotherapy##2##3##(1990-8#1)(1994-7#1)
treated by combined##3##3##(2006-8#1)(2007-11#1)(2011-2#1)
treated by complete##3##3##(2012-2#2)(2012-3#1)
treated by conservative##4##3##(2007-11#1)(2008-2#1)(2009-5#1)(2013-7#1)
treated by continuous##2##3##(2007-8#1)(2008-4#1)
treated by curative##2##3##(1991-2#1)(1992-8#1)
treated by cytoreductive surgery##2##4##(2006-6#2)
treated by definitive##3##3##(1991-4#1)(1994-12#1)(2007-8#1)
treated by dialysis##3##3##(2007-7#1)(2008-1#1)(2008-4#1)
treated by diet##2##3##(1992-5#1)(2006-6#1)
treated by either##2##3##(1994-12#1)(2008-9#1)
treated by embolization##3##3##(1992-9#1)(2007-8#1)(2008-7#1)
treated by endoscopic papillotomy##2##4##(1991-4#1)(1997-8#1)
treated by endoscopic##6##3##(1991-4#1)(1992-1#1)(1997-8#1)(2008-12#1)(2008-5#1)(2012-1#1)
treated by excision of##2##4##(2008-6#1)(2009-5#1)
treated by external fixation##2##4##(1993-8#1)(2008-4#1)
treated by external##6##3##(1990-6#1)(1993-11#1)(1993-8#1)(2006-4#1)(2007-8#1)(2008-4#1)
treated by extra-anatomic##2##3##(2007-8#2)
treated by gavage##3##3##(2005-7#1)(2008-9#1)(2013-8#1)
treated by general##3##3##(1993-2#1)(1994-11#1)(2013-1#1)
treated by hemodialysis##2##3##(2006-6#1)(2008-10#1)
treated by increasing##2##3##(1997-4#1)(2012-2#1)
treated by internal##3##3##(1990-3#1)(2007-8#1)(2011-2#1)
treated by laparoscopic##2##3##(2006-6#1)(2009-6#1)
treated by local excision##2##4##(1990-6#1)(2008-3#1)
treated by local##6##3##(1990-6#1)(1995-4#1)(1996-6#1)(2006-10#1)(2007-11#1)(2008-3#1)
treated by mastectomy##2##3##(2004-1#1)(2013-1#1)
treated by means of##4##4##(1993-10#1)(1994-12#1)(2007-8#1)(2008-3#1)
treated by monotherapy##2##3##(1990-2#1)(2008-10#1)
treated by nipple-preserving mastectomy##2##4##(1996-3#2)
treated by open reduction##2##4##(2008-7#1)(2009-4#1)
treated by open##4##3##(1997-8#1)(2008-7#1)(2009-4#1)(2012-12#1)
treated by orthotopic liver transplantation##2##5##(2005-12#2)
treated by percutaneous drainage##2##4##(1991-8#1)(2012-12#1)
treated by percutaneous##4##3##(1991-8#1)(1993-8#1)(2007-11#1)(2012-12#1)
treated by primary##2##3##(1993-11#1)(2009-9#1)
treated by radical exeresis##2##4##(1994-6#2)
treated by radical##7##3##(1990-3#1)(1994-6#2)(1994-7#1)(1995-11#1)(2007-7#1)(2008-6#1)
treated by radiosurgery##3##3##(2008-7#2)(2011-2#1)
treated by radiotherapy alone##2##4##(2007-2#1)(2011-2#1)
treated by radiotherapy and##2##4##(1991-8#1)(2007-11#1)
treated by radiotherapy with##2##4##(1990-12#1)(2007-4#1)
treated by radiotherapy##8##3##(1990-12#1)(1991-8#1)(1992-10#1)(1994-4#1)(2007-11#1)(2007-2#1)(2007-4#1)(2011-2#1)
treated by staged##2##3##(2007-2#1)(2008-10#1)
treated by surgery##8##3##(1992-5#1)(1993-10#1)(1994-4#1)(2007-2#2)(2008-5#1)(2008-7#1)(2008-8#1)
treated by surgical resection##3##4##(2006-10#1)(2007-8#1)(2008-6#1)
treated by surgical##12##3##(2006-10#2)(2007-11#1)(2007-5#1)(2007-8#1)(2008-6#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
treated by the##16##3##(1992-8#1)(1995-11#1)(2006-2#1)(2007-11#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
treated by this method##2##4##(2007-12#1)(2007-8#1)
treated by this##3##3##(2007-12#1)(2007-8#1)(2008-1#1)
treated by total##2##3##(1992-11#1)(2008-4#1)
treated by wide##2##3##(2004-1#1)(2012-2#1)
treated by##395##2##(1990-10#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#4)(1991-3#3)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#5)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-5#4)(1992-8#3)(1992-9#4)(1993-10#3)(1993-11#2)(1993-2#1)(1993-3#1)(1993-4#4)(1993-8#2)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-4#3)(1994-5#1)(1994-6#2)(1994-7#2)(1994-8#2)(1995-10#1)(1995-11#2)(1995-4#1)(1995-9#1)(1996-11#2)(1996-3#3)(1996-6#1)(1996-9#1)(1997-1#4)(1997-2#1)(1997-3#2)(1997-4#4)(1997-6#1)(1997-8#2)(2004-1#4)(2004-2#1)(2004-9#1)(2005-10#2)(2005-12#2)(2005-5#1)(2005-7#3)(2005-8#1)(2005-9#2)(2006-10#5)(2006-11#1)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#8)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#12)(2007-12#1)(2007-2#6)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#6)(2007-8#26)(2007-9#3)(2008-1#5)(2008-10#20)(2008-11#4)(2008-12#5)(2008-2#4)(2008-3#9)(2008-4#7)(2008-5#10)(2008-6#6)(2008-7#18)(2008-8#3)(2008-9#8)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#4)(2009-6#1)(2009-9#3)(2010-2#2)(2010-6#1)(2011-1#3)(2011-2#19)(2012-1#3)(2012-11#1)(2012-12#9)(2012-2#10)(2012-3#5)(2012-7#1)(2013-1#8)(2013-7#1)(2013-8#6)
treated case##3##2##(2007-12#1)(2007-7#1)(2013-1#1)
treated cases##6##2##(2005-11#1)(2008-12#1)(2008-7#2)(2011-2#1)(2013-1#1)
treated catheters##3##2##(2007-7#3)
treated cattle##3##2##(1997-4#1)(2006-10#1)(2007-6#1)
treated cell##2##2##(2009-2#2)
treated cells and##2##3##(1990-9#1)(2006-7#1)
treated cells expressed##2##3##(1994-2#1)(2008-11#1)
treated cells##24##2##(1990-7#1)(1990-9#2)(1991-12#1)(1991-5#3)(1992-6#1)(1993-3#1)(1993-9#1)(1994-2#4)(1994-6#1)(2006-7#1)(2007-11#1)(2008-11#2)(2008-5#1)(2008-9#1)(2009-3#1)(2010-2#1)(2012-11#1)
treated children##2##2##(1993-2#1)(2011-1#1)
treated chronic##2##2##(1996-6#1)(2007-2#1)
treated chronically with##6##3##(1990-5#1)(1991-8#1)(1996-10#1)(1997-2#1)(2007-11#1)(2008-1#1)
treated conservatively and##10##3##(1993-5#1)(2006-6#1)(2007-7#3)(2008-1#1)(2013-1#4)
treated conservatively by##5##3##(2007-6#1)(2007-8#1)(2008-7#1)(2009-3#1)(2012-12#1)
treated conservatively or surgically##3##4##(2007-11#1)(2007-7#2)
treated conservatively or##5##3##(2007-10#1)(2007-11#1)(2007-7#2)(2008-1#1)
treated conservatively with##5##3##(2007-8#1)(2008-7#1)(2010-5#1)(2010-7#1)(2012-12#1)
treated conservatively##47##2##(1990-10#1)(1992-5#1)(1992-9#1)(1993-10#1)(1993-5#3)(1997-8#1)(2006-6#3)(2007-10#1)(2007-11#1)(2007-6#1)(2007-7#7)(2007-8#3)(2008-1#4)(2008-12#1)(2008-7#5)(2008-9#1)(2009-3#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-12#2)(2013-1#4)
treated continuously with##2##3##(1995-10#1)(2006-10#1)
treated continuously##3##2##(1995-10#1)(2006-10#1)(2008-11#1)
treated control##2##2##(1997-7#1)(2011-2#1)
treated controls##5##2##(1992-8#1)(1996-12#1)(1997-2#1)(1997-4#1)(2009-3#1)
treated corn stover##4##3##(2008-5#4)
treated corn##6##2##(2007-10#1)(2008-5#4)(2013-1#1)
treated cultures##2##2##(1994-2#1)(2008-10#1)
treated daily with##4##3##(2008-10#2)(2010-12#1)(2010-6#1)
treated due to##4##3##(2007-11#1)(2007-8#1)(2011-2#1)(2013-1#1)
treated during the period##2##4##(1992-9#1)(2008-9#1)
treated during the##4##3##(1990-6#1)(1992-9#1)(2006-12#1)(2008-9#1)
treated during##12##2##(1990-6#1)(1991-9#1)(1992-9#1)(2006-12#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#2)
treated each##2##2##(2007-2#1)(2008-10#1)
treated early##5##2##(1992-3#1)(2007-12#1)(2009-3#1)(2010-8#1)(2012-3#1)
treated effectively with##4##3##(2007-10#1)(2007-8#1)(2008-5#1)(2013-1#1)
treated effectively##9##2##(1992-5#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-8#1)(2008-5#1)(2008-7#1)(2013-1#1)
treated efficiently by endoscopic##2##4##(2012-1#2)
treated either##5##2##(1990-12#1)(1994-12#1)(1996-5#1)(2006-11#1)(2007-11#1)
treated embryos##7##2##(1991-2#1)(2006-5#3)(2008-11#2)(2008-12#1)
treated empirically##2##2##(2011-2#1)(2011-3#1)
treated endoscopically##5##2##(1996-11#1)(2006-12#1)(2006-5#1)(2007-3#1)(2008-5#1)
treated females##3##2##(2009-10#3)
treated first##2##2##(1996-5#1)(2008-10#1)
treated for 4 weeks##2##4##(1993-9#1)(2008-4#1)
treated for 4##3##3##(1993-9#1)(1996-1#1)(2008-4#1)
treated for 6##3##3##(1991-4#1)(1995-7#1)(2007-2#1)
treated for a##8##3##(1991-11#1)(1995-9#1)(2008-3#1)(2008-4#3)(2008-8#1)(2013-1#1)
treated for acute##3##3##(1990-2#1)(1997-5#1)(2006-10#1)
treated for breast cancer##4##4##(1990-3#1)(1992-2#1)(2011-2#1)(2013-7#1)
treated for breast##5##3##(1990-3#1)(1992-2#1)(1996-9#1)(2011-2#1)(2013-7#1)
treated for bronchial asthma##2##4##(2010-2#2)
treated for cardiac##2##3##(1992-5#1)(2010-12#1)
treated for cervical##2##3##(1992-3#1)(2012-12#1)
treated for congenital##2##3##(2008-6#1)(2009-3#1)
treated for epilepsy##2##3##(1991-4#1)(1996-1#1)
treated for hypertension##4##3##(1991-6#1)(1994-6#1)(2007-1#1)(2008-10#1)
treated for multiple##2##3##(1990-2#1)(2007-12#1)
treated for prostate cancer##2##4##(1995-8#1)(2008-7#1)
treated for pulmonary tuberculosis##2##4##(2008-7#1)(2010-2#1)
treated for recurrent##2##3##(1992-9#1)(2008-9#1)
treated for renal##2##3##(1997-8#1)(2009-5#1)
treated for seizures##2##3##(2011-1#2)
treated for spinal##3##3##(2006-8#1)(2007-11#1)(2009-3#1)
treated for the first time##2##5##(1990-6#1)(2006-10#1)
treated for the first##3##4##(1990-6#1)(1995-2#1)(2006-10#1)
treated for the##6##3##(1990-6#1)(1995-2#1)(1995-6#1)(2005-11#1)(2006-10#1)(2010-1#1)
treated for tuberculosis##3##3##(1996-3#1)(2007-4#1)(2010-12#1)
treated for up to##2##4##(1996-4#1)(2008-6#1)
treated for##173##2##(1990-10#1)(1990-2#3)(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#3)(1991-10#1)(1991-11#1)(1991-12#1)(1991-4#2)(1991-6#2)(1991-8#2)(1992-1#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#2)(1997-6#1)(1997-8#2)(2005-11#1)(2005-9#1)(2006-10#6)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-11#7)(2007-12#2)(2007-2#3)(2007-4#1)(2007-7#3)(2007-8#5)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#5)(2008-5#1)(2008-6#10)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#4)(2009-4#2)(2009-5#2)(2009-9#1)(2010-1#1)(2010-12#3)(2010-2#3)(2010-3#2)(2010-6#1)(2010-9#2)(2011-1#3)(2011-11#1)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
treated from 1996##2##3##(2007-7#1)(2009-2#1)
treated from##8##2##(2005-10#1)(2006-5#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-9#1)(2009-2#1)
treated group (p = NS)##2##5##(1990-11#2)
treated group (p##3##3##(1990-11#3)
treated group was##3##3##(2009-8#2)(2013-1#1)
treated group##28##2##(1990-11#4)(1990-7#1)(1991-5#1)(1992-5#1)(1993-12#1)(1996-11#1)(1997-6#1)(2005-7#1)(2005-8#1)(2006-5#1)(2007-8#3)(2007-9#1)(2008-5#3)(2008-9#1)(2009-4#1)(2009-8#2)(2011-1#1)(2012-12#1)(2013-1#2)
treated groups compared to##2##4##(2008-5#1)(2009-7#1)
treated groups##16##2##(1994-8#2)(1996-11#1)(2006-4#1)(2006-5#1)(2007-9#1)(2008-12#1)(2008-4#1)(2008-5#2)(2009-7#1)(2011-1#1)(2012-12#1)(2012-2#3)
treated hair##2##2##(2008-5#2)
treated hemispheres##2##2##(2006-11#2)
treated here##2##2##(2010-3#1)(2013-7#1)
treated human##4##2##(1991-4#1)(1991-9#1)(1997-6#1)(2008-10#1)
treated hypertensives##5##2##(1994-8#2)(2008-10#3)
treated in Orthopaedic##2##3##(2007-11#2)
treated in a single##4##4##(1997-5#1)(2010-10#1)(2012-2#1)(2013-8#1)
treated in a##30##3##(1990-4#1)(1991-5#1)(1991-6#1)(1993-5#1)(1995-3#1)(1996-3#1)(1997-5#1)(2005-10#1)(2006-1#1)(2006-10#2)(2006-6#1)(2006-7#2)(2007-7#1)(2008-12#2)(2008-6#1)(2008-7#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
treated in an##2##3##(1991-4#1)(2008-10#1)
treated in general practice##3##4##(1993-2#1)(2006-5#1)(2008-3#1)
treated in general##4##3##(1993-2#1)(2006-5#1)(2008-3#1)(2012-2#1)
treated in our clinic##2##4##(2007-7#1)(2007-8#1)
treated in our department##5##4##(1993-6#1)(2006-11#1)(2008-1#1)(2012-2#1)(2013-1#1)
treated in our hospital##2##4##(1991-2#1)(2007-8#1)
treated in our##14##3##(1991-2#1)(1992-6#1)(1993-5#1)(1993-6#1)(2006-11#1)(2006-7#1)(2007-7#2)(2007-8#2)(2008-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
treated in outpatient##2##3##(2007-8#1)(2012-12#1)
treated in primary##2##3##(1996-6#1)(2011-2#1)
treated in specialized##2##3##(1990-10#1)(2008-6#1)
treated in the Department of##4##5##(1993-1#1)(1995-11#1)(2005-1#1)(2008-7#1)
treated in the Department##5##4##(1991-12#1)(1993-1#1)(1995-11#1)(2005-1#1)(2008-7#1)
treated in the first##2##4##(1993-3#1)(2008-7#1)
treated in the last##2##4##(2006-2#1)(2012-2#1)
treated in the public system##2##5##(2006-10#2)
treated in the same way as##2##6##(1993-3#1)(2008-10#1)
treated in the same way##3##5##(1993-3#1)(1996-7#1)(2008-10#1)
treated in the same##8##4##(1992-4#1)(1992-6#1)(1993-3#1)(1996-7#1)(2007-7#1)(2008-10#1)(2008-6#2)
treated in the years##2##4##(2007-8#1)(2013-1#1)
treated in the##45##3##(1990-5#3)(1991-12#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-3#2)(1993-5#1)(1995-11#1)(1996-7#1)(2005-1#1)(2005-11#1)(2006-10#2)(2006-2#1)(2007-11#3)(2007-7#5)(2007-8#2)(2008-10#1)(2008-11#1)(2008-6#2)(2008-7#2)(2008-8#1)(2010-10#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
treated in their##2##3##(2008-10#1)(2008-9#1)
treated in this way##2##4##(1997-2#1)(2008-5#1)
treated in this##4##3##(1991-12#1)(1997-2#1)(2006-12#1)(2008-5#1)
treated in##167##2##(1990-10#1)(1990-4#1)(1990-5#3)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-4#1)(1992-5#4)(1992-6#2)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#2)(1993-5#3)(1993-6#2)(1995-1#1)(1995-11#1)(1995-3#1)(1995-7#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2005-1#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#5)(2006-11#2)(2006-12#1)(2006-2#2)(2006-5#1)(2006-6#1)(2006-7#3)(2007-11#7)(2007-7#10)(2007-8#11)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#3)(2008-3#3)(2008-5#1)(2008-6#4)(2008-7#4)(2008-8#2)(2008-9#1)(2009-1#1)(2009-3#1)(2009-5#1)(2009-6#3)(2009-9#1)(2010-10#2)(2010-3#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#15)(2012-12#3)(2012-2#9)(2012-3#2)(2013-1#5)(2013-8#2)
treated infections##2##2##(2006-4#1)(2013-8#1)
treated initially with##5##3##(1992-12#1)(2006-10#1)(2007-7#1)(2008-6#1)(2013-1#1)
treated initially##6##2##(1992-12#1)(1996-11#1)(2006-10#1)(2007-7#1)(2008-6#1)(2013-1#1)
treated islets##2##2##(2010-11#1)(2013-1#1)
treated it##3##2##(2007-7#1)(2009-1#1)(2012-2#1)
treated laparoscopically##2##2##(2006-6#1)(2009-6#1)
treated larvae##2##2##(2010-10#1)(2011-1#1)
treated leaf##2##2##(2008-10#2)
treated limbs##2##2##(2006-10#1)(2006-6#1)
treated locally##4##2##(2007-10#1)(2007-11#1)(2007-8#1)(2008-3#1)
treated long##3##2##(1990-6#1)(2007-11#2)
treated male rats##4##3##(1993-6#2)(2008-11#2)
treated medically or surgically##2##4##(2006-2#1)(2010-2#1)
treated medically##9##2##(1996-12#1)(1997-1#1)(2006-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2010-2#1)(2011-2#1)
treated melanoma##2##2##(2012-3#1)(2013-8#1)
treated mice compared to##2##4##(1996-10#1)(2011-1#1)
treated mice were##2##3##(2008-9#1)(2012-2#1)
treated mice##18##2##(1990-4#1)(1992-1#1)(1995-12#1)(1996-10#1)(1997-4#1)(2006-8#1)(2007-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#3)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
treated multiple##3##2##(1992-5#1)(1996-8#1)(2011-2#1)
treated muscle##3##2##(1990-11#2)(1995-9#1)
treated nonoperatively##3##2##(2006-3#1)(2008-8#1)(2013-1#1)
treated of##2##2##(2008-9#1)(2013-1#1)
treated on an##6##3##(1995-2#1)(2007-11#1)(2007-8#2)(2012-2#2)
treated on the basis of##2##5##(1993-9#1)(2008-10#1)
treated on the##4##3##(1993-9#1)(2005-10#1)(2008-10#1)(2008-9#1)
treated on##16##2##(1990-9#1)(1991-12#1)(1993-9#1)(1995-2#2)(2005-10#1)(2006-4#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-9#1)(2010-3#1)(2012-2#2)(2013-1#1)
treated once daily##3##3##(2008-10#1)(2010-8#1)(2013-1#1)
treated once##4##2##(2008-10#1)(2008-5#1)(2010-8#1)(2013-1#1)
treated only with##6##3##(1991-8#1)(1992-5#1)(1993-2#1)(1996-12#1)(1997-1#1)(2008-6#1)
treated only##7##2##(1991-8#1)(1992-5#1)(1993-2#1)(1996-12#1)(1997-1#1)(2007-11#1)(2008-6#1)
treated operatively by##2##3##(1992-8#1)(2007-11#1)
treated operatively##9##2##(1990-4#1)(1992-8#1)(2007-11#4)(2007-7#2)(2008-3#1)
treated or not treated with##3##5##(2007-9#1)(2008-10#1)(2011-2#1)
treated or not##5##3##(1990-7#1)(1990-8#1)(2007-9#1)(2008-10#1)(2011-2#1)
treated or untreated##6##3##(2005-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-11#1)(2012-12#1)
treated or##15##2##(1990-7#1)(1990-8#1)(1992-2#1)(2005-7#1)(2007-11#2)(2007-9#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)
treated orally with##4##3##(1990-12#1)(1993-12#1)(1996-6#1)(2007-2#1)
treated outside##2##2##(1990-10#1)(1991-4#1)
treated over a##4##3##(1990-10#1)(1990-8#1)(2012-2#2)
treated over the##2##3##(2008-6#1)(2008-7#1)
treated over##7##2##(1990-10#1)(1990-3#1)(1990-8#1)(2008-6#1)(2008-7#1)(2012-2#2)
treated palliatively##2##2##(2007-11#1)(2008-6#1)
treated patients and##4##3##(2006-8#1)(2006-9#1)(2012-3#1)(2013-8#1)
treated patients was##3##3##(2007-11#1)(2008-7#1)(2011-1#1)
treated patients were##4##3##(1994-2#1)(2005-9#1)(2011-2#1)(2012-1#1)
treated patients with a##2##4##(2010-10#1)(2013-1#1)
treated patients with##9##3##(1993-6#1)(1994-12#1)(1996-9#1)(2006-10#1)(2007-11#1)(2008-7#1)(2010-10#1)(2011-2#1)(2013-1#1)
treated patients##60##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-7#1)(1992-2#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-4#1)(1996-3#1)(1996-9#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#5)(2008-9#1)(2009-7#1)(2010-10#1)(2010-12#1)(2011-1#2)(2011-2#5)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
treated plants##9##2##(2008-10#5)(2008-11#2)(2008-12#2)
treated prophylactically with##4##3##(1994-3#1)(2008-7#1)(2012-2#1)(2012-3#1)
treated prospectively##2##2##(1997-8#1)(2008-5#1)
treated radically##2##2##(1991-8#1)(2008-6#1)
treated rats showed##2##3##(1991-5#1)(2013-8#1)
treated rats was##2##3##(2008-8#1)(2010-12#1)
treated rats were##2##3##(1991-10#1)(2013-1#1)
treated rats##42##2##(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-12#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-3#1)(1996-10#4)(1996-11#1)(2006-9#2)(2007-1#3)(2007-10#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-4#1)(2013-1#1)(2013-8#2)
treated samples##7##2##(1994-12#1)(1994-3#1)(1994-9#1)(2005-11#1)(2007-8#1)(2008-10#1)(2012-1#1)
treated separately##3##2##(1993-6#1)(2007-11#1)(2008-9#1)
treated seven##2##2##(2006-12#1)(2010-7#1)
treated sewage##2##2##(2008-10#1)(2013-1#1)
treated similarly##3##2##(1993-4#1)(1994-6#1)(2008-6#1)
treated simultaneously in##2##3##(2008-10#1)(2009-6#1)
treated simultaneously with##5##3##(1992-3#1)(1992-9#1)(2006-5#1)(2008-10#1)(2008-7#1)
treated simultaneously##8##2##(1992-3#1)(1992-9#1)(2006-5#1)(2008-10#3)(2008-7#1)(2009-6#1)
treated six patients##2##3##(2006-6#1)(2008-6#1)
treated skin##4##2##(2008-5#4)
treated soil##2##2##(2008-10#1)(2012-12#1)
treated specimens##3##2##(2009-7#1)(2013-1#2)
treated successfully by##5##3##(1990-9#1)(1993-5#1)(1997-3#1)(2008-7#1)(2011-2#1)
treated successfully with antibiotics##3##4##(1991-4#1)(1995-11#1)(1996-4#1)
treated successfully with##21##3##(1991-4#1)(1995-11#1)(1995-2#1)(1996-4#1)(2007-7#3)(2007-8#4)(2008-2#1)(2008-3#1)(2009-11#1)(2009-3#1)(2009-4#1)(2010-5#1)(2012-2#2)(2013-1#2)
treated successfully##36##2##(1990-10#1)(1990-9#1)(1991-4#1)(1992-4#1)(1993-5#1)(1995-11#1)(1995-2#1)(1996-4#1)(1997-3#1)(2006-3#1)(2007-7#3)(2007-8#4)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#3)(2013-1#3)
treated surfaces##2##2##(2005-11#1)(2008-12#1)
treated surgically at the##3##4##(2007-11#1)(2007-7#1)(2008-7#1)
treated surgically at##6##3##(1997-6#1)(2007-11#1)(2007-7#1)(2008-7#1)(2009-1#1)(2010-1#1)
treated surgically by##3##3##(1991-4#1)(2008-8#1)(2013-1#1)
treated surgically due to##3##4##(2007-11#2)(2007-8#1)
treated surgically for##7##3##(2004-1#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-4#1)
treated surgically using##4##3##(2007-7#2)(2008-9#1)(2011-2#1)
treated surgically with##6##3##(1991-6#1)(2006-7#1)(2007-11#1)(2007-7#2)(2007-8#1)
treated surgically##64##2##(1990-10#1)(1990-12#2)(1991-4#2)(1991-6#2)(1993-10#2)(1993-7#1)(1993-8#1)(1997-2#1)(1997-6#1)(2004-1#1)(2005-10#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#7)(2007-7#7)(2007-8#6)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-1#1)(2009-3#1)(2010-1#1)(2010-11#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
treated systemically with##2##3##(1996-1#1)(2006-6#1)
treated ten##2##2##(1990-12#1)(1992-3#1)
treated than##3##2##(1995-3#1)(2008-2#1)(2009-8#1)
treated the##5##2##(1994-5#1)(2008-10#1)(2008-2#1)(2009-2#1)(2013-8#1)
treated through a##2##3##(1991-11#1)(2006-12#1)
treated throughout##3##2##(1996-10#1)(2011-2#1)(2013-1#1)
treated thyroid##2##2##(2006-12#1)(2008-6#1)
treated to remove##3##3##(2007-12#1)(2008-4#1)(2009-11#1)
treated to##12##2##(1994-8#1)(1995-4#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-11#1)(2012-12#1)(2013-1#1)
treated tumours##3##2##(2008-7#3)
treated twice daily with##2##4##(2008-11#1)(2010-8#1)
treated twice with##2##3##(1993-2#1)(2008-10#1)
treated twice##7##2##(1992-3#1)(1993-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-8#1)
treated two cases##2##3##(1993-6#1)(2010-12#1)
treated two patients##4##3##(1991-5#1)(1995-4#1)(2006-12#1)(2007-8#1)
treated two##7##2##(1991-5#1)(1993-6#1)(1994-1#1)(1995-4#1)(2006-12#1)(2007-8#1)(2010-12#1)
treated under##5##2##(1991-9#1)(2007-6#1)(2008-12#1)(2013-1#2)
treated unnecessarily##2##2##(1992-10#1)(1992-8#1)
treated unsuccessfully with##2##3##(2006-4#1)(2007-7#1)
treated unsuccessfully##3##2##(1990-9#1)(2006-4#1)(2007-7#1)
treated up to##3##3##(1993-8#1)(1996-6#1)(2008-3#1)
treated using a##4##3##(2007-8#1)(2011-2#1)(2012-12#1)(2013-7#1)
treated using the##7##3##(2006-12#1)(2006-6#1)(2007-8#1)(2008-6#1)(2010-12#1)(2011-2#1)(2013-8#1)
treated using this##4##3##(1990-3#1)(2005-6#1)(2008-8#1)(2010-12#1)
treated using##37##2##(1990-3#1)(1991-2#1)(1991-3#1)(1993-10#1)(1996-3#1)(2005-11#1)(2005-6#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#4)(2008-10#2)(2008-6#1)(2008-8#1)(2009-8#1)(2010-12#2)(2010-3#2)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#2)
treated via##5##2##(2006-2#1)(2006-8#3)(2011-2#1)
treated was##2##2##(1993-9#1)(2008-6#1)
treated waste water##5##3##(2008-10#2)(2012-2#3)
treated wastewater from a##2##4##(2008-10#1)(2012-12#1)
treated wastewater samples##2##3##(2008-10#1)(2012-12#1)
treated wastewater##5##2##(2008-10#3)(2012-12#2)
treated water and##2##3##(1997-4#1)(2008-1#1)
treated water##5##2##(1997-4#2)(2006-2#1)(2008-1#1)(2008-5#1)
treated were##2##2##(2006-6#1)(2011-2#1)
treated wheat##2##2##(2008-12#2)
treated with 0##15##3##(1994-11#1)(1994-12#1)(1995-2#1)(1996-12#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#1)(2010-7#1)(2010-8#1)(2011-2#1)
treated with 1##12##3##(1990-12#1)(1992-9#1)(1993-7#1)(1993-8#1)(1994-11#1)(1996-12#1)(2008-10#4)(2009-2#1)(2012-12#1)
treated with 1- and 2-methoxynaphthalene##3##5##(2011-2#3)
treated with 10##5##3##(1992-11#1)(1992-7#1)(2008-10#1)(2008-5#1)(2008-7#1)
treated with 100 microg##2##4##(2009-3#2)
treated with 100##3##3##(1991-12#1)(2009-3#2)
treated with 17-MT and##4##4##(2013-7#4)
treated with 17-MT##5##3##(2013-7#5)
treated with 2##5##3##(1994-12#1)(1996-11#1)(1996-12#1)(1997-5#1)(2008-10#1)
treated with 20##2##3##(1991-8#2)
treated with 30##3##3##(1991-2#1)(1995-1#1)(2006-5#1)
treated with 300 mg##2##4##(1990-2#1)(1994-3#1)
treated with 300 mg/day of##2##5##(1995-11#2)
treated with 300##5##3##(1990-2#1)(1994-3#1)(1995-11#2)(2011-1#1)
treated with 4##4##3##(2007-6#1)(2008-10#2)(2013-1#1)
treated with 5##2##3##(1994-6#1)(2005-7#1)
treated with 50 microM##2##4##(1995-8#1)(2005-10#1)
treated with 50##3##3##(1995-8#1)(2005-10#1)(2008-5#1)
treated with 500##3##3##(1990-7#1)(1995-3#1)(2008-6#1)
treated with 6##3##3##(1991-6#1)(1992-10#1)(2008-4#1)
treated with 75##2##3##(2008-3#1)(2011-2#1)
treated with 8##2##3##(2009-5#2)
treated with 80##2##3##(1991-3#1)(2008-5#1)
treated with Ad-HGF##3##3##(2008-9#3)
treated with B##3##3##(2008-10#1)(2008-3#2)
treated with BNR##2##3##(2008-10#2)
treated with C##2##3##(2008-10#1)(2011-2#1)
treated with C-D instrumentation##2##4##(2007-7#2)
treated with CO2 laser##3##4##(1995-2#1)(1996-1#1)(2008-4#1)
treated with COC##2##3##(1996-12#2)
treated with CT##4##3##(2011-2#4)
treated with Co60 and##2##4##(2007-10#2)
treated with Co60##6##3##(2007-10#6)
treated with DENA (at##2##4##(1990-4#2)
treated with ECT##2##3##(2008-12#1)(2011-2#1)
treated with Ender##2##3##(2007-11#1)(2007-8#1)
treated with GM1##2##3##(1993-3#1)(2008-10#1)
treated with GNPs##2##3##(2010-12#2)
treated with H2O2##4##3##(1994-2#1)(1995-8#2)(1997-6#1)
treated with IVIG##3##3##(2005-11#1)(2006-4#2)
treated with LPS##3##3##(1993-3#1)(2008-11#1)(2010-4#1)
treated with Lyprinol(R)##2##3##(2008-10#2)
treated with MH##2##3##(2008-9#2)
treated with Microsphaeropsis sp##3##4##(2008-10#3)
treated with NJE##2##3##(2013-8#2)
treated with Org 2766##2##4##(1994-10#2)
treated with PDGF and H7##2##5##(1990-3#2)
treated with PRL##2##3##(1996-8#2)
treated with RA or##2##4##(1992-1#1)(2008-11#1)
treated with S##3##3##(1992-1#2)(2006-9#1)
treated with SVF-enhanced autologous fat grafts##2##6##(2012-12#2)
treated with TCDD##2##3##(1991-10#1)(1994-8#1)
treated with TNFalpha##2##3##(2006-10#1)(2008-10#1)
treated with a CO(2) laser##2##5##(2007-12#2)
treated with a NSAID##2##4##(2006-10#1)(2007-12#1)
treated with a chemical carcinogen##2##5##(2008-3#1)(2009-8#1)
treated with a combination of##11##5##(1990-10#1)(1991-2#2)(1991-3#1)(2005-7#1)(2007-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2011-2#1)
treated with a combination##13##4##(1990-10#1)(1990-2#1)(1991-2#2)(1991-3#1)(1992-10#1)(2005-7#1)(2007-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2011-2#1)
treated with a combined##2##4##(1993-9#1)(2007-5#1)
treated with a high##2##4##(2006-9#1)(2012-12#1)
treated with a new##3##4##(1990-10#1)(1992-3#1)(1993-2#1)
treated with a second##2##4##(2004-12#1)(2007-8#1)
treated with a single##3##4##(2006-2#1)(2007-8#1)(2012-2#1)
treated with a variety of##4##5##(1991-3#1)(1991-9#1)(2006-12#1)(2008-7#1)
treated with a##107##3##(1990-10#3)(1990-12#1)(1990-2#2)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-5#1)(1991-9#1)(1992-10#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-9#1)(1997-6#1)(1997-8#1)(2004-10#1)(2004-12#2)(2005-10#1)(2005-7#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-8#5)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#2)(2009-1#1)(2009-3#1)(2009-4#1)(2009-8#2)(2010-12#2)(2010-3#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#9)
treated with acamprosate##2##3##(2008-2#2)
treated with adjuvant radiotherapy##2##4##(2011-1#1)(2013-1#1)
treated with adjuvant tamoxifen##2##4##(1991-4#1)(2004-2#1)
treated with adjuvant##7##3##(1991-4#1)(1992-2#1)(2004-2#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
treated with aggressive##4##3##(1992-6#1)(2006-6#1)(2009-6#1)(2010-3#1)
treated with alcohol##2##3##(1997-8#1)(2012-2#1)
treated with amitriptyline hydrochloride##2##4##(2005-10#2)
treated with ammonium##3##3##(1997-8#1)(2008-10#2)
treated with amphotericin B##2##4##(2008-12#1)(2012-2#1)
treated with an oral##2##4##(1990-8#1)(1994-6#1)
treated with an##24##3##(1990-8#2)(1992-11#2)(1992-2#1)(1994-2#1)(1994-6#1)(1997-8#1)(2005-11#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-6#1)(2010-10#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
treated with and without##2##4##(1990-10#1)(2008-8#1)
treated with and##3##3##(1990-10#1)(2008-8#1)(2010-12#1)
treated with androgen deprivation therapy##2##5##(2008-7#1)(2012-3#1)
treated with androgen##3##3##(2008-7#1)(2012-3#1)(2013-8#1)
treated with anti-tumor necrosis factor##2##5##(2011-2#2)
treated with antibiotic##2##3##(2011-2#1)(2012-12#1)
treated with antibiotics and##3##4##(1996-11#1)(2007-12#1)(2011-2#1)
treated with antibiotics##10##3##(1996-1#1)(1996-11#1)(2005-10#1)(2007-12#1)(2007-7#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
treated with anticoagulation##2##3##(1997-2#1)(2010-6#1)
treated with anticonvulsants##2##3##(2012-2#1)(2013-7#1)
treated with antidepressants##2##3##(2005-6#1)(2008-3#1)
treated with antifungal##2##3##(2007-12#1)(2011-2#1)
treated with any##2##3##(2007-8#1)(2013-8#1)
treated with appropriate antibiotics##2##4##(2007-7#2)
treated with appropriate##3##3##(2007-7#2)(2008-11#1)
treated with arthroscopic excision##2##4##(2011-2#2)
treated with arthroscopic##3##3##(2011-2#2)(2012-12#1)
treated with aspirin##3##3##(1996-11#1)(2006-10#1)(2008-3#1)
treated with atrazine##2##3##(2013-1#2)
treated with azathioprine##4##3##(2007-12#1)(2007-8#3)
treated with azithromycin##2##3##(2013-1#1)(2013-8#1)
treated with bacterial##3##3##(1997-8#1)(2006-10#1)(2008-10#1)
treated with band ligation and sclerotherapy##2##6##(2013-1#2)
treated with band ligation##3##4##(2013-1#3)
treated with beta##2##3##(1995-10#1)(2013-1#1)
treated with betamethasone##2##3##(2007-7#2)
treated with biologics##2##3##(2012-2#2)
treated with bisphosphonates##3##3##(2007-11#1)(2008-6#1)(2013-1#1)
treated with both##10##3##(1990-12#1)(1992-2#2)(1997-6#1)(2008-10#2)(2008-11#2)(2008-5#1)(2010-7#1)
treated with butyric esters##2##4##(1991-5#2)
treated with caffeine##2##3##(1995-8#1)(2009-3#1)
treated with calcium##2##3##(1990-3#1)(1995-11#1)
treated with carbon dioxide##2##4##(2007-8#2)
treated with carbon##3##3##(1992-6#1)(2007-8#2)
treated with carboplatin##2##3##(2006-12#1)(2009-8#1)
treated with cathepsin##2##3##(1992-5#1)(2009-3#1)
treated with centrifuged fat##2##4##(2012-12#2)
treated with chemotherapy and##4##4##(1992-8#1)(2005-11#1)(2007-9#1)(2011-2#1)
treated with chemotherapy##23##3##(1990-10#1)(1991-4#1)(1991-6#1)(1992-8#1)(2004-1#2)(2005-11#1)(2006-12#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-6#3)(2008-7#1)(2009-7#1)(2009-8#2)(2011-2#5)
treated with chloroquine phosphate##2##4##(2008-4#2)
treated with chloroquine##3##3##(2008-4#3)
treated with chronic##2##3##(1993-9#1)(2008-10#1)
treated with cisplatin##4##3##(1992-12#1)(1992-8#1)(2008-5#1)(2012-2#1)
treated with clotrimazole##2##3##(2007-7#2)
treated with clozapine##2##3##(2007-7#2)
treated with co-artemether##2##3##(2007-2#2)
treated with combination chemotherapy##2##4##(2007-10#1)(2007-6#1)
treated with combination##6##3##(1990-6#1)(1997-6#1)(2007-10#2)(2007-6#1)(2007-7#1)
treated with combined therapy##2##4##(1992-6#1)(2007-8#1)
treated with combined##3##3##(1992-6#1)(2007-8#1)(2009-4#1)
treated with conditioned medium##2##4##(1992-5#1)(2012-12#1)
treated with conservative surgery and##2##5##(2008-6#1)(2011-2#1)
treated with conservative##3##3##(2006-8#1)(2008-6#1)(2011-2#1)
treated with continuous##2##3##(1990-9#1)(1994-10#1)
treated with conventional##4##3##(2008-1#1)(2008-10#1)(2008-12#1)(2011-1#1)
treated with corn oil##2##4##(2008-6#1)(2013-1#1)
treated with corticosteroid##4##3##(1993-2#1)(2007-7#1)(2010-6#1)(2013-8#1)
treated with corticosteroids and##2##4##(1994-6#1)(2006-10#1)
treated with corticosteroids##3##3##(1993-6#1)(1994-6#1)(2006-10#1)
treated with curative##2##3##(1991-2#1)(2008-6#1)
treated with cycloheximide##2##3##(1993-3#2)
treated with cyclophosphamide##5##3##(1991-8#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#1)
treated with cyclosporin##2##3##(2007-11#1)(2008-1#1)
treated with cyclosporine and##2##4##(2006-10#1)(2007-8#1)
treated with cyclosporine##4##3##(2006-10#1)(2007-8#1)(2008-5#1)(2010-6#1)
treated with definitive radiotherapy##2##4##(1991-4#1)(2010-12#1)
treated with definitive##3##3##(1991-4#1)(2010-12#1)(2011-2#1)
treated with dexamethasone##5##3##(1993-2#1)(1994-11#1)(1997-6#2)(2007-7#1)
treated with dieldrin##2##3##(2006-4#2)
treated with diet##2##3##(1996-1#1)(2006-2#1)
treated with different##11##3##(1992-12#1)(1992-8#1)(1994-10#1)(2008-4#2)(2008-5#1)(2009-2#1)(2013-1#4)
treated with diltiazem##3##3##(1991-11#2)(2008-7#1)
treated with docetaxel##2##3##(2008-6#1)(2013-7#1)
treated with drugs##7##3##(1990-2#2)(1992-9#1)(1993-1#1)(1993-2#1)(1994-6#1)(2008-10#1)
treated with each##2##3##(1995-2#1)(2008-10#1)
treated with either##22##3##(1990-11#1)(1991-7#1)(1991-8#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-10#1)(1996-9#1)(2005-7#1)(2006-1#1)(2006-8#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-12#1)
treated with endobronchial##2##3##(2007-8#1)(2008-5#1)
treated with endoscopic##2##3##(2006-8#1)(2013-8#1)
treated with endovascular##4##3##(1997-2#1)(2007-10#1)(2007-7#1)(2010-12#1)
treated with epirubicin##3##3##(1991-2#1)(1994-10#1)(2008-6#1)
treated with epoetin beta##2##4##(2008-7#2)
treated with ethanol extract##2##4##(2008-10#1)(2012-2#1)
treated with ethanol##6##3##(1995-3#1)(1996-2#1)(2008-10#2)(2012-2#1)(2013-8#1)
treated with external beam##2##4##(2006-12#1)(2008-6#1)
treated with external radiotherapy##2##4##(1993-2#1)(2012-2#1)
treated with external##5##3##(1993-2#1)(2006-12#1)(2007-8#1)(2008-6#1)(2012-2#1)
treated with extracorporeal shock wave lithotripsy (ESWL)##3##7##(1996-12#2)(2007-7#1)
treated with fat grafting##3##4##(2012-12#2)(2013-1#1)
treated with five##2##3##(2008-6#1)(2012-1#1)
treated with fluoxetine##2##3##(1993-2#1)(2005-10#1)
treated with folic acid##2##4##(2008-3#1)(2008-7#1)
treated with formaldehyde##5##3##(2008-1#1)(2008-2#2)(2008-8#2)
treated with fungicides##3##3##(2008-10#3)
treated with gamma##2##3##(2006-12#1)(2008-8#1)
treated with glucocorticoids##2##3##(1994-6#1)(1996-12#1)
treated with glutaraldehyde##5##3##(1991-5#1)(2004-9#2)(2005-10#2)
treated with granulocyte colony-stimulating factor (G-CSF)##2##6##(2006-10#1)(2008-7#1)
treated with haemodialysis##2##3##(1992-7#1)(2007-7#1)
treated with haloperidol##2##3##(1997-1#1)(2004-3#1)
treated with heparin##3##3##(2005-1#1)(2010-3#1)(2013-8#1)
treated with high doses of##4##5##(1994-3#1)(2006-10#1)(2007-11#1)(2012-2#1)
treated with high##11##3##(1990-6#2)(1994-3#1)(1994-6#1)(2006-10#1)(2007-11#1)(2007-7#1)(2012-2#1)(2013-1#3)
treated with home mechanical ventilation##2##5##(1995-2#2)
treated with human##2##3##(1995-10#1)(2009-10#1)
treated with hydrogen peroxide##3##4##(1990-4#2)(1995-8#1)
treated with hypofractionated radiotherapy##2##4##(1992-10#1)(2008-6#1)
treated with i##2##3##(2007-6#1)(2008-7#1)
treated with imatinib##2##3##(2007-12#1)(2009-3#1)
treated with immunosuppressive agents##3##4##(2006-10#1)(2010-6#1)(2013-7#1)
treated with immunosuppressive##4##3##(2006-10#2)(2010-6#1)(2013-7#1)
treated with immunotherapy##2##3##(2006-8#1)(2010-12#1)
treated with increasing doses of##2##5##(1990-5#1)(1991-1#1)
treated with increasing##3##3##(1990-5#1)(1991-1#1)(2008-10#1)
treated with infliximab##7##3##(2006-10#1)(2008-5#1)(2008-8#1)(2010-9#1)(2011-2#3)
treated with inhaled insulin compared to##2##6##(2008-8#2)
treated with inhaled##8##3##(1990-9#1)(1993-5#1)(2007-11#3)(2008-8#2)(2010-2#1)
treated with insulin##6##3##(1992-7#1)(1996-11#1)(2006-6#1)(2007-5#1)(2008-3#2)
treated with intensive##3##3##(1990-3#1)(2006-10#1)(2011-1#1)
treated with intermittent##3##3##(1996-2#1)(1996-8#1)(2007-8#1)
treated with internal##2##3##(2008-10#1)(2013-1#1)
treated with intraarterial##2##3##(2006-11#1)(2007-9#1)
treated with intravenous antibiotics##4##4##(2006-10#1)(2008-1#1)(2011-1#1)(2013-1#1)
treated with intravenous##14##3##(2006-10#1)(2006-4#1)(2007-7#1)(2007-9#1)(2008-1#2)(2009-8#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
treated with intravitreal##2##3##(2007-3#1)(2009-8#1)
treated with iron##2##3##(1995-6#1)(2012-2#1)
treated with itraconazole##4##3##(2007-7#1)(2008-1#1)(2008-5#2)
treated with laminectomy followed by radiotherapy##2##6##(1991-9#1)(1996-9#1)
treated with laparotomy##2##3##(1991-3#1)(2008-9#1)
treated with laser##4##3##(1990-12#1)(1995-2#1)(2006-6#1)(2008-5#1)
treated with lipofilling technique##2##4##(2013-1#2)
treated with local##7##3##(1990-10#1)(2006-10#1)(2006-4#1)(2007-10#2)(2008-7#1)(2012-2#1)
treated with lovastatin##3##3##(1991-7#2)(1994-3#1)
treated with low doses of##2##5##(2006-10#1)(2008-5#1)
treated with low##8##3##(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
treated with magnesium##3##3##(1991-3#1)(2005-1#1)(2010-8#1)
treated with mechanical##2##3##(1995-5#1)(2012-2#1)
treated with medical therapy##2##4##(1992-10#1)(2013-1#1)
treated with methadone##2##3##(2007-2#1)(2010-5#1)
treated with methotrexate##2##3##(1997-3#1)(2008-6#1)
treated with methylprednisolone##4##3##(2006-4#1)(2008-1#1)(2013-8#2)
treated with metronidazole##2##3##(2006-10#1)(2008-4#1)
treated with microsurgery##2##3##(2005-5#1)(2008-7#1)
treated with morphine##2##3##(2008-5#1)(2008-7#1)
treated with multiple##3##3##(1991-10#1)(2006-10#1)(2006-6#1)
treated with narrow-band ultraviolet B##2##5##(2011-1#2)
treated with natural##2##3##(2006-10#2)
treated with neoadjuvant chemotherapy##2##4##(1994-2#1)(2009-4#1)
treated with neoadjuvant##4##3##(1994-2#1)(2009-4#3)
treated with nerve growth factor##2##5##(1993-11#1)(1995-5#1)
treated with nicotine##3##3##(1996-10#1)(2010-8#1)(2011-1#1)
treated with no##2##3##(1997-3#1)(1997-6#1)
treated with one of##3##4##(2006-8#1)(2008-10#1)(2012-2#1)
treated with one##6##3##(2004-12#1)(2006-10#1)(2006-8#1)(2008-10#2)(2012-2#1)
treated with only##4##3##(2006-10#1)(2007-7#1)(2008-5#1)(2011-2#1)
treated with or without##2##4##(1991-10#1)(2008-10#1)
treated with oral##20##3##(1990-11#1)(1990-3#1)(1991-4#1)(1992-2#2)(1996-6#1)(1996-8#1)(2006-10#2)(2007-2#1)(2007-7#1)(2007-8#3)(2008-10#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-8#2)
treated with palliative radiation therapy##2##5##(2008-7#1)(2012-12#1)
treated with palliative radiation##3##4##(2008-7#1)(2012-12#1)(2012-2#1)
treated with palliative##6##3##(2007-2#1)(2007-4#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#1)
treated with penicillin##3##3##(1990-9#1)(1991-7#1)(1993-7#1)
treated with percutaneous fixation##2##4##(2008-9#1)(2009-2#1)
treated with percutaneous##7##3##(2006-10#1)(2006-8#2)(2008-9#1)(2009-2#1)(2010-7#1)(2013-8#1)
treated with peritoneal dialysis##2##4##(2008-7#1)(2011-2#1)
treated with peritoneal##4##3##(2008-7#1)(2011-2#2)(2012-2#1)
treated with phorbol 12-myristate 13-acetate (PMA)##2##6##(1994-3#1)(2008-5#1)
treated with phorbol##3##3##(1991-5#1)(1994-3#1)(2008-5#1)
treated with photochemotherapy##3##3##(2007-7#2)(2010-6#1)
treated with photodynamic therapy##4##4##(2008-5#2)(2012-2#1)(2012-3#1)
treated with phrenic-musculocutaneous nerve transfer##3##5##(2008-9#3)
treated with placebo##4##3##(1990-6#1)(2007-9#1)(2008-1#1)(2008-2#1)
treated with platinum-based##2##3##(1990-6#1)(2010-8#1)
treated with potassium##3##3##(1996-5#1)(1996-6#1)(2008-10#1)
treated with potent topical##2##4##(2012-3#2)
treated with praziquantel##2##3##(1996-12#1)(2010-12#1)
treated with primary##3##3##(1992-6#1)(2008-3#2)
treated with radiation therapy##5##4##(2006-12#1)(2010-12#1)(2012-1#1)(2012-2#2)
treated with radiation##8##3##(1991-12#1)(2006-12#1)(2008-6#1)(2010-12#1)(2012-1#1)(2012-2#3)
treated with radical surgery##2##4##(1991-4#1)(2011-2#1)
treated with radical##8##3##(1991-4#1)(1993-8#1)(2004-1#1)(2007-11#2)(2011-2#3)
treated with radiosurgery##3##3##(2005-5#2)(2008-7#1)
treated with radiotherapy and##3##4##(1997-7#1)(2008-11#1)(2008-7#1)
treated with radiotherapy##10##3##(1991-5#1)(1993-9#1)(1997-7#1)(2006-1#1)(2006-12#1)(2008-11#2)(2008-7#1)(2012-1#1)(2013-1#1)
treated with recombinant##5##3##(1991-10#1)(1991-8#1)(2010-12#1)(2011-2#1)(2012-2#1)
treated with red##2##3##(2006-4#1)(2011-2#1)
treated with regular##2##3##(2008-12#1)(2013-8#1)
treated with repeated##3##3##(1991-5#1)(1996-10#1)(2012-2#1)
treated with resection##2##3##(2008-10#1)(2010-2#1)
treated with resveratrol##4##3##(2008-10#1)(2011-2#1)(2012-4#1)(2013-1#1)
treated with retinoic acid##2##4##(1990-8#1)(1992-9#1)
treated with retrograde##2##3##(2006-12#1)(2013-1#1)
treated with rt-PA##2##3##(2007-10#2)
treated with saline or##2##4##(1991-11#1)(2013-8#1)
treated with sclerotherapy and##2##4##(2013-1#2)
treated with segmental##2##3##(2007-8#1)(2009-3#1)
treated with several##2##3##(2006-5#1)(2008-8#1)
treated with simple##3##3##(1990-6#1)(1991-4#1)(2008-5#1)
treated with simvastatin##2##3##(1997-6#1)(2008-4#1)
treated with snake venom##4##4##(1992-3#1)(2008-5#3)
treated with sodium##9##3##(1990-7#1)(1991-11#1)(1992-1#1)(1992-3#1)(2005-8#1)(2007-3#1)(2008-10#1)(2010-8#1)(2012-2#1)
treated with solutions##2##3##(2005-11#1)(2008-5#1)
treated with spinal##2##3##(2007-11#1)(2012-12#1)
treated with standard##6##3##(1992-4#1)(1996-11#1)(2004-9#1)(2008-6#1)(2008-7#1)(2008-8#1)
treated with steroids and##2##4##(1991-8#1)(2013-8#1)
treated with steroids##4##3##(1991-8#1)(1992-5#1)(2009-3#1)(2013-8#1)
treated with sub-cutaneous insulin##2##4##(2008-8#2)
treated with such##2##3##(1991-6#1)(1992-4#1)
treated with surgery alone##4##4##(1991-8#1)(1995-5#1)(2012-3#2)
treated with surgery and##5##4##(2008-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
treated with surgery##17##3##(1991-8#1)(1992-10#1)(1995-5#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-8#1)
treated with surgical excision##6##4##(2008-10#1)(2008-2#1)(2010-5#1)(2012-1#2)(2012-3#1)
treated with surgical##11##3##(2008-10#1)(2008-2#1)(2010-5#1)(2011-2#1)(2012-1#3)(2012-3#1)(2013-1#2)(2013-8#1)
treated with systemic antibiotics alone##2##5##(1994-12#1)(2013-8#1)
treated with systemic chemotherapy##2##4##(2008-5#1)(2008-6#1)
treated with systemic##8##3##(1993-5#1)(1994-12#1)(2008-5#2)(2008-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
treated with tacrolimus##3##3##(2004-12#2)(2008-3#1)
treated with tamoxifen##6##3##(1993-12#1)(1993-6#1)(2004-1#3)(2007-11#1)
treated with teletherapy##2##3##(2011-2#2)
treated with thalidomide##2##3##(2007-10#2)
treated with the anti-angiogenic agents##2##5##(1995-5#2)
treated with the combination of##5##5##(1994-8#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-4#1)
treated with the combination##7##4##(1993-9#1)(1994-8#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-4#1)
treated with the drug##6##4##(1990-10#1)(1991-11#1)(1994-6#1)(2007-11#2)(2008-11#1)
treated with the inhibitor##2##4##(1993-3#1)(2010-10#1)
treated with the microtubule-disrupting agent##2##5##(1997-6#1)(2007-10#1)
treated with the standard##3##4##(2006-10#1)(2007-11#1)(2009-3#1)
treated with the##84##3##(1990-10#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-4#1)(1991-5#2)(1991-8#2)(1991-9#1)(1992-10#3)(1992-6#1)(1993-3#1)(1993-9#2)(1994-4#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#3)(1996-2#1)(1996-6#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#2)(2006-10#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#4)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#4)(2008-7#1)(2009-3#2)(2010-10#1)(2010-4#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-1#2)
treated with therapeutic##2##3##(2006-12#1)(2010-12#1)
treated with these agents##2##4##(2008-10#1)(2008-11#1)
treated with these drugs##2##4##(1994-5#1)(2008-11#1)
treated with these##8##3##(1992-3#1)(1994-5#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#2)
treated with this regimen##2##4##(2007-8#1)(2013-1#1)
treated with this##10##3##(1993-11#1)(1996-1#1)(2004-1#1)(2006-7#1)(2007-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2013-1#1)
treated with three different modalities##2##5##(2007-7#2)
treated with three different##5##4##(2007-7#2)(2008-5#1)(2010-5#1)(2013-1#1)
treated with three##7##3##(2004-12#1)(2007-7#2)(2008-5#1)(2010-5#1)(2012-2#1)(2013-1#1)
treated with thrombolytic therapy##3##4##(1994-5#1)(2007-9#1)(2008-3#1)
treated with tissue plasminogen activator##2##5##(1994-5#1)(2007-9#1)
treated with total##2##3##(1992-10#1)(2007-5#1)
treated with traditional##2##3##(2011-2#1)(2012-2#1)
treated with transarterial##5##3##(2008-7#1)(2013-8#4)
treated with tumor##2##3##(1993-7#1)(2011-2#1)
treated with tunicamycin##2##3##(1990-7#1)(1991-7#1)
treated with two##9##3##(1990-12#1)(1997-7#2)(2004-12#1)(2005-8#1)(2006-2#1)(2008-8#1)(2009-8#1)(2012-12#1)
treated with unilateral##2##3##(2007-8#1)(2011-2#1)
treated with vancomycin##4##3##(2007-12#2)(2007-7#1)(2011-2#1)
treated with various concentrations##2##4##(1992-8#1)(1996-12#1)
treated with various##8##3##(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#1)(1996-12#1)(1997-8#1)(2008-8#1)(2012-12#1)
treated with varying##2##3##(1994-11#1)(2008-11#1)
treated with vehicle##2##3##(2005-7#1)(2013-1#1)
treated with wedge filters##3##4##(2007-10#3)
treated with wide##5##3##(2008-5#2)(2008-6#1)(2009-5#1)(2013-7#1)
treated with##2130##2##(1990-10#8)(1990-11#11)(1990-12#15)(1990-2#12)(1990-3#7)(1990-4#7)(1990-5#9)(1990-6#12)(1990-7#6)(1990-8#7)(1990-9#8)(1991-1#2)(1991-10#7)(1991-11#10)(1991-12#5)(1991-2#10)(1991-3#9)(1991-4#7)(1991-5#15)(1991-6#6)(1991-7#9)(1991-8#14)(1991-9#10)(1992-1#7)(1992-10#15)(1992-11#5)(1992-12#8)(1992-2#10)(1992-3#13)(1992-4#7)(1992-5#7)(1992-6#9)(1992-7#3)(1992-8#13)(1992-9#9)(1993-1#4)(1993-10#1)(1993-11#6)(1993-12#3)(1993-2#13)(1993-3#9)(1993-4#2)(1993-5#3)(1993-6#7)(1993-7#5)(1993-8#4)(1993-9#9)(1994-1#1)(1994-10#7)(1994-11#6)(1994-12#8)(1994-2#11)(1994-3#10)(1994-4#1)(1994-5#8)(1994-6#10)(1994-8#9)(1994-9#3)(1995-1#3)(1995-10#5)(1995-11#10)(1995-12#4)(1995-2#9)(1995-3#13)(1995-4#3)(1995-5#8)(1995-6#3)(1995-7#4)(1995-8#11)(1995-9#3)(1996-1#9)(1996-10#6)(1996-11#9)(1996-12#13)(1996-2#6)(1996-3#2)(1996-4#2)(1996-5#6)(1996-6#7)(1996-7#1)(1996-8#9)(1996-9#5)(1997-1#6)(1997-2#7)(1997-3#10)(1997-4#7)(1997-5#4)(1997-6#12)(1997-7#6)(1997-8#14)(2004-1#8)(2004-10#2)(2004-12#7)(2004-2#1)(2004-3#3)(2004-9#6)(2005-1#3)(2005-10#13)(2005-11#9)(2005-12#3)(2005-5#3)(2005-6#1)(2005-7#6)(2005-8#5)(2006-1#2)(2006-10#43)(2006-11#2)(2006-12#14)(2006-2#7)(2006-4#16)(2006-5#7)(2006-6#23)(2006-7#6)(2006-8#12)(2006-9#3)(2007-1#1)(2007-10#26)(2007-11#43)(2007-12#13)(2007-2#9)(2007-3#4)(2007-4#5)(2007-5#3)(2007-6#6)(2007-7#63)(2007-8#52)(2007-9#14)(2008-1#24)(2008-10#130)(2008-11#39)(2008-12#12)(2008-2#10)(2008-3#30)(2008-4#19)(2008-5#67)(2008-6#45)(2008-7#55)(2008-8#39)(2008-9#26)(2009-1#1)(2009-10#3)(2009-11#3)(2009-12#1)(2009-2#6)(2009-3#11)(2009-4#6)(2009-5#6)(2009-6#3)(2009-7#3)(2009-8#12)(2009-9#2)(2010-1#1)(2010-10#6)(2010-11#3)(2010-12#26)(2010-2#4)(2010-3#7)(2010-4#7)(2010-5#9)(2010-6#9)(2010-7#9)(2010-8#10)(2010-9#1)(2011-1#22)(2011-12#4)(2011-2#87)(2012-1#11)(2012-10#1)(2012-12#37)(2012-2#46)(2012-3#17)(2012-4#2)(2013-1#89)(2013-7#15)(2013-8#41)
treated within the##3##3##(2006-10#1)(2007-12#1)(2008-3#1)
treated within##5##2##(2006-10#1)(2007-10#1)(2007-12#1)(2008-3#1)(2008-7#1)
treated without##5##2##(1992-9#1)(1993-10#1)(2007-8#1)(2011-2#1)(2012-2#1)
treated women##6##2##(1991-10#1)(1994-12#2)(1994-5#1)(2007-11#1)(2008-7#1)
treated##4499##1##(1990-10#23)(1990-11#21)(1990-12#26)(1990-2#20)(1990-3#15)(1990-4#14)(1990-5#17)(1990-6#22)(1990-7#9)(1990-8#12)(1990-9#24)(1991-1#2)(1991-10#11)(1991-11#16)(1991-12#13)(1991-2#25)(1991-3#18)(1991-4#22)(1991-5#25)(1991-6#21)(1991-7#13)(1991-8#26)(1991-9#21)(1992-1#12)(1992-10#20)(1992-11#10)(1992-12#11)(1992-2#18)(1992-3#22)(1992-4#10)(1992-5#25)(1992-6#15)(1992-7#3)(1992-8#25)(1992-9#27)(1993-1#7)(1993-10#13)(1993-11#10)(1993-12#11)(1993-2#23)(1993-3#15)(1993-4#8)(1993-5#12)(1993-6#16)(1993-7#8)(1993-8#10)(1993-9#22)(1994-1#2)(1994-10#9)(1994-11#12)(1994-12#19)(1994-2#22)(1994-3#14)(1994-4#5)(1994-5#14)(1994-6#20)(1994-7#3)(1994-8#19)(1994-9#6)(1995-1#5)(1995-10#7)(1995-11#17)(1995-12#7)(1995-2#17)(1995-3#19)(1995-4#6)(1995-5#13)(1995-6#5)(1995-7#7)(1995-8#17)(1995-9#7)(1996-1#14)(1996-10#14)(1996-11#20)(1996-12#19)(1996-2#7)(1996-3#12)(1996-4#5)(1996-5#9)(1996-6#17)(1996-7#3)(1996-8#13)(1996-9#11)(1997-1#15)(1997-2#16)(1997-3#18)(1997-4#22)(1997-5#8)(1997-6#20)(1997-7#9)(1997-8#22)(2004-1#14)(2004-10#2)(2004-11#1)(2004-12#7)(2004-2#2)(2004-3#3)(2004-9#7)(2005-1#4)(2005-10#20)(2005-11#23)(2005-12#6)(2005-5#5)(2005-6#4)(2005-7#14)(2005-8#9)(2005-9#8)(2006-1#5)(2006-10#92)(2006-11#13)(2006-12#34)(2006-2#20)(2006-3#3)(2006-4#28)(2006-5#23)(2006-6#52)(2006-7#16)(2006-8#34)(2006-9#11)(2007-1#8)(2007-10#43)(2007-11#129)(2007-12#25)(2007-2#26)(2007-3#13)(2007-4#9)(2007-5#4)(2007-6#12)(2007-7#123)(2007-8#157)(2007-9#29)(2008-1#47)(2008-10#254)(2008-11#69)(2008-12#38)(2008-2#37)(2008-3#71)(2008-4#48)(2008-5#123)(2008-6#98)(2008-7#130)(2008-8#68)(2008-9#62)(2009-1#6)(2009-10#9)(2009-11#8)(2009-12#2)(2009-2#13)(2009-3#24)(2009-4#16)(2009-5#18)(2009-6#11)(2009-7#8)(2009-8#17)(2009-9#8)(2010-1#5)(2010-10#11)(2010-11#8)(2010-12#50)(2010-2#17)(2010-3#19)(2010-4#14)(2010-5#17)(2010-6#18)(2010-7#15)(2010-8#14)(2010-9#7)(2011-1#52)(2011-10#1)(2011-11#1)(2011-12#8)(2011-2#185)(2011-3#1)(2011-7#1)(2012-1#24)(2012-10#1)(2012-11#6)(2012-12#79)(2012-2#109)(2012-3#41)(2012-4#2)(2012-7#1)(2013-1#163)(2013-7#21)(2013-8#70)
treated) and##2##2##(1992-8#1)(2006-9#1)
treated)##6##1##(1992-8#2)(2004-8#1)(2006-11#1)(2006-9#1)(2009-6#1)
treated-Pennisetum##3##1##(2008-10#3)
treated? What##2##2##(2007-5#1)(2011-12#1)
treated?##5##1##(2007-5#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-12#1)
treatedwith##2##1##(2008-11#2)
treatement of##3##2##(2007-11#1)(2007-8#1)(2013-1#1)
treatement##6##1##(2006-6#1)(2007-11#1)(2007-8#2)(2008-2#1)(2013-1#1)
treating ADHD##2##2##(2008-2#1)(2010-11#1)
treating HIV##3##2##(1995-6#1)(2007-12#1)(2008-6#1)
treating a patient with##3##4##(1996-12#1)(2008-1#1)(2012-12#1)
treating a patient##5##3##(1996-12#1)(2008-1#1)(2012-12#1)(2013-1#2)
treating a variety of diseases##2##5##(1992-9#1)(2011-2#1)
treating a variety of##5##4##(1992-9#1)(2007-5#1)(2008-1#1)(2011-2#1)(2013-1#1)
treating a##19##2##(1992-2#1)(1992-9#1)(1995-6#2)(1996-12#1)(2006-6#1)(2006-9#1)(2007-12#1)(2007-5#1)(2008-1#2)(2008-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#3)
treating acute ischemic stroke##2##4##(2007-10#1)(2012-12#1)
treating acute##8##2##(2006-10#3)(2007-10#1)(2007-4#1)(2012-1#1)(2012-12#1)(2013-1#1)
treating alcohol##2##2##(2008-2#2)
treating all##3##2##(2007-7#1)(2009-11#1)(2010-1#1)
treating an##2##2##(1993-9#1)(2009-3#1)
treating and preventing##6##3##(1997-4#1)(2006-10#1)(2006-12#1)(2009-10#1)(2012-3#1)(2013-1#1)
treating and##8##2##(1997-4#1)(2006-10#1)(2006-12#1)(2008-11#1)(2009-10#1)(2012-3#2)(2013-1#1)
treating atopic dermatitis##2##3##(2006-10#1)(2010-8#1)
treating bacterial infections##2##3##(2010-11#1)(2012-2#1)
treating both##3##2##(2008-8#1)(2009-8#1)(2012-11#1)
treating brain##2##2##(2007-10#1)(2013-8#1)
treating cancer##6##2##(2005-10#1)(2008-1#1)(2008-5#1)(2011-2#1)(2013-1#2)
treating cells with##3##3##(1991-6#1)(1997-8#1)(2008-4#1)
treating certain##2##2##(1996-7#1)(2011-1#1)
treating chronic hepatitis B##3##4##(2006-10#1)(2009-8#1)(2012-2#1)
treating chronic##8##2##(1991-2#1)(1995-2#1)(2005-10#1)(2006-10#1)(2006-8#1)(2009-10#1)(2009-8#1)(2012-2#1)
treating clinician##2##2##(2005-12#1)(2008-12#1)
treating concomitant##3##2##(2007-10#1)(2012-12#2)
treating conditions##4##2##(2005-8#1)(2006-12#1)(2007-8#1)(2009-4#1)
treating diabetes##2##2##(2007-5#1)(2008-3#1)
treating disease##4##2##(2005-7#1)(2008-11#1)(2010-11#1)(2013-1#1)
treating diseases##4##2##(2008-10#1)(2009-6#1)(2010-5#1)(2013-1#1)
treating each##2##2##(1994-3#1)(2011-1#1)
treating established##3##2##(1991-12#1)(1993-11#1)(1996-10#1)
treating hepatoma##2##2##(2012-12#2)
treating high##2##2##(1990-12#1)(2008-5#1)
treating hip##2##2##(2007-11#1)(2008-12#1)
treating hypertension in##2##3##(1992-6#1)(1994-12#1)
treating hypertension##5##2##(1992-6#1)(1994-12#1)(1996-2#1)(2008-11#1)(2009-9#1)
treating hypokalaemia##2##2##(2007-9#2)
treating in##2##2##(1994-6#1)(2007-11#1)
treating individuals##3##2##(1994-5#1)(2007-10#1)(2008-5#1)
treating infections##3##2##(2012-1#1)(2013-1#1)(2013-8#1)
treating inflammatory##2##2##(2005-6#1)(2007-7#1)
treating intracranial##2##2##(2006-10#1)(2007-1#1)
treating it##2##2##(2010-2#1)(2013-8#1)
treating large##2##2##(1990-10#1)(2010-8#1)
treating malaria##2##2##(2006-4#1)(2007-2#1)
treating many##3##2##(2012-11#2)(2013-1#1)
treating moderate to severe##2##4##(2005-11#1)(2006-9#1)
treating municipal##2##2##(2008-6#1)(2009-6#1)
treating neuropathic pain##3##3##(2006-12#3)
treating of##2##2##(2005-10#1)(2006-6#1)
treating oral##2##2##(2006-2#1)(2013-8#1)
treating osteoarthritis##2##2##(2006-10#1)(2007-11#1)
treating our##2##2##(2004-1#1)(2006-10#1)
treating pain associated with##2##4##(2006-7#1)(2009-5#1)
treating pain##4##2##(1991-2#1)(2006-10#1)(2006-7#1)(2009-5#1)
treating patients at##2##3##(2012-3#1)(2013-7#1)
treating patients who have##2##4##(2006-9#1)(2008-1#1)
treating patients who##4##3##(2005-7#1)(2006-9#1)(2008-1#1)(2009-6#1)
treating patients with advanced##3##4##(1991-8#1)(2005-10#1)(2008-5#1)
treating patients with chronic pain##3##5##(1992-9#1)(2006-8#1)(2011-2#1)
treating patients with##35##3##(1991-5#1)(1991-8#1)(1992-4#1)(1992-9#1)(1993-2#1)(1995-12#1)(1996-10#1)(2005-10#1)(2005-6#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#2)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#2)(2009-8#1)(2010-12#2)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
treating patients##48##2##(1991-5#1)(1991-8#1)(1992-4#1)(1992-9#1)(1993-2#1)(1995-12#1)(1996-10#1)(1996-12#1)(2005-10#1)(2005-6#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-8#3)(2006-9#2)(2007-10#2)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-6#1)(2009-8#1)(2010-12#2)(2010-3#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
treating physician##14##2##(1992-8#1)(1993-12#1)(1993-6#1)(1996-3#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-7#1)(2008-8#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-8#1)
treating physicians##6##2##(1991-2#1)(2007-9#1)(2009-7#1)(2010-11#1)(2010-12#1)(2013-8#1)
treating primary##2##2##(1991-2#2)
treating prostate cancer##3##3##(2006-10#1)(2008-4#1)(2008-7#1)
treating prostate##4##2##(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#1)
treating severe##6##2##(1991-3#1)(2008-5#1)(2009-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
treating skin diseases will##2##4##(2007-8#2)
treating skin##4##2##(2007-8#2)(2012-3#1)(2013-1#1)
treating some of the##2##4##(1993-6#1)(2006-2#1)
treating some##4##2##(1993-6#1)(2006-2#1)(2007-11#1)(2009-6#1)
treating specific##2##2##(2005-7#1)(2013-1#1)
treating such cases##3##3##(2013-1#1)(2013-7#2)
treating the patient##2##3##(1993-8#1)(2008-1#1)
treating the symptoms##4##3##(1994-1#1)(2008-7#1)(2011-1#1)(2011-2#1)
treating the underlying##3##3##(1991-12#1)(2008-3#1)(2009-9#1)
treating the##49##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-8#1)(1991-12#1)(1991-8#1)(1992-5#1)(1993-4#1)(1993-5#1)(1993-8#1)(1994-1#1)(2005-11#1)(2006-12#3)(2006-4#2)(2006-5#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#3)(2009-9#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#3)
treating their##2##2##(2006-4#1)(2007-12#1)
treating them as##2##3##(2008-12#1)(2008-7#1)
treating them##7##2##(1994-11#1)(2006-4#1)(2007-10#1)(2008-12#1)(2008-7#1)(2009-2#1)(2012-12#1)
treating these patients##2##3##(2007-6#1)(2008-12#1)
treating these##10##2##(1991-9#1)(2006-12#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2013-1#2)
treating this##5##2##(1991-3#1)(1993-9#1)(2005-12#1)(2008-7#1)(2011-2#1)
treating uncomplicated##4##2##(2007-2#1)(2008-11#1)(2010-12#1)(2012-1#1)
treating women with##2##3##(2011-12#1)(2011-2#1)
treating women##3##2##(2008-6#1)(2011-12#1)(2011-2#1)
treating##664##1##(1990-10#2)(1990-11#1)(1990-12#2)(1990-4#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#5)(1991-3#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-2#4)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#3)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#3)(1993-8#2)(1993-9#2)(1994-1#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#3)(1995-8#2)(1996-1#2)(1996-10#3)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-1#2)(2004-11#1)(2004-3#2)(2005-10#6)(2005-11#3)(2005-12#2)(2005-6#3)(2005-7#8)(2005-8#4)(2005-9#1)(2006-1#2)(2006-10#26)(2006-11#1)(2006-12#12)(2006-2#4)(2006-3#1)(2006-4#6)(2006-5#7)(2006-6#5)(2006-7#1)(2006-8#9)(2006-9#6)(2007-1#2)(2007-10#10)(2007-11#20)(2007-12#11)(2007-2#2)(2007-3#2)(2007-4#5)(2007-5#4)(2007-6#2)(2007-7#8)(2007-8#23)(2007-9#5)(2008-1#12)(2008-10#19)(2008-11#11)(2008-12#10)(2008-2#9)(2008-3#14)(2008-4#7)(2008-5#16)(2008-6#6)(2008-7#12)(2008-8#13)(2008-9#6)(2009-10#4)(2009-11#4)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#5)(2009-5#3)(2009-6#6)(2009-7#4)(2009-8#5)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#6)(2010-12#12)(2010-2#4)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#5)(2011-1#10)(2011-12#2)(2011-2#24)(2012-1#3)(2012-11#6)(2012-12#15)(2012-2#10)(2012-3#11)(2013-1#40)(2013-7#4)(2013-8#9)
treatise of##3##2##(2006-12#1)(2007-5#1)(2010-6#1)
treatise on elephants##2##3##(2008-1#2)
treatise on##3##2##(2008-1#2)(2012-2#1)
treatise##11##1##(1995-4#1)(2006-12#1)(2007-5#5)(2008-1#2)(2010-6#1)(2012-2#1)
treatment (0##4##2##(2004-11#1)(2007-2#1)(2011-2#1)(2012-12#1)
treatment (1##3##2##(1995-6#1)(2006-2#1)(2008-1#1)
treatment (10##4##2##(1996-2#1)(2008-11#1)(2008-3#1)(2012-3#1)
treatment (18##3##2##(2007-8#1)(2011-1#2)
treatment (20##3##2##(1993-10#1)(1996-2#1)(2006-2#1)
treatment (200##2##2##(1990-8#1)(1994-9#1)
treatment (30 mg/kg##2##3##(1993-3#1)(1996-12#1)
treatment (40##2##2##(1991-4#1)(2013-1#1)
treatment (5##2##2##(1997-4#1)(2008-7#1)
treatment (50##3##2##(1994-2#1)(1994-8#1)(1997-2#1)
treatment (8 x##2##3##(1997-7#2)
treatment (8##3##2##(1997-7#2)(2006-2#1)
treatment (P &lt##3##3##(1994-10#1)(2011-2#1)(2011-3#1)
treatment (P = 0##4##4##(2008-6#1)(2012-3#1)(2013-1#2)
treatment (P =##5##3##(2007-10#1)(2008-6#1)(2012-3#1)(2013-1#2)
treatment (P##8##2##(1994-10#1)(2007-10#1)(2008-6#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#2)
treatment (Phase##2##2##(2011-2#2)
treatment (RT)##2##2##(2007-6#1)(2012-11#1)
treatment (a##2##2##(1995-12#1)(2008-8#1)
treatment (a)##2##2##(2008-6#2)
treatment (from##2##2##(2008-12#1)(2012-3#1)
treatment (i##3##2##(1992-10#1)(1993-3#1)(2008-10#1)
treatment (including##3##2##(2008-6#1)(2008-9#1)(2013-8#1)
treatment (mean##2##2##(2008-7#1)(2012-2#1)
treatment (n =##3##3##(1993-1#1)(1995-12#1)(2009-3#1)
treatment (no##2##2##(2008-10#1)(2009-8#1)
treatment (p &lt##3##3##(2009-12#1)(2012-2#2)
treatment (p = 0##3##4##(1992-5#1)(2007-11#2)
treatment (p##8##2##(1991-8#1)(1992-5#1)(2007-11#2)(2009-12#1)(2012-2#2)(2013-8#1)
treatment (surgery##3##2##(1991-10#1)(1993-10#1)(1995-8#1)
treatment (total##2##2##(1996-12#1)(2007-11#1)
treatment - a##2##3##(2010-5#1)(2011-2#1)
treatment -##6##2##(2007-11#1)(2007-8#1)(2008-6#1)(2010-5#1)(2011-2#1)(2012-3#1)
treatment 1##4##2##(1990-11#1)(1994-11#1)(2008-7#2)
treatment 5##2##2##(1990-10#1)(1994-10#1)
treatment A##2##2##(1996-6#1)(2011-2#1)
treatment a significant##2##3##(1990-11#1)(2007-8#1)
treatment a##5##2##(1990-11#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-8#1)
treatment acceptability##3##2##(2011-2#2)(2013-1#1)
treatment according to the##3##4##(2004-12#1)(2007-7#1)(2008-9#1)
treatment according to##8##3##(2004-12#1)(2005-1#1)(2007-11#1)(2007-7#1)(2008-12#1)(2008-9#1)(2011-1#2)
treatment achieves a##2##3##(2010-12#1)(2012-12#1)
treatment adequacy of major depressive episodes in France]##2##8##(2010-6#2)
treatment adherence in##3##3##(2006-1#1)(2008-7#1)(2011-1#1)
treatment adherence##18##2##(2006-1#4)(2006-5#1)(2008-11#1)(2008-7#1)(2009-9#1)(2010-11#5)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
treatment administered##2##2##(2008-10#1)(2012-2#1)
treatment administration##3##2##(1996-6#1)(2006-6#1)(2008-7#1)
treatment advances##4##2##(2004-1#1)(2006-11#1)(2006-9#1)(2013-1#1)
treatment affected the##2##3##(1993-7#1)(2008-10#1)
treatment affected##5##2##(1993-7#1)(1996-1#1)(1996-10#1)(2008-10#1)(2010-4#1)
treatment after 3##2##3##(2008-12#1)(2008-5#1)
treatment after##22##2##(1993-8#1)(1994-2#1)(1996-1#1)(1997-8#3)(2007-12#2)(2007-2#1)(2007-8#1)(2008-12#1)(2008-5#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-9#2)(2010-12#2)(2011-2#2)
treatment against##8##2##(1991-2#1)(1995-9#1)(2007-2#1)(2008-4#3)(2010-12#1)(2010-4#1)
treatment agents for##2##3##(1991-1#1)(2013-1#1)
treatment aimed at##4##3##(2004-1#1)(2009-12#1)(2010-1#1)(2010-9#1)
treatment algorithm and##2##3##(2008-8#1)(2012-2#1)
treatment algorithm is##2##3##(2006-10#1)(2007-9#1)
treatment algorithm##13##2##(1996-12#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-3#2)(2008-8#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
treatment algorithms for##2##3##(2009-11#1)(2009-5#1)
treatment algorithms##5##2##(1997-2#1)(2009-11#2)(2009-5#1)(2010-12#1)
treatment all##3##2##(1991-5#1)(2009-6#1)(2010-10#1)
treatment alliance##2##2##(1993-1#1)(2007-12#1)
treatment allowed##2##2##(2007-11#1)(2007-8#1)
treatment alone at##2##3##(2005-12#1)(2008-11#1)
treatment alone did not##2##4##(1991-7#1)(1996-12#1)
treatment alone in##3##3##(2008-10#1)(2008-5#1)(2010-12#1)
treatment alone is##2##3##(1992-6#1)(2008-5#1)
treatment alone or##2##3##(2004-1#1)(2008-10#1)
treatment alone##29##2##(1991-3#1)(1991-7#2)(1992-6#1)(1993-12#1)(1995-9#1)(1996-12#1)(2004-1#1)(2005-12#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-5#3)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
treatment along with##3##3##(2007-8#1)(2008-10#1)(2011-1#1)
treatment also caused##2##3##(1995-2#1)(1995-3#1)
treatment also induced a##2##4##(1992-11#1)(2008-7#1)
treatment also induced##3##3##(1992-11#1)(2008-10#1)(2008-7#1)
treatment also resulted in##3##4##(1994-3#1)(1995-10#1)(2008-10#1)
treatment also showed##2##3##(2009-12#1)(2013-1#1)
treatment also##27##2##(1990-11#1)(1992-11#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-5#1)(1996-8#1)(1997-5#1)(1997-7#1)(2006-9#1)(2007-11#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-8#1)(2011-2#1)(2013-1#1)
treatment altered the##2##3##(1990-2#1)(1991-2#1)
treatment alternative to punishment##2##4##(2012-2#2)
treatment alternative##4##2##(2007-7#1)(2011-2#1)(2012-2#2)
treatment alternatives for the##2##4##(2006-11#1)(2011-2#1)
treatment alternatives to##2##3##(1994-2#1)(2009-3#1)
treatment alternatives##7##2##(1994-2#1)(2006-11#1)(2007-7#1)(2008-5#1)(2009-3#1)(2009-6#1)(2011-2#1)
treatment alters the##3##3##(2007-11#1)(2010-12#2)
treatment although##2##2##(2006-8#1)(2007-8#1)
treatment among##12##2##(1993-2#1)(1996-12#1)(2007-6#1)(2008-3#1)(2009-12#1)(2009-9#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#1)
treatment and 1##2##3##(2008-10#1)(2011-2#1)
treatment and 2##3##3##(1991-6#1)(2007-8#1)(2013-1#1)
treatment and a##6##3##(2006-10#1)(2007-2#1)(2008-10#1)(2008-2#1)(2009-5#1)(2011-2#1)
treatment and after##8##3##(1992-5#1)(1995-11#1)(1997-4#1)(2008-10#1)(2008-7#2)(2013-8#2)
treatment and an##2##3##(1994-5#1)(2011-1#1)
treatment and are##2##3##(2007-7#1)(2010-11#1)
treatment and as##3##3##(2005-7#1)(2011-1#1)(2011-2#1)
treatment and at##5##3##(1991-3#1)(1995-9#1)(2008-7#1)(2009-9#1)(2013-8#1)
treatment and bone##2##3##(2006-10#2)
treatment and care among hard-to-reach##2##5##(2010-12#2)
treatment and care of##4##4##(1990-5#2)(1991-11#1)(2010-12#1)
treatment and care##13##3##(1990-5#3)(1991-11#1)(2007-12#2)(2009-7#2)(2010-12#3)(2010-5#1)(2013-1#1)
treatment and clinical##2##3##(2007-2#1)(2010-7#1)
treatment and compared##2##3##(2010-4#1)(2012-1#1)
treatment and control group##2##4##(2008-9#1)(2010-3#1)
treatment and control groups##3##4##(2008-10#1)(2011-2#1)(2012-3#1)
treatment and control of##3##4##(2007-2#1)(2007-8#1)(2008-1#1)
treatment and control##9##3##(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-3#1)
treatment and criminal justice##2##4##(2008-6#1)(2009-9#1)
treatment and disposal##2##3##(1997-4#1)(2008-10#1)
treatment and emerging##2##3##(2008-5#1)(2013-8#1)
treatment and evaluation of##2##4##(2007-6#1)(2012-1#1)
treatment and evaluation##3##3##(2007-6#1)(2012-1#2)
treatment and eventually##2##3##(1991-5#1)(1992-10#1)
treatment and follow-up of##2##4##(2011-1#1)(2011-2#1)
treatment and follow-up##9##3##(1992-3#1)(2007-10#1)(2008-7#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-12#1)
treatment and following##2##3##(1996-9#1)(2011-2#1)
treatment and for##2##3##(2007-4#1)(2008-12#1)
treatment and had##2##3##(2007-8#1)(2012-12#1)
treatment and in##5##3##(1992-12#1)(2008-1#1)(2008-10#1)(2009-2#1)(2009-8#1)
treatment and intervention##2##3##(2012-2#2)
treatment and ion##2##3##(2008-1#1)(2008-10#1)
treatment and is##4##3##(1995-4#1)(2008-2#2)(2012-2#1)
treatment and its##5##3##(1992-12#1)(2008-10#1)(2012-1#1)(2013-1#1)(2013-8#1)
treatment and laboratory##2##3##(2006-4#1)(2011-2#1)
treatment and long term##2##4##(2007-11#1)(2013-1#1)
treatment and long##3##3##(1992-8#1)(2007-11#1)(2013-1#1)
treatment and management of the##2##5##(2007-5#1)(2011-1#1)
treatment and management of##6##4##(2007-2#1)(2007-5#1)(2008-4#1)(2009-10#1)(2011-1#1)(2013-8#1)
treatment and management##7##3##(2007-2#1)(2007-5#1)(2008-4#1)(2009-10#1)(2011-1#1)(2012-2#1)(2013-8#1)
treatment and may##2##3##(2006-7#1)(2008-7#1)
treatment and monitoring of##3##4##(2007-12#1)(2013-1#2)
treatment and monitoring##4##3##(2007-12#1)(2010-2#1)(2013-1#2)
treatment and nontreatment##2##3##(1993-11#1)(2006-9#1)
treatment and number of##2##4##(2007-4#1)(2010-2#1)
treatment and on days 1##2##5##(2004-10#1)(2008-4#1)
treatment and outcome in##2##4##(2007-2#1)(2010-8#1)
treatment and outcome of##4##4##(2006-2#1)(2008-6#1)(2008-7#1)(2013-7#1)
treatment and outcome##14##3##(1993-3#1)(2006-10#1)(2006-2#1)(2007-2#1)(2007-3#1)(2008-6#2)(2008-7#2)(2009-4#1)(2010-3#1)(2010-8#1)(2012-2#1)(2013-7#1)
treatment and outcomes##4##3##(2008-11#1)(2008-3#1)(2011-1#2)
treatment and patients##2##3##(2006-10#1)(2011-2#1)
treatment and pharmacotherapy##2##3##(1991-2#1)(2013-1#1)
treatment and planning##2##3##(2006-2#1)(2012-12#1)
treatment and possible##3##3##(1993-8#1)(2006-3#1)(2007-1#1)
treatment and prevention are discussed##2##5##(2008-10#1)(2011-1#1)
treatment and prevention are##4##4##(2007-1#1)(2007-11#1)(2008-10#1)(2011-1#1)
treatment and prevention of depression##2##5##(2008-12#1)(2011-2#1)
treatment and prevention of influenza virus infections##2##7##(2006-10#1)(2008-5#1)
treatment and prevention of##32##4##(1993-10#1)(1993-2#1)(2005-7#1)(2005-8#1)(2006-10#4)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-12#2)(2012-2#1)
treatment and prevention##51##3##(1993-10#1)(1993-2#2)(1996-3#1)(1997-3#1)(2005-7#1)(2005-8#1)(2006-10#5)(2006-2#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#3)
treatment and prognosis of patients##2##5##(2006-8#1)(2010-11#1)
treatment and prognosis of this##2##5##(2006-7#1)(2011-2#1)
treatment and prognosis of##8##4##(1993-3#1)(1995-9#1)(2006-10#1)(2006-7#1)(2006-8#1)(2010-11#1)(2010-8#1)(2011-2#1)
treatment and prognosis##20##3##(1991-8#1)(1993-3#1)(1995-9#1)(2006-10#1)(2006-7#1)(2006-8#2)(2007-12#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#3)(2013-1#1)
treatment and prophylaxis of##4##4##(2006-6#1)(2008-5#2)(2010-6#1)
treatment and prophylaxis##7##3##(1994-6#1)(1995-7#1)(2006-6#1)(2008-5#2)(2010-6#2)
treatment and proved##2##3##(1992-8#1)(2008-10#1)
treatment and quality of life##2##5##(2006-7#1)(2006-8#1)
treatment and quality##3##3##(2006-7#1)(2006-8#1)(2008-10#1)
treatment and recovery##2##3##(1991-1#1)(2009-9#1)
treatment and reduces##2##3##(2007-8#1)(2008-11#1)
treatment and rehabilitation##6##3##(1995-5#1)(2007-11#3)(2007-7#1)(2012-12#1)
treatment and reports##2##3##(2007-7#1)(2008-5#1)
treatment and research##3##3##(2008-6#1)(2010-11#1)(2012-3#1)
treatment and result##2##3##(2006-1#1)(2010-10#1)
treatment and some##3##3##(1991-4#1)(1991-6#1)(2007-8#1)
treatment and subsequently##2##3##(2008-4#2)
treatment and support services##2##4##(2006-1#1)(2009-5#1)
treatment and support##3##3##(1997-3#1)(2006-1#1)(2009-5#1)
treatment and supportive##2##3##(2008-7#1)(2012-3#1)
treatment and surgical##3##3##(2010-3#1)(2011-2#1)(2012-2#1)
treatment and survival##3##3##(1994-6#1)(1996-12#1)(2007-8#1)
treatment and that the##2##4##(2004-11#1)(2006-12#1)
treatment and that##4##3##(1992-7#1)(2004-11#1)(2006-12#1)(2007-6#1)
treatment and the other##2##4##(1996-12#1)(2006-2#1)
treatment and the results##2##4##(2008-10#1)(2011-2#1)
treatment and the use of##2##5##(1993-5#1)(2008-9#1)
treatment and the##49##3##(1990-10#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#2)(1991-2#1)(1991-6#1)(1992-6#1)(1993-5#1)(1996-11#1)(1996-12#1)(1997-3#2)(2005-3#1)(2006-2#1)(2006-6#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-5#1)(2008-9#2)(2009-4#1)(2009-8#2)(2010-3#1)(2010-4#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#3)(2013-7#2)
treatment and their##2##3##(1990-3#1)(2013-1#1)
treatment and then##2##3##(2005-6#1)(2008-5#1)
treatment and therapy##2##3##(2010-5#1)(2012-12#1)
treatment and this##2##3##(1992-12#1)(2006-9#1)
treatment and to##10##3##(1996-8#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-5#1)(2007-8#2)(2008-5#1)(2013-8#1)
treatment and was##4##3##(1993-10#1)(2008-10#2)(2012-1#1)
treatment and were##6##3##(1996-1#1)(2006-5#1)(2008-10#2)(2008-5#1)(2012-2#1)
treatment and withdrawal##2##3##(1996-12#1)(2008-10#1)
treatment and##624##2##(1990-10#1)(1990-12#2)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#6)(1991-1#2)(1991-10#2)(1991-11#4)(1991-12#1)(1991-2#5)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#4)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#4)(1992-2#3)(1992-3#2)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#4)(1992-9#1)(1993-10#2)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#2)(1993-5#1)(1993-7#3)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#4)(1994-7#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-4#1)(1995-5#2)(1995-7#1)(1995-9#3)(1996-1#4)(1996-10#1)(1996-11#4)(1996-12#4)(1996-2#1)(1996-3#2)(1996-4#1)(1996-8#4)(1996-9#1)(1997-3#6)(1997-4#4)(1997-6#1)(2004-10#1)(2004-11#1)(2004-4#3)(2004-9#1)(2005-1#1)(2005-12#1)(2005-3#1)(2005-4#1)(2005-6#1)(2005-7#3)(2005-8#2)(2006-1#2)(2006-10#21)(2006-12#3)(2006-2#5)(2006-3#1)(2006-4#1)(2006-5#4)(2006-6#5)(2006-7#4)(2006-8#5)(2006-9#2)(2007-1#3)(2007-10#3)(2007-11#18)(2007-12#8)(2007-2#8)(2007-3#2)(2007-4#4)(2007-5#2)(2007-6#4)(2007-7#7)(2007-8#19)(2007-9#1)(2008-1#9)(2008-10#37)(2008-11#9)(2008-12#7)(2008-2#7)(2008-3#7)(2008-4#12)(2008-5#20)(2008-6#9)(2008-7#14)(2008-8#4)(2008-9#10)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#4)(2009-6#3)(2009-7#2)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#10)(2010-2#2)(2010-3#4)(2010-4#4)(2010-5#4)(2010-6#7)(2010-7#2)(2010-8#2)(2011-1#12)(2011-12#2)(2011-2#32)(2011-3#1)(2012-1#8)(2012-11#2)(2012-12#11)(2012-2#16)(2012-3#4)(2013-1#26)(2013-7#3)(2013-8#14)
treatment and/or##2##2##(2008-10#1)(2008-4#1)
treatment appeared to be##2##4##(1990-2#1)(2008-10#1)
treatment appeared to##3##3##(1990-2#1)(2008-10#1)(2008-5#1)
treatment appeared##5##2##(1990-2#1)(1994-5#1)(2008-10#1)(2008-5#1)(2011-2#1)
treatment appears to##5##3##(1994-6#1)(2006-10#1)(2007-4#1)(2007-9#1)(2008-4#1)
treatment appears##6##2##(1994-4#1)(1994-6#1)(2006-10#1)(2007-4#1)(2007-9#1)(2008-4#1)
treatment application##2##2##(2008-10#1)(2011-2#1)
treatment applied to##3##3##(2007-5#1)(2010-4#1)(2012-12#1)
treatment applied##7##2##(1993-1#1)(2007-11#1)(2007-5#1)(2007-7#2)(2010-4#1)(2012-12#1)
treatment approach in##2##3##(2007-2#1)(2012-3#1)
treatment approach is##3##3##(2009-6#1)(2012-12#1)(2013-8#1)
treatment approach that##2##3##(2008-12#1)(2013-8#1)
treatment approach to##3##3##(2008-7#2)(2013-8#1)
treatment approach##30##2##(1990-10#1)(1992-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#3)(2009-6#2)(2010-1#2)(2010-12#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#3)
treatment approaches and##3##3##(1996-4#1)(2012-2#1)(2013-1#1)
treatment approaches are##2##3##(2008-11#1)(2008-5#1)
treatment approaches for##2##3##(1997-1#1)(2005-7#1)
treatment approaches has##2##3##(2005-7#1)(2010-3#1)
treatment approaches have##3##3##(2006-10#1)(2006-12#1)(2012-2#1)
treatment approaches in##2##3##(2005-6#1)(2005-7#1)
treatment approaches##37##2##(1996-4#1)(1996-9#1)(1997-1#2)(2005-10#1)(2005-6#1)(2005-7#4)(2006-10#3)(2006-12#1)(2006-2#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-12#2)(2010-3#3)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
treatment are also##4##3##(1993-9#1)(2007-11#2)(2008-6#1)
treatment are critical##3##3##(2007-12#1)(2007-2#1)(2011-2#1)
treatment are described##7##3##(1993-6#1)(1996-8#1)(2007-12#1)(2008-2#1)(2012-1#1)(2013-1#2)
treatment are discussed##14##3##(1993-9#1)(1994-9#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2007-2#1)(2007-8#3)(2008-11#1)(2008-2#1)(2013-1#1)
treatment are essential for##2##4##(2007-7#1)(2008-8#1)
treatment are essential##5##3##(1992-8#1)(1996-2#1)(2007-7#1)(2008-8#1)(2013-8#1)
treatment are important##6##3##(1993-9#1)(2007-2#1)(2007-3#1)(2007-8#1)(2010-9#1)(2013-1#1)
treatment are necessary##2##3##(2009-6#1)(2012-1#1)
treatment are presented##2##3##(2011-1#1)(2011-2#1)
treatment are reported##2##3##(2007-7#1)(2013-8#1)
treatment are reviewed##4##3##(1990-9#2)(1995-7#1)(2011-2#1)
treatment are the##3##3##(1992-4#1)(1997-4#1)(2008-9#1)
treatment are##113##2##(1990-12#2)(1990-9#2)(1991-1#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-9#3)(1994-9#1)(1995-11#1)(1995-7#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-4#2)(1997-5#1)(2004-12#1)(2005-6#1)(2005-7#1)(2005-9#2)(2006-1#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2007-11#5)(2007-12#3)(2007-2#3)(2007-3#1)(2007-4#2)(2007-7#3)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-12#1)(2009-2#1)(2009-6#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
treatment arm##6##2##(2007-8#1)(2008-5#1)(2009-10#1)(2010-12#3)
treatment arms##3##2##(2004-1#1)(2005-11#1)(2008-6#1)
treatment as a means##2##4##(2005-12#1)(2008-3#1)
treatment as a##7##3##(1992-2#1)(1995-1#1)(2005-12#1)(2007-11#1)(2008-3#2)(2012-2#1)
treatment as an##4##3##(1997-8#1)(2007-12#1)(2012-12#1)(2012-2#1)
treatment as it##2##3##(2010-5#1)(2012-3#1)
treatment as recommended by the##2##5##(1990-6#1)(2011-2#1)
treatment as well as in##2##5##(1990-3#1)(1996-2#1)
treatment as well as##10##4##(1990-3#1)(1996-2#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-2#1)(2013-1#2)(2013-7#1)
treatment as well##11##3##(1990-3#1)(1996-2#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#1)(2013-1#2)(2013-7#1)
treatment as##49##2##(1990-3#1)(1990-4#2)(1990-6#1)(1990-9#1)(1991-11#1)(1992-12#1)(1992-2#1)(1995-1#1)(1996-2#1)(1997-8#1)(2004-12#1)(2004-3#1)(2005-12#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#2)(2008-9#2)(2009-2#1)(2010-5#1)(2011-2#2)(2011-7#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#2)(2013-8#1)
treatment assignment##2##2##(1997-3#1)(2008-7#1)
treatment associated##3##2##(2007-8#2)(2010-11#1)
treatment at 4##2##3##(1994-12#1)(2007-8#1)
treatment at 50##2##3##(1991-12#1)(1993-11#1)
treatment at a##10##3##(1990-3#1)(1991-5#1)(1995-12#1)(1995-5#2)(2008-8#1)(2009-9#1)(2011-1#1)(2012-1#1)(2012-12#1)
treatment at all##3##3##(2006-10#1)(2007-8#1)(2013-1#1)
treatment at different##2##3##(2008-8#2)
treatment at the first##2##4##(2007-7#1)(2007-9#1)
treatment at the same##2##4##(2008-7#1)(2008-8#1)
treatment at the time of##2##5##(2007-11#1)(2007-5#1)
treatment at the##18##3##(1990-8#1)(1996-2#1)(2006-2#1)(2007-11#2)(2007-5#1)(2007-7#1)(2007-9#2)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
treatment at##82##2##(1990-3#1)(1990-8#1)(1991-12#2)(1991-5#1)(1991-7#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-5#2)(1996-2#1)(1997-7#1)(2005-11#2)(2005-12#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-10#6)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#5)(2009-8#1)(2009-9#1)(2010-4#3)(2011-1#4)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
treatment attendance##3##2##(2008-7#3)
treatment attenuated the##2##3##(1995-12#1)(1997-5#1)
treatment barriers##2##2##(1996-3#1)(2009-11#1)
treatment based on the##2##4##(2007-12#1)(2007-8#1)
treatment based on##13##3##(1995-2#1)(1996-2#1)(1997-3#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-12#1)(2012-3#1)(2013-7#1)
treatment based##14##2##(1995-2#1)(1996-2#1)(1997-3#1)(2006-2#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-12#1)(2012-3#1)(2013-7#1)
treatment be##2##2##(1990-11#1)(1991-2#1)
treatment because of the##6##4##(1990-10#1)(1994-6#1)(2005-8#1)(2008-11#1)(2011-1#1)(2012-1#1)
treatment because of##9##3##(1990-10#1)(1994-6#1)(1994-9#1)(2005-8#1)(2008-11#1)(2008-3#1)(2011-1#1)(2011-12#1)(2012-1#1)
treatment because##12##2##(1990-1#1)(1990-10#1)(1994-6#2)(1994-9#1)(2005-8#1)(2006-10#1)(2008-11#1)(2008-3#1)(2011-1#1)(2011-12#1)(2012-1#1)
treatment before##8##2##(1991-9#1)(1995-5#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-7#1)(2013-1#2)
treatment began##4##2##(1990-10#1)(1992-8#1)(2007-7#1)(2008-5#1)
treatment begins##2##2##(1990-2#1)(2012-3#1)
treatment being##5##2##(2007-11#1)(2007-4#1)(2007-8#1)(2008-5#1)(2009-6#1)
treatment benefit##5##2##(2006-7#1)(2008-6#1)(2009-8#1)(2010-12#2)
treatment benefits##6##2##(1993-5#1)(1997-6#1)(2009-2#1)(2010-12#1)(2013-7#2)
treatment between the##2##3##(1996-9#1)(2008-5#1)
treatment between##4##2##(1996-9#1)(2006-9#1)(2008-11#1)(2008-5#1)
treatment blocked##2##2##(1992-12#1)(1994-2#1)
treatment both in##2##3##(2008-5#1)(2012-1#1)
treatment both##3##2##(2008-5#1)(2010-2#1)(2012-1#1)
treatment but not significantly (P = 0##2##7##(1996-9#1)(2007-8#1)
treatment but the##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
treatment but##19##2##(1996-4#1)(1996-9#1)(1997-8#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
treatment by an##2##3##(1990-7#1)(1996-5#1)
treatment by electrical stimulation of the auditory cortex##2##8##(2010-7#2)
treatment by reducing the##2##4##(2007-11#1)(2008-7#1)
treatment by reducing##3##3##(2007-11#1)(2008-7#1)(2013-8#1)
treatment by the##5##3##(1993-3#1)(2007-7#1)(2007-8#1)(2008-4#1)(2012-2#1)
treatment by##78##2##(1990-4#2)(1990-5#1)(1990-7#1)(1991-2#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-10#1)(1993-3#1)(1994-5#1)(1995-11#1)(1995-3#2)(1995-6#1)(1996-2#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-6#1)(2004-1#1)(2005-1#1)(2005-6#1)(2005-7#2)(2006-10#2)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#4)(2007-7#1)(2007-8#3)(2007-9#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-12#4)(2010-7#3)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#1)
treatment can be considered##2##4##(1997-5#1)(2012-2#1)
treatment can be used to##2##5##(1997-6#1)(2008-4#1)
treatment can be used##3##4##(1997-6#1)(2008-4#1)(2013-8#1)
treatment can be##26##3##(1990-10#1)(1990-6#1)(1993-6#1)(1996-11#1)(1996-3#1)(1997-3#1)(1997-5#1)(1997-6#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-4#2)(2008-5#3)(2009-11#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
treatment can decrease##2##3##(2006-10#1)(2006-2#1)
treatment can only be##2##4##(1995-5#1)(2007-11#1)
treatment can reduce##3##3##(2010-12#1)(2013-1#2)
treatment can##61##2##(1990-10#1)(1990-6#2)(1993-6#1)(1995-5#1)(1995-6#1)(1996-11#2)(1996-12#1)(1996-3#1)(1997-3#1)(1997-5#1)(1997-6#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-4#2)(2008-5#4)(2008-8#1)(2009-11#1)(2009-2#1)(2010-10#2)(2010-12#4)(2010-5#1)(2010-6#1)(2010-8#1)(2011-11#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#2)
treatment cannot be offered##2##4##(2006-8#1)(2010-12#1)
treatment cannot be##6##3##(1991-11#1)(2006-10#1)(2006-8#1)(2010-12#1)(2012-12#1)(2012-3#1)
treatment cannot##10##2##(1991-11#1)(1993-2#1)(2006-10#1)(2006-8#1)(2007-7#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
treatment capacity##2##2##(1991-11#2)
treatment carries##2##2##(2011-2#1)(2013-1#1)
treatment caused a##3##3##(1997-7#1)(2008-10#1)(2013-7#1)
treatment caused significant##2##3##(1993-12#1)(2008-10#1)
treatment caused##14##2##(1990-2#1)(1993-12#1)(1994-5#1)(1996-12#1)(1997-7#1)(2004-11#1)(2005-12#1)(2007-11#1)(2008-10#3)(2008-12#1)(2010-1#1)(2013-7#1)
treatment causes##2##2##(1992-6#1)(1995-12#1)
treatment center##3##2##(1991-8#1)(2007-9#1)(2008-8#1)
treatment centers##5##2##(1997-5#1)(2008-7#1)(2010-11#1)(2013-1#1)(2013-8#1)
treatment centre in##2##3##(1991-8#1)(2007-6#1)
treatment centre##4##2##(1991-8#1)(2005-8#1)(2006-6#1)(2007-6#1)
treatment centres##7##2##(1990-5#1)(1996-11#1)(2005-9#1)(2007-7#1)(2008-11#1)(2008-2#1)(2013-8#1)
treatment cessation##2##2##(2010-2#1)(2010-9#1)
treatment challenges##5##2##(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
treatment characteristics##6##2##(2006-10#2)(2006-2#2)(2012-2#1)(2013-1#1)
treatment choice for##2##3##(1991-6#1)(2013-8#1)
treatment choice##6##2##(1991-6#1)(1995-11#1)(2007-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
treatment choices and##3##3##(1997-1#1)(2009-12#1)(2010-11#1)
treatment choices##4##2##(1997-1#1)(2005-7#1)(2009-12#1)(2010-11#1)
treatment classes##3##2##(2008-10#3)
treatment clinics##2##2##(1991-1#1)(2013-1#1)
treatment combined with##3##3##(1991-2#1)(1996-2#1)(2007-8#1)
treatment combining##2##2##(2010-12#1)(2011-2#1)
treatment compared to##6##3##(1997-6#1)(2008-3#1)(2010-6#1)(2012-2#2)(2012-6#1)
treatment compared with those##2##4##(2006-4#1)(2008-2#1)
treatment compared with##3##3##(1997-5#1)(2006-4#1)(2008-2#1)
treatment compared##9##2##(1997-5#1)(1997-6#1)(2006-4#1)(2008-2#1)(2008-3#1)(2010-6#1)(2012-2#2)(2012-6#1)
treatment comparison##4##2##(1993-5#1)(2008-8#2)(2013-7#1)
treatment comparisons##4##2##(1994-4#1)(1995-8#1)(1997-4#1)(2008-10#1)
treatment completely##2##2##(1991-4#1)(1992-5#1)
treatment completion and##2##3##(2007-10#2)
treatment completion##6##2##(2007-10#3)(2008-10#1)(2008-2#1)(2008-6#1)
treatment compliance##4##2##(1997-4#1)(2008-8#1)(2011-2#1)(2012-3#1)
treatment complications##2##2##(2006-10#1)(2012-3#1)
treatment comprised##2##2##(2007-7#1)(2008-6#1)
treatment comprises##2##2##(1994-3#1)(2008-6#1)
treatment concept##3##2##(1994-8#1)(2006-10#1)(2008-12#1)
treatment concepts in##2##3##(1995-5#1)(2008-5#1)
treatment concepts##6##2##(1995-5#1)(2006-8#1)(2008-5#1)(2009-5#1)(2013-1#2)
treatment condition##7##2##(1997-8#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-5#1)(2011-1#2)
treatment conditions were##2##3##(2008-5#2)
treatment conditions##7##2##(1995-11#1)(2007-6#2)(2008-4#1)(2008-5#3)
treatment considerations##5##2##(2004-3#1)(2006-5#1)(2008-1#1)(2012-12#1)(2013-1#1)
treatment consisted of##10##3##(1990-3#1)(1991-6#1)(1992-10#1)(1997-5#1)(1997-8#1)(2004-10#1)(2008-7#1)(2010-5#1)(2010-8#1)(2013-1#1)
treatment consisted##12##2##(1990-3#1)(1991-6#1)(1992-10#2)(1997-5#1)(1997-8#1)(2004-10#1)(2007-8#1)(2008-7#1)(2010-5#1)(2010-8#1)(2013-1#1)
treatment consisting of##6##3##(1996-4#1)(2007-8#1)(2008-2#1)(2010-3#1)(2010-5#1)(2010-9#1)
treatment consists of##5##3##(1991-6#1)(2006-10#1)(2008-7#1)(2010-12#1)(2012-12#1)
treatment consists##7##2##(1990-6#1)(1991-6#1)(2006-10#1)(2008-7#1)(2010-12#1)(2012-12#2)
treatment continued##3##2##(1991-12#1)(2008-10#1)(2011-2#1)
treatment continues to be##2##4##(1997-3#1)(2006-10#1)
treatment continues to##3##3##(1997-3#1)(2006-10#1)(2007-4#1)
treatment cost##3##2##(2007-8#1)(2008-1#1)(2012-12#1)
treatment costs for##2##3##(2006-2#1)(2008-10#1)
treatment costs##13##2##(1997-6#1)(2005-11#1)(2006-2#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-12#1)(2010-1#1)(2011-2#2)
treatment could be##7##3##(1993-12#1)(1993-2#1)(1996-3#1)(2004-9#1)(2008-6#1)(2010-12#1)(2013-8#1)
treatment could not##2##3##(2008-10#1)(2012-12#1)
treatment could##15##2##(1990-6#1)(1993-12#1)(1993-2#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-3#1)(2004-9#1)(2007-8#1)(2008-10#1)(2008-6#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
treatment course##5##2##(2006-10#1)(2008-10#2)(2008-5#1)(2011-2#1)
treatment courses##3##2##(1992-10#1)(1993-9#1)(2008-5#1)
treatment currently##2##2##(2007-7#1)(2008-7#1)
treatment cycle##5##2##(2007-4#2)(2008-6#2)(2010-12#1)
treatment cycles##3##2##(1991-6#1)(1991-8#1)(2010-6#1)
treatment data##2##2##(2006-12#1)(2006-7#1)
treatment decision##3##2##(1994-1#1)(2009-5#1)(2010-8#1)
treatment decision-making##4##2##(2008-7#2)(2008-9#1)(2011-2#1)
treatment decisions are##3##3##(2007-11#1)(2013-1#2)
treatment decisions##23##2##(2004-1#1)(2005-11#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#4)
treatment decreased the##4##3##(1990-10#1)(1993-12#1)(1994-6#1)(1996-5#1)
treatment decreased##11##2##(1990-10#1)(1993-12#1)(1993-7#1)(1994-6#1)(1996-5#1)(2004-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#1)(2010-11#1)
treatment delay for##2##3##(2008-3#1)(2010-11#1)
treatment delay##5##2##(2008-3#1)(2008-4#1)(2010-11#3)
treatment delayed the onset and##2##5##(1993-2#1)(1996-10#1)
treatment delays and##2##3##(2008-3#1)(2010-3#1)
treatment delays##5##2##(1990-7#1)(2005-9#1)(2008-3#1)(2008-7#1)(2010-3#1)
treatment delivery##8##2##(1995-2#1)(2006-5#1)(2007-6#1)(2008-2#1)(2008-6#1)(2009-11#1)(2013-1#2)
treatment demonstrated a##2##3##(1994-10#1)(2008-6#1)
treatment demonstrated##4##2##(1991-6#1)(1993-1#1)(1994-10#1)(2008-6#1)
treatment depends on##8##3##(1993-6#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-12#1)(2008-5#1)(2010-12#1)(2011-2#1)
treatment design was##2##3##(2008-10#1)(2011-1#1)
treatment despite##2##2##(1990-3#1)(2012-2#1)
treatment did not affect##7##4##(1991-2#1)(1996-3#1)(1996-5#1)(1997-8#2)(2007-8#1)(2008-10#1)
treatment did not change##2##4##(2005-11#1)(2008-10#1)
treatment did not have any##2##5##(1993-12#1)(2008-5#1)
treatment did not have##3##4##(1993-12#1)(1997-8#1)(2008-5#1)
treatment did not increase the##2##5##(1992-4#1)(2006-6#1)
treatment did not significantly alter##2##5##(1994-9#1)(1995-12#1)
treatment did not##29##3##(1991-2#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-4#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-8#3)(2005-11#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-5#1)(2009-5#1)(2013-1#1)
treatment differed##2##2##(1992-3#1)(2007-11#1)
treatment difference##8##2##(1994-9#1)(1996-12#2)(1996-7#1)(1996-8#1)(1997-2#2)(1997-7#1)
treatment differences were##2##3##(2006-11#1)(2008-3#1)
treatment differences##5##2##(1995-12#1)(1997-2#1)(2006-11#1)(2008-10#1)(2008-3#1)
treatment different##3##2##(2006-8#1)(2008-10#1)(2013-8#1)
treatment difficult##2##2##(2007-2#1)(2012-2#1)
treatment directed##2##2##(2006-9#1)(2008-2#1)
treatment discontinuation##6##2##(2008-11#2)(2008-6#1)(2010-12#1)(2012-12#1)(2013-1#1)
treatment do not##2##3##(1992-9#1)(2008-7#1)
treatment do##3##2##(1990-9#1)(1992-9#1)(2008-7#1)
treatment does not##9##3##(1994-2#1)(1994-6#1)(1996-12#1)(1997-1#1)(2006-10#1)(2007-7#1)(2008-4#1)(2008-7#1)(2008-8#1)
treatment dramatically##3##2##(2009-3#1)(2009-8#2)
treatment due to##7##3##(2007-11#1)(2007-6#1)(2008-3#1)(2009-8#2)(2010-12#1)(2013-1#1)
treatment duration was 6##2##4##(2005-10#1)(2007-8#1)
treatment duration was##6##3##(1996-11#1)(2005-10#1)(2007-7#1)(2007-8#2)(2013-8#1)
treatment duration##18##2##(1994-10#1)(1996-11#2)(2005-10#1)(2007-7#1)(2007-8#2)(2008-2#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-8#1)(2011-2#4)(2012-3#1)(2013-8#1)
treatment duration&quot##2##2##(2009-9#2)
treatment durations##2##2##(1996-11#1)(2007-12#1)
treatment during pregnancy##3##3##(1995-12#2)(2011-2#1)
treatment during the##5##3##(1990-4#1)(1990-5#1)(2008-5#1)(2008-9#1)(2012-3#1)
treatment during##21##2##(1990-2#1)(1990-4#1)(1990-5#1)(1991-4#1)(1995-12#2)(2006-2#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
treatment earlier##2##2##(2008-10#1)(2010-12#1)
treatment early##3##2##(2008-8#1)(2011-2#1)(2013-8#1)
treatment effect and##3##3##(1996-8#1)(1997-2#1)(2008-8#1)
treatment effect in##2##3##(2007-11#1)(2007-9#1)
treatment effect is##3##3##(1994-11#1)(2012-2#1)(2013-1#1)
treatment effect of##2##3##(1992-11#1)(1997-4#1)
treatment effect on##4##3##(1996-6#1)(2007-11#1)(2008-8#2)
treatment effect##49##2##(1992-11#1)(1992-6#1)(1993-9#3)(1994-11#1)(1994-6#1)(1996-12#1)(1996-3#2)(1996-6#2)(1996-8#3)(1997-2#3)(1997-3#3)(1997-4#2)(2005-9#1)(2006-5#1)(2006-6#1)(2007-11#4)(2007-9#2)(2008-10#1)(2008-3#1)(2008-8#5)(2012-1#1)(2012-12#2)(2012-2#4)(2013-1#3)
treatment effective##2##2##(2010-12#1)(2011-2#1)
treatment effectiveness##8##2##(1991-1#1)(1993-12#1)(2006-10#1)(2006-5#1)(2008-10#1)(2008-6#1)(2010-11#1)(2010-4#1)
treatment effects associated with manual therapy##2##6##(2012-2#2)
treatment effects for##2##3##(1997-7#1)(2013-8#1)
treatment effects in##9##3##(1992-9#1)(1994-5#1)(2006-5#1)(2008-11#1)(2008-6#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-6#1)
treatment effects of##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
treatment effects##46##2##(1991-6#1)(1992-3#1)(1992-9#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-2#2)(1997-3#1)(1997-7#1)(2006-2#1)(2006-5#2)(2007-5#1)(2008-10#1)(2008-11#4)(2008-6#1)(2008-7#2)(2008-9#1)(2009-8#3)(2009-9#3)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-6#1)(2013-1#1)(2013-8#1)
treatment efficacy and##4##3##(2008-11#2)(2008-5#1)(2009-3#1)
treatment efficacy in##2##3##(2005-3#1)(2013-8#1)
treatment efficacy is##2##3##(2005-3#1)(2008-8#1)
treatment efficacy of##3##3##(2005-3#1)(2007-7#1)(2007-8#1)
treatment efficacy##29##2##(1992-9#1)(1996-2#1)(2005-3#3)(2005-6#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-3#1)(2009-8#1)(2010-1#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-8#1)
treatment efficiency and##2##3##(1991-6#1)(2006-8#1)
treatment efficiency##4##2##(1991-6#1)(2005-11#1)(2006-8#2)
treatment efforts##3##2##(2007-12#1)(2007-3#1)(2009-12#1)
treatment elements##2##2##(2006-12#1)(2008-11#1)
treatment engagement and attendance##2##4##(2008-7#2)
treatment engagement##3##2##(2008-7#2)(2012-3#1)
treatment enhanced##2##2##(1991-3#1)(2013-8#1)
treatment era##2##2##(2007-8#1)(2010-5#1)
treatment especially in##3##3##(2007-2#1)(2010-2#1)(2012-3#1)
treatment evaluation##4##2##(1990-2#1)(2006-11#1)(2007-2#1)(2012-2#1)
treatment even at##2##3##(1993-4#1)(2012-3#1)
treatment even##7##2##(1991-2#1)(1993-4#1)(1996-9#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-3#1)
treatment exerted##2##2##(1995-12#1)(2008-7#1)
treatment exists##2##2##(2009-3#1)(2012-12#1)
treatment expenditures##4##2##(2005-9#4)
treatment experience##2##2##(2006-7#1)(2013-1#1)
treatment facilities or##2##3##(1995-6#1)(2008-1#1)
treatment facilities##14##2##(1995-6#1)(1996-11#1)(1996-2#1)(1997-8#1)(2007-12#1)(2007-2#4)(2008-1#1)(2008-10#2)(2011-2#1)(2013-1#1)
treatment facility##5##2##(2006-7#2)(2007-2#1)(2008-6#1)(2009-5#1)
treatment failed to alter##2##4##(1994-5#1)(1996-1#1)
treatment failed to##4##3##(1994-5#1)(1996-1#1)(1997-2#1)(2005-6#1)
treatment failed##10##2##(1994-5#1)(1996-1#1)(1997-2#1)(2005-6#1)(2006-7#1)(2007-8#1)(2009-5#1)(2009-6#1)(2013-1#2)
treatment failure and##3##3##(2006-11#1)(2009-3#1)(2013-8#1)
treatment failure##28##2##(2005-8#1)(2006-11#2)(2006-6#3)(2006-8#1)(2006-9#1)(2007-11#2)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-3#1)(2009-7#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-5#1)(2012-12#2)(2013-8#2)
treatment failures in##2##3##(2008-7#1)(2009-4#1)
treatment failures##14##2##(1993-3#1)(1996-11#3)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#1)(2012-3#1)
treatment field##4##2##(2007-10#1)(2008-3#1)(2008-6#2)
treatment fields##4##2##(1993-9#1)(2007-10#2)(2008-6#1)
treatment fits##2##2##(2008-7#1)(2010-12#1)
treatment five##2##2##(1991-6#1)(2009-5#1)
treatment focuses##2##2##(1991-2#1)(2006-10#1)
treatment followed by##6##3##(1994-3#1)(1997-3#1)(2005-11#1)(2008-11#2)(2008-5#1)
treatment followed##7##2##(1994-3#1)(1997-3#1)(2005-11#1)(2008-11#2)(2008-5#1)(2013-8#1)
treatment following##8##2##(1991-9#1)(1994-8#1)(2007-11#1)(2008-1#1)(2008-4#1)(2009-6#1)(2010-12#1)(2011-3#1)
treatment for 3##2##3##(2007-10#1)(2013-8#1)
treatment for 4##2##3##(2008-10#1)(2012-3#1)
treatment for 6 months##2##4##(1994-4#1)(2013-8#1)
treatment for AVMs##2##3##(1997-3#1)(1997-6#1)
treatment for Alzheimer's disease##3##4##(1991-1#1)(2008-10#1)(2008-5#1)
treatment for Crohn's disease##2##4##(2007-12#1)(2010-12#1)
treatment for HIV infection##3##4##(2005-6#1)(2008-10#1)(2010-12#1)
treatment for HIV##4##3##(2005-10#1)(2005-6#1)(2008-10#1)(2010-12#1)
treatment for NPC##3##3##(2006-12#3)
treatment for OSA##2##3##(2006-10#1)(2007-1#1)
treatment for PDA##3##3##(2012-2#3)
treatment for Parkinson's disease##4##4##(1994-6#1)(1997-5#1)(2008-3#1)(2009-11#1)
treatment for a breast##2##4##(2008-7#1)(2012-3#1)
treatment for a given##2##4##(1993-2#1)(2005-7#1)
treatment for a long time##2##5##(2011-1#2)
treatment for a##16##3##(1993-2#1)(1994-6#1)(2005-7#1)(2006-8#1)(2007-7#2)(2008-11#1)(2008-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
treatment for actinic keratosis##2##4##(2010-8#2)
treatment for acute ischemic stroke##5##5##(2007-10#3)(2007-9#2)
treatment for acute myocardial infarction##3##5##(1990-3#1)(2008-3#1)(2013-1#1)
treatment for acute##20##3##(1990-3#1)(1995-1#1)(2005-11#1)(2005-9#1)(2007-10#4)(2007-7#1)(2007-8#2)(2007-9#2)(2008-3#3)(2010-12#1)(2013-1#2)(2013-8#1)
treatment for advanced##6##3##(2006-9#1)(2007-8#2)(2011-2#3)
treatment for alcohol abuse##2##4##(1990-2#1)(1994-2#1)
treatment for alcohol dependence##3##4##(2006-10#1)(2008-1#1)(2008-2#1)
treatment for alcohol##6##3##(1990-2#1)(1993-3#1)(1994-2#1)(2006-10#1)(2008-1#1)(2008-2#1)
treatment for alcoholism##2##3##(1990-12#1)(2012-1#1)
treatment for allergic rhinitis##3##4##(2007-11#1)(2008-5#1)(2013-1#1)
treatment for an orthopaedic disease to date##2##7##(2012-12#2)
treatment for an##4##3##(2005-9#1)(2006-7#1)(2012-12#2)
treatment for at least 6 months##2##6##(2006-8#1)(2009-6#1)
treatment for at least##3##4##(2006-8#1)(2009-6#1)(2009-9#1)
treatment for breast cancer##7##4##(1990-12#1)(1992-7#1)(2004-1#1)(2005-9#1)(2008-9#1)(2010-7#2)
treatment for breast##8##3##(1990-11#1)(1990-12#1)(1992-7#1)(2004-1#1)(2005-9#1)(2008-9#1)(2010-7#2)
treatment for cancer through##2##4##(2008-7#2)
treatment for cancer##6##3##(2007-2#1)(2008-10#1)(2008-7#4)
treatment for cardiovascular disease##3##4##(2005-10#1)(2007-11#1)(2008-1#1)
treatment for central##2##3##(2006-12#1)(2006-5#1)
treatment for cerebral##3##3##(1991-11#1)(1993-1#1)(1996-3#1)
treatment for cervical##3##3##(2005-10#1)(2007-11#1)(2010-12#1)
treatment for children with end-stage renal disease##2##7##(2007-7#1)(2007-9#1)
treatment for children with##7##4##(1995-9#1)(2007-2#1)(2007-7#1)(2007-9#1)(2009-4#1)(2012-2#1)(2013-1#1)
treatment for children##11##3##(1995-9#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-9#1)(2009-4#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
treatment for chronic hepatitis##2##4##(2012-2#2)
treatment for chronic##14##3##(1993-8#2)(2004-3#1)(2005-8#1)(2006-12#1)(2006-2#1)(2007-6#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
treatment for colorectal##2##3##(2006-10#1)(2012-1#1)
treatment for coronary##2##3##(1994-11#1)(2007-11#1)
treatment for cystic hygroma##2##4##(1996-12#2)
treatment for deep##2##3##(2007-10#1)(2007-8#1)
treatment for delirium##2##3##(2004-3#2)
treatment for dental##2##3##(2005-9#1)(2008-6#1)
treatment for depression##3##3##(1991-10#1)(2013-8#2)
treatment for developmental dysplasia of the hip##2##7##(2007-7#2)
treatment for diabetes##2##3##(2008-5#1)(2010-11#1)
treatment for diabetic##2##3##(2005-7#1)(2012-2#1)
treatment for each patient##3##4##(2006-2#1)(2007-10#1)(2013-1#1)
treatment for each##7##3##(1993-3#1)(2006-2#1)(2007-10#1)(2012-3#1)(2013-1#2)(2013-8#1)
treatment for early##4##3##(2006-6#1)(2008-5#1)(2010-5#1)(2012-1#1)
treatment for end-stage renal##2##4##(2008-1#1)(2011-2#1)
treatment for end-stage##6##3##(2005-7#1)(2006-10#1)(2008-1#1)(2008-2#1)(2011-2#1)(2011-3#1)
treatment for epilepsy##3##3##(1996-10#1)(2008-5#2)
treatment for heart failure##2##4##(2011-2#1)(2012-12#1)
treatment for hepatic##3##3##(1997-8#1)(2006-6#1)(2007-7#1)
treatment for his##2##3##(1996-3#1)(2012-12#1)
treatment for hydrocephalus##2##3##(2006-5#1)(2012-12#1)
treatment for hypertension##4##3##(1990-5#1)(1993-12#1)(1996-9#1)(2005-9#1)
treatment for idiopathic scoliosis##3##4##(2007-7#1)(2007-8#1)(2008-11#1)
treatment for individuals with##2##4##(2008-10#1)(2013-8#1)
treatment for individuals##3##3##(2008-10#1)(2012-12#1)(2013-8#1)
treatment for inflammatory bowel##2##4##(2012-11#2)
treatment for insomnia##4##3##(2007-6#1)(2013-1#3)
treatment for liver##2##3##(2008-1#1)(2009-8#1)
treatment for local recurrence##2##4##(1994-8#1)(2008-6#1)
treatment for local##3##3##(1994-8#1)(2008-6#1)(2008-7#1)
treatment for localized prostate cancer##3##5##(2006-9#2)(2008-7#1)
treatment for localized##4##3##(2006-9#2)(2008-7#1)(2012-1#1)
treatment for low back pain##2##5##(1993-6#1)(1993-9#1)
treatment for lower##3##3##(2008-6#1)(2011-2#2)
treatment for many##5##3##(2006-12#1)(2006-3#1)(2007-11#1)(2009-4#1)(2009-6#1)
treatment for marijuana dependence##2##4##(2012-12#2)
treatment for massive##2##3##(1992-9#1)(2012-3#1)
treatment for metastatic##3##3##(1991-8#1)(2013-8#2)
treatment for migraine##2##3##(2005-7#1)(2011-1#1)
treatment for mild##2##3##(2006-2#1)(2008-1#1)
treatment for more than##2##4##(2007-3#1)(2011-2#1)
treatment for most##5##3##(1990-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-6#1)
treatment for obstructive sleep##2##4##(2007-1#1)(2010-5#1)
treatment for obstructive##3##3##(2007-1#1)(2008-6#1)(2010-5#1)
treatment for ocular##2##3##(2005-8#1)(2007-11#1)
treatment for patients with##26##4##(1992-8#1)(1992-9#1)(1994-5#1)(1995-4#1)(2005-11#1)(2005-6#1)(2006-6#1)(2006-9#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-6#3)(2008-7#2)(2009-5#1)(2010-12#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
treatment for patients##30##3##(1992-8#1)(1992-9#1)(1994-5#1)(1995-4#1)(2005-11#1)(2005-6#1)(2006-6#1)(2006-9#2)(2007-11#2)(2007-12#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#3)(2008-7#2)(2009-5#1)(2009-8#1)(2010-12#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#2)
treatment for postpneumonectomy empyema in patients##2##6##(2007-8#2)
treatment for presumed##2##3##(2007-3#1)(2008-4#1)
treatment for primary##6##3##(2006-10#1)(2006-7#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#1)
treatment for prostate cancer##2##4##(2008-7#1)(2013-1#1)
treatment for psoriasis##2##3##(1993-11#1)(2012-12#1)
treatment for psychiatric disorders##2##4##(1995-3#1)(2010-7#1)
treatment for recurrent##3##3##(1991-3#1)(2006-6#1)(2010-5#1)
treatment for refractory##4##3##(2006-10#1)(2008-11#1)(2008-8#1)(2009-6#1)
treatment for renal##3##3##(1991-12#1)(2006-9#1)(2007-7#1)
treatment for resistant##2##3##(2005-8#1)(2013-8#1)
treatment for schizophrenia##3##3##(2004-12#1)(2005-8#1)(2013-8#1)
treatment for scoliosis##3##3##(2007-7#3)
treatment for several##2##3##(1993-11#1)(2007-8#1)
treatment for severe##7##3##(2006-11#1)(2007-8#1)(2010-12#1)(2010-5#1)(2013-8#3)
treatment for skeletal metastases from soft tissue sarcomas##2##8##(2008-6#2)
treatment for solid##2##3##(2008-3#1)(2008-7#1)
treatment for some##4##3##(2006-2#1)(2007-9#1)(2008-4#1)(2010-1#1)
treatment for spinal##2##3##(2007-11#1)(2012-12#1)
treatment for stable##2##3##(2007-8#2)
treatment for substance##2##3##(2007-1#1)(2009-9#1)
treatment for symptomatic cerebral vasospasm after##2##6##(2006-11#2)
treatment for symptomatic##7##3##(1991-12#1)(1993-3#1)(2006-10#1)(2006-11#2)(2012-2#1)(2012-3#1)
treatment for the condition##2##4##(1996-11#1)(1997-8#1)
treatment for the disease##2##4##(1994-9#1)(2007-11#1)
treatment for the first##2##4##(1994-2#1)(2007-1#1)
treatment for the management of##2##5##(2008-3#1)(2008-6#1)
treatment for the patients##2##4##(2006-2#1)(2011-1#1)
treatment for the##34##3##(1990-12#1)(1994-2#1)(1994-9#1)(1995-5#1)(1996-11#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-9#2)(2010-3#1)(2011-1#1)(2012-12#1)
treatment for their##3##3##(1992-1#1)(1995-4#1)(2004-3#1)
treatment for these##8##3##(1994-6#1)(2005-7#1)(2006-11#1)(2007-1#1)(2007-8#1)(2008-1#1)(2011-2#1)(2013-8#1)
treatment for this condition##9##4##(2006-10#1)(2006-5#2)(2006-9#2)(2007-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
treatment for this population##2##4##(2009-11#2)
treatment for this##22##3##(1993-5#1)(1993-8#1)(1997-8#1)(2006-10#1)(2006-5#2)(2006-9#2)(2007-7#2)(2007-9#1)(2008-11#1)(2008-7#1)(2009-11#2)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
treatment for those##3##3##(1992-5#1)(2007-7#1)(2012-3#1)
treatment for three##2##3##(2010-6#1)(2012-11#1)
treatment for tinnitus##4##3##(2010-12#1)(2010-3#2)(2013-1#1)
treatment for toxic##2##3##(2006-11#1)(2012-11#1)
treatment for type##3##3##(2009-3#1)(2010-7#1)(2011-2#1)
treatment for ulcerative##2##3##(2009-8#1)(2012-11#1)
treatment for unresectable##3##3##(2006-6#3)
treatment for unruptured AVMs in##2##5##(2008-7#2)
treatment for use in##2##4##(1991-3#1)(2008-12#1)
treatment for various##6##3##(1993-3#1)(1996-2#1)(2006-10#1)(2007-2#1)(2007-7#1)(2012-2#1)
treatment for women##2##3##(1996-4#1)(2009-9#1)
treatment for years##2##3##(1991-11#1)(2007-8#1)
treatment for##801##2##(1990-11#2)(1990-12#6)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#4)(1992-2#1)(1992-3#2)(1992-5#3)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#3)(1993-3#5)(1993-4#1)(1993-5#3)(1993-6#1)(1993-8#4)(1993-9#2)(1994-11#1)(1994-2#2)(1994-3#1)(1994-4#2)(1994-5#2)(1994-6#4)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#2)(1995-4#3)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#4)(1996-4#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2004-1#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-3#7)(2004-9#2)(2005-1#1)(2005-10#5)(2005-11#3)(2005-12#1)(2005-6#3)(2005-7#10)(2005-8#9)(2005-9#7)(2006-10#20)(2006-11#7)(2006-12#13)(2006-2#8)(2006-3#3)(2006-5#6)(2006-6#15)(2006-7#6)(2006-8#5)(2006-9#10)(2007-1#6)(2007-10#11)(2007-11#23)(2007-12#8)(2007-2#8)(2007-3#4)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#21)(2007-8#29)(2007-9#5)(2008-1#8)(2008-10#24)(2008-11#13)(2008-12#5)(2008-2#5)(2008-3#14)(2008-4#6)(2008-5#15)(2008-6#16)(2008-7#26)(2008-8#3)(2008-9#8)(2009-11#4)(2009-3#2)(2009-4#3)(2009-5#5)(2009-6#3)(2009-8#4)(2009-9#5)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#20)(2010-2#4)(2010-3#5)(2010-4#1)(2010-5#5)(2010-6#2)(2010-7#6)(2010-8#3)(2010-9#2)(2011-1#12)(2011-12#2)(2011-2#32)(2011-3#2)(2011-7#1)(2012-1#7)(2012-11#8)(2012-12#24)(2012-2#23)(2012-3#13)(2013-1#33)(2013-7#4)(2013-8#25)
treatment forms##6##2##(1990-4#1)(1990-6#1)(2006-11#1)(2011-2#3)
treatment from a##3##3##(1993-2#1)(2007-11#1)(2013-1#1)
treatment from the##7##3##(1992-9#1)(1997-8#1)(2006-6#1)(2008-5#1)(2009-1#1)(2011-1#1)(2013-8#1)
treatment from##24##2##(1992-9#1)(1993-2#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-11#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-1#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#2)(2013-8#2)
treatment further##2##2##(1993-2#1)(2013-1#1)
treatment gains##3##2##(2007-12#1)(2007-4#1)(2011-2#1)
treatment gave##2##2##(1990-9#1)(1996-5#1)
treatment give##2##2##(1992-9#1)(1994-2#1)
treatment given to##2##3##(1993-3#1)(2005-12#1)
treatment given##5##2##(1993-3#1)(2005-12#1)(2007-7#1)(2008-4#1)(2010-8#1)
treatment goal##4##2##(2006-5#1)(2007-11#1)(2011-7#1)(2013-1#1)
treatment goals and##2##3##(2007-7#1)(2013-1#1)
treatment goals are##2##3##(2011-2#1)(2013-8#1)
treatment goals for##2##3##(2008-8#1)(2011-2#1)
treatment goals##14##2##(2007-7#1)(2007-8#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-5#1)(2011-12#3)(2011-2#2)(2013-1#1)(2013-8#1)
treatment group (n =##2##4##(2006-5#1)(2012-2#1)
treatment group and##6##3##(2006-6#1)(2008-2#1)(2008-5#1)(2009-4#1)(2012-3#1)(2013-8#1)
treatment group compared with##2##4##(2008-5#1)(2010-8#1)
treatment group compared##3##3##(2008-5#1)(2010-12#1)(2010-8#1)
treatment group had##5##3##(1990-12#1)(2006-10#1)(2009-4#1)(2013-1#2)
treatment group or a##2##4##(2008-10#1)(2013-8#1)
treatment group receiving##4##3##(1991-1#2)(1991-2#1)(2004-3#1)
treatment group showed##2##3##(1997-8#1)(2007-8#1)
treatment group to##2##3##(1994-6#1)(1994-9#1)
treatment group was##5##3##(2006-4#1)(2006-8#1)(2007-7#1)(2008-9#1)(2012-1#1)
treatment group were##4##3##(1995-9#1)(2008-5#2)(2013-1#1)
treatment group##80##2##(1990-12#1)(1990-2#1)(1991-1#3)(1991-2#2)(1992-3#1)(1992-6#1)(1993-12#1)(1994-5#2)(1994-6#2)(1994-9#2)(1995-9#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-3#2)(1997-8#1)(2004-3#1)(2006-10#1)(2006-4#4)(2006-5#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#7)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2010-12#2)(2010-7#1)(2010-8#3)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#2)
treatment groups and##3##3##(1993-1#1)(2004-3#1)(2006-5#1)
treatment groups for##2##3##(2007-9#1)(2008-11#1)
treatment groups in##5##3##(1992-3#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-2#1)
treatment groups of##2##3##(2006-1#1)(2007-1#1)
treatment groups were compared##2##4##(1995-10#1)(2007-8#1)
treatment groups were similar##3##4##(1992-10#1)(1993-7#1)(2007-8#1)
treatment groups were##12##3##(1991-1#1)(1991-8#1)(1992-10#2)(1993-7#1)(1995-10#1)(2004-1#1)(2006-9#1)(2007-8#2)(2008-10#1)(2012-3#1)
treatment groups##98##2##(1990-11#1)(1990-3#4)(1991-1#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-10#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-7#1)(1994-12#3)(1994-5#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-3#2)(1995-4#1)(1995-9#1)(1996-10#1)(1997-3#1)(1997-7#1)(2004-1#2)(2004-3#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-5#2)(2006-8#1)(2006-9#1)(2007-1#2)(2007-11#1)(2007-8#4)(2007-9#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#2)
treatment guidelines and##3##3##(1990-9#1)(2006-5#1)(2011-1#1)
treatment guidelines for##2##3##(2011-2#2)
treatment guidelines in##2##3##(2006-9#1)(2008-10#1)
treatment guidelines recommend##2##3##(2009-11#1)(2012-2#1)
treatment guidelines##26##2##(1990-9#1)(1997-2#1)(2006-12#1)(2006-5#4)(2006-9#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-11#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#5)(2012-2#1)(2013-1#1)
treatment had a##2##3##(2007-8#1)(2009-7#1)
treatment had been##4##3##(1990-9#1)(2007-10#1)(2008-7#1)(2013-8#1)
treatment had failed##4##3##(1997-8#1)(2006-5#1)(2007-11#1)(2008-4#1)
treatment had included##2##3##(2008-6#1)(2010-3#1)
treatment had no effect on the##3##6##(1993-2#1)(1995-9#1)(1997-5#1)
treatment had no effect on##9##5##(1992-3#1)(1993-2#1)(1995-11#1)(1995-9#1)(1996-10#1)(1997-4#1)(1997-5#1)(2011-2#1)(2013-1#1)
treatment had significantly##2##3##(2006-10#1)(2008-10#1)
treatment had##33##2##(1990-9#1)(1991-4#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-6#1)(1995-11#1)(1995-9#1)(1996-10#1)(1997-4#2)(1997-5#1)(1997-8#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-3#1)(2011-2#2)(2013-1#2)(2013-8#1)
treatment has become##5##3##(1995-4#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-6#1)
treatment has been shown to##2##5##(2008-7#1)(2008-9#1)
treatment has been used for##2##5##(2004-4#1)(2011-3#1)
treatment has been used##4##4##(1997-5#1)(2004-4#1)(2009-5#1)(2011-3#1)
treatment has been##22##3##(1990-12#1)(1993-1#1)(1993-9#1)(1997-5#1)(2004-4#1)(2006-10#2)(2006-6#1)(2006-7#1)(2007-11#1)(2007-8#3)(2008-10#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#1)(2011-1#1)(2011-3#1)
treatment has doubled since 1984##2##5##(2006-8#2)
treatment has focused on##3##4##(1994-2#1)(2005-2#1)(2009-12#1)
treatment has increased##2##3##(1993-1#1)(2009-6#1)
treatment has not been##5##4##(1996-3#1)(2007-11#1)(2007-8#1)(2010-5#1)(2011-1#1)
treatment has not yet been##2##5##(1992-5#1)(2007-11#1)
treatment has not##8##3##(1992-5#1)(1996-3#1)(2007-11#2)(2007-8#1)(2010-5#1)(2011-1#1)(2013-1#1)
treatment has proved to be##2##5##(1992-10#1)(2010-8#1)
treatment has to be##3##4##(1997-4#1)(2006-10#1)(2008-8#1)
treatment has##73##2##(1990-12#3)(1992-10#1)(1992-5#1)(1993-1#2)(1993-11#1)(1993-9#2)(1994-2#1)(1994-3#1)(1995-12#1)(1995-4#1)(1996-3#1)(1997-3#1)(1997-4#3)(1997-5#1)(2004-4#1)(2005-2#1)(2005-7#1)(2006-10#5)(2006-6#2)(2006-7#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-8#6)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#2)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-3#1)(2012-2#1)(2013-1#1)
treatment have been well##2##4##(2008-12#1)(2013-1#1)
treatment have been##10##3##(1992-3#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2012-12#1)(2013-1#2)
treatment have##26##2##(1990-12#1)(1990-4#1)(1991-8#2)(1992-3#1)(1993-5#1)(1996-6#1)(1997-1#1)(2005-10#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-7#1)(2010-2#1)(2010-5#1)(2012-12#2)(2012-2#2)(2013-1#2)
treatment head##3##2##(2008-3#2)(2009-11#1)
treatment history##5##2##(1990-12#1)(2006-7#1)(2008-11#1)(2009-12#1)(2011-2#1)
treatment if##8##2##(1991-8#1)(1992-5#1)(1996-2#1)(2006-10#1)(2006-4#1)(2008-10#1)(2008-4#1)(2010-12#1)
treatment immediately after##2##3##(1991-8#1)(2011-2#1)
treatment immediately##3##2##(1991-8#1)(2008-1#1)(2011-2#1)
treatment implications##6##2##(1993-12#1)(2007-11#1)(2007-7#1)(2008-2#2)(2008-9#1)
treatment improved##3##2##(2011-2#1)(2013-1#2)
treatment improves the##3##3##(2007-11#1)(2007-4#1)(2008-7#1)
treatment improves##7##2##(2007-11#1)(2007-4#1)(2008-6#1)(2008-7#1)(2010-8#1)(2012-3#1)(2013-8#1)
treatment in 12##2##3##(2005-1#1)(2009-12#1)
treatment in 21##3##3##(2007-7#1)(2007-8#1)(2011-2#1)
treatment in Iceland##2##3##(2006-10#2)
treatment in June##2##3##(2005-8#1)(2008-12#1)
treatment in a patient with##4##5##(2006-10#2)(2010-6#1)(2012-12#1)
treatment in a##35##3##(1990-11#1)(1990-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1995-10#1)(1995-5#2)(1996-1#1)(1996-3#1)(1996-7#1)(1997-2#1)(2005-9#1)(2006-10#2)(2006-8#1)(2007-1#1)(2007-7#1)(2007-9#2)(2008-6#1)(2008-8#1)(2009-1#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
treatment in acute##2##3##(1993-8#1)(2007-11#1)
treatment in adolescent##2##3##(2007-7#2)
treatment in adults with##3##4##(2008-12#1)(2011-2#1)(2012-3#1)
treatment in adults##6##3##(1992-11#1)(1996-11#1)(2005-12#1)(2008-12#1)(2011-2#1)(2012-3#1)
treatment in all patients##2##4##(2007-7#1)(2011-2#1)
treatment in all##4##3##(1991-10#1)(2007-7#1)(2008-4#1)(2011-2#1)
treatment in an##6##3##(1992-5#1)(2005-11#1)(2008-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
treatment in bone##2##3##(2004-2#1)(2007-11#1)
treatment in both the##2##4##(2007-8#1)(2011-2#1)
treatment in both##5##3##(1996-7#1)(2007-8#1)(2009-4#1)(2010-11#1)(2011-2#1)
treatment in cases of##2##4##(1990-8#1)(2007-6#1)
treatment in certain##2##3##(1997-3#1)(2006-2#1)
treatment in children##4##3##(2006-10#1)(2008-11#1)(2011-1#1)(2012-12#1)
treatment in comparison to##2##4##(2007-6#1)(2008-5#1)
treatment in diffuse##2##3##(1995-5#1)(2005-12#1)
treatment in each##2##3##(1993-3#1)(1995-2#1)
treatment in eastern##2##3##(2005-9#1)(2012-3#1)
treatment in four##2##3##(1997-3#1)(2012-3#1)
treatment in hospital##3##3##(1991-11#1)(1992-5#1)(1993-5#1)
treatment in hospitals##2##3##(1992-6#1)(2013-8#1)
treatment in human##3##3##(1996-11#1)(1996-5#1)(2008-6#1)
treatment in infants##2##3##(2006-7#1)(2006-8#1)
treatment in inflammatory##2##3##(2006-10#1)(2008-5#1)
treatment in juvenile##2##3##(1993-5#1)(2007-11#1)
treatment in managing##2##3##(2006-8#1)(2012-12#1)
treatment in metastatic##3##3##(1990-10#1)(1992-12#1)(2009-2#1)
treatment in most##3##3##(1997-8#1)(2008-7#1)(2008-9#1)
treatment in only##2##3##(1993-2#1)(2006-10#1)
treatment in order to##4##4##(1993-11#1)(2006-7#1)(2008-1#1)(2008-12#1)
treatment in our##3##3##(2007-7#1)(2012-12#1)(2013-1#1)
treatment in patients with a##3##5##(1993-10#1)(2008-10#1)(2008-2#1)
treatment in patients with breast cancer##2##6##(1992-10#1)(1993-11#1)
treatment in patients with chronic thromboembolic pulmonary hypertension]##2##8##(2010-6#2)
treatment in patients with chronic##5##5##(1993-11#1)(2008-5#1)(2010-6#2)(2011-2#1)
treatment in patients with##40##4##(1990-3#1)(1991-10#1)(1991-5#1)(1992-10#1)(1993-10#1)(1993-11#2)(1993-6#1)(1994-12#2)(1995-4#1)(1997-5#1)(2005-12#1)(2006-12#1)(2006-2#1)(2006-5#2)(2007-10#1)(2007-11#5)(2007-12#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-6#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
treatment in patients##46##3##(1990-3#1)(1991-10#1)(1991-5#1)(1992-10#1)(1993-10#1)(1993-11#2)(1993-6#1)(1994-12#2)(1995-4#1)(1996-8#1)(1997-5#1)(2005-12#1)(2006-12#1)(2006-2#1)(2006-5#2)(2007-10#1)(2007-11#5)(2007-12#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-6#2)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
treatment in pregnancy##3##3##(1990-12#1)(2009-4#1)(2010-2#1)
treatment in prevention##2##3##(2008-7#1)(2010-12#1)
treatment in primary##3##3##(1995-4#1)(1996-2#1)(2009-12#1)
treatment in rheumatoid arthritis##4##4##(2007-11#2)(2007-3#2)
treatment in some##3##3##(2007-7#1)(2008-5#1)(2010-4#1)
treatment in specialized##2##3##(1995-11#2)
treatment in the United##2##4##(2004-1#1)(2006-12#1)
treatment in the context of##2##5##(2012-12#1)(2012-3#1)
treatment in the elderly##2##4##(1990-1#1)(1990-11#1)
treatment in the form##2##4##(2007-7#1)(2008-6#1)
treatment in the intensive care unit##3##6##(2005-8#1)(2006-10#1)(2010-11#1)
treatment in the outpatient setting##2##5##(2006-10#1)(2010-9#1)
treatment in the whole##2##4##(1992-5#1)(2006-6#1)
treatment in the##72##3##(1990-1#1)(1990-11#1)(1990-2#2)(1991-5#1)(1991-9#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-8#1)(1996-11#1)(1996-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-1#1)(2005-11#1)(2005-3#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#3)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
treatment in these patients##2##4##(2007-11#1)(2008-5#1)
treatment in these##3##3##(2007-11#1)(2008-5#1)(2008-8#1)
treatment in this##6##3##(1997-6#1)(2006-3#1)(2008-11#1)(2008-7#2)(2010-6#1)
treatment in those with##2##4##(2008-7#1)(2011-2#1)
treatment in type##2##3##(2007-11#1)(2011-2#1)
treatment in vivo##3##3##(1990-12#1)(1994-8#1)(1994-9#1)
treatment in which##2##3##(2007-11#1)(2012-11#1)
treatment in young##2##3##(2006-1#1)(2008-6#1)
treatment in##473##2##(1990-1#1)(1990-10#2)(1990-11#4)(1990-12#2)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#3)(1990-8#3)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#3)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#2)(1992-10#3)(1992-11#2)(1992-12#3)(1992-3#2)(1992-5#3)(1992-6#3)(1992-8#2)(1993-1#1)(1993-10#1)(1993-11#6)(1993-12#2)(1993-2#3)(1993-3#2)(1993-5#2)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#3)(1994-4#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-4#2)(1995-5#3)(1995-6#2)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#3)(1996-12#2)(1996-2#1)(1996-3#3)(1996-5#2)(1996-7#2)(1996-8#2)(1997-2#1)(1997-3#5)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#3)(2004-1#1)(2004-2#1)(2005-1#2)(2005-11#2)(2005-12#3)(2005-3#1)(2005-7#1)(2005-8#2)(2005-9#3)(2006-1#1)(2006-10#15)(2006-12#9)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#6)(2006-7#3)(2006-8#5)(2007-1#4)(2007-10#2)(2007-11#28)(2007-12#4)(2007-2#1)(2007-3#2)(2007-5#2)(2007-6#5)(2007-7#16)(2007-8#10)(2007-9#3)(2008-1#2)(2008-10#7)(2008-11#7)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#8)(2008-6#6)(2008-7#10)(2008-8#5)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#2)(2009-9#1)(2010-11#5)(2010-12#6)(2010-2#3)(2010-4#2)(2010-5#6)(2010-6#6)(2010-8#2)(2010-9#1)(2011-1#11)(2011-2#18)(2012-1#1)(2012-11#1)(2012-12#15)(2012-2#10)(2012-3#8)(2012-7#1)(2013-1#13)(2013-7#2)(2013-8#7)
treatment include##7##2##(2006-10#1)(2006-11#1)(2006-2#1)(2006-8#1)(2007-12#2)(2007-2#1)
treatment included the##2##3##(2007-11#1)(2008-6#1)
treatment included##9##2##(1990-12#1)(1997-1#1)(1997-5#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-6#1)(2009-3#1)
treatment includes the##3##3##(2008-10#1)(2008-6#1)(2012-2#1)
treatment includes##9##2##(1994-2#1)(2006-7#1)(2008-1#1)(2008-10#1)(2008-6#1)(2010-7#1)(2011-2#2)(2012-2#1)
treatment including##13##2##(1992-5#1)(1996-12#1)(1996-3#1)(2006-5#1)(2006-8#1)(2007-2#1)(2007-8#2)(2008-8#1)(2010-12#1)(2011-1#1)(2012-1#1)(2013-8#1)
treatment increased the##6##3##(1990-3#1)(1991-3#1)(1996-12#1)(1997-7#1)(2006-5#1)(2011-1#1)
treatment increased##18##2##(1990-3#1)(1991-3#1)(1994-2#1)(1995-10#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-7#1)(2006-5#2)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-11#1)
treatment increases the##2##3##(1994-9#1)(2010-12#1)
treatment increases##6##2##(1992-8#1)(1994-10#1)(1994-2#1)(1994-6#1)(1994-9#1)(2010-12#1)
treatment indicates that##2##3##(1996-5#1)(2008-10#1)
treatment indicator##2##2##(1996-7#1)(2012-11#1)
treatment induced a significant##2##4##(2007-10#1)(2008-10#1)
treatment induced a##5##3##(1990-11#1)(1994-6#1)(1995-10#1)(2007-10#1)(2008-10#1)
treatment induced an##4##3##(1992-11#1)(1994-11#1)(1994-2#1)(2008-5#1)
treatment induced##18##2##(1990-11#1)(1991-7#1)(1992-11#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-10#1)(2006-12#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-6#1)(2011-10#1)(2012-3#1)
treatment induces##4##2##(2008-12#1)(2010-7#1)(2012-12#2)
treatment influenced##2##2##(1993-2#1)(2006-12#1)
treatment information##3##2##(1996-3#1)(2006-10#1)(2006-9#1)
treatment inhibited the##2##3##(1991-12#1)(2012-2#1)
treatment inhibited##4##2##(1991-12#1)(2008-5#1)(2009-4#1)(2012-2#1)
treatment inhibits##2##2##(1993-8#1)(1995-1#1)
treatment initiation##7##2##(2006-9#1)(2007-10#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-4#1)(2010-8#1)
treatment instituted##3##2##(2006-10#1)(2007-4#1)(2008-1#1)
treatment intensity##2##2##(2010-4#1)(2011-2#1)
treatment interaction##3##2##(1995-12#1)(1997-2#2)
treatment interruption##8##2##(1990-2#1)(2007-1#1)(2008-7#1)(2009-4#3)(2011-2#2)
treatment interval was##2##3##(1991-6#1)(2012-12#1)
treatment interval##4##2##(1991-6#1)(2008-12#2)(2012-12#1)
treatment intervention##6##2##(1995-12#1)(2007-11#1)(2007-12#1)(2010-1#1)(2012-3#2)
treatment interventions##8##2##(1996-6#1)(2007-10#1)(2008-3#1)(2008-6#1)(2009-11#1)(2012-2#1)(2013-8#2)
treatment into##4##2##(2006-9#1)(2008-7#1)(2009-6#1)(2010-4#1)
treatment intolerant or##2##3##(1993-1#2)
treatment involved##9##2##(1990-2#1)(1991-2#1)(2007-11#1)(2007-7#1)(2007-8#3)(2011-1#1)(2012-12#1)
treatment involves##3##2##(2006-3#1)(2008-6#1)(2013-1#1)
treatment involving##4##2##(1992-3#1)(2008-10#1)(2011-2#1)(2012-2#1)
treatment is a##16##3##(1990-12#1)(1993-8#1)(1996-9#1)(2006-1#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2009-5#1)(2009-6#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
treatment is aimed at##2##4##(1997-3#1)(2008-10#1)
treatment is also##9##3##(1990-7#1)(1991-12#1)(2006-10#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2009-10#1)
treatment is always##4##3##(1995-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
treatment is an important##2##4##(2009-2#1)(2010-2#1)
treatment is an##8##3##(1991-2#1)(2007-7#1)(2008-4#1)(2008-7#1)(2009-2#1)(2010-2#1)(2011-1#1)(2013-1#1)
treatment is applied##3##3##(2008-9#2)(2010-12#1)
treatment is associated with##6##4##(1993-9#1)(2007-11#1)(2008-6#1)(2008-7#1)(2010-2#1)(2010-6#1)
treatment is available for##2##4##(2006-10#1)(2007-2#1)
treatment is available##5##3##(2006-10#1)(2007-2#1)(2008-1#1)(2008-5#1)(2008-8#1)
treatment is based on the##3##5##(1990-10#1)(2005-11#1)(2007-12#1)
treatment is based on##7##4##(1990-10#1)(2005-11#1)(2005-7#1)(2007-12#1)(2008-8#1)(2011-1#1)(2011-2#1)
treatment is based##8##3##(1990-10#1)(2005-11#1)(2005-7#1)(2007-11#1)(2007-12#1)(2008-8#1)(2011-1#1)(2011-2#1)
treatment is carried out##2##4##(1991-9#1)(2013-1#1)
treatment is considered##5##3##(1992-9#1)(2005-11#1)(2007-8#1)(2010-6#1)(2011-2#1)
treatment is controversial##2##3##(2013-1#1)(2013-8#1)
treatment is crucial to##2##4##(2010-2#1)(2012-3#1)
treatment is crucial##4##3##(1996-12#1)(1996-9#1)(2010-2#1)(2012-3#1)
treatment is delayed##4##3##(1995-7#1)(2008-12#1)(2008-7#1)(2010-12#1)
treatment is dependent on##3##4##(2007-7#1)(2008-4#1)(2009-9#1)
treatment is desirable##2##3##(2006-8#1)(2008-12#1)
treatment is developed##2##3##(2006-10#1)(2008-10#1)
treatment is difficult and##4##4##(1990-5#1)(2005-11#1)(2013-1#2)
treatment is difficult##6##3##(1990-5#1)(1995-5#1)(2005-11#1)(2011-1#1)(2013-1#2)
treatment is discussed in##3##4##(2008-8#1)(2008-9#2)
treatment is discussed##7##3##(1992-2#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2013-8#1)
treatment is effective in##2##4##(2008-5#1)(2012-2#1)
treatment is effective##7##3##(1990-3#1)(1991-4#1)(2005-11#1)(2007-11#2)(2008-5#1)(2012-2#1)
treatment is essential to##2##4##(1993-8#1)(2011-2#1)
treatment is essential##5##3##(1991-6#1)(1993-8#1)(2007-11#1)(2011-1#1)(2011-2#1)
treatment is generally well tolerated##2##5##(2008-3#2)
treatment is generally##3##3##(1990-12#1)(2008-3#2)
treatment is given##3##3##(2007-11#1)(2008-2#2)
treatment is important##2##3##(1996-12#1)(2012-12#1)
treatment is in##2##3##(1990-2#1)(2006-2#1)
treatment is indicated for##2##4##(1993-8#1)(2008-9#1)
treatment is indicated in##4##4##(1990-3#1)(2012-2#2)(2013-8#1)
treatment is indicated##11##3##(1990-3#1)(1993-10#1)(1993-8#1)(1994-4#1)(2007-8#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-2#2)(2013-8#1)
treatment is initiated##3##3##(1994-6#1)(2007-7#1)(2010-3#1)
treatment is likely to##2##4##(2008-5#1)(2008-8#1)
treatment is limited##3##3##(1993-6#1)(2007-11#1)(2007-9#1)
treatment is mainly##2##3##(2007-6#1)(2008-8#1)
treatment is more##4##3##(1995-9#1)(2012-12#3)
treatment is necessary##4##3##(1997-2#1)(2008-10#1)(2008-11#2)
treatment is needed in##2##4##(1996-11#1)(2007-7#1)
treatment is needed##3##3##(1990-5#1)(1996-11#1)(2007-7#1)
treatment is not yet##2##4##(1991-2#1)(2005-1#1)
treatment is not##17##3##(1991-2#1)(1991-6#1)(1993-5#1)(1995-9#1)(1997-3#1)(2005-1#1)(2005-12#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-6#1)(2013-1#1)
treatment is now##3##3##(1994-4#1)(2008-3#1)(2013-1#1)
treatment is of##4##3##(1993-6#1)(2008-1#1)(2011-2#2)
treatment is often##8##3##(1991-2#1)(1991-6#1)(2006-4#1)(2007-8#1)(2008-2#1)(2009-5#1)(2013-1#1)(2013-7#1)
treatment is one of the##2##5##(2007-11#1)(2008-10#1)
treatment is only##2##3##(1990-12#1)(2009-8#1)
treatment is poor in##2##4##(2006-1#1)(2007-10#1)
treatment is possible##4##3##(2007-8#1)(2008-1#1)(2008-2#1)(2008-7#1)
treatment is proposed##2##3##(2008-10#1)(2008-6#1)
treatment is quite##2##3##(2007-11#1)(2011-12#1)
treatment is recommended for##3##4##(1990-12#1)(2008-9#1)(2013-1#1)
treatment is recommended##7##3##(1990-12#1)(2007-2#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
treatment is required to##2##4##(1996-9#1)(2008-12#1)
treatment is required##6##3##(1996-9#1)(2005-11#1)(2005-2#1)(2008-12#1)(2008-2#1)(2008-9#1)
treatment is revealed##2##3##(1992-11#1)(2013-1#1)
treatment is safe and##2##4##(2007-8#1)(2010-1#1)
treatment is similar to that##2##5##(2008-10#1)(2013-1#1)
treatment is still limited##2##4##(2006-4#1)(2008-11#1)
treatment is still##9##3##(1991-4#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-9#1)
treatment is superior to##3##4##(1996-12#1)(1997-8#1)(2008-5#1)
treatment is surgery##3##3##(1991-5#1)(1993-3#1)(2013-1#1)
treatment is technically##2##3##(1997-5#1)(2013-1#1)
treatment is the##13##3##(1993-5#1)(1997-2#1)(2005-11#1)(2006-11#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-7#2)(2010-12#1)(2012-2#1)(2013-1#1)
treatment is to be considered##2##5##(1995-7#1)(2008-7#1)
treatment is to##12##3##(1991-6#1)(1991-8#1)(1993-3#1)(1995-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-2#1)(2011-2#1)
treatment is used to##2##4##(1994-12#1)(2009-8#1)
treatment is used##5##3##(1990-11#1)(1994-12#1)(2006-2#1)(2009-8#1)(2010-12#1)
treatment is usually##4##3##(1990-9#1)(2006-10#1)(2008-7#1)(2010-9#1)
treatment is vital##2##3##(2007-10#1)(2011-1#1)
treatment is warranted##4##3##(1991-7#1)(2006-3#1)(2011-2#1)(2013-1#1)
treatment is well##2##3##(1990-12#1)(2011-7#1)
treatment is widely##2##3##(2006-12#1)(2010-10#1)
treatment is with##2##3##(1996-11#1)(2013-7#1)
treatment is##426##2##(1990-10#2)(1990-11#1)(1990-12#5)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#4)(1991-4#2)(1991-5#1)(1991-6#5)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#4)(1993-5#3)(1993-6#2)(1993-8#4)(1993-9#3)(1994-11#1)(1994-12#1)(1994-4#3)(1994-6#2)(1994-7#1)(1995-2#1)(1995-3#1)(1995-5#4)(1995-7#2)(1995-9#3)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#2)(1996-3#1)(1996-9#3)(1997-2#4)(1997-3#2)(1997-5#3)(1997-8#2)(2004-11#1)(2005-1#1)(2005-11#9)(2005-12#1)(2005-2#1)(2005-7#3)(2005-8#1)(2006-1#2)(2006-10#9)(2006-11#1)(2006-12#8)(2006-2#2)(2006-3#1)(2006-4#2)(2006-6#2)(2006-7#1)(2006-8#1)(2007-10#3)(2007-11#24)(2007-12#4)(2007-2#3)(2007-4#2)(2007-6#2)(2007-7#9)(2007-8#8)(2007-9#2)(2008-1#8)(2008-10#10)(2008-11#5)(2008-12#4)(2008-2#5)(2008-3#9)(2008-4#5)(2008-5#8)(2008-6#5)(2008-7#16)(2008-8#8)(2008-9#8)(2009-10#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#3)(2009-8#3)(2009-9#5)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#8)(2010-2#4)(2010-3#4)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#9)(2011-12#2)(2011-2#17)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#12)(2012-2#11)(2012-3#2)(2013-1#23)(2013-7#2)(2013-8#6)
treatment issues##5##2##(1993-9#1)(1995-6#1)(2004-12#1)(2005-7#1)(2011-2#1)
treatment it is##2##3##(1995-9#1)(2005-1#1)
treatment it##4##2##(1995-9#1)(2005-1#1)(2006-10#1)(2013-8#1)
treatment lead##2##2##(2008-5#1)(2012-3#1)
treatment leads to a##2##4##(2008-6#1)(2011-1#1)
treatment leads to##9##3##(1996-5#1)(2006-2#1)(2007-1#1)(2008-10#2)(2008-6#1)(2008-9#1)(2011-1#1)(2013-1#1)
treatment led to a##4##4##(1991-7#1)(1993-7#1)(1996-5#1)(1997-3#1)
treatment led to the##2##4##(1996-5#1)(2006-8#1)
treatment led to##11##3##(1991-7#1)(1993-7#1)(1996-5#2)(1996-6#1)(1997-3#1)(2005-8#2)(2006-8#1)(2008-10#1)(2013-7#1)
treatment length##2##2##(2006-9#1)(2013-8#1)
treatment less##2##2##(2008-5#1)(2011-2#1)
treatment lower##2##2##(2008-7#1)(2009-10#1)
treatment made##2##2##(2007-9#1)(2009-6#1)
treatment make##2##2##(2007-4#1)(2008-10#1)
treatment makes##2##2##(2008-4#1)(2009-3#1)
treatment management##3##2##(2007-7#1)(2008-8#1)(2010-12#1)
treatment markedly##2##2##(1993-11#1)(2006-10#1)
treatment may be performed##2##4##(1992-10#1)(2006-5#1)
treatment may be required##2##4##(2007-3#1)(2008-9#1)
treatment may be##22##3##(1990-6#1)(1991-11#1)(1992-10#1)(1992-6#1)(1993-5#1)(1993-6#1)(1995-10#1)(1995-5#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-9#1)(2010-7#1)(2012-2#1)(2013-1#1)
treatment may cause##2##3##(1995-4#1)(2010-12#1)
treatment may have a##2##4##(2007-11#1)(2007-8#1)
treatment may have##5##3##(1997-8#1)(2004-7#1)(2007-11#1)(2007-8#1)(2008-6#1)
treatment may improve##4##3##(1992-4#1)(2010-6#1)(2012-2#1)(2012-3#1)
treatment may include##3##3##(2007-2#1)(2008-6#1)(2011-2#1)
treatment may induce##2##3##(1993-2#1)(2010-12#1)
treatment may not##3##3##(2007-12#1)(2008-4#1)(2009-5#1)
treatment may##65##2##(1990-6#1)(1991-11#1)(1991-12#1)(1991-4#1)(1992-10#1)(1992-4#1)(1992-6#1)(1993-2#2)(1993-5#1)(1993-6#1)(1995-10#1)(1995-4#1)(1995-5#1)(1996-2#1)(1997-8#1)(2004-7#1)(2006-10#2)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-6#2)(2007-8#3)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-9#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#4)
treatment measures##2##2##(1997-7#1)(2008-4#1)
treatment method and##2##3##(2006-12#1)(2012-3#1)
treatment method for##3##3##(2006-3#1)(2007-8#2)
treatment method of choice##2##4##(2007-11#1)(2007-8#1)
treatment method of##3##3##(2007-11#1)(2007-8#1)(2011-2#1)
treatment method should##2##3##(2007-11#1)(2011-2#1)
treatment method was applied##2##4##(2007-11#1)(2008-10#1)
treatment method was##4##3##(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)
treatment method##29##2##(2006-12#1)(2006-3#1)(2007-11#5)(2007-7#3)(2007-8#6)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#4)(2012-3#1)(2013-8#1)
treatment methods and##3##3##(2006-4#1)(2007-7#1)(2008-10#1)
treatment methods are##2##3##(2007-8#1)(2008-1#1)
treatment methods for##2##3##(1990-9#1)(2006-10#1)
treatment methods in use##2##4##(2007-11#2)
treatment methods in##3##3##(2007-11#2)(2012-2#1)
treatment methods used##2##3##(2007-8#1)(2012-12#1)
treatment methods##38##2##(1990-12#1)(1990-9#1)(1992-9#1)(1995-5#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#6)(2007-7#2)(2007-8#6)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-2#1)(2009-5#1)(2009-8#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
treatment methods]##2##2##(1991-2#1)(2011-12#1)
treatment might be##5##3##(1993-9#1)(2006-1#1)(2006-10#1)(2008-6#1)(2011-12#1)
treatment might##9##2##(1992-8#1)(1993-9#1)(2006-1#1)(2006-10#3)(2008-10#1)(2008-6#1)(2011-12#1)
treatment modalities and##6##3##(1995-5#1)(1996-12#1)(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)
treatment modalities are##8##3##(2005-12#1)(2006-11#1)(2007-11#1)(2007-8#1)(2008-7#1)(2010-2#1)(2011-2#1)(2013-7#1)
treatment modalities for##7##3##(2004-1#1)(2006-10#1)(2006-6#1)(2008-2#1)(2009-8#1)(2010-12#1)(2012-2#1)
treatment modalities have been introduced##3##5##(1990-5#1)(1997-8#1)(2013-1#1)
treatment modalities have been used##3##5##(1995-1#1)(2010-8#1)(2011-1#1)
treatment modalities have been##7##4##(1990-5#1)(1995-1#1)(1997-8#1)(2009-3#1)(2010-8#1)(2011-1#1)(2013-1#1)
treatment modalities have##9##3##(1990-5#1)(1995-1#1)(1997-8#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
treatment modalities in##3##3##(2006-10#1)(2006-9#1)(2011-2#1)
treatment modalities is##2##3##(2008-6#1)(2011-2#1)
treatment modalities may##2##3##(2008-7#1)(2011-2#1)
treatment modalities of##9##3##(1992-9#1)(1993-8#1)(1994-2#1)(2007-3#1)(2008-7#1)(2010-8#1)(2012-2#1)(2013-1#2)
treatment modalities that have been##2##5##(2011-1#1)(2012-3#1)
treatment modalities that##4##3##(2007-11#1)(2007-12#1)(2011-1#1)(2012-3#1)
treatment modalities were observed##2##4##(1996-9#1)(2006-8#1)
treatment modalities were##4##3##(1996-9#1)(2006-8#1)(2007-6#1)(2011-1#1)
treatment modalities##121##2##(1990-5#1)(1990-6#1)(1991-9#2)(1992-3#1)(1992-9#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-7#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-9#1)(1997-8#1)(2004-1#1)(2005-11#1)(2005-12#1)(2005-7#5)(2005-8#1)(2006-10#8)(2006-11#3)(2006-12#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#4)(2008-7#6)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-6#1)(2010-8#4)(2011-1#4)(2011-2#9)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#1)
treatment modality for patients with##2##5##(2006-1#1)(2010-11#1)
treatment modality for the##2##4##(1990-11#1)(2006-3#1)
treatment modality for##15##3##(1990-11#1)(1997-1#1)(2004-11#1)(2006-1#1)(2006-12#1)(2006-3#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-5#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
treatment modality in##8##3##(2005-8#1)(2006-10#1)(2006-8#1)(2007-3#1)(2009-10#1)(2009-9#1)(2012-12#2)
treatment modality is##3##3##(2007-11#1)(2007-8#1)(2012-2#1)
treatment modality over##2##3##(2006-10#1)(2007-12#1)
treatment modality##65##2##(1990-11#1)(1990-4#3)(1991-9#1)(1992-10#1)(1994-3#2)(1997-1#1)(1997-6#1)(2004-11#1)(2005-12#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-3#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#3)(2011-2#4)(2012-12#4)(2012-2#2)(2013-1#1)(2013-7#1)
treatment model##3##2##(2008-10#1)(2011-2#1)(2012-12#1)
treatment models for adults##2##4##(2008-2#2)
treatment models to##2##3##(2008-10#1)(2009-11#1)
treatment models##10##2##(2008-10#1)(2008-2#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-11#1)(2011-1#2)(2012-12#1)
treatment monitoring##4##2##(2006-8#1)(2009-4#1)(2010-8#1)(2011-2#1)
treatment months##2##2##(2007-7#1)(2009-7#1)
treatment more##2##2##(2007-6#1)(2011-1#1)
treatment most##3##2##(1996-11#1)(2006-8#1)(2008-5#1)
treatment must be##13##3##(1991-11#1)(1991-2#1)(1991-8#1)(1995-4#1)(2006-3#1)(2006-5#1)(2007-12#1)(2008-3#1)(2008-5#2)(2010-12#1)(2012-12#1)(2012-3#1)
treatment must##16##2##(1991-11#1)(1991-2#1)(1991-8#1)(1994-5#1)(1995-4#1)(2006-3#1)(2006-5#1)(2007-12#1)(2008-3#2)(2008-5#2)(2010-12#1)(2012-12#2)(2012-3#1)
treatment naïve##2##2##(2008-5#1)(2009-10#1)
treatment near##2##2##(1992-9#1)(2008-7#1)
treatment need##8##2##(2008-1#1)(2008-5#1)(2012-11#2)(2012-12#2)(2013-7#1)(2013-8#1)
treatment needs to be##4##4##(1995-2#1)(2007-9#1)(2008-7#1)(2009-6#1)
treatment needs##8##2##(1995-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-6#1)(2012-3#1)(2013-7#1)
treatment no##2##2##(1996-1#1)(2007-2#1)
treatment nonadherence##2##2##(2009-9#2)
treatment nor##3##2##(1993-12#1)(1995-12#1)(2009-4#1)
treatment occurred in##3##3##(1990-12#1)(2007-8#1)(2011-2#1)
treatment of &quot##4##3##(1990-6#1)(2007-11#1)(2010-4#1)(2012-2#1)
treatment of 1##3##3##(2007-3#1)(2008-11#1)(2010-4#1)
treatment of 11 patients##3##4##(1996-9#1)(2006-10#1)(2007-11#1)
treatment of 12##2##3##(2007-8#1)(2012-2#1)
treatment of 18##2##3##(2006-4#1)(2007-7#1)
treatment of 21##2##3##(1992-8#1)(2009-2#1)
treatment of 28##2##3##(1994-2#1)(1997-2#1)
treatment of 4##2##3##(1996-2#1)(2007-11#1)
treatment of 69 patients##2##4##(1996-8#1)(2006-6#1)
treatment of AD##3##3##(2004-12#1)(2008-7#1)(2010-2#1)
treatment of ADHD##5##3##(2008-2#2)(2010-11#1)(2011-2#2)
treatment of AF##2##3##(2008-10#1)(2010-12#1)
treatment of AIDS##2##3##(1994-8#1)(2011-3#1)
treatment of AIDS-related##2##3##(2005-8#1)(2009-6#1)
treatment of AKs##2##3##(2006-12#2)
treatment of ALL##2##3##(2011-2#2)
treatment of AP##2##3##(2006-6#2)
treatment of AVMs##2##3##(2006-2#1)(2008-9#1)
treatment of Alzheimer##2##3##(1995-1#1)(2004-12#1)
treatment of Alzheimer's disease (AD)##2##5##(2005-8#1)(2008-5#1)
treatment of Alzheimer's disease##9##4##(1992-7#1)(1993-11#1)(1996-8#1)(2005-6#1)(2005-8#1)(2006-12#1)(2008-11#1)(2008-5#2)
treatment of Alzheimer's disease]##2##4##(1991-8#1)(2012-12#1)
treatment of Alzheimer's##11##3##(1991-8#1)(1992-7#1)(1993-11#1)(1996-8#1)(2005-6#1)(2005-8#1)(2006-12#1)(2008-11#1)(2008-5#2)(2012-12#1)
treatment of AtT-20##2##3##(1990-12#1)(1995-12#1)
treatment of BA##2##3##(2008-7#2)
treatment of BII phobia##2##4##(2012-2#2)
treatment of CIN##2##3##(1990-12#1)(2006-10#1)
treatment of CLE##2##3##(2005-11#2)
treatment of CML##4##3##(1997-3#1)(2010-4#1)(2011-1#1)(2012-12#1)
treatment of CMV disease##2##4##(1993-8#1)(2007-11#1)
treatment of CMV##3##3##(1993-8#1)(2007-11#1)(2010-12#1)
treatment of Chiari I malformation##2##5##(2006-5#2)
treatment of Crohn's disease##10##4##(1994-5#1)(1994-6#1)(2006-10#1)(2006-2#1)(2007-11#3)(2008-4#1)(2010-12#1)(2013-1#1)
treatment of Crohn's##11##3##(1994-5#1)(1994-6#1)(2006-10#1)(2006-2#1)(2007-11#3)(2008-4#1)(2010-12#1)(2012-11#1)(2013-1#1)
treatment of DDH##6##3##(2007-11#1)(2007-8#5)
treatment of DME##2##3##(2011-7#2)
treatment of ESRD##3##3##(2007-12#1)(2007-7#1)(2007-8#1)
treatment of GERD##2##3##(2006-2#1)(2012-2#1)
treatment of GHF##2##3##(2011-2#2)
treatment of Graves' hyperthyroidism are##2##5##(2011-2#2)
treatment of Graves' hyperthyroidism##4##4##(2011-2#4)
treatment of Graves'##5##3##(2011-2#5)
treatment of H##2##3##(2006-2#1)(2006-8#1)
treatment of HCV##3##3##(2008-10#2)(2012-1#1)
treatment of HER2-positive##2##3##(2013-1#2)
treatment of HF##4##3##(2005-7#1)(2008-10#1)(2008-4#1)(2008-5#1)
treatment of HIV infection##8##4##(2005-10#1)(2005-7#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-5#2)
treatment of HIV##20##3##(1992-4#1)(1995-12#1)(1995-3#1)(1995-6#1)(2005-10#1)(2005-7#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-12#4)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-8#1)(2009-4#1)
treatment of HIV-1 infection##3##4##(1991-2#1)(2008-5#1)(2009-11#1)
treatment of HIV-1##4##3##(1991-2#1)(1993-9#1)(2008-5#1)(2009-11#1)
treatment of HIV-infected##3##3##(1997-8#1)(2007-11#1)(2010-9#1)
treatment of HL-60##2##3##(1991-9#1)(1994-11#1)
treatment of HRC##2##3##(2008-4#2)
treatment of Helicobacter pylori infection]##2##5##(2006-2#1)(2011-2#1)
treatment of Helicobacter pylori##4##4##(2006-10#1)(2006-2#1)(2010-12#1)(2011-2#1)
treatment of Hodgkin's disease##3##4##(1991-9#1)(2009-2#2)
treatment of Hodgkin's##7##3##(1990-9#1)(1991-9#1)(1993-9#1)(2008-4#2)(2009-2#2)
treatment of IBD##2##3##(2006-10#1)(2008-4#1)
treatment of IL-1 beta##2##4##(1994-11#2)
treatment of MRSA##2##3##(2008-5#1)(2009-6#1)
treatment of NAFLD##2##3##(2013-1#2)
treatment of OCD##5##3##(2006-9#1)(2008-3#1)(2008-6#2)(2010-2#1)
treatment of P##3##3##(1992-7#1)(2012-2#2)
treatment of PC12 cells with##2##5##(2008-11#2)
treatment of PC12 cells##3##4##(1992-9#1)(2008-11#2)
treatment of PD##8##3##(2008-11#1)(2008-7#5)(2012-1#1)(2012-2#1)
treatment of Parkinson disease (PD)##2##5##(2006-4#1)(2013-7#1)
treatment of Parkinson disease##3##4##(2006-4#1)(2013-7#2)
treatment of Parkinson's disease (PD)##3##5##(2005-7#1)(2005-8#1)(2008-10#1)
treatment of Parkinson's disease##16##4##(1992-3#1)(1995-12#1)(1996-1#1)(1996-3#2)(2005-7#2)(2005-8#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#2)
treatment of Perthes' disease##3##4##(2007-7#3)
treatment of RA##6##3##(2007-11#2)(2008-5#2)(2013-8#2)
treatment of RE##3##3##(2008-8#3)
treatment of S##2##3##(2008-5#1)(2010-8#1)
treatment of SUI##2##3##(2008-3#1)(2008-8#1)
treatment of T1##2##3##(1991-4#1)(2011-2#1)
treatment of TB##2##3##(2007-11#1)(2013-7#1)
treatment of TBI##2##3##(2008-10#1)(2008-9#1)
treatment of TN##2##3##(2010-12#1)(2011-2#1)
treatment of Type##3##3##(2005-8#1)(2006-7#1)(2010-10#1)
treatment of VAP##2##3##(2005-8#1)(2010-7#1)
treatment of Zenker's##3##3##(1990-3#2)(2007-8#1)
treatment of a case of##2##5##(2007-11#1)(2012-2#1)
treatment of a congenital splenic cyst with##2##7##(1997-8#2)
treatment of a number of##4##5##(2005-6#1)(2005-7#1)(2007-7#1)(2011-2#1)
treatment of a patient with##6##5##(2006-10#1)(2007-11#2)(2008-10#1)(2011-2#1)(2012-12#1)
treatment of a variety of##6##5##(1996-4#1)(2006-8#1)(2008-11#1)(2008-5#2)(2013-8#1)
treatment of a wide range of##2##6##(2006-10#1)(2011-2#1)
treatment of a wide variety of##2##6##(2008-5#1)(2010-12#1)
treatment of a wide##4##4##(2006-10#1)(2008-5#1)(2010-12#1)(2011-2#1)
treatment of a##73##3##(1990-9#1)(1991-1#1)(1991-2#1)(1991-7#1)(1992-6#2)(1993-8#2)(1994-12#1)(1994-2#1)(1994-4#1)(1994-6#1)(1996-4#1)(1996-6#1)(1997-8#3)(2004-2#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-8#1)(2007-1#1)(2007-11#5)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-6#2)(2009-7#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#7)(2012-12#3)(2012-2#1)(2013-1#4)(2013-8#2)
treatment of abdominal aortic aneurysms##3##5##(1990-8#1)(1992-8#1)(2008-8#1)
treatment of abdominal aortic##6##4##(1990-8#1)(1992-8#1)(1996-2#1)(2006-10#1)(2008-8#1)(2010-12#1)
treatment of abdominal##10##3##(1990-8#1)(1992-8#2)(1996-2#1)(2006-10#1)(2006-4#1)(2008-8#2)(2008-9#1)(2010-12#1)
treatment of achalasia##3##3##(1993-10#1)(2011-1#2)
treatment of acne and##3##4##(2006-12#1)(2010-3#1)(2010-5#1)
treatment of acne vulgaris##12##4##(1997-8#1)(2007-7#2)(2008-5#5)(2010-5#1)(2010-8#3)
treatment of acne##19##3##(1997-8#1)(2006-12#2)(2007-10#1)(2007-7#2)(2008-3#1)(2008-5#5)(2010-3#1)(2010-5#3)(2010-8#3)
treatment of actinic keratoses##2##4##(2006-12#1)(2010-8#1)
treatment of active##4##3##(2006-2#1)(2007-11#1)(2012-3#1)(2013-8#1)
treatment of acute and chronic##2##5##(2006-8#1)(2007-2#1)
treatment of acute and##3##4##(1994-11#1)(2006-8#1)(2007-2#1)
treatment of acute bacterial##4##4##(1991-12#1)(1991-3#1)(2008-3#1)(2010-11#1)
treatment of acute coronary syndrome##2##5##(2006-9#1)(2013-1#1)
treatment of acute exacerbations##4##4##(1991-12#1)(1991-6#2)(2011-2#1)
treatment of acute ischemic stroke##3##5##(2007-9#3)
treatment of acute ischemic##5##4##(2005-9#1)(2007-10#1)(2007-9#3)
treatment of acute lumbar painful syndrome##2##6##(2005-10#2)
treatment of acute migraine##4##4##(1994-4#1)(2005-7#1)(2007-7#1)(2012-2#1)
treatment of acute myocardial infarction##2##5##(2008-3#1)(2012-2#1)
treatment of acute myocardial##4##4##(1991-6#1)(1995-5#1)(2008-3#1)(2012-2#1)
treatment of acute or chronic##2##5##(1990-7#1)(2006-10#1)
treatment of acute rejection##3##4##(2007-11#2)(2008-10#1)
treatment of acute stroke##4##4##(2007-10#2)(2007-9#1)(2009-11#1)
treatment of acute##93##3##(1990-5#1)(1990-7#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-4#2)(1991-6#3)(1991-9#1)(1992-2#2)(1992-3#1)(1992-8#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-4#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-3#1)(1997-7#1)(2005-1#1)(2005-10#4)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#9)(2007-2#1)(2007-7#3)(2007-8#1)(2007-9#4)(2008-10#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-7#1)(2010-11#1)(2010-12#4)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)
treatment of adolescents##2##3##(1992-3#1)(2005-6#1)
treatment of adult##11##3##(1995-6#1)(1996-1#1)(2005-12#1)(2006-8#1)(2007-11#1)(2007-6#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2012-12#1)
treatment of adults with##4##4##(1997-8#1)(2007-11#1)(2008-11#1)(2008-3#1)
treatment of adults##7##3##(1996-11#1)(1997-8#1)(2007-11#1)(2008-11#1)(2008-3#1)(2009-3#1)(2011-1#1)
treatment of advanced disease##2##4##(1992-8#1)(2006-10#1)
treatment of advanced soft tissue limb sarcoma##2##7##(2006-6#2)
treatment of advanced stages of##2##5##(2008-4#1)(2011-2#1)
treatment of advanced##28##3##(1990-12#3)(1991-4#1)(1992-8#1)(1993-6#1)(1994-12#1)(1994-7#1)(1996-3#1)(2006-10#1)(2006-6#3)(2007-11#3)(2007-8#2)(2008-4#2)(2008-5#2)(2008-6#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)
treatment of affective disorders##3##4##(1991-11#1)(1996-12#1)(2011-2#1)
treatment of affective##4##3##(1991-11#1)(1992-8#1)(1996-12#1)(2011-2#1)
treatment of aged##2##3##(2007-11#1)(2008-12#1)
treatment of airway##2##3##(1995-12#1)(2009-1#1)
treatment of alcohol dependence##5##4##(1991-12#3)(2008-2#2)
treatment of alcohol##7##3##(1990-2#1)(1991-12#3)(2005-6#1)(2008-2#2)
treatment of alcoholic chronic pancreatitis##3##5##(2009-7#3)
treatment of alcoholic##4##3##(1995-11#1)(2009-7#3)
treatment of alcoholism##3##3##(1990-12#1)(1994-5#1)(1995-11#1)
treatment of all patients##2##4##(2008-5#1)(2012-2#1)
treatment of all##5##3##(1993-10#1)(1996-11#1)(2008-5#1)(2009-8#1)(2012-2#1)
treatment of allergic conjunctivitis##2##4##(2007-11#2)
treatment of allergic rhinitis in children##3##6##(2007-11#2)(2013-8#1)
treatment of allergic rhinitis##8##4##(2007-11#5)(2007-2#1)(2011-2#1)(2013-8#1)
treatment of allergic##14##3##(2005-7#1)(2005-9#1)(2007-11#7)(2007-2#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
treatment of amblyopia##2##3##(2012-12#2)
treatment of an abdominal aortic aneurysm##2##6##(2011-2#2)
treatment of an acute##3##4##(2007-9#1)(2011-2#2)
treatment of an arteriovenous##2##4##(2007-10#1)(2007-7#1)
treatment of an##24##3##(1992-6#1)(1997-5#1)(2005-11#1)(2005-8#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#2)(2007-9#2)(2008-10#1)(2008-7#1)(2010-11#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-2#1)(2012-3#1)
treatment of anaphylaxis##2##3##(2009-12#1)(2013-8#1)
treatment of anemia##4##3##(1996-2#1)(2007-4#1)(2007-7#1)(2008-1#1)
treatment of aneurysms##2##3##(2008-5#1)(2010-12#1)
treatment of angina pectoris##3##4##(2010-8#1)(2011-2#1)(2013-1#1)
treatment of animals with##2##4##(1991-3#1)(2008-7#1)
treatment of animals##3##3##(1991-3#1)(2008-3#1)(2008-7#1)
treatment of ankle##2##3##(2009-1#1)(2012-2#1)
treatment of anxiety disorders##2##4##(2007-7#1)(2008-6#1)
treatment of anxiety##6##3##(2007-7#1)(2008-6#1)(2009-9#3)(2012-12#1)
treatment of any##4##3##(1991-12#1)(1996-9#1)(2007-8#1)(2010-2#1)
treatment of aorta##2##3##(2008-10#1)(2013-8#1)
treatment of aortic##3##3##(1990-8#1)(1992-8#1)(2007-3#1)
treatment of arrhythmia##2##3##(2005-7#1)(2010-12#1)
treatment of arrhythmias##3##3##(1995-11#1)(2010-12#1)(2011-1#1)
treatment of arterial hypertension]##4##4##(1993-11#1)(1993-2#1)(1995-4#1)(1996-3#1)
treatment of arterial##5##3##(1993-11#1)(1993-2#1)(1995-4#1)(1996-3#1)(2011-2#1)
treatment of arteriovenous malformation##2##4##(2007-10#1)(2008-7#1)
treatment of arteriovenous##4##3##(1996-9#1)(2006-2#1)(2007-10#1)(2008-7#1)
treatment of arthritis##4##3##(1991-8#1)(2005-8#1)(2008-3#1)(2008-5#1)
treatment of arthrosis##2##3##(1993-11#1)(1997-6#1)
treatment of articular##2##3##(2007-11#1)(2012-3#1)
treatment of ascites and##2##4##(2009-8#2)
treatment of ascites##5##3##(2007-12#1)(2007-5#1)(2009-8#3)
treatment of asthma##19##3##(1991-4#1)(1992-2#1)(1992-3#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-8#2)(2007-11#3)(2008-3#3)(2013-1#1)(2013-7#1)
treatment of asymptomatic##2##3##(2006-10#1)(2006-11#1)
treatment of atrial fibrillation in##3##5##(1995-4#1)(2011-2#1)(2012-3#1)
treatment of atrial fibrillation##9##4##(1995-4#2)(2006-10#1)(2006-9#1)(2007-8#2)(2008-7#1)(2011-2#1)(2012-3#1)
treatment of atrial##10##3##(1995-4#2)(2006-10#1)(2006-9#1)(2007-8#2)(2008-1#1)(2008-7#1)(2011-2#1)(2012-3#1)
treatment of attention deficit hyperactivity disorder##3##6##(2006-12#1)(2006-2#1)(2008-6#1)
treatment of autism##2##3##(2010-7#1)(2012-2#1)
treatment of autoimmune disease##2##4##(1991-12#2)
treatment of autoimmune diseases##2##4##(2005-8#1)(2012-3#1)
treatment of autoimmune##9##3##(1991-12#2)(1993-11#1)(2005-8#1)(2007-11#1)(2012-2#1)(2012-3#2)(2013-8#1)
treatment of axillary##2##3##(1991-8#1)(2008-5#1)
treatment of back##3##3##(1997-2#1)(1997-6#1)(2006-8#1)
treatment of bacterial meningitis##2##4##(2008-11#1)(2010-12#1)
treatment of bacterial##7##3##(2005-11#1)(2006-10#1)(2006-5#1)(2008-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
treatment of basal cell##3##4##(2005-8#1)(2007-11#2)
treatment of benign adrenal##2##4##(2008-10#1)(2008-9#1)
treatment of benign and malignant##2##5##(2006-10#1)(2011-2#1)
treatment of benign prostatic##4##4##(1993-10#1)(1994-11#1)(2006-9#1)(2008-5#1)
treatment of benign##14##3##(1990-5#1)(1990-6#1)(1992-2#1)(1993-10#1)(1994-11#1)(2006-10#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#1)
treatment of biceps##2##3##(2013-7#2)
treatment of bilateral##2##3##(2013-1#1)(2013-7#1)
treatment of bile duct##2##4##(2008-3#1)(2008-5#1)
treatment of biliary and pancreatic tract diseases##2##7##(1991-12#2)
treatment of biliary atresia##2##4##(2010-2#1)(2013-1#1)
treatment of biliary##9##3##(1991-12#2)(2006-10#2)(2006-2#1)(2006-6#1)(2007-5#1)(2010-2#1)(2013-1#1)
treatment of bipolar depression##2##4##(2013-8#2)
treatment of bipolar disorder##4##4##(2008-8#3)(2011-12#1)
treatment of bipolar##7##3##(2008-3#1)(2008-8#3)(2011-12#1)(2013-8#2)
treatment of bone defects##2##4##(2007-11#1)(2007-8#1)
treatment of bone metastases to proximal femur##2##7##(2007-11#2)
treatment of bone metastases to the##3##6##(2007-11#3)
treatment of bone metastases to##5##5##(2007-11#5)
treatment of bone metastases##13##4##(1993-10#1)(2007-11#11)(2008-7#1)
treatment of bone metastasis##2##4##(1993-11#1)(2011-2#1)
treatment of bone##22##3##(1993-10#1)(1993-11#1)(2006-10#1)(2007-11#13)(2007-8#2)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#1)
treatment of borderline##2##3##(2005-6#1)(2008-6#1)
treatment of both##10##3##(1991-3#1)(1994-9#1)(2005-8#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-3#1)(2010-1#1)(2011-1#1)(2013-1#1)
treatment of brachial plexus##2##4##(2008-9#2)
treatment of brain##9##3##(1990-5#1)(1995-2#1)(1995-4#1)(2005-8#2)(2006-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
treatment of breakthrough pain in##2##5##(2007-2#1)(2011-2#1)
treatment of breast cancer and##2##5##(1990-11#1)(2010-1#1)
treatment of breast cancer in##2##5##(1993-1#1)(2010-8#1)
treatment of breast cancer patients with##2##6##(2005-10#2)
treatment of breast cancer patients##4##5##(1993-11#1)(2005-10#3)
treatment of breast cancer##25##4##(1990-11#2)(1992-5#1)(1993-1#1)(1993-11#3)(1993-4#1)(1993-8#1)(1995-11#1)(1995-12#1)(1996-11#1)(1997-3#1)(2004-1#2)(2005-10#4)(2008-5#1)(2009-5#1)(2010-1#1)(2010-8#1)(2011-1#1)(2012-1#1)
treatment of breast##30##3##(1990-11#2)(1990-2#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#3)(1993-4#1)(1993-6#1)(1993-8#1)(1995-11#1)(1995-12#1)(1996-11#1)(1997-3#1)(1997-7#1)(2004-1#2)(2005-10#4)(2008-3#1)(2008-5#1)(2009-5#1)(2010-1#1)(2010-8#1)(2011-1#1)(2012-1#1)
treatment of bronchial##4##3##(1996-7#1)(2008-1#1)(2008-5#1)(2013-8#1)
treatment of brush border membrane##2##5##(1990-2#2)
treatment of cSSTIs##2##3##(2008-3#2)
treatment of cancer and##3##4##(2005-7#1)(2005-8#1)(2008-5#1)
treatment of cancer during pregnancy##2##5##(2013-1#2)
treatment of cancer pain##3##4##(2006-12#1)(2006-6#1)(2007-3#1)
treatment of cancer##58##3##(1990-3#1)(1990-9#1)(1992-3#1)(1993-3#1)(1994-4#1)(1995-8#1)(2004-9#1)(2005-10#1)(2005-6#1)(2005-7#3)(2005-8#3)(2006-11#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-3#2)(2007-4#1)(2008-1#5)(2008-10#2)(2008-11#2)(2008-5#9)(2008-7#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-10#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#4)
treatment of cancers##3##3##(2008-5#2)(2008-8#1)
treatment of carcinoma of the anal canal##2##7##(1994-4#1)(2007-4#1)
treatment of carcinoma of the##4##5##(1990-12#1)(1991-3#1)(1994-4#1)(2007-4#1)
treatment of carcinoma##5##3##(1990-12#1)(1991-3#1)(1991-9#1)(1994-4#1)(2007-4#1)
treatment of cardiac##5##3##(1990-9#1)(1991-9#1)(2005-8#1)(2007-8#1)(2008-5#1)
treatment of cardiovascular diseases##4##4##(2006-9#1)(2007-8#1)(2008-1#1)(2010-8#1)
treatment of cardiovascular##15##3##(1993-5#1)(1996-8#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-8#1)(2008-1#3)(2008-3#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-1#1)
treatment of carotid artery##2##4##(2006-11#1)(2007-8#1)
treatment of carotid##4##3##(1990-5#1)(2006-11#1)(2007-8#1)(2008-8#1)
treatment of carpal tunnel syndrome##3##5##(1997-6#1)(2007-8#1)(2008-5#1)
treatment of cartilage##2##3##(2007-11#2)
treatment of cat-scratch disease with ciprofloxacin##2##6##(1991-4#2)
treatment of cells expressing##2##4##(1992-8#2)
treatment of cells with the##3##5##(1991-12#1)(1992-8#1)(2008-11#1)
treatment of cells with##15##4##(1991-12#1)(1992-8#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-5#1)(1996-9#1)(2007-3#1)(2008-11#3)(2008-8#1)
treatment of cells##23##3##(1991-12#1)(1992-12#1)(1992-8#3)(1994-12#1)(1994-3#2)(1994-9#1)(1995-3#2)(1995-5#1)(1995-6#3)(1996-5#1)(1996-9#1)(1997-1#1)(2007-3#1)(2008-11#3)(2008-8#1)
treatment of central##3##3##(2008-7#1)(2010-6#1)(2011-2#1)
treatment of cerebral metastases]##2##4##(1997-4#1)(2011-1#1)
treatment of cerebral##11##3##(1990-3#1)(1991-11#1)(1996-8#1)(1997-4#1)(2006-10#2)(2007-9#1)(2008-8#1)(2008-9#1)(2011-1#2)
treatment of certain spinal##3##4##(2007-11#1)(2007-8#1)(2008-8#1)
treatment of certain##10##3##(1992-9#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)
treatment of cervical intraepithelial neoplasia##5##5##(1991-2#2)(1994-12#1)(1994-4#1)(2012-3#1)
treatment of cervical##13##3##(1991-1#1)(1991-2#2)(1992-2#1)(1994-12#1)(1994-4#1)(1996-3#1)(2005-10#1)(2007-10#1)(2007-11#1)(2008-9#1)(2012-3#1)(2013-8#1)
treatment of chemotherapy-induced##8##3##(2007-11#1)(2008-3#1)(2008-7#4)(2008-8#1)(2010-11#1)
treatment of chest##3##3##(1991-2#1)(2007-8#1)(2008-3#1)
treatment of childhood##8##3##(1991-8#1)(2008-11#2)(2008-3#1)(2008-7#1)(2011-2#2)(2012-2#1)
treatment of children and adolescents##3##5##(1991-2#1)(1993-1#1)(2008-4#1)
treatment of children and##4##4##(1991-2#1)(1993-1#1)(1993-9#1)(2008-4#1)
treatment of children with high##2##5##(1993-9#1)(2008-9#1)
treatment of children with moyamoya disease##2##6##(2006-11#2)
treatment of children with##20##4##(1992-11#1)(1993-9#1)(1994-6#1)(2006-10#3)(2006-11#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-9#1)(2011-2#1)(2013-1#1)
treatment of children##27##3##(1991-2#1)(1992-11#1)(1993-1#1)(1993-9#2)(1994-6#1)(2006-10#3)(2006-11#2)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-3#1)(2010-9#1)(2011-2#1)(2013-1#1)
treatment of choice for patients with##7##6##(2006-11#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-7#1)(2009-12#1)(2010-10#1)
treatment of choice for patients##8##5##(2006-11#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-4#1)(2007-7#1)(2009-12#1)(2010-10#1)
treatment of choice for this##2##5##(2007-11#1)(2007-8#1)
treatment of choice for##40##4##(1991-9#1)(1994-12#1)(1994-6#1)(1994-7#1)(1995-8#1)(1997-3#1)(2005-5#1)(2006-10#5)(2006-11#1)(2006-5#2)(2006-9#1)(2007-11#2)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-6#2)(2010-8#1)(2011-2#1)(2013-1#2)
treatment of choice in##23##4##(1990-9#1)(1991-6#2)(1991-9#1)(1992-10#1)(1992-12#1)(1993-8#1)(1994-3#1)(1994-4#1)(2006-1#1)(2006-10#1)(2007-11#2)(2007-7#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
treatment of choice is##11##4##(1990-2#1)(1991-9#1)(1994-5#1)(1996-9#1)(2004-1#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-4#1)(2010-12#1)(2013-1#1)
treatment of choice##120##3##(1990-2#2)(1990-6#2)(1990-9#2)(1991-10#1)(1991-6#2)(1991-9#4)(1992-10#2)(1992-12#1)(1992-3#1)(1992-9#2)(1993-10#1)(1993-5#2)(1993-8#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-8#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-1#1)(2005-5#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-4#2)(2006-5#2)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#4)(2007-8#8)(2008-1#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-6#4)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#3)
treatment of choledocholithiasis##2##3##(1997-8#1)(2005-12#1)
treatment of chronic anal fissure##3##5##(2008-12#2)(2011-2#1)
treatment of chronic and acute##2##5##(1991-11#1)(2010-2#1)
treatment of chronic heart failure (CHF)##3##6##(2007-9#1)(2009-10#1)(2012-3#1)
treatment of chronic heart failure##5##5##(2007-9#1)(2008-5#1)(2008-7#1)(2009-10#1)(2012-3#1)
treatment of chronic hepatitis B##4##5##(2006-10#1)(2007-11#1)(2009-8#2)
treatment of chronic hepatitis C##6##5##(2007-11#2)(2007-12#1)(2009-5#1)(2009-7#1)(2012-12#1)
treatment of chronic hepatitis##10##4##(2006-10#1)(2007-11#3)(2007-12#1)(2009-5#1)(2009-7#1)(2009-8#2)(2012-12#1)
treatment of chronic inflammation##2##4##(2007-11#1)(2008-1#1)
treatment of chronic inflammatory##4##4##(1990-5#1)(2007-7#1)(2008-4#1)(2008-5#1)
treatment of chronic liver disease##2##5##(1993-11#1)(2006-2#1)
treatment of chronic low back pain##3##6##(2006-10#1)(2006-7#1)(2006-8#1)
treatment of chronic lymphocytic leukemia (CLL)##2##6##(2005-9#1)(2009-12#1)
treatment of chronic lymphocytic##3##4##(2005-9#1)(2008-7#1)(2009-12#1)
treatment of chronic myeloid leukemia##4##5##(2009-3#2)(2010-11#2)
treatment of chronic obstructive pulmonary disease (COPD)##2##7##(2007-11#1)(2010-5#1)
treatment of chronic obstructive pulmonary disease##4##6##(1991-12#1)(2006-10#1)(2007-11#1)(2010-5#1)
treatment of chronic obstructive##5##4##(1991-12#1)(1995-2#1)(2006-10#1)(2007-11#1)(2010-5#1)
treatment of chronic pain patients##3##5##(2006-12#1)(2006-8#1)(2008-3#1)
treatment of chronic pain##14##4##(1990-5#1)(1991-2#1)(1993-5#1)(1995-9#1)(1996-7#1)(2005-7#1)(2006-12#3)(2006-8#3)(2008-3#1)(2010-6#1)
treatment of chronic pancreatitis##2##4##(2006-6#2)
treatment of chronic##108##3##(1990-5#2)(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1993-11#1)(1993-5#2)(1995-2#1)(1995-9#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-4#1)(2005-10#1)(2005-7#1)(2005-9#1)(2006-10#3)(2006-12#3)(2006-2#2)(2006-4#2)(2006-6#4)(2006-7#5)(2006-8#6)(2007-11#5)(2007-12#1)(2007-6#2)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-5#1)(2009-7#1)(2009-8#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#2)(2011-2#5)(2012-1#2)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#2)
treatment of clinical##3##3##(2006-10#1)(2006-11#1)(2012-3#1)
treatment of clinically localized##2##4##(1994-7#1)(2006-10#1)
treatment of cocaine abuse##2##4##(1991-1#2)
treatment of cocaine##3##3##(1991-1#3)
treatment of cognitive and##2##4##(1991-6#1)(1996-11#1)
treatment of cognitive##3##3##(1991-6#1)(1996-11#1)(2008-7#1)
treatment of colon and rectal cancer##3##6##(1992-8#1)(2011-2#2)
treatment of colon##6##3##(1992-8#1)(2006-6#1)(2007-3#1)(2008-3#1)(2011-2#2)
treatment of colorectal cancer##7##4##(1994-2#1)(1996-1#1)(2007-9#1)(2008-5#2)(2009-4#1)(2012-1#1)
treatment of colorectal liver metastases##5##5##(2006-6#1)(2010-11#2)(2012-3#2)
treatment of colorectal liver##6##4##(2006-6#1)(2010-11#2)(2012-1#1)(2012-3#2)
treatment of colorectal##19##3##(1994-2#1)(1995-9#1)(1996-1#1)(2006-6#1)(2007-9#1)(2008-5#2)(2009-4#1)(2010-11#2)(2010-12#1)(2012-1#6)(2012-3#2)
treatment of combined##2##3##(2006-3#1)(2012-1#1)
treatment of common marmosets##2##4##(1990-5#2)
treatment of common##4##3##(1990-5#2)(2009-5#1)(2013-7#1)
treatment of community-acquired pneumonia##3##4##(2006-10#1)(2007-12#1)(2008-3#1)
treatment of community-acquired##4##3##(2006-10#1)(2007-12#1)(2008-3#2)
treatment of complex##6##3##(2006-10#2)(2006-3#1)(2006-6#1)(2007-8#1)(2009-9#1)
treatment of complicated##6##3##(2005-12#1)(2008-3#3)(2011-1#1)(2012-2#1)
treatment of complications of##2##4##(2007-11#1)(2008-1#1)
treatment of complications##4##3##(2006-10#1)(2006-6#1)(2007-11#1)(2008-1#1)
treatment of congenital adrenal hyperplasia##4##5##(2008-4#4)
treatment of congenital dislocation of the hip##2##7##(2006-9#1)(2007-11#1)
treatment of congenital heart defects##2##5##(1997-8#2)
treatment of congenital heart disease##3##5##(1992-6#1)(1993-10#1)(2006-10#1)
treatment of congenital heart##5##4##(1992-6#1)(1993-10#1)(1997-8#2)(2006-10#1)
treatment of congenital##17##3##(1990-3#1)(1990-9#1)(1992-6#1)(1993-10#1)(1997-8#2)(2005-10#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-11#1)(2008-4#4)(2008-7#1)(2009-5#1)
treatment of congestive cardiac failure##2##5##(1996-3#1)(2010-7#1)
treatment of congestive heart failure##3##5##(1992-6#1)(2005-9#1)(2007-11#1)
treatment of congestive##5##3##(1992-6#1)(1996-3#1)(2005-9#1)(2007-11#1)(2010-7#1)
treatment of control##2##3##(1994-6#2)
treatment of coronary artery disease##4##5##(2006-11#1)(2006-6#1)(2008-6#1)(2008-8#1)
treatment of coronary artery##7##4##(2006-11#1)(2006-6#1)(2007-8#2)(2008-6#1)(2008-8#1)(2011-2#1)
treatment of coronary heart##2##4##(2008-4#2)
treatment of coronary##12##3##(1992-4#1)(2006-11#1)(2006-6#1)(2007-8#2)(2008-11#1)(2008-4#2)(2008-6#1)(2008-8#1)(2009-5#1)(2011-2#1)
treatment of cryptococcal meningitis in the##2##6##(1991-2#1)(2011-2#1)
treatment of cultured##3##3##(1990-5#1)(1994-11#1)(2012-12#1)
treatment of cutaneous lupus##2##4##(2005-11#2)
treatment of cutaneous##6##3##(2005-11#3)(2007-2#2)(2009-2#1)
treatment of cystic##3##3##(1991-2#1)(1996-12#1)(2007-6#1)
treatment of data##3##3##(2008-10#2)(2011-2#1)
treatment of deep venous thrombosis##3##5##(1990-12#1)(1994-7#1)(2008-7#1)
treatment of deep##6##3##(1990-12#1)(1994-7#1)(2005-8#1)(2008-7#1)(2010-5#1)(2012-3#1)
treatment of defects##2##3##(2011-2#1)(2012-2#1)
treatment of degenerative##8##3##(1996-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-7#1)(2011-1#2)(2013-8#1)
treatment of delayed##2##3##(2007-11#1)(2008-1#1)
treatment of delirium##3##3##(2009-9#2)(2011-2#1)
treatment of dementia##4##3##(1996-9#1)(2006-3#1)(2008-11#2)
treatment of dental##5##3##(1991-1#1)(1991-5#1)(1995-9#1)(2008-7#1)(2013-1#1)
treatment of depression in##4##4##(1996-12#1)(2006-6#1)(2010-2#2)
treatment of depression##39##3##(1994-8#1)(1995-5#1)(1995-7#1)(1996-12#3)(2004-3#2)(2005-9#5)(2006-6#1)(2006-9#1)(2008-2#3)(2008-4#4)(2008-6#3)(2008-8#1)(2009-10#2)(2010-2#2)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#4)
treatment of depressive##3##3##(1995-5#1)(2005-7#1)(2006-4#1)
treatment of developmental dislocation of the hip##2##7##(2007-11#1)(2007-8#1)
treatment of developmental dislocation##4##4##(2007-11#2)(2007-8#2)
treatment of developmental dysplasia of the hip##5##7##(2007-8#5)
treatment of developmental hip dislocation##2##5##(2007-8#2)
treatment of developmental hip dysplasia##2##5##(2007-7#2)
treatment of developmental hip##4##4##(2007-7#2)(2007-8#2)
treatment of developmental##15##3##(2007-11#2)(2007-7#2)(2007-8#11)
treatment of diabetes and##2##4##(2008-1#2)
treatment of diabetes mellitus##3##4##(1992-3#1)(2008-4#1)(2010-11#1)
treatment of diabetes##22##3##(1992-3#2)(1993-9#1)(2005-7#1)(2005-8#3)(2007-5#2)(2008-1#3)(2008-4#5)(2008-5#1)(2010-11#1)(2010-12#1)(2010-4#1)(2012-3#1)
treatment of diabetic complications##2##4##(2008-1#2)
treatment of diabetic foot##2##4##(2008-12#1)(2011-2#1)
treatment of diabetic nephropathy##2##4##(2008-1#1)(2013-1#1)
treatment of diabetic##16##3##(1991-11#1)(2005-7#1)(2006-1#2)(2007-7#1)(2008-1#7)(2008-12#1)(2008-4#1)(2011-2#1)(2013-1#1)
treatment of diarrhoea##2##3##(2010-12#2)
treatment of different diseases##3##4##(1993-11#1)(2008-1#1)(2012-12#1)
treatment of different types of##2##5##(2010-12#1)(2011-2#1)
treatment of different##9##3##(1993-11#1)(2008-1#1)(2008-10#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
treatment of diffuse##5##3##(2007-12#1)(2008-10#1)(2009-2#2)(2012-2#1)
treatment of direct inguinal##2##4##(1990-6#2)
treatment of direct##3##3##(1990-6#2)(1996-1#1)
treatment of disease##9##3##(1990-12#1)(1997-3#1)(2007-4#1)(2008-10#1)(2008-11#1)(2009-3#1)(2009-7#1)(2010-1#1)(2011-2#1)
treatment of diseases and injuries of the##3##7##(2007-7#2)(2007-8#1)
treatment of diseases and##4##4##(2007-7#2)(2007-8#2)
treatment of diseases caused by##2##5##(1994-9#1)(2008-3#1)
treatment of diseases of the##2##5##(2007-7#1)(2011-2#1)
treatment of diseases##17##3##(1994-4#1)(1994-9#1)(2005-7#1)(2006-10#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-11#1)(2008-3#1)(2008-4#1)(2010-4#1)(2011-2#2)(2013-1#1)
treatment of diverticulitis##2##3##(2010-8#2)
treatment of drug##3##3##(2008-4#1)(2009-8#1)(2012-3#1)
treatment of dry eye##3##4##(2006-10#1)(2007-1#2)
treatment of dry##5##3##(2006-10#1)(2006-12#1)(2007-1#2)(2008-5#1)
treatment of dual##2##3##(2009-8#1)(2013-7#1)
treatment of dyslipidemia in##2##4##(2008-1#1)(2011-2#1)
treatment of dyslipidemia##3##3##(2008-1#1)(2008-10#1)(2011-2#1)
treatment of dysphagia in patients with##2##6##(1993-6#1)(2007-8#1)
treatment of dysplastic##2##3##(2007-7#2)
treatment of early breast cancer##4##5##(1994-9#1)(2008-5#2)(2010-7#1)
treatment of early gastric cancer##2##5##(2008-5#1)(2010-12#1)
treatment of early stage cervical cancer##2##6##(2009-2#1)(2011-2#1)
treatment of early stage##5##4##(2009-2#1)(2009-5#2)(2010-8#1)(2011-2#1)
treatment of early##26##3##(1994-9#1)(1995-11#1)(1995-8#1)(2005-10#1)(2005-7#1)(2006-10#3)(2007-11#1)(2007-8#1)(2008-5#4)(2008-7#2)(2009-2#3)(2009-5#2)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#2)
treatment of early-stage##3##3##(1995-8#1)(2007-12#1)(2010-12#1)
treatment of ectopic pregnancy##4##4##(1997-2#1)(2004-10#3)
treatment of ectopic##5##3##(1997-2#2)(2004-10#3)
treatment of elderly patients with##2##5##(1990-10#1)(2005-10#1)
treatment of elderly##4##3##(1990-1#1)(1990-10#1)(2005-10#1)(2010-12#1)
treatment of emphysema##2##3##(2008-5#1)(2009-1#1)
treatment of end-stage##7##3##(2006-10#1)(2007-2#1)(2007-4#2)(2010-12#1)(2010-6#1)(2011-2#1)
treatment of endometriosis##8##3##(1992-2#2)(1994-9#2)(2007-10#1)(2007-8#1)(2008-5#1)(2011-1#1)
treatment of epilepsy and##2##4##(2008-1#1)(2008-11#1)
treatment of epilepsy in##2##4##(2006-3#1)(2008-11#1)
treatment of epilepsy##12##3##(1990-9#1)(1996-3#1)(2006-10#1)(2006-3#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#1)(2011-1#1)(2013-7#1)
treatment of erythema##3##3##(2007-11#1)(2008-5#1)(2012-2#1)
treatment of erythrocytes##2##3##(1992-1#1)(1993-9#1)
treatment of esophageal cancer##7##4##(2006-10#5)(2009-3#1)(2013-8#1)
treatment of esophageal carcinoma##2##4##(2006-10#1)(2007-8#1)
treatment of esophageal##15##3##(1991-5#1)(1993-2#1)(2006-10#7)(2006-2#2)(2007-8#1)(2008-12#1)(2009-3#1)(2013-8#1)
treatment of essential hypertension##4##4##(1992-8#1)(1993-2#1)(1996-9#1)(2008-7#1)
treatment of essential##5##3##(1990-9#1)(1992-8#1)(1993-2#1)(1996-9#1)(2008-7#1)
treatment of established osteoporosis##2##4##(1993-11#1)(2007-11#1)
treatment of established##6##3##(1993-11#1)(2006-10#2)(2007-11#1)(2010-11#1)(2010-7#1)
treatment of exogenous post-concussion syndrome##2##5##(1990-10#2)
treatment of extrahepatic biliary lithiasis##2##5##(1991-5#1)(1993-10#1)
treatment of facial##2##3##(2008-9#1)(2009-2#1)
treatment of familial hypercholesterolemia##3##4##(1991-9#1)(1993-9#2)
treatment of familial##5##3##(1991-9#1)(1993-9#2)(2012-1#2)
treatment of fatigue##2##3##(1992-2#1)(2006-10#1)
treatment of fecal##2##3##(1992-10#1)(2013-1#1)
treatment of female##4##3##(1994-5#1)(2007-9#1)(2008-9#1)(2010-11#1)
treatment of femoral neck fractures##2##5##(1991-9#1)(2007-8#1)
treatment of femoral shaft fractures##2##5##(2007-11#2)
treatment of femoral##7##3##(1991-9#1)(2007-11#4)(2007-8#1)(2008-7#1)
treatment of fibromyalgia##4##3##(1996-2#1)(2006-10#2)(2010-12#1)
treatment of fibrotic##2##3##(2008-1#1)(2012-12#1)
treatment of flail chest##3##4##(2007-8#3)
treatment of follicular lymphoma##2##4##(2010-11#1)(2012-2#1)
treatment of follicular##3##3##(2010-11#1)(2012-2#2)
treatment of fractures of the##5##5##(1993-8#1)(2006-10#1)(2007-8#1)(2008-9#1)(2009-2#1)
treatment of fractures##10##3##(1992-4#1)(1993-8#1)(2006-10#1)(2007-11#1)(2007-8#3)(2008-9#1)(2009-2#1)(2009-8#1)
treatment of fresh leachate in an expanded granular sludge bed##2##10##(2011-2#2)
treatment of functional##3##3##(2006-6#1)(2011-1#1)(2013-8#1)
treatment of fungal infections##4##4##(2005-7#1)(2006-4#1)(2008-7#1)(2011-2#1)
treatment of fungal##6##3##(2005-7#1)(2005-8#1)(2006-4#1)(2008-3#1)(2008-7#1)(2011-2#1)
treatment of gastric cancer##3##4##(2006-2#1)(2006-4#1)(2008-5#1)
treatment of gastric carcinoma##3##4##(2006-2#1)(2007-11#1)(2011-2#1)
treatment of gastric##10##3##(2005-9#1)(2006-2#2)(2006-4#1)(2007-11#1)(2008-3#1)(2008-5#2)(2010-5#1)(2011-2#1)
treatment of gastroesophageal reflux disease##4##5##(2008-3#2)(2008-5#2)
treatment of gastroesophageal reflux##6##4##(1992-11#1)(1992-3#1)(2008-3#2)(2008-5#2)
treatment of gastrointestinal##4##3##(1990-9#1)(2006-10#2)(2012-2#1)
treatment of giant cell##2##4##(2006-12#2)
treatment of giant##6##3##(1990-12#1)(1990-4#1)(2006-12#2)(2008-7#1)(2008-9#1)
treatment of glioblastoma##5##3##(1995-9#1)(2011-2#1)(2011-3#1)(2012-11#2)
treatment of glioma##3##3##(1993-3#1)(2011-11#1)(2013-1#1)
treatment of gout##4##3##(1990-11#1)(1991-8#1)(2006-10#1)(2007-11#1)
treatment of haematological malignancies##2##4##(2007-11#1)(2013-1#1)
treatment of haematological##3##3##(2006-6#1)(2007-11#1)(2013-1#1)
treatment of head and neck cancer##3##6##(2007-11#1)(2007-12#1)(2010-12#1)
treatment of head and neck##5##5##(2007-11#1)(2007-12#1)(2010-12#1)(2011-2#1)(2013-8#1)
treatment of heart failure##13##4##(1990-3#2)(1996-6#1)(2005-10#1)(2005-7#1)(2006-6#1)(2008-5#2)(2009-10#2)(2010-6#1)(2012-3#2)
treatment of heart##15##3##(1990-3#2)(1991-8#1)(1994-8#1)(1996-6#1)(2005-10#1)(2005-7#1)(2006-6#1)(2008-5#2)(2009-10#2)(2010-6#1)(2012-3#2)
treatment of hematological malignancies##2##4##(2008-10#1)(2013-1#1)
treatment of hematological##3##3##(2007-4#1)(2008-10#1)(2013-1#1)
treatment of hemifacial##2##3##(2006-12#1)(2011-1#1)
treatment of hemodialysis##2##3##(2007-7#2)
treatment of hepatic hydatid##3##4##(2008-10#1)(2008-3#1)(2013-1#1)
treatment of hepatic##7##3##(1991-8#1)(1993-9#1)(2006-10#1)(2008-10#1)(2008-3#1)(2010-12#1)(2013-1#1)
treatment of hepatitis C virus##3##5##(2005-7#1)(2007-11#1)(2008-10#1)
treatment of hepatitis C##4##4##(2005-7#1)(2007-11#1)(2008-10#1)(2009-7#1)
treatment of hepatitis##6##3##(2005-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2009-7#1)(2010-6#1)
treatment of hepatocellular carcinoma##7##4##(1994-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-8#1)(2013-7#1)(2013-8#1)
treatment of heterozygous familial hypercholesterolemia##4##5##(1993-9#4)
treatment of high blood pressure##2##5##(1992-6#1)(1993-2#1)
treatment of high blood##3##4##(1992-6#1)(1993-2#1)(2008-3#1)
treatment of high##7##3##(1992-1#2)(1992-6#1)(1993-2#1)(2006-10#1)(2008-3#1)(2013-8#1)
treatment of hip##4##3##(2007-7#1)(2007-8#1)(2009-2#1)(2011-2#1)
treatment of hot flashes in##2##5##(2008-7#2)
treatment of hot flashes##5##4##(2008-7#5)
treatment of human cancer##2##4##(1997-4#1)(2008-1#1)
treatment of human cancers##2##4##(2006-8#1)(2013-1#1)
treatment of human disease##3##4##(1994-5#1)(2010-2#1)(2010-3#1)
treatment of human diseases##3##4##(2006-6#1)(2007-11#1)(2010-7#1)
treatment of human immunodeficiency##2##4##(1995-1#1)(2005-10#1)
treatment of human##24##3##(1994-5#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-7#1)(1996-3#1)(1997-4#1)(2005-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#2)
treatment of hypercholesterolemia##4##3##(1991-6#1)(2006-5#1)(2008-1#1)(2008-8#1)
treatment of hyperemesis gravidarum##2##4##(1996-8#2)
treatment of hyperglycemia in##2##4##(2008-1#1)(2013-1#1)
treatment of hyperglycemia##3##3##(2008-1#1)(2008-3#1)(2013-1#1)
treatment of hyperhomocysteinemia##6##3##(2007-10#2)(2008-3#4)
treatment of hyperlipidaemia##2##3##(1990-2#1)(1993-9#1)
treatment of hyperlipidemia##3##3##(1995-11#1)(2005-9#1)(2006-10#1)
treatment of hyperparathyroidism##2##3##(2005-12#1)(2013-1#1)
treatment of hypertension and##3##4##(1992-4#1)(1992-8#1)(2008-1#1)
treatment of hypertension in older##2##5##(1992-6#1)(1995-10#1)
treatment of hypertension in the elderly##2##6##(2008-7#1)(2009-9#1)
treatment of hypertension in the##4##5##(1993-3#1)(1997-5#1)(2008-7#1)(2009-9#1)
treatment of hypertension in##8##4##(1990-1#1)(1992-6#1)(1993-3#1)(1995-10#1)(1997-5#1)(2008-1#1)(2008-7#1)(2009-9#1)
treatment of hypertension##49##3##(1990-1#1)(1990-12#1)(1990-6#1)(1991-5#1)(1992-4#1)(1992-6#1)(1992-8#5)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-8#1)(1994-6#1)(1994-7#1)(1995-10#1)(1995-11#1)(1996-9#2)(1997-5#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-3#1)(2008-7#2)(2008-8#2)(2009-1#1)(2009-4#1)(2009-9#2)(2010-12#1)(2011-2#1)(2012-12#1)
treatment of hypertension]##3##3##(1992-4#1)(1993-2#1)(1996-12#1)
treatment of hypertensive##2##3##(2006-10#1)(2011-1#1)
treatment of hypertrophic##3##3##(1992-9#1)(2009-4#1)(2011-12#1)
treatment of hyperuricemia in##2##4##(2008-5#1)(2008-7#1)
treatment of hyperuricemia##4##3##(2007-7#1)(2008-5#1)(2008-7#2)
treatment of hypoparathyroidism##2##3##(1997-8#1)(2013-8#1)
treatment of hypotension and##2##4##(2005-7#1)(2006-10#1)
treatment of iatrogenic##2##3##(2008-7#1)(2013-7#1)
treatment of idiopathic scoliosis##8##4##(2007-11#1)(2007-7#5)(2007-8#2)
treatment of idiopathic##17##3##(1990-9#1)(1993-11#1)(2005-6#1)(2006-10#1)(2007-11#2)(2007-7#6)(2007-8#2)(2008-8#2)(2013-1#1)
treatment of immunological##2##3##(1990-8#1)(2007-11#1)
treatment of incidentally##2##3##(1991-4#1)(2010-9#1)
treatment of increased##2##3##(1992-11#1)(2006-11#1)
treatment of individual##2##3##(2006-10#1)(2008-1#1)
treatment of individuals##2##3##(2006-10#1)(2008-6#1)
treatment of infected individuals##2##4##(1992-12#1)(2008-3#1)
treatment of infected##7##3##(1990-7#1)(1992-12#1)(2006-5#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-2#1)
treatment of infection and##2##4##(2012-2#1)(2013-1#1)
treatment of infection in##2##4##(2007-12#1)(2008-5#1)
treatment of infection##8##3##(1994-11#1)(2007-12#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
treatment of infections caused by##4##5##(1990-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
treatment of infections in##3##4##(1993-5#2)(2008-5#1)
treatment of infections##9##3##(1990-8#1)(1993-5#2)(2008-3#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-8#2)
treatment of infectious complications##2##4##(1994-4#1)(2011-2#1)
treatment of infectious diseases are##2##5##(2008-11#1)(2008-4#1)
treatment of infectious diseases##4##4##(1996-11#1)(2008-11#1)(2008-3#1)(2008-4#1)
treatment of infectious##8##3##(1990-2#1)(1994-4#1)(1996-11#1)(2008-11#1)(2008-3#1)(2008-4#1)(2011-2#2)
treatment of infective##2##3##(2006-10#1)(2008-1#1)
treatment of infertility caused by##2##5##(2013-8#2)
treatment of infertility##8##3##(1991-3#1)(1995-7#1)(2005-7#1)(2007-11#1)(2009-2#1)(2010-8#1)(2013-8#2)
treatment of inflammation##3##3##(1992-11#1)(2008-8#2)
treatment of inflammatory bowel disease##9##5##(2005-6#1)(2005-8#1)(2006-10#4)(2006-2#1)(2011-1#1)(2012-11#1)
treatment of inflammatory diseases##5##4##(1995-12#1)(2008-10#1)(2011-1#2)(2012-12#1)
treatment of inflammatory##33##3##(1993-11#1)(1995-12#1)(2005-6#1)(2005-7#4)(2005-8#2)(2006-10#5)(2006-12#1)(2006-2#1)(2007-11#3)(2007-8#1)(2008-10#1)(2008-3#2)(2008-5#1)(2009-1#1)(2010-5#1)(2011-1#3)(2012-11#1)(2012-12#2)(2013-1#1)
treatment of inguinal##2##3##(1996-9#1)(2011-2#1)
treatment of injuries##5##3##(2005-9#1)(2007-11#2)(2007-12#1)(2007-8#1)
treatment of inoperable##3##3##(1990-6#1)(2009-5#1)(2013-1#1)
treatment of insomnia##3##3##(2007-6#1)(2011-2#1)(2013-1#1)
treatment of insulin-dependent diabetes##4##4##(1992-6#2)(1993-11#1)(2008-1#1)
treatment of internal##2##3##(2011-12#1)(2013-1#1)
treatment of intestinal##4##3##(2006-10#1)(2006-5#1)(2007-11#1)(2008-12#1)
treatment of intracranial aneurysms##2##4##(1997-3#1)(2008-7#1)
treatment of intracranial hypertension##2##4##(1997-6#2)
treatment of intracranial##7##3##(1995-9#1)(1997-3#1)(1997-6#2)(2006-11#1)(2008-7#1)(2013-7#1)
treatment of intractable##4##3##(2005-7#1)(2006-12#1)(2006-8#1)(2007-7#1)
treatment of intrahepatic portosystemic shunts in six cats##2##8##(1996-9#2)
treatment of invasive##9##3##(2007-10#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-11#1)(2011-2#1)(2013-1#1)
treatment of iron##2##3##(2012-2#1)(2013-7#1)
treatment of irritable bowel syndrome##2##5##(2008-3#1)(2010-6#1)
treatment of irritable bowel##3##4##(2008-3#1)(2010-6#1)(2013-1#1)
treatment of irritable##4##3##(1990-8#1)(2008-3#1)(2010-6#1)(2013-1#1)
treatment of ischemic heart disease##3##5##(1995-6#1)(2010-6#2)
treatment of ischemic##9##3##(1995-6#1)(2005-7#1)(2005-8#1)(2008-12#1)(2010-6#2)(2012-11#1)(2012-12#1)(2013-1#1)
treatment of isolated##3##3##(1994-3#1)(1995-8#1)(1997-4#1)
treatment of joint##2##3##(2007-11#1)(2011-2#1)
treatment of juvenile##2##3##(2007-11#1)(2011-2#1)
treatment of kidney stones##2##4##(2006-9#1)(2008-12#1)
treatment of kidney##4##3##(2006-9#1)(2007-8#1)(2008-12#1)(2012-12#1)
treatment of knee osteoarthritis##2##4##(2007-5#1)(2013-1#1)
treatment of knee##4##3##(1995-8#1)(2007-5#1)(2011-1#1)(2013-1#1)
treatment of late##2##3##(2004-1#1)(2007-11#1)
treatment of latent##2##3##(2007-12#1)(2008-8#1)
treatment of lateral##3##3##(2007-11#1)(2007-7#2)
treatment of lead intoxication##2##4##(1995-3#1)(2013-8#1)
treatment of lead##3##3##(1995-3#1)(2007-4#1)(2013-8#1)
treatment of left main coronary##3##5##(2008-3#1)(2009-12#1)(2009-5#1)
treatment of left##4##3##(2008-10#1)(2008-3#1)(2009-12#1)(2009-5#1)
treatment of leishmaniasis##2##3##(2008-10#1)(2010-5#1)
treatment of lipid##2##3##(2007-8#1)(2008-10#1)
treatment of lithiasis##2##3##(1990-5#1)(1991-3#1)
treatment of liver metastases##3##4##(1995-4#1)(1997-6#1)(2008-8#1)
treatment of liver metastases]##2##4##(2008-8#1)(2008-9#1)
treatment of liver##13##3##(1995-4#1)(1997-6#1)(2005-10#3)(2006-10#1)(2006-6#1)(2006-8#1)(2008-1#1)(2008-8#2)(2008-9#1)(2009-8#1)
treatment of localized prostate cancer##2##5##(2005-8#1)(2013-1#1)
treatment of localized##8##3##(1995-2#1)(2005-8#1)(2010-3#1)(2011-2#2)(2012-3#1)(2013-1#2)
treatment of locally advanced breast##2##5##(1994-2#1)(2008-9#1)
treatment of locally advanced##7##4##(1992-3#1)(1994-2#1)(1995-9#1)(2008-2#1)(2008-9#1)(2009-5#1)(2010-12#1)
treatment of locally recurrent##2##4##(2008-6#1)(2012-1#1)
treatment of locally##9##3##(1992-3#1)(1994-2#1)(1995-9#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-12#1)(2012-1#1)
treatment of lone atrial fibrillation##2##5##(2011-2#2)
treatment of long bone##2##4##(2007-11#1)(2010-6#1)
treatment of long##3##3##(2007-11#1)(2008-3#1)(2010-6#1)
treatment of low back##3##4##(1993-11#1)(2006-8#1)(2007-8#1)
treatment of low-grade##2##3##(1994-7#1)(2006-12#1)
treatment of lower##5##3##(2006-10#1)(2006-9#2)(2007-11#1)(2007-6#1)
treatment of lumbar spinal##2##4##(2006-7#1)(2008-12#1)
treatment of lumbar##13##3##(1990-10#1)(1995-9#1)(2005-10#1)(2006-12#1)(2006-7#1)(2007-1#1)(2007-8#4)(2008-12#1)(2008-8#1)(2009-5#1)
treatment of lung cancer##5##4##(2004-1#1)(2007-8#3)(2010-8#1)
treatment of lung##8##3##(2004-1#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-7#1)(2010-8#1)
treatment of macular##2##3##(2008-1#1)(2011-2#1)
treatment of major##5##3##(1992-2#1)(2004-3#1)(2006-10#1)(2008-8#1)(2011-12#1)
treatment of malaria in##2##4##(2008-2#1)(2012-12#1)
treatment of malaria on the##2##5##(2011-2#1)(2013-8#1)
treatment of malaria with##2##4##(1993-8#1)(2007-1#1)
treatment of malaria##18##3##(1993-8#2)(2006-10#1)(2007-1#1)(2007-6#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)(2009-6#1)(2010-6#1)(2011-2#2)(2012-12#2)(2013-8#1)
treatment of malignancies##4##3##(1997-4#1)(2007-11#3)
treatment of malignancy associated##2##4##(2010-5#1)(2010-7#1)
treatment of malignant diseases##2##4##(1992-2#1)(2011-1#1)
treatment of malignant glioma##2##4##(1993-9#1)(2008-5#1)
treatment of malignant##22##3##(1990-12#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-2#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-4#2)(1997-5#1)(2007-1#1)(2007-11#1)(2007-5#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
treatment of mandibular##2##3##(2007-2#1)(2007-7#1)
treatment of mantle cell##3##4##(2010-11#2)(2012-2#1)
treatment of many cancers##2##4##(2006-8#1)(2008-7#1)
treatment of many patients##2##4##(2007-2#1)(2009-2#1)
treatment of many##14##3##(1991-12#1)(2006-8#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2011-3#1)(2013-1#1)
treatment of maxillary##2##3##(1991-4#1)(2011-2#1)
treatment of medically intractable cerebral vasospasm##2##6##(2006-11#2)
treatment of medically intractable##3##4##(1990-9#1)(2006-11#2)
treatment of melanoma patients##2##4##(2005-10#1)(2005-11#1)
treatment of membrane##2##3##(1997-8#1)(2008-6#1)
treatment of membranes##2##3##(1990-3#1)(1996-8#1)
treatment of meningitis##2##3##(1992-11#1)(2009-3#1)
treatment of menorrhagia##2##3##(1991-11#1)(1993-9#1)
treatment of mental disorders##4##4##(2007-2#2)(2008-6#1)(2011-2#1)
treatment of mental##7##3##(2007-2#2)(2008-6#1)(2011-2#3)(2012-2#1)
treatment of mentally##2##3##(1990-2#1)(2006-6#1)
treatment of metabolic syndrome##2##4##(2008-3#2)
treatment of metabolic##3##3##(1997-4#1)(2008-3#2)
treatment of metastases##3##3##(2006-9#1)(2007-11#1)(2007-7#1)
treatment of metastatic RCC##2##4##(2009-11#2)
treatment of metastatic bone tumors##3##5##(2007-11#3)
treatment of metastatic bone##4##4##(2007-11#3)(2012-3#1)
treatment of metastatic colorectal##2##4##(2008-7#1)(2012-1#1)
treatment of metastatic##25##3##(1990-2#1)(1994-4#1)(1994-5#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#5)(2008-3#1)(2008-6#1)(2008-7#1)(2009-11#3)(2009-4#1)(2009-8#3)(2010-3#1)(2010-7#1)(2012-1#1)(2012-3#1)
treatment of methicillin-resistant Staphylococcus aureus##2##5##(2007-12#1)(2010-6#1)
treatment of mice with an##2##5##(1995-2#1)(1996-10#1)
treatment of mice with##5##4##(1995-2#1)(1996-10#2)(2008-7#2)
treatment of mice##7##3##(1992-3#1)(1995-2#1)(1996-10#3)(2008-7#2)
treatment of microsomes##2##3##(1993-3#1)(1994-2#1)
treatment of microtitre##2##3##(1994-9#2)
treatment of migraine attacks##2##4##(2004-12#1)(2007-10#1)
treatment of migraine##10##3##(1990-7#1)(1994-11#1)(2004-12#1)(2005-7#2)(2007-10#1)(2008-6#1)(2008-9#1)(2009-9#2)
treatment of mild##4##3##(1991-9#1)(1992-6#1)(1994-8#1)(1997-8#1)
treatment of minor##2##3##(1992-3#1)(1992-6#1)
treatment of moderate to severe##9##5##(2005-6#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-8#2)(2012-2#1)(2012-3#1)
treatment of moderate to##10##4##(2005-6#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-8#2)(2012-2#1)(2012-3#1)
treatment of moderate##12##3##(2005-6#1)(2006-10#1)(2008-3#2)(2008-5#3)(2008-7#1)(2009-8#2)(2012-2#1)(2012-3#1)
treatment of mood disorders##4##4##(1992-8#1)(2008-7#2)(2013-8#1)
treatment of mood##5##3##(1992-8#2)(2008-7#2)(2013-8#1)
treatment of morbid obesity##4##4##(1993-3#1)(2006-5#1)(2012-12#1)(2013-1#1)
treatment of most##3##3##(1994-10#1)(2007-12#1)(2013-8#1)
treatment of motor##2##3##(1995-12#1)(2012-12#1)
treatment of mouse##2##3##(1990-2#1)(1996-5#1)
treatment of mucormycosis##4##3##(2009-6#1)(2011-2#3)
treatment of multiple myeloma##6##4##(2007-12#1)(2007-8#1)(2008-1#1)(2008-3#2)(2012-12#1)
treatment of multiple##16##3##(1994-12#1)(2005-1#1)(2005-7#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#3)(2012-12#2)(2013-1#1)
treatment of nasopharyngeal cancer##2##4##(2008-8#2)
treatment of nasopharyngeal carcinoma##2##4##(1993-9#1)(2006-12#1)
treatment of nasopharyngeal##4##3##(1993-9#1)(2006-12#1)(2008-8#2)
treatment of neck##3##3##(2007-7#1)(2008-8#1)(2008-9#1)
treatment of necrotizing##2##3##(2007-12#1)(2009-3#1)
treatment of neonatal##7##3##(1991-9#1)(1993-5#2)(1996-1#1)(2009-9#1)(2010-7#1)(2012-3#1)
treatment of neonates##2##3##(1991-9#1)(2006-10#1)
treatment of neoplasms##2##3##(1992-8#1)(2010-2#1)
treatment of neoplastic##5##3##(1990-12#1)(1997-5#1)(2006-12#1)(2007-11#1)(2007-8#1)
treatment of nephrolithiasis##2##3##(2008-10#1)(2012-12#1)
treatment of nerve##2##3##(2012-2#2)
treatment of neurodegenerative diseases##3##4##(1994-5#1)(2005-8#1)(2008-11#1)
treatment of neurodegenerative##9##3##(1994-5#1)(2005-8#2)(2007-11#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#1)
treatment of neuroendocrine tumors##2##4##(1993-12#1)(2011-2#1)
treatment of neuropathic pain with##2##5##(1997-3#1)(2008-9#1)
treatment of neuropathic pain##13##4##(1996-5#1)(1997-3#1)(2005-9#1)(2006-10#1)(2006-12#1)(2008-1#2)(2008-7#1)(2008-9#4)(2010-7#1)
treatment of neuropathic##14##3##(1996-5#1)(1997-3#1)(2005-9#1)(2006-10#1)(2006-12#1)(2008-1#2)(2008-10#1)(2008-7#1)(2008-9#4)(2010-7#1)
treatment of newborn##2##3##(1993-5#1)(2008-8#1)
treatment of newly diagnosed##3##4##(2008-5#1)(2009-8#2)
treatment of non-metastatic##3##3##(1991-9#1)(1992-6#1)(2008-10#1)
treatment of non-small-cell lung##3##4##(2004-1#1)(2009-5#1)(2011-12#1)
treatment of non-toxic multinodular goitre##2##5##(1993-6#2)
treatment of nonmetastatic##2##3##(2010-3#2)
treatment of normal serum##2##4##(1990-2#1)(1997-2#1)
treatment of normal##4##3##(1990-2#1)(1997-2#1)(2008-4#1)(2008-5#1)
treatment of obesity and##2##4##(2005-8#1)(2008-4#1)
treatment of obesity##10##3##(2005-8#1)(2006-10#1)(2006-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2011-2#1)(2012-3#1)
treatment of obstructive sleep apnea##2##5##(2007-6#1)(2010-5#1)
treatment of ocular melanoma##3##4##(2010-9#3)
treatment of ocular##4##3##(2007-12#1)(2010-9#3)
treatment of one##2##3##(2010-12#1)(2012-3#1)
treatment of onychomycosis##2##3##(2008-3#2)
treatment of open fractures##2##4##(2009-9#1)(2013-8#1)
treatment of open##7##3##(1991-6#1)(2007-11#1)(2007-8#1)(2009-8#1)(2009-9#2)(2013-8#1)
treatment of opioid dependence##2##4##(2008-6#1)(2009-4#1)
treatment of opioid##5##3##(2006-10#1)(2007-10#1)(2008-11#1)(2008-6#1)(2009-4#1)
treatment of opportunistic##3##3##(2006-10#1)(2008-5#1)(2011-2#1)
treatment of oral##4##3##(1993-12#1)(2006-8#1)(2007-12#1)(2012-2#1)
treatment of organ transplant##2##4##(2005-9#1)(2007-11#1)
treatment of organ##3##3##(2005-7#1)(2005-9#1)(2007-11#1)
treatment of organic##2##3##(2008-10#1)(2008-5#1)
treatment of orofacial##2##3##(2009-10#1)(2013-1#1)
treatment of osteoarthritis##7##3##(2006-10#1)(2006-3#1)(2007-11#3)(2007-7#1)(2011-1#1)
treatment of osteoporosis and##2##4##(2012-12#1)(2013-1#1)
treatment of osteoporosis in##3##4##(2007-7#1)(2008-7#2)
treatment of osteoporosis##36##3##(1990-11#1)(1991-11#1)(1993-11#6)(1997-6#3)(1997-7#1)(2005-1#4)(2005-3#2)(2005-7#1)(2007-11#2)(2007-7#1)(2007-8#3)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)(2012-12#2)(2013-1#2)
treatment of osteoporotic##5##3##(2005-3#1)(2007-11#1)(2007-8#3)
treatment of osteosarcoma##6##3##(2010-3#5)(2013-7#1)
treatment of other##6##3##(2005-7#1)(2006-10#1)(2008-2#1)(2008-5#1)(2008-7#2)
treatment of our##3##3##(2006-10#1)(2009-10#1)(2012-2#1)
treatment of ovarian##3##3##(1991-8#1)(2005-11#1)(2010-12#1)
treatment of paediatric##3##3##(2007-4#2)(2008-11#1)
treatment of pain and##6##4##(2006-10#1)(2006-11#1)(2007-8#1)(2010-6#1)(2011-1#1)(2012-3#1)
treatment of pain associated with osteoarthritis of the knee##2##9##(2006-10#1)(2007-11#1)
treatment of pain associated with##5##5##(2005-8#1)(2006-10#2)(2007-11#1)(2010-1#1)
treatment of pain in##4##4##(1996-2#1)(2007-11#1)(2008-8#2)
treatment of pain##29##3##(1993-9#1)(1996-2#1)(1996-7#1)(2005-7#1)(2005-8#1)(2006-10#5)(2006-11#2)(2006-12#1)(2006-6#2)(2007-11#3)(2007-8#1)(2008-11#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-6#2)(2010-8#1)(2011-1#1)(2012-3#1)
treatment of painful##5##3##(2006-8#1)(2007-11#1)(2008-7#1)(2008-8#1)(2013-1#1)
treatment of pancreatic cancer##2##4##(1992-4#1)(2011-2#1)
treatment of pancreatic pseudocysts##2##4##(1991-8#1)(2005-10#1)
treatment of pancreatic##8##3##(1990-9#1)(1991-8#1)(1992-4#1)(1993-6#1)(2005-10#1)(2006-10#1)(2006-8#1)(2011-2#1)
treatment of pancreatitis##2##3##(2006-6#2)
treatment of panic disorder##3##4##(2005-7#1)(2008-3#2)
treatment of panic##6##3##(1990-11#1)(1992-2#1)(2005-10#1)(2005-7#1)(2008-3#2)
treatment of partial##2##3##(2006-12#1)(2006-4#1)
treatment of pathological fractures##3##4##(2007-11#3)
treatment of pathological##6##3##(2007-11#5)(2013-1#1)
treatment of pathologies##2##3##(2008-7#1)(2009-5#1)
treatment of patients affected by##3##5##(2008-7#1)(2011-2#1)(2013-1#1)
treatment of patients after##2##4##(2006-8#2)
treatment of patients on##2##4##(2006-8#1)(2011-2#1)
treatment of patients presenting with##2##5##(2007-1#1)(2008-7#1)
treatment of patients suffering from Alzheimer dementia##2##7##(2006-6#2)
treatment of patients suffering from##4##5##(2005-9#2)(2006-6#2)
treatment of patients who##2##4##(1994-12#1)(2007-10#1)
treatment of patients with Barrett esophagus##2##6##(2006-10#2)
treatment of patients with MRSA##2##5##(2011-2#2)
treatment of patients with PD##2##5##(2006-4#1)(2008-11#1)
treatment of patients with ST-segment elevation myocardial infarction##2##8##(2008-3#1)(2009-5#1)
treatment of patients with active herpes labialis##2##7##(2012-2#2)
treatment of patients with active##3##5##(2012-2#3)
treatment of patients with acute ischemic stroke##2##7##(2012-12#1)(2013-7#1)
treatment of patients with acute##8##5##(2007-11#1)(2008-3#2)(2008-5#1)(2009-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
treatment of patients with advanced##6##5##(1991-6#1)(1993-12#1)(1997-6#1)(2008-6#2)(2011-12#1)
treatment of patients with cardiovascular##2##5##(2010-4#1)(2011-2#1)
treatment of patients with chronic pain##2##6##(2007-12#1)(2012-3#1)
treatment of patients with chronic##7##5##(1992-10#1)(2006-7#1)(2007-12#1)(2010-12#1)(2011-2#1)(2012-3#2)
treatment of patients with diabetic##2##5##(2007-8#1)(2011-1#1)
treatment of patients with ischemic##2##5##(1996-9#1)(2007-9#1)
treatment of patients with liver##2##5##(2008-8#1)(2009-4#1)
treatment of patients with metastatic##3##5##(2007-11#2)(2010-12#1)
treatment of patients with multiple brain metastases##2##7##(2006-7#2)
treatment of patients with multiple##4##5##(2006-7#2)(2011-1#2)
treatment of patients with pulmonary##2##5##(2008-1#1)(2010-11#1)
treatment of patients with refractory##2##5##(2006-3#1)(2011-1#1)
treatment of patients with renal##3##5##(1990-12#1)(2006-9#1)(2009-11#1)
treatment of patients with rheumatoid arthritis (RA)##2##7##(2006-10#1)(2008-8#1)
treatment of patients with rheumatoid arthritis##3##6##(2006-10#2)(2008-8#1)
treatment of patients with severe##3##5##(1992-1#1)(1993-1#1)(2012-3#1)
treatment of patients with this##2##5##(2007-4#1)(2008-12#1)
treatment of patients with##151##4##(1990-10#1)(1990-12#1)(1991-11#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-10#2)(1993-1#1)(1993-10#3)(1993-11#1)(1993-12#1)(1993-8#2)(1993-9#2)(1994-6#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-7#1)(1996-9#1)(1997-6#1)(2004-1#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-6#1)(2006-10#10)(2006-11#2)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#1)(2006-6#2)(2006-7#3)(2006-8#3)(2006-9#4)(2007-11#7)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#4)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#5)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#4)(2008-9#1)(2009-11#1)(2009-2#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#6)(2011-12#2)(2011-2#6)(2011-7#1)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
treatment of patients##178##3##(1990-10#1)(1990-12#1)(1991-11#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-10#2)(1993-1#1)(1993-10#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#2)(1993-9#2)(1994-12#1)(1994-6#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-7#1)(1996-9#1)(1997-6#1)(2004-1#1)(2005-1#2)(2005-10#1)(2005-11#1)(2005-6#1)(2005-9#2)(2006-10#11)(2006-11#2)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#1)(2006-6#4)(2006-7#3)(2006-8#6)(2006-9#4)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#3)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#6)(2007-9#2)(2008-1#4)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#6)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#1)(2009-11#1)(2009-2#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#7)(2011-12#2)(2011-2#8)(2011-7#1)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
treatment of pediatric##7##3##(2008-5#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#2)
treatment of pelvic endometriosis##3##4##(1992-1#1)(1995-2#1)(2011-1#1)
treatment of pelvic##7##3##(1992-1#1)(1992-3#1)(1995-2#1)(2007-11#1)(2007-4#1)(2008-11#1)(2011-1#1)
treatment of peptic ulcer disease##7##5##(1995-4#1)(1996-2#1)(1997-1#1)(2006-10#4)
treatment of peptic ulcer##8##4##(1995-4#1)(1996-2#1)(1997-1#1)(2006-10#4)(2007-2#1)
treatment of peptic##9##3##(1991-11#1)(1995-4#1)(1996-2#1)(1997-1#1)(2006-10#4)(2007-2#1)
treatment of perennial##2##3##(2008-3#1)(2013-1#1)
treatment of perforated##3##3##(1993-6#1)(1993-9#1)(2006-10#1)
treatment of periodontal##3##3##(2007-12#1)(2011-1#1)(2013-7#1)
treatment of peripheral nerves##3##4##(2006-12#3)
treatment of peripheral##8##3##(1991-5#1)(1994-10#1)(2006-12#3)(2007-11#1)(2011-1#2)
treatment of peritoneal##2##3##(1990-4#1)(2006-6#1)
treatment of persistent epithelial##2##4##(2007-1#1)(2011-2#1)
treatment of persistent##8##3##(2006-12#1)(2007-1#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#1)
treatment of personality disorders##3##4##(2005-7#2)(2012-12#1)
treatment of persons##2##3##(2006-7#1)(2007-8#1)
treatment of pituitary##2##3##(2013-8#2)
treatment of plaque psoriasis##2##4##(2008-5#1)(2008-6#1)
treatment of pleural##3##3##(2006-7#1)(2010-3#1)(2011-2#1)
treatment of pneumonia##2##3##(2007-12#1)(2008-5#1)
treatment of portal##2##3##(1995-9#1)(2009-9#1)
treatment of positive##2##3##(1990-4#1)(2005-7#1)
treatment of postmenopausal osteoporosis##10##4##(1993-11#1)(1995-11#1)(2005-3#1)(2007-11#1)(2008-3#1)(2008-8#3)(2012-2#2)
treatment of postoperative pain##2##4##(2006-10#1)(2008-3#1)
treatment of postoperative##7##3##(1991-4#1)(2006-10#2)(2007-5#1)(2007-8#1)(2008-3#1)(2010-2#1)
treatment of potential##3##3##(2005-10#1)(2008-7#1)(2010-12#1)
treatment of primary and metastatic##2##5##(2006-6#1)(2007-7#1)
treatment of primary and##4##4##(1992-11#1)(2006-6#1)(2007-7#1)(2013-1#1)
treatment of primary biliary cirrhosis##6##5##(2004-11#3)(2006-10#3)
treatment of primary sclerosing cholangitis##2##5##(2004-11#1)(2009-8#1)
treatment of primary##30##3##(1990-3#1)(1991-6#1)(1992-11#1)(1997-5#1)(2004-11#4)(2006-10#3)(2006-6#2)(2007-10#1)(2007-2#1)(2007-7#3)(2008-4#1)(2008-8#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-3#2)(2011-2#1)(2012-12#1)(2013-1#3)
treatment of prostate cancer##10##4##(2005-10#1)(2005-7#1)(2006-10#1)(2008-4#2)(2011-2#1)(2013-1#2)(2013-8#2)
treatment of prostatic##2##3##(1996-12#1)(2008-10#1)
treatment of proximal humerus fractures##2##5##(2007-8#2)
treatment of proximal humerus##3##4##(2007-8#2)(2009-4#1)
treatment of proximal##5##3##(1992-8#1)(2007-11#1)(2007-8#2)(2009-4#1)
treatment of pruritus##2##3##(2005-7#2)
treatment of pseudoarthroses##2##3##(2007-11#2)
treatment of pseudoarthrosis##3##3##(2007-8#2)(2009-3#1)
treatment of psoriasis and##4##4##(2005-8#1)(2006-10#1)(2007-7#1)(2008-5#1)
treatment of psoriasis with##3##4##(1990-6#1)(1993-11#1)(2008-5#1)
treatment of psoriasis##25##3##(1990-6#1)(1993-11#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-11#2)(2007-7#3)(2007-8#4)(2008-1#2)(2008-12#1)(2008-5#4)(2008-6#2)(2011-1#1)(2012-3#1)
treatment of psoriatic##7##3##(1990-6#1)(2006-10#2)(2008-3#2)(2009-11#1)(2011-2#1)
treatment of psychiatric symptoms##2##4##(2009-12#1)(2013-8#1)
treatment of psychiatric##6##3##(2008-7#1)(2008-8#1)(2009-12#1)(2013-1#1)(2013-8#2)
treatment of pulmonary and##3##4##(1997-1#1)(2010-10#1)(2010-3#1)
treatment of pulmonary arterial##2##4##(2008-10#1)(2008-4#1)
treatment of pulmonary hypertension##3##4##(2006-10#1)(2010-5#1)(2010-6#1)
treatment of pulmonary##14##3##(1991-11#1)(1997-1#1)(2005-8#2)(2006-10#2)(2008-1#1)(2008-10#1)(2008-4#1)(2010-10#1)(2010-3#2)(2010-5#1)(2010-6#1)
treatment of rat##4##3##(1991-5#1)(1992-3#1)(1993-4#1)(2008-8#1)
treatment of rats with##12##4##(1990-12#1)(1990-2#1)(1990-5#1)(1992-5#1)(1994-11#1)(1995-12#1)(1997-1#1)(1997-7#1)(1997-8#1)(2008-10#2)(2012-2#1)
treatment of rats##16##3##(1990-12#1)(1990-2#1)(1990-5#1)(1992-5#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-12#1)(1997-1#1)(1997-7#1)(1997-8#1)(2008-10#3)(2011-2#1)(2012-2#1)
treatment of recipient mice##2##4##(1991-12#1)(1996-10#1)
treatment of rectal cancer##3##4##(2008-8#1)(2009-4#1)(2011-2#1)
treatment of rectal##5##3##(2008-8#1)(2009-12#2)(2009-4#1)(2011-2#1)
treatment of recurrent disease##2##4##(2008-12#1)(2012-2#1)
treatment of recurrent##17##3##(1992-10#1)(1996-9#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-12#1)(2008-5#1)(2009-3#1)(2009-8#1)(2010-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
treatment of red blood cells##2##5##(1994-6#1)(2013-1#1)
treatment of refractory rejection##2##4##(2007-11#2)
treatment of refractory##22##3##(1991-3#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-11#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#3)
treatment of relapsed##2##3##(2010-12#2)
treatment of relapsing##2##3##(2007-11#1)(2009-2#1)
treatment of renal cell carcinoma##4##5##(1992-8#1)(2007-8#1)(2010-12#1)(2011-12#1)
treatment of renal cell##5##4##(1992-8#1)(2007-8#1)(2010-12#1)(2011-12#1)(2011-2#1)
treatment of renal oncocytoma##2##4##(1992-5#2)
treatment of renal##15##3##(1992-5#2)(1992-8#1)(1994-9#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)
treatment of resectable##2##3##(2004-1#1)(2013-1#1)
treatment of resistant##6##3##(2007-11#1)(2007-7#1)(2008-3#1)(2009-12#1)(2010-6#1)(2011-2#1)
treatment of respiratory diseases##2##4##(1996-3#1)(2007-1#1)
treatment of respiratory distress syndrome (RDS)##2##6##(1993-5#1)(2007-11#1)
treatment of respiratory##9##3##(1990-7#1)(1993-5#1)(1996-3#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-2#1)(2011-2#1)
treatment of restenosis##3##3##(2005-7#1)(2007-11#1)(2008-5#1)
treatment of retinal##2##3##(2009-4#1)(2011-1#1)
treatment of retroperitoneal sarcomas##2##4##(2006-6#1)(2008-6#1)
treatment of rheumatoid arthritis is##2##5##(2007-11#1)(2008-3#1)
treatment of rheumatoid arthritis##31##4##(1990-6#2)(1991-8#1)(1992-11#1)(1993-3#1)(2006-10#5)(2006-4#1)(2007-11#9)(2007-7#1)(2008-3#5)(2008-5#3)(2008-8#1)(2010-4#1)
treatment of rheumatoid arthritis]##3##4##(1991-11#1)(1992-10#1)(1994-6#1)
treatment of rheumatoid##34##3##(1990-6#2)(1991-11#1)(1991-8#1)(1992-10#1)(1992-11#1)(1993-3#1)(1994-6#1)(2006-10#5)(2006-4#1)(2007-11#9)(2007-7#1)(2008-3#5)(2008-5#3)(2008-8#1)(2010-4#1)
treatment of ruptured##3##3##(2006-10#1)(2006-4#2)
treatment of schistosomiasis##2##3##(2006-10#1)(2012-3#1)
treatment of schizophrenia and##10##4##(1991-4#1)(2005-7#2)(2005-8#1)(2008-5#1)(2008-6#2)(2008-8#2)(2011-2#1)
treatment of schizophrenia##27##3##(1991-4#1)(1995-8#1)(2005-7#3)(2005-8#1)(2006-12#1)(2006-9#1)(2007-8#2)(2008-5#1)(2008-6#3)(2008-8#2)(2008-9#1)(2009-12#1)(2010-7#1)(2011-1#4)(2011-12#1)(2011-2#2)(2012-12#1)
treatment of scleroderma##2##3##(1993-9#1)(2007-11#1)
treatment of scoliosis##7##3##(2007-11#1)(2007-7#3)(2007-8#3)
treatment of seasonal allergic rhinitis##2##5##(2007-11#1)(2011-2#1)
treatment of seasonal##3##3##(2007-11#1)(2010-8#1)(2011-2#1)
treatment of secondary##3##3##(2005-10#1)(2008-3#1)(2013-8#1)
treatment of seizures##4##3##(1997-3#1)(2009-3#2)(2011-1#1)
treatment of selected##3##3##(1990-5#1)(1991-12#1)(2006-5#1)
treatment of several##13##3##(2005-8#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-5#1)(2009-1#1)(2009-10#1)(2010-11#1)(2010-12#1)(2011-1#1)
treatment of severe and##2##4##(2006-10#1)(2006-6#1)
treatment of severe##45##3##(1990-2#1)(1990-8#1)(1991-1#1)(1991-8#1)(1992-6#1)(1993-5#1)(1995-5#1)(2005-7#1)(2006-10#3)(2006-2#1)(2006-6#3)(2006-8#1)(2007-11#1)(2007-12#3)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#2)(2009-3#2)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
treatment of short stature##2##4##(2007-8#1)(2013-1#1)
treatment of short##5##3##(1993-5#1)(2007-8#1)(2008-3#1)(2008-4#1)(2013-1#1)
treatment of shoulder instability##2##4##(2007-11#2)
treatment of shoulder##3##3##(2007-11#3)
treatment of significant##2##3##(2006-9#1)(2007-8#1)
treatment of simple##2##3##(2009-6#1)(2012-2#1)
treatment of skeletal##3##3##(2007-11#1)(2009-8#1)(2013-1#1)
treatment of skin diseases##2##4##(2006-12#1)(2007-7#1)
treatment of skin##9##3##(1990-6#1)(1992-10#1)(2006-12#1)(2007-7#2)(2008-3#2)(2011-1#1)(2012-3#1)
treatment of sleep##2##3##(1993-11#1)(2007-6#1)
treatment of small bowel##2##4##(2009-2#1)(2010-12#1)
treatment of small##6##3##(1990-6#1)(1995-12#1)(1996-6#1)(2009-2#1)(2010-12#1)(2010-8#1)
treatment of snoring and obstructive sleep apnea syndrome##2##8##(2005-10#1)(2007-6#1)
treatment of snoring and##3##4##(2005-10#1)(2007-12#1)(2007-6#1)
treatment of soft tissue sarcomas##3##5##(2008-6#2)(2013-7#1)
treatment of soft tissue##5##4##(2006-6#1)(2008-6#3)(2013-7#1)
treatment of soil##3##3##(2008-10#1)(2013-8#2)
treatment of solid tumors##4##4##(2005-6#1)(2006-11#1)(2006-6#1)(2008-7#1)
treatment of solid tumours##3##4##(1992-6#1)(2007-7#1)(2008-8#1)
treatment of solid##8##3##(1992-6#1)(2005-6#1)(2005-7#1)(2006-11#1)(2006-6#1)(2007-7#1)(2008-7#1)(2008-8#1)
treatment of some##8##3##(2006-10#1)(2006-7#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
treatment of spinal metastases##5##4##(2006-2#2)(2007-11#2)(2008-7#1)
treatment of spinal metastatic##2##4##(2007-11#2)
treatment of spinal overload syndrome##2##5##(2007-7#2)
treatment of spinal##20##3##(2005-8#1)(2006-2#2)(2007-11#7)(2007-7#3)(2007-8#2)(2008-7#3)(2009-4#1)(2013-8#1)
treatment of spine##2##3##(2007-11#1)(2007-8#1)
treatment of spontaneous##3##3##(2007-8#1)(2008-11#1)(2008-7#1)
treatment of squamous##2##3##(2006-10#1)(2011-12#1)
treatment of stage II##3##4##(2006-6#1)(2007-4#1)(2009-10#1)
treatment of stage##8##3##(1994-8#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-4#1)(2007-8#2)(2009-10#1)
treatment of stress urinary incontinence##10##5##(1994-5#1)(2006-10#2)(2006-9#5)(2008-3#1)(2013-1#1)
treatment of stroke patients##2##4##(2007-9#2)
treatment of stroke##8##3##(2005-8#1)(2005-9#1)(2007-9#4)(2008-2#1)(2011-2#1)
treatment of substance abuse##2##4##(2006-9#1)(2008-6#1)
treatment of such cases##2##4##(2004-10#1)(2007-7#1)
treatment of such complications##2##4##(2011-2#1)(2013-7#1)
treatment of such##15##3##(1990-9#1)(1997-5#1)(2004-10#1)(2005-6#1)(2006-6#1)(2007-7#1)(2008-5#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#4)(2013-7#1)
treatment of superficial##4##3##(2008-5#2)(2011-1#1)(2012-3#1)
treatment of superior vena cava##2##5##(2007-8#1)(2010-8#1)
treatment of superior##3##3##(2007-8#1)(2010-8#1)(2012-12#1)
treatment of suppression##2##3##(2012-12#2)
treatment of supracondylar##2##3##(2009-3#1)(2013-8#1)
treatment of surgical##3##3##(1990-2#1)(2007-8#1)(2008-5#1)
treatment of suspected##3##3##(1993-5#1)(2007-2#2)
treatment of symptomatic pancreas##2##4##(1995-4#2)
treatment of symptomatic##12##3##(1991-4#1)(1993-8#1)(1995-4#2)(2006-11#2)(2007-11#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-12#1)(2013-7#1)
treatment of systemic fungal infections##2##5##(1997-2#1)(2005-8#1)
treatment of systemic sclerosis##2##4##(1991-12#1)(2007-7#1)
treatment of systemic##10##3##(1991-12#1)(1992-4#1)(1992-5#1)(1997-2#1)(2005-8#1)(2007-11#2)(2007-7#1)(2008-11#1)(2008-7#1)
treatment of teeth with##2##4##(2012-2#2)
treatment of tennis elbow##4##4##(2007-11#4)
treatment of testicular##2##3##(1995-5#1)(2008-10#1)
treatment of that##2##3##(2006-5#1)(2008-1#1)
treatment of the adult##2##4##(1994-11#1)(1996-12#1)
treatment of the affected##2##4##(1996-3#1)(2008-1#1)
treatment of the animals##2##4##(1994-2#1)(2010-4#1)
treatment of the breast##2##4##(1990-11#1)(1993-8#1)
treatment of the cells with the##2##6##(1996-5#1)(1997-7#1)
treatment of the cells with##8##5##(1990-11#1)(1995-11#1)(1995-12#1)(1996-5#1)(1997-4#1)(1997-7#1)(2008-11#1)(2008-4#1)
treatment of the cells##10##4##(1990-11#1)(1993-9#1)(1995-11#1)(1995-12#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-7#1)(2008-11#1)(2008-4#1)
treatment of the chronic##4##4##(1997-3#1)(2007-8#1)(2008-5#2)
treatment of the data##3##4##(2008-10#3)
treatment of the disease has been##2##6##(2007-11#1)(2007-5#1)
treatment of the disease##7##4##(2005-11#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-9#1)(2011-1#1)(2013-8#1)
treatment of the disorder##4##4##(1996-6#1)(2006-10#1)(2006-8#1)(2011-12#1)
treatment of the elbow joint in##2##6##(2007-11#2)
treatment of the enzyme with##2##5##(1993-9#1)(1995-6#1)
treatment of the enzyme##3##4##(1992-6#1)(1993-9#1)(1995-6#1)
treatment of the extract##2##4##(1995-6#1)(2007-8#1)
treatment of the gel##2##4##(2005-11#1)(2008-10#1)
treatment of the hepatocytes with##2##5##(1991-6#1)(1993-3#1)
treatment of the idiopathic scoliosis##2##5##(2007-8#2)
treatment of the individual##3##4##(1992-2#1)(2006-10#1)(2008-10#1)
treatment of the infection##2##4##(1991-6#1)(2007-12#1)
treatment of the membranes with##2##5##(1991-4#1)(1992-7#1)
treatment of the metabolic##2##4##(2006-8#1)(2008-1#1)
treatment of the most##4##4##(1993-2#1)(1996-2#1)(1997-3#1)(2007-11#1)
treatment of the old##2##4##(1993-1#1)(1996-1#1)
treatment of the patient##4##4##(1997-3#1)(2007-12#1)(2007-7#1)(2010-12#1)
treatment of the patients with##4##5##(1994-5#1)(2008-5#1)(2008-9#1)(2012-2#1)
treatment of the patients##7##4##(1994-5#1)(2005-10#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)
treatment of the primary tumor##3##5##(2008-10#1)(2008-6#1)(2010-3#1)
treatment of the primary tumour##2##5##(1991-6#1)(2009-2#1)
treatment of the primary##5##4##(1991-6#1)(2008-10#1)(2008-6#1)(2009-2#1)(2010-3#1)
treatment of the rheumatoid##2##4##(2007-11#1)(2007-8#1)
treatment of the sample##3##4##(2008-10#3)
treatment of the tumor##2##4##(2013-1#1)(2013-7#1)
treatment of the two##2##4##(2007-1#1)(2008-1#1)
treatment of the underlying##5##4##(1991-12#1)(2007-11#2)(2007-7#1)(2012-12#1)
treatment of the urine sample##2##5##(2008-10#2)
treatment of the various##3##4##(1991-2#1)(1996-12#1)(2007-8#1)
treatment of the venous##2##4##(2006-10#1)(2011-3#1)
treatment of the##291##3##(1990-11#3)(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-4#1)(1991-6#3)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#2)(1993-1#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#3)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#2)(1996-8#1)(1997-1#3)(1997-2#1)(1997-3#4)(1997-4#1)(1997-7#1)(1997-8#2)(2005-10#3)(2005-11#4)(2005-3#1)(2005-4#1)(2005-7#2)(2005-8#1)(2006-10#5)(2006-12#2)(2006-2#2)(2006-3#1)(2006-6#2)(2006-7#1)(2006-8#4)(2006-9#5)(2007-1#1)(2007-11#18)(2007-12#6)(2007-2#1)(2007-3#1)(2007-5#2)(2007-7#5)(2007-8#11)(2007-9#1)(2008-1#6)(2008-10#26)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#6)(2008-5#8)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#7)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-9#2)(2010-10#1)(2010-12#3)(2010-3#2)(2010-4#2)(2010-5#1)(2011-1#4)(2011-12#2)(2011-2#9)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#3)(2013-8#3)
treatment of their##2##3##(2004-1#1)(2012-12#1)
treatment of these cells##2##4##(1992-6#1)(1996-10#1)
treatment of these conditions##3##4##(1993-6#1)(2008-3#1)(2010-5#1)
treatment of these diseases##4##4##(2007-1#1)(2010-2#1)(2010-3#1)(2012-3#1)
treatment of these lesions##5##4##(2006-2#1)(2007-8#1)(2009-9#1)(2010-12#1)(2010-8#1)
treatment of these patients has##2##5##(1991-12#1)(2007-7#1)
treatment of these patients##15##4##(1991-12#1)(1991-4#1)(1995-2#1)(2005-8#1)(2006-7#1)(2007-11#2)(2007-7#2)(2007-8#2)(2009-2#1)(2009-6#1)(2011-1#1)(2012-12#1)
treatment of these postoperative problems##2##5##(2006-12#1)(2007-12#1)
treatment of these tumors##2##4##(2006-12#1)(2013-1#1)
treatment of these##64##3##(1991-1#1)(1991-12#1)(1991-4#2)(1992-6#1)(1993-12#1)(1993-6#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-10#1)(1997-3#1)(1997-4#1)(2004-11#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-12#4)(2006-2#2)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-7#2)(2007-8#3)(2008-1#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
treatment of third##2##3##(2006-8#1)(2007-1#1)
treatment of this condition in##2##5##(2006-10#1)(2008-6#1)
treatment of this condition##12##4##(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(2006-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2013-1#1)(2013-8#1)
treatment of this disease in##2##5##(1994-7#1)(2006-8#1)
treatment of this disease##16##4##(1993-6#1)(1994-7#1)(2005-8#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-6#1)(2011-2#1)(2011-7#1)(2012-12#1)
treatment of this disorder##7##4##(2006-8#1)(2008-12#1)(2008-2#1)(2008-6#1)(2009-5#1)(2010-12#1)(2013-1#1)
treatment of this group of##2##5##(1994-2#1)(2008-8#1)
treatment of this important##2##4##(2007-12#1)(2007-7#1)
treatment of this pathology##2##4##(2007-2#1)(2013-1#1)
treatment of this patient##3##4##(2004-3#1)(2006-10#1)(2013-1#1)
treatment of this rare##5##4##(2006-12#1)(2007-7#1)(2008-5#1)(2012-12#1)(2012-2#1)
treatment of this syndrome##2##4##(2006-9#1)(2007-9#1)
treatment of this uncommon##2##4##(2007-4#1)(2011-2#1)
treatment of this##76##3##(1991-9#1)(1992-3#2)(1992-5#2)(1992-8#1)(1993-1#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-7#1)(1995-2#1)(1996-6#1)(2004-3#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#4)(2011-7#1)(2012-12#4)(2012-2#1)(2013-1#6)(2013-8#1)
treatment of thoracic##8##3##(2006-7#4)(2007-7#1)(2007-8#1)(2013-7#2)
treatment of thoraco-lumbar scoliosis##2##4##(2007-7#2)
treatment of those patients with##2##5##(2006-6#1)(2011-2#1)
treatment of those##6##3##(2006-6#1)(2008-3#3)(2008-4#1)(2011-2#1)
treatment of three##2##3##(1997-3#1)(2011-12#1)
treatment of thromboembolic disorders##2##4##(2005-7#2)
treatment of thromboembolic##3##3##(2005-7#2)(2008-1#1)
treatment of thrombotic##2##3##(2005-8#1)(2011-2#1)
treatment of thyroid cancer##2##4##(2006-9#1)(2008-3#1)
treatment of thyroid##5##3##(1994-10#1)(2006-9#1)(2008-3#1)(2008-6#1)(2013-1#1)
treatment of tinnitus##2##3##(2010-3#1)(2010-7#1)
treatment of tissue##2##3##(1990-7#1)(2007-11#1)
treatment of tomato plants with##2##5##(2008-10#2)
treatment of toxic##2##3##(2007-5#1)(2010-7#1)
treatment of traumatic shoulder instability##2##5##(2007-11#2)
treatment of traumatic##6##3##(2007-11#4)(2008-8#1)(2012-2#1)
treatment of tubal##3##3##(1992-8#1)(1994-12#1)(1994-3#1)
treatment of tuberculosis##7##3##(1990-6#1)(1996-3#1)(2007-2#1)(2008-10#1)(2008-8#2)(2010-12#1)
treatment of tumor##3##3##(2008-1#1)(2008-2#1)(2008-7#1)
treatment of type 2 diabetes##10##5##(1994-4#1)(1996-11#1)(2006-12#1)(2007-5#1)(2008-1#1)(2011-2#3)(2013-1#1)(2013-7#1)
treatment of type 2##11##4##(1994-4#1)(1996-11#1)(2006-12#1)(2007-5#1)(2008-1#2)(2011-2#3)(2013-1#1)(2013-7#1)
treatment of type##14##3##(1994-4#1)(1996-11#1)(2006-1#1)(2006-12#1)(2007-5#1)(2008-1#2)(2008-9#1)(2011-2#3)(2011-3#1)(2013-1#1)(2013-7#1)
treatment of ulcerative colitis and##2##5##(2006-10#2)
treatment of ulcerative colitis##7##4##(2006-10#6)(2006-2#1)
treatment of uncomplicated malaria##3##4##(2006-2#2)(2010-12#1)
treatment of uncomplicated##8##3##(1992-9#1)(1993-2#1)(2006-2#2)(2008-3#1)(2009-6#1)(2010-12#2)
treatment of unresectable##7##3##(1995-4#1)(2006-6#1)(2008-6#3)(2010-12#1)(2010-3#1)
treatment of unruptured##3##3##(1996-12#2)(2009-7#1)
treatment of unstable fractures##2##4##(2006-8#1)(2007-8#1)
treatment of unstable##7##3##(2006-8#2)(2007-11#1)(2007-8#2)(2008-9#1)(2012-2#1)
treatment of upper##2##3##(2004-2#1)(2013-8#1)
treatment of ureteral##3##3##(1991-11#1)(2009-1#1)(2013-1#1)
treatment of ureteric##2##3##(1991-9#1)(2006-10#1)
treatment of urinary incontinence in##2##5##(2008-10#1)(2012-3#1)
treatment of urinary incontinence##4##4##(2005-9#1)(2006-9#1)(2008-10#1)(2012-3#1)
treatment of urinary tract infection##2##5##(2007-7#1)(2009-5#1)
treatment of urinary tract infections##6##5##(1991-12#2)(1997-4#1)(2007-7#1)(2010-3#1)(2013-8#1)
treatment of urinary tract##8##4##(1991-12#2)(1997-4#1)(2007-7#2)(2009-5#1)(2010-3#1)(2013-8#1)
treatment of urinary##15##3##(1991-12#2)(1996-3#1)(1997-4#1)(1997-5#1)(2005-9#1)(2006-9#1)(2007-7#2)(2008-10#1)(2009-5#1)(2010-3#1)(2010-8#1)(2012-3#1)(2013-8#1)
treatment of uveitis##5##3##(2006-10#1)(2007-11#1)(2013-7#3)
treatment of various diseases##7##4##(1997-2#1)(1997-6#1)(2005-3#1)(2008-10#2)(2008-3#1)(2008-8#1)
treatment of various##28##3##(1993-9#1)(1996-11#1)(1997-2#1)(1997-6#1)(2005-3#2)(2005-8#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)(2010-8#1)(2011-1#1)(2013-7#1)(2013-8#1)
treatment of vascular diseases##2##4##(2006-10#1)(2008-5#1)
treatment of vascular##5##3##(2006-10#1)(2007-12#1)(2007-6#2)(2008-5#1)
treatment of vasovagal syncope##2##4##(2006-9#2)
treatment of venous congestion##2##4##(2007-7#2)
treatment of venous##6##3##(1990-3#1)(1990-6#1)(2005-7#1)(2007-7#2)(2011-2#1)
treatment of vertebral##5##3##(2006-6#1)(2007-11#1)(2007-8#1)(2008-8#1)(2011-2#1)
treatment of viral infections##4##4##(2007-12#1)(2007-9#2)(2008-5#1)
treatment of viral##8##3##(1995-6#1)(2007-12#1)(2007-9#2)(2008-1#1)(2008-5#1)(2008-6#1)(2012-2#1)
treatment of visceral##2##3##(1990-9#1)(2006-10#1)
treatment of vitiligo##2##3##(1992-6#1)(2007-7#1)
treatment of women in the##2##5##(1994-12#1)(2006-1#1)
treatment of women with##5##4##(1995-5#2)(2004-2#1)(2007-8#1)(2008-11#1)
treatment of women##8##3##(1994-12#1)(1995-5#2)(2004-2#1)(2006-1#1)(2007-8#1)(2008-11#1)(2009-9#1)
treatment of wounds##5##3##(1991-7#1)(2006-6#1)(2008-4#1)(2008-5#1)(2012-3#1)
treatment of##5558##2##(1990-1#2)(1990-10#7)(1990-11#17)(1990-12#20)(1990-2#20)(1990-3#16)(1990-4#8)(1990-5#17)(1990-6#27)(1990-7#9)(1990-8#8)(1990-9#22)(1991-1#12)(1991-10#3)(1991-11#15)(1991-12#33)(1991-2#16)(1991-3#12)(1991-4#19)(1991-5#7)(1991-6#17)(1991-7#6)(1991-8#18)(1991-9#26)(1992-1#12)(1992-10#11)(1992-11#9)(1992-12#9)(1992-2#14)(1992-3#26)(1992-4#10)(1992-5#11)(1992-6#23)(1992-7#5)(1992-8#31)(1992-9#14)(1993-1#7)(1993-10#14)(1993-11#31)(1993-12#9)(1993-2#16)(1993-3#12)(1993-4#7)(1993-5#20)(1993-6#11)(1993-7#1)(1993-8#22)(1993-9#34)(1994-1#2)(1994-10#4)(1994-11#18)(1994-12#14)(1994-2#10)(1994-3#12)(1994-4#13)(1994-5#12)(1994-6#14)(1994-7#7)(1994-8#14)(1994-9#15)(1995-1#3)(1995-10#1)(1995-11#11)(1995-12#13)(1995-2#10)(1995-3#9)(1995-4#13)(1995-5#18)(1995-6#15)(1995-7#4)(1995-8#11)(1995-9#13)(1996-1#10)(1996-10#7)(1996-11#12)(1996-12#15)(1996-2#14)(1996-3#19)(1996-4#3)(1996-5#8)(1996-6#11)(1996-7#5)(1996-8#15)(1996-9#16)(1997-1#11)(1997-2#13)(1997-3#18)(1997-4#11)(1997-5#12)(1997-6#16)(1997-7#15)(1997-8#20)(2004-1#10)(2004-10#5)(2004-11#5)(2004-12#4)(2004-2#5)(2004-3#7)(2004-4#1)(2004-9#2)(2005-1#12)(2005-10#44)(2005-11#30)(2005-12#8)(2005-3#10)(2005-4#1)(2005-5#2)(2005-6#15)(2005-7#85)(2005-8#63)(2005-9#24)(2006-1#6)(2006-10#218)(2006-11#22)(2006-12#62)(2006-2#37)(2006-3#15)(2006-4#26)(2006-5#15)(2006-6#73)(2006-7#33)(2006-8#52)(2006-9#44)(2007-1#16)(2007-10#25)(2007-11#304)(2007-12#70)(2007-2#20)(2007-3#15)(2007-4#21)(2007-5#14)(2007-6#22)(2007-7#124)(2007-8#194)(2007-9#31)(2008-1#96)(2008-10#121)(2008-11#65)(2008-12#33)(2008-2#36)(2008-3#142)(2008-4#73)(2008-5#171)(2008-6#64)(2008-7#114)(2008-8#92)(2008-9#55)(2009-1#10)(2009-10#22)(2009-11#11)(2009-12#13)(2009-2#39)(2009-3#30)(2009-4#19)(2009-5#26)(2009-6#15)(2009-7#10)(2009-8#36)(2009-9#22)(2010-1#7)(2010-10#12)(2010-11#25)(2010-12#83)(2010-2#17)(2010-3#34)(2010-4#20)(2010-5#19)(2010-6#35)(2010-7#18)(2010-8#34)(2010-9#16)(2011-1#80)(2011-10#1)(2011-11#1)(2011-12#20)(2011-2#225)(2011-3#8)(2011-7#6)(2012-1#28)(2012-11#6)(2012-12#85)(2012-2#101)(2012-3#56)(2013-1#167)(2013-7#43)(2013-8#81)
treatment offers##4##2##(1992-9#1)(2007-5#1)(2008-10#1)(2012-2#1)
treatment often##3##2##(2006-10#1)(2007-11#1)(2009-12#1)
treatment on activated carbons##2##4##(2005-11#2)
treatment on left ventricular##2##4##(1995-6#1)(2005-10#1)
treatment on plasma##2##3##(1993-12#1)(2012-12#1)
treatment on postoperative##2##3##(1994-3#1)(2013-8#1)
treatment on serum##2##3##(2007-8#1)(2011-1#1)
treatment on the central##2##4##(1992-8#1)(1996-12#1)
treatment on the development of##2##5##(1996-4#1)(2007-2#1)
treatment on the same##2##4##(1996-12#1)(2007-10#1)
treatment on the##38##3##(1990-12#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#2)(1994-11#1)(1994-2#1)(1994-3#1)(1995-12#2)(1996-12#2)(1996-4#1)(1996-5#1)(1997-5#1)(1997-7#2)(2006-10#1)(2007-10#1)(2007-11#2)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-5#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-8#1)
treatment on this##3##3##(1994-2#1)(2008-5#1)(2013-1#1)
treatment on##139##2##(1990-10#1)(1990-12#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-10#1)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#3)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#3)(1996-10#2)(1996-12#2)(1996-2#1)(1996-4#2)(1996-5#1)(1997-3#1)(1997-5#1)(1997-7#3)(1997-8#1)(2005-1#1)(2005-10#2)(2005-11#4)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-6#2)(2007-10#3)(2007-11#3)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#8)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2009-11#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-12#4)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#4)(2012-8#1)(2013-1#6)(2013-7#1)(2013-8#3)
treatment once##2##2##(2007-9#1)(2013-1#1)
treatment only##12##2##(1990-4#2)(1994-11#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-8#1)(2008-10#1)(2010-12#1)(2010-3#1)(2011-1#1)
treatment onset##2##2##(1992-9#1)(2009-10#1)
treatment option and##3##3##(2004-3#1)(2007-8#1)(2008-6#1)
treatment option as##2##3##(2005-5#1)(2011-1#1)
treatment option for acute pain##2##5##(2011-1#2)
treatment option for patients with##7##5##(1997-3#1)(2006-10#1)(2007-11#2)(2007-8#1)(2009-8#1)(2010-11#1)
treatment option for patients##8##4##(1997-3#1)(2006-10#2)(2007-11#2)(2007-8#1)(2009-8#1)(2010-11#1)
treatment option for the##4##4##(2007-12#1)(2008-10#1)(2008-12#1)(2011-1#1)
treatment option for##38##3##(1997-3#1)(2006-10#4)(2006-11#1)(2006-12#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2012-12#3)(2012-2#2)(2013-1#1)
treatment option in##8##3##(2005-6#1)(2007-11#3)(2008-3#1)(2011-2#1)(2012-2#2)
treatment option is##3##3##(2007-8#1)(2008-7#1)(2011-2#1)
treatment option that##2##3##(2008-6#1)(2012-12#1)
treatment option with##2##3##(2006-12#1)(2012-12#1)
treatment option##84##2##(1994-3#1)(1996-8#1)(1997-3#1)(2004-3#1)(2005-5#1)(2005-6#1)(2006-10#4)(2006-11#1)(2006-12#3)(2006-9#1)(2007-11#6)(2007-12#1)(2007-6#1)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#1)(2008-12#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#2)(2009-5#1)(2009-8#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#5)
treatment options also##2##3##(2005-8#1)(2011-1#1)
treatment options and prognosis##2##4##(2008-3#1)(2010-2#1)
treatment options and##11##3##(1996-12#1)(1996-9#1)(2005-12#1)(2006-10#1)(2006-7#1)(2007-4#1)(2008-3#1)(2008-6#1)(2010-2#1)(2011-2#2)
treatment options are available##3##4##(2005-11#1)(2008-1#1)(2010-6#1)
treatment options are discussed##3##4##(2005-12#1)(2007-12#1)(2008-12#1)
treatment options are limited##2##4##(2006-10#1)(2013-8#1)
treatment options are reviewed##2##4##(2006-4#1)(2012-3#1)
treatment options are##19##3##(1990-4#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-12#1)(2008-1#2)(2008-12#1)(2009-5#2)(2010-4#1)(2010-6#1)(2012-3#2)(2013-1#1)(2013-8#1)
treatment options available to##4##4##(1993-11#1)(2007-11#1)(2011-2#1)(2012-3#1)
treatment options available##9##3##(1993-11#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-6#1)(2010-12#1)(2011-2#1)(2012-3#1)
treatment options exist##2##3##(2006-3#1)(2006-7#1)
treatment options for chronic##2##4##(2010-8#1)(2011-2#1)
treatment options for conjunctival##2##4##(2006-11#1)(2009-8#1)
treatment options for patients with##4##5##(2006-5#1)(2007-11#1)(2008-1#1)(2008-5#1)
treatment options for patients##7##4##(2006-5#1)(2007-11#1)(2008-1#1)(2008-5#1)(2011-2#2)(2012-12#1)
treatment options for the##5##4##(2010-7#1)(2012-2#2)(2013-1#1)(2013-8#1)
treatment options for##36##3##(2005-6#1)(2006-11#1)(2006-5#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
treatment options have been described##2##5##(2007-8#1)(2013-1#1)
treatment options have expanded##2##4##(2007-10#1)(2009-2#1)
treatment options have##6##3##(2006-10#1)(2007-10#1)(2007-8#1)(2009-2#1)(2012-2#1)(2013-1#1)
treatment options in the management of##2##6##(2008-5#1)(2009-8#1)
treatment options in the##3##4##(2008-5#1)(2009-2#1)(2009-8#1)
treatment options in##8##3##(2006-10#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-4#1)(2011-12#1)(2012-3#1)
treatment options include##2##3##(2010-12#1)(2013-1#1)
treatment options including##2##3##(2007-6#1)(2012-3#1)
treatment options is##3##3##(2008-10#1)(2008-5#1)(2009-6#1)
treatment options of##4##3##(2006-5#1)(2009-2#1)(2012-2#1)(2013-8#1)
treatment options such as##2##4##(2005-6#1)(2007-11#1)
treatment options that##2##3##(2008-11#1)(2008-8#1)
treatment options to##5##3##(2007-12#1)(2007-5#1)(2007-8#1)(2008-3#1)(2011-1#1)
treatment options will be##3##4##(2008-6#1)(2008-8#1)(2009-5#1)
treatment options with##2##3##(2007-7#1)(2012-12#1)
treatment options##214##2##(1990-4#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-8#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-8#1)(2005-11#3)(2005-12#2)(2005-6#2)(2005-7#1)(2005-8#1)(2006-10#9)(2006-11#1)(2006-12#5)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#3)(2006-7#2)(2006-8#1)(2006-9#4)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#2)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#1)(2007-8#6)(2008-1#4)(2008-10#1)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#7)(2008-6#7)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#2)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#6)(2009-6#4)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#6)(2010-2#3)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#4)(2011-12#2)(2011-2#12)(2012-1#1)(2012-12#7)(2012-2#9)(2012-3#6)(2013-1#11)(2013-7#2)(2013-8#5)
treatment options]##2##2##(2009-2#1)(2013-7#1)
treatment or by##5##3##(1992-1#1)(1992-3#1)(1996-5#1)(1997-7#1)(2007-12#1)
treatment or in##2##3##(1995-12#1)(2008-4#1)
treatment or prevention of##3##4##(2006-2#1)(2008-3#1)(2011-2#1)
treatment or the##4##3##(2007-10#1)(2007-11#1)(2008-7#1)(2013-8#1)
treatment or to##3##3##(1994-11#1)(2012-11#2)
treatment or treatment with##2##4##(1992-8#1)(1995-12#1)
treatment or##72##2##(1990-12#1)(1990-4#1)(1990-6#1)(1991-2#2)(1992-1#1)(1992-3#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-5#1)(1993-9#1)(1994-11#3)(1995-12#2)(1996-10#1)(1996-5#1)(1997-4#2)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-2#1)(2006-7#2)(2006-8#2)(2007-10#2)(2007-11#3)(2007-12#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#4)(2012-11#2)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#2)
treatment outcome among##2##3##(2006-7#1)(2010-5#1)
treatment outcome and continuous quality improvement##2##6##(1993-12#2)
treatment outcome and##4##3##(1993-12#2)(1995-9#1)(2005-6#1)
treatment outcome for##2##3##(2007-11#1)(2010-12#1)
treatment outcome in patients##2##4##(1994-8#1)(2007-8#1)
treatment outcome in##15##3##(1994-8#1)(1995-1#1)(2007-7#6)(2007-8#4)(2010-1#1)(2013-1#1)(2013-7#1)
treatment outcome was##2##3##(2007-11#1)(2012-12#1)
treatment outcome##62##2##(1991-12#1)(1993-12#2)(1994-12#1)(1994-8#1)(1995-1#3)(1995-12#1)(1995-9#1)(2005-6#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-7#1)(2007-11#4)(2007-7#8)(2007-8#9)(2008-11#2)(2008-2#1)(2008-6#2)(2008-9#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#5)(2013-7#2)
treatment outcomes and##3##3##(1992-12#1)(2010-10#1)(2012-2#1)
treatment outcomes in##8##3##(2006-12#1)(2006-7#1)(2006-9#1)(2007-1#1)(2009-3#1)(2010-2#1)(2012-1#1)(2013-1#1)
treatment outcomes of##5##3##(2006-10#1)(2007-7#1)(2010-12#1)(2011-2#1)(2013-8#1)
treatment outcomes##50##2##(1992-12#1)(1994-3#1)(1997-2#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-6#2)(2009-2#1)(2009-3#4)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#2)(2011-1#4)(2011-2#5)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
treatment over a##2##3##(1996-6#1)(2011-2#1)
treatment over the##5##3##(1990-12#1)(2006-10#1)(2007-11#1)(2008-7#2)
treatment over##14##2##(1990-12#1)(1992-3#1)(1996-6#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-7#2)(2009-11#1)(2009-9#1)(2011-2#2)(2012-12#1)(2013-1#1)
treatment package##2##2##(2006-7#2)
treatment paradigm for patients with##3##5##(2009-11#1)(2010-12#1)(2010-4#1)
treatment paradigm for##4##3##(2009-11#1)(2010-12#1)(2010-4#1)(2013-1#1)
treatment paradigm##5##2##(1996-10#1)(2009-11#1)(2010-12#1)(2010-4#1)(2013-1#1)
treatment paradigms with##2##3##(2010-12#2)
treatment paradigms##7##2##(2006-8#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-12#3)
treatment parameters and##2##3##(2007-4#1)(2008-10#1)
treatment parameters in##2##3##(2008-10#1)(2008-6#1)
treatment parameters##11##2##(2007-4#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-6#1)(2010-9#1)
treatment patients with##3##3##(1993-1#1)(2007-11#1)(2008-5#1)
treatment patients##5##2##(1993-1#1)(1996-12#1)(2007-11#1)(2008-5#1)(2013-1#1)
treatment patterns##2##2##(1994-12#1)(2013-1#1)
treatment per##3##2##(1996-12#1)(2008-10#1)(2008-5#1)
treatment performed##5##2##(2007-8#1)(2008-12#1)(2008-2#1)(2013-8#2)
treatment period of##4##3##(1990-8#1)(1995-1#1)(2006-12#1)(2006-3#1)
treatment period the##2##3##(1990-11#1)(1997-1#1)
treatment period##42##2##(1990-11#1)(1990-7#1)(1990-8#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-5#1)(1994-12#3)(1995-1#2)(1995-12#1)(1997-1#1)(1997-5#1)(1997-6#1)(2006-10#2)(2006-12#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2011-1#4)(2011-2#1)(2013-1#1)
treatment periods##6##2##(1995-1#1)(2004-12#1)(2007-7#1)(2008-11#3)
treatment phase##6##2##(2007-9#1)(2008-3#1)(2008-4#3)(2010-8#1)
treatment plan for##2##3##(2011-2#2)
treatment plan is##3##3##(2010-9#1)(2013-1#2)
treatment plan that##2##3##(2010-2#1)(2011-1#1)
treatment plan##33##2##(1992-10#1)(1993-3#1)(1996-7#1)(2006-5#1)(2007-12#3)(2007-6#1)(2007-7#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-9#4)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
treatment planning and##4##3##(1991-4#1)(1992-8#1)(2012-11#1)(2013-8#1)
treatment planning for##8##3##(2006-10#1)(2008-3#1)(2008-7#1)(2009-11#2)(2011-1#1)(2012-12#1)(2013-7#1)
treatment planning is##4##3##(1993-8#1)(2008-7#1)(2009-11#1)(2009-2#1)
treatment planning of##5##3##(1994-12#1)(2007-11#1)(2007-6#1)(2009-11#1)(2009-2#1)
treatment planning system##2##3##(2008-3#2)
treatment planning systems##3##3##(1994-8#1)(1996-12#1)(2009-11#1)
treatment planning using##2##3##(1995-9#1)(1997-3#1)
treatment planning##79##2##(1991-12#2)(1991-4#1)(1992-8#1)(1993-1#1)(1993-8#1)(1994-12#1)(1994-3#3)(1994-7#2)(1994-8#1)(1994-9#1)(1995-8#1)(1995-9#1)(1996-12#1)(1997-3#2)(2004-1#1)(2005-6#1)(2006-10#2)(2006-2#2)(2006-5#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-6#1)(2008-11#2)(2008-3#5)(2008-6#1)(2008-7#7)(2008-8#1)(2009-11#5)(2009-2#3)(2009-3#3)(2009-5#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#3)(2011-1#3)(2011-2#1)(2012-11#1)(2012-12#3)(2013-1#3)(2013-7#1)(2013-8#1)
treatment plans and##2##3##(1993-1#1)(2006-5#1)
treatment plans for##3##3##(2006-9#1)(2009-5#1)(2013-1#1)
treatment plans were##2##3##(2008-3#1)(2013-1#1)
treatment plans##13##2##(1992-12#2)(1993-1#1)(2006-1#1)(2006-5#1)(2006-9#1)(2008-3#2)(2009-3#1)(2009-5#1)(2012-2#1)(2013-1#2)
treatment plant (WWTP)##5##3##(2007-8#1)(2008-10#3)(2013-1#1)
treatment plant and##2##3##(2007-8#1)(2008-10#1)
treatment plant##20##2##(1992-6#1)(2005-11#2)(2006-8#1)(2007-10#3)(2007-12#2)(2007-8#2)(2008-10#5)(2008-12#3)(2013-1#1)
treatment plants in##2##3##(2008-1#1)(2008-7#1)
treatment plants##12##2##(2008-1#1)(2008-10#5)(2008-6#1)(2008-7#2)(2009-6#1)(2010-5#2)
treatment plus##2##2##(1997-8#1)(2012-12#1)
treatment policy##10##2##(1997-3#1)(1997-6#1)(2005-9#1)(2007-7#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)
treatment portals##2##2##(2009-2#2)
treatment possibilities in##3##3##(1990-4#1)(1997-7#1)(2008-3#1)
treatment possibilities##7##2##(1990-4#1)(1992-2#1)(1993-11#1)(1997-7#1)(2006-12#1)(2008-3#1)(2011-2#1)
treatment practice##2##2##(1996-6#1)(2006-8#1)
treatment practices for##2##3##(2007-9#1)(2013-8#1)
treatment practices##7##2##(1997-3#1)(2006-7#1)(2007-10#1)(2007-9#1)(2008-5#1)(2008-6#1)(2013-8#1)
treatment preferences in##2##3##(2009-11#1)(2010-11#1)
treatment preferences##7##2##(2009-11#2)(2010-11#2)(2010-4#2)(2012-3#1)
treatment prescribed by##2##3##(1997-6#1)(2011-1#1)
treatment prescribed##4##2##(1997-6#1)(2011-1#2)(2012-2#1)
treatment preserved##2##2##(1997-8#1)(2012-2#1)
treatment prevented the##3##3##(1990-2#1)(1994-11#1)(1996-4#1)
treatment prevented##7##2##(1990-2#1)(1994-11#1)(1996-4#1)(1997-7#1)(2008-10#1)(2008-5#1)(2013-1#1)
treatment prevents##3##2##(2006-10#1)(2011-2#2)
treatment principle for##2##3##(2007-10#1)(2013-1#1)
treatment principle##3##2##(1993-3#1)(2007-10#1)(2013-1#1)
treatment principles##2##2##(2007-4#1)(2012-2#1)
treatment prior to##7##3##(1995-4#1)(1996-12#1)(2006-5#1)(2007-8#1)(2008-10#1)(2011-1#2)
treatment problem##3##2##(2006-10#1)(2007-11#2)
treatment problems##3##2##(1990-6#1)(2006-12#1)(2007-11#1)
treatment procedure##8##2##(1990-8#1)(2007-11#2)(2007-6#2)(2007-7#1)(2009-10#1)(2012-2#1)
treatment procedures for##2##3##(1993-5#1)(2008-10#1)
treatment procedures##12##2##(1992-1#1)(1993-5#2)(1997-8#1)(2005-10#2)(2007-11#1)(2008-10#2)(2010-11#1)(2011-2#1)(2012-2#1)
treatment process##12##2##(1992-5#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-7#1)(2009-6#2)(2011-1#1)(2011-12#1)
treatment processes to##2##3##(2013-1#2)
treatment processes##8##2##(2007-11#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-2#1)(2013-1#3)
treatment produced a##3##3##(1990-7#1)(1997-5#1)(2007-11#1)
treatment produced an##3##3##(1994-10#1)(2007-2#1)(2009-8#1)
treatment produced##9##2##(1990-7#1)(1994-10#1)(1997-5#1)(2006-6#1)(2007-11#2)(2007-2#1)(2009-8#1)(2011-2#1)
treatment produces##3##2##(1994-10#1)(2007-11#1)(2010-4#1)
treatment program was##2##3##(1992-9#1)(2007-8#1)
treatment program were##2##3##(1995-1#1)(2007-2#1)
treatment program##31##2##(1991-2#2)(1992-9#2)(1993-1#1)(1994-6#1)(1995-1#1)(1996-11#1)(1996-3#2)(1997-2#2)(2006-7#2)(2007-11#1)(2007-12#2)(2007-2#2)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#2)(2009-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)
treatment programme for##2##3##(1991-2#1)(1991-4#1)
treatment programme in##2##3##(1990-11#1)(2009-3#1)
treatment programme##5##2##(1990-11#1)(1991-2#1)(1991-4#1)(1995-5#1)(2009-3#1)
treatment programmes##10##2##(1991-4#2)(1995-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
treatment programs and##3##3##(2007-2#1)(2012-2#1)(2013-8#1)
treatment programs can##2##3##(2008-6#2)
treatment programs for##4##3##(2004-3#1)(2007-2#2)(2008-11#1)
treatment programs have been##2##4##(1994-12#1)(2009-7#1)
treatment programs in##3##3##(2007-8#1)(2008-2#1)(2011-1#1)
treatment programs that##3##3##(2006-10#1)(2007-2#1)(2008-6#1)
treatment programs to##3##3##(1993-2#1)(2008-1#1)(2010-9#1)
treatment programs##48##2##(1993-2#1)(1994-12#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-3#1)(2004-3#1)(2005-10#1)(2006-10#2)(2006-7#1)(2007-2#6)(2007-8#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#9)(2009-7#2)(2009-9#1)(2010-2#2)(2010-3#1)(2010-9#1)(2011-1#1)(2012-2#5)(2013-7#1)(2013-8#2)
treatment prospects##2##2##(2007-11#1)(2008-3#1)
treatment protocol for##5##3##(1992-5#1)(2007-12#1)(2008-7#1)(2009-3#1)(2009-4#1)
treatment protocol in##4##3##(2008-6#1)(2008-8#1)(2012-3#2)
treatment protocol is##2##3##(2004-3#1)(2006-12#1)
treatment protocol was##3##3##(1995-5#1)(2008-10#1)(2012-2#1)
treatment protocol##36##2##(1992-5#1)(1995-5#1)(1996-8#1)(1997-1#1)(2004-3#1)(2006-12#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
treatment protocols and##4##3##(2007-1#1)(2008-11#1)(2008-2#1)(2010-12#1)
treatment protocols for##8##3##(2007-8#1)(2011-12#1)(2011-2#2)(2012-12#3)(2012-3#1)
treatment protocols##36##2##(1992-12#1)(1995-8#1)(1996-10#1)(1997-2#1)(1997-8#1)(2006-12#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-3#1)(2009-6#3)(2009-7#1)(2010-12#1)(2011-12#1)(2011-2#7)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#1)
treatment provided to elderly##2##4##(2012-3#2)
treatment provided##7##2##(1992-5#1)(1997-4#1)(2007-8#1)(2008-5#1)(2011-12#1)(2012-3#2)
treatment providers##6##2##(1993-12#1)(2008-6#2)(2008-7#1)(2009-9#1)(2012-11#1)
treatment provides##2##2##(2006-2#1)(2011-12#1)
treatment quality##2##2##(2007-8#1)(2010-3#1)
treatment raises the##2##3##(1993-10#1)(1996-3#1)
treatment ranged##2##2##(2006-12#1)(2008-5#1)
treatment rate##2##2##(1991-12#1)(2012-3#1)
treatment rates and##2##3##(2008-3#2)
treatment rates##6##2##(2008-3#5)(2008-8#1)
treatment rationale##2##2##(1990-8#1)(2008-2#1)
treatment received##4##2##(1991-2#1)(1993-1#1)(1996-1#1)(2012-12#1)
treatment recently##3##2##(1994-7#1)(2006-10#1)(2009-10#1)
treatment recommendation##3##2##(2011-2#1)(2013-1#2)
treatment recommendations##22##2##(1990-4#1)(1992-12#1)(1996-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-6#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2011-2#1)(2013-1#2)
treatment recommended by the##2##4##(1996-11#1)(2008-12#1)
treatment recommended##3##2##(1996-11#1)(2008-10#1)(2008-12#1)
treatment reduced medical##2##3##(1995-1#2)
treatment reduced the##9##3##(1994-2#1)(1996-12#1)(2004-4#1)(2008-10#2)(2008-5#1)(2009-1#1)(2011-2#1)(2012-12#1)
treatment reduced##21##2##(1993-9#1)(1994-2#1)(1995-1#2)(1995-8#1)(1996-12#1)(2004-4#1)(2005-11#1)(2007-11#3)(2008-10#3)(2008-5#1)(2009-1#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
treatment reduces the##2##3##(1994-9#1)(1996-5#1)
treatment reduces##7##2##(1992-2#1)(1994-2#1)(1994-9#1)(1996-5#2)(2010-11#1)(2012-2#1)
treatment refractory##2##2##(2008-11#1)(2009-9#1)
treatment regardless of##2##3##(1991-11#1)(2008-7#1)
treatment regime and##3##3##(2007-11#1)(2011-1#1)(2011-2#1)
treatment regime for##3##3##(2008-3#1)(2012-12#2)
treatment regime##10##2##(2007-11#1)(2008-3#1)(2008-8#1)(2010-10#1)(2011-1#3)(2011-2#1)(2012-12#2)
treatment regimen for##6##3##(1991-12#1)(1995-9#1)(1997-1#1)(2008-10#1)(2010-12#2)
treatment regimen is##4##3##(1993-9#1)(2007-11#1)(2007-8#1)(2011-12#1)
treatment regimen of##3##3##(2009-10#1)(2011-2#1)(2012-3#1)
treatment regimen was##2##3##(2007-2#1)(2007-9#1)
treatment regimen with##2##3##(1993-2#1)(2007-10#1)
treatment regimen##41##2##(1991-12#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1995-3#1)(1995-8#1)(1995-9#1)(1997-1#1)(2005-10#1)(2005-9#1)(2006-1#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
treatment regimens for##3##3##(1991-2#1)(2005-6#1)(2007-8#1)
treatment regimens in##2##3##(2007-7#1)(2008-6#1)
treatment regimens that are##2##4##(1993-9#1)(2005-10#1)
treatment regimens that##3##3##(1993-9#1)(2005-10#1)(2007-8#1)
treatment regimens were##3##3##(2007-6#1)(2008-10#1)(2012-2#1)
treatment regimens##42##2##(1991-2#1)(1992-12#1)(1993-7#1)(1993-9#1)(1995-12#1)(1995-2#1)(2004-1#1)(2005-10#1)(2005-11#1)(2005-6#1)(2005-8#2)(2006-10#1)(2006-12#1)(2007-11#3)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2009-6#1)(2010-6#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
treatment regimes##8##2##(2005-11#2)(2008-3#1)(2009-12#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-3#1)
treatment related costs##3##3##(2009-12#3)
treatment related mortality##2##3##(2011-2#1)(2013-8#1)
treatment related##10##2##(2006-4#1)(2008-6#2)(2008-7#1)(2009-12#3)(2011-2#2)(2013-8#1)
treatment relies on##3##3##(2007-5#1)(2008-5#1)(2012-2#1)
treatment remains elusive##2##3##(2006-10#1)(2006-5#1)
treatment remains##15##2##(1993-11#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-5#1)(2006-7#1)(2006-9#1)(2008-6#1)(2008-7#2)(2009-8#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
treatment required##3##2##(1991-2#1)(1993-11#1)(2011-10#1)
treatment requires the##2##3##(2007-9#1)(2011-2#1)
treatment requires##9##2##(1992-2#1)(1995-4#1)(1997-4#1)(2007-11#1)(2007-9#1)(2008-3#1)(2009-6#1)(2011-2#1)(2013-1#1)
treatment research##4##2##(2004-3#1)(2006-11#1)(2010-12#1)(2012-2#1)
treatment resistance##3##2##(2006-12#1)(2010-7#1)(2011-2#1)
treatment resistant depression##2##3##(2011-2#1)(2012-12#1)
treatment response and##4##3##(1997-8#1)(2008-12#1)(2009-11#2)
treatment response in patients with##2##5##(2010-6#1)(2013-7#1)
treatment response in##7##3##(1996-8#1)(2007-2#2)(2008-11#1)(2008-9#1)(2010-6#1)(2013-7#1)
treatment response to##2##3##(2008-12#1)(2008-6#1)
treatment response##53##2##(1991-8#1)(1993-1#1)(1995-1#2)(1995-2#1)(1996-8#1)(1997-2#1)(1997-8#1)(2005-8#1)(2006-10#3)(2006-7#1)(2006-9#2)(2007-11#1)(2007-2#2)(2007-4#1)(2008-1#3)(2008-11#1)(2008-12#4)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#2)(2009-4#1)(2010-11#1)(2010-12#5)(2010-6#2)(2010-9#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
treatment responses##2##2##(2005-8#1)(2006-10#1)
treatment restored the##3##3##(1991-5#1)(1997-5#1)(2008-5#1)
treatment restores##2##2##(1997-5#1)(1997-8#1)
treatment resulted in a significant##3##5##(2011-1#1)(2012-3#1)(2013-1#1)
treatment resulted in a##12##4##(1990-2#1)(1990-6#1)(1993-6#1)(1993-9#1)(1994-11#1)(2005-8#1)(2007-12#1)(2008-10#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
treatment resulted in significant##2##4##(1993-9#1)(2009-5#1)
treatment resulted in##25##3##(1990-2#1)(1990-6#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-6#1)(1995-5#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-6#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
treatment resulted##27##2##(1990-2#1)(1990-6#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-6#1)(1995-5#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-6#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-5#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
treatment resulting in##3##3##(2008-6#1)(2009-2#1)(2010-8#1)
treatment results and##2##3##(1994-4#1)(2011-2#1)
treatment results in a##3##4##(1990-11#1)(1992-12#1)(1996-12#1)
treatment results in changes in##2##5##(1996-5#1)(2007-4#1)
treatment results in children with ALL and##3##7##(2011-2#3)
treatment results in##13##3##(1990-11#1)(1992-12#1)(1993-11#1)(1996-11#1)(1996-12#1)(1996-5#1)(2007-4#1)(2009-8#1)(2011-2#5)
treatment results of patients##3##4##(2007-11#1)(2007-7#1)(2011-2#1)
treatment results of##14##3##(1996-9#1)(1997-3#1)(2004-1#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-6#1)(2008-7#2)(2011-2#3)(2013-1#1)
treatment results##47##2##(1990-11#1)(1990-2#1)(1992-12#1)(1993-11#1)(1994-4#1)(1995-9#2)(1996-11#1)(1996-12#1)(1996-5#1)(1996-9#2)(1997-3#1)(2004-1#1)(2007-11#5)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-6#1)(2008-7#3)(2009-8#1)(2010-12#1)(2011-12#1)(2011-2#14)(2011-3#1)(2013-1#1)(2013-7#1)
treatment results]##2##2##(1996-3#1)(2011-2#1)
treatment retention##3##2##(2008-6#1)(2013-8#2)
treatment revealed##5##2##(1991-4#1)(1996-4#1)(2007-7#2)(2008-10#1)
treatment reversed##2##2##(1993-2#1)(1995-12#1)
treatment satisfaction##3##2##(1993-2#1)(1995-2#1)(2009-12#1)
treatment schedule##8##2##(1991-8#2)(1993-11#1)(1995-11#1)(1997-7#1)(2007-11#1)(2007-7#1)(2007-8#1)
treatment schedules##4##2##(1997-8#1)(2006-6#1)(2007-11#1)(2008-10#1)
treatment seeking##4##2##(2008-3#1)(2010-2#1)(2011-1#1)(2011-12#1)
treatment seems to be##3##4##(2008-5#1)(2008-6#1)(2012-12#1)
treatment seems to##4##3##(1994-6#1)(2008-5#1)(2008-6#1)(2012-12#1)
treatment seems##6##2##(1994-6#1)(1995-5#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-12#1)
treatment selection and##2##3##(2008-7#1)(2009-9#1)
treatment selection##12##2##(2005-6#1)(2007-8#1)(2008-7#2)(2009-2#1)(2009-9#1)(2012-2#4)(2013-1#2)
treatment selections##2##2##(2006-12#1)(2011-2#1)
treatment sequelae##2##2##(2006-10#1)(2009-10#1)
treatment sequence##2##2##(1995-10#1)(2008-6#1)
treatment service##3##2##(1990-12#1)(1991-1#2)
treatment services##12##2##(1991-1#1)(2006-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#2)(2010-8#3)(2012-1#1)
treatment session##3##2##(2007-7#1)(2008-12#1)(2010-8#1)
treatment sessions##7##2##(1992-5#1)(1996-11#1)(2007-8#1)(2008-10#1)(2012-1#1)(2012-12#1)(2013-1#1)
treatment setting##8##2##(1992-1#1)(1995-12#1)(2005-7#1)(2007-10#1)(2008-12#1)(2008-2#1)(2009-9#1)(2013-1#1)
treatment settings##6##2##(2005-9#1)(2006-10#1)(2009-7#2)(2012-12#1)(2013-7#1)
treatment should be applied##2##4##(1993-1#1)(2007-7#1)
treatment should be considered##3##4##(1993-4#1)(1996-12#1)(2008-7#1)
treatment should be continued for##3##5##(1990-9#1)(1992-11#1)(2007-11#1)
treatment should be initiated##2##4##(1994-4#1)(2008-10#1)
treatment should be performed##2##4##(2008-4#1)(2012-3#1)
treatment should be used##3##4##(1990-7#1)(2011-2#2)
treatment should be##50##3##(1990-7#1)(1990-9#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-10#1)(1993-4#1)(1993-8#1)(1994-4#1)(1995-1#1)(1996-12#1)(1997-6#1)(2006-10#2)(2007-11#6)(2007-12#3)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-7#2)(2009-11#1)(2009-6#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
treatment should not be##2##4##(2007-8#1)(2010-8#1)
treatment should##64##2##(1990-11#1)(1990-7#1)(1990-9#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-10#1)(1993-4#1)(1993-8#2)(1994-4#1)(1995-1#1)(1996-12#1)(1997-3#1)(1997-6#1)(2006-10#2)(2007-11#7)(2007-12#3)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)
treatment show##2##2##(1995-9#1)(2007-4#1)
treatment showed a##4##3##(2006-7#1)(2007-12#1)(2008-10#1)(2013-8#1)
treatment showed significant##2##3##(1991-5#1)(2012-2#1)
treatment showed that the##3##4##(1993-9#1)(2005-11#1)(2008-11#1)
treatment showed that##9##3##(1991-12#1)(1992-4#1)(1993-11#1)(1993-9#1)(1994-8#1)(2005-11#1)(2008-11#1)(2008-5#1)(2010-8#1)
treatment showed##25##2##(1991-12#1)(1991-5#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-8#1)(2005-11#1)(2006-7#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
treatment side effects##3##3##(2006-12#1)(2008-2#1)(2008-7#1)
treatment side##4##2##(2006-12#1)(2008-2#1)(2008-7#1)(2012-1#1)
treatment significantly (P &lt##2##4##(1995-3#1)(2008-10#1)
treatment significantly improved##2##3##(2008-7#1)(2012-2#1)
treatment significantly increased##3##3##(1990-3#1)(1995-7#1)(1997-6#1)
treatment significantly induced##2##3##(2011-10#1)(2013-8#1)
treatment significantly reduced the##3##4##(1995-12#1)(2010-8#1)(2012-2#1)
treatment significantly reduced##6##3##(1991-5#1)(1995-12#1)(2010-8#1)(2012-2#1)(2013-1#2)
treatment significantly##25##2##(1990-3#1)(1991-5#1)(1995-12#1)(1995-3#1)(1995-7#1)(1996-12#1)(1997-6#1)(1997-8#1)(2008-10#3)(2008-7#2)(2009-2#1)(2010-1#2)(2010-8#1)(2011-10#1)(2011-2#1)(2012-2#2)(2013-1#3)(2013-8#1)
treatment since##2##2##(2006-10#1)(2007-5#1)
treatment site##3##2##(2006-8#1)(2008-7#1)(2011-2#1)
treatment sites##2##2##(2012-12#2)
treatment skills##3##2##(1997-3#1)(2012-1#2)
treatment slightly##2##2##(1990-10#1)(1993-2#1)
treatment so that##3##3##(1992-11#1)(2008-3#1)(2008-8#1)
treatment so##4##2##(1992-11#1)(2008-1#1)(2008-3#1)(2008-8#1)
treatment solutions##2##2##(2007-9#1)(2009-9#1)
treatment some##2##2##(1993-2#1)(2009-12#1)
treatment soon##2##2##(1995-3#1)(2008-1#1)
treatment staff##2##2##(2009-10#2)
treatment stages##3##2##(2007-9#1)(2008-7#1)(2013-1#1)
treatment started##4##2##(1992-10#1)(1993-7#1)(2008-10#2)
treatment status##2##2##(2008-11#2)
treatment strategies aimed at slowing##2##5##(2007-5#1)(2007-9#1)
treatment strategies and options##2##4##(2008-11#1)(2011-2#1)
treatment strategies and##6##3##(2008-11#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-2#1)(2011-2#1)
treatment strategies are##9##3##(1991-7#1)(1996-11#1)(1997-8#1)(2006-1#1)(2007-11#1)(2007-8#1)(2008-8#1)(2010-2#1)(2010-4#1)
treatment strategies for these##2##4##(2006-10#1)(2012-3#1)
treatment strategies for##21##3##(1994-5#1)(1996-9#1)(2006-10#3)(2006-5#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2012-3#2)(2013-8#1)
treatment strategies have been##2##4##(2006-10#1)(2010-8#1)
treatment strategies in##2##3##(1994-1#1)(2011-2#1)
treatment strategies include##2##3##(2006-10#1)(2009-8#1)
treatment strategies of##2##3##(2009-6#1)(2010-12#1)
treatment strategies should##2##3##(2010-10#1)(2013-1#1)
treatment strategies that can##2##4##(2008-9#1)(2011-2#1)
treatment strategies that##6##3##(2005-7#1)(2006-11#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
treatment strategies##110##2##(1991-6#1)(1991-7#1)(1993-11#1)(1994-1#1)(1994-5#1)(1996-11#1)(1996-2#1)(1996-6#2)(1996-9#1)(1997-8#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#6)(2006-11#4)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-11#4)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#5)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#3)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#6)(2013-1#2)(2013-8#7)
treatment strategy and##2##3##(2008-3#1)(2009-6#1)
treatment strategy for the infertile##2##5##(2011-1#2)
treatment strategy for the##3##4##(2011-1#2)(2013-1#1)
treatment strategy for##7##3##(1993-3#1)(1996-3#1)(2007-3#1)(2011-1#2)(2012-12#1)(2013-1#1)
treatment strategy in##3##3##(2007-6#1)(2008-4#1)(2012-3#1)
treatment strategy is##5##3##(1995-10#1)(1997-6#1)(2008-7#1)(2010-5#1)(2012-2#1)
treatment strategy of##3##3##(1997-7#1)(2008-7#1)(2011-2#1)
treatment strategy to##3##3##(2006-10#1)(2007-1#1)(2009-7#1)
treatment strategy##51##2##(1993-11#1)(1993-3#1)(1993-5#1)(1995-10#1)(1996-3#1)(1996-6#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-7#3)(2009-10#1)(2009-6#4)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)
treatment stratification##2##2##(2008-6#1)(2012-2#1)
treatment studies in##2##3##(1993-11#1)(2006-2#1)
treatment studies##10##2##(1993-11#1)(2006-2#2)(2006-4#1)(2008-2#1)(2008-5#2)(2008-9#1)(2012-1#2)
treatment study##6##2##(1993-6#1)(1997-8#1)(2010-1#1)(2012-2#1)(2012-3#2)
treatment success##8##2##(2006-6#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
treatment such as##4##3##(1990-4#1)(1993-8#1)(2007-3#1)(2007-6#1)
treatment suggested that##2##3##(1991-10#1)(2008-10#1)
treatment suggested##3##2##(1991-10#1)(2005-11#1)(2008-10#1)
treatment suggests that##3##3##(1997-8#1)(2007-11#1)(2008-10#1)
treatment suggests##4##2##(1997-8#1)(2007-11#1)(2008-10#2)
treatment suppressed##2##2##(1992-3#1)(2008-10#1)
treatment system##6##2##(2005-11#2)(2012-12#1)(2012-2#2)(2013-1#1)
treatment systems##4##2##(1991-3#1)(2008-3#1)(2009-6#1)(2009-8#1)
treatment targeting##2##2##(2006-10#1)(2008-2#1)
treatment targets and##3##3##(2006-9#1)(2010-12#1)(2012-12#1)
treatment targets##7##2##(2006-9#1)(2007-11#2)(2010-1#1)(2010-12#1)(2012-12#1)(2012-2#1)
treatment team##6##2##(1992-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2011-2#1)
treatment teams##2##2##(2007-8#1)(2010-3#1)
treatment technique##3##2##(2007-4#1)(2008-12#1)(2009-4#1)
treatment techniques that##2##3##(2006-11#1)(2008-10#1)
treatment techniques##6##2##(1993-11#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-4#1)(2008-10#1)
treatment technologies##3##2##(2008-1#1)(2008-3#1)(2012-2#1)
treatment teens##2##2##(2013-1#2)
treatment temperature##3##2##(2008-5#1)(2009-3#1)(2011-2#1)
treatment temperatures##2##2##(2008-10#1)(2008-5#1)
treatment than##9##2##(1990-3#1)(1990-9#1)(1992-6#1)(1993-8#1)(1994-6#1)(2007-7#1)(2008-4#1)(2009-10#1)(2013-1#1)
treatment that could be##2##4##(2007-11#1)(2013-1#1)
treatment that could##3##3##(2005-12#1)(2007-11#1)(2013-1#1)
treatment that has##2##3##(2007-11#1)(2008-1#1)
treatment that is##4##3##(1994-3#1)(1996-2#1)(2008-3#1)(2008-7#1)
treatment that was##2##3##(2008-10#1)(2013-1#1)
treatment that##33##2##(1994-3#1)(1996-2#1)(1997-8#1)(2004-12#1)(2005-12#1)(2006-5#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-4#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)
treatment the disease##2##3##(1992-12#1)(1994-7#1)
treatment the patient##4##3##(1990-9#1)(1994-5#1)(2007-9#1)(2009-4#1)
treatment the##33##2##(1990-2#2)(1990-9#1)(1991-2#1)(1991-9#1)(1992-12#2)(1992-4#1)(1993-12#1)(1994-3#3)(1994-5#1)(1994-7#1)(1995-3#1)(1996-3#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-4#1)(2011-1#1)(2013-7#1)
treatment there is##2##3##(2010-1#1)(2012-12#1)
treatment there was a##2##4##(2007-11#1)(2011-1#1)
treatment there was##3##3##(2004-2#1)(2007-11#1)(2011-1#1)
treatment there##7##2##(2004-2#1)(2006-5#2)(2007-11#1)(2010-1#1)(2011-1#1)(2012-12#1)
treatment they were##2##3##(1997-8#1)(2006-10#1)
treatment they##4##2##(1990-5#1)(1996-3#1)(1997-8#1)(2006-10#1)
treatment through the##2##3##(1994-10#1)(2012-3#1)
treatment through##6##2##(1991-6#1)(1994-10#1)(1996-3#1)(2008-11#1)(2012-3#1)(2013-1#1)
treatment till##3##2##(2007-4#1)(2007-7#1)(2007-8#1)
treatment time and##2##3##(2009-5#1)(2013-1#1)
treatment time##21##2##(1992-10#2)(1994-2#1)(1994-4#1)(1994-7#1)(1995-4#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
treatment times##4##2##(1991-7#1)(1994-12#1)(1994-4#1)(2010-3#1)
treatment to achieve##2##3##(2007-7#1)(2011-2#1)
treatment to all##2##3##(1996-12#1)(2013-7#1)
treatment to avoid##2##3##(1994-3#1)(2008-1#1)
treatment to be##6##3##(2006-11#1)(2007-10#1)(2007-7#1)(2009-2#1)(2009-6#1)(2011-12#1)
treatment to control##2##3##(2004-1#1)(2008-10#1)
treatment to improve##3##3##(1995-11#1)(2008-6#1)(2009-7#1)
treatment to patients##3##3##(1994-2#1)(1995-12#1)(2010-9#1)
treatment to prevent##2##3##(2008-5#1)(2012-12#1)
treatment to restore##3##3##(2007-11#2)(2012-3#1)
treatment to the##10##3##(1992-12#1)(1995-3#1)(1996-1#1)(2007-12#1)(2007-8#2)(2008-4#1)(2008-5#1)(2010-3#1)(2012-2#1)
treatment to##109##2##(1990-5#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1993-10#1)(1993-7#1)(1994-11#3)(1994-2#1)(1994-3#1)(1994-6#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#1)(1997-7#1)(1997-8#1)(2004-1#1)(2005-10#2)(2005-11#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#4)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-6#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#3)
treatment today##3##2##(1993-10#1)(2006-10#1)(2008-6#1)
treatment tools##3##2##(2008-6#2)(2010-5#1)
treatment toward##2##2##(2008-6#1)(2008-7#1)
treatment trial##7##2##(1993-2#1)(1996-11#1)(2008-8#2)(2009-12#1)(2011-10#1)(2013-1#1)
treatment trials##9##2##(2005-10#1)(2005-8#1)(2006-9#1)(2007-10#1)(2007-9#3)(2008-12#1)(2012-3#1)
treatment type##2##2##(2008-6#1)(2012-1#1)
treatment under##5##2##(1992-11#1)(1995-10#1)(1995-2#1)(1995-8#1)(2010-3#1)
treatment unit and##2##3##(2010-9#2)
treatment unit##4##2##(2008-1#1)(2010-9#3)
treatment unless##2##2##(2006-10#1)(2009-8#1)
treatment until the##2##3##(2007-8#1)(2011-1#1)
treatment until##3##2##(2007-8#1)(2008-1#1)(2011-1#1)
treatment updates##2##2##(2010-9#1)(2012-1#1)
treatment use##3##2##(2011-2#1)(2013-1#2)
treatment used in##2##3##(1991-4#1)(2005-11#1)
treatment used##7##2##(1991-4#1)(1992-9#1)(1993-9#1)(2005-11#1)(2007-3#1)(2007-7#1)(2010-11#1)
treatment using a##3##3##(1990-6#1)(2007-8#1)(2010-9#1)
treatment using the##3##3##(1994-11#1)(1996-3#1)(1997-3#1)
treatment using##37##2##(1990-6#1)(1994-11#1)(1994-6#1)(1995-5#1)(1996-11#1)(1996-3#1)(1997-3#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#2)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-9#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
treatment usually##3##2##(1995-5#1)(2008-5#1)(2012-11#1)
treatment utilization##3##2##(1991-1#1)(2008-3#2)
treatment variables##3##2##(1994-7#1)(2005-9#1)(2007-11#1)
treatment varied##3##2##(1994-7#1)(2007-10#2)
treatment varies##2##2##(2006-5#1)(2009-9#1)
treatment versus##4##2##(2009-4#1)(2009-9#1)(2010-10#1)(2013-1#1)
treatment via##3##2##(2008-3#1)(2011-1#1)(2012-12#1)
treatment visit##2##2##(2007-12#1)(2008-3#1)
treatment volume##4##2##(2008-11#1)(2008-6#2)(2009-8#1)
treatment ward##2##2##(2007-11#1)(2013-8#1)
treatment was 2##2##3##(1993-6#1)(2008-12#1)
treatment was 42##2##3##(1994-12#1)(1995-5#1)
treatment was 56##3##3##(1991-9#1)(2004-1#2)
treatment was a##2##3##(2007-7#1)(2007-8#1)
treatment was able to##4##4##(1996-1#1)(2008-4#1)(2009-7#1)(2013-1#1)
treatment was administered for##3##4##(1992-12#1)(1993-2#1)(2012-12#1)
treatment was administered##8##3##(1992-12#1)(1993-2#1)(1994-6#1)(1995-9#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
treatment was also compared##2##4##(1993-9#1)(1995-5#1)
treatment was also##5##3##(1993-9#1)(1995-5#1)(1996-5#1)(2008-6#1)(2013-7#1)
treatment was applied##4##3##(2007-8#2)(2009-7#1)(2012-2#1)
treatment was assessed using##2##4##(2007-7#1)(2012-2#1)
treatment was associated with##3##4##(2010-5#1)(2011-2#1)(2013-8#1)
treatment was based on##3##4##(1990-8#1)(2006-6#1)(2011-2#1)
treatment was carried out in##2##5##(1992-4#1)(2008-10#1)
treatment was carried out##3##4##(1992-4#1)(2008-10#1)(2012-12#1)
treatment was completed##3##3##(2006-10#1)(2010-12#1)(2013-8#1)
treatment was conservative##2##3##(1993-6#1)(2013-1#1)
treatment was continued until##2##4##(1991-3#1)(1992-4#1)
treatment was continued with##2##4##(2008-10#1)(2011-1#1)
treatment was continued##7##3##(1991-3#1)(1992-4#1)(2006-4#1)(2008-1#1)(2008-10#1)(2011-1#1)(2012-2#1)
treatment was correlated with##2##4##(2008-10#1)(2013-1#1)
treatment was delayed##2##3##(1990-6#1)(2011-2#1)
treatment was discontinued##5##3##(1995-6#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
treatment was effective in##4##4##(2008-7#1)(2011-2#2)(2013-1#1)
treatment was effective##8##3##(2005-11#1)(2006-6#1)(2008-2#1)(2008-7#1)(2011-2#3)(2013-1#1)
treatment was estimated##2##3##(2007-11#1)(2008-11#1)
treatment was evaluated by##3##4##(1997-3#1)(2006-8#1)(2007-7#1)
treatment was evaluated in##2##4##(1990-3#1)(2007-7#1)
treatment was evaluated##6##3##(1990-3#1)(1997-3#1)(2006-8#1)(2007-7#2)(2008-5#1)
treatment was found to be##3##5##(1993-1#1)(2004-12#1)(2009-7#1)
treatment was found to##5##4##(1993-1#1)(2004-12#1)(2008-5#1)(2008-7#1)(2009-7#1)
treatment was found##8##3##(1993-1#1)(2004-12#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#1)
treatment was given##6##3##(1990-11#1)(1994-11#1)(2006-9#1)(2007-2#1)(2011-1#1)(2012-3#1)
treatment was greater##2##3##(1995-5#1)(2004-1#1)
treatment was higher##2##3##(2012-3#1)(2012-6#1)
treatment was highly##2##3##(2008-6#1)(2009-8#1)
treatment was ineffective##3##3##(1993-2#1)(2008-10#1)(2013-8#1)
treatment was initiated##5##3##(1996-9#1)(2006-10#1)(2007-6#1)(2010-4#1)(2012-3#1)
treatment was instituted##2##3##(2006-10#1)(2006-11#1)
treatment was lost##2##3##(1992-3#1)(1996-9#1)
treatment was most##2##3##(1990-4#1)(2013-1#1)
treatment was necessary##2##3##(1991-3#1)(2010-4#1)
treatment was not##15##3##(1990-10#1)(1992-8#1)(1993-11#1)(1993-5#2)(1994-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
treatment was observed in##2##4##(1993-5#1)(2005-1#1)
treatment was observed##4##3##(1990-7#1)(1993-5#1)(2005-1#1)(2008-10#1)
treatment was obtained from the##2##5##(2006-8#1)(2008-6#1)
treatment was obtained##3##3##(2006-8#1)(2007-11#1)(2008-6#1)
treatment was performed in##3##4##(1990-6#1)(1997-2#1)(2009-8#1)
treatment was performed##14##3##(1990-10#1)(1990-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-12#1)(2009-3#2)(2009-8#1)(2011-2#1)(2013-8#1)
treatment was shown to##3##4##(1994-9#1)(2009-2#1)(2010-8#1)
treatment was significantly##4##3##(1990-12#1)(1993-1#1)(2008-3#1)(2010-4#1)
treatment was started##7##3##(1991-9#1)(2007-10#2)(2007-2#1)(2009-4#1)(2010-2#1)(2011-1#1)
treatment was stopped##4##3##(1990-10#1)(1993-1#1)(2010-1#2)
treatment was studied##2##3##(1994-6#1)(1995-12#1)
treatment was successful and##3##4##(1990-9#1)(2008-10#1)(2013-8#1)
treatment was successfully##2##3##(2005-9#1)(2008-10#1)
treatment was surgery##2##3##(2008-6#1)(2012-2#1)
treatment was the##2##3##(1993-12#1)(2007-12#1)
treatment was to##3##3##(1991-6#1)(2007-11#1)(2008-10#1)
treatment was unsuccessful##3##3##(1995-11#1)(2007-8#1)(2012-3#1)
treatment was used##2##3##(1990-12#1)(2007-11#1)
treatment was well tolerated and##3##5##(2005-8#2)(2007-11#1)
treatment was well tolerated##9##4##(1991-12#1)(1992-12#1)(2005-8#2)(2006-6#2)(2007-11#1)(2012-3#1)(2013-7#1)
treatment was well##10##3##(1991-12#1)(1992-12#1)(1994-8#1)(2005-8#2)(2006-6#2)(2007-11#1)(2012-3#1)(2013-7#1)
treatment was##312##2##(1990-10#3)(1990-11#2)(1990-12#2)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#2)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-6#2)(1991-8#2)(1991-9#2)(1992-12#2)(1992-3#2)(1992-4#3)(1992-5#2)(1992-8#1)(1992-9#2)(1993-1#3)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-5#3)(1993-6#2)(1993-8#1)(1993-9#5)(1994-11#3)(1994-12#2)(1994-2#3)(1994-3#1)(1994-4#1)(1994-6#4)(1994-7#1)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#2)(1995-3#1)(1995-5#3)(1995-6#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#3)(1997-2#1)(1997-3#2)(1997-6#1)(2004-1#4)(2004-12#1)(2005-1#1)(2005-11#1)(2005-8#2)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-4#1)(2006-6#6)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#7)(2007-12#1)(2007-2#3)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#11)(2007-8#7)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#11)(2008-6#7)(2008-7#5)(2008-8#1)(2009-11#1)(2009-2#1)(2009-3#4)(2009-4#1)(2009-7#3)(2009-8#3)(2010-1#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#11)(2011-3#1)(2012-1#1)(2012-12#7)(2012-2#5)(2012-3#7)(2012-6#1)(2013-1#18)(2013-7#2)(2013-8#8)
treatment water contamination##3##3##(2011-12#3)
treatment water##8##2##(2011-12#8)
treatment way##2##2##(2007-11#2)
treatment we##4##2##(1995-12#1)(2007-7#1)(2008-7#1)(2009-6#1)
treatment well##4##2##(2007-8#1)(2008-5#1)(2010-7#1)(2012-1#1)
treatment were also##3##3##(2007-11#1)(2009-10#1)(2011-2#1)
treatment were analyzed##2##3##(2007-11#1)(2011-1#1)
treatment were assessed##3##3##(2007-11#1)(2008-7#1)(2010-4#1)
treatment were determined##2##3##(2008-12#1)(2008-5#1)
treatment were developed##2##3##(2010-12#1)(2012-3#1)
treatment were examined##3##3##(1995-12#1)(2006-10#1)(2008-7#1)
treatment were found##3##3##(2006-12#1)(2007-2#1)(2012-5#1)
treatment were observed##3##3##(1990-6#1)(1992-6#1)(1996-12#1)
treatment were performed##2##3##(1996-5#1)(2009-3#1)
treatment were recorded##3##3##(2008-5#1)(2011-1#1)(2012-2#1)
treatment were reported##3##3##(1991-7#1)(2006-8#1)(2013-1#1)
treatment were significantly higher##2##4##(1996-12#1)(2012-2#1)
treatment were significantly##4##3##(1996-12#1)(2006-7#1)(2010-2#1)(2012-2#1)
treatment were similar##2##3##(1995-1#1)(2008-3#1)
treatment were used##2##3##(2007-7#1)(2009-2#1)
treatment were##91##2##(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-6#1)(1992-7#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#4)(1996-5#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#6)(2007-2#1)(2007-7#2)(2007-8#2)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#4)(2008-6#2)(2008-7#3)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#5)
treatment when the##2##3##(1992-6#1)(1994-10#1)
treatment when##9##2##(1992-6#1)(1994-10#1)(2006-8#1)(2007-8#3)(2009-6#1)(2010-3#1)(2012-12#1)
treatment which can##4##3##(1990-6#1)(2005-7#1)(2006-6#1)(2008-1#1)
treatment which is##2##3##(1990-2#1)(1991-12#1)
treatment which##20##2##(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-12#1)(1992-10#1)(1992-5#1)(1997-6#1)(2005-11#2)(2005-7#1)(2006-6#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-2#1)(2013-1#2)(2013-8#1)
treatment while the##3##3##(2008-11#1)(2008-7#1)(2009-10#1)
treatment while##10##2##(1991-12#1)(1994-2#1)(1996-2#1)(1996-3#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-2#1)
treatment will also##2##3##(2006-10#1)(2010-12#1)
treatment will be discussed##2##4##(2008-12#1)(2008-8#1)
treatment will be reviewed##2##4##(2007-6#1)(2009-7#1)
treatment will be##12##3##(2007-11#1)(2007-6#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#2)(2009-7#1)(2010-10#1)(2012-12#1)
treatment will##29##2##(1993-7#2)(1995-6#1)(1996-4#1)(1997-2#1)(2006-10#2)(2007-1#1)(2007-11#1)(2007-6#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#4)(2009-7#2)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#1)
treatment with 0##6##3##(1992-1#1)(1994-8#1)(1995-8#1)(2007-1#1)(2008-10#1)(2008-5#1)
treatment with 1 microM##2##4##(1991-4#1)(2003-11#1)
treatment with 1##12##3##(1990-3#1)(1990-6#1)(1991-4#1)(1992-5#1)(1994-10#1)(1995-9#1)(1997-6#1)(2003-11#1)(2007-11#1)(2008-10#1)(2008-5#1)(2010-7#1)
treatment with 10 nM##3##4##(1993-3#1)(1994-5#1)(1995-12#1)
treatment with 10##8##3##(1990-3#1)(1990-6#1)(1991-6#1)(1993-3#1)(1994-5#1)(1995-12#1)(2011-1#1)(2011-12#1)
treatment with 10(-7) M##3##4##(1993-11#1)(1994-3#1)(2008-11#1)
treatment with 100 nM alpha-MSH##2##5##(1995-2#2)
treatment with 100##4##3##(1995-11#1)(1995-2#2)(2009-3#1)
treatment with 2##2##3##(1992-8#1)(1993-1#1)
treatment with 3 mM##2##4##(1994-5#1)(2008-10#1)
treatment with 3##5##3##(1992-12#1)(1993-8#1)(1994-5#1)(2008-10#1)(2011-1#1)
treatment with 4##2##3##(1992-11#1)(2008-4#1)
treatment with 50##3##3##(1995-8#2)(2008-10#1)
treatment with ACE inhibitors##2##4##(1992-12#1)(2006-10#1)
treatment with BBP on days##2##5##(1993-3#2)
treatment with BCG and##2##4##(2010-12#2)
treatment with BCNU##2##3##(1995-5#2)
treatment with C##2##3##(1994-8#1)(2008-1#1)
treatment with CO2 laser##3##4##(1991-6#1)(1995-2#1)(2006-10#1)
treatment with CoQ10##2##3##(1991-5#2)
treatment with EDTA##3##3##(1992-12#1)(1996-1#1)(2008-5#1)
treatment with EGTA##2##3##(1990-3#1)(1994-6#1)
treatment with FUra##2##3##(1997-8#2)
treatment with HCl##2##3##(1994-9#1)(2007-11#1)
treatment with IL-1##2##3##(1990-12#1)(1995-12#1)
treatment with L-arginine##3##3##(1995-12#1)(1997-2#2)
treatment with L-deprenyl##5##3##(1994-6#2)(1996-7#3)
treatment with MPTP##2##3##(1990-5#1)(2005-8#1)
treatment with Metalaxyl##2##3##(2008-10#2)
treatment with PDBu for##2##4##(1995-3#2)
treatment with PEG##2##3##(1991-4#1)(2008-12#1)
treatment with PMA##3##3##(1991-4#1)(1994-2#1)(1995-2#1)
treatment with R-PIA##2##3##(1997-1#2)
treatment with RA##2##3##(1993-9#1)(1994-9#1)
treatment with RS61443##2##3##(1995-2#2)
treatment with T##2##3##(2008-10#2)
treatment with TPA##5##3##(1990-10#1)(1990-12#1)(1994-3#1)(1994-6#1)(1997-3#1)
treatment with VPA##4##3##(2011-2#4)
treatment with Zileuton##2##3##(2010-5#2)
treatment with a bisphosphonate##2##4##(2008-8#2)
treatment with a combination of##3##5##(1994-8#1)(1995-7#1)(2013-8#1)
treatment with a##42##3##(1990-10#1)(1990-11#1)(1990-9#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-7#2)(1996-10#1)(1997-2#1)(1997-7#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-8#3)(2007-9#1)(2008-10#4)(2008-4#1)(2008-8#2)(2009-8#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
treatment with acid##2##3##(1990-6#1)(1996-3#1)
treatment with alcohol##4##3##(1993-3#1)(1997-8#1)(2008-4#1)(2008-9#1)
treatment with alkaline phosphatase##2##4##(1994-12#1)(1996-6#1)
treatment with alkaline##3##3##(1994-12#1)(1996-6#1)(1997-6#1)
treatment with ampicillin##2##3##(2009-12#2)
treatment with an##22##3##(1991-1#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-3#1)(1993-12#1)(1993-4#1)(1996-12#1)(1997-6#1)(2006-4#1)(2007-7#1)(2008-10#3)(2008-4#3)(2008-5#1)(2010-12#1)(2011-2#2)(2013-7#1)
treatment with angiotensin-converting enzyme##2##4##(1992-3#1)(1992-4#1)
treatment with antibacterial##2##3##(2005-7#1)(2013-1#1)
treatment with antibiotic##3##3##(1991-3#1)(2008-7#1)(2008-9#1)
treatment with antibiotics##8##3##(1991-4#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2011-2#1)(2012-2#1)
treatment with antibodies##2##3##(1995-11#1)(2010-12#1)
treatment with anticoagulants##2##3##(2006-10#1)(2008-7#1)
treatment with antireflux##2##3##(2006-10#1)(2013-8#1)
treatment with antithyroid drugs##2##4##(2006-11#1)(2012-3#1)
treatment with appropriate##3##3##(2005-8#1)(2008-9#1)(2010-9#1)
treatment with at least##2##4##(2007-11#1)(2008-5#1)
treatment with beclomethasone dipropionate##2##4##(1990-9#1)(2008-1#1)
treatment with biological agents##2##4##(2007-11#2)
treatment with bismuth oxide##2##4##(1993-8#2)
treatment with bismuth##3##3##(1993-8#2)(1995-4#1)
treatment with bisphosphonates##2##3##(2008-1#1)(2010-1#1)
treatment with boceprevir##3##3##(2012-1#3)
treatment with bone##2##3##(2010-10#1)(2011-1#1)
treatment with both##4##3##(1996-12#1)(2004-3#1)(2005-12#1)(2008-9#1)
treatment with calcium channel blockers##2##5##(1995-2#1)(1996-6#1)
treatment with calcium##3##3##(1995-12#1)(1995-2#1)(1996-6#1)
treatment with cetuximab and##2##4##(2011-2#2)
treatment with chemotherapy##3##3##(2007-12#1)(2008-7#1)(2012-2#1)
treatment with chloroquine##4##3##(1994-3#1)(2008-4#1)(2011-2#2)
treatment with cisplatin##3##3##(1992-2#1)(1994-6#1)(2008-4#1)
treatment with clozapine##4##3##(1996-12#1)(1997-8#1)(2008-12#2)
treatment with copper aspirinate##2##4##(2008-5#2)
treatment with corticosteroids and##2##4##(2006-10#1)(2007-6#1)
treatment with corticosteroids##5##3##(2006-10#3)(2007-6#1)(2012-2#1)
treatment with curative##2##3##(2008-1#1)(2010-5#1)
treatment with cycloheximide##4##3##(1993-3#2)(1994-11#1)(1996-11#1)
treatment with cyclosporin##2##3##(2008-1#1)(2012-1#1)
treatment with darodipine##2##3##(1995-1#2)
treatment with diclofenac sodium 3%##2##5##(2010-8#2)
treatment with diclofenac sodium##3##4##(1997-1#1)(2010-8#2)
treatment with diet alone##2##4##(1991-2#1)(1996-1#1)
treatment with diet##4##3##(1991-2#1)(1991-7#2)(1996-1#1)
treatment with different##2##3##(2008-3#1)(2012-3#1)
treatment with doxycycline##2##3##(2007-2#1)(2008-2#1)
treatment with drugs that##2##4##(2007-10#1)(2010-12#1)
treatment with drugs##4##3##(1994-6#1)(1994-9#1)(2007-10#1)(2010-12#1)
treatment with either praziquantel or oxamniquine##2##6##(2010-12#2)
treatment with either##19##3##(1990-5#1)(1990-6#1)(1992-5#1)(1992-8#1)(1994-11#1)(1994-2#1)(1995-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-5#2)(2008-6#1)(2010-12#3)(2012-2#1)
treatment with endoglycosidase F##2##4##(1990-7#1)(1991-2#1)
treatment with epoetin##2##3##(2008-7#2)
treatment with etanercept##2##3##(2007-8#1)(2012-2#1)
treatment with ethanol##2##3##(1994-10#1)(2012-2#1)
treatment with exogenous##2##3##(1996-3#1)(2007-12#1)
treatment with fluconazole##3##3##(1992-11#1)(2006-8#1)(2007-7#1)
treatment with fluocinonide 0##2##4##(2010-8#2)
treatment with forskolin##2##3##(1995-5#1)(1997-5#1)
treatment with furosemide##4##3##(1992-8#4)
treatment with glucocorticoids##2##3##(2006-10#1)(2011-2#1)
treatment with glutaraldehyde##2##3##(2004-9#1)(2008-10#1)
treatment with growth##2##3##(2008-4#1)(2008-8#1)
treatment with haloperidol##5##3##(1995-12#2)(1996-12#2)(1996-8#1)
treatment with heparin##2##3##(1997-5#1)(2007-10#1)
treatment with high dose##3##4##(1990-12#1)(2005-7#1)(2006-10#1)
treatment with high##4##3##(1990-12#1)(2005-7#1)(2005-8#1)(2006-10#1)
treatment with high-dose##4##3##(1994-10#1)(2004-11#1)(2006-10#1)(2007-11#1)
treatment with human##3##3##(1992-6#1)(1995-5#1)(1996-6#1)
treatment with imatinib##3##3##(2008-6#2)(2013-8#1)
treatment with indomethacin is##2##4##(1992-2#1)(1997-6#1)
treatment with indomethacin##3##3##(1992-2#1)(1996-12#1)(1997-6#1)
treatment with infliximab and##3##4##(2006-10#1)(2013-8#2)
treatment with infliximab##8##3##(2006-10#1)(2010-9#1)(2011-2#1)(2013-7#1)(2013-8#4)
treatment with inhaled##2##3##(2008-8#1)(2011-2#1)
treatment with insulin##5##3##(1991-10#1)(1993-12#1)(1994-8#1)(2008-8#1)(2013-8#1)
treatment with interferon alpha is##2##5##(1997-3#2)
treatment with interferon gamma##2##4##(1991-3#1)(2007-2#1)
treatment with interferon##7##3##(1991-3#1)(1996-5#1)(1996-6#1)(1997-3#2)(2007-2#1)(2010-12#1)
treatment with interferon-alpha-2a##4##3##(2007-11#3)(2010-6#1)
treatment with intravenous immunoglobulin##3##4##(2006-10#1)(2007-10#1)(2010-8#1)
treatment with intravenous##7##3##(1993-5#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-9#1)(2010-12#1)(2010-8#1)
treatment with isoniazid##2##3##(1993-7#1)(2007-2#1)
treatment with lamivudine##2##3##(2008-5#1)(2009-8#1)
treatment with liposomal##2##3##(2008-5#1)(2010-3#1)
treatment with lithium##2##3##(2004-11#1)(2008-2#1)
treatment with low doses of aminoglutethimide##2##6##(1990-10#2)
treatment with low##3##3##(1990-10#2)(2008-11#1)
treatment with low-dose##2##3##(2006-10#1)(2007-7#1)
treatment with medication##2##3##(2008-3#1)(2010-11#1)
treatment with methotrexate##6##3##(1990-9#1)(1992-8#2)(2007-11#3)
treatment with mianserin##4##3##(2008-6#4)
treatment with mitoxantrone##2##3##(1991-6#1)(1994-12#1)
treatment with morphine##2##3##(1995-12#1)(1996-10#1)
treatment with mud compresses##3##4##(2006-10#3)
treatment with olbetam##2##3##(2006-6#2)
treatment with one##2##3##(2008-1#1)(2012-3#1)
treatment with oral antibiotics##2##4##(2007-7#1)(2013-8#1)
treatment with oral##5##3##(2006-12#1)(2007-7#2)(2008-1#1)(2013-8#1)
treatment with other##5##3##(1995-11#1)(1995-12#1)(2006-10#1)(2006-12#1)(2009-11#1)
treatment with pegylated interferon##2##4##(2010-2#1)(2011-2#1)
treatment with pegylated##4##3##(2009-7#1)(2010-12#1)(2010-2#1)(2011-2#1)
treatment with penicillin##3##3##(1991-7#1)(1995-7#1)(2006-10#1)
treatment with phorbol 12-myristate 13-acetate##2##5##(1996-4#1)(1996-8#1)
treatment with potassium##2##3##(2007-5#1)(2010-4#1)
treatment with praziquantel##2##3##(2005-8#1)(2007-2#1)
treatment with prednisolone##2##3##(2007-8#1)(2013-1#1)
treatment with prednisone##4##3##(1990-11#2)(1992-2#1)(2008-7#1)
treatment with quinapril##2##3##(1995-3#2)
treatment with radiotherapy and##2##4##(1996-2#1)(2013-7#1)
treatment with radiotherapy##3##3##(1996-2#1)(2009-3#1)(2013-7#1)
treatment with recombinant GH##2##4##(2007-11#1)(2010-8#1)
treatment with reserpine##2##3##(1993-2#1)(1996-2#1)
treatment with rhIL-11##2##3##(2007-11#2)
treatment with rituximab##2##3##(2009-8#1)(2012-2#1)
treatment with selective serotonin reuptake inhibitors##2##6##(2008-1#1)(2008-8#1)
treatment with selective##3##3##(2007-1#1)(2008-1#1)(2008-8#1)
treatment with sermorelin##2##3##(2007-11#2)
treatment with several##3##3##(1991-2#1)(1992-11#1)(1997-4#1)
treatment with simvastatin##4##3##(1991-1#2)(2012-2#2)
treatment with sodium hydroxide##2##4##(2005-11#1)(2008-10#1)
treatment with sodium##8##3##(1990-11#1)(1991-11#1)(1991-12#1)(1994-11#1)(1995-8#1)(1997-7#1)(2005-11#1)(2008-10#1)
treatment with soybean##2##3##(1995-8#1)(2012-2#1)
treatment with special##3##3##(1997-4#1)(2007-11#1)(2008-10#1)
treatment with steroids##4##3##(1994-5#1)(2006-8#1)(2007-7#1)(2008-1#1)
treatment with surgical resection##2##4##(2007-11#1)(2012-3#1)
treatment with surgical##3##3##(2007-11#1)(2008-6#1)(2012-3#1)
treatment with systemic##2##3##(2004-10#1)(2013-1#1)
treatment with tacrolimus##2##3##(2008-10#1)(2012-2#1)
treatment with tamoxifen and progestin##2##5##(1992-2#2)
treatment with tamoxifen##4##3##(1992-2#2)(1996-4#2)
treatment with the antiwrinkle agent##2##5##(2008-5#2)
treatment with the dopamine##2##4##(1993-3#1)(1996-5#1)
treatment with the drug##2##4##(1990-2#1)(2008-10#1)
treatment with the selective##2##4##(1991-2#1)(1997-2#1)
treatment with the synthetic##2##4##(2008-5#1)(2011-2#1)
treatment with the##70##3##(1990-10#1)(1990-2#1)(1991-12#1)(1991-2#2)(1991-8#1)(1992-4#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-12#1)(1995-1#2)(1995-2#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(2003-11#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-4#1)(2007-1#1)(2007-11#4)(2007-8#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#1)(2008-8#2)(2009-3#1)(2009-4#2)(2010-6#1)(2011-2#4)(2012-2#1)(2012-3#2)
treatment with these drugs##3##4##(2010-5#2)(2012-2#1)
treatment with these##5##3##(2008-5#1)(2010-5#2)(2011-2#1)(2012-2#1)
treatment with this agent##2##4##(1991-12#1)(1994-7#1)
treatment with this drug##4##4##(1991-11#1)(1991-7#1)(2007-11#1)(2008-1#1)
treatment with this##9##3##(1991-11#2)(1991-12#1)(1991-7#1)(1994-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)
treatment with thymostimulin##3##3##(1990-2#2)(1992-5#1)
treatment with thyroxine##2##3##(2006-11#1)(2007-8#1)
treatment with topical##4##3##(1997-5#1)(2007-8#1)(2012-11#1)(2012-2#1)
treatment with transforming growth factor-beta1##2##5##(2006-9#2)
treatment with tumor##2##3##(1993-7#1)(2013-8#1)
treatment with ursodeoxycholic acid##2##4##(1996-4#1)(2004-11#1)
treatment with vancomycin##2##3##(2007-12#2)
treatment with various##5##3##(1992-5#1)(1992-7#1)(2008-1#1)(2008-3#1)(2008-4#1)
treatment with very##2##3##(2006-3#1)(2007-4#1)
treatment with vitamin##5##3##(1996-3#1)(2008-8#2)(2013-8#2)
treatment with zinc##2##3##(1991-1#1)(1996-11#1)
treatment with##1256##2##(1990-1#1)(1990-10#7)(1990-11#5)(1990-12#7)(1990-2#10)(1990-3#7)(1990-4#1)(1990-5#7)(1990-6#4)(1990-7#2)(1990-9#10)(1991-1#5)(1991-10#1)(1991-11#8)(1991-12#7)(1991-2#7)(1991-3#7)(1991-4#8)(1991-5#7)(1991-6#5)(1991-7#6)(1991-8#6)(1991-9#5)(1992-1#7)(1992-10#1)(1992-11#10)(1992-12#8)(1992-2#11)(1992-3#10)(1992-4#5)(1992-5#5)(1992-6#3)(1992-7#2)(1992-8#11)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#9)(1993-12#5)(1993-2#5)(1993-3#14)(1993-4#3)(1993-5#3)(1993-6#1)(1993-7#5)(1993-8#5)(1993-9#8)(1994-10#4)(1994-11#11)(1994-12#6)(1994-2#4)(1994-3#8)(1994-5#7)(1994-6#7)(1994-7#1)(1994-8#5)(1994-9#8)(1995-1#6)(1995-10#1)(1995-11#6)(1995-12#17)(1995-2#13)(1995-3#12)(1995-4#3)(1995-5#10)(1995-6#1)(1995-7#3)(1995-8#7)(1995-9#1)(1996-1#6)(1996-10#6)(1996-11#6)(1996-12#16)(1996-2#3)(1996-3#9)(1996-4#5)(1996-5#6)(1996-6#8)(1996-7#4)(1996-8#4)(1996-9#7)(1997-1#6)(1997-2#8)(1997-3#7)(1997-4#6)(1997-5#9)(1997-6#11)(1997-7#3)(1997-8#5)(2003-11#3)(2004-1#1)(2004-10#2)(2004-11#3)(2004-3#5)(2004-4#1)(2004-9#1)(2005-1#3)(2005-10#1)(2005-11#7)(2005-12#1)(2005-6#1)(2005-7#4)(2005-8#7)(2006-1#1)(2006-10#30)(2006-11#3)(2006-12#6)(2006-2#5)(2006-3#1)(2006-4#5)(2006-6#4)(2006-8#5)(2006-9#2)(2007-1#4)(2007-10#5)(2007-11#44)(2007-12#7)(2007-2#10)(2007-4#2)(2007-5#3)(2007-6#2)(2007-7#21)(2007-8#28)(2007-9#9)(2008-1#16)(2008-10#59)(2008-11#13)(2008-12#6)(2008-2#6)(2008-3#13)(2008-4#17)(2008-5#35)(2008-6#21)(2008-7#19)(2008-8#15)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#4)(2009-3#4)(2009-4#4)(2009-6#5)(2009-7#5)(2009-8#10)(2009-9#1)(2010-1#1)(2010-10#5)(2010-11#1)(2010-12#20)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#11)(2010-6#4)(2010-7#4)(2010-8#6)(2010-9#3)(2011-1#11)(2011-10#1)(2011-12#2)(2011-2#36)(2012-1#9)(2012-11#2)(2012-12#10)(2012-2#20)(2012-3#14)(2013-1#20)(2013-7#8)(2013-8#18)
treatment within a##2##3##(1994-9#1)(2008-8#1)
treatment within the##2##3##(2007-7#1)(2011-3#1)
treatment within##8##2##(1992-9#1)(1994-9#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-8#1)(2011-3#1)(2012-3#1)
treatment without##18##2##(1992-10#1)(1992-9#1)(1993-11#1)(1994-3#1)(1995-8#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-8#1)(2009-6#2)(2010-10#1)(2011-2#1)(2013-1#2)
treatment workers##2##2##(2008-8#2)
treatment would be##3##3##(2007-8#1)(2010-2#1)(2013-7#1)
treatment would improve##2##3##(1991-3#1)(2007-8#1)
treatment would##8##2##(1991-3#1)(1991-6#1)(2007-8#2)(2008-3#1)(2009-5#1)(2010-2#1)(2013-7#1)
treatment yielded##2##2##(1990-2#1)(2008-10#1)
treatment##18773##1##(1990-1#6)(1990-10#44)(1990-11#50)(1990-12#76)(1990-2#64)(1990-3#58)(1990-4#46)(1990-5#58)(1990-6#66)(1990-7#29)(1990-8#30)(1990-9#57)(1991-1#46)(1991-10#24)(1991-11#52)(1991-12#75)(1991-2#82)(1991-3#47)(1991-4#49)(1991-5#28)(1991-6#68)(1991-7#27)(1991-8#66)(1991-9#53)(1992-1#34)(1992-10#44)(1992-11#36)(1992-12#59)(1992-2#47)(1992-3#84)(1992-4#33)(1992-5#55)(1992-6#56)(1992-7#19)(1992-8#81)(1992-9#54)(1993-1#45)(1993-10#34)(1993-11#82)(1993-12#46)(1993-2#78)(1993-3#63)(1993-4#22)(1993-5#55)(1993-6#33)(1993-7#22)(1993-8#61)(1993-9#97)(1994-1#6)(1994-10#23)(1994-11#57)(1994-12#50)(1994-2#59)(1994-3#61)(1994-4#30)(1994-5#48)(1994-6#86)(1994-7#23)(1994-8#40)(1994-9#52)(1995-1#39)(1995-10#22)(1995-11#54)(1995-12#88)(1995-2#44)(1995-3#56)(1995-4#35)(1995-5#72)(1995-6#34)(1995-7#16)(1995-8#35)(1995-9#54)(1996-1#45)(1996-10#44)(1996-11#63)(1996-12#104)(1996-2#58)(1996-3#77)(1996-4#22)(1996-5#50)(1996-6#51)(1996-7#26)(1996-8#45)(1996-9#57)(1997-1#38)(1997-2#66)(1997-3#86)(1997-4#47)(1997-5#53)(1997-6#58)(1997-7#53)(1997-8#86)(2003-11#6)(2004-1#34)(2004-10#12)(2004-11#16)(2004-12#17)(2004-2#10)(2004-3#33)(2004-4#11)(2004-7#1)(2004-9#13)(2005-1#32)(2005-10#86)(2005-11#103)(2005-12#30)(2005-2#3)(2005-3#16)(2005-4#4)(2005-5#3)(2005-6#35)(2005-7#149)(2005-8#114)(2005-9#54)(2006-1#30)(2006-10#537)(2006-11#67)(2006-12#167)(2006-2#112)(2006-3#38)(2006-4#58)(2006-5#79)(2006-6#165)(2006-7#101)(2006-8#145)(2006-9#105)(2007-1#58)(2007-10#124)(2007-11#787)(2007-12#226)(2007-2#131)(2007-3#44)(2007-4#64)(2007-5#53)(2007-6#94)(2007-7#373)(2007-8#533)(2007-9#111)(2008-1#234)(2008-10#640)(2008-11#244)(2008-12#143)(2008-2#123)(2008-3#364)(2008-4#212)(2008-5#465)(2008-6#307)(2008-7#448)(2008-8#252)(2008-9#154)(2009-1#17)(2009-10#70)(2009-11#66)(2009-12#56)(2009-2#91)(2009-3#92)(2009-4#69)(2009-5#80)(2009-6#92)(2009-7#59)(2009-8#129)(2009-9#76)(2010-1#35)(2010-10#45)(2010-11#84)(2010-12#322)(2010-2#80)(2010-3#89)(2010-4#84)(2010-5#97)(2010-6#91)(2010-7#49)(2010-8#119)(2010-9#58)(2011-1#322)(2011-10#8)(2011-11#5)(2011-12#81)(2011-2#737)(2011-3#25)(2011-7#11)(2012-1#107)(2012-10#1)(2012-11#50)(2012-12#377)(2012-2#398)(2012-3#265)(2012-5#2)(2012-6#4)(2012-7#1)(2012-8#1)(2012-9#1)(2013-1#657)(2013-7#122)(2013-8#324)
treatment&quot##7##1##(1993-5#1)(1994-11#3)(1996-11#1)(2008-10#1)(2013-1#1)
treatment's##3##1##(1996-10#1)(2012-1#1)(2012-3#1)
treatment(s)##3##1##(2012-2#3)
treatment) and the##2##3##(1991-2#1)(2010-5#1)
treatment) and##6##2##(1991-2#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-7#1)(2010-5#1)
treatment) of##2##2##(2008-6#1)(2013-7#1)
treatment) on##2##2##(1990-10#1)(1994-3#1)
treatment) were##3##2##(1992-11#2)(2006-11#1)
treatment)##59##1##(1990-10#1)(1990-12#1)(1990-3#1)(1990-8#1)(1991-2#1)(1992-11#2)(1992-3#1)(1992-4#2)(1994-3#1)(1994-8#2)(1995-11#1)(1996-12#2)(2005-1#1)(2006-10#2)(2006-11#1)(2007-10#1)(2007-2#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#2)(2008-7#4)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
treatment- and##2##2##(2008-12#1)(2009-5#1)
treatment--a##2##1##(2010-3#1)(2012-12#1)
treatment-associated##2##1##(2008-7#1)(2009-4#1)
treatment-based classification##2##2##(2008-12#2)
treatment-effectiveness##2##1##(1992-1#2)
treatment-free survival time was##2##4##(2008-8#2)
treatment-free survival##3##2##(2008-8#3)
treatment-induced mucositis##2##2##(2008-3#1)(2008-7#1)
treatment-induced##11##1##(1990-2#1)(1996-12#1)(1997-2#1)(2006-3#1)(2008-3#1)(2008-7#2)(2009-7#1)(2010-12#1)(2011-1#1)(2012-12#1)
treatment-limiting##3##1##(1994-2#1)(2008-7#1)(2011-2#1)
treatment-naive##3##1##(2005-6#1)(2012-12#1)(2012-2#1)
treatment-naïve##5##1##(2009-12#1)(2009-4#1)(2009-8#1)(2012-2#1)(2013-1#1)
treatment-planning system##2##2##(2009-11#1)(2010-9#1)
treatment-planning##3##1##(1990-12#1)(2009-11#1)(2010-9#1)
treatment-refractory##8##1##(1992-3#1)(2005-6#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2011-2#1)
treatment-related attitudes and behaviors##2##4##(2011-1#2)
treatment-related complications##2##2##(2007-3#1)(2011-2#1)
treatment-related death occurred##3##3##(1991-4#1)(1991-6#1)(1992-2#1)
treatment-related inflammatory leukogram and minimal decreased erythron of chronic inflammation that would be consistent with necrosis and chronic active inflammation of the skin##2##23##(2008-9#2)
treatment-related mortality##2##2##(2006-6#2)
treatment-related neoplasms##3##2##(2008-9#3)
treatment-related##34##1##(1991-4#1)(1991-6#1)(1992-2#1)(1997-1#1)(2005-10#1)(2006-6#3)(2007-10#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#11)(2011-1#2)(2011-2#1)(2012-12#1)
treatment-resistant depressed patients##2##3##(2011-2#2)
treatment-resistant depression##9##2##(1996-1#1)(2008-6#1)(2011-1#2)(2011-2#2)(2012-12#3)
treatment-resistant major##2##2##(2011-2#1)(2012-12#1)
treatment-resistant schizophrenic patients##6##3##(2008-12#5)(2008-6#1)
treatment-resistant##30##1##(1990-1#1)(1990-9#1)(1991-11#1)(1996-1#1)(2005-7#2)(2006-10#1)(2007-11#2)(2008-12#5)(2008-6#3)(2011-1#2)(2011-2#5)(2012-12#5)(2013-8#1)
treatment-seeking##5##1##(2006-9#1)(2007-12#1)(2008-2#1)(2008-8#1)(2009-9#1)
treatment?##21##1##(1991-8#1)(1993-5#1)(1994-1#2)(1994-9#1)(1995-1#1)(1996-3#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-5#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-7#3)
treatment?]##4##1##(1991-5#1)(1993-3#1)(1994-8#1)(2008-9#1)
treatment]##91##1##(1990-11#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-6#3)(1991-9#1)(1992-10#1)(1992-3#2)(1992-5#2)(1993-10#1)(1993-2#2)(1993-3#1)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-4#3)(1994-5#2)(1994-8#1)(1995-4#1)(1995-5#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#2)(2005-8#1)(2006-2#1)(2006-8#2)(2007-2#1)(2007-5#4)(2007-9#1)(2008-10#3)(2008-12#1)(2008-4#3)(2008-8#1)(2008-9#1)(2009-5#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-11#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
treatments (control##2##2##(2012-9#1)(2013-7#1)
treatments (i##2##2##(1995-9#1)(2008-1#1)
treatments (mean##3##2##(1990-12#1)(2010-8#2)
treatments (p##2##2##(2010-11#1)(2013-1#1)
treatments 3##2##2##(2008-7#2)
treatments affected the##2##3##(2008-10#1)(2008-7#1)
treatments affected##4##2##(1990-5#1)(1993-9#1)(2008-10#1)(2008-7#1)
treatments after##3##2##(2008-7#1)(2010-12#1)(2013-7#1)
treatments against the##2##3##(2006-6#1)(2007-8#1)
treatments also##5##2##(1996-5#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#1)
treatments and ranged from##2##4##(2011-12#2)
treatments and the##10##3##(1990-4#1)(2004-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2012-11#2)(2012-3#1)
treatments and their##2##3##(2007-12#1)(2010-12#1)
treatments and##62##2##(1990-4#1)(1991-2#1)(1992-5#1)(1993-5#1)(1993-7#1)(1994-2#1)(1995-2#1)(1995-9#1)(1997-7#1)(2004-11#1)(2006-10#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#2)(2009-5#1)(2010-1#1)(2010-12#3)(2011-1#1)(2011-12#2)(2011-2#7)(2012-1#1)(2012-11#2)(2012-2#1)(2012-3#3)(2012-5#2)(2013-1#4)(2013-7#1)
treatments applied##3##2##(2008-10#2)(2008-5#1)
treatments are also##2##3##(2006-12#1)(2012-3#1)
treatments are available##5##3##(1990-10#1)(2007-11#1)(2008-11#1)(2010-10#1)(2011-10#1)
treatments are being##4##3##(2006-11#1)(2008-12#1)(2010-8#1)(2011-2#1)
treatments are discussed##3##3##(2008-4#1)(2008-6#1)(2009-9#1)
treatments are not##5##3##(1996-12#1)(1997-4#1)(2008-11#1)(2008-4#1)(2011-2#1)
treatments are required##3##3##(2008-10#1)(2008-2#1)(2012-3#1)
treatments are used##2##3##(1993-2#1)(2009-7#1)
treatments are##55##2##(1990-10#1)(1993-2#2)(1996-12#1)(1997-3#2)(1997-4#1)(2006-11#1)(2006-12#3)(2006-2#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-2#2)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)
treatments as well as##3##4##(2006-12#1)(2006-8#1)(2008-10#1)
treatments as##9##2##(2004-9#1)(2006-12#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-12#1)
treatments at a##2##3##(1995-11#1)(2007-8#1)
treatments at##12##2##(1992-9#1)(1994-10#1)(1995-11#1)(2004-2#1)(2005-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-8#1)(2009-3#1)(2009-5#1)
treatments available for##4##3##(2008-2#1)(2009-6#1)(2010-7#1)(2013-8#1)
treatments available##6##2##(2008-2#1)(2008-8#1)(2009-6#1)(2010-7#1)(2011-2#1)(2013-8#1)
treatments based on##4##3##(2006-10#1)(2008-1#1)(2008-10#1)(2010-7#1)
treatments besides##3##2##(2011-12#1)(2013-1#2)
treatments but##2##2##(2004-10#1)(2008-7#1)
treatments by##3##2##(2008-10#1)(2009-4#1)(2009-5#1)
treatments can be##3##3##(2006-9#1)(2008-5#1)(2010-12#1)
treatments can##10##2##(1992-3#1)(1993-9#1)(2006-9#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-2#1)(2013-1#2)
treatments commonly##2##2##(1996-12#1)(2012-12#1)
treatments compared with##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
treatments consisting of##2##3##(2004-11#1)(2008-10#1)
treatments containing##3##2##(2008-10#1)(2008-5#2)
treatments could be##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
treatments could##4##2##(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)
treatments currently##3##2##(2006-10#1)(2006-7#1)(2010-6#1)
treatments did not differ significantly##2##5##(2008-10#1)(2010-8#1)
treatments did not##3##3##(2008-10#1)(2009-6#1)(2010-8#1)
treatments during the##3##3##(2008-10#2)(2013-7#1)
treatments during##5##2##(2008-10#2)(2008-5#1)(2013-1#1)(2013-7#1)
treatments focusing on##2##3##(2008-5#1)(2010-6#1)
treatments for 12##2##3##(2008-3#1)(2009-10#1)
treatments for adolescent##3##3##(2009-7#1)(2013-1#2)
treatments for early##2##3##(2004-1#1)(2009-8#1)
treatments for inflammatory bowel disease##2##5##(2006-10#2)
treatments for left##2##3##(2005-12#1)(2011-2#1)
treatments for neurological diseases##2##4##(2008-1#2)
treatments for pain##4##3##(2005-8#2)(2006-10#1)(2008-3#1)
treatments for patients with##2##4##(2006-10#1)(2010-10#1)
treatments for patients##3##3##(2006-10#1)(2010-10#1)(2013-8#1)
treatments for the##4##3##(2006-12#1)(2008-5#1)(2008-7#1)(2013-1#1)
treatments for these##3##3##(2006-12#1)(2007-8#1)(2008-2#1)
treatments for this##2##3##(2008-4#1)(2009-1#1)
treatments for##124##2##(1990-9#1)(1991-1#1)(1991-3#1)(1993-3#2)(1993-9#1)(1996-11#1)(1997-2#1)(2004-1#1)(2004-12#1)(2005-11#1)(2005-12#1)(2005-4#1)(2005-7#2)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#4)(2006-3#1)(2006-7#2)(2007-11#4)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#5)(2008-5#2)(2008-6#8)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#2)(2009-11#1)(2009-3#2)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#3)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#4)
treatments given##4##2##(1997-4#1)(2008-10#1)(2011-2#1)(2012-12#1)
treatments had no effect on the##2##6##(1994-12#1)(1996-5#1)
treatments had no##3##3##(1994-12#1)(1996-5#1)(2007-3#1)
treatments had##6##2##(1993-2#1)(1994-12#1)(1996-5#1)(2007-3#1)(2008-10#1)(2010-4#1)
treatments has been##2##3##(1992-9#1)(2007-6#1)
treatments has##9##2##(1992-9#1)(2005-11#1)(2007-6#1)(2007-8#1)(2008-6#1)(2010-7#1)(2010-8#1)(2012-12#2)
treatments have become##2##3##(2008-9#1)(2009-2#1)
treatments have been proposed##2##4##(1993-1#1)(2006-10#1)
treatments have been##9##3##(1993-1#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-8#1)(2009-7#1)(2010-7#1)(2013-8#1)
treatments have similar##2##3##(2009-6#1)(2011-2#1)
treatments have##26##2##(1993-1#1)(2005-7#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#3)(2013-8#1)
treatments in a##3##3##(2010-4#1)(2012-2#1)(2012-3#1)
treatments in the##8##3##(1993-1#1)(2007-12#1)(2008-4#1)(2011-2#1)(2013-1#4)
treatments in which##2##3##(2006-8#1)(2008-5#1)
treatments in##46##2##(1990-2#1)(1990-6#1)(1993-1#1)(1995-8#1)(1996-6#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-12#3)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#1)(2009-10#2)(2009-7#1)(2010-1#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#4)
treatments include##2##2##(2010-5#1)(2012-2#1)
treatments including##5##2##(2005-8#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-7#1)
treatments increased the##2##3##(2008-10#1)(2009-8#1)
treatments increased##4##2##(2008-10#2)(2009-8#1)(2013-7#1)
treatments indicate##2##2##(1996-8#1)(2006-10#1)
treatments involving##3##2##(1995-2#1)(2008-10#2)
treatments is##8##2##(1992-2#1)(1992-9#1)(1995-9#1)(1997-4#1)(2006-10#2)(2006-6#1)(2013-1#1)
treatments may be possible##2##4##(2010-12#1)(2011-2#1)
treatments may be##4##3##(1993-5#1)(2010-12#1)(2011-2#1)(2012-12#1)
treatments may##9##2##(1993-5#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-12#1)
treatments might##4##2##(1994-5#1)(2008-5#1)(2009-6#1)(2010-5#1)
treatments of disease##2##3##(2010-1#1)(2012-2#1)
treatments of experiment##2##3##(2008-10#2)
treatments of the##10##3##(1993-12#1)(1994-8#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-7#1)(2011-2#1)
treatments of these##2##3##(1994-11#1)(2008-9#1)
treatments of##68##2##(1990-6#1)(1990-7#1)(1991-10#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-5#1)(1996-12#1)(2004-9#1)(2005-11#3)(2006-10#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-6#3)(2007-8#1)(2008-1#2)(2008-10#5)(2008-2#2)(2008-3#5)(2008-5#2)(2008-6#2)(2008-7#6)(2008-9#1)(2009-11#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-8#2)
treatments on seed##2##3##(2008-10#1)(2008-5#1)
treatments on the##11##3##(1990-6#1)(1995-12#1)(1996-7#1)(2004-9#1)(2008-10#1)(2008-12#3)(2008-5#1)(2010-4#1)(2013-8#1)
treatments on these##2##3##(2008-3#1)(2011-2#1)
treatments on##31##2##(1990-6#1)(1992-3#2)(1994-12#1)(1994-6#1)(1995-12#1)(1996-7#1)(1997-4#1)(2004-9#1)(2005-11#1)(2005-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#4)(2008-3#1)(2008-5#3)(2008-9#1)(2009-4#1)(2010-4#2)(2011-2#1)(2013-8#1)
treatments or##7##2##(1996-8#1)(2004-4#1)(2005-12#1)(2007-7#1)(2010-8#1)(2011-1#1)(2013-1#1)
treatments per##2##2##(2007-6#1)(2008-10#1)
treatments produced##2##2##(2004-10#1)(2007-7#1)
treatments provided##2##2##(2007-11#1)(2013-8#1)
treatments received##2##2##(2008-10#1)(2011-2#1)
treatments reduced##3##2##(2008-10#1)(2009-3#1)(2012-11#1)
treatments remains##2##2##(1997-5#1)(2008-11#1)
treatments result in##2##3##(1992-6#1)(2006-12#1)
treatments resulted in a##2##4##(1991-3#1)(2007-2#1)
treatments resulted in##8##3##(1991-3#1)(2006-7#1)(2007-2#1)(2008-10#2)(2008-5#1)(2010-9#1)(2013-1#1)
treatments resulted##9##2##(1991-3#1)(2006-7#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-5#1)(2010-9#1)(2013-1#1)
treatments should be##3##3##(2006-12#1)(2012-12#2)
treatments should##7##2##(2004-10#1)(2006-12#1)(2008-6#1)(2011-2#2)(2012-12#2)
treatments showed##2##2##(1997-6#1)(2008-10#1)
treatments significantly reduced the##3##4##(1991-4#1)(1995-10#1)(2008-10#1)
treatments significantly reduced##4##3##(1991-4#1)(1995-10#1)(2008-10#2)
treatments significantly##6##2##(1991-4#1)(1992-8#1)(1995-10#1)(1995-12#1)(2008-10#2)
treatments studied##2##2##(1993-5#1)(2007-7#1)
treatments such as##18##3##(1992-4#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#1)(2011-2#3)
treatments tested##2##2##(2008-10#1)(2008-6#1)
treatments than##4##2##(2006-10#1)(2006-12#1)(2008-10#1)(2012-9#1)
treatments that are##3##3##(2005-11#1)(2012-2#2)
treatments that induce##2##3##(2008-7#2)
treatments that often have##2##4##(2008-4#1)(2010-8#1)
treatments that prevent##3##3##(2008-10#1)(2008-12#1)(2013-8#1)
treatments that were##3##3##(2005-11#1)(2008-10#1)(2013-1#1)
treatments that##39##2##(1993-5#1)(1994-2#1)(1995-3#1)(2005-11#3)(2005-8#1)(2006-10#1)(2007-1#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#2)(2008-8#1)(2009-11#2)(2010-11#1)(2010-2#1)(2010-5#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
treatments to control##2##3##(2008-10#2)
treatments to improve##2##3##(2009-8#1)(2013-8#1)
treatments to increase##2##3##(2008-10#1)(2010-8#1)
treatments to patients##2##3##(1995-12#1)(2005-7#1)
treatments to reduce##4##3##(2006-12#1)(2008-10#1)(2011-2#1)(2013-8#1)
treatments to##22##2##(1991-2#1)(1993-5#1)(1995-12#1)(2004-4#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-8#1)(2011-12#1)(2011-2#1)(2013-8#2)
treatments under##3##2##(2006-11#1)(2009-8#1)(2010-9#1)
treatments until##2##2##(2007-2#1)(2008-10#1)
treatments used for##3##3##(2006-10#1)(2006-12#1)(2008-7#1)
treatments used##8##2##(1990-10#1)(2006-10#1)(2006-12#1)(2008-7#1)(2009-7#1)(2010-2#1)(2011-2#1)(2013-1#1)
treatments was also##3##3##(2007-2#1)(2007-8#1)(2010-4#1)
treatments was##16##2##(1996-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-7#1)(2010-2#1)(2010-4#1)(2011-12#1)
treatments were applied##3##3##(2008-10#1)(2008-5#1)(2012-8#1)
treatments were arranged in a##2##5##(2007-5#1)(2008-10#1)
treatments were compared with##2##4##(2004-10#1)(2008-10#1)
treatments were conducted##2##3##(2006-11#1)(2011-1#1)
treatments were determined##2##3##(2004-4#1)(2008-8#1)
treatments were effective in##2##4##(2008-10#1)(2011-12#1)
treatments were for##2##3##(2007-6#1)(2013-8#1)
treatments were made##2##3##(1994-6#1)(2012-11#1)
treatments were not##2##3##(2008-10#2)
treatments were performed##2##3##(2006-7#1)(2008-5#1)
treatments were repeated##2##3##(2008-10#1)(2008-5#1)
treatments were##65##2##(1994-6#1)(1995-5#1)(1996-1#1)(2004-10#1)(2004-4#3)(2006-11#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#7)(2008-8#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#2)(2012-8#1)(2013-1#5)(2013-8#4)
treatments when##3##2##(1997-2#1)(2008-10#2)
treatments which##7##2##(1993-5#1)(1994-2#1)(1997-4#1)(2008-11#1)(2008-4#1)(2009-7#1)(2012-3#1)
treatments with a##2##3##(2007-7#1)(2012-2#1)
treatments with different##3##3##(2005-11#1)(2008-10#1)(2012-3#1)
treatments with respect to##2##4##(2004-1#1)(2004-9#1)
treatments with these##2##3##(1991-5#1)(1994-6#1)
treatments with##56##2##(1991-5#2)(1992-3#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#2)(1996-11#1)(1997-5#1)(2004-1#1)(2004-9#1)(2005-11#1)(2005-3#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#19)(2008-12#1)(2008-3#1)(2008-8#2)(2008-9#1)(2010-12#2)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#3)
treatments##1499##1##(1990-10#4)(1990-12#4)(1990-2#3)(1990-4#3)(1990-5#3)(1990-6#6)(1990-7#3)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#5)(1991-4#1)(1991-5#2)(1991-6#3)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#3)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#4)(1992-9#6)(1993-1#2)(1993-11#2)(1993-12#6)(1993-2#5)(1993-3#5)(1993-5#10)(1993-7#1)(1993-9#5)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#5)(1994-4#1)(1994-5#2)(1994-6#4)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#6)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#4)(1995-8#2)(1995-9#5)(1996-1#1)(1996-11#2)(1996-12#9)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#8)(1997-5#4)(1997-6#1)(1997-7#2)(1997-8#1)(2004-1#3)(2004-10#9)(2004-11#2)(2004-12#1)(2004-2#3)(2004-3#3)(2004-4#10)(2004-9#4)(2005-10#1)(2005-11#11)(2005-12#5)(2005-3#1)(2005-4#1)(2005-6#2)(2005-7#11)(2005-8#9)(2005-9#2)(2006-1#2)(2006-10#38)(2006-11#4)(2006-12#19)(2006-2#2)(2006-3#3)(2006-4#1)(2006-5#12)(2006-6#11)(2006-7#6)(2006-8#12)(2006-9#6)(2007-1#10)(2007-10#6)(2007-11#23)(2007-12#19)(2007-2#12)(2007-3#3)(2007-4#6)(2007-5#5)(2007-6#12)(2007-7#15)(2007-8#21)(2007-9#4)(2008-1#18)(2008-10#184)(2008-11#19)(2008-12#33)(2008-2#15)(2008-3#25)(2008-4#23)(2008-5#53)(2008-6#22)(2008-7#38)(2008-8#21)(2008-9#17)(2009-1#1)(2009-10#9)(2009-11#9)(2009-12#1)(2009-2#4)(2009-3#10)(2009-4#5)(2009-5#4)(2009-6#10)(2009-7#13)(2009-8#12)(2009-9#8)(2010-1#6)(2010-10#4)(2010-11#6)(2010-12#18)(2010-2#12)(2010-3#1)(2010-4#18)(2010-5#9)(2010-6#4)(2010-7#9)(2010-8#17)(2010-9#6)(2011-1#10)(2011-10#1)(2011-12#23)(2011-2#64)(2011-3#2)(2011-7#1)(2012-1#5)(2012-11#6)(2012-12#31)(2012-2#33)(2012-3#19)(2012-4#1)(2012-5#2)(2012-6#1)(2012-8#1)(2012-9#3)(2013-1#70)(2013-7#9)(2013-8#22)
treatments) and##2##2##(1990-12#1)(2008-2#1)
treatments)##4##1##(1990-12#2)(2006-6#1)(2008-2#1)
treatments?##2##1##(2012-3#1)(2013-7#1)
treatments]##4##1##(2007-2#1)(2007-9#1)(2013-7#1)(2013-8#1)
treats a##2##2##(2009-5#1)(2011-12#1)
treats the##7##2##(2005-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-7#1)(2010-7#1)(2012-1#1)
treats##26##1##(1991-2#1)(1993-1#1)(1995-1#1)(1995-8#1)(2005-11#1)(2006-3#2)(2007-12#2)(2007-2#2)(2007-5#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-4#1)(2010-7#2)(2011-12#1)(2012-1#1)(2012-11#1)(2012-3#1)
treaty##6##1##(1996-1#1)(2007-8#3)(2008-1#1)(2009-5#1)
tredecaurelia##2##1##(2008-12#2)
tree Peltogyne purpurea##3##3##(2008-5#3)
tree Peltogyne##4##2##(2008-5#4)
tree analyses##3##2##(2008-10#2)(2012-3#1)
tree analysis showed that the##2##5##(2009-5#1)(2013-8#1)
tree analysis showed that##3##4##(2006-7#1)(2009-5#1)(2013-8#1)
tree analysis##11##2##(1992-5#1)(2005-11#1)(2005-12#1)(2006-7#1)(2006-8#1)(2007-8#1)(2009-10#1)(2009-5#1)(2013-1#2)(2013-8#1)
tree and##16##2##(1994-11#1)(2006-8#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2009-2#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-3#2)(2013-8#1)
tree are##4##2##(2007-8#1)(2008-4#1)(2010-6#1)(2012-2#1)
tree based on##5##3##(2008-10#3)(2010-8#1)(2013-1#1)
tree by##4##2##(1994-9#1)(2008-10#1)(2008-2#1)(2012-3#1)
tree can be##2##3##(2007-12#1)(2008-10#1)
tree canopies##3##2##(2008-10#3)
tree canopy##8##2##(2008-10#8)
tree community##2##2##(2008-8#1)(2008-9#1)
tree constructed##2##2##(2008-10#1)(2008-8#1)
tree cover##2##2##(2008-5#2)
tree crowns##3##2##(2013-7#3)
tree cultivated##2##2##(2008-10#1)(2012-11#1)
tree density##2##2##(2009-10#2)
tree diseases##3##2##(2006-2#1)(2008-10#2)
tree during##2##2##(2007-8#1)(2008-10#1)
tree for the##3##3##(2008-10#1)(2008-3#2)
tree for##7##2##(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-9#1)(2013-7#1)
tree from the##3##3##(2007-3#1)(2008-10#1)(2010-10#1)
tree from##4##2##(1994-8#1)(2007-3#1)(2008-10#1)(2010-10#1)
tree fruits##2##2##(1991-11#2)
tree growth##4##2##(1990-8#1)(2004-4#1)(2008-10#1)(2010-4#1)
tree has##2##2##(2006-10#1)(2006-5#1)
tree holes##5##2##(2008-9#5)
tree improvement##3##2##(2006-12#2)(2008-10#1)
tree in the##2##3##(1993-6#1)(2011-12#1)
tree in##12##2##(1993-6#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-12#1)(2012-12#4)(2013-7#1)
tree is also##2##3##(2008-5#1)(2012-11#1)
tree is##9##2##(2006-10#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2010-12#1)(2010-6#1)(2012-11#1)
tree kernel (BioLK-method)##2##3##(2012-2#2)
tree leaves##2##2##(2005-10#2)
tree mortality##2##2##(1994-3#2)
tree nut-related foods and fermented foods##2##6##(2011-1#2)
tree nut-related foods##3##3##(2011-1#3)
tree of life##3##3##(2009-5#1)(2011-2#1)(2012-3#1)
tree of the##3##3##(1991-6#1)(1997-2#1)(1997-7#1)
tree of##13##2##(1990-4#1)(1991-4#1)(1991-6#1)(1996-7#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-8#3)(2009-5#1)(2011-2#1)(2012-3#1)
tree on##2##2##(1992-12#1)(2008-10#1)
tree or##3##2##(2007-1#1)(2008-10#1)(2009-8#1)
tree pathogens##3##2##(2006-5#1)(2008-10#2)
tree pollen##5##2##(1997-6#3)(2011-2#1)(2013-8#1)
tree pruning##3##2##(2008-5#3)
tree reconstruction##2##2##(2008-8#1)(2009-12#1)
tree seedling##2##2##(2004-4#1)(2008-5#1)
tree seedlings##4##2##(2008-10#1)(2008-5#3)
tree showed##2##2##(1992-2#1)(1996-4#1)
tree sparrows##2##2##(2008-5#2)
tree species and##3##3##(2007-3#1)(2007-6#1)(2008-5#1)
tree species in the##2##4##(2006-12#1)(2007-3#1)
tree species richness##2##3##(1994-3#1)(2013-7#1)
tree species that##3##3##(2007-6#1)(2008-5#2)
tree species to##2##3##(2008-10#1)(2009-8#1)
tree species with##2##3##(2008-5#1)(2013-7#1)
tree species##33##2##(1994-3#1)(2006-12#1)(2007-3#3)(2007-6#3)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#7)(2008-8#3)(2008-9#1)(2009-8#3)(2012-6#2)(2012-9#1)(2013-7#3)
tree structure##2##2##(2008-2#2)
tree susceptibility##3##2##(2008-10#3)
tree that grows##2##3##(2008-5#2)
tree that##3##2##(2008-5#3)
tree to##4##2##(2006-10#1)(2007-3#1)(2008-10#1)(2008-2#1)
tree topologies##4##2##(2008-4#1)(2010-6#1)(2012-3#2)
tree topology##3##2##(2006-5#1)(2008-7#1)(2012-3#1)
tree trunks and##2##3##(2008-10#1)(2013-7#1)
tree using##4##2##(1995-3#1)(2008-10#1)(2008-4#1)(2009-4#1)
tree was constructed using the##2##5##(2008-12#1)(2013-8#1)
tree was constructed##5##3##(1990-8#1)(2005-11#1)(2008-12#1)(2013-8#2)
tree was##12##2##(1990-8#1)(1995-3#1)(2005-11#1)(2008-10#2)(2008-12#1)(2008-3#1)(2010-7#1)(2011-1#1)(2013-8#3)
tree were##4##2##(2006-11#1)(2007-8#1)(2008-3#1)(2012-3#1)
tree which##2##2##(1991-5#1)(2013-7#1)
tree with##2##2##(1990-10#1)(2010-8#1)
tree##480##1##(1990-10#1)(1990-4#1)(1990-8#2)(1991-1#1)(1991-11#2)(1991-4#3)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-2#3)(1992-5#1)(1992-8#1)(1993-6#2)(1993-9#1)(1994-11#3)(1994-2#2)(1994-3#3)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#3)(1995-8#1)(1996-1#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#1)(2004-2#1)(2004-4#3)(2005-10#3)(2005-11#7)(2005-12#1)(2006-10#10)(2006-11#5)(2006-12#3)(2006-2#3)(2006-5#5)(2006-7#1)(2006-8#2)(2007-1#3)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#11)(2007-6#4)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#3)(2008-10#102)(2008-11#5)(2008-12#2)(2008-2#10)(2008-3#6)(2008-4#11)(2008-5#42)(2008-6#1)(2008-7#3)(2008-8#18)(2008-9#12)(2009-10#6)(2009-12#3)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-8#5)(2009-9#2)(2010-10#4)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#14)(2010-7#2)(2010-8#5)(2010-9#4)(2011-1#6)(2011-12#2)(2011-2#9)(2012-1#1)(2012-11#3)(2012-12#5)(2012-2#6)(2012-3#12)(2012-6#2)(2012-9#1)(2013-1#5)(2013-7#12)(2013-8#8)
tree)##8##1##(2006-12#1)(2007-6#1)(2008-10#2)(2010-6#2)(2012-3#2)
tree-based decision model to##2##4##(2010-8#2)
tree-based method##3##2##(2012-3#3)
tree-based##9##1##(1994-3#1)(2008-2#2)(2010-8#2)(2012-3#4)
tree-like chemical graphs with given upper and lower bounds on path frequencies##2##12##(2012-3#2)
tree-like chemical graphs##3##3##(2012-3#3)
tree-like##4##1##(2008-4#1)(2012-3#3)
tree-structured subset VLVQs##2##3##(2008-2#2)
tree-structured##6##1##(2008-2#5)(2008-5#1)
treefrog##3##1##(2009-9#3)
treefrogs##4##1##(2009-5#2)(2009-9#2)
trees affected##2##2##(2008-10#1)(2013-1#1)
trees and shrubs##4##3##(2007-6#1)(2008-10#2)(2010-6#1)
trees and##32##2##(2007-3#2)(2007-6#1)(2008-10#15)(2008-3#1)(2008-5#3)(2008-7#1)(2010-6#2)(2011-12#2)(2012-12#1)(2012-3#1)(2012-9#1)(2013-1#1)(2013-8#1)
trees are##8##2##(2007-3#1)(2008-10#2)(2008-8#1)(2010-6#2)(2011-2#1)(2013-7#1)
trees at##5##2##(2008-10#3)(2008-9#1)(2011-12#1)
trees based on the##2##4##(2007-6#1)(2008-4#1)
trees based on##3##3##(2007-6#1)(2008-4#2)
trees based##4##2##(2007-6#1)(2008-4#2)(2013-8#1)
trees by##6##2##(2008-10#5)(2008-5#1)
trees derived from##2##3##(2008-10#2)
trees during the##2##3##(2008-10#1)(2008-12#1)
trees during##4##2##(2008-10#3)(2008-12#1)
trees expressing##2##2##(2006-12#1)(2008-10#1)
trees for all##2##3##(2008-10#2)
trees for the##4##3##(2006-12#1)(2008-1#1)(2008-10#1)(2008-3#1)
trees for##14##2##(2005-12#1)(2006-12#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#1)(2010-6#1)(2011-2#2)
trees from 15##2##3##(2008-10#2)
trees from##7##2##(2007-1#1)(2008-10#5)(2011-10#1)
trees generated##3##2##(2008-10#2)(2008-9#1)
trees grafted on trifoliate orange##2##5##(2008-10#2)
trees grew##2##2##(1996-2#1)(2008-8#1)
trees had##2##2##(2008-10#2)
trees have been##2##3##(1993-6#1)(2008-10#1)
trees have##5##2##(1993-6#1)(2008-10#2)(2011-2#2)
trees having##2##2##(2006-12#1)(2012-8#1)
trees in a##4##3##(2008-10#3)(2008-9#1)
trees in all directions##2##4##(2008-10#2)
trees in the field and##2##5##(2008-10#1)(2011-12#1)
trees in the field##5##4##(2008-10#3)(2011-12#2)
trees in the##14##3##(1991-7#1)(2007-1#1)(2008-10#10)(2011-12#2)
trees in three##2##3##(2008-10#1)(2008-6#1)
trees in##45##2##(1991-7#1)(2007-1#1)(2007-3#1)(2007-6#1)(2008-10#31)(2008-5#3)(2008-6#2)(2008-9#1)(2011-12#2)(2012-2#1)(2013-1#1)
trees infected with##7##3##(2008-10#7)
trees infected##8##2##(2008-10#8)
trees inoculated with##2##3##(2008-10#2)
trees is##5##2##(2006-12#1)(2007-9#1)(2008-10#2)(2008-8#1)
trees located##3##2##(2007-3#1)(2008-10#2)
trees occurred##2##2##(2008-10#2)
trees of a##2##3##(2008-10#1)(2010-10#1)
trees of the##2##3##(2008-10#1)(2008-5#1)
trees of##12##2##(1994-3#1)(1995-11#1)(2008-10#2)(2008-5#4)(2010-10#1)(2010-3#1)(2010-6#1)(2012-2#1)
trees on the##4##3##(2008-10#3)(2008-5#1)
trees on##7##2##(2008-10#5)(2008-5#2)
trees or##5##2##(2006-10#1)(2008-10#2)(2008-5#1)(2011-2#1)
trees produced##4##2##(1993-6#1)(1997-4#1)(2008-10#1)(2008-9#1)
trees showed##2##2##(2008-10#2)
trees than##2##2##(2008-10#1)(2010-6#1)
trees that had##2##3##(2008-10#1)(2011-12#1)
trees that##8##2##(1993-6#1)(2008-10#1)(2008-8#1)(2010-6#2)(2011-12#1)(2012-2#1)(2012-7#1)
trees throughout##2##2##(2008-10#2)
trees to a##2##3##(2008-10#1)(2013-7#1)
trees to##6##2##(2008-10#4)(2012-8#1)(2013-7#1)
trees treated with##2##3##(2008-10#1)(2011-2#1)
trees treated##3##2##(2008-10#2)(2011-2#1)
trees using##2##2##(2008-4#1)(2008-9#1)
trees was##10##2##(2004-4#1)(2008-10#5)(2008-12#1)(2008-5#2)(2012-9#1)
trees were constructed##2##3##(2008-8#2)
trees were not significantly##2##4##(2008-10#2)
trees were removed##2##3##(2008-10#2)
trees were treated##2##3##(2008-10#2)
trees were##27##2##(1995-3#1)(2007-3#1)(2008-10#19)(2008-8#2)(2011-2#3)(2012-6#1)
trees will##2##2##(2010-4#1)(2010-6#1)
trees with EFNs##2##3##(2011-12#2)
trees with##19##2##(1994-3#1)(2006-11#1)(2006-12#1)(2008-1#1)(2008-10#6)(2008-4#1)(2008-5#1)(2010-6#1)(2011-12#4)(2012-3#2)
trees within##5##2##(2008-10#5)
trees without##2##2##(2008-10#1)(2011-12#1)
trees##521##1##(1991-5#2)(1991-7#1)(1993-6#3)(1994-3#2)(1994-6#1)(1995-11#2)(1995-3#1)(1996-2#1)(1996-3#1)(1997-4#1)(2004-2#1)(2004-4#2)(2005-12#1)(2006-10#5)(2006-11#1)(2006-12#8)(2007-1#4)(2007-2#3)(2007-3#8)(2007-6#3)(2007-9#1)(2008-1#3)(2008-10#279)(2008-11#1)(2008-12#3)(2008-2#4)(2008-3#2)(2008-4#9)(2008-5#26)(2008-6#8)(2008-7#6)(2008-8#14)(2008-9#11)(2009-2#1)(2009-6#2)(2009-8#2)(2010-10#2)(2010-3#1)(2010-4#3)(2010-6#22)(2010-8#1)(2011-10#1)(2011-12#18)(2011-2#17)(2012-12#2)(2012-2#6)(2012-3#5)(2012-6#2)(2012-7#1)(2012-8#2)(2012-9#2)(2013-1#3)(2013-7#6)(2013-8#4)
trees)##8##1##(2007-6#1)(2008-10#3)(2008-2#1)(2008-5#1)(2012-2#1)(2012-6#1)
trefoil##6##1##(1991-1#1)(2006-10#2)(2010-12#3)
trehalase##5##1##(1996-10#3)(2008-6#1)(2013-1#1)
trehalose and##8##2##(1991-9#1)(1993-8#2)(2005-11#1)(2006-12#1)(2006-5#3)
trehalose concentrations##2##2##(2005-12#1)(2008-10#1)
trehalose content of##2##3##(2011-1#2)
trehalose content##5##2##(2011-1#5)
trehalose in##2##2##(2006-5#1)(2007-12#1)
trehalose supplementation##2##2##(2013-1#2)
trehalose to##2##2##(2013-1#2)
trehalose was not##2##3##(1991-9#1)(2013-1#1)
trehalose was##3##2##(1991-9#1)(2007-12#1)(2013-1#1)
trehalose##61##1##(1990-10#1)(1991-9#8)(1993-8#3)(1996-4#1)(1997-2#5)(2005-11#3)(2005-12#1)(2006-12#1)(2006-5#4)(2007-12#2)(2008-10#8)(2008-11#3)(2008-5#3)(2008-6#1)(2011-1#8)(2012-3#2)(2013-1#7)
trehalose)##4##1##(2005-12#3)(2013-1#1)
trehalose-supplemented diet##4##2##(2013-1#4)
trellis##5##1##(2008-10#1)(2008-3#4)
trematode Schistosoma mansoni##2##3##(1995-1#1)(2006-10#1)
trematode species##5##2##(2007-6#1)(2008-5#1)(2013-1#3)
trematode##17##1##(1995-1#1)(1997-6#1)(2006-10#1)(2007-2#1)(2007-3#1)(2007-6#2)(2008-12#1)(2008-4#2)(2008-5#2)(2011-1#2)(2013-1#3)
trematodes##4##1##(2008-4#2)(2010-8#1)(2013-1#1)
tremendous application in##2##3##(2008-7#1)(2013-1#1)
tremendous diversity of##2##3##(2006-10#1)(2009-12#1)
tremendous efforts##2##2##(2006-6#1)(2008-1#1)
tremendous impact on##5##3##(2006-6#1)(2007-10#1)(2008-1#1)(2008-10#1)(2012-3#1)
tremendous importance##2##2##(2005-8#1)(2008-5#1)
tremendous increase in##2##3##(1990-10#1)(2008-9#1)
tremendous insight##2##2##(2008-11#1)(2008-4#1)
tremendous interest in using##3##4##(2008-4#1)(2008-5#1)(2011-2#1)
tremendous interest in##4##3##(2008-4#1)(2008-5#1)(2009-3#1)(2011-2#1)
tremendous interest##5##2##(2008-10#1)(2008-4#1)(2008-5#1)(2009-3#1)(2011-2#1)
tremendous potential in##2##3##(2008-12#1)(2008-2#1)
tremendous potential##3##2##(2008-12#1)(2008-2#1)(2011-2#1)
tremendous progress has been made in the##2##7##(2008-11#1)(2008-7#1)
tremendous progress in##3##3##(2008-1#1)(2008-5#1)(2010-6#1)
tremendous progress##7##2##(2006-10#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-7#1)(2010-6#1)
tremendous therapeutic potential##2##3##(2008-1#1)(2008-6#1)
tremendous variation in##2##3##(2008-10#1)(2008-11#1)
tremendous variation##3##2##(2008-10#2)(2008-11#1)
tremendous##82##1##(1990-10#1)(1991-3#1)(1992-1#1)(1996-4#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-9#2)(2008-1#7)(2008-10#5)(2008-11#4)(2008-12#3)(2008-2#1)(2008-4#6)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-6#2)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#4)
tremendously over the last##2##4##(2005-7#1)(2012-12#1)
tremendously##9##1##(2005-7#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-8#2)(2009-3#1)(2010-12#1)(2012-12#1)
tremolite &quot##2##2##(1991-12#2)
tremolite##23##1##(1991-12#22)(2010-9#1)
tremor (ET)##4##2##(2008-7#3)(2013-1#1)
tremor amplitude##2##2##(2008-7#2)
tremor and rigidity##4##3##(2006-4#1)(2008-11#2)(2008-7#1)
tremor and##14##2##(1991-5#1)(2005-7#1)(2006-12#1)(2006-4#1)(2007-11#1)(2008-11#3)(2008-7#5)(2009-3#1)
tremor appeared##2##2##(2008-7#1)(2013-8#1)
tremor at rest##6##3##(2008-7#6)
tremor at##7##2##(1993-11#1)(2008-7#6)
tremor in patients##2##3##(2008-7#2)
tremor in##5##2##(2008-11#1)(2008-7#3)(2012-3#1)
tremor induced by##2##3##(1995-12#2)
tremor is##4##2##(2006-10#1)(2008-11#3)
tremor on##2##2##(2011-12#1)(2012-3#1)
tremor was##5##2##(2005-10#1)(2008-7#3)(2012-3#1)
tremor##115##1##(1990-4#1)(1990-5#1)(1991-11#1)(1991-5#1)(1993-11#3)(1993-9#5)(1994-3#2)(1994-6#1)(1995-12#2)(1997-2#1)(1997-6#5)(2005-10#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-4#2)(2006-6#1)(2007-11#1)(2007-8#1)(2008-11#10)(2008-2#1)(2008-4#1)(2008-7#51)(2008-8#1)(2009-3#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-12#1)(2012-3#4)(2013-1#1)(2013-8#5)
tremor-suppressing##2##1##(1993-9#2)
tremorine and cold tremor activity in unanesthetized rats##2##8##(1997-6#2)
tremorine and cold tremor activity in unanesthetized##3##7##(1997-6#3)
tremorine##4##1##(1997-6#4)
tremors and##2##2##(2006-12#1)(2012-2#1)
tremors were##2##2##(2008-7#2)
tremors##12##1##(1993-9#2)(2006-12#1)(2007-9#1)(2008-2#1)(2008-7#3)(2011-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
trench##9##1##(1991-2#2)(1992-3#1)(2007-12#1)(2008-10#1)(2008-3#3)(2009-9#1)
trenches##11##1##(1991-3#1)(1993-12#1)(2006-4#1)(2006-8#1)(2007-12#3)(2007-4#2)(2008-10#1)(2008-3#1)
trend &lt##2##2##(2007-10#1)(2009-10#1)
trend = less than 0##2##5##(1991-5#2)
trend =##3##2##(1991-5#2)(1992-9#1)
trend across##2##2##(1990-7#1)(2008-10#1)
trend analyses##3##2##(2006-10#2)(2012-2#1)
trend analysis##4##2##(2008-11#1)(2008-8#1)(2009-8#1)(2013-8#1)
trend and##9##2##(1990-11#1)(1993-12#1)(1996-2#1)(2005-12#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-4#1)(2013-8#1)
trend are##4##2##(1995-10#1)(1995-11#1)(2008-5#1)(2013-8#1)
trend as##4##2##(2005-11#1)(2007-6#1)(2008-10#1)(2011-12#1)
trend based on##2##3##(1997-6#1)(2010-12#1)
trend between##2##2##(2008-7#1)(2012-2#1)
trend by##3##2##(1993-6#1)(2011-2#1)(2012-2#1)
trend during the##2##3##(1992-7#1)(2012-12#1)
trend during##4##2##(1992-7#1)(2008-1#1)(2012-12#1)(2012-3#1)
trend emerged##2##2##(1990-12#1)(2008-12#1)
trend for a##2##3##(1991-2#1)(2005-10#1)
trend for better##2##3##(2005-10#1)(2008-9#1)
trend for earlier##2##3##(2006-10#2)
trend for the discriminative accuracy to be decreased by PCPA##2##10##(1992-11#2)
trend for the##10##3##(1990-3#1)(1992-11#2)(2005-11#1)(2006-2#1)(2006-8#1)(2007-11#1)(2008-10#1)(2009-6#1)(2009-8#1)
trend for##31##2##(1990-2#1)(1990-3#1)(1991-2#1)(1992-11#2)(1995-1#1)(1995-11#1)(2005-10#2)(2005-11#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-9#2)(2009-6#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2013-1#1)
trend from##4##2##(1990-8#1)(2007-7#1)(2008-10#1)(2011-2#1)
trend has been##4##3##(1990-11#1)(2007-3#1)(2007-7#1)(2008-3#1)
trend has##8##2##(1990-11#1)(1990-6#1)(1993-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-3#1)(2009-3#1)
trend in incidence##2##3##(1996-2#1)(1997-1#1)
trend in life expectancy in Norway##2##6##(1996-3#2)
trend in risk with##2##4##(1992-9#2)
trend in risk##3##3##(1992-9#2)(2008-12#1)
trend in the number of##2##5##(1990-11#1)(1996-11#1)
trend in the##16##3##(1990-11#1)(1990-6#1)(1993-10#1)(1994-2#1)(1995-10#1)(1995-12#1)(1996-11#1)(1996-8#1)(1997-7#1)(2007-3#1)(2009-3#1)(2011-2#2)(2012-12#2)(2013-7#1)
trend in##76##2##(1990-11#2)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-8#1)(1992-9#2)(1993-10#1)(1993-2#1)(1994-2#2)(1995-10#1)(1995-12#2)(1995-4#1)(1995-5#2)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#3)(1996-8#1)(1997-1#1)(1997-5#1)(1997-7#2)(2006-10#4)(2006-12#1)(2006-4#1)(2007-1#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#3)(2009-3#1)(2009-5#1)(2010-7#2)(2011-2#5)(2012-12#8)(2013-1#1)(2013-7#1)
trend is##17##2##(1991-3#1)(1992-3#1)(1997-1#1)(2006-10#2)(2007-11#1)(2007-12#3)(2007-3#1)(2007-7#2)(2008-1#1)(2008-11#1)(2010-9#1)(2012-12#1)(2013-1#1)
trend may##2##2##(2012-12#1)(2013-7#1)
trend observed in##3##3##(2007-6#1)(2007-7#1)(2012-2#1)
trend observed##5##2##(2007-6#1)(2007-7#1)(2009-12#1)(2010-4#1)(2012-2#1)
trend of changes##2##3##(1990-8#1)(2008-12#1)
trend of decreasing##3##3##(2008-10#1)(2008-11#1)(2010-4#1)
trend of incidence and##2##4##(2005-10#1)(2011-2#1)
trend of the##11##3##(1990-2#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-2#2)(2008-4#1)(2012-12#1)(2012-2#1)(2012-7#1)(2013-1#1)
trend of these##2##3##(2006-6#1)(2012-2#1)
trend of##74##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-6#1)(1994-9#1)(1995-3#1)(1995-6#1)(2005-10#1)(2005-11#3)(2006-10#1)(2006-12#1)(2006-6#1)(2007-12#2)(2007-6#3)(2007-8#3)(2007-9#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2009-12#2)(2010-12#3)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#5)(2013-7#1)(2013-8#4)
trend over time##2##3##(2011-1#1)(2011-2#1)
trend over##3##2##(2010-8#1)(2011-1#1)(2011-2#1)
trend seems to be##2##4##(2006-10#1)(2011-2#1)
trend studies##2##2##(1995-5#1)(2007-4#1)
trend throughout the##2##3##(1990-8#1)(2010-5#1)
trend to increase in##2##4##(2006-8#1)(2008-7#1)
trend to##19##2##(1990-3#1)(1992-5#1)(1994-1#1)(1997-1#1)(2006-10#1)(2006-8#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2010-9#1)(2012-1#2)(2012-11#2)(2013-7#1)(2013-8#1)
trend toward a disproportionately higher##2##5##(2006-12#2)
trend toward a##5##3##(1992-9#1)(2006-12#2)(2008-5#1)(2008-7#1)
trend toward an##2##3##(1995-5#1)(1996-11#1)
trend toward earlier##2##3##(2006-7#1)(2006-9#1)
trend toward greater##4##3##(1997-2#1)(2006-7#1)(2006-8#1)(2008-10#1)
trend toward##48##2##(1990-5#1)(1991-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-3#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-7#3)(2006-8#2)(2006-9#2)(2007-11#1)(2007-12#2)(2007-2#2)(2007-9#1)(2008-10#3)(2008-5#1)(2008-7#3)(2009-2#2)(2009-3#1)(2009-4#1)(2010-7#1)(2011-12#1)(2011-2#4)(2012-2#1)(2013-1#1)
trend towards a lower##2##4##(2011-2#1)(2012-2#1)
trend towards a##5##3##(1990-12#1)(2008-7#2)(2011-2#1)(2012-2#1)
trend towards decreased##2##3##(1990-6#1)(2006-10#1)
trend towards earlier##2##3##(1992-8#1)(2006-10#1)
trend towards greater##2##3##(2006-10#1)(2011-2#1)
trend towards improved##3##3##(2008-6#2)(2010-3#1)
trend towards increasing##3##3##(2007-12#1)(2007-7#1)(2007-8#1)
trend towards more##3##3##(2008-9#1)(2009-4#1)(2010-3#1)
trend towards the##2##3##(2006-10#1)(2008-12#1)
trend towards##52##2##(1990-12#2)(1990-6#1)(1992-8#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-3#1)(1996-4#1)(1997-2#1)(2005-1#2)(2006-10#5)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#3)(2008-9#1)(2009-3#2)(2009-4#1)(2010-11#1)(2010-3#2)(2011-12#1)(2011-2#3)(2012-11#1)(2012-2#1)
trend was also##2##3##(1990-12#1)(1995-1#1)
trend was found##3##3##(1992-10#1)(2008-7#1)(2009-4#1)
trend was not observed##2##4##(2008-12#1)(2012-12#1)
trend was not##4##3##(2008-12#1)(2008-6#1)(2012-12#1)(2012-2#1)
trend was observed for##3##4##(2007-7#1)(2008-10#1)(2009-4#1)
trend was observed in##7##4##(1995-5#2)(1996-8#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-1#1)
trend was observed##12##3##(1995-5#2)(1996-8#1)(2007-7#2)(2008-10#2)(2008-5#1)(2009-1#1)(2009-4#1)(2011-2#1)(2012-12#1)
trend was seen for##2##4##(2006-2#1)(2012-1#1)
trend was seen##3##3##(2006-2#1)(2007-7#1)(2012-1#1)
trend was##39##2##(1990-12#1)(1992-10#1)(1995-1#1)(1995-5#2)(1996-8#1)(1997-7#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-7#3)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-1#1)(2009-2#1)(2009-3#1)(2009-4#2)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-8#1)
trend we##2##2##(1997-5#1)(2008-1#1)
trend will##3##2##(1991-6#1)(2007-7#1)(2011-2#1)
trend with time##2##3##(1990-4#1)(1993-9#1)
trend with##6##2##(1990-4#1)(1993-9#1)(2006-2#1)(2008-7#1)(2009-5#1)(2010-9#1)
trend within##2##2##(1991-3#1)(1996-6#1)
trend##559##1##(1990-11#5)(1990-12#5)(1990-2#4)(1990-3#4)(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#1)(1990-8#4)(1990-9#2)(1991-11#1)(1991-2#1)(1991-3#3)(1991-5#2)(1991-6#5)(1991-8#1)(1992-1#2)(1992-10#1)(1992-11#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#4)(1993-1#1)(1993-10#1)(1993-12#3)(1993-2#2)(1993-6#3)(1993-9#2)(1994-1#1)(1994-2#4)(1994-3#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#3)(1995-10#2)(1995-11#3)(1995-12#3)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#8)(1995-6#2)(1995-9#2)(1996-1#2)(1996-11#2)(1996-2#6)(1996-3#6)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#4)(1997-1#5)(1997-2#2)(1997-3#2)(1997-5#2)(1997-6#3)(1997-7#3)(1997-8#2)(2004-9#1)(2005-1#2)(2005-10#3)(2005-11#7)(2005-12#1)(2005-8#1)(2006-1#1)(2006-10#20)(2006-11#1)(2006-12#5)(2006-2#5)(2006-4#2)(2006-6#4)(2006-7#3)(2006-8#8)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#6)(2007-12#12)(2007-2#4)(2007-3#6)(2007-4#1)(2007-5#3)(2007-6#5)(2007-7#13)(2007-8#6)(2007-9#6)(2008-1#5)(2008-10#22)(2008-11#13)(2008-12#9)(2008-2#3)(2008-3#11)(2008-4#6)(2008-5#9)(2008-6#6)(2008-7#16)(2008-8#8)(2008-9#4)(2009-1#1)(2009-10#2)(2009-12#3)(2009-2#5)(2009-3#6)(2009-4#4)(2009-5#2)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#6)(2010-2#1)(2010-3#2)(2010-4#5)(2010-5#1)(2010-7#4)(2010-8#3)(2010-9#3)(2011-1#7)(2011-12#5)(2011-2#30)(2012-1#4)(2012-11#3)(2012-12#18)(2012-2#12)(2012-3#6)(2012-7#1)(2012-9#1)(2013-1#10)(2013-7#4)(2013-8#13)
trended##4##1##(1996-2#1)(2008-3#1)(2012-3#1)(2013-1#1)
trending##5##1##(1994-7#1)(2006-8#1)(2008-10#1)(2008-12#1)(2010-9#1)
trends among women in##2##4##(2007-4#2)
trends among##3##2##(1993-1#1)(2007-4#2)
trends and consequences##2##3##(2008-4#1)(2011-12#1)
trends and correlates##2##3##(1993-3#1)(2013-1#1)
trends and current##2##3##(1996-3#1)(2008-10#1)
trends and directions##2##3##(2008-7#1)(2009-11#1)
trends and disparities in##2##4##(2011-2#2)
trends and disparities##3##3##(2011-2#3)
trends and issues in##2##4##(1994-2#1)(2008-1#1)
trends and issues##3##3##(1994-2#1)(2008-1#1)(2008-3#1)
trends and##50##2##(1991-2#1)(1991-3#1)(1991-6#1)(1992-11#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-1#2)(1996-1#1)(1996-2#2)(1996-3#2)(1997-7#1)(2006-10#1)(2006-5#1)(2007-4#1)(2007-7#1)(2007-9#2)(2008-1#4)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-3#1)(2010-8#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
trends are##15##2##(1991-3#1)(1992-1#1)(1993-5#1)(1994-5#2)(1996-8#1)(1997-2#1)(2006-10#2)(2007-12#1)(2008-1#3)(2008-7#1)(2009-3#1)
trends at##2##2##(1993-6#1)(2011-2#1)
trends between##4##2##(1993-12#2)(2004-4#1)(2012-12#1)
trends continue##2##2##(2004-1#1)(2008-7#1)
trends continued##2##2##(1991-2#1)(2007-8#1)
trends for more##2##3##(1993-12#1)(1995-1#1)
trends for the##2##3##(1991-1#1)(2004-3#1)
trends for##17##2##(1991-1#1)(1991-2#1)(1991-3#1)(1993-12#1)(1993-3#1)(1995-1#1)(1996-2#1)(2004-3#1)(2005-11#1)(2007-11#2)(2008-5#1)(2008-6#1)(2009-11#1)(2011-2#2)(2012-12#1)
trends from 1955 to##2##4##(1990-4#1)(1993-6#1)
trends from the##2##3##(1994-3#1)(2012-1#1)
trends from##12##2##(1990-3#1)(1990-4#1)(1991-8#1)(1993-6#1)(1994-3#1)(1996-3#1)(2007-4#1)(2008-11#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-1#1)
trends in AIDS incidence##2##4##(1997-2#2)
trends in HIV##3##3##(1992-9#1)(1996-8#2)
trends in Medicare##2##3##(1991-1#1)(1997-1#1)
trends in cancer##4##3##(1990-9#1)(2006-12#2)(2012-3#1)
trends in clinical##2##3##(2005-8#1)(2006-2#1)
trends in diaphyseal##2##3##(2009-10#2)
trends in drug##2##3##(1993-2#1)(2008-8#1)
trends in females##2##3##(1994-6#1)(1996-3#1)
trends in global##2##3##(2006-7#1)(2009-8#1)
trends in growth of preschool children from rural Maharashtra##2##9##(2013-1#2)
trends in health care facility construction##2##6##(1991-2#2)
trends in health care##3##4##(1991-2#2)(2006-9#1)
trends in health inequalities##2##4##(2012-1#2)
trends in health##6##3##(1990-12#1)(1991-2#2)(2006-9#1)(2012-1#2)
trends in hospital##3##3##(1990-12#1)(1993-12#1)(1996-1#1)
trends in incidence##2##3##(1994-9#1)(1995-5#1)
trends in managed care##2##4##(1992-2#1)(2009-6#1)
trends in medical##2##3##(1991-1#1)(1994-1#1)
trends in mortality##2##3##(1995-4#1)(2007-9#1)
trends in research##2##3##(2006-2#1)(2007-11#1)
trends in the United States##2##5##(1990-12#1)(1993-3#1)
trends in the data##2##4##(2008-2#1)(2008-4#1)
trends in the development of##2##5##(1990-9#1)(2008-10#1)
trends in the evolution of##2##5##(2010-3#2)
trends in the incidence of##2##5##(2006-10#1)(2007-8#1)
trends in the management of##2##5##(1995-3#1)(2008-5#1)
trends in the surgical treatment of##2##6##(1992-4#1)(2008-8#1)
trends in the treatment of##2##5##(2005-8#1)(2007-12#1)
trends in the use of##3##5##(1991-3#1)(1993-12#1)(2006-5#1)
trends in the##58##3##(1990-12#2)(1990-9#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1995-3#1)(1996-3#2)(1996-8#1)(1996-9#1)(1997-2#1)(2004-9#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-2#1)(2006-4#2)(2006-5#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-9#1)(2010-3#2)(2011-2#1)(2012-12#1)
trends in utilization##2##3##(1991-3#1)(2007-4#1)
trends in##240##2##(1990-10#1)(1990-12#5)(1990-4#2)(1990-9#2)(1991-1#4)(1991-12#2)(1991-2#4)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-6#2)(1992-7#2)(1992-9#2)(1993-1#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-1#2)(1994-12#2)(1994-4#1)(1994-6#2)(1994-7#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-4#1)(1995-5#1)(1996-1#4)(1996-3#7)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#3)(1997-7#1)(2004-10#1)(2004-9#1)(2005-10#1)(2005-8#3)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#3)(2006-3#1)(2006-4#3)(2006-5#3)(2006-6#2)(2006-7#1)(2006-9#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#7)(2007-9#4)(2008-1#6)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#6)(2008-9#3)(2009-10#3)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#4)(2010-7#3)(2010-8#2)(2011-1#1)(2011-2#6)(2012-1#3)(2012-12#7)(2012-2#1)(2012-3#3)(2012-7#1)(2013-1#7)(2013-7#1)(2013-8#2)
trends observed in##2##3##(2008-10#1)(2011-9#1)
trends observed##4##2##(2008-10#1)(2008-6#1)(2009-2#1)(2011-9#1)
trends of the##4##3##(2005-11#1)(2007-11#1)(2007-7#1)(2012-12#1)
trends of these##4##3##(1993-4#1)(2010-4#1)(2012-2#1)(2013-1#1)
trends of##32##2##(1990-8#1)(1993-4#1)(1994-12#2)(2005-10#1)(2005-11#1)(2006-1#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-3#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)
trends on##2##2##(2008-10#1)(2011-1#1)
trends over time##8##3##(1990-12#1)(2008-10#1)(2008-7#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-12#2)
trends promoting##2##2##(1997-3#1)(2008-11#1)
trends seen in##2##3##(1997-4#1)(2008-1#1)
trends since##2##2##(1995-1#1)(2008-8#1)
trends suggest that##3##3##(1996-2#1)(2006-10#1)(2007-3#1)
trends that are##2##3##(1991-1#1)(1996-2#1)
trends that##10##2##(1991-1#1)(1995-2#1)(1996-2#1)(2005-11#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
trends toward##6##2##(1995-3#1)(2005-8#1)(2007-12#1)(2008-2#1)(2010-12#1)(2012-3#1)
trends towards##5##2##(2006-10#2)(2007-7#1)(2008-7#1)(2012-3#1)
trends were also##2##3##(1993-1#1)(2007-10#1)
trends were calculated##2##3##(2011-2#2)
trends were found for the##2##5##(1991-11#1)(2008-10#1)
trends were found##4##3##(1991-11#1)(2008-10#1)(2008-11#1)(2012-1#1)
trends were##22##2##(1991-11#1)(1991-5#1)(1993-1#1)(1994-1#1)(1995-5#2)(2005-11#1)(2006-5#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
trends with the##2##3##(2012-12#1)(2012-2#1)
trends with##3##2##(2006-5#1)(2012-12#1)(2012-2#1)
trends within the##2##3##(1991-3#1)(2010-3#1)
trends within##4##2##(1991-3#1)(1995-12#1)(1997-2#1)(2010-3#1)
trends##581##1##(1990-10#1)(1990-12#8)(1990-3#1)(1990-4#3)(1990-8#1)(1990-9#2)(1991-1#7)(1991-11#2)(1991-12#3)(1991-2#7)(1991-3#8)(1991-4#1)(1991-5#3)(1991-6#3)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#4)(1992-4#1)(1992-6#2)(1992-7#2)(1992-9#3)(1993-1#5)(1993-12#6)(1993-2#4)(1993-3#5)(1993-4#1)(1993-5#1)(1993-6#2)(1993-9#3)(1994-1#5)(1994-12#5)(1994-2#3)(1994-3#2)(1994-4#1)(1994-5#2)(1994-6#2)(1994-7#1)(1994-9#2)(1995-1#7)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#4)(1995-4#2)(1995-5#3)(1996-1#7)(1996-2#5)(1996-3#11)(1996-6#2)(1996-8#4)(1996-9#1)(1997-1#2)(1997-2#7)(1997-3#3)(1997-4#1)(1997-7#2)(2004-1#1)(2004-10#1)(2004-3#1)(2004-4#1)(2004-9#2)(2005-10#2)(2005-11#5)(2005-8#5)(2005-9#1)(2006-1#3)(2006-10#9)(2006-11#3)(2006-12#3)(2006-2#3)(2006-3#1)(2006-4#4)(2006-5#7)(2006-6#2)(2006-7#1)(2006-9#3)(2007-1#1)(2007-10#2)(2007-11#8)(2007-12#3)(2007-2#1)(2007-3#2)(2007-4#8)(2007-5#3)(2007-6#2)(2007-7#10)(2007-8#10)(2007-9#8)(2008-1#20)(2008-10#27)(2008-11#9)(2008-12#5)(2008-2#3)(2008-3#8)(2008-4#6)(2008-5#5)(2008-6#6)(2008-7#16)(2008-8#12)(2008-9#7)(2009-10#4)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#4)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#5)(2010-4#4)(2010-5#8)(2010-6#1)(2010-7#3)(2010-8#7)(2011-1#6)(2011-12#3)(2011-2#27)(2011-9#1)(2012-1#6)(2012-12#20)(2012-2#7)(2012-3#9)(2012-7#1)(2013-1#12)(2013-7#2)(2013-8#3)
trends)##2##1##(1994-12#1)(2008-8#1)
trends]##6##1##(1990-2#1)(1990-9#1)(1991-7#1)(2006-2#1)(2011-1#1)(2013-1#1)
trepanation##3##1##(1991-11#2)(2010-12#1)
trephination##3##1##(2010-7#1)(2012-12#2)
trephine biopsy##4##2##(2005-12#3)(2008-1#1)
trephine##7##1##(1992-6#1)(1995-11#1)(2005-12#3)(2008-1#1)(2008-6#1)
treponemes##4##1##(2006-8#1)(2008-9#3)
trespass##2##1##(1991-10#2)
tretinoin##10##1##(1993-12#1)(1996-8#2)(2005-8#1)(2010-12#6)
tri##2##1##(2011-12#2)
tri- and diacylglycerols##2##3##(1991-10#2)
tri- and pentavalent##2##3##(2008-10#1)(2009-6#1)
tri- and##13##2##(1990-12#1)(1991-10#3)(1991-9#1)(1992-12#1)(1994-3#1)(1996-7#1)(2006-12#1)(2008-10#3)(2009-6#1)
tri- or##3##2##(2008-10#1)(2008-4#1)(2013-7#1)
tri-##25##1##(1990-12#1)(1991-10#3)(1991-2#1)(1991-9#1)(1992-12#1)(1992-7#1)(1993-11#1)(1994-3#1)(1996-7#1)(2006-12#1)(2007-6#1)(2008-10#5)(2008-3#2)(2008-4#1)(2008-7#1)(2009-6#1)(2010-4#1)(2013-7#1)
tri-Calciphor##4##1##(1994-6#4)
tri-allelic##3##1##(2008-12#2)(2008-4#1)
tri-colour light emitting diode##2##4##(2008-10#2)
tri-colour##4##1##(2008-10#4)
tri-iodide##3##1##(2008-10#3)
tri-iodothyronine##4##1##(1991-2#1)(1991-7#1)(1996-5#1)(2012-1#1)
tri-methylation##4##1##(2009-10#3)(2013-1#1)
tri-n-butyl phosphate (TBP) and##2##4##(2008-10#2)
tri-n-butylphosphate (TBP)##3##2##(2008-10#3)
tri-n-butylphosphine in order to##2##4##(2008-10#2)
tri-n-butyltin##3##1##(1996-5#1)(2008-5#2)
tri-n-octylamine and##2##2##(1997-1#1)(2008-10#1)
tri-n-octylamine##3##1##(1997-1#1)(2008-10#2)
tri-snRNP##2##1##(1995-6#2)
triacetal oxa cages##2##3##(1996-5#2)
triacetate##10##1##(1990-9#2)(2004-7#1)(2007-11#1)(2007-12#1)(2008-10#4)(2013-1#1)
triacontanol##2##1##(1997-1#2)
triacrylate (it is reactive and therefore not available as pure##2##10##(2008-9#2)
triacrylate (technical grade) (CAS No##2##5##(2008-9#2)
triacrylate as a potential contact sensitizer##2##6##(2008-9#2)
triacrylate by skin painting for 3 months##2##7##(2008-9#2)
triacrylate by skin painting for##3##5##(2008-9#3)
triacrylate for 6 months had significantly increased incidences##2##8##(2008-9#2)
triacrylate induced a neutrophil count increase##2##6##(2008-9#2)
triacrylate is##2##2##(2008-9#2)
triacrylate to induce contact hypersensitization##2##5##(2008-9#2)
triacrylate was nominated by the National Cancer Institute for testing##2##10##(2008-9#2)
triacrylate was##3##2##(2008-9#3)
triacrylate##32##1##(2008-9#32)
triacrylate) in acetone dermally for 2 weeks or 3 months##2##10##(2008-9#2)
triacrylate/kg body weight in acetone 5 days per week for 14 weeks##4##12##(2008-9#4)
triacrylate/kg body weight in acetone 5 days per week for##9##10##(2008-9#9)
triactinomyxon##2##1##(2008-4#2)
triacyl##2##1##(1990-4#1)(1991-1#1)
triacylglycerol (TAG)##2##2##(2004-11#1)(2013-1#1)
triacylglycerol (TG)##4##2##(1990-2#1)(1992-4#1)(1993-9#1)(1995-6#1)
triacylglycerol and cholesterol##3##3##(1991-2#2)(2008-7#1)
triacylglycerol and##6##2##(1991-2#3)(1995-1#1)(2008-7#1)(2011-2#1)
triacylglycerol in##2##2##(1991-2#2)
triacylglycerol synthesis##3##2##(1990-5#1)(1991-2#1)(2013-8#1)
triacylglycerol##37##1##(1990-2#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-2#10)(1992-4#2)(1993-6#1)(1993-9#1)(1995-1#2)(1995-3#3)(1995-6#1)(1995-8#2)(1996-2#1)(1997-3#1)(2004-11#1)(2006-10#2)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
triacylglycerol-rich lipoprotein##2##2##(1995-4#2)
triacylglycerol-rich##6##1##(1990-2#1)(1995-1#2)(1995-4#2)(1997-4#1)
triacylglycerols and##4##2##(1990-2#1)(2008-5#1)(2008-9#1)(2012-12#1)
triacylglycerols in##5##2##(1990-8#2)(1996-6#1)(2004-8#1)(2008-5#1)
triacylglycerols were##2##2##(1990-9#1)(1995-1#1)
triacylglycerols##22##1##(1990-2#1)(1990-8#2)(1990-9#2)(1993-6#1)(1995-1#1)(1996-6#2)(1996-7#1)(1997-3#2)(2004-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-9#2)(2012-1#1)(2012-12#1)
triacyloglycerides##2##1##(2008-12#2)
triad in##2##2##(2010-1#2)
triad of chymotrypsin##2##3##(1995-5#2)
triad of fever##2##3##(2008-8#1)(2009-11#1)
triad of##29##2##(1992-3#1)(1995-2#1)(1995-5#3)(1996-3#1)(1996-5#1)(1996-7#1)(2005-7#1)(2006-10#2)(2006-8#1)(2007-2#1)(2007-7#2)(2007-9#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
triad##62##1##(1991-8#1)(1992-12#1)(1992-3#2)(1993-3#3)(1994-12#1)(1995-2#1)(1995-3#1)(1995-5#4)(1996-3#1)(1996-5#1)(1996-7#2)(1997-6#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#4)(2009-9#1)(2010-1#4)(2010-2#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#4)(2013-1#1)(2013-8#1)
triad&quot##3##1##(2006-3#1)(2012-12#2)
triad]##2##1##(1992-10#1)(1994-3#1)
triadic vesicles##3##2##(1991-7#1)(1992-3#1)(1995-6#1)
triadic##8##1##(1991-7#1)(1992-1#2)(1992-3#1)(1994-3#1)(1994-5#1)(1995-6#1)(2012-1#1)
triadimenol##3##1##(2008-10#2)(2011-2#1)
triadin##11##1##(1991-7#2)(1994-12#8)(2006-10#1)
triads of##4##2##(1993-12#1)(1993-2#1)(1994-5#1)(2007-9#1)
triads##14##1##(1992-1#3)(1993-12#2)(1993-2#1)(1993-3#3)(1994-5#1)(2007-9#1)(2008-10#1)(2009-8#1)(2011-12#1)
triage and acuity##2##3##(2007-3#1)(2007-7#1)
triage and##5##2##(2006-2#1)(2007-3#1)(2007-7#1)(2008-3#1)(2013-1#1)
triage of patients with##2##4##(2008-3#2)
triage of patients##5##3##(2007-9#1)(2008-3#4)
triage of suspected scaphoid fractures##2##5##(2008-9#2)
triage of suspected scaphoid##3##4##(2008-9#3)
triage of##8##2##(2007-9#1)(2008-3#4)(2008-9#3)
triage system##2##2##(2007-5#1)(2007-7#1)
triage to colposcopy##2##3##(2006-10#1)(2007-12#1)
triage to##4##2##(2006-10#1)(2007-12#1)(2007-7#1)(2008-3#1)
triage with##2##2##(2008-9#1)(2011-12#1)
triage##51##1##(1997-1#1)(2005-10#1)(2006-10#4)(2006-2#1)(2007-10#2)(2007-12#4)(2007-3#2)(2007-5#2)(2007-7#3)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#8)(2008-7#3)(2008-9#5)(2009-10#1)(2009-3#1)(2009-5#2)(2010-8#2)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#2)
trial (RCT)##9##2##(2005-11#1)(2006-2#1)(2008-10#1)(2011-2#1)(2013-1#4)(2013-8#1)
trial (n =##2##3##(2007-10#1)(2007-2#1)
trial (p &lt##2##3##(2008-5#1)(2011-1#1)
trial OR##2##2##(2011-2#2)
trial and error##3##3##(1995-1#1)(2008-10#1)(2008-3#1)
trial and in##2##3##(2007-10#1)(2009-12#1)
trial and the##2##3##(1990-1#1)(2008-7#1)
trial and were randomized to##2##5##(2012-2#2)
trial and##32##2##(1990-1#1)(1995-1#1)(1995-11#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-1#1)(2005-11#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2010-12#1)(2010-3#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
trial are##8##2##(1991-10#1)(1991-9#1)(1994-4#1)(1994-9#1)(1995-8#1)(1996-3#1)(2007-5#1)(2011-3#1)
trial as well as##2##4##(2009-12#1)(2010-6#1)
trial as##4##2##(2008-5#1)(2009-12#1)(2010-6#1)(2012-2#1)
trial assessing the##2##3##(2007-10#1)(2012-2#1)
trial assessing##4##2##(1993-2#1)(2007-10#1)(2010-12#1)(2012-2#1)
trial at##4##2##(1990-5#1)(1992-2#1)(1994-4#1)(2011-1#1)
trial by trial##2##3##(2012-1#2)
trial by##5##2##(1996-11#2)(2006-5#1)(2012-1#2)
trial compared##5##2##(2008-5#1)(2009-4#2)(2013-8#2)
trial comparing a##2##3##(2007-7#1)(2010-9#1)
trial comparing different doses##2##4##(1995-9#1)(2007-11#1)
trial comparing the##2##3##(2008-4#1)(2009-5#1)
trial comparing two##3##3##(1993-1#1)(1994-7#1)(1997-2#1)
trial comparing##24##2##(1991-11#1)(1992-12#1)(1993-1#2)(1993-11#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-9#1)(1997-2#1)(2004-1#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-7#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-9#1)(2012-3#1)
trial comparison##2##2##(1990-8#1)(2008-10#1)
trial conducted by the##2##4##(1996-1#1)(2005-11#1)
trial conducted in a##3##4##(1990-11#1)(2008-10#1)(2010-2#1)
trial conducted in##5##3##(1990-11#1)(2008-10#2)(2010-11#1)(2010-2#1)
trial conducted##8##2##(1990-11#1)(1996-1#1)(2005-11#1)(2008-10#2)(2010-11#1)(2010-2#1)(2012-12#1)
trial confirms##2##2##(1994-6#1)(2004-12#1)
trial consisted of##2##3##(1993-6#1)(2008-7#1)
trial court##6##2##(1990-11#1)(1990-3#1)(1992-12#1)(1993-7#1)(1997-1#1)(1997-5#1)
trial court's##2##2##(1990-3#1)(1992-12#1)
trial data##16##2##(1993-12#1)(2004-3#1)(2005-10#2)(2005-7#1)(2006-5#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#2)(2013-1#1)
trial demonstrated that##4##3##(1997-2#1)(2008-5#1)(2009-4#1)(2010-4#1)
trial demonstrated##6##2##(1997-2#1)(2008-3#1)(2008-5#2)(2009-4#1)(2010-4#1)
trial design and implementation##2##4##(2007-7#2)
trial design and##4##3##(2006-12#1)(2007-11#1)(2007-7#2)
trial design in##2##3##(2005-7#1)(2012-3#1)
trial design##21##2##(1997-4#1)(2005-7#1)(2005-8#1)(2006-12#1)(2007-11#3)(2007-7#2)(2007-9#2)(2008-5#1)(2008-8#1)(2009-5#1)(2010-3#1)(2010-7#1)(2011-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
trial designed to evaluate the##2##5##(2008-4#1)(2011-2#1)
trial designed to##5##3##(2005-10#1)(2005-7#1)(2008-4#1)(2010-10#1)(2011-2#1)
trial designs##3##2##(1994-9#1)(1997-8#1)(2011-2#1)
trial early##3##2##(1995-6#1)(2013-8#2)
trial evaluated the##2##3##(2007-11#1)(2007-8#1)
trial evaluating##5##2##(2005-10#1)(2008-5#1)(2008-7#2)(2010-12#1)
trial evidence##9##2##(2005-10#1)(2005-7#1)(2007-10#1)(2008-3#3)(2008-6#1)(2008-7#1)(2012-2#1)
trial examining the##2##3##(2006-11#1)(2012-1#1)
trial experiences##2##2##(1992-2#2)
trial failed to show##2##4##(2006-10#1)(2008-10#1)
trial failed to##3##3##(2006-10#2)(2008-10#1)
trial following##2##2##(2005-11#1)(2008-5#1)
trial for counterbalance order##3##4##(2013-8#3)
trial for the same indication##2##5##(2008-5#2)
trial for the treatment of##3##5##(2005-8#1)(2008-5#2)
trial for the##8##3##(1997-4#1)(2005-8#1)(2007-2#1)(2007-8#1)(2008-5#4)
trial for##31##2##(1992-11#1)(1994-5#1)(1995-9#1)(1996-4#1)(1997-4#1)(2005-7#1)(2005-8#2)(2005-9#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#11)(2010-10#1)(2011-2#1)(2012-2#1)(2013-8#3)
trial from##3##2##(1996-12#1)(2008-7#1)(2011-1#1)
trial had##3##2##(1990-2#1)(2007-9#1)(2011-2#1)
trial has been completed##2##4##(2005-9#1)(2007-5#1)
trial has been published##2##4##(1990-1#1)(2012-2#1)
trial has been##8##3##(1990-1#1)(1990-2#1)(2005-9#1)(2007-2#1)(2007-5#1)(2009-6#1)(2012-2#1)(2013-1#1)
trial has so far##2##4##(2006-10#1)(2007-9#1)
trial has##15##2##(1990-1#1)(1990-2#1)(1996-12#1)(2005-8#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-9#1)(2009-6#1)(2010-7#1)(2012-2#1)(2013-1#1)
trial in 10##2##3##(2008-5#2)
trial in a##5##3##(1990-5#1)(1993-4#1)(1997-5#1)(2008-10#1)(2012-3#1)
trial in general##2##3##(1994-2#1)(1997-6#1)
trial in patients with##6##4##(1993-2#1)(2007-11#3)(2007-9#1)(2009-3#1)
trial in patients##8##3##(1992-12#1)(1993-2#1)(2007-11#3)(2007-8#1)(2007-9#1)(2009-3#1)
trial in the##7##3##(1995-9#1)(1996-8#1)(2005-11#1)(2007-9#1)(2008-4#1)(2010-11#1)(2012-2#1)
trial in which##6##3##(1990-6#1)(2007-8#2)(2008-10#1)(2013-1#1)(2013-7#1)
trial in##71##2##(1990-10#1)(1990-5#2)(1990-6#1)(1991-12#1)(1992-10#1)(1992-12#1)(1993-2#2)(1993-4#1)(1994-2#1)(1994-8#1)(1995-9#2)(1996-12#1)(1996-8#2)(1996-9#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-9#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-8#3)(2007-9#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#8)(2008-7#2)(2008-8#2)(2009-3#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
trial included##2##2##(2008-5#1)(2011-2#1)
trial indicated that##2##3##(2004-1#1)(2013-8#1)
trial involved##2##2##(2008-3#1)(2008-5#1)
trial involving##4##2##(1992-9#1)(2007-4#1)(2010-12#1)(2010-2#1)
trial is a##2##3##(1996-2#1)(1996-6#1)
trial is currently##2##3##(2008-7#1)(2010-12#1)
trial is needed to##3##4##(2007-8#1)(2010-12#1)(2011-2#1)
trial is the first##2##4##(2008-5#1)(2011-2#1)
trial is the##4##3##(1993-12#1)(1996-6#1)(2008-5#1)(2011-2#1)
trial is##27##2##(1991-11#1)(1993-12#1)(1994-4#1)(1996-2#1)(1996-6#2)(2004-2#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-5#2)(2008-7#3)(2008-8#1)(2010-12#3)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#1)
trial judge##5##2##(1995-12#1)(1996-11#2)(1996-5#1)(1997-5#1)
trial lasting##2##2##(1990-6#1)(2010-12#1)
trial may##3##2##(1996-8#1)(1997-6#1)(2009-12#1)
trial means##2##2##(1991-1#2)
trial methodology##3##2##(2007-7#1)(2008-10#1)(2010-2#1)
trial might be##2##3##(1993-9#1)(1997-6#1)
trial of a##20##3##(1990-4#1)(1990-5#1)(1993-7#1)(1994-9#1)(1995-5#1)(2005-8#1)(2006-10#3)(2006-2#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-4#1)(2011-1#2)(2012-3#1)(2013-1#2)
trial of acyclovir for##2##4##(1991-12#1)(1994-3#1)
trial of adjuvant##3##3##(1993-9#1)(1995-4#1)(2008-3#1)
trial of an##4##3##(1993-9#1)(1997-7#2)(2011-2#1)
trial of clomethiazole in##2##4##(2007-9#2)
trial of efavirenz in combination with##2##6##(2008-5#2)
trial of high##2##3##(1995-4#2)
trial of infliximab in##2##4##(2007-11#1)(2009-6#1)
trial of local##2##3##(1990-10#1)(1995-3#1)
trial of maintenance##3##3##(1991-2#1)(1995-1#1)(2006-9#1)
trial of manual therapy##2##4##(2012-2#1)(2012-3#1)
trial of neoadjuvant##2##3##(2007-11#1)(2012-3#1)
trial of oral##2##3##(1997-3#1)(2005-7#1)
trial of patients##3##3##(1994-2#1)(2008-5#1)(2012-3#1)
trial of surgical##2##3##(1994-10#1)(2008-8#1)
trial of the effects of##2##5##(2006-7#1)(2010-2#1)
trial of the##14##3##(1990-2#1)(1992-10#1)(1996-8#1)(2005-8#1)(2006-7#1)(2006-8#1)(2007-7#2)(2008-10#1)(2009-10#1)(2010-2#1)(2010-8#1)(2012-2#1)(2012-3#1)
trial of therapy##2##3##(2006-10#1)(2010-4#1)
trial of this##2##3##(2005-11#1)(2009-4#1)
trial of##213##2##(1990-10#2)(1990-2#2)(1990-4#1)(1990-5#2)(1990-6#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-10#4)(1992-12#2)(1992-2#1)(1992-3#1)(1992-8#1)(1993-1#2)(1993-10#1)(1993-12#4)(1993-4#1)(1993-5#1)(1993-7#1)(1993-9#3)(1994-10#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-4#5)(1995-5#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-7#4)(1997-8#1)(2004-1#2)(2004-3#3)(2005-10#2)(2005-11#1)(2005-7#1)(2005-8#6)(2005-9#2)(2006-10#9)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#3)(2006-9#3)(2007-10#1)(2007-11#6)(2007-12#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#2)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#3)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#4)(2012-12#2)(2012-2#8)(2012-3#6)(2013-1#8)(2013-8#1)
trial on the##5##3##(1993-5#1)(1994-6#1)(1997-4#1)(2012-3#1)(2013-1#1)
trial on##19##2##(1993-11#1)(1993-5#1)(1994-6#2)(1995-12#1)(1996-1#1)(1996-6#1)(1997-4#1)(2005-7#1)(2007-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)
trial one-dimensional##2##2##(2008-3#2)
trial or##3##2##(1995-2#1)(1996-6#1)(2007-8#1)
trial participants in##2##3##(2007-7#1)(2009-6#1)
trial participants##7##2##(1991-10#2)(2007-7#2)(2009-6#2)(2012-3#1)
trial participation and##2##3##(2007-7#2)
trial participation##7##2##(2007-7#2)(2008-11#1)(2008-5#1)(2012-3#1)(2013-1#2)
trial period##4##2##(1992-3#1)(2004-3#1)(2006-12#1)(2008-3#1)
trial phase##2##2##(2008-3#1)(2008-5#1)
trial protocol##2##2##(2008-8#2)
trial recruitment##4##2##(2006-11#1)(2010-11#2)(2012-3#1)
trial report##4##2##(2011-2#2)(2013-1#2)
trial reported##2##2##(2009-11#1)(2011-2#1)
trial reports##2##2##(1992-10#1)(2008-7#1)
trial results##10##2##(1993-9#1)(1995-8#1)(2006-12#1)(2008-5#2)(2008-8#1)(2009-4#1)(2010-12#2)(2010-8#1)
trial should be##3##3##(1996-6#1)(2006-10#1)(2008-7#1)
trial should##4##2##(1996-6#2)(2006-10#1)(2008-7#1)
trial showed a##2##3##(2008-5#1)(2010-12#1)
trial showed that##8##3##(2007-11#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-6#1)(2013-8#1)
trial showed##14##2##(2007-11#1)(2007-8#1)(2007-9#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-5#1)(2009-6#2)(2010-12#1)(2013-8#1)
trial site##3##2##(2008-10#2)(2010-3#1)
trial sponsored by the National##2##5##(1991-10#1)(2005-8#1)
trial study##5##2##(2007-8#1)(2009-12#1)(2011-2#1)(2012-2#1)(2013-7#1)
trial subjects##2##2##(1991-3#1)(1994-12#1)
trial system##4##2##(2007-4#2)(2008-10#1)(2008-3#1)
trial testing the##2##3##(2006-2#1)(2012-1#1)
trial testing##3##2##(2006-2#1)(2007-5#1)(2012-1#1)
trial than##2##2##(1992-10#1)(2009-8#1)
trial that##13##2##(1993-2#1)(1995-2#1)(1995-9#2)(1997-4#1)(2006-3#1)(2007-7#2)(2007-8#1)(2008-7#1)(2008-8#1)(2009-6#1)(2013-1#1)
trial the##5##2##(1990-3#1)(2006-6#1)(2008-3#1)(2009-11#1)(2011-2#1)
trial to assess the efficacy and safety of##3##8##(1997-1#1)(2008-8#1)(2012-2#1)
trial to assess the efficacy##4##5##(1997-1#1)(2008-7#1)(2008-8#1)(2012-2#1)
trial to assess the##5##4##(1997-1#1)(2006-11#1)(2008-7#1)(2008-8#1)(2012-2#1)
trial to compare the efficacy##2##5##(2011-1#1)(2012-2#1)
trial to compare the##5##4##(2007-10#1)(2007-9#1)(2008-9#1)(2011-1#1)(2012-2#1)
trial to compare##7##3##(1991-8#1)(2006-5#1)(2007-10#1)(2007-9#1)(2008-9#1)(2011-1#1)(2012-2#1)
trial to determine##3##3##(1990-6#1)(2008-1#1)(2010-6#1)
trial to establish##2##3##(1995-9#1)(2007-12#1)
trial to evaluate the##2##4##(2008-7#1)(2010-3#1)
trial to evaluate##7##3##(1994-12#1)(1997-4#1)(2007-8#1)(2008-5#2)(2008-7#1)(2010-3#1)
trial to test the##3##4##(1995-5#1)(1997-3#1)(2010-10#1)
trial to test##5##3##(1991-12#1)(1993-10#1)(1995-5#1)(1997-3#1)(2010-10#1)
trial to trial##2##3##(2008-11#1)(2012-1#1)
trial to##46##2##(1990-6#1)(1991-12#1)(1991-8#1)(1993-10#1)(1994-12#1)(1995-5#2)(1995-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-11#1)(2006-5#2)(2007-10#2)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-12#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#2)(2012-1#1)(2012-2#3)
trial using a##3##3##(1996-8#1)(2005-7#1)(2012-12#1)
trial using##6##2##(1996-8#1)(2005-7#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
trial was an##2##3##(2005-11#1)(2007-5#1)
trial was carried out to##3##5##(1997-6#1)(2008-4#1)(2008-6#1)
trial was carried out##7##4##(1997-6#2)(2005-8#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-12#1)
trial was conducted in##3##4##(1991-2#1)(2007-7#1)(2008-3#1)
trial was conducted on##3##4##(2008-5#1)(2013-1#2)
trial was conducted to compare the##3##6##(1994-7#1)(1995-4#1)(1997-2#1)
trial was conducted to compare##4##5##(1994-7#1)(1995-4#1)(1997-2#1)(2010-8#1)
trial was conducted to determine the##2##6##(2008-10#1)(2011-2#1)
trial was conducted to##9##4##(1994-7#1)(1995-4#1)(1997-2#1)(2008-10#1)(2008-12#1)(2009-4#1)(2010-4#1)(2010-8#1)(2011-2#1)
trial was conducted with##2##4##(2004-1#1)(2008-3#1)
trial was conducted##20##3##(1991-2#1)(1994-7#1)(1995-4#1)(1997-2#1)(2004-1#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2009-4#1)(2010-4#1)(2010-8#2)(2011-2#1)(2013-1#2)
trial was designed to evaluate the##2##6##(2008-6#1)(2013-1#1)
trial was designed to##3##4##(2006-8#1)(2008-6#1)(2013-1#1)
trial was made##2##3##(1996-1#1)(2008-3#1)
trial was performed in##2##4##(2008-3#1)(2012-1#1)
trial was performed##8##3##(1991-3#1)(1992-12#1)(1993-2#1)(1994-6#1)(1996-9#1)(2008-3#1)(2008-4#1)(2012-1#1)
trial was planned to##2##4##(2004-1#1)(2007-10#1)
trial was to compare##2##4##(2004-1#1)(2013-1#1)
trial was to##4##3##(2004-1#1)(2008-7#1)(2012-2#1)(2013-1#1)
trial was undertaken to determine the##2##6##(2006-8#1)(2008-8#1)
trial was undertaken to##3##4##(1991-2#1)(2006-8#1)(2008-8#1)
trial was##65##2##(1991-1#1)(1991-2#2)(1991-3#1)(1992-12#1)(1993-2#2)(1994-6#1)(1994-7#1)(1995-4#1)(1996-1#1)(1996-9#1)(1997-2#1)(1997-6#2)(2004-1#3)(2005-11#1)(2005-8#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-12#1)(2009-4#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#1)
trial wavefunction##2##2##(2012-2#2)
trial we##3##2##(1996-8#1)(2008-7#1)(2010-4#1)
trial were##8##2##(1991-12#1)(1993-12#1)(1993-9#1)(2005-10#1)(2007-5#1)(2008-5#2)(2012-2#1)
trial where##2##2##(1996-2#1)(2006-6#1)
trial which##3##2##(1993-2#1)(2005-8#1)(2008-5#1)
trial will be##3##3##(2008-5#3)
trial will##12##2##(1990-1#1)(1995-9#1)(2005-8#1)(2007-1#1)(2008-5#7)(2011-12#1)
trial with a##3##3##(2008-8#2)(2012-2#1)
trial with this##2##3##(1992-8#1)(1994-8#1)
trial with two parallel##2##4##(2008-10#1)(2008-3#1)
trial with two##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
trial with##25##2##(1992-8#1)(1994-6#1)(1994-8#1)(1996-9#1)(2006-1#1)(2006-10#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#4)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
trial would##4##2##(2005-11#1)(2008-3#1)(2009-6#1)(2012-2#1)
trial##1585##1##(1990-1#4)(1990-10#6)(1990-11#2)(1990-12#3)(1990-2#5)(1990-3#5)(1990-4#2)(1990-5#6)(1990-6#5)(1990-7#4)(1990-8#1)(1990-9#2)(1991-1#5)(1991-10#6)(1991-11#5)(1991-12#4)(1991-2#4)(1991-3#7)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#3)(1992-1#4)(1992-10#11)(1992-11#4)(1992-12#8)(1992-2#9)(1992-3#5)(1992-5#3)(1992-6#1)(1992-8#2)(1992-9#2)(1993-1#6)(1993-10#2)(1993-11#3)(1993-12#9)(1993-2#11)(1993-3#2)(1993-4#4)(1993-5#5)(1993-6#2)(1993-7#4)(1993-9#10)(1994-10#2)(1994-11#1)(1994-12#3)(1994-2#6)(1994-3#4)(1994-4#7)(1994-5#1)(1994-6#9)(1994-7#3)(1994-8#9)(1994-9#3)(1995-1#7)(1995-11#2)(1995-12#5)(1995-2#5)(1995-3#1)(1995-4#7)(1995-5#8)(1995-6#2)(1995-8#5)(1995-9#16)(1996-1#4)(1996-11#8)(1996-12#6)(1996-2#5)(1996-3#7)(1996-4#2)(1996-5#2)(1996-6#19)(1996-7#2)(1996-8#14)(1996-9#3)(1997-1#4)(1997-2#5)(1997-3#7)(1997-4#10)(1997-5#8)(1997-6#8)(1997-7#7)(1997-8#4)(2004-1#11)(2004-10#1)(2004-12#1)(2004-2#1)(2004-3#5)(2004-4#1)(2005-10#8)(2005-11#13)(2005-6#1)(2005-7#15)(2005-8#32)(2005-9#5)(2006-1#2)(2006-10#34)(2006-11#5)(2006-12#7)(2006-2#5)(2006-3#2)(2006-5#6)(2006-6#13)(2006-7#3)(2006-8#8)(2006-9#7)(2007-1#4)(2007-10#20)(2007-11#44)(2007-12#10)(2007-2#9)(2007-3#2)(2007-4#6)(2007-5#7)(2007-7#35)(2007-8#27)(2007-9#21)(2008-1#5)(2008-10#49)(2008-11#11)(2008-12#5)(2008-2#4)(2008-3#35)(2008-4#12)(2008-5#87)(2008-6#14)(2008-7#36)(2008-8#50)(2008-9#3)(2009-10#4)(2009-11#12)(2009-12#11)(2009-2#2)(2009-3#3)(2009-4#13)(2009-5#9)(2009-6#12)(2009-7#1)(2009-8#4)(2010-1#3)(2010-10#13)(2010-11#6)(2010-12#24)(2010-2#12)(2010-3#7)(2010-4#12)(2010-5#8)(2010-6#6)(2010-7#4)(2010-8#10)(2010-9#3)(2011-1#14)(2011-10#1)(2011-12#7)(2011-2#40)(2011-3#1)(2012-1#13)(2012-11#5)(2012-12#24)(2012-2#48)(2012-3#38)(2013-1#72)(2013-7#8)(2013-8#28)
trial)##8##1##(1992-10#1)(1994-10#1)(2008-10#2)(2008-8#1)(2009-10#1)(2010-8#1)(2012-12#1)
trial-based##2##1##(2009-6#1)(2013-1#1)
trial-by-trial##4##1##(1993-2#1)(1994-2#1)(1995-1#1)(1997-1#1)
trial?##3##1##(2006-10#1)(2007-1#1)(2012-3#1)
trial]##8##1##(1991-2#1)(1991-3#1)(1994-2#1)(1995-9#1)(2006-2#1)(2010-4#1)(2011-2#1)(2013-1#1)
trialists##4##1##(1993-12#1)(1994-9#1)(2008-10#1)(2012-2#1)
trialkyl##3##1##(1996-5#1)(2008-10#2)
trials (RCT)##5##2##(2009-4#1)(2010-9#1)(2011-2#2)(2013-8#1)
trials (RCTs) were##2##3##(2006-12#1)(2013-1#1)
trials (RCTs)##19##2##(1993-12#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-12#2)(2013-1#1)
trials (n =##2##3##(1993-12#2)
trials (p##2##2##(2013-8#2)
trials (phase##2##2##(2008-11#1)(2010-12#1)
trials -##4##2##(2012-3#4)
trials about##2##2##(2007-8#1)(2009-2#1)
trials across##2##2##(2008-10#1)(2008-12#1)
trials addressing the##2##3##(2008-4#1)(2011-2#1)
trials against##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
trials aimed at##3##3##(1996-8#1)(2008-5#1)(2009-1#1)
trials also##4##2##(2004-2#1)(2008-1#1)(2010-3#1)(2013-1#1)
trials among##2##2##(2007-7#1)(2013-1#1)
trials and FDA##3##3##(2012-12#1)(2013-1#2)
trials and also##3##3##(2007-11#1)(2008-5#1)(2010-12#1)
trials and discuss the##3##4##(1995-2#1)(2006-10#1)(2008-1#1)
trials and discuss##5##3##(1995-2#1)(2006-10#1)(2008-1#1)(2008-5#1)(2010-3#1)
trials and in##3##3##(1997-1#1)(2005-6#1)(2005-7#1)
trials and meta-analyses have##2##4##(1996-6#1)(2010-12#1)
trials and meta-analyses##7##3##(1991-3#1)(1993-12#1)(1996-6#2)(2008-5#1)(2010-12#1)(2010-2#1)
trials and one##2##3##(2008-8#1)(2012-12#1)
trials and other##3##3##(1996-3#1)(2007-11#1)(2008-11#1)
trials and registries##2##3##(2009-10#1)(2011-2#1)
trials and the##11##3##(2005-11#1)(2005-8#1)(2006-4#1)(2007-11#2)(2008-5#1)(2008-6#1)(2010-12#1)(2011-1#1)(2013-1#2)
trials and will##2##3##(2007-7#1)(2008-5#1)
trials and##117##2##(1990-9#1)(1991-3#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-9#1)(1993-12#2)(1993-2#1)(1995-12#1)(1995-2#2)(1995-9#1)(1996-3#1)(1996-6#2)(1997-1#1)(2005-10#1)(2005-11#1)(2005-6#1)(2005-7#4)(2005-8#3)(2006-10#1)(2006-4#1)(2006-5#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#1)(2007-4#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#11)(2008-6#1)(2008-8#4)(2008-9#1)(2009-10#3)(2009-11#3)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#8)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#6)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#1)
trials are also##2##3##(2005-7#1)(2007-11#1)
trials are available##8##3##(2005-10#1)(2006-10#1)(2006-5#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-8#1)
trials are awaited##4##3##(2005-7#1)(2007-11#1)(2007-8#1)(2009-10#1)
trials are conducted##2##3##(1996-12#1)(2006-11#1)
trials are currently ongoing in##2##5##(2008-1#1)(2010-12#1)
trials are currently##5##3##(2005-7#1)(2007-11#1)(2008-1#1)(2008-5#1)(2010-12#1)
trials are designed to##2##4##(1994-9#1)(2010-12#1)
trials are designed##3##3##(1994-9#1)(2010-12#1)(2012-2#1)
trials are discussed##3##3##(2007-6#1)(2008-12#1)(2008-7#1)
trials are essential##2##3##(2006-10#1)(2007-10#1)
trials are expected##2##3##(2004-12#1)(2008-5#1)
trials are in progress in##2##5##(2005-11#1)(2005-7#1)
trials are in progress##3##4##(1996-3#1)(2005-11#1)(2005-7#1)
trials are lacking##2##3##(2008-5#1)(2009-7#1)
trials are mandatory##2##3##(2007-11#1)(2009-2#1)
trials are necessary to##4##4##(2006-10#1)(2007-11#1)(2008-5#1)(2010-12#1)
trials are necessary##5##3##(2006-10#1)(2007-11#1)(2008-5#1)(2010-12#2)
trials are needed to define##2##5##(2011-2#1)(2012-2#1)
trials are needed to##8##4##(2004-11#1)(2007-10#1)(2008-7#1)(2011-2#2)(2012-2#2)(2013-1#1)
trials are needed##12##3##(2004-11#1)(2007-10#1)(2007-8#2)(2008-7#1)(2009-7#1)(2011-12#1)(2011-2#2)(2012-2#2)(2013-1#1)
trials are not##4##3##(1997-4#1)(2006-11#1)(2008-3#1)(2008-5#1)
trials are now##4##3##(2006-10#1)(2007-11#1)(2012-2#1)(2013-8#1)
trials are required to identify##2##5##(2004-2#1)(2007-11#1)
trials are required to##6##4##(1997-8#1)(2004-2#1)(2007-11#1)(2007-8#1)(2010-6#1)(2013-1#1)
trials are required##7##3##(1997-8#1)(2004-2#1)(2007-11#1)(2007-8#1)(2010-6#1)(2013-1#1)(2013-8#1)
trials are underway to##2##4##(2004-1#1)(2005-7#1)
trials are underway##6##3##(2004-1#1)(2005-6#1)(2005-7#1)(2007-11#1)(2008-5#1)(2012-2#1)
trials are warranted to##3##4##(1992-12#1)(2006-10#1)(2008-5#1)
trials are warranted##4##3##(1992-12#1)(2006-10#1)(2008-5#1)(2011-2#1)
trials are##125##2##(1992-12#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1994-9#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-1#3)(2004-11#1)(2004-12#1)(2004-2#1)(2005-10#1)(2005-11#3)(2005-6#1)(2005-7#6)(2005-8#2)(2006-10#8)(2006-11#3)(2006-5#1)(2007-1#1)(2007-10#2)(2007-11#11)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#1)(2008-12#2)(2008-3#2)(2008-5#10)(2008-7#2)(2008-8#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-7#2)(2010-11#1)(2010-12#7)(2010-6#1)(2010-8#1)(2011-12#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#4)(2013-8#2)
trials as a##8##3##(1993-2#1)(2005-11#1)(2005-8#3)(2008-5#3)
trials as an antithrombotic##2##4##(1994-3#1)(2005-9#1)
trials as an##4##3##(1994-3#1)(1996-4#1)(2005-9#1)(2008-5#1)
trials as well as the##3##5##(1993-2#1)(1997-3#1)(2008-7#1)
trials as well as##4##4##(1993-2#1)(1997-3#1)(2008-1#1)(2008-7#1)
trials as##26##2##(1993-2#2)(1994-3#1)(1994-8#1)(1996-4#1)(1997-3#1)(2005-11#1)(2005-7#1)(2005-8#3)(2005-9#1)(2006-11#1)(2008-1#1)(2008-5#5)(2008-7#1)(2008-8#1)(2009-6#1)(2010-1#1)(2010-12#1)(2013-1#2)
trials at the##2##3##(2009-6#1)(2009-9#1)
trials at##12##2##(1995-9#2)(1996-11#1)(2007-7#1)(2008-10#2)(2008-11#2)(2009-6#1)(2009-9#1)(2012-2#1)(2013-8#1)
trials because of##2##3##(2007-9#1)(2008-10#1)
trials because##4##2##(2006-6#1)(2007-11#1)(2007-9#1)(2008-10#1)
trials before##2##2##(2007-11#1)(2011-2#1)
trials began in##2##3##(2005-8#1)(2005-9#1)
trials between##2##2##(1997-3#1)(2006-10#1)
trials but##2##2##(1992-10#1)(1996-8#1)
trials by##9##2##(1994-2#1)(1996-9#1)(2005-8#2)(2006-6#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-5#1)
trials can be##2##3##(2006-6#1)(2013-8#1)
trials can##3##2##(2006-11#1)(2006-6#1)(2013-8#1)
trials clearly##2##2##(1996-9#1)(2009-8#1)
trials compared with##2##3##(2008-10#2)
trials compared##4##2##(2008-10#3)(2008-7#1)
trials comparing the##3##3##(2007-11#1)(2009-12#1)(2012-3#1)
trials comparing##14##2##(1991-12#1)(1995-9#2)(1996-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-6#2)(2009-12#2)(2009-3#1)(2010-5#1)(2012-3#1)
trials conducted in##6##3##(1996-7#1)(2007-4#1)(2008-10#3)(2008-8#1)
trials conducted to##3##3##(2005-7#1)(2006-11#1)(2008-10#1)
trials conducted##14##2##(1996-7#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-4#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-8#1)(2010-5#1)
trials confirm the##3##3##(1991-12#1)(1994-2#1)(2009-5#1)
trials confirm##4##2##(1991-12#1)(1994-2#1)(2006-10#1)(2009-5#1)
trials continue to##2##3##(2006-10#2)
trials could not##2##3##(1990-4#1)(2008-10#1)
trials could##3##2##(1990-4#1)(2008-10#1)(2010-1#1)
trials dealing with##4##3##(2007-5#1)(2007-7#1)(2008-10#1)(2008-5#1)
trials demonstrate that the##2##4##(1990-4#1)(1996-8#1)
trials demonstrate that##4##3##(1990-4#1)(1996-8#1)(2008-3#1)(2008-5#1)
trials demonstrated that##5##3##(2006-10#1)(2007-11#3)(2008-3#1)
trials designed to##4##3##(1994-9#1)(1996-12#1)(1997-4#1)(2008-11#1)
trials did not##2##3##(2006-10#1)(2008-5#1)
trials during##3##2##(2010-8#1)(2013-1#2)
trials evaluating the##3##3##(2006-9#1)(2008-2#1)(2008-5#1)
trials evaluating##12##2##(1996-2#1)(2006-6#1)(2006-9#1)(2007-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-2#1)(2013-7#1)
trials focused on##3##3##(2008-5#1)(2010-6#1)(2011-2#1)
trials for CF##2##3##(2008-5#2)
trials for Crohn's disease##2##4##(2005-8#2)
trials for asthma##2##3##(2005-8#2)
trials for breast cancer##2##4##(2004-2#1)(2005-7#1)
trials for chronic obstructive pulmonary disease (COPD)##2##7##(2005-8#2)
trials for detecting##2##3##(1997-2#2)
trials for malignant glioma##2##4##(2006-12#1)(2006-7#1)
trials for malignant##3##3##(2005-8#1)(2006-12#1)(2006-7#1)
trials for the management of##2##5##(2005-8#1)(2008-7#1)
trials for the treatment of##12##5##(1993-11#1)(2005-6#1)(2005-8#4)(2005-9#3)(2007-11#1)(2008-5#1)(2010-7#1)
trials for the##17##3##(1993-11#1)(2005-6#1)(2005-8#7)(2005-9#3)(2007-11#1)(2008-5#2)(2008-7#1)(2010-7#1)
trials for this indication##2##4##(2005-6#1)(2008-5#1)
trials for##88##2##(1993-11#1)(1993-2#1)(1994-8#1)(1995-5#1)(1997-2#2)(1997-7#1)(2004-2#1)(2005-6#3)(2005-7#8)(2005-8#19)(2005-9#5)(2006-10#2)(2006-12#5)(2006-7#2)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-11#1)(2008-3#2)(2008-5#10)(2008-7#2)(2008-8#1)(2009-2#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-7#1)(2012-11#3)(2012-12#1)(2012-3#1)(2013-8#2)
trials had several##2##3##(2008-10#1)(2008-8#1)
trials had to##2##3##(2008-10#1)(2013-8#1)
trials had##5##2##(2008-10#3)(2008-8#1)(2013-8#1)
trials has been##3##3##(1996-6#1)(2005-7#1)(2009-11#1)
trials has##6##2##(1993-12#1)(1996-6#1)(2005-7#1)(2007-10#1)(2007-11#1)(2009-11#1)
trials have been conducted in##2##5##(2007-11#1)(2013-1#1)
trials have been conducted##7##4##(1992-10#1)(2005-7#1)(2007-11#2)(2008-1#1)(2008-11#1)(2013-1#1)
trials have been initiated in##2##5##(2005-7#1)(2007-11#1)
trials have been initiated##3##4##(2005-7#1)(2007-11#2)
trials have been performed##4##4##(1993-11#1)(2006-10#1)(2008-10#1)(2013-1#1)
trials have been published so far##2##6##(2006-8#1)(2008-8#1)
trials have been reported##2##4##(2007-11#1)(2010-12#1)
trials have been successfully##2##4##(1997-4#1)(2005-8#1)
trials have been##27##3##(1992-10#1)(1993-11#1)(1993-9#1)(1997-4#1)(2004-1#2)(2005-7#2)(2005-8#2)(2006-10#1)(2006-8#1)(2007-11#7)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-12#1)(2012-1#1)(2013-1#2)
trials have commenced in##2##4##(2005-8#1)(2005-9#1)
trials have commenced##3##3##(2005-8#1)(2005-9#1)(2008-5#1)
trials have consistently##2##3##(2008-3#1)(2008-5#1)
trials have demonstrated a##2##4##(2007-11#1)(2010-12#1)
trials have demonstrated that##12##4##(1991-7#1)(2005-10#1)(2007-11#1)(2007-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2012-1#1)(2013-1#2)(2013-8#1)
trials have demonstrated the benefits of##2##6##(1991-6#1)(2005-7#1)
trials have demonstrated the efficacy of##2##6##(2007-11#1)(2008-8#1)
trials have demonstrated the##6##4##(1991-6#1)(2005-7#1)(2007-11#2)(2008-8#1)(2012-12#1)
trials have demonstrated##26##3##(1991-6#1)(1991-7#1)(1996-8#1)(2005-10#1)(2005-7#1)(2007-1#1)(2007-11#5)(2007-3#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#3)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
trials have established the efficacy of##2##6##(2008-3#1)(2011-1#1)
trials have failed to##4##4##(2007-8#1)(2007-9#1)(2008-5#1)(2011-2#1)
trials have focused on##3##4##(1997-1#1)(2004-1#1)(2010-2#1)
trials have focused##4##3##(1997-1#1)(2004-1#1)(2007-9#1)(2010-2#1)
trials have indicated that##4##4##(1992-4#1)(1993-11#1)(2005-10#1)(2013-8#1)
trials have not demonstrated##2##4##(2007-11#1)(2008-10#1)
trials have not##6##3##(1993-9#1)(1996-9#1)(2007-11#1)(2008-10#1)(2008-5#1)(2013-1#1)
trials have now##3##3##(1996-9#1)(2006-10#1)(2006-9#1)
trials have provided##3##3##(2009-6#1)(2009-8#1)(2011-2#1)
trials have recently demonstrated##3##4##(2008-5#1)(2009-3#1)(2012-2#1)
trials have recently##4##3##(2008-5#1)(2009-3#1)(2010-12#1)(2012-2#1)
trials have reported##3##3##(2007-11#2)(2008-7#1)
trials have shown that##8##4##(2004-2#1)(2008-5#3)(2009-6#1)(2010-4#2)(2012-3#1)
trials have shown##12##3##(2004-2#1)(2007-11#2)(2007-9#1)(2008-3#1)(2008-5#3)(2009-6#1)(2010-4#2)(2012-3#1)
trials have suggested that##3##4##(1996-3#1)(2004-1#1)(2012-12#1)
trials have##134##2##(1991-6#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-4#1)(1993-11#2)(1993-2#1)(1993-9#2)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-4#1)(2004-1#6)(2004-2#1)(2005-10#2)(2005-11#1)(2005-7#4)(2005-8#3)(2005-9#1)(2006-10#3)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#17)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#6)(2008-5#11)(2008-6#1)(2008-7#2)(2008-8#4)(2009-3#1)(2009-6#2)(2009-8#4)(2010-12#4)(2010-2#1)(2010-4#2)(2010-5#2)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
trials in Alzheimer's##2##3##(2007-9#1)(2012-3#1)
trials in Australia##2##3##(1993-12#1)(2008-10#1)
trials in December 1997##2##4##(2008-5#2)
trials in Europe##2##3##(2005-7#1)(2008-5#1)
trials in MDD##2##3##(2009-9#1)(2012-3#1)
trials in a##4##3##(1996-12#1)(1996-8#1)(2005-11#1)(2008-3#1)
trials in advanced##2##3##(1996-12#1)(2008-3#1)
trials in both##4##3##(2005-11#1)(2008-11#1)(2008-5#1)(2010-6#1)
trials in children##2##3##(2008-5#1)(2011-1#1)
trials in healthy##2##3##(1991-6#1)(2005-7#1)
trials in humans##4##3##(2005-8#1)(2006-6#1)(2010-5#1)(2011-2#1)
trials in oncology##3##3##(2008-8#1)(2009-12#1)(2010-1#1)
trials in paediatric##2##3##(2008-11#1)(2012-3#1)
trials in patients undergoing##2##4##(2006-10#1)(2008-5#1)
trials in patients with##14##4##(2005-7#2)(2005-8#2)(2006-8#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-11#1)(2011-1#1)
trials in patients##18##3##(2005-10#1)(2005-7#2)(2005-8#2)(2006-10#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-3#3)(2008-5#2)(2008-7#1)(2010-11#1)(2011-1#1)
trials in primary##2##3##(1993-9#1)(2005-11#1)
trials in radiology##2##3##(2007-4#2)
trials in renal##2##3##(2007-11#2)
trials in the US for##3##5##(2008-5#3)
trials in the US##5##4##(2005-8#1)(2007-11#1)(2008-5#3)
trials in the management of anal##2##6##(2010-5#2)
trials in the management of##3##5##(1991-12#1)(2010-5#2)
trials in the##17##3##(1990-11#1)(1991-12#1)(1997-7#1)(2005-11#1)(2005-8#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-5#4)(2009-3#1)(2010-5#2)(2012-3#1)
trials in this area##2##4##(2010-12#1)(2012-12#1)
trials in this##3##3##(2008-5#1)(2010-12#1)(2012-12#1)
trials in which the##3##4##(2009-4#1)(2011-1#1)(2012-12#1)
trials in which##9##3##(1994-4#1)(1995-8#1)(2007-11#1)(2007-5#1)(2009-4#1)(2009-9#2)(2011-1#1)(2012-12#1)
trials in##164##2##(1990-11#1)(1990-12#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-6#1)(1993-12#3)(1993-3#1)(1993-9#1)(1994-2#4)(1994-4#1)(1994-8#1)(1995-8#1)(1996-12#2)(1996-8#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-11#5)(2005-7#8)(2005-8#8)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#9)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-10#9)(2008-11#8)(2008-12#1)(2008-3#7)(2008-5#18)(2008-7#7)(2008-8#4)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-5#3)(2010-6#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#4)(2012-3#6)(2013-1#1)(2013-8#2)
trials include##4##2##(2006-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
trials including##4##2##(2007-10#1)(2008-6#1)(2009-11#1)(2010-1#1)
trials indicate that##4##3##(2005-10#1)(2005-7#1)(2008-5#1)(2012-1#1)
trials indicate##8##2##(1996-12#1)(2005-10#1)(2005-7#1)(2006-10#1)(2008-5#1)(2009-3#2)(2012-1#1)
trials involve##3##2##(1997-4#1)(2008-5#1)(2010-7#1)
trials involving 145##2##3##(2007-10#1)(2013-8#1)
trials involving patients with##2##4##(2006-8#1)(2008-6#1)
trials involving##30##2##(1993-5#2)(1996-6#1)(2005-9#1)(2006-8#1)(2007-10#2)(2007-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2010-11#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#12)
trials is essential##2##3##(1993-12#1)(2008-3#1)
trials is still##2##3##(1992-10#1)(2010-6#1)
trials is the##2##3##(1997-4#1)(2007-11#1)
trials is##25##2##(1992-10#1)(1993-12#1)(1993-3#1)(1993-6#1)(1996-6#1)(1997-4#1)(1997-6#1)(2005-7#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2010-12#1)(2010-3#1)(2010-6#1)(2013-1#2)(2013-7#1)
trials may be##3##3##(2008-7#1)(2008-8#1)(2009-4#1)
trials may##5##2##(1996-8#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-4#1)
trials measuring##2##2##(2007-2#1)(2012-2#1)
trials must be##3##3##(1997-4#1)(2007-11#2)
trials must##5##2##(1995-9#1)(1997-4#1)(2006-10#1)(2007-11#2)
trials of a##6##3##(1995-5#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-5#1)
trials of adult##2##3##(2012-12#1)(2012-2#1)
trials of both##2##3##(2006-10#1)(2006-12#1)
trials of candidate##2##3##(2005-8#1)(2007-7#1)
trials of combination##2##3##(1995-5#1)(2010-10#1)
trials of complex interventions##4##4##(2012-3#4)
trials of endarterectomy##2##3##(2007-9#1)(2008-8#1)
trials of epoetin##2##3##(2007-11#1)(2008-7#1)
trials of human##2##3##(1991-3#1)(1996-9#1)
trials of hypothermia for##2##4##(2008-8#2)
trials of intravenous##2##3##(2007-10#1)(2008-8#1)
trials of medication##2##3##(1997-3#1)(2008-6#1)
trials of neuroprotective##2##3##(2007-10#1)(2008-2#1)
trials of new##2##3##(2008-4#1)(2011-2#1)
trials of novel##2##3##(2006-10#1)(2007-8#1)
trials of oral##2##3##(2007-11#1)(2012-3#1)
trials of patients with##2##4##(2007-11#1)(2008-7#1)
trials of patients##3##3##(2007-11#1)(2008-7#1)(2010-11#1)
trials of the##13##3##(1992-10#1)(1993-2#1)(1996-6#1)(1997-6#1)(1997-8#1)(2005-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)(2011-2#1)(2012-1#1)
trials of therapies##3##3##(1993-7#1)(2004-11#1)(2010-3#1)
trials of these##2##3##(2007-11#2)
trials of this##2##3##(2007-11#1)(2012-3#1)
trials of treatment##2##3##(1991-10#1)(2009-9#1)
trials of##192##2##(1990-11#1)(1991-10#1)(1991-12#1)(1991-3#2)(1991-6#1)(1991-9#1)(1992-10#2)(1992-4#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-7#1)(1993-8#1)(1994-2#1)(1994-5#2)(1994-9#1)(1995-5#3)(1995-9#1)(1996-3#1)(1996-6#1)(1996-9#2)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-1#1)(2004-11#1)(2005-10#2)(2005-12#1)(2005-7#8)(2005-8#5)(2005-9#2)(2006-10#15)(2006-11#1)(2006-12#1)(2006-5#2)(2006-8#2)(2006-9#1)(2007-10#3)(2007-11#15)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#6)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#8)(2008-8#9)(2008-9#1)(2009-10#1)(2009-11#3)(2009-12#1)(2009-4#1)(2009-7#1)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#3)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#11)(2013-1#5)(2013-7#1)(2013-8#2)
trials on a##4##3##(1994-8#1)(2005-9#1)(2008-12#1)(2012-1#1)
trials on the##4##3##(2007-4#1)(2008-7#1)(2011-12#1)(2012-3#1)
trials on this##2##3##(2010-3#1)(2011-2#1)
trials on##43##2##(1991-5#1)(1991-6#1)(1992-10#1)(1993-8#1)(1994-2#1)(1994-8#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-7#1)(2007-4#1)(2008-1#3)(2008-10#6)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
trials or##8##2##(1994-6#1)(1996-3#1)(1996-7#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-3#1)(2010-12#1)
trials over##5##2##(1997-7#1)(2006-5#1)(2008-10#2)(2012-11#1)
trials per day##2##3##(1993-12#1)(1994-3#1)
trials per##4##2##(1990-11#1)(1992-12#1)(1993-12#1)(1994-3#1)
trials performed with##2##3##(2008-2#1)(2010-4#1)
trials performed##3##2##(1991-3#1)(2008-2#1)(2010-4#1)
trials provide##2##2##(2006-5#1)(2008-6#1)
trials published##4##2##(1996-3#1)(1997-1#1)(2004-1#1)(2007-4#1)
trials regarding##2##2##(2011-2#1)(2013-1#1)
trials registered##2##2##(2008-3#1)(2012-2#1)
trials reported##3##2##(1997-1#1)(2007-11#1)(2008-7#1)
trials revealed that##3##3##(2008-10#1)(2011-1#1)(2012-1#1)
trials should be##4##3##(1996-6#1)(1996-9#1)(2010-4#1)(2010-8#1)
trials should##9##2##(1993-12#1)(1996-6#1)(1996-9#1)(2005-10#1)(2006-10#1)(2007-1#1)(2008-6#1)(2010-4#1)(2010-8#1)
trials show that##5##3##(1991-12#1)(1995-9#1)(2010-5#1)(2012-1#1)(2012-12#1)
trials show##8##2##(1990-1#1)(1991-12#1)(1995-9#1)(1997-1#1)(2006-10#1)(2010-5#1)(2012-1#1)(2012-12#1)
trials showed that##4##3##(2004-11#1)(2008-5#1)(2008-7#1)(2009-6#1)
trials showed##9##2##(2004-11#1)(2007-11#2)(2008-10#2)(2008-5#1)(2008-7#1)(2009-6#1)(2010-12#1)
trials such##2##2##(2008-3#1)(2010-5#1)
trials suggest that it##2##4##(2005-9#1)(2008-7#1)
trials suggest that##7##3##(2005-9#1)(2007-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-2#1)
trials suggest##8##2##(2005-9#1)(2007-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-5#1)(2011-2#1)
trials testing##6##2##(2006-12#1)(2008-11#1)(2010-12#1)(2010-6#1)(2012-12#2)
trials than##4##2##(1996-12#1)(1996-6#1)(2008-5#1)(2013-8#1)
trials that have demonstrated##2##4##(1996-9#1)(2007-8#1)
trials that have##6##3##(1993-12#1)(1996-9#1)(2006-11#1)(2007-8#1)(2008-6#1)(2009-11#1)
trials that used##2##3##(2007-8#1)(2009-9#1)
trials that were##2##3##(1992-10#1)(2010-2#1)
trials that##34##2##(1992-10#1)(1993-12#1)(1995-1#1)(1995-8#1)(1996-8#1)(1996-9#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#5)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-9#1)(2010-12#2)(2010-2#1)(2012-3#1)(2013-8#1)
trials the##6##2##(1991-3#1)(1992-9#2)(1993-7#1)(1997-3#1)(2008-8#1)
trials they##2##2##(2007-9#1)(2008-11#1)
trials to ascertain the##2##4##(2008-12#1)(2010-12#1)
trials to be##3##3##(2006-1#1)(2006-12#1)(2011-2#1)
trials to compare##2##3##(1993-5#1)(2007-10#1)
trials to criterion##4##3##(1993-2#1)(1993-3#1)(1993-7#1)(2011-2#1)
trials to date##4##3##(2005-7#1)(2006-11#1)(2007-11#1)(2012-2#1)
trials to determine the##2##4##(2010-8#1)(2012-1#1)
trials to determine##5##3##(2007-10#1)(2008-1#1)(2010-8#1)(2011-1#1)(2012-1#1)
trials to evaluate##3##3##(2006-6#1)(2007-7#1)(2011-2#1)
trials to identify##2##3##(2006-10#1)(2009-2#1)
trials to study##2##3##(1995-5#1)(2008-8#1)
trials to test##2##3##(1993-10#1)(2009-5#1)
trials to##48##2##(1992-12#1)(1993-10#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-7#1)(1995-12#1)(1995-5#1)(1995-9#3)(1996-8#1)(2005-6#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-8#2)(2009-2#1)(2009-5#1)(2010-12#1)(2010-8#2)(2011-1#3)(2011-2#4)(2012-1#1)(2012-2#3)(2013-1#1)
trials under##2##2##(1994-6#1)(2012-1#1)
trials used##4##2##(2007-10#2)(2007-11#1)(2008-10#1)
trials using a##3##3##(2006-10#1)(2013-1#2)
trials using##35##2##(1994-11#1)(1994-9#1)(1996-9#2)(1997-1#1)(1997-4#1)(2004-1#1)(2006-10#2)(2006-4#1)(2007-11#5)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-7#1)(2012-12#1)(2012-3#4)(2013-1#2)(2013-8#1)
trials was implemented##2##3##(2006-6#1)(2012-2#1)
trials was##15##2##(1992-12#1)(1993-2#1)(1993-3#1)(2005-7#1)(2005-8#2)(2006-6#1)(2006-8#1)(2008-10#3)(2008-12#1)(2008-5#1)(2012-2#1)(2013-8#1)
trials we##3##2##(2006-10#1)(2007-10#1)(2013-8#1)
trials were completed in##2##4##(2005-7#1)(2008-5#1)
trials were conducted with##2##4##(2007-6#1)(2008-10#1)
trials were conducted##6##3##(2007-2#1)(2007-6#1)(2008-10#3)(2011-2#1)
trials were performed##3##3##(2007-5#1)(2009-9#1)(2012-3#1)
trials were selected##2##3##(2008-10#1)(2008-6#1)
trials were used to##3##4##(2011-12#1)(2013-1#2)
trials were##35##2##(1990-4#1)(2005-6#2)(2005-7#2)(2005-8#1)(2007-10#1)(2007-2#1)(2007-5#2)(2007-6#2)(2008-10#4)(2008-5#2)(2008-6#1)(2008-7#1)(2009-9#3)(2010-12#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#6)
trials where##5##2##(1995-2#1)(1996-8#1)(1997-3#1)(2007-8#1)(2009-3#1)
trials which have##2##3##(2005-8#1)(2010-2#1)
trials which will##2##3##(2007-1#2)
trials which##12##2##(1994-5#1)(1996-12#2)(1996-6#2)(2005-8#1)(2007-1#2)(2007-11#1)(2010-2#1)(2012-12#1)(2012-3#1)
trials will be##3##3##(1995-12#1)(2006-10#1)(2007-1#1)
trials will need to##2##4##(1996-9#1)(2008-7#1)
trials will provide##2##3##(1991-12#1)(2007-1#1)
trials will##21##2##(1991-12#1)(1994-9#1)(1995-12#1)(1996-6#1)(1996-9#1)(2005-10#1)(2006-10#2)(2007-1#2)(2007-4#3)(2007-9#1)(2008-7#1)(2009-12#1)(2011-12#2)(2011-2#1)(2012-1#1)(2013-7#1)
trials with &quot##2##3##(2008-5#1)(2012-12#1)
trials with a##5##3##(2005-5#1)(2007-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
trials with an##6##3##(1992-2#1)(2007-6#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
trials with high##2##3##(2007-11#1)(2008-10#1)
trials with multiple treatments##3##4##(1993-5#3)
trials with multiple##5##3##(1992-2#1)(1993-5#3)(1995-2#1)
trials with new##2##3##(1990-10#1)(2007-11#1)
trials with no##3##3##(2008-3#1)(2013-1#2)
trials with other##2##3##(2005-7#1)(2007-11#1)
trials with survival data##2##4##(2012-2#2)
trials with survival##3##3##(2012-2#2)(2012-3#1)
trials with the##7##3##(1995-9#1)(2005-8#1)(2006-10#2)(2007-11#1)(2007-7#1)(2009-8#1)
trials with two##2##3##(1992-9#1)(2008-10#1)
trials with##102##2##(1990-10#1)(1991-2#1)(1992-10#1)(1992-2#2)(1992-9#1)(1993-5#3)(1994-3#1)(1995-2#1)(1995-9#1)(1997-3#1)(2005-5#1)(2005-7#3)(2005-8#4)(2006-10#4)(2006-9#1)(2007-1#3)(2007-10#3)(2007-11#13)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#6)(2008-6#1)(2008-7#2)(2009-11#1)(2009-8#1)(2010-11#1)(2010-12#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#7)(2012-3#7)(2013-1#6)(2013-8#1)
trials within##3##2##(1997-5#1)(2011-2#1)(2012-3#1)
trials without##3##2##(2006-8#1)(2008-10#1)(2009-6#1)
trials worldwide##2##2##(2007-3#1)(2008-8#1)
trials would be##2##3##(2007-5#1)(2008-5#1)
trials##2504##1##(1990-1#2)(1990-10#3)(1990-11#3)(1990-12#1)(1990-3#1)(1990-4#4)(1990-9#2)(1991-1#1)(1991-10#1)(1991-12#8)(1991-2#1)(1991-3#6)(1991-5#1)(1991-6#6)(1991-7#2)(1991-8#3)(1991-9#2)(1992-10#13)(1992-12#6)(1992-2#5)(1992-3#1)(1992-4#4)(1992-6#4)(1992-8#4)(1992-9#11)(1993-1#2)(1993-10#1)(1993-11#8)(1993-12#27)(1993-2#12)(1993-3#6)(1993-4#2)(1993-5#7)(1993-6#6)(1993-7#3)(1993-8#7)(1993-9#8)(1994-11#5)(1994-12#1)(1994-2#11)(1994-3#5)(1994-4#4)(1994-5#5)(1994-6#6)(1994-7#1)(1994-8#7)(1994-9#13)(1995-1#6)(1995-11#1)(1995-12#10)(1995-2#11)(1995-4#1)(1995-5#8)(1995-6#4)(1995-8#2)(1995-9#19)(1996-1#2)(1996-10#2)(1996-11#2)(1996-12#16)(1996-2#1)(1996-3#9)(1996-4#2)(1996-6#24)(1996-7#5)(1996-8#21)(1996-9#13)(1997-1#8)(1997-2#3)(1997-3#12)(1997-4#10)(1997-5#2)(1997-6#7)(1997-7#6)(1997-8#7)(2004-1#16)(2004-11#3)(2004-12#1)(2004-2#4)(2004-3#1)(2005-10#13)(2005-11#22)(2005-12#1)(2005-3#1)(2005-5#1)(2005-6#10)(2005-7#71)(2005-8#67)(2005-9#18)(2006-1#1)(2006-10#100)(2006-11#13)(2006-12#14)(2006-2#6)(2006-3#2)(2006-4#8)(2006-5#10)(2006-6#11)(2006-7#3)(2006-8#22)(2006-9#10)(2007-1#14)(2007-10#38)(2007-11#141)(2007-12#6)(2007-2#5)(2007-3#5)(2007-4#18)(2007-5#10)(2007-6#8)(2007-7#24)(2007-8#26)(2007-9#31)(2008-1#25)(2008-10#132)(2008-11#49)(2008-12#17)(2008-2#14)(2008-3#49)(2008-4#16)(2008-5#134)(2008-6#15)(2008-7#46)(2008-8#53)(2008-9#8)(2009-1#1)(2009-10#8)(2009-11#20)(2009-12#7)(2009-2#7)(2009-3#14)(2009-4#12)(2009-5#10)(2009-6#10)(2009-7#5)(2009-8#15)(2009-9#15)(2010-1#6)(2010-10#5)(2010-11#17)(2010-12#56)(2010-2#18)(2010-3#11)(2010-4#5)(2010-5#14)(2010-6#10)(2010-7#5)(2010-8#16)(2010-9#3)(2011-1#23)(2011-12#12)(2011-2#55)(2011-3#2)(2011-7#1)(2012-1#27)(2012-11#8)(2012-12#48)(2012-2#47)(2012-3#74)(2013-1#82)(2013-7#6)(2013-8#60)
trials) and##2##2##(2008-10#2)
trials)##21##1##(1991-1#2)(1992-10#1)(1994-2#1)(1996-9#1)(2005-9#1)(2006-12#1)(2008-10#4)(2008-2#3)(2008-5#1)(2009-11#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
trials?##4##1##(1993-12#1)(2009-6#1)(2010-12#1)(2012-3#1)
trials]##3##1##(1991-6#1)(1992-2#1)(2009-5#1)
triamcinolone acetonide and##3##3##(1996-6#2)(2007-11#1)
triamcinolone acetonide are##2##3##(1996-6#1)(2007-11#1)
triamcinolone acetonide##20##2##(1990-11#2)(1991-9#1)(1996-6#7)(1996-7#1)(2006-10#1)(2007-11#2)(2007-2#1)(2007-7#2)(2010-12#2)(2011-2#1)
triamcinolone for the treatment of##2##5##(2008-1#1)(2011-12#1)
triamcinolone for##3##2##(2008-1#1)(2011-12#1)(2011-2#1)
triamcinolone hexacetonide##3##2##(1992-5#1)(2007-11#2)
triamcinolone in##3##2##(1991-2#1)(2008-1#1)(2011-2#1)
triamcinolone##38##1##(1990-11#2)(1991-2#1)(1991-9#1)(1992-5#1)(1996-3#1)(1996-6#7)(1996-7#1)(1997-7#2)(2006-10#2)(2006-8#1)(2007-11#4)(2007-2#1)(2007-7#2)(2008-1#3)(2008-10#1)(2009-6#1)(2010-12#2)(2011-12#1)(2011-2#4)
triamine##3##1##(2008-4#1)(2008-5#1)(2010-2#1)
triamterene##7##1##(2006-9#1)(2008-10#6)
triangle and##5##2##(2007-7#1)(2008-6#3)(2011-2#1)
triangle formed by the##2##4##(2010-8#1)(2011-2#1)
triangle mesh##6##2##(2008-6#4)(2012-3#2)
triangle meshes##2##2##(2008-6#1)(2010-12#1)
triangle of##2##2##(2005-9#1)(2008-2#1)
triangle programmed coulometric flow titration##2##5##(2008-10#2)
triangle##56##1##(1992-12#1)(1996-2#1)(2005-9#3)(2007-11#6)(2007-7#2)(2007-9#2)(2008-10#3)(2008-2#2)(2008-3#2)(2008-6#20)(2009-3#1)(2010-12#3)(2010-5#1)(2010-8#2)(2011-2#5)(2012-3#2)
triangle)##2##1##(2008-6#1)(2010-8#1)
triangles##7##1##(2008-2#2)(2008-5#1)(2008-6#2)(2009-12#1)(2010-5#1)
triangula##2##1##(2008-5#1)(2010-2#1)
triangular design##2##2##(2008-10#2)
triangular fibrocartilage complex (TFCC)##2##4##(2006-3#1)(2008-9#1)
triangular fibrocartilage complex##3##3##(2006-3#1)(2006-4#1)(2008-9#1)
triangular lattice of air##2##4##(2007-11#1)(2007-12#1)
triangular lattice of##3##3##(1994-5#1)(2007-11#1)(2007-12#1)
triangular lattice##4##2##(1994-5#1)(2007-11#1)(2007-12#2)
triangular lattices##2##2##(2007-12#2)
triangular mesh##2##2##(2008-2#2)
triangular meshes##2##2##(2008-6#2)
triangular profilometry##3##2##(2008-3#3)
triangular shape##2##2##(2007-12#1)(2008-10#1)
triangular surfaces##2##2##(2008-3#2)
triangular waves##3##2##(2008-10#3)
triangular##66##1##(1994-5#1)(1994-9#2)(1996-12#1)(2005-1#1)(2006-3#2)(2006-4#3)(2006-5#1)(2007-11#2)(2007-12#8)(2008-1#1)(2008-10#8)(2008-2#6)(2008-3#16)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-2#1)(2010-5#2)(2010-6#2)(2010-8#1)(2012-12#2)
triangular-partition fuzzy##2##2##(2007-12#2)
triangular-shaped##3##1##(2008-3#2)(2010-12#1)
triangular-wave##2##1##(2007-8#1)(2008-3#1)
triangular/oval lymph nodes in##2##4##(2005-1#2)
triangulated irregular##2##2##(2008-6#2)
triangulated##6##1##(2008-6#3)(2010-10#1)(2010-8#1)(2013-1#1)
triangulation and##3##2##(2008-2#3)
triangulation configuration##2##2##(2008-3#2)
triangulation of##2##2##(2007-12#1)(2013-1#1)
triangulation##31##1##(2007-10#1)(2007-11#2)(2007-12#2)(2008-2#8)(2008-3#6)(2008-6#1)(2009-11#1)(2009-2#1)(2010-4#1)(2012-12#3)(2013-1#2)(2013-7#3)
triangulation-based##2##1##(2010-7#2)
triangulum##2##1##(2007-12#2)
triantennary complex-type##4##2##(1993-11#2)(1994-5#2)
triantennary##8##1##(1993-11#3)(1994-5#2)(1995-2#1)(1997-4#1)(2008-8#1)
triatomic##2##1##(2009-2#1)(2012-2#1)
triatominae bugs##2##2##(2006-10#2)
triatomine bugs##3##2##(2012-12#3)
triatomine species##2##2##(2004-11#1)(2012-12#1)
triatomine##7##1##(1994-3#1)(2004-11#1)(2012-12#5)
triatomines##2##1##(1994-3#1)(2008-8#1)
triatriatum##7##1##(1993-8#4)(2008-12#1)(2008-4#2)
triaxial antenna for microwave##2##4##(2007-12#2)
triaxial dielectric##3##2##(2008-2#3)
triaxial##7##1##(2007-12#3)(2007-6#1)(2008-2#3)
triazene##2##1##(1992-9#1)(1993-4#1)
triazine and##2##2##(1991-8#1)(2008-10#1)
triazine dendrimers##2##2##(2010-8#2)
triazine derivative##2##2##(2008-2#2)
triazine##16##1##(1991-8#1)(1997-2#2)(2005-11#1)(2007-5#1)(2008-10#5)(2008-2#2)(2010-8#4)
triazines##11##1##(1991-8#1)(2008-10#10)
triazolam and##2##2##(1996-12#1)(1996-6#1)
triazolam##10##1##(1990-11#1)(1991-12#1)(1993-2#3)(1993-8#1)(1996-12#2)(1996-6#1)(2007-11#1)
triazole derivatives##3##2##(2008-5#1)(2010-12#2)
triazole##16##1##(2005-9#1)(2006-11#3)(2007-11#2)(2008-10#2)(2008-3#1)(2008-5#3)(2010-11#1)(2010-12#2)(2012-12#1)
triazoles for##2##2##(2011-2#2)
triazoles##13##1##(1992-5#3)(2005-7#1)(2007-11#3)(2010-3#1)(2011-12#1)(2011-2#4)
tribal areas of##2##3##(2013-1#2)
tribal college students##3##3##(2013-1#3)
tribal college##4##2##(2013-1#4)
tribal groups##2##2##(1994-9#1)(2012-2#1)
tribal##22##1##(1994-9#1)(2006-12#2)(2008-8#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#15)
tribals of Mahakoshal region of central India##2##7##(2010-3#1)(2010-5#1)
tribasic complex of amine derivative of beta-cyclodextrindien-Cu2+ -benzoic##2##8##(2005-4#2)
tribasic complex of##3##3##(2005-4#3)
tribasic complex##4##2##(2005-4#4)
tribasic sequence##2##2##(1991-9#2)
tribasic##6##1##(1991-9#2)(2005-4#4)
tribe of##4##2##(1994-9#1)(1996-6#1)(1997-2#1)(2012-11#1)
tribe##12##1##(1994-6#1)(1994-9#1)(1996-6#2)(1997-2#1)(2007-12#1)(2008-5#1)(2009-12#1)(2012-11#1)(2013-1#1)(2013-7#2)
tribes have##2##2##(1991-12#2)
tribes in##2##2##(2013-7#2)
tribes##16##1##(1991-12#2)(1997-4#1)(2008-12#1)(2008-8#3)(2013-1#1)(2013-7#8)
triblock copolymer##2##2##(2005-11#2)
triblock copolymers were##2##3##(2005-11#1)(2010-12#1)
triblock copolymers##5##2##(2005-11#1)(2008-10#1)(2009-11#2)(2010-12#1)
triblock##7##1##(2005-11#3)(2008-10#1)(2009-11#2)(2010-12#1)
triblockcopolymers##2##1##(2006-5#2)
tribological behaviour##2##2##(2004-9#2)
tribological##5##1##(2004-9#3)(2009-4#1)(2010-4#1)
tribosphenic##2##1##(2006-7#2)
tribromoarsenazo-cetylpyridinium##2##1##(2008-10#2)
tribunal##2##1##(2010-12#2)
tributaries of the##3##3##(2004-4#1)(2010-8#2)
tributaries##7##1##(2004-4#1)(2009-9#1)(2010-8#5)
tributary veins##2##2##(2007-8#2)
tributary##6##1##(1991-6#1)(2007-8#2)(2009-3#1)(2010-8#1)(2013-1#1)
tribute to the##2##3##(2008-5#2)
tribute to##8##2##(2007-11#1)(2008-11#2)(2008-3#1)(2008-5#2)(2009-5#1)(2013-1#1)
tribute##10##1##(1993-9#1)(2007-11#1)(2008-11#2)(2008-3#1)(2008-5#2)(2009-5#1)(2012-11#1)(2013-1#1)
tributyl phosphate (TBP)##2##3##(2008-10#2)
tributyl phosphate##3##2##(2008-10#3)
tributyl##4##1##(2008-10#4)
tributyltin (TBT)##5##2##(2004-4#2)(2007-8#1)(2008-11#1)(2010-5#1)
tributyltin and##2##2##(1992-6#1)(2007-8#1)
tributyltin chloride in rats##2##4##(1995-2#1)(1996-12#1)
tributyltin chloride##5##2##(1995-2#2)(1996-12#2)(2008-10#1)
tributyltin hydride##3##2##(1994-5#1)(2008-4#1)(2009-12#1)
tributyltin##20##1##(1992-6#3)(1994-5#1)(1995-2#2)(1996-12#2)(2004-4#2)(2007-8#2)(2008-10#2)(2008-11#1)(2008-4#2)(2009-12#1)(2010-5#2)
tributyrin##6##1##(1990-6#3)(1992-3#1)(1995-8#1)(1996-5#1)
tricalcium phosphate (TCP)##2##3##(2004-9#1)(2008-5#1)
tricalcium phosphate##10##2##(2004-9#2)(2008-5#7)(2012-3#1)
tricarboxylic acid (TCA)##3##3##(1993-6#1)(2008-10#1)(2012-1#1)
tricarboxylic acid cycle##7##3##(1990-2#1)(2008-7#4)(2008-8#1)(2009-10#1)
tricarboxylic acid##10##2##(1990-2#1)(1993-6#1)(2008-10#1)(2008-7#4)(2008-8#1)(2009-10#1)(2012-1#1)
triceps brachii and##3##3##(2010-4#1)(2012-1#1)(2012-3#1)
triceps brachii##5##2##(2008-5#1)(2010-4#1)(2012-1#1)(2012-3#2)
triceps skin fold thickness##2##4##(2006-12#1)(2012-2#1)
triceps##18##1##(1990-7#1)(1991-5#1)(2006-12#1)(2006-3#1)(2007-11#3)(2007-9#2)(2008-5#1)(2008-9#1)(2009-3#1)(2010-3#1)(2010-4#1)(2012-1#1)(2012-2#1)(2012-3#2)
trichiasis##2##1##(2007-5#1)(2010-10#1)
trichinellosis##2##1##(1996-12#1)(2010-12#1)
trichinosis##4##1##(1995-9#1)(2008-10#3)
trichiura##8##1##(2006-2#1)(2007-7#3)(2011-1#2)(2012-2#1)(2012-3#1)
trichloracetic acid##2##2##(1991-6#1)(2006-12#1)
trichlorfon and##4##2##(1993-2#1)(2008-10#3)
trichlorfon##13##1##(1991-8#1)(1993-2#2)(2008-10#8)(2008-6#1)(2013-1#1)
trichloride and##2##2##(2008-10#1)(2008-3#1)
trichloride to##2##2##(1990-2#1)(1997-2#1)
trichloride##7##1##(1990-2#1)(1997-2#1)(2008-10#4)(2008-3#1)
trichloroacetaldehyde hydrate (TCAH)##2##3##(2008-10#2)
trichloroacetate##3##1##(1995-3#1)(2008-10#1)(2008-4#1)
trichloroacetic acid (TCA) and##2##4##(2008-10#2)
trichloroacetic acid (TCA)##8##3##(1995-3#1)(1995-6#1)(1996-11#1)(2007-8#1)(2008-10#3)(2009-5#1)
trichloroacetic acid in##2##3##(1990-6#1)(2007-8#1)
trichloroacetic acid##26##2##(1990-11#1)(1990-6#1)(1990-8#1)(1991-2#1)(1995-12#1)(1995-3#3)(1995-6#1)(1996-11#1)(1997-1#1)(2007-8#3)(2008-10#7)(2008-5#1)(2009-5#1)(2010-4#3)
trichloroacetic##28##1##(1990-11#1)(1990-6#1)(1990-8#1)(1991-2#1)(1995-12#1)(1995-3#3)(1995-6#1)(1996-11#2)(1997-1#1)(2007-8#3)(2008-10#8)(2008-5#1)(2009-5#1)(2010-4#3)
trichloroethanol##3##1##(1990-6#1)(2012-2#2)
trichloroethene##3##1##(2006-3#1)(2008-10#2)
trichloroethylene (TCE)##9##2##(1996-11#1)(2004-4#1)(2006-12#1)(2007-4#1)(2008-10#3)(2010-4#1)(2012-12#1)
trichloroethylene##27##1##(1992-5#2)(1996-11#1)(1997-4#1)(2004-4#1)(2006-12#2)(2007-4#2)(2008-10#13)(2008-7#2)(2010-2#1)(2010-4#1)(2012-12#1)
trichloroisocyanuric acid##2##2##(2008-10#2)
trichloromethane and isoamyl alcohol##2##4##(2005-4#2)
trichloromethane and##3##2##(2005-4#2)(2008-10#1)
trichloromethane##6##1##(2005-4#2)(2007-11#1)(2008-10#3)
trichobezoars##3##1##(2006-2#1)(2012-1#2)
trichoblast-targeted expression##2##2##(2006-12#2)
trichoblasts##2##1##(2006-12#2)
trichobézoard##3##1##(2012-2#3)
trichocarpa F(1) progeny##2##3##(2008-10#2)
trichocarpa and##2##2##(2008-10#2)
trichocarpa x P##3##3##(2008-10#3)
trichocarpa##12##1##(2008-10#12)
trichodea##4##1##(2007-12#2)(2013-8#2)
trichodiene synthase with##2##3##(1995-2#2)
trichodiene synthase##8##2##(1995-2#7)(2008-10#1)
trichodiene##9##1##(1995-2#8)(2008-10#1)
trichofolliculoma##3##1##(2008-9#3)
trichogen and tormogen cells##2##4##(2007-12#2)
trichoid##4##1##(2007-12#3)(2013-8#1)
trichome##3##1##(1991-4#1)(2006-12#1)(2008-9#1)
trichomes of ca##4##3##(2007-3#4)
trichomes of##9##2##(1991-4#1)(1997-6#2)(2007-3#5)(2008-5#1)
trichomes on##2##2##(2007-1#1)(2007-3#1)
trichomes##28##1##(1991-4#1)(1997-6#2)(2006-12#4)(2007-1#2)(2007-3#6)(2008-10#1)(2008-5#11)(2008-8#1)
trichomonas##2##1##(2006-4#1)(2007-6#1)
trichomoniasis and##2##2##(1992-2#1)(2011-1#1)
trichomoniasis in##2##2##(2008-10#1)(2008-5#1)
trichomoniasis##11##1##(1992-2#1)(2007-10#1)(2007-6#1)(2007-7#3)(2008-10#1)(2008-5#2)(2011-1#1)(2011-2#1)
trichophagia##2##1##(2012-1#2)
trichosanthin##5##1##(1994-2#2)(2008-10#2)(2008-8#1)
trichosporium OB3b##4##2##(1995-2#1)(1997-4#1)(2008-6#2)
trichothecene toxin##2##2##(2008-10#2)
trichothecene type##3##2##(2008-10#3)
trichothecene##12##1##(2008-10#9)(2008-11#3)
trichothecenes##7##1##(2008-10#5)(2008-8#1)(2010-7#1)
trichothiodystrophy##2##1##(2005-11#1)(2008-8#1)
trichotillomania##6##1##(2007-12#2)(2007-7#1)(2011-2#1)(2012-11#2)
trichotoxin##2##1##(1991-1#2)
trichovirus##2##1##(2008-10#2)
trichroic prism assembly##2##3##(2008-3#2)
trichrome stain##2##2##(2008-11#1)(2010-12#1)
trichrome##6##1##(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-3#1)
tricine##2##1##(1992-1#1)(1992-11#1)
trick##4##1##(2006-7#1)(2007-11#1)(2007-9#1)(2009-9#1)
tricks and##2##2##(1995-12#1)(2008-11#1)
tricks in##2##2##(2006-7#1)(2008-1#1)
tricks##8##1##(1990-5#1)(1990-7#1)(1995-12#1)(1996-3#1)(2006-7#1)(2008-1#1)(2008-11#1)(2011-2#1)
tricky##3##1##(1992-12#1)(1992-5#1)(2008-4#1)
triclinic##16##1##(1996-2#10)(1997-7#2)(2007-11#4)
triclosan##8##1##(2008-5#6)(2009-2#1)(2012-2#1)
triclosan-containing##2##1##(2008-5#1)(2011-2#1)
tricolor##3##1##(2007-3#2)(2008-3#1)
tricornutum##2##1##(2008-7#1)(2012-2#1)
tricortical##4##1##(2008-7#1)(2009-10#2)(2009-9#1)
tricosanoic acid##2##2##(1990-11#1)(2007-12#1)
tricuspid annular plane systolic excursion##2##5##(2010-10#1)(2011-2#1)
tricuspid annulus##3##2##(2006-9#1)(2007-8#1)(2008-11#1)
tricuspid regurgitation##3##2##(1994-3#1)(2007-9#1)(2008-7#1)
tricuspid stenosis##2##2##(2007-9#1)(2008-4#1)
tricuspid valve annulus##2##3##(2007-8#1)(2012-1#1)
tricuspid valve insufficiency##2##3##(2007-8#1)(2012-2#1)
tricuspid valve##18##2##(1992-10#1)(1997-1#1)(1997-2#1)(2007-12#3)(2007-7#1)(2007-8#3)(2009-5#2)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#2)
tricuspid##34##1##(1991-3#1)(1992-10#1)(1994-3#1)(1997-1#1)(1997-2#1)(2006-9#1)(2007-12#3)(2007-7#1)(2007-8#5)(2007-9#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-5#2)(2010-10#1)(2011-1#5)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)
tricuspis##5##1##(2011-12#5)
tricyclic antidepressant drugs##3##3##(1990-8#1)(2006-10#1)(2008-10#1)
tricyclic antidepressant##10##2##(1990-8#1)(1995-7#3)(1996-12#1)(1997-3#1)(2006-10#1)(2007-4#1)(2008-10#1)(2010-1#1)
tricyclic antidepressants (TCAs)##2##3##(1996-7#1)(2007-11#1)
tricyclic antidepressants has##2##3##(1996-1#1)(2012-2#1)
tricyclic antidepressants##21##2##(1991-11#2)(1991-8#1)(1996-1#1)(1996-7#1)(1997-8#4)(2005-8#1)(2006-10#2)(2007-11#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-9#1)(2010-12#1)(2012-2#2)
tricyclic compound##2##2##(1996-5#1)(1997-2#1)
tricyclic ring##2##2##(1995-7#1)(2008-3#1)
tricyclic##57##1##(1990-11#1)(1990-8#1)(1991-11#3)(1991-8#1)(1995-3#2)(1995-7#4)(1996-1#1)(1996-12#1)(1996-5#3)(1996-7#1)(1997-2#3)(1997-3#1)(1997-8#4)(2005-8#1)(2006-10#3)(2006-12#3)(2007-1#2)(2007-11#5)(2007-4#1)(2007-6#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2012-2#2)
tricyclics##4##1##(2008-11#2)(2011-12#1)(2012-2#1)
tricyclohexylphosphine##2##1##(1996-2#1)(2010-5#1)
tridecapeptide##3##1##(1990-7#2)(1992-8#1)
tridentate ligand##2##2##(1994-9#1)(2008-3#1)
tridentate ligands##2##2##(1997-7#1)(2008-5#1)
tridentate##16##1##(1994-9#2)(1997-7#4)(2008-3#1)(2008-5#7)(2010-3#1)(2010-5#1)
tridimensional##4##1##(1990-4#1)(2009-1#1)(2010-6#1)(2012-1#1)
tridiphane##4##1##(1990-3#4)
tried a##2##2##(2005-11#1)(2007-8#1)
tried and##2##2##(1996-2#1)(2006-2#1)
tried as##5##2##(2007-11#1)(2007-7#1)(2007-8#1)(2008-5#2)
tried for##4##2##(1990-5#1)(1995-12#1)(2007-7#1)(2008-10#1)
tried in the##2##3##(2005-11#1)(2008-7#1)
tried in##8##2##(1993-3#1)(2005-11#1)(2006-2#1)(2007-3#2)(2008-1#1)(2008-7#1)(2010-7#1)
tried on##2##2##(1994-2#1)(2008-10#1)
tried out##2##2##(1992-4#1)(2004-4#1)
tried smoking##3##2##(1991-8#1)(1991-9#1)(2013-1#1)
tried to achieve##2##3##(1990-12#1)(2010-2#1)
tried to design##2##3##(2006-5#1)(2010-8#1)
tried to develop##2##3##(1990-9#1)(2008-10#1)
tried to elucidate##2##3##(1997-5#1)(2009-5#1)
tried to establish##2##3##(1997-4#1)(2008-11#1)
tried to evaluate##2##3##(1990-9#1)(2007-8#1)
tried to find out##2##4##(2007-10#1)(2011-1#1)
tried to find##4##3##(1993-5#1)(2006-6#1)(2007-10#1)(2011-1#1)
tried to identify##3##3##(1994-2#1)(2006-8#1)(2011-1#1)
tried to make##2##3##(2007-8#1)(2010-8#1)
tried to turn##3##3##(1994-3#2)(2009-7#1)
tried to##74##2##(1990-10#1)(1990-12#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-4#1)(1991-5#1)(1993-5#1)(1994-2#1)(1994-3#2)(1995-12#2)(1995-3#1)(1995-4#1)(1996-12#1)(1996-5#2)(1996-6#1)(1997-4#1)(1997-5#2)(1997-6#1)(2005-1#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-3#1)(2008-8#3)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
tried with##2##2##(2008-10#1)(2010-7#1)
tried##127##1##(1990-10#1)(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-4#1)(1991-5#1)(1991-8#3)(1991-9#2)(1992-4#1)(1992-8#2)(1993-10#1)(1993-3#2)(1993-5#1)(1994-2#2)(1994-3#2)(1995-12#3)(1995-3#1)(1995-4#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#3)(1996-6#1)(1997-4#1)(1997-5#2)(1997-6#1)(2004-4#1)(2005-1#1)(2005-11#2)(2005-7#1)(2006-10#1)(2006-2#2)(2006-5#2)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-3#2)(2007-6#1)(2007-7#3)(2007-8#9)(2007-9#1)(2008-1#3)(2008-10#8)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2009-2#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#3)(2010-8#2)(2011-1#3)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
trienzymatic##2##1##(2008-10#2)
trienzyme##4##1##(2008-10#3)(2009-8#1)
triepoxides##2##1##(1996-5#2)
tries to clarify the##2##4##(2006-10#1)(2008-8#1)
tries to establish##2##3##(1997-6#1)(2007-11#1)
tries to evaluate the##2##4##(2010-5#1)(2013-1#1)
tries to find##2##3##(1991-4#1)(2007-10#1)
tries to##28##2##(1991-4#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-5#1)(1997-6#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-6#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-1#2)(2013-1#2)(2013-8#1)
tries##30##1##(1990-6#1)(1991-4#1)(1992-7#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-5#1)(1997-6#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-6#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-1#2)(2013-1#2)(2013-8#1)
triethanolamine (TEA) as##3##3##(2008-10#3)
triethanolamine (TEA)##5##2##(2008-10#5)
triethanolamine##9##1##(1992-12#1)(2008-10#7)(2008-4#1)
triethoxy silane##3##2##(2005-11#3)
triethyl phosphate##3##2##(1990-2#1)(2008-11#2)
triethylamine (TEA) and##2##3##(2008-10#2)
triethylamine (TEA)##4##2##(1997-3#1)(2007-11#1)(2008-10#2)
triethylamine and##5##2##(1996-5#2)(2008-10#3)
triethylamine as##2##2##(1996-5#2)
triethylamine in##2##2##(1996-8#1)(2008-10#1)
triethylamine##41##1##(1990-8#3)(1996-5#5)(1996-8#1)(1997-3#5)(2007-11#2)(2007-8#1)(2008-10#14)(2008-12#1)(2008-7#3)(2010-11#1)(2010-5#1)(2010-6#1)(2013-7#1)(2013-8#2)
triethylamine)##2##1##(1996-8#1)(2012-11#1)
triethylammonium phosphate##3##2##(1991-3#1)(1996-6#2)
triethylammonium##4##1##(1991-3#1)(1996-6#2)(2008-10#1)
triethylene glycol dimethacrylate (TEGDMA)##3##4##(2004-9#1)(2013-1#1)(2013-8#1)
triethylene glycol dimethacrylate##5##3##(2004-9#1)(2008-8#1)(2013-1#1)(2013-7#1)(2013-8#1)
triethylene glycol##7##2##(2004-9#1)(2007-11#1)(2008-10#1)(2008-8#1)(2013-1#1)(2013-7#1)(2013-8#1)
triethylenetetramine##4##1##(2008-10#4)
trifida##3##1##(2007-11#3)
triflate to##3##2##(1995-11#1)(1996-5#1)(1997-7#1)
triflate##8##1##(1995-11#1)(1996-5#1)(1996-8#1)(1997-7#2)(2007-11#1)(2008-8#1)(2012-3#1)
triflates##5##1##(2007-11#1)(2010-5#3)(2010-6#1)
trifloxystrobin##4##1##(2008-10#3)(2011-2#1)
triflumuron##2##1##(2008-10#1)(2011-2#1)
trifluoperazine and##2##2##(2008-10#2)
trifluoperazine##8##1##(1990-10#1)(1990-3#1)(1990-7#1)(1991-8#1)(1994-12#1)(1996-2#1)(2008-10#2)
trifluoride##5##1##(1991-12#1)(1992-3#1)(2007-11#2)(2008-10#1)
trifluorinated##2##1##(2006-12#2)
trifluoroacetate##4##1##(1994-9#2)(1997-4#2)
trifluoroacetic acid (TFA) and##2##4##(2007-8#1)(2008-10#1)
trifluoroacetic acid (TFA)##6##3##(1990-11#1)(1991-3#2)(2007-8#1)(2008-10#2)
trifluoroacetic acid in##3##3##(1994-9#1)(1996-5#1)(2012-12#1)
trifluoroacetic acid were##2##3##(1990-12#1)(2006-3#1)
trifluoroacetic acid##20##2##(1990-11#1)(1990-12#1)(1991-3#2)(1994-9#1)(1995-3#1)(1996-5#1)(1997-3#1)(2006-12#1)(2006-3#2)(2007-11#1)(2007-8#1)(2008-10#3)(2010-6#1)(2012-12#3)
trifluoroacetic anhydride (TFAA)##2##3##(2010-4#1)(2013-7#1)
trifluoroacetic anhydride##3##2##(1991-12#1)(2010-4#1)(2013-7#1)
trifluoroacetic##25##1##(1990-11#1)(1990-12#1)(1990-8#1)(1991-12#1)(1991-3#2)(1994-9#1)(1995-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(2006-12#1)(2006-3#2)(2007-11#1)(2007-8#1)(2008-10#3)(2010-4#1)(2010-6#1)(2012-12#3)(2013-7#1)
trifluoroacetylated##5##1##(1991-2#1)(1991-7#1)(1995-3#3)
trifluoroethanol (TFE)##2##2##(1997-4#1)(2010-7#1)
trifluoroethanol and##2##2##(1991-5#1)(2009-8#1)
trifluoroethanol##15##1##(1991-5#1)(1993-2#1)(1993-6#3)(1994-11#1)(1994-8#1)(1995-2#2)(1996-5#2)(1997-4#1)(2009-8#2)(2010-7#1)
trifluoroethyl##2##1##(1992-5#1)(2009-8#1)
trifluoromethanesulfonate##2##1##(1996-10#1)(2008-5#1)
trifluoromethanesulfonato##2##1##(1990-3#2)
trifluoromethyl ketone inhibitor##2##3##(1993-11#2)
trifluoromethyl ketone##3##2##(1993-11#3)
trifluoromethyl ketones##3##2##(1994-9#2)(2008-5#1)
trifluoromethyl##9##1##(1993-11#3)(1994-9#3)(2007-12#1)(2008-10#1)(2008-5#1)
triflupromazine##3##1##(2008-10#3)
trifluralin##3##1##(1991-8#1)(2008-10#1)(2008-5#1)
triflusal##2##1##(2007-8#2)
trifocal##2##1##(2008-6#1)(2009-3#1)
trifoliata##4##1##(2008-10#1)(2008-5#1)(2010-3#2)
trifoliata)##2##1##(2008-10#2)
trifoliate orange (Poncirus##2##3##(2008-10#2)
trifoliate orange adjacent to P##2##5##(2008-10#2)
trifoliate orange##11##2##(2008-10#11)
trifolii from##2##2##(2008-10#2)
trifolii strain##2##2##(2011-2#2)
trifolii##16##1##(2008-10#6)(2009-3#2)(2010-3#2)(2011-2#6)
trifolii)##2##1##(2008-10#1)(2009-3#1)
trifunctional protein##8##2##(1993-12#2)(1994-6#1)(1995-1#3)(1996-2#2)
trifunctional silane##2##2##(2008-10#2)
trifunctional##19##1##(1991-8#4)(1992-10#1)(1993-12#5)(1994-6#1)(1995-1#3)(1996-2#3)(2008-10#2)
trigeminal (V)##3##2##(1995-5#1)(1996-5#1)(1997-6#1)
trigeminal and sphenopalatine##3##3##(2006-11#3)
trigeminal and##6##2##(1991-11#1)(1995-11#2)(2006-11#3)
trigeminal artery##6##2##(1991-6#2)(2007-9#1)(2008-12#1)(2008-7#2)
trigeminal cistern##2##2##(1993-1#2)
trigeminal complex##5##2##(1990-4#3)(1991-11#1)(2010-12#1)
trigeminal ganglia##4##2##(1996-8#1)(1997-5#3)
trigeminal ganglion (TG)##2##3##(2009-12#1)(2012-3#1)
trigeminal ganglion and##2##3##(1996-2#1)(2008-6#1)
trigeminal ganglion cells were##2##4##(1990-7#1)(1997-3#1)
trigeminal ganglion cells##4##3##(1990-4#1)(1990-7#1)(1997-3#1)(2012-2#1)
trigeminal ganglion neurons##6##3##(1990-3#1)(1990-7#1)(1996-12#3)(1996-3#1)
trigeminal ganglion##24##2##(1990-3#1)(1990-4#2)(1990-7#2)(1991-8#1)(1996-12#3)(1996-2#1)(1996-3#1)(1997-3#3)(2006-7#2)(2008-6#2)(2008-7#1)(2009-12#1)(2011-2#1)(2012-2#2)(2012-3#1)
trigeminal mesencephalic##3##2##(1990-4#1)(1992-3#1)(1995-11#1)
trigeminal motor nucleus##6##3##(1990-4#1)(1990-9#1)(1995-7#1)(1996-9#2)(1997-2#1)
trigeminal motor##7##2##(1990-4#2)(1990-9#1)(1995-7#1)(1996-9#2)(1997-2#1)
trigeminal nerve##28##2##(1990-12#1)(1991-8#2)(1992-8#1)(1993-12#1)(1995-11#2)(1996-5#3)(1997-8#1)(2006-11#2)(2006-12#1)(2007-12#2)(2007-3#1)(2011-1#4)(2011-2#6)(2013-7#1)
trigeminal neuralgia##19##2##(1990-12#1)(1996-4#1)(2006-12#1)(2006-8#1)(2008-5#1)(2008-7#2)(2010-12#2)(2011-12#1)(2011-2#8)(2013-1#1)
trigeminal neurinomas##4##2##(2006-12#4)
trigeminal neurons##2##2##(1990-3#1)(1991-8#1)
trigeminal neuropathy##2##2##(2006-11#1)(2006-3#1)
trigeminal nociceptive##2##2##(1997-2#1)(2010-12#1)
trigeminal nuclei##3##2##(1991-11#1)(1996-3#1)(1996-9#1)
trigeminal nucleus##17##2##(1990-4#4)(1991-11#1)(1994-2#1)(1994-6#1)(1995-11#1)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2008-9#1)(2012-2#1)
trigeminal sensory##7##2##(1990-4#2)(1992-6#1)(1993-1#1)(1995-7#1)(1997-3#1)(2007-1#1)
trigeminal subnucleus caudalis##3##3##(1991-8#2)(1994-2#1)
trigeminal##171##1##(1990-12#2)(1990-3#3)(1990-4#14)(1990-7#2)(1990-9#3)(1991-11#4)(1991-6#2)(1991-8#6)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#3)(1993-12#2)(1994-2#2)(1994-6#1)(1995-11#7)(1995-5#3)(1995-7#3)(1996-12#3)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#4)(1996-8#1)(1996-9#6)(1997-1#1)(1997-2#4)(1997-3#6)(1997-5#4)(1997-6#1)(1997-8#1)(2006-11#6)(2006-12#6)(2006-3#2)(2006-7#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#3)(2007-9#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#5)(2008-9#2)(2009-12#1)(2010-12#7)(2011-1#4)(2011-12#1)(2011-2#15)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)
trigeminally induced apnoea##3##3##(1996-5#3)
trigeminovascular##4##1##(1994-9#1)(2007-10#1)(2008-5#1)(2012-2#1)
trigger a variety of##2##4##(1991-1#1)(2008-4#1)
trigger a##12##2##(1991-1#1)(1991-4#1)(1995-2#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-9#1)(2011-1#1)
trigger an##6##2##(1992-1#1)(2006-10#1)(2006-7#1)(2010-1#1)(2010-4#1)(2011-2#1)
trigger and##3##2##(1994-8#1)(2007-11#1)(2009-6#1)
trigger apoptosis##6##2##(2008-4#2)(2009-4#1)(2012-1#1)(2013-1#1)(2013-8#1)
trigger cell##2##2##(2006-12#1)(2011-1#1)
trigger factor for##3##3##(2012-12#1)(2012-3#1)(2013-1#1)
trigger factor is a##2##4##(1996-4#2)
trigger factor##8##2##(1996-4#4)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
trigger factors##2##2##(2008-5#1)(2009-7#1)
trigger finger in##2##3##(2008-9#2)
trigger finger release##3##3##(2006-4#1)(2008-9#2)
trigger finger##5##2##(2006-4#1)(2008-9#4)
trigger for an##2##3##(1994-5#1)(2006-4#1)
trigger for##20##2##(1991-4#1)(1991-5#1)(1992-11#1)(1993-10#1)(1994-5#1)(1996-11#1)(1997-3#1)(2006-2#1)(2006-4#1)(2007-11#1)(2008-1#1)(2008-11#3)(2008-9#2)(2009-9#1)(2012-11#1)(2012-2#1)(2012-3#1)
trigger germination##2##2##(2008-10#1)(2011-2#1)
trigger its##2##2##(2010-7#1)(2012-12#1)
trigger mechanisms of##2##3##(2006-6#2)
trigger of##8##2##(1995-2#1)(1997-2#1)(2003-11#1)(2008-1#2)(2011-2#1)(2012-2#1)(2012-3#1)
trigger oocyte##2##2##(2007-12#1)(2013-1#1)
trigger or##4##2##(1992-8#1)(2005-11#1)(2006-10#1)(2011-1#1)
trigger other##2##2##(1991-3#1)(1995-8#1)
trigger point therapy##3##3##(2007-11#1)(2009-3#1)(2010-3#1)
trigger point##7##2##(2007-11#2)(2008-7#1)(2009-3#1)(2010-12#1)(2010-3#1)(2013-1#1)
trigger points##11##2##(2006-12#1)(2007-6#1)(2008-12#3)(2009-7#1)(2010-12#2)(2010-9#2)(2012-3#1)
trigger resistance##2##2##(1995-3#1)(2009-8#1)
trigger the activation of##2##4##(2013-1#1)(2013-8#1)
trigger the activation##3##3##(2008-8#1)(2013-1#1)(2013-8#1)
trigger the disease##2##3##(1991-2#1)(2006-10#1)
trigger the##18##2##(1991-10#1)(1991-2#1)(1992-7#1)(1993-3#1)(1994-10#1)(1997-4#1)(1997-6#1)(2005-9#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-3#1)(2012-2#2)(2013-1#1)(2013-8#1)
trigger this##2##2##(1994-9#1)(2010-2#1)
trigger was##4##2##(2012-11#1)(2013-1#3)
trigger##222##1##(1990-11#2)(1990-5#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-7#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-10#1)(1993-3#1)(1993-4#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#4)(1994-8#1)(1994-9#2)(1995-1#1)(1995-2#3)(1995-3#1)(1995-8#1)(1996-10#2)(1996-11#1)(1996-2#2)(1996-4#4)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(2003-11#1)(2005-11#2)(2005-9#2)(2006-10#7)(2006-12#4)(2006-2#2)(2006-3#2)(2006-4#2)(2006-6#3)(2006-7#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-6#2)(2007-9#2)(2008-1#4)(2008-10#9)(2008-11#7)(2008-12#4)(2008-2#2)(2008-4#5)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#11)(2009-3#4)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#4)(2010-1#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#2)(2010-7#1)(2010-8#2)(2010-9#4)(2011-1#6)(2011-2#7)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#6)(2012-3#8)(2013-1#11)(2013-7#1)(2013-8#3)
triggered a##10##2##(1990-7#1)(1995-2#1)(1995-6#1)(1996-3#2)(1996-5#1)(1996-8#1)(2008-4#1)(2010-12#1)(2011-1#1)
triggered an##2##2##(1997-2#1)(2008-10#1)
triggered and##2##2##(1994-5#1)(2006-10#1)
triggered by a##8##3##(1990-11#1)(1990-8#1)(1991-9#1)(1993-12#1)(1994-12#1)(2007-12#1)(2009-10#1)(2012-2#1)
triggered by activation of##2##4##(2009-8#1)(2012-1#1)
triggered by fire##4##3##(2009-10#4)
triggered by several##2##3##(1994-8#1)(1997-6#1)
triggered by stimulation of the##2##5##(1992-9#2)
triggered by the same##2##4##(1995-3#1)(1997-3#1)
triggered by the##17##3##(1990-6#1)(1990-7#1)(1991-3#1)(1991-5#1)(1993-11#1)(1994-10#1)(1994-9#1)(1995-12#2)(1995-3#1)(1997-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#2)(2010-7#1)
triggered by##120##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#3)(1990-8#2)(1991-10#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-9#1)(1992-1#2)(1992-2#1)(1992-8#1)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#1)(1994-10#1)(1994-12#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-7#1)(1996-11#2)(1996-12#1)(1996-2#1)(1997-3#1)(1997-6#2)(1997-8#1)(2004-12#5)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#2)(2007-11#2)(2007-12#2)(2007-6#2)(2007-8#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#7)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#2)(2012-2#5)(2012-3#3)(2013-1#2)(2013-8#1)
triggered during##3##2##(1994-11#1)(1996-5#1)(2008-7#1)
triggered in the##2##3##(1997-4#1)(2008-10#1)
triggered in##4##2##(1994-12#1)(1997-4#1)(2008-1#1)(2008-10#1)
triggered movement##2##2##(1996-1#2)
triggered release of##3##3##(2008-10#2)(2009-11#1)
triggered release##4##2##(1995-11#1)(2008-10#2)(2009-11#1)
triggered the##8##2##(1990-7#1)(1993-8#1)(2008-10#2)(2008-7#1)(2011-12#1)(2012-2#1)(2012-3#1)
triggered when##3##2##(2008-10#1)(2008-8#1)(2009-3#1)
triggered with##2##2##(1991-7#1)(2011-1#1)
triggered##217##1##(1990-11#2)(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#5)(1990-8#2)(1991-10#1)(1991-2#1)(1991-3#1)(1991-4#3)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-2#1)(1992-8#1)(1992-9#4)(1993-10#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-11#3)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#3)(1995-6#4)(1995-7#1)(1996-1#2)(1996-10#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-8#3)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#2)(1997-8#1)(2004-12#5)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-9#1)(2007-11#3)(2007-12#3)(2007-6#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#7)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#4)(2009-10#7)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#1)(2010-12#4)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-2#9)(2012-3#4)(2013-1#5)(2013-8#1)
triggerfish##2##1##(2007-5#2)
triggering a cascade of##2##4##(1996-6#1)(2005-11#1)
triggering a##6##2##(1992-6#2)(1993-9#1)(1996-6#1)(2005-11#1)(2011-1#1)
triggering agent##2##2##(1995-11#1)(2007-2#1)
triggering agents of##2##3##(1990-6#1)(2006-10#1)
triggering agents##3##2##(1990-6#1)(2006-10#1)(2011-2#1)
triggering by##2##2##(1991-7#1)(2005-11#1)
triggering event##4##2##(1990-7#1)(1992-3#1)(1996-1#1)(2008-10#1)
triggering events##3##2##(1995-3#1)(2006-10#1)(2011-2#1)
triggering factor##2##2##(1992-10#1)(2011-2#1)
triggering factors##2##2##(2007-6#1)(2013-1#1)
triggering in the##2##3##(2011-1#2)
triggering in##4##2##(1991-5#1)(2008-2#1)(2011-1#2)
triggering level##2##2##(2008-3#2)
triggering mechanism of##2##3##(2008-8#1)(2009-8#1)
triggering of the##3##3##(2008-10#1)(2008-8#2)
triggering of##24##2##(1990-8#1)(1992-9#1)(1993-11#1)(1997-6#1)(2005-7#1)(2006-10#2)(2008-10#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-8#6)(2009-10#1)(2009-8#1)(2010-6#1)(2013-1#2)
triggering rapid##2##2##(1990-7#1)(2010-8#1)
triggering system##2##2##(2007-9#2)
triggering the##9##2##(1992-3#1)(1995-6#1)(1996-2#1)(1997-7#1)(2007-12#1)(2008-10#1)(2010-11#1)(2011-2#1)(2012-2#1)
triggering##136##1##(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#1)(1991-5#1)(1991-6#2)(1991-7#2)(1992-10#1)(1992-11#1)(1992-3#2)(1992-6#2)(1992-9#1)(1993-11#1)(1993-9#4)(1994-11#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-11#2)(1995-3#2)(1995-4#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-4#1)(1997-6#2)(1997-7#1)(2005-11#3)(2005-7#1)(2006-10#6)(2006-6#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#3)(2008-1#3)(2008-10#4)(2008-12#2)(2008-2#3)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#8)(2008-9#4)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#4)(2010-11#2)(2010-12#1)(2010-2#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#5)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#1)(2012-7#1)(2013-1#4)
triggers a##18##2##(1993-11#1)(1993-2#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-12#1)(2012-3#2)
triggers acute##2##2##(2006-10#1)(2010-1#1)
triggers an##3##2##(1993-12#1)(1997-6#1)(2009-5#1)
triggers are##2##2##(1997-1#1)(2006-10#1)
triggers cell death##2##3##(2009-3#1)(2010-12#1)
triggers for##3##2##(2008-12#1)(2008-6#1)(2011-12#1)
triggers of##5##2##(1990-11#1)(1990-6#1)(2006-9#1)(2008-11#1)(2010-5#1)
triggers resistance##2##2##(2008-10#1)(2009-8#1)
triggers sprouting of##2##3##(1993-12#2)
triggers the release of##2##4##(2006-3#1)(2009-12#1)
triggers the release##3##3##(1990-4#1)(2006-3#1)(2009-12#1)
triggers the##15##2##(1990-4#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-11#1)(1997-7#1)(2005-9#1)(2006-3#1)(2008-8#1)(2009-12#1)(2011-1#1)(2013-1#1)(2013-7#1)
triggers were##3##2##(2006-7#1)(2012-12#2)
triggers##119##1##(1990-11#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#2)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-8#1)(1996-4#1)(1996-5#1)(1997-1#2)(1997-6#3)(1997-7#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-7#4)(2006-9#2)(2007-11#3)(2007-12#2)(2007-6#1)(2007-9#2)(2008-10#5)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#5)(2010-1#1)(2010-12#5)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#2)
triggers)##3##1##(2012-12#2)(2012-2#1)
triglyceride (TG) levels##4##3##(1995-6#1)(1996-2#1)(2010-8#2)
triglyceride (TG)##9##2##(1995-6#1)(1996-2#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-8#2)(2013-1#1)
triglyceride accumulation##4##2##(2006-2#1)(2008-1#2)(2008-11#1)
triglyceride and cholesterol levels were##3##5##(1993-3#1)(1994-11#1)(2006-2#1)
triglyceride and cholesterol levels##4##4##(1991-4#1)(1993-3#1)(1994-11#1)(2006-2#1)
triglyceride and cholesterol##5##3##(1990-8#1)(1991-4#1)(1993-3#1)(1994-11#1)(2006-2#1)
triglyceride and free cholesterol##2##4##(1996-4#2)
triglyceride and low##2##3##(1997-8#1)(2008-1#1)
triglyceride and##18##2##(1990-8#1)(1991-4#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-11#1)(1996-4#2)(1997-2#1)(1997-8#1)(2006-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-11#1)(2011-1#1)(2012-6#1)
triglyceride concentrations in##2##3##(1993-12#1)(2007-11#1)
triglyceride concentrations##4##2##(1993-12#1)(2007-11#1)(2008-12#1)(2008-3#1)
triglyceride content##2##2##(1997-2#1)(2008-11#1)
triglyceride content)##2##2##(2010-8#2)
triglyceride contents##4##2##(1993-12#2)(2007-11#1)(2010-8#1)
triglyceride in##3##2##(1991-12#1)(1996-9#1)(2011-1#1)
triglyceride level was##2##3##(2007-7#1)(2013-8#1)
triglyceride level##6##2##(2007-7#1)(2008-3#2)(2009-8#1)(2013-8#2)
triglyceride levels and##3##3##(1997-2#1)(2005-10#1)(2007-1#1)
triglyceride levels in##3##3##(1997-7#1)(2007-11#1)(2008-10#1)
triglyceride levels were significantly higher##2##5##(1992-11#1)(2011-11#1)
triglyceride levels were significantly##3##4##(1992-11#1)(2010-4#1)(2011-11#1)
triglyceride levels were##5##3##(1992-11#2)(2008-10#1)(2010-4#1)(2011-11#1)
triglyceride levels##34##2##(1992-11#3)(1993-9#1)(1995-12#1)(1995-6#1)(1997-2#2)(1997-7#3)(2004-11#1)(2005-10#1)(2007-1#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-11#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-11#1)(2012-2#1)(2013-1#4)
triglyceride may##2##2##(2008-1#1)(2012-6#1)
triglyceride removal from the circulation##2##5##(1997-2#2)
triglyceride secretion##2##2##(1997-2#2)
triglyceride serum levels##2##3##(1992-10#1)(2007-11#1)
triglyceride serum##3##2##(1991-11#1)(1992-10#1)(2007-11#1)
triglyceride to##2##2##(1993-11#1)(2008-3#1)
triglyceride turnover##2##2##(1997-2#2)
triglyceride was##3##2##(1991-12#1)(2004-11#1)(2008-12#1)
triglyceride##163##1##(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#5)(1991-2#1)(1991-4#2)(1991-9#1)(1992-10#1)(1992-11#4)(1992-3#3)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#3)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#2)(1995-12#1)(1995-2#1)(1995-6#4)(1996-11#1)(1996-2#1)(1996-4#2)(1996-9#2)(1997-1#1)(1997-2#13)(1997-4#2)(1997-7#3)(1997-8#1)(2004-11#8)(2005-10#2)(2005-7#1)(2006-2#2)(2007-1#4)(2007-11#6)(2007-2#3)(2007-7#1)(2007-8#2)(2008-1#7)(2008-10#7)(2008-11#4)(2008-12#3)(2008-3#11)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#2)(2009-2#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-8#5)(2011-1#4)(2011-11#3)(2011-2#1)(2012-2#1)(2012-6#3)(2013-1#5)(2013-8#2)
triglyceride-rich lipoproteins in##2##3##(1990-8#1)(1995-6#1)
triglyceride-rich lipoproteins##8##2##(1990-8#1)(1993-12#1)(1995-6#5)(2008-1#1)
triglyceride-rich##12##1##(1990-8#1)(1993-12#1)(1994-11#1)(1995-2#1)(1995-6#6)(2008-1#1)(2008-6#1)
triglyceride/HDL##3##1##(1997-8#2)(2008-3#1)
triglyceride/high-density##2##1##(2008-3#1)(2010-12#1)
triglyceride/total##2##1##(1991-12#2)
triglyceridemia##4##1##(1991-12#2)(2004-11#1)(2006-10#1)
triglycerides (P less than 0##2##5##(1991-10#1)(1992-6#1)
triglycerides (P##3##2##(1991-10#1)(1992-6#1)(1996-9#1)
triglycerides (TG) and##2##3##(2007-9#1)(2008-10#1)
triglycerides (TG) were##2##3##(2007-1#1)(2007-11#1)
triglycerides (TG)##5##2##(1997-2#1)(2007-1#1)(2007-11#1)(2007-9#1)(2008-10#1)
triglycerides (p =##2##3##(2008-3#2)
triglycerides (r =##2##3##(2008-3#1)(2010-4#1)
triglycerides after##2##2##(2008-5#2)
triglycerides and lower##2##3##(1991-10#1)(2008-3#1)
triglycerides and##19##2##(1991-10#1)(1992-4#1)(1994-11#2)(1995-6#2)(2004-1#1)(2005-10#4)(2006-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2012-2#1)(2013-7#1)
triglycerides are##2##2##(2005-10#1)(2011-2#1)
triglycerides as##2##2##(1991-10#1)(2006-6#1)
triglycerides at##2##2##(1995-6#1)(2010-4#1)
triglycerides by##2##2##(2006-8#1)(2013-1#1)
triglycerides decreased##2##2##(1991-6#1)(2008-3#1)
triglycerides in the##2##3##(2006-2#1)(2010-12#1)
triglycerides in##14##2##(1991-11#1)(1991-12#2)(1992-11#1)(1992-12#2)(1997-3#2)(2005-10#1)(2006-2#1)(2010-12#2)(2012-2#1)(2013-1#1)
triglycerides level of##2##3##(1995-6#1)(2008-8#1)
triglycerides level##4##2##(1995-6#1)(2007-9#1)(2008-3#1)(2008-8#1)
triglycerides levels##5##2##(1992-8#2)(2007-1#1)(2008-3#1)(2010-5#1)
triglycerides of##4##2##(1991-10#1)(1997-5#1)(2010-10#1)(2013-1#1)
triglycerides were##7##2##(1990-8#2)(1991-12#1)(1995-6#1)(2011-1#1)(2011-12#1)(2013-8#1)
triglycerides with##2##2##(2008-6#1)(2010-5#1)
triglycerides##193##1##(1990-4#1)(1990-8#3)(1991-10#5)(1991-11#1)(1991-12#4)(1991-2#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-11#2)(1992-12#3)(1992-3#2)(1992-4#2)(1992-6#4)(1992-8#3)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-9#2)(1994-11#2)(1995-11#1)(1995-6#8)(1996-3#2)(1996-4#3)(1996-7#1)(1996-9#2)(1997-2#3)(1997-3#3)(1997-5#1)(1997-7#1)(1997-8#1)(2004-1#2)(2004-11#1)(2005-10#6)(2005-7#1)(2006-2#2)(2006-6#2)(2006-8#1)(2006-9#4)(2007-1#2)(2007-10#1)(2007-11#2)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#2)(2008-12#2)(2008-3#21)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#3)(2009-10#1)(2009-11#2)(2009-3#1)(2010-10#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#6)(2010-5#3)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-2#7)(2012-3#1)(2013-1#13)(2013-7#1)(2013-8#1)
triglycerides)##6##1##(1992-12#1)(1994-3#1)(2007-7#1)(2007-8#2)(2013-1#1)
trigonal bipyramidal with##2##3##(1994-9#1)(1997-7#1)
trigonal bipyramidal##3##2##(1994-9#1)(1997-7#1)(2008-10#1)
trigonal##10##1##(1993-11#1)(1994-9#1)(1996-2#3)(1996-8#1)(1997-4#1)(1997-7#1)(2008-10#2)
trigonal-prismatic##2##1##(2010-5#2)
trigone##3##1##(2006-12#1)(2006-5#1)(2008-10#1)
trigonelline##3##1##(2008-10#3)
trihalomethane##3##1##(1994-3#2)(2008-10#1)
trihalomethanes (THMs)##4##2##(2007-8#1)(2008-10#3)
trihalomethanes##16##1##(1994-3#1)(2007-8#2)(2008-10#12)(2008-9#1)
trihedral junctions##2##2##(2008-6#2)
trihydrochloride)##2##1##(1995-12#1)(1996-12#1)
trihydroxy bile salts##2##3##(1997-8#1)(2005-11#1)
trihydroxy##5##1##(1995-3#1)(1996-11#1)(1997-8#2)(2005-11#1)
trihydroxycholestanoic acid##2##2##(1991-10#2)
trihydroxycholestanoic##3##1##(1991-10#3)
triiodide ion##2##2##(2008-10#2)
triiodide##10##1##(2008-10#9)(2010-4#1)
triiodothyronine (T3) and##2##3##(1991-10#1)(1994-11#1)
triiodothyronine (T3)##9##2##(1991-10#1)(1991-12#1)(1993-4#1)(1994-11#2)(1995-10#1)(1997-8#1)(2008-6#1)(2008-7#1)
triiodothyronine and##2##2##(1991-5#1)(1994-12#1)
triiodothyronine to##2##2##(1994-9#1)(2006-9#1)
triiodothyronine##29##1##(1990-3#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-8#1)(1993-4#1)(1994-11#3)(1994-12#1)(1994-9#3)(1995-10#2)(1995-11#1)(1997-8#1)(2006-9#1)(2007-5#1)(2008-11#1)(2008-6#1)(2008-7#1)(2012-12#2)(2012-2#2)
triiron cluster##2##2##(2010-5#2)
triisooctylamine##2##1##(2008-10#2)
trilineage##2##1##(2008-9#1)(2012-12#1)
trilinear##7##1##(2007-11#1)(2008-10#4)(2011-1#2)
trillion by##2##2##(1993-3#1)(2008-10#1)
trillion for##2##2##(1992-3#1)(2008-10#1)
trillion trillion##2##2##(2007-9#2)
trillion##17##1##(1992-3#1)(1993-3#2)(1996-5#1)(2007-12#1)(2007-8#1)(2007-9#3)(2008-10#6)(2008-12#1)(2008-2#1)
trilobite##4##1##(2007-12#2)(2012-12#2)
trilobites##7##1##(2007-12#7)
trilogy##2##1##(2008-10#2)
trim##8##1##(1992-8#1)(1993-5#1)(1993-6#1)(2007-12#1)(2010-12#4)
trimannosyl core##3##2##(1991-2#1)(1996-2#1)(2008-11#1)
trimebutine (10##2##2##(1990-7#2)
trimebutine##6##1##(1990-7#6)
trimedlure##3##1##(2004-2#3)
trimellitic anhydride (TMA)##4##3##(1995-11#1)(1997-2#1)(2008-10#2)
trimellitic anhydride##5##2##(1995-11#1)(1997-2#1)(2008-10#3)
trimellitic##7##1##(1995-11#1)(1997-2#1)(2008-10#5)
trimeperidine and##3##2##(2012-3#3)
trimeperidine##5##1##(2012-3#5)
trimer and##3##2##(1994-6#1)(1995-6#1)(2008-10#1)
trimer of##7##2##(1994-6#1)(1995-1#1)(1995-11#1)(1995-3#1)(1997-2#1)(2005-11#1)(2007-3#1)
trimer##44##1##(1990-2#1)(1991-4#1)(1991-8#3)(1992-9#2)(1993-3#2)(1994-2#1)(1994-5#1)(1994-6#3)(1994-9#4)(1995-1#1)(1995-11#2)(1995-3#1)(1995-4#1)(1995-6#2)(1995-8#1)(1996-7#3)(1997-2#1)(1997-3#1)(2005-11#1)(2006-3#3)(2006-8#1)(2007-11#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-8#2)
trimeric G proteins##2##3##(1992-11#1)(1994-9#1)
trimeric G##3##2##(1992-11#2)(1994-9#1)
trimeric protein##2##2##(1995-8#1)(1996-7#1)
trimeric##29##1##(1991-12#1)(1992-11#2)(1994-12#1)(1994-5#1)(1994-8#3)(1994-9#3)(1995-3#2)(1995-6#1)(1995-8#3)(1996-7#2)(1997-7#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#3)
trimerisation##2##1##(1994-9#2)
trimerization of##2##2##(1997-6#1)(1997-7#1)
trimerization##3##1##(1994-9#1)(1997-6#1)(1997-7#1)
trimers and tetramers##2##3##(2007-11#2)
trimers and##4##2##(1994-6#1)(1996-8#1)(2007-11#2)
trimers are##2##2##(1994-9#1)(2006-12#1)
trimers in##3##2##(1991-10#1)(1995-11#1)(2008-4#1)
trimers on##2##2##(2005-11#2)
trimers##30##1##(1990-9#2)(1991-10#1)(1991-4#1)(1991-8#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-4#2)(1996-6#1)(1996-8#1)(1997-2#2)(2005-11#3)(2006-12#4)(2006-3#3)(2007-11#2)(2008-11#1)(2008-4#1)(2008-8#1)(2011-1#1)
trimesic##3##1##(2005-11#1)(2006-12#1)(2008-10#1)
trimester -##2##2##(2011-1#2)
trimester abortion##6##2##(1996-12#2)(1997-7#1)(2006-8#1)(2007-2#1)(2008-7#1)
trimester and##3##2##(1995-8#1)(2008-1#1)(2012-3#1)
trimester decidual cells##2##3##(1995-10#2)
trimester exposure##3##2##(2008-8#1)(2013-1#2)
trimester fetal abnormality##2##3##(2004-10#2)
trimester fetal##3##2##(2004-10#2)(2008-1#1)
trimester for##3##2##(1993-3#3)
trimester maternal##2##2##(1996-12#1)(2012-2#1)
trimester of gestation##2##3##(2008-5#1)(2010-6#1)
trimester of pregnancy##27##3##(1990-12#1)(1990-3#2)(1991-12#2)(1992-10#1)(1992-2#4)(1992-4#1)(1994-9#1)(1996-12#1)(1996-7#2)(2007-11#1)(2007-2#2)(2008-12#2)(2008-2#1)(2008-4#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
trimester of##33##2##(1990-12#1)(1990-3#2)(1990-6#1)(1991-12#2)(1992-10#1)(1992-2#4)(1992-4#1)(1994-9#1)(1996-12#1)(1996-7#2)(2007-11#2)(2007-2#2)(2008-1#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
trimester to##2##2##(1991-6#1)(1995-9#1)
trimester ultrasound##3##2##(1996-12#2)(2008-7#1)
trimester were##2##2##(2008-5#1)(2011-1#1)
trimester with##2##2##(2007-7#1)(2012-3#1)
trimester##139##1##(1990-12#2)(1990-2#1)(1990-3#3)(1990-6#2)(1990-9#2)(1991-12#2)(1991-3#1)(1991-4#1)(1991-6#1)(1992-10#1)(1992-2#6)(1992-4#1)(1992-6#1)(1993-10#1)(1993-12#1)(1993-3#4)(1994-2#1)(1994-3#1)(1994-4#3)(1994-9#2)(1995-10#4)(1995-8#2)(1995-9#1)(1996-12#9)(1996-4#1)(1996-7#2)(1997-7#1)(1997-8#2)(2004-10#3)(2004-11#1)(2006-8#1)(2007-11#2)(2007-12#5)(2007-2#5)(2007-3#1)(2007-7#1)(2008-1#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#3)(2009-10#1)(2009-11#1)(2009-7#2)(2010-12#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#9)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#8)(2013-8#1)
trimester)##2##1##(2008-1#1)(2010-8#1)
trimester]##2##1##(1991-12#1)(2008-9#1)
trimesters of gestation##2##3##(1993-12#2)
trimesters of pregnancy##3##3##(2011-1#3)
trimesters of##5##2##(1993-12#2)(2011-1#3)
trimesters##12##1##(1993-12#3)(2007-7#1)(2009-5#3)(2010-12#2)(2011-1#3)
trimestre##5##1##(2011-2#1)(2013-1#4)
trimetazidine##2##1##(2008-8#1)(2013-7#1)
trimethaphan##2##1##(1990-7#1)(1996-12#1)
trimethoprim in##2##2##(2008-11#2)
trimethoprim##11##1##(1992-1#1)(1995-2#1)(2006-11#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-7#1)
trimethoprim-sulfamethoxazole##16##1##(1996-3#1)(1997-3#1)(2005-8#2)(2006-10#1)(2007-2#1)(2007-4#1)(2009-2#1)(2009-8#1)(2010-8#1)(2010-9#1)(2012-2#2)(2013-8#3)
trimethoprim/sulfamethoxazole##8##1##(2005-8#1)(2006-10#3)(2006-5#1)(2007-9#1)(2009-5#1)(2011-2#1)
trimethoxysilane and dimethyldiethoxysilane##2##3##(2007-11#2)
trimethoxysilane##5##1##(2005-11#1)(2007-11#4)
trimethyl ammonium bromide##4##3##(2005-11#2)(2008-10#2)
trimethyl##8##1##(1994-8#1)(1996-5#2)(2005-11#2)(2006-10#1)(2008-10#2)
trimethylamine (TMA) in##2##3##(2007-8#1)(2008-10#1)
trimethylamine (TMA)##4##2##(2007-8#1)(2008-10#3)
trimethylamine and##2##2##(2008-10#1)(2012-11#1)
trimethylamine dehydrogenase##4##2##(1995-2#4)
trimethylamine microcarriers##5##2##(2008-11#5)
trimethylamine##21##1##(1995-2#5)(2007-8#1)(2008-10#8)(2008-11#6)(2012-11#1)
trimethylammonium##4##1##(2007-6#1)(2008-10#2)(2008-6#1)
trimethylarsine oxide##3##2##(2008-10#3)
trimethylarsine##4##1##(2008-10#3)(2009-6#1)
trimethylated##2##1##(1996-5#1)(2009-6#1)
trimethylolpropane triacrylate##12##2##(2008-9#12)
trimethylolpropane##20##1##(1996-12#1)(2008-9#19)
trimethylphosphine##3##1##(1990-8#2)(2010-5#1)
trimethylselenonium ion##2##2##(2008-10#2)
trimethylselenonium##3##1##(2008-10#3)
trimethylsilyl (TMS)##3##2##(1997-3#1)(2005-11#1)(2008-10#1)
trimethylsilyl derivatives##4##2##(1990-8#1)(2008-10#3)
trimethylsilyl##14##1##(1990-8#1)(1996-5#1)(1997-3#1)(2005-11#1)(2005-12#2)(2007-11#1)(2008-10#5)(2008-5#1)(2010-2#1)
trimethyltin chloride##2##2##(2008-10#1)(2012-2#1)
trimethyltin##4##1##(2008-10#1)(2012-2#1)(2013-1#2)
trimetoquinol hydrochloride##2##2##(1990-8#2)
trimetoquinol##4##1##(1990-8#3)(1996-5#1)
trimipramine##6##1##(1995-2#5)(1997-8#1)
trimmed##14##1##(1993-11#1)(1995-5#1)(1996-7#5)(2007-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-4#1)(2013-7#1)
trimming from birth##2##3##(1995-5#2)
trimming of##2##2##(1995-2#1)(2010-12#1)
trimming##17##1##(1992-3#1)(1995-2#1)(1995-5#2)(2007-12#1)(2007-8#1)(2008-2#2)(2008-9#1)(2009-12#3)(2009-9#1)(2010-12#3)(2013-7#1)
trimodal distribution##2##2##(1990-5#1)(2008-9#1)
trimodal##5##1##(1990-5#1)(1996-3#1)(2007-2#1)(2008-9#1)(2013-8#1)
trimodality protocol##2##2##(2008-10#1)(2012-3#1)
trimodality##5##1##(2006-6#3)(2008-10#1)(2012-3#1)
trimolecular##5##1##(1990-6#1)(1992-5#1)(2007-11#1)(2007-7#1)(2008-10#1)
trims##2##1##(1992-8#1)(2012-2#1)
trimyristin and myristicin##3##3##(2010-11#3)
trimyristin##6##1##(2010-1#3)(2010-11#3)
trinary signed-digit##4##2##(2008-2#4)
trinitrate##16##1##(1992-6#1)(1995-11#1)(1995-9#2)(1996-10#3)(2006-12#1)(2007-10#3)(2007-8#2)(2008-8#2)(2009-5#1)
trinitrophenol##4##1##(1992-8#1)(1993-4#1)(2008-10#2)
trinitrophenyl##2##1##(2008-10#1)(2008-4#1)
trinitrotoluene (TNT)##4##2##(2008-10#2)(2010-2#1)(2013-7#1)
trinitrotoluene by##2##2##(2008-10#1)(2008-12#1)
trinitrotoluene##7##1##(2008-10#4)(2008-12#1)(2010-2#1)(2013-7#1)
trinuclear complex##2##2##(1997-7#2)
trinuclear units##2##2##(1997-7#2)
trinuclear##9##1##(1997-7#4)(2008-10#3)(2008-3#1)(2010-5#1)
trinucleotid##2##1##(1997-6#1)(2008-2#1)
trinucleotide repeat expansions##2##3##(2006-11#2)
trinucleotide repeat##10##2##(1994-12#1)(1995-11#1)(1996-7#1)(1997-1#1)(1997-3#2)(2006-11#2)(2008-7#2)
trinucleotide repeats and##2##3##(1994-11#1)(1996-11#1)
trinucleotide repeats##13##2##(1992-1#1)(1994-11#3)(1994-12#1)(1996-11#1)(1997-3#1)(1997-4#1)(1997-5#1)(2006-2#1)(2007-6#1)(2010-7#1)(2012-2#1)
trinucleotide##32##1##(1991-9#1)(1992-1#1)(1992-2#1)(1994-11#3)(1994-12#3)(1995-11#1)(1995-3#1)(1996-11#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#1)(1997-5#1)(2004-1#1)(2006-11#2)(2006-2#1)(2007-6#1)(2008-11#1)(2008-7#2)(2010-7#1)(2012-2#2)
trio of##4##2##(1996-11#1)(2007-11#1)(2007-9#1)(2012-1#1)
trio##7##1##(1996-11#2)(2007-11#1)(2007-9#1)(2008-12#1)(2008-7#1)(2012-1#1)
trioctylamine##3##1##(2008-10#1)(2009-11#1)(2013-8#1)
trioctylphosphine oxide##4##2##(2008-10#3)(2010-7#1)
triode and diode##2##3##(2008-2#2)
triode##3##1##(2008-2#3)
triolein and##4##2##(1992-3#1)(2004-11#1)(2008-10#1)(2008-7#1)
triolein##6##1##(1992-3#1)(1994-3#1)(2004-11#1)(2004-4#1)(2008-10#1)(2008-7#1)
triols with##3##2##(2007-11#1)(2012-11#2)
triols##4##1##(1990-12#1)(2007-11#1)(2012-11#2)
triorganophosphinegold(I)##4##1##(2008-3#2)(2008-5#2)
triorganotin##5##1##(2008-5#4)(2013-1#1)
trios##2##1##(2008-12#1)(2009-4#1)
triose phosphates##2##2##(1990-3#1)(1992-4#1)
triose##5##1##(1990-3#1)(1992-4#2)(1993-8#1)(2008-6#1)
triose-phosphate isomerase##5##2##(1994-3#1)(1995-8#4)
triosephosphate isomerase##3##2##(1992-1#1)(1993-11#1)(1995-1#1)
triosephosphate##4##1##(1992-1#1)(1993-11#2)(1995-1#1)
triosephosphates##4##1##(1995-9#1)(2008-1#3)
trioses##4##1##(1995-1#3)(1997-6#1)
triosmium alkylidyne carbonyl cluster##2##4##(2007-11#2)
trioxadispiroketal##3##1##(2009-9#3)
trioxide##27##1##(1994-11#2)(2005-10#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-8#2)(2010-8#4)(2011-2#3)(2012-12#2)(2012-2#3)(2013-1#5)(2013-8#1)
trip by##2##2##(2008-2#1)(2008-3#1)
trip or##2##2##(2009-10#1)(2011-2#1)
trip to##4##2##(2007-2#2)(2007-5#1)(2007-9#1)
trip##13##1##(1993-2#1)(2007-11#2)(2007-2#2)(2007-5#1)(2007-9#1)(2008-2#1)(2008-3#1)(2009-10#1)(2011-2#2)(2012-12#1)
tripalmitat##2##1##(2013-1#2)
tripartite influence model of body image and eating disturbance##3##9##(2007-12#3)
tripartite leader##2##2##(1997-3#1)(1997-8#1)
tripartite regulation of##2##3##(1996-12#1)(1997-2#1)
tripartite symbiosis##2##2##(2011-1#2)
tripartite synapse##2##2##(2009-8#1)(2013-1#1)
tripartite##23##1##(1990-6#2)(1991-5#1)(1994-5#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#4)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#2)(2009-8#1)(2011-1#2)(2013-1#1)(2013-7#1)
tripeptide amide##2##2##(1992-3#1)(2013-7#1)
tripeptide glutathione##2##2##(1990-7#1)(2009-8#1)
tripeptide sequence##3##2##(1992-5#1)(1997-2#1)(2008-5#1)
tripeptide##51##1##(1990-12#1)(1990-2#4)(1990-5#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-9#2)(1992-10#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#6)(1992-8#1)(1993-9#2)(1994-10#1)(1994-9#2)(1997-2#1)(2006-12#3)(2006-8#1)(2008-10#1)(2008-4#2)(2008-5#3)(2009-8#1)(2010-3#1)(2011-1#2)(2011-2#1)(2013-7#1)
tripeptides and##2##2##(1990-12#1)(1995-6#1)
tripeptides in##2##2##(1994-9#1)(2006-10#1)
tripeptides of##2##2##(2006-10#1)(2008-4#1)
tripeptides with##2##2##(1990-7#1)(2006-10#1)
tripeptides##17##1##(1990-12#2)(1990-7#1)(1990-8#1)(1994-5#4)(1994-9#2)(1995-6#1)(2006-10#5)(2008-4#1)
tripeptidyl##2##1##(1993-5#1)(1995-6#1)
tripetala extract##2##2##(2009-5#2)
tripetala##5##1##(2009-5#5)
triphasic##17##1##(1990-5#1)(1990-7#1)(1990-9#1)(1992-12#1)(1995-10#1)(1997-1#1)(2004-11#2)(2006-6#2)(2008-3#1)(2008-5#6)
triphenylamine-based##3##1##(2010-4#3)
triphenylarsine oxide##2##2##(2008-10#1)(2008-5#1)
triphenylphosphine oxide##2##2##(1996-2#1)(2008-5#1)
triphenylphosphine##6##1##(1996-2#2)(1996-5#1)(2008-5#1)(2009-7#1)(2010-5#1)
triphenyltin hydroxide##3##2##(2011-12#3)
triphenyltin##7##1##(2008-10#1)(2008-3#1)(2008-5#1)(2011-12#3)(2012-2#1)
triphosphatase and##2##2##(1990-11#1)(2010-10#1)
triphosphatase##16##1##(1990-11#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-5#2)(1994-8#1)(1995-3#1)(1996-1#1)(1996-8#1)(1996-9#1)(2006-10#1)(2008-9#1)(2010-10#1)(2013-1#2)
triphosphatase)##2##1##(1996-1#2)
triphosphate (GTP) at##2##3##(1992-6#1)(2008-7#1)
triphosphate (GTP)##5##2##(1991-9#1)(1992-6#1)(1995-6#1)(2007-9#1)(2008-7#1)
triphosphate and##4##2##(1990-10#1)(1995-12#1)(1995-2#1)(1996-8#1)
triphosphate diphosphohydrolases##6##2##(2008-4#6)
triphosphate form of##2##3##(1991-4#1)(2008-5#1)
triphosphate form##3##2##(1991-4#2)(2008-5#1)
triphosphate in##3##2##(1990-12#1)(1993-7#1)(1997-8#1)
triphosphate into##2##2##(1990-10#1)(2009-12#1)
triphosphate is an##2##3##(1992-8#1)(1995-3#1)
triphosphate is##3##2##(1992-8#1)(1995-3#1)(2008-4#1)
triphosphate nick-end labeling##2##3##(2006-11#1)(2007-1#1)
triphosphate per##2##2##(1990-5#1)(1994-11#1)
triphosphate to##2##2##(1995-11#1)(2008-9#1)
triphosphate was##2##2##(1995-2#2)
triphosphate##124##1##(1990-10#2)(1990-12#2)(1990-5#4)(1990-9#2)(1991-4#3)(1991-5#2)(1991-9#3)(1992-11#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#3)(1993-11#1)(1993-7#1)(1994-11#1)(1994-2#1)(1995-11#2)(1995-12#3)(1995-2#11)(1995-3#5)(1995-6#4)(1996-10#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-6#3)(1997-7#1)(1997-8#2)(2005-7#1)(2005-8#2)(2006-11#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-9#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#20)(2008-5#2)(2008-7#3)(2008-9#2)(2009-12#2)(2009-4#1)(2009-8#1)(2010-4#2)(2011-1#3)(2012-12#5)(2013-1#1)
triphosphates (dNTPs)##3##2##(1990-3#1)(2008-2#1)(2008-9#1)
triphosphates and##5##2##(1990-11#1)(1995-10#1)(2008-4#2)(2008-7#1)
triphosphates of##3##2##(1994-3#1)(1996-5#1)(1996-6#1)
triphosphates##32##1##(1990-11#2)(1990-3#1)(1993-4#1)(1993-8#1)(1994-3#1)(1995-10#2)(1995-3#1)(1996-4#1)(1996-5#4)(1996-6#2)(1997-7#1)(2008-2#2)(2008-4#10)(2008-7#1)(2008-9#1)(2010-8#1)
triphosphopyridoxal##2##1##(1990-12#1)(1992-11#1)
tripitramine##4##1##(1994-9#1)(1996-1#2)(1997-7#1)
triple A syndrome##2##3##(1995-12#2)
triple antibiotic paste##5##3##(2012-2#3)(2013-1#2)
triple antibiotic##6##2##(2011-1#1)(2012-2#3)(2013-1#2)
triple bond##4##2##(1994-9#1)(2005-11#2)(2010-5#1)
triple cage olfactometer##2##3##(2004-11#2)
triple combination therapy##6##3##(2006-2#1)(2008-5#1)(2013-1#4)
triple combination##12##2##(1995-5#2)(2006-2#1)(2008-5#4)(2011-2#1)(2013-1#4)
triple combinations##3##2##(1994-9#1)(2008-3#1)(2008-5#1)
triple helical##4##2##(1994-9#1)(1996-7#2)(1996-8#1)
triple helices##5##2##(1995-5#1)(1996-4#2)(2006-10#1)(2006-12#1)
triple helix formation##7##3##(1992-12#1)(1994-12#1)(1995-5#3)(1996-8#1)(2006-10#1)
triple helix in##3##3##(1997-4#1)(2006-12#1)(2013-1#1)
triple helix is##2##3##(2008-4#1)(2013-1#1)
triple helix##34##2##(1991-6#1)(1992-12#1)(1992-2#3)(1992-9#1)(1994-12#1)(1994-8#1)(1995-3#2)(1995-5#6)(1996-7#1)(1996-8#1)(1997-4#1)(2006-10#1)(2006-12#2)(2008-4#1)(2009-7#2)(2013-1#8)(2013-8#1)
triple immunosuppression##3##2##(2007-11#2)(2008-1#1)
triple immunosuppressive##2##2##(1995-2#1)(2008-1#1)
triple mutant##5##2##(1990-11#1)(1995-3#2)(1996-7#2)
triple mutants##2##2##(1994-8#1)(2011-1#1)
triple mutation##3##2##(1995-3#1)(1997-7#1)(2008-8#1)
triple nucleoside##2##2##(2005-7#2)
triple quadrupole MS##2##3##(2008-10#1)(2013-8#1)
triple quadrupole##4##2##(2007-8#1)(2008-10#2)(2013-8#1)
triple resonance##2##2##(2009-7#2)
triple sequentially fused pentagons##2##4##(2010-12#2)
triple test##5##2##(1990-10#2)(1992-2#1)(1996-12#1)(2012-3#1)
triple test&quot##3##2##(1992-2#2)(2006-9#1)
triple therapy for the##2##4##(2006-2#1)(2007-3#1)
triple therapy with##2##3##(2007-11#1)(2007-7#1)
triple therapy##13##2##(1995-3#2)(2005-7#1)(2006-2#2)(2007-11#2)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#2)
triple vessel coronary artery disease##2##5##(2007-9#2)
triple vessel coronary##3##3##(2007-8#1)(2007-9#2)
triple vessel disease##3##3##(1990-4#1)(1991-6#1)(2013-8#1)
triple vessel##6##2##(1990-4#1)(1991-6#1)(2007-8#1)(2007-9#2)(2013-8#1)
triple viral##2##2##(1997-6#1)(2008-4#1)
triple##208##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-6#2)(1991-9#1)(1992-12#1)(1992-2#6)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-8#2)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#5)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#9)(1995-5#9)(1995-8#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-4#4)(1996-5#3)(1996-6#1)(1996-7#6)(1996-8#3)(1997-4#2)(1997-6#3)(1997-7#2)(2004-11#2)(2005-11#2)(2005-7#3)(2006-1#1)(2006-10#4)(2006-12#4)(2006-2#3)(2006-9#1)(2007-10#2)(2007-11#5)(2007-12#1)(2007-3#1)(2007-7#3)(2007-8#6)(2007-9#3)(2008-1#4)(2008-10#10)(2008-3#2)(2008-4#2)(2008-5#7)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#2)(2009-7#4)(2009-8#2)(2010-12#3)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#20)(2013-8#3)
triple&quot##2##1##(2011-2#2)
triple-antibody sandwich##3##2##(2008-10#3)
triple-antibody##4##1##(2008-10#4)
triple-blind##3##1##(1997-3#2)(2013-1#1)
triple-crystal diffractometer for high-energy##2##4##(2006-5#2)
triple-crystal diffractometer##4##2##(2006-5#4)
triple-crystal##5##1##(2006-5#5)
triple-decker##2##1##(2008-12#2)
triple-helical##9##1##(1995-1#1)(1995-10#1)(1996-4#2)(1997-4#1)(2011-1#4)
triple-helix formation##4##2##(1992-9#2)(2008-4#2)
triple-helix##5##1##(1992-9#2)(2008-4#3)
triple-layer model##2##2##(2005-11#2)
triple-layer##4##1##(2005-11#3)(2012-2#1)
triple-quantum filtered##2##2##(2006-10#2)
triple-resistant##2##1##(1993-9#1)(2008-10#1)
triple-resonance ionization spectroscopy##2##3##(2008-3#2)
triple-resonance##7##1##(1993-6#1)(2008-3#2)(2009-7#4)
triple-stage##2##1##(2008-10#2)
triple-stranded##4##1##(1990-7#1)(1994-9#1)(2006-12#1)(2011-1#1)
triple-vessel disease##2##2##(2006-7#1)(2007-8#1)
triple-vessel##5##1##(2005-9#1)(2006-7#1)(2007-8#2)(2011-2#1)
tripled in##5##2##(2006-10#1)(2008-8#1)(2009-5#1)(2010-6#1)(2012-12#1)
tripled the##2##2##(1995-3#1)(1996-4#1)
tripled##19##1##(1990-11#1)(1990-2#1)(1992-4#1)(1995-3#1)(1996-4#1)(2006-10#1)(2007-11#2)(2007-12#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2012-12#1)
triples##4##1##(1992-6#1)(1993-1#1)(1996-4#2)
triplet and##2##2##(2006-5#1)(2012-2#1)
triplet ground state##2##3##(1997-7#1)(2011-1#1)
triplet pregnancies##4##2##(1992-1#4)
triplet regimen##2##2##(2004-1#2)
triplet repeats##3##2##(1995-8#1)(1996-11#1)(1996-5#1)
triplet state of##2##3##(1997-7#1)(2008-8#1)
triplet state##7##2##(1995-1#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-8#1)
triplet states of##2##3##(1992-8#1)(2008-2#1)
triplet states##3##2##(1992-8#1)(2008-2#1)(2012-2#1)
triplet##77##1##(1990-10#1)(1990-3#1)(1992-1#4)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#4)(1995-12#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#4)(1997-7#2)(2004-1#2)(2004-10#2)(2005-8#1)(2006-11#5)(2006-5#4)(2007-11#1)(2007-12#6)(2008-10#6)(2008-2#3)(2008-3#3)(2008-8#1)(2009-10#2)(2009-2#1)(2010-4#2)(2010-5#1)(2011-1#1)(2012-11#1)(2012-2#2)
triplet-state properties##2##2##(1993-11#2)
triplet-triplet##5##1##(1992-8#1)(1993-3#1)(1995-1#1)(2009-7#1)(2010-4#1)
triplets and##2##2##(1996-6#1)(2008-12#1)
triplets are##3##2##(1994-12#1)(1996-6#1)(1996-9#1)
triplets may##2##2##(1991-7#1)(1996-6#1)
triplets of the##2##3##(1996-5#1)(2008-10#1)
triplets of##3##2##(1992-4#1)(1996-5#1)(2008-10#1)
triplets##24##1##(1990-1#1)(1991-12#1)(1991-7#1)(1992-4#1)(1993-9#1)(1994-12#1)(1995-5#1)(1995-6#1)(1996-5#1)(1996-6#4)(1996-9#1)(2006-5#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-6#1)(2010-7#1)(2012-3#1)
triplex DNA##3##2##(1995-5#1)(2006-10#1)(2008-8#1)
triplex formation and##2##3##(2006-12#1)(2008-9#1)
triplex formation##21##2##(1992-12#1)(1993-8#8)(1994-12#1)(1995-3#1)(1995-5#6)(1996-4#2)(2006-12#1)(2008-9#1)
triplex has##2##2##(1994-9#1)(1995-1#1)
triplex is##3##2##(1992-9#1)(1993-8#1)(1995-3#1)
triplex##56##1##(1992-12#2)(1992-9#2)(1993-8#9)(1993-9#1)(1994-12#1)(1994-9#2)(1995-1#4)(1995-3#6)(1995-5#11)(1996-4#4)(2006-10#3)(2006-12#3)(2008-4#4)(2008-8#1)(2008-9#3)
triplex-forming##3##1##(1992-9#1)(1995-5#1)(2006-12#1)
triplex-to-duplex transition##3##2##(1992-9#3)
triplexes formed by cyclic##2##4##(2006-12#2)
triplexes formed##3##2##(1995-3#1)(2006-12#2)
triplexes have##3##2##(1994-9#1)(2008-8#2)
triplexes is##2##2##(2006-10#1)(2008-8#1)
triplexes were##2##2##(1993-3#1)(2006-12#1)
triplexes##25##1##(1993-3#2)(1993-8#1)(1994-12#2)(1994-9#4)(1995-3#2)(1995-5#2)(1996-4#2)(2006-10#1)(2006-12#4)(2008-4#1)(2008-8#4)
triplicate measurements##4##2##(2007-8#1)(2008-10#3)
triplicate##16##1##(1994-11#1)(1995-2#1)(2006-8#1)(2007-8#2)(2008-10#6)(2008-12#1)(2010-11#1)(2012-12#1)(2013-7#1)(2013-8#1)
triplicated##3##1##(1996-3#1)(2008-7#2)
triplication of##2##2##(1997-2#1)(2012-3#1)
triplication##3##1##(1997-2#1)(2008-7#1)(2012-3#1)
triplicators##2##1##(2007-12#2)
tripling of##2##2##(2007-12#1)(2008-1#1)
tripling the##2##2##(2008-2#1)(2012-3#1)
tripling##10##1##(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#3)(2011-2#2)(2012-3#1)
triploid crucian carp##4##3##(2010-5#4)
triploid fish##2##2##(2008-7#1)(2010-8#1)
triploid ginbuna##2##2##(2008-5#2)
triploid##18##1##(1995-4#1)(2008-5#4)(2008-7#2)(2009-12#2)(2010-3#2)(2010-5#4)(2010-8#1)(2013-8#2)
triploid)##2##1##(2008-5#1)(2008-8#1)
triploid-tetraploid mosaics##2##2##(2010-3#2)
triploids of L##2##3##(2008-5#2)
triploids##6##1##(2008-5#3)(2010-3#2)(2013-8#1)
triploidy##5##1##(1992-8#1)(1995-8#1)(1996-12#1)(2008-7#2)
triply phosphorylated##2##2##(2013-8#2)
triply reflecting telescope##2##3##(2008-2#2)
triply resonant##2##2##(2007-11#1)(2007-12#1)
triply##8##1##(1990-8#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-8#1)(2013-8#2)
tripod##10##1##(1992-10#2)(1994-12#2)(2008-10#2)(2008-5#4)
tripodal compound##2##2##(2008-10#2)
tripodal##6##1##(1997-7#1)(2007-11#1)(2007-3#1)(2008-10#3)
tripolar##2##1##(2009-3#1)(2011-12#1)
tripolyphosphate##4##1##(1994-3#1)(1997-4#1)(2008-10#2)
tripropylamine##5##1##(2008-10#4)(2010-7#1)
trips and##2##2##(2009-4#1)(2013-1#1)
trips##14##1##(1996-1#1)(2007-12#2)(2008-12#1)(2009-4#1)(2009-5#1)(2010-2#1)(2011-2#3)(2013-1#3)(2013-7#1)
triptan##5##1##(2008-5#1)(2008-9#4)
triptans##5##1##(2007-10#1)(2008-5#2)(2008-9#1)(2012-2#1)
triptolide##2##1##(2008-11#1)(2013-8#1)
triptych##2##1##(1993-2#1)(2008-7#1)
triradiate##4##1##(1993-8#1)(2008-10#3)
triradiatus##3##1##(2010-8#3)
tris (2##3##2##(2008-10#2)(2013-8#1)
tris##5##1##(2008-10#4)(2013-8#1)
tris(2##23##1##(1990-12#1)(1996-2#2)(2005-11#1)(2008-10#19)
tris(2-ethylhexyl) phosphate##3##2##(2008-10#3)
tris(2-ethylhexyl)phosphate (TEHP)##3##2##(2008-10#3)
tris(3##7##1##(1993-2#1)(1997-7#1)(2008-10#3)(2010-5#2)
tris(4##2##1##(2007-9#1)(2008-10#1)
tris(hydroxymethyl)aminomethane##2##1##(1990-7#1)(2008-10#1)
tris(pentafluorophenyl)borane##2##1##(2010-5#2)
tris(trimethylsilyl)silanes##2##1##(2009-5#2)
tris- and tetrakisphosphate##2##3##(1990-7#2)
tris- and##4##2##(1990-7#2)(1994-9#1)(2010-5#1)
tris-##5##1##(1990-7#2)(1992-2#1)(1994-9#1)(2010-5#1)
tris-(2##4##1##(2007-8#1)(2008-10#3)
tris-(3##4##1##(2008-10#4)
tris-indole##2##1##(2007-11#2)
trisaccharide##9##1##(1991-8#1)(1991-9#1)(1994-5#3)(1995-3#1)(1996-2#1)(1996-4#1)(1996-7#1)
trisaccharides##4##1##(1992-12#2)(1994-5#1)(2007-1#1)
triserialis##4##1##(2008-5#3)(2012-2#1)
triseriatus (Say)##2##2##(2004-11#1)(2008-12#1)
triseriatus##8##1##(2004-11#4)(2008-12#4)
trismus##5##1##(2007-12#2)(2008-7#1)(2013-1#2)
trisodium##3##1##(2007-3#1)(2007-8#1)(2008-10#1)
trisomic mice##2##2##(2012-2#2)
trisomic##4##1##(1997-2#1)(2009-12#1)(2012-2#2)
trisomics were##2##2##(2009-12#2)
trisomics##6##1##(2009-12#6)
trisomies were##2##2##(1997-4#1)(2010-1#1)
trisomies##6##1##(1993-10#1)(1996-12#1)(1997-4#1)(2008-7#2)(2010-1#1)
trisomy 13##4##2##(1995-8#2)(1996-12#1)(2008-4#1)
trisomy 16##3##2##(1991-8#2)(1997-2#1)
trisomy 18##7##2##(1995-8#2)(1997-4#1)(2007-2#2)(2008-4#1)(2012-3#1)
trisomy 21##12##2##(1991-12#1)(1995-8#1)(1996-2#1)(1996-6#2)(1997-4#3)(2007-2#1)(2008-7#1)(2009-10#1)(2012-3#1)
trisomy 8##8##2##(1996-3#3)(2008-3#1)(2013-1#4)
trisomy of mouse chromosome 17##2##5##(2008-7#2)
trisomy of##3##2##(2008-7#2)(2010-1#1)
trisomy##50##1##(1991-12#1)(1991-8#2)(1995-8#5)(1996-12#2)(1996-2#1)(1996-3#3)(1996-6#3)(1997-2#1)(1997-4#4)(1997-5#1)(2007-2#4)(2008-3#1)(2008-4#2)(2008-7#4)(2008-8#1)(2009-10#1)(2010-1#1)(2011-2#3)(2012-1#1)(2012-3#5)(2013-1#4)
trisphosphate (IP3)##2##2##(1991-10#1)(1996-1#1)
trisphosphate and##3##2##(1990-10#1)(1991-2#1)(1994-10#1)
trisphosphate production##6##2##(1990-8#1)(1991-12#1)(1991-8#1)(1993-3#2)(1994-12#1)
trisphosphate receptor##3##2##(1992-8#1)(1993-6#1)(1995-2#1)
trisphosphate##37##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-8#5)(1991-10#1)(1991-12#4)(1991-2#2)(1991-8#1)(1992-12#1)(1992-8#1)(1993-3#3)(1993-6#4)(1994-10#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-1#2)(2006-10#2)(2008-4#1)(2010-2#1)
trisphosphates##5##1##(1991-3#1)(1991-8#1)(1994-12#1)(1997-1#2)
tristable##2##1##(2010-12#2)
tristeza virus (CTV) and##2##4##(2008-10#2)
tristeza virus (CTV) isolates T3##2##5##(2008-10#2)
tristeza virus (CTV)##11##3##(2008-10#10)(2008-5#1)
tristeza virus##22##2##(2008-10#20)(2008-5#2)
tristeza##23##1##(2008-10#21)(2008-5#2)
tristimulus colorimeter##2##2##(1996-7#2)
tristimulus colorimetry##5##2##(2008-10#4)(2008-5#1)
tristimulus##7##1##(1996-7#2)(2008-10#4)(2008-5#1)
trisubstituted##3##1##(1994-9#1)(2007-11#1)(2008-4#1)
trisulfate##3##1##(1994-8#3)
trisulphated##2##1##(1997-3#2)
triterpene acids##2##2##(2007-1#2)
triterpene components##2##2##(2011-3#2)
triterpene##10##1##(1990-10#2)(2007-1#2)(2007-11#1)(2008-11#1)(2011-3#2)(2012-11#1)(2012-2#1)
triterpenes were##2##2##(2007-1#1)(2008-11#1)
triterpenes##8##1##(2006-12#1)(2007-1#2)(2008-11#5)
triterpenic derivatives##3##2##(2008-5#3)
triterpenic##4##1##(2008-5#4)
triterpenoid glycosides##2##2##(2010-6#2)
triterpenoid saponins##4##2##(2007-1#1)(2013-1#3)
triterpenoid##12##1##(2007-1#4)(2008-8#1)(2010-2#1)(2010-6#2)(2012-2#1)(2013-1#3)
triterpenoids from##2##2##(2006-12#1)(2012-3#1)
triterpenoids##10##1##(1991-10#3)(2006-12#2)(2007-1#1)(2012-2#3)(2012-3#1)
trithorax##6##1##(1995-11#1)(1996-10#2)(1997-7#3)
tritiated thymidine incorporation##2##3##(1991-10#1)(2007-1#1)
tritiated thymidine##7##2##(1991-10#2)(1991-9#1)(2007-1#1)(2008-4#1)(2008-9#1)(2011-12#1)
tritiated water##4##2##(1991-2#1)(2008-11#3)
tritiated##36##1##(1990-2#2)(1990-4#1)(1990-7#1)(1991-10#3)(1991-12#1)(1991-2#2)(1991-9#2)(1992-6#2)(1992-8#2)(1993-12#1)(1993-5#1)(1993-8#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1996-2#1)(1996-5#1)(1996-7#1)(2006-5#1)(2007-1#1)(2008-11#3)(2008-4#1)(2008-9#2)(2011-12#1)
triticale##5##1##(2008-10#2)(2008-5#2)(2013-1#1)
tritici and P##4##3##(2008-10#4)
tritici and##6##2##(2008-10#6)
tritici attack##2##2##(2008-10#2)
tritici blotch of wheat##2##4##(2008-10#2)
tritici blotch of##3##3##(2008-10#3)
tritici blotch##11##2##(2008-10#11)
tritici has##2##2##(2008-10#1)(2012-2#1)
tritici on winter wheat##2##4##(2008-10#2)
tritici races##4##2##(2008-10#4)
tritici was##2##2##(2008-10#2)
tritici##75##1##(2008-10#72)(2009-8#1)(2011-12#1)(2012-2#1)
tritici)##9##1##(2008-10#8)(2012-2#1)
tritici-repentis in##3##2##(2008-10#3)
tritici-repentis isolates##2##2##(2008-10#2)
tritici-repentis race##3##2##(2008-10#3)
tritici-repentis were##2##2##(2008-10#2)
tritici-repentis##47##1##(2007-7#1)(2008-10#46)
triticina from Ethiopia##2##3##(2008-10#2)
triticina from durum wheat from South America##2##7##(2008-10#2)
triticina from durum wheat from##3##5##(2008-10#3)
triticina from durum wheat##4##4##(2008-10#4)
triticina from##10##2##(2008-10#10)
triticina isolates from##2##3##(2008-10#2)
triticina isolates##3##2##(2008-10#3)
triticina on##3##2##(2008-10#3)
triticina##49##1##(2008-10#48)(2012-2#1)
triticirepentis##2##1##(2008-10#2)
tritimovirus##3##1##(2008-10#3)
tritium was released##2##3##(1996-7#2)
tritium was##3##2##(1990-7#1)(1996-7#2)
tritium##22##1##(1990-12#1)(1990-7#3)(1991-2#1)(1991-5#3)(1993-8#1)(1994-5#3)(1994-9#1)(1995-10#5)(1995-7#1)(1996-7#2)(2008-11#1)
tritocerebral commissure##3##2##(2007-12#3)
tritocerebral innervation##2##2##(2007-12#2)
tritocerebral##7##1##(2007-12#7)
tritocerebrum##6##1##(2007-12#5)(2008-9#1)
triton X-100##4##2##(1991-5#1)(1994-6#1)(2006-5#1)(2008-10#1)
triton tumor##2##2##(2007-8#2)
triton##6##1##(1991-5#1)(1994-6#1)(2006-5#1)(2007-8#2)(2008-10#1)
tritrophic food##3##2##(2008-9#3)
tritrophic##5##1##(2008-9#4)(2009-8#1)
triturated##3##1##(2005-12#1)(2008-10#1)(2008-11#1)
trituration##2##1##(2004-9#1)(2008-11#1)
trityl##5##1##(1992-12#2)(2005-7#2)(2010-4#1)
triumph of##2##2##(1997-5#1)(2008-8#1)
triumph##3##1##(1997-5#1)(2006-5#1)(2008-8#1)
triumvirate of##2##2##(1994-2#1)(2011-2#1)
trivalent and pentavalent##2##3##(1997-7#1)(2008-10#1)
trivalent and##4##2##(1997-7#1)(2008-10#1)(2008-12#1)(2012-2#1)
trivalent arsenic##3##2##(2008-10#3)
trivalent cations##8##2##(1991-9#1)(1995-8#1)(2008-10#6)
trivalent form##2##2##(2008-10#1)(2008-12#1)
trivalent lanthanides##2##2##(2008-10#2)
trivalent metal ions##3##3##(1993-6#1)(2008-10#2)
trivalent metal##7##2##(1990-2#1)(1993-6#1)(1996-8#1)(2007-8#1)(2008-10#3)
trivalent state##5##2##(2008-10#5)
trivalent vaccine##2##2##(1997-6#1)(2007-2#1)
trivalent##71##1##(1990-2#1)(1991-9#1)(1993-6#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-6#2)(1997-7#1)(2005-4#1)(2005-7#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-8#1)(2007-9#1)(2008-10#35)(2008-12#2)(2008-7#1)(2008-9#2)(2010-11#2)(2010-2#2)(2010-5#1)(2010-9#1)(2011-2#3)(2012-2#1)
trivalvular and ischemic heart disease##2##5##(1993-5#2)
trivial to##2##2##(2007-12#1)(2008-2#1)
trivial trauma##2##2##(2007-10#1)(2008-4#1)
trivial##23##1##(1994-1#1)(1994-2#1)(1995-5#1)(1996-10#1)(1997-6#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#1)
trizma-chloranilate##2##1##(2008-10#2)
trk family##4##2##(1991-5#1)(1996-12#1)(1996-3#2)
trk receptors##7##2##(1996-12#3)(1996-3#3)(1997-5#1)
trk##16##1##(1991-5#2)(1995-11#2)(1996-12#5)(1996-3#5)(1997-5#2)
trkA and trkC##2##3##(1997-5#2)
trkA expressing##2##2##(1996-3#2)
trkA expression in##2##3##(1997-5#2)
trkA mRNA##3##2##(1995-11#1)(1997-2#1)(1997-5#1)
trkA##19##1##(1995-11#1)(1996-12#4)(1996-3#5)(1997-2#2)(1997-5#6)(1997-6#1)
trkA-##2##1##(1995-8#2)
trkB and trkC##3##3##(1995-11#2)(1996-12#1)
trkB encodes##2##2##(1991-5#2)
trkB##20##1##(1991-5#6)(1995-11#3)(1996-12#11)
trkB-##2##1##(1995-8#2)
trkC mRNA##2##2##(1995-11#2)
trkC##13##1##(1995-11#4)(1996-12#3)(1996-3#1)(1997-5#4)(2006-8#1)
trkC-like proteins IR##2##3##(1995-8#2)
trkC-like proteins##3##2##(1995-8#3)
trkC-like##4##1##(1995-8#4)
trks##2##1##(1996-12#2)
trnL intron##2##2##(2008-12#2)
trnM##2##1##(1994-12#2)
trocar and sleeve is inserted##2##5##(1991-12#2)
trocar##19##1##(1990-12#1)(1990-8#1)(1991-12#2)(1995-3#1)(2006-4#1)(2006-6#3)(2007-7#1)(2007-8#2)(2008-12#1)(2009-3#2)(2012-12#4)
trocars##5##1##(2006-6#5)
trochanter by##2##2##(2005-3#1)(2006-6#1)
trochanter of the##2##3##(2007-12#2)
trochanter##13##1##(1993-11#1)(2005-3#1)(2006-10#2)(2006-6#1)(2007-11#3)(2007-12#2)(2007-7#1)(2008-5#1)(2008-9#1)
trochanteric bursitis##4##2##(2006-10#4)
trochanteric fat pad##2##3##(2011-12#2)
trochanteric fat##4##2##(2011-12#4)
trochanteric fracture##2##2##(2007-7#1)(2010-2#1)
trochanteric fractures##2##2##(2007-8#1)(2013-1#1)
trochanteric hip fractures##2##3##(2007-7#2)
trochanteric pain syndrome##4##3##(2006-10#3)(2013-7#1)
trochanteric##33##1##(2006-10#8)(2007-11#5)(2007-7#8)(2007-8#1)(2008-7#1)(2010-2#1)(2011-12#7)(2013-1#1)(2013-7#1)
trochlear nerve##2##2##(2011-2#2)
trochlear##7##1##(2006-11#1)(2006-5#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)
troglitazone##6##1##(2006-10#2)(2008-3#1)(2008-5#1)(2010-11#2)
troglodytes##2##1##(2008-1#1)(2009-10#1)
troleandomycin##3##1##(1990-12#2)(2011-3#1)
trolley##2##1##(2007-4#1)(2008-11#1)
trolox equivalent antioxidant capacity (TEAC)##2##5##(2006-10#1)(2008-5#1)
trolox equivalent antioxidant capacity##3##4##(2006-10#1)(2008-5#1)(2012-2#1)
trolox##12##1##(1995-12#2)(2006-10#1)(2008-10#4)(2008-5#2)(2010-12#1)(2010-4#1)(2012-2#1)
trometamol##3##1##(2008-5#1)(2012-12#2)
tromethamine##2##1##(1990-2#1)(2008-9#1)
troops##6##1##(2006-2#1)(2006-4#1)(2007-7#1)(2009-6#1)(2010-12#1)(2011-1#1)
tropane##3##1##(1994-9#1)(1995-1#1)(2013-8#1)
tropane-2 beta-carboxylic acid methyl ester##2##5##(1991-12#2)
tropeolin##2##1##(2008-10#2)
tropes##2##1##(2009-10#2)
tropharium##7##1##(2007-12#6)(2008-12#1)
trophectoderm (TE)##2##2##(2006-5#1)(2008-5#1)
trophectoderm determinant genes##4##3##(2012-12#4)
trophectoderm fate##4##2##(2012-12#4)
trophectoderm##15##1##(1991-12#2)(2006-5#2)(2008-11#1)(2008-5#1)(2008-9#1)(2012-12#8)
trophectodermal cell##6##2##(2012-12#6)
trophectodermal##7##1##(1991-12#1)(2012-12#6)
trophic action##2##2##(1992-6#1)(1993-3#1)
trophic actions##2##2##(1995-8#1)(1997-6#1)
trophic and##2##2##(2008-10#1)(2008-6#1)
trophic cascades in terrestrial##2##4##(2008-8#2)
trophic cascades##6##2##(2008-8#6)
trophic complexity##2##2##(2008-8#2)
trophic conditions##4##2##(1991-12#2)(1996-5#1)(2004-4#1)
trophic core##2##2##(2007-12#2)
trophic effect on##4##3##(1993-5#1)(1993-6#2)(1995-12#1)
trophic effect##7##2##(1990-7#1)(1993-5#1)(1993-6#2)(1995-10#1)(1995-12#1)(1997-1#1)
trophic effects of##2##3##(1995-5#1)(1997-6#1)
trophic effects##5##2##(1995-5#1)(1997-6#1)(2008-8#1)(2009-8#1)(2013-1#1)
trophic factor in##3##3##(1995-8#1)(1996-12#1)(1997-6#1)
trophic factor##13##2##(1990-7#1)(1991-3#2)(1992-7#1)(1993-4#1)(1994-5#1)(1995-8#1)(1996-12#1)(1996-4#2)(1997-6#2)(2008-1#1)
trophic factors and their##2##4##(1997-4#1)(2008-1#1)
trophic factors##13##2##(1990-7#2)(1993-4#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-4#1)(2008-1#2)(2008-11#1)(2008-8#1)(2012-1#1)
trophic groups##2##2##(2008-5#1)(2008-9#1)
trophic guilds##3##2##(2010-8#3)
trophic hormone##3##2##(1990-4#1)(1991-10#2)
trophic level##9##2##(2004-4#1)(2008-5#1)(2008-8#3)(2008-9#4)
trophic levels and##4##3##(2008-5#1)(2008-8#1)(2009-2#1)(2013-1#1)
trophic levels##23##2##(2004-2#2)(2007-3#1)(2008-5#1)(2008-8#6)(2008-9#8)(2009-2#1)(2009-6#1)(2013-1#3)
trophic relationships##2##2##(2006-5#1)(2007-3#1)
trophic signals##2##2##(1991-5#1)(1996-2#1)
trophic skin##2##2##(2007-7#1)(2007-8#1)
trophic spectrum##2##2##(2008-5#2)
trophic status##2##2##(2010-8#1)(2012-2#1)
trophic structure##2##2##(2008-9#2)
trophic support##4##2##(1991-12#1)(1991-3#1)(1996-3#1)(2009-10#1)
trophic transition networks##2##3##(2010-6#2)
trophic transition##3##2##(2010-6#3)
trophic ulcers##2##2##(2007-7#1)(2007-8#1)
trophic##163##1##(1990-3#1)(1990-4#1)(1990-7#4)(1991-10#5)(1991-11#1)(1991-12#3)(1991-3#5)(1991-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#2)(1994-5#1)(1995-10#1)(1995-12#2)(1995-5#2)(1995-8#3)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#2)(1996-5#3)(1996-6#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#4)(2004-2#2)(2004-4#3)(2006-5#1)(2007-11#1)(2007-12#2)(2007-3#6)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#11)(2008-6#1)(2008-7#3)(2008-8#19)(2008-9#17)(2009-10#1)(2009-2#1)(2009-6#1)(2009-8#2)(2010-6#3)(2010-8#8)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
trophic-level##2##1##(2008-8#1)(2009-2#1)
trophism##3##1##(1993-3#1)(2006-12#1)(2011-1#1)
trophoblast and##4##2##(1992-1#1)(1994-5#1)(1994-9#1)(2012-1#1)
trophoblast antigens##2##2##(1992-1#2)
trophoblast cells##5##2##(1994-5#1)(1995-11#1)(1997-8#1)(2011-2#1)(2013-1#1)
trophoblast invasion##5##2##(1994-9#5)
trophoblast##30##1##(1992-1#4)(1993-12#1)(1994-5#3)(1994-9#8)(1995-11#1)(1995-8#1)(1996-12#1)(1997-8#2)(2007-4#1)(2011-2#1)(2012-1#1)(2012-12#5)(2013-1#1)
trophoblastic disease##6##2##(1994-3#2)(1994-5#1)(2007-4#1)(2007-8#2)
trophoblastic tissue##3##2##(1992-8#1)(1994-5#1)(1995-8#1)
trophoblastic##21##1##(1992-8#1)(1994-3#2)(1994-5#4)(1994-6#2)(1995-8#2)(2007-4#1)(2007-8#6)(2008-7#2)(2008-9#1)
trophoblasts and##2##2##(1996-12#1)(2012-2#1)
trophoblasts##9##1##(1992-3#1)(1992-8#2)(1994-9#2)(1996-12#3)(2012-2#1)
trophocytes##2##1##(2007-12#2)
trophodynamics##2##1##(2008-11#1)(2010-8#1)
trophophoresy##2##1##(2007-12#2)
trophozoite##4##1##(1990-2#2)(1994-5#1)(1997-7#1)
trophozoites of B##2##3##(2007-12#1)(2013-1#1)
trophozoites##3##1##(2007-12#1)(2011-2#1)(2013-1#1)
tropic##7##1##(1992-6#1)(1995-1#1)(1995-9#1)(1996-3#1)(2008-10#1)(2008-9#1)(2009-8#1)
tropica in a##2##3##(2012-2#2)
tropica##9##1##(1992-2#2)(2007-2#1)(2012-12#3)(2012-2#3)
tropica]##3##1##(1992-4#2)(1992-5#1)
tropical Africa to##2##3##(2008-12#1)(2012-11#1)
tropical Africa##5##2##(2006-10#1)(2006-4#2)(2008-12#1)(2012-11#1)
tropical America##6##2##(2007-3#2)(2008-10#3)(2008-5#1)
tropical Eastern##2##2##(2013-7#2)
tropical Pacific##5##2##(1990-8#1)(2006-7#1)(2007-12#1)(2007-5#2)
tropical and sub-tropical regions##3##4##(1991-11#1)(1994-9#1)(2011-2#1)
tropical and sub-tropical##5##3##(1991-11#1)(1994-9#1)(2010-7#1)(2011-2#1)(2013-7#1)
tropical and subtropical areas##4##4##(2007-7#1)(2008-10#2)(2011-2#1)
tropical and subtropical regions of the world##3##7##(2008-11#1)(2012-2#1)(2013-1#1)
tropical and subtropical regions##5##4##(2007-3#1)(2008-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
tropical and subtropical##17##3##(1992-4#1)(1993-8#1)(2006-4#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
tropical and temperate##2##3##(2007-9#1)(2008-9#1)
tropical and##27##2##(1991-11#1)(1992-4#1)(1993-8#1)(1994-9#1)(2006-4#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
tropical anvil cirrus##2##3##(2008-2#2)
tropical areas##4##2##(1996-11#1)(2008-5#1)(2010-12#1)(2013-7#1)
tropical climate##2##2##(1992-7#1)(2007-9#1)
tropical coastal##2##2##(2011-12#1)(2012-2#1)
tropical countries##8##2##(1995-9#1)(2007-2#1)(2007-5#1)(2008-3#1)(2010-4#2)(2011-11#1)(2013-1#1)
tropical deciduous forest##3##3##(2007-3#1)(2008-5#2)
tropical disease##3##2##(2006-5#1)(2007-7#1)(2013-8#1)
tropical diseases in##3##3##(2007-2#1)(2011-2#2)
tropical diseases##10##2##(2007-2#2)(2008-8#1)(2009-4#1)(2011-2#3)(2012-2#3)
tropical dry forest in##2##4##(2007-3#2)
tropical dry forest##7##3##(2007-3#3)(2008-5#2)(2013-7#2)
tropical dry##9##2##(2007-3#3)(2008-5#2)(2013-7#4)
tropical environment##6##2##(1995-6#1)(1996-12#2)(2008-10#2)(2008-5#1)
tropical environments##2##2##(1996-12#1)(2008-10#1)
tropical fish##4##2##(2008-10#1)(2008-5#2)(2008-8#1)
tropical forage##2##2##(2008-10#1)(2011-12#1)
tropical forest diversity##2##3##(1994-3#2)
tropical forest in##2##3##(2008-5#2)
tropical forest##12##2##(1994-3#3)(2008-5#7)(2011-2#1)(2013-7#1)
tropical forests##10##2##(1991-12#1)(1992-5#1)(1994-3#2)(2008-10#1)(2008-5#2)(2013-7#3)
tropical isolates grouped together##2##4##(2008-10#2)
tropical isolates than##2##3##(2008-10#2)
tropical isolates##14##2##(2008-10#14)
tropical lowland##3##2##(2008-5#2)(2008-8#1)
tropical maize##2##2##(2008-10#1)(2012-3#1)
tropical marine##5##2##(2007-1#3)(2007-11#1)(2007-5#1)
tropical medicine and##2##3##(2010-1#2)
tropical medicine##10##2##(1995-9#3)(2006-10#1)(2007-2#1)(2010-1#4)(2012-12#1)
tropical plant##2##2##(1993-9#1)(2008-8#1)
tropical populations##2##2##(2007-3#1)(2013-7#1)
tropical rain forests##2##3##(1994-3#1)(2008-8#1)
tropical rain##3##2##(1994-3#1)(2008-8#1)(2008-9#1)
tropical rainforest##5##2##(1992-8#1)(2007-12#2)(2007-3#1)(2013-7#1)
tropical rat mite Ornithonyssus bacoti##2##5##(2006-10#2)
tropical regions##6##2##(1996-12#2)(2007-3#2)(2008-5#1)(2012-12#1)
tropical river humic substances##3##4##(2008-10#3)
tropical rural populations##2##3##(1996-11#2)
tropical skin##2##2##(2007-12#1)(2011-2#1)
tropical tree##3##2##(2005-11#1)(2008-5#1)(2008-9#1)
tropical understory plants##2##3##(2008-8#2)
tropical upwelling ecosystem in##2##4##(2008-5#2)
tropical waters##2##2##(2007-3#2)
tropical##302##1##(1990-8#1)(1991-11#4)(1991-12#1)(1992-11#2)(1992-4#1)(1992-5#1)(1992-7#2)(1992-8#1)(1993-8#1)(1993-9#1)(1994-3#6)(1994-9#1)(1995-1#1)(1995-6#1)(1995-7#1)(1995-9#4)(1996-11#5)(1996-12#5)(1996-2#2)(1996-3#2)(2005-11#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-4#4)(2006-5#2)(2006-6#1)(2006-7#3)(2006-8#2)(2007-1#3)(2007-11#1)(2007-12#4)(2007-2#9)(2007-3#23)(2007-5#7)(2007-7#3)(2007-8#3)(2007-9#4)(2008-1#1)(2008-10#50)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#3)(2008-5#36)(2008-8#12)(2008-9#4)(2009-4#1)(2009-6#1)(2009-8#3)(2010-1#4)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#2)(2010-7#2)(2011-11#1)(2011-12#2)(2011-2#12)(2012-11#1)(2012-12#2)(2012-2#10)(2012-3#1)(2013-1#2)(2013-7#18)(2013-8#2)
tropicalis and##4##2##(2007-7#1)(2008-5#2)(2012-2#1)
tropicalis is##2##2##(2006-7#1)(2008-8#1)
tropicalis##34##1##(1990-3#1)(1990-5#2)(1991-8#6)(1991-9#4)(1992-11#2)(1995-3#1)(2006-7#1)(2007-7#2)(2008-10#2)(2008-5#5)(2008-8#2)(2009-9#1)(2010-5#1)(2010-6#1)(2012-2#1)(2012-3#2)
tropicamide eye drop test##2##4##(2008-7#2)
tropicamide##8##1##(2006-8#1)(2008-7#7)
tropics and##7##2##(2007-3#1)(2008-10#2)(2010-12#1)(2011-2#2)(2012-3#1)
tropics##38##1##(1995-12#2)(1996-12#1)(2006-4#1)(2006-5#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-9#2)(2008-10#7)(2008-3#2)(2008-4#4)(2008-5#1)(2008-9#1)(2010-12#1)(2010-6#1)(2010-7#3)(2011-2#2)(2012-3#1)(2013-7#2)(2013-8#2)
tropin##6##1##(1991-1#3)(1991-12#2)(1993-5#1)
tropisetron##8##1##(1994-12#1)(1995-7#2)(1996-3#2)(2008-4#2)(2008-7#1)
tropism among##2##2##(2007-11#2)
tropism and##4##2##(2008-5#1)(2010-7#1)(2012-11#1)(2013-1#1)
tropism for the##2##3##(1992-9#1)(2009-10#1)
tropism for##4##2##(1992-9#1)(2007-11#1)(2008-9#1)(2009-10#1)
tropism of the##2##3##(2009-10#1)(2009-7#1)
tropism of##4##2##(2008-5#1)(2009-10#1)(2009-7#1)(2009-8#1)
tropism##30##1##(1991-9#1)(1992-9#1)(1995-2#1)(2006-10#2)(2007-10#1)(2007-11#6)(2008-12#1)(2008-5#2)(2008-9#1)(2009-10#3)(2009-7#2)(2009-8#1)(2010-7#1)(2011-1#1)(2012-11#2)(2012-12#2)(2013-1#2)
tropisms##6##1##(2008-10#1)(2008-5#2)(2009-8#2)(2011-1#1)
tropocollagen molecule##2##2##(2009-7#2)
tropocollagen molecules##2##2##(2009-7#2)
tropocollagen##4##1##(2009-7#4)
tropolone##2##1##(2007-8#1)(2008-10#1)
tropomyosin to actin##2##3##(1994-9#1)(1995-5#1)
tropomyosin to##4##2##(1992-8#1)(1994-9#1)(1995-5#1)(1996-5#1)
tropomyosin was##2##2##(1996-9#2)
tropomyosin were##2##2##(1994-9#1)(1996-5#1)
tropomyosin##34##1##(1990-12#2)(1991-6#2)(1992-8#3)(1992-9#4)(1994-3#1)(1994-5#1)(1994-9#9)(1995-1#1)(1995-5#1)(1996-5#4)(1996-8#1)(1996-9#4)(2010-12#1)
tropomyosins##2##1##(1990-12#1)(1997-7#1)
troponin C (TnC) and##2##4##(1995-5#1)(1995-8#1)
troponin C (TnC)##4##3##(1994-11#1)(1995-5#1)(1995-6#1)(1995-8#1)
troponin C in##3##3##(1991-2#1)(1997-2#2)
troponin C was##2##3##(1994-11#1)(1997-2#1)
troponin C##30##2##(1991-12#2)(1991-2#6)(1991-4#3)(1994-11#3)(1995-5#2)(1995-6#1)(1995-8#2)(1997-2#10)(2010-5#1)
troponin I (TnI)##4##3##(1995-8#1)(2007-8#1)(2008-7#1)(2010-12#1)
troponin I (cTnl)##2##3##(2006-6#2)
troponin I##28##2##(1995-5#2)(1995-8#2)(2006-6#2)(2007-7#1)(2007-8#1)(2008-10#8)(2008-7#3)(2010-12#3)(2010-6#1)(2011-12#1)(2011-2#2)(2013-1#2)
troponin T (TnT)##2##3##(2007-8#1)(2010-4#1)
troponin T (cTnT)##2##3##(2007-8#1)(2011-2#1)
troponin T and##2##3##(1991-12#1)(2008-3#1)
troponin T in##2##3##(2005-9#1)(2007-2#1)
troponin T p&lt##2##3##(2007-8#2)
troponin T##19##2##(1991-12#2)(1996-8#1)(2005-9#1)(2007-2#1)(2007-8#5)(2008-3#1)(2008-7#3)(2009-6#2)(2010-4#2)(2011-2#1)
troponin and##4##2##(1990-12#1)(1996-5#2)(2008-5#1)
troponin components##2##2##(1991-12#2)
troponin in##3##2##(1994-3#2)(2012-3#1)
troponin level##2##2##(2007-8#1)(2012-3#1)
troponin levels##2##2##(2010-2#1)(2013-7#1)
troponin release##2##2##(2008-6#2)
troponin##120##1##(1990-12#3)(1991-12#7)(1991-2#8)(1991-4#3)(1991-8#1)(1994-11#3)(1994-3#4)(1995-5#4)(1995-6#5)(1995-8#4)(1996-5#5)(1996-6#1)(1996-8#1)(1997-2#11)(1997-7#3)(2005-9#1)(2006-6#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#7)(2008-10#9)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#6)(2009-6#2)(2010-12#3)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#2)(2013-7#2)
troponin-I release in##2##3##(2008-6#2)
troponin-I release with##2##3##(2008-6#2)
troponin-I release##4##2##(2008-6#4)
troponin-I##10##1##(2007-8#2)(2008-3#1)(2008-6#7)
troponin-tropomyosin##2##1##(1996-5#2)
troponins and##3##2##(2010-9#1)(2011-1#1)(2011-2#1)
troponins##7##1##(1991-12#1)(1995-8#1)(2007-8#2)(2010-9#1)(2011-1#1)(2011-2#1)
tropopause##3##1##(2008-3#3)
troposphere and lower stratosphere##4##4##(2008-2#1)(2008-3#3)
troposphere and##6##2##(2008-2#2)(2008-3#4)
troposphere or##2##2##(1992-3#1)(2008-3#1)
troposphere##24##1##(1992-3#1)(1996-5#1)(2007-11#1)(2008-2#12)(2008-3#8)(2008-5#1)
tropospheric aerosols##5##2##(2008-2#2)(2008-3#3)
tropospheric and stratospheric##4##3##(1994-7#1)(2008-11#1)(2008-3#2)
tropospheric and total ozone##2##4##(2008-2#2)
tropospheric and##6##2##(1994-7#1)(2008-11#1)(2008-2#2)(2008-3#2)
tropospheric measurements##2##2##(1996-5#1)(2008-3#1)
tropospheric ozone measurements##4##3##(2008-2#3)(2008-3#1)
tropospheric ozone##17##2##(1992-3#1)(2007-8#1)(2008-2#11)(2008-3#4)
tropospheric photolysis##2##2##(2008-3#2)
tropospheric water-vapor mixing##2##3##(2008-3#2)
tropospheric water-vapor##4##2##(2008-2#2)(2008-3#2)
tropospheric##54##1##(1992-3#1)(1994-7#1)(1996-5#2)(2007-8#1)(2008-11#2)(2008-2#22)(2008-3#24)(2012-2#1)
trospium chloride was##2##3##(2008-3#2)
trospium chloride##6##2##(2008-3#4)(2012-12#2)
trouble and##2##2##(2007-10#1)(2009-11#1)
trouble in##3##2##(1990-3#1)(2008-10#1)(2013-1#1)
trouble spots##2##2##(1992-6#1)(2007-10#1)
trouble with##4##2##(1990-6#1)(1997-8#1)(2008-7#2)
trouble##36##1##(1990-3#1)(1990-6#1)(1992-6#1)(1993-2#1)(1994-9#1)(1995-12#1)(1997-8#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-7#2)(2010-2#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
trouble-shooting##2##1##(2008-6#1)(2008-9#1)
troubled by##2##2##(2007-2#1)(2007-9#1)
troubled children##2##2##(2007-9#1)(2008-11#1)
troubled times##2##2##(2008-7#1)(2008-8#1)
troubled##11##1##(1990-8#1)(1993-5#1)(1995-1#1)(1996-3#1)(2007-2#1)(2007-9#3)(2008-11#1)(2008-7#1)(2008-8#1)
troubles and##2##2##(1990-12#1)(2013-1#1)
troubles de##2##2##(2008-11#1)(2013-1#1)
troubles in##3##2##(1993-1#1)(2011-1#1)(2013-1#1)
troubles over##2##2##(2008-11#1)(2011-1#1)
troubles##21##1##(1990-12#1)(1993-1#1)(1994-3#1)(1994-6#1)(2007-10#1)(2008-11#2)(2011-1#2)(2012-12#1)(2012-2#3)(2013-1#8)
troubleshoot##2##1##(1994-2#1)(2008-11#1)
troubleshooting##12##1##(2007-3#2)(2008-1#2)(2008-4#4)(2008-9#2)(2010-7#1)(2011-2#1)
troublesome belching##7##2##(2013-8#7)
troublesome symptoms##2##2##(2007-12#1)(2008-3#1)
troublesome##34##1##(1993-12#1)(1994-3#1)(1996-11#1)(2006-1#1)(2006-10#3)(2007-11#1)(2007-12#1)(2007-8#3)(2008-10#2)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-6#1)(2011-2#1)(2013-8#8)
troubling##5##1##(2004-3#1)(2007-8#1)(2008-1#1)(2008-7#1)(2012-11#1)
trough concentrations##2##2##(1997-4#1)(2007-11#1)
trough in##2##2##(2005-11#1)(2007-10#1)
trough levels##5##2##(1995-2#1)(2006-4#2)(2008-8#1)(2009-1#1)
trough plasma concentrations##2##3##(1992-8#1)(2005-8#1)
trough plasma##4##2##(1992-4#1)(1992-8#1)(2005-8#1)(2012-12#1)
trough reflector##2##2##(2008-2#2)
trough the##3##2##(2008-9#1)(2010-4#1)(2012-2#1)
trough##34##1##(1992-4#1)(1992-8#3)(1993-12#1)(1995-2#3)(1997-4#1)(2005-11#1)(2005-8#1)(2006-2#1)(2006-4#2)(2007-10#1)(2007-11#3)(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-8#1)(2008-9#1)(2009-1#3)(2009-7#1)(2010-4#1)(2010-9#1)(2012-12#1)(2012-2#2)
troughs##5##1##(2008-10#2)(2008-2#1)(2009-3#1)(2010-10#1)
trout (Oncorhynchus mykiss)##9##3##(1992-1#1)(1993-5#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-5#1)(2013-7#1)
trout (Oncorhynchus##11##2##(1992-1#1)(1993-5#1)(2008-5#1)(2008-6#1)(2008-7#5)(2009-5#1)(2013-7#1)
trout (Salmo##2##2##(2008-3#1)(2008-5#1)
trout MT##2##2##(1994-11#1)(1997-2#1)
trout Onchorhynchus##2##2##(2010-8#2)
trout Oncorhynchus##11##2##(1992-12#1)(2010-8#8)(2012-3#2)
trout P450 LMC5##3##3##(1991-4#3)
trout P450##4##2##(1991-4#4)
trout and##8##2##(1990-3#1)(1991-4#1)(1993-8#1)(1997-2#3)(2008-3#2)
trout fisheries##2##2##(2009-5#2)
trout liver##6##2##(1990-12#2)(1991-4#1)(1992-6#1)(1996-11#1)(1997-3#1)
trout saccular macula##2##3##(1991-9#2)
trout were##2##2##(2008-7#1)(2009-5#1)
trout##126##1##(1990-10#2)(1990-12#2)(1990-3#1)(1990-5#1)(1991-4#7)(1991-9#2)(1992-1#4)(1992-12#2)(1992-6#2)(1993-4#2)(1993-5#1)(1993-8#1)(1994-11#2)(1994-5#3)(1995-7#3)(1996-11#3)(1997-2#6)(1997-3#2)(1997-9#4)(2005-10#3)(2005-8#3)(2007-9#2)(2008-10#2)(2008-11#3)(2008-3#8)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#8)(2009-4#4)(2009-5#6)(2009-6#2)(2010-4#2)(2010-8#14)(2012-3#9)(2013-7#2)
trout)##2##1##(1997-9#1)(2008-4#1)
troutCYP1A-CAT construct##2##2##(2008-11#2)
troutCYP1A-CAT##5##1##(2008-11#5)
trouve##2##1##(2013-1#2)
trp operator##4##2##(1992-6#2)(1994-3#2)
trp operon##3##2##(1990-9#2)(1994-6#1)
trp promoter##2##2##(1990-9#1)(2008-10#1)
trp repressor##9##2##(1992-1#2)(1992-6#3)(1992-8#4)
trp##27##1##(1990-7#2)(1990-9#4)(1992-1#2)(1992-6#5)(1992-8#4)(1993-12#1)(1994-3#3)(1994-6#2)(1994-8#2)(1996-12#1)(2008-10#1)
trpC genes##2##2##(1990-9#1)(1997-2#1)
trpC promoter##2##2##(2008-10#2)
trpC##6##1##(1990-9#1)(1997-2#2)(2008-10#2)(2011-1#1)
trpD and##2##2##(1990-9#1)(1997-2#1)
trpD##4##1##(1990-3#1)(1990-9#1)(1997-2#2)
trpE##3##1##(1990-3#1)(1990-9#1)(1995-12#1)
truancy and##2##2##(2005-10#2)
truancy##3##1##(2005-10#3)
truck and##2##2##(2008-5#1)(2011-2#1)
truck drivers##5##2##(1991-6#2)(2012-3#3)
truck##15##1##(1991-6#2)(2007-8#1)(2008-5#6)(2008-7#1)(2011-2#2)(2012-3#3)
truckers##3##1##(2012-3#3)
trucking of manure##2##3##(2008-5#2)
trucking##5##1##(2008-5#4)(2013-1#1)
truckloads exceeding 20 ng/g##2##4##(2008-10#2)
truckloads##3##1##(2008-10#3)
trucks##3##1##(1994-3#1)(2006-11#1)(2007-10#1)
true &quot##3##2##(1995-12#1)(2006-6#1)(2011-2#1)
true absorption and endogenous fecal excretion of##3##7##(2010-2#3)
true absorption of Zn##2##4##(2010-2#2)
true absorption##6##2##(2008-12#1)(2010-2#5)
true airspeed sensor##2##3##(2007-11#2)
true alarm##3##2##(1997-6#2)(1997-8#1)
true and false##3##3##(2007-8#1)(2008-3#1)(2010-1#1)
true and##13##2##(1993-5#1)(1994-9#3)(1995-6#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-1#1)(2010-2#1)(2011-2#1)
true aneurysms##2##2##(2010-8#1)(2011-2#1)
true associations##3##2##(1990-3#1)(2012-11#1)(2012-3#1)
true at##3##2##(2006-10#1)(2008-10#1)(2008-7#1)
true benefit of##2##3##(1995-12#1)(2009-11#1)
true breathing-zone sampling##3##3##(2010-5#3)
true causal##2##2##(2012-3#2)
true clinical##2##2##(2007-11#1)(2012-2#1)
true cut biopsy##2##3##(2011-2#2)
true cysts##2##2##(1992-5#1)(2012-3#1)
true density##2##2##(2008-10#1)(2010-12#1)
true difference##2##2##(1992-2#1)(1995-5#1)
true disease##2##2##(2006-2#1)(2008-10#1)
true even##3##2##(1995-5#1)(2006-4#1)(2012-2#1)
true event probability##2##3##(1996-1#2)
true exposures##2##2##(2008-7#2)
true for many##2##3##(2006-8#1)(2008-12#1)
true for patients with##2##4##(1997-8#1)(2010-12#1)
true for patients##3##3##(1997-8#1)(2006-10#1)(2010-12#1)
true for some##3##3##(2010-4#1)(2013-1#2)
true for the##11##3##(1990-12#1)(1992-9#1)(1994-2#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-3#2)(2012-2#1)
true for##44##2##(1990-12#2)(1990-5#1)(1991-8#1)(1991-9#1)(1992-9#1)(1993-2#1)(1994-2#1)(1994-3#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-12#3)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-11#3)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)
true fungi##2##2##(2008-10#2)
true health care##2##3##(1997-1#1)(2009-12#1)
true hermaphroditism##3##2##(2006-7#2)(2008-5#1)
true hermaphrodits##2##2##(2006-7#2)
true image##3##2##(2008-2#2)(2008-3#1)
true in the##6##3##(1992-1#1)(1994-12#1)(2007-5#1)(2010-10#1)(2010-11#1)(2013-1#1)
true in##18##2##(1992-1#1)(1992-2#1)(1992-9#1)(1994-12#1)(1994-8#1)(2006-2#1)(2007-5#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-10#1)(2010-11#2)(2011-1#1)(2012-3#1)(2013-1#1)
true incidence and prevalence of##2##5##(2010-6#1)(2011-1#1)
true incidence of##6##3##(2006-8#1)(2007-2#1)(2008-8#1)(2011-2#1)(2013-1#2)
true incidence##10##2##(1994-9#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#2)
true intraocular pressure and modulus of elasticity##3##7##(2007-9#3)
true intraocular pressure##5##3##(2007-9#5)
true leaf##3##2##(2008-9#3)
true leaves##6##2##(2008-10#6)
true lumen##9##2##(2007-8#4)(2008-11#4)(2012-2#1)
true of##7##2##(1991-5#1)(1991-9#1)(1992-10#1)(1993-9#1)(1996-10#1)(2008-9#1)(2013-7#1)
true only##2##2##(2006-4#1)(2009-8#1)
true or false##2##3##(1997-6#1)(2007-12#1)
true or##3##2##(1997-6#1)(2007-12#1)(2008-1#1)
true outliers##2##2##(2007-11#2)
true partnership##2##2##(2008-2#1)(2010-3#1)
true phase##3##2##(2008-2#2)(2008-3#1)
true positive##5##2##(1990-6#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-1#1)
true positives##6##2##(2008-10#1)(2008-12#1)(2009-3#1)(2012-3#1)(2013-1#2)
true prevalence of##2##3##(2008-12#1)(2012-3#1)
true prevalence##4##2##(1991-5#1)(2006-12#1)(2008-12#1)(2012-3#1)
true profiles##2##2##(2008-2#2)
true real-time##2##2##(2007-11#1)(2007-12#1)
true recrudescence##2##2##(2006-10#2)
true refusers##2##2##(1991-6#2)
true regarding##2##2##(1990-1#1)(2009-5#1)
true relationship##2##2##(1997-4#1)(2007-10#1)
true risk##3##2##(1992-3#1)(1993-9#1)(2012-1#1)
true scene##2##2##(2008-3#2)
true schizophreniform disorder##2##3##(1995-11#2)
true spectra and intrinsic##2##4##(2006-10#2)
true spectra and##3##3##(2006-10#3)
true that##3##2##(2007-11#1)(2008-10#1)(2012-2#1)
true time##3##2##(2007-1#1)(2007-12#2)
true to##3##2##(1990-12#1)(2007-11#1)(2010-2#1)
true value of##7##3##(1993-6#1)(2006-10#3)(2006-12#1)(2008-10#1)(2008-9#1)
true value##10##2##(1993-6#1)(1995-4#1)(2006-10#3)(2006-12#1)(2008-10#2)(2008-2#1)(2008-9#1)
true values##3##2##(1995-4#2)(1995-6#1)
true vocal fold##3##3##(2008-5#1)(2011-2#1)(2012-2#1)
true vocal##4##2##(2008-5#1)(2011-2#2)(2012-2#1)
true when the##2##3##(2008-10#1)(2011-3#1)
true when##5##2##(1991-7#1)(2005-12#1)(2008-10#1)(2010-12#1)(2011-3#1)
true whether##3##2##(1996-5#1)(2006-9#1)(2008-4#1)
true with##3##2##(1993-6#1)(2006-8#1)(2007-9#1)
true##589##1##(1990-1#2)(1990-10#2)(1990-12#3)(1990-3#1)(1990-5#2)(1990-6#3)(1990-8#6)(1991-1#1)(1991-5#5)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#3)(1993-12#3)(1993-2#1)(1993-5#2)(1993-6#5)(1993-7#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#6)(1995-11#4)(1995-12#3)(1995-2#2)(1995-4#5)(1995-5#4)(1995-6#2)(1995-9#1)(1996-1#3)(1996-10#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#4)(1996-8#1)(1997-1#1)(1997-2#4)(1997-3#4)(1997-4#1)(1997-5#2)(1997-6#3)(1997-8#4)(2004-2#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-4#1)(2005-7#1)(2006-10#12)(2006-12#5)(2006-2#3)(2006-3#1)(2006-4#4)(2006-6#3)(2006-7#4)(2006-8#8)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#11)(2007-12#13)(2007-2#4)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#14)(2007-9#15)(2008-1#8)(2008-10#46)(2008-11#11)(2008-12#8)(2008-2#20)(2008-3#28)(2008-4#5)(2008-5#7)(2008-6#2)(2008-7#16)(2008-8#11)(2008-9#11)(2009-11#3)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#6)(2010-12#9)(2010-2#8)(2010-3#3)(2010-4#1)(2010-5#4)(2010-6#4)(2010-7#3)(2010-8#6)(2010-9#1)(2011-1#6)(2011-2#21)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#8)(2012-2#15)(2012-3#17)(2012-7#1)(2013-1#21)(2013-7#4)
true&quot##8##1##(2006-7#2)(2008-10#1)(2010-12#2)(2011-12#1)(2011-2#1)(2012-2#1)
true-positive rates##2##2##(2012-3#2)
true-positive##4##1##(1992-4#1)(2012-3#3)
true-time delay device##2##3##(2007-12#1)(2008-2#1)
true-time delay##7##2##(2007-12#6)(2008-2#1)
true-time delays that##2##3##(2007-11#1)(2007-12#1)
true-time delays##7##2##(2007-11#1)(2007-12#4)(2008-2#2)
true-time##14##1##(2007-11#1)(2007-12#10)(2008-2#3)
true-time-delay (TTD)##3##2##(2007-12#1)(2008-3#2)
true-time-delay module for##2##3##(2007-12#1)(2008-3#1)
true-time-delay steering system##2##3##(2008-2#2)
true-time-delay steering##3##2##(2008-2#3)
true-time-delay##13##1##(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#6)
true?##3##1##(2005-9#1)(2009-11#1)(2013-8#1)
trueness##2##1##(2008-10#2)
truly causal##2##2##(2012-3#2)
truly novel##2##2##(2007-11#1)(2010-11#1)
truly the##2##2##(1991-3#1)(2007-12#1)
truly##73##1##(1991-3#1)(1992-10#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-3#1)(2004-4#1)(2006-10#3)(2006-12#3)(2006-4#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#5)(2013-1#1)(2013-7#1)(2013-8#3)
truncal obesity##2##2##(2009-4#1)(2011-2#1)
truncal vagotomy##2##2##(1990-6#1)(2006-8#1)
truncal##8##1##(1990-6#1)(2006-6#1)(2006-8#1)(2007-11#3)(2009-4#1)(2011-2#1)
truncate##3##1##(1993-2#1)(2008-3#1)(2008-5#1)
truncated DNA polymerase from Thermus thermophilus (delta Tth polymerase)##2##9##(1996-4#2)
truncated FGFR##3##2##(1992-2#3)
truncated FGFR1##2##2##(1992-2#2)
truncated N-terminal##2##2##(1993-7#1)(2011-2#1)
truncated Poisson##2##2##(1997-8#2)
truncated alpha##2##2##(1994-8#1)(1995-6#1)
truncated and##6##2##(1990-7#1)(1994-12#1)(2008-11#1)(2008-3#1)(2008-8#1)(2013-7#1)
truncated at the##2##3##(1995-6#1)(2008-2#1)
truncated at##3##2##(1993-8#1)(1995-6#1)(2008-2#1)
truncated derivatives##2##2##(1994-5#2)
truncated form of the##6##4##(1992-12#1)(1992-2#1)(1992-6#1)(1993-2#1)(1994-10#1)(1994-9#1)
truncated form of##14##3##(1991-12#1)(1992-12#1)(1992-2#2)(1992-6#1)(1993-2#1)(1994-10#1)(1994-9#2)(1995-8#1)(2006-8#1)(2008-11#1)(2008-9#1)(2012-12#1)
truncated form##17##2##(1990-4#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-6#1)(1993-2#1)(1994-10#1)(1994-9#2)(1995-8#1)(2006-8#1)(2007-11#1)(2008-11#1)(2008-9#1)(2012-12#1)
truncated forms of##9##3##(1990-3#1)(1991-2#1)(1991-5#1)(1994-11#1)(1994-8#1)(1995-6#1)(1997-4#3)
truncated forms##11##2##(1990-2#1)(1990-3#1)(1991-2#1)(1991-5#1)(1994-11#1)(1994-8#1)(1995-6#1)(1997-4#3)(2008-4#1)
truncated gamma##2##2##(1994-9#2)
truncated human##2##2##(1990-8#1)(1997-4#1)
truncated in the N-terminal##2##4##(1992-9#1)(1994-12#1)
truncated in##3##2##(1992-9#1)(1994-12#1)(1997-6#1)
truncated mutant##3##2##(2008-9#3)
truncated mutants##2##2##(1992-9#1)(2008-9#1)
truncated octahedron##2##2##(2009-2#2)
truncated peptides##4##2##(1994-2#1)(1995-2#2)(1997-4#1)
truncated prior to the##2##4##(1994-8#1)(2008-8#1)
truncated product of##2##3##(1997-6#1)(1997-8#1)
truncated product##4##2##(1997-6#1)(1997-8#1)(2008-1#1)(2012-3#1)
truncated protein##5##2##(1990-7#1)(1991-5#1)(1993-9#1)(1997-1#1)(1997-5#1)
truncated proteins##5##2##(1992-6#1)(1996-2#1)(2008-10#1)(2012-12#2)
truncated receptor##2##2##(1991-5#1)(1995-10#1)
truncated singular-value decomposition##2##3##(2008-3#2)
truncated the##2##2##(1997-3#1)(2008-2#1)
truncated version of##4##3##(1994-9#1)(1995-8#1)(1996-11#1)(1996-8#1)
truncated version##5##2##(1994-9#1)(1995-8#1)(1996-11#1)(1996-8#1)(1997-7#1)
truncated##208##1##(1990-10#2)(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-6#1)(1990-7#3)(1990-8#1)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#1)(1991-4#1)(1991-5#3)(1991-9#1)(1992-1#2)(1992-12#3)(1992-2#7)(1992-3#1)(1992-6#3)(1992-8#3)(1992-9#3)(1993-11#1)(1993-2#1)(1993-4#3)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-5#2)(1994-8#6)(1994-9#7)(1995-1#1)(1995-10#3)(1995-2#7)(1995-3#1)(1995-5#2)(1995-6#4)(1995-8#3)(1996-1#1)(1996-10#2)(1996-11#5)(1996-12#3)(1996-2#2)(1996-4#2)(1996-5#2)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#5)(1997-5#1)(1997-6#4)(1997-7#6)(1997-8#4)(2005-10#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-4#1)(2006-8#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#6)(2008-9#5)(2009-12#1)(2009-2#4)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-3#1)(2013-7#1)(2013-8#1)
truncating the##3##2##(2008-10#2)(2008-3#1)
truncating##5##1##(1990-5#1)(2008-10#2)(2008-3#1)(2008-8#1)
truncation and deletion mutants##2##4##(1991-12#2)
truncation and##4##2##(1990-4#1)(1991-12#2)(2008-11#1)
truncation at the##2##3##(1993-2#1)(1994-12#1)
truncation of the##8##3##(1990-8#1)(1995-1#1)(1997-4#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)
truncation of##14##2##(1990-8#1)(1992-8#1)(1993-11#1)(1995-1#1)(1995-11#1)(1997-4#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-12#1)
truncation test##4##2##(2004-2#1)(2008-4#3)
truncation##45##1##(1990-12#1)(1990-4#1)(1990-8#2)(1991-12#2)(1991-5#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#2)(1994-12#1)(1994-2#1)(1995-1#2)(1995-10#2)(1995-11#1)(1995-3#2)(1996-10#1)(1997-4#2)(2004-2#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-6#2)(2008-8#1)(2009-12#1)(2011-12#1)
truncations##5##1##(1990-12#1)(1994-1#1)(1995-3#1)(1995-6#1)(2009-6#1)
truncatula in##2##2##(2008-10#1)(2011-12#1)
truncatula##26##1##(2008-10#11)(2008-7#1)(2009-10#1)(2009-3#2)(2009-8#5)(2011-12#4)(2011-2#1)(2012-11#1)
truncatum##5##1##(2007-11#2)(2008-10#3)
truncatus##7##1##(2007-3#1)(2007-6#6)
trunk BF##2##2##(2006-6#2)
trunk and breast##2##3##(1994-6#2)
trunk and extremities##6##3##(2005-11#1)(2007-7#2)(2008-6#1)(2010-6#1)(2013-8#1)
trunk and limbs##4##3##(2007-6#1)(2007-7#1)(2008-5#1)(2013-8#1)
trunk and##25##2##(1994-6#2)(1996-3#1)(2005-11#1)(2006-4#1)(2007-11#1)(2007-6#1)(2007-7#4)(2007-8#2)(2008-5#1)(2008-6#2)(2008-9#1)(2009-10#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#2)
trunk by##2##2##(1994-2#1)(2006-6#1)
trunk during##2##2##(1995-8#1)(2006-7#1)
trunk in the##5##3##(2007-12#1)(2007-7#1)(2008-10#1)(2010-7#1)(2011-1#1)
trunk in##10##2##(1995-8#1)(2006-7#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-6#1)(2010-7#1)(2011-1#1)(2013-1#1)
trunk limbs##3##2##(2007-12#3)
trunk muscle activity##2##3##(2012-12#2)
trunk of the subdiaphragmatic vagus were##2##6##(1993-12#2)
trunk of the##9##3##(1993-12#2)(1997-3#1)(2006-12#1)(2008-12#2)(2008-4#1)(2008-7#1)(2012-2#1)
trunk of##14##2##(1993-12#2)(1997-3#1)(2006-12#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-12#2)(2012-2#1)
trunk on the right##2##4##(1990-2#1)(1996-3#1)
trunk on the##3##3##(1990-2#1)(1996-3#1)(2007-8#1)
trunk on##4##2##(1990-2#1)(1996-3#1)(2007-8#1)(2010-7#1)
trunk rotation in##2##3##(1995-8#1)(1996-1#1)
trunk rotation##4##2##(1995-8#1)(1996-1#2)(2008-12#1)
trunk strength and stability on##2##5##(2008-12#2)
trunk strength and stability##3##4##(2008-12#3)
trunk##172##1##(1990-2#1)(1991-12#1)(1991-2#1)(1991-3#1)(1993-12#3)(1993-9#1)(1994-1#1)(1994-2#1)(1994-6#2)(1995-8#6)(1996-1#2)(1996-3#2)(1997-3#4)(1997-8#1)(2005-10#1)(2005-11#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#5)(2006-7#6)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#11)(2007-8#10)(2008-10#6)(2008-12#6)(2008-4#4)(2008-5#5)(2008-6#15)(2008-7#6)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-6#2)(2010-7#4)(2010-8#1)(2011-1#4)(2011-12#2)(2011-2#6)(2012-12#8)(2012-2#5)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#3)
trunk)##3##1##(1996-5#1)(2006-6#1)(2011-1#1)
trunk]##2##1##(1993-5#1)(2012-3#1)
trunks and##4##2##(1996-2#1)(2008-10#2)(2013-7#1)
trunks of##2##2##(2007-12#1)(2008-10#1)
trunks##13##1##(1991-9#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-3#1)(2007-12#2)(2008-10#4)(2008-3#1)(2013-7#1)
trust and##7##2##(1995-12#1)(2006-6#1)(2008-1#2)(2010-4#1)(2012-12#1)(2013-8#1)
trust between##4##2##(1994-12#1)(1996-1#1)(2004-12#1)(2007-4#1)
trust fund##2##2##(1990-12#1)(1993-1#1)
trust in doctors##2##3##(2011-1#1)(2012-3#1)
trust in the##2##3##(2007-11#1)(2008-3#1)
trust in##16##2##(2007-11#2)(2007-2#1)(2007-4#1)(2008-12#1)(2008-3#1)(2009-4#2)(2009-6#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
trust the##2##2##(2012-2#1)(2013-8#1)
trust to##2##2##(1997-4#1)(2009-9#1)
trust##92##1##(1990-12#1)(1991-1#1)(1992-10#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-9#2)(1996-1#3)(1996-2#1)(1997-3#2)(1997-4#2)(1997-7#1)(2004-12#1)(2004-2#2)(2006-10#1)(2006-6#1)(2006-7#1)(2007-10#2)(2007-11#3)(2007-2#2)(2007-4#3)(2007-9#1)(2008-1#3)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#4)(2009-4#2)(2009-6#2)(2009-8#1)(2009-9#2)(2010-10#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#4)(2011-9#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#4)(2013-8#7)
trusted##11##1##(1992-1#1)(2007-2#1)(2008-11#1)(2008-7#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#2)
trustee##6##1##(1992-3#1)(1993-1#1)(1993-2#1)(1994-1#1)(1995-1#1)(1996-12#1)
trustees and CEOs##2##3##(1995-3#2)
trustees##18##1##(1990-12#1)(1993-2#4)(1993-3#2)(1994-2#3)(1995-3#3)(1996-2#1)(2007-4#3)(2012-2#1)
trusteeship##2##1##(1993-2#2)
trusting##4##1##(1994-12#1)(2008-12#1)(2012-3#2)
trusts##7##1##(1997-5#1)(2008-11#2)(2009-7#1)(2011-2#1)(2013-8#2)
trustworthiness##2##1##(1994-2#1)(2009-11#1)
trustworthy##10##1##(1992-3#1)(2006-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
truth about##4##2##(1995-1#1)(2008-11#1)(2008-6#1)(2008-8#1)
truth is##2##2##(1994-2#1)(2008-2#1)
truth of the##2##3##(1992-6#1)(2006-3#1)
truth telling in##2##3##(2013-1#2)
truth##24##1##(1992-6#1)(1994-2#1)(1995-1#1)(1996-9#1)(1997-5#1)(2006-3#1)(2007-10#1)(2007-9#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#2)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
truthful##2##1##(1991-2#1)(2008-10#1)
truths about##2##2##(1991-1#1)(2011-2#1)
truths##3##1##(1991-1#1)(2008-1#1)(2011-2#1)
trutta##8##1##(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-8#3)
trxA##4##1##(2008-4#2)(2009-10#2)
trxB##2##1##(2009-10#2)
trxC##2##1##(2009-10#2)
trxQ##3##1##(2009-10#3)
try and##5##2##(2006-10#1)(2008-1#1)(2008-3#1)(2008-4#1)(2010-12#1)
try to address these##2##4##(2008-11#1)(2009-11#1)
try to address##3##3##(2008-11#1)(2009-11#1)(2011-2#1)
try to define##2##3##(2006-11#1)(2008-1#1)
try to establish##2##3##(1993-6#1)(2008-9#1)
try to explain the##2##4##(2008-10#1)(2009-11#1)
try to explain##4##3##(1993-9#1)(2008-10#1)(2009-11#2)
try to find##3##3##(2006-10#1)(2008-2#1)(2009-4#1)
try to give##2##3##(2009-10#1)(2010-5#1)
try to identify##2##3##(2007-2#1)(2008-9#1)
try to improve##2##3##(2011-2#1)(2012-3#1)
try to keep##2##3##(1996-3#1)(2009-2#1)
try to preserve##2##3##(2007-12#2)
try to show##2##3##(2006-3#1)(2009-10#1)
try to understand how the##2##5##(1992-3#1)(2009-10#1)
try to understand how##3##4##(1992-3#1)(2009-10#1)(2009-7#1)
try to understand##6##3##(1992-3#1)(1994-11#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-5#1)
try to##72##2##(1991-12#1)(1992-3#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-3#2)(1997-3#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-11#1)(2006-3#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-1#1)(2009-10#3)(2009-11#3)(2009-2#1)(2009-4#3)(2009-6#2)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-5#2)(2010-7#1)(2011-1#3)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
try##87##1##(1991-1#1)(1991-12#1)(1992-1#1)(1992-3#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-2#1)(1996-3#2)(1997-3#2)(1997-5#1)(1997-7#1)(2006-10#2)(2006-11#1)(2006-3#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-5#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#3)(2008-7#1)(2008-9#4)(2009-1#1)(2009-10#3)(2009-11#3)(2009-2#1)(2009-4#3)(2009-6#2)(2009-7#1)(2009-8#1)(2010-12#3)(2010-2#1)(2010-5#2)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
trygliceride##2##1##(2008-7#1)(2010-1#1)
trying to determine##2##3##(2007-8#2)
trying to develop##3##3##(1994-3#1)(2006-10#1)(2008-12#1)
trying to get##2##3##(2007-9#1)(2011-1#1)
trying to lose weight##5##4##(2009-2#3)(2010-7#1)(2013-7#1)
trying to make##4##3##(2007-8#1)(2008-2#1)(2010-8#1)(2011-2#1)
trying to meet##2##3##(2007-10#1)(2008-3#1)
trying to prevent##2##3##(2009-12#1)(2010-9#1)
trying to understand##5##3##(1995-1#1)(2005-8#1)(2006-12#1)(2009-10#1)(2009-2#1)
trying to##76##2##(1990-3#1)(1990-4#1)(1992-6#1)(1993-2#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#2)(2007-10#1)(2007-12#1)(2007-8#5)(2007-9#3)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#5)(2009-4#1)(2009-6#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#4)(2013-7#1)
trying##82##1##(1990-3#1)(1990-4#1)(1992-12#1)(1992-6#1)(1993-2#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#3)(2007-10#1)(2007-12#1)(2007-8#5)(2007-9#3)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#5)(2009-4#1)(2009-6#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
trypan blue dye exclusion assay##2##5##(2008-11#2)
trypan blue dye exclusion##4##4##(1992-9#1)(2008-11#2)(2008-8#1)
trypan blue exclusion##6##3##(2008-1#1)(2008-11#2)(2008-9#1)(2012-11#1)(2013-1#1)
trypan blue staining##2##3##(2010-5#2)
trypan blue test and##2##4##(2007-11#1)(2013-1#1)
trypan blue##22##2##(1992-9#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#7)(2008-4#1)(2008-8#1)(2008-9#1)(2010-5#2)(2010-7#1)(2012-11#1)(2013-1#2)
trypan##23##1##(1992-9#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#7)(2008-4#1)(2008-8#1)(2008-9#1)(2010-5#2)(2010-7#1)(2012-11#1)(2013-1#2)
trypanocidal drugs and##2##3##(1997-7#1)(2007-8#1)
trypanocidal drugs##3##2##(1997-7#1)(2007-8#2)
trypanocidal##4##1##(1997-7#1)(2007-6#1)(2007-8#2)
trypanosomatid parasites of plants##3##4##(2008-10#3)
trypanosomatid parasites##5##2##(2008-10#4)(2008-3#1)
trypanosomatid##10##1##(1995-11#2)(1996-8#1)(2006-10#1)(2008-10#4)(2008-3#1)(2013-8#1)
trypanosomatids##3##1##(2006-10#2)(2008-10#1)
trypanosome cells##2##2##(1993-9#2)
trypanosome##11##1##(1993-9#3)(1994-9#1)(1995-8#2)(1997-4#1)(2006-10#1)(2007-6#3)
trypanosomes is##2##2##(2006-10#1)(2010-2#1)
trypanosomes##18##1##(1990-7#2)(1994-6#2)(2006-10#5)(2006-12#1)(2007-6#1)(2010-2#2)(2013-1#2)(2013-8#3)
trypanosomiasis in##3##2##(2006-10#1)(2013-1#2)
trypanosomiasis is##2##2##(2006-10#1)(2012-2#1)
trypanosomiasis##14##1##(1994-2#1)(2006-10#6)(2006-5#1)(2007-6#2)(2012-2#1)(2013-1#3)
trypanosomiasis)##3##1##(2008-2#1)(2008-5#2)
trypanosomosis control##3##2##(1997-7#1)(2007-8#2)
trypanosomosis##5##1##(1997-7#2)(2007-8#3)
trypanothione reductase##2##2##(1990-12#2)
trypanotolerance##2##1##(2006-10#2)
trypomastigotes which##2##2##(1990-10#1)(1990-7#1)
trypomastigotes##4##1##(1990-10#3)(1990-7#1)
trypsin S214K##2##2##(1992-3#2)
trypsin activity##2##2##(1993-5#1)(2008-10#1)
trypsin and chymotrypsin##7##3##(1990-5#1)(1990-9#1)(1991-9#2)(1992-9#1)(1996-9#1)(2009-4#1)
trypsin and kallikrein##2##3##(1990-5#2)
trypsin and the##2##3##(1996-12#1)(2008-4#1)
trypsin and##27##2##(1990-11#1)(1990-5#3)(1990-9#1)(1991-2#1)(1991-8#1)(1991-9#2)(1992-12#3)(1992-9#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-7#1)(1996-12#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-2#1)(2005-8#1)(2008-4#1)(2009-4#2)
trypsin at##2##2##(1990-7#1)(1991-3#1)
trypsin but##2##2##(1995-6#1)(1996-3#1)
trypsin by##4##2##(1990-12#1)(1990-9#1)(1992-11#1)(2008-7#1)
trypsin cleavage patterns##2##3##(1990-11#2)
trypsin cleavage##3##2##(1990-11#2)(1990-3#1)
trypsin cleaved##4##2##(1991-3#1)(1993-11#3)
trypsin digest of##2##3##(2008-5#1)(2010-2#1)
trypsin digestion of##2##3##(1990-5#1)(1997-1#1)
trypsin digestion##10##2##(1990-2#1)(1990-5#2)(1991-5#1)(1991-8#1)(1993-11#1)(1994-9#1)(1995-3#1)(1997-1#1)(2008-9#1)
trypsin fragments##3##2##(1990-4#3)
trypsin immobilized##3##2##(1997-2#2)(2013-8#1)
trypsin inhibitor and##5##3##(1990-11#1)(1990-3#1)(1991-8#1)(1992-8#1)(1995-7#1)
trypsin inhibitor##49##2##(1990-11#1)(1990-12#3)(1990-3#3)(1990-5#2)(1990-8#1)(1991-11#1)(1991-2#3)(1991-5#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-6#2)(1992-8#1)(1993-5#2)(1994-3#2)(1994-6#1)(1994-9#1)(1995-10#1)(1995-2#2)(1995-4#3)(1995-5#1)(1995-7#1)(1996-11#1)(1997-2#1)(1997-4#1)(1997-5#2)(2006-10#2)(2008-10#4)(2008-7#1)
trypsin inhibitors##2##2##(1991-9#1)(1996-6#1)
trypsin inhibitory activity##3##3##(1993-11#3)
trypsin inhibitory##4##2##(1991-12#1)(1993-11#3)
trypsin is##4##2##(1990-12#1)(1992-3#1)(2008-11#1)(2008-9#1)
trypsin or protease##2##3##(1994-5#1)(1995-6#1)
trypsin or##7##2##(1991-1#1)(1991-2#1)(1992-11#1)(1992-6#1)(1994-5#1)(1995-6#1)(2008-10#1)
trypsin output##3##2##(1991-2#3)
trypsin removes##2##2##(1992-8#1)(1996-5#1)
trypsin specific##2##2##(2009-4#2)
trypsin treatment in##2##3##(1990-5#1)(1993-3#1)
trypsin treatment of##5##3##(1992-8#1)(1993-3#1)(1996-11#1)(1996-5#1)(1996-8#1)
trypsin treatment##15##2##(1990-10#1)(1990-5#2)(1991-11#1)(1992-3#1)(1992-8#1)(1993-3#4)(1996-11#1)(1996-5#2)(1996-8#1)(2008-7#1)
trypsin was used to##2##4##(1990-2#1)(1990-8#1)
trypsin was##6##2##(1990-2#1)(1990-8#1)(1990-9#1)(1995-2#1)(2008-7#2)
trypsin##281##1##(1990-10#1)(1990-11#4)(1990-12#10)(1990-2#6)(1990-3#6)(1990-4#4)(1990-5#14)(1990-6#1)(1990-7#3)(1990-8#5)(1990-9#4)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#9)(1991-3#6)(1991-5#4)(1991-7#2)(1991-8#4)(1991-9#7)(1992-11#6)(1992-12#6)(1992-3#9)(1992-5#1)(1992-6#5)(1992-7#2)(1992-8#5)(1992-9#2)(1993-11#7)(1993-3#6)(1993-5#3)(1993-8#3)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#4)(1995-10#1)(1995-2#4)(1995-3#6)(1995-4#3)(1995-5#2)(1995-6#3)(1995-7#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#6)(1996-5#5)(1996-6#6)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#6)(1997-4#2)(1997-5#3)(1997-8#1)(2004-9#2)(2005-8#1)(2006-10#3)(2006-8#1)(2006-9#1)(2007-8#1)(2008-10#11)(2008-11#6)(2008-4#1)(2008-5#2)(2008-7#7)(2008-8#4)(2008-9#3)(2009-4#6)(2010-2#1)(2013-8#3)
trypsin(ogen)##2##1##(1995-3#2)
trypsin)##5##1##(1991-8#1)(2008-10#3)(2009-8#1)
trypsin-activated PDE##2##2##(1990-2#2)
trypsin-cleaved C3##4##2##(1991-3#4)
trypsin-digested##2##1##(1990-2#1)(1993-11#1)
trypsin-like activity##3##2##(1990-12#1)(1990-3#1)(1991-2#1)
trypsin-like protease##3##2##(1991-1#1)(1994-3#1)(2011-12#1)
trypsin-like protease(s) secreted from P##2##5##(1994-3#2)
trypsin-like protease(s)##4##2##(1994-3#4)
trypsin-like serine proteases##2##3##(1995-6#1)(1996-2#1)
trypsin-like serine##4##2##(1995-5#1)(1995-6#2)(1996-2#1)
trypsin-like##19##1##(1990-12#1)(1990-3#1)(1991-1#1)(1991-2#1)(1991-8#1)(1994-12#1)(1994-3#5)(1995-5#1)(1995-6#2)(1996-2#1)(2008-5#3)(2011-12#1)
trypsin-resistant fragment##3##2##(1990-5#3)
trypsin-resistant##6##1##(1990-5#4)(1990-7#1)(1993-8#1)
trypsin-sensitive##3##1##(1990-8#1)(1995-5#1)(1996-7#1)
trypsin-treated##6##1##(1992-6#1)(1993-11#1)(1993-3#2)(1997-6#1)(2011-2#1)
trypsin-type##2##1##(1994-12#1)(2008-5#1)
trypsinization of##3##2##(1990-2#1)(2008-11#1)(2012-12#1)
trypsinization##5##1##(1990-2#1)(1992-9#1)(2008-11#2)(2012-12#1)
trypsinized##4##1##(2008-11#1)(2008-4#2)(2012-12#1)
trypsinogen activation##4##2##(1990-8#1)(1995-3#1)(2006-10#2)
trypsinogen##15##1##(1990-8#2)(1992-12#3)(1995-3#2)(1996-2#1)(2006-10#7)
trypsinolysis of##3##2##(1991-3#1)(1993-11#1)(1994-9#1)
trypsinolysis##5##1##(1991-3#3)(1993-11#1)(1994-9#1)
trypsins##5##1##(1990-12#2)(1992-3#1)(1996-6#2)
tryptamine##9##1##(1991-11#1)(1993-6#1)(1994-8#1)(1996-8#1)(2007-8#1)(2008-10#1)(2009-8#3)
tryptase TL2 on the##2##4##(1994-6#2)
tryptase TL2##5##2##(1994-6#5)
tryptase activity was##2##3##(1997-7#2)
tryptase and##6##2##(1990-5#1)(1990-9#1)(1997-7#3)(2008-5#1)
tryptase in the##2##3##(1990-5#1)(2012-12#1)
tryptase##26##1##(1990-5#2)(1990-9#3)(1993-3#1)(1994-6#5)(1997-7#5)(2004-12#2)(2008-1#1)(2008-4#1)(2008-5#2)(2008-7#1)(2012-12#3)
tryptase-containing##2##1##(1997-7#2)
tryptase-like enzyme##3##2##(2008-5#3)
tryptase-like##5##1##(2008-5#5)
tryptic cleavage at##2##3##(1990-3#2)
tryptic cleavage of the##2##4##(1990-3#2)
tryptic cleavage of##4##3##(1990-3#2)(1991-8#1)(1992-11#1)
tryptic cleavage##14##2##(1990-3#7)(1991-8#1)(1992-11#1)(1992-4#1)(1994-8#2)(1995-6#2)
tryptic digest of bovine serum albumin##2##6##(2010-1#1)(2013-1#1)
tryptic digest of##5##3##(1990-8#1)(1997-2#1)(2008-8#1)(2010-1#1)(2013-1#1)
tryptic digestion and##2##3##(1993-8#1)(1997-4#1)
tryptic digestion followed by##2##4##(1991-2#1)(2006-5#1)
tryptic digestion##16##2##(1990-3#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-8#1)(1993-6#1)(1993-8#2)(1994-8#1)(1995-1#1)(1997-4#1)(2006-5#1)(2008-1#2)(2009-12#1)(2009-4#1)
tryptic digests##2##2##(1990-12#1)(1993-11#1)
tryptic fragment of the##2##4##(1991-2#1)(1993-4#1)
tryptic fragment of##3##3##(1991-2#1)(1993-4#1)(1994-8#1)
tryptic fragment##4##2##(1991-2#1)(1991-8#1)(1993-4#1)(1994-8#1)
tryptic fragments##6##2##(1990-2#1)(1992-3#1)(1993-8#1)(1996-8#1)(2006-12#1)(2008-10#1)
tryptic peptide of##2##3##(1993-4#1)(1993-6#1)
tryptic peptide##10##2##(1990-11#2)(1991-2#1)(1991-7#1)(1993-12#1)(1993-4#2)(1993-6#1)(1996-8#1)(2008-10#1)
tryptic peptides of##3##3##(1990-4#1)(1990-9#1)(1991-2#1)
tryptic peptides##19##2##(1990-2#1)(1990-4#1)(1990-7#1)(1990-9#1)(1991-1#2)(1991-2#2)(1991-5#1)(1992-7#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#1)(2007-8#1)(2008-4#1)(2008-7#1)
tryptic phosphopeptide##4##2##(1990-11#1)(1992-10#1)(1993-11#1)(1995-2#1)
tryptic phosphopeptides##2##2##(1990-3#1)(1995-6#1)
tryptic proteolysis##2##2##(1990-12#1)(1995-6#1)
tryptic soy##2##2##(2006-8#1)(2008-10#1)
tryptic##97##1##(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#9)(1990-4#1)(1990-5#1)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#3)(1991-12#1)(1991-2#5)(1991-5#1)(1991-7#2)(1991-8#3)(1992-10#1)(1992-11#1)(1992-3#2)(1992-4#1)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-4#3)(1993-6#3)(1993-8#3)(1994-11#1)(1994-12#1)(1994-8#5)(1995-1#1)(1995-2#2)(1995-6#4)(1996-8#2)(1997-2#1)(1997-4#1)(1997-6#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-1#1)(2013-1#1)
tryptone##3##1##(2008-6#1)(2013-7#2)
tryptophan (Trp) residues##2##3##(1990-2#1)(2008-4#1)
tryptophan (Trp)##4##2##(1990-2#1)(2008-10#1)(2008-11#1)(2008-4#1)
tryptophan 2##2##2##(1993-3#1)(1995-3#1)
tryptophan 201##2##2##(1993-11#2)
tryptophan and##20##2##(1991-2#1)(1991-7#1)(1991-8#1)(1992-6#1)(1993-11#1)(1993-2#1)(1995-1#1)(1995-11#1)(1995-3#1)(2007-12#1)(2007-8#5)(2008-10#1)(2008-11#2)(2008-3#1)(2009-8#1)
tryptophan at##3##2##(1994-8#1)(2008-10#1)(2012-12#1)
tryptophan catabolites##2##2##(2007-8#1)(2012-3#1)
tryptophan column##3##2##(2011-2#3)
tryptophan fluorescence quenching##2##3##(1995-2#1)(1997-4#1)
tryptophan fluorescence##21##2##(1990-3#2)(1990-7#1)(1991-4#2)(1991-5#2)(1991-7#1)(1991-9#1)(1992-6#1)(1995-11#1)(1995-2#2)(1995-5#2)(1996-7#1)(1997-4#2)(2006-10#1)(2008-4#1)(2009-5#1)
tryptophan hydroxylase (TRH)##2##3##(1996-12#1)(1996-5#1)
tryptophan hydroxylase activity##3##3##(1990-5#2)(1992-3#1)
tryptophan hydroxylase in##2##3##(1992-3#1)(1996-5#1)
tryptophan hydroxylase##12##2##(1990-5#2)(1991-5#1)(1992-3#2)(1994-11#1)(1995-7#2)(1996-12#1)(1996-5#2)(2012-2#1)
tryptophan in human serum##2##4##(1993-2#2)
tryptophan in serum##2##3##(1993-2#1)(1995-3#1)
tryptophan in##9##2##(1991-11#1)(1993-2#3)(1995-1#1)(1995-3#1)(2006-1#1)(2008-10#1)(2009-8#1)
tryptophan is##3##2##(1992-12#1)(1995-1#1)(1997-1#1)
tryptophan levels##2##2##(1995-3#2)
tryptophan metabolism##4##2##(2006-1#1)(2008-7#1)(2009-10#1)(2012-1#1)
tryptophan methyl ester hydrochloride##3##4##(2008-10#3)
tryptophan methyl##4##2##(2008-10#4)
tryptophan mutants##2##2##(1994-11#1)(2008-7#1)
tryptophan or tyrosine##2##3##(2008-4#2)
tryptophan or##4##2##(1992-2#1)(2008-4#2)(2008-7#1)
tryptophan pyrrolase##4##2##(2006-1#4)
tryptophan residue##15##2##(1990-7#2)(1991-2#3)(1991-4#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-6#2)(1995-10#1)(1996-7#1)(2005-11#1)(2008-10#1)
tryptophan residues in the##2##4##(1992-8#1)(1997-4#1)
tryptophan residues in##6##3##(1991-12#1)(1991-5#1)(1992-6#1)(1992-8#1)(1995-6#1)(1997-4#1)
tryptophan residues of##3##3##(1992-12#1)(1993-11#1)(1997-8#1)
tryptophan residues to the##3##4##(1994-11#1)(2006-10#1)(2008-6#1)
tryptophan residues to##4##3##(1992-12#1)(1994-11#1)(2006-10#1)(2008-6#1)
tryptophan residues##35##2##(1990-5#1)(1990-8#2)(1991-12#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-12#2)(1992-6#3)(1992-8#2)(1993-11#2)(1993-8#1)(1994-11#1)(1994-9#2)(1995-2#1)(1995-5#2)(1995-6#1)(1997-4#3)(1997-8#3)(2006-10#2)(2008-10#1)(2008-6#1)
tryptophan side chains##2##3##(1997-4#1)(2010-5#1)
tryptophan side-chain analogs##3##3##(1992-12#2)(1993-6#1)
tryptophan synthase beta##2##3##(1990-9#2)
tryptophan synthase##9##2##(1990-2#3)(1990-9#2)(1991-4#2)(1996-8#2)
tryptophan to##3##2##(1990-8#1)(1994-3#1)(1996-11#1)
tryptophan was##3##2##(1992-6#1)(2007-8#1)(2009-8#1)
tryptophan were##2##2##(1997-4#1)(2006-8#1)
tryptophan##250##1##(1990-2#4)(1990-3#2)(1990-5#3)(1990-7#4)(1990-8#3)(1990-9#2)(1991-11#3)(1991-12#1)(1991-2#4)(1991-4#7)(1991-5#6)(1991-6#1)(1991-7#10)(1991-8#3)(1991-9#2)(1992-12#6)(1992-2#2)(1992-3#2)(1992-6#11)(1992-8#3)(1992-9#2)(1993-11#9)(1993-2#6)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#6)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#5)(1995-10#1)(1995-11#2)(1995-2#4)(1995-3#5)(1995-5#5)(1995-6#1)(1995-7#3)(1996-11#2)(1996-12#1)(1996-5#2)(1996-7#2)(1996-8#2)(1997-1#2)(1997-3#1)(1997-4#9)(1997-7#1)(1997-8#3)(2005-11#1)(2006-1#6)(2006-10#3)(2006-4#1)(2006-7#1)(2006-8#1)(2007-12#5)(2007-8#8)(2008-10#20)(2008-11#6)(2008-3#5)(2008-4#4)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#4)(2010-5#1)(2010-6#1)(2011-2#3)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)
tryptophan)##3##1##(1990-12#1)(1997-4#2)
tryptophan-2##3##1##(1992-2#3)
tryptophan-hyperproducing strain##2##2##(1994-6#2)
tryptophan-rich##4##1##(1992-8#1)(1993-12#1)(1993-8#2)
tryptophan-synthase##2##1##(1995-4#2)
tryptophanase##2##1##(1993-11#1)(2008-11#1)
tryptophane and tyrosine##2##3##(2008-10#2)
tryptophane and##4##2##(2007-8#1)(2008-10#3)
tryptophane residues##2##2##(2005-11#1)(2008-9#1)
tryptophane##7##1##(2005-11#1)(2007-8#2)(2008-10#3)(2008-9#1)
tryptophans and##2##2##(1991-4#1)(1992-12#1)
tryptophans in the##2##3##(1995-5#1)(1997-1#1)
tryptophans in##6##2##(1991-12#1)(1991-7#1)(1995-5#3)(1997-1#1)
tryptophans to##2##2##(1991-8#1)(1995-2#1)
tryptophans were##3##2##(1994-11#3)
tryptophans which are##2##3##(1994-11#1)(1995-2#1)
tryptophans##32##1##(1991-12#1)(1991-4#2)(1991-7#2)(1991-8#1)(1992-12#2)(1993-11#1)(1994-11#11)(1995-11#1)(1995-2#4)(1995-5#3)(1997-1#2)(1997-4#2)
tryptophanyl##3##1##(1991-7#1)(1994-9#1)(1996-8#1)
tryptophanyl-tRNA synthetase##11##2##(1991-12#2)(1992-3#2)(1993-6#2)(1994-3#2)(1994-9#3)
tryptophanyl-tRNA##12##1##(1991-12#2)(1992-3#2)(1993-6#2)(1994-3#2)(1994-9#4)
très rare##3##2##(2012-2#2)(2013-1#1)
très##10##1##(2009-10#1)(2012-2#6)(2013-1#3)
ts mutants of##2##3##(2008-10#2)
ts mutants##7##2##(1995-9#1)(2008-10#6)
ts mutation##2##2##(1990-5#1)(1994-2#1)
ts phenotypes##2##2##(1994-12#1)(2008-10#1)
ts##17##1##(1990-4#1)(1990-5#3)(1994-12#1)(1994-2#1)(1995-9#1)(1997-3#1)(2008-10#8)(2008-8#1)
ts+##2##1##(1992-4#2)
ts-110##2##1##(1991-8#1)(1992-11#1)
ts85 cells##9##2##(1992-6#6)(1995-11#3)
ts85##10##1##(1992-6#7)(1995-11#3)
tsBN423##4##1##(1992-4#4)
tsBN75 and tsBN423##3##3##(1992-4#3)
tsBN75##4##1##(1992-4#4)
tsetse and sleeping sickness##3##4##(2008-2#3)
tsetse and##5##2##(1997-7#1)(2006-10#1)(2008-2#3)
tsetse flies##8##2##(2006-10#1)(2006-2#1)(2008-2#2)(2010-1#1)(2010-4#1)(2013-8#2)
tsetse##23##1##(1997-7#1)(2004-11#1)(2006-10#4)(2006-2#1)(2006-5#2)(2008-2#9)(2010-1#1)(2010-4#2)(2013-8#2)
tsg24 gene##2##2##(1994-9#2)
tsg24##3##1##(1994-9#3)
tsoongianolides##3##1##(2006-12#3)
tsp at##3##2##(1991-12#1)(1993-12#1)(1993-2#1)
tsp mapping##2##2##(1991-6#1)(1993-9#1)
tsp of the##2##3##(1991-12#1)(1995-11#1)
tsp region##2##2##(1996-8#2)
tsp were##2##2##(1991-8#1)(1993-11#1)
tsp##21##1##(1991-12#4)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-9#1)(1995-11#1)(1995-8#3)(1996-8#3)
tst##2##1##(1997-2#2)
tsunami##7##1##(1990-11#1)(2008-4#1)(2008-8#1)(2010-8#1)(2012-2#1)(2013-1#2)
tsunamis##2##1##(1990-11#1)(2013-8#1)
tsutsugamushi##2##1##(2010-12#1)(2013-1#1)
tsx gene##4##2##(1990-11#4)
tsx##6##1##(1990-11#6)
tuatara##7##1##(2010-3#7)
tub2##6##1##(1994-3#4)(2008-10#2)
tubal anastomosis##2##2##(1991-3#2)
tubal and##2##2##(1990-2#1)(1996-12#1)
tubal disease##6##2##(1990-2#3)(1991-12#1)(1993-1#1)(1994-9#1)
tubal ectopic pregnancy##9##3##(1993-3#1)(2009-5#1)(2011-2#2)(2012-2#4)(2013-7#1)
tubal heterotopic pregnancy##3##3##(2011-1#3)
tubal infertility##5##2##(1990-10#2)(1990-2#1)(1994-9#1)(2007-8#1)
tubal ligation may be##2##4##(1996-8#2)
tubal ligation##8##2##(1993-12#1)(1996-8#3)(2004-10#1)(2006-10#1)(2007-7#1)(2008-7#1)
tubal obstruction##2##2##(1993-1#2)
tubal occlusion##7##2##(1991-11#1)(1991-12#2)(1993-1#1)(1995-7#1)(2011-1#2)
tubal patency##4##2##(1991-11#1)(1994-12#1)(1996-2#1)(2011-1#1)
tubal pregnancies##4##2##(1992-8#2)(1994-12#1)(2004-10#1)
tubal pregnancy is##2##3##(1994-3#1)(1996-12#1)
tubal pregnancy##8##2##(1992-8#2)(1994-3#2)(1996-12#1)(2011-1#1)(2012-2#2)
tubal sterilization##6##2##(1993-3#2)(1995-1#1)(2006-4#2)(2012-2#1)
tubal##92##1##(1990-10#2)(1990-2#5)(1991-11#3)(1991-12#3)(1991-3#4)(1992-1#1)(1992-8#5)(1993-1#5)(1993-12#3)(1993-3#3)(1994-11#1)(1994-12#5)(1994-3#2)(1994-9#2)(1995-1#2)(1995-12#1)(1995-7#3)(1996-12#3)(1996-2#1)(1996-3#3)(1996-8#3)(2004-10#4)(2006-10#1)(2006-4#2)(2007-7#1)(2007-8#1)(2008-7#1)(2009-5#1)(2010-8#1)(2011-1#7)(2011-2#3)(2012-2#9)(2013-7#1)
tube (PMT)##4##2##(2008-10#3)(2010-9#1)
tube agglutination test##4##3##(2005-9#1)(2006-2#1)(2007-2#1)(2012-2#1)
tube agglutination##6##2##(1990-12#1)(2005-12#1)(2005-9#1)(2006-2#1)(2007-2#1)(2012-2#1)
tube and ovary##2##3##(2011-1#2)
tube and the##6##3##(1995-4#1)(2007-9#1)(2008-10#2)(2010-12#1)(2010-5#1)
tube and##30##2##(1991-11#1)(1991-6#1)(1995-4#1)(1996-9#1)(1997-4#1)(2005-4#1)(2006-6#2)(2006-7#1)(2007-1#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-1#1)(2010-12#2)(2010-5#1)(2011-1#3)(2011-2#1)(2012-12#2)
tube as a##2##3##(2007-12#1)(2008-4#1)
tube as an##2##3##(1990-12#1)(2006-10#1)
tube as##7##2##(1990-12#1)(1996-8#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-4#1)
tube at##5##2##(2008-10#4)(2008-2#1)
tube atomizer is##2##3##(2008-10#2)
tube atomizer##7##2##(2008-10#7)
tube by##3##2##(1993-9#1)(2008-10#1)(2013-8#1)
tube can be##3##3##(1997-5#2)(2013-8#1)
tube can##5##2##(1997-5#2)(2007-11#1)(2011-1#1)(2013-8#1)
tube cells##2##2##(2009-8#2)
tube containing##2##2##(2008-8#1)(2010-5#1)
tube defects (NTDs)##2##3##(2009-10#1)(2012-2#1)
tube defects and##3##3##(1996-5#1)(2007-11#1)(2011-1#1)
tube defects##23##2##(1993-2#1)(1995-3#1)(1996-12#1)(1996-5#1)(1996-6#2)(2004-10#1)(2006-8#1)(2007-11#4)(2009-10#2)(2010-12#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#1)
tube development##2##2##(2008-10#1)(2009-10#1)
tube diameter##2##2##(2008-10#1)(2008-7#1)
tube displacement and##2##3##(2007-11#2)
tube displacement##3##2##(2007-11#2)(2009-2#1)
tube drainage and##3##3##(2007-9#2)(2013-8#1)
tube drainage was##2##3##(2007-8#1)(2011-2#1)
tube drainage##13##2##(2007-8#3)(2007-9#3)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#1)(2013-8#3)
tube during##2##2##(2007-12#1)(2008-10#1)
tube elongation##3##2##(2008-10#1)(2008-8#1)(2009-12#1)
tube feeding in##2##3##(1992-5#1)(1996-8#1)
tube feeding is##3##3##(1996-8#1)(2011-2#2)
tube feeding##11##2##(1992-5#1)(1996-8#3)(2005-10#1)(2007-8#1)(2010-7#2)(2011-1#1)(2011-2#2)
tube filled with##2##3##(2008-10#2)
tube for the##2##3##(2008-10#1)(2008-5#1)
tube for##14##2##(1993-3#1)(2005-4#1)(2006-6#1)(2007-8#3)(2008-10#6)(2008-3#1)(2008-5#1)
tube formation in##2##3##(2008-10#1)(2012-12#1)
tube formation induced by##2##4##(2013-8#2)
tube formation##16##2##(1991-8#2)(1995-2#1)(2008-10#5)(2010-10#1)(2010-12#1)(2010-6#1)(2012-12#1)(2013-8#4)
tube furnace##4##2##(2008-2#1)(2008-3#2)(2009-2#1)
tube gel##2##2##(2007-10#1)(2008-4#1)
tube growth##16##2##(1993-4#1)(2008-10#9)(2008-11#1)(2009-10#1)(2009-12#2)(2009-8#2)
tube has##4##2##(1992-1#1)(1995-4#1)(2008-10#1)(2010-7#1)
tube have##2##2##(2005-4#1)(2013-8#1)
tube in a##2##3##(2008-5#1)(2013-8#1)
tube in situ##2##3##(2009-6#1)(2012-2#1)
tube in the##2##3##(1993-10#1)(2006-10#1)
tube in##7##2##(1993-10#1)(2006-10#1)(2008-10#1)(2008-5#1)(2009-6#1)(2012-2#1)(2013-8#1)
tube inserted##2##2##(2010-12#1)(2013-1#1)
tube insertion and##2##3##(2005-10#1)(2005-12#1)
tube insertion##5##2##(2005-10#1)(2005-12#1)(2006-10#1)(2007-8#2)
tube into the##2##3##(2008-5#1)(2009-8#1)
tube is a##2##3##(2006-6#1)(2009-6#1)
tube is##19##2##(1990-8#1)(1996-3#1)(1996-8#1)(1997-4#1)(1997-5#3)(2006-10#2)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-5#1)(2012-3#1)
tube length##6##2##(2008-10#4)(2008-2#1)(2008-3#1)
tube lifetime##5##2##(2008-10#5)
tube lipsticks##2##2##(2012-12#2)
tube management of##2##3##(2008-8#2)
tube obstruction##2##2##(1992-1#1)(1995-4#1)
tube of a##2##3##(2008-8#1)(2011-1#1)
tube of the##3##3##(2008-10#1)(2008-5#1)(2011-12#1)
tube of##9##2##(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-8#1)(2011-1#1)(2011-12#1)
tube on##4##2##(1993-6#3)(2008-3#1)
tube or a##2##3##(2006-10#1)(2010-12#1)
tube or##8##2##(1996-9#1)(2006-10#3)(2006-12#1)(2008-2#1)(2010-12#2)
tube packed with##3##3##(2008-10#3)
tube placement and##3##3##(1990-8#1)(2006-10#1)(2010-7#1)
tube placement in##2##3##(2006-7#1)(2009-5#1)
tube placement##15##2##(1990-8#3)(2006-10#3)(2006-7#1)(2007-10#1)(2007-8#1)(2009-5#1)(2009-9#1)(2010-7#3)(2011-2#1)
tube removal##2##2##(1991-3#1)(2007-10#1)
tube robots##3##2##(2012-1#2)(2012-2#1)
tube test##11##2##(1993-9#1)(1994-3#1)(2006-10#1)(2011-1#8)
tube that##5##2##(1991-11#1)(2006-8#1)(2008-10#1)(2008-4#1)(2010-8#1)
tube thoracostomy##13##2##(2006-10#1)(2007-3#1)(2007-7#4)(2007-8#4)(2008-1#1)(2008-10#1)(2012-2#1)
tube to##4##2##(2005-11#1)(2006-10#2)(2008-11#1)
tube type##2##2##(2008-7#1)(2010-5#1)
tube using##2##2##(2007-4#1)(2008-11#1)
tube voltage##3##2##(1997-8#2)(2013-8#1)
tube wall##5##2##(1994-9#1)(2005-11#3)(2009-6#1)
tube was inserted for##2##4##(2005-12#1)(2006-2#1)
tube was inserted to##2##4##(2010-12#1)(2011-2#1)
tube was inserted##8##3##(2005-12#1)(2006-2#1)(2007-7#1)(2007-8#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-1#1)
tube was removed##3##3##(1997-6#1)(2012-12#2)
tube was##27##2##(1991-3#1)(1991-5#2)(1993-2#1)(1996-8#2)(1997-6#1)(2005-12#1)(2005-4#1)(2006-2#2)(2007-7#2)(2007-8#1)(2008-10#4)(2009-6#2)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-8#2)
tube were##4##2##(2005-12#1)(2008-10#2)(2012-2#1)
tube with a##5##3##(1997-6#1)(2006-6#1)(2007-12#1)(2008-10#2)
tube with an##2##3##(1994-9#1)(2008-10#1)
tube with##12##2##(1994-9#1)(1997-6#1)(2006-6#1)(2007-12#1)(2008-10#4)(2008-3#1)(2011-1#1)(2012-12#1)(2013-8#1)
tube within##2##2##(2006-10#1)(2007-8#1)
tube without##2##2##(2007-8#1)(2008-10#1)
tube##674##1##(1990-12#4)(1990-4#1)(1990-8#5)(1991-11#5)(1991-3#3)(1991-4#2)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#3)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-1#3)(1993-10#3)(1993-12#2)(1993-2#6)(1993-3#1)(1993-4#2)(1993-6#3)(1993-9#5)(1994-11#1)(1994-12#3)(1994-3#2)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#5)(1995-2#1)(1995-3#2)(1995-4#4)(1995-5#2)(1996-12#3)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#3)(1996-8#7)(1996-9#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#9)(1997-6#5)(1997-8#2)(2004-10#1)(2005-10#5)(2005-11#8)(2005-12#4)(2005-4#8)(2005-9#1)(2006-10#29)(2006-12#3)(2006-2#3)(2006-4#1)(2006-6#6)(2006-7#5)(2006-8#3)(2007-1#1)(2007-10#7)(2007-11#12)(2007-12#10)(2007-2#4)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#7)(2007-8#27)(2007-9#6)(2008-1#3)(2008-10#124)(2008-11#10)(2008-12#1)(2008-2#16)(2008-3#16)(2008-4#5)(2008-5#9)(2008-6#3)(2008-7#9)(2008-8#13)(2008-9#2)(2009-10#8)(2009-11#2)(2009-12#5)(2009-2#5)(2009-4#2)(2009-5#2)(2009-6#10)(2009-7#1)(2009-8#9)(2009-9#4)(2010-1#1)(2010-10#1)(2010-12#14)(2010-2#1)(2010-5#9)(2010-6#1)(2010-7#11)(2010-8#3)(2010-9#1)(2011-1#20)(2011-12#1)(2011-2#11)(2012-1#8)(2012-12#15)(2012-2#10)(2012-3#3)(2013-1#4)(2013-8#19)
tube)##3##1##(2005-4#1)(2008-10#1)(2013-8#1)
tube-like##3##1##(1997-6#1)(2008-7#1)(2010-2#1)
tube]##5##1##(1995-4#1)(1997-5#1)(2005-4#2)(2013-1#1)
tubed##3##1##(1990-6#2)(2011-2#1)
tuber maxillae##2##2##(2010-2#2)
tuber tissue was##2##3##(2008-10#2)
tuber tissue##3##2##(2008-10#3)
tuber yield##3##2##(2008-10#3)
tuber##36##1##(1991-5#1)(1992-12#1)(1994-10#1)(1996-9#1)(1997-2#1)(1997-6#1)(2006-11#1)(2007-2#1)(2008-10#22)(2008-5#1)(2008-9#3)(2010-2#2)
tubercle##27##1##(1991-2#2)(1991-5#1)(1992-7#1)(1993-6#1)(1996-12#4)(1996-4#1)(1997-3#2)(2007-2#2)(2008-10#1)(2008-8#2)(2008-9#3)(2009-5#1)(2009-8#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
tubercles##6##1##(1996-10#1)(2007-12#1)(2008-5#2)(2008-6#2)
tubercular infection##2##2##(2012-12#2)
tubercular lymphadenopathy##2##2##(2010-8#1)(2010-9#1)
tubercular origin##2##2##(1997-8#1)(2010-12#1)
tubercular patients##2##2##(2008-1#1)(2008-7#1)
tubercular##17##1##(1995-10#1)(1997-8#2)(2006-10#1)(2007-7#2)(2008-1#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
tuberculeuse##2##1##(2012-2#2)
tuberculids##7##1##(1993-2#1)(2007-7#3)(2012-2#3)
tuberculin skin test conversion rate##2##5##(2007-2#2)
tuberculin skin test was##2##4##(1997-4#1)(2013-1#1)
tuberculin skin test##10##3##(1990-6#1)(1997-4#1)(2007-2#2)(2010-5#1)(2011-11#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
tuberculin skin testing##2##3##(2006-2#1)(2007-2#1)
tuberculin skin tests##2##3##(2007-2#1)(2012-2#1)
tuberculin skin##15##2##(1990-6#1)(1997-4#1)(2006-2#2)(2007-2#4)(2010-5#1)(2011-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
tuberculin test and risk of##2##5##(2013-1#2)
tuberculin test and the##2##4##(1996-12#1)(2013-1#1)
tuberculin test and##5##3##(1996-12#1)(2011-2#1)(2013-1#3)
tuberculin test was##2##3##(1990-6#1)(1996-12#1)
tuberculin test##13##2##(1990-6#1)(1994-4#1)(1996-12#3)(1997-8#2)(2011-2#2)(2013-1#4)
tuberculin testing##2##2##(1990-6#1)(2006-2#1)
tuberculin##41##1##(1990-6#7)(1991-5#1)(1992-10#1)(1993-7#1)(1994-4#2)(1996-12#3)(1997-4#1)(1997-8#2)(2006-2#3)(2006-6#1)(2007-2#4)(2008-11#1)(2010-4#1)(2010-5#1)(2011-11#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#1)
tuberculins##4##1##(2011-1#4)
tuberculoid granuloma##2##2##(2007-7#2)
tuberculoid##5##1##(2007-7#4)(2011-2#1)
tuberculoma##3##1##(1990-6#1)(2012-2#1)(2012-3#1)
tuberculose appendiculaire##2##2##(2012-2#2)
tuberculose hépatique##4##2##(2012-2#4)
tuberculose##8##1##(2012-2#8)
tuberculosis (MDR-TB) in##2##3##(1991-8#1)(2013-1#1)
tuberculosis (MDR-TB)##5##2##(1991-8#1)(2007-11#1)(2007-7#1)(2010-10#1)(2013-1#1)
tuberculosis (PTB)##3##2##(2007-12#1)(2011-1#1)(2013-8#1)
tuberculosis (TB) and HIV##2##4##(2010-12#1)(2010-4#1)
tuberculosis (TB) and##4##3##(2009-4#1)(2010-12#1)(2010-4#1)(2011-11#1)
tuberculosis (TB) is##7##3##(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2010-10#1)(2010-5#1)(2012-12#1)
tuberculosis (TB)##38##2##(1991-3#1)(1995-9#2)(1996-11#1)(1996-3#4)(2005-9#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-4#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-11#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
tuberculosis H37Rv##3##2##(2008-7#2)(2012-3#1)
tuberculosis after##2##2##(2009-6#1)(2012-2#1)
tuberculosis among##11##2##(1991-8#1)(2005-10#3)(2005-9#1)(2011-1#5)(2013-7#1)
tuberculosis and HIV-1/AIDS##2##3##(2009-4#2)
tuberculosis and M##3##3##(2008-7#2)(2012-3#1)
tuberculosis and influenza##2##3##(2009-4#2)
tuberculosis and poliomyelitis##2##3##(2006-8#1)(2008-8#1)
tuberculosis and##48##2##(1993-3#1)(1993-7#2)(1995-2#1)(1995-3#1)(1996-11#1)(1996-3#1)(1996-4#1)(1997-3#1)(1997-4#1)(1997-5#1)(2005-11#2)(2005-8#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-5#2)(2008-7#6)(2008-8#1)(2009-4#5)(2009-5#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-2#2)(2012-3#4)(2013-1#1)
tuberculosis and/or M##2##3##(2012-3#2)
tuberculosis are##6##2##(1995-2#1)(2007-2#1)(2008-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
tuberculosis at Biosafety Level 3 containment are also discussed##3##9##(2008-9#3)
tuberculosis at##7##2##(1990-9#1)(1997-2#1)(2008-9#3)(2009-7#1)(2011-2#1)
tuberculosis by##8##2##(1994-3#1)(2007-3#1)(2007-7#4)(2008-5#1)(2010-8#1)
tuberculosis case notification##2##3##(2013-7#1)(2013-8#1)
tuberculosis case##3##2##(1996-3#1)(2013-7#1)(2013-8#1)
tuberculosis cases##8##2##(1995-9#1)(2005-10#2)(2007-12#1)(2007-4#1)(2011-1#1)(2013-8#2)
tuberculosis centers of##2##3##(2008-12#2)
tuberculosis clinically##2##2##(1991-11#1)(2007-12#1)
tuberculosis complex##7##2##(1996-11#1)(2007-7#1)(2007-9#1)(2008-7#3)(2011-1#1)
tuberculosis control programme##3##3##(1995-9#2)(2013-8#1)
tuberculosis control##8##2##(1995-9#2)(1997-8#1)(2007-2#1)(2010-5#1)(2013-7#1)(2013-8#2)
tuberculosis directly observed therapy##2##4##(1996-3#2)
tuberculosis disease##2##2##(1990-6#1)(2005-10#1)
tuberculosis drug discovery##2##3##(2011-1#2)
tuberculosis during the##2##3##(2007-2#1)(2013-1#1)
tuberculosis during##4##2##(2006-10#1)(2007-12#1)(2007-2#1)(2013-1#1)
tuberculosis from##5##2##(1990-12#2)(2007-7#1)(2011-2#1)(2013-8#1)
tuberculosis gene##2##2##(1996-9#2)
tuberculosis genome##2##2##(2008-7#1)(2012-2#1)
tuberculosis has been##2##3##(1997-8#1)(2010-4#1)
tuberculosis has##4##2##(1997-8#1)(2007-11#1)(2007-8#1)(2010-4#1)
tuberculosis in BCG vaccinated individuals##2##5##(2010-12#2)
tuberculosis in Saudi Arabia##2##4##(2006-12#2)
tuberculosis in a##12##3##(1990-6#1)(2004-1#1)(2005-7#1)(2007-12#1)(2009-7#2)(2010-12#1)(2011-2#1)(2013-1#4)
tuberculosis in an##2##3##(2011-2#1)(2013-1#1)
tuberculosis in children##6##3##(2006-10#1)(2008-10#1)(2011-2#3)(2012-3#1)
tuberculosis in patients with##2##4##(1991-1#1)(2008-10#1)
tuberculosis in patients##4##3##(1991-1#1)(1993-10#1)(1996-3#1)(2008-10#1)
tuberculosis in the##9##3##(1995-2#1)(1995-3#1)(1996-3#1)(2006-6#1)(2007-11#2)(2008-7#1)(2009-7#1)(2010-4#1)
tuberculosis in##78##2##(1990-12#1)(1990-6#1)(1991-1#1)(1993-10#1)(1993-7#1)(1994-3#1)(1995-2#1)(1995-3#2)(1996-3#2)(1996-6#1)(1997-3#1)(2004-1#1)(2005-10#1)(2005-7#2)(2006-10#1)(2006-12#2)(2006-6#2)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#2)(2008-7#1)(2009-4#1)(2009-5#1)(2009-7#3)(2010-12#7)(2010-4#1)(2011-1#2)(2011-11#1)(2011-2#7)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#9)
tuberculosis infection among healthcare professionals##2##5##(2013-1#2)
tuberculosis infection among##4##3##(2007-4#1)(2011-1#1)(2013-1#2)
tuberculosis infection is##3##3##(1990-6#2)(2012-2#1)
tuberculosis infection##22##2##(1990-6#3)(2007-12#1)(2007-4#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#4)(2011-2#1)(2012-2#1)(2013-1#2)
tuberculosis is a rare disease##2##5##(2008-12#1)(2008-3#1)
tuberculosis is a rare##5##4##(1993-3#1)(2007-8#1)(2008-12#1)(2008-3#1)(2013-8#1)
tuberculosis is a##7##3##(1993-3#1)(2007-8#1)(2008-12#1)(2008-3#1)(2009-5#1)(2010-8#1)(2013-8#1)
tuberculosis is high##2##3##(1995-10#1)(2009-6#1)
tuberculosis is still##2##3##(1997-8#1)(2007-8#1)
tuberculosis is##17##2##(1993-3#1)(1993-7#1)(1995-10#1)(1995-3#1)(1997-8#1)(2007-8#2)(2008-12#1)(2008-3#1)(2008-7#2)(2009-5#1)(2009-6#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-8#1)
tuberculosis isolates in##2##3##(2007-7#1)(2008-12#1)
tuberculosis isolates##8##2##(2007-7#5)(2008-12#2)(2011-2#1)
tuberculosis mortality##6##2##(2009-4#6)
tuberculosis mycolic acids##2##3##(2008-9#2)
tuberculosis of the hip##3##4##(2010-2#3)
tuberculosis of the##9##3##(2006-2#1)(2006-6#1)(2007-7#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-2#3)
tuberculosis of##16##2##(1993-8#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-12#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-8#1)
tuberculosis or##3##2##(1996-10#1)(2007-8#1)(2012-2#1)
tuberculosis patients at##2##3##(1996-3#1)(2013-1#1)
tuberculosis patients in##3##3##(2008-8#1)(2011-2#1)(2013-8#1)
tuberculosis patients##16##2##(1993-11#1)(1995-9#1)(1996-3#2)(2005-9#1)(2007-2#2)(2008-7#1)(2008-8#1)(2011-1#3)(2011-2#1)(2013-1#2)(2013-8#1)
tuberculosis presenting as##2##3##(2010-10#1)(2012-12#1)
tuberculosis presenting with##2##3##(2007-12#1)(2008-7#1)
tuberculosis presenting##4##2##(2007-12#1)(2008-7#1)(2010-10#1)(2012-12#1)
tuberculosis rate##2##2##(1990-12#1)(2013-8#1)
tuberculosis should be##2##3##(1990-12#1)(2012-12#1)
tuberculosis showing##2##2##(2007-2#1)(2012-3#1)
tuberculosis strains##3##2##(2007-7#1)(2007-9#1)(2008-9#1)
tuberculosis surveillance##2##2##(2011-2#1)(2013-8#1)
tuberculosis testing and treatment program##2##5##(1997-2#2)
tuberculosis testing and treatment##3##4##(1997-2#3)
tuberculosis that##3##2##(2007-11#1)(2007-8#1)(2011-2#1)
tuberculosis the##2##2##(1996-11#1)(2011-2#1)
tuberculosis to##4##2##(1994-3#1)(2006-8#2)(2007-7#1)
tuberculosis treatment##6##2##(1991-6#1)(1996-11#1)(2007-12#1)(2007-2#1)(2008-7#1)(2012-3#1)
tuberculosis under##2##2##(1996-3#1)(2013-1#1)
tuberculosis using##2##2##(1996-11#1)(2009-6#1)
tuberculosis vaccine##2##2##(2007-11#1)(2011-2#1)
tuberculosis was the##2##3##(2007-7#1)(2007-8#1)
tuberculosis was##13##2##(1990-9#1)(1993-3#1)(1993-7#3)(1996-4#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2012-3#2)
tuberculosis were##8##2##(1995-10#2)(2006-6#1)(2007-7#1)(2007-8#3)(2011-1#1)
tuberculosis with atlantoaxial dislocation##2##4##(2008-12#2)
tuberculosis with##8##2##(1992-2#1)(1996-11#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#2)
tuberculosis within the##2##3##(2008-7#1)(2008-8#1)
tuberculosis##799##1##(1990-10#1)(1990-12#10)(1990-6#6)(1990-9#4)(1991-1#1)(1991-11#4)(1991-12#1)(1991-3#2)(1991-4#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-2#1)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#4)(1993-5#1)(1993-7#8)(1993-8#1)(1994-3#6)(1994-4#2)(1994-7#5)(1995-10#6)(1995-2#10)(1995-3#4)(1995-5#1)(1995-9#8)(1996-10#4)(1996-11#10)(1996-12#4)(1996-3#18)(1996-4#3)(1996-6#2)(1996-7#3)(1996-8#1)(1996-9#3)(1997-2#4)(1997-3#3)(1997-4#2)(1997-5#3)(1997-7#1)(1997-8#3)(2004-1#1)(2005-10#8)(2005-11#6)(2005-7#4)(2005-8#1)(2005-9#3)(2006-10#12)(2006-11#1)(2006-12#4)(2006-2#1)(2006-5#1)(2006-6#12)(2006-7#3)(2006-8#6)(2007-1#1)(2007-10#3)(2007-11#11)(2007-12#15)(2007-2#15)(2007-3#4)(2007-4#8)(2007-6#1)(2007-7#38)(2007-8#28)(2007-9#3)(2008-1#6)(2008-10#16)(2008-11#2)(2008-12#13)(2008-3#3)(2008-4#8)(2008-5#8)(2008-7#47)(2008-8#6)(2008-9#21)(2009-2#2)(2009-4#16)(2009-5#5)(2009-6#6)(2009-7#13)(2009-9#1)(2010-10#11)(2010-11#2)(2010-12#29)(2010-2#4)(2010-4#11)(2010-5#4)(2010-7#4)(2010-8#7)(2011-1#38)(2011-11#2)(2011-2#33)(2012-11#1)(2012-12#8)(2012-2#27)(2012-3#25)(2013-1#46)(2013-7#5)(2013-8#18)
tuberculosis--a##2##1##(1996-4#1)(2012-2#1)
tuberculosis-like disease in##3##3##(2007-2#3)
tuberculosis]##14##1##(1990-6#1)(1990-9#1)(1992-2#1)(1993-3#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-3#1)(2006-6#1)(2008-4#1)(2009-5#2)(2012-11#1)(2013-1#1)
tuberculostatic##2##1##(1995-5#1)(2010-12#1)
tuberculous aortitis##2##2##(2007-8#2)
tuberculous epididymo-orchitis##3##2##(2007-7#1)(2011-2#2)
tuberculous gonitis in##3##3##(2007-8#3)
tuberculous gonitis##4##2##(2007-8#4)
tuberculous infection##4##2##(1990-12#1)(1990-6#1)(1993-4#1)(2008-4#1)
tuberculous lymphadenitis##5##2##(1996-6#1)(2006-8#2)(2007-7#1)(2008-1#1)
tuberculous meningitis##5##2##(2007-2#1)(2011-2#2)(2013-7#1)(2013-8#1)
tuberculous osteitis##2##2##(1997-3#1)(2006-10#1)
tuberculous patients##2##2##(1996-11#1)(2009-4#1)
tuberculous##62##1##(1990-12#1)(1990-6#2)(1992-12#1)(1992-7#1)(1993-1#1)(1993-4#1)(1995-9#1)(1996-11#1)(1996-4#1)(1996-6#1)(1997-3#1)(1997-8#3)(2005-7#2)(2006-10#3)(2006-8#3)(2007-2#1)(2007-7#5)(2007-8#13)(2008-1#1)(2008-4#1)(2008-7#3)(2009-4#1)(2009-5#1)(2010-1#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-7#2)(2013-8#1)
tuberculum##2##1##(1995-12#1)(2006-12#1)
tuberis##2##1##(2008-6#2)
tuberoinfundibular##3##1##(1992-8#2)(2010-10#1)
tuberosity##7##1##(1990-6#1)(2007-1#4)(2008-12#1)(2008-8#1)
tuberosum##17##1##(1992-12#2)(1993-12#1)(1994-10#1)(1996-9#1)(1997-4#1)(2008-10#5)(2008-5#1)(2008-7#1)(2011-12#1)(2012-2#3)
tuberosum)##4##1##(2008-10#3)(2011-12#1)
tuberous roots##2##2##(2008-11#1)(2008-9#1)
tuberous sclerosis and the##2##4##(2008-1#2)
tuberous sclerosis complex##2##3##(2008-7#1)(2012-11#1)
tuberous sclerosis##13##2##(1993-12#1)(1997-8#1)(2006-12#1)(2007-8#2)(2008-1#3)(2008-7#1)(2010-6#1)(2011-2#2)(2012-11#1)
tuberous##17##1##(1993-12#1)(1995-5#1)(1997-8#1)(2006-12#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-11#1)(2008-7#1)(2008-9#1)(2010-6#1)(2011-2#2)(2012-11#1)
tubers and##3##2##(2008-10#2)(2013-8#1)
tubers collected##2##2##(2008-10#2)
tubers examined##2##2##(2008-10#2)
tubers grown in##3##3##(2008-10#2)(2008-12#1)
tubers of##5##2##(2007-1#1)(2008-10#3)(2012-12#1)
tubers was##4##2##(2006-11#1)(2008-10#3)
tubers were##6##2##(2008-10#6)
tubers##58##1##(1991-11#1)(1992-12#2)(2006-11#2)(2007-1#2)(2008-10#46)(2008-12#2)(2010-5#1)(2012-12#1)(2013-8#1)
tubes and##12##2##(1990-12#2)(1991-1#1)(2005-4#1)(2008-10#2)(2008-3#1)(2008-7#3)(2009-2#1)(2009-8#1)
tubes are##2##2##(1996-8#1)(2013-8#1)
tubes at##3##2##(1991-8#1)(2008-10#1)(2011-1#1)
tubes containing##3##2##(1990-12#1)(2007-9#1)(2009-3#1)
tubes for##3##2##(2007-12#1)(2008-9#1)(2010-5#1)
tubes from##2##2##(1990-11#1)(2008-10#1)
tubes have##2##2##(1991-12#1)(2009-6#1)
tubes in##6##2##(1991-3#1)(2006-10#1)(2008-10#1)(2009-7#1)(2012-12#1)(2012-2#1)
tubes is##3##2##(2008-12#1)(2009-8#1)(2013-1#1)
tubes of##7##2##(2005-11#1)(2008-10#4)(2008-8#2)
tubes on##2##2##(2008-10#2)
tubes resulted in##2##3##(2009-2#1)(2011-12#1)
tubes that##4##2##(1992-6#1)(2007-12#1)(2008-10#1)(2008-2#1)
tubes to##5##2##(2008-10#3)(2009-8#1)(2012-1#1)
tubes was##2##2##(1992-8#1)(2011-12#1)
tubes were##10##2##(1993-2#1)(2005-2#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-9#1)(2013-1#1)
tubes with##6##2##(2008-10#1)(2008-2#1)(2008-7#1)(2009-7#1)(2011-1#1)(2013-1#1)
tubes##203##1##(1990-11#2)(1990-12#3)(1990-3#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-11#2)(1992-6#1)(1992-8#1)(1993-2#1)(1993-4#1)(1995-5#1)(1996-2#2)(1996-8#2)(1997-2#1)(1997-6#1)(2004-12#1)(2005-10#1)(2005-11#3)(2005-2#1)(2005-4#1)(2006-10#2)(2006-12#2)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#7)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-10#56)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#9)(2008-8#3)(2008-9#2)(2009-10#5)(2009-12#2)(2009-2#6)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#6)(2010-10#1)(2010-12#1)(2010-5#2)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-12#3)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#6)(2013-1#7)(2013-8#3)
tubing and##3##2##(1996-8#1)(2008-10#1)(2011-1#1)
tubing is##5##2##(2008-11#5)
tubing of##3##2##(1991-4#1)(2008-10#1)(2008-2#1)
tubing was##2##2##(1991-2#1)(1997-3#1)
tubing##59##1##(1991-2#1)(1991-3#1)(1991-4#1)(1992-1#1)(1993-2#1)(1995-6#1)(1996-8#1)(1997-3#3)(2006-10#1)(2007-1#3)(2007-7#1)(2007-8#2)(2008-10#18)(2008-11#11)(2008-2#1)(2008-3#1)(2008-5#2)(2009-7#1)(2009-9#1)(2011-1#5)(2013-8#2)
tuboperitoneal##2##1##(1990-6#1)(2011-1#1)
tubular acidosis##5##2##(2007-3#1)(2007-7#1)(2008-1#2)(2013-1#1)
tubular adenoma of the##2##4##(2009-1#1)(2013-1#1)
tubular adenoma##5##2##(1997-5#1)(2008-5#1)(2009-1#2)(2013-1#1)
tubular adenomas##3##2##(2009-1#2)(2011-2#1)
tubular and##5##2##(1993-2#1)(1995-11#1)(2007-12#1)(2008-6#1)(2010-2#1)
tubular associations##2##2##(2005-8#2)
tubular atrophy##4##2##(1993-3#1)(1995-2#1)(2012-12#1)(2013-8#1)
tubular bones##5##2##(1993-4#1)(1996-12#2)(2009-3#1)(2010-5#1)
tubular carcinoma##3##2##(1995-4#3)
tubular cell##2##2##(1991-11#1)(2007-9#1)
tubular cells and##2##3##(1992-3#1)(2012-12#1)
tubular cells in##3##3##(1991-4#2)(1996-12#1)
tubular cells##20##2##(1990-4#1)(1991-4#4)(1991-8#1)(1992-3#1)(1992-7#1)(1993-11#1)(1995-11#1)(1996-12#1)(1997-8#2)(2005-1#1)(2007-9#1)(2008-6#1)(2008-8#1)(2011-2#2)(2012-12#1)
tubular damage in##2##3##(1990-4#1)(1991-11#1)
tubular damage##8##2##(1990-4#2)(1990-6#1)(1991-11#2)(1993-12#1)(1997-2#1)(2011-2#1)
tubular disorders##2##2##(1991-8#1)(2007-7#1)
tubular electrode##4##2##(2008-10#4)
tubular epithelial cells of##2##4##(1994-5#1)(2007-5#1)
tubular epithelial cells##10##3##(1992-3#1)(1994-5#1)(2007-5#1)(2009-10#3)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
tubular epithelial##12##2##(1990-5#1)(1992-3#1)(1994-5#1)(2007-5#1)(2009-10#3)(2009-3#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
tubular epithelium##5##2##(1993-4#1)(1994-5#2)(2009-2#1)(2010-2#1)
tubular fluid##2##2##(1995-6#2)
tubular function##2##2##(1991-9#1)(1993-4#1)
tubular injury##2##2##(1993-12#1)(2012-12#1)
tubular interstitial changes##2##3##(1993-2#2)
tubular interstitial##3##2##(1993-2#3)
tubular lysosomes##3##2##(1990-8#3)
tubular membrane##2##2##(2008-10#1)(2009-7#1)
tubular necrosis in the##2##4##(1994-5#1)(1996-12#1)
tubular necrosis##16##2##(1994-3#1)(1994-5#1)(1995-2#3)(1996-12#1)(2005-12#2)(2006-2#1)(2008-1#1)(2008-4#1)(2010-4#1)(2012-12#3)(2012-2#1)
tubular or##2##2##(1993-2#1)(2008-6#1)
tubular proteinuria##3##2##(1990-12#1)(1990-6#1)(2008-1#1)
tubular reabsorption of phosphate##4##4##(2006-10#4)
tubular reabsorption of##5##3##(1993-4#1)(2006-10#4)
tubular reabsorption##7##2##(1990-7#1)(1993-4#1)(2006-10#5)
tubular reactor##2##2##(2008-10#1)(2008-5#1)
tubular structure##4##2##(2007-9#1)(2008-2#1)(2010-12#1)(2013-1#1)
tubular structures lined##2##3##(2008-2#1)(2008-5#1)
tubular structures##10##2##(1990-8#1)(1993-4#1)(1994-6#1)(1995-11#1)(2008-2#1)(2008-5#2)(2008-7#2)(2009-2#1)
tubular system of##2##3##(1997-4#1)(2008-10#1)
tubular toxicity##2##2##(2008-8#2)
tubular##263##1##(1990-10#1)(1990-12#1)(1990-4#4)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#5)(1990-9#1)(1991-11#4)(1991-12#1)(1991-2#1)(1991-4#4)(1991-8#5)(1991-9#2)(1992-2#1)(1992-3#2)(1992-6#9)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#6)(1993-3#2)(1993-4#6)(1994-3#2)(1994-5#4)(1994-6#3)(1994-7#4)(1994-9#1)(1995-11#5)(1995-2#4)(1995-4#6)(1995-6#2)(1996-12#4)(1996-2#1)(1996-6#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#2)(2004-11#1)(2005-1#1)(2005-12#2)(2005-8#2)(2006-10#6)(2006-2#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-12#6)(2007-3#1)(2007-5#1)(2007-7#4)(2007-8#4)(2007-9#7)(2008-1#5)(2008-10#19)(2008-11#2)(2008-2#5)(2008-4#5)(2008-5#8)(2008-6#6)(2008-7#5)(2008-8#5)(2008-9#1)(2009-1#4)(2009-10#3)(2009-12#2)(2009-2#3)(2009-3#2)(2009-7#2)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#8)(2012-1#2)(2012-12#6)(2012-2#5)(2013-1#7)(2013-7#2)(2013-8#3)
tubularised incised plate (TIP)##2##4##(2009-10#1)(2009-5#1)
tubularized incised plate##3##3##(2008-10#1)(2009-5#2)
tubule and the##2##3##(1993-3#1)(1997-6#1)
tubule and##6##2##(1991-2#1)(1993-3#2)(1997-6#1)(2008-7#1)(2012-12#1)
tubule cells##9##2##(1990-11#1)(1991-5#1)(1991-8#1)(1992-8#3)(1994-9#1)(2008-11#1)(2008-7#1)
tubule degeneration##8##2##(2008-9#8)
tubule development##2##2##(1997-6#2)
tubule diameter of##2##3##(2008-5#2)
tubule diameter##4##2##(2008-12#1)(2008-5#3)
tubule formation##3##2##(1991-2#1)(2008-11#1)(2012-4#1)
tubule from##2##2##(1994-7#1)(2008-11#1)
tubule may##2##2##(1990-11#1)(2007-12#1)
tubule##75##1##(1990-11#2)(1990-9#1)(1991-2#2)(1991-5#1)(1991-8#1)(1991-9#2)(1992-7#1)(1992-8#3)(1993-12#1)(1993-3#2)(1994-5#1)(1994-7#2)(1994-9#1)(1996-8#1)(1997-1#1)(1997-6#6)(1997-8#1)(2007-12#2)(2007-5#2)(2007-7#1)(2007-9#2)(2008-11#4)(2008-12#1)(2008-5#3)(2008-7#3)(2008-9#15)(2009-10#3)(2009-3#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-4#1)(2013-1#1)(2013-8#1)
tubules and##12##2##(1990-6#1)(1991-2#1)(1994-8#1)(1995-11#1)(1995-2#1)(2007-12#1)(2007-7#1)(2008-12#1)(2008-7#1)(2010-12#1)(2013-8#2)
tubules are##4##2##(2006-5#1)(2007-9#1)(2008-1#1)(2008-3#1)
tubules at##2##2##(2008-6#1)(2012-2#1)
tubules from##4##2##(1993-7#1)(1995-6#1)(1997-6#1)(2008-7#1)
tubules in the##4##3##(1992-8#1)(1993-3#1)(1996-1#1)(1997-7#1)
tubules in##7##2##(1992-8#1)(1993-3#1)(1996-1#2)(1997-7#1)(2008-10#1)(2009-10#1)
tubules isolated from##2##3##(1990-2#1)(1997-6#1)
tubules of the##2##3##(1997-6#1)(2007-12#1)
tubules of##8##2##(1993-7#1)(1994-3#1)(1996-5#1)(1997-6#1)(2007-12#2)(2008-4#1)(2010-9#1)
tubules to##2##2##(2010-4#2)
tubules were##4##2##(1996-12#1)(1997-6#2)(2012-2#1)
tubules with##6##2##(1997-1#1)(2007-12#2)(2007-7#1)(2008-7#1)(2011-2#1)
tubules##123##1##(1990-2#2)(1990-6#1)(1990-9#1)(1991-11#2)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-7#1)(1992-8#2)(1993-3#1)(1993-7#2)(1994-3#2)(1994-5#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-6#2)(1996-1#3)(1996-12#1)(1996-5#1)(1996-7#2)(1997-1#5)(1997-6#11)(1997-7#1)(1997-8#1)(2006-5#2)(2006-8#1)(2007-12#9)(2007-5#2)(2007-7#4)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#9)(2008-8#2)(2008-9#2)(2009-10#3)(2010-12#1)(2010-4#4)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#7)(2013-8#2)
tubuli##2##1##(1993-4#1)(2013-7#1)
tubulin and actin##3##3##(1993-6#2)(1995-3#1)
tubulin and##8##2##(1990-10#1)(1992-6#1)(1993-6#2)(1995-3#1)(1997-4#1)(2006-7#1)(2010-11#1)
tubulin as##2##2##(1995-5#1)(2006-10#1)
tubulin assembly##3##2##(1994-5#1)(1997-4#2)
tubulin carboxypeptidase##2##2##(1992-6#2)
tubulin dimer##4##2##(1993-8#2)(1995-5#1)(2008-6#1)
tubulin from the budding yeast Saccharomyces cerevisiae##2##7##(1993-8#2)
tubulin gene##2##2##(1993-8#1)(2005-11#1)
tubulin in##2##2##(1991-7#1)(2009-2#1)
tubulin is##2##2##(1990-5#1)(1993-8#1)
tubulin isoforms##2##2##(2010-7#1)(2012-2#1)
tubulin polymerization and##3##3##(1992-9#1)(1993-8#1)(1994-9#1)
tubulin polymerization##7##2##(1992-9#1)(1993-8#1)(1994-12#1)(1994-9#1)(2008-8#1)(2009-10#1)(2009-9#1)
tubulin self-assembly##2##2##(1990-7#2)
tubulin was##5##2##(1990-10#1)(1994-2#2)(1997-4#1)(2008-6#1)
tubulin with##4##2##(1992-5#1)(1992-9#1)(1993-3#1)(1994-3#1)
tubulin##127##1##(1990-10#6)(1990-3#1)(1990-5#7)(1990-6#1)(1990-7#2)(1991-4#1)(1991-5#2)(1991-7#3)(1991-9#1)(1992-5#1)(1992-6#5)(1992-8#2)(1992-9#6)(1993-3#1)(1993-6#3)(1993-8#13)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#4)(1994-9#2)(1995-2#3)(1995-3#2)(1995-5#11)(1997-4#8)(2004-12#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-12#3)(2006-7#1)(2007-12#1)(2007-8#5)(2008-11#2)(2008-6#3)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-7#2)(2011-12#2)(2012-2#1)
tubulin-GDP##2##1##(1995-1#2)
tubulin-colchicine##2##1##(1995-5#2)
tubulin-dimer binding##2##2##(2012-12#2)
tubulins##2##1##(2006-10#1)(2007-8#1)
tubulo-interstitial kidney disease##3##3##(2008-1#3)
tubulo-interstitial nephritis##2##2##(2007-7#2)
tubulo-interstitial##8##1##(2007-7#2)(2008-1#4)(2008-4#2)
tubulo-villous adenoma##2##2##(1993-10#1)(2012-12#1)
tubulo-villous##3##1##(1993-10#1)(2011-1#1)(2012-12#1)
tubulogenesis##10##1##(1991-11#1)(1997-6#7)(2010-9#1)(2012-12#1)
tubuloglomerular feedback##2##2##(2005-1#1)(2010-9#1)
tubulointerstitial nephritis##4##2##(2006-10#1)(2007-7#1)(2011-2#1)(2012-12#1)
tubulointerstitial##9##1##(2006-10#1)(2007-2#2)(2007-7#2)(2011-2#2)(2012-12#1)(2013-1#1)
tubulopapillary carcinomas##2##2##(2013-8#2)
tubulovesicles##4##1##(1997-1#2)(2006-10#2)
tubulovesicular structures##2##2##(1990-8#2)
tubulus cell line LLC-PK1##2##4##(1997-6#2)
tubulus##3##1##(1997-6#2)(2007-12#1)
tuf gene##2##2##(2008-10#2)
tuf##5##1##(2008-10#5)
tuft##5##1##(2007-12#1)(2009-5#1)(2010-2#1)(2010-5#1)(2010-6#1)
tufted deer##3##2##(2009-5#3)
tufted##4##1##(1991-9#1)(2009-5#3)
tufts##5##1##(1996-7#2)(2006-10#1)(2008-10#1)(2010-2#1)
tug-of-war##2##1##(2007-9#1)(2008-8#1)
tularemia##3##1##(2008-11#1)(2011-1#1)(2012-2#1)
tulip sign##2##2##(2013-1#2)
tulip##3##1##(2009-12#1)(2013-1#2)
tum-5##2##1##(2008-11#2)
tumbled##2##1##(1996-11#1)(2013-1#1)
tumbling of##2##2##(1992-1#1)(1994-9#1)
tumbling##9##1##(1991-2#1)(1992-1#2)(1994-9#2)(2006-11#1)(2008-5#1)(2012-3#1)(2013-1#1)
tumefaciens cells present during##2##4##(2008-10#2)
tumefaciens cells##5##2##(2008-10#5)
tumefaciens strain##2##2##(2008-10#1)(2012-2#1)
tumefaciens##37##1##(1990-5#3)(1992-5#3)(1995-1#2)(1997-2#1)(1997-4#1)(2005-1#2)(2006-3#2)(2007-11#2)(2007-12#2)(2008-10#14)(2008-9#2)(2011-2#2)(2012-2#1)
tumefaction##2##1##(2010-12#2)
tumeurs##3##1##(2012-2#2)(2013-1#1)
tumor &quot##2##2##(1990-10#1)(1995-1#1)
tumor (PNET)##2##2##(2007-12#1)(2007-7#1)
tumor (WT)##3##2##(1990-12#1)(1991-10#1)(2013-1#1)
tumor (p=0##2##2##(2010-12#2)
tumor -##2##2##(2007-8#1)(2013-8#1)
tumor 14##2##2##(2011-2#2)
tumor AUC##3##2##(1995-5#3)
tumor DNA##2##2##(2007-11#1)(2008-8#1)
tumor DPD##2##2##(2008-7#2)
tumor ablation##4##2##(2006-6#1)(2007-12#1)(2013-1#2)
tumor accompanied by##2##3##(1994-7#1)(2007-4#1)
tumor adjacent lung tissue##2##4##(1990-5#2)
tumor after##4##2##(2005-10#1)(2009-3#1)(2010-8#1)(2011-1#1)
tumor aggressiveness##4##2##(1990-10#1)(2006-6#1)(2011-2#1)(2013-8#1)
tumor and a##3##3##(2005-10#1)(2007-12#1)(2008-10#1)
tumor and embryonic##2##3##(2009-3#2)
tumor and immune cells##2##4##(2005-10#1)(2007-1#1)
tumor and immune system##2##4##(2009-2#1)(2012-2#1)
tumor and immune##5##3##(2005-10#1)(2007-1#1)(2009-2#1)(2011-1#1)(2012-2#1)
tumor and it##2##3##(2009-4#1)(2012-3#1)
tumor and liver##2##3##(1990-2#1)(1995-5#1)
tumor and normal##6##3##(1993-9#1)(1994-8#1)(1994-9#1)(1997-7#1)(2008-1#1)(2011-1#1)
tumor and other##3##3##(1995-10#1)(1997-6#1)(2010-8#1)
tumor and reconstruction##3##3##(2007-11#1)(2007-12#2)
tumor and severe##2##3##(1993-6#1)(2007-10#1)
tumor and the##11##3##(1991-10#1)(1993-1#1)(1993-11#2)(1996-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2008-11#1)(2010-12#1)(2012-2#1)
tumor and##113##2##(1990-2#3)(1990-5#1)(1990-9#1)(1991-10#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-5#1)(1996-11#2)(1996-2#1)(1996-6#2)(1997-6#1)(1997-7#1)(2005-10#2)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#2)(2006-12#2)(2006-5#1)(2006-6#2)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-12#3)(2010-3#3)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#2)
tumor angiogenesis and##3##3##(1996-11#1)(1997-7#1)(2010-12#1)
tumor angiogenesis in##3##3##(2007-8#1)(2008-1#1)(2012-12#1)
tumor angiogenesis##24##2##(1993-9#1)(1994-12#1)(1995-1#2)(1996-11#1)(1997-7#1)(2005-8#1)(2007-3#1)(2007-8#1)(2008-1#3)(2008-10#1)(2009-3#1)(2009-7#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#3)(2013-8#1)
tumor angiogenic##2##2##(2008-11#1)(2008-8#1)
tumor antigen were##2##3##(1995-2#1)(2008-4#1)
tumor antigen##10##2##(1991-12#1)(1993-11#1)(1995-2#2)(1996-4#1)(1997-4#1)(2008-4#1)(2008-8#1)(2009-3#1)(2013-1#1)
tumor antigens can##2##3##(2008-5#2)
tumor antigens in##2##3##(1991-12#1)(2006-10#1)
tumor antigens is##2##3##(1997-7#2)
tumor antigens##18##2##(1991-12#2)(1994-8#1)(1997-7#2)(2006-10#2)(2007-8#1)(2008-4#4)(2008-5#4)(2008-9#1)(2009-3#1)
tumor are##6##2##(1990-10#1)(1994-12#1)(1996-6#1)(2006-6#1)(2009-3#1)(2013-1#1)
tumor areas##3##2##(2010-2#1)(2012-12#2)
tumor arising from the##2##4##(1992-12#1)(2009-10#1)
tumor arising from##5##3##(1992-12#1)(1993-9#1)(2007-12#1)(2009-10#1)(2012-12#1)
tumor arising in the##3##4##(1990-2#1)(2009-1#1)(2012-2#1)
tumor arising in##5##3##(1990-2#1)(1991-2#1)(1994-12#1)(2009-1#1)(2012-2#1)
tumor arising##11##2##(1990-2#1)(1991-2#1)(1992-12#1)(1993-9#1)(1994-12#1)(2006-4#1)(2007-12#1)(2009-1#1)(2009-10#1)(2012-12#1)(2012-2#1)
tumor as##7##2##(2007-10#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-4#1)(2008-6#1)
tumor associated with a##3##4##(2008-6#1)(2013-1#2)
tumor associated with##4##3##(2007-3#1)(2008-6#1)(2013-1#2)
tumor associated##7##2##(2007-3#1)(2007-9#1)(2008-6#1)(2008-8#1)(2010-12#1)(2013-1#2)
tumor at the##2##3##(1992-6#1)(2007-11#1)
tumor at##9##2##(1992-1#1)(1992-6#1)(2007-10#1)(2007-11#1)(2008-6#1)(2010-12#1)(2011-2#2)(2013-1#1)
tumor bearing mice##2##3##(1992-8#1)(1994-6#1)
tumor bearing##6##2##(1992-8#1)(1994-6#1)(2011-2#2)(2012-2#1)(2013-1#1)
tumor before##2##2##(2008-5#1)(2010-3#1)
tumor biology and##2##3##(2010-5#1)(2011-2#1)
tumor biology##10##2##(2005-8#1)(2006-6#1)(2008-10#1)(2009-3#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#1)
tumor biomarkers in##2##3##(2013-1#2)
tumor boron concentrations of approximately##2##5##(1995-2#2)
tumor burden and##2##3##(1991-4#1)(2008-5#1)
tumor burden##11##2##(1990-12#1)(1991-4#1)(1995-4#1)(1997-7#1)(2006-6#1)(2008-5#2)(2011-2#1)(2012-12#2)(2013-1#1)
tumor by##6##2##(2006-4#1)(2006-6#1)(2008-11#1)(2008-3#1)(2013-1#2)
tumor can##3##2##(1992-4#1)(2006-12#1)(2008-12#1)
tumor cell adhesion to##3##4##(2008-1#1)(2009-3#2)
tumor cell adhesion##5##3##(1992-9#1)(1994-12#1)(2008-1#1)(2009-3#2)
tumor cell and##2##3##(2009-3#1)(2010-12#1)
tumor cell apoptosis##5##3##(2010-1#3)(2012-1#1)(2012-12#1)
tumor cell contamination##2##3##(2005-8#2)
tumor cell cultures##2##3##(1997-7#1)(2009-6#1)
tumor cell death##4##3##(2007-3#1)(2008-9#2)(2013-1#1)
tumor cell growth and##3##4##(2008-9#1)(2010-2#1)(2012-12#1)
tumor cell growth in vitro##2##5##(1997-5#1)(2013-1#1)
tumor cell growth in##5##4##(1991-7#2)(1997-5#1)(2012-3#1)(2013-1#1)
tumor cell growth##16##3##(1991-7#2)(1991-8#1)(1997-5#1)(2006-10#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-9#1)(2010-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
tumor cell invasion and##2##4##(1993-4#1)(2008-11#1)
tumor cell invasion##5##3##(1993-4#1)(1994-9#1)(2008-11#2)(2012-1#1)
tumor cell killing##3##3##(1991-4#2)(2008-11#1)
tumor cell line that##2##4##(1995-10#1)(2008-4#1)
tumor cell line##24##3##(1990-12#3)(1990-7#1)(1991-7#1)(1993-3#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-10#2)(1995-3#2)(1995-6#1)(1995-8#1)(1996-4#1)(1997-4#1)(1997-7#1)(2007-11#1)(2008-11#2)(2008-4#1)(2008-5#1)(2010-7#1)
tumor cell lines and that##2##5##(1992-11#1)(2008-8#1)
tumor cell lines and##4##4##(1990-11#1)(1992-11#1)(1994-5#1)(2008-8#1)
tumor cell lines by##2##4##(1992-9#1)(2010-2#1)
tumor cell lines in vitro and in vivo##2##8##(1991-6#1)(1995-6#1)
tumor cell lines in vitro##3##5##(1991-6#1)(1995-3#1)(1995-6#1)
tumor cell lines in##4##4##(1991-6#1)(1994-5#1)(1995-3#1)(1995-6#1)
tumor cell lines of##2##4##(1995-3#1)(1997-7#1)
tumor cell lines that##2##4##(1994-5#1)(2010-5#1)
tumor cell lines was##3##4##(1990-12#1)(1992-2#1)(2010-2#1)
tumor cell lines were##6##4##(1991-2#1)(1992-2#2)(1995-3#1)(1996-10#1)(2006-12#1)
tumor cell lines##86##3##(1990-11#1)(1990-12#1)(1990-6#3)(1991-2#1)(1991-6#2)(1991-7#2)(1991-9#1)(1992-11#3)(1992-2#9)(1992-8#2)(1992-9#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-5#3)(1994-7#1)(1994-9#5)(1995-1#1)(1995-12#1)(1995-3#3)(1995-6#1)(1996-10#1)(1996-4#1)(1996-5#1)(1997-7#2)(2005-10#1)(2005-7#1)(2006-12#1)(2007-11#5)(2008-11#3)(2008-3#2)(2008-5#8)(2008-7#1)(2008-8#1)(2008-9#3)(2010-2#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#5)
tumor cell lysis##3##3##(1991-9#2)(1994-3#1)
tumor cell migration##7##3##(2005-7#1)(2008-11#1)(2011-2#4)(2013-1#1)
tumor cell nuclei##2##3##(1993-11#1)(1996-6#1)
tumor cell population##2##3##(2009-3#1)(2013-8#1)
tumor cell proliferation##5##3##(1991-8#1)(1997-7#1)(2010-12#1)(2012-11#2)
tumor cell resistance to##2##4##(2006-10#2)
tumor cell survival##2##3##(1991-12#1)(2011-1#1)
tumor cell suspension##3##3##(2006-6#2)(2008-6#1)
tumor cell##222##2##(1990-11#1)(1990-12#5)(1990-4#1)(1990-5#2)(1990-6#3)(1990-7#1)(1991-12#1)(1991-2#2)(1991-4#2)(1991-6#2)(1991-7#6)(1991-8#4)(1991-9#3)(1992-11#3)(1992-2#9)(1992-8#2)(1992-9#2)(1993-11#2)(1993-3#1)(1993-4#1)(1993-9#1)(1994-10#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#3)(1994-7#1)(1994-8#1)(1994-9#7)(1995-1#1)(1995-10#2)(1995-12#1)(1995-3#5)(1995-6#3)(1995-8#2)(1996-10#1)(1996-11#2)(1996-4#3)(1996-5#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-7#6)(2005-10#1)(2005-11#1)(2005-7#2)(2005-8#3)(2006-10#3)(2006-12#2)(2006-6#2)(2007-11#7)(2007-12#1)(2007-3#1)(2007-5#1)(2008-1#3)(2008-10#1)(2008-11#11)(2008-3#2)(2008-4#5)(2008-5#11)(2008-6#3)(2008-7#1)(2008-8#4)(2008-9#7)(2009-12#1)(2009-3#5)(2009-6#2)(2010-1#3)(2010-12#2)(2010-2#3)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#5)(2012-1#4)(2012-11#3)(2012-12#8)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
tumor cell-derived##2##2##(1994-6#2)
tumor cells after##2##3##(1991-2#1)(2008-9#1)
tumor cells and on##2##4##(1990-5#1)(1993-9#1)
tumor cells and the##5##4##(1992-3#1)(1995-3#1)(1997-7#1)(2010-11#1)(2011-1#1)
tumor cells and##25##3##(1990-12#1)(1990-5#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-4#1)(1993-7#1)(1993-9#1)(1994-12#1)(1995-3#3)(1997-7#1)(2006-10#1)(2007-3#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-1#3)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
tumor cells are##8##3##(1991-5#1)(1993-4#1)(1993-9#1)(1996-4#1)(2008-1#2)(2008-4#1)(2008-6#1)
tumor cells as the targets for##2##6##(2008-4#2)
tumor cells as the##3##4##(1990-4#1)(2008-4#2)
tumor cells as##8##3##(1990-4#1)(1991-12#1)(1997-4#1)(2008-11#1)(2008-4#2)(2009-2#1)(2010-5#1)
tumor cells at##2##3##(1994-2#1)(2008-4#1)
tumor cells by##9##3##(1990-10#1)(1991-7#1)(1991-9#1)(1992-12#1)(1994-7#1)(1997-8#1)(2008-11#1)(2008-9#2)
tumor cells can##2##3##(1992-7#1)(1994-10#1)
tumor cells could##3##3##(1992-7#1)(2005-6#1)(2008-9#1)
tumor cells destroyed##2##3##(2008-4#1)(2010-3#1)
tumor cells evade##2##3##(2006-10#1)(2010-3#1)
tumor cells exhibit##2##3##(2010-12#1)(2010-3#1)
tumor cells expressing##2##3##(1993-9#1)(1995-5#1)
tumor cells for##3##3##(1992-8#1)(1994-12#1)(2008-11#1)
tumor cells from##5##3##(1995-3#1)(2008-4#2)(2008-5#1)(2010-3#1)
tumor cells had##4##3##(1993-4#1)(2006-12#1)(2007-12#2)
tumor cells has been##2##4##(1993-6#1)(1994-2#1)
tumor cells has##3##3##(1993-6#1)(1993-9#1)(1994-2#1)
tumor cells have been##3##4##(1996-8#1)(1997-4#1)(2006-10#1)
tumor cells have##6##3##(1991-8#1)(1995-8#1)(1996-8#1)(1997-4#1)(2005-8#1)(2006-10#1)
tumor cells in a##3##4##(1993-9#1)(2008-4#1)(2011-1#1)
tumor cells in bone marrow##2##5##(2010-3#1)(2011-2#1)
tumor cells in the##5##4##(1990-4#1)(1993-9#1)(1994-7#1)(2008-11#1)(2012-1#1)
tumor cells in vitro and##3##5##(1995-8#1)(2008-5#1)(2009-4#1)
tumor cells in vitro##6##4##(1995-2#1)(1995-8#1)(2008-4#1)(2008-5#1)(2009-3#1)(2009-4#1)
tumor cells in##29##3##(1990-12#1)(1990-4#1)(1990-5#1)(1991-4#1)(1991-6#1)(1993-9#2)(1994-5#1)(1994-7#1)(1995-2#1)(1995-8#1)(1996-3#1)(2005-7#1)(2007-11#1)(2008-11#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
tumor cells into##3##3##(1991-6#1)(1995-8#1)(2007-12#1)
tumor cells is##5##3##(1991-9#1)(1994-10#1)(2009-3#1)(2010-3#1)(2011-1#1)
tumor cells may be##2##4##(1994-5#1)(1997-7#1)
tumor cells may##6##3##(1992-12#1)(1993-4#1)(1993-7#1)(1994-5#1)(1997-4#1)(1997-7#1)
tumor cells of##4##3##(1990-12#1)(1991-5#1)(2008-11#1)(2009-2#1)
tumor cells or##4##3##(1994-12#1)(1995-2#1)(2008-6#1)(2008-9#1)
tumor cells showed##5##3##(1990-10#1)(1996-3#2)(2007-12#1)(2012-1#1)
tumor cells than##2##3##(2008-11#1)(2008-4#1)
tumor cells that can##2##4##(2005-10#1)(2009-12#1)
tumor cells that##4##3##(2005-10#1)(2008-10#1)(2009-12#1)(2010-2#1)
tumor cells through##2##3##(1993-4#1)(2012-3#1)
tumor cells to##16##3##(1991-2#1)(1991-7#1)(1992-7#2)(1993-10#1)(1994-12#1)(1994-2#1)(1994-5#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2009-9#1)
tumor cells using##2##3##(1991-9#1)(2006-6#1)
tumor cells was##4##3##(1990-10#1)(1992-9#2)(2012-1#1)
tumor cells were positive for##4##5##(1996-9#1)(2007-12#1)(2010-7#1)(2012-1#1)
tumor cells were##22##3##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-9#1)(1992-8#1)(1993-9#1)(1994-12#1)(1994-5#2)(1996-9#1)(2005-8#1)(2007-12#1)(2007-5#1)(2008-11#2)(2008-5#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-7#1)(2012-1#1)
tumor cells with##7##3##(1994-3#1)(1994-6#1)(1996-10#1)(2007-10#1)(2008-4#1)(2010-12#1)(2012-1#1)
tumor cells##457##2##(1990-10#6)(1990-11#2)(1990-12#7)(1990-2#1)(1990-4#2)(1990-5#4)(1990-6#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-4#3)(1991-5#3)(1991-6#2)(1991-7#6)(1991-8#3)(1991-9#8)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#1)(1992-7#7)(1992-8#10)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#3)(1993-4#10)(1993-6#2)(1993-7#4)(1993-8#1)(1993-9#14)(1994-10#3)(1994-11#2)(1994-12#9)(1994-2#6)(1994-3#1)(1994-5#12)(1994-6#3)(1994-7#2)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#3)(1995-2#3)(1995-3#6)(1995-5#3)(1995-6#5)(1995-8#6)(1996-10#1)(1996-3#4)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#5)(1997-4#5)(1997-5#1)(1997-7#5)(1997-8#1)(2005-10#2)(2005-6#1)(2005-7#1)(2005-8#2)(2006-10#7)(2006-12#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#8)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#3)(2008-11#26)(2008-3#1)(2008-4#24)(2008-5#9)(2008-6#8)(2008-7#2)(2008-8#6)(2008-9#13)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#15)(2009-4#4)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#6)(2010-2#5)(2010-3#8)(2010-5#1)(2010-6#1)(2010-7#3)(2011-1#10)(2011-2#4)(2012-1#8)(2012-12#6)(2012-2#2)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#4)
tumor cells) and##2##3##(1997-7#1)(2013-8#1)
tumor cells)##3##2##(1994-7#1)(1997-7#1)(2013-8#1)
tumor characteristics and##2##3##(1993-7#1)(2009-2#1)
tumor characteristics##10##2##(1993-7#1)(2008-10#1)(2008-6#3)(2009-2#1)(2010-12#1)(2010-8#1)(2011-2#2)
tumor classification##4##2##(1994-12#1)(2008-6#1)(2013-1#2)
tumor colonies in##2##3##(1991-3#1)(2013-1#1)
tumor colony##2##2##(1990-12#1)(1997-8#1)
tumor combined with##3##3##(1997-6#1)(2009-2#2)
tumor component##2##2##(2007-12#1)(2011-2#1)
tumor composed of##4##3##(2008-7#1)(2009-5#2)(2011-1#1)
tumor considered to##2##3##(2010-12#2)
tumor considered##3##2##(1991-6#1)(2010-12#2)
tumor contrast##3##2##(2007-12#1)(2008-4#1)(2012-2#1)
tumor control and##2##3##(2006-6#1)(2007-8#1)
tumor control probability of a human##2##6##(1995-4#2)
tumor control probability##3##3##(1995-4#2)(2009-8#1)
tumor control rate##3##3##(2005-5#1)(2006-11#1)(2006-12#1)
tumor control##20##2##(1990-4#1)(1994-4#2)(1995-4#2)(1995-9#1)(2004-1#1)(2005-5#1)(2006-11#2)(2006-12#3)(2006-6#2)(2007-5#1)(2007-8#2)(2008-5#1)(2009-8#1)
tumor could be##3##3##(2008-12#1)(2008-2#1)(2008-7#1)
tumor could##4##2##(2007-5#1)(2008-12#1)(2008-2#1)(2008-7#1)
tumor coverage and##2##3##(2008-6#2)
tumor coverage##3##2##(2008-6#3)
tumor delineation##3##2##(2007-8#1)(2009-11#2)
tumor demonstrated##3##2##(2006-12#1)(2007-12#1)(2009-1#1)
tumor depth##2##2##(2006-10#1)(2011-2#1)
tumor derived##3##2##(1991-8#1)(2007-5#1)(2013-1#1)
tumor destruction##2##2##(2010-8#1)(2011-2#1)
tumor detection and##2##3##(2008-3#1)(2013-1#1)
tumor detection##8##2##(1993-11#1)(2008-3#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#2)
tumor development and progression##2##4##(1994-12#1)(2007-8#1)
tumor development and##7##3##(1991-12#1)(1993-8#1)(1994-12#1)(2007-8#1)(2008-7#1)(2009-4#1)(2013-8#1)
tumor development in##5##3##(2007-4#1)(2008-11#1)(2008-8#1)(2010-2#1)(2011-2#1)
tumor development was##3##3##(1992-7#1)(1993-7#1)(2013-1#1)
tumor development##35##2##(1990-5#1)(1990-6#1)(1991-12#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-7#2)(1993-8#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-8#1)(1997-7#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#2)
tumor diagnosed##2##2##(2011-2#1)(2012-1#1)
tumor diagnosis and##2##3##(2008-8#1)(2011-2#1)
tumor diagnosis##4##2##(1991-2#1)(2008-12#1)(2008-8#1)(2011-2#1)
tumor diameter and number of involved structures/organs##2##7##(2007-8#2)
tumor diameter was##3##3##(2006-11#1)(2013-8#2)
tumor diameter##7##2##(2006-11#1)(2007-8#3)(2008-2#1)(2013-8#2)
tumor did not##3##3##(1991-9#1)(2009-3#1)(2013-8#1)
tumor differentiation##4##2##(1996-6#1)(2006-10#1)(2009-3#1)(2011-1#1)
tumor disease##2##2##(2009-12#1)(2013-1#1)
tumor dissection##2##2##(2006-5#2)
tumor dissemination##3##2##(1992-4#1)(2012-12#1)(2013-8#1)
tumor dose of##2##3##(1992-10#1)(2008-3#1)
tumor dose##4##2##(1992-10#1)(1993-9#1)(2008-3#1)(2008-6#1)
tumor doses##2##2##(1991-12#1)(2007-6#1)
tumor downstaging##2##2##(2007-7#1)(2010-6#1)
tumor during##3##2##(1990-6#1)(2005-10#1)(2011-1#1)
tumor dynamics##2##2##(2008-8#2)
tumor emboli##4##2##(2011-2#4)
tumor embolism##3##2##(2013-7#3)
tumor engraftment##2##2##(2013-1#2)
tumor enhancement##4##2##(1994-5#1)(1996-3#2)(2010-12#1)
tumor entity##2##2##(1996-9#1)(2008-6#1)
tumor environment##4##2##(2005-7#1)(2007-10#1)(2009-3#1)(2009-6#1)
tumor eradication##2##2##(1997-7#1)(2010-11#1)
tumor excision##4##2##(2005-9#1)(2007-8#1)(2008-10#1)(2011-1#1)
tumor exhibited##2##2##(1990-2#1)(2012-1#1)
tumor extension##5##2##(1990-12#1)(2007-10#1)(2010-10#1)(2011-1#1)(2013-1#1)
tumor extensions##3##2##(2005-11#1)(2005-9#1)(2006-12#1)
tumor extracts##2##2##(1997-7#2)
tumor foci##2##2##(2010-11#2)
tumor followed##2##2##(2007-8#1)(2013-8#1)
tumor for##2##2##(2010-3#1)(2011-2#1)
tumor formation and progression##2##4##(2010-2#1)(2011-1#1)
tumor formation and##5##3##(2008-8#1)(2009-3#1)(2010-2#1)(2011-1#1)(2013-8#1)
tumor formation in vivo##2##4##(2008-1#1)(2013-1#1)
tumor formation in##7##3##(1990-4#1)(1991-8#1)(2008-1#1)(2008-11#1)(2011-2#1)(2013-1#2)
tumor formation##26##2##(1990-4#1)(1991-10#1)(1991-12#1)(1991-8#1)(1992-2#1)(1993-7#1)(1996-11#1)(1997-2#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-8#2)(2009-10#1)(2009-3#1)(2010-2#1)(2011-1#1)(2011-2#2)(2013-1#3)(2013-8#1)
tumor free##2##2##(1992-5#1)(1993-2#1)
tumor from##6##2##(1990-10#1)(2006-12#1)(2007-11#1)(2009-8#1)(2012-2#1)(2013-1#1)
tumor gene##3##2##(1991-10#1)(2007-12#1)(2008-4#1)
tumor generally##2##2##(1990-4#1)(2008-9#1)
tumor genesis##2##2##(1990-12#1)(2011-2#1)
tumor grade##8##2##(1993-9#1)(1994-9#1)(2008-6#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)
tumor grading##2##2##(1997-8#1)(2011-2#1)
tumor growing in##2##3##(1991-6#1)(2013-8#1)
tumor growth and invasion##2##4##(2012-2#1)(2013-1#1)
tumor growth and metastases##2##4##(2008-5#1)(2008-6#1)
tumor growth and metastasis of##2##5##(1994-12#1)(2009-6#1)
tumor growth and metastasis##11##4##(1994-12#2)(1996-6#1)(2008-8#2)(2009-3#3)(2009-6#1)(2012-2#1)(2013-8#1)
tumor growth and progression##2##4##(2005-11#2)
tumor growth and##33##3##(1991-9#2)(1994-12#2)(1994-6#1)(1995-5#1)(1996-10#1)(1996-6#1)(2005-11#2)(2007-11#1)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#1)(2009-3#4)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2011-11#1)(2012-2#2)(2013-1#2)(2013-8#1)
tumor growth associated##2##3##(2008-3#2)
tumor growth but##2##3##(2010-12#1)(2012-12#1)
tumor growth by##2##3##(2005-8#1)(2008-6#1)
tumor growth compared to the##2##5##(2008-6#1)(2012-12#1)
tumor growth factor##2##3##(2005-10#1)(2008-5#1)
tumor growth in the##2##4##(1992-2#1)(1997-7#1)
tumor growth in##14##3##(1990-11#1)(1991-5#1)(1991-9#1)(1992-2#1)(1994-6#1)(1996-6#1)(1997-7#2)(2005-10#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-12#1)(2013-7#1)
tumor growth inhibition##2##3##(1992-1#1)(2013-8#1)
tumor growth is##2##3##(2009-4#1)(2010-12#1)
tumor growth may##2##3##(1991-6#1)(2009-2#1)
tumor growth of##3##3##(1990-7#1)(2007-8#1)(2013-7#1)
tumor growth rate##3##3##(1993-11#2)(2011-2#1)
tumor growth rates##3##3##(1992-7#2)(2011-2#1)
tumor growth was##2##3##(1996-4#1)(2013-7#1)
tumor growth with##3##3##(1997-7#1)(2007-12#1)(2013-8#1)
tumor growth##152##2##(1990-11#1)(1990-7#1)(1990-9#1)(1991-12#2)(1991-5#1)(1991-6#2)(1991-9#4)(1992-1#1)(1992-2#1)(1992-7#3)(1993-1#3)(1993-11#3)(1994-11#1)(1994-12#3)(1994-5#1)(1994-6#6)(1994-9#1)(1995-3#1)(1995-5#3)(1996-10#1)(1996-4#1)(1996-6#2)(1997-7#3)(2005-10#3)(2005-11#3)(2005-8#1)(2006-11#1)(2006-12#1)(2006-2#2)(2006-4#1)(2006-6#1)(2006-7#2)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-5#4)(2008-6#4)(2008-7#4)(2008-8#5)(2008-9#4)(2009-2#1)(2009-3#6)(2009-4#1)(2009-6#1)(2009-9#1)(2010-1#3)(2010-12#5)(2010-2#2)(2010-3#1)(2011-1#2)(2011-11#1)(2011-2#5)(2012-1#2)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#10)(2013-7#3)(2013-8#6)
tumor growth?##2##2##(1994-5#1)(1994-6#1)
tumor had a##3##3##(1991-4#1)(1993-6#1)(2013-7#1)
tumor had been##2##3##(2007-11#1)(2009-5#1)
tumor had##11##2##(1991-4#1)(1991-9#1)(1993-6#1)(1994-12#1)(1995-1#1)(1995-4#1)(2006-12#1)(2007-11#1)(2008-12#1)(2009-5#1)(2013-7#1)
tumor has been##3##3##(2007-7#1)(2010-11#1)(2012-12#1)
tumor has##9##2##(1990-8#1)(2006-12#2)(2007-11#1)(2007-7#1)(2008-4#1)(2010-11#1)(2010-12#1)(2012-12#1)
tumor have been##2##3##(2007-8#1)(2008-8#1)
tumor heterogeneity##2##2##(1994-12#1)(2010-7#1)
tumor if##2##2##(2006-10#1)(2007-11#1)
tumor imaging##3##2##(2007-8#2)(2010-6#1)
tumor immunity##5##2##(1995-2#1)(1995-8#1)(2005-10#1)(2008-4#1)(2010-3#1)
tumor immunogenicity##4##2##(1991-9#2)(1995-8#1)(2005-8#1)
tumor immunology have##2##3##(2006-10#1)(2008-1#1)
tumor immunology##9##2##(2005-10#2)(2005-8#1)(2006-10#2)(2008-1#1)(2008-4#2)(2008-5#1)
tumor immunotherapy##9##2##(1994-5#1)(2005-10#2)(2008-8#1)(2009-3#2)(2011-2#2)(2012-2#1)
tumor implantation##2##2##(2006-6#2)
tumor in 66##3##3##(2008-3#1)(2008-6#1)(2010-3#1)
tumor in a##6##3##(1994-2#1)(2007-2#2)(2008-5#1)(2009-11#1)(2011-2#1)
tumor in all##2##3##(2007-8#1)(2013-1#1)
tumor in an##3##3##(1996-10#1)(2006-12#1)(2012-11#1)
tumor in children and##2##4##(2011-1#1)(2013-7#1)
tumor in children##6##3##(1991-10#1)(2007-12#1)(2008-10#1)(2010-9#1)(2011-1#1)(2013-7#1)
tumor in deep##2##3##(2006-6#2)
tumor in the breast##2##4##(2008-3#1)(2008-9#1)
tumor in the gastric##2##4##(1990-10#1)(2007-9#1)
tumor in the left lower lobe##3##6##(2007-8#3)
tumor in the left##9##4##(2006-12#2)(2007-8#3)(2008-10#1)(2013-1#2)(2013-8#1)
tumor in the lower rectum##2##5##(1993-5#1)(2010-12#1)
tumor in the pancreas##2##4##(2010-12#1)(2011-2#1)
tumor in the right##3##4##(1995-4#1)(2007-8#1)(2012-3#1)
tumor in the##39##3##(1990-10#1)(1993-5#1)(1994-3#1)(1995-4#1)(1996-6#1)(2006-10#1)(2006-12#2)(2006-7#1)(2007-11#1)(2007-6#1)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-12#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
tumor in vivo##2##3##(1995-5#1)(2013-1#1)
tumor in which##2##3##(1990-6#1)(2008-6#1)
tumor in##90##2##(1990-10#1)(1990-6#1)(1991-10#1)(1992-3#1)(1993-5#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-4#1)(1995-5#1)(1996-10#1)(1996-6#1)(2006-10#1)(2006-12#3)(2006-5#2)(2006-6#2)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-6#1)(2007-8#7)(2007-9#1)(2008-1#2)(2008-10#4)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#3)(2008-9#1)(2009-11#1)(2009-5#1)(2010-12#3)(2010-3#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#8)(2013-7#2)(2013-8#3)
tumor incidence in##3##3##(1992-5#1)(1993-7#1)(2013-1#1)
tumor incidence##13##2##(1990-5#1)(1990-6#1)(1992-5#1)(1993-11#1)(1993-7#1)(1994-2#1)(1994-4#1)(1997-7#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#2)
tumor indicator##2##2##(1991-12#1)(1996-11#1)
tumor induction resulted in##2##4##(1995-1#1)(2008-8#1)
tumor induction was##2##3##(1990-5#1)(1993-7#1)
tumor induction##10##2##(1990-5#1)(1992-5#1)(1993-7#1)(1995-1#1)(1996-11#1)(2008-4#1)(2008-8#3)(2009-10#1)
tumor infiltration##2##2##(1994-9#1)(2013-1#1)
tumor inhibition##3##2##(2011-1#1)(2012-3#2)
tumor initiating##3##2##(1990-7#1)(2010-12#1)(2013-1#1)
tumor initiation and progression##4##4##(2008-7#1)(2008-8#3)
tumor initiation and##6##3##(2008-7#1)(2008-8#3)(2009-9#1)(2011-2#1)
tumor initiation##9##2##(1996-11#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-9#1)(2011-2#1)(2012-12#1)
tumor initiator in##2##3##(1992-7#1)(1993-9#1)
tumor initiator##4##2##(1990-7#2)(1992-7#1)(1993-9#1)
tumor injection##3##2##(2008-8#3)
tumor invasion and metastasis##7##4##(1993-7#1)(1993-9#1)(1997-6#1)(2008-5#1)(2008-8#1)(2012-12#1)(2012-3#1)
tumor invasion and##11##3##(1993-7#1)(1993-9#1)(1997-6#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-3#2)
tumor invasion into the##2##4##(2011-2#1)(2012-2#1)
tumor invasion##24##2##(1993-4#1)(1993-7#1)(1993-9#1)(1994-9#1)(1997-6#1)(2005-5#1)(2006-12#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
tumor involution##2##2##(1990-12#2)
tumor involving the##2##3##(2005-9#1)(2010-7#1)
tumor is a rare##3##4##(1990-12#1)(2007-3#1)(2007-8#1)
tumor is a##9##3##(1990-12#1)(1992-12#1)(1994-6#1)(2006-12#1)(2007-3#1)(2007-8#3)(2008-2#1)
tumor is an##2##3##(2012-2#1)(2013-7#1)
tumor is not##2##3##(2007-5#1)(2011-12#1)
tumor is poor##2##3##(1992-6#1)(2006-7#1)
tumor is rare##2##3##(1997-1#1)(2007-8#1)
tumor is relatively##2##3##(2008-9#1)(2013-8#1)
tumor is suspected##2##3##(2008-6#1)(2009-3#1)
tumor is the##2##3##(2008-7#1)(2012-12#1)
tumor is##61##2##(1990-12#1)(1991-2#2)(1991-7#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1994-6#1)(1996-9#1)(1997-1#3)(2005-5#1)(2006-12#2)(2006-2#1)(2006-6#2)(2006-7#1)(2006-9#1)(2007-3#1)(2007-5#1)(2007-8#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-3#1)(2010-12#3)(2010-2#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#4)(2013-7#1)(2013-8#1)
tumor lesion##2##2##(2007-12#1)(2010-12#1)
tumor lesions##3##2##(2007-11#1)(2009-12#1)(2013-8#1)
tumor lines##3##2##(1994-9#2)(2009-10#1)
tumor load##2##2##(1997-4#1)(2010-12#1)
tumor localization##8##2##(1990-9#1)(1993-7#1)(2012-11#1)(2012-2#1)(2013-7#4)
tumor located in the left##3##5##(2007-8#1)(2009-8#1)(2012-3#1)
tumor located in the##10##4##(1996-6#1)(2006-1#1)(2006-2#1)(2006-5#1)(2007-8#3)(2009-8#1)(2011-12#1)(2012-3#1)
tumor location in##2##3##(2006-12#1)(2006-5#1)
tumor location##7##2##(2006-12#1)(2006-5#1)(2008-11#1)(2010-3#2)(2010-9#1)(2012-3#1)
tumor lysis syndrome##7##3##(2008-7#7)
tumor malignancy##7##2##(1993-8#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
tumor margin##2##2##(2006-11#1)(2008-8#1)
tumor marker for##4##3##(1992-3#1)(1993-1#1)(1995-2#1)(2008-4#1)
tumor marker in##3##3##(1990-8#1)(1993-6#1)(2005-12#1)
tumor marker##25##2##(1990-8#2)(1990-9#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-3#1)(1993-1#2)(1993-6#1)(1995-10#1)(1995-2#2)(1996-11#1)(1997-7#1)(2005-12#1)(2008-4#4)(2009-4#1)(2009-5#1)(2011-1#2)(2011-2#1)
tumor markers and##2##3##(1990-8#1)(1994-7#1)
tumor markers in##3##3##(1990-10#2)(2007-4#1)
tumor markers of##2##3##(1996-3#1)(2010-8#1)
tumor markers were##3##3##(1994-7#1)(1995-4#1)(2013-7#1)
tumor markers##35##2##(1990-10#3)(1990-8#1)(1991-2#1)(1991-4#1)(1991-8#2)(1992-12#1)(1994-7#2)(1995-4#2)(1996-2#1)(1996-3#2)(2006-10#3)(2006-9#2)(2007-1#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-2#2)(2013-7#1)
tumor mass but##2##3##(2007-10#1)(2007-3#1)
tumor mass of##2##3##(1996-6#1)(2011-2#1)
tumor mass was##2##3##(2006-12#1)(2009-2#1)
tumor mass##18##2##(1990-6#1)(1990-9#1)(1992-1#1)(1993-11#1)(1996-6#1)(2006-12#1)(2007-10#2)(2007-3#2)(2008-1#1)(2008-6#1)(2009-2#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
tumor masses in the##2##4##(2008-1#1)(2011-2#1)
tumor masses##8##2##(1991-2#1)(1991-4#1)(2008-1#1)(2008-5#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-2#1)
tumor may be##3##3##(1997-1#1)(2007-2#1)(2012-3#1)
tumor measuring##2##2##(1994-7#1)(2013-8#1)
tumor metastasis and##2##3##(2008-1#1)(2012-12#1)
tumor metastasis##17##2##(1990-11#1)(1991-2#1)(1991-5#1)(1992-8#3)(1994-8#1)(1994-9#1)(1995-8#1)(1997-7#1)(2008-1#1)(2008-8#3)(2008-9#1)(2012-12#1)(2012-3#1)
tumor metastatic##2##2##(2007-6#1)(2008-9#1)
tumor micro-environment##2##2##(1991-7#2)
tumor microenvironment in##5##3##(2009-6#1)(2011-1#2)(2013-1#2)
tumor microenvironment is##2##3##(2011-1#2)
tumor microenvironment that##2##3##(2010-3#1)(2011-1#1)
tumor microenvironment##30##2##(1997-7#1)(2005-10#1)(2009-3#6)(2009-6#1)(2010-11#2)(2010-12#1)(2010-3#1)(2011-1#9)(2012-2#1)(2013-1#6)(2013-8#1)
tumor microenvironments##3##2##(2011-1#3)
tumor model is##3##3##(1991-9#1)(1996-5#1)(2008-11#1)
tumor model##20##2##(1991-7#1)(1991-9#1)(1992-2#1)(1992-9#2)(1993-1#1)(1996-5#1)(1997-1#1)(2007-3#1)(2008-11#1)(2008-4#4)(2008-8#3)(2009-6#1)(2010-2#1)(2013-7#1)
tumor models##11##2##(1992-7#1)(1993-9#1)(1994-12#1)(1996-10#1)(2005-8#1)(2008-4#1)(2008-5#1)(2010-2#2)(2012-3#1)(2013-1#1)
tumor motion##2##2##(2009-5#2)
tumor multiplicity in##2##3##(1994-5#1)(1997-4#1)
tumor multiplicity##5##2##(1993-9#1)(1994-5#2)(1997-4#1)(2011-2#1)
tumor necrosis factor (TNF) cytotoxicity##2##5##(1995-3#1)(1995-8#1)
tumor necrosis factor (TNF) on##3##5##(1990-2#1)(1991-2#1)(1992-11#1)
tumor necrosis factor (TNF) receptor##2##5##(1994-2#1)(1996-5#1)
tumor necrosis factor (TNF)##29##4##(1990-12#1)(1990-2#1)(1991-1#1)(1991-2#1)(1992-11#1)(1992-12#1)(1993-3#1)(1994-2#3)(1994-8#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-5#2)(1997-4#1)(1997-5#1)(1997-6#2)(2006-10#1)(2006-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-2#1)(2012-3#2)
tumor necrosis factor (TNF)-alpha and##2##5##(1996-12#1)(2008-5#1)
tumor necrosis factor (TNF)-alpha levels##2##5##(2008-10#2)
tumor necrosis factor (TNF)-alpha##9##4##(1992-8#1)(1994-12#1)(1996-12#1)(1996-5#1)(2005-7#1)(2008-10#2)(2008-5#2)
tumor necrosis factor (TNF)-α##2##4##(2011-12#1)(2011-2#1)
tumor necrosis factor alpha (TNF alpha)##3##6##(1991-9#1)(1993-6#1)(1994-9#1)
tumor necrosis factor alpha (TNF)##3##5##(1990-5#1)(1992-7#1)(1996-5#1)
tumor necrosis factor alpha (TNF-alpha) and##2##6##(1995-6#1)(2008-11#1)
tumor necrosis factor alpha (TNF-alpha)##6##5##(1993-12#1)(1995-6#1)(2006-12#1)(2008-1#1)(2008-11#1)(2008-5#1)
tumor necrosis factor alpha (TNFalpha)##3##5##(1997-4#1)(2006-3#1)(2013-8#1)
tumor necrosis factor alpha and##4##5##(1994-8#1)(2008-11#1)(2008-4#1)(2011-2#1)
tumor necrosis factor alpha have##2##5##(2006-10#1)(2010-9#1)
tumor necrosis factor alpha in##2##5##(1990-10#1)(1995-3#1)
tumor necrosis factor alpha##36##4##(1990-10#2)(1990-4#1)(1990-5#1)(1991-5#1)(1991-9#1)(1992-7#1)(1993-12#1)(1993-6#1)(1994-8#1)(1994-9#2)(1995-3#1)(1995-6#1)(1996-4#1)(1996-5#2)(1997-4#1)(2006-10#2)(2006-12#1)(2006-3#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#2)(2010-9#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#2)(2013-8#1)
tumor necrosis factor alpha)##2##4##(2008-1#2)
tumor necrosis factor and##3##4##(2006-10#2)(2006-8#1)
tumor necrosis factor antagonists##2##4##(2006-10#1)(2012-12#1)
tumor necrosis factor cytotoxicity##2##4##(1992-7#1)(1995-3#1)
tumor necrosis factor in##4##4##(1990-12#1)(1991-12#1)(2006-10#1)(2013-7#1)
tumor necrosis factor inhibitors##2##4##(2006-10#1)(2011-2#1)
tumor necrosis factor is##2##4##(1990-2#1)(1990-3#1)
tumor necrosis factor precursor##2##4##(1991-8#2)
tumor necrosis factor receptor##4##4##(1993-3#1)(1995-1#1)(1997-5#1)(2006-10#1)
tumor necrosis factor receptor-associated factor##2##5##(1996-5#2)
tumor necrosis factor##138##3##(1990-10#2)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#2)(1991-1#2)(1991-12#2)(1991-2#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-4#1)(1996-5#9)(1997-2#1)(1997-4#3)(1997-5#2)(1997-6#3)(1997-8#1)(2005-7#1)(2006-10#14)(2006-12#1)(2006-3#1)(2006-8#2)(2007-7#1)(2008-1#4)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#6)(2013-7#1)(2013-8#1)
tumor necrosis factor-alpha (TNF)##2##4##(1993-12#1)(2007-1#1)
tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6)##4##7##(1992-8#1)(2008-1#1)(2008-10#1)(2008-3#1)
tumor necrosis factor-alpha (TNF-alpha) and##6##5##(1992-8#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#1)
tumor necrosis factor-alpha (TNF-alpha) mRNA##2##5##(1994-5#1)(2008-9#1)
tumor necrosis factor-alpha (TNF-alpha)##30##4##(1992-12#1)(1992-3#1)(1992-8#2)(1993-6#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-9#1)(1997-5#1)(2006-10#1)(2006-2#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-3#3)(2008-7#2)(2008-9#2)(2009-9#1)(2010-7#1)(2012-2#1)(2013-1#1)
tumor necrosis factor-alpha (TNF-α)##4##4##(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
tumor necrosis factor-alpha (TNFalpha)##2##4##(2007-12#1)(2010-7#1)
tumor necrosis factor-alpha and##8##4##(1994-11#1)(1995-10#1)(1995-12#1)(1995-3#1)(2008-3#1)(2008-5#2)(2008-7#1)
tumor necrosis factor-alpha in human##2##5##(1992-8#1)(1994-6#1)
tumor necrosis factor-alpha in##5##4##(1991-12#1)(1991-5#1)(1992-8#1)(1994-6#1)(1997-8#1)
tumor necrosis factor-alpha production in mice##2##6##(1997-7#2)
tumor necrosis factor-alpha production in##4##5##(1997-7#2)(2006-10#1)(2009-9#1)
tumor necrosis factor-alpha production##5##4##(1994-5#1)(1997-7#2)(2006-10#1)(2009-9#1)
tumor necrosis factor-alpha##92##3##(1990-9#1)(1991-10#1)(1991-12#3)(1991-5#1)(1992-12#2)(1992-3#1)(1992-7#1)(1992-8#3)(1993-12#1)(1993-6#1)(1994-11#3)(1994-5#2)(1994-6#1)(1994-8#3)(1995-10#1)(1995-12#2)(1995-3#3)(1995-4#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#1)(2005-8#1)(2006-10#7)(2006-12#1)(2006-2#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-9#2)(2009-10#1)(2009-2#1)(2009-9#2)(2010-12#1)(2010-7#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#4)
tumor necrosis factor-induced##2##3##(1994-2#1)(1995-8#1)
tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)##2##6##(2006-10#1)(2009-3#1)
tumor necrosis factor-related apoptosis-inducing ligand##3##5##(2006-10#1)(2009-3#1)(2009-7#1)
tumor necrosis factor-α inhibitors##4##4##(2013-1#4)
tumor necrosis factor-α##12##3##(2010-12#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#7)(2013-8#1)
tumor necrosis##261##2##(1990-10#2)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-9#2)(1991-1#2)(1991-10#1)(1991-12#5)(1991-2#1)(1991-5#2)(1991-6#2)(1991-8#2)(1991-9#1)(1992-11#2)(1992-12#3)(1992-3#3)(1992-7#3)(1992-8#4)(1992-9#1)(1993-12#2)(1993-3#2)(1993-6#2)(1994-10#1)(1994-11#4)(1994-12#1)(1994-2#5)(1994-5#2)(1994-6#1)(1994-8#5)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#4)(1995-2#1)(1995-3#6)(1995-4#1)(1995-6#1)(1995-8#2)(1995-9#2)(1996-1#2)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#10)(1996-9#1)(1997-2#1)(1997-4#3)(1997-5#4)(1997-6#5)(1997-7#2)(1997-8#2)(2005-7#1)(2005-8#1)(2006-10#22)(2006-12#2)(2006-2#1)(2006-3#1)(2006-8#2)(2007-1#1)(2007-12#3)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#2)(2009-2#2)(2009-3#1)(2009-7#1)(2009-9#2)(2010-12#2)(2010-3#2)(2010-7#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-11#2)(2012-12#1)(2012-2#6)(2012-3#7)(2013-1#12)(2013-7#2)(2013-8#3)
tumor necrosis) in##2##3##(1990-12#1)(1992-6#1)
tumor nests##7##2##(1990-6#1)(2008-5#6)
tumor nodule##5##2##(2008-6#1)(2011-2#1)(2013-1#2)(2013-7#1)
tumor nodules##6##2##(1993-6#1)(2011-2#1)(2013-1#4)
tumor not##3##2##(1994-12#1)(2005-10#1)(2012-12#1)
tumor occurred in##2##3##(2006-12#1)(2012-2#1)
tumor occurring at a##2##4##(1997-3#1)(2010-3#1)
tumor occurring##3##2##(1997-3#2)(2010-3#1)
tumor of a living mouse##2##5##(1995-1#2)
tumor of a patient##2##4##(1990-11#1)(2013-1#1)
tumor of a##5##3##(1990-11#1)(1995-1#2)(1996-4#1)(2013-1#1)
tumor of infancy is a rare##2##6##(2008-10#1)(2012-2#1)
tumor of infancy is##4##4##(2008-10#1)(2012-2#3)
tumor of infancy was##2##4##(2008-10#2)
tumor of infancy##11##3##(2007-12#1)(2008-10#4)(2012-2#6)
tumor of soft tissue##2##4##(2009-3#1)(2012-2#1)
tumor of the bone##3##4##(2008-6#1)(2010-3#1)(2012-2#1)
tumor of the breast##6##4##(1994-12#1)(1994-6#1)(1995-4#3)(1996-6#1)
tumor of the endometrium##2##4##(2011-1#1)(2012-2#1)
tumor of the heart##2##4##(2007-8#1)(2010-7#1)
tumor of the kidney##3##4##(2008-10#2)(2013-1#1)
tumor of the larynx##2##4##(1993-6#2)
tumor of the pancreas##5##4##(1992-5#1)(2007-10#1)(2008-3#1)(2010-12#2)
tumor of the skin##2##4##(2008-6#1)(2012-1#1)
tumor of the temporal bone##2##5##(2006-12#1)(2011-2#1)
tumor of the##60##3##(1991-4#1)(1991-6#1)(1992-2#1)(1992-5#1)(1993-6#2)(1994-12#1)(1994-6#1)(1995-4#3)(1996-6#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#4)(2008-10#4)(2008-12#2)(2008-3#1)(2008-6#2)(2008-9#1)(2009-2#1)(2009-3#3)(2009-5#1)(2009-7#1)(2010-12#2)(2010-3#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-2#5)(2012-3#1)(2013-1#1)(2013-7#1)
tumor of##104##2##(1990-11#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-5#1)(1993-10#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#2)(1995-4#3)(1996-4#1)(1996-6#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#7)(2008-10#9)(2008-11#1)(2008-12#3)(2008-3#1)(2008-6#2)(2008-7#1)(2008-9#3)(2009-12#1)(2009-2#1)(2009-3#4)(2009-5#1)(2009-7#2)(2010-12#3)(2010-3#2)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#8)(2012-1#1)(2012-2#13)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
tumor often##3##2##(2008-12#1)(2010-7#1)(2012-3#1)
tumor on the##2##3##(1995-4#1)(2012-12#1)
tumor on##5##2##(1995-4#1)(2006-7#1)(2007-3#1)(2010-8#1)(2012-12#1)
tumor operation##2##2##(2007-8#2)
tumor or a##3##3##(2006-12#1)(2009-1#1)(2010-12#1)
tumor or its##2##3##(2005-3#1)(2009-5#1)
tumor or tissue##2##3##(2008-8#2)
tumor or##14##2##(1996-10#1)(1996-3#1)(2005-3#1)(2006-10#1)(2006-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-8#2)(2009-1#1)(2009-5#1)(2010-12#1)
tumor originating from##3##3##(1993-6#1)(2007-8#1)(2010-12#1)
tumor over##2##2##(2009-8#1)(2010-3#1)
tumor oxygenation##3##2##(1995-9#1)(2008-11#1)(2008-3#1)
tumor patients and##3##3##(1996-11#1)(2005-10#1)(2012-1#1)
tumor patients##11##2##(1993-7#1)(1994-3#1)(1995-9#1)(1996-11#1)(1997-7#1)(2005-10#1)(2006-12#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-1#1)
tumor patients]##2##2##(1996-2#1)(2013-8#1)
tumor phase##2##2##(2013-8#2)
tumor phenotype##2##2##(2008-5#1)(2011-1#1)
tumor population##3##2##(2008-11#1)(2008-9#1)(2011-2#1)
tumor position##5##2##(2009-11#5)
tumor presence##2##2##(2012-3#2)
tumor presented##2##2##(2007-8#1)(2008-5#1)
tumor presenting as##3##3##(2006-10#1)(2007-2#1)(2009-4#1)
tumor products that##2##3##(2006-10#1)(2007-3#1)
tumor progression and metastasis##3##4##(1997-4#1)(1997-7#1)(2012-1#1)
tumor progression and##9##3##(1991-4#1)(1997-4#1)(1997-7#1)(2007-6#1)(2009-3#2)(2010-7#1)(2012-1#1)(2013-8#1)
tumor progression in##4##3##(1993-9#1)(1994-5#1)(1994-8#1)(2010-12#1)
tumor progression was##2##3##(2007-7#1)(2013-1#1)
tumor progression with##2##3##(1993-10#1)(2012-12#1)
tumor progression##47##2##(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-9#1)(1993-10#1)(1993-8#1)(1993-9#2)(1994-5#1)(1994-8#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-5#1)(2009-3#5)(2009-6#1)(2010-12#3)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#1)
tumor proliferation##2##2##(1995-4#1)(2011-2#1)
tumor promoter##13##2##(1991-5#1)(1992-2#1)(1992-5#1)(1992-9#2)(1993-7#2)(1993-8#1)(1993-9#1)(2007-12#2)(2012-3#2)
tumor promoters in##3##3##(1991-7#1)(1993-7#1)(1994-9#1)
tumor promoters##16##2##(1990-9#1)(1991-7#2)(1992-2#1)(1992-5#1)(1992-9#4)(1993-7#5)(1994-9#1)(2006-5#1)
tumor promoting activity##2##3##(1992-3#1)(1994-11#1)
tumor promoting##6##2##(1990-4#1)(1991-9#1)(1992-3#1)(1994-11#3)
tumor promotion in##5##3##(1992-7#1)(1992-8#2)(1993-8#1)(1996-11#1)
tumor promotion##9##2##(1992-7#2)(1992-8#2)(1993-7#1)(1993-8#2)(1994-12#1)(1996-11#1)
tumor protein##2##2##(2010-12#2)
tumor protruded##2##2##(1991-12#1)(2013-8#1)
tumor rats##4##2##(1991-8#4)
tumor recurred and##2##3##(2007-12#1)(2011-2#1)
tumor recurred##5##2##(1996-12#1)(2007-12#1)(2007-4#1)(2008-6#1)(2011-2#1)
tumor recurrence (11 cases)##2##4##(2007-12#2)
tumor recurrence after##5##3##(2006-11#1)(2007-12#2)(2009-1#1)(2011-2#1)
tumor recurrence is##2##3##(2006-6#1)(2008-2#1)
tumor recurrence was##3##3##(2007-12#2)(2011-2#1)
tumor recurrence##37##2##(1991-4#1)(1994-8#1)(1996-12#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-5#1)(2006-6#1)(2007-12#9)(2007-7#1)(2008-2#1)(2008-8#1)(2009-1#1)(2009-5#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#3)(2013-1#2)(2013-8#1)
tumor recurrences##2##2##(2006-6#1)(2007-7#1)
tumor reduction##3##2##(1992-8#1)(2006-12#1)(2007-12#1)
tumor regression and##2##3##(1991-8#1)(2008-3#1)
tumor regression in##6##3##(1992-12#1)(1996-4#1)(2009-4#1)(2010-3#1)(2011-11#1)(2011-2#1)
tumor regression is##2##3##(1996-10#2)
tumor regression##24##2##(1991-8#2)(1992-12#2)(1994-3#1)(1994-5#1)(1995-11#1)(1995-9#1)(1996-10#4)(1996-4#2)(2005-10#1)(2005-11#1)(2008-11#1)(2008-3#1)(2009-11#1)(2009-4#1)(2009-9#1)(2010-3#1)(2011-11#1)(2011-2#1)
tumor regressions##2##2##(2004-1#1)(2008-1#1)
tumor regrew##2##2##(2005-10#1)(2007-12#1)
tumor rejection##4##2##(1997-7#2)(2008-11#1)(2010-3#1)
tumor relapse##3##2##(2006-6#1)(2008-6#1)(2012-1#1)
tumor relapses##2##2##(2007-8#1)(2008-6#1)
tumor remained##3##2##(2006-5#1)(2007-11#1)(2011-1#1)
tumor remission##3##2##(1991-8#1)(2010-5#1)(2013-8#1)
tumor removal was##3##3##(2006-5#1)(2007-1#2)
tumor removal##9##2##(2004-2#1)(2006-5#3)(2006-8#1)(2007-1#2)(2007-11#1)(2007-12#1)
tumor resection and##8##3##(2006-10#1)(2007-11#3)(2007-12#1)(2009-8#1)(2011-2#1)(2013-8#1)
tumor resection in##3##3##(2007-1#1)(2007-7#2)
tumor resection was achieved in##3##5##(2005-5#1)(2007-1#1)(2011-2#1)
tumor resection was##4##3##(2005-5#1)(2007-1#1)(2011-2#2)
tumor resection with##2##3##(2007-11#1)(2012-3#1)
tumor resection##36##2##(1997-7#1)(2005-5#1)(2005-9#1)(2006-10#3)(2006-5#1)(2006-8#1)(2007-1#3)(2007-11#5)(2007-12#2)(2007-7#3)(2008-2#1)(2009-4#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#5)(2012-3#2)(2013-1#1)(2013-8#2)
tumor resections##5##2##(2006-5#2)(2007-7#3)
tumor response and##4##3##(1993-9#1)(2006-12#1)(2013-1#2)
tumor response to##7##3##(1995-9#1)(1997-4#1)(2006-11#1)(2006-12#2)(2008-12#1)(2010-3#1)
tumor response was##3##3##(1991-2#1)(1991-6#1)(2008-5#1)
tumor response##22##2##(1991-2#1)(1991-6#1)(1992-2#1)(1993-9#1)(1995-9#1)(1997-4#1)(2006-11#1)(2006-12#3)(2006-6#4)(2008-12#1)(2008-5#2)(2009-4#1)(2009-8#1)(2010-3#1)(2013-1#2)
tumor responses and##2##3##(2006-6#1)(2011-2#1)
tumor responses##5##2##(1992-9#1)(2006-6#1)(2008-7#1)(2010-7#1)(2011-2#1)
tumor revealed the##2##3##(1996-3#1)(2012-12#1)
tumor revealed##6##2##(1995-5#1)(1995-9#1)(1996-3#1)(2007-12#1)(2010-12#1)(2012-12#1)
tumor samples from##2##3##(1990-5#1)(2010-12#1)
tumor samples showed##2##3##(2008-4#1)(2008-6#1)
tumor samples were##3##3##(1990-12#2)(2013-8#1)
tumor samples##20##2##(1990-12#2)(1990-5#2)(1993-9#1)(1994-6#1)(1997-7#2)(2006-12#1)(2008-1#1)(2008-4#1)(2008-6#2)(2008-9#2)(2010-12#1)(2010-7#1)(2012-12#2)(2013-8#1)
tumor selectivity and toxicity of##2##5##(1995-5#2)
tumor selectivity and##3##3##(1995-5#3)
tumor selectivity##5##2##(1995-5#3)(2005-8#1)(2008-1#1)
tumor sensitivity##2##2##(2008-8#1)(2011-1#1)
tumor shape##3##2##(2007-12#3)
tumor should be considered in the differential diagnosis##2##8##(2007-4#1)(2008-10#1)
tumor should be##6##3##(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-5#2)
tumor should##8##2##(1992-8#1)(2007-12#1)(2007-4#2)(2007-8#1)(2008-10#1)(2008-5#2)
tumor showed a##2##3##(1991-10#1)(2011-2#1)
tumor showed##12##2##(1991-10#1)(1996-3#1)(2006-10#1)(2007-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-7#1)(2013-8#1)
tumor showing##2##2##(1991-7#1)(1994-12#1)
tumor shrinkage##3##2##(1995-10#1)(2006-12#2)
tumor site in##2##3##(2006-7#1)(2008-12#1)
tumor site##11##2##(1990-10#1)(1991-10#1)(1997-7#1)(2005-10#1)(2006-7#2)(2008-1#1)(2008-11#1)(2008-12#1)(2010-12#1)(2011-2#1)
tumor sites of##2##3##(2008-11#1)(2010-8#1)
tumor sites##10##2##(2007-11#1)(2008-11#2)(2008-5#1)(2010-2#1)(2010-8#1)(2011-1#2)(2012-11#2)
tumor situated in##3##3##(2007-11#1)(2013-1#2)
tumor size and##12##3##(1991-8#1)(1994-12#1)(1994-4#2)(1996-6#3)(2004-1#1)(2007-1#1)(2007-6#1)(2009-2#1)(2011-1#1)
tumor size in##3##3##(2008-7#1)(2009-1#1)(2009-5#1)
tumor size or##2##3##(1996-3#1)(2011-2#1)
tumor size significantly##2##3##(1995-10#1)(2008-9#1)
tumor size was##3##3##(2011-2#2)(2012-2#1)
tumor size##58##2##(1990-12#1)(1990-8#1)(1991-6#1)(1991-8#1)(1993-9#1)(1994-12#1)(1994-4#2)(1994-6#1)(1995-10#2)(1995-4#2)(1995-5#1)(1996-3#1)(1996-6#6)(1997-8#1)(2004-1#1)(2004-12#1)(2006-11#2)(2007-1#1)(2007-6#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-2#2)(2009-5#1)(2010-10#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
tumor size)##2##2##(1997-7#1)(2008-10#1)
tumor sizes##3##2##(1991-6#1)(2011-2#2)
tumor specific##4##2##(1994-3#1)(2008-8#1)(2011-2#1)(2012-11#1)
tumor specimens##10##2##(1994-12#1)(1997-7#1)(2007-6#1)(2008-1#1)(2008-4#1)(2010-3#1)(2012-12#2)(2012-3#1)(2013-8#1)
tumor spheroid##4##2##(2008-11#3)(2013-1#1)
tumor spheroids##5##2##(1995-1#1)(2008-11#3)(2012-2#1)
tumor spread##9##2##(1992-8#1)(2005-11#1)(2007-9#1)(2008-1#1)(2008-7#1)(2009-5#1)(2010-3#1)(2011-1#1)(2013-8#1)
tumor stage and##4##3##(1992-11#1)(1997-5#1)(2006-7#1)(2008-6#1)
tumor stage##21##2##(1990-12#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1995-9#2)(1997-5#1)(2006-7#1)(2007-10#1)(2008-1#1)(2008-2#1)(2008-6#3)(2013-1#1)(2013-8#4)
tumor staging##8##2##(1991-9#1)(2005-5#4)(2006-6#1)(2008-8#1)(2010-3#1)
tumor stroma and##2##3##(1994-2#1)(2010-12#1)
tumor stroma##5##2##(1994-2#1)(2007-9#2)(2010-12#1)(2011-1#1)
tumor subtype##2##2##(2011-12#1)(2013-1#1)
tumor suppression and##3##3##(2011-1#1)(2012-12#1)(2013-1#1)
tumor suppression##9##2##(1995-8#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#3)
tumor suppressor activity##6##3##(1994-5#1)(1995-2#1)(1995-6#1)(2009-5#1)(2010-2#1)(2012-12#1)
tumor suppressor and##2##3##(1994-5#1)(2008-9#1)
tumor suppressor function##4##3##(1994-12#1)(2008-6#1)(2008-8#1)(2009-4#1)
tumor suppressor gene expression##2##4##(1997-4#2)
tumor suppressor gene in##5##4##(1991-11#1)(1993-9#2)(2007-1#1)(2007-5#1)
tumor suppressor gene is##3##4##(2006-8#1)(2009-5#1)(2010-2#1)
tumor suppressor gene p53##6##4##(1994-9#1)(2006-10#1)(2007-11#1)(2008-10#2)(2010-12#1)
tumor suppressor gene product##4##4##(1994-8#1)(1996-1#1)(1996-5#1)(2009-9#1)
tumor suppressor gene##52##3##(1990-12#1)(1990-6#1)(1991-10#1)(1991-11#2)(1991-2#1)(1993-9#2)(1994-12#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-2#1)(1996-1#2)(1996-11#1)(1996-5#1)(1996-6#1)(1997-4#2)(2006-10#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-3#1)(2007-5#1)(2008-10#2)(2008-9#3)(2009-11#1)(2009-5#1)(2009-9#2)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#7)(2012-2#2)(2013-1#2)
tumor suppressor genes in##3##4##(1990-12#1)(2007-12#1)(2008-7#1)
tumor suppressor genes##20##3##(1990-12#1)(1993-12#1)(1995-6#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-7#2)(2009-12#2)(2009-5#1)(2011-2#5)
tumor suppressor in##3##3##(2008-1#1)(2008-8#1)(2011-2#1)
tumor suppressor mechanisms##2##3##(2008-8#1)(2011-1#1)
tumor suppressor p53##5##3##(1996-4#2)(2007-8#1)(2009-7#1)(2011-2#1)
tumor suppressor protein##7##3##(1994-12#1)(1995-6#1)(1995-7#1)(2009-9#2)(2010-12#1)(2011-1#1)
tumor suppressor proteins##2##3##(1995-6#1)(2008-11#1)
tumor suppressor##126##2##(1990-12#2)(1990-6#1)(1991-10#1)(1991-11#2)(1991-2#1)(1993-12#1)(1993-9#3)(1994-12#3)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-2#3)(1995-6#6)(1995-7#1)(1996-1#2)(1996-11#1)(1996-4#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(2006-10#2)(2006-12#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#5)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#3)(2009-7#1)(2009-9#5)(2010-12#2)(2010-2#3)(2010-3#1)(2011-1#3)(2011-2#16)(2012-12#4)(2012-2#3)(2013-1#6)(2013-8#1)
tumor suppressors##4##2##(2007-10#1)(2009-12#2)(2010-5#1)
tumor surface##2##2##(2007-8#1)(2011-2#1)
tumor surgery##5##2##(2006-11#2)(2006-12#1)(2007-12#1)(2013-8#1)
tumor syndromes##4##2##(2006-12#2)(2009-12#1)(2011-2#1)
tumor system##3##2##(1993-7#1)(1997-7#1)(2006-10#1)
tumor take##2##2##(2008-6#2)
tumor target##3##2##(1994-9#1)(1995-2#1)(2008-5#1)
tumor targeting and##2##3##(2010-10#1)(2010-2#1)
tumor targeting of##2##3##(1996-4#1)(2013-7#1)
tumor targeting##8##2##(1993-11#2)(1996-4#1)(2010-10#1)(2010-2#1)(2010-6#1)(2012-2#1)(2013-7#1)
tumor targets##3##2##(1994-2#1)(2013-1#2)
tumor that is##4##3##(2009-12#1)(2009-9#1)(2010-5#1)(2011-1#1)
tumor that usually##3##3##(2009-1#1)(2010-3#1)(2012-3#1)
tumor that##18##2##(1992-9#1)(2006-12#1)(2007-12#1)(2007-6#1)(2009-1#1)(2009-12#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-8#1)
tumor the##2##2##(2007-11#1)(2011-1#1)
tumor therapies##2##2##(1991-2#2)
tumor therapy##7##2##(1991-2#1)(1991-4#1)(1992-9#1)(2010-3#1)(2011-1#1)(2012-3#1)(2013-8#1)
tumor thickness##3##2##(1992-4#2)(1994-12#1)
tumor thrombus in the##3##4##(2011-2#2)(2012-2#1)
tumor thrombus in##4##3##(2011-2#3)(2012-2#1)
tumor thrombus##10##2##(1992-8#1)(2006-7#1)(2011-2#4)(2012-2#4)
tumor tissue and##3##3##(1994-2#1)(2007-12#1)(2012-2#1)
tumor tissue by##2##3##(1990-12#1)(1990-2#1)
tumor tissue samples##2##3##(2004-1#1)(2009-4#1)
tumor tissue##40##2##(1990-12#1)(1990-2#1)(1991-4#1)(1992-3#1)(1992-9#3)(1993-11#1)(1994-2#1)(1994-3#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-4#1)(1997-7#4)(1997-8#1)(2004-1#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-4#3)(2009-6#1)(2010-12#2)(2012-1#1)(2012-2#2)
tumor tissues and##2##3##(1991-5#1)(1996-4#1)
tumor tissues of##2##3##(1993-7#1)(1994-2#1)
tumor tissues##17##2##(1991-5#1)(1992-11#1)(1993-7#1)(1994-12#1)(1994-2#2)(1996-4#1)(2005-7#1)(2008-1#1)(2008-11#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2010-7#1)
tumor to##7##2##(1990-6#1)(1995-5#1)(2007-8#1)(2008-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
tumor treatment##4##2##(2006-6#2)(2008-3#1)(2009-6#1)
tumor type and##2##3##(2010-2#1)(2012-2#1)
tumor type or##2##3##(1996-11#1)(2008-7#1)
tumor type##16##2##(1996-11#1)(1997-7#1)(2005-10#1)(2006-8#2)(2007-2#1)(2008-7#4)(2010-12#1)(2010-2#2)(2011-2#1)(2012-12#1)(2012-2#1)
tumor types##17##2##(1990-12#2)(1990-4#1)(1991-8#1)(1993-9#1)(1997-8#1)(2005-11#1)(2007-6#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-2#1)
tumor uptake of (111)In-DOTA-GSG-KCCYSL##2##4##(2010-10#2)
tumor uptake of##3##3##(2010-10#3)
tumor uptake##8##2##(2008-5#1)(2010-10#3)(2010-6#2)(2013-1#2)
tumor vaccines##2##2##(2008-4#1)(2011-1#1)
tumor variants##2##2##(1992-9#2)
tumor vascular##2##2##(2008-3#2)
tumor vascularity##2##2##(1996-3#1)(2011-2#1)
tumor vascularization and##2##3##(2008-1#1)(2009-4#1)
tumor vascularization##6##2##(2008-1#1)(2008-11#3)(2009-4#1)(2012-1#1)
tumor vasculature##10##2##(1993-9#2)(1994-5#1)(1994-9#1)(1996-11#1)(2008-3#1)(2008-5#1)(2009-3#1)(2010-2#2)
tumor versus normal##2##3##(2008-5#1)(2012-2#1)
tumor vessels##3##2##(1993-9#1)(2008-1#1)(2010-12#1)
tumor virus##9##2##(1992-12#1)(1992-8#2)(1994-11#2)(1994-12#1)(1994-7#1)(1996-4#1)(2008-10#1)
tumor volume was##2##3##(2006-12#2)
tumor volume##14##2##(1995-9#2)(2006-12#3)(2006-4#1)(2007-4#1)(2009-2#2)(2010-11#1)(2010-12#1)(2011-11#1)(2012-11#2)
tumor volumes##6##2##(1992-9#1)(1994-12#1)(2006-2#1)(2010-9#1)(2013-1#2)
tumor was a##6##3##(1991-10#1)(1992-2#1)(2006-10#1)(2007-12#1)(2011-2#1)(2013-7#1)
tumor was achieved##3##3##(2008-6#1)(2008-8#1)(2011-2#1)
tumor was classified##2##3##(1990-2#1)(2005-5#1)
tumor was composed of##9##4##(1991-8#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-6#1)(2012-1#1)(2013-1#1)(2013-8#1)
tumor was composed##10##3##(1991-8#1)(2008-12#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-6#1)(2012-1#1)(2013-1#1)(2013-8#1)
tumor was considered##2##3##(2010-3#1)(2013-7#1)
tumor was debulked##2##3##(2006-12#2)
tumor was demonstrated##2##3##(2006-12#1)(2008-6#1)
tumor was diagnosed as a##3##5##(1995-4#1)(2010-12#1)(2012-1#1)
tumor was diagnosed as##11##4##(1994-7#1)(1995-4#1)(1996-12#1)(1996-3#1)(1996-6#1)(2007-12#1)(2010-12#1)(2010-2#1)(2012-1#2)(2013-8#1)
tumor was diagnosed##13##3##(1994-7#1)(1995-4#1)(1996-12#1)(1996-3#1)(1996-6#2)(2007-12#1)(2010-11#1)(2010-12#1)(2010-2#1)(2012-1#2)(2013-8#1)
tumor was found on##2##4##(2006-12#1)(2008-10#1)
tumor was found##6##3##(1993-10#1)(1995-4#1)(2006-12#1)(2007-11#1)(2008-10#1)(2009-3#1)
tumor was localized##2##3##(2006-2#1)(2007-8#1)
tumor was located in the##2##5##(2008-5#1)(2013-8#1)
tumor was located in##3##4##(2008-5#2)(2013-8#1)
tumor was negative for##2##4##(2010-12#1)(2012-2#1)
tumor was not a##2##4##(1994-7#1)(1995-10#1)
tumor was not##5##3##(1994-7#1)(1995-10#1)(1995-2#1)(2007-8#1)(2008-12#1)
tumor was noted##2##3##(1992-6#1)(2013-8#1)
tumor was observed in##2##4##(1991-8#1)(1992-6#1)
tumor was observed##4##3##(1991-8#1)(1992-10#1)(1992-6#1)(2008-5#1)
tumor was obtained##2##3##(2006-2#1)(2006-5#1)
tumor was performed in##3##4##(2006-12#1)(2006-8#1)(2008-6#1)
tumor was performed##7##3##(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2008-6#1)(2010-9#1)(2013-1#1)
tumor was positive for##2##4##(2007-5#1)(2012-2#1)
tumor was removed##5##3##(2006-12#5)
tumor was surgically##3##3##(2007-8#1)(2011-1#1)(2011-2#1)
tumor was suspected##2##3##(1992-12#1)(2008-6#1)
tumor was treated##2##3##(2006-10#1)(2006-12#1)
tumor was##148##2##(1990-2#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-8#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-6#4)(1992-8#1)(1993-10#1)(1993-11#1)(1993-4#1)(1994-3#1)(1994-7#5)(1995-10#1)(1995-2#2)(1995-4#2)(1996-12#1)(1996-3#2)(1996-4#1)(1996-6#3)(1996-9#1)(2004-9#1)(2005-10#2)(2005-5#1)(2006-10#3)(2006-12#15)(2006-2#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-10#4)(2008-12#5)(2008-5#4)(2008-6#4)(2008-7#2)(2008-8#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-7#2)(2010-11#2)(2010-12#8)(2010-2#2)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-1#4)(2012-12#1)(2012-2#4)(2013-1#4)(2013-7#2)(2013-8#4)
tumor weight##4##2##(2008-8#1)(2009-8#1)(2011-2#2)
tumor were##8##2##(1991-8#1)(1992-2#1)(2008-10#2)(2008-2#1)(2008-5#1)(2011-2#1)(2012-3#1)
tumor when inoculated##2##3##(2008-4#2)
tumor which##6##2##(1990-6#1)(1992-1#1)(2007-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
tumor while##3##2##(1992-8#1)(1994-5#1)(2007-9#1)
tumor with a##9##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-3#1)(2013-7#1)
tumor with an aggressive##2##4##(1993-3#1)(2010-12#1)
tumor with an##5##3##(1993-3#1)(2007-6#1)(2008-3#1)(2008-5#1)(2010-12#1)
tumor with the##2##3##(1994-12#1)(2013-1#1)
tumor with##53##2##(1991-4#1)(1992-1#1)(1992-10#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-7#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-1#3)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#3)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#2)
tumor within##2##2##(1994-11#1)(2008-11#1)
tumor without##3##2##(1990-3#1)(2007-12#1)(2007-8#1)
tumor xenograft##2##2##(1995-8#1)(2008-6#1)
tumor xenografts in nude mice##2##5##(1993-7#1)(2008-6#1)
tumor xenografts in##4##3##(1993-7#1)(2008-6#2)(2013-7#1)
tumor xenografts##12##2##(1993-7#1)(1994-3#1)(1994-6#1)(1995-3#1)(2004-1#2)(2008-6#2)(2010-10#1)(2010-12#1)(2013-7#1)(2013-8#1)
tumor yield##2##2##(1990-5#1)(2013-1#1)
tumor##4396##1##(1990-10#19)(1990-11#11)(1990-12#37)(1990-2#15)(1990-3#2)(1990-4#12)(1990-5#19)(1990-6#22)(1990-7#11)(1990-8#11)(1990-9#12)(1991-1#3)(1991-10#12)(1991-11#2)(1991-12#24)(1991-2#24)(1991-3#2)(1991-4#16)(1991-5#11)(1991-6#18)(1991-7#24)(1991-8#34)(1991-9#39)(1992-1#7)(1992-10#6)(1992-11#11)(1992-12#22)(1992-2#26)(1992-3#12)(1992-4#6)(1992-5#10)(1992-6#11)(1992-7#20)(1992-8#36)(1992-9#35)(1993-1#9)(1993-10#5)(1993-11#25)(1993-12#9)(1993-2#2)(1993-3#6)(1993-4#16)(1993-5#2)(1993-6#11)(1993-7#26)(1993-8#8)(1993-9#42)(1994-10#5)(1994-11#17)(1994-12#48)(1994-2#22)(1994-3#16)(1994-4#6)(1994-5#31)(1994-6#25)(1994-7#20)(1994-8#18)(1994-9#23)(1995-1#14)(1995-10#17)(1995-11#2)(1995-12#8)(1995-2#21)(1995-3#19)(1995-4#20)(1995-5#21)(1995-6#15)(1995-7#2)(1995-8#20)(1995-9#14)(1996-1#5)(1996-10#13)(1996-11#18)(1996-12#6)(1996-2#6)(1996-3#20)(1996-4#21)(1996-5#17)(1996-6#27)(1996-8#1)(1996-9#5)(1997-1#11)(1997-2#8)(1997-3#3)(1997-4#16)(1997-5#7)(1997-6#9)(1997-7#49)(1997-8#10)(2004-1#6)(2004-12#1)(2004-2#1)(2004-9#1)(2005-10#25)(2005-11#13)(2005-12#4)(2005-3#1)(2005-5#13)(2005-6#1)(2005-7#6)(2005-8#14)(2005-9#7)(2006-1#2)(2006-10#81)(2006-11#15)(2006-12#81)(2006-2#10)(2006-3#1)(2006-4#4)(2006-5#22)(2006-6#43)(2006-7#18)(2006-8#11)(2006-9#16)(2007-1#16)(2007-10#24)(2007-11#61)(2007-12#81)(2007-2#11)(2007-3#18)(2007-4#21)(2007-5#15)(2007-6#18)(2007-7#32)(2007-8#109)(2007-9#12)(2008-1#49)(2008-10#63)(2008-11#96)(2008-12#29)(2008-2#17)(2008-3#32)(2008-4#81)(2008-5#96)(2008-6#84)(2008-7#44)(2008-8#74)(2008-9#62)(2009-1#11)(2009-10#17)(2009-11#12)(2009-12#15)(2009-2#26)(2009-3#78)(2009-4#19)(2009-5#25)(2009-6#13)(2009-7#12)(2009-8#14)(2009-9#12)(2010-1#16)(2010-10#9)(2010-11#12)(2010-12#110)(2010-2#42)(2010-3#51)(2010-4#1)(2010-5#10)(2010-6#14)(2010-7#19)(2010-8#12)(2010-9#16)(2011-1#83)(2011-11#3)(2011-12#14)(2011-2#194)(2012-1#39)(2012-11#17)(2012-12#80)(2012-2#106)(2012-3#53)(2013-1#175)(2013-7#37)(2013-8#88)
tumor&quot##2##1##(2006-12#1)(2007-8#1)
tumor's##13##1##(2006-12#1)(2006-6#1)(2007-5#1)(2008-5#1)(2008-6#3)(2009-5#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
tumor)##6##1##(1990-12#1)(1995-10#1)(2007-11#1)(2008-4#1)(2009-7#1)(2010-3#1)
tumor-associated antigen##6##2##(1991-5#1)(1995-5#1)(1995-8#1)(1995-9#1)(2008-11#2)
tumor-associated antigens (TAA) and##2##4##(1996-10#1)(2008-6#1)
tumor-associated antigens (TAA)##3##3##(1996-10#1)(2008-6#1)(2009-8#1)
tumor-associated antigens in##2##3##(1993-11#1)(2013-7#1)
tumor-associated antigens##14##2##(1991-9#1)(1993-11#1)(1993-9#1)(1996-10#1)(2006-10#1)(2006-9#1)(2008-11#1)(2008-6#1)(2009-3#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-7#1)
tumor-associated macrophages##5##2##(1991-9#1)(2011-2#1)(2012-1#2)(2013-7#1)
tumor-associated stromal cells##2##3##(2009-4#2)
tumor-associated viruses##4##2##(1995-9#1)(2009-12#3)
tumor-associated##42##1##(1991-5#1)(1991-9#2)(1993-11#1)(1993-9#3)(1994-12#1)(1994-5#1)(1994-6#1)(1995-5#1)(1995-8#1)(1995-9#2)(1996-10#1)(1996-3#1)(2005-11#1)(2006-10#1)(2006-9#1)(2008-11#5)(2008-6#2)(2009-12#3)(2009-3#1)(2009-4#2)(2009-8#1)(2010-1#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#2)(2013-7#2)
tumor-bearing animals##3##2##(1991-12#1)(2007-11#1)(2008-8#1)
tumor-bearing mice was##2##3##(2008-5#1)(2008-9#1)
tumor-bearing mice##25##2##(1990-7#4)(1991-9#1)(1992-7#2)(1992-9#1)(1994-3#1)(1996-11#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#2)(2012-1#1)(2012-11#2)(2013-1#1)(2013-8#1)
tumor-bearing mouse##2##2##(1992-5#1)(2013-8#1)
tumor-bearing nude##2##2##(1993-9#1)(2010-1#1)
tumor-bearing##39##1##(1990-2#1)(1990-7#4)(1991-12#1)(1991-9#1)(1992-5#1)(1992-7#2)(1992-9#1)(1993-9#1)(1994-11#3)(1994-3#1)(1995-8#1)(1996-11#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#4)(2008-9#2)(2010-1#1)(2012-1#1)(2012-11#2)(2013-1#1)(2013-8#2)
tumor-cell heterogeneity##2##2##(1992-9#2)
tumor-cell lysis##6##2##(1991-9#3)(1993-9#3)
tumor-cell##8##1##(1991-9#3)(1992-9#2)(1993-9#3)
tumor-derived##10##1##(1991-2#1)(1995-12#1)(1995-6#1)(1996-10#1)(2005-10#1)(2007-3#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
tumor-free margins##3##2##(2005-11#1)(2007-12#1)(2013-1#1)
tumor-free##10##1##(1990-10#2)(1993-9#1)(1995-10#1)(1995-2#1)(2005-11#1)(2006-5#1)(2007-12#2)(2013-1#1)
tumor-host##2##1##(1994-6#1)(2008-4#1)
tumor-induced angiogenesis##2##2##(2008-11#2)
tumor-induced##8##1##(1991-9#1)(1994-12#1)(1995-3#1)(2008-11#2)(2008-7#3)
tumor-infiltrating T cells##2##3##(2011-1#2)
tumor-infiltrating lymphocytes (TILs)##2##3##(1991-9#1)(1997-7#1)
tumor-infiltrating lymphocytes##8##2##(1990-8#1)(1991-7#1)(1991-9#2)(1994-5#1)(1997-7#2)(2012-2#1)
tumor-infiltrating##11##1##(1990-8#1)(1991-7#1)(1991-9#2)(1994-5#1)(1997-7#2)(2011-1#2)(2012-2#1)(2013-1#1)
tumor-initiating activity##2##2##(1990-7#1)(1993-9#1)
tumor-initiating##4##1##(1990-7#2)(1993-9#1)(2011-1#1)
tumor-like lesions##5##2##(2007-7#2)(2008-9#1)(2013-1#2)
tumor-like##13##1##(1990-3#1)(1991-11#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-9#1)(2010-7#2)(2011-2#1)(2012-3#1)(2013-1#2)
tumor-promoting genes##2##2##(2009-12#1)(2013-1#1)
tumor-promoting phorbol ester##3##3##(1991-8#1)(1994-3#1)(1994-8#1)
tumor-promoting phorbol##5##2##(1990-9#1)(1991-8#1)(1993-8#1)(1994-3#1)(1994-8#1)
tumor-promoting##12##1##(1990-9#1)(1991-8#1)(1992-5#1)(1993-7#2)(1993-8#1)(1994-3#1)(1994-8#1)(2009-12#1)(2010-4#1)(2011-1#1)(2013-1#1)
tumor-reactive cytotoxic cells##2##3##(1995-5#2)
tumor-reactive##4##1##(1995-5#2)(2012-12#1)(2012-2#1)
tumor-related##9##1##(1990-12#1)(2006-6#1)(2006-8#1)(2008-4#1)(2008-6#2)(2008-7#1)(2009-2#1)(2010-12#1)
tumor-restricted##2##1##(2005-6#1)(2007-3#1)
tumor-secreted##2##1##(1991-9#1)(2009-10#1)
tumor-selective##3##1##(1994-5#1)(2008-5#1)(2010-7#1)
tumor-specific cytotoxicity by##3##3##(1991-9#2)(2013-8#1)
tumor-specific cytotoxicity##7##2##(1991-9#5)(1997-7#1)(2013-8#1)
tumor-specific##34##1##(1991-9#7)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#3)(1997-4#1)(1997-7#2)(2005-6#1)(2005-8#1)(2006-10#2)(2007-11#2)(2007-3#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-1#2)(2013-1#2)(2013-8#1)
tumor-suppressing##2##1##(2006-10#1)(2012-12#1)
tumor-suppressive activity##2##2##(1991-9#1)(2013-8#1)
tumor-suppressive##3##1##(1991-9#1)(2012-12#1)(2013-8#1)
tumor-suppressor gene##5##2##(1993-8#1)(1993-9#1)(1995-5#1)(2006-10#1)(2009-12#1)
tumor-suppressor genes##4##2##(1993-8#1)(2004-1#1)(2006-10#1)(2008-9#1)
tumor-suppressor##11##1##(1993-8#2)(1993-9#1)(1995-5#1)(1995-8#1)(2004-1#1)(2006-10#2)(2008-9#1)(2009-12#1)(2012-2#1)
tumor-targeting##3##1##(1995-5#1)(2007-8#1)(2010-11#1)
tumor/blood##3##1##(1993-11#1)(1995-2#2)
tumor/nontumor##2##1##(1993-11#2)
tumor?##3##1##(1995-12#1)(1995-9#1)(2006-12#1)
tumor]##15##1##(1990-12#1)(1990-2#1)(1992-8#1)(1994-3#3)(1994-5#1)(1996-3#1)(1997-6#1)(2006-7#1)(2007-8#1)(2008-12#1)(2009-5#1)(2012-3#1)(2013-8#1)
tumoral calcinosis##2##2##(2011-2#2)
tumoral cell##2##2##(1992-2#1)(2010-9#1)
tumoral cells##6##2##(1990-8#1)(1992-2#3)(2005-11#1)(2011-1#1)
tumoral development##2##2##(1995-5#1)(2010-9#1)
tumoral disease##2##2##(2007-11#2)
tumoral infiltration##2##2##(1990-3#1)(1992-11#1)
tumoral invasion##2##2##(1991-6#1)(2007-9#1)
tumoral lesions##3##2##(1993-5#1)(2011-1#1)(2012-2#1)
tumoral mucins##3##2##(2011-2#3)
tumoral spheroids##2##2##(2011-2#2)
tumoral##56##1##(1990-3#1)(1990-4#1)(1990-6#2)(1990-8#1)(1991-6#2)(1992-11#1)(1992-2#4)(1992-5#1)(1993-5#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-5#1)(1996-3#1)(1997-3#1)(2005-11#1)(2007-1#1)(2007-11#2)(2007-8#2)(2007-9#4)(2008-4#4)(2010-12#4)(2010-9#2)(2011-1#2)(2011-2#10)(2012-2#2)(2013-1#2)
tumoricidal##7##1##(1993-9#2)(1997-7#1)(2006-10#1)(2008-4#1)(2013-1#2)
tumorigen##2##1##(1992-7#1)(1993-9#1)
tumorigenesis and metastasis##3##3##(2007-10#1)(2011-12#1)(2012-12#1)
tumorigenesis and progression of multiple##2##5##(2013-1#2)
tumorigenesis and progression##3##3##(2012-12#1)(2013-1#2)
tumorigenesis and the##2##3##(2008-3#1)(2012-12#1)
tumorigenesis and##13##2##(1990-8#1)(2007-10#1)(2008-3#1)(2008-5#1)(2011-12#1)(2012-12#5)(2012-3#1)(2013-1#2)
tumorigenesis by##3##2##(1990-6#1)(2008-11#1)(2008-8#1)
tumorigenesis in mice##3##3##(1992-8#2)(1993-12#1)
tumorigenesis in transgenic mice##2##4##(1990-11#1)(1992-12#1)
tumorigenesis in vivo##3##3##(1995-9#1)(1996-5#1)(2012-2#1)
tumorigenesis in##19##2##(1990-11#1)(1990-5#1)(1992-12#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-9#2)(1995-9#1)(1996-5#1)(2008-1#1)(2008-3#3)(2010-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
tumorigenesis induced by PEUs##2##4##(2008-11#2)
tumorigenesis induced by biomaterials##2##4##(2008-11#2)
tumorigenesis induced by##4##3##(2008-11#4)
tumorigenesis of##5##2##(1992-9#1)(1995-10#1)(2010-3#1)(2011-2#2)
tumorigenesis protocol##2##2##(1993-9#2)
tumorigenesis through##4##2##(1994-12#1)(2008-5#1)(2011-1#1)(2011-2#1)
tumorigenesis was observed##2##3##(1992-9#1)(1996-5#1)
tumorigenesis was##3##2##(1992-2#1)(1992-9#1)(1996-5#1)
tumorigenesis with##2##2##(1992-8#1)(2012-1#1)
tumorigenesis##125##1##(1990-11#1)(1990-5#2)(1990-6#3)(1990-8#2)(1991-3#1)(1991-5#1)(1992-12#1)(1992-2#2)(1992-7#1)(1992-8#4)(1992-9#4)(1993-12#1)(1993-8#1)(1993-9#4)(1994-11#1)(1994-12#1)(1994-7#1)(1995-10#1)(1995-2#1)(1995-8#1)(1995-9#4)(1996-5#2)(1997-5#1)(1997-7#1)(2006-10#2)(2006-12#1)(2007-10#3)(2007-5#1)(2008-1#3)(2008-11#5)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#7)(2010-3#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#2)(2012-12#10)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#5)
tumorigenic and metastatic##2##3##(1990-8#1)(1991-9#1)
tumorigenic and##4##2##(1990-8#1)(1991-9#2)(2008-4#1)
tumorigenic cell lines##2##3##(1997-1#2)
tumorigenic cell##3##2##(1997-1#3)
tumorigenic clones##2##2##(1992-9#2)
tumorigenic effect##2##2##(1991-2#1)(1995-11#1)
tumorigenic in##4##2##(1992-9#2)(2008-4#1)(2008-5#1)
tumorigenic potential of##2##3##(1992-11#1)(1992-7#1)
tumorigenic potential##6##2##(1992-11#1)(1992-7#1)(1992-9#1)(2008-11#1)(2009-3#1)(2012-12#1)
tumorigenic spleens##2##2##(2013-8#2)
tumorigenic##44##1##(1990-11#1)(1990-8#1)(1991-2#1)(1991-9#2)(1992-11#1)(1992-7#1)(1992-9#11)(1993-1#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-2#1)(1997-1#3)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2009-12#2)(2009-3#2)(2012-12#1)(2013-8#2)
tumorigenicity in A/J mice##2##4##(1996-11#2)
tumorigenicity in A/J##3##3##(1996-11#3)
tumorigenicity in##8##2##(1990-11#1)(1991-9#1)(1992-2#1)(1992-9#1)(1996-11#3)(1997-2#1)
tumorigenicity of the##2##3##(1993-1#1)(1995-5#1)
tumorigenicity of##8##2##(1990-12#1)(1991-3#1)(1992-7#1)(1993-1#1)(1994-6#1)(1995-5#1)(2012-12#2)
tumorigenicity##21##1##(1990-11#1)(1990-12#1)(1990-4#1)(1991-3#1)(1991-9#2)(1992-2#1)(1992-7#1)(1992-9#1)(1993-1#1)(1994-6#1)(1995-5#1)(1996-11#3)(1997-2#1)(2008-6#1)(2008-9#1)(2012-12#2)(2013-1#1)
tumorous lesion##2##2##(2008-7#1)(2013-8#1)
tumorous lesions##3##2##(1994-5#1)(2008-6#1)(2009-10#1)
tumorous lymphoblasts##2##2##(2008-5#2)
tumorous##12##1##(1991-9#1)(1993-8#1)(1994-5#1)(2008-1#1)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-10#1)(2013-8#1)
tumors (9##3##2##(1990-9#1)(1992-10#1)(2007-8#1)
tumors (GCTs)##2##2##(2006-1#1)(2007-10#1)
tumors (NETs) are a##2##4##(2011-2#2)
tumors (NETs)##3##2##(2011-2#3)
tumors (P = 0##7##4##(2004-1#3)(2008-3#2)(2008-7#1)(2012-3#1)
tumors (SMT)##2##2##(2006-12#1)(2013-1#1)
tumors (lung##2##2##(1990-12#1)(1992-5#1)
tumors (median##2##2##(2007-12#2)
tumors (n =##3##3##(1990-7#1)(2008-3#1)(2008-7#1)
tumors 2##2##2##(1994-5#1)(2007-8#1)
tumors a##2##2##(1993-8#1)(2009-12#1)
tumors after##7##2##(1990-7#1)(1992-9#1)(2006-12#1)(2008-11#1)(2010-2#1)(2011-1#1)(2012-12#1)
tumors also##3##2##(1992-2#1)(2007-2#1)(2008-7#1)
tumors and has##2##3##(2008-5#1)(2008-7#1)
tumors and healthy##2##3##(1993-7#1)(2012-1#1)
tumors and in##6##3##(1992-5#1)(1994-7#1)(1995-12#1)(2008-1#1)(2008-3#1)(2010-12#1)
tumors and its##3##3##(1997-7#1)(2008-11#1)(2012-12#1)
tumors and serum##2##3##(2007-11#1)(2010-12#1)
tumors and the##10##3##(1990-10#1)(1992-12#1)(1992-7#1)(2007-10#1)(2007-12#1)(2008-4#1)(2008-6#1)(2010-12#1)(2012-2#2)
tumors and their##3##3##(1997-8#1)(2006-12#2)
tumors and therefore##2##3##(1993-6#1)(2005-11#1)
tumors and to##2##3##(1990-12#1)(2007-10#1)
tumors and tumor-like##3##3##(2007-7#1)(2007-8#1)(2010-7#1)
tumors and was##2##3##(1992-4#1)(2012-12#1)
tumors and with##2##3##(1993-8#1)(2012-2#1)
tumors and##139##2##(1990-10#1)(1990-12#1)(1990-8#1)(1991-12#1)(1991-4#1)(1992-12#1)(1992-4#1)(1992-5#2)(1992-7#2)(1992-8#1)(1992-9#2)(1993-10#1)(1993-11#1)(1993-6#1)(1993-7#1)(1993-8#2)(1994-10#1)(1994-12#1)(1994-4#1)(1994-6#1)(1994-7#1)(1995-12#1)(1997-3#1)(1997-7#2)(1997-8#1)(2004-1#2)(2005-11#1)(2006-11#2)(2006-12#4)(2006-4#1)(2006-8#2)(2007-10#2)(2007-11#4)(2007-12#3)(2007-4#2)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#3)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#5)(2008-7#7)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#2)(2010-1#1)(2010-12#7)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#5)(2011-2#8)(2012-1#2)(2012-12#3)(2012-2#4)(2013-1#3)(2013-7#1)(2013-8#2)
tumors and/or##3##2##(2006-2#1)(2007-11#1)(2012-2#1)
tumors appear to have a##2##5##(2006-12#1)(2008-6#1)
tumors appear to##3##3##(2006-12#1)(2008-6#1)(2008-9#1)
tumors appeared##3##2##(1990-6#1)(1991-9#1)(2013-1#1)
tumors are a##2##3##(2007-8#1)(2012-2#1)
tumors are also##2##3##(2008-4#1)(2008-7#1)
tumors are characterized by##2##4##(1995-1#1)(2012-12#1)
tumors are extremely rare##2##4##(2010-12#1)(2012-2#1)
tumors are generally##2##3##(2008-6#1)(2010-3#1)
tumors are mostly##2##3##(1997-8#1)(2008-5#1)
tumors are not##4##3##(2006-12#1)(2008-8#1)(2012-2#1)(2012-3#1)
tumors are rare##9##3##(1992-9#1)(2007-10#1)(2010-1#1)(2012-12#1)(2012-2#1)(2013-1#4)
tumors are rarely##2##3##(2005-9#1)(2009-2#1)
tumors are the most common type of##2##7##(2006-2#1)(2011-1#1)
tumors are the most##3##4##(2006-2#1)(2007-11#1)(2011-1#1)
tumors are the##5##3##(2005-5#1)(2005-9#1)(2006-2#1)(2007-11#1)(2011-1#1)
tumors are uncommon##2##3##(2006-12#1)(2010-5#1)
tumors are very rare##3##4##(1991-9#1)(2007-8#1)(2008-8#1)
tumors are##75##2##(1991-7#1)(1991-9#1)(1992-9#3)(1994-2#1)(1995-1#1)(1996-10#1)(1996-11#1)(1997-8#1)(2005-5#1)(2005-9#2)(2006-10#1)(2006-12#4)(2006-2#3)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#6)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-2#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#2)(2011-1#1)(2011-2#4)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#1)
tumors arise##2##2##(1990-7#1)(2006-1#1)
tumors arising from##3##3##(2005-9#1)(2006-12#1)(2011-2#1)
tumors arising in##2##3##(1995-1#1)(2013-1#1)
tumors arising##5##2##(1995-1#1)(2005-9#1)(2006-12#1)(2011-2#1)(2013-1#1)
tumors as well as##4##4##(1994-7#1)(2008-7#1)(2009-11#1)(2011-2#1)
tumors as well##7##3##(1994-7#1)(2006-6#1)(2007-11#1)(2008-7#1)(2009-11#1)(2011-2#2)
tumors as##17##2##(1991-6#1)(1993-7#1)(1994-7#1)(2005-12#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-7#1)(2009-11#1)(2009-5#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#1)
tumors at##9##2##(1990-5#1)(1990-8#1)(1992-7#1)(1992-8#1)(1993-10#1)(2008-3#1)(2008-8#1)(2012-3#1)(2013-1#1)
tumors based on##4##3##(1992-8#1)(2012-11#2)(2012-2#1)
tumors be##2##2##(1992-8#1)(1996-9#1)
tumors but not##2##3##(2009-5#1)(2011-2#1)
tumors but##5##2##(2006-12#1)(2009-3#1)(2009-5#2)(2011-2#1)
tumors by endoscopic ultrasonography##2##4##(1992-7#1)(2013-1#1)
tumors by##17##2##(1992-7#2)(1993-1#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-2#1)(2005-5#1)(2006-12#1)(2006-6#1)(2008-1#1)(2008-3#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
tumors can be##7##3##(2005-11#1)(2006-12#1)(2008-11#1)(2010-11#1)(2010-9#1)(2012-2#1)(2013-1#1)
tumors can##16##2##(1991-10#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-8#2)(2008-11#2)(2010-11#1)(2010-9#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
tumors compared to##3##3##(1992-7#1)(2008-7#1)(2009-8#1)
tumors composed of##2##3##(2011-2#1)(2013-1#1)
tumors continued to##2##3##(1993-1#1)(1995-5#1)
tumors could be##2##3##(2006-10#1)(2008-5#1)
tumors could##6##2##(1991-10#2)(1995-10#1)(2006-10#1)(2008-5#1)(2013-8#1)
tumors demonstrate##2##2##(2006-12#1)(2012-12#1)
tumors derived from##4##3##(1992-1#1)(1994-12#1)(1996-4#1)(2006-9#1)
tumors detected##2##2##(2008-1#1)(2008-4#1)
tumors developed in##4##3##(1993-9#1)(2006-12#1)(2008-10#1)(2011-1#1)
tumors developed##5##2##(1993-9#1)(2006-12#2)(2008-10#1)(2011-1#1)
tumors developing in##3##3##(2011-2#1)(2012-12#1)(2013-1#1)
tumors diagnosed as##2##3##(1995-4#1)(2008-11#1)
tumors diagnosed##3##2##(1995-4#1)(2007-8#1)(2008-11#1)
tumors did not##5##3##(1993-11#1)(2008-10#1)(2008-6#1)(2012-12#2)
tumors established##2##2##(1996-4#1)(1997-7#1)
tumors express##2##2##(1997-4#1)(2013-8#1)
tumors expressed##4##2##(1992-12#1)(1996-10#1)(1997-7#1)(2012-12#1)
tumors following##2##2##(2008-4#1)(2012-2#1)
tumors for which##3##3##(1990-6#1)(2007-12#1)(2009-5#1)
tumors for##5##2##(1990-6#1)(2007-12#1)(2008-3#1)(2009-5#1)(2011-1#1)
tumors found in##2##3##(1990-2#1)(1994-6#1)
tumors from patients with##2##4##(1993-11#2)
tumors from the##3##3##(2006-12#1)(2007-7#1)(2010-12#1)
tumors from##18##2##(1990-7#1)(1991-9#1)(1992-2#1)(1993-11#3)(1993-9#2)(1995-5#1)(1997-7#1)(2006-12#1)(2007-7#1)(2008-6#2)(2010-1#1)(2010-12#1)(2011-1#1)(2013-1#1)
tumors generally##2##2##(2008-4#1)(2010-3#1)
tumors gradually##2##2##(1994-11#1)(2010-9#1)
tumors had a##3##3##(1995-1#1)(2012-3#1)(2013-1#1)
tumors had##11##2##(1991-2#1)(1993-1#1)(1993-9#1)(1995-1#1)(1995-2#1)(1995-4#2)(2007-4#1)(2007-8#1)(2012-3#1)(2013-1#1)
tumors has been##4##3##(1997-7#1)(2006-12#1)(2012-12#1)(2013-1#1)
tumors has##10##2##(1997-7#1)(2006-11#1)(2006-12#2)(2006-8#1)(2007-10#1)(2008-7#1)(2012-12#2)(2013-1#1)
tumors have been##5##3##(1991-9#1)(2006-6#1)(2008-5#1)(2010-12#1)(2013-1#1)
tumors have##14##2##(1991-9#1)(1993-11#1)(2006-1#1)(2006-6#2)(2007-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-11#1)(2010-12#1)(2011-2#2)(2013-1#1)
tumors if##2##2##(1993-4#1)(1996-4#1)
tumors in Syrian hamsters##2##4##(1992-5#2)
tumors in a##5##3##(1995-2#1)(1995-8#1)(2007-8#1)(2012-2#1)(2012-3#1)
tumors in adult patients##2##4##(2006-12#1)(2008-5#1)
tumors in adult##3##3##(2006-12#1)(2008-5#1)(2012-2#1)
tumors in adults##3##3##(2008-2#1)(2011-1#1)(2013-8#1)
tumors in both##2##3##(1991-10#1)(2008-9#1)
tumors in children##4##3##(1990-2#1)(1993-9#1)(2006-8#1)(2008-10#1)
tumors in children]##3##3##(1990-5#2)(1996-7#1)
tumors in comparison with##2##4##(1992-9#1)(2010-12#1)
tumors in humans##5##3##(2008-12#1)(2008-4#1)(2010-2#1)(2012-1#1)(2012-2#1)
tumors in long bones##3##4##(2007-11#2)(2007-8#1)
tumors in mice##7##3##(1990-7#1)(1991-9#2)(1992-1#1)(1993-4#1)(1997-7#1)(2009-10#1)
tumors in nude mice##6##4##(1992-11#2)(1993-1#1)(1993-9#2)(2008-8#1)
tumors in only##2##3##(2010-6#1)(2013-1#1)
tumors in rats##2##3##(1993-9#1)(1994-5#1)
tumors in the left##2##4##(1992-2#1)(2009-5#1)
tumors in the##30##3##(1990-6#1)(1990-9#1)(1992-2#1)(1993-11#1)(1993-7#1)(1995-2#1)(2006-10#1)(2006-6#2)(2007-11#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-3#3)(2010-7#3)(2011-2#2)(2012-3#1)(2013-1#1)
tumors in these##2##3##(1990-9#1)(1992-5#1)
tumors in this##4##3##(1995-8#1)(1997-4#1)(2005-9#1)(2008-4#1)
tumors in vivo##4##3##(1992-8#1)(1994-5#1)(1994-8#1)(2008-2#1)
tumors in which##4##3##(1994-7#1)(2006-7#1)(2007-12#1)(2008-5#1)
tumors in##142##2##(1990-2#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-9#3)(1992-1#1)(1992-11#2)(1992-2#2)(1992-4#1)(1992-5#3)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#2)(1993-4#2)(1993-7#2)(1993-9#4)(1994-10#1)(1994-2#1)(1994-5#2)(1994-7#1)(1994-8#1)(1995-2#2)(1995-5#2)(1995-8#2)(1995-9#1)(1996-10#2)(1996-11#1)(1996-7#1)(1997-4#1)(1997-7#1)(2005-9#1)(2006-10#1)(2006-12#2)(2006-6#3)(2006-7#1)(2006-8#1)(2007-11#6)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#7)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#3)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-1#2)(2010-12#2)(2010-2#2)(2010-3#3)(2010-6#1)(2010-7#3)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#3)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#1)
tumors include##3##2##(2007-12#1)(2010-1#1)(2011-2#1)
tumors including##4##2##(1994-12#1)(2009-10#1)(2011-1#1)(2013-1#1)
tumors induced by##7##3##(1990-5#1)(1991-10#1)(1992-2#1)(1995-1#1)(1996-11#1)(2008-7#1)(2013-7#1)
tumors induced##10##2##(1990-10#1)(1990-5#1)(1991-10#1)(1992-2#1)(1995-1#2)(1996-1#1)(1996-11#1)(2008-7#1)(2013-7#1)
tumors involved##2##2##(2011-2#1)(2012-2#1)
tumors involving the##7##3##(1993-1#1)(2005-9#1)(2006-12#1)(2007-1#1)(2008-6#1)(2009-3#1)(2010-7#1)
tumors is a##6##3##(1997-7#1)(2005-10#1)(2007-11#1)(2011-2#1)(2012-12#1)(2012-3#1)
tumors is discussed##2##3##(1996-11#1)(2008-3#1)
tumors is higher##2##3##(2006-9#1)(2008-5#1)
tumors is not##2##3##(1993-9#1)(2007-6#1)
tumors is reviewed##2##3##(2008-1#1)(2008-9#1)
tumors is still##2##3##(2005-5#1)(2007-6#1)
tumors is##34##2##(1991-12#1)(1991-2#1)(1991-9#1)(1992-8#1)(1993-9#1)(1996-11#1)(1997-7#2)(1997-8#2)(2005-10#1)(2005-5#1)(2006-6#1)(2006-9#1)(2007-11#2)(2007-6#2)(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-12#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
tumors leading to##2##3##(2008-5#1)(2012-12#1)
tumors less than##3##3##(1991-12#1)(2007-8#1)(2011-2#1)
tumors located in the##3##4##(2006-8#1)(2013-1#2)
tumors located in##4##3##(2006-8#1)(2011-1#1)(2013-1#2)
tumors may be##4##3##(1997-7#1)(2004-2#1)(2008-6#2)
tumors may##11##2##(1990-6#1)(1993-6#1)(1994-2#1)(1997-7#1)(1997-8#1)(2004-2#1)(2005-10#1)(2008-6#2)(2009-5#1)(2011-12#1)
tumors occurred in the##2##4##(1995-2#1)(2006-10#1)
tumors occurred in##4##3##(1991-8#1)(1995-2#1)(2006-10#1)(2008-4#1)
tumors of a##3##3##(1994-12#1)(2008-10#1)(2008-8#1)
tumors of different immunogenic activity##2##5##(2012-1#2)
tumors of different##6##3##(2007-12#2)(2008-2#1)(2012-1#2)(2013-1#1)
tumors of infancy##2##3##(2010-1#1)(2011-2#1)
tumors of mesenchymal origin##3##4##(1996-4#1)(2007-8#1)(2011-2#1)
tumors of other##3##3##(1990-2#1)(1992-12#1)(2011-1#1)
tumors of the central nervous system##5##6##(1991-5#1)(1996-4#1)(2005-10#1)(2006-12#1)(2010-12#1)
tumors of the colon##2##4##(1993-9#1)(2006-2#1)
tumors of the gastrointestinal tract##4##5##(2008-1#1)(2008-6#1)(2012-12#1)(2012-2#1)
tumors of the gastrointestinal##5##4##(2008-1#1)(2008-6#1)(2008-8#1)(2012-12#1)(2012-2#1)
tumors of the head and neck##2##6##(2006-12#1)(2013-8#1)
tumors of the heart##4##4##(2007-11#1)(2007-12#1)(2007-8#1)(2012-12#1)
tumors of the nervous system##3##5##(2006-12#1)(2007-11#2)
tumors of the oral cavity##2##5##(1991-10#1)(2012-12#1)
tumors of the ovary##8##4##(1993-10#1)(1993-9#3)(2007-8#2)(2012-1#2)
tumors of the palate##2##4##(1991-1#2)
tumors of the pancreas##5##4##(1990-9#1)(1993-5#2)(2008-3#1)(2010-12#1)
tumors of the pelvic##3##4##(1990-5#2)(1993-8#1)
tumors of the small intestine##4##5##(1991-5#2)(1997-3#1)(2009-2#1)
tumors of the spine##4##4##(1992-10#1)(2006-10#1)(2006-2#1)(2008-9#1)
tumors of the stomach##2##4##(1993-4#1)(1993-9#1)
tumors of the temporal bone##2##5##(2005-5#1)(2006-12#1)
tumors of the testis##3##4##(1994-10#1)(2006-10#1)(2007-6#1)
tumors of the uterine cervix##2##5##(2007-7#1)(2012-2#1)
tumors of the uterine##3##4##(2007-7#1)(2011-1#1)(2012-2#1)
tumors of the##108##3##(1990-5#2)(1990-9#2)(1991-1#2)(1991-10#1)(1991-4#1)(1991-5#3)(1991-8#1)(1991-9#1)(1992-10#1)(1992-5#1)(1992-8#1)(1993-10#2)(1993-4#4)(1993-5#3)(1993-8#2)(1993-9#5)(1994-10#1)(1994-6#1)(1995-11#1)(1996-4#1)(1997-3#1)(2005-10#1)(2005-5#1)(2005-9#1)(2006-10#5)(2006-12#6)(2006-2#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#4)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-8#1)(2008-9#2)(2009-2#4)(2009-7#1)(2010-12#3)(2010-3#1)(2011-1#2)(2011-2#3)(2012-1#3)(2012-12#4)(2012-2#4)(2013-1#2)(2013-8#2)
tumors of##157##2##(1990-2#3)(1990-5#4)(1990-9#2)(1991-1#2)(1991-10#1)(1991-4#1)(1991-5#3)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#2)(1993-4#4)(1993-5#3)(1993-8#2)(1993-9#6)(1994-10#1)(1994-12#1)(1994-6#2)(1995-1#1)(1995-11#1)(1996-4#2)(1997-3#2)(1997-7#1)(2005-10#1)(2005-5#1)(2005-9#1)(2006-10#5)(2006-12#6)(2006-2#3)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#3)(2007-6#1)(2007-7#2)(2007-8#9)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-6#2)(2008-8#2)(2008-9#2)(2009-2#4)(2009-3#1)(2009-4#1)(2009-7#1)(2010-1#2)(2010-12#3)(2010-3#1)(2010-5#2)(2010-6#1)(2011-1#4)(2011-2#7)(2012-1#5)(2012-12#6)(2012-2#5)(2013-1#3)(2013-8#3)
tumors on the##3##3##(2011-2#2)(2012-2#1)
tumors on##5##2##(1997-8#1)(2007-12#1)(2011-2#2)(2012-2#1)
tumors or hematologic malignancies##2##4##(2007-9#1)(2008-7#1)
tumors or inflammatory##2##3##(2008-7#1)(2010-2#1)
tumors or trauma##2##3##(2005-5#1)(2007-9#1)
tumors or##18##2##(1990-12#1)(1991-9#1)(1994-4#1)(1997-3#1)(2005-5#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-9#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-7#1)(2010-12#1)(2010-2#1)(2010-5#1)
tumors originate from##2##3##(2008-8#1)(2012-2#1)
tumors per mouse at a total initiator dose of 1##2##10##(1990-7#2)
tumors per mouse##6##3##(1990-7#4)(1992-7#1)(1996-11#1)
tumors per##7##2##(1990-7#4)(1992-7#2)(1996-11#1)
tumors presented with##2##3##(2008-3#2)
tumors rarely##2##2##(2009-9#1)(2011-12#1)
tumors regressed##2##2##(1993-11#1)(1996-4#1)
tumors removed##2##2##(2011-2#1)(2012-3#1)
tumors represent##2##2##(2010-1#1)(2011-1#1)
tumors requires##3##2##(2010-9#1)(2012-2#1)(2012-3#1)
tumors resistant to##2##3##(2010-2#1)(2011-2#1)
tumors should be##5##3##(1992-8#1)(2004-2#1)(2006-12#1)(2007-8#1)(2011-2#1)
tumors show##2##2##(1992-7#1)(2008-6#1)
tumors showed a##2##3##(1992-4#1)(2008-5#1)
tumors showed##11##2##(1992-4#1)(1993-9#1)(1996-6#1)(2007-2#3)(2008-4#1)(2008-5#1)(2010-12#1)(2012-2#1)(2013-1#1)
tumors such as##9##3##(1990-5#1)(1994-9#1)(2006-12#1)(2006-2#2)(2008-5#1)(2010-12#1)(2010-5#1)(2013-1#1)
tumors tend to be##2##4##(2008-6#1)(2010-3#1)
tumors than in##3##3##(1993-9#1)(1996-3#1)(2012-12#1)
tumors than##8##2##(1992-9#1)(1993-7#1)(1993-9#1)(1996-3#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
tumors that are##5##3##(1993-11#1)(2008-2#1)(2008-4#1)(2011-2#2)
tumors that can##3##3##(2006-6#1)(2010-2#1)(2012-11#1)
tumors that have##2##3##(2008-6#1)(2012-2#1)
tumors that involve##2##3##(2006-12#1)(2006-6#1)
tumors that occur##2##3##(1990-12#1)(2012-3#1)
tumors that were##3##3##(2006-12#1)(2007-7#1)(2008-9#1)
tumors that##35##2##(1990-12#1)(1993-11#1)(1994-12#1)(1996-11#1)(2005-5#1)(2006-12#2)(2006-2#1)(2006-6#4)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#2)(2010-2#2)(2010-6#1)(2011-2#7)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
tumors through##2##2##(2013-1#1)(2013-8#1)
tumors to be##2##3##(2006-12#1)(2011-2#1)
tumors to the##3##3##(1992-10#1)(2007-6#1)(2011-2#1)
tumors to##12##2##(1992-10#1)(1997-5#1)(2006-12#2)(2007-11#1)(2007-6#1)(2007-8#1)(2010-7#1)(2011-2#2)(2013-7#2)
tumors treated with##6##3##(1992-2#1)(2005-5#3)(2007-8#1)(2012-12#1)
tumors treated##7##2##(1992-2#1)(1994-4#1)(2005-5#3)(2007-8#1)(2012-12#1)
tumors using##7##2##(1991-10#1)(1992-5#1)(1994-2#1)(2007-8#1)(2008-5#2)(2013-1#1)
tumors via##2##2##(2008-3#1)(2010-7#1)
tumors was 3##2##3##(2004-1#1)(2009-7#1)
tumors was increased##2##3##(1995-5#2)
tumors was investigated##2##3##(1990-7#1)(2008-2#1)
tumors was not##2##3##(1992-7#1)(1995-5#1)
tumors was##29##2##(1990-10#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-9#1)(1992-7#1)(1993-11#1)(1994-2#1)(1995-5#3)(1996-11#1)(2004-1#2)(2006-10#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-6#1)(2007-8#2)(2008-11#1)(2008-2#1)(2008-3#2)(2009-10#1)(2009-7#1)(2010-12#1)(2013-1#1)
tumors were detected in##2##4##(1995-8#1)(2013-1#1)
tumors were examined##3##3##(1993-9#1)(2012-2#1)(2013-1#1)
tumors were found to##2##4##(1992-1#1)(1994-7#1)
tumors were found##4##3##(1992-1#1)(1994-7#1)(2007-7#1)(2013-1#1)
tumors were identified##2##3##(1993-5#1)(2011-1#1)
tumors were induced##2##3##(1993-7#1)(2008-10#1)
tumors were investigated##2##3##(2007-12#1)(2008-3#1)
tumors were located in the##4##5##(1995-10#1)(2006-8#1)(2009-7#1)(2013-1#1)
tumors were metastases from the glioblastoma##2##6##(1993-11#1)(2008-7#1)
tumors were observed in the##2##5##(1992-9#1)(1994-5#1)
tumors were observed in##3##4##(1992-9#1)(1994-5#1)(2008-10#1)
tumors were observed##5##3##(1992-5#1)(1992-9#1)(1994-5#1)(2006-12#1)(2008-10#1)
tumors were of##2##3##(1994-5#1)(1995-10#1)
tumors were positive##2##3##(2004-1#1)(2013-8#1)
tumors were removed##2##3##(2006-5#1)(2008-8#1)
tumors were studied##3##3##(1990-6#1)(1991-4#1)(2009-11#1)
tumors were treated with##2##4##(2006-6#1)(2007-8#1)
tumors were##74##2##(1990-2#2)(1990-6#1)(1990-8#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-4#1)(1992-5#1)(1992-7#2)(1992-9#2)(1993-1#3)(1993-11#1)(1993-5#1)(1993-7#2)(1993-9#1)(1994-12#1)(1994-5#2)(1994-7#1)(1995-10#3)(1995-8#1)(1996-11#2)(1996-5#1)(1997-1#1)(2004-1#1)(2005-5#1)(2006-11#2)(2006-12#3)(2006-5#1)(2006-6#1)(2006-8#1)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#3)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#5)(2013-8#4)
tumors when##4##2##(1990-12#1)(1992-2#1)(2005-5#1)(2006-6#1)
tumors which##7##2##(1990-10#1)(1991-9#1)(2006-1#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#1)
tumors will##4##2##(2007-6#1)(2008-5#1)(2009-8#1)(2013-1#1)
tumors with a##7##3##(1991-4#1)(1996-6#1)(1997-2#1)(2006-10#1)(2008-5#1)(2010-12#1)(2012-12#1)
tumors with high##4##3##(1991-12#1)(1993-11#1)(2007-12#1)(2010-6#1)
tumors with low##2##3##(1993-11#1)(2007-12#1)
tumors with respect to##2##4##(2009-4#1)(2011-1#1)
tumors with the##2##3##(1992-1#1)(1993-6#1)
tumors with varying degrees of##2##5##(2007-8#1)(2008-4#1)
tumors with##69##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1991-10#1)(1991-12#2)(1991-4#1)(1992-1#1)(1993-11#2)(1993-6#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-2#1)(2005-5#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-6#2)(2007-8#3)(2008-11#1)(2008-12#2)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#3)(2009-10#1)(2009-4#1)(2009-8#1)(2010-12#3)(2010-6#1)(2011-1#2)(2011-2#7)(2012-12#2)(2013-1#2)(2013-7#3)(2013-8#1)
tumors within the##2##3##(2010-7#1)(2011-2#1)
tumors within##4##2##(1991-7#1)(1992-1#1)(2010-7#1)(2011-2#1)
tumors without##5##2##(2008-6#1)(2010-11#1)(2012-12#2)(2012-2#1)
tumors##2120##1##(1990-10#7)(1990-11#5)(1990-12#8)(1990-2#14)(1990-3#2)(1990-4#5)(1990-5#13)(1990-6#12)(1990-7#11)(1990-8#3)(1990-9#10)(1991-1#3)(1991-10#11)(1991-11#1)(1991-12#15)(1991-2#8)(1991-3#2)(1991-4#8)(1991-5#8)(1991-6#4)(1991-7#5)(1991-8#5)(1991-9#21)(1992-1#7)(1992-10#6)(1992-11#4)(1992-12#4)(1992-2#14)(1992-3#2)(1992-4#9)(1992-5#16)(1992-6#1)(1992-7#19)(1992-8#15)(1992-9#24)(1993-1#12)(1993-10#9)(1993-11#16)(1993-12#3)(1993-4#11)(1993-5#5)(1993-6#3)(1993-7#13)(1993-8#10)(1993-9#25)(1994-10#3)(1994-11#1)(1994-12#16)(1994-2#7)(1994-3#5)(1994-4#5)(1994-5#10)(1994-6#5)(1994-7#9)(1994-8#4)(1994-9#1)(1995-1#10)(1995-10#9)(1995-11#1)(1995-12#1)(1995-2#14)(1995-3#2)(1995-4#9)(1995-5#10)(1995-6#1)(1995-7#2)(1995-8#4)(1995-9#3)(1996-1#2)(1996-10#9)(1996-11#17)(1996-12#3)(1996-3#1)(1996-4#13)(1996-5#1)(1996-6#3)(1996-7#1)(1996-9#2)(1997-1#3)(1997-2#1)(1997-3#6)(1997-4#2)(1997-5#3)(1997-7#19)(1997-8#9)(2004-1#10)(2004-2#2)(2004-9#2)(2005-10#13)(2005-11#4)(2005-12#1)(2005-5#17)(2005-6#1)(2005-7#5)(2005-8#3)(2005-9#6)(2006-1#7)(2006-10#22)(2006-11#17)(2006-12#71)(2006-2#15)(2006-4#1)(2006-5#15)(2006-6#30)(2006-7#8)(2006-8#16)(2006-9#8)(2007-1#7)(2007-10#12)(2007-11#42)(2007-12#33)(2007-2#8)(2007-3#5)(2007-4#6)(2007-5#10)(2007-6#13)(2007-7#15)(2007-8#66)(2007-9#8)(2008-1#21)(2008-10#22)(2008-11#27)(2008-12#10)(2008-2#13)(2008-3#25)(2008-4#27)(2008-5#32)(2008-6#43)(2008-7#48)(2008-8#19)(2008-9#18)(2009-10#9)(2009-11#4)(2009-12#5)(2009-2#11)(2009-3#11)(2009-4#9)(2009-5#14)(2009-6#1)(2009-7#5)(2009-8#6)(2009-9#4)(2010-1#15)(2010-10#2)(2010-11#5)(2010-12#51)(2010-2#14)(2010-3#24)(2010-4#1)(2010-5#12)(2010-6#5)(2010-7#15)(2010-8#2)(2010-9#12)(2011-1#38)(2011-12#6)(2011-2#115)(2012-1#19)(2012-11#7)(2012-12#52)(2012-2#50)(2012-3#26)(2013-1#85)(2013-7#14)(2013-8#31)
tumors) or##3##2##(1992-5#2)(1995-5#1)
tumors)##17##1##(1991-10#1)(1991-9#1)(1992-5#4)(1992-9#1)(1993-9#1)(1995-5#2)(2005-8#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-8#1)(2010-12#1)(2012-2#1)
tumors?##2##1##(1994-8#1)(2006-6#1)
tumors]##31##1##(1990-9#1)(1991-3#2)(1991-6#1)(1991-9#2)(1993-10#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-3#4)(1994-7#1)(1996-3#1)(2005-10#2)(2008-7#1)(2010-9#4)(2011-1#2)(2012-3#1)(2013-1#4)(2013-8#1)
tumour (n =##2##3##(1994-3#2)
tumour ablation##2##2##(2008-2#1)(2008-7#1)
tumour and a non-tumour cell lines##2##6##(2008-5#2)
tumour and a##3##3##(2008-5#2)(2008-8#1)
tumour and target volumes for radiotherapy##2##6##(2008-2#2)
tumour and the##6##3##(1991-11#1)(1991-4#1)(2006-8#1)(2007-8#1)(2008-7#2)
tumour and##41##2##(1990-4#1)(1990-9#1)(1991-11#1)(1991-4#1)(1992-1#1)(1992-10#1)(1992-6#1)(1992-8#3)(1993-9#1)(1995-12#1)(1997-3#1)(2005-7#1)(2006-8#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#1)(2012-12#1)(2012-2#1)(2012-8#1)(2013-1#2)(2013-7#1)
tumour angiogenesis##2##2##(2005-7#1)(2008-1#1)
tumour arising in##3##3##(2011-2#1)(2012-2#2)
tumour arising##4##2##(2006-9#1)(2011-2#1)(2012-2#2)
tumour as the##2##3##(2011-12#1)(2013-7#1)
tumour as##3##2##(2008-7#1)(2011-12#1)(2013-7#1)
tumour at the##2##3##(2006-8#1)(2007-8#1)
tumour at##4##2##(2006-8#1)(2007-8#1)(2008-5#1)(2012-2#1)
tumour bearing mice##2##3##(2008-5#2)
tumour bed##4##2##(2008-7#2)(2011-2#2)
tumour before##2##2##(2008-1#1)(2011-3#1)
tumour biology##2##2##(1990-11#1)(2008-6#1)
tumour biopsy##2##2##(1996-12#2)
tumour burden##2##2##(2005-11#1)(2006-8#1)
tumour but##3##2##(2008-6#1)(2012-12#1)(2012-2#1)
tumour cell invasion##2##3##(1992-9#1)(2009-4#1)
tumour cell line##6##3##(1990-6#2)(2008-11#3)(2008-2#1)
tumour cell lines in##2##4##(1993-9#1)(1995-12#1)
tumour cell lines##6##3##(1992-9#1)(1993-9#1)(1995-12#1)(1997-1#1)(1997-7#1)(2008-5#1)
tumour cell##25##2##(1990-6#2)(1991-3#1)(1992-9#3)(1993-9#1)(1994-3#1)(1995-12#2)(1997-1#2)(1997-7#1)(2007-4#1)(2008-11#4)(2008-2#1)(2008-5#1)(2008-6#1)(2009-4#2)(2009-9#1)(2013-8#1)
tumour cells and##5##3##(1995-12#1)(1997-4#1)(2008-5#1)(2011-2#1)(2013-7#1)
tumour cells are##3##3##(2007-9#1)(2010-12#1)(2011-2#1)
tumour cells by##2##3##(1993-9#1)(2008-11#1)
tumour cells in##2##3##(2008-7#1)(2008-9#1)
tumour cells showed##2##3##(1992-10#1)(2005-12#1)
tumour cells to##4##3##(1992-9#2)(2008-6#1)(2013-8#1)
tumour cells were##3##3##(2004-2#1)(2008-6#1)(2011-1#1)
tumour cells with##3##3##(1994-6#1)(2005-12#1)(2011-1#1)
tumour cells##62##2##(1990-6#2)(1990-8#1)(1991-6#2)(1992-10#2)(1992-9#5)(1993-7#1)(1993-9#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-2#1)(1997-3#2)(1997-4#1)(2004-2#1)(2005-12#2)(2007-10#1)(2007-11#3)(2007-7#1)(2007-9#1)(2008-11#2)(2008-5#6)(2008-6#4)(2008-7#2)(2008-9#1)(2009-4#2)(2009-9#1)(2010-12#1)(2010-3#2)(2011-1#3)(2011-2#4)(2013-7#1)(2013-8#1)
tumour degradation##2##2##(1990-5#2)
tumour development##5##2##(1992-3#1)(1995-2#1)(2007-6#1)(2009-3#1)(2009-4#1)
tumour diameter##2##2##(1993-8#1)(2008-6#1)
tumour differentiation##3##2##(1990-2#1)(1991-7#1)(2008-6#1)
tumour diseases##2##2##(1990-10#1)(2011-2#1)
tumour embolism##2##2##(2008-6#2)
tumour excision##6##2##(1995-5#1)(2008-1#1)(2008-6#3)(2008-7#1)
tumour following##3##2##(2008-6#2)(2008-7#1)
tumour formation##8##2##(1991-7#1)(2005-11#1)(2008-9#1)(2009-4#1)(2009-5#1)(2011-3#1)(2012-12#2)
tumour from##2##2##(1993-1#1)(2008-7#1)
tumour grade or##2##3##(2006-8#1)(2011-2#1)
tumour grade##11##2##(1993-8#1)(1996-3#1)(1996-6#1)(2006-8#1)(2007-2#1)(2008-8#1)(2011-12#1)(2011-2#4)
tumour growth and##3##3##(1995-12#1)(2007-11#2)
tumour growth was##3##3##(1990-9#1)(2008-7#1)(2011-2#1)
tumour growth##20##2##(1990-9#1)(1991-5#1)(1993-8#1)(1993-9#1)(1995-12#1)(1997-3#1)(2004-1#1)(2006-8#1)(2007-10#1)(2007-11#3)(2008-5#1)(2008-7#3)(2010-12#1)(2011-2#2)(2013-8#1)
tumour has##2##2##(2008-7#1)(2012-2#1)
tumour in mice##2##3##(1990-6#1)(2008-9#1)
tumour in patients with##2##4##(2013-1#1)(2013-7#1)
tumour in the digestive tract##2##5##(1991-5#1)(1993-10#1)
tumour in the gizzard##2##4##(2008-5#2)
tumour in the left##3##4##(1995-12#2)(2007-8#1)
tumour in the##16##3##(1991-5#1)(1993-10#1)(1995-12#2)(2007-8#1)(2008-12#1)(2008-5#2)(2008-7#4)(2008-8#1)(2012-3#2)(2013-7#1)
tumour in##33##2##(1990-6#1)(1991-5#1)(1993-10#1)(1994-3#1)(1994-4#1)(1995-12#2)(2006-10#1)(2007-11#2)(2007-8#1)(2008-12#1)(2008-5#2)(2008-7#6)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#3)(2013-8#1)
tumour incidence##2##2##(1996-11#1)(2010-9#1)
tumour induced by##2##3##(1995-11#1)(2008-5#1)
tumour infiltrating lymphocytes##2##3##(2007-11#2)
tumour infiltration and##2##3##(2006-10#1)(2007-5#1)
tumour infiltration##5##2##(2006-10#1)(2007-5#3)(2013-1#1)
tumour initiating##2##2##(1992-2#2)
tumour invasion##3##2##(2005-7#1)(2008-6#1)(2008-7#1)
tumour is a##4##3##(1993-3#1)(2008-7#1)(2012-2#1)(2012-8#1)
tumour is difficult##2##3##(2013-8#2)
tumour is##27##2##(1993-3#1)(1995-8#1)(1997-3#1)(2004-1#2)(2006-6#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-6#2)(2008-7#2)(2011-1#3)(2011-2#1)(2012-2#4)(2012-8#1)(2013-7#1)(2013-8#2)
tumour kill##4##2##(2008-7#4)
tumour located enzymes##2##3##(2005-7#2)
tumour located##4##2##(2005-7#3)(2008-7#1)
tumour location##3##2##(2006-8#3)
tumour margin##2##2##(2006-8#2)
tumour marker##11##2##(1990-1#1)(1990-11#1)(1992-9#1)(1993-1#1)(1995-12#1)(2004-10#2)(2006-10#1)(2008-10#1)(2010-10#1)(2012-12#1)
tumour markers is##2##3##(2005-12#2)
tumour markers were##2##3##(2008-5#1)(2012-12#1)
tumour markers##13##2##(1992-2#1)(1997-2#1)(2005-12#4)(2008-3#1)(2008-5#2)(2012-12#1)(2013-1#3)
tumour mass##7##2##(1993-8#1)(2008-1#1)(2008-5#2)(2008-6#1)(2008-7#2)
tumour microenvironment##5##2##(2009-3#1)(2009-4#1)(2010-7#1)(2012-12#2)
tumour mimics##2##2##(2012-2#2)
tumour model##2##2##(1991-11#1)(1992-2#1)
tumour models##4##2##(1995-12#1)(2007-11#1)(2008-4#1)(2008-5#1)
tumour necrosis factor (TNF)##5##4##(1990-2#1)(1996-2#2)(2007-11#2)
tumour necrosis factor (TNF)-alpha##3##4##(1995-5#1)(2007-11#1)(2011-2#1)
tumour necrosis factor alpha (TNF alpha)##2##6##(1993-7#1)(1994-8#1)
tumour necrosis factor alpha (mTNF-alpha)##2##5##(1994-3#2)
tumour necrosis factor alpha##9##4##(1992-8#1)(1993-6#1)(1993-7#1)(1994-3#3)(1994-8#1)(2007-11#1)(2012-11#1)
tumour necrosis factor##23##3##(1990-2#1)(1992-8#1)(1993-6#1)(1993-7#1)(1994-3#4)(1994-8#1)(1995-5#1)(1996-2#2)(1997-1#2)(2007-11#5)(2008-7#1)(2010-4#1)(2011-2#1)(2012-11#1)
tumour necrosis factor-alpha (TNF-alpha)##3##4##(1992-8#1)(1996-12#1)(2010-9#1)
tumour necrosis factor-alpha (TNFalpha)##3##4##(2007-11#2)(2007-6#1)
tumour necrosis factor-alpha##20##3##(1992-8#2)(1996-12#1)(2007-11#10)(2007-12#1)(2007-6#1)(2008-7#1)(2009-9#1)(2010-9#2)(2013-1#1)
tumour necrosis factor-α##2##3##(2012-1#1)(2013-8#1)
tumour necrosis##54##2##(1990-2#1)(1992-8#3)(1993-6#1)(1993-7#1)(1994-3#5)(1994-8#1)(1995-5#1)(1996-12#1)(1996-2#2)(1997-1#2)(2007-11#15)(2007-12#2)(2007-6#1)(2008-10#1)(2008-6#3)(2008-7#2)(2009-9#1)(2010-10#1)(2010-4#1)(2010-9#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#2)(2013-1#1)(2013-8#1)
tumour nodules##3##2##(2008-6#1)(2008-7#2)
tumour of the breast##5##4##(1990-4#1)(2004-2#1)(2008-6#2)(2013-8#1)
tumour of the cystic duct##2##5##(2008-12#2)
tumour of the lung##5##4##(2008-4#2)(2008-7#2)(2013-7#1)
tumour of the ovary##2##4##(2013-8#2)
tumour of the small intestine##2##5##(1992-6#1)(2006-2#1)
tumour of the thyroid##2##4##(2006-2#2)
tumour of the urinary##2##4##(1993-9#1)(2008-10#1)
tumour of the##42##3##(1990-4#1)(1992-6#1)(1993-10#1)(1993-9#1)(2004-2#1)(2006-2#3)(2007-8#1)(2008-10#2)(2008-12#2)(2008-4#2)(2008-6#6)(2008-7#4)(2010-3#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#3)(2012-2#1)(2013-7#1)(2013-8#5)
tumour of##54##2##(1990-4#1)(1992-6#1)(1993-10#1)(1993-9#1)(1994-3#1)(2004-2#1)(2006-10#1)(2006-2#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-4#2)(2008-6#7)(2008-7#5)(2010-3#1)(2011-1#3)(2011-12#2)(2011-2#3)(2012-12#4)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#5)
tumour or##2##2##(2007-8#1)(2008-7#1)
tumour patients##2##2##(1990-8#1)(2007-5#1)
tumour perfusion##3##2##(2008-7#3)
tumour presenting##2##2##(2008-3#1)(2008-6#1)
tumour progression and metastasis##2##4##(2009-9#1)(2012-2#1)
tumour progression and##4##3##(2007-5#1)(2007-6#1)(2009-9#1)(2012-2#1)
tumour progression by##2##3##(2011-2#1)(2013-8#1)
tumour progression in human##2##4##(1992-9#1)(2013-8#1)
tumour progression in##4##3##(1992-9#2)(2007-11#1)(2013-8#1)
tumour progression##26##2##(1991-3#1)(1992-9#3)(1994-4#1)(2005-11#1)(2007-11#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-4#1)(2009-4#3)(2009-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#3)
tumour promoter##6##2##(1993-7#2)(1995-5#1)(2008-2#1)(2012-2#2)
tumour promoting##3##2##(1992-2#3)
tumour promotion##2##2##(2005-11#1)(2007-10#1)
tumour recurrence##11##2##(1993-2#1)(1993-3#1)(2006-6#1)(2008-1#3)(2008-3#1)(2008-7#2)(2013-1#1)(2013-8#1)
tumour registries##2##2##(2008-7#2)
tumour removal##6##2##(2006-10#1)(2006-6#1)(2007-11#1)(2008-7#2)(2008-9#1)
tumour resection##3##2##(2007-11#1)(2008-6#1)(2012-8#1)
tumour response to therapy##2##4##(2004-2#1)(2008-7#1)
tumour response to##3##3##(2004-2#1)(2008-7#2)
tumour response##8##2##(2004-2#2)(2007-11#1)(2008-6#1)(2008-7#2)(2012-2#1)(2013-8#1)
tumour responses##3##2##(2008-6#2)(2008-7#1)
tumour showed##2##2##(2008-6#1)(2013-7#1)
tumour site##3##2##(2008-6#2)(2013-8#1)
tumour sites##3##2##(2005-7#1)(2008-8#1)(2012-12#1)
tumour size was##2##3##(2004-2#1)(2008-6#1)
tumour size##18##2##(1990-6#1)(1992-5#1)(1993-9#1)(1995-5#1)(1996-3#1)(1997-3#1)(1997-8#1)(2004-2#3)(2007-2#1)(2008-6#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)
tumour so##2##2##(1993-3#1)(2007-11#1)
tumour specific##2##2##(2007-11#1)(2011-1#1)
tumour spread##6##2##(1991-7#1)(2006-10#1)(2008-1#1)(2012-2#3)
tumour stage and##2##3##(2006-10#1)(2008-3#1)
tumour stage##4##2##(1992-1#1)(2006-10#1)(2008-3#1)(2011-2#1)
tumour suppressor gene p53##2##4##(1996-10#1)(2007-9#1)
tumour suppressor gene product##2##4##(1994-2#1)(1996-10#1)
tumour suppressor gene##14##3##(1992-3#1)(1994-2#2)(1996-10#3)(1997-5#1)(1997-7#1)(2007-6#1)(2007-9#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-5#1)
tumour suppressor genes##12##3##(1993-3#1)(1995-2#2)(1997-3#1)(2003-11#1)(2007-11#1)(2008-7#2)(2009-3#1)(2009-4#1)(2010-12#1)(2011-2#1)
tumour suppressor##34##2##(1990-9#1)(1991-11#1)(1992-3#1)(1993-3#1)(1994-2#2)(1995-2#2)(1996-10#3)(1997-3#1)(1997-5#1)(1997-7#1)(2003-11#3)(2007-11#2)(2007-6#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#3)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#1)(2011-2#2)(2012-3#1)
tumour surgery##2##2##(1996-8#1)(2012-12#1)
tumour targeting##2##2##(2007-11#1)(2008-7#1)
tumour that##2##2##(2010-9#1)(2012-3#1)
tumour therapy##2##2##(1990-10#1)(2005-12#1)
tumour thrombus is##2##3##(2008-6#2)
tumour tissue##5##2##(1991-3#1)(1992-10#2)(1996-6#1)(2013-8#1)
tumour tissues##4##2##(1991-5#1)(1992-2#1)(1993-10#1)(2008-5#1)
tumour to##7##2##(1990-2#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-4#1)
tumour treatment##2##2##(1992-5#1)(2008-1#1)
tumour type##5##2##(1993-12#1)(2006-8#1)(2008-3#1)(2011-12#1)(2012-1#1)
tumour types##7##2##(1995-2#1)(1996-6#1)(2008-2#1)(2008-6#1)(2009-10#1)(2011-2#1)(2013-1#1)
tumour volume##7##2##(1992-8#1)(1997-4#2)(2008-2#3)(2011-3#1)
tumour was diagnosed as##2##4##(2012-2#1)(2013-7#1)
tumour was diagnosed##4##3##(1990-5#1)(2007-8#1)(2012-2#1)(2013-7#1)
tumour was found##2##3##(1995-11#1)(2012-2#1)
tumour was suspected##2##3##(1992-4#1)(2006-10#1)
tumour was##37##2##(1990-5#1)(1991-6#1)(1992-4#1)(1995-11#1)(1995-8#1)(2006-10#2)(2006-6#1)(2007-8#2)(2008-5#1)(2008-6#4)(2008-7#9)(2009-10#1)(2011-2#1)(2012-12#3)(2012-2#4)(2013-7#1)(2013-8#3)
tumour were##3##2##(1991-6#1)(2007-2#1)(2010-9#1)
tumour which##5##2##(2010-3#1)(2012-2#1)(2012-3#1)(2013-8#2)
tumour with##10##2##(1991-11#1)(2006-9#2)(2007-11#1)(2007-8#1)(2008-10#1)(2008-6#2)(2012-8#1)(2013-1#1)
tumour##1071##1##(1990-1#2)(1990-10#4)(1990-11#5)(1990-2#3)(1990-4#3)(1990-5#8)(1990-6#8)(1990-8#3)(1990-9#7)(1991-11#4)(1991-3#4)(1991-4#1)(1991-5#3)(1991-6#6)(1991-7#14)(1991-9#1)(1992-1#3)(1992-10#6)(1992-12#1)(1992-2#11)(1992-3#3)(1992-4#2)(1992-5#4)(1992-6#4)(1992-8#8)(1992-9#14)(1993-1#2)(1993-10#8)(1993-12#1)(1993-2#1)(1993-3#7)(1993-4#6)(1993-6#2)(1993-7#4)(1993-8#6)(1993-9#7)(1994-2#2)(1994-3#10)(1994-4#3)(1994-6#2)(1994-8#2)(1995-10#2)(1995-11#2)(1995-12#10)(1995-2#6)(1995-5#5)(1995-6#1)(1995-8#3)(1996-1#1)(1996-10#3)(1996-11#4)(1996-12#3)(1996-2#3)(1996-3#6)(1996-4#1)(1996-6#4)(1996-8#2)(1997-1#5)(1997-2#1)(1997-3#10)(1997-4#6)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#1)(2003-11#3)(2004-1#4)(2004-10#3)(2004-2#12)(2005-11#7)(2005-12#10)(2005-7#8)(2006-10#13)(2006-2#3)(2006-6#10)(2006-8#14)(2006-9#3)(2007-10#4)(2007-11#53)(2007-12#2)(2007-2#4)(2007-4#2)(2007-5#9)(2007-6#5)(2007-7#3)(2007-8#19)(2007-9#5)(2008-1#17)(2008-10#17)(2008-11#8)(2008-12#4)(2008-2#13)(2008-3#16)(2008-4#9)(2008-5#29)(2008-6#100)(2008-7#94)(2008-8#5)(2008-9#7)(2009-10#2)(2009-2#3)(2009-3#5)(2009-4#16)(2009-5#3)(2009-7#1)(2009-9#6)(2010-10#2)(2010-12#5)(2010-3#5)(2010-4#1)(2010-5#1)(2010-7#2)(2010-9#8)(2011-1#15)(2011-12#9)(2011-2#37)(2011-3#5)(2012-1#3)(2012-11#2)(2012-12#27)(2012-2#35)(2012-3#10)(2012-8#4)(2013-1#23)(2013-7#12)(2013-8#33)
tumour)##5##1##(1993-3#1)(2007-9#1)(2008-6#2)(2012-2#1)
tumour-associated antigens##2##2##(2007-11#2)
tumour-associated##7##1##(1993-2#2)(1994-12#1)(2007-11#4)
tumour-bearing##11##1##(1992-1#3)(1993-8#1)(1996-1#1)(2006-6#1)(2007-11#1)(2008-5#1)(2012-1#3)
tumour-like##2##1##(1997-5#1)(2008-6#1)
tumour-specific##3##1##(2007-11#2)(2011-1#1)
tumour-suppressor gene##2##2##(1993-9#1)(2008-6#1)
tumoural progression amongst##2##3##(2013-1#2)
tumoural progression##5##2##(2013-1#5)
tumoural##11##1##(2008-5#2)(2012-11#2)(2012-2#1)(2013-1#6)
tumourigenesis##6##1##(1994-12#1)(2005-12#1)(2008-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
tumourigenic##2##1##(2008-6#2)
tumourous##3##1##(1991-3#1)(2008-5#1)(2008-7#1)
tumours (n =##2##3##(1996-4#1)(2011-2#1)
tumours (n=4)##3##2##(2008-12#3)
tumours a##2##2##(2004-2#1)(2010-12#1)
tumours and in the##2##4##(1992-10#1)(2009-4#1)
tumours and in##4##3##(1990-10#1)(1992-10#1)(1997-3#1)(2009-4#1)
tumours and the##5##3##(1997-3#1)(2006-9#1)(2008-1#1)(2008-8#1)(2012-2#1)
tumours and thus##2##3##(1994-10#1)(2007-11#1)
tumours and##37##2##(1990-10#1)(1990-8#1)(1991-12#1)(1991-6#1)(1992-10#1)(1992-11#2)(1994-10#1)(1994-11#1)(1994-7#1)(1996-6#1)(1997-2#1)(1997-3#2)(2004-2#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-6#4)(2008-8#1)(2009-4#2)(2010-12#1)(2011-2#1)(2012-2#3)
tumours are benign##2##3##(2008-6#1)(2012-2#1)
tumours are rare##2##3##(2007-8#1)(2008-10#1)
tumours are##26##2##(1990-2#1)(1990-5#1)(1991-6#1)(1992-8#1)(1994-6#1)(1995-9#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#4)(2008-7#3)(2008-8#1)(2009-10#2)(2009-4#1)(2012-2#3)(2012-3#1)
tumours arising from##2##3##(2010-7#1)(2011-2#1)
tumours arising##3##2##(2008-6#1)(2010-7#1)(2011-2#1)
tumours at##4##2##(2008-6#3)(2008-7#1)
tumours but##2##2##(2007-11#1)(2007-9#1)
tumours commonly##2##2##(2008-6#1)(2010-2#1)
tumours could##2##2##(1990-8#1)(2008-7#1)
tumours display##2##2##(2008-11#2)
tumours exhibited##2##2##(1994-10#1)(2008-6#1)
tumours expressed##2##2##(1995-12#1)(2013-1#1)
tumours following##3##2##(1990-8#1)(2008-6#1)(2012-2#1)
tumours from patients in the##2##5##(1993-11#2)
tumours from##6##2##(1992-2#1)(1993-11#2)(2008-1#1)(2008-7#1)(2011-2#1)
tumours had raised##2##3##(1992-11#2)
tumours had##5##2##(1990-5#1)(1990-9#1)(1992-11#2)(2004-2#1)
tumours has##2##2##(2006-12#1)(2009-8#1)
tumours have been##3##3##(1995-2#1)(2008-6#1)(2008-7#1)
tumours have##6##2##(1990-5#1)(1995-2#2)(2008-6#1)(2008-7#1)(2012-2#1)
tumours in Lagos##2##3##(2010-9#1)(2011-1#1)
tumours in a##3##3##(1990-12#1)(1991-7#1)(2012-3#1)
tumours in adults##2##3##(2013-1#2)
tumours in children##2##3##(2008-7#2)
tumours in mice##2##3##(1991-9#1)(2008-7#1)
tumours in patients with HIV##2##5##(1994-4#2)
tumours in patients##3##3##(1994-4#2)(2008-6#1)
tumours in the head and neck##2##6##(1997-6#1)(2007-11#1)
tumours in the##9##3##(1991-8#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-6#1)(2007-11#2)(2012-2#1)(2013-1#1)
tumours in##42##2##(1990-12#1)(1991-11#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-6#1)(1994-4#3)(1996-12#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-11#3)(2007-8#1)(2008-3#1)(2008-6#2)(2008-7#5)(2010-12#1)(2010-3#1)(2010-9#3)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
tumours is##10##2##(1990-2#1)(1991-11#1)(1991-6#1)(2005-11#1)(2006-6#1)(2007-11#1)(2008-2#1)(2009-2#1)(2011-3#1)(2012-12#1)
tumours like##3##2##(2007-10#2)(2010-3#1)
tumours may be##3##3##(1990-11#1)(2007-8#2)
tumours may##5##2##(1990-11#1)(2007-8#2)(2012-2#1)(2013-8#1)
tumours occurred##2##2##(1990-11#1)(2010-12#1)
tumours of bone##3##3##(2008-6#3)
tumours of the breast##3##4##(1992-10#1)(2004-2#2)
tumours of the central nervous system##2##6##(1996-4#1)(2006-10#1)
tumours of the lung##2##4##(2009-10#1)(2013-8#1)
tumours of the##34##3##(1990-9#4)(1991-11#1)(1992-10#1)(1993-5#1)(1993-9#2)(1994-9#1)(1996-4#1)(2004-2#2)(2006-10#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-6#6)(2008-7#1)(2009-10#1)(2011-2#1)(2012-2#3)(2013-8#2)
tumours of##46##2##(1990-8#1)(1990-9#4)(1991-11#1)(1991-9#1)(1992-10#1)(1993-5#1)(1993-9#2)(1994-10#1)(1994-3#1)(1994-9#1)(1996-4#1)(2004-2#2)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#11)(2008-7#1)(2009-10#1)(2011-2#1)(2012-2#3)(2013-8#2)
tumours on the##2##3##(1991-6#1)(2011-3#1)
tumours or##2##2##(1992-11#1)(2008-3#1)
tumours that are##2##3##(2011-2#1)(2012-2#1)
tumours that##7##2##(1996-8#1)(2004-2#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)
tumours to##4##2##(1996-11#1)(2007-11#1)(2008-7#1)(2011-2#1)
tumours treated##2##2##(2008-6#1)(2012-2#1)
tumours usually##2##2##(2008-7#1)(2012-2#1)
tumours was found##2##3##(1991-6#1)(1992-11#1)
tumours was##12##2##(1991-6#2)(1992-11#1)(1992-12#1)(1996-5#1)(2004-2#1)(2006-8#1)(2008-6#2)(2008-7#2)(2008-8#1)
tumours were cancers##2##3##(2006-10#2)
tumours were present in the##2##5##(2006-8#1)(2007-12#1)
tumours were##33##2##(1990-12#2)(1990-5#1)(1991-7#1)(1993-1#2)(1993-2#1)(1997-4#1)(1997-6#1)(2004-1#1)(2004-2#2)(2006-10#2)(2006-6#1)(2006-8#3)(2007-12#2)(2007-2#1)(2007-8#4)(2008-5#1)(2008-6#1)(2008-7#1)(2011-11#1)(2011-2#1)(2013-8#3)
tumours when##2##2##(2008-7#1)(2011-2#1)
tumours which have##3##3##(2008-4#2)(2008-9#1)
tumours which##7##2##(1990-9#1)(1991-9#1)(2008-4#2)(2008-7#1)(2008-9#1)(2013-8#1)
tumours who##5##2##(2007-7#1)(2007-8#1)(2008-6#2)(2013-7#1)
tumours with##14##2##(1992-9#1)(1993-9#1)(1994-10#1)(2005-11#2)(2006-10#1)(2007-10#1)(2007-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-3#1)(2012-2#1)(2013-7#1)
tumours without##3##2##(1991-5#1)(1993-9#1)(2013-1#1)
tumours##667##1##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#11)(1990-6#1)(1990-8#8)(1990-9#11)(1991-11#6)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#9)(1991-7#3)(1991-8#2)(1991-9#6)(1992-10#2)(1992-11#10)(1992-12#10)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#3)(1993-10#3)(1993-11#5)(1993-12#1)(1993-2#1)(1993-5#4)(1993-6#1)(1993-8#1)(1993-9#8)(1994-10#9)(1994-11#2)(1994-2#1)(1994-3#1)(1994-4#3)(1994-6#6)(1994-7#1)(1994-9#1)(1995-12#2)(1995-2#8)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#1)(1996-3#1)(1996-4#4)(1996-5#3)(1996-6#2)(1996-8#2)(1997-2#3)(1997-3#3)(1997-4#5)(1997-6#3)(1997-7#1)(1997-8#1)(2004-1#2)(2004-2#13)(2005-11#4)(2005-12#3)(2005-7#2)(2005-9#1)(2006-10#8)(2006-12#2)(2006-6#7)(2006-7#1)(2006-8#13)(2006-9#2)(2007-10#5)(2007-11#24)(2007-12#3)(2007-2#2)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#17)(2007-9#4)(2008-1#12)(2008-10#4)(2008-11#5)(2008-12#7)(2008-2#8)(2008-3#16)(2008-4#6)(2008-5#10)(2008-6#74)(2008-7#48)(2008-8#7)(2008-9#1)(2009-10#4)(2009-11#1)(2009-2#1)(2009-4#8)(2009-5#3)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#4)(2010-7#1)(2010-9#4)(2011-1#7)(2011-11#1)(2011-12#1)(2011-2#22)(2011-3#3)(2012-1#1)(2012-12#7)(2012-2#38)(2012-3#6)(2013-1#13)(2013-7#8)(2013-8#14)
tumours)##5##1##(1991-6#1)(1992-9#1)(2007-8#2)(2012-1#1)
tumultuous##2##1##(1992-1#1)(1996-2#1)
tuna fish##3##2##(2011-2#2)(2012-11#1)
tuna##10##1##(1994-5#2)(2008-6#1)(2010-8#2)(2011-2#2)(2012-11#3)
tunability from##2##2##(2007-12#2)
tunability in the##2##3##(2007-11#1)(2007-12#1)
tunability in##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
tunability is achieved by##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
tunability is achieved##4##3##(2007-11#2)(2007-12#1)(2008-2#1)
tunability is##6##2##(2007-11#3)(2007-12#2)(2008-2#1)
tunability of the##6##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
tunability of##7##2##(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
tunability over##3##2##(2007-11#1)(2008-1#1)(2008-3#1)
tunability##34##1##(2007-11#10)(2007-12#15)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-7#1)
tunable 20-fs##2##2##(2008-1#2)
tunable ArF excimer laser##2##4##(2007-12#1)(2008-2#1)
tunable CO(2) laser##2##3##(2008-10#1)(2008-3#1)
tunable CO(2)##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
tunable Fabry-Perot etalon##2##3##(2008-3#2)
tunable Fabry-Perot##3##2##(2008-1#1)(2008-3#2)
tunable KrF excimer laser##2##4##(2008-3#2)
tunable Ti##4##2##(2008-2#3)(2008-3#1)
tunable Tm##2##2##(2007-12#2)
tunable across the visible##2##4##(2008-1#1)(2008-2#1)
tunable across the##3##3##(2007-12#1)(2008-1#1)(2008-2#1)
tunable across##4##2##(2007-12#2)(2008-1#1)(2008-2#1)
tunable and##5##2##(2007-11#2)(2007-12#2)(2009-8#1)
tunable between##3##2##(2006-5#1)(2008-1#1)(2008-3#1)
tunable by##3##2##(2007-12#2)(2012-2#1)
tunable coherent##2##2##(2007-12#1)(2008-3#1)
tunable compensation##2##2##(2007-11#1)(2007-12#1)
tunable continuous-wave##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
tunable control over the##3##4##(2008-12#3)
tunable control over##4##3##(2008-12#4)
tunable control##5##2##(2007-12#1)(2008-12#4)
tunable cw##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
tunable diode laser absorption spectrometer##3##5##(2008-3#3)
tunable diode laser absorption##4##4##(2008-2#1)(2008-3#3)
tunable diode laser as a local oscillator##2##7##(2008-2#2)
tunable diode laser as a##3##5##(2007-12#1)(2008-2#2)
tunable diode laser spectrometer##2##4##(2008-3#2)
tunable diode laser##14##3##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#8)
tunable diode lasers##4##3##(2007-12#1)(2008-3#3)
tunable diode##18##2##(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#11)
tunable dye laser##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
tunable dye##4##2##(2005-4#1)(2007-12#1)(2008-10#1)(2008-2#1)
tunable external cavity diode laser##2##5##(2008-2#2)
tunable external cavity##3##3##(2008-2#2)(2008-3#1)
tunable external-cavity diode laser##2##4##(2007-12#2)
tunable external-cavity##5##2##(2007-11#1)(2007-12#4)
tunable far-infrared radiation##3##3##(2007-11#2)(2007-12#1)
tunable far-infrared##4##2##(2007-11#2)(2007-12#1)(2008-2#1)
tunable femtosecond##2##2##(2008-2#1)(2009-4#1)
tunable fiber ring##3##3##(2007-11#1)(2008-3#2)
tunable fiber##5##2##(2007-11#2)(2008-3#3)
tunable fiber-film coupler##2##3##(2008-2#2)
tunable fiber-film##3##2##(2008-2#2)(2008-3#1)
tunable filter##20##2##(2007-11#1)(2007-12#6)(2008-1#1)(2008-10#2)(2008-2#7)(2008-3#3)
tunable filters##8##2##(2007-11#1)(2007-12#3)(2008-10#2)(2008-3#2)
tunable frequency##3##2##(2007-11#1)(2008-2#1)(2013-7#1)
tunable from 1##5##3##(2007-11#2)(2007-12#2)(2008-3#1)
tunable from##18##2##(2007-11#2)(2007-12#8)(2008-1#2)(2008-2#4)(2008-3#2)
tunable in a##2##3##(2007-11#2)
tunable in the visible##2##4##(2007-12#2)
tunable in the##13##3##(2007-11#1)(2007-12#7)(2008-1#1)(2008-2#3)(2008-3#1)
tunable in##18##2##(2007-11#3)(2007-12#9)(2008-1#1)(2008-2#4)(2008-3#1)
tunable infrared##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
tunable interferometric filter##2##3##(2008-2#2)
tunable laser diode##5##3##(2007-12#3)(2008-2#1)(2008-3#1)
tunable laser source##2##3##(2007-12#1)(2008-3#1)
tunable laser##19##2##(2007-11#1)(2007-12#7)(2007-8#1)(2008-2#3)(2008-3#7)
tunable lasers##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
tunable microwave##2##2##(2007-12#1)(2008-1#1)
tunable mid-infrared##4##2##(2007-11#1)(2007-12#2)(2008-1#1)
tunable narrow-band##3##2##(2007-11#2)(2008-2#1)
tunable narrow-bandwidth##2##2##(2007-11#1)(2008-2#1)
tunable operation of a diode-pumped##2##5##(2007-12#1)(2008-2#1)
tunable operation of a##4##4##(2007-12#2)(2008-2#1)(2008-3#1)
tunable operation##5##2##(2007-12#2)(2008-2#2)(2008-3#1)
tunable optical parametric oscillator based on##2##6##(2007-12#2)
tunable optical parametric oscillator##3##4##(2007-12#2)(2008-1#1)
tunable optical##9##2##(2007-11#2)(2007-12#3)(2008-1#1)(2008-2#2)(2008-3#1)
tunable output from##2##3##(2008-1#1)(2008-3#1)
tunable output of a##2##4##(2007-12#1)(2008-2#1)
tunable output power##2##3##(2008-2#2)
tunable output##7##2##(2007-12#1)(2008-1#1)(2008-2#3)(2008-3#1)(2013-8#1)
tunable over a##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
tunable over##15##2##(2007-11#7)(2007-12#4)(2008-2#3)(2009-4#1)
tunable phase##2##2##(2007-11#1)(2007-12#1)
tunable properties##2##2##(2006-5#1)(2008-7#1)
tunable pulsed##3##2##(2007-12#1)(2008-3#2)
tunable radiation in##2##3##(2007-12#1)(2008-2#1)
tunable regenerative amplifier##2##3##(2007-12#1)(2008-2#1)
tunable second-harmonic##2##2##(2008-3#1)(2011-1#1)
tunable signal##2##2##(2007-12#1)(2008-3#1)
tunable single-frequency##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
tunable terahertz##2##2##(2007-12#2)
tunable to##2##2##(2008-2#1)(2008-5#1)
tunable ultraviolet##4##2##(2007-11#1)(2008-2#3)
tunable wavelength conversion of##2##4##(2007-12#2)
tunable wavelength##4##2##(2007-12#2)(2008-3#2)
tunable##403##1##(1992-6#1)(2005-4#1)(2006-4#2)(2006-5#2)(2007-11#51)(2007-12#126)(2007-8#2)(2007-9#1)(2008-1#24)(2008-10#8)(2008-12#4)(2008-2#78)(2008-3#75)(2008-5#1)(2008-7#2)(2009-4#3)(2009-6#1)(2009-8#2)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#3)(2012-11#4)(2012-2#4)(2013-1#1)(2013-7#1)(2013-8#3)
tundra##2##1##(2008-9#1)(2011-2#1)
tune the output##2##3##(2007-12#1)(2013-7#1)
tune the##24##2##(1992-3#1)(2005-10#1)(2006-11#1)(2007-12#5)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)(2013-1#1)(2013-7#1)
tune with##3##2##(2007-12#1)(2008-12#1)(2009-6#1)
tune##37##1##(1992-3#1)(2005-10#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#7)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#2)(2009-8#1)(2010-2#2)(2010-8#1)(2012-12#1)(2013-1#1)(2013-7#1)
tuneable##2##1##(2008-7#2)
tuned and##2##2##(2007-12#1)(2010-4#1)
tuned at##2##2##(2007-12#2)
tuned by adjustment of the##2##5##(2007-12#2)
tuned by use of##2##4##(2007-11#2)
tuned by##16##2##(1996-2#1)(2007-11#4)(2007-12#4)(2008-2#3)(2008-6#1)(2010-5#1)(2011-1#1)(2012-2#1)
tuned for##4##2##(2008-2#1)(2008-4#1)(2008-7#1)(2011-1#1)
tuned from 2##2##3##(2007-12#2)
tuned from##11##2##(2007-11#3)(2007-12#6)(2008-2#1)(2008-7#1)
tuned in the range##2##4##(2007-12#1)(2008-1#1)
tuned in the##3##3##(2007-12#2)(2008-1#1)
tuned in##4##2##(2007-12#3)(2008-1#1)
tuned over a##2##3##(2007-11#1)(2008-3#1)
tuned over##13##2##(2007-11#5)(2007-12#5)(2008-1#1)(2008-3#2)
tuned the##5##2##(2007-11#2)(2007-12#1)(2008-3#2)
tuned to the##9##3##(1991-1#2)(2006-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#1)
tuned to##23##2##(1991-1#2)(2006-10#1)(2007-12#3)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-2#5)(2008-3#2)(2008-9#2)(2009-10#1)(2009-3#1)(2011-1#1)(2013-1#1)
tuned with a##2##3##(2008-2#1)(2008-7#1)
tuned with##4##2##(2007-11#1)(2008-2#2)(2008-7#1)
tuned##132##1##(1991-1#2)(1992-12#2)(1993-2#1)(1994-12#2)(1995-2#1)(1995-5#1)(1996-2#1)(2006-10#1)(2006-11#1)(2007-11#20)(2007-12#36)(2007-5#2)(2007-8#1)(2007-9#1)(2008-1#4)(2008-11#2)(2008-2#18)(2008-3#13)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
tunes the##2##2##(1997-1#1)(2010-12#1)
tunes##5##1##(1997-1#1)(2006-12#1)(2008-10#1)(2010-12#1)(2011-2#1)
tungiasis in##2##2##(2007-2#1)(2011-1#1)
tungiasis##5##1##(2007-2#3)(2011-1#2)
tungro disease##2##2##(2008-10#2)
tungro##5##1##(2008-10#5)
tungstate##11##1##(1992-8#1)(2005-4#1)(2007-12#1)(2008-10#3)(2008-2#3)(2013-8#2)
tungstate-coated graphite##2##2##(2005-4#2)
tungstates##3##1##(2008-1#1)(2008-3#2)
tungsten (VI)##2##2##(2008-10#1)(2009-11#1)
tungsten and##3##2##(2005-11#1)(2007-5#1)(2008-10#1)
tungsten as##2##2##(1992-1#1)(1994-3#1)
tungsten based##3##2##(2008-10#2)(2009-11#1)
tungsten can##2##2##(2008-10#1)(2009-2#1)
tungsten carbide (WC) and##2##4##(2005-11#1)(2005-8#1)
tungsten carbide##6##2##(1994-6#2)(2005-11#1)(2005-8#1)(2007-12#1)(2008-10#1)
tungsten coil atomizer##5##3##(2008-10#5)
tungsten coil electrothermal atomic absorption spectrometry##6##6##(2008-10#6)
tungsten coil electrothermal atomic absorption##7##5##(2008-10#7)
tungsten coil##17##2##(2007-11#1)(2007-8#1)(2008-10#15)
tungsten electrode##2##2##(2008-10#2)
tungsten in##10##2##(2008-10#10)
tungsten nanoparticles##2##2##(2008-10#2)
tungsten ores##2##2##(2005-4#1)(2008-10#1)
tungsten oxide##5##2##(2005-11#1)(2008-10#3)(2008-2#1)
tungsten oxide-based##2##2##(2008-10#2)
tungsten plus noble metal##2##4##(2008-10#2)
tungsten tip##2##2##(2007-12#2)
tungsten was##2##2##(2008-10#2)
tungsten wire preconcentration##2##3##(2008-10#2)
tungsten wire##10##2##(2008-10#9)(2009-5#1)
tungsten with##2##2##(2008-10#2)
tungsten##110##1##(1992-1#1)(1992-7#1)(1992-8#3)(1994-3#1)(1994-6#5)(1997-8#1)(2005-11#3)(2005-4#3)(2005-8#1)(2007-11#3)(2007-12#3)(2007-5#1)(2007-8#2)(2008-10#74)(2008-2#2)(2009-11#2)(2009-2#1)(2009-5#1)(2010-2#1)(2010-4#1)
tungsten(VI)##5##1##(2008-10#5)
tungsten-halogen lamps##2##2##(2008-2#1)(2008-3#1)
tungsten-halogen##3##1##(2008-10#1)(2008-2#1)(2008-3#1)
tungsten-tantalum##2##1##(1994-8#2)
tungstosilicate##2##1##(1996-2#1)(2010-5#1)
tunic granulocytes##3##2##(2008-7#3)
tunic##11##1##(2008-5#2)(2008-7#8)(2009-2#1)
tunica albuginea##3##2##(2011-1#1)(2011-2#1)(2012-3#1)
tunica vaginalis##3##2##(2008-10#2)(2012-2#1)
tunica##13##1##(1992-12#1)(1996-7#1)(2006-10#1)(2008-10#2)(2008-11#1)(2009-10#3)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
tunicamycin##17##1##(1990-3#1)(1990-7#1)(1991-7#1)(1991-9#1)(1993-4#2)(1993-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1997-1#1)(1997-2#1)(2008-11#1)(2012-2#1)(2013-1#2)
tunicamycin-treated##2##1##(1990-12#1)(1990-3#1)
tunicata##2##1##(2007-11#2)
tunicate##6##1##(1993-7#1)(1994-8#1)(1997-6#2)(2008-5#2)
tunicates##2##1##(2008-8#2)
tuning and spectral properties of distributed feedback##2##7##(2008-3#2)
tuning and##8##2##(2007-12#2)(2008-2#1)(2008-3#3)(2008-9#1)(2013-7#1)
tuning approach##2##2##(2007-12#2)
tuning at##2##2##(1993-12#1)(2008-3#1)
tuning by use of##2##4##(2007-12#2)
tuning by##8##2##(1995-12#1)(2006-5#1)(2007-12#4)(2008-3#2)
tuning capability##3##2##(2007-11#1)(2007-12#2)
tuning characteristics##2##2##(2008-3#1)(2013-7#1)
tuning curve for##2##3##(1996-2#1)(2008-2#1)
tuning curve##3##2##(1996-2#1)(2008-11#1)(2008-2#1)
tuning curves##2##2##(2008-11#1)(2008-8#1)
tuning element##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
tuning fork##3##2##(2007-11#1)(2007-12#1)(2013-8#1)
tuning from##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
tuning in a continuous-wave##3##4##(2007-12#3)
tuning in a##7##3##(2007-12#7)
tuning in the##2##3##(2007-11#1)(2008-3#1)
tuning in##11##2##(2007-11#1)(2007-12#8)(2008-11#1)(2008-3#1)
tuning is achieved##3##3##(2008-2#2)(2008-3#1)
tuning is##7##2##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#1)
tuning of a single-mode##3##4##(2007-11#2)(2007-12#1)
tuning of a##9##3##(2007-11#3)(2007-12#4)(2008-1#1)(2008-3#1)
tuning of an##4##3##(2007-11#2)(2007-12#2)
tuning of the crystal##2##4##(2008-3#2)
tuning of the model##2##4##(1993-6#1)(2008-7#1)
tuning of the output##2##4##(2007-12#1)(2008-3#1)
tuning of the pump laser##4##5##(2007-11#2)(2007-12#2)
tuning of the pump##5##4##(2007-11#3)(2007-12#2)
tuning of the spectrum shape##2##5##(2008-2#2)
tuning of the##37##3##(1993-6#1)(2007-11#6)(2007-12#17)(2008-1#1)(2008-2#4)(2008-3#5)(2008-7#1)(2008-8#1)(2009-5#1)
tuning of##74##2##(1993-6#1)(2006-12#1)(2007-11#12)(2007-12#32)(2008-1#2)(2008-11#1)(2008-2#7)(2008-3#9)(2008-7#1)(2008-8#2)(2009-2#1)(2009-3#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-12#1)
tuning or##3##2##(2008-3#2)(2011-1#1)
tuning over a range##2##4##(2008-2#1)(2008-3#1)
tuning over a wide##2##4##(2008-2#2)
tuning over a##6##3##(2008-1#1)(2008-2#4)(2008-3#1)
tuning over the range##2##4##(2007-12#1)(2008-2#1)
tuning over##13##2##(2007-12#6)(2008-1#1)(2008-2#5)(2008-3#1)
tuning properties##3##2##(2008-11#3)
tuning provided##2##2##(2007-12#1)(2008-1#1)
tuning range and is##2##4##(2007-11#1)(2007-12#1)
tuning range and##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
tuning range are##2##3##(2007-11#1)(2008-2#1)
tuning range from##3##3##(2007-11#1)(2007-12#2)
tuning range is##4##3##(2007-11#2)(2007-12#2)
tuning range of from 800 to##2##6##(2008-2#2)
tuning range of the##3##4##(2007-12#2)(2008-2#1)
tuning range of##23##3##(2007-11#2)(2007-12#7)(2008-1#1)(2008-2#8)(2008-3#4)(2011-1#1)
tuning range was##3##3##(2007-12#2)(2008-2#1)
tuning range##58##2##(2007-11#10)(2007-12#21)(2008-1#1)(2008-2#18)(2008-3#7)(2011-1#1)
tuning ranges of the##2##4##(2008-2#1)(2008-3#1)
tuning ranges##3##2##(2008-2#2)(2008-3#1)
tuning rate of##3##3##(2007-12#1)(2008-10#2)
tuning rate##5##2##(2007-12#1)(2008-10#4)
tuning results##2##2##(2007-12#1)(2008-2#1)
tuning speeds##2##2##(2007-11#2)
tuning the wavelength of the##4##5##(2006-4#1)(2007-11#2)(2007-12#1)
tuning the##27##2##(1992-5#1)(1993-2#1)(1996-5#1)(2006-4#1)(2007-11#4)(2007-12#8)(2008-10#1)(2008-2#5)(2008-3#1)(2010-12#1)(2010-4#2)(2010-8#1)
tuning their##2##2##(1993-2#1)(2008-7#1)
tuning to##3##2##(2007-12#1)(2008-3#2)
tuning was##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2012-2#1)
tuning width##2##2##(2008-11#1)(2008-2#1)
tuning with##6##2##(2007-12#5)(2008-2#1)
tuning##327##1##(1992-2#1)(1992-5#1)(1993-12#2)(1993-2#2)(1993-6#1)(1995-11#1)(1995-12#1)(1996-2#2)(1996-5#1)(1997-6#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-11#44)(2007-12#116)(2008-1#8)(2008-10#5)(2008-11#10)(2008-2#55)(2008-3#39)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-2#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-1#5)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#5)(2013-8#1)
tunnel by##3##2##(2007-12#1)(2008-3#1)(2008-9#1)
tunnel catheter##2##2##(2007-7#2)
tunnel connective tissue graft##2##4##(2010-4#2)
tunnel diode##5##2##(2008-3#5)
tunnel environment##3##2##(2012-12#3)
tunnel in##3##2##(2008-4#1)(2008-9#1)(2013-7#1)
tunnel infection##3##2##(2011-2#2)(2011-3#1)
tunnel is##4##2##(2005-12#1)(2008-4#1)(2008-9#2)
tunnel junctions##2##2##(1990-7#1)(2008-7#1)
tunnel length from 2##2##4##(2013-1#2)
tunnel length##3##2##(2013-1#3)
tunnel placement##2##2##(2008-4#1)(2013-7#1)
tunnel release##12##2##(2006-3#2)(2006-4#1)(2008-5#1)(2008-9#6)(2010-9#1)(2011-1#1)
tunnel surface area##2##3##(2013-1#2)
tunnel surface##3##2##(2013-1#3)
tunnel syndrome in##4##3##(1996-2#1)(2007-10#1)(2007-8#1)(2012-12#1)
tunnel syndrome is##4##3##(2006-3#1)(2008-12#1)(2009-9#1)(2012-2#1)
tunnel syndrome##52##2##(1991-8#2)(1994-11#1)(1996-12#1)(1996-2#1)(1997-6#1)(2006-3#3)(2006-4#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-8#3)(2008-12#6)(2008-5#2)(2008-8#1)(2008-9#15)(2009-9#3)(2010-8#2)(2012-12#1)(2012-2#4)(2013-1#1)
tunnel##176##1##(1990-7#1)(1991-11#1)(1991-12#1)(1991-8#2)(1994-11#3)(1995-1#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-6#1)(2005-12#3)(2006-10#1)(2006-3#6)(2006-4#3)(2006-6#2)(2007-10#2)(2007-11#2)(2007-12#5)(2007-5#1)(2007-7#3)(2007-8#5)(2007-9#2)(2008-10#2)(2008-11#2)(2008-12#8)(2008-2#1)(2008-3#8)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#35)(2009-10#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#4)(2010-4#2)(2010-5#3)(2010-8#2)(2010-9#4)(2011-1#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#9)(2012-2#5)(2013-1#14)(2013-7#4)
tunneled and cuffed hemodialysis catheters##2##5##(2007-7#2)
tunneled central venous##2##3##(2007-7#2)
tunneled in##2##2##(2007-7#1)(2011-2#1)
tunneled##13##1##(2007-7#10)(2007-8#1)(2011-1#1)(2011-2#1)
tunneling and##2##2##(1996-5#1)(2007-12#1)
tunneling barrier##2##2##(2007-12#2)
tunneling cantilevers##2##2##(2008-3#2)
tunneling effect##3##2##(2008-1#1)(2008-3#2)
tunneling in##3##2##(1990-8#1)(1995-11#1)(1995-2#1)
tunneling is##4##2##(2007-12#1)(2007-7#1)(2008-2#2)
tunneling microscope (STM)##4##3##(1990-4#1)(1992-2#1)(2008-8#1)(2010-7#1)
tunneling microscope was used to##2##5##(1996-5#1)(2008-8#1)
tunneling microscope##18##2##(1990-11#1)(1990-4#1)(1991-11#2)(1991-5#1)(1992-1#2)(1992-2#1)(1996-5#1)(2007-11#1)(2007-12#4)(2008-3#1)(2008-8#2)(2010-7#1)
tunneling microscopy (STM)##2##3##(2006-12#2)
tunneling microscopy##14##2##(1990-12#1)(1990-4#1)(1991-11#1)(1991-3#1)(1992-5#1)(1993-8#1)(1995-2#1)(2005-11#1)(2006-12#2)(2007-12#1)(2007-9#2)(2008-2#1)
tunneling of##2##2##(2007-12#1)(2012-1#1)
tunneling pathway##3##2##(1991-5#1)(1995-2#2)
tunneling spectroscopy##4##2##(1993-8#1)(2010-7#3)
tunneling through##3##2##(1992-11#1)(2008-3#1)(2009-3#1)
tunneling##105##1##(1990-11#1)(1990-12#1)(1990-4#2)(1990-7#1)(1990-8#2)(1991-11#3)(1991-12#1)(1991-3#1)(1991-5#3)(1992-1#2)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-10#1)(1995-11#2)(1995-2#4)(1996-5#2)(2005-11#1)(2006-10#1)(2006-12#2)(2007-11#3)(2007-12#15)(2007-3#1)(2007-7#2)(2007-9#4)(2008-1#1)(2008-10#1)(2008-2#6)(2008-3#12)(2008-8#2)(2009-3#1)(2009-9#3)(2010-4#3)(2010-7#5)(2011-2#1)(2012-1#1)(2013-1#2)
tunnelled catheters##2##2##(2006-6#2)
tunnelled##8##1##(2006-6#4)(2007-7#4)
tunnelling process##2##2##(2006-7#1)(2008-7#1)
tunnelling##7##1##(2005-4#1)(2006-7#2)(2007-7#1)(2008-7#2)(2012-2#1)
tunnels and##2##2##(2008-6#1)(2012-1#1)
tunnels per stalk in the gelatin capsule technique##2##8##(2011-2#2)
tunnels per stalk##5##3##(2011-2#5)
tunnels that##2##2##(2007-2#1)(2008-9#1)
tunnels##30##1##(2007-2#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-10#7)(2010-4#1)(2011-2#7)(2012-1#1)(2012-12#5)(2013-1#3)(2013-7#1)
tup1##3##1##(1990-4#2)(1995-4#1)
tuple-loading##2##1##(2009-9#2)
turanose and##2##2##(1992-12#1)(2009-6#1)
turanose##3##1##(1992-12#2)(2009-6#1)
turbid biological tissues##2##3##(2008-2#1)(2008-3#1)
turbid biological##5##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
turbid coastal and inland waters##2##5##(2008-3#2)
turbid coastal waters##3##3##(2008-3#3)
turbid coastal##5##2##(2008-3#5)
turbid material##2##2##(2008-2#1)(2008-3#1)
turbid media are also##2##4##(2007-12#1)(2008-2#1)
turbid media are##5##3##(2007-12#1)(2008-2#2)(2008-3#1)(2011-2#1)
turbid media by use of a##2##6##(2007-12#1)(2008-3#1)
turbid media by use of##8##5##(2007-12#2)(2008-2#2)(2008-3#4)
turbid media by##13##3##(2007-11#1)(2007-12#3)(2008-2#4)(2008-3#5)
turbid media in a##2##4##(2007-12#1)(2008-3#1)
turbid media in##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
turbid media is##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
turbid media on a microscopic level##2##6##(2008-3#2)
turbid media over a##2##4##(2007-12#1)(2008-3#1)
turbid media that##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
turbid media to##2##3##(2008-2#1)(2008-3#1)
turbid media using##4##3##(1994-2#1)(1997-6#1)(2011-1#2)
turbid media were##3##3##(2008-2#1)(2008-3#2)
turbid media with a##2##4##(2008-3#2)
turbid media with##6##3##(2007-12#1)(2008-2#1)(2008-3#4)
turbid media##107##2##(1994-2#1)(1997-6#1)(2007-11#7)(2007-12#23)(2008-2#29)(2008-3#41)(2009-10#1)(2011-1#3)(2011-2#1)
turbid medium are##2##3##(2008-2#1)(2008-3#1)
turbid medium such as##3##4##(2008-3#3)
turbid medium with##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
turbid medium##53##2##(2007-11#3)(2007-12#15)(2008-2#18)(2008-3#17)
turbid samples##6##2##(2008-2#1)(2008-3#5)
turbid slab##2##2##(2008-2#2)
turbid suspensions with##2##3##(2008-3#1)(2011-2#1)
turbid suspensions##4##2##(2008-2#1)(2008-3#2)(2011-2#1)
turbid water##3##2##(2008-2#3)
turbid waters##2##2##(2008-3#2)
turbid##210##1##(1990-2#1)(1994-2#1)(1994-3#1)(1995-2#1)(1997-6#1)(2007-11#12)(2007-12#42)(2008-10#1)(2008-2#61)(2008-3#80)(2008-6#1)(2009-10#1)(2009-4#1)(2010-8#1)(2011-1#3)(2011-2#2)
turbidimetric determination of##2##3##(2008-10#2)
turbidimetric##6##1##(1990-11#1)(1993-12#1)(2008-10#3)(2008-12#1)
turbidimetry##3##1##(1995-2#1)(2004-9#1)(2005-11#1)
turbidity and emulsifying##2##3##(2013-8#2)
turbidity and##8##2##(1990-11#1)(1990-7#1)(2008-2#1)(2008-3#1)(2010-5#1)(2011-2#1)(2013-8#2)
turbidity as a function of##2##5##(1993-9#1)(1995-8#1)
turbidity as##3##2##(1993-9#1)(1995-8#1)(2005-11#1)
turbidity changes##2##2##(1990-2#1)(2009-9#1)
turbidity increase of##2##3##(2005-11#1)(2008-6#1)
turbidity is##2##2##(2007-5#1)(2008-2#1)
turbidity measurements##4##2##(2005-11#3)(2008-2#1)
turbidity of the##5##3##(1990-12#1)(2005-11#1)(2008-10#3)
turbidity of##6##2##(1990-12#1)(2005-11#1)(2008-10#3)(2009-9#1)
turbidity test##4##2##(2006-2#4)
turbidity zone of##2##3##(2013-8#2)
turbidity##69##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-7#2)(1993-9#1)(1994-3#1)(1995-8#1)(1997-1#1)(1997-4#1)(2005-11#7)(2006-2#4)(2007-5#6)(2008-1#1)(2008-10#10)(2008-2#6)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#2)(2009-9#4)(2010-5#1)(2010-8#2)(2011-2#2)(2012-11#1)(2012-12#1)(2013-7#1)(2013-8#4)
turbimetric##2##1##(2009-9#2)
turbinate and##2##2##(1995-5#1)(2008-5#1)
turbinate in##3##2##(2008-5#3)
turbinate region##2##2##(2008-11#1)(2013-1#1)
turbinate##12##1##(1995-5#1)(2008-11#1)(2008-4#1)(2008-5#6)(2008-7#1)(2012-1#1)(2013-1#1)
turbine##9##1##(1992-2#2)(2007-12#1)(2008-1#1)(2008-2#1)(2008-5#2)(2008-6#2)
turbo##6##1##(2006-3#1)(2007-5#1)(2007-9#1)(2008-2#1)(2011-2#2)
turbogenerators in##2##2##(2008-2#2)
turbogenerators##3##1##(2008-2#3)
turbolence##2##1##(2007-7#2)
turbostratic##3##1##(1993-4#3)
turbot (Scophthalmus maximus)##3##3##(2010-5#1)(2012-2#2)
turbot Psetta maxima red blood cells##2##6##(2010-8#2)
turbot Psetta maxima##3##3##(2010-8#3)
turbot##12##1##(1996-11#2)(2010-5#5)(2010-8#3)(2012-2#2)
turbulence and##11##2##(2005-6#1)(2008-2#3)(2008-3#6)(2012-2#1)
turbulence are##4##2##(2008-2#1)(2008-3#3)
turbulence at altitudes##2##3##(2007-12#1)(2008-2#1)
turbulence by##3##2##(2007-12#1)(2008-3#2)
turbulence can be##2##3##(2008-3#1)(2008-8#1)
turbulence effects##2##2##(2007-11#1)(2008-3#1)
turbulence in the##4##3##(1993-8#1)(2008-3#3)
turbulence in##5##2##(1993-8#1)(2008-3#3)(2009-6#1)
turbulence is##7##2##(2007-12#3)(2008-2#2)(2008-3#2)
turbulence of##2##2##(1993-3#1)(2008-3#1)
turbulence on##6##2##(2008-3#6)
turbulence outer scale##4##3##(2008-2#2)(2008-3#2)
turbulence parameters##2##2##(2008-3#2)
turbulence promoter##2##2##(2008-7#2)
turbulence spectrum##3##2##(2008-2#3)
turbulence to##2##2##(1995-10#1)(2007-11#1)
turbulence was##2##2##(2008-3#2)
turbulence we##2##2##(2007-12#1)(2008-2#1)
turbulence were##2##2##(2008-2#2)
turbulence with##3##2##(2007-12#1)(2008-3#2)
turbulence##143##1##(1990-7#1)(1991-12#2)(1992-1#1)(1992-11#1)(1992-8#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1995-10#1)(1995-5#1)(2005-6#1)(2007-11#4)(2007-12#14)(2007-2#1)(2008-1#1)(2008-12#1)(2008-2#29)(2008-3#68)(2008-5#1)(2008-7#2)(2008-8#2)(2009-6#2)(2011-2#1)(2012-2#2)(2013-1#1)
turbulence-induced index of refraction fluctuations##2##5##(2008-3#2)
turbulence-induced phase distortions##3##3##(2008-2#1)(2008-3#2)
turbulence-induced phase##5##2##(2008-2#3)(2008-3#2)
turbulence-induced##11##1##(2008-2#4)(2008-3#7)
turbulent and##4##2##(2008-2#2)(2008-9#1)(2011-2#1)
turbulent atmosphere is##2##3##(2008-2#1)(2008-3#1)
turbulent atmosphere##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
turbulent conditions##3##2##(2007-12#1)(2008-2#1)(2008-7#1)
turbulent diffusion is too##2##4##(2008-8#2)
turbulent diffusion##3##2##(2008-8#3)
turbulent flames##3##2##(2007-12#2)(2008-3#1)
turbulent flow fields##2##3##(1994-11#1)(2008-2#1)
turbulent flow##6##2##(1994-11#1)(2008-2#3)(2008-3#1)(2008-9#1)
turbulent flows and##2##3##(1992-1#1)(2008-3#1)
turbulent flows##6##2##(1992-1#1)(2008-2#1)(2008-3#3)(2008-9#1)
turbulent media##2##2##(2008-2#1)(2009-2#1)
turbulent mixing##2##2##(1994-5#1)(2013-1#1)
turbulent patterns##3##2##(2008-3#3)
turbulent##77##1##(1992-1#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-11#2)(1994-12#1)(1994-5#2)(1995-5#1)(1997-6#1)(2007-11#2)(2007-12#7)(2007-8#1)(2007-9#1)(2008-11#1)(2008-2#19)(2008-3#23)(2008-7#1)(2008-8#4)(2008-9#3)(2009-2#1)(2009-4#1)(2011-2#1)(2013-1#1)
turcica##13##1##(1991-6#1)(2008-10#11)(2013-1#1)
turcicum race 1##4##3##(2008-10#4)
turcicum##10##1##(2008-10#10)
turcicum)##2##1##(2008-10#2)
turf battles##2##2##(1993-5#1)(1995-1#1)
turf grass##2##2##(2008-10#2)
turf on##2##2##(2008-10#1)(2013-1#1)
turf##26##1##(1993-5#1)(1995-1#1)(1995-7#1)(2007-3#1)(2008-10#13)(2008-11#2)(2011-12#3)(2011-2#1)(2013-1#3)
turfgrass##8##1##(2008-10#6)(2011-12#2)
turfgrasses##4##1##(2008-10#4)
turgidiscabies##5##1##(2008-10#5)
turgidum no##2##2##(2008-10#2)
turgidum sp##3##2##(2008-10#3)
turgidum subsp##4##2##(2012-3#4)
turgidum##13##1##(2008-10#5)(2008-5#2)(2008-8#1)(2012-3#5)
turgidum)##2##1##(2008-10#2)
turgor##4##1##(2008-2#1)(2009-6#1)(2013-1#2)
turkestani##3##1##(2008-12#3)
turkey GH cDNA##2##3##(1990-12#2)
turkey GH##6##2##(1990-12#6)
turkey adrenocortical cell##2##3##(1993-3#2)
turkey and##2##2##(2010-4#1)(2011-1#1)
turkey breeder hens##2##3##(2008-5#2)
turkey embryos##5##2##(2004-11#1)(2008-5#4)
turkey growth hormone##2##3##(1990-12#2)
turkey hens##2##2##(2013-1#2)
turkey herpesvirus##5##2##(2013-8#5)
turkey muscle##5##2##(2010-4#5)
turkey poults and##2##3##(1997-6#1)(2008-5#1)
turkey poults##14##2##(1997-6#3)(2005-9#2)(2008-5#9)
turkey rhinotracheitis virus (TRTV)##4##4##(1997-6#1)(2008-5#3)
turkey rhinotracheitis virus##6##3##(1997-6#1)(2008-5#5)
turkey rhinotracheitis##7##2##(1997-6#1)(2008-5#6)
turkey toms##2##2##(2013-1#2)
turkey##73##1##(1990-12#8)(1990-2#1)(1991-2#1)(1992-6#1)(1993-3#2)(1996-3#1)(1997-6#6)(2004-11#3)(2005-9#2)(2007-8#1)(2008-5#26)(2010-4#7)(2011-1#2)(2012-2#2)(2013-1#4)(2013-8#6)
turkeys and##2##2##(2008-5#1)(2011-1#1)
turkeys by##2##2##(2004-11#1)(2008-5#1)
turkeys caused by##2##3##(2004-11#1)(2013-8#1)
turkeys in##3##2##(1997-6#2)(2013-1#1)
turkeys##38##1##(1992-10#1)(1997-6#3)(2004-11#3)(2005-9#1)(2007-6#1)(2007-8#3)(2008-5#6)(2011-1#1)(2013-1#10)(2013-8#9)
turkmenica##3##1##(2011-2#3)
turmeric and##2##2##(1992-9#1)(2012-3#1)
turmeric feeding on brain##2##4##(1994-8#2)
turmeric##13##1##(1992-9#2)(1994-8#7)(2008-11#1)(2008-4#1)(2010-12#1)(2012-3#1)
turmoil##2##1##(1991-3#1)(1994-10#1)
turn a##3##2##(2007-11#1)(2009-12#1)(2011-1#1)
turn about##2##2##(2007-12#1)(2008-3#1)
turn ahead##2##2##(2007-12#2)
turn and##2##2##(1995-5#1)(2011-12#1)
turn around##2##2##(2008-1#1)(2011-2#1)
turn back##2##2##(2008-3#1)(2008-8#1)
turn conformations##2##2##(1992-7#1)(1993-6#1)
turn containing Cys-34##2##3##(1994-5#2)
turn for##2##2##(1994-10#1)(1994-12#1)
turn in this##2##3##(1993-6#1)(2013-1#1)
turn in##5##2##(1993-6#1)(1995-5#1)(2008-1#1)(2012-12#1)(2013-1#1)
turn into##2##2##(2005-10#1)(2008-11#1)
turn is##14##2##(1990-12#1)(1990-6#1)(1994-12#1)(1994-5#1)(1996-4#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-4#2)(2010-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
turn leads to##8##3##(1996-2#1)(2007-11#1)(2007-9#1)(2008-12#1)(2008-5#2)(2008-8#1)(2010-12#1)
turn leads##9##2##(1996-2#1)(1996-6#1)(2007-11#1)(2007-9#1)(2008-12#1)(2008-5#2)(2008-8#1)(2010-12#1)
turn malignant##2##2##(2007-4#1)(2007-7#1)
turn of events##2##3##(2007-8#1)(2012-2#1)
turn of the century##7##4##(1997-3#1)(2006-10#1)(2006-6#1)(2007-4#1)(2008-5#2)(2013-7#1)
turn of the##14##3##(1990-12#1)(1997-3#2)(2006-10#2)(2006-6#1)(2007-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#1)(2013-7#1)
turn of##21##2##(1990-12#1)(1991-1#1)(1995-6#1)(1997-3#3)(2006-10#2)(2006-6#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
turn off##4##2##(1995-2#1)(1995-6#1)(2006-10#1)(2007-12#1)
turn on the##2##3##(1992-6#1)(2008-5#1)
turn on##4##2##(1992-6#1)(2008-5#1)(2012-12#1)(2012-2#1)
turn our##3##2##(2006-12#1)(2007-6#1)(2010-12#1)
turn out to be##7##4##(1996-12#1)(2006-12#1)(2008-10#1)(2009-5#1)(2013-1#2)(2013-8#1)
turn out to##8##3##(1996-12#1)(1997-8#1)(2006-12#1)(2008-10#1)(2009-5#1)(2013-1#2)(2013-8#1)
turn over##4##2##(1993-6#1)(2008-8#1)(2011-2#1)(2012-2#1)
turn region##3##2##(1993-6#2)(1994-9#1)
turn secondary##2##2##(1994-5#1)(2006-10#1)
turn the##6##2##(2006-9#1)(2007-10#1)(2007-9#1)(2008-8#1)(2009-7#1)(2012-1#1)
turn this##2##2##(1994-3#1)(2011-2#1)
turn to the##3##3##(1992-3#1)(2008-9#1)(2009-10#1)
turn to##14##2##(1992-12#1)(1992-3#1)(1992-8#1)(1994-10#1)(1996-2#1)(2004-9#1)(2008-10#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-3#1)(2013-7#1)
turn to?##2##2##(1996-3#1)(2011-1#1)
turn with##2##2##(1993-3#1)(2006-10#1)
turn your##2##2##(1994-12#1)(1995-2#1)
turn##523##1##(1990-11#3)(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#3)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#8)(1993-7#1)(1993-8#1)(1994-1#2)(1994-10#2)(1994-11#3)(1994-12#9)(1994-2#3)(1994-3#4)(1994-5#5)(1994-9#5)(1995-1#3)(1995-10#1)(1995-12#6)(1995-2#6)(1995-3#6)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#3)(1996-1#2)(1996-12#4)(1996-2#3)(1996-3#4)(1996-4#4)(1996-5#2)(1996-6#2)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#5)(1997-7#1)(1997-8#1)(2004-11#1)(2004-9#2)(2005-10#1)(2005-11#4)(2005-12#1)(2005-5#1)(2005-7#2)(2005-8#2)(2006-10#13)(2006-11#1)(2006-12#3)(2006-2#5)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#2)(2006-9#2)(2007-10#4)(2007-11#9)(2007-12#15)(2007-3#3)(2007-4#4)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#3)(2007-9#4)(2008-1#9)(2008-10#24)(2008-11#11)(2008-12#8)(2008-2#8)(2008-3#9)(2008-4#8)(2008-5#15)(2008-6#3)(2008-7#10)(2008-8#18)(2008-9#10)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#4)(2009-3#1)(2009-4#4)(2009-5#4)(2009-6#1)(2009-7#4)(2009-8#3)(2009-9#3)(2010-1#2)(2010-10#4)(2010-11#2)(2010-12#7)(2010-2#6)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#2)(2010-9#1)(2011-1#8)(2011-11#1)(2011-12#1)(2011-2#7)(2012-1#9)(2012-12#11)(2012-2#12)(2012-3#4)(2013-1#12)(2013-7#5)(2013-8#5)
turn-around time and##2##3##(1996-8#1)(2012-12#1)
turn-around time##3##2##(1996-6#1)(1996-8#1)(2012-12#1)
turn-like##3##1##(1995-10#1)(1996-7#2)
turn-on##2##1##(2007-12#1)(2010-4#1)
turn-over of##2##2##(1993-6#1)(2006-4#1)
turn-over##3##1##(1993-6#1)(2006-3#1)(2006-4#1)
turn-taking##3##1##(2012-2#3)
turnaroud time##2##2##(2013-1#2)
turnaround time (TAT)##2##3##(2010-6#1)(2011-2#1)
turnaround time##8##2##(1992-2#1)(1996-3#1)(2008-1#1)(2008-10#2)(2009-11#1)(2010-6#1)(2011-2#1)
turnaround times##2##2##(2007-4#1)(2012-12#1)
turnaround##16##1##(1990-5#1)(1992-2#1)(1994-9#1)(1996-3#1)(2007-4#1)(2008-1#1)(2008-10#2)(2009-11#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#1)
turned a##2##2##(1993-2#1)(1996-9#1)
turned by the##2##3##(1993-2#1)(2008-8#1)
turned down a##2##3##(1996-5#1)(2007-9#1)
turned down##4##2##(1994-7#1)(1996-5#1)(2007-9#1)(2008-7#1)
turned into##9##2##(1992-12#1)(1993-3#1)(1995-6#1)(1997-1#1)(2007-9#1)(2008-4#1)(2008-5#1)(2009-3#1)(2013-7#1)
turned off##5##2##(1992-1#1)(1995-8#1)(2008-11#1)(2010-4#1)(2011-12#1)
turned on and##2##3##(1990-10#1)(1991-11#1)
turned on by##2##3##(1996-5#1)(2008-7#1)
turned on##8##2##(1990-10#1)(1991-11#1)(1994-12#1)(1996-5#1)(2006-8#1)(2008-10#2)(2008-7#1)
turned out to be a case of##2##7##(2007-7#1)(2012-2#1)
turned out to be a very##2##6##(1991-5#1)(2008-11#1)
turned out to be a##9##5##(1991-5#1)(1992-4#1)(1994-3#1)(1997-6#1)(2007-11#1)(2007-7#1)(2008-11#1)(2011-1#1)(2012-2#1)
turned out to be an##2##5##(2009-9#1)(2012-2#1)
turned out to be highly##2##5##(2007-11#1)(2011-2#1)
turned out to be identical to##3##6##(1992-12#1)(1995-6#1)(1997-8#1)
turned out to be##46##4##(1990-3#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-5#2)(1992-12#1)(1992-4#1)(1993-3#2)(1993-5#1)(1994-3#1)(1995-6#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-9#1)(2007-11#2)(2007-7#3)(2007-9#2)(2008-10#3)(2008-11#2)(2008-2#3)(2009-9#1)(2010-12#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#3)
turned out to have##4##4##(1991-3#1)(2006-8#2)(2008-10#1)
turned out to##53##3##(1990-3#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#2)(1992-12#1)(1992-4#1)(1993-3#2)(1993-5#1)(1994-3#1)(1995-6#1)(1996-3#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-8#1)(2004-9#1)(2006-8#2)(2007-11#2)(2007-7#3)(2007-9#3)(2008-10#4)(2008-11#2)(2008-2#3)(2008-5#1)(2009-9#1)(2010-12#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#3)
turned out##62##2##(1990-3#2)(1990-5#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#2)(1992-12#1)(1992-4#1)(1993-3#2)(1993-5#1)(1994-3#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-6#2)(1997-8#1)(2004-9#1)(2006-8#3)(2007-11#2)(2007-7#3)(2007-8#1)(2007-9#3)(2008-10#4)(2008-11#2)(2008-2#3)(2008-5#1)(2009-9#1)(2010-12#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#3)
turned over##4##2##(1994-3#1)(2008-11#1)(2010-3#1)(2013-1#1)
turned to the##3##3##(1995-12#1)(1996-1#1)(2006-5#1)
turned to##13##2##(1991-8#1)(1993-11#1)(1995-12#1)(1996-1#1)(1996-12#1)(2006-5#1)(2008-11#2)(2008-12#1)(2008-5#1)(2009-12#1)(2009-5#1)(2010-1#1)
turned##125##1##(1990-10#1)(1990-11#1)(1990-3#2)(1990-5#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-8#2)(1992-1#1)(1992-12#2)(1992-4#1)(1993-11#1)(1993-2#2)(1993-3#3)(1993-5#1)(1994-12#1)(1994-3#3)(1994-7#1)(1995-1#1)(1995-12#1)(1995-6#2)(1995-8#1)(1996-1#2)(1996-12#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#2)(1997-8#1)(2004-9#1)(2006-5#1)(2006-8#4)(2007-11#3)(2007-3#1)(2007-7#3)(2007-8#2)(2007-9#5)(2008-1#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-2#4)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#3)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#4)(2013-1#4)(2013-7#1)
turner##3##1##(2008-6#1)(2009-12#2)
turning behaviour##4##2##(1993-4#1)(1995-12#2)(1997-2#1)
turning direction##3##2##(2012-12#3)
turning directions##2##2##(2012-12#2)
turning into##7##2##(1997-4#1)(2007-12#2)(2008-1#1)(2008-9#3)
turning movement##2##2##(1993-3#2)
turning off##2##2##(1996-5#1)(2012-11#1)
turning on##2##2##(1992-4#1)(2013-7#1)
turning point in##3##3##(2008-2#1)(2009-10#1)(2012-1#1)
turning point of##2##3##(1995-7#1)(2008-2#1)
turning point##16##2##(1993-1#3)(1995-7#1)(1997-6#1)(2006-8#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#3)(2009-10#1)(2009-2#1)(2009-7#1)(2012-1#1)
turning speed##2##2##(1991-5#1)(2008-10#1)
turning the##5##2##(2007-11#2)(2010-11#1)(2011-1#1)(2012-11#1)
turning to the##2##3##(2010-12#1)(2011-1#1)
turning to##10##2##(1991-4#1)(1993-3#1)(1996-1#1)(2005-11#1)(2008-11#1)(2008-4#1)(2009-11#1)(2009-9#1)(2010-12#1)(2011-1#1)
turning##83##1##(1990-4#1)(1991-4#1)(1991-5#2)(1992-4#1)(1993-1#3)(1993-11#1)(1993-3#3)(1993-4#1)(1995-1#1)(1995-12#3)(1995-6#1)(1995-7#1)(1996-1#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-11#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-3#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#3)(2008-4#1)(2008-9#5)(2009-10#2)(2009-11#1)(2009-2#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-11#3)(2012-12#6)(2012-3#1)(2013-7#2)
turnings as##2##2##(2007-8#1)(2008-10#1)
turnings##6##1##(2007-8#2)(2008-10#4)
turnip mosaic potyvirus##2##3##(2008-10#2)
turnip mosaic##5##2##(2008-10#5)
turnip yellow mosaic virus RNA by##2##6##(1990-2#1)(1992-9#1)
turnip yellow mosaic virus RNA##3##5##(1990-2#1)(1992-9#2)
turnip yellow mosaic virus##5##4##(1990-2#1)(1992-9#2)(1997-3#2)
turnip##20##1##(1990-2#1)(1990-4#1)(1992-9#2)(1996-9#1)(1997-3#3)(2008-10#10)(2009-8#2)
turnkey operation##2##2##(2007-12#1)(2007-9#1)
turnkey##3##1##(2007-12#1)(2007-9#1)(2008-10#1)
turnoff time##3##2##(1995-1#3)
turnoff##4##1##(1991-5#1)(1995-1#3)
turnout##2##1##(1996-12#1)(2008-3#1)
turnover and protein kinase##2##4##(1992-4#1)(1994-3#1)
turnover and regional attrition among physiotherapists in##2##7##(1994-3#2)
turnover and regional attrition##4##4##(1994-3#4)
turnover and##31##2##(1991-11#1)(1991-12#1)(1991-5#1)(1991-8#2)(1992-12#1)(1992-4#1)(1993-3#1)(1994-3#5)(1995-1#2)(1995-12#1)(1997-7#1)(2006-10#1)(2006-11#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-6#1)(2009-5#1)(2009-6#1)(2009-9#1)(2011-1#1)(2011-2#3)
turnover are##2##2##(1993-6#1)(2008-7#1)
turnover as well as##2##4##(1994-12#1)(1997-6#1)
turnover as##3##2##(1994-12#1)(1997-6#1)(2004-11#1)
turnover at##2##2##(1990-5#1)(1997-7#1)
turnover by##2##2##(1995-6#1)(2008-1#1)
turnover do not##2##3##(1996-1#1)(2010-8#1)
turnover during the##2##3##(1993-11#1)(2006-10#1)
turnover during##4##2##(1993-11#1)(1995-6#1)(2006-10#1)(2008-4#1)
turnover for##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
turnover in cells##2##3##(1996-11#1)(2013-1#1)
turnover in liver##2##3##(1992-4#1)(2012-12#1)
turnover in male##2##3##(1994-10#1)(1997-2#1)
turnover in rat##2##3##(1990-10#1)(1991-11#1)
turnover in the CNS##2##4##(1992-10#1)(2007-11#1)
turnover in the hippocampus##2##4##(1990-11#1)(1992-10#1)
turnover in the olfactory organ of##2##6##(2007-12#2)
turnover in the##18##3##(1990-11#1)(1990-12#2)(1991-9#1)(1992-10#2)(1992-11#1)(1993-9#1)(1994-10#2)(1995-3#1)(1997-5#1)(2005-3#1)(2007-11#1)(2007-12#2)(2008-10#1)(2013-1#1)
turnover in vivo##2##3##(1994-10#1)(2008-11#1)
turnover in##58##2##(1990-10#1)(1990-11#1)(1990-12#3)(1991-10#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-9#3)(1992-10#2)(1992-11#1)(1992-4#3)(1992-5#2)(1992-7#1)(1992-9#1)(1993-9#4)(1994-10#4)(1994-12#3)(1994-3#1)(1994-8#2)(1995-3#1)(1996-11#1)(1997-2#2)(1997-5#1)(1997-6#1)(2005-3#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-7#1)(2010-11#1)(2012-12#1)(2013-1#5)
turnover is extremely##2##3##(1995-9#1)(2008-10#1)
turnover is##11##2##(1991-5#1)(1992-5#1)(1994-12#1)(1995-12#1)(1995-9#1)(1996-2#1)(1996-9#1)(2007-2#1)(2008-10#1)(2011-1#1)(2012-2#1)
turnover markers in##5##3##(2006-10#4)(2013-8#1)
turnover markers##11##2##(2006-10#5)(2010-10#1)(2011-2#1)(2013-1#2)(2013-8#2)
turnover may##2##2##(1994-8#1)(2006-10#1)
turnover number and##2##3##(1991-11#1)(1991-4#1)
turnover number##8##2##(1990-7#2)(1991-11#1)(1991-4#1)(1994-9#2)(1995-8#1)(1996-5#1)
turnover of DA in##2##4##(1993-2#1)(1994-10#1)
turnover of DA##3##3##(1993-2#2)(1994-10#1)
turnover of the LDL receptor##2##5##(1990-7#2)
turnover of the##13##3##(1990-7#2)(1990-8#1)(1992-1#1)(1992-3#1)(1993-8#1)(1994-2#1)(1995-10#1)(1996-4#1)(1996-7#1)(2005-8#1)(2008-10#1)(2008-4#1)
turnover of##60##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-7#3)(1990-8#1)(1991-1#1)(1991-5#1)(1992-1#2)(1992-12#1)(1992-3#2)(1993-11#1)(1993-2#3)(1993-3#1)(1993-8#3)(1993-9#1)(1994-10#2)(1994-2#1)(1994-3#1)(1995-10#1)(1995-3#2)(1996-2#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#3)(2005-7#1)(2005-8#1)(2006-12#1)(2006-8#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-4#2)(2008-9#1)(2009-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
turnover or##3##2##(1992-1#1)(1997-2#1)(2006-10#1)
turnover rate and##2##3##(1995-3#1)(2008-12#1)
turnover rate in##2##3##(1991-2#1)(1994-10#1)
turnover rate of the##2##4##(1991-4#2)
turnover rate of##9##3##(1991-4#2)(1994-10#2)(1995-3#1)(1996-3#2)(1996-4#1)(2008-5#1)
turnover rate was##2##3##(1990-7#1)(2008-5#1)
turnover rate##25##2##(1990-7#1)(1991-2#1)(1991-4#2)(1994-10#3)(1995-11#1)(1995-3#4)(1996-3#2)(1996-4#1)(1996-7#1)(2008-12#1)(2008-5#5)(2008-9#1)(2009-4#1)(2009-5#1)
turnover rates and discrimination values##2##5##(2013-1#2)
turnover rates and##4##3##(2008-10#1)(2013-1#3)
turnover rates of##3##3##(1994-10#1)(2004-11#1)(2013-1#1)
turnover rates were##4##3##(1994-10#1)(1997-3#1)(2007-5#2)
turnover rates##19##2##(1990-11#1)(1990-3#1)(1991-2#1)(1991-9#1)(1994-10#2)(1995-3#1)(1997-3#1)(2004-11#1)(2006-10#1)(2007-5#4)(2008-10#1)(2013-1#4)
turnover reactions##3##2##(1994-9#3)
turnover time##2##2##(1994-12#1)(2006-10#1)
turnover to##2##2##(2013-1#2)
turnover was##2##2##(1996-6#1)(2008-10#1)
turnover were##2##2##(1990-12#1)(1995-12#1)
turnover with##2##2##(1995-12#1)(2008-4#1)
turnover##391##1##(1990-10#4)(1990-11#2)(1990-12#9)(1990-2#3)(1990-3#2)(1990-5#2)(1990-7#6)(1990-8#1)(1990-9#1)(1991-1#4)(1991-10#4)(1991-11#4)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#3)(1991-5#4)(1991-6#1)(1991-8#4)(1991-9#4)(1992-1#4)(1992-10#3)(1992-11#2)(1992-12#3)(1992-3#5)(1992-4#6)(1992-5#5)(1992-6#4)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#6)(1993-2#6)(1993-3#2)(1993-6#4)(1993-8#3)(1993-9#7)(1994-10#12)(1994-11#3)(1994-12#8)(1994-2#1)(1994-3#8)(1994-5#1)(1994-8#4)(1994-9#7)(1995-1#4)(1995-10#2)(1995-11#3)(1995-12#6)(1995-3#10)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#3)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#10)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#4)(2004-11#3)(2005-10#1)(2005-3#1)(2005-7#1)(2005-8#1)(2006-10#12)(2006-11#2)(2006-12#1)(2006-6#1)(2006-8#2)(2007-11#2)(2007-12#5)(2007-2#1)(2007-4#1)(2007-5#4)(2007-8#3)(2008-1#3)(2008-10#10)(2008-11#6)(2008-12#1)(2008-3#4)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#9)(2008-8#2)(2008-9#5)(2009-10#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#16)(2013-7#3)(2013-8#3)
turnover)##4##1##(1991-1#1)(1995-10#1)(1997-5#1)(2008-8#1)
turnovers##2##1##(2006-4#2)
turns and the##2##3##(2006-10#1)(2008-10#1)
turns and##7##2##(1991-4#1)(1995-12#3)(2006-10#1)(2008-10#2)
turns on##2##2##(2007-11#1)(2008-2#1)
turns out that the##3##4##(2007-5#1)(2008-11#1)(2013-8#1)
turns out that##10##3##(1990-12#1)(1997-1#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#3)(2012-2#1)(2013-8#1)
turns out to be a##5##5##(2008-2#1)(2008-3#1)(2008-5#1)(2012-2#2)
turns out to be very##2##5##(2005-11#1)(2008-9#1)
turns out to be##16##4##(2005-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)(2012-2#3)
turns out to##19##3##(2005-11#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)(2012-12#1)(2012-2#3)
turns out##29##2##(1990-12#1)(1997-1#1)(2005-11#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)(2012-12#1)(2012-2#4)(2013-8#1)
turns over##3##2##(1995-1#1)(1997-4#1)(1997-7#1)
turns to##6##2##(1991-4#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-8#1)(2011-1#1)
turns with##2##2##(1993-11#1)(2011-12#1)
turns##82##1##(1990-11#1)(1990-12#1)(1991-4#3)(1993-11#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-6#1)(1994-12#1)(1994-9#1)(1995-1#2)(1995-12#7)(1995-7#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-12#2)(2007-11#2)(2007-12#2)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-2#7)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-5#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-12#5)(2012-2#5)(2013-8#1)
turns/beat length)##2##2##(2007-12#2)
turns/m##4##1##(2007-12#4)
turpentine##5##1##(1991-7#1)(1991-9#1)(1994-8#1)(2006-12#2)
turpentine-induced##2##1##(1990-2#1)(1992-12#1)
turtle nesting##2##2##(2007-5#2)
turtle olfactory##2##2##(1994-5#2)
turtle species##2##2##(2008-8#1)(2011-2#1)
turtle##26##1##(1994-5#2)(1995-3#4)(1996-6#1)(2007-2#3)(2007-3#2)(2007-5#4)(2008-8#2)(2010-3#2)(2011-2#2)(2012-12#1)(2013-1#3)
turtles and##3##2##(2013-1#3)
turtles##16##1##(2007-2#3)(2008-4#3)(2008-5#2)(2009-4#3)(2013-1#5)
tussilaginis##2##1##(2008-10#2)
tutelage of mothers and children##2##5##(2009-4#2)
tutor role##3##2##(2008-11#3)
tutor##9##1##(1994-12#1)(2008-11#6)(2008-12#2)
tutor-less##2##1##(2012-1#2)
tutored##3##1##(2005-10#2)(2006-12#1)
tutorial performance##2##2##(2006-12#2)
tutorial support##7##2##(2008-11#7)
tutorial##32##1##(1992-2#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-2#2)(2005-10#1)(2006-12#3)(2008-10#1)(2008-11#7)(2008-12#4)(2009-10#1)(2009-2#1)(2009-9#2)(2012-11#1)(2012-12#2)(2013-8#1)
tutorials in##2##2##(2010-3#2)
tutorials##8##1##(1991-3#1)(2005-10#1)(2006-12#1)(2008-11#1)(2008-7#1)(2010-3#2)(2013-8#1)
tutoring##10##1##(1994-2#1)(2005-10#9)
tutors and##3##2##(2006-12#1)(2008-11#1)(2013-1#1)
tutors to##2##2##(2008-12#2)
tutors##9##1##(2006-12#1)(2008-10#1)(2008-11#2)(2008-12#4)(2013-1#1)
tweaking the##2##2##(2007-8#1)(2008-6#1)
tweezer experiments##2##2##(2008-5#1)(2009-12#1)
tweezer##4##1##(2007-11#1)(2008-5#1)(2009-12#2)
tweezer-type dithiocarbamoyl##2##2##(2008-10#2)
tweezer-type##5##1##(2008-10#5)
tweezers have##2##2##(2007-11#1)(2011-12#1)
tweezers to##3##2##(2007-11#1)(2009-12#1)(2012-2#1)
tweezers##38##1##(1991-11#1)(1994-6#1)(2006-12#5)(2006-9#4)(2007-11#11)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-8#1)(2009-12#4)(2009-5#2)(2011-12#2)(2012-2#1)
twelfth thoracic##2##2##(2007-4#1)(2008-6#1)
twelfth week##2##2##(2007-11#2)
twelfth##8##1##(1991-6#1)(2007-11#2)(2007-4#1)(2008-10#1)(2008-6#1)(2011-2#2)
twelve and##2##2##(1992-3#1)(2008-9#1)
twelve benzodiazepines##2##2##(1996-6#2)
twelve days after##2##3##(1995-12#1)(2007-8#1)
twelve days##4##2##(1995-12#2)(2007-8#1)(2008-12#1)
twelve different##4##2##(1992-7#1)(1994-8#1)(1995-2#1)(1997-3#1)
twelve hours after the##2##4##(2009-5#1)(2009-8#1)
twelve hours##5##2##(1993-12#1)(2009-5#1)(2009-8#1)(2011-1#1)(2012-1#1)
twelve month##2##2##(2006-8#1)(2007-11#1)
twelve months of##2##3##(2006-10#1)(2012-3#1)
twelve months##11##2##(2006-10#1)(2006-4#1)(2006-8#2)(2007-11#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
twelve of##5##2##(1991-10#1)(1991-7#1)(1993-12#1)(1996-10#1)(1996-6#1)
twelve patients are##2##3##(2007-7#1)(2007-8#1)
twelve patients with chronic##3##4##(1990-8#1)(1991-6#1)(2007-7#1)
twelve patients##10##2##(1990-8#1)(1991-6#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-5#1)(2012-2#1)(2013-1#1)
twelve samples##3##2##(2007-1#1)(2008-10#2)
twelve species of##2##3##(2008-8#2)
twelve weeks##2##2##(2008-1#1)(2013-1#1)
twelve years##4##2##(1993-10#1)(1994-6#1)(2010-7#1)(2011-2#1)
twelve##127##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-10#1)(1993-12#3)(1993-2#2)(1993-9#1)(1994-12#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-12#2)(1995-2#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#4)(1997-3#1)(1997-8#2)(2005-10#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-8#4)(2007-1#2)(2007-11#2)(2007-12#1)(2007-3#2)(2007-5#3)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#3)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#5)(2011-3#2)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#3)
twelve-##2##1##(2007-4#2)
twelve-month##6##1##(1993-2#1)(2007-3#2)(2007-7#1)(2013-1#2)
twelve-year-old girl##2##2##(1993-10#1)(1995-12#1)
twelve-year-old##3##1##(1993-10#1)(1995-12#1)(2007-8#1)
twenties##4##1##(2007-2#1)(2008-6#1)(2010-12#1)(2011-1#1)
twentieth anniversary##3##2##(1995-1#2)(2013-1#1)
twentieth centuries##3##2##(2010-1#2)(2013-8#1)
twentieth century##33##2##(2005-7#1)(2006-10#1)(2007-11#2)(2008-10#2)(2008-12#2)(2008-3#1)(2008-7#5)(2008-8#2)(2009-10#1)(2009-2#1)(2009-4#2)(2009-7#2)(2010-1#3)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-8#1)
twentieth##49##1##(1990-2#1)(1992-12#1)(1993-6#1)(1995-1#2)(2005-7#1)(2006-10#1)(2007-11#2)(2008-10#4)(2008-12#2)(2008-3#1)(2008-7#5)(2008-8#2)(2009-10#1)(2009-2#1)(2009-4#2)(2009-7#2)(2010-1#6)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#2)
twentieth-century##8##1##(2008-4#1)(2008-7#3)(2010-1#2)(2010-7#2)
twenty amino##2##2##(1992-5#1)(2008-11#1)
twenty blind duplicates##2##3##(2009-8#2)
twenty eight##3##2##(2007-11#1)(2007-8#1)(2008-4#1)
twenty five##3##2##(2006-5#2)(2008-5#1)
twenty four##4##2##(1993-3#1)(2005-4#1)(2009-2#1)(2013-8#1)
twenty million people##2##3##(2008-9#1)(2012-12#1)
twenty minutes##3##2##(1990-7#1)(2006-4#1)(2013-7#1)
twenty nine##3##2##(2006-8#1)(2011-1#1)(2011-2#1)
twenty of##2##2##(1991-2#1)(2009-10#1)
twenty patients##4##2##(1990-11#1)(2006-8#1)(2007-7#1)(2012-2#1)
twenty seven##2##2##(1992-10#1)(2007-7#1)
twenty six##6##2##(2005-4#2)(2007-1#1)(2009-5#1)(2011-2#1)(2013-8#1)
twenty three##2##2##(2006-10#1)(2012-2#1)
twenty times##2##2##(2005-7#1)(2008-7#1)
twenty two##3##2##(1997-7#1)(2008-2#1)(2009-11#1)
twenty year##2##2##(2007-2#1)(2007-7#1)
twenty years ago##2##3##(1993-12#1)(2011-2#1)
twenty years of##3##3##(1997-6#1)(2007-8#1)(2012-12#1)
twenty years##21##2##(1990-12#1)(1990-5#1)(1991-3#1)(1992-1#1)(1992-4#1)(1993-12#1)(1995-12#1)(1996-2#1)(1997-6#1)(2005-11#1)(2006-1#1)(2007-8#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-11#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
twenty##119##1##(1990-10#1)(1990-11#3)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#2)(1992-1#2)(1992-10#1)(1992-4#1)(1992-5#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-12#1)(1995-9#2)(1996-2#2)(1997-3#1)(1997-6#2)(1997-7#1)(2005-11#1)(2005-4#3)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-8#4)(2007-1#4)(2007-11#1)(2007-12#1)(2007-2#3)(2007-3#1)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#3)(2009-6#1)(2009-8#2)(2010-11#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#4)
twenty-eight##5##1##(1996-6#1)(2009-8#2)(2011-1#1)(2012-11#1)
twenty-first century in##2##3##(2011-1#1)(2013-1#1)
twenty-first century##17##2##(1994-2#1)(1995-2#1)(1996-12#2)(1997-1#3)(1997-3#1)(2005-11#1)(2006-7#3)(2008-12#1)(2009-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
twenty-five patients##2##2##(2007-11#1)(2008-7#1)
twenty-five years##4##2##(1990-3#1)(2004-1#1)(2007-1#1)(2008-1#1)
twenty-five##11##1##(1990-3#1)(1993-2#1)(2004-1#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-12#1)
twenty-four hours of incubation##2##4##(1993-12#2)
twenty-four hours of##3##3##(1993-12#2)(2007-8#1)
twenty-four hours##5##2##(1990-5#1)(1993-12#2)(2007-8#1)(2008-9#1)
twenty-four months##2##2##(1990-3#1)(2008-8#1)
twenty-four##17##1##(1990-3#1)(1990-5#1)(1993-12#2)(1996-6#1)(2006-11#1)(2006-4#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2010-4#1)
twenty-nine##4##1##(1993-12#1)(1995-12#1)(2006-2#1)(2011-1#1)
twenty-one patients##2##2##(1990-10#1)(1991-5#1)
twenty-one women##2##2##(1996-1#1)(1996-12#1)
twenty-one##11##1##(1990-10#1)(1991-2#1)(1991-5#1)(1993-12#1)(1996-1#1)(1996-12#1)(2007-1#1)(2007-12#1)(2007-7#1)(2008-1#1)(2010-4#1)
twenty-seven patients##2##2##(1990-12#1)(2009-9#1)
twenty-seven##7##1##(1990-12#1)(1996-8#1)(2004-12#1)(2006-9#1)(2008-10#1)(2009-9#1)(2012-2#1)
twenty-six##11##1##(1991-12#1)(1992-11#1)(1997-2#1)(2004-10#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-3#1)
twenty-three patients##2##2##(1991-12#1)(2008-6#1)
twenty-three##5##1##(1990-9#1)(1991-12#1)(2007-10#1)(2008-6#1)(2010-8#1)
twenty-two##7##1##(1996-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-10#1)
twice a day for eight##3##5##(1996-12#1)(2013-1#2)
twice a day for##6##4##(1995-12#1)(1996-12#1)(2006-10#1)(2008-5#1)(2013-1#2)
twice a day##25##3##(1990-2#1)(1990-8#1)(1991-7#2)(1993-1#1)(1995-12#1)(1995-2#2)(1996-12#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-5#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
twice a day)##6##3##(2007-10#2)(2008-5#3)(2010-6#1)
twice a multiple of the laser's effective cavity length##2##9##(2008-2#2)
twice a week for 4 weeks##2##6##(2008-10#1)(2012-1#1)
twice a week for##10##4##(1990-3#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2010-1#1)(2012-1#1)(2012-12#1)
twice a week##17##3##(1990-11#1)(1990-3#1)(1991-9#1)(1994-2#1)(2006-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-1#1)(2012-1#1)(2012-12#1)(2013-1#2)
twice a year##3##3##(1994-9#1)(2007-8#1)(2013-8#1)
twice a##55##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-7#2)(1991-9#1)(1993-1#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#2)(1996-12#1)(1997-8#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-5#6)(2008-6#1)(2008-9#1)(2009-6#1)(2010-1#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#2)
twice after##2##2##(2006-10#1)(2007-10#1)
twice ambient CO(2) (650 microl l(-1)) plus##2##7##(2004-4#2)
twice ambient O(3) (2 x##2##5##(2004-4#2)
twice ambient##4##2##(2004-4#4)
twice and##5##2##(1994-1#1)(1995-11#1)(2008-12#2)(2010-3#1)
twice as effective as##2##4##(2008-5#1)(2008-6#1)
twice as great as##2##4##(1995-12#1)(2012-2#1)
twice as great##4##3##(1995-12#1)(2008-4#1)(2010-5#1)(2012-2#1)
twice as high as in the##2##6##(2008-11#2)
twice as high as that##2##5##(1997-3#1)(2008-11#1)
twice as high as##6##4##(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#3)
twice as high in the##2##5##(1992-10#1)(1993-4#1)
twice as high in##5##4##(1992-10#1)(1992-7#1)(1993-4#1)(2010-12#1)(2013-1#1)
twice as high##15##3##(1992-10#1)(1992-7#1)(1993-4#1)(1997-3#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-11#4)(2010-12#1)(2012-2#1)(2013-1#1)
twice as large as the##3##5##(1992-3#1)(1993-1#1)(2006-12#1)
twice as large as##4##4##(1992-3#1)(1993-1#1)(2006-12#1)(2008-2#1)
twice as large##7##3##(1991-8#2)(1992-3#1)(1993-1#1)(2006-12#1)(2008-2#1)(2008-6#1)
twice as likely to be##3##5##(2008-11#1)(2010-11#1)(2011-12#1)
twice as likely to have##2##5##(2008-1#1)(2011-2#1)
twice as likely to##8##4##(1996-9#1)(2008-1#1)(2008-11#1)(2010-11#1)(2011-12#1)(2011-2#2)(2013-1#1)
twice as likely##10##3##(1996-9#1)(2006-5#1)(2008-1#1)(2008-11#2)(2010-11#1)(2011-12#1)(2011-2#2)(2013-1#1)
twice as long as##3##4##(1991-2#1)(2007-12#1)(2009-3#1)
twice as long##4##3##(1991-2#1)(2007-12#1)(2008-11#1)(2009-3#1)
twice as many##9##3##(1993-1#1)(1994-6#1)(1997-6#1)(2006-8#1)(2008-10#2)(2008-12#1)(2009-11#1)(2013-1#1)
twice as much as##2##4##(1991-2#1)(1994-2#1)
twice as much##5##3##(1991-2#1)(1994-2#1)(1997-6#1)(2006-11#1)(2008-12#1)
twice as potent as##2##4##(1993-3#1)(2005-8#1)
twice as##74##2##(1990-10#1)(1991-2#2)(1991-8#2)(1992-10#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-1#2)(1993-3#2)(1993-4#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-12#1)(1996-9#1)(1997-3#1)(1997-6#2)(2005-11#1)(2005-12#1)(2005-8#1)(2006-11#1)(2006-12#1)(2006-5#2)(2006-8#1)(2007-12#3)(2008-1#1)(2008-10#8)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-11#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-12#1)(2011-2#3)(2012-2#2)(2013-1#3)(2013-8#1)
twice before##3##2##(2007-11#1)(2008-7#1)(2011-2#1)
twice by##2##2##(1996-12#1)(1997-8#1)
twice daily and##6##3##(1992-3#1)(1997-4#2)(2005-7#1)(2007-10#1)(2007-8#1)
twice daily during##2##3##(1990-8#1)(2008-3#1)
twice daily for 2##2##4##(1994-2#1)(2008-5#1)
twice daily for 3 months##2##5##(2008-5#2)
twice daily for 3##4##4##(1996-1#1)(2008-10#1)(2008-5#2)
twice daily for three##2##4##(2008-5#1)(2009-8#1)
twice daily for##20##3##(1993-11#1)(1994-2#1)(1995-12#1)(1996-1#2)(1997-4#1)(2006-10#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#4)(2009-4#1)(2009-5#1)(2009-8#1)(2010-8#1)
twice daily in##3##3##(1996-1#1)(2006-5#1)(2008-3#1)
twice daily on postoperative days 2 through 4##2##8##(2012-2#2)
twice daily on##3##3##(2009-8#1)(2012-2#2)
twice daily was##4##3##(1991-12#1)(1996-1#1)(2009-8#1)(2010-8#1)
twice daily##87##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-4#1)(1992-3#1)(1993-11#1)(1994-10#1)(1994-2#1)(1995-12#1)(1996-1#4)(1996-11#3)(1996-12#1)(1996-2#2)(1997-1#1)(1997-4#3)(1997-8#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-2#1)(2006-5#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#2)(2007-7#2)(2007-8#4)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#7)(2008-6#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#4)(2010-8#5)(2010-9#1)(2011-1#1)(2011-12#2)(2012-2#4)(2013-7#1)
twice daily)##4##2##(1992-8#1)(1993-12#1)(1993-7#1)(1996-2#1)
twice during the##2##3##(2007-5#2)
twice during##4##2##(2007-5#2)(2009-9#1)(2011-2#1)
twice from##3##2##(1992-7#1)(2008-10#1)(2009-4#1)
twice higher##2##2##(1991-7#1)(2008-10#1)
twice in##8##2##(1991-8#1)(1996-7#2)(2007-7#1)(2007-9#1)(2010-8#1)(2011-1#1)(2012-1#1)
twice normal##2##2##(1995-2#1)(1996-5#1)
twice of that##2##3##(2007-12#1)(2007-9#1)
twice or##4##2##(1992-2#1)(1992-3#1)(2006-3#1)(2008-12#1)
twice that in##4##3##(1991-5#1)(1995-12#1)(2008-10#1)(2008-9#1)
twice that of the##4##4##(1992-1#1)(1995-11#1)(2007-12#1)(2008-5#1)
twice that of##11##3##(1992-1#1)(1995-11#1)(1995-3#1)(1997-8#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
twice that##21##2##(1990-3#1)(1991-5#1)(1992-1#1)(1993-9#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-12#3)(2007-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#1)
twice the amount of##2##4##(1993-6#1)(2012-2#1)
twice the amplitude of the##2##5##(2006-8#2)
twice the efficiency and##2##4##(2008-3#1)(2013-7#1)
twice the efficiency##3##3##(2008-2#1)(2008-3#1)(2013-7#1)
twice the frequency##2##3##(2008-3#1)(2012-2#1)
twice the magnitude of##2##4##(2007-11#1)(2008-2#1)
twice the number of##2##4##(1992-8#1)(1993-3#1)
twice the size of##2##4##(1990-10#1)(2007-10#1)
twice the upper limit of##2##5##(1995-10#1)(2008-1#1)
twice the value of the##2##5##(2008-7#1)(2010-4#1)
twice the value##3##3##(2008-10#1)(2008-7#1)(2010-4#1)
twice the##59##2##(1990-10#1)(1990-11#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-10#1)(1995-12#1)(1996-10#1)(1996-12#1)(1997-6#2)(2004-4#1)(2006-8#2)(2007-10#1)(2007-11#4)(2007-12#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#8)(2008-3#8)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-7#2)(2013-8#1)
twice to##2##2##(1992-9#1)(2008-10#1)
twice using##3##2##(2006-5#1)(2008-11#1)(2011-1#1)
twice weekly and##2##3##(1996-4#1)(2008-10#1)
twice weekly for##2##3##(2006-10#1)(2008-10#1)
twice weekly from##2##3##(2008-12#1)(2012-6#1)
twice weekly##10##2##(1992-12#1)(1996-4#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2012-6#1)
twice with##5##2##(1993-2#1)(1997-2#1)(2006-5#1)(2007-12#1)(2008-10#1)
twice within##5##2##(1990-7#1)(1992-10#1)(1996-6#1)(2007-12#1)(2009-4#1)
twice##433##1##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#2)(1990-7#2)(1990-8#2)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-7#3)(1991-8#3)(1991-9#1)(1992-1#1)(1992-10#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-7#2)(1992-8#3)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-12#2)(1994-2#4)(1994-6#1)(1994-7#2)(1994-8#1)(1994-9#3)(1995-10#1)(1995-11#2)(1995-12#5)(1995-2#3)(1995-3#2)(1995-5#1)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#4)(1996-12#5)(1996-2#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-6#4)(1997-8#5)(2004-2#1)(2004-4#5)(2004-9#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#8)(2006-6#3)(2006-7#1)(2006-8#5)(2007-1#2)(2007-10#7)(2007-11#11)(2007-12#14)(2007-3#2)(2007-5#2)(2007-6#1)(2007-7#7)(2007-8#9)(2007-9#3)(2008-1#2)(2008-10#28)(2008-11#13)(2008-12#7)(2008-2#13)(2008-3#12)(2008-4#1)(2008-5#22)(2008-6#7)(2008-7#6)(2008-8#2)(2008-9#3)(2009-11#2)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#7)(2010-9#2)(2011-1#4)(2011-12#3)(2011-2#12)(2012-1#3)(2012-12#2)(2012-2#12)(2012-3#1)(2012-6#1)(2013-1#12)(2013-7#3)(2013-8#6)
twice-daily injections of##2##3##(1997-2#1)(2006-5#1)
twice-daily##14##1##(1991-12#1)(1997-2#1)(1997-5#1)(2006-5#1)(2008-3#1)(2008-5#2)(2009-3#1)(2010-8#4)(2011-2#2)
twice-weekly##3##1##(1992-8#1)(1997-6#1)(2008-10#1)
twig lesions##4##2##(2008-10#4)
twig##13##1##(2008-10#9)(2008-9#2)(2012-5#2)
twigs formed during the experimental period##2##6##(2012-5#2)
twigs##7##1##(2007-6#1)(2008-10#1)(2010-12#1)(2012-5#4)
twilight polarization##2##2##(2008-2#2)
twilight##5##1##(2008-10#1)(2008-2#4)
twill##2##1##(2007-11#1)(2008-3#1)
twin and##2##2##(1993-1#1)(2009-6#1)
twin beams##8##2##(2007-11#3)(2007-12#3)(2008-1#2)
twin birth##2##2##(1990-6#1)(2004-10#1)
twin births##5##2##(1990-6#3)(1995-6#1)(2004-10#1)
twin block##2##2##(2012-2#1)(2013-1#1)
twin brothers##2##2##(1990-12#1)(2012-3#1)
twin gestation##5##2##(1995-6#1)(2009-6#2)(2013-1#2)
twin gestations##5##2##(1992-12#3)(2012-3#2)
twin had##2##2##(2008-9#1)(2011-12#1)
twin is##3##2##(2004-10#2)(2012-2#1)
twin pairs reported significantly closer relationships than##2##7##(1997-5#2)
twin pairs##15##2##(1993-9#3)(1994-2#1)(1996-8#1)(1997-5#7)(2008-12#1)(2008-7#2)
twin pairs)##2##2##(1997-5#2)
twin pregnancies##8##2##(1992-12#4)(1993-1#1)(2007-11#2)(2010-8#1)
twin pregnancy with##2##3##(2004-10#1)(2010-8#1)
twin pregnancy##10##2##(2004-10#3)(2007-11#2)(2007-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
twin relationship##2##2##(1997-5#2)
twin studies##6##2##(1997-5#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-12#1)(2012-12#1)
twin study##2##2##(2008-12#1)(2009-12#1)
twin was##4##2##(1992-12#2)(2011-12#2)
twin##157##1##(1990-12#1)(1990-6#4)(1991-3#1)(1992-12#10)(1993-1#5)(1993-9#5)(1994-10#1)(1994-2#3)(1995-1#1)(1995-6#2)(1996-12#2)(1996-3#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#12)(2004-10#10)(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#3)(2006-4#1)(2007-11#9)(2007-12#4)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#1)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#1)(2008-7#3)(2008-9#5)(2009-12#1)(2009-5#2)(2009-6#3)(2010-1#1)(2010-12#3)(2010-8#3)(2011-1#7)(2011-12#5)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#1)
twin-cavity narrow-band interference##2##3##(2008-2#2)
twin-cavity##3##1##(2008-2#3)
twin-conformer model##2##2##(1995-6#2)
twin-conformer##3##1##(1995-6#3)
twin-core fiber##2##2##(2007-12#1)(2008-2#1)
twin-core##5##1##(2007-11#1)(2007-12#3)(2008-2#1)
twin-hole fiber##2##2##(2007-11#1)(2007-12#1)
twin-image##3##1##(2007-12#2)(2008-3#1)
twin-photon##3##1##(2007-11#3)
twin-reporter vector##2##2##(1991-7#2)
twin-ridge laterally coupled diode##2##4##(2007-11#2)
twin-ridge##3##1##(2007-11#3)
twin-twin transfusion syndrome##2##3##(2004-10#1)(2011-8#1)
twinned aragonite##2##2##(2008-7#2)
twinned##3##1##(2008-7#2)(2010-8#1)
twinning on##2##2##(2008-7#1)(2012-2#1)
twinning##19##1##(1996-3#1)(2005-7#1)(2006-2#2)(2008-11#1)(2008-7#3)(2011-12#2)(2012-2#3)(2013-1#6)
twins and##8##2##(1991-2#1)(1996-12#1)(1997-7#2)(1997-8#1)(2007-11#1)(2010-1#1)(2011-2#1)
twins are##2##2##(2011-12#1)(2012-2#1)
twins delivered at##2##3##(1995-6#1)(2010-8#1)
twins discordant for##2##3##(1996-8#1)(2008-6#1)
twins in a##3##3##(2004-10#1)(2013-1#2)
twins in##12##2##(1992-12#1)(2004-10#1)(2006-4#1)(2008-10#1)(2008-12#3)(2010-2#1)(2010-8#2)(2013-1#2)
twins is##2##2##(2011-1#1)(2011-12#1)
twins were##5##2##(1992-12#1)(2004-10#1)(2007-8#1)(2008-11#1)(2011-2#1)
twins who##2##2##(2008-12#1)(2011-1#1)
twins with##3##2##(2007-12#1)(2008-11#1)(2011-2#1)
twins##106##1##(1990-6#1)(1991-2#1)(1992-12#4)(1993-1#1)(1993-2#1)(1993-8#1)(1993-9#4)(1995-6#3)(1996-12#1)(1996-8#2)(1997-7#5)(1997-8#1)(2004-10#3)(2006-4#1)(2007-11#1)(2007-12#2)(2007-8#4)(2008-10#2)(2008-11#5)(2008-12#6)(2008-3#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-5#1)(2009-7#2)(2009-9#3)(2010-1#5)(2010-10#1)(2010-12#1)(2010-2#3)(2010-7#2)(2010-8#6)(2011-1#4)(2011-12#3)(2011-2#6)(2012-2#7)(2012-3#1)(2013-1#4)
twins'##2##1##(2008-9#1)(2010-7#1)
twist in##5##2##(1991-2#1)(2007-12#1)(2008-12#1)(2009-4#1)(2012-2#1)
twist of the##2##3##(1993-3#1)(2008-3#1)
twist of##3##2##(1993-3#1)(2007-9#1)(2008-3#1)
twist rate##4##2##(2007-12#2)(2008-2#2)
twist##38##1##(1990-8#1)(1991-2#1)(1993-3#1)(1994-9#1)(1995-1#1)(1997-5#1)(2007-11#1)(2007-12#6)(2007-4#1)(2007-9#1)(2008-12#1)(2008-2#3)(2008-3#5)(2008-7#1)(2009-4#7)(2011-2#2)(2012-2#2)(2013-7#2)
twisted at a rate of 8 turns/m##2##7##(2007-12#2)
twisted fiber##2##2##(2007-12#2)
twisted nematic liquid##2##3##(2008-2#2)
twisted nematic liquid-crystal##2##3##(2008-2#2)
twisted nematic##9##2##(2007-12#2)(2008-2#6)(2008-3#1)
twisted peptide##2##2##(1993-11#1)(1995-8#1)
twisted##35##1##(1990-9#2)(1992-4#1)(1993-11#2)(1994-8#1)(1995-8#1)(1997-7#1)(2007-11#4)(2007-12#9)(2008-2#7)(2008-3#1)(2008-7#2)(2008-8#2)(2010-9#1)(2011-12#1)
twisted-nematic liquid-crystal##4##2##(2007-12#2)(2008-2#2)
twisting and##2##2##(1995-1#1)(2007-12#1)
twisting cytometry##2##2##(2008-7#2)
twisting of the##2##3##(2007-12#1)(2012-2#1)
twisting##12##1##(1995-1#1)(2006-8#1)(2007-12#2)(2007-4#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#2)(2012-2#2)
twists and##2##2##(1995-1#1)(2008-3#1)
twists##19##1##(1995-1#2)(1995-10#1)(1997-5#2)(2007-1#1)(2007-10#1)(2007-8#10)(2008-10#1)(2008-3#1)
twitch and##2##2##(1993-11#1)(2008-3#1)
twitch contraction##3##2##(1990-2#1)(2013-8#2)
twitch forces to##2##3##(2012-7#2)
twitch muscles##2##2##(1993-12#2)
twitch responses##4##2##(1990-11#1)(1990-5#2)(1993-11#1)
twitch##23##1##(1990-11#1)(1990-2#1)(1990-5#2)(1991-11#1)(1993-11#4)(1993-12#2)(1994-10#1)(1994-9#1)(1996-12#2)(1997-4#1)(2008-12#1)(2008-3#1)(2012-7#2)(2013-8#3)
twitch-matching##2##1##(1993-11#2)
twitches##4##1##(1993-11#1)(1996-9#2)(1997-4#1)
twitchin##3##1##(1994-8#3)
twitching of##2##2##(1991-5#1)(2006-4#1)
twitching##5##1##(1990-5#1)(1991-5#1)(2006-4#1)(2009-9#1)(2011-12#1)
two &quot##8##2##(1993-2#1)(1995-3#1)(1996-9#1)(1997-6#1)(2007-8#1)(2008-10#2)(2008-5#1)
two (0##2##2##(2007-8#1)(2008-9#1)
two (1##3##2##(2007-2#1)(2007-8#2)
two (15##2##2##(2008-1#1)(2010-4#1)
two (3##4##2##(2008-3#1)(2008-6#1)(2012-3#2)
two (5##2##2##(2010-4#1)(2011-2#1)
two (5%)##2##2##(2006-10#1)(2012-2#1)
two -##3##2##(1996-7#1)(2007-6#2)
two 10-min##3##2##(1993-5#1)(1994-2#1)(1997-8#1)
two 2##2##2##(1990-4#1)(2008-10#1)
two 3##2##2##(1990-7#1)(2008-9#1)
two 4##2##2##(1996-5#1)(2008-3#1)
two 5'##2##2##(1994-2#1)(2008-9#1)
two 50##2##2##(1992-11#1)(2008-10#1)
two 500 mg/kg##2##3##(2008-9#2)
two 6##2##2##(1991-9#1)(2009-3#1)
two 6-month##2##2##(2006-3#1)(2012-3#1)
two 7-hydroxyisoellipticine derivatives##2##3##(1991-2#2)
two A##3##2##(1996-8#1)(1997-5#1)(2008-10#1)
two ATP-binding motifs##3##3##(1996-2#3)
two ATP-binding##5##2##(1990-10#1)(1995-9#1)(1996-2#3)
two Arabidopsis thaliana cDNAs##2##4##(1997-6#2)
two Arabidopsis##3##2##(1997-6#2)(2006-12#1)
two Assistant Consultant##2##3##(2008-1#2)
two Australian##2##2##(2008-10#1)(2013-8#1)
two B##2##2##(2008-10#1)(2008-12#1)
two BDNF##2##2##(1997-2#1)(2013-1#1)
two C##3##2##(1992-2#2)(2004-7#1)
two C-terminal amino acid residues##2##5##(1992-8#2)
two C-terminal##3##2##(1992-8#2)(1995-8#1)
two CCAAT##3##2##(1994-9#2)(2008-9#1)
two CO(2)##3##2##(2008-10#2)(2008-3#1)
two Ca(2+)-binding##2##2##(1992-6#1)(1994-8#1)
two Ca2+ release##2##3##(1993-6#1)(1995-3#1)
two Ca2+##5##2##(1993-6#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-3#1)
two Chinese##2##2##(1992-2#1)(2012-2#1)
two DNA fragments##2##3##(1996-11#1)(2010-12#1)
two DNA probes##2##3##(2007-8#1)(2008-10#1)
two DNA##9##2##(1991-10#1)(1991-6#1)(1993-8#1)(1994-12#1)(1996-11#1)(2006-12#1)(2007-8#1)(2008-10#1)(2010-12#1)
two DNA-binding proteins##2##3##(1992-12#1)(1994-2#1)
two DNA-binding##3##2##(1990-10#1)(1992-12#1)(1994-2#1)
two Danish porcelain factories##2##4##(1994-6#2)
two Danish##3##2##(1994-6#2)(1997-5#1)
two Drosophila##3##2##(1990-12#1)(2008-9#2)
two Dutch##2##2##(2008-10#2)
two EIA##2##2##(2007-12#2)
two Egyptian##3##2##(1994-11#2)(2011-2#1)
two European##3##2##(2008-10#1)(2008-7#1)(2012-12#1)
two FDA##2##2##(2012-12#2)
two G##3##2##(1991-8#1)(1993-6#1)(1994-12#1)
two G-protein coupled##2##3##(2009-3#1)(2012-2#1)
two GO-signatures##4##2##(2013-1#4)
two Gaussian##2##2##(2008-10#1)(2008-2#1)
two Gram##2##2##(2012-12#2)
two H(2)O molecules##2##3##(2008-8#2)
two H3 variants##2##3##(1996-4#1)(1997-1#1)
two HSA##2##2##(1992-8#1)(2008-10#1)
two Health##2##2##(2008-1#1)(2008-9#1)
two His residues##2##3##(2008-3#1)(2008-8#1)
two His##3##2##(1993-11#1)(2008-3#1)(2008-8#1)
two Indian species##2##3##(2007-1#2)
two Indian##4##2##(2007-1#2)(2007-7#1)(2013-8#1)
two Italian##4##2##(2008-10#2)(2012-5#2)
two Japanese##2##2##(1996-5#1)(2013-8#1)
two Km values##2##3##(1992-11#1)(1992-3#1)
two LEDs##2##2##(2008-10#2)
two Lys residues##2##3##(1990-10#1)(1996-5#1)
two MP##2##2##(1991-8#1)(2013-1#1)
two Mg2+##2##2##(1994-12#1)(1995-6#1)
two N-linked glycosylation sites##2##4##(1992-12#1)(1992-9#1)
two N-linked##4##2##(1991-3#1)(1992-12#1)(1992-9#1)(2008-11#1)
two N-terminal##3##2##(1993-3#1)(1994-10#1)(1995-10#1)
two N-terminally##2##2##(1994-8#2)
two NIST##2##2##(2008-10#2)
two NO donors##2##3##(1992-11#1)(1995-5#1)
two Nd##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
two North##2##2##(2010-10#1)(2010-4#1)
two ORFs##4##2##(1991-9#1)(1994-12#1)(1997-3#1)(1997-4#1)
two P##2##2##(2008-10#2)
two PC##2##2##(2008-10#1)(2010-8#1)
two PCR##3##2##(2006-8#1)(2008-10#1)(2008-5#1)
two PSV isolates##2##3##(2012-11#2)
two QTL##3##2##(2008-10#2)(2012-3#1)
two QTLs for##3##3##(2008-8#2)(2012-11#1)
two QTLs##4##2##(2008-10#1)(2008-8#2)(2012-11#1)
two Quercus species##2##3##(2012-5#2)
two RNA##6##2##(1996-4#1)(2006-12#1)(2008-10#1)(2008-4#2)(2013-1#1)
two RNAs##3##2##(1995-10#1)(1996-5#1)(2008-8#1)
two RYR##2##2##(1994-9#2)
two S##6##2##(1995-1#1)(2006-10#1)(2008-10#4)
two SH2 domains##2##3##(1993-6#2)
two SNPs##4##2##(2009-4#1)(2012-3#3)
two Southern##2##2##(2010-4#1)(2010-8#1)
two Sp1 binding domains##2##4##(1995-3#2)
two Spanish##2##2##(2008-10#1)(2010-4#1)
two Ssh7##2##2##(2008-9#2)
two States##5##2##(1992-3#3)(1996-1#1)(1996-11#1)
two Swedish##2##2##(1994-2#1)(2006-8#1)
two T##4##2##(1990-7#1)(1991-6#1)(2008-10#1)(2008-11#1)
two Ti##2##2##(2008-3#2)
two Trp residues##2##3##(1990-5#1)(1997-8#1)
two X chromosomes##2##3##(1995-11#1)(2008-4#1)
two X##3##2##(1995-11#1)(2008-10#1)(2008-4#1)
two X-ray##2##2##(2006-4#1)(2012-2#1)
two Zn2+-native##2##2##(1997-4#2)
two absorbers##2##2##(2007-12#1)(2008-3#1)
two absorption##2##2##(2008-10#1)(2008-3#1)
two academic##4##2##(2010-2#1)(2010-7#1)(2013-1#2)
two accessible##2##2##(1994-12#1)(1994-5#1)
two accessory bodies##2##3##(2007-12#2)
two acid##3##2##(1991-1#1)(1991-2#1)(2008-10#1)
two acidic##3##2##(1991-10#1)(1991-12#1)(1991-6#1)
two actin monomers##3##3##(1991-5#3)
two actin##4##2##(1991-5#3)(1996-10#1)
two active proteins##2##3##(1990-11#1)(1990-8#1)
two active site##2##3##(1995-5#1)(1996-12#1)
two active##20##2##(1990-11#1)(1990-8#1)(1991-12#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-5#1)(1996-12#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#4)(2008-5#1)(2011-1#3)
two activities##9##2##(1990-7#1)(1991-10#1)(1991-9#1)(1992-3#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-7#1)(2012-12#1)
two acute##3##2##(1993-2#1)(2011-1#1)(2012-12#1)
two additional##40##2##(1990-4#1)(1990-5#1)(1991-11#1)(1991-2#2)(1991-9#1)(1992-11#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-5#1)(1996-9#1)(1997-5#1)(2005-11#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#1)(2010-7#1)(2010-8#1)(2011-2#1)
two adducts##4##2##(1990-2#2)(1994-8#2)
two adenosine residues##2##3##(1990-6#1)(1997-4#1)
two adenosine##5##2##(1990-4#2)(1990-6#1)(1991-10#1)(1997-4#1)
two adjacent clusters##2##3##(1990-5#1)(1996-5#1)
two adjacent##27##2##(1990-5#3)(1991-2#1)(1991-7#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-3#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-4#1)(2007-12#4)(2007-4#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2010-10#1)(2010-12#1)
two adolescent##2##2##(2010-2#1)(2011-1#1)
two adsorbents##2##2##(2008-10#2)
two adult##9##2##(1990-2#1)(1991-6#1)(1994-2#1)(1996-11#1)(2004-10#1)(2005-2#1)(2008-5#1)(2010-4#1)(2010-7#1)
two adults##2##2##(2011-2#1)(2012-2#1)
two advanced##3##2##(2008-8#1)(2013-1#2)
two affected##4##2##(1990-12#1)(1995-1#1)(1997-5#1)(2008-7#1)
two after##3##2##(1992-1#1)(2006-9#1)(2008-10#1)
two age groups##10##3##(1996-11#2)(1997-4#1)(2006-10#1)(2007-7#2)(2007-8#2)(2008-1#1)(2012-1#1)
two age-matched subgroups of##2##4##(2008-7#1)(2013-1#1)
two age-matched##4##2##(1997-6#1)(2008-7#1)(2008-9#1)(2013-1#1)
two agencies##2##2##(1994-2#1)(1997-2#1)
two agents in##2##3##(2008-10#1)(2008-8#1)
two agents##12##2##(1992-1#1)(1993-4#1)(1994-6#1)(1997-1#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-8#3)(2009-6#2)
two ages##4##2##(1991-11#1)(1991-9#1)(1993-2#1)(2006-12#1)
two agonist##2##2##(1994-11#1)(1995-11#1)
two aims##4##2##(1996-2#1)(2007-12#1)(2008-10#1)(2008-7#1)
two algorithms##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
two aligned##2##2##(2007-12#1)(2008-3#1)
two alleles##12##2##(1990-4#1)(1991-11#1)(1992-5#1)(1993-3#1)(1993-6#2)(1994-9#1)(1995-1#1)(1995-5#1)(2006-2#1)(2008-10#1)(2008-12#1)
two allelic##3##2##(1990-5#1)(1997-1#1)(2008-4#1)
two almond cultivars##2##3##(2008-10#2)
two alpha##5##2##(1990-7#1)(1991-12#1)(1991-2#1)(1995-2#1)(2008-5#1)
two alpha-helical##2##2##(1991-5#1)(1994-8#1)
two alpha-helices##3##2##(1992-9#1)(1994-3#1)(1997-4#1)
two also##3##2##(1996-11#1)(2008-6#1)(2008-7#1)
two alternate protocols are provided##2##5##(2008-2#1)(2008-4#1)
two alternate protocols are##3##4##(2008-2#2)(2008-4#1)
two alternate protocols##9##3##(2008-2#2)(2008-4#5)(2008-9#2)
two alternate##10##2##(2008-10#1)(2008-2#2)(2008-4#5)(2008-9#2)
two alternating##2##2##(1995-5#1)(2008-3#1)
two alternative methods##2##3##(1997-4#1)(2008-3#1)
two alternative pathways##2##3##(1994-12#1)(2006-10#1)
two alternative strategies##2##3##(2007-11#1)(2008-7#1)
two alternative##26##2##(1991-2#1)(1992-9#1)(1993-6#1)(1994-12#2)(1995-12#1)(1997-4#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-5#1)(2010-8#1)(2012-2#1)
two alternatively spliced transcripts##3##4##(1991-9#1)(1994-12#2)
two alternatively spliced##7##3##(1991-9#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-2#1)(1997-7#1)
two alternatives##4##2##(1996-1#1)(2006-2#1)(2012-12#1)(2013-1#1)
two amino acid changes##2##4##(1997-7#1)(2008-10#1)
two amino acid substitutions##4##4##(1992-9#1)(1995-8#1)(2008-10#1)(2010-4#1)
two amino acid##11##3##(1991-8#1)(1992-9#1)(1995-8#1)(1997-7#1)(1997-9#1)(2005-11#1)(2008-10#4)(2010-4#1)
two amino acids at the##2##5##(1991-8#1)(2008-10#1)
two amino acids##15##3##(1990-11#1)(1991-10#2)(1991-11#1)(1991-8#1)(1992-7#1)(1993-11#2)(1995-8#1)(1996-5#1)(2006-3#1)(2007-8#1)(2008-10#2)(2010-12#1)
two amino groups##4##3##(2006-10#2)(2007-11#1)(2008-5#1)
two amino##31##2##(1990-11#1)(1991-10#2)(1991-11#1)(1991-8#2)(1992-7#1)(1992-9#1)(1993-11#2)(1995-8#2)(1996-2#1)(1996-5#1)(1997-7#1)(1997-9#1)(2005-11#1)(2006-10#2)(2006-3#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-5#1)(2010-12#1)(2010-4#1)
two analogs##3##2##(1993-8#1)(1994-11#1)(1995-12#1)
two analyses##4##2##(1995-6#1)(2008-2#1)(2008-7#1)(2008-9#1)
two analytes##5##2##(2008-10#5)
two analytic approaches##2##3##(2005-10#2)
two analytic##4##2##(2005-10#2)(2005-11#1)(2008-3#1)
two analytical##6##2##(2008-10#4)(2010-11#1)(2010-5#1)
two anatomical##2##2##(2007-7#1)(2008-5#1)
two and a half years##2##5##(2007-7#1)(2008-5#1)
two and a half##5##4##(1990-5#1)(2007-1#1)(2007-7#2)(2008-5#1)
two and a##7##3##(1990-5#1)(1997-3#1)(2007-1#1)(2007-7#2)(2007-8#1)(2008-5#1)
two and eight weeks##2##4##(1992-3#1)(2007-7#1)
two and five##3##3##(1993-8#1)(1995-9#1)(2006-8#1)
two and four hours##2##4##(2007-2#2)
two and four##6##3##(1991-6#1)(1992-4#1)(2006-8#1)(2007-2#2)(2008-10#1)
two and half months##2##4##(2012-2#1)(2013-8#1)
two and half##3##3##(2010-5#1)(2012-2#1)(2013-8#1)
two and seven days##2##4##(2008-10#1)(2013-1#1)
two and three##15##3##(1990-7#1)(1992-9#1)(1993-3#1)(2005-4#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-9#1)(2009-10#1)(2009-5#1)(2010-8#1)
two and##55##2##(1990-3#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-6#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-3#1)(1993-8#1)(1995-9#1)(1997-2#1)(1997-3#1)(2005-4#1)(2006-12#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-2#2)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
two angles##3##2##(2006-8#1)(2008-2#2)
two animals were##2##3##(2007-5#1)(2008-5#1)
two animals##6##2##(1996-12#1)(1997-8#1)(2007-5#1)(2007-8#1)(2008-12#1)(2008-5#1)
two anionic##2##2##(1992-9#1)(2008-10#1)
two annual##3##2##(2008-5#2)(2012-3#1)
two ant##2##2##(2007-12#1)(2008-8#1)
two anti-HGL##2##2##(1995-8#2)
two antibiotics)##2##2##(1995-3#2)
two antibodies##6##2##(1991-2#1)(1995-10#1)(1995-6#1)(1996-6#1)(2008-7#2)
two anticoccidial drugs##2##3##(2008-5#2)
two antigenically##2##2##(1991-3#1)(2008-4#1)
two antigens##6##2##(1990-12#1)(1992-8#1)(2008-10#1)(2008-4#2)(2009-8#1)
two antioxidants##4##2##(2008-10#1)(2008-5#1)(2008-9#2)
two apparent##4##2##(1996-8#1)(2008-3#1)(2011-1#1)(2012-2#1)
two appear to##2##3##(1995-2#1)(2008-5#1)
two applications##2##2##(2008-10#1)(2008-3#1)
two approaches are##4##3##(2007-3#1)(2008-9#1)(2010-11#1)(2012-2#1)
two approaches for##2##3##(2008-4#1)(2012-3#1)
two approaches to the##2##4##(2008-7#1)(2011-2#1)
two approaches to##10##3##(1994-2#1)(1995-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-9#1)(2011-2#1)(2012-2#2)
two approaches##34##2##(1994-12#1)(1994-2#1)(1995-2#1)(1996-11#1)(2007-10#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-1#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#5)(2012-3#2)(2013-1#1)
two appropriate oligonucleotide primers##2##4##(2008-2#1)(2008-9#1)
two appropriate##3##2##(2008-2#1)(2008-9#1)(2010-5#1)
two approximate methods##2##3##(2008-3#1)(2008-7#1)
two approximate##3##2##(2007-12#1)(2008-3#1)(2008-7#1)
two approximations##3##2##(1994-8#1)(2008-2#2)
two aqueous##2##2##(2008-10#1)(2011-1#1)
two architectural frameworks##2##3##(2007-12#2)
two are only##2##3##(2011-1#1)(2012-12#1)
two are##17##2##(1990-11#1)(1993-8#1)(1995-11#1)(1995-3#1)(2007-11#2)(2007-3#2)(2008-3#2)(2008-4#1)(2008-8#2)(2009-12#1)(2011-1#1)(2012-12#1)(2012-3#1)
two areas##25##2##(1990-8#1)(1991-11#2)(1994-2#1)(1995-2#1)(1996-2#1)(1997-1#1)(2005-9#1)(2007-10#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-8#1)(2010-6#1)(2013-1#3)(2013-8#1)
two arginine##2##2##(1995-2#1)(1996-7#1)
two arms##13##2##(1992-4#1)(1994-9#1)(2007-12#2)(2008-10#1)(2008-2#5)(2008-3#1)(2010-3#1)(2010-7#1)
two aromatic##3##2##(2004-2#1)(2007-11#1)(2011-10#1)
two articles##3##2##(1994-12#1)(1997-6#1)(2013-8#1)
two artificial##2##2##(1992-3#1)(2008-7#1)
two as##4##2##(1990-11#1)(1995-2#1)(2006-7#1)(2008-5#1)
two asparagine-linked##2##2##(2008-1#1)(2008-8#1)
two aspects of program evaluation##2##5##(1993-12#2)
two aspects of##10##3##(1993-12#2)(1996-7#1)(2007-12#1)(2008-10#2)(2008-11#2)(2012-12#1)(2012-3#1)
two aspects##13##2##(1993-12#2)(1996-5#1)(1996-7#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
two assays##9##2##(1993-11#1)(1994-12#1)(2004-9#1)(2006-7#1)(2008-10#2)(2009-11#1)(2012-1#1)(2012-2#1)
two assessments##2##2##(1991-9#1)(2012-1#1)
two associated##2##2##(1993-9#1)(1994-12#1)
two assumptions##4##2##(2007-9#1)(2008-2#1)(2008-9#1)(2012-2#1)
two asymmetric divisions##2##3##(2007-12#1)(2009-5#1)
two asymmetrically##2##2##(2008-2#1)(2009-2#1)
two at the##2##3##(2013-7#2)
two at##4##2##(1992-12#1)(1995-1#1)(2013-7#2)
two atomic detectors##2##3##(2008-10#2)
two atomic##3##2##(2008-10#3)
two attributes##2##2##(2008-4#1)(2013-1#1)
two atypical isolates##2##3##(2008-10#2)
two atypical##4##2##(1993-9#1)(2007-8#1)(2008-10#2)
two authors##2##2##(2010-2#1)(2013-1#1)
two autoimmune diseases##2##3##(2007-5#1)(2007-7#1)
two automatic##3##2##(2006-2#1)(2008-10#2)
two auxiliary##2##2##(2008-3#2)
two available##4##2##(1991-10#1)(2011-2#1)(2013-1#2)
two avian##3##2##(1993-12#1)(2008-5#1)(2008-9#1)
two axes of##2##3##(2008-10#1)(2008-3#1)
two axes##6##2##(2008-10#1)(2008-3#3)(2010-6#1)(2012-2#1)
two axial##3##2##(1994-3#1)(2007-4#1)(2008-3#1)
two bacteria##4##2##(2005-12#1)(2008-10#2)(2008-8#1)
two bacterial##8##2##(1991-8#1)(1994-11#1)(1994-3#2)(1995-5#2)(2006-5#1)(2008-10#1)
two bands of##5##3##(1991-8#1)(1991-9#1)(1993-12#1)(1994-6#1)(2008-10#1)
two bands were##2##3##(1996-10#1)(2009-8#1)
two bands##15##2##(1991-8#1)(1991-9#1)(1993-11#1)(1993-12#1)(1994-6#1)(1995-12#1)(1995-7#1)(1995-8#1)(1996-10#1)(1997-6#1)(2006-8#2)(2008-10#1)(2008-3#1)(2009-8#1)
two base##3##2##(1992-2#1)(1993-9#1)(2008-10#1)
two baseline##3##2##(2013-1#2)(2013-8#1)
two basic and##2##3##(1990-11#1)(2008-9#1)
two basic methods##2##3##(2006-3#1)(2008-4#1)
two basic protocols##2##3##(2008-4#1)(2008-9#1)
two basic types of##3##4##(2005-10#1)(2008-2#1)(2009-4#1)
two basic##28##2##(1990-11#1)(1991-11#1)(1994-6#2)(1997-2#1)(2005-10#1)(2006-3#1)(2007-11#1)(2007-7#1)(2008-2#3)(2008-3#2)(2008-4#4)(2008-7#1)(2008-9#2)(2009-1#1)(2009-4#1)(2009-9#1)(2010-9#1)(2012-12#1)(2013-1#2)
two batches of##2##3##(1996-8#1)(2013-7#1)
two batches##3##2##(1996-8#1)(2008-11#1)(2013-7#1)
two bays##2##2##(2007-3#1)(2007-5#1)
two beams is##4##3##(2007-12#1)(2008-3#3)
two beams that##2##3##(2007-12#1)(2008-3#1)
two beams with a##2##4##(2007-12#2)
two beams##18##2##(2007-12#7)(2008-2#5)(2008-3#6)
two because of##2##3##(1991-3#1)(2008-6#1)
two behavioral##2##2##(1991-8#1)(1993-3#1)
two being##3##2##(1993-7#1)(1997-4#1)(2013-1#1)
two beta chains##2##3##(1994-9#2)
two beta polypeptides##2##3##(1994-5#2)
two beta##5##2##(1991-7#1)(1994-5#2)(1994-9#2)
two bidentate##2##2##(2008-4#1)(2010-5#1)
two biliverdin-IX##2##2##(1994-9#2)
two binary##4##2##(2007-10#1)(2007-11#1)(2008-3#2)
two bind##2##2##(1995-11#2)
two binding modes##3##3##(1994-8#1)(1995-8#1)(2008-9#1)
two binding sites for##2##4##(1994-8#1)(1995-1#1)
two binding sites with##2##4##(1992-2#1)(1996-5#1)
two binding sites##12##3##(1991-4#1)(1992-12#1)(1992-2#1)(1992-9#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-5#1)(1996-4#1)(1996-5#1)(1996-6#1)(2008-10#1)
two binding##18##2##(1991-4#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-9#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-5#1)(1995-8#2)(1996-4#1)(1996-5#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-9#1)
two binomial probabilities##2##3##(1997-6#2)
two binomial##4##2##(1994-9#1)(1997-6#3)
two biochemically##2##2##(1994-8#1)(2008-9#1)
two biological##5##2##(2008-10#2)(2008-4#1)(2008-5#1)(2011-1#1)
two biomedical##2##2##(2008-7#1)(2010-9#1)
two biotypes##3##2##(1991-7#1)(2008-10#2)
two bipolar##2##2##(2007-12#2)
two birds##2##2##(2011-2#1)(2012-3#1)
two bivariate##2##2##(1995-9#1)(2012-1#1)
two bladder##4##2##(2008-10#3)(2008-4#1)
two blocks##2##2##(1996-3#1)(2007-12#1)
two body image education posters##2##5##(2006-7#2)
two body##4##2##(1996-9#1)(2006-7#2)(2012-2#1)
two boys##3##2##(1996-3#1)(1997-3#1)(2009-2#1)
two brain##2##2##(1996-12#1)(1997-8#1)
two branched##2##2##(1991-7#1)(2007-12#1)
two branches##2##2##(1991-9#1)(2008-3#1)
two brands of##2##3##(1992-2#1)(2013-8#1)
two bridging##3##2##(2007-11#1)(2008-4#1)(2009-2#1)
two broad categories##2##3##(2006-7#1)(2009-12#1)
two broad classes of##2##4##(1996-7#1)(2006-12#1)
two broad##11##2##(1991-8#1)(1994-2#1)(1996-7#1)(2006-12#1)(2006-7#1)(2008-10#1)(2008-12#1)(2009-12#1)(2009-4#1)(2010-10#1)(2010-5#1)
two brothers with##3##3##(1990-1#1)(1996-3#1)(2009-4#1)
two brothers##8##2##(1990-1#1)(1990-6#1)(1996-3#1)(2007-7#1)(2009-4#1)(2009-5#1)(2009-9#1)(2011-2#1)
two by two##3##3##(1996-8#1)(2008-10#1)(2008-2#1)
two by##5##2##(1995-3#1)(1996-8#1)(1997-7#1)(2008-10#1)(2008-2#1)
two cDNA clones##4##3##(1990-8#1)(1993-2#1)(2006-8#1)(2008-11#1)
two cDNAs##8##2##(1993-2#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-10#1)(1997-3#1)(2008-7#2)
two calcium-binding proteins##2##3##(1996-5#1)(1996-9#1)
two calcium-binding##3##2##(1991-7#1)(1996-5#1)(1996-9#1)
two calibrated##2##2##(2008-6#1)(2013-1#1)
two calibration##4##2##(2008-10#3)(2008-2#1)
two can be##3##3##(2008-10#1)(2010-8#1)(2011-2#1)
two can##4##2##(2007-4#1)(2008-10#1)(2010-8#1)(2011-2#1)
two capsules##2##2##(1991-3#1)(2008-5#1)
two captive##3##2##(2007-2#2)(2008-5#1)
two carbon atoms##2##3##(1991-9#1)(1992-6#1)
two carbon##3##2##(1991-9#1)(1992-6#1)(2008-7#1)
two carbons##2##2##(1990-2#1)(2007-8#1)
two carboxyl groups##2##3##(1990-7#1)(2005-12#1)
two carboxyl##3##2##(1990-5#1)(1990-7#1)(2005-12#1)
two carboxylate##2##2##(1996-11#1)(2008-5#1)
two carboxylic##2##2##(1996-5#1)(2008-10#1)
two cardiac##2##2##(2006-12#1)(2008-7#1)
two carriers##4##2##(1992-3#1)(2008-10#1)(2008-11#2)
two cascaded##3##2##(2008-2#1)(2008-3#2)
two case reports and review##2##5##(2008-6#1)(2009-8#1)
two case reports and##4##4##(2006-8#1)(2007-3#1)(2008-6#1)(2009-8#1)
two case reports of##3##4##(1996-3#1)(2008-6#1)(2013-7#1)
two case reports##22##3##(1990-12#1)(1993-1#1)(1993-7#1)(1996-3#1)(2006-10#1)(2006-12#4)(2006-2#1)(2006-8#1)(2007-2#1)(2007-3#1)(2008-11#1)(2008-4#1)(2008-6#2)(2009-8#1)(2010-2#1)(2013-1#1)(2013-7#2)
two case studies of##3##4##(2008-8#1)(2013-1#2)
two case studies presented##2##4##(1995-2#1)(2008-4#1)
two case studies##12##3##(1995-2#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-6#1)(2013-1#3)
two case##41##2##(1990-12#1)(1993-1#1)(1993-12#1)(1993-7#1)(1993-8#1)(1995-2#1)(1996-3#1)(2006-10#2)(2006-12#4)(2006-2#1)(2006-4#1)(2006-8#2)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-6#2)(2008-8#1)(2009-6#1)(2009-8#1)(2010-2#2)(2013-1#6)(2013-7#2)(2013-8#1)
two case-control studies##2##3##(1995-6#1)(2011-2#1)
two casein##2##2##(1994-8#1)(2008-8#1)
two cases and a##4##4##(2006-5#1)(2007-7#1)(2007-8#1)(2008-7#1)
two cases and##21##3##(1992-12#1)(1994-10#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-7#4)(2009-4#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#1)
two cases are presented##3##4##(1990-4#1)(1990-5#1)(2008-5#1)
two cases are reported##2##4##(1991-5#1)(2012-2#1)
two cases are the first##2##5##(2007-8#2)
two cases are the##3##4##(1997-1#1)(2007-8#2)
two cases are##8##3##(1990-4#1)(1990-5#1)(1991-5#1)(1997-1#1)(2007-8#2)(2008-5#1)(2012-2#1)
two cases had##3##3##(2006-3#1)(2008-7#1)(2013-1#1)
two cases in which##4##4##(1996-5#1)(2008-1#1)(2008-10#1)(2011-2#1)
two cases in##5##3##(1995-5#1)(1996-5#1)(2008-1#1)(2008-10#1)(2011-2#1)
two cases of acute##4##4##(2007-2#1)(2008-4#1)(2009-4#2)
two cases of intestinal##2##4##(2006-2#1)(2007-2#1)
two cases of malignant##2##4##(1991-12#1)(1993-6#1)
two cases of patients##2##4##(2006-12#1)(2007-8#1)
two cases of pulmonary##2##4##(1994-6#1)(2007-9#1)
two cases of this entity##2##5##(1990-10#1)(2009-9#1)
two cases of this##4##4##(1990-10#1)(1996-3#1)(1996-9#1)(2009-9#1)
two cases of##138##3##(1990-10#2)(1990-2#1)(1990-5#1)(1991-12#1)(1992-10#2)(1992-3#1)(1992-5#1)(1992-8#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-6#1)(1996-3#3)(1996-6#1)(1996-9#1)(1997-3#1)(1997-6#1)(2005-10#2)(2005-12#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-3#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#3)(2007-3#1)(2007-4#2)(2007-7#2)(2007-8#9)(2007-9#3)(2008-1#4)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#1)(2009-4#3)(2009-6#1)(2009-8#1)(2009-9#4)(2010-10#1)(2010-11#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#8)(2013-7#2)(2013-8#3)
two cases report and##2##4##(2011-2#1)(2012-2#1)
two cases that were##2##4##(1990-10#1)(2009-1#1)
two cases that##5##3##(1990-10#1)(1995-8#1)(2009-1#1)(2013-1#2)
two cases the##4##3##(1993-3#1)(2006-8#1)(2007-11#1)(2008-1#1)
two cases was##3##3##(1993-2#1)(1995-6#1)(1997-3#1)
two cases were##8##3##(1992-1#1)(1997-8#1)(2005-8#1)(2007-2#1)(2007-7#1)(2008-10#1)(2010-2#1)(2010-3#1)
two cases with##11##3##(1992-5#1)(1996-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-6#2)(2010-12#1)(2011-2#1)(2013-1#2)
two cases##353##2##(1990-10#4)(1990-12#4)(1990-2#1)(1990-4#1)(1990-5#2)(1990-8#2)(1991-12#3)(1991-4#1)(1991-5#2)(1991-6#1)(1992-1#1)(1992-10#4)(1992-11#2)(1992-12#1)(1992-3#1)(1992-5#2)(1992-8#2)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#3)(1993-9#1)(1994-10#1)(1994-5#1)(1994-6#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-8#4)(2004-10#1)(2005-10#4)(2005-11#1)(2005-12#2)(2005-2#1)(2005-7#2)(2005-8#3)(2006-10#5)(2006-11#1)(2006-12#7)(2006-2#3)(2006-3#2)(2006-4#2)(2006-5#4)(2006-6#1)(2006-8#5)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#6)(2007-2#8)(2007-3#1)(2007-4#2)(2007-7#9)(2007-8#19)(2007-9#4)(2008-1#8)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#6)(2008-5#4)(2008-6#6)(2008-7#16)(2008-8#4)(2008-9#1)(2009-1#1)(2009-10#5)(2009-12#2)(2009-3#2)(2009-4#4)(2009-6#2)(2009-8#6)(2009-9#5)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#12)(2012-1#1)(2012-11#4)(2012-12#7)(2012-2#10)(2012-3#6)(2013-1#19)(2013-7#4)(2013-8#5)
two cases]##8##2##(2007-8#1)(2008-4#1)(2009-5#1)(2012-2#1)(2013-1#4)
two catalytic##8##2##(1990-8#1)(1991-9#1)(1992-12#1)(1995-10#1)(1995-3#1)(1995-5#2)(2008-4#1)
two categories for##2##3##(1995-6#1)(2010-11#1)
two categories of##7##3##(2006-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
two categories##22##2##(1990-8#1)(1995-6#1)(1997-4#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
two cationic##3##2##(1990-7#1)(1994-12#1)(1996-5#1)
two cations##3##2##(2008-10#3)
two cats##2##2##(1993-2#2)
two causal##2##2##(2008-10#1)(2012-3#1)
two cavities##2##2##(2007-12#1)(2008-2#1)
two cell line##2##3##(1990-11#1)(2007-1#1)
two cell lines expressing##2##4##(1993-3#1)(1994-12#1)
two cell lines##33##3##(1990-10#3)(1990-11#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-7#1)(1992-11#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-2#1)(2008-11#7)(2008-7#1)(2008-9#4)(2010-7#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
two cell populations##6##3##(1993-9#1)(1995-11#2)(2008-1#1)(2008-2#2)
two cell types##16##3##(1990-3#1)(1990-5#1)(1992-1#1)(1992-9#1)(1993-3#1)(1995-3#2)(1996-11#1)(1996-6#1)(1997-4#1)(2008-11#2)(2008-4#1)(2008-7#1)(2012-12#1)(2012-2#1)
two cell##65##2##(1990-10#3)(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-9#1)(1991-10#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-9#2)(1993-3#2)(1993-9#2)(1994-12#1)(1995-11#2)(1995-2#2)(1995-3#2)(1995-5#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-4#1)(2006-5#1)(2007-1#1)(2008-1#1)(2008-11#9)(2008-2#2)(2008-4#1)(2008-7#2)(2008-9#5)(2009-8#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-12#4)(2012-2#2)
two cells##3##2##(1994-12#1)(2007-10#1)(2008-12#1)
two cellular##3##2##(1991-1#1)(1992-11#1)(1995-2#1)
two centers##4##2##(2007-7#1)(2007-8#1)(2008-1#1)(2013-7#1)
two central##5##2##(1990-2#1)(2008-10#1)(2008-2#1)(2011-2#1)(2012-1#1)
two centrosymmetric##2##2##(2007-12#1)(2008-3#1)
two centuries##2##2##(1993-7#1)(2007-12#1)
two certified materials##3##3##(2008-10#3)
two certified reference materials##6##4##(2008-10#6)
two certified reference##7##3##(2008-10#7)
two certified##11##2##(2006-8#1)(2008-10#10)
two chain form##2##3##(1990-11#1)(1990-8#1)
two chain##5##2##(1990-11#2)(1990-8#1)(2012-3#2)
two chains##3##2##(1995-6#1)(2006-12#1)(2009-8#1)
two chambers##3##2##(2006-10#1)(2008-8#1)(2011-2#1)
two changes##2##2##(1996-11#1)(1996-4#1)
two channel flow cells##2##4##(2008-10#2)
two channel##4##2##(1995-5#1)(2007-11#1)(2008-10#2)
two channels##6##2##(1990-5#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)
two characteristic##5##2##(1993-6#1)(2004-4#1)(2005-11#1)(2008-10#1)(2008-2#1)
two characteristics of##2##3##(1995-10#1)(1997-6#1)
two characteristics##5##2##(1995-10#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-5#1)
two chemical##4##2##(2008-10#1)(2008-3#1)(2009-9#1)(2010-4#1)
two chemically different##2##3##(2005-11#2)
two chemically##6##2##(1990-11#1)(1992-9#1)(2005-11#2)(2006-4#1)(2007-12#1)
two chemicals##2##2##(1997-2#1)(2008-10#1)
two chemometric methods##2##3##(2008-10#1)(2010-5#1)
two chemometric##3##2##(2008-10#1)(2008-3#1)(2010-5#1)
two children in##3##3##(2007-9#1)(2008-1#1)(2008-10#1)
two children with##6##3##(1990-12#1)(1992-5#1)(2007-1#1)(2007-8#1)(2008-9#1)(2011-1#1)
two children##24##2##(1990-12#1)(1992-5#1)(1996-11#1)(2006-10#2)(2007-1#2)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
two chimeric proteins##2##3##(1994-6#1)(1994-9#1)
two chimeric##3##2##(1994-6#1)(1994-9#1)(2008-1#1)
two chiral##2##2##(2007-11#1)(2008-10#1)
two chloride##3##2##(1997-7#1)(2008-10#1)(2008-3#1)
two chloroplast##2##2##(2009-8#1)(2012-11#1)
two cholesterol##2##2##(1994-9#1)(2005-10#1)
two chromatographic##3##2##(1992-6#1)(2008-10#2)
two chromophores##3##2##(1993-3#1)(1994-5#1)(2006-10#1)
two chromosomal##3##2##(1994-8#1)(1997-3#1)(2008-12#1)
two chromosomes##2##2##(1996-6#1)(2008-4#1)
two clades##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
two class-II restriction endonucleases from##2##5##(1993-9#2)
two classes according to the##2##5##(1994-9#1)(1995-11#1)
two classes of binding sites##3##5##(1990-3#1)(1992-12#1)(1994-3#1)
two classes of human##2##4##(1994-6#2)
two classes of protamines##2##4##(1990-9#2)
two classes of specific##2##4##(1990-5#1)(1990-7#1)
two classes of##41##3##(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#2)(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-5#1)(1993-1#1)(1994-3#2)(1994-6#2)(1994-8#1)(1995-6#1)(1995-8#2)(1996-10#2)(1996-3#1)(1996-4#1)(1996-7#1)(1997-6#1)(1997-8#1)(2005-6#1)(2006-9#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#2)(2009-2#1)(2012-2#1)
two classes##52##2##(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-1#1)(1994-12#1)(1994-3#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#2)(1995-6#1)(1995-8#2)(1996-10#2)(1996-3#1)(1996-4#1)(1996-7#1)(1997-6#1)(1997-8#1)(2005-6#1)(2006-12#1)(2006-9#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-7#2)(2009-2#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-2#1)
two classical##3##2##(1995-12#1)(2008-4#1)(2013-1#1)
two cleavage sites##2##3##(1991-9#1)(2011-1#1)
two clinical cases of##2##4##(1993-3#1)(2011-2#1)
two clinical cases##7##3##(1990-1#1)(1992-6#1)(1993-3#1)(2008-2#1)(2008-4#1)(2010-9#1)(2011-2#1)
two clinical trials##2##3##(1997-2#1)(2013-1#1)
two clinical##27##2##(1990-1#1)(1990-5#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-2#1)(1997-2#1)(2006-10#1)(2006-2#1)(2006-8#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
two clinically##2##2##(2007-7#1)(2008-10#1)
two clonal##3##2##(1990-9#1)(1995-12#1)(2008-10#1)
two cloned genes##2##3##(1995-8#1)(1997-2#1)
two cloned##7##2##(1995-8#1)(1996-12#1)(1997-2#1)(2006-8#1)(2008-10#1)(2008-9#2)
two clones##14##2##(1990-5#1)(1993-2#1)(1993-8#1)(1994-12#1)(1996-10#1)(1997-2#1)(1997-6#1)(1997-7#1)(2008-10#3)(2008-11#3)
two closed##3##2##(1990-11#1)(1994-5#1)(2012-3#1)
two closely related grasshopper species##2##5##(2011-12#2)
two closely related species##2##4##(1991-11#1)(2008-8#1)
two closely related##20##3##(1990-12#1)(1991-11#1)(1991-2#1)(1993-4#1)(1993-9#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-8#1)(2011-12#2)(2012-3#1)
two closely spaced##5##3##(2007-11#1)(2008-10#1)(2008-2#2)(2011-1#1)
two closely##28##2##(1990-12#1)(1991-11#1)(1991-2#1)(1993-4#1)(1993-9#1)(1994-8#1)(1995-8#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-8#1)(2011-1#1)(2011-12#2)(2012-3#1)
two clusters are##2##3##(1994-2#1)(1997-8#1)
two clusters of fimbrial genes##2##5##(1996-6#1)(1997-4#1)
two clusters of##6##3##(1994-5#1)(1995-12#1)(1996-6#1)(1997-4#1)(2008-10#2)
two clusters##12##2##(1994-2#2)(1994-5#1)(1995-12#1)(1996-6#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#1)
two coastal##2##2##(1991-8#1)(2008-2#1)
two codominant alleles##2##3##(1990-3#1)(1990-8#1)
two codominant##3##2##(1990-3#1)(1990-8#1)(2008-5#1)
two codons##2##2##(1997-4#1)(2008-9#1)
two cognitive##2##2##(2008-7#1)(2011-1#1)
two coherent##6##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
two cohorts of##9##3##(1993-1#1)(1997-3#1)(2004-11#1)(2007-8#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#2)
two cohorts##11##2##(1993-1#1)(1997-3#1)(2004-11#1)(2007-8#1)(2008-11#2)(2011-2#1)(2012-2#2)(2013-1#2)
two coils##3##2##(1997-7#1)(2008-4#1)(2013-7#1)
two collections##4##2##(2008-10#2)(2008-7#1)(2011-1#1)
two collimated##2##2##(2007-11#1)(2008-2#1)
two colloidal particles##2##3##(2005-11#2)
two colorectal##2##2##(1991-3#1)(2008-4#1)
two colors##5##2##(2007-12#1)(2008-1#1)(2008-2#1)(2008-9#2)
two columns##4##2##(1997-2#1)(2006-12#1)(2008-10#1)(2012-1#1)
two combinations##2##2##(2008-5#1)(2008-8#1)
two commercial##18##2##(1991-10#1)(1997-8#1)(2005-9#1)(2006-7#1)(2007-2#1)(2008-10#7)(2008-3#1)(2008-5#1)(2010-4#1)(2011-1#2)(2011-12#1)
two commercially available##8##3##(1994-9#1)(1996-6#1)(2004-4#1)(2007-7#1)(2008-5#2)(2011-1#1)(2013-1#1)
two common bean##3##3##(2008-10#1)(2008-12#1)(2009-8#1)
two common haplotypes##2##3##(2008-10#1)(2008-2#1)
two common polymorphisms##2##3##(2007-10#1)(2010-10#1)
two common##24##2##(1990-5#1)(1997-3#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-9#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-5#1)(2012-2#1)(2013-8#1)
two commonly used methods##2##4##(2008-10#1)(2008-9#1)
two commonly used##12##3##(1990-10#1)(1992-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-9#2)(2009-12#1)(2009-6#1)
two commonly##13##2##(1990-10#1)(1992-8#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#1)(2008-9#2)(2009-12#1)(2009-6#1)
two communities##6##2##(2008-9#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-11#1)(2012-2#1)
two companies##2##2##(2005-8#1)(2008-5#1)
two compared##3##2##(1991-3#1)(1996-6#1)(2008-10#1)
two comparison##3##2##(1996-3#1)(2006-3#1)(2008-2#1)
two compartments##9##2##(1992-1#1)(1992-10#1)(1994-12#2)(1995-2#1)(1996-10#1)(2008-5#1)(2010-5#1)(2012-1#1)
two competing approaches##2##3##(2012-3#2)
two competing effects##2##3##(2008-10#1)(2008-3#1)
two competing lengths##2##3##(1991-3#2)
two competing processes##2##3##(1995-3#1)(2005-11#1)
two competing species in##2##4##(2008-8#2)
two competing##21##2##(1991-3#2)(1994-3#1)(1995-3#1)(1997-2#1)(2004-11#1)(2005-11#1)(2007-12#2)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#2)(2012-3#3)(2013-1#2)(2013-7#1)
two competitive##2##2##(1991-9#1)(1997-1#1)
two competitors##2##2##(1995-4#1)(2008-8#1)
two complementary##18##2##(1992-6#2)(1993-11#1)(1993-6#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-7#2)(1997-7#1)(2005-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-12#1)(2012-3#1)
two complete##4##2##(1993-11#1)(1994-3#1)(2006-10#1)(2008-10#1)
two complex##4##2##(2008-2#2)(2010-1#1)(2010-3#1)
two complexes are##2##3##(1992-6#1)(1995-1#1)
two complexes have##2##3##(1997-7#1)(2005-4#1)
two complexes were##2##3##(2005-4#1)(2008-3#1)
two complexes##19##2##(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1995-1#1)(1995-8#2)(1996-2#1)(1997-7#1)(2005-4#3)(2008-10#3)(2008-3#1)(2008-5#1)(2012-12#1)
two component##17##2##(1991-12#1)(1994-2#1)(1995-12#1)(1996-9#1)(2005-4#1)(2007-8#2)(2008-10#4)(2008-5#1)(2008-8#1)(2010-10#1)(2010-2#1)(2012-1#1)(2012-3#1)
two components are##2##3##(2008-10#1)(2008-3#1)
two components in##2##3##(2005-11#1)(2005-4#1)
two components is##2##3##(1995-3#1)(2007-12#1)
two components of##11##3##(1990-12#1)(2008-2#2)(2008-3#1)(2008-8#2)(2008-9#1)(2010-4#1)(2012-11#2)(2012-12#1)
two components on the##2##4##(1991-2#1)(2008-3#1)
two components##55##2##(1990-12#2)(1990-8#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-11#1)(1992-2#1)(1992-5#1)(1994-11#1)(1994-12#1)(1995-10#1)(1995-3#2)(1995-6#1)(1996-2#1)(1996-9#1)(1997-7#3)(2005-11#2)(2005-12#1)(2005-4#1)(2007-12#3)(2007-8#2)(2008-10#5)(2008-2#4)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-4#1)(2010-7#1)(2012-11#2)(2012-12#1)
two composite##2##2##(2007-12#1)(2008-10#1)
two compounds in##4##3##(1996-6#1)(2008-10#2)(2011-3#1)
two compounds##30##2##(1991-9#2)(1992-6#1)(1994-11#1)(1994-3#1)(1995-3#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-7#2)(2004-2#2)(2005-9#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#4)(2009-2#1)(2011-3#1)(2012-11#1)
two comprehensive##2##2##(2006-12#1)(2008-6#1)
two concentrations of tetrol I-1##2##5##(2008-10#2)
two concentrations of##8##3##(2005-11#1)(2008-10#4)(2008-3#2)(2008-5#1)
two concentrations##9##2##(2005-11#1)(2008-10#5)(2008-3#2)(2008-5#1)
two concentric##5##2##(2007-11#1)(2007-12#2)(2008-2#2)
two concepts##3##2##(2008-2#1)(2009-12#1)(2010-5#1)
two conclusions##2##2##(1990-6#1)(1992-3#1)
two conditions are##2##3##(1990-2#1)(2006-10#1)
two conditions in##2##3##(2007-10#1)(2007-8#1)
two conditions##34##2##(1990-2#1)(1991-2#1)(1992-11#3)(1993-2#1)(1993-6#1)(1994-5#1)(1995-8#1)(1996-10#1)(1997-4#1)(2006-10#1)(2007-10#2)(2007-4#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#3)(2008-9#1)(2009-11#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
two conferences##2##2##(2008-2#1)(2012-2#1)
two conflicting##2##2##(2008-10#1)(2009-6#1)
two confocal##2##2##(2007-12#1)(2008-3#1)
two conformational isomers##3##3##(1991-5#1)(2006-12#2)
two conformations##5##2##(1990-8#1)(1992-3#1)(2005-4#2)(2010-7#1)
two connected##2##2##(1990-8#1)(2010-9#1)
two consecutive days##3##3##(2008-6#1)(2009-10#1)(2013-8#1)
two consecutive years##6##3##(2007-2#1)(2008-10#1)(2008-5#2)(2013-1#1)(2013-7#1)
two consecutive##54##2##(1990-7#1)(1991-1#1)(1991-9#1)(1992-8#1)(1994-12#1)(1994-6#1)(1994-8#2)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#1)(2006-9#1)(2007-12#3)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-1#2)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
two conserved regions of##2##4##(1993-6#1)(1994-5#1)
two conserved regions##6##3##(1991-12#1)(1993-11#1)(1993-6#1)(1993-7#1)(1994-5#1)(1997-4#1)
two conserved residues##4##3##(1992-11#1)(1995-1#2)(1995-5#1)
two conserved##17##2##(1990-4#1)(1990-9#1)(1991-12#1)(1991-7#1)(1992-11#1)(1993-11#1)(1993-6#1)(1993-7#1)(1994-5#1)(1995-1#2)(1995-5#1)(1996-5#1)(1997-4#2)(2008-10#1)(2008-8#1)
two constants##2##2##(2008-10#2)
two constituent##4##2##(1994-3#1)(2007-12#2)(2008-7#1)
two constructs##5##2##(1995-1#1)(2008-10#1)(2008-8#1)(2009-12#1)(2012-12#1)
two contact##2##2##(1990-12#1)(2006-10#1)
two contexts##2##2##(1993-1#1)(2009-10#1)
two contiguous##2##2##(1995-1#1)(2010-2#1)
two continuous##2##2##(1992-2#1)(1994-9#1)
two contributions are##2##3##(2006-10#1)(2007-12#1)
two contributions##3##2##(2006-10#1)(2007-12#1)(2008-3#1)
two control groups##5##3##(1990-11#1)(1992-8#1)(1993-12#1)(2009-5#1)(2010-8#1)
two control measures##3##3##(2008-10#3)
two control##12##2##(1990-11#1)(1992-8#1)(1993-12#1)(1995-10#1)(1996-1#2)(1997-4#1)(2008-10#3)(2009-5#1)(2010-8#1)
two controls##4##2##(1992-5#1)(1992-8#1)(2008-1#1)(2008-11#1)
two conventional hybrids##2##3##(2011-2#2)
two conventional##8##2##(2007-8#1)(2008-2#3)(2008-3#2)(2011-2#2)
two cooperative##3##2##(1991-5#1)(1992-9#1)(1995-12#1)
two copies each##2##3##(1994-5#1)(2011-2#1)
two copies of the##4##4##(2006-12#1)(2008-10#1)(2013-1#2)
two copies of##15##3##(1990-12#1)(1993-6#1)(1994-9#1)(1995-8#1)(1996-10#1)(1996-6#1)(1997-3#1)(1997-8#1)(2006-12#1)(2008-10#1)(2008-9#2)(2012-2#1)(2013-1#2)
two copies##21##2##(1990-11#1)(1990-12#1)(1993-6#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-10#2)(1996-6#2)(1997-3#1)(1997-8#1)(2006-12#1)(2008-10#1)(2008-9#2)(2011-2#1)(2012-2#1)(2013-1#2)
two copper##4##2##(1990-7#1)(1997-1#1)(2006-8#1)(2008-10#1)
two core##3##2##(1993-12#1)(2006-3#1)(2013-8#1)
two correlated##2##2##(2008-9#1)(2012-1#1)
two correlation parameters##2##3##(2010-2#2)
two correlation##4##2##(1992-1#1)(2008-2#1)(2010-2#2)
two correlations##2##2##(1997-4#1)(2008-3#1)
two corresponding##4##2##(1996-12#2)(2013-8#2)
two cortical##2##2##(1996-3#1)(1997-8#1)
two counterpropagating##5##2##(2007-11#1)(2007-12#4)
two counties of Romania##2##4##(2010-12#2)
two counties of##3##3##(2010-1#1)(2010-12#2)
two counties##6##2##(2007-8#1)(2008-10#1)(2010-1#1)(2010-12#2)(2010-5#1)
two countries##8##2##(1991-4#1)(1992-1#1)(1993-3#1)(1997-8#1)(2005-5#1)(2007-7#1)(2007-8#1)(2008-7#1)
two coupled##9##2##(2006-10#2)(2007-11#1)(2007-12#2)(2008-3#2)(2009-8#1)(2013-8#1)
two couples of##2##3##(2008-10#2)
two courses of##3##3##(2007-8#1)(2008-6#1)(2012-2#1)
two courses##4##2##(2007-8#1)(2008-6#2)(2012-2#1)
two criteria##2##2##(2007-12#1)(2008-3#1)
two critical requirements##2##3##(1993-2#1)(2008-11#1)
two critical##10##2##(1992-2#1)(1993-2#1)(2005-11#1)(2006-10#1)(2006-12#1)(2008-11#1)(2008-2#1)(2009-11#1)(2010-12#1)(2011-2#1)
two cross##2##2##(2008-2#1)(2008-3#1)
two cross-sectional surveys##2##3##(2012-3#2)
two cross-sectional##4##2##(2004-9#1)(2012-3#3)
two crossed##2##2##(2008-2#1)(2008-3#1)
two crystal forms##3##3##(1995-4#1)(2008-8#2)
two crystallographically##2##2##(1996-2#1)(2006-4#1)
two cultivars of##4##3##(2008-10#2)(2008-12#1)(2008-5#1)
two cultivars##13##2##(2008-10#10)(2008-12#2)(2008-5#1)
two culturally##2##2##(2007-6#1)(2012-2#1)
two culture##5##2##(1993-7#1)(1996-11#1)(2008-11#2)(2008-7#1)
two current##2##2##(1994-5#1)(2006-8#1)
two currently##3##2##(1997-4#1)(2006-10#1)(2010-8#1)
two currents##2##2##(1996-5#1)(2008-6#1)
two curved##2##2##(1997-2#1)(2008-2#1)
two cutaneous##2##2##(2008-5#1)(2011-2#1)
two cw##3##2##(2007-12#2)(2008-2#1)
two cyanine##5##2##(2005-11#1)(2008-10#2)(2008-3#2)
two cycles of##9##3##(1990-6#1)(1994-4#1)(1996-9#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-4#1)
two cycles to##3##3##(2008-6#2)(2008-8#1)
two cycles##15##2##(1990-6#1)(1994-4#1)(1996-9#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-6#3)(2008-8#2)(2009-4#1)(2010-9#1)
two cyclic##4##2##(1993-5#1)(2006-10#1)(2008-10#2)
two cylindrical lenses##2##3##(2008-10#1)(2008-3#1)
two cylindrical##4##2##(2008-10#1)(2008-3#2)(2010-2#1)
two cysteine residues##10##3##(1990-12#1)(1991-1#1)(1992-1#1)(1992-8#2)(1994-11#1)(1994-5#1)(1995-11#1)(1995-2#1)(2009-10#1)
two cysteine##11##2##(1990-12#1)(1991-1#1)(1992-1#1)(1992-8#3)(1994-11#1)(1994-5#1)(1995-11#1)(1995-2#1)(2009-10#1)
two cysteines##2##2##(1992-2#1)(1995-2#1)
two cytokines##4##2##(1991-3#1)(1995-12#1)(1995-6#1)(2005-10#1)
two cytologists##3##2##(2008-6#3)
two cytoplasmic##3##2##(1995-3#1)(2008-8#2)
two daily##3##2##(1990-12#1)(1993-11#1)(2010-4#1)
two data sets##5##3##(2007-10#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-9#1)
two data##8##2##(2007-10#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-9#1)(2013-1#2)
two datasets##4##2##(2006-5#1)(2008-6#1)(2009-10#1)(2013-8#1)
two daughter##2##2##(1990-12#1)(1994-11#1)
two daughters##2##2##(1996-3#1)(2007-12#1)
two day old##2##3##(2008-12#1)(2008-8#1)
two day##4##2##(1995-9#1)(2008-11#1)(2008-12#1)(2008-8#1)
two days after##6##3##(1992-5#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-5#1)(2009-2#1)
two days later##3##3##(2006-8#1)(2007-11#1)(2010-5#1)
two days of##5##3##(1994-7#1)(2005-8#1)(2008-11#2)(2008-6#1)
two days on##2##3##(2008-12#1)(2010-12#1)
two days##43##2##(1990-8#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-12#1)(1994-7#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-3#1)(2005-3#1)(2005-8#1)(2006-8#2)(2007-11#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#3)(2008-5#4)(2008-6#1)(2009-2#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
two deaths##3##2##(2007-8#1)(2008-11#1)(2008-6#1)
two decades ago##5##3##(1992-10#1)(2008-1#1)(2010-3#1)(2010-5#1)(2013-1#1)
two decades and##4##3##(2008-10#1)(2008-2#1)(2008-7#1)(2012-12#1)
two decades by##2##3##(1994-3#1)(2007-2#1)
two decades have shown##2##4##(2008-3#1)(2009-8#1)
two decades have witnessed##2##4##(2006-2#1)(2009-9#1)
two decades have##10##3##(2006-11#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-2#1)(2008-3#1)(2009-8#1)(2009-9#1)(2010-11#1)(2013-1#1)
two decades in##4##3##(2006-2#1)(2008-5#2)(2011-3#1)
two decades of research##3##4##(2007-11#1)(2008-6#1)(2012-2#1)
two decades of the##3##4##(2008-8#1)(2010-12#1)(2013-7#1)
two decades of##17##3##(2005-12#1)(2006-1#1)(2007-11#1)(2007-3#1)(2008-12#1)(2008-6#1)(2008-8#3)(2009-2#1)(2009-4#1)(2010-12#2)(2010-5#1)(2011-1#1)(2012-2#1)(2013-7#1)
two decades##144##2##(1990-6#1)(1991-10#1)(1991-5#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-4#1)(1993-4#1)(1994-3#2)(1995-1#1)(1995-12#1)(1995-4#1)(1996-3#1)(2005-12#2)(2005-7#3)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#8)(2006-11#1)(2006-12#1)(2006-2#2)(2006-6#3)(2006-7#1)(2006-9#1)(2007-11#4)(2007-12#3)(2007-2#3)(2007-3#1)(2007-8#3)(2008-1#4)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#3)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-7#2)(2010-8#1)(2011-1#5)(2011-2#3)(2011-3#2)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#3)(2013-8#1)
two decoction samples##2##3##(2012-3#2)
two deficiencies##2##2##(1995-1#1)(2008-2#1)
two deficits##2##2##(2008-4#2)
two deformable##2##2##(2007-11#2)
two degradation products##2##3##(2008-10#2)
two degrees of freedom##3##4##(1993-9#1)(2006-6#1)(2008-10#1)
two degrees##4##2##(1993-9#1)(2006-6#1)(2007-12#1)(2008-10#1)
two deletions##2##2##(1993-3#1)(1995-1#1)
two departments##3##2##(1995-12#2)(2006-8#1)
two depth intervals (0-3 and##2##5##(2007-5#2)
two depths##3##2##(2007-3#1)(2007-5#1)(2008-2#1)
two derivatives of##2##3##(2007-1#1)(2008-8#1)
two derivatives##3##2##(2007-1#1)(2007-10#1)(2008-8#1)
two design##2##2##(2008-3#1)(2008-5#1)
two detection##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
two detector systems##2##3##(2007-12#2)
two developed##2##2##(2008-4#1)(2012-12#1)
two developmental##5##2##(1993-9#1)(2006-9#1)(2009-4#1)(2009-7#1)(2009-8#1)
two devices##2##2##(1992-10#1)(2012-3#1)
two diagnostic##4##2##(1997-8#1)(2006-10#1)(2009-3#1)(2011-2#1)
two dicots##2##2##(1991-6#1)(2008-10#1)
two died##3##2##(2007-8#1)(2008-7#1)(2011-1#1)
two dietary##5##2##(1991-12#1)(2008-12#1)(2008-3#1)(2010-6#1)(2010-8#1)
two diets##2##2##(2008-3#1)(2009-9#1)
two different LHC-II complexes##2##4##(2008-4#2)
two different RNA molecules##2##4##(1990-11#1)(1991-6#1)
two different administration##3##3##(2006-6#3)
two different age groups##3##4##(2007-8#1)(2008-6#1)(2012-1#1)
two different amino acid##2##4##(1997-7#1)(2006-7#1)
two different approaches for##2##4##(2008-10#1)(2012-3#1)
two different approaches to##4##4##(1993-3#1)(2008-12#1)(2008-9#1)(2010-12#1)
two different approaches##11##3##(1993-3#1)(1995-12#1)(1995-5#1)(1996-11#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-12#1)(2012-3#1)
two different assay systems##2##4##(1990-5#1)(1993-12#1)
two different assay##3##3##(1990-5#1)(1992-4#1)(1993-12#1)
two different carriers##2##3##(1990-11#1)(1992-8#1)
two different cell##2##3##(1992-2#1)(2008-4#1)
two different classes of##3##4##(1992-3#1)(1992-4#1)(1992-9#1)
two different classes##4##3##(1992-3#1)(1992-4#1)(1992-9#1)(1997-6#1)
two different configurations##2##3##(2007-11#1)(2008-10#1)
two different crosslinking##2##3##(1995-1#1)(2007-8#1)
two different domains of##2##4##(1995-8#1)(1997-2#1)
two different drugs##2##3##(1990-2#1)(2011-1#1)
two different experimental##4##3##(1995-7#1)(2007-12#1)(2007-8#1)(2008-4#1)
two different experiments##2##3##(2008-10#1)(2008-2#1)
two different extracellular##2##3##(1991-9#1)(1992-6#1)
two different fluorescence##2##3##(2005-8#1)(2008-5#1)
two different fluorescent##2##3##(1991-6#1)(2008-6#1)
two different forms of##7##4##(1991-11#1)(1994-8#1)(2006-9#1)(2008-2#1)(2008-4#1)(2010-5#1)(2012-12#1)
two different forms##9##3##(1990-6#1)(1991-11#1)(1991-12#1)(1994-8#1)(2006-9#1)(2008-2#1)(2008-4#1)(2010-5#1)(2012-12#1)
two different functional##2##3##(2005-11#1)(2008-10#1)
two different genotypes##2##3##(2006-11#1)(2008-10#1)
two different groups of##2##4##(2008-10#1)(2008-5#1)
two different groups##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
two different growth##2##3##(1990-8#1)(2008-5#1)
two different instruments##3##3##(2008-2#1)(2008-3#1)(2010-3#1)
two different kind of##2##4##(1993-11#1)(2008-10#1)
two different laboratories##2##3##(2008-10#1)(2013-8#1)
two different layers##2##3##(2010-5#2)
two different levels of##4##4##(1990-2#1)(2004-11#1)(2008-10#1)(2008-7#1)
two different levels##5##3##(1990-2#1)(1991-6#1)(2004-11#1)(2008-10#1)(2008-7#1)
two different localities##2##3##(2007-1#1)(2008-4#1)
two different manners##2##3##(2008-10#1)(2008-2#1)
two different masses##2##3##(2007-10#1)(2008-4#1)
two different measures##3##3##(2008-9#1)(2013-1#2)
two different mechanisms##7##3##(1990-12#1)(1994-2#1)(1995-1#2)(2008-5#1)(2012-12#2)
two different methods using##2##4##(1996-11#1)(2008-5#1)
two different methods##13##3##(1995-1#1)(1996-11#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2010-12#1)
two different modalities##2##3##(2013-1#2)
two different models and##2##4##(2008-10#1)(2008-5#1)
two different models of##2##4##(2007-10#2)
two different models##5##3##(2007-10#2)(2007-8#1)(2008-10#1)(2008-5#1)
two different molecular##2##3##(1990-7#1)(2008-10#1)
two different molecules##2##3##(1994-5#1)(2008-4#1)
two different one-step##2##3##(1995-1#1)(2008-7#1)
two different operators##3##3##(2008-10#1)(2008-5#1)(2010-7#1)
two different organic solvents##2##4##(2007-8#1)(2008-10#1)
two different orientations##3##3##(1992-7#1)(1995-8#1)(2007-12#1)
two different patterns##2##3##(1997-7#1)(2006-1#1)
two different phases##4##3##(2008-11#1)(2008-5#1)(2010-2#1)(2011-2#1)
two different physiotherapy##2##3##(2004-1#2)
two different populations of##3##4##(2008-10#1)(2008-3#1)(2009-2#1)
two different populations##6##3##(2007-2#1)(2008-10#1)(2008-3#1)(2009-2#2)(2011-1#1)
two different preparations##2##3##(1993-12#1)(2011-1#1)
two different procedures##4##3##(1992-12#1)(1996-9#1)(2008-10#2)
two different processes##3##3##(2008-10#2)(2008-3#1)
two different promoters##3##3##(1994-12#2)(1996-2#1)
two different proteins to##2##4##(1996-7#1)(2009-5#1)
two different proteins##4##3##(1995-8#1)(1996-7#1)(2008-2#1)(2009-5#1)
two different regimens##2##3##(1990-4#1)(1993-1#1)
two different regions of##3##4##(1992-6#1)(1994-11#1)(2008-10#1)
two different regions##4##3##(1991-12#1)(1992-6#1)(1994-11#1)(2008-10#1)
two different sample##4##3##(2008-12#1)(2008-2#1)(2008-4#1)(2012-12#1)
two different sequences##2##3##(1993-1#1)(1996-5#1)
two different sets of##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
two different settings##4##3##(1996-7#1)(2006-8#1)(2007-12#1)(2012-12#1)
two different single-stranded##2##3##(1996-9#1)(2010-5#1)
two different sites##3##3##(1991-1#1)(2008-5#1)(2012-3#1)
two different situations##2##3##(2007-12#1)(2007-8#1)
two different sized##2##3##(1991-10#1)(2008-9#1)
two different sizes##4##3##(1990-8#1)(1995-8#1)(2008-10#1)(2008-6#1)
two different soils##2##3##(2008-10#1)(2008-6#1)
two different species##2##3##(1994-11#1)(2008-7#1)
two different stages##2##3##(2008-12#1)(2008-4#1)
two different strategies##2##3##(2012-12#1)(2012-2#1)
two different subunits##5##3##(1991-10#2)(1994-2#1)(1994-6#1)(1996-9#1)
two different techniques for##2##4##(2007-12#1)(2008-4#1)
two different techniques##6##3##(1993-2#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-4#1)(2011-1#1)
two different timescales##2##3##(2008-9#2)
two different transcripts##2##3##(1994-8#1)(2008-8#1)
two different treatment##2##3##(1996-10#1)(2012-2#1)
two different treatments##2##3##(1992-9#1)(2008-6#1)
two different types of##19##4##(1991-1#1)(1993-8#1)(1995-1#1)(1996-10#1)(1996-2#1)(1996-7#1)(2006-6#1)(2007-12#2)(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-7#1)
two different wavelengths##3##3##(2008-2#1)(2008-3#1)(2011-1#1)
two different ways##8##3##(1992-11#1)(1993-7#1)(1995-6#1)(1996-9#1)(2006-10#1)(2007-12#1)(2011-2#1)(2012-2#1)
two different##619##2##(1990-10#2)(1990-11#6)(1990-12#9)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#4)(1991-1#3)(1991-10#5)(1991-11#3)(1991-12#2)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#4)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#3)(1992-4#3)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#2)(1993-1#3)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#5)(1994-12#5)(1994-2#4)(1994-5#2)(1994-6#2)(1994-8#4)(1994-9#1)(1995-1#6)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#7)(1996-1#1)(1996-10#3)(1996-11#2)(1996-12#1)(1996-2#4)(1996-5#1)(1996-7#7)(1996-9#5)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#4)(1997-5#2)(1997-6#3)(1997-7#6)(1997-8#1)(2004-1#2)(2004-11#1)(2004-8#1)(2004-9#3)(2005-11#7)(2005-12#1)(2005-8#1)(2006-1#2)(2006-10#3)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#4)(2006-7#2)(2006-8#2)(2006-9#2)(2007-1#2)(2007-10#3)(2007-11#9)(2007-12#22)(2007-2#2)(2007-5#1)(2007-7#3)(2007-8#12)(2007-9#3)(2008-1#4)(2008-10#84)(2008-11#11)(2008-12#10)(2008-2#20)(2008-3#22)(2008-4#19)(2008-5#18)(2008-6#9)(2008-7#9)(2008-8#6)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#5)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2010-1#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#3)(2010-4#4)(2010-5#4)(2010-7#2)(2010-8#4)(2011-1#11)(2011-12#1)(2011-2#11)(2012-1#4)(2012-12#8)(2012-2#9)(2012-3#7)(2013-1#10)(2013-7#2)(2013-8#5)
two diffraction##3##2##(2008-2#1)(2008-3#2)
two diffractive##2##2##(2007-12#1)(2008-2#1)
two digital holograms##2##3##(2008-3#2)
two dimensional (2D)##3##3##(2006-6#1)(2008-11#1)(2010-5#1)
two dimensional NMR##3##3##(1991-8#1)(2008-11#1)(2008-3#1)
two dimensional##19##2##(1990-7#1)(1991-8#1)(1997-6#1)(2006-10#1)(2006-6#2)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#3)(2009-9#1)(2010-2#1)(2010-5#1)(2010-7#2)
two dimensions of##3##3##(2008-3#2)(2008-6#1)
two dimensions##37##2##(1991-11#1)(1996-2#1)(1996-4#1)(1997-6#1)(1997-8#1)(2005-11#2)(2007-11#1)(2007-12#3)(2008-1#1)(2008-11#1)(2008-2#9)(2008-3#8)(2008-6#1)(2008-8#1)(2010-7#1)(2012-3#1)(2013-1#2)(2013-8#1)
two diode lasers##3##3##(2007-11#1)(2007-12#2)
two diode##5##2##(2006-12#1)(2007-11#1)(2007-12#2)(2009-11#1)
two direct detection methods##2##4##(2008-3#2)
two direct##5##2##(1995-6#1)(2007-6#1)(2008-10#1)(2008-3#2)
two directions##5##2##(1991-9#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-2#1)
two disciplines##3##2##(1996-1#1)(2008-11#1)(2009-7#1)
two discrete regions of##2##4##(1990-3#1)(1992-10#1)
two discrete##7##2##(1990-3#1)(1992-10#1)(1993-3#1)(1993-8#1)(1994-8#1)(1997-4#1)(2010-12#1)
two diseases##22##2##(1991-10#1)(1994-8#1)(1997-7#1)(2006-10#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#9)(2008-11#1)(2012-12#1)(2012-3#2)
two disorders has##2##3##(2008-10#1)(2012-2#1)
two disorders##11##2##(1997-5#2)(2005-10#1)(2006-10#1)(2007-2#1)(2007-6#1)(2008-10#1)(2009-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
two distal##2##2##(2007-8#1)(2008-5#1)
two distances##3##2##(2008-2#1)(2008-3#1)(2012-1#1)
two distant##3##2##(2004-2#1)(2008-10#1)(2008-5#1)
two distantly related##3##3##(1995-3#1)(2008-10#1)(2008-7#1)
two distinct approaches##2##3##(2008-5#1)(2012-2#1)
two distinct binding sites##2##4##(1990-7#1)(1995-5#1)
two distinct classes of##2##4##(1993-2#1)(2008-7#1)
two distinct clusters of##2##4##(2008-10#2)
two distinct clusters that##2##4##(2008-10#2)
two distinct clusters##6##3##(2008-10#6)
two distinct components##2##3##(1990-7#1)(2008-2#1)
two distinct external##2##3##(2007-11#1)(2010-4#1)
two distinct forms of##4##4##(1992-3#1)(1997-4#1)(2005-8#1)(2008-11#1)
two distinct forms##5##3##(1992-3#1)(1994-8#1)(1997-4#1)(2005-8#1)(2008-11#1)
two distinct genetic groups##2##4##(2008-10#1)(2010-10#1)
two distinct genetic##3##3##(1994-6#1)(2008-10#1)(2010-10#1)
two distinct groups of##6##4##(1994-3#1)(1997-2#1)(2008-10#1)(2008-7#1)(2010-10#1)(2013-8#1)
two distinct groups##13##3##(1991-9#1)(1994-3#1)(1997-2#1)(2008-10#6)(2008-7#1)(2010-10#1)(2013-1#1)(2013-8#1)
two distinct heteromeric DNA-binding forms##2##5##(1993-11#2)
two distinct mechanisms##4##3##(1993-6#1)(1996-2#2)(2008-10#1)
two distinct modes##2##3##(1992-6#1)(2007-11#1)
two distinct orientations for##2##4##(1991-5#1)(1994-9#1)
two distinct orientations##3##3##(1991-5#1)(1994-9#1)(1997-7#1)
two distinct pathways##4##3##(1990-5#1)(1991-2#1)(1992-3#1)(2008-11#1)
two distinct phase states##2##4##(2007-12#2)
two distinct phases##2##3##(2008-5#1)(2008-7#1)
two distinct populations##5##3##(1991-8#1)(1994-11#1)(2008-10#1)(2008-9#2)
two distinct processes##2##3##(1991-3#1)(2010-3#1)
two distinct proteins##2##3##(1995-6#1)(2008-10#1)
two distinct receptors##2##3##(1990-7#1)(1991-2#1)
two distinct regions of##4##4##(1990-3#1)(1990-9#1)(1995-1#1)(2008-10#1)
two distinct regions##10##3##(1990-3#1)(1990-6#1)(1990-9#1)(1991-10#1)(1995-1#1)(1996-4#1)(1996-5#1)(1996-8#1)(2007-12#1)(2008-10#1)
two distinct sets##3##3##(1991-2#1)(1994-12#1)(1996-2#1)
two distinct stages of##2##4##(1994-12#1)(2006-5#1)
two distinct stages##3##3##(1994-12#1)(2006-5#1)(2010-10#1)
two distinct subgroups of##2##4##(2008-10#1)(2010-2#1)
two distinct subgroups##3##3##(2008-10#2)(2010-2#1)
two distinct types of##4##4##(1992-12#1)(2006-10#1)(2010-1#1)(2012-12#1)
two distinct types##6##3##(1990-4#1)(1992-12#1)(2006-10#1)(2008-10#1)(2010-1#1)(2012-12#1)
two distinct##227##2##(1990-11#2)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-2#4)(1991-3#3)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#2)(1992-8#1)(1993-11#4)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-3#2)(1994-6#1)(1994-8#6)(1994-9#3)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#2)(1996-11#1)(1996-2#4)(1996-4#1)(1996-5#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-4#5)(1997-6#2)(1997-7#2)(2004-9#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#3)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-11#3)(2007-12#5)(2007-4#1)(2007-8#1)(2008-10#35)(2008-11#5)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#7)(2009-1#1)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#4)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#4)
two distinctive##6##2##(1990-5#1)(1991-8#1)(1992-9#1)(2008-1#1)(2008-10#1)(2008-11#1)
two distribution##3##2##(2005-11#1)(2008-10#1)(2011-1#1)
two districts of##4##3##(1994-6#1)(2008-10#1)(2008-3#2)
two districts##12##2##(1994-6#1)(2008-10#2)(2008-2#3)(2008-3#2)(2010-3#1)(2010-7#1)(2012-3#2)
two disulfide bonds##5##3##(1992-6#1)(1993-8#2)(1996-7#1)(2008-12#1)
two disulfide bridges##2##3##(1995-5#1)(2005-8#1)
two disulfide##7##2##(1992-6#1)(1993-8#2)(1995-5#1)(1996-7#1)(2005-8#1)(2008-12#1)
two disulfides##2##2##(1992-6#1)(2008-9#1)
two divergent##11##2##(1993-5#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-11#1)(2008-10#2)(2010-4#2)(2012-12#1)
two divisions##4##2##(1991-11#1)(1996-9#3)
two documented##2##2##(2010-8#1)(2011-2#1)
two domains in##2##3##(1994-2#1)(2008-7#1)
two domains##33##2##(1990-10#1)(1990-11#1)(1990-7#1)(1991-2#2)(1991-3#1)(1991-7#1)(1991-9#2)(1992-3#1)(1994-2#1)(1994-9#1)(1995-1#2)(1995-3#1)(1995-4#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-5#1)(2007-11#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2012-2#1)(2013-7#2)
two dominant##6##2##(2004-4#1)(2005-11#2)(2008-10#2)(2008-3#1)
two dose##2##2##(1991-3#1)(2008-9#1)
two doses of##8##3##(1991-10#1)(1995-5#1)(1997-1#2)(2007-2#1)(2008-4#1)(2012-1#1)(2012-12#1)
two doses##14##2##(1991-10#1)(1992-3#1)(1993-4#1)(1995-5#1)(1997-1#2)(2004-12#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-4#1)(2010-5#1)(2012-1#1)(2012-12#1)
two double##2##2##(1995-5#1)(1997-2#1)
two double-stranded##2##2##(1991-6#1)(1996-9#1)
two dozen##7##2##(1991-10#1)(1995-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2011-1#1)(2012-11#1)
two drinks##3##2##(1994-2#3)
two droplets##3##2##(2008-3#3)
two drug combination##2##3##(2008-6#1)(2010-3#1)
two drug##6##2##(1990-2#1)(1991-12#1)(1993-6#1)(2008-6#1)(2010-3#2)
two drugs are##5##3##(1992-3#1)(1993-4#1)(1995-3#1)(1995-9#1)(2005-8#1)
two drugs differ##2##3##(1995-7#1)(2008-11#1)
two drugs in the##3##4##(1997-4#1)(2008-10#1)(2011-2#1)
two drugs in##6##3##(1993-2#1)(1997-4#1)(2008-10#2)(2011-2#2)
two drugs simultaneously##2##3##(1993-8#1)(2012-2#1)
two drugs were##2##3##(1991-9#1)(1995-6#1)
two drugs##42##2##(1990-5#4)(1990-9#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-2#1)(1993-4#1)(1993-8#2)(1994-11#1)(1995-12#1)(1995-3#2)(1995-6#1)(1995-7#2)(1995-9#1)(1996-1#1)(1997-4#2)(2005-8#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-11#4)(2010-3#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
two dummies##3##2##(2006-11#3)
two dyes##4##2##(2005-4#1)(2008-10#1)(2008-2#2)
two each##2##2##(2008-9#1)(2012-2#1)
two earlier studies##2##3##(1994-2#1)(2008-11#1)
two earlier##3##2##(1994-2#1)(2008-10#1)(2008-11#1)
two early##6##2##(1990-10#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-7#1)(2011-2#1)
two earthquakes##2##2##(1990-11#1)(2012-2#1)
two ecological##2##2##(1990-5#1)(2008-5#1)
two edges##2##2##(2006-6#1)(2008-2#1)
two educational##2##2##(2007-7#1)(2010-6#1)
two effective##3##2##(2008-2#1)(2009-4#1)(2011-2#1)
two effects on##2##3##(1996-9#1)(2008-5#1)
two effects##11##2##(1990-8#1)(1996-9#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#2)(2012-12#1)(2012-3#1)
two elderly##2##2##(1994-2#1)(2007-7#1)
two electrochemical##2##2##(2008-10#1)(2008-4#1)
two electrode##4##2##(1993-12#1)(2007-12#1)(2008-10#2)
two electrodes##8##2##(2007-12#1)(2008-10#5)(2008-2#1)(2013-1#1)
two electrons##3##2##(1995-10#1)(2008-10#2)
two elemental##2##2##(2008-10#1)(2008-11#1)
two elementary##2##2##(2008-3#1)(2009-2#1)
two elements are##2##3##(1993-9#1)(2008-3#1)
two elements of##3##3##(1994-8#1)(1997-4#1)(2007-11#1)
two elements##12##2##(1990-5#1)(1993-6#1)(1993-9#1)(1994-6#1)(1994-8#1)(1994-9#1)(1997-4#1)(1997-5#1)(2005-10#1)(2007-11#1)(2008-11#1)(2008-3#1)
two email surveys were used to establish potential risk factors for this error##2##13##(2013-1#2)
two emergency##2##2##(1992-5#1)(2006-10#1)
two emission##2##2##(2008-3#1)(2010-5#1)
two enantiomers of##3##3##(1995-3#1)(1996-9#1)(2008-10#1)
two enantiomers##7##2##(1992-8#1)(1993-11#1)(1995-3#1)(1996-3#1)(1996-9#1)(2008-10#2)
two endemic##2##2##(2005-9#1)(2008-5#1)
two endogenous##2##2##(1990-7#1)(1994-2#1)
two endoparasitoids of whiteflies##2##4##(2007-6#2)
two endothermic##2##2##(1990-7#1)(2007-11#1)
two entities##5##2##(1990-12#1)(2004-11#1)(2006-12#2)(2008-6#1)
two environments##7##2##(2008-10#3)(2008-5#1)(2008-8#2)(2010-5#1)
two enzymatic##3##2##(1993-2#1)(2008-5#1)(2009-8#1)
two enzyme activities##4##3##(1991-4#1)(1991-9#1)(1995-8#1)(2005-7#1)
two enzyme##9##2##(1991-4#1)(1991-9#1)(1993-11#1)(1995-10#1)(1995-11#1)(1995-8#1)(2005-7#1)(2008-10#1)(2008-5#1)
two enzymes##37##2##(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-5#1)(1991-7#1)(1992-2#1)(1992-4#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-3#3)(1994-8#2)(1995-1#1)(1995-10#2)(1995-5#1)(1995-7#2)(1996-7#1)(1996-9#2)(1997-1#1)(1997-7#2)(2005-11#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2009-8#1)
two ependymomas##2##2##(2006-12#1)(2006-5#1)
two epidermal##2##2##(1995-6#1)(2008-10#1)
two episodes of##2##3##(2008-11#1)(2008-12#1)
two episodes##4##2##(2006-7#1)(2008-11#1)(2008-12#1)(2010-12#1)
two equal##9##2##(2005-11#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-3#1)(2012-2#1)
two equations##2##2##(2008-10#2)
two equilibrium##2##2##(1994-8#1)(2008-8#1)
two equivalent##5##2##(1995-2#1)(2007-12#1)(2008-3#1)(2008-5#1)(2009-6#1)
two equivalents of##4##3##(2007-9#1)(2008-11#1)(2008-4#1)(2010-5#1)
two essential##8##2##(1990-3#2)(1994-9#1)(2006-4#1)(2008-2#1)(2008-3#1)(2012-2#1)(2013-7#1)
two estrogen##2##2##(1994-12#1)(2008-4#1)
two etalons##2##2##(2008-2#1)(2008-3#1)
two evaluations##2##2##(1992-8#1)(2008-7#1)
two events are##2##3##(1995-6#1)(2012-2#1)
two events##7##2##(1991-8#1)(1995-12#1)(1995-6#1)(1996-4#1)(2011-2#2)(2012-2#1)
two examinations##5##2##(1996-11#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)
two examined##2##2##(1991-7#1)(2009-4#1)
two example##5##2##(2008-3#4)(2012-1#1)
two examples of##4##3##(1994-9#1)(1995-1#1)(1995-6#1)(2008-3#1)
two examples##13##2##(1992-9#1)(1994-4#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-8#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-1#1)(2010-5#1)
two exceptional##2##2##(1995-6#1)(2007-1#1)
two exceptions##3##2##(1990-2#1)(1997-8#1)(2012-2#1)
two excitation windows##2##3##(2011-1#2)
two excitation##6##2##(2008-10#1)(2008-3#3)(2011-1#2)
two exhibited##2##2##(2008-10#2)
two existing##3##2##(1991-3#1)(2008-3#1)(2012-2#1)
two exons##9##2##(1991-6#1)(1992-4#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(2008-9#1)
two experimental and##2##3##(1996-1#1)(2013-1#1)
two experimental approaches##3##3##(1991-5#1)(1992-12#1)(1994-9#1)
two experimental groups##5##3##(1993-12#1)(2007-9#1)(2009-12#1)(2010-2#1)(2013-8#1)
two experimental models of##2##4##(1991-10#1)(1991-12#1)
two experimental models##3##3##(1991-10#1)(1991-12#1)(1997-4#1)
two experimental##26##2##(1991-10#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-12#1)(1993-12#1)(1994-8#1)(1994-9#1)(1996-1#1)(1997-4#1)(2006-10#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
two experiments##38##2##(1992-8#1)(1993-12#1)(1994-2#1)(1995-8#1)(2006-4#1)(2007-1#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2010-8#2)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#2)
two exploratory studies##2##3##(2006-6#1)(2008-1#1)
two exponential terms##2##3##(1994-11#1)(2005-11#1)
two exponential##4##2##(1994-11#1)(1997-7#1)(2005-11#1)(2008-3#1)
two exposed##2##2##(1990-3#1)(1995-2#1)
two expression systems##2##3##(1995-5#1)(1997-4#1)
two expression vectors##2##3##(1994-3#1)(2008-10#1)
two expression##5##2##(1994-3#1)(1995-12#1)(1995-5#1)(1997-4#1)(2008-10#1)
two external-cavity##2##2##(2007-12#1)(2008-1#1)
two extinction##2##2##(2008-2#1)(2008-3#1)
two extracellular##2##2##(1995-5#1)(2008-6#1)
two extraction##2##2##(2007-8#1)(2008-7#1)
two extreme##7##2##(1991-2#1)(1995-12#1)(1996-11#1)(2008-10#1)(2008-11#2)(2008-2#1)
two extremes of the##2##4##(1997-6#1)(2008-8#1)
two extremes##10##2##(1994-9#1)(1997-6#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)
two extremities##2##2##(1992-6#1)(1996-4#1)
two eyes##7##2##(1992-7#1)(1994-2#1)(1994-8#1)(2010-5#1)(2011-1#2)(2011-2#1)
two face##2##2##(2009-4#2)
two faces of a##2##4##(2008-2#1)(2010-12#1)
two faces of##3##3##(2008-2#1)(2008-5#1)(2010-12#1)
two factor I-cofactor##2##3##(1990-7#2)
two factor solution##2##3##(2006-4#1)(2012-3#1)
two factor##5##2##(1990-7#2)(2006-4#1)(2008-5#1)(2012-3#1)
two factors have##2##3##(1991-6#1)(2004-10#1)
two factors in##2##3##(1990-10#1)(2009-4#1)
two factors to##2##3##(1992-12#1)(2007-5#1)
two factors were##2##3##(2008-10#2)
two factors##48##2##(1990-10#1)(1990-12#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-12#2)(1993-4#1)(1995-5#1)(1996-3#1)(1996-4#1)(1997-4#2)(2004-10#1)(2005-10#1)(2005-11#1)(2006-12#1)(2007-5#1)(2007-9#1)(2008-10#10)(2008-11#3)(2008-2#1)(2008-6#1)(2008-7#3)(2009-4#1)(2009-6#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
two families and##2##3##(1991-12#1)(2012-3#1)
two families of##9##3##(1993-12#1)(1994-5#1)(1996-8#1)(2007-12#1)(2008-7#2)(2009-11#1)(2009-2#1)(2012-1#1)
two families##16##2##(1990-3#1)(1991-12#2)(1993-10#1)(1993-12#1)(1994-2#1)(1994-5#1)(1996-11#1)(1996-8#1)(2007-12#1)(2008-7#2)(2009-11#1)(2009-2#1)(2012-1#1)(2012-3#1)
two family##3##2##(2007-12#1)(2011-2#1)(2013-1#1)
two farms##6##2##(1994-7#1)(2008-5#3)(2013-1#1)(2013-8#1)
two fatty acid##4##3##(1990-11#1)(1990-4#1)(1992-4#1)(1995-12#1)
two fatty acids##2##3##(1991-5#1)(1994-12#1)
two fatty##6##2##(1990-11#1)(1990-4#1)(1991-5#1)(1992-4#1)(1994-12#1)(1995-12#1)
two features of the##2##4##(1994-9#1)(2007-11#1)
two features of##3##3##(1994-9#1)(2007-11#2)
two features##8##2##(1991-2#1)(1994-9#1)(2005-11#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-4#1)
two female patients##4##3##(1996-8#1)(2007-8#1)(2008-7#1)(2009-8#1)
two female##10##2##(1996-6#1)(1996-8#1)(1996-9#1)(1997-7#1)(2004-11#1)(2007-8#3)(2008-7#1)(2009-8#1)
two females##10##2##(1994-2#1)(1997-6#1)(2006-10#1)(2007-2#1)(2008-7#1)(2008-9#1)(2011-12#1)(2012-12#1)(2013-1#2)
two ferredoxins##2##2##(1995-5#2)
two fetuses##3##2##(1990-2#1)(1992-6#2)
two fiber##8##2##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#2)
two fibers##2##2##(2008-10#1)(2013-1#1)
two fibrinolytic##2##2##(1991-8#1)(1992-5#1)
two field experiments##5##3##(2006-3#1)(2008-10#4)
two field locations##3##3##(2008-10#2)(2008-11#1)
two field sites##3##3##(2008-10#2)(2013-1#1)
two field trials##4##3##(2008-10#4)
two field##19##2##(2006-3#1)(2007-11#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
two fields in##2##3##(2008-10#2)
two fields##11##2##(1991-2#1)(1997-3#1)(2007-1#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#1)
two fingers##4##2##(1990-10#1)(1991-10#1)(1991-12#1)(1996-8#1)
two first years##3##3##(1995-9#2)(2012-2#1)
two first##7##2##(1995-9#2)(2007-12#1)(2008-3#1)(2010-12#1)(2012-2#1)(2013-1#1)
two first-order##4##2##(1990-5#1)(2008-10#3)
two fish species##7##3##(1991-9#1)(2008-12#1)(2010-8#1)(2012-2#3)(2012-3#1)
two fixed##5##2##(2008-10#1)(2008-3#3)(2010-12#1)
two flagellins##2##2##(1990-2#2)
two flanking##2##2##(1993-3#1)(2008-10#1)
two flights##2##2##(2008-2#2)
two flocks##3##2##(1992-10#1)(1997-3#2)
two flow##4##2##(1992-8#1)(1997-2#1)(2008-10#2)
two fluorescence##2##2##(1996-11#1)(2008-8#1)
two fluorescent##6##2##(1991-5#1)(1993-8#1)(1994-10#1)(2008-10#3)
two fluorescently labeled##2##3##(1990-2#1)(2007-3#1)
two fluorophores##3##2##(2008-1#2)(2008-2#1)
two fluoroscopic images##2##3##(2007-5#1)(2008-8#1)
two fold the##2##3##(1991-8#1)(2012-2#1)
two fold##14##2##(1991-8#1)(1993-6#1)(1993-8#1)(2006-9#1)(2008-11#3)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-2#3)
two folds##3##2##(2008-11#1)(2008-12#1)(2008-6#1)
two follow-up##2##2##(1990-2#1)(1994-6#1)
two for three##2##3##(1990-8#1)(1994-2#1)
two for##16##2##(1990-2#1)(1990-8#1)(1991-2#1)(1991-7#1)(1993-6#1)(1994-2#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#3)(2009-7#1)(2012-1#1)(2013-8#1)
two force plate variables##2##4##(2008-10#2)
two force##3##2##(2008-10#2)(2008-7#1)
two forces##2##2##(2008-8#1)(2012-2#1)
two formae speciales##2##3##(2008-10#2)
two former##2##2##(1991-3#1)(2006-8#1)
two forms in##2##3##(1993-8#1)(2012-1#1)
two forms of ATP sulfurylase##2##5##(1991-5#2)
two forms of the##6##4##(1990-2#1)(1995-9#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-5#1)
two forms of this protein##2##5##(1991-12#1)(1994-8#1)
two forms of##46##3##(1990-11#1)(1990-2#2)(1990-5#1)(1991-12#2)(1991-5#2)(1991-8#1)(1992-11#1)(1992-12#2)(1992-5#1)(1992-6#1)(1993-7#1)(1994-11#2)(1994-6#1)(1994-8#1)(1995-5#1)(1995-9#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-4#2)(2007-11#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-11#1)(2009-9#1)(2010-5#4)(2011-2#1)(2012-3#1)
two forms##63##2##(1990-11#1)(1990-2#3)(1990-5#1)(1991-10#1)(1991-12#3)(1991-5#3)(1991-8#1)(1992-11#1)(1992-12#2)(1992-5#1)(1992-6#1)(1993-7#1)(1993-8#1)(1994-11#4)(1994-6#1)(1994-8#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-7#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-11#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-5#4)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#1)
two formulations of##4##3##(1993-6#1)(1996-1#2)(2012-12#1)
two formulations##10##2##(1993-6#2)(1995-2#1)(1996-1#2)(1996-12#1)(2008-10#1)(2009-5#1)(2010-2#1)(2012-12#1)
two fractions with##2##3##(1992-4#1)(1994-3#1)
two fractions##9##2##(1990-12#2)(1991-2#1)(1992-11#1)(1992-4#1)(1994-3#1)(1996-12#1)(2006-10#1)(2012-11#1)
two fractures##3##2##(2007-11#1)(2011-1#1)(2011-2#1)
two fragments of##5##3##(1994-2#1)(1996-12#1)(1996-8#1)(2008-4#1)(2010-4#1)
two fragments were##2##3##(1997-7#1)(2008-8#1)
two fragments##16##2##(1990-12#1)(1990-5#1)(1991-2#1)(1992-12#1)(1994-2#2)(1996-12#1)(1996-8#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#1)(2010-4#1)
two free##3##2##(1990-3#1)(2008-3#1)(2008-6#1)
two free-standing##2##2##(1994-9#1)(2007-8#1)
two frequencies##6##2##(1990-5#1)(1996-7#1)(2007-12#1)(2008-3#2)(2010-7#1)
two from groups of##2##4##(1996-12#2)
two from the##2##3##(2007-1#1)(2008-9#1)
two from##10##2##(1995-6#1)(1996-12#2)(1996-9#1)(2007-1#1)(2008-10#3)(2008-5#1)(2008-9#1)
two fully##2##2##(2007-3#1)(2008-8#1)
two functional domains##3##3##(1993-11#1)(1997-1#1)(1997-6#1)
two functional##12##2##(1991-2#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-9#2)(1996-2#1)(1996-9#1)(1997-1#1)(1997-6#1)(2006-11#1)(2010-11#1)
two functionally distinct##3##3##(1997-6#1)(2008-1#1)(2010-7#1)
two functionally##7##2##(1996-5#1)(1997-6#2)(2008-1#1)(2008-9#1)(2009-8#1)(2010-7#1)
two functions##8##2##(1991-12#1)(1993-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)
two fundamental##9##2##(1991-2#1)(2008-1#3)(2008-2#2)(2008-7#1)(2008-9#1)(2011-1#1)
two fundamentally different##2##3##(2008-2#1)(2008-4#1)
two fungal species##2##3##(2012-2#1)(2012-3#1)
two fungal##4##2##(2007-11#1)(2008-10#1)(2012-2#1)(2012-3#1)
two fungi##7##2##(2006-3#1)(2008-10#6)
two fungicide##2##2##(2008-10#2)
two fungicides (carbendazim and chlorothalonil)##2##5##(1997-4#2)
two further patients##2##3##(1991-10#1)(2008-6#1)
two further##9##2##(1990-5#1)(1991-10#1)(1991-11#1)(1994-2#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)
two fusion##2##2##(1995-2#1)(2013-1#1)
two gene##3##2##(1991-5#1)(1994-2#1)(1996-6#1)
two genera of##4##3##(2006-12#1)(2008-10#1)(2008-9#1)(2012-12#1)
two genera##10##2##(2005-12#1)(2006-12#1)(2008-10#5)(2008-9#1)(2012-12#1)(2012-2#1)
two general##13##2##(1991-2#1)(1991-3#1)(1992-11#1)(1995-5#1)(1996-10#1)(2007-12#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-1#1)(2012-3#1)(2013-1#2)
two generations##9##2##(1990-11#1)(1991-8#1)(1995-11#1)(1995-9#1)(1996-6#1)(2004-4#1)(2008-10#1)(2008-5#1)(2009-5#1)
two generic##2##2##(2008-10#1)(2008-2#1)
two genes are##10##3##(1990-4#1)(1990-5#1)(1990-9#1)(1993-3#2)(1994-11#1)(1996-5#1)(2008-10#1)(2008-4#1)(2008-7#1)
two genes encoding##3##3##(1995-8#1)(2008-9#1)(2009-10#1)
two genes for##3##3##(1994-3#1)(2008-10#2)
two genes have##2##3##(2008-5#1)(2009-8#1)
two genes in##2##3##(1991-2#1)(2010-3#1)
two genes of the##4##4##(1992-2#1)(1993-11#1)(2008-10#2)
two genes on chromosome##2##4##(1990-9#1)(2008-10#1)
two genes that##2##3##(1990-8#1)(1992-2#1)
two genes was##3##3##(1991-9#1)(1997-7#1)(2008-1#1)
two genes were##2##3##(1993-3#1)(2008-10#1)
two genes with additive effects##2##5##(2008-10#2)
two genes with##3##3##(2008-10#2)(2010-3#1)
two genes##80##2##(1990-10#1)(1990-11#1)(1990-4#1)(1990-5#3)(1990-8#2)(1990-9#2)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#2)(1992-2#2)(1992-8#2)(1993-11#1)(1993-12#1)(1993-3#3)(1993-6#2)(1994-11#2)(1994-12#1)(1994-3#1)(1995-8#2)(1996-11#1)(1996-3#1)(1996-5#1)(1996-7#2)(1997-1#1)(1997-7#3)(1997-9#1)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#4)(2009-10#2)(2009-8#1)(2010-3#2)(2012-3#3)
two genetic lines of##2##4##(1997-6#2)
two genetic loci##2##3##(2006-5#1)(2010-2#1)
two genetic##8##2##(1997-6#2)(2006-10#1)(2006-5#1)(2008-10#2)(2010-2#1)(2012-1#1)
two genetically distinct##3##3##(1995-6#1)(2008-10#1)(2008-6#1)
two genetically##8##2##(1995-6#1)(1996-5#1)(2008-10#2)(2008-6#3)(2011-2#1)
two genomic##4##2##(1990-12#1)(1992-11#1)(1997-2#1)(2008-10#1)
two genotypes of##4##3##(2007-1#1)(2008-10#3)
two genotypes##14##2##(2006-2#1)(2007-1#2)(2007-8#1)(2008-10#8)(2008-4#1)(2011-1#1)
two geographically##3##2##(2006-5#1)(2008-10#2)
two geometries##4##2##(1990-8#1)(1996-8#1)(2007-12#2)
two giant##2##2##(1996-9#1)(2005-12#1)
two girls aged##2##3##(1996-3#1)(1997-6#1)
two girls with##3##3##(1996-12#1)(2006-10#2)
two girls##6##2##(1996-12#1)(1996-3#1)(1997-6#1)(2006-10#2)(2007-7#1)
two glass##4##2##(1991-5#1)(1996-12#1)(2007-12#1)(2008-3#1)
two glycoproteins##4##2##(1990-7#1)(1992-4#1)(1994-6#1)(2013-8#1)
two goals##2##2##(2008-1#1)(2008-12#1)
two gold##2##2##(1996-2#1)(2008-2#1)
two government##2##2##(2008-8#1)(2011-1#1)
two graft##2##2##(2007-7#1)(2012-12#1)
two gram##2##2##(2010-12#2)
two grasses##3##2##(2008-5#3)
two grating##7##2##(2005-4#1)(2007-12#1)(2008-3#5)
two gratings##9##2##(1997-8#2)(2007-12#1)(2008-2#1)(2008-3#5)
two greenhouse##2##2##(2008-10#1)(2011-2#1)
two groEL-like genes##2##3##(1993-11#2)
two group##4##2##(1996-2#1)(2009-8#1)(2011-1#2)
two groups (p = 0##5##5##(2010-8#1)(2011-2#1)(2012-2#3)
two groups according to the##8##5##(1996-12#1)(1997-2#1)(1997-7#1)(2006-5#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-7#1)
two groups according to##10##4##(1996-12#1)(1997-2#1)(1997-7#1)(2006-5#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-7#1)
two groups after##3##3##(1992-8#1)(2011-2#1)(2013-8#1)
two groups and##7##3##(1993-2#1)(1994-2#1)(1997-6#1)(2008-10#1)(2012-12#1)(2012-2#1)(2012-3#1)
two groups are##3##3##(1992-6#1)(2005-1#1)(2008-1#1)
two groups at##6##3##(1991-3#1)(1993-4#1)(2011-2#1)(2012-12#1)(2013-1#2)
two groups by##3##3##(1992-12#1)(1995-12#1)(2008-10#1)
two groups depending on##2##4##(1991-9#1)(2013-1#1)
two groups did not differ##6##5##(1990-6#1)(1991-3#1)(1992-4#1)(2007-8#1)(2010-4#1)(2011-1#1)
two groups had##4##3##(1990-2#1)(1996-2#1)(2007-1#1)(2011-1#1)
two groups in##14##3##(1990-2#1)(1990-6#1)(1995-4#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
two groups of 10##3##4##(2005-10#1)(2008-5#1)(2009-4#1)
two groups of ELBW infants##4##5##(2006-7#1)(2006-8#3)
two groups of mice##3##4##(2007-12#1)(2013-1#2)
two groups of patients were##3##5##(1991-3#1)(1995-6#1)(2013-8#1)
two groups of patients with cANCA##2##6##(2007-2#2)
two groups of patients with##4##5##(2007-2#3)(2010-12#1)
two groups of patients##20##4##(1990-11#1)(1990-12#1)(1990-5#1)(1991-3#1)(1991-9#1)(1992-6#1)(1993-5#1)(1995-6#1)(1996-4#1)(2006-6#1)(2006-8#1)(2007-2#3)(2007-7#1)(2007-8#1)(2008-10#1)(2010-12#1)(2013-1#1)(2013-8#1)
two groups of rats##5##4##(1991-2#1)(1995-10#1)(1997-5#1)(2008-7#1)(2009-11#1)
two groups of students##2##4##(1997-2#1)(2008-11#1)
two groups of subjects##4##4##(1995-12#1)(2008-11#1)(2010-2#1)(2011-1#1)
two groups of##112##3##(1990-11#1)(1990-12#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-9#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-4#1)(1993-5#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#3)(1996-4#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2005-10#2)(2006-10#1)(2006-2#1)(2006-6#2)(2006-7#1)(2006-8#5)(2007-12#1)(2007-2#3)(2007-6#1)(2007-7#2)(2007-8#4)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#12)(2008-6#1)(2008-7#4)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#5)(2013-8#1)
two groups on the##3##4##(2008-3#1)(2009-8#1)(2011-2#1)
two groups on##6##3##(1992-11#1)(2007-7#1)(2008-3#1)(2009-8#1)(2011-2#1)(2012-1#1)
two groups regarding##4##3##(1992-12#1)(1996-12#1)(2012-2#2)
two groups that##4##3##(2008-10#2)(2008-5#1)(2013-1#1)
two groups using##3##3##(1996-2#1)(2012-2#2)
two groups were also##2##4##(2008-10#1)(2008-6#1)
two groups were comparable##5##4##(1992-5#1)(2007-7#1)(2008-6#1)(2009-11#1)(2011-2#1)
two groups were compared##4##4##(2009-12#1)(2011-1#1)(2011-2#2)
two groups were found in##2##5##(1990-2#1)(1997-8#1)
two groups were not##2##4##(1992-2#1)(1995-10#1)
two groups were##35##3##(1990-2#1)(1990-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1994-7#1)(1995-10#1)(1996-5#1)(1997-8#1)(2005-4#1)(2006-8#1)(2007-3#1)(2007-7#2)(2007-9#1)(2008-10#2)(2008-4#1)(2008-6#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2011-1#1)(2011-2#3)(2012-11#1)(2013-1#2)(2013-8#1)
two groups with##10##3##(1994-7#1)(1995-10#1)(1995-7#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2013-1#1)
two groups##575##2##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#3)(1990-5#2)(1990-6#2)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#2)(1991-3#6)(1991-4#1)(1991-6#3)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#7)(1992-12#5)(1992-2#3)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#1)(1993-1#5)(1993-11#2)(1993-12#2)(1993-2#1)(1993-4#2)(1993-5#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#3)(1994-7#3)(1994-9#1)(1995-1#1)(1995-10#3)(1995-11#3)(1995-12#6)(1995-2#1)(1995-3#1)(1995-4#2)(1995-5#1)(1995-6#2)(1995-7#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#6)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#3)(1996-7#3)(1996-8#2)(1996-9#4)(1997-2#4)(1997-3#3)(1997-4#1)(1997-5#4)(1997-6#4)(1997-7#3)(1997-8#3)(2004-11#1)(2004-12#1)(2005-1#2)(2005-10#3)(2005-4#3)(2005-7#1)(2006-10#4)(2006-2#3)(2006-4#3)(2006-5#3)(2006-6#4)(2006-7#2)(2006-8#10)(2006-9#4)(2007-1#3)(2007-10#1)(2007-11#6)(2007-12#3)(2007-2#8)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#4)(2007-7#14)(2007-8#27)(2007-9#10)(2008-1#4)(2008-10#39)(2008-11#6)(2008-12#10)(2008-2#4)(2008-3#5)(2008-4#8)(2008-5#20)(2008-6#7)(2008-7#14)(2008-8#8)(2008-9#2)(2009-10#1)(2009-11#3)(2009-12#2)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#5)(2010-8#3)(2010-9#1)(2011-1#11)(2011-12#1)(2011-2#33)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#8)(2012-2#19)(2012-3#5)(2013-1#25)(2013-7#2)(2013-8#13)
two growing seasons##6##3##(2008-10#5)(2013-1#1)
two growth##4##2##(1993-3#1)(1996-6#1)(2004-10#1)(2007-7#1)
two guided##2##2##(2007-12#1)(2008-3#1)
two habitat##3##2##(2004-2#1)(2008-8#2)
two habitats##2##2##(2004-2#1)(2007-6#1)
two had##15##2##(1990-3#1)(1990-4#1)(1991-8#1)(1992-6#1)(1992-8#1)(1996-6#1)(2004-2#1)(2006-6#1)(2007-1#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-8#1)(2009-8#1)
two hairpin##2##2##(1994-8#2)
two halves of the##4##4##(1990-11#1)(1990-4#1)(1994-3#1)(2008-11#1)
two halves of##6##3##(1990-11#1)(1990-4#1)(1991-10#1)(1994-3#1)(2008-11#1)(2011-3#1)
two halves##8##2##(1990-11#1)(1990-4#1)(1991-10#1)(1994-3#1)(1997-7#1)(2007-12#1)(2008-11#1)(2011-3#1)
two haploid nuclei##3##3##(2008-9#3)
two haploid##4##2##(2008-9#4)
two haplotypes##2##2##(2008-10#2)
two have##3##2##(2006-7#1)(2008-10#1)(2013-8#1)
two health##8##2##(1992-1#1)(1996-6#1)(1997-4#1)(2005-8#2)(2009-11#1)(2011-2#1)(2012-2#1)
two healthcare##2##2##(2007-11#1)(2009-4#1)
two healthy##3##2##(1991-5#1)(2010-2#1)(2011-2#1)
two heat shock proteins##2##4##(1991-11#1)(2012-12#1)
two heat-shock##2##2##(1993-6#1)(1994-8#1)
two heavy##2##2##(1991-8#1)(1992-4#1)
two helical##2##2##(1990-7#1)(1994-9#1)
two helices##10##2##(1990-11#1)(1991-5#1)(1992-6#1)(1993-1#3)(1993-6#3)(1995-11#1)
two heme##3##2##(1990-8#1)(1997-4#1)(2008-8#1)
two hepatic##2##2##(1991-8#1)(2010-5#1)
two herbs##4##2##(1992-2#3)(2012-3#1)
two herds##3##2##(1990-6#1)(1992-2#1)(1994-4#1)
two hierarchical##2##2##(1993-4#1)(2008-10#1)
two high affinity binding sites in##2##6##(1991-1#1)(1995-3#1)
two high affinity##3##3##(1991-1#1)(1995-3#1)(1995-6#1)
two high molecular weight##3##4##(1992-5#1)(2008-10#2)
two high##14##2##(1991-1#1)(1992-5#2)(1993-3#1)(1995-3#1)(1995-6#1)(2005-9#1)(2007-1#1)(2008-10#3)(2008-11#1)(2011-2#1)(2013-8#1)
two high-affinity##4##2##(1991-4#1)(1995-6#1)(2008-4#1)(2008-9#1)
two high-molecular-weight##2##2##(2006-12#1)(2006-3#1)
two high-resolution##5##2##(1992-6#1)(2008-2#3)(2008-4#1)
two higher doses##2##3##(1992-11#1)(1993-3#1)
two higher##5##2##(1992-11#1)(1993-3#1)(1994-8#1)(2008-3#1)(2010-5#1)
two highly conserved##8##3##(1990-11#1)(1992-11#1)(1992-6#1)(1993-11#1)(1995-3#1)(1996-5#1)(1997-7#1)(2008-4#1)
two highly divergent##2##3##(1990-6#1)(2010-8#1)
two highly homologous##3##3##(1992-4#1)(1995-11#1)(2008-11#1)
two highly##27##2##(1990-11#1)(1990-6#1)(1991-11#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-11#1)(1994-3#1)(1995-11#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2010-8#1)(2011-1#1)(2012-11#1)(2012-12#2)
two histidine residues in fatty acid ethyl ester synthase-III##2##9##(1992-4#2)
two histidine residues##5##3##(1991-12#1)(1992-4#2)(1995-5#1)(2008-7#1)
two histidine##7##2##(1991-12#1)(1992-1#1)(1992-4#2)(1992-8#1)(1995-5#1)(2008-7#1)
two holograms with a short time separation##2##7##(2008-3#2)
two holograms##5##2##(2007-12#1)(2008-3#4)
two homologous##13##2##(1992-12#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#2)(1995-10#1)(1996-7#1)(1997-2#1)(1997-7#3)
two hormones##6##2##(1995-12#1)(2006-10#1)(2008-11#2)(2008-6#1)(2011-2#1)
two horses##3##2##(1990-3#2)(1991-6#1)
two hospitals in##5##3##(1993-6#1)(2008-11#1)(2008-7#1)(2012-12#1)(2013-8#1)
two hospitals##14##2##(1990-2#1)(1991-7#1)(1993-6#1)(1994-1#1)(1994-12#1)(1995-1#1)(2006-8#1)(2008-11#1)(2008-7#1)(2010-4#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
two host species##4##3##(2008-8#1)(2008-9#1)(2010-2#1)(2012-3#1)
two host##6##2##(2007-6#1)(2008-8#1)(2008-9#2)(2010-2#1)(2012-3#1)
two hours after##5##3##(1997-3#1)(2007-12#1)(2010-7#1)(2011-12#1)(2013-1#1)
two hours in##3##3##(1992-3#1)(2007-2#1)(2012-3#1)
two hours of##4##3##(1990-9#1)(1994-3#1)(1997-6#1)(2010-7#1)
two hours per##2##3##(1992-6#1)(2008-12#1)
two hours##32##2##(1990-9#1)(1992-3#1)(1992-6#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1997-3#1)(1997-6#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#1)(2009-4#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-12#1)(2011-2#1)(2012-11#2)(2012-12#1)(2012-3#1)(2013-1#1)
two hours)##2##2##(1996-2#1)(2007-3#1)
two human brain##2##3##(1993-8#1)(1995-7#1)
two human cDNA##2##3##(1991-6#1)(1993-6#1)
two human cell lines##2##4##(1993-11#1)(2008-8#1)
two human monoclonal antibodies##2##4##(1993-5#2)
two human##30##2##(1991-12#1)(1991-6#1)(1992-12#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-7#1)(1996-11#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-2#1)(2010-10#1)(2012-4#1)
two hundred##3##2##(1990-6#1)(2007-2#1)(2013-1#1)
two hybrid system and##2##4##(1994-2#1)(2005-11#1)
two hybrid system##3##3##(1994-2#2)(2005-11#1)
two hybrid##5##2##(1994-2#2)(2005-11#1)(2008-2#1)(2008-7#1)
two hybridizable##2##2##(2008-9#2)
two hybrids##3##2##(1990-10#1)(2008-10#2)
two hydride##2##2##(1997-7#2)
two hydrogen bonds##6##3##(1991-2#1)(1994-5#1)(1995-5#1)(1996-7#2)(1997-7#1)
two hydrogen##7##2##(1991-2#1)(1994-5#1)(1995-5#1)(1996-7#2)(1997-7#1)(2012-3#1)
two hydrophilic##4##2##(2005-11#2)(2007-8#1)(2008-8#1)
two hydrophobic groups##2##3##(2005-11#2)
two hydrophobic regions##2##3##(1990-8#1)(1996-5#1)
two hydrophobic##6##2##(1990-8#1)(1995-6#1)(1996-5#2)(2005-11#2)
two hypersensitive##2##2##(1992-9#1)(1994-9#1)
two hypervariable regions##3##3##(1991-2#1)(1992-11#1)(2008-5#1)
two hypotheses about the##2##4##(2005-10#1)(2008-9#1)
two hypotheses concerning##2##3##(1991-5#1)(2007-8#1)
two hypotheses##13##2##(1991-5#1)(1994-2#1)(1996-4#1)(2005-10#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-8#1)
two hypothetical##3##2##(1993-12#1)(2008-7#1)(2010-11#1)
two identical subunits of##3##4##(1990-3#1)(1991-2#1)(1993-3#1)
two identical subunits##7##3##(1990-3#1)(1991-11#1)(1991-2#1)(1991-9#1)(1992-3#1)(1993-3#1)(2009-8#1)
two identical##33##2##(1990-12#1)(1990-2#2)(1990-3#1)(1991-11#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-8#1)(1997-2#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#4)(2008-3#4)(2009-4#1)(2009-8#1)(2013-1#1)
two identified##4##2##(1991-11#1)(1995-5#1)(1996-4#1)(1996-9#1)
two illustrative cases##2##3##(2007-1#2)
two image fusion##2##3##(2008-3#2)
two image##3##2##(2008-2#1)(2008-3#2)
two images are##3##3##(2007-11#1)(2008-3#1)(2008-6#1)
two images##14##2##(2007-11#1)(2007-12#1)(2008-2#5)(2008-3#5)(2008-6#1)(2011-1#1)
two immiscible phases##2##3##(2008-10#2)
two immiscible##6##2##(1993-8#1)(2008-10#4)(2008-8#1)
two immunoglobulin-like domains##2##3##(1992-12#1)(1994-12#1)
two important aspects##3##3##(2008-11#1)(2009-6#1)(2013-1#1)
two important issues##2##3##(2008-3#1)(2008-5#1)
two important public health##2##4##(2011-1#1)(2013-1#1)
two important##29##2##(1991-12#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-1#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-5#1)(2008-9#1)(2009-6#1)(2009-8#1)(2011-1#2)(2011-12#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
two improvements##2##2##(2007-12#1)(2008-3#1)
two in the##14##3##(1993-6#2)(1994-12#1)(1994-9#1)(1995-3#1)(1996-12#1)(1996-6#1)(2008-1#1)(2008-10#2)(2010-8#1)(2011-3#1)(2013-7#2)
two in vitro models##3##4##(1992-12#1)(1996-4#1)(2008-5#1)
two in vitro##6##3##(1992-12#1)(1992-8#1)(1996-4#1)(2008-10#1)(2008-5#1)(2012-2#1)
two in##38##2##(1990-5#1)(1992-12#2)(1992-8#1)(1993-12#1)(1993-5#1)(1993-6#2)(1994-12#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-6#2)(2005-11#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#7)(2008-2#1)(2008-5#2)(2009-6#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-7#2)
two in-line##2##2##(2008-2#2)
two inappropriate rust species##2##4##(2008-10#2)
two inbred strains of mice##3##5##(1990-2#2)(1994-2#1)
two inbred##4##2##(1990-2#2)(1994-2#1)(2009-10#1)
two incident##2##2##(2007-12#1)(2008-3#1)
two incoherently##2##2##(1997-7#1)(2007-12#1)
two independent and##2##3##(2005-11#1)(2008-10#1)
two independent conformations##2##3##(1991-3#2)
two independent methods##3##3##(1994-9#1)(1996-1#1)(1996-4#1)
two independent pathways##2##3##(1990-2#1)(1994-11#1)
two independent samples of##3##4##(2007-12#1)(2011-1#1)(2013-1#1)
two independent samples##4##3##(2007-12#1)(2010-7#1)(2011-1#1)(2013-1#1)
two independent studies##3##3##(1995-12#1)(2006-9#1)(2012-3#1)
two independent techniques##2##3##(2008-3#2)
two independent variables##2##3##(1997-1#1)(2011-2#1)
two independent##78##2##(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-3#2)(1992-5#1)(1992-6#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-1#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-7#1)(1997-8#2)(2005-11#1)(2006-12#2)(2006-4#1)(2006-8#1)(2006-9#1)(2007-11#5)(2007-12#3)(2008-10#7)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#3)(2009-6#1)(2009-8#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
two independently tunable##2##3##(2008-3#2)
two independently##9##2##(1990-8#1)(1995-12#1)(1997-7#1)(2005-7#1)(2008-3#2)(2009-7#1)(2011-2#1)(2013-8#1)
two indexes##3##2##(2007-3#1)(2008-10#1)(2011-2#1)
two indicators of##2##3##(2008-4#1)(2009-11#1)
two indicators##4##2##(2008-10#1)(2008-4#1)(2008-9#1)(2009-11#1)
two indirect##2##2##(1996-9#1)(2012-12#1)
two individual##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2008-9#1)
two individuals##7##2##(1995-6#1)(2006-12#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-3#1)
two infections##2##2##(1994-4#1)(2008-6#1)
two infectious##2##2##(2008-10#1)(2013-1#1)
two inhibitor##2##2##(1994-3#1)(1997-3#1)
two inhibitors of##2##3##(1990-11#1)(1995-8#1)
two inhibitory##2##2##(1992-6#1)(2006-7#1)
two initial##2##2##(2008-2#1)(2008-9#1)
two initially##4##2##(1994-9#1)(2007-12#1)(2008-1#1)(2008-3#1)
two initiation##2##2##(1992-9#1)(1997-6#1)
two initiatives##2##2##(1993-12#1)(1996-4#1)
two injection##2##2##(1992-3#1)(2010-2#1)
two injections of##2##3##(1995-12#1)(2009-8#1)
two injections##5##2##(1995-12#1)(2008-10#1)(2008-4#1)(2009-8#1)(2013-1#1)
two innovative##2##2##(2005-9#1)(2011-2#1)
two input##6##2##(2007-12#3)(2008-2#2)(2008-3#1)
two insect##3##2##(1990-7#1)(1992-11#1)(2012-12#1)
two instances##3##2##(1991-12#1)(1995-2#1)(2004-10#1)
two institutions##3##2##(2007-10#1)(2008-11#1)(2009-4#1)
two instruments##8##2##(2008-10#2)(2008-3#5)(2012-2#1)
two insulin##3##2##(1991-8#1)(1992-10#1)(1994-6#1)
two intense##2##2##(2006-12#1)(2007-11#1)
two intensities##3##2##(1993-12#1)(2008-2#2)
two interacting##6##2##(1997-5#1)(2008-1#1)(2009-8#2)(2011-2#1)(2012-12#1)
two interactions##2##2##(1996-7#1)(2008-11#1)
two interconvertible##2##2##(1990-8#1)(1994-3#1)
two interconverting##2##2##(1991-2#1)(1995-11#1)
two interesting##3##2##(1992-12#1)(2005-11#1)(2008-12#1)
two interfaces##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
two interfering##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
two interferograms##2##2##(2008-2#2)
two interferometry images##2##3##(2008-3#2)
two intermediate regions##3##3##(1990-3#3)
two intermediate##4##2##(1990-3#3)(1996-2#1)
two internal##4##2##(1996-3#1)(1997-1#1)(2007-12#1)(2008-9#1)
two interrelated receptor binding sites##2##5##(1991-3#2)
two interrelated##3##2##(1991-3#2)(2006-10#1)
two interspecific hybrid##2##3##(2008-10#2)
two interspecific##3##2##(2008-10#3)
two intervention##2##2##(1996-1#1)(2012-1#1)
two interventions##3##2##(1995-9#1)(2008-4#1)(2013-1#1)
two intracavity##2##2##(2007-11#1)(2007-12#1)
two intramolecular##3##2##(1995-2#1)(1996-5#1)(2008-4#1)
two intrapartum##2##2##(2011-2#2)
two introns and##2##3##(1995-8#1)(1995-9#1)
two introns in##2##3##(1997-4#1)(2010-5#1)
two introns##25##2##(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#3)(1991-5#1)(1991-9#1)(1992-8#1)(1993-2#2)(1993-5#1)(1993-6#1)(1993-8#2)(1994-3#1)(1995-2#2)(1995-8#1)(1995-9#1)(1996-4#1)(1997-4#1)(2008-10#1)(2008-6#1)(2010-5#1)
two inverted repeat sequences##2##4##(2008-8#2)
two inverted repeats##2##3##(1993-12#1)(1997-2#1)
two inverted##5##2##(1993-12#1)(1996-7#1)(1997-2#1)(2008-8#2)
two investigators##2##2##(1996-7#1)(2013-1#1)
two ionic##3##2##(2007-12#1)(2008-5#2)
two iron##2##2##(1992-4#1)(2009-9#1)
two irreversible##3##2##(1990-8#1)(1994-6#1)(2008-5#1)
two is##5##2##(1991-3#1)(2007-8#1)(2010-7#1)(2011-2#2)
two islands##3##2##(1991-4#1)(2007-2#1)(2008-8#1)
two isoforms have##2##3##(1992-8#1)(1995-2#1)
two isoforms of a##3##4##(1992-11#1)(1995-2#1)(1996-5#1)
two isoforms of pIGFBP-4##2##4##(1991-12#2)
two isoforms of rat kidney prostaglandin##2##6##(1994-9#2)
two isoforms of the##5##4##(1991-1#1)(1992-8#1)(1994-8#1)(1995-3#1)(1996-3#1)
two isoforms of##22##3##(1991-1#1)(1991-12#2)(1992-11#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#2)(1995-2#2)(1995-3#1)(1996-3#1)(1996-5#1)(1997-2#1)(2007-10#1)(2012-2#1)
two isoforms##38##2##(1991-1#1)(1991-12#2)(1992-1#2)(1992-11#1)(1992-8#2)(1993-12#2)(1994-11#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-8#4)(1994-9#2)(1995-2#3)(1995-3#2)(1995-8#1)(1995-9#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-6#1)(2007-10#1)(2007-12#1)(2012-2#2)
two isolated##8##2##(1990-12#1)(1991-8#1)(1992-4#1)(1994-12#1)(2005-11#2)(2008-4#1)(2011-1#1)
two isolates of R##3##4##(2008-10#3)
two isolates of the##2##4##(2008-10#1)(2011-12#1)
two isolates of##16##3##(1991-8#2)(2008-10#12)(2008-5#1)(2011-12#1)
two isolates that##2##3##(2008-10#2)
two isolates were##3##3##(2008-10#3)
two isolates##42##2##(1991-8#2)(1997-8#1)(2008-10#32)(2008-5#3)(2009-6#1)(2011-12#1)(2012-12#1)(2012-2#1)
two isomeric species##2##3##(1990-3#1)(1991-2#1)
two isomeric##8##2##(1990-3#1)(1991-2#1)(2007-1#2)(2007-11#2)(2008-10#1)(2010-5#1)
two isomers in##2##3##(2005-11#1)(2008-4#1)
two isomers of##2##3##(1993-12#1)(2008-10#1)
two isomers##12##2##(1990-12#1)(1991-4#1)(1993-12#1)(1996-2#1)(2005-11#1)(2006-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-3#1)(2010-5#1)
two isotypes of##4##3##(1990-8#2)(1994-11#1)(2008-4#1)
two isozyme##2##2##(1991-1#1)(1994-12#1)
two isozymes##2##2##(1994-12#1)(1996-3#1)
two isozymic forms##2##3##(1990-4#2)
two issues##5##2##(1992-3#1)(2008-10#1)(2009-11#1)(2010-7#1)(2013-8#1)
two items of##2##3##(1996-2#1)(2008-8#1)
two items##4##2##(1996-2#1)(2008-1#1)(2008-8#1)(2010-4#1)
two joint##2##2##(1992-3#1)(2008-8#1)
two jointed##2##2##(2007-12#1)(2013-1#1)
two key amino acid residues##2##5##(1994-9#2)
two key enzymes##2##3##(2008-5#1)(2012-2#1)
two key factors##3##3##(1997-2#1)(2008-10#1)(2008-12#1)
two key##24##2##(1990-9#1)(1994-9#2)(1997-2#2)(2005-8#1)(2006-10#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2009-9#1)(2011-1#1)(2012-2#2)
two kinases##3##2##(1994-8#1)(1995-11#1)(2009-8#1)
two kinds of perturbations##2##4##(2008-10#2)
two kinds of##51##3##(1992-11#2)(1992-8#1)(1993-3#1)(1994-2#1)(1995-9#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-4#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-12#1)(2007-4#1)(2008-10#10)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#4)(2010-11#1)(2011-3#1)(2012-1#1)(2012-3#1)(2013-8#3)
two kinds##53##2##(1992-11#2)(1992-8#1)(1993-3#1)(1994-2#1)(1995-9#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-4#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-12#2)(2007-4#1)(2008-10#10)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#1)(2010-11#1)(2011-3#1)(2012-1#1)(2012-3#1)(2013-8#3)
two kinetic##3##2##(1992-8#1)(1997-4#1)(2008-10#1)
two known compounds##4##3##(2006-12#1)(2007-1#2)(2008-3#1)
two known retinoic##2##3##(1994-12#1)(1995-1#1)
two known##20##2##(1990-1#1)(1990-3#1)(1991-12#1)(1992-3#1)(1994-12#1)(1995-1#2)(1995-6#1)(1997-2#1)(2006-12#2)(2007-1#4)(2007-12#1)(2008-2#2)(2008-3#1)(2009-8#1)
two labeled##2##2##(2008-10#1)(2008-4#1)
two laboratories##2##2##(1995-11#1)(2008-10#1)
two laboratory##2##2##(2008-10#1)(2008-8#1)
two lakes##2##2##(2007-3#1)(2010-6#1)
two languages##4##2##(2008-4#1)(2008-9#1)(2009-4#1)(2012-1#1)
two large##24##2##(1992-2#1)(1993-9#1)(1994-12#1)(1996-7#1)(1997-1#1)(1997-4#2)(2006-4#1)(2007-4#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2012-1#1)(2013-8#1)
two large-scale##2##2##(2006-4#1)(2011-12#1)
two largest lineages##3##3##(2008-10#3)
two largest##10##2##(1992-7#1)(1995-6#1)(2008-10#6)(2008-4#1)(2011-1#1)
two laser beams##3##3##(2008-2#1)(2008-3#2)
two laser##9##2##(2007-11#2)(2008-2#3)(2008-3#2)(2008-5#1)(2013-7#1)
two lasers##8##2##(2007-12#5)(2008-3#2)(2011-1#1)
two lasing##2##2##(2007-11#1)(2007-12#1)
two last##2##2##(2007-11#1)(2008-10#1)
two latent##2##2##(2007-8#1)(2009-7#1)
two lateral##3##2##(2007-12#1)(2008-7#1)(2011-2#1)
two laterally##2##2##(2008-2#2)
two latter##4##2##(1990-11#1)(1996-2#1)(2008-10#1)(2008-5#1)
two layered##2##2##(1993-7#1)(2007-9#1)
two layers of##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
two layers##14##2##(1994-6#1)(2007-12#1)(2008-10#2)(2008-12#2)(2008-2#5)(2008-3#3)
two leading##4##2##(2007-2#2)(2008-12#1)(2011-2#1)
two leaf##2##2##(2008-10#2)
two learning##2##2##(1996-3#1)(2008-12#1)
two legs##3##2##(1994-9#1)(2012-1#1)(2012-3#1)
two lesions##12##2##(1996-6#1)(2006-12#1)(2006-7#1)(2007-2#1)(2007-8#1)(2008-5#1)(2008-6#2)(2012-12#1)(2012-3#1)(2013-1#2)
two leukemia cell lines##2##4##(2008-3#1)(2011-2#1)
two level factorial##2##3##(2008-10#2)
two level##4##2##(2008-10#3)(2008-7#1)
two levels for##2##3##(1994-12#1)(2008-11#1)
two levels of##7##3##(1993-12#1)(2006-8#1)(2008-10#1)(2008-4#1)(2009-4#1)(2012-3#1)(2013-8#1)
two levels##21##2##(1992-9#1)(1993-12#2)(1994-12#1)(1995-1#1)(1996-12#1)(2006-7#1)(2006-8#3)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#1)(2012-3#1)(2013-8#1)
two life##2##2##(2006-10#1)(2008-5#1)
two lifetimes##2##2##(1991-7#1)(1996-8#1)
two ligands##10##2##(1991-10#1)(1995-1#1)(1996-2#1)(1996-6#1)(1997-2#2)(2005-11#1)(2008-10#3)
two ligated species##2##3##(1990-8#2)
two light##3##2##(1997-6#1)(2008-10#2)
two limiting cases##2##3##(2008-10#1)(2008-7#1)
two lineages##5##2##(2008-8#2)(2010-6#1)(2011-2#1)(2013-1#1)
two linear##7##2##(1995-2#1)(2008-10#3)(2008-2#2)(2011-2#1)
two lines of##3##3##(1994-2#2)(1995-12#1)
two lines##9##2##(1994-12#1)(1994-2#2)(1995-12#1)(1997-8#1)(2006-12#1)(2008-10#2)(2008-3#1)
two linked##2##2##(2008-11#1)(2012-2#1)
two linkers##2##2##(1991-8#1)(1994-6#1)
two lipid##3##2##(1990-2#1)(1991-9#1)(2006-10#1)
two lipophilic##4##2##(1994-5#1)(1996-11#2)(2008-10#1)
two liquid##2##2##(2005-11#1)(2008-10#1)
two liquid-crystal##2##2##(2008-2#1)(2008-3#1)
two lithium##2##2##(1997-7#1)(2007-11#1)
two loading##2##2##(2008-10#1)(2012-2#1)
two local recurrences##3##3##(1991-4#1)(1996-6#1)(2013-8#1)
two local##9##2##(1991-4#1)(1994-3#1)(1996-12#1)(1996-6#1)(2006-2#1)(2007-12#1)(2008-6#1)(2008-9#1)(2013-8#1)
two locations in##7##3##(2007-5#1)(2008-1#1)(2008-10#5)
two locations##20##2##(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-5#1)(2012-12#1)
two loci was##2##3##(1994-8#1)(2004-11#1)
two loci##13##2##(1993-11#1)(1993-6#1)(1994-8#1)(1996-11#1)(1996-3#1)(1997-5#1)(2004-11#1)(2008-10#3)(2008-4#1)(2008-9#1)(2012-3#1)
two long##11##2##(1991-12#1)(1995-8#1)(1997-3#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-4#1)(2012-2#1)
two long-lived##2##2##(1991-8#1)(2009-5#1)
two long-term##3##2##(1997-3#1)(2008-5#1)(2010-10#1)
two longitudinal modes##2##3##(2007-12#2)
two longitudinal studies##3##3##(2009-9#1)(2010-2#1)(2010-3#1)
two longitudinal##6##2##(2007-12#2)(2009-9#1)(2010-2#1)(2010-3#1)(2011-2#1)
two loop-containing regions of##2##4##(1992-9#2)
two loops##5##2##(1992-11#2)(1996-10#1)(1996-7#2)
two low molecular##2##3##(1991-8#1)(1994-12#1)
two low##9##2##(1991-5#1)(1991-8#1)(1994-12#1)(2007-3#2)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
two lower##5##2##(1992-11#1)(1993-4#1)(1993-9#1)(2005-8#1)(2008-10#1)
two mRNA forms##2##3##(1990-2#1)(1997-2#1)
two mRNA species##2##3##(1990-2#2)
two mRNA##5##2##(1990-2#3)(1997-2#1)(2008-8#1)
two mRNAs##4##2##(1992-6#1)(1992-8#1)(1994-6#1)(1996-11#1)
two main approaches##3##3##(2008-4#2)(2008-9#1)
two main categories##5##3##(1993-11#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-11#1)
two main clusters##3##3##(2008-10#2)(2008-5#1)
two main components##7##3##(1993-8#1)(2006-6#1)(2008-1#2)(2008-7#1)(2013-1#2)
two main families##2##3##(2008-1#1)(2012-2#1)
two main gaits are distinguished##2##5##(2012-12#2)
two main groups##7##3##(1991-10#1)(1997-3#1)(2006-2#1)(2008-10#2)(2008-5#1)(2013-8#1)
two main methods of##2##4##(1992-2#1)(2007-7#1)
two main methods##4##3##(1992-2#1)(2007-12#1)(2007-7#1)(2008-4#1)
two main options for##2##4##(2008-4#1)(2009-10#1)
two main parts##3##3##(2007-3#1)(2007-8#1)(2008-11#1)
two main peaks##2##3##(1992-7#1)(2008-10#1)
two main reasons for##2##4##(1996-6#1)(2011-2#1)
two main reasons##5##3##(1996-1#1)(1996-6#1)(2006-2#1)(2009-6#1)(2011-2#1)
two main##110##2##(1991-10#1)(1991-9#2)(1992-2#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-5#1)(1996-1#1)(1996-11#2)(1996-6#2)(1997-3#1)(1997-6#1)(2004-3#1)(2006-10#2)(2006-2#2)(2006-3#1)(2006-5#1)(2006-6#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#8)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#3)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#3)
two maize##5##2##(2008-12#3)(2008-7#2)
two major NORs##2##3##(1993-12#2)
two major approaches##2##3##(2008-4#1)(2012-2#1)
two major areas##2##3##(1990-12#1)(2008-10#1)
two major bands##3##3##(1991-2#1)(1992-5#1)(2009-11#1)
two major categories##3##3##(2008-11#1)(2008-4#2)
two major challenges##3##3##(2006-6#1)(2008-10#1)(2012-2#1)
two major clades##2##3##(2007-12#1)(2008-10#1)
two major classes of##3##4##(2005-7#1)(2008-5#1)(2009-8#1)
two major classes##4##3##(1995-3#1)(2005-7#1)(2008-5#1)(2009-8#1)
two major clusters##2##3##(2008-10#1)(2012-12#1)
two major functions##2##3##(1994-6#1)(2012-2#1)
two major groups of##3##4##(1990-5#1)(2008-10#2)
two major groups##7##3##(1990-5#1)(2004-11#1)(2006-10#1)(2008-10#4)
two major labeled bands##2##4##(1992-12#1)(1992-7#1)
two major metabolites##5##3##(1990-12#1)(1990-6#1)(1993-2#1)(1996-6#1)(2008-10#1)
two major pathways##3##3##(2008-9#1)(2010-2#1)(2011-2#1)
two major peaks of##4##4##(1990-7#1)(1993-12#1)(1993-6#1)(1995-3#1)
two major polypeptides of 100##2##5##(1991-2#1)(1995-2#1)
two major polypeptides##3##3##(1991-2#1)(1995-2#1)(1995-5#1)
two major problems##2##3##(1990-2#1)(1994-11#1)
two major protein bands##2##4##(1992-12#1)(2008-7#1)
two major protein##4##3##(1991-9#1)(1992-12#1)(2008-7#1)(2008-8#1)
two major proteins##2##3##(1990-8#1)(2008-10#1)
two major sources of##2##4##(1994-8#1)(2008-5#1)
two major sources##3##3##(1994-8#1)(2008-11#1)(2008-5#1)
two major##170##2##(1990-12#4)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#2)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-8#1)(1991-9#2)(1992-12#2)(1992-5#1)(1992-6#1)(1992-7#2)(1993-11#1)(1993-12#5)(1993-2#1)(1993-6#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-12#1)(1995-2#3)(1995-3#3)(1995-5#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2004-11#1)(2004-12#2)(2005-7#2)(2006-10#2)(2006-6#1)(2007-12#3)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#3)(2008-10#24)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#4)(2008-7#2)(2008-8#5)(2008-9#3)(2009-11#1)(2009-6#3)(2009-8#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#2)(2011-2#4)(2012-11#2)(2012-12#2)(2012-2#5)
two male##4##2##(1991-2#1)(1992-3#1)(1996-9#1)(2008-11#1)
two males aged##2##3##(2007-2#1)(2012-12#1)
two males##8##2##(1995-5#1)(2007-2#1)(2007-7#1)(2008-5#1)(2008-8#2)(2008-9#1)(2012-12#1)
two mammalian##2##2##(1991-12#1)(1993-12#1)
two marine##3##2##(2007-3#1)(2008-10#1)(2013-7#1)
two marker##2##2##(1992-3#1)(2008-5#1)
two markers##8##2##(1990-4#1)(2005-10#1)(2007-1#1)(2007-7#1)(2008-10#2)(2010-12#1)(2012-2#1)
two matched##4##2##(2008-1#1)(2008-11#1)(2008-3#1)(2011-2#1)
two materials in##3##3##(1990-11#1)(2007-12#1)(2008-5#1)
two materials##12##2##(1990-11#1)(2004-9#2)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#2)
two maternal##2##2##(1997-7#1)(2009-9#1)
two mathematical##3##2##(2008-10#2)(2013-8#1)
two mating types##2##3##(2008-10#2)
two mating##4##2##(1992-12#1)(2008-10#2)(2013-1#1)
two matrix metalloproteinases##2##3##(1994-12#1)(2007-1#1)
two matrix##4##2##(1994-12#3)(2007-1#1)
two may##2##2##(1992-2#1)(2007-7#1)
two mean##2##2##(1994-8#1)(2008-10#1)
two measurements of the##2##4##(2008-2#1)(2008-3#1)
two measurements of##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
two measurements##7##2##(1995-9#1)(2007-12#1)(2008-2#1)(2008-3#3)(2008-5#1)
two measures of##11##3##(1991-4#1)(1994-5#1)(1994-8#1)(1996-8#1)(1997-7#1)(2007-10#1)(2007-5#1)(2008-11#1)(2009-12#1)(2009-5#1)(2012-2#1)
two measures were##2##3##(1992-4#1)(2008-9#1)
two measures##20##2##(1991-4#1)(1992-4#1)(1994-5#1)(1994-8#1)(1996-8#1)(1997-7#1)(2007-10#1)(2007-5#1)(2008-11#2)(2008-6#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-5#1)(2010-3#1)(2010-8#1)(2012-2#2)
two mechanisms by which##2##4##(1995-2#1)(2010-4#1)
two mechanisms for the##2##4##(1993-3#1)(2008-10#1)
two mechanisms for##4##3##(1993-3#1)(1995-2#1)(2008-10#2)
two mechanisms of##4##3##(1993-12#1)(1995-2#1)(2008-3#1)(2008-7#1)
two mechanisms that##2##3##(2008-8#1)(2010-4#1)
two mechanisms##29##2##(1993-12#1)(1993-3#1)(1993-6#1)(1995-11#1)(1995-2#3)(1995-5#1)(1995-8#1)(1996-5#1)(1997-4#1)(2006-10#2)(2007-12#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-4#2)(2010-5#1)(2011-2#1)(2012-2#1)
two mechanistically distinct##2##3##(2009-9#1)(2012-2#1)
two media##2##2##(2006-10#1)(2007-11#1)
two mediastinal compartments##3##3##(2007-8#3)
two medical##7##2##(1995-11#1)(1995-8#1)(1996-1#1)(1996-6#1)(2006-4#1)(2011-1#1)(2013-1#1)
two meetings##2##2##(2012-12#2)
two meiotic##2##2##(2008-10#1)(2012-2#1)
two members of a##3##4##(1990-10#1)(2007-12#1)(2009-9#1)
two members of the matrix metalloproteinase##3##6##(1994-11#1)(2012-12#2)
two members of the##9##4##(1990-7#1)(1991-6#1)(1994-11#1)(1995-2#1)(1996-5#1)(2008-3#1)(2008-7#1)(2012-12#2)
two members of this family##2##5##(1994-3#1)(2009-8#1)
two members of this##3##4##(1994-3#1)(1996-8#1)(2009-8#1)
two members of##15##3##(1990-10#1)(1990-7#1)(1991-6#1)(1994-11#1)(1994-3#1)(1995-2#1)(1996-5#1)(1996-8#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-8#1)(2009-9#1)(2012-12#2)
two members##16##2##(1990-10#1)(1990-7#1)(1991-6#1)(1994-11#1)(1994-3#1)(1995-2#1)(1996-5#1)(1996-8#1)(2007-12#1)(2007-3#1)(2008-3#1)(2008-7#1)(2009-8#1)(2009-9#1)(2012-12#2)
two membrane##3##2##(1990-2#1)(1993-11#1)(2008-10#1)
two membranes##7##2##(1997-8#1)(2005-11#2)(2008-10#2)(2008-11#1)(2009-6#1)
two men##5##2##(1991-5#1)(1994-11#1)(1996-3#1)(2008-10#1)(2010-7#1)
two mentioned##3##2##(2008-10#1)(2008-12#2)
two mesocosms##2##2##(2010-8#2)
two messengers##2##2##(1990-7#1)(1993-9#1)
two metabolic##2##2##(1997-6#1)(2008-7#1)
two metabolites##6##2##(1991-5#1)(1993-2#1)(1995-3#1)(2005-7#1)(2007-11#1)(2008-10#1)
two metal ions##6##3##(1991-4#1)(1995-2#1)(1997-6#1)(2008-10#2)(2010-5#1)
two metal##11##2##(1991-4#1)(1995-2#1)(1997-6#1)(2005-11#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-5#1)(2011-1#1)
two metals##9##2##(1991-12#1)(1991-5#1)(2004-4#1)(2008-10#6)
two metastatic##2##2##(2008-10#1)(2010-5#1)
two methodologies for##2##3##(1992-3#1)(2008-10#1)
two methods and##2##3##(2008-10#1)(2012-3#1)
two methods are equivalent##2##4##(2008-3#2)
two methods are##10##3##(1997-2#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-4#1)(2012-12#1)
two methods differ##2##3##(1997-6#1)(2008-2#1)
two methods for the##2##4##(2008-10#1)(2008-3#1)
two methods for##15##3##(1992-10#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#3)(2008-9#1)(2010-12#1)(2012-1#1)
two methods in##5##3##(1992-12#1)(1996-11#1)(1996-12#1)(2011-12#1)(2013-7#1)
two methods of calcium phosphate-based eukaryotic cell transfection##3##8##(2008-1#1)(2008-2#1)(2008-4#1)
two methods of##24##3##(1997-2#1)(2004-9#1)(2005-4#1)(2006-8#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-7#1)(2013-1#1)
two methods provide##2##3##(2009-10#1)(2012-3#1)
two methods to##8##3##(1994-11#1)(2007-3#1)(2008-3#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-3#1)
two methods using##3##3##(1994-5#1)(1996-2#1)(1997-2#1)
two methods were compared##2##4##(2010-9#1)(2011-1#1)
two methods were found##2##4##(1996-8#1)(2009-6#1)
two methods were##13##3##(1996-8#1)(2007-3#1)(2008-10#5)(2008-7#1)(2009-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-7#1)
two methods with##2##3##(1995-2#1)(2012-2#1)
two methods##168##2##(1990-12#2)(1990-9#1)(1992-10#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-2#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-8#1)(1997-2#3)(1997-6#1)(2004-9#1)(2005-4#2)(2006-1#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#3)(2007-8#4)(2008-1#1)(2008-10#39)(2008-11#4)(2008-12#1)(2008-2#11)(2008-3#10)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#3)(2012-7#1)(2013-1#2)(2013-7#2)(2013-8#1)
two methylene groups##2##3##(2005-11#1)(2008-5#1)
two microorganisms##2##2##(1990-12#1)(2013-1#1)
two microsomal##2##2##(1994-9#1)(1995-3#1)
two milk##2##2##(1995-10#1)(2010-2#1)
two million##3##2##(2004-9#1)(2010-4#1)(2011-2#1)
two minor##10##2##(1993-12#1)(1994-2#1)(1995-6#1)(1995-8#1)(1997-8#1)(2004-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
two minutes##6##2##(1990-5#1)(1991-3#1)(1991-8#1)(1992-11#1)(2007-5#2)
two mirrors##5##2##(2006-5#1)(2007-12#1)(2008-2#1)(2008-3#2)
two miscible##3##2##(2008-2#1)(2008-3#1)(2011-2#1)
two mitochondrial derivatives##5##3##(2007-12#4)(2008-7#1)
two mitochondrial##8##2##(1991-7#1)(1997-4#1)(2007-12#4)(2008-7#1)(2013-7#1)
two mixtures##4##2##(2005-11#3)(2008-10#1)
two mobile##2##2##(1996-6#1)(2012-12#1)
two modalities##4##2##(2007-12#1)(2008-8#1)(2012-1#1)(2012-12#1)
two model parameters##2##3##(2008-7#2)
two model##10##2##(1991-6#1)(1995-8#1)(2004-4#1)(2005-11#1)(2008-7#2)(2008-9#1)(2010-4#1)(2012-11#1)(2013-7#1)
two models are##4##3##(1995-8#1)(2005-11#1)(2008-10#1)(2011-12#1)
two models for##2##3##(1991-1#1)(2008-8#1)
two models is##2##3##(2008-2#1)(2008-3#1)
two models of##8##3##(1992-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-8#1)
two models were compared##2##4##(1991-2#1)(2008-2#1)
two models were##4##3##(1990-10#1)(1991-2#1)(1992-5#1)(2008-2#1)
two models##33##2##(1990-10#1)(1991-1#1)(1991-2#1)(1992-5#1)(1992-8#1)(1995-8#2)(1996-3#1)(2005-11#1)(2007-10#1)(2007-11#3)(2007-2#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#3)(2008-8#4)(2008-9#1)(2009-8#3)(2010-8#1)(2011-12#1)
two modes of##15##3##(1990-9#1)(1993-9#1)(1994-11#1)(1995-11#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#1)(2008-8#2)(2008-9#1)(2009-4#1)(2011-1#1)
two modes##20##2##(1990-9#1)(1991-2#1)(1993-9#1)(1994-11#1)(1995-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-8#2)(2008-9#1)(2009-4#1)(2011-1#1)
two modifications##2##2##(2009-10#1)(2009-2#1)
two modified##3##2##(1993-11#1)(1997-1#1)(1997-2#1)
two modulation##2##2##(2006-12#1)(2007-12#1)
two modules##4##2##(2008-11#1)(2008-2#1)(2008-3#1)(2010-9#1)
two molecular##8##2##(1991-4#1)(2006-2#1)(2006-8#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
two molecules are##2##3##(1990-4#1)(1995-3#1)
two molecules in the asymmetric unit##3##6##(1991-4#1)(2008-8#1)(2009-3#1)
two molecules in the##4##4##(1991-4#1)(1992-9#1)(2008-8#1)(2009-3#1)
two molecules of##12##3##(1990-11#1)(1990-9#1)(1991-5#1)(1992-2#3)(1992-3#1)(1993-12#1)(1993-3#1)(1994-5#1)(1994-9#1)(2009-2#1)
two molecules##31##2##(1990-11#1)(1990-3#1)(1990-4#2)(1990-9#1)(1991-4#1)(1991-5#1)(1992-2#3)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2010-10#1)(2011-1#1)
two monkeys##5##2##(1995-12#1)(1995-8#1)(2005-11#3)
two monoclonal antibodies (MAbs)##2##4##(1990-12#1)(2008-10#1)
two monoclonal antibodies against##2##4##(1994-9#1)(2009-11#1)
two monoclonal antibodies directed against the##2##6##(1992-12#1)(1992-2#1)
two monoclonal antibodies directed##3##4##(1992-12#1)(1992-2#1)(1995-3#1)
two monoclonal antibodies##17##3##(1990-10#2)(1990-12#1)(1991-10#1)(1991-4#1)(1992-12#1)(1992-2#1)(1993-2#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-9#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-11#1)
two monoclonal##18##2##(1990-10#2)(1990-12#1)(1991-10#1)(1991-2#1)(1991-4#1)(1992-12#1)(1992-2#1)(1993-2#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-9#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-11#1)
two monolayer##2##2##(2007-9#1)(2008-3#1)
two monomeric##2##2##(1993-8#1)(2006-12#1)
two monomers##4##2##(1992-4#1)(2012-12#2)(2012-2#1)
two mononuclear##2##2##(1997-7#1)(2010-5#1)
two monthly##2##2##(2008-5#2)
two months after the##5##4##(1994-12#1)(1995-9#1)(2008-8#1)(2010-10#1)(2012-2#1)
two months after##13##3##(1991-3#1)(1994-12#1)(1995-9#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-8#2)(2010-10#2)(2012-2#1)(2013-1#1)
two months and##3##3##(1991-10#1)(2008-4#1)(2008-5#1)
two months duration##3##3##(2008-7#1)(2009-2#1)(2012-12#1)
two months in##3##3##(2007-9#1)(2008-3#1)(2009-3#1)
two months later##5##3##(2006-4#1)(2007-12#1)(2007-5#1)(2013-1#2)
two months of age##3##4##(1990-2#1)(2006-1#1)(2010-10#1)
two months of therapy##2##4##(2013-1#2)
two months of treatment##2##4##(2008-8#1)(2013-1#1)
two months of##14##3##(1990-2#1)(1992-11#1)(2006-1#1)(2007-7#1)(2008-5#1)(2008-8#1)(2010-10#1)(2011-2#1)(2013-1#6)
two months were##2##3##(2008-6#1)(2010-4#1)
two months without##3##3##(1997-6#1)(2008-10#1)(2008-2#1)
two months##72##2##(1990-2#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-11#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-11#2)(1995-9#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-1#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-10#3)(2010-4#2)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#9)
two more##13##2##(1991-9#1)(1996-2#1)(2007-12#2)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#2)(2010-12#1)
two morphological##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
two morphologically##4##2##(1995-8#1)(2007-12#1)(2008-10#1)(2008-8#1)
two mosquito##4##2##(2004-11#1)(2007-5#1)(2008-2#1)(2008-5#1)
two most common##14##3##(1991-8#1)(2004-10#1)(2005-7#1)(2005-8#1)(2006-4#1)(2007-12#4)(2007-6#1)(2008-10#1)(2008-3#1)(2012-12#1)(2012-2#1)
two most important##7##3##(1991-2#1)(1992-5#1)(1993-1#1)(1993-11#1)(2007-8#2)(2008-5#1)
two most widely used##3##4##(1992-6#1)(2005-9#1)(2008-9#1)
two most##42##2##(1991-2#1)(1991-5#1)(1991-8#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#1)(2004-10#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-3#2)(2006-4#1)(2007-12#5)(2007-5#1)(2007-6#1)(2007-8#2)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#2)(2008-9#1)(2009-12#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)
two motifs##3##2##(1996-4#1)(1997-7#1)(2012-3#1)
two mouse strains##2##3##(1992-4#1)(1996-10#1)
two mouse##7##2##(1992-1#1)(1992-4#1)(1993-6#1)(1996-10#1)(1997-6#1)(2008-4#1)(2008-8#1)
two movements at##2##3##(1994-3#2)
two multigenic families##2##3##(1997-9#2)
two murine##5##2##(1994-3#1)(1994-4#1)(1996-6#1)(2008-4#1)(2008-6#1)
two muscles##3##2##(1991-6#1)(2010-4#1)(2012-1#1)
two mutant forms##2##3##(1994-11#1)(1997-4#1)
two mutant##10##2##(1990-8#1)(1992-6#1)(1993-12#1)(1994-11#1)(1994-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1997-4#1)(2008-8#1)
two mutants were##2##3##(1990-6#1)(2008-12#1)
two mutants##11##2##(1990-5#1)(1990-6#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1997-4#1)(1997-7#1)(2008-12#1)(2008-5#1)(2008-9#1)
two mutated##3##2##(1990-4#2)(2008-12#1)
two mutations in##3##3##(1990-11#1)(2006-10#1)(2010-4#1)
two mutations were##3##3##(1993-11#1)(1995-1#1)(1995-6#1)
two mutations##13##2##(1990-11#1)(1991-1#1)(1991-4#1)(1992-11#1)(1993-11#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-6#1)(2006-10#1)(2008-12#1)(2010-4#1)(2012-12#1)
two mutually exclusive##3##3##(1991-6#1)(2008-1#1)(2008-8#1)
two mutually##8##2##(1991-6#1)(1995-8#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-11#1)(2008-8#1)
two national##2##2##(1992-1#1)(2012-3#1)
two nationally representative##3##3##(1993-1#1)(2008-10#1)(2008-11#1)
two native##3##2##(1990-5#1)(1994-8#1)(2008-5#1)
two natural##9##2##(1995-3#1)(1996-5#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-6#1)(2013-7#1)
two naturally occurring##5##3##(1991-10#1)(1991-12#1)(1994-9#1)(2008-11#1)(2008-3#1)
two naturally##6##2##(1991-10#1)(1991-12#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-3#1)
two near-infrared wavelengths##2##3##(2008-2#2)
two near-infrared##3##2##(2008-2#2)(2008-3#1)
two nebulizers##2##2##(1996-12#1)(2008-10#1)
two negative peaks##2##3##(1990-5#1)(2013-8#1)
two negative##5##2##(1990-5#1)(1997-2#1)(2007-10#1)(2009-8#1)(2013-8#1)
two negatively charged##2##3##(1991-5#1)(1997-5#1)
two neighboring##4##2##(2005-11#1)(2007-11#1)(2008-10#1)(2008-3#1)
two nematode##2##2##(2008-10#2)
two nested##3##2##(1994-9#1)(2010-8#1)(2012-12#1)
two neurobiological##2##2##(1993-11#1)(2008-7#1)
two neurons##5##2##(1990-4#1)(1991-11#1)(1993-12#1)(1993-2#1)(2009-5#1)
two neurotransmitters##2##2##(1996-7#1)(2008-10#1)
two new algorithms##2##3##(2008-3#2)
two new approaches to##2##4##(2007-12#1)(2008-2#1)
two new approaches##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
two new cases and##2##4##(2008-10#1)(2008-6#1)
two new cases of##2##4##(2006-12#1)(2008-10#1)
two new cases##5##3##(1990-11#1)(2006-12#1)(2008-10#2)(2008-6#1)
two new derivatives of##2##4##(1992-6#1)(2008-10#1)
two new features##2##3##(2008-10#1)(2008-2#1)
two new genotypes##2##3##(2008-10#2)
two new measures##2##3##(1992-9#1)(2010-4#1)
two new methods##3##3##(1996-2#1)(2008-10#1)(2012-3#1)
two new repetitive elements##2##4##(2011-12#2)
two new species##6##3##(2008-5#4)(2011-2#1)(2013-8#1)
two new tospovirus species##2##4##(2008-10#2)
two new##116##2##(1990-11#1)(1991-2#1)(1992-2#2)(1992-6#1)(1992-9#2)(1993-12#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-4#2)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-6#1)(1997-1#1)(1997-7#2)(1997-8#1)(2005-8#1)(2006-10#1)(2006-12#7)(2006-4#1)(2006-5#1)(2007-1#7)(2007-10#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-8#2)(2008-10#21)(2008-11#3)(2008-2#8)(2008-3#2)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-12#2)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
two newly described##2##3##(2008-10#2)
two newly##5##2##(1991-2#1)(2008-1#1)(2008-10#2)(2012-2#1)
two newspapers##2##2##(1992-9#1)(1997-5#1)
two noncollinear##2##2##(2007-12#2)
two nonidentical subunits##4##3##(1992-4#1)(1992-9#1)(1997-6#1)(2008-8#1)
two nonidentical##5##2##(1992-4#1)(1992-9#1)(1994-8#1)(1997-6#1)(2008-8#1)
two nonlinear##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2012-3#1)
two nonphotosynthetic orchids##2##3##(1997-4#2)
two normal##4##2##(1992-3#1)(1993-7#1)(2012-2#1)(2012-3#1)
two normally##3##2##(1990-10#1)(2007-11#1)(2010-3#1)
two novel genes##2##3##(1993-8#1)(1997-2#1)
two novel##36##2##(1990-2#2)(1990-4#2)(1990-7#1)(1991-12#1)(1992-12#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-3#2)(1995-6#1)(1996-2#1)(1997-2#1)(2005-7#1)(2005-8#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-11#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-9#2)(2011-2#1)(2013-1#2)
two nuclear##6##2##(1990-11#1)(1991-2#1)(1993-12#1)(1995-2#1)(1996-5#1)(2004-1#1)
two nuclei##2##2##(2008-10#2)
two nucleoli##2##2##(2008-5#1)(2008-7#1)
two nucleoside##2##2##(2005-7#1)(2008-5#1)
two nucleotide##4##2##(1991-2#1)(1992-9#1)(1996-12#1)(2008-11#1)
two nucleotides##4##2##(1997-2#1)(1997-4#1)(2008-10#1)(2008-5#1)
two numerical##2##2##(1996-5#1)(2007-11#1)
two nurses##3##2##(1994-10#1)(2006-2#1)(2009-2#1)
two nutritional##2##2##(2008-11#1)(2013-7#1)
two object##5##2##(1991-1#1)(1994-6#1)(2007-12#1)(2008-2#2)
two objective##4##2##(1990-10#1)(1993-6#1)(2008-3#1)(2008-9#1)
two objectives##4##2##(1992-2#1)(1994-2#1)(2011-1#1)(2011-2#1)
two objects##5##2##(1992-11#1)(1993-7#1)(1996-7#1)(2008-2#1)(2012-1#1)
two oblique##2##2##(2006-11#1)(2008-7#1)
two observations##9##2##(1990-10#1)(1994-12#1)(1995-1#1)(1995-9#1)(2006-6#1)(2008-10#1)(2008-11#1)(2010-10#1)(2010-3#1)
two observers##3##2##(1993-1#1)(2011-2#1)(2012-12#1)
two occasions##8##2##(1991-8#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)
two of 10##2##3##(2006-9#1)(2011-1#1)
two of a##2##3##(1990-10#1)(2008-11#1)
two of five##2##3##(2008-10#1)(2012-12#1)
two of four##8##3##(1990-2#1)(1992-2#1)(1996-11#1)(1996-12#1)(2008-10#4)
two of his##2##3##(1993-2#1)(2007-12#1)
two of our##3##3##(1991-3#1)(1995-8#1)(1997-5#1)
two of the 10 centers##2##5##(1991-10#1)(2007-9#1)
two of the 10##3##4##(1991-10#1)(1993-7#1)(2007-9#1)
two of the four##11##4##(1992-11#1)(1992-3#1)(1994-2#1)(1996-5#1)(1997-2#1)(2008-10#3)(2008-5#1)(2008-7#1)(2012-2#1)
two of the major##3##4##(1995-7#1)(2005-8#1)(2008-10#1)
two of the most common##2##5##(2012-2#2)
two of the most##10##4##(2005-11#1)(2006-12#1)(2006-6#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-2#2)
two of the other##2##4##(2004-2#1)(2006-10#1)
two of the six##3##4##(1993-3#1)(2008-10#1)(2010-5#1)
two of the subjects##2##4##(1993-9#1)(1996-5#1)
two of the three patients##2##5##(1995-1#1)(2006-8#1)
two of the three##12##4##(1991-3#1)(1994-5#1)(1995-1#1)(1997-4#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-10#3)(2008-2#1)(2008-8#1)
two of the##129##3##(1990-1#1)(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-10#2)(1991-3#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-3#5)(1992-6#1)(1993-1#1)(1993-3#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-2#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#3)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-2#1)(2004-4#2)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-4#2)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#2)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-9#2)(2008-10#15)(2008-2#3)(2008-3#1)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#2)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-11#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)
two of them also##2##4##(1992-2#1)(2008-4#1)
two of them were##4##4##(2004-2#1)(2007-7#1)(2008-10#1)(2008-9#1)
two of them##26##3##(1991-5#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-10#1)(1994-2#1)(1995-6#1)(1996-3#1)(1996-9#1)(2004-2#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-9#2)(2009-2#1)(2011-12#1)(2012-3#1)
two of these had##2##4##(1994-6#1)(1995-5#1)
two of these patients##3##4##(2004-1#1)(2008-2#1)(2011-1#1)
two of these regions##2##4##(1993-6#1)(1993-8#1)
two of these were##2##4##(1996-3#1)(1997-8#1)
two of these##36##3##(1990-12#1)(1990-8#1)(1991-1#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-1#1)(2006-9#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-9#1)(2011-1#1)(2012-11#1)(2013-1#1)
two of three experiments##2##4##(2008-10#2)
two of three##8##3##(1992-2#1)(2008-10#5)(2008-11#1)(2008-5#1)
two of which were##3##4##(1995-1#1)(1997-2#1)(2006-12#1)
two of which##18##3##(1993-3#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-6#1)(1996-3#1)(1997-2#1)(1997-4#1)(2006-10#1)(2006-11#1)(2006-12#1)(2008-10#3)(2008-5#1)(2008-8#1)(2010-2#1)(2013-8#1)
two of whom##3##3##(1990-8#1)(1991-5#1)(2008-7#1)
two of##272##2##(1990-1#1)(1990-10#3)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-8#3)(1991-1#1)(1991-10#2)(1991-3#2)(1991-5#2)(1991-6#2)(1992-1#2)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#6)(1992-6#1)(1992-8#3)(1992-9#1)(1993-1#3)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#3)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#2)(1994-11#4)(1994-12#1)(1994-2#3)(1994-5#1)(1994-6#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#2)(1996-11#3)(1996-12#2)(1996-2#2)(1996-3#5)(1996-5#3)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#2)(1997-8#1)(2004-1#1)(2004-2#2)(2004-4#2)(2005-11#2)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#3)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#2)(2007-2#2)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#3)(2008-10#33)(2008-11#4)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#12)(2008-6#3)(2008-7#7)(2008-8#4)(2008-9#5)(2009-2#1)(2009-9#1)(2010-2#2)(2010-5#1)(2011-1#4)(2011-12#1)(2011-2#4)(2012-11#3)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#1)
two older##2##2##(1992-12#1)(2006-11#1)
two oligonucleotides##4##2##(1991-1#1)(1991-6#1)(2006-8#1)(2011-2#1)
two on the##2##3##(2008-12#1)(2008-2#1)
two on##5##2##(1997-5#1)(2008-10#2)(2008-12#1)(2008-2#1)
two one-dimensional##3##2##(2007-12#1)(2008-1#1)(2008-2#1)
two one-sided tests procedure##2##4##(1995-4#2)
two one-sided tests procedures##3##4##(1995-4#3)
two one-sided tests##5##3##(1995-4#5)
two one-sided##6##2##(1995-4#6)
two open reading frames (ORFs)##2##5##(1996-6#1)(2008-10#1)
two open reading frames##12##4##(1990-1#1)(1990-11#1)(1990-5#1)(1991-7#2)(1991-9#1)(1994-9#1)(1996-6#1)(2005-11#1)(2008-10#3)
two open reading##13##3##(1990-1#1)(1990-11#1)(1990-5#1)(1991-7#2)(1991-9#1)(1994-9#2)(1996-6#1)(2005-11#1)(2008-10#3)
two open##14##2##(1990-1#1)(1990-11#2)(1990-5#1)(1991-7#2)(1991-9#1)(1994-9#2)(1996-6#1)(2005-11#1)(2008-10#3)
two open-ended questions##2##3##(2007-9#1)(2013-1#1)
two open-ended##3##2##(1992-12#1)(2007-9#1)(2013-1#1)
two operons##3##2##(1993-11#2)(1997-1#1)
two opioid peptides##2##3##(1992-11#2)
two opposed##2##2##(1990-12#1)(2012-2#1)
two opposing##5##2##(1995-9#1)(1996-12#1)(2006-12#1)(2007-11#1)(2008-9#1)
two opposite sides##2##3##(2008-11#1)(2008-8#1)
two opposite##6##2##(2005-11#1)(2007-6#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-1#1)
two optical##8##2##(1990-8#1)(2007-12#3)(2008-10#1)(2008-3#3)
two options##2##2##(2008-8#1)(2011-2#1)
two or four##3##3##(1996-12#1)(2008-2#1)(2008-3#1)
two or more different##2##4##(1992-7#1)(2010-12#1)
two or more drugs##2##4##(1997-2#1)(2008-10#1)
two or more groups##4##4##(1994-5#1)(1994-9#1)(2008-10#1)(2008-9#1)
two or more levels##2##4##(2006-8#1)(2007-11#1)
two or more of##5##4##(1990-8#1)(1994-3#1)(1997-2#1)(2007-7#1)(2008-4#1)
two or more operations##2##4##(1991-2#1)(2006-3#1)
two or more pathogens##2##4##(2008-10#2)
two or more sex partners##2##5##(2012-1#1)(2012-12#1)
two or more steps##2##4##(1990-8#1)(2006-5#1)
two or more##98##3##(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-12#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-2#2)(1993-9#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-4#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-4#2)(1996-5#1)(1997-2#5)(1997-4#1)(1997-7#1)(1997-8#1)(2005-12#1)(2006-10#4)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-8#3)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#11)(2008-11#1)(2008-3#3)(2008-4#4)(2008-9#5)(2009-2#1)(2009-5#1)(2010-1#1)(2010-12#2)(2010-8#2)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
two or one##2##3##(1995-11#1)(2006-12#1)
two or possibly three##2##4##(1997-1#1)(2011-2#1)
two or three dimensions##2##4##(2007-12#1)(2007-8#1)
two or three distinct##2##4##(1994-3#1)(2008-10#1)
two or three times##3##4##(1994-1#1)(2007-7#1)(2008-5#1)
two or three##36##3##(1990-10#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-10#2)(1992-8#1)(1994-1#1)(1994-3#2)(1995-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(2005-10#1)(2005-3#1)(2005-7#1)(2006-8#1)(2007-12#3)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-10#1)(2012-2#1)
two or##151##2##(1990-10#1)(1990-3#1)(1990-6#1)(1990-8#3)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-12#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-2#2)(1993-9#1)(1994-1#1)(1994-3#3)(1994-5#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#1)(1995-4#1)(1995-6#1)(1996-10#1)(1996-12#3)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-12#1)(2005-3#1)(2005-7#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#1)(2006-8#4)(2007-11#1)(2007-12#4)(2007-3#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#16)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#6)(2009-10#1)(2009-2#1)(2009-5#2)(2010-1#1)(2010-12#2)(2010-8#2)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
two orchid##4##2##(2008-10#4)
two orders of magnitude higher than##2##6##(1995-8#1)(2012-2#1)
two orders of magnitude higher##3##5##(1995-8#1)(1996-11#1)(2012-2#1)
two orders of magnitude in##2##5##(1990-12#1)(1990-5#1)
two orders of magnitude lower than##3##6##(1995-8#1)(2008-10#1)(2008-7#1)
two orders of magnitude##31##4##(1990-11#1)(1990-12#1)(1990-5#1)(1995-8#2)(1996-11#1)(1997-2#1)(1997-4#1)(2005-12#1)(2008-10#13)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-12#1)(2012-2#1)(2013-8#1)
two orders##32##2##(1990-11#1)(1990-12#1)(1990-5#1)(1994-5#1)(1995-8#2)(1996-11#1)(1997-2#1)(1997-4#1)(2005-12#1)(2008-10#13)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-12#1)(2012-2#1)(2013-8#1)
two organic##6##2##(1996-5#1)(2006-3#1)(2007-11#1)(2008-10#1)(2009-10#2)
two organisms##6##2##(1991-3#1)(1993-11#1)(1997-2#1)(2006-10#1)(2008-10#1)(2008-7#1)
two orientations##3##2##(1994-9#1)(1997-8#1)(2008-3#1)
two orthogonal polarization modes##3##4##(2007-11#2)(2008-3#1)
two orthogonal polarization##6##3##(2007-11#3)(2008-2#2)(2008-3#1)
two orthogonal polarizations##2##3##(2007-12#1)(2008-3#1)
two orthogonal##22##2##(1997-8#1)(2007-11#3)(2007-12#4)(2008-1#1)(2008-2#5)(2008-3#8)
two orthogonal-polarized components##2##3##(2008-3#2)
two orthogonally polarized components##2##4##(2007-11#1)(2008-3#1)
two orthogonally polarized##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
two other CAD risk factors##2##5##(1991-7#2)
two other VACTERL malformations##2##4##(1996-6#2)
two other genes##3##3##(1990-11#1)(2007-2#1)(2012-11#1)
two other groups##4##3##(1992-1#1)(2008-12#1)(2008-5#1)(2008-7#1)
two other methods##2##3##(2008-3#1)(2008-6#1)
two other patients##6##3##(1992-11#1)(1994-3#1)(1997-3#1)(2006-9#1)(2007-7#1)(2007-8#1)
two other proteins##2##3##(1991-1#1)(1997-6#1)
two other regions##3##3##(1990-10#1)(1990-7#1)(1997-7#1)
two other species##4##3##(2007-6#1)(2008-10#1)(2008-9#1)(2011-2#1)
two other subtypes##2##3##(1992-7#1)(1997-5#1)
two other subunits##2##3##(1996-5#1)(2009-2#1)
two other##133##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-7#4)(1990-8#1)(1991-1#2)(1991-2#1)(1991-6#1)(1991-7#2)(1992-1#2)(1992-11#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-6#2)(1993-8#1)(1994-12#2)(1994-3#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#3)(1996-2#1)(1996-4#1)(1996-5#3)(1996-6#4)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#4)(2013-8#2)
two others##11##2##(1991-4#1)(1993-1#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-5#1)(2007-7#1)(2008-10#2)(2008-8#1)(2010-5#1)
two out of seven##3##4##(1990-7#1)(1990-8#1)(2007-8#1)
two out of the##3##4##(1993-8#1)(2008-2#1)(2011-2#1)
two out of three cases##2##5##(1991-12#1)(1996-12#1)
two out of three##5##4##(1991-12#1)(1996-12#1)(2006-12#1)(2008-1#1)(2008-5#1)
two out of##13##3##(1990-7#1)(1990-8#1)(1991-12#1)(1992-4#1)(1993-8#1)(1994-2#1)(1996-12#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-5#1)(2011-2#1)
two outbreaks of##2##3##(2008-11#1)(2008-5#1)
two outcome groups##2##3##(2008-7#1)(2009-4#1)
two outcome##3##2##(2008-7#1)(2009-4#1)(2010-7#1)
two outer ring electrodes##2##4##(2008-10#2)
two output##2##2##(2007-11#1)(2008-2#1)
two overlaid##2##2##(2008-3#2)
two overlapping genomic##2##3##(1991-4#1)(1997-8#1)
two overlapping##11##2##(1990-9#1)(1991-4#1)(1991-5#1)(1992-6#1)(1994-3#1)(1996-10#1)(1996-2#1)(1996-6#1)(1997-8#1)(2012-3#2)
two oxidative##2##2##(1991-2#1)(2008-4#1)
two oxygen atoms##2##3##(1997-1#1)(2008-5#1)
two oxygen##3##2##(1997-1#1)(2008-5#1)(2010-12#1)
two paediatric##2##2##(2008-9#1)(2010-7#1)
two pairs of IR receptors##2##5##(2007-12#2)
two pairs of degenerate primers##2##5##(2008-10#2)
two pairs of##29##3##(1991-7#1)(1992-7#1)(1994-5#2)(1994-9#2)(1995-2#1)(1995-3#1)(1995-8#1)(2005-11#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#7)(2007-8#1)(2008-10#3)(2008-5#1)(2010-11#1)(2012-1#1)(2012-11#1)(2013-7#1)
two pairs##31##2##(1991-7#1)(1992-2#1)(1992-7#1)(1993-12#1)(1994-5#2)(1994-9#2)(1995-2#1)(1995-3#1)(1995-8#1)(2005-11#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#7)(2007-8#1)(2008-10#3)(2008-5#1)(2010-11#1)(2012-1#1)(2012-11#1)(2013-7#1)
two palatal roots##4##3##(2013-1#4)
two palatal##8##2##(2013-1#8)
two papers##6##2##(2005-7#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-4#1)(2009-8#1)
two paradigms##2##2##(2006-6#1)(2008-2#1)
two parallel measurements##2##3##(2005-9#2)
two parallel##13##2##(1995-11#1)(2005-9#2)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-5#1)(2011-1#1)
two parameters can##2##3##(2008-2#1)(2008-3#1)
two parameters is##2##3##(1990-12#1)(1995-12#1)
two parameters that##2##3##(2008-2#1)(2008-9#1)
two parameters were##2##3##(1992-11#1)(2008-10#1)
two parameters##42##2##(1990-12#1)(1990-3#1)(1992-11#1)(1992-6#1)(1992-8#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1997-5#1)(2005-11#4)(2007-10#1)(2007-2#2)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#5)(2008-3#3)(2008-6#2)(2008-7#2)(2008-9#1)(2010-4#1)(2010-8#1)(2012-2#1)
two parasitic##2##2##(1996-1#1)(2007-1#1)
two parasitoid species##2##3##(2007-6#1)(2008-8#1)
two parinaroyl##2##2##(1990-4#2)
two partial##6##2##(1990-8#1)(1991-5#1)(1995-12#1)(1997-7#1)(2008-5#1)(2011-1#1)
two partially##7##2##(1996-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-6#1)(2010-10#1)
two particles##4##2##(2005-11#2)(2008-3#2)
two particular##3##2##(1990-7#1)(2006-12#1)(2013-8#1)
two parties##4##2##(1991-6#1)(1994-1#1)(2006-8#1)(2008-8#1)
two parts##27##2##(1993-1#1)(1994-1#1)(1996-11#2)(1997-2#1)(1997-6#1)(1997-7#1)(2006-4#1)(2006-7#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#4)
two patch##2##2##(2005-12#2)
two pathogenic fungi##2##3##(2008-10#1)(2011-1#1)
two pathogenic species##2##3##(2008-10#2)
two pathogenic##4##2##(2008-10#3)(2011-1#1)
two pathogenicity groups##2##3##(2008-10#2)
two pathogenicity##3##2##(2008-10#3)
two pathogens##10##2##(2008-10#7)(2008-7#1)(2008-9#1)(2010-4#1)
two pathologists##2##2##(1992-8#1)(2011-2#1)
two pathotypes##2##2##(2008-10#2)
two paths##3##2##(1996-1#1)(2008-2#1)(2008-3#1)
two pathways may##2##3##(1996-11#1)(2011-1#1)
two pathways to##2##3##(1992-5#1)(2008-1#1)
two pathways##19##2##(1992-5#1)(1994-11#1)(1994-3#1)(1995-3#1)(1996-11#1)(1996-5#1)(1996-8#1)(2008-1#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#1)
two patient groups##6##3##(1992-5#1)(1996-5#1)(2006-7#1)(2007-4#1)(2007-9#1)(2008-3#1)
two patient##9##2##(1992-5#1)(1993-12#1)(1996-5#1)(2006-7#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-3#1)(2013-1#1)
two patients a##4##3##(2006-12#1)(2006-8#1)(2008-7#1)(2008-9#1)
two patients and##6##3##(2006-12#1)(2006-8#1)(2007-7#1)(2007-8#1)(2010-5#1)(2012-12#1)
two patients are##2##3##(1992-2#1)(2008-6#1)
two patients at the##2##4##(1991-5#1)(2010-7#1)
two patients at##3##3##(1991-5#1)(2006-7#1)(2010-7#1)
two patients complained of##2##4##(1990-6#1)(2008-8#1)
two patients developed##3##3##(1996-9#1)(2006-11#1)(2011-1#1)
two patients had##10##3##(1991-4#1)(1995-6#1)(2006-11#1)(2007-8#2)(2008-10#1)(2008-4#2)(2013-1#1)(2013-8#1)
two patients in the##2##4##(1992-11#1)(2010-12#1)
two patients in##7##3##(1992-11#1)(1994-10#1)(2006-7#1)(2008-6#1)(2010-12#1)(2010-2#1)(2013-1#1)
two patients of##2##3##(2007-7#1)(2008-11#1)
two patients required##2##3##(2006-6#1)(2008-1#1)
two patients suffered from##2##4##(2007-8#1)(2010-10#1)
two patients suffering from##4##4##(1993-10#1)(1997-6#1)(2013-1#2)
two patients the##3##3##(1993-5#1)(2006-6#2)
two patients treated##3##3##(1992-3#1)(1992-4#1)(2008-6#1)
two patients underwent##5##3##(2006-11#1)(2006-12#1)(2006-8#1)(2007-8#1)(2008-8#1)
two patients we##2##3##(1996-9#1)(2007-8#1)
two patients were diagnosed##2##4##(2012-12#1)(2012-2#1)
two patients were included in##2##5##(2007-9#1)(2012-3#1)
two patients were included##3##4##(2006-8#1)(2007-9#1)(2012-3#1)
two patients were treated##2##4##(1990-6#1)(2006-8#1)
two patients were##15##3##(1990-2#1)(1990-6#1)(1994-11#1)(2004-1#1)(2006-11#1)(2006-8#2)(2007-2#1)(2007-9#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
two patients who developed##2##4##(2008-1#1)(2012-2#1)
two patients who had##2##4##(1995-11#1)(1997-8#1)
two patients who have##2##4##(1990-4#1)(2008-3#1)
two patients who presented with##2##5##(2008-6#1)(2009-10#1)
two patients who presented##3##4##(2007-9#1)(2008-6#1)(2009-10#1)
two patients who received##2##4##(1993-1#1)(2013-1#1)
two patients who##15##3##(1990-4#1)(1993-1#1)(1995-11#1)(1996-6#1)(1997-8#1)(2006-6#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
two patients with chronic##2##4##(1992-11#1)(2007-11#1)
two patients with type##2##4##(2007-8#2)
two patients with##68##3##(1990-3#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-5#1)(1994-11#1)(1994-2#1)(1995-10#1)(1995-11#1)(1995-5#1)(1996-3#1)(1996-7#1)(1996-9#2)(2006-10#2)(2006-11#1)(2006-12#3)(2006-6#1)(2006-7#1)(2007-11#2)(2007-8#5)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-4#1)(2010-7#2)(2011-1#2)(2011-2#2)(2012-12#2)(2013-1#5)
two patients without##3##3##(2007-7#1)(2008-5#1)(2013-1#1)
two patients##263##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#4)(1990-4#3)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#3)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#3)(1991-5#2)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#1)(1993-1#2)(1993-10#1)(1993-2#2)(1993-5#2)(1994-10#1)(1994-11#2)(1994-2#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#6)(1997-4#1)(1997-6#1)(1997-8#1)(2004-1#1)(2006-1#1)(2006-10#4)(2006-11#6)(2006-12#10)(2006-3#1)(2006-5#2)(2006-6#9)(2006-7#4)(2006-8#6)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#9)(2007-8#19)(2007-9#2)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#5)(2008-5#4)(2008-6#8)(2008-7#14)(2008-8#3)(2008-9#6)(2009-10#3)(2009-2#1)(2009-4#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#3)(2010-7#3)(2011-1#5)(2011-2#9)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#12)(2013-8#1)
two patients)##4##2##(2006-8#1)(2007-9#1)(2008-6#1)(2011-2#1)
two pattern recognition methods##2##4##(2008-10#2)
two patterns of##5##3##(1992-5#1)(2004-11#1)(2008-2#1)(2012-2#1)(2013-8#1)
two patterns##8##2##(1992-5#1)(2004-11#2)(2008-2#1)(2008-5#1)(2012-1#1)(2012-2#1)(2013-8#1)
two pea##2##2##(2008-10#2)
two peaks of##9##3##(1990-2#1)(1991-4#2)(1992-1#2)(1992-12#2)(1995-6#1)(2013-1#1)
two peaks were identified##2##4##(2008-10#1)(2008-11#1)
two peaks were##3##3##(2008-10#2)(2008-11#1)
two peaks##35##2##(1990-2#2)(1990-5#2)(1990-8#3)(1991-10#1)(1991-12#1)(1991-4#2)(1991-5#1)(1992-1#2)(1992-12#2)(1993-11#1)(1994-3#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-6#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2010-12#1)(2011-1#2)(2011-2#1)(2013-1#1)
two peanut genotypes##2##3##(2008-10#2)
two pediatric patients with##2##4##(2007-7#1)(2008-5#1)
two pediatric##3##2##(2007-7#1)(2008-5#1)(2013-1#1)
two people##2##2##(1994-12#1)(2008-10#1)
two peptide fragments##3##3##(1991-7#1)(1995-1#1)(2006-12#1)
two peptide sequences##2##3##(1995-5#1)(2008-10#1)
two peptide##7##2##(1991-7#1)(1992-10#1)(1994-11#1)(1995-1#1)(1995-5#1)(2006-12#1)(2008-10#1)
two peptides are##2##3##(1992-6#1)(2011-2#1)
two peptides have##2##3##(1991-9#1)(2006-12#1)
two peptides in##3##3##(1991-2#1)(1992-11#1)(1994-11#1)
two peptides were##3##3##(1990-5#1)(1995-11#1)(2008-7#1)
two peptides##33##2##(1990-10#2)(1990-11#1)(1990-5#1)(1990-6#1)(1991-2#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-11#3)(1994-12#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-4#1)(1997-4#1)(2006-12#2)(2008-10#2)(2008-3#1)(2008-7#1)(2010-2#1)(2011-2#1)
two per cent##3##3##(1995-12#3)
two per##5##2##(1995-12#3)(2007-10#1)(2008-6#1)
two percent##3##2##(2010-8#1)(2013-1#1)(2013-8#1)
two periods of##3##3##(2006-4#1)(2011-12#1)(2011-2#1)
two periods were compared##2##4##(2006-8#1)(2011-2#1)
two periods##16##2##(1996-3#1)(2006-4#1)(2006-7#2)(2006-8#2)(2007-12#1)(2010-4#2)(2011-12#1)(2011-2#4)(2012-3#1)(2013-1#1)
two peripheral##2##2##(2011-1#1)(2013-1#1)
two permanent##2##2##(1996-12#1)(2007-3#1)
two perpendicular directions##2##3##(1990-9#1)(2008-3#1)
two perpendicular##10##2##(1990-9#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)(2012-12#2)
two perspectives##2##2##(2007-6#1)(2008-6#1)
two pertussis toxin substrates##2##4##(1990-3#1)(1991-9#1)
two pertussis##3##2##(1990-3#1)(1991-9#1)(1992-2#1)
two phage-displayed##2##2##(1994-12#1)(1994-9#1)
two pharmacologically##2##2##(1991-3#1)(1993-3#1)
two phase I##3##3##(1994-9#1)(1995-2#1)(2005-8#1)
two phase differences##2##3##(2008-3#2)
two phase##13##2##(1994-9#1)(1995-2#1)(2005-8#1)(2007-12#2)(2008-2#1)(2008-3#5)(2008-5#2)
two phase-only##2##2##(2008-3#2)
two phase-systems##2##2##(2008-10#2)
two phases in##3##3##(1992-4#1)(2008-10#1)(2008-5#1)
two phases of the##4##4##(1994-12#1)(1996-1#1)(1996-2#1)(2008-3#1)
two phases of##9##3##(1990-2#1)(1994-12#1)(1996-1#1)(1996-2#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-12#1)
two phases to##2##3##(1992-8#1)(2008-2#1)
two phases was##3##3##(1991-6#1)(2008-10#1)(2012-11#1)
two phases were##2##3##(1990-10#1)(1993-12#1)
two phases##47##2##(1990-10#1)(1990-2#1)(1991-6#1)(1991-8#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-4#1)(2004-12#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#1)(2010-11#1)(2010-12#2)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#1)
two phasors##2##2##(2008-2#2)
two phenol sulphotransferase genes##2##4##(1994-11#2)
two phenomena that##2##3##(2007-12#1)(2008-7#1)
two phenomena##9##2##(1995-5#1)(2005-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-7#1)(2009-2#1)
two phenotypic##3##2##(1993-2#1)(2010-3#1)(2013-8#1)
two phosphonic acids##2##3##(2008-10#2)
two phosphoproteins##4##2##(1990-11#2)(1994-11#1)(1995-11#1)
two phosphoryl groups##2##3##(1992-4#1)(2008-10#1)
two phosphorylated##3##2##(1991-2#1)(1996-5#1)(2008-8#1)
two photon##2##2##(2008-11#1)(2013-1#1)
two photons##2##2##(1992-4#1)(2007-11#1)
two photoproducts##3##2##(1991-7#1)(1995-1#2)
two photorefractive##2##2##(2007-11#1)(2008-2#1)
two phylogenetically##3##2##(1996-8#1)(2006-12#1)(2008-10#1)
two physically##4##2##(1994-6#1)(2005-11#1)(2008-11#1)(2009-12#1)
two physiological##2##2##(1993-6#1)(1997-4#1)
two pieces of the##2##4##(2008-2#1)(2010-10#1)
two pioneering##2##2##(1992-12#1)(2005-7#1)
two pixels##2##2##(2007-11#2)
two placebo-controlled##2##2##(1993-11#1)(2009-11#1)
two plane##6##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)
two planes of##2##3##(2007-12#1)(2010-5#1)
two planes##4##2##(2007-11#1)(2007-12#1)(2007-7#1)(2010-5#1)
two plant species##4##3##(2008-10#2)(2008-5#1)(2009-3#1)
two plant##9##2##(1994-3#2)(2007-1#1)(2008-10#3)(2008-5#1)(2008-9#1)(2009-3#1)
two plants were##2##3##(2008-10#1)(2008-8#1)
two plants##6##2##(1994-6#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-12#1)
two plasmids##4##2##(1990-3#1)(1991-5#1)(1997-3#1)(2011-2#1)
two plates of##2##3##(2008-9#1)(2010-10#1)
two plates##3##2##(2008-2#1)(2008-9#1)(2010-10#1)
two plots were treated##2##4##(2008-10#2)
two pneumonia##2##2##(2007-7#1)(2007-8#1)
two point mutations##6##3##(1991-8#1)(1993-11#1)(1993-8#1)(1996-5#1)(1997-7#1)(2010-12#1)
two point sets##3##3##(2008-2#3)
two point##11##2##(1991-8#1)(1993-11#1)(1993-8#1)(1996-5#1)(1997-7#1)(2008-2#4)(2008-3#1)(2010-12#1)
two points in a##2##4##(1990-11#1)(2008-2#1)
two points in four images##2##5##(2008-6#2)
two points in##7##3##(1990-11#1)(2006-9#1)(2007-12#1)(2008-2#1)(2008-6#2)(2012-1#1)
two points of##3##3##(1996-7#1)(2007-1#1)(2012-12#1)
two points##13##2##(1990-11#1)(1996-4#1)(1996-7#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-12#1)(2008-2#1)(2008-6#2)(2011-12#1)(2012-1#1)(2012-12#1)
two polar nuclei##2##3##(2009-12#2)
two polar##6##2##(1996-12#1)(1996-5#1)(2006-12#1)(2008-10#1)(2009-12#2)
two polarization##7##2##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#1)
two polarized##2##2##(2008-10#1)(2008-3#1)
two polyadenylation signals##3##3##(1992-11#1)(1995-3#1)(1997-2#1)
two polyclonal antibodies against##2##4##(1994-11#1)(1995-2#1)
two polyclonal antibodies##3##3##(1994-11#1)(1995-2#1)(1997-3#1)
two polyclonal##4##2##(1991-7#1)(1994-11#1)(1995-2#1)(1997-3#1)
two polymerase chain reaction (PCR)-based##2##5##(2008-10#1)(2008-4#1)
two polymerase chain##3##3##(2008-10#2)(2008-4#1)
two polymers##5##2##(1991-7#1)(2004-9#1)(2005-11#1)(2008-10#2)
two polymorphic##2##2##(2008-10#2)
two polymorphisms##2##2##(1994-8#1)(1997-8#1)
two polypeptide##3##2##(1990-12#1)(1995-12#1)(1996-2#1)
two polypeptides of##4##3##(1991-8#1)(1992-1#1)(1995-12#1)(1996-10#1)
two polypeptides##7##2##(1991-8#1)(1992-1#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-10#1)(2005-11#1)
two pools of##2##3##(1993-3#1)(1995-11#1)
two populations are##4##3##(2007-12#1)(2007-3#1)(2008-8#1)(2012-1#1)
two populations by##2##3##(1997-6#1)(2009-9#1)
two populations of I##2##4##(2008-6#1)(2013-8#1)
two populations of an##2##4##(2008-5#1)(2013-1#1)
two populations of cells##4##4##(1992-8#1)(1994-3#1)(1995-11#1)(2008-4#1)
two populations of##22##3##(1990-2#2)(1990-5#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-5#1)(1994-3#1)(1994-5#1)(1995-11#2)(2007-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2013-1#2)(2013-8#2)
two populations##58##2##(1990-2#2)(1990-5#1)(1992-10#1)(1992-11#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-5#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#2)(1997-6#1)(2007-12#2)(2007-2#1)(2007-3#3)(2007-5#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#2)(2009-9#1)(2010-8#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#2)
two port##2##2##(2006-6#1)(2007-7#1)
two portions with##2##3##(1992-11#1)(1993-3#1)
two portions##6##2##(1992-11#1)(1993-3#1)(1994-9#1)(2008-10#2)(2012-12#1)
two ports and a 5-6 cm long utility incision without any kind of rib spreading##2##15##(2012-12#2)
two ports##3##2##(2008-2#1)(2012-12#2)
two position##2##2##(2005-8#1)(2007-7#1)
two positions of##2##3##(2008-10#1)(2013-1#1)
two positions on the##2##4##(2008-2#2)
two positions##12##2##(1994-5#1)(1994-6#1)(1995-1#1)(1997-2#1)(1997-4#1)(2007-8#2)(2008-10#1)(2008-2#3)(2013-1#1)
two possibilities##2##2##(1995-1#1)(1997-1#1)
two possible configurations##2##3##(2008-10#1)(2008-3#1)
two possible mechanisms##4##3##(1994-12#1)(1995-7#1)(2006-7#1)(2008-10#1)
two possible scenarios##2##3##(1996-3#1)(2008-10#1)
two possible##28##2##(1990-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-10#1)(1995-2#2)(1995-3#1)(1995-7#1)(1996-3#1)(1997-1#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-7#1)(2007-4#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2009-11#1)(2009-12#1)
two post-treatment##2##2##(1994-6#1)(2009-12#1)
two postamplifiers##2##2##(2007-12#1)(2008-2#1)
two postmenopausal##2##2##(1990-12#1)(2005-11#1)
two potential N-linked glycosylation sites##2##5##(1993-2#1)(1994-11#1)
two potential##16##2##(1990-4#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-1#1)(2012-3#1)
two potentially##3##2##(2007-6#1)(2008-2#1)(2010-2#1)
two predominant effects##2##3##(2005-11#2)
two predominant##5##2##(1997-6#1)(2005-11#2)(2006-5#1)(2008-5#1)
two preparations##8##2##(1992-2#2)(1992-8#1)(1992-9#1)(1996-2#1)(1997-2#1)(2004-12#2)
two presentation methods##2##3##(2008-1#2)
two presented##3##2##(2007-10#1)(2007-6#1)(2007-9#1)
two presynaptically-acting phospholipase A2 neurotoxins##2##5##(1995-1#2)
two prevailing##2##2##(1997-8#1)(2007-5#1)
two previous##7##2##(1997-6#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-9#1)(2011-2#1)
two previously described##2##3##(1994-10#1)(2008-10#1)
two previously##15##2##(1990-7#1)(1991-12#1)(1994-10#1)(1995-3#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
two prey species##2##3##(2008-8#2)
two prey##3##2##(2008-8#3)
two primary##12##2##(1992-9#1)(1996-3#1)(1996-4#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#2)(2011-2#1)(2013-1#2)(2013-8#1)
two primer pairs##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
two primer sets##2##3##(2008-10#2)
two primer##5##2##(2008-10#3)(2008-11#1)(2011-2#1)
two primers##2##2##(2008-5#1)(2008-8#1)
two principal components##4##3##(2008-10#2)(2012-1#1)(2013-7#1)
two principal##8##2##(1995-1#1)(1995-8#1)(2005-11#1)(2008-10#2)(2010-5#1)(2012-1#1)(2013-7#1)
two principles##2##2##(1996-9#1)(2006-8#1)
two private##2##2##(1992-6#1)(2012-2#1)
two probes##5##2##(1990-5#1)(1997-2#1)(2008-10#2)(2008-5#1)
two problems##8##2##(1992-9#1)(2008-2#2)(2008-3#3)(2008-5#2)
two procedures are##2##3##(2008-10#1)(2008-2#1)
two procedures##22##2##(1992-4#1)(1995-1#2)(1996-2#1)(2005-5#1)(2006-10#1)(2006-3#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#1)(2009-12#2)(2009-2#1)(2010-12#1)(2012-12#2)(2012-2#1)
two processes are##4##3##(1990-12#1)(1995-2#2)(2013-1#1)
two processes that are##2##4##(2012-2#2)
two processes that##3##3##(1992-5#1)(2012-2#2)
two processes##29##2##(1990-12#1)(1991-6#1)(1992-1#1)(1992-5#1)(1992-8#1)(1995-2#2)(1996-11#1)(1996-6#1)(2005-11#3)(2006-10#2)(2006-12#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-2#1)(2009-8#2)(2010-3#1)(2011-2#1)(2012-2#2)(2013-1#1)
two products of##3##3##(1992-11#1)(2007-1#1)(2010-12#1)
two products##11##2##(1990-10#1)(1991-10#1)(1992-11#1)(1994-8#1)(1995-6#1)(2007-1#1)(2008-10#3)(2008-5#1)(2010-12#1)
two progenitors of the##2##4##(2007-12#2)
two progenitors##3##2##(2007-12#2)(2008-12#1)
two projected##2##2##(1993-12#1)(2007-12#1)
two projection##2##2##(1995-12#1)(2008-6#1)
two projections##2##2##(1990-4#1)(2007-7#1)
two projects##6##2##(1990-6#1)(2007-2#1)(2013-1#4)
two proliferation assays##2##3##(2007-2#1)(2008-4#1)
two prominent##6##2##(1990-12#1)(1990-7#1)(1991-3#1)(1994-6#1)(1994-9#1)(2008-10#1)
two promising##3##2##(2006-10#1)(2008-3#1)(2010-2#1)
two promoters##6##2##(1991-7#1)(1994-8#1)(1996-11#1)(1997-2#1)(2006-12#1)(2008-9#1)
two properties of the##2##4##(1994-8#1)(1994-9#1)
two properties##4##2##(1990-3#1)(1994-8#1)(1994-9#1)(2008-2#1)
two proposed##2##2##(1994-1#1)(2008-10#1)
two prospective##5##2##(1993-1#1)(2007-6#1)(2008-11#1)(2008-7#1)(2010-10#1)
two protease inhibitors##2##3##(1995-9#1)(2008-5#1)
two protective##2##2##(2008-1#1)(2008-10#1)
two protein bands##2##3##(1993-3#1)(2008-10#1)
two protein kinase C##2##4##(1990-4#1)(1993-3#1)
two protein products##2##3##(1990-3#1)(1995-8#1)
two protein##21##2##(1990-3#1)(1990-4#2)(1991-2#1)(1991-3#1)(1992-2#1)(1992-6#1)(1993-3#2)(1993-8#1)(1994-12#1)(1994-3#1)(1995-8#1)(1997-4#1)(1997-6#1)(2005-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)
two proteins are##6##3##(1990-8#1)(1991-9#1)(1993-11#1)(1996-5#1)(1997-4#1)(2008-4#1)
two proteins in##5##3##(1992-12#1)(1994-3#1)(1994-5#1)(1996-1#1)(1996-4#1)
two proteins of##8##3##(1991-12#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-2#1)(1994-6#1)(2008-10#1)
two proteins that##6##3##(1993-6#1)(1995-2#1)(1995-3#1)(2008-12#1)(2010-12#1)(2012-12#1)
two proteins to##3##3##(1990-11#1)(1990-7#1)(1995-3#1)
two proteins##83##2##(1990-11#2)(1990-12#1)(1990-6#1)(1990-7#3)(1990-8#2)(1991-10#1)(1991-12#2)(1991-2#2)(1991-9#3)(1992-12#2)(1992-2#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-6#3)(1993-8#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#3)(1995-3#3)(1995-6#2)(1996-1#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-11#3)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2012-12#1)(2012-2#1)
two proteolytic enzymes##2##3##(2006-10#1)(2008-10#1)
two protocols are##2##3##(2008-2#1)(2008-4#1)
two protocols for the##2##4##(2008-4#2)
two protocols for##10##3##(2008-2#1)(2008-4#5)(2008-9#3)(2013-7#1)
two protocols that##5##3##(2008-4#4)(2008-9#1)
two protocols##30##2##(1994-3#1)(2005-11#1)(2008-2#2)(2008-4#17)(2008-9#5)(2009-10#1)(2009-9#1)(2011-12#1)(2013-7#1)
two protons##4##2##(1991-2#1)(1991-9#1)(1994-10#1)(1994-9#1)
two provenances##2##2##(2004-4#1)(2012-5#1)
two proximal##3##2##(1995-3#1)(1995-8#1)(2007-8#1)
two pseudogenes##4##2##(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)
two psychiatric##2##2##(1994-8#1)(2006-7#1)
two pulmonary##2##2##(1993-5#1)(2012-3#1)
two pulses##7##2##(2006-10#1)(2007-11#1)(2007-12#4)(2013-7#1)
two pump##3##2##(2007-11#2)(2007-12#1)
two purified##2##2##(1991-12#1)(1992-7#1)
two putative sigma##2##3##(1993-9#1)(1994-5#1)
two putative zinc##2##3##(1993-3#1)(1994-12#1)
two putative##24##2##(1990-11#1)(1991-10#1)(1992-3#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-9#1)(1994-10#2)(1994-12#2)(1994-5#1)(1995-2#1)(1995-8#1)(1996-5#1)(1997-4#1)(1997-7#1)(2008-10#3)(2008-12#1)(2008-8#1)(2008-9#1)
two pyridine##4##2##(1997-7#1)(2006-12#2)(2012-12#1)
two pyridines##2##2##(1997-7#2)
two quail strains and their reciprocal crosses##2##7##(2008-12#2)
two quantitative models##2##3##(1991-5#1)(2007-11#1)
two quantitative trait loci##2##4##(2008-10#1)(2012-11#1)
two quantitative##6##2##(1991-5#1)(1992-2#1)(2007-11#1)(2008-10#2)(2012-11#1)
two questions##11##2##(1997-1#1)(2005-7#1)(2006-7#2)(2007-7#1)(2008-7#2)(2008-8#1)(2010-12#1)(2012-3#1)(2013-8#1)
two quinoline##2##2##(2009-3#2)
two quinone##2##2##(1996-5#1)(1997-3#1)
two rRNA operons##3##3##(1990-5#3)
two rRNA##4##2##(1990-5#3)(2009-5#1)
two rabbit GRO##2##3##(1994-12#2)
two rabbit##3##2##(1991-2#1)(1994-12#2)
two races of##4##3##(2008-10#3)(2008-8#1)
two races##5##2##(2008-10#4)(2008-8#1)
two random amplified polymorphic DNA (RAPD) markers##2##7##(2008-10#2)
two random phase codes##3##4##(2007-12#1)(2008-3#2)
two random phase##4##3##(2007-12#1)(2008-3#3)
two random##6##2##(2007-12#1)(2008-10#2)(2008-3#3)
two randomised##2##2##(2005-12#1)(2012-2#1)
two randomized clinical trials##2##4##(1993-9#1)(2012-2#1)
two randomized##5##2##(1993-9#1)(1994-9#1)(2008-5#1)(2012-2#1)(2013-1#1)
two randomly##2##2##(2010-8#1)(2011-1#1)
two ranges##4##2##(1991-3#1)(1993-3#1)(1996-5#1)(2008-10#1)
two rare cases of##3##4##(1993-3#1)(2006-11#1)(2013-8#1)
two rare variants##3##3##(1990-8#1)(1991-8#1)(2012-3#1)
two rare##9##2##(1990-8#2)(1991-8#1)(1993-3#1)(1993-7#1)(2006-11#1)(2012-3#2)(2013-8#1)
two rat strains##4##3##(1992-2#1)(1993-12#1)(2008-11#1)(2012-3#1)
two rat##5##2##(1992-2#1)(1993-12#1)(1993-4#1)(2008-11#1)(2012-3#1)
two rather than one##2##4##(1997-4#1)(2011-12#1)
two rather##3##2##(1997-4#1)(2011-12#1)(2013-1#1)
two ratios##2##2##(2008-3#1)(2008-9#1)
two rays##2##2##(2008-3#2)
two reaction##2##2##(2008-10#1)(2008-3#1)
two reactions are##2##3##(1996-9#1)(2008-10#1)
two reactions##7##2##(1992-12#1)(1993-12#1)(1994-9#1)(1996-9#1)(2008-10#3)
two reactors##3##2##(2008-10#3)
two reading interventions##3##3##(2004-10#3)
two reagent##3##2##(2007-8#1)(2008-10#2)
two reagents was##2##3##(1992-9#1)(2011-1#1)
two reagents##4##2##(1992-9#1)(2008-10#1)(2008-11#1)(2011-1#1)
two real##4##2##(2008-10#1)(2009-11#1)(2010-1#1)(2010-12#1)
two reasons for##2##3##(2008-2#1)(2008-3#1)
two reasons##6##2##(1991-1#1)(1994-6#1)(2008-2#1)(2008-3#1)(2009-2#1)(2009-8#1)
two recent papers##2##3##(2006-10#1)(2007-8#1)
two recent studies on##2##4##(1994-2#1)(2009-5#1)
two recent studies##5##3##(1993-1#1)(1994-2#1)(1995-6#1)(2008-2#1)(2009-5#1)
two recent##15##2##(1991-4#1)(1993-1#1)(1994-2#1)(1995-6#1)(2004-1#1)(2006-10#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-2#1)(2008-5#1)(2009-5#1)(2009-8#1)(2013-1#1)
two recently##9##2##(1993-11#1)(1995-3#1)(1995-6#1)(1997-4#1)(2008-11#1)(2008-3#1)(2013-1#3)
two receptor##15##2##(1990-11#1)(1990-8#2)(1991-12#1)(1991-4#1)(1991-8#1)(1992-5#1)(1993-6#2)(1994-11#1)(1996-10#1)(1996-12#2)(2008-11#1)(2008-7#1)
two receptors##12##2##(1992-1#1)(1992-5#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-1#1)(1996-5#1)(1997-6#1)(2006-10#2)(2008-9#1)(2012-2#1)
two recessive genes were detected in##3##6##(2008-10#3)
two recessive genes##5##3##(2008-10#5)
two recognition sites##2##3##(1991-8#1)(1995-1#1)
two recognition##3##2##(1991-8#1)(1992-3#1)(1995-1#1)
two recombinant plasmids##2##3##(1997-2#1)(2013-1#1)
two recombinant##9##2##(1994-5#2)(1995-1#1)(1995-12#1)(1997-2#1)(2006-10#1)(2008-1#1)(2008-7#1)(2013-1#1)
two recombining##2##2##(2008-8#1)(2012-1#1)
two reconstruction##2##2##(2008-2#1)(2012-1#1)
two red##2##2##(1997-4#1)(2008-3#1)
two redox##3##2##(1995-2#1)(2008-10#2)
two reduction peaks##2##3##(2008-10#2)
two reference groups##2##3##(1991-9#1)(2011-2#1)
two reference##9##2##(1991-9#1)(2008-10#4)(2008-11#1)(2008-3#1)(2011-2#2)
two regimens##2##2##(1990-12#1)(1992-2#1)
two regimes##5##2##(2005-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)
two regions are##4##3##(1995-2#1)(2006-1#1)(2008-10#1)(2008-8#1)
two regions of the##3##4##(1992-9#1)(1993-11#1)(2007-8#1)
two regions of##8##3##(1990-3#1)(1992-9#1)(1993-11#1)(1996-2#1)(2007-7#1)(2007-8#2)(2008-7#1)
two regions on##3##3##(1990-10#1)(1991-11#1)(2012-3#1)
two regions##36##2##(1990-10#1)(1990-3#2)(1991-11#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-9#2)(1993-11#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-7#1)(1996-2#1)(1996-8#1)(1997-5#1)(1997-6#1)(2006-1#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-2#2)(2008-7#3)(2008-8#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)
two regulatory##6##2##(1990-5#1)(1991-11#1)(1992-11#1)(1995-2#1)(1995-3#1)(2006-12#1)
two related##16##2##(1991-7#1)(1992-1#1)(1992-12#1)(1993-12#1)(1994-11#1)(1994-9#1)(1996-5#2)(1997-1#1)(2006-12#1)(2007-12#2)(2007-2#1)(2008-10#2)(2008-7#1)
two relative##2##2##(2008-5#1)(2011-2#1)
two relatively##6##2##(1997-1#1)(2005-7#1)(2007-8#1)(2008-7#1)(2008-8#1)(2008-9#1)
two relevant##3##2##(2008-3#1)(2009-12#1)(2012-11#1)
two remained##2##2##(2008-1#1)(2012-12#1)
two remaining##8##2##(1994-2#1)(1996-11#1)(2008-10#2)(2008-5#1)(2008-8#2)(2012-2#1)
two repeat##3##2##(1994-9#1)(2008-12#1)(2008-7#1)
two repeated##3##2##(1990-3#1)(1996-5#1)(2008-7#1)
two repeats of##3##3##(1994-12#1)(1996-6#1)(2013-8#1)
two repeats##4##2##(1991-12#1)(1994-12#1)(1996-6#1)(2013-8#1)
two replicas##2##2##(1992-12#1)(2007-11#1)
two replications##3##2##(1993-2#1)(2008-10#2)
two reports##2##2##(2008-9#1)(2013-1#1)
two representative##9##2##(2008-10#3)(2008-4#1)(2008-9#1)(2009-12#1)(2010-10#1)(2012-11#1)(2012-2#1)
two representatives of##2##3##(1995-6#1)(2008-8#1)
two reproductive##3##2##(1995-11#1)(2008-8#2)
two requirements for##2##3##(1991-7#1)(2008-4#1)
two requirements##3##2##(1991-7#1)(2008-2#1)(2008-4#1)
two research##2##2##(2007-10#1)(2007-9#1)
two researchers##2##2##(2007-9#1)(2012-12#1)
two residues in##2##3##(1991-4#1)(1996-5#1)
two residues##14##2##(1990-12#1)(1990-5#1)(1991-2#3)(1991-4#1)(1993-11#1)(1993-3#1)(1993-8#1)(1996-5#1)(1996-8#1)(2007-12#1)(2008-5#1)(2008-8#1)
two resin cements##2##3##(2009-8#1)(2013-8#1)
two resin##6##2##(1997-2#1)(2004-9#1)(2009-8#1)(2012-12#2)(2013-8#1)
two resins##4##2##(2008-10#4)
two resistant##5##2##(2008-10#2)(2008-8#1)(2012-1#1)(2012-3#1)
two resonant##2##2##(2007-12#1)(2008-1#1)
two response##2##2##(1997-7#1)(2010-4#1)
two responses##8##2##(1990-8#2)(1991-6#1)(1995-4#2)(1997-4#2)(2008-10#1)
two restriction##3##2##(1990-12#1)(2008-10#1)(2008-2#1)
two results##3##2##(1997-8#1)(2008-2#1)(2008-8#1)
two reversible##3##2##(2008-4#1)(2009-9#1)(2010-5#1)
two ribosomal##3##2##(1997-4#2)(2009-5#1)
two rings##2##2##(1992-5#1)(1994-9#1)
two risk##5##2##(1996-8#2)(2011-2#1)(2013-1#2)
two rival##2##2##(2008-11#1)(2008-12#1)
two rivers##2##2##(2007-5#1)(2013-1#1)
two roles in##2##3##(1996-8#1)(1997-1#1)
two roles##4##2##(1996-1#1)(1996-8#1)(1997-1#1)(2009-10#1)
two roots of the##2##4##(2008-3#1)(2008-7#1)
two roots##4##2##(2008-3#1)(2008-7#2)(2011-2#1)
two rounds of cross-sectional##3##4##(2012-3#3)
two rounds of##7##3##(2008-11#1)(2008-12#1)(2008-4#1)(2012-3#4)
two rounds##9##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2012-3#4)
two routes##3##2##(2009-10#1)(2009-7#1)(2011-2#1)
two rows##2##2##(2008-12#1)(2012-2#1)
two rural##5##2##(2006-4#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-6#1)
two salinities##2##2##(2007-5#2)
two sample portions##2##3##(2008-10#2)
two sample##9##2##(1992-11#1)(2006-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2011-2#1)
two samples and##2##3##(2008-10#1)(2011-12#1)
two samples from##2##3##(2010-8#1)(2013-1#1)
two samples of##6##3##(1993-1#1)(2007-12#1)(2008-10#2)(2009-4#1)(2009-7#1)
two samples ranged from##3##4##(2008-10#3)
two samples were##2##3##(2011-2#1)(2012-2#1)
two samples##32##2##(1993-1#1)(1993-4#1)(1994-9#1)(2004-10#1)(2005-11#1)(2007-12#1)(2008-10#11)(2008-2#1)(2008-4#1)(2009-4#3)(2009-7#1)(2010-1#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
two sampling##4##2##(2008-10#4)
two scales##8##2##(1993-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-3#1)(2010-4#1)(2013-1#1)(2013-8#1)
two scattering##2##2##(2008-2#1)(2008-3#1)
two scenarios##3##2##(1996-3#1)(2008-11#1)(2008-8#1)
two schemes##2##2##(1997-1#1)(2008-3#1)
two school##2##2##(2008-6#1)(2010-1#1)
two schools##4##2##(1994-2#1)(2007-9#1)(2008-9#1)(2010-3#1)
two scientific##2##2##(2008-9#1)(2012-12#1)
two scores##2##2##(2008-5#1)(2013-1#1)
two screening##4##2##(1996-4#1)(2008-10#2)(2013-1#1)
two screws##3##2##(2008-6#1)(2009-3#1)(2011-1#1)
two seasons##17##2##(2007-11#1)(2008-10#10)(2008-5#2)(2009-4#3)(2012-8#1)
two second-order##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-6#1)
two secondary##3##2##(2007-12#2)(2008-3#1)
two sections##7##2##(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-2#1)(2013-1#1)
two seed##3##2##(2006-5#1)(2008-1#1)(2008-10#1)
two segmental##2##2##(1990-8#1)(2008-10#1)
two segments##8##2##(1990-2#1)(1993-3#1)(1994-9#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)
two selected wavelengths##2##3##(2008-2#1)(2010-5#1)
two selected##7##2##(1995-3#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-5#1)
two selection##3##2##(1996-4#1)(2007-12#1)(2008-7#1)
two selective##2##2##(2011-2#1)(2013-1#1)
two semiconductor##3##2##(2007-12#2)(2008-3#1)
two sensilla##2##2##(2007-12#2)
two sensing##2##2##(2008-10#1)(2008-3#1)
two separate clusters##2##3##(1996-5#1)(2008-10#1)
two separate experiments##4##3##(1990-9#1)(1992-6#1)(2008-10#1)(2008-11#1)
two separate genes##2##3##(1992-6#1)(1993-9#1)
two separate mechanisms##2##3##(1990-4#1)(1996-12#1)
two separate phenomena##2##3##(1990-12#1)(2011-2#1)
two separate sites##2##3##(1994-2#1)(2008-7#1)
two separate studies##3##3##(1991-11#1)(2008-8#1)(2009-11#1)
two separate##97##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-4#1)(1990-9#1)(1991-11#1)(1991-5#1)(1992-1#1)(1992-6#2)(1992-8#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-2#2)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-5#3)(1996-6#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-12#1)(2006-10#1)(2006-12#2)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-8#2)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-2#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
two separated##2##2##(1993-5#1)(2005-11#1)
two sequence##2##2##(1995-8#1)(2008-10#1)
two sequences for##2##3##(1996-12#1)(2006-3#1)
two sequences of##2##3##(2006-6#1)(2008-4#1)
two sequences##14##2##(1992-4#1)(1992-8#1)(1993-3#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-4#1)(2006-3#1)(2006-6#1)(2008-10#1)(2008-4#4)
two sequential##7##2##(1991-12#1)(1994-3#1)(1995-2#1)(1996-12#1)(1997-1#1)(2008-10#1)(2008-2#1)
two sera##2##2##(1995-2#1)(2012-12#1)
two serially##2##2##(2008-10#1)(2008-3#1)
two series of peptides##2##4##(1995-3#2)
two series of##12##3##(1995-11#1)(1995-3#2)(1996-9#1)(1997-7#1)(2005-11#1)(2008-10#4)(2008-5#1)(2008-9#1)
two series##14##2##(1995-11#1)(1995-3#2)(1996-9#1)(1997-7#2)(2005-11#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-9#1)
two serine##2##2##(1994-12#1)(1995-5#1)
two serious##3##2##(2008-2#1)(2009-9#1)(2010-3#1)
two serological##3##2##(1992-5#1)(2008-5#1)(2013-8#1)
two serotypes##2##2##(2008-10#2)
two sessions##2##2##(1996-9#1)(2012-1#1)
two sets of experiments##4##4##(1993-8#1)(2009-8#1)(2013-1#2)
two sets of genes##2##4##(1992-2#1)(1992-7#1)
two sets of intellectual property protection##2##6##(2008-6#2)
two sets of modified##2##4##(2008-10#1)(2008-3#1)
two sets of the##3##4##(1997-6#1)(2007-10#1)(2008-3#1)
two sets of##60##3##(1991-12#1)(1991-2#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-12#2)(1993-8#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-6#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#9)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-6#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-8#2)(2011-1#1)(2012-3#1)(2013-1#4)
two sets##64##2##(1991-12#1)(1991-2#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-12#2)(1993-8#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-6#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#10)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-8#2)(2011-1#1)(2012-3#1)(2013-1#4)
two settings##2##2##(2007-8#1)(2008-2#1)
two severely##2##2##(1990-5#1)(2005-7#1)
two sexes##5##2##(1991-6#1)(2006-5#1)(2007-12#1)(2008-5#1)(2010-4#1)
two shampoos##2##2##(2008-10#1)(2008-5#1)
two share##2##2##(2009-8#1)(2013-8#1)
two shearing interferograms##2##3##(2008-3#2)
two shells##3##2##(1996-2#2)(2008-12#1)
two short##6##2##(1994-9#1)(1996-2#2)(1997-8#1)(2010-7#1)(2012-2#1)
two shots##3##2##(1995-5#1)(2012-1#2)
two showed##2##2##(1994-6#1)(2009-8#1)
two sibling species##2##3##(2004-11#1)(2008-9#1)
two sibling yeast species##2##4##(1996-6#2)
two sibling##5##2##(1990-5#1)(1996-6#2)(2004-11#1)(2008-9#1)
two siblings for each##2##4##(2011-12#2)
two siblings with##3##3##(2007-7#1)(2008-7#1)(2009-3#1)
two siblings##8##2##(1996-3#1)(2007-7#1)(2008-7#1)(2009-3#2)(2010-10#1)(2011-12#2)
two sides of the##2##4##(2008-10#1)(2011-2#1)
two sides##5##2##(1995-1#1)(2008-10#2)(2008-8#1)(2011-2#1)
two sigma##2##2##(1992-4#1)(1997-5#1)
two signal transduction systems##2##4##(1992-9#1)(2007-12#1)
two signal##7##2##(1992-9#1)(1996-4#1)(2007-12#3)(2008-4#1)(2008-9#1)
two signaling##4##2##(2009-6#1)(2012-12#3)
two signals##11##2##(1991-4#1)(1996-1#1)(1996-5#1)(2008-2#2)(2008-3#5)(2008-7#1)
two significant##4##2##(1995-11#1)(2004-9#1)(2006-8#1)(2008-10#1)
two silent##2##2##(1996-11#1)(2008-8#1)
two silicon##3##2##(2008-5#1)(2012-12#1)(2013-1#1)
two similar but##2##3##(1994-6#1)(2008-3#1)
two similar##14##2##(1990-8#1)(1991-11#1)(1993-5#1)(1994-6#1)(1994-9#1)(1995-2#1)(1997-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-6#1)(2013-8#2)
two simple##11##2##(1994-11#1)(1994-8#1)(2007-11#1)(2007-12#1)(2007-9#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#1)(2012-3#1)
two simultaneous##5##2##(1997-3#1)(2005-11#1)(2008-1#2)(2008-5#1)
two simultaneously##2##2##(2007-12#1)(2008-10#1)
two single##14##2##(1993-9#1)(1995-1#1)(1995-3#1)(1995-6#2)(1996-10#1)(1996-4#1)(1997-3#1)(2008-10#2)(2008-11#1)(2011-1#1)(2011-3#1)(2013-1#1)
two single-mode##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
two single-point mutants##2##3##(1993-11#1)(2008-9#1)
two sisters##4##2##(1995-10#1)(2007-7#1)(2007-8#1)(2010-10#1)
two sites in the##3##4##(1997-3#1)(2008-10#1)(2013-1#1)
two sites in##9##3##(1995-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(2008-10#2)(2008-5#1)(2012-3#1)(2013-1#1)
two sites of##3##3##(1990-11#1)(1992-6#1)(2008-5#1)
two sites on the##2##4##(1992-8#1)(1994-5#1)
two sites to##2##3##(1996-6#1)(2007-9#1)
two sites with##2##3##(1995-11#1)(2012-12#1)
two sites##60##2##(1990-11#1)(1990-3#1)(1990-5#2)(1990-7#2)(1990-9#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-4#1)(1994-5#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-3#1)(1995-8#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#7)(2008-4#1)(2008-5#5)(2008-8#1)(2011-1#1)(2011-12#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#3)
two situations##6##2##(1992-2#1)(1996-7#1)(2005-12#1)(2006-1#1)(2008-10#1)(2010-6#1)
two size##2##2##(1995-11#1)(2010-8#1)
two sizes of##2##3##(1993-4#1)(2008-2#1)
two sizes##3##2##(1993-4#1)(2007-12#1)(2008-2#1)
two skin##2##2##(2008-5#1)(2010-2#1)
two slightly##3##2##(1996-3#1)(2007-12#1)(2008-2#1)
two small proteins##3##3##(1994-5#1)(2008-10#1)(2008-9#1)
two small##17##2##(1991-5#1)(1992-10#1)(1994-11#2)(1994-12#1)(1994-5#1)(1995-3#2)(1995-8#1)(1997-3#1)(2004-1#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-8#1)
two smaller##7##2##(1990-5#1)(1995-3#1)(1995-8#1)(1997-6#1)(2007-12#2)(2012-3#1)
two sodium##2##2##(1996-2#1)(2008-10#1)
two soft##3##2##(2012-1#1)(2013-1#2)
two soil##3##2##(2008-10#1)(2008-11#1)(2012-5#1)
two soils##11##2##(1993-8#1)(2005-10#1)(2008-10#5)(2008-11#1)(2008-6#1)(2013-8#2)
two solanaceous species##2##3##(1996-8#2)
two solid##2##2##(2008-10#1)(2008-7#1)
two solitudes##2##2##(1995-1#1)(1996-1#1)
two soluble##2##2##(1990-7#1)(1992-6#1)
two solutions##4##2##(1990-11#1)(2005-11#1)(2008-2#1)(2013-1#1)
two solvation##2##2##(2006-10#2)
two somatic##2##2##(1992-11#1)(1995-5#1)
two sources of##6##3##(1990-6#1)(2006-10#1)(2007-2#1)(2009-5#1)(2009-7#1)(2011-1#1)
two sources##17##2##(1990-11#1)(1990-6#1)(1991-12#2)(1991-6#1)(2004-11#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-2#1)(2008-3#1)(2008-9#1)(2009-5#1)(2009-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
two soybean##2##2##(2008-10#1)(2008-12#1)
two spatial scales##3##3##(2008-10#1)(2008-8#1)(2010-8#1)
two spatial##9##2##(1993-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#2)(2010-12#1)(2010-8#1)
two spatially separated##2##3##(2007-12#1)(2008-7#1)
two spatially##4##2##(2007-12#2)(2008-10#1)(2008-7#1)
two special##4##2##(2008-9#1)(2010-12#1)(2010-4#1)(2011-2#1)
two specialists##2##2##(2008-5#1)(2008-8#1)
two species and##3##3##(1991-6#1)(2008-10#2)
two species are##7##3##(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#1)
two species from##2##3##(2008-5#1)(2013-7#1)
two species have##2##3##(1993-6#1)(2008-9#1)
two species in the##3##4##(1991-5#1)(1991-6#1)(2007-12#1)
two species in##7##3##(1991-5#1)(1991-6#1)(2007-12#1)(2008-8#2)(2011-12#1)(2011-2#1)
two species of African##2##4##(2010-8#2)
two species of Biomphalaria##2##4##(1993-6#1)(1994-6#1)
two species of Papilio butterfly##2##5##(2008-3#2)
two species of fish##3##4##(1991-7#1)(1996-11#1)(2008-10#1)
two species of halacarid mites##2##5##(2007-12#2)
two species of insect##2##4##(1991-10#1)(2011-2#1)
two species of##51##3##(1990-12#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-7#1)(1993-6#1)(1994-3#2)(1994-6#1)(1996-11#1)(1997-4#2)(2005-11#1)(2007-12#4)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#5)(2008-7#2)(2008-8#2)(2008-9#2)(2009-8#2)(2010-8#3)(2011-2#1)(2012-11#1)(2013-1#2)
two species pairs##2##3##(2008-2#1)(2013-7#1)
two species that##4##3##(1992-10#1)(1995-10#1)(2008-8#1)(2010-3#1)
two species was##2##3##(1990-7#1)(2013-1#1)
two species were##6##3##(1994-11#1)(1994-3#1)(2006-5#1)(2008-10#2)(2008-6#1)
two species with##3##3##(2012-8#1)(2013-1#2)
two species##175##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-7#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#2)(1992-10#1)(1992-12#1)(1992-4#1)(1993-12#2)(1993-2#1)(1993-6#2)(1994-11#2)(1994-12#1)(1994-3#5)(1994-6#1)(1995-10#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#2)(1997-6#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#2)(2007-1#2)(2007-12#6)(2007-3#1)(2007-5#3)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#27)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#3)(2008-5#11)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#11)(2009-8#2)(2010-10#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#9)(2011-12#5)(2011-2#6)(2012-11#1)(2012-2#1)(2012-3#1)(2012-5#1)(2012-8#1)(2013-1#5)(2013-7#2)
two species-specific##2##2##(1995-12#1)(2008-12#1)
two specific examples##2##3##(1990-8#1)(2011-1#1)
two specific inhibitors of##2##4##(1995-3#1)(1996-2#1)
two specific inhibitors##3##3##(1995-3#1)(1996-2#1)(2007-8#1)
two specific##25##2##(1990-8#1)(1992-7#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-3#1)(1996-10#1)(1996-2#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-2#1)(2011-1#1)(2012-12#2)
two specified##2##2##(2008-1#1)(2008-2#1)
two specimens##4##2##(1990-1#1)(2006-11#1)(2007-1#1)(2011-2#1)
two spectra##2##2##(2005-4#1)(2008-3#1)
two spectral##4##2##(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#1)
two spectrally##2##2##(1992-8#1)(2007-11#1)
two spectrometer positions##2##3##(2007-12#2)
two spectrometer##3##2##(2007-12#2)(2008-10#1)
two spheres##2##2##(1995-5#1)(2005-11#1)
two spiking##2##2##(2008-11#1)(2009-3#1)
two split##2##2##(2008-11#1)(2008-3#1)
two spots##2##2##(2007-12#1)(2010-12#1)
two stable##9##2##(1990-7#1)(1992-7#1)(1993-12#1)(1997-8#1)(2006-10#1)(2007-9#3)(2012-11#1)
two stacked##2##2##(1994-5#1)(2008-3#1)
two stage promotion##3##3##(1990-6#3)
two stage##15##2##(1990-12#1)(1990-6#4)(1992-2#1)(2006-6#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-10#1)(2011-11#1)(2012-12#1)
two stages of##5##3##(1991-6#1)(1994-12#1)(2008-12#1)(2008-2#2)
two stages##19##2##(1991-6#1)(1992-10#1)(1992-4#1)(1994-12#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2009-10#1)(2009-3#1)(2010-8#2)(2011-2#1)(2012-2#1)
two standard reference materials##5##4##(2005-4#1)(2008-10#4)
two standard##9##2##(1992-1#1)(2005-4#1)(2006-8#1)(2008-10#5)(2008-5#1)
two states of Eastern India##2##5##(2011-1#2)
two states of##3##3##(1997-4#1)(2011-1#2)
two states with##2##3##(2007-12#1)(2009-7#1)
two states##14##2##(1991-3#2)(1991-4#2)(1994-10#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-2#2)(2009-7#1)(2011-1#2)(2012-3#1)
two statistically##2##2##(2007-12#1)(2011-1#1)
two stay sutures are made at the proximal apex and distal apex of the recipient s inferior vena cava with the donor s##2##23##(2008-11#2)
two stay sutures are##3##4##(2008-11#3)
two stem##3##2##(1990-7#1)(2007-12#1)(2009-8#1)
two stents##2##2##(2009-5#1)(2010-4#1)
two step AFB cold staining method##2##6##(2007-8#2)
two step AFB##3##3##(2007-8#3)
two step##7##2##(1991-5#1)(2006-10#1)(2007-8#4)(2008-10#1)
two steps from the##2##4##(1995-1#1)(2008-8#1)
two steps from##3##3##(1991-10#1)(1995-1#1)(2008-8#1)
two steps of##8##3##(1990-8#1)(1993-2#1)(1993-8#1)(2007-11#1)(2008-10#1)(2010-2#1)(2011-1#2)
two steps##47##2##(1990-7#1)(1990-8#1)(1991-10#1)(1991-6#1)(1992-9#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#2)(1995-2#1)(2005-11#1)(2006-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2008-10#11)(2008-2#2)(2008-3#3)(2008-8#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#2)
two stereoisomers##3##2##(1994-8#1)(1995-10#2)
two sticks of##2##3##(2008-4#1)(2009-2#1)
two stimuli##4##2##(1991-12#1)(1992-7#1)(1994-6#1)(2011-12#1)
two stocks of##3##3##(2010-8#3)
two strains and##3##3##(2007-6#1)(2012-2#1)(2013-1#1)
two strains of M##3##4##(1991-9#1)(1997-3#2)
two strains of mice##3##4##(1992-4#1)(2008-10#1)(2013-8#1)
two strains of##19##3##(1990-3#1)(1991-5#1)(1991-9#1)(1992-4#1)(1997-2#1)(1997-3#2)(2006-10#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-8#1)(2013-8#3)
two strains that##3##3##(2008-10#3)
two strains were##3##3##(1993-11#1)(2008-10#1)(2011-1#1)
two strains##57##2##(1990-12#1)(1990-3#1)(1991-5#1)(1991-6#3)(1991-9#1)(1992-4#1)(1993-11#2)(1994-2#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-2#2)(1997-3#2)(2004-11#1)(2006-10#1)(2006-8#2)(2007-6#2)(2007-8#1)(2008-10#16)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#3)
two strands of##3##3##(1990-5#1)(2008-1#1)(2008-9#1)
two strategies to##2##3##(1996-1#1)(2012-1#1)
two strategies##9##2##(1996-1#1)(1997-4#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-8#1)(2010-7#1)(2012-1#1)
two streams of##3##3##(1996-1#1)(2008-10#1)(2008-8#1)
two streams##5##2##(1995-5#1)(1996-1#1)(2008-10#2)(2008-8#1)
two strikingly different##2##3##(2008-11#1)(2008-9#1)
two strikingly##3##2##(2008-11#1)(2008-7#1)(2008-9#1)
two strong##2##2##(1991-7#1)(1995-6#1)
two strongest##3##2##(2008-10#1)(2010-12#1)(2013-8#1)
two strongly##2##2##(2008-5#1)(2008-8#1)
two structural##8##2##(1993-4#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-11#1)(1996-2#2)(2005-11#1)
two structurally and##2##3##(2008-5#1)(2008-7#1)
two structurally distinct forms##2##4##(1992-5#1)(1997-7#1)
two structurally related##2##3##(1996-12#1)(2011-2#1)
two structurally similar##2##3##(1994-11#1)(1996-5#1)
two structurally##12##2##(1992-12#1)(1992-5#1)(1994-11#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-7#1)(2006-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
two structure##2##2##(1992-9#1)(2005-11#1)
two structures in##3##3##(1995-7#1)(1997-4#1)(2008-10#1)
two structures is##2##3##(2010-6#1)(2012-2#1)
two structures##14##2##(1993-6#1)(1994-3#1)(1995-3#1)(1995-7#2)(1997-4#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-6#2)(2012-2#1)
two students##3##2##(1992-2#1)(1992-5#1)(2008-11#1)
two studies in##4##3##(1992-4#1)(1996-8#1)(2008-10#1)(2009-9#1)
two studies of##2##3##(2010-2#1)(2010-7#1)
two studies reported##2##3##(2011-1#2)
two studies were##2##3##(1994-2#1)(2010-8#1)
two studies##37##2##(1991-11#1)(1992-4#2)(1993-9#1)(1994-2#1)(1995-1#1)(1996-8#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-10#1)(2009-2#1)(2009-9#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
two study groups##5##3##(1991-11#1)(2007-8#1)(2007-9#1)(2010-4#1)(2011-2#1)
two study sites##2##3##(2007-2#2)
two study##9##2##(1991-11#1)(2007-2#2)(2007-8#1)(2007-9#1)(2010-4#1)(2011-2#2)(2013-7#1)
two sub-chronic##2##2##(1997-3#2)
two subfamilies##7##2##(1995-3#1)(1996-11#1)(2008-4#2)(2008-5#1)(2008-8#2)
two subgel phases##2##3##(2006-10#2)
two subgroup##2##2##(2008-10#2)
two subgroups according to the##2##5##(2008-10#1)(2011-2#1)
two subgroups of##7##3##(1994-3#1)(2006-6#2)(2008-10#1)(2008-7#3)
two subgroups##28##2##(1990-8#1)(1993-11#1)(1994-3#1)(1997-7#1)(2006-6#2)(2007-2#1)(2007-8#2)(2008-10#9)(2008-5#1)(2008-7#3)(2008-9#1)(2009-4#2)(2011-2#1)(2013-1#2)
two subjects##7##2##(1990-12#1)(1991-8#1)(1994-6#1)(1996-5#1)(2007-2#1)(2008-12#2)
two sublines of##2##3##(1990-10#1)(1991-1#1)
two sublines##3##2##(1990-10#1)(1991-1#2)
two subplots (furrow and##2##4##(2008-10#2)
two subpopulations of##3##3##(1995-10#1)(2008-10#1)(2008-11#1)
two subpopulations##6##2##(1995-10#1)(2008-10#3)(2008-11#2)
two subsamples##2##2##(2009-12#1)(2013-7#1)
two subsequent years##2##3##(2008-10#1)(2010-2#1)
two subsequent##8##2##(1990-9#1)(1995-11#1)(1996-11#1)(2008-10#2)(2009-6#1)(2010-2#1)(2013-1#1)
two subsets of##2##3##(2008-4#2)
two subsets##4##2##(2008-4#3)(2010-8#1)
two subspecies##3##2##(2004-11#1)(2006-8#1)(2008-5#1)
two substances are##2##3##(1993-11#1)(1996-1#1)
two substances##6##2##(1990-12#1)(1993-11#1)(1996-1#1)(2006-10#1)(2008-10#1)(2008-11#1)
two substrates in a##2##4##(1994-5#2)
two substrates##12##2##(1990-2#1)(1992-10#1)(1994-5#4)(1997-2#1)(1997-8#1)(2008-10#1)(2008-7#3)
two subtypes of##4##3##(1992-11#1)(1994-12#1)(1995-3#1)(2008-8#1)
two subtypes##11##2##(1991-11#2)(1991-4#1)(1992-11#1)(1992-4#1)(1994-12#1)(1995-3#1)(1997-8#1)(2007-12#1)(2008-3#1)(2008-8#1)
two subunits are##2##3##(1994-12#1)(2008-4#1)
two subunits of the##3##4##(1990-4#1)(1992-9#1)(2006-8#1)
two subunits of##8##3##(1990-3#1)(1990-4#1)(1992-2#1)(1992-9#1)(1993-8#1)(1995-6#1)(1997-2#1)(2006-8#1)
two subunits##36##2##(1990-1#2)(1990-3#1)(1990-4#1)(1990-8#1)(1991-10#2)(1991-12#2)(1992-11#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-6#1)(1993-8#1)(1994-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-2#1)(2006-10#4)(2006-8#1)(2008-1#1)(2008-4#1)(2008-9#2)(2010-5#3)(2011-1#1)(2012-12#1)
two successful##2##2##(1996-8#1)(2008-11#1)
two successive injections##2##3##(2008-10#1)(2012-12#1)
two successive steps##2##3##(2006-10#1)(2008-2#1)
two successive##19##2##(1991-12#1)(1991-2#1)(1992-6#1)(1993-12#1)(1995-11#1)(2006-10#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#3)(2008-3#2)(2008-7#1)(2012-12#1)
two such cases of##2##4##(2009-3#1)(2010-7#1)
two such cases##4##3##(2007-7#1)(2009-3#1)(2010-7#1)(2012-3#1)
two such##13##2##(1997-4#1)(2007-12#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-3#1)(2010-7#1)(2012-3#1)
two sugars##2##2##(1994-6#1)(1997-8#1)
two suggestions##2##2##(1996-12#1)(2006-5#1)
two sulfonylureas##2##2##(1992-3#2)
two superconductors##2##2##(2008-7#1)(2012-2#1)
two support protocols##3##3##(2008-4#3)
two surface integration approaches##2##4##(2008-3#2)
two surface##12##2##(1991-8#1)(1992-12#1)(1997-6#1)(2007-12#1)(2008-3#5)(2008-6#1)(2008-9#1)(2012-1#1)
two surfaces##9##2##(1997-8#1)(2005-10#1)(2008-12#1)(2008-2#2)(2010-10#2)(2010-7#1)(2012-2#1)
two surfactants##2##2##(2005-11#2)
two surgeons##2##2##(1990-12#1)(2006-6#1)
two surgical techniques##2##3##(2011-2#2)
two surgical##4##2##(2006-6#1)(2009-6#1)(2011-2#2)
two surveys##6##2##(1993-8#1)(2007-7#1)(2008-10#1)(2012-12#1)(2012-3#1)(2013-7#1)
two survived##2##2##(1994-9#2)
two susceptible##2##2##(2008-10#2)
two sympatric##3##2##(2008-10#1)(2012-3#2)
two syndromes##3##2##(1995-5#1)(2008-4#1)(2009-12#1)
two synthetic peptides##2##3##(1992-11#1)(1995-3#1)
two synthetic##12##2##(1991-5#1)(1992-11#1)(1995-3#1)(1995-6#1)(1996-7#1)(2008-10#1)(2008-5#2)(2008-9#1)(2009-10#2)(2009-12#1)
two systems for##3##3##(1994-2#1)(2007-8#1)(2008-2#1)
two systems have##2##3##(2005-11#1)(2008-3#1)
two systems##23##2##(1990-8#1)(1991-3#1)(1992-10#1)(1994-2#1)(1996-5#1)(2005-11#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-7#1)(2009-9#1)(2011-2#2)
two tRNA##2##2##(1995-3#1)(1995-4#1)
two tandem##5##2##(1990-10#1)(1991-9#1)(1994-12#1)(2008-8#1)(2008-9#1)
two tandemly##3##2##(1990-12#1)(1991-7#1)(1995-8#1)
two target##4##2##(1992-11#1)(2007-8#1)(2008-1#1)(2012-11#1)
two tasks were##2##3##(2008-11#1)(2008-9#1)
two tasks##8##2##(1991-2#1)(1994-8#1)(2006-3#1)(2008-11#2)(2008-4#1)(2008-9#1)(2012-2#1)
two teachers##3##2##(1991-12#1)(2007-7#1)(2008-11#1)
two techniques are##5##3##(1996-5#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-2#1)
two techniques for the##2##4##(1994-12#1)(2008-10#1)
two techniques for##3##3##(1994-12#1)(2008-10#1)(2008-11#1)
two techniques gave##2##3##(2008-10#1)(2008-2#1)
two techniques have##2##3##(2008-12#1)(2010-7#1)
two techniques is##3##3##(1992-2#1)(2008-10#1)(2010-5#1)
two techniques were##2##3##(2005-11#1)(2007-8#1)
two techniques##40##2##(1992-2#1)(1992-8#1)(1994-12#1)(1995-5#1)(1995-9#1)(1996-5#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)
two technologies##4##2##(2006-10#1)(2008-9#1)(2011-12#1)(2011-2#1)
two teleost##3##2##(1996-11#1)(2008-1#1)(2008-7#1)
two telomeres##2##2##(1991-7#1)(2008-5#1)
two temperature conditions##2##3##(2008-12#1)(2012-12#1)
two temperature##3##2##(2005-11#1)(2008-12#1)(2012-12#1)
two temperatures##4##2##(2007-12#1)(2008-11#1)(2012-1#1)(2012-2#1)
two temporally##2##2##(2008-11#1)(2009-9#1)
two terminal oxidases##2##3##(1990-7#1)(1995-6#1)
two terminal##7##2##(1990-7#1)(1993-11#1)(1995-6#1)(1996-10#1)(1997-3#1)(2008-10#2)
two terms##6##2##(2005-11#1)(2008-10#1)(2008-2#3)(2008-3#1)
two test##9##2##(1994-5#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-8#1)
two tests and##3##3##(1996-2#1)(1996-9#1)(2006-10#1)
two tests in##2##3##(1991-6#1)(2008-5#1)
two tests##18##2##(1990-11#1)(1991-6#1)(1993-5#1)(1993-6#1)(1994-2#1)(1994-8#1)(1996-2#1)(1996-4#1)(1996-9#2)(2006-10#3)(2008-10#2)(2008-5#1)(2012-12#1)(2012-3#1)
two that##2##2##(1993-11#1)(2008-8#1)
two theories##2##2##(2006-7#1)(2008-2#1)
two thin##2##2##(2007-11#1)(2008-3#1)
two thirds of all##3##4##(1991-11#1)(2007-9#1)(2009-3#1)
two thirds of patients##3##4##(2008-3#1)(2010-9#1)(2011-2#1)
two thirds of the##9##4##(1992-3#1)(1995-11#1)(2004-12#1)(2006-10#2)(2006-8#1)(2007-2#1)(2009-4#1)(2012-12#1)
two thirds of##20##3##(1991-11#1)(1992-3#1)(1995-11#1)(1995-2#1)(2004-12#1)(2005-8#1)(2006-10#2)(2006-8#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-2#1)(2008-3#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-9#1)(2011-2#1)(2012-12#1)
two thirds##26##2##(1991-11#1)(1991-3#1)(1992-3#1)(1995-11#1)(1995-2#1)(2004-12#1)(2005-8#1)(2006-10#3)(2006-8#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-2#1)(2008-3#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
two thymocyte subsets##2##3##(1995-8#2)
two tier##3##2##(1990-3#3)
two tightly linked loci##2##4##(2008-10#2)
two tightly##4##2##(1997-4#1)(2007-11#1)(2008-10#2)
two time constants##2##3##(2008-10#1)(2008-3#1)
two time intervals##2##3##(2007-6#1)(2008-12#1)
two time periods##8##3##(1996-11#1)(2008-11#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#3)
two time##18##2##(1996-11#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#1)(2010-1#2)(2010-11#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
two times a day##2##4##(1993-10#1)(2008-10#1)
two times a##3##3##(1993-10#1)(2008-10#1)(2009-6#1)
two times as##2##3##(1995-2#1)(2012-2#1)
two times each##2##3##(2005-8#2)
two times faster##2##3##(2008-10#1)(2008-5#1)
two times greater##2##3##(2007-12#1)(2008-5#1)
two times higher as compared with##2##6##(2007-12#1)(2009-5#1)
two times higher than##2##4##(2004-4#1)(2010-9#1)
two times higher##6##3##(2004-4#1)(2007-12#1)(2008-2#1)(2009-5#1)(2010-9#1)(2013-1#1)
two times more##2##3##(1990-4#1)(2007-9#1)
two times the average##2##4##(1993-4#1)(2008-10#1)
two times the##6##3##(1993-4#1)(1993-6#1)(2007-12#2)(2008-10#1)(2012-2#1)
two times##39##2##(1990-4#1)(1993-10#1)(1993-4#1)(1993-6#1)(1995-2#1)(1995-8#1)(1997-8#1)(2004-11#1)(2004-4#1)(2005-8#2)(2007-10#1)(2007-12#7)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#3)(2009-5#1)(2009-6#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#4)(2013-1#1)(2013-8#1)
two tissue culture adapted CDV strains##3##6##(1997-6#3)
two tissue##8##2##(1994-5#1)(1995-8#1)(1997-6#3)(2006-6#1)(2008-5#1)(2012-2#1)
two tissues##6##2##(1993-7#1)(1996-7#1)(2008-10#1)(2008-3#1)(2010-12#1)(2012-12#1)
two to 10##2##3##(2007-12#2)
two to five##5##3##(1992-11#1)(1996-8#1)(2008-10#2)(2012-2#1)
two to four indicators##2##4##(2007-8#2)
two to four times##3##4##(1992-8#1)(2008-2#1)(2008-5#1)
two to four##19##3##(1990-11#1)(1991-6#1)(1992-8#1)(1993-9#1)(2006-10#2)(2007-8#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#1)(2010-8#2)(2013-8#1)
two to nine weeks after##2##5##(1996-12#2)
two to seven##3##3##(1997-5#1)(2008-11#1)(2008-5#1)
two to six##3##3##(2008-10#1)(2008-5#1)(2009-12#1)
two to three days##2##4##(2007-12#1)(2007-5#1)
two to three times higher##3##5##(2006-10#1)(2008-2#1)(2008-6#1)
two to three times more##2##5##(1996-3#1)(2008-10#1)
two to three times##11##4##(1992-3#1)(1995-6#1)(1996-3#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-6#1)(2012-2#1)
two to three##31##3##(1991-12#1)(1992-1#1)(1992-3#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-8#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2012-2#1)
two to##77##2##(1990-11#1)(1991-12#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-6#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-8#2)(1997-5#1)(2005-12#1)(2006-10#3)(2006-4#1)(2006-5#1)(2006-8#1)(2007-12#4)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#16)(2008-11#3)(2008-2#3)(2008-3#1)(2008-5#5)(2008-6#2)(2008-7#1)(2009-12#1)(2010-8#2)(2012-2#2)(2013-8#1)
two tomato##3##2##(1991-11#1)(1997-2#1)(2008-10#1)
two tones##4##2##(1995-12#2)(2008-4#1)(2013-8#1)
two tools for##2##3##(1994-12#1)(2008-4#1)
two tools##3##2##(1994-12#1)(2008-4#1)(2008-7#1)
two traditionally##2##2##(2007-1#1)(2008-11#1)
two traits##4##2##(2007-3#1)(2008-8#1)(2008-9#2)
two transcription start points##3##4##(1990-11#1)(1991-12#1)(1993-7#1)
two transcription##5##2##(1990-11#1)(1991-12#1)(1993-7#1)(1995-3#1)(1996-11#1)
two transcriptional##3##2##(1993-3#1)(1996-4#1)(2013-8#1)
two transcripts##6##2##(1991-9#1)(1993-6#1)(1997-1#1)(1997-3#1)(1997-6#1)(2008-8#1)
two transects were##2##3##(2007-3#1)(2008-10#1)
two transects##3##2##(2007-3#1)(2008-10#1)(2008-5#1)
two transformants##2##2##(2008-4#1)(2008-8#1)
two transgene##2##2##(1993-6#1)(2011-2#1)
two transgenic##2##2##(1994-2#1)(2006-12#1)
two transition states##3##3##(1992-9#1)(1996-11#1)(2006-3#1)
two transition##6##2##(1992-9#1)(1996-11#1)(1997-7#1)(2006-3#1)(2012-12#2)
two transitions##2##2##(2007-12#1)(2010-4#1)
two transmembrane domains##3##3##(2008-4#2)(2008-8#1)
two transmembrane##4##2##(2008-4#3)(2008-8#1)
two treated##2##2##(2008-12#1)(2012-2#1)
two treatment groups were##2##4##(1995-10#1)(2007-8#1)
two treatment groups##13##3##(1992-3#1)(1992-6#1)(1993-1#1)(1995-10#1)(1995-4#1)(1995-9#1)(1997-7#1)(2007-8#1)(2008-3#2)(2008-5#1)(2008-6#1)(2012-1#1)
two treatment methods##2##3##(1992-9#1)(2012-2#1)
two treatment studies##2##3##(2008-5#2)
two treatment##25##2##(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1995-10#1)(1995-4#2)(1995-9#1)(1997-7#2)(2004-12#1)(2006-11#1)(2007-8#3)(2008-3#2)(2008-5#3)(2008-6#1)(2012-1#1)(2012-2#1)(2012-3#1)(2012-5#1)
two treatments is##2##3##(1995-9#1)(1997-4#1)
two treatments with##2##3##(2008-12#1)(2008-9#1)
two treatments##32##2##(1992-9#1)(1993-11#1)(1993-5#1)(1995-2#1)(1995-9#3)(1996-12#1)(1996-7#1)(1997-2#1)(1997-4#1)(2004-10#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-12#2)(2008-9#2)(2009-6#2)(2009-8#1)(2010-2#1)(2011-12#1)(2012-2#1)(2013-1#2)(2013-7#2)
two trends##3##2##(2007-9#1)(2008-12#1)(2008-6#1)
two trials##9##2##(1993-12#1)(1994-3#1)(1997-3#1)(2004-1#2)(2005-7#1)(2008-10#2)(2008-5#1)
two tributaries of the##2##4##(2010-8#2)
two tropical##4##2##(2008-10#3)(2008-5#1)
two tryptic peptides##2##3##(1994-11#1)(1994-8#1)
two tryptophan residues##5##3##(1991-5#1)(1992-6#2)(1993-11#2)
two tryptophan##6##2##(1991-5#1)(1992-6#2)(1992-9#1)(1993-11#2)
two tryptophans##3##2##(1991-4#1)(1995-2#2)
two tumors##3##2##(1995-1#1)(1995-10#1)(2006-12#1)
two tumour##2##2##(1993-3#1)(2005-12#1)
two turns##2##2##(1995-1#1)(2008-9#1)
two two-chain forms##3##3##(1991-8#3)
two type I##2##3##(2008-10#2)
two types in the##2##4##(1996-11#1)(2005-4#1)
two types of NF1-GRD##2##4##(1992-8#2)
two types of PD##2##4##(2008-7#2)
two types of binding sites##4##5##(1990-12#1)(1992-3#1)(2008-10#1)(2008-5#1)
two types of breast##2##4##(2008-12#1)(2010-2#1)
two types of cells##4##4##(1993-1#1)(1997-1#1)(2008-11#1)(2012-1#1)
two types of colonies##2##4##(1993-8#1)(1993-9#1)
two types of distortion##2##4##(2008-2#2)
two types of elongated##2##4##(1994-2#1)(2008-5#1)
two types of grating##2##4##(2008-2#2)
two types of hamster cyclin-dependent##2##5##(1993-12#2)
two types of homologous DNA pairing activity in mouse##2##9##(1992-6#2)
two types of metalloproteinases which convert big##2##7##(1991-7#2)
two types of metalloproteinases##3##4##(1991-7#3)
two types of optical##2##4##(2008-10#1)(2008-3#1)
two types of receptors##2##4##(1994-2#1)(1996-4#1)
two types of repeated##2##4##(1995-1#1)(2009-12#1)
two types of study##2##4##(2008-11#1)(2012-2#1)
two types of the##2##4##(1991-5#1)(2008-11#1)
two types of##238##3##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#2)(1990-7#2)(1990-9#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-7#4)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#2)(1992-8#4)(1993-1#2)(1993-11#3)(1993-12#5)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#2)(1994-5#1)(1994-8#3)(1995-1#2)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#3)(1996-5#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#3)(2004-9#1)(2005-11#3)(2005-12#1)(2005-4#2)(2005-8#2)(2006-10#2)(2006-11#1)(2006-12#5)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#6)(2007-4#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#8)(2008-3#9)(2008-4#1)(2008-5#14)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#3)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#4)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#3)(2013-8#4)
two types##269##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#2)(1990-4#1)(1990-6#1)(1990-7#2)(1990-9#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#1)(1991-7#4)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#2)(1992-8#4)(1993-1#2)(1993-11#3)(1993-12#6)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#2)(1994-5#1)(1994-8#3)(1995-1#2)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#3)(1996-5#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#3)(2004-12#1)(2004-9#1)(2005-11#3)(2005-12#1)(2005-4#3)(2005-8#2)(2006-10#3)(2006-11#1)(2006-12#5)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#8)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#5)(2008-12#2)(2008-2#8)(2008-3#10)(2008-4#1)(2008-5#16)(2008-6#1)(2008-7#9)(2008-8#4)(2008-9#4)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-11#4)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#4)(2013-8#4)
two typical##7##2##(1997-7#1)(2005-11#1)(2005-6#1)(2007-11#1)(2008-3#2)(2008-9#1)
two tyrosine residues##3##3##(1990-12#1)(1991-7#1)(1994-6#1)
two tyrosine##5##2##(1990-12#1)(1991-7#1)(1994-6#1)(1995-3#1)(1996-5#1)
two tyrosines##2##2##(1992-9#1)(2010-8#1)
two unaffected##2##2##(1993-12#1)(1996-3#1)
two unbranched neurons##2##3##(2007-12#2)
two underwent##2##2##(2011-2#1)(2013-8#1)
two unequal##3##2##(2005-11#2)(2008-5#1)
two unique##11##2##(1991-1#1)(1991-2#1)(1992-3#1)(1992-4#1)(1996-10#1)(2006-12#1)(2008-10#2)(2008-11#1)(2009-6#1)(2012-2#1)
two units of##6##3##(1993-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1996-11#1)(2008-5#1)
two units##7##2##(1993-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1996-11#1)(2008-10#1)(2008-5#1)
two universal curves##2##3##(2005-11#2)
two universal##4##2##(1990-11#1)(2005-11#2)(2008-10#1)
two universities##2##2##(2007-12#1)(2008-11#1)
two university hospitals in##2##4##(2006-8#2)
two unknown##7##2##(1995-4#1)(2007-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)
two unrelated##12##2##(1990-8#1)(1993-6#1)(1994-12#1)(1996-5#1)(1996-7#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-10#1)(2013-1#1)
two until##2##2##(2006-10#1)(2007-12#1)
two unusual##4##2##(2005-7#1)(2008-7#1)(2009-12#1)(2013-1#1)
two upstream regions##2##3##(1995-12#1)(2008-10#1)
two upstream##6##2##(1990-8#1)(1993-3#1)(1993-5#1)(1994-9#1)(1995-12#1)(2008-10#1)
two urban slums##2##3##(2011-1#2)
two urban##8##2##(2007-4#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-1#1)(2011-1#2)
two used##2##2##(2008-10#2)
two vaccinated##2##2##(2008-5#1)(2013-1#1)
two valleys##2##2##(2008-10#2)
two values##6##2##(1990-12#1)(1990-3#1)(1991-6#1)(2008-11#1)(2008-3#2)
two valve replacement surgery##3##4##(2007-9#3)
two variables were##2##3##(1993-2#1)(2008-10#1)
two variables##16##2##(1993-11#1)(1993-2#1)(1995-3#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-7#1)(2013-8#1)
two variant isoforms##2##3##(1991-12#2)
two variant##5##2##(1991-12#2)(1993-12#1)(1994-11#1)(1995-3#1)
two variants of the##2##4##(1992-1#1)(2010-8#1)
two variants of##4##3##(1990-7#1)(1992-1#1)(2010-8#1)(2012-1#1)
two variants##11##2##(1990-6#3)(1990-7#1)(1991-11#1)(1992-1#1)(1995-5#1)(2008-3#1)(2008-6#1)(2010-8#1)(2012-1#1)
two variations##2##2##(2008-12#1)(2011-2#1)
two varieties##5##2##(2007-7#1)(2008-10#3)(2008-5#1)
two vectors##3##2##(2007-12#1)(2008-8#1)(2011-3#1)
two vein##2##2##(2007-8#1)(2012-2#1)
two versions of the##3##4##(2007-12#1)(2007-8#1)(2010-12#1)
two versions of##4##3##(2007-12#1)(2007-8#1)(2010-1#1)(2010-12#1)
two versions##7##2##(2007-12#1)(2007-8#1)(2010-1#1)(2010-12#2)(2011-1#1)(2012-12#1)
two very different##5##3##(1992-7#1)(1993-2#1)(1996-11#1)(2008-7#1)(2013-7#1)
two very distinct##2##3##(1994-3#1)(2008-10#1)
two very##10##2##(1992-7#1)(1993-12#1)(1993-2#1)(1994-3#1)(1996-11#1)(2008-10#1)(2008-7#1)(2009-2#1)(2011-2#1)(2013-7#1)
two views##3##2##(1995-5#1)(2008-6#2)
two villages##3##2##(1992-12#1)(1994-9#1)(1997-6#1)
two vineyards##2##2##(2008-10#2)
two viral##2##2##(2008-10#1)(2009-11#1)
two viruses##16##2##(1995-2#1)(2006-10#1)(2007-6#2)(2008-10#10)(2008-9#1)(2013-8#1)
two visible wavelengths##2##3##(2008-3#1)(2010-5#1)
two visible##4##2##(2006-10#1)(2007-12#1)(2008-3#1)(2010-5#1)
two visual##3##2##(1992-9#1)(1995-5#1)(2008-1#1)
two vital##2##2##(2013-7#1)(2013-8#1)
two volumetric##2##2##(1990-8#1)(2010-5#1)
two volunteers with##2##3##(1990-4#1)(2007-12#1)
two was##3##2##(1990-8#1)(2007-1#1)(2008-11#1)
two water molecules##5##3##(1994-12#1)(1994-9#1)(1996-2#1)(2006-1#1)(2008-8#1)
two water##8##2##(1994-12#1)(1994-9#1)(1995-5#1)(1996-2#1)(2006-1#1)(2008-5#1)(2008-8#1)(2010-8#1)
two wave fronts##3##3##(2008-2#2)(2008-3#1)
two wave##4##2##(1993-12#1)(2008-2#2)(2008-3#1)
two waveguides are##2##3##(2007-11#1)(2008-3#1)
two waveguides##6##2##(2007-11#3)(2007-12#1)(2008-3#2)
two wavelength windows##2##3##(2008-3#2)
two wavelength##5##2##(2008-10#1)(2008-2#1)(2008-3#3)
two wavelengths simultaneously##2##3##(2008-2#1)(2008-9#1)
two wavelengths to##2##3##(2008-2#1)(2008-3#1)
two wavelengths was##2##3##(2008-2#1)(2008-3#1)
two wavelengths##33##2##(2007-12#2)(2008-1#1)(2008-10#4)(2008-2#9)(2008-3#15)(2008-9#1)(2011-1#1)
two waves##3##2##(2007-12#2)(2008-3#1)
two way##2##2##(2007-3#1)(2009-5#1)
two ways of##3##3##(2008-2#2)(2008-8#1)
two ways to##3##3##(2008-4#1)(2008-9#1)(2012-3#1)
two ways##31##2##(1990-11#1)(1992-10#1)(1992-11#1)(1992-4#1)(1993-3#1)(1994-12#1)(1996-4#1)(2005-8#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-6#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-7#1)
two week##3##2##(1997-3#1)(2008-11#1)(2008-3#1)
two weeks after the##5##4##(1993-7#1)(1996-10#2)(1997-2#1)(2011-2#1)
two weeks after##11##3##(1993-7#1)(1995-12#1)(1995-2#1)(1996-10#2)(1997-2#1)(2007-1#1)(2008-5#1)(2010-7#1)(2011-2#1)(2013-8#1)
two weeks and##9##3##(1990-3#1)(1991-9#1)(1996-9#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-5#1)(2013-8#1)
two weeks before##4##3##(2007-4#1)(2008-2#1)(2008-8#1)(2013-8#1)
two weeks during the##3##4##(1990-6#1)(2006-10#1)(2013-1#1)
two weeks following the##2##4##(1993-12#1)(2009-6#1)
two weeks following##3##3##(1993-12#1)(2006-9#1)(2009-6#1)
two weeks later##5##3##(1991-6#2)(1992-3#2)(2007-8#1)
two weeks of treatment##5##4##(1990-10#1)(1994-6#1)(2007-2#2)(2010-8#1)
two weeks of##21##3##(1990-10#1)(1990-11#1)(1993-2#1)(1993-3#1)(1994-6#2)(1996-2#1)(1996-3#1)(2006-9#1)(2007-2#2)(2007-3#1)(2008-10#1)(2008-7#1)(2009-6#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#1)
two weeks to##4##3##(2005-12#1)(2008-5#1)(2011-2#1)(2012-2#1)
two weeks was##2##3##(2006-7#1)(2013-1#1)
two weeks##130##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-6#2)(1991-7#2)(1991-9#2)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-7#4)(1994-12#1)(1994-6#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-8#1)(1996-1#1)(1996-10#2)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(2004-9#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-7#2)(2006-8#2)(2006-9#3)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-2#1)(2009-5#2)(2009-6#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#6)(2012-1#1)(2012-2#3)(2013-1#4)(2013-8#3)
two weeks'##2##2##(1990-8#1)(1993-11#1)
two well resolved##2##3##(2009-9#2)
two well##4##2##(2008-2#1)(2009-9#2)(2013-1#1)
two well-characterized##3##2##(1995-2#1)(2008-1#1)(2012-3#1)
two well-defined##3##2##(2007-12#1)(2008-10#1)(2013-1#1)
two well-known##4##2##(1991-12#1)(2008-2#2)(2009-7#1)
two well-separated peaks##2##3##(1991-7#1)(1997-2#1)
two well-separated##4##2##(1991-7#1)(1997-2#1)(2007-12#1)(2008-10#1)
two well-studied##2##2##(1995-3#1)(2008-8#1)
two were not##2##3##(2008-4#1)(2008-7#1)
two were observed##2##3##(1997-3#1)(2012-2#1)
two were of##2##3##(2006-12#1)(2008-9#1)
two were sent for##2##4##(2008-5#2)
two were treated by##2##4##(2008-7#2)
two were##45##2##(1990-7#1)(1990-9#1)(1993-2#1)(1994-4#1)(1994-6#1)(1996-5#1)(1997-3#2)(2005-11#1)(2006-11#2)(2006-12#1)(2006-3#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-8#6)(2008-10#3)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#1)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#1)
two wheat DH##2##3##(2008-8#2)
two wheat##5##2##(2008-12#3)(2008-8#2)
two white##3##2##(1990-12#2)(2008-10#1)
two widely available##2##3##(2006-2#1)(2008-9#1)
two widely used##4##3##(2007-7#1)(2008-3#1)(2008-4#1)(2008-8#1)
two widely##6##2##(2006-2#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
two wild-type##2##2##(2008-10#1)(2012-3#1)
two willows##2##2##(2012-3#2)
two with##17##2##(1991-4#1)(1991-7#1)(1992-7#1)(1994-9#1)(1996-3#1)(1997-8#1)(2005-10#2)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-9#1)(2010-12#1)(2010-2#1)
two within isolates of C##2##5##(2008-10#2)
two women aged##2##3##(1990-10#1)(2006-10#1)
two women with##3##3##(2004-2#1)(2007-8#1)(2008-11#1)
two women##9##2##(1990-10#1)(1993-8#1)(1996-2#1)(2004-2#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-3#1)(2013-1#1)
two wood##2##2##(2008-5#1)(2011-2#1)
two word classes##2##3##(2008-2#1)(2012-11#1)
two words##2##2##(2008-2#1)(2012-2#1)
two workers##2##2##(1994-6#2)
two writing beams##3##3##(2007-11#1)(2008-2#2)
two year study##2##3##(2008-5#1)(2011-2#1)
two year##10##2##(1991-9#1)(1993-9#1)(2006-8#1)(2007-6#1)(2008-12#1)(2008-5#1)(2009-4#1)(2010-8#1)(2010-9#1)(2011-2#1)
two year-old boy##2##3##(1992-8#1)(2011-2#1)
two year-old##3##2##(1992-8#1)(2009-11#1)(2011-2#1)
two years (2007 and##3##4##(2013-1#2)(2013-8#1)
two years (OR =##2##4##(2011-2#2)
two years after the##6##4##(1993-3#1)(2006-8#1)(2007-12#1)(2007-3#1)(2008-2#1)(2011-2#1)
two years after##17##3##(1990-10#1)(1991-3#1)(1993-3#1)(1994-3#1)(1996-3#1)(2006-8#1)(2007-12#2)(2007-3#2)(2007-7#1)(2008-2#1)(2009-9#1)(2010-8#1)(2011-2#2)(2013-1#1)
two years ago##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
two years and the##3##4##(2007-8#1)(2009-9#2)
two years and##10##3##(1992-5#1)(1997-8#1)(2007-1#1)(2007-3#1)(2007-8#1)(2009-9#2)(2011-12#1)(2012-2#1)(2013-8#1)
two years apart##3##3##(2008-10#1)(2013-8#2)
two years before##2##3##(1990-12#1)(2013-1#1)
two years beyond##2##3##(1990-12#1)(1996-12#1)
two years follow-up##2##3##(2009-9#1)(2010-11#1)
two years following##3##3##(2005-12#1)(2010-10#1)(2013-1#1)
two years from##3##3##(2008-4#1)(2009-2#1)(2013-1#1)
two years in a##2##4##(1997-2#1)(2007-7#1)
two years in the##2##4##(1994-1#1)(2008-5#1)
two years in##9##3##(1991-9#1)(1994-1#1)(1997-2#1)(1997-5#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-5#1)
two years later##4##3##(1994-3#1)(2007-9#1)(2009-4#1)(2013-1#1)
two years of age or older##2##6##(2010-10#2)
two years of age##10##4##(1991-8#1)(1994-9#1)(1996-1#1)(2006-10#2)(2007-7#1)(2010-10#3)(2012-12#1)
two years of follow-up##2##4##(2008-1#1)(2013-8#1)
two years of operation##2##4##(1994-2#1)(2011-2#1)
two years of the study##2##5##(1997-8#1)(2008-10#1)
two years of the##3##4##(1997-8#1)(2008-10#1)(2012-3#1)
two years of therapy##3##4##(2008-1#3)
two years of treatment##3##4##(1994-6#1)(2007-8#1)(2012-3#1)
two years of##44##3##(1990-5#1)(1991-8#1)(1993-1#1)(1994-2#1)(1994-6#2)(1994-9#1)(1996-1#1)(1996-2#1)(1996-7#1)(1997-8#1)(2006-10#4)(2006-8#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#5)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2010-10#3)(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
two years old##3##3##(1992-10#1)(2011-2#1)(2012-12#1)
two years previously##2##3##(2006-11#1)(2008-10#1)
two years prior to##2##4##(1993-11#1)(2006-8#1)
two years she##2##3##(2006-11#1)(2012-12#1)
two years since the##2##4##(2007-12#1)(2008-7#1)
two years the##2##3##(1992-3#1)(2012-2#1)
two years to##5##3##(1996-11#1)(2011-1#1)(2011-11#1)(2013-1#2)
two years was##4##3##(1992-5#1)(2007-11#1)(2008-10#1)(2009-9#1)
two years were##5##3##(2005-7#1)(2006-10#1)(2008-1#2)(2013-1#1)
two years without##2##3##(1997-5#1)(2011-2#1)
two years##237##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1993-1#2)(1993-11#2)(1993-3#1)(1993-8#2)(1994-1#1)(1994-2#1)(1994-3#2)(1994-6#2)(1994-9#1)(1995-4#1)(1995-5#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#4)(1996-6#1)(1996-7#1)(1996-8#2)(1997-2#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#4)(2004-9#1)(2005-12#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#7)(2006-11#2)(2006-4#1)(2006-8#5)(2007-1#2)(2007-11#2)(2007-12#4)(2007-3#3)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#5)(2007-9#3)(2008-1#13)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#3)(2008-4#6)(2008-5#7)(2008-7#2)(2008-8#2)(2009-2#2)(2009-4#1)(2009-9#5)(2010-10#5)(2010-11#3)(2010-8#1)(2011-1#2)(2011-11#2)(2011-12#1)(2011-2#14)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#17)(2013-7#3)(2013-8#9)
two yeast##4##2##(1997-6#1)(2008-11#1)(2008-4#1)(2008-8#1)
two yeasts##2##2##(2008-10#1)(2013-1#1)
two young##4##2##(1992-5#1)(1996-3#1)(2007-8#1)(2008-3#1)
two zero crossings##2##3##(2007-12#1)(2008-3#1)
two zinc atoms##2##3##(1994-11#1)(2010-5#1)
two zinc fingers##2##3##(1991-10#1)(1991-6#1)
two zinc##7##2##(1991-10#1)(1991-6#1)(1994-11#1)(1995-11#1)(2008-3#1)(2008-7#1)(2010-5#1)
two zones##3##2##(2008-10#1)(2008-5#2)
two##17323##1##(1990-1#10)(1990-10#60)(1990-11#82)(1990-12#97)(1990-2#71)(1990-3#66)(1990-4#51)(1990-5#81)(1990-6#40)(1990-7#74)(1990-8#85)(1990-9#37)(1991-1#34)(1991-10#49)(1991-11#50)(1991-12#86)(1991-2#87)(1991-3#61)(1991-4#46)(1991-5#60)(1991-6#59)(1991-7#57)(1991-8#61)(1991-9#71)(1992-1#43)(1992-10#33)(1992-11#74)(1992-12#66)(1992-2#72)(1992-3#81)(1992-4#52)(1992-5#49)(1992-6#74)(1992-7#24)(1992-8#76)(1992-9#71)(1993-1#40)(1993-10#6)(1993-11#83)(1993-12#106)(1993-2#59)(1993-3#68)(1993-4#24)(1993-5#25)(1993-6#78)(1993-7#25)(1993-8#55)(1993-9#48)(1994-1#8)(1994-10#19)(1994-11#94)(1994-12#124)(1994-2#92)(1994-3#93)(1994-4#7)(1994-5#70)(1994-6#72)(1994-7#7)(1994-8#101)(1994-9#111)(1995-1#81)(1995-10#36)(1995-11#66)(1995-12#65)(1995-2#96)(1995-3#104)(1995-4#28)(1995-5#71)(1995-6#73)(1995-7#18)(1995-8#94)(1995-9#31)(1996-1#35)(1996-10#44)(1996-11#67)(1996-12#74)(1996-2#97)(1996-3#69)(1996-4#50)(1996-5#110)(1996-6#61)(1996-7#62)(1996-8#50)(1996-9#70)(1997-1#45)(1997-2#100)(1997-3#56)(1997-4#113)(1997-5#37)(1997-6#89)(1997-7#114)(1997-8#70)(1997-9#4)(2003-11#1)(2004-1#10)(2004-10#15)(2004-11#23)(2004-12#10)(2004-2#16)(2004-3#2)(2004-4#16)(2004-7#2)(2004-8#1)(2004-9#23)(2005-1#2)(2005-10#34)(2005-11#150)(2005-12#24)(2005-2#2)(2005-3#2)(2005-4#26)(2005-5#5)(2005-6#3)(2005-7#29)(2005-8#38)(2005-9#19)(2006-1#14)(2006-10#185)(2006-11#41)(2006-12#141)(2006-2#30)(2006-3#31)(2006-4#43)(2006-5#44)(2006-6#62)(2006-7#43)(2006-8#118)(2006-9#26)(2007-1#74)(2007-10#39)(2007-11#226)(2007-12#506)(2007-2#101)(2007-3#56)(2007-4#28)(2007-5#51)(2007-6#44)(2007-7#142)(2007-8#262)(2007-9#95)(2008-1#157)(2008-10#1898)(2008-11#308)(2008-12#146)(2008-2#526)(2008-3#617)(2008-4#291)(2008-5#482)(2008-6#177)(2008-7#306)(2008-8#301)(2008-9#278)(2009-1#10)(2009-10#61)(2009-11#36)(2009-12#43)(2009-2#46)(2009-3#42)(2009-4#68)(2009-5#39)(2009-6#45)(2009-7#24)(2009-8#85)(2009-9#51)(2010-1#18)(2010-10#49)(2010-11#27)(2010-12#88)(2010-2#68)(2010-3#39)(2010-4#76)(2010-5#78)(2010-6#24)(2010-7#51)(2010-8#106)(2010-9#19)(2011-1#180)(2011-10#3)(2011-11#4)(2011-12#48)(2011-2#343)(2011-3#15)(2012-1#87)(2012-11#54)(2012-12#193)(2012-2#265)(2012-3#167)(2012-4#1)(2012-5#10)(2012-6#2)(2012-7#1)(2012-8#2)(2012-9#1)(2013-1#387)(2013-7#75)(2013-8#165)
two)##4##1##(2007-12#1)(2007-2#1)(2008-5#1)(2008-8#1)
two- and one-dimensional##3##3##(2008-3#2)(2010-5#1)
two- and three-dimensional##16##3##(1994-8#1)(2005-10#1)(2006-6#1)(2007-12#1)(2008-2#4)(2008-3#4)(2008-7#1)(2012-2#1)(2013-1#2)
two- and three-photon##2##3##(2008-1#1)(2008-3#1)
two- and##32##2##(1994-8#1)(1995-1#1)(2005-10#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#6)(2008-3#8)(2008-7#1)(2009-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#2)
two- or three-dimensional##2##3##(2007-11#1)(2008-3#1)
two- or##6##2##(2005-8#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-7#1)
two- to fivefold##2##3##(1995-12#1)(2008-10#1)
two- to three-fold##3##3##(1996-3#1)(1997-8#2)
two- to threefold higher transformation efficiency##2##6##(2006-12#2)
two- to threefold##4##3##(1992-11#2)(2006-12#2)
two- to##17##2##(1992-11#2)(1993-7#1)(1994-5#1)(1995-12#1)(1996-3#1)(1997-8#3)(2005-10#1)(2006-10#1)(2006-12#2)(2006-8#1)(2006-9#1)(2008-10#2)
two-##62##1##(1992-11#2)(1993-7#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-4#1)(1996-3#1)(1997-8#3)(2005-10#2)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#4)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#6)(2008-3#11)(2008-7#2)(2008-9#1)(2009-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#2)
two-alternative forced##2##2##(2012-1#1)(2012-12#1)
two-alternative##4##1##(2009-11#1)(2011-2#1)(2012-1#1)(2012-12#1)
two-and-a-half##2##1##(1993-7#1)(2008-10#1)
two-and-half##2##1##(2008-1#1)(2008-2#1)
two-arm##2##1##(1993-5#1)(2007-11#1)
two-band##3##1##(2008-2#1)(2008-3#2)
two-base##3##1##(2006-12#2)(2008-10#1)
two-beam coupling gain##4##3##(2007-11#1)(2007-12#3)
two-beam coupling##15##2##(2007-11#1)(2007-12#9)(2008-2#1)(2008-3#4)
two-beam interference method##2##3##(2008-3#2)
two-beam interference##4##2##(2008-3#4)
two-beam interferometer##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
two-beam phase-stepping##3##2##(2008-2#3)
two-beam##35##1##(2007-11#1)(2007-12#10)(2008-2#11)(2008-3#13)
two-body##2##1##(2007-9#1)(2011-2#1)
two-bottle##2##1##(1993-12#1)(1996-12#1)
two-bounce##3##1##(2008-2#3)
two-camera##2##1##(2008-2#2)
two-cascade microaperture-per-channel##2##2##(2008-3#2)
two-celled##2##1##(2008-10#1)(2009-12#1)
two-center##4##1##(2007-12#2)(2007-8#1)(2013-1#1)
two-chain form by##2##3##(1992-12#2)
two-chain molecule##2##2##(1990-11#1)(1994-11#1)
two-chain tPA##2##2##(2008-5#2)
two-chain urokinase-type plasminogen activator##2##4##(1990-11#1)(1991-1#1)
two-chain##19##1##(1990-11#3)(1991-1#1)(1991-8#3)(1992-12#3)(1992-7#1)(1994-11#1)(1996-2#1)(2005-7#1)(2008-5#2)(2012-3#3)
two-channel flow##2##2##(2007-1#1)(2008-10#1)
two-channel manifold##2##2##(2008-10#2)
two-channel##17##1##(2007-1#1)(2007-11#2)(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#5)(2008-7#1)(2009-2#1)
two-choice##5##1##(1992-9#1)(2009-9#1)(2010-2#1)(2011-12#2)
two-class##6##1##(2008-6#3)(2009-9#1)(2010-4#1)(2012-1#1)
two-coil CASL##2##2##(2009-10#2)
two-coil##6##1##(2009-10#3)(2013-7#3)
two-color analysis##2##2##(2008-4#2)
two-color excitation##4##2##(2007-12#1)(2007-8#1)(2008-3#2)
two-color experiments##2##2##(2007-12#1)(2008-3#1)
two-color flow##2##2##(1992-8#1)(1995-12#1)
two-color light##2##2##(2008-3#2)
two-color measurement##2##2##(2008-3#2)
two-color pump-probe##2##2##(1996-2#1)(2007-12#1)
two-color pyrometry##2##2##(2008-2#1)(2008-3#1)
two-color recording##4##2##(2008-1#1)(2008-2#1)(2008-3#2)
two-color##51##1##(1992-8#1)(1995-12#2)(1996-2#1)(1997-3#1)(2006-5#1)(2007-11#1)(2007-12#11)(2007-8#1)(2008-1#4)(2008-2#8)(2008-3#14)(2008-4#4)(2008-8#1)(2008-9#1)
two-color-change##2##1##(2008-10#2)
two-colour microarray##2##2##(2008-7#2)
two-colour##4##1##(2008-5#2)(2008-7#2)
two-column##2##1##(1992-12#1)(2008-4#1)
two-compartment model##2##2##(1996-5#1)(2008-1#1)
two-compartment##5##1##(1996-5#1)(2008-1#2)(2008-11#1)(2010-11#1)
two-component regulatory system##5##3##(1996-12#1)(1996-4#1)(1997-4#1)(2007-12#2)
two-component regulatory systems##3##3##(1994-12#1)(1995-1#1)(1995-6#1)
two-component regulatory##8##2##(1994-12#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-4#1)(1997-4#1)(2007-12#2)
two-component signal transducers in##3##4##(1996-12#2)(1997-4#1)
two-component signal transducers##5##3##(1996-12#3)(1997-4#2)
two-component signal transduction##3##3##(1996-12#1)(1997-4#2)
two-component signal##8##2##(1996-12#4)(1997-4#4)
two-component system##5##2##(1997-7#1)(2009-6#4)
two-component systems##4##2##(1996-12#1)(1997-7#1)(2008-10#1)(2008-2#1)
two-component##42##1##(1990-12#1)(1994-12#1)(1995-1#1)(1995-5#2)(1995-6#1)(1996-12#6)(1996-4#1)(1997-4#6)(1997-7#2)(2005-11#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-2#4)(2008-3#3)(2009-6#4)(2011-1#2)
two-compound mixtures##2##2##(2008-10#1)(2008-11#1)
two-cycle##5##1##(2007-11#1)(2007-12#1)(2008-12#1)(2008-3#2)
two-cyclic orbit##2##2##(2007-9#2)
two-cyclic##3##1##(2007-9#3)
two-day meeting##3##2##(2005-9#1)(2008-5#2)
two-day##7##1##(1993-1#1)(2005-9#1)(2008-10#1)(2008-5#3)(2011-12#1)
two-dimension SnO2##2##2##(2005-4#2)
two-dimension##4##1##(2005-4#2)(2008-10#1)(2011-3#1)
two-dimensional (2-D)##20##2##(1993-9#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#7)(2008-3#6)
two-dimensional (2D) gel electrophoresis##3##4##(1994-11#1)(2005-8#1)(2007-12#1)
two-dimensional (2D) photonic crystal##2##4##(2007-11#1)(2007-12#1)
two-dimensional (2D)##38##2##(1991-4#1)(1991-7#1)(1994-11#1)(1996-2#1)(1997-8#1)(2005-8#1)(2007-11#4)(2007-12#6)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2009-10#1)(2009-11#1)(2010-5#2)(2010-6#1)(2011-1#3)(2011-2#1)(2011-7#1)(2012-2#1)(2012-4#1)(2013-1#1)
two-dimensional 1H NMR##7##3##(1990-11#1)(1990-9#1)(1991-4#1)(1994-11#1)(1994-5#1)(1995-2#1)(1995-3#1)
two-dimensional 1H##9##2##(1990-11#1)(1990-9#1)(1991-4#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-3#1)
two-dimensional 1H-NMR spectroscopy##2##3##(1990-4#1)(1991-2#1)
two-dimensional 1H-NMR##4##2##(1990-4#1)(1990-9#1)(1991-2#1)(1995-3#1)
two-dimensional Fourier##3##2##(2008-2#2)(2008-3#1)
two-dimensional Gabor##2##2##(2011-1#2)
two-dimensional Gaussian##4##2##(2008-10#4)
two-dimensional NMR and the iterative relaxation matrix approach##2##8##(1996-7#2)
two-dimensional NMR and##3##3##(1992-12#1)(1996-7#2)
two-dimensional NMR techniques##3##3##(1990-9#1)(2008-8#1)(2008-9#1)
two-dimensional NMR##12##2##(1990-9#1)(1991-2#1)(1992-12#1)(1993-6#1)(1995-1#1)(1996-7#3)(2007-1#1)(2008-8#1)(2008-9#1)(2012-8#1)
two-dimensional PAGE##2##2##(1990-11#1)(2008-9#1)
two-dimensional Raman##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
two-dimensional analysis of##2##3##(1995-8#1)(2008-5#1)
two-dimensional analysis##6##2##(1995-8#1)(2008-3#2)(2008-4#1)(2008-5#2)
two-dimensional and axisymmetric##2##3##(2008-3#2)
two-dimensional and three-dimensional##3##3##(1994-9#1)(2008-2#1)(2010-9#1)
two-dimensional and##6##2##(1994-9#1)(1995-6#1)(2008-2#1)(2008-3#2)(2010-9#1)
two-dimensional angular optical scattering##2##4##(2007-12#1)(2008-3#1)
two-dimensional array of##9##3##(2006-2#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#3)
two-dimensional array##14##2##(2006-2#1)(2007-11#1)(2007-12#2)(2008-2#5)(2008-3#5)
two-dimensional arrays of##5##3##(1990-7#1)(2006-12#1)(2008-1#1)(2008-3#2)
two-dimensional arrays##6##2##(1990-7#1)(2006-12#1)(2008-1#1)(2008-3#2)(2008-4#1)
two-dimensional beam from the##2##4##(2007-12#2)
two-dimensional beam##6##2##(2007-12#3)(2008-2#3)
two-dimensional characterization of##2##3##(2007-12#1)(2008-2#1)
two-dimensional correlated##2##2##(1990-10#1)(1990-7#1)
two-dimensional correlation##2##2##(2007-11#1)(2013-7#1)
two-dimensional crystals##2##2##(1993-11#1)(2007-3#1)
two-dimensional data##8##2##(2007-11#2)(2007-12#1)(2008-3#5)
two-dimensional densities of deposited##2##4##(2008-10#2)
two-dimensional difference equations##2##3##(2008-3#2)
two-dimensional difference##3##2##(2008-3#2)(2008-4#1)
two-dimensional diffusion##2##2##(2008-2#1)(2008-3#1)
two-dimensional digital micromirror##4##3##(2007-12#2)(2008-2#2)
two-dimensional digital##7##2##(2007-12#2)(2008-2#3)(2008-3#1)(2008-4#1)
two-dimensional discrete soliton networks##3##4##(2007-11#1)(2007-12#2)
two-dimensional echocardiographic##2##2##(1997-8#1)(2007-8#1)
two-dimensional echocardiography was##2##3##(1991-11#1)(1997-8#1)
two-dimensional echocardiography##8##2##(1991-11#2)(1997-8#1)(2007-8#1)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
two-dimensional electric-field##2##2##(2007-12#1)(2008-3#1)
two-dimensional electron systems##2##3##(1992-12#1)(1995-7#1)
two-dimensional electron##3##2##(1992-12#1)(1995-2#1)(1995-7#1)
two-dimensional electrophoresis and##2##3##(1997-2#1)(2008-4#1)
two-dimensional electrophoresis under non-denaturing conditions##2##5##(1990-6#2)
two-dimensional electrophoresis##11##2##(1990-6#2)(1993-8#1)(1994-11#1)(1994-12#1)(1995-7#1)(1996-8#1)(1997-2#1)(2008-2#1)(2008-4#2)
two-dimensional electrophoretic##2##2##(2008-4#1)(2008-7#1)
two-dimensional fast Fourier transform##3##4##(2005-11#1)(2008-3#2)
two-dimensional fractional Fourier##2##3##(2008-2#2)
two-dimensional fractional fourier##2##3##(2008-2#2)
two-dimensional fractional##5##2##(2008-2#4)(2008-3#1)
two-dimensional gas chromatography with time-of-flight mass spectrometry##2##7##(2008-10#2)
two-dimensional gas chromatography with##3##4##(2008-10#3)
two-dimensional gas chromatography##7##3##(2007-11#1)(2008-10#4)(2011-1#2)
two-dimensional gas##11##2##(2007-11#1)(2008-10#5)(2011-1#5)
two-dimensional gel electrophoresis and##3##4##(1990-5#1)(1993-12#1)(2010-1#1)
two-dimensional gel electrophoresis##24##3##(1990-10#1)(1990-5#1)(1990-7#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#2)(1994-8#2)(1995-11#2)(1995-12#1)(1995-3#1)(1995-8#1)(1997-4#1)(2008-10#2)(2008-7#2)(2008-9#1)(2010-1#1)(2010-12#1)(2013-1#1)
two-dimensional gel##29##2##(1990-10#1)(1990-5#2)(1990-7#2)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-8#2)(1995-11#2)(1995-12#1)(1995-3#1)(1995-8#1)(1997-4#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-9#2)(2010-1#1)(2010-12#1)(2013-1#1)
two-dimensional gels##4##2##(1992-9#1)(1996-4#1)(2008-1#1)(2010-11#1)
two-dimensional homonuclear##2##2##(1990-5#1)(1993-11#1)
two-dimensional image##3##2##(2007-12#2)(2008-3#1)
two-dimensional images of the##2##4##(2008-2#1)(2008-3#1)
two-dimensional images of##5##3##(2007-12#2)(2008-2#1)(2008-3#1)(2009-12#1)
two-dimensional images were produced##2##4##(2007-12#1)(2008-2#1)
two-dimensional images were##3##3##(2007-12#2)(2008-2#1)
two-dimensional images##15##2##(1992-9#1)(2007-12#5)(2008-2#6)(2008-3#2)(2009-12#1)
two-dimensional imaging of##2##3##(2007-12#1)(2008-7#1)
two-dimensional imaging through##2##3##(2007-12#2)
two-dimensional imaging##12##2##(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#2)(2008-7#1)
two-dimensional infrared##2##2##(2007-11#1)(2010-2#1)
two-dimensional instantaneous##2##2##(2008-3#2)
two-dimensional interleaving##2##2##(2008-2#2)
two-dimensional laser-induced fluorescence##2##3##(2007-12#2)
two-dimensional lattice##2##2##(1992-3#1)(2008-7#1)
two-dimensional measurement principle##3##3##(2008-3#3)
two-dimensional measurement##5##2##(2008-3#5)
two-dimensional measurements of##2##3##(2008-2#1)(2008-3#1)
two-dimensional nonlinear photonic##2##3##(2007-11#2)
two-dimensional nuclear magnetic resonance (NMR) spectroscopy##2##6##(1991-4#1)(1992-11#1)
two-dimensional nuclear magnetic resonance spectroscopy##2##5##(1996-5#1)(1997-1#1)
two-dimensional nuclear magnetic resonance##6##4##(1991-4#1)(1992-11#1)(1992-12#1)(1996-5#1)(1997-1#1)(2007-1#1)
two-dimensional nuclear##7##2##(1990-7#1)(1991-4#1)(1992-11#1)(1992-12#1)(1996-5#1)(1997-1#1)(2007-1#1)
two-dimensional numerical##4##2##(2007-9#1)(2008-2#1)(2008-3#1)(2009-6#1)
two-dimensional object##2##2##(1992-9#1)(2007-12#1)
two-dimensional objects##2##2##(2007-12#1)(2008-2#1)
two-dimensional optical##7##2##(1991-12#1)(2007-12#1)(2008-1#2)(2008-2#1)(2008-3#2)
two-dimensional periodic##5##2##(1992-3#1)(2008-3#3)(2008-7#1)
two-dimensional phase unwrapping##2##3##(2008-3#2)
two-dimensional phase##5##2##(2008-2#2)(2008-3#3)
two-dimensional photonic crystal slabs##4##4##(2007-11#1)(2007-12#1)(2008-7#2)
two-dimensional photonic crystal##12##3##(2007-11#6)(2007-12#4)(2008-7#2)
two-dimensional photonic crystals##3##3##(2007-12#2)(2008-3#1)
two-dimensional photonic##15##2##(2007-11#6)(2007-12#6)(2008-3#1)(2008-7#2)
two-dimensional photonic-crystal##4##2##(2007-11#2)(2007-12#2)
two-dimensional polyacrylamide gel electrophoresis##8##4##(1990-11#1)(1991-6#1)(1994-12#1)(1994-8#1)(1995-12#1)(1997-2#1)(2007-5#1)(2010-2#1)
two-dimensional polyacrylamide gels##2##3##(1994-9#1)(1997-2#1)
two-dimensional polyacrylamide##11##2##(1990-11#2)(1991-6#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(1997-2#2)(2007-5#1)(2010-2#1)
two-dimensional problem##2##2##(2008-2#2)
two-dimensional profiles of##3##3##(2008-2#2)(2008-3#1)
two-dimensional proton nuclear magnetic resonance spectroscopy##2##6##(1990-2#1)(1992-1#1)
two-dimensional proton nuclear magnetic resonance##3##5##(1990-2#1)(1992-1#1)(1992-9#1)
two-dimensional proton##4##2##(1990-2#1)(1992-1#1)(1992-12#1)(1992-9#1)
two-dimensional random##2##2##(2008-2#1)(2008-3#1)
two-dimensional reconstruction##2##2##(2008-3#2)
two-dimensional sampling MTF##2##3##(2008-2#2)
two-dimensional scan##3##2##(2008-2#1)(2008-3#2)
two-dimensional signal##2##2##(2007-11#1)(2008-2#1)
two-dimensional slices##2##2##(2007-11#1)(2008-2#1)
two-dimensional sodium dodecyl sulfate polyacrylamide gel electrophoresis##2##7##(2008-10#1)(2008-2#1)
two-dimensional sodium dodecyl##3##3##(1991-8#1)(2008-10#1)(2008-2#1)
two-dimensional solid-state imagers##2##3##(2008-3#2)
two-dimensional space##6##2##(2007-12#2)(2008-11#3)(2013-8#1)
two-dimensional spatial##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
two-dimensional square##2##2##(1991-4#1)(2008-2#1)
two-dimensional surface##2##2##(2005-11#1)(2008-3#1)
two-dimensional surfaces##3##2##(2008-3#2)(2010-12#1)
two-dimensional system##4##2##(1992-5#1)(2007-12#1)(2008-3#2)
two-dimensional systems##2##2##(1991-12#1)(2011-2#1)
two-dimensional temperature##2##2##(2007-12#1)(2008-2#1)
two-dimensional ultrasound##2##2##(2008-3#1)(2009-6#1)
two-dimensional wave##2##2##(2008-2#1)(2008-3#1)
two-dimensional waveguide##2##2##(2007-11#1)(2008-3#1)
two-dimensional##729##1##(1990-10#3)(1990-11#6)(1990-2#1)(1990-4#2)(1990-5#3)(1990-6#3)(1990-7#6)(1990-9#4)(1991-11#3)(1991-12#4)(1991-2#2)(1991-4#4)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#4)(1992-3#2)(1992-5#1)(1992-9#6)(1993-11#7)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#3)(1993-9#4)(1994-11#4)(1994-12#3)(1994-5#1)(1994-8#3)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#4)(1995-3#3)(1995-5#2)(1995-6#1)(1995-7#4)(1995-8#2)(1996-2#5)(1996-4#3)(1996-5#4)(1996-7#3)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#4)(2005-11#5)(2005-8#1)(2006-10#4)(2006-12#5)(2006-2#1)(2006-4#3)(2006-5#2)(2007-1#2)(2007-11#45)(2007-12#99)(2007-3#1)(2007-5#1)(2007-8#3)(2007-9#3)(2008-1#9)(2008-10#24)(2008-11#13)(2008-2#115)(2008-3#143)(2008-4#13)(2008-5#4)(2008-6#2)(2008-7#14)(2008-8#4)(2008-9#5)(2009-10#3)(2009-11#2)(2009-12#1)(2009-6#2)(2009-7#1)(2010-1#2)(2010-11#1)(2010-12#6)(2010-2#2)(2010-5#3)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#12)(2011-2#5)(2011-7#1)(2012-12#1)(2012-2#5)(2012-3#1)(2012-4#1)(2012-8#1)(2013-1#2)(2013-7#1)(2013-8#2)
two-dimensionally##4##1##(2004-9#1)(2006-12#1)(2008-10#1)(2008-7#1)
two-directional##2##1##(2007-11#2)
two-domain structure##2##2##(1991-6#1)(2008-4#1)
two-domain##8##1##(1991-2#1)(1991-6#1)(1991-9#1)(1994-9#1)(1997-5#1)(2008-4#1)(2010-10#2)
two-dose##3##1##(2008-1#1)(2008-4#1)(2009-5#1)
two-drug##4##1##(1995-3#2)(2006-2#1)(2007-8#1)
two-electrode voltage clamp##3##3##(1997-7#1)(2008-8#2)
two-electrode##5##1##(1997-7#1)(2008-10#1)(2008-2#1)(2008-8#2)
two-electron irreversible cathodic peak##2##4##(2008-10#2)
two-electron irreversible##3##2##(2008-10#3)
two-electron transfer##2##2##(1992-1#1)(1995-10#1)
two-electron##14##1##(1990-2#1)(1992-1#1)(1993-6#1)(1993-8#1)(1995-1#1)(1995-10#1)(1996-6#1)(2008-10#6)(2008-11#1)
two-electron-reduced##6##1##(1990-10#1)(1990-12#2)(1992-3#1)(1995-10#2)
two-element cavity##2##2##(2007-12#2)
two-element##4##1##(2007-12#2)(2008-3#1)(2013-7#1)
two-factor##3##1##(1993-6#1)(2008-10#1)(2008-5#1)
two-flux model##2##2##(2008-2#2)
two-flux##3##1##(2008-2#3)
two-fold after##2##2##(1992-8#1)(1995-9#1)
two-fold by##2##2##(1991-1#1)(1996-2#1)
two-fold compulsion##2##2##(2009-6#2)
two-fold greater##2##2##(1993-6#1)(2009-9#1)
two-fold higher##6##2##(1990-7#1)(1995-10#1)(1996-11#1)(2006-8#1)(2008-4#2)
two-fold in##2##2##(1996-9#1)(2008-7#1)
two-fold increase in##4##3##(1992-12#1)(1994-11#1)(1995-10#2)
two-fold increase##7##2##(1990-7#1)(1992-12#1)(1994-11#1)(1994-8#1)(1995-10#2)(2008-4#1)
two-fold##53##1##(1990-11#1)(1990-7#2)(1991-1#1)(1991-12#2)(1991-3#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#2)(1994-11#1)(1994-3#1)(1994-8#1)(1995-10#4)(1995-9#1)(1996-11#1)(1996-2#2)(1996-9#1)(1997-2#2)(1997-6#1)(2006-8#2)(2007-10#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#2)(2009-12#1)(2009-6#2)(2009-9#1)(2010-8#1)(2012-12#2)(2013-1#1)
two-fold)##2##1##(2007-8#1)(2008-2#1)
two-frequency lidar inversion##3##3##(2008-3#3)
two-frequency optical##2##2##(2007-12#1)(2008-3#1)
two-frequency##9##1##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#6)
two-generation##3##1##(2008-10#2)(2010-1#1)
two-grating##3##1##(2007-12#2)(2008-3#1)
two-hybrid assay##4##2##(1995-6#1)(2008-4#1)(2008-5#1)(2008-9#1)
two-hybrid system to##2##3##(2008-8#1)(2008-9#1)
two-hybrid system##26##2##(1992-7#3)(1995-1#1)(1995-3#1)(1996-5#2)(1997-1#1)(1997-7#1)(2008-2#1)(2008-4#1)(2008-8#9)(2008-9#6)
two-hybrid##49##1##(1992-7#3)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#3)(1997-1#1)(1997-7#1)(2004-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#7)(2008-5#1)(2008-7#4)(2008-8#10)(2008-9#8)(2009-10#1)(2011-2#1)
two-input##4##1##(2008-3#4)
two-laser##5##1##(1996-5#1)(2008-2#2)(2008-3#2)
two-layer SIS##2##2##(2008-5#2)
two-layer diffusion##2##2##(2008-3#2)
two-layer media##2##2##(2008-3#2)
two-layer model##3##2##(1996-12#1)(2008-2#1)(2008-3#1)
two-layer turbid##3##2##(2008-2#1)(2008-3#2)
two-layer##35##1##(1996-12#1)(2005-11#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-11#1)(2008-2#7)(2008-3#15)(2008-5#2)(2010-2#1)(2011-1#1)
two-layered tissue##2##2##(2008-2#2)
two-layered turbid media##5##3##(2008-2#5)
two-layered##9##1##(2007-9#1)(2008-2#8)
two-lens objective##3##2##(2008-2#3)
two-lens##4##1##(2008-2#4)
two-level full factorial##2##3##(2008-10#2)
two-level microfluidic device##2##3##(2008-11#2)
two-level model##3##2##(1993-5#1)(2005-11#1)(2007-12#1)
two-level phase##2##2##(2007-11#1)(2007-12#1)
two-level##28##1##(1993-5#1)(1994-8#1)(1994-9#2)(1996-8#1)(2005-11#2)(2007-11#3)(2007-12#3)(2007-7#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-7#1)(2009-11#1)(2009-3#1)(2010-4#1)(2012-3#1)
two-lever##2##1##(1992-12#1)(1997-7#1)
two-line##6##1##(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)
two-locus##6##1##(2008-10#2)(2008-4#2)(2008-8#1)(2011-2#1)
two-mirror##11##1##(2007-12#3)(2008-1#1)(2008-2#6)(2008-3#1)
two-mode laser##2##2##(2007-11#1)(2008-3#1)
two-mode##11##1##(1996-6#1)(2007-11#2)(2007-12#5)(2008-3#2)(2013-1#1)
two-modulator generalized ellipsometer##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
two-modulator generalized##4##2##(2008-1#2)(2008-2#1)(2008-3#1)
two-month##12##1##(1994-3#1)(1995-9#1)(2005-12#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-5#1)(2009-9#1)(2010-8#1)(2011-3#1)(2012-3#1)(2013-1#1)
two-needle##2##1##(2008-10#1)(2008-5#1)
two-node model##3##2##(1992-3#3)
two-parameter##6##1##(1993-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-7#1)
two-parent families##2##2##(2010-4#1)(2011-1#1)
two-parent##3##1##(2010-2#1)(2010-4#1)(2011-1#1)
two-part article##9##2##(1992-12#1)(1992-3#1)(1993-2#1)(1994-1#1)(1994-2#1)(1994-3#1)(2007-2#2)(2007-6#1)
two-part series##9##2##(1990-12#1)(1993-2#1)(1996-2#2)(2006-12#1)(2007-5#1)(2008-10#2)(2011-1#1)
two-part##25##1##(1990-12#1)(1992-12#1)(1992-3#1)(1993-2#2)(1994-1#1)(1994-2#1)(1994-3#1)(1996-2#2)(2005-8#1)(2006-12#1)(2007-2#2)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-5#2)(2011-1#1)(2012-3#1)(2013-1#2)
two-particle##2##1##(1990-12#1)(1995-5#1)
two-patch##2##1##(2008-8#2)
two-period##4##1##(1994-5#3)(1996-12#1)
two-person##2##1##(2006-10#1)(2008-11#1)
two-phase extraction of##2##3##(2008-10#1)(2012-1#1)
two-phase extraction##7##2##(2008-10#1)(2008-6#4)(2012-1#2)
two-phase partition##2##2##(1993-4#1)(1994-12#1)
two-phase process##3##2##(1995-1#1)(2008-10#1)(2008-12#1)
two-phase sampling##2##2##(1997-2#1)(2010-11#1)
two-phase solvent system composed of##3##5##(2008-10#1)(2011-1#2)
two-phase solvent system##4##3##(2008-10#1)(2011-1#2)(2013-7#1)
two-phase system is##2##3##(2008-10#2)
two-phase system of tetrabutylammonium bromide##3##5##(2008-10#3)
two-phase system of##7##3##(1992-11#1)(2007-6#1)(2008-10#5)
two-phase system##21##2##(1992-11#2)(2007-6#2)(2008-10#12)(2008-6#1)(2010-8#1)(2011-2#2)(2012-1#1)
two-phase systems##11##2##(1990-3#2)(2008-10#4)(2008-6#1)(2008-7#3)(2010-4#1)
two-phase zone##3##2##(1990-2#3)
two-phase zones##2##2##(1990-2#2)
two-phase##80##1##(1990-12#1)(1990-2#6)(1990-3#2)(1992-11#3)(1992-12#1)(1993-4#1)(1994-12#1)(1995-1#1)(1996-5#1)(1996-6#1)(1997-2#1)(2005-11#1)(2006-10#1)(2007-12#3)(2007-5#1)(2007-6#2)(2007-9#1)(2008-10#21)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#7)(2008-7#3)(2009-7#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#3)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
two-photon LIF##3##2##(2008-2#2)(2008-3#1)
two-photon absorber##2##2##(2007-12#2)
two-photon absorbing##2##2##(2007-12#1)(2011-1#1)
two-photon absorption (TPA)##3##3##(2007-11#1)(2007-12#2)
two-photon absorption and##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
two-photon absorption at##2##3##(2007-11#1)(2008-2#1)
two-photon absorption can##2##3##(2007-12#2)
two-photon absorption coefficient##5##3##(2007-11#2)(2007-12#2)(2008-2#1)
two-photon absorption cross##2##3##(2007-11#1)(2007-12#1)
two-photon absorption in a##6##4##(2007-11#4)(2007-12#2)
two-photon absorption in semiconductors##2##4##(2007-11#2)
two-photon absorption in the##2##4##(2007-12#2)
two-photon absorption in##13##3##(1993-6#1)(2007-11#6)(2007-12#5)(2008-2#1)
two-photon absorption##52##2##(1993-6#1)(2007-11#19)(2007-12#18)(2008-1#1)(2008-2#3)(2008-3#6)(2009-11#1)(2010-5#1)(2010-7#2)
two-photon coherent excitation##2##3##(2007-12#2)
two-photon conductivity##2##2##(2007-12#2)
two-photon dye-doped SiNPs##2##3##(2011-1#2)
two-photon emission##2##2##(2007-11#1)(2009-4#1)
two-photon excitation and##2##3##(2008-1#1)(2008-3#1)
two-photon excitation fluorescence imaging##2##4##(2008-3#2)
two-photon excitation fluorescence##4##3##(2008-2#1)(2008-3#2)(2009-4#1)
two-photon excitation for##2##3##(2007-12#1)(2008-3#1)
two-photon excitation##41##2##(1996-11#7)(2007-11#3)(2007-12#4)(2008-1#1)(2008-10#1)(2008-2#6)(2008-3#15)(2009-2#1)(2009-4#1)(2011-1#2)
two-photon excited emission##2##3##(2007-11#2)
two-photon excited fluorescence (TPF) is##2##5##(2007-11#1)(2008-10#1)
two-photon excited fluorescence (TPF)##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
two-photon excited fluorescence##5##3##(1995-8#1)(2007-11#2)(2008-10#1)(2008-3#1)
two-photon excited##9##2##(1995-8#1)(2007-11#5)(2008-10#1)(2008-3#1)(2009-6#1)
two-photon exposure of##2##3##(2007-12#2)
two-photon exposure##4##2##(2007-12#4)
two-photon fluorescence detection##2##3##(2007-11#2)
two-photon fluorescence imaging##5##3##(2008-2#3)(2008-3#2)
two-photon fluorescence microscope based on a##2##6##(2007-11#2)
two-photon fluorescence microscope##5##3##(2007-11#2)(2007-12#2)(2008-3#1)
two-photon fluorescence microscopy##5##3##(1996-11#1)(2008-2#1)(2008-3#1)(2011-1#2)
two-photon fluorescence spectroscopy##3##3##(2007-11#1)(2008-3#2)
two-photon fluorescence##30##2##(1996-11#1)(2007-11#8)(2007-12#2)(2008-2#6)(2008-3#9)(2011-1#4)
two-photon imaging##2##2##(2007-11#1)(2008-4#1)
two-photon laser scanning microscopy and confocal laser scanning microscopy##2##9##(2008-10#1)(2008-8#1)
two-photon laser-induced fluorescence (LIF)##2##4##(2008-2#2)
two-photon laser-induced fluorescence##6##3##(2008-2#5)(2008-3#1)
two-photon microscope##2##2##(2008-3#2)
two-photon microscopy##11##2##(2007-12#3)(2008-1#1)(2008-11#2)(2008-3#2)(2008-4#1)(2009-4#1)(2011-1#1)
two-photon photorefractive effect##2##3##(2008-3#2)
two-photon process##5##2##(1994-3#1)(2007-11#1)(2007-12#1)(2008-3#2)
two-photon spectroscopy##2##2##(2007-11#1)(2008-2#1)
two-photon three-dimensional##3##2##(2007-12#2)(2008-3#1)
two-photon transition##3##2##(2007-12#1)(2008-3#2)
two-photon transitions##3##2##(1996-11#1)(2007-12#2)
two-photon##232##1##(1992-8#1)(1993-6#1)(1994-3#1)(1995-8#1)(1996-11#9)(2006-5#1)(2007-11#43)(2007-12#53)(2008-1#5)(2008-10#3)(2008-11#2)(2008-2#30)(2008-3#52)(2008-4#2)(2008-8#2)(2009-11#1)(2009-2#2)(2009-4#6)(2009-6#1)(2009-7#1)(2010-1#1)(2010-5#1)(2010-7#3)(2011-1#10)
two-photon-excited fluorescence##7##2##(2007-12#3)(2008-2#2)(2008-3#2)
two-photon-excited##10##1##(2007-12#5)(2008-2#2)(2008-3#3)
two-photon-induced##4##1##(2007-12#1)(2008-1#2)(2008-3#1)
two-photon-pumped##2##1##(2007-12#2)
two-piece##2##1##(2008-2#1)(2011-2#1)
two-point affected sibpair linkage analysis##2##5##(2008-9#2)
two-point affected##3##2##(1997-5#1)(2008-9#2)
two-point discrimination##4##2##(2008-9#4)
two-point radiometric##2##2##(1996-3#1)(2008-2#1)
two-point##22##1##(1994-9#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-5#1)(2007-11#2)(2007-12#4)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#6)(2012-3#1)
two-pore domain##2##2##(2012-2#1)(2013-8#1)
two-pore##3##1##(2010-12#1)(2012-2#1)(2013-8#1)
two-port##2##1##(2007-7#1)(2013-7#1)
two-process##2##1##(2009-8#2)
two-pronucleus##2##1##(2010-12#2)
two-pulse and stimulated photon echoes##2##5##(2007-12#2)
two-pulse##4##1##(2006-5#1)(2007-12#2)(2008-2#1)
two-pupil##2##1##(2008-2#2)
two-row##2##1##(2008-10#2)
two-sample studies##2##2##(1993-4#1)(1996-3#1)
two-sample##6##1##(1993-4#1)(1996-2#1)(1996-3#1)(1997-4#1)(2009-9#1)(2010-7#1)
two-sensor##2##1##(2007-12#1)(2008-3#1)
two-sided test##2##2##(1996-8#2)
two-sided tests in clinical trials##2##5##(1996-8#2)
two-sided tests##3##2##(1993-4#1)(1996-8#2)
two-sided##19##1##(1992-1#1)(1993-4#1)(1993-6#2)(1996-1#1)(1996-12#1)(1996-8#4)(2008-2#3)(2008-3#1)(2008-5#1)(2011-1#4)
two-site binding##2##2##(1995-5#1)(2009-7#1)
two-site immunochemiluminometric##2##2##(1992-1#1)(1992-9#1)
two-site model##2##2##(1995-1#1)(2013-8#1)
two-site##16##1##(1990-12#1)(1991-3#1)(1992-1#1)(1992-8#1)(1992-9#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-7#1)(2008-10#1)(2009-7#1)(2013-8#4)
two-species##6##1##(1994-10#1)(2008-7#2)(2008-8#2)(2008-9#1)
two-sphere##3##1##(1995-5#2)(2008-2#1)
two-stage Fowler-Stephens##2##2##(2006-2#1)(2012-2#1)
two-stage approach##6##2##(2007-8#1)(2008-1#1)(2009-10#1)(2009-5#2)(2012-3#1)
two-stage cluster sampling##2##3##(2009-10#1)(2011-2#1)
two-stage coronary##3##2##(1996-12#2)(1996-9#1)
two-stage designs##2##2##(1996-8#1)(2008-2#1)
two-stage least##2##2##(2008-11#1)(2012-12#1)
two-stage mechanism##2##2##(1990-11#1)(1996-5#1)
two-stage method##3##2##(2006-5#1)(2008-4#1)(2008-9#1)
two-stage papain technique##2##3##(1994-12#2)
two-stage procedure##8##2##(1991-12#1)(1991-6#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2012-2#1)(2013-1#1)
two-stage process##6##2##(2006-9#1)(2007-2#1)(2008-11#2)(2008-3#1)(2008-6#1)
two-stage randomized trials with##2##4##(2012-3#2)
two-stage repair##4##2##(2008-10#1)(2009-5#3)
two-stage revision has##2##3##(2008-8#1)(2012-12#1)
two-stage revision##5##2##(2008-8#3)(2010-9#1)(2012-12#1)
two-stage sampling##3##2##(1994-5#2)(2009-10#1)
two-stage surgery##2##2##(2006-12#1)(2008-6#1)
two-stage##123##1##(1990-11#1)(1991-12#2)(1991-6#1)(1992-2#1)(1993-7#1)(1994-12#2)(1994-5#2)(1994-8#1)(1996-11#1)(1996-12#2)(1996-5#1)(1996-8#2)(1996-9#1)(1997-2#1)(2006-12#2)(2006-2#1)(2006-3#2)(2006-4#2)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#8)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#6)(2008-12#1)(2008-2#6)(2008-3#6)(2008-4#2)(2008-6#5)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#4)(2009-11#2)(2009-12#1)(2009-5#7)(2009-9#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#3)
two-staged##6##1##(2008-1#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)
two-state model##17##2##(1990-7#2)(1990-8#3)(1991-8#2)(1992-9#2)(1995-5#1)(1995-6#1)(1997-2#3)(1997-4#1)(2006-10#1)(2007-11#1)
two-state transition##4##2##(1991-4#2)(1992-10#1)(1993-8#1)
two-state unfolding##3##2##(1990-5#1)(1993-11#1)(1997-2#1)
two-state##43##1##(1990-5#1)(1990-7#2)(1990-8#4)(1991-4#2)(1991-5#1)(1991-8#2)(1992-10#1)(1992-9#5)(1993-11#3)(1993-8#1)(1994-5#1)(1995-10#1)(1995-4#4)(1995-5#1)(1995-6#2)(1996-11#2)(1997-2#5)(1997-4#1)(2006-10#1)(2007-11#1)(2008-7#1)(2009-10#1)
two-step PCR##3##2##(2008-10#2)(2011-1#1)
two-step Pegasys treatment##2##3##(2012-2#2)
two-step approach##6##2##(1994-8#1)(1997-2#1)(2006-2#1)(2011-12#2)(2012-3#1)
two-step binding##2##2##(1990-7#1)(1992-9#1)
two-step chromatographic##3##2##(2009-4#1)(2012-12#2)
two-step excitation##3##2##(2007-12#3)
two-step leaching method##2##3##(2008-10#2)
two-step learning method##2##3##(2008-3#2)
two-step method##7##2##(1990-2#1)(1990-7#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-6#1)(2009-6#1)
two-step model for##3##3##(1995-6#2)(1996-10#1)
two-step physical algorithm##2##3##(2008-3#2)
two-step procedure is##2##3##(2007-8#1)(2008-3#1)
two-step procedure##11##2##(1994-11#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2010-4#1)(2012-3#1)
two-step process##10##2##(1994-2#1)(1994-8#1)(1995-1#1)(1995-5#1)(2007-12#1)(2008-2#1)(2008-6#2)(2009-4#1)(2012-3#1)
two-step purification##4##2##(1992-1#1)(1993-12#1)(1995-1#1)(1997-3#1)
two-step reaction##4##2##(1996-5#1)(1997-4#1)(2008-10#1)(2008-6#1)
two-step recoded##2##2##(2008-2#2)
two-step sequential leaching procedure##3##4##(2008-10#3)
two-step sol-gel##3##2##(2008-10#3)
two-step##142##1##(1990-2#2)(1990-7#3)(1991-5#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-11#1)(1992-9#1)(1993-12#1)(1993-4#1)(1994-11#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-10#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2004-9#1)(2005-11#3)(2005-12#1)(2005-8#1)(2006-2#1)(2007-12#8)(2007-8#1)(2008-1#1)(2008-10#22)(2008-11#3)(2008-12#2)(2008-2#8)(2008-3#13)(2008-5#1)(2008-6#5)(2008-9#3)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-8#4)
two-story##2##1##(2008-2#2)
two-stranded alpha-helical coiled-coil##4##3##(1992-6#2)(1993-3#2)
two-stranded##8##1##(1992-6#2)(1993-3#2)(1995-4#1)(1995-6#2)(2011-2#1)
two-subunit##2##1##(1990-9#1)(1991-5#1)
two-tailed##2##1##(2005-11#1)(2007-1#1)
two-third of##3##2##(2007-7#1)(2008-1#1)(2008-12#1)
two-third##4##1##(2007-7#1)(2008-1#1)(2008-12#1)(2011-2#1)
two-thirds of patients##2##3##(1996-12#1)(2009-6#1)
two-thirds of the patients##3##4##(2004-4#1)(2007-11#1)(2008-11#1)
two-thirds of the##25##3##(1990-12#1)(1990-7#1)(1991-8#1)(1991-9#1)(1994-12#1)(1995-11#1)(1996-9#1)(1997-2#1)(2004-4#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-2#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
two-thirds of##45##2##(1990-12#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-10#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#2)(1995-9#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-4#1)(2004-4#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-2#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
two-thirds the##3##2##(1995-6#1)(2007-8#1)(2008-10#1)
two-thirds##61##1##(1990-11#1)(1990-12#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-3#1)(1992-5#1)(1994-12#1)(1994-5#1)(1994-9#2)(1995-11#1)(1995-3#1)(1995-6#3)(1995-9#1)(1996-12#2)(1996-9#1)(1997-2#1)(1997-4#1)(2004-4#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2009-4#1)(2009-6#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#1)
two-to##2##1##(2006-10#1)(2008-10#1)
two-tone discrimination##2##2##(1992-12#1)(1996-1#1)
two-tone face##2##2##(2009-4#2)
two-tone method##2##2##(2008-3#2)
two-tone##13##1##(1991-1#1)(1992-12#1)(1996-1#1)(2008-11#1)(2008-2#2)(2008-3#5)(2009-4#2)
two-wave coupling##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
two-wave mixing in a##4##4##(2007-12#1)(2008-1#1)(2008-3#2)
two-wave mixing in photorefractive crystals##2##5##(2008-3#2)
two-wave mixing in photorefractive materials##2##5##(2008-1#2)
two-wave mixing in photorefractive##5##4##(2008-1#3)(2008-3#2)
two-wave mixing in##16##3##(2007-11#1)(2007-12#3)(2008-1#4)(2008-2#2)(2008-3#6)
two-wave mixing##26##2##(2007-11#2)(2007-12#5)(2008-1#6)(2008-2#2)(2008-3#11)
two-wave##35##1##(2007-11#2)(2007-12#8)(2008-1#6)(2008-2#3)(2008-3#14)(2009-7#1)(2010-3#1)
two-wave-mixing##3##1##(2008-1#2)(2008-2#1)
two-wavelength interferogram##2##2##(2008-2#2)
two-wavelength lidar inversion techniques##2##4##(2008-3#2)
two-wavelength lidar##5##2##(2008-2#2)(2008-3#3)
two-wavelength method##2##2##(2008-3#2)
two-wavelength nonlinear##3##2##(2008-1#2)(2008-3#1)
two-wavelength passive quadrature##2##3##(2008-2#2)
two-wavelength##27##1##(2007-12#1)(2008-1#2)(2008-2#11)(2008-3#13)
two-way ANOVA and##2##3##(2008-12#2)
two-way active avoidance##4##3##(1991-2#1)(1993-6#2)(2008-4#1)
two-way analyses of##2##3##(2007-11#1)(2008-4#1)
two-way analysis of variance##6##4##(1996-6#1)(1996-9#1)(2007-8#2)(2007-9#1)(2012-2#1)
two-way factorial##2##2##(2008-10#1)(2008-9#1)
two-way sexters##3##2##(2013-1#3)
two-way text pagers##3##3##(2010-8#3)
two-way text paging systems##2##4##(2010-8#2)
two-way text paging##3##3##(2010-8#3)
two-way text##8##2##(2010-8#8)
two-way##46##1##(1991-2#1)(1993-1#1)(1993-6#2)(1993-9#1)(1994-2#1)(1994-9#1)(1996-5#1)(1996-6#1)(1996-9#1)(2004-12#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#2)(2008-8#1)(2008-9#1)(2010-10#1)(2010-2#1)(2010-8#8)(2011-1#3)(2011-2#1)(2012-2#3)(2013-1#3)
two-week intervals##4##2##(1994-7#1)(2004-9#1)(2007-5#1)(2008-5#1)
two-week period##3##2##(2008-10#1)(2008-3#1)(2009-6#1)
two-week##18##1##(1990-11#1)(1994-7#1)(2004-9#1)(2005-12#1)(2006-10#1)(2006-9#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-12#1)(2009-6#3)(2010-4#1)(2011-3#1)(2012-2#1)
two-word constructions##2##2##(2010-2#2)
two-word##3##1##(2010-2#3)
two-year follow-up##4##2##(2008-5#1)(2009-2#1)(2012-1#1)(2012-3#1)
two-year period##8##2##(1993-8#1)(1996-2#1)(1996-3#1)(2006-8#1)(2007-3#1)(2010-2#1)(2012-2#1)(2013-1#1)
two-year##38##1##(1990-12#1)(1991-1#1)(1992-3#1)(1993-11#1)(1993-7#1)(1993-8#1)(1994-1#1)(1995-1#1)(1995-2#1)(1995-5#2)(1996-2#1)(1996-3#1)(1997-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#3)(2008-12#1)(2008-3#1)(2008-5#1)(2009-2#1)(2009-4#1)(2010-2#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)
two-year-old##3##1##(2012-2#1)(2013-8#2)
two?##3##1##(1993-9#1)(2008-12#1)(2013-8#1)
twofold and##4##2##(1996-5#1)(2008-10#2)(2012-3#1)
twofold axis in the##2##4##(1991-12#2)
twofold higher##4##2##(1997-1#1)(2008-3#2)(2008-7#1)
twofold in##4##2##(1990-11#1)(1992-6#1)(2007-12#2)
twofold increase in##10##3##(1994-12#1)(1994-2#1)(2008-2#3)(2008-4#1)(2008-7#2)(2009-8#1)(2011-1#1)
twofold increase##13##2##(1994-10#1)(1994-12#1)(1994-2#1)(1996-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#2)(2009-8#1)(2011-1#1)
twofold or##3##2##(2006-10#1)(2008-10#2)
twofold##88##1##(1990-11#1)(1990-12#1)(1990-3#2)(1991-12#2)(1991-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#2)(1997-1#1)(1997-5#1)(2004-4#1)(2006-10#1)(2006-12#3)(2006-3#2)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#3)(2008-10#10)(2008-11#4)(2008-2#4)(2008-3#6)(2008-4#1)(2008-7#4)(2008-8#2)(2009-3#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2012-3#2)(2013-1#2)
two weeks##3##1##(2011-1#3)
tying##12##1##(1995-1#2)(1996-2#1)(2006-6#1)(2007-5#2)(2007-7#1)(2010-12#2)(2010-3#3)
tyloses##4##1##(2008-10#4)
tylosin were##2##2##(2006-5#1)(2008-5#1)
tylosin##6##1##(2006-5#2)(2008-10#1)(2008-5#3)
tymovirus##3##1##(1997-3#1)(2008-10#2)
tymoviruses##3##1##(2008-10#3)
tympanic membrane (TM)##2##3##(2009-7#1)(2010-3#1)
tympanic membrane keratinocytes##3##3##(2012-8#3)
tympanic membrane##15##2##(1991-3#2)(1995-4#1)(2007-10#1)(2009-7#3)(2010-3#3)(2012-12#1)(2012-8#4)
tympanic temperature##2##2##(2007-10#2)
tympanic thermography##2##2##(1991-8#2)
tympanic thermometer##2##2##(2008-2#2)
tympanic##27##1##(1991-3#2)(1991-8#3)(1992-8#1)(1995-4#2)(2006-12#1)(2007-10#3)(2008-2#3)(2008-4#1)(2009-7#3)(2010-3#3)(2012-12#1)(2012-8#4)
tympanoplasty##3##1##(1995-4#1)(2008-9#1)(2010-7#1)
tympanotomy##4##1##(2007-9#1)(2008-9#3)
typ##2##1##(1992-5#1)(2007-11#1)
type (DAT)##3##2##(1995-11#1)(1996-11#1)(2008-6#1)
type (P##2##2##(2008-10#2)
type (eluted at##2##3##(1996-11#2)
type (eluted##3##2##(1996-11#3)
type (i##2##2##(1994-2#2)
type (n =##2##3##(2010-8#2)
type 1 (AT1) receptor##2##4##(1992-2#1)(2008-1#1)
type 1 (HIV-1) infection##5##4##(2008-2#5)
type 1 (HIV-1)##43##3##(1990-11#1)(1990-2#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-9#3)(1994-2#1)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-6#1)(2006-4#1)(2007-11#1)(2008-11#1)(2008-2#8)(2011-2#1)(2012-1#1)
type 1 (NF1) and type 2 (NF2)##2##7##(1997-3#1)(2006-12#1)
type 1 (NF1)##13##3##(1991-12#1)(1991-5#1)(1992-8#2)(1994-12#1)(1994-2#1)(1997-3#1)(2006-12#1)(2007-12#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-7#1)
type 1 (Th1)##7##3##(1996-10#2)(2008-11#1)(2008-8#1)(2009-9#2)(2012-2#1)
type 1 5' long terminal repeat##2##6##(1993-8#2)
type 1 and 2 diabetes##4##5##(2005-10#1)(2007-8#1)(2012-12#2)
type 1 and 2##6##4##(2005-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2012-12#2)
type 1 and type 2 diabetes mellitus##4##7##(2006-3#1)(2008-1#1)(2010-11#1)(2013-1#1)
type 1 and type 2 diabetes##17##6##(2005-10#1)(2006-3#1)(2008-1#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-11#1)(2012-12#2)(2012-4#2)(2013-1#5)
type 1 and type 2 immune responses##2##7##(2008-10#2)
type 1 and type 2 sites##2##6##(1993-6#2)
type 1 and type 2##32##5##(1990-12#1)(1992-8#1)(1993-2#2)(1993-6#3)(1994-4#1)(1997-3#1)(2005-10#1)(2006-3#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-12#2)(2012-4#2)(2013-1#5)
type 1 and type##33##4##(1990-12#2)(1992-8#1)(1993-2#2)(1993-6#3)(1994-4#1)(1997-3#1)(2005-10#1)(2006-3#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-12#2)(2012-4#2)(2013-1#5)
type 1 and##55##3##(1990-12#2)(1990-5#1)(1991-2#1)(1991-7#1)(1992-8#1)(1992-9#1)(1993-2#2)(1993-6#3)(1994-11#1)(1994-4#1)(1997-3#1)(2005-10#2)(2006-3#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-1#4)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#4)(2012-2#1)(2012-4#2)(2013-1#9)
type 1 angiotensin II receptor##2##5##(1992-3#2)
type 1 angiotensin II##4##4##(1992-3#3)(1992-7#1)
type 1 astrocytes##3##3##(1990-7#1)(1992-8#1)(1993-11#1)
type 1 by##2##3##(1991-2#1)(2007-12#1)
type 1 cells##2##3##(1995-12#2)
type 1 collagen##5##3##(1994-9#1)(2007-3#2)(2008-5#1)(2010-1#1)
type 1 copper##2##3##(1993-6#1)(1994-8#1)
type 1 cysts##2##3##(1992-6#2)
type 1 cytokine##2##3##(1996-10#1)(2008-3#1)
type 1 cytokines##2##3##(2005-10#2)
type 1 delta protein phosphatase##2##5##(1993-6#2)
type 1 diabetes (T1D)##2##4##(2007-5#1)(2013-8#1)
type 1 diabetes and##6##4##(2008-1#1)(2008-3#1)(2009-3#1)(2009-9#2)(2012-2#1)
type 1 diabetes in##3##4##(2007-5#3)
type 1 diabetes mellitus and##2##5##(2009-1#1)(2009-11#1)
type 1 diabetes mellitus is##3##5##(2007-5#1)(2008-1#1)(2012-12#1)
type 1 diabetes mellitus##25##4##(1990-6#1)(1991-12#1)(2005-12#1)(2006-1#1)(2007-5#3)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-7#1)(2009-1#1)(2009-11#1)(2010-11#1)(2011-1#2)(2012-1#1)(2012-12#1)(2013-1#4)
type 1 diabetes patients##7##4##(2005-10#1)(2008-1#1)(2013-1#5)
type 1 diabetes##110##3##(1990-10#1)(1990-6#1)(1991-12#1)(1991-3#2)(1992-9#1)(1993-11#1)(2005-10#7)(2005-12#1)(2006-1#3)(2006-6#1)(2007-5#21)(2007-8#1)(2008-1#10)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#3)(2009-1#1)(2009-11#3)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-11#2)(2010-12#2)(2010-5#1)(2011-1#5)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#2)(2012-3#1)(2012-4#2)(2013-1#13)(2013-8#3)
type 1 diabetes?##2##3##(2007-5#1)(2008-1#1)
type 1 diabetic patient##3##4##(2008-1#1)(2013-1#2)
type 1 diabetic patients##7##4##(1991-10#1)(2005-10#1)(2007-5#1)(2010-12#1)(2012-1#1)(2012-4#2)
type 1 diabetic##13##3##(1991-10#1)(2005-1#1)(2005-10#1)(2007-5#1)(2008-1#3)(2010-12#1)(2012-1#1)(2012-4#2)(2013-1#2)
type 1 from##2##3##(2007-12#1)(2008-5#1)
type 1 gene##5##3##(1991-12#1)(1991-5#1)(1992-7#1)(1992-8#1)(1994-8#1)
type 1 human immunodeficiency virus (HIV-1)##2##6##(1994-12#1)(2011-1#1)
type 1 human immunodeficiency virus##5##5##(1993-6#1)(1994-12#1)(1996-4#1)(2007-11#1)(2011-1#1)
type 1 in##10##3##(1992-6#1)(1993-6#1)(1994-2#1)(1994-5#1)(1996-4#1)(2007-6#1)(2008-12#1)(2008-7#1)(2010-12#1)(2012-12#1)
type 1 infection##4##3##(1991-1#1)(1995-7#1)(1996-4#1)(2007-2#1)
type 1 iodothyronine deiodinase##3##4##(1995-12#2)(2008-10#1)
type 1 is##3##3##(2012-3#1)(2013-1#2)
type 1 or##3##3##(1995-5#1)(2006-10#1)(2008-1#1)
type 1 patients##2##3##(1992-6#1)(1994-2#1)
type 1 primary hyperoxaluria##3##4##(1990-10#2)(1992-6#1)
type 1 protein##5##3##(1993-6#1)(1993-7#1)(1997-7#1)(2013-1#2)
type 1 receptor##12##3##(1992-2#1)(1992-3#2)(1992-7#2)(1996-11#2)(1997-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
type 1 regulatory##2##3##(2007-12#1)(2007-5#1)
type 1 repeats of TSP1##2##5##(1995-3#2)
type 1 repeats of##4##4##(1995-3#4)
type 1 repeats##5##3##(1995-3#4)(2007-12#1)
type 1 tissue##2##3##(2010-12#1)(2010-6#1)
type 1 to##2##3##(1994-4#1)(2010-12#1)
type 1 was##2##3##(2008-12#1)(2011-1#1)
type 1 with##2##3##(2008-1#1)(2013-1#1)
type 1##523##2##(1990-10#3)(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#3)(1990-6#1)(1990-7#1)(1991-1#2)(1991-10#2)(1991-12#3)(1991-2#4)(1991-3#4)(1991-5#2)(1991-6#2)(1991-7#1)(1991-9#2)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#6)(1992-6#6)(1992-7#4)(1992-8#8)(1992-9#2)(1993-11#3)(1993-12#2)(1993-2#3)(1993-6#11)(1993-7#2)(1993-8#2)(1993-9#5)(1994-11#1)(1994-12#3)(1994-2#6)(1994-3#3)(1994-4#2)(1994-5#3)(1994-6#4)(1994-8#4)(1994-9#5)(1995-1#5)(1995-12#5)(1995-2#2)(1995-3#7)(1995-5#1)(1995-6#2)(1995-7#2)(1995-8#4)(1996-1#1)(1996-10#5)(1996-11#4)(1996-4#4)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#6)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#2)(2004-2#1)(2005-1#2)(2005-10#13)(2005-12#1)(2005-9#1)(2006-1#3)(2006-10#7)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#2)(2006-7#2)(2006-9#1)(2007-10#1)(2007-11#8)(2007-12#10)(2007-2#9)(2007-3#3)(2007-5#24)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#22)(2008-10#8)(2008-11#6)(2008-12#4)(2008-2#10)(2008-3#5)(2008-4#5)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#6)(2008-9#1)(2009-1#3)(2009-11#3)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#5)(2010-1#1)(2010-11#4)(2010-12#7)(2010-3#1)(2010-5#2)(2010-6#2)(2011-1#12)(2011-12#2)(2011-2#7)(2012-1#5)(2012-11#4)(2012-12#13)(2012-2#10)(2012-3#5)(2012-4#6)(2013-1#42)(2013-7#1)(2013-8#6)
type 1)##4##2##(1991-9#1)(2006-10#2)(2008-10#1)
type 1- and##2##3##(1994-6#1)(2008-10#1)
type 1-diabetes##3##2##(2008-11#1)(2010-11#2)
type 1-like##2##2##(1997-7#2)
type 16 was##2##3##(1990-5#1)(1994-1#1)
type 16##14##2##(1990-10#1)(1990-5#2)(1993-12#1)(1993-9#1)(1994-1#2)(1995-2#2)(2006-10#4)(2011-2#1)
type 18##3##2##(1990-7#1)(1993-12#1)(2011-2#1)
type 1A angiotensin II receptor##2##5##(1996-5#2)
type 1A##11##2##(1992-3#1)(1992-7#1)(1993-4#1)(1995-10#1)(1996-5#3)(1997-3#1)(2008-1#1)(2008-7#2)
type 2 (HSV-2)##4##3##(1991-4#1)(1991-9#1)(2008-10#1)(2012-3#1)
type 2 (NF2)##4##3##(1997-3#2)(2006-12#2)
type 2 (Th2)##3##3##(1996-10#1)(2008-8#1)(2009-9#1)
type 2 (non-insulin dependent)##2##4##(1991-5#1)(1994-12#1)
type 2 DM and##4##4##(2010-10#2)(2011-11#1)(2012-2#1)
type 2 DM##14##3##(2007-1#1)(2008-3#4)(2008-8#1)(2010-10#2)(2011-11#3)(2011-2#1)(2012-2#2)
type 2 and 3##2##4##(2007-11#1)(2008-10#1)
type 2 and##7##3##(1994-2#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2013-1#1)
type 2 angiotensin II receptor##2##5##(1994-9#2)
type 2 autoimmune hepatitis##2##4##(2006-10#2)
type 2 copper##2##3##(1992-9#1)(1993-6#1)
type 2 cytokines##5##3##(2005-10#4)(2008-2#1)
type 2 diabetes (DM2)##2##4##(2006-9#1)(2008-7#1)
type 2 diabetes (T2D)##6##4##(2008-1#1)(2009-3#1)(2012-12#1)(2012-6#1)(2013-7#1)(2013-8#1)
type 2 diabetes and an##2##5##(2008-1#2)
type 2 diabetes and cardiovascular disease##4##6##(2007-5#1)(2008-1#1)(2008-3#1)(2012-12#1)
type 2 diabetes and cardiovascular diseases##2##6##(2008-3#1)(2012-2#1)
type 2 diabetes and cardiovascular##7##5##(2007-5#1)(2008-1#1)(2008-3#2)(2009-3#1)(2012-12#1)(2012-2#1)
type 2 diabetes and metabolic syndrome##4##6##(2008-1#1)(2009-11#1)(2013-1#2)
type 2 diabetes and the metabolic syndrome##2##7##(2008-1#1)(2008-7#1)
type 2 diabetes and##30##4##(2005-10#1)(2007-5#1)(2007-8#1)(2008-1#8)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#2)(2009-11#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2012-4#1)(2013-1#2)
type 2 diabetes as##3##4##(2005-10#1)(2013-1#2)
type 2 diabetes from##2##4##(2010-8#1)(2011-2#1)
type 2 diabetes has been##2##5##(2008-4#1)(2008-7#1)
type 2 diabetes has##5##4##(2008-3#3)(2008-4#1)(2008-7#1)
type 2 diabetes have##5##4##(2007-1#1)(2008-1#2)(2011-1#1)(2011-2#1)
type 2 diabetes in the##3##5##(2006-2#1)(2008-12#1)(2009-12#1)
type 2 diabetes in##27##4##(1994-12#1)(2006-2#2)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#5)(2009-12#1)(2009-7#1)(2010-10#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
type 2 diabetes is##6##4##(2005-10#1)(2006-2#1)(2008-1#2)(2008-3#1)(2010-12#1)
type 2 diabetes mellitus (DM)##6##5##(2007-1#1)(2008-3#3)(2008-8#1)(2011-1#1)
type 2 diabetes mellitus (DM2)##2##5##(2008-3#1)(2011-2#1)
type 2 diabetes mellitus (T2D)##3##5##(2011-2#1)(2012-12#1)(2012-2#1)
type 2 diabetes mellitus (T2DM)##14##5##(2008-1#2)(2008-3#1)(2009-11#2)(2009-9#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#5)
type 2 diabetes mellitus and metabolic syndrome##3##7##(2008-1#1)(2008-3#1)(2009-11#1)
type 2 diabetes mellitus and##12##5##(2008-1#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-11#1)(2010-10#1)(2012-2#2)(2013-1#2)
type 2 diabetes mellitus in children##2##6##(2008-1#1)(2013-1#1)
type 2 diabetes mellitus in secondary failure##2##7##(1990-11#2)
type 2 diabetes mellitus in##9##5##(1990-11#2)(2008-1#1)(2008-3#1)(2009-4#1)(2009-7#1)(2010-10#1)(2011-2#1)(2013-1#1)
type 2 diabetes mellitus model##2##5##(2012-1#2)
type 2 diabetes mellitus patients##2##5##(2010-10#1)(2012-2#1)
type 2 diabetes mellitus were##3##5##(2008-3#2)(2011-11#1)
type 2 diabetes mellitus##123##4##(1990-11#2)(1990-2#1)(2005-10#2)(2006-12#1)(2006-3#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-5#2)(2007-8#1)(2008-1#18)(2008-10#1)(2008-3#20)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-11#12)(2009-4#1)(2009-7#1)(2009-9#1)(2010-10#4)(2010-11#1)(2010-8#1)(2011-1#4)(2011-11#2)(2011-2#6)(2012-1#5)(2012-12#1)(2012-2#7)(2012-5#1)(2013-1#13)(2013-7#1)(2013-8#2)
type 2 diabetes or##2##4##(1994-4#1)(2013-1#1)
type 2 diabetes patients##13##4##(2006-2#1)(2008-11#1)(2008-3#2)(2008-7#1)(2009-11#2)(2011-1#1)(2011-2#2)(2012-2#2)(2013-7#1)
type 2 diabetes should##2##4##(1996-11#2)
type 2 diabetes treated with##2##5##(2008-3#1)(2012-4#1)
type 2 diabetes treated##3##4##(2008-3#1)(2011-2#1)(2012-4#1)
type 2 diabetes was##2##4##(2008-5#1)(2012-2#1)
type 2 diabetes##439##3##(1990-11#2)(1990-2#1)(1992-5#3)(1993-4#1)(1994-12#1)(1994-4#2)(1995-9#1)(1996-11#3)(2005-10#15)(2006-10#1)(2006-12#1)(2006-2#10)(2006-3#1)(2006-9#2)(2007-1#3)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#11)(2007-6#1)(2007-8#6)(2008-1#68)(2008-10#5)(2008-11#4)(2008-12#2)(2008-3#65)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#18)(2008-8#5)(2009-1#1)(2009-11#20)(2009-12#2)(2009-3#4)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#7)(2010-11#2)(2010-12#5)(2010-3#1)(2010-4#5)(2010-8#5)(2010-9#1)(2011-1#12)(2011-11#2)(2011-12#1)(2011-2#23)(2012-1#6)(2012-11#1)(2012-12#15)(2012-2#21)(2012-3#9)(2012-4#4)(2012-5#3)(2012-6#2)(2013-1#24)(2013-7#4)(2013-8#5)
type 2 diabetes?##3##3##(2008-1#1)(2010-12#1)(2012-5#1)
type 2 diabetes]##4##3##(2005-10#1)(2006-2#1)(2011-1#1)(2013-7#1)
type 2 diabetic patient##2##4##(2006-2#1)(2008-1#1)
type 2 diabetic patients has##2##5##(2005-10#1)(2008-1#1)
type 2 diabetic patients with##2##5##(1993-2#1)(2009-2#1)
type 2 diabetic patients##24##4##(1991-5#1)(1993-2#3)(2005-10#2)(2006-2#3)(2007-5#1)(2008-1#2)(2009-2#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#2)
type 2 diabetic subjects##3##4##(2008-1#1)(2011-12#1)(2013-1#1)
type 2 diabetic##44##3##(1991-5#1)(1993-2#3)(2005-10#2)(2006-2#4)(2007-5#3)(2008-1#7)(2008-3#1)(2008-5#2)(2009-2#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
type 2 diabetics with##3##4##(2008-3#2)(2013-8#1)
type 2 diabetics##9##3##(1990-2#1)(2006-6#2)(2006-9#1)(2007-5#1)(2008-3#3)(2013-8#1)
type 2 fibers##2##3##(1994-4#2)
type 2 immunity##4##3##(2008-2#2)(2012-12#2)
type 2 in##4##3##(1991-8#1)(2009-1#1)(2009-3#1)(2011-12#1)
type 2 lepra reaction##4##4##(2009-5#4)
type 2 patients##3##3##(2007-9#2)(2013-1#1)
type 2 receptor##8##3##(1993-3#1)(1994-11#2)(1994-8#2)(2012-1#1)(2013-1#1)(2013-8#1)
type 2 response##2##3##(2009-9#1)(2012-12#1)
type 2 was##2##3##(1991-8#1)(2007-11#1)
type 2##677##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-7#1)(1990-8#1)(1991-4#1)(1991-5#2)(1991-8#4)(1991-9#2)(1992-12#1)(1992-5#3)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#5)(1993-3#1)(1993-4#2)(1993-6#4)(1993-7#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#4)(1994-6#1)(1994-8#3)(1994-9#4)(1995-10#1)(1995-11#2)(1995-12#1)(1995-6#2)(1995-9#1)(1996-10#1)(1996-11#3)(1996-4#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-7#1)(2005-10#26)(2005-11#3)(2005-8#1)(2006-10#5)(2006-12#4)(2006-2#17)(2006-3#1)(2006-6#6)(2006-9#5)(2007-1#5)(2007-10#2)(2007-11#8)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#15)(2007-6#1)(2007-8#7)(2007-9#3)(2008-1#79)(2008-10#11)(2008-11#5)(2008-12#2)(2008-2#5)(2008-3#74)(2008-4#6)(2008-5#7)(2008-6#1)(2008-7#18)(2008-8#8)(2008-9#1)(2009-1#2)(2009-11#21)(2009-12#2)(2009-2#1)(2009-3#5)(2009-4#2)(2009-5#5)(2009-7#2)(2009-8#2)(2009-9#4)(2010-1#1)(2010-10#9)(2010-11#2)(2010-12#10)(2010-2#1)(2010-3#2)(2010-4#5)(2010-8#5)(2010-9#1)(2011-1#19)(2011-11#5)(2011-12#3)(2011-2#32)(2012-1#9)(2012-11#1)(2012-12#23)(2012-2#26)(2012-3#11)(2012-4#4)(2012-5#5)(2012-6#2)(2013-1#33)(2013-7#5)(2013-8#11)
type 2) and##2##3##(1993-2#1)(1997-2#1)
type 2)##8##2##(1992-7#1)(1993-2#1)(1997-2#1)(2006-10#2)(2008-1#1)(2008-6#1)(2012-2#1)
type 2A and 2B##2##4##(1993-12#2)
type 2A and##3##3##(1993-12#3)
type 2A protein phosphatase in##3##5##(1991-4#3)
type 2A protein phosphatase##6##4##(1990-11#1)(1991-4#3)(1995-5#2)
type 2A was##2##3##(1991-7#1)(1993-12#1)
type 2A##16##2##(1990-11#1)(1990-12#1)(1991-4#3)(1991-7#1)(1992-8#1)(1993-12#5)(1995-5#2)(1995-8#2)
type 2B##2##2##(1993-12#2)
type 2C##2##2##(1994-12#2)
type 2]##2##2##(1997-3#1)(2005-11#1)
type 2b##3##2##(2007-12#1)(2008-5#1)(2013-1#1)
type 3 MT##2##3##(2008-10#2)
type 3 and##2##3##(1995-11#1)(1995-6#1)
type 3 isoform##2##3##(2005-8#1)(2008-4#1)
type 3 repeats##2##3##(1994-5#2)
type 3##36##2##(1994-2#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-6#2)(1995-8#1)(1997-4#1)(2005-8#1)(2006-1#2)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#2)(2008-7#1)(2009-11#2)(2009-9#1)(2010-12#1)(2011-1#2)(2012-12#1)(2013-1#4)
type 4##7##2##(1993-12#1)(1995-6#1)(1996-3#1)(2007-11#3)(2010-8#1)
type 5 acid phosphatase##3##4##(1990-4#3)
type 5 and##2##3##(1994-5#1)(1994-8#1)
type 5 receptor##2##3##(1994-11#2)
type 5##19##2##(1990-4#3)(1993-3#1)(1994-11#2)(1994-5#1)(1994-8#1)(1995-2#1)(1997-4#1)(1997-8#1)(2007-10#1)(2008-4#1)(2008-9#1)(2009-10#1)(2010-12#2)(2011-2#1)(2012-12#1)
type 6##5##2##(1991-2#1)(1995-6#1)(2009-10#1)(2013-1#2)
type 7##2##2##(1991-7#1)(1995-6#1)
type 9##4##2##(1992-9#2)(2013-1#2)
type 9A##2##2##(1991-9#2)
type A NT##2##3##(1990-5#2)
type A acute aortic dissection##2##5##(2007-8#2)
type A and B##3##4##(1997-6#2)(2009-9#1)
type A and##6##3##(1997-6#2)(2005-8#1)(2007-11#1)(2008-5#1)(2009-9#1)
type A aortic dissection##8##4##(2007-8#7)(2008-10#1)
type A aortic##11##3##(2007-8#10)(2008-10#1)
type A behavior##2##3##(2005-10#2)
type A dissection##5##3##(1993-10#1)(2007-8#2)(2013-1#2)
type A gamma-aminobutyric acid receptor##3##5##(1994-3#2)(1995-2#1)
type A heavy chain##2##4##(1990-5#2)
type A or##2##3##(1994-2#1)(1997-6#1)
type A receptor blocker##2##4##(1994-2#2)
type A receptor##3##3##(1994-12#1)(1994-2#2)
type A##90##2##(1990-12#2)(1990-2#1)(1990-5#5)(1990-9#1)(1991-9#2)(1993-10#1)(1993-6#1)(1994-12#2)(1994-2#3)(1994-3#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-10#1)(1997-1#1)(1997-2#1)(1997-6#6)(2005-10#2)(2005-5#1)(2005-8#1)(2005-9#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-6#2)(2007-7#1)(2007-8#17)(2008-10#7)(2008-2#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#2)(2013-8#1)
type B acute aortic##2##4##(2012-2#2)
type B and C##2##4##(1994-12#1)(2010-4#1)
type B and##5##3##(1994-12#1)(2005-11#1)(2006-2#1)(2008-11#1)(2010-4#1)
type B botulism##2##3##(1995-9#1)(2007-12#1)
type B dissection##4##3##(2007-8#1)(2009-5#1)(2013-1#2)
type B receptor blocker##2##4##(1994-2#2)
type B receptors##2##3##(1994-2#2)
type B vaccine##4##3##(1991-8#2)(2007-2#1)(2008-4#1)
type B virus##2##3##(1997-6#2)
type B##66##2##(1991-8#2)(1993-4#2)(1993-6#1)(1994-12#1)(1994-2#5)(1994-9#1)(1995-9#2)(1996-3#2)(1997-1#1)(1997-4#2)(1997-6#6)(2005-11#1)(2006-12#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#4)(2008-7#2)(2008-8#2)(2009-3#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-4#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
type C chronic liver disease##2##5##(1992-3#2)
type C hepatitis##3##3##(1992-11#1)(2008-4#2)
type C##25##2##(1992-11#1)(1992-3#5)(1992-6#2)(1997-1#5)(1997-6#1)(2005-5#1)(2006-9#1)(2007-6#1)(2008-10#1)(2008-4#3)(2009-5#1)(2009-9#1)(2010-12#1)(2012-2#1)
type C1##2##2##(1990-9#2)
type Ca2+##3##2##(1992-11#1)(1993-11#1)(2008-8#1)
type D##5##2##(1997-6#1)(1997-8#1)(2006-8#2)(2010-8#1)
type E##13##2##(1990-5#1)(1992-2#2)(1997-6#1)(2006-5#7)(2007-12#1)(2008-5#1)
type I AOD with gross instability##2##6##(2012-3#2)
type I AOD##3##3##(2012-3#3)
type I IFN##5##3##(1996-11#2)(2007-11#2)(2012-2#1)
type I IFNs##4##3##(1995-12#3)(2007-11#1)
type I Myosin##2##3##(2008-10#2)
type I NOS##3##3##(1991-12#1)(1995-7#2)
type I SHG##2##3##(2008-2#2)
type I V skin##2##4##(2007-8#2)
type I alpha regulatory subunit##3##5##(1990-2#3)
type I and II##11##4##(1990-3#1)(1990-6#1)(1993-11#1)(1994-4#1)(1994-5#1)(1995-12#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-6#1)(2010-2#1)
type I and III##2##4##(1991-1#2)
type I and type II diabetes##2##6##(2008-9#1)(2010-11#1)
type I and type II fibroblasts##2##6##(1992-4#1)(1997-3#1)
type I and type II receptors##4##6##(1994-11#1)(1994-3#1)(1996-5#2)
type I and type II##23##5##(1992-4#1)(1994-11#1)(1994-2#1)(1994-3#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-5#3)(1997-3#1)(2005-10#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)(2010-11#1)(2010-2#1)(2012-3#1)
type I and type##25##4##(1991-2#1)(1992-4#1)(1994-11#1)(1994-2#1)(1994-3#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-5#3)(1997-3#1)(2005-10#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2010-11#1)(2010-2#1)(2012-3#1)
type I and##46##3##(1990-3#1)(1990-6#1)(1991-1#2)(1991-11#1)(1991-2#1)(1992-4#1)(1993-11#2)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-5#4)(1997-1#1)(1997-3#1)(2005-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-11#1)(2010-2#3)(2012-3#1)
type I angiotensin II receptor genes##2##6##(1992-4#2)
type I angiotensin II receptor##4##5##(1991-5#1)(1992-4#3)
type I angiotensin II##5##4##(1991-5#1)(1992-4#4)
type I autophagy##4##3##(2007-9#4)
type I beta##2##3##(1995-2#1)(2007-12#1)
type I cells##4##3##(2007-12#2)(2011-12#2)
type I chitinases##2##3##(1992-8#2)
type I collagen fibrils##2##4##(2008-1#1)(2010-8#1)
type I collagen in##4##4##(1995-6#1)(1996-4#1)(2008-11#1)(2008-9#1)
type I collagen##42##3##(1992-11#2)(1994-3#1)(1994-5#1)(1995-5#1)(1995-6#1)(1996-4#6)(1996-7#1)(1997-1#2)(1997-4#1)(1997-7#3)(1997-8#1)(2005-11#1)(2005-3#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-8#1)(2008-9#3)(2009-3#1)(2009-7#1)(2010-4#1)(2010-8#2)(2011-1#2)(2012-12#3)(2013-1#1)(2013-8#1)
type I copper proteins##2##4##(1993-11#1)(1994-9#1)
type I copper##3##3##(1993-11#2)(1994-9#1)
type I diabetes and##3##4##(1990-5#1)(2007-5#1)(2009-2#1)
type I diabetes mellitus##7##4##(1993-12#1)(2007-7#1)(2009-2#3)(2011-2#1)(2013-1#1)
type I diabetes##20##3##(1990-5#1)(1992-5#1)(1993-12#1)(1993-9#1)(1994-4#1)(1996-9#1)(2006-6#1)(2006-7#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-9#1)(2009-2#4)(2011-2#1)(2013-1#1)
type I diabetic patients with##2##5##(1991-10#1)(1993-12#1)
type I diabetic patients##3##4##(1991-10#1)(1993-12#2)
type I diabetic##5##3##(1991-10#1)(1993-12#2)(2012-12#2)
type I endoleak##2##3##(2007-8#2)
type I endoleaks##3##3##(2007-8#3)
type I epidermal transglutaminase##2##4##(1994-12#2)
type I error rate##5##4##(1993-5#1)(2012-1#1)(2012-3#3)
type I error rates and##2##5##(2010-2#1)(2012-3#1)
type I error rates that##2##5##(2012-3#2)
type I error rates##12##4##(1993-4#1)(2010-2#2)(2011-2#1)(2012-3#5)(2013-1#3)
type I error##32##3##(1992-2#1)(1993-4#1)(1993-5#1)(1994-9#1)(1995-2#1)(2008-10#3)(2010-2#2)(2011-2#1)(2012-1#1)(2012-3#17)(2013-1#3)
type I errors##5##3##(1992-2#2)(2008-7#1)(2011-2#1)(2012-3#1)
type I hypersensitivity reactions##2##4##(2008-8#1)(2010-5#1)
type I hypersensitivity##3##3##(2008-8#2)(2010-5#1)
type I interferon##7##3##(1996-11#1)(1996-5#1)(2010-2#1)(2011-1#3)(2012-2#1)
type I interferons##3##3##(1995-12#2)(2008-4#1)
type I iodothyronine 5'-deiodinase##4##4##(1990-12#3)(1992-5#1)
type I iodothyronine##5##3##(1990-12#3)(1992-12#1)(1992-5#1)
type I keratin##2##3##(1996-2#2)
type I mRNA##2##3##(1991-12#1)(1995-12#1)
type I malformation##2##3##(1992-2#1)(2008-7#1)
type I muscle##2##3##(1991-10#1)(2008-1#1)
type I or II##2##4##(2005-7#1)(2012-3#1)
type I or##3##3##(1994-3#1)(2005-7#1)(2012-3#1)
type I procollagen##2##3##(1991-1#1)(2008-7#1)
type I quasi phase matching##2##5##(2007-11#1)(2007-12#1)
type I receptor##6##3##(1990-9#1)(1995-12#1)(1996-5#1)(2008-9#1)(2009-4#2)
type I second-harmonic generation##3##4##(2007-11#1)(2008-2#2)
type I second-harmonic##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
type I topoisomerase##2##3##(1997-4#2)
type I transmembrane##2##3##(1995-2#1)(2012-12#1)
type I##436##2##(1990-11#8)(1990-12#4)(1990-2#3)(1990-3#2)(1990-4#4)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#5)(1991-10#3)(1991-11#1)(1991-12#4)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#3)(1992-11#3)(1992-12#1)(1992-2#4)(1992-3#4)(1992-4#5)(1992-5#4)(1992-8#4)(1992-9#1)(1993-11#7)(1993-12#5)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#4)(1994-4#2)(1994-5#3)(1994-7#1)(1994-9#2)(1995-11#1)(1995-12#12)(1995-2#8)(1995-3#7)(1995-4#1)(1995-5#4)(1995-6#1)(1995-7#2)(1996-10#3)(1996-11#3)(1996-12#1)(1996-2#4)(1996-4#6)(1996-5#11)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#2)(1997-3#2)(1997-4#6)(1997-5#1)(1997-7#4)(1997-8#3)(2005-10#1)(2005-11#1)(2005-3#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-6#2)(2006-7#2)(2006-9#1)(2007-11#11)(2007-12#18)(2007-2#1)(2007-5#1)(2007-7#4)(2007-8#11)(2007-9#7)(2008-1#8)(2008-10#9)(2008-11#11)(2008-12#1)(2008-2#7)(2008-3#7)(2008-4#2)(2008-5#12)(2008-6#5)(2008-7#6)(2008-8#4)(2008-9#8)(2009-2#5)(2009-3#3)(2009-4#2)(2009-7#1)(2010-11#1)(2010-2#6)(2010-4#2)(2010-5#2)(2010-8#3)(2011-1#6)(2011-12#2)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#3)(2012-3#26)(2013-1#10)(2013-8#3)
type IA##6##2##(1995-5#2)(2007-11#2)(2011-2#1)(2013-7#1)
type II (n =##2##4##(1990-4#1)(2008-7#1)
type II AgGaS(2)##2##3##(2007-12#1)(2008-2#1)
type II DM in##3##4##(2007-2#3)
type II DM was##2##4##(2007-2#2)
type II DM##13##3##(2007-2#12)(2008-7#1)
type II DNA topoisomerase##2##4##(1991-4#1)(1996-7#1)
type II activin receptor##2##4##(1994-8#2)
type II afferents##3##3##(1990-4#3)
type II and type III##3##5##(1991-7#1)(2006-10#1)(2006-2#1)
type II and type##5##4##(1991-7#1)(1995-12#1)(2006-10#1)(2006-2#1)(2008-11#1)
type II and##11##3##(1991-7#1)(1995-12#2)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-7#1)
type II antifreeze##2##3##(1992-5#2)
type II autophagy##2##3##(2007-9#2)
type II cAMP-dependent##2##3##(1994-9#1)(1995-11#1)
type II cell##4##3##(1993-3#1)(1994-12#1)(1995-2#1)(1995-3#1)
type II cells were##2##4##(1995-8#1)(2011-12#1)
type II cells##16##3##(1990-11#3)(1990-7#1)(1993-9#2)(1994-12#2)(1995-3#4)(1995-8#2)(2007-12#1)(2011-12#1)
type II collagen (CII)##2##4##(1996-4#1)(2008-4#1)
type II collagen##14##3##(1991-5#1)(1994-8#1)(1996-10#1)(1996-4#1)(1997-1#2)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2009-4#1)
type II collagen-induced arthritis##4##4##(1996-10#1)(1997-1#2)(2006-4#1)
type II diabetes and##5##4##(1994-2#1)(2009-4#1)(2010-7#2)(2012-1#1)
type II diabetes mellitus (DM)##3##5##(2007-2#2)(2008-7#1)
type II diabetes mellitus and##5##5##(1993-12#1)(1996-1#1)(2006-6#1)(2008-7#2)
type II diabetes mellitus##17##4##(1991-7#1)(1993-12#3)(1996-1#2)(1996-11#1)(2005-8#1)(2006-6#2)(2007-2#3)(2008-10#1)(2008-7#3)
type II diabetes##34##3##(1990-5#1)(1991-5#1)(1991-7#1)(1993-12#3)(1994-2#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-11#2)(1996-9#1)(2005-8#2)(2006-6#2)(2007-2#3)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#4)(2008-9#1)(2009-4#1)(2010-11#1)(2010-7#2)(2012-1#1)
type II diabetes]##2##3##(1991-11#1)(1995-11#1)
type II diabetic patients##3##4##(1993-12#1)(2005-8#1)(2008-5#1)
type II diabetic##5##3##(1993-12#1)(1994-3#1)(1996-4#1)(2005-8#1)(2008-5#1)
type II diabetics##4##3##(1991-11#1)(1996-1#2)(2008-3#1)
type II duplication##2##3##(1994-10#2)
type II enzyme##8##3##(1995-3#2)(1997-2#6)
type II enzymes##4##3##(1990-7#3)(1997-4#1)
type II fatty acid synthase of##2##6##(1993-9#2)
type II fatty acid synthase##5##5##(1993-9#5)
type II gene##3##3##(1995-10#2)(2007-12#1)
type II hair keratins##2##4##(2008-5#2)
type II inosine 5'-monophosphate dehydrogenase##2##5##(1994-11#2)
type II integral membrane##2##4##(1997-4#1)(2013-7#1)
type II is##7##3##(1991-12#1)(1991-7#1)(1992-12#1)(1993-12#1)(1994-9#1)(1995-3#1)(2007-7#1)
type II membrane##3##3##(1991-10#1)(1994-3#1)(2013-8#1)
type II pC-collagen##2##3##(1994-8#2)
type II pN-collagen##2##3##(1994-8#2)
type II parametric##2##3##(2007-11#1)(2007-12#1)
type II phase-matched KTP##2##4##(2007-11#1)(2008-2#1)
type II phase-matched optical parametric oscillator##2##6##(2007-12#2)
type II phase-matched##5##3##(2007-11#1)(2007-12#3)(2008-2#1)
type II phospholipase A2##5##4##(1994-2#4)(1995-12#1)
type II pneumocytes##8##3##(1990-7#2)(1993-9#1)(1994-12#1)(1994-5#3)(1996-9#1)
type II procollagen##6##3##(1994-8#4)(1997-2#2)
type II quadratic solitons excited##2##5##(2007-12#1)(2008-1#1)
type II quasi-phase-matched##2##3##(2007-12#2)
type II receptor is##2##4##(1993-3#1)(1996-5#1)
type II receptor was##2##4##(1993-3#1)(2006-9#1)
type II receptor##14##3##(1991-6#1)(1993-3#4)(1994-8#1)(1995-2#1)(1995-3#1)(1996-5#2)(1997-2#2)(2006-9#1)(2008-9#1)
type II receptors##7##3##(1993-3#1)(1994-11#2)(1994-3#1)(1996-5#2)(2011-2#1)
type II sIL-1R##2##3##(1995-2#2)
type II second-harmonic generation in##3##5##(2007-11#1)(2007-12#1)(2008-1#1)
type II second-harmonic generation##6##4##(2007-11#1)(2007-12#4)(2008-1#1)
type II sites##3##3##(1991-6#3)
type II topoisomerase##2##3##(1991-4#1)(2012-3#1)
type II topology##3##3##(1997-7#3)
type II was##2##3##(1991-4#1)(1992-8#1)
type II##393##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-4#4)(1990-5#1)(1990-6#1)(1990-7#6)(1990-9#1)(1991-1#1)(1991-10#3)(1991-11#2)(1991-12#2)(1991-3#1)(1991-4#5)(1991-5#2)(1991-6#6)(1991-7#5)(1991-8#1)(1991-9#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#4)(1992-6#4)(1992-8#1)(1993-11#1)(1993-12#8)(1993-3#8)(1993-6#1)(1993-9#10)(1994-10#3)(1994-11#7)(1994-12#6)(1994-2#6)(1994-3#5)(1994-5#6)(1994-8#12)(1994-9#4)(1995-10#2)(1995-11#4)(1995-12#4)(1995-2#9)(1995-3#13)(1995-4#1)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#5)(1996-1#4)(1996-10#2)(1996-11#2)(1996-12#1)(1996-2#3)(1996-4#3)(1996-5#9)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#11)(1997-3#1)(1997-4#2)(1997-5#2)(1997-7#3)(1997-8#1)(2005-10#1)(2005-8#3)(2006-10#3)(2006-2#4)(2006-4#2)(2006-6#2)(2006-9#1)(2007-11#9)(2007-12#29)(2007-2#16)(2007-5#2)(2007-7#4)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#6)(2008-11#3)(2008-2#7)(2008-3#5)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#10)(2008-8#1)(2008-9#2)(2009-3#4)(2009-4#3)(2009-7#1)(2010-11#1)(2010-2#1)(2010-4#4)(2010-7#2)(2011-12#3)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
type II)##5##2##(1995-11#1)(2007-12#1)(2007-7#1)(2011-2#1)(2013-8#1)
type IIA##4##2##(2007-11#1)(2007-7#1)(2008-3#1)(2011-2#1)
type III MPGN cases##2##4##(2007-2#2)
type III and IV collagen##2##5##(2013-8#2)
type III and##4##3##(1990-6#1)(2006-10#1)(2013-8#2)
type III collagen aminopropeptide##2##4##(1990-7#2)
type III fractures##3##3##(2007-11#1)(2007-8#1)(2012-2#1)
type III hyperlipoproteinemia##5##3##(1992-2#4)(2010-12#1)
type III procollagen##5##3##(1991-1#1)(1991-2#1)(1992-9#1)(1993-6#1)(2006-2#1)
type III receptor##3##3##(1991-4#1)(1992-11#1)(2008-5#1)
type III receptors were##2##4##(1992-11#2)
type III receptors##5##3##(1991-4#2)(1992-11#3)
type III secretion system of##2##5##(1996-8#1)(2011-1#1)
type III secretion system##8##4##(1996-8#1)(2006-10#1)(2007-12#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
type III secretion##12##3##(1996-8#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-9#3)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
type III sub-populations##2##3##(2008-8#2)
type III##104##2##(1990-6#4)(1990-7#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-2#1)(1991-4#6)(1991-5#3)(1991-7#3)(1992-11#4)(1992-12#2)(1992-2#4)(1992-9#1)(1993-6#2)(1993-8#1)(1994-9#2)(1995-6#2)(1996-3#1)(1996-8#1)(1997-7#1)(1997-8#1)(2006-10#3)(2006-2#5)(2007-11#2)(2007-12#3)(2007-2#3)(2007-7#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-3#3)(2009-7#2)(2009-8#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#6)
type III-like sequences##3##3##(1992-6#3)
type IIIB##2##2##(2011-2#1)(2013-8#1)
type IIIa##3##2##(1997-7#1)(2007-11#1)(2011-3#1)
type IIa##7##2##(1990-3#1)(1994-2#1)(2007-11#1)(2007-12#1)(2008-4#1)(2013-8#2)
type IIb##2##2##(2007-12#1)(2009-1#1)
type IV Ehlers-Danlos syndrome##5##4##(2004-10#5)
type IV and V##3##4##(2007-7#2)(2011-3#1)
type IV and##8##3##(1990-2#1)(1992-6#1)(2007-7#4)(2007-8#1)(2011-3#1)
type IV collagen and##3##4##(1993-12#1)(1994-7#1)(2007-12#1)
type IV collagen in##4##4##(1993-11#1)(1994-7#2)(2010-11#1)
type IV collagen##19##3##(1990-12#2)(1991-9#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-7#4)(1995-2#2)(1997-3#1)(2006-8#1)(2007-12#1)(2009-2#1)(2010-11#1)
type IV collagenase##9##3##(1991-2#2)(1992-2#2)(2008-11#1)(2008-8#4)
type IV skin and##2##4##(2007-7#1)(2007-8#1)
type IV##76##2##(1990-12#4)(1990-2#4)(1991-2#2)(1991-8#1)(1991-9#1)(1992-2#2)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-9#2)(1994-7#4)(1995-12#1)(1995-2#2)(1996-4#1)(1997-3#1)(1997-4#2)(1997-5#1)(2004-10#5)(2005-5#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#5)(2007-8#2)(2008-11#3)(2008-5#1)(2008-6#1)(2008-8#5)(2009-2#2)(2009-3#3)(2009-9#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#2)
type IV) and##4##3##(2006-10#1)(2008-5#1)(2013-1#2)
type IV)##6##2##(2006-10#1)(2008-5#1)(2008-8#1)(2009-11#1)(2013-1#2)
type IX collagen##4##3##(1991-5#1)(1992-5#3)
type I]##2##2##(1990-12#1)(2009-5#1)
type Ia (PHP-Ia)##2##3##(1992-11#1)(2011-1#1)
type Ia##3##2##(1992-11#2)(2011-1#1)
type Ib##4##2##(2010-4#1)(2011-3#2)(2013-7#1)
type P##3##2##(1996-12#1)(2008-10#2)
type Q##2##2##(1993-11#2)
type R1##2##2##(1993-11#1)(1996-9#1)
type STMV##4##2##(2008-10#4)
type V collagen##8##3##(1990-12#1)(2007-9#7)
type V skin##8##3##(2007-7#4)(2007-8#4)
type V##24##2##(1990-12#2)(1992-11#1)(1992-12#1)(2007-11#1)(2007-7#4)(2007-8#4)(2007-9#7)(2010-4#1)(2012-12#3)
type V1 vasopressin##2##3##(1994-9#2)
type VI collagen##7##3##(1993-3#7)
type VII collagen gene expression##2##5##(1991-10#2)
type VII collagen##7##3##(1991-10#4)(1992-3#3)
type VIII collagen##4##3##(1990-8#4)
type W##3##2##(2008-10#3)
type X collagen##4##3##(1992-8#1)(1993-12#1)(2008-11#1)(2013-8#1)
type X##7##2##(1992-8#1)(1993-12#1)(1995-1#2)(2008-11#2)(2013-8#1)
type a##4##2##(1995-11#1)(2006-10#1)(2007-10#1)(2008-4#1)
type addition##2##2##(1997-1#1)(2007-8#1)
type affected the##2##3##(2008-10#1)(2008-5#1)
type allele##2##2##(2008-10#1)(2012-11#1)
type among##3##2##(2007-10#1)(2008-10#1)(2011-2#1)
type and age##2##3##(2006-10#1)(2013-1#1)
type and amount of##2##4##(2008-10#1)(2011-2#1)
type and are##2##3##(1994-9#1)(1996-4#1)
type and concentration of##6##4##(1992-8#1)(2006-5#1)(2008-10#4)
type and concentration##7##3##(1992-8#1)(2005-12#1)(2006-5#1)(2008-10#4)
type and duration of##3##4##(1997-3#1)(2006-10#1)(2008-7#1)
type and duration##5##3##(1997-3#1)(2006-10#1)(2007-1#1)(2008-1#1)(2008-7#1)
type and extent of##4##4##(1995-12#1)(2007-11#1)(2008-4#1)(2010-2#1)
type and frequency of##6##4##(1993-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2009-6#1)(2012-2#1)
type and its##6##3##(2007-11#1)(2008-10#3)(2009-3#1)(2010-8#1)
type and least amount of eluent for elution of##2##9##(2008-10#2)
type and least amount of eluent for##3##7##(2008-10#3)
type and least amount of##5##5##(2008-10#5)
type and location of##3##4##(2006-5#1)(2011-2#1)(2012-12#1)
type and location##5##3##(2006-5#1)(2008-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
type and method##2##3##(2007-9#1)(2009-3#1)
type and not##2##3##(2008-2#1)(2008-8#1)
type and number of procedures##2##5##(2006-12#1)(2007-7#1)
type and number of##4##4##(1997-3#1)(2006-12#1)(2007-7#2)
type and only##3##3##(1993-3#1)(2011-2#1)(2013-7#1)
type and position##2##3##(1991-4#1)(2009-7#1)
type and proportion of##2##4##(2013-7#2)
type and quantity of##2##4##(2008-4#1)(2012-12#1)
type and relative##2##3##(2008-2#1)(2010-5#1)
type and severity of##6##4##(2006-8#1)(2007-11#1)(2007-12#1)(2008-2#1)(2010-12#1)(2013-1#1)
type and size of the##2##5##(2008-10#1)(2009-9#1)
type and size##3##3##(2008-10#1)(2009-9#1)(2011-12#1)
type and stage##4##3##(2007-11#1)(2008-8#1)(2011-2#2)
type and the##16##3##(1990-2#1)(1991-7#1)(1992-4#1)(1992-7#1)(1992-8#1)(1996-5#1)(1996-8#1)(2004-11#1)(2006-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2010-4#1)(2012-12#1)
type and to##2##3##(2008-2#1)(2008-8#1)
type and two##3##3##(1991-7#1)(2005-11#1)(2008-9#1)
type and volume of##2##4##(2008-10#2)
type and volume##3##3##(2008-10#3)
type and##242##2##(1990-2#1)(1990-3#2)(1990-4#1)(1991-10#2)(1991-4#3)(1991-7#5)(1991-8#1)(1991-9#1)(1992-4#2)(1992-7#1)(1992-8#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#2)(1994-10#1)(1994-3#1)(1994-6#1)(1994-9#3)(1995-10#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-8#3)(1997-1#1)(1997-3#3)(1997-7#1)(1997-8#1)(2004-11#2)(2004-4#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-7#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-5#2)(2006-6#2)(2006-8#4)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#40)(2008-11#6)(2008-12#1)(2008-2#9)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#7)(2008-8#7)(2008-9#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#11)(2012-1#3)(2012-12#6)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#3)(2013-8#2)
type are the##2##3##(2008-8#1)(2009-5#1)
type are##15##2##(1994-5#1)(1995-11#1)(1996-2#1)(1997-4#1)(2008-10#1)(2008-3#2)(2008-8#2)(2009-5#1)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
type as well as##4##4##(1995-5#1)(2007-8#1)(2008-11#1)(2008-4#1)
type as##9##2##(1995-5#1)(1997-6#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-2#1)(2012-11#1)(2012-2#1)
type b (Hib)##4##3##(1997-3#1)(2007-11#1)(2008-1#1)(2009-5#1)
type b##25##2##(1990-12#2)(1991-2#3)(1995-3#1)(1995-5#6)(1996-3#1)(1997-3#1)(2006-10#1)(2007-11#3)(2007-2#1)(2008-1#2)(2008-10#1)(2009-5#2)(2012-12#1)
type being##3##2##(2013-1#2)(2013-7#1)
type benzodiazepine binding sites##2##4##(1991-11#2)
type beta##4##2##(1991-1#2)(1992-12#1)(1992-8#1)
type binding##2##2##(1991-8#1)(1994-9#1)
type but##4##2##(1995-11#1)(2008-4#1)(2008-5#1)(2013-7#1)
type by##2##2##(2008-10#1)(2008-11#1)
type can be##3##3##(2008-10#1)(2008-2#1)(2008-8#1)
type can##6##2##(1993-11#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-8#1)
type cells##7##2##(1991-8#1)(1994-3#1)(1994-9#2)(2008-10#1)(2008-2#1)(2010-4#1)
type characteristics##2##2##(1996-1#1)(2010-4#1)
type cheese##2##2##(2005-12#1)(2011-2#1)
type chickens##2##2##(2005-9#1)(2013-8#1)
type classification##3##2##(2008-5#1)(2008-6#1)(2012-12#1)
type composition##7##2##(2010-4#3)(2011-2#4)
type consists of##2##3##(1996-5#1)(2007-12#1)
type contained##3##2##(1997-3#3)
type contains##3##2##(1990-6#1)(2008-2#1)(2008-7#1)
type coordination##2##2##(2008-3#1)(2010-5#1)
type could##2##2##(1992-2#1)(1994-3#1)
type cystomas##2##2##(1990-2#2)
type data##4##2##(1996-7#1)(2008-10#3)
type de##2##2##(2011-2#1)(2013-1#1)
type did not affect the##2##5##(2007-6#1)(2008-10#1)
type did not affect##3##4##(2007-6#1)(2008-10#2)
type distribution##3##2##(1990-12#1)(2011-2#2)
type epithelium##2##2##(1990-2#1)(2008-7#1)
type for the##6##3##(1991-10#1)(1997-4#1)(2007-11#2)(2008-2#1)(2008-3#1)
type for##11##2##(1991-10#1)(1992-8#1)(1997-4#1)(2007-11#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-12#1)
type found##2##2##(1996-4#1)(2011-2#1)
type frequency##3##2##(2008-10#1)(2013-1#2)
type from##3##2##(1992-4#1)(1993-9#1)(2008-7#1)
type gene##2##2##(2005-11#2)
type genes##5##2##(2005-11#2)(2008-10#2)(2010-12#1)
type genotype##2##2##(2013-1#2)
type glutamate receptor antagonist##2##4##(2008-11#2)
type glutamate receptor##4##3##(1995-5#2)(2008-11#2)
type glutamate##6##2##(1993-12#1)(1995-5#3)(2008-11#2)
type granulosa cell tumor##2##4##(2012-2#2)
type had##3##2##(2004-11#1)(2008-10#1)(2008-11#1)
type has a##3##3##(1991-11#1)(2008-1#1)(2008-2#1)
type has##5##2##(1991-11#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-2#1)
type have##3##2##(2005-10#1)(2007-11#1)(2012-2#1)
type hypersensitivity (DTH)##4##3##(1991-12#2)(2008-11#2)
type hypersensitivity##8##2##(1991-12#2)(2008-10#4)(2008-11#2)
type in the same##2##4##(2012-12#2)
type in the##18##3##(1996-11#4)(1996-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#3)(2013-1#2)
type in which##2##3##(1997-6#1)(2008-4#1)
type in##55##2##(1990-4#1)(1990-6#1)(1992-6#1)(1993-8#1)(1994-8#1)(1995-10#1)(1995-6#1)(1996-11#4)(1996-7#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#2)(2007-10#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-12#3)(2013-1#2)(2013-8#1)
type indicated##2##2##(1993-9#1)(2008-10#1)
type interactions##3##2##(2008-9#1)(2013-1#2)
type into##2##2##(2008-8#1)(2009-9#1)
type is a##2##3##(1996-11#1)(2008-10#1)
type is known##3##3##(1990-5#1)(2013-1#2)
type is more likely to be##2##6##(2011-2#1)(2013-1#1)
type is the##5##3##(1994-5#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-3#1)
type is##35##2##(1990-12#1)(1990-5#1)(1992-1#1)(1994-5#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-3#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-3#2)(2008-4#2)(2008-5#2)(2008-8#3)(2011-12#1)(2011-2#1)(2012-11#1)(2012-3#2)(2013-1#3)(2013-8#1)
type isolate##3##2##(2008-10#2)(2008-4#1)
type isolates of##2##3##(2008-10#2)
type isolates##3##2##(2008-10#3)
type known##2##2##(1993-11#1)(2008-4#1)
type ligands##2##2##(2008-10#1)(2010-5#1)
type locality of E##3##4##(2008-4#3)
type locality##4##2##(2007-3#1)(2008-4#3)
type may be##2##3##(1994-2#1)(2010-8#1)
type may##3##2##(1994-2#1)(2008-8#1)(2010-8#1)
type models##2##2##(2007-10#1)(2007-3#1)
type morphology and growth characteristics of winter wheat##2##8##(2013-8#2)
type occurred##2##2##(2008-10#1)(2008-5#1)
type of AFD and##2##4##(1996-6#2)
type of CP and##2##4##(2011-2#2)
type of DNA##3##3##(1995-11#1)(1997-6#1)(2010-8#1)
type of DNA-binding domain##2##4##(1997-4#2)
type of GN##2##3##(2007-8#2)
type of GTP-binding protein##2##4##(1992-11#1)(1993-3#1)
type of SAR##2##3##(1991-1#1)(1995-6#1)
type of a##4##3##(2007-12#1)(2008-10#2)(2010-5#1)
type of abuse##2##3##(2012-12#2)
type of access##2##3##(2007-7#1)(2007-8#1)
type of accident##2##3##(1991-12#1)(2013-8#1)
type of acid##2##3##(2012-2#1)(2013-1#1)
type of activity##6##3##(1990-3#1)(1991-1#1)(1994-2#1)(2007-6#1)(2008-11#1)(2008-8#1)
type of alcohol##2##3##(1994-8#1)(2012-2#1)
type of alkaloid##3##3##(2006-12#1)(2011-3#2)
type of amyloidosis##2##3##(2011-2#2)
type of analysis is##3##4##(2006-2#1)(2008-9#2)
type of analysis##5##3##(2006-2#1)(2008-10#1)(2008-11#1)(2008-9#2)
type of anesthesia in##2##4##(1993-4#1)(2007-11#1)
type of anesthesia##5##3##(1993-4#1)(2007-11#3)(2007-12#1)
type of animal##2##3##(2006-12#1)(2007-12#1)
type of aortic root prosthesis##2##5##(2007-9#2)
type of array##2##3##(2007-11#1)(2008-2#1)
type of arrhythmia##2##3##(1993-10#1)(2010-12#1)
type of assay##3##3##(2008-4#1)(2008-9#1)(2009-3#1)
type of bacteria##3##3##(2006-3#1)(2011-2#1)(2012-1#1)
type of bilayer##2##3##(1990-2#1)(1993-8#1)
type of binding##3##3##(1992-12#1)(1997-5#1)(2008-10#1)
type of bone##3##3##(2007-12#1)(2008-4#1)(2011-1#1)
type of brain##2##3##(2007-1#1)(2009-4#1)
type of cancer in##2##4##(1997-5#1)(2013-1#1)
type of cancer##6##3##(1996-3#1)(1997-5#1)(1997-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
type of carcinoma##2##3##(1997-8#1)(2009-6#1)
type of cell death##3##4##(1992-9#1)(2008-8#1)(2013-1#1)
type of cell holder##2##4##(2008-2#2)
type of cell in the##2##5##(2007-9#1)(2008-12#1)
type of cell in##3##4##(2007-9#1)(2008-12#2)
type of cell##9##3##(1992-9#1)(2007-9#1)(2008-10#1)(2008-12#2)(2008-2#2)(2008-8#1)(2013-1#1)
type of cells##5##3##(1992-9#1)(1996-3#1)(2007-12#1)(2007-9#1)(2008-12#1)
type of cellular##2##3##(2006-7#1)(2012-12#1)
type of cerebral palsy##2##4##(2007-7#1)(2011-2#1)
type of clinical##3##3##(1994-8#1)(2006-10#1)(2012-1#1)
type of colony##3##3##(1993-9#2)(2007-12#1)
type of complication##2##3##(1990-5#1)(2007-12#1)
type of compound##2##3##(1997-2#1)(2006-12#1)
type of control##2##3##(2010-2#1)(2011-2#1)
type of damage##4##3##(1991-5#1)(2008-3#1)(2008-6#2)
type of data##5##3##(1996-12#1)(1996-2#1)(2010-8#1)(2012-1#1)(2012-12#1)
type of defect##2##3##(2007-11#1)(2007-12#1)
type of defense##2##3##(2008-10#1)(2009-6#1)
type of delivery##3##3##(1994-7#1)(2011-1#1)(2012-3#1)
type of developmental##2##3##(2008-12#1)(2013-1#1)
type of device##5##3##(1994-11#1)(2008-10#1)(2008-4#1)(2011-2#1)(2013-1#1)
type of diabetes##6##3##(1993-2#2)(2007-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
type of diagnostic##2##3##(1996-3#1)(2008-10#1)
type of digestive##2##3##(2007-12#1)(2011-12#1)
type of disease##5##3##(1990-4#1)(2006-11#1)(2006-6#1)(2010-4#1)(2013-8#1)
type of dislocation##2##3##(2010-3#1)(2012-12#1)
type of donor##3##3##(2008-1#2)(2013-1#1)
type of drug##2##3##(1996-9#1)(2008-8#1)
type of drugs##2##3##(1996-5#1)(1996-6#1)
type of dural arteriovenous shunts##2##5##(1996-9#2)
type of dysplasia##2##3##(2007-11#2)
type of education and##2##4##(1994-2#1)(2008-1#1)
type of education##4##3##(1994-2#1)(2008-1#1)(2008-11#1)(2008-12#1)
type of effect##3##3##(1991-1#3)
type of endometrial carcinoma##2##4##(2011-2#1)(2012-1#1)
type of endometrial##3##3##(1994-9#1)(2011-2#1)(2012-1#1)
type of enzyme##3##3##(1992-2#1)(1992-3#1)(1995-2#1)
type of error##3##3##(2006-6#1)(2008-2#1)(2008-6#1)
type of event##5##3##(1993-3#1)(1997-4#1)(2007-11#1)(2008-9#1)(2012-2#1)
type of exercise##2##3##(2008-10#1)(2013-1#1)
type of experiment##2##3##(2008-4#2)
type of feeding##2##3##(1994-2#1)(2007-7#1)
type of filter##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
type of fistula##2##3##(2006-12#1)(2007-7#1)
type of fixative##2##3##(2008-11#1)(2011-2#1)
type of food##2##3##(2008-4#1)(2012-2#1)
type of fracture##7##3##(2007-7#1)(2007-8#3)(2011-2#2)(2012-12#1)
type of gas##2##3##(2008-2#1)(2008-3#1)
type of genetic##3##3##(2008-7#1)(2008-9#1)(2012-3#1)
type of glaucoma##2##3##(2009-8#1)(2011-2#1)
type of glutamate receptors##3##4##(2008-1#1)(2008-3#1)(2009-3#1)
type of graft##3##3##(1990-4#1)(2009-9#2)
type of gynecologic##2##3##(2011-1#1)(2013-8#1)
type of health care##2##4##(1994-1#1)(2007-4#1)
type of health##8##3##(1992-2#1)(1994-1#2)(2005-12#1)(2007-4#1)(2008-7#1)(2013-1#2)
type of hemocyte was##2##4##(2008-5#2)
type of hernias##2##3##(2011-1#2)
type of high school##2##4##(2008-1#1)(2013-1#1)
type of human##2##3##(2006-10#1)(2011-1#1)
type of illness##2##3##(1991-6#1)(1993-12#1)
type of immune##2##3##(1991-9#1)(1997-8#1)
type of impact##2##3##(2005-10#1)(2012-2#1)
type of infection##4##3##(2005-8#1)(2007-7#1)(2009-2#1)(2009-3#1)
type of information could be##2##5##(2005-9#1)(2007-6#1)
type of information##13##3##(1990-12#1)(1994-1#1)(2004-2#1)(2005-9#1)(2006-7#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-5#1)(2011-2#1)(2012-12#1)
type of inhibition##3##3##(1990-10#1)(1991-9#1)(1993-3#1)
type of initial##2##3##(1994-5#1)(2010-6#1)
type of injury##10##3##(1992-4#1)(2006-10#1)(2006-4#1)(2007-11#2)(2007-12#1)(2008-9#1)(2013-1#3)
type of insurance##2##3##(1992-1#1)(1996-3#1)
type of interaction##8##3##(1991-4#1)(1995-11#1)(1997-2#2)(2006-9#1)(2008-10#1)(2008-7#1)(2012-1#1)
type of intervention##8##3##(1994-1#1)(2008-2#1)(2008-7#2)(2008-9#1)(2011-12#1)(2012-1#1)(2012-2#1)
type of ion##2##3##(1993-9#1)(2007-8#1)
type of irrational beliefs##2##4##(2010-5#2)
type of laser##5##3##(1994-2#1)(2007-12#1)(2008-2#1)(2010-1#1)(2010-8#1)
type of latex##2##3##(1990-12#1)(2008-10#1)
type of leadership style##2##4##(1992-2#2)
type of lesion in##2##4##(2006-12#1)(2007-8#1)
type of lesion##4##3##(1990-4#1)(2006-12#1)(2007-7#1)(2007-8#1)
type of lesions and in##2##5##(2006-2#1)(2008-11#1)
type of lesions##3##3##(2006-2#1)(2008-11#1)(2008-8#1)
type of light##2##3##(2007-12#1)(2007-9#1)
type of linker##2##3##(1991-12#1)(1997-4#1)
type of lung cancer##2##4##(2008-1#1)(2013-8#1)
type of lymphoma##3##3##(2007-6#1)(2009-1#1)(2011-2#1)
type of magnetic##2##3##(2008-10#1)(2012-11#1)
type of malignancy##6##3##(2005-11#1)(2005-12#1)(2008-10#2)(2008-7#1)(2009-5#1)
type of malignant##5##3##(1990-10#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-7#1)
type of management##2##3##(2006-10#1)(2007-8#1)
type of matrix##3##3##(2008-10#2)(2012-2#1)
type of measurement##2##3##(2008-3#2)
type of medication##2##3##(2007-7#1)(2010-8#1)
type of meningitis##2##3##(2004-12#2)
type of mentoring relationship##2##4##(2009-4#2)
type of mentoring##3##3##(2009-4#3)
type of metabolic##2##3##(1994-11#1)(2007-9#1)
type of methodology##2##3##(2008-10#1)(2011-1#1)
type of mineralization##2##3##(2008-10#2)
type of model##4##3##(1997-2#1)(2005-11#1)(2007-12#1)(2008-5#1)
type of mutation##3##3##(1990-8#1)(1992-2#1)(2013-1#1)
type of neoplasm##2##3##(2007-11#1)(2011-2#1)
type of neural##2##3##(1995-11#1)(1995-12#1)
type of neuron##4##3##(1991-3#1)(1994-10#2)(2008-10#1)
type of nicotine replacement##2##4##(2013-1#2)
type of oligosaccharide##5##3##(1990-7#1)(1994-8#2)(1997-4#2)
type of oligosaccharides##2##3##(1994-8#1)(1997-4#1)
type of operation##7##3##(1990-3#2)(1991-11#1)(1992-10#1)(1995-9#1)(2007-7#1)(2007-8#1)
type of opioid receptors##2##4##(1997-7#1)(2010-12#1)
type of opioid##5##3##(1995-7#3)(1997-7#1)(2010-12#1)
type of optical##6##3##(2007-12#2)(2008-2#1)(2008-3#3)
type of organism##2##3##(2004-4#1)(2005-7#1)
type of osteosynthesis##2##3##(2007-8#1)(2013-8#1)
type of pain##3##3##(2008-4#1)(2009-7#1)(2010-3#1)
type of pathology##2##3##(1992-10#1)(1996-12#1)
type of patient##5##3##(1991-5#1)(2005-7#1)(2007-9#1)(2008-9#1)(2011-12#1)
type of permanent##2##3##(2007-7#1)(2008-10#1)
type of planning##3##3##(1993-3#1)(1994-1#1)(2008-8#1)
type of plant##2##3##(2008-10#1)(2011-1#1)
type of practice##2##3##(2006-2#1)(2007-9#1)
type of primary##8##3##(2007-11#3)(2007-12#1)(2008-1#2)(2010-11#1)(2011-2#1)
type of probe##2##3##(2007-10#1)(2009-4#1)
type of procedure performed##2##4##(1996-5#1)(2007-11#1)
type of procedure##3##3##(1996-5#1)(2007-11#1)(2013-1#1)
type of program##6##3##(1993-12#1)(1993-2#1)(1997-1#1)(2007-2#1)(2012-11#2)
type of protein##2##3##(1990-5#1)(2010-12#1)
type of radiation##4##3##(2008-12#2)(2008-6#1)(2008-7#1)
type of rapid##2##3##(2008-1#1)(2011-1#1)
type of reaction##2##3##(1991-5#1)(1994-3#1)
type of receptor##2##3##(1992-6#1)(1993-5#1)
type of recording##2##3##(2008-3#1)(2011-1#1)
type of regulation##2##3##(1997-6#1)(2013-1#1)
type of renal##3##3##(1995-5#1)(2011-2#1)(2012-12#1)
type of research##8##3##(1990-8#1)(1993-1#1)(1993-11#1)(1994-7#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-4#1)
type of residential area##2##4##(2010-3#2)
type of response##6##3##(1996-12#1)(2005-4#1)(2006-10#1)(2008-10#1)(2008-7#1)(2012-3#1)
type of sample##7##3##(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2011-1#1)
type of samples##3##3##(2008-10#3)
type of seizures##2##3##(2007-2#1)(2011-1#1)
type of service##4##3##(1992-3#1)(1996-2#1)(1997-1#1)(2011-2#1)
type of services##2##3##(1993-2#1)(2011-1#1)
type of side effects##2##4##(1996-3#1)(2004-3#1)
type of situation##2##3##(1996-1#1)(2009-6#1)
type of skin cancer##3##4##(2007-11#2)(2007-12#1)
type of skin##4##3##(2007-11#2)(2007-12#1)(2008-5#1)
type of small##2##3##(1990-5#1)(1997-5#1)
type of specialty##2##3##(2007-12#1)(2009-9#1)
type of stationary phase##2##4##(2008-10#1)(2008-11#1)
type of sterilization##2##3##(1991-3#2)
type of steroid##2##3##(2006-12#2)
type of steroids##2##3##(2006-9#1)(2008-4#1)
type of stress##2##3##(2006-3#1)(2007-11#1)
type of stroke##2##3##(2007-9#1)(2013-8#1)
type of structural change##2##4##(2007-12#1)(2008-7#1)
type of structural##3##3##(2007-12#1)(2008-4#1)(2008-7#1)
type of study##12##3##(1992-9#1)(1995-9#1)(1997-7#1)(2006-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-6#1)(2012-3#1)(2013-1#2)
type of subunit##2##3##(1990-5#2)
type of surface##2##3##(2008-10#1)(2009-2#1)
type of surgery and##2##4##(2007-12#1)(2010-6#1)
type of surgery##12##3##(1993-12#1)(2004-2#1)(2006-10#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-6#2)(2011-2#1)
type of surgical and##2##4##(1990-12#1)(2006-10#1)
type of surgical intervention##3##4##(2009-12#1)(2012-2#1)(2013-1#1)
type of surgical##13##3##(1990-12#1)(1997-2#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-2#1)(2008-8#2)(2009-12#1)(2012-2#3)(2013-1#1)
type of symptom##3##3##(2008-10#1)(2008-7#1)(2009-9#1)
type of system##3##3##(2008-1#1)(2008-2#1)(2009-6#1)
type of the disease##4##4##(1991-11#1)(1991-12#1)(1996-3#1)(2008-1#1)
type of the##39##3##(1990-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#2)(1995-11#2)(1996-3#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#5)(2008-7#1)(2008-8#1)(2012-12#1)
type of therapy##4##3##(1993-9#1)(1994-6#1)(2006-3#1)(2007-12#1)
type of these##2##3##(1991-9#1)(2008-4#1)
type of transplant##2##3##(2011-2#2)
type of treatment##18##3##(1991-11#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-3#1)(2004-4#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-3#1)(2007-7#1)(2008-10#1)(2010-2#1)(2011-2#2)
type of tumor##6##3##(1990-2#1)(1992-4#1)(1993-11#1)(2007-12#1)(2008-9#1)(2011-2#1)
type of tumour and##2##4##(1992-10#1)(2008-3#1)
type of tumour##8##3##(1992-10#1)(1993-3#1)(1993-9#1)(2008-3#1)(2008-6#2)(2009-2#1)(2010-12#1)
type of vaccine##5##3##(1993-3#1)(2005-9#1)(2007-2#1)(2007-7#1)(2011-2#1)
type of valve##3##3##(2006-8#1)(2008-3#1)(2013-1#1)
type of vascular access##3##4##(2007-7#3)
type of vascular##4##3##(2006-6#1)(2007-7#3)
type of vector##2##3##(2008-10#1)(2008-11#1)
type of visual##3##3##(1991-12#1)(2011-2#2)
type of work##5##3##(1995-9#1)(2008-4#1)(2009-9#1)(2011-1#1)(2013-1#1)
type of##1509##2##(1990-1#1)(1990-10#3)(1990-11#3)(1990-12#8)(1990-2#5)(1990-3#4)(1990-4#4)(1990-5#7)(1990-6#6)(1990-7#5)(1990-8#4)(1990-9#5)(1991-1#6)(1991-10#1)(1991-11#7)(1991-12#6)(1991-2#3)(1991-3#9)(1991-4#2)(1991-5#6)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#4)(1992-1#2)(1992-10#3)(1992-11#2)(1992-12#3)(1992-2#8)(1992-3#4)(1992-4#3)(1992-5#1)(1992-6#9)(1992-7#3)(1992-8#2)(1992-9#6)(1993-1#2)(1993-10#5)(1993-11#10)(1993-12#9)(1993-2#9)(1993-3#9)(1993-4#3)(1993-5#2)(1993-6#2)(1993-8#1)(1993-9#8)(1994-1#6)(1994-10#4)(1994-11#5)(1994-12#4)(1994-2#8)(1994-3#8)(1994-4#2)(1994-5#1)(1994-6#5)(1994-7#2)(1994-8#9)(1994-9#6)(1995-1#1)(1995-10#1)(1995-11#10)(1995-12#2)(1995-2#3)(1995-4#1)(1995-5#5)(1995-6#3)(1995-7#3)(1995-8#2)(1995-9#4)(1996-1#4)(1996-10#1)(1996-12#6)(1996-2#3)(1996-3#11)(1996-4#4)(1996-5#3)(1996-6#5)(1996-7#3)(1996-8#3)(1996-9#5)(1997-1#9)(1997-2#10)(1997-3#3)(1997-4#13)(1997-5#5)(1997-6#7)(1997-7#7)(1997-8#3)(2004-12#2)(2004-2#2)(2004-3#1)(2004-4#4)(2004-9#1)(2005-1#1)(2005-10#3)(2005-11#15)(2005-12#4)(2005-4#3)(2005-5#1)(2005-7#3)(2005-8#2)(2005-9#2)(2006-1#2)(2006-10#15)(2006-11#2)(2006-12#11)(2006-2#6)(2006-3#3)(2006-4#1)(2006-5#2)(2006-6#6)(2006-7#3)(2006-8#6)(2006-9#4)(2007-1#6)(2007-10#5)(2007-11#37)(2007-12#53)(2007-2#7)(2007-3#4)(2007-4#7)(2007-5#2)(2007-6#7)(2007-7#30)(2007-8#28)(2007-9#15)(2008-1#19)(2008-10#124)(2008-11#35)(2008-12#17)(2008-2#35)(2008-3#40)(2008-4#30)(2008-5#35)(2008-6#14)(2008-7#27)(2008-8#19)(2008-9#24)(2009-1#3)(2009-10#2)(2009-11#3)(2009-12#2)(2009-2#5)(2009-3#8)(2009-4#8)(2009-5#4)(2009-6#4)(2009-7#5)(2009-8#2)(2009-9#11)(2010-1#2)(2010-11#5)(2010-12#7)(2010-2#7)(2010-3#6)(2010-4#6)(2010-5#10)(2010-6#7)(2010-7#1)(2010-8#11)(2010-9#4)(2011-1#24)(2011-12#5)(2011-2#53)(2011-3#3)(2012-1#13)(2012-11#6)(2012-12#23)(2012-2#24)(2012-3#16)(2013-1#51)(2013-7#11)(2013-8#21)
type on the basis of##2##5##(1990-4#1)(1997-3#1)
type on the##5##3##(1990-4#1)(1997-3#1)(2008-2#1)(2008-7#1)(2011-2#1)
type on##17##2##(1990-4#1)(1994-8#2)(1996-6#1)(1997-3#1)(2004-11#1)(2007-1#1)(2007-4#1)(2008-10#3)(2008-2#3)(2008-5#1)(2008-7#1)(2011-2#1)
type one##2##2##(1992-6#1)(2007-6#1)
type or##25##2##(1994-10#1)(1994-12#2)(1994-9#1)(1995-6#1)(1996-11#1)(1996-6#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
type patients##3##2##(2007-8#2)(2012-1#1)
type plasminogen activator##5##3##(1990-8#1)(1994-3#1)(1995-3#1)(1996-9#1)(2008-11#1)
type plasminogen##6##2##(1990-8#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-9#1)(2008-11#1)
type protein and##2##3##(1990-2#1)(1995-10#1)
type protein##12##2##(1990-2#1)(1991-4#1)(1992-8#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-10#1)(1996-11#2)(1996-8#1)(2008-11#2)
type reaction##2##2##(1995-9#1)(2012-1#1)
type receptor##6##2##(1995-10#1)(1995-5#1)(1996-11#1)(1996-5#1)(1996-8#2)
type receptors##2##2##(1991-9#1)(1997-1#1)
type showed##2##2##(2008-6#1)(2010-2#1)
type species of the genus##28##5##(1997-2#1)(2007-2#1)(2008-10#1)(2011-2#25)
type species of the##32##4##(1997-2#1)(2007-2#1)(2008-10#2)(2008-6#1)(2011-2#27)
type species##42##2##(1997-2#1)(2007-2#1)(2008-10#3)(2008-6#1)(2008-9#1)(2011-2#33)(2013-7#2)
type specific##12##2##(1990-4#1)(1990-7#1)(1996-2#1)(1997-7#1)(2007-8#1)(2008-11#2)(2008-12#2)(2008-3#1)(2009-8#1)(2012-12#1)
type specificity of##2##3##(1990-9#1)(2012-12#1)
type specificity##3##2##(1990-9#1)(2008-10#1)(2012-12#1)
type specimens##2##2##(2007-5#1)(2013-8#1)
type strain (SEBR##3##3##(2011-2#3)
type strain genome from the##2##5##(2011-2#2)
type strain genome from##3##4##(2011-2#3)
type strain of a##3##4##(2006-8#1)(2011-2#2)
type strain of the species##2##5##(2011-2#2)
type strain of the##4##4##(2011-2#4)
type strain of##10##3##(1997-3#1)(2006-5#1)(2006-8#1)(2008-10#1)(2011-2#6)
type strain was##3##3##(2006-8#1)(2008-12#1)(2012-2#1)
type strain##91##2##(1991-2#1)(1992-10#3)(1992-12#1)(1993-11#1)(1994-6#1)(1997-3#1)(2006-11#1)(2006-5#1)(2006-8#5)(2008-10#7)(2008-12#1)(2008-5#1)(2008-8#4)(2008-9#2)(2011-2#57)(2012-2#2)(2012-3#2)
type strain)##3##2##(2006-8#2)(2011-2#1)
type strains of##3##3##(2008-10#2)(2011-2#1)
type strains##9##2##(1990-12#1)(1990-5#1)(1991-9#1)(1997-6#1)(1997-8#1)(2006-11#1)(2008-10#2)(2011-2#1)
type than##3##2##(1991-5#1)(2007-12#1)(2007-4#1)
type that are##3##3##(2008-10#2)(2013-7#1)
type that##13##2##(1995-12#1)(1996-5#1)(2006-5#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-6#1)(2008-9#1)(2011-2#1)(2013-7#1)
type three secretion system##2##4##(2008-11#2)
type three secretion##3##3##(2008-11#2)(2013-1#1)
type to the##3##3##(1990-12#1)(1990-2#1)(2008-2#1)
type to##10##2##(1990-12#2)(1990-2#1)(1993-2#1)(1996-10#1)(2004-11#1)(2006-11#1)(2007-12#1)(2008-12#1)(2008-2#1)
type tumor##2##2##(1991-7#1)(1994-12#1)
type under##4##2##(2008-10#1)(2008-8#1)(2010-10#1)(2013-1#1)
type used##8##2##(1997-3#1)(2005-9#1)(2008-2#2)(2008-7#1)(2012-12#3)
type using##3##2##(2008-10#1)(2008-2#1)(2008-7#1)
type virus##2##2##(2008-10#1)(2012-11#1)
type was characterized by##2##4##(2004-11#1)(2010-4#1)
type was the##5##3##(1990-11#1)(2008-3#2)(2012-12#1)(2013-8#1)
type was##34##2##(1990-11#1)(1990-5#1)(1991-5#2)(1996-11#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-11#1)(2004-4#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-10#9)(2008-3#2)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#2)
type were found in##2##4##(1991-11#1)(1992-6#1)
type were##28##2##(1990-2#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-8#1)(1992-6#1)(1995-2#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-2#1)(2010-4#1)(2011-1#1)(2011-12#1)(2012-2#1)
type when##5##2##(2006-8#1)(2008-10#2)(2013-1#2)
type which was##2##3##(2008-12#1)(2008-5#1)
type which##6##2##(1991-9#1)(1993-7#1)(1996-12#1)(1997-5#1)(2008-12#1)(2008-5#1)
type will be##2##3##(1994-5#1)(2008-5#1)
type will##3##2##(1994-5#1)(2008-5#1)(2008-8#1)
type with a##6##3##(1991-2#1)(1992-9#1)(1996-11#1)(1997-7#1)(2007-11#1)(2007-6#1)
type with the##5##3##(1994-9#1)(2008-5#1)(2008-7#1)(2009-6#1)(2013-7#1)
type with##22##2##(1991-2#1)(1991-7#1)(1992-9#1)(1994-9#1)(1995-3#1)(1996-11#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-5#1)(2007-6#1)(2008-10#2)(2008-5#3)(2008-7#1)(2009-6#1)(2010-2#1)(2011-1#1)(2013-7#1)(2013-8#1)
type within##3##2##(1994-3#1)(2008-3#1)(2008-9#1)
type##6388##1##(1990-1#1)(1990-10#12)(1990-11#26)(1990-12#43)(1990-2#31)(1990-3#12)(1990-4#19)(1990-5#25)(1990-6#17)(1990-7#25)(1990-8#18)(1990-9#16)(1991-1#20)(1991-10#25)(1991-11#16)(1991-12#25)(1991-2#22)(1991-3#24)(1991-4#25)(1991-5#27)(1991-6#11)(1991-7#34)(1991-8#22)(1991-9#30)(1992-1#5)(1992-10#7)(1992-11#24)(1992-12#14)(1992-2#25)(1992-3#27)(1992-4#12)(1992-5#15)(1992-6#37)(1992-7#14)(1992-8#30)(1992-9#18)(1993-1#2)(1993-10#6)(1993-11#38)(1993-12#42)(1993-2#23)(1993-3#36)(1993-4#18)(1993-5#6)(1993-6#29)(1993-7#4)(1993-8#14)(1993-9#29)(1994-1#9)(1994-10#18)(1994-11#26)(1994-12#34)(1994-2#43)(1994-3#31)(1994-4#10)(1994-5#22)(1994-6#20)(1994-7#7)(1994-8#40)(1994-9#38)(1995-1#13)(1995-10#18)(1995-11#31)(1995-12#32)(1995-2#34)(1995-3#35)(1995-4#7)(1995-5#30)(1995-6#28)(1995-7#9)(1995-8#18)(1995-9#10)(1996-1#13)(1996-10#16)(1996-11#31)(1996-12#11)(1996-2#16)(1996-3#21)(1996-4#26)(1996-5#41)(1996-6#11)(1996-7#13)(1996-8#22)(1996-9#15)(1997-1#30)(1997-2#38)(1997-3#36)(1997-4#47)(1997-5#21)(1997-6#41)(1997-7#36)(1997-8#27)(2004-10#5)(2004-11#13)(2004-12#3)(2004-2#3)(2004-3#1)(2004-4#7)(2004-9#1)(2005-1#3)(2005-10#53)(2005-11#40)(2005-12#13)(2005-3#1)(2005-4#5)(2005-5#4)(2005-7#7)(2005-8#9)(2005-9#8)(2006-1#9)(2006-10#61)(2006-11#14)(2006-12#27)(2006-2#38)(2006-3#5)(2006-4#6)(2006-5#16)(2006-6#25)(2006-7#9)(2006-8#28)(2006-9#15)(2007-1#18)(2007-10#21)(2007-11#114)(2007-12#160)(2007-2#46)(2007-3#14)(2007-4#11)(2007-5#51)(2007-6#16)(2007-7#69)(2007-8#161)(2007-9#42)(2008-1#152)(2008-10#463)(2008-11#123)(2008-12#39)(2008-2#109)(2008-3#164)(2008-4#91)(2008-5#128)(2008-6#43)(2008-7#111)(2008-8#90)(2008-9#60)(2009-1#9)(2009-10#8)(2009-11#34)(2009-12#9)(2009-2#19)(2009-3#39)(2009-4#26)(2009-5#24)(2009-6#9)(2009-7#14)(2009-8#25)(2009-9#30)(2010-1#4)(2010-10#10)(2010-11#17)(2010-12#49)(2010-2#29)(2010-3#13)(2010-4#44)(2010-5#28)(2010-6#10)(2010-7#7)(2010-8#37)(2010-9#9)(2011-1#90)(2011-11#5)(2011-12#21)(2011-2#267)(2011-3#9)(2012-1#44)(2012-11#19)(2012-12#101)(2012-2#99)(2012-3#73)(2012-4#10)(2012-5#5)(2012-6#3)(2012-9#4)(2013-1#210)(2013-7#42)(2013-8#82)
type&quot##6##1##(1997-8#1)(2007-12#4)(2008-9#1)
type'##2##1##(1997-5#2)
type(s)##5##1##(1990-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-1#1)
type) and##5##2##(1996-1#1)(1996-6#1)(2008-10#1)(2008-5#2)
type) based on##2##3##(1994-10#1)(1996-3#1)
type) is##2##2##(1990-3#1)(1991-9#1)
type) to##2##2##(1997-4#1)(2009-7#1)
type) were##4##2##(1997-3#1)(2007-6#1)(2008-10#1)(2011-2#1)
type)##41##1##(1990-12#1)(1990-3#1)(1990-8#1)(1991-1#1)(1991-9#2)(1992-9#1)(1993-9#1)(1994-10#1)(1994-6#1)(1995-2#1)(1996-1#2)(1996-3#1)(1996-6#1)(1997-3#1)(1997-4#1)(2004-1#1)(2006-4#1)(2006-5#1)(2007-6#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-5#3)(2008-8#1)(2009-7#1)(2010-2#1)(2010-3#2)(2011-2#1)(2013-8#1)
type- and##5##2##(1991-9#1)(2005-11#1)(2009-10#1)(2009-2#1)(2012-3#1)
type-##6##1##(1991-9#1)(2005-11#1)(2008-2#1)(2009-10#1)(2009-2#1)(2012-3#1)
type-1 (AT1) receptor##3##3##(1992-5#1)(1993-3#1)(2005-7#1)
type-1 and type-2##2##3##(1994-10#1)(1996-6#1)
type-1 has been##2##3##(1994-9#1)(2013-7#1)
type-1 receptor##2##2##(1992-3#1)(1992-5#1)
type-1##52##1##(1990-11#2)(1990-2#1)(1990-7#2)(1990-8#1)(1992-2#2)(1992-3#1)(1992-5#4)(1993-12#2)(1993-3#1)(1993-7#1)(1994-10#4)(1994-11#1)(1994-9#2)(1995-3#2)(1996-6#3)(1996-8#3)(1997-3#1)(1997-4#1)(2005-7#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2009-11#1)(2009-12#1)(2009-7#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
type-12##2##1##(1991-12#2)
type-2 EBV may be##2##4##(1993-7#2)
type-2 EBV may##3##3##(1993-7#3)
type-2 astrocytes##4##2##(1994-10#4)
type-2 diabetes and##2##3##(2011-1#1)(2012-3#1)
type-2 diabetes mellitus##5##3##(2008-1#1)(2010-4#2)(2011-12#1)(2011-2#1)
type-2 diabetes##16##2##(2008-1#1)(2008-7#4)(2008-8#1)(2009-12#1)(2010-3#1)(2010-4#2)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
type-2 diabetic##2##2##(1995-8#1)(2012-3#1)
type-2 diabetics in##2##3##(2010-4#1)(2012-3#1)
type-2 diabetics##3##2##(2010-4#1)(2012-3#2)
type-2 plasmids##2##2##(1996-6#2)
type-2##48##1##(1992-12#4)(1992-5#1)(1993-3#2)(1993-7#3)(1994-10#7)(1994-6#1)(1995-8#1)(1996-6#4)(2008-1#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-8#1)(2010-3#1)(2010-4#3)(2010-6#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-2#1)(2012-3#7)
type-5##4##1##(1990-4#2)(2007-1#1)(2010-10#1)
type-A##3##1##(1993-3#1)(2007-6#1)(2008-8#1)
type-D retrovirus##2##2##(1992-9#2)
type-I collagen##4##2##(1990-12#1)(2008-11#1)(2008-5#2)
type-I polyketide synthases##2##3##(2013-1#2)
type-I sequence##2##2##(1993-5#2)
type-I##19##1##(1990-12#1)(1991-8#1)(1992-8#1)(1993-5#3)(1996-5#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#3)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
type-II cells##7##2##(1994-3#7)
type-II diabetics##5##2##(2007-7#5)
type-II##20##1##(1990-4#1)(1992-12#2)(1992-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#7)(1994-6#1)(2007-7#5)
type-IV collagenase##2##2##(1992-9#1)(2008-11#1)
type-IV##5##1##(1992-9#3)(2008-11#1)(2011-2#1)
type-specific expression of the mouse peripherin gene requires both upstream and intragenic sequences##2##13##(1996-3#2)
type-specific expression##3##2##(1992-9#1)(1996-3#2)
type-specific gene##2##2##(2008-7#1)(2013-8#1)
type-specific manner##3##2##(1994-9#1)(1995-11#1)(1995-8#1)
type-specific serology##3##2##(2008-10#3)
type-specific##34##1##(1992-7#1)(1992-9#2)(1993-12#3)(1993-8#1)(1994-9#3)(1995-11#1)(1995-3#2)(1995-8#1)(1996-3#2)(1996-5#2)(1996-7#2)(2007-10#1)(2007-12#3)(2008-10#3)(2008-6#1)(2008-7#1)(2009-9#1)(2012-12#1)(2012-3#1)(2013-8#2)
typeI##4##1##(2007-11#2)(2008-1#2)
typeII##4##1##(2007-11#2)(2008-1#2)
type]##5##1##(1994-3#1)(1996-9#1)(2009-5#1)(2011-1#1)(2012-2#1)
typed as B##2##3##(1994-12#1)(2007-12#1)
typed as##10##2##(1992-6#1)(1994-12#5)(2007-12#3)(2008-5#1)
typed by##4##2##(1997-8#1)(2007-3#1)(2008-3#1)(2012-12#1)
typed for##3##2##(1994-12#1)(2007-2#1)(2012-3#1)
typed using##2##2##(2007-2#1)(2011-2#1)
typed##30##1##(1992-6#1)(1993-6#2)(1994-12#6)(1994-8#1)(1996-5#1)(1996-7#2)(1997-5#1)(1997-8#1)(2007-12#3)(2007-2#3)(2007-3#1)(2008-3#1)(2008-5#2)(2009-4#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
types 1 and 2##9##4##(1992-12#1)(1992-4#1)(1992-8#1)(1997-4#3)(2007-12#1)(2008-7#1)(2013-8#1)
types 1 and##10##3##(1992-12#1)(1992-4#1)(1992-8#1)(1997-4#3)(2007-12#1)(2008-7#2)(2013-8#1)
types 1##12##2##(1992-12#1)(1992-4#1)(1992-8#1)(1997-4#3)(2007-12#2)(2008-4#1)(2008-7#2)(2013-8#1)
types 16##2##2##(1993-9#1)(2010-7#1)
types 2 and 3##2##4##(2007-11#1)(2013-1#1)
types 2 and##3##3##(2007-11#1)(2008-4#1)(2013-1#1)
types 6 and 11##2##4##(1993-9#1)(1997-4#1)
types 6##3##2##(1993-9#2)(1997-4#1)
types I and II##8##4##(1990-11#1)(1991-12#1)(1995-1#1)(2006-12#1)(2007-2#1)(2008-2#1)(2008-9#1)(2011-2#1)
types I and III##5##4##(1994-9#1)(2007-2#1)(2008-11#1)(2008-7#2)
types I and IV##2##4##(1990-12#1)(1994-12#1)
types I and##16##3##(1990-11#1)(1990-12#1)(1991-12#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-1#1)(2006-12#1)(2007-2#2)(2008-11#1)(2008-2#1)(2008-7#2)(2008-9#1)(2011-2#1)
types I##20##2##(1990-10#1)(1990-11#1)(1990-12#1)(1991-12#1)(1992-11#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-10#1)(2006-12#1)(2007-2#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#1)
types II and##2##3##(1991-4#1)(2010-8#1)
types IIA##2##2##(2012-2#2)
types IV and VII collagens##2##5##(2008-5#2)
types IV and##3##3##(1990-12#1)(2008-5#2)
types after##3##2##(1990-11#1)(2008-11#1)(2008-5#1)
types also##2##2##(1991-5#1)(1995-2#1)
types among##4##2##(1990-12#1)(1990-4#1)(2007-2#1)(2008-10#1)
types and amounts of##3##4##(1992-3#2)(2008-5#1)
types and can##2##3##(2008-3#1)(2008-4#1)
types and degrees of##2##4##(2007-7#1)(2008-2#1)
types and different##2##3##(2008-3#1)(2010-7#1)
types and its##3##3##(2008-4#2)(2011-12#1)
types and least amount of eluent##2##6##(2008-10#2)
types and levels of##2##4##(1997-3#1)(2008-10#1)
types and present##2##3##(2006-3#1)(2008-5#1)
types and six VCGs##3##4##(2008-10#3)
types and sizes of##2##4##(2009-1#1)(2010-8#1)
types and sizes##3##3##(2009-1#1)(2010-8#2)
types and##106##2##(1990-5#1)(1991-1#1)(1992-3#3)(1992-8#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-3#2)(1997-3#1)(1997-6#1)(2004-12#1)(2004-4#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-11#1)(2006-3#2)(2006-5#1)(2006-7#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#2)(2008-10#14)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#4)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-3#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#7)
types are considered##2##3##(2008-2#1)(2008-3#1)
types are found##2##3##(2008-7#1)(2013-1#1)
types are present##2##3##(1992-7#1)(2007-12#1)
types are the##2##3##(2010-8#1)(2013-1#1)
types are##39##2##(1992-3#1)(1992-7#1)(1994-1#1)(1994-12#1)(1995-9#1)(1997-6#1)(2007-12#7)(2007-8#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-6#1)(2009-7#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)
types as well##3##3##(1990-5#1)(2005-12#1)(2008-6#1)
types as##5##2##(1990-5#1)(2005-12#1)(2006-7#1)(2008-6#1)(2009-9#1)
types at##4##2##(1995-12#1)(2007-9#1)(2008-12#1)(2010-4#1)
types based on the##2##4##(1990-3#1)(2007-10#1)
types based on their##3##4##(1993-2#1)(1997-4#1)(2006-12#1)
types based on##9##3##(1990-3#1)(1993-2#1)(1997-4#1)(2006-12#2)(2007-10#2)(2008-10#2)
types being##2##2##(2008-2#1)(2008-4#1)
types but##3##2##(2008-4#1)(2008-5#1)(2008-6#1)
types by##7##2##(1991-5#1)(1997-1#1)(2007-10#1)(2008-10#1)(2008-3#1)(2009-2#1)(2010-4#1)
types can be##9##3##(1995-11#1)(1996-9#1)(2006-6#1)(2008-10#1)(2008-4#1)(2010-12#1)(2011-2#1)(2013-1#2)
types can##14##2##(1994-9#1)(1995-11#1)(1996-9#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-4#2)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
types containing##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
types detected##4##2##(2008-10#1)(2008-2#1)(2013-1#2)
types did not##3##3##(2008-10#2)(2011-2#1)
types exist##2##2##(2008-7#1)(2008-9#1)
types expressed##3##2##(2008-4#2)(2008-8#1)
types for##11##2##(1993-2#1)(1997-8#1)(2004-4#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2012-3#1)
types found in the##2##4##(2008-1#1)(2008-10#1)
types found in##4##3##(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#1)
types from##7##2##(2005-8#1)(2008-10#2)(2008-4#1)(2009-3#2)(2013-1#1)
types had the##2##3##(1993-4#1)(2013-8#1)
types had##3##2##(1991-7#1)(1993-4#1)(2013-8#1)
types have been##8##3##(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
types have##15##2##(1992-11#1)(1992-12#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-9#1)(2011-1#1)(2012-12#3)(2012-3#1)(2013-7#1)
types in a##5##3##(1993-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2011-2#1)
types in both##3##3##(1996-6#1)(2007-12#1)(2008-4#1)
types in populations of C##2##5##(2008-10#2)
types in the##19##3##(1993-2#1)(1994-11#1)(1996-11#1)(1997-6#1)(2005-4#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-8#2)(2010-11#1)(2012-12#1)(2013-1#2)
types in##75##2##(1990-11#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1996-11#2)(1996-6#1)(1996-9#1)(1997-4#1)(1997-6#1)(2004-11#1)(2005-4#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-5#1)(2008-1#2)(2008-10#8)(2008-11#3)(2008-2#4)(2008-3#2)(2008-4#5)(2008-5#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-4#1)(2009-8#3)(2010-11#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-5#1)(2013-1#3)(2013-7#1)(2013-8#3)
types including melanoma##2##3##(2009-3#1)(2010-7#1)
types including the##2##3##(1991-2#1)(2008-7#1)
types including##12##2##(1991-2#1)(1996-1#1)(2008-1#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-5#1)(2010-7#1)(2012-3#1)
types involved in##2##3##(2008-10#1)(2008-5#1)
types is the##3##3##(1990-5#1)(1991-2#1)(2012-2#1)
types is unknown##2##3##(2008-1#1)(2012-12#1)
types is##16##2##(1990-12#1)(1990-5#1)(1991-2#1)(1992-6#1)(2007-12#2)(2008-1#1)(2008-11#2)(2008-7#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
types known##2##2##(2008-4#1)(2012-2#1)
types may be##2##3##(2007-11#1)(2010-4#1)
types may##5##2##(2007-11#1)(2007-9#1)(2008-7#1)(2010-4#1)(2012-9#1)
types most##2##2##(1991-11#1)(1997-2#1)
types occurred at##2##3##(1991-5#1)(2008-10#1)
types occurred##4##2##(1991-5#1)(2008-10#2)(2009-5#1)
types of &quot##4##3##(1996-7#1)(2006-9#1)(2008-10#1)(2011-1#1)
types of CWP##3##3##(2008-10#3)
types of DNA damage in##2##5##(1993-7#1)(2010-2#1)
types of DNA damage##4##4##(1993-7#1)(1994-3#1)(1994-5#1)(2010-2#1)
types of DNA##5##3##(1993-7#1)(1994-3#1)(1994-5#1)(2007-3#1)(2010-2#1)
types of FGFR can##2##4##(1992-2#2)
types of G proteins##2##4##(1990-3#1)(2008-4#1)
types of HPV##2##3##(2010-12#1)(2012-12#1)
types of Haemophilus influenzae##2##4##(2009-5#2)
types of K(+)##2##3##(2008-8#1)(2009-12#1)
types of NF1-GRD##3##3##(1992-8#3)
types of PCNA##2##3##(1996-11#2)
types of RNA##3##3##(1994-11#1)(1997-2#1)(2006-10#1)
types of SPME fiber##2##4##(2008-10#1)(2009-8#1)
types of accidents and##2##4##(1990-6#1)(2011-2#1)
types of actions##2##3##(1991-1#1)(2012-2#1)
types of active##2##3##(1994-10#1)(2010-7#1)
types of activities##2##3##(1991-1#1)(2007-6#1)
types of alcoholic beverages##3##4##(2008-10#2)(2013-1#1)
types of alterations##2##3##(1996-10#1)(2008-11#1)
types of alternative##2##3##(1991-1#1)(2008-8#1)
types of antibiotics##2##3##(2011-2#1)(2012-12#1)
types of approaches##2##3##(1993-6#1)(2007-5#1)
types of arrhythmias##2##3##(1990-11#1)(2010-12#1)
types of artificial##3##3##(1990-12#1)(2006-6#1)(2008-10#1)
types of assays##2##3##(2008-4#1)(2009-3#1)
types of bacteria##3##3##(2008-4#1)(2008-5#1)(2012-12#1)
types of behavioral##4##3##(1991-1#1)(2007-12#1)(2010-6#1)(2011-2#1)
types of benign##3##3##(2007-9#1)(2008-3#1)(2010-12#1)
types of binding sites##6##4##(1990-12#1)(1992-3#2)(1995-5#1)(2008-10#1)(2008-5#1)
types of bonded##2##3##(1997-8#1)(2008-10#1)
types of bone##2##3##(2008-4#1)(2009-4#1)
types of boundary##2##3##(2005-11#1)(2009-10#1)
types of brain##3##3##(1995-5#1)(2013-1#2)
types of calcium##2##3##(1995-8#1)(1996-9#1)
types of cancer and##3##4##(1992-9#1)(2008-7#1)(2010-4#1)
types of cancer in##2##4##(2008-1#1)(2010-10#1)
types of cancer##33##3##(1990-8#1)(1992-8#1)(1992-9#1)(1993-12#1)(1995-1#1)(1995-5#1)(1997-2#1)(1997-7#1)(2006-8#1)(2007-11#2)(2008-1#2)(2008-11#1)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
types of cancers##11##3##(1994-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2011-1#2)(2011-2#2)(2012-2#1)
types of carbon##3##3##(2008-10#1)(2008-3#1)(2013-8#1)
types of carcinoma cells##2##4##(1991-10#1)(1992-8#1)
types of carcinoma##4##3##(1991-10#1)(1992-8#1)(1994-3#1)(2009-5#1)
types of carcinomas##3##3##(1990-5#1)(1994-12#1)(2012-3#1)
types of cargo##2##3##(2008-7#1)(2011-12#1)
types of catechol##2##3##(1993-11#2)
types of cationic amphiphiles##2##4##(1990-3#1)(2008-11#1)
types of cationic##3##3##(1990-3#2)(2008-11#1)
types of cell##2##3##(1993-8#1)(1994-8#1)
types of cells are##3##4##(1996-3#1)(2007-12#1)(2008-2#1)
types of cells##36##3##(1990-3#1)(1991-3#1)(1991-9#1)(1993-1#2)(1993-12#1)(1993-3#1)(1993-7#1)(1993-8#1)(1995-3#1)(1996-3#1)(1997-1#1)(1997-5#1)(1997-8#1)(2005-1#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#5)(2008-7#1)(2008-8#1)(2008-9#2)(2010-3#1)(2010-9#1)(2012-1#1)(2012-11#2)
types of cellular##3##3##(1994-3#1)(2007-12#1)(2010-3#1)
types of chronic##3##3##(2006-10#1)(2010-7#1)(2012-12#1)
types of clinical##3##3##(1994-8#1)(2013-1#2)
types of cochlear##2##3##(1996-3#1)(2008-9#1)
types of commercial##5##3##(2008-10#3)(2008-3#1)(2008-5#1)
types of common##2##3##(1996-4#1)(2010-5#1)
types of complex##3##3##(2007-9#1)(2008-10#1)(2008-5#1)
types of complexes with##2##4##(1992-12#1)(1995-1#1)
types of complications##2##3##(1990-4#1)(2007-11#1)
types of compound##2##3##(1993-12#1)(2010-8#1)
types of constrictive pericarditis##2##4##(2012-1#2)
types of coping strategies##3##4##(1994-12#2)(2008-1#1)
types of correlation filter##2##4##(2007-12#1)(2008-3#1)
types of corruption##2##3##(2006-5#1)(2012-3#1)
types of damage##5##3##(1990-8#1)(2006-6#1)(2007-12#2)(2008-3#1)
types of data##11##3##(1997-8#1)(2007-7#1)(2008-1#2)(2008-11#2)(2008-4#2)(2008-7#1)(2009-9#1)(2011-2#1)
types of defect##2##3##(2007-12#1)(2008-3#1)
types of degenerative changes##2##4##(1997-3#1)(2012-12#1)
types of depression##4##3##(2010-12#1)(2011-2#3)
types of diabetes##4##3##(1995-5#1)(2008-1#1)(2013-1#2)
types of disease##6##3##(1992-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-12#1)
types of diseases##3##3##(2008-4#1)(2012-11#2)
types of disorders##2##3##(2005-7#1)(2008-4#1)
types of drug##3##3##(1991-12#1)(1991-7#1)(2013-8#1)
types of drugs##2##3##(1990-6#1)(1996-3#1)
types of electrode##2##3##(2008-10#2)
types of electrodes##2##3##(2008-10#2)
types of environmental##3##3##(2008-10#1)(2011-1#1)(2013-1#1)
types of error##2##3##(2008-3#2)
types of errors and##2##4##(2008-11#1)(2011-2#1)
types of errors##5##3##(2006-6#1)(2008-11#1)(2011-2#1)(2013-1#2)
types of evidence##2##3##(2008-10#1)(2008-7#1)
types of experimental##4##3##(1993-3#1)(1996-8#1)(2006-10#1)(2012-2#1)
types of experiments##6##3##(1990-3#1)(1996-11#1)(2006-5#1)(2008-4#1)(2008-7#1)(2009-11#1)
types of exposure to terror##2##5##(2009-7#2)
types of exposure to##3##4##(2009-7#3)
types of exposure##5##3##(2008-5#1)(2009-7#4)
types of facets##3##3##(2006-4#3)
types of factor##2##3##(2005-7#1)(2008-3#1)
types of factors##3##3##(2009-4#1)(2012-1#2)
types of fibers##3##3##(2008-10#2)(2010-8#1)
types of fixation##3##3##(2013-1#1)(2013-8#2)
types of fluorescence##2##3##(1994-5#2)
types of food##4##3##(1991-11#2)(2008-11#1)(2008-6#1)
types of fractures##3##3##(2007-8#1)(2013-8#2)
types of friends were##2##4##(2009-7#2)
types of friends##3##3##(2009-7#3)
types of functional##2##3##(1991-9#1)(1993-3#1)
types of gas media##2##4##(2008-10#2)
types of gastric cancer##2##4##(2008-7#1)(2009-3#1)
types of gastric##4##3##(1993-4#1)(1997-1#1)(2008-7#1)(2009-3#1)
types of genes##2##3##(1994-3#1)(1995-11#1)
types of genetic##3##3##(1996-11#1)(2008-10#1)(2011-3#1)
types of gingival##2##3##(2010-4#1)(2013-1#1)
types of glands##2##3##(2007-12#2)
types of glass##2##3##(2008-2#1)(2008-3#1)
types of glucose##3##3##(1997-4#1)(2012-11#2)
types of grating##3##3##(2007-11#1)(2008-2#2)
types of grey cast iron##2##5##(2008-10#2)
types of headache##2##3##(1994-9#1)(2008-5#1)
types of health##4##3##(1990-12#1)(1994-12#1)(1996-1#1)(1996-2#1)
types of hemocytes##2##3##(2008-5#2)
types of hip##3##3##(2007-7#2)(2012-2#1)
types of honey##2##3##(2008-10#2)
types of hospitals##2##3##(1990-6#1)(1992-12#1)
types of human adenovirus have been##2##6##(2013-8#2)
types of human adenovirus##4##4##(2013-8#4)
types of human cancer##2##4##(2008-4#1)(2013-1#1)
types of human papillomavirus (HPV)##2##5##(2011-2#1)(2012-2#1)
types of human##12##3##(1991-10#1)(2008-4#1)(2008-9#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#5)
types of hydrogen bonding##2##4##(2005-11#1)(2010-7#1)
types of hydrogen##3##3##(2005-11#1)(2008-10#1)(2010-7#1)
types of imaging##2##3##(2007-4#1)(2009-9#1)
types of in vitro##3##4##(1995-12#1)(2008-10#1)(2008-5#1)
types of incompatibility##3##3##(2005-10#3)
types of infection##2##3##(2007-12#1)(2013-1#1)
types of infections##2##3##(1990-12#1)(2007-11#1)
types of infectious##2##3##(2007-11#1)(2012-1#1)
types of inflammation##2##3##(2006-9#1)(2011-2#1)
types of inflammatory##2##3##(2006-10#1)(2012-3#1)
types of influenza##2##3##(2007-8#1)(2011-2#1)
types of information are##2##4##(1991-5#1)(1997-7#1)
types of information##7##3##(1991-5#1)(1997-1#1)(1997-7#2)(2008-4#3)
types of inhibitor##2##3##(1995-6#2)
types of injuries##4##3##(1997-2#1)(2007-12#1)(2008-6#1)(2013-1#1)
types of injury##2##3##(2012-2#2)
types of insults##2##3##(2008-9#2)
types of interactions##6##3##(2005-11#1)(2007-10#1)(2008-4#2)(2008-8#1)(2011-1#1)
types of internal modulation##2##4##(2008-1#2)
types of interventions were##2##4##(2006-8#1)(2012-12#1)
types of interventions##6##3##(2006-4#1)(2006-8#1)(2012-12#2)(2013-1#1)(2013-7#1)
types of invasive##3##3##(1996-11#1)(2013-1#2)
types of iron##2##3##(1991-11#1)(2010-4#1)
types of isoflavones##2##3##(2010-3#2)
types of job##2##3##(1994-6#1)(2008-2#1)
types of junctions##3##3##(2008-7#1)(2009-10#2)
types of kenkey##3##3##(1997-4#3)
types of learning and memory##2##5##(1995-4#1)(2008-1#1)
types of lesion##3##3##(1996-9#2)(2008-6#1)
types of lesions##4##3##(1992-6#1)(2007-12#1)(2007-8#1)(2008-6#1)
types of lung cancer##5##4##(1990-12#1)(1991-10#1)(1996-9#2)(2006-12#1)
types of malignancies##2##3##(2008-7#1)(2009-3#1)
types of malignancy##2##3##(1991-10#1)(1992-10#1)
types of malignant##2##3##(2008-4#1)(2009-5#1)
types of maltreatment##4##3##(2008-9#4)
types of managed care plans##2##5##(1994-1#1)(1995-12#1)
types of managed care##3##4##(1994-1#1)(1995-12#1)(1997-2#1)
types of mass##2##3##(2006-5#1)(2008-4#1)
types of materials##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
types of matrices##3##3##(2008-10#1)(2008-11#2)
types of measurement##3##3##(1991-4#1)(2008-2#1)(2008-3#1)
types of measurements##4##3##(1995-3#1)(2008-10#2)(2008-5#1)
types of measures##2##3##(2012-12#1)(2013-7#1)
types of meat##2##3##(1991-5#1)(2008-10#1)
types of medical##7##3##(1993-1#1)(1995-10#1)(1995-3#1)(1997-1#1)(1997-3#1)(2007-4#1)(2008-1#1)
types of medication##2##3##(2005-7#1)(2011-2#1)
types of membranes##2##3##(2006-10#1)(2008-10#1)
types of mental##2##3##(2011-2#1)(2013-1#1)
types of messages##2##3##(2007-12#1)(2008-3#1)
types of microbes##5##3##(2011-2#1)(2012-12#2)(2012-2#2)
types of microorganisms##2##3##(2007-2#1)(2008-5#1)
types of models##2##3##(2008-10#1)(2010-1#1)
types of molecular##4##3##(1993-7#1)(2008-5#1)(2008-9#1)(2013-7#1)
types of molecules##3##3##(1994-9#1)(1996-4#1)(2008-10#1)
types of monitoring##2##3##(2008-10#1)(2010-8#1)
types of motion##3##3##(2008-2#1)(2008-9#2)
types of motivation##3##3##(1993-6#1)(2013-1#2)
types of multiple##3##3##(1991-12#1)(2012-3#1)(2013-7#1)
types of muscle##2##3##(2008-6#1)(2013-1#1)
types of music##2##3##(2007-6#1)(2008-9#1)
types of nanoparticles##4##3##(2007-8#3)(2009-3#1)
types of natural##3##3##(1991-2#1)(2008-10#1)(2008-5#1)
types of nerve##3##3##(1991-9#1)(1994-5#1)(1995-11#1)
types of neurones##2##3##(1991-2#1)(1995-11#1)
types of neurons were##2##4##(1993-2#1)(2013-7#1)
types of neurons##12##3##(1990-2#2)(1993-2#1)(1995-11#1)(1995-9#1)(1997-2#1)(2007-10#1)(2008-11#2)(2009-8#2)(2013-7#1)
types of non-covalent##2##3##(2006-10#1)(2007-8#1)
types of objectives##2##3##(2008-9#2)
types of oligosaccharides##4##3##(1990-10#2)(1993-8#1)(1994-8#1)
types of operations##2##3##(1990-12#1)(2008-9#1)
types of opioid receptors##3##4##(1990-7#1)(1995-11#1)(2010-12#1)
types of optical##7##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)
types of organelles##2##3##(2008-4#1)(2009-10#1)
types of organisms##2##3##(2008-7#2)
types of pain##10##3##(1996-7#1)(2004-12#1)(2006-6#1)(2007-12#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)
types of particle##2##3##(2008-10#1)(2008-3#1)
types of partners##2##3##(2012-3#2)
types of passive avoidance##2##4##(1991-4#1)(1994-5#1)
types of passive##3##3##(1991-4#1)(1994-5#1)(2008-11#1)
types of patients##5##3##(2005-6#1)(2006-1#1)(2006-5#1)(2008-8#1)(2009-6#1)
types of peptides##3##3##(1990-12#1)(1997-2#2)
types of play##2##3##(1993-12#2)
types of plywood##2##3##(2008-7#2)
types of porouscarriers##2##3##(2008-11#2)
types of possible##3##3##(2007-9#1)(2012-11#2)
types of potassium channels##2##4##(2007-12#1)(2010-12#1)
types of potassium##3##3##(2007-12#1)(2008-8#1)(2010-12#1)
types of procedures##4##3##(1995-2#1)(2008-4#1)(2009-5#1)(2009-8#1)
types of progenitor cells##2##4##(2008-9#2)
types of projects##2##3##(1995-6#1)(2012-3#1)
types of prostatitis##2##3##(2008-10#1)(2008-6#1)
types of protein interaction##2##4##(2008-7#2)
types of protein##3##3##(1990-6#1)(2008-7#2)
types of proteins##2##3##(2007-6#1)(2008-4#1)
types of pulmonary##2##3##(1990-7#1)(2006-10#1)
types of questions##2##3##(2007-3#1)(2008-4#1)
types of raw materials##2##4##(2008-10#2)
types of reactions##2##3##(2008-10#2)
types of reactors##2##3##(2008-10#2)
types of receptors##11##3##(1990-11#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-11#1)(1996-4#1)(1997-1#1)(2007-11#1)(2008-4#3)
types of recombinant##2##3##(1992-11#1)(2013-1#1)
types of recommendations##2##3##(2010-9#1)(2012-3#1)
types of regression##2##3##(1992-9#1)(2008-10#1)
types of relationships##5##3##(1993-1#1)(2008-7#1)(2008-8#1)(2013-1#2)
types of research##2##3##(2010-1#1)(2010-2#1)
types of resistance##3##3##(2008-10#3)
types of retinal##2##3##(1993-12#1)(2009-4#1)
types of risk##2##3##(1992-12#1)(2005-5#1)
types of roles##2##3##(1990-12#1)(2007-9#1)
types of sample##2##3##(2008-3#1)(2008-9#1)
types of samples##5##3##(2008-10#3)(2011-1#1)(2012-2#1)
types of sarcomas##3##3##(2008-6#3)
types of sensilla##3##3##(2007-12#3)
types of sequence##2##3##(1996-11#1)(1996-7#1)
types of services##4##3##(1994-2#1)(1996-3#1)(2008-2#1)(2012-11#1)
types of silicon photodiode at oblique incidence##2##7##(2008-3#2)
types of single##2##3##(2008-3#2)
types of skin##4##3##(2006-12#1)(2007-8#1)(2008-12#1)(2008-5#1)
types of soils##2##3##(2008-10#2)
types of solid##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
types of sounds##2##3##(2010-8#1)(2011-1#1)
types of spores##2##3##(2008-10#1)(2008-8#1)
types of standards##2##3##(2004-12#2)
types of stem cells##2##4##(2006-10#1)(2008-5#1)
types of stimuli##3##3##(2012-1#1)(2012-2#1)(2013-8#1)
types of stress##6##3##(1992-12#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)
types of stressors##2##3##(1990-5#1)(2012-2#1)
types of studies##7##3##(2008-4#1)(2009-5#3)(2010-4#1)(2010-9#1)(2012-3#1)
types of study##3##3##(2008-11#1)(2011-2#1)(2012-2#1)
types of subunits##2##3##(1990-12#1)(1990-3#1)
types of sugars##2##3##(2008-5#1)(2011-2#1)
types of suicide##2##3##(1991-10#1)(2013-7#1)
types of surgery##3##3##(1991-3#1)(1994-12#1)(2007-7#1)
types of surgical##4##3##(1991-3#1)(2008-4#1)(2010-2#1)(2011-1#1)
types of synaptic##3##3##(1994-10#1)(1997-3#1)(2008-11#1)
types of technical change##2##4##(1992-1#2)
types of the disease##2##4##(2007-11#1)(2007-7#1)
types of the mutations specific for the disease##2##8##(1991-4#1)(1991-5#1)
types of the##25##3##(1990-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1995-10#1)(1996-9#2)(2004-9#1)(2005-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-4#1)(2012-12#1)
types of therapy##2##3##(1994-12#1)(1995-10#1)
types of these##2##3##(2008-10#1)(2010-10#1)
types of thymomas##2##3##(2007-8#1)(2008-7#1)
types of thyroid cancer##2##4##(1990-3#1)(1995-5#1)
types of tissue##2##3##(2006-10#1)(2008-6#1)
types of tobacco##3##3##(2005-10#1)(2008-10#2)
types of training##2##3##(1993-9#1)(1997-5#1)
types of traumatic##2##3##(2007-7#1)(2008-9#1)
types of treatment##4##3##(1991-10#1)(2008-8#1)(2008-9#1)(2009-12#1)
types of treatments##2##3##(2008-5#1)(2009-6#1)
types of trematode##2##3##(2011-1#2)
types of tumor##3##3##(1995-8#1)(1997-7#1)(2010-9#1)
types of tumors##7##3##(1995-3#1)(2008-11#3)(2008-7#1)(2010-2#1)(2011-2#1)
types of urine in the glove box##2##7##(2004-11#2)
types of urine##3##3##(2004-11#3)
types of vaccine##2##3##(2007-11#2)
types of vascular access##2##4##(2007-7#2)
types of vascular##3##3##(2007-7#3)
types of vegetables##2##3##(1991-5#1)(2008-10#1)
types of vibration##2##3##(2008-3#2)
types of water##5##3##(2006-2#1)(2008-1#1)(2008-10#2)(2008-2#1)
types of wounds##2##3##(2008-11#1)(2008-9#1)
types of wrinkles##4##3##(2008-5#4)
types of##1929##2##(1990-10#3)(1990-11#3)(1990-12#17)(1990-2#5)(1990-3#7)(1990-4#2)(1990-5#6)(1990-6#6)(1990-7#3)(1990-8#3)(1990-9#3)(1991-1#7)(1991-10#7)(1991-11#7)(1991-12#10)(1991-2#6)(1991-3#5)(1991-4#6)(1991-5#6)(1991-6#1)(1991-7#7)(1991-8#1)(1991-9#10)(1992-1#3)(1992-10#1)(1992-11#3)(1992-12#10)(1992-2#6)(1992-3#10)(1992-4#1)(1992-5#1)(1992-6#5)(1992-7#2)(1992-8#8)(1992-9#3)(1993-1#6)(1993-11#10)(1993-12#13)(1993-2#6)(1993-3#9)(1993-4#4)(1993-5#3)(1993-6#5)(1993-7#6)(1993-8#8)(1993-9#6)(1994-1#1)(1994-10#3)(1994-11#4)(1994-12#13)(1994-2#9)(1994-3#13)(1994-5#5)(1994-6#1)(1994-7#1)(1994-8#7)(1994-9#6)(1995-1#7)(1995-10#5)(1995-11#8)(1995-12#6)(1995-2#3)(1995-3#10)(1995-4#5)(1995-5#7)(1995-6#6)(1995-7#1)(1995-8#5)(1995-9#1)(1996-1#1)(1996-10#3)(1996-11#9)(1996-12#4)(1996-2#10)(1996-3#6)(1996-4#7)(1996-5#2)(1996-6#3)(1996-7#5)(1996-8#2)(1996-9#8)(1997-1#7)(1997-2#14)(1997-3#7)(1997-4#8)(1997-5#6)(1997-6#3)(1997-7#10)(1997-8#6)(2003-11#1)(2004-11#4)(2004-12#3)(2004-3#1)(2004-4#1)(2004-9#3)(2005-1#1)(2005-10#6)(2005-11#18)(2005-12#1)(2005-4#3)(2005-5#1)(2005-6#1)(2005-7#5)(2005-8#7)(2005-9#1)(2006-1#2)(2006-10#25)(2006-11#3)(2006-12#12)(2006-2#5)(2006-3#1)(2006-4#6)(2006-5#12)(2006-6#10)(2006-7#3)(2006-8#16)(2006-9#3)(2007-1#6)(2007-10#7)(2007-11#27)(2007-12#55)(2007-2#4)(2007-3#5)(2007-4#8)(2007-5#3)(2007-6#4)(2007-7#20)(2007-8#22)(2007-9#11)(2008-1#23)(2008-10#154)(2008-11#49)(2008-12#11)(2008-2#49)(2008-3#59)(2008-4#53)(2008-5#59)(2008-6#18)(2008-7#53)(2008-8#31)(2008-9#41)(2009-1#2)(2009-10#17)(2009-11#1)(2009-12#6)(2009-2#4)(2009-3#10)(2009-4#15)(2009-5#11)(2009-6#8)(2009-7#15)(2009-8#7)(2009-9#8)(2010-1#7)(2010-10#6)(2010-11#2)(2010-12#15)(2010-2#6)(2010-3#6)(2010-4#10)(2010-5#7)(2010-6#2)(2010-7#3)(2010-8#16)(2010-9#12)(2011-1#22)(2011-12#5)(2011-2#50)(2011-3#2)(2011-7#1)(2012-1#18)(2012-11#12)(2012-12#27)(2012-2#30)(2012-3#21)(2012-8#1)(2012-9#1)(2013-1#69)(2013-7#14)(2013-8#25)
types on##3##2##(2006-9#1)(2008-5#1)(2013-8#1)
types or##5##2##(2006-12#1)(2008-4#1)(2010-11#1)(2010-2#1)(2011-1#1)
types present##2##2##(1991-9#1)(2005-11#1)
types seem to##2##3##(1992-9#1)(1996-6#1)
types show##3##2##(2007-10#2)(2008-10#1)
types showed##4##2##(1990-12#1)(2008-10#1)(2011-2#1)(2012-3#1)
types showing##2##2##(1990-3#1)(1993-2#1)
types such as the##3##4##(2008-1#1)(2008-10#1)(2009-9#1)
types such as##11##3##(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-4#1)(2009-9#1)(2012-2#1)(2012-3#1)(2013-1#2)
types suggests that##2##3##(2012-2#1)(2013-1#1)
types tested##4##2##(1991-5#1)(1993-7#1)(1997-1#1)(2009-2#1)
types than the##2##3##(2007-9#1)(2008-10#1)
types than##4##2##(1994-5#1)(2006-12#1)(2007-9#1)(2008-10#1)
types that are##4##3##(1993-11#1)(2008-1#1)(2008-10#1)(2011-2#1)
types that can be##2##4##(2006-12#1)(2008-9#1)
types that have##2##3##(2008-1#1)(2011-1#1)
types that were##2##3##(2008-10#2)
types that##16##2##(1993-11#1)(1995-3#1)(1996-1#1)(2006-12#1)(2007-11#2)(2008-1#2)(2008-10#5)(2008-9#1)(2011-1#1)(2011-2#1)
types to the##2##3##(1997-8#1)(2008-10#1)
types to##10##2##(1993-7#1)(1995-3#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2012-2#1)
types under##2##2##(2008-8#1)(2009-3#1)
types used in##2##3##(2005-9#1)(2008-9#1)
types used##5##2##(2005-9#1)(2008-11#2)(2008-9#1)(2012-2#1)
types using##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
types was found##2##3##(1994-12#1)(2010-6#1)
types was##15##2##(1990-2#1)(1991-9#1)(1994-12#1)(1997-3#1)(2006-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-12#1)(2013-1#1)
types were associated with##2##4##(1991-5#1)(2012-3#1)
types were detected##3##3##(1992-9#1)(2008-10#2)
types were determined##2##3##(2008-5#2)
types were found##5##3##(1991-5#1)(1992-4#1)(1995-6#1)(2008-10#2)
types were identified##3##3##(2007-2#1)(2007-3#1)(2013-1#1)
types were observed##2##3##(1992-6#1)(2011-2#1)
types were obtained##2##3##(1997-3#1)(2008-6#1)
types were present in##2##4##(2008-10#2)
types were used for##2##4##(2012-2#1)(2013-1#1)
types were used##4##3##(1993-8#1)(2008-3#1)(2012-2#1)(2013-1#1)
types were##56##2##(1990-4#1)(1990-6#1)(1991-2#1)(1991-5#4)(1991-8#1)(1991-9#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-5#1)(1995-6#1)(1997-2#1)(1997-3#1)(2004-1#1)(2005-10#1)(2007-2#1)(2007-3#1)(2008-10#14)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
types when the##2##3##(1991-12#1)(2008-6#1)
types when##4##2##(1991-12#1)(1993-5#1)(2004-11#1)(2008-6#1)
types which are##2##3##(2008-3#1)(2011-12#1)
types which##5##2##(1994-3#1)(2006-5#1)(2008-3#1)(2008-5#1)(2011-12#1)
types with different##2##3##(1992-9#1)(2007-8#1)
types with high##2##3##(2008-10#1)(2008-8#1)
types with the##2##3##(1994-1#1)(2013-8#1)
types with##19##2##(1991-10#1)(1992-9#1)(1994-1#1)(2004-2#1)(2006-11#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
types within a##2##3##(1994-9#1)(2008-11#1)
types within##4##2##(1993-2#1)(1994-9#1)(2008-11#1)(2008-4#1)
types##3188##1##(1990-10#6)(1990-11#8)(1990-12#29)(1990-2#9)(1990-3#13)(1990-4#7)(1990-5#10)(1990-6#9)(1990-7#4)(1990-8#5)(1990-9#3)(1991-1#11)(1991-10#9)(1991-11#11)(1991-12#15)(1991-2#15)(1991-3#5)(1991-4#7)(1991-5#18)(1991-6#4)(1991-7#9)(1991-8#3)(1991-9#20)(1992-1#7)(1992-10#2)(1992-11#7)(1992-12#14)(1992-2#6)(1992-3#15)(1992-4#6)(1992-5#2)(1992-6#11)(1992-7#3)(1992-8#12)(1992-9#10)(1993-1#6)(1993-11#14)(1993-12#18)(1993-2#12)(1993-3#14)(1993-4#7)(1993-5#8)(1993-6#9)(1993-7#9)(1993-8#11)(1993-9#14)(1994-1#4)(1994-10#5)(1994-11#7)(1994-12#21)(1994-2#12)(1994-3#17)(1994-5#10)(1994-6#2)(1994-7#1)(1994-8#10)(1994-9#11)(1995-1#11)(1995-10#9)(1995-11#10)(1995-12#10)(1995-2#6)(1995-3#24)(1995-4#5)(1995-5#11)(1995-6#8)(1995-7#1)(1995-8#6)(1995-9#3)(1996-1#3)(1996-10#5)(1996-11#14)(1996-12#7)(1996-2#13)(1996-3#6)(1996-4#7)(1996-5#4)(1996-6#11)(1996-7#5)(1996-8#3)(1996-9#12)(1997-1#11)(1997-2#21)(1997-3#10)(1997-4#24)(1997-5#6)(1997-6#13)(1997-7#16)(1997-8#10)(2003-11#1)(2004-1#1)(2004-11#9)(2004-12#5)(2004-2#2)(2004-3#1)(2004-4#3)(2004-9#4)(2005-1#1)(2005-10#10)(2005-11#24)(2005-12#2)(2005-4#4)(2005-5#2)(2005-6#1)(2005-7#5)(2005-8#13)(2005-9#2)(2006-1#2)(2006-10#35)(2006-11#10)(2006-12#21)(2006-2#6)(2006-3#3)(2006-4#7)(2006-5#15)(2006-6#14)(2006-7#9)(2006-8#19)(2006-9#4)(2007-1#6)(2007-10#14)(2007-11#39)(2007-12#88)(2007-2#11)(2007-3#7)(2007-4#10)(2007-5#6)(2007-6#5)(2007-7#30)(2007-8#33)(2007-9#19)(2008-1#37)(2008-10#271)(2008-11#95)(2008-12#17)(2008-2#76)(2008-3#84)(2008-4#101)(2008-5#109)(2008-6#28)(2008-7#87)(2008-8#54)(2008-9#62)(2009-1#3)(2009-10#22)(2009-11#1)(2009-12#12)(2009-2#6)(2009-3#19)(2009-4#21)(2009-5#13)(2009-6#13)(2009-7#17)(2009-8#17)(2009-9#14)(2010-1#7)(2010-10#8)(2010-11#8)(2010-12#22)(2010-2#15)(2010-3#7)(2010-4#21)(2010-5#12)(2010-6#5)(2010-7#9)(2010-8#22)(2010-9#16)(2011-1#38)(2011-12#10)(2011-2#82)(2011-3#3)(2011-7#1)(2012-1#20)(2012-11#15)(2012-12#54)(2012-2#62)(2012-3#34)(2012-4#1)(2012-5#2)(2012-8#1)(2012-9#2)(2013-1#110)(2013-7#21)(2013-8#46)
types&quot##2##1##(1992-8#1)(2010-4#1)
types) and##4##2##(1991-2#1)(2005-4#1)(2008-12#1)(2011-2#1)
types)##11##1##(1991-1#1)(1991-2#1)(2005-4#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
typhi and##3##2##(2007-7#1)(2008-8#1)(2012-2#1)
typhi in##3##2##(1997-6#1)(2007-7#1)(2007-8#1)
typhi infection##2##2##(2008-8#2)
typhi is##2##2##(1990-6#1)(2007-7#1)
typhi##32##1##(1990-12#2)(1990-6#3)(1991-5#1)(1997-6#2)(2007-2#1)(2007-3#1)(2007-7#7)(2007-8#3)(2008-2#1)(2008-5#2)(2008-8#4)(2010-12#1)(2010-2#1)(2010-4#1)(2012-2#1)(2013-7#1)
typhimurium ATCC##2##2##(2008-5#1)(2012-2#1)
typhimurium and##4##2##(1990-6#1)(1994-5#1)(1997-3#1)(2008-9#1)
typhimurium chromosome##2##2##(1990-3#2)
typhimurium is##2##2##(1991-6#1)(2006-8#1)
typhimurium orotate phosphoribosyltransferase (OPRTase)##3##4##(1995-8#3)
typhimurium orotate phosphoribosyltransferase##5##3##(1995-8#5)
typhimurium strain##2##2##(2008-10#1)(2008-9#1)
typhimurium strains##4##2##(2008-9#3)(2011-2#1)
typhimurium to##3##2##(2005-11#1)(2008-5#1)(2009-5#1)
typhimurium was##3##2##(1990-3#1)(2006-8#1)(2012-11#1)
typhimurium##111##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#7)(1990-6#2)(1990-9#4)(1991-1#2)(1991-12#1)(1991-6#2)(1991-7#2)(1992-11#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-5#7)(1994-8#2)(1995-1#2)(1995-8#6)(1996-10#1)(1996-2#3)(1996-3#1)(1996-6#2)(1996-8#1)(1997-1#3)(1997-3#1)(1997-4#2)(2005-11#3)(2005-12#1)(2006-8#5)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#7)(2008-8#3)(2008-9#8)(2009-2#1)(2009-5#3)(2010-4#5)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-2#2)
typhoid fever##10##2##(1991-5#1)(1992-2#1)(1997-6#1)(2004-9#1)(2007-2#6)
typhoid outbreaks in##2##3##(2007-2#1)(2008-7#1)
typhoid outbreaks##3##2##(2007-2#1)(2008-7#2)
typhoid vaccine##2##2##(2010-12#2)
typhoid##44##1##(1990-9#1)(1991-5#2)(1992-2#1)(1993-7#3)(1994-4#1)(1997-6#1)(2004-9#1)(2006-1#1)(2006-2#1)(2006-6#1)(2007-2#19)(2007-7#3)(2008-7#2)(2010-12#6)(2011-2#1)
typhoidal Salmonellae##2##2##(2011-12#1)(2012-2#1)
typhus and##2##2##(2011-2#1)(2013-1#1)
typhus group##2##2##(2006-2#2)
typhus imported##2##2##(1997-6#2)
typhus in##2##2##(2008-4#1)(2010-12#1)
typhus##21##1##(1997-6#4)(2006-2#2)(2007-2#1)(2007-7#1)(2008-4#3)(2010-12#4)(2011-2#1)(2013-1#5)
typica##2##1##(2007-12#1)(2013-1#1)
typical &quot##2##2##(2009-9#1)(2011-2#1)
typical CpG##2##2##(2007-11#2)
typical DNA##2##2##(1994-3#1)(1997-7#1)
typical EOG##2##2##(2008-5#2)
typical HNSCC##2##2##(2010-7#2)
typical MR##2##2##(1997-8#1)(2007-7#1)
typical Michaelis-Menten kinetics##2##3##(1997-2#1)(2008-10#1)
typical Michaelis-Menten##3##2##(1997-2#1)(2008-10#1)(2012-2#1)
typical TATA box##3##3##(1994-12#1)(1996-10#1)(1997-6#1)
typical TATA##4##2##(1990-5#1)(1994-12#1)(1996-10#1)(1997-6#1)
typical acute##3##2##(2005-11#1)(2007-11#1)(2010-2#1)
typical adult##3##2##(2005-3#1)(2008-10#1)(2008-11#1)
typical and atypical antipsychotic##2##4##(2004-3#1)(2011-1#1)
typical and atypical antipsychotics##3##4##(2008-8#1)(2009-12#1)(2009-9#1)
typical and atypical neuroleptic##2##4##(1990-5#2)
typical and atypical neuroleptics##2##4##(1990-5#1)(1996-12#1)
typical and atypical##16##3##(1990-5#3)(1996-12#2)(2004-3#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-12#3)(2009-4#1)(2009-9#1)(2011-1#1)(2012-1#1)
typical and##29##2##(1990-5#3)(1993-3#1)(1994-9#1)(1996-12#2)(2004-3#1)(2005-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-12#3)(2009-4#1)(2009-9#1)(2010-10#1)(2011-1#5)(2011-2#1)(2012-1#2)
typical antipsychotics##3##2##(2009-9#1)(2010-6#1)(2012-1#1)
typical appearance of##4##3##(2007-3#1)(2007-4#1)(2010-4#1)(2012-2#1)
typical applications of##2##3##(1996-5#1)(2008-10#1)
typical applications##5##2##(1996-5#2)(2008-10#2)(2008-2#1)
typical behavior##2##2##(2007-2#1)(2008-4#1)
typical biological##2##2##(2008-2#1)(2008-3#1)
typical case##13##2##(1991-9#1)(1994-12#1)(1995-5#1)(1996-7#1)(2007-12#1)(2007-6#1)(2008-1#2)(2008-3#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
typical cases of##2##3##(1992-11#1)(2008-9#1)
typical cases##4##2##(1992-11#1)(1993-10#1)(2006-1#1)(2008-9#1)
typical cell##2##2##(1997-8#1)(2008-7#1)
typical characteristics of##3##3##(1990-9#1)(1994-8#1)(2005-5#1)
typical characteristics##4##2##(1990-9#1)(1994-8#1)(2005-5#1)(2013-7#1)
typical clinical presentation##3##3##(1995-5#1)(2008-1#1)(2008-10#1)
typical clinical signs of##3##4##(2008-5#2)(2011-2#1)
typical clinical signs##4##3##(2008-5#3)(2011-2#1)
typical clinical symptoms##3##3##(1995-2#1)(2008-1#1)(2013-1#1)
typical clinical##23##2##(1990-2#1)(1990-3#1)(1993-3#1)(1995-2#1)(1995-5#1)(1996-7#1)(2006-4#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-5#4)(2008-7#3)(2011-2#1)(2012-12#1)(2013-1#3)
typical concentrations##2##2##(2008-10#2)
typical contact##2##2##(2005-11#1)(2008-3#1)
typical data##2##2##(2008-2#1)(2008-9#1)
typical development##3##2##(2006-10#1)(2009-4#1)(2012-1#1)
typical diabetic glomerulopathy##2##3##(2005-10#2)
typical disease##2##2##(2008-5#1)(2009-3#1)
typical emotional development##2##3##(2009-12#2)
typical environmental##2##2##(2008-10#1)(2013-1#1)
typical error##2##2##(2008-12#2)
typical examples##5##2##(1994-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-12#1)
typical experimental##3##2##(2006-4#1)(2008-1#1)(2008-3#1)
typical exponential##2##2##(2007-11#1)(2008-10#1)
typical external##2##2##(1997-4#1)(2008-10#1)
typical facial##2##2##(1990-9#1)(2010-12#1)
typical feature of##5##3##(1995-8#1)(1997-6#1)(2005-11#1)(2008-10#1)(2008-8#1)
typical feature##7##2##(1990-8#1)(1995-8#1)(1997-6#1)(2005-11#1)(2008-10#1)(2008-8#2)
typical features of##11##3##(1991-3#1)(1991-5#1)(1993-2#1)(1993-7#1)(1995-2#1)(2007-12#1)(2007-7#1)(2008-8#1)(2012-2#2)(2013-7#1)
typical features##12##2##(1991-3#1)(1991-5#1)(1993-2#1)(1993-7#1)(1995-2#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-8#1)(2012-2#2)(2013-7#1)
typical field##3##2##(1996-8#1)(2008-3#1)(2008-5#1)
typical findings in##2##3##(1993-1#1)(2008-5#1)
typical findings##4##2##(1993-1#1)(2008-5#1)(2009-9#1)(2010-6#1)
typical for a##6##3##(2005-11#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-6#1)
typical for protein##2##3##(2006-10#2)
typical for the##8##3##(1991-6#1)(1996-2#1)(1996-7#1)(2006-10#1)(2007-12#1)(2008-12#1)(2008-2#1)(2012-12#1)
typical for##61##2##(1990-11#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-7#1)(1994-12#2)(1994-2#1)(1995-12#1)(1996-2#2)(1996-3#1)(1996-7#1)(1997-2#1)(1997-6#1)(2005-11#1)(2006-10#3)(2006-4#1)(2006-6#1)(2007-11#4)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2009-2#1)(2011-1#4)(2011-2#1)(2012-12#1)(2013-1#5)
typical form of##4##3##(1997-8#1)(2008-4#1)(2008-7#1)(2010-6#1)
typical functional##2##2##(1994-9#1)(2007-11#1)
typical granulomata##2##2##(1994-6#1)(2013-8#1)
typical head##2##2##(2007-12#1)(2008-7#1)
typical histological##2##2##(1990-5#1)(2007-8#1)
typical hypersensitive reaction##2##3##(2008-10#2)
typical imaging##6##2##(2006-5#1)(2008-6#1)(2008-9#1)(2010-2#1)(2012-3#1)(2013-8#1)
typical in##4##2##(1992-9#1)(2007-12#1)(2008-10#1)(2011-1#1)
typical infectious##2##2##(2008-11#1)(2008-5#1)
typical ischemic##2##2##(1993-11#1)(2007-8#1)
typical ladder##2##2##(1991-3#1)(1991-5#1)
typical language development##2##3##(2009-8#1)(2011-1#1)
typical laser##2##2##(2008-3#1)(2008-9#1)
typical leaf##2##2##(2008-10#2)
typical location##3##2##(1991-4#1)(1991-6#1)(2007-11#1)
typical methods##2##2##(2008-3#1)(2009-3#1)
typical morphology##2##2##(2007-3#1)(2008-5#1)
typical of a##8##3##(1992-4#1)(1995-5#1)(1995-8#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)
typical of an##2##3##(1995-1#1)(1996-12#1)
typical of apoptosis##3##3##(1992-3#2)(2008-6#1)
typical of astrocytes##2##3##(1990-2#1)(2008-7#1)
typical of free-living##2##3##(2011-2#2)
typical of integral membrane proteins##2##5##(1990-5#1)(1990-6#1)
typical of many##2##3##(1996-1#1)(2013-1#1)
typical of other##3##3##(1993-2#1)(1994-9#1)(2012-1#1)
typical of strains##2##3##(2008-10#1)(2008-5#1)
typical of the##12##3##(1990-11#1)(1994-11#1)(1994-6#1)(1996-4#1)(2007-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)
typical of those##2##3##(1993-8#1)(2004-9#1)
typical of type##2##3##(1990-11#1)(1997-4#1)
typical of##174##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-1#1)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-11#2)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-6#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#3)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-4#1)(1997-2#1)(1997-4#2)(1997-7#2)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#4)(2006-4#1)(2006-5#1)(2006-6#1)(2007-1#2)(2007-11#4)(2007-12#6)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#23)(2008-11#4)(2008-12#5)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#7)(2008-9#2)(2009-10#1)(2009-7#3)(2009-8#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#1)
typical operating##4##2##(1995-12#1)(2006-4#1)(2007-11#1)(2008-2#1)
typical or atypical##3##3##(2010-12#1)(2011-12#1)(2012-1#1)
typical or##4##2##(2010-12#1)(2011-12#1)(2012-1#1)(2012-3#1)
typical parameters##4##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
typical pathologic##2##2##(2006-10#1)(2009-1#1)
typical patients##2##2##(1997-1#1)(2005-10#1)
typical peaks##2##2##(1991-4#1)(2007-8#1)
typical pharmaceutical##2##2##(1994-9#1)(2008-10#1)
typical physiological conditions##2##3##(1990-2#2)
typical plant##3##2##(1997-2#1)(1997-8#1)(2013-8#1)
typical presentation##4##2##(2007-11#1)(2008-11#1)(2011-1#1)(2013-8#1)
typical problems##2##2##(2008-10#2)
typical product##2##2##(2008-10#1)(2013-1#1)
typical profile of##2##3##(1992-8#1)(2009-6#1)
typical properties of##2##3##(2007-9#1)(2008-11#1)
typical radiographic features of##2##4##(2006-5#1)(2012-2#1)
typical radiological and##2##3##(1992-4#1)(2008-3#1)
typical radiological##4##2##(1992-4#1)(2007-7#1)(2008-3#1)(2008-6#1)
typical representative of##2##3##(2006-6#1)(2013-8#1)
typical response##3##2##(1996-2#2)(2008-10#1)
typical root##3##2##(2007-12#1)(2008-10#2)
typical samples##2##2##(2008-10#2)
typical sampling##2##2##(2008-10#1)(2008-3#1)
typical sequence##3##2##(1992-3#1)(2010-9#1)(2012-12#1)
typical signal peptide##3##3##(1990-4#1)(1991-7#1)(1992-4#1)
typical signal##5##2##(1990-4#1)(1991-7#1)(1992-4#1)(1994-2#1)(2008-10#1)
typical signature of##2##3##(1993-11#1)(2007-9#1)
typical skin lesions##2##3##(1997-5#1)(2012-2#1)
typical skin##4##2##(1997-5#1)(1997-8#1)(2006-4#1)(2012-2#1)
typical smoker##2##2##(2010-2#2)
typical spectral##2##2##(1990-12#1)(2008-3#1)
typical symptom##2##2##(1990-12#1)(2009-4#1)
typical symptoms and signs##2##4##(1995-2#1)(2010-12#1)
typical symptoms and##3##3##(1995-2#1)(2008-10#1)(2010-12#1)
typical symptoms of##6##3##(2005-11#1)(2006-10#1)(2008-10#2)(2012-12#1)(2013-8#1)
typical symptoms##15##2##(1991-4#2)(1995-2#1)(2005-11#1)(2006-10#1)(2008-10#5)(2009-4#1)(2009-9#1)(2010-12#1)(2012-12#1)(2013-8#1)
typical systems##2##2##(1997-2#1)(2008-10#1)
typical to the##2##3##(2007-1#1)(2013-1#1)
typical to##3##2##(2007-1#1)(2009-11#1)(2013-1#1)
typical values##3##2##(1994-9#1)(2008-3#1)(2012-12#1)
typical##1132##1##(1990-11#4)(1990-12#4)(1990-2#4)(1990-3#4)(1990-4#1)(1990-5#8)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#2)(1991-3#5)(1991-4#6)(1991-5#4)(1991-6#3)(1991-7#3)(1991-8#2)(1991-9#4)(1992-1#2)(1992-11#4)(1992-12#1)(1992-2#5)(1992-3#6)(1992-4#4)(1992-5#2)(1992-6#4)(1992-7#3)(1992-8#3)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#4)(1993-12#2)(1993-2#3)(1993-3#6)(1993-7#1)(1993-8#3)(1993-9#2)(1994-1#3)(1994-10#1)(1994-11#3)(1994-12#9)(1994-2#3)(1994-3#3)(1994-6#5)(1994-8#7)(1994-9#10)(1995-1#3)(1995-11#2)(1995-12#4)(1995-2#5)(1995-3#2)(1995-4#1)(1995-5#6)(1995-6#8)(1995-8#6)(1995-9#1)(1996-1#2)(1996-10#3)(1996-12#6)(1996-2#8)(1996-3#4)(1996-4#3)(1996-5#4)(1996-6#2)(1996-7#5)(1996-8#3)(1996-9#1)(1997-1#3)(1997-2#9)(1997-3#2)(1997-4#7)(1997-5#5)(1997-6#4)(1997-7#3)(1997-8#7)(2004-11#2)(2004-12#4)(2004-2#1)(2004-3#2)(2004-4#1)(2004-9#4)(2005-1#1)(2005-10#5)(2005-11#14)(2005-12#2)(2005-3#1)(2005-5#1)(2005-6#1)(2005-7#1)(2005-8#5)(2006-1#1)(2006-10#17)(2006-11#3)(2006-12#4)(2006-2#2)(2006-4#7)(2006-5#3)(2006-6#4)(2006-8#1)(2006-9#2)(2007-1#7)(2007-10#5)(2007-11#30)(2007-12#37)(2007-2#5)(2007-3#6)(2007-4#4)(2007-5#2)(2007-6#2)(2007-7#10)(2007-8#19)(2007-9#4)(2008-1#14)(2008-10#121)(2008-11#22)(2008-12#14)(2008-2#37)(2008-3#50)(2008-4#13)(2008-5#34)(2008-6#14)(2008-7#22)(2008-8#18)(2008-9#11)(2009-1#1)(2009-10#7)(2009-11#6)(2009-12#8)(2009-2#4)(2009-3#4)(2009-4#8)(2009-5#6)(2009-6#2)(2009-7#4)(2009-8#7)(2009-9#7)(2010-1#1)(2010-10#5)(2010-12#6)(2010-2#7)(2010-3#1)(2010-4#6)(2010-5#7)(2010-6#7)(2010-7#2)(2010-8#2)(2010-9#5)(2011-1#20)(2011-12#3)(2011-2#26)(2011-3#1)(2012-1#9)(2012-12#12)(2012-2#24)(2012-3#9)(2013-1#22)(2013-7#5)(2013-8#9)
typical&quot##3##1##(1993-12#1)(2009-11#1)(2009-4#1)
typically &lt##2##2##(2008-10#1)(2011-12#1)
typically a##8##2##(1990-7#1)(1995-12#1)(2007-12#1)(2007-3#1)(2008-3#1)(2009-10#1)(2010-3#1)(2011-2#1)
typically accompanied by##2##3##(1991-3#1)(2012-12#1)
typically affects the##2##3##(2011-2#1)(2012-3#1)
typically affects##3##2##(1991-12#1)(2011-2#1)(2012-3#1)
typically among the most##2##4##(2006-7#1)(2008-11#1)
typically an##2##2##(2007-11#1)(2008-5#1)
typically are associated with##2##4##(1995-1#1)(2012-2#1)
typically are##6##2##(1995-1#1)(1997-7#1)(2008-10#2)(2008-2#1)(2012-2#1)
typically associated with##11##3##(1992-9#1)(1994-5#1)(2006-11#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-2#1)(2009-3#1)(2011-2#1)(2012-2#2)
typically based on##3##3##(1996-6#1)(2008-3#1)(2009-11#1)
typically be##2##2##(2008-10#1)(2010-12#1)
typically been##3##2##(2005-12#1)(2006-12#1)(2007-3#1)
typically carried##2##2##(2008-11#1)(2012-3#1)
typically caused by##2##3##(1992-5#1)(2012-2#1)
typically characterized by##4##3##(1994-8#1)(2005-11#1)(2008-4#1)(2012-11#1)
typically characterized##5##2##(1994-8#1)(2005-11#1)(2008-4#1)(2009-7#1)(2012-11#1)
typically collected in##2##3##(2012-12#1)(2013-1#1)
typically comes##2##2##(2008-1#1)(2013-8#1)
typically consist of##2##3##(2008-7#1)(2008-9#1)
typically contain##3##2##(1991-2#1)(2007-1#1)(2008-5#1)
typically contained##2##2##(2008-10#1)(2009-7#1)
typically develop##2##2##(2005-9#1)(2007-5#1)
typically developed##3##2##(1991-1#1)(2013-1#2)
typically developing (TD) peers##2##4##(2009-10#1)(2012-3#1)
typically developing (TD)##4##3##(2009-10#1)(2009-4#2)(2012-3#1)
typically developing adolescents##3##3##(2012-2#3)
typically developing children##3##3##(2008-12#1)(2011-12#1)(2013-7#1)
typically developing individuals##4##3##(2009-4#2)(2010-2#1)(2012-3#1)
typically developing##21##2##(2008-12#1)(2009-10#1)(2009-4#5)(2010-2#1)(2010-4#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#4)(2012-3#2)(2013-7#2)
typically develops when##2##3##(2008-4#1)(2010-2#1)
typically develops##5##2##(1991-12#1)(2008-4#2)(2010-2#1)(2011-2#1)
typically encountered in##2##3##(2008-3#1)(2009-11#1)
typically encountered##3##2##(2008-10#1)(2008-3#1)(2009-11#1)
typically exhibit a##2##3##(2007-4#1)(2008-10#1)
typically exhibit##5##2##(1993-9#1)(1996-3#1)(2007-4#1)(2008-10#1)(2009-11#1)
typically expressed##2##2##(2006-8#1)(2008-4#1)
typically found in##4##3##(1993-11#1)(2008-10#1)(2011-2#1)(2013-7#1)
typically found##5##2##(1993-11#1)(2008-10#1)(2011-1#1)(2011-2#1)(2013-7#1)
typically had##2##2##(2008-1#1)(2008-10#1)
typically has##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
typically have a##3##3##(2006-10#1)(2007-12#1)(2007-3#1)
typically have low##2##3##(1991-11#1)(2008-9#1)
typically have##16##2##(1991-11#1)(1994-3#1)(2006-10#1)(2006-7#1)(2007-12#3)(2007-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-1#1)
typically higher than##3##3##(2006-5#1)(2010-2#2)
typically in electronic health records (EHRs)##2##6##(2013-1#2)
typically in the##8##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-1#1)(2009-5#1)(2012-2#1)(2013-7#1)
typically in##13##2##(2006-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-1#1)(2009-5#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
typically include##3##2##(1994-4#1)(1997-8#1)(2011-2#1)
typically increase##2##2##(1995-12#1)(2011-2#1)
typically involve##5##2##(2009-10#2)(2010-11#1)(2011-12#1)(2012-1#1)
typically involved##4##2##(1997-1#1)(2009-3#1)(2012-12#1)(2013-1#1)
typically involves##6##2##(2007-8#1)(2009-2#1)(2009-3#1)(2010-8#1)(2011-2#1)(2012-1#1)
typically is##5##2##(1992-2#1)(2008-10#1)(2008-2#1)(2010-4#1)(2012-3#1)
typically less##2##2##(2007-12#1)(2008-10#1)
typically located##3##2##(1995-1#1)(2006-12#1)(2008-8#1)
typically low##4##2##(2008-10#2)(2008-11#1)(2008-8#1)
typically made##2##2##(1995-2#1)(2010-2#1)
typically managed##3##2##(2008-5#1)(2011-2#1)(2012-2#1)
typically measured##3##2##(2005-11#1)(2008-8#1)(2009-6#1)
typically not##4##2##(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#1)
typically observed in##4##3##(2008-11#1)(2008-3#1)(2013-1#2)
typically observed upon##2##3##(1996-7#1)(2009-8#1)
typically observed##7##2##(1996-7#1)(2006-11#1)(2008-11#1)(2008-3#1)(2009-8#1)(2013-1#2)
typically occur in##2##3##(2007-7#1)(2008-7#1)
typically occurring##2##2##(2008-10#1)(2010-12#1)
typically occurs in##3##3##(2006-10#1)(2007-11#1)(2013-7#1)
typically occurs##4##2##(2006-10#1)(2007-11#1)(2007-8#1)(2013-7#1)
typically of the order of##2##5##(2006-2#1)(2008-2#1)
typically of##3##2##(2006-2#1)(2008-2#1)(2008-3#1)
typically on the order of##2##5##(2009-11#1)(2010-7#1)
typically on##3##2##(2008-5#1)(2009-11#1)(2010-7#1)
typically performed##4##2##(1994-3#1)(2008-10#1)(2009-9#1)(2012-3#1)
typically poor##2##2##(2007-12#1)(2012-2#1)
typically present with##3##3##(2005-10#1)(2006-7#1)(2009-8#1)
typically present##6##2##(1996-4#1)(2004-3#1)(2005-10#1)(2006-7#1)(2009-8#1)(2012-2#1)
typically presented##2##2##(1997-7#1)(2010-6#1)
typically presents in childhood or adolescence##2##6##(2005-12#1)(2012-2#1)
typically presents##5##2##(2005-12#1)(2007-7#1)(2008-11#1)(2009-3#1)(2012-2#1)
typically produce##2##2##(2008-7#1)(2010-12#1)
typically provide##2##2##(2008-7#1)(2011-1#1)
typically reported for##3##3##(1996-5#1)(2008-8#2)
typically reported##4##2##(1994-2#1)(1996-5#1)(2008-8#2)
typically require##4##2##(1995-9#1)(1997-8#1)(2006-5#1)(2012-3#1)
typically requires##4##2##(1997-8#1)(2007-12#1)(2008-2#1)(2011-1#1)
typically result in##3##3##(1993-2#1)(2006-10#1)(2011-2#1)
typically result##4##2##(1993-2#1)(2006-10#1)(2011-2#1)(2013-7#1)
typically results from##2##3##(2006-9#1)(2008-7#1)
typically results in##3##3##(2008-8#2)(2009-6#1)
typically results##5##2##(2006-9#1)(2008-7#1)(2008-8#2)(2009-6#1)
typically seen in##3##3##(1997-7#1)(2007-4#2)
typically seen##4##2##(1997-7#1)(2006-12#1)(2007-4#2)
typically show##2##2##(1995-12#1)(1995-5#1)
typically shows##2##2##(2006-10#1)(2009-6#1)
typically silent##2##2##(2006-10#1)(2009-4#1)
typically slow##2##2##(2007-11#1)(2008-10#1)
typically slower than##3##3##(2007-12#2)(2012-12#1)
typically stronger##2##2##(2008-10#1)(2010-4#1)
typically takes##2##2##(2008-2#1)(2011-12#1)
typically the##4##2##(1996-4#1)(2008-10#2)(2012-3#1)
typically treated with##5##3##(2013-8#5)
typically used for##7##3##(2005-8#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-7#1)(2008-4#1)
typically used in##8##3##(1997-8#1)(2006-4#1)(2008-9#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-1#2)
typically used to##2##3##(2007-6#1)(2009-9#1)
typically used##22##2##(1992-1#1)(1993-11#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-9#1)(2007-12#2)(2007-6#1)(2007-7#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-9#2)(2010-12#1)(2010-9#1)(2011-2#1)(2013-1#2)
typically with a##2##3##(2008-10#1)(2009-8#1)
typically within##2##2##(2008-3#2)
typically yield##2##2##(2008-3#1)(2008-7#1)
typically##549##1##(1990-7#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-9#1)(1994-2#1)(1994-3#4)(1994-4#1)(1994-5#1)(1994-8#2)(1995-1#3)(1995-12#3)(1995-2#2)(1995-3#3)(1995-5#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-4#2)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-7#3)(1997-8#5)(2003-11#1)(2004-3#1)(2004-8#1)(2005-10#2)(2005-11#3)(2005-12#3)(2005-8#3)(2005-9#1)(2006-10#10)(2006-11#3)(2006-12#6)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#4)(2006-7#5)(2006-8#1)(2006-9#4)(2007-1#1)(2007-10#2)(2007-11#9)(2007-12#20)(2007-2#2)(2007-3#3)(2007-4#5)(2007-5#2)(2007-6#2)(2007-7#6)(2007-8#6)(2007-9#2)(2008-1#6)(2008-10#45)(2008-11#17)(2008-12#6)(2008-2#14)(2008-3#19)(2008-4#20)(2008-5#9)(2008-6#2)(2008-7#15)(2008-8#15)(2008-9#8)(2009-1#1)(2009-10#6)(2009-11#4)(2009-2#2)(2009-3#4)(2009-4#6)(2009-5#3)(2009-6#3)(2009-7#6)(2009-8#8)(2009-9#5)(2010-10#2)(2010-11#2)(2010-12#5)(2010-2#7)(2010-3#1)(2010-4#4)(2010-6#4)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#6)(2011-12#6)(2011-2#19)(2012-1#5)(2012-11#3)(2012-12#9)(2012-2#17)(2012-3#13)(2012-5#1)(2013-1#22)(2013-7#8)(2013-8#8)
typification##2##1##(2010-12#1)(2010-5#1)
typified by a##4##3##(2013-7#3)(2013-8#1)
typified by the##2##3##(1996-3#1)(1996-6#1)
typified by##14##2##(1996-3#1)(1996-6#1)(2005-8#1)(2006-12#1)(2006-6#1)(2008-1#1)(2008-10#1)(2009-7#1)(2010-2#1)(2013-7#4)(2013-8#1)
typified##17##1##(1996-3#1)(1996-6#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-7#1)(2010-2#1)(2013-7#5)(2013-8#1)
typify##3##1##(1992-3#1)(2008-10#1)(2008-6#1)
typing a##2##2##(1993-9#1)(2008-9#1)
typing and##6##2##(1996-12#1)(2008-5#1)(2010-4#1)(2012-1#1)(2012-2#1)(2013-8#1)
typing assays##2##2##(2008-10#1)(2008-12#1)
typing by##4##2##(2007-8#1)(2008-6#1)(2008-9#1)(2011-2#1)
typing could##2##2##(1992-9#1)(2010-4#1)
typing has##4##2##(1991-6#1)(2007-5#1)(2008-4#1)(2010-7#1)
typing in samples##2##3##(2008-12#2)
typing in##7##2##(1996-7#1)(1997-8#1)(2007-2#1)(2008-12#3)(2011-2#1)
typing is##3##2##(1996-6#1)(2008-12#1)(2013-1#1)
typing method##3##2##(1996-7#1)(1997-8#1)(2008-12#1)
typing methods for##2##3##(2006-8#1)(2010-4#1)
typing methods##7##2##(2006-8#1)(2007-8#1)(2008-4#2)(2008-6#1)(2010-4#1)(2011-2#1)
typing of all##2##3##(1992-6#1)(2010-4#1)
typing of the##2##3##(2011-2#1)(2012-3#1)
typing of##23##2##(1991-12#1)(1992-6#1)(1994-8#1)(1996-12#1)(1997-8#1)(2005-7#2)(2007-1#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-12#1)(2008-6#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
typing revealed that##2##3##(1997-8#1)(2007-2#1)
typing should be##2##3##(2010-4#1)(2013-8#1)
typing showed that##2##3##(1997-3#1)(2007-12#1)
typing showed##3##2##(1997-3#1)(2007-12#1)(2007-2#1)
typing system for##2##3##(1996-7#1)(1997-8#1)
typing system##4##2##(1995-11#1)(1996-7#1)(1997-8#1)(2008-12#1)
typing the##2##2##(2007-11#1)(2008-10#1)
typing to##4##2##(2005-8#1)(2008-10#2)(2008-12#1)
typing was##4##2##(1997-8#1)(2007-2#2)(2013-8#1)
typing with the##2##3##(2012-3#1)(2013-8#1)
typing##138##1##(1990-5#1)(1991-12#1)(1991-6#1)(1992-2#4)(1992-6#2)(1992-9#1)(1993-12#2)(1993-9#2)(1994-12#1)(1994-3#4)(1994-8#1)(1995-11#1)(1995-3#2)(1996-12#3)(1996-6#3)(1996-7#3)(1997-3#1)(1997-8#9)(2005-7#2)(2005-8#1)(2006-10#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#6)(2007-5#1)(2007-7#3)(2007-8#4)(2008-10#13)(2008-11#1)(2008-12#14)(2008-4#6)(2008-5#1)(2008-6#3)(2008-9#2)(2009-5#1)(2010-4#8)(2010-7#1)(2011-2#10)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#5)
typings were##3##2##(1992-9#1)(1994-3#1)(2013-8#1)
typographical##2##1##(2007-12#1)(2007-5#1)
typological##3##1##(1994-2#1)(2008-4#1)(2013-7#1)
typologies of##3##2##(1994-2#1)(2008-10#1)(2011-1#1)
typologies##9##1##(1994-2#3)(1996-2#1)(2008-10#1)(2008-8#1)(2010-10#1)(2011-1#1)(2013-8#1)
typology and##3##2##(1994-2#1)(2010-10#1)(2012-12#1)
typology of##15##2##(1990-12#1)(1991-6#1)(2006-3#1)(2006-7#1)(2008-12#2)(2008-8#2)(2010-10#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
typology##41##1##(1990-12#1)(1991-6#1)(1992-1#1)(1994-2#5)(1996-12#1)(2006-3#1)(2006-7#1)(2008-12#2)(2008-5#2)(2008-7#2)(2008-8#3)(2010-10#5)(2010-12#1)(2010-5#2)(2012-12#7)(2012-3#1)(2013-1#3)(2013-8#2)
typoselectivity##2##1##(1996-9#2)
tyrR+##2##1##(1991-12#2)
tyramide##2##1##(2008-10#1)(2008-4#1)
tyramine oxidase##3##2##(2009-9#3)
tyramine##17##1##(1990-2#1)(1991-5#1)(1992-8#1)(1995-6#1)(1996-8#1)(1997-6#1)(1997-8#1)(2005-9#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-7#2)(2009-9#3)
tyraminergic##3##1##(2006-12#3)
tyrosinase activity and melanin##2##4##(1991-5#2)
tyrosinase activity and##4##3##(1991-5#2)(1992-3#1)(2013-1#1)
tyrosinase activity##14##2##(1991-3#1)(1991-5#2)(1992-3#3)(1994-3#1)(1995-2#1)(2008-5#2)(2013-1#4)
tyrosinase and horse-radish peroxidase##4##4##(2008-10#4)
tyrosinase and the##2##3##(1995-2#1)(2008-5#1)
tyrosinase and##10##2##(1995-2#1)(2008-10#5)(2008-5#4)
tyrosinase biosensor##3##2##(2008-10#3)
tyrosinase by##2##2##(1991-7#1)(2008-5#1)
tyrosinase cDNA##4##2##(1991-7#2)(1995-8#2)
tyrosinase electrode##2##2##(2008-10#2)
tyrosinase enzyme##6##2##(2008-10#5)(2008-5#1)
tyrosinase expression##3##2##(1995-8#1)(2007-10#2)
tyrosinase in##2##2##(1995-8#1)(2008-10#1)
tyrosinase inhibition##2##2##(2008-10#1)(2008-5#1)
tyrosinase inhibitor##2##2##(2013-1#2)
tyrosinase inhibitors##2##2##(2006-12#1)(2013-1#1)
tyrosinase inhibitory##2##2##(2006-12#1)(2008-5#1)
tyrosinase mRNA##4##2##(1995-8#1)(2007-10#1)(2008-5#2)
tyrosinase was##4##2##(1995-8#1)(2008-10#2)(2008-5#1)
tyrosinase##108##1##(1991-3#1)(1991-5#2)(1991-7#4)(1991-9#1)(1992-3#4)(1994-12#2)(1994-3#2)(1995-2#2)(1995-8#9)(1996-2#1)(1996-9#1)(1997-4#2)(2006-12#3)(2007-10#3)(2007-8#4)(2007-9#1)(2008-10#32)(2008-5#23)(2012-12#1)(2013-1#10)
tyrosinase-based carbon paste electrode##2##4##(2008-10#2)
tyrosinase-related protein##3##2##(1992-4#2)(1995-8#1)
tyrosinase-related protein-1 (TRP-1)##2##3##(2008-5#1)(2013-1#1)
tyrosinase-related##6##1##(1992-4#2)(1995-2#1)(1995-8#1)(2008-5#1)(2013-1#1)
tyrosinate fluorescence##6##2##(1990-9#2)(1991-5#4)
tyrosinate##7##1##(1990-9#2)(1991-5#5)
tyrosine (Tyr) and phenylalanine (Phe)##2##5##(1990-4#1)(2013-1#1)
tyrosine (Tyr)##3##2##(1990-4#1)(2005-4#1)(2013-1#1)
tyrosine 151##2##2##(1991-4#2)
tyrosine aminotransferase (TAT)##3##3##(1991-11#1)(1994-12#1)(1997-4#1)
tyrosine aminotransferase##7##2##(1991-11#1)(1991-2#3)(1994-12#2)(1997-4#1)
tyrosine and serine/threonine##2##3##(1995-2#1)(1995-3#1)
tyrosine and threonine##3##3##(1990-11#1)(1995-3#1)(1996-2#1)
tyrosine and tryptophan##2##3##(1991-5#1)(1991-7#1)
tyrosine and##16##2##(1990-10#1)(1990-11#2)(1991-2#2)(1991-5#1)(1991-7#2)(1993-9#1)(1995-2#1)(1995-3#3)(1996-2#1)(1996-5#1)(2008-10#1)
tyrosine are##2##2##(1991-4#1)(1996-9#1)
tyrosine at amino acid##2##4##(1990-10#1)(1997-3#1)
tyrosine at position##2##3##(1991-4#1)(1995-3#1)
tyrosine at##8##2##(1990-10#1)(1991-4#1)(1994-11#1)(1995-3#1)(1995-6#1)(1997-3#1)(2008-10#2)
tyrosine autophosphorylation of##2##3##(1990-7#1)(1991-11#1)
tyrosine autophosphorylation site##2##3##(1995-3#2)
tyrosine autophosphorylation##7##2##(1990-7#1)(1991-11#1)(1992-12#1)(1994-12#2)(1995-3#2)
tyrosine by##3##2##(1990-5#1)(1997-8#1)(2008-5#1)
tyrosine group##2##2##(1990-2#1)(1991-4#1)
tyrosine hydroxylase (TH) activity##2##4##(1992-12#1)(2008-11#1)
tyrosine hydroxylase (TH) and##4##4##(1990-5#1)(1991-9#1)(1996-4#1)(1996-5#1)
tyrosine hydroxylase (TH) gene##3##4##(1997-2#1)(1997-5#1)(1997-6#1)
tyrosine hydroxylase (TH) in the##2##5##(2008-10#1)(2011-2#1)
tyrosine hydroxylase (TH) in##3##4##(1992-8#1)(2008-10#1)(2011-2#1)
tyrosine hydroxylase (TH) mRNA##5##4##(1990-12#1)(1993-8#1)(1995-11#1)(1996-12#1)(1997-2#1)
tyrosine hydroxylase (TH)##33##3##(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-12#2)(1996-4#1)(1996-5#3)(1997-2#2)(1997-3#1)(1997-5#2)(1997-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#1)
tyrosine hydroxylase activity##2##3##(1997-5#2)
tyrosine hydroxylase and##6##3##(1991-7#1)(1991-9#1)(1993-5#1)(1995-9#1)(1996-12#1)(1997-3#1)
tyrosine hydroxylase content##2##3##(1997-5#2)
tyrosine hydroxylase expression in##2##4##(1995-12#1)(1996-10#1)
tyrosine hydroxylase expression##4##3##(1992-3#1)(1995-12#2)(1996-10#1)
tyrosine hydroxylase gene##3##3##(1994-2#1)(1997-2#1)(1997-5#1)
tyrosine hydroxylase immunoreactive neurites##3##4##(1995-9#3)
tyrosine hydroxylase immunoreactive##6##3##(1995-11#1)(1995-9#5)
tyrosine hydroxylase immunoreactivity in##2##4##(1994-2#2)
tyrosine hydroxylase immunoreactivity##6##3##(1990-5#1)(1994-2#2)(1995-11#2)(2005-8#1)
tyrosine hydroxylase in##3##3##(1991-7#1)(1993-8#1)(1994-10#1)
tyrosine hydroxylase##93##2##(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#1)(1991-12#2)(1991-5#2)(1991-7#3)(1991-9#2)(1992-11#1)(1992-12#2)(1992-3#1)(1992-8#2)(1993-5#1)(1993-6#2)(1993-8#2)(1994-10#2)(1994-12#2)(1994-2#3)(1994-5#1)(1995-11#6)(1995-12#3)(1995-5#1)(1995-7#2)(1995-9#7)(1996-10#2)(1996-12#3)(1996-4#1)(1996-5#4)(1996-9#1)(1997-2#3)(1997-3#2)(1997-5#11)(1997-6#2)(1997-8#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-10#2)(2010-12#1)(2011-2#1)
tyrosine hydroxylase-immunoreactive neurons##3##3##(1991-3#1)(1996-5#1)(2013-8#1)
tyrosine hydroxylase-immunoreactive##6##2##(1990-5#1)(1991-3#1)(1996-1#1)(1996-5#1)(1996-6#1)(2013-8#1)
tyrosine hydroxylase-positive neurons##2##3##(2008-3#1)(2009-10#1)
tyrosine hydroxylase-positive##5##2##(1995-12#1)(1996-1#1)(1997-6#1)(2008-3#1)(2009-10#1)
tyrosine in##5##2##(1990-3#1)(1991-7#1)(1991-9#1)(1996-7#1)(2012-12#1)
tyrosine into##2##2##(2008-11#1)(2008-5#1)
tyrosine is##3##2##(2007-11#1)(2008-5#1)(2010-2#1)
tyrosine kinase (Btk)##2##3##(1994-9#1)(2007-2#1)
tyrosine kinase (TK)##3##3##(1997-1#1)(1997-7#1)(2012-12#1)
tyrosine kinase 3##3##3##(2008-5#1)(2009-9#1)(2010-10#1)
tyrosine kinase Axl##3##3##(2012-12#1)(2013-1#2)
tyrosine kinase PYK2##2##3##(1995-8#2)
tyrosine kinase activation and##2##4##(1994-8#1)(2009-6#1)
tyrosine kinase activation##4##3##(1991-10#1)(1994-8#1)(2008-8#1)(2009-6#1)
tyrosine kinase activities##2##3##(1993-8#2)
tyrosine kinase activity and##2##4##(1994-8#1)(1995-3#1)
tyrosine kinase activity by##4##4##(1993-4#1)(1993-8#1)(1994-2#1)(1996-5#1)
tyrosine kinase activity in the##2##5##(1995-3#1)(2008-3#1)
tyrosine kinase activity in vitro##2##5##(1991-12#1)(1991-7#1)
tyrosine kinase activity in##5##4##(1991-12#1)(1991-7#1)(1992-7#1)(1995-3#1)(2008-3#1)
tyrosine kinase activity is##2##4##(1994-9#1)(2011-1#1)
tyrosine kinase activity of the##3##5##(1992-8#2)(1996-5#1)
tyrosine kinase activity of##8##4##(1990-9#1)(1992-8#2)(1994-9#1)(1995-2#1)(1996-5#1)(2009-7#1)(2011-2#1)
tyrosine kinase activity##46##3##(1990-12#3)(1990-4#2)(1990-9#1)(1991-12#1)(1991-7#1)(1992-12#1)(1992-7#3)(1992-8#2)(1993-4#1)(1993-7#3)(1993-8#1)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-5#3)(1997-1#1)(2008-1#1)(2008-3#2)(2008-4#1)(2009-7#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
tyrosine kinase and its##2##4##(1994-9#1)(2010-4#1)
tyrosine kinase and##13##3##(1992-7#1)(1993-12#1)(1994-2#1)(1994-9#2)(1995-3#1)(1996-2#1)(2009-3#1)(2010-4#1)(2012-12#2)(2012-2#1)(2013-1#1)
tyrosine kinase as##2##3##(1991-12#1)(1992-9#1)
tyrosine kinase domain##14##3##(1990-4#1)(1992-12#2)(1994-6#2)(1995-2#1)(1996-11#1)(1996-5#1)(1997-6#1)(2008-5#2)(2009-8#1)(2010-12#1)(2010-4#1)
tyrosine kinase encoded by##2##4##(1993-6#1)(1994-8#1)
tyrosine kinase gene##3##3##(1992-9#1)(1993-6#1)(2008-7#1)
tyrosine kinase growth factor##2##4##(1996-4#1)(2004-2#1)
tyrosine kinase in the##3##4##(1993-8#1)(1995-8#1)(1996-5#1)
tyrosine kinase in##8##3##(1993-4#1)(1993-6#1)(1993-8#1)(1994-3#1)(1995-8#1)(1996-5#2)(1997-4#1)
tyrosine kinase inhibitor (TKI)##3##4##(2009-3#3)
tyrosine kinase inhibitor genistein##3##4##(1993-8#1)(1994-12#1)(2008-3#1)
tyrosine kinase inhibitor imatinib##2##4##(2008-6#1)(2010-11#1)
tyrosine kinase inhibitor methyl 2##2##5##(1996-12#2)
tyrosine kinase inhibitor##34##3##(1990-11#2)(1991-8#1)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-5#1)(1996-12#2)(2008-1#1)(2008-3#2)(2008-5#2)(2008-6#2)(2009-3#3)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-2#1)
tyrosine kinase inhibitors (TKIs)##7##4##(2008-1#1)(2009-11#2)(2012-1#1)(2012-12#2)(2012-2#1)
tyrosine kinase inhibitors have##2##4##(2005-7#1)(2010-4#1)
tyrosine kinase inhibitors in##4##4##(2008-1#1)(2008-5#1)(2009-3#2)
tyrosine kinase inhibitors that##3##4##(1994-3#1)(1996-6#1)(2012-12#1)
tyrosine kinase inhibitors##37##3##(1993-3#1)(1993-8#1)(1994-3#1)(1994-9#1)(1996-6#3)(2005-6#1)(2005-7#1)(2005-8#1)(2008-1#2)(2008-5#2)(2009-11#2)(2009-3#4)(2010-12#2)(2010-4#2)(2010-5#2)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#1)(2013-1#1)(2013-8#1)
tyrosine kinase is involved in##2##5##(1991-7#1)(1993-4#1)
tyrosine kinase is##4##3##(1991-7#1)(1993-4#1)(1995-8#1)(1997-6#1)
tyrosine kinase may##2##3##(1993-3#1)(1994-9#1)
tyrosine kinase of##3##3##(1990-11#1)(1992-3#1)(1996-6#1)
tyrosine kinase pathway in##2##4##(2008-3#1)(2009-4#1)
tyrosine kinase pathway##4##3##(1991-12#1)(1995-3#1)(2008-3#1)(2009-4#1)
tyrosine kinase receptor##13##3##(1991-12#1)(1991-5#3)(1993-3#1)(1993-6#1)(1994-8#1)(1995-3#1)(1996-4#1)(1996-5#1)(2005-6#1)(2009-2#1)(2013-1#1)
tyrosine kinase receptors and##2##4##(1995-2#1)(1995-3#1)
tyrosine kinase receptors##7##3##(1993-6#1)(1994-5#1)(1995-2#1)(1995-3#1)(2008-1#1)(2008-8#1)(2012-3#1)
tyrosine kinase signaling##3##3##(1994-8#1)(1994-9#1)(1996-12#1)
tyrosine kinase that is expressed##2##5##(1997-7#1)(2008-5#1)
tyrosine kinase that is##5##4##(1991-9#1)(1995-8#1)(1997-6#1)(1997-7#1)(2008-5#1)
tyrosine kinase that plays##2##4##(2008-7#1)(2012-12#1)
tyrosine kinase that##9##3##(1991-9#1)(1995-10#1)(1995-8#1)(1997-6#1)(1997-7#1)(2008-5#1)(2008-7#1)(2012-12#2)
tyrosine kinase was##2##3##(1992-7#1)(1994-2#1)
tyrosine kinase which##2##3##(1994-3#1)(1996-11#1)
tyrosine kinase##331##2##(1990-11#4)(1990-12#3)(1990-3#1)(1990-4#4)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#6)(1991-5#7)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-11#3)(1992-12#6)(1992-3#3)(1992-5#1)(1992-7#9)(1992-8#2)(1992-9#3)(1993-12#1)(1993-3#3)(1993-4#5)(1993-6#7)(1993-7#4)(1993-8#10)(1993-9#2)(1994-12#2)(1994-2#4)(1994-3#4)(1994-5#2)(1994-6#6)(1994-8#12)(1994-9#15)(1995-1#1)(1995-10#1)(1995-11#2)(1995-2#7)(1995-3#9)(1995-5#1)(1995-6#4)(1995-8#8)(1996-1#1)(1996-11#3)(1996-12#3)(1996-2#1)(1996-4#2)(1996-5#13)(1996-6#10)(1996-9#2)(1997-1#2)(1997-4#1)(1997-6#5)(1997-7#2)(2004-2#1)(2005-6#2)(2005-7#1)(2005-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#5)(2008-3#6)(2008-4#1)(2008-5#9)(2008-6#3)(2008-7#4)(2008-8#3)(2009-11#2)(2009-2#1)(2009-3#9)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#7)(2010-5#3)(2010-7#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-1#2)(2012-12#14)(2012-2#6)(2012-3#2)(2013-1#6)(2013-8#2)
tyrosine kinase-dependent##2##2##(1991-8#1)(2005-8#1)
tyrosine kinase-mediated##3##2##(1991-8#1)(1994-9#2)
tyrosine kinases (PTKs)##5##3##(1992-9#1)(1993-3#2)(1995-11#1)(1997-7#1)
tyrosine kinases and##8##3##(1991-7#1)(1993-7#1)(1994-11#1)(1995-8#1)(1996-2#1)(2011-2#1)(2012-12#2)
tyrosine kinases are##3##3##(1995-6#1)(2008-5#1)(2012-12#1)
tyrosine kinases as##3##3##(1991-12#1)(2008-5#1)(2013-1#1)
tyrosine kinases in the##2##4##(2007-10#1)(2012-12#1)
tyrosine kinases in##4##3##(1992-9#1)(1993-6#1)(2007-10#1)(2012-12#1)
tyrosine kinases involves the##2##4##(1994-12#1)(1995-3#1)
tyrosine kinases of##3##3##(1990-7#1)(1991-7#1)(2008-8#1)
tyrosine kinases that##2##3##(1992-3#1)(2010-8#1)
tyrosine kinases which##2##3##(1992-12#1)(2008-4#1)
tyrosine kinases##83##2##(1990-7#2)(1991-12#1)(1991-7#2)(1992-1#1)(1992-11#2)(1992-12#4)(1992-3#1)(1992-9#2)(1993-3#3)(1993-6#2)(1993-7#1)(1993-8#2)(1994-11#2)(1994-12#2)(1994-3#2)(1994-6#2)(1994-8#1)(1995-11#2)(1995-2#2)(1995-3#3)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#3)(1996-9#1)(1997-3#1)(1997-7#1)(2005-7#2)(2005-8#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-12#6)(2012-2#1)(2013-1#1)
tyrosine modules##2##2##(1996-5#2)
tyrosine motifs##4##2##(1996-5#1)(1996-9#2)(2008-4#1)
tyrosine nitration##2##2##(2008-5#1)(2010-1#1)
tyrosine phosphatase (PTPase)##6##3##(1992-10#1)(1992-6#1)(1993-3#1)(1994-5#1)(1997-7#1)(2008-8#1)
tyrosine phosphatase SHP-1##3##3##(2007-8#1)(2008-2#2)
tyrosine phosphatase activity##4##3##(1992-12#2)(1993-3#1)(1995-2#1)
tyrosine phosphatase epsilon##2##3##(2009-6#2)
tyrosine phosphatase inhibitor##2##3##(1994-11#1)(1995-5#1)
tyrosine phosphatase##35##2##(1991-10#3)(1992-10#1)(1992-12#3)(1992-6#2)(1993-11#1)(1993-3#2)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-2#3)(1995-5#1)(1995-9#1)(1996-5#1)(1997-7#2)(2007-8#1)(2008-2#2)(2008-8#1)(2009-6#2)(2009-7#1)
tyrosine phosphatases (PTPases)##2##3##(1994-10#1)(2005-7#1)
tyrosine phosphatases and##2##3##(1994-5#1)(2012-12#1)
tyrosine phosphatases##20##2##(1992-8#2)(1994-10#2)(1994-5#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-6#4)(1997-7#1)(2005-7#2)(2008-2#1)(2008-4#1)(2012-12#2)
tyrosine phosphoprotein##4##2##(1994-9#1)(1995-3#2)(1996-2#1)
tyrosine phosphorylated in##2##3##(1996-10#1)(2012-3#1)
tyrosine phosphorylated##13##2##(1990-7#1)(1993-3#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-12#1)(1996-1#1)(1996-10#1)(1996-2#2)(1997-7#1)(2008-6#1)(2012-3#1)
tyrosine phosphorylation and activation of##9##5##(1992-8#1)(1993-8#1)(1994-9#1)(1995-3#2)(1995-6#1)(1996-2#1)(1996-5#2)
tyrosine phosphorylation and nuclear##2##4##(1993-9#1)(1996-5#1)
tyrosine phosphorylation and respiratory-burst activity triggered by PMA##2##8##(1994-6#2)
tyrosine phosphorylation and respiratory-burst activity##4##5##(1994-6#4)
tyrosine phosphorylation and the##2##4##(1994-6#1)(2012-12#1)
tyrosine phosphorylation and##31##3##(1990-7#1)(1992-11#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-6#8)(1994-9#1)(1995-3#2)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#5)(1997-2#1)(1997-7#1)(2012-12#1)(2012-3#1)
tyrosine phosphorylation as##2##3##(1992-11#1)(1996-12#1)
tyrosine phosphorylation in Swiss 3T3 cells##2##6##(1994-9#2)
tyrosine phosphorylation in##21##3##(1990-3#1)(1990-7#1)(1991-12#1)(1992-3#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-9#2)(1995-3#2)(1995-5#3)(1996-5#1)(2008-4#1)(2010-8#1)(2012-3#2)
tyrosine phosphorylation induced by##3##4##(1990-9#1)(1996-5#1)(1997-6#1)
tyrosine phosphorylation is an##2##4##(1990-3#1)(2011-1#1)
tyrosine phosphorylation is##6##3##(1990-3#1)(1994-2#1)(1995-5#1)(1996-5#2)(2011-1#1)
tyrosine phosphorylation may be##2##4##(1992-3#1)(1997-1#1)
tyrosine phosphorylation of 41-kDa and 43-kDa##2##6##(1992-6#2)
tyrosine phosphorylation of IRS-I##2##4##(1997-1#2)
tyrosine phosphorylation of IRS1##2##4##(1994-12#2)
tyrosine phosphorylation of MAP kinase in##2##6##(1994-3#2)
tyrosine phosphorylation of MAP kinase##4##5##(1994-3#4)
tyrosine phosphorylation of NR2B##6##4##(1995-12#2)(1996-5#1)(1997-2#3)
tyrosine phosphorylation of PLC-gamma 1 and##2##6##(1990-11#1)(1993-3#1)
tyrosine phosphorylation of PLC-gamma 1##3##5##(1990-11#1)(1993-3#1)(1995-6#1)
tyrosine phosphorylation of PLC-gamma##4##4##(1990-11#1)(1993-3#1)(1994-6#1)(1995-6#1)
tyrosine phosphorylation of Shc##4##4##(1994-12#1)(1995-8#1)(1997-7#2)
tyrosine phosphorylation of a##3##4##(1991-12#1)(1992-3#1)(1997-7#1)
tyrosine phosphorylation of cellular proteins##4##5##(1992-10#1)(1992-12#1)(1994-12#1)(1996-5#1)
tyrosine phosphorylation of cellular##5##4##(1992-10#1)(1992-12#1)(1994-12#1)(1995-3#1)(1996-5#1)
tyrosine phosphorylation of focal adhesion kinase##2##6##(1997-7#2)
tyrosine phosphorylation of multiple##2##4##(1992-10#1)(1993-8#1)
tyrosine phosphorylation of p125FAK##2##4##(1994-9#2)
tyrosine phosphorylation of p95vav in##2##5##(1995-3#2)
tyrosine phosphorylation of p95vav##3##4##(1995-3#3)
tyrosine phosphorylation of paxillin##6##4##(1996-5#4)(1997-7#2)
tyrosine phosphorylation of proteins##2##4##(1995-2#1)(1995-8#1)
tyrosine phosphorylation of several##4##4##(1992-8#1)(1994-6#2)(1994-9#1)
tyrosine phosphorylation of the GH receptor##2##6##(1995-3#2)
tyrosine phosphorylation of the receptor##2##5##(1992-9#1)(1995-3#1)
tyrosine phosphorylation of the##18##4##(1990-3#1)(1991-3#1)(1992-6#1)(1992-9#1)(1993-4#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#6)(1996-2#1)(1996-5#1)(1997-6#1)(2008-4#1)
tyrosine phosphorylation of this##2##4##(1996-8#1)(1997-7#1)
tyrosine phosphorylation of##106##3##(1990-11#1)(1990-3#1)(1991-12#1)(1991-3#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#5)(1992-8#2)(1992-9#1)(1993-3#2)(1993-4#1)(1993-8#3)(1994-12#8)(1994-3#5)(1994-6#3)(1994-8#1)(1994-9#6)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#13)(1995-6#3)(1995-8#2)(1996-2#2)(1996-5#11)(1996-8#1)(1997-1#2)(1997-2#4)(1997-6#1)(1997-7#11)(2008-4#2)(2008-8#1)(2012-12#1)(2012-3#1)
tyrosine phosphorylation on##2##3##(1993-3#1)(1993-9#1)
tyrosine phosphorylation sites##3##3##(1995-3#1)(1995-6#1)(2005-8#1)
tyrosine phosphorylation to##2##3##(1990-11#1)(2011-1#1)
tyrosine phosphorylation was observed##2##4##(1990-7#1)(1991-12#1)
tyrosine phosphorylation was##6##3##(1990-7#1)(1991-12#1)(1992-8#1)(1994-6#1)(1997-1#1)(1997-7#1)
tyrosine phosphorylation##233##2##(1990-11#4)(1990-3#4)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#3)(1991-3#1)(1991-5#1)(1992-10#3)(1992-11#3)(1992-12#1)(1992-3#4)(1992-4#1)(1992-6#5)(1992-8#4)(1992-9#2)(1993-3#4)(1993-4#2)(1993-6#1)(1993-8#7)(1993-9#2)(1994-12#11)(1994-2#1)(1994-3#6)(1994-6#15)(1994-8#5)(1994-9#11)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#22)(1995-5#5)(1995-6#6)(1995-8#4)(1996-12#3)(1996-2#5)(1996-4#1)(1996-5#22)(1996-6#1)(1996-8#1)(1997-1#6)(1997-2#5)(1997-3#1)(1997-6#4)(1997-7#19)(2005-8#1)(2008-4#3)(2008-8#1)(2010-8#1)(2011-1#2)(2012-12#2)(2012-3#5)
tyrosine phosphorylations of##2##3##(1990-12#1)(2012-12#1)
tyrosine protein kinase activity##4##4##(1991-11#1)(1992-3#3)
tyrosine protein kinase inhibitor##2##4##(1991-11#1)(1994-3#1)
tyrosine protein kinase p56lck##2##4##(1991-11#2)
tyrosine protein kinase##14##3##(1990-12#2)(1990-3#1)(1990-8#1)(1991-11#4)(1992-3#4)(1994-3#1)(2008-4#1)
tyrosine protein kinases##12##3##(1990-12#3)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-8#2)(2005-7#1)(2008-4#2)
tyrosine protein##30##2##(1990-12#5)(1990-3#1)(1990-7#1)(1990-8#1)(1991-11#4)(1991-12#1)(1991-2#1)(1991-5#1)(1992-3#4)(1992-8#2)(1994-3#1)(1994-9#1)(1996-5#1)(2005-7#1)(2008-4#3)(2013-7#2)
tyrosine residue in##2##3##(1994-8#1)(1996-5#1)
tyrosine residue##19##2##(1991-2#1)(1991-6#1)(1992-1#1)(1992-6#1)(1993-11#1)(1994-6#1)(1994-8#2)(1995-11#1)(1996-5#2)(1996-6#1)(1997-6#2)(2005-8#1)(2008-4#2)(2009-5#1)(2011-1#1)
tyrosine residue(s)##2##2##(1992-3#1)(1994-12#1)
tyrosine residues are phosphorylated##2##4##(1994-6#1)(2008-4#1)
tyrosine residues are##4##3##(1990-10#1)(1994-6#1)(1996-10#1)(2008-4#1)
tyrosine residues for##2##3##(1990-12#1)(1991-7#1)
tyrosine residues in the##3##4##(1992-8#1)(1993-9#1)(1995-3#1)
tyrosine residues in##11##3##(1990-5#2)(1991-12#1)(1992-8#1)(1993-6#1)(1993-9#1)(1995-12#1)(1995-3#2)(1995-8#1)(2008-8#1)
tyrosine residues is##2##3##(1994-11#1)(1995-1#1)
tyrosine residues located in##2##4##(1995-6#1)(2008-4#1)
tyrosine residues may##3##3##(1992-9#2)(1994-11#1)
tyrosine residues of the##2##4##(1990-5#1)(1995-3#1)
tyrosine residues of various##2##4##(2006-6#1)(2008-1#1)
tyrosine residues of##9##3##(1990-3#1)(1990-5#1)(1995-3#2)(2006-6#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)
tyrosine residues on the##2##4##(1990-5#1)(1996-4#1)
tyrosine residues on##3##3##(1990-5#1)(1996-4#1)(2012-3#1)
tyrosine residues were##3##3##(1990-12#1)(1995-3#1)(2005-11#1)
tyrosine residues##72##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#3)(1990-5#5)(1991-12#1)(1991-2#3)(1991-5#1)(1991-7#3)(1992-3#1)(1992-8#2)(1992-9#4)(1993-5#1)(1993-6#1)(1993-9#2)(1994-11#4)(1994-2#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-3#6)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-5#2)(1997-9#1)(2005-11#1)(2005-7#1)(2006-6#1)(2008-1#1)(2008-4#8)(2008-7#1)(2008-8#3)(2011-2#1)(2012-3#1)
tyrosine sulfate in##9##3##(1990-3#9)
tyrosine sulfate##11##2##(1990-3#11)
tyrosine sulfation##5##2##(1990-3#5)
tyrosine through##2##2##(1990-3#1)(2008-10#1)
tyrosine to##6##2##(1993-12#2)(1993-9#1)(1996-2#1)(1997-7#1)(2012-12#1)
tyrosine was##3##2##(1995-3#1)(1996-9#1)(2008-10#1)
tyrosine##1158##1##(1990-10#3)(1990-11#12)(1990-12#13)(1990-2#2)(1990-3#29)(1990-4#6)(1990-5#15)(1990-7#11)(1990-8#5)(1990-9#2)(1991-1#2)(1991-10#4)(1991-11#7)(1991-12#15)(1991-2#12)(1991-3#3)(1991-4#7)(1991-5#13)(1991-6#2)(1991-7#14)(1991-8#4)(1991-9#8)(1992-1#2)(1992-10#4)(1992-11#9)(1992-12#21)(1992-3#16)(1992-4#2)(1992-5#1)(1992-6#9)(1992-7#9)(1992-8#18)(1992-9#12)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#13)(1993-4#7)(1993-5#2)(1993-6#15)(1993-7#5)(1993-8#21)(1993-9#9)(1994-10#4)(1994-11#8)(1994-12#22)(1994-2#9)(1994-3#13)(1994-5#5)(1994-6#28)(1994-8#27)(1994-9#35)(1995-1#6)(1995-10#1)(1995-11#13)(1995-12#9)(1995-2#17)(1995-3#52)(1995-5#9)(1995-6#15)(1995-7#3)(1995-8#16)(1995-9#8)(1996-1#4)(1996-10#5)(1996-11#4)(1996-12#9)(1996-2#14)(1996-3#1)(1996-4#5)(1996-5#55)(1996-6#14)(1996-7#1)(1996-8#4)(1996-9#8)(1997-1#9)(1997-2#15)(1997-3#5)(1997-4#3)(1997-5#13)(1997-6#20)(1997-7#27)(1997-8#2)(1997-9#1)(2004-2#1)(2005-11#1)(2005-4#2)(2005-6#2)(2005-7#7)(2005-8#7)(2006-10#2)(2006-11#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#9)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#10)(2008-4#24)(2008-5#19)(2008-6#4)(2008-7#6)(2008-8#9)(2008-9#2)(2009-10#3)(2009-11#2)(2009-2#1)(2009-3#9)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#8)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#8)(2011-3#1)(2012-1#2)(2012-12#29)(2012-2#9)(2012-3#10)(2013-1#9)(2013-7#3)(2013-8#3)
tyrosine)##6##1##(1991-4#1)(1991-7#2)(1993-3#1)(2008-10#1)(2008-5#1)
tyrosine-114##2##1##(1995-5#2)
tyrosine-75##2##1##(1991-4#2)
tyrosine-based##3##1##(1996-5#1)(2007-8#1)(2012-1#1)
tyrosine-beta##3##1##(1991-3#3)
tyrosine-hydroxylase##2##1##(1993-5#1)(1995-9#1)
tyrosine-kinase##2##1##(1995-8#1)(2008-6#1)
tyrosine-kinases##2##1##(1996-2#1)(2011-1#1)
tyrosine-phosphorylated peptides##4##2##(2008-1#2)(2008-4#2)
tyrosine-phosphorylated proteins##3##2##(1991-10#1)(1994-12#1)(1995-1#1)
tyrosine-phosphorylated substrates##2##2##(2008-4#2)
tyrosine-phosphorylated##26##1##(1991-10#2)(1992-10#1)(1994-12#1)(1995-1#2)(1995-2#1)(1995-3#2)(1995-6#2)(1995-8#1)(1996-4#1)(1996-5#2)(1997-6#1)(1997-7#1)(2007-8#1)(2008-1#2)(2008-4#4)(2008-8#1)(2012-12#1)
tyrosine-specific protein kinase##2##3##(1992-1#1)(1992-5#1)
tyrosine-specific protein##5##2##(1990-9#2)(1992-1#1)(1992-5#1)(1995-1#1)
tyrosine-specific##7##1##(1990-11#1)(1990-9#2)(1992-1#1)(1992-5#2)(1995-1#1)
tyrosine-sulfated proteins##2##2##(1990-3#2)
tyrosine-sulfated##5##1##(1990-3#5)
tyrosine139cysteine##2##1##(2012-12#2)
tyrosinemia type I##2##3##(1992-8#1)(1992-9#1)
tyrosinemia##5##1##(1992-8#4)(1992-9#1)
tyrosines at 32##2##3##(1993-9#2)
tyrosines at##3##2##(1992-9#1)(1993-9#2)
tyrosines in the##3##3##(1992-9#1)(1995-2#1)(2011-1#1)
tyrosines in##5##2##(1992-9#1)(1993-6#1)(1995-2#1)(2010-8#1)(2011-1#1)
tyrosines on##2##2##(1991-1#1)(1994-9#1)
tyrosines to the##2##3##(1992-12#1)(2006-10#1)
tyrosines to##3##2##(1992-12#1)(1995-1#1)(2006-10#1)
tyrosines##28##1##(1991-1#2)(1992-12#3)(1992-9#4)(1993-6#2)(1993-9#4)(1994-6#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-9#1)(2006-10#1)(2010-1#1)(2010-8#2)(2011-1#1)
tyrosol galactoside##2##2##(2011-2#2)
tyrosyl phosphorylation of SHC proteins##2##5##(1995-3#2)
tyrosyl phosphorylation of SHC##3##4##(1995-3#3)
tyrosyl phosphorylation of##5##3##(1994-9#1)(1995-3#4)
tyrosyl phosphorylation##8##2##(1993-3#1)(1993-6#1)(1994-9#1)(1995-3#4)(1997-7#1)
tyrosyl protein sulfotransferase##2##3##(1991-12#2)
tyrosyl radical##10##2##(1991-7#1)(1993-11#2)(1995-10#3)(1997-7#4)
tyrosyl residue##4##2##(1990-12#2)(1991-7#1)(2008-8#1)
tyrosyl residues##3##2##(1991-12#1)(2008-1#1)(2008-2#1)
tyrosyl##39##1##(1990-12#2)(1990-2#2)(1990-7#1)(1991-12#4)(1991-7#5)(1992-12#3)(1993-11#2)(1993-3#1)(1993-6#1)(1994-9#1)(1995-1#1)(1995-10#3)(1995-3#4)(1997-3#1)(1997-7#5)(2008-1#1)(2008-2#1)(2008-8#1)
tyrosyl-tRNA synthetase in##2##3##(1995-1#1)(1997-2#1)
tyrosyl-tRNA synthetase##4##2##(1995-1#2)(1996-2#1)(1997-2#1)
tyrosylphosphorylation##3##1##(1992-11#3)
tyrphostin 23##2##2##(1992-12#2)
tyrphostin##7##1##(1992-12#4)(1994-12#1)(1994-9#1)(1997-6#1)
u is##2##2##(2008-2#1)(2008-8#1)
u##34##1##(1990-11#1)(1990-6#1)(1991-11#1)(1991-3#1)(1991-5#6)(1994-12#1)(1994-9#2)(1997-2#2)(1997-4#1)(2006-9#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#3)(2010-4#1)(2012-2#2)(2013-1#2)
u-PA activity##2##2##(1991-10#1)(1996-9#1)
u-PA and its##2##3##(1993-12#1)(1993-3#1)
u-PA and u-PAR##2##3##(1993-3#2)
u-PA and##6##2##(1991-1#1)(1993-12#1)(1993-3#3)(2008-4#1)
u-PA antigen##2##2##(1993-12#2)
u-PA in##3##2##(1990-11#1)(1994-3#1)(1996-9#1)
u-PA was##3##2##(1993-4#1)(2008-11#2)
u-PA##36##1##(1990-11#10)(1991-1#5)(1991-10#2)(1993-12#4)(1993-3#4)(1993-4#1)(1994-3#3)(1996-9#3)(2008-11#3)(2008-4#1)
u-PAR mRNA##2##2##(1993-12#1)(1993-3#1)
u-PAR##4##1##(1993-12#1)(1993-3#3)
u-shaped##3##1##(2008-7#1)(2012-12#2)
uH2A##2##1##(1994-8#2)
uM)##2##1##(2008-11#2)
uPA activity was##2##3##(1990-5#2)
uPA and the##2##3##(1990-12#1)(2008-11#1)
uPA and uPAR##2##3##(1995-5#1)(1997-7#1)
uPA and##4##2##(1990-12#1)(1995-5#1)(1997-7#1)(2008-11#1)
uPA are##2##2##(2007-12#1)(2008-11#1)
uPA by##2##2##(1990-12#1)(2008-11#1)
uPA that##2##2##(2008-11#2)
uPA##43##1##(1990-11#1)(1990-12#5)(1990-5#5)(1995-5#4)(1996-8#2)(1997-4#2)(1997-7#7)(2007-12#2)(2008-11#15)
uPA-IgG##5##1##(1997-4#5)
uPAR complexes##5##2##(1997-7#5)
uPAR levels##3##2##(1995-5#3)
uPAR was##2##2##(1995-5#1)(1997-7#1)
uPAR##17##1##(1995-5#6)(1997-4#2)(1997-7#9)
u])##3##1##(2012-12#3)
uberis##3##1##(1993-2#1)(1996-8#2)
uberrima fides##2##2##(1997-8#2)
ubiG##2##1##(1996-7#2)
ubidiai##3##1##(2008-5#3)
ubihydroquinone##3##1##(1992-3#1)(1997-3#2)
ubiquinol and alpha-tocopherol##2##3##(1997-6#2)
ubiquinol oxidase##4##2##(1992-11#2)(1995-1#2)
ubiquinol##14##1##(1992-11#3)(1994-5#2)(1995-1#2)(1996-9#3)(1997-6#2)(2005-8#2)
ubiquinol-1##2##1##(1994-5#1)(2006-8#1)
ubiquinol-10 in##3##2##(1997-2#3)
ubiquinol-10##14##1##(1997-2#13)(1997-8#1)
ubiquinone and##2##2##(1992-3#2)
ubiquinone biosynthesis##2##2##(1996-7#2)
ubiquinone molecules##2##2##(1992-3#1)(1995-3#1)
ubiquinone of the##3##3##(1992-3#2)(2011-1#1)
ubiquinone oxidoreductase (complex I)##2##4##(1994-8#1)(1997-8#1)
ubiquinone oxidoreductase##4##2##(1993-12#1)(1994-8#1)(1997-8#1)(2008-10#1)
ubiquinone pool##3##2##(1990-8#1)(1992-3#1)(1997-7#1)
ubiquinone reductase##2##2##(1992-11#1)(1995-8#1)
ubiquinone with##3##2##(1992-3#2)(1994-8#1)
ubiquinone##39##1##(1990-7#3)(1990-8#3)(1992-11#1)(1992-3#9)(1993-12#1)(1994-11#1)(1994-8#2)(1995-3#3)(1995-6#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-7#5)(1997-3#1)(1997-7#1)(1997-8#1)(2007-8#2)(2008-10#1)(2011-1#1)
ubiquinone-10##3##1##(1997-2#3)
ubiquitin and the##2##3##(1995-5#1)(2012-3#1)
ubiquitin and##5##2##(1992-3#1)(1994-2#1)(1994-9#1)(1995-5#1)(2012-3#1)
ubiquitin can also be##2##4##(2007-8#1)(2012-3#1)
ubiquitin chains in##2##3##(2012-3#2)
ubiquitin chains##3##2##(2012-3#3)
ubiquitin conjugates##5##2##(1991-1#1)(1994-2#3)(1994-9#1)
ubiquitin from##2##2##(2008-1#1)(2008-9#1)
ubiquitin ligase in the##2##4##(2009-10#1)(2013-1#1)
ubiquitin ligase##9##2##(1996-4#1)(2009-10#2)(2011-3#2)(2012-11#1)(2012-12#2)(2013-1#1)
ubiquitin ligases##5##2##(2009-10#1)(2012-12#1)(2013-1#3)
ubiquitin moieties##2##2##(2012-3#2)
ubiquitin moiety##2##2##(1996-10#2)
ubiquitin molecules##2##2##(2012-3#2)
ubiquitin pathway components##2##3##(2007-12#2)
ubiquitin pathway##5##2##(1995-12#1)(2007-12#2)(2009-8#2)
ubiquitin promoter##2##2##(2008-9#2)
ubiquitin protein##2##2##(1993-8#1)(1997-3#1)
ubiquitin system##3##2##(2008-1#2)(2012-12#1)
ubiquitin##88##1##(1991-1#4)(1991-7#2)(1991-8#1)(1992-3#1)(1993-6#1)(1993-7#1)(1993-8#2)(1994-10#1)(1994-2#4)(1994-9#3)(1995-12#1)(1995-3#3)(1995-5#1)(1996-10#2)(1996-4#3)(1997-2#2)(1997-3#1)(1997-7#1)(2005-12#1)(2006-12#1)(2007-12#2)(2007-8#2)(2008-1#6)(2008-4#2)(2008-7#1)(2008-9#4)(2009-10#3)(2009-7#2)(2009-8#3)(2011-3#2)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#14)(2013-1#5)
ubiquitin-activating enzyme##6##2##(1991-1#1)(1992-4#2)(2007-12#2)(2012-2#1)
ubiquitin-binding domain##2##2##(1997-7#2)
ubiquitin-binding domains##3##2##(1997-7#2)(2012-3#1)
ubiquitin-binding##6##1##(1997-7#5)(2012-3#1)
ubiquitin-conjugating enzymes##3##2##(1993-7#1)(2007-12#2)
ubiquitin-conjugating##5##1##(1993-7#2)(2007-12#2)(2009-8#1)
ubiquitin-dependent proteasomal degradation##2##3##(2009-7#1)(2013-1#1)
ubiquitin-dependent protein degradation##2##3##(1991-7#1)(2009-7#1)
ubiquitin-dependent proteolysis##4##2##(1991-7#2)(1991-9#1)(1992-11#1)
ubiquitin-dependent##12##1##(1991-7#5)(1991-9#1)(1992-11#1)(1994-9#1)(1995-6#1)(2009-7#2)(2013-1#1)
ubiquitin-extension protein gene in##2##4##(1997-2#2)
ubiquitin-extension protein##3##2##(1997-2#3)
ubiquitin-like domain##2##2##(2009-7#2)
ubiquitin-like modifier-1 (SUMO-1)##2##3##(2011-1#1)(2011-2#1)
ubiquitin-like protein##2##2##(1993-8#1)(2007-8#1)
ubiquitin-like##10##1##(1993-6#1)(1993-8#1)(2007-8#1)(2008-4#1)(2009-7#2)(2011-1#1)(2011-2#2)(2012-3#1)
ubiquitin-mediated degradation##2##2##(1994-9#2)
ubiquitin-mediated##4##1##(1992-11#1)(1994-9#2)(2007-12#1)
ubiquitin-positive##3##1##(2006-12#1)(2008-9#1)(2011-2#1)
ubiquitin-proteasome system##5##2##(2007-12#1)(2010-4#2)(2011-2#1)(2012-2#1)
ubiquitin-proteasome##11##1##(2007-12#1)(2008-9#5)(2010-4#2)(2011-2#1)(2012-2#1)(2012-3#1)
ubiquitin-protein conjugates##7##2##(1990-2#3)(1991-1#1)(1994-11#1)(1994-2#1)(2008-4#1)
ubiquitin-protein conjugation##2##2##(1991-7#2)
ubiquitin-protein ligases##5##2##(1995-6#2)(2007-12#3)
ubiquitin-protein##15##1##(1990-2#3)(1991-1#1)(1991-7#3)(1994-11#1)(1994-2#1)(1995-6#2)(2007-12#3)(2008-4#1)
ubiquitinated histone##3##2##(1994-8#3)
ubiquitinated##9##1##(1994-2#2)(1994-8#5)(1997-7#1)(2012-12#1)
ubiquitination and##2##2##(2009-8#1)(2011-1#1)
ubiquitination is##2##2##(2008-8#1)(2013-1#1)
ubiquitination of##4##2##(1991-6#1)(2006-10#1)(2008-4#1)(2008-8#1)
ubiquitination##28##1##(1990-2#1)(1991-6#2)(1991-7#2)(1993-7#2)(1996-4#2)(2006-10#1)(2008-4#2)(2008-8#2)(2008-9#4)(2009-10#1)(2009-7#1)(2009-8#2)(2011-1#3)(2012-3#1)(2013-1#2)
ubiquitous and abundant##2##3##(2008-10#1)(2011-1#1)
ubiquitous and highly conserved##2##4##(1991-5#1)(1992-12#1)
ubiquitous and##7##2##(1991-5#1)(1992-12#1)(1993-8#1)(2008-10#1)(2008-8#1)(2010-12#1)(2011-1#1)
ubiquitous casein kinase II (CKII)##2##5##(1991-10#2)
ubiquitous component of##2##3##(2006-10#1)(2013-8#1)
ubiquitous distribution##2##2##(1996-7#1)(2008-10#1)
ubiquitous enzymes##2##2##(2007-12#1)(2013-8#1)
ubiquitous factor##3##2##(1990-11#1)(1993-6#1)(1994-12#1)
ubiquitous in biological systems##3##4##(1991-11#1)(2009-10#1)(2010-3#1)
ubiquitous in the environment##2##4##(2010-9#1)(2011-2#1)
ubiquitous in the##5##3##(2008-10#1)(2008-9#1)(2010-6#1)(2010-9#1)(2011-2#1)
ubiquitous in##26##2##(1991-11#1)(1995-12#1)(2006-10#2)(2008-1#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#1)
ubiquitous mitochondrial##2##2##(1995-6#2)
ubiquitous nature of the##2##4##(2008-10#1)(2008-7#1)
ubiquitous nature##3##2##(2007-8#1)(2008-10#1)(2008-7#1)
ubiquitous neuronal##2##2##(1996-2#1)(2007-10#1)
ubiquitous presence of##3##3##(1997-4#1)(2008-2#1)(2013-1#1)
ubiquitous presence##4##2##(1997-4#1)(2008-2#1)(2011-2#1)(2013-1#1)
ubiquitous protein##4##2##(1996-5#1)(2008-7#1)(2009-10#1)(2013-1#1)
ubiquitous proteins##2##2##(1996-8#1)(2008-5#1)
ubiquitous second##2##2##(2008-4#1)(2009-6#1)
ubiquitous##158##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1990-8#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-5#3)(1992-10#1)(1992-11#3)(1992-12#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-6#3)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-4#3)(1997-6#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#1)(2007-10#1)(2007-12#2)(2007-2#3)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#12)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#2)(2010-10#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-9#1)(2011-1#4)(2011-12#3)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
ubiquitously expressed and##4##3##(1991-1#1)(2008-4#1)(2010-2#1)(2013-8#1)
ubiquitously expressed##23##2##(1991-1#1)(1992-6#1)(1994-12#1)(1995-1#3)(1995-8#1)(1996-10#1)(1996-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-11#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
ubiquitously in all##2##3##(1997-2#1)(1997-4#1)
ubiquitously in##5##2##(1991-6#1)(1994-2#1)(1997-2#1)(1997-4#1)(2010-7#1)
ubiquitously present in the environment##2##5##(2009-10#1)(2011-1#1)
ubiquitously##45##1##(1990-4#1)(1991-1#1)(1991-6#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-1#3)(1995-11#1)(1995-6#1)(1995-8#1)(1996-10#2)(1996-2#1)(1997-2#1)(1997-4#3)(1997-7#2)(1997-8#1)(2005-11#1)(2006-6#1)(2008-4#1)(2008-8#1)(2009-10#2)(2009-8#1)(2010-2#1)(2010-7#4)(2011-1#2)(2011-2#2)(2012-2#1)(2013-8#2)
ubiquity##4##1##(1993-3#1)(2008-9#1)(2011-12#1)(2012-3#1)
ubiquitylated##2##1##(2009-8#1)(2013-1#1)
ubiquitylates Aurora-A##2##2##(2012-12#2)
ubiquitylation and##2##2##(2011-1#2)
ubiquitylation of##2##2##(2012-12#1)(2013-8#1)
ubiquitylation##8##1##(2008-1#2)(2011-1#3)(2012-12#2)(2013-8#1)
ucp##2##1##(1994-9#2)
ucsd##2##1##(2013-1#2)
uda##3##1##(1991-9#3)
udder##2##1##(1990-6#1)(2011-2#1)
udel##2##1##(2008-7#2)
ug ml(-1)##3##2##(2008-11#3)
ugly##10##1##(1994-12#1)(2006-12#2)(2006-8#1)(2007-8#1)(2008-7#4)(2011-2#1)
uidA##5##1##(1994-3#1)(2008-10#2)(2008-5#1)(2008-8#1)
uk##2##1##(2006-12#1)(2009-4#1)
uk/##2##1##(2008-7#2)
ulcer =##3##2##(2008-5#3)
ulcer after##4##2##(2007-9#1)(2008-12#2)(2010-7#1)
ulcer and gastric cancer##2##4##(2006-8#1)(2008-1#1)
ulcer and other##2##3##(2006-10#1)(2006-2#1)
ulcer and##18##2##(1992-11#2)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-3#1)(2007-8#2)(2008-1#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
ulcer bleeding##7##2##(1992-10#2)(2012-2#2)(2013-1#1)(2013-8#2)
ulcer bleedings##2##2##(1992-5#2)
ulcer disease (PUD)##4##3##(2006-10#1)(2006-8#1)(2007-3#1)(2008-5#1)
ulcer disease and gastric##2##4##(2006-2#1)(2010-12#1)
ulcer disease and its##3##4##(2006-10#1)(2006-8#1)(2007-7#1)
ulcer disease and##7##3##(2006-10#2)(2006-2#1)(2006-8#1)(2007-7#1)(2008-12#1)(2010-12#1)
ulcer disease in the##2##4##(2006-10#1)(2006-2#1)
ulcer disease in##5##3##(2006-10#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-9#1)
ulcer disease is##3##3##(1997-1#1)(2006-10#2)
ulcer disease##55##2##(1991-5#1)(1992-9#2)(1993-2#1)(1995-4#1)(1996-11#1)(1996-2#1)(1997-1#3)(1997-3#1)(1997-6#1)(2006-10#18)(2006-2#2)(2006-8#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-9#2)(2008-12#2)(2008-5#5)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#2)(2011-2#1)
ulcer has been##3##3##(2005-12#2)(2007-7#1)
ulcer have##2##2##(2007-2#1)(2009-2#1)
ulcer healing in the colon##2##5##(2008-12#2)
ulcer healing in##3##3##(2007-11#1)(2008-12#2)
ulcer healing##14##2##(1994-3#1)(1995-4#1)(2006-10#1)(2007-11#3)(2008-12#2)(2010-12#1)(2012-2#4)(2013-8#1)
ulcer hemorrhage##2##2##(2006-10#1)(2013-1#1)
ulcer in a##4##3##(2007-5#1)(2010-4#1)(2011-2#1)(2012-2#1)
ulcer in##11##2##(2005-10#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-5#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)
ulcer index##4##2##(1991-2#1)(2009-5#2)(2010-12#1)
ulcer is a##5##3##(1990-3#1)(1990-9#1)(1996-11#1)(2008-9#1)(2010-8#1)
ulcer is##11##2##(1990-3#1)(1990-9#1)(1992-11#1)(1993-6#1)(1996-11#1)(2006-2#1)(2008-12#1)(2008-9#1)(2010-4#1)(2010-8#1)(2013-1#1)
ulcer may be##2##3##(2008-12#1)(2011-2#1)
ulcer may##3##2##(2008-12#1)(2011-2#1)(2012-2#1)
ulcer model##6##2##(2010-12#3)(2012-2#3)
ulcer models##2##2##(1992-6#1)(2005-11#1)
ulcer of the stomach##2##4##(2008-9#2)
ulcer of the##6##3##(1990-3#1)(2007-7#1)(2008-11#1)(2008-9#2)(2011-2#1)
ulcer of##8##2##(1990-11#1)(1990-3#1)(2007-7#1)(2008-11#1)(2008-9#2)(2009-10#1)(2011-2#1)
ulcer on the##2##3##(2007-7#1)(2008-5#1)
ulcer on##3##2##(2007-11#1)(2007-7#1)(2008-5#1)
ulcer or##2##2##(2005-3#1)(2010-12#1)
ulcer patients and##3##3##(1997-3#1)(2007-3#1)(2008-5#1)
ulcer patients##13##2##(1992-9#1)(1997-1#2)(1997-3#1)(2006-8#1)(2007-3#6)(2008-5#2)
ulcer perforation##2##2##(2007-11#1)(2007-9#1)
ulcer prevention##2##2##(2007-7#1)(2008-12#1)
ulcer protective##4##2##(2010-12#3)(2012-2#1)
ulcer recurrence##3##2##(1991-8#1)(2007-9#1)(2012-1#1)
ulcer should undergo##2##3##(1995-3#1)(2008-10#1)
ulcer surgery##2##2##(2006-10#1)(2007-3#1)
ulcer that does not heal##2##5##(2008-1#2)
ulcer that##4##2##(2008-1#3)(2008-9#1)
ulcer to##3##2##(2006-8#1)(2008-12#1)(2008-5#1)
ulcer treatment##2##2##(1991-2#1)(2007-3#1)
ulcer was##8##2##(1992-6#1)(2006-8#2)(2008-12#1)(2008-5#2)(2008-8#1)(2011-2#1)
ulcer with##4##2##(1991-4#1)(1992-10#1)(2007-7#1)(2008-12#1)
ulcer wound##4##2##(2013-1#4)
ulcer##359##1##(1990-11#1)(1990-12#2)(1990-3#4)(1990-6#6)(1990-9#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#7)(1992-11#4)(1992-5#3)(1992-6#4)(1992-8#1)(1992-9#3)(1993-2#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-10#2)(1995-12#1)(1995-3#1)(1995-4#2)(1995-9#1)(1996-1#1)(1996-11#4)(1996-2#1)(1996-6#1)(1996-7#2)(1997-1#5)(1997-3#3)(1997-6#1)(2005-10#1)(2005-11#5)(2005-12#4)(2005-3#1)(2006-10#31)(2006-11#1)(2006-2#7)(2006-6#1)(2006-8#17)(2006-9#4)(2007-1#1)(2007-11#8)(2007-12#2)(2007-2#6)(2007-3#12)(2007-5#3)(2007-7#16)(2007-8#8)(2007-9#5)(2008-1#6)(2008-10#2)(2008-11#4)(2008-12#16)(2008-5#18)(2008-7#1)(2008-8#3)(2008-9#10)(2009-10#2)(2009-2#1)(2009-5#2)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#13)(2010-4#6)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#11)(2012-1#2)(2012-11#2)(2012-12#5)(2012-2#13)(2012-3#7)(2013-1#10)(2013-8#10)
ulcer]##9##1##(1993-6#1)(1994-3#1)(1996-12#1)(1997-3#1)(2006-6#1)(2007-5#1)(2012-11#1)(2012-12#1)(2012-3#1)
ulcerated lesion on##2##3##(2007-8#1)(2013-1#1)
ulcerated mass on the##2##4##(2007-2#1)(2007-6#1)
ulcerated psoriatic plaques##2##3##(2012-2#2)
ulcerated tumors were##2##3##(2007-8#2)
ulcerated##22##1##(1990-6#1)(1991-9#1)(2005-11#1)(2005-7#1)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#5)(2009-10#1)(2010-12#1)(2012-2#3)(2012-3#1)(2013-1#3)
ulceration and##8##2##(1996-11#1)(1996-12#2)(2006-11#1)(2006-6#1)(2006-9#1)(2009-2#1)(2012-1#1)
ulceration following##2##2##(2008-3#1)(2013-1#1)
ulceration in##4##2##(1991-8#1)(2009-5#1)(2012-2#1)(2013-1#1)
ulceration is the##2##3##(2008-1#1)(2013-7#1)
ulceration is##4##2##(1996-12#1)(2008-1#1)(2012-1#1)(2013-7#1)
ulceration of the mouth in##2##5##(2008-5#1)(2012-2#1)
ulceration of the##8##3##(1991-4#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-11#1)(2012-2#1)(2013-7#1)
ulceration of##13##2##(1990-6#1)(1991-4#1)(1996-8#2)(2005-7#1)(2007-10#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-11#1)(2012-2#1)(2013-7#1)
ulceration was##4##2##(1990-10#1)(2007-7#1)(2013-1#2)
ulceration##87##1##(1990-10#2)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-5#1)(1996-11#2)(1996-12#5)(1996-3#1)(1996-8#2)(1997-1#1)(2005-10#1)(2005-7#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#2)(2008-1#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-12#2)(2010-4#1)(2010-8#1)(2010-9#2)(2011-12#1)(2012-1#8)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#4)(2013-7#2)(2013-8#4)
ulcerations and##4##2##(2007-10#1)(2007-8#1)(2008-5#1)(2010-7#1)
ulcerations in the##2##3##(2006-7#1)(2007-7#1)
ulcerations##20##1##(1992-2#1)(1993-10#1)(1997-8#1)(2005-10#1)(2006-7#1)(2007-10#2)(2007-12#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-5#1)(2010-12#2)(2010-7#1)
ulcerative colitis (UC) are##2##4##(2010-12#1)(2011-2#1)
ulcerative colitis (UC) is##2##4##(1991-9#1)(2010-12#1)
ulcerative colitis (UC)##13##3##(1991-9#1)(2005-6#1)(2006-10#1)(2007-4#1)(2009-8#1)(2010-12#4)(2011-2#1)(2012-11#1)(2012-3#1)(2013-8#1)
ulcerative colitis and Crohn disease##2##5##(2006-10#2)
ulcerative colitis and Crohn's disease##4##5##(1995-8#1)(2006-2#2)(2008-12#1)
ulcerative colitis and Crohn's##5##4##(1995-8#1)(2006-2#2)(2008-12#1)(2012-11#1)
ulcerative colitis and##12##3##(1995-8#1)(2005-8#1)(2006-10#3)(2006-2#2)(2008-12#1)(2011-12#1)(2012-11#2)(2013-8#1)
ulcerative colitis are##3##3##(1996-2#1)(2006-10#1)(2012-12#1)
ulcerative colitis in##3##3##(1991-6#1)(2007-2#1)(2012-11#1)
ulcerative colitis is##5##3##(1992-9#1)(1995-9#1)(2005-7#1)(2007-10#1)(2012-1#1)
ulcerative colitis on##2##3##(1995-10#1)(2012-12#1)
ulcerative colitis patients and##2##4##(1994-2#1)(2011-1#1)
ulcerative colitis patients##4##3##(1992-9#1)(1994-2#1)(2005-12#1)(2011-1#1)
ulcerative colitis the##2##3##(2006-10#1)(2008-12#1)
ulcerative colitis were##4##3##(1990-7#1)(1992-9#1)(1994-2#1)(1995-10#1)
ulcerative colitis with##2##3##(2007-4#1)(2008-5#1)
ulcerative colitis##142##2##(1990-7#2)(1990-9#2)(1991-6#2)(1991-9#1)(1992-9#4)(1993-10#1)(1994-2#3)(1994-6#2)(1995-10#3)(1995-8#1)(1995-9#1)(1996-2#1)(1996-8#2)(1997-8#1)(2005-11#1)(2005-12#2)(2005-6#1)(2005-7#2)(2005-8#2)(2006-10#26)(2006-12#1)(2006-2#10)(2006-9#1)(2007-10#4)(2007-11#1)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-5#6)(2009-4#2)(2009-5#3)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#14)(2011-1#4)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#6)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
ulcerative colitis]##13##2##(1990-6#1)(1993-2#1)(2005-11#1)(2007-9#1)(2008-12#1)(2012-11#7)(2013-8#1)
ulcerative lesions##3##2##(2007-8#1)(2010-12#1)(2013-1#1)
ulcerative pancolitis##2##2##(2010-12#2)
ulcerative rectocolitis##3##2##(1990-3#1)(1992-3#2)
ulcerative##175##1##(1990-3#1)(1990-6#1)(1990-7#2)(1990-9#2)(1991-3#1)(1991-6#2)(1991-9#2)(1992-3#3)(1992-9#4)(1993-10#1)(1993-2#1)(1994-2#3)(1994-6#2)(1995-10#3)(1995-8#1)(1995-9#1)(1996-2#1)(1996-8#2)(1997-5#1)(1997-8#1)(2005-11#2)(2005-12#2)(2005-6#1)(2005-7#2)(2005-8#2)(2006-10#26)(2006-12#1)(2006-2#10)(2006-8#1)(2006-9#1)(2007-10#4)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#1)(2008-12#3)(2008-5#6)(2009-4#2)(2009-5#3)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#19)(2011-1#4)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#13)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#3)
ulcerogenic stimuli##2##2##(1993-12#2)
ulcerogenic##8##1##(1993-12#3)(2006-10#1)(2010-2#2)(2011-1#2)
ulceronecrotic##3##1##(2011-2#3)
ulcerous##4##1##(1990-1#1)(1997-5#1)(2006-2#1)(2009-2#1)
ulcers and other##2##3##(1996-11#1)(2006-8#1)
ulcers and##19##2##(1992-3#1)(1995-2#1)(1996-11#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-5#1)(2010-12#1)(2012-2#1)(2013-8#2)
ulcers are##7##2##(1990-5#1)(2007-10#1)(2007-8#1)(2013-1#4)
ulcers as well##2##3##(2005-11#1)(2007-7#1)
ulcers as##3##2##(2005-11#1)(2005-7#1)(2007-7#1)
ulcers associated with##5##3##(2007-11#1)(2013-1#4)
ulcers at##4##2##(1995-3#1)(2005-11#1)(2010-9#1)(2012-2#1)
ulcers by##2##2##(1992-6#1)(2008-5#1)
ulcers during##2##2##(2006-9#1)(2007-7#1)
ulcers in a##3##3##(2007-7#2)(2012-2#1)
ulcers in the##3##3##(1990-11#1)(2005-12#1)(2010-12#1)
ulcers in##16##2##(1990-11#1)(2005-12#1)(2006-10#1)(2007-7#4)(2007-9#1)(2008-12#1)(2009-10#1)(2010-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
ulcers induced by##3##3##(2005-11#1)(2008-12#1)(2009-5#1)
ulcers is##3##2##(1990-12#1)(2006-10#1)(2007-11#1)
ulcers of the lower##2##4##(1990-3#1)(2007-11#1)
ulcers of the##7##3##(1990-3#1)(1992-5#1)(2007-11#1)(2008-5#1)(2008-8#2)(2012-11#1)
ulcers of##13##2##(1990-3#1)(1992-10#1)(1992-5#1)(2007-11#1)(2007-7#3)(2008-5#1)(2008-8#2)(2012-11#1)(2012-12#1)(2012-2#1)
ulcers often##3##2##(1997-3#1)(2013-1#2)
ulcers or##2##2##(1993-8#1)(2012-2#1)
ulcers that##3##2##(1991-11#1)(2013-1#2)
ulcers was##2##2##(2007-8#1)(2012-2#1)
ulcers were##8##2##(1996-11#1)(2006-6#1)(2007-10#1)(2007-3#2)(2008-5#1)(2009-2#1)(2012-3#1)
ulcers with##3##2##(1990-12#1)(1991-9#1)(2006-2#1)
ulcers##231##1##(1990-11#1)(1990-12#3)(1990-3#5)(1990-5#2)(1990-6#1)(1991-11#2)(1991-6#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-3#1)(1992-5#3)(1992-6#1)(1992-8#1)(1993-2#2)(1993-4#1)(1993-8#3)(1995-11#1)(1995-2#1)(1995-3#2)(1996-11#5)(1996-7#1)(1997-1#1)(1997-3#3)(2005-11#5)(2005-12#2)(2005-7#4)(2006-10#11)(2006-2#2)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#5)(2007-10#8)(2007-11#10)(2007-2#3)(2007-3#2)(2007-5#2)(2007-7#17)(2007-8#11)(2007-9#1)(2008-1#4)(2008-12#5)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#14)(2008-8#4)(2009-10#1)(2009-2#2)(2009-5#1)(2010-10#3)(2010-12#6)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#12)(2012-3#2)(2013-1#20)(2013-7#1)(2013-8#6)
ulcers]##5##1##(1990-5#1)(1993-8#2)(2006-6#1)(2007-2#1)
ulcus##2##1##(1992-5#2)
ulna at the##2##3##(2009-3#1)(2013-1#1)
ulna in a##3##3##(2009-3#1)(2011-2#2)
ulna in##6##2##(2007-11#1)(2007-8#1)(2009-3#1)(2011-2#2)(2013-8#1)
ulna was##2##2##(2007-8#2)
ulna##30##1##(1995-6#2)(2006-11#1)(2006-3#4)(2006-4#1)(2006-6#1)(2007-11#2)(2007-7#1)(2007-8#4)(2009-3#8)(2010-3#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
ulnae##3##1##(1996-12#1)(2006-7#1)(2007-8#1)
ulnar and tibial##2##3##(2011-2#2)
ulnar and##4##2##(2006-4#1)(2007-11#1)(2011-2#2)
ulnar collateral ligament##5##3##(2006-3#5)
ulnar digits##2##2##(2008-9#2)
ulnar impaction syndrome##2##3##(2006-3#1)(2006-4#1)
ulnar impaction##3##2##(2006-3#2)(2006-4#1)
ulnar nerve compression##4##3##(2006-4#1)(2008-9#3)
ulnar nerve in##2##3##(1992-6#1)(2007-7#1)
ulnar nerve##28##2##(1992-6#2)(1993-11#1)(1996-9#1)(2006-3#1)(2006-4#1)(2007-10#1)(2007-11#3)(2007-6#1)(2007-7#1)(2008-12#1)(2008-4#1)(2008-9#11)(2011-2#1)(2012-3#1)(2013-8#1)
ulnar neuropraxia##2##2##(2007-6#2)
ulnar osteotomy##4##2##(2008-4#4)
ulnar shortening##5##2##(2006-3#4)(2006-4#1)
ulnar##86##1##(1992-6#2)(1993-11#1)(1996-3#1)(1996-9#1)(1997-3#2)(2006-3#21)(2006-4#4)(2007-10#1)(2007-11#7)(2007-2#1)(2007-6#3)(2007-7#2)(2007-8#1)(2008-12#1)(2008-4#6)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#18)(2009-2#1)(2010-11#1)(2011-2#4)(2012-3#1)(2013-7#1)(2013-8#2)
ulnar-positive##2##1##(2008-9#2)
ulnaris##13##1##(1996-6#2)(2006-3#1)(2006-4#1)(2007-4#5)(2008-9#2)(2009-5#2)
ultimate aim##6##2##(1997-1#1)(2006-10#1)(2011-2#1)(2012-10#1)(2013-1#2)
ultimate carcinogen##2##2##(1990-11#1)(1995-5#1)
ultimate carcinogens##3##2##(1991-5#1)(1992-3#1)(1993-9#1)
ultimate clinical##3##2##(2007-12#1)(2013-1#2)
ultimate end##3##2##(2010-8#1)(2012-2#2)
ultimate fate of##3##3##(2006-2#1)(2008-10#2)
ultimate function##2##2##(2009-10#1)(2012-3#1)
ultimate goal in##2##3##(2005-7#1)(2008-7#1)
ultimate goal is to##5##4##(1992-2#1)(1993-6#1)(2005-7#1)(2008-11#1)(2012-3#1)
ultimate goal is##6##3##(1992-1#1)(1992-2#1)(1993-6#1)(2005-7#1)(2008-11#1)(2012-3#1)
ultimate goal of the##3##4##(2004-4#1)(2008-7#1)(2011-1#1)
ultimate goal of##17##3##(1994-3#2)(1997-8#1)(2004-4#1)(2006-1#1)(2006-2#1)(2006-4#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-2#1)
ultimate goal to##2##3##(2008-1#1)(2009-9#1)
ultimate goal was to##2##4##(2007-3#1)(2012-2#1)
ultimate goal##32##2##(1992-1#1)(1992-2#1)(1993-6#1)(1994-3#2)(1996-12#1)(1997-8#1)(2004-4#1)(2005-7#2)(2006-1#1)(2006-2#1)(2006-4#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#3)(2009-6#2)(2009-9#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-2#2)(2012-3#1)
ultimate goals in##3##3##(2008-10#2)(2008-7#1)
ultimate goals of##4##3##(2007-4#1)(2008-7#1)(2009-2#1)(2010-2#1)
ultimate goals##9##2##(2006-5#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-7#2)(2009-2#1)(2010-2#1)
ultimate load##2##2##(2007-1#1)(2013-1#1)
ultimate objective of##2##3##(2007-2#1)(2010-6#1)
ultimate objective##3##2##(2007-2#1)(2009-6#1)(2010-6#1)
ultimate outcome##6##2##(1991-12#1)(1994-6#1)(1997-3#2)(2007-7#1)(2008-11#1)
ultimate pH##2##2##(2010-4#2)
ultimate physical##2##2##(2007-9#1)(2008-7#1)
ultimate product##2##2##(1992-6#2)
ultimate stretch ratio##2##3##(2007-4#2)
ultimate success of##2##3##(1996-12#1)(1997-1#1)
ultimate tensile strength##2##3##(2012-2#2)
ultimate test##2##2##(2004-2#1)(2007-9#1)
ultimate##174##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-6#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#2)(1992-8#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-3#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-1#2)(1996-12#2)(1996-3#1)(1997-1#3)(1997-3#2)(1997-8#1)(2004-2#1)(2004-4#1)(2005-11#3)(2005-7#2)(2005-9#1)(2006-1#2)(2006-10#2)(2006-12#1)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#1)(2007-1#2)(2007-11#1)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#7)(2007-7#1)(2007-8#1)(2007-9#4)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#9)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#4)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-10#1)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#5)(2013-7#1)
ultimately a##2##2##(2008-7#1)(2009-10#1)
ultimately allow##2##2##(1991-6#1)(1994-11#1)
ultimately be used to##2##4##(2009-3#1)(2011-2#1)
ultimately be used##3##3##(1992-12#1)(2009-3#1)(2011-2#1)
ultimately be##12##2##(1992-12#1)(1993-2#1)(1994-3#1)(1994-5#1)(2005-8#1)(2006-6#1)(2007-9#1)(2009-10#1)(2009-3#1)(2010-8#1)(2011-2#1)(2013-8#1)
ultimately become##2##2##(2007-10#1)(2007-4#1)
ultimately control the##2##3##(1992-10#1)(1997-6#1)
ultimately depend##2##2##(2006-12#1)(2009-7#1)
ultimately develop##2##2##(2010-12#1)(2011-2#1)
ultimately fused##2##2##(2008-6#1)(2010-3#1)
ultimately help to explain##2##4##(1994-9#1)(2008-4#1)
ultimately help to##4##3##(1994-9#1)(1995-7#1)(2008-4#1)(2009-5#1)
ultimately improve the##2##3##(2007-11#1)(2009-12#1)
ultimately improve##3##2##(2006-2#1)(2007-11#1)(2009-12#1)
ultimately improving treatment recommendations and patient outcome prediction##2##8##(2013-1#2)
ultimately improving##3##2##(2008-3#1)(2013-1#2)
ultimately in##3##2##(1994-4#1)(2005-5#1)(2008-3#1)
ultimately influence##3##2##(1991-4#1)(1997-3#1)(2013-8#1)
ultimately lead to the##3##4##(1996-6#1)(2004-12#1)(2009-10#1)
ultimately lead to##12##3##(1996-6#1)(1997-1#1)(2004-12#1)(2007-9#1)(2008-11#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-2#1)(2011-2#2)(2013-1#1)
ultimately leading to##7##3##(2008-2#1)(2008-4#1)(2008-9#1)(2009-3#1)(2010-1#1)(2011-2#1)(2012-12#1)
ultimately leading##8##2##(2007-2#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-3#1)(2010-1#1)(2011-2#1)(2012-12#1)
ultimately leads to##6##3##(1993-11#1)(1995-3#1)(2008-10#1)(2008-11#1)(2010-12#1)(2012-12#1)
ultimately may##3##2##(1993-1#1)(1993-11#1)(2008-5#1)
ultimately progress to##2##3##(2009-8#1)(2011-2#1)
ultimately require##4##2##(1994-7#1)(1995-1#1)(2006-6#1)(2009-3#1)
ultimately responsible for##2##3##(1991-7#1)(2008-10#1)
ultimately result in the##2##4##(1991-12#1)(2012-12#1)
ultimately result in##6##3##(1991-12#1)(1993-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
ultimately resulting in##3##3##(2010-11#1)(2011-12#1)(2011-2#1)
ultimately results in##3##3##(2008-8#1)(2010-3#1)(2012-12#1)
ultimately results##4##2##(2008-7#1)(2008-8#1)(2010-3#1)(2012-12#1)
ultimately the##7##2##(2006-8#1)(2006-9#1)(2007-9#1)(2008-5#1)(2008-8#1)(2010-5#1)(2013-1#1)
ultimately to better##2##3##(2006-7#1)(2012-12#1)
ultimately to the##4##3##(2005-12#1)(2008-11#1)(2009-8#1)(2010-5#1)
ultimately to##14##2##(1994-12#1)(1994-7#1)(1996-5#1)(1997-6#1)(2005-12#1)(2006-12#1)(2006-7#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-5#1)(2012-12#1)(2013-8#1)
ultimately will##2##2##(1992-12#1)(2012-2#1)
ultimately##296##1##(1990-12#1)(1990-3#1)(1990-4#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1992-10#1)(1992-12#3)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-7#2)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#2)(1995-12#5)(1995-2#2)(1995-3#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#3)(2004-11#1)(2004-12#1)(2004-3#2)(2005-11#1)(2005-12#1)(2005-5#1)(2005-7#3)(2005-8#2)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#4)(2006-3#2)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#3)(2006-9#2)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#2)(2007-4#1)(2007-6#4)(2007-7#3)(2007-8#2)(2007-9#4)(2008-1#1)(2008-10#6)(2008-11#5)(2008-2#3)(2008-3#7)(2008-4#4)(2008-5#3)(2008-6#4)(2008-7#9)(2008-8#12)(2008-9#7)(2009-10#3)(2009-12#3)(2009-2#1)(2009-3#4)(2009-4#3)(2009-5#5)(2009-6#5)(2009-7#4)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#5)(2010-2#3)(2010-3#4)(2010-5#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#10)(2012-1#1)(2012-12#7)(2012-2#6)(2012-3#1)(2013-1#13)(2013-7#1)(2013-8#6)
ultimobranchial gland was##3##3##(2008-5#3)
ultimobranchial gland##4##2##(2008-5#4)
ultimobranchial glands##2##2##(2008-5#2)
ultimobranchial##7##1##(1990-12#1)(2008-5#6)
ultimum and##5##2##(2008-10#5)
ultimum on##3##2##(2008-10#3)
ultimum var##6##2##(2008-10#6)
ultimum##40##1##(2008-10#40)
ultra fast liquid chromatography-ion trap time of flight mass##2##9##(2012-12#2)
ultra fast##3##2##(1992-3#1)(2012-12#2)
ultra high molecular weight polyethylene (UHMWPE)##2##6##(2004-9#1)(2009-3#1)
ultra high performance liquid##4##4##(2012-12#2)(2013-8#2)
ultra high##10##2##(1992-3#2)(2004-9#1)(2008-10#1)(2009-3#1)(2010-4#1)(2012-12#2)(2013-8#2)
ultra low##2##2##(2010-1#1)(2013-1#1)
ultra performance liquid chromatography coupled with##2##6##(2012-3#2)
ultra performance liquid chromatography##4##4##(2011-1#2)(2012-3#2)
ultra performance liquid chromatography-electrospray##2##4##(2011-1#1)(2012-3#1)
ultra performance liquid chromatography-tandem mass spectrometry##2##6##(2011-1#1)(2012-12#1)
ultra performance liquid chromatography-tandem mass##3##5##(2011-1#1)(2012-12#2)
ultra performance liquid##12##3##(2011-1#6)(2012-12#2)(2012-3#3)(2013-7#1)
ultra trace amounts of##9##4##(2008-10#9)
ultra trace analysis##3##3##(2008-10#3)
ultra trace##22##2##(2008-10#22)
ultra violet radiation##2##3##(2008-1#1)(2008-9#1)
ultra violet##5##2##(2008-1#2)(2008-10#1)(2008-9#1)(2010-5#1)
ultra##67##1##(1992-3#3)(1992-6#1)(2004-9#1)(2005-7#1)(2007-12#1)(2008-1#2)(2008-10#28)(2008-11#2)(2008-2#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#6)(2012-12#6)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#2)
ultra-centrifugation##2##1##(2006-10#1)(2008-8#1)
ultra-clean air##2##2##(2006-6#2)
ultra-clean##5##1##(2006-6#4)(2007-8#1)
ultra-dilute solutions##2##2##(2008-10#2)
ultra-fast##2##1##(1994-2#1)(2010-1#1)
ultra-fine##3##1##(2008-10#2)(2008-5#1)
ultra-high dimensional##2##2##(2012-1#2)
ultra-high molecular weight polyethylene (UHMWPE)##2##5##(2004-9#1)(2008-12#1)
ultra-high molecular weight polyethylene##5##4##(2004-9#2)(2008-12#2)(2009-4#1)
ultra-high resolution##2##2##(2011-7#2)
ultra-high##20##1##(1994-3#1)(2004-9#2)(2008-10#2)(2008-11#1)(2008-12#2)(2009-11#1)(2009-3#1)(2009-4#2)(2011-7#2)(2012-1#3)(2012-2#1)(2013-1#2)
ultra-highly pure Er2O3 and Ho2O3##2##5##(2005-4#2)
ultra-low doses of##2##3##(2012-1#1)(2013-1#1)
ultra-low friction##2##2##(1993-2#2)
ultra-low protein##2##2##(2008-11#2)
ultra-low##7##1##(1993-2#2)(2007-8#1)(2008-11#2)(2012-1#1)(2013-1#1)
ultra-performance liquid##5##2##(2007-8#2)(2012-3#2)(2013-1#1)
ultra-pure water and##2##3##(2008-10#2)
ultra-pure water##3##2##(2008-10#3)
ultra-pure##5##1##(2008-10#5)
ultra-sensitive##10##1##(1997-5#1)(2007-8#3)(2008-10#4)(2009-12#1)(2010-7#1)
ultra-short acting##2##2##(2006-10#2)
ultra-short##4##1##(2006-10#2)(2008-10#1)(2011-1#1)
ultra-slow##3##1##(2011-2#3)
ultra-structure##2##1##(2008-5#2)
ultra-thin layer method##2##3##(2008-11#2)
ultra-thin layer of##2##3##(1991-5#2)
ultra-thin layer##5##2##(1991-5#3)(2008-11#2)
ultra-thin##8##1##(1991-5#3)(2005-12#1)(2007-8#1)(2008-11#3)
ultra-trace amounts of Cr(VI)##2##4##(2008-10#2)
ultra-trace levels of##4##3##(2008-10#3)(2008-3#1)
ultra-trace##19##1##(2008-10#18)(2008-3#1)
ultra-violet absorption##2##2##(2007-2#1)(2008-10#1)
ultra-violet##5##1##(2007-2#1)(2008-10#1)(2008-5#1)(2010-4#1)(2012-2#1)
ultra-wideband##3##1##(2008-2#1)(2011-2#2)
ultrabrief bilateral ECT##2##3##(2012-12#2)
ultrabrief pulse##4##2##(2012-12#4)
ultrabrief##7##1##(2012-12#7)
ultrabroadband optical##3##2##(2007-12#3)
ultrabroadband##11##1##(2007-11#3)(2007-12#5)(2008-2#2)(2008-3#1)
ultracentrifugation and gel filtration##2##4##(1991-7#1)(1995-8#1)
ultracentrifugation and gel##3##3##(1991-7#1)(1995-8#1)(2008-11#1)
ultracentrifugation and##10##2##(1991-7#1)(1993-3#1)(1995-1#1)(1995-6#3)(1995-8#1)(2006-12#1)(2008-11#1)(2011-2#1)
ultracentrifugation##50##1##(1990-2#2)(1990-5#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-2#2)(1991-7#2)(1992-12#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-5#1)(1994-8#1)(1995-1#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#4)(1995-7#1)(1995-8#2)(1996-4#1)(1997-2#2)(1997-4#2)(1997-6#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#4)(2008-7#1)(2011-2#1)(2012-2#1)
ultracold atoms##3##2##(2007-11#2)(2007-12#1)
ultracold##5##1##(2007-11#2)(2007-12#2)(2012-2#1)
ultracompact##2##1##(2007-12#2)
ultracytochemical##2##1##(2007-9#1)(2008-7#1)
ultradian clock-driven respiratory oscillations##2##4##(2005-8#2)
ultradian clock-driven##3##2##(2005-8#3)
ultradian rhythm##3##2##(1996-3#3)
ultradian##10##1##(1993-12#1)(1994-3#1)(1996-3#4)(2005-8#4)
ultraendurance runners##4##2##(2013-8#4)
ultraendurance##5##1##(2013-8#5)
ultrafast all-optical##6##2##(2007-12#5)(2008-3#1)
ultrafast electric field##2##3##(2007-12#2)
ultrafast infrared##2##2##(2007-11#1)(2008-8#1)
ultrafast laser pulses and##2##4##(2007-11#2)
ultrafast laser pulses##3##3##(2007-11#2)(2007-12#1)
ultrafast laser##11##2##(2007-11#7)(2007-12#2)(2008-3#2)
ultrafast nonlinear interferometer##4##3##(2007-12#1)(2008-1#1)(2008-2#2)
ultrafast nonlinear##5##2##(2007-12#1)(2008-1#2)(2008-2#2)
ultrafast optical data##2##3##(2007-12#1)(2008-3#1)
ultrafast optical##11##2##(2007-11#1)(2007-12#8)(2008-3#2)
ultrafast phase##2##2##(2007-11#1)(2007-12#1)
ultrafast pulse##2##2##(2007-11#1)(2007-12#1)
ultrafast pulsed##2##2##(2007-12#1)(2008-2#1)
ultrafast pulses##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
ultrafast signal##2##2##(2007-11#1)(2008-2#1)
ultrafast spectroscopy##2##2##(2007-11#1)(2008-3#1)
ultrafast time##2##2##(2006-6#1)(2009-6#1)
ultrafast walk-off-free##2##2##(2007-11#2)
ultrafast##114##1##(1995-1#1)(1997-8#1)(2006-10#1)(2006-6#3)(2007-11#27)(2007-12#45)(2008-1#5)(2008-10#1)(2008-2#6)(2008-3#17)(2008-7#1)(2008-8#1)(2009-6#1)(2012-8#4)
ultrafiltered urine##2##2##(1995-7#2)
ultrafiltered urines##2##2##(2008-12#2)
ultrafiltered##10##1##(1990-5#2)(1994-10#1)(1995-7#3)(2008-12#2)(2008-2#1)(2012-3#1)
ultrafiltrate##9##1##(1994-2#2)(2008-1#2)(2008-11#2)(2010-5#1)(2011-1#1)(2011-2#1)
ultrafiltration and##12##2##(1990-11#1)(1992-3#1)(1994-10#1)(1996-12#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)
ultrafiltration followed by##2##3##(1996-4#1)(2007-8#1)
ultrafiltration for##3##2##(1993-2#1)(2008-10#2)
ultrafiltration in##3##2##(2008-1#1)(2008-10#1)(2012-1#1)
ultrafiltration is##3##2##(2008-10#2)(2012-3#1)
ultrafiltration membrane##3##2##(2008-10#3)
ultrafiltration membranes##2##2##(1992-3#1)(2011-2#1)
ultrafiltration method##2##2##(1993-12#1)(1995-12#1)
ultrafiltration methods##3##2##(1990-10#1)(1993-12#1)(2008-10#1)
ultrafiltration of##2##2##(2007-12#1)(2011-2#1)
ultrafiltration or##2##2##(1996-5#1)(2008-7#1)
ultrafiltration process##2##2##(2008-10#2)
ultrafiltration rate##2##2##(2008-1#1)(2011-1#1)
ultrafiltration rates up to 200%##2##5##(2008-1#2)
ultrafiltration rates##4##2##(2007-7#1)(2008-1#3)
ultrafiltration was##3##2##(2008-1#2)(2013-8#1)
ultrafiltration##116##1##(1990-10#1)(1990-11#1)(1990-7#1)(1990-8#2)(1992-3#3)(1992-4#1)(1993-12#5)(1993-2#1)(1993-8#1)(1994-10#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#4)(1996-4#1)(1996-5#1)(2004-8#2)(2005-11#4)(2007-11#1)(2007-12#5)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#9)(2008-10#33)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#5)(2010-12#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-8#1)
ultrafine##4##1##(2005-11#1)(2007-12#1)(2008-11#1)(2013-8#1)
ultrafine-tunable##2##1##(2007-12#2)
ultrahigh resolution##2##2##(2008-10#1)(2010-2#1)
ultrahigh vacuum##11##2##(1990-11#1)(1995-7#1)(2006-4#1)(2008-2#3)(2008-7#3)(2012-1#1)(2013-8#1)
ultrahigh##25##1##(1990-11#1)(1995-2#1)(1995-5#1)(1995-7#1)(2006-4#1)(2006-6#1)(2007-12#4)(2008-10#2)(2008-2#4)(2008-3#1)(2008-7#3)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
ultrahigh-intensity##2##1##(2007-12#1)(2008-3#1)
ultrahigh-numerical-aperture fiber##2##2##(2007-11#2)
ultrahigh-numerical-aperture##3##1##(2007-11#2)(2008-3#1)
ultrahigh-resolution##4##1##(2007-12#2)(2008-3#1)(2011-1#1)
ultrahigh-sensitivity##2##1##(2007-12#1)(2008-7#1)
ultralow frequency##2##2##(2008-9#2)
ultralow##10##1##(1996-8#1)(2006-5#2)(2007-12#1)(2008-3#2)(2008-7#1)(2008-9#2)(2010-4#1)
ultralow-noise##3##1##(2007-11#2)(2007-12#1)
ultramarathon##6##1##(2013-8#6)
ultramarine##2##1##(2008-10#2)
ultramicroelectrode was##2##2##(2008-10#2)
ultramicroelectrode##6##1##(1993-12#1)(1995-6#1)(2008-10#4)
ultramicroscopic##2##1##(2009-4#1)(2013-8#1)
ultramicroscopy##2##1##(2009-4#2)
ultramicrosensors based on electropolymerized films of##2##6##(2008-10#2)
ultramicrosensors##4##1##(2008-10#4)
ultrananocrystalline diamond##2##2##(2006-12#2)
ultraprecision##2##1##(2008-3#2)
ultrapure dialysate##2##2##(2008-1#2)
ultrapure water##7##2##(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#3)
ultrapure##9##1##(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#3)
ultrapurified water##2##2##(2008-10#2)
ultrapurified##4##1##(1995-2#2)(2008-10#2)
ultrarapid metabolizers##3##2##(2008-10#2)(2010-12#1)
ultrarapid##5##1##(2008-10#4)(2010-12#1)
ultrarelativistic##3##1##(1992-9#1)(1993-3#1)(1995-5#1)
ultrasensitive assay##2##2##(1992-8#2)
ultrasensitive##21##1##(1991-1#1)(1992-8#4)(2006-6#2)(2006-9#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#1)(2009-11#1)(2009-5#1)(2010-5#1)(2012-2#1)
ultrashort laser pulses by##2##4##(2007-11#1)(2008-2#1)
ultrashort laser pulses from##2##4##(2007-11#1)(2007-12#1)
ultrashort laser pulses in air##3##5##(2007-11#1)(2008-1#2)
ultrashort laser pulses in##4##4##(2007-11#1)(2008-1#2)(2008-3#1)
ultrashort laser pulses##16##3##(2007-11#4)(2007-12#3)(2008-1#2)(2008-2#2)(2008-3#4)(2012-2#1)
ultrashort laser##20##2##(2007-11#5)(2007-12#5)(2008-1#3)(2008-2#2)(2008-3#4)(2012-2#1)
ultrashort light pulses##5##3##(2007-11#3)(2007-12#1)(2008-3#1)
ultrashort light##6##2##(2007-11#3)(2007-12#2)(2008-3#1)
ultrashort optical pulses##11##3##(2007-11#4)(2007-12#6)(2008-2#1)
ultrashort optical##16##2##(2007-11#6)(2007-12#7)(2008-2#1)(2008-3#2)
ultrashort pulse duration##2##3##(2007-12#1)(2008-1#1)
ultrashort pulse##12##2##(2007-11#2)(2007-12#5)(2008-1#1)(2008-3#4)
ultrashort pulsed##2##2##(2007-12#1)(2008-3#1)
ultrashort pulses by##5##3##(2007-12#4)(2008-1#1)
ultrashort pulses from a##3##4##(2007-12#2)(2008-3#1)
ultrashort pulses from##4##3##(2007-12#3)(2008-3#1)
ultrashort pulses in##2##3##(2007-12#2)
ultrashort pulses##30##2##(2007-11#4)(2007-12#22)(2008-1#1)(2008-3#2)(2012-2#1)
ultrashort pump pulse at 800 nm##2##6##(2007-11#1)(2007-12#1)
ultrashort soliton##3##2##(2007-11#2)(2007-12#1)
ultrashort##109##1##(2007-11#28)(2007-12#53)(2008-1#5)(2008-2#5)(2008-3#15)(2010-12#1)(2012-2#2)
ultrashort-pulse laser##3##2##(2007-12#1)(2008-2#2)
ultrashort-pulse optical##2##2##(2007-12#2)
ultrashort-pulse##11##1##(2007-11#4)(2007-12#5)(2008-2#2)
ultrasmall pores##2##2##(2007-12#2)
ultrasmall##6##1##(1995-3#1)(2007-11#2)(2007-12#2)(2010-4#1)
ultrasonic agitation and vortex mixing##2##5##(2008-10#2)
ultrasonic agitation##4##2##(2008-10#4)
ultrasonic amplitude##2##2##(2007-11#1)(2008-10#1)
ultrasonic and##11##2##(1991-1#1)(1993-2#1)(2007-8#1)(2008-2#1)(2008-5#1)(2011-1#1)(2012-1#2)(2012-12#1)(2013-1#2)
ultrasonic assessment##2##2##(2007-7#1)(2010-12#1)
ultrasonic assisted##2##2##(2008-10#2)
ultrasonic bath and##3##3##(2008-10#3)
ultrasonic bath##13##2##(1992-2#1)(2008-10#12)
ultrasonic beam was focused into##2##5##(2007-12#1)(2008-3#1)
ultrasonic beam##7##2##(2007-11#1)(2007-12#3)(2008-3#3)
ultrasonic calls from pups##2##4##(1992-9#2)
ultrasonic calls##5##2##(1992-9#5)
ultrasonic cavitation##3##2##(2009-2#1)(2013-8#2)
ultrasonic echo##2##2##(2010-8#1)(2012-3#1)
ultrasonic equipment##2##2##(1992-12#1)(2006-10#1)
ultrasonic examination##2##2##(1990-9#1)(1991-12#1)
ultrasonic extraction (USE)##2##3##(2007-8#1)(2008-10#1)
ultrasonic extraction and##3##3##(2008-10#2)(2013-8#1)
ultrasonic extraction##9##2##(1997-1#1)(2007-8#2)(2008-10#3)(2011-12#2)(2013-8#1)
ultrasonic field to the##2##4##(2007-12#1)(2008-2#1)
ultrasonic field##9##2##(2007-12#2)(2008-10#2)(2008-2#4)(2008-3#1)
ultrasonic fields##3##2##(2007-12#1)(2008-2#2)
ultrasonic homogenizer##2##2##(2004-9#1)(2008-10#1)
ultrasonic image##2##2##(1993-10#1)(2012-3#1)
ultrasonic imaging##3##2##(2008-2#2)(2012-3#1)
ultrasonic inhaler##3##2##(1993-2#3)
ultrasonic irradiation##2##2##(2008-10#1)(2008-5#1)
ultrasonic method##4##2##(1997-6#2)(2008-10#1)(2008-5#1)
ultrasonic modulation of multiply scattered coherent light##2##7##(2007-12#2)
ultrasonic modulation of##5##3##(2007-12#4)(2008-2#1)
ultrasonic modulation##6##2##(2007-12#4)(2008-2#2)
ultrasonic nebulization##9##2##(1991-1#1)(2008-10#7)(2008-3#1)
ultrasonic nebulizer##6##2##(1991-1#3)(1993-2#2)(2008-10#1)
ultrasonic nebulizers##3##2##(1991-1#1)(1993-2#1)(1996-2#1)
ultrasonic power of 50W and the cavitation time of 15##2##10##(2013-8#2)
ultrasonic power##4##2##(2008-10#1)(2013-8#3)
ultrasonic scalpel##9##2##(2007-8#5)(2008-3#1)(2010-8#3)
ultrasonic scanner for##2##3##(1991-9#1)(1992-11#1)
ultrasonic slurry sampling electrothermal##2##4##(2008-10#2)
ultrasonic slurry sampling##4##3##(2008-10#4)
ultrasonic slurry##5##2##(2008-10#5)
ultrasonic surface displacements##3##3##(2007-11#3)
ultrasonic technique##2##2##(2007-9#1)(2011-2#1)
ultrasonic transducer##3##2##(1990-9#1)(1993-5#1)(2008-3#1)
ultrasonic treatment##3##2##(1993-2#2)(2009-12#1)
ultrasonic treatments##5##2##(2007-2#5)
ultrasonic vibration##2##2##(2005-11#2)
ultrasonic vocalization##4##2##(1994-8#3)(2008-4#1)
ultrasonic wave propagation##3##3##(2004-9#2)(2009-7#1)
ultrasonic wave##8##2##(2004-9#2)(2006-5#2)(2007-12#2)(2008-2#1)(2009-7#1)
ultrasonic waves##3##2##(2004-9#1)(2005-12#1)(2012-3#1)
ultrasonic##235##1##(1990-12#1)(1990-2#3)(1990-9#2)(1991-1#6)(1991-12#1)(1991-4#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#6)(1993-10#1)(1993-2#10)(1993-5#2)(1994-2#1)(1994-8#3)(1994-9#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-6#3)(2004-9#5)(2005-11#3)(2005-12#1)(2006-10#1)(2006-5#2)(2007-11#8)(2007-12#18)(2007-2#5)(2007-4#1)(2007-7#1)(2007-8#9)(2007-9#1)(2008-10#55)(2008-11#6)(2008-2#15)(2008-3#10)(2008-4#1)(2008-5#6)(2009-10#1)(2009-12#1)(2009-2#3)(2009-5#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-8#5)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#2)(2013-8#7)
ultrasonic-assisted extraction of##2##3##(2008-10#2)
ultrasonic-assisted extraction##5##2##(2008-10#4)(2011-1#1)
ultrasonic-assisted##6##1##(2008-10#5)(2011-1#1)
ultrasonic-based sample treatment##2##3##(2008-10#2)
ultrasonically guided percutaneous##2##3##(1991-2#1)(2007-8#1)
ultrasonically##5##1##(1991-2#1)(1992-12#1)(2007-8#1)(2008-11#1)(2012-3#1)
ultrasonically-guided fine needle##2##3##(1990-10#2)
ultrasonically-guided##3##1##(1990-10#3)
ultrasonication of the##2##3##(2010-4#1)(2012-2#1)
ultrasonication##11##1##(1997-2#1)(2007-8#2)(2008-10#5)(2010-4#2)(2012-2#1)
ultrasonogram##3##1##(2006-10#1)(2007-10#1)(2008-5#1)
ultrasonographic (USG)##2##2##(2005-1#1)(2012-12#1)
ultrasonographic examination##4##2##(1996-12#1)(2005-12#1)(2006-5#2)
ultrasonographic examinations##2##2##(1990-9#1)(2006-5#1)
ultrasonographic finding##2##2##(1993-10#1)(2012-3#1)
ultrasonographic findings##7##2##(1997-3#2)(1997-7#1)(2006-10#1)(2007-10#1)(2008-12#1)(2010-12#1)
ultrasonographic guidance##5##2##(2008-8#1)(2011-1#2)(2012-12#2)
ultrasonographic guided##2##2##(2005-12#1)(2010-12#1)
ultrasonographic images##3##2##(2007-10#2)(2008-10#1)
ultrasonographic pregnancy diagnoses##2##3##(2006-5#2)
ultrasonographic##55##1##(1990-9#2)(1991-12#1)(1992-8#1)(1993-10#2)(1993-12#1)(1993-7#1)(1994-3#1)(1996-12#1)(1996-6#1)(1997-3#3)(1997-7#1)(2005-1#1)(2005-12#2)(2006-10#1)(2006-5#7)(2007-10#5)(2007-3#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#2)(2010-9#1)(2011-1#5)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-8#1)
ultrasonographically##3##1##(1996-6#1)(2007-11#1)(2007-8#1)
ultrasonography (EUS) has##2##3##(1993-5#1)(2008-2#1)
ultrasonography (EUS)##7##2##(1990-9#1)(1993-5#1)(2006-10#1)(2008-2#2)(2008-5#1)(2013-1#1)
ultrasonography (US) and##2##3##(2004-2#1)(2006-10#1)
ultrasonography (US)##7##2##(1996-6#1)(2004-2#1)(2006-10#1)(2008-1#1)(2010-12#2)(2012-2#1)
ultrasonography (USG)##2##2##(2008-7#1)(2011-1#1)
ultrasonography and CT##2##3##(1993-9#1)(2008-5#1)
ultrasonography and computed tomography##2##4##(2008-10#1)(2013-7#1)
ultrasonography and##24##2##(1990-5#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-9#1)(2007-3#2)(2007-5#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#2)(2011-1#2)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
ultrasonography are the##2##3##(2009-7#1)(2012-2#1)
ultrasonography are##3##2##(2007-8#1)(2009-7#1)(2012-2#1)
ultrasonography as##3##2##(1991-6#1)(1996-11#1)(2006-12#1)
ultrasonography at##3##2##(1995-6#1)(2010-4#1)(2011-1#1)
ultrasonography can##3##2##(1991-11#1)(2007-4#1)(2010-5#1)
ultrasonography demonstrated##2##2##(1996-3#2)
ultrasonography findings##2##2##(2006-1#1)(2013-7#1)
ultrasonography for##3##2##(1991-4#1)(2010-11#1)(2012-3#1)
ultrasonography has##2##2##(1991-4#1)(1992-3#1)
ultrasonography in a##2##3##(2007-8#1)(2008-4#1)
ultrasonography in detecting##2##3##(2008-5#1)(2009-8#1)
ultrasonography in primary##2##3##(1992-4#1)(2009-9#1)
ultrasonography in the diagnosis of##6##5##(1993-10#1)(2006-1#2)(2007-8#1)(2010-12#1)(2013-7#1)
ultrasonography in the##10##3##(1990-9#1)(1993-10#1)(1993-5#1)(2006-1#2)(2006-6#1)(2007-8#1)(2010-12#2)(2013-7#1)
ultrasonography in this##2##3##(2006-10#1)(2012-2#1)
ultrasonography in##35##2##(1990-9#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-10#1)(1993-5#3)(2006-1#2)(2006-10#2)(2006-4#1)(2006-6#1)(2007-11#1)(2007-3#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-8#1)(2009-9#1)(2010-12#4)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
ultrasonography is##7##2##(1990-9#1)(1993-10#1)(1994-6#1)(2006-10#1)(2006-2#1)(2007-7#1)(2011-2#1)
ultrasonography of the liver##3##4##(1993-10#2)(2005-12#1)
ultrasonography of the##8##3##(1993-10#2)(2005-12#1)(2006-1#1)(2008-12#1)(2008-7#1)(2010-12#1)(2012-2#1)
ultrasonography of##11##2##(1993-10#2)(1994-5#2)(2005-12#1)(2006-1#1)(2006-5#1)(2008-12#1)(2008-7#1)(2010-12#1)(2012-2#1)
ultrasonography or##4##2##(2007-8#1)(2011-2#1)(2013-1#2)
ultrasonography revealed##5##2##(1996-3#1)(2005-12#1)(2007-5#1)(2007-8#1)(2008-5#1)
ultrasonography should##2##2##(1994-2#1)(2007-4#1)
ultrasonography showed##5##2##(1992-10#1)(1996-11#1)(2005-12#1)(2007-8#1)(2008-5#1)
ultrasonography studies##2##2##(2011-2#1)(2012-12#1)
ultrasonography to##2##2##(2007-11#1)(2012-12#1)
ultrasonography was##9##2##(1992-3#1)(1996-11#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-8#2)(2008-9#1)(2011-1#1)
ultrasonography were##3##2##(1990-9#1)(1993-10#1)(1995-10#1)
ultrasonography##236##1##(1990-10#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-9#4)(1991-11#2)(1991-4#2)(1991-6#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-10#12)(1993-2#1)(1993-5#9)(1993-9#1)(1994-2#1)(1994-5#2)(1994-6#2)(1995-10#1)(1995-2#1)(1995-6#1)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#5)(1996-6#1)(1996-9#1)(1997-8#2)(2004-2#1)(2005-11#2)(2005-12#3)(2005-7#1)(2006-1#5)(2006-10#7)(2006-12#1)(2006-2#3)(2006-4#1)(2006-5#4)(2006-6#1)(2007-10#2)(2007-11#4)(2007-3#5)(2007-4#3)(2007-5#3)(2007-7#3)(2007-8#11)(2007-9#2)(2008-1#2)(2008-10#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#8)(2008-6#2)(2008-7#5)(2008-9#1)(2009-1#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#14)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#7)(2011-12#2)(2011-2#7)(2012-12#3)(2012-2#7)(2012-3#2)(2013-1#11)(2013-7#3)(2013-8#2)
ultrasonography)##2##1##(2012-2#1)(2013-1#1)
ultrasonography-guided celiac plexus block##2##4##(2006-10#2)
ultrasonography-guided##5##1##(1995-4#1)(2005-12#1)(2006-10#2)(2012-12#1)
ultrasonography]##5##1##(1992-6#1)(1993-5#1)(2009-1#1)(2012-1#1)(2013-8#1)
ultrasound (CEUS) in the##2##4##(2008-7#1)(2010-12#1)
ultrasound (CEUS) in##3##3##(2008-7#1)(2010-12#1)(2012-2#1)
ultrasound (CEUS)##7##2##(2008-7#1)(2010-12#3)(2012-2#3)
ultrasound (EUS) is##2##3##(2007-5#1)(2013-1#1)
ultrasound (EUS)##6##2##(1991-9#1)(2006-2#1)(2007-5#1)(2008-2#1)(2010-12#1)(2013-1#1)
ultrasound (US) and##2##3##(2010-12#1)(2013-1#1)
ultrasound (US)##11##2##(1992-7#1)(2007-10#1)(2007-9#1)(2008-9#1)(2010-12#4)(2011-1#1)(2011-2#1)(2013-1#1)
ultrasound allows for##2##3##(2007-8#1)(2013-1#1)
ultrasound amplitude##3##2##(2008-10#3)
ultrasound analysis##2##2##(1990-5#1)(2011-1#1)
ultrasound and a##2##3##(2007-7#1)(2011-2#1)
ultrasound and angiography##2##3##(2006-11#1)(2007-9#1)
ultrasound and computed tomography##4##4##(2005-10#1)(2008-1#1)(2010-12#1)(2012-11#1)
ultrasound and conventional##2##3##(2007-4#2)
ultrasound and endoscopic difficultes in the##2##6##(2008-8#2)
ultrasound and magnetic resonance##2##4##(1994-2#1)(2010-5#1)
ultrasound and near-infrared diffusive light imaging##2##6##(2007-12#1)(2008-3#1)
ultrasound and##50##2##(1990-6#1)(1991-10#1)(1992-2#1)(1993-5#1)(1994-2#1)(1994-5#1)(1995-3#1)(2005-10#1)(2006-10#3)(2006-11#1)(2006-2#1)(2007-11#3)(2007-12#1)(2007-4#3)(2007-5#1)(2007-7#3)(2007-9#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-5#1)(2009-6#2)(2010-12#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#3)
ultrasound apparatuses##2##2##(2007-8#2)
ultrasound are##2##2##(2006-10#1)(2013-8#1)
ultrasound array##5##2##(2007-12#1)(2008-3#2)(2011-1#2)
ultrasound as a screening test for osteoporosis##2##7##(2006-10#2)
ultrasound as a##6##3##(2006-10#3)(2008-7#1)(2012-12#1)(2013-8#1)
ultrasound aspects##2##2##(2009-5#1)(2013-1#1)
ultrasound assisted pseudo-digestion##3##3##(2008-10#3)
ultrasound assisted##6##2##(2007-7#1)(2008-10#5)
ultrasound bath##2##2##(2008-10#2)
ultrasound bladder scanner##4##3##(2006-6#4)
ultrasound can be##2##3##(2009-6#1)(2011-2#1)
ultrasound can##5##2##(1993-5#1)(2008-7#1)(2009-6#1)(2011-2#2)
ultrasound contrast agents##2##3##(2007-9#1)(2008-8#1)
ultrasound contrast##4##2##(2007-9#1)(2008-8#1)(2012-2#2)
ultrasound control##3##2##(2007-7#2)(2008-7#1)
ultrasound demonstrated a##3##3##(2006-10#1)(2013-1#2)
ultrasound detection##3##2##(2007-11#1)(2009-5#2)
ultrasound device##2##2##(2008-5#1)(2008-8#1)
ultrasound diagnosis of##4##3##(2006-6#3)(2006-9#1)
ultrasound diagnosis##7##2##(1990-10#1)(2006-6#5)(2006-9#1)
ultrasound diagnostics##2##2##(1990-3#2)
ultrasound energy##4##2##(2008-10#4)
ultrasound evaluation of##2##3##(2006-5#1)(2008-4#1)
ultrasound exam##2##2##(2007-9#1)(2011-2#1)
ultrasound examination demonstrated##2##3##(1992-2#1)(1996-11#1)
ultrasound examination of the##11##4##(1990-9#2)(2007-11#2)(2007-7#1)(2007-8#3)(2010-12#2)(2012-2#1)
ultrasound examination of##12##3##(1990-9#2)(1992-12#1)(2007-11#2)(2007-7#1)(2007-8#3)(2010-12#2)(2012-2#1)
ultrasound examination was##2##3##(2007-11#1)(2008-1#1)
ultrasound examination##35##2##(1990-4#1)(1990-9#3)(1991-6#1)(1992-12#2)(1992-2#1)(1993-5#2)(1994-6#1)(1995-8#1)(1996-11#3)(1997-8#1)(2006-6#1)(2007-11#3)(2007-7#2)(2007-8#4)(2008-1#1)(2010-12#3)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
ultrasound examinations of the##2##4##(1990-6#1)(2007-10#1)
ultrasound examinations of##3##3##(1990-6#1)(2007-10#1)(2007-9#1)
ultrasound examinations were performed##2##4##(2007-7#1)(2008-4#1)
ultrasound examinations##8##2##(1990-6#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-4#1)
ultrasound fetometry##3##2##(2008-4#2)(2011-2#1)
ultrasound field##4##2##(2008-10#1)(2008-3#1)(2013-1#2)
ultrasound finding##2##2##(2013-1#2)
ultrasound findings##9##2##(1996-11#1)(1996-4#1)(2006-11#1)(2006-6#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-4#2)
ultrasound for the assessment of##2##5##(2007-7#1)(2009-4#1)
ultrasound for the##3##3##(2006-10#1)(2007-7#1)(2009-4#1)
ultrasound for##10##2##(2006-10#1)(2007-3#1)(2007-7#3)(2007-8#2)(2008-10#1)(2009-4#1)(2009-5#1)
ultrasound frequency##4##2##(2008-10#4)
ultrasound guidance and##2##3##(2007-7#1)(2013-1#1)
ultrasound guidance for##4##3##(1992-12#1)(2007-7#1)(2008-1#1)(2013-1#1)
ultrasound guidance to##2##3##(2007-7#2)
ultrasound guidance##21##2##(1992-12#1)(2007-7#8)(2008-1#3)(2008-11#1)(2010-12#3)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
ultrasound guided percutaneous##2##3##(2009-7#1)(2010-12#1)
ultrasound guided##12##2##(1993-3#1)(1996-3#1)(2006-6#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#1)(2009-7#1)(2010-12#1)(2010-5#1)(2013-7#1)
ultrasound has##7##2##(1991-6#1)(2007-7#1)(2008-1#1)(2008-7#2)(2012-2#2)
ultrasound have##2##2##(1995-5#1)(2006-6#1)
ultrasound image##2##2##(1994-4#1)(2008-2#1)
ultrasound images##5##2##(1996-1#1)(2007-11#1)(2007-8#1)(2010-6#2)
ultrasound imaging in##3##3##(2008-5#1)(2010-12#2)
ultrasound imaging##10##2##(2005-10#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-12#2)(2011-1#2)(2012-2#2)
ultrasound in 29##2##3##(1993-8#1)(2008-1#1)
ultrasound in a##3##3##(1991-8#1)(2012-3#1)(2013-1#1)
ultrasound in the biliary##2##4##(2006-10#1)(2010-12#1)
ultrasound in the detection of##2##5##(2007-8#1)(2008-2#1)
ultrasound in the evaluation of##3##5##(2009-6#1)(2013-1#2)
ultrasound in the presence of the photosensitizing drug Photofrin II##2##10##(1993-8#2)
ultrasound in the##17##3##(1990-2#1)(1993-8#2)(2006-10#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-2#1)(2009-10#1)(2009-6#3)(2010-12#2)(2013-1#2)
ultrasound in##50##2##(1990-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-6#1)(1993-8#4)(1994-6#1)(1996-12#1)(1997-3#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-8#2)(2008-1#3)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#3)(2009-7#1)(2009-9#1)(2010-12#3)(2010-8#1)(2011-12#1)(2011-2#1)(2011-5#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)
ultrasound is a new##2##4##(2006-10#1)(2012-12#1)
ultrasound is a##4##3##(2006-10#2)(2008-7#1)(2012-12#1)
ultrasound is##16##2##(1992-7#1)(1993-5#1)(1995-10#1)(2006-10#4)(2007-8#1)(2008-10#1)(2008-7#2)(2009-6#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
ultrasound markers for fetal##2##4##(1996-12#2)
ultrasound markers##3##2##(1996-12#3)
ultrasound may##2##2##(2006-10#1)(2012-2#1)
ultrasound measurement of##2##3##(1992-2#1)(2006-12#1)
ultrasound measurements##2##2##(2008-12#1)(2011-1#1)
ultrasound method##2##2##(1991-6#1)(2010-12#1)
ultrasound of the pancreas##2##4##(2006-10#1)(2010-12#1)
ultrasound of the##9##3##(1997-8#1)(2006-10#4)(2009-5#1)(2010-12#1)(2012-2#1)(2013-8#1)
ultrasound of##12##2##(1997-8#1)(2006-10#4)(2008-3#1)(2008-7#1)(2009-5#1)(2010-12#2)(2012-2#1)(2013-8#1)
ultrasound on the##2##3##(2008-10#1)(2011-2#1)
ultrasound on##5##2##(2008-10#1)(2011-2#2)(2012-2#1)(2013-1#1)
ultrasound or CT##2##3##(2005-10#1)(2007-6#1)
ultrasound or##12##2##(1994-9#1)(2005-10#1)(2007-6#1)(2007-8#2)(2008-10#1)(2008-6#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
ultrasound pachymetry in##2##3##(2010-1#1)(2012-12#1)
ultrasound pachymetry##4##2##(2007-3#1)(2010-1#1)(2012-12#1)(2012-2#1)
ultrasound plus##2##2##(1995-3#1)(2013-8#1)
ultrasound probe##4##2##(1992-12#1)(2006-5#1)(2007-8#1)(2008-2#1)
ultrasound probes##3##2##(1992-12#1)(2007-7#1)(2009-12#1)
ultrasound pulses##4##2##(1991-8#2)(2008-3#2)
ultrasound results##4##2##(2007-3#1)(2008-3#1)(2009-5#1)(2010-12#1)
ultrasound scan (USS)##2##3##(2004-2#1)(2006-2#1)
ultrasound scan of##2##3##(1995-10#1)(2007-3#1)
ultrasound scan##16##2##(1990-2#1)(1995-10#1)(1997-3#1)(2004-10#1)(2004-2#1)(2006-2#1)(2007-3#1)(2008-10#1)(2008-6#2)(2011-2#1)(2012-12#2)(2013-1#3)
ultrasound scanning in##4##3##(1993-8#3)(2007-8#1)
ultrasound scanning was##2##3##(2008-4#1)(2008-7#1)
ultrasound scanning##15##2##(1992-11#1)(1992-12#1)(1993-8#3)(1994-7#1)(1996-1#1)(2005-11#1)(2006-6#1)(2007-2#1)(2007-4#1)(2007-8#2)(2008-4#1)(2008-7#1)
ultrasound scans and##2##3##(1992-7#1)(2012-12#1)
ultrasound scans##10##2##(1990-6#1)(1992-7#2)(1994-7#1)(2004-10#1)(2007-5#1)(2011-2#2)(2012-12#1)(2013-7#1)
ultrasound screening for##2##3##(2007-4#1)(2008-11#1)
ultrasound screening##7##2##(1990-6#1)(1994-6#1)(2007-4#1)(2007-7#1)(2008-11#1)(2010-4#1)(2012-3#1)
ultrasound shear##3##2##(2008-5#3)
ultrasound showed##4##2##(1992-7#1)(2007-7#1)(2007-8#1)(2009-6#1)
ultrasound studies##6##2##(1990-5#1)(1996-8#1)(2007-8#2)(2008-7#2)
ultrasound study of##2##3##(2006-12#1)(2008-4#1)
ultrasound study##9##2##(1996-12#1)(2006-12#1)(2007-8#1)(2008-4#1)(2008-7#2)(2008-8#1)(2011-2#1)(2013-7#1)
ultrasound systems##2##2##(2007-5#1)(2010-8#1)
ultrasound technique##4##2##(2007-7#2)(2007-8#2)
ultrasound technology##2##2##(1994-6#1)(2006-6#1)
ultrasound tests##2##2##(1991-4#1)(2010-8#1)
ultrasound therapy##3##2##(2007-7#2)(2007-8#1)
ultrasound to##10##2##(1992-12#1)(1992-5#1)(1993-8#1)(2007-2#1)(2007-8#2)(2008-3#1)(2011-2#1)(2013-1#2)
ultrasound transducers##4##2##(2008-3#1)(2010-8#3)
ultrasound was##8##2##(1991-8#1)(2007-7#1)(2008-1#1)(2009-3#1)(2010-12#1)(2013-1#2)(2013-8#1)
ultrasound while##2##2##(2008-3#1)(2013-8#1)
ultrasound with##9##2##(1991-8#1)(2006-10#2)(2006-6#1)(2008-12#1)(2008-7#1)(2008-8#1)(2012-1#1)(2013-1#1)
ultrasound##806##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#6)(1990-9#4)(1991-10#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-6#3)(1991-8#9)(1991-9#2)(1992-11#2)(1992-12#9)(1992-2#3)(1992-5#1)(1992-6#1)(1992-7#6)(1993-1#3)(1993-3#1)(1993-5#12)(1993-8#11)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#6)(1994-7#3)(1994-9#1)(1995-10#2)(1995-12#2)(1995-3#2)(1995-5#1)(1995-8#1)(1996-1#2)(1996-11#4)(1996-12#6)(1996-2#1)(1996-3#2)(1996-4#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-8#4)(2004-10#2)(2004-2#1)(2005-10#8)(2005-11#3)(2005-12#1)(2005-9#1)(2006-1#1)(2006-10#30)(2006-11#2)(2006-12#3)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#19)(2006-8#1)(2006-9#1)(2007-10#5)(2007-11#15)(2007-12#9)(2007-2#3)(2007-3#6)(2007-4#6)(2007-5#5)(2007-6#2)(2007-7#41)(2007-8#43)(2007-9#6)(2008-1#17)(2008-10#49)(2008-11#7)(2008-12#5)(2008-2#6)(2008-3#21)(2008-4#8)(2008-5#6)(2008-6#8)(2008-7#35)(2008-8#15)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#8)(2009-5#11)(2009-6#10)(2009-7#6)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#38)(2010-4#3)(2010-5#5)(2010-6#2)(2010-7#1)(2010-8#10)(2010-9#1)(2011-1#9)(2011-12#2)(2011-2#29)(2011-5#1)(2012-1#3)(2012-11#1)(2012-12#17)(2012-2#26)(2012-3#14)(2013-1#44)(2013-7#4)(2013-8#13)
ultrasound-assisted acid leaching##3##3##(2008-10#3)
ultrasound-assisted extraction and microwave-assisted digestion##2##5##(2008-10#2)
ultrasound-assisted extraction and##3##3##(2008-10#3)
ultrasound-assisted extraction procedure##2##3##(2008-10#2)
ultrasound-assisted extraction##11##2##(2008-10#9)(2013-1#2)
ultrasound-assisted pseudo-digestion##2##2##(2008-10#2)
ultrasound-assisted##21##1##(2006-10#1)(2008-10#17)(2008-3#1)(2013-1#2)
ultrasound-guided aspiration##3##2##(2007-3#2)(2008-8#1)
ultrasound-guided cannulation of the##2##4##(2007-7#2)
ultrasound-guided drainage##3##2##(2012-12#3)
ultrasound-guided hookwire##2##2##(2007-8#2)
ultrasound-guided percutaneous biopsy##2##3##(2008-1#1)(2012-12#1)
ultrasound-guided percutaneous##3##2##(1993-11#1)(2008-1#1)(2012-12#1)
ultrasound-guided puncture##2##2##(2006-2#1)(2007-7#1)
ultrasound-guided regional anesthesia##3##3##(2012-2#3)
ultrasound-guided##37##1##(1991-2#1)(1993-11#1)(1995-4#1)(2006-10#3)(2006-2#1)(2007-2#1)(2007-3#2)(2007-7#4)(2007-8#3)(2008-1#2)(2008-11#1)(2008-8#1)(2009-4#1)(2010-12#1)(2012-12#4)(2012-2#6)(2013-1#1)(2013-7#3)
ultrasound-modulated optical tomography in biological tissue##2##6##(2007-12#1)(2008-3#1)
ultrasound-modulated optical tomography##5##3##(2007-12#3)(2008-3#2)
ultrasound-modulated optical##7##2##(2007-12#3)(2008-2#2)(2008-3#2)
ultrasound-modulated##9##1##(2007-12#4)(2008-2#2)(2008-3#3)
ultrasound]##8##1##(1993-9#1)(1996-3#1)(1996-6#1)(2007-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
ultrasounds##8##1##(1994-7#1)(1994-8#1)(2004-9#1)(2007-8#2)(2008-10#2)(2008-5#1)
ultrastable##2##1##(2006-12#1)(2007-12#1)
ultrastructural alterations##6##2##(1996-3#1)(2007-9#1)(2008-10#1)(2008-5#1)(2012-11#2)
ultrastructural analysis of##2##3##(2008-9#1)(2011-2#1)
ultrastructural analysis##6##2##(1990-12#1)(1996-9#1)(2007-6#1)(2008-7#1)(2008-9#1)(2011-2#1)
ultrastructural and biochemical##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
ultrastructural and cytochemical##2##3##(2007-12#1)(2008-10#1)
ultrastructural and##13##2##(1991-2#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-8#1)(2006-10#1)(2007-12#2)(2008-10#2)(2008-4#1)(2008-7#1)(2012-2#1)
ultrastructural changes in the##3##4##(2008-12#1)(2009-2#1)(2011-1#1)
ultrastructural changes in##7##3##(1995-11#1)(2008-10#2)(2008-12#1)(2008-6#1)(2009-2#1)(2011-1#1)
ultrastructural changes of##2##3##(2008-10#1)(2008-5#1)
ultrastructural changes that occur##2##4##(2007-9#1)(2008-10#1)
ultrastructural changes##18##2##(1994-11#1)(1994-5#2)(1995-11#1)(1995-6#1)(2007-9#1)(2008-10#7)(2008-12#1)(2008-5#1)(2008-6#1)(2009-2#1)(2011-1#1)
ultrastructural characteristics##5##2##(1996-5#1)(2007-3#1)(2008-5#2)(2010-8#1)
ultrastructural damage in##2##3##(2007-5#2)
ultrastructural damage##5##2##(1993-3#1)(2007-5#4)
ultrastructural distribution##2##2##(1990-4#1)(2011-2#1)
ultrastructural evidence##2##2##(1997-2#1)(2009-7#1)
ultrastructural examination##8##2##(1992-2#1)(1992-6#2)(1992-9#1)(2006-8#1)(2007-12#1)(2007-6#1)(2008-11#1)
ultrastructural features consistent with##2##4##(2010-11#2)
ultrastructural features of the##7##4##(1991-8#1)(2007-12#2)(2007-9#1)(2008-5#1)(2008-7#1)(2010-4#1)
ultrastructural features of##11##3##(1990-4#1)(1991-8#1)(1992-1#1)(1992-8#1)(2007-12#2)(2007-9#1)(2008-5#2)(2008-7#1)(2010-4#1)
ultrastructural features##19##2##(1990-4#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-12#1)(2007-12#2)(2007-9#3)(2008-5#2)(2008-7#2)(2010-11#2)(2010-4#1)
ultrastructural investigation on four species##2##5##(2007-12#2)
ultrastructural investigation##6##2##(1991-3#1)(2006-11#1)(2007-12#2)(2008-10#1)(2008-7#1)
ultrastructural kidney##2##2##(2007-9#2)
ultrastructural level##9##2##(1991-9#1)(1995-6#1)(1996-1#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-7#2)(2011-2#1)
ultrastructural localization of##4##3##(1992-3#1)(1992-8#1)(2008-5#1)(2011-2#1)
ultrastructural modifications of##2##3##(1992-6#2)
ultrastructural modifications##3##2##(1992-6#2)(2008-10#1)
ultrastructural morphology of the##2##4##(2007-12#1)(2008-7#1)
ultrastructural morphology##4##2##(1991-9#1)(2007-12#1)(2008-7#2)
ultrastructural observations##2##2##(2008-5#1)(2011-2#1)
ultrastructural organization##2##2##(2008-7#1)(2009-11#1)
ultrastructural studies on##2##3##(2008-5#1)(2008-7#1)
ultrastructural studies##14##2##(1992-2#1)(1992-8#1)(1993-11#1)(1994-8#1)(2005-5#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-5#2)(2008-6#1)(2008-7#2)(2011-12#1)
ultrastructural study of the##3##4##(2008-1#1)(2008-7#2)
ultrastructural study of##9##3##(1992-4#1)(1994-10#1)(1994-2#1)(1994-6#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-7#2)
ultrastructural study##18##2##(1992-4#1)(1992-6#1)(1993-11#1)(1994-10#1)(1994-2#2)(1994-6#1)(2007-9#3)(2008-1#1)(2008-10#1)(2008-5#2)(2008-7#3)(2009-7#1)
ultrastructural techniques##2##2##(1996-9#1)(2003-11#1)
ultrastructural##185##1##(1990-11#1)(1990-12#1)(1990-4#3)(1991-2#1)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#2)(1992-4#2)(1992-6#5)(1992-8#4)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-10#1)(1994-11#2)(1994-2#2)(1994-5#3)(1994-6#1)(1994-8#2)(1995-11#3)(1995-3#1)(1995-6#3)(1996-1#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(2003-11#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-12#11)(2007-3#1)(2007-5#5)(2007-6#2)(2007-9#12)(2008-1#2)(2008-10#17)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#14)(2008-6#2)(2008-7#20)(2008-9#2)(2009-11#1)(2009-2#2)(2009-7#2)(2010-11#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#2)(2012-2#5)
ultrastructurally indistinguishable from those of##2##5##(1997-7#1)(2013-8#1)
ultrastructurally investigated in##2##3##(1995-11#1)(2008-10#1)
ultrastructurally investigated##3##2##(1995-11#1)(2008-10#2)
ultrastructurally##15##1##(1990-6#1)(1991-3#1)(1991-6#1)(1991-8#1)(1994-12#2)(1995-11#1)(1997-7#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2013-8#1)
ultrastructure and function of##3##4##(2007-12#2)(2008-5#1)
ultrastructure and##11##2##(1993-9#1)(1995-6#1)(1996-3#1)(2007-12#4)(2008-10#1)(2008-5#1)(2012-2#1)(2013-1#1)
ultrastructure in the##2##3##(2012-2#2)
ultrastructure in##6##2##(1991-1#1)(2008-5#1)(2012-2#3)(2013-7#1)
ultrastructure of a##3##3##(2007-12#2)(2009-10#1)
ultrastructure of spermatozoa##2##3##(2007-12#1)(2008-7#1)
ultrastructure of the##18##3##(1994-9#1)(1995-11#1)(1996-3#1)(2007-12#9)(2007-9#2)(2008-12#1)(2008-5#2)(2012-2#1)
ultrastructure of##57##2##(1993-3#1)(1994-9#1)(1995-11#1)(1995-7#2)(1996-3#1)(1996-6#2)(2005-11#1)(2007-12#15)(2007-3#2)(2007-5#2)(2007-9#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#5)(2008-7#10)(2008-8#1)(2009-10#2)(2009-3#1)(2010-12#1)(2012-1#1)(2012-2#2)
ultrastructure##95##1##(1991-1#1)(1993-3#1)(1993-9#2)(1994-9#1)(1995-11#2)(1995-6#1)(1995-7#2)(1996-3#2)(1996-6#2)(1997-4#1)(2005-11#1)(2007-12#23)(2007-3#3)(2007-5#4)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#8)(2008-6#1)(2008-7#11)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#1)(2009-7#1)(2010-12#2)(2012-1#2)(2012-2#6)(2013-1#1)(2013-7#3)
ultrastructures of synoviocytes##3##3##(2006-4#3)
ultrastructures of##4##2##(2006-4#3)(2008-4#1)
ultrastructures##6##1##(2006-4#3)(2008-4#1)(2012-1#2)
ultrathin carbon##2##2##(2010-4#2)
ultrathin films##6##2##(1990-2#1)(2005-11#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-12#1)
ultrathin polymer films##2##3##(2008-10#2)
ultrathin polymer##3##2##(2008-10#3)
ultrathin sections of##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
ultrathin sections##9##2##(1990-12#1)(1995-7#1)(1997-2#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-7#1)
ultrathin transnasal##2##2##(2007-2#1)(2010-12#1)
ultrathin##38##1##(1990-12#1)(1990-2#1)(1990-4#1)(1995-7#2)(1997-2#2)(2005-11#2)(2006-12#1)(2006-4#2)(2007-12#2)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#3)
ultratrace amounts of Hg(II)##2##4##(2008-10#2)
ultratrace amounts of##8##3##(2008-10#8)
ultratrace analysis##2##2##(2008-10#2)
ultratrace levels##2##2##(2007-8#1)(2008-10#1)
ultratrace orthophosphate in seawater##2##4##(2007-8#2)
ultratrace##21##1##(1992-4#1)(2007-8#3)(2008-10#16)(2008-3#1)
ultraviolet (UV) and##2##3##(2003-11#1)(2005-11#1)
ultraviolet (UV) damage##2##3##(1991-3#1)(1995-6#1)
ultraviolet (UV) irradiation##3##3##(2006-12#1)(2007-8#1)(2010-4#1)
ultraviolet (UV) laser##3##3##(2007-11#1)(2008-3#1)(2008-5#1)
ultraviolet (UV) light##3##3##(1991-6#1)(1997-4#1)(2005-11#1)
ultraviolet (UV) radiation##5##3##(2005-11#1)(2008-10#1)(2008-5#2)(2011-2#1)
ultraviolet (UV)##33##2##(1991-3#1)(1991-6#1)(1995-6#1)(1996-6#1)(1997-1#1)(1997-4#1)(2003-11#1)(2005-11#4)(2006-12#1)(2007-11#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#6)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#2)
ultraviolet (UV)-induced##2##2##(2008-10#1)(2008-5#1)
ultraviolet A (UVA)##2##3##(1991-12#1)(1994-3#1)
ultraviolet A radiation##2##3##(1997-1#1)(2010-12#1)
ultraviolet A##8##2##(1990-9#1)(1991-12#3)(1994-3#1)(1997-1#1)(2008-5#1)(2010-12#1)
ultraviolet B##10##2##(1993-5#1)(1996-6#2)(2008-5#2)(2009-6#1)(2010-7#1)(2011-1#2)(2011-2#1)
ultraviolet absorbance at##2##3##(2005-4#1)(2008-7#1)
ultraviolet absorbance##9##2##(1990-12#1)(1992-2#1)(1996-3#1)(1997-8#1)(2005-4#1)(2008-10#3)(2008-7#1)
ultraviolet absorption and fluorescence##2##4##(1990-7#1)(1990-8#1)
ultraviolet absorption at##5##3##(1993-2#1)(1996-8#2)(1997-8#1)(2008-10#1)
ultraviolet absorption##9##2##(1990-7#1)(1990-8#1)(1992-9#1)(1993-2#1)(1996-8#2)(1997-8#1)(2008-10#1)(2008-5#1)
ultraviolet and visible light##2##4##(2008-10#2)
ultraviolet and visible##3##3##(2006-12#1)(2008-10#2)
ultraviolet and##9##2##(1992-3#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2011-2#1)
ultraviolet at##2##2##(2007-12#1)(2008-10#1)
ultraviolet circular##2##2##(1992-8#1)(2008-10#1)
ultraviolet detection after pre-column derivatization with##2##6##(2008-10#1)(2012-12#1)
ultraviolet detection at##10##3##(1990-9#1)(1993-2#1)(1995-1#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-8#2)(2008-10#1)(2008-5#1)
ultraviolet detection##33##2##(1990-11#1)(1990-6#1)(1990-9#1)(1993-2#2)(1994-12#1)(1995-1#1)(1996-5#1)(1996-6#1)(1996-8#4)(1997-2#1)(1997-3#1)(1997-8#2)(2008-10#11)(2008-5#1)(2011-2#1)(2012-12#2)(2013-7#1)
ultraviolet detector##7##2##(1990-6#1)(1992-7#1)(1996-6#2)(1997-8#1)(2008-10#1)(2012-2#1)
ultraviolet dielectric coatings##2##3##(2007-12#2)
ultraviolet dielectric##3##2##(2007-12#2)(2008-3#1)
ultraviolet exposure##2##2##(2008-5#1)(2008-8#1)
ultraviolet for##2##2##(2008-3#2)
ultraviolet frequency##2##2##(2007-12#2)
ultraviolet generation##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
ultraviolet illumination##3##2##(2006-8#1)(2007-12#1)(2013-8#1)
ultraviolet irradiance##2##2##(2008-2#2)
ultraviolet irradiation##13##2##(1992-6#1)(1993-3#1)(1995-11#1)(1996-5#1)(1996-6#1)(2005-11#2)(2008-10#2)(2008-3#2)(2010-8#1)(2013-1#1)
ultraviolet labelling##2##2##(2008-10#2)
ultraviolet laser radiation##2##3##(2007-11#1)(2008-10#1)
ultraviolet laser##11##2##(1995-7#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)
ultraviolet light (UV)##3##3##(1991-3#1)(2004-4#1)(2007-2#1)
ultraviolet light and##4##3##(1991-3#1)(1996-6#1)(2007-12#1)(2007-8#1)
ultraviolet light damage##2##3##(1996-11#1)(2007-11#1)
ultraviolet light is##2##3##(2008-5#1)(2011-2#1)
ultraviolet light##44##2##(1990-5#3)(1990-7#1)(1991-3#2)(1991-8#1)(1994-5#1)(1996-11#1)(1996-3#1)(1996-6#2)(1997-1#1)(1997-4#1)(2004-4#1)(2005-7#1)(2006-11#1)(2007-11#2)(2007-12#6)(2007-2#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-9#2)(2010-7#1)(2010-8#1)(2011-2#1)(2013-8#1)
ultraviolet lithography##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
ultraviolet measurements##2##2##(2008-2#1)(2008-7#1)
ultraviolet or visible##2##3##(2008-10#2)
ultraviolet or##3##2##(1990-6#1)(2008-10#2)
ultraviolet photoelectron spectroscopy##2##3##(2007-9#1)(2010-4#1)
ultraviolet pulses##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
ultraviolet radiation (UVR)##4##3##(1995-4#1)(2006-12#1)(2007-11#1)(2011-2#1)
ultraviolet radiation on##2##3##(2005-11#1)(2010-12#1)
ultraviolet radiation##30##2##(1990-5#1)(1994-8#1)(1995-4#1)(1997-7#1)(2005-11#1)(2006-12#2)(2007-11#6)(2007-12#2)(2007-8#1)(2008-11#1)(2008-2#4)(2008-3#1)(2008-5#2)(2010-12#1)(2011-2#5)
ultraviolet region##15##2##(1990-5#1)(1994-2#1)(1995-1#1)(2007-11#2)(2008-10#4)(2008-2#5)(2008-3#1)
ultraviolet solar spectra##2##3##(2008-3#2)
ultraviolet source##2##2##(2007-12#1)(2008-2#1)
ultraviolet spectra of alpha##2##4##(2005-4#2)
ultraviolet spectra##7##2##(1993-2#1)(2005-4#2)(2006-12#1)(2008-2#2)(2008-3#1)
ultraviolet spectrophotometry##2##2##(2008-10#2)
ultraviolet spectroradiometers##2##2##(2008-2#2)
ultraviolet spectroscopy##2##2##(1994-6#1)(2005-11#1)
ultraviolet spectrum##2##2##(2005-4#2)
ultraviolet to the near infrared##2##5##(2007-11#1)(2008-3#1)
ultraviolet to the##4##3##(2007-11#1)(2008-3#3)
ultraviolet##386##1##(1990-11#2)(1990-12#1)(1990-5#7)(1990-6#3)(1990-7#2)(1990-8#1)(1990-9#2)(1991-12#4)(1991-3#3)(1991-6#1)(1991-8#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-2#4)(1993-3#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-3#2)(1996-5#2)(1996-6#9)(1996-8#6)(1997-1#4)(1997-2#1)(1997-3#2)(1997-4#2)(1997-7#1)(1997-8#5)(2003-11#1)(2004-4#1)(2005-11#8)(2005-4#6)(2005-7#1)(2006-11#1)(2006-12#7)(2006-8#1)(2007-11#23)(2007-12#38)(2007-2#1)(2007-8#7)(2007-9#1)(2008-1#6)(2008-10#46)(2008-11#3)(2008-2#36)(2008-3#42)(2008-5#21)(2008-7#2)(2008-8#1)(2008-9#2)(2009-6#1)(2009-8#1)(2010-12#6)(2010-4#3)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#11)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
ultraviolet-##2##1##(2007-12#1)(2008-2#1)
ultraviolet-A##2##1##(2008-4#2)
ultraviolet-B (UVB)##3##2##(2008-11#2)(2010-7#1)
ultraviolet-B radiation##2##2##(2008-11#1)(2010-7#1)
ultraviolet-B##10##1##(2006-12#1)(2007-7#2)(2008-11#3)(2008-7#1)(2010-7#3)
ultraviolet-visible (UV-vis)##3##2##(2008-10#2)(2009-11#1)
ultraviolet-visible absorption##3##2##(1990-12#1)(2006-2#1)(2008-10#1)
ultraviolet-visible light##3##2##(2008-2#2)(2013-7#1)
ultraviolet-visible spectra##3##2##(2005-4#2)(2008-2#1)
ultraviolet-visible spectroscopy##5##2##(2005-11#1)(2007-11#1)(2008-10#2)(2010-4#1)
ultraviolet-visible##25##1##(1990-12#1)(1993-2#1)(1993-6#1)(1994-7#1)(2005-11#1)(2005-4#2)(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-2#4)(2009-11#1)(2010-4#1)(2013-7#1)
ultravoilet A (UVA)##2##3##(2008-5#2)
ultravoilet##3##1##(2008-5#3)
ultraweak light emission from##2##4##(1991-7#2)
ultraweak light##4##2##(1991-7#3)(2008-3#1)
ultraweak##5##1##(1991-7#3)(2008-3#1)(2008-5#1)
ultrawideband##5##1##(2007-12#3)(2008-2#2)
um in##2##2##(2010-11#2)
um##7##1##(1996-2#2)(2008-11#1)(2010-11#2)(2011-2#2)
umbelliferone##2##1##(1990-3#1)(2006-10#1)
umbilical and##3##2##(1995-9#1)(2010-9#1)(2013-1#1)
umbilical area and##2##3##(2006-7#1)(2008-10#1)
umbilical area##4##2##(1990-8#1)(2006-7#1)(2008-10#2)
umbilical arterial##2##2##(1990-11#1)(1994-5#1)
umbilical arteries##3##2##(2006-5#2)(2007-9#1)
umbilical artery Doppler##2##3##(1994-3#1)(2011-2#1)
umbilical artery and##2##3##(1993-4#1)(1995-6#1)
umbilical artery systolic/diastolic ratios##2##4##(1992-2#2)
umbilical artery##25##2##(1990-8#1)(1990-9#1)(1992-1#5)(1992-2#3)(1993-4#1)(1994-3#2)(1994-5#1)(1995-3#6)(1995-6#1)(1996-6#1)(2004-10#1)(2008-11#1)(2011-2#1)
umbilical blood flow##2##3##(1992-1#2)
umbilical blood##3##2##(1992-1#2)(2012-12#1)
umbilical catheter##4##2##(2011-2#4)
umbilical cord arteries##4##3##(2009-8#4)
umbilical cord blood (UCB)##4##4##(2007-11#1)(2007-8#1)(2011-2#1)(2012-11#1)
umbilical cord blood##13##3##(2007-11#1)(2007-8#2)(2008-1#1)(2008-11#2)(2008-8#2)(2011-2#1)(2012-11#2)(2012-12#1)(2013-1#1)
umbilical cord blood-derived##2##3##(2007-11#1)(2008-1#1)
umbilical cord in##2##3##(2004-10#1)(2006-12#1)
umbilical cord vein##2##3##(2008-11#1)(2011-8#1)
umbilical cord##49##2##(1990-12#1)(1993-11#1)(1994-3#1)(1995-2#1)(1996-12#2)(1996-2#1)(1997-3#1)(2004-10#1)(2006-12#1)(2007-11#2)(2007-3#1)(2007-8#2)(2008-1#2)(2008-11#5)(2008-3#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-8#6)(2009-9#3)(2010-5#1)(2011-1#1)(2011-2#2)(2011-8#1)(2012-11#2)(2012-12#3)(2012-3#1)(2013-1#1)
umbilical evagination of the bladder##2##5##(2008-10#2)
umbilical hernias##2##2##(2008-9#2)
umbilical port##2##2##(2011-1#1)(2012-12#1)
umbilical vein endothelial cells (HEC)##2##5##(1995-3#2)
umbilical vein endothelial cells##57##4##(1990-11#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#5)(1994-3#2)(1994-8#3)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-3#1)(1997-1#2)(1997-7#1)(2008-10#4)(2008-11#4)(2008-7#1)(2008-8#2)(2008-9#3)(2009-8#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-2#2)(2013-7#1)(2013-8#1)
umbilical vein endothelial##61##3##(1990-11#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#5)(1994-3#2)(1994-8#3)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-3#1)(1997-1#2)(1997-7#1)(2008-10#4)(2008-11#6)(2008-7#1)(2008-8#2)(2008-9#3)(2009-8#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-2#2)(2013-7#1)(2013-8#2)
umbilical vein pH##2##3##(1993-7#2)
umbilical vein##73##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-7#3)(1993-9#1)(1994-2#5)(1994-3#2)(1994-8#4)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-3#2)(1997-1#2)(1997-7#1)(2004-9#1)(2008-10#4)(2008-11#6)(2008-7#1)(2008-8#2)(2008-9#3)(2009-8#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-2#2)(2013-7#1)(2013-8#3)
umbilical veins##5##2##(1992-2#1)(1993-3#1)(1994-6#1)(2008-8#1)(2008-9#1)
umbilical venous catheterization##2##3##(2008-4#1)(2010-10#1)
umbilical venous pressure##3##3##(1992-1#3)
umbilical venous##8##2##(1992-1#4)(1993-7#1)(1994-5#1)(2008-4#1)(2010-10#1)
umbilical##211##1##(1990-11#3)(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#5)(1990-9#2)(1991-1#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-1#11)(1992-2#4)(1993-11#2)(1993-12#1)(1993-3#3)(1993-4#1)(1993-6#2)(1993-7#4)(1993-9#1)(1994-2#5)(1994-3#7)(1994-5#3)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#8)(1995-6#2)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#1)(1997-1#2)(1997-3#1)(1997-7#1)(2004-10#2)(2004-9#1)(2006-12#1)(2006-5#2)(2006-7#1)(2007-11#2)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#10)(2008-11#12)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#8)(2009-8#7)(2009-9#3)(2010-10#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-9#3)(2011-1#3)(2011-12#1)(2011-2#11)(2011-8#1)(2012-11#2)(2012-12#6)(2012-2#4)(2012-3#2)(2013-1#8)(2013-7#2)(2013-8#3)
umbilicus##9##1##(2007-8#2)(2010-2#1)(2010-6#2)(2011-1#1)(2011-2#2)(2012-12#1)
umblical##2##1##(2011-2#2)
umbo##4##1##(2007-3#1)(2007-5#3)
umbrella of##9##2##(2006-7#1)(2008-1#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)
umbrella term##2##2##(2006-10#1)(2007-6#1)
umbrella##27##1##(1992-6#2)(1993-10#1)(1994-9#2)(1997-8#3)(2006-10#1)(2006-7#1)(2007-6#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-4#1)(2009-6#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#2)
umol/L##2##1##(2008-4#2)
umuC##2##1##(1993-12#2)
un cas de##3##3##(2012-2#2)(2013-1#1)
un cas##5##2##(2011-2#1)(2012-2#3)(2013-1#1)
un développement##2##2##(2008-11#1)(2012-2#1)
un effet##2##2##(2008-5#2)
un kyste hydatique##2##3##(2012-2#2)
un problème##3##2##(2011-2#1)(2012-2#1)(2013-1#1)
un syndrome##5##2##(2013-1#5)
un##55##1##(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#4)(2009-4#1)(2011-2#2)(2012-2#26)(2013-1#17)
un- or underphosphorylated##2##3##(1996-2#2)
un- or##3##2##(1996-2#2)(2008-11#1)
un-fused IGPS in TT##2##4##(2007-7#2)
un-fused IGPS##4##2##(2007-7#4)
un-fused##6##1##(2007-7#6)
un-ingested##2##1##(2008-5#2)
un-substituted##3##1##(2009-3#3)
un-treated##3##1##(2008-12#3)
unabated##4##1##(2007-7#1)(2008-10#1)(2008-7#1)(2013-1#1)
unable to account##2##3##(1996-8#1)(2008-2#1)
unable to achieve##4##3##(2006-12#1)(2008-10#1)(2008-12#1)(2010-12#1)
unable to afford##4##3##(1994-12#1)(1997-6#1)(2007-7#1)(2008-11#1)
unable to apply##2##3##(1995-5#1)(2006-8#1)
unable to be##2##3##(2007-11#1)(2009-6#1)
unable to bind##4##3##(1994-9#3)(1995-2#1)
unable to block##4##3##(1990-2#1)(1992-5#1)(1992-7#1)(1994-9#1)
unable to compete##2##3##(1992-12#1)(1993-8#1)
unable to complete##2##3##(1990-4#1)(2008-7#1)
unable to confer##2##3##(1994-11#1)(1995-3#1)
unable to continue##2##3##(1997-7#1)(2006-8#1)
unable to convert##3##3##(1991-8#1)(1996-8#1)(1997-4#1)
unable to demonstrate##8##3##(1990-6#1)(1991-2#1)(1995-12#1)(1996-12#1)(1997-3#1)(2006-10#1)(2008-8#1)(2009-9#1)
unable to detect any##4##4##(1996-2#1)(1996-3#1)(2008-5#1)(2009-5#1)
unable to detect##8##3##(1990-11#1)(1996-2#1)(1996-3#2)(2006-10#1)(2007-9#1)(2008-5#1)(2009-5#1)
unable to discern##3##3##(2004-9#1)(2006-12#1)(2010-2#1)
unable to discriminate##2##3##(1990-10#1)(1996-2#1)
unable to distinguish##3##3##(1997-5#1)(2010-8#1)(2013-1#1)
unable to do so##2##4##(1990-6#1)(2006-10#1)
unable to establish##2##3##(2008-10#1)(2008-9#1)
unable to explain##2##3##(1990-12#1)(2008-7#1)
unable to find##4##3##(1997-6#1)(2008-2#1)(2013-1#2)
unable to form##4##3##(1990-5#1)(1993-11#1)(1994-5#1)(2008-10#1)
unable to fully##3##3##(1993-8#1)(1995-10#1)(2007-2#1)
unable to give##3##3##(2006-10#1)(2008-7#1)(2009-6#1)
unable to grow in##2##4##(1995-2#1)(2008-11#1)
unable to grow##7##3##(1991-12#1)(1995-2#1)(1995-5#2)(1996-7#1)(2008-11#1)(2008-6#1)
unable to identify##4##3##(2008-11#1)(2008-12#1)(2013-1#2)
unable to induce##4##3##(1991-9#1)(1992-9#1)(1994-12#1)(2008-10#1)
unable to infect##6##3##(2008-10#5)(2013-1#1)
unable to influence the##2##4##(2007-11#1)(2008-2#1)
unable to inhibit##7##3##(1991-5#1)(1991-8#1)(1992-7#1)(1994-5#1)(1994-6#1)(1995-6#1)(2008-6#1)
unable to maintain an adequate##3##5##(2010-7#2)(2011-2#1)
unable to maintain##5##3##(1990-11#1)(1993-8#1)(2010-7#2)(2011-2#1)
unable to occlude Ca2+##2##4##(1994-10#2)
unable to penetrate the##3##4##(1996-9#1)(2005-11#1)(2008-10#1)
unable to penetrate##4##3##(1996-9#1)(2005-11#1)(2008-10#1)(2008-3#1)
unable to perform##3##3##(1990-8#1)(2008-1#1)(2008-7#1)
unable to predict##4##3##(2006-9#1)(2007-11#1)(2008-2#1)(2012-2#1)
unable to prevent the##3##4##(1990-11#1)(1992-7#1)(1994-5#1)
unable to prevent##6##3##(1990-11#1)(1992-7#1)(1994-5#1)(1995-5#1)(1996-10#1)(1997-7#1)
unable to protect##2##3##(1991-9#1)(2007-7#1)
unable to provide##6##3##(1990-11#1)(2008-2#1)(2011-1#1)(2012-2#2)(2013-1#1)
unable to reach##3##3##(2007-6#1)(2008-4#1)(2011-12#1)
unable to recognize##2##3##(1997-6#1)(2008-10#1)
unable to replicate##3##3##(1993-11#1)(1996-9#1)(2010-12#1)
unable to reproduce##2##3##(1991-5#1)(1996-12#1)
unable to resolve##2##3##(1990-8#1)(2007-12#1)
unable to respond##2##3##(2007-2#1)(2008-1#1)
unable to return##2##3##(2008-7#1)(2008-9#1)
unable to secrete##3##3##(1993-9#1)(2008-10#1)(2012-2#1)
unable to stimulate##2##3##(1990-9#1)(2008-8#1)
unable to support##4##3##(1990-6#1)(1997-3#1)(2008-5#1)(2008-9#1)
unable to sustain the##3##4##(1990-2#1)(2006-7#1)(2012-2#1)
unable to synthesize##6##3##(1992-12#2)(1995-7#1)(2008-11#1)(2008-5#1)(2008-7#1)
unable to take advantage of##2##5##(1995-6#1)(2008-4#1)
unable to take##4##3##(1993-3#1)(1995-6#1)(2008-1#1)(2008-4#1)
unable to tolerate##5##3##(2005-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-8#1)
unable to undergo the##2##4##(2011-2#1)(2012-12#1)
unable to undergo##3##3##(2011-2#1)(2012-12#2)
unable to walk##3##3##(2006-7#1)(2011-12#1)(2012-2#1)
unable to work##3##3##(2005-11#1)(2006-8#1)(2012-12#1)
unable to##317##2##(1990-10#2)(1990-11#4)(1990-12#2)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#3)(1990-8#4)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#3)(1991-8#4)(1991-9#2)(1992-11#1)(1992-12#3)(1992-2#2)(1992-5#2)(1992-7#3)(1992-9#2)(1993-11#3)(1993-3#1)(1993-6#1)(1993-8#3)(1993-9#4)(1994-10#3)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#4)(1995-10#1)(1995-12#3)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#7)(1995-6#3)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#3)(1996-9#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#2)(2004-9#2)(2005-11#2)(2005-8#1)(2006-10#5)(2006-12#3)(2006-6#1)(2006-7#2)(2006-8#5)(2006-9#1)(2007-1#1)(2007-11#6)(2007-12#4)(2007-2#3)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#21)(2008-11#6)(2008-12#2)(2008-2#8)(2008-3#2)(2008-4#6)(2008-5#8)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#5)(2009-10#1)(2009-5#1)(2009-6#4)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#3)(2010-2#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-12#3)(2011-2#5)(2011-7#1)(2012-1#2)(2012-12#3)(2012-2#9)(2012-3#2)(2013-1#14)(2013-8#1)
unable##322##1##(1990-10#2)(1990-11#4)(1990-12#2)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#3)(1990-8#4)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#2)(1991-5#3)(1991-8#4)(1991-9#2)(1992-11#2)(1992-12#3)(1992-2#2)(1992-5#2)(1992-7#3)(1992-9#2)(1993-11#3)(1993-3#1)(1993-6#1)(1993-8#3)(1993-9#4)(1994-10#3)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#4)(1995-10#1)(1995-12#3)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#7)(1995-6#3)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#3)(1996-9#3)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#2)(2004-9#2)(2005-11#2)(2005-8#1)(2006-10#5)(2006-12#3)(2006-6#1)(2006-7#2)(2006-8#5)(2006-9#1)(2007-1#1)(2007-11#6)(2007-12#4)(2007-2#3)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#21)(2008-11#6)(2008-12#2)(2008-2#8)(2008-3#2)(2008-4#7)(2008-5#8)(2008-6#2)(2008-7#8)(2008-8#5)(2008-9#5)(2009-10#1)(2009-5#1)(2009-6#4)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#3)(2010-2#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-12#3)(2011-2#5)(2011-7#1)(2012-1#2)(2012-12#3)(2012-2#9)(2012-3#2)(2013-1#14)(2013-8#1)
unacceptable and##3##2##(1992-2#1)(2005-8#1)(2008-7#1)
unacceptable as##2##2##(2007-8#2)
unacceptable cosmetic##2##2##(2007-8#1)(2008-5#1)
unacceptable for##4##2##(2007-12#1)(2007-4#1)(2008-10#1)(2008-5#1)
unacceptable in##5##2##(1996-8#1)(2008-6#1)(2008-7#1)(2008-8#1)(2013-1#1)
unacceptable level of##2##3##(2008-6#1)(2013-1#1)
unacceptable levels of##2##3##(2006-10#1)(2007-2#1)
unacceptable toxicity##3##2##(2006-12#1)(2008-6#1)(2009-8#1)
unacceptable##53##1##(1990-2#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-11#1)(1994-8#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-9#1)(2011-2#3)(2012-2#1)(2013-1#3)
unacceptably high##12##2##(1995-2#1)(1995-6#1)(2004-9#1)(2007-11#2)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#2)
unacceptably##16##1##(1990-5#1)(1993-9#1)(1995-2#1)(1995-6#1)(1996-12#1)(2004-9#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#2)
unaccompanied by##4##2##(1993-6#1)(2010-12#1)(2012-2#1)(2013-8#1)
unaccompanied##5##1##(1993-6#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
unaccounted for##4##2##(1992-2#1)(1993-9#1)(1994-5#1)(1997-3#1)
unaccounted##6##1##(1992-2#1)(1993-9#1)(1994-5#1)(1996-4#1)(1997-3#1)(2007-8#1)
unaccustomed to##2##2##(1991-2#1)(1994-3#1)
unaccustomed##3##1##(1991-2#1)(1994-3#1)(2008-5#1)
unacetylated##5##1##(1990-12#2)(1994-9#3)
unacknowledged##4##1##(2007-7#1)(2008-11#1)(2009-9#1)(2010-10#1)
unactivated##2##1##(1995-1#1)(1995-7#1)
unaddressed##2##1##(2008-11#1)(2010-1#1)
unadjusted##9##1##(1992-2#1)(2007-8#4)(2010-2#1)(2010-8#1)(2011-1#2)
unaffected and##2##2##(1992-6#1)(2010-5#1)
unaffected by age##5##3##(1991-12#1)(1991-6#3)(1993-12#1)
unaffected by either##2##3##(1995-5#1)(2007-8#1)
unaffected by in vitro##2##4##(1993-12#1)(1997-4#1)
unaffected by increasing the##2##4##(1991-2#1)(1996-8#1)
unaffected by increasing##3##3##(1991-2#1)(1995-11#1)(1996-8#1)
unaffected by superoxide dismutase##2##4##(1990-3#1)(1993-11#1)
unaffected by the addition of##2##5##(1991-8#1)(1996-6#1)
unaffected by the presence of##7##5##(1992-6#1)(1994-3#1)(1997-4#1)(2008-10#2)(2011-12#2)
unaffected by the presence##9##4##(1992-6#1)(1994-3#1)(1997-4#1)(2008-10#4)(2011-12#2)
unaffected by the##35##3##(1990-11#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#4)(2009-12#1)(2010-4#1)(2011-12#2)
unaffected by these##2##3##(1990-10#1)(1994-9#1)
unaffected by treatment with##2##4##(1991-12#1)(1995-12#1)
unaffected by treatment##3##3##(1991-12#1)(1995-12#1)(2008-10#1)
unaffected by##153##2##(1990-10#2)(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#1)(1990-7#3)(1990-8#1)(1991-1#3)(1991-10#1)(1991-12#4)(1991-2#2)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#2)(1992-11#2)(1992-12#1)(1992-3#3)(1992-4#3)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#3)(1993-3#3)(1993-6#2)(1994-11#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#1)(1995-5#6)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#5)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-4#3)(1997-5#2)(1997-6#2)(1997-8#3)(2004-11#1)(2005-8#1)(2006-3#1)(2006-5#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-10#14)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2009-12#2)(2009-9#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-4#1)(2013-1#1)
unaffected children##2##2##(2007-2#2)
unaffected controls##2##2##(2013-1#2)
unaffected flocks##2##2##(2008-5#2)
unaffected in the##3##3##(1990-3#1)(1991-2#1)(1996-5#1)
unaffected in##11##2##(1990-3#1)(1990-4#1)(1991-2#1)(1994-12#1)(1995-3#1)(1995-5#1)(1996-3#1)(1996-5#1)(2005-8#1)(2008-7#2)
unaffected individuals##4##2##(1995-12#1)(1996-5#1)(1997-5#1)(2008-9#1)
unaffected or##4##2##(1990-5#1)(1991-5#1)(1993-11#1)(2008-10#1)
unaffected persons##2##2##(1994-12#1)(1997-5#1)
unaffected relatives##3##2##(1993-12#1)(1997-8#1)(2009-10#1)
unaffected siblings##2##2##(1996-1#1)(2007-8#1)
unaffected##310##1##(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#2)(1990-5#2)(1990-7#6)(1990-8#3)(1990-9#1)(1991-1#4)(1991-10#4)(1991-12#5)(1991-2#3)(1991-5#2)(1991-6#3)(1991-7#3)(1991-8#2)(1991-9#4)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#4)(1992-4#3)(1992-6#4)(1992-8#3)(1992-9#2)(1993-11#2)(1993-12#5)(1993-3#4)(1993-4#1)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#5)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#5)(1994-8#7)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#9)(1995-2#1)(1995-3#2)(1995-5#8)(1995-6#1)(1995-7#2)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#7)(1996-3#5)(1996-4#1)(1996-5#3)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-3#2)(1997-4#5)(1997-5#5)(1997-6#2)(1997-8#5)(2004-11#1)(2005-11#1)(2005-8#3)(2006-10#1)(2006-12#3)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#3)(2007-7#2)(2007-8#4)(2008-10#21)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#2)(2009-12#3)(2009-4#1)(2009-9#4)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-9#2)(2011-1#2)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2012-4#1)(2012-5#1)(2012-8#1)(2013-1#5)
unaffiliated organizations##2##2##(2009-4#2)
unaffiliated##4##1##(1995-1#1)(2009-4#3)
unaffordable##3##1##(1996-5#1)(2008-4#1)(2010-11#1)
unaided##4##1##(2004-7#1)(2006-4#1)(2007-1#1)(2008-10#1)
unaltered after##3##2##(1994-12#1)(1994-2#1)(2012-2#1)
unaltered by pretreatment with##2##4##(1991-6#1)(1993-4#1)
unaltered by##10##2##(1990-4#1)(1991-12#1)(1991-6#1)(1993-4#1)(1997-7#1)(2008-10#1)(2008-11#2)(2010-12#1)(2011-2#1)
unaltered during##3##2##(1993-2#1)(1994-11#1)(2008-8#1)
unaltered in both##3##3##(1996-12#1)(2008-10#1)(2013-8#1)
unaltered in the presence of##2##5##(1991-7#1)(1993-7#1)
unaltered in##11##2##(1991-7#1)(1993-12#1)(1993-7#1)(1996-12#3)(1997-5#2)(2008-10#1)(2010-10#1)(2013-8#1)
unaltered##86##1##(1990-2#1)(1990-4#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-6#1)(1991-7#2)(1992-3#1)(1992-9#2)(1993-12#3)(1993-2#1)(1993-4#2)(1993-7#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#5)(1997-5#2)(1997-7#2)(2005-11#1)(2006-12#1)(2007-11#1)(2008-10#6)(2008-11#7)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#3)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
unambigously##2##1##(2007-1#1)(2008-10#1)
unambiguous and reproducible manner##2##4##(2013-1#2)
unambiguous and##3##2##(2007-12#1)(2013-1#2)
unambiguous assignment of##2##3##(1995-11#1)(1996-8#1)
unambiguous determination of##4##3##(1995-8#1)(2008-10#1)(2008-3#2)
unambiguous identification of##2##3##(2008-10#1)(2008-4#1)
unambiguous identification##3##2##(2008-10#1)(2008-4#1)(2012-12#1)
unambiguous measurement##2##2##(2007-12#2)
unambiguous##51##1##(1991-2#1)(1991-9#1)(1993-4#1)(1994-2#1)(1995-11#1)(1995-8#1)(1995-9#2)(1996-8#1)(2006-12#1)(2006-5#2)(2006-6#2)(2007-11#1)(2007-12#4)(2007-4#1)(2008-10#3)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
unambiguously by##2##2##(1992-12#1)(1995-10#1)
unambiguously identified the##2##3##(1995-2#1)(1995-4#1)
unambiguously identified##6##2##(1994-12#1)(1995-2#1)(1995-4#1)(1997-4#1)(2008-10#2)
unambiguously identify##3##2##(2007-12#1)(2008-5#1)(2013-8#1)
unambiguously identifying##2##2##(2008-9#1)(2013-8#1)
unambiguously that the##3##3##(1991-3#1)(1991-4#1)(1997-7#1)
unambiguously that##4##2##(1991-3#1)(1991-4#1)(1997-7#1)(2008-10#1)
unambiguously the presence of##2##4##(1990-3#1)(2006-4#1)
unambiguously the##5##2##(1990-3#1)(1993-2#1)(1994-8#1)(1995-12#1)(2006-4#1)
unambiguously##50##1##(1990-3#2)(1991-3#1)(1991-4#1)(1992-12#1)(1993-11#1)(1993-2#1)(1994-12#2)(1994-8#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-4#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-4#1)(2007-12#4)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-6#1)(2013-8#2)
unamended soil##2##2##(2008-10#2)
unamended##4##1##(2006-8#1)(2008-10#3)
unamplified##6##1##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)
unanesthetized rats##6##2##(1991-9#1)(1992-3#1)(1997-2#2)(1997-6#2)
unanesthetized##15##1##(1991-9#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-7#2)(1997-2#3)(1997-6#3)(2007-10#2)(2008-4#1)
unanimous in##2##2##(2007-2#1)(2010-11#1)
unanimous##6##1##(1995-3#1)(2005-10#1)(2007-2#1)(2008-8#1)(2010-11#1)(2011-2#1)
unanimously##10##1##(1991-9#1)(1993-3#1)(1993-8#1)(1995-6#1)(2004-2#1)(2007-9#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-3#1)
unanswered question##2##2##(2011-1#1)(2012-2#1)
unanswered questions about##4##3##(2005-11#1)(2007-12#1)(2007-2#1)(2008-8#1)
unanswered questions are##2##3##(1995-12#1)(2012-2#1)
unanswered questions regarding the##3##4##(2008-1#1)(2009-8#1)(2011-2#1)
unanswered questions##19##2##(1993-8#1)(1995-12#1)(1996-12#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-2#1)
unanswered##45##1##(1992-2#1)(1993-8#1)(1995-11#1)(1995-12#2)(1996-11#1)(1996-12#1)(2005-11#1)(2006-10#4)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#3)(2009-8#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
unanticipated admission##4##2##(2006-10#4)
unanticipated consequences##3##2##(1990-12#1)(1991-2#1)(2008-11#1)
unanticipated findings##2##2##(1994-11#1)(2008-12#1)
unanticipated##26##1##(1990-12#1)(1991-2#1)(1992-9#1)(1994-11#1)(1996-2#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-10#6)(2006-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
unapertured##2##1##(2008-3#2)
unapodized##4##1##(2007-12#1)(2008-2#2)(2008-3#1)
unappreciated##6##1##(1991-12#1)(1991-2#1)(1996-4#1)(2008-11#1)(2012-12#1)(2013-1#1)
unassembled membrane protein##3##3##(1996-5#3)
unassembled membrane##4##2##(1996-5#4)
unassembled##6##1##(1996-5#4)(2005-8#1)(2009-10#1)
unassisted##8##1##(1995-1#1)(2006-5#1)(2007-10#1)(2007-2#1)(2008-6#1)(2008-8#1)(2012-1#2)
unassociated with##6##2##(1994-6#1)(2007-10#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-2#1)
unattached##4##1##(1991-11#1)(2008-11#1)(2008-8#1)(2010-3#1)
unattainable##8##1##(1992-2#1)(1995-4#1)(1996-5#1)(2006-7#1)(2007-11#1)(2007-4#1)(2009-6#1)(2010-2#1)
unattended for##2##2##(2008-11#2)
unattended operation##3##2##(2008-10#2)(2008-2#1)
unattended stimulus##4##2##(2010-5#4)
unattended##20##1##(1995-3#1)(1997-1#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#3)(2008-8#1)(2008-9#1)(2010-5#5)
unattractive##8##1##(2006-2#1)(2007-12#6)(2008-9#1)
unauthorized immigrant patients##2##3##(2012-11#2)
unauthorized immigrants##2##2##(2012-11#2)
unauthorized##9##1##(1994-2#1)(1995-12#1)(1996-12#1)(2005-8#1)(2007-12#1)(2012-11#4)
unavailability of##8##2##(1991-9#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-3#2)
unavailability##11##1##(1991-9#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#2)
unavailable for##2##2##(2007-11#1)(2007-2#1)
unavailable to##4##2##(2005-8#1)(2008-11#1)(2012-12#1)(2012-2#1)
unavailable##39##1##(1994-4#1)(1994-8#1)(1995-1#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-3#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#2)(2008-10#3)(2008-11#2)(2008-2#2)(2008-7#1)(2009-3#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)
unavoidable if##3##2##(1991-11#1)(2008-10#1)(2008-4#1)
unavoidable##29##1##(1991-11#1)(1992-2#1)(1996-9#1)(1997-4#1)(1997-5#1)(2006-2#2)(2006-5#2)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2009-3#1)(2009-5#1)(2009-9#1)(2011-2#1)(2012-3#1)
unavoidably##5##1##(2007-12#1)(2007-6#1)(2008-2#2)(2008-3#1)
unaware of the##7##3##(2008-6#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#1)(2013-8#1)
unaware of their##2##3##(2008-10#1)(2008-3#1)
unaware of##19##2##(1995-12#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
unaware that##2##2##(2006-10#1)(2010-12#1)
unaware##23##1##(1995-12#1)(1996-9#1)(1997-2#1)(2006-10#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-4#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
unawareness of##3##2##(2007-3#1)(2011-1#2)
unawareness##5##1##(2006-1#2)(2007-3#1)(2011-1#2)
unbalance##7##1##(1992-10#1)(1996-3#2)(2008-11#1)(2012-1#3)
unbalanced Mach-Zehnder##2##2##(2007-12#1)(2008-2#1)
unbalanced and##2##2##(1997-7#1)(2013-1#1)
unbalanced data##3##2##(1994-8#1)(1995-12#1)(2010-12#1)
unbalanced translocations##2##2##(2010-1#2)
unbalanced##42##1##(1990-10#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-7#1)(2005-10#2)(2007-12#4)(2007-2#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)(2010-1#2)(2010-11#2)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#3)
unbearable##5##1##(1993-9#1)(1996-3#1)(2006-7#1)(2009-6#1)(2011-12#1)
unbelievable##2##1##(1997-6#1)(2008-4#1)
unbiased analysis of##2##3##(2008-4#1)(2012-12#1)
unbiased and##4##2##(2008-2#2)(2008-5#1)(2009-9#1)
unbiased estimates of relative and attributable##2##6##(1995-6#2)
unbiased estimates of##4##3##(1995-6#2)(1997-1#1)(2010-3#1)
unbiased estimates##5##2##(1995-6#2)(1997-1#1)(2008-3#1)(2010-3#1)
unbiased estimators##2##2##(1997-2#1)(2012-1#1)
unbiased measure of##2##3##(1995-6#1)(2009-11#1)
unbiased##56##1##(1990-11#1)(1991-3#1)(1995-4#1)(1995-6#3)(1996-12#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-5#1)(2007-12#3)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
unbiasedly##2##1##(1996-2#1)(2008-1#1)
unbinding of##2##2##(1995-10#1)(2009-12#1)
unbinding##3##1##(1995-10#1)(2009-12#1)(2010-4#1)
unbleached##3##1##(2008-1#2)(2008-6#1)
unblended##2##1##(2008-2#1)(2011-1#1)
unblinded study##2##2##(1992-8#1)(2009-6#1)
unblinded##4##1##(1992-8#1)(1994-2#1)(1996-12#1)(2009-6#1)
unblocked##4##1##(1994-5#2)(1996-5#1)(2008-4#1)
unbooked cases delivering at##2##4##(2012-2#2)
unbooked##4##1##(2007-3#1)(2008-7#1)(2012-2#2)
unborn child##4##2##(2008-2#2)(2010-2#1)(2013-1#1)
unborn##6##1##(2008-11#1)(2008-2#2)(2010-2#1)(2012-2#1)(2013-1#1)
unbound (free)##2##2##(1990-10#1)(2008-10#1)
unbound state##2##2##(1997-2#1)(2009-12#1)
unbound##36##1##(1990-10#1)(1990-12#4)(1990-3#1)(1991-2#1)(1991-7#1)(1991-9#1)(1993-12#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-11#1)(1996-4#2)(1996-5#2)(1997-2#1)(1997-4#2)(1997-7#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-8#2)(2009-12#1)(2012-2#1)
unbounded##4##1##(2008-8#2)(2009-10#1)(2009-5#1)
unbranched neurons##3##2##(2007-12#3)
unbranched##18##1##(1991-7#1)(1994-5#1)(1994-8#1)(1996-8#1)(2007-12#7)(2007-5#2)(2008-5#2)(2010-10#1)(2010-11#1)(2012-2#1)
unbudded period of the##3##4##(1992-3#3)
unbudded period of##4##3##(1992-3#4)
unbudded period##5##2##(1992-3#5)
unbuffered saline##2##2##(1993-3#2)
unbuffered##9##1##(1991-12#1)(1993-12#1)(1993-3#4)(2008-10#2)(2009-12#1)
unburned skin##3##2##(2006-9#3)
unburned##7##1##(2006-9#3)(2008-10#2)(2008-3#2)
unc-104 and unc-116##2##3##(1995-3#2)
unc-104##5##1##(1991-5#3)(1995-3#2)
unc-86 protein is##3##3##(1990-11#3)
unc-86 protein##5##2##(1990-11#5)
unc-86##10##1##(1990-11#10)
uncalibrated phase##2##2##(2008-3#2)
uncalibrated##7##1##(2008-10#2)(2008-2#1)(2008-3#3)(2008-6#1)
uncapped RNAs##3##2##(2008-10#2)(2008-9#1)
uncapped viral RNAs##2##3##(2008-10#2)
uncapped##12##1##(1992-2#2)(1996-9#1)(2008-10#6)(2008-9#1)(2009-6#1)(2010-2#1)
uncemented total##3##2##(2008-3#1)(2009-4#1)(2012-12#1)
uncemented##13##1##(1993-8#2)(2007-11#3)(2008-3#2)(2008-8#1)(2009-3#1)(2009-4#2)(2012-12#1)(2013-1#1)
uncensored data##3##2##(1995-9#3)
uncensored##4##1##(1995-9#3)(1997-2#1)
uncertain about the##2##3##(2008-8#1)(2012-2#1)
uncertain about##3##2##(2008-8#1)(2011-2#1)(2012-2#1)
uncertain and##7##2##(1992-1#1)(2005-10#1)(2007-3#1)(2008-5#2)(2008-8#1)(2009-9#1)
uncertain at the##2##3##(1996-12#1)(2006-12#1)
uncertain at##4##2##(1996-12#1)(1997-6#1)(2006-12#1)(2012-11#1)
uncertain for##2##2##(1993-2#1)(2006-10#1)
uncertain harms##2##2##(1997-8#2)
uncertain how##3##2##(2007-9#1)(2009-5#1)(2009-9#1)
uncertain in the##2##3##(2010-12#1)(2012-2#1)
uncertain nonlinear##2##2##(2008-2#2)
uncertain pathogenesis##2##2##(2006-5#1)(2010-12#1)
uncertain value##4##2##(2007-10#3)(2008-10#1)
uncertain whether##5##2##(1991-11#1)(1993-9#1)(2006-8#1)(2007-11#1)(2008-2#1)
uncertain##179##1##(1990-2#1)(1990-3#1)(1990-9#2)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-4#1)(1992-7#2)(1993-10#3)(1993-11#2)(1993-12#1)(1993-2#2)(1993-5#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-4#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#2)(2004-1#1)(2004-10#1)(2005-10#4)(2005-11#2)(2005-3#2)(2005-7#1)(2006-10#10)(2006-12#2)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#9)(2007-11#3)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#3)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#4)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#1)
uncertainties about##3##2##(1992-1#1)(1995-1#1)(2010-7#1)
uncertainties and##3##2##(1995-12#1)(2008-3#1)(2010-9#1)
uncertainties are##4##2##(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
uncertainties associated with this##2##4##(2008-2#2)
uncertainties associated with##4##3##(2008-2#3)(2008-3#1)
uncertainties associated##5##2##(2008-10#1)(2008-2#3)(2008-3#1)
uncertainties concerning##2##2##(1994-5#1)(2013-8#1)
uncertainties for the##2##3##(2008-2#1)(2008-3#1)
uncertainties for##4##2##(1995-4#1)(2008-10#1)(2008-2#1)(2008-3#1)
uncertainties in speciation##2##3##(2008-10#2)
uncertainties in the##15##3##(1995-6#1)(1997-5#1)(2006-10#1)(2006-7#1)(2008-11#1)(2008-2#1)(2008-3#8)(2008-5#1)
uncertainties in##31##2##(1995-6#1)(1996-12#2)(1997-5#1)(2006-10#1)(2006-7#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#11)(2008-5#2)(2009-4#1)(2013-1#2)
uncertainties involved in the##2##4##(2008-2#1)(2008-3#1)
uncertainties involved in##4##3##(2008-2#2)(2008-3#1)(2009-11#1)
uncertainties obtained##2##2##(2007-12#1)(2008-2#1)
uncertainties of the##3##3##(2005-7#1)(2007-12#1)(2008-3#1)
uncertainties of##5##2##(2005-7#1)(2007-12#2)(2008-3#2)
uncertainties on the##2##3##(1993-9#1)(2008-10#1)
uncertainties on##3##2##(1993-9#1)(2008-10#2)
uncertainties regarding##3##2##(1996-8#1)(2007-11#1)(2008-4#1)
uncertainties resulting##2##2##(2008-10#1)(2008-8#1)
uncertainties still##3##2##(2008-11#1)(2008-7#1)(2010-2#1)
uncertainties that are due to##2##5##(2008-3#2)
uncertainties that##3##2##(2008-2#1)(2008-3#2)
uncertainties##118##1##(1990-10#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-4#1)(1995-6#1)(1996-12#2)(1996-4#1)(1996-8#1)(1997-5#1)(2005-7#2)(2006-10#2)(2006-12#1)(2006-7#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#12)(2008-11#2)(2008-2#17)(2008-3#37)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#3)(2009-3#1)(2009-4#1)(2010-2#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
uncertainty (1##2##2##(2007-12#1)(2008-10#1)
uncertainty U##2##2##(2008-10#2)
uncertainty about the##12##3##(1992-9#1)(1994-1#1)(1994-7#1)(1995-11#1)(1997-4#1)(1997-7#1)(2008-10#2)(2008-9#1)(2010-11#1)(2010-3#1)(2011-2#1)
uncertainty about##20##2##(1992-9#1)(1994-1#1)(1994-7#1)(1995-11#1)(1996-11#1)(1997-4#1)(1997-7#1)(2006-5#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-11#1)(2010-3#1)(2011-2#2)(2012-11#1)(2013-8#1)
uncertainty analysis of the##2##4##(2008-2#2)
uncertainty analysis of##3##3##(2008-2#2)(2008-3#1)
uncertainty and##14##2##(1995-11#1)(1995-3#1)(2007-11#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-10#1)(2009-12#1)(2011-2#1)(2013-1#1)(2013-7#1)
uncertainty are##4##2##(2008-10#3)(2008-2#1)
uncertainty as to whether##2##4##(1990-6#1)(2007-11#1)
uncertainty as to##5##3##(1990-6#1)(1993-7#1)(2007-11#1)(2008-8#1)(2009-8#1)
uncertainty as##6##2##(1990-6#1)(1993-7#1)(2007-11#1)(2008-11#1)(2008-8#1)(2009-8#1)
uncertainty associated with the##6##4##(2008-10#4)(2008-3#1)(2009-11#1)
uncertainty associated with##8##3##(1996-12#1)(2008-10#5)(2008-3#1)(2009-11#1)
uncertainty associated##9##2##(1996-12#1)(2008-10#6)(2008-3#1)(2009-11#1)
uncertainty between##2##2##(1992-12#1)(2008-5#1)
uncertainty budget##4##2##(2008-10#4)
uncertainty components##2##2##(2008-10#1)(2008-2#1)
uncertainty estimates##2##2##(2008-10#1)(2012-1#1)
uncertainty estimation##2##2##(2008-10#1)(2010-2#1)
uncertainty exists##3##2##(2007-9#1)(2010-3#1)(2012-12#1)
uncertainty for the##3##3##(2008-10#1)(2008-3#2)
uncertainty for##7##2##(1991-2#1)(2008-10#1)(2008-2#2)(2008-3#3)
uncertainty in estimating##3##3##(1991-2#1)(1996-12#1)(2011-12#1)
uncertainty in parameter##2##3##(2008-10#2)
uncertainty in the decay constant##2##5##(1992-2#1)(2008-10#1)
uncertainty in the##18##3##(1992-2#1)(2005-11#1)(2008-10#2)(2008-2#4)(2008-3#5)(2008-7#2)(2009-11#1)(2010-6#1)(2013-1#1)
uncertainty in volumetric operations##2##4##(2008-10#2)
uncertainty in##51##2##(1991-2#1)(1992-2#1)(1992-5#1)(1996-12#2)(1996-3#1)(2005-11#1)(2008-10#12)(2008-2#7)(2008-3#8)(2008-7#4)(2009-11#1)(2009-12#1)(2010-10#1)(2010-6#2)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
uncertainty intervals##6##2##(2008-10#6)
uncertainty introduced by the##2##4##(1992-6#1)(2008-3#1)
uncertainty is##9##2##(1993-3#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2011-2#1)(2012-12#1)
uncertainty of 0##5##3##(2006-4#1)(2008-2#1)(2008-3#3)
uncertainty of 1##2##3##(2008-2#1)(2008-3#1)
uncertainty of an##2##3##(2008-1#1)(2008-2#1)
uncertainty of analytical assays##3##4##(2008-10#3)
uncertainty of approximately##3##3##(1992-2#1)(2008-2#2)
uncertainty of less than 0##2##5##(2008-10#1)(2008-3#1)
uncertainty of less than##4##4##(2008-10#1)(2008-2#1)(2008-3#2)
uncertainty of the analytical##2##4##(2008-10#2)
uncertainty of the##19##3##(1992-5#1)(2007-12#1)(2007-4#1)(2008-10#4)(2008-2#3)(2008-3#5)(2012-1#1)(2012-12#3)
uncertainty of##67##2##(1992-2#1)(1992-5#1)(1992-9#1)(1993-4#1)(1994-1#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#5)(2007-4#1)(2008-1#1)(2008-10#12)(2008-2#13)(2008-3#19)(2008-5#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#3)
uncertainty on the##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
uncertainty on##5##2##(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#1)
uncertainty regarding how##2##3##(2006-12#1)(2008-12#1)
uncertainty regarding the##2##3##(2012-1#1)(2012-2#1)
uncertainty regarding##8##2##(2006-12#1)(2008-12#1)(2008-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)
uncertainty remains##2##2##(1992-1#1)(2008-8#1)
uncertainty score threshold##2##3##(2009-8#2)
uncertainty score##4##2##(2009-8#4)
uncertainty source##2##2##(2008-10#1)(2008-3#1)
uncertainty to##4##2##(1996-3#1)(2008-2#1)(2008-5#2)
uncertainty tolerance in##2##3##(2008-5#2)
uncertainty was##2##2##(2008-2#2)
uncertainty were##2##2##(2007-8#1)(2008-11#1)
uncertainty when##3##2##(2008-8#1)(2009-12#1)(2009-7#1)
uncertainty whether##2##2##(1992-12#1)(2008-8#1)
uncertainty with##4##2##(2008-12#1)(2009-8#1)(2010-10#1)(2012-12#1)
uncertainty##373##1##(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#2)(1992-1#1)(1992-12#2)(1992-2#2)(1992-5#2)(1992-6#3)(1992-9#3)(1993-12#2)(1993-3#4)(1993-4#1)(1993-7#2)(1994-1#2)(1994-6#1)(1994-7#1)(1995-11#2)(1995-3#1)(1995-6#2)(1996-11#1)(1996-12#6)(1996-3#2)(1997-3#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-9#2)(2007-11#8)(2007-12#6)(2007-4#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#75)(2008-11#7)(2008-12#5)(2008-2#41)(2008-3#54)(2008-4#1)(2008-5#7)(2008-7#13)(2008-8#7)(2008-9#1)(2009-10#2)(2009-11#2)(2009-12#3)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#6)(2009-9#1)(2010-10#4)(2010-11#1)(2010-2#3)(2010-3#2)(2010-6#3)(2010-8#1)(2011-12#2)(2011-2#11)(2012-1#7)(2012-11#2)(2012-12#11)(2012-2#5)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#1)
uncertainty)##2##1##(1997-4#1)(2012-1#1)
uncertified home care agencies##2##4##(1995-3#2)
uncertified seeds##3##2##(2008-12#3)
uncertified##6##1##(1995-3#2)(2008-12#3)(2013-8#1)
unchallenged##5##1##(1995-3#1)(2005-9#1)(2008-7#1)(2010-12#1)(2011-1#1)
unchanged after##9##2##(1990-6#1)(1990-8#1)(1991-2#1)(1991-8#1)(1995-12#1)(1996-10#1)(1996-9#1)(1997-1#1)(2008-8#1)
unchanged and##5##2##(1992-1#1)(1996-3#1)(2007-11#1)(2007-8#2)
unchanged as##2##2##(2008-10#1)(2012-3#1)
unchanged at##7##2##(1995-5#1)(1996-12#1)(1997-4#1)(2007-8#1)(2008-7#1)(2010-11#1)(2010-2#1)
unchanged between##2##2##(1991-4#1)(2004-12#1)
unchanged by the##4##3##(1991-12#1)(1993-12#1)(1994-5#1)(2008-10#1)
unchanged by##14##2##(1991-12#1)(1991-2#1)(1993-12#1)(1993-3#1)(1994-12#2)(1994-5#1)(1995-10#1)(1995-5#1)(1996-2#1)(2006-5#1)(2008-10#1)(2008-8#1)(2013-1#1)
unchanged during the##5##3##(1990-10#1)(1992-12#1)(1996-7#1)(2008-5#1)(2008-7#1)
unchanged during##12##2##(1990-10#1)(1991-1#1)(1991-10#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-10#1)(1995-2#1)(1996-7#1)(2008-5#1)(2008-7#1)
unchanged for##10##2##(1991-11#1)(1992-3#1)(1992-6#1)(1995-3#1)(1995-8#1)(1996-12#1)(2007-7#1)(2008-5#1)(2008-8#1)(2009-12#1)
unchanged from##7##2##(1993-3#1)(1995-5#1)(1996-6#1)(1997-1#1)(2008-3#1)(2009-2#1)(2013-1#1)
unchanged in patients##2##3##(2011-12#1)(2013-1#1)
unchanged in the three##2##4##(1991-6#1)(1995-12#1)
unchanged in the##13##3##(1990-12#1)(1991-5#1)(1991-6#1)(1995-12#1)(1995-7#1)(1996-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-6#1)
unchanged in urine##2##3##(2006-12#1)(2008-5#1)
unchanged in##42##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-11#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-7#1)(1996-1#1)(1996-12#1)(2005-5#1)(2006-11#1)(2006-12#1)(2006-2#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-6#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2012-6#1)(2013-1#1)
unchanged on day 3##2##4##(1994-2#2)
unchanged on##3##2##(1994-2#2)(1997-1#1)
unchanged or decreased##3##3##(2007-8#1)(2008-10#1)(2008-11#1)
unchanged or##11##2##(1990-6#1)(1993-12#1)(1994-5#1)(1994-9#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-8#1)
unchanged over the##4##3##(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#1)
unchanged over##6##2##(1992-10#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2012-2#1)
unchanged protein##2##2##(2007-10#1)(2010-8#1)
unchanged throughout the course of##2##5##(1995-9#1)(2013-1#1)
unchanged throughout the##6##3##(1991-2#1)(1995-9#1)(2008-7#2)(2008-9#1)(2013-1#1)
unchanged when##4##2##(1991-2#1)(1993-6#1)(1993-8#1)(2008-8#1)
unchanged with the##2##3##(1992-2#1)(2011-2#1)
unchanged with##8##2##(1992-2#1)(1995-5#1)(1995-9#1)(2007-1#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-2#1)
unchanged##352##1##(1990-10#2)(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#4)(1990-6#3)(1990-7#2)(1990-8#3)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#8)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#3)(1991-8#4)(1991-9#2)(1992-1#4)(1992-10#2)(1992-11#3)(1992-12#1)(1992-2#5)(1992-3#2)(1992-6#5)(1993-10#1)(1993-12#4)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#4)(1993-8#2)(1993-9#2)(1994-11#4)(1994-12#3)(1994-2#3)(1994-3#3)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#2)(1995-12#4)(1995-2#3)(1995-3#4)(1995-5#5)(1995-6#1)(1995-7#2)(1995-8#1)(1995-9#3)(1996-1#2)(1996-10#3)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#2)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#3)(1996-9#2)(1997-1#4)(1997-4#1)(1997-7#1)(1997-8#3)(2004-10#1)(2004-12#1)(2005-11#1)(2005-5#1)(2005-8#1)(2006-10#3)(2006-11#3)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-1#2)(2007-10#5)(2007-11#4)(2007-12#4)(2007-2#1)(2007-7#3)(2007-8#12)(2007-9#3)(2008-1#2)(2008-10#21)(2008-11#7)(2008-2#3)(2008-3#10)(2008-4#2)(2008-5#8)(2008-6#2)(2008-7#8)(2008-8#7)(2008-9#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-12#1)(2011-2#5)(2012-1#3)(2012-12#2)(2012-2#6)(2012-3#10)(2012-6#1)(2013-1#5)(2013-7#1)(2013-8#5)
unchanging##3##1##(1993-6#1)(2006-6#1)(2009-2#1)
uncharacterised##3##1##(2006-8#1)(2012-12#2)
uncharacterized or partially characterized##2##4##(2008-1#1)(2008-10#1)
uncharacterized proteins##2##2##(2008-4#1)(2009-8#1)
uncharacterized virus was isolated from##2##5##(2008-10#2)
uncharacterized##39##1##(1991-12#1)(1991-9#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-8#2)(1996-10#1)(1996-6#1)(1997-3#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-8#1)
uncharged amino acids to the stability of##2##7##(1992-6#2)
uncharged chains##2##2##(2007-8#2)
uncharged dextran##2##2##(1996-11#2)
uncharged polymer layer##3##3##(2005-11#3)
uncharged residues##2##2##(1992-6#1)(1994-9#1)
uncharged##23##1##(1990-8#1)(1991-7#1)(1992-6#3)(1994-8#2)(1994-9#1)(1995-5#1)(1996-11#2)(2005-11#4)(2007-10#1)(2007-8#2)(2008-10#2)(2008-5#1)(2008-7#1)(2009-2#1)
uncharted##2##1##(1994-1#1)(2007-8#1)
unchecked##4##1##(1991-2#1)(1992-1#1)(2005-12#1)(2010-4#1)
uncinate process##2##2##(2008-3#1)(2010-12#1)
uncinate##5##1##(2007-11#1)(2008-3#1)(2008-7#2)(2010-12#1)
uncini and##2##2##(2008-5#2)
uncinulatum##5##1##(2008-10#5)
unclarified##2##1##(2008-1#1)(2008-4#1)
unclassifiable##2##1##(2008-6#1)(2009-2#1)
unclassified isolates##2##2##(2008-10#2)
unclassified##10##1##(1991-5#1)(1993-8#1)(1993-9#1)(2006-8#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-6#1)(2009-8#1)
unclear and##16##2##(1993-11#1)(1994-4#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2010-3#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
unclear as to##2##3##(1997-4#1)(2013-1#1)
unclear as##4##2##(1997-4#1)(2010-12#1)(2013-1#2)
unclear at##2##2##(1996-9#1)(2006-10#1)
unclear because##3##2##(1991-1#1)(1993-7#1)(2008-9#1)
unclear but may##3##3##(1991-5#1)(1996-9#1)(2006-10#1)
unclear but the##2##3##(1995-10#1)(2007-12#1)
unclear but##8##2##(1991-5#1)(1993-10#1)(1995-10#1)(1996-9#1)(2006-10#1)(2007-12#1)(2008-1#1)(2012-3#1)
unclear despite##2##2##(2009-5#1)(2012-12#1)
unclear etiology##2##2##(1992-9#1)(1993-8#1)
unclear how much##2##3##(2008-1#1)(2008-8#1)
unclear how the##3##3##(2008-8#1)(2009-8#1)(2011-2#1)
unclear how##16##2##(1991-4#1)(1995-9#1)(2006-8#1)(2008-1#1)(2008-8#2)(2009-5#2)(2009-8#2)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
unclear if patients##2##3##(2010-5#1)(2012-12#1)
unclear if##14##2##(1996-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-3#1)(2010-5#1)(2011-12#1)(2012-1#1)(2012-12#1)(2013-1#3)(2013-8#1)
unclear in##4##2##(2006-10#2)(2007-7#1)(2008-10#1)
unclear risk of bias##2##4##(2013-8#2)
unclear terms are##2##3##(1993-2#2)
unclear terms##3##2##(1993-2#3)
unclear to what extent the##2##5##(2007-10#1)(2012-2#1)
unclear to##4##2##(1993-2#1)(2007-10#1)(2008-11#1)(2012-2#1)
unclear what##8##2##(1994-12#1)(2007-8#1)(2007-9#1)(2009-8#1)(2012-1#1)(2012-12#1)(2013-1#2)
unclear whether the##13##3##(1994-5#1)(1996-1#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-8#2)(2010-10#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
unclear whether their##2##3##(2008-9#1)(2010-3#1)
unclear whether these##7##3##(1993-6#1)(2007-11#1)(2008-6#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-2#1)
unclear whether this##7##3##(1990-9#1)(1996-1#1)(2005-10#1)(2006-4#1)(2008-11#2)(2013-1#1)
unclear whether##50##2##(1990-9#1)(1991-2#1)(1991-6#1)(1993-6#1)(1994-5#1)(1995-7#1)(1996-1#2)(1997-4#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#2)
unclear why##3##2##(2006-10#1)(2008-10#1)(2009-8#1)
unclear##436##1##(1990-2#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-2#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-10#1)(1993-11#3)(1993-12#1)(1993-2#5)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#4)(1995-5#3)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#3)(1996-10#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#6)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-7#3)(1997-8#1)(2004-1#1)(2005-10#3)(2005-11#2)(2005-12#2)(2005-7#1)(2006-10#15)(2006-12#1)(2006-2#4)(2006-4#2)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#5)(2007-11#5)(2007-12#5)(2007-2#2)(2007-3#1)(2007-4#2)(2007-6#3)(2007-7#5)(2007-8#6)(2007-9#2)(2008-1#11)(2008-10#15)(2008-11#15)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#8)(2008-5#6)(2008-6#3)(2008-7#10)(2008-8#18)(2008-9#8)(2009-10#3)(2009-11#2)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#6)(2009-6#4)(2009-7#2)(2009-8#9)(2009-9#1)(2010-10#5)(2010-11#1)(2010-12#8)(2010-2#2)(2010-3#4)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#7)(2011-12#1)(2011-2#16)(2012-1#7)(2012-11#3)(2012-12#13)(2012-2#12)(2012-3#8)(2013-1#25)(2013-7#4)(2013-8#13)
unclearly##3##1##(2011-2#1)(2013-1#2)
uncleavable TaqI sites##2##3##(1994-12#2)
uncleavable##5##1##(1991-7#1)(1994-12#2)(1996-2#1)(1997-8#1)
uncleaved##8##1##(1990-5#1)(1991-10#1)(1993-12#1)(1995-1#1)(1995-8#1)(2007-11#2)(2008-4#1)
uncles##3##1##(1993-3#1)(2006-8#1)(2007-2#1)
uncloned##3##1##(1992-9#1)(1993-7#1)(2008-10#1)
unclosed##2##1##(1992-2#1)(2011-1#1)
uncoated and coated##2##3##(2008-10#1)(2008-2#1)
uncoated and immunoglobulin-coated sheep red blood cells##2##7##(1991-8#2)
uncoated and##5##2##(1991-8#2)(2008-10#1)(2008-2#1)(2012-11#1)
uncoated fiber##2##2##(2007-12#1)(2008-2#1)
uncoated fused-silica capillary##3##3##(2008-10#3)
uncoated probes##2##2##(2008-2#2)
uncoated tips##2##2##(2007-12#2)
uncoated##42##1##(1991-8#2)(1994-6#1)(1996-5#1)(2007-12#6)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#8)(2008-3#7)(2008-5#2)(2009-4#1)(2012-11#1)
uncoil##2##1##(1992-4#1)(2009-7#1)
uncoils##2##1##(2009-7#2)
uncollapsed##2##1##(2012-3#2)
uncomfortable and##2##2##(2012-12#1)(2013-8#1)
uncomfortable discussing sex##2##3##(2007-2#1)(2010-5#1)
uncomfortable##13##1##(2005-11#1)(2005-7#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-3#1)(2009-2#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
uncommon among the##2##3##(2007-7#1)(2009-7#1)
uncommon among##4##2##(2006-10#1)(2007-7#1)(2008-9#1)(2009-7#1)
uncommon and the##2##3##(1996-9#1)(2010-8#1)
uncommon and usually##2##3##(2007-8#1)(2013-1#1)
uncommon and##20##2##(1990-6#1)(1990-8#1)(1992-5#1)(1994-11#1)(1995-1#1)(1996-12#1)(1996-9#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-12#1)(2012-12#1)(2013-1#2)
uncommon as##2##2##(2005-11#1)(2006-7#1)
uncommon association##2##2##(2007-7#1)(2011-1#1)
uncommon benign##4##2##(1990-5#1)(2010-6#1)(2011-12#1)(2013-7#1)
uncommon but##19##2##(2005-10#1)(2005-8#1)(2006-10#3)(2006-3#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-8#2)
uncommon case of##6##3##(1992-9#1)(1993-6#1)(2006-10#1)(2007-10#1)(2011-2#2)
uncommon cause of acute##2##4##(2008-1#1)(2013-8#1)
uncommon cause of##17##3##(1992-6#1)(2006-10#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
uncommon cause##19##2##(1992-6#1)(2006-10#1)(2006-4#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
uncommon clinical entities##4##3##(2013-1#4)
uncommon clinical entity##5##3##(2007-4#1)(2007-7#1)(2007-8#1)(2011-1#1)(2011-2#1)
uncommon clinical##12##2##(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#4)
uncommon combination of##2##3##(2007-12#1)(2013-1#1)
uncommon complication of##4##3##(1990-5#1)(1993-9#1)(2008-7#1)(2009-9#1)
uncommon complication##8##2##(1990-5#1)(1993-9#1)(2006-10#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
uncommon condition##12##2##(2005-9#1)(2006-10#2)(2006-3#1)(2007-7#2)(2007-8#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-7#1)
uncommon disease in##3##3##(1995-7#1)(2008-7#1)(2009-5#1)
uncommon disease which occurs##2##4##(2008-1#2)
uncommon disease##17##2##(1993-5#1)(1995-7#1)(2006-10#2)(2007-11#1)(2007-2#1)(2008-1#3)(2008-12#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
uncommon event##3##2##(2007-8#1)(2008-6#1)(2009-12#1)
uncommon findings##2##2##(1996-12#1)(2012-2#1)
uncommon for##2##2##(1992-4#1)(2007-12#1)
uncommon forms of##2##3##(1992-6#1)(2013-1#1)
uncommon in adults##2##3##(2007-7#1)(2010-12#1)
uncommon in the##4##3##(2007-9#1)(2009-3#1)(2013-1#1)(2013-7#1)
uncommon in##33##2##(1990-5#1)(1992-5#1)(1992-8#1)(1996-11#1)(1997-1#1)(2005-11#2)(2005-8#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-10#1)(2010-12#2)(2012-3#1)(2013-1#3)(2013-7#1)
uncommon infectious##2##2##(2007-12#1)(2007-7#1)
uncommon injury##2##2##(2006-3#1)(2007-9#1)
uncommon lesion of##2##3##(2012-2#1)(2013-8#1)
uncommon lesion##4##2##(2012-2#1)(2013-1#2)(2013-8#1)
uncommon lesions##6##2##(1991-12#1)(2007-8#1)(2008-6#1)(2010-5#2)(2011-2#1)
uncommon location##4##2##(2006-10#1)(2012-12#1)(2012-3#1)(2013-1#1)
uncommon manifestation of##5##3##(2006-10#1)(2007-10#1)(2007-7#1)(2008-1#1)(2010-5#1)
uncommon manifestation##6##2##(2006-10#1)(2007-10#1)(2007-7#1)(2008-1#1)(2010-5#1)(2013-7#1)
uncommon neoplasm##4##2##(2006-10#1)(2009-7#1)(2012-1#1)(2012-2#1)
uncommon occurrence##4##2##(2006-9#1)(2007-7#1)(2010-6#1)(2012-12#1)
uncommon presentation of##2##3##(2006-10#1)(2011-2#1)
uncommon presentation##4##2##(2006-10#1)(2011-2#2)(2012-2#1)
uncommon presentations##2##2##(2005-11#1)(2008-11#1)
uncommon primary##2##2##(2012-2#2)
uncommon serious##2##2##(2011-2#2)
uncommon syndrome##3##2##(1991-5#1)(2007-8#1)(2008-6#1)
uncommon to##5##2##(2006-10#1)(2007-8#1)(2008-4#1)(2008-7#1)(2013-8#1)
uncommon tumor of the##2##4##(2007-8#1)(2011-2#1)
uncommon tumor##7##2##(2007-8#1)(2008-9#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#1)
uncommon tumors##3##2##(1990-12#1)(2010-5#1)(2012-12#1)
uncommon variant of##2##3##(2005-12#1)(2011-1#1)
uncommon vascular##3##2##(2006-12#1)(2009-5#1)(2012-3#1)
uncommon with##2##2##(2005-7#1)(2006-12#1)
uncommon##449##1##(1990-10#1)(1990-12#1)(1990-5#4)(1990-6#1)(1990-8#2)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#5)(1992-8#3)(1992-9#1)(1993-10#2)(1993-12#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-1#1)(1994-11#2)(1994-2#1)(1994-4#1)(1994-6#1)(1995-1#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-11#2)(1996-12#3)(1996-3#1)(1996-9#2)(1997-1#2)(1997-6#1)(2005-10#2)(2005-11#6)(2005-12#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#3)(2006-10#24)(2006-12#4)(2006-2#1)(2006-3#4)(2006-4#5)(2006-5#2)(2006-7#1)(2006-8#3)(2006-9#3)(2007-10#4)(2007-11#4)(2007-12#9)(2007-2#5)(2007-3#3)(2007-4#1)(2007-5#2)(2007-7#25)(2007-8#20)(2007-9#4)(2008-1#9)(2008-10#9)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#4)(2008-6#9)(2008-7#14)(2008-8#5)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#3)(2009-4#2)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#2)(2010-12#11)(2010-2#1)(2010-4#1)(2010-5#11)(2010-6#3)(2010-8#3)(2010-9#3)(2011-1#7)(2011-12#2)(2011-2#22)(2011-3#1)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#8)(2012-2#22)(2012-3#10)(2013-1#29)(2013-7#8)(2013-8#12)
uncommonly encountered##3##2##(2006-7#1)(2007-7#1)(2013-8#1)
uncommonly##12##1##(2006-7#2)(2007-7#3)(2008-10#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-4#1)(2012-2#1)(2013-8#1)
uncompensated care##5##2##(1992-1#1)(1996-1#3)(2008-11#1)
uncompensated resistance##2##2##(2006-12#1)(2008-10#1)
uncompensated##10##1##(1992-1#1)(1992-11#1)(1996-1#3)(2006-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-8#1)
uncompetitive inhibition##5##2##(1991-12#1)(1992-7#1)(1995-3#1)(1995-7#1)(2010-11#1)
uncompetitive with##2##2##(1990-3#1)(1992-12#1)
uncompetitive##20##1##(1990-11#1)(1990-3#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-7#1)(1994-5#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-10#1)(1996-8#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-5#1)(2009-3#2)(2010-11#2)
uncomplexed tetrol I-1##3##3##(2008-10#3)
uncomplexed tetrol##4##2##(2008-10#4)
uncomplexed##23##1##(1990-2#1)(1994-2#1)(1995-1#2)(1996-2#1)(1996-6#3)(2008-10#6)(2008-5#4)(2010-12#2)(2010-9#1)(2011-1#2)
uncomplicated CABG surgery##2##3##(2007-11#1)(2007-8#1)
uncomplicated and##4##2##(2007-8#1)(2008-6#1)(2009-3#2)
uncomplicated cases##4##2##(1992-5#1)(1994-2#1)(2006-10#1)(2011-3#1)
uncomplicated disease##3##2##(1990-8#1)(1992-2#1)(2010-12#1)
uncomplicated essential hypertension##2##3##(1992-4#1)(2008-3#1)
uncomplicated falciparum malaria##2##3##(2006-2#1)(2011-2#1)
uncomplicated hypertension##4##2##(2005-12#1)(2008-3#1)(2010-12#2)
uncomplicated malaria in##2##3##(2005-8#1)(2009-6#1)
uncomplicated malaria##9##2##(2005-8#3)(2006-2#2)(2007-2#2)(2009-6#1)(2010-12#1)
uncomplicated procedure##2##2##(1992-12#1)(1996-9#1)
uncomplicated urinary tract infection##3##4##(1993-1#1)(2009-5#1)(2011-2#1)
uncomplicated urinary tract infections##4##4##(1992-9#1)(1993-1#1)(2008-11#1)(2008-5#1)
uncomplicated urinary tract##8##3##(1992-9#1)(1993-1#2)(1997-5#1)(2008-11#1)(2008-5#1)(2009-5#1)(2011-2#1)
uncomplicated##94##1##(1990-12#1)(1990-8#1)(1990-9#1)(1991-3#2)(1991-4#1)(1992-12#1)(1992-2#3)(1992-4#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-2#1)(1996-2#1)(1996-9#1)(1997-5#1)(2005-12#1)(2005-8#4)(2005-9#1)(2006-10#2)(2006-12#1)(2006-2#4)(2007-11#2)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#6)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-12#4)(2010-5#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#2)(2013-1#2)
uncompressed##3##1##(2008-2#2)(2011-1#1)
unconcentrated##2##1##(2007-2#1)(2008-11#1)
unconditional calculation##3##2##(1992-6#3)
unconditional expression##2##2##(1992-6#2)
unconditional logistic regression analysis##2##4##(2008-11#1)(2011-1#1)
unconditional sample size##2##3##(1992-6#1)(1995-8#1)
unconditional##21##1##(1992-2#3)(1992-6#7)(1993-1#1)(1995-4#2)(1995-8#1)(1996-7#1)(2006-8#1)(2008-11#2)(2008-9#2)(2011-1#1)
unconditionally##3##1##(1993-7#1)(1994-9#1)(2013-7#1)
unconditioned motor activity##2##3##(1993-2#2)
unconditioned stimulus##7##2##(1992-10#1)(1993-12#1)(1995-12#1)(1996-7#1)(1997-7#1)(2008-5#1)(2013-8#1)
unconditioned##17##1##(1991-11#1)(1992-10#1)(1993-12#1)(1993-2#3)(1993-6#1)(1995-12#2)(1996-2#1)(1996-7#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2012-2#1)(2013-8#1)
unconfined##2##1##(2006-6#1)(2011-1#1)
unconfirmed##5##1##(1992-5#1)(1996-9#1)(2007-8#1)(2008-10#1)(2008-12#1)
unconjugated Fib75##3##2##(1990-12#3)
unconjugated bile acids in the gallbladder##2##6##(1996-4#2)
unconjugated bile acids##3##3##(1996-4#3)
unconjugated bile##5##2##(1992-3#1)(1996-4#3)(2008-11#1)
unconjugated bilirubin##4##2##(1990-1#1)(1992-3#2)(1996-12#1)
unconjugated estrogen##2##2##(2006-5#2)
unconjugated estrogens##4##2##(2006-5#4)
unconjugated ursodeoxycholic acid##3##3##(1996-4#3)
unconjugated##36##1##(1990-1#1)(1990-11#2)(1990-12#4)(1991-5#1)(1992-3#3)(1993-12#1)(1996-12#1)(1996-4#8)(2006-5#6)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#2)(2009-5#1)(2010-7#1)(2013-1#1)
unconnected##2##1##(2008-12#1)(2013-8#1)
unconscious and##2##2##(2006-4#1)(2007-7#1)
unconscious on##2##2##(1991-9#1)(2011-12#1)
unconscious patients##2##2##(2006-10#1)(2011-1#1)
unconscious state##2##2##(2010-7#1)(2012-11#1)
unconscious##29##1##(1990-3#1)(1991-12#1)(1991-9#1)(1992-12#1)(1997-8#1)(2006-10#1)(2006-3#1)(2006-4#3)(2007-3#1)(2007-7#1)(2008-11#2)(2008-12#3)(2008-5#1)(2009-9#1)(2010-1#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
unconsciousness and##2##2##(1995-3#1)(2010-1#1)
unconsciousness in##2##2##(2007-10#1)(2007-11#1)
unconsciousness##11##1##(1995-3#1)(1996-4#1)(2007-10#1)(2007-11#1)(2008-2#1)(2010-1#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
unconstitutional##6##1##(1990-12#1)(1994-2#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-7#1)
unconstrained handwritten texts##2##3##(2008-6#2)
unconstrained knee##3##2##(2007-4#3)
unconstrained##17##1##(1994-12#2)(2007-4#5)(2008-1#1)(2008-2#1)(2008-3#1)(2008-6#3)(2008-7#1)(2009-10#1)(2010-8#1)(2012-12#1)
unconstructive##2##1##(2009-7#2)
unconsumed##2##1##(2008-10#1)(2011-12#1)
uncontaminated##6##1##(1992-12#1)(1992-8#1)(1997-4#1)(2008-10#2)(2008-11#1)
uncontrollable bleeding from the nidus and##2##6##(2008-7#1)(2008-9#1)
uncontrollable bleeding##3##2##(2007-12#1)(2008-7#1)(2008-9#1)
uncontrollable##14##1##(1995-11#1)(2006-10#1)(2007-12#2)(2007-9#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-8#1)(2010-9#1)(2011-3#1)(2012-12#1)
uncontrolled acute and procedural pain##2##5##(2011-2#2)
uncontrolled and##2##2##(1997-1#1)(2013-8#1)
uncontrolled batch cultures##2##3##(1994-11#1)(2008-11#1)
uncontrolled cell##2##2##(1996-4#1)(2005-7#1)
uncontrolled diabetes mellitus##2##3##(2007-7#1)(2008-12#1)
uncontrolled diabetes##5##2##(2005-10#1)(2007-7#1)(2008-12#1)(2012-2#1)(2013-8#1)
uncontrolled hypertension in high-risk##2##4##(2010-4#2)
uncontrolled hypertension in##3##3##(2008-4#1)(2010-4#2)
uncontrolled hypertension##8##2##(2008-4#1)(2008-8#1)(2010-4#2)(2010-7#2)(2011-1#1)(2012-2#1)
uncontrolled on##2##2##(2008-3#1)(2012-3#1)
uncontrolled proliferation of##3##3##(2008-4#1)(2009-3#1)(2011-2#1)
uncontrolled proliferation##4##2##(2008-4#1)(2009-3#1)(2011-2#2)
uncontrolled studies##6##2##(1990-9#1)(1997-1#1)(2006-10#1)(2007-11#3)
uncontrolled study##3##2##(2007-7#1)(2008-10#1)(2012-3#1)
uncontrolled trials##2##2##(1990-9#1)(2007-8#1)
uncontrolled##94##1##(1990-9#2)(1991-2#1)(1992-10#1)(1992-5#1)(1992-6#1)(1993-5#1)(1993-8#1)(1994-11#2)(1995-3#2)(1996-4#1)(1996-7#1)(1997-1#2)(1997-2#1)(2004-11#1)(2005-10#1)(2005-12#1)(2005-5#1)(2005-7#1)(2006-10#7)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-2#1)(2007-3#2)(2007-7#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-8#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-8#2)(2010-4#2)(2010-5#1)(2010-7#3)(2011-1#1)(2011-2#4)(2012-1#4)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#6)
unconventional approach to asymmetric catalysis##2##5##(2010-6#2)
unconventional splicing of bZIP60 mRNA to produce the active transcription factor##2##11##(2012-2#2)
unconventional##30##1##(1990-11#1)(1991-4#1)(1991-6#1)(1992-10#1)(1992-8#1)(1994-6#1)(1995-11#1)(1996-7#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-2#1)(2010-12#1)(2010-3#1)(2010-6#2)(2011-2#2)(2012-2#4)
unconvinced##2##1##(1995-10#1)(2011-1#1)
uncooked##3##1##(2006-10#1)(2007-2#1)(2008-2#1)
uncooled##3##1##(2008-1#1)(2008-10#1)(2008-3#1)
uncooperative##3##1##(1993-6#1)(2006-10#1)(2013-1#1)
uncoordinated and##2##2##(2008-4#1)(2010-3#1)
uncoordinated##11##1##(1990-12#1)(2007-10#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-5#3)(2009-8#1)(2010-3#1)(2010-5#1)
uncorrectable##3##1##(1991-2#1)(2008-3#2)
uncorrected bias##2##2##(2008-10#2)
uncorrected single ventricle##2##3##(2008-9#1)(2009-4#1)
uncorrected##23##1##(1990-10#1)(1990-3#2)(1990-4#1)(1993-4#1)(2006-5#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-9#1)(2009-4#2)(2009-6#1)(2009-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
uncorrelated error##2##2##(1995-4#2)
uncorrelated measurement error##2##3##(1995-4#2)
uncorrelated with the##2##3##(1992-6#1)(2008-10#1)
uncorrelated##22##1##(1992-6#1)(1994-8#1)(1995-2#1)(1995-4#4)(2006-10#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#2)(2010-2#1)(2010-6#1)(2011-1#1)
uncorroborated evidence##2##2##(1990-12#1)(1993-4#1)
uncouple##8##1##(1990-7#1)(1991-10#1)(1991-7#1)(1996-4#1)(1996-5#1)(1997-7#1)(2008-11#1)(2009-8#1)
uncoupled Na+ transport##2##3##(1990-3#2)
uncoupled electron transfer##3##3##(1997-7#3)
uncoupled electron##4##2##(1997-7#4)
uncoupled from the##3##3##(2006-5#1)(2008-3#1)(2009-6#1)
uncoupled from##5##2##(1994-5#1)(2006-5#1)(2008-3#1)(2008-8#1)(2009-6#1)
uncoupled in##2##2##(1991-11#1)(2008-11#1)
uncoupled respiration##3##2##(2005-8#2)(2008-7#1)
uncoupled##29##1##(1990-3#2)(1991-11#1)(1991-9#2)(1992-7#1)(1992-9#1)(1994-5#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-7#4)(1997-8#1)(2005-8#2)(2006-5#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#2)(2012-2#1)
uncoupler##7##1##(1990-8#1)(1991-12#1)(1991-2#1)(1995-2#1)(1995-7#1)(1996-4#1)(2006-8#1)
uncouplers of oxidative phosphorylation##2##4##(1991-2#1)(1994-12#1)
uncouplers##4##1##(1990-12#1)(1991-2#1)(1994-12#2)
uncoupling between the##2##3##(2006-8#1)(2010-5#1)
uncoupling of the##5##3##(1992-7#1)(1995-1#1)(1995-11#1)(2007-3#1)(2008-9#1)
uncoupling of##12##2##(1991-12#1)(1992-7#1)(1993-11#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(2005-10#1)(2005-8#1)(2007-3#1)(2008-9#2)
uncoupling protein 2##2##3##(2008-10#1)(2012-1#1)
uncoupling protein##13##2##(1991-3#7)(1994-9#2)(1997-6#1)(2008-10#2)(2012-1#1)
uncoupling##43##1##(1991-12#2)(1991-3#8)(1991-8#1)(1992-3#1)(1992-7#1)(1993-11#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-3#1)(1996-1#1)(1997-2#4)(1997-6#1)(1997-7#1)(2004-12#1)(2005-10#1)(2005-8#2)(2006-8#2)(2007-3#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-9#2)(2009-8#1)(2010-5#1)(2012-1#1)
uncoupling&quot##2##1##(1992-11#1)(2008-11#1)
uncover the genetic##2##3##(2006-2#1)(2009-10#1)
uncover the underlying##2##3##(2006-7#1)(2012-2#1)
uncover the##20##2##(1993-5#1)(1997-4#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-12#2)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
uncover##45##1##(1993-5#1)(1995-1#1)(1995-12#1)(1996-6#1)(1997-1#1)(1997-4#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-4#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-12#3)(2010-2#1)(2011-12#1)(2011-9#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#2)
uncovered a new##3##3##(1992-2#1)(2007-11#1)(2011-12#1)
uncovered a##10##2##(1992-2#1)(1997-7#1)(2007-11#2)(2007-9#1)(2008-11#1)(2008-8#3)(2011-12#1)
uncovered by##5##2##(1995-2#1)(1995-9#1)(1997-4#1)(2008-1#1)(2010-8#1)
uncovered in the##2##3##(1991-7#1)(1995-5#1)
uncovered in##4##2##(1991-7#1)(1995-5#1)(2006-1#1)(2009-10#1)
uncovered the##2##2##(2007-8#1)(2009-9#1)
uncovered two##2##2##(2008-10#1)(2008-6#1)
uncovered##65##1##(1991-11#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-2#1)(1993-10#1)(1994-2#1)(1995-2#1)(1995-5#1)(1995-9#1)(1997-4#1)(1997-7#1)(2004-12#1)(2004-9#2)(2005-12#1)(2006-1#1)(2006-5#1)(2007-11#4)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-12#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-2#3)(2012-3#4)(2013-1#2)(2013-8#1)
uncovering the##3##2##(2006-10#1)(2007-12#1)(2013-7#1)
uncovering##17##1##(1995-5#1)(2005-7#2)(2006-10#1)(2007-1#1)(2007-12#2)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-12#1)(2013-1#2)(2013-7#1)
uncovers a##2##2##(2012-12#1)(2012-2#1)
uncovers##6##1##(2008-11#1)(2009-3#1)(2010-8#1)(2012-12#1)(2012-2#2)
uncritical##5##1##(1993-5#1)(1994-2#1)(1996-2#1)(2007-8#1)(2009-2#1)
uncritically##2##1##(2006-10#1)(2006-12#1)
uncrossed tectopontine pathway##2##3##(1993-3#2)
uncrossed##3##1##(1993-3#2)(1996-3#1)
uncrosslinked##4##1##(1991-8#1)(1995-2#2)(2011-2#1)
uncuffed##2##1##(2006-10#1)(2007-7#1)
uncultivable bacteria##2##2##(2007-7#2)
uncultivated##6##1##(1991-11#1)(2008-10#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
unculturable##2##1##(1996-8#1)(2008-9#1)
uncultured autologous tumor##2##3##(1991-9#2)
uncultured##7##1##(1991-9#3)(2008-10#2)(2008-11#1)(2011-1#1)
uncured##3##1##(2005-11#1)(2006-9#1)(2008-4#1)
uncut##3##1##(1992-11#1)(1993-3#1)(2008-10#1)
und der##2##2##(2007-12#1)(2011-1#1)
und##15##1##(1990-10#1)(1994-3#3)(1997-4#1)(2007-12#2)(2008-10#2)(2008-11#1)(2009-2#1)(2011-1#1)(2013-8#3)
undamaged 19-mer##2##2##(1995-2#2)
undamaged DNA##2##2##(1994-7#1)(1995-2#1)
undamaged plants##4##2##(2008-8#4)
undamaged##22##1##(1994-7#1)(1995-12#1)(1995-2#6)(2006-12#1)(2006-6#1)(2008-2#1)(2008-8#6)(2009-4#2)(2011-2#1)(2012-1#1)(2013-1#1)
undamped##2##1##(1990-3#1)(1994-5#1)
undec-7-ene##2##1##(2007-11#1)(2008-10#1)
undecalcified##2##1##(2008-5#2)
undecanoic##2##1##(2005-11#2)
undecided as##2##2##(2007-2#1)(2007-9#1)
undecided##4##1##(2005-8#1)(2006-10#1)(2007-2#1)(2007-9#1)
undecimpunctata subsp##2##2##(2008-10#2)
undecose##2##1##(1997-4#2)
undefined in##2##2##(2008-3#1)(2008-5#1)
undefined mechanism##2##2##(1993-9#1)(1996-9#1)
undefined##37##1##(1990-10#1)(1990-12#1)(1990-6#1)(1991-10#2)(1992-4#2)(1993-12#2)(1993-9#1)(1994-8#1)(1995-3#1)(1996-9#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
undeflected##2##1##(2007-11#1)(2008-2#1)
undeformed##5##1##(1993-11#1)(2005-11#1)(2006-8#1)(2008-2#2)
undegradable##2##1##(2008-4#1)(2009-12#1)
undegraded 125IUdR##2##2##(1993-11#2)
undegraded##4##1##(1993-11#2)(1995-9#1)(2006-8#1)
undelivered##2##1##(2004-10#1)(2007-7#1)
undeniable##4##1##(1990-4#1)(2008-8#1)(2009-10#1)(2012-12#1)
undepleted ground-state population density##3##4##(2008-3#3)
under &quot##6##2##(1991-12#1)(1993-6#1)(1997-4#1)(2008-5#2)(2010-12#1)
under 0##3##2##(2004-9#1)(2008-11#2)
under 1 year of age##2##5##(1992-7#1)(1993-12#1)
under 1##8##2##(1991-9#1)(1992-7#1)(1993-12#1)(1997-7#1)(2006-5#1)(2008-11#2)(2009-4#1)
under 10 years##3##3##(1994-3#1)(2008-10#1)(2012-12#1)
under 10##4##2##(1994-3#1)(1996-7#1)(2008-10#1)(2012-12#1)
under 12 months##2##3##(1993-12#1)(2007-8#1)
under 12##5##2##(1993-12#1)(2007-8#1)(2010-2#1)(2011-2#2)
under 14 years##3##3##(1990-12#1)(2007-11#1)(2008-6#1)
under 15 years old##2##4##(2011-1#1)(2012-2#1)
under 15 years##4##3##(2007-6#1)(2007-7#1)(2011-1#1)(2012-2#1)
under 15##8##2##(1990-3#1)(2007-6#1)(2007-7#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#2)
under 18 months of age##2##5##(2008-9#2)
under 18##4##2##(2006-2#1)(2008-9#3)
under 19 years##2##3##(2006-2#1)(2011-2#1)
under 2 years##4##3##(1991-8#1)(2008-9#1)(2010-12#1)(2012-2#1)
under 2##10##2##(1990-3#1)(1991-8#1)(1992-7#1)(1995-1#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-2#1)
under 20 years of age##2##5##(2008-7#1)(2012-3#1)
under 20 years##4##3##(2008-7#1)(2011-1#1)(2012-12#1)(2012-3#1)
under 20##5##2##(2008-10#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-3#1)
under 24##2##2##(1997-1#1)(2011-2#1)
under 25##3##2##(1991-8#1)(2006-1#1)(2007-3#1)
under 2500##2##2##(2008-10#1)(2012-2#1)
under 3 years old##2##4##(2008-10#1)(2010-12#1)
under 3 years##3##3##(2008-10#1)(2010-12#1)(2011-2#1)
under 3##5##2##(1997-4#1)(2008-10#1)(2008-12#1)(2010-12#1)(2011-2#1)
under 30 years##2##3##(1992-2#1)(1994-2#1)
under 30##6##2##(1991-4#1)(1992-2#1)(1994-2#1)(1997-2#1)(1997-3#1)(2009-4#1)
under 30) and##2##3##(2008-10#1)(2008-3#1)
under 35 years of age##3##5##(1990-9#1)(2007-5#2)
under 35##4##2##(1990-9#1)(2007-5#2)(2008-1#1)
under 40##2##2##(2007-3#1)(2010-12#1)
under 45 years of age##2##5##(2007-7#1)(2011-1#1)
under 45##5##2##(1992-2#1)(2005-11#1)(2007-7#1)(2010-12#1)(2011-1#1)
under 48##2##2##(1990-12#1)(2008-5#1)
under 49 years of age##2##5##(1991-3#2)
under 5 min##2##3##(1996-8#1)(2008-10#1)
under 5##18##2##(1991-7#1)(1996-12#1)(1996-8#1)(2006-2#2)(2007-2#2)(2008-10#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)
under 5% CO(2)##4##3##(2008-11#4)
under 5%##7##2##(2006-2#1)(2006-4#1)(2008-10#1)(2008-11#4)
under 50##7##2##(1991-6#1)(1992-8#1)(2006-2#3)(2011-2#2)
under 6##5##2##(1997-3#1)(2007-12#1)(2007-7#1)(2012-12#1)(2013-1#1)
under 60 years##2##3##(2007-7#1)(2013-8#1)
under 60##3##2##(2007-7#1)(2008-7#1)(2013-8#1)
under 65##3##2##(1991-12#1)(1995-12#1)(1996-5#1)
under 70 years##2##3##(1990-12#1)(2008-7#1)
under 70##4##2##(1990-12#1)(2008-10#1)(2008-2#1)(2008-7#1)
under ADA##2##2##(1995-12#1)(1996-12#1)
under Ca(2+)-free##2##2##(1991-12#1)(1994-2#1)
under E##2##2##(1995-11#2)
under HIPAA##4##2##(2006-7#2)(2007-12#1)(2008-4#1)
under High##2##2##(1996-6#1)(2012-1#1)
under LabVIEW##3##2##(2008-10#3)
under Medicaid##6##2##(1990-12#1)(1991-1#1)(1992-2#2)(1997-2#1)(2006-8#1)
under Medicare##12##2##(1991-1#1)(1991-2#3)(1991-3#1)(1992-1#1)(1992-2#2)(1994-1#2)(1995-12#1)(1996-2#1)
under N(2)##2##2##(2006-12#1)(2008-10#1)
under PPS##4##2##(1992-2#3)(1993-3#1)
under Pi-sufficient##2##2##(2009-8#2)
under Project##2##2##(2006-11#2)
under ROC##2##2##(2010-8#1)(2011-1#1)
under Title##2##2##(1991-10#1)(1993-3#1)
under US guidance##3##3##(1996-6#2)(2007-7#1)
under UV irradiation##4##3##(1997-1#1)(2008-10#1)(2008-3#1)(2009-7#1)
under UV##9##2##(1997-1#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-7#1)(2010-1#1)
under X-ray control##2##3##(2007-11#1)(2007-7#1)
under a completely off-resonant condition##2##5##(2008-1#2)
under a condition##2##3##(1990-10#1)(2006-4#1)
under a confocal laser##2##4##(1992-9#1)(2008-8#1)
under a different##3##3##(1992-11#1)(1993-3#1)(2005-11#1)
under a dominant##2##3##(1997-5#1)(2009-4#1)
under a fixed##2##3##(1991-1#1)(2011-12#1)
under a fully##2##3##(1996-3#1)(2008-2#1)
under a gradient##2##3##(2007-8#2)
under a high##3##3##(1991-5#1)(2008-2#2)
under a light microscope##3##4##(1992-7#1)(2010-8#1)(2013-8#1)
under a linear##2##3##(1996-8#1)(2011-2#1)
under a low##2##3##(2004-9#1)(2007-12#1)
under a managed care##2##4##(1994-12#2)
under a microscope##3##3##(2007-12#2)(2008-11#1)
under a range of##4##4##(1995-12#1)(2007-12#1)(2008-10#1)(2011-12#1)
under a reflux condenser##2##4##(2007-11#2)
under a single##4##3##(1992-1#1)(1997-5#1)(2007-9#1)(2012-2#1)
under a variety of conditions##7##5##(1990-2#1)(1992-2#1)(1994-11#1)(1996-3#1)(2008-9#1)(2011-2#1)(2012-1#1)
under a variety of experimental conditions##4##6##(1993-11#1)(1995-10#1)(2008-7#1)(2011-1#1)
under a variety of##20##4##(1990-2#1)(1992-2#1)(1993-11#1)(1994-11#1)(1995-10#1)(1995-2#1)(1996-3#1)(1996-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)
under a wide range of##7##5##(2005-11#1)(2008-10#2)(2008-11#1)(2008-8#2)(2011-12#1)
under a wide variety of##3##5##(1991-8#1)(2008-2#1)(2008-3#1)
under a wide##10##3##(1991-8#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#2)(2011-12#1)
under a##185##2##(1990-10#1)(1990-2#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-2#2)(1992-7#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-3#2)(1996-5#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-5#3)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#7)(2005-8#1)(2006-10#2)(2006-4#2)(2006-5#1)(2006-6#1)(2007-10#3)(2007-11#7)(2007-12#6)(2007-4#1)(2007-5#1)(2007-8#5)(2007-9#1)(2008-1#4)(2008-10#14)(2008-11#7)(2008-2#14)(2008-3#7)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#1)(2009-4#3)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-12#3)(2011-2#4)(2012-1#2)(2012-2#4)(2012-3#1)(2012-9#1)(2013-1#5)(2013-8#4)
under abiotic stresses##2##3##(2006-12#1)(2009-8#1)
under abiotic##4##2##(2006-12#2)(2009-6#1)(2009-8#1)
under abnormal##2##2##(1997-2#1)(2013-1#1)
under acetic##2##2##(2008-6#1)(2010-12#1)
under acid and alkaline conditions##2##5##(2008-5#2)
under acid conditions (pH##2##4##(1990-12#1)(2010-2#1)
under acid conditions##5##3##(1990-12#1)(2007-11#1)(2008-10#1)(2008-5#1)(2010-2#1)
under acid##8##2##(1990-12#1)(2007-11#1)(2008-10#1)(2008-5#4)(2010-2#1)
under acidic and basic##2##4##(2008-10#1)(2008-5#1)
under acidic conditions was##3##4##(1990-8#1)(2006-8#1)(2008-10#1)
under acidic conditions##15##3##(1990-8#1)(1991-12#1)(1994-2#1)(1996-11#1)(1996-5#1)(2006-8#1)(2007-8#1)(2008-10#6)(2008-3#1)(2009-2#1)
under acidic##23##2##(1990-8#1)(1991-12#1)(1991-4#1)(1994-2#1)(1994-9#1)(1996-11#1)(1996-5#1)(2006-8#1)(2007-8#1)(2008-10#9)(2008-3#1)(2008-5#1)(2009-2#1)(2011-1#1)(2012-12#1)
under activation of##2##3##(2008-9#2)
under active development##3##3##(2008-10#1)(2008-4#1)(2010-9#1)
under active investigation##5##3##(2005-10#1)(2006-10#1)(2008-7#1)(2009-5#1)(2010-11#1)
under active##10##2##(1995-5#1)(2005-10#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-9#1)(2012-2#1)
under actual use conditions##2##4##(2008-10#1)(2008-5#1)
under actual##3##2##(1991-12#1)(2008-10#1)(2008-5#1)
under acute condition##2##3##(1992-12#2)
under acute##3##2##(1992-12#2)(1995-12#1)
under adequate##2##2##(1994-2#1)(2007-8#1)
under adverse conditions##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
under aerobic and anaerobic conditions##3##5##(1991-2#1)(2006-8#1)(2008-5#1)
under aerobic conditions and##3##4##(1991-2#1)(1992-4#1)(2008-7#1)
under aerobic conditions at##3##4##(2007-12#2)(2008-5#1)
under aerobic conditions##20##3##(1991-2#2)(1991-7#1)(1991-8#1)(1992-4#1)(1994-11#1)(1996-6#1)(1997-8#1)(2006-3#1)(2006-8#3)(2007-12#2)(2008-10#2)(2008-5#1)(2008-7#2)(2010-6#1)
under aerobic##25##2##(1991-2#3)(1991-7#1)(1991-8#1)(1992-4#1)(1993-4#1)(1994-11#1)(1996-6#1)(1997-8#1)(2006-3#1)(2006-8#4)(2007-12#2)(2008-10#2)(2008-5#2)(2008-7#2)(2010-6#1)(2013-1#1)
under affected##2##2##(1993-3#1)(2012-2#1)
under age 16 years##2##4##(2006-11#1)(2007-1#1)
under age 20##2##3##(1992-2#1)(1997-3#1)
under age 45##2##3##(1997-3#1)(2009-5#1)
under age##15##2##(1990-9#1)(1992-2#1)(1994-3#3)(1994-9#1)(1995-10#1)(1997-3#3)(2006-11#1)(2006-2#1)(2007-1#1)(2007-8#1)(2009-5#1)
under air##3##2##(1996-7#1)(2005-11#1)(2006-11#1)
under alkaline conditions (pH##2##4##(1991-7#1)(1992-2#1)
under alkaline conditions##10##3##(1991-7#1)(1992-2#1)(1995-3#1)(1996-5#1)(1996-8#1)(2006-8#2)(2007-10#1)(2008-10#2)
under alkaline##11##2##(1991-7#1)(1992-2#1)(1995-3#1)(1996-5#1)(1996-8#1)(2006-8#2)(2007-10#1)(2008-10#3)
under all conditions of##2##4##(1990-4#1)(2008-3#1)
under all conditions tested##2##4##(1995-10#1)(2008-10#1)
under all conditions##12##3##(1990-4#1)(1990-8#2)(1995-1#1)(1995-10#1)(1995-8#1)(2005-11#1)(2008-10#3)(2008-3#1)(2008-5#1)
under all three##2##3##(1995-5#1)(1997-1#1)
under all weather conditions##2##4##(2008-10#1)(2008-3#1)
under all##23##2##(1990-4#1)(1990-8#3)(1991-2#2)(1992-8#1)(1993-12#1)(1995-1#1)(1995-10#1)(1995-5#1)(1995-8#1)(1997-1#1)(2005-11#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#1)(2013-8#1)
under alternative##3##2##(1995-2#1)(2008-7#1)(2012-12#1)
under ambient CO(2)##2##3##(2008-10#2)
under ambient conditions##10##3##(2008-10#3)(2008-5#1)(2008-7#1)(2009-12#1)(2010-4#2)(2010-9#1)(2012-2#1)
under ambient##15##2##(1992-8#1)(1994-7#1)(2008-10#6)(2008-5#1)(2008-7#1)(2009-12#1)(2010-4#2)(2010-9#1)(2012-2#1)
under an applied##3##3##(2008-10#1)(2008-7#1)(2009-9#1)
under an electron microscope##2##4##(1997-6#1)(2008-1#1)
under an optical microscope##2##4##(2008-5#1)(2009-10#1)
under an optimized##2##3##(2012-2#1)(2013-7#1)
under an oxygen##2##3##(2005-11#2)
under an##33##2##(1992-6#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-9#1)(1997-3#1)(1997-6#1)(2005-11#3)(2006-10#1)(2006-12#1)(2006-7#1)(2007-11#2)(2007-2#1)(2008-1#2)(2008-10#3)(2008-3#1)(2008-5#2)(2008-7#2)(2009-10#1)(2009-9#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
under anaerobic condition##2##3##(1991-3#1)(1994-6#1)
under anaerobic conditions in##2##4##(2008-6#1)(2013-1#1)
under anaerobic conditions than under aerobic conditions##2##7##(2006-8#1)(2008-10#1)
under anaerobic conditions##19##3##(1991-2#1)(1991-8#1)(1994-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#2)(1997-4#1)(2006-10#2)(2006-8#2)(2008-10#1)(2008-6#1)(2008-7#1)(2013-1#3)
under anaerobic growth##2##3##(2006-8#1)(2008-7#1)
under anaerobic##26##2##(1991-2#1)(1991-3#1)(1991-8#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#2)(1997-4#1)(2006-10#2)(2006-8#3)(2007-12#1)(2008-10#2)(2008-6#1)(2008-7#2)(2010-2#1)(2013-1#3)
under anaerobiosis and##2##3##(2008-10#1)(2008-12#1)
under anaerobiosis##4##2##(2008-10#1)(2008-12#1)(2008-6#2)
under anaesthesia and##2##3##(2007-11#1)(2010-7#1)
under anaesthesia##7##2##(1995-5#1)(1995-9#1)(1996-2#1)(2006-6#1)(2007-1#1)(2007-11#1)(2010-7#1)
under analysis##8##2##(2005-8#1)(2006-10#1)(2007-5#1)(2008-10#1)(2008-3#2)(2010-10#1)(2011-2#1)
under and##2##2##(2008-5#1)(2013-8#1)
under anesthesia and##2##3##(1996-11#1)(2011-7#1)
under anesthesia##11##2##(1994-2#1)(1996-11#1)(2006-10#1)(2007-8#1)(2008-4#2)(2008-8#1)(2009-3#1)(2011-2#1)(2011-7#1)(2012-2#1)
under anhydrous conditions##2##3##(2010-2#2)
under any circumstances##3##3##(1990-3#1)(1995-6#1)(2011-3#1)
under any condition##2##3##(2008-2#1)(2009-10#1)
under any##9##2##(1990-3#1)(1990-7#1)(1995-6#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#1)(2011-3#1)
under applied pressure##2##3##(1995-1#2)
under applied##4##2##(1995-1#2)(1995-7#1)(2005-12#1)
under appropriate conditions##7##3##(1997-5#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-7#1)(2010-12#1)
under appropriate##11##2##(1997-5#1)(2006-12#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-12#1)
under aqueous##3##2##(1995-3#1)(2010-7#1)(2012-3#1)
under artificial inoculation##2##3##(2008-10#2)
under artificial##3##2##(2008-10#2)(2013-7#1)
under atmospheric##2##2##(2008-11#2)
under attack##2##2##(1996-11#1)(2007-4#1)
under attention condition##2##3##(2008-8#2)
under axial compression##3##3##(2006-9#1)(2007-4#1)(2013-1#1)
under background##2##2##(2008-2#2)
under basal conditions and##3##4##(1997-2#1)(2008-11#1)(2013-1#1)
under basal conditions##14##3##(1990-12#1)(1990-6#1)(1993-12#1)(1994-2#1)(1995-5#1)(1996-4#1)(1997-2#1)(1997-7#1)(2008-11#2)(2008-8#2)(2013-1#2)
under basal##17##2##(1990-12#1)(1990-6#1)(1991-5#1)(1993-12#1)(1994-2#1)(1995-12#1)(1995-5#1)(1996-4#1)(1997-2#1)(1997-7#1)(2008-11#2)(2008-8#3)(2013-1#2)
under base##2##2##(2007-11#1)(2012-12#1)
under basic conditions##4##3##(1996-10#1)(2005-11#1)(2005-4#1)(2009-3#1)
under basic##6##2##(1996-10#1)(2005-11#1)(2005-4#1)(2009-3#1)(2010-4#1)(2013-7#1)
under batch equilibrium binding conditions##2##5##(1997-2#2)
under batch equilibrium##3##3##(1997-2#3)
under batch##4##2##(1997-2#3)(2008-10#1)
under better##2##2##(1990-6#1)(2007-4#1)
under biologically reasonable##2##3##(2008-9#1)(2010-6#1)
under biologically##3##2##(2008-9#1)(2010-6#2)
under both aerobic and anaerobic conditions##3##6##(1995-11#1)(2006-10#1)(2006-8#1)
under both anchorage-dependent and anchorage-independent conditions##2##6##(1997-1#2)
under both conditions##5##3##(1994-2#1)(1994-6#1)(1996-1#1)(1997-4#1)(2010-2#1)
under both hypoxic and aerobic##2##5##(1995-6#2)
under both normal and disease##2##5##(2007-8#1)(2011-2#1)
under both normal and##4##4##(1995-11#1)(2007-8#1)(2008-10#1)(2011-2#1)
under both pH conditions##2##4##(1991-5#1)(1994-8#1)
under both physiological and pathological conditions##3##6##(1992-4#1)(2006-2#1)(2008-4#1)
under both physiological##4##3##(1991-2#1)(1992-4#1)(2006-2#1)(2008-4#1)
under both##57##2##(1990-11#1)(1991-2#1)(1991-5#1)(1992-4#2)(1992-7#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#2)(1995-6#3)(1995-7#1)(1995-8#1)(1996-1#1)(1997-1#3)(1997-4#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-8#1)(2010-1#1)(2010-2#1)(2011-2#1)(2012-2#2)(2013-8#1)
under buffer##2##2##(1990-8#1)(2008-2#1)
under bursty traffic conditions##2##4##(2008-2#2)
under capitated##2##2##(1995-3#1)(1996-2#1)
under captopril##2##2##(1992-5#1)(1993-9#1)
under cardiopulmonary bypass (CPB)##2##4##(2007-9#1)(2013-1#1)
under cardiopulmonary bypass and##2##4##(2007-8#1)(2013-1#1)
under cardiopulmonary bypass##11##3##(2006-12#1)(2007-8#4)(2007-9#2)(2008-7#1)(2013-1#3)
under careful##4##2##(2007-8#1)(2008-1#1)(2008-11#1)(2012-2#1)
under cell-cycle control##3##3##(1991-7#3)
under certain circumstances it##3##4##(1995-9#1)(2007-3#1)(2011-2#1)
under certain circumstances##14##3##(1990-3#1)(1990-4#1)(1991-4#1)(1994-3#1)(1995-8#1)(1995-9#1)(2005-11#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-5#1)(2011-12#1)(2011-2#1)(2012-2#1)
under certain conditions and##2##4##(1994-12#1)(2007-11#1)
under certain conditions##31##3##(1991-12#1)(1991-8#1)(1992-10#1)(1992-3#2)(1992-4#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-2#2)(1996-10#1)(1996-8#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#2)(2012-3#1)(2013-7#1)
under certain environmental conditions##3##4##(1993-2#1)(2008-10#1)(2012-3#1)
under certain pathophysiological conditions##2##4##(1990-3#1)(1990-5#1)
under certain physiological conditions##2##4##(1990-11#1)(1990-12#1)
under certain##63##2##(1990-11#1)(1990-12#1)(1990-3#2)(1990-4#1)(1990-5#1)(1991-12#1)(1991-4#1)(1991-8#1)(1992-10#1)(1992-3#2)(1992-4#1)(1992-5#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-2#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-8#1)(1997-3#1)(1997-7#1)(2005-11#2)(2006-10#2)(2007-11#2)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
under chloral hydrate anesthesia##2##4##(1996-10#1)(2007-12#1)
under chronic##5##2##(1991-5#1)(1996-3#1)(2007-9#1)(2008-10#1)(2010-7#1)
under circumstances where##3##3##(1991-12#1)(1993-11#1)(1993-12#1)
under circumstances##4##2##(1991-12#1)(1993-11#1)(1993-12#1)(2008-11#1)
under clear skies##2##3##(2008-3#2)
under clear##3##2##(2007-12#1)(2008-3#2)
under clinical investigation##3##3##(1997-1#1)(2007-11#1)(2010-6#1)
under clinical trial conditions##2##4##(2013-1#2)
under clinical##11##2##(1990-11#1)(1993-6#1)(1997-1#1)(2007-11#2)(2007-5#1)(2010-6#1)(2010-8#1)(2012-12#1)(2013-1#2)
under coherent illumination##3##3##(2008-2#1)(2008-3#2)
under cold and salt stress##2##5##(2009-10#2)
under cold##4##2##(2008-4#1)(2009-10#2)(2011-1#1)
under combined shear##2##3##(2007-4#2)
under combined spinal##2##3##(2008-7#2)
under combined##7##2##(1993-8#1)(2007-4#2)(2008-7#2)(2010-7#1)(2012-12#1)
under commercial conditions##2##3##(2008-10#2)
under commercial##4##2##(2008-10#4)
under comparable##2##2##(1992-12#1)(2008-10#1)
under compression##4##2##(2005-11#1)(2009-3#1)(2009-7#1)(2011-2#1)
under compressive##2##2##(2007-4#1)(2008-11#1)
under computed##2##2##(1992-12#1)(2007-5#1)
under computer control##3##3##(2008-10#1)(2008-2#1)(2010-12#1)
under condition 1##2##3##(1996-6#2)
under condition##4##2##(1996-6#3)(2011-1#1)
under conditions conducive to##2##4##(1990-3#1)(2008-7#1)
under conditions designed to##2##4##(2008-5#1)(2010-8#1)
under conditions favoring##2##3##(1991-10#1)(1992-12#1)
under conditions in which the##6##5##(1991-6#1)(1996-9#1)(1997-2#1)(1997-4#1)(2010-5#2)
under conditions in which##16##4##(1991-6#1)(1993-1#1)(1993-11#1)(1995-3#1)(1996-9#1)(1997-2#3)(1997-4#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-4#1)(2010-5#2)(2012-12#1)
under conditions of a##3##4##(2006-10#1)(2008-3#1)(2009-2#1)
under conditions of chronic##2##4##(1992-6#1)(1995-12#1)
under conditions of exposure to##2##5##(2012-1#2)
under conditions of high##6##4##(1992-7#1)(1995-7#1)(2004-10#1)(2005-11#1)(2006-10#1)(2006-6#1)
under conditions of high-intensity light exposure##2##6##(2012-1#2)
under conditions of hunger and satiety##2##6##(2012-1#2)
under conditions of limited##2##4##(2009-6#1)(2010-8#1)
under conditions of natural##2##4##(2008-10#1)(2012-1#1)
under conditions of overtraining##2##4##(2012-1#2)
under conditions of oxidative stress##2##5##(2008-4#1)(2010-3#1)
under conditions of partial##2##4##(1996-2#1)(2008-4#1)
under conditions of poor chromatographic resolution##3##6##(2008-10#3)
under conditions of reduced##5##4##(1991-9#1)(1994-3#1)(2008-11#1)(2008-12#1)(2012-1#1)
under conditions of retinoid stores absence##2##6##(2013-1#2)
under conditions of retinoid stores##3##5##(2013-1#3)
under conditions of severe##2##4##(1991-5#1)(2008-9#1)
under conditions of stress##2##4##(1995-5#1)(1996-5#1)
under conditions of##117##3##(1990-11#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-7#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#2)(1996-2#1)(1996-5#1)(1996-7#1)(1997-1#2)(1997-5#1)(1997-8#1)(2004-10#1)(2005-11#3)(2006-10#2)(2006-6#2)(2007-11#2)(2007-12#2)(2007-6#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#2)(2008-7#1)(2008-9#2)(2009-2#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#8)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#16)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
under conditions similar to those##2##5##(1994-11#1)(2007-11#1)
under conditions similar to##4##4##(1994-11#1)(1994-2#1)(2007-11#1)(2008-12#1)
under conditions that maximize the##2##5##(1990-2#1)(2008-4#1)
under conditions that maximize##4##4##(1990-2#1)(2008-11#1)(2008-4#1)(2012-2#1)
under conditions that produced##2##4##(1994-10#1)(2008-11#1)
under conditions that##24##3##(1990-2#1)(1991-3#1)(1991-7#1)(1993-6#1)(1994-10#1)(1994-9#2)(1995-1#1)(1996-5#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-2#1)(2011-1#1)(2012-2#2)
under conditions where it##2##4##(1992-7#1)(1997-2#1)
under conditions where no##2##4##(1990-12#1)(1992-3#1)
under conditions where the##7##4##(1990-11#1)(1991-8#2)(1992-11#1)(1995-3#1)(1995-8#1)(2008-3#1)
under conditions where##21##3##(1990-11#1)(1990-12#1)(1991-8#2)(1992-11#1)(1992-3#2)(1992-7#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-8#2)(1996-5#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)
under conditions which may##2##4##(1993-3#1)(1995-4#1)
under conditions which##8##3##(1992-8#1)(1993-3#1)(1994-11#1)(1994-6#1)(1995-2#1)(1995-4#1)(2007-5#1)(2008-10#1)
under conditions##218##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#6)(1992-4#1)(1992-6#2)(1992-7#2)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#2)(1994-10#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#3)(1995-10#1)(1995-12#2)(1995-2#2)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#1)(1995-7#2)(1995-8#2)(1996-1#1)(1996-2#1)(1996-5#3)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-10#1)(2005-11#3)(2006-10#2)(2006-4#2)(2006-6#2)(2007-11#5)(2007-12#3)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#14)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#8)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#8)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#4)(2012-1#16)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#1)
under conscious##2##2##(2006-10#1)(2007-9#1)
under conservative##2##2##(2009-11#1)(2013-1#1)
under consideration as##2##3##(1992-3#1)(2012-2#1)
under consideration by the##2##4##(1994-12#1)(1995-12#1)
under consideration for##3##3##(2007-9#2)(2008-3#1)
under consideration##30##2##(1990-6#1)(1992-3#1)(1994-12#1)(1995-12#1)(1996-11#1)(1996-12#2)(2004-1#1)(2005-11#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-9#3)(2008-1#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
under constant conditions##2##3##(2010-5#1)(2013-7#1)
under constant##16##2##(1991-2#2)(1992-12#1)(1996-2#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2010-3#1)(2010-5#1)(2012-3#2)(2013-7#1)
under constraints##3##2##(2008-11#2)(2010-3#1)
under construction##6##2##(2007-11#1)(2007-12#1)(2008-3#2)(2009-12#1)(2012-2#1)
under continual##3##2##(2006-10#1)(2007-2#1)(2012-2#1)
under continuous flow##3##3##(2008-10#2)(2008-11#1)
under continuous##13##2##(1992-5#1)(1997-1#1)(2007-12#3)(2008-10#5)(2008-11#1)(2009-11#1)(2013-8#1)
under contrasting##3##2##(2011-1#1)(2013-8#2)
under control and##3##3##(1991-5#1)(1995-7#1)(2010-8#1)
under control conditions##8##3##(1991-11#1)(1991-6#1)(1992-10#1)(1995-12#2)(1995-7#1)(1996-3#1)(2006-5#1)
under control in##2##3##(1997-8#1)(2008-8#1)
under control of a##3##4##(1990-11#1)(1993-6#1)(1997-7#1)
under control of an##2##4##(1992-3#1)(1994-11#1)
under control of the##19##4##(1990-11#2)(1991-4#1)(1991-5#1)(1991-8#1)(1992-4#1)(1994-2#1)(1995-4#1)(1995-8#1)(1996-3#1)(1996-9#1)(1997-7#2)(2008-10#1)(2008-5#2)(2011-10#1)(2011-12#1)(2012-2#1)
under control of##28##3##(1990-11#3)(1991-4#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-4#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-3#1)(1996-9#1)(1997-7#3)(2008-10#1)(2008-11#1)(2008-5#2)(2009-4#1)(2011-10#1)(2011-12#1)(2012-2#1)
under control##54##2##(1990-11#3)(1991-11#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-10#1)(1992-3#1)(1992-4#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-7#2)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-7#3)(1997-8#1)(2006-5#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-5#2)(2008-8#2)(2009-4#1)(2010-12#1)(2010-8#1)(2011-10#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
under controlled and field conditions##2##5##(2008-10#2)
under controlled and##3##3##(2008-10#3)
under controlled conditions and a##2##5##(2008-10#1)(2012-2#1)
under controlled conditions and##5##4##(2008-10#4)(2012-2#1)
under controlled conditions for##2##4##(2008-10#1)(2012-12#1)
under controlled conditions in##3##4##(1996-9#1)(2008-10#1)(2010-12#1)
under controlled conditions##29##3##(1991-3#1)(1993-8#1)(1996-9#1)(2008-10#17)(2008-11#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
under controlled environment##2##3##(2007-1#1)(2008-10#1)
under controlled environmental conditions##6##4##(2006-3#1)(2008-10#5)
under controlled laboratory conditions##2##4##(2007-11#1)(2007-5#1)
under controlled laboratory##3##3##(2007-11#1)(2007-5#1)(2008-10#1)
under controlled##52##2##(1991-3#1)(1993-8#1)(1996-9#1)(2006-3#2)(2007-1#1)(2007-11#1)(2007-5#1)(2007-8#2)(2008-10#30)(2008-11#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-8#1)
under conventional tillage##3##3##(2013-8#3)
under conventional##8##2##(1996-4#1)(2008-10#2)(2012-12#2)(2013-8#3)
under culture##2##2##(1991-2#1)(2007-5#1)
under current##3##2##(1993-6#1)(2006-10#1)(2013-7#1)
under curve##8##2##(1991-10#1)(1994-7#1)(2008-7#1)(2011-2#2)(2012-1#1)(2013-7#1)(2013-8#1)
under cyclic loading##2##3##(2008-5#1)(2009-3#1)
under cyclic##3##2##(2008-5#1)(2008-7#1)(2009-3#1)
under dark##3##2##(1993-12#1)(1994-5#1)(2012-2#1)
under daylight conditions##2##3##(2007-11#1)(2008-10#1)
under debate##10##2##(1993-8#1)(1995-11#1)(2007-8#2)(2008-3#1)(2008-7#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-12#1)
under decoherence##2##2##(2012-2#2)
under deep##2##2##(2007-8#2)
under defined conditions##4##3##(1991-12#1)(1994-11#1)(2008-4#1)(2008-7#1)
under defined##6##2##(1991-12#1)(1994-11#2)(2008-4#1)(2008-7#2)
under denaturing conditions##11##3##(1990-11#1)(1991-4#1)(1994-5#1)(1996-7#1)(2008-10#1)(2008-2#2)(2008-4#3)(2008-5#1)
under denaturing##13##2##(1990-11#1)(1991-4#1)(1992-2#1)(1994-5#1)(1996-7#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#3)(2008-5#1)
under development and##4##3##(2007-11#1)(2008-10#2)(2011-2#1)
under development are##2##3##(2007-10#1)(2007-5#1)
under development as a##2##4##(2008-11#1)(2009-9#1)
under development as##3##3##(1994-4#1)(2008-11#1)(2009-9#1)
under development by Novartis for the potential treatment of##2##9##(2005-8#2)
under development by Novartis##3##4##(2005-8#2)(2008-5#1)
under development by SmithKline Beecham##3##5##(2005-8#1)(2008-5#2)
under development by the##3##4##(2005-7#2)(2008-7#1)
under development by##35##3##(2005-6#1)(2005-7#5)(2005-8#8)(2005-9#6)(2008-5#14)(2008-7#1)
under development for the##2##4##(1991-5#1)(2008-5#1)
under development for##4##3##(1991-5#1)(1994-9#1)(2008-5#1)(2013-1#1)
under development in##2##3##(2009-4#1)(2010-8#1)
under development to##2##3##(2006-6#1)(2008-3#1)
under development##87##2##(1991-12#1)(1991-5#1)(1992-2#1)(1994-4#1)(1994-9#1)(1995-9#1)(1996-12#1)(2004-12#1)(2005-6#1)(2005-7#8)(2005-8#10)(2005-9#6)(2006-10#1)(2006-11#1)(2006-6#2)(2006-9#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#15)(2008-7#3)(2008-8#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-12#2)(2013-1#1)
under development)##2##2##(2007-12#1)(2008-5#1)
under diagnosis##3##2##(1990-12#1)(1997-8#1)(2013-8#1)
under different circumstances##4##3##(2005-7#1)(2006-10#2)(2013-7#1)
under different clinical##2##3##(1996-8#1)(2013-1#1)
under different conditions and##2##4##(1993-12#1)(1996-1#1)
under different conditions of temperature##2##5##(2005-11#1)(2008-10#1)
under different conditions of##6##4##(1991-2#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2012-1#1)
under different conditions##25##3##(1991-2#1)(1992-8#1)(1993-12#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-3#1)(2005-11#2)(2005-4#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-4#1)(2012-1#2)(2013-8#1)
under different cultivation conditions##2##4##(1995-6#1)(2007-11#1)
under different dietary conditions##2##4##(2008-10#2)
under different environmental conditions##5##4##(2008-10#3)(2008-8#1)(2011-2#1)
under different excitation conditions##2##4##(2008-2#2)
under different experimental conditions##4##4##(1991-6#1)(1997-2#1)(2005-11#1)(2008-10#1)
under different growth conditions##3##4##(2006-8#1)(2008-10#1)(2009-10#1)
under different illumination##2##3##(2008-10#1)(2008-3#1)
under different laboratory##2##3##(2008-10#1)(2011-1#1)
under different moisture##3##3##(2008-10#1)(2008-12#1)(2011-12#1)
under different operating conditions##2##4##(2008-2#1)(2011-1#1)
under different pH##4##3##(1991-3#1)(2008-10#2)(2010-12#1)
under different physiological conditions##2##4##(1996-10#1)(2008-3#1)
under different storage##2##3##(2006-1#1)(2008-3#1)
under different stresses##2##3##(2008-7#1)(2012-1#1)
under different temperature and##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
under different temperature##4##3##(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
under different tillage##2##3##(2008-10#1)(2013-8#1)
under different##149##2##(1990-8#1)(1991-1#1)(1991-2#4)(1991-3#1)(1991-6#1)(1991-7#1)(1992-8#1)(1993-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-6#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-9#1)(2004-4#2)(2005-10#1)(2005-11#5)(2005-4#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-12#2)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-6#2)(2007-8#1)(2007-9#1)(2008-10#25)(2008-11#1)(2008-12#1)(2008-2#10)(2008-3#6)(2008-4#1)(2008-5#8)(2008-7#7)(2008-8#2)(2009-10#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#4)(2012-12#1)(2013-1#3)(2013-7#2)(2013-8#3)
under differential##2##2##(2008-7#1)(2010-12#1)
under difficult conditions##3##3##(1991-5#1)(2008-2#1)(2008-6#1)
under difficult##4##2##(1991-5#1)(2008-2#1)(2008-6#1)(2010-2#1)
under dim##2##2##(1995-9#1)(1997-1#1)
under direct endoscopic inspection##2##4##(1997-5#2)
under direct microscopic##2##3##(2005-5#1)(2010-6#1)
under direct vision##6##3##(1990-6#1)(1991-12#1)(2006-3#1)(2007-8#3)
under direct##14##2##(1990-6#1)(1991-12#1)(1996-4#1)(1997-5#2)(2005-5#1)(2006-3#1)(2007-11#1)(2007-8#3)(2010-2#1)(2010-6#1)(2011-2#1)
under disassembly of the Golgi complex caused by brefeldin A##2##10##(1990-12#2)
under discussion as##2##3##(1992-11#1)(1997-4#1)
under discussion##11##2##(1992-11#1)(1992-5#1)(1997-4#1)(1997-5#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2009-5#1)(2012-3#1)
under disease progress curve##3##4##(2008-10#3)
under distinct genetic control##2##4##(2011-2#2)
under double##2##2##(2008-11#1)(2011-2#1)
under drip irrigation than under furrow irrigation##2##7##(2008-10#2)
under drip irrigation##3##3##(2008-10#2)(2013-8#1)
under drought stress##3##3##(2008-12#1)(2009-8#1)(2011-1#1)
under drought##4##2##(2008-12#1)(2009-8#1)(2011-1#1)(2012-6#1)
under dry conditions##3##3##(2007-4#1)(2008-10#2)
under dry##5##2##(2007-4#1)(2008-10#3)(2008-5#1)
under dynamic conditions##3##3##(2006-10#1)(2008-10#1)(2012-4#1)
under dynamic##7##2##(2006-10#1)(2006-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-4#1)
under each of##3##3##(1994-9#2)(2006-5#1)
under each##6##2##(1994-9#2)(2004-4#1)(2006-5#1)(2008-7#1)(2013-1#1)
under either##10##2##(1992-12#1)(1995-6#1)(1997-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-4#1)(2010-10#1)(2013-7#1)(2013-8#1)
under electron microscope##2##3##(1995-7#1)(2008-8#1)
under electron microscopy##2##3##(2007-12#1)(2007-9#1)
under electron##5##2##(1990-4#1)(1995-7#1)(2007-12#1)(2007-9#1)(2008-8#1)
under elevated CO(2) concentration##3##4##(2008-10#2)(2008-8#1)
under elevated CO(2) concentrations##3##4##(2008-10#3)
under elevated CO(2)##6##3##(2008-10#5)(2008-8#1)
under elevated##9##2##(2006-12#1)(2008-10#6)(2008-8#1)(2010-10#1)
under endoscopic visualization##2##3##(2005-5#2)
under environmental conditions##2##3##(2007-11#1)(2008-2#1)
under environmental##5##2##(1993-2#1)(2007-11#1)(2008-2#1)(2008-8#1)(2010-4#1)
under epidural anaesthesia##3##3##(2006-12#1)(2008-7#1)(2011-12#1)
under epidural anesthesia##2##3##(2013-1#2)
under epidural##7##2##(1992-8#2)(2006-12#1)(2008-7#1)(2011-12#1)(2013-1#2)
under equal##2##2##(2006-7#1)(2012-1#1)
under equilibrium conditions##7##3##(1991-11#1)(1993-6#3)(1997-2#1)(1997-4#1)(2008-5#1)
under equilibrium##8##2##(1991-11#1)(1993-6#3)(1995-11#1)(1997-2#1)(1997-4#1)(2008-5#1)
under ether anesthesia##2##3##(2008-12#1)(2008-8#1)
under ether##3##2##(2008-1#1)(2008-12#1)(2008-8#1)
under evaluation in a##2##4##(1992-6#1)(2007-1#1)
under evaluation in the##2##4##(2008-2#1)(2011-2#1)
under evaluation in##5##3##(1992-6#1)(2007-1#1)(2008-2#1)(2011-2#1)(2013-1#1)
under evaluation##12##2##(1992-6#1)(1997-2#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2009-9#1)(2011-2#1)(2011-3#1)(2013-1#1)
under examination##4##2##(2007-12#1)(2007-5#1)(2008-10#1)(2008-9#1)
under experimental conditions in##2##4##(1993-3#1)(2008-5#1)
under experimental conditions##16##3##(1992-1#1)(1992-12#1)(1993-3#1)(1994-6#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-7#2)(2009-8#1)(2010-2#1)(2010-5#1)
under experimental##18##2##(1992-1#1)(1992-12#1)(1993-3#1)(1994-6#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#2)(2009-8#1)(2010-2#1)(2010-5#1)(2013-8#1)
under external drive##2##3##(2007-12#2)
under external perturbations##3##3##(2008-2#2)(2008-3#1)
under external##5##2##(2007-12#2)(2008-2#2)(2008-3#1)
under extreme conditions##2##3##(2007-8#1)(2008-10#1)
under extreme##5##2##(1991-12#1)(2007-8#1)(2008-10#1)(2010-4#1)(2012-12#1)
under fasting conditions##2##3##(2006-1#1)(2010-12#1)
under fasting##4##2##(1994-8#1)(2006-1#1)(2010-12#1)(2011-1#1)
under favorable conditions##2##3##(2004-4#1)(2008-2#1)
under favorable##4##2##(2004-4#1)(2008-10#1)(2008-12#1)(2008-2#1)
under federal and state##2##4##(1994-3#1)(1996-3#1)
under feedback control##3##3##(1996-8#2)(2008-3#1)
under fertility investigation##2##3##(1992-12#2)
under field conditions and##2##4##(2008-10#2)
under field conditions at##3##4##(2008-10#3)
under field conditions for##2##4##(2004-2#1)(2008-10#1)
under field conditions##35##3##(2004-2#1)(2005-7#1)(2005-9#1)(2006-3#1)(2008-10#25)(2008-12#1)(2008-5#1)(2010-10#1)(2011-2#1)(2013-8#2)
under field##36##2##(2004-2#1)(2005-7#1)(2005-9#1)(2006-3#1)(2008-10#25)(2008-12#1)(2008-5#1)(2008-9#1)(2010-10#1)(2011-2#1)(2013-8#2)
under fire##2##2##(1995-6#1)(1996-12#1)
under first-order##2##2##(1992-3#1)(1993-6#1)
under five different##2##3##(2008-10#1)(2011-12#1)
under five years living in households##2##6##(2011-2#2)
under five years living in##3##5##(2011-2#3)
under five years of age##3##5##(1993-5#1)(2006-8#1)(2011-1#1)
under five years##13##3##(1990-12#1)(1993-5#1)(2006-8#1)(2008-1#3)(2011-1#1)(2011-2#4)(2012-12#2)
under five##21##2##(1990-12#1)(1991-4#1)(1993-5#1)(2006-2#1)(2006-8#1)(2008-1#3)(2008-10#2)(2008-2#1)(2008-5#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#2)
under fixed##2##2##(1992-12#1)(2008-10#1)
under flow conditions##6##3##(1991-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-10#1)
under flow##11##2##(1991-5#1)(1993-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2009-10#1)(2010-5#1)
under fluorescence microscopy##2##3##(1993-11#1)(2009-4#1)
under fluoroscopic guidance##3##3##(2006-7#1)(2006-8#1)(2013-1#1)
under fluoroscopic##5##2##(2006-3#1)(2006-7#1)(2006-8#1)(2011-1#1)(2013-1#1)
under fluoroscopy##4##2##(2006-8#3)(2007-9#1)
under follow-up##2##2##(1996-12#1)(2008-5#1)
under formation of##2##3##(1992-12#1)(2010-5#1)
under four different##2##3##(1995-4#1)(2005-12#1)
under four##7##2##(1990-12#1)(1991-2#1)(1995-4#1)(2005-12#1)(2008-6#1)(2008-9#1)(2012-6#1)
under full##3##2##(1991-3#1)(2008-8#1)(2013-1#1)
under fungal##2##2##(1990-6#1)(2008-10#1)
under furrow and##2##3##(2008-10#2)
under furrow irrigation##7##3##(2008-10#7)
under furrow##9##2##(2008-10#9)
under gamma irradiation##3##3##(2004-9#1)(2010-5#2)
under general anaesthesia and##2##4##(2008-7#1)(2013-8#1)
under general anaesthesia were##3##4##(1996-12#1)(2010-7#2)
under general anaesthesia##18##3##(1991-11#1)(1993-2#1)(1993-7#1)(1995-4#1)(1996-12#1)(1997-6#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-7#1)(2009-6#1)(2010-7#4)(2011-12#1)(2013-1#1)(2013-8#1)
under general anesthesia##20##3##(1991-2#1)(1992-12#2)(1993-1#1)(1994-12#1)(1995-3#1)(1996-12#2)(2007-7#1)(2007-8#2)(2008-5#2)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)
under general##41##2##(1991-11#1)(1991-2#1)(1992-12#2)(1993-1#1)(1993-2#1)(1993-7#1)(1994-12#1)(1995-3#1)(1995-4#1)(1996-12#3)(1997-6#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-7#1)(2007-8#3)(2008-2#1)(2008-5#2)(2008-7#1)(2009-6#1)(2010-3#1)(2010-7#4)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
under genetic control##3##3##(1990-7#1)(2008-10#1)(2009-3#1)
under genetic drift##2##3##(2013-1#2)
under genetic##7##2##(1990-7#1)(1994-11#1)(2008-10#1)(2008-2#1)(2009-3#1)(2013-1#2)
under glass##3##2##(1995-3#1)(2008-2#1)(2009-2#1)
under glow discharge conditions##3##4##(2004-9#3)
under glucocorticoid##2##2##(1994-10#1)(2006-9#1)
under glucose##2##2##(2010-10#1)(2012-2#1)
under good##6##2##(1992-8#1)(2007-8#1)(2008-10#1)(2008-7#1)(2012-12#2)
under grazing##2##2##(2007-9#1)(2010-4#1)
under great pressure##2##3##(2006-8#1)(2008-11#1)
under greenhouse conditions were##2##4##(2008-10#2)
under greenhouse conditions##13##3##(2008-10#13)
under greenhouse##14##2##(2008-10#14)
under growth chamber##2##3##(2008-10#2)
under growth##4##2##(1995-10#1)(2008-10#3)
under halothane anesthesia##3##3##(1992-8#1)(2009-2#1)(2009-6#1)
under harsh conditions##2##3##(2010-10#1)(2012-12#1)
under health care reform##2##4##(1994-2#1)(1995-12#1)
under health care##4##3##(1993-3#1)(1994-2#1)(1994-7#1)(1995-12#1)
under health reform##2##3##(1995-1#1)(1995-12#1)
under health##6##2##(1993-3#1)(1994-2#1)(1994-7#1)(1995-1#1)(1995-12#2)
under heat stress##3##3##(2008-12#1)(2012-2#2)
under heat##5##2##(1995-3#1)(2008-12#1)(2008-7#1)(2012-2#2)
under high concentration conditions##2##4##(2008-9#2)
under high glucose conditions##2##4##(1992-8#1)(2008-1#1)
under high glucose##3##3##(1992-8#1)(2008-1#1)(2011-2#1)
under high pressure##9##3##(1992-11#1)(1996-1#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#2)
under high shear stress##2##4##(1992-12#1)(2009-7#1)
under high shear##3##3##(1992-12#1)(2008-11#1)(2009-7#1)
under high temperature##3##3##(2008-10#1)(2008-12#1)(2008-6#1)
under high##42##2##(1990-5#1)(1992-11#1)(1992-12#1)(1992-8#1)(1994-3#2)(1996-1#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-11#2)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#2)(2009-7#1)(2010-10#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-7#1)(2013-1#2)
under higher##3##2##(2009-3#1)(2011-1#1)(2011-12#1)
under highly##2##2##(2008-3#1)(2008-5#1)
under his##3##2##(1996-6#1)(2006-6#1)(2010-5#1)
under hot##2##2##(2008-12#1)(2010-4#1)
under hydrodynamic conditions##2##3##(2008-10#1)(2008-9#1)
under hydrodynamic##4##2##(1994-11#1)(2008-10#1)(2008-4#1)(2008-9#1)
under hydrostatic pressure##2##3##(1995-1#1)(1996-2#1)
under hydrothermal conditions##2##3##(2007-5#1)(2010-5#1)
under hyperthermic conditions##3##3##(2006-6#3)
under hypoxia##4##2##(1996-6#3)(2012-12#1)
under hypoxic condition##3##3##(2013-8#3)
under hypoxic conditions and##2##4##(2006-10#1)(2009-9#1)
under hypoxic conditions##7##3##(1994-5#1)(1996-6#1)(1997-7#1)(2006-10#1)(2008-11#1)(2009-9#1)(2012-12#1)
under hypoxic##14##2##(1994-5#1)(1996-6#1)(1997-7#1)(2006-10#1)(2008-11#1)(2008-5#1)(2009-9#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-8#4)
under ideal conditions##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
under ideal##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2009-9#1)
under identical conditions##14##3##(1990-5#1)(1991-12#1)(1991-2#1)(1991-6#1)(1993-8#1)(1994-8#2)(1995-1#2)(2007-11#1)(2008-10#1)(2010-5#1)(2011-1#1)(2011-2#1)
under identical experimental conditions##4##4##(1993-3#1)(1997-2#1)(2008-10#1)(2008-2#1)
under identical experimental##5##3##(1992-1#1)(1993-3#1)(1997-2#1)(2008-10#1)(2008-2#1)
under identical solvent conditions##2##4##(2006-10#2)
under identical##24##2##(1990-5#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-1#1)(1993-3#2)(1993-8#1)(1994-8#2)(1995-1#2)(1997-2#1)(2006-10#2)(2007-11#1)(2007-4#1)(2008-10#2)(2008-2#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#1)
under illumination##6##2##(1992-8#1)(1994-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-6#1)
under in vitro conditions##3##4##(1993-2#1)(1996-9#1)(2007-11#1)
under in vitro##6##3##(1993-2#1)(1996-9#1)(2007-11#1)(2010-12#1)(2010-8#1)(2011-12#1)
under in vivo conditions##2##4##(1992-3#1)(2009-3#1)
under in vivo##3##3##(1992-3#1)(2009-3#1)(2011-1#1)
under in##11##2##(1992-3#1)(1993-2#1)(1996-9#1)(2005-9#1)(2007-11#1)(2008-2#1)(2009-3#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#1)
under inattention condition##2##3##(2008-8#2)
under incoherent illumination##3##3##(2008-2#2)(2008-3#1)
under increased##6##2##(2008-10#1)(2008-11#1)(2009-8#1)(2010-8#1)(2012-1#1)(2012-2#1)
under increasing scrutiny##2##3##(2008-12#1)(2010-11#1)
under increasing##5##2##(1995-3#1)(2004-4#1)(2007-8#1)(2008-12#1)(2010-11#1)
under induced##2##2##(2011-1#2)
under industrial##2##2##(2007-8#1)(2008-2#1)
under inflammatory conditions##2##3##(2006-10#1)(2012-2#1)
under inflammatory##3##2##(2006-10#1)(2008-4#1)(2012-2#1)
under influence of##2##3##(2008-10#1)(2011-1#1)
under influence##3##2##(1997-2#1)(2008-10#1)(2011-1#1)
under infrared##2##2##(2008-10#1)(2010-5#1)
under initial velocity conditions##2##4##(1992-6#1)(1995-11#1)
under initial##4##2##(1992-6#1)(1995-11#1)(2011-2#2)
under initiative of##2##3##(2008-5#2)
under injury conditions##2##3##(2008-5#1)(2013-1#1)
under intense##5##2##(2007-5#1)(2008-1#1)(2008-10#2)(2008-7#1)
under intensive investigation##2##3##(1995-3#1)(2011-3#1)
under intensive##5##2##(1995-3#1)(2005-11#1)(2008-7#1)(2011-3#1)(2012-3#1)
under inverse sampling##3##3##(1995-9#1)(1996-3#2)
under investigation and##2##3##(2006-12#1)(2011-2#1)
under investigation are##3##3##(1997-4#1)(2004-12#1)(2008-2#1)
under investigation as##2##3##(1997-2#1)(2007-11#1)
under investigation for##4##3##(2005-8#1)(2007-8#1)(2008-8#1)(2012-2#1)
under investigation have been##2##4##(2006-5#1)(2006-6#1)
under investigation include##3##3##(2006-11#1)(2008-3#1)(2008-9#1)
under investigation is##3##3##(1991-5#1)(2008-2#1)(2008-7#1)
under investigation using##2##3##(1993-2#1)(1996-5#1)
under investigation##78##2##(1991-5#1)(1991-8#1)(1991-9#1)(1992-5#1)(1993-2#1)(1993-5#1)(1994-5#1)(1995-10#1)(1995-7#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(2004-12#1)(2005-11#1)(2005-6#1)(2005-7#3)(2005-8#1)(2006-10#5)(2006-11#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#2)(2010-12#1)(2010-4#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
under isocratic condition##2##3##(2008-10#1)(2008-5#1)
under isocratic conditions##3##3##(1990-12#1)(1993-2#1)(1996-5#1)
under isocratic##7##2##(1990-12#1)(1993-2#1)(1996-5#1)(2005-12#1)(2008-10#1)(2008-5#1)(2009-10#1)
under isothermal##4##2##(2008-10#2)(2009-7#2)
under its##4##2##(1991-10#1)(1996-12#1)(2006-6#1)(2008-5#1)
under lab conditions##2##3##(2008-10#2)
under laboratory conditions##28##3##(1991-9#1)(2005-12#1)(2007-11#1)(2007-12#1)(2007-3#3)(2007-5#1)(2007-6#3)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#3)(2012-2#2)
under laboratory conditions]##4##3##(2007-3#3)(2008-5#1)
under laboratory##33##2##(1991-9#1)(1994-3#1)(2005-12#1)(2007-11#1)(2007-12#1)(2007-3#6)(2007-5#1)(2007-6#3)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#3)(2012-2#2)
under laminar flow condition##2##4##(2007-8#2)
under laminar##3##2##(2005-11#1)(2007-8#2)
under laparoscopic control##2##3##(2006-6#2)
under large deformation##2##3##(2009-7#2)
under large##6##2##(2006-11#1)(2008-11#1)(2008-6#2)(2009-7#2)
under laser##3##2##(2007-11#1)(2012-2#1)(2013-1#1)
under license from##2##3##(2005-7#1)(2005-8#1)
under light conditions##2##3##(1994-3#1)(2009-8#1)
under light##9##2##(1994-3#1)(1996-5#1)(2008-10#1)(2008-11#1)(2009-6#1)(2009-8#1)(2012-1#1)(2012-3#1)(2013-7#1)
under limited##2##2##(2007-1#1)(2007-12#1)
under limiting##4##2##(1996-8#1)(1997-4#1)(2008-6#1)(2011-10#1)
under liquid##2##2##(2008-1#1)(2009-5#1)
under load##3##2##(2007-8#1)(2008-6#1)(2013-1#1)
under local anaesthesia and##2##4##(1996-12#1)(2007-7#1)
under local anaesthesia##12##3##(1991-11#1)(1991-9#1)(1994-2#1)(1996-12#2)(2007-7#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#2)
under local anesthesia and##4##4##(1992-12#1)(1993-1#1)(1996-12#1)(2007-8#1)
under local anesthesia##21##3##(1991-11#1)(1992-12#5)(1992-3#1)(1992-4#1)(1993-1#1)(1996-12#1)(2006-10#1)(2007-11#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-5#1)(2008-6#1)(2012-3#1)
under local##35##2##(1991-11#2)(1991-9#1)(1992-12#5)(1992-3#1)(1992-4#1)(1993-1#1)(1994-2#1)(1996-12#4)(2006-10#1)(2007-11#1)(2007-7#5)(2007-8#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2011-1#2)(2012-2#1)(2012-3#1)
under long daylengths##2##3##(2012-3#2)
under long##4##2##(2012-3#2)(2013-8#2)
under long-term nicotine treatment##2##4##(1997-5#2)
under long-term##4##2##(1994-2#1)(1997-5#2)(2008-10#1)
under low DO##2##3##(2010-8#2)
under low concentration conditions##2##4##(2008-9#2)
under low concentration##3##3##(1997-1#1)(2008-9#2)
under low light##2##3##(2006-12#1)(2008-2#1)
under low stringency##2##3##(1990-2#1)(1997-4#1)
under low##28##2##(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1991-8#1)(1996-5#1)(1997-1#1)(1997-4#1)(2004-2#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-9#2)(2009-4#1)(2010-8#3)(2013-1#2)
under low-energy##2##2##(2008-2#2)
under low-salt##2##2##(1991-11#1)(2012-12#1)
under lower temperatures##2##3##(2008-10#2)
under lower##5##2##(2006-11#1)(2008-10#2)(2008-9#1)(2013-1#1)
under managed care##5##3##(1995-2#2)(1997-2#2)(1997-3#1)
under managed competition##2##3##(1994-3#1)(1995-1#1)
under managed##9##2##(1994-3#1)(1995-1#2)(1995-2#2)(1997-1#1)(1997-2#2)(1997-3#1)
under many##2##2##(2008-10#1)(2008-8#1)
under marginally sodic##2##3##(2007-10#2)
under maximal stimulation##2##3##(2004-12#1)(2007-4#1)
under measurement##2##2##(2008-2#1)(2008-3#1)
under medical treatment##2##3##(1993-10#1)(1995-3#1)
under medical##5##2##(1991-3#1)(1993-10#1)(1995-3#1)(1996-12#1)(1996-3#1)
under mesophilic conditions##3##3##(2006-8#1)(2011-2#1)(2013-1#1)
under mesophilic##5##2##(2006-8#3)(2011-2#1)(2013-1#1)
under metabolic##2##2##(1991-2#1)(2011-1#1)
under metal-free conditions##2##3##(2010-6#2)
under methanogenic##4##2##(2004-4#2)(2006-8#2)
under microgravity##2##2##(1994-2#1)(1997-2#1)
under microwave irradiation##16##3##(2006-12#1)(2007-10#2)(2007-11#10)(2007-12#1)(2008-10#1)(2013-1#1)
under microwave##19##2##(2006-12#1)(2007-10#2)(2007-11#10)(2007-12#1)(2008-10#1)(2008-5#2)(2011-2#1)(2013-1#1)
under microwaves##2##2##(2006-12#1)(2008-5#1)
under mild conditions and##2##4##(1992-8#1)(2009-12#1)
under mild conditions##20##3##(1990-11#1)(1992-1#1)(1992-8#1)(1996-2#1)(2006-12#1)(2007-10#1)(2007-11#4)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#2)(2010-3#1)(2010-7#1)(2013-8#1)
under mild##26##2##(1990-11#1)(1992-1#1)(1992-8#1)(1996-2#1)(1996-5#2)(2006-12#1)(2007-10#1)(2007-11#4)(2008-10#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2013-8#1)
under moderate##3##2##(1996-5#1)(2008-3#1)(2010-4#1)
under more##5##2##(1995-5#1)(2008-11#2)(2008-2#1)(2008-5#1)
under most conditions##2##3##(2008-8#1)(2008-9#1)
under most##3##2##(2008-5#1)(2008-8#1)(2008-9#1)
under mouth conditions##2##3##(2008-10#2)
under multiple reaction monitoring (MRM)##2##5##(2008-10#1)(2013-8#1)
under multiple reaction monitoring##3##4##(2008-10#1)(2011-1#1)(2013-8#1)
under multiple##5##2##(1997-4#1)(2008-10#1)(2008-9#1)(2011-1#1)(2013-8#1)
under national leprosy eradication programme in Satara district##2##8##(2012-12#2)
under national##3##2##(1995-1#1)(2012-12#2)
under native conditions##4##3##(1995-8#1)(1997-2#1)(2008-7#1)(2011-2#1)
under native##5##2##(1995-8#1)(1996-8#1)(1997-2#1)(2008-7#1)(2011-2#1)
under natural conditions and##3##4##(2008-10#2)(2013-7#1)
under natural conditions in##2##4##(2007-11#1)(2008-9#1)
under natural conditions were##2##4##(1997-6#1)(2008-10#1)
under natural conditions##17##3##(1997-6#1)(2005-11#1)(2007-11#2)(2007-3#1)(2008-10#8)(2008-9#1)(2013-1#2)(2013-7#1)
under natural field conditions##3##4##(2008-10#3)
under natural inoculum pressure##2##4##(2008-10#2)
under natural##32##2##(1997-6#1)(2005-11#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#16)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2013-1#2)(2013-7#1)
under near-physiological conditions##3##3##(1992-9#1)(1997-6#1)(2008-9#1)
under neutral conditions##5##3##(1990-8#1)(1996-10#1)(2007-11#1)(2008-4#1)(2010-11#1)
under neutral##7##2##(1990-8#1)(1996-10#1)(2007-11#1)(2008-4#1)(2010-11#1)(2010-2#1)(2010-3#1)
under nitrogen and##2##3##(1993-2#1)(1997-3#1)
under nitrogen##5##2##(1990-8#1)(1993-2#1)(1997-3#1)(1997-8#1)(2010-4#1)
under no CO(2) supply was##3##5##(2008-11#3)
under no CO(2) supply##4##4##(2008-11#4)
under no##7##2##(2008-11#4)(2008-2#1)(2012-2#1)(2013-8#1)
under no-tillage##3##2##(2013-8#3)
under noise##2##2##(2006-10#1)(2008-6#1)
under non-denaturing conditions##6##3##(1990-6#2)(1993-9#1)(1994-9#1)(1995-3#1)(1997-6#1)
under non-isothermal conditions##2##3##(2011-2#2)
under non-reducing conditions##3##3##(1990-12#1)(1994-12#1)(1995-8#1)
under non-reducing##4##2##(1990-12#1)(1990-2#1)(1994-12#1)(1995-8#1)
under noncollimated illumination##2##3##(2008-2#2)
under nondenaturing conditions##5##3##(1993-3#1)(2008-2#1)(2008-4#3)
under nondenaturing##6##2##(1993-3#1)(2008-2#1)(2008-4#3)(2010-11#1)
under nonreducing conditions##4##3##(1991-6#1)(1991-7#1)(1994-8#1)(2008-4#1)
under nonshock conditions##2##3##(1990-11#2)
under normal and##9##3##(1990-10#1)(1993-11#1)(1994-12#1)(1996-12#1)(2007-12#1)(2008-5#1)(2009-2#1)(2012-12#1)(2013-8#1)
under normal circumstances##3##3##(2005-7#1)(2006-7#1)(2012-3#1)
under normal condition##3##3##(2007-12#1)(2008-11#1)(2008-12#1)
under normal conditions and##4##4##(2005-8#1)(2008-8#1)(2009-3#1)(2010-9#1)
under normal conditions of##2##4##(1995-1#1)(1995-7#1)
under normal conditions##17##3##(1992-8#1)(1994-11#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-7#1)(2005-8#1)(2007-3#1)(2007-9#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-9#1)(2012-2#1)
under normal incidence##3##3##(2007-12#1)(2008-2#1)(2008-7#1)
under normal laboratory##2##3##(2008-5#1)(2013-1#1)
under normal physiological conditions##4##4##(1993-11#1)(1993-4#1)(2011-2#1)(2012-2#1)
under normal physiological##5##3##(1993-11#1)(1993-4#1)(2007-7#1)(2011-2#1)(2012-2#1)
under normal##57##2##(1990-10#1)(1992-11#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-4#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-7#1)(1996-12#1)(2005-7#1)(2005-8#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-7#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
under normoxia##4##2##(2009-9#1)(2010-8#1)(2012-12#2)
under normoxic conditions##4##3##(1992-10#1)(1994-5#1)(1997-4#1)(2011-1#1)
under observation##2##2##(2006-8#1)(2013-8#1)
under occlusion##3##2##(2007-11#1)(2008-5#2)
under one and##2##3##(1992-6#1)(2008-1#1)
under one roof##2##3##(2008-2#1)(2008-6#1)
under one year##3##3##(2012-12#2)(2013-8#1)
under one##10##2##(1992-6#1)(1995-2#1)(1995-8#1)(2008-1#1)(2008-2#1)(2008-6#1)(2010-4#1)(2012-12#2)(2013-8#1)
under optimal conditions for##3##4##(1994-6#1)(2008-10#2)
under optimal conditions##14##3##(1991-5#1)(1992-2#1)(1994-6#1)(1995-8#1)(2008-10#7)(2008-2#1)(2009-7#1)(2013-1#1)
under optimal reaction conditions##2##4##(2008-10#1)(2008-8#1)
under optimal##23##2##(1991-5#1)(1992-2#1)(1994-6#1)(1995-8#2)(1996-7#1)(2007-8#1)(2008-10#10)(2008-2#1)(2008-8#1)(2009-10#1)(2009-7#1)(2009-9#1)(2013-1#1)
under optimised##2##2##(2007-8#1)(2008-10#1)
under optimized conditions##8##3##(1997-5#1)(2006-12#1)(2007-8#1)(2008-10#2)(2009-6#1)(2011-2#1)(2012-1#1)
under optimized##11##2##(1994-2#1)(1997-5#1)(2006-12#1)(2007-8#1)(2008-10#4)(2009-6#1)(2011-2#1)(2012-1#1)
under optimum conditions##10##3##(2008-10#7)(2008-11#1)(2008-3#1)(2013-1#1)
under optimum##12##2##(2008-10#9)(2008-11#1)(2008-3#1)(2013-1#1)
under or##2##2##(2006-12#1)(2008-5#1)
under orchard conditions##2##3##(2008-10#2)
under osmotic stress##8##3##(1992-7#1)(1996-4#1)(2008-4#1)(2008-9#3)(2009-8#1)(2013-7#1)
under other conditions##2##3##(1994-8#1)(1995-12#1)
under other##4##2##(1994-8#1)(1995-12#1)(2007-12#1)(2008-5#1)
under otherwise identical conditions##2##4##(1990-3#1)(1995-2#1)
under otherwise##4##2##(1990-3#1)(1995-2#1)(2007-12#1)(2008-8#1)
under our conditions##4##3##(1990-11#1)(2005-9#2)(2006-6#1)
under our experimental conditions##6##4##(1990-3#1)(1991-10#1)(1991-12#1)(1994-6#2)(2008-8#1)
under our##15##2##(1990-11#1)(1990-3#1)(1991-10#1)(1991-12#1)(1994-6#2)(1995-9#1)(2005-9#2)(2006-6#1)(2006-8#1)(2007-3#1)(2007-8#1)(2008-8#1)(2011-2#1)
under outpatient##2##2##(1990-11#1)(2013-8#1)
under oxidative conditions##2##3##(1995-8#1)(2007-11#1)
under oxidative stress##6##3##(1994-6#1)(1997-8#2)(2005-7#1)(2010-12#1)(2012-1#1)
under oxidative##9##2##(1994-6#1)(1995-8#1)(1997-8#2)(2005-7#1)(2007-11#1)(2008-11#1)(2010-12#1)(2012-1#1)
under oxygen##3##2##(2007-12#1)(2008-11#1)(2008-4#1)
under pH control##2##3##(1997-2#1)(2008-11#1)
under pH##3##2##(1997-2#1)(2008-11#1)(2008-6#1)
under paraxial approximation##2##3##(2008-2#2)
under partial##3##2##(1991-3#1)(2007-5#1)(2008-10#1)
under particular conditions##4##3##(1992-12#2)(2008-4#2)
under particular##6##2##(1990-9#1)(1992-12#2)(1995-9#1)(2008-4#2)
under pathological conditions##6##3##(1996-1#1)(2005-8#1)(2008-11#1)(2008-4#2)(2013-8#1)
under pathophysiological conditions##3##3##(1996-9#1)(2008-8#1)(2011-1#1)
under periodic##3##2##(2007-8#1)(2007-9#1)(2008-2#1)
under persistent##2##2##(1996-12#1)(2008-10#1)
under pharmacological##2##2##(1990-2#1)(2010-12#1)
under phase##4##2##(2007-10#1)(2007-2#1)(2008-5#1)(2013-1#1)
under phosphate-limiting condition##2##3##(2007-12#2)
under photopic##2##2##(2011-2#2)
under physiologic and pathologic conditions##2##5##(1993-12#1)(2007-11#1)
under physiologic and##3##3##(1993-12#1)(1995-2#1)(2007-11#1)
under physiologic conditions##2##3##(1992-7#1)(2009-10#1)
under physiologic##5##2##(1992-7#1)(1993-12#1)(1995-2#1)(2007-11#1)(2009-10#1)
under physiological and pathological conditions##2##5##(1997-2#1)(2008-4#1)
under physiological and pathophysiological conditions##2##5##(2010-11#1)(2011-1#1)
under physiological and##5##3##(1997-2#1)(1997-4#1)(2008-4#1)(2010-11#1)(2011-1#1)
under physiological conditions and##3##4##(2008-1#1)(2008-3#1)(2008-7#1)
under physiological conditions is##3##4##(1994-3#1)(1996-11#1)(1997-4#1)
under physiological conditions##38##3##(1990-12#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-6#1)(1991-7#2)(1992-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-11#2)(1996-4#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-12#1)(2007-2#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-5#3)(2008-7#4)(2008-8#1)(2012-2#1)
under physiological or pathological conditions##2##5##(1996-6#1)(2012-2#1)
under physiological##50##2##(1990-12#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-6#1)(1991-7#2)(1992-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-11#2)(1996-4#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(2006-12#2)(2007-2#1)(2008-1#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#1)(2010-11#1)(2011-1#1)(2012-2#2)
under polychromatic illumination##2##3##(2008-2#2)
under poor##2##2##(2008-10#1)(2008-2#1)
under positive##3##2##(1992-4#1)(1994-11#1)(2008-7#1)
under practical##4##2##(2005-5#1)(2008-7#2)(2011-1#1)
under pre- and post-maximal clenching effort conditions##2##7##(2010-9#2)
under predation##2##2##(2007-12#1)(2008-8#1)
under present##2##2##(2011-1#1)(2012-2#1)
under pressure and the##2##4##(2005-12#1)(2010-5#1)
under pressure and##3##3##(2005-12#1)(2008-11#1)(2010-5#1)
under pressure to##2##3##(1994-3#1)(2005-12#1)
under pressure was##2##3##(2005-12#1)(2007-8#1)
under pressure##25##2##(1990-3#1)(1992-1#1)(1992-12#2)(1994-3#1)(1995-2#3)(2005-11#1)(2005-12#5)(2005-8#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-11#2)(2009-5#1)(2010-2#1)(2010-5#1)(2012-12#1)(2013-1#1)
under prolonged##2##2##(1994-5#1)(2008-5#1)
under proper##2##2##(2008-10#1)(2008-11#1)
under prospective##2##2##(1993-1#1)(2012-12#1)
under pseudo-first order conditions##2##4##(2008-10#1)(2008-5#1)
under pulsed##3##2##(2007-11#2)(2007-12#1)
under quiescent conditions##2##3##(2005-11#1)(2008-7#1)
under real conditions##2##3##(2008-10#1)(2008-2#1)
under real##7##2##(2006-10#2)(2008-10#2)(2008-2#2)(2008-8#1)
under realistic conditions##2##3##(2008-2#1)(2008-3#1)
under realistic##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2012-1#2)
under reduced ambient pressure##2##4##(2006-12#2)
under reduced oxygen conditions##2##4##(2006-9#2)
under reduced oxygen##3##3##(2006-9#2)(2008-10#1)
under reduced pressure and##2##4##(2008-10#1)(2008-11#1)
under reduced pressure##5##3##(1992-2#1)(2008-10#1)(2008-11#2)(2013-7#1)
under reduced##14##2##(1992-2#1)(2006-12#2)(2006-9#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-7#1)(2013-1#1)(2013-7#1)
under reducing conditions and##2##4##(1990-11#1)(1995-8#1)
under reducing conditions##19##3##(1990-11#1)(1990-12#2)(1990-5#2)(1991-6#1)(1991-7#1)(1992-12#1)(1993-3#1)(1994-12#1)(1995-5#1)(1995-8#2)(1995-9#1)(1997-2#2)(1997-8#1)(2008-1#1)(2008-10#1)
under reducing##20##2##(1990-11#1)(1990-12#2)(1990-5#2)(1991-6#1)(1991-7#1)(1992-12#1)(1993-3#1)(1994-12#1)(1995-5#1)(1995-8#2)(1995-9#1)(1997-2#2)(1997-8#1)(2008-1#1)(2008-10#1)(2009-4#1)
under reductive conditions##4##3##(1995-5#1)(2008-3#2)(2010-4#1)
under reflux##2##2##(2007-11#1)(2008-10#1)
under refrigeration##4##2##(2005-11#1)(2011-2#1)(2012-12#2)
under regional##4##2##(1992-11#1)(2006-1#1)(2006-10#1)(2010-7#1)
under regular##4##2##(2008-5#2)(2012-12#2)
under repeated##3##2##(2008-7#1)(2010-4#1)(2013-7#1)
under reported##2##2##(2006-10#1)(2007-2#1)
under researched##2##2##(2011-2#2)
under resonance conditions##4##3##(2007-12#4)
under resting and##2##3##(1996-7#1)(2009-12#1)
under resting conditions##3##3##(2007-10#1)(2008-4#1)(2008-8#1)
under resting##5##2##(1996-7#1)(2007-10#1)(2008-4#1)(2008-8#1)(2009-12#1)
under restricted##2##2##(2008-10#1)(2008-5#1)
under review##13##2##(1991-11#1)(1993-12#1)(2005-7#1)(2005-8#2)(2006-10#5)(2007-11#1)(2007-9#1)(2010-3#1)
under rice-wheat system##2##3##(2008-12#2)
under risk##3##2##(2009-10#2)(2013-1#1)
under rotating magnetic fields##2##4##(2005-11#2)
under rotating##3##2##(2005-11#2)(2009-7#1)
under routine##2##2##(1997-2#1)(2008-10#1)
under salinity##2##2##(1997-6#1)(2008-11#1)
under salt stress##3##3##(2008-11#1)(2008-12#1)(2009-8#1)
under salt##5##2##(2008-11#1)(2008-12#1)(2009-10#1)(2009-6#1)(2009-8#1)
under scrutiny##10##2##(1991-7#1)(1993-5#1)(1994-6#1)(1997-3#1)(2006-10#1)(2006-6#1)(2008-8#1)(2012-12#1)(2013-1#2)
under sedation##3##2##(2007-2#1)(2011-2#1)(2013-1#1)
under selection for##3##3##(2008-4#1)(2008-8#2)
under selection pressure##2##3##(1997-4#1)(2008-6#1)
under selection##8##2##(1997-4#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#3)(2010-4#1)
under selective##4##2##(1996-7#1)(2008-10#1)(2008-2#1)(2011-2#1)
under semi-controlled conditions##4##3##(2008-5#4)
under semi-natural conditions##2##3##(2008-7#1)(2010-8#1)
under septic##2##2##(1994-11#1)(2008-11#1)
under serum free conditions##2##4##(1990-5#1)(2008-11#1)
under serum-free conditions##8##3##(1992-12#1)(1992-8#1)(1993-3#1)(2007-6#1)(2008-11#3)(2008-7#1)
under serum-free##11##2##(1992-12#1)(1992-8#1)(1993-3#1)(1995-11#1)(2007-6#1)(2008-11#5)(2008-7#1)
under several conditions##3##3##(1996-9#1)(2006-12#1)(2007-11#1)
under several different##4##3##(1994-12#1)(2008-10#1)(2008-11#2)
under several##14##2##(1994-12#1)(1996-9#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2013-1#1)
under severe##3##2##(2006-12#1)(2007-12#1)(2008-2#1)
under shear##2##2##(1990-12#1)(2005-11#1)
under short-term##2##2##(1997-3#1)(2008-10#1)
under shorter##2##2##(2008-8#1)(2013-8#1)
under significant##2##2##(2006-6#1)(2010-8#1)
under similar conditions as##2##4##(2006-11#1)(2008-10#1)
under similar conditions##19##3##(1990-9#1)(1991-10#1)(1991-3#1)(1992-1#1)(1994-8#1)(1995-2#1)(2004-8#1)(2006-11#1)(2007-11#1)(2008-10#6)(2008-5#1)(2009-6#1)(2009-7#1)(2010-7#1)
under similar experimental conditions##2##4##(2008-11#1)(2008-4#1)
under similar reaction conditions##2##4##(1996-5#1)(2006-4#1)
under similar##30##2##(1990-9#1)(1991-10#1)(1991-2#1)(1991-3#2)(1992-1#1)(1994-8#1)(1995-2#1)(1996-5#1)(2004-8#1)(2006-11#3)(2006-4#1)(2006-6#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-6#1)(2009-7#1)(2010-7#1)
under simulated physiological conditions##2##4##(1997-4#1)(2009-7#1)
under simulated##6##2##(1997-4#1)(2008-10#1)(2008-9#1)(2009-7#1)(2010-4#1)(2013-7#1)
under single-turnover conditions ([E] &gt##2##5##(1995-10#2)
under six years##2##3##(2011-1#1)(2012-2#1)
under six##6##2##(2008-10#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
under slightly##2##2##(1994-3#1)(2010-7#1)
under snow cover##2##3##(2008-10#2)
under sodium##2##2##(2008-10#1)(2012-3#1)
under solvent-free conditions##4##3##(2007-10#1)(2007-11#2)(2008-5#1)
under some circumstances##4##3##(1997-2#1)(2006-10#1)(2008-2#1)(2010-10#1)
under some conditions##6##3##(1991-5#1)(1992-3#1)(1996-10#1)(2008-9#1)(2009-8#1)(2010-5#1)
under some##13##2##(1991-5#1)(1992-3#1)(1996-10#1)(1997-2#1)(2006-10#1)(2008-2#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2012-1#1)
under spatially##2##2##(2006-10#1)(2008-8#1)
under special conditions##2##3##(1996-2#1)(2007-9#1)
under special##3##2##(1996-2#1)(2005-11#1)(2007-9#1)
under specific conditions##7##3##(1995-12#1)(1996-5#1)(1996-8#1)(2007-11#1)(2008-11#1)(2008-6#1)(2011-3#1)
under specific##14##2##(1992-10#1)(1995-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-3#1)(2012-12#1)
under specified conditions##2##3##(2008-10#1)(2011-1#1)
under sperm-limited conditions##3##3##(2008-8#3)
under spherical illumination##2##3##(2008-2#2)
under spinal anaesthesia##3##3##(2011-1#1)(2011-12#2)
under spinal anesthesia is##2##4##(2013-7#2)
under spinal anesthesia##7##3##(1996-12#1)(2012-12#1)(2013-7#5)
under spinal##10##2##(1996-12#1)(2011-1#1)(2011-12#2)(2012-12#1)(2013-7#5)
under stable conditions##2##3##(1997-8#1)(2008-5#1)
under stable##3##2##(1995-11#1)(1997-8#1)(2008-5#1)
under standard assay conditions##3##4##(1990-3#1)(1991-2#1)(1992-4#1)
under standard conditions##9##3##(1993-12#1)(1995-1#1)(1995-8#1)(2006-12#2)(2007-12#1)(2007-6#1)(2008-11#1)(2008-7#1)
under standard growth conditions##3##4##(2006-12#1)(2009-8#1)(2012-3#1)
under standard##24##2##(1990-3#1)(1990-7#1)(1990-8#1)(1991-2#1)(1992-4#1)(1993-12#1)(1994-11#1)(1995-1#1)(1995-8#1)(1996-4#1)(2006-12#3)(2007-12#1)(2007-6#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-8#1)(2012-3#1)(2013-8#1)
under standardized conditions##2##3##(1991-12#1)(2009-3#1)
under standardized##3##2##(1991-12#2)(2009-3#1)
under static conditions##5##3##(1990-12#2)(2005-11#1)(2007-4#1)(2008-4#1)
under static##8##2##(1990-12#2)(1992-12#1)(1997-4#1)(2005-11#1)(2007-4#1)(2008-4#1)(2008-7#1)
under stationary conditions##2##3##(2008-10#1)(2008-7#1)
under stationary##3##2##(2008-10#2)(2008-7#1)
under steady state##3##3##(1990-12#1)(1994-5#1)(2008-10#1)
under steady-state conditions in##3##4##(1997-2#1)(2007-3#1)(2011-2#1)
under steady-state conditions##6##3##(1991-1#1)(1994-5#1)(1997-1#1)(1997-2#1)(2007-3#1)(2011-2#1)
under steady-state##8##2##(1990-5#1)(1991-1#1)(1994-5#1)(1995-10#1)(1997-1#1)(1997-2#1)(2007-3#1)(2011-2#1)
under sterile conditions##3##3##(1990-12#1)(2008-11#1)(2008-8#1)
under sterile##5##2##(1990-12#1)(1992-8#2)(2008-11#1)(2008-8#1)
under steroid##2##2##(1994-12#1)(2009-4#1)
under stress conditions##7##3##(1995-12#1)(2007-8#1)(2009-6#1)(2009-8#2)(2012-2#1)(2013-7#1)
under stress##13##2##(1992-3#1)(1995-12#1)(1995-2#1)(2007-12#1)(2007-8#1)(2008-6#1)(2009-3#1)(2009-6#1)(2009-8#3)(2012-2#1)(2013-7#1)
under stressful conditions##3##3##(2009-6#1)(2012-3#2)
under strict##6##2##(1990-11#1)(2007-9#1)(2008-6#1)(2008-8#1)(2009-10#1)(2012-3#1)
under strictly controlled conditions##3##4##(2008-12#1)(2008-5#1)(2010-1#1)
under strictly##5##2##(1992-12#1)(1995-11#1)(2008-12#1)(2008-5#1)(2010-1#1)
under stringent##3##2##(1991-12#1)(1992-4#1)(2009-7#1)
under strong##8##2##(1993-3#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-2#1)(2010-8#1)(2013-1#1)
under study are##3##3##(2009-9#1)(2010-12#1)(2011-2#1)
under study for##2##3##(2004-12#1)(2009-10#1)
under study in the##2##4##(2005-7#1)(2008-10#1)
under study in##4##3##(2005-7#1)(2008-10#2)(2012-2#1)
under study is##5##3##(1994-5#1)(2007-10#1)(2008-2#1)(2008-3#2)
under study to be##2##4##(2007-8#1)(2008-10#1)
under study to##3##3##(2005-11#1)(2007-8#1)(2008-10#1)
under study was comprised of##2##5##(2008-10#2)
under study were##5##3##(1990-10#1)(2005-11#2)(2008-10#2)
under study##72##2##(1990-10#2)(1990-8#1)(1991-9#1)(1992-3#1)(1993-6#1)(1994-3#1)(1994-5#1)(1997-2#1)(1997-7#1)(1997-8#4)(2004-11#1)(2004-12#1)(2005-11#3)(2005-7#1)(2005-8#1)(2006-10#1)(2007-10#2)(2007-12#1)(2007-5#2)(2007-8#2)(2008-1#2)(2008-10#19)(2008-2#2)(2008-3#5)(2008-4#1)(2009-10#1)(2009-3#1)(2009-8#1)(2009-9#2)(2010-12#2)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
under subpicosecond##2##2##(2008-1#1)(2008-3#1)
under subsurface drip irrigation##6##4##(2008-10#6)
under subsurface-drip irrigation##2##3##(2008-10#2)
under such circumstances##3##3##(1990-12#1)(2007-11#1)(2011-12#1)
under such conditions##3##3##(1992-10#1)(1994-4#1)(2011-1#1)
under such##9##2##(1990-12#1)(1992-10#1)(1994-4#1)(2006-12#1)(2007-11#1)(2009-10#1)(2011-1#1)(2011-12#2)
under suitable conditions##2##3##(2007-11#1)(2008-10#1)
under suitable##4##2##(1995-10#1)(2007-11#1)(2008-10#2)
under sun and##2##3##(2007-3#2)
under sun##3##2##(2007-3#3)
under sunlight##3##2##(1994-3#3)
under supervision##3##2##(2007-4#1)(2007-7#1)(2012-2#1)
under suspicion##2##2##(1990-8#1)(2007-8#1)
under symmetrical##2##2##(1994-11#1)(2007-12#1)
under tension##6##2##(2005-11#1)(2007-12#1)(2007-7#1)(2008-7#1)(2011-12#1)(2011-2#1)
under test and##2##3##(2008-3#2)
under test in##2##3##(2008-2#2)
under test is##2##3##(2007-12#1)(2008-3#1)
under test##17##2##(1991-12#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#8)
under that##2##2##(1991-2#1)(2013-7#1)
under the 10th centile##2##4##(1990-12#1)(1992-1#1)
under the ADA##4##3##(1995-6#1)(1996-11#1)(1996-5#1)(1997-5#1)
under the Americans with Disabilities Act (ADA)##8##7##(1995-12#3)(1996-11#1)(1996-12#1)(1996-6#1)(1997-5#2)
under the Americans with Disabilities Act##9##6##(1995-12#4)(1996-11#1)(1996-12#1)(1996-6#1)(1997-5#2)
under the Americans##10##3##(1995-12#4)(1996-11#1)(1996-12#1)(1996-6#1)(1997-5#2)(2004-9#1)
under the Boren Amendment##2##4##(1993-12#2)
under the C##2##3##(1996-7#1)(2011-1#1)
under the DNL condition##2##4##(2008-3#2)
under the European##2##3##(2008-10#1)(2008-12#1)
under the Health Care Quality Improvement Act##3##7##(1991-1#1)(1991-3#1)(1994-1#1)
under the Health##4##3##(1991-1#1)(1991-3#1)(1994-1#1)(2006-8#1)
under the Israeli##2##3##(2008-7#1)(2013-7#1)
under the Medicare fee schedule##2##5##(1994-1#2)
under the Medicare program##4##4##(1991-1#1)(1994-3#1)(1995-1#1)(1997-3#1)
under the Medicare##8##3##(1991-1#1)(1991-2#1)(1993-12#1)(1994-1#2)(1994-3#1)(1995-1#1)(1997-3#1)
under the Mental Health Act##2##5##(2010-1#1)(2013-1#1)
under the Ministry of Health##2##5##(2005-11#1)(2007-7#1)
under the Ministry of##4##4##(1990-9#1)(2005-11#1)(2007-7#1)(2012-2#1)
under the National##3##3##(1994-2#1)(2008-7#1)(2009-4#1)
under the Portuguese Empire##2##4##(2009-10#2)
under the ROC curve##11##4##(2007-8#1)(2008-10#1)(2008-2#1)(2010-2#1)(2010-8#1)(2010-9#1)(2012-1#2)(2013-1#3)
under the ROC##13##3##(1992-2#1)(2007-8#2)(2008-10#1)(2008-2#1)(2010-2#1)(2010-8#1)(2010-9#1)(2012-1#2)(2013-1#3)
under the SNL condition##3##4##(2008-3#3)
under the Tax Equity and Fiscal Responsibility Act (TEFRA) of 1982 (Public Law 97-248)##2##14##(1993-12#1)(1994-3#1)
under the United##2##3##(2009-11#1)(2012-2#1)
under the action of a##3##5##(2007-12#1)(2008-10#1)(2008-3#1)
under the action of##8##4##(2006-7#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2011-2#1)
under the aegis of the##3##5##(1990-6#1)(1993-9#1)(2008-9#1)
under the age of 17##2##5##(1993-4#1)(2005-9#1)
under the age of 18##3##5##(1990-5#1)(1997-1#1)(2008-12#1)
under the age of 3##2##5##(2009-5#1)(2011-2#1)
under the age of 45##2##5##(1991-12#1)(2005-8#1)
under the age of 5##2##5##(2010-6#1)(2011-2#1)
under the age of##24##4##(1990-5#1)(1991-10#1)(1991-12#2)(1992-2#1)(1993-12#1)(1993-4#1)(1995-12#1)(1997-1#1)(2005-8#2)(2005-9#1)(2007-2#2)(2007-3#1)(2007-7#1)(2008-12#1)(2008-9#1)(2009-5#1)(2010-6#1)(2011-12#1)(2011-2#2)(2012-2#1)
under the agro-climatic##2##3##(2008-12#2)
under the alternative hypothesis##2##4##(1992-6#1)(2012-2#1)
under the alternative##3##3##(1992-6#1)(2012-2#1)(2013-1#1)
under the assay conditions##2##4##(1993-11#1)(2008-9#1)
under the assumption of##4##4##(1997-7#1)(2008-10#1)(2008-11#1)(2013-8#1)
under the assumption that a##2##5##(1995-9#1)(2008-12#1)
under the assumption that the##6##5##(2008-2#1)(2008-5#1)(2008-7#1)(2009-5#1)(2013-8#2)
under the assumption that##10##4##(1993-12#1)(1995-9#1)(2007-3#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-5#1)(2013-8#2)
under the assumption##14##3##(1993-12#1)(1995-9#1)(1997-7#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-5#1)(2013-8#3)
under the assumptions##2##3##(1993-9#1)(2008-2#1)
under the auspices of the Better Beginnings##2##7##(1995-3#2)
under the auspices of the World Health Organization##2##8##(2006-10#2)
under the auspices of the##10##5##(1992-4#1)(1994-12#1)(1994-2#1)(1995-3#2)(2006-10#2)(2007-5#1)(2008-10#1)(2008-11#1)
under the auspices of##12##4##(1992-4#1)(1994-12#1)(1994-2#1)(1995-3#2)(1996-2#1)(2006-10#2)(2007-5#1)(2008-10#1)(2008-11#1)(2011-1#1)
under the auspices##13##3##(1992-4#1)(1994-12#1)(1994-2#1)(1995-3#2)(1996-2#1)(2006-10#2)(2007-5#1)(2008-10#1)(2008-11#1)(2011-1#1)(2013-7#1)
under the best##2##3##(2007-8#1)(2010-12#1)
under the brand name##3##4##(1997-7#1)(2006-10#1)(2009-8#1)
under the capsule##2##3##(2008-11#2)
under the care of##3##4##(2007-7#1)(2008-6#1)(2012-12#1)
under the category of##2##4##(2007-6#1)(2008-5#1)
under the combined application of organic and inorganic fertilizers##2##9##(2013-8#2)
under the combined##4##3##(2012-1#1)(2013-8#3)
under the common law##2##4##(1995-12#1)(2004-12#1)
under the concentration-time curve##3##4##(1995-2#1)(2008-7#1)(2011-1#1)
under the condition of##6##4##(1996-6#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
under the condition that##3##4##(2005-4#1)(2008-1#1)(2008-2#1)
under the condition##9##3##(1996-6#1)(2005-11#1)(2005-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)
under the conditions described##2##4##(1996-11#1)(2006-6#1)
under the conditions employed##5##4##(1994-9#1)(1995-10#1)(1997-7#1)(2008-10#2)
under the conditions of nitric oxide synthesis##2##7##(2013-1#2)
under the conditions of these experiments##2##6##(1990-7#1)(1993-3#1)
under the conditions of this##2##5##(1990-6#1)(1995-2#1)
under the conditions of##21##4##(1990-6#1)(1990-7#1)(1993-3#1)(1993-8#1)(1995-2#1)(1995-3#1)(2006-12#2)(2008-10#4)(2008-3#1)(2009-2#1)(2010-12#1)(2010-7#1)(2012-12#1)(2013-1#2)(2013-8#2)
under the conditions used##6##4##(1991-2#1)(1992-9#1)(1994-9#1)(1996-2#1)(1997-1#1)(2009-12#1)
under the conditions when##2##4##(1990-8#1)(2008-11#1)
under the conditions##42##3##(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-2#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-9#2)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-7#1)(2006-12#2)(2006-6#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-7#2)(2009-12#1)(2009-2#1)(2010-12#1)(2010-7#1)(2012-12#1)(2013-1#2)(2013-8#2)
under the control of a constitutive##2##6##(2006-11#1)(2008-10#1)
under the control of a##15##5##(1990-12#1)(1990-7#1)(1991-9#1)(1992-10#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-4#1)(1997-4#1)(2006-11#1)(2006-12#1)(2008-10#1)
under the control of either the##3##6##(1994-11#1)(1994-8#1)(1997-4#1)
under the control of either##4##5##(1994-11#1)(1994-8#1)(1997-4#1)(2010-12#1)
under the control of its own promoter##2##7##(1995-2#1)(2008-10#1)
under the control of its##3##5##(1995-2#1)(2007-9#1)(2008-10#1)
under the control of several##2##5##(2006-10#1)(2008-7#1)
under the control of the cauliflower mosaic virus 35S promoter##3##10##(1997-4#1)(2008-10#1)(2008-5#1)
under the control of the cauliflower mosaic virus##4##8##(1997-4#1)(2008-10#2)(2008-5#1)
under the control of the lac promoter##4##7##(1990-10#1)(1992-3#1)(1995-2#1)(2008-10#1)
under the control of the polyhedrin promoter of##2##8##(1994-11#1)(1997-4#1)
under the control of the tac promoter##2##7##(1995-1#2)
under the control of the tac##3##6##(1995-1#2)(1995-8#1)
under the control of the##52##5##(1990-10#2)(1990-4#1)(1991-12#2)(1992-3#1)(1992-8#1)(1993-12#2)(1993-4#1)(1993-5#3)(1993-6#1)(1994-11#1)(1994-12#2)(1995-1#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-8#1)(1997-1#1)(1997-4#3)(1997-5#2)(2006-12#3)(2007-9#1)(2008-10#7)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2013-7#1)
under the control of two##3##5##(1990-12#1)(1994-2#1)(1995-5#1)
under the control of various##2##5##(1994-2#1)(1996-5#1)
under the control of##131##4##(1990-10#2)(1990-12#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-5#3)(1993-6#3)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#2)(1995-12#3)(1995-2#3)(1995-5#2)(1995-6#2)(1995-8#3)(1996-11#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-4#9)(1997-5#2)(1997-6#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-12#7)(2007-11#1)(2007-9#2)(2008-10#10)(2008-11#5)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#4)(2009-2#1)(2009-8#1)(2010-12#2)(2010-2#1)(2011-2#1)(2013-7#1)(2013-8#1)
under the control##134##3##(1990-10#2)(1990-12#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-5#3)(1993-6#3)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#2)(1995-12#3)(1995-2#3)(1995-5#2)(1995-6#2)(1995-8#3)(1996-11#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-4#9)(1997-5#2)(1997-6#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-12#7)(2006-6#1)(2007-11#1)(2007-9#2)(2008-10#10)(2008-11#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#4)(2009-2#1)(2009-8#1)(2010-12#2)(2010-2#1)(2011-2#1)(2013-7#1)(2013-8#1)
under the current##4##3##(1997-1#1)(2006-8#1)(2009-7#1)(2010-8#1)
under the curve (AUC)##8##4##(1994-12#1)(1996-6#1)(2004-1#1)(2008-11#1)(2008-5#1)(2011-1#1)(2012-12#1)(2012-3#1)
under the curve 0##2##4##(2007-8#2)
under the curve for##2##4##(2008-10#1)(2012-12#1)
under the curve of 0##2##5##(2012-3#1)(2013-1#1)
under the curve of##7##4##(2005-8#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
under the curve##41##3##(1992-9#1)(1993-11#1)(1994-12#2)(1996-1#1)(1996-6#1)(2004-1#1)(2005-8#1)(2006-10#1)(2006-7#2)(2007-10#1)(2007-2#1)(2007-8#3)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#1)
under the diagnosis of##2##4##(1991-8#1)(2007-12#1)
under the different conditions##2##4##(1993-11#1)(2008-10#1)
under the different##4##3##(1993-11#1)(2004-4#1)(2008-10#2)
under the direct control of##2##5##(1995-9#1)(2012-2#1)
under the direct##3##3##(1995-9#1)(2006-11#1)(2012-2#1)
under the direction of##3##4##(1991-3#1)(2006-10#1)(2007-8#1)
under the direction##4##3##(1991-3#1)(2006-10#1)(2007-8#1)(2008-2#1)
under the disease progress curve (AUDPC)##10##6##(2008-10#10)
under the disease progress curve and##3##6##(2008-10#3)
under the disease progress curve##21##5##(2008-10#21)
under the disease progress##23##4##(2008-10#23)
under the effect of cocaine##2##5##(2013-8#2)
under the effect of##13##4##(1994-11#1)(2007-8#1)(2008-4#1)(2010-12#1)(2012-1#5)(2012-2#1)(2013-8#3)
under the electron microscope##2##4##(1990-5#1)(2008-7#1)
under the excitation##3##3##(1990-5#1)(2008-10#1)(2013-8#1)
under the experimental conditions used##2##5##(1990-2#1)(1994-12#1)
under the experimental conditions##5##4##(1990-2#1)(1994-12#1)(2008-10#3)
under the extreme conditions##2##4##(1996-5#1)(2008-10#1)
under the federal##3##3##(1993-1#1)(2007-2#1)(2007-4#1)
under the first##3##3##(1992-6#1)(2010-2#1)(2012-2#1)
under the following conditions##5##4##(1995-2#1)(1996-5#1)(2008-5#2)(2008-6#1)
under the following optimized reaction conditions##2##6##(2008-5#2)
under the following optimized##3##4##(2008-10#1)(2008-5#2)
under the following##11##3##(1995-2#1)(1996-5#1)(2007-7#1)(2008-10#2)(2008-5#4)(2008-6#1)(2010-12#1)
under the framework of##2##4##(2008-2#1)(2012-3#1)
under the general##2##3##(1990-8#1)(2008-4#1)
under the generic term &quot##2##5##(2007-2#1)(2012-2#1)
under the guidance of##5##4##(2007-4#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-8#1)
under the heading of##5##4##(2006-3#1)(2008-11#1)(2009-9#1)(2010-7#1)(2013-1#1)
under the heading##6##3##(2006-3#1)(2007-7#1)(2008-11#1)(2009-9#1)(2010-7#1)(2013-1#1)
under the headings##4##3##(1991-12#1)(1996-3#1)(2007-4#1)(2008-11#1)
under the high##2##3##(2007-8#1)(2011-1#1)
under the hypothetical##2##3##(2005-4#1)(2009-5#1)
under the influence of a##2##5##(1990-12#1)(2005-11#1)
under the influence of alcohol or drugs##3##7##(2007-10#1)(2011-1#1)(2013-8#1)
under the influence of alcohol##10##5##(1991-9#1)(1995-8#1)(2005-8#1)(2005-9#1)(2007-10#1)(2008-7#1)(2009-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
under the influence of an electric field##2##7##(1993-12#1)(2010-2#1)
under the influence of an##3##5##(1993-12#1)(2008-3#1)(2010-2#1)
under the influence of moisture##2##5##(2008-10#2)
under the influence of psilocybin##3##5##(2013-8#3)
under the influence of the##5##5##(1990-12#1)(1993-3#1)(1996-4#1)(1997-7#1)(2008-10#1)
under the influence of##54##4##(1990-11#1)(1990-12#2)(1991-9#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-7#1)(1994-9#1)(1995-8#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-4#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-12#1)(2006-5#1)(2007-10#2)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#4)
under the influence##55##3##(1990-11#1)(1990-12#2)(1991-9#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-7#1)(1994-9#1)(1995-8#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-4#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-12#1)(2006-5#1)(2007-10#2)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#4)
under the kidney##3##3##(2008-11#2)(2008-4#1)
under the law##3##3##(1996-11#1)(2005-11#2)
under the light##2##3##(1991-10#1)(2008-8#1)
under the low##2##3##(1994-3#1)(2013-1#1)
under the lowest##2##3##(2008-10#1)(2012-2#1)
under the microscope##2##3##(2005-5#1)(2008-7#1)
under the more##3##3##(1990-10#1)(2009-10#1)(2010-2#1)
under the name of##4##4##(2008-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
under the name##7##3##(2007-3#1)(2007-5#1)(2008-10#2)(2011-1#1)(2011-2#1)(2013-8#1)
under the new##4##3##(1992-12#1)(1992-2#1)(2006-1#1)(2011-2#1)
under the null hypothesis##3##4##(2012-3#1)(2013-1#2)
under the null##4##3##(2010-3#1)(2012-3#1)(2013-1#2)
under the operating microscope##2##4##(2007-1#1)(2011-2#1)
under the operating##3##3##(2006-5#1)(2007-1#1)(2011-2#1)
under the optimal conditions##4##4##(2008-10#4)
under the optimal##7##3##(2005-11#1)(2008-10#5)(2008-4#1)
under the optimized conditions##7##4##(2004-12#1)(2008-10#3)(2011-1#1)(2013-1#1)(2013-7#1)
under the optimized##8##3##(2004-12#1)(2008-10#4)(2011-1#1)(2013-1#1)(2013-7#1)
under the optimum allocation##2##4##(1992-2#2)
under the optimum conditions##4##4##(2008-10#4)
under the optimum##9##3##(1992-2#2)(2008-10#7)
under the plasma concentration time curve##2##6##(1996-11#1)(2004-12#1)
under the plasma concentration##3##4##(1991-12#1)(1996-11#1)(2004-12#1)
under the plasma membrane##3##4##(1993-4#1)(1995-8#1)(1997-6#1)
under the plasma##10##3##(1991-12#1)(1993-4#1)(1995-8#1)(1996-11#1)(1996-5#1)(1997-6#1)(2004-12#1)(2008-5#1)(2008-8#2)
under the present experimental##2##4##(2008-10#1)(2008-5#1)
under the present##5##3##(1990-8#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-8#1)
under the proposed##2##3##(1995-2#1)(2008-10#1)
under the prospective payment system##2##5##(1992-12#1)(1993-1#1)
under the protocol##2##3##(1996-11#1)(2005-11#1)
under the provisions of the##2##5##(1991-1#1)(2005-5#1)
under the purview of##2##4##(2012-1#1)(2013-1#1)
under the reaction conditions##2##4##(2005-7#1)(2008-10#1)
under the receiver operating characteristic curve##4##6##(2006-6#1)(2010-2#2)(2012-2#1)
under the receiver operating curve##3##5##(2008-3#1)(2012-3#1)(2013-1#1)
under the receiver operating##8##4##(2006-6#1)(2007-8#1)(2008-3#1)(2010-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
under the regulatory control of##2##5##(1994-11#1)(2006-8#1)
under the responsibility of the##2##5##(2008-4#1)(2011-1#1)
under the responsibility of##3##4##(2008-11#1)(2008-4#1)(2011-1#1)
under the right##2##3##(2006-8#1)(2010-3#1)
under the rubric of##2##4##(2008-11#1)(2008-5#1)
under the rule##2##3##(2006-7#1)(2009-2#1)
under the same chromatographic conditions##2##5##(2008-10#2)
under the same condition##2##4##(1991-5#1)(1994-9#1)
under the same conditions as##4##5##(1992-7#1)(1992-8#1)(1996-2#1)(2008-5#1)
under the same conditions used##2##5##(1992-2#1)(2008-10#1)
under the same conditions##37##4##(1990-2#1)(1990-4#1)(1991-3#2)(1991-4#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-6#1)(1995-10#1)(1995-2#1)(1995-5#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#2)(2004-9#1)(2006-5#1)(2008-10#7)(2008-12#1)(2008-5#1)(2009-4#1)(2009-5#1)(2010-4#1)(2011-2#1)(2013-8#2)
under the same environmental conditions##3##5##(1993-7#1)(1994-6#1)(2008-10#1)
under the same experimental conditions##12##5##(1990-10#1)(1990-8#2)(1997-2#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-5#1)(2010-12#1)
under the same experimental##14##4##(1990-10#1)(1990-8#2)(1997-2#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-12#1)
under the same##68##3##(1990-10#1)(1990-2#1)(1990-4#1)(1990-8#2)(1991-12#1)(1991-3#2)(1991-4#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-5#1)(1995-8#3)(1996-11#1)(1996-12#1)(1996-2#2)(1997-2#1)(2004-9#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-4#2)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#2)
under the skin##4##3##(2007-7#1)(2008-3#1)(2008-8#1)(2010-7#1)
under the sponsorship of the##2##5##(2005-12#1)(2007-1#1)
under the statute##3##3##(1993-1#2)(2006-7#1)
under the stress of##2##4##(2004-11#1)(2013-8#1)
under the stress##3##3##(2004-11#1)(2009-6#1)(2013-8#1)
under the strong##2##3##(2008-5#1)(2012-3#1)
under the supervision of a##2##5##(2006-2#1)(2012-12#1)
under the supervision of##3##4##(2006-2#1)(2006-8#1)(2012-12#1)
under the surface##2##3##(1991-9#1)(2005-11#1)
under the term &quot##2##4##(1994-3#1)(2013-7#1)
under the term##3##3##(1994-3#1)(2011-2#1)(2013-7#1)
under the three##2##3##(2008-10#1)(2008-2#1)
under the tissue##2##3##(1994-11#1)(2007-3#1)
under the transcriptional control of##3##5##(1993-12#1)(1995-2#1)(2011-2#1)
under the treatment##2##3##(1990-3#1)(2008-8#1)
under the two##3##3##(1997-1#1)(2008-10#1)(2008-8#1)
under the umbrella of##7##4##(2008-1#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2011-2#1)
under the umbrella##8##3##(2006-10#1)(2008-1#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2011-2#1)
under the zygomatic arch##2##4##(2007-12#2)
under the##1060##2##(1990-1#1)(1990-10#4)(1990-11#1)(1990-12#7)(1990-2#6)(1990-3#2)(1990-4#3)(1990-5#5)(1990-6#2)(1990-7#3)(1990-8#9)(1990-9#1)(1991-1#4)(1991-10#3)(1991-11#1)(1991-12#8)(1991-2#5)(1991-3#6)(1991-4#2)(1991-5#3)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#3)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#6)(1992-3#4)(1992-4#2)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#4)(1993-10#1)(1993-11#3)(1993-12#15)(1993-3#4)(1993-4#3)(1993-5#3)(1993-6#6)(1993-7#1)(1993-8#2)(1993-9#4)(1994-1#3)(1994-11#5)(1994-12#10)(1994-2#4)(1994-3#8)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#3)(1994-9#9)(1995-1#3)(1995-10#2)(1995-11#3)(1995-12#11)(1995-2#9)(1995-3#7)(1995-5#3)(1995-6#6)(1995-8#8)(1995-9#2)(1996-1#3)(1996-11#10)(1996-12#4)(1996-2#5)(1996-3#3)(1996-4#3)(1996-5#5)(1996-6#4)(1996-7#2)(1996-8#1)(1997-1#8)(1997-2#3)(1997-3#2)(1997-4#14)(1997-5#7)(1997-6#2)(1997-7#5)(2004-1#1)(2004-11#1)(2004-12#3)(2004-4#3)(2004-9#2)(2005-10#1)(2005-11#10)(2005-12#1)(2005-4#2)(2005-5#2)(2005-7#3)(2005-8#4)(2005-9#2)(2006-1#2)(2006-10#11)(2006-11#4)(2006-12#10)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#4)(2006-6#4)(2006-7#7)(2006-8#6)(2007-1#2)(2007-10#3)(2007-11#4)(2007-12#20)(2007-2#6)(2007-3#4)(2007-4#4)(2007-5#4)(2007-6#2)(2007-7#9)(2007-8#19)(2007-9#3)(2008-1#13)(2008-10#125)(2008-11#31)(2008-12#9)(2008-2#20)(2008-3#24)(2008-4#9)(2008-5#25)(2008-6#7)(2008-7#20)(2008-8#13)(2008-9#11)(2009-10#9)(2009-11#1)(2009-12#2)(2009-2#4)(2009-3#1)(2009-4#4)(2009-5#5)(2009-6#3)(2009-7#2)(2009-8#6)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#10)(2010-2#8)(2010-3#3)(2010-4#2)(2010-6#2)(2010-7#4)(2010-8#8)(2010-9#2)(2011-1#14)(2011-12#1)(2011-2#25)(2012-1#11)(2012-12#13)(2012-2#16)(2012-3#9)(2012-9#1)(2013-1#27)(2013-7#10)(2013-8#31)
under their##4##2##(1997-6#1)(2005-11#1)(2011-1#1)(2011-12#1)
under therapy##3##2##(1992-5#1)(1996-4#1)(2008-10#1)
under thermal##4##2##(2007-11#1)(2007-12#2)(2008-5#1)
under thermophilic conditions##2##3##(2006-8#2)
under these circumstances##5##3##(1992-2#1)(1993-3#1)(1996-9#1)(2008-7#1)(2011-1#1)
under these conditions were##2##4##(1990-7#1)(2006-5#1)
under these conditions##65##3##(1990-12#2)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-3#2)(1993-4#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-8#1)(1995-9#2)(1996-7#1)(1997-2#2)(1997-7#1)(2005-11#1)(2006-10#1)(2006-5#2)(2006-8#1)(2006-9#1)(2007-11#4)(2008-10#5)(2008-11#2)(2008-6#2)(2008-7#2)(2009-10#1)(2009-11#1)(2010-12#1)(2012-12#1)(2013-7#1)
under these experimental conditions##6##4##(1991-1#1)(1991-12#1)(1993-2#1)(1996-5#1)(1997-2#1)(2008-10#1)
under these same##2##3##(1991-4#1)(2008-11#1)
under these two##2##3##(2005-12#1)(2007-10#1)
under these##99##2##(1990-12#3)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-8#1)(1995-9#2)(1996-5#3)(1996-7#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-7#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-5#2)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#4)(2007-9#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#4)(2008-7#3)(2009-10#1)(2009-11#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-7#1)
under this condition##9##3##(1992-6#1)(1995-11#1)(1996-9#1)(1997-4#1)(2008-10#2)(2008-4#1)(2008-6#1)(2011-2#1)
under this##28##2##(1991-9#1)(1992-12#1)(1992-6#1)(1993-8#1)(1994-3#1)(1995-10#1)(1995-11#1)(1996-9#1)(1997-1#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
under those##4##2##(2007-11#1)(2008-4#1)(2009-4#1)(2012-2#1)
under three conditions##3##3##(1997-1#1)(2007-4#1)(2011-2#1)
under three different conditions##2##4##(1997-1#1)(1997-3#1)
under three different sets of conditions##3##6##(2008-10#1)(2008-2#1)(2008-4#1)
under three different##8##3##(1997-1#1)(1997-3#1)(2006-11#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)
under three years of age in##2##6##(2011-1#1)(2012-2#1)
under three years of age##3##5##(2007-7#1)(2011-1#1)(2012-2#1)
under three##17##2##(1996-8#1)(1997-1#2)(1997-3#1)(1997-5#1)(2006-1#1)(2006-11#1)(2007-10#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
under tight control##3##3##(1996-4#1)(2006-10#1)(2009-8#1)
under total internal reflection##2##4##(2007-11#1)(2007-12#1)
under total intravenous anaesthesia##2##4##(2008-5#1)(2011-2#1)
under total##5##2##(2007-11#1)(2007-12#1)(2008-3#1)(2008-5#1)(2011-2#1)
under traditional##2##2##(2008-11#1)(2008-5#1)
under transcriptional control of the##3##5##(1994-12#1)(1997-3#1)(2010-10#1)
under transcriptional control of##4##4##(1994-12#1)(1997-3#1)(2008-7#1)(2010-10#1)
under transcriptional control##5##3##(1990-11#1)(1994-12#1)(1997-3#1)(2008-7#1)(2010-10#1)
under transcriptional##6##2##(1990-11#1)(1991-1#1)(1994-12#1)(1997-3#1)(2008-7#1)(2010-10#1)
under transient##2##2##(1995-10#1)(1997-1#1)
under treated##4##2##(2006-10#4)
under treatment with##7##3##(1991-11#1)(1996-4#1)(1997-1#1)(2006-2#1)(2010-12#1)(2010-5#1)(2011-1#1)
under treatment##19##2##(1991-11#1)(1994-9#1)(1996-11#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-10#1)(2010-12#1)(2010-5#2)(2011-1#1)(2012-11#2)(2012-3#1)
under trial##3##2##(1990-7#1)(1997-3#1)(2008-10#1)
under two conditions##3##3##(1995-8#1)(2007-4#1)(2013-1#1)
under two different##7##3##(1995-7#1)(1996-7#1)(2007-9#1)(2008-11#1)(2008-7#1)(2010-4#1)(2013-8#1)
under two##22##2##(1991-7#1)(1992-10#1)(1995-7#1)(1995-8#1)(1996-7#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
under two-photon excitation##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
under typical operating conditions##3##4##(1995-12#1)(2006-4#1)(2007-11#1)
under typical##6##2##(1995-12#1)(1997-8#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-3#1)
under ultrahigh vacuum conditions##2##4##(2012-1#1)(2013-8#1)
under ultrahigh vacuum##3##3##(2008-7#1)(2012-1#1)(2013-8#1)
under ultrasonic##4##2##(2008-10#2)(2008-5#1)(2009-2#1)
under ultrasonographic control were##2##4##(2011-2#2)
under ultrasonographic control##3##3##(2011-2#3)
under ultrasonographic guidance##2##3##(2012-12#2)
under ultrasonographic##6##2##(2007-7#1)(2011-2#3)(2012-12#2)
under ultrasound guidance##2##3##(2008-1#1)(2010-4#1)
under ultrasound##4##2##(2008-1#1)(2008-10#1)(2008-7#1)(2010-4#1)
under ultraviolet illumination##2##3##(2006-8#1)(2013-8#1)
under ultraviolet irradiation##2##3##(2005-11#1)(2008-3#1)
under ultraviolet light##4##3##(2007-2#1)(2008-5#1)(2008-9#1)(2010-7#1)
under ultraviolet##8##2##(2005-11#1)(2006-8#1)(2007-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-7#1)(2013-8#1)
under unfavorable##2##2##(2005-11#1)(2008-5#1)
under universal##2##2##(1995-1#1)(2008-4#1)
under urethane anaesthesia##2##3##(2008-12#1)(2012-12#1)
under urethane##3##2##(1992-3#1)(2008-12#1)(2012-12#1)
under vacuum packaging##2##3##(2011-2#2)
under vacuum##7##2##(2010-1#1)(2010-12#1)(2010-4#2)(2011-2#3)
under variable##5##2##(2007-2#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-3#1)
under various conditions of##3##4##(2008-10#3)
under various conditions##16##3##(1990-11#1)(1990-8#1)(1992-6#1)(1993-9#1)(1994-12#1)(1996-6#1)(1997-1#1)(2005-11#2)(2007-8#1)(2008-10#4)(2008-4#1)(2012-1#1)
under various controlled##2##3##(1997-6#1)(2008-10#1)
under various environmental conditions##2##4##(2008-10#1)(2008-3#1)
under various extreme environmental conditions##2##5##(2013-8#2)
under various growth conditions##3##4##(1996-6#1)(1997-1#1)(2008-5#1)
under various growth##4##3##(1996-6#1)(1997-1#1)(2006-12#1)(2008-5#1)
under various impact conditions##2##4##(2006-11#1)(2007-1#1)
under various loading##2##3##(2006-11#1)(2007-12#1)
under various##54##2##(1990-11#1)(1990-8#1)(1992-6#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-3#1)(1996-2#1)(1996-6#2)(1997-1#2)(1997-6#2)(1997-8#1)(2005-11#2)(2006-11#2)(2006-12#2)(2006-5#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-1#1)(2012-1#1)(2012-3#1)(2013-8#2)
under varying conditions of##2##4##(2008-10#1)(2008-9#1)
under varying conditions##6##3##(1995-3#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-9#1)
under varying##15##2##(1992-12#1)(1995-3#1)(1997-2#1)(2004-9#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-9#2)(2013-1#1)
under very mild conditions##2##4##(2007-11#1)(2009-11#1)
under very mild##3##3##(2007-11#2)(2009-11#1)
under very##9##2##(1995-4#1)(1996-11#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-3#1)(2009-11#1)
under video##3##2##(2007-8#1)(2008-9#1)(2010-2#1)
under video-assisted thoracoscopy##2##3##(2007-8#2)
under visible light##3##3##(2008-8#1)(2010-7#1)(2013-8#1)
under visual control##3##3##(1994-2#1)(2010-12#1)(2013-1#1)
under voltage clamp##2##3##(1991-5#1)(1991-9#1)
under voltage-clamp##2##2##(1993-2#1)(1995-6#1)
under water stress##5##3##(2008-12#1)(2008-5#2)(2008-8#2)
under water##9##2##(2006-8#1)(2008-10#1)(2008-12#2)(2008-5#2)(2008-8#2)(2011-12#1)
under way in##3##3##(1995-12#1)(2008-4#1)(2011-2#1)
under way on##2##3##(1996-9#1)(2006-4#1)
under way to##4##3##(1996-6#1)(2007-11#1)(2008-2#1)(2009-8#1)
under way##23##2##(1993-11#1)(1993-6#1)(1995-12#1)(1996-6#1)(1996-9#1)(2004-12#1)(2005-7#1)(2005-8#1)(2006-4#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-2#2)(2008-4#1)(2008-7#4)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
under well defined##2##3##(2008-11#1)(2008-2#1)
under well-oxygenated conditions##2##3##(1992-9#1)(2008-4#1)
under well-watered and drought##2##4##(2008-12#2)
under wet conditions##2##3##(2008-10#2)
under what conditions##5##3##(1994-12#1)(2007-12#1)(2008-8#1)(2008-9#1)(2012-3#1)
under what##8##2##(1994-12#1)(2007-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2012-3#2)
under which a##4##3##(1994-7#1)(2007-11#1)(2007-12#1)(2010-10#1)
under which an##2##3##(2007-5#1)(2012-12#1)
under which conditions##3##3##(2005-11#1)(2008-7#1)(2010-9#1)
under which such##3##3##(1994-12#1)(1997-1#1)(2008-10#1)
under which the##11##3##(1995-12#1)(2004-9#1)(2005-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-8#1)(2012-2#2)(2013-8#1)
under which they were##2##4##(2006-10#1)(2012-12#1)
under which##73##2##(1990-12#1)(1990-9#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(2004-10#1)(2004-9#1)(2005-11#3)(2006-10#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#8)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#2)(2012-12#2)(2012-2#2)(2013-8#1)
under white light##2##3##(1992-7#2)
under whole-cell voltage-clamp##2##3##(1991-8#1)(1997-2#1)
under working conditions##2##3##(2008-10#2)
under##5933##1##(1990-1#1)(1990-10#8)(1990-11#20)(1990-12#39)(1990-2#13)(1990-3#18)(1990-4#8)(1990-5#18)(1990-6#11)(1990-7#17)(1990-8#23)(1990-9#6)(1991-1#14)(1991-10#12)(1991-11#10)(1991-12#32)(1991-2#36)(1991-3#21)(1991-4#11)(1991-5#18)(1991-6#11)(1991-7#20)(1991-8#20)(1991-9#13)(1992-1#12)(1992-10#8)(1992-11#9)(1992-12#40)(1992-2#29)(1992-3#23)(1992-4#15)(1992-5#10)(1992-6#15)(1992-7#11)(1992-8#22)(1992-9#10)(1993-1#9)(1993-10#3)(1993-11#10)(1993-12#30)(1993-2#12)(1993-3#25)(1993-4#7)(1993-5#9)(1993-6#23)(1993-7#4)(1993-8#13)(1993-9#13)(1994-1#7)(1994-10#4)(1994-11#29)(1994-12#35)(1994-2#28)(1994-3#34)(1994-4#2)(1994-5#18)(1994-6#20)(1994-7#5)(1994-8#15)(1994-9#25)(1995-1#28)(1995-10#18)(1995-11#16)(1995-12#41)(1995-2#37)(1995-3#30)(1995-4#9)(1995-5#15)(1995-6#21)(1995-7#11)(1995-8#34)(1995-9#14)(1996-1#14)(1996-10#8)(1996-11#21)(1996-12#30)(1996-2#23)(1996-3#18)(1996-4#12)(1996-5#32)(1996-6#28)(1996-7#12)(1996-8#14)(1996-9#14)(1997-1#34)(1997-2#45)(1997-3#26)(1997-4#38)(1997-5#20)(1997-6#18)(1997-7#16)(1997-8#22)(1997-9#1)(2004-1#2)(2004-10#2)(2004-11#4)(2004-12#8)(2004-2#2)(2004-4#15)(2004-5#2)(2004-8#1)(2004-9#10)(2005-1#1)(2005-10#6)(2005-11#82)(2005-12#14)(2005-4#6)(2005-5#8)(2005-6#3)(2005-7#22)(2005-8#30)(2005-9#13)(2006-1#11)(2006-10#84)(2006-11#25)(2006-12#47)(2006-2#15)(2006-3#10)(2006-4#9)(2006-5#19)(2006-6#26)(2006-7#18)(2006-8#45)(2006-9#7)(2007-1#12)(2007-10#26)(2007-11#117)(2007-12#119)(2007-2#22)(2007-3#21)(2007-4#23)(2007-5#25)(2007-6#12)(2007-7#32)(2007-8#95)(2007-9#32)(2008-1#55)(2008-10#672)(2008-11#157)(2008-12#42)(2008-2#155)(2008-3#143)(2008-4#81)(2008-5#180)(2008-6#46)(2008-7#133)(2008-8#97)(2008-9#60)(2009-1#1)(2009-10#40)(2009-11#10)(2009-12#10)(2009-2#15)(2009-3#18)(2009-4#24)(2009-5#13)(2009-6#17)(2009-7#16)(2009-8#37)(2009-9#19)(2010-1#11)(2010-10#19)(2010-11#14)(2010-12#57)(2010-2#29)(2010-3#12)(2010-4#31)(2010-5#24)(2010-6#12)(2010-7#24)(2010-8#40)(2010-9#13)(2011-1#75)(2011-10#3)(2011-12#24)(2011-2#129)(2011-3#6)(2011-7#1)(2012-1#57)(2012-11#2)(2012-12#85)(2012-2#101)(2012-3#44)(2012-4#1)(2012-6#3)(2012-7#1)(2012-9#2)(2013-1#131)(2013-7#44)(2013-8#110)
under- and over-nutrition##2##3##(2012-1#2)
under- and over-treatment##2##3##(2006-3#1)(2012-2#1)
under- and##6##2##(2005-10#1)(2006-3#1)(2008-10#1)(2012-1#2)(2012-2#1)
under- or##7##2##(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-3#1)(2010-7#2)
under-##13##1##(2005-10#1)(2006-3#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-3#1)(2010-7#2)(2012-1#2)(2012-2#1)
under-2-years mortality##2##2##(2011-1#2)
under-2-years##4##1##(2011-1#4)
under-appreciated##3##1##(2005-10#1)(2008-9#1)(2009-8#1)
under-diagnosed in##2##2##(2007-11#1)(2010-9#1)
under-diagnosed##5##1##(2006-10#1)(2007-11#1)(2010-9#1)(2011-2#2)
under-diagnosis of##3##2##(2007-11#1)(2011-2#1)(2012-2#1)
under-diagnosis##4##1##(2007-11#1)(2010-12#1)(2011-2#1)(2012-2#1)
under-dosage##2##1##(2006-10#1)(2008-6#1)
under-estimated##2##1##(2007-8#1)(2009-8#1)
under-explored##3##1##(2009-5#1)(2010-8#1)(2012-9#1)
under-five children##4##2##(2008-2#1)(2013-1#3)
under-five mortality in Nigeria##3##4##(2009-6#1)(2009-7#1)(2012-12#1)
under-five mortality##9##2##(1991-4#1)(2009-6#5)(2009-7#2)(2012-12#1)
under-five##18##1##(1991-4#1)(2008-2#5)(2009-6#5)(2009-7#3)(2012-12#1)(2013-1#3)
under-nutrition##3##1##(2012-1#1)(2012-12#2)
under-recognised and##3##2##(1996-8#1)(2010-10#1)(2012-3#1)
under-recognised##6##1##(1996-8#1)(2006-4#1)(2010-10#1)(2010-12#1)(2012-2#1)(2012-3#1)
under-recognized##11##1##(1994-2#1)(2006-12#1)(2007-10#1)(2008-10#1)(2008-7#1)(2009-5#1)(2010-12#2)(2010-7#1)(2012-3#2)
under-reported in##2##2##(2006-4#1)(2006-8#1)
under-reported##6##1##(1993-6#1)(1996-8#1)(2006-4#1)(2006-8#1)(2007-2#1)(2007-3#1)
under-reporting of##2##2##(1996-11#1)(2010-8#1)
under-reporting##6##1##(1996-11#1)(2008-12#1)(2009-3#1)(2010-8#1)(2012-1#2)
under-representation of##2##2##(2007-6#1)(2010-12#1)
under-represented in the##2##3##(1997-8#1)(2012-3#1)
under-represented##3##1##(1997-8#1)(2006-6#1)(2012-3#1)
under-researched##4##1##(2008-2#1)(2008-5#1)(2012-11#1)(2013-7#1)
under-served##2##1##(2008-6#1)(2012-11#1)
under-studied##3##1##(2011-2#1)(2013-1#1)(2013-8#1)
under-treated##3##1##(2005-7#1)(2007-6#1)(2010-7#1)
under-treatment##4##1##(1990-12#1)(2007-8#1)(2010-12#1)(2011-2#1)
under-utilized in##2##2##(2005-12#1)(2012-1#1)
underage drinking##3##2##(2010-7#3)
underage##4##1##(2010-7#3)(2013-1#1)
underappreciated##11##1##(1993-6#1)(2006-10#2)(2006-5#1)(2006-7#1)(2006-9#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
underarm##10##1##(2006-12#2)(2008-5#8)
underarms##2##1##(2008-5#2)
undercare##2##1##(1994-2#1)(1994-3#1)
undercompensation##2##1##(2008-8#2)
undercooked meat##2##2##(2007-12#1)(2007-9#1)
underdetermined##2##1##(2008-3#1)(2008-7#1)
underdeveloped and##2##2##(1997-2#1)(2013-1#1)
underdeveloped countries##5##2##(1990-2#2)(1996-2#1)(2008-1#1)(2011-2#1)
underdeveloped##14##1##(1990-2#2)(1996-2#1)(1997-2#1)(1997-5#1)(2005-9#1)(2007-7#1)(2008-1#1)(2008-11#1)(2009-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
underdevelopment of##2##2##(2008-1#1)(2011-1#1)
underdevelopment##3##1##(2008-1#1)(2009-7#1)(2011-1#1)
underdiagnosed and undertreated##4##3##(2008-8#1)(2011-2#1)(2013-8#2)
underdiagnosed and##6##2##(1991-9#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-8#2)
underdiagnosed because##2##2##(2007-12#1)(2007-8#1)
underdiagnosed or##2##2##(2007-7#1)(2008-7#1)
underdiagnosed##23##1##(1990-8#1)(1991-9#1)(1995-11#2)(1997-3#1)(2005-7#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-1#1)(2010-6#1)(2011-2#2)(2012-12#1)(2013-8#2)
underdiagnosis##5##1##(2006-10#2)(2008-11#1)(2012-3#1)(2013-7#1)
underdominance##3##1##(2008-10#3)
underdosed##2##1##(2008-3#1)(2008-6#1)
underdosing##2##1##(1997-3#1)(2010-9#1)
underestimate and##2##2##(2005-10#1)(2006-9#1)
underestimate the true##3##3##(1990-3#1)(2006-12#1)(2008-7#1)
underestimate the##14##2##(1990-3#1)(1991-12#1)(1991-3#1)(2006-12#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2013-8#1)
underestimate##30##1##(1990-3#1)(1990-8#1)(1991-12#1)(1991-3#2)(1992-6#1)(1994-3#1)(2005-10#2)(2005-11#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-9#1)(2011-2#2)(2013-8#1)
underestimated and##6##2##(1992-9#1)(1994-6#1)(1995-2#1)(2007-11#1)(2012-12#1)(2012-3#1)
underestimated at##2##2##(1996-5#1)(2008-10#1)
underestimated by about##2##3##(1994-8#1)(2005-11#1)
underestimated by##3##2##(1994-8#1)(2005-11#1)(2008-4#1)
underestimated in the past##3##4##(1996-3#1)(2008-10#1)(2008-3#1)
underestimated in the##4##3##(1996-3#1)(2008-10#1)(2008-3#1)(2008-8#1)
underestimated in##6##2##(1996-3#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-7#1)
underestimated role##2##2##(2006-10#1)(2012-12#1)
underestimated the effect of##2##4##(1997-4#1)(2010-10#1)
underestimated the##8##2##(1997-4#1)(2007-2#1)(2007-6#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-10#1)(2012-12#1)
underestimated##84##1##(1990-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-4#2)(1994-6#1)(1994-8#1)(1995-2#1)(1996-3#1)(1996-5#1)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#1)(2004-2#1)(2005-10#1)(2005-11#2)(2006-10#2)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-3#1)(2009-4#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-12#1)(2012-1#2)(2012-12#5)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#2)
underestimates the barrier heights##2##4##(2008-8#2)
underestimates the##10##2##(1993-1#1)(1994-2#1)(1997-3#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-8#2)(2012-2#1)
underestimates##16##1##(1993-1#1)(1994-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-6#1)(2008-8#2)(2012-2#2)
underestimating the##3##2##(2008-5#1)(2010-12#1)(2012-2#1)
underestimating##8##1##(2007-7#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-8#1)(2012-2#2)
underestimation of the##8##3##(1995-3#1)(2007-2#1)(2008-2#1)(2008-3#2)(2010-5#1)(2011-12#1)(2012-3#1)
underestimation of##15##2##(1990-2#1)(1995-3#1)(1995-5#1)(2007-2#1)(2008-2#1)(2008-3#3)(2009-10#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-3#2)
underestimation was##3##2##(2007-11#1)(2010-10#1)(2013-1#1)
underestimation##25##1##(1990-2#1)(1995-3#1)(1995-5#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#4)(2009-10#1)(2010-10#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
underevaluated##3##1##(1990-12#1)(2013-1#2)
underexpanded##2##1##(2008-3#2)
underexpansion##2##1##(2010-5#2)
underexplored##4##1##(2008-10#1)(2010-1#1)(2013-1#2)
underexpression of##2##2##(1994-6#1)(1997-7#1)
underexpression##3##1##(1994-6#1)(1997-7#1)(2009-6#1)
underfilling##2##1##(1997-7#1)(2008-12#1)
undergo HIV-antibody testing##3##3##(1996-5#3)
undergo Pd-catalyzed##2##2##(2008-4#1)(2009-5#1)
undergo a major##2##3##(1990-6#1)(1996-12#1)
undergo a thorough medical##2##4##(2007-8#1)(2008-12#1)
undergo a two-state##2##3##(1993-8#1)(1997-2#1)
undergo a##47##2##(1990-6#1)(1991-1#1)(1992-12#2)(1992-7#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-7#1)(2006-12#1)(2006-5#1)(2006-6#2)(2006-9#1)(2007-11#1)(2007-12#4)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#2)(2009-7#1)(2010-1#1)(2010-4#1)(2010-7#2)(2012-1#1)(2012-2#2)(2013-1#1)
undergo alternative splicing##2##3##(2009-10#1)(2010-1#1)
undergo an AIDS test##2##4##(1992-9#2)
undergo an apparent##2##3##(1994-5#1)(1996-2#1)
undergo an irreversible##2##3##(1995-3#1)(1996-2#1)
undergo an##26##2##(1991-10#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-9#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-3#1)(1995-5#1)(1996-2#3)(1997-3#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2009-3#1)(2010-3#1)(2010-4#1)(2011-1#1)
undergo any##3##2##(1997-4#1)(2008-11#1)(2012-3#1)
undergo apoptosis after##2##3##(1991-10#1)(1996-7#1)
undergo apoptosis and are##2##4##(2010-12#1)(2010-3#1)
undergo apoptosis and##3##3##(2006-10#1)(2010-12#1)(2010-3#1)
undergo apoptosis when##2##3##(1995-2#1)(1997-2#1)
undergo apoptosis##24##2##(1991-10#1)(1993-9#1)(1994-10#1)(1994-5#1)(1995-2#4)(1996-7#1)(1997-2#2)(2006-10#1)(2006-11#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)
undergo axonal##2##2##(1996-9#1)(2007-11#1)
undergo cardiac##3##2##(1995-12#1)(2007-8#1)(2010-2#1)
undergo changes##2##2##(1996-6#1)(2009-4#1)
undergo chemotherapy##3##2##(1996-6#1)(2011-2#2)
undergo cleavage##2##2##(1995-8#1)(1996-5#1)
undergo closed##2##2##(2007-12#1)(2011-2#1)
undergo conformational change##2##3##(1991-12#1)(2009-3#1)
undergo differentiation##4##2##(2007-11#1)(2008-7#1)(2009-6#1)(2012-2#1)
undergo dynamic##2##2##(2008-11#1)(2008-4#1)
undergo elective resection after##2##4##(2010-8#2)
undergo elective##5##2##(2010-8#2)(2011-2#1)(2012-12#1)(2013-7#1)
undergo extensive##3##2##(1994-12#1)(1996-12#1)(2008-4#1)
undergo further##11##2##(2006-4#1)(2006-7#1)(2008-10#1)(2009-4#1)(2011-8#1)(2012-12#3)(2013-1#3)
undergo hypertrophy##3##2##(1993-12#3)
undergo irreversible##2##2##(1995-3#1)(1997-7#1)
undergo large##2##2##(1996-6#1)(1997-5#1)
undergo major##4##2##(1996-11#1)(2009-5#1)(2010-10#1)(2012-2#1)
undergo malignant change##2##3##(1996-12#1)(2012-2#1)
undergo malignant##3##2##(1992-9#1)(1996-12#1)(2012-2#1)
undergo maturation##2##2##(1994-8#1)(2008-7#1)
undergo oxidative##2##2##(1994-6#1)(2007-11#1)
undergo periodic##3##2##(1996-9#1)(2008-1#1)(2009-11#1)
undergo phase##2##2##(2005-7#1)(2008-2#1)
undergo plastic changes##2##3##(1991-6#1)(1994-8#1)
undergo plastic##3##2##(1991-6#1)(1994-8#1)(2010-9#1)
undergo programmed cell death##2##4##(2003-11#1)(2009-3#1)
undergo proliferation##2##2##(1991-5#1)(2008-4#1)
undergo prophylactic implantation of an##3##5##(2009-10#3)
undergo proteolytic processing##2##3##(1993-6#1)(2008-11#1)
undergo proteolytic##4##2##(1990-7#1)(1993-6#1)(2008-11#1)(2008-4#1)
undergo radical##2##2##(1993-9#1)(2008-10#1)
undergo rapid##7##2##(1990-6#1)(1996-2#1)(1996-5#1)(2006-5#1)(2008-8#1)(2009-9#1)(2010-5#1)
undergo re-operation##2##2##(2007-4#1)(2007-8#1)
undergo regular##2##2##(2006-2#1)(2008-10#1)
undergo resection##2##2##(2010-8#1)(2013-1#1)
undergo reversible##3##2##(1994-3#1)(2006-10#1)(2008-7#1)
undergo significant##4##2##(1992-3#1)(1994-9#1)(2008-8#1)(2011-2#1)
undergo similar##2##2##(1990-2#1)(1992-6#1)
undergo spontaneous##6##2##(1993-3#1)(1995-12#1)(1995-3#1)(1996-4#1)(2008-7#1)(2008-8#1)
undergo structural changes##2##3##(1995-5#2)
undergo surgery for##2##3##(2006-12#1)(2007-8#1)
undergo surgery##8##2##(2006-12#2)(2007-8#1)(2009-7#1)(2012-2#1)(2013-1#3)
undergo surgical procedures##2##3##(2007-12#1)(2008-8#1)
undergo surgical##5##2##(2007-12#1)(2008-4#1)(2008-8#2)(2009-4#1)
undergo the##15##2##(1992-8#1)(1993-5#1)(1995-6#2)(2008-10#1)(2008-11#1)(2009-5#2)(2009-6#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#2)
undergo this##3##2##(1994-12#1)(2008-7#2)
undergo training##2##2##(1994-3#1)(1995-6#1)
undergo two##2##2##(2008-10#1)(2010-11#1)
undergo various##2##2##(2009-8#1)(2013-1#1)
undergo##479##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#4)(1990-3#2)(1990-6#4)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#4)(1991-12#1)(1991-3#5)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#6)(1992-3#4)(1992-5#1)(1992-6#3)(1992-7#3)(1992-8#1)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#3)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#3)(1994-3#3)(1994-5#5)(1994-6#3)(1994-8#4)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#5)(1995-5#4)(1995-6#6)(1995-8#2)(1996-11#3)(1996-12#5)(1996-2#6)(1996-3#3)(1996-4#2)(1996-5#6)(1996-6#4)(1996-7#2)(1996-9#4)(1997-2#5)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#4)(1997-8#1)(2003-11#1)(2004-2#1)(2004-3#1)(2005-10#1)(2005-2#2)(2005-7#2)(2006-10#9)(2006-11#1)(2006-12#5)(2006-2#4)(2006-4#2)(2006-5#3)(2006-6#4)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#15)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#11)(2007-9#3)(2008-1#6)(2008-10#19)(2008-11#9)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#10)(2008-5#6)(2008-6#3)(2008-7#11)(2008-8#7)(2008-9#2)(2009-10#7)(2009-11#1)(2009-3#4)(2009-4#4)(2009-5#5)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#3)(2010-3#2)(2010-4#8)(2010-5#3)(2010-6#2)(2010-7#5)(2010-8#3)(2010-9#4)(2011-1#4)(2011-12#1)(2011-2#15)(2011-8#1)(2012-1#4)(2012-12#10)(2012-2#11)(2012-3#8)(2013-1#12)(2013-7#2)
undergoes a conformational change##3##4##(1990-5#1)(1993-3#1)(1995-8#1)
undergoes a relatively slow undetected isomerization##2##6##(1992-10#2)
undergoes a small##2##3##(1990-5#1)(2007-11#1)
undergoes a transition from##2##4##(1993-3#1)(2005-11#1)
undergoes a transition to a##2##5##(1994-8#1)(1997-7#1)
undergoes a transition##5##3##(1990-5#1)(1993-3#1)(1994-8#1)(1997-7#1)(2005-11#1)
undergoes a##42##2##(1990-11#1)(1990-5#3)(1990-7#1)(1991-5#1)(1992-10#2)(1992-12#2)(1993-3#3)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-5#2)(1996-7#1)(1997-5#1)(1997-7#1)(2005-11#1)(2007-11#3)(2007-12#1)(2007-4#1)(2008-10#4)(2008-3#1)(2008-7#1)(2008-9#1)(2009-6#1)(2013-1#1)
undergoes an##5##2##(1991-7#1)(1996-4#2)(2006-2#1)(2009-7#1)
undergoes autophosphorylation##2##2##(1993-6#1)(1994-11#1)
undergoes binding-induced folding##2##3##(2010-5#2)
undergoes disulfide##2##2##(1990-2#1)(1994-3#1)
undergoes dramatic##2##2##(2007-12#1)(2008-9#1)
undergoes extensive metabolism in##2##4##(1996-5#1)(2007-11#1)
undergoes extensive##5##2##(1995-3#1)(1996-5#1)(2007-11#1)(2008-11#1)(2008-5#1)
undergoes hydrolysis##3##2##(1990-5#1)(2008-10#1)(2009-8#1)
undergoes large##2##2##(1993-2#1)(2008-3#1)
undergoes metathesis##2##2##(2006-3#1)(2010-5#1)
undergoes rapid degradation in##2##4##(1996-2#1)(2008-5#1)
undergoes rapid##7##2##(1990-5#1)(1995-10#1)(1995-2#1)(1996-2#1)(2007-11#1)(2008-5#1)(2009-8#1)
undergoes regular cycles of sexual recombination##2##6##(2008-10#2)
undergoes several##2##2##(2008-10#1)(2013-8#1)
undergoes specific##2##2##(1993-6#1)(1994-11#1)
undergoes spontaneous##2##2##(1994-8#1)(1996-4#1)
undergoes the##3##2##(1994-5#1)(2008-8#1)(2011-3#1)
undergoes two##2##2##(2006-5#1)(2009-5#1)
undergoes##185##1##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#5)(1990-7#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#3)(1991-7#1)(1991-9#2)(1992-10#4)(1992-12#2)(1992-7#2)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-6#3)(1994-11#5)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#3)(1995-1#3)(1995-10#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#3)(1996-11#1)(1996-12#1)(1996-2#3)(1996-4#3)(1996-5#7)(1996-7#1)(1997-2#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#2)(2006-5#1)(2007-11#9)(2007-12#5)(2007-3#1)(2007-4#1)(2007-8#2)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#3)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#4)(2010-10#1)(2010-12#1)(2010-4#2)(2010-5#4)(2011-12#1)(2011-2#3)(2011-3#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
undergoing Brownian##2##2##(2005-11#1)(2008-2#1)
undergoing CABG##6##2##(2007-10#1)(2007-8#4)(2010-5#1)
undergoing PCI##2##2##(2006-7#1)(2010-12#1)
undergoing a dramatic##2##3##(1996-12#1)(2007-12#1)
undergoing a major##4##3##(1992-1#1)(1992-12#1)(1994-3#1)(2010-6#1)
undergoing a process##2##3##(1993-9#1)(2012-3#1)
undergoing a second##2##3##(1991-4#1)(2007-9#1)
undergoing a surgical procedure##2##4##(2007-12#2)
undergoing a##30##2##(1991-4#1)(1992-1#2)(1992-12#1)(1993-9#1)(1994-3#1)(1996-12#1)(1996-2#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-12#3)(2007-9#1)(2008-11#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-6#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
undergoing abortion##3##2##(1994-9#1)(1996-12#2)
undergoing active##6##2##(2006-8#1)(2008-7#1)(2009-5#1)(2010-10#2)(2012-2#1)
undergoing an operation##2##3##(2011-2#1)(2013-7#1)
undergoing an##7##2##(1992-1#1)(1996-5#1)(2008-10#1)(2008-6#1)(2010-12#1)(2011-2#1)(2013-7#1)
undergoing anesthesia and surgery##3##4##(2006-10#3)
undergoing anesthesia##4##2##(2006-10#4)
undergoing angioplasty##2##2##(2008-11#1)(2008-5#1)
undergoing apoptosis##7##2##(1994-12#1)(2003-11#1)(2006-2#1)(2007-1#1)(2007-2#1)(2008-11#1)(2008-8#1)
undergoing autologous##2##2##(2007-11#1)(2012-2#1)
undergoing bilateral##5##2##(2007-8#2)(2008-5#1)(2009-3#2)
undergoing caesarean section##3##3##(2008-7#2)(2011-2#1)
undergoing cancer treatment with##2##4##(2007-12#2)
undergoing cardiac surgery##26##3##(2006-10#3)(2007-10#1)(2007-8#15)(2007-9#3)(2008-12#1)(2008-4#1)(2012-2#1)(2013-1#1)
undergoing cardiac surgery?##7##3##(2007-8#7)
undergoing cardiac##36##2##(2006-10#3)(2007-10#1)(2007-8#23)(2007-9#4)(2008-12#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
undergoing cardiopulmonary##4##2##(2007-9#1)(2008-5#1)(2009-8#1)(2013-8#1)
undergoing chemotherapy for##3##3##(1990-9#1)(1991-11#1)(2005-7#1)
undergoing chemotherapy##8##2##(1990-9#1)(1991-11#1)(2005-7#1)(2007-7#2)(2008-7#2)(2012-2#1)
undergoing chronic##3##2##(1996-12#1)(2007-7#1)(2013-1#1)
undergoing cleft lip##2##3##(2011-2#1)(2012-12#1)
undergoing clinical evaluation##4##3##(1992-10#1)(1995-3#1)(2008-7#2)
undergoing clinical trials##6##3##(1991-3#1)(1994-8#1)(2005-7#2)(2006-10#1)(2012-12#1)
undergoing clinical##13##2##(1991-3#1)(1991-8#1)(1992-10#1)(1992-3#1)(1994-8#1)(1995-3#1)(1996-9#1)(2005-7#2)(2006-10#1)(2008-7#2)(2012-12#1)
undergoing coronary artery bypass grafts##2##5##(2006-9#1)(2007-8#1)
undergoing coronary artery bypass##23##4##(1997-8#2)(2006-10#2)(2006-9#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#6)(2007-9#3)(2008-12#1)(2008-6#1)(2013-1#3)
undergoing coronary artery##27##3##(1997-3#1)(1997-8#2)(2006-10#2)(2006-9#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#6)(2007-9#4)(2008-12#2)(2008-6#1)(2010-12#1)(2013-1#3)
undergoing coronary surgery##3##3##(2007-8#3)
undergoing coronary##37##2##(1991-9#1)(1995-12#1)(1996-9#1)(1997-3#1)(1997-8#2)(2006-10#2)(2006-9#1)(2007-10#2)(2007-11#2)(2007-7#1)(2007-8#9)(2007-9#4)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-12#1)(2013-1#3)
undergoing diagnostic and##2##3##(2006-10#2)
undergoing diagnostic##6##2##(2006-10#3)(2006-7#1)(2006-8#1)(2008-4#1)
undergoing dialysis##8##2##(2007-12#1)(2007-8#1)(2008-1#1)(2010-4#1)(2011-2#1)(2013-1#3)
undergoing elective laparoscopic cholecystectomy##2##4##(2010-7#1)(2011-1#1)
undergoing elective##19##2##(1991-5#1)(1993-4#1)(1995-6#1)(2004-1#1)(2005-12#1)(2007-8#1)(2007-9#5)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
undergoing emergency##2##2##(2007-9#1)(2010-7#1)
undergoing endovascular##3##2##(2006-11#1)(2006-12#1)(2007-8#1)
undergoing evaluation##2##2##(1992-3#1)(2005-8#1)
undergoing exchange##2##2##(1993-11#1)(1995-6#1)
undergoing gastrointestinal surgery##3##3##(2005-8#2)(2007-8#1)
undergoing hemodialysis##12##2##(1993-9#1)(1994-12#1)(2008-7#3)(2009-2#3)(2010-12#1)(2010-5#1)(2011-2#1)(2013-8#1)
undergoing infertility##2##2##(2008-10#1)(2012-3#1)
undergoing intensive immunosuppressive therapy##2##4##(2006-10#2)
undergoing intensive##5##2##(1994-5#1)(1997-6#1)(2006-10#2)(2008-7#1)
undergoing interventional procedures##2##3##(2006-8#2)
undergoing interventional##3##2##(2006-8#3)
undergoing kidney##3##2##(2008-1#1)(2013-1#2)
undergoing knee joint arthroscopy##2##4##(2007-11#2)
undergoing laparoscopic cholecystectomy##2##3##(2007-3#1)(2010-5#1)
undergoing laparoscopic##10##2##(1991-3#1)(1994-3#1)(2007-3#1)(2010-11#2)(2010-5#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
undergoing lipid##2##2##(1996-2#1)(2011-1#1)
undergoing liver##2##2##(2006-2#1)(2012-1#1)
undergoing long-term##3##2##(1992-6#1)(1995-3#1)(2008-10#1)
undergoing maintenance HD##2##3##(2008-1#1)(2010-4#1)
undergoing maintenance##4##2##(1995-2#1)(2008-1#1)(2009-2#1)(2010-4#1)
undergoing major##5##2##(1990-12#1)(1996-12#1)(2006-10#1)(2007-8#1)(2009-10#1)
undergoing mitral valve replacement##2##4##(2007-9#2)
undergoing mitral valve##3##3##(2007-9#3)
undergoing non-cardiac surgery##3##3##(2006-10#2)(2013-1#1)
undergoing non-cardiac##5##2##(2006-10#2)(2007-8#1)(2013-1#2)
undergoing noncardiac surgery##3##3##(1990-12#1)(2008-3#1)(2012-3#1)
undergoing oral##5##2##(1993-1#4)(2007-12#1)
undergoing orthopedic surgery##3##3##(2007-7#1)(2011-2#2)
undergoing orthopedic##4##2##(2007-7#1)(2008-5#1)(2011-2#2)
undergoing oscillatory##2##2##(2008-12#1)(2009-8#1)
undergoing percutaneous coronary intervention (PCI)##3##5##(2006-10#1)(2010-12#1)(2013-1#1)
undergoing percutaneous coronary intervention##7##4##(2006-10#1)(2008-3#3)(2010-12#1)(2013-1#1)(2013-7#1)
undergoing percutaneous coronary##8##3##(2005-7#1)(2006-10#1)(2008-3#3)(2010-12#1)(2013-1#1)(2013-7#1)
undergoing percutaneous##9##2##(2005-7#1)(2006-10#1)(2007-9#1)(2008-3#3)(2010-12#1)(2013-1#1)(2013-7#1)
undergoing peripheral revascularization##2##3##(2009-7#2)
undergoing peripheral##3##2##(2006-10#1)(2009-7#2)
undergoing phase II##2##3##(2005-8#1)(2012-3#1)
undergoing phase III trials for the##2##6##(2005-8#1)(2005-9#1)
undergoing phase III trials##3##4##(2005-8#2)(2005-9#1)
undergoing phase III##4##3##(2005-8#2)(2005-9#2)
undergoing phase##8##2##(2005-8#4)(2005-9#2)(2007-12#1)(2012-3#1)
undergoing primary percutaneous coronary intervention##2##5##(2008-3#1)(2010-7#1)
undergoing primary##12##2##(2007-7#1)(2007-8#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
undergoing radical##5##2##(1990-10#1)(2006-9#1)(2007-11#2)(2009-4#1)
undergoing radiotherapy##2##2##(2007-11#1)(2008-7#1)
undergoing rapid##4##2##(1992-4#1)(1996-9#1)(2012-12#2)
undergoing regular dialysis treatment##2##4##(1995-1#1)(2010-12#1)
undergoing regular dialysis##3##3##(1995-1#1)(1995-3#1)(2010-12#1)
undergoing rehabilitation##4##2##(2007-11#2)(2012-1#1)(2012-3#1)
undergoing renal transplantation##3##3##(2007-11#1)(2008-4#1)(2013-1#1)
undergoing repair of##2##3##(2007-8#1)(2007-9#1)
undergoing routine##2##2##(2006-10#1)(2012-2#1)
undergoing stressful##2##2##(2006-9#1)(2008-10#1)
undergoing surgery for##8##3##(2006-10#1)(2006-12#1)(2007-8#1)(2008-4#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
undergoing surgery##30##2##(1990-10#1)(1991-8#1)(1993-10#1)(1993-5#1)(2006-10#3)(2006-12#1)(2006-5#1)(2007-12#4)(2007-8#2)(2008-4#1)(2008-7#3)(2008-8#2)(2011-1#1)(2011-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
undergoing surgical##7##2##(2007-7#3)(2007-8#1)(2008-7#1)(2009-7#1)(2010-11#1)
undergoing the##11##2##(1994-7#2)(1994-9#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-12#1)(2009-9#1)
undergoing therapy for##3##3##(1993-12#1)(2006-9#1)(2009-4#1)
undergoing therapy##5##2##(1991-10#1)(1993-12#1)(2006-9#1)(2009-4#1)(2011-2#1)
undergoing thoracic surgery##5##3##(1990-10#1)(1991-2#1)(2006-10#1)(2012-12#2)
undergoing thoracic/thoracolumbar level fusion##2##4##(2012-3#2)
undergoing thoracotomy##2##2##(2007-12#1)(2007-8#1)
undergoing three##2##2##(2012-12#1)(2013-8#1)
undergoing total joint arthroplasty##2##4##(2012-12#2)
undergoing total knee##3##3##(1996-3#1)(2007-10#1)(2009-3#1)
undergoing total##11##2##(1996-3#1)(2006-10#1)(2006-8#1)(2007-10#2)(2007-7#1)(2007-8#1)(2009-3#1)(2011-2#1)(2012-12#2)
undergoing treatment for##4##3##(1991-8#1)(2008-10#2)(2013-1#1)
undergoing treatment of##2##3##(2010-7#1)(2011-1#1)
undergoing treatment##11##2##(1990-8#1)(1991-8#1)(2006-8#1)(2007-11#1)(2008-10#3)(2008-5#1)(2010-7#1)(2011-1#1)(2013-1#1)
undergoing valve replacement##2##3##(2007-8#1)(2011-2#1)
undergoing vestibular##2##2##(1997-7#1)(2012-3#1)
undergoing##787##1##(1990-10#4)(1990-12#3)(1990-2#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#3)(1991-11#2)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#4)(1991-9#1)(1992-1#4)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#2)(1993-1#4)(1993-10#1)(1993-11#1)(1993-12#3)(1993-4#2)(1993-5#1)(1993-9#2)(1994-11#3)(1994-12#4)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#1)(1994-7#2)(1994-8#3)(1994-9#4)(1995-1#2)(1995-12#4)(1995-2#4)(1995-3#5)(1995-5#1)(1995-6#2)(1995-8#1)(1996-10#3)(1996-12#6)(1996-2#2)(1996-3#4)(1996-4#2)(1996-5#2)(1996-8#2)(1996-9#5)(1997-1#1)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#2)(2003-11#1)(2004-1#1)(2004-10#1)(2005-11#5)(2005-12#2)(2005-7#5)(2005-8#8)(2005-9#2)(2006-10#41)(2006-11#7)(2006-12#6)(2006-2#4)(2006-5#2)(2006-6#4)(2006-7#2)(2006-8#13)(2006-9#7)(2007-1#1)(2007-10#7)(2007-11#19)(2007-12#22)(2007-2#3)(2007-3#2)(2007-5#3)(2007-7#13)(2007-8#82)(2007-9#30)(2008-1#5)(2008-10#12)(2008-11#8)(2008-12#6)(2008-2#1)(2008-3#11)(2008-4#8)(2008-5#16)(2008-6#7)(2008-7#37)(2008-8#10)(2008-9#4)(2009-10#4)(2009-11#2)(2009-12#5)(2009-2#5)(2009-3#4)(2009-4#3)(2009-5#2)(2009-7#3)(2009-8#4)(2009-9#1)(2010-10#5)(2010-11#5)(2010-12#10)(2010-2#2)(2010-3#2)(2010-4#4)(2010-5#4)(2010-6#2)(2010-7#9)(2010-8#1)(2010-9#5)(2011-1#9)(2011-12#6)(2011-2#26)(2012-1#3)(2012-12#18)(2012-2#17)(2012-3#17)(2013-1#31)(2013-7#7)(2013-8#14)
undergone RP##2##2##(2010-10#2)
undergone a##33##2##(1990-11#1)(1991-7#1)(1992-2#1)(1994-7#2)(1994-8#1)(1996-12#1)(1996-3#2)(1996-5#1)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#4)(2009-10#1)(2010-12#1)(2010-6#2)(2011-12#1)(2013-8#1)
undergone an##7##2##(1992-6#1)(1992-8#1)(2006-8#2)(2008-5#1)(2011-12#1)(2012-2#1)
undergone any##3##2##(2008-11#1)(2008-6#1)(2012-1#1)
undergone at least one##3##4##(1990-8#1)(1995-6#1)(2011-2#1)
undergone bilateral##2##2##(2009-3#1)(2009-9#1)
undergone both##2##2##(1997-6#1)(2007-7#1)
undergone by##2##2##(2008-10#2)
undergone clinical##2##2##(2007-7#2)
undergone considerable##2##2##(2008-9#1)(2009-2#1)
undergone coronary bypass##2##3##(1995-3#1)(2007-8#1)
undergone coronary##5##2##(1995-3#1)(1996-6#1)(2007-8#2)(2013-8#1)
undergone curative##2##2##(1997-7#1)(2006-10#1)
undergone extensive##4##2##(1992-2#1)(2006-10#1)(2007-11#1)(2008-1#1)
undergone liver transplantation##2##3##(2006-10#1)(2009-2#1)
undergone liver##3##2##(1991-8#1)(2006-10#1)(2009-2#1)
undergone lung transplantation##2##3##(2006-10#1)(2012-12#1)
undergone major##2##2##(2008-12#1)(2010-6#1)
undergone mastectomy##2##2##(1991-4#1)(1994-12#1)
undergone more than##2##3##(1992-9#1)(2008-9#1)
undergone multiple##3##2##(2006-8#1)(2008-7#1)(2012-2#1)
undergone numerous##2##2##(2006-10#1)(2008-7#1)
undergone percutaneous##2##2##(1995-11#1)(2009-6#1)
undergone radiation##2##2##(2005-9#1)(2008-7#1)
undergone radical##3##2##(2004-2#1)(2006-2#1)(2013-1#1)
undergone rapid growth##2##3##(1996-3#1)(2007-11#1)
undergone rapid##5##2##(1996-3#1)(2007-11#1)(2009-5#1)(2010-12#1)(2012-12#1)
undergone resection of##2##3##(2004-12#2)
undergone several##2##2##(2008-11#1)(2009-5#1)
undergone significant##4##2##(1993-8#1)(2007-7#1)(2010-5#1)(2013-1#1)
undergone splenectomy##2##2##(1990-9#1)(1994-9#1)
undergone substantial##4##2##(1993-3#1)(2007-6#1)(2008-11#1)(2009-9#1)
undergone successful##2##2##(2007-11#1)(2008-7#1)
undergone surgery##8##2##(1990-9#1)(1992-10#1)(1993-7#1)(1996-3#1)(1997-2#1)(2006-12#1)(2006-2#1)(2010-8#1)
undergone surgical##4##2##(1993-6#1)(1996-8#1)(2007-7#1)(2009-12#1)
undergone the##3##2##(1995-3#1)(2008-7#1)(2013-1#1)
undergone this##2##2##(1994-2#1)(2008-6#1)
undergone total##3##2##(1990-9#1)(1994-3#1)(2006-10#1)
undergone##262##1##(1990-10#2)(1990-11#1)(1990-3#2)(1990-6#1)(1990-8#2)(1990-9#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#2)(1991-8#1)(1992-10#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-3#1)(1993-6#2)(1993-7#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#4)(1994-6#1)(1994-7#2)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#1)(1995-3#2)(1995-6#1)(1996-12#1)(1996-3#5)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-2#2)(1997-6#3)(1997-7#1)(2004-12#2)(2004-2#1)(2005-11#4)(2005-8#1)(2005-9#1)(2006-10#10)(2006-11#2)(2006-12#3)(2006-2#3)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#5)(2006-8#7)(2006-9#1)(2007-11#6)(2007-12#2)(2007-2#3)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#10)(2007-8#7)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#6)(2008-5#3)(2008-6#4)(2008-7#9)(2008-9#6)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#2)(2009-6#1)(2009-9#3)(2010-10#2)(2010-12#2)(2010-3#1)(2010-5#3)(2010-6#4)(2010-8#3)(2011-12#2)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#4)
undergraduate and graduate courses##2##4##(2006-5#1)(2009-4#1)
undergraduate and graduate students##3##4##(2005-12#1)(2006-5#1)(2008-1#1)
undergraduate and graduate##6##3##(2005-12#1)(2006-5#2)(2008-1#1)(2008-12#1)(2009-4#1)
undergraduate and postgraduate##5##3##(1994-12#1)(2006-10#1)(2007-10#1)(2008-11#1)(2012-1#1)
undergraduate and##13##2##(1994-12#1)(2005-12#1)(2006-10#1)(2006-5#2)(2007-10#1)(2008-1#1)(2008-11#2)(2008-12#2)(2009-4#1)(2012-1#1)
undergraduate control##2##2##(2008-4#1)(2009-7#1)
undergraduate course##2##2##(2008-11#1)(2012-3#1)
undergraduate courses in##2##3##(2008-1#1)(2008-11#1)
undergraduate courses##3##2##(2008-1#1)(2008-11#1)(2010-9#1)
undergraduate curriculum of##4##3##(2011-2#4)
undergraduate curriculum##7##2##(1996-11#1)(2008-12#1)(2011-2#4)(2013-1#1)
undergraduate dental curriculum##4##3##(2012-1#3)(2013-1#1)
undergraduate dental students in##2##4##(2009-2#1)(2012-2#1)
undergraduate dental students##4##3##(2009-2#1)(2012-1#1)(2012-2#2)
undergraduate dental##11##2##(2009-2#2)(2012-1#5)(2012-2#2)(2013-1#2)
undergraduate education##12##2##(1991-1#1)(1993-3#6)(1994-2#1)(1996-1#1)(2010-3#2)(2013-1#1)
undergraduate female students##3##3##(2007-12#3)
undergraduate health administration##3##3##(1991-1#1)(1992-12#1)(1993-2#1)
undergraduate health##7##2##(1991-1#1)(1992-12#1)(1993-2#1)(2007-12#2)(2008-12#1)(2011-2#1)
undergraduate medical students##4##3##(2006-1#1)(2010-2#1)(2012-2#1)(2013-1#1)
undergraduate medical##10##2##(2005-10#1)(2006-1#1)(2006-10#2)(2008-4#1)(2008-7#1)(2010-2#2)(2012-2#1)(2013-1#1)
undergraduate nurse education##2##3##(2008-12#2)
undergraduate nurse##4##2##(2008-11#1)(2008-12#3)
undergraduate nurses to provide smoking cessation advice and help##2##9##(2012-3#2)
undergraduate nurses to##3##3##(2008-12#1)(2012-3#2)
undergraduate nurses##7##2##(2008-12#5)(2012-3#2)
undergraduate nursing curriculum##2##3##(2008-11#1)(2008-12#1)
undergraduate nursing education##3##3##(2006-5#1)(2008-11#2)
undergraduate nursing students and##2##4##(2008-12#2)
undergraduate nursing students##18##3##(2005-12#1)(2006-12#1)(2007-8#3)(2008-11#8)(2008-12#4)(2011-1#1)
undergraduate nursing##30##2##(2005-12#1)(2006-12#1)(2006-5#1)(2007-8#4)(2008-11#12)(2008-12#8)(2008-6#1)(2011-1#1)(2012-3#1)
undergraduate participants##3##2##(2008-5#1)(2010-7#1)(2012-1#1)
undergraduate programs##5##2##(1991-1#4)(2005-10#1)
undergraduate student##2##2##(2012-1#1)(2012-3#1)
undergraduate students from##2##3##(2005-8#1)(2008-12#1)
undergraduate students of Niger Delta##2##5##(2009-5#2)
undergraduate students of nursing##2##4##(2008-12#2)
undergraduate students of##6##3##(2007-1#1)(2008-12#2)(2009-5#2)(2013-1#1)
undergraduate students were##2##3##(2009-11#1)(2012-2#1)
undergraduate students##18##2##(1995-3#1)(1997-5#1)(2005-8#1)(2007-1#1)(2007-12#1)(2008-11#1)(2008-12#3)(2009-11#1)(2009-5#2)(2010-7#1)(2012-1#1)(2012-2#3)(2013-1#1)
undergraduate students'##2##2##(2008-11#2)
undergraduate training##6##2##(2006-10#1)(2007-6#4)(2012-2#1)
undergraduate women##2##2##(2007-12#2)
undergraduate##188##1##(1991-1#8)(1991-6#1)(1992-12#1)(1993-2#1)(1993-3#6)(1994-12#1)(1994-2#1)(1995-3#1)(1996-1#1)(1996-11#1)(1997-5#1)(2005-10#4)(2005-12#3)(2005-8#1)(2006-1#1)(2006-10#4)(2006-12#3)(2006-5#3)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#10)(2007-6#4)(2007-7#1)(2007-8#4)(2008-1#2)(2008-11#29)(2008-12#28)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-2#2)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#1)(2010-2#2)(2010-3#2)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#6)(2012-1#9)(2012-11#1)(2012-2#8)(2012-3#7)(2013-1#8)(2013-7#1)(2013-8#1)
undergraduates##19##1##(1996-2#1)(2006-10#2)(2007-12#1)(2007-3#2)(2007-4#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-6#1)(2012-1#1)(2012-2#1)
underground coal miners##2##3##(2008-6#2)
underground drinking water##3##3##(2007-10#2)(2008-10#1)
underground is##2##2##(2008-1#2)
underground shovelers##2##2##(2008-6#2)
underground##20##1##(1997-6#1)(2007-1#1)(2007-10#2)(2007-3#1)(2007-7#1)(2008-1#3)(2008-10#5)(2008-6#4)(2008-8#1)(2010-4#1)
underinsurance##2##1##(1994-2#1)(2011-1#1)
underinsured patients##3##2##(2008-11#3)
underinsured##9##1##(1991-4#1)(1992-3#1)(2007-11#1)(2008-11#5)(2011-1#1)
underivatized amino acids##7##3##(2008-10#7)
underivatized##24##1##(1990-10#1)(1990-7#3)(1993-1#1)(1993-2#1)(1995-5#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-3#1)(1997-8#1)(2006-5#1)(2008-10#8)(2010-7#1)(2013-7#1)
underlie a number of##2##4##(1997-7#1)(2010-8#1)
underlie a##5##2##(1996-5#1)(1997-7#1)(2008-10#1)(2009-4#1)(2010-8#1)
underlie membrane##2##2##(1997-4#1)(2011-1#1)
underlie one##2##2##(1996-5#1)(2009-2#1)
underlie the development of##3##4##(1991-8#1)(1993-8#1)(2012-12#1)
underlie the functional##2##3##(2006-12#1)(2012-1#1)
underlie the origin##2##3##(1994-8#1)(2006-5#1)
underlie the##51##2##(1991-8#3)(1993-8#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-2#5)(1996-5#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#2)(2010-4#1)(2011-1#1)(2012-1#2)(2012-11#1)(2012-12#3)(2013-1#1)
underlie these##7##2##(1990-8#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-9#1)(2009-3#1)(2011-2#1)
underlie this##8##2##(1994-3#1)(1996-8#1)(2006-12#1)(2007-5#1)(2008-11#1)(2009-8#1)(2012-12#2)
underlie##143##1##(1990-11#1)(1990-8#1)(1991-1#1)(1991-8#3)(1993-11#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-2#6)(1996-4#1)(1996-5#4)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#5)(2006-12#2)(2006-5#1)(2006-9#2)(2007-11#3)(2007-12#4)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#7)(2008-9#3)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-2#2)(2010-4#3)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#3)(2012-11#1)(2012-12#8)(2012-2#1)(2013-1#6)(2013-8#2)
underlies a##3##2##(1991-6#2)(1994-9#1)
underlies both##2##2##(2013-1#2)
underlies many##2##2##(1994-8#1)(1997-1#1)
underlies the development of##2##4##(2005-10#1)(2008-4#1)
underlies the##17##2##(1991-11#1)(1996-5#1)(2005-10#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
underlies these##2##2##(2010-5#1)(2012-3#1)
underlies##42##1##(1990-5#1)(1991-11#1)(1991-6#2)(1991-8#1)(1992-11#1)(1994-8#1)(1994-9#1)(1996-5#1)(1997-1#1)(1997-2#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)
underline that##9##2##(1991-5#1)(1993-6#1)(1994-11#1)(1996-3#1)(2006-12#1)(2006-2#2)(2008-9#1)(2012-12#1)
underline the importance of the##2##5##(1991-1#1)(2008-11#1)
underline the importance of##12##4##(1990-11#1)(1990-9#1)(1991-1#1)(1991-6#1)(1992-6#1)(1993-3#1)(1995-12#1)(2008-11#1)(2008-12#1)(2008-7#2)(2011-1#1)
underline the need for##5##4##(1990-8#1)(2005-11#1)(2008-1#1)(2008-3#1)(2011-2#1)
underline the potential of##2##4##(2008-10#1)(2008-11#1)
underline the##39##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-12#1)(1997-6#1)(2005-11#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-12#1)(2011-1#3)(2011-2#1)
underline##54##1##(1990-11#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#1)(1995-12#1)(1996-3#1)(1997-6#1)(2005-11#1)(2006-12#1)(2006-2#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-9#1)(2010-12#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
underlined and##2##2##(1990-5#1)(1991-6#1)
underlined in##2##2##(2008-10#1)(2008-2#1)
underlined the diagnostic##2##3##(1991-6#1)(2007-10#1)
underlined the importance of##2##4##(2008-8#1)(2013-1#1)
underlined the##9##2##(1991-10#1)(1991-6#1)(1996-4#1)(2006-10#1)(2006-4#2)(2007-10#1)(2008-8#1)(2013-1#1)
underlined##41##1##(1990-10#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-4#2)(1991-6#2)(1992-1#1)(1992-9#1)(1993-5#1)(1994-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-4#1)(1996-9#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-4#2)(2007-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#5)(2012-2#1)(2013-1#1)
underlines that##2##2##(1991-4#1)(1994-12#1)
underlines the difficulties##2##3##(1990-6#1)(1996-12#1)
underlines the importance of##8##4##(1991-3#1)(1992-6#1)(2005-12#1)(2008-2#1)(2008-8#1)(2011-2#1)(2013-1#2)
underlines the need##2##3##(2007-12#1)(2013-1#1)
underlines the##29##2##(1990-10#1)(1990-6#1)(1991-3#1)(1991-6#1)(1992-5#1)(1992-6#1)(1996-12#1)(1997-1#1)(2005-11#1)(2005-12#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-8#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#4)
underlines##31##1##(1990-10#1)(1990-6#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-5#1)(1992-6#1)(1994-12#1)(1996-12#1)(1997-1#1)(2005-11#1)(2005-12#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-8#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#4)
underling##2##1##(2008-10#1)(2008-5#1)
underlining the importance of##4##4##(1990-8#1)(1992-4#1)(1992-6#1)(1994-8#1)
underlining the need of##2##4##(2006-8#1)(2013-8#1)
underlining the role of##2##4##(2008-5#1)(2012-3#1)
underlining the##16##2##(1990-5#1)(1990-8#1)(1992-4#1)(1992-6#1)(1994-8#1)(1996-3#1)(2005-8#1)(2006-8#1)(2007-5#1)(2008-5#2)(2008-7#1)(2011-2#2)(2012-3#1)(2013-8#1)
underlining##21##1##(1990-5#1)(1990-8#1)(1992-4#1)(1992-6#1)(1994-11#1)(1994-8#1)(1996-3#1)(2005-8#1)(2006-8#1)(2007-5#1)(2007-9#1)(2008-5#2)(2008-7#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
underly##6##1##(1991-12#1)(2008-11#2)(2011-2#1)(2012-12#2)
underlying a##4##2##(1991-12#1)(2008-3#1)(2010-4#1)(2010-9#1)
underlying acute##2##2##(2009-10#2)
underlying aging##2##2##(2009-5#1)(2012-3#1)
underlying anatomical##2##2##(1997-8#1)(2005-7#1)
underlying assumption##2##2##(2008-3#1)(2011-12#1)
underlying assumptions and##3##3##(1995-1#1)(2005-8#1)(2008-7#1)
underlying assumptions of##2##3##(2008-8#1)(2012-2#1)
underlying assumptions##11##2##(1991-8#1)(1992-1#1)(1992-3#1)(1995-1#1)(1996-3#1)(2005-8#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-8#1)(2012-2#1)
underlying basis for##2##3##(2006-4#1)(2008-7#1)
underlying biological and##2##3##(2006-6#1)(2011-1#1)
underlying biological processes##2##3##(2009-8#1)(2010-12#1)
underlying biological##9##2##(2006-6#1)(2008-11#2)(2008-5#1)(2009-10#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-1#1)
underlying biology##7##2##(2007-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-12#1)(2012-2#1)
underlying bone##2##2##(2007-8#1)(2008-7#1)
underlying brain##4##2##(1996-3#1)(2007-12#1)(2011-1#1)(2013-8#1)
underlying cardiac hypertrophy##2##3##(2008-7#2)
underlying cardiac##8##2##(1991-2#1)(2007-2#1)(2008-7#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)
underlying cardiovascular disease##3##3##(2006-2#1)(2010-2#1)(2013-7#1)
underlying cardiovascular##4##2##(2006-2#1)(2010-12#1)(2010-2#1)(2013-7#1)
underlying cause for the##2##4##(2007-11#1)(2010-6#1)
underlying cause for##7##3##(2006-10#1)(2007-10#1)(2007-11#1)(2008-1#1)(2010-6#1)(2011-1#1)(2013-8#1)
underlying cause is##2##3##(1995-5#1)(2010-10#1)
underlying cause of this##2##4##(2009-3#1)(2010-12#1)
underlying cause of##14##3##(1991-12#1)(1994-11#1)(1995-11#1)(1995-2#1)(2007-3#1)(2008-1#2)(2008-11#1)(2008-3#1)(2009-3#1)(2010-10#1)(2010-12#2)(2010-2#1)
underlying cause##31##2##(1991-12#1)(1991-8#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-12#1)(2005-11#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-3#1)(2008-1#4)(2008-11#1)(2008-3#1)(2009-3#1)(2010-10#2)(2010-12#2)(2010-2#2)(2010-6#1)(2011-1#1)(2013-8#1)
underlying causes of##5##3##(1991-12#1)(2007-11#1)(2007-4#1)(2012-2#1)(2013-1#1)
underlying causes##10##2##(1991-12#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-7#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#1)
underlying cellular##6##2##(1992-8#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-7#1)(2009-5#1)
underlying central##2##2##(2006-12#1)(2008-10#1)
underlying chronic liver disease##2##4##(2013-8#2)
underlying chronic##6##2##(1993-2#1)(2008-3#1)(2012-11#1)(2012-12#1)(2013-8#2)
underlying circadian clocks##2##3##(2006-7#1)(2011-1#1)
underlying cognitive##4##2##(1992-9#1)(2006-2#1)(2008-11#1)(2012-2#1)
underlying condition##7##2##(2006-3#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-4#1)(2011-2#2)
underlying conditions##6##2##(1994-3#1)(2005-8#1)(2007-7#1)(2008-5#1)(2008-8#1)(2010-12#1)
underlying constructs##2##2##(1992-1#1)(2010-3#1)
underlying data##4##2##(2010-5#1)(2012-3#1)(2013-1#2)
underlying database##2##2##(2008-4#2)
underlying defect##3##2##(1996-6#1)(1997-7#1)(2004-11#1)
underlying determinants##4##2##(2008-2#1)(2008-3#1)(2012-3#2)
underlying diabetes##2##2##(2009-11#1)(2012-12#1)
underlying different##2##2##(2006-5#1)(2008-5#1)
underlying disease and##6##3##(1994-9#1)(2005-10#1)(2006-11#1)(2007-11#1)(2008-1#1)(2011-3#1)
underlying disease in##2##3##(1992-8#1)(2012-12#1)
underlying disease or##2##3##(2007-7#1)(2011-1#1)
underlying disease##51##2##(1991-2#1)(1992-8#1)(1994-9#1)(1995-9#1)(1997-4#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-6#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#3)(2009-12#1)(2010-12#2)(2010-6#1)(2011-1#1)(2011-2#5)(2011-3#2)(2012-12#1)(2012-2#4)(2013-1#2)(2013-7#2)(2013-8#1)
underlying diseases##12##2##(1991-2#1)(1993-5#1)(1996-3#1)(1997-3#1)(2005-11#1)(2006-10#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)
underlying each##2##2##(2007-8#1)(2010-7#1)
underlying enhanced##2##2##(1994-11#1)(2008-10#1)
underlying epithelial##2##2##(2006-11#1)(2009-5#1)
underlying etiology##2##2##(2008-12#1)(2013-7#1)
underlying factors##5##2##(1997-1#1)(2006-6#1)(2007-2#1)(2008-12#1)(2010-11#1)
underlying genetic basis##3##3##(2006-5#1)(2007-10#1)(2008-6#1)
underlying genetic mechanisms##3##3##(2006-5#2)(2013-1#1)
underlying genetic##18##2##(1991-3#1)(1997-3#1)(2004-11#1)(2006-5#3)(2007-10#1)(2007-12#1)(2008-4#1)(2008-6#1)(2009-10#1)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
underlying health##2##2##(1993-6#1)(1995-2#1)
underlying heart defects##2##3##(2010-10#1)(2010-12#1)
underlying heart disease##2##3##(1995-4#1)(2008-7#1)
underlying heart##4##2##(1995-4#1)(2008-7#1)(2010-10#1)(2010-12#1)
underlying hypothalamic temperature##2##3##(1993-12#2)
underlying ideas##2##2##(2008-7#1)(2009-2#1)
underlying illness##3##2##(1992-2#1)(2007-11#1)(2007-12#1)
underlying illnesses##2##2##(2005-8#1)(2011-1#1)
underlying immune deficiency##2##3##(1994-6#1)(2007-2#1)
underlying immune##6##2##(1994-6#1)(2006-10#1)(2007-2#1)(2008-10#2)(2009-9#1)
underlying in##2##2##(2004-10#1)(2008-4#1)
underlying insulin resistance##2##3##(2008-1#1)(2008-3#1)
underlying intensity##2##2##(2008-2#1)(2010-11#1)
underlying lesion##2##2##(2006-11#1)(2007-10#1)
underlying linear##2##2##(2008-8#1)(2009-8#1)
underlying liver disease##6##3##(1995-9#1)(2006-10#2)(2007-11#1)(2011-2#1)(2013-8#1)
underlying lumbar##2##2##(2006-8#1)(2013-1#1)
underlying lung##2##2##(2005-8#1)(2006-10#1)
underlying malignancy in##3##3##(2006-10#2)(2007-7#1)
underlying malignancy##7##2##(2005-11#1)(2006-10#3)(2007-7#1)(2011-1#1)(2011-2#1)
underlying matrix##3##2##(2008-5#2)(2012-2#1)
underlying mechanism for the##6##4##(1995-2#1)(2006-2#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-12#1)
underlying mechanism is##3##3##(2007-11#1)(2010-7#1)(2012-2#1)
underlying mechanism of this##2##4##(1993-9#1)(2008-1#1)
underlying mechanism of##9##3##(1990-4#1)(1993-9#1)(1995-12#1)(2008-1#2)(2008-7#1)(2009-12#1)(2009-8#1)(2010-7#1)
underlying mechanism was##3##3##(1991-3#1)(2007-10#1)(2008-2#1)
underlying mechanism##40##2##(1990-4#1)(1991-3#1)(1993-4#1)(1993-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-9#1)(2006-2#1)(2006-7#1)(2007-10#2)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2009-12#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-7#2)(2011-1#2)(2011-12#1)(2012-2#4)(2013-1#2)
underlying mechanisms and##5##3##(2007-10#1)(2008-11#1)(2008-4#1)(2011-12#1)(2012-1#1)
underlying mechanisms are##2##3##(2008-3#1)(2010-11#1)
underlying mechanisms for##3##3##(1990-2#1)(2008-11#1)(2013-1#1)
underlying mechanisms in##2##3##(2008-8#1)(2012-2#1)
underlying mechanisms of##19##3##(1995-12#1)(1996-7#1)(2006-10#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
underlying mechanisms that##3##3##(1996-5#1)(2012-1#1)(2013-1#1)
underlying mechanisms##60##2##(1990-2#1)(1992-11#1)(1993-1#1)(1994-8#1)(1995-12#1)(1996-5#1)(1996-7#1)(1997-6#1)(2005-11#1)(2006-10#3)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-3#2)(2009-4#2)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-8#1)(2011-1#1)(2011-12#2)(2012-1#3)(2012-12#3)(2012-2#2)(2013-1#3)
underlying medical##7##2##(2004-11#1)(2005-8#1)(2006-10#1)(2009-9#1)(2011-12#1)(2011-2#1)(2012-2#1)
underlying metabolic##4##2##(2008-3#3)(2012-2#1)
underlying molecular mechanism##3##3##(1995-11#1)(1997-5#1)(2012-2#1)
underlying molecular mechanisms##4##3##(2008-7#1)(2009-8#1)(2010-12#1)(2012-2#1)
underlying molecular##10##2##(1995-11#1)(1997-5#1)(2007-7#2)(2008-11#1)(2008-7#1)(2009-8#1)(2010-12#1)(2012-2#2)
underlying muscle##2##2##(1992-2#1)(2012-12#1)
underlying mutations##3##2##(2008-8#1)(2008-9#1)(2012-11#1)
underlying natural##2##2##(2008-11#2)
underlying network##2##2##(1997-4#1)(2010-10#1)
underlying neural substrates##2##3##(2006-4#1)(2010-12#1)
underlying neural##3##2##(1995-11#1)(2006-4#1)(2010-12#1)
underlying neuropathic pain##2##3##(2006-12#2)
underlying organic heart disease##2##4##(1990-3#1)(2006-2#1)
underlying organic##3##2##(1990-3#1)(2005-8#1)(2006-2#1)
underlying pathological mechanisms##2##3##(2007-11#1)(2008-11#1)
underlying pathology##7##2##(1992-6#1)(1996-1#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)
underlying pathophysiological mechanism##3##3##(2005-10#1)(2008-3#1)(2011-2#1)
underlying pathophysiological mechanisms##3##3##(2008-3#1)(2009-11#1)(2010-12#1)
underlying pathophysiological##7##2##(1990-2#1)(2005-10#1)(2008-3#2)(2009-11#1)(2010-12#1)(2011-2#1)
underlying pathophysiology##9##2##(1996-12#1)(2006-10#1)(2008-10#1)(2008-7#1)(2009-10#1)(2012-2#2)(2012-3#1)(2013-1#1)
underlying physical##2##2##(1997-2#1)(2008-3#1)
underlying point##3##2##(1996-3#2)(2010-11#1)
underlying pollen##2##2##(2011-12#1)(2011-2#1)
underlying population##2##2##(2008-10#1)(2011-2#1)
underlying principles of##2##3##(1997-4#1)(2008-9#1)
underlying principles##4##2##(1997-4#1)(2008-9#3)
underlying problem##3##2##(2008-3#1)(2008-8#1)(2013-1#1)
underlying process##3##2##(1996-11#1)(2009-9#1)(2010-1#1)
underlying processes of language##2##4##(2011-1#2)
underlying processes of##3##3##(2008-10#1)(2011-1#2)
underlying processes such as##2##4##(2005-8#1)(2009-11#1)
underlying processes##6##2##(2005-8#1)(2008-10#1)(2009-11#1)(2010-6#1)(2011-1#2)
underlying psychiatric##2##2##(1991-12#1)(2008-12#1)
underlying psychological##2##2##(2006-2#1)(2009-5#1)
underlying reasons for##2##3##(1996-2#1)(2010-7#1)
underlying reasons##4##2##(1990-3#1)(1996-2#1)(2007-8#1)(2010-7#1)
underlying regulatory mechanisms##2##3##(1994-8#1)(2008-11#1)
underlying regulatory##4##2##(1994-8#1)(2007-11#1)(2008-11#1)(2010-3#1)
underlying renal##2##2##(2005-10#1)(2007-8#1)
underlying resistance##2##2##(2006-10#1)(2009-10#1)
underlying risk##4##2##(1994-2#1)(2006-10#1)(2007-10#1)(2012-12#1)
underlying root##2##2##(1996-3#1)(2012-12#1)
underlying serious##2##2##(1991-4#1)(2011-2#1)
underlying sex change##2##3##(2010-5#2)
underlying sex##3##2##(2010-5#2)(2012-1#1)
underlying sexual development##2##3##(1995-11#1)(2010-3#1)
underlying sexual##3##2##(1995-11#1)(2008-11#1)(2010-3#1)
underlying social##5##2##(1994-1#1)(2008-11#1)(2008-4#1)(2008-8#1)(2013-8#1)
underlying some of##2##3##(1990-5#1)(2010-7#1)
underlying some##3##2##(1990-5#1)(2008-11#1)(2010-7#1)
underlying statistical##2##2##(2006-10#1)(2010-9#1)
underlying stimulation-induced feeding in the sulcal prefrontal cortex##2##8##(1994-3#2)
underlying stimulation-induced feeding##3##3##(1994-3#3)
underlying structure##4##2##(2007-12#1)(2008-1#1)(2008-2#1)(2012-3#1)
underlying structures##5##2##(2007-12#1)(2007-8#3)(2011-2#1)
underlying such##3##2##(2006-10#1)(2008-11#1)(2012-12#1)
underlying synaptic##2##2##(2008-11#1)(2009-9#1)
underlying systemic disease##2##3##(2006-10#1)(2011-2#1)
underlying systemic##4##2##(2006-10#2)(2011-1#1)(2011-2#1)
underlying the HR##2##3##(2008-10#2)
underlying the above-mentioned##2##3##(1995-1#1)(2008-3#1)
underlying the association between##3##4##(1991-8#1)(2009-6#1)(2011-2#1)
underlying the concept of##2##4##(2009-4#1)(2009-8#1)
underlying the development of##9##4##(1996-10#1)(1996-4#1)(2007-5#1)(2008-1#2)(2010-12#2)(2013-1#2)
underlying the development##10##3##(1996-10#1)(1996-4#1)(2006-10#1)(2007-5#1)(2008-1#2)(2010-12#2)(2013-1#2)
underlying the disease##3##3##(2008-8#1)(2010-2#1)(2011-1#1)
underlying the disorder##2##3##(2006-9#1)(2012-3#1)
underlying the establishment and maintenance of##2##6##(2006-10#1)(2008-9#1)
underlying the evolution of##2##4##(2005-8#1)(2009-2#1)
underlying the generation of##3##4##(2008-1#1)(2008-4#1)(2008-7#1)
underlying the observed##2##3##(2009-5#1)(2010-12#1)
underlying the pathophysiology of##2##4##(1992-3#1)(2013-8#1)
underlying the practice of##2##4##(1994-3#1)(2007-12#1)
underlying the regulation of##3##4##(2008-11#1)(2008-8#1)(2011-2#1)
underlying the response##2##3##(1994-10#1)(2008-3#1)
underlying the toxicity##2##3##(1992-11#1)(2009-4#1)
underlying the##175##2##(1990-10#1)(1990-3#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-10#2)(1994-11#3)(1994-2#1)(1994-3#2)(1995-1#3)(1995-12#1)(1995-4#2)(1995-5#1)(1995-8#1)(1996-10#3)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1997-1#1)(2004-11#2)(2004-4#1)(2005-10#1)(2005-11#1)(2005-8#2)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#6)(2007-4#2)(2007-5#1)(2007-7#1)(2008-1#5)(2008-10#3)(2008-11#7)(2008-3#3)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#7)(2009-10#5)(2009-12#2)(2009-2#1)(2009-4#2)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#1)
underlying their##7##2##(1992-7#1)(1996-12#1)(2008-3#1)(2009-3#1)(2010-8#1)(2013-1#1)(2013-7#1)
underlying theoretical##2##2##(2006-8#1)(2013-8#1)
underlying theory of##2##3##(2010-7#1)(2013-1#1)
underlying theory##4##2##(2007-11#1)(2010-7#1)(2012-1#1)(2013-1#1)
underlying these##16##2##(2006-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-11#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-8#1)
underlying this effect##3##3##(1997-1#1)(2008-10#1)(2010-12#1)
underlying this phenomenon##3##3##(2006-10#1)(2008-1#1)(2008-10#1)
underlying this process##4##3##(1993-4#1)(1996-7#1)(2006-10#1)(2012-12#1)
underlying this relationship##2##3##(1996-2#1)(2012-1#1)
underlying this##35##2##(1990-7#1)(1991-3#1)(1992-11#1)(1993-2#1)(1993-4#1)(1995-1#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-4#1)(2006-10#3)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-12#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)
underlying those##2##2##(2007-10#1)(2009-12#1)
underlying tissue##3##2##(1991-2#1)(1991-5#1)(2010-6#1)
underlying tissues##3##2##(2008-10#1)(2008-4#1)(2013-7#1)
underlying tumor##3##2##(1992-12#1)(2008-8#1)(2012-12#1)
underlying tumour##2##2##(1996-1#1)(2009-9#1)
underlying values##2##2##(1994-8#1)(2009-4#1)
underlying vascular##3##2##(1992-11#1)(2007-10#1)(2007-8#1)
underlying vasculitis##2##2##(2006-10#1)(2007-11#1)
underlying wave##3##2##(2008-3#2)(2008-9#1)
underlying##1284##1##(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#6)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#6)(1991-3#4)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#5)(1991-9#3)(1992-1#4)(1992-11#6)(1992-12#2)(1992-2#3)(1992-3#4)(1992-4#1)(1992-6#3)(1992-7#1)(1992-8#3)(1992-9#4)(1993-1#3)(1993-10#1)(1993-11#2)(1993-12#5)(1993-2#4)(1993-3#1)(1993-4#4)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#2)(1994-11#7)(1994-2#7)(1994-3#7)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#8)(1995-11#6)(1995-12#5)(1995-2#3)(1995-3#1)(1995-4#5)(1995-5#4)(1995-7#1)(1995-8#2)(1995-9#4)(1996-1#6)(1996-10#7)(1996-11#1)(1996-12#10)(1996-2#5)(1996-3#9)(1996-4#1)(1996-5#5)(1996-6#1)(1996-7#5)(1996-8#2)(1997-1#5)(1997-2#2)(1997-3#4)(1997-4#7)(1997-5#3)(1997-6#3)(1997-7#1)(1997-8#4)(2004-10#1)(2004-11#5)(2004-4#2)(2004-7#1)(2005-10#5)(2005-11#9)(2005-12#1)(2005-7#3)(2005-8#13)(2006-10#44)(2006-11#7)(2006-12#4)(2006-2#6)(2006-3#3)(2006-4#4)(2006-5#5)(2006-6#5)(2006-7#6)(2006-8#7)(2006-9#3)(2007-10#12)(2007-11#18)(2007-12#32)(2007-2#6)(2007-3#4)(2007-4#6)(2007-5#2)(2007-7#12)(2007-8#16)(2007-9#5)(2008-1#32)(2008-10#28)(2008-11#43)(2008-12#12)(2008-2#16)(2008-3#31)(2008-4#22)(2008-5#18)(2008-6#10)(2008-7#46)(2008-8#30)(2008-9#19)(2009-10#22)(2009-11#6)(2009-12#6)(2009-2#3)(2009-3#4)(2009-4#17)(2009-5#10)(2009-6#4)(2009-7#3)(2009-8#13)(2009-9#10)(2010-1#4)(2010-10#9)(2010-11#13)(2010-12#24)(2010-2#15)(2010-3#5)(2010-4#5)(2010-5#6)(2010-6#8)(2010-7#9)(2010-8#8)(2010-9#5)(2011-1#25)(2011-12#10)(2011-2#35)(2011-3#3)(2012-1#18)(2012-11#7)(2012-12#36)(2012-2#52)(2012-3#17)(2013-1#35)(2013-7#11)(2013-8#20)
undermethylated##4##1##(1990-8#1)(1991-5#1)(1993-6#1)(2007-11#1)
undermine the goals##2##3##(1995-1#1)(2008-11#1)
undermine the##11##2##(1993-12#1)(1994-3#1)(1995-1#1)(2007-8#1)(2008-11#2)(2008-8#1)(2009-9#1)(2010-12#2)(2012-2#1)
undermine##22##1##(1993-12#2)(1994-3#1)(1995-1#2)(1996-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-8#2)(2008-9#1)(2009-11#2)(2009-9#1)(2010-12#2)(2012-12#1)(2012-2#1)(2012-3#1)
undermined by##2##2##(2008-8#1)(2010-2#1)
undermined the##5##2##(1993-5#1)(1996-11#1)(2006-7#1)(2008-12#1)(2012-3#1)
undermined##9##1##(1993-5#1)(1996-11#1)(2006-4#1)(2006-7#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-2#1)(2012-3#1)
undermines the##4##2##(2007-7#1)(2007-8#1)(2007-9#1)(2011-2#1)
undermines##12##1##(1992-2#1)(1997-1#1)(2006-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-2#1)
undermining##10##1##(2006-9#5)(2007-8#1)(2008-10#1)(2008-9#1)(2009-10#1)(2013-1#1)
underneath a##3##2##(2008-2#2)(2012-2#1)
underneath the surface##2##3##(2008-5#2)
underneath the##13##2##(1995-8#1)(1996-6#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2010-2#1)
underneath##25##1##(1994-9#1)(1995-8#1)(1996-6#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-8#2)(2008-11#3)(2008-2#4)(2008-4#1)(2008-5#3)(2009-6#1)(2010-2#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#1)
undernourished##10##1##(1990-2#1)(1991-12#1)(2005-10#1)(2008-2#3)(2008-7#3)(2011-2#1)
undernourishment##3##1##(1990-6#1)(1991-6#1)(1997-6#1)
undernutrition and##2##2##(1991-11#2)
undernutrition in rural##2##3##(1992-10#1)(2006-4#1)
undernutrition##10##1##(1991-11#2)(1992-10#1)(1997-4#1)(2006-4#2)(2008-7#2)(2011-2#1)(2012-12#1)
underperfused##2##1##(2007-11#1)(2007-8#1)
underphosphorylated##5##1##(1993-6#2)(1993-8#1)(1996-2#2)
underpin a##2##2##(2008-9#1)(2012-3#1)
underpin the##4##2##(2008-11#1)(2008-5#1)(2008-9#1)(2009-12#1)
underpin##13##1##(2005-8#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-9#3)(2009-12#1)(2010-9#1)(2012-3#1)(2013-1#1)
underpinned by a##2##3##(2008-10#1)(2011-2#1)
underpinned by##6##2##(2006-3#1)(2008-10#1)(2008-12#2)(2011-12#1)(2011-2#1)
underpinned##7##1##(2006-3#1)(2008-10#1)(2008-12#3)(2011-12#1)(2011-2#1)
underpinning the##4##2##(2005-5#1)(2010-12#1)(2010-4#1)(2013-1#1)
underpinning##13##1##(2005-5#1)(2007-12#1)(2008-11#2)(2008-7#2)(2009-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
underpinnings and##2##2##(2009-6#1)(2011-1#1)
underpinnings of the##9##3##(1996-1#1)(1996-2#1)(1996-3#1)(2006-2#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-11#2)
underpinnings of##27##2##(1991-12#1)(1991-2#1)(1993-2#2)(1993-4#1)(1995-1#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-8#1)(2006-2#1)(2006-5#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-11#3)(2008-4#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
underpinnings##33##1##(1991-12#1)(1991-2#1)(1993-2#2)(1993-4#1)(1995-1#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-8#1)(2006-2#1)(2006-5#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-11#5)(2008-2#1)(2008-4#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
underpins the##5##2##(2008-1#1)(2008-9#2)(2009-9#1)(2010-12#1)
underpins##7##1##(2008-1#1)(2008-7#1)(2008-9#2)(2009-9#1)(2010-12#1)(2012-2#1)
underpowered to##5##2##(2007-8#2)(2010-8#1)(2012-3#2)
underpowered##7##1##(2007-7#1)(2007-8#3)(2010-8#1)(2012-3#2)
underprescribed##2##1##(2004-3#1)(2010-12#1)
underprivileged##5##1##(1991-5#1)(1995-7#1)(2007-5#1)(2007-7#1)(2011-12#1)
underrecognized and##4##2##(2007-4#1)(2007-7#1)(2008-6#1)(2012-3#1)
underrecognized##7##1##(2005-9#1)(2006-10#1)(2007-4#1)(2007-7#1)(2008-6#1)(2008-8#1)(2012-3#1)
underreported in##2##2##(1997-5#1)(2013-1#1)
underreported##7##1##(1997-5#1)(2007-3#1)(2007-7#1)(2008-3#1)(2011-1#2)(2013-1#1)
underreporting of Lyme disease##2##4##(1997-3#2)
underreporting of##5##2##(1992-5#1)(1997-3#2)(2009-10#1)(2012-12#1)
underreporting##15##1##(1991-6#1)(1992-5#1)(1994-6#1)(1997-3#3)(2007-12#1)(2007-2#1)(2009-10#2)(2010-5#1)(2012-12#4)
underrepresent##2##1##(2010-7#1)(2013-1#1)
underrepresented in clinical trials##3##4##(2007-9#1)(2010-8#1)(2013-1#1)
underrepresented in##6##2##(2007-4#1)(2007-9#1)(2008-5#1)(2008-6#1)(2010-8#1)(2013-1#1)
underrepresented minority##2##2##(2012-3#2)
underrepresented##12##1##(2007-4#2)(2007-9#1)(2008-10#1)(2008-5#2)(2008-6#1)(2010-8#1)(2011-1#1)(2012-3#2)(2013-1#1)
undersampled data##2##2##(2006-10#2)
undersampled##9##1##(2006-10#3)(2008-1#1)(2008-2#1)(2008-3#4)
undersampling is##2##2##(2008-2#1)(2012-1#1)
undersampling##6##1##(2008-1#2)(2008-2#3)(2012-1#1)
underscore the importance of##16##4##(1990-6#1)(1991-2#1)(1993-2#1)(1995-12#1)(1996-1#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-2#1)(2013-8#1)
underscore the necessity of##2##4##(1995-6#1)(2009-12#1)
underscore the need for##5##4##(1995-1#1)(2007-4#1)(2007-6#1)(2009-5#1)(2010-1#1)
underscore the need to##2##4##(1991-6#1)(2005-10#1)
underscore the need##7##3##(1991-6#1)(1995-1#1)(2005-10#1)(2007-4#1)(2007-6#1)(2009-5#1)(2010-1#1)
underscore the potential of##2##4##(2009-9#1)(2013-1#1)
underscore the potential##3##3##(2008-7#1)(2009-9#1)(2013-1#1)
underscore the usefulness of##2##4##(1997-7#1)(2011-2#1)
underscore the##47##2##(1990-6#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-5#1)(1993-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1997-1#1)(1997-7#1)(2004-3#1)(2005-10#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-6#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#3)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
underscore##53##1##(1990-6#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-5#1)(1993-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1997-1#1)(1997-7#1)(2004-3#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-4#2)(2007-6#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#3)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
underscored by the##5##3##(1993-7#1)(2005-10#1)(2008-1#1)(2008-5#1)(2012-12#1)
underscored by##7##2##(1993-7#1)(1995-8#1)(2005-10#1)(2008-1#1)(2008-3#1)(2008-5#1)(2012-12#1)
underscored the##5##2##(2007-5#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-4#1)
underscored##16##1##(1990-12#1)(1993-7#1)(1995-8#1)(2005-10#1)(2005-8#1)(2007-5#1)(2008-1#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-4#1)(2012-12#2)
underscores a##2##2##(2011-2#2)
underscores that##2##2##(1996-8#1)(2008-2#1)
underscores the critical##2##3##(1995-3#1)(2008-7#1)
underscores the importance of the##2##5##(1993-9#1)(1996-12#1)
underscores the importance of##13##4##(1990-12#1)(1990-8#1)(1993-9#1)(1996-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
underscores the necessity##2##3##(1992-5#1)(2005-8#1)
underscores the need for##4##4##(1993-5#1)(2005-8#1)(2006-10#1)(2008-9#1)
underscores the need to use##2##5##(2007-5#1)(2009-8#1)
underscores the need to##7##4##(1997-3#1)(2007-5#1)(2007-9#1)(2008-3#1)(2008-9#1)(2009-8#1)(2013-1#1)
underscores the need##11##3##(1993-5#1)(1997-3#1)(2005-8#1)(2006-10#1)(2007-5#1)(2007-9#1)(2008-3#1)(2008-9#2)(2009-8#1)(2013-1#1)
underscores the potential##2##3##(2006-10#1)(2007-11#1)
underscores the##43##2##(1990-12#1)(1990-8#1)(1991-1#1)(1992-5#1)(1993-5#1)(1993-9#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-4#1)(1997-3#2)(2005-8#2)(2006-10#3)(2007-11#1)(2007-5#1)(2007-9#2)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#3)(2008-9#2)(2009-2#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#1)(2012-1#1)(2012-2#2)(2013-1#2)
underscores##49##1##(1990-12#1)(1990-8#1)(1991-1#1)(1992-5#1)(1993-5#1)(1993-9#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-3#2)(2005-8#2)(2006-10#3)(2007-11#1)(2007-12#1)(2007-5#1)(2007-9#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#3)(2008-9#2)(2009-2#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
underscoring a##2##2##(2006-7#1)(2011-1#1)
underscoring the importance of##2##4##(2010-4#1)(2012-1#1)
underscoring the need##2##3##(2007-10#1)(2011-2#1)
underscoring the##9##2##(2007-10#1)(2008-1#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
underscoring##13##1##(2006-7#1)(2007-10#1)(2008-1#1)(2008-8#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
underserved and##2##2##(2007-8#1)(2010-5#1)
underserved areas##2##2##(2008-1#1)(2010-11#1)
underserved communities##3##2##(2012-1#1)(2012-2#2)
underserved populations##6##2##(2005-7#1)(2007-11#1)(2008-3#1)(2008-4#1)(2011-1#1)(2012-3#1)
underserved women##3##2##(1996-2#1)(2011-2#2)
underserved##29##1##(1996-2#1)(1997-1#2)(2005-7#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2010-11#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
underservice##2##1##(1994-3#1)(2012-2#1)
undershoot##2##1##(1996-2#1)(2007-9#1)
undershoot'##2##1##(1997-6#2)
underspecified##3##1##(2006-3#1)(2013-1#2)
understaging##4##1##(1993-5#2)(2008-10#1)(2008-8#1)
understand about##2##2##(2008-7#2)
understand and be##2##3##(1997-4#1)(2013-8#1)
understand and explain##2##3##(1993-8#1)(2012-3#1)
understand and respond to##2##4##(1994-3#1)(2011-2#1)
understand and##40##2##(1991-9#1)(1992-1#1)(1993-8#1)(1994-2#2)(1994-3#1)(1996-1#1)(1997-3#1)(1997-4#1)(2006-5#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-10#1)(2010-11#2)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
understand better the role of##3##5##(1994-8#1)(1994-9#1)(2007-12#1)
understand better the##5##3##(1994-8#1)(1994-9#2)(2007-12#1)(2009-12#1)
understand better##8##2##(1993-5#1)(1994-3#1)(1994-8#1)(1994-9#2)(2007-12#1)(2009-12#1)(2010-2#1)
understand biological##2##2##(2009-7#1)(2011-1#1)
understand both##2##2##(2010-10#1)(2013-1#1)
understand cellular##2##2##(2004-11#1)(2008-11#1)
understand clinical##2##2##(2007-4#1)(2011-1#1)
understand current##2##2##(1995-1#1)(2007-4#1)
understand gene##2##2##(2008-7#1)(2008-8#1)
understand how an##2##3##(2007-12#1)(2009-7#1)
understand how best to##3##4##(2007-9#1)(2011-2#1)(2012-3#1)
understand how such##3##3##(2008-1#1)(2008-11#1)(2010-5#1)
understand how the##13##3##(1992-3#1)(1993-6#1)(1997-6#1)(2006-10#1)(2007-8#1)(2008-12#1)(2008-3#2)(2008-5#1)(2009-10#1)(2010-4#1)(2010-6#1)(2011-2#1)
understand how they##3##3##(2007-2#1)(2008-8#1)(2011-1#1)
understand how##66##2##(1992-3#1)(1993-5#1)(1993-6#1)(1994-11#1)(1995-5#1)(1995-6#1)(1996-4#2)(1997-4#1)(1997-6#1)(2006-10#3)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-11#3)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
understand human##2##2##(2007-4#1)(2008-10#1)
understand if##4##2##(2010-2#2)(2012-2#1)(2013-7#1)
understand individual##2##2##(2008-7#1)(2012-3#1)
understand its##9##2##(1993-12#1)(2006-3#1)(2008-2#1)(2008-5#2)(2009-10#1)(2010-2#1)(2010-4#1)(2010-7#1)
understand mechanisms##4##2##(2008-11#2)(2008-9#1)(2013-1#1)
understand more about the##3##4##(2007-11#1)(2008-11#1)(2009-6#1)
understand more about##6##3##(2007-11#1)(2008-1#1)(2008-11#2)(2008-7#1)(2009-6#1)
understand more##7##2##(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-7#1)(2009-6#1)
understand one##2##2##(2006-7#1)(2012-3#1)
understand our##2##2##(1996-3#1)(2006-10#1)
understand patient perceptions##2##3##(1996-1#1)(2008-8#1)
understand potential##3##2##(2013-1#3)
understand processes of##2##3##(2008-7#1)(2010-4#1)
understand processes##3##2##(2008-7#1)(2010-4#1)(2012-2#1)
understand some##3##2##(2008-12#1)(2008-9#2)
understand that in the##2##4##(1993-3#1)(2008-1#1)
understand that the##3##3##(2006-10#1)(2006-7#1)(2009-9#1)
understand that##20##2##(1991-1#1)(1992-3#1)(1993-3#1)(1995-12#1)(1996-3#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-10#1)(2008-1#2)(2008-11#2)(2009-10#1)(2009-9#1)(2010-1#1)(2010-8#1)(2012-1#1)
understand the advantages and##3##4##(2004-2#1)(2009-3#1)(2010-8#1)
understand the basic##2##3##(2006-2#1)(2011-1#1)
understand the basis for##2##4##(1996-11#1)(1997-7#1)
understand the basis of##2##4##(1997-2#1)(2008-10#1)
understand the basis##4##3##(1996-11#1)(1997-2#1)(1997-7#1)(2008-10#1)
understand the behavior of##3##4##(2008-3#1)(2011-2#1)(2012-12#1)
understand the benefits##3##3##(2008-6#1)(2010-2#1)(2013-1#1)
understand the biochemical##2##3##(1990-8#1)(2008-7#1)
understand the biological significance of the##2##6##(2010-12#1)(2012-3#1)
understand the biological##5##3##(1993-8#1)(2007-6#1)(2010-12#1)(2011-1#1)(2012-3#1)
understand the biology of##3##4##(2010-3#1)(2011-1#1)(2012-12#1)
understand the causes and consequences of##2##6##(2008-8#1)(2010-3#1)
understand the complex##7##3##(2008-11#1)(2008-4#1)(2010-12#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
understand the concept of##3##4##(1997-7#1)(2009-7#1)(2012-3#1)
understand the consequences##5##3##(1994-2#1)(2008-2#1)(2008-4#2)(2009-5#1)
understand the contribution of##2##4##(1994-3#1)(2010-5#1)
understand the current##3##3##(2007-4#1)(2011-2#1)(2012-12#1)
understand the determinants of##2##4##(1991-4#1)(1996-3#1)
understand the development of##2##4##(2008-10#1)(2012-3#1)
understand the development##4##3##(2008-10#1)(2008-12#2)(2012-3#1)
understand the developmental##2##3##(1995-2#1)(1996-3#1)
understand the difference##2##3##(1996-1#1)(1997-6#1)
understand the distribution##2##3##(2007-8#1)(2009-12#1)
understand the dynamics and##3##4##(2012-1#1)(2012-3#2)
understand the dynamics of##7##4##(1994-2#1)(2007-9#1)(2008-10#1)(2008-2#1)(2009-3#1)(2010-9#1)(2012-1#1)
understand the dynamics##10##3##(1994-2#1)(2007-9#1)(2008-10#1)(2008-2#1)(2009-3#1)(2010-9#1)(2012-1#2)(2012-3#2)
understand the effects of##7##4##(1990-10#1)(1996-11#1)(1996-4#1)(1997-7#1)(2007-12#1)(2013-8#2)
understand the epidemiology of##2##4##(2008-10#1)(2008-11#1)
understand the evolution and##2##4##(2008-10#1)(2010-3#1)
understand the evolution of##2##4##(2008-11#1)(2009-2#1)
understand the evolution##4##3##(2008-10#1)(2008-11#1)(2009-2#1)(2010-3#1)
understand the factors that##2##4##(2008-7#1)(2012-2#1)
understand the factors which##4##4##(2007-10#1)(2007-6#1)(2013-1#2)
understand the factors##9##3##(2006-12#1)(2007-10#1)(2007-6#1)(2008-10#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#2)
understand the formation##2##3##(1992-6#1)(2012-2#1)
understand the function of##8##4##(1995-10#1)(1996-12#1)(1997-8#1)(2006-12#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-12#1)
understand the functional##5##3##(1992-11#1)(1992-4#1)(2007-12#1)(2008-4#1)(2009-9#1)
understand the fundamental##2##3##(1996-7#1)(2010-4#1)
understand the genesis of##2##4##(1996-8#1)(2008-12#1)
understand the genetic##6##3##(1994-9#1)(2008-10#2)(2008-8#1)(2012-1#1)(2013-8#1)
understand the geographical##2##3##(2008-10#1)(2012-3#1)
understand the impact of##3##4##(1995-12#1)(2007-12#1)(2008-10#1)
understand the importance of##3##4##(1994-12#1)(2008-1#2)
understand the importance##4##3##(1994-12#1)(2008-1#2)(2009-8#1)
understand the indications for##2##4##(2008-7#1)(2012-3#1)
understand the influence of##5##4##(1990-7#1)(1991-12#1)(2004-9#1)(2006-11#1)(2013-8#1)
understand the long-term##2##3##(2011-2#1)(2012-12#1)
understand the mechanism of##11##4##(1991-12#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-12#1)(2004-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2013-8#1)
understand the mechanism underlying##2##4##(1993-4#1)(2009-4#1)
understand the mechanism##17##3##(1991-12#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-4#1)(1994-11#1)(1994-12#1)(2004-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-6#1)(2008-8#2)(2009-4#1)(2013-8#1)
understand the mechanisms that##2##4##(2008-10#1)(2010-8#1)
understand the mechanisms underlying the##2##5##(1992-4#1)(1994-10#1)
understand the mechanisms##13##3##(1992-4#1)(1993-12#1)(1994-10#1)(1995-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2010-12#1)(2010-4#1)(2010-8#1)
understand the metabolic##2##3##(1993-12#1)(2012-2#1)
understand the microbial##2##3##(2008-5#1)(2012-2#1)
understand the molecular basis of##7##5##(1997-1#1)(1997-2#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-2#1)
understand the molecular basis##8##4##(1997-1#1)(1997-2#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-2#1)
understand the molecular events##2##4##(1995-8#1)(2005-8#1)
understand the molecular mechanism of##5##5##(1992-8#1)(1993-8#1)(1994-11#1)(1995-2#1)(1997-5#1)
understand the molecular mechanism##6##4##(1992-8#1)(1993-8#1)(1994-11#1)(1995-2#1)(1997-5#1)(2012-2#1)
understand the molecular mechanisms of##2##5##(2008-10#1)(2008-4#1)
understand the molecular mechanisms##4##4##(2008-10#2)(2008-4#1)(2011-1#1)
understand the molecular##23##3##(1992-8#1)(1993-8#1)(1994-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-5#1)(2005-8#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-9#1)(2011-1#2)(2012-2#2)(2013-8#1)
understand the nature of##6##4##(2006-8#1)(2008-10#3)(2009-8#1)(2010-7#1)
understand the nature##10##3##(2006-10#1)(2006-8#1)(2008-10#4)(2008-5#1)(2009-8#1)(2010-7#1)(2012-12#1)
understand the needs##2##3##(2007-3#1)(2013-1#1)
understand the origin of##3##4##(1996-4#1)(2010-5#1)(2012-12#1)
understand the origin##4##3##(1996-4#1)(2008-5#1)(2010-5#1)(2012-12#1)
understand the pathophysiological##2##3##(2007-11#1)(2010-12#1)
understand the pathophysiology of##5##4##(1996-12#1)(2008-1#2)(2008-10#1)(2008-7#1)
understand the pathophysiology##7##3##(1996-12#1)(2006-5#1)(2008-1#2)(2008-10#1)(2008-7#1)(2008-9#1)
understand the performance of##2##4##(2008-5#1)(2008-7#1)
understand the physical##4##3##(2007-12#1)(2008-1#1)(2008-5#1)(2008-7#1)
understand the physiological significance of the##2##6##(1994-6#1)(2010-3#1)
understand the physiological##4##3##(1993-11#1)(1994-6#1)(1997-2#1)(2010-3#1)
understand the potential##5##3##(1994-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)
understand the prevalence of##2##4##(2011-1#2)
understand the process of##3##4##(2006-11#1)(2011-2#1)(2012-3#1)
understand the process##4##3##(2006-11#1)(2008-5#1)(2011-2#1)(2012-3#1)
understand the processes##2##3##(2007-8#1)(2009-3#1)
understand the properties of##2##4##(2008-12#1)(2012-1#1)
understand the regulation of##3##4##(1996-5#1)(2009-10#1)(2010-10#1)
understand the regulation##5##3##(1990-4#1)(1992-11#1)(1996-5#1)(2009-10#1)(2010-10#1)
understand the relationship between maternal depressed mood and##2##8##(2010-2#2)
understand the relationship between##14##4##(1995-2#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
understand the relationship of##2##4##(1993-2#1)(2007-4#1)
understand the relationship##16##3##(1993-2#1)(1995-2#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
understand the response##2##3##(2008-10#1)(2012-2#1)
understand the role of the##3##5##(1997-6#1)(2008-7#1)(2012-3#1)
understand the role of these##2##5##(2006-8#1)(2008-11#1)
understand the role of this##2##5##(1991-6#1)(2008-6#1)
understand the role of##19##4##(1991-6#1)(1994-11#1)(1996-9#1)(1997-2#1)(1997-6#1)(2005-10#2)(2006-8#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-7#2)(2012-2#1)(2012-3#1)
understand the role##20##3##(1991-6#1)(1994-11#1)(1996-9#1)(1997-2#1)(1997-6#1)(2005-10#2)(2006-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-7#2)(2012-2#1)(2012-3#1)
understand the separation mechanism##2##4##(1996-8#1)(2011-2#1)
understand the significance of##3##4##(1996-7#1)(2007-7#1)(2012-12#1)
understand the social##2##3##(2011-2#1)(2013-1#1)
understand the structural and##2##4##(1995-3#1)(2009-2#1)
understand the structural basis##2##4##(1993-8#1)(1997-9#1)
understand the structural##5##3##(1993-8#1)(1995-3#1)(1997-9#1)(2008-8#1)(2009-2#1)
understand the##515##2##(1990-10#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-12#3)(1991-3#1)(1991-4#1)(1991-6#1)(1992-11#3)(1992-12#1)(1992-3#1)(1992-4#2)(1992-6#2)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#4)(1995-3#2)(1995-5#2)(1995-8#1)(1996-1#2)(1996-11#3)(1996-12#2)(1996-2#2)(1996-3#3)(1996-4#3)(1996-5#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#2)(1997-9#1)(2004-12#1)(2004-2#1)(2004-9#1)(2005-10#3)(2005-3#1)(2005-7#1)(2005-8#1)(2006-10#9)(2006-11#3)(2006-12#2)(2006-2#3)(2006-5#3)(2006-7#2)(2006-8#5)(2007-1#1)(2007-10#6)(2007-11#5)(2007-12#11)(2007-2#1)(2007-3#3)(2007-4#5)(2007-5#1)(2007-6#3)(2007-7#3)(2007-8#3)(2007-9#4)(2008-1#8)(2008-10#37)(2008-11#20)(2008-12#7)(2008-2#7)(2008-3#10)(2008-4#12)(2008-5#11)(2008-6#4)(2008-7#13)(2008-8#7)(2008-9#6)(2009-1#1)(2009-10#4)(2009-11#2)(2009-12#5)(2009-2#3)(2009-3#5)(2009-4#2)(2009-5#4)(2009-6#1)(2009-7#5)(2009-8#5)(2009-9#5)(2010-10#1)(2010-12#7)(2010-2#3)(2010-3#4)(2010-4#3)(2010-5#3)(2010-7#1)(2010-8#6)(2010-9#4)(2011-1#11)(2011-12#1)(2011-2#11)(2012-1#5)(2012-11#1)(2012-12#19)(2012-2#18)(2012-3#14)(2013-1#18)(2013-7#2)(2013-8#11)
understand their possible##2##3##(2005-8#1)(2009-10#1)
understand their role and##2##4##(1990-12#1)(2008-3#1)
understand their role##3##3##(1990-12#1)(2008-3#1)(2008-5#1)
understand their##36##2##(1990-12#1)(1993-1#1)(1993-2#2)(1994-3#1)(1997-1#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-3#1)(2007-9#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
understand these##12##2##(1993-3#1)(1994-11#1)(2004-12#1)(2005-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-12#1)(2011-2#1)
understand this phenomenon##7##3##(2006-7#2)(2009-9#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
understand this process##2##3##(1994-2#1)(2008-7#1)
understand this##24##2##(1992-6#1)(1994-2#2)(1994-8#1)(1996-12#1)(2006-7#2)(2007-12#2)(2007-7#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-10#1)(2009-9#2)(2010-12#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
understand what it##2##3##(2009-10#1)(2012-1#1)
understand what##12##2##(1996-6#1)(2006-10#1)(2006-7#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#1)(2012-1#2)(2013-8#2)
understand when##2##2##(2008-11#1)(2008-2#1)
understand whether##4##2##(1997-4#1)(2008-5#1)(2012-2#1)(2013-1#1)
understand which##2##2##(1991-3#1)(2008-11#1)
understand why##13##2##(1990-9#1)(1997-6#1)(2006-6#1)(2006-8#1)(2006-9#1)(2008-10#1)(2010-2#2)(2010-4#1)(2010-8#2)(2012-3#1)(2013-8#1)
understand##981##1##(1990-10#2)(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#2)(1990-9#2)(1991-1#1)(1991-12#3)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#4)(1992-4#2)(1992-6#4)(1992-8#1)(1993-1#2)(1993-11#2)(1993-12#4)(1993-2#3)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#3)(1993-8#4)(1993-9#1)(1994-10#1)(1994-11#5)(1994-12#3)(1994-2#6)(1994-3#8)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#4)(1995-1#2)(1995-10#1)(1995-12#5)(1995-2#5)(1995-3#4)(1995-5#3)(1995-6#1)(1995-8#1)(1996-1#4)(1996-11#3)(1996-12#4)(1996-2#2)(1996-3#6)(1996-4#5)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#4)(1997-3#4)(1997-4#7)(1997-5#1)(1997-6#6)(1997-7#3)(1997-8#2)(1997-9#1)(2004-11#2)(2004-12#2)(2004-2#2)(2004-9#1)(2005-10#5)(2005-11#1)(2005-3#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#21)(2006-11#3)(2006-12#4)(2006-2#4)(2006-3#1)(2006-5#5)(2006-6#1)(2006-7#9)(2006-8#8)(2006-9#1)(2007-1#1)(2007-10#9)(2007-11#6)(2007-12#20)(2007-2#4)(2007-3#4)(2007-4#10)(2007-5#2)(2007-6#5)(2007-7#4)(2007-8#7)(2007-9#11)(2008-1#14)(2008-10#50)(2008-11#39)(2008-12#16)(2008-2#15)(2008-3#17)(2008-4#15)(2008-5#21)(2008-6#7)(2008-7#27)(2008-8#19)(2008-9#16)(2009-1#1)(2009-10#11)(2009-11#4)(2009-12#8)(2009-2#6)(2009-3#6)(2009-4#6)(2009-5#7)(2009-6#7)(2009-7#10)(2009-8#8)(2009-9#9)(2010-1#3)(2010-10#5)(2010-11#3)(2010-12#12)(2010-2#10)(2010-3#7)(2010-4#9)(2010-5#8)(2010-6#3)(2010-7#5)(2010-8#11)(2010-9#5)(2011-1#21)(2011-10#1)(2011-12#2)(2011-2#20)(2012-1#14)(2012-11#1)(2012-12#24)(2012-2#33)(2012-3#24)(2013-1#48)(2013-7#6)(2013-8#22)
understandable language##2##2##(1992-12#1)(1996-2#1)
understandable##14##1##(1992-12#1)(1995-12#1)(1996-11#1)(1996-2#1)(1996-3#1)(2006-12#1)(2007-8#1)(2008-11#2)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
understandably##2##1##(1993-3#1)(2012-2#1)
understanding a##4##2##(2008-7#1)(2010-3#1)(2010-8#1)(2011-12#1)
understanding about the##3##3##(1992-8#1)(2011-2#1)(2012-1#1)
understanding about##10##2##(1992-6#1)(1992-8#1)(1994-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#1)(2012-1#1)(2013-1#1)
understanding among##3##2##(1995-3#1)(1997-2#1)(2010-2#1)
understanding and appreciation of##2##4##(2008-1#1)(2009-8#1)
understanding and appreciation##3##3##(2005-10#1)(2008-1#1)(2009-8#1)
understanding and improve##3##3##(2004-10#1)(2006-11#1)(2012-12#1)
understanding and interpretation of##5##4##(2008-7#2)(2009-12#1)(2013-1#2)
understanding and management##2##3##(2006-9#1)(2011-2#1)
understanding and managing##3##3##(2006-10#1)(2006-9#1)(2009-6#1)
understanding and predicting the##2##4##(2007-1#1)(2007-12#1)
understanding and predicting##5##3##(2007-1#1)(2007-12#1)(2012-1#1)(2013-1#2)
understanding and the##3##3##(2006-10#1)(2008-6#1)(2009-4#1)
understanding and treating##4##3##(1995-2#1)(2008-7#1)(2010-11#1)(2012-12#1)
understanding and treatment of##4##4##(1994-5#1)(1995-6#1)(2008-4#1)(2008-7#1)
understanding and##85##2##(1991-12#1)(1992-12#1)(1993-12#1)(1994-12#1)(1994-5#2)(1995-2#1)(1995-6#1)(1996-1#1)(1997-3#1)(1997-8#1)(2004-10#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#4)(2006-11#1)(2006-3#1)(2006-7#1)(2006-8#1)(2006-9#3)(2007-1#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#3)(2009-4#4)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#11)
understanding are##2##2##(2010-11#1)(2012-2#1)
understanding as##6##2##(1993-1#1)(1996-2#1)(1997-8#1)(2006-10#1)(2006-7#1)(2008-12#1)
understanding better the##2##3##(1996-12#1)(2006-10#1)
understanding between##4##2##(1993-9#1)(2006-7#1)(2013-1#1)(2013-8#1)
understanding biological systems##2##3##(2009-12#1)(2012-2#1)
understanding biological##4##2##(2008-5#1)(2009-12#1)(2011-2#1)(2012-2#1)
understanding both##3##2##(2008-11#1)(2009-5#1)(2010-6#1)
understanding customer##2##2##(1996-2#1)(1996-3#1)
understanding details of##2##3##(2007-12#1)(2008-3#1)
understanding development##4##2##(2012-1#3)(2013-8#1)
understanding different##3##2##(2007-12#1)(2008-12#1)(2009-4#1)
understanding evolution##2##2##(1997-8#1)(2012-3#1)
understanding evolutionary##2##2##(2008-10#1)(2012-3#1)
understanding failures and building on successes##2##6##(2013-1#2)
understanding fasciolosis transmission in the Andes##2##6##(2008-8#2)
understanding for##2##2##(1996-10#1)(2008-12#1)
understanding functional##2##2##(2010-7#1)(2010-8#1)
understanding how consumers##2##3##(2008-8#2)
understanding how different##2##3##(1996-3#1)(2006-2#1)
understanding how the##5##3##(1995-11#1)(2006-10#1)(2006-2#1)(2008-2#1)(2010-2#1)
understanding how these##2##3##(2009-10#1)(2010-2#1)
understanding how they##2##3##(1994-11#1)(2008-9#1)
understanding how to best##2##4##(2006-10#1)(2008-6#1)
understanding how to##4##3##(2005-9#1)(2006-10#1)(2008-6#1)(2008-9#1)
understanding how##36##2##(1991-12#1)(1993-11#1)(1994-11#1)(1995-11#1)(1996-3#1)(1996-5#1)(1997-1#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-2#2)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#1)(2010-2#2)(2011-2#1)(2012-2#3)(2013-1#2)
understanding human##3##2##(1995-8#1)(2008-11#1)(2012-3#1)
understanding in systems biology##3##4##(2006-10#3)
understanding in the##4##3##(2008-10#1)(2008-5#1)(2010-10#1)(2011-2#1)
understanding in this##2##3##(1992-9#1)(1997-1#1)
understanding in##17##2##(1992-9#1)(1997-1#1)(2004-9#1)(2006-10#4)(2006-12#1)(2007-4#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-6#1)(2011-2#1)(2012-1#1)
understanding individual differences##2##3##(2008-5#1)(2009-9#1)
understanding individual##3##2##(1997-3#1)(2008-5#1)(2009-9#1)
understanding interactions between##2##3##(2007-11#1)(2008-10#1)
understanding interactions##3##2##(2007-11#1)(2008-10#1)(2008-8#1)
understanding is a##3##3##(2008-12#1)(2008-9#1)(2010-3#1)
understanding is##15##2##(1990-12#1)(1991-12#1)(1995-11#1)(1996-3#1)(1997-3#1)(2006-10#1)(2008-12#2)(2008-8#1)(2008-9#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
understanding its##7##2##(1995-3#1)(2006-10#1)(2007-1#1)(2007-11#1)(2010-1#1)(2011-1#1)(2013-1#1)
understanding long-term##2##2##(2009-9#1)(2010-2#1)
understanding mechanisms of##8##3##(1990-4#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-8#1)(2010-11#1)(2012-2#2)
understanding mechanisms##11##2##(1990-4#1)(1997-6#1)(2006-10#2)(2007-12#1)(2008-11#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-2#2)
understanding molecular##2##2##(2011-2#1)(2013-8#1)
understanding of C##2##3##(2007-12#1)(2011-2#1)
understanding of MYC##2##3##(2011-1#2)
understanding of PHC##2##3##(2010-11#2)
understanding of T##2##3##(2008-4#1)(2011-12#1)
understanding of a##7##3##(1996-8#1)(2006-7#1)(2008-12#1)(2008-7#2)(2013-1#2)
understanding of all##2##3##(1995-12#1)(2010-7#1)
understanding of bacterial##3##3##(2008-10#2)(2012-2#1)
understanding of basic##3##3##(2006-10#2)(2006-4#1)
understanding of biofilm formation##2##4##(2006-11#1)(2011-11#1)
understanding of biological processes##2##4##(1991-5#1)(2009-12#1)
understanding of biological##4##3##(1991-5#1)(2008-10#1)(2009-12#1)(2010-9#1)
understanding of both the##3##4##(2008-10#1)(2010-3#1)(2012-1#1)
understanding of both##5##3##(2008-10#1)(2009-12#1)(2010-3#2)(2012-1#1)
understanding of brain function##2##4##(1997-5#1)(2009-5#1)
understanding of brain##3##3##(1997-5#1)(2007-4#1)(2009-5#1)
understanding of cancer##4##3##(2007-11#1)(2009-12#1)(2009-6#1)(2012-12#1)
understanding of cell##2##3##(2008-7#2)
understanding of cellular physiology##2##4##(1994-11#1)(2005-7#1)
understanding of cellular##5##3##(1994-11#1)(2005-7#1)(2007-8#1)(2008-7#2)
understanding of changes##2##3##(2008-3#1)(2008-9#1)
understanding of climate change##2##4##(2007-8#1)(2013-8#1)
understanding of clinical##2##3##(2008-11#2)
understanding of community##3##3##(1993-1#1)(2008-12#1)(2011-1#1)
understanding of complex##3##3##(2007-12#1)(2007-9#1)(2009-4#1)
understanding of coronary vasospasm##2##4##(2010-12#2)
understanding of cortical##2##3##(2011-12#1)(2013-1#1)
understanding of current##2##3##(2008-8#1)(2013-8#1)
understanding of disease pathogenesis and##2##5##(2006-10#1)(2010-6#1)
understanding of disease pathophysiology and##2##5##(2007-10#1)(2010-9#1)
understanding of disease pathophysiology##3##4##(2006-10#1)(2007-10#1)(2010-9#1)
understanding of disease##9##3##(1997-7#1)(2006-10#2)(2007-10#1)(2008-10#1)(2010-6#1)(2010-9#1)(2011-7#1)(2013-8#1)
understanding of diseases##2##3##(2005-8#1)(2006-10#1)
understanding of each##3##3##(2006-10#1)(2009-4#1)(2012-11#1)
understanding of epidemiology##2##3##(2011-2#1)(2012-12#1)
understanding of evolutionary##3##3##(2008-7#1)(2010-7#1)(2013-8#1)
understanding of function##2##3##(2008-12#1)(2009-12#1)
understanding of fundamental##4##3##(1995-3#1)(2008-11#1)(2009-8#1)(2010-2#1)
understanding of gene regulation##2##4##(2008-7#1)(2010-12#1)
understanding of gene##6##3##(2008-4#1)(2008-7#1)(2009-2#1)(2010-10#1)(2010-12#1)(2012-3#1)
understanding of general##2##3##(1990-12#1)(2008-9#1)
understanding of health##4##3##(1993-3#1)(2009-8#1)(2013-1#2)
understanding of how and##2##4##(2008-9#1)(2013-7#1)
understanding of how parents##2##4##(1993-12#1)(2010-9#1)
understanding of how the##4##4##(1993-1#1)(2005-11#1)(2009-12#1)(2011-1#1)
understanding of how these##6##4##(2005-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)
understanding of how##59##3##(1991-12#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-2#1)(1996-11#1)(1997-3#1)(2005-11#2)(2006-10#7)(2006-11#2)(2006-2#1)(2007-12#2)(2008-10#4)(2008-11#2)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#5)(2009-12#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-3#1)(2010-9#3)(2011-1#1)(2011-2#3)(2012-12#2)(2013-7#1)
understanding of human health##2##4##(1993-9#1)(2006-6#1)
understanding of human##6##3##(1991-4#1)(1993-9#1)(2006-6#1)(2007-2#1)(2008-11#1)(2008-4#1)
understanding of immune##6##3##(1996-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-4#1)(2011-1#1)
understanding of immunology and##2##4##(2007-11#1)(2008-11#1)
understanding of individual##3##3##(2007-4#1)(2008-10#1)(2012-1#1)
understanding of influence##2##3##(2007-8#1)(2008-5#1)
understanding of interactions between##5##4##(2005-11#1)(2008-11#1)(2010-12#2)(2011-1#1)
understanding of iron's role in##2##5##(2012-2#2)
understanding of isthmus-dependent##2##3##(2006-9#2)
understanding of its role in##4##5##(2007-12#1)(2011-2#1)(2013-1#2)
understanding of its##24##3##(1990-12#1)(1991-2#1)(1991-8#1)(1994-3#1)(1997-1#1)(2006-2#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#2)(2013-1#3)
understanding of learning##2##3##(2007-8#1)(2013-1#1)
understanding of life##2##3##(2005-8#1)(2008-4#1)
understanding of mammalian##2##3##(2008-11#1)(2008-8#1)
understanding of mechanisms##6##3##(1997-3#1)(1997-5#1)(2012-12#1)(2012-2#2)(2013-1#1)
understanding of mental##2##3##(2008-12#2)
understanding of molecular##5##3##(2005-7#1)(2006-10#1)(2007-10#1)(2008-11#1)(2011-2#1)
understanding of natural##2##3##(2008-7#1)(2012-3#1)
understanding of neurogenesis##2##3##(2007-12#1)(2008-9#1)
understanding of pain##2##3##(2006-10#1)(2006-12#1)
understanding of pathogenesis and##2##4##(2005-8#1)(2010-12#1)
understanding of pathogenesis##3##3##(2005-8#1)(2007-11#1)(2010-12#1)
understanding of pathophysiology##3##3##(2006-10#1)(2008-9#1)(2013-1#1)
understanding of pediatric##2##3##(2010-5#1)(2011-2#1)
understanding of physiological##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
understanding of plant##2##3##(2008-7#1)(2012-1#1)
understanding of problems##2##3##(1992-1#1)(2007-9#1)
understanding of pulmonary##2##3##(1997-3#1)(2005-9#1)
understanding of risk factors##2##4##(2008-8#1)(2012-3#1)
understanding of several##2##3##(2008-7#1)(2008-9#1)
understanding of skin##2##3##(2008-5#2)
understanding of some of the##2##5##(2008-4#1)(2009-12#1)
understanding of some##4##3##(1993-12#1)(1993-3#1)(2008-4#1)(2009-12#1)
understanding of such##5##3##(2005-11#1)(2007-12#1)(2008-7#1)(2008-8#1)(2009-5#1)
understanding of the action of##3##5##(1995-6#1)(1997-2#1)(2012-3#1)
understanding of the aetiology and##2##5##(1997-1#1)(2006-10#1)
understanding of the aetiology##4##4##(1997-1#1)(2006-10#1)(2009-4#2)
understanding of the anatomy and##2##5##(2007-8#1)(2008-8#1)
understanding of the animal##2##4##(2007-12#1)(2010-4#1)
understanding of the association##2##4##(2008-7#1)(2009-11#1)
understanding of the basic mechanisms##4##5##(2006-10#1)(2010-10#1)(2013-1#2)
understanding of the basic##7##4##(2006-10#2)(2007-12#1)(2009-4#1)(2010-10#1)(2013-1#2)
understanding of the biological##6##4##(1991-4#1)(1996-6#1)(2008-7#1)(2009-11#1)(2012-2#1)(2013-8#1)
understanding of the biology and##4##5##(2006-10#1)(2008-10#1)(2012-3#1)(2013-1#1)
understanding of the biology of the##4##6##(2008-10#1)(2008-3#1)(2008-7#1)(2010-12#1)
understanding of the biology of##15##5##(1997-3#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
understanding of the biology##19##4##(1997-3#1)(2006-10#2)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#2)(2013-1#2)
understanding of the biomechanical##2##4##(2006-7#1)(2008-8#1)
understanding of the biomolecular##2##4##(1991-9#1)(2008-1#1)
understanding of the brain##4##4##(1990-6#1)(1997-5#1)(2008-2#1)(2009-9#1)
understanding of the causal##2##4##(2008-6#1)(2011-1#1)
understanding of the cellular and molecular##2##6##(2006-11#1)(2007-11#1)
understanding of the cellular interactions##2##5##(1992-12#1)(2011-1#1)
understanding of the cellular##4##4##(1992-12#1)(2006-11#1)(2007-11#1)(2011-1#1)
understanding of the changes##2##4##(1991-5#1)(2005-7#1)
understanding of the characteristics##2##4##(1992-1#1)(2007-8#1)
understanding of the chemistry of##2##5##(1996-8#1)(2009-2#1)
understanding of the clinical##9##4##(1993-8#1)(2005-8#1)(2006-12#1)(2006-5#1)(2008-10#1)(2008-11#2)(2011-1#1)(2013-8#1)
understanding of the complex mechanisms##2##5##(2008-4#1)(2010-12#1)
understanding of the complex##12##4##(1995-6#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-9#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-1#1)
understanding of the complexity of the##2##6##(2006-10#1)(2007-12#1)
understanding of the complexity of##4##5##(1996-3#1)(2006-10#1)(2007-12#1)(2007-8#1)
understanding of the concept##2##4##(2006-10#1)(2012-11#1)
understanding of the condition##2##4##(2006-10#1)(2006-4#1)
understanding of the consequences of##2##5##(2007-9#1)(2008-11#1)
understanding of the contribution of##2##5##(1995-5#1)(2009-3#1)
understanding of the control of the##2##6##(2006-11#1)(2010-8#1)
understanding of the control of##3##5##(2006-11#1)(2007-8#1)(2010-8#1)
understanding of the control##4##4##(2005-11#1)(2006-11#1)(2007-8#1)(2010-8#1)
understanding of the current##2##4##(2008-10#1)(2011-1#1)
understanding of the data##4##4##(2008-7#2)(2008-9#1)(2012-3#1)
understanding of the development of##3##5##(1990-7#1)(1991-3#1)(2008-7#1)
understanding of the development##4##4##(1990-7#1)(1991-3#1)(2008-7#2)
understanding of the differences##2##4##(2007-4#1)(2012-1#1)
understanding of the different##3##4##(2006-11#1)(2008-1#1)(2012-1#1)
understanding of the disease##7##4##(1995-5#1)(1996-2#1)(2005-8#2)(2006-10#1)(2007-12#1)(2013-7#1)
understanding of the diversity##2##4##(2005-11#1)(2008-5#1)
understanding of the dynamics of the##3##6##(2008-10#2)(2008-11#1)
understanding of the dynamics of##5##5##(1997-3#1)(2008-10#2)(2008-11#1)(2010-3#1)
understanding of the ecology of SNC##2##6##(2008-10#2)
understanding of the ecology of##4##5##(2008-10#3)(2008-11#1)
understanding of the ecology##5##4##(2008-10#3)(2008-11#1)(2008-9#1)
understanding of the effect of##2##5##(1995-12#1)(2008-8#1)
understanding of the effect##4##4##(1995-12#1)(2008-8#1)(2013-1#2)
understanding of the effects of##7##5##(1994-6#1)(2006-10#1)(2008-3#2)(2009-7#1)(2010-2#1)(2011-2#1)
understanding of the epidemiology and##2##5##(2005-11#1)(2007-11#1)
understanding of the epidemiology of##4##5##(2007-8#1)(2008-10#1)(2009-10#1)(2013-1#1)
understanding of the epidemiology##9##4##(2005-11#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-10#1)(2010-6#1)(2013-1#1)
understanding of the essential##2##4##(2005-7#1)(2006-10#1)
understanding of the etiology of##3##5##(2007-11#1)(2007-12#1)(2008-10#1)
understanding of the evolution of##5##5##(1994-5#1)(2008-10#1)(2008-7#1)(2010-5#1)(2010-8#1)
understanding of the evolution##6##4##(1994-5#1)(2008-10#1)(2008-7#2)(2010-5#1)(2010-8#1)
understanding of the extent##2##4##(2008-11#1)(2011-2#1)
understanding of the factors##4##4##(1997-4#1)(2006-10#1)(2008-9#1)(2012-1#1)
understanding of the formation of##2##5##(1992-2#1)(2008-10#1)
understanding of the function of##5##5##(1997-6#1)(2006-10#1)(2007-8#2)(2009-9#1)
understanding of the functional##2##4##(2004-4#1)(2008-7#1)
understanding of the functions##2##4##(2006-10#1)(2013-8#1)
understanding of the general##2##4##(2008-9#1)(2010-12#1)
understanding of the genetic basis of##5##6##(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-2#1)
understanding of the genetic##11##4##(2006-10#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2012-11#1)(2012-2#1)
understanding of the genetics##3##4##(2006-10#1)(2008-4#1)(2009-3#1)
understanding of the history of##2##5##(1997-1#1)(2009-10#1)
understanding of the human##2##4##(2008-11#1)(2009-11#1)
understanding of the immune##2##4##(1996-11#1)(2006-10#1)
understanding of the immuno-pathogenesis of psoriasis##2##6##(2008-1#2)
understanding of the impact of##4##5##(1994-2#1)(2006-10#1)(2007-5#1)(2011-2#1)
understanding of the implications of the##2##6##(2006-8#1)(2013-1#1)
understanding of the importance of##4##5##(1991-12#1)(2007-12#2)(2010-12#1)
understanding of the incidence##2##4##(2008-2#1)(2011-2#1)
understanding of the infection process and the##2##7##(1992-12#1)(2008-10#1)
understanding of the influence of##3##5##(2008-11#1)(2011-1#2)
understanding of the injury mechanisms and the kinematics of the shoulder##2##11##(2007-4#2)
understanding of the interaction between##4##5##(2006-10#2)(2013-1#2)
understanding of the interactions between##5##5##(1993-9#1)(1994-11#1)(1996-5#1)(2006-10#2)
understanding of the interactions##7##4##(1993-9#2)(1994-11#1)(1996-5#1)(2006-10#2)(2012-1#1)
understanding of the international##2##4##(1993-1#1)(2007-4#1)
understanding of the interrelationships##2##4##(2008-10#1)(2008-12#1)
understanding of the manner in which##2##6##(2006-6#1)(2012-3#1)
understanding of the mechanism of##6##5##(1994-8#1)(1994-9#1)(1995-1#1)(2006-11#1)(2007-11#1)(2011-1#1)
understanding of the mechanism##8##4##(1990-8#1)(1994-8#1)(1994-9#1)(1995-1#1)(2006-11#1)(2007-11#1)(2009-4#1)(2011-1#1)
understanding of the mechanisms by which##3##6##(2006-10#1)(2008-1#1)(2013-1#1)
understanding of the mechanisms involved in##4##6##(1997-3#1)(2006-10#1)(2008-1#1)(2008-4#1)
understanding of the mechanisms involved##5##5##(1997-3#1)(2006-10#1)(2008-1#1)(2008-4#1)(2010-10#1)
understanding of the mechanisms of##15##5##(1995-11#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-4#2)(2008-3#1)(2008-7#3)(2008-9#1)(2010-2#1)(2010-3#1)(2011-2#2)
understanding of the mechanisms that are##2##6##(2006-10#1)(2011-2#1)
understanding of the mechanisms that control##3##6##(2006-6#1)(2008-7#1)(2008-9#1)
understanding of the mechanisms that##9##5##(2005-11#1)(2006-10#1)(2006-6#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
understanding of the mechanisms underlying the##3##6##(2006-10#2)(2011-2#1)
understanding of the mechanisms underlying##5##5##(1997-8#1)(2006-10#2)(2007-3#1)(2011-2#1)
understanding of the mechanisms##43##4##(1995-11#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#8)(2006-6#1)(2007-11#1)(2007-3#1)(2007-4#2)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#4)(2008-9#2)(2009-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
understanding of the medical##3##4##(1993-10#1)(2006-8#1)(2013-8#1)
understanding of the metabolic##2##4##(1995-1#1)(2004-11#1)
understanding of the metabolism##2##4##(2008-3#1)(2008-7#1)
understanding of the molecular basis of the##2##7##(2008-1#1)(2008-8#1)
understanding of the molecular basis of##8##6##(1994-9#1)(1995-11#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-8#1)(2011-2#1)
understanding of the molecular mechanism of the##2##7##(1996-4#1)(2011-1#1)
understanding of the molecular mechanism of##3##6##(1995-1#1)(1996-4#1)(2011-1#1)
understanding of the molecular mechanisms of##3##6##(2008-11#1)(2008-6#1)(2009-3#1)
understanding of the molecular mechanisms##5##5##(2008-1#1)(2008-11#1)(2008-6#1)(2009-3#1)(2012-12#1)
understanding of the molecular##25##4##(1991-12#1)(1994-9#1)(1995-1#1)(1995-11#2)(1996-4#2)(2005-8#2)(2006-10#1)(2007-8#1)(2008-1#2)(2008-11#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)
understanding of the movements##2##4##(2005-10#1)(2012-3#1)
understanding of the natural history of these##2##7##(1997-8#1)(2006-12#1)
understanding of the natural history of##3##6##(1997-8#1)(2006-12#1)(2013-1#1)
understanding of the nature of##6##5##(1992-3#1)(1994-11#1)(1995-1#1)(2008-11#1)(2008-6#1)(2011-1#1)
understanding of the nature##7##4##(1992-3#1)(1994-11#1)(1995-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-1#1)
understanding of the neural mechanisms underlying##3##6##(2008-7#1)(2012-12#1)(2012-2#1)
understanding of the neural##6##4##(1993-2#1)(2008-7#1)(2009-9#1)(2012-12#1)(2012-2#2)
understanding of the neurobiology##2##4##(2009-10#1)(2012-12#1)
understanding of the neuronal##2##4##(1993-12#1)(2007-12#1)
understanding of the normal##2##4##(2008-1#1)(2009-9#1)
understanding of the pathogenesis and##2##5##(2006-8#1)(2008-9#1)
understanding of the pathogenesis of the disease##2##7##(2005-8#1)(2006-2#1)
understanding of the pathogenesis of these##2##6##(2006-12#1)(2007-10#1)
understanding of the pathogenesis of##23##5##(1990-9#1)(1994-3#1)(1997-5#1)(2004-11#1)(2005-8#3)(2006-10#2)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-5#1)(2008-1#2)(2008-3#1)(2008-7#1)(2008-9#1)(2013-1#2)(2013-8#1)
understanding of the pathogenesis##25##4##(1990-9#1)(1994-3#1)(1997-5#1)(2004-11#1)(2005-8#3)(2006-10#2)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-5#1)(2008-1#2)(2008-3#1)(2008-7#1)(2008-9#2)(2013-1#2)(2013-8#1)
understanding of the pathological basis of##2##6##(2005-8#1)(2007-11#1)
understanding of the pathological##4##4##(2005-8#1)(2006-8#1)(2007-11#1)(2008-9#1)
understanding of the pathology##2##4##(2008-10#1)(2010-3#1)
understanding of the pathophysiological mechanisms of##3##6##(2007-11#1)(2008-1#1)(2011-2#1)
understanding of the pathophysiological mechanisms##4##5##(2006-11#1)(2007-11#1)(2008-1#1)(2011-2#1)
understanding of the pathophysiological##6##4##(2005-8#2)(2006-11#1)(2007-11#1)(2008-1#1)(2011-2#1)
understanding of the pathophysiology and##2##5##(2006-10#1)(2008-8#1)
understanding of the pathophysiology of the disease##2##7##(2008-3#1)(2012-12#1)
understanding of the pathophysiology of the##3##6##(2008-3#1)(2012-11#1)(2012-12#1)
understanding of the pathophysiology of##10##5##(2005-10#1)(2005-11#1)(2006-10#3)(2006-9#1)(2008-3#1)(2012-11#1)(2012-12#1)(2013-8#1)
understanding of the pathophysiology##17##4##(2005-10#2)(2005-11#1)(2005-8#2)(2006-10#4)(2006-9#1)(2008-3#1)(2008-8#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
understanding of the patient##3##4##(2009-8#1)(2013-1#2)
understanding of the physical##3##4##(2008-10#1)(2008-3#1)(2008-7#1)
understanding of the physiological##8##4##(1997-3#1)(1997-8#1)(2006-10#1)(2008-2#1)(2008-4#2)(2008-9#1)(2010-2#1)
understanding of the physiology and##3##5##(2006-10#1)(2010-3#1)(2013-1#1)
understanding of the physiology of the##3##6##(2006-10#1)(2009-3#1)(2012-12#1)
understanding of the physiology##6##4##(2006-10#2)(2009-3#1)(2010-3#1)(2012-12#1)(2013-1#1)
understanding of the potential##4##4##(2005-7#1)(2006-10#1)(2007-12#1)(2011-12#1)
understanding of the principles##3##4##(1995-3#1)(2008-4#1)(2012-12#1)
understanding of the process of##3##5##(2007-8#1)(2010-2#1)(2012-3#1)
understanding of the process##7##4##(1994-12#1)(1995-1#1)(1996-8#1)(2007-8#1)(2010-2#1)(2011-2#1)(2012-3#1)
understanding of the processes##4##4##(1992-6#1)(1996-12#1)(2006-10#1)(2010-9#1)
understanding of the regulation of##4##5##(1995-2#1)(2006-10#1)(2008-1#1)(2008-5#1)
understanding of the relationship between structure and##2##7##(2009-5#1)(2010-4#1)
understanding of the relationship between the##2##6##(2008-7#1)(2012-5#1)
understanding of the relationship between##9##5##(2006-10#1)(2006-5#1)(2006-7#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-4#1)(2012-5#1)(2013-7#1)
understanding of the relationship##10##4##(2006-10#1)(2006-5#1)(2006-7#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-4#1)(2012-5#1)(2013-7#1)
understanding of the relationships##2##4##(2006-10#1)(2007-9#1)
understanding of the relevant##2##4##(2008-7#1)(2009-5#1)
understanding of the role of##30##5##(1991-8#1)(1992-11#1)(1992-2#1)(1993-3#2)(1995-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-1#1)(2009-12#1)(2010-11#1)(2010-4#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
understanding of the role##34##4##(1991-8#1)(1992-11#1)(1992-2#1)(1993-3#2)(1995-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(2005-9#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-1#1)(2009-12#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
understanding of the roles of##2##5##(2004-12#1)(2007-11#1)
understanding of the roles##4##4##(2004-12#1)(2007-11#1)(2008-4#1)(2009-8#1)
understanding of the scope of##2##5##(2006-5#1)(2008-1#1)
understanding of the significance of##3##5##(1990-2#1)(1997-1#1)(2012-3#1)
understanding of the stability of##2##5##(2010-12#1)(2011-2#1)
understanding of the types of##2##5##(2007-12#1)(2008-7#1)
understanding of the underlying genetic##2##5##(2004-11#1)(2009-10#1)
understanding of the underlying##11##4##(1997-3#1)(2004-11#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-10#1)(2010-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
understanding of the unique##3##4##(1996-8#1)(2007-12#1)(2007-9#1)
understanding of the use of##2##5##(2007-4#1)(2008-11#1)
understanding of the various##3##4##(2005-8#1)(2007-12#1)(2013-1#1)
understanding of the##795##3##(1990-1#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#1)(1992-6#3)(1992-8#1)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#4)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#5)(1995-11#3)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#4)(1995-6#2)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#3)(1996-4#3)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#6)(1997-1#4)(1997-2#1)(1997-3#6)(1997-4#2)(1997-5#2)(1997-6#1)(1997-8#4)(2004-11#3)(2004-12#1)(2004-4#1)(2005-10#4)(2005-11#7)(2005-12#1)(2005-7#7)(2005-8#16)(2005-9#1)(2006-1#1)(2006-10#64)(2006-11#8)(2006-12#5)(2006-2#2)(2006-3#2)(2006-4#3)(2006-5#4)(2006-6#3)(2006-7#2)(2006-8#8)(2006-9#1)(2007-10#2)(2007-11#20)(2007-12#18)(2007-2#2)(2007-3#1)(2007-4#8)(2007-5#2)(2007-7#2)(2007-8#14)(2007-9#8)(2008-1#18)(2008-10#37)(2008-11#25)(2008-12#7)(2008-2#5)(2008-3#15)(2008-4#12)(2008-5#12)(2008-6#8)(2008-7#32)(2008-8#15)(2008-9#14)(2009-1#2)(2009-10#4)(2009-11#4)(2009-12#3)(2009-2#3)(2009-3#6)(2009-4#8)(2009-5#3)(2009-6#2)(2009-7#5)(2009-8#4)(2009-9#6)(2010-10#4)(2010-11#5)(2010-12#8)(2010-2#6)(2010-3#4)(2010-4#4)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#3)(2010-9#4)(2011-1#14)(2011-10#1)(2011-12#1)(2011-2#25)(2012-1#12)(2012-11#5)(2012-12#16)(2012-2#12)(2012-3#16)(2012-5#1)(2013-1#27)(2013-7#3)(2013-8#13)
understanding of their molecular mechanisms of##2##6##(1995-6#1)(2012-12#1)
understanding of their molecular##3##4##(1995-6#1)(2011-1#1)(2012-12#1)
understanding of their potential##2##4##(2008-10#1)(2012-12#1)
understanding of their roles##2##4##(2006-10#1)(2011-1#1)
understanding of their##27##3##(1995-5#1)(1995-6#1)(2005-10#1)(2006-10#3)(2007-11#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-7#1)(2009-7#1)(2010-12#2)(2010-2#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
understanding of these factors##2##4##(2010-8#1)(2011-2#1)
understanding of these issues##2##4##(2007-4#1)(2010-5#1)
understanding of these mechanisms##2##4##(2007-8#1)(2010-5#1)
understanding of these molecular##2##4##(2008-2#1)(2013-1#1)
understanding of these processes is##3##5##(2007-8#1)(2008-10#1)(2012-2#1)
understanding of these processes##4##4##(2006-10#1)(2007-8#1)(2008-10#1)(2012-2#1)
understanding of these##33##3##(2006-10#4)(2006-2#1)(2006-3#1)(2006-6#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#2)(2009-5#2)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
understanding of this complex##3##4##(1996-12#1)(2008-5#1)(2008-7#1)
understanding of this effect##2##4##(2009-8#1)(2010-5#1)
understanding of this technology##2##4##(2006-10#1)(2007-12#1)
understanding of this very##2##4##(1995-12#1)(2008-9#1)
understanding of this##32##3##(1991-3#1)(1991-6#1)(1993-1#1)(1993-3#1)(1994-8#1)(1995-12#1)(1996-12#1)(2005-7#1)(2006-10#3)(2006-9#2)(2007-11#1)(2007-12#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
understanding of tissue##2##3##(2006-6#1)(2007-7#1)
understanding of tree##2##3##(2008-10#1)(2010-4#1)
understanding of tumor immunology##2##4##(2005-10#1)(2006-10#1)
understanding of vascular##2##3##(2007-6#1)(2008-10#1)
understanding of viral##3##3##(2006-10#1)(2013-1#1)(2013-8#1)
understanding of ways to##2##4##(2009-4#1)(2012-3#1)
understanding of what##9##3##(1992-9#1)(1996-12#1)(1996-5#1)(2005-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)
understanding of why##2##3##(2008-2#1)(2008-9#1)
understanding of##1568##2##(1990-1#1)(1990-11#1)(1990-12#5)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#5)(1991-2#2)(1991-3#4)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#2)(1992-1#4)(1992-11#1)(1992-12#8)(1992-2#3)(1992-3#2)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#5)(1993-10#2)(1993-11#2)(1993-12#5)(1993-2#3)(1993-3#7)(1993-6#1)(1993-8#2)(1993-9#5)(1994-1#1)(1994-11#5)(1994-12#1)(1994-2#6)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#3)(1995-1#6)(1995-11#4)(1995-12#6)(1995-2#2)(1995-3#3)(1995-5#5)(1995-6#3)(1995-9#1)(1996-10#1)(1996-11#4)(1996-12#6)(1996-2#5)(1996-3#4)(1996-4#5)(1996-5#3)(1996-6#2)(1996-7#2)(1996-8#10)(1997-1#7)(1997-2#2)(1997-3#11)(1997-4#2)(1997-5#5)(1997-6#1)(1997-7#1)(1997-8#6)(2004-11#5)(2004-12#2)(2004-2#1)(2004-4#2)(2005-10#9)(2005-11#12)(2005-12#2)(2005-2#1)(2005-4#1)(2005-5#1)(2005-7#12)(2005-8#22)(2005-9#2)(2006-1#1)(2006-10#114)(2006-11#14)(2006-12#9)(2006-2#7)(2006-3#5)(2006-4#5)(2006-5#6)(2006-6#8)(2006-7#3)(2006-8#9)(2006-9#6)(2007-1#2)(2007-10#6)(2007-11#32)(2007-12#39)(2007-2#3)(2007-3#3)(2007-4#15)(2007-5#3)(2007-6#3)(2007-7#8)(2007-8#25)(2007-9#13)(2008-1#27)(2008-10#72)(2008-11#51)(2008-12#30)(2008-2#12)(2008-3#18)(2008-4#29)(2008-5#27)(2008-6#12)(2008-7#59)(2008-8#27)(2008-9#41)(2009-1#2)(2009-10#7)(2009-11#6)(2009-12#9)(2009-2#4)(2009-3#11)(2009-4#18)(2009-5#9)(2009-6#4)(2009-7#9)(2009-8#14)(2009-9#10)(2010-1#2)(2010-10#7)(2010-11#9)(2010-12#23)(2010-2#14)(2010-3#8)(2010-4#8)(2010-5#9)(2010-6#5)(2010-7#5)(2010-8#8)(2010-9#10)(2011-1#38)(2011-10#1)(2011-11#1)(2011-12#4)(2011-2#50)(2011-7#2)(2012-1#27)(2012-11#7)(2012-12#31)(2012-2#42)(2012-3#31)(2012-5#1)(2013-1#51)(2013-7#4)(2013-8#27)
understanding on how the##2##4##(2009-10#1)(2012-3#1)
understanding on how##3##3##(2009-10#1)(2009-12#1)(2012-3#1)
understanding on the##7##3##(2008-5#1)(2009-12#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
understanding on##10##2##(2008-5#1)(2009-10#1)(2009-12#2)(2009-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
understanding or##2##2##(2013-1#2)
understanding patterns##2##2##(2006-5#1)(2011-1#1)
understanding regarding the##3##3##(2008-8#1)(2012-3#1)(2013-1#1)
understanding regarding##6##2##(2005-8#1)(2008-4#1)(2008-8#1)(2010-3#1)(2012-3#1)(2013-1#1)
understanding social##2##2##(2008-6#1)(2012-1#1)
understanding stem cell differentiation##2##4##(2010-12#2)
understanding such##2##2##(2008-5#1)(2010-4#1)
understanding that a##2##3##(1996-3#1)(2010-4#1)
understanding that##10##2##(1996-3#1)(2006-12#1)(2007-11#1)(2007-2#1)(2008-9#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#1)(2012-1#1)
understanding the basis of##2##4##(1990-4#1)(2008-3#1)
understanding the benefits and##2##4##(1996-12#1)(2009-12#1)
understanding the biological##2##3##(2009-5#1)(2010-3#1)
understanding the biology##4##3##(2009-6#1)(2009-8#1)(2010-11#1)(2011-12#1)
understanding the catalytic mechanism of##2##5##(1995-6#1)(2009-2#1)
understanding the complex##4##3##(2005-8#1)(2007-4#1)(2007-5#1)(2011-2#1)
understanding the connection##3##3##(2007-10#1)(2013-1#2)
understanding the differences in##2##4##(2008-8#1)(2010-12#1)
understanding the disease in##2##4##(1993-11#1)(2010-7#1)
understanding the disease##4##3##(1993-11#1)(2007-7#1)(2008-6#1)(2010-7#1)
understanding the effects of##2##4##(1997-5#1)(2008-2#1)
understanding the effects##4##3##(1993-12#1)(1997-5#1)(2007-4#1)(2008-2#1)
understanding the epidemiology##2##3##(2008-10#1)(2012-3#1)
understanding the evolution of##6##4##(2008-11#1)(2008-6#1)(2008-8#2)(2012-2#1)(2013-1#1)
understanding the factors that##3##4##(1992-1#1)(2008-10#1)(2010-2#1)
understanding the function of the##2##5##(1990-4#1)(2008-9#1)
understanding the function of##8##4##(1990-4#1)(2005-11#1)(2007-12#1)(2008-4#1)(2008-9#2)(2009-6#1)(2009-9#1)
understanding the functions##2##3##(2008-4#1)(2010-11#1)
understanding the impact of##4##4##(1994-1#1)(2007-12#1)(2009-12#1)(2010-1#1)
understanding the in vivo##2##4##(2006-10#1)(2009-2#1)
understanding the legal##2##3##(2008-2#1)(2010-9#1)
understanding the meaning of##2##4##(2008-11#1)(2011-2#1)
understanding the mechanism and##2##4##(2008-1#1)(2008-9#1)
understanding the mechanism of##5##4##(2006-7#1)(2006-8#1)(2008-10#1)(2008-8#1)(2010-12#1)
understanding the mechanism##7##3##(2006-7#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-12#1)
understanding the mechanisms of##4##4##(1991-12#1)(1994-8#1)(2009-8#1)(2011-1#1)
understanding the mechanisms underlying##5##4##(1990-5#1)(2007-11#1)(2008-9#1)(2011-1#1)(2013-1#1)
understanding the mechanisms##15##3##(1990-5#1)(1991-12#1)(1994-8#1)(1997-6#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-9#1)(2009-8#1)(2010-3#1)(2011-1#4)(2013-1#1)
understanding the molecular basis of##4##5##(1993-9#1)(2008-11#2)(2008-9#1)
understanding the molecular basis##5##4##(1993-9#1)(1994-3#1)(2008-11#2)(2008-9#1)
understanding the molecular mechanisms involved in##2##6##(2006-10#1)(2011-1#1)
understanding the molecular mechanisms##3##4##(2006-10#1)(2011-1#1)(2011-2#1)
understanding the molecular##13##3##(1992-4#1)(1993-9#1)(1994-11#1)(1994-3#1)(2006-10#1)(2008-11#3)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
understanding the natural##2##3##(2008-4#1)(2012-2#1)
understanding the nature and##3##4##(1996-7#1)(2008-4#1)(2012-2#1)
understanding the nature of##5##4##(1993-11#1)(1995-10#1)(2004-12#1)(2006-12#1)(2008-7#1)
understanding the nature##8##3##(1993-11#1)(1995-10#1)(1996-7#1)(2004-12#1)(2006-12#1)(2008-4#1)(2008-7#1)(2012-2#1)
understanding the pathobiology##2##3##(2010-5#1)(2011-1#1)
understanding the pathogenesis of##5##4##(1993-11#1)(2008-1#1)(2010-12#3)
understanding the pathophysiology of##7##4##(2006-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-10#1)(2011-1#1)(2012-12#1)
understanding the pathophysiology##8##3##(2006-10#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-10#1)(2011-1#1)(2012-12#1)
understanding the patterns##2##3##(2007-12#1)(2013-8#1)
understanding the physical##2##3##(2006-10#1)(2007-8#1)
understanding the physiological##3##3##(1993-6#1)(2008-10#1)(2009-4#1)
understanding the process of##3##4##(2008-1#1)(2008-12#1)(2009-12#1)
understanding the processes##2##3##(1993-2#1)(2006-10#1)
understanding the regulation of##3##4##(2006-10#1)(2008-11#1)(2008-4#1)
understanding the relationship between##4##4##(1992-2#1)(2008-6#1)(2011-2#1)(2012-1#1)
understanding the relationship##5##3##(1992-2#1)(1997-2#1)(2008-6#1)(2011-2#1)(2012-1#1)
understanding the relationships between##2##4##(1992-12#1)(2007-1#1)
understanding the relative importance of##2##5##(2006-12#1)(2009-6#1)
understanding the role of##13##4##(1990-11#1)(1991-11#1)(1991-3#1)(2005-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-11#1)(2012-2#2)(2013-8#1)
understanding the role##15##3##(1990-11#1)(1991-11#1)(1991-3#1)(2004-9#1)(2005-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-11#1)(2011-2#1)(2012-2#2)(2013-8#1)
understanding the social and##2##4##(2006-2#1)(2008-6#1)
understanding the social##3##3##(2006-2#1)(2008-11#1)(2008-6#1)
understanding the spread of##2##4##(2008-1#1)(2008-10#1)
understanding the structure and function of##2##6##(2008-5#1)(2012-11#1)
understanding the structure##3##3##(2008-5#1)(2011-2#1)(2012-11#1)
understanding the underlying##3##3##(2008-10#1)(2008-2#1)(2008-6#1)
understanding the##332##2##(1990-11#1)(1990-4#2)(1990-5#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-6#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1993-11#3)(1993-12#2)(1993-2#2)(1993-6#1)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-8#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#3)(1995-6#1)(1995-8#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-7#2)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-11#1)(2004-12#2)(2004-4#1)(2004-9#1)(2005-11#2)(2005-4#1)(2005-8#2)(2006-10#9)(2006-12#3)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#4)(2007-10#2)(2007-11#8)(2007-12#7)(2007-3#1)(2007-4#5)(2007-5#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#7)(2008-10#13)(2008-11#11)(2008-12#3)(2008-2#6)(2008-3#6)(2008-4#9)(2008-5#4)(2008-6#5)(2008-7#4)(2008-8#4)(2008-9#7)(2009-12#4)(2009-2#3)(2009-3#2)(2009-4#4)(2009-5#2)(2009-6#5)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#9)(2010-2#3)(2010-3#4)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#10)(2011-12#1)(2011-2#11)(2012-1#5)(2012-11#1)(2012-12#9)(2012-2#13)(2012-3#3)(2012-5#1)(2013-1#6)(2013-8#5)
understanding their role##2##3##(1995-1#1)(2011-1#1)
understanding their##10##2##(1990-5#1)(1995-1#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-8#1)
understanding these processes##2##3##(1995-8#1)(2012-2#1)
understanding these##6##2##(1995-8#1)(2006-3#1)(2007-4#1)(2007-8#1)(2011-2#1)(2012-2#1)
understanding this complex##2##3##(2007-9#1)(2013-8#1)
understanding this##10##2##(2005-8#1)(2006-7#2)(2007-9#1)(2008-10#1)(2008-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
understanding to##3##2##(2007-11#1)(2009-12#1)(2011-1#1)
understanding transcriptional##2##2##(2006-12#1)(2008-11#1)
understanding was##4##2##(2008-7#3)(2012-2#1)
understanding what##4##2##(1992-9#1)(2007-12#1)(2008-4#1)(2012-2#1)
understanding why##5##2##(2008-10#1)(2008-11#1)(2009-10#1)(2010-4#1)(2011-12#1)
understanding with##3##2##(1990-8#1)(2013-1#2)
understanding##2459##1##(1990-1#1)(1990-11#2)(1990-12#6)(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-11#1)(1991-12#11)(1991-2#3)(1991-3#8)(1991-4#2)(1991-5#3)(1991-6#3)(1991-7#2)(1991-8#3)(1991-9#3)(1992-1#5)(1992-10#1)(1992-11#3)(1992-12#10)(1992-2#6)(1992-3#4)(1992-4#2)(1992-6#4)(1992-8#2)(1992-9#4)(1993-1#6)(1993-10#2)(1993-11#6)(1993-12#9)(1993-2#5)(1993-3#7)(1993-6#2)(1993-8#2)(1993-9#10)(1994-1#2)(1994-10#2)(1994-11#7)(1994-12#4)(1994-2#7)(1994-3#6)(1994-5#4)(1994-6#3)(1994-8#4)(1994-9#3)(1995-1#9)(1995-10#1)(1995-11#7)(1995-12#7)(1995-2#4)(1995-3#8)(1995-4#1)(1995-5#6)(1995-6#5)(1995-8#5)(1995-9#1)(1996-1#2)(1996-10#2)(1996-11#4)(1996-12#10)(1996-2#9)(1996-3#9)(1996-4#6)(1996-5#4)(1996-6#2)(1996-7#5)(1996-8#12)(1996-9#2)(1997-1#10)(1997-2#4)(1997-3#15)(1997-4#4)(1997-5#6)(1997-6#4)(1997-7#2)(1997-8#14)(2004-10#1)(2004-11#6)(2004-12#5)(2004-2#1)(2004-4#3)(2004-9#2)(2005-10#13)(2005-11#16)(2005-12#2)(2005-2#1)(2005-4#2)(2005-5#1)(2005-7#13)(2005-8#29)(2005-9#3)(2006-1#1)(2006-10#150)(2006-11#15)(2006-12#16)(2006-2#12)(2006-3#9)(2006-4#7)(2006-5#8)(2006-6#8)(2006-7#12)(2006-8#13)(2006-9#11)(2007-1#9)(2007-10#11)(2007-11#45)(2007-12#61)(2007-2#4)(2007-3#5)(2007-4#27)(2007-5#5)(2007-6#4)(2007-7#10)(2007-8#33)(2007-9#17)(2008-1#39)(2008-10#102)(2008-11#75)(2008-12#46)(2008-2#25)(2008-3#29)(2008-4#47)(2008-5#42)(2008-6#23)(2008-7#83)(2008-8#47)(2008-9#59)(2009-1#2)(2009-10#11)(2009-11#6)(2009-12#23)(2009-2#8)(2009-3#14)(2009-4#30)(2009-5#14)(2009-6#12)(2009-7#14)(2009-8#21)(2009-9#16)(2010-1#5)(2010-10#10)(2010-11#15)(2010-12#41)(2010-2#22)(2010-3#20)(2010-4#12)(2010-5#13)(2010-6#9)(2010-7#7)(2010-8#11)(2010-9#13)(2011-1#57)(2011-10#1)(2011-11#1)(2011-12#8)(2011-2#78)(2011-7#3)(2012-1#44)(2012-11#10)(2012-12#53)(2012-2#77)(2012-3#46)(2012-5#2)(2012-9#1)(2013-1#98)(2013-7#8)(2013-8#41)
understanding]##2##1##(1990-5#1)(1996-4#1)
understandings and##2##2##(2008-12#1)(2011-1#1)
understandings of the##6##3##(2008-11#1)(2008-7#1)(2010-5#1)(2013-1#2)(2013-7#1)
understandings of##17##2##(2006-7#1)(2008-11#1)(2008-7#2)(2009-7#1)(2010-5#2)(2013-1#5)(2013-7#5)
understandings on##2##2##(1990-12#1)(2009-2#1)
understandings##26##1##(1990-12#1)(1994-12#1)(2006-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2009-2#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-5#2)(2011-1#1)(2013-1#5)(2013-7#5)
understands that##2##2##(2004-1#1)(2007-4#1)
understands the##4##2##(1994-1#1)(1994-2#1)(2008-11#1)(2009-2#1)
understands##7##1##(1994-1#1)(1994-2#1)(2004-1#1)(2007-2#1)(2007-4#1)(2008-11#1)(2009-2#1)
understatement##2##1##(1991-1#1)(2008-12#1)
understood about the##3##3##(1997-3#1)(2007-12#1)(2008-4#1)
understood about##6##2##(1992-1#1)(1997-3#1)(2006-10#1)(2007-12#1)(2008-4#1)(2009-5#1)
understood and cannot be##2##4##(1996-6#1)(2008-4#1)
understood and needs further##2##4##(2011-1#1)(2013-7#1)
understood and supported##2##3##(1993-2#1)(2008-1#1)
understood and the##2##3##(2008-5#1)(2009-7#1)
understood and##38##2##(1990-5#1)(1993-2#2)(1993-3#1)(1994-2#1)(1996-1#1)(1996-6#1)(1997-3#1)(2004-3#1)(2005-10#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-7#1)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#3)
understood as a##9##3##(1990-12#1)(1992-7#1)(1993-3#1)(2006-8#1)(2008-10#2)(2008-2#1)(2008-6#1)(2010-12#1)
understood as an##6##3##(1994-3#1)(1996-7#1)(2007-12#1)(2008-10#1)(2011-2#1)(2013-8#1)
understood as the##6##3##(2006-7#1)(2007-12#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-7#1)
understood as##28##2##(1990-12#1)(1992-7#1)(1993-3#1)(1994-3#1)(1995-2#1)(1996-7#1)(2005-7#1)(2006-7#2)(2006-8#1)(2007-12#3)(2008-10#3)(2008-2#1)(2008-6#1)(2009-2#1)(2010-12#1)(2011-12#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
understood at the molecular level##2##5##(1995-2#1)(2008-10#1)
understood at the##3##3##(1995-2#1)(2008-10#1)(2009-4#1)
understood at##4##2##(1995-2#1)(1997-7#1)(2008-10#1)(2009-4#1)
understood but may##2##3##(1996-5#1)(2007-11#1)
understood but##4##2##(1996-5#1)(2007-11#1)(2008-4#1)(2012-1#1)
understood by all##2##3##(1991-7#1)(1993-2#1)
understood by the##3##3##(1992-3#1)(1997-6#1)(2005-11#1)
understood by##17##2##(1991-7#1)(1992-3#1)(1993-2#1)(1994-1#1)(1995-7#1)(1997-6#1)(2005-11#1)(2006-12#1)(2006-7#1)(2008-10#1)(2008-4#2)(2009-12#1)(2010-2#1)(2010-9#1)(2012-12#1)(2013-8#1)
understood from##4##2##(1990-7#1)(2008-8#1)(2009-10#1)(2009-7#1)
understood how##2##2##(2008-4#1)(2013-1#1)
understood in terms of the##2##5##(1996-4#1)(2006-12#1)
understood in terms of##7##4##(1996-4#1)(2006-12#1)(2007-5#1)(2010-12#1)(2010-5#1)(2011-1#1)(2013-7#1)
understood in the context of##3##5##(2006-4#1)(2007-8#1)(2009-10#1)
understood in##21##2##(1993-6#1)(1996-4#1)(2005-7#1)(2006-12#1)(2006-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#2)(2009-10#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#2)
understood is##2##2##(2008-9#1)(2009-11#1)
understood on the##2##3##(1990-5#1)(2008-7#1)
understood only if##2##3##(2007-12#1)(2012-1#1)
understood than##2##2##(2007-3#1)(2013-1#1)
understood that the##4##3##(1991-1#1)(1991-12#1)(2012-12#1)(2012-3#1)
understood that##12##2##(1991-1#1)(1991-12#1)(1993-12#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
understood the##7##2##(1992-12#1)(1994-2#1)(1996-9#2)(2006-9#1)(2008-11#1)(2013-1#1)
understood their##2##2##(1996-1#1)(2008-11#1)
understood to be##4##3##(2006-5#1)(2010-12#1)(2012-1#1)(2012-11#1)
understood to##7##2##(2006-5#1)(2009-1#1)(2010-12#1)(2010-8#1)(2012-1#1)(2012-11#1)(2012-3#1)
understood which##2##2##(2008-1#1)(2008-4#1)
understood why some##2##3##(1994-4#2)
understood why##4##2##(1994-4#2)(2008-1#1)(2011-1#1)
understood with##3##2##(2005-7#1)(2009-4#1)(2011-2#1)
understood yet##2##2##(2008-7#1)(2010-9#1)
understood##602##1##(1990-1#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#3)(1991-2#3)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#3)(1992-3#3)(1992-5#1)(1992-7#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#4)(1993-4#1)(1993-6#2)(1993-9#2)(1994-1#1)(1994-10#2)(1994-11#1)(1994-2#2)(1994-3#1)(1994-4#2)(1994-7#1)(1994-8#1)(1995-12#1)(1995-2#3)(1995-5#3)(1995-6#2)(1995-7#1)(1995-8#2)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#3)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#1)(2003-11#1)(2004-11#2)(2004-12#2)(2004-3#1)(2005-10#6)(2005-11#3)(2005-7#4)(2005-8#2)(2006-1#1)(2006-10#21)(2006-11#2)(2006-12#3)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#6)(2006-8#2)(2006-9#5)(2007-1#1)(2007-10#2)(2007-11#10)(2007-12#17)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#2)(2007-7#5)(2007-8#7)(2007-9#4)(2008-1#13)(2008-10#23)(2008-11#12)(2008-12#3)(2008-2#2)(2008-3#10)(2008-4#18)(2008-5#13)(2008-6#3)(2008-7#15)(2008-8#8)(2008-9#9)(2009-1#1)(2009-10#7)(2009-11#3)(2009-12#2)(2009-2#3)(2009-3#6)(2009-4#5)(2009-5#6)(2009-6#2)(2009-7#3)(2009-8#7)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#6)(2010-12#9)(2010-2#7)(2010-3#6)(2010-4#2)(2010-5#5)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#13)(2011-10#1)(2011-12#2)(2011-2#16)(2012-1#5)(2012-11#1)(2012-12#16)(2012-2#26)(2012-3#12)(2013-1#27)(2013-7#9)(2013-8#17)
understory plants##4##2##(2007-3#1)(2008-5#1)(2008-8#2)
understory shrub Jacquinia nervosa##2##4##(2008-5#2)
understory shrub##3##2##(2007-3#1)(2008-5#2)
understory shrubs##2##2##(2007-3#1)(2008-8#1)
understory species##2##2##(2007-3#1)(2008-9#1)
understory##23##1##(2007-3#5)(2008-10#1)(2008-5#6)(2008-8#5)(2008-9#6)
understudied##6##1##(2005-6#1)(2008-10#1)(2011-1#1)(2012-2#1)(2013-1#2)
undersupplied##2##1##(2008-9#2)
undertake a##7##2##(2008-10#1)(2008-11#3)(2008-3#1)(2011-2#1)(2012-2#1)
undertake an##2##2##(2008-12#1)(2012-3#1)
undertake its##2##2##(1994-1#1)(2011-1#1)
undertake research##2##2##(1991-7#1)(2010-11#1)
undertake the##7##2##(2005-8#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-8#1)(2009-3#1)(2012-3#1)
undertake this##3##2##(2007-10#1)(2008-11#2)
undertake##52##1##(1991-3#2)(1991-7#1)(1992-1#1)(1992-9#1)(1993-12#1)(1994-1#2)(1995-4#1)(1996-2#1)(1996-7#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-4#1)(2006-5#1)(2006-7#2)(2007-10#2)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-3#1)(2010-1#1)(2010-11#2)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#3)
undertaken among##4##2##(2007-7#1)(2011-12#1)(2012-2#1)(2012-3#1)
undertaken and##3##2##(2006-3#1)(2008-10#2)
undertaken as a##2##3##(2012-3#2)
undertaken as##4##2##(2007-5#1)(2008-5#1)(2012-3#2)
undertaken at a##3##3##(1993-11#1)(1993-12#1)(2013-1#1)
undertaken at the##4##3##(2007-2#1)(2007-8#1)(2008-11#1)(2008-5#1)
undertaken at##14##2##(1992-10#1)(1993-11#1)(1993-12#1)(1996-6#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)(2013-1#2)
undertaken before##2##2##(1996-6#1)(2008-2#1)
undertaken by a##2##3##(2007-11#1)(2009-11#1)
undertaken by alliances##2##3##(2013-1#2)
undertaken by an##2##3##(1991-3#1)(1993-9#1)
undertaken by each##2##3##(1996-1#1)(2009-4#1)
undertaken by the##6##3##(1994-12#1)(1997-3#1)(2008-1#1)(2008-10#1)(2009-4#1)(2010-3#1)
undertaken by##31##2##(1990-4#1)(1991-3#1)(1993-9#1)(1994-12#1)(1995-1#1)(1996-1#1)(1997-3#1)(1997-8#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#2)(2009-4#2)(2010-3#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#3)
undertaken during##4##2##(2007-10#1)(2008-4#1)(2011-1#2)
undertaken for the##2##3##(2008-10#1)(2012-2#1)
undertaken for##9##2##(2007-10#1)(2007-8#1)(2008-10#1)(2012-12#5)(2012-2#1)
undertaken from##6##2##(1995-12#1)(2007-7#1)(2008-1#1)(2012-3#1)(2013-1#2)
undertaken if##2##2##(2008-11#1)(2008-9#1)
undertaken in all##2##3##(2007-8#2)
undertaken in order to##6##4##(1990-12#1)(1991-5#1)(2005-12#1)(2006-6#1)(2007-1#1)(2007-10#1)
undertaken in support of the##2##5##(1994-12#1)(2008-10#1)
undertaken in the last decade##3##5##(2008-7#1)(2012-12#2)
undertaken in the##16##3##(1991-5#1)(1996-5#1)(1997-1#1)(2007-11#1)(2007-3#1)(2008-5#2)(2008-7#1)(2009-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-8#1)
undertaken in this##5##3##(2006-2#1)(2007-7#1)(2009-10#1)(2010-7#2)
undertaken in##76##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1991-5#2)(1991-8#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-10#1)(1994-12#1)(1994-3#2)(1996-2#1)(1996-5#1)(1997-1#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-11#1)(2006-2#1)(2006-6#2)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#4)(2008-3#4)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-6#1)(2010-7#2)(2011-1#2)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
undertaken on the##2##3##(1993-11#1)(2007-2#1)
undertaken on##13##2##(1990-12#1)(1990-3#1)(1993-11#1)(1995-5#1)(2006-10#1)(2007-2#1)(2007-8#2)(2009-8#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)
undertaken over a##3##3##(1993-9#1)(2007-2#1)(2012-2#1)
undertaken routinely##2##2##(1990-4#1)(2012-12#1)
undertaken that##3##2##(1992-12#1)(2007-10#1)(2008-10#1)
undertaken through the##2##3##(1991-6#1)(2012-2#1)
undertaken through##3##2##(1991-6#1)(2008-11#1)(2012-2#1)
undertaken to assess the##13##4##(1991-12#1)(1991-9#1)(1994-6#1)(1997-2#1)(2007-10#2)(2008-10#2)(2008-2#1)(2008-6#1)(2013-1#1)(2013-7#1)(2013-8#1)
undertaken to assess##16##3##(1991-12#1)(1991-9#1)(1993-12#1)(1994-6#1)(1995-11#1)(1997-2#1)(2007-10#3)(2008-10#2)(2008-2#1)(2008-6#1)(2013-1#1)(2013-7#1)(2013-8#1)
undertaken to better##2##3##(1993-12#1)(2005-8#1)
undertaken to characterize the##3##4##(1994-2#1)(2007-7#1)(2008-10#1)
undertaken to compare##7##3##(1992-3#1)(1995-2#1)(1997-8#1)(2006-12#1)(2008-5#2)(2011-2#1)
undertaken to control##2##3##(2008-11#1)(2011-2#1)
undertaken to detect the##2##4##(2008-10#1)(2009-2#1)
undertaken to detect##3##3##(2005-12#1)(2008-10#1)(2009-2#1)
undertaken to determine if##4##4##(1993-11#1)(1994-8#1)(2008-7#1)(2012-3#1)
undertaken to determine the prevalence of##2##6##(2012-12#1)(2012-2#1)
undertaken to determine the prevalence##3##5##(2006-10#1)(2012-12#1)(2012-2#1)
undertaken to determine the##27##4##(1990-4#1)(1991-4#1)(1993-4#1)(1994-2#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-4#1)(2006-10#2)(2006-8#1)(2007-8#2)(2008-12#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-3#1)(2009-4#1)(2010-4#1)(2012-12#1)(2012-2#1)
undertaken to determine whether##8##4##(1993-2#1)(1993-6#1)(1996-1#1)(2004-11#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-6#1)
undertaken to determine##45##3##(1990-4#1)(1991-4#1)(1993-11#1)(1993-2#2)(1993-4#1)(1993-6#1)(1994-10#1)(1994-2#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-4#1)(2004-11#1)(2006-10#2)(2006-8#1)(2007-1#1)(2007-12#1)(2007-8#3)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-3#1)(2009-4#1)(2010-4#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
undertaken to develop##4##3##(1992-11#1)(1993-9#1)(2006-10#1)(2008-2#1)
undertaken to elucidate##2##3##(1997-7#1)(2008-10#1)
undertaken to establish a##3##4##(1993-2#1)(2011-2#1)(2012-12#1)
undertaken to establish##8##3##(1990-11#1)(1993-2#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#2)
undertaken to evaluate whether##2##4##(2006-8#1)(2011-2#1)
undertaken to evaluate##25##3##(1991-4#1)(1996-1#1)(1996-11#1)(2006-1#1)(2006-5#1)(2006-8#7)(2007-10#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
undertaken to examine how##2##4##(1993-2#1)(2011-2#1)
undertaken to examine the##6##4##(1991-8#1)(1994-6#1)(1996-6#1)(2008-7#1)(2009-12#1)(2010-12#1)
undertaken to examine##14##3##(1991-8#1)(1993-2#1)(1994-6#1)(1996-6#1)(2007-3#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#1)
undertaken to explore the relationship between##2##6##(1993-2#1)(2009-5#1)
undertaken to explore the##4##4##(1991-10#1)(1993-2#1)(2009-5#1)(2012-3#1)
undertaken to further##2##3##(2006-8#1)(2012-2#1)
undertaken to get##2##3##(2010-11#1)(2013-1#1)
undertaken to identify##5##3##(1993-3#1)(1993-6#1)(2006-2#1)(2012-12#1)(2012-3#1)
undertaken to investigate the##12##4##(1991-2#1)(1994-12#1)(1994-3#1)(1995-6#1)(2006-10#1)(2006-9#1)(2007-9#1)(2008-7#1)(2008-8#1)(2010-3#1)(2012-2#2)
undertaken to investigate##16##3##(1991-2#1)(1994-12#1)(1994-3#1)(1995-6#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-9#1)(2007-9#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-3#1)(2012-2#2)(2013-1#1)
undertaken to provide##2##3##(1994-12#1)(2006-7#1)
undertaken to quantify the##2##4##(2008-11#1)(2012-2#1)
undertaken to study the##10##4##(1994-12#1)(1997-8#1)(2006-1#2)(2007-7#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-8#2)
undertaken to understand##3##3##(1994-3#1)(2008-5#1)(2010-5#1)
undertaken to verify##2##3##(2007-11#1)(2010-3#1)
undertaken to##230##2##(1990-11#1)(1990-4#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-8#1)(1991-9#1)(1992-11#2)(1992-3#1)(1993-11#1)(1993-12#2)(1993-2#5)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-6#2)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#3)(2004-11#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-1#3)(2006-10#6)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#9)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#2)(2007-7#5)(2007-8#5)(2007-9#1)(2008-10#13)(2008-11#8)(2008-12#2)(2008-2#4)(2008-3#2)(2008-5#7)(2008-6#2)(2008-7#11)(2008-8#3)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#8)(2012-12#7)(2012-2#9)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#4)
undertaken under##2##2##(2008-10#2)
undertaken using a##5##3##(1996-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-3#1)
undertaken using the##5##3##(1997-5#1)(2006-12#1)(2008-10#1)(2009-7#1)(2013-1#1)
undertaken using##17##2##(1992-9#1)(1996-12#1)(1997-5#2)(2006-12#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-3#1)(2011-2#1)(2013-1#2)
undertaken with the##6##3##(1990-12#1)(2006-10#1)(2007-7#1)(2007-8#1)(2011-1#1)(2012-11#1)
undertaken with##15##2##(1990-12#1)(2006-10#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-1#1)(2012-11#1)
undertaken within the##3##3##(1992-6#1)(2006-6#1)(2008-11#1)
undertaken within##5##2##(1992-6#1)(2006-6#1)(2008-11#3)
undertaken##591##1##(1990-10#1)(1990-11#3)(1990-12#5)(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#1)(1991-8#3)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#4)(1992-5#1)(1992-6#3)(1992-9#1)(1993-1#1)(1993-11#4)(1993-12#5)(1993-2#5)(1993-3#2)(1993-4#1)(1993-5#3)(1993-6#2)(1993-9#4)(1994-1#1)(1994-10#2)(1994-11#2)(1994-12#5)(1994-2#3)(1994-3#5)(1994-6#3)(1994-8#1)(1994-9#1)(1995-1#5)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#4)(1995-6#2)(1996-1#4)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-5#2)(1996-6#4)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#4)(2004-1#1)(2004-10#1)(2004-11#1)(2005-10#3)(2005-11#2)(2005-12#2)(2005-7#1)(2005-8#3)(2005-9#1)(2006-1#3)(2006-10#13)(2006-11#1)(2006-12#4)(2006-2#2)(2006-3#2)(2006-4#2)(2006-5#1)(2006-6#4)(2006-7#1)(2006-8#13)(2006-9#1)(2007-1#3)(2007-10#13)(2007-11#7)(2007-12#3)(2007-2#5)(2007-3#6)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#14)(2007-8#16)(2007-9#2)(2008-1#7)(2008-10#35)(2008-11#25)(2008-12#7)(2008-2#6)(2008-3#8)(2008-4#4)(2008-5#18)(2008-6#3)(2008-7#16)(2008-8#6)(2008-9#6)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#6)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#9)(2011-12#5)(2011-2#17)(2011-3#1)(2012-1#2)(2012-11#2)(2012-12#24)(2012-2#19)(2012-3#13)(2013-1#14)(2013-7#3)(2013-8#9)
undertakes##3##1##(1992-12#1)(2008-11#1)(2008-12#1)
undertaking a##9##2##(1993-12#1)(2007-10#1)(2008-10#1)(2008-11#5)(2008-12#1)
undertaking research##2##2##(1996-2#1)(2005-7#1)
undertaking the##6##2##(1992-7#1)(1996-7#1)(2008-11#1)(2008-12#2)(2013-8#1)
undertaking this##4##2##(1996-8#1)(2006-10#1)(2007-8#1)(2008-11#1)
undertaking##57##1##(1991-12#1)(1992-7#1)(1993-12#1)(1994-1#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(2004-2#1)(2005-7#2)(2006-10#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#4)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#13)(2008-12#4)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
undertakings##2##1##(2008-1#1)(2008-11#1)
undertook a study##4##3##(1990-5#1)(1996-7#1)(2007-7#1)(2009-6#1)
undertook a##23##2##(1990-5#1)(1991-11#1)(1991-7#1)(1991-9#1)(1992-3#1)(1993-8#1)(1996-7#1)(1996-8#1)(2005-5#1)(2006-11#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#2)(2008-5#1)(2008-8#1)(2009-6#1)(2010-8#1)(2013-1#2)
undertook an analysis of##2##4##(1995-2#1)(2006-9#1)
undertook an##3##2##(1995-2#1)(2006-9#1)(2008-10#1)
undertook and##3##2##(2009-10#1)(2013-1#2)
undertook the##4##2##(1990-5#1)(1997-2#1)(2006-9#1)(2008-1#1)
undertook this study to##3##4##(2006-12#1)(2007-7#2)
undertook this study##5##3##(2006-12#1)(2007-7#2)(2008-1#1)(2008-7#1)
undertook this##6##2##(2006-10#1)(2006-12#1)(2007-7#2)(2008-1#1)(2008-7#1)
undertook##48##1##(1990-4#1)(1990-5#2)(1991-11#1)(1991-7#1)(1991-9#1)(1992-3#1)(1993-8#1)(1994-11#1)(1995-2#1)(1996-7#1)(1996-8#1)(1997-2#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-9#2)(2007-10#2)(2007-12#2)(2007-3#1)(2007-7#3)(2007-8#4)(2008-1#2)(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-1#4)(2013-8#1)
undertransmitted##2##1##(2009-4#2)
undertreated##14##1##(1993-9#1)(1996-7#1)(2007-12#2)(2007-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2011-2#2)(2013-8#2)
undertreatment of##6##2##(1996-7#2)(2008-4#1)(2010-3#2)(2011-1#1)
undertreatment##8##1##(1992-8#1)(1996-7#2)(2008-3#1)(2008-4#1)(2010-3#2)(2011-1#1)
underuse of warfarin and antiplatelets##3##5##(2007-10#3)
underuse of##6##2##(2006-10#2)(2007-10#4)
underuse##8##1##(1990-8#1)(2006-10#2)(2007-10#4)(2008-3#1)
underused in##4##2##(2008-12#1)(2008-3#2)(2010-8#1)
underused##20##1##(2005-7#1)(2007-10#3)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-3#4)(2008-4#1)(2009-11#1)(2009-3#1)(2010-8#1)(2012-11#2)(2013-1#1)
underutilised##2##1##(2011-12#1)(2012-12#1)
underutilization of##4##2##(1996-1#1)(2008-3#1)(2010-4#1)(2011-2#1)
underutilization##5##1##(1996-1#1)(1997-2#1)(2008-3#1)(2010-4#1)(2011-2#1)
underutilized in##3##2##(2008-11#1)(2012-1#1)(2012-3#1)
underutilized##21##1##(1992-1#1)(1992-12#1)(1996-1#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-5#1)(2011-1#1)(2012-1#2)(2012-11#1)(2012-3#1)
undervalued##3##1##(2006-7#1)(2009-2#1)(2009-8#1)
undervaluing##2##1##(2004-2#1)(2010-5#1)
underwater##15##1##(2006-4#1)(2008-10#3)(2008-2#3)(2008-3#6)(2010-2#1)(2010-8#1)
underway by##2##2##(1997-7#1)(2008-11#1)
underway in our##3##3##(2008-2#1)(2009-4#1)(2010-12#1)
underway in the##4##3##(1995-3#1)(1996-4#1)(1997-3#1)(2005-6#1)
underway in##14##2##(1992-1#1)(1994-12#1)(1995-3#1)(1996-4#1)(1997-3#1)(2005-6#1)(2005-7#1)(2006-10#1)(2006-9#1)(2007-2#1)(2008-10#1)(2008-2#1)(2009-4#1)(2010-12#1)
underway on##2##2##(2006-10#1)(2007-11#1)
underway that##2##2##(1996-3#1)(2009-10#1)
underway to determine the##2##4##(2008-4#1)(2010-4#1)
underway to determine##3##3##(2008-4#1)(2009-3#1)(2010-4#1)
underway to evaluate##2##3##(2005-7#1)(2008-5#1)
underway to##19##2##(1991-1#1)(1993-11#1)(1994-10#1)(1994-5#1)(2004-1#1)(2005-7#2)(2007-11#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#2)(2009-1#1)(2009-3#1)(2010-4#1)(2012-2#1)
underway##76##1##(1990-12#1)(1991-1#1)(1992-1#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-5#1)(1995-3#1)(1996-3#1)(1996-4#1)(1997-3#1)(1997-7#1)(2004-1#1)(2005-6#1)(2005-7#5)(2005-8#1)(2006-10#4)(2006-7#2)(2006-9#1)(2007-11#6)(2007-12#1)(2007-2#1)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#4)(2008-8#4)(2009-1#1)(2009-10#2)(2009-3#1)(2009-4#1)(2010-12#3)(2010-4#1)(2012-12#1)(2012-2#2)(2013-1#2)
underweight and overweight##2##3##(1991-12#2)
underweight and##3##2##(1991-12#2)(2007-12#1)
underweight children##2##2##(2010-7#1)(2012-2#1)
underweight is##2##2##(2008-1#1)(2010-6#1)
underweight##24##1##(1991-12#3)(1996-9#1)(2007-12#4)(2007-7#1)(2008-1#2)(2008-12#1)(2010-6#2)(2010-7#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#2)
underwent 12##4##2##(1996-4#1)(2007-10#1)(2007-12#1)(2008-4#1)
underwent 60##2##2##(2007-8#1)(2011-2#1)
underwent CABG and##2##3##(2007-10#1)(2007-8#1)
underwent CABG##10##2##(1993-5#2)(2007-10#2)(2007-8#5)(2013-1#1)
underwent CTA##3##2##(2008-9#3)
underwent GVBD##2##2##(1995-2#2)
underwent RRT##2##2##(2012-3#2)
underwent TMS in##2##3##(2011-2#2)
underwent a cesarean section##2##4##(2006-10#1)(2007-7#1)
underwent a combined##2##3##(2008-11#1)(2008-9#1)
underwent a complete physical##2##4##(1997-7#1)(2006-12#1)
underwent a complete##3##3##(1997-7#1)(2006-12#2)
underwent a comprehensive##2##3##(2009-10#1)(2012-12#1)
underwent a definitive##2##3##(2008-7#1)(2012-2#1)
underwent a general##2##3##(2004-10#1)(2013-1#1)
underwent a laparoscopic##3##3##(2006-6#1)(2010-3#1)(2012-12#1)
underwent a laparotomy##2##3##(2008-12#1)(2008-6#1)
underwent a left##3##3##(2008-4#1)(2008-6#1)(2008-7#1)
underwent a major##2##3##(1991-11#1)(2008-1#1)
underwent a modified radical##2##4##(1994-12#1)(2008-9#1)
underwent a new##4##3##(1991-9#1)(2007-8#1)(2008-7#1)(2012-3#1)
underwent a posterior##3##3##(2006-8#2)(2011-2#1)
underwent a second##4##3##(1993-5#1)(1997-3#1)(2007-8#1)(2010-12#1)
underwent a standard##2##3##(2007-9#1)(2011-2#1)
underwent a successful##3##3##(2007-8#2)(2010-7#1)
underwent a surgical##3##3##(2006-10#1)(2007-8#1)(2012-2#1)
underwent a total knee arthroplasty##2##5##(2010-3#1)(2012-12#1)
underwent a total of##2##4##(2008-1#1)(2010-12#1)
underwent a total##9##3##(2007-8#1)(2008-1#1)(2009-3#1)(2010-12#1)(2010-3#1)(2011-12#2)(2012-12#1)(2013-1#1)
underwent a trial of##2##4##(2005-10#1)(2006-8#1)
underwent a##156##2##(1990-3#1)(1990-9#1)(1991-11#1)(1991-5#1)(1991-7#1)(1991-9#1)(1993-5#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-8#1)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#1)(2004-10#1)(2004-2#1)(2005-10#1)(2005-5#1)(2006-10#7)(2006-12#6)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#4)(2006-9#2)(2007-10#5)(2007-11#1)(2007-7#3)(2007-8#12)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-12#3)(2008-4#1)(2008-6#3)(2008-7#7)(2008-9#9)(2009-10#2)(2009-3#2)(2010-10#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#4)(2011-2#10)(2012-1#2)(2012-12#5)(2012-2#7)(2012-3#2)(2013-1#7)(2013-8#3)
underwent activation##2##2##(1995-5#1)(1996-7#1)
underwent acute##2##2##(2011-2#1)(2013-1#1)
underwent additional##3##2##(1991-4#1)(1996-3#1)(2010-2#1)
underwent adjuvant##3##2##(2007-12#1)(2010-6#1)(2011-2#1)
underwent ambulatory##2##2##(1992-8#1)(2008-3#1)
underwent an arthroscopic##2##3##(1992-12#1)(2013-1#1)
underwent an emergency##4##3##(2007-8#1)(2011-2#1)(2013-1#2)
underwent an off-pump##2##3##(2006-12#1)(2007-8#1)
underwent an oral glucose tolerance test (OGTT)##2##7##(1994-12#1)(2007-8#1)
underwent an oral glucose tolerance test##3##6##(1994-12#1)(2007-8#1)(2008-3#1)
underwent an urgent##2##3##(2007-8#1)(2012-2#1)
underwent an##46##2##(1990-5#1)(1990-6#1)(1992-12#1)(1993-10#1)(1994-12#1)(1995-1#1)(2006-10#1)(2006-12#3)(2006-6#1)(2006-8#1)(2007-11#1)(2007-5#1)(2007-8#6)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#3)(2009-3#1)(2011-1#1)(2011-2#5)(2012-2#3)(2013-1#7)
underwent angiography##2##2##(2006-12#1)(2008-4#1)
underwent angioplasty and##2##3##(2006-11#1)(2007-7#1)
underwent angioplasty##3##2##(2006-11#1)(2007-7#2)
underwent anterior##5##2##(2005-5#1)(2006-7#1)(2007-11#1)(2007-7#1)(2007-8#1)
underwent aortic valve replacement##3##4##(2007-8#1)(2008-1#1)(2010-7#1)
underwent aortic##4##2##(2007-8#2)(2008-1#1)(2010-7#1)
underwent apoptosis##5##2##(2008-10#1)(2008-11#4)
underwent appendectomy##3##2##(1997-8#1)(2008-10#1)(2010-6#1)
underwent arterial##3##2##(2006-10#1)(2007-8#1)(2011-3#1)
underwent arthrodesis##2##2##(2008-6#2)
underwent arthroscopic##5##2##(2006-10#1)(2007-11#1)(2008-6#1)(2008-7#1)(2013-1#1)
underwent at least one##2##4##(2007-7#1)(2008-6#1)
underwent balloon##3##2##(2007-9#1)(2008-4#1)(2011-2#1)
underwent baseline##2##2##(2007-8#1)(2010-3#1)
underwent bilateral##7##2##(2006-8#2)(2007-8#3)(2007-9#1)(2008-9#1)
underwent biopsy##5##2##(2008-5#1)(2008-7#1)(2010-11#1)(2012-3#1)(2013-7#1)
underwent bone marrow##2##3##(2005-12#1)(2013-8#1)
underwent bone##4##2##(1991-11#1)(2005-12#1)(2011-2#1)(2013-8#1)
underwent both##2##2##(2012-2#2)
underwent cardiac surgery at the##2##5##(2005-7#1)(2007-8#1)
underwent cardiac surgery##3##3##(2005-7#1)(2007-8#2)
underwent cardiac##6##2##(2005-7#1)(2007-8#3)(2008-11#1)(2012-3#1)
underwent cardiopulmonary##2##2##(2006-10#1)(2007-8#1)
underwent cervicotomy##2##2##(2013-1#2)
underwent chemotherapy##2##2##(2007-11#1)(2013-1#1)
underwent closed reduction##2##3##(2006-4#1)(2009-3#1)
underwent colonoscopy##2##2##(1993-10#1)(2011-2#1)
underwent colposcopy##2##2##(2006-10#2)
underwent combined treatment##2##3##(2006-11#1)(2007-11#1)
underwent combined##5##2##(2006-11#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-8#1)
underwent complete resection##2##3##(1990-8#1)(2013-8#1)
underwent complete##9##2##(1990-10#1)(1990-6#1)(1990-8#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-8#2)(2013-8#1)
underwent computed tomography##2##3##(2010-10#1)(2012-2#1)
underwent conventional surgery##2##3##(1995-9#1)(2008-11#1)
underwent conventional##5##2##(1995-9#1)(2007-8#1)(2007-9#1)(2008-11#1)(2013-1#1)
underwent coronary angiography##4##3##(1993-12#1)(2008-3#1)(2008-7#1)(2013-8#1)
underwent coronary artery bypass grafting##5##5##(2007-8#4)(2007-9#1)
underwent coronary artery bypass##6##4##(2007-8#5)(2007-9#1)
underwent coronary artery##7##3##(2007-8#5)(2007-9#1)(2012-2#1)
underwent coronary##17##2##(1993-12#1)(2007-8#8)(2007-9#2)(2008-3#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-4#1)(2013-8#1)
underwent correction of##2##3##(2008-9#1)(2009-10#1)
underwent cosmetic##3##2##(2007-12#1)(2007-8#1)(2009-9#1)
underwent curative surgery##2##3##(1991-6#1)(1995-10#1)
underwent curative##3##2##(1991-6#1)(1995-10#1)(2011-2#1)
underwent detailed##2##2##(1995-10#1)(2006-8#1)
underwent diffusion##2##2##(2009-11#1)(2010-7#1)
underwent distal##2##2##(1993-1#1)(2010-12#1)
underwent duplex##2##2##(1990-7#1)(2005-10#1)
underwent echocardiography##2##2##(2008-12#1)(2008-5#1)
underwent either##6##2##(1993-5#1)(1996-3#1)(2006-8#1)(2007-9#1)(2009-3#1)(2011-2#1)
underwent elective surgery##2##3##(1990-10#1)(1992-8#1)
underwent elective##8##2##(1990-10#1)(1992-8#1)(2007-8#2)(2008-11#1)(2012-12#2)(2013-8#1)
underwent embolization##2##2##(1991-2#1)(2008-7#1)
underwent emergency surgery##2##3##(2008-11#1)(2010-12#1)
underwent emergency##7##2##(1992-5#1)(1993-10#1)(2005-12#1)(2008-1#1)(2008-11#1)(2009-6#1)(2010-12#1)
underwent endoscopic retrograde##2##3##(2007-3#1)(2007-8#1)
underwent endoscopic therapy##2##3##(2012-2#2)
underwent endoscopic##6##2##(2006-5#1)(2007-3#1)(2007-8#1)(2011-2#1)(2012-2#2)
underwent endoscopy##2##2##(1993-2#1)(2011-2#1)
underwent examination##2##2##(1991-12#1)(2007-11#1)
underwent excision of##3##3##(2008-9#1)(2011-12#1)(2012-1#1)
underwent excision##4##2##(2008-6#1)(2008-9#1)(2011-12#1)(2012-1#1)
underwent excisional##2##2##(1995-4#1)(2004-1#1)
underwent extensive##3##2##(2006-4#1)(2008-5#1)(2012-3#1)
underwent fMRI##2##2##(2012-2#1)(2013-8#1)
underwent first##2##2##(1994-9#1)(2007-8#1)
underwent full-text review##2##3##(2012-12#2)
underwent further##3##2##(2008-6#2)(2008-7#1)
underwent heart##2##2##(1991-12#1)(1993-8#1)
underwent implantation of##2##3##(2007-10#2)
underwent in##2##2##(2007-11#1)(2012-2#1)
underwent incisional biopsy##2##3##(1997-6#1)(2010-11#1)
underwent initial laparotomy##2##3##(2012-2#2)
underwent insertion of##2##3##(2005-4#1)(2008-3#1)
underwent intraoperative##3##2##(1990-9#1)(1993-10#1)(2006-11#1)
underwent joint##2##2##(2007-11#1)(2008-1#1)
underwent kidney##3##2##(2013-1#2)(2013-7#1)
underwent laminectomy##2##2##(2006-7#1)(2012-12#1)
underwent laparoscopic myomectomy##2##3##(1993-12#1)(2006-6#1)
underwent laparoscopic##8##2##(1993-12#1)(1994-2#1)(2006-6#1)(2007-7#1)(2008-12#1)(2008-5#2)(2011-2#1)
underwent laparotomy##2##2##(1990-9#1)(2007-7#1)
underwent laser##2##2##(1991-1#1)(2011-1#1)
underwent left Lateral##2##3##(2008-1#2)
underwent left##7##2##(2008-1#2)(2008-5#1)(2008-6#1)(2010-9#1)(2012-12#2)
underwent liver transplantation##2##3##(1996-7#1)(2013-1#1)
underwent lobectomy##2##2##(2008-5#1)(2011-2#1)
underwent local##2##2##(2007-8#1)(2009-3#1)
underwent lumbar##3##2##(2006-8#2)(2007-11#1)
underwent lung resection##2##3##(2007-8#2)
underwent lung transplantation##3##3##(1994-3#1)(2006-8#1)(2010-10#1)
underwent lung##5##2##(1994-3#1)(2006-8#1)(2007-8#2)(2010-10#1)
underwent magnetic resonance imaging##3##4##(2005-10#1)(2010-3#1)(2011-2#1)
underwent magnetic resonance##4##3##(2005-10#1)(2006-3#1)(2010-3#1)(2011-2#1)
underwent mastectomy##2##2##(1995-10#1)(2008-4#1)
underwent median sternotomy##3##3##(2007-8#2)(2008-1#1)
underwent mitotic##2##2##(1995-8#1)(2013-1#1)
underwent multielemental##2##2##(2008-10#2)
underwent multiple##3##2##(2006-10#1)(2007-8#1)(2011-2#1)
underwent myocardial revascularisation##2##3##(2007-9#1)(2008-6#1)
underwent myocardial##3##2##(2007-8#1)(2007-9#1)(2008-6#1)
underwent off-pump##2##2##(2007-8#2)
underwent omental transfer based on blood supply from##2##8##(2007-8#2)
underwent omental transfer based on##3##5##(2007-8#3)
underwent open reduction and internal fixation##2##6##(2008-12#1)(2009-3#1)
underwent open reduction##3##3##(2008-12#1)(2009-3#1)(2013-1#1)
underwent open##7##2##(2008-10#1)(2008-12#1)(2008-5#1)(2009-3#1)(2012-12#1)(2013-1#2)
underwent open-heart surgery##2##3##(2007-9#1)(2008-11#1)
underwent operation##3##2##(1993-4#1)(2006-2#1)(2007-10#1)
underwent operations##2##2##(1996-4#1)(2011-2#1)
underwent operative##2##2##(1996-3#1)(2006-9#1)
underwent orthotopic liver transplantation from##2##5##(1992-12#1)(2013-8#1)
underwent orthotopic liver transplantation##4##4##(1991-11#1)(1992-12#1)(1995-2#1)(2013-8#1)
underwent pancreaticoduodenectomy##2##2##(2006-6#1)(2013-1#1)
underwent partial##3##2##(2011-2#1)(2012-3#1)(2013-7#1)
underwent percutaneous##4##2##(1994-11#1)(2006-8#2)(2013-1#1)
underwent peritoneal##2##2##(1994-4#1)(2011-2#1)
underwent posterior##5##2##(2006-8#2)(2008-11#1)(2008-8#1)(2009-3#1)
underwent preoperative##3##2##(1996-8#1)(2005-5#1)(2008-7#1)
underwent primary##6##2##(1990-5#1)(1996-9#1)(2007-11#1)(2007-7#1)(2008-6#2)
underwent pulmonary CTA##2##3##(2010-8#2)
underwent pulmonary##3##2##(2007-8#1)(2010-8#2)
underwent radical orchiectomy##2##3##(2007-11#1)(2009-7#1)
underwent radical prostatectomy##2##3##(2007-11#1)(2011-2#1)
underwent radical surgery##5##3##(1990-6#1)(1990-9#1)(1992-10#2)(1997-7#1)
underwent radical surgical treatment##2##4##(2011-2#2)
underwent radical surgical##3##3##(2009-2#1)(2011-2#2)
underwent radical##15##2##(1990-3#1)(1990-6#1)(1990-9#1)(1992-10#2)(1994-7#1)(1997-7#1)(2007-11#2)(2009-2#2)(2009-7#1)(2011-2#3)
underwent radiographic evaluation##2##3##(2007-2#2)
underwent radiotherapy##5##2##(1990-10#1)(2006-12#1)(2006-5#1)(2007-8#1)(2011-2#1)
underwent reimplantation with the Nucleus Freedom or Nucleus 5 device##2##10##(2012-2#2)
underwent reimplantation##3##2##(2008-1#1)(2012-2#2)
underwent renal biopsy##2##3##(2008-1#1)(2013-1#1)
underwent renal##4##2##(2008-1#2)(2010-4#1)(2013-1#1)
underwent reoperation##3##2##(2006-12#1)(2007-8#1)(2007-9#1)
underwent repeat##3##2##(1992-2#1)(1992-3#1)(2005-5#1)
underwent repeated surgical##2##3##(2006-12#1)(2012-12#1)
underwent repeated##4##2##(2006-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
underwent resection of the##5##4##(1991-8#1)(2007-11#1)(2007-8#1)(2008-6#2)
underwent resection of##9##3##(1991-8#1)(2006-12#2)(2007-11#1)(2007-8#2)(2008-6#2)(2012-12#1)
underwent resection##11##2##(1991-8#1)(2006-12#3)(2006-6#1)(2007-11#1)(2007-8#2)(2008-6#2)(2012-12#1)
underwent resections##2##2##(1991-4#1)(1992-6#1)
underwent retransplantation##2##2##(1995-2#1)(2008-8#1)
underwent revision##4##2##(2006-7#1)(2007-8#1)(2012-12#1)(2013-1#1)
underwent right##2##2##(2008-1#1)(2012-1#1)
underwent routine##2##2##(2012-2#2)
underwent salvage##2##2##(1990-6#1)(2010-3#1)
underwent serial##2##2##(1997-8#1)(2010-7#1)
underwent simultaneous##3##2##(2007-8#2)(2008-7#1)
underwent single##2##2##(2006-8#1)(2012-12#1)
underwent single-stage##2##2##(2007-8#1)(2008-10#1)
underwent spinal##3##2##(2006-8#1)(2008-7#1)(2012-3#1)
underwent splenectomy##2##2##(2007-5#1)(2011-12#1)
underwent subsequent##3##2##(1992-10#1)(1992-7#1)(2006-12#1)
underwent subtotal gastrectomy##2##3##(2005-12#1)(2009-8#1)
underwent subtotal##4##2##(2005-12#1)(2008-7#1)(2009-8#1)(2012-12#1)
underwent successful kidney transplantation##2##4##(2006-8#1)(2010-4#1)
underwent successful##10##2##(1995-7#1)(2006-8#1)(2007-8#2)(2008-12#1)(2009-5#1)(2010-4#1)(2013-1#2)(2013-8#1)
underwent surgery after##3##3##(2008-6#1)(2008-7#1)(2013-1#1)
underwent surgery and##5##3##(1991-10#1)(1992-12#1)(1992-6#1)(2010-6#1)(2011-1#1)
underwent surgery at a##2##4##(2006-4#1)(2011-2#1)
underwent surgery at##6##3##(2006-4#1)(2007-11#2)(2008-6#1)(2011-1#1)(2011-2#1)
underwent surgery for##13##3##(1992-8#1)(1994-2#1)(2005-11#1)(2006-11#1)(2007-7#1)(2007-8#2)(2008-3#1)(2008-8#1)(2009-2#1)(2010-2#1)(2011-1#1)(2011-2#1)
underwent surgery in the##3##4##(2006-8#1)(2008-7#1)(2013-1#1)
underwent surgery in##6##3##(2006-10#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-7#1)(2013-1#1)
underwent surgery on##2##3##(2007-8#1)(2012-3#1)
underwent surgery to remove##2##4##(2007-12#1)(2007-8#1)
underwent surgery##57##2##(1991-10#1)(1991-6#1)(1992-12#1)(1992-6#1)(1992-8#1)(1994-2#1)(1996-2#1)(1997-3#1)(2004-1#1)(2005-11#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-5#1)(2006-8#2)(2007-11#6)(2007-12#2)(2007-7#1)(2007-8#6)(2008-1#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-2#1)(2010-2#1)(2010-6#1)(2011-1#4)(2011-12#1)(2011-2#3)(2012-3#2)(2013-1#4)
underwent surgical exploration##3##3##(1991-12#1)(2007-3#1)(2010-12#1)
underwent surgical intervention##4##3##(2006-8#1)(2008-3#1)(2011-1#1)(2011-2#1)
underwent surgical reconstruction##2##3##(2007-7#1)(2008-4#1)
underwent surgical removal##3##3##(1992-10#1)(1992-4#2)
underwent surgical repair##3##3##(2006-4#1)(2007-8#1)(2008-12#1)
underwent surgical resection##3##3##(2006-12#1)(2007-8#1)(2012-1#1)
underwent surgical treatment##6##3##(1993-10#1)(1993-6#1)(2006-10#1)(2009-8#1)(2011-2#1)(2013-8#1)
underwent surgical##33##2##(1991-12#1)(1991-5#1)(1992-10#1)(1992-4#2)(1993-10#1)(1993-6#1)(1996-3#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-8#1)
underwent the procedure##5##3##(2007-1#1)(2007-8#1)(2008-8#2)(2012-12#1)
underwent the same##4##3##(1994-6#1)(2007-7#1)(2012-12#1)(2013-1#1)
underwent the##24##2##(1990-8#1)(1994-6#1)(2005-5#1)(2006-12#1)(2007-1#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-4#1)(2008-7#2)(2008-8#2)(2011-2#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#1)
underwent this procedure##5##3##(1990-2#1)(1996-12#1)(2006-5#1)(2008-11#1)(2012-3#1)
underwent this technique##2##3##(2006-12#1)(2008-6#1)
underwent this##8##2##(1990-2#1)(1996-12#1)(2006-12#1)(2006-5#1)(2008-11#2)(2008-6#1)(2012-3#1)
underwent thoracic##5##2##(2007-8#2)(2008-6#1)(2012-12#1)(2012-2#1)
underwent thoracotomy and##2##3##(2007-8#1)(2011-2#1)
underwent thoracotomy##5##2##(2007-3#1)(2007-8#3)(2011-2#1)
underwent three##3##2##(2007-7#1)(2012-12#1)(2013-1#1)
underwent total abdominal hysterectomy##2##4##(1996-12#1)(2013-1#1)
underwent total##15##2##(1992-12#1)(1996-12#2)(2006-10#1)(2006-12#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-5#2)(2008-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
underwent transcatheter closure of##2##4##(1996-6#1)(2008-11#1)
underwent transient##2##2##(2008-10#1)(2010-10#1)
underwent treatment at##2##3##(2007-11#1)(2008-7#1)
underwent treatment##5##2##(2006-10#1)(2006-11#1)(2007-11#1)(2008-7#1)(2011-1#1)
underwent tumor##2##2##(2007-10#1)(2010-3#1)
underwent two##6##2##(1997-6#1)(2006-7#1)(2007-12#2)(2008-5#1)(2009-6#1)
underwent unilateral##2##2##(1996-5#1)(2006-8#1)
underwent upper##3##2##(2006-8#1)(2008-11#1)(2011-2#1)
underwent urgent##2##2##(2007-8#1)(2008-4#1)
underwent valve replacement##2##3##(2007-8#2)
underwent ventral##2##2##(2006-5#2)
underwent whole##2##2##(2007-8#1)(2010-7#1)
underwent wide##2##2##(1991-10#1)(1992-4#1)
underwent##1231##1##(1990-10#4)(1990-11#1)(1990-2#3)(1990-3#3)(1990-5#4)(1990-6#7)(1990-7#3)(1990-8#2)(1990-9#4)(1991-1#2)(1991-10#2)(1991-11#5)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#5)(1991-7#2)(1991-8#2)(1991-9#1)(1992-10#5)(1992-12#4)(1992-2#2)(1992-3#3)(1992-4#3)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#4)(1993-1#2)(1993-10#6)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#1)(1993-4#1)(1993-5#6)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#5)(1994-4#1)(1994-6#1)(1994-7#1)(1994-9#2)(1995-1#2)(1995-10#5)(1995-11#3)(1995-2#7)(1995-3#2)(1995-4#2)(1995-5#1)(1995-7#1)(1995-8#2)(1995-9#5)(1996-12#3)(1996-2#1)(1996-3#4)(1996-4#2)(1996-5#5)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#4)(1997-1#1)(1997-3#3)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#9)(2004-1#3)(2004-10#2)(2004-2#1)(2005-10#4)(2005-11#2)(2005-12#5)(2005-4#1)(2005-5#8)(2005-7#1)(2006-1#2)(2006-10#23)(2006-11#13)(2006-12#26)(2006-2#1)(2006-3#3)(2006-4#4)(2006-5#11)(2006-6#14)(2006-7#8)(2006-8#34)(2006-9#4)(2007-1#2)(2007-10#21)(2007-11#33)(2007-12#10)(2007-2#2)(2007-3#8)(2007-5#3)(2007-6#1)(2007-7#24)(2007-8#129)(2007-9#17)(2008-1#22)(2008-10#20)(2008-11#25)(2008-12#12)(2008-3#10)(2008-4#13)(2008-5#25)(2008-6#30)(2008-7#31)(2008-8#8)(2008-9#25)(2009-1#1)(2009-10#6)(2009-11#2)(2009-2#5)(2009-3#15)(2009-5#1)(2009-6#5)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#4)(2010-11#2)(2010-12#10)(2010-2#4)(2010-3#9)(2010-4#4)(2010-5#2)(2010-6#4)(2010-7#7)(2010-8#3)(2010-9#2)(2011-1#16)(2011-12#10)(2011-2#82)(2011-3#2)(2012-1#5)(2012-12#32)(2012-2#36)(2012-3#23)(2013-1#62)(2013-4#1)(2013-7#6)(2013-8#19)
underwinding##2##1##(1995-3#1)(1995-8#1)
underwriters##9##1##(1992-3#1)(1993-12#2)(1993-3#2)(1995-3#1)(1996-12#1)(1997-2#1)(1997-8#1)
underwriting factors##5##2##(1993-3#5)
underwriting standards##3##2##(1997-8#2)(2009-4#1)
underwriting##20##1##(1992-2#1)(1992-3#1)(1993-12#2)(1993-3#6)(1993-9#1)(1994-2#1)(1995-1#2)(1996-2#1)(1997-8#3)(2009-4#1)(2012-12#1)
undescended testis##11##2##(1997-6#1)(2006-7#4)(2008-10#2)(2012-12#1)(2012-2#3)
undescended##14##1##(1997-6#1)(2006-7#4)(2008-10#4)(2012-12#1)(2012-2#4)
undescribed species of the##2##4##(2008-10#1)(2008-5#1)
undescribed species of##4##3##(2008-10#3)(2008-5#1)
undescribed species##9##2##(2008-10#5)(2008-5#2)(2008-6#1)(2012-11#1)
undescribed species)##2##2##(1993-4#1)(2010-3#1)
undescribed##45##1##(1990-7#1)(1993-4#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-2#1)(2006-12#1)(2006-8#3)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#17)(2008-5#2)(2008-6#1)(2009-5#1)(2010-3#1)(2011-1#3)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#2)
undesirable and##3##2##(2008-5#1)(2008-9#1)(2012-2#1)
undesirable effects of##4##3##(2006-10#3)(2008-7#1)
undesirable effects##8##2##(2006-10#3)(2007-11#1)(2007-3#1)(2008-4#1)(2008-7#1)(2009-6#1)
undesirable outcome##2##2##(2008-7#1)(2011-2#1)
undesirable side effects associated with##2##5##(1995-12#1)(2007-8#1)
undesirable side effects on##2##4##(1993-12#1)(2011-2#1)
undesirable side effects##8##3##(1993-12#1)(1995-12#1)(2006-10#1)(2006-5#1)(2007-8#1)(2008-7#1)(2010-6#1)(2011-2#1)
undesirable side##10##2##(1993-11#1)(1993-12#1)(1995-12#1)(1996-8#1)(2006-10#1)(2006-5#1)(2007-8#1)(2008-7#1)(2010-6#1)(2011-2#1)
undesirable traits##2##2##(2006-12#1)(2009-10#1)
undesirable##76##1##(1990-3#1)(1991-3#2)(1992-4#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-2#1)(1996-8#1)(2005-11#2)(2005-7#1)(2006-10#8)(2006-12#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-8#3)(2008-10#3)(2008-11#5)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-4#3)(2010-6#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#2)
undesired adverse##2##2##(1993-1#1)(1996-4#1)
undesired##29##1##(1991-12#1)(1993-1#1)(1993-2#1)(1994-12#1)(1995-2#1)(1996-4#2)(1997-2#1)(1997-5#1)(2004-3#1)(2005-11#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#3)(2008-8#1)(2008-9#1)(2009-12#1)(2010-2#1)(2013-8#1)
undetectable by##6##2##(1994-8#1)(1994-9#2)(1995-6#1)(1997-2#1)(2005-9#1)
undetectable in normal##2##3##(1996-9#1)(2013-1#1)
undetectable in the##8##3##(1991-12#1)(1991-3#1)(1991-5#1)(1994-11#1)(1996-11#1)(1996-12#1)(1997-6#1)(1997-7#1)
undetectable in##34##2##(1990-11#2)(1990-5#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-3#1)(1992-6#1)(1994-11#1)(1994-3#1)(1995-6#1)(1996-11#5)(1996-12#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-11#1)(2009-10#1)(2010-10#1)(2012-12#1)(2012-2#1)(2013-1#2)
undetectable level by##2##3##(1992-1#1)(1994-3#1)
undetectable level##3##2##(1990-9#1)(1992-1#1)(1994-3#1)
undetectable levels in##2##3##(2007-11#1)(2011-1#1)
undetectable levels of##3##3##(1991-9#1)(1995-2#1)(2008-10#1)
undetectable levels##19##2##(1990-2#1)(1991-5#1)(1991-9#1)(1994-12#1)(1995-2#1)(1997-2#2)(2005-11#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-10#5)(2008-5#1)(2011-1#1)(2012-1#1)
undetectable on##4##2##(1991-12#1)(1995-6#1)(2008-7#1)(2008-8#1)
undetectable plasma##2##2##(2010-4#1)(2012-2#1)
undetectable serum##2##2##(2006-10#1)(2009-8#1)
undetectable viral##3##2##(2008-10#1)(2009-6#1)(2013-1#1)
undetectable##114##1##(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-3#1)(1992-6#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-8#3)(1994-9#4)(1995-12#1)(1995-2#2)(1995-6#3)(1995-8#1)(1996-11#5)(1996-12#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(2004-4#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-9#1)(2007-11#2)(2008-1#1)(2008-10#9)(2008-12#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#2)(2009-8#2)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#1)
undetected and##6##2##(1993-9#1)(1995-12#1)(2008-10#1)(2009-6#1)(2009-7#1)(2010-2#1)
undetected in##3##2##(1997-6#2)(2009-8#1)
undetected or##2##2##(2009-3#1)(2013-8#1)
undetected##40##1##(1990-2#1)(1992-10#2)(1992-8#1)(1993-10#1)(1993-9#1)(1995-12#1)(1996-12#1)(1997-6#2)(1997-7#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-6#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-3#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-8#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
undetermined in##2##2##(1991-3#1)(2008-7#1)
undetermined##37##1##(1990-11#1)(1991-3#1)(1991-7#1)(1992-2#1)(1993-1#1)(1993-5#1)(1994-12#1)(1995-3#1)(1997-7#1)(2006-10#6)(2006-2#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-1#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-8#3)
undeveloped immune##2##2##(2008-3#1)(2011-2#1)
undeveloped##9##1##(2008-3#4)(2009-3#1)(2010-8#2)(2010-9#1)(2011-2#1)
undiagnosed and untreated##2##3##(2007-10#1)(2012-12#1)
undiagnosed and##4##2##(2007-10#1)(2009-1#1)(2012-12#2)
undiagnosed disease##3##2##(1990-3#1)(2004-7#1)(2008-5#1)
undiagnosed for##3##2##(2006-10#1)(2006-6#1)(2007-7#1)
undiagnosed patients##2##2##(2006-10#1)(2007-2#1)
undiagnosed pheochromocytoma##3##2##(2007-12#2)(2012-12#1)
undiagnosed small peripheral##2##3##(2007-8#2)
undiagnosed##67##1##(1990-3#1)(1991-11#1)(1992-7#1)(1996-11#1)(1996-12#2)(2004-7#1)(2006-10#5)(2006-2#1)(2006-4#1)(2006-6#2)(2007-10#1)(2007-12#2)(2007-2#2)(2007-7#2)(2007-8#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#3)(2009-2#2)(2009-3#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#3)(2012-2#2)(2013-1#6)(2013-8#3)
undifferentiated F9 cells##4##3##(1992-9#2)(1993-3#2)
undifferentiated P19 cells##2##3##(1990-11#1)(1992-12#1)
undifferentiated PC12 cell deaths at##2##5##(2013-8#2)
undifferentiated PC12 cells##2##3##(2008-4#1)(2013-8#1)
undifferentiated PC12##4##2##(2008-4#1)(2013-8#3)
undifferentiated Tera2 cells##2##3##(1996-5#2)
undifferentiated and differentiated##2##3##(2008-11#1)(2012-2#1)
undifferentiated and##7##2##(1991-9#2)(1994-6#1)(1997-2#1)(1997-5#1)(2008-11#1)(2012-2#1)
undifferentiated carcinoma##10##2##(1991-8#2)(1993-3#1)(1995-10#1)(2007-5#1)(2008-3#4)(2010-7#1)
undifferentiated cell mass##2##3##(2007-12#1)(2009-6#1)
undifferentiated cells and##2##3##(1993-7#1)(2009-4#1)
undifferentiated cells have##2##3##(1992-3#1)(2008-1#1)
undifferentiated cells that##2##3##(2007-12#1)(2008-1#1)
undifferentiated cells##21##2##(1991-4#1)(1992-12#1)(1992-3#3)(1992-9#1)(1993-7#2)(1994-2#1)(1994-6#1)(1996-5#1)(2007-12#2)(2008-1#2)(2008-11#1)(2008-4#2)(2008-5#1)(2009-4#1)(2009-8#1)
undifferentiated connective tissue disease##3##4##(2006-10#3)
undifferentiated connective tissue dysplasia syndrome##2##5##(2010-12#1)(2012-1#1)
undifferentiated connective tissue dysplasia##4##4##(2010-12#2)(2012-1#2)
undifferentiated connective tissue##7##3##(2006-10#3)(2010-12#2)(2012-1#2)
undifferentiated embryonic stem cells##2##4##(2008-11#2)
undifferentiated febrile illness##2##3##(2013-1#1)(2013-8#1)
undifferentiated fever##3##2##(2011-2#1)(2013-8#2)
undifferentiated hESC##3##2##(2008-11#1)(2008-9#2)
undifferentiated neuroblasts##2##2##(1991-9#2)
undifferentiated spondarthritides##2##2##(1990-6#2)
undifferentiated state##6##2##(1996-5#1)(2008-1#1)(2008-11#1)(2012-1#1)(2012-12#1)(2013-1#1)
undifferentiated thyroid##2##2##(1990-3#1)(1992-8#1)
undifferentiated tumour cells##2##3##(1994-8#1)(2008-5#1)
undifferentiated##131##1##(1990-11#1)(1990-3#1)(1990-6#3)(1991-4#1)(1991-8#2)(1991-9#6)(1992-1#1)(1992-12#2)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#4)(1993-12#1)(1993-3#3)(1993-6#1)(1993-7#3)(1994-2#1)(1994-6#2)(1994-8#1)(1995-10#1)(1995-6#1)(1996-4#1)(1996-5#4)(1997-2#2)(1997-5#1)(2005-10#1)(2006-10#8)(2007-12#5)(2007-5#2)(2008-1#5)(2008-10#1)(2008-11#9)(2008-3#4)(2008-4#4)(2008-5#3)(2008-8#1)(2008-9#3)(2009-12#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-8#1)(2010-12#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#6)(2012-1#4)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#7)
undigested##9##1##(1991-8#1)(1992-12#2)(1993-11#1)(1994-12#1)(2006-2#1)(2008-10#2)(2008-12#1)
undiluted plasma##2##2##(2005-8#1)(2012-11#1)
undiluted samples##3##2##(2008-10#3)
undiluted serum##4##2##(1993-12#4)
undiluted##21##1##(1991-12#1)(1993-12#4)(1995-1#1)(2005-8#2)(2008-10#9)(2010-4#1)(2012-11#1)(2013-1#2)
undirected##3##1##(1994-12#1)(2011-2#1)(2012-3#1)
undisclosed##3##1##(1997-5#1)(2005-7#1)(2009-4#1)
undiscovered##7##1##(1994-2#1)(1996-5#1)(2007-8#1)(2008-10#1)(2012-2#1)(2012-3#1)(2013-8#1)
undisputable##2##1##(2006-8#1)(2013-1#1)
undisputed##4##1##(2006-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
undissociated uric acid##2##3##(2007-8#2)
undissociated##6##1##(1995-8#1)(2006-10#1)(2007-8#2)(2008-6#1)(2011-2#1)
undissolved##2##1##(2008-10#2)
undistorted##7##1##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)(2010-2#1)
undisturbed soil columns##2##3##(2004-4#2)
undisturbed soil##3##2##(2004-4#2)(2008-10#1)
undisturbed##11##1##(1992-9#1)(2004-4#2)(2006-10#1)(2006-5#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-12#1)
undivided##2##1##(2010-2#1)(2011-2#1)
undo##3##1##(1990-4#1)(1991-1#1)(2009-10#1)
undocked lambs##3##2##(1994-4#3)
undocked##4##1##(1994-4#4)
undocumented##2##1##(2008-12#1)(2008-8#1)
undoped PbO(2)##2##2##(2008-10#2)
undoped YAG##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
undoped and##2##2##(2007-12#1)(2008-10#1)
undoped nematic liquid crystals##2##4##(2007-11#1)(2007-12#1)
undoped##31##1##(2005-11#1)(2005-4#2)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#4)(2008-2#9)(2008-3#5)(2008-5#2)(2008-7#1)
undoubted##2##1##(1990-8#1)(1994-3#1)
undoubtedly have##2##2##(1991-12#1)(1994-3#1)
undoubtedly includes##2##2##(2009-4#1)(2012-12#1)
undoubtedly##44##1##(1990-2#1)(1990-5#1)(1991-12#2)(1991-8#1)(1992-3#1)(1992-9#1)(1994-3#1)(1995-10#1)(1995-12#2)(1996-11#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#2)(2008-1#1)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-12#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
undrugged behavior##5##2##(1993-3#5)
undrugged controls##2##2##(1993-3#1)(1993-9#1)
undrugged##10##1##(1992-7#1)(1993-12#1)(1993-3#7)(1993-9#1)
undue burden##3##2##(1995-9#2)(1997-7#1)
undue burden&quot##3##2##(1992-6#2)(2005-11#1)
undue inducement##2##2##(2009-6#2)
undue##24##1##(1992-2#1)(1992-3#1)(1992-6#2)(1994-12#1)(1995-9#2)(1996-5#1)(1997-1#1)(1997-7#1)(2005-11#1)(2006-6#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-11#3)(2008-5#1)(2008-6#1)(2009-6#3)(2010-8#1)
undulata##3##1##(1997-3#1)(2008-5#2)
undulate (vs##3##2##(2008-5#3)
undulate##4##1##(2008-5#3)(2011-2#1)
undulated##2##1##(2007-12#1)(2010-10#1)
undulation##3##1##(2009-7#3)
undulations in##2##2##(1992-3#1)(1993-8#1)
undulations##3##1##(1991-11#1)(1992-3#1)(1993-8#1)
undulator A##4##2##(2006-5#4)
undulator radiation and##2##3##(2006-4#2)
undulator radiation##3##2##(2006-4#2)(2006-5#1)
undulator##13##1##(2006-4#6)(2006-5#7)
undulators##5##1##(2006-4#4)(2006-5#1)
undulosa##6##1##(2008-10#6)
unduly##4##1##(1992-3#1)(2007-12#1)(2008-10#1)(2009-12#1)
undyed##2##1##(2007-12#1)(2008-2#1)
une complication##4##2##(2011-2#2)(2012-2#2)
une hépatomégalie##2##2##(2012-2#2)
une masse##2##2##(2012-2#2)
une pathologie rare qui survient habituellement chez des adolescents présentant des troubles psychiques##2##13##(2012-2#2)
une pathologie##5##2##(2011-2#1)(2012-2#2)(2013-1#2)
une patiente##2##2##(2012-2#1)(2013-1#1)
une prise en charge##4##4##(2011-2#1)(2012-2#2)(2013-1#1)
une##74##1##(2008-11#3)(2008-5#12)(2011-2#8)(2012-2#29)(2013-1#22)
uneasy##2##1##(1996-6#1)(2009-2#1)
unedited##5##1##(1990-11#2)(1993-12#2)(1997-4#1)
uneducated##4##1##(1994-3#1)(1994-7#1)(2012-12#1)(2012-2#1)
uneffective concentration of##2##3##(1991-2#2)
uneffective##3##1##(1991-2#2)(1992-12#1)
unembalmed cadavers##3##2##(2006-11#1)(2007-4#1)(2009-1#1)
unembalmed human cadavers##3##3##(2006-11#1)(2007-4#2)
unembalmed human##4##2##(2006-11#1)(2007-4#3)
unembalmed##11##1##(2006-11#2)(2007-4#7)(2009-1#1)(2012-2#1)
unemployed and underemployed##2##3##(2013-1#2)
unemployed and##4##2##(2006-8#1)(2008-10#1)(2013-1#2)
unemployed workers##5##2##(2013-1#5)
unemployed##28##1##(1992-2#1)(1993-5#1)(1994-4#1)(1995-12#1)(1997-2#2)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-11#1)(2010-2#3)(2011-1#1)(2012-11#1)(2013-1#9)
unemployment (OR##2##2##(2011-1#1)(2012-2#1)
unemployment and##6##2##(1997-3#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-9#1)(2013-1#1)
unemployment as an##2##3##(1997-3#1)(2013-1#1)
unemployment benefits##2##2##(1996-11#1)(2008-7#1)
unemployment is##3##2##(1991-11#1)(1993-7#1)(1997-3#1)
unemployment or economic inactivity##3##4##(2013-1#3)
unemployment or##4##2##(1997-3#1)(2013-1#3)
unemployment was##2##2##(1990-4#1)(2006-8#1)
unemployment##48##1##(1990-4#1)(1991-11#2)(1992-11#1)(1993-3#1)(1993-7#1)(1996-10#1)(1996-11#1)(1997-2#2)(1997-3#9)(1997-8#1)(2006-8#3)(2007-10#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-7#1)(2008-9#3)(2010-6#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#7)
unencapsulated##2##1##(2008-5#1)(2013-1#1)
unenergized##2##1##(1992-6#2)
unenhanced MRA##2##2##(2008-7#2)
unenhanced transcription##2##2##(1995-6#2)
unenhanced##7##1##(1995-6#3)(2008-7#2)(2010-12#1)(2012-2#1)
unequal access to health##2##4##(1991-3#1)(2006-8#1)
unequal access to##3##3##(1991-3#1)(2006-8#1)(2013-1#1)
unequal access##5##2##(1991-3#1)(2006-8#1)(2007-7#1)(2012-2#1)(2013-1#1)
unequal and##2##2##(2008-10#1)(2008-4#1)
unequal competitors##2##2##(2008-8#2)
unequal error protection##2##3##(2008-2#2)
unequal mirrors##3##2##(2008-3#3)
unequal recombination in##2##3##(2008-1#1)(2008-8#1)
unequal sample sizes##3##3##(1991-12#1)(1996-3#1)(2012-1#1)
unequal segregation of##2##3##(2007-12#1)(2008-10#1)
unequal sister chromatid##2##3##(1993-12#2)
unequal size##2##2##(1994-5#1)(2011-12#1)
unequal thicknesses##2##2##(2008-3#2)
unequal variances using a generalized least-squares method##2##7##(2012-1#2)
unequal variances##3##2##(1995-12#1)(2012-1#2)
unequal wavelength spacing##2##3##(2007-11#2)
unequal##74##1##(1991-12#1)(1991-3#1)(1992-12#1)(1992-7#1)(1993-1#1)(1993-12#2)(1993-6#1)(1994-2#1)(1994-5#1)(1995-12#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-11#2)(2006-8#2)(2007-11#3)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#3)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-12#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-12#2)(2011-2#1)(2012-1#7)(2012-2#1)(2012-3#1)(2013-1#1)
unequally spaced##3##2##(1992-2#2)(1997-2#1)
unequally##7##1##(1992-2#2)(1997-2#1)(2008-5#1)(2008-7#2)(2009-10#1)
unequivocal and##2##2##(1996-3#1)(2011-3#1)
unequivocal detection of##2##3##(2008-11#1)(2013-7#1)
unequivocal diagnosis##3##2##(1990-8#1)(1996-7#1)(1997-3#1)
unequivocal evidence for##2##3##(1992-5#1)(2012-3#1)
unequivocal evidence that##2##3##(2008-10#1)(2012-1#1)
unequivocal evidence##4##2##(1992-5#1)(2008-10#1)(2012-1#1)(2012-3#1)
unequivocal identification of##2##3##(1991-3#1)(2009-8#1)
unequivocal##32##1##(1990-6#1)(1990-8#1)(1991-3#1)(1991-9#1)(1992-2#3)(1992-5#1)(1995-11#1)(1995-3#1)(1996-3#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-11#1)(2012-3#1)(2013-7#1)
unequivocally demonstrate##2##2##(1993-6#1)(2007-8#1)
unequivocally demonstrated##5##2##(1997-8#1)(2006-11#1)(2007-11#1)(2011-2#1)(2012-12#1)
unequivocally revealed##2##2##(1990-8#1)(2010-5#1)
unequivocally that##3##2##(1990-7#1)(1995-8#1)(2010-3#1)
unequivocally the##4##2##(1992-9#1)(1995-1#1)(2007-12#1)(2010-4#1)
unequivocally##37##1##(1990-7#1)(1990-8#1)(1992-9#1)(1993-6#1)(1994-1#1)(1995-1#1)(1995-8#1)(1996-7#1)(1997-6#1)(1997-8#1)(2005-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2009-7#1)(2010-3#1)(2010-4#1)(2010-5#2)(2011-2#2)(2012-12#1)
unerupted teeth##2##2##(2011-1#1)(2013-1#1)
unerupted##5##1##(2008-5#1)(2011-1#1)(2012-2#2)(2013-1#1)
unessential##4##1##(1990-8#1)(1991-10#1)(2008-10#1)(2008-11#1)
unesterified cholesterol##3##2##(1990-8#1)(1994-9#2)
unesterified##6##1##(1990-8#2)(1990-9#1)(1994-9#2)(1996-2#1)
unethical trade practices##2##3##(2008-7#2)
unethical##13##1##(1992-12#1)(1995-4#1)(2005-12#1)(2006-10#1)(2006-4#2)(2007-12#1)(2008-12#3)(2008-7#2)(2009-9#1)
uneven and##2##2##(2007-7#1)(2008-11#1)
uneven distribution of the##3##4##(1994-6#1)(2008-10#1)(2010-9#1)
uneven distribution of##9##3##(1992-8#1)(1993-6#1)(1994-6#1)(2007-7#2)(2008-10#2)(2010-9#1)(2013-1#1)
uneven distribution##11##2##(1992-8#1)(1993-6#1)(1994-6#1)(2007-7#3)(2008-1#1)(2008-10#2)(2010-9#1)(2013-1#1)
uneven##42##1##(1990-12#1)(1991-5#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-6#1)(1994-9#1)(1996-12#1)(1996-5#1)(2004-11#1)(2005-8#1)(2006-2#1)(2007-11#1)(2007-7#5)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
unevenly distributed across##2##3##(1995-2#1)(2008-10#1)
unevenly distributed##5##2##(1992-1#1)(1993-5#1)(1995-2#1)(2008-10#2)
unevenly##11##1##(1992-1#1)(1993-5#1)(1995-2#1)(2007-11#1)(2008-1#1)(2008-10#4)(2009-5#1)(2009-6#1)
unevenness##2##1##(2008-5#1)(2008-8#1)
uneventful and the##3##3##(2007-2#1)(2012-12#1)(2012-3#1)
uneventful and##6##2##(2007-2#1)(2008-10#1)(2008-12#1)(2009-5#1)(2012-12#1)(2012-3#1)
uneventful outcome##2##2##(1994-6#1)(2013-1#1)
uneventful postoperative course##2##3##(2007-8#1)(2011-2#1)
uneventful postoperative##3##2##(2007-8#1)(2011-12#1)(2011-2#1)
uneventful recovery##21##2##(1993-9#1)(1994-2#1)(1997-3#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-12#1)(2008-3#1)(2009-3#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
uneventful##83##1##(1991-11#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-6#1)(1996-8#1)(1997-3#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#13)(2008-1#2)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#2)(2010-6#1)(2010-7#3)(2010-9#1)(2011-1#1)(2011-12#4)(2011-2#7)(2012-12#5)(2012-2#4)(2012-3#3)(2013-1#7)
uneventfully with##4##2##(2006-8#1)(2008-8#1)(2013-1#2)
uneventfully##16##1##(1994-12#1)(2006-8#1)(2007-8#4)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#2)(2013-1#3)
unexpected adverse##2##2##(2007-11#1)(2009-5#1)
unexpected and##9##2##(1994-3#1)(1996-3#1)(1996-6#1)(2007-11#1)(2008-11#1)(2008-6#1)(2009-2#1)(2011-1#2)
unexpected because##4##2##(2007-11#1)(2010-2#1)(2011-2#1)(2012-3#1)
unexpected but##3##2##(1992-10#1)(2010-3#1)(2010-4#1)
unexpected complication##2##2##(1990-3#1)(2010-12#1)
unexpected death in##4##3##(1991-11#1)(2005-8#1)(2008-4#1)(2008-8#1)
unexpected death##11##2##(1990-8#1)(1991-11#1)(1992-6#1)(2005-8#4)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)
unexpected discovery##3##2##(1994-11#1)(2007-11#1)(2007-9#1)
unexpected effects##3##2##(2006-10#1)(2008-3#1)(2013-1#1)
unexpected events##3##2##(2007-5#1)(2008-11#1)(2008-4#1)
unexpected finding that##2##3##(1991-12#1)(1992-1#1)
unexpected finding was the##3##4##(1990-11#1)(1990-2#1)(1995-8#1)
unexpected finding was##4##3##(1990-11#1)(1990-2#1)(1992-6#1)(1995-8#1)
unexpected finding##10##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-12#1)(1992-1#1)(1992-6#1)(1995-8#1)(2008-1#1)(2008-12#1)(2008-5#1)
unexpected findings##8##2##(1990-12#1)(1993-11#1)(2006-9#1)(2007-4#2)(2008-10#1)(2008-8#1)(2012-2#1)
unexpected given##3##2##(2007-7#1)(2013-1#2)
unexpected outcome##3##2##(1994-11#1)(2010-9#1)(2012-2#1)
unexpected red cell antibodies##2##4##(1994-9#2)
unexpected result##3##2##(1996-1#1)(2007-10#1)(2007-12#1)
unexpected results are##2##3##(2005-11#1)(2007-4#1)
unexpected results##4##2##(1990-7#1)(1991-2#1)(2005-11#1)(2007-4#1)
unexpected role##4##2##(1994-12#1)(1997-6#1)(2009-6#1)(2012-12#1)
unexpected that##2##2##(1992-7#1)(2009-10#1)
unexpected##217##1##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#2)(1990-3#1)(1990-7#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-4#1)(1992-1#1)(1992-10#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#5)(1992-7#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-11#3)(1994-12#2)(1994-3#1)(1994-6#2)(1994-9#3)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-3#4)(1996-4#1)(1996-5#1)(1996-6#3)(1996-7#2)(1997-2#1)(1997-6#1)(1997-7#1)(2004-11#1)(2004-4#1)(2005-11#4)(2005-7#1)(2005-8#4)(2006-10#5)(2006-11#1)(2006-12#1)(2006-4#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#7)(2007-12#2)(2007-4#3)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#4)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#4)(2009-1#1)(2009-10#3)(2009-11#1)(2009-2#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#5)(2010-11#1)(2010-12#3)(2010-2#4)(2010-3#2)(2010-4#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#2)(2012-12#9)(2012-2#7)(2012-3#6)(2013-1#6)(2013-7#2)
unexpected-contents##2##1##(2012-1#2)
unexpectedly discovered##2##2##(1996-9#1)(2008-5#1)
unexpectedly high##10##2##(1991-12#1)(1996-12#1)(1996-7#1)(2007-12#1)(2007-2#1)(2008-7#1)(2009-2#1)(2009-3#1)(2011-1#1)(2011-2#1)
unexpectedly large##4##2##(1994-9#1)(2007-12#1)(2012-12#1)(2013-1#1)
unexpectedly low##4##2##(1991-1#1)(1997-4#1)(2008-11#1)(2013-8#1)
unexpectedly to##3##2##(1990-2#1)(2007-12#1)(2008-11#1)
unexpectedly##71##1##(1990-11#1)(1990-2#1)(1991-1#2)(1991-12#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-5#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-6#1)(1996-12#2)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-8#2)(2006-10#2)(2007-12#5)(2007-2#2)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#2)(2009-3#1)(2009-6#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
unexplained acute##2##2##(2007-7#1)(2013-1#1)
unexplained and the##2##3##(1995-6#1)(2006-10#1)
unexplained and##4##2##(1995-6#1)(1996-8#1)(2006-10#1)(2010-12#1)
unexplained death##2##2##(1995-1#2)
unexplained fever##3##2##(1993-11#1)(1994-12#1)(2006-10#1)
unexplained infant death##2##3##(1992-11#2)
unexplained infant##4##2##(1992-11#4)
unexplained persistent##2##2##(2006-10#2)
unexplained recurrent miscarriages##2##3##(2012-2#1)(2012-3#1)
unexplained recurrent##6##2##(2006-10#1)(2008-4#1)(2012-2#1)(2012-3#2)(2013-1#1)
unexplained##94##1##(1990-12#1)(1990-2#1)(1990-9#1)(1991-11#1)(1991-12#1)(1992-1#1)(1992-11#6)(1992-2#2)(1992-8#1)(1993-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#2)(1995-6#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-11#1)(2004-3#1)(2005-10#2)(2006-10#9)(2006-2#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#4)(2008-8#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-7#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#4)(2013-8#2)
unexploited##7##1##(2005-7#1)(2008-5#3)(2009-3#2)(2010-11#1)
unexplored##25##1##(1992-12#1)(1993-11#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#6)(2012-3#1)(2013-1#1)(2013-7#1)
unexposed cells##2##2##(1990-7#1)(1994-11#1)
unexposed control##2##2##(1990-7#1)(1994-6#1)
unexposed controls##3##2##(2008-10#2)(2009-5#1)
unexposed to##2##2##(2008-5#1)(2012-3#1)
unexposed zones is##2##3##(2008-3#2)
unexposed##27##1##(1990-7#2)(1991-2#1)(1992-6#1)(1994-11#1)(1994-6#2)(1995-1#1)(2004-4#2)(2006-5#3)(2008-10#3)(2008-3#3)(2008-5#2)(2008-9#1)(2009-5#3)(2012-3#2)
unexpressed##5##1##(1992-1#3)(1996-4#1)(2008-9#1)
unfair##5##1##(1992-12#1)(1992-3#1)(1995-6#1)(2011-1#1)(2012-3#1)
unfairly##4##1##(1994-3#1)(1996-11#1)(2012-2#1)(2012-3#1)
unfairness##2##1##(1992-12#1)(2010-8#1)
unfaithful##2##1##(2006-7#1)(2010-12#1)
unfamiliar animals##2##2##(2010-2#2)
unfamiliar face##2##2##(2009-4#2)
unfamiliar faces##3##2##(2007-8#1)(2008-1#2)
unfamiliar group##3##2##(2010-2#3)
unfamiliar individuals##3##2##(2010-2#3)
unfamiliar to many##4##3##(2006-8#1)(2007-12#1)(2008-11#1)(2008-2#1)
unfamiliar to##5##2##(2006-8#1)(2007-12#1)(2008-11#1)(2008-2#1)(2010-5#1)
unfamiliar with the##3##3##(1994-2#1)(2007-4#1)(2010-5#1)
unfamiliar with##9##2##(1994-2#1)(1996-2#1)(2005-10#1)(2007-4#1)(2008-4#2)(2010-12#1)(2010-5#1)(2012-12#1)
unfamiliar##60##1##(1992-2#1)(1994-2#2)(1994-8#1)(1995-8#1)(1996-2#1)(1996-5#1)(2005-10#1)(2006-3#3)(2006-8#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#5)(2008-7#3)(2009-4#4)(2010-12#1)(2010-2#13)(2010-5#2)(2012-12#2)(2013-1#2)(2013-7#2)
unfamiliarity with##3##2##(1990-12#1)(2009-10#2)
unfamiliarity##4##1##(1990-12#1)(1990-3#1)(2009-10#2)
unfavorable conditions##3##2##(1993-3#1)(2007-3#1)(2013-8#1)
unfavorable course##2##2##(2008-6#1)(2009-2#1)
unfavorable decision making##2##3##(2013-7#2)
unfavorable effect##2##2##(1992-4#1)(2009-8#1)
unfavorable environments##2##2##(2009-7#1)(2012-1#1)
unfavorable for##2##2##(2008-10#1)(2010-5#1)
unfavorable histology##2##2##(1990-8#1)(2007-6#1)
unfavorable in##3##2##(1991-11#1)(2008-2#1)(2011-2#1)
unfavorable interaction##3##2##(1996-8#1)(1997-7#1)(2011-2#1)
unfavorable outcome and##2##3##(2007-7#1)(2008-11#1)
unfavorable outcome##9##2##(2007-7#1)(2007-9#1)(2008-11#1)(2009-8#1)(2012-12#1)(2012-3#4)
unfavorable prognosis##3##2##(2007-8#1)(2009-2#1)(2013-1#1)
unfavorable##86##1##(1990-8#1)(1991-11#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-3#2)(1995-12#1)(1995-5#1)(1996-10#1)(1996-6#1)(1996-8#4)(1997-1#1)(1997-7#3)(2005-11#2)(2006-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#2)(2009-7#1)(2009-8#2)(2010-2#1)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#3)(2013-7#3)(2013-8#2)
unfavorably with##2##2##(2006-10#1)(2007-3#1)
unfavourable prognostic criteria##2##3##(1992-1#2)
unfavourable prognostic##6##2##(1992-1#2)(1995-10#1)(1996-11#1)(2004-2#1)(2008-6#1)
unfavourable to##2##2##(1995-2#1)(2013-1#1)
unfavourable trend##2##2##(1996-3#1)(2006-8#1)
unfavourable##40##1##(1991-12#1)(1991-3#1)(1992-1#2)(1992-2#1)(1992-3#1)(1993-8#1)(1995-10#1)(1995-2#1)(1995-4#1)(1996-11#1)(1996-3#1)(1997-3#2)(2004-2#1)(2005-11#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-11#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
unfeasible to##2##2##(1997-2#1)(2012-2#1)
unfeasible##7##1##(1993-12#1)(1997-2#1)(2006-9#1)(2008-10#1)(2012-1#2)(2012-2#1)
unfed##5##1##(2004-11#3)(2007-12#2)
unfertilized eggs and##3##3##(1992-11#1)(1993-6#1)(2008-5#1)
unfertilized eggs##12##2##(1992-11#2)(1992-6#1)(1993-6#3)(1997-6#1)(2008-5#2)(2008-9#2)(2013-1#1)
unfertilized human oocytes and##3##4##(1994-11#2)(2011-2#1)
unfertilized##19##1##(1992-11#2)(1992-6#2)(1993-6#3)(1994-11#3)(1995-6#1)(1997-6#1)(2008-5#2)(2008-8#1)(2008-9#2)(2011-2#1)(2013-1#1)
unfilled##6##1##(1990-7#1)(1991-2#1)(1993-6#1)(2007-4#1)(2013-8#2)
unfiltered##4##1##(2006-5#1)(2007-12#1)(2008-10#2)
unfinished##8##1##(2006-4#1)(2006-7#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)
unfit for the##2##3##(2005-12#1)(2008-11#1)
unfit for##4##2##(2005-12#1)(2007-5#1)(2008-11#1)(2008-3#1)
unfit patients##3##2##(1991-3#3)
unfit to##2##2##(1993-5#1)(2013-8#1)
unfit##10##1##(1991-3#3)(1993-5#1)(2005-12#1)(2007-5#1)(2008-11#1)(2008-3#1)(2010-5#1)(2013-8#1)
unfitness to##2##2##(1993-5#2)
unfitness##3##1##(1993-5#2)(1995-6#1)
unfixed cells##3##2##(1992-8#1)(2008-4#2)
unfixed##8##1##(1991-8#1)(1992-8#1)(1994-9#1)(1997-2#1)(2008-4#4)
unfocused##4##1##(2006-5#1)(2008-2#1)(2008-3#1)(2009-10#1)
unfold##5##1##(1993-12#1)(1993-9#1)(2005-11#1)(2006-10#1)(2008-10#1)
unfolded and##3##2##(2008-10#1)(2008-3#1)(2010-5#1)
unfolded conformations##2##2##(1994-8#1)(1995-3#1)
unfolded form##2##2##(1990-7#1)(1995-3#1)
unfolded forms##2##2##(1993-11#1)(1995-5#1)
unfolded in##2##2##(1995-2#1)(2010-5#1)
unfolded polypeptide##3##2##(1993-9#1)(1995-8#1)(2005-10#1)
unfolded protein in the endoplasmic reticulum##2##6##(1997-4#2)
unfolded protein response element##2##4##(1997-1#1)(1997-4#1)
unfolded protein response##6##3##(1997-1#1)(1997-4#2)(2009-8#1)(2011-2#1)(2012-3#1)
unfolded protein##17##2##(1992-6#1)(1993-11#1)(1995-10#1)(1997-1#1)(1997-2#2)(1997-4#5)(1997-7#2)(2008-4#1)(2009-8#1)(2011-2#1)(2012-3#1)
unfolded proteins##5##2##(1994-8#1)(1995-10#1)(1997-4#1)(2005-10#1)(2008-4#1)
unfolded state and##2##3##(1997-2#2)
unfolded state##7##2##(1993-11#2)(1995-4#1)(1995-5#1)(1997-2#3)
unfolded states of ubiquitin##2##4##(1995-3#2)
unfolded states of##4##3##(1995-3#2)(1997-7#1)(2009-9#1)
unfolded states##11##2##(1993-6#2)(1995-3#3)(1995-4#1)(1995-5#1)(1997-4#1)(1997-7#1)(2009-5#1)(2009-9#1)
unfolded##81##1##(1990-7#2)(1990-9#1)(1991-7#1)(1992-6#2)(1992-9#1)(1993-11#4)(1993-6#2)(1993-9#1)(1994-11#1)(1994-8#6)(1995-10#3)(1995-2#1)(1995-3#5)(1995-4#5)(1995-5#3)(1995-6#1)(1995-8#1)(1996-10#1)(1997-1#1)(1997-2#7)(1997-4#7)(1997-7#3)(2005-10#2)(2006-10#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#3)(2009-5#1)(2009-8#1)(2009-9#1)(2010-5#4)(2011-2#1)(2012-2#1)(2012-3#1)
unfolding and refolding##2##3##(1990-2#1)(2008-10#1)
unfolding and##8##2##(1990-2#1)(1994-8#1)(1995-3#1)(1995-4#1)(2006-6#2)(2008-10#1)(2008-4#1)
unfolding at##2##2##(1994-8#1)(1996-11#1)
unfolding by##3##2##(1993-6#2)(1997-7#1)
unfolding curve##2##2##(1992-9#1)(1995-2#1)
unfolding events##2##2##(1995-3#1)(1995-5#1)
unfolding experiments##4##2##(1994-11#2)(1994-6#1)(2008-9#1)
unfolding free energies##2##3##(1997-2#2)
unfolding free##3##2##(1997-2#3)
unfolding in the##4##3##(1990-7#1)(1992-9#1)(1993-10#1)(2007-12#1)
unfolding in##5##2##(1990-7#1)(1992-9#1)(1993-10#1)(1995-5#1)(2007-12#1)
unfolding intermediate##3##2##(1994-8#3)
unfolding is##5##2##(1990-7#1)(1995-5#1)(1997-2#1)(2007-12#1)(2010-5#1)
unfolding mechanism##4##2##(1992-6#3)(1995-5#1)
unfolding model##3##2##(1990-5#1)(1993-11#1)(1997-2#1)
unfolding of RNA##2##3##(2008-4#2)
unfolding of a##5##3##(1994-2#1)(1995-8#1)(2006-10#1)(2007-12#1)(2013-1#1)
unfolding of acidic fibroblast growth factor##2##6##(1993-6#2)
unfolding of bovine beta-lactoglobulin##2##4##(1995-5#2)
unfolding of local segments##2##4##(1995-5#2)
unfolding of the DHFR domain##2##5##(1994-2#2)
unfolding of the N-terminal##3##4##(1996-11#1)(1997-2#2)
unfolding of the intermediate state##2##5##(1995-5#1)(1997-4#1)
unfolding of the protein##3##4##(1991-6#1)(1997-2#1)(1997-6#1)
unfolding of the##20##3##(1990-5#1)(1991-6#1)(1992-6#1)(1994-2#2)(1994-8#2)(1995-10#1)(1995-2#1)(1995-5#3)(1996-11#1)(1997-2#3)(1997-4#1)(1997-6#1)(2007-11#1)(2008-4#1)
unfolding of trp aporepressor##3##4##(1990-7#1)(1994-8#2)
unfolding of##50##2##(1990-5#1)(1990-7#1)(1991-6#2)(1992-6#1)(1993-11#1)(1993-3#1)(1993-6#3)(1994-2#3)(1994-8#5)(1995-10#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#7)(1995-8#1)(1996-11#1)(1997-1#1)(1997-2#5)(1997-4#2)(1997-6#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-4#4)(2013-1#1)
unfolding pathway of##3##3##(1994-8#1)(1995-3#1)(2009-7#1)
unfolding pathways##2##2##(1994-8#1)(1995-4#1)
unfolding pattern of the##2##4##(1995-5#2)
unfolding process##2##2##(1994-8#1)(1995-3#1)
unfolding reaction##5##2##(1990-2#1)(1995-1#1)(1995-5#1)(1997-2#1)(1997-4#1)
unfolding symphony of##2##3##(2011-1#2)
unfolding transition##7##2##(1990-7#1)(1992-10#1)(1994-8#1)(1995-2#1)(1995-5#1)(2008-4#2)
unfolding was##2##2##(1995-5#2)
unfolding##183##1##(1990-2#3)(1990-5#8)(1990-7#5)(1991-6#2)(1992-10#1)(1992-6#7)(1992-9#2)(1993-10#1)(1993-11#5)(1993-3#1)(1993-6#6)(1994-11#2)(1994-2#4)(1994-6#1)(1994-8#16)(1995-1#3)(1995-10#4)(1995-2#4)(1995-3#9)(1995-4#4)(1995-5#25)(1995-8#5)(1996-11#3)(1996-4#1)(1997-1#1)(1997-2#17)(1997-4#4)(1997-6#1)(1997-7#3)(2005-11#1)(2006-10#2)(2006-12#2)(2006-6#2)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#2)(2008-4#8)(2008-9#2)(2009-7#1)(2009-9#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-6#1)(2013-1#1)
unfolds##9##1##(1994-3#1)(1994-8#1)(1995-5#1)(1996-11#1)(1996-9#1)(1997-4#1)(2006-10#1)(2009-12#1)(2009-7#1)
unforced##2##1##(2006-10#1)(2007-9#1)
unforeseen##4##1##(1991-10#1)(2008-2#1)(2009-4#1)(2011-2#1)
unfortunate randomization sequences##2##3##(2012-2#2)
unfortunate##15##1##(1993-3#1)(1994-9#1)(1995-2#1)(2005-7#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-6#2)(2010-5#1)(2010-6#1)(2012-2#2)
unfortunately the##3##2##(2007-10#1)(2007-11#2)
unfortunately this##2##2##(2007-4#1)(2008-11#1)
unfortunately##31##1##(1990-6#1)(1992-5#1)(1993-10#1)(1993-3#1)(1994-3#1)(1996-7#1)(1997-2#1)(2005-10#1)(2005-6#1)(2006-3#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-4#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-7#1)(2012-12#1)(2012-3#2)(2013-7#1)
unfounded and##2##2##(1990-2#1)(2011-2#1)
unfounded##7##1##(1990-2#1)(1993-2#1)(2007-12#1)(2008-3#1)(2011-1#2)(2011-2#1)
unfractionated RNA is immobilized by slot or dot blotting##4##9##(2008-2#1)(2008-4#3)
unfractionated and low molecular weight##2##5##(1997-2#1)(2007-11#1)
unfractionated bone cells##3##3##(2008-11#3)
unfractionated bone##4##2##(2008-11#3)(2010-6#1)
unfractionated heparin (UFH)##5##3##(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2013-8#1)
unfractionated heparin for##2##3##(2007-10#1)(2008-7#1)
unfractionated heparin in##2##3##(1994-7#1)(2007-10#1)
unfractionated heparin or low-molecular-weight##2##4##(2006-10#1)(2013-7#1)
unfractionated heparin was##2##3##(1997-2#1)(2008-3#1)
unfractionated heparin##20##2##(1990-12#1)(1994-7#1)(1997-2#2)(2006-10#1)(2007-10#5)(2007-11#1)(2007-7#1)(2008-1#1)(2008-3#2)(2008-7#1)(2009-8#1)(2013-7#1)(2013-8#2)
unfractionated##36##1##(1990-12#1)(1990-5#1)(1991-2#2)(1993-11#1)(1994-7#1)(1997-2#3)(2006-10#1)(2006-9#1)(2007-10#5)(2007-11#2)(2007-7#1)(2008-1#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-7#1)(2009-8#1)(2010-3#1)(2010-6#1)(2013-7#1)(2013-8#2)
unfragmented##4##1##(1995-3#1)(2008-8#2)(2008-9#1)
unfulfilled##2##1##(2011-1#1)(2013-8#1)
unfused##4##1##(1990-3#1)(1993-6#1)(1994-2#1)(2005-11#1)
ungated##2##1##(2007-11#1)(2009-5#1)
unglycosylated and glycosylated##2##3##(1992-3#1)(2008-11#1)
unglycosylated##10##1##(1992-3#2)(1994-8#1)(1994-9#3)(1996-9#1)(2007-9#2)(2008-11#1)
ungraftable##2##1##(2007-8#2)
ungual##2##1##(2008-5#1)(2011-2#1)
unguarded seedlings##2##2##(2008-10#2)
unguiculata##4##1##(1993-4#2)(2008-12#2)
unguiculata)##3##1##(2008-10#3)
unguium##6##1##(2007-7#1)(2008-5#5)
ungulate and bird introductions to New Zealand##2##7##(2008-8#2)
ungulate##6##1##(1995-2#1)(2006-5#1)(2008-8#3)(2008-9#1)
ungulates were##2##2##(2007-2#1)(2008-8#1)
ungulates##9##1##(1991-3#1)(2004-11#1)(2007-2#2)(2008-5#1)(2008-8#2)(2009-4#2)
unhappiness##2##1##(2006-12#2)
unhappy##3##1##(1993-3#1)(2007-12#1)(2011-2#1)
unhealthy alcohol use##2##3##(2008-11#1)(2012-11#1)
unhealthy assimilation&quot##2##2##(2010-12#2)
unhealthy diet##4##2##(2010-6#4)
unhealthy eating patterns among##3##4##(2006-7#3)
unhealthy eating patterns##4##3##(2006-7#3)(2008-1#1)
unhealthy prepregnancy weight##2##3##(2013-1#2)
unhealthy weight control##4##3##(2012-2#4)
unhealthy weight##6##2##(2008-11#2)(2012-2#4)
unhealthy##39##1##(1991-6#1)(1993-2#1)(1994-8#1)(1997-6#1)(2004-11#1)(2006-7#3)(2008-1#1)(2008-11#4)(2008-3#1)(2009-3#1)(2010-12#2)(2010-6#5)(2011-2#3)(2012-1#3)(2012-11#1)(2012-2#4)(2013-1#5)(2013-8#1)
unheated##5##1##(1990-12#2)(1990-2#1)(2008-2#1)(2008-3#1)
unhelpful in##2##2##(1997-8#1)(2008-9#1)
unhelpful##10##1##(1995-4#1)(1995-9#1)(1997-8#1)(2008-11#1)(2008-9#1)(2009-11#1)(2009-4#1)(2011-12#1)(2012-3#2)
unhindered##7##1##(1993-3#1)(2008-3#3)(2008-4#1)(2010-5#1)(2012-2#1)
unhomogenized tissue##2##2##(2008-2#2)
unhygienic##2##1##(2006-10#1)(2011-12#1)
uni- and##2##2##(2008-10#1)(2008-6#1)
uni-##4##1##(1997-7#1)(2007-10#1)(2008-10#1)(2008-6#1)
uni-condylar arthroplasty##2##2##(2007-5#2)
uniaxial and biaxial##2##3##(2006-4#1)(2007-1#1)
uniaxial centered##2##2##(2008-3#2)
uniaxial crystal##4##2##(2008-1#1)(2008-3#3)
uniaxial crystals##5##2##(2006-4#1)(2008-2#3)(2008-3#1)
uniaxial cyclic tensile##2##3##(2008-11#1)(2012-7#1)
uniaxial impacts##2##2##(2007-1#2)
uniaxial orientation##2##2##(2010-4#2)
uniaxial strain##2##2##(2008-11#1)(2008-2#1)
uniaxial tensile##2##2##(2006-11#1)(2008-11#1)
uniaxial tension##2##2##(2009-7#1)(2012-2#1)
uniaxial##50##1##(1991-7#2)(1993-8#1)(2004-9#1)(2005-11#1)(2006-11#1)(2006-4#2)(2007-1#3)(2008-1#3)(2008-11#3)(2008-2#8)(2008-3#17)(2009-7#1)(2010-4#2)(2011-2#3)(2012-2#1)(2012-7#1)
uniaxially aligned##2##2##(2005-11#2)
uniaxially oriented##2##2##(2008-3#1)(2010-4#1)
uniaxially##5##1##(2005-11#2)(2007-11#1)(2008-3#1)(2010-4#1)
unicellular and##2##2##(2011-1#1)(2012-12#1)
unicellular eukaryotic##2##2##(2007-3#1)(2011-1#1)
unicellular green alga##3##3##(1990-3#1)(1991-5#1)(2013-1#1)
unicellular green##4##2##(1990-3#1)(1991-5#1)(2013-1#2)
unicellular parasites##3##2##(2008-3#1)(2010-3#1)(2013-8#1)
unicellular##31##1##(1990-3#1)(1991-5#1)(1994-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-6#3)(1996-9#3)(2006-10#1)(2006-12#1)(2007-2#1)(2007-3#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-3#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
unicolor laccase-modified##2##2##(2008-10#2)
unicolor##6##1##(2008-10#3)(2011-12#3)
unicompartmental knee arthroplasty##2##3##(2007-7#1)(2013-1#1)
unicompartmental knee##6##2##(2007-7#2)(2012-12#2)(2013-1#2)
unicompartmental##8##1##(2007-7#3)(2012-12#2)(2013-1#3)
unicondylar##2##1##(2007-7#1)(2011-2#1)
unicystic ameloblastoma##3##2##(2012-2#3)
unicystic##4##1##(2012-2#3)(2013-1#1)
unidentate##2##1##(2005-11#1)(2007-11#1)
unidentified Gram-positive##2##2##(2006-5#1)(2006-8#1)
unidentified bacterium##3##2##(2006-3#1)(2006-5#2)
unidentified factors##3##2##(1995-6#1)(2007-6#1)(2008-10#1)
unidentified gene##2##2##(1991-7#1)(1992-9#1)
unidentified genes##2##2##(1990-3#1)(1994-3#1)
unidentified ligand##3##2##(1991-5#1)(2008-10#1)(2008-4#1)
unidentified noncholinergic neurons##2##3##(1997-6#2)
unidentified polar products##2##3##(1995-7#2)
unidentified product##2##2##(1994-3#1)(1995-4#1)
unidentified protein##2##2##(1992-4#1)(1994-5#1)
unidentified species of##3##3##(2007-3#1)(2008-10#1)(2008-5#1)
unidentified species##4##2##(2007-3#1)(2008-10#1)(2008-5#1)(2010-8#1)
unidentified targets##3##2##(1995-11#1)(2006-10#1)(2008-9#1)
unidentified##125##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-8#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-4#2)(1992-9#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#3)(1995-10#2)(1995-11#2)(1995-2#2)(1995-3#2)(1995-4#1)(1995-6#2)(1995-7#2)(1995-8#2)(1995-9#1)(1996-10#2)(1996-12#1)(1996-2#3)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#1)(2006-10#1)(2006-3#1)(2006-5#3)(2006-8#1)(2007-12#1)(2007-3#1)(2007-6#2)(2007-8#1)(2008-1#1)(2008-10#15)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-9#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#2)
unidimensional measure##3##2##(2007-12#2)(2012-1#1)
unidimensional model of##2##3##(2010-2#1)(2012-1#1)
unidimensional##10##1##(1996-2#1)(2006-6#1)(2007-12#2)(2008-2#1)(2010-2#1)(2011-2#1)(2012-1#2)(2012-2#1)
unidimensionality##4##1##(2007-12#2)(2011-2#1)(2012-2#1)
unidirectional flow##2##2##(2011-2#2)
unidirectional growth##2##2##(2008-7#1)(2008-8#1)
unidirectional ring cavity##2##3##(2007-12#2)
unidirectional ring##3##2##(2007-12#2)(2008-2#1)
unidirectional##48##1##(1990-12#1)(1991-12#1)(1991-7#1)(1992-1#1)(1992-2#1)(1992-4#1)(1995-6#2)(1996-5#1)(1997-3#2)(1997-4#2)(2006-12#2)(2007-10#2)(2007-11#1)(2007-12#6)(2007-3#2)(2008-10#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#3)(2012-3#1)
unidirectionally##3##1##(1991-2#1)(1995-8#1)(2008-7#1)
unification of the##2##3##(1997-5#1)(2009-10#1)
unification of##3##2##(1994-10#1)(1997-5#1)(2009-10#1)
unification##8##1##(1994-10#1)(1994-12#1)(1997-5#1)(2007-11#1)(2008-12#1)(2009-10#1)(2010-12#1)(2010-9#1)
unified analysis##3##2##(2008-3#1)(2010-11#1)(2012-3#1)
unified framework for##3##3##(2008-2#1)(2013-1#2)
unified framework##6##2##(2008-2#3)(2010-2#1)(2013-1#2)
unified method for##2##3##(1993-12#1)(1994-9#1)
unified method##3##2##(1993-12#1)(1994-9#1)(2012-2#1)
unified model##4##2##(2009-10#1)(2010-2#2)(2012-2#1)
unified molecular##2##2##(2008-12#1)(2012-2#1)
unified protocol##2##2##(2012-2#2)
unified the##2##2##(2008-9#1)(2009-2#1)
unified theory of##3##3##(1997-5#1)(2007-11#1)(2009-12#1)
unified treatment##2##2##(2011-2#2)
unified##82##1##(1990-12#1)(1992-1#1)(1993-1#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-7#2)(1994-9#1)(1995-1#1)(1996-4#1)(1996-8#1)(1997-3#2)(1997-5#1)(1997-7#1)(2005-12#1)(2005-5#1)(2007-10#1)(2007-11#4)(2007-12#4)(2008-12#2)(2008-2#4)(2008-3#7)(2008-4#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-11#2)(2010-12#2)(2010-2#3)(2010-8#2)(2011-2#3)(2012-1#1)(2012-2#7)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
unifies##5##1##(2008-3#2)(2011-2#2)(2012-3#1)
unifocal##3##1##(1991-11#1)(2008-6#1)(2013-1#1)
uniform TE(0) wave##2##3##(2007-12#2)
uniform across##3##2##(2008-2#1)(2009-4#1)(2010-8#1)
uniform anastomosis##2##2##(2006-6#2)
uniform and##16##2##(2005-11#1)(2008-10#3)(2008-2#4)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-2#1)(2010-4#1)(2010-5#1)
uniform approach to##2##3##(2008-3#1)(2010-7#1)
uniform approaches##2##2##(2007-9#1)(2010-3#1)
uniform beam##5##2##(2007-12#3)(2008-2#2)
uniform beams##2##2##(2008-2#2)
uniform circular##3##2##(2008-3#3)
uniform claims##2##2##(1992-2#1)(1997-3#1)
uniform clinical##2##2##(2006-8#1)(2008-4#1)
uniform coatings##2##2##(1993-4#1)(2008-10#1)
uniform connectedness##2##2##(2008-9#2)
uniform contrast for##2##3##(2007-12#2)
uniform data##2##2##(1996-2#1)(1997-3#1)
uniform definition##4##2##(2008-10#1)(2010-7#2)(2011-1#1)
uniform description of##2##3##(1997-4#1)(2006-10#1)
uniform dispersion##2##2##(2007-11#1)(2008-5#1)
uniform distribution in##2##3##(2008-8#1)(2012-12#1)
uniform distribution of cells##2##4##(2008-11#1)(2012-1#1)
uniform distribution of the##3##4##(2008-10#1)(2009-2#1)(2010-4#1)
uniform distribution of##9##3##(2008-10#1)(2008-11#1)(2009-11#1)(2009-2#1)(2010-12#1)(2010-4#3)(2012-1#1)
uniform distribution##14##2##(1993-2#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-11#1)(2009-2#1)(2010-12#1)(2010-4#3)(2011-1#1)(2012-1#1)(2012-12#1)
uniform drug##3##2##(1992-8#1)(2008-12#1)(2012-12#1)
uniform expression##3##2##(1995-12#1)(2004-11#1)(2008-8#1)
uniform field##2##2##(2008-2#1)(2012-3#1)
uniform fluorescent##2##2##(2008-9#1)(2009-7#1)
uniform for##3##2##(1992-10#1)(2008-10#1)(2012-2#1)
uniform grating##2##2##(2008-3#1)(2013-8#1)
uniform growth##2##2##(2008-10#1)(2013-1#1)
uniform guidelines##2##2##(2007-2#1)(2009-4#1)
uniform illumination of##2##3##(2008-1#1)(2008-3#1)
uniform illumination##5##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#2)
uniform in size##2##3##(2008-1#1)(2008-10#1)
uniform in##11##2##(1996-3#1)(2005-11#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-10#5)(2013-8#1)
uniform increase##2##2##(1996-2#1)(2011-12#1)
uniform intervention##2##2##(2006-10#1)(2008-10#1)
uniform irradiance and phase##2##4##(2008-2#2)
uniform irradiance##4##2##(2008-2#3)(2008-3#1)
uniform medium##2##2##(2007-12#1)(2008-2#1)
uniform on-axis##2##2##(2007-12#1)(2008-2#1)
uniform orientation##3##2##(1992-7#2)(2008-7#1)
uniform over##3##2##(2008-10#1)(2008-5#1)(2012-3#1)
uniform particle##2##2##(2008-3#1)(2013-7#1)
uniform pattern of##2##3##(1993-8#1)(1995-6#1)
uniform pattern##3##2##(1993-8#1)(1995-6#1)(2012-3#1)
uniform projection##3##2##(2006-10#3)
uniform quantization##3##2##(2008-2#3)
uniform reporting of##2##3##(2006-10#2)
uniform set of##4##3##(2007-4#1)(2008-10#1)(2008-6#1)(2008-7#1)
uniform shell designs##2##3##(2008-10#2)
uniform size##4##2##(1994-3#1)(1995-2#1)(2008-10#1)(2008-2#1)
uniform spatial##2##2##(2008-8#2)
uniform structure##2##2##(2007-12#1)(2008-5#1)
uniform system of##2##3##(2006-12#1)(2012-2#1)
uniform temperature distribution##2##3##(2007-11#1)(2008-10#1)
uniform thickness##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
uniform trend of##2##3##(2007-12#1)(2010-4#1)
uniform with##2##2##(2008-10#1)(2010-12#1)
uniform within##2##2##(1997-6#1)(2008-3#1)
uniform##398##1##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-7#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#3)(1994-3#3)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#3)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#3)(1996-6#1)(1997-2#2)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-11#2)(2005-11#10)(2005-5#1)(2005-8#1)(2006-10#10)(2006-11#2)(2006-12#2)(2006-5#1)(2006-6#3)(2006-8#2)(2006-9#1)(2007-11#14)(2007-12#22)(2007-2#2)(2007-4#2)(2007-8#3)(2007-9#8)(2008-1#2)(2008-10#41)(2008-11#4)(2008-12#1)(2008-2#43)(2008-3#38)(2008-4#3)(2008-5#9)(2008-6#5)(2008-7#5)(2008-8#7)(2008-9#7)(2009-11#2)(2009-12#1)(2009-2#4)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#3)(2010-3#3)(2010-4#7)(2010-5#2)(2010-7#4)(2010-8#4)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#4)(2012-3#4)(2013-1#5)(2013-7#2)(2013-8#3)
uniformed##3##1##(1995-6#2)(2007-11#1)
uniformis and B##2##3##(1997-2#2)
uniformis##3##1##(1997-2#3)
uniformity and##13##2##(1997-2#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2010-3#2)
uniformity are##2##2##(2008-2#1)(2010-5#1)
uniformity error##3##2##(2008-2#1)(2008-3#2)
uniformity in a##2##3##(2008-10#1)(2008-3#1)
uniformity in##8##2##(1996-8#1)(2006-7#1)(2008-10#1)(2008-3#2)(2008-8#1)(2008-9#1)(2011-2#1)
uniformity is##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
uniformity of better than Deltaf/f##2##5##(2008-3#2)
uniformity of calibration##2##3##(1996-12#2)
uniformity of the##8##3##(1996-12#1)(2007-11#1)(2008-2#2)(2008-3#3)(2010-7#1)
uniformity of##24##2##(1996-12#4)(2006-12#1)(2006-5#1)(2007-11#2)(2007-6#1)(2008-10#1)(2008-2#3)(2008-3#8)(2010-7#2)(2012-2#1)
uniformity over##2##2##(2007-11#1)(2008-3#1)
uniformity to##2##2##(2005-11#1)(2008-3#1)
uniformity was##2##2##(2008-3#2)
uniformity##114##1##(1995-3#1)(1995-9#1)(1996-12#4)(1996-8#1)(1997-2#1)(2005-11#2)(2006-12#1)(2006-5#2)(2006-7#1)(2007-11#5)(2007-12#6)(2007-2#1)(2007-6#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#11)(2008-3#40)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-5#1)(2010-7#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
uniformly across##3##2##(2007-12#1)(2009-10#1)(2010-8#1)
uniformly and##3##2##(2008-10#2)(2008-4#1)
uniformly available##3##2##(1995-1#2)(2012-2#1)
uniformly dispersed in the##2##4##(2008-5#1)(2013-7#1)
uniformly dispersed##3##2##(2008-5#2)(2013-7#1)
uniformly distributed across the##2##4##(1991-2#1)(2010-6#1)
uniformly distributed in##2##3##(1990-5#1)(2007-1#1)
uniformly distributed throughout the##2##4##(1995-11#1)(2008-10#1)
uniformly distributed within##2##3##(1990-5#1)(2008-10#1)
uniformly distributed##20##2##(1990-5#3)(1991-2#1)(1995-11#1)(1995-3#1)(1996-4#1)(2007-1#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-8#1)(2009-7#1)(2010-6#1)(2012-12#1)
uniformly express the##2##3##(1991-12#1)(2009-3#1)
uniformly expressed##4##2##(1994-9#1)(2008-6#1)(2009-8#1)(2012-12#1)
uniformly fatal##5##2##(2007-11#1)(2008-11#1)(2010-12#1)(2012-1#1)(2012-2#1)
uniformly high##4##2##(2006-12#1)(2007-7#1)(2008-10#2)
uniformly in##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
uniformly labeled##3##2##(1992-3#1)(2008-2#1)(2009-7#1)
uniformly negative##2##2##(2007-12#2)
uniformly over##2##2##(2007-6#1)(2008-2#1)
uniformly positive##2##2##(1996-3#1)(2010-8#1)
uniformly successful##2##2##(2008-1#1)(2008-7#1)
uniformly the best##2##3##(1991-2#1)(2009-8#1)
uniformly the##3##2##(1990-8#1)(1991-2#1)(2009-8#1)
uniformly throughout the##3##3##(1990-6#1)(1994-8#1)(2008-10#1)
uniformly within##2##2##(2008-10#1)(2008-3#1)
uniformly##149##1##(1990-10#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#3)(1995-3#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#2)(1997-3#1)(1997-6#1)(2004-9#1)(2006-10#1)(2006-12#4)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#9)(2007-6#2)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#19)(2008-11#2)(2008-2#6)(2008-3#11)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-3#1)(2009-7#5)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#3)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-7#1)
unify the##5##2##(2007-8#1)(2008-1#1)(2008-2#1)(2008-6#1)(2008-7#1)
unify##12##1##(2007-11#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)
unifying explanation for the##2##4##(1993-7#1)(2010-7#1)
unifying hypothesis that##2##3##(2006-9#1)(2008-1#1)
unifying hypothesis##6##2##(1992-1#1)(1996-4#1)(2006-9#1)(2008-1#1)(2008-11#1)(2009-7#1)
unifying mechanism for##2##3##(2010-8#2)
unifying##34##1##(1992-1#1)(1992-8#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-6#2)(1995-4#1)(1996-4#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-9#1)(2007-7#2)(2008-1#1)(2008-11#3)(2008-4#2)(2008-7#1)(2008-8#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-5#1)(2010-7#2)(2010-8#3)(2011-12#1)
unigene##2##1##(2006-12#1)(2008-7#1)
unigenes##3##1##(2008-10#1)(2010-4#1)(2010-5#1)
unilamellar egg##3##2##(1990-11#1)(1990-2#1)(1992-3#1)
unilamellar liposomes in##2##3##(1993-8#1)(2008-9#1)
unilamellar liposomes##7##2##(1990-2#1)(1993-8#1)(1994-12#1)(1995-10#1)(1995-2#1)(2008-9#2)
unilamellar vesicle##2##2##(1990-11#1)(1990-2#1)
unilamellar vesicles (LUV)##2##3##(1991-9#1)(1992-6#1)
unilamellar vesicles (LUVs)##3##3##(2008-10#1)(2008-5#1)(2013-7#1)
unilamellar vesicles (about##2##3##(1995-8#2)
unilamellar vesicles and##3##3##(1991-9#1)(1992-6#1)(1994-11#1)
unilamellar vesicles formed##3##3##(1990-2#1)(1991-4#1)(1992-12#1)
unilamellar vesicles of egg##2##4##(1993-3#1)(2009-12#1)
unilamellar vesicles of##5##3##(1990-4#1)(1993-3#1)(1994-11#1)(1994-5#1)(2009-12#1)
unilamellar vesicles##48##2##(1990-2#9)(1990-4#1)(1991-10#1)(1991-4#2)(1991-5#3)(1991-7#1)(1991-9#3)(1992-12#1)(1992-6#2)(1993-3#1)(1994-11#2)(1994-2#1)(1994-5#2)(1995-2#1)(1995-8#2)(1997-1#1)(1997-5#1)(1997-7#1)(2006-10#1)(2008-10#3)(2008-11#2)(2008-5#1)(2009-12#1)(2012-2#2)(2013-7#3)
unilamellar##69##1##(1990-11#3)(1990-2#13)(1990-3#2)(1990-4#1)(1991-10#1)(1991-2#1)(1991-4#2)(1991-5#3)(1991-7#1)(1991-9#4)(1992-12#1)(1992-3#2)(1992-6#2)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#2)(1995-10#1)(1995-2#2)(1995-8#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-5#1)(1997-7#1)(2006-10#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-9#2)(2009-12#1)(2012-2#2)(2013-7#3)
unilateral 6-hydroxydopamine lesions##2##3##(1994-2#1)(1997-2#1)
unilateral 6-hydroxydopamine##5##2##(1990-7#1)(1994-2#1)(1995-12#1)(1997-2#1)(2012-2#1)
unilateral 6-hydroxydopamine-induced##2##2##(1994-10#1)(1996-12#1)
unilateral AGm##3##2##(1992-9#2)(1993-9#1)
unilateral PPC operates##2##3##(1992-9#2)
unilateral STN DBS##2##3##(2012-2#2)
unilateral adrenal hyperplasia##2##3##(2006-9#2)
unilateral adrenalectomy##3##2##(1997-1#1)(2006-10#2)
unilateral and bilateral Perthes disease##2##5##(2007-7#2)
unilateral and bilateral lesions of##2##5##(1992-9#1)(2008-7#1)
unilateral and bilateral steering tasks##2##5##(2012-1#2)
unilateral and bilateral##12##3##(1992-9#1)(1996-1#1)(1996-9#1)(2007-7#4)(2008-7#1)(2008-8#1)(2011-2#1)(2012-1#2)
unilateral and##14##2##(1992-9#1)(1996-1#1)(1996-9#1)(2007-7#4)(2008-7#1)(2008-8#2)(2011-2#1)(2012-1#2)(2013-8#1)
unilateral approach##2##2##(2007-8#2)
unilateral biting##3##2##(2011-12#3)
unilateral brain##2##2##(1990-2#1)(2009-4#1)
unilateral carotid##2##2##(1996-1#1)(2011-3#1)
unilateral cervical##2##2##(2008-4#1)(2008-7#1)
unilateral chyluria##2##2##(2008-10#2)
unilateral cleft lip and palate##3##5##(2009-8#1)(2013-1#2)
unilateral cleft lip and##4##4##(2009-8#1)(2011-2#1)(2013-1#2)
unilateral cleft lip##5##3##(2009-8#1)(2011-2#1)(2013-1#3)
unilateral cleft##8##2##(2009-7#1)(2009-8#1)(2011-2#3)(2013-1#3)
unilateral cochlear##2##2##(2008-9#2)
unilateral control##2##2##(2012-1#2)
unilateral destruction of##2##3##(1993-9#1)(1994-3#1)
unilateral disease##3##2##(2007-7#3)
unilateral dopamine##3##2##(1990-7#1)(1995-5#2)
unilateral dorsal rhizotomy##2##3##(1995-7#2)
unilateral generalized hypertrichosis##2##3##(2007-7#2)
unilateral headache##2##2##(2006-8#1)(2010-12#1)
unilateral herniorrhaphy##2##2##(1996-8#2)
unilateral hindpaw inflammation##2##3##(1994-5#2)
unilateral hip##2##2##(2007-7#1)(2008-8#1)
unilateral hydronephrosis##2##2##(2008-1#2)
unilateral ibotenic acid##2##3##(1994-12#1)(1995-12#1)
unilateral illumination##2##2##(1991-2#2)
unilateral in##3##2##(1991-9#1)(2008-1#1)(2008-12#1)
unilateral knee##2##2##(2006-1#1)(2008-8#1)
unilateral labyrinthectomy (UL)##2##3##(1993-9#1)(1997-7#1)
unilateral left##2##2##(1995-12#1)(2008-10#1)
unilateral lesion of the##2##4##(1996-2#1)(1996-9#1)
unilateral lesions of##4##3##(1992-10#1)(1993-12#1)(1995-12#1)(1995-8#1)
unilateral lesions##7##2##(1990-5#1)(1992-10#1)(1993-12#1)(1995-12#1)(1995-8#1)(2009-4#2)
unilateral movements##3##2##(1993-7#1)(2013-1#2)
unilateral nasal##4##2##(2009-2#2)(2013-1#2)
unilateral neglect##7##2##(1995-12#1)(1996-2#1)(1996-5#1)(2009-10#1)(2009-2#2)(2012-2#1)
unilateral nephrectomy##6##2##(1992-7#2)(1992-9#2)(2005-10#1)(2006-7#1)
unilateral nevoid telangiectasia##2##3##(2011-2#2)
unilateral nevus comedonicus##2##3##(2007-8#2)
unilateral nigral##2##2##(1994-10#1)(1996-2#1)
unilateral obstruction##2##2##(1992-5#1)(2011-1#1)
unilateral occlusion##2##2##(2008-7#1)(2011-1#1)
unilateral or bilateral##15##3##(1990-5#1)(1992-11#1)(1992-9#1)(1995-12#1)(1995-8#1)(2006-9#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-12#1)(2009-4#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
unilateral pareses##2##2##(1990-4#2)
unilateral parietal cortex lesions##2##4##(1993-7#2)
unilateral parietal##3##2##(1993-7#3)
unilateral pulmonary##2##2##(2008-11#1)(2010-3#1)
unilateral rhizotomy##2##2##(1995-7#2)
unilateral right##2##2##(2009-4#1)(2013-8#1)
unilateral rubella retinopathy in##2##4##(2011-2#2)
unilateral statolith removal in crayfish##2##5##(2008-5#2)
unilateral statolith removal##3##3##(2008-5#3)
unilateral thermocoagulatory##2##2##(1996-9#2)
unilateral tinnitus##2##2##(2006-12#2)
unilateral transtibial##2##2##(2007-10#1)(2007-7#1)
unilateral ultra-brief##2##2##(2010-7#2)
unilateral vestibular deafferentation##2##3##(1996-9#2)
unilateral vestibular loss##2##3##(2011-1#2)
unilateral vestibular##7##2##(1991-2#2)(1995-12#1)(1996-9#2)(2011-1#2)
unilateral visual##3##2##(2008-11#1)(2009-8#1)(2011-1#1)
unilateral vs bilateral fusion##2##4##(2008-8#2)
unilateral##396##1##(1990-2#2)(1990-4#3)(1990-5#2)(1990-6#1)(1990-7#2)(1991-10#1)(1991-11#1)(1991-2#4)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#2)(1992-3#1)(1992-5#2)(1992-7#4)(1992-9#8)(1993-10#1)(1993-12#5)(1993-2#2)(1993-4#2)(1993-6#1)(1993-7#5)(1993-9#4)(1994-10#2)(1994-12#2)(1994-2#4)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#12)(1995-2#2)(1995-4#1)(1995-5#4)(1995-7#4)(1995-8#3)(1996-1#5)(1996-10#1)(1996-12#4)(1996-2#4)(1996-3#1)(1996-5#2)(1996-8#4)(1996-9#8)(1997-1#2)(1997-2#1)(1997-3#2)(1997-5#2)(1997-7#3)(2004-1#1)(2004-10#1)(2005-10#4)(2005-5#1)(2005-8#1)(2006-1#3)(2006-10#8)(2006-11#1)(2006-12#5)(2006-2#2)(2006-5#2)(2006-7#1)(2006-8#4)(2006-9#4)(2007-1#1)(2007-10#6)(2007-11#5)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#18)(2007-8#9)(2007-9#3)(2008-1#4)(2008-10#6)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#12)(2008-8#10)(2008-9#2)(2009-10#3)(2009-2#5)(2009-3#1)(2009-4#6)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#7)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#13)(2011-12#3)(2011-2#14)(2011-3#1)(2012-1#8)(2012-11#2)(2012-12#3)(2012-2#14)(2013-1#16)(2013-8#8)
unilaterally in##4##2##(1992-10#1)(1996-12#3)
unilaterally nominated##2##2##(2009-7#2)
unilaterally##32##1##(1990-4#1)(1990-6#1)(1991-6#1)(1992-10#1)(1993-12#1)(1994-10#2)(1994-12#1)(1995-1#1)(1995-12#2)(1996-1#1)(1996-10#1)(1996-12#3)(1996-9#1)(1997-3#1)(1997-7#1)(2006-4#2)(2007-1#1)(2007-4#2)(2007-7#1)(2008-7#2)(2008-9#1)(2009-7#2)(2010-5#1)(2011-2#1)
unilineal vertical transmission##2##3##(1996-5#2)
unilineal##3##1##(1995-11#1)(1996-5#2)
unilocular##2##1##(2008-7#1)(2009-4#1)
unimanual##4##1##(1994-3#2)(2007-2#1)(2013-1#1)
unimers##2##1##(2005-11#1)(2008-3#1)
unimodal and##2##2##(2008-2#1)(2011-1#1)
unimodal function of##2##3##(2008-8#2)
unimodal##15##1##(1991-2#1)(1991-9#1)(1996-3#1)(1997-1#1)(2008-10#2)(2008-2#2)(2008-8#3)(2010-2#1)(2011-1#1)(2012-2#1)(2013-8#1)
unimodality##2##1##(2008-10#2)
unimodally##2##1##(2008-8#2)
unimolecular dissociation##2##2##(2006-3#1)(2011-1#1)
unimolecular reaction##2##2##(1991-7#1)(1991-8#1)
unimolecular##15##1##(1991-5#2)(1991-7#1)(1991-8#1)(1994-9#2)(1996-2#3)(2006-3#2)(2007-9#2)(2008-2#1)(2011-1#1)
unimpacted##4##1##(2006-12#2)(2009-7#2)
unimpaired##9##1##(1991-2#1)(1994-6#1)(1996-2#1)(1996-5#1)(2006-3#1)(2009-10#1)(2012-1#2)(2012-2#1)
unimpeded##2##1##(2008-10#1)(2012-2#1)
unimportant for##4##2##(1997-4#1)(2008-2#1)(2008-9#1)(2012-3#1)
unimportant##17##1##(1990-8#1)(1995-5#1)(1997-3#1)(1997-4#1)(2004-11#1)(2007-5#1)(2007-8#1)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#1)(2010-6#1)(2012-11#2)(2012-3#2)
uninduced and##2##2##(1992-1#1)(1994-8#1)
uninduced##10##1##(1991-1#1)(1992-1#2)(1992-5#2)(1994-8#1)(1997-4#1)(2005-12#1)(2007-6#1)(2011-1#1)
uninephrectomy and##2##2##(2011-2#1)(2013-8#1)
uninfected and##2##2##(2008-10#1)(2008-5#1)
uninfected cell##2##2##(1991-12#1)(2008-7#1)
uninfected cells##11##2##(1991-4#1)(1992-7#7)(1993-6#2)(1997-2#1)
uninfected control##3##2##(1993-6#1)(2011-1#1)(2011-2#1)
uninfected controls##3##2##(1995-2#1)(2009-8#1)(2010-7#1)
uninfected females##3##2##(2012-3#3)
uninfected mice##2##2##(1996-11#1)(2008-10#1)
uninfected plants##2##2##(2008-10#2)
uninfected tissue##2##2##(1994-11#1)(2008-10#1)
uninfected women##2##2##(1994-9#2)
uninfected##77##1##(1990-12#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-7#8)(1993-6#3)(1994-11#3)(1994-5#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-5#2)(1997-2#1)(1997-3#4)(2006-10#1)(2007-2#3)(2007-6#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-8#1)(2010-7#1)(2011-1#2)(2011-12#2)(2011-2#1)(2012-2#1)(2012-3#3)
uninformative##6##1##(1995-8#1)(1997-6#1)(2008-10#2)(2011-2#1)(2012-2#1)
uninformed as to the##2##4##(1991-10#1)(2007-5#1)
uninformed##9##1##(1991-10#2)(1992-12#1)(1995-5#1)(1996-1#1)(2006-5#2)(2007-5#1)(2008-11#1)
uninitiated##4##1##(1996-2#1)(2008-9#1)(2010-2#1)(2011-1#1)
uninjected##4##1##(1995-3#1)(1996-8#1)(1997-7#1)(2008-10#1)
uninjured##12##1##(1991-9#1)(1993-11#1)(1993-12#1)(1997-6#5)(2006-11#1)(2007-4#1)(2012-3#1)(2013-1#1)
uninoculated controls##2##2##(2008-10#2)
uninoculated leaves of##2##3##(2008-10#2)
uninoculated leaves##9##2##(2008-10#9)
uninoculated upper leaves##2##3##(2008-10#2)
uninoculated##19##1##(1996-2#1)(2008-10#17)(2008-5#1)
uninstructed##2##1##(2004-10#1)(2008-11#1)
uninsured and underinsured##3##3##(2008-11#3)
uninsured and##6##2##(1994-2#1)(1995-12#1)(2008-11#3)(2011-2#1)
uninsured is##2##2##(1990-12#1)(1993-12#1)
uninsured or underinsured##2##3##(2007-11#1)(2008-11#1)
uninsured patients##5##2##(1995-1#3)(1997-2#1)(2008-11#1)
uninsured persons##2##2##(1991-2#1)(1997-2#1)
uninsured will##2##2##(1995-12#1)(2007-9#1)
uninsured##54##1##(1990-12#2)(1991-2#1)(1991-4#1)(1992-2#3)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-1#6)(1995-12#3)(1996-1#1)(1997-2#2)(1997-3#4)(2007-11#2)(2007-3#1)(2007-9#1)(2008-10#1)(2008-11#12)(2008-6#1)(2011-1#1)(2011-2#4)(2012-11#1)(2013-1#2)
unintelligible##3##1##(2008-11#1)(2009-2#1)(2012-2#1)
unintended child bearing##2##3##(2007-7#2)
unintended childbearing##5##2##(2007-7#5)
unintended consequences##8##2##(1995-1#1)(2007-11#1)(2007-4#1)(2012-1#1)(2013-1#4)
unintended pregnancies##3##2##(2008-11#1)(2013-1#2)
unintended pregnancy##6##2##(2005-11#1)(2007-3#3)(2008-7#1)(2013-1#1)
unintended##38##1##(1992-12#1)(1992-2#1)(1993-12#1)(1995-1#1)(1997-3#1)(2005-11#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-3#3)(2007-4#1)(2007-7#7)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-8#1)(2012-1#1)(2013-1#7)
unintentional CO poisonings##2##3##(1996-11#2)
unintentional injuries##3##2##(2012-1#1)(2012-12#1)(2013-1#1)
unintentional injury##10##2##(2008-11#1)(2008-6#1)(2009-2#3)(2012-1#1)(2013-1#4)
unintentional weight loss##3##3##(2008-10#1)(2012-12#1)(2012-2#1)
unintentional weight##4##2##(2006-10#1)(2008-10#1)(2012-12#1)(2012-2#1)
unintentional##42##1##(1990-8#1)(1991-12#1)(1992-10#1)(1992-8#1)(1994-1#1)(1996-11#3)(2005-8#2)(2006-10#2)(2006-12#2)(2006-2#2)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-1#1)(2009-10#1)(2009-2#3)(2009-8#1)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#2)
unintentionally##3##1##(1996-9#1)(2008-10#1)(2009-10#1)
uninterpretable##2##1##(2008-9#1)(2010-5#1)
uninterrupted skin-to-skin contact##2##3##(2006-9#2)
uninterrupted##21##1##(1993-2#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#2)(1996-5#1)(1997-4#1)(2005-11#1)(2006-9#2)(2007-12#1)(2008-10#3)(2008-7#1)(2008-8#3)(2011-1#1)(2012-12#1)
uninvestigated dyspepsia##2##2##(2006-2#1)(2011-2#1)
uninvestigated##3##1##(2006-10#1)(2006-2#1)(2011-2#1)
uninvolved in##2##2##(1996-4#1)(2008-4#1)
uninvolved##7##1##(1992-6#1)(1994-2#1)(1996-4#1)(2007-10#1)(2008-4#1)(2009-10#1)(2010-3#1)
union after fracture##2##3##(2007-11#2)
union after##3##2##(2007-11#3)
union and non-union staff in##2##5##(1994-3#2)
union and the##3##3##(2007-11#1)(2011-2#1)(2012-11#1)
union and##13##2##(1994-3#2)(2006-8#1)(2007-11#2)(2007-7#2)(2007-8#2)(2011-2#1)(2012-11#1)(2012-2#2)
union at##3##2##(2007-8#2)(2012-2#1)
union has##6##2##(1996-3#1)(2007-10#5)
union in##8##2##(1994-8#1)(2006-7#1)(2007-11#1)(2007-7#2)(2007-8#2)(2012-2#1)
union involvement##2##2##(1996-3#2)
union is##2##2##(2006-3#1)(2007-7#1)
union movement##2##2##(1991-2#1)(1993-3#1)
union occurred in##2##3##(2008-8#1)(2013-8#1)
union of the##5##3##(2006-3#2)(2007-7#1)(2008-4#1)(2013-8#1)
union of##17##2##(1995-3#1)(2005-8#1)(2006-3#2)(2007-10#1)(2007-11#3)(2007-7#1)(2008-4#1)(2008-6#1)(2009-4#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-8#1)
union on##3##2##(2006-10#1)(2007-11#2)
union or##2##2##(2007-11#1)(2007-7#1)
union processes by using these agents##2##6##(2007-11#2)
union processes##5##2##(2007-11#5)
union rate##2##2##(2009-10#1)(2012-2#1)
union was achieved in##4##4##(2007-11#1)(2007-7#1)(2007-8#1)(2011-2#1)
union was achieved##7##3##(2007-11#2)(2007-7#1)(2007-8#2)(2008-9#1)(2011-2#1)
union was observed after##2##4##(2013-1#2)
union was observed in##2##4##(2013-1#1)(2013-8#1)
union was observed##4##3##(2013-1#3)(2013-8#1)
union was##20##2##(2006-3#1)(2007-11#5)(2007-7#3)(2007-8#2)(2008-9#1)(2009-10#1)(2011-2#1)(2013-1#3)(2013-8#3)
union were##2##2##(2007-10#1)(2007-3#1)
union with##4##2##(1997-6#1)(2007-7#1)(2008-8#1)(2012-2#1)
union##165##1##(1991-2#1)(1992-2#2)(1993-3#2)(1993-8#1)(1994-3#2)(1994-7#1)(1994-8#1)(1995-12#4)(1995-3#1)(1996-3#3)(1997-2#1)(1997-6#1)(2005-8#1)(2006-10#2)(2006-3#6)(2006-7#1)(2006-8#1)(2007-10#9)(2007-11#46)(2007-3#1)(2007-7#14)(2007-8#15)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-8#3)(2008-9#1)(2009-10#4)(2009-4#1)(2010-12#2)(2011-2#5)(2012-11#1)(2012-2#10)(2012-3#1)(2013-1#9)(2013-8#5)
unionacean bivalves##2##2##(1996-11#2)
unionacean mussels##2##2##(1996-11#2)
unionacean##4##1##(1996-11#4)
unionized##4##1##(1996-3#2)(2006-5#1)(2012-2#1)
unionizing##2##1##(1993-6#1)(2008-1#1)
unions##14##1##(1993-6#1)(1995-5#2)(1996-3#1)(2006-5#1)(2007-10#2)(2007-4#1)(2008-5#1)(2013-1#4)(2013-8#1)
uniparental disomy##2##2##(1996-12#1)(2009-4#1)
uniparental##8##1##(1996-12#2)(1996-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-4#1)
unipolar and bipolar depression##2##4##(1992-8#1)(2008-7#1)
unipolar and bipolar##4##3##(1992-8#1)(2007-8#2)(2008-7#1)
unipolar and##7##2##(1992-8#1)(1995-11#1)(2007-8#4)(2008-7#1)
unipolar depression##6##2##(1992-8#1)(1996-7#1)(2006-9#1)(2009-9#2)(2012-2#1)
unipolar disorder##2##2##(1992-8#1)(1995-11#1)
unipolar disorders##5##2##(1995-11#3)(1997-5#1)(2008-12#1)
unipolar major depression##4##3##(1995-1#1)(1996-7#2)(2005-6#1)
unipolar major##5##2##(1995-1#1)(1996-7#2)(2005-6#1)(2005-7#1)
unipolar stimulation##2##2##(2013-8#2)
unipolar##41##1##(1992-8#3)(1993-12#1)(1995-1#1)(1995-11#5)(1996-3#1)(1996-7#3)(1997-5#3)(2005-6#1)(2005-7#1)(2006-9#2)(2007-12#1)(2007-7#1)(2007-8#7)(2008-10#1)(2008-12#1)(2008-7#1)(2009-9#2)(2010-12#1)(2010-2#1)(2012-2#1)(2013-7#1)(2013-8#2)
uniporter##2##1##(2008-8#2)
unique AFLP profiles##2##3##(2008-10#2)
unique AFLP##5##2##(2008-10#5)
unique AR##2##2##(1996-5#2)
unique DNA fingerprints##2##3##(2008-10#2)
unique DNA##7##2##(1996-6#1)(1997-9#1)(2008-10#3)(2008-2#1)(2008-4#1)
unique PCR##4##2##(1997-4#1)(2006-8#3)
unique ability to##8##3##(2008-11#1)(2008-4#1)(2008-9#1)(2009-8#1)(2010-11#1)(2011-1#1)(2012-12#1)(2012-2#1)
unique ability##13##2##(1994-10#1)(1997-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-8#1)(2010-11#1)(2011-1#1)(2012-12#1)(2012-2#1)
unique advantage of this approach##2##5##(2008-10#1)(2008-4#1)
unique advantage of##3##3##(2006-12#1)(2008-10#1)(2008-4#1)
unique advantage##7##2##(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-6#1)
unique advantages##6##2##(1990-5#1)(2007-12#2)(2008-3#1)(2011-3#1)(2013-1#1)
unique alleles in##2##3##(2011-2#2)
unique alleles##4##2##(2005-10#1)(2008-10#1)(2011-2#2)
unique amino acid sequences##2##4##(1993-12#1)(2008-8#1)
unique amino acid##5##3##(1993-12#1)(1994-5#1)(1996-8#1)(2008-4#1)(2008-8#1)
unique among##17##2##(1992-10#1)(1993-12#1)(1993-5#1)(1994-2#1)(1995-8#1)(1996-8#1)(2006-1#1)(2006-10#1)(2006-9#1)(2008-10#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
unique anaesthetic##2##2##(2006-10#1)(2006-4#1)
unique anatomical##2##2##(2005-8#1)(2010-5#1)
unique anatomy##4##2##(2010-11#1)(2011-2#1)(2013-1#2)
unique and different##3##3##(2006-10#1)(2007-1#1)(2011-3#1)
unique and potentially##2##3##(1993-12#1)(2008-7#1)
unique and trustable##2##3##(2012-3#2)
unique and useful##3##3##(2008-7#1)(2008-8#1)(2008-9#1)
unique and##45##2##(1992-1#1)(1992-2#1)(1993-12#1)(1994-8#1)(1996-12#1)(1997-4#1)(2006-10#3)(2006-4#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-3#1)(2012-2#2)(2012-3#3)
unique antigen##2##2##(1995-2#1)(2012-1#1)
unique antimicrobial peptides##2##3##(1992-11#2)
unique approach to##6##3##(1994-3#1)(1995-2#1)(1996-3#1)(2007-7#1)(2008-9#1)(2009-8#1)
unique approach##7##2##(1994-3#1)(1995-2#1)(1996-3#1)(2007-7#1)(2008-7#1)(2008-9#1)(2009-8#1)
unique approaches##3##2##(2008-10#1)(2009-4#1)(2013-1#1)
unique arrangement##2##2##(1991-2#1)(2010-2#1)
unique as##3##2##(1990-5#1)(2008-1#1)(2013-7#1)
unique aspects of##5##3##(1996-8#1)(2007-6#1)(2008-10#1)(2010-6#1)(2010-8#1)
unique association##3##2##(2007-7#1)(2009-3#1)(2012-3#1)
unique behavioral##2##2##(1995-12#1)(2008-10#1)
unique binding##5##2##(1992-1#1)(1994-12#1)(1996-10#1)(2008-10#1)(2012-3#1)
unique biological##4##2##(1996-8#1)(2007-9#1)(2009-8#1)(2012-2#1)
unique bone##2##2##(2007-8#1)(2008-9#1)
unique but##3##2##(1991-11#1)(1994-2#1)(1995-3#1)
unique cDNA##2##2##(1997-7#1)(2008-7#1)
unique case of##13##3##(2005-10#1)(2007-10#3)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#1)(2013-1#2)
unique case##18##2##(2005-10#2)(2007-10#4)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-11#1)(2011-1#1)(2012-12#1)(2013-1#2)
unique cell populations##2##3##(2006-10#1)(2010-11#1)
unique cell##3##2##(2006-10#1)(2010-11#1)(2012-2#1)
unique cellular##3##2##(1991-2#1)(2011-2#1)(2012-2#1)
unique challenges for the##2##4##(1991-3#1)(2010-9#1)
unique challenges in##4##3##(2006-10#1)(2009-6#1)(2011-12#1)(2011-2#1)
unique challenges that##2##3##(2007-10#1)(2008-1#1)
unique challenges to##3##3##(2011-2#1)(2013-1#2)
unique challenges##21##2##(1991-3#1)(1997-2#1)(2006-10#1)(2006-5#1)(2007-10#1)(2008-1#1)(2008-4#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#4)(2013-8#1)
unique characteristic of the##2##4##(1994-5#1)(1996-5#1)
unique characteristics and##4##3##(1992-1#2)(2008-10#1)(2012-12#1)
unique characteristics of##11##3##(1990-11#1)(1996-3#1)(2006-10#1)(2006-3#1)(2007-11#1)(2008-2#1)(2008-8#1)(2009-2#1)(2011-2#1)(2013-1#2)
unique characteristics such as##2##4##(1991-5#1)(2010-4#1)
unique characteristics##27##2##(1990-11#1)(1991-5#1)(1991-8#1)(1992-1#2)(1994-6#1)(1996-3#1)(2006-10#1)(2006-3#3)(2007-11#2)(2008-10#3)(2008-2#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
unique chemical and physical properties##2##5##(2008-10#1)(2010-7#1)
unique chemical##6##2##(1993-12#2)(2008-10#3)(2010-7#1)
unique clinical##7##2##(1993-3#1)(1995-11#1)(2005-12#1)(2008-7#2)(2011-2#1)(2013-8#1)
unique cloning sites##6##3##(1990-5#1)(1991-4#1)(1991-9#2)(1995-2#1)(1996-10#1)
unique cloning##7##2##(1990-5#1)(1991-4#1)(1991-9#2)(1992-8#1)(1995-2#1)(1996-10#1)
unique combination of functional##2##4##(1992-2#1)(2012-2#1)
unique combination of##13##3##(1991-8#1)(1992-2#1)(1996-1#1)(1997-1#1)(2006-12#1)(2008-1#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
unique combination##14##2##(1991-8#1)(1992-2#1)(1996-1#1)(1997-1#1)(2006-12#1)(2008-1#1)(2008-3#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
unique components##3##2##(2008-4#2)(2010-9#1)
unique conformation##2##2##(1992-5#1)(2006-12#1)
unique contribution to the##2##4##(2011-2#1)(2012-1#1)
unique contribution##5##2##(1994-2#2)(2011-2#1)(2012-1#1)(2012-3#1)
unique contributions##2##2##(1993-2#1)(2007-11#1)
unique data set##2##3##(2012-12#2)
unique data##10##2##(1995-6#1)(1996-2#6)(2008-10#1)(2012-12#2)
unique dataset##3##2##(2012-3#1)(2013-1#2)
unique delivery system##3##3##(2007-2#3)
unique delivery##4##2##(2007-2#3)(2010-12#1)
unique design and##2##3##(2007-4#1)(2011-2#1)
unique distribution patterns##3##3##(1996-6#1)(2008-6#2)
unique distribution##4##2##(1996-6#1)(2007-12#1)(2008-6#2)
unique domain##2##2##(1990-7#1)(2008-7#1)
unique drug##2##2##(2008-11#1)(2012-2#1)
unique ecological##2##2##(2009-6#1)(2013-8#1)
unique educational##3##2##(1993-1#1)(2007-2#1)(2008-10#1)
unique effects of##2##3##(2010-1#1)(2011-1#1)
unique effects##4##2##(2010-1#1)(2011-1#1)(2012-1#1)(2012-12#1)
unique electronic and##2##3##(2006-2#1)(2008-10#1)
unique electronic properties##2##3##(2010-7#2)
unique electronic##6##2##(2006-2#1)(2008-10#2)(2008-7#1)(2010-7#2)
unique environments##2##2##(1994-2#1)(2008-11#1)
unique enzyme##4##2##(1990-4#1)(1996-2#1)(1997-9#1)(2011-2#1)
unique experience##3##2##(2006-11#1)(2008-7#1)(2013-1#1)
unique family##3##2##(1995-3#1)(2008-4#1)(2008-7#1)
unique feature of the##4##4##(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)
unique feature of these##2##4##(1990-9#1)(2008-10#1)
unique feature of this##5##4##(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)
unique feature of##16##3##(1990-9#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-9#2)(2012-2#1)
unique feature##19##2##(1990-9#1)(1993-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-9#1)(2012-2#1)
unique features of such##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
unique features of this##4##4##(1991-10#1)(2008-10#1)(2009-6#1)(2011-1#1)
unique features of##15##3##(1991-10#1)(1991-2#1)(1994-3#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-7#1)(2009-12#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
unique features that##3##3##(1991-12#1)(2008-10#1)(2010-8#1)
unique features##29##2##(1991-10#1)(1991-12#2)(1991-2#1)(1994-3#1)(1997-2#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
unique feeding##2##2##(1995-5#1)(2012-12#1)
unique for each##2##3##(2008-10#1)(2008-4#1)
unique for the##2##3##(1994-12#1)(2008-10#1)
unique for##11##2##(1993-11#1)(1994-12#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-4#1)(2010-7#1)(2012-12#1)
unique form of##6##3##(1993-11#1)(1993-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
unique function##4##2##(1991-5#1)(1996-1#1)(2008-11#1)(2009-7#1)
unique functional properties##2##3##(1990-8#1)(2008-8#1)
unique functions##2##2##(2010-10#1)(2010-5#1)
unique genes##4##2##(1997-6#2)(2008-10#1)(2011-1#1)
unique genetic##5##2##(1996-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-1#1)
unique genomic##2##2##(2012-2#1)(2013-8#1)
unique genotypes##5##2##(2008-10#5)
unique group of##4##3##(1996-3#1)(2006-10#1)(2007-2#1)(2008-10#1)
unique group##6##2##(1996-3#1)(2006-10#1)(2007-2#2)(2008-10#2)
unique health##2##2##(2008-11#1)(2008-6#1)
unique human##4##2##(1990-5#1)(1992-8#1)(1995-11#1)(2013-8#1)
unique in its##6##3##(1990-12#1)(1992-6#1)(2006-10#1)(2006-8#1)(2008-8#1)(2013-8#1)
unique in possessing##2##3##(1993-9#1)(2008-7#1)
unique in terms of##2##4##(2006-10#1)(2007-12#1)
unique in that it##8##4##(1993-6#1)(1995-9#1)(1996-6#1)(1997-4#1)(2008-11#1)(2008-4#1)(2009-8#1)(2013-8#1)
unique in that they##2##4##(2007-12#1)(2008-11#1)
unique in that this##2##4##(1994-5#1)(1994-9#1)
unique in that##15##3##(1992-10#1)(1993-6#1)(1994-5#1)(1994-9#1)(1995-9#1)(1996-6#1)(1997-4#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2009-8#1)(2013-8#1)
unique in the##8##3##(1990-5#1)(1993-9#1)(1996-12#1)(2007-12#1)(2008-12#1)(2008-2#1)(2012-1#1)(2013-1#1)
unique in this##2##3##(2008-11#1)(2011-2#1)
unique in##53##2##(1990-12#1)(1990-4#1)(1990-5#1)(1992-10#1)(1992-5#1)(1992-6#2)(1993-6#1)(1993-9#2)(1994-12#1)(1994-5#1)(1994-9#1)(1995-9#1)(1996-12#2)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#1)(2004-3#1)(2006-10#3)(2006-8#2)(2007-11#1)(2007-12#3)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-8#3)
unique influence##3##2##(2009-8#1)(2012-1#1)(2013-1#1)
unique information##5##2##(1994-8#1)(2007-8#1)(2008-1#1)(2009-9#1)(2010-8#1)
unique insight##3##2##(1992-6#1)(2007-8#1)(2010-4#1)
unique instrument##2##2##(2007-12#1)(2008-2#1)
unique interaction between##2##3##(1994-9#1)(2008-10#1)
unique iron-binding stability##3##3##(1996-5#3)
unique iron-binding##4##2##(1996-5#4)
unique issues##2##2##(2007-12#1)(2013-1#1)
unique localization##2##2##(2010-12#1)(2011-2#1)
unique mRNA##2##2##(1991-9#1)(2006-8#1)
unique macronutrient composition##3##3##(2008-3#3)
unique macronutrient##4##2##(2008-3#4)
unique management issues##2##3##(2010-6#1)(2012-3#1)
unique management##4##2##(2010-6#1)(2010-7#1)(2012-3#1)(2013-8#1)
unique marker##3##2##(1993-8#1)(2008-10#1)(2012-12#1)
unique markers##2##2##(2006-12#1)(2007-12#1)
unique mechanism for##2##3##(1995-8#1)(2008-11#1)
unique mechanism##6##2##(1994-2#1)(1995-8#1)(2008-11#1)(2008-3#1)(2009-11#1)(2009-8#1)
unique mechanisms of##3##3##(1995-2#1)(1996-8#1)(2012-1#1)
unique mechanisms##4##2##(1995-2#1)(1996-8#1)(2012-1#1)(2012-12#1)
unique members##2##2##(1994-9#1)(2008-10#1)
unique metabolic pathways##2##3##(2013-8#2)
unique metabolic##4##2##(2009-8#1)(2013-8#3)
unique molecular structure##2##3##(2007-11#1)(2008-3#1)
unique molecular##9##2##(1995-2#1)(1995-6#1)(1997-7#1)(2007-1#1)(2007-11#1)(2008-3#2)(2009-4#1)(2011-1#1)
unique motility##2##2##(2007-8#1)(2008-11#1)
unique mutation##3##2##(1991-11#1)(1995-1#1)(2005-9#1)
unique natural##3##2##(1995-9#1)(2008-12#1)(2010-7#1)
unique nature of##6##3##(2007-1#1)(2008-4#1)(2008-8#1)(2009-4#1)(2013-1#1)(2013-8#1)
unique needs##5##2##(1994-3#3)(2010-11#1)(2010-8#1)
unique nucleotide##3##2##(1993-8#1)(2010-10#1)(2012-3#1)
unique opportunities and##2##3##(2007-2#1)(2009-9#1)
unique opportunities for the##2##4##(1995-1#1)(2010-5#1)
unique opportunities for##5##3##(1995-1#1)(2008-7#1)(2009-9#1)(2010-5#1)(2013-1#1)
unique opportunities to##2##3##(2007-11#1)(2008-7#1)
unique opportunities##11##2##(1995-1#1)(2007-11#1)(2007-2#1)(2008-7#2)(2009-9#2)(2010-2#1)(2010-5#1)(2012-12#1)(2013-1#1)
unique opportunity to##25##3##(1991-8#1)(1992-10#1)(1995-10#1)(1995-6#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
unique opportunity##31##2##(1990-4#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-10#1)(1995-10#1)(1995-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
unique optical properties##3##3##(2009-11#1)(2010-1#1)(2010-12#1)
unique optical##4##2##(2009-11#1)(2010-1#1)(2010-12#1)(2010-6#1)
unique or##3##2##(1997-1#1)(2008-10#2)
unique organization##2##2##(1994-1#1)(2010-7#1)
unique pair of##3##3##(1990-6#1)(2008-10#1)(2008-6#1)
unique pattern of##3##3##(1990-2#1)(1991-2#1)(1993-12#1)
unique patterns of##2##3##(2007-12#1)(2009-9#1)
unique patterns##3##2##(2007-12#1)(2008-12#1)(2009-9#1)
unique peptide##3##2##(1991-7#1)(1994-3#1)(2011-1#1)
unique peptides##2##2##(2008-4#1)(2011-1#1)
unique pharmacological##3##2##(1993-9#1)(1997-5#1)(2008-3#1)
unique phenomenon##4##2##(1994-8#1)(2007-12#1)(2008-10#1)(2008-2#1)
unique physical and chemical characteristics##2##5##(2009-8#1)(2010-7#1)
unique physical and chemical properties##2##5##(2008-10#1)(2013-8#1)
unique physical and chemical##5##4##(2008-10#1)(2008-7#1)(2009-8#1)(2010-7#1)(2013-8#1)
unique physical and##6##3##(2008-10#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-7#1)(2013-8#1)
unique physical##7##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-7#1)(2013-8#1)
unique physiologic##2##2##(1993-12#1)(2012-3#1)
unique picture##2##2##(2006-4#1)(2007-12#1)
unique point##3##2##(1991-1#1)(1991-7#1)(2008-10#1)
unique points##2##2##(2008-3#2)
unique population##4##2##(2008-5#1)(2012-2#1)(2013-1#2)
unique position in##3##3##(2007-12#1)(2008-12#1)(2010-12#1)
unique position##17##2##(1995-3#1)(1996-1#2)(1997-1#1)(2006-10#1)(2007-12#1)(2007-2#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
unique potential for##2##3##(2007-11#1)(2008-11#1)
unique potential##4##2##(1997-4#1)(2007-11#1)(2008-11#1)(2012-2#1)
unique practices##2##2##(2007-12#1)(2007-4#1)
unique predictor of##2##3##(2008-10#1)(2010-1#1)
unique predictor##4##2##(2008-10#1)(2010-1#2)(2012-3#1)
unique predictors of##2##3##(2010-8#1)(2012-2#1)
unique presentation##4##2##(2005-8#1)(2007-2#1)(2008-8#1)(2013-8#1)
unique problems and##2##3##(2006-10#1)(2009-10#1)
unique problems##5##2##(2005-8#1)(2006-10#1)(2007-12#1)(2008-10#1)(2009-10#1)
unique profiles of##4##3##(1991-9#1)(1993-12#1)(2010-4#1)(2012-11#1)
unique properties and##3##3##(1997-4#1)(2008-10#1)(2011-2#1)
unique properties of the##2##4##(1992-7#1)(2007-11#1)
unique properties of##16##3##(1990-7#1)(1992-7#1)(1993-4#1)(2007-11#3)(2007-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2011-1#1)(2012-1#1)(2012-2#1)(2013-7#1)
unique properties that make##2##4##(2006-10#1)(2012-2#1)
unique properties##32##2##(1990-7#1)(1992-7#1)(1993-3#1)(1993-4#1)(1996-4#1)(1997-4#2)(2006-10#1)(2007-11#4)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-7#1)
unique property of the##2##4##(1996-2#1)(2008-10#1)
unique property of##7##3##(1993-9#1)(1994-3#1)(1995-2#1)(1996-2#1)(2007-11#1)(2008-10#1)(2012-2#1)
unique property##9##2##(1993-9#1)(1994-3#1)(1995-2#1)(1996-2#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-2#1)(2012-2#1)
unique protein##4##2##(1990-5#1)(1994-3#1)(1994-8#1)(2008-9#1)
unique proteins##2##2##(2011-2#1)(2013-1#1)
unique purpose##2##2##(1993-12#1)(2008-1#1)
unique radiation##2##2##(2008-6#2)
unique reagents##3##2##(2008-10#1)(2008-4#1)(2010-7#1)
unique reflections##2##2##(2006-5#2)
unique region##4##2##(1990-5#1)(1994-8#1)(1995-3#1)(2006-3#1)
unique regulatory##3##2##(2011-2#2)(2012-3#1)
unique relationship between##2##3##(2007-12#1)(2013-1#1)
unique relationship##3##2##(2007-12#1)(2012-2#1)(2013-1#1)
unique relative##2##2##(1994-3#1)(2007-4#1)
unique requirements for##2##3##(2008-3#1)(2010-8#1)
unique requirements##5##2##(2006-10#1)(2008-11#1)(2008-3#1)(2010-7#1)(2010-8#1)
unique resistance##2##2##(2009-3#1)(2011-3#1)
unique restriction enzyme##2##3##(1991-9#1)(1995-1#1)
unique restriction fragment length polymorphism##2##5##(2008-10#1)(2008-5#1)
unique restriction sites##4##3##(1990-3#2)(1990-5#1)(1994-3#1)
unique restriction##11##2##(1990-3#2)(1990-5#1)(1990-7#1)(1991-9#1)(1994-3#1)(1995-1#1)(2007-8#1)(2008-10#2)(2008-5#1)
unique risk factors##2##3##(2011-2#1)(2013-1#1)
unique risk##3##2##(2010-6#1)(2011-2#1)(2013-1#1)
unique role for##2##3##(1997-7#1)(2012-1#1)
unique role##11##2##(1994-11#1)(1996-4#1)(1997-1#1)(1997-4#1)(1997-7#2)(2007-2#1)(2009-10#2)(2009-3#1)(2012-1#1)
unique roles in the##3##4##(1991-4#1)(1996-3#1)(2013-1#1)
unique roles in##4##3##(1991-4#1)(1992-10#1)(1996-3#1)(2013-1#1)
unique roles##5##2##(1991-4#1)(1992-10#1)(1996-3#1)(1996-8#1)(2013-1#1)
unique scheme##2##2##(2008-3#2)
unique segments are arranged##3##4##(1996-7#3)
unique segments##5##2##(1996-7#5)
unique sequence of##3##3##(1990-11#1)(1996-5#1)(2012-2#1)
unique sequence##10##2##(1990-10#1)(1990-11#1)(1991-6#1)(1993-12#1)(1993-6#1)(1993-9#1)(1995-3#1)(1996-5#1)(2012-2#1)(2013-1#1)
unique sequences of##3##3##(1997-2#1)(2008-10#1)(2008-7#1)
unique sequences were##2##3##(2008-7#1)(2008-9#1)
unique sequences##11##2##(1995-8#2)(1996-10#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-1#1)
unique short##3##2##(1992-12#1)(1994-1#1)(2013-8#1)
unique site##6##2##(1990-7#1)(1991-7#2)(1995-2#1)(1995-6#1)(1995-8#1)
unique situation##3##2##(1994-12#1)(2006-10#1)(2008-12#1)
unique skills##2##2##(2008-1#1)(2011-1#1)
unique species##3##2##(1995-2#1)(2008-10#1)(2010-4#1)
unique specificity##4##2##(1994-12#1)(2008-1#1)(2008-10#1)(2008-11#1)
unique spectra##2##2##(2007-12#2)
unique spectral##2##2##(2008-10#1)(2010-5#1)
unique spectroscopic##2##2##(1990-7#1)(2007-11#1)
unique stable##2##2##(1990-3#1)(2013-1#1)
unique structural##4##2##(1993-8#1)(2011-1#1)(2012-1#1)(2012-2#1)
unique structure of##4##3##(1997-3#1)(2006-10#1)(2007-9#1)(2009-3#1)
unique structure##10##2##(1991-2#2)(1991-7#1)(1993-11#1)(1996-7#1)(1997-3#1)(2006-10#1)(2007-9#1)(2009-3#1)(2010-4#1)
unique substitutions##2##2##(1994-12#1)(1996-10#1)
unique substrate specificity##2##3##(1992-3#1)(1995-2#1)
unique substrate##3##2##(1992-3#1)(1995-2#1)(2011-1#1)
unique subtype of PTSD##2##4##(2007-7#2)
unique subtype of##3##3##(2005-7#1)(2007-7#2)
unique subtype##4##2##(2005-7#1)(2007-7#2)(2011-1#1)
unique system##5##2##(2008-10#1)(2008-5#1)(2009-8#1)(2013-1#2)
unique tissue distribution##2##3##(1993-9#1)(2008-4#1)
unique tissue##5##2##(1991-5#1)(1993-9#1)(2008-4#1)(2008-5#1)(2010-11#1)
unique to a##4##3##(2008-10#1)(2008-4#1)(2008-9#2)
unique to each##9##3##(1992-11#1)(1995-3#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-2#1)(2013-8#1)
unique to the##30##3##(1990-6#1)(1991-9#1)(1992-1#1)(1994-8#1)(1996-12#1)(1996-8#1)(1997-4#1)(2006-4#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-7#2)(2011-12#1)(2011-2#2)(2012-2#1)(2013-7#1)
unique to these##2##3##(1996-7#1)(2007-11#1)
unique to this##6##3##(1992-12#1)(1992-6#1)(1995-6#1)(2008-11#1)(2008-7#1)(2009-9#1)
unique to##107##2##(1990-4#1)(1990-6#1)(1991-12#2)(1991-2#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-6#1)(1993-2#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-3#1)(1995-6#2)(1996-11#1)(1996-12#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-2#4)(2008-3#1)(2008-4#5)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
unique transcription##2##2##(1991-7#1)(2005-7#1)
unique treatment##2##2##(2008-8#1)(2010-3#1)
unique type of##2##3##(2005-7#1)(2008-10#1)
unique type##3##2##(1992-4#1)(2005-7#1)(2008-10#1)
unique use##2##2##(2008-10#1)(2010-9#1)
unique value##3##2##(1996-3#1)(2007-12#1)(2008-7#1)
unique variance in##2##3##(2007-12#1)(2009-4#1)
unique variance##4##2##(2007-12#1)(2009-4#1)(2009-9#1)(2010-6#1)
unique variant##2##2##(2007-11#1)(2008-10#1)
unique viral##2##2##(2006-10#1)(2012-2#1)
unique virulence##2##2##(2008-10#2)
unique##1744##1##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#4)(1990-4#6)(1990-5#11)(1990-6#2)(1990-7#7)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#3)(1991-11#2)(1991-12#10)(1991-2#11)(1991-3#9)(1991-4#3)(1991-5#6)(1991-6#2)(1991-7#10)(1991-8#7)(1991-9#8)(1992-1#5)(1992-10#4)(1992-11#7)(1992-12#5)(1992-2#4)(1992-3#4)(1992-4#3)(1992-5#4)(1992-6#7)(1992-7#2)(1992-8#3)(1992-9#1)(1993-1#3)(1993-11#5)(1993-12#13)(1993-2#4)(1993-3#6)(1993-4#3)(1993-5#1)(1993-6#3)(1993-8#10)(1993-9#6)(1994-1#5)(1994-10#3)(1994-11#2)(1994-12#9)(1994-2#8)(1994-3#14)(1994-5#8)(1994-6#1)(1994-8#9)(1994-9#9)(1995-1#8)(1995-10#2)(1995-11#7)(1995-12#4)(1995-2#13)(1995-3#7)(1995-4#1)(1995-5#2)(1995-6#8)(1995-8#8)(1995-9#2)(1996-1#5)(1996-10#4)(1996-11#4)(1996-12#11)(1996-2#12)(1996-3#9)(1996-4#4)(1996-5#13)(1996-6#5)(1996-7#11)(1996-8#10)(1997-1#8)(1997-2#9)(1997-3#2)(1997-4#14)(1997-5#2)(1997-6#6)(1997-7#6)(1997-8#4)(1997-9#2)(2004-12#3)(2004-3#2)(2004-9#1)(2005-10#5)(2005-11#6)(2005-12#1)(2005-7#4)(2005-8#8)(2005-9#1)(2006-1#1)(2006-10#42)(2006-11#5)(2006-12#10)(2006-2#1)(2006-3#7)(2006-4#6)(2006-5#8)(2006-6#2)(2006-7#2)(2006-8#8)(2006-9#3)(2007-1#5)(2007-10#11)(2007-11#33)(2007-12#53)(2007-2#16)(2007-4#6)(2007-5#3)(2007-6#1)(2007-7#6)(2007-8#16)(2007-9#5)(2008-1#18)(2008-10#133)(2008-11#38)(2008-12#12)(2008-2#32)(2008-3#50)(2008-4#53)(2008-5#27)(2008-6#16)(2008-7#47)(2008-8#24)(2008-9#25)(2009-1#1)(2009-10#7)(2009-11#5)(2009-12#6)(2009-2#3)(2009-3#7)(2009-4#11)(2009-5#6)(2009-6#8)(2009-7#3)(2009-8#16)(2009-9#10)(2010-1#6)(2010-10#4)(2010-11#7)(2010-12#14)(2010-2#10)(2010-3#10)(2010-4#11)(2010-5#10)(2010-6#6)(2010-7#20)(2010-8#12)(2010-9#6)(2011-1#22)(2011-12#6)(2011-2#36)(2011-3#3)(2011-7#2)(2012-1#17)(2012-10#1)(2012-11#10)(2012-12#23)(2012-2#46)(2012-3#26)(2012-5#1)(2013-1#62)(2013-7#11)(2013-8#35)
uniquely associated with##3##3##(2006-3#1)(2008-9#1)(2009-8#1)
uniquely determine the##2##3##(1995-9#1)(2007-12#1)
uniquely determined by##2##3##(2007-12#1)(2008-2#1)
uniquely determined##3##2##(2005-11#1)(2007-12#1)(2008-2#1)
uniquely distributed##2##2##(1993-8#1)(1997-4#1)
uniquely expressed##3##2##(1996-12#1)(2006-10#1)(2011-2#1)
uniquely human##2##2##(2007-12#1)(2008-5#1)
uniquely poised to##2##3##(2006-2#1)(2007-1#1)
uniquely positioned to##4##3##(1992-1#1)(1996-2#1)(2007-5#1)(2010-4#1)
uniquely positioned##6##2##(1992-1#1)(1992-4#1)(1996-2#1)(2007-12#1)(2007-5#1)(2010-4#1)
uniquely sensitive to##2##3##(1993-11#1)(2012-2#1)
uniquely shared by##2##3##(2013-8#2)
uniquely suited to##2##3##(1990-5#1)(2012-12#1)
uniquely suited##3##2##(1990-5#1)(2010-12#1)(2012-12#1)
uniquely##95##1##(1990-5#2)(1991-1#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-4#2)(1992-5#1)(1992-6#3)(1993-11#1)(1993-8#3)(1994-10#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-4#4)(1997-6#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-3#2)(2006-4#1)(2007-1#1)(2007-11#3)(2007-12#7)(2007-5#1)(2008-1#3)(2008-10#3)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#4)(2009-7#2)(2009-8#2)(2010-12#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-12#4)(2012-2#1)(2013-8#4)
uniqueness and no##2##3##(2009-3#1)(2013-8#1)
uniqueness and##6##2##(2006-12#1)(2007-11#1)(2009-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
uniqueness in##3##2##(2007-12#2)(2010-10#1)
uniqueness is##2##2##(2008-3#2)
uniqueness of the solution##2##4##(2008-2#1)(2009-10#1)
uniqueness of the##7##3##(1993-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2009-10#1)(2012-3#1)
uniqueness of this##2##3##(2005-8#1)(2007-4#1)
uniqueness of##18##2##(1990-12#1)(1993-4#1)(1993-9#1)(2005-8#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-9#1)(2009-10#1)(2010-8#1)(2012-3#1)(2013-8#1)
uniqueness##48##1##(1990-12#1)(1990-5#1)(1993-4#1)(1993-9#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-12#5)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#5)(2009-10#1)(2009-3#2)(2010-10#2)(2010-8#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#5)
unirradiated cells to##2##3##(1995-2#1)(1995-6#1)
unirradiated normal tissue##3##3##(2008-6#3)
unirradiated##13##1##(1991-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#4)
unisensory and multisensory##2##3##(2012-1#1)(2012-2#1)
unisensory##7##1##(2012-1#3)(2012-2#4)
unisexual species##2##2##(2010-3#2)
unisexual##7##1##(2008-9#4)(2010-3#3)
unisexual-bisexual complex##2##2##(2010-3#2)
unisite##2##1##(1994-11#1)(1996-7#1)
unit (CFU)##3##2##(2007-12#1)(2008-9#1)(2012-12#1)
unit (Sanki##2##2##(1994-12#2)
unit BP##4##2##(2007-8#4)
unit a##2##2##(2008-4#1)(2013-8#1)
unit according to##2##3##(2009-5#1)(2012-12#1)
unit activity in the##2##4##(1993-12#1)(1993-6#1)
unit activity was recorded##2##4##(1991-3#1)(1992-9#1)
unit activity was##3##3##(1991-3#1)(1992-9#1)(1996-12#1)
unit activity##11##2##(1990-7#1)(1991-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-2#1)(1996-12#1)(1997-7#1)(2008-4#2)
unit addresses some##2##3##(2008-4#1)(2008-9#1)
unit addresses##7##2##(2008-2#2)(2008-4#3)(2008-9#2)
unit after##3##2##(2006-4#2)(2011-2#1)
unit aims to##2##3##(2008-9#1)(2011-2#1)
unit also contains protocols that##2##5##(2008-4#1)(2008-9#1)
unit also contains##5##3##(2008-1#1)(2008-4#3)(2008-9#1)
unit also includes protocols##3##4##(2008-1#1)(2008-4#2)
unit also includes##6##3##(2008-1#2)(2008-4#4)
unit also outlines the##2##4##(2008-4#2)
unit also presents##5##3##(2008-2#1)(2008-4#3)(2008-9#1)
unit also provides##4##3##(2008-1#2)(2008-4#2)
unit also##29##2##(2008-1#6)(2008-2#1)(2008-4#19)(2008-9#3)
unit and a##3##3##(1995-1#1)(2007-8#1)(2010-9#1)
unit and day hospital##2##4##(2006-7#1)(2008-7#1)
unit and its##2##3##(2006-7#1)(2008-4#1)
unit and the##6##3##(1992-9#1)(2006-10#2)(2007-10#1)(2007-8#1)(2008-10#1)
unit and to##2##3##(1996-2#1)(2010-9#1)
unit and##48##2##(1990-11#1)(1991-7#1)(1992-4#1)(1992-9#1)(1995-1#1)(1996-2#1)(2006-10#5)(2006-12#1)(2006-7#2)(2007-10#3)(2007-11#1)(2007-7#2)(2007-8#4)(2008-10#6)(2008-11#2)(2008-2#1)(2008-4#2)(2008-7#2)(2009-5#1)(2010-9#2)(2011-12#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
unit are##21##2##(1990-12#1)(1992-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#10)(2008-9#4)(2010-7#1)(2012-3#1)
unit area of##5##3##(1992-3#1)(1997-5#1)(2006-7#1)(2008-10#1)(2008-7#1)
unit area##16##2##(1992-3#1)(1995-12#1)(1997-5#1)(2004-12#1)(2006-7#1)(2008-10#3)(2008-12#2)(2008-3#2)(2008-7#1)(2008-8#1)(2010-8#1)(2013-8#1)
unit as the##2##3##(1991-3#1)(1996-4#1)
unit as##5##2##(1991-3#1)(1992-1#1)(1996-4#1)(2008-4#1)(2012-2#1)
unit assumes##2##2##(2008-4#2)
unit at a##7##3##(1992-3#1)(2004-9#1)(2005-2#3)(2008-5#1)(2012-3#1)
unit at the##2##3##(1992-4#1)(2011-2#1)
unit at##17##2##(1990-10#1)(1990-9#1)(1992-3#1)(1992-4#1)(1994-3#1)(1996-2#1)(1997-2#1)(2004-9#1)(2005-2#3)(2006-4#1)(2008-1#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-3#1)
unit attached to##2##3##(1992-6#1)(2007-3#1)
unit attached##3##2##(1992-6#1)(2007-3#1)(2008-10#1)
unit begins with a##2##4##(2008-4#2)
unit begins with##3##3##(2008-4#3)
unit between##4##2##(2005-11#1)(2007-10#1)(2007-3#1)(2012-3#1)
unit by##4##2##(1996-11#1)(1997-1#1)(2008-9#1)(2012-3#1)
unit can be##9##3##(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-9#1)
unit can##13##2##(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#5)(2008-9#1)(2010-3#1)(2010-9#1)
unit care##3##2##(2008-8#1)(2009-11#1)(2009-8#1)
unit cell and##2##3##(1996-11#1)(2007-12#1)
unit cell constants##2##3##(1996-2#1)(2008-8#1)
unit cell dimensions of a =##3##6##(1991-4#1)(1991-7#1)(1996-2#1)
unit cell dimensions of##5##4##(1991-4#1)(1991-7#2)(1996-2#1)(1997-7#1)
unit cell dimensions##10##3##(1991-12#2)(1991-4#1)(1991-7#2)(1994-6#1)(1996-2#3)(1997-7#1)
unit cell parameters##2##3##(1996-2#1)(2008-10#1)
unit cell##32##2##(1991-12#2)(1991-4#1)(1991-7#2)(1992-9#1)(1993-3#1)(1994-6#1)(1994-9#2)(1995-6#1)(1996-11#1)(1996-2#6)(1997-7#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-7#1)
unit cells##3##2##(2007-12#1)(2008-7#2)
unit characteristics##2##2##(2008-1#1)(2013-1#1)
unit consisting of##2##3##(2007-11#1)(2008-7#1)
unit consists of a##3##4##(1995-6#1)(2010-2#1)(2011-2#1)
unit consists of##6##3##(1995-6#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-2#1)(2011-2#1)
unit containing##3##2##(1993-2#1)(1994-5#1)(2008-7#1)
unit contains two##2##3##(1994-9#1)(2008-4#1)
unit contains##15##2##(1992-4#1)(1994-9#2)(2008-1#3)(2008-4#7)(2008-9#2)
unit costs##5##2##(1992-12#1)(1995-3#1)(2006-10#1)(2006-12#1)(2010-4#1)
unit covers##13##2##(2008-2#1)(2008-4#8)(2008-9#4)
unit deals exclusively with the parasite Schistosoma mansoni##2##8##(2008-4#2)
unit deals exclusively with##3##4##(2008-4#2)(2008-9#1)
unit deals with the##2##4##(2008-4#1)(2008-9#1)
unit deals with##3##3##(2008-4#2)(2008-9#1)
unit deals##6##2##(2008-4#4)(2008-9#2)
unit defines##2##2##(2008-4#1)(2008-9#1)
unit describes a basic##2##4##(2008-4#2)
unit describes a##72##3##(2008-1#7)(2008-2#2)(2008-4#42)(2008-9#21)
unit describes an assay for##2##5##(2008-4#2)
unit describes an assay of##2##5##(2008-4#2)
unit describes an assay##5##4##(2008-4#5)
unit describes an##15##3##(2008-1#1)(2008-4#10)(2008-9#4)
unit describes assays for##2##4##(2008-4#1)(2008-9#1)
unit describes assays##3##3##(2008-1#1)(2008-4#1)(2008-9#1)
unit describes different##2##3##(2008-1#1)(2008-4#1)
unit describes how##15##3##(2008-2#3)(2008-4#11)(2008-9#1)
unit describes preparation of##4##4##(2008-4#4)
unit describes preparation##5##3##(2008-4#4)(2008-9#1)
unit describes protocols for##15##4##(2008-1#4)(2008-2#2)(2008-4#8)(2008-9#1)
unit describes protocols##22##3##(2008-1#5)(2008-2#2)(2008-4#11)(2008-9#4)
unit describes the ChIP##2##4##(2008-1#1)(2008-2#1)
unit describes the basic##5##4##(2008-2#1)(2008-4#2)(2008-9#2)
unit describes the methods##3##4##(2008-1#2)(2008-9#1)
unit describes the most common##2##5##(2008-1#1)(2008-4#1)
unit describes the##131##3##(2008-1#10)(2008-2#11)(2008-4#87)(2008-9#23)
unit describes two##17##3##(2008-1#1)(2008-2#1)(2008-4#12)(2008-9#3)
unit describes##423##2##(2008-1#41)(2008-2#27)(2008-4#269)(2008-9#86)
unit details the materials and##3##5##(2008-4#3)
unit details the##9##3##(2008-2#1)(2008-4#7)(2008-9#1)
unit details##18##2##(2008-2#2)(2008-4#13)(2008-9#3)
unit discusses how##2##3##(2008-4#2)
unit discusses many of the##2##5##(2008-4#1)(2008-9#1)
unit discusses the##20##3##(2008-1#1)(2008-4#9)(2008-9#10)
unit discusses##49##2##(2008-1#2)(2008-2#1)(2008-4#22)(2008-9#24)
unit dose##2##2##(2004-12#1)(2008-7#1)
unit during the##2##3##(2006-6#1)(2011-2#1)
unit firing##2##2##(1993-9#1)(2008-8#1)
unit focuses on the##6##4##(2008-4#6)
unit focuses on##15##3##(2008-1#1)(2008-4#10)(2008-9#4)
unit focuses##17##2##(2008-1#1)(2008-4#12)(2008-9#4)
unit for difficult##2##3##(2010-3#2)
unit for further##2##3##(2006-4#1)(2008-10#1)
unit for the##3##3##(1996-2#1)(1997-8#1)(2008-10#1)
unit for##30##2##(1991-11#1)(1993-6#1)(1995-6#2)(1996-1#1)(1996-2#1)(1996-9#1)(1997-8#1)(2006-4#1)(2007-10#1)(2008-10#5)(2008-2#2)(2008-4#5)(2008-7#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-3#2)
unit from the##2##3##(2007-7#1)(2008-10#1)
unit from##7##2##(1993-10#1)(1993-5#1)(2007-7#1)(2008-10#1)(2008-4#1)(2009-9#1)(2010-2#1)
unit gives a##2##3##(2008-2#1)(2008-4#1)
unit gives##5##2##(2008-2#2)(2008-4#1)(2008-9#2)
unit has been##4##3##(1992-12#1)(2008-4#2)(2008-5#1)
unit has##9##2##(1992-12#1)(2006-10#1)(2006-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2011-7#1)
unit if##2##2##(2005-11#1)(2011-1#1)
unit illustrates how to##2##4##(2008-4#1)(2008-9#1)
unit illustrates##3##2##(2008-4#2)(2008-9#1)
unit in India##3##3##(2007-10#1)(2011-1#2)
unit in a public##2##4##(1991-3#1)(1993-1#1)
unit in a##9##3##(1990-5#1)(1991-3#1)(1991-7#1)(1993-1#1)(1993-7#1)(2008-3#2)(2008-7#1)(2012-2#1)
unit in an##4##3##(1992-2#1)(2007-2#1)(2010-11#1)(2012-3#1)
unit in the##14##3##(1991-11#1)(1991-9#1)(1992-12#1)(1994-9#1)(1997-1#1)(1997-6#1)(2005-8#1)(2007-11#1)(2007-3#1)(2008-2#1)(2008-8#2)(2011-1#1)(2012-2#1)
unit in##45##2##(1990-5#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-7#1)(1994-12#1)(1994-9#1)(1995-8#1)(1997-1#1)(1997-6#1)(1997-7#1)(2005-8#1)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#3)(2008-9#1)(2010-11#1)(2011-1#3)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
unit includes a##4##3##(2007-12#1)(2008-1#1)(2008-9#2)
unit includes protocols for the##4##5##(2008-4#1)(2008-9#3)
unit includes protocols for##5##4##(2008-4#2)(2008-9#3)
unit includes the##2##3##(2008-4#2)
unit includes##17##2##(2007-12#1)(2008-1#2)(2008-4#9)(2008-9#5)
unit increase in##5##3##(2007-10#2)(2010-10#1)(2013-1#2)
unit is a##6##3##(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#2)
unit is an##2##3##(2008-4#1)(2008-9#1)
unit is focused on##2##4##(2008-4#2)
unit is often##2##3##(2007-7#1)(2011-2#1)
unit is the##4##3##(1995-8#1)(2007-7#1)(2008-4#2)
unit is to##15##3##(2008-1#1)(2008-11#1)(2008-4#9)(2008-9#4)
unit is##74##2##(1990-8#1)(1995-1#1)(1995-5#1)(1995-6#1)(1995-8#1)(2006-11#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-1#3)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#30)(2008-7#1)(2008-9#14)(2010-8#1)(2011-2#2)(2013-8#1)
unit length of##4##3##(2006-10#1)(2008-2#1)(2008-4#1)(2008-5#1)
unit length##5##2##(2006-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)
unit lengths##2##2##(1992-1#1)(2010-7#1)
unit lenses##2##2##(2007-11#2)
unit level##2##2##(2008-10#1)(2012-3#1)
unit management##4##2##(1996-2#1)(2008-3#2)(2012-2#1)
unit mass of the gel##2##5##(2008-10#2)
unit mass##4##2##(2008-10#3)(2008-7#1)
unit may##2##2##(1997-2#1)(2013-1#1)
unit membrane##5##2##(1992-1#2)(1996-9#1)(2007-12#1)(2008-7#1)
unit more##3##2##(1990-8#1)(2008-5#2)
unit of a tertiary##2##4##(2007-7#1)(2009-7#1)
unit of a##6##3##(2006-10#1)(2007-7#2)(2009-7#1)(2010-8#1)(2013-8#1)
unit of analysis##9##3##(1994-5#2)(1996-3#1)(1997-1#1)(2010-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
unit of hepatic##2##3##(2006-11#2)
unit of meaning##2##3##(2008-7#1)(2012-3#1)
unit of the##29##3##(1991-11#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-2#1)(1993-4#1)(1993-5#2)(1994-3#1)(1994-8#1)(1995-11#2)(1995-2#1)(1996-1#1)(1996-2#2)(2007-10#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-7#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
unit of time##4##3##(1996-3#1)(2007-6#1)(2008-5#1)(2008-9#1)
unit of##119##2##(1990-3#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#2)(1991-9#1)(1992-10#2)(1992-12#1)(1992-2#1)(1993-12#2)(1993-4#1)(1993-5#2)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-11#2)(1995-2#2)(1995-6#1)(1995-8#2)(1996-1#2)(1996-12#1)(1996-2#3)(1996-3#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-10#1)(2005-11#2)(2006-10#1)(2006-11#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-3#2)(2007-6#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#4)(2008-9#2)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#1)
unit offers a##4##3##(2008-4#3)(2008-9#1)
unit offers##10##2##(1994-10#1)(2008-4#8)(2008-9#1)
unit on the##3##3##(1990-5#1)(1991-6#1)(2008-10#1)
unit on##11##2##(1990-5#1)(1991-6#1)(1996-2#2)(2008-1#1)(2008-10#1)(2008-9#4)(2012-2#1)
unit operations in##3##3##(2012-2#3)
unit operations##4##2##(2008-11#1)(2012-2#3)
unit or##3##2##(2008-3#2)(2012-3#1)
unit outlines a##2##3##(2008-9#2)
unit outlines##13##2##(2008-4#11)(2008-9#2)
unit patients##17##2##(2005-8#1)(2006-10#4)(2006-4#1)(2007-7#1)(2009-11#2)(2009-3#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-12#2)(2012-2#2)
unit per##2##2##(2009-6#1)(2010-11#1)
unit presents a##33##3##(2008-1#1)(2008-2#2)(2008-4#19)(2008-9#11)
unit presents an alternative to differential display that allows the quantification of transcripts##3##13##(2008-2#3)
unit presents an overview of##5##5##(2008-4#3)(2008-9#2)
unit presents an##10##3##(2008-2#3)(2008-4#5)(2008-9#2)
unit presents protocols for##18##4##(2008-2#1)(2008-4#7)(2008-9#10)
unit presents protocols##21##3##(2008-2#2)(2008-4#8)(2008-9#11)
unit presents the##8##3##(2008-4#4)(2008-9#4)
unit presents##116##2##(2008-1#2)(2008-2#12)(2008-4#58)(2008-9#44)
unit provides a##33##3##(2008-1#6)(2008-2#1)(2008-4#19)(2008-9#7)
unit provides an excellent##4##4##(2008-9#4)
unit provides an overview of##16##5##(2008-2#1)(2008-4#14)(2008-9#1)
unit provides an##26##3##(2008-1#1)(2008-2#1)(2008-4#19)(2008-9#5)
unit provides basic##2##3##(2008-4#2)
unit provides detailed protocols##2##4##(2008-4#1)(2008-9#1)
unit provides detailed##5##3##(2008-4#2)(2008-9#3)
unit provides information on##2##4##(2008-2#1)(2008-9#1)
unit provides information##3##3##(2008-2#2)(2008-9#1)
unit provides procedures for##2##4##(2008-4#2)
unit provides##114##2##(2008-1#11)(2008-2#7)(2008-4#68)(2008-8#1)(2008-9#27)
unit recording##3##2##(1992-1#1)(1994-8#1)(1996-10#1)
unit recordings##5##2##(1995-12#2)(1995-5#1)(1996-12#1)(2008-4#1)
unit responses to##2##3##(1995-12#1)(1995-7#1)
unit responses##7##2##(1995-11#2)(1995-12#3)(1995-7#1)(1996-12#1)
unit reviews##7##2##(2008-4#5)(2008-9#2)
unit should be##7##3##(1996-12#1)(2005-5#1)(2007-9#1)(2008-1#1)(2008-9#3)
unit should##8##2##(1996-12#1)(2005-5#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-9#3)
unit stay##6##2##(2005-8#1)(2007-8#4)(2007-9#1)
unit takes##2##2##(2008-4#1)(2008-9#1)
unit temperature##2##2##(2012-12#2)
unit than##2##2##(1990-5#1)(2010-2#1)
unit that##11##2##(1990-5#1)(1991-7#1)(1992-1#1)(1995-6#1)(2006-6#1)(2008-3#2)(2009-10#1)(2010-12#1)(2011-2#1)(2012-3#1)
unit the##5##2##(1997-6#1)(2007-3#1)(2007-8#2)(2008-9#1)
unit time##4##2##(1996-4#1)(2008-2#1)(2008-3#1)(2008-7#1)
unit to a##2##3##(1991-6#1)(2008-10#1)
unit to##12##2##(1990-7#1)(1991-6#1)(1995-8#1)(2006-10#1)(2006-6#1)(2006-7#1)(2008-10#2)(2008-4#2)(2008-9#1)(2012-12#1)
unit treatment##2##2##(2006-10#1)(2009-4#1)
unit uses##4##2##(2007-12#1)(2008-2#1)(2008-4#1)(2008-9#1)
unit volume of##3##3##(1994-3#1)(1996-10#1)(2009-8#1)
unit volume##5##2##(1994-3#1)(1996-10#1)(2005-11#1)(2008-2#1)(2009-8#1)
unit was obtained##2##3##(2005-11#1)(2008-8#1)
unit was##25##2##(1990-3#1)(1990-9#2)(1993-12#1)(1994-3#1)(1996-7#1)(1997-2#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#3)(2008-8#1)(2008-9#2)(2010-2#1)(2011-1#1)(2011-3#1)(2012-12#1)
unit water systems##2##3##(2011-12#2)
unit water##3##2##(2011-12#3)
unit we##2##2##(2008-9#1)(2013-1#1)
unit were##9##2##(1990-12#1)(1992-12#1)(1995-1#1)(1996-2#1)(2007-8#2)(2010-12#1)(2013-1#1)(2013-8#1)
unit where##2##2##(1992-1#1)(2007-7#1)
unit which##2##2##(1994-2#1)(2010-1#1)
unit will be##2##3##(2006-10#1)(2008-4#1)
unit will##11##2##(2006-10#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-4#2)(2008-9#3)(2011-2#1)
unit with##13##2##(1992-6#1)(1993-9#1)(1995-9#1)(2006-10#1)(2006-4#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2013-8#1)
unit within##2##2##(1995-1#1)(2008-1#1)
unit without##2##2##(2006-4#1)(2010-10#1)
unit##2397##1##(1990-10#2)(1990-11#4)(1990-12#5)(1990-2#4)(1990-3#3)(1990-4#2)(1990-5#9)(1990-6#3)(1990-7#3)(1990-8#3)(1990-9#5)(1991-1#2)(1991-11#3)(1991-12#6)(1991-2#6)(1991-3#5)(1991-4#2)(1991-5#1)(1991-6#5)(1991-7#9)(1991-8#2)(1991-9#2)(1992-1#10)(1992-10#2)(1992-11#1)(1992-12#10)(1992-2#5)(1992-3#3)(1992-4#4)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#4)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#6)(1993-2#5)(1993-3#5)(1993-4#2)(1993-5#4)(1993-6#3)(1993-7#2)(1993-8#1)(1993-9#6)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#7)(1994-2#4)(1994-3#8)(1994-4#1)(1994-5#6)(1994-6#5)(1994-8#6)(1994-9#7)(1995-1#6)(1995-10#1)(1995-11#5)(1995-12#9)(1995-2#4)(1995-3#3)(1995-4#2)(1995-5#6)(1995-6#8)(1995-7#3)(1995-8#6)(1995-9#5)(1996-1#3)(1996-10#2)(1996-11#3)(1996-12#6)(1996-2#16)(1996-3#2)(1996-4#2)(1996-5#2)(1996-6#2)(1996-7#5)(1996-9#4)(1997-1#3)(1997-2#8)(1997-3#2)(1997-4#4)(1997-5#2)(1997-6#4)(1997-7#6)(1997-8#2)(2004-1#1)(2004-10#3)(2004-11#3)(2004-12#2)(2004-9#1)(2005-1#2)(2005-10#4)(2005-11#9)(2005-12#1)(2005-2#3)(2005-5#4)(2005-7#1)(2005-8#14)(2005-9#1)(2006-1#1)(2006-10#43)(2006-11#5)(2006-12#6)(2006-2#1)(2006-4#16)(2006-5#2)(2006-6#5)(2006-7#9)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#14)(2007-11#20)(2007-12#21)(2007-2#8)(2007-3#7)(2007-4#2)(2007-5#3)(2007-6#2)(2007-7#19)(2007-8#34)(2007-9#17)(2008-1#93)(2008-10#89)(2008-11#23)(2008-12#3)(2008-2#106)(2008-3#43)(2008-4#757)(2008-5#17)(2008-7#27)(2008-8#18)(2008-9#312)(2009-10#1)(2009-11#4)(2009-2#1)(2009-3#7)(2009-4#4)(2009-5#4)(2009-6#5)(2009-7#2)(2009-8#5)(2009-9#7)(2010-1#2)(2010-10#8)(2010-11#12)(2010-12#10)(2010-2#10)(2010-3#6)(2010-4#2)(2010-5#2)(2010-7#4)(2010-8#6)(2010-9#5)(2011-1#15)(2011-12#6)(2011-2#30)(2011-3#1)(2011-7#1)(2012-11#6)(2012-12#12)(2012-2#31)(2012-3#16)(2013-1#25)(2013-7#3)(2013-8#14)
unit&quot##2##1##(1994-3#1)(1996-7#1)
unit's##3##1##(1992-2#1)(2006-10#1)(2008-10#1)
unit) for water in##2##4##(2008-10#2)
unit)##16##1##(1991-8#1)(1994-3#1)(1995-9#1)(2004-12#1)(2006-4#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
unit-cell##2##1##(1991-12#1)(2006-4#1)
unit-dose##2##1##(2006-11#1)(2008-9#1)
unit-specific##3##1##(2008-8#1)(2011-1#1)(2013-1#1)
unit-weight##2##1##(1992-2#2)
unit/ml##2##1##(1992-8#1)(1993-8#1)
unit?##3##1##(1996-12#1)(2006-4#2)
unit]##14##1##(1990-6#1)(1991-3#1)(1993-5#1)(1995-9#1)(1996-4#1)(2009-1#1)(2009-6#1)(2009-9#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
unitary conductance##4##2##(1994-11#1)(1994-5#2)(1995-6#1)
unitary currents##2##2##(1994-3#2)
unitary##23##1##(1990-2#1)(1992-1#1)(1992-11#1)(1992-8#1)(1994-11#1)(1994-3#2)(1994-5#2)(1995-6#1)(1997-7#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-4#2)
unite!##3##1##(2007-10#1)(2009-12#2)
unite##12##1##(1992-5#1)(1994-1#1)(1995-1#1)(1996-7#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-12#1)(2012-2#1)
united after##2##2##(2008-4#1)(2009-4#1)
united at##2##2##(2007-8#1)(2010-12#1)
united in their##2##3##(1990-10#1)(2009-4#1)
united in##3##2##(1990-10#1)(2009-4#1)(2011-2#1)
united the##2##2##(1996-3#1)(2008-11#1)
united##29##1##(1990-10#1)(1990-4#2)(1996-3#1)(2005-4#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-4#2)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
united-residue##2##1##(2008-9#1)(2010-2#1)
unites##6##1##(1991-4#1)(1992-12#1)(2006-12#1)(2008-8#1)(2011-1#1)(2011-2#1)
units (CFU) of##4##3##(1996-12#1)(2006-8#2)(2013-7#1)
units (CFU)##7##2##(1992-7#1)(1996-12#1)(2006-8#2)(2008-10#1)(2008-5#1)(2013-7#1)
units (CFU-GM)##2##2##(1991-10#1)(1995-1#1)
units (MUs)##2##2##(1993-9#1)(2009-10#1)
units (PFU) per##2##3##(1997-3#1)(2007-11#1)
units (PFU)##4##2##(1997-3#1)(2007-11#1)(2010-5#1)(2012-2#1)
units (i##2##2##(2007-12#1)(2008-4#1)
units (the##2##2##(2008-10#2)
units 5##2##2##(1994-11#1)(2012-12#1)
units above##2##2##(1991-7#1)(1992-1#1)
units all##3##2##(1993-5#2)(1996-11#1)
units and a##7##3##(2005-11#1)(2006-12#2)(2007-1#1)(2007-7#1)(2009-9#1)(2012-11#1)
units and are##2##3##(1994-3#1)(2008-4#1)
units and have##2##3##(1994-5#1)(2012-2#1)
units and the##8##3##(1991-2#1)(1992-3#1)(2005-8#1)(2006-10#1)(2008-10#2)(2010-7#1)(2013-8#1)
units and were##2##3##(1992-1#1)(2008-4#1)
units and##60##2##(1991-2#1)(1992-1#2)(1992-12#1)(1992-3#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1996-12#1)(1996-5#1)(1997-7#3)(2005-11#2)(2005-8#2)(2006-10#4)(2006-12#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#3)(2008-5#1)(2008-8#1)(2009-9#1)(2010-11#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
units are not##2##3##(1992-11#1)(1995-12#1)
units are proposed##2##3##(2008-3#1)(2010-8#1)
units are##21##2##(1992-11#1)(1995-12#1)(1995-5#2)(1996-5#1)(1997-1#1)(1997-7#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#2)(2010-5#2)(2010-8#1)(2012-2#1)
units at 6 mo##2##4##(2007-8#2)
units at##12##2##(1997-8#1)(2007-8#4)(2008-10#1)(2008-7#1)(2010-8#1)(2011-1#1)(2012-11#1)(2012-12#2)
units belonging to##2##3##(1993-6#1)(2008-10#1)
units by##7##2##(1990-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)
units can be##2##3##(1992-9#1)(1995-6#1)
units can##5##2##(1992-9#1)(1995-6#1)(1996-12#1)(2008-8#1)(2009-11#1)
units could##2##2##(2005-5#1)(2008-5#1)
units during##2##2##(2007-12#1)(2013-1#1)
units every##3##2##(2008-7#2)(2012-12#1)
units exhibit##2##2##(2006-12#1)(2011-2#1)
units exhibited##2##2##(1996-2#1)(2011-1#1)
units for patients##2##3##(2007-7#1)(2013-1#1)
units for##10##2##(1993-6#1)(1994-1#1)(2004-11#1)(2006-4#1)(2007-7#1)(2008-3#2)(2008-9#1)(2013-1#2)
units from##9##2##(1991-6#1)(1992-3#1)(1992-9#1)(1995-3#1)(1996-2#1)(2006-10#1)(2007-11#1)(2008-4#1)(2013-1#1)
units had been##2##3##(1995-9#1)(2011-2#1)
units had##9##2##(1992-4#1)(1995-6#1)(1995-9#1)(2008-12#1)(2011-1#1)(2011-2#3)(2013-8#1)
units has been##2##3##(1996-2#1)(2009-5#1)
units has##3##2##(1996-2#1)(2006-10#1)(2009-5#1)
units have##4##2##(1995-6#1)(2009-12#1)(2010-5#1)(2011-1#1)
units higher than that##3##4##(1995-5#2)(2008-10#1)
units higher than##4##3##(1991-4#1)(1995-5#2)(2008-10#1)
units higher##5##2##(1991-4#1)(1995-5#2)(2008-10#2)
units in Denmark##2##3##(1992-8#2)
units in a##4##3##(2005-10#1)(2008-10#1)(2011-1#1)(2012-11#1)
units in addition to##2##4##(1994-5#1)(1997-7#1)
units in the case of##3##5##(2008-10#3)
units in the city##2##4##(2004-10#1)(2011-2#1)
units in the##28##3##(1990-6#1)(1991-2#1)(1991-4#1)(1995-3#1)(1995-6#1)(1996-2#2)(1997-6#1)(2004-10#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-12#3)(2008-10#3)(2008-5#1)(2008-8#1)(2009-10#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
units in their##2##3##(2005-12#1)(2008-10#1)
units in this chapter##2##4##(2008-9#2)
units in which##2##3##(1991-7#1)(2008-7#1)
units in##86##2##(1990-6#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#2)(1993-4#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-5#1)(1995-1#1)(1995-3#2)(1995-6#2)(1996-2#3)(1996-5#1)(1997-6#1)(1997-7#1)(2004-10#1)(2005-10#1)(2005-12#1)(2005-5#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-12#5)(2007-2#1)(2008-1#2)(2008-10#7)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#4)(2008-9#4)(2009-10#2)(2009-2#1)(2009-5#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#7)(2012-11#1)(2012-2#1)(2013-1#3)
units increases##2##2##(1995-9#1)(2010-5#1)
units is required to##2##4##(1990-7#1)(2010-8#1)
units is##11##2##(1990-7#1)(1995-8#1)(1996-2#1)(1996-9#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-7#2)(2009-10#1)(2010-8#1)
units longer than##2##3##(1990-7#1)(1993-4#1)
units may##4##2##(1996-1#1)(2006-12#1)(2011-1#1)(2013-8#1)
units ml-1)##2##2##(1992-1#1)(2008-11#1)
units must##2##2##(1994-2#1)(2007-12#1)
units need to##2##3##(1994-6#1)(2011-1#1)
units observed in##3##3##(2008-10#2)(2012-11#1)
units of a##3##3##(1993-12#1)(1993-2#1)(2013-8#1)
units of analysis##2##3##(2009-4#1)(2012-3#1)
units of blood##4##3##(1996-11#1)(2007-7#1)(2008-12#1)(2013-1#1)
units of brown snake antivenom to neutralise the defibrination coagulopathy##2##10##(2006-4#2)
units of each##2##3##(2012-2#1)(2013-8#1)
units of fresh frozen plasma##2##5##(1990-2#1)(1994-9#1)
units of red blood cells (RBCs)##2##6##(1994-12#1)(1994-9#1)
units of the rat##2##4##(1991-11#1)(2013-8#1)
units of the##17##3##(1990-11#1)(1990-3#1)(1990-7#1)(1991-11#1)(1991-4#1)(1992-10#1)(1992-9#1)(1996-8#1)(2005-7#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#1)(2010-3#1)(2013-1#1)(2013-8#1)
units of this##2##3##(1992-12#1)(2008-4#1)
units of time(-1))##2##3##(2008-10#2)
units of##108##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-4#1)(1992-10#1)(1992-12#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-9#7)(1995-11#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#1)(2005-7#1)(2006-12#2)(2006-4#2)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-9#2)(2009-3#1)(2009-4#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#3)
units offer##2##2##(2007-11#1)(2008-2#1)
units on the##2##3##(2006-10#1)(2008-12#1)
units on##11##2##(1996-2#2)(1996-7#1)(2006-10#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-9#1)(2010-5#1)(2011-2#1)
units or##4##2##(2008-10#1)(2009-2#1)(2011-1#1)(2012-1#1)
units per episode##2##3##(2005-12#2)
units per mg##2##3##(1991-12#1)(1992-12#1)
units per ml##2##3##(1990-12#1)(2006-1#1)
units per##19##2##(1990-12#1)(1991-12#1)(1992-12#1)(1992-3#1)(1994-3#1)(1994-9#1)(1996-3#1)(2005-12#2)(2006-1#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2011-12#1)(2011-2#1)
units produced##2##2##(2007-1#1)(2008-2#1)
units recorded from the##2##4##(1995-11#2)
units responded to##2##3##(1996-1#1)(1997-3#1)
units responded##3##2##(1993-2#1)(1996-1#1)(1997-3#1)
units such as##2##3##(2008-11#1)(2008-12#1)
units such##3##2##(1995-4#1)(2008-11#1)(2008-12#1)
units tested##4##2##(1991-6#1)(1992-3#1)(1994-2#1)(2013-1#1)
units than the##2##3##(1993-3#1)(2013-1#1)
units than##3##2##(1993-3#1)(2008-2#1)(2013-1#1)
units that are##3##3##(1994-3#1)(2007-12#1)(2008-7#1)
units that##10##2##(1994-3#1)(1994-9#1)(1996-2#1)(2006-5#1)(2007-12#2)(2008-1#1)(2008-7#1)(2008-8#1)(2009-8#1)
units there##3##2##(2008-10#2)(2010-5#1)
units to form##2##3##(2008-2#1)(2008-7#1)
units to the##2##3##(1990-8#1)(2008-10#1)
units to##12##2##(1990-8#1)(1992-1#1)(1995-11#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-2#1)(2011-2#2)(2013-7#1)
units transfused##2##2##(1992-6#1)(2005-12#1)
units using##4##2##(2008-10#1)(2011-2#1)(2013-1#2)
units was recorded in##3##4##(1990-7#1)(1992-1#1)(1993-2#1)
units was##16##2##(1990-7#1)(1991-6#2)(1992-1#1)(1993-2#1)(1994-9#1)(1995-9#1)(1997-3#1)(2005-12#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
units weekly##2##2##(1992-6#1)(2008-7#1)
units were activated by##2##4##(2008-4#2)
units were caring for a total of##2##7##(2011-2#2)
units were caring for##3##4##(2011-2#3)
units were##32##2##(1991-6#1)(1992-6#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-4#1)(1997-1#1)(1997-3#1)(2004-11#1)(2006-10#1)(2006-8#1)(2007-4#1)(2008-10#3)(2008-12#1)(2008-4#2)(2009-9#1)(2011-2#7)(2012-12#1)(2013-8#1)
units when##2##2##(1995-3#1)(2011-1#1)
units which##3##2##(1993-6#1)(1994-9#1)(2007-12#1)
units while##2##2##(2007-6#1)(2012-2#1)
units whose##2##2##(1992-7#1)(2013-8#1)
units with 25 patients or more##2##6##(2011-2#2)
units with a##4##3##(1991-4#1)(2007-8#1)(2012-11#1)(2013-1#1)
units with different##2##3##(1993-12#1)(2013-1#1)
units with fewer than 25 patients##2##6##(2011-2#2)
units with##29##2##(1990-11#1)(1991-4#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-11#1)(1996-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2009-10#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-2#2)(2013-1#4)
units within the ODN-chains##3##4##(2008-10#3)
units within the##7##3##(1992-4#1)(1994-12#1)(2008-10#4)(2010-10#1)
units##1045##1##(1990-1#2)(1990-10#1)(1990-11#4)(1990-12#5)(1990-2#2)(1990-3#3)(1990-6#2)(1990-7#9)(1990-8#2)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#6)(1991-3#2)(1991-4#4)(1991-5#1)(1991-6#6)(1991-7#3)(1991-8#3)(1992-1#9)(1992-10#2)(1992-11#2)(1992-12#7)(1992-2#2)(1992-3#6)(1992-4#5)(1992-6#4)(1992-7#4)(1992-8#4)(1992-9#4)(1993-1#4)(1993-12#8)(1993-2#5)(1993-3#2)(1993-4#2)(1993-5#2)(1993-6#4)(1993-8#2)(1993-9#6)(1994-1#1)(1994-11#5)(1994-12#9)(1994-2#2)(1994-3#11)(1994-5#7)(1994-6#2)(1994-8#5)(1994-9#15)(1995-1#5)(1995-11#9)(1995-12#7)(1995-3#10)(1995-4#4)(1995-5#5)(1995-6#14)(1995-8#1)(1995-9#5)(1996-1#3)(1996-11#3)(1996-12#4)(1996-2#16)(1996-3#3)(1996-4#1)(1996-5#7)(1996-6#4)(1996-7#3)(1996-8#2)(1996-9#5)(1997-1#4)(1997-2#3)(1997-3#9)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#10)(1997-8#1)(2004-10#2)(2004-11#6)(2004-12#1)(2004-2#1)(2005-10#2)(2005-11#6)(2005-12#5)(2005-5#4)(2005-7#1)(2005-8#9)(2005-9#2)(2006-1#1)(2006-10#15)(2006-12#10)(2006-4#8)(2006-5#5)(2006-8#4)(2006-9#3)(2007-1#3)(2007-10#4)(2007-11#26)(2007-12#24)(2007-2#3)(2007-3#4)(2007-4#2)(2007-5#2)(2007-6#3)(2007-7#15)(2007-8#13)(2007-9#2)(2008-1#17)(2008-10#96)(2008-11#18)(2008-12#15)(2008-2#14)(2008-3#17)(2008-4#22)(2008-5#23)(2008-6#2)(2008-7#19)(2008-8#12)(2008-9#12)(2009-10#7)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#7)(2009-8#1)(2009-9#3)(2010-10#3)(2010-11#5)(2010-12#3)(2010-2#8)(2010-3#4)(2010-4#4)(2010-5#10)(2010-6#1)(2010-7#4)(2010-8#6)(2010-9#1)(2011-1#16)(2011-12#1)(2011-2#48)(2012-1#1)(2012-11#11)(2012-12#12)(2012-2#14)(2012-3#7)(2013-1#38)(2013-7#5)(2013-8#14)
units&quot##2##1##(2008-8#1)(2011-2#1)
units'##2##1##(2008-11#1)(2011-2#1)
units) and##2##2##(2010-10#1)(2011-2#1)
units) inhibited##2##2##(1992-11#1)(2008-10#1)
units) was##3##2##(1994-12#1)(2005-11#1)(2007-11#1)
units)##28##1##(1991-6#1)(1992-11#1)(1992-12#2)(1994-12#1)(1994-8#1)(1995-3#1)(1997-3#1)(2005-11#1)(2007-11#2)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2010-10#1)(2011-2#3)(2013-1#1)
units/kg##4##1##(1992-11#1)(2007-7#1)(2007-9#1)(2009-10#1)
units/kg/week##2##1##(2007-7#2)
units/l##2##1##(1995-7#2)
units/mg##9##1##(1990-1#2)(1990-2#1)(1991-8#1)(1992-3#2)(1994-8#1)(1995-3#1)(1996-2#1)
units/mg)##2##1##(1993-11#2)
units/ml concentration##2##2##(1994-11#2)
units/ml##11##1##(1990-12#1)(1992-5#1)(1992-8#1)(1994-11#2)(1995-4#1)(2008-10#3)(2008-5#1)(2009-10#1)
units/ml)##8##1##(1991-12#2)(1993-11#1)(1995-4#2)(1995-7#1)(2006-5#2)
units?##3##1##(2006-10#1)(2007-7#1)(2013-8#1)
units]##6##1##(1993-8#1)(1994-6#1)(1996-9#1)(1997-7#1)(2011-1#1)(2011-2#1)
unity among##2##2##(1990-11#1)(1990-6#1)
unity and##3##2##(1995-3#1)(1997-8#1)(2013-8#1)
unity for##6##2##(1990-10#2)(1991-5#2)(1996-11#1)(2008-3#1)
unity in##3##2##(2008-12#1)(2008-3#1)(2008-4#1)
unity of##5##2##(1994-3#1)(2008-4#1)(2010-4#1)(2010-8#1)(2013-1#1)
unity##62##1##(1990-10#3)(1990-11#1)(1990-6#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-5#2)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-5#2)(1994-8#2)(1995-1#1)(1995-10#1)(1995-3#1)(1996-11#1)(1996-12#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-5#1)(2007-12#3)(2008-12#1)(2008-2#4)(2008-3#13)(2008-4#2)(2010-1#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
univalent metal##4##2##(2008-10#4)
univalent##12##1##(1990-3#1)(1997-4#1)(2008-10#6)(2009-12#1)(2012-3#1)(2013-7#2)
univalents##4##1##(2013-7#4)
univariate analyses##8##2##(1990-6#1)(1994-12#1)(1997-4#1)(2007-10#1)(2008-5#1)(2008-6#1)(2011-2#1)(2013-8#1)
univariate analysis and##3##3##(2008-6#1)(2012-12#1)(2012-2#1)
univariate analysis##28##2##(1990-8#1)(1991-10#1)(1991-2#1)(1992-6#1)(1994-7#1)(1995-4#1)(1997-2#1)(2004-2#1)(2006-10#1)(2006-6#2)(2007-10#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-6#3)(2009-2#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
univariate and bivariate analysis##2##4##(2008-5#1)(2013-1#1)
univariate and multivariate analyses##8##4##(1995-10#1)(2008-6#2)(2008-7#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-8#1)
univariate and multivariate logistic regression##2##5##(2011-2#1)(2013-1#1)
univariate and multivariate##15##3##(1992-6#1)(1995-10#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-6#2)(2008-7#1)(2009-10#1)(2010-3#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
univariate and##18##2##(1992-6#1)(1995-10#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-10#1)(2010-3#1)(2010-8#1)(2011-2#2)(2013-1#2)(2013-8#1)
univariate calibration##7##2##(2008-10#7)
univariate method##5##2##(2008-10#5)
univariate##95##1##(1990-6#1)(1990-8#1)(1991-10#1)(1991-2#1)(1992-1#1)(1992-6#3)(1993-12#1)(1994-11#1)(1994-12#1)(1994-7#1)(1995-10#1)(1995-4#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(2004-2#1)(2006-10#1)(2006-6#2)(2007-10#3)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#19)(2008-11#2)(2008-5#2)(2008-6#6)(2008-7#1)(2009-10#2)(2009-2#3)(2009-4#2)(2009-8#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
univariately##4##1##(1997-3#1)(2007-10#2)(2012-1#1)
univentricular heart##4##2##(1996-12#1)(2007-8#1)(2009-4#1)(2012-3#1)
univentricular##6##1##(1996-12#2)(2007-8#2)(2009-4#1)(2012-3#1)
universal acceptance##2##2##(2006-5#1)(2010-12#1)
universal access to health##2##4##(1996-1#1)(2008-6#1)
universal access to##7##3##(1996-1#1)(2008-6#1)(2008-9#1)(2009-7#2)(2010-8#1)(2012-12#1)
universal access##12##2##(1990-12#1)(1994-2#1)(1996-1#1)(2008-6#1)(2008-9#1)(2009-5#1)(2009-7#2)(2010-2#2)(2010-8#1)(2012-12#1)
universal and##10##2##(2007-11#1)(2007-9#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
universal antenatal home visit##2##4##(2013-1#2)
universal approach##2##2##(1994-12#1)(2012-12#1)
universal coverage##8##2##(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-1#1)(1997-6#1)(2010-12#1)(2012-12#1)
universal detection##3##2##(2008-10#2)(2011-2#1)
universal guidelines for precautions##2##4##(2010-3#2)
universal guidelines##3##2##(2010-11#1)(2010-3#2)
universal health care##4##3##(1994-2#1)(1995-1#1)(2006-2#1)(2007-12#1)
universal health insurance##5##3##(1991-2#4)(2012-1#1)
universal health##10##2##(1991-2#4)(1994-2#1)(1995-1#1)(1996-2#1)(2006-2#1)(2007-12#1)(2012-1#1)
universal human##3##2##(1995-9#1)(2008-11#1)(2009-10#1)
universal in##8##2##(1992-5#1)(1997-2#1)(2007-6#1)(2007-8#1)(2012-12#2)(2012-2#1)(2013-1#1)
universal infection control precautions##2##4##(2007-7#2)
universal insurance coverage##2##3##(1994-1#1)(1995-12#1)
universal liposomal nanovesicles for immunoassays##2##5##(2008-10#2)
universal method##2##2##(2009-11#1)(2010-12#1)
universal personal##2##2##(2008-1#2)
universal precautions and##2##3##(2007-12#1)(2010-12#1)
universal precautions are##2##3##(2010-3#1)(2012-2#1)
universal precautions##17##2##(1991-12#2)(1996-1#1)(1996-11#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-7#1)(2010-12#1)(2010-3#4)(2012-2#2)
universal primer##4##2##(2006-5#1)(2008-10#3)
universal primers##4##2##(1996-8#1)(2008-10#2)(2008-8#1)
universal protein G-liposomal nanovesicles##3##4##(2008-10#3)
universal quasi-chemical##2##2##(2008-5#2)
universal reagent for##3##3##(2008-10#3)
universal reagents for##2##3##(2008-10#2)
universal roles##2##2##(2007-12#2)
universal salt##2##2##(2007-2#1)(2013-1#1)
universal scaling##3##2##(2005-11#1)(2012-11#1)(2012-2#1)
universal screening##5##2##(1993-9#1)(2009-3#1)(2012-2#1)(2013-1#1)(2013-7#1)
universal sequencing##2##2##(1990-11#1)(1991-7#1)
universal tendencies##2##2##(2012-12#2)
universal testing machine##8##3##(2008-11#1)(2008-12#2)(2009-7#1)(2009-8#1)(2010-12#1)(2013-1#1)(2013-8#1)
universal tetrapyrrole##3##2##(1995-3#3)
universal treatment##2##2##(2006-10#1)(2011-1#1)
universal use of##2##3##(2008-8#1)(2011-1#1)
universal vaccination##3##2##(2006-2#1)(2007-12#1)(2009-11#1)
universal##337##1##(1990-11#1)(1990-12#4)(1990-4#1)(1991-12#3)(1991-2#5)(1991-5#1)(1991-6#2)(1991-7#3)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-9#1)(1994-1#1)(1994-12#4)(1994-2#3)(1994-3#1)(1995-1#3)(1995-12#2)(1995-2#1)(1995-3#4)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#2)(2005-11#5)(2005-12#1)(2005-4#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#5)(2006-11#4)(2006-2#3)(2006-3#1)(2006-5#5)(2006-6#1)(2006-8#1)(2006-9#2)(2007-1#2)(2007-11#5)(2007-12#11)(2007-2#1)(2007-3#1)(2007-5#2)(2007-6#2)(2007-7#7)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#29)(2008-11#9)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#9)(2008-9#7)(2009-10#4)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#4)(2009-8#1)(2010-11#1)(2010-12#9)(2010-2#5)(2010-3#6)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#4)(2011-1#5)(2011-12#1)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#10)(2012-2#15)(2012-3#3)(2013-1#15)(2013-7#1)(2013-8#5)
universal&quot##2##1##(1995-1#1)(2009-3#1)
universalis##2##1##(2007-8#1)(2011-2#1)
universalist##4##1##(2008-12#2)(2011-2#2)
universality in##2##2##(2010-5#1)(2013-7#1)
universality of the##2##3##(1992-12#1)(2008-4#1)
universality##7##1##(1992-1#1)(1992-12#1)(2008-4#2)(2010-5#1)(2012-2#1)(2013-7#1)
universally accepted##6##2##(2006-12#1)(2007-4#1)(2008-1#1)(2008-3#1)(2008-9#1)(2012-2#1)
universally accessible##2##2##(2008-11#1)(2010-2#1)
universally applicable##5##2##(2006-10#1)(2008-1#1)(2008-4#1)(2008-8#1)(2009-6#1)
universally available##4##2##(1991-11#1)(1994-9#1)(2006-2#1)(2011-2#1)
universally conserved##3##2##(1995-8#1)(2007-12#1)(2012-1#1)
universally effective##2##2##(2006-12#1)(2008-12#1)
universally in##3##2##(1992-10#1)(2012-12#2)
universally reported##2##2##(2006-7#1)(2008-11#1)
universally susceptible to##2##3##(2008-5#1)(2012-2#1)
universally transfusable##2##2##(1996-3#2)
universally##65##1##(1990-7#1)(1991-11#1)(1992-10#1)(1992-2#1)(1994-5#1)(1994-9#1)(1995-8#1)(1996-1#1)(1996-3#2)(2005-8#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-6#2)(2009-9#1)(2010-2#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-8#1)
universals##2##1##(2008-12#1)(2008-2#1)
universe and##2##2##(1995-6#1)(2008-12#1)
universe of##3##2##(1994-2#1)(2008-5#1)(2008-7#1)
universe##27##1##(1991-12#1)(1992-3#1)(1994-2#1)(1994-3#1)(1995-6#1)(1996-12#1)(2007-8#4)(2007-9#1)(2008-12#4)(2008-4#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#3)
universities and the##2##3##(2005-5#1)(2009-4#1)
universities and##14##2##(1997-5#1)(2005-12#1)(2005-5#1)(2006-12#1)(2007-9#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#2)(2013-1#1)
universities in##2##2##(1990-12#1)(2005-8#1)
universities to##4##2##(2006-4#1)(2007-9#1)(2009-4#1)(2011-2#1)
universities were##2##2##(1997-5#1)(2008-11#1)
universities##73##1##(1990-12#2)(1991-6#1)(1992-3#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-1#1)(1995-5#1)(1996-2#1)(1997-3#1)(1997-5#3)(1997-6#1)(2005-12#1)(2005-3#1)(2005-5#1)(2005-8#3)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-12#1)(2007-8#4)(2007-9#6)(2008-1#2)(2008-10#3)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-4#7)(2011-2#3)(2013-1#5)(2013-8#1)
university affiliation##2##2##(1997-3#1)(2007-6#1)
university and##13##2##(1994-3#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-10#1)(2006-8#1)(2007-2#1)(2008-11#1)(2008-12#2)(2010-10#1)(2011-1#1)(2013-1#1)
university authorities##4##2##(2008-10#3)(2010-3#1)
university campus##4##2##(1996-12#1)(2006-5#1)(2013-1#2)
university center##3##2##(2007-8#1)(2011-2#1)(2013-8#1)
university clinic##2##2##(1992-9#1)(2013-1#1)
university degree##5##2##(1993-5#1)(2006-2#1)(2006-7#1)(2010-3#1)(2011-2#1)
university department##3##2##(1990-9#1)(2005-11#1)(2008-11#1)
university departments##3##2##(1990-10#2)(2008-7#1)
university education##7##2##(1994-12#2)(1994-4#1)(2008-1#1)(2009-7#1)(2012-2#1)(2012-3#1)
university funding##2##2##(1997-8#1)(2012-2#1)
university health center##2##3##(2011-2#2)
university health##5##2##(2007-3#1)(2007-4#1)(2010-5#1)(2011-2#2)
university hospital and##3##3##(1994-4#1)(2011-2#2)
university hospital in Brazil##2##4##(2007-9#1)(2011-2#1)
university hospital in the##2##4##(1993-1#1)(2012-11#1)
university hospital in##14##3##(1990-12#1)(1993-1#1)(2007-2#1)(2007-3#2)(2007-7#1)(2007-9#1)(2011-2#4)(2012-11#1)(2013-1#2)
university hospital of##2##3##(1992-5#1)(2012-2#1)
university hospital who##3##3##(2006-10#1)(2011-2#1)(2012-1#1)
university hospital##50##2##(1990-12#1)(1991-2#1)(1992-5#1)(1993-1#1)(1993-10#1)(1994-4#1)(1995-1#1)(1996-12#1)(2006-10#1)(2007-2#2)(2007-3#2)(2007-7#2)(2007-9#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-1#1)(2009-10#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-11#1)(2011-2#9)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
university hospitals in##3##3##(1990-12#1)(2006-8#2)
university hospitals##17##2##(1990-12#6)(1990-6#1)(1991-2#1)(1992-9#1)(1993-6#1)(1995-9#1)(1997-8#1)(2005-11#1)(2006-8#2)(2007-7#1)(2012-2#1)
university in the##2##3##(2007-12#1)(2008-11#1)
university in##9##2##(1991-11#1)(1997-3#1)(2007-12#1)(2008-11#1)(2008-12#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-3#1)
university is##2##2##(2008-11#1)(2008-4#1)
university medical centres##2##3##(1990-6#1)(2011-2#1)
university medical##3##2##(1990-6#1)(2005-10#1)(2011-2#1)
university of medical sciences##3##4##(2008-12#1)(2011-2#2)
university of##11##2##(2006-2#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-7#1)(2011-2#2)(2012-12#1)(2013-1#2)
university or##2##2##(2009-2#1)(2011-2#1)
university professors##2##2##(1995-2#1)(2007-9#1)
university programs##3##2##(1994-1#1)(1995-1#1)(1996-3#1)
university research##2##2##(1991-3#1)(1997-1#1)
university researchers##3##2##(1996-8#1)(2008-2#1)(2011-2#1)
university setting##2##2##(1993-2#1)(2006-10#1)
university sites##2##2##(2008-11#1)(2009-4#1)
university staff##3##2##(2007-10#1)(2008-12#2)
university students at##2##3##(2012-12#2)
university students from##2##3##(2010-12#1)(2011-2#1)
university students in##5##3##(2007-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
university students##30##2##(1995-11#1)(2006-7#1)(2007-1#1)(2007-12#2)(2007-3#2)(2007-6#1)(2007-9#2)(2008-1#1)(2008-4#1)(2009-4#1)(2009-7#1)(2010-12#3)(2010-3#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#1)
university students'##3##2##(2006-7#1)(2011-2#2)
university teaching hospital in##4##4##(2007-10#1)(2008-7#1)(2012-1#1)(2013-1#1)
university teaching hospital##9##3##(2005-7#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-7#1)(2012-1#1)(2013-1#1)
university teaching##16##2##(1990-12#1)(1990-3#1)(2005-7#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-11#1)(2008-12#1)(2008-7#2)(2011-2#2)(2012-1#1)(2013-1#1)
university to##3##2##(1992-1#1)(2007-12#1)(2007-8#1)
university training##2##2##(1992-3#1)(2008-11#1)
university undergraduate##3##2##(2008-6#1)(2012-2#1)(2013-7#1)
university##325##1##(1990-10#2)(1990-12#10)(1990-3#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-11#1)(1991-2#3)(1991-3#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-9#3)(1993-1#1)(1993-10#1)(1993-2#1)(1993-5#2)(1993-6#1)(1993-9#1)(1994-1#1)(1994-12#3)(1994-3#1)(1994-4#2)(1995-1#4)(1995-11#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-12#2)(1996-3#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-8#2)(2005-10#1)(2005-11#2)(2005-7#2)(2005-9#1)(2006-10#2)(2006-12#1)(2006-2#3)(2006-5#2)(2006-6#1)(2006-7#6)(2006-8#5)(2007-1#1)(2007-10#2)(2007-12#6)(2007-2#5)(2007-3#7)(2007-4#1)(2007-6#4)(2007-7#3)(2007-8#8)(2007-9#6)(2008-1#7)(2008-10#6)(2008-11#20)(2008-12#12)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#1)(2009-1#1)(2009-10#1)(2009-2#2)(2009-4#13)(2009-7#2)(2010-1#2)(2010-10#2)(2010-12#7)(2010-2#1)(2010-3#5)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#4)(2011-11#2)(2011-2#38)(2012-1#6)(2012-11#1)(2012-12#8)(2012-2#10)(2012-3#7)(2013-1#10)(2013-7#1)(2013-8#5)
university'##2##1##(2006-6#1)(2008-12#1)
university-affiliated##5##1##(1994-12#1)(2007-8#1)(2009-4#1)(2011-1#1)(2011-2#1)
univocal##3##1##(1990-6#1)(2008-2#1)(2012-12#1)
unjust##4##1##(1994-1#1)(2008-7#1)(2011-2#1)(2012-12#1)
unjustifiable##2##1##(1991-10#1)(2008-11#1)
unjustified##8##1##(1996-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-4#1)(2009-2#1)(2013-1#1)
unkind##2##1##(2008-4#1)(2011-2#1)
unknowingly##3##1##(1995-5#1)(2008-10#1)(2008-7#1)
unknown a##3##2##(2008-3#1)(2013-1#2)
unknown active##2##2##(1997-2#1)(2012-3#1)
unknown aetiology##4##2##(1994-4#1)(1996-3#1)(2007-2#1)(2010-3#1)
unknown after##2##2##(1990-4#1)(2012-2#1)
unknown analytical##2##2##(2008-10#2)
unknown and the##2##3##(2008-1#1)(2010-6#1)
unknown and there is no##2##5##(2008-5#1)(2011-2#1)
unknown and##21##2##(1990-4#1)(1994-9#1)(1995-12#1)(1995-9#1)(1996-8#1)(1997-7#1)(2004-9#1)(2006-8#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-5#2)(2010-6#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
unknown arsenic species##2##3##(2008-10#2)
unknown aspects of##2##3##(1994-2#1)(2008-7#1)
unknown at present##2##3##(1992-9#1)(2010-4#1)
unknown at##3##2##(1992-9#1)(2008-11#1)(2010-4#1)
unknown background##2##2##(2008-10#1)(2011-1#1)
unknown but may##2##3##(1990-5#1)(2008-3#1)
unknown but##13##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1993-11#1)(1996-3#1)(1996-6#1)(2005-11#1)(2008-12#1)(2008-3#1)(2009-11#1)(2012-3#1)(2013-8#1)
unknown cause##17##2##(1990-6#1)(1990-8#1)(1992-8#1)(1994-9#1)(1995-2#1)(2004-11#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-7#2)(2010-12#1)(2012-12#1)(2012-2#1)
unknown causes##3##2##(1990-6#1)(1995-12#1)(2007-4#1)
unknown chemical##3##2##(2006-12#1)(2008-11#1)(2008-5#1)
unknown class##4##2##(2009-10#1)(2012-3#1)(2013-1#2)
unknown compound##6##2##(1990-8#1)(1996-6#2)(2005-4#1)(2008-10#1)(2010-5#1)
unknown compounds were##2##3##(2008-10#2)
unknown compounds##5##2##(1991-12#1)(2006-12#1)(2008-10#2)(2010-11#1)
unknown concentration##2##2##(2008-10#2)
unknown etiology and##3##3##(2006-10#1)(2010-4#1)(2011-1#1)
unknown etiology that affects##2##4##(2008-10#1)(2008-5#1)
unknown etiology that##5##3##(2005-8#1)(2006-10#1)(2008-10#1)(2008-5#1)(2010-11#1)
unknown etiology which##2##3##(1991-2#1)(2007-2#1)
unknown etiology##48##2##(1991-2#1)(1992-8#1)(1993-7#1)(1994-2#1)(1995-6#1)(1997-8#1)(2005-12#1)(2005-8#2)(2006-10#4)(2006-2#1)(2007-2#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#5)(2008-3#1)(2008-5#1)(2009-7#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-4#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
unknown faces##3##2##(2008-1#1)(2009-4#2)
unknown factors##7##2##(1995-11#1)(1997-8#1)(2006-12#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-5#1)
unknown for##2##2##(2006-2#1)(2012-3#1)
unknown function and##3##3##(1990-9#1)(2008-7#1)(2009-9#1)
unknown function of##3##3##(1995-5#1)(1997-5#1)(2012-12#1)
unknown function that is##3##4##(1991-6#1)(1994-3#1)(2010-10#1)
unknown function##47##2##(1990-5#1)(1990-7#3)(1990-9#1)(1991-6#1)(1991-7#1)(1992-12#2)(1992-9#1)(1993-11#1)(1994-10#1)(1994-3#1)(1994-6#1)(1995-5#1)(1995-8#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#2)(2006-11#1)(2007-12#1)(2008-10#6)(2008-7#5)(2008-9#3)(2009-10#1)(2009-6#1)(2009-9#1)(2010-10#3)(2012-12#1)
unknown functions##6##2##(1991-7#1)(2008-1#1)(2008-4#1)(2009-2#1)(2010-2#1)(2012-2#1)
unknown ganglioside X##2##3##(1990-4#2)
unknown genes##6##2##(1993-6#1)(1996-4#1)(1997-6#1)(2008-9#1)(2012-11#1)(2012-3#1)
unknown how this##2##3##(2008-2#1)(2013-8#1)
unknown how##7##2##(1990-9#1)(2008-10#1)(2008-2#1)(2011-2#2)(2012-3#1)(2013-8#1)
unknown in##12##2##(1991-10#1)(1994-11#1)(1995-2#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-10#1)(2013-1#1)
unknown material##2##2##(2012-1#1)(2012-3#1)
unknown mechanism##5##2##(1994-6#1)(1995-8#1)(1997-4#1)(2007-7#1)(2010-10#1)
unknown mechanisms##5##2##(1990-11#2)(1990-7#1)(1993-9#1)(2008-7#1)
unknown molecular##2##2##(2010-12#1)(2011-1#1)
unknown number of##3##3##(1994-12#1)(2008-9#1)(2010-10#1)
unknown oligosaccharide##2##2##(2005-11#2)
unknown open reading frames##2##4##(1995-4#1)(1996-6#1)
unknown or##8##2##(1996-1#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2009-9#1)
unknown origin##42##2##(1990-2#1)(1991-10#1)(1991-5#1)(1995-9#1)(1996-11#1)(1996-4#1)(1996-6#1)(2006-10#11)(2006-11#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-11#1)(2009-4#1)(2009-5#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
unknown parameters for##2##3##(1995-2#1)(2008-2#1)
unknown parameters##9##2##(1991-12#1)(1995-2#1)(2008-10#2)(2008-2#3)(2008-3#1)(2009-11#1)
unknown pathogenesis##2##2##(1990-5#1)(2012-2#1)
unknown pathway##2##2##(1995-1#1)(2006-2#1)
unknown peaks##3##2##(2008-10#2)(2013-7#1)
unknown plasma##2##2##(2008-10#1)(2009-4#1)
unknown primary site##5##3##(1992-2#1)(1993-10#1)(2007-11#2)(2007-7#1)
unknown primary tumor##2##3##(1992-11#1)(1992-4#1)
unknown primary##12##2##(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-10#1)(2007-11#2)(2007-7#1)(2008-4#1)(2008-6#1)(2011-2#1)(2013-8#1)
unknown protein##5##2##(1992-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-4#1)
unknown proteins##4##2##(1996-6#1)(2008-10#2)(2008-11#1)
unknown reasons##6##2##(1990-5#1)(1991-5#1)(1996-5#1)(1997-1#1)(2006-5#1)(2007-10#1)
unknown refractive index##3##3##(2008-2#1)(2008-3#2)
unknown regulatory##2##2##(1995-6#1)(2009-9#1)
unknown risk##2##2##(1993-3#1)(1994-9#1)
unknown samples##5##2##(1992-8#1)(2007-11#1)(2008-10#2)(2008-2#1)
unknown skull##2##2##(1995-6#2)
unknown structural##3##2##(1994-8#1)(1996-2#1)(2008-7#1)
unknown structures##2##2##(1992-11#1)(2011-2#1)
unknown to most##2##3##(2007-12#1)(2007-5#1)
unknown to what extent these##2##5##(1992-12#1)(2008-3#1)
unknown to##6##2##(1992-12#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#1)(2009-8#1)
unknown until##2##2##(1995-2#1)(2012-2#1)
unknown viruses##2##2##(1994-6#1)(2008-10#1)
unknown what##2##2##(2012-12#1)(2012-3#1)
unknown whether or not##2##4##(2007-10#1)(2007-2#1)
unknown whether the##5##3##(1995-5#1)(2010-3#1)(2012-12#1)(2013-8#2)
unknown whether there is##2##4##(2008-11#1)(2009-11#1)
unknown whether##20##2##(1992-11#1)(1994-11#1)(1995-5#1)(1995-9#1)(1996-12#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-11#2)(2008-7#1)(2009-11#1)(2010-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#3)
unknown why##2##2##(2012-2#1)(2013-8#1)
unknown##1123##1##(1990-1#1)(1990-11#4)(1990-12#3)(1990-2#4)(1990-3#2)(1990-4#5)(1990-5#6)(1990-6#3)(1990-7#7)(1990-8#4)(1990-9#2)(1991-1#1)(1991-10#6)(1991-11#3)(1991-12#5)(1991-2#3)(1991-3#2)(1991-4#2)(1991-5#5)(1991-6#4)(1991-7#3)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#7)(1992-12#6)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#5)(1992-9#3)(1993-10#2)(1993-11#4)(1993-12#2)(1993-2#3)(1993-3#4)(1993-6#9)(1993-7#1)(1993-8#3)(1993-9#3)(1994-10#1)(1994-11#6)(1994-12#5)(1994-2#5)(1994-3#2)(1994-4#1)(1994-5#4)(1994-6#5)(1994-7#1)(1994-8#6)(1994-9#6)(1995-1#3)(1995-11#2)(1995-12#5)(1995-2#13)(1995-3#2)(1995-4#4)(1995-5#4)(1995-6#7)(1995-8#5)(1995-9#6)(1996-1#5)(1996-10#2)(1996-11#2)(1996-12#7)(1996-2#6)(1996-3#4)(1996-4#5)(1996-5#4)(1996-6#8)(1996-7#1)(1996-8#4)(1996-9#6)(1997-1#3)(1997-2#1)(1997-3#7)(1997-4#5)(1997-5#3)(1997-6#5)(1997-7#7)(1997-8#4)(2003-11#1)(2004-11#4)(2004-12#2)(2004-9#1)(2005-10#2)(2005-11#5)(2005-12#2)(2005-4#2)(2005-7#2)(2005-8#6)(2005-9#1)(2006-10#29)(2006-11#2)(2006-12#5)(2006-2#4)(2006-4#1)(2006-5#6)(2006-8#6)(2006-9#2)(2007-1#1)(2007-10#8)(2007-11#24)(2007-12#22)(2007-2#9)(2007-3#2)(2007-4#4)(2007-5#6)(2007-6#1)(2007-7#13)(2007-8#14)(2007-9#5)(2008-1#17)(2008-10#99)(2008-11#25)(2008-12#5)(2008-2#26)(2008-3#28)(2008-4#9)(2008-5#22)(2008-6#10)(2008-7#30)(2008-8#8)(2008-9#12)(2009-10#9)(2009-11#3)(2009-12#1)(2009-2#3)(2009-3#4)(2009-4#9)(2009-5#7)(2009-6#2)(2009-7#5)(2009-8#10)(2009-9#5)(2010-10#9)(2010-11#7)(2010-12#12)(2010-2#3)(2010-3#2)(2010-4#8)(2010-5#8)(2010-6#3)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#14)(2011-12#2)(2011-2#26)(2011-7#1)(2012-1#11)(2012-11#6)(2012-12#22)(2012-2#40)(2012-3#25)(2013-1#23)(2013-7#3)(2013-8#27)
unknown&quot##2##1##(2008-10#1)(2010-8#1)
unknown)##3##1##(2006-10#1)(2007-12#1)(2008-3#1)
unknowns about##2##2##(1993-11#1)(2012-3#1)
unknowns##15##1##(1993-11#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2009-6#1)(2010-11#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
unlabeled ET-1##5##2##(1990-3#2)(1992-6#1)(1995-11#2)
unlabeled IGF-II or IGF-I##2##4##(1992-3#2)
unlabeled and labeled##2##3##(1993-3#1)(2008-4#1)
unlabeled and##3##2##(1993-3#1)(2008-4#1)(2009-10#1)
unlabeled data##5##2##(2008-2#5)
unlabeled dendrites##2##2##(1995-11#1)(1995-6#1)
unlabeled membranes##2##2##(1992-1#2)
unlabeled patterns##3##2##(2008-2#3)
unlabeled peptides##2##2##(1992-6#1)(2008-4#1)
unlabeled protein##2##2##(1997-2#1)(2008-4#1)
unlabeled test peptides##2##3##(2008-4#2)
unlabeled##97##1##(1990-11#2)(1990-12#2)(1990-3#2)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-4#1)(1991-6#1)(1991-8#2)(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#4)(1992-6#3)(1992-9#1)(1993-1#2)(1993-11#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#5)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#5)(1996-2#1)(1996-5#3)(1996-7#2)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-11#1)(2006-3#1)(2006-7#2)(2008-10#1)(2008-2#10)(2008-4#9)(2008-7#1)(2008-9#1)(2009-10#1)(2012-2#2)
unlabelled cells##4##2##(1991-5#3)(2007-9#1)
unlabelled platelet glycoproteins##2##3##(1990-11#2)
unlabelled##32##1##(1990-11#2)(1990-12#1)(1990-8#2)(1991-10#1)(1991-4#2)(1991-5#3)(1991-6#1)(1992-9#1)(1994-2#1)(1994-8#1)(1995-10#2)(1995-12#1)(1996-11#5)(1996-3#1)(1997-1#2)(1997-8#3)(2007-9#1)(2008-11#1)(2012-12#1)
unladen##4##1##(2008-8#1)(2008-9#3)
unlawful##6##1##(1993-9#1)(1997-5#2)(2005-8#1)(2008-9#1)(2012-1#1)
unleashed##2##1##(2009-5#1)(2012-11#1)
unleashing##2##1##(1995-6#1)(2007-4#1)
unlesioned and##2##2##(1994-10#1)(2012-2#1)
unlesioned rats##2##2##(1996-9#1)(2012-2#1)
unlesioned side##3##2##(1994-10#2)(1994-2#1)
unlesioned##14##1##(1994-10#5)(1994-12#2)(1994-2#1)(1996-6#2)(1996-9#1)(1997-1#1)(2012-2#2)
unless a##10##2##(1991-3#1)(1991-5#1)(2006-10#2)(2006-7#1)(2007-2#1)(2007-9#1)(2008-7#1)(2008-9#1)(2009-11#1)
unless an##3##2##(1997-2#1)(2006-8#1)(2007-7#1)
unless high##2##2##(1992-8#1)(2010-9#1)
unless it is##7##3##(2006-4#1)(2006-8#1)(2008-2#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
unless it##9##2##(1994-7#1)(1996-6#1)(2006-4#1)(2006-8#1)(2008-2#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
unless one##3##2##(2006-8#1)(2008-3#1)(2008-4#1)
unless other##2##2##(1994-1#1)(2007-7#1)
unless the##31##2##(1993-4#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-9#1)(1997-5#2)(2004-11#1)(2005-11#1)(2005-5#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#1)(2008-10#4)(2008-3#4)(2008-5#1)(2008-7#1)(2009-2#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
unless their##2##2##(1996-9#1)(2008-10#1)
unless there are##2##3##(2008-11#1)(2010-5#1)
unless there is a medical##2##5##(2007-2#1)(2008-6#1)
unless there is a##7##4##(2005-12#1)(2007-2#2)(2008-6#1)(2012-2#1)(2013-1#2)
unless there is##9##3##(2005-12#1)(2007-2#2)(2008-6#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-1#2)
unless there##12##2##(2005-12#1)(2007-2#2)(2008-11#1)(2008-6#1)(2008-7#1)(2010-5#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-1#2)
unless they are##4##3##(1991-12#1)(1994-6#1)(1996-12#1)(2008-7#1)
unless they have##2##3##(2008-1#1)(2008-9#1)
unless they##9##2##(1991-12#1)(1993-6#1)(1994-6#1)(1996-12#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)
unless we assume##2##3##(2012-3#2)
unless we##4##2##(1996-3#1)(1996-4#1)(2012-3#2)
unless##152##1##(1990-11#3)(1990-12#1)(1990-4#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-7#2)(1992-10#1)(1992-5#1)(1992-8#2)(1993-1#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1994-1#1)(1994-10#1)(1994-3#1)(1994-6#2)(1994-7#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-4#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-5#2)(2004-11#2)(2005-11#1)(2005-12#1)(2005-5#1)(2005-7#1)(2006-10#3)(2006-4#1)(2006-7#1)(2006-8#4)(2006-9#2)(2007-10#1)(2007-11#4)(2007-2#3)(2007-3#2)(2007-4#1)(2007-7#3)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#8)(2008-4#4)(2008-5#1)(2008-6#4)(2008-7#4)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#4)
unlicensed##2##1##(2007-2#1)(2008-9#1)
unliganded and##2##2##(1990-8#1)(1996-11#1)
unliganded##13##1##(1990-7#1)(1990-8#2)(1990-9#1)(1991-2#2)(1992-8#1)(1994-8#1)(1995-5#3)(1996-11#2)
unligated##5##1##(1990-9#1)(1996-4#2)(1996-6#1)(1997-2#1)
unlike GF-1##2##2##(1997-1#2)
unlike a##2##2##(1991-1#1)(2010-1#1)
unlike any##2##2##(1991-3#1)(2010-6#1)
unlike for##4##2##(1997-5#1)(2007-11#1)(2013-1#2)
unlike in the##3##3##(1992-6#1)(1995-11#1)(2008-7#1)
unlike in##11##2##(1992-6#1)(1994-3#1)(1995-11#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-7#2)(2010-6#1)(2011-2#1)
unlike its##3##2##(1995-9#1)(1997-2#1)(2008-5#1)
unlike most##6##2##(2006-10#1)(2006-11#1)(2008-10#1)(2008-4#1)(2009-7#1)(2011-1#1)
unlike other##12##2##(1991-12#1)(1992-10#1)(1992-7#1)(1994-12#1)(1997-2#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-7#1)(2010-5#1)(2011-2#1)
unlike our##2##2##(1994-3#1)(2008-12#1)
unlike previously##2##2##(2006-12#1)(2008-7#1)
unlike several other##2##3##(1991-9#1)(1994-12#1)
unlike that of the##3##4##(1990-11#1)(2008-3#1)(2010-2#1)
unlike that of##4##3##(1990-11#1)(1992-7#1)(2008-3#1)(2010-2#1)
unlike the conventional##2##3##(1990-12#1)(2008-2#1)
unlike the rat##2##3##(1994-2#1)(2008-7#1)
unlike the wild-type enzyme##2##4##(1995-5#1)(2008-4#1)
unlike the wild-type##4##3##(1990-5#1)(1995-5#1)(2008-10#1)(2008-4#1)
unlike the##53##2##(1990-12#1)(1990-5#2)(1990-6#1)(1990-7#2)(1991-2#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-2#2)(1996-4#1)(1996-5#1)(1996-8#2)(2005-11#1)(2005-8#1)(2006-3#1)(2006-5#1)(2007-12#1)(2008-10#3)(2008-2#3)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-8#1)(2010-2#1)(2011-12#1)(2012-2#1)
unlike those of##2##3##(1991-2#1)(2007-11#1)
unlike those##6##2##(1991-1#1)(1991-2#1)(1993-12#1)(2007-11#1)(2011-1#1)(2013-1#1)
unlike##184##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-9#1)(1991-1#3)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#2)(1993-12#1)(1993-2#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#4)(1994-2#2)(1994-3#4)(1994-9#4)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#2)(1995-9#1)(1996-1#1)(1996-2#2)(1996-4#1)(1996-5#4)(1996-8#2)(1997-1#2)(1997-2#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#4)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#9)(2008-8#1)(2008-9#2)(2009-4#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#3)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)
unlikely and##3##2##(1991-12#1)(2007-8#1)(2008-6#1)
unlikely due to##3##3##(1993-7#1)(2008-10#1)(2008-11#1)
unlikely in the near future##2##5##(2007-11#1)(2007-4#1)
unlikely in##4##2##(1994-10#1)(1996-8#1)(2007-11#1)(2007-4#1)
unlikely that a##2##3##(1993-9#1)(1996-12#1)
unlikely that the##12##3##(1990-7#1)(1991-10#1)(1991-11#1)(1993-11#1)(1994-9#1)(1997-6#1)(2006-8#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-11#2)
unlikely that these##3##3##(1990-5#1)(1991-1#1)(2010-2#1)
unlikely that this##3##3##(1990-10#1)(1995-5#1)(2008-10#1)
unlikely that##53##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#2)(1993-11#2)(1993-12#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-12#2)(1995-5#2)(1996-12#2)(1996-7#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-5#1)(2007-9#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#3)(2008-6#1)(2008-8#2)(2009-11#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-11#1)
unlikely to account for##2##4##(1993-12#1)(1996-12#1)
unlikely to affect the##2##4##(2008-10#1)(2008-3#1)
unlikely to affect##3##3##(2008-10#1)(2008-3#1)(2010-11#1)
unlikely to be a##7##4##(1991-12#1)(1996-5#1)(2006-10#1)(2006-8#1)(2007-2#1)(2009-7#1)(2010-1#1)
unlikely to be effective##2##4##(2010-10#1)(2013-8#1)
unlikely to be responsible for the##2##6##(1993-11#1)(2008-10#1)
unlikely to be the##4##4##(1990-8#1)(1997-2#1)(2006-10#1)(2008-2#1)
unlikely to be##50##3##(1990-8#1)(1991-12#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-5#1)(1997-2#1)(2005-10#1)(2006-10#6)(2006-8#1)(2007-11#2)(2007-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#4)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-8#1)(2012-12#2)(2013-1#1)(2013-8#1)
unlikely to benefit from##3##4##(2009-8#1)(2011-2#1)(2012-2#1)
unlikely to explain the##2##4##(1995-3#1)(2008-7#1)
unlikely to have a##2##4##(1990-11#1)(1995-11#1)
unlikely to have##4##3##(1990-11#1)(1991-11#1)(1995-11#1)(2006-10#1)
unlikely to increase##2##3##(1997-6#1)(2008-8#1)
unlikely to provide##3##3##(1994-3#1)(2006-5#2)
unlikely to##119##2##(1990-11#1)(1990-3#1)(1990-6#1)(1990-8#2)(1991-11#1)(1991-12#1)(1992-10#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#2)(1994-3#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-3#2)(1995-6#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-12#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-10#1)(2005-10#1)(2006-10#7)(2006-12#1)(2006-4#1)(2006-5#3)(2006-8#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#4)(2008-8#7)(2008-9#1)(2009-10#1)(2009-3#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#4)(2013-8#1)
unlikely##234##1##(1990-10#1)(1990-11#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#3)(1991-4#1)(1992-10#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-10#1)(1993-11#3)(1993-12#3)(1993-4#1)(1993-6#1)(1993-7#2)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-5#2)(1994-9#2)(1995-11#1)(1995-12#4)(1995-3#3)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#6)(1996-2#1)(1996-5#3)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-6#2)(1997-7#1)(1997-8#2)(2004-10#1)(2005-10#1)(2005-7#1)(2006-10#9)(2006-12#1)(2006-4#2)(2006-5#4)(2006-8#2)(2007-11#4)(2007-12#1)(2007-2#3)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#23)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#5)(2008-8#10)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#1)
unlimited calorie diet##2##3##(2008-3#2)
unlimited life time##2##3##(2008-10#2)
unlimited opportunities##2##2##(1992-3#1)(2007-9#1)
unlimited source of##2##3##(2008-2#1)(2012-12#1)
unlimited supply##2##2##(1994-3#1)(2008-1#1)
unlimited##37##1##(1992-2#1)(1992-3#1)(1993-2#1)(1993-5#1)(1994-3#1)(1996-12#1)(1996-3#1)(2005-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#3)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-9#1)(2012-1#1)(2012-12#1)
unlinked anonymous testing of##2##4##(1991-6#2)
unlinked structural gene##2##3##(1995-1#2)
unlinked structural##3##2##(1995-1#3)
unlinked to the##4##3##(1990-5#1)(1993-12#1)(1994-9#1)(1997-2#1)
unlinked to##7##2##(1990-5#1)(1993-12#1)(1994-9#1)(1997-2#1)(2008-10#2)(2012-3#1)
unlinked##34##1##(1990-5#1)(1991-6#3)(1991-7#2)(1992-8#1)(1993-12#1)(1994-11#1)(1994-9#1)(1995-1#3)(1995-6#2)(1995-8#1)(1996-3#1)(1997-2#2)(2008-10#6)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#2)(2010-6#1)(2011-2#1)(2012-3#2)
unloaded by the##2##3##(2013-1#2)
unloaded foams##2##2##(1997-1#2)
unloaded vesicles##2##2##(1992-10#2)
unloaded##23##1##(1990-11#3)(1991-5#1)(1992-10#2)(1997-1#4)(2006-9#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2010-1#1)(2013-1#4)
unloading##14##1##(1995-2#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-3#1)(2010-10#2)(2010-3#2)(2010-6#1)(2012-12#1)(2013-8#1)
unlock the##3##2##(1996-2#1)(2008-7#1)(2012-12#1)
unlock##5##1##(1996-2#1)(2008-7#1)(2010-1#1)(2012-12#1)(2013-8#1)
unlocked##2##1##(1996-4#2)
unlucky##2##1##(2009-6#1)(2012-3#1)
unmanaged##4##1##(1994-12#1)(1995-2#1)(2008-10#1)(2012-2#1)
unmarried adolescents##2##2##(2007-3#1)(2009-11#1)
unmarried and##4##2##(2007-2#1)(2011-2#2)(2012-3#1)
unmarried women##8##2##(1991-6#1)(1991-8#4)(2008-7#2)(2012-2#1)
unmarried young women##2##3##(2007-3#1)(2007-7#1)
unmarried##30##1##(1990-12#1)(1991-2#1)(1991-6#1)(1991-8#4)(1993-5#1)(2006-8#1)(2007-2#1)(2007-3#5)(2007-7#4)(2008-7#2)(2009-11#1)(2010-4#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#3)
unmask##3##1##(2008-4#1)(2008-7#1)(2009-2#1)
unmasked after##3##2##(1995-11#1)(2008-10#2)
unmasked by##4##2##(1996-9#1)(2008-12#1)(2008-7#1)(2010-12#1)
unmasked##13##1##(1990-2#1)(1993-12#1)(1995-11#1)(1996-9#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-8#1)(2011-2#1)
unmasking of##6##2##(1991-3#1)(1994-11#1)(1996-5#1)(1997-5#1)(2007-11#1)(2008-8#1)
unmasking##8##1##(1991-3#1)(1994-11#1)(1995-10#1)(1996-5#1)(1997-5#1)(2007-11#1)(2008-8#1)(2013-8#1)
unmasks##4##1##(1990-12#1)(1990-2#1)(2009-2#1)(2010-3#1)
unmatched features##2##2##(2008-9#2)
unmatched information##2##2##(2008-9#2)
unmatched##14##1##(1992-10#1)(1992-9#1)(2008-2#1)(2008-9#4)(2010-7#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
unmated##2##1##(2004-11#1)(2009-4#1)
unmeasured third variables##2##3##(2012-1#2)
unmeasured##5##1##(1997-6#1)(2007-4#1)(2012-1#2)(2012-12#1)
unmedicated childbirth##2##2##(2007-2#2)
unmedicated slices##2##2##(1995-12#1)(1996-1#1)
unmedicated##7##1##(1995-11#1)(1995-12#1)(1996-1#1)(2007-2#3)(2012-1#1)
unmet health##2##2##(2008-7#1)(2010-8#1)
unmet healthcare needs in##2##4##(2010-8#2)
unmet medical need and##2##4##(2005-7#1)(2008-1#1)
unmet medical need##4##3##(2005-7#1)(2005-8#1)(2008-1#2)
unmet need for contraception in Zambia##3##6##(2007-7#3)
unmet need for contraception##8##4##(2007-7#7)(2012-11#1)
unmet need for spacing and##2##5##(2007-7#2)
unmet need for spacing##3##4##(2007-7#3)
unmet need for##15##3##(2007-7#10)(2008-7#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-11#1)
unmet need##23##2##(1995-12#1)(2007-7#10)(2008-7#1)(2009-12#1)(2010-8#5)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)
unmet needs and##2##3##(2006-4#1)(2007-11#1)
unmet needs in the##2##4##(2010-11#1)(2010-6#1)
unmet needs in##3##3##(2010-11#1)(2010-6#1)(2013-1#1)
unmet needs##9##2##(1992-1#1)(1995-1#1)(2006-4#1)(2006-9#1)(2007-11#1)(2010-10#1)(2010-11#1)(2010-6#1)(2013-1#1)
unmet service needs##2##3##(2009-9#1)(2013-1#1)
unmet##53##1##(1992-1#1)(1993-2#1)(1995-1#1)(1995-12#1)(1996-3#2)(2005-7#1)(2005-8#2)(2006-4#1)(2006-9#1)(2007-11#1)(2007-7#10)(2008-1#2)(2008-11#2)(2008-5#1)(2008-7#2)(2009-12#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-8#8)(2011-11#1)(2011-2#2)(2012-11#1)(2012-12#3)(2012-2#2)(2013-1#2)
unmethylated CpG##2##2##(2007-11#1)(2008-4#1)
unmethylated DNA##5##2##(1990-11#1)(1995-8#1)(2007-11#3)
unmethylated in the##2##3##(2007-11#2)
unmethylated##23##1##(1990-11#1)(1990-8#2)(1995-2#1)(1995-8#1)(1996-10#1)(1997-7#2)(2007-11#9)(2007-8#3)(2008-4#1)(2009-10#1)(2009-3#1)
unmilled##2##1##(2008-8#2)
unmodeled##2##1##(2008-3#2)
unmodified 5'-OH and 5'-phosphate DNA##2##5##(2008-4#2)
unmodified G##2##2##(1997-1#2)
unmodified ODNs##2##2##(2008-4#2)
unmodified SP-B##2##2##(1994-3#2)
unmodified [Cys222]subtilisin##2##2##(1990-12#2)
unmodified and##7##2##(1991-2#1)(1992-5#1)(1994-9#1)(1995-2#1)(1995-8#1)(2008-10#2)
unmodified bentonite##2##2##(2005-11#2)
unmodified carbon##3##2##(2008-10#3)
unmodified or##2##2##(1995-1#1)(2008-7#1)
unmodified poly(lysine)##2##2##(1994-3#2)
unmodified proteins##2##2##(1993-11#1)(2009-10#1)
unmodified##92##1##(1990-12#2)(1990-7#1)(1991-2#1)(1991-9#3)(1992-10#1)(1992-5#1)(1993-11#2)(1993-3#1)(1994-12#1)(1994-3#4)(1994-5#1)(1994-8#2)(1994-9#2)(1995-1#3)(1995-12#1)(1995-2#4)(1995-8#1)(1996-5#1)(1997-1#2)(1997-4#1)(1997-6#1)(2005-11#3)(2005-8#1)(2006-10#2)(2006-12#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#17)(2008-2#1)(2008-3#1)(2008-4#8)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#4)(2009-4#1)(2009-7#2)(2010-4#2)(2010-5#1)(2011-2#3)(2012-2#1)
unmodulated##5##1##(1997-6#1)(2007-12#3)(2008-3#1)
unmulched##2##1##(2008-10#2)
unmutated IgV(H)##3##2##(2008-9#3)
unmutated##4##1##(2008-9#3)(2012-2#1)
unmyelinated axons##5##2##(1991-9#3)(1994-2#1)(2010-12#1)
unmyelinated fibers in the contralateral L5 ventral root##2##8##(1993-12#2)
unmyelinated fibers in the##5##4##(1993-12#5)
unmyelinated fibers##6##2##(1993-12#5)(1993-7#1)
unmyelinated##19##1##(1991-10#1)(1991-9#3)(1993-12#6)(1993-7#1)(1994-2#1)(1994-5#1)(1996-3#1)(1996-7#1)(1997-3#1)(2005-10#1)(2006-12#1)(2010-12#1)
unnamed Trichoderma anamorphs##2##3##(2008-10#2)
unnamed##9##1##(1991-7#1)(2006-7#1)(2008-10#4)(2008-2#1)(2010-10#1)(2013-7#1)
unnatural amino acids##3##3##(1992-11#1)(2006-5#2)
unnatural amino##4##2##(1992-11#1)(1992-3#1)(2006-5#2)
unnatural base##2##2##(2008-4#2)
unnatural bases##2##2##(2008-4#2)
unnatural##17##1##(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1994-6#1)(2006-5#2)(2006-6#1)(2008-2#1)(2008-4#6)(2008-7#1)(2012-12#1)
unnaturally modified##2##2##(1995-7#1)(2008-4#1)
unnaturally##4##1##(1995-7#1)(2006-11#1)(2006-12#1)(2008-4#1)
unnd##2##1##(1994-3#2)
unneccessary and##2##2##(2012-12#2)
unnecessarily aggressive##2##2##(2010-12#1)(2012-3#1)
unnecessarily##14##1##(1991-4#1)(1992-10#1)(1992-8#1)(1995-3#1)(1995-4#1)(2006-2#1)(2007-8#1)(2008-11#1)(2008-6#1)(2009-6#1)(2010-12#1)(2010-2#1)(2012-3#1)(2013-8#1)
unnecessary and##10##2##(1996-11#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-1#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-2#1)(2010-7#1)
unnecessary for##4##2##(1992-1#1)(1995-2#1)(2010-1#1)(2010-3#1)
unnecessary hospital##2##2##(2009-6#2)
unnecessary in the##2##3##(2006-12#1)(2012-2#1)
unnecessary in##5##2##(2005-7#1)(2006-10#1)(2006-12#1)(2008-10#1)(2012-2#1)
unnecessary interventions##2##2##(2007-2#1)(2008-9#1)
unnecessary laparotomy##2##2##(2007-9#1)(2008-10#1)
unnecessary medical costs##2##3##(1993-12#1)(2011-12#1)
unnecessary procedures##2##2##(1996-3#1)(2010-3#1)
unnecessary risks##3##2##(1991-12#1)(2009-6#1)(2011-12#1)
unnecessary services##3##2##(1995-12#1)(2011-2#1)(2012-3#1)
unnecessary surgery##4##2##(2011-12#1)(2012-12#1)(2012-2#2)
unnecessary surgical intervention##2##3##(1992-9#1)(2007-5#1)
unnecessary surgical##4##2##(1992-9#1)(2007-5#1)(2011-2#2)
unnecessary testing and##2##3##(2006-10#1)(2009-4#1)
unnecessary tests and##2##3##(2011-12#2)
unnecessary tests##4##2##(1997-3#1)(2008-7#1)(2011-12#2)
unnecessary the##2##2##(1991-4#1)(2007-12#1)
unnecessary to##5##2##(1991-5#1)(2006-3#1)(2009-10#1)(2011-12#1)(2012-3#1)
unnecessary treatment##3##2##(2006-7#1)(2006-9#1)(2007-3#1)
unnecessary##141##1##(1990-10#1)(1990-12#2)(1991-11#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-4#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-10#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#2)(1997-2#1)(1997-3#1)(1997-7#1)(2005-10#1)(2005-7#2)(2005-8#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-3#3)(2006-4#2)(2006-5#1)(2006-7#1)(2006-9#1)(2007-1#3)(2007-10#1)(2007-12#2)(2007-2#2)(2007-3#2)(2007-4#3)(2007-5#1)(2007-7#5)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#2)(2009-6#4)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-7#1)(2010-8#1)(2011-12#6)(2011-2#5)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#5)
unneeded##3##1##(2006-10#1)(2008-4#1)(2013-1#1)
unnoticeable colour change (DeltaE&lt##2##4##(2010-2#2)
unnoticed##10##1##(1991-3#1)(1992-8#1)(1997-3#1)(2008-7#2)(2009-6#1)(2011-1#3)(2012-3#1)
unobservable##6##1##(1997-8#1)(2006-12#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-7#1)
unobserved heterogeneity##2##2##(1997-7#1)(2009-4#1)
unobserved##29##1##(1991-1#1)(1991-11#1)(1992-10#1)(1992-6#1)(1995-2#1)(1995-6#1)(1997-7#1)(2005-11#1)(2006-4#1)(2007-2#1)(2008-10#1)(2008-2#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-10#1)(2010-11#2)(2010-2#2)(2011-2#1)(2012-3#2)
unobstructed##10##1##(1991-7#1)(1994-8#1)(1995-4#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)
unobtainable##3##1##(1992-8#1)(2008-3#1)(2009-3#1)
unobtrusive##2##1##(2006-5#1)(2008-11#1)
unoccupied##10##1##(1991-7#1)(1993-9#1)(1994-8#1)(1996-2#2)(1997-3#1)(2008-8#2)(2010-4#1)(2013-1#1)
unofficial payments in government##2##4##(2012-3#2)
unofficial payments##5##2##(2012-3#5)
unofficial##10##1##(2008-2#1)(2012-3#9)
unofficially##3##1##(1991-8#1)(2012-3#2)
unoperated animals##3##2##(1990-7#1)(1996-3#2)
unoperated control##3##2##(1993-12#1)(1994-3#1)(1995-12#1)
unoperated controls##4##2##(1992-11#1)(1992-9#1)(1993-12#1)(1993-6#1)
unoperated##15##1##(1990-7#1)(1991-6#2)(1992-11#1)(1992-9#2)(1993-12#2)(1993-2#1)(1993-6#1)(1994-3#1)(1995-12#1)(1996-3#2)(2009-8#1)
unopposed estrogen##4##2##(1994-9#2)(2006-2#1)(2011-2#1)
unopposed##7##1##(1992-8#1)(1993-12#1)(1994-9#2)(2006-2#1)(2008-1#1)(2011-2#1)
unordered##3##1##(1992-2#1)(2008-10#1)(2008-4#1)
unorganized##3##1##(1990-7#1)(2008-7#1)(2009-6#1)
unoriented samples##2##2##(1995-10#2)
unoriented##8##1##(1991-9#1)(1995-10#3)(2008-4#1)(2008-7#1)(2010-4#2)
unorthodox##4##1##(1990-12#1)(1994-8#1)(2010-2#1)(2010-8#1)
unpackaged ssDNA contains##2##3##(1991-5#2)
unpackaged ssDNA##3##2##(1991-5#3)
unpackaged##7##1##(1991-5#5)(1992-8#2)
unpadded##8##1##(2007-3#1)(2007-4#7)
unpaid caregivers##2##2##(2007-10#2)
unpaid##7##1##(1995-3#2)(2007-10#2)(2007-4#1)(2011-2#1)(2012-3#1)
unpaired anterior aorta##2##3##(2007-12#2)
unpaired electron##2##2##(1997-7#1)(2005-1#1)
unpaired electron-spin density##2##3##(1994-5#2)
unpaired##38##1##(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1995-1#1)(1995-12#1)(1996-8#1)(1997-4#1)(1997-7#1)(2005-1#1)(2007-10#2)(2007-11#1)(2007-12#6)(2008-5#1)(2011-1#2)(2012-2#6)(2012-3#1)(2013-1#1)(2013-8#1)
unpalatable##3##1##(2008-12#1)(2012-3#1)(2013-1#1)
unparallel grating planes in Talbot interferometry##2##6##(2008-3#2)
unparallel grating planes in##3##4##(2008-3#3)
unparalleled##6##1##(1996-3#1)(2010-5#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
unparasitized penultimate##2##2##(1992-6#2)
unparasitized##4##1##(1990-2#1)(1992-6#2)(2007-6#1)
unpasteurized##2##1##(1996-8#1)(2012-2#1)
unperturbed##13##1##(1992-9#1)(1995-3#1)(2005-11#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2012-12#2)
unphosphorylated and phosphorylated myosins##2##4##(1990-7#2)
unphosphorylated and phosphorylated##3##3##(1990-7#2)(2006-12#1)
unphosphorylated and##4##2##(1990-7#2)(1995-3#1)(2006-12#1)
unphosphorylated peptides##4##2##(1995-3#1)(2013-8#3)
unphosphorylated##23##1##(1990-11#1)(1990-2#1)(1990-7#9)(1994-9#1)(1995-1#1)(1995-3#2)(1996-5#1)(2006-12#1)(2008-4#1)(2010-12#2)(2013-8#3)
unpigmented##5##1##(1992-11#1)(2007-12#4)
unplanned and##2##2##(1993-3#1)(2010-10#1)
unplanned or accidental extubations##2##4##(2007-11#2)
unplanned pregnancy##2##2##(1993-2#1)(2004-10#1)
unplanned readmission##2##2##(2007-12#1)(2011-1#1)
unplanned##29##1##(1990-12#1)(1990-8#1)(1991-4#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-3#1)(1997-1#1)(2004-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-10#3)(2010-11#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#1)
unpleasant and##2##2##(1995-1#1)(2008-1#1)
unpleasant for##3##2##(2008-5#2)(2012-3#1)
unpleasant sensations##2##2##(2007-1#2)
unpleasant sensory##3##2##(2005-11#1)(2008-4#1)(2009-9#1)
unpleasant##22##1##(1992-2#2)(1992-5#1)(1994-5#1)(1995-1#1)(1996-7#1)(2005-11#1)(2007-1#2)(2008-1#1)(2008-4#1)(2008-5#4)(2008-6#1)(2009-6#2)(2009-9#1)(2010-5#1)(2011-12#1)(2012-3#1)
unpleasantness of##4##2##(2008-10#3)(2008-5#1)
unpleasantness##8##1##(2008-10#5)(2008-5#1)(2010-4#1)(2013-8#1)
unpolarized fluorescence##3##2##(2007-11#3)
unpolarized incident light##3##3##(2007-12#1)(2008-3#2)
unpolarized light##7##2##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#2)
unpolarized##15##1##(2007-11#3)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#6)
unpolluted habitats##3##2##(2008-5#3)
unpolluted##14##1##(2006-12#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-5#6)(2008-7#1)(2011-1#1)(2011-12#1)
unpopular##5##1##(2004-10#1)(2008-11#2)(2008-4#1)(2013-8#1)
unpracticed##2##1##(1990-11#1)(2010-7#1)
unprecedented challenges##2##2##(1997-1#1)(2012-3#1)
unprecedented increase in the##3##4##(2006-8#1)(2008-1#1)(2008-7#1)
unprecedented levels of##3##3##(1995-1#1)(1995-2#1)(1996-2#1)
unprecedented levels##4##2##(1992-6#1)(1995-1#1)(1995-2#1)(1996-2#1)
unprecedented number of##2##3##(2006-2#1)(2012-1#1)
unprecedented opportunities for##2##3##(2006-6#1)(2013-1#1)
unprecedented opportunities##4##2##(2006-10#1)(2006-6#1)(2007-11#1)(2013-1#1)
unprecedented##83##1##(1990-9#1)(1991-1#1)(1992-6#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#4)(1996-3#1)(1997-1#1)(1997-7#1)(2004-10#1)(2005-11#1)(2005-12#1)(2006-10#3)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-4#1)(2007-6#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-11#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#3)(2009-6#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#2)
unpredictability in##2##2##(2008-8#1)(2012-2#1)
unpredictability of##2##2##(1993-2#1)(2008-12#1)
unpredictability##4##1##(1993-2#1)(2008-12#1)(2008-8#1)(2012-2#1)
unpredictable and##6##2##(1996-2#1)(2005-12#1)(2008-11#1)(2008-4#1)(2009-10#1)(2011-1#1)
unpredictable clinical##3##2##(2008-8#1)(2009-5#1)(2012-2#1)
unpredictable facts and conditions (henceforth called exceptions) may occur##2##9##(2013-1#2)
unpredictable results##2##2##(1993-12#1)(2008-12#1)
unpredictable##61##1##(1992-11#2)(1992-8#1)(1993-12#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-8#2)(1996-2#1)(1996-6#1)(2005-10#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-12#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#6)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-3#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)
unpredictably##7##1##(1991-11#1)(1991-8#1)(1994-3#1)(1997-8#1)(2007-4#1)(2008-6#1)(2008-9#1)
unprepared##4##1##(1994-3#1)(2008-9#1)(2010-1#1)(2010-7#1)
unpretreated##2##1##(2008-10#2)
unprimed##5##1##(1990-5#1)(1991-12#1)(1994-6#1)(1995-2#1)(2008-4#1)
unprocessed type II procollagen##2##4##(1994-8#2)
unprocessed##20##1##(1991-9#1)(1994-8#3)(1997-2#1)(1997-4#1)(1997-8#3)(2007-10#1)(2007-12#2)(2007-7#1)(2008-12#4)(2012-11#1)(2012-12#2)
unproductive##5##1##(1990-2#1)(1991-2#1)(2007-1#1)(2008-9#1)(2010-8#1)
unprofessional##3##1##(2008-6#1)(2011-2#1)(2013-8#1)
unprotected coitus##2##2##(1992-10#2)
unprotected exposure to##2##3##(1992-6#1)(2011-2#1)
unprotected intercourse##4##2##(1995-6#1)(2005-10#1)(2009-12#1)(2011-1#1)
unprotected left main coronary artery##3##5##(2009-12#3)
unprotected left main##6##3##(2008-3#1)(2009-12#4)(2011-2#1)
unprotected receptive##2##2##(2008-12#1)(2011-2#1)
unprotected sex##9##2##(1992-7#1)(1996-12#1)(1996-5#1)(2008-8#1)(2010-9#1)(2012-3#2)(2013-1#2)
unprotected sexual intercourse with##2##4##(2007-2#1)(2012-2#1)
unprotected sexual intercourse##4##3##(1992-6#1)(1997-7#1)(2007-2#1)(2012-2#1)
unprotected sexual##6##2##(1992-6#1)(1997-7#1)(2007-2#1)(2007-7#1)(2008-1#1)(2012-2#1)
unprotected vaginal##2##2##(2011-1#1)(2013-1#1)
unprotected##55##1##(1991-7#1)(1991-8#1)(1992-10#2)(1992-6#2)(1992-7#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-7#1)(2005-10#1)(2007-11#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#5)(2008-5#1)(2008-8#1)(2009-12#5)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#5)(2013-8#1)
unproteolyzed##4##1##(1995-11#4)
unprotonated##9##1##(1991-9#2)(1992-2#1)(1994-11#2)(2008-10#3)(2010-5#1)
unproved##4##1##(1993-8#1)(1994-7#1)(2006-2#1)(2008-10#1)
unproven safety##2##2##(2008-4#1)(2008-7#1)
unproven screening imaging tests##2##4##(2007-4#2)
unproven screening##4##2##(2007-4#4)
unproven##24##1##(1991-3#1)(1995-6#1)(2004-1#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-3#1)(2007-11#2)(2007-4#4)(2007-7#1)(2008-12#1)(2008-4#2)(2008-7#1)(2009-11#1)(2009-3#1)(2010-3#1)
unprovoked seizures##4##2##(2004-11#3)(2013-1#1)
unprovoked##7##1##(1993-3#1)(2004-11#3)(2010-12#2)(2013-1#1)
unpublished data##6##2##(2007-11#1)(2007-5#1)(2008-6#1)(2008-9#1)(2010-11#1)(2013-1#1)
unpublished##25##1##(1990-2#1)(1992-2#1)(1996-6#1)(1997-7#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-9#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-1#1)(2010-11#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
unpublished)##3##1##(2006-6#1)(2007-12#2)
unpumped##2##1##(2007-12#1)(2008-3#1)
unpurified##7##1##(1992-7#1)(1994-8#1)(2005-8#1)(2006-10#1)(2007-1#1)(2008-10#2)
unqualified practitioners##3##2##(2012-3#3)
unqualified##4##1##(2012-2#1)(2012-3#3)
unquantified##4##1##(2008-11#1)(2008-4#3)
unquestionable##3##1##(2008-11#1)(2010-6#1)(2011-2#1)
unquestionably##4##1##(1996-8#1)(2008-10#1)(2008-6#1)(2010-12#1)
unquestioned##3##1##(2006-5#1)(2007-7#2)
unravel the##22##2##(1993-9#1)(1994-8#2)(1997-1#1)(1997-4#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2010-5#1)(2012-12#3)(2013-1#1)(2013-8#1)
unravel these##2##2##(1997-6#1)(2008-11#1)
unravel##36##1##(1993-2#1)(1993-9#1)(1994-8#2)(1995-11#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-10#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-2#1)(2010-5#1)(2012-12#4)(2013-1#1)(2013-8#2)
unraveled##5##1##(1996-2#1)(2005-11#1)(2005-8#1)(2008-1#1)(2011-12#1)
unraveling of the##5##3##(2007-11#1)(2008-7#1)(2009-2#1)(2013-7#1)(2013-8#1)
unraveling of##9##2##(1994-3#2)(2006-12#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-2#1)(2013-7#1)(2013-8#1)
unraveling the##7##2##(1993-4#1)(1995-12#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-8#1)(2013-1#1)
unraveling##20##1##(1993-4#1)(1994-3#2)(1995-12#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
unravelled##7##1##(1994-5#1)(1996-11#1)(2006-10#2)(2007-12#1)(2007-6#1)(2013-7#1)
unravelling of##2##2##(1990-7#1)(1996-6#1)
unravelling the##3##2##(2006-10#1)(2009-8#1)(2010-12#1)
unravelling##6##1##(1990-7#1)(1996-6#1)(2006-10#2)(2009-8#1)(2010-12#1)
unravels the##2##2##(2008-1#1)(2010-12#1)
unreachable##2##1##(2007-3#1)(2011-2#1)
unreacted##8##1##(1991-7#1)(1995-2#1)(2004-9#1)(2005-11#1)(2007-6#1)(2008-10#3)
unreactive##8##1##(1996-4#1)(1996-9#1)(2006-4#1)(2007-11#1)(2008-10#2)(2008-5#1)(2012-2#1)
unrealistic and##3##2##(1993-5#1)(1994-12#1)(2008-7#1)
unrealistic assumption##2##2##(1990-12#1)(2009-4#1)
unrealistic body##2##2##(2006-12#1)(2007-7#1)
unrealistic expectations##3##2##(2009-9#2)(2012-3#1)
unrealistic##24##1##(1990-12#1)(1993-5#1)(1993-7#1)(1994-12#1)(1996-11#1)(2006-12#1)(2007-12#3)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-4#1)(2009-9#2)(2010-12#1)(2010-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
unrealistically high##3##2##(1992-5#1)(2008-10#1)(2013-8#1)
unrealized potential##2##2##(2008-11#1)(2008-12#1)
unrealized##6##1##(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-6#1)(2010-12#1)
unreamed intramedullary##2##2##(1995-3#1)(2013-8#1)
unreamed tibial nail##2##3##(2009-3#2)
unreamed##5##1##(1995-3#2)(2009-3#2)(2013-8#1)
unreasonable to##2##2##(1991-1#1)(2009-4#1)
unreasonable##11##1##(1990-12#2)(1991-1#1)(1992-3#1)(1994-12#1)(1994-4#1)(1996-11#1)(2006-10#1)(2008-7#1)(2009-4#1)(2012-1#1)
unreasonably high##2##2##(1992-3#1)(2008-10#1)
unrecognised in##3##2##(1991-6#1)(2008-7#1)(2010-12#1)
unrecognised##18##1##(1990-3#1)(1990-9#1)(1991-6#1)(1992-9#1)(1993-7#1)(1994-3#1)(1996-6#2)(2007-2#1)(2007-6#1)(2008-7#1)(2008-8#4)(2010-12#1)(2010-5#1)(2012-12#1)
unrecognized and##4##2##(2008-8#1)(2009-1#1)(2010-7#1)(2012-3#1)
unrecognized epidemic##2##2##(2007-9#1)(2012-11#1)
unrecognized in##2##2##(2005-7#1)(2007-2#1)
unrecognized role in##2##3##(1994-9#1)(2008-8#1)
unrecognized role##3##2##(1994-9#1)(1995-5#1)(2008-8#1)
unrecognized##77##1##(1991-2#1)(1991-3#2)(1991-5#1)(1992-11#1)(1992-4#1)(1993-2#1)(1994-7#1)(1994-9#2)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(2005-11#2)(2005-7#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-4#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-1#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-12#2)(2010-2#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#1)
unreduced mature##2##2##(2008-9#2)
unreduced##7##1##(2007-8#1)(2008-7#1)(2008-9#4)(2013-8#1)
unregulated##12##1##(1990-11#1)(1992-5#1)(1993-12#1)(1995-12#1)(2006-10#3)(2007-12#1)(2007-5#1)(2007-8#1)(2008-12#1)(2008-8#1)
unreinforced##4##1##(2004-9#1)(2008-11#3)
unrelated Japanese##4##2##(1991-3#1)(1994-2#1)(1997-1#1)(2013-1#1)
unrelated MLD alleles##2##3##(1997-3#2)
unrelated Turkish families##3##3##(2008-2#1)(2010-10#2)
unrelated and##3##2##(1994-9#1)(2008-7#1)(2009-1#1)
unrelated bone marrow donors##2##4##(1997-8#1)(2008-1#1)
unrelated case-control data##3##3##(2012-3#3)
unrelated causes##3##2##(1994-12#1)(2013-1#1)(2013-7#1)
unrelated control##2##2##(1997-7#1)(2008-12#1)
unrelated controls##2##2##(2009-4#1)(2010-2#1)
unrelated cord blood##3##3##(2010-11#1)(2013-1#2)
unrelated cord##4##2##(2010-11#2)(2013-1#2)
unrelated donor##8##2##(1994-6#1)(2007-11#1)(2007-7#1)(2007-8#2)(2012-12#1)(2013-1#2)
unrelated donors##3##2##(2007-11#1)(2007-7#1)(2012-12#1)
unrelated drugs##2##2##(2010-8#1)(2012-2#1)
unrelated families##5##2##(1993-4#1)(2007-2#2)(2008-1#1)(2008-4#1)
unrelated females##2##2##(1993-6#1)(2008-8#1)
unrelated genes##2##2##(1994-11#1)(2008-6#1)
unrelated hosts##3##2##(2008-8#1)(2009-12#1)(2011-12#1)
unrelated human##2##2##(2010-4#1)(2011-1#1)
unrelated individual##2##2##(2012-12#1)(2012-3#1)
unrelated individuals and##2##3##(2012-3#2)
unrelated individuals data##5##3##(2012-3#5)
unrelated individuals from the##5##4##(2008-12#4)(2012-3#1)
unrelated individuals from##10##3##(1996-7#1)(2008-12#7)(2012-3#2)
unrelated individuals in##3##3##(2012-3#3)
unrelated individuals of##2##3##(2009-4#1)(2011-2#1)
unrelated individuals originating from three different continents (Africa##2##8##(2008-12#1)(2009-5#1)
unrelated individuals sample##2##3##(2012-3#2)
unrelated individuals##42##2##(1996-7#1)(2008-12#10)(2008-8#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-3#27)
unrelated isolates##2##2##(2012-3#2)
unrelated patients with##3##3##(1991-12#1)(1992-11#1)(1996-12#1)
unrelated patients##7##2##(1991-12#2)(1992-11#1)(1996-12#1)(1996-5#1)(2008-3#1)(2008-7#1)
unrelated perturbations##2##2##(1997-7#2)
unrelated plant families##2##3##(2006-12#2)
unrelated plant viruses##2##3##(2008-10#2)
unrelated plant##4##2##(2006-12#2)(2008-10#2)
unrelated protein##2##2##(2008-4#1)(2008-6#1)
unrelated subjects##5##2##(2008-3#1)(2012-3#4)
unrelated to any##5##3##(1993-6#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)
unrelated to either##3##3##(1990-12#1)(1992-6#1)(2008-12#1)
unrelated to that##2##3##(2008-10#1)(2009-4#1)
unrelated to the##31##3##(1991-8#1)(1993-9#1)(1994-3#1)(1995-12#2)(1995-8#1)(1996-1#1)(1997-3#1)(1997-6#2)(2005-11#1)(2006-1#1)(2007-1#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#3)(2013-1#1)
unrelated to their##2##3##(2007-12#1)(2007-3#1)
unrelated to##109##2##(1990-12#2)(1990-5#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#4)(1995-8#2)(1996-1#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#2)(1997-3#2)(1997-6#2)(1997-7#2)(2004-4#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-4#3)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#6)(2013-1#3)
unrelated viruses##2##2##(2008-10#1)(2012-2#1)
unrelated with##2##2##(1994-8#1)(2005-12#1)
unrelated##331##1##(1990-10#1)(1990-12#4)(1990-5#1)(1990-8#3)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#5)(1995-2#1)(1995-8#3)(1996-1#2)(1996-10#3)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#3)(1996-7#3)(1996-9#2)(1997-1#1)(1997-3#7)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#5)(1997-8#3)(2004-4#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#4)(2006-12#4)(2006-5#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#6)(2007-12#3)(2007-2#6)(2007-3#1)(2007-4#2)(2007-7#6)(2007-8#3)(2008-1#8)(2008-10#18)(2008-11#3)(2008-12#15)(2008-2#1)(2008-3#5)(2008-4#4)(2008-5#2)(2008-6#4)(2008-7#5)(2008-8#8)(2008-9#1)(2009-1#2)(2009-10#1)(2009-12#2)(2009-4#5)(2009-5#1)(2009-6#2)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#2)(2010-7#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#10)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#10)(2012-3#38)(2013-1#12)(2013-7#1)
unreliability of##2##2##(1996-3#1)(2006-3#1)
unreliability##4##1##(1996-3#1)(2006-3#1)(2007-11#1)(2008-2#1)
unreliable and##5##2##(2006-10#1)(2006-8#2)(2008-9#1)(2010-2#1)
unreliable data##2##2##(1993-9#1)(2008-7#1)
unreliable in##4##2##(2006-12#1)(2006-3#1)(2008-11#1)(2008-5#1)
unreliable##37##1##(1990-2#1)(1990-8#1)(1991-11#1)(1992-2#1)(1993-9#1)(1994-12#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-8#3)(2007-2#1)(2007-4#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-5#1)(2008-7#1)(2008-9#2)(2010-10#2)(2010-2#1)(2011-12#1)(2012-12#2)(2013-8#1)
unrelieved pain##3##2##(2007-8#1)(2008-7#2)
unrelieved##6##1##(1990-3#1)(1992-5#1)(2007-8#1)(2008-7#2)(2010-8#1)
unremarkable##23##1##(1990-3#1)(1991-9#1)(1992-2#1)(1992-7#1)(1995-1#1)(1995-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-11#2)(2009-2#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
unremitting pain##2##2##(2004-12#1)(2006-6#1)
unremitting##5##1##(2004-12#1)(2006-6#1)(2008-5#1)(2008-6#1)(2013-1#1)
unrepaired##4##1##(2008-4#2)(2008-7#1)(2012-12#1)
unreplicated##2##1##(2008-8#1)(2010-2#1)
unreported association of##2##3##(1996-3#1)(2013-1#1)
unreported##43##1##(1990-4#1)(1990-9#1)(1992-1#1)(1993-4#1)(1994-12#2)(1995-3#1)(1996-3#2)(1997-2#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2012-2#4)(2013-1#1)(2013-8#1)
unrepresentative##3##1##(1991-1#1)(1992-3#1)(2010-11#1)
unresectability##2##1##(2008-5#1)(2010-9#1)
unresectable GIST##2##2##(2008-6#1)(2012-2#1)
unresectable HCC##3##2##(2006-6#1)(2008-3#1)(2010-12#1)
unresectable disease##5##2##(1992-3#1)(2006-12#1)(2006-6#1)(2008-6#2)
unresectable lung cancer##2##3##(1992-10#2)
unresectable or metastatic renal cell cancer##3##6##(2008-6#3)
unresectable or metastatic##5##3##(1994-2#1)(2008-6#4)
unresectable or recurrent##3##3##(2008-6#1)(2012-2#2)
unresectable or##10##2##(1994-2#1)(2007-7#1)(2008-6#5)(2012-2#3)
unresectable pancreatic adenocarcinoma##4##3##(1991-2#1)(2006-6#3)
unresectable pancreatic cancer##2##3##(2006-6#2)
unresectable pancreatic##8##2##(1991-2#1)(2006-6#5)(2008-3#1)(2013-1#1)
unresectable tumors##2##2##(2010-3#1)(2013-8#1)
unresectable##67##1##(1990-10#1)(1991-2#1)(1992-10#2)(1992-3#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-4#2)(2006-12#2)(2006-6#13)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-3#3)(2008-6#13)(2008-7#1)(2010-12#3)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#9)(2013-1#5)(2013-8#1)
unresected choledochal##2##2##(2009-9#2)
unresected##3##1##(2009-9#3)
unresolved cases##2##2##(2010-3#1)(2011-2#1)
unresolved harmonics##3##2##(2008-2#3)
unresolved issue##4##2##(2007-9#1)(2010-2#2)(2012-2#1)
unresolved issues##7##2##(1991-11#1)(1994-12#1)(1995-12#1)(1996-1#1)(1996-8#2)(2008-8#1)
unresolved postoperative pain##2##3##(2010-8#1)(2013-1#1)
unresolved problem in##2##3##(2007-8#1)(2012-2#1)
unresolved problem##4##2##(2007-8#1)(2008-2#1)(2012-2#1)(2013-8#1)
unresolved problems##2##2##(2010-11#1)(2011-3#1)
unresolved question##2##2##(1994-3#1)(1996-4#1)
unresolved questions remain in##2##4##(2006-10#1)(2011-1#1)
unresolved questions remain##3##3##(1997-6#1)(2006-10#1)(2011-1#1)
unresolved questions##4##2##(1997-6#1)(2006-10#1)(2011-1#1)(2013-7#1)
unresolved with##2##2##(2006-2#1)(2012-12#1)
unresolved##85##1##(1990-12#1)(1991-11#1)(1991-3#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-6#1)(1994-12#2)(1994-3#1)(1995-12#2)(1995-3#1)(1995-8#2)(1996-1#1)(1996-4#1)(1996-5#1)(1996-8#3)(1997-6#1)(2005-8#1)(2006-10#4)(2006-2#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#6)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#3)(2013-7#2)(2013-8#1)
unresponsive patients##2##2##(1992-8#1)(2008-6#1)
unresponsive to conservative treatment##2##4##(2007-11#1)(2011-2#1)
unresponsive to conservative##3##3##(2006-8#1)(2007-11#1)(2011-2#1)
unresponsive to conventional treatment##4##4##(1994-2#1)(2006-10#1)(2011-2#1)(2012-12#1)
unresponsive to conventional##6##3##(1994-2#1)(2006-10#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-12#1)
unresponsive to first-line##2##3##(1992-8#1)(2008-5#1)
unresponsive to the##3##3##(1993-11#1)(1995-2#1)(1996-11#1)
unresponsive to##55##2##(1990-10#1)(1990-7#1)(1991-12#3)(1991-4#1)(1992-10#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-4#1)(1996-11#1)(1996-9#1)(1997-1#1)(2004-10#1)(2005-11#1)(2005-8#1)(2006-10#8)(2006-8#1)(2007-11#1)(2007-8#2)(2008-11#2)(2008-4#3)(2008-5#1)(2008-7#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-2#4)(2012-12#4)(2012-2#1)
unresponsive##68##1##(1990-10#1)(1990-7#1)(1991-12#3)(1991-3#1)(1991-4#1)(1992-10#1)(1992-7#2)(1992-8#2)(1993-1#1)(1993-11#2)(1993-2#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-4#1)(1996-11#1)(1996-9#1)(1997-1#1)(2004-10#1)(2005-11#1)(2005-8#1)(2006-10#8)(2006-8#1)(2007-11#2)(2007-8#2)(2008-11#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2010-11#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-2#6)(2012-12#4)(2012-2#1)
unresponsiveness to##6##2##(1993-7#1)(1994-8#1)(1995-2#1)(1996-12#1)(2008-11#1)(2011-12#1)
unresponsiveness##14##1##(1991-3#1)(1993-6#1)(1993-7#2)(1994-8#1)(1995-2#1)(1996-12#2)(2006-10#1)(2008-11#4)(2011-12#1)
unrest and##4##2##(1993-2#1)(2005-8#1)(2010-4#1)(2012-2#1)
unrest##7##1##(1991-3#1)(1993-2#1)(1994-2#1)(1996-7#1)(2005-8#1)(2010-4#1)(2012-2#1)
unrestored##2##1##(2008-5#1)(2011-2#1)
unrestrained free##2##2##(1993-9#1)(1997-1#1)
unrestrained rats##5##2##(1991-11#1)(1993-2#1)(1995-12#1)(1995-2#1)(2008-4#1)
unrestrained##23##1##(1990-8#1)(1991-11#2)(1991-3#1)(1993-12#1)(1993-2#1)(1993-9#2)(1994-11#1)(1995-12#1)(1995-2#4)(1997-1#1)(1997-3#1)(2006-4#1)(2007-12#2)(2007-8#1)(2008-4#1)(2009-3#1)(2012-3#1)
unrestricted access to##2##3##(1992-2#1)(2008-7#1)
unrestricted##19##1##(1991-8#2)(1992-2#1)(1992-4#1)(1994-2#2)(1994-9#1)(2006-10#2)(2007-12#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-4#1)(2010-2#1)(2010-5#1)(2011-2#1)
unretained##4##1##(2008-10#4)
unrevealing##2##1##(1995-2#1)(2006-10#1)
unrewarding##3##1##(2005-8#1)(2008-9#1)(2013-7#1)
unripe fruit extract##4##3##(2005-11#4)
unripe fruit##5##2##(2005-11#4)(2007-1#1)
unripe##10##1##(1992-1#3)(2005-11#4)(2007-1#1)(2007-8#1)(2008-10#1)
unruptured AVMs in##3##3##(2006-2#1)(2008-7#2)
unruptured AVMs##4##2##(2006-2#1)(2008-7#2)(2013-7#1)
unruptured aneurysm##2##2##(1995-11#1)(2013-8#1)
unruptured anterior##2##2##(2008-7#1)(2013-7#1)
unruptured arteriovenous malformations##2##3##(2008-7#2)
unruptured ectopic pregnancies##2##3##(1995-8#1)(1996-12#1)
unruptured intracranial aneurysms##2##3##(2009-7#1)(2013-7#1)
unruptured##18##1##(1995-11#2)(1995-8#1)(1996-12#2)(2004-10#1)(2006-2#1)(2008-6#1)(2008-7#5)(2009-7#1)(2013-7#3)(2013-8#1)
unsafe abortion##7##2##(2007-3#1)(2007-8#1)(2008-11#1)(2011-1#3)(2012-12#1)
unsafe abortions##4##2##(2008-11#3)(2012-11#1)
unsafe conditions##2##2##(2008-1#1)(2011-1#1)
unsafe sex##3##2##(1996-4#1)(2007-2#1)(2012-3#1)
unsafe##27##1##(1994-9#1)(1995-12#1)(1996-4#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-11#6)(2008-12#1)(2008-5#1)(2010-8#1)(2011-1#4)(2012-11#1)(2012-12#3)(2012-3#1)
unsafer&quot##2##1##(2008-3#2)
unsalvageable##3##1##(2008-10#1)(2011-2#1)(2012-2#1)
unsanitary conditions##2##2##(2008-8#1)(2011-2#1)
unsanitary##4##1##(2008-8#1)(2010-3#1)(2011-2#1)(2013-1#1)
unsaponifiable##4##1##(2007-11#1)(2008-5#2)(2008-6#1)
unsatisfactory and##2##2##(1992-11#1)(2006-2#1)
unsatisfactory cases##2##2##(1992-4#2)
unsatisfactory for##2##2##(2008-5#1)(2012-2#1)
unsatisfactory in##4##2##(2007-8#1)(2008-7#2)(2010-11#1)
unsatisfactory response##2##2##(2007-7#1)(2011-2#1)
unsatisfactory results##6##2##(1990-4#1)(1992-8#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-12#1)
unsatisfactory##69##1##(1990-10#1)(1990-2#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-3#1)(1992-11#1)(1992-4#2)(1992-8#1)(1993-2#1)(1994-11#1)(1995-12#1)(1995-9#1)(1996-6#2)(1997-2#1)(2004-11#1)(2005-3#1)(2006-10#1)(2006-2#2)(2006-7#1)(2006-8#1)(2007-11#2)(2007-2#2)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#3)(2008-8#1)(2009-1#1)(2009-5#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-5#1)(2013-1#1)
unsatisfactory&quot##2##1##(2008-1#2)
unsatisfied##4##1##(2006-12#1)(2010-2#1)(2010-8#1)(2011-7#1)
unsaturated FA##4##2##(1994-9#1)(2009-3#2)(2012-1#1)
unsaturated alcohols##3##2##(2005-11#2)(2008-10#1)
unsaturated and##2##2##(2008-10#1)(2010-12#1)
unsaturated fats##2##2##(1991-5#1)(2005-12#1)
unsaturated fatty acid##7##3##(1993-6#1)(1993-8#1)(1997-2#1)(2006-10#2)(2010-2#1)(2010-8#1)
unsaturated fatty acids and##4##4##(1990-8#1)(1992-8#1)(1996-7#1)(2008-5#1)
unsaturated fatty acids including##2##4##(1990-8#1)(2005-12#1)
unsaturated fatty acids were##4##4##(1990-8#1)(1996-5#1)(1996-7#1)(2008-11#1)
unsaturated fatty acids##37##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-8#4)(1991-12#1)(1991-4#1)(1991-6#1)(1992-8#1)(1993-3#1)(1993-6#2)(1994-8#3)(1995-11#1)(1996-11#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#2)(2005-10#1)(2005-12#2)(2006-7#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)
unsaturated fatty##45##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-8#4)(1991-12#1)(1991-4#1)(1991-6#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-6#3)(1993-8#1)(1994-8#3)(1995-11#1)(1996-11#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#2)(1997-2#1)(2005-10#1)(2005-12#2)(2006-10#2)(2006-7#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2010-2#1)(2010-8#1)
unsaturated growth factor##2##3##(2007-9#2)
unsaturated ketones##2##2##(1996-5#2)
unsaturated systems##4##2##(1992-6#1)(2008-7#3)
unsaturated to saturated##3##3##(1995-7#1)(2010-4#1)(2011-1#1)
unsaturated to##5##2##(1994-3#1)(1995-7#1)(2010-4#2)(2011-1#1)
unsaturated##110##1##(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#5)(1990-8#4)(1991-12#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#3)(1993-8#1)(1994-2#1)(1994-3#3)(1994-8#4)(1994-9#2)(1995-11#1)(1995-5#1)(1995-7#2)(1996-11#1)(1996-3#2)(1996-5#4)(1996-6#1)(1996-7#3)(1997-2#1)(1997-7#1)(2005-10#1)(2005-11#2)(2005-12#3)(2006-10#3)(2006-12#1)(2006-4#1)(2006-7#1)(2007-11#6)(2007-12#1)(2007-9#2)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#6)(2008-7#7)(2009-3#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-1#2)(2012-1#1)(2012-12#1)
unsaturation in the##3##3##(1990-11#1)(1992-6#2)
unsaturation index##2##2##(1991-9#1)(1994-3#1)
unsaturation is##2##2##(1992-6#1)(1996-5#1)
unsaturation on##2##2##(1990-2#1)(1992-6#1)
unsaturation percentage##2##2##(2008-10#2)
unsaturation##23##1##(1990-11#2)(1990-2#1)(1990-5#1)(1991-9#1)(1992-6#5)(1993-11#1)(1994-3#1)(1995-11#2)(1995-5#1)(1996-5#1)(2008-10#5)(2008-9#1)(2010-4#1)
unscattered##2##1##(2008-3#2)
unscheduled DNA synthesis##6##3##(1992-1#2)(1994-9#3)(2008-11#1)
unscheduled asthma visits##3##3##(2012-1#3)
unscheduled##12##1##(1991-2#1)(1992-1#2)(1994-9#3)(2008-11#1)(2009-6#1)(2012-1#3)(2012-2#1)
unscientific##4##1##(1990-2#1)(2006-12#1)(2008-7#1)(2012-2#1)
unscorable##2##1##(2012-12#2)
unscreened##8##1##(1993-12#1)(1997-5#3)(2004-2#2)(2007-11#1)(2007-12#1)
unscrupulous##2##1##(1997-3#1)(2006-12#1)
unsealed##2##1##(2007-2#1)(2008-11#1)
unsedated colonoscopy##5##2##(2010-12#5)
unsedated endoscopy##2##2##(2006-10#2)
unsedated##8##1##(2006-10#2)(2010-12#6)
unseeded##5##1##(2007-11#1)(2007-12#1)(2008-3#3)
unseen##9##1##(2006-12#1)(2008-6#1)(2008-7#1)(2010-2#1)(2010-4#1)(2010-8#1)(2012-12#1)(2013-1#2)
unsegmented##3##1##(2007-3#1)(2008-10#2)
unselected controls##2##2##(1993-5#1)(2008-8#1)
unselected patients##4##2##(1991-5#1)(1997-7#1)(2006-8#1)(2007-8#1)
unselected stroke##2##2##(2007-10#1)(2008-8#1)
unselected##24##1##(1991-5#1)(1992-9#1)(1993-5#1)(1993-9#1)(1996-2#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#1)(2006-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2012-2#1)(2012-3#3)
unselective##2##1##(2009-8#1)(2010-5#1)
unsensed and uncorrectable##2##3##(2008-3#2)
unsensitized##4##1##(1992-1#2)(2008-10#2)
unseparated##4##1##(2008-10#1)(2008-4#3)
unsettled questions##2##2##(1990-11#1)(2011-1#1)
unsettled##9##1##(1990-11#1)(1992-12#1)(2006-7#1)(2007-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
unsettles##2##1##(1995-3#1)(2005-3#1)
unsettling##2##1##(1997-3#1)(2009-10#1)
unshared##2##1##(1994-11#1)(2010-8#1)
unshaved##2##1##(2008-5#2)
unshielded##2##1##(2008-7#1)(2013-1#1)
unshifted photorefractive##2##2##(2007-11#2)
unshifted##5##1##(1993-12#1)(1993-6#1)(2007-11#2)(2008-3#1)
unsightly##3##1##(2008-5#1)(2012-3#2)
unsigned##3##1##(1996-6#1)(2012-12#2)
unskilled attendants##2##2##(2006-7#2)
unskilled workers##2##2##(2006-10#1)(2011-12#1)
unskilled##10##1##(1994-4#1)(1995-5#1)(2006-10#1)(2006-7#2)(2011-12#1)(2012-2#1)(2013-1#3)
unsolicited##2##1##(1996-11#1)(2010-4#1)
unsolvable##2##1##(2008-10#1)(2010-12#1)
unsolved issues##3##2##(2006-10#1)(2006-7#1)(2009-8#1)
unsolved problem##5##2##(1990-11#1)(1990-12#1)(2006-10#1)(2007-7#1)(2008-2#1)
unsolved problems##3##2##(2007-12#1)(2010-9#1)(2011-1#1)
unsolved##25##1##(1990-11#1)(1990-12#2)(1992-1#1)(1993-6#1)(1993-8#1)(2006-10#2)(2006-7#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-12#1)(2008-2#1)(2009-2#1)(2009-8#1)(2010-3#1)(2010-9#1)(2011-1#2)(2012-2#2)(2012-3#1)(2013-7#1)
unsound and##2##2##(2006-7#1)(2012-3#1)
unsound##3##1##(1995-4#1)(2006-7#1)(2012-3#1)
unspecialized##2##1##(2007-3#1)(2008-9#1)
unspecific and##2##2##(2008-5#1)(2013-8#1)
unspecific##22##1##(1990-11#1)(1992-10#1)(1993-6#1)(1993-8#1)(1994-3#1)(1995-7#1)(1996-1#1)(1996-9#1)(1997-1#1)(1997-4#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2011-2#2)(2012-11#2)(2012-2#2)(2013-8#1)
unspecified##14##1##(1990-4#2)(1991-8#1)(1994-11#1)(1996-12#1)(1996-5#1)(2007-11#1)(2007-3#1)(2008-11#1)(2008-4#1)(2009-8#1)(2010-2#1)(2010-7#1)(2012-3#1)
unspiked samples##2##2##(1990-12#1)(2008-10#1)
unspiked##5##1##(1990-12#1)(1992-8#1)(2008-10#3)
unspliced RNA##3##2##(1990-4#1)(1990-6#1)(1996-5#1)
unspliced and##2##2##(1997-4#1)(2011-3#1)
unspliced##12##1##(1990-4#1)(1990-6#1)(1991-10#1)(1993-12#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-3#1)(1996-5#2)(1997-4#1)(2011-3#1)
unsprayed areas##2##2##(2008-10#2)
unsprayed##9##1##(2008-10#8)(2011-2#1)
unstabile##2##1##(2007-11#2)
unstable aberrations##2##2##(2013-8#2)
unstable after##2##2##(2008-4#1)(2012-3#1)
unstable alleles##2##2##(2009-5#2)
unstable and##18##2##(1990-12#1)(1991-4#1)(1992-12#1)(1993-7#1)(1995-8#2)(1996-2#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-5#1)(2012-12#2)(2013-1#1)
unstable angina (UA)##3##3##(2005-7#1)(2013-1#1)(2013-8#1)
unstable angina and acute##2##4##(2007-11#1)(2007-8#1)
unstable angina and non-Q-wave##2##4##(2005-12#1)(2005-7#1)
unstable angina and non-ST elevation myocardial infarction in##2##8##(2008-3#2)
unstable angina and non-ST elevation myocardial infarction##5##7##(2008-3#5)
unstable angina and##13##3##(2005-10#2)(2005-12#1)(2005-7#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-3#5)(2008-5#1)
unstable angina or##3##3##(2007-8#2)(2008-5#1)
unstable angina patients##2##3##(2007-1#2)
unstable angina pectoris and##5##4##(1990-12#1)(1991-9#4)
unstable angina pectoris##12##3##(1990-12#3)(1991-9#5)(1996-9#1)(2006-6#1)(2007-11#1)(2011-2#1)
unstable angina##62##2##(1990-12#3)(1991-9#6)(1992-9#1)(1996-9#1)(2005-10#2)(2005-12#2)(2005-7#4)(2006-10#1)(2006-6#2)(2006-7#1)(2007-1#3)(2007-11#5)(2007-7#2)(2007-8#5)(2007-9#1)(2008-10#1)(2008-3#9)(2008-5#4)(2010-12#1)(2011-2#1)(2012-1#2)(2013-1#2)(2013-8#3)
unstable angina/non-ST elevation myocardial infarction##3##5##(2008-3#2)(2009-12#1)
unstable angina/non-ST elevation##4##3##(2008-3#2)(2009-12#1)(2010-12#1)
unstable at##4##2##(1990-2#1)(1990-6#1)(2008-10#1)(2010-8#1)
unstable atherosclerotic plaques##3##3##(2008-4#3)
unstable b-NOS##2##2##(1995-5#2)
unstable cells##2##2##(1995-6#1)(2008-7#1)
unstable coronary##3##2##(2006-6#1)(2009-10#1)(2012-2#1)
unstable distal##3##2##(2006-3#1)(2006-4#1)(2008-9#1)
unstable domains##3##2##(2007-12#2)(2012-2#1)
unstable during the##2##3##(1996-3#1)(2011-7#1)
unstable during##3##2##(1990-5#1)(1996-3#1)(2011-7#1)
unstable form of the##2##4##(1995-5#2)
unstable fractures of the##3##4##(2006-3#1)(2006-8#1)(2007-8#1)
unstable fractures##5##2##(2006-3#1)(2006-8#1)(2007-8#3)
unstable hip##2##2##(2007-7#1)(2009-4#1)
unstable in strong##2##3##(1995-8#1)(2008-11#1)
unstable in the##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2010-1#1)
unstable in##15##2##(1990-11#1)(1990-3#1)(1991-2#1)(1991-8#1)(1992-2#1)(1995-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-1#1)(2011-1#1)
unstable intermediate##3##2##(2008-10#1)(2008-5#1)(2010-2#1)
unstable laser##3##2##(2007-12#1)(2008-2#2)
unstable malaria transmission##2##3##(2006-4#1)(2011-2#1)
unstable malaria##3##2##(2006-4#1)(2011-2#1)(2012-12#1)
unstable or##5##2##(1997-6#1)(2006-4#1)(2006-5#1)(2008-10#1)(2013-1#1)
unstable preferred orientation##3##3##(2013-7#3)
unstable resonator with##3##3##(2008-3#3)
unstable resonator##15##2##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#9)
unstable resonators with a##2##4##(2008-3#2)
unstable resonators##11##2##(2007-11#1)(2008-2#3)(2008-3#7)
unstable since##2##2##(1990-7#1)(1991-2#1)
unstable steady##2##2##(1992-11#1)(2006-10#1)
unstable thoracolumbar burst fractures##4##4##(2006-8#4)
unstable thoracolumbar##6##2##(2006-8#5)(2012-2#1)
unstable to heat and##2##4##(1994-11#1)(1994-9#1)
unstable to##8##2##(1990-7#1)(1992-9#1)(1994-11#1)(1994-9#1)(1995-1#1)(1996-5#1)(2005-11#1)(2010-12#1)
unstable type##3##2##(2007-11#1)(2007-8#1)(2013-8#1)
unstable under##2##2##(1990-12#1)(1991-5#1)
unstable when the##2##3##(1994-5#1)(2005-11#1)
unstable##365##1##(1990-11#1)(1990-12#6)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#4)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#2)(1991-8#1)(1991-9#6)(1992-11#1)(1992-12#1)(1992-2#2)(1992-5#2)(1992-7#1)(1992-9#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#2)(1993-8#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#2)(1995-5#6)(1995-6#2)(1995-8#6)(1996-11#1)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#1)(1996-8#1)(1996-9#2)(1997-4#2)(1997-5#1)(1997-6#1)(2004-11#1)(2005-10#3)(2005-11#6)(2005-12#3)(2005-2#1)(2005-7#4)(2005-9#1)(2006-10#2)(2006-11#2)(2006-3#6)(2006-4#4)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#7)(2007-1#7)(2007-10#1)(2007-11#12)(2007-12#11)(2007-2#1)(2007-6#1)(2007-7#5)(2007-8#14)(2007-9#4)(2008-1#3)(2008-10#16)(2008-11#3)(2008-12#1)(2008-2#14)(2008-3#35)(2008-4#7)(2008-5#7)(2008-6#2)(2008-7#2)(2008-8#7)(2008-9#7)(2009-10#2)(2009-12#1)(2009-2#1)(2009-4#5)(2009-5#4)(2009-6#1)(2010-1#1)(2010-12#5)(2010-2#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2011-7#1)(2012-1#3)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#7)(2013-7#4)(2013-8#12)
unstable&quot##2##1##(2006-11#1)(2008-4#1)
unstable-cavity lasers with##2##3##(2008-3#2)
unstable-cavity lasers##4##2##(2007-12#2)(2008-3#2)
unstable-cavity##5##1##(2007-12#3)(2008-3#2)
unstable-resonator solid-state laser##2##3##(2007-12#2)
unstacked##2##1##(1991-7#1)(1997-6#1)
unstained cells##2##2##(2007-12#1)(2008-11#1)
unstained##11##1##(1991-4#1)(1996-12#1)(2004-9#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-4#1)(2011-1#1)(2012-1#1)(2012-2#1)
unsteadiness##2##1##(2007-9#1)(2011-1#1)
unsteady aerodynamic##3##2##(2005-10#1)(2007-12#1)(2008-2#1)
unsteady state##4##2##(1990-2#1)(1996-12#1)(2010-6#2)
unsteady##21##1##(1990-2#1)(1994-3#1)(1996-12#1)(2005-10#4)(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#1)(2009-9#2)(2010-6#2)(2013-1#1)(2013-8#1)
unsteamed##2##1##(2008-10#2)
unsterile##3##1##(2006-12#1)(2007-2#1)(2007-7#1)
unsterilized##4##1##(2006-9#2)(2008-10#2)
unstimulated T cells##3##3##(1992-4#1)(1996-1#1)(1997-6#1)
unstimulated and stimulated##4##3##(1992-8#1)(1997-8#1)(2007-10#1)(2011-2#1)
unstimulated and##5##2##(1992-8#1)(1997-8#1)(2007-10#1)(2011-2#1)(2012-2#1)
unstimulated cells##10##2##(1991-8#2)(1992-12#1)(1993-8#1)(1994-2#1)(1994-8#1)(1996-11#2)(2006-10#1)(2008-11#1)
unstimulated control##2##2##(1994-2#1)(2007-2#1)
unstimulated lymphocytes##2##2##(1996-1#2)
unstimulated platelets##4##2##(1990-12#1)(1990-5#2)(1991-4#1)
unstimulated whole saliva flow rate##2##5##(2013-8#2)
unstimulated whole##3##2##(1991-8#1)(2013-8#2)
unstimulated##53##1##(1990-11#1)(1990-12#1)(1990-5#2)(1991-2#1)(1991-4#1)(1991-8#3)(1991-9#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#1)(1992-9#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-8#1)(1995-12#1)(1995-8#1)(1996-1#3)(1996-11#3)(1996-2#1)(1997-6#1)(1997-8#1)(2006-10#2)(2006-7#3)(2007-10#2)(2007-2#1)(2007-7#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#4)
unstirred##10##1##(1991-5#7)(2008-10#1)(2008-11#1)(2008-8#1)
unstratified##3##1##(1994-9#1)(1995-9#1)(2008-3#1)
unstressed##9##1##(1992-1#1)(1993-2#1)(1994-3#1)(1995-5#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-2#1)(2013-8#1)
unstructured absorption spectra##3##3##(2008-3#3)
unstructured and##2##2##(1991-3#1)(2006-1#1)
unstructured interviews were conducted##2##4##(2010-3#1)(2012-12#1)
unstructured interviews were##3##3##(2008-11#1)(2010-3#1)(2012-12#1)
unstructured interviews##5##2##(2008-11#2)(2010-10#1)(2010-3#1)(2012-12#1)
unstructured##49##1##(1991-12#1)(1991-3#1)(1991-7#1)(1993-9#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-11#2)(1997-2#1)(1997-6#1)(2005-7#1)(2006-1#1)(2008-11#3)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#11)
unsubstantiated##4##1##(1992-12#1)(2005-8#1)(2008-3#1)(2010-2#1)
unsubstituted##18##1##(1990-4#1)(1990-7#1)(1991-3#1)(1991-8#1)(1992-3#2)(1995-2#1)(1997-2#3)(1997-3#2)(2008-10#3)(2008-3#1)(2009-3#1)(2012-2#1)
unsuccessful and##4##2##(1990-12#1)(1991-7#1)(2007-7#1)(2007-8#1)
unsuccessful attempts to##3##3##(1993-7#1)(1995-6#1)(2004-9#1)
unsuccessful attempts##6##2##(1993-7#1)(1995-6#1)(2004-9#1)(2007-7#1)(2010-12#2)
unsuccessful due to the##2##4##(1993-11#1)(2008-10#1)
unsuccessful in the##2##3##(1992-9#1)(2007-12#1)
unsuccessful in##6##2##(1991-12#1)(1992-9#1)(1993-9#1)(2007-12#1)(2007-7#1)(2008-11#1)
unsuccessful treatment with##2##3##(2013-7#2)
unsuccessful##93##1##(1990-12#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-3#2)(1995-1#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-4#1)(1996-5#2)(1997-1#3)(1997-6#1)(1997-8#1)(2004-9#1)(2005-11#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#4)(2007-12#1)(2007-4#1)(2007-7#4)(2007-8#3)(2007-9#2)(2008-10#4)(2008-11#5)(2008-12#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#2)(2010-12#3)(2010-3#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#3)
unsuccessfully treated with##4##3##(2010-12#1)(2010-2#1)(2013-1#2)
unsuccessfully treated##5##2##(2010-12#1)(2010-2#2)(2013-1#2)
unsuccessfully##11##1##(1990-9#1)(1996-6#1)(2006-4#1)(2007-2#1)(2007-7#1)(2008-10#1)(2010-12#1)(2010-2#2)(2013-1#2)
unsuitable as a##3##3##(1990-11#1)(2007-11#1)(2008-10#1)
unsuitable as##5##2##(1990-11#1)(2007-11#1)(2007-8#1)(2008-10#2)
unsuitable because##2##2##(2005-9#1)(2008-12#1)
unsuitable for further##2##3##(2008-7#1)(2011-2#1)
unsuitable for transplantation##2##3##(2008-3#1)(2009-2#1)
unsuitable for use in##2##4##(2008-10#1)(2008-9#1)
unsuitable for##31##2##(1990-1#1)(1990-4#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-2#1)(1993-4#1)(1994-9#1)(1996-5#1)(2005-10#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#4)(2008-9#3)(2009-2#1)(2010-6#2)(2011-2#1)
unsuitable to##2##2##(2008-10#1)(2013-7#1)
unsuitable##57##1##(1990-1#1)(1990-11#2)(1990-4#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-2#1)(1993-4#1)(1994-5#1)(1994-9#1)(1996-5#1)(2005-10#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-3#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#3)(2009-2#1)(2010-12#1)(2010-6#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#1)
unsuited##2##1##(2008-4#1)(2008-9#1)
unsupervised learning##4##2##(2008-3#1)(2008-7#1)(2013-1#2)
unsupervised pattern recognition##4##3##(2008-10#2)(2009-3#1)(2010-5#1)
unsupervised##23##1##(2005-9#1)(2006-2#1)(2006-5#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-5#1)(2010-7#1)(2013-1#4)
unsupplemented plasma##3##2##(1997-8#3)
unsupplemented##10##1##(1992-9#1)(1993-4#1)(1994-5#1)(1995-5#1)(1997-8#3)(2007-7#1)(2011-2#2)
unsupported and##3##2##(1995-8#2)(2010-1#1)
unsupported##6##1##(1995-8#3)(2008-7#1)(2008-9#1)(2010-1#1)
unsupportive##7##1##(1996-11#1)(2007-7#1)(2010-11#1)(2011-1#2)(2012-12#1)(2013-7#1)
unsure of##3##2##(1990-12#1)(1992-10#1)(2008-11#1)
unsure##10##1##(1990-12#1)(1992-10#1)(1993-8#2)(2006-10#1)(2006-5#1)(2008-11#3)(2012-12#1)
unsurprising##2##1##(2010-10#1)(2012-2#1)
unsuspected##22##1##(1990-6#1)(1992-12#1)(1992-3#1)(1994-2#1)(1994-3#1)(1996-4#1)(1997-6#2)(2006-10#1)(2006-6#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#2)(2012-3#1)
unsustainable##6##1##(2006-7#1)(2007-4#2)(2007-5#1)(2008-7#1)(2011-7#1)
unsustained##3##1##(2006-11#1)(2009-10#2)
unsymmetrical 2##2##2##(2007-11#2)
unsymmetrical##14##1##(1994-9#1)(1996-11#1)(2007-11#6)(2008-10#4)(2008-5#2)
unsynchronized##2##1##(2008-9#1)(2010-4#1)
untagged##3##1##(1994-8#1)(1997-3#1)(2009-10#1)
untapped resource##2##2##(1995-12#1)(2011-1#1)
untapped##10##1##(1990-5#1)(1992-1#1)(1995-12#1)(1996-12#1)(1996-4#1)(2008-11#1)(2008-7#1)(2010-2#1)(2011-1#1)(2012-3#1)
untargeted##3##1##(1995-6#1)(2008-7#1)(2010-5#1)
untenable##4##1##(1995-8#1)(2008-5#1)(2009-5#1)(2009-9#1)
untestable assumptions##2##2##(2011-2#2)
untestable##3##1##(2010-8#1)(2011-2#2)
untested##9##1##(1991-2#1)(1993-12#1)(1993-3#1)(1994-3#1)(2006-10#1)(2008-5#2)(2009-8#1)(2012-2#1)
until 1##3##2##(1990-2#1)(1990-4#1)(2008-8#1)
until 12 months##2##3##(1990-4#1)(1992-8#1)
until 12##6##2##(1990-4#1)(1992-11#1)(1992-8#1)(1995-11#1)(1997-3#1)(2008-4#1)
until 120##2##2##(2007-8#1)(2008-7#1)
until 1980##2##2##(2007-7#1)(2012-2#1)
until 1991##3##2##(1993-5#1)(2008-10#1)(2008-7#1)
until 1993##5##2##(1995-12#1)(1997-5#1)(2006-10#3)
until 1994##2##2##(1996-2#1)(2007-5#1)
until 1996##3##2##(1996-11#1)(2005-9#1)(2007-5#1)
until 1999##2##2##(2004-9#1)(2008-8#1)
until 2 to##2##3##(2008-10#1)(2013-8#1)
until 2##6##2##(1995-5#1)(2007-10#1)(2008-10#2)(2009-4#1)(2013-8#1)
until 20##2##2##(1995-10#1)(1995-12#1)
until 2005##2##2##(2011-2#1)(2012-6#1)
until 2006##2##2##(2007-9#1)(2008-10#1)
until 2008##2##2##(2010-8#1)(2011-2#1)
until 24##2##2##(1997-7#1)(2007-9#1)
until 3 to 5 weeks##2##5##(2008-10#2)
until 3 to##4##3##(2008-10#3)(2009-3#1)
until 31 December##2##3##(2008-6#1)(2008-7#1)
until 4 weeks##3##3##(2008-10#1)(2012-12#1)(2013-8#1)
until 4##6##2##(1993-7#1)(1996-12#1)(2008-10#2)(2012-12#1)(2013-8#1)
until 48 hours##4##3##(1992-11#4)
until 48##6##2##(1992-11#4)(1995-2#1)(2006-12#1)
until 5##3##2##(2008-1#1)(2008-10#1)(2011-2#1)
until 6 to##2##3##(1997-3#1)(2008-10#1)
until 6##3##2##(1991-8#1)(1997-3#1)(2008-10#1)
until 8 h##2##3##(1996-12#1)(2013-1#1)
until 8##4##2##(1991-3#1)(1996-12#1)(2008-10#1)(2013-1#1)
until 9 months##2##3##(2008-3#1)(2013-1#1)
until April##4##2##(1990-6#1)(1992-6#1)(2006-8#1)(2008-10#1)
until August##2##2##(2007-5#1)(2011-2#1)
until Day##2##2##(1994-9#1)(2008-9#1)
until December 2008##2##3##(2011-2#1)(2013-1#1)
until December##8##2##(2007-3#1)(2008-3#2)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
until February##3##2##(1994-12#1)(1996-12#1)(2007-3#1)
until July##3##2##(1996-5#1)(1997-2#1)(2008-10#1)
until June##5##2##(1996-5#1)(2008-10#2)(2011-2#1)(2013-8#1)
until M##2##2##(1992-8#1)(2012-12#1)
until May##3##2##(1995-4#1)(1995-6#1)(2008-10#1)
until November##2##2##(2007-8#1)(2011-2#1)
until October##4##2##(1997-7#1)(2006-1#1)(2006-7#1)(2006-8#1)
until September##2##2##(2006-10#1)(2013-7#1)
until a new##2##3##(1996-8#1)(2010-6#1)
until a plateau##2##3##(1997-7#1)(2010-8#1)
until a significant##2##3##(2011-1#1)(2011-12#1)
until a##25##2##(1991-1#1)(1991-9#1)(1992-9#1)(1995-1#1)(1995-3#1)(1995-4#1)(1996-8#1)(1997-3#1)(1997-7#1)(2004-1#1)(2005-10#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)(2009-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-1#1)
until about##7##2##(1996-12#1)(1996-3#2)(2006-1#1)(2006-10#1)(2007-3#1)(2012-1#1)
until adulthood##5##2##(1993-12#1)(2008-10#2)(2010-12#1)(2011-2#1)
until after 1945##2##3##(2006-2#1)(2009-4#1)
until after##8##2##(1995-2#1)(2006-2#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-4#1)(2010-6#1)
until age##2##2##(1991-10#1)(1996-6#1)
until all##4##2##(1991-4#1)(2005-11#1)(2008-11#1)(2012-3#1)
until an##3##2##(2007-9#1)(2008-4#1)(2011-2#1)
until at least##3##3##(1992-7#1)(2008-10#1)(2011-12#1)
until complete##3##2##(1994-2#1)(2008-10#1)(2008-9#1)
until confluent##2##2##(2008-7#1)(2013-1#1)
until day 25##2##3##(1992-9#1)(2012-2#1)
until day 3##3##3##(1991-1#1)(1997-4#1)(2007-12#1)
until day##13##2##(1991-1#1)(1992-9#1)(1994-8#1)(1996-10#1)(1997-4#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)(2012-2#1)
until death##9##2##(1994-10#1)(1996-3#1)(2007-8#1)(2008-6#1)(2009-4#1)(2012-11#4)
until disease##3##2##(1992-4#1)(2008-10#2)
until either##2##2##(2008-3#1)(2009-3#1)
until exhaustion##2##2##(2007-10#1)(2013-8#1)
until failure##3##2##(2008-6#1)(2009-7#1)(2013-8#1)
until first cannulation##2##3##(2007-7#2)
until first##4##2##(1994-8#1)(2007-7#2)(2008-10#1)
until full recovery##2##3##(2006-10#1)(2010-12#1)
until full##4##2##(2006-10#1)(2008-12#1)(2008-7#1)(2010-12#1)
until further##3##2##(2006-12#1)(2008-3#1)(2012-12#1)
until harvest##8##2##(2008-10#8)
until hatching##4##2##(1993-6#1)(1994-9#1)(1995-5#1)(2008-5#1)
until he##2##2##(2007-6#1)(2008-1#1)
until his death in##2##4##(2006-4#1)(2013-8#1)
until his death##5##3##(1995-3#1)(2006-4#1)(2007-5#1)(2008-7#1)(2013-8#1)
until his##9##2##(1995-3#1)(1997-5#1)(2006-4#1)(2007-11#1)(2007-5#1)(2008-7#2)(2010-3#1)(2013-8#1)
until hospital discharge##2##3##(2007-2#1)(2013-8#1)
until it becomes##2##3##(1993-2#1)(2007-12#1)
until it is##3##3##(1990-11#1)(1995-5#1)(2008-8#1)
until it reaches##2##3##(1997-2#1)(2008-11#1)
until it was##2##3##(1992-2#1)(2010-1#1)
until it##14##2##(1990-11#1)(1992-2#1)(1993-2#2)(1995-2#1)(1995-5#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-1#1)(2013-1#1)
until its##5##2##(2007-8#1)(2008-2#1)(2009-4#1)(2009-7#1)(2011-12#1)
until late in##3##3##(2008-10#3)
until late##7##2##(2008-10#6)(2010-9#1)
until later in life##2##4##(2008-4#1)(2012-3#1)
until later in##4##3##(1995-2#1)(1997-5#1)(2008-4#1)(2012-3#1)
until long-term##3##2##(2007-3#1)(2007-8#1)(2008-3#1)
until loss of##2##3##(2007-8#1)(2012-3#1)
until maximum##2##2##(1990-8#1)(2008-10#1)
until more than##3##3##(1992-8#1)(1995-10#1)(2008-5#1)
until more##5##2##(1992-8#1)(1995-10#1)(2008-10#1)(2008-5#1)(2008-9#1)
until new##2##2##(1990-3#1)(2011-1#1)
until no##2##2##(1994-5#1)(2008-10#1)
until now been##5##3##(1992-12#1)(2007-4#1)(2008-2#1)(2010-7#1)(2012-2#1)
until now has##2##3##(1992-11#1)(2008-7#1)
until now have##2##3##(1997-7#1)(2006-10#1)
until now##43##2##(1990-10#1)(1990-3#1)(1991-1#1)(1991-4#1)(1992-11#1)(1992-12#1)(1993-10#1)(1993-4#1)(1995-11#1)(1996-12#1)(1996-9#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-4#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-7#2)(2011-1#3)(2011-2#2)(2012-2#2)(2012-7#1)
until one##2##2##(1996-3#1)(2009-12#1)
until other##2##2##(1997-2#1)(2008-3#1)
until puberty and##2##3##(1995-12#1)(2008-5#1)
until puberty##3##2##(1995-12#1)(2008-1#1)(2008-5#1)
until reaching the##2##3##(1990-4#1)(2008-5#1)
until reaching##3##2##(1990-4#1)(2008-11#1)(2008-5#1)
until recently has##2##3##(2006-7#1)(2011-7#1)
until recently there has been little##2##6##(2009-4#1)(2012-1#1)
until recently##35##2##(1993-2#1)(1993-7#1)(1994-8#1)(1996-2#1)(2005-12#1)(2005-8#1)(2006-12#1)(2006-7#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-4#1)(2009-5#1)(2010-4#1)(2011-1#2)(2011-2#3)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)
until resolution##2##2##(1991-8#1)(2010-1#1)
until restoration of##2##3##(2006-10#1)(2011-1#1)
until senescence##4##2##(1990-4#3)(1991-6#1)
until some time##2##3##(1997-3#1)(2008-9#1)
until some##3##2##(1997-3#1)(2005-11#1)(2008-9#1)
until stage##3##2##(1994-9#1)(2008-10#1)(2012-2#1)
until symptoms##2##2##(2006-9#1)(2008-7#1)
until the 1950s##2##3##(2008-10#1)(2012-2#1)
until the administration of##2##4##(1993-10#1)(2011-2#1)
until the advent of##2##4##(2008-7#1)(2010-3#1)
until the age of##5##4##(1997-2#1)(2007-7#1)(2008-4#1)(2008-5#1)(2012-2#1)
until the appearance of##2##4##(2007-7#1)(2008-5#1)
until the end of the experiment##5##6##(1992-9#1)(1996-6#2)(2008-4#1)(2008-9#1)
until the end of the study##3##6##(1995-3#1)(2008-8#1)(2008-9#1)
until the end of the##13##5##(1991-12#1)(1992-8#1)(1992-9#2)(1995-3#1)(1996-6#2)(2007-2#1)(2008-4#1)(2008-8#1)(2008-9#2)(2010-8#1)
until the end of##24##4##(1991-12#1)(1992-3#1)(1992-8#1)(1992-9#2)(1995-3#1)(1996-6#2)(2006-10#2)(2007-2#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
until the final##5##3##(2007-10#1)(2007-12#1)(2007-8#1)(2008-2#1)(2009-8#1)
until the first##3##3##(1992-9#1)(2008-7#1)(2012-2#1)
until the introduction of##2##4##(1992-3#1)(2011-7#1)
until the last decade##2##4##(2008-1#1)(2008-8#1)
until the last##6##3##(1994-3#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-8#1)
until the late##3##3##(2005-7#1)(2008-7#1)(2010-1#1)
until the mid-blastula transition##2##4##(1994-5#2)
until the onset of##2##4##(2007-11#1)(2008-6#1)
until the patient##4##3##(1992-1#1)(2006-2#1)(2007-11#1)(2007-8#1)
until the second##3##3##(1996-11#1)(2005-8#1)(2009-3#1)
until the sixth##2##3##(1990-6#1)(2013-1#1)
until the year##2##3##(1990-6#1)(1997-4#1)
until the##185##2##(1990-6#2)(1991-12#2)(1991-4#3)(1991-9#1)(1992-1#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-10#2)(1993-12#1)(1993-3#1)(1993-4#1)(1994-3#2)(1994-5#2)(1994-7#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-11#1)(1996-2#2)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-6#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#7)(2006-12#1)(2006-2#2)(2006-4#1)(2006-6#1)(2006-7#2)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#15)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-12#3)(2010-3#1)(2010-6#1)(2010-8#4)(2011-1#3)(2011-2#9)(2011-7#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
until their##5##2##(1991-11#1)(1994-9#1)(2008-1#1)(2009-12#1)(2011-2#1)
until then##4##2##(2006-12#1)(2008-10#1)(2009-2#2)
until there are##2##3##(1996-3#1)(2008-3#1)
until there is##5##3##(1993-3#2)(1996-3#1)(2008-5#1)(2009-5#1)
until there was##3##3##(1990-11#1)(1994-8#1)(2008-10#1)
until there##12##2##(1990-11#1)(1993-3#2)(1994-8#1)(1996-3#2)(2007-4#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-5#1)
until these##2##2##(2008-1#1)(2011-2#1)
until they are##4##3##(1996-12#1)(2008-11#1)(2008-5#1)(2012-11#1)
until they become##2##3##(2007-9#1)(2008-10#1)
until they##17##2##(1990-2#1)(1991-11#1)(1992-1#1)(1992-11#1)(1996-1#1)(1996-12#1)(2007-1#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-11#1)
until this##2##2##(1994-8#1)(2004-11#1)
until today##3##2##(1995-4#1)(2008-10#2)
until true##2##2##(1997-6#2)
until very recently##4##3##(1995-2#1)(2005-7#1)(2008-11#1)(2008-5#1)
until we##2##2##(1995-9#1)(2008-2#1)
until weaning##2##2##(1992-9#1)(2008-7#1)
until week##2##2##(2006-9#1)(2008-3#1)
until you##2##2##(2003-11#1)(2007-11#1)
until##899##1##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#2)(1990-4#6)(1990-5#1)(1990-6#4)(1990-8#2)(1990-9#1)(1991-1#3)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#1)(1991-3#3)(1991-4#5)(1991-6#1)(1991-8#3)(1991-9#2)(1992-1#4)(1992-11#8)(1992-12#2)(1992-2#2)(1992-3#4)(1992-4#2)(1992-6#2)(1992-7#3)(1992-8#5)(1992-9#7)(1993-1#1)(1993-10#3)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#5)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#3)(1993-9#2)(1994-10#2)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#3)(1994-5#3)(1994-6#1)(1994-7#2)(1994-8#5)(1994-9#4)(1995-1#1)(1995-10#2)(1995-11#4)(1995-12#4)(1995-2#7)(1995-3#4)(1995-4#6)(1995-5#5)(1995-6#1)(1995-9#1)(1996-1#3)(1996-10#2)(1996-11#2)(1996-12#7)(1996-2#5)(1996-3#6)(1996-5#2)(1996-6#5)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#10)(1997-3#7)(1997-4#2)(1997-5#4)(1997-6#5)(1997-7#4)(1997-8#3)(2003-11#1)(2004-1#1)(2004-11#1)(2004-9#1)(2005-10#2)(2005-11#5)(2005-12#2)(2005-5#1)(2005-7#2)(2005-8#2)(2005-9#2)(2006-1#2)(2006-10#22)(2006-11#1)(2006-12#6)(2006-2#6)(2006-4#4)(2006-5#3)(2006-6#2)(2006-7#4)(2006-8#4)(2006-9#4)(2007-1#2)(2007-10#4)(2007-11#10)(2007-12#9)(2007-2#5)(2007-3#4)(2007-4#8)(2007-5#8)(2007-6#1)(2007-7#14)(2007-8#18)(2007-9#6)(2008-1#11)(2008-10#101)(2008-11#12)(2008-12#6)(2008-2#10)(2008-3#17)(2008-4#7)(2008-5#24)(2008-6#9)(2008-7#24)(2008-8#15)(2008-9#14)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#5)(2009-3#4)(2009-4#8)(2009-5#4)(2009-7#5)(2009-8#4)(2009-9#1)(2010-1#6)(2010-10#1)(2010-11#1)(2010-12#13)(2010-2#1)(2010-3#4)(2010-4#6)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#13)(2010-9#1)(2011-1#13)(2011-12#4)(2011-2#35)(2011-7#5)(2012-1#6)(2012-11#8)(2012-12#7)(2012-2#19)(2012-3#6)(2012-6#1)(2012-7#2)(2013-1#20)(2013-7#4)(2013-8#15)
untilted##2##1##(2008-3#1)(2013-1#1)
untouched##7##1##(2008-11#2)(2008-6#1)(2010-5#1)(2011-12#1)(2012-3#1)(2013-7#1)
untoward effects were##2##3##(1992-5#1)(2007-7#1)
untoward effects##4##2##(1990-2#1)(1992-5#1)(1993-9#1)(2007-7#1)
untoward side-effects##2##2##(2008-2#1)(2008-4#1)
untoward##16##1##(1990-2#1)(1990-4#1)(1992-5#1)(1993-9#1)(1994-12#1)(1994-2#1)(1997-4#1)(1997-7#1)(2004-10#1)(2005-12#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-12#1)
untrained female rats##3##3##(2013-1#3)
untrained individuals##2##2##(2007-2#1)(2008-12#1)
untrained limb##2##2##(2013-8#2)
untrained rats##2##2##(1992-8#1)(2013-1#1)
untrained structures##2##2##(2007-4#2)
untrained##29##1##(1992-8#2)(1993-2#2)(1995-12#1)(1996-12#1)(1997-5#1)(2007-1#1)(2007-2#1)(2007-4#5)(2008-12#1)(2008-2#1)(2009-7#1)(2010-12#1)(2010-7#1)(2013-1#7)(2013-8#3)
untransfected cells##3##2##(1991-12#1)(2008-4#1)(2012-12#1)
untransfected control##2##2##(2008-11#1)(2008-8#1)
untransfected##7##1##(1991-12#1)(2007-1#1)(2008-11#1)(2008-4#1)(2008-8#1)(2012-12#1)(2012-3#1)
untransformed C127 cells##3##3##(1991-7#3)
untransformed cells##4##2##(1993-2#2)(1995-8#1)(2011-2#1)
untransformed steroid##3##2##(1990-5#2)(1997-4#1)
untransformed##25##1##(1990-10#1)(1990-5#4)(1991-7#6)(1991-9#1)(1993-2#2)(1994-8#1)(1995-4#1)(1995-5#1)(1995-8#1)(1997-4#1)(2006-12#1)(2008-10#2)(2008-4#1)(2009-12#1)(2011-2#1)
untranslatable##3##1##(2008-10#1)(2012-12#1)(2012-2#1)
untranslated 5'##2##2##(1997-5#1)(2008-10#1)
untranslated leader##3##2##(1990-12#1)(1994-8#1)(1997-2#1)
untranslated region (UTR)##5##3##(1992-8#1)(1997-5#1)(2007-12#1)(2008-10#2)
untranslated region and##4##3##(1992-3#1)(1994-5#1)(1995-10#1)(2008-8#1)
untranslated region is##2##3##(1991-9#1)(2008-8#1)
untranslated region of the##6##4##(1990-5#1)(1991-10#1)(1991-9#2)(1995-2#1)(1997-6#1)
untranslated region of##20##3##(1990-5#1)(1991-10#1)(1991-11#1)(1991-9#2)(1992-11#1)(1992-3#1)(1994-11#2)(1994-5#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-6#2)(1997-8#1)(2007-2#1)(2008-11#1)(2008-7#1)(2012-2#1)
untranslated region that##2##3##(1996-12#1)(2008-10#1)
untranslated region##57##2##(1990-2#1)(1990-5#1)(1991-10#1)(1991-11#1)(1991-7#2)(1991-9#3)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#1)(1993-12#1)(1993-5#2)(1993-6#1)(1994-11#4)(1994-3#1)(1994-5#2)(1994-8#1)(1995-10#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-8#1)(2007-12#2)(2007-2#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#2)(2009-5#2)(2012-2#1)
untranslated regions (UTRs)##2##3##(2006-12#1)(2008-5#1)
untranslated regions and##2##3##(1992-9#1)(2013-8#1)
untranslated regions of the##4##4##(1990-5#1)(1993-2#1)(1997-4#1)(2011-2#1)
untranslated regions of##7##3##(1990-5#1)(1993-2#1)(1994-2#1)(1995-2#1)(1997-4#1)(2010-9#1)(2011-2#1)
untranslated regions##18##2##(1990-5#1)(1992-2#1)(1992-9#1)(1993-12#2)(1993-2#1)(1994-11#1)(1994-2#1)(1995-2#1)(1996-2#1)(1997-4#1)(1997-8#1)(2006-12#1)(2008-10#1)(2008-5#1)(2010-9#1)(2011-2#1)(2013-8#1)
untranslated sequence##5##2##(1992-11#2)(1992-3#2)(1993-8#1)
untranslated##99##1##(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-7#2)(1991-9#3)(1992-11#5)(1992-12#2)(1992-2#2)(1992-3#4)(1992-8#1)(1992-9#2)(1993-12#3)(1993-2#1)(1993-5#2)(1993-6#1)(1993-8#1)(1994-11#5)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#4)(1995-10#2)(1995-2#3)(1995-4#1)(1995-5#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#2)(1997-5#3)(1997-6#3)(1997-8#2)(2006-12#1)(2007-12#2)(2007-2#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#4)(2009-5#2)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
untranslocated##2##1##(1993-2#1)(1995-3#1)
untreatable##9##1##(2006-10#1)(2006-2#1)(2008-1#1)(2008-10#2)(2008-4#1)(2010-5#1)(2012-12#1)(2012-3#1)
untreated J774##2##2##(1996-12#2)
untreated L-TGF-beta 1##2##3##(1990-2#2)
untreated and##19##2##(1990-6#1)(1992-12#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-8#4)(1996-8#1)(1997-1#1)(1997-3#1)(2004-9#1)(2005-11#1)(2005-7#1)(2006-10#1)(2008-10#1)(2010-11#1)(2010-12#1)
untreated animals##6##2##(1995-1#1)(1995-2#1)(1995-6#1)(1996-1#2)(2007-9#1)
untreated area##3##2##(2008-5#2)(2013-8#1)
untreated as well as##2##4##(1994-2#1)(2008-10#1)
untreated catheters##3##2##(2007-7#3)
untreated cells##12##2##(1991-1#1)(1991-7#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-6#1)(1993-8#1)(1995-3#1)(1996-11#1)(2007-1#1)(2007-12#1)(2008-9#1)
untreated cellulose##2##2##(2008-5#2)
untreated control plots##4##3##(2007-6#1)(2008-10#3)
untreated control site##3##3##(2008-5#3)
untreated control##24##2##(1992-12#1)(1993-9#1)(1996-10#1)(1997-4#1)(2007-6#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#5)(2008-7#1)(2011-2#1)(2013-7#1)
untreated control)##2##2##(2008-10#1)(2008-11#1)
untreated controls##15##2##(1991-7#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-3#1)(1997-4#3)(2006-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2012-12#1)
untreated culture##2##2##(1994-9#1)(2010-11#1)
untreated cultures##3##2##(1994-2#1)(1997-7#1)(2006-8#1)
untreated disease##3##2##(2006-6#1)(2009-12#1)(2011-2#1)
untreated dwarf rats##2##3##(1995-12#2)
untreated dwarf##4##2##(1995-12#4)
untreated fiber##2##2##(1991-12#1)(2008-5#1)
untreated fields##2##2##(1995-6#2)
untreated fused-silica##2##2##(1997-3#2)
untreated hair##3##2##(2008-5#3)
untreated human##2##2##(1992-11#1)(1992-2#1)
untreated hypertension##2##2##(2007-9#1)(2008-5#1)
untreated in##2##2##(1992-2#1)(2007-10#1)
untreated islets##2##2##(2010-11#2)
untreated leprosy patients##2##3##(2012-12#2)
untreated male##3##2##(1992-11#1)(1996-9#2)
untreated mice##9##2##(1990-4#1)(2006-7#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-10#1)(2012-11#1)(2013-7#1)
untreated or treated##3##3##(1990-11#1)(2008-11#1)(2008-9#1)
untreated or##13##2##(1990-11#1)(1991-6#1)(1992-9#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-11#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-3#1)
untreated patients and##2##3##(1990-6#1)(1995-1#1)
untreated patients with coronary artery spasm##2##6##(1993-12#2)
untreated patients with##10##3##(1990-12#2)(1990-9#1)(1991-4#1)(1991-9#1)(1993-12#3)(2007-11#1)(2008-7#1)
untreated patients##27##2##(1990-12#2)(1990-6#2)(1990-8#1)(1990-9#1)(1991-4#1)(1991-9#1)(1993-12#3)(1995-1#1)(1995-12#1)(1996-8#1)(2005-10#1)(2007-11#4)(2007-7#3)(2008-3#1)(2008-7#1)(2009-6#1)(2010-6#1)(2013-8#1)
untreated periodontal##2##2##(2006-2#1)(2008-12#1)
untreated plants##3##2##(2008-10#2)(2008-11#1)
untreated rat liver##2##3##(1991-4#1)(1994-8#1)
untreated rat##3##2##(1991-4#1)(1994-8#1)(1997-8#1)
untreated rats and##2##3##(1996-10#1)(1997-3#1)
untreated rats##9##2##(1990-9#1)(1992-12#1)(1993-3#1)(1995-3#1)(1996-10#3)(1996-5#1)(1997-3#1)
untreated samples of##2##3##(1991-11#1)(2008-5#1)
untreated samples##3##2##(1991-11#1)(2007-8#1)(2008-5#1)
untreated soil##3##2##(2008-10#3)
untreated than in##2##3##(1996-9#1)(2008-10#1)
untreated urine##2##2##(1992-1#1)(1993-11#1)
untreated water##3##2##(1997-4#2)(2008-10#1)
untreated wheat##2##2##(2008-10#1)(2008-12#1)
untreated with##2##2##(1990-10#1)(2005-7#1)
untreated wool fibre##2##3##(2008-5#2)
untreated##426##1##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#5)(1990-3#1)(1990-4#1)(1990-6#3)(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-11#3)(1991-12#2)(1991-2#1)(1991-4#2)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#3)(1992-12#4)(1992-2#5)(1992-3#3)(1992-5#2)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#5)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#3)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#3)(1994-8#3)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#9)(1995-2#5)(1995-3#3)(1995-5#2)(1995-6#4)(1995-8#4)(1995-9#2)(1996-1#2)(1996-10#4)(1996-11#4)(1996-12#5)(1996-5#2)(1996-7#1)(1996-8#2)(1996-9#5)(1997-1#3)(1997-3#5)(1997-4#7)(1997-6#2)(1997-7#3)(1997-8#2)(2004-1#1)(2004-3#1)(2004-9#3)(2005-10#1)(2005-11#4)(2005-7#2)(2006-1#1)(2006-10#11)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#3)(2007-1#1)(2007-10#4)(2007-11#5)(2007-12#3)(2007-2#1)(2007-3#2)(2007-6#3)(2007-7#8)(2007-8#3)(2007-9#2)(2008-10#40)(2008-11#9)(2008-12#4)(2008-2#2)(2008-3#4)(2008-4#6)(2008-5#29)(2008-6#5)(2008-7#6)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#3)(2009-8#1)(2010-11#5)(2010-12#3)(2010-2#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#4)(2011-12#2)(2011-2#9)(2012-1#1)(2012-11#1)(2012-12#8)(2012-2#8)(2012-3#5)(2013-1#6)(2013-7#2)(2013-8#7)
untrimmed##2##1##(1996-7#2)
untutored##2##1##(2005-10#2)
untwinned##3##1##(1990-9#1)(1992-8#1)(1994-10#1)
untwisting rate peak##2##3##(2011-2#2)
untwisting rate##4##2##(2011-2#4)
untwisting##5##1##(2011-2#5)
untypable##3##1##(2007-7#1)(2008-5#1)(2010-4#1)
untypical##3##1##(2007-8#1)(2011-2#1)(2012-12#1)
ununited ossicle was##2##3##(2008-9#2)
ununited ossicle##3##2##(2008-9#3)
ununited##4##1##(1991-3#1)(2008-9#3)
unusable for##2##2##(2008-1#1)(2008-5#1)
unusable##4##1##(2005-11#1)(2008-1#2)(2008-5#1)
unused##5##1##(1994-6#1)(2008-10#1)(2008-2#1)(2013-1#2)
unusual DNA##3##2##(1992-8#1)(1993-11#1)(2008-4#1)
unusual MRI##2##2##(2006-1#1)(2012-2#1)
unusual X chromosome-linked dominant##2##4##(1994-8#2)
unusual ability to##2##3##(1994-8#1)(2008-10#1)
unusual actin-encoding gene##2##3##(1991-9#2)
unusual aetiologies##2##2##(2012-2#2)
unusual amino acid##5##3##(1992-2#1)(1992-7#2)(1994-9#1)(2006-12#1)
unusual among##4##2##(1992-5#1)(2007-12#1)(2010-4#1)(2011-12#1)
unusual and##21##2##(1990-6#1)(1993-4#1)(1994-9#1)(1995-12#1)(1996-11#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-6#2)(2008-9#2)(2009-10#2)(2009-2#1)(2009-3#1)(2010-7#1)(2013-1#2)
unusual arrangement##3##2##(1990-11#1)(1997-7#1)(2009-8#1)
unusual aspects of##2##3##(2006-7#1)(2007-8#1)
unusual association##2##2##(2010-12#1)(2010-4#1)
unusual bacterial##2##2##(1994-2#1)(2006-10#1)
unusual because##2##2##(2008-7#1)(2013-8#1)
unusual behavior##2##2##(1997-3#1)(2007-11#1)
unusual but##2##2##(2006-7#1)(2012-2#1)
unusual capacity##2##2##(1994-8#1)(2008-5#1)
unusual case is##3##3##(2006-11#1)(2007-7#1)(2010-3#1)
unusual case of a##16##4##(2006-10#2)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#2)(2009-7#1)(2010-3#1)(2011-2#1)(2013-7#1)(2013-8#1)
unusual case of penetrating ocular trauma with##2##7##(2011-1#2)
unusual case of shoulder pain##2##5##(2006-8#2)
unusual case of##71##3##(1991-10#1)(1992-4#1)(1993-8#1)(1997-5#1)(1997-6#1)(2006-10#3)(2006-4#2)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-10#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-6#2)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#1)
unusual case report##3##3##(2005-11#1)(2010-4#1)(2010-8#1)
unusual case##88##2##(1991-10#1)(1992-4#1)(1993-8#1)(1997-5#1)(1997-6#1)(2005-11#1)(2006-10#3)(2006-11#1)(2006-4#2)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#2)(2007-2#1)(2007-3#2)(2007-4#2)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#2)(2008-10#5)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#2)(2010-8#2)(2010-9#2)(2011-1#5)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#2)
unusual cases of##2##3##(2008-7#1)(2008-8#1)
unusual cases##5##2##(2005-8#1)(2008-1#1)(2008-7#1)(2008-8#2)
unusual cause of acute##2##4##(1993-6#1)(2008-10#1)
unusual cause of##25##3##(1993-6#1)(1996-12#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-4#1)(2012-2#2)(2013-1#5)(2013-8#1)
unusual cause##28##2##(1993-6#1)(1996-12#1)(2006-4#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#2)(2010-10#1)(2010-12#2)(2010-4#1)(2012-2#2)(2013-1#5)(2013-8#1)
unusual causes##2##2##(1991-11#1)(1994-7#1)
unusual cell##2##2##(2008-5#2)
unusual characteristics##3##2##(1990-11#1)(1992-3#1)(2008-2#1)
unusual chemical shifts##2##3##(1990-5#1)(1995-1#1)
unusual clinical presentation of##2##4##(2007-3#1)(2008-11#1)
unusual clinical presentation##6##3##(2007-3#1)(2007-8#1)(2008-11#2)(2008-6#1)(2011-2#1)
unusual clinical##17##2##(1990-3#1)(1990-9#1)(1995-11#1)(1996-1#1)(2006-11#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-6#1)(2011-2#1)
unusual combination of##2##3##(1993-12#1)(1996-4#1)
unusual combination##4##2##(1993-12#1)(1996-4#1)(2007-8#1)(2012-3#1)
unusual complication following##2##3##(2008-7#1)(2010-7#1)
unusual complication of##6##3##(2006-10#1)(2007-7#1)(2009-6#1)(2009-9#1)(2011-2#1)(2013-8#1)
unusual complication##14##2##(1992-11#1)(2006-10#1)(2007-7#2)(2007-8#2)(2008-7#2)(2009-3#1)(2009-6#1)(2009-9#1)(2010-7#1)(2011-2#1)(2013-8#1)
unusual complications of##2##3##(1995-9#1)(2007-7#1)
unusual complications##5##2##(1995-9#1)(2006-11#1)(2007-7#1)(2008-6#1)(2012-2#1)
unusual condition##2##2##(1992-10#1)(2008-4#1)
unusual diagnosis##2##2##(2006-3#1)(2008-4#1)
unusual disease outburst##2##3##(2008-10#2)
unusual disease##6##2##(1995-9#1)(1997-3#1)(1997-6#1)(2005-7#1)(2008-10#2)
unusual diseases##2##2##(1992-2#2)
unusual distribution of##2##3##(1991-3#1)(1992-9#1)
unusual enzymatic##2##2##(1991-2#1)(2006-12#1)
unusual event##2##2##(1990-5#1)(2007-9#1)
unusual feature of##2##3##(1993-6#1)(1994-6#1)
unusual feature##3##2##(1993-6#1)(1994-6#1)(2006-10#1)
unusual features of##2##3##(2007-7#1)(2008-2#1)
unusual features##8##2##(1990-4#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-2#1)(2009-8#1)(2010-3#1)
unusual finding in##2##3##(1997-1#1)(2008-9#1)
unusual finding##7##2##(1997-1#1)(2007-7#2)(2008-12#1)(2008-9#1)(2010-12#1)(2011-1#1)
unusual findings##2##2##(2012-12#1)(2012-2#1)
unusual for##6##2##(1990-8#1)(1990-9#1)(1995-3#1)(2006-10#1)(2009-9#1)(2012-12#1)
unusual form of##7##3##(1991-11#1)(1991-3#1)(1996-7#1)(2006-10#1)(2007-10#1)(2009-6#1)(2012-2#1)
unusual hemorrhagic##2##2##(2007-10#1)(2007-8#1)
unusual histological##2##2##(1991-8#1)(2012-12#1)
unusual in that##5##3##(1991-4#1)(1993-9#1)(1994-12#1)(1996-2#1)(2008-12#1)
unusual in##13##2##(1991-4#3)(1993-9#1)(1994-12#1)(1996-2#1)(2007-7#1)(2008-12#2)(2008-5#1)(2008-7#1)(2009-7#1)(2012-1#1)
unusual increase##2##2##(2008-9#1)(2009-4#1)
unusual infections##2##2##(2006-4#1)(2007-11#1)
unusual injury##2##2##(2008-10#1)(2008-9#1)
unusual kinetic##2##2##(1990-11#1)(2008-7#1)
unusual lesions##2##2##(2007-3#1)(2008-12#1)
unusual location##6##2##(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
unusual locations##6##2##(1991-4#1)(2006-1#1)(2007-11#1)(2009-1#1)(2013-1#2)
unusual manifestation of##3##3##(2008-6#1)(2012-2#1)(2013-7#1)
unusual metastatic##2##2##(1990-6#1)(2009-3#1)
unusual mode of suicide##2##4##(2009-10#2)
unusual mode of##4##3##(2009-10#3)(2009-8#1)
unusual mortality##3##2##(1994-5#1)(1996-11#2)
unusual neoplasm##3##2##(1994-6#1)(2008-10#1)(2009-3#1)
unusual nucleotide##2##2##(2007-12#1)(2012-12#1)
unusual observation of##2##3##(2010-4#1)(2013-1#1)
unusual or##10##2##(2006-10#8)(2007-10#1)(2008-5#1)
unusual organisms##2##2##(2007-12#1)(2007-7#1)
unusual pathology and the##2##4##(2006-2#1)(2007-8#1)
unusual patient##2##2##(1995-3#1)(2012-2#1)
unusual pattern of##5##3##(1992-12#1)(1993-3#1)(2007-2#1)(2008-1#1)(2008-7#1)
unusual patterns of##2##3##(1995-12#2)
unusual patterns##3##2##(1992-2#1)(1995-12#2)
unusual phenomenon##3##2##(2012-1#1)(2012-2#2)
unusual potency##2##2##(1991-3#1)(1995-1#1)
unusual presentation and##6##3##(2006-9#1)(2007-3#1)(2007-9#1)(2008-6#1)(2008-7#1)(2012-2#1)
unusual presentation in a##2##4##(2010-11#1)(2012-3#1)
unusual presentation of a##3##4##(2007-3#1)(2009-3#1)(2010-2#1)
unusual presentation of##25##3##(1996-12#1)(2004-10#1)(2006-10#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-7#2)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
unusual presentation with##3##3##(2008-7#1)(2009-1#1)(2010-4#1)
unusual presentation##54##2##(1996-12#1)(1997-8#1)(2004-10#2)(2006-10#2)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#1)(2007-3#2)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#1)(2008-6#2)(2008-7#5)(2009-1#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-9#2)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
unusual presentations##3##2##(2007-2#1)(2008-12#1)(2010-9#1)
unusual properties##4##2##(1991-3#1)(2007-9#1)(2008-11#1)(2012-2#1)
unusual property##3##2##(1993-3#1)(2007-9#1)(2008-11#1)
unusual protein##2##2##(1991-10#1)(2008-8#1)
unusual radiologic##2##2##(2009-3#1)(2013-8#1)
unusual radiological##2##2##(2008-7#1)(2012-12#1)
unusual reaction##3##2##(2007-8#1)(2010-7#1)(2011-1#1)
unusual shaped##2##2##(2012-2#2)
unusual sites##5##2##(2006-9#1)(2007-8#1)(2008-3#1)(2009-5#1)(2012-2#1)
unusual structural##2##2##(2009-8#1)(2011-1#1)
unusual structure##3##2##(1991-11#1)(1991-5#1)(2006-10#1)
unusual structures##2##2##(1992-6#1)(2013-1#1)
unusual symptoms##2##2##(2007-11#1)(2010-5#1)
unusual thermal##3##2##(1992-9#1)(1996-5#1)(2008-3#1)
unusual to##3##2##(1994-8#1)(2008-7#1)(2012-2#1)
unusual tumor and##2##3##(1991-8#1)(2006-12#1)
unusual tumor##4##2##(1991-8#2)(2006-12#1)(2012-2#1)
unusual variant of##4##3##(2006-12#1)(2009-6#1)(2011-1#1)(2012-2#1)
unusual##797##1##(1990-11#3)(1990-3#3)(1990-4#2)(1990-5#4)(1990-6#6)(1990-7#2)(1990-8#2)(1990-9#5)(1991-10#3)(1991-11#4)(1991-2#2)(1991-3#5)(1991-4#8)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#3)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#4)(1992-3#2)(1992-4#2)(1992-5#4)(1992-6#3)(1992-7#5)(1992-8#1)(1992-9#3)(1993-10#1)(1993-11#3)(1993-12#3)(1993-3#3)(1993-4#1)(1993-6#3)(1993-8#4)(1993-9#3)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#6)(1994-9#2)(1995-1#3)(1995-10#3)(1995-11#3)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#5)(1996-12#2)(1996-2#4)(1996-3#3)(1996-4#2)(1996-5#2)(1996-7#3)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#4)(1997-4#2)(1997-5#2)(1997-6#4)(1997-7#3)(1997-8#2)(2004-10#2)(2005-11#3)(2005-7#2)(2005-8#1)(2006-1#3)(2006-10#35)(2006-11#3)(2006-12#9)(2006-2#2)(2006-3#2)(2006-4#7)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#5)(2006-9#4)(2007-1#1)(2007-10#7)(2007-11#9)(2007-12#12)(2007-2#8)(2007-3#8)(2007-4#5)(2007-5#3)(2007-6#1)(2007-7#27)(2007-8#21)(2007-9#9)(2008-1#7)(2008-10#21)(2008-11#6)(2008-12#11)(2008-2#4)(2008-3#8)(2008-4#11)(2008-5#12)(2008-6#10)(2008-7#24)(2008-8#9)(2008-9#14)(2009-1#2)(2009-10#7)(2009-12#2)(2009-2#3)(2009-3#10)(2009-4#7)(2009-5#5)(2009-6#4)(2009-7#4)(2009-8#10)(2009-9#5)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#10)(2010-2#6)(2010-3#4)(2010-4#8)(2010-5#7)(2010-6#5)(2010-7#4)(2010-8#3)(2010-9#5)(2011-1#14)(2011-12#2)(2011-2#12)(2012-1#2)(2012-11#1)(2012-12#18)(2012-2#44)(2012-3#6)(2013-1#31)(2013-7#8)(2013-8#12)
unusually high incidence of##2##4##(2007-2#1)(2007-3#1)
unusually high##12##2##(1990-10#1)(1990-12#1)(1993-2#1)(1995-5#1)(2006-2#1)(2006-5#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-3#1)
unusually large##10##2##(1990-7#1)(1991-2#1)(1992-12#2)(2007-11#1)(2007-7#1)(2008-10#1)(2009-7#1)(2011-1#1)(2013-7#1)
unusually long##12##2##(1990-12#1)(1991-10#1)(1993-11#1)(1993-4#1)(1994-8#1)(1994-9#1)(1996-10#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)
unusually low##7##2##(1990-9#1)(1991-5#1)(1992-9#1)(1993-6#1)(1996-5#1)(2009-3#1)(2011-2#1)
unusually##87##1##(1990-10#1)(1990-12#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-6#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-5#2)(1996-10#1)(1996-5#1)(1996-7#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-2#1)(2006-4#2)(2006-5#1)(2006-7#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#2)(2009-7#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-7#1)
unutilized##2##1##(2008-5#1)(2009-5#1)
unvaccinated and##2##2##(2013-8#2)
unvaccinated chickens##5##2##(2005-9#2)(2008-5#2)(2013-8#1)
unvaccinated children##2##2##(1997-6#1)(2011-2#1)
unvaccinated control##2##2##(1995-9#1)(2013-8#1)
unvaccinated groups of##2##3##(2008-5#2)
unvaccinated groups##3##2##(1994-2#1)(2008-5#2)
unvaccinated infants##2##2##(1990-2#1)(1995-5#1)
unvaccinated##30##1##(1990-2#2)(1992-2#1)(1994-2#1)(1994-9#1)(1995-5#1)(1995-9#1)(1996-1#1)(1997-3#1)(1997-6#1)(2005-9#3)(2007-2#1)(2008-12#2)(2008-5#5)(2009-5#1)(2011-2#1)(2012-12#1)(2013-8#6)
unvalidated##2##1##(2007-8#1)(2008-12#1)
unvarnished women##3##2##(2008-5#3)
unvegetated##2##1##(2006-6#2)
unveil##4##1##(2008-5#1)(2012-2#2)(2013-1#1)
unveiled the##2##2##(1996-12#1)(2012-3#1)
unveiled##17##1##(1996-12#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-3#1)(2012-11#2)(2012-3#2)(2013-1#1)(2013-7#2)
unveiling the##3##2##(2008-7#2)(2010-2#1)
unveiling##5##1##(1992-4#1)(2008-4#1)(2008-7#2)(2010-2#1)
unveils new##2##2##(1991-9#1)(2012-2#1)
unveils##4##1##(1991-9#1)(1994-9#1)(1995-6#1)(2012-2#1)
unwanted cell##3##2##(2008-11#1)(2010-2#1)(2012-1#1)
unwanted cells##6##2##(2007-2#1)(2008-11#1)(2008-9#2)(2009-10#1)(2012-2#1)
unwanted diffraction orders##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
unwanted effects##6##2##(1996-3#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-9#2)
unwanted interference##2##2##(2008-2#1)(2008-3#1)
unwanted newborns##2##2##(2007-2#2)
unwanted pregnancies and##2##3##(1993-3#1)(2008-1#1)
unwanted pregnancies in##2##3##(1992-2#1)(2008-7#1)
unwanted pregnancies##8##2##(1992-2#1)(1993-3#1)(2008-1#1)(2008-11#2)(2008-7#1)(2012-11#1)(2012-2#1)
unwanted pregnancy and the##3##4##(1997-7#2)(2007-3#1)
unwanted pregnancy and##5##3##(1997-7#2)(2007-3#2)(2012-12#1)
unwanted pregnancy##15##2##(1991-10#1)(1992-2#1)(1994-12#1)(1997-5#1)(1997-7#2)(2007-3#5)(2012-11#2)(2012-12#1)(2013-1#1)
unwanted side effects##7##3##(1991-3#1)(1995-2#1)(2006-10#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-12#1)
unwanted side-effects##4##2##(1991-12#1)(1995-7#1)(2005-8#1)(2006-10#1)
unwanted toxicity##2##2##(2009-12#1)(2010-2#1)
unwanted##127##1##(1991-10#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-2#5)(1992-3#1)(1992-7#1)(1993-10#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-7#1)(1995-2#2)(1995-7#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-7#3)(2004-12#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-5#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#5)(2007-2#4)(2007-3#6)(2007-7#1)(2008-1#2)(2008-10#7)(2008-11#6)(2008-2#10)(2008-3#10)(2008-4#4)(2008-6#1)(2008-7#4)(2008-9#7)(2009-10#2)(2009-12#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-11#3)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)
unwarranted##10##1##(1992-11#1)(1996-12#1)(1997-3#1)(1997-6#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-12#1)(2008-5#1)(2012-2#1)
unwary##3##1##(1993-1#1)(2006-10#1)(2008-3#1)
unwashed##2##1##(2007-1#1)(2007-6#1)
unweighted pair group method with arithmetic##3##6##(2008-10#3)
unweighted pair group method##4##4##(2008-10#4)
unweighted pair-group method with arithmetic average cluster analysis##2##8##(2008-10#2)
unweighted pair-group method with arithmetic average##3##6##(2008-10#3)
unweighted pair-group method with arithmetic##4##5##(2008-10#4)
unweighted pair-group method##5##3##(2008-10#5)
unweighted##17##1##(1991-12#1)(1992-12#1)(2007-8#1)(2008-10#10)(2008-4#1)(2009-12#1)(2012-2#1)(2012-3#1)
unwelcome and##2##2##(2008-11#1)(2008-4#1)
unwelcome##3##1##(2008-11#1)(2008-4#1)(2012-11#1)
unwell##9##1##(1992-2#1)(1993-10#1)(1993-12#1)(2007-2#1)(2008-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
unwieldy##2##1##(2008-2#1)(2008-7#1)
unwilling or##2##2##(2006-10#1)(2008-12#1)
unwilling to undergo##2##3##(1992-6#1)(2011-2#1)
unwilling to##13##2##(1992-6#1)(1993-3#1)(1994-12#1)(1994-3#1)(1996-1#1)(1996-9#1)(2006-12#1)(2006-4#1)(2007-8#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-3#1)
unwilling##16##1##(1992-6#1)(1993-3#1)(1994-12#1)(1994-3#1)(1996-1#1)(1996-9#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-8#1)(2008-12#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-3#1)
unwillingness to experience emotional distress##2##5##(2011-1#2)
unwillingness to##4##2##(2008-2#1)(2011-1#2)(2013-8#1)
unwillingness##6##1##(2008-1#1)(2008-10#1)(2008-2#1)(2011-1#2)(2013-8#1)
unwind##5##1##(1993-3#1)(1994-6#1)(1997-4#1)(2012-1#2)
unwinding and##3##2##(1995-3#1)(1997-7#1)(2012-1#1)
unwinding angle##2##2##(1990-11#2)
unwinding by##2##2##(1994-11#1)(1995-3#1)
unwinding of duplex DNA##2##4##(1994-11#1)(1997-7#1)
unwinding of the duplex DNA##2##5##(1994-11#2)
unwinding of the##4##3##(1994-11#2)(1994-5#1)(1995-11#1)
unwinding of##11##2##(1994-11#5)(1994-5#1)(1995-11#2)(1995-2#1)(1995-3#1)(1997-7#1)
unwinding##41##1##(1990-11#5)(1993-3#4)(1994-11#10)(1994-5#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#6)(1997-1#2)(1997-4#3)(1997-7#4)(2008-5#1)(2012-1#1)
unwise##2##1##(2006-7#1)(2012-1#1)
unwitting##2##1##(2007-4#1)(2011-2#1)
unwooded Chardonnay##2##2##(2008-10#2)
unwounded##3##1##(2008-10#2)(2009-8#1)
unwrap##2##1##(2008-2#2)
unwrapped area##2##2##(2008-2#2)
unwrapped phase##3##2##(2008-2#1)(2008-3#2)
unwrapped##12##1##(2008-2#6)(2008-3#6)
unwrapper##3##1##(2008-2#2)(2008-3#1)
unwrapping algorithm is##2##3##(2008-2#2)
unwrapping algorithm##5##2##(2007-12#2)(2008-2#2)(2008-3#1)
unwrapping algorithms##2##2##(2008-3#2)
unwrapping and##3##2##(2008-2#1)(2008-3#2)
unwrapping is##6##2##(2008-2#3)(2008-3#3)
unwrapping method##2##2##(2008-2#1)(2008-3#1)
unwrapping of##3##2##(2008-2#1)(2008-3#2)
unwrapping problem##2##2##(2008-2#1)(2008-3#1)
unwrapping process##3##2##(2008-2#1)(2008-3#2)
unwrapping through##3##2##(2008-2#1)(2008-3#2)
unwrapping##68##1##(2007-11#1)(2007-12#5)(2008-1#3)(2008-2#24)(2008-3#35)
unwritten##2##1##(2006-5#1)(2012-2#1)
up a biochemical##2##3##(2008-4#2)
up a large##3##3##(2006-6#1)(2008-5#1)(2011-2#1)
up a major##2##3##(2008-11#1)(2009-4#1)
up a national##2##3##(2007-12#1)(2007-8#1)
up a new##6##3##(1995-12#1)(1995-3#1)(2006-5#1)(2008-9#1)(2011-12#1)(2012-2#1)
up a simple##2##3##(1993-11#1)(2008-10#1)
up a##84##2##(1990-6#1)(1990-9#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-7#1)(1994-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(2004-11#1)(2005-8#1)(2006-11#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-12#3)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#4)(2008-7#2)(2008-9#4)(2009-10#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-2#1)(2010-7#2)(2010-8#3)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#3)
up about##2##2##(1992-3#1)(1996-8#1)
up according##2##2##(2007-3#1)(2008-9#1)
up across the##2##3##(1991-3#1)(2008-2#1)
up after the##2##3##(1997-2#1)(2013-8#1)
up after##10##2##(1990-8#1)(1997-2#1)(1997-8#1)(2006-10#1)(2007-11#1)(2008-5#2)(2009-2#1)(2013-1#1)(2013-8#1)
up again##4##2##(1990-2#1)(1996-4#1)(2006-10#1)(2007-8#1)
up an##10##2##(1995-4#1)(2005-5#1)(2006-10#1)(2006-8#1)(2007-4#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
up and down states##2##4##(2008-11#2)
up and down##8##3##(2008-11#4)(2010-12#2)(2010-8#1)(2011-2#1)
up and go&quot##2##3##(2006-10#1)(2012-12#1)
up and running##2##3##(2007-9#1)(2011-2#1)
up and the##2##3##(2006-5#1)(2008-2#1)
up and##75##2##(1990-12#1)(1990-8#1)(1991-11#1)(1992-5#1)(1992-8#1)(1993-6#1)(1994-11#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-5#1)(2005-1#1)(2005-10#1)(2006-10#2)(2006-5#1)(2007-1#2)(2007-11#3)(2007-3#1)(2007-8#1)(2007-9#3)(2008-10#5)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#4)(2009-9#1)(2010-12#2)(2010-3#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-11#1)(2012-12#2)(2012-3#2)(2013-8#2)
up approximately##3##2##(1994-12#1)(1997-4#1)(2006-6#1)
up are##3##2##(2007-12#1)(2012-3#2)
up as a##4##3##(1994-3#1)(2008-10#1)(2008-2#1)(2012-2#1)
up as##11##2##(1994-2#1)(1994-3#1)(2006-5#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2012-11#1)(2012-2#1)
up at 6##2##3##(1995-3#1)(2013-1#1)
up at the end of##3##5##(2007-12#1)(2007-8#1)(2009-2#1)
up at the intersection of##2##5##(2009-5#2)
up at the##8##3##(2007-12#1)(2007-8#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-5#2)
up at##27##2##(1992-5#1)(1995-3#1)(1995-4#1)(1996-12#1)(1996-7#1)(2006-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-5#2)(2010-6#1)(2011-2#1)(2013-1#1)
up based on##4##3##(2008-10#2)(2010-8#1)(2013-1#1)
up between##3##2##(2006-5#1)(2007-7#1)(2013-7#1)
up by a##11##3##(1990-2#1)(1990-8#1)(1995-11#1)(1995-2#1)(2005-11#1)(2007-11#1)(2008-10#3)(2008-5#1)(2012-2#1)
up by the##21##3##(1991-11#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-4#2)(1994-12#1)(1994-5#1)(1994-8#1)(1996-9#1)(1997-3#1)(2006-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2013-8#1)
up by##76##2##(1990-2#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-4#2)(1993-3#1)(1993-5#1)(1994-12#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-6#2)(1996-9#1)(1997-3#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-2#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-11#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
up can be##2##3##(2008-5#1)(2012-12#1)
up can##3##2##(2008-5#1)(2008-7#1)(2012-12#1)
up close##2##2##(1991-2#1)(2008-3#1)
up due to##2##3##(2007-7#1)(2008-3#1)
up during the##2##3##(2006-10#1)(2008-9#1)
up during##5##2##(2006-10#1)(2008-1#1)(2008-9#1)(2010-5#1)(2013-1#1)
up for 13##2##3##(2007-8#1)(2011-1#1)
up for a##7##3##(1995-6#1)(2007-8#1)(2008-8#1)(2010-5#1)(2011-12#1)(2011-2#1)(2013-8#1)
up for health##2##3##(2007-9#1)(2008-8#1)
up for new##2##3##(1994-8#1)(1995-12#1)
up for the##7##3##(2006-2#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2013-8#1)
up for##78##2##(1990-10#1)(1991-9#1)(1992-1#2)(1992-5#1)(1993-5#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-9#1)(1997-8#1)(2005-1#1)(2005-11#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-7#3)(2007-8#5)(2007-9#2)(2008-10#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#4)(2013-1#1)(2013-7#2)(2013-8#4)
up from 11##2##3##(1990-12#1)(1992-3#1)
up from##16##2##(1990-12#1)(1990-2#1)(1992-12#1)(1992-3#1)(1995-11#1)(1996-1#1)(2004-4#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-2#1)(2012-3#1)
up front&quot##2##2##(1994-1#2)
up further##2##2##(1996-12#1)(2012-3#1)
up guidelines for##2##3##(2008-4#1)(2008-5#1)
up in a##8##3##(1994-4#1)(1996-12#1)(2005-9#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#1)(2011-11#1)
up in our##2##3##(2007-2#1)(2008-7#1)
up in the##15##3##(1992-3#1)(1995-12#2)(1995-6#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-6#1)(2011-2#1)(2012-2#1)
up in vitro##2##3##(1992-11#1)(2008-9#1)
up in##53##2##(1991-12#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-8#1)(1994-4#1)(1995-11#1)(1995-12#2)(1995-6#1)(1995-7#1)(1996-12#2)(1996-6#1)(1997-8#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-2#2)(2007-8#1)(2007-9#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-4#2)(2009-6#1)(2010-11#1)(2011-11#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-8#2)
up into the##5##3##(1994-8#1)(1997-3#2)(1997-4#1)(2007-10#1)
up into##15##2##(1990-11#1)(1992-12#1)(1992-3#1)(1994-8#1)(1997-2#1)(1997-3#2)(1997-4#1)(2005-11#1)(2005-8#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-4#1)(2009-8#1)
up is a##2##3##(2006-7#1)(2008-7#1)
up is##9##2##(2006-1#1)(2006-7#1)(2008-11#1)(2008-7#1)(2009-2#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
up less than##2##3##(2006-3#1)(2012-2#1)
up local##3##2##(1996-6#1)(2006-10#1)(2007-8#1)
up mainly##2##2##(1997-3#1)(1997-8#1)
up many##2##2##(2008-7#1)(2009-12#1)
up more##5##2##(1990-10#1)(2007-9#1)(2008-9#1)(2009-5#1)(2010-9#1)
up new opportunities for##3##4##(2008-4#1)(2008-5#1)(2012-2#1)
up new perspectives##2##3##(2008-10#1)(2011-3#1)
up new possibilities for##3##4##(2004-4#1)(2007-8#1)(2008-3#1)
up new possibilities##5##3##(1993-8#1)(2004-4#1)(2007-8#1)(2008-3#1)(2008-8#1)
up new vistas##2##3##(1993-2#1)(2012-2#1)
up new##23##2##(1993-2#1)(1993-8#1)(2004-4#1)(2006-6#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-6#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#2)
up of 3##2##3##(2008-6#1)(2009-3#1)
up of 4##2##3##(2008-3#1)(2013-8#1)
up of a large##2##4##(1995-1#1)(2008-4#1)
up of a##12##3##(1993-6#1)(1995-1#1)(1995-5#1)(1996-2#1)(2004-2#1)(2005-8#1)(2007-12#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-3#1)(2010-9#1)
up of an##5##3##(1991-3#1)(1996-7#1)(2007-10#1)(2008-3#1)(2009-3#1)
up of primary##2##3##(2007-4#1)(2010-3#1)
up of the##9##3##(1991-6#1)(1992-12#1)(1997-7#1)(2006-6#1)(2008-10#1)(2008-5#2)(2013-1#1)(2013-8#1)
up of this##2##3##(2008-11#1)(2013-1#1)
up of women##2##3##(1990-9#1)(2004-2#1)
up of##144##2##(1990-4#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-6#2)(1991-7#1)(1992-12#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-7#1)(2004-2#2)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-12#3)(2006-6#2)(2007-10#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#11)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#4)(2008-5#7)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#2)(2009-2#2)(2009-3#4)(2009-5#2)(2009-7#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#3)(2013-1#5)(2013-7#2)(2013-8#3)
up on a##2##3##(2008-10#1)(2010-11#1)
up on the##4##3##(1997-7#1)(2008-9#1)(2010-4#1)(2012-2#1)
up on##16##2##(1993-3#1)(1997-6#1)(1997-7#1)(2005-11#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2012-1#2)(2012-2#1)
up one##2##2##(1992-12#1)(2007-8#1)
up only##4##2##(1991-10#1)(2007-10#1)(2008-7#1)(2011-2#1)
up opportunities##2##2##(1996-3#1)(2008-3#1)
up or##7##2##(1992-4#1)(1996-3#1)(2006-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)
up our##2##2##(1994-6#1)(2007-2#1)
up over the##2##3##(1995-6#1)(2008-11#1)
up protection##2##2##(1997-2#1)(2010-5#1)
up public##2##2##(1992-6#1)(2008-9#1)
up regulate##2##2##(1994-3#1)(2005-10#1)
up regulation of the##2##4##(1994-5#1)(2010-12#1)
up regulation of##3##3##(1992-11#1)(1994-5#1)(2010-12#1)
up regulation##4##2##(1992-11#1)(1994-5#1)(2008-9#1)(2010-12#1)
up research##2##2##(1990-11#1)(2007-1#1)
up should##2##2##(2006-1#1)(2008-10#1)
up sides and down sides##2##5##(2006-10#2)
up smoking##2##2##(2006-10#1)(2008-4#1)
up some##2##2##(2008-11#1)(2010-12#1)
up stairs##2##2##(2006-12#1)(2008-7#1)
up studies##2##2##(2008-11#1)(2013-8#1)
up study##6##2##(2007-10#1)(2007-7#2)(2007-8#1)(2010-12#1)(2013-1#1)
up such a##3##3##(1991-3#1)(2006-2#1)(2007-4#1)
up such##4##2##(1991-3#1)(2005-8#1)(2006-2#1)(2007-4#1)
up the development of##2##4##(2007-5#1)(2010-7#1)
up the differentiation of##2##4##(2006-12#1)(2008-11#1)
up the entire##2##3##(2007-1#1)(2011-1#1)
up the patients##2##3##(2007-2#1)(2008-4#1)
up the possibility of##7##4##(1990-5#1)(2008-11#1)(2008-7#4)(2009-2#1)
up the possibility##8##3##(1990-5#1)(2008-11#1)(2008-7#4)(2009-2#1)(2009-5#1)
up the release of##2##4##(1997-2#2)
up the sample##2##3##(1991-5#1)(2010-9#1)
up the screening of##2##4##(2008-3#2)
up the way for##2##4##(1995-4#1)(2008-8#1)
up the##143##2##(1990-5#2)(1990-8#1)(1991-2#1)(1991-5#2)(1991-8#1)(1991-9#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-3#2)(1993-5#1)(1993-6#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-7#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#2)(2005-5#1)(2006-10#1)(2006-12#2)(2006-2#2)(2006-3#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-4#1)(2007-5#3)(2007-7#1)(2007-8#3)(2007-9#4)(2008-1#2)(2008-10#7)(2008-11#7)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#3)(2009-10#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
up their act##2##3##(1996-7#1)(2007-6#1)
up their##6##2##(1992-2#1)(1996-7#1)(2007-12#1)(2007-6#1)(2008-2#1)(2009-2#1)
up this challenge##2##3##(2007-8#1)(2010-11#1)
up this##6##2##(1992-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-7#1)(2010-11#1)
up till##4##2##(2007-11#1)(2010-2#1)(2012-12#1)(2012-3#1)
up time##4##2##(1992-8#1)(1996-3#1)(2006-10#1)(2007-2#1)
up to 0##33##3##(1990-5#1)(1990-7#1)(1991-7#1)(1996-8#1)(1997-7#1)(2006-11#1)(2007-12#1)(2008-10#17)(2008-11#1)(2008-3#3)(2008-8#1)(2009-4#1)(2012-1#1)(2012-2#1)(2012-3#1)
up to 1 M NaCl##2##5##(1991-10#1)(1997-2#1)
up to 1 MHz##2##4##(2007-12#1)(2008-3#1)
up to 1 in##2##4##(2006-9#1)(2008-3#1)
up to 1 m##2##4##(2007-10#1)(2008-10#1)
up to 1 mM##4##4##(1991-10#1)(1992-12#1)(1993-3#1)(1994-12#1)
up to 1 mg##2##4##(1995-8#1)(2008-10#1)
up to 1 microM##6##4##(1992-3#1)(1993-8#1)(1994-10#1)(1994-8#1)(1996-10#1)(1997-5#1)
up to 1 mm##3##4##(2006-12#1)(2008-10#1)(2009-8#1)
up to 1 month##2##4##(2008-10#1)(2008-7#1)
up to 1 week##3##4##(1996-10#1)(1996-3#1)(2007-10#1)
up to 1##80##3##(1990-4#2)(1991-10#3)(1991-12#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-8#2)(1994-10#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-8#2)(1995-8#1)(1996-10#2)(1996-3#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-7#3)(2006-9#1)(2007-10#2)(2007-11#4)(2007-12#3)(2007-5#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#3)(2009-8#1)(2010-2#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
up to 1%##3##3##(2008-10#2)(2009-4#1)
up to 10 days##6##4##(1991-3#1)(1992-12#1)(1996-12#1)(2008-8#1)(2009-2#1)(2009-7#1)
up to 10 mM##2##4##(1990-8#1)(1995-3#1)
up to 10 mg l(-1)##2##5##(2008-10#2)
up to 10 mg##4##4##(2008-10#2)(2008-2#1)(2008-5#1)
up to 10 mm##3##4##(1990-2#2)(2006-3#1)
up to 10 years##3##4##(2007-8#2)(2011-2#1)
up to 10##39##3##(1990-2#2)(1990-8#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-11#2)(1992-12#1)(1993-7#1)(1995-3#1)(1996-12#1)(2006-3#1)(2007-1#1)(2007-11#1)(2007-8#2)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
up to 10% of the##3##5##(2007-12#1)(2008-3#1)(2008-6#1)
up to 10% of##6##4##(1991-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)
up to 10%##11##3##(1991-9#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-6#1)(2010-8#1)
up to 10(-5)##2##3##(1996-8#1)(2011-2#1)
up to 10(3)##2##3##(2008-11#1)(2013-8#1)
up to 10(3)-10(4)##2##3##(2006-12#1)(2008-10#1)
up to 10(5)##3##3##(2008-10#2)(2008-11#1)
up to 10-fold##4##3##(1996-12#1)(1997-6#1)(2009-10#1)(2012-2#1)
up to 100 degrees##2##4##(2006-8#1)(2008-2#1)
up to 100 kHz##2##4##(2007-11#1)(2008-3#1)
up to 100 mg##2##4##(2008-10#1)(2008-12#1)
up to 100 microM##9##4##(1990-10#1)(1992-6#1)(1994-10#2)(1994-2#1)(1995-5#1)(2005-8#2)(2008-10#1)
up to 100 muM##2##4##(2008-10#2)
up to 100 times##3##4##(1993-5#1)(2007-11#1)(2011-12#1)
up to 100##40##3##(1990-10#1)(1990-12#1)(1991-2#1)(1991-7#1)(1992-6#1)(1993-11#1)(1993-5#1)(1994-10#2)(1994-2#1)(1995-5#1)(1996-7#1)(1997-8#1)(2005-8#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#2)(2010-2#1)(2011-12#1)(2012-3#1)
up to 100%##8##3##(1990-5#2)(1993-2#1)(1994-2#1)(1994-3#1)(2008-10#2)(2010-5#1)
up to 1000##6##3##(1994-8#1)(1995-7#1)(1997-5#1)(2007-4#1)(2007-8#1)(2008-10#1)
up to 11##7##3##(2006-10#1)(2008-10#3)(2008-11#1)(2008-3#1)(2013-7#1)
up to 11%##2##3##(2005-11#1)(2007-11#1)
up to 110##2##3##(1992-8#1)(1997-7#1)
up to 12 days##4##4##(1995-7#2)(2007-3#1)(2008-5#1)
up to 12 mg##2##4##(2006-8#1)(2008-10#1)
up to 12 months##4##4##(2007-10#1)(2007-9#1)(2009-10#1)(2011-1#1)
up to 12 weeks##2##4##(1993-12#1)(2008-10#1)
up to 12##24##3##(1993-12#1)(1995-7#2)(2006-10#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
up to 12%##2##3##(2007-7#1)(2008-3#1)
up to 120##5##3##(1996-9#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-5#1)
up to 125##2##3##(1997-1#1)(2008-2#1)
up to 13##4##3##(1995-6#1)(2006-5#1)(2008-10#1)(2009-2#1)
up to 14 days##3##4##(1991-9#1)(1992-5#1)(2009-12#1)
up to 14##11##3##(1991-7#1)(1991-9#1)(1992-5#1)(1997-2#1)(1997-6#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-12#1)(2010-5#1)
up to 140##2##3##(2008-8#1)(2010-8#1)
up to 15 days##4##4##(2007-6#1)(2008-5#3)
up to 15 micrograms/ml##2##4##(1994-10#1)(1997-4#1)
up to 15 years##2##4##(2008-11#1)(2013-8#1)
up to 15##27##3##(1990-9#1)(1993-4#1)(1994-10#1)(1994-3#1)(1994-6#1)(1997-1#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-5#4)(2008-7#1)(2008-8#1)(2013-8#1)
up to 15% of##2##4##(2010-5#1)(2010-7#1)
up to 15%##4##3##(2008-10#1)(2010-5#1)(2010-7#1)(2011-2#1)
up to 150##12##3##(1995-2#1)(2007-10#1)(2007-12#2)(2007-3#2)(2008-10#3)(2008-2#1)(2008-4#1)(2011-1#1)
up to 1500##2##3##(1992-7#1)(2009-7#1)
up to 16 years##2##4##(1991-2#1)(2008-9#1)
up to 16##7##3##(1991-2#1)(1992-6#1)(1997-3#1)(2007-11#1)(2008-11#1)(2008-9#1)(2013-8#1)
up to 160##3##3##(2008-2#2)(2011-1#1)
up to 175##2##3##(1994-2#1)(2008-10#1)
up to 18 days##3##4##(2005-11#1)(2008-11#1)(2008-5#1)
up to 18 hours##2##4##(1992-4#1)(2007-2#1)
up to 18 months##3##4##(1995-9#1)(2006-5#1)(2008-5#1)
up to 18##16##3##(1992-3#1)(1992-4#1)(1995-9#1)(1996-7#1)(2005-11#1)(2006-5#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#2)(2011-2#1)
up to 180##3##3##(1993-7#1)(2007-12#1)(2008-2#1)
up to 19##3##3##(2008-8#2)(2013-1#1)
up to 19%##2##3##(2008-11#1)(2013-1#1)
up to 1950##2##3##(1993-1#1)(2008-2#1)
up to 2 h##6##4##(1991-2#1)(1994-9#1)(2008-4#1)(2010-12#1)(2011-12#1)(2013-1#1)
up to 2 months after##2##5##(1996-12#1)(2008-2#1)
up to 2 months##4##4##(1996-12#2)(2005-7#1)(2008-2#1)
up to 2 weeks##3##4##(1990-12#1)(2008-10#2)
up to 2 years after##2##5##(2007-11#1)(2008-7#1)
up to 2 years##7##4##(2006-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-8#1)
up to 2##48##3##(1990-12#1)(1991-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#2)(1994-8#1)(1994-9#2)(1995-7#1)(1996-12#2)(1996-2#1)(1996-5#1)(2005-7#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#4)(2008-10#6)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
up to 2%##2##3##(1995-2#1)(2008-10#1)
up to 2-fold##5##3##(1990-3#1)(1990-4#1)(1991-8#1)(1992-11#1)(1992-3#1)
up to 20 days##2##4##(1991-8#1)(2011-2#1)
up to 20 mg##3##4##(2007-8#1)(2008-10#1)(2008-5#1)
up to 20 mol % alpha-tocopherol##2##6##(2006-10#2)
up to 20 mole percent##2##5##(1990-2#2)
up to 20##33##3##(1990-12#1)(1990-2#2)(1991-2#1)(1991-8#1)(1992-1#1)(1993-2#1)(1994-5#1)(1994-8#2)(1996-7#1)(2004-11#1)(2006-10#2)(2007-12#2)(2007-8#2)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#2)
up to 20% of patients##2##5##(2006-10#1)(2007-11#1)
up to 20% of the##3##5##(2008-6#1)(2008-7#1)(2011-1#1)
up to 20% of##13##4##(1990-8#1)(2006-10#1)(2007-11#2)(2007-7#3)(2008-11#1)(2008-6#1)(2008-7#2)(2009-6#1)(2011-1#1)
up to 20%##21##3##(1990-8#1)(1997-3#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-2#1)(2007-7#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-6#1)(2010-1#1)(2010-8#1)(2011-1#1)
up to 200##13##3##(1991-3#1)(1992-10#1)(1992-4#1)(1997-1#1)(1997-4#1)(2006-12#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-2#1)(2008-3#1)(2013-7#1)
up to 200%##3##3##(1996-2#1)(2008-1#2)
up to 200-fold##3##3##(1994-8#1)(1997-8#1)(2008-10#1)
up to 21 days##5##4##(1990-7#1)(1994-12#1)(1996-7#1)(2006-5#1)(2008-10#1)
up to 21##8##3##(1990-7#1)(1991-6#1)(1994-12#1)(1996-6#1)(1996-7#1)(2006-5#1)(2007-12#1)(2008-10#1)
up to 225##2##3##(2006-8#1)(2012-2#1)
up to 24 h##6##4##(1995-5#1)(2004-9#1)(2006-10#1)(2008-10#1)(2008-7#1)(2011-2#1)
up to 24##11##3##(1995-5#1)(1996-4#1)(2004-9#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-12#1)(2011-2#1)
up to 240##2##3##(2008-10#1)(2008-7#1)
up to 24h of storage##2##5##(2008-10#1)(2010-4#1)
up to 24h##3##3##(2008-10#1)(2008-12#1)(2010-4#1)
up to 25##12##3##(1990-2#1)(1991-5#1)(1993-4#1)(1996-10#1)(1996-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-2#1)
up to 25% of##4##4##(1997-1#1)(2006-12#1)(2008-1#1)(2010-10#1)
up to 25%##6##3##(1997-1#1)(2006-12#1)(2008-1#1)(2010-10#1)(2010-9#1)(2013-1#1)
up to 250##5##3##(1990-4#2)(1996-11#1)(2008-10#1)(2008-4#1)
up to 26##5##3##(1990-4#1)(1996-7#1)(2008-2#1)(2010-2#2)
up to 27##2##3##(2008-8#1)(2008-9#1)
up to 270##2##3##(2008-10#1)(2008-5#1)
up to 28##3##3##(2007-7#1)(2010-11#1)(2011-2#1)
up to 3 days##5##4##(2008-10#2)(2008-11#1)(2008-7#2)
up to 3 months##4##4##(1991-3#1)(2008-10#1)(2009-2#1)(2010-12#1)
up to 3 orders of magnitude##3##6##(1995-11#1)(1996-7#1)(2008-3#1)
up to 3 years##3##4##(1997-8#1)(2007-11#1)(2007-9#1)
up to 3##36##3##(1991-1#1)(1991-3#1)(1992-6#1)(1992-8#1)(1993-9#1)(1995-11#1)(1995-2#1)(1996-7#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-11#1)(2009-2#1)(2010-12#1)(2010-4#1)(2012-3#1)
up to 3%##2##3##(2008-3#1)(2010-3#1)
up to 3-fold##2##3##(1996-5#1)(1996-8#1)
up to 30 days##6##4##(1995-11#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-5#1)(2010-8#1)
up to 30 min##5##4##(1992-3#1)(1995-12#1)(1996-12#1)(1997-8#1)(2008-10#1)
up to 30 nM##2##4##(1990-10#1)(1991-2#1)
up to 30 times##2##4##(1995-8#1)(2006-12#1)
up to 30##34##3##(1990-10#1)(1990-3#1)(1991-2#1)(1991-5#1)(1992-3#1)(1994-11#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-12#2)(2008-10#7)(2008-4#1)(2008-5#2)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
up to 30% of patients##3##5##(2006-9#1)(2007-8#1)(2012-2#1)
up to 30% of the##4##5##(2007-12#1)(2008-10#1)(2011-2#1)(2012-12#1)
up to 30% of##8##4##(2006-9#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
up to 30%##17##3##(1993-9#1)(1996-12#1)(2006-2#1)(2006-9#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
up to 300 degrees C and##2##6##(2008-10#1)(2011-1#1)
up to 300##3##3##(1995-8#1)(2008-10#1)(2011-1#1)
up to 31##2##3##(1996-12#1)(1997-6#1)
up to 32##5##3##(1993-12#2)(1993-3#1)(2007-9#1)(2008-10#1)
up to 34##2##3##(2007-12#1)(2008-2#1)
up to 35##2##3##(1994-12#1)(1997-6#1)
up to 35%##3##3##(2008-10#2)(2009-7#1)
up to 350##4##3##(2007-12#2)(2007-8#1)(2008-3#1)
up to 36##4##3##(1990-12#1)(1994-6#1)(2007-12#1)(2011-2#1)
up to 36%##2##3##(2008-10#1)(2010-12#1)
up to 37##2##3##(2007-1#1)(2008-10#1)
up to 4 hours##4##4##(1993-7#1)(2004-11#1)(2007-7#2)
up to 4 mm##2##4##(2008-7#1)(2009-2#1)
up to 4 months after treatment##2##6##(2013-1#2)
up to 4 months after##3##5##(2010-5#1)(2013-1#2)
up to 4 months##5##4##(2008-11#2)(2010-5#1)(2013-1#2)
up to 4 weeks##2##4##(1996-3#1)(2010-9#1)
up to 4##32##3##(1990-12#1)(1990-4#1)(1990-8#1)(1991-3#1)(1992-6#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1996-3#1)(2004-11#1)(2005-9#1)(2007-10#1)(2007-7#2)(2007-9#1)(2008-10#2)(2008-11#4)(2008-7#1)(2008-9#1)(2009-2#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#1)(2013-1#2)
up to 4% of##2##4##(2008-6#1)(2009-8#1)
up to 4%##4##3##(1996-12#1)(2008-3#1)(2008-6#1)(2009-8#1)
up to 40##8##3##(1990-9#1)(1995-10#1)(1997-7#1)(2004-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2013-1#1)
up to 40% in##2##4##(2008-10#1)(2008-2#1)
up to 40% of the##3##5##(1990-2#1)(2004-9#1)(2008-7#1)
up to 40% of##6##4##(1990-2#1)(2004-9#1)(2007-9#1)(2008-7#1)(2008-8#2)
up to 40%##20##3##(1990-2#1)(1992-3#1)(1995-1#1)(2004-9#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#2)(2010-11#1)(2010-12#1)(2010-9#1)(2013-1#1)
up to 40-60%##2##3##(1994-8#1)(2013-8#1)
up to 400##3##3##(1992-8#1)(1995-6#1)(2008-11#1)
up to 41##4##3##(1993-3#1)(1996-8#1)(1997-1#1)(2008-10#1)
up to 42##3##3##(1990-3#1)(1991-12#1)(2008-10#1)
up to 45 days postinoculation##2##5##(2008-10#2)
up to 45##9##3##(1996-9#1)(2005-7#1)(2006-6#1)(2008-10#2)(2008-4#1)(2008-6#1)(2011-12#1)(2011-2#1)
up to 45%##2##3##(2006-8#1)(2013-8#1)
up to 47%##2##3##(2008-10#1)(2012-3#1)
up to 48 h##3##4##(1997-8#1)(2008-10#2)
up to 48 hours##2##4##(1992-4#1)(1994-6#1)
up to 48##13##3##(1992-4#1)(1994-11#2)(1994-6#1)(1996-5#2)(1997-7#1)(1997-8#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-11#1)
up to 5 days##3##4##(1991-5#1)(2008-10#1)(2009-2#1)
up to 5 years##5##4##(1992-2#1)(2007-5#1)(2008-11#1)(2008-5#1)(2013-1#1)
up to 5##32##3##(1991-5#1)(1992-2#1)(1993-12#1)(1994-2#1)(1996-1#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
up to 5%##5##3##(1996-1#1)(2007-8#1)(2008-10#2)(2008-4#1)
up to 50 degrees C##3##5##(1994-11#1)(2008-10#1)(2008-6#1)
up to 50 microM##4##4##(1990-2#1)(1991-1#1)(1994-10#1)(1995-3#1)
up to 50 nM##2##4##(1990-2#1)(1995-6#1)
up to 50##31##3##(1990-2#2)(1991-1#1)(1991-11#1)(1991-3#1)(1993-5#2)(1994-10#1)(1994-11#1)(1994-3#1)(1995-3#1)(1995-6#1)(2005-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-6#2)(2011-1#1)(2012-3#1)
up to 50% of##10##4##(1997-7#1)(2006-11#1)(2006-3#1)(2008-1#3)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
up to 50%##17##3##(1997-7#1)(2006-11#1)(2006-12#1)(2006-3#1)(2008-1#3)(2008-10#1)(2008-4#1)(2008-5#1)(2009-4#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)
up to 500##10##3##(1990-8#1)(1993-2#1)(1996-2#1)(1997-3#1)(2007-12#2)(2008-10#3)(2008-12#1)
up to 52##2##3##(1997-5#1)(2008-5#1)
up to 56##2##3##(2008-10#2)
up to 56% of##2##4##(2007-8#1)(2008-10#1)
up to 58##2##3##(2009-2#1)(2009-8#1)
up to 6 h after##2##5##(1995-4#1)(2008-5#1)
up to 6 h##5##4##(1995-4#1)(1997-3#1)(2008-5#1)(2008-8#1)(2010-5#1)
up to 6 hours after the onset of symptoms##2##9##(2007-9#2)
up to 6 hours##3##4##(2007-9#2)(2012-12#1)
up to 6 months of##2##5##(2008-10#1)(2010-6#1)
up to 6 months##7##4##(2007-11#1)(2007-8#3)(2008-10#2)(2010-6#1)
up to 6 weeks in##3##5##(1992-8#1)(1996-6#1)(2007-11#1)
up to 6 weeks##6##4##(1992-8#1)(1996-6#1)(2007-11#1)(2008-10#3)
up to 6##40##3##(1990-10#1)(1991-12#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-11#1)(1994-5#1)(1994-9#1)(1995-4#1)(1995-6#1)(1996-6#1)(1997-3#1)(2007-11#2)(2007-12#2)(2007-8#3)(2007-9#2)(2008-10#7)(2008-11#3)(2008-2#2)(2008-5#1)(2008-8#1)(2010-5#1)(2010-6#1)(2012-1#1)(2012-12#1)
up to 6% of##2##4##(2008-1#1)(2010-5#1)
up to 6-fold##3##3##(1992-7#1)(1995-8#1)(2011-2#1)
up to 60 degrees C##3##5##(2008-5#1)(2008-6#2)
up to 60 min##3##4##(1990-1#1)(1993-7#1)(2004-8#1)
up to 60##17##3##(1990-1#1)(1992-12#1)(1993-7#1)(1995-3#1)(1997-1#1)(2004-8#1)(2007-10#1)(2008-10#4)(2008-5#1)(2008-6#3)(2008-8#1)(2013-1#1)
up to 60% of the##3##5##(1996-6#1)(2007-5#1)(2008-10#1)
up to 60% of##5##4##(1996-6#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)
up to 60%##8##3##(1990-5#1)(1996-6#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-3#1)
up to 60-70%##2##3##(1995-8#1)(1996-1#1)
up to 600##5##3##(1996-7#1)(2004-1#1)(2005-11#1)(2007-12#1)(2008-10#1)
up to 60min##2##3##(2008-10#2)
up to 610##2##3##(1997-4#1)(2008-11#1)
up to 62##2##3##(1992-5#1)(1996-9#1)
up to 63##5##3##(1995-5#1)(2006-8#1)(2008-10#2)(2009-2#1)
up to 64##2##3##(2008-10#1)(2013-7#1)
up to 64% of the##2##5##(2008-10#1)(2012-1#1)
up to 65##2##3##(2006-6#1)(2008-12#1)
up to 66##2##3##(1993-9#1)(2008-10#1)
up to 68%##2##3##(2008-10#1)(2008-5#1)
up to 69%##2##3##(2006-7#1)(2008-5#1)
up to 7 days after##2##5##(2008-10#1)(2010-4#1)
up to 7 days##6##4##(2006-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-4#1)
up to 7##14##3##(1992-6#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-5#1)(2010-4#1)(2010-7#1)
up to 7-fold##2##3##(2006-10#1)(2008-11#1)
up to 70 degrees C##2##5##(1995-11#1)(2008-10#1)
up to 70##5##3##(1995-11#1)(2006-12#1)(2008-10#1)(2008-5#1)(2008-8#1)
up to 70% of patients##2##5##(2008-7#2)
up to 70% of##5##4##(2005-7#1)(2008-1#1)(2008-7#2)(2012-12#1)
up to 70%##9##3##(1996-1#1)(2005-7#1)(2006-11#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#2)(2012-12#1)
up to 72 h after##2##5##(2008-10#1)(2008-5#1)
up to 72 h##5##4##(1990-5#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-1#1)
up to 72 hours##2##4##(1993-11#1)(1994-11#1)
up to 72##10##3##(1990-5#1)(1993-11#1)(1994-11#1)(1995-1#1)(1996-12#1)(2008-10#1)(2008-5#1)(2011-2#2)(2012-1#1)
up to 73%##2##3##(2008-10#2)
up to 75##5##3##(1990-8#1)(1994-7#1)(2007-12#1)(2008-10#1)(2013-8#1)
up to 75%##4##3##(2007-11#1)(2008-10#1)(2008-12#1)(2013-1#1)
up to 76##2##3##(2009-11#1)(2011-2#1)
up to 8 h##2##4##(1992-10#1)(1995-11#1)
up to 8 weeks##3##4##(1997-3#1)(2008-10#1)(2008-5#1)
up to 8##21##3##(1990-11#1)(1991-10#1)(1991-11#1)(1992-10#1)(1993-11#1)(1994-11#1)(1995-11#1)(1995-7#1)(1997-3#1)(2004-9#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)
up to 8% of##2##4##(2010-5#1)(2013-8#1)
up to 8%##4##3##(2008-2#1)(2008-3#1)(2010-5#1)(2013-8#1)
up to 80 degrees C##2##5##(1996-12#1)(2008-10#1)
up to 80 times##2##4##(1992-4#1)(2007-9#1)
up to 80##10##3##(1990-12#1)(1992-4#1)(1996-12#1)(1997-1#1)(1997-2#1)(2006-4#1)(2007-9#1)(2008-10#2)(2012-12#1)
up to 80% of the##2##5##(1994-3#1)(2013-1#1)
up to 80% of##5##4##(1994-11#1)(1994-3#1)(2005-8#1)(2008-6#1)(2013-1#1)
up to 80%##10##3##(1994-11#1)(1994-2#1)(1994-3#2)(2005-8#1)(2006-8#1)(2008-10#1)(2008-6#1)(2013-1#1)(2013-8#1)
up to 80-fold##2##3##(1992-6#1)(1994-8#1)
up to 800##2##3##(2008-10#2)
up to 83%##2##3##(2004-12#1)(2006-6#1)
up to 85% of##3##4##(2007-7#1)(2007-9#1)(2008-1#1)
up to 85%##5##3##(1994-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)
up to 9 days##2##4##(1994-4#1)(1995-11#1)
up to 9##6##3##(1994-4#1)(1995-11#1)(1995-2#1)(2006-5#1)(2008-3#1)(2008-4#1)
up to 90 degrees C##2##5##(1990-2#1)(1992-9#1)
up to 90 degrees##4##4##(1990-2#1)(1992-9#1)(2008-2#2)
up to 90 min##2##4##(1994-2#1)(2006-10#1)
up to 90##14##3##(1990-2#1)(1992-9#1)(1994-2#1)(1997-4#1)(2006-10#1)(2007-11#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2009-7#1)
up to 90% of the##2##5##(2008-10#2)
up to 90% of##6##4##(2004-11#1)(2007-9#1)(2008-10#2)(2008-9#1)(2012-2#1)
up to 90%##15##3##(1990-5#1)(1991-5#1)(1994-12#1)(2004-11#1)(2005-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-9#1)(2012-2#1)
up to 900 degrees C for Cd##2##7##(2008-10#2)
up to 900##4##3##(1997-2#1)(2008-10#3)
up to 92%##2##3##(2008-5#1)(2013-8#1)
up to 93%##2##3##(2009-7#1)(2013-8#1)
up to 95##3##3##(1992-12#1)(2007-11#1)(2008-7#1)
up to 95% of##2##4##(1991-12#1)(1994-9#1)
up to 95%##3##3##(1991-12#1)(1994-9#1)(2010-5#1)
up to 96 h##2##4##(1994-3#1)(2004-12#1)
up to 96##4##3##(1993-8#1)(1994-3#1)(2004-12#1)(2005-7#1)
up to 96%##2##3##(1992-6#1)(1994-5#1)
up to 97%##2##3##(2008-1#1)(2010-4#1)
up to 98%##4##3##(1996-5#1)(2008-7#2)(2010-5#1)
up to Day 4##2##4##(2012-12#2)
up to December##3##3##(2005-7#1)(2006-12#1)(2011-7#1)
up to PND 20##2##4##(2008-1#2)
up to PND 30##2##4##(2008-1#2)
up to PND##5##3##(2008-1#5)
up to a 2##2##4##(1994-9#1)(1995-6#1)
up to a certain##3##4##(2005-10#1)(2007-12#1)(2010-9#1)
up to a concentration of 1##2##6##(2006-3#1)(2008-10#1)
up to a concentration of 3##2##6##(1990-5#1)(2008-11#1)
up to a concentration of##9##5##(1990-5#1)(1991-5#1)(2006-3#1)(2008-10#5)(2008-11#1)
up to a concentration##10##4##(1990-5#1)(1991-5#1)(2006-3#1)(2008-10#6)(2008-11#1)
up to a factor of##5##5##(1990-11#1)(1992-3#1)(1995-12#1)(2008-3#1)(2008-7#1)
up to a factor##6##4##(1990-11#1)(1992-3#1)(1995-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
up to a maximum of##3##5##(1994-5#1)(2008-5#1)(2009-9#1)
up to a month##2##4##(2008-2#1)(2012-3#1)
up to a size parameter of 20 at 0##2##9##(2008-3#2)
up to a total dose of##2##6##(1991-2#1)(1993-7#1)
up to a total##4##4##(1991-2#1)(1992-10#1)(1993-7#1)(2012-2#1)
up to a##83##3##(1990-11#1)(1990-4#1)(1990-5#2)(1991-2#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-4#1)(1993-7#1)(1994-2#1)(1994-5#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(2004-11#1)(2005-10#1)(2006-1#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-12#3)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#4)(2008-2#3)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
up to about 10##2##4##(1993-11#1)(2008-10#1)
up to about##10##3##(1992-8#1)(1993-11#1)(1995-9#1)(1997-6#1)(2008-10#5)(2011-12#1)
up to age##7##3##(1991-5#2)(1994-6#1)(1995-1#1)(2007-2#1)(2008-7#1)(2009-7#1)
up to an arbitrary constant##2##5##(2008-3#2)
up to an##11##3##(1994-12#1)(2007-12#3)(2008-10#2)(2008-3#2)(2008-5#1)(2010-8#1)(2011-2#1)
up to and including the##3##5##(1990-12#1)(1991-12#1)(2008-3#1)
up to and including##6##4##(1990-12#1)(1991-12#1)(2005-7#1)(2008-3#1)(2012-1#1)(2012-3#1)
up to approximately##14##3##(1993-12#1)(1994-8#1)(2004-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#3)(2008-9#1)
up to as much as##2##5##(2005-11#1)(2008-2#1)
up to at least 100##3##5##(2008-10#3)
up to at least##8##4##(2007-3#1)(2008-10#6)(2008-7#1)
up to close##2##3##(2006-10#1)(2008-11#1)
up to date on##2##4##(2007-4#1)(2008-10#1)
up to date##14##3##(1990-6#1)(1990-7#1)(2005-9#1)(2006-12#1)(2006-6#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2013-1#2)(2013-7#1)(2013-8#1)
up to day##2##3##(1997-6#1)(2008-4#1)
up to eight##4##3##(1991-7#1)(2008-10#1)(2008-9#1)(2010-11#1)
up to five times##2##4##(2008-3#1)(2010-4#1)
up to five##8##3##(1990-10#1)(1991-2#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-4#1)(2013-1#1)
up to four times##2##4##(1997-7#1)(2008-3#1)
up to four##15##3##(1991-5#1)(1992-3#1)(1992-9#1)(1993-2#1)(1994-9#1)(1995-3#1)(1997-7#1)(2008-10#4)(2008-2#1)(2008-3#1)(2012-2#1)(2013-1#1)
up to fourfold##2##3##(2007-12#1)(2008-7#1)
up to half of##2##4##(2007-11#1)(2013-8#1)
up to half##5##3##(2007-11#1)(2008-5#2)(2008-7#1)(2013-8#1)
up to its##2##3##(2006-9#1)(2008-11#1)
up to late##2##3##(2008-10#2)
up to middle age##4##4##(1991-6#1)(1995-1#1)(1995-9#1)(2008-3#1)
up to more than##3##4##(1995-3#1)(1996-4#1)(2008-10#1)
up to nearly##2##3##(2008-3#1)(2011-1#1)
up to nine##3##3##(1994-12#1)(2008-10#1)(2009-12#1)
up to now##20##3##(1990-8#1)(1991-10#1)(1993-5#1)(1993-7#1)(1994-4#1)(2006-2#1)(2006-6#1)(2007-7#2)(2007-9#1)(2008-10#2)(2008-5#1)(2009-6#1)(2009-7#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-8#1)
up to one third of##3##5##(2007-5#1)(2007-7#1)(2008-12#1)
up to one third##4##4##(2006-1#1)(2007-5#1)(2007-7#1)(2008-12#1)
up to one year##2##4##(1996-1#1)(1997-5#1)
up to one##13##3##(1990-9#1)(1996-1#1)(1997-5#1)(2006-1#1)(2006-12#1)(2006-4#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
up to one-third of##3##4##(1996-2#1)(2007-5#1)(2009-9#1)
up to or##3##3##(1997-7#1)(2007-3#1)(2008-7#1)
up to over##2##3##(1997-4#1)(2005-11#1)
up to pH##2##3##(1991-2#1)(2008-10#1)
up to real##2##3##(2006-2#2)
up to second order##2##4##(2007-11#1)(2008-2#1)
up to seven days##2##4##(2004-9#1)(2013-7#1)
up to seven##5##3##(1995-8#1)(2004-9#1)(2007-7#1)(2008-5#1)(2013-7#1)
up to several hundred##3##4##(2008-2#1)(2008-4#1)(2012-2#1)
up to several##10##3##(1995-7#1)(1997-6#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2010-12#1)(2012-2#1)
up to six times##2##4##(2008-11#1)(2010-12#1)
up to six weeks##2##4##(2008-10#1)(2010-4#1)
up to six##8##3##(2007-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2010-12#2)(2010-4#1)
up to standard##2##3##(2006-11#1)(2008-10#1)
up to temperatures##2##3##(1995-6#1)(2007-12#1)
up to ten##7##3##(1997-8#2)(2008-10#1)(2008-4#1)(2008-8#1)(2010-8#1)(2013-8#1)
up to tens of##2##4##(2008-2#2)
up to that##3##3##(1993-8#1)(2008-3#1)(2012-12#1)
up to the 20th##3##4##(1993-12#1)(2008-11#1)(2008-5#1)
up to the age of##3##5##(1990-6#1)(1991-3#1)(2012-1#1)
up to the dose of##2##5##(1995-12#1)(2013-1#1)
up to the end of##3##5##(1993-9#1)(1995-1#1)(2006-9#1)
up to the final##2##4##(1993-9#1)(2007-1#1)
up to the fourth order##3##5##(2008-3#3)
up to the fourth##5##4##(2008-10#1)(2008-3#3)(2008-9#1)
up to the highest##2##4##(1997-2#1)(2007-12#1)
up to the level##2##4##(1990-8#1)(1992-3#1)
up to the maximum##3##4##(1991-10#1)(2006-7#1)(2008-10#1)
up to the median##2##4##(1992-4#1)(1995-8#1)
up to the stage of##2##5##(1992-2#1)(2008-11#1)
up to the surface##5##4##(1990-8#1)(2004-9#1)(2008-5#3)
up to the year##2##4##(2008-11#1)(2009-7#1)
up to the##101##3##(1990-1#1)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-3#3)(1991-6#1)(1992-2#3)(1992-3#2)(1992-4#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-2#2)(1997-7#1)(2004-9#1)(2005-8#1)(2006-11#1)(2006-4#1)(2006-6#2)(2006-7#1)(2006-9#1)(2007-1#2)(2007-11#1)(2007-12#6)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#5)(2008-5#5)(2008-6#2)(2008-7#3)(2008-9#1)(2009-12#1)(2009-7#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#2)
up to their##2##3##(1994-2#1)(2008-5#1)
up to this##2##3##(1991-6#1)(2006-11#1)
up to three months##2##4##(2006-10#1)(2013-1#1)
up to three times##5##4##(2007-3#1)(2008-2#1)(2010-5#1)(2011-2#2)
up to three years##2##4##(2008-1#1)(2011-1#1)
up to three##21##3##(1991-3#1)(1991-5#1)(1991-9#1)(1992-8#1)(1993-12#1)(2006-10#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2013-1#1)
up to time of##2##4##(1994-11#1)(2008-7#1)
up to today##3##3##(2006-8#2)(2009-6#1)
up to two thirds of all##2##6##(1991-11#1)(2007-9#1)
up to two thirds of##3##5##(1991-11#1)(2007-9#1)(2008-3#1)
up to two years##3##4##(1996-11#1)(2008-11#1)(2010-8#1)
up to two##13##3##(1991-11#3)(1996-11#1)(1997-4#1)(2007-9#1)(2008-11#1)(2008-3#1)(2009-3#1)(2009-4#1)(2010-5#1)(2010-8#1)(2012-3#1)
up to##2012##2##(1990-1#2)(1990-10#5)(1990-11#3)(1990-12#8)(1990-2#11)(1990-3#5)(1990-4#13)(1990-5#9)(1990-6#4)(1990-7#3)(1990-8#11)(1990-9#4)(1991-1#3)(1991-10#7)(1991-11#6)(1991-12#8)(1991-2#11)(1991-3#11)(1991-4#3)(1991-5#11)(1991-6#4)(1991-7#5)(1991-8#4)(1991-9#6)(1992-1#1)(1992-10#6)(1992-11#4)(1992-12#6)(1992-2#9)(1992-3#11)(1992-4#5)(1992-5#2)(1992-6#10)(1992-7#6)(1992-8#11)(1992-9#2)(1993-1#3)(1993-10#1)(1993-11#5)(1993-12#7)(1993-2#5)(1993-3#8)(1993-4#3)(1993-5#5)(1993-6#4)(1993-7#7)(1993-8#5)(1993-9#8)(1994-1#1)(1994-10#5)(1994-11#14)(1994-12#6)(1994-2#9)(1994-3#14)(1994-4#2)(1994-5#7)(1994-6#8)(1994-7#1)(1994-8#13)(1994-9#9)(1995-1#7)(1995-10#1)(1995-11#8)(1995-12#3)(1995-2#5)(1995-3#8)(1995-4#2)(1995-5#3)(1995-6#6)(1995-7#7)(1995-8#9)(1995-9#5)(1996-1#5)(1996-10#3)(1996-11#2)(1996-12#18)(1996-2#5)(1996-3#5)(1996-4#2)(1996-5#8)(1996-6#4)(1996-7#10)(1996-8#5)(1996-9#4)(1997-1#9)(1997-2#11)(1997-3#7)(1997-4#9)(1997-5#6)(1997-6#13)(1997-7#11)(1997-8#11)(2004-1#1)(2004-11#4)(2004-12#2)(2004-8#1)(2004-9#7)(2005-10#2)(2005-11#13)(2005-4#1)(2005-6#1)(2005-7#8)(2005-8#4)(2005-9#2)(2006-1#2)(2006-10#15)(2006-11#7)(2006-12#15)(2006-2#5)(2006-3#5)(2006-4#6)(2006-5#4)(2006-6#10)(2006-7#6)(2006-8#10)(2006-9#4)(2007-1#4)(2007-10#8)(2007-11#41)(2007-12#76)(2007-2#8)(2007-3#8)(2007-4#5)(2007-5#8)(2007-6#5)(2007-7#13)(2007-8#31)(2007-9#19)(2008-1#22)(2008-10#325)(2008-11#66)(2008-12#16)(2008-2#49)(2008-3#68)(2008-4#21)(2008-5#62)(2008-6#19)(2008-7#50)(2008-8#23)(2008-9#15)(2009-10#5)(2009-11#4)(2009-12#3)(2009-2#9)(2009-3#2)(2009-4#6)(2009-5#3)(2009-6#3)(2009-7#8)(2009-8#5)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#12)(2010-2#12)(2010-3#2)(2010-4#14)(2010-5#14)(2010-6#2)(2010-7#4)(2010-8#12)(2010-9#4)(2011-1#18)(2011-12#5)(2011-2#41)(2011-7#1)(2012-1#11)(2012-11#2)(2012-12#19)(2012-2#21)(2012-3#12)(2012-7#1)(2013-1#31)(2013-7#7)(2013-8#21)
up today##3##2##(2005-4#1)(2007-8#1)(2008-10#1)
up until##6##2##(2007-7#1)(2009-3#1)(2009-7#1)(2011-2#2)(2013-8#1)
up via##2##2##(1994-12#1)(2011-2#1)
up was##17##2##(1990-10#1)(2006-8#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-10#2)(2009-11#1)(2010-3#1)(2011-2#4)(2012-2#2)
up when##2##2##(2008-5#1)(2009-10#1)
up with a##4##3##(1994-12#1)(2007-9#1)(2008-8#1)(2009-6#1)
up with all##2##3##(1992-3#1)(2006-9#1)
up with four##2##3##(1997-6#1)(2008-10#1)
up with his##2##3##(1995-1#1)(2007-8#1)
up with research##3##3##(1996-1#1)(2008-7#2)
up with the##12##3##(1996-3#1)(2006-3#1)(2007-1#1)(2007-11#2)(2007-4#2)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)
up with what##2##3##(1993-12#1)(2012-2#1)
up with##71##2##(1992-3#1)(1993-12#1)(1994-12#2)(1995-1#1)(1996-1#1)(1996-3#1)(1996-6#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(2004-4#1)(2005-10#1)(2005-5#1)(2006-1#1)(2006-10#1)(2006-3#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-4#2)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#5)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-6#2)(2010-1#2)(2010-5#1)(2010-7#1)(2011-1#2)(2011-12#3)(2012-2#1)(2013-8#1)
up within##2##2##(1990-11#1)(2008-2#1)
up without##5##2##(1990-5#1)(2007-7#1)(2011-12#3)
up!##2##1##(2006-5#1)(2009-7#1)
up##3532##1##(1990-1#2)(1990-10#8)(1990-11#6)(1990-12#15)(1990-2#16)(1990-3#8)(1990-4#14)(1990-5#12)(1990-6#5)(1990-7#3)(1990-8#18)(1990-9#8)(1991-1#5)(1991-10#10)(1991-11#8)(1991-12#11)(1991-2#18)(1991-3#18)(1991-4#4)(1991-5#14)(1991-6#10)(1991-7#9)(1991-8#7)(1991-9#9)(1992-1#6)(1992-10#7)(1992-11#7)(1992-12#12)(1992-2#12)(1992-3#21)(1992-4#8)(1992-5#12)(1992-6#16)(1992-7#6)(1992-8#17)(1992-9#4)(1993-1#3)(1993-10#3)(1993-11#8)(1993-12#11)(1993-2#8)(1993-3#14)(1993-4#5)(1993-5#10)(1993-6#8)(1993-7#11)(1993-8#7)(1993-9#8)(1994-1#4)(1994-10#6)(1994-11#16)(1994-12#11)(1994-2#11)(1994-3#18)(1994-4#4)(1994-5#12)(1994-6#13)(1994-7#3)(1994-8#16)(1994-9#13)(1995-1#9)(1995-10#2)(1995-11#13)(1995-12#11)(1995-2#9)(1995-3#14)(1995-4#7)(1995-5#6)(1995-6#14)(1995-7#9)(1995-8#10)(1995-9#7)(1996-1#13)(1996-10#4)(1996-11#6)(1996-12#27)(1996-2#11)(1996-3#12)(1996-4#4)(1996-5#13)(1996-6#8)(1996-7#14)(1996-8#8)(1996-9#7)(1997-1#11)(1997-2#17)(1997-3#16)(1997-4#15)(1997-5#10)(1997-6#17)(1997-7#15)(1997-8#16)(2004-1#1)(2004-11#5)(2004-12#2)(2004-2#3)(2004-4#3)(2004-7#1)(2004-8#1)(2004-9#7)(2005-1#2)(2005-10#6)(2005-11#21)(2005-12#3)(2005-4#3)(2005-5#4)(2005-6#1)(2005-7#9)(2005-8#10)(2005-9#3)(2006-1#6)(2006-10#36)(2006-11#10)(2006-12#24)(2006-2#13)(2006-3#11)(2006-4#7)(2006-5#10)(2006-6#21)(2006-7#9)(2006-8#17)(2006-9#6)(2007-1#13)(2007-10#18)(2007-11#68)(2007-12#100)(2007-2#19)(2007-3#12)(2007-4#18)(2007-5#12)(2007-6#13)(2007-7#40)(2007-8#77)(2007-9#50)(2008-1#45)(2008-10#414)(2008-11#120)(2008-12#23)(2008-2#76)(2008-3#100)(2008-4#60)(2008-5#108)(2008-6#31)(2008-7#100)(2008-8#39)(2008-9#47)(2009-10#13)(2009-11#5)(2009-12#6)(2009-2#22)(2009-3#13)(2009-4#14)(2009-5#11)(2009-6#9)(2009-7#19)(2009-8#8)(2009-9#4)(2010-1#4)(2010-10#1)(2010-11#9)(2010-12#25)(2010-2#18)(2010-3#11)(2010-4#21)(2010-5#21)(2010-6#3)(2010-7#11)(2010-8#24)(2010-9#8)(2011-1#42)(2011-11#1)(2011-12#14)(2011-2#94)(2011-3#1)(2011-7#1)(2012-1#16)(2012-11#9)(2012-12#41)(2012-2#54)(2012-3#29)(2012-7#1)(2013-1#77)(2013-7#15)(2013-8#55)
up&quot##5##1##(1993-10#1)(1995-12#1)(1996-4#1)(2008-9#1)(2013-1#1)
up'##2##1##(2006-5#1)(2007-9#1)
up- and down-regulation##3##3##(1990-2#1)(1995-12#1)(1996-7#1)
up- and##4##2##(1990-2#1)(1995-12#1)(1996-7#1)(2006-12#1)
up- or down-regulated##5##3##(1996-2#1)(2008-4#1)(2009-5#1)(2010-4#2)
up- or##11##2##(1996-12#1)(1996-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-4#2)(2012-12#2)
up-##15##1##(1990-2#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-7#1)(2006-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-4#2)(2012-12#2)
up-conversion luminescence was##2##3##(2005-4#2)
up-date##4##1##(1990-7#1)(1996-9#1)(2007-11#2)
up-front##3##1##(1994-2#1)(1997-1#1)(2010-3#1)
up-projection of labels##2##3##(2008-2#2)
up-regulate the##2##2##(1994-10#1)(1997-6#1)
up-regulate##12##1##(1994-10#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-7#1)(1997-6#1)(2008-11#1)(2008-7#2)(2008-9#1)(2009-3#1)(2011-1#1)
up-regulated PEG10 expression##2##3##(2005-10#2)
up-regulated and##4##2##(2008-10#1)(2008-9#1)(2010-4#1)(2010-6#1)
up-regulated by##13##2##(1992-2#2)(1992-8#1)(1993-6#1)(1995-12#1)(1996-11#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-4#1)(2012-12#1)
up-regulated during##3##2##(1993-4#1)(1995-8#1)(2011-2#1)
up-regulated expression of##2##3##(2008-11#1)(2012-12#1)
up-regulated genes##3##2##(2008-10#2)(2009-4#1)
up-regulated in CRC##2##3##(2009-4#2)
up-regulated in resistant##2##3##(2008-10#2)
up-regulated in the##6##3##(1993-2#1)(1995-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-2#1)
up-regulated in##35##2##(1993-2#1)(1995-11#2)(1995-8#1)(1996-8#1)(1997-7#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-4#3)(2008-7#1)(2008-8#1)(2009-4#3)(2009-9#1)(2010-12#2)(2010-4#2)(2010-7#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-8#1)
up-regulated osteopontin gene##2##3##(2008-7#2)
up-regulated the expression of##4##4##(1994-11#1)(2008-3#1)(2009-5#2)
up-regulated the##7##2##(1991-6#1)(1994-11#1)(1996-4#1)(2008-11#1)(2008-3#1)(2009-5#2)
up-regulated whereas##2##2##(2008-10#1)(2012-3#1)
up-regulated##100##1##(1990-10#1)(1991-6#1)(1992-2#2)(1992-8#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-11#1)(1995-11#2)(1995-12#1)(1995-8#3)(1996-11#1)(1996-4#1)(1996-8#1)(1997-4#1)(1997-6#1)(1997-7#3)(2005-10#2)(2005-8#2)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#2)(2008-10#11)(2008-11#5)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-3#1)(2009-4#4)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-4#7)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
up-regulates the expression of##3##4##(1994-6#1)(2007-11#1)(2008-3#1)
up-regulates the##7##2##(1993-12#1)(1994-2#1)(1994-6#1)(2007-11#1)(2008-11#1)(2008-3#1)(2010-2#1)
up-regulates##20##1##(1991-10#1)(1992-8#1)(1993-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-8#1)(1996-8#1)(1997-8#1)(2007-11#4)(2008-11#1)(2008-3#1)(2009-4#1)(2009-8#1)(2010-2#3)
up-regulating##4##1##(1993-12#1)(2008-11#2)(2013-7#1)
up-regulation and##3##2##(1994-12#1)(2008-3#1)(2008-4#1)
up-regulation by##3##2##(1990-5#1)(1994-5#1)(2010-11#1)
up-regulation in the##5##3##(1997-3#1)(1997-7#3)(2013-1#1)
up-regulation in##15##2##(1990-10#1)(1990-2#1)(1995-3#1)(1996-12#2)(1996-3#1)(1997-3#1)(1997-7#5)(2010-7#1)(2012-3#1)(2013-1#1)
up-regulation of ENK mRNA##2##4##(1995-7#2)
up-regulation of GAPDH in EC##2##5##(1994-9#2)
up-regulation of bcl-2##2##3##(1997-8#2)
up-regulation of the##7##3##(1992-8#1)(1994-6#1)(1994-9#1)(1995-2#1)(1996-4#1)(1997-7#1)(2008-4#1)
up-regulation of##74##2##(1990-12#1)(1990-5#1)(1991-5#1)(1992-11#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-4#1)(1994-12#1)(1994-6#2)(1994-9#4)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-7#2)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#2)(2005-9#1)(2006-12#2)(2006-4#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-11#3)(2008-4#4)(2008-9#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2012-1#1)(2012-12#2)(2013-1#5)
up-regulation on##2##2##(2008-8#1)(2013-1#1)
up-regulation was##4##2##(1996-12#1)(1997-7#1)(2006-4#1)(2007-11#1)
up-regulation##111##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#2)(1991-5#1)(1992-11#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-12#2)(1994-5#1)(1994-6#2)(1994-9#5)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-7#2)(1995-9#1)(1996-1#1)(1996-12#5)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#10)(1997-8#2)(2005-9#1)(2006-12#2)(2006-4#2)(2007-10#1)(2007-11#2)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#2)(2010-7#1)(2012-1#1)(2012-12#4)(2012-3#1)(2013-1#8)
up-stream##2##1##(1994-8#1)(2008-10#1)
up-titrating##2##1##(2008-8#1)(2011-1#1)
up-to-date information on##3##3##(1991-1#1)(2005-9#1)(2006-2#1)
up-to-date information##7##2##(1991-1#1)(1993-2#1)(2005-9#1)(2006-2#1)(2008-7#1)(2012-12#1)(2013-8#1)
up-to-date knowledge of##2##3##(2008-10#1)(2009-8#1)
up-to-date problem&quot##2##2##(2013-1#2)
up-to-date review of##2##3##(2006-2#1)(2012-12#1)
up-to-date##41##1##(1991-1#1)(1991-12#1)(1992-1#1)(1992-2#1)(1993-10#1)(1993-2#1)(1993-5#1)(1995-2#1)(2005-5#1)(2005-9#1)(2006-12#1)(2006-2#2)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#2)(2009-2#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#5)(2013-8#1)
up-to-the-minute##2##1##(1994-3#1)(2008-7#1)
up?##4##1##(1994-5#1)(1995-1#1)(1995-9#1)(2007-4#1)
upbeat##2##1##(2005-8#1)(2007-8#1)
upcoding##2##1##(1992-2#1)(2006-8#1)
upcoming years##2##2##(2008-12#1)(2012-12#1)
upcoming##30##1##(1993-1#1)(1996-3#1)(2004-12#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-7#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
upconversion and##2##2##(2007-11#1)(2008-3#1)
upconversion fiber##2##2##(2007-12#2)
upconversion in thulium-doped##2##3##(2007-12#1)(2008-3#1)
upconversion in##7##2##(2007-12#4)(2008-3#2)(2010-5#1)
upconversion laser##3##2##(2007-12#1)(2008-1#2)
upconversion of##3##2##(2007-12#2)(2008-3#1)
upconversion processes##2##2##(2007-12#1)(2008-1#1)
upconversion signals at##2##3##(2007-12#1)(2008-2#1)
upconversion##38##1##(2005-4#1)(2007-11#4)(2007-12#15)(2008-1#4)(2008-2#2)(2008-3#11)(2010-5#1)
upconverted##3##1##(2007-11#1)(2008-3#2)
update and##4##2##(1996-1#1)(2006-8#1)(2007-12#1)(2011-1#1)
update for##4##2##(2006-3#1)(2009-4#1)(2009-9#1)(2012-12#1)
update from the##2##3##(2007-12#1)(2008-6#1)
update in##2##2##(2006-10#1)(2008-10#1)
update knowledge##2##2##(1994-12#1)(2013-1#1)
update of an##4##3##(1994-3#1)(2007-2#1)(2008-8#1)(2012-2#1)
update of pharmacological##2##3##(2005-8#1)(2006-10#1)
update of the##15##3##(1990-6#1)(1997-1#1)(2006-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#3)(2009-6#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
update of##31##2##(1990-6#1)(1994-3#1)(1997-1#1)(2005-7#2)(2005-8#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#3)(2009-4#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
update on current##2##3##(2006-7#1)(2008-6#1)
update on diagnosis and##2##4##(2008-12#1)(2011-2#1)
update on recent##2##3##(1991-3#1)(2008-11#1)
update on research and activities at the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry##2##22##(2007-12#2)
update on research and activities at the Centers for Disease Control and Prevention##3##13##(2007-12#3)
update on the current##3##4##(2009-4#1)(2011-1#1)(2013-1#1)
update on the epidemiology of##2##5##(1995-12#1)(2008-5#1)
update on the##17##3##(1995-12#1)(2006-10#1)(2008-1#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
update on##53##2##(1991-3#1)(1994-1#1)(1995-1#1)(1995-12#1)(2005-7#1)(2006-10#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)
update our knowledge##3##3##(1990-12#1)(1991-3#1)(2013-1#1)
update the internal representation of##2##5##(1995-5#2)
update the##16##2##(1993-9#1)(1994-1#1)(1995-5#2)(1995-6#1)(2005-11#1)(2007-12#1)(2008-3#2)(2008-6#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
update their knowledge##2##3##(2008-5#1)(2010-4#1)
update their##9##2##(2006-6#1)(2006-8#1)(2008-10#1)(2008-5#1)(2010-4#1)(2010-5#1)(2012-11#1)(2012-12#1)(2012-3#1)
update to the##4##3##(2006-10#1)(2008-5#1)(2010-9#1)(2012-1#1)
update to##6##2##(1996-2#1)(2006-10#1)(2008-5#1)(2010-9#1)(2012-1#1)(2012-3#1)
update with##2##2##(2004-2#1)(2012-12#1)
update##267##1##(1990-12#1)(1990-6#1)(1991-1#1)(1991-3#2)(1991-7#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-1#3)(1994-12#1)(1994-3#3)(1994-7#1)(1995-1#1)(1995-12#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(2004-12#1)(2004-2#2)(2005-11#2)(2005-6#1)(2005-7#9)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#13)(2006-2#2)(2006-3#2)(2006-6#1)(2006-7#1)(2006-8#6)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#11)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#3)(2008-1#5)(2008-10#5)(2008-11#4)(2008-12#2)(2008-2#5)(2008-3#6)(2008-4#7)(2008-5#6)(2008-6#9)(2008-7#3)(2008-8#5)(2008-9#4)(2009-12#1)(2009-3#3)(2009-4#3)(2009-5#1)(2009-6#5)(2009-8#3)(2009-9#3)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-5#2)(2010-8#3)(2010-9#3)(2011-1#2)(2011-12#1)(2011-2#11)(2011-9#1)(2012-1#2)(2012-11#4)(2012-12#11)(2012-2#8)(2012-3#7)(2013-1#10)(2013-7#1)(2013-8#2)
updated according to##2##3##(2011-2#1)(2013-8#1)
updated and##7##2##(1992-9#1)(2007-4#2)(2008-8#1)(2010-7#1)(2013-1#2)
updated based on##2##3##(2006-11#1)(2008-6#1)
updated by##3##2##(1993-3#1)(2008-2#2)
updated for##2##2##(1995-9#1)(2008-10#1)
updated guidelines for##2##3##(2008-7#1)(2010-3#1)
updated in the##2##3##(2008-10#1)(2008-5#1)
updated in##4##2##(1994-12#1)(2008-10#1)(2008-5#1)(2010-12#1)
updated information##6##2##(1996-6#1)(2008-1#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-2#1)
updated key##2##2##(2007-3#1)(2013-8#1)
updated on the##4##3##(1993-3#1)(2006-10#1)(2008-1#1)(2008-3#1)
updated overview of the##2##4##(2011-1#1)(2011-2#1)
updated overview of##4##3##(2011-1#1)(2011-2#1)(2012-12#2)
updated overview##5##2##(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#2)
updated the##2##2##(2005-8#1)(2006-3#1)
updated to include##2##3##(1991-9#1)(2008-4#1)
updated to##5##2##(1991-9#1)(2008-4#1)(2008-7#1)(2010-9#1)(2013-1#1)
updated unit##2##2##(2008-4#2)
updated version of##2##3##(2008-10#1)(2008-4#1)
updated with##4##2##(2005-7#2)(2007-10#1)(2009-3#1)
updated##130##1##(1991-9#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#3)(1994-12#1)(1994-2#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-8#1)(2005-7#3)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-3#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#2)(2007-4#2)(2007-5#4)(2007-7#1)(2008-1#3)(2008-10#6)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#7)(2008-5#2)(2008-6#11)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#3)
updates and##5##2##(1991-1#1)(1991-7#1)(2008-3#1)(2012-12#2)
updates are##2##2##(2007-11#1)(2008-3#1)
updates of##2##2##(2008-2#1)(2011-2#1)
updates on the##2##3##(2005-6#1)(2012-1#1)
updates on##4##2##(2005-6#1)(2008-6#1)(2010-5#1)(2012-1#1)
updates the##10##2##(1997-1#1)(2006-10#2)(2007-3#1)(2007-9#1)(2008-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
updates##37##1##(1991-1#2)(1991-7#1)(1992-12#1)(1994-12#1)(1997-1#1)(2005-6#1)(2005-8#1)(2006-10#2)(2007-11#2)(2007-3#1)(2007-9#1)(2008-1#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#2)(2013-7#1)
updating and##2##2##(1992-12#1)(2012-12#1)
updating of##8##2##(1995-9#2)(1996-2#1)(1997-2#1)(2006-8#1)(2008-7#1)(2011-2#1)(2012-11#1)
updating the##7##2##(2006-9#1)(2007-11#1)(2007-3#1)(2008-5#1)(2011-12#2)(2013-1#1)
updating was##2##2##(2012-2#1)(2013-7#1)
updating with##2##2##(1995-9#1)(2007-11#1)
updating##48##1##(1992-12#3)(1994-2#2)(1995-12#1)(1995-9#3)(1996-2#1)(1997-2#1)(2005-10#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#6)(2007-3#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#3)(2011-2#2)(2012-11#2)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
upfield shifts##2##2##(1996-2#1)(2006-10#1)
upfield##8##1##(1991-2#1)(1992-3#1)(1992-4#1)(1993-8#1)(1994-5#1)(1996-2#1)(2006-10#1)(2008-10#1)
upflow##3##1##(2004-4#1)(2007-10#1)(2008-6#1)
upfront chemotherapy##2##2##(2010-2#2)
upfront##9##1##(2008-12#1)(2008-5#1)(2009-6#1)(2010-12#1)(2010-2#3)(2011-2#1)(2012-12#1)
upgrade the##2##2##(1996-3#1)(2013-1#1)
upgrade to##2##2##(2008-10#1)(2012-2#1)
upgrade##15##1##(1995-11#1)(1996-3#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-9#4)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
upgraded to##3##2##(2011-1#1)(2012-2#1)(2013-8#1)
upgraded##10##1##(1992-11#1)(1992-2#1)(1996-2#1)(1996-3#1)(2005-11#1)(2008-3#1)(2009-3#1)(2011-1#1)(2012-2#1)(2013-8#1)
upgrades or##2##2##(1993-2#1)(2008-10#1)
upgrades##7##1##(1992-3#1)(1993-2#1)(1993-3#1)(2008-10#2)(2008-3#1)(2012-2#1)
upgrading of the##3##3##(1993-1#1)(1993-12#1)(2007-11#1)
upgrading of##5##2##(1993-1#1)(1993-12#1)(2007-11#1)(2007-3#1)(2008-10#1)
upgrading##9##1##(1993-1#1)(1993-12#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-9#1)(2010-8#1)(2011-1#1)
upheaval##3##1##(1992-10#1)(1995-8#2)
upheavals##2##1##(2008-8#1)(2012-2#1)
upheld a##6##2##(1991-7#1)(1994-2#1)(1995-12#1)(1996-11#1)(1996-5#1)(1997-5#1)
upheld in##2##2##(2007-5#1)(2009-6#1)
upheld the##5##2##(1992-6#1)(1994-11#1)(1995-12#1)(1996-11#1)(2007-12#1)
upheld##22##1##(1991-1#1)(1991-7#1)(1992-6#1)(1993-5#1)(1994-11#1)(1994-2#1)(1995-12#4)(1996-11#3)(1996-5#1)(1996-6#1)(1997-5#1)(2007-12#1)(2007-5#1)(2008-8#2)(2009-6#1)(2011-1#1)
uphill##3##1##(1996-7#1)(2010-7#1)(2013-1#1)
uphold##4##1##(1993-3#1)(1995-3#1)(2007-11#1)(2012-3#1)
upholding the##3##2##(2008-8#1)(2008-9#1)(2013-8#1)
upholding##5##1##(2004-10#1)(2008-8#1)(2008-9#2)(2013-8#1)
upholds##9##1##(1990-2#1)(1991-10#1)(1992-11#1)(1995-6#3)(1996-12#1)(2010-12#1)(2012-11#1)
upland forest##2##2##(1997-4#2)
upland red soil##2##3##(2013-8#2)
upland red##3##2##(2013-8#3)
upland rice##3##2##(2008-10#3)
upland##17##1##(1993-9#1)(1997-4#3)(2008-10#8)(2008-9#2)(2013-8#3)
uplift of##2##2##(2008-9#2)
uplift##5##1##(1991-6#1)(2008-9#4)
uplifted##3##1##(2008-5#2)(2010-8#1)
uplifting##2##1##(2008-11#1)(2008-5#1)
uplink##3##1##(2007-12#2)(2008-3#1)
upload##3##1##(2008-4#1)(2013-1#2)
uploaded##4##1##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
uploading##2##1##(2008-7#1)(2010-8#1)
upon Ca2+##2##2##(1990-7#1)(1995-1#1)
upon DNA damage##2##3##(2011-2#2)
upon FSK##2##2##(1993-7#2)
upon HBV##2##2##(2012-3#2)
upon RA treatment##2##3##(1992-5#1)(1993-9#1)
upon SDS-PAGE##4##2##(1990-10#1)(1991-7#2)(1994-11#1)
upon UV##2##2##(1995-8#1)(1996-6#1)
upon UV-illumination##2##2##(1991-2#2)
upon a GaAs##2##3##(2007-11#1)(2008-2#1)
upon a close##2##3##(2008-8#1)(2009-6#1)
upon a glass substrate##4##4##(2007-12#4)
upon a glass##6##3##(2007-12#6)
upon a sample##2##3##(1997-2#1)(2008-10#1)
upon a single##2##3##(2006-12#1)(2011-1#1)
upon a substrate##2##3##(2007-12#1)(2008-2#1)
upon a three-year project##2##4##(1996-9#1)(2008-11#1)
upon a variety of##2##4##(2005-12#1)(2008-7#1)
upon a##97##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-8#1)(1992-10#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-8#1)(1995-1#1)(1995-11#1)(1996-12#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(2004-12#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-12#2)(2007-11#6)(2007-12#28)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#9)(2008-3#4)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-6#1)(2010-6#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
upon absorption##2##2##(1990-10#1)(1997-6#1)
upon acidification##2##2##(1994-5#1)(2008-10#1)
upon acquisition##2##2##(1991-2#1)(2008-10#1)
upon activation by##2##3##(1994-3#1)(1995-3#1)
upon activation of##4##3##(1990-11#1)(1992-11#1)(1992-12#1)(1992-7#1)
upon activation with##2##3##(1990-11#1)(1995-3#1)
upon activation##10##2##(1990-11#2)(1992-11#1)(1992-12#1)(1992-7#1)(1994-3#1)(1995-3#2)(2008-11#1)(2012-12#1)
upon adding##2##2##(1994-3#1)(2008-10#1)
upon addition of bile##2##4##(2005-11#2)
upon addition of the##3##4##(1991-5#1)(2005-11#1)(2008-10#1)
upon addition of##30##3##(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-8#1)(1993-6#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-2#2)(1997-1#1)(1997-4#2)(1997-8#1)(2005-11#3)(2006-12#2)(2008-10#5)
upon addition##32##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-8#1)(1993-6#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-2#2)(1997-1#1)(1997-4#2)(1997-8#1)(2005-11#3)(2006-12#2)(2008-1#1)(2008-10#5)(2008-2#1)
upon admission##4##2##(1991-2#1)(1995-9#1)(2008-3#1)(2008-7#1)
upon adsorption of##2##3##(2005-11#1)(2008-10#1)
upon adsorption##5##2##(2005-11#3)(2008-10#2)
upon age##2##2##(1992-2#1)(2009-10#1)
upon ageing##2##2##(1995-7#2)
upon aggregation##2##2##(1994-3#2)
upon aging for both diet groups##2##6##(1995-3#2)
upon aging##4##2##(1995-3#3)(2013-7#1)
upon amino acid##2##3##(2008-10#1)(2008-12#1)
upon an##13##2##(1990-11#1)(1991-11#1)(1991-8#1)(1992-12#1)(1993-11#1)(1993-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2009-12#1)(2011-12#1)
upon analysis of##3##3##(1991-10#1)(1997-1#1)(2008-10#1)
upon and##3##2##(1993-8#1)(2007-8#1)(2011-1#1)
upon annealing##2##2##(2008-3#1)(2009-5#1)
upon any##2##2##(1991-2#1)(2008-1#1)
upon applying a##2##3##(1991-9#1)(2005-11#1)
upon arrival at the hospital##2##5##(2007-8#2)
upon arrival##4##2##(2007-8#2)(2008-2#1)(2010-12#1)
upon as##4##2##(1996-2#1)(1997-8#1)(2007-2#1)(2012-2#1)
upon association##2##2##(1992-6#2)
upon binding PALA##2##3##(1990-8#2)
upon binding of the##4##4##(1994-9#1)(1997-7#1)(2008-1#1)(2008-2#1)
upon binding of##9##3##(1991-12#2)(1992-9#1)(1994-9#1)(1995-6#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-2#1)
upon binding to GroEL##2##4##(1991-7#1)(1995-8#1)
upon binding to##13##3##(1991-7#1)(1992-11#1)(1992-12#1)(1993-3#1)(1995-10#1)(1995-5#1)(1995-8#1)(1996-7#1)(1997-4#1)(1997-7#1)(2006-12#1)(2007-11#1)(2008-9#1)
upon binding##33##2##(1990-8#3)(1991-12#2)(1991-7#1)(1992-11#1)(1992-12#2)(1992-9#1)(1993-3#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-5#3)(1995-6#1)(1995-8#1)(1996-11#1)(1996-7#1)(1997-4#1)(1997-7#2)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#2)
upon blood##2##2##(1995-12#1)(2008-3#1)
upon both##4##2##(1995-11#1)(1997-6#1)(2006-10#1)(2012-2#1)
upon brain##2##2##(1995-3#1)(2010-8#1)
upon by##12##2##(1990-11#1)(1990-5#1)(1991-11#1)(2007-8#1)(2008-10#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-11#1)(2011-12#1)(2011-2#1)
upon calcium binding##2##3##(1991-7#1)(1995-11#1)
upon carbon##2##2##(1993-8#1)(1997-6#1)
upon care providers working within a children's hospital##2##8##(2009-7#2)
upon cell stimulation##2##3##(1992-6#1)(1994-3#1)
upon cell##7##2##(1991-3#1)(1992-6#1)(1994-3#1)(1995-3#1)(1997-4#2)(2008-10#1)
upon cells##2##2##(1991-12#1)(1995-5#1)
upon cellular##3##2##(1995-8#1)(2012-12#1)(2012-3#1)
upon cessation of##3##3##(1991-5#1)(1995-12#1)(2013-8#1)
upon changing##2##2##(2005-11#1)(2008-10#1)
upon chelation##3##2##(2008-5#3)
upon chromosome##2##2##(2008-11#1)(2012-3#1)
upon chronic##2##2##(1991-6#1)(2012-12#1)
upon clinical##11##2##(1990-3#1)(1990-8#1)(1991-4#1)(1997-6#1)(2005-12#1)(2007-11#2)(2007-2#1)(2007-6#1)(2008-12#1)(2012-2#1)
upon completion of##4##3##(1991-11#1)(1992-3#1)(2010-2#1)(2013-8#1)
upon complex formation##4##3##(1994-9#1)(1997-4#1)(2008-10#1)(2009-7#1)
upon complexation##3##2##(1996-6#1)(2005-11#1)(2008-10#1)
upon compression##2##2##(2005-11#2)
upon contact with##4##3##(2008-10#1)(2008-4#1)(2010-12#1)(2010-4#1)
upon cooling##3##2##(1991-2#1)(1991-8#1)(2006-10#1)
upon current##3##2##(2006-7#1)(2010-7#1)(2011-1#1)
upon data##2##2##(2010-12#1)(2010-2#1)
upon de-fluorination##2##2##(2009-2#2)
upon deintercalation##2##2##(2005-11#2)
upon deletion of##2##3##(1992-8#1)(1996-4#1)
upon denaturation##4##2##(1995-10#1)(1997-7#1)(2006-10#2)
upon depletion of##2##3##(2008-8#1)(2013-1#1)
upon differentiation##3##2##(1997-2#1)(2008-11#1)(2010-11#1)
upon dilution##2##2##(1991-8#1)(2008-5#1)
upon discharge##2##2##(1994-9#1)(2007-8#1)
upon discontinuation of##2##3##(1995-9#1)(2005-7#1)
upon drug##2##2##(1992-3#1)(1994-8#1)
upon each##4##2##(1995-5#1)(2006-2#1)(2008-11#1)(2009-5#1)
upon early##2##2##(2010-12#1)(2010-8#1)
upon elution##2##2##(1997-2#1)(2006-12#1)
upon encountering##4##2##(1993-12#1)(1995-5#1)(1995-6#1)(2012-1#1)
upon examination##2##2##(1991-3#1)(2004-12#1)
upon excitation at##2##3##(2008-10#2)
upon excitation##4##2##(2008-10#3)(2010-5#1)
upon existing##4##2##(1990-2#1)(2008-3#1)(2009-9#1)(2010-1#1)
upon exogenous##2##2##(2007-5#1)(2008-11#1)
upon exposure of the##2##4##(1993-11#1)(1996-7#1)
upon exposure of##5##3##(1993-11#1)(1994-6#1)(1994-8#1)(1996-7#1)(2012-12#1)
upon exposure to the##2##4##(1991-5#1)(1992-1#1)
upon exposure to water##2##4##(2012-12#2)
upon exposure to##23##3##(1990-12#1)(1990-5#1)(1991-5#1)(1992-1#1)(1992-8#1)(1993-4#1)(1994-3#1)(1995-10#1)(1996-12#1)(1996-5#1)(1996-9#1)(2005-11#1)(2005-8#1)(2006-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-2#1)(2011-2#1)(2012-12#2)(2012-3#1)
upon exposure##29##2##(1990-12#1)(1990-5#1)(1991-5#1)(1992-1#1)(1992-8#1)(1993-11#1)(1993-4#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-10#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-9#1)(2005-11#1)(2005-8#1)(2006-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-2#1)(2011-2#1)(2012-12#3)(2012-3#2)
upon extensive##2##2##(1992-5#1)(2008-10#1)
upon families##2##2##(1996-9#1)(1997-6#1)
upon fertilization##5##2##(1996-5#2)(2012-12#1)(2012-2#2)
upon findings from##2##3##(1990-11#1)(1991-11#1)
upon findings##3##2##(1990-11#1)(1991-11#1)(1992-4#1)
upon fine needle aspiration cytology##2##5##(2007-10#1)(2008-8#1)
upon food intake##2##3##(1997-8#1)(2008-12#1)
upon for##7##2##(2006-12#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2012-12#1)(2012-2#1)
upon formation of bathorhodopsin##2##4##(1995-10#2)
upon formation of##6##3##(1992-6#2)(1992-9#1)(1993-11#1)(1995-10#2)
upon further##3##2##(1994-6#1)(1995-3#1)(1996-10#1)
upon gel##3##2##(1992-1#2)(2010-4#1)
upon glucose##2##2##(1993-11#1)(2008-7#1)
upon growth##2##2##(1993-4#1)(2008-10#1)
upon health##4##2##(2008-1#2)(2008-11#1)(2012-2#1)
upon hearing##2##2##(2010-2#2)
upon heat shock##3##3##(1994-8#1)(1997-2#1)(2011-1#1)
upon heat##6##2##(1994-8#1)(1997-2#1)(1997-7#1)(2008-7#1)(2011-1#1)(2012-1#1)
upon heating at##2##3##(1994-3#1)(2008-10#1)
upon heating in##2##3##(2008-7#1)(2010-4#1)
upon heating##8##2##(1993-4#1)(1994-3#1)(1996-5#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-4#1)
upon high##2##2##(1990-7#1)(2012-1#1)
upon high-energy-beam sensitive glass##2##4##(2007-12#2)
upon history##2##2##(1997-8#1)(2012-2#1)
upon how##3##2##(2008-7#1)(2010-2#1)(2012-2#1)
upon hybridization to##3##3##(2008-4#3)
upon hybridization##4##2##(2008-4#3)(2012-3#1)
upon illumination##5##2##(1992-1#1)(1996-10#1)(1997-7#1)(2008-4#1)(2012-2#1)
upon immersion of##2##3##(1991-7#2)
upon in the##2##3##(2008-2#1)(2010-3#1)
upon in vivo##3##3##(2008-10#1)(2010-11#1)(2010-2#1)
upon in##10##2##(1990-11#1)(1991-4#1)(1991-6#1)(2006-10#1)(2007-3#1)(2008-10#1)(2008-2#1)(2010-11#1)(2010-2#1)(2010-3#1)
upon incorporation of##3##3##(1990-4#1)(1997-1#1)(2005-11#1)
upon incorporation##4##2##(1990-4#1)(1991-8#1)(1997-1#1)(2005-11#1)
upon increasing the##3##3##(1993-6#1)(1997-2#1)(2008-10#1)
upon increasing##7##2##(1993-6#1)(1996-9#2)(1997-2#1)(2008-10#2)(2008-4#1)
upon incubation with##3##3##(1990-7#1)(1995-7#1)(1996-12#1)
upon incubation##8##2##(1990-5#1)(1990-7#1)(1990-9#1)(1995-7#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-4#1)
upon induction of##4##3##(1994-12#1)(2008-3#1)(2012-12#2)
upon induction with##2##3##(1995-8#2)
upon induction##8##2##(1993-3#1)(1994-12#1)(1995-8#2)(1997-7#1)(2008-3#1)(2012-12#2)
upon infection with##2##3##(1990-7#1)(1997-4#1)
upon infection##6##2##(1990-7#1)(1997-4#1)(2008-10#3)(2009-8#1)
upon inhalation of##2##3##(1992-4#1)(2009-3#1)
upon initial##2##2##(2007-12#1)(2008-6#1)
upon initiation of##2##3##(2008-7#1)(2009-3#1)
upon injection of contrast##2##4##(2006-8#2)
upon injection##3##2##(1991-5#1)(2006-8#2)
upon insertion##3##2##(1994-2#1)(1995-8#1)(2012-3#1)
upon insulin binding##2##3##(1990-7#2)
upon insulin##3##2##(1990-7#2)(2008-6#1)
upon integration##2##2##(1991-4#1)(2009-8#1)
upon interaction with the##3##4##(1996-3#1)(1996-7#1)(2011-2#1)
upon interaction with##7##3##(1991-9#1)(1996-3#1)(1996-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
upon interaction##9##2##(1991-5#1)(1991-9#1)(1996-3#1)(1996-7#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
upon interactions##2##2##(1996-12#1)(2008-7#1)
upon introduction of##2##3##(1995-2#1)(2008-10#1)
upon iron##2##2##(2006-8#1)(2009-8#1)
upon irradiation with UV light##2##5##(2008-10#1)(2008-5#1)
upon irradiation##5##2##(1994-9#1)(2006-12#1)(2008-10#2)(2008-5#1)
upon it##4##2##(2007-12#1)(2008-1#1)(2008-3#1)(2008-5#1)
upon its association with the##2##5##(1994-12#1)(1996-8#1)
upon its##15##2##(1992-6#2)(1994-12#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-8#2)(2007-11#1)(2008-10#5)(2009-3#1)
upon learning##3##2##(1991-2#1)(1993-7#1)(2008-11#1)
upon life##2##2##(2007-10#1)(2007-11#1)
upon ligand binding##8##3##(1995-10#1)(1995-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(2007-12#1)(2008-4#1)
upon ligand##9##2##(1995-10#1)(1995-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(2007-12#1)(2008-4#1)
upon light irradiation##2##3##(1993-12#1)(1997-1#1)
upon light##4##2##(1992-3#1)(1993-12#1)(1997-1#1)(2010-7#1)
upon lowering the pH##2##4##(1991-8#2)
upon lowering the##3##3##(1991-8#2)(2006-10#1)
upon magnetic##2##2##(1996-1#1)(2007-8#1)
upon many factors##2##3##(1993-6#1)(1997-2#1)
upon many##3##2##(1993-6#1)(1994-5#1)(1997-2#1)
upon medical##2##2##(2005-8#1)(2008-3#1)
upon mixing##2##2##(1990-10#1)(2008-6#1)
upon modification of the##2##4##(1995-6#1)(2008-1#1)
upon modification of##5##3##(1995-6#3)(1996-5#1)(2008-1#1)
upon molecular##2##2##(1996-8#1)(2010-3#1)
upon new##2##2##(1996-9#1)(2007-11#1)
upon nicotine stimulation##2##3##(1997-6#2)
upon nurses##2##2##(2005-7#1)(2008-7#1)
upon nutrient##2##2##(1997-6#2)
upon one of the##2##4##(2007-12#1)(2008-3#1)
upon one of##3##3##(2007-12#1)(2008-3#2)
upon one##4##2##(2007-12#1)(2008-11#1)(2008-3#2)
upon other##3##2##(2008-11#1)(2010-3#1)(2010-8#1)
upon our previous##3##3##(1995-12#1)(2013-1#2)
upon our##6##2##(1995-12#1)(1997-1#1)(2008-1#1)(2011-2#1)(2013-1#2)
upon oxidation of the##3##4##(1992-12#1)(2006-12#1)(2008-10#1)
upon oxidation of##4##3##(1992-12#1)(2006-12#1)(2008-10#2)
upon oxidation##5##2##(1991-4#1)(1992-12#1)(2006-12#1)(2008-10#2)
upon pH##3##2##(1990-5#1)(1994-12#1)(1995-2#1)
upon parotid secretion##2##3##(1996-6#2)
upon passage##3##2##(2008-11#3)
upon pattern##2##2##(1991-5#1)(2007-11#1)
upon peptide binding##2##3##(1991-7#2)
upon performance of a spatial location recognition task##2##8##(1994-3#2)
upon performance##4##2##(1992-1#1)(1994-3#2)(2008-12#1)
upon phosphorylation##2##2##(1994-8#2)
upon photoirradiation##2##2##(2005-11#1)(2008-10#1)
upon photoisomerization##3##2##(1995-10#3)
upon platelet##3##2##(1990-12#1)(1991-2#1)(2008-9#1)
upon presentation of##2##3##(1990-11#1)(2011-2#1)
upon pretreatment with##3##3##(1990-11#1)(1996-8#1)(2009-3#1)
upon pretreatment##4##2##(1990-11#1)(1991-2#1)(1996-8#1)(2009-3#1)
upon previous##4##2##(1992-3#1)(2007-12#1)(2008-12#1)(2010-11#1)
upon previously##2##2##(1997-3#1)(2010-8#1)
upon prolonged incubation##2##3##(1990-5#1)(1997-1#1)
upon prolonged##4##2##(1990-5#1)(1993-6#1)(1994-2#1)(1997-1#1)
upon protein##3##2##(1994-8#1)(1995-12#1)(2006-10#1)
upon reaction of##2##3##(1995-1#1)(2007-8#1)
upon reaction##3##2##(1995-1#1)(2007-10#1)(2007-8#1)
upon receptor##2##2##(1991-10#1)(1991-6#1)
upon recognition##2##2##(1991-2#1)(2013-1#1)
upon reduction of##2##3##(1991-8#1)(1992-3#1)
upon reduction with##5##3##(1993-11#2)(1997-6#1)(2007-9#1)(2008-10#1)
upon reduction##11##2##(1990-6#1)(1991-8#1)(1992-3#1)(1993-11#2)(1994-12#1)(1995-10#1)(1997-6#1)(2005-7#1)(2007-9#1)(2008-10#1)
upon reflection of##2##3##(2008-2#2)
upon reinforcement##2##2##(1991-5#2)
upon release##2##2##(1996-4#1)(2012-1#1)
upon removal of the##3##4##(1991-12#1)(1992-11#1)(2008-5#1)
upon removal of##5##3##(1990-10#1)(1991-12#1)(1991-5#1)(1992-11#1)(2008-5#1)
upon reperfusion##5##2##(1996-10#2)(1996-9#2)(2010-7#1)
upon request##2##2##(2010-2#1)(2010-5#1)
upon return to##2##3##(1991-9#1)(1995-8#1)
upon sample##3##2##(1996-5#1)(2005-11#1)(2009-10#1)
upon seed##2##2##(2008-10#1)(2008-7#1)
upon seeing##2##2##(1993-8#1)(2013-7#1)
upon separation##2##2##(1990-7#1)(1991-3#1)
upon serial##3##2##(1991-7#1)(1992-2#1)(1996-11#1)
upon silicon##2##2##(2007-11#1)(2007-12#1)
upon solubilization##2##2##(1990-11#1)(1990-5#1)
upon specific##2##2##(2008-4#1)(2008-7#1)
upon stimulation by##3##3##(1992-11#1)(1993-7#1)(1996-11#1)
upon stimulation of the##3##4##(1994-11#1)(1996-2#1)(1997-6#1)
upon stimulation of##9##3##(1991-11#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-12#1)(1996-2#1)(1997-6#2)(2007-11#1)
upon stimulation with##13##3##(1990-3#1)(1991-5#1)(1992-6#1)(1992-8#1)(1993-4#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-5#1)(2008-11#1)(2008-3#1)
upon stimulation##25##2##(1990-3#1)(1991-11#1)(1991-5#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-6#2)(2007-11#1)(2008-11#1)(2008-3#1)
upon storage##2##2##(2008-5#2)
upon studies##2##2##(2008-1#1)(2012-2#1)
upon subsequent##2##2##(1993-3#1)(2007-11#1)
upon successful##2##2##(2005-8#1)(2009-3#1)
upon successive##2##2##(1993-3#1)(2008-10#1)
upon sugar binding##3##3##(1991-4#2)(2008-10#1)
upon survival##3##2##(1995-8#1)(1997-3#1)(2011-2#1)
upon temperature##3##2##(1992-7#1)(1993-11#1)(2008-10#1)
upon the ability of the##2##5##(1992-3#1)(1992-4#1)
upon the ability of##4##4##(1992-3#1)(1992-4#1)(2006-10#1)(2009-4#1)
upon the action of##3##4##(2006-12#1)(2008-5#1)(2009-4#1)
upon the addition of##10##4##(1990-5#1)(1991-7#2)(1991-8#1)(1992-11#1)(1992-5#1)(1993-3#2)(1993-6#1)(2008-10#1)
upon the apparent##2##3##(1990-5#1)(2008-10#1)
upon the application of##2##4##(2008-11#1)(2008-6#1)
upon the association##2##3##(1994-9#1)(2010-2#1)
upon the assumption that the##2##5##(1993-11#1)(2007-9#1)
upon the binding of##4##4##(1990-7#1)(1992-12#1)(1995-6#1)(2008-11#1)
upon the binding##5##3##(1990-7#1)(1992-12#1)(1995-6#1)(1996-8#1)(2008-11#1)
upon the body##2##3##(1995-12#2)
upon the cell##3##3##(1992-6#1)(1993-12#1)(2008-7#1)
upon the clinical##4##3##(1995-11#1)(2005-11#1)(2006-6#1)(2010-12#1)
upon the concentration of the##2##5##(1990-5#1)(2008-10#1)
upon the concentration of##4##4##(1990-2#1)(1990-5#1)(1994-3#1)(2008-10#1)
upon the conformation##2##3##(1992-12#1)(1994-12#1)
upon the development of a##2##5##(1993-1#1)(1996-3#1)
upon the development of##4##4##(1993-1#1)(1996-3#1)(1997-2#1)(2005-9#1)
upon the development##5##3##(1993-1#1)(1996-3#1)(1997-2#1)(2005-9#1)(2007-12#1)
upon the extent of the##2##5##(2007-8#1)(2010-8#1)
upon the extent to which##2##5##(1994-3#1)(2008-8#1)
upon the extent##4##3##(1994-3#1)(2007-8#1)(2008-8#1)(2010-8#1)
upon the formation of the##2##5##(1990-5#1)(1996-8#1)
upon the formation of##3##4##(1990-5#1)(1996-8#1)(2006-2#1)
upon the function##2##3##(1991-1#1)(1991-12#1)
upon the immunosuppressive##2##3##(1995-1#1)(2011-1#1)
upon the inside of##2##4##(2008-2#1)(2008-3#1)
upon the length of the##2##5##(1995-3#1)(1996-5#1)
upon the local##2##3##(1992-2#1)(2006-12#1)
upon the method of##2##4##(1990-5#1)(1994-5#1)
upon the model##4##3##(1992-2#1)(2008-12#1)(2009-3#1)(2012-12#1)
upon the most##2##3##(2008-10#1)(2008-12#1)
upon the nature of the##4##5##(1991-3#1)(2008-10#2)(2011-1#1)
upon the nature##5##3##(1991-3#1)(2008-10#2)(2008-11#1)(2011-1#1)
upon the onset of##2##4##(1996-5#1)(2004-9#1)
upon the possible##2##3##(1991-1#1)(2006-10#1)
upon the presence of a##2##5##(1990-2#1)(1992-12#1)
upon the presence of##12##4##(1990-2#1)(1991-9#2)(1992-12#1)(1992-9#1)(1993-12#1)(1997-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#1)
upon the presence##14##3##(1990-2#1)(1991-9#2)(1992-12#1)(1992-9#1)(1993-12#1)(1994-11#1)(1997-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#1)
upon the quality of##2##4##(1990-12#1)(1992-3#1)
upon the question##2##3##(2006-10#1)(2008-11#1)
upon the rat##2##3##(1991-5#1)(1992-3#1)
upon the reaction##2##3##(2008-10#2)
upon the results of##3##4##(2006-11#1)(2007-11#1)(2012-3#1)
upon the same##3##3##(1993-8#1)(2007-12#1)(2008-3#1)
upon the severity of the##3##5##(1991-2#1)(2008-6#1)(2011-2#1)
upon the severity##5##3##(1991-2#1)(1991-9#1)(2008-6#1)(2010-7#1)(2011-2#1)
upon the specific##2##3##(2007-8#1)(2010-7#1)
upon the structure of##2##4##(1991-2#1)(1993-8#1)
upon the study##2##3##(2006-10#1)(2011-1#1)
upon the surface of##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
upon the surface##4##3##(1991-12#1)(2007-12#1)(2008-2#1)(2008-3#1)
upon the surrounding##3##3##(2009-6#1)(2013-1#2)
upon the temperature##2##3##(1997-5#1)(2005-11#1)
upon the tissue##2##3##(1994-3#1)(1994-9#1)
upon the transport##2##3##(1992-9#1)(2013-1#1)
upon the two##2##3##(2008-11#1)(2008-12#1)
upon the type of##3##4##(1992-3#1)(2008-7#1)(2009-5#1)
upon the use of##4##4##(2006-4#1)(2008-4#1)(2008-7#1)(2011-1#1)
upon the##476##2##(1990-10#1)(1990-11#4)(1990-12#5)(1990-2#5)(1990-3#1)(1990-4#1)(1990-5#6)(1990-7#2)(1991-1#3)(1991-10#1)(1991-12#3)(1991-2#4)(1991-3#3)(1991-5#3)(1991-6#1)(1991-7#4)(1991-8#2)(1991-9#3)(1992-11#2)(1992-12#4)(1992-2#2)(1992-3#6)(1992-4#2)(1992-5#2)(1992-6#5)(1992-8#1)(1992-9#6)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#4)(1993-2#1)(1993-3#5)(1993-4#1)(1993-5#2)(1993-6#2)(1993-8#2)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#7)(1994-5#3)(1994-7#2)(1994-8#1)(1994-9#6)(1995-1#3)(1995-10#1)(1995-11#3)(1995-12#7)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#5)(1996-5#6)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#3)(1997-2#2)(1997-4#1)(1997-5#2)(1997-6#4)(1997-7#2)(1997-8#2)(2004-9#2)(2005-11#5)(2005-4#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#9)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#8)(2007-12#18)(2007-2#3)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#36)(2008-11#22)(2008-12#8)(2008-2#10)(2008-3#11)(2008-4#8)(2008-5#13)(2008-6#6)(2008-7#15)(2008-8#4)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#4)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#5)(2010-4#2)(2010-6#2)(2010-7#4)(2010-8#1)(2011-1#9)(2011-12#2)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#1)
upon their interactions with##2##4##(2008-4#1)(2010-5#1)
upon their molecular##2##3##(1991-2#1)(1991-7#1)
upon their##26##2##(1990-3#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-5#1)(1992-8#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-2#1)(1996-6#1)(1997-7#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2012-3#1)
upon them##4##2##(1995-12#1)(2005-8#1)(2012-12#2)
upon these##9##2##(1990-12#1)(1991-12#2)(1994-12#1)(2006-10#1)(2008-11#2)(2008-4#1)(2010-9#1)
upon this##15##2##(1990-3#1)(1992-3#1)(1992-6#1)(1994-2#1)(2005-11#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-3#2)
upon those##2##2##(1991-3#1)(2008-5#1)
upon three##2##2##(1992-12#1)(1995-8#1)
upon tissue##2##2##(2008-9#1)(2013-1#1)
upon to develop##4##3##(1996-2#1)(2008-11#1)(2008-12#1)(2009-3#1)
upon to provide##2##3##(1996-7#1)(2012-12#1)
upon to##25##2##(1991-1#1)(1992-3#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-7#1)(2005-8#2)(2006-10#1)(2006-7#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-8#1)(2009-3#1)(2009-9#1)(2010-8#1)(2012-12#1)(2013-1#1)
upon traditional##3##2##(2008-11#1)(2008-5#1)(2012-2#1)
upon transfection into##2##3##(1997-3#1)(1997-4#1)
upon transfection of the##2##4##(1991-2#1)(1994-8#1)
upon transfection##4##2##(1991-2#1)(1994-8#1)(1997-3#1)(1997-4#1)
upon transmission##2##2##(2006-12#1)(2008-5#1)
upon transplantation##3##2##(1991-9#1)(2008-1#1)(2013-1#1)
upon treatment of##2##3##(1992-5#1)(1994-6#1)
upon treatment with TGF-beta##2##4##(2008-11#2)
upon treatment with##17##3##(1992-7#1)(1993-4#1)(1993-9#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(2005-11#1)(2007-11#2)(2008-11#3)(2010-12#1)
upon treatment##21##2##(1992-5#1)(1992-7#1)(1993-4#1)(1993-9#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(2005-11#1)(2007-11#2)(2008-11#3)(2010-12#1)(2011-2#1)(2013-1#1)
upon tumor##3##2##(1995-9#1)(2008-11#1)(2010-9#1)
upon two##2##2##(1994-6#1)(2008-5#1)
upon unfolding##4##2##(1990-5#1)(1992-6#1)(1994-2#1)(1997-2#1)
upon upshift to 37 degrees C##2##6##(1993-9#2)
upon using##3##2##(2005-11#1)(2006-10#1)(2007-8#1)
upon various##2##2##(1991-2#1)(2008-8#1)
upon which further##2##3##(2008-10#1)(2008-7#1)
upon which it##2##3##(1991-3#1)(2011-2#1)
upon which to base##2##4##(1993-3#1)(2008-1#1)
upon which to##4##3##(1993-3#1)(1995-4#1)(2008-1#1)(2013-8#1)
upon which##26##2##(1990-12#1)(1991-3#1)(1991-7#1)(1993-3#1)(1995-4#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#2)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#1)
upon withdrawal##2##2##(1992-11#1)(2008-5#1)
upon##2162##1##(1990-10#8)(1990-11#18)(1990-12#14)(1990-2#8)(1990-3#8)(1990-4#7)(1990-5#21)(1990-6#2)(1990-7#16)(1990-8#7)(1990-9#1)(1991-1#7)(1991-10#3)(1991-11#6)(1991-12#15)(1991-2#20)(1991-3#12)(1991-4#9)(1991-5#18)(1991-6#6)(1991-7#17)(1991-8#12)(1991-9#13)(1992-1#7)(1992-10#4)(1992-11#10)(1992-12#16)(1992-2#5)(1992-3#18)(1992-4#5)(1992-5#9)(1992-6#22)(1992-7#4)(1992-8#11)(1992-9#14)(1993-1#5)(1993-10#1)(1993-11#13)(1993-12#12)(1993-2#4)(1993-3#15)(1993-4#8)(1993-5#7)(1993-6#14)(1993-7#6)(1993-8#6)(1993-9#10)(1994-1#3)(1994-10#1)(1994-11#8)(1994-12#13)(1994-2#7)(1994-3#18)(1994-5#7)(1994-6#9)(1994-7#5)(1994-8#21)(1994-9#18)(1995-1#6)(1995-10#14)(1995-11#9)(1995-12#21)(1995-2#13)(1995-3#24)(1995-4#4)(1995-5#18)(1995-6#18)(1995-7#4)(1995-8#20)(1995-9#3)(1996-1#5)(1996-10#9)(1996-11#8)(1996-12#9)(1996-2#12)(1996-3#7)(1996-4#3)(1996-5#18)(1996-6#6)(1996-7#9)(1996-8#11)(1996-9#13)(1997-1#21)(1997-2#19)(1997-3#7)(1997-4#11)(1997-5#4)(1997-6#21)(1997-7#19)(1997-8#9)(2004-1#1)(2004-11#1)(2004-12#3)(2004-9#2)(2005-10#2)(2005-11#34)(2005-12#3)(2005-3#1)(2005-4#1)(2005-7#8)(2005-8#12)(2005-9#1)(2006-1#1)(2006-10#27)(2006-11#4)(2006-12#17)(2006-2#3)(2006-3#2)(2006-4#4)(2006-5#4)(2006-6#1)(2006-7#6)(2006-8#10)(2006-9#1)(2007-10#5)(2007-11#38)(2007-12#70)(2007-2#7)(2007-3#3)(2007-4#1)(2007-5#3)(2007-6#5)(2007-7#3)(2007-8#16)(2007-9#8)(2008-1#25)(2008-10#156)(2008-11#71)(2008-12#26)(2008-2#30)(2008-3#41)(2008-4#36)(2008-5#51)(2008-6#15)(2008-7#42)(2008-8#22)(2008-9#19)(2009-10#10)(2009-11#2)(2009-12#5)(2009-2#4)(2009-3#10)(2009-4#8)(2009-5#5)(2009-6#6)(2009-7#5)(2009-8#7)(2009-9#5)(2010-1#2)(2010-10#1)(2010-11#11)(2010-12#17)(2010-2#22)(2010-3#3)(2010-4#9)(2010-5#9)(2010-6#4)(2010-7#9)(2010-8#6)(2010-9#3)(2011-1#22)(2011-12#4)(2011-2#28)(2012-1#9)(2012-11#4)(2012-12#27)(2012-2#34)(2012-3#22)(2013-1#26)(2013-7#11)(2013-8#11)
upper GI bleeding##5##3##(1991-2#1)(2008-8#2)(2012-3#2)
upper GI endoscopy##2##3##(2011-12#1)(2011-2#1)
upper GI##11##2##(1991-2#1)(1991-9#1)(2008-11#1)(2008-8#3)(2011-12#2)(2011-2#1)(2012-3#2)
upper abdomen and##4##3##(1990-9#1)(1991-6#1)(1995-10#1)(2009-8#1)
upper abdomen##14##2##(1990-3#1)(1990-8#2)(1990-9#1)(1991-6#1)(1992-5#1)(1993-10#1)(1995-10#1)(2008-3#1)(2008-4#1)(2009-8#1)(2010-12#1)(2012-2#1)(2013-1#1)
upper abdominal pain and##3##4##(1990-3#1)(2007-9#1)(2013-1#1)
upper abdominal pain##6##3##(1990-3#1)(1993-1#1)(2006-10#1)(2006-6#1)(2007-9#1)(2013-1#1)
upper abdominal##17##2##(1990-3#2)(1991-12#2)(1992-2#2)(1992-8#1)(1993-1#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-3#1)(2012-2#1)(2013-1#1)(2013-7#1)
upper aerodigestive tract##11##3##(1993-5#2)(2008-1#1)(2008-5#3)(2009-5#1)(2012-12#1)(2013-1#3)
upper aerodigestive##12##2##(1993-5#2)(2008-1#1)(2008-5#3)(2009-5#1)(2012-12#1)(2013-1#4)
upper airway disease##2##3##(2011-2#2)
upper airway obstruction##8##3##(1992-10#1)(1995-8#1)(2007-8#2)(2008-11#1)(2008-9#1)(2013-1#1)(2013-8#1)
upper airway resistance syndrome (UARS)##2##5##(2007-1#1)(2008-9#1)
upper airway resistance##4##3##(1997-4#1)(2007-1#1)(2008-9#2)
upper airway##27##2##(1990-6#1)(1992-10#1)(1992-4#1)(1995-8#1)(1996-12#1)(1997-4#1)(1997-6#1)(2004-2#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-9#3)(2010-7#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
upper airways##11##2##(1991-6#1)(1992-4#1)(1996-6#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-9#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
upper and lower bounds##3##4##(2006-11#1)(2012-3#2)
upper and lower detection limits##2##5##(2008-10#2)
upper and lower extremities in##2##5##(2011-2#1)(2012-2#1)
upper and lower extremities##8##4##(2006-10#1)(2006-11#1)(2006-9#1)(2007-4#1)(2009-5#1)(2011-2#2)(2012-2#1)
upper and lower extremity##4##4##(2007-11#2)(2010-3#1)(2012-3#1)
upper and lower eyelids##2##4##(2009-9#1)(2011-1#1)
upper and lower feature vectors##2##5##(2012-3#2)
upper and lower limb##3##4##(1990-11#1)(2007-8#2)
upper and lower limbs##4##4##(2006-4#1)(2007-3#1)(2008-6#1)(2008-7#1)
upper and lower limits##2##4##(2007-9#1)(2008-7#1)
upper and lower respiratory tract infections##2##6##(2008-1#1)(2008-3#1)
upper and lower respiratory tract##5##5##(1992-11#1)(2007-2#1)(2008-1#1)(2008-3#1)(2008-5#1)
upper and lower respiratory tracts##2##5##(2008-1#1)(2008-5#1)
upper and lower respiratory##7##4##(1992-11#1)(2007-2#1)(2008-1#2)(2008-3#1)(2008-5#2)
upper and lower##73##3##(1990-11#1)(1991-4#1)(1991-6#1)(1992-11#2)(1992-12#1)(1994-12#1)(2006-10#2)(2006-11#3)(2006-4#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#6)(2008-12#1)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#4)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#6)(2013-1#1)
upper and middle##3##3##(2006-5#2)(2007-11#1)
upper and##83##2##(1990-11#1)(1991-4#1)(1991-6#1)(1992-11#2)(1992-12#1)(1992-7#1)(1994-12#1)(2006-10#2)(2006-11#4)(2006-4#1)(2006-5#2)(2006-8#1)(2006-9#1)(2007-11#4)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#8)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#4)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#6)(2013-1#1)
upper anterior##2##2##(2006-10#1)(2013-8#1)
upper area of the face##2##5##(2009-4#2)
upper area of##3##3##(2009-4#3)
upper arm##17##2##(1991-1#1)(1996-9#1)(2006-6#3)(2007-12#1)(2007-7#4)(2008-4#1)(2008-5#2)(2008-9#1)(2011-2#1)(2013-8#2)
upper asymptote##2##2##(1990-8#1)(2008-10#1)
upper back##7##2##(2006-8#1)(2007-7#1)(2008-7#1)(2010-12#1)(2012-2#2)(2013-7#1)
upper body##13##2##(2004-11#5)(2007-12#3)(2007-4#1)(2008-4#1)(2010-1#1)(2010-6#1)(2012-1#1)
upper bound is##3##3##(1993-2#1)(2007-12#1)(2010-2#1)
upper bound of##5##3##(2007-12#2)(2008-2#1)(2009-5#1)(2010-2#1)
upper bound on the##3##4##(1993-2#1)(1994-6#1)(2008-6#1)
upper bound on##4##3##(1993-2#1)(1994-6#1)(2008-6#1)(2008-7#1)
upper bound##14##2##(1993-2#4)(1994-6#1)(2007-12#3)(2008-2#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-2#2)
upper boundary##4##2##(1995-8#1)(2006-10#1)(2007-12#1)(2008-2#1)
upper bounds for##2##3##(2007-9#1)(2010-2#1)
upper bounds on the##2##4##(2008-2#1)(2012-3#1)
upper bounds on##4##3##(2007-9#2)(2008-2#1)(2012-3#1)
upper bounds##9##2##(1995-1#1)(1996-7#1)(2007-9#3)(2008-2#2)(2010-2#1)(2012-3#1)
upper brachial plexus##2##3##(2008-9#2)
upper canopy##2##2##(2008-8#1)(2011-2#1)
upper cervical cord##3##3##(1992-3#2)(2006-12#1)
upper cervical spinal cord##4##4##(1992-3#1)(2006-12#1)(2008-5#1)(2008-7#1)
upper cervical spine##9##3##(2006-11#1)(2006-6#1)(2007-1#3)(2007-4#3)(2009-3#1)
upper cervical##21##2##(1990-4#1)(1992-3#3)(2006-11#1)(2006-12#2)(2006-6#1)(2007-1#3)(2007-11#1)(2007-4#4)(2008-12#2)(2008-5#1)(2008-7#1)(2009-3#1)
upper chest##3##2##(2007-7#1)(2008-1#1)(2012-12#1)
upper confidence limits on##2##4##(2009-5#1)(2010-2#1)
upper corpus##2##2##(2013-8#2)
upper digestive tract##6##3##(1993-9#1)(1995-5#1)(2007-5#1)(2008-10#2)(2011-2#1)
upper digestive##11##2##(1991-11#1)(1991-5#2)(1992-10#1)(1993-9#1)(1995-5#1)(2007-5#1)(2008-10#2)(2010-12#1)(2011-2#1)
upper end of##3##3##(1994-9#1)(1996-6#1)(2013-1#1)
upper endoscopic examination##2##3##(1997-8#1)(2008-11#1)
upper endoscopy and##3##3##(2006-10#2)(2012-2#1)
upper endoscopy have##2##3##(2006-10#2)
upper endoscopy##8##2##(2006-10#4)(2009-8#1)(2010-12#1)(2012-2#1)(2013-8#1)
upper energies with the mean accuracy of##2##7##(2005-4#2)
upper energies##3##2##(2005-4#3)
upper epigastric##2##2##(1991-5#1)(2010-12#1)
upper esophageal##2##2##(2007-3#1)(2007-8#1)
upper extremities##21##2##(1991-4#1)(1992-1#1)(1993-12#1)(1997-4#1)(2005-1#1)(2006-11#1)(2007-10#1)(2007-4#1)(2007-7#3)(2007-8#1)(2008-6#1)(2010-3#1)(2012-1#2)(2012-12#2)(2013-1#2)(2013-8#1)
upper extremity and##2##3##(2007-1#1)(2007-7#1)
upper extremity function##8##3##(1993-9#1)(2006-4#1)(2008-8#1)(2011-2#1)(2012-1#3)(2012-2#1)
upper extremity in##3##3##(2005-1#1)(2010-9#1)(2012-1#1)
upper extremity injury##3##3##(2006-7#1)(2007-1#2)
upper extremity is described##2##4##(2008-4#1)(2011-2#1)
upper extremity is##3##3##(2006-3#1)(2008-4#1)(2011-2#1)
upper extremity joints##2##3##(2007-11#2)
upper extremity loading##2##3##(2006-11#1)(2007-1#1)
upper extremity training##2##3##(2012-1#2)
upper extremity was##2##3##(2007-1#1)(2008-12#1)
upper extremity##88##2##(1990-11#1)(1991-11#1)(1993-9#1)(2005-1#2)(2006-10#1)(2006-11#3)(2006-3#8)(2006-4#3)(2006-7#1)(2006-8#3)(2007-1#5)(2007-10#3)(2007-11#5)(2007-7#3)(2008-10#1)(2008-12#3)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-5#1)(2009-6#1)(2009-9#2)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#10)(2012-1#15)(2012-2#2)
upper eyelid##6##2##(2007-2#1)(2010-8#3)(2011-1#2)
upper femur##3##2##(2008-6#3)
upper first##3##2##(2011-2#1)(2013-8#2)
upper gastro-intestinal##3##2##(1994-2#1)(2007-9#1)(2010-12#1)
upper gastrointestinal (GI) endoscopy##2##4##(1994-12#1)(2008-5#1)
upper gastrointestinal (GI)##3##3##(1994-12#1)(2008-11#1)(2008-5#1)
upper gastrointestinal bleeding in##2##4##(1995-9#1)(2012-2#1)
upper gastrointestinal bleeding##20##3##(1993-2#1)(1995-9#1)(2006-10#3)(2006-8#2)(2007-5#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#6)
upper gastrointestinal bleeding]##2##3##(2007-5#1)(2008-9#1)
upper gastrointestinal cancer##3##3##(2011-2#3)
upper gastrointestinal endoscopy##12##3##(1991-5#1)(1995-10#2)(1996-3#1)(2006-10#1)(2008-1#1)(2008-5#2)(2010-4#1)(2011-2#1)(2012-2#2)
upper gastrointestinal haemorrhage##5##3##(1990-9#2)(1991-8#1)(1997-8#1)(2006-4#1)
upper gastrointestinal hemorrhage##3##3##(2006-10#1)(2007-7#1)(2010-12#1)
upper gastrointestinal series##2##3##(2011-2#1)(2012-2#1)
upper gastrointestinal tract bleeding##2##4##(2006-10#2)
upper gastrointestinal tract##20##3##(1991-9#1)(1993-5#1)(1994-3#1)(2005-7#1)(2006-10#8)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-5#1)(2012-1#2)(2013-1#1)
upper gastrointestinal##88##2##(1990-9#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1993-2#1)(1993-5#1)(1994-12#1)(1994-3#1)(1995-10#2)(1995-9#1)(1996-3#1)(1997-8#1)(2005-7#1)(2006-10#15)(2006-4#1)(2006-8#5)(2007-2#1)(2007-3#2)(2007-5#3)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#8)(2012-1#2)(2012-2#5)(2013-1#2)(2013-8#6)
upper genital##2##2##(1996-12#2)
upper half of##3##3##(2007-11#1)(2008-6#1)(2009-4#1)
upper healthy##2##2##(2008-10#2)
upper incisors##3##2##(1990-6#1)(1991-4#1)(1995-11#1)
upper intertidal zone##2##3##(2007-5#1)(2008-9#1)
upper jaw fractures##2##3##(2008-9#2)
upper jaw length##2##3##(2010-8#2)
upper jaw##12##2##(1991-1#2)(2007-5#1)(2008-9#4)(2010-2#1)(2010-8#2)(2013-1#1)(2013-7#1)
upper jejunum##3##2##(1997-5#1)(2010-12#2)
upper laser level##2##3##(2008-1#1)(2008-3#1)
upper laser##3##2##(2008-1#1)(2008-3#2)
upper lasing level##4##3##(2008-3#4)
upper layers were##2##3##(1995-10#1)(2010-12#1)
upper layers##4##2##(1992-3#1)(1994-5#1)(1995-10#1)(2010-12#1)
upper leaf##2##2##(2008-10#1)(2009-8#1)
upper leaves##9##2##(2008-10#9)
upper left##4##2##(2007-7#1)(2012-11#1)(2012-2#1)(2013-1#1)
upper leg##2##2##(1995-12#1)(2006-11#1)
upper limb function##2##3##(2012-1#2)
upper limb motion##2##3##(2012-1#2)
upper limb patient simulator##2##4##(2012-1#2)
upper limb rehabilitation##6##3##(2012-1#6)
upper limb stroke rehabilitation##3##4##(2012-1#3)
upper limb##52##2##(1991-4#1)(1992-11#1)(1996-3#1)(2006-11#1)(2006-3#1)(2007-1#1)(2007-11#7)(2007-8#7)(2008-10#1)(2008-7#1)(2008-9#2)(2009-1#2)(2011-2#1)(2012-1#23)(2013-1#2)
upper limbs##16##2##(1993-12#1)(1997-3#1)(2006-10#4)(2007-10#2)(2007-7#1)(2010-12#2)(2011-12#1)(2012-1#1)(2013-1#2)(2013-7#1)
upper limit for the##4##4##(2006-10#1)(2006-12#1)(2006-4#1)(2008-3#1)
upper limit for##5##3##(1993-9#1)(2006-10#1)(2006-12#1)(2006-4#1)(2008-3#1)
upper limit is found to##2##5##(2007-12#2)
upper limit of the##9##4##(1992-2#1)(1993-2#1)(1995-10#2)(1996-1#1)(2008-10#1)(2008-2#2)(2013-1#1)
upper limit of##25##3##(1991-10#1)(1991-5#1)(1991-7#3)(1992-2#1)(1993-2#1)(1995-10#2)(1995-4#1)(1996-1#1)(1997-8#2)(2006-4#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-7#1)(2012-3#1)(2013-1#1)
upper limit on##2##3##(2007-12#1)(2009-2#1)
upper limit##44##2##(1991-10#1)(1991-5#1)(1991-7#3)(1992-2#1)(1993-2#1)(1993-9#1)(1995-10#2)(1995-4#1)(1996-1#1)(1997-8#2)(2006-10#1)(2006-12#1)(2006-4#3)(2007-11#1)(2007-12#5)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#3)(2008-7#2)(2009-2#1)(2012-3#1)(2013-1#2)
upper limits of the##2##4##(2008-10#1)(2009-12#1)
upper limits of##3##3##(1993-2#1)(2008-10#1)(2009-12#1)
upper limits##5##2##(1993-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-12#1)
upper lip##8##2##(1995-11#1)(1995-12#1)(2007-12#2)(2010-8#1)(2011-12#1)(2011-2#1)(2013-7#1)
upper lobe of the##2##4##(1991-11#1)(2008-4#1)
upper lobe was##2##3##(1991-9#1)(2007-8#1)
upper lobe##22##2##(1990-2#1)(1991-11#1)(1991-9#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-4#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#4)
upper lobectomy and##2##3##(2006-10#1)(2007-8#1)
upper lobectomy##11##2##(2006-10#1)(2007-8#9)(2012-1#1)
upper lumbar spondylolysis##2##3##(2009-3#2)
upper lumbar##6##2##(2008-5#1)(2009-3#5)
upper lung##4##2##(2008-1#1)(2012-2#2)(2013-1#1)
upper management##2##2##(1994-12#1)(2008-11#1)
upper mantle##6##2##(1991-6#3)(1991-8#1)(1995-6#1)(2007-9#1)
upper medial quadrant##2##3##(1993-9#1)(2008-8#1)
upper mediastinum##2##2##(1991-11#1)(2007-8#1)
upper motor neuron##2##3##(2006-8#1)(2007-7#1)
upper neck load transducer##2##4##(2007-4#2)
upper neck##5##2##(2007-4#5)
upper nucleus##2##2##(2008-8#2)
upper oesophageal sphincter##3##3##(2011-1#1)(2012-3#2)
upper or lower##6##3##(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-5#1)
upper part of the##10##4##(1991-9#1)(1996-9#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-5#2)(2009-4#1)
upper part of##14##3##(1991-11#1)(1991-9#1)(1993-5#2)(1996-9#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-5#2)(2009-4#1)(2011-2#1)
upper part##16##2##(1991-11#1)(1991-9#1)(1993-5#2)(1993-9#1)(1996-9#1)(1997-5#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-5#2)(2009-4#1)(2011-2#1)
upper phase##12##2##(1990-3#1)(2008-10#9)(2011-1#2)
upper pole of the kidney##3##5##(1992-8#1)(2008-7#1)(2011-2#1)
upper pole##7##2##(1992-3#1)(1992-8#1)(2008-7#2)(2011-2#1)(2013-1#2)
upper portion of the pedicle##2##5##(2007-1#2)
upper portion of the##7##4##(1992-1#1)(1995-11#1)(2006-6#1)(2007-1#2)(2008-5#1)(2009-9#1)
upper portion##8##2##(1992-1#1)(1995-11#1)(2006-6#1)(2007-1#2)(2008-5#1)(2009-9#1)(2012-3#1)
upper quadrant and##2##3##(2005-12#1)(2012-3#1)
upper quadrant of the##3##4##(1991-12#1)(1996-6#1)(2012-2#1)
upper quadrant##8##2##(1991-12#1)(1996-6#1)(2005-12#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
upper rectum##2##2##(1991-5#1)(2008-10#1)
upper region##3##2##(1992-12#1)(2007-5#1)(2008-12#1)
upper renal##2##2##(2007-7#2)
upper reproductive tract##2##3##(1996-12#1)(2007-3#1)
upper respiratory disease##5##3##(2007-2#1)(2008-5#1)(2010-2#1)(2013-8#2)
upper respiratory illness##2##3##(2008-1#1)(2013-8#1)
upper respiratory infection##4##3##(2005-11#1)(2006-10#2)(2010-12#1)
upper respiratory infections##2##3##(2006-10#1)(2008-2#1)
upper respiratory symptoms##3##3##(2009-4#1)(2013-8#2)
upper respiratory tract infection##3##4##(1994-3#1)(2013-8#2)
upper respiratory tract infections##2##4##(1996-12#1)(2009-5#1)
upper respiratory tract##24##3##(1990-8#1)(1992-4#2)(1994-3#1)(1995-12#1)(1996-12#1)(1997-4#1)(2007-4#1)(2008-10#1)(2008-5#5)(2009-5#1)(2010-8#1)(2011-2#1)(2012-12#3)(2013-1#1)(2013-8#3)
upper respiratory##45##2##(1990-8#1)(1992-4#2)(1994-3#1)(1995-12#1)(1996-12#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-10#4)(2007-2#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#6)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#2)(2010-8#1)(2011-2#1)(2012-12#3)(2013-1#1)(2013-8#8)
upper secondary curve was 25 degrees (range##2##7##(2007-7#2)
upper secondary curve was##3##4##(2007-7#3)
upper secondary##4##2##(2007-7#3)(2009-9#1)
upper side##5##2##(2005-10#2)(2007-11#1)(2008-10#2)
upper small##5##2##(1990-2#2)(1995-11#1)(1995-3#1)(2006-10#1)
upper spinal cord##2##3##(2010-12#2)
upper spinal##4##2##(1991-9#1)(2007-10#1)(2010-12#2)
upper spine##3##2##(2006-11#1)(2007-1#2)
upper surface##5##2##(2008-10#1)(2008-3#1)(2008-5#2)(2011-1#1)
upper third of the##5##4##(2008-10#1)(2009-2#1)(2011-12#1)(2012-1#1)(2012-12#1)
upper third##6##2##(2008-10#1)(2009-2#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
upper thoracic##6##2##(1991-6#1)(2006-11#1)(2008-5#1)(2011-2#2)(2012-3#1)
upper torso##2##2##(2007-4#1)(2011-2#1)
upper tract##6##2##(2006-12#1)(2006-9#2)(2008-10#1)(2009-5#2)
upper trapezius##6##2##(2010-9#6)
upper trunk##3##2##(2007-7#2)(2011-2#1)
upper uninoculated leaves##3##3##(2008-10#3)
upper urinary tract##12##3##(1991-9#1)(1992-3#1)(1995-9#1)(2006-10#3)(2006-9#2)(2007-10#1)(2011-2#2)(2013-1#1)
upper urinary##13##2##(1991-9#1)(1992-3#1)(1995-9#1)(2006-10#3)(2006-7#1)(2006-9#2)(2007-10#1)(2011-2#2)(2013-1#1)
upper zone##3##2##(2006-5#2)(2007-8#1)
upper##1181##1##(1990-11#2)(1990-2#4)(1990-3#5)(1990-4#1)(1990-6#2)(1990-8#4)(1990-9#3)(1991-1#3)(1991-10#2)(1991-11#6)(1991-12#4)(1991-2#2)(1991-3#1)(1991-4#4)(1991-5#10)(1991-6#7)(1991-7#3)(1991-8#2)(1991-9#7)(1992-1#2)(1992-10#2)(1992-11#3)(1992-12#2)(1992-2#3)(1992-3#6)(1992-4#4)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#2)(1993-1#1)(1993-10#1)(1993-12#2)(1993-2#9)(1993-4#1)(1993-5#7)(1993-7#1)(1993-8#1)(1993-9#7)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-7#3)(1994-9#4)(1995-1#1)(1995-10#6)(1995-11#4)(1995-12#3)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#2)(1995-9#3)(1996-1#1)(1996-12#5)(1996-3#4)(1996-4#5)(1996-5#1)(1996-6#3)(1996-7#1)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#4)(1997-5#2)(1997-6#3)(1997-8#4)(2004-11#5)(2004-2#1)(2004-4#1)(2005-1#3)(2005-10#3)(2005-11#6)(2005-12#1)(2005-3#2)(2005-4#3)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#46)(2006-11#13)(2006-12#6)(2006-2#1)(2006-3#11)(2006-4#8)(2006-5#4)(2006-6#7)(2006-7#5)(2006-8#12)(2006-9#5)(2007-1#14)(2007-10#12)(2007-11#25)(2007-12#24)(2007-2#4)(2007-3#9)(2007-4#19)(2007-5#16)(2007-7#27)(2007-8#37)(2007-9#13)(2008-1#12)(2008-10#84)(2008-11#9)(2008-12#12)(2008-2#18)(2008-3#33)(2008-4#6)(2008-5#31)(2008-6#8)(2008-7#19)(2008-8#15)(2008-9#27)(2009-1#2)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#6)(2009-4#10)(2009-5#9)(2009-6#4)(2009-8#3)(2009-9#5)(2010-1#2)(2010-12#17)(2010-2#8)(2010-3#2)(2010-4#4)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#11)(2010-9#10)(2011-1#10)(2011-12#5)(2011-2#48)(2012-1#48)(2012-11#1)(2012-12#16)(2012-2#22)(2012-3#17)(2013-1#38)(2013-3#1)(2013-7#7)(2013-8#30)
upper- and##3##2##(2011-2#2)(2012-3#1)
upper-##4##1##(2007-10#1)(2011-2#2)(2012-3#1)
upper-atmosphere##2##1##(2008-2#2)
upper-atmospheric wind##2##2##(2008-2#1)(2008-3#1)
upper-body##3##1##(1992-2#1)(2007-8#1)(2012-1#1)
upper-class##2##1##(2007-8#1)(2013-8#1)
upper-extremity##8##1##(2008-7#1)(2010-9#1)(2011-2#3)(2012-1#3)
upper-half of the face##6##4##(2010-1#6)
upper-layer thickness (l)##2##3##(2008-3#2)
upper-level ontology##2##2##(2008-7#2)
upper-level##3##1##(2005-10#1)(2008-7#2)
upper-limb##10##1##(2007-10#2)(2009-3#1)(2010-9#3)(2012-1#3)(2013-1#1)
upper-middle##4##1##(2008-12#1)(2010-7#1)(2013-8#2)
upper-state lifetime##2##2##(2008-2#1)(2008-3#1)
upper-state##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
upper-stream-limitation##2##1##(2008-8#2)
uppercase##5##1##(2008-11#1)(2008-6#4)
uppermost##9##1##(2005-10#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-5#2)(2013-8#1)
upregulate the expression of##2##4##(2004-3#1)(2010-12#1)
upregulate the##3##2##(2004-3#1)(2010-12#1)(2013-8#1)
upregulate##17##1##(1993-12#1)(1993-4#2)(1996-6#1)(2004-3#1)(2006-10#1)(2007-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
upregulated and##7##2##(1996-8#1)(2009-8#2)(2010-5#1)(2011-2#1)(2013-1#2)
upregulated by the##2##3##(1995-12#1)(2006-10#1)
upregulated by##13##2##(1993-6#1)(1994-11#1)(1995-12#1)(1997-7#1)(2006-10#2)(2007-12#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-2#1)(2013-1#2)
upregulated during##6##2##(1995-12#1)(2008-10#1)(2008-11#1)(2009-8#2)(2012-3#1)
upregulated expression##2##2##(2006-10#1)(2008-11#1)
upregulated genes##2##2##(2007-12#1)(2009-8#1)
upregulated in adenoma tissues when compared with##2##7##(2010-12#2)
upregulated in response to##2##4##(2008-6#1)(2013-7#1)
upregulated in the##11##3##(1996-12#1)(2007-12#1)(2008-10#1)(2008-7#2)(2009-8#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
upregulated in##41##2##(1992-9#1)(1994-12#1)(1995-1#1)(1995-5#1)(1996-12#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-6#1)(2008-7#4)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#2)(2010-12#5)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#5)(2013-7#2)(2013-8#2)
upregulated proteins##2##2##(2009-8#2)
upregulated the expression of##2##4##(1993-12#1)(2009-8#1)
upregulated the##4##2##(1993-12#1)(1996-10#1)(1997-8#1)(2009-8#1)
upregulated upon##2##2##(2008-11#1)(2011-1#1)
upregulated within##2##2##(1996-1#1)(2011-1#1)
upregulated##112##1##(1992-9#1)(1993-12#2)(1993-6#2)(1994-11#1)(1994-12#2)(1994-8#2)(1995-1#2)(1995-12#2)(1995-5#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-8#1)(1997-7#1)(1997-8#1)(2006-10#3)(2006-6#1)(2007-11#2)(2007-12#3)(2007-2#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#5)(2009-3#2)(2009-4#2)(2009-7#1)(2009-8#12)(2010-11#1)(2010-12#7)(2010-5#3)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#12)(2013-7#3)(2013-8#4)
upregulates the##6##2##(1994-8#1)(1996-6#1)(1997-8#1)(2010-10#1)(2010-5#1)(2013-1#1)
upregulates##17##1##(1993-12#1)(1993-6#1)(1993-7#1)(1994-8#1)(1996-10#1)(1996-6#1)(1997-8#1)(2005-12#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-7#1)(2012-12#1)(2013-1#1)(2013-7#1)
upregulating the##2##2##(2009-8#1)(2011-2#1)
upregulating##9##1##(1997-3#1)(2008-4#1)(2009-11#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#2)
upregulation and##7##2##(2007-1#1)(2008-11#1)(2008-4#2)(2009-9#1)(2011-2#1)(2012-2#1)
upregulation in##6##2##(1991-3#1)(1993-7#1)(1996-10#1)(2006-9#1)(2007-3#1)(2013-8#1)
upregulation of ADK##3##3##(2009-8#3)
upregulation of MHC class##2##4##(1994-9#1)(1997-6#1)
upregulation of OPN promoter activity##2##5##(2010-11#2)
upregulation of OPN##3##3##(2010-11#3)
upregulation of contractile proteins##2##4##(2009-9#2)
upregulation of functional##2##3##(1994-8#1)(2008-4#1)
upregulation of the##13##3##(1992-1#1)(1994-11#1)(1994-12#1)(1994-8#1)(1996-11#1)(2004-12#1)(2007-12#1)(2008-5#1)(2011-12#1)(2012-12#3)(2012-2#1)
upregulation of##90##2##(1991-1#1)(1992-1#1)(1992-8#2)(1993-12#1)(1993-3#1)(1993-7#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-4#2)(1997-3#1)(1997-6#1)(2004-12#1)(2006-10#2)(2006-5#1)(2006-9#2)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#5)(2009-9#2)(2010-10#1)(2010-11#5)(2010-12#2)(2010-5#3)(2011-12#1)(2011-2#2)(2012-11#2)(2012-12#5)(2012-2#2)(2012-7#1)(2013-1#4)(2013-8#1)
upregulation##111##1##(1991-1#1)(1991-3#1)(1992-1#1)(1992-8#2)(1993-12#1)(1993-3#1)(1993-7#2)(1994-11#3)(1994-12#2)(1994-2#1)(1994-6#2)(1994-8#5)(1994-9#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-4#2)(1997-3#1)(1997-6#1)(1997-8#1)(2004-12#1)(2005-12#1)(2006-10#2)(2006-5#1)(2006-9#3)(2007-1#1)(2007-11#2)(2007-12#1)(2007-3#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#5)(2009-9#3)(2010-10#1)(2010-11#6)(2010-12#2)(2010-5#3)(2011-12#1)(2011-2#3)(2012-11#2)(2012-12#6)(2012-2#3)(2012-7#1)(2013-1#4)(2013-8#2)
upright and inverted##4##3##(1993-2#1)(2007-8#1)(2008-11#1)(2012-11#1)
upright and##6##2##(1993-2#1)(2007-11#1)(2007-8#1)(2008-11#1)(2010-2#1)(2012-11#1)
upright faces elicited##2##3##(1993-2#1)(2008-11#1)
upright faces##3##2##(1993-2#1)(2008-11#2)
upright or side-lying) positions for birth##2##6##(2007-2#2)
upright or##4##2##(2007-2#2)(2008-6#2)
upright position##2##2##(2007-8#2)
upright posture##2##2##(1995-12#1)(2008-7#1)
upright standing##2##2##(2010-12#2)
upright walking##2##2##(1994-8#1)(2011-1#1)
upright##36##1##(1992-7#1)(1993-2#3)(1994-8#2)(1995-12#1)(2006-11#1)(2007-11#1)(2007-2#2)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#2)(2008-6#2)(2008-7#1)(2009-4#1)(2010-12#2)(2010-2#1)(2011-1#2)(2012-11#1)(2013-1#2)(2013-8#1)
ups and downs##2##3##(1996-3#1)(2007-12#1)
ups##6##1##(1995-3#1)(1996-3#1)(2007-12#1)(2008-6#1)(2013-1#1)(2013-8#1)
upscale##2##1##(2008-11#1)(2008-6#1)
upset by##2##2##(1990-12#1)(2009-2#1)
upset##8##1##(1990-12#1)(1993-1#1)(2006-9#1)(2007-7#1)(2007-9#1)(2008-12#1)(2009-2#1)(2013-1#1)
upsets the##2##2##(1996-8#1)(2008-8#1)
upshift##9##1##(1993-11#2)(1993-9#2)(1994-11#4)(2008-7#1)
upshifted##3##1##(2007-11#2)(2007-12#1)
upside down##6##2##(1993-2#1)(1994-12#2)(2007-8#2)(2010-9#1)
upside-down taper lens end##2##4##(2008-2#2)
upside-down##5##1##(2008-2#2)(2008-3#2)(2010-9#1)
upstaged and##2##2##(2007-6#1)(2012-12#1)
upstaged##6##1##(2007-6#1)(2008-10#1)(2011-2#1)(2012-12#3)
upstate New York##2##3##(1996-3#1)(2013-1#1)
upstate##3##1##(1992-1#1)(1996-3#1)(2013-1#1)
upstream AUG##2##2##(1990-9#1)(1991-1#1)
upstream DNA of##2##3##(1993-12#1)(1996-8#1)
upstream DNA##3##2##(1993-12#1)(1996-7#1)(1996-8#1)
upstream Sp1##2##2##(1993-9#1)(1995-3#1)
upstream activating sequence##5##3##(1991-9#1)(1993-9#1)(1994-9#1)(1995-8#1)(1996-3#1)
upstream activating##6##2##(1991-9#1)(1993-9#1)(1994-9#1)(1995-8#1)(1996-3#1)(1997-4#1)
upstream activation##5##2##(1990-6#2)(1991-7#1)(1993-3#1)(1994-2#1)
upstream activator##3##2##(1994-12#1)(1995-3#1)(2008-4#1)
upstream and downstream of the##3##5##(1992-11#1)(2008-7#1)(2009-11#1)
upstream and downstream of##6##4##(1992-11#2)(1995-12#1)(2008-7#1)(2008-8#1)(2009-11#1)
upstream and downstream sequences##2##4##(2006-5#1)(2008-8#1)
upstream and downstream##14##3##(1990-11#1)(1992-11#2)(1993-5#1)(1995-12#1)(2006-5#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-11#1)(2012-2#1)
upstream and intragenic sequences##5##4##(1996-3#5)
upstream and##22##2##(1990-11#1)(1992-11#2)(1993-5#1)(1993-8#1)(1995-12#1)(1996-3#6)(1997-2#1)(2006-5#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-11#1)(2012-2#1)
upstream element##2##2##(1996-4#1)(1997-4#1)
upstream elements##2##2##(1991-8#1)(1993-12#1)
upstream enhancer##3##2##(1993-3#1)(1994-12#1)(1995-8#1)
upstream ethical engagement##2##3##(2008-11#2)
upstream ethics and##2##3##(2008-11#2)
upstream ethics##3##2##(2008-11#3)
upstream exons##2##2##(1990-8#2)
upstream factor##2##2##(1990-5#1)(1995-2#1)
upstream flanking##3##2##(1993-2#1)(1994-3#2)
upstream from a##6##3##(1990-10#1)(1990-11#1)(1991-12#1)(1992-7#1)(1994-11#1)(1995-8#1)
upstream from the ATG start##2##5##(1993-12#1)(1994-8#1)
upstream from the ATG##3##4##(1991-5#1)(1993-12#1)(1994-8#1)
upstream from the angR gene##2##5##(1990-1#2)
upstream from the cap site##2##5##(1991-12#1)(1991-4#1)
upstream from the gene##2##4##(1993-2#1)(1995-8#1)
upstream from the promoter##3##4##(1991-12#1)(1992-9#1)(1997-4#1)
upstream from the start codon##5##5##(1990-3#1)(1991-6#2)(1993-4#1)(2008-10#1)
upstream from the transcription start point (tsp)##2##7##(1991-12#1)(1993-6#1)
upstream from the transcription start point##4##6##(1990-5#1)(1991-12#1)(1993-3#1)(1993-6#1)
upstream from the translation initiation codon##4##6##(1990-5#1)(1992-11#1)(1993-3#1)(1997-6#1)
upstream from the translation initiation##5##5##(1990-5#1)(1992-11#1)(1993-3#1)(1997-2#1)(1997-6#1)
upstream from the translation##6##4##(1990-5#1)(1992-11#1)(1992-6#1)(1993-3#1)(1997-2#1)(1997-6#1)
upstream from the translational start##3##5##(1991-11#1)(1992-10#1)(2006-8#1)
upstream from the##60##3##(1990-1#2)(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#4)(1990-7#1)(1991-11#2)(1991-12#5)(1991-4#1)(1991-5#1)(1991-6#4)(1992-10#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-9#2)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#3)(1994-12#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(2006-8#1)(2008-10#1)
upstream from this##2##3##(1990-2#1)(1992-3#1)
upstream from##84##2##(1990-1#3)(1990-10#2)(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#4)(1990-7#1)(1990-9#1)(1991-11#2)(1991-12#6)(1991-4#1)(1991-5#1)(1991-6#4)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-11#4)(1993-12#3)(1993-2#2)(1993-3#4)(1993-4#1)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#4)(1994-8#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-2#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(2006-8#1)(2008-10#2)
upstream genes##2##2##(1990-11#1)(1996-12#1)
upstream in the##3##3##(1992-12#1)(1995-8#1)(1997-1#1)
upstream in##4##2##(1992-12#1)(1995-8#1)(1996-2#1)(1997-1#1)
upstream kinases##2##2##(1995-2#1)(2012-12#1)
upstream migration##2##2##(2010-8#2)
upstream molecules##2##2##(2008-11#1)(2013-1#1)
upstream of a minimal promoter##2##5##(1997-2#2)
upstream of a reporter gene##2##5##(1997-4#1)(2008-2#1)
upstream of a##7##3##(1994-6#1)(1997-2#2)(1997-4#1)(1997-7#1)(2006-4#1)(2008-2#1)
upstream of each##2##3##(1996-10#1)(1997-2#1)
upstream of exon##3##3##(1991-6#1)(1997-2#1)(2007-2#1)
upstream of nucleotide##2##3##(1995-3#1)(1997-3#1)
upstream of the ATG##3##4##(1993-3#1)(1994-12#1)(2007-9#1)
upstream of the K##2##4##(1997-7#2)
upstream of the TATA box##2##5##(1993-12#1)(1995-8#1)
upstream of the exon##2##4##(1993-8#1)(1995-6#1)
upstream of the initiator##2##4##(1990-8#1)(1991-3#1)
upstream of the open reading frame##2##6##(1997-2#1)(1997-5#1)
upstream of the polymorphic site##2##5##(2008-4#2)
upstream of the start codon##2##5##(1996-10#1)(2005-11#1)
upstream of the start of transcription##2##6##(1992-9#1)(2008-9#1)
upstream of the start##5##4##(1992-9#1)(1996-10#1)(1997-5#1)(2005-11#1)(2008-9#1)
upstream of the transcription start site##3##6##(1994-3#1)(1994-8#1)(1994-9#1)
upstream of the transcription start##4##5##(1993-2#1)(1994-3#1)(1994-8#1)(1994-9#1)
upstream of the transcription##5##4##(1993-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1997-4#1)
upstream of the transcriptional##2##4##(1995-6#1)(1997-6#1)
upstream of the translation initiation##2##5##(1992-11#1)(1997-2#1)
upstream of the translation start site##3##6##(1997-2#2)(2008-9#1)
upstream of the translation start##5##5##(1995-12#1)(1997-2#3)(2008-9#1)
upstream of the translation##7##4##(1992-11#1)(1995-12#1)(1997-2#4)(2008-9#1)
upstream of the##96##3##(1990-11#1)(1990-4#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#2)(1992-11#2)(1992-12#2)(1992-2#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-12#1)(1995-3#1)(1995-6#3)(1995-8#4)(1996-10#2)(1996-5#1)(1996-7#3)(1997-1#1)(1997-2#9)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#4)(2004-10#1)(2005-11#1)(2006-12#2)(2006-4#1)(2006-9#1)(2007-9#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#3)(2009-4#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
upstream of these##2##3##(1992-9#1)(2012-2#1)
upstream of##155##2##(1990-11#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-2#1)(1991-3#1)(1991-4#3)(1991-6#1)(1991-7#3)(1992-11#2)(1992-12#2)(1992-2#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#2)(1995-6#4)(1995-8#4)(1996-10#3)(1996-2#1)(1996-5#3)(1996-6#2)(1996-7#3)(1996-8#3)(1997-1#1)(1997-2#14)(1997-3#1)(1997-4#7)(1997-5#2)(1997-6#2)(1997-7#5)(2003-11#1)(2004-10#1)(2005-11#1)(2006-11#1)(2006-12#2)(2006-4#2)(2006-5#1)(2006-9#1)(2007-2#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#5)(2009-12#1)(2009-4#2)(2010-12#2)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
upstream or downstream##4##3##(1990-4#1)(1992-3#1)(2008-8#1)(2012-2#1)
upstream process development##2##3##(2011-2#1)(2012-3#1)
upstream process##3##2##(2006-11#1)(2011-2#1)(2012-3#1)
upstream promoter##6##2##(1991-2#1)(1994-12#1)(1994-9#1)(1995-8#1)(1997-5#1)(2008-4#1)
upstream region linked to the##2##5##(1991-2#1)(1995-2#1)
upstream region of the gene##2##5##(1991-3#1)(1996-10#1)
upstream region of the human##2##5##(1991-11#1)(1992-3#1)
upstream region of the##12##4##(1990-9#1)(1991-11#1)(1991-3#2)(1991-8#1)(1992-12#1)(1992-3#1)(1993-3#1)(1995-3#1)(1996-10#2)(1996-11#1)
upstream region of##19##3##(1990-9#1)(1991-11#1)(1991-3#2)(1991-8#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-4#1)(1994-6#1)(1995-3#2)(1996-10#2)(1996-11#1)(1996-3#1)(2008-8#2)(2008-9#1)
upstream region was##2##3##(1993-12#1)(1994-2#1)
upstream region##33##2##(1990-11#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-12#2)(1994-2#2)(1994-6#1)(1995-2#2)(1995-3#2)(1996-10#2)(1996-11#1)(1996-3#1)(1997-2#3)(1997-7#1)(2008-8#2)(2008-9#1)
upstream regions of##5##3##(1991-8#1)(1993-6#1)(2008-10#1)(2008-9#2)
upstream regions##7##2##(1991-8#1)(1993-6#1)(1994-3#1)(1995-12#1)(2008-10#1)(2008-9#2)
upstream regulation##2##2##(1990-5#1)(2008-11#1)
upstream regulators##3##2##(2012-1#1)(2012-2#1)(2013-1#1)
upstream regulatory region and##2##4##(1991-7#1)(2009-5#1)
upstream regulatory region##5##3##(1991-7#1)(1993-2#1)(1994-10#1)(2009-5#2)
upstream regulatory##7##2##(1991-7#1)(1993-2#1)(1994-10#1)(1997-2#1)(1997-6#1)(2009-5#2)
upstream sequence##4##2##(1992-3#1)(1994-9#1)(1995-12#1)(1997-7#1)
upstream sequences##7##2##(1990-6#1)(1990-8#1)(1991-6#1)(1992-3#1)(1995-2#1)(1996-3#1)(2008-9#1)
upstream signaling##2##2##(1994-12#1)(1995-8#1)
upstream signals##2##2##(1996-5#1)(2007-11#1)
upstream to the##3##3##(1990-12#1)(1993-3#1)(1993-9#1)
upstream to##5##2##(1990-12#1)(1993-3#1)(1993-9#1)(1995-10#1)(2008-8#1)
upstream transcriptional##2##2##(1990-5#1)(1996-10#1)
upstream##476##1##(1990-1#3)(1990-10#2)(1990-11#8)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#8)(1990-6#5)(1990-7#2)(1990-8#4)(1990-9#5)(1991-1#2)(1991-11#3)(1991-12#6)(1991-2#3)(1991-3#3)(1991-4#4)(1991-5#1)(1991-6#9)(1991-7#9)(1991-8#3)(1991-9#6)(1992-10#1)(1992-11#5)(1992-12#5)(1992-2#1)(1992-3#5)(1992-6#3)(1992-7#3)(1992-9#4)(1993-11#5)(1993-12#7)(1993-2#5)(1993-3#15)(1993-4#2)(1993-5#4)(1993-6#4)(1993-8#4)(1993-9#7)(1994-10#1)(1994-11#2)(1994-12#12)(1994-2#4)(1994-3#4)(1994-5#1)(1994-6#3)(1994-8#3)(1994-9#6)(1995-1#1)(1995-10#2)(1995-12#4)(1995-2#8)(1995-3#7)(1995-6#5)(1995-8#13)(1996-10#9)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#9)(1996-4#1)(1996-5#5)(1996-6#2)(1996-7#6)(1996-8#7)(1997-1#4)(1997-2#21)(1997-3#1)(1997-4#14)(1997-5#4)(1997-6#4)(1997-7#13)(2003-11#1)(2004-10#1)(2005-11#2)(2006-11#3)(2006-12#3)(2006-4#2)(2006-5#3)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#8)(2008-11#13)(2008-2#2)(2008-3#2)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#9)(2008-9#12)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-8#3)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#3)(2013-1#4)(2013-8#1)
upsurge of##3##2##(2006-10#1)(2008-10#1)(2012-2#1)
uptake (IC50##2##2##(1995-6#2)
uptake IC50 values##2##3##(1995-1#2)
uptake IC50##5##2##(1995-1#5)
uptake ability of##2##3##(2008-11#1)(2008-5#1)
uptake ability##3##2##(2008-11#1)(2008-5#1)(2011-12#1)
uptake activity of##2##3##(1994-2#1)(1994-9#1)
uptake activity##9##2##(1990-12#2)(1994-2#1)(1994-9#1)(2006-3#5)
uptake after##7##2##(1990-9#2)(1991-5#1)(1993-11#1)(1995-5#1)(1996-8#1)(2008-10#1)
uptake and a##4##3##(1995-11#1)(1996-9#1)(2008-1#1)(2012-12#1)
uptake and binding of [11C]nicotine in##2##6##(1993-11#2)
uptake and binding sites in the##2##6##(2008-7#2)
uptake and binding##5##3##(1993-11#2)(1995-1#1)(2008-7#2)
uptake and biolocalization##2##3##(1992-9#2)
uptake and decarboxylation##2##3##(1992-8#1)(2008-11#1)
uptake and degradation of##3##4##(1990-2#1)(1991-8#1)(1992-12#1)
uptake and efflux##5##3##(1992-6#4)(2008-11#1)
uptake and its##2##3##(1995-11#1)(2008-11#1)
uptake and metabolism of 4-n-nonylphenol##2##5##(2008-11#2)
uptake and metabolism of##4##4##(1995-2#1)(1997-8#1)(2008-11#2)
uptake and metabolism##7##3##(1991-12#1)(1994-12#1)(1995-2#1)(1997-8#1)(2008-11#2)(2013-8#1)
uptake and phosphorylation##2##3##(1995-2#1)(2008-7#1)
uptake and processing##2##3##(1991-5#1)(1997-4#1)
uptake and prolonged##2##3##(1992-2#1)(2008-5#1)
uptake and release in##3##4##(1991-1#1)(1996-12#1)(1996-6#1)
uptake and release of##3##4##(1996-12#1)(2008-10#1)(2008-8#1)
uptake and release##14##3##(1991-1#1)(1991-8#1)(1995-6#3)(1996-12#2)(1996-6#1)(2008-10#4)(2008-8#1)(2012-2#1)
uptake and stripping of these metal ions##2##7##(2008-10#2)
uptake and the##3##3##(1992-8#1)(1996-7#1)(2008-10#1)
uptake and tissue distribution of##2##5##(1995-3#1)(2008-12#1)
uptake and utilization##2##3##(1996-11#1)(2008-5#1)
uptake and##148##2##(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-2#3)(1992-6#6)(1992-7#2)(1992-8#2)(1992-9#2)(1993-11#3)(1993-12#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#2)(1994-2#1)(1994-9#2)(1995-1#1)(1995-11#6)(1995-2#2)(1995-3#3)(1995-6#4)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-4#1)(1997-7#3)(1997-8#2)(2004-4#1)(2005-8#2)(2006-12#2)(2006-7#1)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#16)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#6)(2008-8#1)(2008-9#2)(2009-3#2)(2009-8#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
uptake are##4##2##(1992-3#1)(1994-3#2)(2008-8#1)
uptake as a##2##3##(1995-1#1)(2010-10#1)
uptake as##6##2##(1991-5#1)(1995-1#1)(2008-12#1)(2008-6#1)(2010-10#2)
uptake assay in##2##3##(1992-8#1)(2008-10#1)
uptake assay##4##2##(1990-2#1)(1992-8#1)(2008-10#1)(2008-5#1)
uptake at 4 degrees C##2##5##(1995-11#2)
uptake at the##3##3##(1990-7#1)(2006-10#1)(2011-2#1)
uptake at##12##2##(1990-7#1)(1991-9#1)(1992-6#2)(1993-4#1)(1994-10#1)(1994-11#1)(1994-9#1)(1995-11#2)(2006-10#1)(2011-2#1)
uptake between the##4##3##(1993-11#1)(2004-4#1)(2013-8#2)
uptake between##6##2##(1992-3#1)(1992-8#1)(1993-11#1)(2004-4#1)(2013-8#2)
uptake blocker##3##2##(1990-2#1)(1992-7#1)(1993-3#1)
uptake but##5##2##(1992-11#1)(1995-11#1)(1996-6#1)(2010-11#1)(2010-6#1)
uptake by M##2##3##(1993-3#1)(2012-2#1)
uptake by PRP##4##3##(1990-1#4)
uptake by a##2##3##(2008-5#1)(2010-12#1)
uptake by cultured##7##3##(1991-9#2)(1994-12#1)(1995-1#1)(1995-11#1)(2004-11#1)(2013-7#1)
uptake by hepatocytes##4##3##(1990-5#1)(1993-4#1)(1994-11#1)(2004-11#1)
uptake by human##2##3##(1994-3#1)(2009-9#1)
uptake by the liver##2##4##(1990-3#1)(1993-9#1)
uptake by the##14##3##(1990-2#1)(1990-3#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-3#1)(1993-9#1)(1994-3#2)(1995-11#1)(1996-12#1)(1996-5#1)(2010-1#1)
uptake by two##2##3##(1995-1#1)(1995-11#1)
uptake by yeast cells##3##4##(1990-2#1)(2008-10#2)
uptake by##112##2##(1990-1#5)(1990-10#3)(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-4#1)(1991-7#1)(1991-9#3)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#5)(1992-8#2)(1992-9#1)(1993-3#3)(1993-4#2)(1993-5#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-3#4)(1994-9#2)(1995-1#3)(1995-11#4)(1995-6#1)(1996-1#3)(1996-12#1)(1996-2#3)(1996-5#2)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-11#2)(2004-4#1)(2005-8#1)(2006-10#2)(2006-11#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-5#2)(2011-2#1)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#1)
uptake can be##2##3##(1990-7#1)(2012-12#1)
uptake can##3##2##(1990-7#1)(1995-2#1)(2012-12#1)
uptake capability##2##2##(2008-2#1)(2008-6#1)
uptake capacity of##2##3##(2010-12#1)(2012-3#1)
uptake capacity##7##2##(2008-5#2)(2008-6#2)(2010-12#2)(2012-3#1)
uptake could##2##2##(1997-5#1)(2004-11#1)
uptake decreased##2##2##(1991-1#1)(2011-2#1)
uptake does not result from##2##5##(1995-11#2)
uptake does not##3##3##(1993-8#1)(1995-11#2)
uptake dose-dependently##2##2##(1991-4#1)(1994-3#1)
uptake during the##3##3##(1997-3#1)(2008-10#1)(2012-12#1)
uptake during##7##2##(1992-4#1)(1995-8#1)(1997-3#1)(2004-11#1)(2008-10#1)(2008-5#1)(2012-12#1)
uptake efficiency##3##2##(2008-10#1)(2010-2#1)(2012-2#1)
uptake for the##2##3##(2008-12#1)(2008-7#1)
uptake for##7##2##(1992-11#1)(1995-1#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)
uptake from a##2##3##(1996-2#1)(2008-6#1)
uptake from the##6##3##(1996-11#1)(1997-1#1)(2004-11#1)(2006-10#1)(2007-12#1)(2008-11#1)
uptake from##15##2##(1990-3#1)(1992-1#1)(1992-7#1)(1995-11#2)(1995-3#1)(1996-11#1)(1996-2#1)(1997-1#1)(2004-11#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-6#1)(2010-8#1)
uptake half-life##2##2##(1992-7#2)
uptake has##4##2##(1990-12#1)(1993-4#1)(2009-8#1)(2010-10#1)
uptake in a dose-dependent##3##4##(1991-3#1)(1992-9#1)(1995-11#1)
uptake in a##8##3##(1991-10#1)(1991-3#1)(1992-9#1)(1995-11#1)(1996-12#1)(2010-2#1)(2013-1#1)(2013-8#1)
uptake in both##2##3##(1995-1#1)(1997-1#1)
uptake in cultured##5##3##(1990-7#1)(1990-8#2)(1992-4#1)(1994-3#1)
uptake in membrane vesicles##2##4##(1990-9#1)(1991-5#1)
uptake in most##2##3##(1991-10#1)(1996-7#1)
uptake in rabbit##3##3##(1993-11#1)(1994-9#1)(1996-1#1)
uptake in rat##5##3##(1990-9#1)(1991-2#1)(1992-9#1)(1997-1#1)(2008-8#1)
uptake in response to##2##4##(1992-2#1)(2004-11#1)
uptake in the midgut##2##4##(2008-10#2)
uptake in the presence of##2##5##(1991-4#1)(1993-8#1)
uptake in the presence##3##4##(1991-4#1)(1993-8#1)(2008-6#1)
uptake in the septum##2##4##(1991-5#2)
uptake in the##31##3##(1990-9#1)(1991-1#1)(1991-4#1)(1991-5#3)(1992-11#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-5#1)(1996-12#1)(1996-2#1)(1997-1#1)(2006-10#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#2)(2011-2#1)
uptake in this##2##3##(1995-1#1)(2009-8#1)
uptake in three##2##3##(1995-7#1)(1996-2#1)
uptake in##112##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-7#2)(1990-8#3)(1990-9#3)(1991-1#1)(1991-10#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#4)(1992-11#2)(1992-2#2)(1992-3#1)(1992-4#2)(1992-6#2)(1992-7#1)(1992-9#3)(1993-11#2)(1993-12#1)(1993-4#1)(1993-8#2)(1993-9#1)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#2)(1995-6#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-8#1)(2004-11#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-12#3)(2010-2#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
uptake increased##2##2##(2008-7#2)
uptake inhibition##6##2##(1991-9#2)(1993-4#2)(1994-12#1)(1995-6#1)
uptake inhibitor##7##2##(1990-5#3)(1991-5#2)(1996-5#1)(1997-8#1)
uptake inhibitors##10##2##(1990-2#1)(1990-5#1)(1991-3#1)(1993-4#2)(1996-12#2)(1996-5#1)(2005-9#1)(2008-8#1)
uptake into synaptosomes##2##3##(1990-7#1)(1993-4#1)
uptake into the liver and##2##5##(1996-1#1)(2010-12#1)
uptake into the##12##3##(1991-8#1)(1991-9#1)(1992-4#1)(1992-6#1)(1993-4#1)(1994-12#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-8#1)(2008-5#1)(2010-12#1)
uptake into##44##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-5#1)(1990-7#4)(1991-10#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-4#2)(1992-6#2)(1992-8#1)(1993-2#1)(1993-4#2)(1994-12#2)(1994-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-11#2)(2005-7#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-10#1)(2010-11#1)(2010-12#2)
uptake is a##2##3##(1995-11#1)(2008-10#1)
uptake is activated by##2##4##(1990-11#1)(1990-9#1)
uptake is mediated by##2##4##(1991-1#1)(1992-3#1)
uptake is##23##2##(1990-11#2)(1990-12#2)(1990-9#1)(1991-1#1)(1991-8#1)(1992-3#2)(1993-4#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-11#3)(1995-7#1)(2005-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)
uptake kinetics##4##2##(1990-7#1)(1993-3#1)(2009-5#1)(2013-7#1)
uptake measurements##3##2##(1995-1#2)(2010-12#1)
uptake mechanism of##3##3##(1991-1#1)(1992-5#1)(2012-1#1)
uptake mechanism##10##2##(1990-8#1)(1990-9#1)(1991-1#2)(1992-5#1)(1995-8#1)(1997-5#2)(2010-12#1)(2012-1#1)
uptake mechanisms of##2##3##(1994-5#1)(1995-3#1)
uptake mechanisms##5##2##(1990-12#1)(1994-5#1)(1995-3#1)(2006-10#1)(2009-3#1)
uptake nor##2##2##(1990-2#1)(1995-6#1)
uptake occurred##3##2##(1992-1#1)(1995-11#1)(2011-2#1)
uptake of 1##2##3##(1991-3#1)(2008-5#1)
uptake of 125I-Ox-LDL##2##3##(1990-8#1)(1991-8#1)
uptake of 131I-MIBG##2##3##(1990-10#2)
uptake of 14C-5HT##2##3##(1995-11#2)
uptake of 2##2##3##(1994-5#2)
uptake of 45Ca##2##3##(1993-3#2)
uptake of 45Ca2+##2##3##(1997-2#2)
uptake of CH₃As(OH)₂##2##3##(2010-11#2)
uptake of Ca2+##4##3##(1993-4#1)(1994-11#2)(1997-1#1)
uptake of DNA##2##3##(1991-8#1)(2008-9#1)
uptake of Fe(II)##2##3##(1992-4#1)(1996-6#1)
uptake of HDL##2##3##(1996-8#2)
uptake of TMA-DPH##2##3##(1990-5#2)
uptake of VLDL##3##3##(1991-2#2)(1995-8#1)
uptake of [3H]##2##3##(1991-9#1)(1992-11#1)
uptake of a##3##3##(1994-8#1)(2007-11#1)(2008-6#1)
uptake of arsenic##2##3##(2008-10#1)(2009-10#1)
uptake of bile acids##3##4##(1992-3#1)(1994-12#1)(2008-11#1)
uptake of biotin##2##3##(1997-3#1)(2009-9#1)
uptake of both##4##3##(1992-1#1)(1994-3#1)(1994-6#1)(1997-7#1)
uptake of cadmium##3##3##(1995-3#1)(1996-7#1)(2008-5#1)
uptake of choline into##2##4##(1994-10#1)(1994-3#1)
uptake of glucose but##2##4##(2010-11#2)
uptake of glucose##4##3##(1992-6#1)(2008-11#1)(2010-11#2)
uptake of glutamate##3##3##(1990-12#3)
uptake of glutamine##2##3##(1990-3#1)(2008-11#1)
uptake of insulin##2##3##(1990-11#1)(2009-11#1)
uptake of iron by##2##4##(1992-1#1)(2006-10#1)
uptake of iron##5##3##(1992-1#1)(1992-4#1)(2006-10#1)(2008-10#1)(2009-9#1)
uptake of labelled adenosine##2##4##(1997-8#2)
uptake of labelled##3##3##(1996-9#1)(1997-8#2)
uptake of leucine##2##3##(1995-11#2)
uptake of liposomes##2##3##(1992-6#1)(1997-1#1)
uptake of low-density lipoprotein##2##4##(1995-10#1)(2011-2#1)
uptake of mature aspartate aminotransferase by isolated mitochondria##2##8##(1990-7#2)
uptake of mercury from amalgam fillings##3##6##(1995-6#3)
uptake of mercury##4##3##(1995-6#4)
uptake of polio vaccination##3##4##(2012-12#3)
uptake of sodium##2##3##(1994-6#1)(2008-9#1)
uptake of the##31##3##(1990-5#1)(1990-8#1)(1991-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-6#1)(1994-8#1)(1995-1#1)(1996-5#2)(1997-1#1)(1997-2#1)(2005-11#2)(2006-10#1)(2007-7#1)(2008-11#2)(2008-2#1)(2008-4#1)(2010-11#1)(2011-1#2)(2012-11#2)(2013-1#2)(2013-7#2)
uptake of these##4##3##(1990-4#1)(1991-10#1)(1993-9#1)(2008-10#1)
uptake of this##4##3##(1996-8#1)(2008-3#1)(2012-11#2)
uptake of two##2##3##(1992-3#1)(1994-9#1)
uptake of##316##2##(1990-1#1)(1990-10#2)(1990-11#6)(1990-12#3)(1990-3#4)(1990-4#3)(1990-5#4)(1990-7#2)(1990-8#3)(1991-1#4)(1991-10#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#3)(1991-9#3)(1992-1#2)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#8)(1992-4#6)(1992-5#3)(1992-6#5)(1992-8#1)(1992-9#1)(1993-11#4)(1993-12#1)(1993-3#4)(1993-4#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-11#5)(1994-12#2)(1994-3#4)(1994-5#6)(1994-6#5)(1994-8#3)(1994-9#6)(1995-1#2)(1995-10#3)(1995-11#6)(1995-2#3)(1995-3#1)(1995-5#3)(1995-6#5)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#3)(1996-4#1)(1996-5#4)(1996-6#2)(1996-7#2)(1996-8#4)(1996-9#2)(1997-1#7)(1997-2#5)(1997-3#2)(1997-7#4)(1997-8#3)(2004-11#2)(2005-11#6)(2005-8#1)(2006-1#1)(2006-10#3)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#2)(2008-1#3)(2008-10#15)(2008-11#11)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-9#2)(2010-10#4)(2010-11#5)(2010-12#2)(2010-5#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-11#7)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#4)
uptake on the##5##3##(1996-5#1)(2008-10#1)(2011-1#1)(2013-1#2)
uptake on##7##2##(1993-9#1)(1996-5#1)(2008-10#1)(2010-12#1)(2011-1#1)(2013-1#2)
uptake or##4##2##(1992-7#1)(1995-2#1)(2008-1#1)(2008-11#1)
uptake process##6##2##(1990-11#2)(1991-5#1)(2006-10#1)(2008-10#1)(2008-7#1)
uptake processes##2##2##(1992-3#1)(1994-3#1)
uptake properties##4##2##(2008-10#1)(2008-5#1)(2012-11#2)
uptake rate and the##2##4##(1994-5#1)(2008-7#1)
uptake rate and##4##3##(1994-5#1)(2008-11#2)(2008-7#1)
uptake rate for##2##3##(1990-8#1)(2008-7#1)
uptake rate increased##2##3##(1995-1#1)(2008-11#1)
uptake rate of a##2##4##(1994-5#1)(2008-11#1)
uptake rate of##5##3##(1990-8#1)(1994-5#1)(1994-8#1)(2005-4#1)(2008-11#1)
uptake rate was##2##3##(1994-5#1)(2008-11#1)
uptake rate##26##2##(1990-12#1)(1990-8#2)(1994-5#5)(1994-8#1)(1995-1#1)(1997-8#2)(2005-4#1)(2008-10#2)(2008-11#7)(2008-7#4)
uptake rates are##4##3##(2007-11#2)(2008-10#1)(2008-7#1)
uptake rates in##3##3##(1994-5#1)(2007-11#1)(2008-8#1)
uptake rates of##3##3##(1992-6#1)(1994-8#1)(2008-11#1)
uptake rates were##2##3##(1992-8#1)(2008-11#1)
uptake rates##22##2##(1992-6#1)(1992-8#3)(1994-5#1)(1994-8#1)(1995-1#1)(2007-11#3)(2008-10#6)(2008-11#3)(2008-7#2)(2008-8#1)
uptake remained##2##2##(1991-9#2)
uptake respectively##2##2##(1990-7#1)(1992-7#1)
uptake results from##2##3##(1995-11#2)
uptake signal##2##2##(1991-7#1)(2005-4#1)
uptake similarly##2##2##(1990-8#1)(1991-4#1)
uptake site##5##2##(1993-4#3)(1995-5#1)(1996-10#1)
uptake sites and##2##3##(1990-2#1)(1995-7#1)
uptake sites##9##2##(1990-2#2)(1994-12#1)(1995-7#4)(2008-7#2)
uptake stimulated by##2##3##(1994-8#1)(2008-11#1)
uptake studies##3##2##(1991-10#1)(2007-11#1)(2008-10#1)
uptake such as##2##3##(1993-9#1)(2008-10#1)
uptake system for##4##3##(1990-11#2)(1990-12#1)(1992-8#1)
uptake system in##2##3##(1990-12#1)(1995-11#1)
uptake system is##3##3##(1992-8#1)(1994-3#1)(2008-10#1)
uptake system of##2##3##(1990-1#1)(1996-1#1)
uptake system that is##2##4##(1995-11#1)(2006-10#1)
uptake system##24##2##(1990-1#1)(1990-11#2)(1990-12#2)(1992-8#3)(1993-7#1)(1994-12#1)(1994-3#1)(1995-11#4)(1996-1#2)(1996-8#1)(1997-7#1)(2006-10#1)(2008-10#2)(2008-7#1)(2011-2#1)
uptake systems##6##2##(1992-8#1)(1994-11#1)(2008-7#3)(2012-2#1)
uptake than##4##2##(1995-6#1)(1997-1#1)(2010-6#2)
uptake through##2##2##(1994-6#1)(1995-11#1)
uptake to a##2##3##(1990-2#1)(2006-10#1)
uptake to##9##2##(1990-10#1)(1990-2#1)(1991-8#1)(1992-6#1)(1995-3#1)(1996-8#1)(2006-10#1)(2008-6#1)(2013-8#1)
uptake values##2##2##(2010-8#1)(2013-1#1)
uptake via##6##2##(1995-5#1)(1996-6#1)(1997-1#1)(2005-11#1)(2012-2#1)(2013-1#1)
uptake was assessed##2##3##(1991-5#1)(1997-8#1)
uptake was demonstrated##2##3##(2006-7#1)(2012-11#1)
uptake was found##2##3##(1992-3#2)
uptake was inhibited by##4##4##(1990-2#2)(1990-4#1)(1991-1#1)
uptake was linear up to##2##5##(1991-1#1)(1992-3#1)
uptake was linear##3##3##(1991-1#1)(1992-3#2)
uptake was measured##2##3##(1990-11#1)(1995-11#1)
uptake was not##2##3##(1992-8#1)(2008-5#1)
uptake was observed for##2##4##(1995-11#1)(2013-1#1)
uptake was observed with##2##4##(1993-8#1)(1997-1#1)
uptake was observed##9##3##(1991-5#1)(1993-8#1)(1995-11#1)(1995-5#1)(1997-1#1)(1997-7#1)(2005-11#1)(2008-11#1)(2013-1#1)
uptake was obtained##2##3##(2008-11#1)(2008-12#1)
uptake was##67##2##(1990-11#1)(1990-2#4)(1990-3#1)(1990-4#1)(1990-7#1)(1991-1#2)(1991-5#2)(1991-9#1)(1992-11#2)(1992-3#10)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#2)(1995-5#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-7#2)(1997-8#1)(2004-11#2)(2005-11#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-5#1)(2011-2#1)(2012-11#1)(2013-1#2)(2013-8#1)
uptake were##9##2##(1992-11#1)(1993-3#1)(1993-9#1)(1995-1#1)(1996-5#1)(1997-6#1)(2006-8#1)(2008-12#1)(2013-8#1)
uptake whereas the##2##3##(1990-11#1)(2006-7#1)
uptake whereas##3##2##(1990-11#1)(2004-11#1)(2006-7#1)
uptake which##2##2##(1990-12#1)(1997-8#1)
uptake with##4##2##(1991-4#2)(2008-10#1)(2008-2#1)
uptake within##2##2##(1994-3#1)(2006-7#1)
uptake##1514##1##(1990-1#10)(1990-10#7)(1990-11#22)(1990-12#16)(1990-2#20)(1990-3#9)(1990-4#5)(1990-5#11)(1990-7#14)(1990-8#15)(1990-9#13)(1991-1#17)(1991-10#8)(1991-12#5)(1991-2#9)(1991-3#4)(1991-4#7)(1991-5#15)(1991-6#4)(1991-7#4)(1991-8#10)(1991-9#16)(1992-1#6)(1992-11#14)(1992-12#4)(1992-2#8)(1992-3#36)(1992-4#12)(1992-5#4)(1992-6#30)(1992-7#10)(1992-8#17)(1992-9#9)(1993-11#13)(1993-12#5)(1993-2#4)(1993-3#15)(1993-4#20)(1993-5#1)(1993-6#3)(1993-7#2)(1993-8#11)(1993-9#13)(1994-10#6)(1994-11#13)(1994-12#14)(1994-2#3)(1994-3#25)(1994-4#1)(1994-5#18)(1994-6#7)(1994-8#7)(1994-9#18)(1995-1#25)(1995-10#4)(1995-11#47)(1995-2#8)(1995-3#8)(1995-5#9)(1995-6#23)(1995-7#10)(1995-8#4)(1996-1#14)(1996-10#1)(1996-11#4)(1996-12#12)(1996-2#15)(1996-3#1)(1996-4#3)(1996-5#14)(1996-6#7)(1996-7#9)(1996-8#10)(1996-9#10)(1997-1#19)(1997-2#13)(1997-3#4)(1997-4#6)(1997-5#4)(1997-6#4)(1997-7#12)(1997-8#17)(2004-11#15)(2004-2#1)(2004-4#4)(2005-10#1)(2005-11#14)(2005-4#2)(2005-7#1)(2005-8#6)(2005-9#1)(2006-1#1)(2006-10#20)(2006-11#1)(2006-12#2)(2006-3#7)(2006-7#6)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#7)(2007-12#5)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#14)(2008-10#71)(2008-11#65)(2008-12#13)(2008-2#5)(2008-3#9)(2008-4#9)(2008-5#26)(2008-6#14)(2008-7#35)(2008-8#12)(2008-9#7)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#5)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#7)(2009-9#4)(2010-1#1)(2010-10#12)(2010-11#9)(2010-12#18)(2010-2#4)(2010-4#3)(2010-5#3)(2010-6#6)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#5)(2011-12#3)(2011-2#17)(2012-1#4)(2012-11#15)(2012-12#11)(2012-2#16)(2012-3#6)(2012-5#1)(2013-1#22)(2013-7#9)(2013-8#22)
uptake)##5##1##(1990-12#1)(1990-9#1)(1995-8#1)(2005-10#1)(2008-8#1)
uptake2##4##1##(1996-6#4)
uptaken##2##1##(1990-9#1)(2012-6#1)
uptakes of##2##2##(1990-11#1)(1991-1#1)
uptakes##10##1##(1990-11#2)(1990-9#1)(1991-1#1)(1997-7#1)(2006-7#2)(2008-10#1)(2012-11#2)
upto 1##2##2##(2012-3#1)(2013-7#1)
upto 6##2##2##(2007-7#1)(2008-10#1)
upto the##2##2##(2013-7#1)(2013-8#1)
upto##16##1##(1991-3#1)(2007-7#3)(2008-10#4)(2008-7#2)(2008-8#1)(2010-5#1)(2012-3#1)(2013-7#2)(2013-8#1)
upturn##2##1##(1993-1#1)(2011-2#1)
upward and downward##5##3##(2007-10#1)(2008-2#1)(2008-3#2)(2009-11#1)
upward and##6##2##(2007-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-11#1)
upward capillary transfer of DNA from##2##6##(2008-4#2)
upward flow##2##2##(2008-4#2)
upward gaze##2##2##(2007-10#2)
upward irradiance##2##2##(2008-2#1)(2008-3#1)
upward to##2##2##(2008-10#1)(2009-7#1)
upward trend in##6##3##(1990-11#1)(1990-2#1)(1993-10#1)(1997-1#1)(2007-1#1)(2007-7#1)
upward trend of##2##3##(2005-11#1)(2008-3#1)
upward trend##12##2##(1990-11#1)(1990-2#1)(1990-8#2)(1993-10#1)(1997-1#1)(1997-6#1)(2005-11#1)(2007-1#1)(2007-7#1)(2008-3#1)(2011-2#1)
upward trends were##2##3##(1995-5#2)
upward trends##3##2##(1994-6#1)(1995-5#2)
upward##69##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#2)(1993-10#1)(1994-6#2)(1994-8#2)(1995-5#3)(1996-1#2)(1997-1#1)(1997-6#1)(2005-1#1)(2005-11#1)(2006-8#1)(2007-1#2)(2007-10#3)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#5)(2008-5#2)(2008-7#3)(2009-11#2)(2009-3#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-9#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-3#1)
upwardly##5##1##(1996-8#1)(2006-7#1)(2008-11#2)(2013-1#1)
upwards in##2##2##(2008-3#1)(2012-3#1)
upwards of##2##2##(1994-2#1)(2008-11#1)
upwards##14##1##(1990-9#1)(1992-6#1)(1993-5#1)(1994-11#1)(1994-2#1)(1995-5#1)(1996-9#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)(2011-1#1)(2012-3#1)
upwelling and downwelling##2##3##(2008-2#1)(2013-8#1)
upwelling and##3##2##(2008-2#1)(2013-7#1)(2013-8#1)
upwelling ecosystem##3##2##(2008-5#3)
upwelling irradiance##4##2##(2008-2#1)(2008-3#3)
upwelling radiance##8##2##(2008-2#5)(2008-3#3)
upwelling system##2##2##(2007-5#1)(2011-2#1)
upwelling##30##1##(1991-5#1)(1993-7#1)(2007-5#2)(2008-2#9)(2008-3#7)(2008-5#6)(2011-2#2)(2013-7#1)(2013-8#1)
upwind of the##2##3##(2008-10#2)
upwind##5##1##(1992-6#1)(2008-10#3)(2008-3#1)
ura3##2##1##(1991-7#1)(1993-5#1)
ura4##2##1##(1996-7#2)
ura5##3##1##(1993-5#1)(1995-4#2)
urachal adenocarcinoma##2##2##(2010-2#2)
urachal cyst associated with pseudomyxoma peritonei##2##6##(2009-5#2)
urachal cyst associated with##4##4##(2009-5#4)
urachal cyst##8##2##(2006-7#1)(2008-10#3)(2009-5#4)
urachal##18##1##(2006-7#1)(2008-10#6)(2008-6#3)(2009-5#4)(2010-2#4)
urachus##5##1##(2008-6#1)(2010-2#4)
uracil and##3##2##(1994-9#1)(1996-6#1)(1997-8#1)
uracil at##2##2##(1994-9#1)(2008-10#1)
uracil nucleotide##3##2##(1990-4#3)
uracil nucleotides in mouse liver and intestine##2##7##(1990-4#2)
uracil nucleotides##6##2##(1990-4#3)(1990-5#1)(2008-4#2)
uracil or cytosine##2##3##(2008-5#2)
uracil or##4##2##(1997-2#1)(2008-5#3)
uracil ring##3##2##(1990-4#1)(2010-2#2)
uracil was##2##2##(1992-12#1)(2013-1#1)
uracil##49##1##(1990-4#7)(1990-5#1)(1991-7#1)(1992-1#1)(1992-12#2)(1992-3#3)(1993-11#1)(1994-7#1)(1994-8#2)(1994-9#3)(1996-5#1)(1996-6#3)(1996-7#1)(1997-2#2)(1997-8#3)(2007-11#1)(2008-10#4)(2008-4#2)(2008-5#5)(2010-2#2)(2011-1#1)(2013-1#2)
uracil-DNA glycosylase##3##2##(1994-7#2)(2008-5#1)
uracil-DNA##4##1##(1994-7#2)(1995-3#1)(2008-5#1)
uracils##3##1##(1994-11#1)(1995-6#1)(2013-7#1)
uraemic patients##5##2##(1993-11#2)(1995-3#1)(2007-7#2)
uraemic syndrome and##2##3##(2006-6#1)(2008-6#1)
uraemic syndrome##4##2##(1991-8#1)(1997-2#1)(2006-6#1)(2008-6#1)
uraemic##11##1##(1991-8#1)(1993-11#3)(1995-3#1)(1997-2#1)(2006-4#1)(2006-6#1)(2007-7#2)(2008-6#1)
uralensis Fisch was##2##3##(2008-11#2)
uralensis Fisch##3##2##(2008-11#3)
uranium (VI)##7##2##(2005-11#3)(2008-10#4)
uranium and mixed rare-earth elements##2##5##(2008-10#2)
uranium and##7##2##(2008-10#6)(2013-1#1)
uranium atom##2##2##(2005-11#1)(2005-4#1)
uranium by##6##2##(2008-10#6)
uranium carbide##3##2##(2008-10#3)
uranium from aqueous solution##2##4##(2008-10#2)
uranium from##10##2##(2006-3#2)(2008-10#8)
uranium in the##2##3##(2008-10#2)
uranium in##11##2##(2008-10#11)
uranium is important##2##3##(2008-10#2)
uranium is##6##2##(2006-4#1)(2008-10#5)
uranium isotopes in##2##3##(2008-10#2)
uranium isotopes##4##2##(2008-10#4)
uranium mine##2##2##(2008-10#1)(2013-1#1)
uranium ore##3##2##(2008-10#1)(2013-1#2)
uranium reduction##2##2##(2006-3#2)
uranium removal##3##2##(2013-8#3)
uranium was##3##2##(2008-10#1)(2013-8#2)
uranium with##5##2##(2006-4#1)(2008-10#4)
uranium##117##1##(1993-4#1)(1993-9#1)(1995-7#1)(2005-11#4)(2005-4#2)(2006-3#5)(2006-4#4)(2008-10#80)(2008-3#1)(2008-5#1)(2010-5#2)(2013-1#10)(2013-8#5)
uranium(VI) and thorium(IV) prior to##3##5##(2008-10#3)
uranium(VI) and thorium(IV)##5##3##(2008-10#5)
uranium(VI) and zinc(II)##3##3##(2008-10#3)
uranium(VI) and##8##2##(2008-10#8)
uranium(VI) from##3##2##(2008-10#3)
uranium(VI) on##2##2##(2008-10#2)
uranium(VI) with##3##2##(2008-10#3)
uranium(VI)##31##1##(2008-10#31)
uranium-induced developmental toxicity##3##3##(1993-4#3)
uranium-induced##4##1##(1993-4#4)
uranyl acetate##5##2##(1993-4#2)(1997-2#1)(2007-9#1)(2008-10#1)
uranyl ion##8##2##(2008-10#8)
uranyl membrane sensor with##2##4##(2008-10#2)
uranyl nitrate##4##2##(2008-10#2)(2008-8#2)
uranyl phosphate##2##2##(1997-7#2)
uranyl##33##1##(1992-4#1)(1993-4#2)(1997-2#2)(1997-7#3)(2005-11#1)(2007-9#1)(2008-10#21)(2008-8#2)
urapidil##6##1##(1990-5#3)(1991-3#1)(1992-7#2)
urate and phosphate##4##3##(2006-10#4)
urate and##10##2##(1993-2#1)(1996-3#1)(1997-8#1)(2006-10#6)(2008-10#1)
urate crystals in the##2##4##(2007-11#2)
urate crystals##4##2##(2006-10#2)(2007-11#2)
urate oxidase and##3##3##(2008-10#3)
urate oxidase##11##2##(1990-2#1)(1991-12#1)(2008-10#8)(2010-4#1)
urate urolithiasis##2##2##(2010-2#2)
urate uroliths are##2##3##(2010-2#2)
urate uroliths##3##2##(2010-2#3)
urate##55##1##(1990-2#1)(1991-12#2)(1991-8#1)(1992-4#2)(1993-2#2)(1993-8#2)(1996-3#1)(1997-8#4)(2006-10#13)(2007-11#3)(2008-10#15)(2008-5#1)(2010-2#5)(2010-4#1)(2013-1#2)
urate-lowering##2##1##(2006-10#2)
urban Canadian municipalities##2##3##(2013-8#2)
urban Canadian##3##2##(2012-2#1)(2013-8#2)
urban adolescent girls##2##3##(2009-10#1)(2013-1#1)
urban adolescent##5##2##(1991-1#1)(2009-10#1)(2009-7#2)(2013-1#1)
urban adolescents of color##2##4##(2009-7#2)
urban adolescents##4##2##(2009-7#3)(2013-1#1)
urban aerosols##2##2##(2008-11#1)(2008-2#1)
urban air quality##5##3##(2008-11#5)
urban air##6##2##(2008-11#6)
urban and desert localities##2##4##(2013-1#2)
urban and desert##5##3##(2013-1#5)
urban and peri-urban##3##3##(2007-2#2)(2011-1#1)
urban and rural areas of##3##5##(2010-12#1)(2010-7#1)(2013-8#1)
urban and rural areas##13##4##(1991-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1996-3#1)(2006-2#1)(2006-8#1)(2007-2#1)(2007-7#1)(2009-4#1)(2010-12#1)(2010-7#1)(2013-8#1)
urban and rural communities in##3##5##(1997-1#1)(2007-3#1)(2011-2#1)
urban and rural communities##5##4##(1997-1#2)(2007-3#1)(2008-2#1)(2011-2#1)
urban and rural hospitals##3##4##(1992-12#1)(1992-2#1)(2007-2#1)
urban and rural locations##2##4##(2008-10#1)(2012-2#1)
urban and rural populations##2##4##(2011-11#1)(2012-2#1)
urban and rural regions##2##4##(2011-1#1)(2012-3#1)
urban and rural##45##3##(1991-3#1)(1992-12#3)(1992-2#1)(1993-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1996-3#2)(1997-1#2)(2006-2#1)(2006-8#1)(2007-2#3)(2007-3#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-11#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
urban and suburban areas##2##4##(2008-11#1)(2010-8#1)
urban and suburban##5##3##(2007-7#1)(2008-11#1)(2010-8#1)(2013-1#2)
urban and##68##2##(1991-12#1)(1991-3#1)(1991-6#1)(1992-12#4)(1992-2#1)(1993-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1996-3#2)(1997-1#2)(2006-2#1)(2006-8#1)(2007-2#5)(2007-3#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-11#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#10)(2013-8#2)
urban area of##11##3##(2007-2#1)(2008-11#1)(2008-6#2)(2008-7#1)(2009-10#2)(2012-12#3)(2013-1#1)
urban area was##2##3##(1996-3#1)(2009-4#1)
urban area##31##2##(1993-9#1)(1996-3#1)(1997-2#1)(2007-2#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#4)(2008-7#1)(2009-10#2)(2009-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#5)(2012-3#1)(2013-1#1)
urban areas and##5##3##(1994-2#1)(2008-5#1)(2009-4#1)(2011-2#1)(2012-3#1)
urban areas of the##2##4##(1992-9#1)(2008-6#1)
urban areas of##10##3##(1991-6#1)(1992-9#1)(1997-4#1)(2005-12#1)(2008-3#1)(2008-6#1)(2009-6#1)(2011-12#1)(2011-2#1)(2013-8#1)
urban areas##49##2##(1991-11#1)(1991-12#2)(1991-6#1)(1992-12#1)(1992-6#1)(1992-9#2)(1994-2#2)(1994-3#1)(1995-1#1)(1995-4#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-12#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2009-4#3)(2009-6#2)(2009-7#1)(2010-2#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
urban atmosphere##3##2##(2008-11#1)(2008-2#1)(2009-6#1)
urban based##2##2##(2008-7#1)(2010-3#1)
urban beneficiaries##5##2##(1994-2#2)(1996-3#3)
urban black##2##2##(2004-10#2)
urban centers##3##2##(2012-12#2)(2013-1#1)
urban centre##2##2##(1992-1#1)(2007-3#1)
urban children##6##2##(1992-4#1)(2008-3#2)(2010-9#1)(2012-2#2)
urban clinic##3##2##(2007-7#1)(2012-12#1)(2013-1#1)
urban clinics##3##2##(2006-2#3)
urban communities##4##2##(2007-9#1)(2010-3#1)(2010-6#2)
urban community##9##2##(1992-12#1)(1996-3#1)(1997-3#1)(2007-10#1)(2007-9#2)(2008-3#1)(2010-3#1)(2011-1#1)
urban county##3##2##(2007-11#2)(2008-3#1)
urban diabetics##4##2##(2008-6#4)
urban district##2##2##(2007-9#1)(2010-4#1)
urban dogs##2##2##(2008-12#1)(2012-2#1)
urban dust##2##2##(2008-10#2)
urban dust)##2##2##(2007-8#1)(2008-10#1)
urban dwellers##3##2##(2011-11#3)
urban emergency##3##2##(2007-4#1)(2007-5#1)(2007-7#1)
urban enrollees##2##2##(1994-2#2)
urban environment##5##2##(1994-1#1)(2004-12#1)(2007-10#1)(2008-10#1)(2008-5#1)
urban environments##3##2##(2008-11#1)(2010-1#1)(2010-2#1)
urban families from##2##3##(2008-2#1)(2010-6#1)
urban female subjects##2##3##(1997-1#2)
urban fox##2##2##(1991-12#2)
urban health##5##2##(1994-11#1)(1994-4#1)(1997-4#1)(2009-10#1)(2013-8#1)
urban hospital##7##2##(2005-10#1)(2007-2#1)(2007-7#1)(2008-3#2)(2011-1#1)(2013-1#1)
urban hospitals##8##2##(1990-12#2)(1990-2#1)(1992-1#1)(1992-12#3)(2008-7#1)
urban location##2##2##(1992-12#1)(2012-1#1)
urban medical center##2##3##(1997-1#1)(2007-9#1)
urban neighborhood##3##2##(2007-2#1)(2010-9#2)
urban ozone##2##2##(2008-11#2)
urban participants##3##2##(2007-12#3)
urban particulate matter##6##3##(2007-8#2)(2008-10#4)
urban patients##2##2##(1996-2#1)(2007-7#1)
urban pharmacies##5##2##(2013-1#5)
urban planning##2##2##(2010-8#1)(2013-1#1)
urban population in Tianjin##2##4##(2010-12#2)
urban population in##5##3##(1990-2#1)(1993-9#1)(2010-12#2)(2011-1#1)
urban population of##7##3##(1991-1#1)(1996-3#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2010-10#1)
urban population##20##2##(1990-2#1)(1991-1#1)(1993-9#2)(1996-3#1)(2006-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2010-1#1)(2010-10#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
urban populations##5##2##(1995-5#1)(2006-4#1)(2011-11#2)(2012-12#1)
urban residents (p##2##3##(1997-2#1)(2011-2#1)
urban residents##5##2##(1997-2#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
urban sample of##3##3##(2007-12#1)(2009-7#1)(2013-1#1)
urban sample##6##2##(2006-4#1)(2007-12#1)(2007-9#1)(2009-7#1)(2010-4#1)(2013-1#1)
urban schools##2##2##(2008-12#1)(2010-1#1)
urban setting in##2##3##(2011-2#1)(2013-7#1)
urban setting##8##2##(1996-1#1)(2006-4#1)(2007-4#1)(2008-2#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-7#1)
urban settings##6##2##(2007-12#1)(2007-7#1)(2012-12#2)(2013-1#2)
urban sites in##2##3##(2008-10#1)(2008-11#1)
urban sites##3##2##(2008-10#1)(2008-11#2)
urban slum##8##2##(2008-8#1)(2009-10#1)(2011-12#2)(2012-2#2)(2012-3#2)
urban slums##5##2##(2009-10#1)(2011-1#2)(2012-3#2)
urban subjects##6##2##(1997-1#6)
urban teaching hospital##2##3##(1993-12#1)(2012-3#1)
urban teaching hospitals##2##3##(1993-12#1)(1996-3#1)
urban teaching##4##2##(1993-12#2)(1996-3#1)(2012-3#1)
urban teens##2##2##(2013-1#2)
urban trauma##2##2##(2011-2#1)(2013-8#1)
urban veterans##2##2##(2012-1#2)
urban waste samples##2##3##(2008-10#2)
urban waste##3##2##(1995-11#1)(2008-10#2)
urban wastewater##2##2##(2008-10#2)
urban women##3##2##(2012-3#1)(2013-1#2)
urban youth##4##2##(2006-7#1)(2007-2#1)(2009-7#1)(2010-9#1)
urban zones##2##2##(2007-11#1)(2007-2#1)
urban##582##1##(1990-12#2)(1990-2#2)(1991-1#2)(1991-11#1)(1991-12#6)(1991-3#1)(1991-6#2)(1992-1#2)(1992-12#13)(1992-2#1)(1992-4#1)(1992-6#1)(1992-9#2)(1993-10#1)(1993-12#3)(1993-2#1)(1993-9#3)(1994-1#2)(1994-11#1)(1994-2#10)(1994-3#2)(1994-4#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#11)(1997-1#13)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#2)(2004-10#2)(2004-11#1)(2004-12#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-2#4)(2006-4#3)(2006-5#1)(2006-7#1)(2006-8#2)(2007-10#4)(2007-11#3)(2007-12#12)(2007-2#15)(2007-3#3)(2007-4#3)(2007-5#3)(2007-7#9)(2007-8#8)(2007-9#10)(2008-1#2)(2008-10#31)(2008-11#26)(2008-12#5)(2008-2#8)(2008-3#27)(2008-4#4)(2008-5#4)(2008-6#16)(2008-7#4)(2008-8#7)(2008-9#2)(2009-10#6)(2009-4#7)(2009-6#4)(2009-7#12)(2009-8#2)(2009-9#2)(2010-1#3)(2010-10#1)(2010-12#4)(2010-2#2)(2010-3#4)(2010-4#5)(2010-5#1)(2010-6#4)(2010-7#3)(2010-8#5)(2010-9#5)(2011-1#17)(2011-11#8)(2011-12#4)(2011-2#14)(2012-1#10)(2012-11#4)(2012-12#21)(2012-2#19)(2012-3#15)(2012-7#1)(2013-1#45)(2013-7#2)(2013-8#20)
urban)##3##1##(2008-2#2)(2011-11#1)
urban-based##3##1##(2007-7#1)(2008-1#1)(2008-3#1)
urban-rural differences in##3##3##(1992-12#1)(2008-11#1)(2012-1#1)
urban-rural##5##1##(1992-12#1)(1994-2#1)(2008-11#1)(2010-8#1)(2012-1#1)
urbanization and##2##2##(2008-2#1)(2008-3#1)
urbanization##14##1##(1991-12#1)(1992-4#1)(1992-5#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#3)(2011-1#1)(2012-1#1)(2012-12#1)
urbanized and##2##2##(1991-12#1)(2008-2#1)
urbanized##4##1##(1991-12#1)(2008-2#1)(2010-4#1)(2011-1#1)
urbanizing##3##1##(2007-2#1)(2008-5#2)
urbilaterian##2##1##(2007-12#2)
urceolata##3##1##(2008-8#1)(2008-9#2)
urchin Diadema antillarum##3##3##(2007-5#2)(2008-5#1)
urchin Diadema##5##2##(2007-3#1)(2007-5#3)(2008-5#1)
urchin Loxechinus albus##2##3##(2007-5#2)
urchin Lytechinus variegatus##5##3##(2007-5#4)(2008-8#1)
urchin densities##2##2##(2008-5#1)(2011-2#1)
urchin species in##2##3##(2007-5#1)(2009-2#1)
urchin##78##1##(1990-10#4)(1990-2#1)(1990-5#1)(1991-2#2)(1993-9#3)(1995-3#5)(1995-6#1)(1995-8#2)(1996-10#2)(1996-5#5)(1997-4#2)(2006-10#2)(2007-3#3)(2007-5#19)(2008-11#1)(2008-4#1)(2008-5#9)(2008-6#2)(2008-8#3)(2009-2#1)(2009-7#1)(2011-2#4)(2012-2#2)(2013-8#2)
urchins in##2##2##(2007-5#2)
urchins per##2##2##(2007-5#2)
urchins##28##1##(1990-5#1)(1994-11#1)(1997-4#1)(2007-3#1)(2007-5#17)(2008-4#1)(2008-5#2)(2009-2#2)(2010-10#1)(2011-2#1)
urea and creatinine##3##3##(1997-3#1)(2008-1#1)(2008-4#1)
urea and guanidine-HCl##2##3##(1997-2#2)
urea and guanidinium chloride##2##4##(1990-8#2)
urea and guanidinium##3##3##(1990-8#2)(2009-9#1)
urea and the##2##3##(1995-3#1)(2011-1#1)
urea and thiourea##2##3##(2008-10#2)
urea and##36##2##(1990-5#1)(1990-8#2)(1991-1#1)(1991-4#1)(1991-7#1)(1992-11#1)(1992-7#1)(1994-12#1)(1994-9#1)(1995-3#1)(1996-3#1)(1997-2#2)(1997-3#1)(2005-11#1)(2007-10#1)(2008-1#1)(2008-10#9)(2008-4#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#1)(2013-8#1)
urea at##2##2##(1995-2#1)(2009-3#1)
urea biosensor##4##2##(2008-10#4)
urea biosensors were##2##3##(2008-10#2)
urea biosensors##3##2##(2008-10#3)
urea breath test##3##3##(1990-2#1)(2006-2#2)
urea clearance##4##2##(2007-6#2)(2008-1#2)
urea concentration and##2##3##(1990-7#1)(2008-1#1)
urea concentration in##5##3##(1990-7#1)(2007-8#1)(2008-1#2)(2008-4#1)
urea concentration##16##2##(1990-7#2)(1993-11#2)(1995-5#2)(2007-8#1)(2008-1#4)(2008-10#2)(2008-4#2)(2008-7#1)
urea concentrations##3##2##(2008-1#1)(2008-7#1)(2011-1#1)
urea cycle##11##2##(1991-9#1)(1992-7#2)(1993-3#1)(1996-9#1)(2008-7#3)(2009-8#2)(2010-11#1)
urea denaturation##4##2##(1994-5#1)(1995-5#1)(1997-7#2)
urea derivative##2##2##(2007-10#1)(2008-1#1)
urea determination in##2##3##(2008-10#2)
urea determination##5##2##(2007-8#1)(2008-10#4)
urea effect##2##2##(1996-5#2)
urea enzyme##2##2##(2008-10#2)
urea excretion in##2##3##(2008-10#1)(2010-8#1)
urea excretion##3##2##(2008-10#1)(2008-7#1)(2010-8#1)
urea gel electrophoresis##2##3##(1996-5#1)(2007-1#1)
urea in the mobile phase##2##5##(2008-10#2)
urea in the##4##3##(2008-10#4)
urea in##12##2##(1993-4#1)(1996-8#1)(1997-8#1)(2008-10#8)(2011-1#1)
urea increases##2##2##(1996-5#1)(2008-4#1)
urea is##2##2##(1997-7#1)(1997-8#1)
urea kinetics##3##2##(2008-1#3)
urea level##3##2##(2007-12#1)(2007-7#1)(2012-2#1)
urea levels##2##2##(1990-3#1)(2007-6#1)
urea metabolism##2##2##(2010-8#1)(2011-2#1)
urea nitrogen (BUN)##6##3##(1994-5#2)(2006-4#1)(2007-7#1)(2009-6#1)(2013-1#1)
urea nitrogen and creatinine##2##4##(2006-10#1)(2008-4#1)
urea nitrogen and serum creatinine##2##5##(2010-11#1)(2012-2#1)
urea nitrogen and##6##3##(1990-12#1)(2006-10#1)(2008-10#1)(2008-4#1)(2010-11#1)(2012-2#1)
urea nitrogen##25##2##(1990-12#1)(1990-3#1)(1994-5#2)(1995-12#1)(1995-3#1)(2006-10#2)(2006-2#1)(2006-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-5#2)(2009-6#1)(2010-11#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
urea or##9##2##(1995-4#1)(1995-5#1)(1995-8#1)(1996-5#1)(2006-8#1)(2007-11#3)(2008-10#1)
urea production##5##2##(2008-11#3)(2008-7#1)(2009-4#1)
urea responsiveness to a##2##4##(1996-5#2)
urea sensor has##2##3##(2008-10#2)
urea sensor##3##2##(2008-10#3)
urea solution##3##2##(2007-11#1)(2008-10#1)(2008-4#1)
urea synthesis##3##2##(1990-3#1)(1993-11#2)
urea the##3##2##(1990-10#1)(1995-6#1)(2008-4#1)
urea to##2##2##(1993-5#1)(2008-10#1)
urea transport##2##2##(1995-6#2)
urea transporter##2##2##(1995-6#2)
urea was##2##2##(2005-11#1)(2010-8#1)
urea were##8##2##(1995-10#1)(1995-3#1)(2007-2#1)(2008-11#1)(2011-2#3)(2013-8#1)
urea with##5##2##(1997-7#1)(2008-10#2)(2008-3#1)(2010-4#1)
urea##334##1##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#3)(1990-5#2)(1990-7#2)(1990-8#2)(1991-1#1)(1991-4#1)(1991-7#3)(1991-9#3)(1992-11#2)(1992-3#4)(1992-7#3)(1993-11#5)(1993-3#2)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-5#4)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#6)(1995-3#8)(1995-4#2)(1995-5#5)(1995-6#6)(1995-8#1)(1996-3#2)(1996-5#9)(1996-8#4)(1996-9#1)(1997-2#3)(1997-3#1)(1997-6#2)(1997-7#6)(1997-8#3)(2004-12#2)(2005-11#3)(2006-10#4)(2006-2#3)(2006-4#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#1)(2007-2#1)(2007-6#3)(2007-7#3)(2007-8#4)(2008-1#14)(2008-10#67)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#17)(2008-5#4)(2008-7#7)(2008-8#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#1)(2010-4#3)(2010-5#2)(2010-8#5)(2011-1#5)(2011-2#11)(2012-2#7)(2012-3#1)(2013-1#4)(2013-8#8)
urea)##5##1##(1992-5#2)(1994-9#1)(1995-12#1)(2008-10#1)
urea-N##2##1##(2012-2#2)
urea-denatured##5##1##(1995-3#2)(2009-7#2)(2011-1#1)
urea-functionalized##2##1##(2008-10#2)
urea-gradient gel electrophoresis##2##3##(2008-4#2)
urea-gradient gel##3##2##(2008-4#3)
urea-induced unfolding of trp aporepressor from Escherichia coli##2##8##(1990-7#1)(1994-8#1)
urea-induced unfolding of##3##3##(1990-7#1)(1993-6#1)(1994-8#1)
urea-induced unfolding##6##2##(1990-2#1)(1990-7#1)(1993-6#2)(1994-8#2)
urea-induced##7##1##(1990-2#1)(1990-7#1)(1993-6#2)(1994-8#2)(1995-5#1)
urea-rich cells##2##2##(1997-7#2)
ureafaciens##2##1##(1994-11#2)
urealyticum and##3##2##(1997-3#2)(2011-2#1)
urealyticum at##2##2##(2007-12#2)
urealyticum in semen of infertile##2##5##(2008-12#2)
urealyticum in##3##2##(2008-12#2)(2013-1#1)
urealyticum meningitis in a premature##2##5##(2007-12#2)
urealyticum was##2##2##(2007-12#1)(2008-12#1)
urealyticum##23##1##(1997-3#3)(2006-10#1)(2007-12#7)(2008-12#7)(2008-5#1)(2011-2#2)(2013-1#1)(2013-8#1)
ureaplasma##4##1##(2007-12#1)(2007-8#1)(2011-2#1)(2013-8#1)
ureas##6##1##(1996-8#3)(2008-1#1)(2013-1#2)
urease activity##2##2##(1990-2#1)(1992-7#1)
urease and##3##2##(2008-10#1)(2013-1#2)
urease enzyme##2##2##(2007-8#1)(2008-10#1)
urease has##2##2##(2008-10#1)(2013-1#1)
urease on the##2##3##(2008-10#2)
urease on##3##2##(2007-8#1)(2008-10#2)
urease reagent##2##2##(1991-12#2)
urease test##11##2##(1991-4#1)(1992-5#1)(1993-5#1)(2005-12#1)(2007-2#1)(2007-7#1)(2008-4#1)(2008-5#1)(2010-5#1)(2012-12#1)(2012-2#1)
urease##63##1##(1990-2#1)(1991-12#4)(1991-4#1)(1992-11#1)(1992-5#1)(1992-7#1)(1993-5#2)(1994-11#2)(1994-6#1)(1995-3#3)(1996-2#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-12#3)(2006-2#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#18)(2008-4#2)(2008-5#2)(2009-2#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-7#2)
ureases##4##1##(1996-2#1)(2013-1#3)
uredinia##11##1##(2008-10#11)
uredinial density and latent period##2##5##(2008-10#2)
uredinial density and##3##3##(2008-10#3)
uredinial density##4##2##(2008-10#4)
uredinial diameter##3##2##(2008-10#3)
uredinial##8##1##(2008-10#8)
urediniospore germination##4##2##(2008-10#4)
urediniospore##6##1##(2008-10#6)
urediniospores and##3##2##(2008-10#3)
urediniospores of##2##2##(2008-10#2)
urediniospores##12##1##(2008-10#12)
uredinium area##6##2##(2008-10#6)
uredinium size##2##2##(2008-10#2)
uredinium##8##1##(2008-10#8)
urediospore##2##1##(2008-10#2)
uredospore production##4##2##(2008-10#4)
ureide##2##1##(1997-8#2)
ureides##6##1##(1997-8#6)
uremia and##2##2##(1993-2#1)(2010-3#1)
uremia##15##1##(1990-11#1)(1990-4#1)(1990-5#1)(1993-2#1)(1994-9#1)(1997-4#1)(2006-10#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2010-12#1)(2010-3#1)(2011-2#1)
uremic children receiving##2##3##(1996-8#2)
uremic diabetic##2##2##(1991-6#1)(2008-1#1)
uremic environment##2##2##(2008-11#1)(2013-1#1)
uremic oxalosis##2##2##(2011-2#2)
uremic parathyroid hyperplasia##5##3##(2008-5#5)
uremic patients and##2##3##(2007-7#1)(2008-1#1)
uremic patients undergoing maintenance hemodialysis##2##5##(1995-2#1)(2009-2#1)
uremic patients##23##2##(1991-1#1)(1995-2#1)(1996-3#1)(2007-7#10)(2008-1#2)(2009-2#1)(2009-7#2)(2013-7#5)
uremic symptoms and##2##3##(2007-7#1)(2011-2#1)
uremic syndrome in##2##3##(2007-12#1)(2008-8#1)
uremic syndrome##12##2##(1996-3#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-4#1)(2008-8#1)(2011-12#1)(2011-2#1)(2013-1#2)
uremic toxins##2##2##(2013-8#2)
uremic##66##1##(1991-1#1)(1991-6#1)(1995-2#1)(1996-3#2)(1996-8#2)(2007-12#1)(2007-7#14)(2007-8#6)(2008-1#4)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#6)(2008-8#1)(2009-2#1)(2009-7#2)(2011-12#1)(2011-2#4)(2013-1#5)(2013-7#5)(2013-8#3)
ureolytic activity##2##2##(2013-1#2)
ureter and the##2##3##(2008-10#2)
ureter and##9##2##(1997-4#1)(2006-9#1)(2008-10#2)(2008-3#1)(2009-5#1)(2011-2#1)(2012-11#1)(2012-3#1)
ureter in##4##2##(2007-10#1)(2008-9#2)(2013-7#1)
ureter is##7##2##(1990-12#1)(2006-7#1)(2007-10#1)(2008-10#1)(2008-7#1)(2009-5#1)(2013-8#1)
ureter stones##2##2##(1990-12#2)
ureter was##3##2##(1996-3#1)(2007-6#1)(2008-1#1)
ureter with##2##2##(2006-9#1)(2013-8#1)
ureter##71##1##(1990-12#5)(1992-3#1)(1992-9#1)(1996-12#4)(1996-3#2)(1997-3#5)(1997-4#4)(2006-7#3)(2006-9#3)(2007-10#2)(2007-12#1)(2007-6#2)(2008-1#2)(2008-10#8)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#4)(2009-5#4)(2011-2#2)(2012-11#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#4)(2013-8#3)
ureter]##2##1##(1993-10#1)(2009-5#1)
ureteral arteries##2##2##(1997-4#2)
ureteral calculi##2##2##(1990-12#1)(1993-10#1)
ureteral obstruction secondary to##3##4##(2007-10#2)(2008-10#1)
ureteral obstruction##13##2##(1992-4#1)(1993-12#1)(1994-4#2)(2006-2#1)(2006-7#3)(2007-10#2)(2008-1#1)(2008-10#1)(2011-1#1)
ureteral reconstruction##2##2##(2013-8#2)
ureteral reimplantation##4##2##(2006-9#1)(2008-1#2)(2008-10#1)
ureteral strictures##5##2##(2013-1#3)(2013-8#2)
ureteral valves##2##2##(2008-10#2)
ureteral##67##1##(1990-11#1)(1990-12#1)(1991-11#1)(1991-6#1)(1992-4#1)(1993-10#1)(1993-12#1)(1994-4#2)(1997-4#6)(2006-2#1)(2006-7#7)(2006-8#1)(2006-9#2)(2007-10#2)(2007-2#1)(2007-7#2)(2008-1#4)(2008-10#8)(2008-7#3)(2009-1#1)(2010-11#1)(2011-1#2)(2013-1#8)(2013-8#9)
ureteric bud##2##2##(2008-10#2)
ureteric injury##4##2##(2008-8#2)(2010-3#1)(2013-1#1)
ureteric length##2##2##(2008-10#1)(2008-8#1)
ureteric obstruction and##2##3##(2008-10#1)(2008-3#1)
ureteric obstruction##7##2##(2004-10#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-3#1)
ureteric re-implantation##2##2##(2008-10#1)(2008-4#1)
ureteric stones##4##2##(1991-9#1)(2007-6#3)
ureteric stricture##5##2##(2009-5#1)(2013-1#4)
ureteric##39##1##(1991-9#1)(1997-3#2)(2004-10#1)(2006-10#1)(2007-6#3)(2008-1#3)(2008-10#14)(2008-3#1)(2008-4#1)(2008-8#4)(2009-5#2)(2010-3#1)(2013-1#5)
uretero-neocystostomy##2##1##(2008-1#2)
ureterocystoplasty##2##1##(2007-9#1)(2008-10#1)
ureteropelvic junction obstruction and##2##4##(2006-10#1)(2008-10#1)
ureteropelvic junction obstruction in##2##4##(2007-8#1)(2008-7#1)
ureteropelvic junction obstruction##10##3##(2006-10#1)(2007-10#1)(2007-8#1)(2008-10#5)(2008-7#2)
ureteropelvic junction##12##2##(2006-10#1)(2007-10#1)(2007-8#1)(2008-10#5)(2008-7#4)
ureterorenoscopic##2##1##(2007-6#1)(2012-12#1)
ureteroscopic##2##1##(2011-1#2)
ureteroscopy##7##1##(1993-10#2)(2006-9#1)(2007-10#1)(2011-1#1)(2011-2#2)
ureterosigmoidostomy##3##1##(1996-3#2)(2011-2#1)
ureterovesical##3##1##(1991-5#1)(2008-1#1)(2008-7#1)
ureters in##3##2##(1994-4#1)(1997-6#1)(2006-6#1)
ureters were##2##2##(1996-3#1)(2008-1#1)
ureters with##6##2##(2007-2#1)(2008-10#5)
ureters##28##1##(1994-4#1)(1996-12#3)(1996-3#1)(1997-6#5)(2006-6#1)(2006-8#1)(2007-2#1)(2007-4#1)(2008-1#4)(2008-10#7)(2008-3#1)(2011-2#1)(2012-11#1)
urethan##5##1##(1992-5#5)
urethane and##3##2##(1994-2#1)(2008-4#1)(2011-2#1)
urethane anesthetized##2##2##(1992-3#1)(1997-8#1)
urethane##18##1##(1992-3#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-2#1)(1994-5#2)(1996-2#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
urethane-anaesthetized##4##1##(1991-5#1)(1996-12#2)(1996-3#1)
urethane-anesthetized ovariectomized rats##2##3##(1997-3#1)(1997-5#1)
urethane-anesthetized rats##6##2##(1992-8#1)(1993-2#2)(1996-12#1)(1996-9#1)(1997-7#1)
urethane-anesthetized##10##1##(1991-5#1)(1992-8#1)(1993-2#2)(1996-12#1)(1996-9#1)(1997-3#1)(1997-5#2)(1997-7#1)
urethane-urea copolymers##3##2##(2008-3#3)
urethra and##8##2##(1997-8#1)(2008-10#3)(2012-2#1)(2013-1#2)(2013-8#1)
urethra as##2##2##(1996-11#1)(2012-3#1)
urethra by##2##2##(1997-7#2)
urethra in##5##2##(1994-3#1)(1996-11#1)(2008-10#2)(2009-5#1)
urethra is##2##2##(2008-10#1)(2013-8#1)
urethra to##3##2##(2013-1#2)(2013-8#1)
urethra was##2##2##(2008-10#2)
urethra with##2##2##(2006-1#1)(2008-10#1)
urethra##64##1##(1990-7#2)(1991-2#2)(1994-3#1)(1996-11#3)(1996-12#1)(1997-7#5)(1997-8#1)(2005-7#1)(2006-1#1)(2006-8#1)(2006-9#1)(2007-7#2)(2008-10#22)(2008-9#1)(2009-5#1)(2010-11#2)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#6)
urethra]##3##1##(1991-4#1)(2006-7#1)(2008-10#1)
urethral and##5##2##(2006-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-8#1)
urethral cases##3##2##(2008-10#3)
urethral catheter##5##2##(1990-11#2)(2008-10#1)(2011-1#1)(2013-1#1)
urethral catheterization##3##2##(2006-6#1)(2013-1#2)
urethral dilatation##2##2##(1991-4#2)
urethral discharge##4##2##(1992-12#1)(2007-7#2)(2007-8#1)
urethral dissection##2##2##(2008-10#2)
urethral diverticulum in a female##2##5##(2008-10#2)
urethral diverticulum##5##2##(2008-10#3)(2012-2#2)
urethral duplication##3##2##(2008-10#3)
urethral inflammation##4##2##(1990-7#4)
urethral injuries##3##2##(2011-1#1)(2013-8#2)
urethral injury##2##2##(2006-6#1)(2008-10#1)
urethral meatus##3##2##(1992-1#2)(2010-11#1)
urethral mucosa##2##2##(1990-7#1)(2007-7#1)
urethral obstruction and anesthetized with##2##5##(2013-1#2)
urethral obstruction##6##2##(2008-10#1)(2013-1#5)
urethral plate##7##2##(2008-10#2)(2009-5#5)
urethral plug##2##2##(1995-5#2)
urethral polyp##4##2##(2006-1#2)(2011-12#2)
urethral realignment##2##2##(2013-8#2)
urethral reconstruction##3##2##(2006-10#1)(2009-5#1)(2013-8#1)
urethral stricture##4##2##(1990-4#1)(1991-4#1)(2007-7#1)(2008-10#1)
urethral strictures##3##2##(1990-4#1)(2007-9#1)(2008-10#1)
urethral syndrome##2##2##(1992-1#1)(1992-9#1)
urethral valve##9##2##(2008-10#5)(2011-11#1)(2011-2#3)
urethral valves##11##2##(1991-11#1)(2006-10#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#6)
urethral##157##1##(1990-11#2)(1990-4#4)(1990-7#5)(1991-11#1)(1991-4#5)(1992-1#5)(1992-12#1)(1992-9#1)(1995-5#3)(1996-11#1)(2005-9#1)(2006-1#2)(2006-10#3)(2006-6#2)(2006-7#1)(2006-8#3)(2006-9#2)(2007-11#1)(2007-3#1)(2007-7#14)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#42)(2008-3#2)(2008-7#1)(2009-11#1)(2009-4#1)(2009-5#7)(2009-7#1)(2010-11#1)(2010-8#1)(2011-1#3)(2011-11#1)(2011-12#3)(2011-2#4)(2012-2#4)(2013-1#10)(2013-8#14)
urethritis and cervicitis##3##3##(2006-10#1)(2008-3#1)(2011-2#1)
urethritis and##9##2##(2006-10#2)(2008-10#1)(2008-3#1)(2011-2#2)(2012-2#1)(2013-1#2)
urethritis in##4##2##(2007-7#3)(2008-3#1)
urethritis or##2##2##(2006-10#1)(2011-2#1)
urethritis was##2##2##(2007-8#2)
urethritis##32##1##(1990-6#1)(1991-12#1)(1996-1#1)(2006-10#6)(2007-7#5)(2007-8#3)(2008-10#3)(2008-12#1)(2008-3#3)(2011-2#4)(2012-2#2)(2013-1#2)
urethrocutaneous fistula##2##2##(2009-10#2)
urethrocystoscopy##2##1##(2011-12#2)
urethrogenital##2##1##(1994-2#2)
urethroplasty in##2##2##(2007-7#2)
urethroplasty is##6##2##(2009-5#5)(2013-8#1)
urethroplasty or Snodgrass##2##3##(2008-10#1)(2009-5#1)
urethroplasty with##3##2##(2008-10#1)(2009-5#2)
urethroplasty##24##1##(1990-4#1)(2007-7#2)(2008-10#2)(2009-10#3)(2009-5#12)(2011-12#1)(2013-8#3)
urethroscopy##4##1##(1990-4#1)(2006-1#1)(2008-10#2)
urethrostomy##3##1##(2008-10#2)(2013-1#1)
urethrotomy##4##1##(1990-4#1)(1991-4#1)(2007-7#1)(2009-4#1)
urge for##2##2##(2006-4#1)(2008-1#1)
urge incontinence and##2##3##(1997-5#1)(2006-7#1)
urge incontinence##4##2##(1997-5#1)(2006-7#1)(2006-9#1)(2007-7#1)
urge to##6##2##(1991-6#1)(1992-6#1)(2006-7#2)(2007-2#1)(2007-7#1)
urge urinary incontinence (UUI)##2##4##(2007-8#1)(2011-1#1)
urge urinary incontinence##4##3##(2007-8#1)(2008-3#2)(2011-1#1)
urge us to##2##3##(1990-2#1)(2008-12#1)
urge##29##1##(1990-2#1)(1991-6#1)(1992-11#1)(1992-6#1)(1993-9#2)(1995-9#1)(1997-5#1)(1997-6#1)(2006-2#1)(2006-4#1)(2006-7#3)(2006-9#1)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-12#1)(2008-2#1)(2008-3#2)(2009-9#1)(2011-1#2)
urged the##2##2##(1991-7#1)(1996-6#1)
urged to provide##2##3##(1990-4#1)(2007-2#1)
urged to##9##2##(1990-4#1)(1990-9#1)(1991-6#1)(1995-2#1)(1995-5#1)(1996-2#1)(2007-2#1)(2007-4#1)(2008-11#1)
urged##20##1##(1990-4#1)(1990-9#1)(1991-6#1)(1991-7#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-2#1)(2007-4#1)(2008-11#1)(2008-8#1)(2010-12#1)
urgence##3##1##(2011-2#1)(2012-2#2)
urgency and##4##2##(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#1)
urgency in##2##2##(2008-10#1)(2008-11#1)
urgency of the##3##3##(2007-7#1)(2010-7#1)(2013-1#1)
urgency of##10##2##(1996-1#2)(2006-10#2)(2007-7#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
urgency to##2##2##(1997-1#1)(1997-8#1)
urgency##25##1##(1990-3#1)(1990-5#1)(1991-6#1)(1996-1#2)(1997-1#1)(1997-8#1)(2006-10#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
urgent and emergency##2##3##(2011-1#2)
urgent and##9##2##(1992-6#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-1#2)(2012-2#1)
urgent angiography +/- angioplasty##2##4##(1997-8#2)
urgent attention##3##2##(2006-10#1)(2008-11#1)(2010-4#1)
urgent care##5##2##(2007-2#1)(2010-8#1)(2012-2#1)(2013-1#2)
urgent cesarean section##3##3##(1993-4#2)(2008-4#1)
urgent clinical##2##2##(2008-3#1)(2012-12#1)
urgent diseases##2##2##(2008-7#1)(2013-8#1)
urgent endoscopic##2##2##(2006-6#2)
urgent for the##2##3##(1994-12#1)(2007-10#1)
urgent medical transportation by road##2##5##(2013-1#2)
urgent medical##3##2##(2007-9#1)(2013-1#2)
urgent need for new##2##4##(2008-11#1)(2010-12#1)
urgent need for##17##3##(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
urgent need of##3##3##(2007-8#1)(2008-11#1)(2008-5#1)
urgent need to##24##3##(1994-2#1)(1996-12#1)(2004-10#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-12#1)(2007-3#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-5#1)(2011-1#1)(2012-1#2)(2012-12#2)
urgent need##47##2##(1994-2#1)(1996-12#1)(2004-10#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#4)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#2)(2010-12#1)(2010-2#1)(2010-5#2)(2011-1#2)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#4)(2013-1#1)
urgent needs##2##2##(1990-12#1)(2008-10#1)
urgent requirement##3##2##(1992-2#1)(2008-11#1)(2008-7#1)
urgent surgery##6##2##(1993-10#1)(2006-10#1)(2006-4#1)(2007-8#1)(2008-4#1)(2013-1#1)
urgent surgical decompression##2##3##(2008-1#1)(2008-6#1)
urgent surgical##6##2##(2006-4#1)(2008-1#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)
urgent therapy##2##2##(2007-10#1)(2011-2#1)
urgent to implement##2##3##(2012-3#1)(2013-8#1)
urgent to##5##2##(2006-10#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
urgent##181##1##(1990-12#1)(1990-2#2)(1991-5#1)(1992-2#1)(1992-6#1)(1993-10#1)(1993-4#2)(1994-10#1)(1994-12#1)(1994-2#1)(1995-7#1)(1996-12#2)(1996-2#1)(1996-4#1)(1997-4#1)(1997-7#1)(1997-8#2)(2004-10#1)(2005-7#4)(2006-10#8)(2006-12#1)(2006-4#3)(2006-6#4)(2006-8#1)(2007-10#5)(2007-11#1)(2007-12#3)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#10)(2007-9#3)(2008-1#5)(2008-10#4)(2008-11#6)(2008-3#5)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#4)(2009-2#1)(2009-4#2)(2009-5#2)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#9)(2011-3#1)(2011-9#1)(2012-1#4)(2012-11#1)(2012-12#7)(2012-2#6)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#3)
urgently needed to provide##2##4##(2008-3#1)(2011-2#1)
urgently needed to##10##3##(2005-8#1)(2005-9#1)(2006-1#1)(2007-10#1)(2008-3#2)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
urgently needed##32##2##(1993-11#1)(1993-5#1)(1994-10#1)(1995-2#1)(1996-3#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-8#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#3)(2013-7#1)
urgently needs##2##2##(1996-12#1)(2007-7#1)
urgently required in##4##3##(2008-2#1)(2008-4#1)(2010-6#1)(2011-2#1)
urgently required##9##2##(1990-11#1)(1995-5#1)(2005-11#1)(2007-10#1)(2008-2#1)(2008-4#1)(2010-3#1)(2010-6#1)(2011-2#1)
urgently##60##1##(1990-11#1)(1991-3#2)(1993-11#1)(1993-5#1)(1994-10#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-3#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-10#3)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
urges us##2##2##(2006-8#1)(2008-5#1)
urges##18##1##(1990-7#1)(1991-11#1)(1991-9#1)(1992-1#1)(1994-2#1)(1995-1#1)(1995-5#1)(1996-5#1)(2005-10#1)(2006-8#1)(2007-2#1)(2007-9#2)(2008-5#1)(2008-6#1)(2009-10#1)(2012-3#1)(2013-7#1)
urging##6##1##(1990-5#1)(1996-11#1)(1996-12#1)(2007-9#1)(2011-1#1)(2011-12#1)
uric acid (UA) and##3##4##(1991-5#1)(2006-4#1)(2008-10#1)
uric acid (UA)##8##3##(1991-5#1)(2006-4#1)(2008-10#6)
uric acid and ascorbic acid##3##5##(2008-10#3)
uric acid and creatinine##4##4##(2008-10#3)(2010-4#1)
uric acid and##19##3##(1991-2#1)(1993-2#1)(2006-10#2)(2008-10#10)(2009-6#3)(2010-4#1)(2011-1#1)
uric acid biosensor##2##3##(2008-10#2)
uric acid by##5##3##(2007-2#1)(2008-10#3)(2011-2#1)
uric acid clearance##2##3##(2006-10#2)
uric acid concentration##3##3##(2008-10#2)(2010-4#1)
uric acid concentrations##3##3##(2008-5#1)(2010-4#2)
uric acid handling##2##3##(2006-10#2)
uric acid in the presence of##2##6##(1997-2#1)(2008-10#1)
uric acid in##11##3##(1997-2#2)(2007-2#1)(2008-10#7)(2013-1#1)
uric acid level##2##3##(1990-11#1)(2006-10#1)
uric acid levels and##2##4##(2011-1#2)
uric acid levels were higher in##2##6##(1995-12#1)(2011-1#1)
uric acid levels##9##3##(1995-12#1)(1996-9#1)(2008-7#2)(2011-1#5)
uric acid transport##2##3##(2011-2#2)
uric acid was##5##3##(1996-9#1)(2006-10#1)(2007-8#1)(2008-10#2)
uric acid were##6##3##(1990-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
uric acid##161##2##(1990-11#2)(1990-4#1)(1991-2#2)(1991-5#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-8#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-8#4)(2006-10#11)(2006-4#1)(2006-5#2)(2007-2#5)(2007-8#4)(2008-10#59)(2008-3#3)(2008-4#3)(2008-5#9)(2008-7#4)(2009-6#5)(2010-4#7)(2011-1#8)(2011-2#6)(2012-12#2)(2012-2#3)(2013-1#7)
uric##170##1##(1990-11#2)(1990-4#1)(1991-2#2)(1991-5#1)(1992-2#2)(1993-12#1)(1993-2#1)(1993-8#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-8#4)(2006-10#11)(2006-4#1)(2006-5#2)(2007-2#6)(2007-8#5)(2008-10#64)(2008-3#3)(2008-4#3)(2008-5#9)(2008-7#4)(2009-6#5)(2010-4#7)(2011-1#8)(2011-2#6)(2012-12#2)(2012-2#3)(2013-1#7)(2013-7#1)
uricase##16##1##(1990-11#6)(1992-4#1)(1992-8#4)(1995-3#1)(1997-2#1)(2008-10#3)
uridine (U)##3##2##(1991-4#1)(2008-11#1)(2010-11#1)
uridine and##4##2##(1992-12#1)(2006-12#1)(2008-4#1)(2010-2#1)
uridine at##2##2##(1990-7#1)(1995-8#1)
uridine diphosphate galactose##2##3##(1995-3#1)(1995-8#1)
uridine diphosphate##5##2##(1995-3#2)(1995-8#2)(2008-5#1)
uridine in##4##2##(1992-11#1)(1996-6#2)(2006-11#1)
uridine incorporation##2##2##(1990-7#1)(1992-11#1)
uridine monophosphate synthase##2##3##(1993-2#1)(1995-8#1)
uridine monophosphate##4##2##(1993-2#1)(1995-8#2)(2007-11#1)
uridine phosphorylase (UrdPase##2##3##(1996-6#2)
uridine phosphorylase from##2##3##(1996-6#1)(2005-11#1)
uridine phosphorylase##5##2##(1996-6#4)(2005-11#1)
uridine released from##2##3##(1996-6#2)
uridine residues##4##2##(1995-3#1)(1997-5#1)(2008-4#2)
uridine transport##7##2##(1995-10#2)(1995-8#5)
uridine was##2##2##(2005-11#2)
uridine with##3##2##(1993-8#1)(1996-6#1)(2008-4#1)
uridine##100##1##(1990-5#1)(1990-7#2)(1991-1#1)(1991-3#1)(1991-4#2)(1992-11#3)(1992-12#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#2)(1993-9#1)(1994-3#1)(1994-6#2)(1995-10#2)(1995-3#5)(1995-6#1)(1995-8#10)(1996-5#1)(1996-6#27)(1996-8#1)(1997-2#1)(1997-5#1)(1997-8#2)(2005-11#6)(2006-11#2)(2006-12#1)(2006-3#1)(2007-11#1)(2008-11#1)(2008-4#10)(2008-5#1)(2008-9#2)(2010-11#1)(2010-2#1)(2011-1#1)(2012-3#1)
uridine-5'-monophosphate##2##1##(1996-5#1)(2013-7#1)
uridines##2##1##(1991-8#1)(1996-6#1)
uridyl##2##1##(1993-11#1)(1996-7#1)
uridylate##4##1##(1990-5#2)(1996-8#2)
urinalysis is##3##2##(1993-2#2)(2006-10#1)
urinalysis was##2##2##(2008-10#1)(2010-8#1)
urinalysis##17##1##(1993-2#4)(1996-1#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#1)(2009-6#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-8#1)
urinary 1-hydroxypyrene##2##2##(1992-3#2)
urinary 5-methyl-2'-deoxycytidine##2##2##(1995-1#2)
urinary 8OHdG##3##2##(2008-10#3)
urinary Bence Jones protein (BJP-DIA)##2##5##(1992-3#2)
urinary CEA##3##2##(2008-2#3)
urinary Cd##3##2##(1997-4#3)
urinary Co##2##2##(1994-6#2)
urinary Gla##3##2##(1991-12#3)
urinary Hg expressed as microgram##2##5##(1993-8#2)
urinary Hg level##2##3##(1993-8#2)
urinary Hg##5##2##(1993-8#5)
urinary LH surge##2##3##(1992-1#1)(1995-12#1)
urinary LH testing##2##3##(1992-1#2)
urinary LH##5##2##(1992-1#4)(1995-12#1)
urinary NAG##3##2##(1990-11#2)(1997-8#1)
urinary abnormalities##3##2##(2007-7#1)(2012-2#1)(2013-8#1)
urinary albumin excretion and##2##4##(2008-1#1)(2008-3#1)
urinary albumin excretion in clinical##2##5##(2013-1#2)
urinary albumin excretion rate##2##4##(2011-1#1)(2012-1#1)
urinary albumin excretion##8##3##(2006-1#1)(2008-1#1)(2008-3#1)(2011-1#1)(2012-1#1)(2013-1#3)
urinary albumin##11##2##(1994-6#1)(2006-1#1)(2008-1#1)(2008-3#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#4)
urinary alkalinization##2##2##(2007-7#1)(2008-3#1)
urinary aluminum excretion with and without DFO treatment) were##2##9##(1992-11#2)
urinary amino acid##2##3##(1995-2#1)(1997-4#1)
urinary and fecal##3##3##(1994-5#1)(1996-12#1)(2011-2#1)
urinary and reproductive##2##3##(1992-12#1)(2009-7#1)
urinary and##11##2##(1992-12#1)(1994-5#1)(1996-12#2)(2006-4#1)(2008-10#1)(2009-12#1)(2009-7#1)(2011-12#1)(2011-2#2)
urinary apo(a)##5##2##(1997-2#5)
urinary arsenic##3##2##(1995-11#2)(2008-10#1)
urinary biomarkers##3##2##(2010-2#1)(2012-1#1)(2013-7#1)
urinary bladder and##11##3##(1991-5#1)(1992-8#1)(1993-3#1)(1996-11#3)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-7#1)
urinary bladder cancer in##2##4##(2007-11#1)(2011-2#1)
urinary bladder cancer##14##3##(1990-12#1)(1992-11#1)(1995-12#2)(2006-10#2)(2007-11#1)(2007-7#1)(2008-4#1)(2011-2#3)(2012-2#1)(2013-1#1)
urinary bladder carcinoma##2##3##(1990-12#1)(2008-2#1)
urinary bladder distension##2##3##(1992-2#2)
urinary bladder from##2##3##(1997-5#2)
urinary bladder in##3##3##(1991-5#1)(1994-4#1)(1997-2#1)
urinary bladder tumour##2##3##(2012-12#2)
urinary bladder were##2##3##(1992-12#1)(1993-9#1)
urinary bladder##117##2##(1990-12#2)(1990-7#2)(1991-12#2)(1991-4#1)(1991-5#2)(1991-6#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#3)(1992-4#1)(1992-8#4)(1993-2#2)(1993-3#2)(1993-7#1)(1993-9#2)(1994-4#1)(1994-8#1)(1995-12#2)(1995-5#1)(1996-11#3)(1996-12#1)(1996-8#1)(1997-2#2)(1997-5#4)(2004-2#1)(2006-10#2)(2006-7#1)(2006-9#1)(2007-11#4)(2007-3#1)(2007-4#2)(2007-7#3)(2008-10#3)(2008-12#1)(2008-2#2)(2008-4#2)(2008-7#4)(2008-9#3)(2009-2#2)(2009-4#1)(2009-5#2)(2009-7#4)(2010-8#1)(2011-2#9)(2012-1#3)(2012-12#6)(2012-2#6)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
urinary calcium excretion##6##3##(1990-2#1)(1992-10#1)(2007-9#4)
urinary calcium##7##2##(1990-2#1)(1992-10#1)(1992-8#1)(2007-9#4)
urinary calculi##7##2##(2006-9#1)(2007-10#1)(2008-1#2)(2008-10#1)(2010-12#1)(2010-2#1)
urinary catecholamine##2##2##(2006-9#1)(2011-2#1)
urinary catheter##2##2##(1996-12#1)(2010-11#1)
urinary catheters##4##2##(1996-12#3)(2011-2#1)
urinary cobalt concentrations##2##3##(1994-6#2)
urinary cobalt##7##2##(1994-6#6)(2008-10#1)
urinary collagen##2##2##(1994-12#1)(2006-10#1)
urinary column##4##2##(2006-7#4)
urinary complications##2##2##(1995-9#1)(2008-1#1)
urinary concentration of##3##3##(1991-5#1)(2010-4#2)
urinary concentrations of##7##3##(1990-4#1)(1995-6#1)(1996-6#1)(2007-3#3)(2010-4#1)
urinary content of##2##3##(1997-8#1)(2012-3#1)
urinary cortisol##3##2##(1990-5#1)(2012-12#2)
urinary creatinine##5##2##(1996-9#1)(1997-8#1)(2006-10#1)(2008-10#1)(2009-6#1)
urinary cytokine levels##3##3##(1996-12#3)
urinary derivation##4##2##(1990-9#2)(2012-1#2)
urinary disturbance##2##2##(2006-6#1)(2008-7#1)
urinary diversion##4##2##(1991-11#1)(2008-10#3)
urinary dolichol##3##2##(1991-12#3)
urinary dolichols##6##2##(1991-12#6)
urinary dysfunction##3##2##(2006-10#1)(2008-7#2)
urinary endotoxin##3##2##(1996-1#1)(1996-12#2)
urinary excretion of adenosine-deaminase-binding protein##2##5##(1991-8#2)
urinary excretion of adrenaline##2##4##(1990-7#1)(2007-4#1)
urinary excretion of cobalt##2##4##(1994-6#2)
urinary excretion of##38##3##(1990-4#2)(1990-5#1)(1990-7#2)(1991-1#1)(1991-12#1)(1991-8#2)(1992-1#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-2#1)(1994-5#4)(1994-6#2)(1995-11#7)(1995-3#1)(1995-4#2)(1995-6#1)(1996-11#1)(2007-4#2)(2008-7#1)(2009-6#1)(2012-2#1)
urinary excretion##47##2##(1990-4#2)(1990-5#1)(1990-7#2)(1991-1#1)(1991-12#1)(1991-8#2)(1992-1#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-5#4)(1994-6#3)(1995-11#7)(1995-3#1)(1995-4#2)(1995-6#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-8#1)(2007-4#2)(2008-7#1)(2009-11#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
urinary excretions of##3##3##(1993-12#1)(2007-3#1)(2008-7#1)
urinary flow##4##2##(1990-10#1)(2008-10#3)
urinary free##4##2##(1990-8#2)(2006-1#1)(2011-2#1)
urinary frequency##2##2##(2006-10#1)(2008-3#1)
urinary gamma-carboxyglutamic acid##2##3##(1991-12#2)
urinary glycosaminoglycan##2##2##(1992-5#1)(1993-11#1)
urinary glycosaminoglycans##2##2##(1996-7#1)(2011-2#1)
urinary guanidinoacetic acid excretion##4##4##(1992-7#4)
urinary incontinence (SUI)##6##3##(2007-8#1)(2008-3#1)(2008-8#1)(2011-1#2)(2011-2#1)
urinary incontinence (UI) and##2##4##(2010-10#1)(2011-1#1)
urinary incontinence (UI)##5##3##(1994-5#1)(2010-10#1)(2011-1#2)(2011-2#1)
urinary incontinence after##2##3##(2011-2#1)(2012-3#1)
urinary incontinence and##3##3##(1992-8#1)(2008-3#1)(2013-1#1)
urinary incontinence are##2##3##(2007-8#2)
urinary incontinence in elderly##2##4##(1994-5#1)(2011-1#1)
urinary incontinence in patients with##2##5##(2008-10#2)
urinary incontinence in##11##3##(1992-2#1)(1994-5#1)(2006-7#1)(2008-10#4)(2011-1#1)(2012-3#1)(2013-1#2)
urinary incontinence is##2##3##(2008-4#1)(2013-1#1)
urinary incontinence##80##2##(1990-4#1)(1991-3#1)(1992-2#1)(1992-8#1)(1994-5#5)(1994-7#1)(1996-2#2)(2005-9#1)(2006-10#4)(2006-12#1)(2006-7#5)(2006-9#10)(2007-10#1)(2007-4#2)(2007-8#5)(2008-10#6)(2008-3#5)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#3)(2009-4#1)(2010-10#1)(2011-1#8)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
urinary incontinence]##2##2##(1990-4#1)(1997-2#1)
urinary infection##10##2##(1996-3#1)(2006-12#1)(2007-12#4)(2007-3#1)(2008-10#1)(2010-4#1)(2011-1#1)
urinary infections##6##2##(1990-3#1)(1992-12#1)(2006-10#2)(2008-10#2)
urinary intervention##2##2##(2007-8#2)
urinary iodine excretion##5##3##(2006-10#1)(2011-1#4)
urinary iodine levels of##2##4##(2007-4#1)(2012-2#1)
urinary iodine was##2##3##(2006-4#2)
urinary iodine##9##2##(2006-10#1)(2006-4#2)(2007-4#1)(2011-1#4)(2012-2#1)
urinary isolates##5##2##(2007-7#2)(2008-10#1)(2008-4#1)(2009-5#1)
urinary lead##2##2##(2008-10#2)
urinary leak##3##2##(2008-1#1)(2008-10#1)(2012-3#1)
urinary level##2##2##(1995-1#1)(2012-2#1)
urinary levels of##8##3##(1990-4#1)(1991-7#1)(1993-11#1)(1993-12#1)(1995-1#1)(1995-4#1)(2004-12#1)(2009-9#1)
urinary losses##2##2##(2006-6#1)(2008-10#1)
urinary markers##4##2##(1993-2#1)(1996-12#1)(1996-9#1)(2007-3#1)
urinary mercury##2##2##(1993-8#1)(1995-3#1)
urinary metabolite##2##2##(1990-3#1)(1991-8#1)
urinary metabolites##5##2##(1990-11#1)(1990-8#1)(1991-5#1)(2010-5#1)(2013-7#1)
urinary modified nucleosides##3##3##(1993-9#2)(1996-11#1)
urinary mutagenicity##4##2##(1993-9#4)
urinary neopterin##4##2##(2007-2#2)(2008-10#2)
urinary nitrite and citrulline levels##2##5##(2008-7#2)
urinary nucleoside levels##2##3##(1993-9#2)
urinary nucleosides##4##2##(1990-8#1)(1996-11#1)(1997-2#2)
urinary obstruction##3##2##(1990-3#1)(2008-1#2)
urinary oligosaccharide patterns##2##3##(1993-11#2)
urinary oncopterin##2##2##(1997-3#2)
urinary or##2##2##(1997-3#1)(2010-4#1)
urinary organic##2##2##(1992-1#1)(1996-6#1)
urinary output##5##2##(1994-9#1)(2007-1#2)(2007-10#1)(2013-1#1)
urinary oxalate##3##2##(1990-10#1)(2007-8#1)(2008-10#1)
urinary phenol##2##2##(1994-10#2)
urinary problems in##2##3##(2008-7#1)(2010-8#1)
urinary protein and##2##3##(1997-8#1)(2008-1#1)
urinary protein excretion##5##3##(1993-12#1)(1997-8#1)(2007-7#1)(2007-8#2)
urinary protein##10##2##(1991-9#1)(1993-12#1)(1997-8#2)(2006-4#1)(2007-7#1)(2007-8#2)(2008-1#1)(2013-8#1)
urinary protein/osmolality ratio##3##3##(2008-5#3)
urinary protein/osmolality##4##2##(2008-5#4)
urinary proteins##5##2##(1990-12#1)(2007-11#3)(2013-8#1)
urinary pseudouridine and 1-methyladenosine##3##4##(1992-3#3)
urinary retention##8##2##(1993-9#1)(2006-10#1)(2007-7#1)(2008-10#2)(2009-4#1)(2009-5#1)(2013-8#1)
urinary sample##3##2##(2008-10#2)(2011-2#1)
urinary samples##3##2##(1995-2#1)(2013-1#2)
urinary schistosomiasis only##2##3##(1996-12#2)
urinary schistosomiasis##14##2##(1996-12#6)(2007-2#5)(2007-6#1)(2007-7#1)(2008-10#1)
urinary sediment##4##2##(1997-7#2)(2008-1#1)(2013-8#1)
urinary sodium##2##2##(2008-4#1)(2011-2#1)
urinary steroid##3##2##(1994-10#1)(1995-4#2)
urinary stone protein##4##3##(1992-4#3)(1993-6#1)
urinary stone##8##2##(1992-4#3)(1993-6#1)(1995-7#1)(2006-10#1)(2007-8#1)(2008-4#1)
urinary stones##3##2##(1993-6#1)(2011-2#2)
urinary stress incontinence##5##3##(1994-3#1)(1995-5#1)(1996-12#1)(2007-12#1)(2008-1#1)
urinary stress##6##2##(1994-3#1)(1995-5#2)(1996-12#1)(2007-12#1)(2008-1#1)
urinary symptoms##7##2##(2004-10#2)(2007-10#1)(2007-12#1)(2008-12#1)(2012-12#1)(2012-3#1)
urinary system##3##2##(1992-1#1)(2007-8#1)(2011-2#1)
urinary taurine##6##2##(1997-3#6)
urinary thioether##2##2##(2013-1#2)
urinary total##6##2##(1993-1#1)(2008-5#5)
urinary tract and##4##3##(1992-9#1)(1996-12#1)(2008-10#1)(2013-1#1)
urinary tract can be##2##4##(1991-9#1)(1992-9#1)
urinary tract caused by##2##4##(2006-6#1)(2007-11#1)
urinary tract have##2##3##(2006-10#1)(2008-8#1)
urinary tract in##3##3##(1990-11#1)(2006-9#1)(2008-9#1)
urinary tract infection (UTI)##9##4##(2006-10#1)(2007-7#1)(2008-1#1)(2008-6#1)(2009-1#1)(2009-5#2)(2011-2#2)
urinary tract infection and##6##4##(2006-10#1)(2006-2#1)(2008-10#1)(2008-4#3)
urinary tract infection by##3##4##(2006-10#1)(2008-1#1)(2011-2#1)
urinary tract infection in##4##4##(2007-12#1)(2007-8#1)(2008-1#1)(2011-2#1)
urinary tract infection was##2##4##(1993-1#1)(2007-8#1)
urinary tract infection with##2##4##(2008-10#1)(2009-5#1)
urinary tract infection##67##3##(1990-11#1)(1993-1#2)(1994-2#1)(1996-1#1)(1996-12#2)(1996-8#1)(2005-10#1)(2005-8#1)(2006-10#7)(2006-2#1)(2006-9#3)(2007-12#4)(2007-7#5)(2007-8#3)(2008-1#4)(2008-10#3)(2008-4#4)(2008-6#2)(2008-7#2)(2009-1#1)(2009-5#4)(2009-6#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#1)
urinary tract infections (UTIs) are##2##5##(2005-8#1)(2008-6#1)
urinary tract infections (UTIs)##7##4##(2005-8#1)(2007-12#1)(2008-10#1)(2008-6#1)(2010-11#1)(2012-12#1)(2013-1#1)
urinary tract infections and##9##4##(1991-12#1)(1995-5#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
urinary tract infections in##9##4##(1992-9#1)(1993-1#1)(1993-2#1)(1996-12#1)(2006-9#1)(2007-10#2)(2007-12#1)(2007-7#1)
urinary tract infections##59##3##(1991-12#3)(1992-12#1)(1992-9#1)(1993-1#1)(1993-2#2)(1995-5#1)(1996-12#1)(1997-4#2)(2005-8#1)(2005-9#1)(2006-10#2)(2006-6#1)(2006-9#1)(2007-10#2)(2007-12#2)(2007-4#1)(2007-7#3)(2007-8#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-6#2)(2009-5#1)(2010-11#3)(2010-3#1)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#3)
urinary tract infections]##3##3##(1993-11#1)(1997-5#1)(2013-8#1)
urinary tract is##2##3##(2008-10#1)(2012-12#1)
urinary tract neoplasms##2##3##(1991-5#1)(1992-12#1)
urinary tract pathogens##2##3##(2010-3#1)(2013-1#1)
urinary tract symptoms and##3##4##(2006-9#1)(2008-6#1)(2013-8#1)
urinary tract symptoms##11##3##(2006-9#5)(2008-1#1)(2008-10#1)(2008-6#2)(2013-1#1)(2013-8#1)
urinary tract##226##2##(1990-11#3)(1990-8#2)(1991-11#1)(1991-12#4)(1991-5#3)(1991-9#1)(1992-12#5)(1992-3#1)(1992-6#1)(1992-9#4)(1993-1#3)(1993-11#1)(1993-2#2)(1994-2#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#6)(1996-8#1)(1997-2#1)(1997-4#3)(1997-5#1)(2005-10#1)(2005-8#3)(2005-9#1)(2006-10#13)(2006-12#1)(2006-2#1)(2006-6#3)(2006-7#1)(2006-9#12)(2007-10#3)(2007-11#1)(2007-12#7)(2007-4#1)(2007-5#2)(2007-7#11)(2007-8#5)(2008-1#8)(2008-10#17)(2008-11#1)(2008-4#4)(2008-5#1)(2008-6#6)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#2)(2009-5#6)(2009-6#2)(2009-8#1)(2010-11#4)(2010-2#3)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#13)(2012-11#1)(2012-12#5)(2012-2#7)(2012-3#2)(2013-1#10)(2013-8#8)
urinary tracts##7##2##(1991-11#2)(2006-7#3)(2007-9#2)
urinary trypsin inhibitory activity##2##4##(1993-11#2)
urinary trypsin##3##2##(1993-11#2)(1994-3#1)
urinary uric acid##3##3##(1997-2#1)(2006-10#2)
urinary volume of##2##3##(1993-2#1)(2007-7#1)
urinary##1073##1##(1990-10#2)(1990-11#8)(1990-12#7)(1990-2#3)(1990-3#4)(1990-4#8)(1990-5#2)(1990-7#5)(1990-8#9)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#5)(1991-12#21)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#9)(1991-6#1)(1991-7#1)(1991-8#5)(1991-9#3)(1992-1#10)(1992-10#2)(1992-11#4)(1992-12#10)(1992-2#3)(1992-3#11)(1992-4#5)(1992-5#1)(1992-6#1)(1992-7#5)(1992-8#9)(1992-9#4)(1993-1#5)(1993-11#12)(1993-12#8)(1993-2#9)(1993-3#3)(1993-6#2)(1993-7#3)(1993-8#8)(1993-9#14)(1994-10#3)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#2)(1994-5#11)(1994-6#12)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#5)(1995-11#10)(1995-12#4)(1995-2#2)(1995-3#3)(1995-4#8)(1995-5#4)(1995-6#2)(1995-7#4)(1995-9#3)(1996-1#4)(1996-11#6)(1996-12#30)(1996-2#2)(1996-3#6)(1996-5#1)(1996-6#2)(1996-7#3)(1996-8#7)(1996-9#4)(1997-2#14)(1997-3#11)(1997-4#7)(1997-5#7)(1997-7#2)(1997-8#9)(2004-10#3)(2004-12#2)(2004-2#2)(2005-10#3)(2005-12#1)(2005-8#3)(2005-9#2)(2006-1#2)(2006-10#33)(2006-12#3)(2006-2#1)(2006-4#4)(2006-6#5)(2006-7#17)(2006-9#28)(2007-1#2)(2007-10#7)(2007-11#11)(2007-12#14)(2007-2#9)(2007-3#8)(2007-4#10)(2007-5#2)(2007-6#1)(2007-7#25)(2007-8#23)(2007-9#6)(2008-1#22)(2008-10#71)(2008-11#1)(2008-12#2)(2008-2#6)(2008-3#8)(2008-4#10)(2008-5#19)(2008-6#6)(2008-7#18)(2008-8#2)(2008-9#4)(2009-1#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#7)(2009-4#3)(2009-5#13)(2009-6#8)(2009-7#5)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#6)(2010-12#3)(2010-2#6)(2010-3#2)(2010-4#7)(2010-5#3)(2010-7#1)(2010-8#3)(2011-1#17)(2011-12#3)(2011-2#41)(2012-1#8)(2012-11#2)(2012-12#17)(2012-2#23)(2012-3#10)(2013-1#30)(2013-7#3)(2013-8#20)
urinary-tract infection##2##2##(1995-9#2)
urinary-tract##5##1##(1991-11#1)(1992-9#2)(1995-9#2)
urinary-type plasminogen activator##4##3##(1990-11#4)
urination##6##1##(1990-10#1)(2006-7#2)(2008-6#1)(2012-2#1)(2013-1#1)
urine (MSU)##2##2##(2007-10#1)(2010-8#1)
urine (p = 0##2##4##(2008-7#2)
urine CEA##2##2##(2008-2#2)
urine DPD##3##2##(2008-10#3)
urine after a##2##3##(1996-8#1)(2008-10#1)
urine after##13##2##(1990-8#1)(1990-9#1)(1993-2#3)(1996-8#2)(2008-10#4)(2008-11#1)(2009-2#1)
urine analysis and##2##3##(2007-11#1)(2007-9#1)
urine analysis##7##2##(1991-12#1)(1993-8#1)(1996-12#1)(2006-12#1)(2007-11#1)(2007-7#1)(2007-9#1)
urine analytes##3##2##(2008-10#3)
urine and bladder washings##2##4##(2007-9#2)
urine and blood##3##3##(1993-12#1)(1994-6#1)(2008-10#1)
urine and detergents##2##3##(2008-10#2)
urine and faeces##2##3##(1990-12#1)(2010-8#1)
urine and feces##5##3##(1990-11#1)(2006-12#1)(2010-11#2)(2010-12#1)
urine and hair samples##3##4##(2008-10#3)
urine and hair specimens##3##4##(2007-8#3)
urine and hair##6##3##(2007-8#3)(2008-10#3)
urine and increase##2##3##(1990-12#2)
urine and pharmaceuticals##3##3##(2008-10#3)
urine and plasma##12##3##(1990-11#1)(1990-3#2)(1990-6#1)(1993-2#1)(1996-5#2)(1997-3#3)(2008-10#1)(2010-11#1)
urine and saliva of##2##4##(2008-10#1)(2008-12#1)
urine and saliva##3##3##(2008-10#2)(2008-12#1)
urine and serum by##2##4##(1990-8#1)(2008-10#1)
urine and serum of##2##4##(1992-8#1)(2012-3#1)
urine and serum samples##5##4##(2008-10#4)(2010-5#1)
urine and serum##29##3##(1990-2#2)(1990-8#2)(1992-8#2)(1995-8#1)(1996-5#1)(2005-4#1)(2008-10#17)(2008-2#1)(2010-5#1)(2012-3#1)
urine and##114##2##(1990-11#4)(1990-12#3)(1990-2#2)(1990-3#2)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#3)(1991-9#1)(1992-11#1)(1992-2#1)(1992-8#2)(1993-11#1)(1993-12#3)(1993-2#1)(1994-10#1)(1994-5#1)(1994-6#2)(1995-3#1)(1995-8#1)(1996-1#1)(1996-5#4)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#3)(2005-11#1)(2005-4#1)(2006-12#1)(2006-8#1)(2007-2#1)(2007-8#3)(2007-9#2)(2008-10#44)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-11#3)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
urine as a##2##3##(2004-11#1)(2008-10#1)
urine as an##2##3##(1992-3#1)(2006-10#1)
urine as##9##2##(1990-12#1)(1992-3#1)(1996-8#1)(2004-11#1)(2006-10#1)(2008-10#2)(2011-2#1)(2013-8#1)
urine based on the##2##4##(1990-12#1)(2008-10#1)
urine based on##3##3##(1990-12#1)(2008-10#1)(2010-5#1)
urine based##4##2##(1990-12#1)(2008-10#1)(2010-10#1)(2010-5#1)
urine but##2##2##(1990-12#1)(2012-11#1)
urine by HPLC##2##3##(1993-11#1)(1994-8#1)
urine by a##3##3##(1993-9#1)(1996-12#1)(2008-10#1)
urine by capillary##7##3##(1993-2#1)(1994-9#1)(1996-5#2)(1996-6#1)(2007-8#2)
urine by electrothermal atomic absorption spectrometry##2##6##(2008-10#2)
urine by electrothermal##3##3##(2007-11#1)(2008-10#2)
urine by fibrin/Celite##2##3##(1990-12#2)
urine by gas##3##3##(1990-6#1)(1996-6#1)(1996-8#1)
urine by high performance liquid chromatography##2##6##(2008-10#2)
urine by high performance liquid##4##5##(2008-10#3)(2011-1#1)
urine by high-performance liquid chromatography with##5##6##(1990-11#1)(1990-6#1)(1990-8#1)(1992-2#1)(1996-8#1)
urine by high-performance liquid chromatography##15##5##(1990-11#3)(1990-12#2)(1990-6#3)(1990-8#2)(1992-2#1)(1993-2#1)(1996-8#1)(1997-3#1)(1997-8#1)
urine by liquid chromatography##2##4##(1992-2#1)(1997-3#1)
urine by liquid##4##3##(1992-2#1)(1997-3#1)(2007-8#1)(2008-10#1)
urine by reversed-phase##2##3##(1996-8#1)(2008-11#1)
urine by the##2##3##(2008-10#1)(2008-7#1)
urine by##86##2##(1990-11#4)(1990-12#5)(1990-6#4)(1990-8#3)(1992-11#2)(1992-2#2)(1993-11#1)(1993-2#2)(1993-9#3)(1994-8#1)(1994-9#1)(1995-12#1)(1996-12#3)(1996-5#3)(1996-6#2)(1996-8#4)(1997-3#2)(1997-6#1)(1997-8#1)(2005-12#2)(2006-10#1)(2007-11#1)(2007-2#1)(2007-8#5)(2008-10#23)(2008-11#1)(2008-2#1)(2008-7#1)(2010-4#1)(2011-1#2)(2013-1#2)
urine calcium and##2##3##(1990-10#1)(2013-8#1)
urine calcium##3##2##(1990-10#1)(2007-9#1)(2013-8#1)
urine chemistry analyser##3##3##(2007-10#3)
urine collection##8##2##(1992-2#3)(2005-7#1)(2006-10#1)(2007-12#1)(2008-10#1)(2011-1#1)
urine collections##5##2##(1990-10#1)(1990-11#1)(1995-12#1)(2011-2#1)(2013-1#1)
urine concentration##2##2##(1996-12#1)(2012-2#1)
urine concentrations##4##2##(1991-12#1)(1992-8#1)(1994-6#1)(2011-12#1)
urine could be##3##3##(1990-8#1)(1992-2#1)(2013-8#1)
urine creatinine##5##2##(1990-11#1)(1997-8#4)
urine culture and susceptibility##2##4##(2010-8#1)(2011-2#1)
urine culture##14##2##(1996-1#1)(2006-8#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-5#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-3#1)
urine cultures##10##2##(1996-1#1)(2007-10#1)(2007-12#2)(2007-7#2)(2008-4#2)(2008-5#1)(2009-1#1)
urine cytology in##2##3##(2007-7#1)(2013-8#1)
urine cytology##6##2##(2007-4#1)(2007-7#1)(2008-10#1)(2012-2#1)(2013-8#2)
urine derivation##2##2##(2011-2#2)
urine drug screens##3##3##(2006-7#3)
urine drug##6##2##(2006-7#3)(2006-8#2)(2008-7#1)
urine during##3##2##(1990-3#1)(2004-12#1)(2008-10#1)
urine examination##2##2##(1990-9#1)(2011-1#1)
urine flow rate##2##3##(1993-4#2)
urine flow##7##2##(1993-4#2)(1995-12#1)(1995-2#2)(1995-5#1)(1997-8#1)
urine following##2##2##(1993-2#1)(1996-8#1)
urine for##13##2##(1996-3#7)(1996-8#1)(1997-3#1)(2007-4#1)(2008-10#2)(2008-7#1)
urine from a patient with##3##5##(1993-11#2)(1997-3#1)
urine from patients with##3##4##(1993-11#1)(1993-9#1)(2008-10#1)
urine from##23##2##(1990-6#1)(1991-9#2)(1992-1#2)(1993-11#3)(1993-2#2)(1993-9#1)(1995-11#1)(1995-7#1)(1997-3#3)(2004-11#4)(2008-10#1)(2010-2#1)(2012-3#1)
urine glucose##2##2##(1991-12#1)(2008-7#1)
urine has been developed and##2##5##(1994-6#1)(2007-8#1)
urine has been developed##9##4##(1990-1#1)(1993-2#1)(1994-6#1)(2007-8#1)(2008-10#5)
urine has been##10##3##(1990-1#1)(1993-2#1)(1994-6#1)(2007-8#1)(2008-10#6)
urine have##2##2##(1994-12#1)(2008-10#1)
urine in the##5##3##(1991-11#1)(1994-6#1)(2004-11#2)(2008-12#1)
urine in##15##2##(1990-12#1)(1991-11#1)(1993-2#1)(1994-6#1)(1994-9#1)(2004-11#2)(2008-1#1)(2008-10#2)(2008-12#1)(2009-2#1)(2009-9#1)(2012-12#1)(2012-3#1)
urine is also##2##3##(1996-8#2)
urine is described##5##3##(1990-12#1)(1994-6#1)(1996-8#1)(1997-3#1)(2008-10#1)
urine is reported##2##3##(1990-8#1)(2008-10#1)
urine is##23##2##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-12#1)(1993-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-8#4)(1997-3#1)(2008-10#5)(2009-6#1)(2009-7#1)(2011-2#1)
urine leak##2##2##(2008-1#1)(2012-12#1)
urine levels##2##2##(1993-2#1)(2008-10#1)
urine matrix##5##2##(2007-8#1)(2008-10#4)
urine measurements##2##2##(1994-6#1)(2011-2#1)
urine media##3##2##(2008-10#3)
urine nitrite and citrulline levels##2##5##(2006-10#2)
urine nitrite##3##2##(2006-10#2)(2008-7#1)
urine nitrogen##3##2##(1993-5#2)(1994-12#1)
urine nonsecretory RNase and##2##4##(1990-7#2)
urine nonsecretory RNase##4##3##(1990-7#4)
urine obtained by##2##3##(1996-1#1)(2008-10#1)
urine obtained##3##2##(1996-1#1)(2008-10#1)(2008-7#1)
urine of cancer patients##2##4##(1993-8#1)(2008-10#1)
urine of hard metal workers##3##5##(1994-6#3)
urine of healthy volunteers##2##4##(1996-8#1)(2013-1#1)
urine of healthy##5##3##(1991-12#1)(1995-3#1)(1996-8#1)(2008-10#1)(2013-1#1)
urine of patients under##2##4##(1996-2#1)(2008-10#1)
urine of patients with##10##4##(1992-7#2)(1993-11#2)(1996-12#1)(1997-2#2)(2005-8#1)(2008-7#2)
urine of patients##16##3##(1990-4#1)(1992-7#2)(1993-11#2)(1996-12#1)(1996-2#1)(1997-2#2)(2005-8#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-7#2)(2009-5#1)
urine of rats##2##3##(2009-3#1)(2013-8#1)
urine of the patients with cancer of the pancreas##2##9##(2008-7#2)
urine of the patients with cancer of the##3##8##(2008-7#3)
urine of the##9##3##(1993-2#1)(1995-3#2)(1997-8#1)(2007-7#1)(2008-7#3)(2009-1#1)
urine of##70##2##(1990-12#1)(1990-4#1)(1991-11#1)(1991-12#2)(1991-9#1)(1992-2#1)(1992-3#3)(1992-7#2)(1992-8#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-8#1)(1994-5#1)(1994-6#7)(1995-1#1)(1995-11#1)(1995-3#3)(1996-1#1)(1996-12#6)(1996-2#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-8#2)(2005-8#1)(2006-10#1)(2007-7#2)(2008-10#5)(2008-7#6)(2009-1#1)(2009-3#2)(2009-5#1)(2010-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
urine or feces##2##3##(1996-12#1)(2009-6#1)
urine or##7##2##(1994-8#1)(1996-12#1)(2008-11#1)(2008-2#1)(2009-4#1)(2009-6#1)(2013-7#1)
urine osmolality and##2##3##(2009-12#1)(2013-1#1)
urine osmolality##3##2##(2009-12#1)(2013-1#2)
urine output##8##2##(1991-6#2)(2006-10#1)(2007-8#1)(2008-7#1)(2009-4#1)(2012-12#1)(2012-2#1)
urine pregnancy tests##2##3##(2007-7#1)(2011-2#1)
urine protein##7##2##(1990-11#2)(1995-8#1)(2007-8#2)(2011-1#1)(2011-3#1)
urine ranged##3##2##(1992-2#2)(1996-8#1)
urine respectively##2##2##(1991-8#1)(2005-12#1)
urine results##2##2##(1995-2#1)(1996-12#1)
urine sample was collected##2##4##(1993-8#1)(2011-1#1)
urine sample was##7##3##(1990-8#1)(1993-8#1)(1996-12#1)(2005-8#1)(2007-8#1)(2008-10#1)(2011-1#1)
urine sample##34##2##(1990-2#1)(1990-8#2)(1993-1#1)(1993-11#1)(1993-8#1)(1996-12#2)(1996-3#1)(1996-5#1)(2005-12#1)(2005-8#1)(2007-1#1)(2007-2#1)(2007-8#1)(2008-10#11)(2011-1#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
urine samples after a##3##4##(1993-2#1)(2008-10#2)
urine samples after##4##3##(1993-2#1)(2008-10#2)(2010-4#1)
urine samples and in##2##4##(2008-10#2)
urine samples and##8##3##(2007-8#1)(2008-10#7)
urine samples are##3##3##(2008-10#3)
urine samples by the##2##4##(2008-10#1)(2009-5#1)
urine samples by##11##3##(1993-2#2)(1996-12#1)(2005-12#1)(2008-10#4)(2009-5#1)(2010-11#1)(2011-1#1)
urine samples containing##2##3##(2008-10#2)
urine samples for##3##3##(1990-6#1)(1994-6#1)(2012-12#1)
urine samples from patients##2##4##(1996-8#1)(1997-3#1)
urine samples from##18##3##(1990-2#1)(1993-11#1)(1993-2#1)(1993-4#1)(1995-12#1)(1995-2#1)(1996-8#1)(1996-9#1)(1997-3#2)(2005-12#1)(2007-3#1)(2008-10#6)
urine samples in##2##3##(1990-11#1)(2010-4#1)
urine samples is##4##3##(1995-2#1)(2008-10#3)
urine samples of##6##3##(1993-8#1)(1996-12#1)(1996-3#1)(2008-10#3)
urine samples or##2##3##(1993-11#1)(2008-10#1)
urine samples showed##2##3##(2007-8#1)(2011-1#1)
urine samples that were##2##4##(1996-8#1)(2007-2#1)
urine samples that##3##3##(1996-8#1)(2007-2#1)(2008-10#1)
urine samples to##2##3##(2008-10#1)(2008-12#1)
urine samples using##3##3##(2008-10#2)(2008-3#1)
urine samples was##5##3##(1991-7#1)(2008-10#2)(2008-4#1)(2009-5#1)
urine samples were collected##3##4##(1993-11#1)(2007-2#1)(2007-8#1)
urine samples were diluted##2##4##(1993-11#1)(2008-10#1)
urine samples were obtained##3##4##(1991-10#1)(1995-4#1)(2012-1#1)
urine samples were performed on##2##5##(1992-2#2)
urine samples were##26##3##(1990-6#1)(1991-10#1)(1992-2#2)(1993-11#2)(1995-4#1)(1996-2#1)(1996-8#1)(1997-4#1)(2005-12#1)(2005-8#1)(2007-2#2)(2007-8#1)(2008-10#9)(2010-12#1)(2012-1#1)
urine samples with##3##3##(1997-2#1)(2008-10#1)(2010-4#1)
urine samples##189##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-6#2)(1990-8#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-2#3)(1992-4#1)(1992-8#1)(1993-1#1)(1993-11#6)(1993-2#4)(1993-4#1)(1993-8#2)(1994-6#1)(1995-12#1)(1995-2#2)(1995-4#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#4)(1996-9#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-8#1)(2005-12#7)(2005-8#2)(2007-2#4)(2007-3#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#87)(2008-12#2)(2008-3#1)(2008-4#1)(2009-5#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#5)(2010-5#1)(2011-1#4)(2012-1#1)(2012-12#1)(2013-7#1)(2013-8#2)
urine samples)##2##2##(2008-10#1)(2011-2#1)
urine secretory RNase##2##3##(1990-7#2)
urine should be##2##3##(1990-4#1)(2008-10#1)
urine should##3##2##(1990-4#1)(1994-6#1)(2008-10#1)
urine showed##3##2##(1990-3#1)(1992-3#1)(2007-2#1)
urine specimen##3##2##(2007-12#1)(2008-10#1)(2008-12#1)
urine specimens by##3##3##(2008-10#3)
urine specimens from##2##3##(1995-11#1)(2008-10#1)
urine specimens obtained from##2##4##(1997-8#1)(2013-7#1)
urine specimens were##3##3##(1996-12#1)(2007-7#1)(2008-10#1)
urine specimens with##2##3##(2008-10#1)(2010-4#1)
urine specimens##26##2##(1990-10#1)(1991-8#1)(1992-8#1)(1993-8#1)(1995-11#2)(1995-2#1)(1996-12#2)(1997-8#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#4)(2008-10#6)(2008-3#1)(2010-4#1)(2013-7#1)
urine spiked with##2##3##(2005-12#1)(2008-10#1)
urine test to##2##3##(1996-12#1)(2006-10#1)
urine testing##3##2##(1993-8#1)(1997-3#1)(2006-8#1)
urine tests##4##2##(1993-12#2)(2006-10#2)
urine to##3##2##(1996-12#1)(2008-10#1)(2011-12#1)
urine using##10##2##(1991-12#1)(1996-1#1)(1997-3#1)(2007-8#1)(2008-10#5)(2008-3#1)
urine values##2##2##(1995-3#2)
urine volume and##4##3##(1995-2#1)(2007-6#1)(2008-5#1)(2013-8#1)
urine volume##16##2##(1992-7#1)(1993-2#2)(1995-12#1)(1995-2#1)(2006-6#5)(2007-6#1)(2008-3#1)(2008-5#1)(2011-3#1)(2012-2#1)(2013-8#1)
urine volumes##3##2##(1993-2#2)(2006-6#1)
urine was 8##2##3##(1993-8#1)(1996-8#1)
urine was collected##4##3##(1993-8#1)(1997-3#1)(2008-12#1)(2008-3#1)
urine was determined##2##3##(1992-3#1)(2013-8#1)
urine was found to be##2##5##(1990-12#1)(1995-3#1)
urine was performed##2##3##(1996-8#1)(2005-8#1)
urine was##27##2##(1990-12#2)(1990-8#1)(1992-3#1)(1992-7#1)(1993-8#2)(1995-2#1)(1995-3#1)(1996-8#2)(1997-3#2)(2005-8#1)(2006-8#1)(2008-10#9)(2008-12#1)(2008-3#1)(2013-8#1)
urine we##2##2##(1995-7#1)(1997-2#1)
urine were##24##2##(1990-8#4)(1992-2#2)(1992-5#1)(1993-2#1)(1994-2#1)(1996-6#1)(1996-8#2)(1997-3#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-5#1)(2010-8#1)(2013-1#1)
urine which##2##2##(1992-3#1)(1993-10#1)
urine while##2##2##(1993-12#1)(1994-6#1)
urine with a##2##3##(2007-7#1)(2008-10#1)
urine with##10##2##(1990-12#1)(1990-2#1)(2007-7#1)(2008-10#6)(2011-2#1)
urine without##3##2##(2008-10#2)(2010-5#1)
urine##1375##1##(1990-1#1)(1990-10#5)(1990-11#19)(1990-12#31)(1990-2#11)(1990-3#6)(1990-4#3)(1990-5#1)(1990-6#15)(1990-7#9)(1990-8#26)(1990-9#2)(1991-1#2)(1991-10#3)(1991-11#4)(1991-12#14)(1991-2#1)(1991-5#3)(1991-6#2)(1991-7#2)(1991-8#3)(1991-9#6)(1992-1#4)(1992-11#4)(1992-2#19)(1992-3#11)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#5)(1992-8#13)(1992-9#4)(1993-1#3)(1993-10#1)(1993-11#16)(1993-12#13)(1993-2#26)(1993-4#5)(1993-5#2)(1993-8#11)(1993-9#10)(1994-10#2)(1994-12#4)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#33)(1994-8#3)(1994-9#5)(1995-1#4)(1995-11#4)(1995-12#8)(1995-2#10)(1995-3#12)(1995-4#2)(1995-5#1)(1995-6#1)(1995-7#6)(1995-8#2)(1996-1#8)(1996-12#27)(1996-2#2)(1996-3#10)(1996-5#15)(1996-6#12)(1996-7#3)(1996-8#36)(1996-9#5)(1997-2#8)(1997-3#30)(1997-4#2)(1997-6#3)(1997-7#1)(1997-8#18)(2004-11#11)(2004-12#2)(2005-11#1)(2005-12#14)(2005-4#2)(2005-7#2)(2005-8#5)(2006-10#19)(2006-12#3)(2006-4#1)(2006-6#8)(2006-7#4)(2006-8#8)(2006-9#1)(2007-1#3)(2007-10#6)(2007-11#5)(2007-12#6)(2007-2#10)(2007-3#1)(2007-4#3)(2007-6#1)(2007-7#18)(2007-8#42)(2007-9#4)(2008-1#9)(2008-10#349)(2008-11#5)(2008-12#9)(2008-2#7)(2008-3#8)(2008-4#6)(2008-5#8)(2008-7#20)(2008-8#1)(2009-1#2)(2009-12#2)(2009-2#4)(2009-3#3)(2009-4#2)(2009-5#5)(2009-6#3)(2009-7#2)(2009-9#4)(2010-10#1)(2010-11#7)(2010-12#7)(2010-2#1)(2010-3#1)(2010-4#7)(2010-5#7)(2010-8#6)(2011-1#19)(2011-12#5)(2011-2#21)(2011-3#2)(2012-1#2)(2012-11#2)(2012-12#5)(2012-2#8)(2012-3#6)(2013-1#12)(2013-7#8)(2013-8#17)
urine) is##3##2##(2007-8#1)(2008-10#1)(2011-2#1)
urine)##13##1##(1992-2#2)(1997-3#1)(2005-8#1)(2007-2#1)(2007-8#2)(2008-10#4)(2010-6#1)(2011-2#1)
urine-derived FSH##3##2##(2007-11#3)
urine-derived##4##1##(2007-11#4)
urines were##2##2##(1993-7#1)(2008-10#1)
urines##15##1##(1990-8#2)(1992-5#1)(1993-7#1)(1995-2#1)(1995-7#3)(1996-3#1)(2008-10#2)(2008-12#2)(2010-12#1)(2013-8#1)
urinoma##9##1##(1993-12#2)(2008-10#5)(2011-2#2)
urn model##2##2##(2008-2#2)
urn##5##1##(2008-2#5)
urns##2##1##(2008-2#2)
urocanic acid##2##2##(2008-10#1)(2011-2#1)
urocortin##3##1##(1997-5#2)(2013-1#1)
urodele##3##1##(1991-3#1)(1996-5#1)(1997-3#1)
urodeles##3##1##(1991-3#1)(1996-5#1)(2008-7#1)
urodynamic investigation##2##2##(1995-9#2)
urodynamic studies##4##2##(2008-10#3)(2011-1#1)
urodynamic study##2##2##(1994-3#1)(2011-1#1)
urodynamic##14##1##(1994-3#1)(1995-9#2)(2008-10#5)(2008-7#2)(2011-1#3)(2012-12#1)
urodynamics##5##1##(1991-11#1)(2006-10#1)(2006-9#1)(2008-1#1)(2008-10#1)
uroepithelial##3##1##(1991-12#1)(1996-12#1)(2005-10#1)
urofollitropin and##2##2##(2007-11#2)
urofollitropin##7##1##(2007-11#7)
urogenital anomalies##2##2##(2008-10#1)(2008-7#1)
urogenital atrophy and##2##3##(2004-10#2)
urogenital atrophy##4##2##(2004-10#4)
urogenital endoscopic surgery##5##3##(2004-2#5)
urogenital infections##4##2##(1990-6#1)(1991-11#1)(1996-9#1)(2013-7#1)
urogenital ridges##2##2##(1994-11#2)
urogenital sinus##12##2##(1995-11#1)(2006-8#2)(2008-10#9)
urogenital symptoms##2##2##(2013-1#2)
urogenital system##2##2##(2004-2#1)(2006-7#1)
urogenital tract and##2##3##(2008-10#1)(2008-5#1)
urogenital tract##12##2##(1993-1#1)(1995-5#1)(1997-2#1)(1997-5#1)(1997-6#1)(2004-2#1)(2007-11#1)(2008-10#1)(2008-5#2)(2012-3#1)(2013-1#1)
urogenital##63##1##(1990-6#1)(1990-9#1)(1991-11#1)(1992-6#1)(1993-1#1)(1994-10#1)(1994-11#3)(1995-11#1)(1995-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#2)(2004-10#5)(2004-2#7)(2006-6#1)(2006-7#2)(2006-8#2)(2007-11#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#12)(2008-5#3)(2008-7#1)(2008-9#1)(2009-4#1)(2012-3#2)(2013-1#3)(2013-7#1)
urography##6##1##(1990-11#1)(1990-9#1)(2006-7#1)(2008-7#1)(2011-2#2)
uroguanylin##2##1##(2006-10#1)(2009-9#1)
urogynecologic mesh##4##2##(2013-1#4)
urogynecologic##8##1##(2013-1#8)
urogynecologist##2##1##(1992-1#1)(2011-12#1)
urokinase (UK)##2##2##(1992-12#1)(2007-10#1)
urokinase and plasminogen are##2##4##(1994-6#1)(1996-2#1)
urokinase and##6##2##(1994-6#1)(1996-2#1)(1996-9#1)(1997-5#1)(2005-7#1)(2008-5#1)
urokinase infusion##2##2##(2006-11#1)(2007-9#1)
urokinase inhibitors##2##2##(2005-7#2)
urokinase or##2##2##(1990-6#1)(1997-2#1)
urokinase plasminogen activator (uPA)##2##4##(1996-8#1)(1997-4#1)
urokinase plasminogen activator receptor##4##4##(1995-5#1)(2009-4#1)(2013-1#2)
urokinase plasminogen activator##7##3##(1990-11#1)(1995-5#1)(1996-8#1)(1997-4#1)(2009-4#1)(2013-1#2)
urokinase plasminogen##8##2##(1990-11#1)(1995-5#1)(1996-8#1)(1997-4#2)(2009-4#1)(2013-1#2)
urokinase were##2##2##(1996-2#2)
urokinase##57##1##(1990-11#3)(1990-12#1)(1990-5#1)(1990-6#1)(1992-12#3)(1992-6#1)(1992-7#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#5)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(2005-7#5)(2006-11#1)(2007-10#2)(2007-11#1)(2007-7#3)(2007-9#5)(2008-5#3)(2008-7#2)(2009-4#1)(2013-1#2)
urokinase)##2##1##(1990-11#2)
urokinase-type plasminogen activator (u-PA)##7##4##(1990-11#1)(1991-1#1)(1991-10#1)(1993-12#1)(1993-3#1)(1994-3#1)(1996-9#1)
urokinase-type plasminogen activator (uPA)##5##4##(1990-12#1)(1990-5#1)(1997-7#1)(2007-12#1)(2008-11#1)
urokinase-type plasminogen activator activity##2##4##(1991-10#1)(1996-9#1)
urokinase-type plasminogen activator and its receptor##2##6##(1993-3#1)(1997-7#1)
urokinase-type plasminogen activator and##3##4##(1993-3#1)(1995-6#1)(1997-7#1)
urokinase-type plasminogen activator##25##3##(1990-11#4)(1990-12#1)(1990-5#1)(1991-1#1)(1991-10#2)(1991-9#1)(1992-6#1)(1993-12#1)(1993-3#2)(1994-3#2)(1995-6#1)(1996-2#1)(1996-9#2)(1997-7#2)(2007-12#1)(2008-11#2)
urokinase-type plasminogen##26##2##(1990-11#4)(1990-12#1)(1990-5#1)(1991-1#2)(1991-10#2)(1991-9#1)(1992-6#1)(1993-12#1)(1993-3#2)(1994-3#2)(1995-6#1)(1996-2#1)(1996-9#2)(1997-7#2)(2007-12#1)(2008-11#2)
urokinase-type##28##1##(1990-11#4)(1990-12#1)(1990-5#1)(1991-1#2)(1991-10#2)(1991-9#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-3#2)(1994-3#3)(1995-6#1)(1996-2#1)(1996-9#2)(1997-7#2)(2007-12#1)(2008-11#2)
urolith##4##1##(2010-2#3)(2013-1#1)
urolithiasis in##2##2##(2008-10#1)(2010-2#1)
urolithiasis##22##1##(1991-3#1)(1992-9#2)(1995-1#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2010-2#9)(2011-2#2)(2012-2#1)(2013-1#1)
uroliths are##5##2##(2010-2#5)
uroliths##11##1##(2010-2#11)
urologic cancer surgeries##2##3##(2008-7#2)
urologic cancer surgery##2##3##(2008-7#2)
urologic cancer##6##2##(2006-9#1)(2008-7#5)
urologic diseases##3##2##(1997-7#1)(2008-10#1)(2008-8#1)
urologic malignancy##2##2##(2006-9#1)(2008-6#1)
urologic oncology##3##2##(2006-10#1)(2006-9#1)(2011-2#1)
urologic surgery##3##2##(1991-9#1)(2006-6#1)(2008-10#1)
urologic trauma##2##2##(2013-8#2)
urologic##39##1##(1990-12#1)(1990-6#1)(1991-9#1)(1992-1#1)(1995-8#1)(1997-7#1)(2006-10#2)(2006-6#1)(2006-9#9)(2007-8#3)(2008-10#4)(2008-6#1)(2008-7#5)(2008-8#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#3)
urological abnormalities##2##2##(1991-11#1)(2007-12#1)
urological and##2##2##(1996-9#1)(2010-12#1)
urological anomalies##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
urological complications##6##2##(1995-9#1)(2007-11#1)(2007-7#1)(2008-1#3)
urological diseases##2##2##(2006-7#2)
urological group##2##2##(1991-11#2)
urological management of SCI patients##2##5##(2007-11#2)
urological problems##2##2##(2008-10#2)
urological procedures##2##2##(2006-6#1)(2008-10#1)
urological surgery##7##2##(1990-4#1)(2009-2#1)(2013-8#5)
urological##56##1##(1990-4#2)(1991-11#3)(1991-8#1)(1995-9#1)(1996-9#1)(2006-12#1)(2006-6#1)(2006-7#4)(2006-9#1)(2007-11#3)(2007-12#1)(2007-5#2)(2007-7#1)(2008-1#3)(2008-10#11)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#3)(2009-7#1)(2010-11#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-8#5)
urologist with##2##2##(2008-10#1)(2012-12#1)
urologist##13##1##(1994-4#1)(2006-7#2)(2007-10#1)(2007-5#1)(2008-10#1)(2008-3#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)
urologists and##2##2##(2008-10#1)(2008-6#1)
urologists##30##1##(1996-12#3)(1996-3#1)(2006-9#11)(2007-5#1)(2008-10#3)(2008-6#5)(2009-3#1)(2010-7#1)(2011-2#3)(2012-12#1)
urologists'##2##1##(1996-12#1)(2010-11#1)
urology clinic##2##2##(2008-10#1)(2010-2#1)
urology##37##1##(1992-1#1)(2006-10#2)(2006-9#10)(2007-3#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#9)(2008-5#1)(2008-7#1)(2008-8#3)(2009-4#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-12#1)
urology]##5##1##(1991-9#1)(2007-11#1)(2008-10#1)(2013-7#2)
uromodulin (UMOD) gene##2##3##(2007-7#1)(2012-12#1)
uronic acid and##3##3##(1995-2#1)(2007-1#1)(2011-2#1)
uronic acid##6##2##(1995-2#1)(2006-12#1)(2007-1#2)(2011-2#2)
uronic acids##4##2##(2006-12#3)(2006-8#1)
uronic##11##1##(1995-2#1)(1995-4#1)(2006-12#4)(2006-8#1)(2007-1#2)(2011-2#2)
uropathogen##2##1##(2008-5#2)
uropathogenic E##4##2##(1995-2#1)(1996-8#2)(2008-9#1)
uropathogenic##7##1##(1995-2#1)(1996-8#3)(2007-7#1)(2008-9#1)(2013-8#1)
uropathogens##4##1##(2007-7#3)(2011-2#1)
uropathy in##4##2##(2007-7#1)(2008-10#2)(2008-4#1)
uropathy##20##1##(1990-8#1)(2006-10#2)(2006-8#1)(2007-7#5)(2007-8#1)(2008-1#2)(2008-10#5)(2008-4#2)(2009-5#1)
uroplakin##3##1##(1995-1#3)
uroporphyria##2##1##(1994-6#2)
uroporphyrin##10##1##(1990-1#3)(1991-10#7)
uroporphyrinogen III synthase##2##3##(1995-4#2)
uroporphyrinogen III##6##2##(1991-5#3)(1995-4#3)
uroporphyrinogen##9##1##(1991-10#1)(1991-5#5)(1995-4#3)
urosepsis##7##1##(1996-12#2)(2010-11#1)(2012-2#2)(2013-1#2)
urotensin##3##1##(1995-1#2)(2008-7#1)
urothelial cancer in the##2##4##(2007-7#2)
urothelial carcinoma of the bladder##3##5##(2011-2#1)(2013-1#2)
urothelial carcinoma of the##4##4##(2011-2#1)(2012-2#1)(2013-1#2)
urothelial carcinoma##11##2##(1990-6#1)(1993-6#1)(2008-2#1)(2011-2#3)(2012-2#3)(2013-1#2)
urothelial cells##2##2##(1995-1#1)(2013-8#1)
urothelial malignancies##2##2##(2006-9#2)
urothelial##24##1##(1990-6#1)(1993-6#1)(1995-1#2)(2006-9#2)(2007-7#2)(2008-10#1)(2008-2#2)(2010-12#1)(2010-8#1)(2011-2#3)(2012-2#5)(2013-1#2)(2013-8#1)
urothelium in##2##2##(2008-10#1)(2012-1#1)
urothelium##9##1##(1992-12#1)(1995-1#2)(2008-10#2)(2011-12#1)(2012-1#1)(2013-8#2)
urotoxicity##2##1##(2010-8#2)
uroweb##2##1##(2006-9#2)
ursinus)##2##1##(1996-12#1)(2008-10#1)
ursodeoxycholic acid (UDCA)##2##3##(1991-12#1)(1995-8#1)
ursodeoxycholic acid and##4##3##(1996-4#1)(2006-10#1)(2006-2#1)(2012-3#1)
ursodeoxycholic acid in##4##3##(2004-11#1)(2006-10#1)(2008-12#1)(2008-8#1)
ursodeoxycholic acid may provide benefit##2##5##(2005-8#2)
ursodeoxycholic acid may##3##3##(2005-8#2)(2006-10#1)
ursodeoxycholic acid therapy##5##3##(1996-4#4)(2004-11#1)
ursodeoxycholic acid##34##2##(1991-12#1)(1995-8#1)(1996-4#12)(2004-11#6)(2005-12#1)(2005-8#2)(2006-10#6)(2006-2#2)(2008-12#1)(2008-8#1)(2012-3#1)
ursolic acid##4##2##(2007-1#1)(2008-5#1)(2012-12#1)(2012-3#1)
urticae##3##1##(2007-6#1)(2008-8#1)(2011-2#1)
urticaria and angioedema##2##3##(2007-7#1)(2007-8#1)
urticaria and pruritus##2##3##(2013-1#2)
urticaria and##14##2##(2005-11#1)(2006-10#1)(2007-7#2)(2007-8#1)(2010-5#1)(2010-6#2)(2011-1#1)(2013-1#5)
urticaria by##2##2##(1990-6#1)(2007-7#1)
urticaria in##2##2##(2006-8#1)(2008-7#1)
urticaria syndrome##2##2##(1990-6#2)
urticaria was##2##2##(2006-10#1)(2008-5#1)
urticaria##67##1##(1990-6#3)(1991-11#1)(1995-6#1)(1996-11#1)(2005-11#1)(2005-7#1)(2006-10#4)(2006-4#1)(2006-8#1)(2007-11#3)(2007-2#2)(2007-7#21)(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#3)(2010-1#1)(2010-12#1)(2010-5#1)(2010-6#6)(2011-1#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-1#7)
urticarial skin##2##2##(1990-12#1)(1990-8#1)
urticarial##6##1##(1990-12#1)(1990-8#1)(2006-4#1)(2007-7#1)(2010-1#1)(2012-2#1)
us a new##3##3##(2008-11#1)(2008-8#1)(2012-2#1)
us a very##2##3##(1997-1#1)(2008-2#1)
us a##13##2##(1997-1#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-10#1)(2012-2#1)
us about enhancing##2##3##(2010-10#1)(2012-3#1)
us about the##6##3##(2008-1#1)(2008-4#1)(2008-8#1)(2009-5#1)(2011-12#1)(2012-12#1)
us about their##2##3##(2007-6#1)(2012-1#1)
us about##18##2##(2007-6#1)(2008-1#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-7#2)(2010-10#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
us all##3##2##(1997-1#1)(2008-12#1)(2012-12#1)
us and##5##2##(1994-8#1)(2007-7#1)(2008-1#2)(2008-10#1)
us as a##2##3##(2007-8#1)(2008-1#1)
us as##9##2##(1995-6#1)(2007-8#1)(2008-1#3)(2008-7#1)(2010-7#1)(2013-1#2)
us assume that##2##3##(1990-5#1)(2007-6#1)
us because of##2##3##(2006-10#1)(2007-12#1)
us because##4##2##(2006-10#1)(2007-12#1)(2009-6#1)(2011-2#1)
us better##3##2##(2007-12#1)(2009-1#1)(2009-8#1)
us between##2##2##(1992-1#1)(2008-3#1)
us closer to##2##3##(1995-3#1)(1996-11#1)
us earlier##2##2##(1996-4#1)(2012-3#1)
us for a##2##3##(2008-11#1)(2008-8#1)
us for the first time##3##5##(1991-12#1)(2009-7#1)(2013-1#1)
us for the##4##3##(1991-12#1)(2008-10#1)(2009-7#1)(2013-1#1)
us for##9##2##(1991-12#1)(1992-10#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-7#1)(2012-3#1)(2013-1#1)
us from##8##2##(1992-3#1)(1993-3#1)(1996-6#2)(2007-12#1)(2008-4#2)(2009-8#1)
us in our##2##3##(2007-3#1)(2011-2#1)
us in the##5##3##(2008-10#2)(2009-11#1)(2009-4#1)(2010-3#1)
us in##17##2##(1996-11#1)(2006-12#1)(2007-3#1)(2007-4#1)(2008-10#2)(2008-12#1)(2009-10#1)(2009-11#1)(2009-4#1)(2010-2#2)(2010-3#1)(2010-7#1)(2011-2#2)(2013-8#1)
us into##3##2##(2006-10#1)(2007-11#1)(2013-1#1)
us is to##2##3##(1994-2#1)(2008-10#1)
us is##4##2##(1994-2#1)(2006-7#1)(2007-7#1)(2008-10#1)
us of the##3##3##(1997-3#1)(2008-12#1)(2012-3#1)
us of##7##2##(1995-1#1)(1997-3#1)(2007-7#1)(2008-12#1)(2008-7#1)(2008-8#1)(2012-3#1)
us recognize##2##2##(1993-3#1)(2009-4#1)
us that##9##2##(1992-2#1)(1995-1#1)(2007-12#1)(2007-2#1)(2008-11#1)(2012-3#1)(2013-8#3)
us the opportunity to##3##4##(2011-2#1)(2012-2#1)(2012-3#1)
us the##10##2##(2007-9#1)(2008-4#2)(2008-9#1)(2009-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
us to a##3##3##(2007-2#1)(2008-7#1)(2012-1#1)
us to achieve the##2##4##(2008-2#1)(2008-3#1)
us to achieve##5##3##(2007-12#1)(2008-12#1)(2008-2#2)(2008-3#1)
us to also##2##3##(2007-12#1)(2008-10#1)
us to analyse##3##3##(1995-12#1)(2006-10#1)(2008-7#1)
us to analyze the##3##4##(1992-12#1)(2008-8#1)(2012-1#1)
us to analyze##4##3##(1992-12#1)(2008-8#1)(2011-1#1)(2012-1#1)
us to apply##2##3##(2007-12#1)(2007-7#1)
us to assess the##7##4##(1996-11#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-8#2)(2013-1#1)
us to assess##9##3##(1994-5#1)(1994-8#1)(1996-11#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-8#2)(2013-1#1)
us to assume that##2##4##(2005-11#1)(2008-5#1)
us to assume##3##3##(1994-6#1)(2005-11#1)(2008-5#1)
us to avoid the##2##4##(2007-7#1)(2008-3#1)
us to avoid##4##3##(1991-6#1)(2007-7#1)(2008-3#2)
us to be##2##3##(1991-2#1)(1992-1#1)
us to believe##2##3##(2009-3#1)(2013-7#1)
us to better understand the##5##5##(2006-10#1)(2008-10#1)(2009-5#1)(2010-5#1)(2010-9#1)
us to better understand##6##4##(2006-10#1)(2008-10#1)(2009-5#1)(2010-5#1)(2010-9#1)(2013-1#1)
us to better##7##3##(2006-10#1)(2008-10#1)(2009-5#1)(2010-5#1)(2010-9#1)(2012-12#1)(2013-1#1)
us to build##2##3##(2008-2#1)(2012-12#1)
us to calculate the##7##4##(1991-2#2)(2006-10#1)(2007-12#1)(2008-2#1)(2008-7#1)(2008-8#1)
us to calculate##9##3##(1991-2#2)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)
us to carry out##3##4##(1991-5#1)(2006-6#1)(2008-3#1)
us to characterize the##3##4##(1993-9#1)(2007-12#1)(2008-3#1)
us to characterize##5##3##(1993-9#1)(1996-7#1)(2006-12#1)(2007-12#1)(2008-3#1)
us to classify##2##3##(1992-4#1)(2012-2#1)
us to clone##2##3##(1991-9#1)(1997-8#1)
us to compare the##2##4##(2008-5#1)(2012-12#1)
us to compare##3##3##(1995-5#1)(2008-5#1)(2012-12#1)
us to conclude that the##4##5##(1993-8#1)(1996-12#1)(2008-10#2)
us to conclude that##16##4##(1991-10#1)(1991-2#1)(1993-8#1)(1994-8#1)(1996-12#1)(1997-2#1)(1997-5#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-6#1)(2010-4#1)(2011-2#1)
us to conclude##20##3##(1991-10#1)(1991-2#1)(1993-12#1)(1993-8#1)(1994-8#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-5#1)(2007-11#1)(2008-10#5)(2008-3#1)(2008-6#1)(2010-4#1)(2011-1#1)(2011-2#1)
us to conduct a##2##4##(2008-12#1)(2012-12#1)
us to conduct##4##3##(2007-7#1)(2008-12#1)(2008-3#1)(2012-12#1)
us to confirm##2##3##(2008-8#1)(2011-1#1)
us to consider that##2##4##(2007-7#1)(2008-7#1)
us to consider##5##3##(1993-6#1)(2007-7#1)(2008-3#1)(2008-7#2)
us to construct and##2##4##(1995-6#1)(2008-10#1)
us to construct##3##3##(1995-6#1)(2008-10#1)(2008-7#1)
us to continue##2##3##(1992-2#1)(2004-9#1)
us to decipher the##2##4##(1997-9#1)(2011-1#1)
us to deduce the##3##4##(1990-12#1)(2007-12#2)
us to define##2##3##(2007-11#1)(2007-12#1)
us to derive##2##3##(2008-2#1)(2008-8#1)
us to describe the##2##4##(2008-10#1)(2008-3#1)
us to describe##7##3##(1991-2#1)(1995-5#1)(2006-3#1)(2008-10#1)(2008-3#2)(2008-4#1)
us to design##2##3##(2008-5#1)(2013-7#1)
us to detect##4##3##(1990-5#1)(2008-2#1)(2008-3#1)(2012-3#1)
us to determine the##18##4##(1990-12#1)(1991-2#1)(1992-9#1)(1996-8#1)(1997-2#1)(1997-8#1)(2004-9#1)(2007-12#1)(2007-9#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)
us to determine whether##3##4##(1996-12#1)(2008-8#1)(2012-2#1)
us to determine##33##3##(1990-12#1)(1990-2#1)(1991-2#1)(1992-9#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-8#1)(2004-9#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#2)(2011-2#1)(2012-2#1)
us to develop a new##3##5##(1993-3#1)(1994-9#1)(2007-5#1)
us to develop a##6##4##(1992-11#1)(1993-3#1)(1993-4#1)(1994-9#1)(2007-5#1)(2008-7#1)
us to develop an##2##4##(2007-7#1)(2012-3#1)
us to develop##15##3##(1992-11#1)(1993-3#1)(1993-4#1)(1994-9#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-5#2)(2012-11#1)(2012-3#2)
us to differentiate the##2##4##(2008-10#1)(2009-10#1)
us to differentiate##7##3##(2007-8#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-10#1)(2012-2#1)
us to dissect the##2##4##(2009-3#1)(2011-2#1)
us to distinguish the##2##4##(2005-11#1)(2011-1#1)
us to distinguish##7##3##(1997-8#1)(2005-11#1)(2008-10#1)(2008-3#1)(2011-1#2)(2011-10#1)
us to draw##3##3##(2008-5#1)(2012-12#2)
us to easily##2##3##(2007-11#1)(2008-3#1)
us to elucidate the##2##4##(1994-8#1)(1996-8#1)
us to elucidate##3##3##(1994-8#1)(1996-8#1)(2012-3#1)
us to establish a##2##4##(2005-11#1)(2008-10#1)
us to establish##5##3##(2005-11#1)(2008-10#1)(2008-3#2)(2009-10#1)
us to estimate the##3##4##(2007-11#1)(2007-12#1)(2011-1#1)
us to estimate##9##3##(1990-8#1)(1992-6#1)(2007-11#1)(2007-12#2)(2008-12#1)(2011-1#2)(2013-8#1)
us to evaluate the##4##4##(2007-11#1)(2008-3#1)(2008-5#2)
us to evaluate##6##3##(1990-6#1)(1993-8#1)(2007-11#1)(2008-3#1)(2008-5#2)
us to examine the##6##4##(1996-3#1)(1997-2#1)(1997-4#1)(2008-1#1)(2011-2#1)(2013-1#1)
us to examine##11##3##(1996-3#1)(1997-2#1)(1997-4#1)(2007-9#1)(2008-1#1)(2009-10#1)(2009-4#2)(2010-7#1)(2011-2#1)(2013-1#1)
us to expect##2##3##(1994-3#1)(2008-2#1)
us to explain the##2##4##(1996-5#1)(2007-9#1)
us to explain##3##3##(1996-5#1)(2007-9#1)(2008-10#1)
us to explore##5##3##(2006-10#1)(2008-3#1)(2009-4#1)(2010-4#1)(2012-3#1)
us to extract##2##3##(2008-10#1)(2009-8#1)
us to find the##2##4##(1996-9#1)(2008-2#1)
us to find##5##3##(1990-2#1)(1996-2#1)(1996-9#1)(2004-3#1)(2008-2#1)
us to follow##2##3##(1992-6#1)(2008-11#1)
us to formulate##2##3##(2007-9#1)(2012-3#1)
us to further##4##3##(1994-3#1)(2008-3#1)(2013-1#2)
us to generate##3##3##(1993-2#1)(1995-11#1)(2010-7#1)
us to hypothesize that##2##4##(2008-4#1)(2013-8#1)
us to hypothesize##3##3##(2008-4#1)(2009-4#1)(2013-8#1)
us to identify a##2##4##(1991-5#1)(1995-3#1)
us to identify##14##3##(1990-11#1)(1991-5#1)(1991-9#1)(1992-7#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-9#1)
us to improve##4##3##(2008-11#1)(2008-3#1)(2009-11#1)(2012-11#1)
us to increase##2##3##(2007-7#1)(2008-2#1)
us to initiate##3##3##(1995-12#1)(2008-1#1)(2008-10#1)
us to interpret##3##3##(2008-10#1)(2009-2#1)(2010-3#1)
us to investigate the##7##4##(1992-12#1)(1993-12#1)(1994-8#1)(2008-1#1)(2008-4#1)(2008-8#1)(2012-3#1)
us to investigate##13##3##(1992-12#1)(1993-12#1)(1994-8#1)(1995-12#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2011-2#1)(2012-3#1)
us to isolate a##2##4##(1993-12#1)(1996-5#1)
us to isolate and##2##4##(1990-2#1)(1993-8#1)
us to isolate##8##3##(1990-2#1)(1993-12#1)(1993-8#1)(1996-5#1)(1997-4#1)(2008-2#1)(2008-3#1)(2012-11#1)
us to localize##3##3##(1990-2#1)(2007-11#1)(2008-2#1)
us to locate the##2##4##(1990-7#1)(1995-5#1)
us to lock##2##3##(2007-12#1)(2008-2#1)
us to make a##3##4##(2008-10#1)(2013-7#2)
us to make##7##3##(2008-10#2)(2008-7#1)(2010-12#1)(2012-12#1)(2013-7#2)
us to map the##2##4##(1993-11#1)(2008-5#1)
us to map##3##3##(1993-11#1)(2006-4#1)(2008-5#1)
us to measure the##5##4##(1993-8#1)(1997-4#1)(2007-11#1)(2008-3#1)(2010-7#1)
us to measure##8##3##(1993-8#1)(1997-4#1)(2007-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2010-7#1)
us to observe##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2008-5#1)
us to obtain a##5##4##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-3#1)
us to obtain the##2##4##(2007-11#1)(2008-2#1)
us to obtain three-dimensional##3##4##(2007-12#1)(2012-12#2)
us to obtain##18##3##(1995-8#1)(1997-8#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#4)(2008-3#1)(2008-5#1)(2010-8#1)(2012-12#2)(2012-3#1)
us to optimize##2##3##(2007-12#1)(2008-11#1)
us to overcome the##2##4##(1995-6#1)(2008-10#1)
us to overcome##4##3##(1995-6#1)(2007-8#1)(2008-10#1)(2013-1#1)
us to perform a##4##4##(2006-8#1)(2009-8#1)(2011-2#1)(2012-1#1)
us to perform the##2##4##(2008-3#1)(2013-1#1)
us to perform##11##3##(1995-4#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
us to plan##2##3##(2005-5#1)(2010-5#1)
us to postulate the##2##4##(1993-6#1)(1995-3#1)
us to postulate##5##3##(1992-6#1)(1993-6#1)(1995-3#1)(1996-12#1)(2013-1#1)
us to predict the##3##4##(2009-11#1)(2011-2#1)(2013-8#1)
us to predict##7##3##(1995-8#1)(2007-1#1)(2008-2#1)(2009-11#1)(2011-2#2)(2013-8#1)
us to present##3##3##(2008-3#1)(2008-5#1)(2009-5#1)
us to preserve the##2##4##(2008-10#1)(2008-5#1)
us to process##2##3##(2008-10#1)(2008-3#1)
us to produce##5##3##(1991-6#1)(2007-11#1)(2007-12#2)(2008-2#1)
us to propose a model##4##5##(1991-3#1)(1993-11#1)(1993-3#1)(1994-12#1)
us to propose a##8##4##(1991-3#1)(1991-8#1)(1993-11#1)(1993-3#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
us to propose that##5##4##(2006-10#1)(2007-12#1)(2008-11#1)(2008-8#1)(2009-8#1)
us to propose##18##3##(1991-3#1)(1991-8#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-8#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#1)(2009-8#1)(2010-12#1)
us to provide##2##3##(2012-2#2)
us to quantify the##2##4##(1994-8#1)(2008-1#1)
us to quantify##5##3##(1994-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-2#1)
us to re-examine##2##3##(2007-8#1)(2008-7#1)
us to reach##2##3##(1992-5#1)(2008-1#1)
us to recognize##4##3##(2008-10#1)(2009-4#1)(2009-9#1)(2010-8#1)
us to reconsider the##2##4##(1991-1#1)(2006-4#1)
us to reconstruct the##3##4##(2007-12#2)(2008-2#1)
us to recover the##2##4##(2007-12#1)(2011-1#1)
us to reduce the##4##4##(1994-12#1)(1996-6#1)(2007-12#1)(2008-4#1)
us to reduce##8##3##(1994-12#1)(1996-6#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-4#1)
us to relate the##2##4##(2008-2#1)(2008-5#1)
us to relate##4##3##(1997-4#1)(2008-2#1)(2008-5#1)(2008-7#1)
us to report this case##2##5##(2008-7#2)
us to report this##3##4##(2006-8#1)(2008-7#2)
us to report##4##3##(2006-8#1)(2008-7#2)(2010-6#1)
us to retrieve##3##3##(2008-2#3)
us to reveal##3##3##(1991-8#1)(2009-3#1)(2011-2#1)
us to run##2##3##(1994-6#1)(2007-8#1)
us to select##2##3##(1993-4#1)(2008-5#1)
us to separate##3##3##(1996-9#1)(2008-10#1)(2008-3#1)
us to speculate##2##3##(1990-5#1)(1996-4#1)
us to study the influence of##2##6##(2008-10#1)(2012-2#1)
us to study the##11##4##(1993-2#1)(1996-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-9#1)(2011-2#1)(2012-2#1)
us to study##18##3##(1991-7#1)(1992-11#1)(1993-2#1)(1996-11#1)(2006-10#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-9#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
us to suggest that the##2##5##(1994-2#1)(2008-5#1)
us to suggest that##4##4##(1994-2#1)(1996-3#1)(1996-4#1)(2008-5#1)
us to suggest##7##3##(1994-2#1)(1994-5#1)(1996-3#1)(1996-4#1)(2008-5#2)(2010-4#1)
us to support##3##3##(2005-5#1)(2008-5#1)(2008-7#1)
us to suspect##2##3##(1991-4#1)(2011-2#1)
us to synthesize##2##3##(1992-6#1)(2006-8#1)
us to test the hypothesis that##3##6##(1990-8#1)(1994-10#1)(1997-7#1)
us to test the##7##4##(1990-8#1)(1994-10#1)(1997-7#1)(2008-3#1)(2008-5#1)(2008-8#2)
us to test##9##3##(1990-8#1)(1994-10#1)(1997-7#1)(2008-3#1)(2008-5#1)(2008-8#4)
us to the##7##3##(1994-6#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-12#1)
us to tune##2##3##(2008-2#1)(2008-3#1)
us to understand how##3##4##(1993-5#1)(2006-10#1)(2010-4#1)
us to understand why##2##4##(1997-6#1)(2010-2#1)
us to understand##10##3##(1993-5#1)(1994-11#1)(1997-6#1)(2006-10#1)(2008-2#1)(2008-7#1)(2009-7#1)(2010-2#1)(2010-4#2)
us to use##7##3##(1993-12#1)(1993-3#1)(2006-10#1)(2007-12#1)(2008-3#1)(2010-4#1)(2011-2#1)
us to##681##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#8)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#2)(1991-1#2)(1991-10#1)(1991-2#6)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#3)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#6)(1993-2#3)(1993-3#5)(1993-4#2)(1993-5#1)(1993-6#2)(1993-8#5)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#5)(1994-7#1)(1994-8#6)(1994-9#2)(1995-1#2)(1995-11#2)(1995-12#4)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#3)(1995-8#2)(1996-11#3)(1996-12#5)(1996-2#3)(1996-3#3)(1996-4#2)(1996-5#3)(1996-6#2)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#6)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#4)(1997-9#1)(2004-12#1)(2004-3#1)(2004-9#2)(2005-11#5)(2005-5#2)(2006-10#13)(2006-12#4)(2006-3#2)(2006-4#2)(2006-6#1)(2006-7#1)(2006-8#4)(2007-1#1)(2007-10#1)(2007-11#17)(2007-12#36)(2007-2#1)(2007-3#1)(2007-5#3)(2007-7#6)(2007-8#6)(2007-9#6)(2008-1#7)(2008-10#60)(2008-11#8)(2008-12#4)(2008-2#39)(2008-3#44)(2008-4#7)(2008-5#22)(2008-6#4)(2008-7#20)(2008-8#15)(2008-9#4)(2009-10#3)(2009-11#2)(2009-2#2)(2009-3#3)(2009-4#7)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#7)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#7)(2010-5#5)(2010-6#2)(2010-7#4)(2010-8#3)(2010-9#2)(2011-1#13)(2011-10#1)(2011-2#16)(2012-1#4)(2012-11#3)(2012-12#10)(2012-2#9)(2012-3#12)(2013-1#9)(2013-7#4)(2013-8#8)
us well##2##2##(2007-7#1)(2008-11#1)
us who##2##2##(1994-2#1)(2008-10#1)
us with a##12##3##(1991-4#1)(1992-1#1)(1992-8#1)(1997-5#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-6#1)(2008-9#2)(2012-2#1)(2013-8#1)
us with an opportunity to##2##5##(1997-3#1)(2008-7#1)
us with an##6##3##(1994-6#1)(1997-3#1)(2008-7#2)(2012-3#2)
us with the##4##3##(2006-2#1)(2008-11#2)(2013-1#1)
us with##42##2##(1990-8#1)(1991-4#1)(1992-1#1)(1992-8#1)(1994-6#1)(1995-12#1)(1997-3#1)(1997-5#1)(2006-2#1)(2007-5#1)(2007-7#4)(2008-11#3)(2008-6#1)(2008-7#4)(2008-9#5)(2011-1#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#2)
us##1017##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#9)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#3)(1991-1#2)(1991-10#1)(1991-12#1)(1991-2#7)(1991-3#2)(1991-4#2)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#3)(1992-10#3)(1992-11#2)(1992-12#3)(1992-2#4)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#3)(1993-12#6)(1993-2#3)(1993-3#7)(1993-4#2)(1993-5#1)(1993-6#2)(1993-8#5)(1993-9#1)(1994-1#3)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#7)(1994-3#4)(1994-5#3)(1994-6#6)(1994-7#1)(1994-8#7)(1994-9#2)(1995-1#5)(1995-11#4)(1995-12#7)(1995-2#3)(1995-3#4)(1995-4#1)(1995-5#3)(1995-6#6)(1995-8#3)(1996-11#6)(1996-12#5)(1996-2#3)(1996-3#3)(1996-4#3)(1996-5#3)(1996-6#4)(1996-7#1)(1996-8#4)(1996-9#2)(1997-1#5)(1997-2#4)(1997-3#4)(1997-4#6)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#4)(1997-9#1)(2004-12#1)(2004-3#1)(2004-9#2)(2005-11#7)(2005-5#2)(2006-10#22)(2006-12#5)(2006-2#2)(2006-3#2)(2006-4#2)(2006-6#2)(2006-7#4)(2006-8#4)(2007-1#2)(2007-10#1)(2007-11#23)(2007-12#42)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#4)(2007-6#3)(2007-7#17)(2007-8#9)(2007-9#9)(2008-1#17)(2008-10#74)(2008-11#22)(2008-12#9)(2008-2#49)(2008-3#48)(2008-4#14)(2008-5#32)(2008-6#7)(2008-7#28)(2008-8#23)(2008-9#14)(2009-1#1)(2009-10#7)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#4)(2009-4#9)(2009-5#3)(2009-6#3)(2009-7#6)(2009-8#9)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#4)(2010-2#4)(2010-3#3)(2010-4#8)(2010-5#7)(2010-6#3)(2010-7#6)(2010-8#5)(2010-9#5)(2011-1#19)(2011-10#1)(2011-12#1)(2011-2#28)(2012-1#5)(2012-11#6)(2012-12#14)(2012-2#17)(2012-3#25)(2012-8#1)(2013-1#23)(2013-7#6)(2013-8#16)
us?##7##1##(1996-3#1)(1997-4#1)(2006-9#1)(2008-7#1)(2009-10#1)(2009-5#1)(2012-3#1)
usCRP##2##1##(2012-2#2)
usability and##5##2##(2010-3#1)(2013-1#4)
usability for##2##2##(2009-11#1)(2013-8#1)
usability of##8##2##(1991-3#2)(2007-12#1)(2007-5#1)(2008-12#1)(2010-10#1)(2012-1#1)(2012-12#1)
usability testing##5##2##(2010-10#1)(2013-1#4)
usability##45##1##(1991-3#2)(2007-12#1)(2007-4#2)(2007-5#3)(2007-7#1)(2008-10#1)(2008-12#2)(2008-6#2)(2008-7#2)(2009-11#2)(2010-10#2)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#18)(2013-8#1)
usable data##3##2##(1993-12#1)(2006-11#1)(2012-12#1)
usable for##4##2##(2007-7#1)(2008-11#1)(2013-1#2)
usable in a##2##3##(2007-8#1)(2008-3#1)
usable in##5##2##(1993-5#1)(2007-8#1)(2008-2#1)(2008-3#1)(2012-12#1)
usable life of the knee prosthesis##2##6##(2007-8#2)
usable life of##3##3##(2007-7#1)(2007-8#2)
usable surveys##2##2##(2010-11#1)(2011-1#1)
usable##34##1##(1991-12#1)(1993-12#2)(1993-5#1)(1994-2#1)(1996-2#1)(2005-12#1)(2006-11#1)(2007-11#1)(2007-7#3)(2007-8#3)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#3)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#1)
usage among##3##2##(2007-6#1)(2007-8#1)(2012-2#1)
usage analysis##2##2##(1992-8#1)(1997-5#1)
usage and the##2##3##(2008-5#1)(2008-9#1)
usage and##24##2##(1990-11#1)(1993-1#1)(1995-3#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)
usage are##3##2##(2007-7#1)(2008-1#1)(2008-3#1)
usage as##6##2##(1990-4#1)(2007-11#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-3#1)
usage at##3##2##(2012-12#1)(2013-1#2)
usage by##3##2##(1997-2#1)(2005-10#1)(2005-12#1)
usage for##7##2##(2007-11#1)(2008-10#2)(2008-3#1)(2008-6#2)(2011-2#1)
usage in a##4##3##(2005-12#1)(2010-3#1)(2013-1#2)
usage in clinical##4##3##(2013-1#4)
usage in the##5##3##(1990-11#1)(1996-8#1)(1997-4#1)(2008-1#1)(2011-2#1)
usage in##30##2##(1990-11#1)(1990-6#1)(1991-12#2)(1991-8#1)(1992-6#1)(1996-10#1)(1996-8#1)(1997-4#1)(2005-12#2)(2006-12#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-7#1)(2009-4#1)(2010-3#3)(2011-2#1)(2013-1#6)
usage indicators##2##2##(2012-3#2)
usage is associated with##4##4##(2013-1#4)
usage is##12##2##(1991-8#3)(1997-1#1)(2008-2#1)(2008-5#1)(2010-3#1)(2012-2#1)(2013-1#4)
usage may##2##2##(2004-1#1)(2010-12#1)
usage of a##4##3##(2007-7#1)(2008-12#1)(2008-2#1)(2012-12#1)
usage of antibiotics##2##3##(1996-12#1)(2006-8#1)
usage of bisphosphonate in##2##4##(2005-3#2)
usage of bisphosphonate##3##3##(2005-3#3)
usage of bone##2##3##(2007-8#1)(2008-8#1)
usage of modern##2##3##(2005-10#1)(2011-2#1)
usage of multiple##2##3##(1993-5#1)(2008-5#1)
usage of the##20##3##(1990-9#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-9#1)(1996-4#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-9#1)(2009-3#1)(2011-2#1)(2013-8#2)
usage of these agents##2##4##(2006-10#2)
usage of these##7##3##(1994-12#1)(1996-2#1)(2005-9#1)(2006-10#2)(2008-5#1)(2008-8#1)
usage of traditional##2##3##(1997-2#1)(2008-1#1)
usage of##112##2##(1990-11#1)(1990-9#1)(1991-7#1)(1992-12#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#4)(1994-9#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1997-2#3)(1997-8#1)(2005-10#1)(2005-11#1)(2005-3#3)(2005-9#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-11#5)(2007-6#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#6)(2008-6#4)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#2)(2009-5#3)(2010-12#2)(2010-2#2)(2010-4#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
usage on##3##2##(1996-3#1)(2004-10#1)(2009-12#1)
usage pattern##2##2##(1993-11#1)(2007-11#1)
usage patterns##2##2##(2012-3#1)(2013-8#1)
usage segmentation##2##2##(1997-1#2)
usage than##2##2##(2006-6#1)(2008-10#1)
usage to enterprise##2##3##(2008-12#2)
usage to##7##2##(1996-3#1)(1997-8#1)(2008-12#2)(2008-3#1)(2008-7#1)(2010-5#1)
usage tracking##2##2##(1991-12#2)
usage was##3##2##(1991-4#1)(1995-3#1)(1996-3#1)
usage##342##1##(1990-11#3)(1990-4#1)(1990-6#2)(1990-9#3)(1991-1#1)(1991-12#4)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#6)(1992-12#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#3)(1993-2#1)(1993-3#3)(1993-4#3)(1993-5#1)(1993-6#2)(1993-9#1)(1994-12#4)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#3)(1995-3#2)(1995-4#1)(1995-5#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#5)(1996-4#1)(1996-8#1)(1997-1#3)(1997-2#5)(1997-4#2)(1997-5#1)(1997-7#2)(1997-8#3)(2004-1#1)(2004-10#2)(2005-10#3)(2005-11#1)(2005-12#3)(2005-3#3)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-6#2)(2006-7#2)(2006-8#3)(2007-10#1)(2007-11#8)(2007-12#2)(2007-2#1)(2007-3#2)(2007-4#3)(2007-6#7)(2007-7#3)(2007-8#8)(2007-9#1)(2008-1#7)(2008-10#16)(2008-11#5)(2008-12#6)(2008-2#2)(2008-3#9)(2008-4#6)(2008-5#13)(2008-6#6)(2008-7#6)(2008-8#5)(2008-9#6)(2009-12#2)(2009-3#3)(2009-4#1)(2009-5#4)(2010-12#3)(2010-2#3)(2010-3#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#12)(2012-12#6)(2012-2#12)(2012-3#9)(2013-1#32)(2013-8#4)
usage-based##2##1##(1997-1#1)(2008-2#1)
usagers##2##1##(2013-1#2)
use (P&lt##2##2##(2007-8#2)
use (e##2##2##(2007-11#1)(2013-1#1)
use (p=0##2##2##(2008-11#1)(2011-2#1)
use Internet##2##2##(2008-2#1)(2010-3#1)
use Monte Carlo##2##3##(2008-2#2)
use a Bayesian##2##3##(2012-3#1)(2013-1#1)
use a CAQDAS##2##3##(2005-8#2)
use a Markov##2##3##(2009-4#1)(2012-1#1)
use a combination of##8##4##(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#3)(2008-4#1)(2008-9#1)
use a different##2##3##(2008-8#1)(2008-9#1)
use a fast##2##3##(2008-2#1)(2008-3#1)
use a linear##3##3##(2007-9#1)(2008-3#1)(2012-3#1)
use a method based on color##2##6##(2010-8#2)
use a model##2##3##(2008-10#1)(2008-11#1)
use a random-effects model to##2##5##(1995-2#1)(1996-7#1)
use a simple##7##3##(2007-12#1)(2008-10#3)(2008-3#2)(2010-7#1)
use a variety of##6##4##(1993-12#1)(1995-1#1)(2007-12#1)(2008-1#1)(2012-2#2)
use a very##2##3##(1992-10#1)(2008-3#1)
use a##198##2##(1990-3#1)(1990-5#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-10#3)(1992-3#1)(1992-4#1)(1992-8#2)(1993-12#2)(1993-2#1)(1993-6#2)(1994-3#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#3)(1995-4#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-8#1)(2004-12#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-3#2)(2006-6#1)(2006-7#4)(2007-11#4)(2007-12#14)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#3)(2008-1#2)(2008-10#13)(2008-11#3)(2008-12#3)(2008-2#12)(2008-3#19)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#4)(2009-11#4)(2009-2#1)(2009-3#1)(2009-4#3)(2009-6#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-2#4)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#6)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#6)(2013-1#7)(2013-8#1)
use across the##2##3##(2008-8#1)(2009-4#1)
use across##7##2##(1995-3#1)(2007-12#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-7#1)(2012-2#1)
use after##7##2##(2007-6#1)(2007-9#1)(2008-1#1)(2008-6#1)(2009-5#1)(2010-2#1)(2011-2#1)
use against##6##2##(1993-2#1)(2006-1#1)(2007-6#1)(2008-10#2)(2012-12#1)
use alcohol##3##2##(2005-10#1)(2012-12#2)
use all available##2##3##(1992-9#1)(2012-3#1)
use all##3##2##(1992-9#1)(2012-3#1)(2013-7#1)
use allowed##2##2##(2006-7#1)(2008-11#1)
use alone##2##2##(2006-10#1)(2007-8#1)
use also##4##2##(1990-3#1)(2011-2#1)(2013-1#2)
use alternative##2##2##(2008-8#1)(2009-7#1)
use alternatives##2##2##(2008-8#1)(2011-12#1)
use among adolescents##2##3##(2008-5#1)(2010-4#1)
use among middle school students##2##5##(2012-12#2)
use among our##2##3##(2007-7#1)(2011-2#1)
use among peers##3##3##(2013-1#3)
use among young##2##3##(2008-9#1)(2012-1#1)
use among##58##2##(1990-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1996-6#1)(2005-11#1)(2006-7#2)(2007-12#1)(2007-7#3)(2008-1#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-7#2)(2010-2#2)(2010-4#2)(2011-1#2)(2011-2#3)(2012-1#3)(2012-11#2)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#3)
use an automated procedure to##2##5##(2008-11#1)(2010-2#1)
use an##38##2##(1991-6#1)(1992-3#1)(1992-6#1)(1993-10#1)(1994-3#1)(1995-1#1)(2004-3#1)(2004-9#1)(2005-5#1)(2006-2#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#1)
use analytical##3##2##(2007-9#1)(2008-2#1)(2012-2#1)
use and (ii)##2##3##(2008-10#1)(2008-7#1)
use and HIV##3##3##(2007-11#2)(2012-11#1)
use and a##3##3##(2007-2#1)(2008-10#1)(2011-1#1)
use and abuse##6##3##(1991-1#1)(2008-11#2)(2010-7#1)(2012-2#2)
use and application of##2##4##(2008-10#1)(2013-7#1)
use and can##2##3##(2008-11#1)(2008-4#1)
use and communication##2##3##(2008-9#1)(2009-5#1)
use and cost of##2##4##(1995-3#1)(2006-8#1)
use and expenditures##6##3##(1990-12#1)(1991-12#1)(1991-3#1)(1994-2#1)(1995-3#1)(2007-2#1)
use and for##3##3##(1992-12#1)(2007-2#1)(2013-7#1)
use and high##4##3##(2007-7#1)(2008-10#1)(2008-8#1)(2010-2#1)
use and its##4##3##(2007-8#1)(2008-1#2)(2008-6#1)
use and low##3##3##(2008-9#1)(2009-7#2)
use and misuse of##2##4##(2008-8#1)(2009-4#1)
use and misuse##4##3##(1991-12#1)(2008-11#1)(2008-8#1)(2009-4#1)
use and offer##3##3##(1991-12#1)(2013-1#2)
use and other##5##3##(1997-6#1)(2008-1#1)(2008-9#1)(2011-2#1)(2013-1#1)
use and patients##2##3##(2008-9#1)(2012-2#1)
use and perceptions of##2##4##(2010-8#1)(2011-2#1)
use and potential##4##3##(1997-8#1)(2008-1#1)(2008-12#1)(2008-3#1)
use and prevalence of##2##4##(2012-3#2)
use and psychosis##3##3##(2005-10#3)
use and reduction##2##3##(2007-9#1)(2009-5#1)
use and resistance##2##3##(2005-8#1)(2013-1#1)
use and satisfaction##2##3##(2007-7#1)(2012-3#1)
use and smoking##2##3##(2007-8#1)(2012-12#1)
use and that##3##3##(1992-9#1)(2008-1#1)(2008-3#1)
use and the risk of##3##5##(1994-2#1)(2008-11#1)(2008-8#1)
use and the##17##3##(1994-2#1)(2005-11#2)(2006-10#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
use and their##2##3##(2008-9#1)(2010-12#1)
use and therapeutic##2##3##(2006-12#1)(2013-8#1)
use and those##2##3##(2006-3#1)(2008-9#1)
use and to##2##3##(2007-8#1)(2013-1#1)
use and treatment##2##3##(2006-10#1)(2011-1#1)
use and trend of drugs##2##5##(2010-12#2)
use and trend of##3##4##(2010-12#3)
use and trends##3##3##(2012-12#3)
use and##314##2##(1990-12#1)(1990-2#1)(1991-1#4)(1991-12#3)(1991-3#1)(1991-5#1)(1991-8#2)(1992-1#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-9#1)(1993-2#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-7#1)(1995-1#1)(1995-2#2)(1995-3#3)(1996-11#1)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#1)(2004-10#1)(2004-4#1)(2005-10#5)(2005-11#2)(2005-6#1)(2005-8#2)(2006-10#8)(2006-12#2)(2006-2#1)(2006-3#2)(2006-6#1)(2006-7#1)(2006-8#4)(2007-1#1)(2007-10#4)(2007-11#3)(2007-12#2)(2007-2#7)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#6)(2007-8#5)(2007-9#1)(2008-1#8)(2008-10#10)(2008-11#15)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#7)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#9)(2008-9#11)(2009-10#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#5)(2009-6#1)(2009-7#5)(2009-8#3)(2009-9#1)(2010-12#6)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#4)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#5)(2011-12#2)(2011-2#9)(2012-1#4)(2012-11#1)(2012-12#6)(2012-2#5)(2012-3#9)(2013-1#24)(2013-7#2)(2013-8#7)
use antibodies##2##2##(1991-12#1)(2008-11#1)
use any##7##2##(1992-2#1)(1997-2#1)(2007-2#1)(2008-3#1)(2010-12#1)(2013-1#2)
use appears to be##4##4##(1993-12#1)(2006-10#1)(2008-5#1)(2009-8#1)
use appropriate##3##2##(2011-2#1)(2012-2#1)(2013-8#1)
use are discussed##3##3##(1993-5#1)(2007-10#1)(2008-4#1)
use are not##2##3##(2006-5#1)(2008-11#1)
use are the##3##3##(2008-1#1)(2008-9#2)
use are under##2##3##(2008-7#1)(2011-2#1)
use are##44##2##(1990-2#1)(1991-11#1)(1992-6#1)(1993-12#1)(1993-5#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-3#1)(1996-3#1)(1996-6#1)(1997-2#1)(2005-10#1)(2005-8#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-10#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
use as a model##2##4##(2008-6#1)(2013-8#1)
use as a parameter##2##4##(1990-9#1)(1994-7#1)
use as a screening##2##4##(2008-5#1)(2012-1#1)
use as a standard##2##4##(1997-5#1)(2007-11#1)
use as a therapeutic##2##4##(2007-11#1)(2010-10#1)
use as a##66##3##(1990-9#1)(1991-9#1)(1992-6#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-7#1)(1997-5#1)(1997-6#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#5)(2007-12#3)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#2)(2009-7#1)(2010-10#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#3)(2013-1#1)(2013-7#2)(2013-8#2)
use as an effective##2##4##(2005-7#1)(2008-5#1)
use as an index##2##4##(1993-12#2)
use as an##27##3##(1990-8#1)(1993-12#3)(1995-2#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(2005-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2010-2#1)(2010-6#1)(2012-1#1)(2013-1#1)(2013-8#1)
use as drug##2##3##(1991-9#1)(1992-3#1)
use as live##2##3##(2012-2#1)(2013-8#1)
use as part of##2##4##(2008-2#1)(2013-8#1)
use as probes for##2##4##(1996-11#1)(2008-10#1)
use as probiotics##2##3##(2006-5#1)(2012-2#1)
use as templates##3##3##(2008-2#1)(2008-7#1)(2010-4#1)
use as therapeutic drugs##2##4##(2007-11#1)(2008-11#1)
use as therapeutic##3##3##(2006-7#1)(2007-11#1)(2008-11#1)
use as well as##6##4##(2007-8#1)(2008-9#1)(2013-1#4)
use as##191##2##(1990-11#1)(1990-3#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-9#2)(1992-3#1)(1992-6#1)(1993-12#3)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-7#3)(1996-8#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-4#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#8)(2007-12#5)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#10)(2008-11#9)(2008-12#1)(2008-2#15)(2008-3#4)(2008-4#5)(2008-5#9)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#3)(2009-3#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#7)(2012-3#1)(2013-1#8)(2013-7#3)(2013-8#5)
use assessed##2##2##(2010-2#1)(2011-1#1)
use associated with##3##3##(2008-8#1)(2009-4#1)(2010-8#1)
use at last##3##3##(2012-11#1)(2012-3#2)
use at the##8##3##(1990-12#1)(1993-12#1)(2006-5#1)(2008-10#1)(2008-3#1)(2009-1#1)(2012-2#1)(2013-8#1)
use at##20##2##(1990-12#2)(1991-2#1)(1993-12#1)(2006-5#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)(2009-1#1)(2009-2#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#3)(2013-8#1)
use available evidence##2##3##(2007-4#1)(2008-11#1)
use available##5##2##(2005-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-5#1)
use because##6##2##(1992-11#1)(2007-2#1)(2008-10#1)(2008-11#2)(2012-12#1)
use before##2##2##(2007-9#1)(2012-3#1)
use behavior##7##2##(2011-1#1)(2011-12#2)(2012-3#3)(2013-1#1)
use behaviors##10##2##(1994-2#2)(1996-1#4)(2012-3#1)(2013-1#3)
use between##2##2##(1991-6#1)(2008-12#1)
use both in##2##3##(2008-12#1)(2008-3#1)
use both##7##2##(2007-2#1)(2008-12#1)(2008-3#3)(2009-2#1)(2012-3#1)
use but only##3##3##(2009-7#1)(2012-1#2)
use but##10##2##(2006-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-6#1)(2012-1#2)
use by children##2##3##(2007-12#1)(2012-2#1)
use by other##2##3##(2005-12#1)(2007-4#1)
use by patients##4##3##(1993-6#1)(2006-8#2)(2007-12#1)
use by the##8##3##(2005-8#1)(2006-8#1)(2007-10#1)(2008-3#1)(2008-5#2)(2011-1#1)(2013-8#1)
use by women##3##3##(1994-5#1)(1996-11#1)(2007-11#1)
use by##74##2##(1991-1#2)(1992-12#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-5#1)(1994-6#1)(1995-12#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#2)(1997-1#1)(1997-2#1)(2004-10#1)(2005-12#1)(2005-8#3)(2006-10#3)(2006-2#1)(2006-8#4)(2007-10#1)(2007-11#3)(2007-12#3)(2007-4#1)(2007-7#3)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-8#1)(2009-3#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
use can be##6##3##(1996-10#1)(1996-11#1)(2006-8#1)(2007-8#1)(2012-1#1)(2013-1#1)
use can##14##2##(1991-10#1)(1996-10#1)(1996-11#1)(2005-10#1)(2005-12#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-5#1)(2009-9#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
use cases##11##2##(2008-7#1)(2013-1#10)
use causes##2##2##(2008-11#1)(2013-1#1)
use caution##2##2##(2007-5#1)(2008-7#1)
use cell##4##2##(2010-12#2)(2012-12#2)
use cells##2##2##(1996-2#1)(2008-11#1)
use certain##3##2##(2008-11#1)(2010-2#1)(2012-1#1)
use chirped pulses##2##3##(2007-11#1)(2007-12#1)
use chirped##3##2##(2007-11#2)(2007-12#1)
use climate##2##2##(2007-9#1)(2012-12#1)
use clinical data##2##3##(1992-6#1)(1997-2#1)
use clinical##6##2##(1992-6#1)(1997-2#1)(2006-10#1)(2006-5#1)(2006-6#1)(2009-4#1)
use clinically##2##2##(2011-1#1)(2011-2#1)
use clusters##2##2##(2012-3#1)(2013-1#1)
use computer##2##2##(1995-2#1)(2007-12#1)
use concentrations for new anticoccidial##2##5##(2008-5#2)
use conditions##3##2##(2005-11#1)(2008-10#1)(2008-5#1)
use condom##2##2##(2010-8#2)
use condoms during##2##3##(2007-6#1)(2011-12#1)
use condoms##16##2##(1990-6#1)(1994-12#1)(1997-5#1)(1997-7#1)(2006-7#1)(2007-6#3)(2007-7#2)(2008-4#3)(2009-5#1)(2011-12#1)(2012-3#1)
use contraception##2##2##(2005-12#1)(2012-12#1)
use contraceptives##2##2##(1990-6#1)(2012-12#1)
use could be##2##3##(2006-9#1)(2008-6#1)
use could##5##2##(1995-8#1)(2006-9#1)(2008-11#1)(2008-6#1)(2012-2#1)
use current##2##2##(2007-7#1)(2011-3#1)
use data from a##3##4##(1997-7#1)(2012-12#1)(2013-1#1)
use data from the##7##4##(2006-6#1)(2008-3#1)(2008-8#1)(2010-2#1)(2011-12#1)(2012-12#1)(2012-3#1)
use data from##12##3##(1997-7#1)(2006-6#1)(2007-12#1)(2008-3#1)(2008-8#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
use data##18##2##(1997-7#1)(2006-6#1)(2007-12#1)(2008-3#1)(2008-8#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#3)
use decarboxylated##2##2##(2009-8#1)(2013-8#1)
use declined##2##2##(2007-7#1)(2012-3#1)
use depends on the##2##4##(2008-10#1)(2011-1#1)
use deterministic##2##2##(1996-3#1)(2008-9#1)
use diagnostic##3##2##(1990-10#1)(1990-2#1)(2007-7#1)
use did not##2##3##(2008-11#1)(2010-2#1)
use different models##2##3##(1992-6#1)(2008-3#1)
use different##23##2##(1991-8#1)(1992-6#1)(1993-12#1)(1993-6#1)(1995-1#1)(1995-3#1)(1996-2#1)(1997-6#1)(2007-1#1)(2007-6#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-11#1)(2012-2#1)(2013-1#3)
use directly##2##2##(1990-12#1)(2012-3#1)
use disorder and##3##3##(2009-11#1)(2012-12#1)(2013-1#1)
use disorder##17##2##(2008-1#1)(2008-6#1)(2009-11#2)(2010-2#1)(2010-6#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
use disorders (AUDs)##2##3##(2005-6#1)(2008-11#1)
use disorders and##3##3##(2004-3#1)(2010-6#1)(2012-12#1)
use disorders in adolescents##2##4##(2005-6#1)(2008-6#1)
use disorders in##6##3##(2004-3#1)(2005-6#1)(2008-6#1)(2012-12#1)(2012-3#2)
use disorders##37##2##(1997-5#3)(2004-3#3)(2005-6#3)(2005-7#1)(2008-1#1)(2008-11#1)(2008-6#2)(2009-10#1)(2009-12#1)(2009-9#1)(2010-2#3)(2010-6#3)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#5)(2012-3#4)(2013-8#2)
use does not##3##3##(1993-2#1)(2005-7#1)(2009-5#1)
use drugs##5##2##(1990-3#1)(1991-7#1)(1994-2#1)(2007-11#1)(2009-9#1)
use due to the##2##4##(1991-12#1)(2011-1#1)
use due to##4##3##(1991-12#1)(2007-7#1)(2011-1#1)(2013-1#1)
use during initial##2##3##(2007-10#1)(2008-6#1)
use during pregnancy##3##3##(1991-1#1)(2008-11#1)(2010-2#1)
use during the##4##3##(2006-10#1)(2006-4#1)(2010-7#1)(2012-3#1)
use during##27##2##(1991-1#1)(1991-12#1)(1992-5#1)(1994-3#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-1#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-7#3)(2010-8#1)(2011-1#2)(2012-3#1)(2013-8#1)
use early in##2##3##(2008-11#1)(2009-7#1)
use efficiency (NUE)##2##3##(2012-1#1)(2013-8#1)
use efficiency of##2##3##(2008-10#1)(2013-8#1)
use efficiency##10##2##(2008-10#2)(2008-5#2)(2008-9#2)(2012-1#1)(2013-8#3)
use either##5##2##(2005-12#1)(2008-2#1)(2008-3#1)(2012-2#2)
use electrical##3##2##(2006-4#1)(2011-2#2)
use family##4##2##(2006-1#1)(2010-8#1)(2011-1#1)(2012-3#1)
use fewer animals##2##3##(2008-8#1)(2008-9#1)
use fewer##4##2##(2008-2#2)(2008-8#1)(2008-9#1)
use for a##6##3##(1996-3#1)(2008-10#1)(2008-3#1)(2010-8#1)(2010-9#1)(2012-1#1)
use for decades##3##3##(2006-10#1)(2007-4#1)(2010-4#1)
use for detection of##2##4##(2007-8#1)(2008-10#1)
use for in vivo##2##4##(2008-1#1)(2008-2#1)
use for in##3##3##(2008-1#1)(2008-2#1)(2008-4#1)
use for other##2##3##(2008-11#1)(2012-12#1)
use for protein##2##3##(2007-11#1)(2007-8#1)
use for several years##2##4##(2007-11#2)
use for the##17##3##(1990-12#1)(1995-3#2)(2006-7#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#3)(2010-2#1)(2010-8#1)
use for these##2##3##(1995-2#1)(2012-12#1)
use for treating##2##3##(2009-7#1)(2013-1#1)
use for treatment of##3##4##(2008-5#1)(2011-1#1)(2012-12#1)
use for##138##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-1#1)(1991-12#1)(1992-1#1)(1992-2#1)(1994-3#1)(1995-2#2)(1995-3#3)(1995-5#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-4#1)(2005-12#1)(2005-7#1)(2006-10#4)(2006-12#2)(2006-6#2)(2006-7#2)(2007-11#6)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#6)(2008-1#1)(2008-10#21)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#1)(2009-3#3)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#4)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
use from##6##2##(1991-9#1)(2005-3#1)(2008-12#1)(2009-7#3)
use functional##2##2##(2007-8#1)(2012-2#1)
use gesture to##2##3##(2010-2#2)
use groundwater##2##2##(2007-10#2)
use had##2##2##(2006-7#1)(2011-12#1)
use has been associated with##3##5##(2006-9#1)(2008-6#1)(2008-8#1)
use has been limited##2##4##(1992-2#1)(2007-2#1)
use has been##14##3##(1991-6#1)(1992-2#1)(1996-5#1)(2006-9#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-9#1)(2011-2#1)
use has increased##3##3##(1990-3#1)(1992-2#1)(2007-8#1)
use has not been##2##4##(2007-8#1)(2012-12#1)
use has##27##2##(1990-3#1)(1991-6#1)(1992-2#2)(1994-3#1)(1995-8#1)(1996-5#1)(2006-9#1)(2007-2#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-9#2)(2010-7#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
use have been##4##3##(2007-10#1)(2008-10#1)(2009-6#1)(2010-9#1)
use have not##2##3##(2008-11#1)(2008-2#1)
use have##9##2##(1997-6#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-6#1)(2010-9#1)
use health##4##2##(1991-6#1)(2008-3#1)(2013-1#2)
use high##4##2##(1997-8#1)(2008-10#1)(2008-5#1)(2008-6#1)
use highly##2##2##(2008-4#1)(2008-7#1)
use improved##2##2##(1990-12#1)(2009-11#1)
use improves the##2##3##(2005-5#1)(2007-11#1)
use improves##3##2##(2005-5#1)(2007-11#1)(2008-3#1)
use in Canada##2##3##(2007-7#1)(2008-6#1)
use in Crohn's disease##2##4##(2007-11#2)
use in India##2##3##(2009-9#1)(2010-7#1)
use in MDIs will##2##4##(1992-3#1)(1996-1#1)
use in New##2##3##(1991-1#1)(2004-2#1)
use in a case##3##4##(1993-9#1)(2013-1#2)
use in a variety of##4##5##(1993-4#1)(2005-6#2)(2012-2#1)
use in a wide##2##4##(2005-11#1)(2008-5#1)
use in a##45##3##(1990-2#1)(1991-1#1)(1992-12#1)(1992-3#1)(1993-4#1)(1993-9#1)(1995-3#1)(1996-11#1)(1996-3#1)(1997-8#1)(2005-11#1)(2005-6#2)(2006-10#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#3)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-11#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#4)
use in acute stroke##2##4##(2007-9#1)(2008-8#1)
use in acute##5##3##(2007-11#1)(2007-9#2)(2008-5#1)(2008-8#1)
use in adult##2##3##(1996-9#1)(2013-8#1)
use in aerosol##2##3##(1994-1#1)(1994-12#1)
use in all##4##3##(1991-9#1)(2008-10#1)(2008-3#1)(2013-1#1)
use in allergic rhinitis##2##4##(2007-11#1)(2008-5#1)
use in allergic##3##3##(2007-11#1)(2008-10#1)(2008-5#1)
use in an ELISA##3##4##(1994-9#1)(1995-2#1)(1996-10#1)
use in an##12##3##(1994-9#1)(1995-2#1)(1996-10#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#3)(2008-7#1)(2010-2#1)
use in animal##2##3##(2008-11#1)(2011-2#1)
use in assessing##2##3##(1997-1#1)(2006-10#1)
use in biological##3##3##(2005-11#1)(2006-6#1)(2008-10#1)
use in both##5##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-11#1)
use in cancer##2##3##(1991-9#1)(1994-12#1)
use in children##6##3##(2006-10#2)(2007-5#1)(2008-11#1)(2011-2#1)(2012-2#1)
use in children's products##2##4##(2005-7#2)
use in chronic##2##3##(1991-6#1)(2007-11#1)
use in clinical practice is##2##5##(1997-7#1)(2005-7#1)
use in clinical practice##9##4##(1997-7#1)(2005-7#1)(2006-10#1)(2007-5#1)(2008-2#1)(2008-6#1)(2009-12#1)(2011-2#1)(2012-3#1)
use in clinical##17##3##(1997-7#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-11#2)(2007-5#1)(2007-7#1)(2008-2#1)(2008-6#1)(2009-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
use in combination with##4##4##(2005-9#1)(2006-6#1)(2008-10#2)
use in conjunction with##4##4##(2008-10#1)(2008-4#1)(2009-2#2)
use in conservation##2##3##(2013-7#1)(2013-8#1)
use in cosmetic##2##3##(2008-5#2)
use in cosmetics##2##3##(2008-5#2)
use in determining the##2##4##(2007-11#1)(2008-4#1)
use in determining##4##3##(1991-1#1)(2007-11#1)(2008-10#1)(2008-4#1)
use in different##2##3##(2008-10#1)(2008-12#1)
use in disorders of##2##4##(2006-12#1)(2008-7#1)
use in early##2##3##(2007-10#1)(2012-3#1)
use in experiments##2##3##(2007-11#1)(2008-4#1)
use in forensic##6##3##(1996-5#1)(1996-6#2)(1997-3#1)(2008-10#1)(2008-6#1)
use in gene therapy##2##4##(2010-1#2)
use in gene##3##3##(2008-10#1)(2010-1#2)
use in general##2##3##(1990-6#1)(2008-6#1)
use in high##2##3##(1995-8#1)(2008-8#1)
use in high-resolution##3##3##(2007-12#1)(2008-3#2)
use in hospital##2##3##(2008-2#1)(2013-8#1)
use in human gene therapy##3##5##(1993-2#1)(1994-5#1)(1997-4#1)
use in human##5##3##(1993-2#1)(1994-5#1)(1997-4#1)(2006-12#1)(2008-5#1)
use in humans##3##3##(2006-10#2)(2007-1#1)
use in industrial##3##3##(2006-8#1)(2008-7#1)(2012-2#1)
use in inflammatory##2##3##(2004-12#1)(2010-5#1)
use in liver##2##3##(2007-11#1)(2008-11#1)
use in living##2##3##(2009-7#1)(2010-4#1)
use in many##3##3##(2007-12#1)(2008-4#2)
use in medical##5##3##(2007-7#1)(2008-11#1)(2009-8#1)(2012-1#1)(2013-8#1)
use in modeling##2##3##(2007-4#1)(2008-2#1)
use in most##2##3##(2006-11#1)(2013-1#1)
use in older##3##3##(1996-2#1)(2008-3#1)(2012-12#1)
use in optical##4##3##(2007-11#1)(2008-3#2)(2009-5#1)
use in other##4##3##(2006-10#1)(2008-2#1)(2012-12#2)
use in our##2##3##(2008-5#1)(2009-2#1)
use in patients with##14##4##(1997-4#1)(2005-6#1)(2005-7#1)(2006-2#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#1)(2010-11#1)(2010-12#1)(2012-2#1)
use in patients##19##3##(1997-4#1)(2005-6#1)(2005-7#1)(2006-2#1)(2006-8#2)(2007-11#4)(2007-12#1)(2007-7#1)(2007-8#1)(2010-11#1)(2010-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
use in pediatric patients##3##4##(2007-3#1)(2008-10#1)(2011-2#1)
use in pediatric##5##3##(2005-8#1)(2007-3#1)(2008-10#1)(2011-1#1)(2011-2#1)
use in pharmaceutical##2##3##(2005-10#1)(2011-2#1)
use in practice##2##3##(2008-10#1)(2008-11#1)
use in pregnancy##5##3##(2006-10#1)(2006-8#1)(2008-11#1)(2008-8#1)(2010-2#1)
use in preventing##2##3##(2008-10#1)(2008-5#1)
use in primary##2##3##(2010-12#1)(2013-7#1)
use in protein##2##3##(1992-8#1)(2008-7#1)
use in routine clinical practice##2##5##(2007-10#1)(2008-3#1)
use in routine##5##3##(2007-10#1)(2008-10#3)(2008-3#1)
use in skin##2##3##(2008-3#1)(2008-5#1)
use in special##2##3##(2011-1#1)(2012-2#1)
use in studies##4##3##(1993-12#1)(1993-8#1)(1995-2#1)(2008-10#1)
use in studying##2##3##(2008-10#1)(2008-9#1)
use in the U##2##4##(1997-1#1)(2008-1#1)
use in the USA##3##4##(2005-7#2)(2006-10#1)
use in the United States are##2##6##(1993-1#1)(2005-8#1)
use in the United States##7##5##(1991-8#1)(1993-1#1)(1996-7#1)(2005-8#1)(2007-12#1)(2007-9#1)(2009-11#1)
use in the active##2##4##(2006-2#1)(2008-4#1)
use in the assessment of##3##5##(2007-1#1)(2008-6#1)(2011-1#1)
use in the construction of##4##5##(1994-12#1)(2004-9#1)(2008-10#1)(2008-9#1)
use in the context of##3##5##(2010-7#1)(2013-1#2)
use in the detection of##3##5##(2006-12#1)(2008-3#1)(2008-5#1)
use in the development of##3##5##(2006-10#1)(2006-5#1)(2008-10#1)
use in the diagnosis and##2##5##(1991-8#1)(2007-11#1)
use in the diagnosis##4##4##(1991-8#1)(1995-12#1)(1996-4#1)(2007-11#1)
use in the early##2##4##(2006-10#1)(2013-1#1)
use in the elderly##2##4##(2006-3#1)(2006-9#1)
use in the last##2##4##(2006-8#1)(2012-12#1)
use in the management of##7##5##(2005-7#1)(2007-11#1)(2007-8#1)(2008-2#1)(2009-12#1)(2009-4#1)(2013-8#1)
use in the operating room##2##5##(2006-9#1)(2007-5#1)
use in the operating##3##4##(1996-9#1)(2006-9#1)(2007-5#1)
use in the optimization of##2##5##(2008-10#1)(2008-2#1)
use in the study of##2##5##(2008-11#1)(2008-9#1)
use in the therapy of##2##5##(1994-6#1)(2005-7#1)
use in the treatment of patients with##2##7##(2007-12#1)(2009-3#1)
use in the treatment of##22##5##(1996-4#1)(2005-7#2)(2005-9#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#2)(2008-3#1)(2008-5#1)(2008-6#1)(2009-3#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
use in the##179##3##(1990-8#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-8#2)(1992-2#1)(1993-1#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-4#2)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-6#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#6)(2005-8#1)(2005-9#2)(2006-10#8)(2006-12#3)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#12)(2007-12#4)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#5)(2007-9#1)(2008-1#5)(2008-10#9)(2008-11#3)(2008-12#3)(2008-2#4)(2008-3#5)(2008-4#7)(2008-5#3)(2008-6#2)(2008-7#2)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#2)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-7#4)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#4)
use in these##5##3##(1994-6#1)(2007-7#1)(2008-10#2)(2008-4#1)
use in this##8##3##(1990-1#1)(1996-2#1)(2006-10#1)(2008-1#1)(2008-6#2)(2008-8#1)(2010-6#1)
use in treating##3##3##(2006-10#1)(2007-10#1)(2011-1#1)
use in treatment of##2##4##(2008-11#1)(2013-7#1)
use in two##2##3##(2006-8#1)(2009-6#1)
use in various##3##3##(1995-5#1)(2008-10#1)(2008-3#1)
use in women with##2##4##(1991-1#1)(2006-10#1)
use in##896##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#3)(1991-1#6)(1991-12#3)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#3)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#4)(1992-3#5)(1992-5#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#6)(1993-2#1)(1993-4#2)(1993-5#1)(1993-8#2)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#3)(1994-5#3)(1994-6#5)(1994-9#3)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#6)(1995-3#1)(1995-5#3)(1995-8#2)(1995-9#1)(1996-1#3)(1996-10#2)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#3)(1996-7#2)(1996-8#2)(1996-9#4)(1997-1#5)(1997-2#1)(1997-3#4)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#3)(2004-12#1)(2004-2#3)(2004-3#1)(2004-4#1)(2004-9#5)(2005-10#2)(2005-11#5)(2005-12#3)(2005-4#1)(2005-6#3)(2005-7#16)(2005-8#7)(2005-9#5)(2006-1#2)(2006-10#35)(2006-11#2)(2006-12#9)(2006-2#5)(2006-3#2)(2006-4#4)(2006-5#2)(2006-6#4)(2006-7#1)(2006-8#8)(2006-9#3)(2007-1#2)(2007-10#7)(2007-11#41)(2007-12#27)(2007-2#2)(2007-3#3)(2007-4#6)(2007-5#3)(2007-6#3)(2007-7#12)(2007-8#12)(2007-9#7)(2008-1#15)(2008-10#63)(2008-11#23)(2008-12#6)(2008-2#21)(2008-3#42)(2008-4#24)(2008-5#27)(2008-6#8)(2008-7#12)(2008-8#8)(2008-9#7)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#8)(2009-2#4)(2009-3#5)(2009-4#6)(2009-5#3)(2009-6#2)(2009-7#11)(2009-8#4)(2009-9#3)(2010-1#3)(2010-10#2)(2010-11#11)(2010-12#5)(2010-2#3)(2010-3#1)(2010-4#9)(2010-5#3)(2010-6#1)(2010-7#5)(2010-8#3)(2010-9#4)(2011-1#11)(2011-12#6)(2011-2#14)(2011-3#1)(2012-1#5)(2012-11#5)(2012-12#16)(2012-2#11)(2012-3#12)(2012-8#1)(2013-1#23)(2013-7#6)(2013-8#18)
use include##2##2##(1996-2#1)(2006-10#1)
use increased##4##2##(2007-10#1)(2009-12#1)(2010-4#1)(2012-3#1)
use indicators##2##2##(2003-12#1)(2008-11#1)
use individual##2##2##(2007-2#1)(2012-2#1)
use information##5##2##(2009-2#1)(2010-8#1)(2011-2#1)(2013-1#2)
use interactively in##2##3##(2008-3#2)
use internet##2##2##(2012-2#2)
use iron##2##2##(2008-1#1)(2008-3#1)
use is a key##2##4##(2009-8#1)(2012-3#1)
use is a##4##3##(1996-7#1)(2009-8#1)(2012-12#1)(2012-3#1)
use is an##2##3##(2006-2#1)(2007-12#1)
use is associated with several##2##5##(2007-10#1)(2007-11#1)
use is associated with##8##4##(2007-10#2)(2007-11#1)(2007-8#1)(2008-2#1)(2009-2#1)(2010-12#1)(2013-1#1)
use is becoming##2##3##(2008-7#1)(2013-8#1)
use is essential for##3##4##(2005-8#1)(2007-11#1)(2007-8#1)
use is important##2##3##(2012-12#1)(2013-1#1)
use is likely to##2##4##(2006-10#1)(2010-12#1)
use is limited by##6##4##(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-4#1)(2013-7#1)
use is limited due to##2##5##(2007-8#1)(2008-5#1)
use is limited in##2##4##(2011-2#1)(2013-8#1)
use is limited##11##3##(2006-10#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2009-4#1)(2011-2#1)(2013-7#1)(2013-8#1)
use is not##5##3##(1990-6#1)(2007-2#1)(2008-5#1)(2010-2#1)(2012-12#1)
use is of##2##3##(1997-2#1)(1997-3#1)
use is still##3##3##(1994-12#1)(2009-10#1)(2012-12#1)
use is the##3##3##(2007-12#1)(2008-7#1)(2013-8#1)
use is to##4##3##(2007-5#1)(2008-7#1)(2010-11#1)(2012-1#1)
use is unlikely to be##2##5##(1993-9#1)(2010-1#1)
use is##117##2##(1990-2#1)(1990-6#1)(1991-11#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-5#1)(1996-7#1)(1996-9#4)(1997-2#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#5)(2006-2#2)(2006-9#1)(2007-10#3)(2007-11#5)(2007-12#4)(2007-2#2)(2007-5#2)(2007-8#6)(2008-1#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#4)(2011-3#1)(2012-1#4)(2012-12#6)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
use it for##6##3##(1994-11#1)(1997-3#1)(2008-11#2)(2013-7#2)
use it in##3##3##(2008-2#2)(2009-3#1)
use it to##8##3##(1996-8#1)(2007-11#2)(2007-4#1)(2007-8#1)(2008-3#1)(2008-7#1)(2013-8#1)
use it##29##2##(1992-11#1)(1992-4#1)(1994-11#1)(1996-1#1)(1996-8#1)(1997-3#1)(2006-10#2)(2006-5#1)(2007-11#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-11#3)(2008-2#2)(2008-3#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-7#1)(2010-4#1)(2012-3#1)(2013-7#2)(2013-8#1)
use its##3##2##(2007-1#1)(2008-5#1)(2012-2#1)
use just##2##2##(2007-12#1)(2007-8#1)
use knowledge##2##2##(2010-7#1)(2012-3#1)
use large##2##2##(2008-2#1)(2012-2#1)
use less##4##2##(1990-5#1)(2008-10#1)(2008-11#1)(2013-1#1)
use limited##2##2##(1997-1#1)(2007-5#1)
use longitudinal##2##2##(2009-4#1)(2012-12#1)
use may affect##2##3##(2008-9#1)(2013-1#1)
use may be##8##3##(1996-12#1)(2004-4#1)(2006-12#1)(2008-3#1)(2011-1#1)(2011-7#1)(2012-1#1)(2012-12#1)
use may##25##2##(1996-10#1)(1996-12#1)(2004-4#1)(2005-10#2)(2006-11#1)(2006-12#1)(2007-11#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
use measurements of##4##3##(1990-2#1)(2008-2#1)(2008-5#1)(2008-8#1)
use measurements##5##2##(1990-2#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)
use method##2##2##(2008-3#1)(2013-1#1)
use methods##3##2##(1994-11#1)(1994-7#1)(2008-4#1)
use might##2##2##(2006-10#1)(2012-12#1)
use molecular##4##2##(2005-8#1)(2008-11#1)(2012-12#2)
use more##3##2##(2007-6#1)(2010-1#1)(2012-1#1)
use morphological##2##2##(2007-12#1)(2008-8#1)
use multiple##11##2##(2005-8#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-11#1)(2011-1#2)
use neuromuscular##2##2##(1993-9#1)(2008-8#1)
use new##3##2##(1994-12#1)(1997-2#1)(2012-3#1)
use nonlinear##3##2##(2007-11#1)(2007-12#1)(2007-9#1)
use norms##2##2##(2007-4#1)(2012-3#1)
use not only##2##3##(2006-2#1)(2008-5#1)
use not##3##2##(2006-10#1)(2006-2#1)(2008-5#1)
use numerical##3##2##(2008-2#2)(2008-3#1)
use of &quot##10##3##(1992-10#1)(1996-3#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-12#1)(2009-5#1)(2010-12#1)(2010-5#1)(2012-12#1)
use of (1)##2##3##(1990-9#1)(2008-1#1)
use of 0##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
use of 123-I MIBG imaging##2##5##(2012-2#2)
use of 2##2##3##(1996-5#1)(2008-4#1)
use of AM##2##3##(1992-2#1)(2007-1#1)
use of ATP##2##3##(1995-2#1)(1996-9#1)
use of BPA##2##3##(2010-9#2)
use of Bacillus-based BCAs##2##4##(2008-10#2)
use of Benzodiazepines##2##3##(2008-2#2)
use of CAM treatments##2##4##(2013-1#2)
use of CAM##4##3##(2008-10#1)(2013-1#3)
use of CBT##3##3##(2007-6#3)
use of CD-ROM##2##3##(1991-3#1)(1995-3#1)
use of CECs##2##3##(2008-2#2)
use of CEUS##3##3##(2010-12#3)
use of CO(2)##2##3##(2007-8#1)(2008-3#1)
use of CT##7##3##(1992-12#1)(2006-10#1)(2007-7#1)(2008-3#1)(2011-2#1)(2013-1#2)
use of CpG##2##3##(1993-6#1)(2009-3#1)
use of DFO and##2##4##(2008-3#2)
use of DHEAS##2##3##(1995-12#2)
use of DM##2##3##(1995-3#1)(1996-3#1)
use of DNA microarrays##3##4##(2008-4#1)(2008-7#1)(2012-3#1)
use of DNA##9##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2012-3#2)(2013-8#1)
use of FFP##2##3##(2005-12#2)
use of Fourier##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
use of G-CSF##3##3##(1994-3#1)(2007-3#1)(2010-12#1)
use of GFP##3##3##(1996-6#1)(2008-10#1)(2008-11#1)
use of GP IIb/IIIa##2##4##(2005-7#2)
use of Gaussian##3##3##(1993-9#1)(2008-2#1)(2008-6#1)
use of HA##2##3##(1993-12#1)(2009-7#1)
use of HAART##2##3##(2005-10#1)(2013-8#1)
use of HPLC##3##3##(1990-8#1)(1991-5#2)
use of HRCT##2##3##(2005-8#2)
use of IR##2##3##(2007-7#1)(2008-3#1)
use of Ligasure##2##3##(2007-8#1)(2009-2#1)
use of MRI for##2##4##(1993-5#1)(2007-4#1)
use of MRI##7##3##(1993-5#1)(1995-1#1)(1996-8#1)(2007-11#1)(2007-4#1)(2012-12#1)(2013-1#1)
use of MTX##3##3##(2006-10#1)(2008-8#2)
use of Medicare's##2##3##(1994-12#1)(1994-2#1)
use of Mersilene mesh in##2##5##(1990-4#2)
use of Mersilene mesh##3##4##(1990-4#3)
use of MgCl2##2##3##(1990-7#2)
use of N##4##3##(2007-1#1)(2008-10#1)(2008-4#1)(2011-1#1)
use of N-acetylcysteine in##2##4##(1991-9#1)(2006-4#1)
use of N-acetylcysteine##3##3##(1991-9#2)(2006-4#1)
use of NHPs##2##3##(2008-10#2)
use of NMDA receptor modulators in the treatment of treatment-resistant depression##2##11##(2012-12#2)
use of NiTinol##2##3##(2006-6#2)
use of OCT##2##3##(2009-4#1)(2011-7#1)
use of Oblimersen##2##3##(2008-5#2)
use of PCR##5##3##(1995-1#1)(2006-10#1)(2006-8#1)(2008-4#1)(2008-5#1)
use of PDT##2##3##(2005-7#1)(2009-4#1)
use of RNA##2##3##(2008-7#1)(2012-11#1)
use of Raman spectroscopy##2##4##(2008-3#1)(2010-5#1)
use of Raman##3##3##(2007-12#1)(2008-3#1)(2010-5#1)
use of SPME##3##3##(2008-10#3)
use of TCD##2##3##(2012-1#2)
use of TNF-α antagonists in aphthous ulceration##2##7##(2012-1#2)
use of TNF-α antagonists in##3##5##(2012-1#3)
use of TNF-α##4##3##(2012-1#3)(2013-7#1)
use of ULDA##2##3##(2007-9#2)
use of UV##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
use of VCT services was##2##5##(2013-1#2)
use of X-ray##6##3##(2006-4#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#2)
use of Xenopus oocytes##3##4##(1990-7#1)(2007-12#2)
use of a &quot##2##4##(2007-7#1)(2008-4#1)
use of a 5x10(-4) M Fe(III)-1x10(-3) M Fe(II) buffer containing 0##2##11##(2008-10#2)
use of a Nd##4##4##(2007-12#3)(2008-3#1)
use of a PCR-based##2##4##(1995-2#1)(1995-6#1)
use of a binary##2##4##(2008-2#1)(2008-3#1)
use of a chirped##2##4##(2007-11#1)(2007-12#1)
use of a coherent##3##4##(2007-12#1)(2008-3#2)
use of a combination of##8##5##(1996-9#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-7#1)
use of a combined##2##4##(2007-1#1)(2008-10#1)
use of a commercial##5##4##(1991-8#1)(2007-8#1)(2008-10#1)(2008-2#1)(2013-8#1)
use of a commercially available##2##5##(2007-12#1)(2008-11#1)
use of a composite##2##4##(2008-10#1)(2008-2#1)
use of a computer##3##4##(2008-11#1)(2008-2#1)(2008-3#1)
use of a conceptual##2##4##(2010-8#1)(2012-3#1)
use of a continuous##5##4##(1993-4#1)(1994-3#1)(2008-2#1)(2008-6#1)(2013-8#1)
use of a diffraction grating##2##5##(2007-12#1)(2008-3#1)
use of a diffractive##2##4##(2007-12#1)(2008-3#1)
use of a digital##3##4##(1993-2#1)(2007-12#2)
use of a diode laser##2##5##(2008-1#1)(2008-3#1)
use of a diode##3##4##(2008-1#1)(2008-3#1)(2008-4#1)
use of a dual-wavelength##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
use of a few##2##4##(2007-12#1)(2008-10#1)
use of a fiber##4##4##(2007-12#2)(2008-2#2)
use of a flexible##2##4##(1992-1#1)(2007-8#1)
use of a focused##5##4##(2007-12#2)(2008-10#1)(2008-2#1)(2011-1#1)
use of a hand-held##2##4##(2005-7#1)(2008-10#1)
use of a highly##4##4##(2007-12#1)(2007-8#1)(2008-3#2)
use of a hybrid##2##4##(2008-2#1)(2012-12#1)
use of a joint transform correlator##2##6##(2008-2#1)(2008-3#1)
use of a large##5##4##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
use of a laser##4##4##(2007-12#2)(2008-2#2)
use of a linear##4##4##(1993-10#1)(2008-2#1)(2008-3#1)(2011-12#1)
use of a liquid##2##4##(2007-12#2)
use of a liquid-crystal##4##4##(2007-11#2)(2008-3#2)
use of a local##2##4##(2007-11#1)(2008-3#1)
use of a low##2##4##(2008-3#2)
use of a low-cost##2##4##(2008-10#1)(2008-3#1)
use of a method##2##4##(2008-2#1)(2008-3#1)
use of a modified##9##4##(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#2)(2008-3#1)
use of a multiple##3##4##(1995-2#1)(2008-4#2)
use of a nearly degenerate broadband##2##6##(2008-3#2)
use of a new##13##4##(1991-1#1)(1992-2#1)(1992-4#1)(1997-5#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-6#1)(2008-2#2)(2008-3#2)(2009-2#1)
use of a newly##2##4##(2006-2#1)(2008-2#1)
use of a nonlinear##4##4##(2007-12#2)(2008-2#1)(2008-3#1)
use of a novel technique##4##5##(2007-11#1)(2007-12#3)
use of a novel##12##4##(2007-11#2)(2007-12#6)(2008-3#1)(2008-5#1)(2008-9#1)(2013-1#1)
use of a number of##3##5##(1991-12#1)(2008-2#1)(2008-9#1)
use of a particular##2##4##(2007-7#1)(2008-3#1)
use of a phase mask##3##5##(2007-12#2)(2008-2#1)
use of a photorefractive##3##4##(2007-12#2)(2008-3#1)
use of a previously##2##4##(2008-11#1)(2008-3#1)
use of a relatively##2##4##(2009-5#1)(2009-8#1)
use of a scanning##4##4##(2007-11#1)(2008-3#3)
use of a screening##2##4##(2008-10#1)(2008-5#1)
use of a second-order##2##4##(2008-2#1)(2008-3#1)
use of a segmented##2##4##(2007-12#1)(2008-2#1)
use of a set of##5##5##(1993-9#1)(2007-9#1)(2008-10#2)(2008-3#1)
use of a short##3##4##(2007-11#1)(2008-1#1)(2008-3#1)
use of a simple##12##4##(1992-6#1)(2006-12#1)(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#2)(2008-4#1)
use of a single Raman signal##2##6##(2007-12#1)(2008-3#1)
use of a single##18##4##(1995-8#1)(2007-11#2)(2007-12#4)(2008-10#2)(2008-2#1)(2008-3#6)(2008-6#1)(2009-10#1)
use of a slit##3##4##(2008-2#2)(2008-3#1)
use of a small##3##4##(2008-3#2)(2008-9#1)
use of a solid##2##4##(2008-10#1)(2008-3#1)
use of a spatial##3##4##(1991-12#1)(2007-12#2)
use of a specially designed##2##5##(2007-12#1)(2008-11#1)
use of a specially##3##4##(2007-11#1)(2007-12#1)(2008-11#1)
use of a spiritually based##2##5##(2010-10#2)
use of a standard##5##4##(1991-12#1)(2008-2#1)(2008-3#3)
use of a structured##3##4##(2007-2#1)(2008-3#1)(2010-3#1)
use of a suitable##4##4##(1990-11#1)(2007-12#1)(2008-2#1)(2008-7#1)
use of a synthetic graft##2##5##(2007-7#1)(2011-2#1)
use of a synthetic##5##4##(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2011-2#1)
use of a thin##2##4##(2007-12#1)(2008-1#1)
use of a three-dimensional##2##4##(2007-12#1)(2008-10#1)
use of a trochanteric claw plate##4##6##(2007-11#4)
use of a two-step##4##4##(2007-12#1)(2008-3#1)(2008-9#1)(2013-8#1)
use of a uniform##2##4##(1993-3#1)(1996-12#1)
use of a variety of##5##5##(1991-9#1)(1993-3#1)(2004-9#1)(2008-2#1)(2008-3#1)
use of a volume##2##4##(2007-12#1)(2008-3#1)
use of a weak##2##4##(2007-10#1)(2007-12#1)
use of a wedged##2##4##(2007-12#2)
use of a wide range of##2##6##(1996-3#1)(2007-11#1)
use of a wide##3##4##(1996-11#1)(1996-3#1)(2007-11#1)
use of a##971##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#2)(1991-1#1)(1991-12#5)(1991-2#3)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#3)(1992-1#2)(1992-10#2)(1992-11#1)(1992-2#3)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#5)(1993-4#3)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#4)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#3)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#3)(1997-3#4)(1997-5#1)(1997-7#1)(2004-9#1)(2005-11#3)(2005-12#1)(2005-7#1)(2005-8#2)(2006-10#6)(2006-11#3)(2006-12#3)(2006-2#1)(2006-3#2)(2006-4#2)(2006-5#5)(2006-6#3)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#75)(2007-12#161)(2007-2#2)(2007-6#1)(2007-7#14)(2007-8#15)(2007-9#3)(2008-1#15)(2008-10#70)(2008-11#10)(2008-12#6)(2008-2#105)(2008-3#187)(2008-4#12)(2008-5#9)(2008-6#9)(2008-7#8)(2008-8#3)(2008-9#11)(2009-1#1)(2009-10#3)(2009-11#3)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#3)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#4)(2010-3#2)(2010-4#3)(2010-5#1)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#4)(2011-12#2)(2011-2#9)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#6)(2012-3#6)(2013-1#11)(2013-7#3)(2013-8#9)
use of abortion##2##3##(1994-2#1)(2006-4#1)
use of adaptive optics##4##4##(2007-12#3)(2011-1#1)
use of adaptive##7##3##(2007-12#3)(2008-2#2)(2008-3#1)(2011-1#1)
use of additional##6##3##(2007-11#1)(2007-12#2)(2009-5#1)(2010-2#2)
use of adeno-associated virus##2##4##(1995-12#1)(2005-7#1)
use of adenovirus##2##3##(1994-8#1)(2005-9#1)
use of adjuvant##7##3##(1994-8#1)(1995-4#1)(2006-12#1)(2007-11#1)(2007-2#1)(2008-7#1)(2010-5#1)
use of advance directives##3##4##(1992-12#1)(1993-2#1)(2010-8#1)
use of advanced##6##3##(1992-9#1)(2007-4#2)(2009-2#1)(2013-1#2)
use of aerosol##3##3##(1997-1#1)(2008-10#1)(2010-3#1)
use of aerosolized##2##3##(2006-10#2)
use of agricultural##2##3##(2008-11#1)(2008-12#1)
use of alcohol and drugs##2##5##(2006-8#1)(2008-9#1)
use of alcohol and##4##4##(2006-8#1)(2008-9#1)(2009-5#2)
use of alcohol##11##3##(1991-8#2)(1991-9#2)(2006-8#1)(2008-9#1)(2009-5#2)(2012-12#2)(2013-8#1)
use of all##6##3##(1992-1#1)(2006-8#1)(2007-12#1)(2008-2#1)(2010-8#1)(2013-8#1)
use of allogeneic##2##3##(2008-11#1)(2009-3#1)
use of alternative medicine##2##4##(1997-6#1)(2008-10#1)
use of alternative therapies##2##4##(2004-4#1)(2006-10#1)
use of alternative##14##3##(1990-4#2)(1995-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-8#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-12#1)(2010-4#1)(2011-2#1)
use of amiodarone##2##3##(1993-6#1)(2008-11#1)
use of an active##2##4##(1995-1#1)(2007-11#1)
use of an agent##2##4##(2008-5#1)(2012-3#1)
use of an antibody##3##4##(1993-8#1)(2006-12#1)(2008-4#1)
use of an array of##3##5##(2006-5#1)(2008-3#2)
use of an assistive device##2##5##(2008-12#1)(2012-2#1)
use of an auxiliary##2##4##(2007-11#1)(2008-2#1)
use of an average##2##4##(2007-12#1)(2008-3#1)
use of an effective##3##4##(2006-10#1)(2008-2#1)(2008-3#1)
use of an electronic##3##4##(1993-10#1)(2008-4#1)(2009-10#1)
use of an empirical##2##4##(2008-2#1)(2008-7#1)
use of an external cavity##2##5##(2007-11#1)(2008-3#1)
use of an external##4##4##(2006-4#1)(2007-11#1)(2007-12#1)(2008-3#1)
use of an external-cavity diode laser##2##6##(2008-2#1)(2008-3#1)
use of an external-cavity##4##4##(2007-11#1)(2008-2#1)(2008-3#2)
use of an in vitro##2##5##(1996-1#1)(1996-2#1)
use of an interactive##2##4##(2007-4#1)(2012-2#1)
use of an iterative##2##4##(2008-2#1)(2010-2#1)
use of an optical fiber##2##5##(2007-11#2)
use of an optical##7##4##(2007-11#3)(2007-12#2)(2008-3#2)
use of an optically##4##4##(2007-11#1)(2007-12#2)(2008-1#1)
use of an optimization##2##4##(2008-2#1)(2008-3#1)
use of an optimized phase mask##2##6##(2008-3#2)
use of an optimized##3##4##(2007-12#1)(2008-3#2)
use of an ultrasonic##2##4##(1992-2#1)(2007-12#1)
use of an##202##3##(1990-12#1)(1990-3#1)(1991-10#1)(1991-3#1)(1991-7#1)(1992-2#1)(1993-10#1)(1993-12#1)(1993-2#2)(1993-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#2)(1997-1#1)(2004-12#1)(2004-4#1)(2006-10#2)(2006-12#1)(2006-4#2)(2006-5#3)(2007-10#1)(2007-11#17)(2007-12#29)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-8#1)(2008-1#4)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#23)(2008-3#31)(2008-4#4)(2008-5#6)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-2#2)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#7)(2013-8#1)
use of analgesic##2##3##(2008-7#1)(2008-8#1)
use of analgesics##12##3##(1993-10#1)(1993-9#1)(1996-12#2)(2006-6#1)(2006-7#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-11#1)(2010-7#1)(2012-2#1)
use of analytical##2##3##(2008-10#2)
use of and##4##3##(1990-12#1)(1991-2#1)(1991-3#1)(1996-2#1)
use of angiotensin-converting enzyme##2##4##(1993-12#1)(2013-1#1)
use of animal models##3##4##(1993-12#1)(2005-8#1)(2008-7#1)
use of animal##5##3##(1993-12#1)(2005-8#1)(2008-11#1)(2008-7#1)(2013-1#1)
use of animals for##3##4##(2008-10#1)(2008-4#1)(2012-2#1)
use of animals in research##2##5##(2005-10#1)(2007-3#1)
use of animals in##6##4##(1996-12#1)(2005-10#1)(2007-3#1)(2008-10#1)(2012-2#2)
use of animals##11##3##(1990-12#1)(1996-12#1)(2005-10#1)(2005-7#1)(2007-3#1)(2008-10#2)(2008-4#1)(2012-2#3)
use of antibacterial##2##3##(1997-3#1)(2012-3#1)
use of antibiotic##4##3##(1993-11#1)(1996-11#1)(2008-7#1)(2012-2#1)
use of antibiotics and##3##4##(1997-5#1)(2012-2#1)(2013-1#1)
use of antibiotics in##4##4##(1997-5#1)(2006-2#1)(2011-2#1)(2012-1#1)
use of antibiotics##29##3##(1992-12#1)(1997-5#3)(2006-10#3)(2006-2#1)(2006-7#1)(2007-11#2)(2007-6#1)(2008-1#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#2)(2012-1#2)(2012-2#5)(2013-1#1)(2013-8#2)
use of anticoagulant##2##3##(2006-10#1)(2007-7#1)
use of anticoagulants##7##3##(1995-4#1)(2006-10#1)(2011-1#1)(2012-12#4)
use of antidepressant##2##3##(2010-4#1)(2011-1#1)
use of antidepressants##4##3##(2006-7#1)(2006-9#1)(2013-8#2)
use of antifungal##2##3##(2006-10#1)(2012-11#1)
use of antimicrobial agents in##2##5##(1990-6#1)(2010-9#1)
use of antimicrobial agents##3##4##(1990-6#1)(2010-9#1)(2013-1#1)
use of antimicrobial##9##3##(1990-6#1)(1997-5#1)(2007-7#1)(2008-11#1)(2008-5#1)(2010-9#1)(2012-3#1)(2013-1#2)
use of antimicrobials in food-producing animals##2##6##(2010-4#2)
use of antimicrobials##3##3##(2007-7#1)(2010-4#2)
use of antioxidants and##2##4##(2005-8#1)(2011-2#1)
use of antioxidants##3##3##(2005-8#1)(2011-2#1)(2013-8#1)
use of antipsychotic##2##3##(2009-4#1)(2010-6#1)
use of antiretroviral##2##3##(2010-8#1)(2012-2#1)
use of antisense##3##3##(2005-8#1)(2006-12#1)(2008-5#1)
use of antiviral drugs for##2##5##(2008-4#2)
use of any##7##3##(2004-4#1)(2006-10#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-9#1)
use of appropriate##17##3##(1993-2#1)(1994-9#1)(2007-12#2)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-8#1)(2011-2#1)(2012-12#1)
use of aprotinin in coronary artery bypass graft surgery##2##9##(2007-8#2)
use of aprotinin##5##3##(1990-3#1)(2007-8#4)
use of artificial intelligence##2##4##(1996-10#1)(2008-10#1)
use of artificial neural networks##2##5##(2008-10#1)(2009-3#1)
use of artificial##7##3##(1996-10#1)(2006-10#1)(2007-1#1)(2008-10#2)(2009-3#1)(2009-4#1)
use of aspirin##6##3##(1990-3#1)(1996-2#2)(2006-10#1)(2008-3#1)(2010-6#1)
use of assisted reproductive##3##4##(2008-11#1)(2009-4#2)
use of asthma##3##3##(2006-8#1)(2010-5#1)(2011-12#1)
use of atomic force microscopy##2##5##(2008-2#2)
use of atomic##3##3##(2008-2#2)(2011-1#1)
use of atypical##3##3##(2007-7#1)(2007-8#1)(2008-4#1)
use of autocorrelation##2##3##(2008-3#2)
use of autologous##6##3##(2008-1#1)(2009-3#1)(2011-12#1)(2012-12#3)
use of automated##7##3##(1995-1#1)(1995-11#1)(1996-12#1)(2008-10#1)(2008-3#1)(2013-1#2)
use of available resources##2##4##(1990-10#1)(2008-1#1)
use of available##9##3##(1990-10#1)(1991-12#1)(1992-2#2)(1994-3#1)(2006-9#1)(2008-1#1)(2009-10#1)(2013-1#1)
use of bacterial##3##3##(1990-2#1)(1990-9#1)(2012-2#1)
use of barrier##2##3##(2010-7#1)(2013-8#1)
use of benzodiazepines and chronic somatic##2##6##(2004-4#2)
use of benzodiazepines##3##3##(1996-9#1)(2004-4#2)
use of beta##4##3##(1991-7#1)(1995-2#1)(2005-9#1)(2008-10#1)
use of beta-blockers##3##3##(1997-5#2)(2010-12#1)
use of bilateral##3##3##(2007-8#1)(2008-1#1)(2010-8#1)
use of biocides##2##3##(2008-3#2)
use of bioinformatics##2##3##(2007-1#1)(2008-11#1)
use of biological##2##3##(2007-4#1)(2012-3#1)
use of biologically##2##3##(2008-6#1)(2010-1#1)
use of biologics##2##3##(2005-11#1)(2010-12#1)
use of biotherapeutics##2##3##(2007-11#1)(2008-10#1)
use of birth##2##3##(1991-12#1)(2008-7#1)
use of bisphosphonates##2##3##(2007-8#1)(2010-3#1)
use of blood components##2##4##(2007-9#1)(2010-8#1)
use of blood##3##3##(2007-9#1)(2010-2#1)(2010-8#1)
use of bone graft##2##4##(2006-3#1)(2013-1#1)
use of bone##12##3##(1994-9#1)(1997-6#1)(2006-3#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-8#1)(2010-6#1)(2012-12#2)(2013-1#1)
use of both##28##3##(1996-5#1)(1997-2#2)(1997-8#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-2#3)(2013-1#2)
use of boundary##2##3##(1991-3#1)(1997-2#1)
use of broad-spectrum antibiotics##2##4##(2006-8#1)(2007-8#1)
use of calcium antagonists##2##4##(2005-12#1)(2008-7#1)
use of calcium channel blockers##3##5##(1996-9#1)(2007-8#1)(2008-11#1)
use of calcium##12##3##(1990-3#1)(1996-9#1)(1997-1#1)(2005-12#1)(2005-4#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-3#1)(2012-12#1)
use of calcium-based phosphate binders##3##5##(2007-8#1)(2012-12#1)(2013-1#1)
use of cannabis is##2##4##(2005-10#1)(2013-8#1)
use of cannabis##7##3##(2005-10#4)(2009-7#1)(2013-8#2)
use of capillary electrophoresis##4##4##(1996-5#3)(2008-10#1)
use of capillary##5##3##(1996-5#4)(2008-10#1)
use of carbon dioxide##3##4##(1992-1#1)(2007-8#2)
use of carbon##5##3##(1992-1#1)(2007-11#1)(2007-8#2)(2008-5#1)
use of cardiac##4##3##(1995-8#1)(2007-7#1)(2008-3#1)(2009-4#1)
use of cardiopulmonary bypass##6##4##(2006-10#1)(2007-8#4)(2013-1#1)
use of cardiovascular##4##3##(2008-3#1)(2008-4#1)(2009-12#1)(2009-4#1)
use of carvedilol with##2##4##(2011-1#2)
use of case studies as##2##5##(2008-11#2)
use of cell##6##3##(1992-7#1)(1997-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)
use of central venous catheters##2##5##(2007-7#1)(2008-7#1)
use of central venous##3##4##(2007-7#1)(2008-7#2)
use of central##4##3##(2007-7#2)(2008-7#2)
use of certain##4##3##(1992-8#1)(1994-12#1)(2008-11#1)(2008-3#1)
use of certificated##3##3##(2008-12#3)
use of certified seeds##2##4##(2008-12#2)
use of cervical##3##3##(2007-11#1)(2007-7#1)(2009-5#1)
use of cheap##2##3##(1994-4#1)(2008-2#1)
use of chemical pesticides##2##4##(2007-5#1)(2008-9#1)
use of chemical##9##3##(1991-12#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-11#2)(2008-9#1)(2012-2#1)(2013-8#1)
use of chemicals##3##3##(2007-5#1)(2008-10#1)(2013-8#1)
use of chemotherapy as##2##4##(2008-9#1)(2009-3#1)
use of chemotherapy##8##3##(2005-11#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
use of children's##2##3##(1992-1#1)(1992-3#1)
use of chloroquine##3##3##(2008-11#1)(2010-12#2)
use of chromatographic##3##3##(2008-10#2)(2010-9#1)
use of chronic##2##3##(2008-5#1)(2012-12#1)
use of chymopapain##2##3##(2007-1#2)
use of cigarettes and alcohol##2##5##(1991-9#2)
use of cimetidine##2##3##(2008-11#2)
use of classical##2##3##(2011-2#1)(2012-3#1)
use of clean##2##3##(2008-1#1)(2009-5#1)
use of climate information for malaria##2##6##(2008-8#2)
use of clinical data in##3##5##(2006-5#1)(2013-1#2)
use of clinical##10##3##(1993-12#2)(1994-5#1)(1995-2#1)(2006-2#1)(2006-5#1)(2011-12#1)(2012-12#1)(2013-1#2)
use of cocaine in##3##4##(2004-3#1)(2006-8#1)(2013-8#1)
use of cocaine##7##3##(1991-1#1)(1991-5#1)(1996-5#1)(2004-3#1)(2006-8#1)(2010-11#1)(2013-8#1)
use of coherent##2##3##(2007-12#1)(2008-3#1)
use of colonoscopy##2##3##(2006-2#1)(2010-12#1)
use of color##2##3##(2007-12#1)(2008-6#1)
use of combination therapy in##2##5##(2008-2#1)(2010-10#1)
use of combination therapy##6##4##(1996-9#1)(2008-2#1)(2010-10#3)(2012-2#1)
use of combination##11##3##(1996-9#1)(2008-2#1)(2008-6#1)(2010-10#3)(2010-11#1)(2012-11#1)(2012-2#1)(2012-3#2)
use of combined oral##2##4##(2008-5#1)(2013-1#1)
use of combined##6##3##(1993-6#1)(2007-10#1)(2008-10#2)(2008-5#1)(2013-1#1)
use of communication strategies##4##4##(2012-3#4)
use of community resources##2##4##(2008-1#1)(2008-6#1)
use of community##4##3##(1996-1#1)(2008-1#1)(2008-6#1)(2012-12#1)
use of complementary and alternative medicine##2##6##(2005-10#1)(2010-7#1)
use of complementary##3##3##(2005-10#1)(2006-5#1)(2010-7#1)
use of composite##3##3##(1990-5#1)(2008-10#1)(2013-8#1)
use of computed tomography##2##4##(1997-4#1)(2008-9#1)
use of computed##3##3##(1990-3#1)(1997-4#1)(2008-9#1)
use of computer simulation##2##4##(2007-11#1)(2010-8#1)
use of computer software##3##4##(2008-7#1)(2008-9#2)
use of computer##12##3##(1990-9#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#2)(2010-8#1)(2012-2#1)
use of computer-generated holograms with##2##5##(2007-12#2)
use of computer-generated##3##3##(2007-12#2)(2008-2#1)
use of computerized##5##3##(1991-1#1)(1995-3#1)(1996-8#1)(2007-1#1)(2013-1#1)
use of computers and##2##4##(1996-2#1)(2008-12#1)
use of computers in teaching##2##5##(1993-3#2)
use of computers in##3##4##(1993-3#2)(2006-10#1)
use of computers##5##3##(1993-3#2)(1996-2#1)(2006-10#1)(2008-12#1)
use of concepts##2##3##(2007-8#1)(2008-10#1)
use of condoms during##2##4##(2009-5#1)(2011-2#1)
use of condoms was##2##4##(2006-7#1)(2011-1#1)
use of condoms##13##3##(1993-2#1)(1996-1#1)(2006-7#2)(2008-2#1)(2009-5#2)(2011-1#1)(2011-2#4)(2012-3#1)
use of consumer surveys##2##4##(1996-2#1)(1996-3#1)
use of consumer##3##3##(1996-2#2)(1996-3#1)
use of continuous##5##3##(2006-1#1)(2007-11#1)(2007-8#1)(2008-3#1)(2009-7#1)
use of contraceptives was##2##4##(1996-6#2)
use of contraceptives##5##3##(1994-9#1)(1996-6#2)(2006-2#1)(2012-2#1)
use of conventional##13##3##(2006-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)(2011-2#1)(2013-7#1)
use of coping strategies##2##4##(2011-1#1)(2013-1#1)
use of cord blood##3##4##(2007-8#1)(2008-1#1)(2008-11#1)
use of corticosteroids##4##3##(2006-10#1)(2007-11#1)(2009-8#1)(2012-3#1)
use of cost effectiveness##2##4##(1993-2#1)(2008-7#1)
use of cost##3##3##(1992-1#1)(1993-2#1)(2008-7#1)
use of crack cocaine##2##4##(2008-1#1)(2008-10#1)
use of crack##3##3##(2008-1#1)(2008-10#2)
use of critical##3##3##(1995-12#3)
use of crude tissue section lysates##2##6##(1996-12#2)
use of culture##2##3##(1996-6#1)(2008-7#1)
use of current##2##3##(1992-3#1)(2013-1#1)
use of currently available##3##4##(2006-10#1)(2006-11#1)(2013-8#1)
use of cyclosporin as baseline##2##5##(2007-11#2)
use of cyclosporin##7##3##(2005-8#1)(2007-11#6)
use of cyclosporine##2##3##(1993-11#1)(1995-2#1)
use of cytokine##2##3##(2006-10#1)(2008-6#1)
use of cytokines in##2##4##(1995-12#1)(2007-11#1)
use of cytokines##3##3##(1994-3#1)(1995-12#1)(2007-11#1)
use of dapsone##2##3##(2008-11#1)(2011-2#1)
use of data for##2##4##(1996-2#2)
use of data from##2##4##(1996-6#1)(2011-2#1)
use of data standards##2##4##(2010-8#1)(2012-3#1)
use of data##12##3##(1992-12#1)(1994-7#1)(1996-2#2)(1996-3#2)(1996-6#1)(2005-11#1)(2008-3#1)(2010-8#1)(2011-2#1)(2012-3#1)
use of deep##4##3##(2006-10#1)(2008-1#1)(2009-12#1)(2012-2#1)
use of dendrimers as anti-infective and anti-inflammatory drugs##2##8##(2008-1#2)
use of dendrimers##3##3##(2008-1#3)
use of devices##2##3##(2006-10#1)(2010-8#1)
use of diagnostic imaging##2##4##(2007-11#1)(2007-4#1)
use of diagnostic ultrasound##2##4##(1994-6#1)(2013-8#1)
use of diagnostic##7##3##(1994-6#1)(2006-6#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-7#1)(2013-8#1)
use of dietary supplements##2##4##(2008-10#1)(2009-2#1)
use of dietary##3##3##(1994-2#1)(2008-10#1)(2009-2#1)
use of different types of##3##5##(2008-6#1)(2010-4#1)(2011-2#1)
use of different wavelengths##2##4##(2007-12#1)(2008-2#1)
use of different##47##3##(1990-2#3)(1995-1#1)(2005-10#1)(2005-11#1)(2007-11#2)(2007-12#4)(2008-10#10)(2008-11#1)(2008-2#4)(2008-3#6)(2008-5#1)(2008-6#2)(2008-9#2)(2009-2#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#2)
use of differential##2##3##(1996-1#1)(2007-11#1)
use of diffractive##4##3##(2008-2#2)(2008-3#2)
use of digital speckle photography##2##5##(2008-3#2)
use of digital##9##3##(1992-9#1)(2007-12#1)(2008-3#5)(2008-7#1)(2010-8#1)
use of digoxin##2##3##(1991-2#1)(2009-10#1)
use of dilute##2##3##(2008-10#1)(2008-3#1)
use of diode##2##3##(2007-12#1)(2008-3#1)
use of direct##7##3##(1990-12#1)(2007-11#1)(2007-12#3)(2008-10#1)(2010-8#1)
use of distilled water##3##4##(2010-3#3)
use of distraction##2##3##(2007-12#1)(2011-1#1)
use of diuretics and##3##4##(1992-9#1)(1995-10#1)(1996-9#1)
use of diuretics##5##3##(1992-9#1)(1995-10#1)(1996-9#1)(2006-8#1)(2008-1#1)
use of doll therapy in dementia##3##6##(2013-8#3)
use of dolls##2##3##(2011-2#1)(2013-8#1)
use of donated##2##3##(1993-7#1)(2006-7#1)
use of dose##2##3##(2008-7#2)
use of dried blood spots##2##5##(1991-8#1)(2010-11#1)
use of dried##3##3##(1991-8#1)(1994-6#1)(2010-11#1)
use of drops##2##3##(2008-10#2)
use of drug##3##3##(1997-7#1)(2006-10#1)(2007-2#1)
use of drug-eluting stents##2##4##(2008-8#1)(2009-5#1)
use of drugs and##3##4##(1990-4#1)(2006-8#1)(2011-1#1)
use of drugs in##2##4##(1996-6#1)(2006-10#1)
use of drugs is##2##4##(2008-4#1)(2011-12#1)
use of drugs##24##3##(1990-4#2)(1991-12#1)(1993-5#2)(1995-1#1)(1996-6#2)(1997-2#1)(2006-10#3)(2006-8#1)(2007-2#1)(2008-11#1)(2008-4#1)(2008-7#2)(2010-1#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-7#1)
use of drugs]##3##3##(1993-5#1)(1995-9#1)(2011-12#1)
use of dynamic##2##3##(2008-1#1)(2008-3#1)
use of early##5##3##(1991-3#1)(1997-1#1)(2007-8#1)(2008-11#1)(2012-12#1)
use of economic##2##3##(1991-12#2)
use of effective##6##3##(2007-7#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-10#1)(2013-8#1)
use of either##13##3##(1996-2#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-5#1)(2008-6#1)(2009-6#1)(2012-12#1)(2013-8#1)
use of electrically stimulated muscle of isolated##2##7##(1992-11#1)(1995-3#1)
use of electrically##3##3##(1992-11#1)(1995-3#1)(2008-9#1)
use of electronic health##2##4##(2010-8#1)(2012-11#1)
use of electronic medical##2##4##(2008-8#1)(2010-8#1)
use of electronic##9##3##(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-10#1)(2010-8#2)(2012-11#1)
use of electrospinning##3##3##(2008-5#1)(2010-10#2)
use of embryonic stem cells for medical-therapeutical purposes##3##8##(2006-7#1)(2006-8#2)
use of embryonic stem cells for##9##6##(2006-7#2)(2006-8#7)
use of embryonic stem cells##13##5##(2006-7#3)(2006-8#9)(2008-11#1)
use of embryonic##14##3##(2006-7#3)(2006-8#9)(2008-11#1)(2008-9#1)
use of embryos##2##3##(1996-2#1)(2006-7#1)
use of emergency##2##3##(2004-10#1)(2010-5#1)
use of emerging##4##3##(2006-6#1)(2007-12#1)(2008-10#1)(2012-12#1)
use of endoscopic##6##3##(2006-10#2)(2006-2#1)(2007-12#1)(2012-12#1)(2012-3#1)
use of endoscopy##2##3##(2006-10#1)(2006-2#1)
use of enhanced stromal vascular fraction##2##6##(2012-12#2)
use of epidemiology##2##3##(1993-11#1)(1994-3#1)
use of epidurals##2##3##(2006-10#1)(2007-2#1)
use of equipment##2##3##(1994-12#1)(2012-12#1)
use of etanercept in##2##4##(2006-10#2)
use of evidence##3##3##(2008-12#1)(2010-9#1)(2012-3#1)
use of existing datasets##2##4##(2011-2#1)(2012-12#1)
use of existing##9##3##(1994-3#1)(2006-9#1)(2008-11#1)(2008-3#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#2)
use of exogenous##2##3##(1991-10#1)(2007-11#1)
use of expensive##2##3##(2006-6#1)(2008-4#1)
use of experimental##5##3##(2008-2#1)(2008-8#1)(2010-2#1)(2010-4#1)(2012-11#1)
use of exploratory relative to directed coping##2##7##(2007-12#2)
use of external##6##3##(2007-11#2)(2007-12#1)(2008-11#1)(2008-7#1)(2009-1#1)
use of extracorporeal##2##3##(1997-6#1)(2009-7#1)
use of fast##5##3##(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)
use of feedback and##2##4##(2009-10#1)(2012-1#1)
use of feedback##3##3##(2009-10#2)(2012-1#1)
use of fiber##2##3##(2007-11#1)(2007-12#1)
use of financial##2##3##(1994-1#1)(2007-4#1)
use of first##4##3##(1991-12#1)(2008-10#1)(2008-2#1)(2008-6#1)
use of flow cytometry in##2##5##(2008-9#2)
use of flow cytometry##5##4##(2008-9#5)
use of flow##7##3##(2007-8#1)(2008-10#1)(2008-9#5)
use of fluorescence##4##3##(1993-3#1)(2005-11#1)(2008-10#1)(2008-5#1)
use of fluorescent probes##2##4##(2007-11#1)(2008-9#1)
use of fluorescent##8##3##(1995-5#1)(2006-12#1)(2007-11#2)(2007-3#1)(2008-1#1)(2008-4#1)(2008-9#1)
use of fluoride toothpaste##2##4##(2006-2#2)
use of fluoride##3##3##(2006-2#2)(2013-1#1)
use of fluoroquinolones##3##3##(1991-12#1)(2010-11#2)
use of fluorouracil##2##3##(1996-1#1)(2010-11#1)
use of focused##2##3##(2007-11#1)(2008-10#1)
use of force##3##3##(1995-5#1)(1995-6#1)(2007-3#1)
use of functional##9##3##(1996-2#1)(2006-3#2)(2007-10#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#1)
use of fungicides##2##3##(2008-10#2)
use of gamma##3##3##(1990-11#1)(2008-11#1)(2011-2#1)
use of gel##3##3##(1992-11#1)(1995-3#2)
use of gene expression##2##4##(2008-7#1)(2009-5#1)
use of gene##8##3##(1991-11#1)(1991-9#1)(2007-11#2)(2007-8#1)(2008-7#1)(2009-5#1)(2012-11#1)
use of genetic algorithms##2##4##(2007-12#1)(2008-10#1)
use of genetic information##2##4##(1996-2#1)(1997-8#1)
use of genetic##9##3##(1993-3#1)(1996-2#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#1)(2011-2#1)(2012-2#1)
use of genetically modified##2##4##(1997-3#1)(2010-4#1)
use of genetically##6##3##(1997-3#1)(2007-8#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-1#1)
use of geographic##2##3##(2006-10#1)(2008-10#1)
use of geometric phase##2##4##(2007-12#2)
use of geometric##4##3##(2007-12#2)(2008-2#1)(2010-8#1)
use of geometrical##2##3##(2008-2#2)
use of geospatial data for##2##5##(2008-8#2)
use of geospatial data##4##4##(2008-8#4)
use of glass-ionomer cement##2##4##(2013-1#1)(2013-8#1)
use of gloves##3##3##(2005-8#1)(2009-5#2)
use of glucocorticoids##2##3##(2007-8#1)(2012-12#1)
use of glycoprotein IIb/IIIa inhibitors##4##5##(2005-7#1)(2008-3#3)
use of glycoprotein IIb/IIIa##5##4##(2005-7#1)(2008-3#4)
use of gold##2##3##(1992-11#1)(2008-3#1)
use of government and##2##4##(2012-3#2)
use of group##3##3##(2007-2#1)(2008-11#1)(2008-6#1)
use of growth factors##2##4##(2007-12#1)(2008-9#1)
use of guided##2##3##(2008-1#1)(2012-3#1)
use of habitual##2##3##(2008-11#2)
use of handover forms##3##4##(2012-11#3)
use of hazardous##5##3##(1996-5#1)(2008-10#1)(2008-2#1)(2008-9#2)
use of health care resources##3##5##(1996-12#1)(2007-7#1)(2008-1#1)
use of health care services##2##5##(1993-12#1)(1993-6#1)
use of health care##9##4##(1993-12#1)(1993-6#1)(1996-12#1)(1996-3#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-11#1)
use of health information technology##2##5##(2012-1#1)(2013-1#1)
use of health information##4##4##(2012-1#1)(2012-12#2)(2013-1#1)
use of health services##3##4##(1991-4#1)(1994-2#1)(2007-10#1)
use of health##18##3##(1991-4#1)(1993-12#2)(1993-6#1)(1994-2#1)(1996-12#1)(1996-3#1)(1996-9#1)(2006-10#1)(2007-10#2)(2007-7#1)(2008-1#1)(2008-11#1)(2012-1#1)(2012-12#2)(2013-1#1)
use of healthcare##2##3##(2006-12#1)(2008-9#1)
use of heating##3##3##(1990-2#2)(2008-2#1)
use of hepatitis B##2##4##(2006-2#1)(2007-11#1)
use of hepatitis##3##3##(1990-10#1)(2006-2#1)(2007-11#1)
use of herbal medicines##4##4##(2006-8#3)(2010-3#1)
use of herbal products##2##4##(2006-10#1)(2013-1#1)
use of herbal##8##3##(2006-10#1)(2006-8#4)(2008-10#1)(2010-3#1)(2013-1#1)
use of herbs in##2##4##(2008-2#2)
use of high dose##4##4##(2005-11#1)(2006-10#1)(2008-11#1)(2008-6#1)
use of high temperature##2##4##(2008-10#2)
use of high##20##3##(2005-11#2)(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-8#1)(2013-1#1)
use of high-dose##4##3##(1991-2#1)(1992-8#1)(2006-10#1)(2007-11#1)
use of high-voltage electric shocks to introduce DNA into##2##9##(2008-1#1)(2008-2#1)
use of higher##2##3##(2008-6#1)(2008-7#1)
use of highly active antiretroviral therapy (HAART)##2##7##(2008-3#1)(2009-5#1)
use of highly efficient##3##4##(2007-12#3)
use of highly sensitive##3##4##(2007-5#1)(2008-3#1)(2010-4#1)
use of highly##11##3##(2005-10#1)(2007-11#1)(2007-12#3)(2007-5#1)(2008-1#1)(2008-3#2)(2009-5#1)(2010-4#1)
use of holographic##3##3##(2007-12#1)(2008-2#2)
use of holography##2##3##(2008-2#2)
use of homologous##6##3##(1992-3#1)(1993-11#1)(1996-9#2)(2008-5#1)(2010-8#1)
use of homology##2##3##(1996-2#1)(2008-7#1)
use of hospital services##2##4##(1991-1#1)(2012-3#1)
use of hospital##6##3##(1991-1#1)(1991-2#1)(1993-11#1)(1994-2#2)(2012-3#1)
use of host##3##3##(1991-9#1)(2008-10#2)
use of human immunodeficiency virus##2##5##(2007-11#1)(2012-12#1)
use of human##16##3##(1992-5#2)(1993-2#1)(2005-12#1)(2007-11#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2012-11#1)(2012-12#3)(2012-3#1)(2013-1#1)
use of humor##3##3##(2008-10#1)(2011-2#2)
use of hypertonic solutions##2##4##(1996-9#2)
use of hypnotic medication##2##4##(2007-6#2)
use of hypothermia##3##3##(2006-10#2)(2008-8#1)
use of image##3##3##(1996-2#1)(2007-12#1)(2008-4#1)
use of imaging##6##3##(2007-11#1)(2007-12#1)(2007-4#2)(2008-3#1)(2009-4#1)
use of immunoblotting##3##3##(1994-8#1)(2008-1#1)(2008-2#1)
use of immunohistochemistry##2##3##(2005-7#1)(2008-12#1)
use of immunomodulatory##3##3##(1991-5#1)(2006-10#1)(2008-10#1)
use of immunosuppressive medications##2##4##(2006-10#2)
use of immunosuppressive##4##3##(1994-5#1)(2006-10#2)(2007-7#1)
use of immunotherapy##2##3##(2006-10#1)(2008-1#1)
use of implants##7##3##(1996-3#1)(2007-11#5)(2007-12#1)
use of improved water sources and sanitation##2##7##(2012-2#2)
use of improved water sources##3##5##(2012-2#3)
use of improved water sources/sanitation##2##5##(2012-2#2)
use of improved water##5##4##(2012-2#5)
use of improved##6##3##(2012-2#6)
use of in vitro##2##4##(2008-10#1)(2008-4#1)
use of in##4##3##(1993-7#1)(2008-10#1)(2008-2#1)(2008-4#1)
use of in-line##3##3##(2007-12#3)
use of inactivated##3##3##(2004-12#1)(2007-2#1)(2008-4#1)
use of increasingly##3##3##(2008-11#1)(2008-2#1)(2008-4#1)
use of independent##3##3##(1993-9#1)(1994-3#1)(2008-3#1)
use of indigenous medicines##3##4##(2012-2#2)(2013-1#1)
use of indirect##2##3##(2008-11#1)(2011-1#1)
use of indium tin oxide##2##5##(2008-2#1)(2008-3#1)
use of indwelling##2##3##(2008-1#1)(2008-7#1)
use of infliximab in##2##4##(2006-10#1)(2011-2#1)
use of infliximab##3##3##(2006-10#2)(2011-2#1)
use of information for##2##4##(2006-2#1)(2008-9#1)
use of information technology##3##4##(2008-10#2)(2011-1#1)
use of information##10##3##(1992-2#1)(1996-12#1)(1997-8#1)(2006-2#1)(2008-10#2)(2008-9#1)(2010-8#1)(2011-1#1)(2013-1#1)
use of inhalational##3##3##(1991-6#1)(2006-10#1)(2011-2#1)
use of inhaled corticosteroids in##2##5##(2005-11#1)(2011-2#1)
use of inhaled corticosteroids##3##4##(2005-11#2)(2011-2#1)
use of inhaled##5##3##(2005-11#2)(2006-10#2)(2011-2#1)
use of inhibitors##2##3##(2008-4#2)
use of insecticides##2##3##(2007-6#1)(2008-12#1)
use of insulin##4##3##(2006-1#1)(2008-1#1)(2009-11#1)(2013-1#1)
use of integrated##2##3##(2007-11#1)(2011-1#1)
use of interference##2##3##(2008-3#1)(2013-1#1)
use of interferon##3##3##(1993-6#1)(2006-2#1)(2007-11#1)
use of intermittent##2##3##(1997-7#1)(2008-1#1)
use of interpreters##2##3##(2013-8#2)
use of interventional##2##3##(1994-3#1)(2006-8#1)
use of interventions##6##3##(2007-10#1)(2007-2#1)(2008-6#1)(2011-2#3)
use of intra-arterial##2##3##(2007-10#1)(2013-7#1)
use of intramedullary locking nail##3##5##(2007-11#3)
use of intraoperative##4##3##(1993-10#1)(2007-8#1)(2012-12#1)(2013-7#1)
use of intravascular ultrasound##2##4##(2007-8#1)(2010-5#1)
use of intravascular##3##3##(1994-5#1)(2007-8#1)(2010-5#1)
use of intravenous immunoglobulin##2##4##(2007-11#2)
use of intravenous t-PA##2##4##(2007-10#1)(2007-9#1)
use of intravenous##15##3##(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-9#2)(2008-1#1)(2010-3#1)(2010-7#1)(2012-12#1)
use of intraventricular##2##3##(2007-10#1)(2008-7#1)
use of intravitreal bevacizumab##2##4##(2011-2#1)(2012-12#1)
use of invasive procedures##2##4##(2005-12#1)(2007-4#1)
use of invasive##5##3##(2005-12#1)(2005-8#1)(2006-2#1)(2007-4#1)(2011-2#1)
use of iodized salt##3##4##(2006-10#1)(2013-1#2)
use of ion##2##3##(1993-2#1)(2008-10#1)
use of isotretinoin in acne##2##5##(2010-5#1)(2011-1#1)
use of its##6##3##(1991-1#1)(1991-2#1)(2008-10#1)(2008-3#2)(2010-10#1)
use of joint##2##3##(2008-11#1)(2008-2#1)
use of ketamine##4##3##(2007-2#1)(2010-2#1)(2010-7#1)(2012-12#1)
use of known##2##3##(2007-11#2)
use of labels##4##3##(1992-3#1)(2006-7#1)(2008-4#2)
use of laboratory medicine##2##4##(1995-5#2)
use of laboratory tests##4##4##(1991-2#1)(1994-12#1)(1996-1#1)(1996-9#1)
use of laboratory##10##3##(1991-2#1)(1993-2#1)(1993-8#1)(1994-12#1)(1995-5#2)(1996-1#1)(1996-9#1)(2008-10#2)
use of laparoscopic##7##3##(1992-5#1)(1993-2#1)(1993-3#1)(2008-10#1)(2008-5#1)(2011-2#2)
use of laparoscopy for##2##4##(2010-8#1)(2011-2#1)
use of laparoscopy##4##3##(2008-3#1)(2010-8#1)(2011-2#2)
use of large##8##3##(2006-8#2)(2007-11#1)(2008-1#1)(2008-12#1)(2012-12#1)(2013-1#2)
use of large-scale##2##3##(2008-7#1)(2013-1#1)
use of laryngeal mask##2##4##(2008-2#1)(2008-8#1)
use of laser##10##3##(1990-5#1)(1991-1#1)(1991-9#1)(2006-12#1)(2006-7#1)(2008-10#3)(2008-3#2)
use of lasers##3##3##(1993-12#1)(1993-3#1)(1994-6#1)
use of learning resources##2##4##(2008-11#2)
use of learning##3##3##(2008-11#2)(2008-2#1)
use of less##6##3##(1993-6#1)(2007-11#1)(2007-12#1)(2008-3#1)(2011-1#1)(2011-2#1)
use of levodopa##2##3##(2008-7#2)
use of levofloxacin##2##3##(2008-11#1)(2010-11#1)
use of light##3##3##(2007-11#1)(2008-3#2)
use of limited resources##2##4##(2005-5#1)(2008-7#1)
use of limited##4##3##(2005-5#1)(2008-10#1)(2008-3#1)(2008-7#1)
use of limiting##2##3##(1993-7#1)(2008-4#1)
use of linear##4##3##(2008-11#1)(2008-3#2)(2011-1#1)
use of liposomes as analytical##2##5##(2008-10#2)
use of liquid##4##3##(2007-12#1)(2008-10#1)(2008-4#1)(2010-7#1)
use of liquid-crystal##2##3##(2008-2#2)
use of live##4##3##(1990-6#1)(2009-5#1)(2010-8#1)(2011-2#1)
use of local##5##3##(2007-11#1)(2007-2#1)(2008-2#1)(2008-7#1)(2009-3#1)
use of long-term##3##3##(1996-6#1)(2008-4#1)(2013-1#1)
use of low doses of##2##5##(2008-11#1)(2008-6#1)
use of low##9##3##(1990-2#1)(2007-11#2)(2007-2#1)(2008-11#1)(2008-2#1)(2008-6#1)(2012-3#1)(2013-8#1)
use of low-coherence##8##3##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#3)
use of low-dose##4##3##(1996-9#1)(2007-7#1)(2007-8#1)(2008-3#1)
use of low-power laser##2##4##(2011-2#2)
use of lower##2##3##(2008-10#1)(2008-6#1)
use of machine##4##3##(2007-11#2)(2008-7#1)(2010-2#1)
use of magnesium##3##3##(2007-8#1)(2008-6#1)(2011-1#1)
use of magnetic resonance imaging in##2##6##(1991-5#1)(2007-4#1)
use of magnetic resonance imaging##5##5##(1991-5#1)(2007-10#1)(2007-4#2)(2011-12#1)
use of magnetic resonance##6##4##(1991-5#1)(2007-10#1)(2007-4#2)(2007-7#1)(2011-12#1)
use of magnetic##8##3##(1991-5#1)(2007-10#1)(2007-4#2)(2007-7#1)(2010-11#1)(2011-12#1)(2012-12#1)
use of maintenance##2##3##(2008-1#1)(2012-2#1)
use of mammography##4##3##(1990-12#1)(1991-8#1)(2005-9#1)(2006-10#1)
use of many of##2##4##(2008-12#1)(2011-2#1)
use of marijuana and##2##4##(2006-8#1)(2012-1#1)
use of marijuana##5##3##(1996-11#1)(2006-8#1)(2009-7#1)(2012-1#1)(2013-8#1)
use of markers##2##3##(2008-10#1)(2010-9#1)
use of masks##2##3##(1996-3#1)(2007-9#1)
use of maternal##2##3##(1992-9#1)(2009-7#1)
use of matrix##3##3##(2005-4#1)(2007-3#1)(2008-10#1)
use of mean##2##3##(2008-2#2)
use of measurement##2##3##(1992-6#1)(1993-3#1)
use of mechanical##2##3##(1991-5#1)(2007-10#1)
use of medical##14##3##(1990-12#1)(1992-12#1)(1993-6#1)(1994-9#1)(1995-12#1)(1996-2#1)(1996-6#1)(2004-7#1)(2007-10#2)(2008-11#3)(2008-4#1)
use of medication##4##3##(1993-12#1)(2011-1#1)(2011-2#2)
use of medications in##2##4##(2008-3#1)(2008-8#1)
use of medications##8##3##(1993-9#1)(2005-6#1)(2007-11#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-8#1)
use of medicinal plants##2##4##(2009-10#1)(2011-2#1)
use of medicinal##4##3##(2007-7#1)(2008-8#1)(2009-10#1)(2011-2#1)
use of medicines in a general population sample##2##8##(2008-11#2)
use of medicines in a##3##5##(2008-11#2)(2011-2#1)
use of medicines##13##3##(1992-2#1)(2006-2#2)(2008-11#5)(2008-8#2)(2009-3#1)(2011-1#1)(2011-2#1)
use of mefloquine##2##3##(1996-8#1)(2011-2#1)
use of membrane##2##3##(1991-5#1)(2008-10#1)
use of mental health##2##4##(1996-3#1)(2010-2#1)
use of metal##4##3##(2008-3#1)(2008-5#1)(2012-11#2)
use of metformin##3##3##(2008-1#2)(2012-3#1)
use of methanol##3##3##(2008-10#1)(2008-6#1)(2010-5#1)
use of methods##2##3##(2006-10#1)(2008-12#1)
use of methotrexate in the treatment of psoriatic arthritis##2##9##(2006-10#2)
use of methotrexate##3##3##(2006-10#3)
use of microarray technologies##2##4##(2008-7#1)(2009-10#1)
use of microarray technology##2##4##(2006-10#1)(2008-7#1)
use of microarray##5##3##(2006-10#1)(2006-5#1)(2008-7#2)(2009-10#1)
use of microarrays##2##3##(2008-10#1)(2008-7#1)
use of microwave##3##3##(2007-10#1)(2007-11#1)(2007-8#1)
use of microwaves##2##3##(1996-7#1)(2008-10#1)
use of mid-infrared##2##3##(2007-12#2)
use of minimally invasive##2##4##(2007-8#1)(2007-9#1)
use of mixed##3##3##(2008-10#2)(2008-2#1)
use of mixtures##2##3##(2008-10#2)
use of mobile##3##3##(1996-8#1)(2008-12#1)(2013-8#1)
use of model##4##3##(1991-5#1)(2007-12#1)(2008-10#1)(2008-6#1)
use of models##4##3##(1997-8#1)(2007-8#1)(2008-10#1)(2008-3#1)
use of modern contraceptive methods##2##5##(1990-2#1)(1990-6#1)
use of modern technology##2##4##(2008-10#1)(2011-2#1)
use of modern##8##3##(1990-2#1)(1990-6#1)(2006-2#1)(2007-6#1)(2008-10#2)(2009-5#1)(2011-2#1)
use of modified##5##3##(2008-10#2)(2008-4#1)(2010-9#1)(2011-2#1)
use of molecular diagnostic##2##4##(2013-1#2)
use of molecular markers##2##4##(1997-7#1)(2008-10#1)
use of molecular##12##3##(1991-5#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)(2009-8#1)(2012-2#1)(2013-1#2)
use of monoclonal antibodies##5##4##(1993-6#1)(1995-3#1)(2008-11#2)(2009-8#1)
use of monoclonal##7##3##(1993-6#1)(1995-3#1)(1997-7#1)(2008-11#2)(2009-8#1)(2010-12#1)
use of more##15##3##(1997-8#1)(2006-10#1)(2006-6#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2010-2#1)(2011-2#2)(2012-11#1)(2013-1#1)
use of morphine in##2##4##(2007-2#1)(2008-3#1)
use of morphine##4##3##(1992-5#2)(2007-2#1)(2008-3#1)
use of mosquito nets##4##4##(2006-4#2)(2007-2#1)(2013-8#1)
use of multidimensional##4##3##(1995-5#1)(2008-2#1)(2010-11#1)(2012-3#1)
use of multilayer##2##3##(2008-10#1)(2008-2#1)
use of multimode deformable plane mirrors##2##6##(2008-2#2)
use of multimode##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
use of multiple##28##3##(1990-8#1)(1991-3#1)(1993-6#1)(1995-4#1)(2006-10#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#4)(2008-4#2)(2008-7#1)(2009-4#1)(2009-8#1)(2010-11#2)(2010-9#2)(2011-12#1)(2012-1#1)
use of multivariate##5##3##(2008-10#4)(2008-3#1)
use of myocardial##2##3##(1993-12#1)(2013-1#1)
use of nalbuphine##2##3##(1992-5#2)
use of nanomaterials in##2##4##(2007-8#1)(2012-11#1)
use of nanomaterials##3##3##(2007-8#1)(2010-7#1)(2012-11#1)
use of nanoparticle##2##3##(2007-11#1)(2010-12#1)
use of nanoparticles##3##3##(2007-11#1)(2008-7#1)(2013-1#1)
use of naproxen##2##3##(2006-10#2)
use of natural and synthetic##2##5##(2008-10#1)(2008-3#1)
use of natural##3##3##(2008-10#1)(2008-3#1)(2010-7#1)
use of near infrared spectroscopy##2##5##(2008-10#2)
use of near##3##3##(2008-10#3)
use of negative##2##3##(2007-12#1)(2011-2#1)
use of nematicides##2##3##(2008-10#2)
use of neural##2##3##(2006-7#1)(2013-1#1)
use of new generation##2##4##(2007-11#1)(2012-3#1)
use of new##12##3##(1991-12#1)(1991-4#1)(1996-11#1)(2006-10#2)(2007-11#1)(2008-11#1)(2008-4#2)(2009-9#1)(2012-3#1)(2013-8#1)
use of newer##3##3##(2006-5#1)(2010-11#1)(2011-12#1)
use of nicotine replacement therapy##2##5##(2008-6#1)(2012-3#1)
use of nicotine##3##3##(1994-7#1)(2008-6#1)(2012-3#1)
use of nitric oxide##4##4##(2004-12#1)(2006-10#1)(2009-6#1)(2010-12#1)
use of non##2##3##(2005-7#1)(2007-5#1)
use of non-invasive##2##3##(1990-5#1)(2013-1#1)
use of non-steroidal anti-inflammatory drugs##4##5##(2006-7#1)(2008-12#1)(2010-2#1)(2010-3#1)
use of nonlinear##4##3##(2007-11#2)(2007-12#1)(2012-2#1)
use of nonpharmacological##2##3##(2013-1#1)(2013-8#1)
use of nonspecific##2##3##(2006-10#1)(2006-2#1)
use of nonsteroidal anti-inflammatory drugs##3##5##(2007-2#1)(2007-4#1)(2012-12#1)
use of novel##10##3##(1993-9#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-11#1)(2011-1#1)
use of nucleoside analogues##2##4##(2006-10#1)(2008-1#1)
use of numerical##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
use of nursing##2##3##(1991-2#1)(2011-2#1)
use of nylon wool##2##4##(2008-4#2)
use of objective##4##3##(2007-11#2)(2008-11#1)(2009-2#1)
use of off-duty police##2##4##(1994-2#2)
use of on-line##3##3##(2006-5#1)(2008-10#1)(2010-4#1)
use of one of##2##4##(2008-10#1)(2008-2#1)
use of one##8##3##(1995-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)(2012-12#1)
use of only the##2##4##(2008-3#2)
use of only##14##3##(1990-4#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-9#1)(2010-6#1)
use of opiates##3##3##(1996-5#1)(2008-3#1)(2012-3#1)
use of opioid##2##3##(2006-10#1)(2009-7#1)
use of opioids in FMS##2##5##(2011-2#2)
use of opioids in##4##4##(2007-2#1)(2011-2#3)
use of opioids##10##3##(2006-10#2)(2006-12#1)(2007-2#1)(2008-3#1)(2008-7#1)(2010-2#1)(2011-2#3)
use of optical cavities##2##4##(2007-11#1)(2008-3#1)
use of optical coherence tomography##4##5##(2007-12#1)(2008-3#1)(2011-7#2)
use of optical methods##2##4##(2007-5#1)(2008-3#1)
use of optical##23##3##(2005-11#1)(2007-11#3)(2007-12#4)(2007-5#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#7)(2009-5#1)(2011-7#2)
use of optically##2##3##(2008-3#1)(2009-10#1)
use of optoelectronic##2##3##(2008-2#1)(2008-3#1)
use of oral contraceptives##10##4##(1990-11#3)(1991-2#1)(1991-5#1)(1991-8#1)(1992-4#1)(1993-9#1)(2008-11#2)
use of oral health services##3##5##(2012-2#3)
use of oral##29##3##(1990-11#3)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-4#1)(1993-9#1)(1996-3#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-11#2)(2008-3#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-2#3)
use of organic solvents##5##4##(2006-6#1)(2008-10#3)(2008-5#1)
use of organic##7##3##(2006-6#1)(2007-11#1)(2008-10#4)(2008-5#1)
use of other drugs##2##4##(2005-10#1)(2008-8#1)
use of other##13##3##(1992-12#1)(1993-9#1)(2005-10#1)(2005-7#1)(2006-9#2)(2008-10#2)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#2)
use of our##6##3##(1990-3#1)(1995-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
use of outcome measures##2##4##(2008-11#2)
use of paclitaxel##2##3##(1995-8#1)(2008-7#1)
use of pairwise##2##3##(1991-9#1)(1995-8#1)
use of parallel##2##3##(2007-12#1)(2008-2#1)
use of parenteral##2##3##(2005-10#2)
use of partial##3##3##(2008-10#1)(2008-3#2)
use of partially resistant##2##4##(2008-10#2)
use of partially##3##3##(2007-12#1)(2008-10#2)
use of passive##3##3##(2010-10#1)(2011-1#1)(2012-1#1)
use of pathogen-specific##2##3##(2007-5#2)
use of patient satisfaction##3##4##(1996-1#2)(1996-3#1)
use of patient##5##3##(1996-1#2)(1996-3#1)(2006-10#1)(2010-5#1)
use of pelvimetry##2##3##(1994-4#2)
use of percutaneous##4##3##(1990-8#1)(2006-12#1)(2007-8#1)(2012-12#1)
use of periodically poled KTiOPO(4)##2##5##(2007-12#2)
use of permanent##2##3##(2007-8#1)(2008-10#1)
use of personal protective##2##4##(2008-12#1)(2009-12#1)
use of personal##4##3##(1994-3#1)(2008-12#1)(2009-12#1)(2009-5#1)
use of phages##2##3##(2011-12#1)(2012-2#1)
use of pharmaceutical##2##3##(2008-1#1)(2013-8#1)
use of pharmacological##3##3##(2005-10#1)(2008-1#1)(2013-8#1)
use of pharmacotherapy##2##3##(2008-4#1)(2013-1#1)
use of phase##7##3##(2007-11#1)(2008-2#1)(2008-3#5)
use of phenobarbital##2##3##(1997-5#2)
use of photodynamic therapy##2##4##(2012-2#1)(2012-3#1)
use of photon##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
use of photorefractive##3##3##(2007-12#1)(2008-3#2)
use of physical restraints##2##4##(2010-10#2)
use of physical##5##3##(2005-8#1)(2006-12#1)(2010-10#2)(2013-1#1)
use of physician extenders##2##4##(1991-12#1)(1996-12#1)
use of physician##4##3##(1991-12#1)(1995-12#2)(1996-12#1)
use of placebos for pain management in##2##7##(2007-12#2)
use of placebos##3##3##(1995-9#1)(2007-12#2)
use of plain##3##3##(2007-2#1)(2008-5#1)(2008-7#1)
use of planar##3##3##(2007-12#2)(2008-3#1)
use of plant##2##3##(2008-7#1)(2013-8#1)
use of plasma##2##3##(2005-10#1)(2008-3#1)
use of plasmodes##2##3##(2010-2#2)
use of plastic##3##3##(1990-10#1)(2007-11#1)(2007-5#1)
use of polarization##3##3##(2008-3#3)
use of polarized light##2##4##(2008-3#2)
use of polarized##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
use of polyethylene glycol##2##4##(1994-3#1)(2008-4#1)
use of polyethylene##3##3##(1994-3#1)(1997-6#1)(2008-4#1)
use of polymerase chain reaction##3##5##(2006-10#1)(2007-8#1)(2010-6#1)
use of polymerase chain##4##4##(1995-6#1)(2006-10#1)(2007-8#1)(2010-6#1)
use of polymethylmethacrylate##2##3##(2006-2#1)(2007-11#1)
use of polystyrene##2##3##(2007-11#1)(2013-1#1)
use of porous##2##3##(2004-9#1)(2013-8#1)
use of positive##2##3##(2009-10#1)(2011-2#1)
use of post-hospital##2##3##(1990-12#1)(1995-3#1)
use of postmenopausal##3##3##(1993-11#1)(1993-6#1)(2008-3#1)
use of potent##3##3##(2006-10#1)(2007-11#1)(2008-2#1)
use of prenatal care##5##4##(1992-2#2)(1993-3#2)(1995-12#1)
use of preoperative##2##3##(1990-11#1)(2007-4#1)
use of prescription##4##3##(2007-10#2)(2011-1#1)(2013-1#1)
use of preserved bovine pericardium##2##5##(2009-10#2)
use of preventive services##2##4##(1994-2#2)
use of preventive##4##3##(1994-2#3)(2013-8#1)
use of prior##3##3##(1995-4#1)(1996-9#1)(2010-6#1)
use of probiotics##4##3##(2006-12#1)(2008-4#1)(2012-1#2)
use of professional##3##3##(1993-2#1)(1996-1#1)(2008-11#1)
use of prophylactic##10##3##(1990-6#1)(2006-9#1)(2007-12#1)(2008-3#2)(2008-7#3)(2012-1#1)(2012-3#1)
use of prosthetic##3##3##(2007-7#1)(2011-2#1)(2013-8#1)
use of protective equipment##2##4##(2005-11#1)(2008-12#1)
use of protective##3##3##(2005-11#1)(2006-11#1)(2008-12#1)
use of proteins##2##3##(2006-6#1)(2013-7#1)
use of psychoactive substances##3##4##(2008-1#1)(2009-2#1)(2013-1#1)
use of psychological##2##3##(2008-10#1)(2012-2#1)
use of psychotropic drugs##5##4##(1992-10#2)(2005-11#1)(2009-3#1)(2011-2#1)
use of psychotropic##6##3##(1992-10#2)(2005-11#1)(2005-9#1)(2009-3#1)(2011-2#1)
use of public reporting##2##4##(2010-11#2)
use of public##7##3##(1995-12#1)(2005-10#1)(2010-11#2)(2011-12#1)(2012-3#1)(2013-8#1)
use of pulmonary##2##3##(2007-8#1)(2010-6#1)
use of pulsed##5##3##(1992-3#1)(1995-4#1)(2006-12#1)(2008-1#1)(2012-3#1)
use of quantitative##2##3##(2007-11#1)(2010-8#1)
use of quantum##3##3##(2007-12#1)(2007-2#1)(2008-2#1)
use of rabies##3##3##(1996-8#2)(2007-11#1)
use of race##3##3##(2007-3#1)(2007-4#1)(2008-10#1)
use of radiography##2##3##(1996-2#1)(2007-7#1)
use of radioisotope##2##3##(1991-9#1)(1996-11#1)
use of radioisotopes##8##3##(2008-10#1)(2008-2#2)(2008-4#3)(2008-9#2)
use of radiolabeled##2##3##(1996-9#1)(2008-2#1)
use of radiosurgery##2##3##(1995-12#1)(2008-7#1)
use of rapid##6##3##(1995-6#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-8#1)
use of ray##2##3##(2008-2#1)(2008-3#1)
use of readily available##4##4##(2008-10#2)(2008-5#1)(2008-8#1)
use of real##2##3##(2008-3#1)(2013-1#1)
use of real-time PCR##2##4##(2007-10#1)(2007-8#1)
use of real-time##4##3##(2007-10#1)(2007-8#1)(2008-6#1)(2012-2#1)
use of receptor##2##3##(2006-10#1)(2011-12#1)
use of recombinant human erythropoietin##2##5##(2007-7#1)(2008-1#1)
use of recombinant human##5##4##(2006-9#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-7#1)
use of recombinant##13##3##(2006-9#1)(2007-11#4)(2007-7#2)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-1#1)
use of reference##3##3##(1995-1#1)(1996-10#1)(2008-10#1)
use of reflection and##2##4##(2008-11#1)(2008-3#1)
use of reflection##5##3##(2008-11#2)(2008-12#1)(2008-3#2)
use of reflective##3##3##(2008-11#1)(2008-3#1)(2013-1#1)
use of regional anaesthesia##4##4##(2006-10#3)(2013-1#1)
use of regional##8##3##(1993-4#2)(2006-10#5)(2013-1#1)
use of regular##3##3##(1995-9#1)(2007-11#1)(2008-7#1)
use of regulations##2##3##(2008-11#2)
use of rescue##2##3##(2007-9#1)(2008-5#1)
use of research##5##3##(1996-1#1)(2008-12#1)(2009-2#1)(2010-11#1)(2010-4#1)
use of resistant cultivars##3##4##(2008-10#3)
use of resources and##2##4##(2011-1#1)(2011-2#1)
use of resources##13##3##(1991-2#1)(1992-3#2)(1994-3#1)(1995-12#1)(1997-5#1)(2006-10#1)(2007-8#1)(2008-10#1)(2011-1#1)(2011-2#1)(2013-1#2)
use of restraints in##2##4##(2004-12#1)(2008-7#1)
use of restricted antibiotics##2##4##(2012-2#2)
use of reverse##2##3##(2008-3#1)(2008-9#1)
use of rhBMP##2##3##(2012-12#2)
use of rhBMP-2##2##3##(2009-8#1)(2012-12#1)
use of rhodium##2##3##(2008-10#2)
use of right##2##3##(2006-10#1)(2010-7#1)
use of rigid##2##3##(2006-6#1)(2012-2#1)
use of routine##4##3##(2008-7#1)(2008-9#1)(2009-4#1)(2013-8#1)
use of satellite##3##3##(2008-10#1)(2008-2#1)(2008-9#1)
use of scanning electron microscopy##2##5##(2008-10#1)(2012-2#1)
use of scanning##4##3##(2008-1#1)(2008-10#1)(2008-7#1)(2012-2#1)
use of screening mammography##2##4##(1995-4#1)(2008-10#1)
use of screening##4##3##(1995-4#1)(2007-4#1)(2008-10#1)(2008-11#1)
use of secondary##3##3##(1993-2#1)(2008-3#1)(2009-2#1)
use of selective media##2##4##(2008-10#2)
use of selective##7##3##(1997-5#2)(2007-7#1)(2008-10#3)(2008-12#1)
use of self##2##3##(1997-3#1)(2007-2#1)
use of sensors##2##3##(2008-10#2)
use of sequential##2##3##(1991-9#1)(2007-5#1)
use of serum##5##3##(1994-11#1)(2006-9#1)(2008-11#1)(2009-10#1)(2013-8#1)
use of services##7##3##(1991-2#1)(1993-3#1)(1995-3#1)(1997-8#1)(2008-9#1)(2012-1#1)(2012-2#1)
use of several##15##3##(1995-2#1)(1996-12#1)(1996-3#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-1#1)
use of short##5##3##(2006-11#1)(2007-12#1)(2007-8#1)(2008-2#1)(2013-1#1)
use of short-term##2##3##(2008-10#1)(2009-11#1)
use of silicone##2##3##(2007-8#2)
use of similar##3##3##(2008-10#1)(2012-1#1)(2012-2#1)
use of simple##11##3##(1991-9#1)(1992-9#1)(1994-11#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2010-4#1)(2011-1#1)
use of simulated##4##3##(2007-12#1)(2008-12#1)(2008-2#2)
use of simulation##5##3##(1991-5#1)(2006-6#1)(2008-10#1)(2008-7#1)(2009-4#1)
use of simulations##4##3##(2008-12#2)(2008-3#2)
use of single##3##3##(2007-4#1)(2007-8#1)(2008-10#1)
use of site-directed mutagenesis##3##4##(1990-7#1)(1991-10#1)(1993-6#1)
use of skin##2##3##(2010-6#1)(2010-8#1)
use of small##4##3##(2007-7#1)(2008-3#1)(2008-5#1)(2009-7#1)
use of snus##3##3##(2012-12#3)
use of social media in oncology##2##6##(2013-1#2)
use of social media##3##4##(2012-2#1)(2013-1#2)
use of social services##2##4##(2011-1#1)(2011-2#1)
use of social##10##3##(1992-2#1)(1997-3#1)(2006-4#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)
use of sodium##6##3##(1990-2#1)(1990-8#1)(1994-9#1)(2006-4#1)(2007-8#1)(2010-8#1)
use of soil##2##3##(2006-3#1)(2008-10#1)
use of solid##2##3##(2008-5#1)(2008-7#1)
use of soluble##2##3##(2004-12#1)(2008-9#1)
use of somatostatin##2##3##(1991-5#1)(2006-1#1)
use of some##5##3##(2008-10#1)(2008-3#1)(2010-12#1)(2011-1#1)(2013-8#1)
use of space##2##3##(2008-2#1)(2011-2#1)
use of spatial##7##3##(1993-2#1)(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)
use of special##3##3##(1991-11#1)(1992-7#1)(2007-12#1)
use of specialized##3##3##(2005-8#1)(2008-9#1)(2010-4#1)
use of specific##14##3##(1990-6#1)(1992-2#1)(1996-5#1)(2006-7#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-11#1)(2009-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
use of spectroscopic ellipsometry##2##4##(2008-2#1)(2008-3#1)
use of speech##3##3##(2011-1#2)(2012-2#1)
use of spiritual##2##3##(2008-4#1)(2010-2#1)
use of stable##5##3##(1990-12#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-6#1)
use of standard##15##3##(1997-6#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2011-2#1)(2013-1#5)(2013-8#1)
use of standardized##2##3##(2006-10#1)(2008-4#1)
use of statistics in##2##4##(1996-3#1)(2013-8#1)
use of statistics##5##3##(1996-3#1)(2007-12#1)(2008-3#1)(2009-4#1)(2013-8#1)
use of stem cells##3##4##(2006-8#1)(2008-11#1)(2012-12#1)
use of stem##4##3##(2006-6#1)(2006-8#1)(2008-11#1)(2012-12#1)
use of stents was similar##2##5##(2006-7#1)(2006-8#1)
use of stents##5##3##(1994-11#1)(2006-10#2)(2006-7#1)(2006-8#1)
use of steroids##4##3##(2005-8#1)(2006-8#1)(2007-9#1)(2008-6#1)
use of stimulant##2##3##(1995-1#1)(2010-11#1)
use of stochastic##2##3##(2007-12#1)(2008-2#1)
use of storytelling##4##3##(1992-3#1)(2008-11#3)
use of strategies to##2##4##(1996-9#1)(2007-12#1)
use of subcutaneous##2##3##(1997-8#1)(2012-3#1)
use of subjective##2##3##(1992-2#1)(1994-4#1)
use of subsequent##2##3##(2008-2#1)(2012-1#1)
use of such a##5##4##(1994-9#1)(2007-12#1)(2008-10#1)(2008-2#1)(2012-3#1)
use of such an##2##4##(2008-11#1)(2012-2#1)
use of such systems##2##4##(2006-10#1)(2006-6#1)
use of such techniques##2##4##(1994-9#1)(2006-10#1)
use of such##29##3##(1990-11#1)(1990-8#1)(1991-5#1)(1992-1#1)(1993-12#1)(1994-9#2)(2004-9#1)(2005-8#1)(2006-10#2)(2006-4#1)(2006-6#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2012-12#2)(2012-2#2)(2012-3#1)
use of sulfide##3##3##(2007-8#3)
use of sunscreen##2##3##(2007-1#1)(2008-8#1)
use of supercritical##2##3##(2008-10#2)
use of supplemental##3##3##(1992-9#1)(2010-2#1)(2012-2#1)
use of supportive care##2##4##(2008-7#1)(2011-2#1)
use of surface##4##3##(2006-12#1)(2008-10#1)(2008-2#1)(2010-6#1)
use of surgical magnification##2##4##(2006-2#2)
use of surgical##5##3##(2006-2#2)(2006-6#1)(2007-8#1)(2012-3#1)
use of symbolic##2##3##(2008-2#1)(2009-4#1)
use of synchronous##3##3##(2008-10#2)(2008-6#1)
use of synchrotron radiation in the##2##6##(2006-5#1)(2008-3#1)
use of synchrotron radiation##4##4##(2006-4#1)(2006-5#2)(2008-3#1)
use of synthetic cannabinoids##2##4##(2005-10#1)(2013-7#1)
use of synthetic peptides##5##4##(1990-3#1)(1995-3#1)(2008-2#1)(2008-4#2)
use of synthetic##16##3##(1990-3#1)(1992-4#1)(1995-3#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#2)(2008-4#2)(2008-8#1)(2010-7#1)(2011-2#1)(2013-7#2)
use of tacrolimus##2##3##(2006-10#1)(2007-11#1)
use of targeted therapies##2##4##(2008-8#1)(2011-2#1)
use of targeted##5##3##(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
use of techniques of##2##4##(2007-11#1)(2007-12#1)
use of techniques##5##3##(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2009-12#1)
use of technology in##4##4##(1990-12#1)(2008-10#1)(2008-12#2)
use of technology##11##3##(1990-12#1)(1993-5#1)(1994-12#1)(1995-12#1)(2008-10#1)(2008-11#3)(2008-12#3)
use of telemedicine##2##3##(1996-3#1)(2013-1#1)
use of temporal##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
use of terlipressin##2##3##(2008-12#2)
use of testa of groundnut shell##2##6##(2007-10#2)
use of testing##2##3##(2012-2#1)(2013-1#1)
use of tests##3##3##(1990-9#1)(1994-5#1)(2008-7#1)
use of thalidomide in##3##4##(2006-10#1)(2008-5#2)
use of thalidomide##5##3##(2006-10#1)(2007-11#2)(2008-5#2)
use of the CO 2##2##5##(1992-3#2)
use of the CO##3##4##(1992-3#2)(2006-12#1)
use of the World##2##4##(2006-5#1)(2008-2#1)
use of the above##2##4##(1992-6#1)(2012-1#1)
use of the algorithm##2##4##(2008-2#1)(2008-3#1)
use of the approximation##2##4##(1996-3#1)(2009-9#1)
use of the argon##2##4##(1994-3#1)(2008-10#1)
use of the automated##4##4##(2007-7#1)(2008-10#3)
use of the available##6##4##(1991-2#1)(1991-9#1)(1995-10#1)(1997-4#1)(2007-3#1)(2008-9#1)
use of the benefit and in##2##6##(1994-2#1)(1995-3#1)
use of the cationic##2##4##(1996-5#1)(2008-10#1)
use of the concept of##2##5##(2008-3#1)(2009-2#1)
use of the conventional##3##4##(2008-12#1)(2008-3#2)
use of the couch##2##4##(2011-2#2)
use of the data##4##4##(2008-11#1)(2008-2#1)(2008-3#1)(2012-3#1)
use of the database##2##4##(1990-3#1)(2008-4#1)
use of the device in##3##5##(2007-11#1)(2008-11#1)(2010-6#1)
use of the device##4##4##(2007-11#1)(2007-7#1)(2008-11#1)(2010-6#1)
use of the domestic##2##4##(2007-12#1)(2008-8#1)
use of the drug##4##4##(1990-6#1)(2006-10#1)(2009-10#2)
use of the electron##2##4##(1990-8#1)(2008-3#1)
use of the estimated##2##4##(2007-10#1)(2008-10#1)
use of the experimental##3##4##(2008-2#1)(2008-3#2)
use of the fact that##2##5##(2008-4#1)(2008-9#1)
use of the fiber##2##4##(1992-1#1)(2008-3#1)
use of the first##2##4##(2008-10#1)(2011-1#1)
use of the fluorescent##2##4##(1991-11#1)(2008-4#1)
use of the generalized##3##4##(1992-2#1)(2008-2#1)(2008-3#1)
use of the generated##2##4##(2004-9#1)(2008-7#1)
use of the hematopoietic growth##2##5##(2008-7#1)(2010-12#1)
use of the highly##2##4##(1993-5#1)(2013-8#1)
use of the homologous##2##4##(2006-11#1)(2008-5#1)
use of the interferometer##2##4##(2007-11#2)
use of the internal##2##4##(2008-2#1)(2008-9#1)
use of the internet##3##4##(2007-7#2)(2008-12#1)
use of the laser##2##4##(1991-3#1)(1993-3#1)
use of the latter##2##4##(2007-12#1)(2008-2#1)
use of the linear##3##4##(1995-6#1)(2010-5#1)(2013-1#1)
use of the low##2##4##(2008-10#1)(2008-3#1)
use of the method##4##4##(1991-7#1)(1994-12#1)(2008-12#1)(2008-2#1)
use of the model##2##4##(1993-4#1)(2008-11#1)
use of the most##3##4##(2006-5#1)(2008-8#1)(2011-1#1)
use of the name##2##4##(2008-10#2)
use of the new##3##4##(1991-1#1)(2007-7#1)(2008-11#1)
use of the next generation of##2##6##(1996-11#1)(2008-2#1)
use of the oil##2##4##(2008-5#1)(2011-2#1)
use of the phase##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
use of the polymerase chain reaction##4##6##(1990-3#1)(2006-10#1)(2008-4#2)
use of the principles##2##4##(1993-12#1)(2007-12#1)
use of the prone##2##4##(1992-11#1)(1992-4#1)
use of the proposed##4##4##(1993-6#1)(2008-10#2)(2008-2#1)
use of the radial##4##4##(2007-11#1)(2007-8#2)(2011-2#1)
use of the sensor##2##4##(2008-10#1)(2010-2#1)
use of the simple##2##4##(1991-9#1)(2007-12#1)
use of the spatial##2##4##(2007-11#2)
use of the standard##4##4##(2008-10#2)(2008-3#1)(2008-5#1)
use of the system##6##4##(1992-12#1)(1993-1#1)(1994-12#1)(1994-3#1)(2008-10#2)
use of the tables##2##4##(1996-1#2)
use of the technique##7##4##(2006-10#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-3#1)(2009-5#1)(2012-12#1)
use of the term##2##4##(2006-12#1)(2008-1#1)
use of the time##2##4##(2008-8#1)(2010-9#1)
use of the vaccine##4##4##(1990-9#1)(2007-11#1)(2010-10#1)(2011-2#1)
use of the various##2##4##(2005-8#1)(2011-2#1)
use of the well-known##3##4##(2007-12#1)(2008-3#1)(2010-12#1)
use of the##793##3##(1990-10#1)(1990-12#4)(1990-3#2)(1990-6#1)(1990-8#2)(1990-9#3)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#4)(1991-5#2)(1991-7#5)(1991-8#1)(1991-9#4)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#1)(1993-1#2)(1993-11#3)(1993-12#5)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-10#1)(1994-12#2)(1994-2#2)(1994-3#4)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#4)(1995-6#3)(1995-8#1)(1996-1#3)(1996-11#1)(1996-3#4)(1996-5#3)(1996-6#1)(1996-7#3)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#4)(1997-5#1)(1997-7#1)(2004-10#1)(2004-12#1)(2004-3#1)(2004-9#2)(2005-10#1)(2005-12#1)(2005-5#1)(2005-7#2)(2005-8#1)(2006-10#14)(2006-11#4)(2006-12#6)(2006-2#1)(2006-4#1)(2006-5#7)(2006-6#4)(2006-7#4)(2006-8#3)(2007-1#2)(2007-10#7)(2007-11#32)(2007-12#51)(2007-2#4)(2007-3#2)(2007-4#2)(2007-6#2)(2007-7#13)(2007-8#22)(2007-9#3)(2008-1#11)(2008-10#75)(2008-11#22)(2008-12#7)(2008-2#67)(2008-3#103)(2008-4#23)(2008-5#13)(2008-6#2)(2008-7#11)(2008-8#10)(2008-9#9)(2009-10#4)(2009-11#3)(2009-12#2)(2009-2#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#4)(2010-8#5)(2010-9#5)(2011-1#4)(2011-12#1)(2011-2#15)(2012-1#3)(2012-12#8)(2012-2#6)(2012-3#7)(2013-1#14)(2013-7#2)(2013-8#7)
use of theophylline##2##3##(1991-2#1)(2007-2#1)
use of therapeutic##2##3##(2007-5#1)(2013-1#1)
use of thermal##4##3##(1992-7#1)(2008-10#1)(2008-3#2)
use of these agents in##5##5##(2005-6#1)(2006-10#1)(2007-11#1)(2008-2#1)(2008-3#1)
use of these agents##15##4##(1996-7#1)(2005-6#1)(2005-8#1)(2006-10#4)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)
use of these cells##2##4##(2008-1#1)(2013-1#1)
use of these compounds##3##4##(1991-4#1)(1991-6#1)(2012-1#1)
use of these devices and##2##5##(2005-12#1)(2010-9#1)
use of these devices##3##4##(2005-12#1)(2010-9#1)(2011-2#1)
use of these drugs in the treatment of##2##8##(2007-11#2)
use of these drugs in the##3##6##(2007-11#2)(2010-6#1)
use of these drugs in##5##5##(2007-11#3)(2010-6#2)
use of these drugs##10##4##(1996-4#1)(2006-5#1)(2007-11#3)(2008-10#1)(2008-11#1)(2008-8#1)(2010-6#2)
use of these instruments##3##4##(1991-6#1)(2008-3#1)(2011-2#1)
use of these materials##2##4##(2007-11#1)(2008-2#1)
use of these methods##5##4##(1996-2#1)(2006-10#1)(2006-2#1)(2008-2#1)(2008-7#1)
use of these modified##3##4##(2005-11#1)(2008-4#1)(2008-7#1)
use of these probes##2##4##(1990-4#1)(2008-9#1)
use of these procedures##4##4##(2006-10#1)(2008-6#1)(2011-1#1)(2011-2#1)
use of these services##2##4##(2010-8#1)(2012-3#1)
use of these substances##3##4##(1991-11#1)(1991-9#1)(2006-8#1)
use of these surfaces##2##4##(2010-4#1)(2013-1#1)
use of these systems##3##4##(2008-10#2)(2008-2#1)
use of these techniques in##4##5##(2006-10#2)(2007-12#1)(2008-11#1)
use of these techniques##10##4##(2006-10#2)(2006-9#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-8#1)(2012-12#1)(2013-1#1)
use of these tests##3##4##(1995-2#1)(2006-10#1)(2006-8#1)
use of these##150##3##(1990-4#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-2#1)(1994-11#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-3#2)(1997-4#1)(2004-12#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-4#1)(2005-6#1)(2005-8#1)(2006-10#11)(2006-2#2)(2006-5#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-11#8)(2007-12#4)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#12)(2008-11#2)(2008-2#11)(2008-3#7)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#4)(2009-8#1)(2010-3#1)(2010-4#3)(2010-6#2)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)
use of thiazolidinediones##2##3##(2008-3#1)(2010-10#1)
use of third-order##3##3##(2007-11#1)(2007-12#2)
use of this antibody##2##4##(1991-2#1)(1991-3#1)
use of this approach with##3##5##(2007-11#1)(2007-12#1)(2010-9#1)
use of this approach##6##4##(2007-11#1)(2007-12#2)(2008-2#2)(2010-9#1)
use of this device in##2##5##(2008-3#1)(2008-5#1)
use of this device##6##4##(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)
use of this diet##2##4##(1995-3#1)(2007-5#1)
use of this drug in the##3##6##(1991-12#1)(2007-7#1)(2008-6#1)
use of this drug in##4##5##(1991-12#1)(2007-3#1)(2007-7#1)(2008-6#1)
use of this drug##6##4##(1991-12#1)(2006-12#1)(2006-6#1)(2007-3#1)(2007-7#1)(2008-6#1)
use of this information##4##4##(1997-8#2)(2013-1#2)
use of this instrument##4##4##(1990-4#1)(2007-8#1)(2008-11#1)(2008-2#1)
use of this material##2##4##(1990-9#1)(2008-2#1)
use of this method##6##4##(1995-2#1)(1997-1#1)(2007-12#2)(2007-8#1)(2008-6#1)
use of this new##3##4##(1991-7#1)(2008-2#1)(2008-3#1)
use of this plant##2##4##(2008-10#1)(2008-11#1)
use of this protein##3##4##(1992-12#1)(1992-8#1)(2012-2#1)
use of this system for##2##5##(1997-4#1)(2006-5#1)
use of this system##7##4##(1997-3#1)(1997-4#1)(2006-5#1)(2007-5#1)(2008-3#3)
use of this technique in##4##5##(2007-6#1)(2008-1#1)(2008-2#1)(2010-12#1)
use of this technique to##2##5##(2007-8#1)(2008-2#1)
use of this technique##15##4##(2005-7#1)(2006-10#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-2#2)(2008-3#2)(2008-7#1)(2010-12#1)(2011-2#1)
use of this technology##6##4##(2007-11#1)(2008-7#2)(2013-1#3)
use of this test##2##4##(2008-4#1)(2011-2#1)
use of this therapy##2##4##(2007-10#1)(2007-11#1)
use of this tool##3##4##(2008-3#1)(2011-12#1)(2012-7#1)
use of this##159##3##(1990-12#1)(1990-4#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-7#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#2)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-3#1)(2006-5#2)(2006-6#1)(2006-8#3)(2007-10#2)(2007-11#8)(2007-12#11)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#6)(2008-1#1)(2008-10#7)(2008-11#5)(2008-2#13)(2008-3#14)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#6)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-12#3)(2010-4#1)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#6)(2013-8#1)
use of those##2##3##(2006-2#1)(2007-12#1)
use of three##5##3##(1991-12#1)(1992-9#1)(2008-10#1)(2008-2#1)(2013-1#1)
use of thromboelastography##2##3##(2007-8#2)
use of thrombolytic therapy##4##4##(1997-1#1)(1997-8#1)(2007-10#1)(2007-5#1)
use of time##3##3##(1992-2#1)(1997-8#1)(2008-1#1)
use of time-resolved##5##3##(2007-12#1)(2008-3#3)(2009-5#1)
use of tissue plasminogen activator##2##5##(2007-9#2)
use of tissue##6##3##(1992-8#1)(1997-8#1)(2007-11#1)(2007-9#2)(2009-10#1)
use of tobacco##2##3##(1993-5#1)(2008-6#1)
use of tools##2##3##(2007-1#1)(2012-12#1)
use of topical tranexamic acid##3##5##(2007-8#3)
use of topical##9##3##(2005-8#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-3#1)
use of total reflection##2##4##(2008-2#1)(2008-3#1)
use of total##7##3##(1995-3#1)(2004-11#1)(2006-9#1)(2008-1#1)(2008-2#1)(2008-3#2)
use of traditional##10##3##(1994-4#1)(2005-12#1)(2005-6#1)(2008-12#2)(2009-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
use of transgenic##4##3##(2005-8#2)(2008-11#1)(2013-1#1)
use of transmission##3##3##(2006-4#1)(2008-2#2)
use of transrectal##2##3##(1991-12#1)(1997-8#1)
use of treated##2##3##(1997-4#1)(2008-9#1)
use of treatment##5##3##(2005-7#2)(2006-10#1)(2006-12#1)(2011-2#1)
use of treatments##3##3##(2007-11#1)(2010-12#1)(2010-8#1)
use of tricyclic##3##3##(1990-11#1)(2006-10#1)(2012-2#1)
use of tumor necrosis factor##2##5##(2006-10#1)(2011-2#1)
use of tumor necrosis##4##4##(2006-10#1)(2011-2#1)(2013-1#2)
use of tumor##5##3##(1996-2#1)(2006-10#1)(2011-2#1)(2013-1#2)
use of tumour necrosis##2##4##(2007-12#1)(2012-11#1)
use of tumour##4##3##(2005-7#1)(2007-12#1)(2008-3#1)(2012-11#1)
use of tunable diode lasers##2##5##(2008-3#2)
use of tunable##4##3##(2008-2#2)(2008-3#2)
use of two different##5##4##(2007-11#1)(2008-2#1)(2008-3#2)(2012-2#1)
use of two wavelengths##3##4##(2008-2#1)(2008-3#2)
use of two##52##3##(1990-12#1)(1990-3#1)(1991-3#1)(1991-5#1)(1997-6#1)(2006-5#1)(2007-11#6)(2007-12#4)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#11)(2008-4#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-5#1)(2010-6#1)(2010-8#1)(2012-2#1)(2013-1#1)
use of two-dimensional##5##3##(1992-1#1)(1994-11#1)(1997-6#1)(2007-12#1)(2008-2#1)
use of two-photon absorption in a##3##6##(2007-11#2)(2007-12#1)
use of two-photon excitation##4##4##(2007-11#3)(2008-2#1)
use of two-photon##7##3##(2007-11#5)(2007-12#1)(2008-2#1)
use of ultrasonography and##2##4##(1992-8#1)(2011-2#1)
use of ultrasonography##5##3##(1991-4#1)(1992-8#1)(2009-8#1)(2011-2#2)
use of ultrasound and##2##4##(2006-10#1)(2006-11#1)
use of ultrasound in##2##4##(2006-6#1)(2008-1#1)
use of ultrasound to##2##4##(1992-12#1)(2013-1#1)
use of ultrasound with color Doppler##2##6##(2006-10#2)
use of ultrasound##12##3##(1990-3#1)(1992-12#1)(2006-10#3)(2006-11#1)(2006-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2013-1#1)
use of universal precautions##2##4##(1996-1#1)(2007-12#1)
use of urban##3##3##(1992-12#2)(1995-11#1)
use of urinary##2##3##(1991-12#1)(2010-5#1)
use of vaccines##8##3##(1995-9#1)(2006-10#1)(2007-6#1)(2009-9#1)(2010-2#1)(2013-8#3)
use of valproate##2##3##(2008-3#1)(2010-12#1)
use of varied##2##3##(2006-1#1)(2008-10#1)
use of various kinds of##2##5##(2007-8#1)(2008-4#1)
use of various types of##2##5##(2008-10#1)(2012-2#1)
use of various##17##3##(1994-6#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-4#1)(2008-5#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
use of vector quantization##2##4##(2008-2#1)(2008-3#1)
use of very short##2##4##(1991-7#1)(2007-12#1)
use of video##2##3##(2008-4#1)(2008-8#1)
use of video-assisted thoracic surgery (VATS)##2##6##(2007-8#2)
use of virus##2##3##(1994-11#1)(2008-5#1)
use of visual##2##3##(2007-11#1)(2007-12#1)
use of vitamin E##2##4##(1992-9#1)(2008-7#1)
use of vitamin##8##3##(1992-9#3)(2007-7#2)(2008-1#2)(2008-7#1)
use of water##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2009-8#1)
use of water-soluble##2##3##(2004-9#1)(2008-10#1)
use of wavelength modulation spectroscopy##2##5##(2008-2#2)
use of weak opioids##2##4##(2006-10#2)
use of withdrawal##2##3##(2012-11#2)
use of wood##2##3##(1992-10#1)(1997-6#1)
use of ziprasidone##3##3##(2005-6#1)(2008-6#2)
use of##8134##2##(1990-10#8)(1990-11#14)(1990-12#25)(1990-2#11)(1990-3#14)(1990-4#12)(1990-5#16)(1990-6#13)(1990-7#8)(1990-8#14)(1990-9#13)(1991-1#9)(1991-10#7)(1991-11#9)(1991-12#34)(1991-2#23)(1991-3#18)(1991-4#8)(1991-5#23)(1991-6#9)(1991-7#14)(1991-8#19)(1991-9#26)(1992-1#17)(1992-10#9)(1992-11#12)(1992-12#17)(1992-2#20)(1992-3#26)(1992-4#11)(1992-5#12)(1992-6#11)(1992-7#9)(1992-8#11)(1992-9#17)(1993-1#5)(1993-10#7)(1993-11#15)(1993-12#26)(1993-2#25)(1993-3#24)(1993-4#9)(1993-5#8)(1993-6#14)(1993-7#3)(1993-8#7)(1993-9#16)(1994-1#4)(1994-10#2)(1994-11#14)(1994-12#21)(1994-2#26)(1994-3#27)(1994-4#7)(1994-5#7)(1994-6#14)(1994-7#4)(1994-8#8)(1994-9#19)(1995-1#14)(1995-10#3)(1995-11#7)(1995-12#32)(1995-2#25)(1995-3#29)(1995-4#7)(1995-5#14)(1995-6#9)(1995-7#2)(1995-8#10)(1995-9#7)(1996-1#26)(1996-10#6)(1996-11#18)(1996-12#20)(1996-2#26)(1996-3#25)(1996-4#4)(1996-5#27)(1996-6#19)(1996-7#6)(1996-8#12)(1996-9#28)(1997-1#16)(1997-2#24)(1997-3#24)(1997-4#16)(1997-5#21)(1997-6#15)(1997-7#13)(1997-8#21)(2004-1#2)(2004-10#5)(2004-11#1)(2004-12#12)(2004-3#2)(2004-4#9)(2004-7#1)(2004-8#1)(2004-9#7)(2005-1#1)(2005-10#24)(2005-11#30)(2005-12#18)(2005-4#3)(2005-5#4)(2005-6#8)(2005-7#35)(2005-8#47)(2005-9#7)(2006-1#6)(2006-10#220)(2006-11#18)(2006-12#45)(2006-2#39)(2006-3#13)(2006-4#28)(2006-5#39)(2006-6#36)(2006-7#32)(2006-8#59)(2006-9#20)(2007-1#18)(2007-10#55)(2007-11#367)(2007-12#530)(2007-2#39)(2007-3#19)(2007-4#35)(2007-5#22)(2007-6#28)(2007-7#94)(2007-8#157)(2007-9#39)(2008-1#126)(2008-10#620)(2008-11#221)(2008-12#76)(2008-2#481)(2008-3#699)(2008-4#170)(2008-5#128)(2008-6#95)(2008-7#165)(2008-8#83)(2008-9#105)(2009-1#5)(2009-10#34)(2009-11#20)(2009-12#15)(2009-2#26)(2009-3#17)(2009-4#30)(2009-5#36)(2009-6#13)(2009-7#18)(2009-8#25)(2009-9#11)(2010-1#8)(2010-10#19)(2010-11#36)(2010-12#53)(2010-2#30)(2010-3#30)(2010-4#31)(2010-5#28)(2010-6#24)(2010-7#21)(2010-8#49)(2010-9#24)(2011-1#70)(2011-10#2)(2011-12#21)(2011-2#191)(2011-3#6)(2011-7#5)(2012-1#41)(2012-10#1)(2012-11#26)(2012-12#106)(2012-2#126)(2012-3#88)(2012-7#1)(2012-8#1)(2013-1#224)(2013-7#24)(2013-8#97)
use on a##6##3##(1997-1#1)(2007-11#1)(2008-3#1)(2008-4#2)(2008-5#1)
use on the##3##3##(1992-6#1)(2008-5#1)(2010-9#1)
use on##39##2##(1991-2#1)(1991-5#1)(1992-6#1)(1997-1#1)(2004-4#1)(2006-10#4)(2006-12#1)(2007-10#1)(2007-11#2)(2008-10#3)(2008-3#4)(2008-4#2)(2008-5#3)(2008-8#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-2#1)(2010-9#1)(2011-2#1)(2013-1#2)(2013-8#2)
use one##3##2##(1993-2#1)(2008-10#1)(2008-3#1)
use only##10##2##(1991-12#1)(1991-3#1)(1991-5#1)(1993-6#1)(2006-2#1)(2008-3#2)(2008-6#1)(2010-9#1)(2012-1#1)
use optical correlation##2##3##(2008-3#2)
use optical##7##2##(2007-12#2)(2008-2#1)(2008-3#3)(2008-4#1)
use or for##2##3##(1991-7#1)(1996-2#1)
use or##30##2##(1990-5#1)(1991-7#1)(1991-9#1)(1996-2#1)(1996-6#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-5#2)(2010-11#1)(2010-2#1)(2011-12#1)(2012-1#2)(2012-12#1)(2013-7#2)
use other##3##2##(1996-6#1)(2007-11#1)(2007-12#1)
use our##4##2##(1994-2#1)(2008-3#2)(2012-3#1)
use outside##2##2##(1991-1#1)(2008-1#1)
use over the##4##3##(1995-4#1)(2007-11#1)(2008-7#1)(2012-12#1)
use over##8##2##(1995-4#1)(2007-11#1)(2008-3#1)(2008-7#1)(2009-7#1)(2011-1#1)(2012-12#1)(2013-7#1)
use patient##4##2##(1996-12#1)(2010-8#1)(2013-1#2)
use patterns to##2##3##(2011-1#1)(2012-3#1)
use patterns##10##2##(1991-1#1)(2008-10#2)(2008-8#1)(2008-9#1)(2010-2#1)(2011-1#1)(2012-3#2)(2013-1#1)
use population##2##2##(1996-12#1)(2010-6#1)
use practices##5##2##(2008-1#1)(2008-12#1)(2008-3#1)(2012-3#2)
use prevention and##2##3##(1997-1#1)(2007-12#1)
use prior to##3##3##(2005-8#1)(2006-8#1)(2010-3#1)
use produces a##2##3##(1996-3#1)(2011-2#1)
use rates##4##2##(1990-12#1)(1994-2#2)(2010-8#1)
use rather than##2##3##(1992-9#1)(1993-6#1)
use reduces the##2##3##(2007-10#1)(2008-2#1)
use reduces##3##2##(2007-10#1)(2008-2#1)(2010-5#1)
use remain##2##2##(2007-4#1)(2009-1#1)
use remained##2##2##(2010-1#1)(2013-1#1)
use remains##5##2##(1992-2#1)(1997-1#1)(2008-11#1)(2009-9#1)(2011-2#1)
use remote##3##2##(2008-2#1)(2008-3#1)(2008-4#1)
use requires further##2##3##(2007-11#1)(2013-7#1)
use requires##4##2##(2007-11#1)(2007-12#1)(2012-2#1)(2013-7#1)
use research##8##2##(1997-2#1)(2008-11#1)(2008-12#1)(2008-8#2)(2009-3#1)(2010-5#1)(2010-8#1)
use results from##3##3##(1992-6#2)(2012-1#1)
use retrospective##3##2##(2006-5#1)(2013-1#2)
use score##2##2##(2012-12#1)(2013-1#1)
use service##2##2##(2010-10#1)(2011-1#1)
use services##2##2##(2010-10#1)(2012-2#1)
use several##7##2##(2005-4#1)(2006-10#1)(2006-5#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)
use should be encouraged##3##4##(1996-12#1)(2011-2#1)(2012-1#1)
use should be##7##3##(1993-8#1)(1996-12#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
use should##12##2##(1990-4#1)(1993-8#1)(1996-12#1)(2006-10#1)(2006-12#1)(2007-6#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
use showed##2##2##(2004-4#1)(2008-10#1)
use signal##2##2##(2005-7#1)(2008-3#1)
use simulation##2##2##(2008-9#1)(2009-12#1)
use so##3##2##(2008-1#1)(2008-11#1)(2012-12#1)
use social media##2##3##(2013-1#2)
use some form##2##3##(1996-2#1)(2006-10#1)
use some of##2##3##(1993-9#1)(2008-10#1)
use some##8##2##(1993-9#1)(1996-2#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-4#1)(2013-1#2)
use standard##2##2##(2007-9#1)(2008-2#1)
use standards##2##2##(2004-12#1)(2013-1#1)
use statistics##2##2##(2010-9#1)(2013-8#1)
use such##7##2##(1995-9#1)(1997-4#1)(2007-10#1)(2008-3#2)(2009-9#1)(2013-1#1)
use surgery##2##2##(2007-12#1)(2012-3#1)
use text messaging##3##3##(2008-7#1)(2013-1#2)
use than is##2##3##(1995-11#1)(2008-11#1)
use than the##2##3##(1992-3#1)(1996-10#1)
use than##16##2##(1992-3#1)(1995-11#1)(1996-10#1)(2006-9#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-6#1)(2012-2#3)(2013-1#2)
use that##9##2##(2008-1#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-3#1)(2012-12#1)(2013-1#1)(2013-8#2)
use the Genetic Analysis Workshop 17##2##6##(2012-3#2)
use the Internet to##3##4##(2007-12#2)(2008-7#1)
use the Internet##5##3##(2007-12#2)(2007-7#1)(2007-9#1)(2008-7#1)
use the apparatus with##2##4##(2012-1#2)
use the best##2##3##(1997-5#1)(2008-9#1)
use the current##2##3##(2008-3#1)(2008-4#1)
use the data to##2##4##(1993-9#1)(2009-12#1)
use the data##4##3##(1993-9#1)(1995-3#1)(1996-7#1)(2009-12#1)
use the detector##2##3##(2007-11#1)(2008-10#1)
use the device##2##3##(2012-1#1)(2012-3#1)
use the expanded##2##3##(1992-6#1)(2013-1#1)
use the information##6##3##(1997-8#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)
use the measurements##2##3##(1997-3#1)(2007-12#1)
use the method##3##3##(1996-6#1)(2008-3#2)
use the model to##2##4##(1995-8#1)(2007-7#1)
use the model##3##3##(1995-8#1)(2007-7#1)(2008-11#1)
use the most##2##3##(2007-10#1)(2013-7#1)
use the new##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
use the products##2##3##(2006-10#2)
use the ratio##2##3##(2008-3#1)(2013-8#1)
use the relative EC50/IC50##3##4##(2012-2#3)
use the resulting##2##3##(2010-8#1)(2011-12#1)
use the results from##2##4##(1994-3#1)(2008-9#1)
use the same##12##3##(1994-12#1)(1995-11#1)(1996-2#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-8#1)(2012-2#1)
use the system##4##3##(1994-2#1)(2008-5#1)(2008-8#1)(2012-12#1)
use the term &quot##3##4##(1990-11#1)(2009-4#1)(2011-1#1)
use the term##5##3##(1990-11#1)(1997-6#1)(2004-11#1)(2009-4#1)(2011-1#1)
use the terms##2##3##(2010-7#1)(2011-12#1)
use the##271##2##(1990-11#1)(1990-2#2)(1990-3#1)(1991-1#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-2#1)(1993-8#1)(1993-9#3)(1994-11#2)(1994-12#1)(1994-2#4)(1994-3#5)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-2#3)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-10#1)(2004-11#1)(2004-9#1)(2005-12#2)(2005-4#1)(2006-10#6)(2006-2#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#7)(2007-12#14)(2007-7#4)(2007-8#3)(2007-9#3)(2008-1#7)(2008-10#11)(2008-11#6)(2008-2#18)(2008-3#22)(2008-4#17)(2008-5#2)(2008-7#9)(2008-8#5)(2008-9#9)(2009-12#3)(2009-4#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#2)(2012-1#4)(2012-11#1)(2012-12#3)(2012-2#8)(2012-3#12)(2013-1#4)(2013-7#1)(2013-8#1)
use their hand repetitively##3##4##(2008-9#3)
use their##23##2##(1992-2#1)(1992-7#1)(1994-12#1)(1997-4#1)(2005-12#1)(2006-10#2)(2007-12#1)(2007-2#1)(2007-6#1)(2008-11#2)(2008-9#3)(2011-1#2)(2011-12#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
use them to##7##3##(1993-12#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-7#1)(2013-7#1)
use there is##2##3##(2006-9#1)(2008-5#1)
use there##3##2##(1997-8#1)(2006-9#1)(2008-5#1)
use these data to##2##4##(1994-2#1)(2008-8#1)
use these data##3##3##(1994-2#1)(2007-4#1)(2008-8#1)
use these##29##2##(1990-12#1)(1991-1#2)(1994-2#1)(1994-8#1)(1995-6#1)(1995-8#2)(1996-12#2)(1996-2#1)(1997-2#1)(2006-10#2)(2007-4#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-2#1)(2009-4#1)(2010-10#1)(2010-3#1)(2012-1#1)(2013-7#1)
use this approach to##2##4##(2008-4#1)(2011-12#1)
use this approach##4##3##(2008-2#1)(2008-4#1)(2010-3#1)(2011-12#1)
use this data##2##3##(1991-12#1)(2008-6#1)
use this information to##2##4##(2007-6#1)(2008-7#1)
use this information##3##3##(2007-6#1)(2008-7#2)
use this method to##3##4##(2008-3#1)(2008-7#1)(2010-6#1)
use this method##6##3##(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-6#1)
use this model##2##3##(2008-5#1)(2010-10#1)
use this property to##2##4##(2007-11#1)(2008-11#1)
use this property##3##3##(2007-11#1)(2008-11#1)(2008-2#1)
use this technique to##3##4##(2007-12#1)(2008-1#1)(2008-4#1)
use this technique##6##3##(2006-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)
use this to##4##3##(1994-2#1)(2006-7#1)(2008-7#1)(2009-12#1)
use this tool##2##3##(2007-4#1)(2008-7#1)
use this##72##2##(1990-12#1)(1991-12#1)(1993-9#2)(1994-2#1)(1997-2#1)(2006-10#1)(2006-3#2)(2006-7#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#7)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#1)
use through the##2##3##(2008-5#1)(2013-7#1)
use through##4##2##(2008-5#1)(2009-7#1)(2013-1#1)(2013-7#1)
use to analyze##2##3##(1993-3#1)(2008-1#1)
use to determine the##3##4##(2007-12#1)(2008-3#1)(2012-12#1)
use to determine##4##3##(2007-12#1)(2008-3#1)(2008-7#1)(2012-12#1)
use to make decisions##2##4##(2008-1#1)(2010-8#1)
use to make##4##3##(1990-12#1)(2008-1#1)(2008-3#1)(2010-8#1)
use to prevent##3##3##(1994-12#1)(2008-12#1)(2013-8#1)
use to provide##3##3##(1993-6#1)(2007-4#1)(2008-10#1)
use to survive##2##3##(2006-5#1)(2013-1#1)
use to treat##3##3##(2007-3#1)(2008-11#1)(2012-2#1)
use to##88##2##(1990-12#1)(1990-2#1)(1992-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#2)(1995-1#1)(1995-2#1)(1996-5#1)(2005-10#1)(2006-5#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-9#2)(2008-1#4)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#4)(2008-5#2)(2008-7#1)(2008-9#3)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#4)(2009-7#1)(2009-9#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-12#3)(2012-2#4)(2013-1#5)(2013-8#1)
use tobacco##3##2##(1991-5#1)(2005-9#1)(2008-4#1)
use today##2##2##(1995-12#1)(2010-7#1)
use tools##2##2##(2006-10#1)(2008-4#1)
use treated##2##2##(1997-4#1)(2010-2#1)
use treatment##2##2##(2011-1#1)(2012-12#1)
use two##14##2##(1990-8#1)(1993-12#1)(1996-8#1)(2005-11#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-2#1)(2012-3#1)(2013-1#2)
use under##4##2##(1992-3#1)(1995-2#1)(2008-6#1)(2010-6#1)
use varied##2##2##(2008-5#1)(2011-1#1)
use various##8##2##(2007-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-2#1)(2012-12#1)
use very##3##2##(2008-2#1)(2008-7#1)(2009-10#1)
use was a##2##3##(2013-1#1)(2013-7#1)
use was associated with a##2##5##(1993-12#1)(2007-8#1)
use was associated with##4##4##(1993-12#1)(2006-3#1)(2007-7#1)(2007-8#1)
use was evaluated##2##3##(2005-11#1)(2006-5#1)
use was found to##2##4##(2004-4#1)(2009-7#1)
use was low##2##3##(1993-9#1)(2008-4#1)
use was not##2##3##(2008-12#1)(2012-12#1)
use was significantly higher among##3##5##(2006-2#2)(2007-3#1)
use was##44##2##(1990-2#1)(1993-10#1)(1993-12#1)(1993-9#1)(1994-3#1)(1994-9#1)(1997-6#1)(2004-4#1)(2005-11#1)(2006-2#3)(2006-3#2)(2006-5#1)(2006-8#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-1#1)(2009-7#3)(2010-12#1)(2010-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
use wavelet##2##2##(2008-2#1)(2008-3#1)
use were##21##2##(1996-11#1)(1997-6#1)(2004-9#1)(2006-3#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#4)(2008-5#1)(2008-9#1)(2009-2#1)(2009-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
use when##14##2##(1997-3#1)(2006-10#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-9#1)(2011-2#1)(2013-1#6)
use which##4##2##(1991-3#1)(2004-12#1)(2012-2#1)(2013-7#1)
use whole##2##2##(1991-12#1)(2008-11#1)
use will##6##2##(2006-10#1)(2010-12#1)(2011-2#2)(2011-7#1)(2012-12#1)
use with a##5##3##(1997-3#1)(2006-10#1)(2007-9#1)(2008-2#1)(2011-1#1)
use with an##3##3##(2006-10#1)(2008-10#1)(2008-2#1)
use with the##8##3##(1996-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#2)(2012-3#1)
use with##92##2##(1990-9#1)(1992-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-3#1)(2004-11#1)(2005-6#1)(2006-10#2)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#8)(2008-11#2)(2008-2#6)(2008-3#4)(2008-4#8)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-2#3)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#16)(2013-1#1)(2013-8#1)
use within a##3##3##(2007-10#1)(2008-2#1)(2008-9#1)
use within non-commercial partnerships of##2##5##(2012-3#2)
use within the##4##3##(1993-5#1)(2008-10#1)(2008-11#1)(2008-4#1)
use within##17##2##(1993-5#1)(1997-2#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-7#1)(2012-2#3)(2012-3#2)
use without##5##2##(1993-2#1)(2007-11#1)(2008-11#1)(2008-5#1)(2010-11#1)
use would##3##2##(2005-10#1)(2007-7#1)(2008-8#1)
use##13628##1##(1990-1#1)(1990-10#11)(1990-11#20)(1990-12#38)(1990-2#22)(1990-3#23)(1990-4#15)(1990-5#20)(1990-6#20)(1990-7#11)(1990-8#21)(1990-9#22)(1991-1#34)(1991-10#9)(1991-11#16)(1991-12#55)(1991-2#30)(1991-3#28)(1991-4#9)(1991-5#31)(1991-6#20)(1991-7#16)(1991-8#27)(1991-9#37)(1992-1#26)(1992-10#13)(1992-11#19)(1992-12#31)(1992-2#34)(1992-3#45)(1992-4#19)(1992-5#19)(1992-6#21)(1992-7#11)(1992-8#16)(1992-9#25)(1993-1#15)(1993-10#11)(1993-11#19)(1993-12#55)(1993-2#37)(1993-3#30)(1993-4#12)(1993-5#12)(1993-6#24)(1993-7#3)(1993-8#14)(1993-9#31)(1994-1#12)(1994-10#5)(1994-11#21)(1994-12#39)(1994-2#53)(1994-3#55)(1994-4#12)(1994-5#15)(1994-6#26)(1994-7#7)(1994-8#14)(1994-9#28)(1995-1#27)(1995-10#4)(1995-11#11)(1995-12#47)(1995-2#49)(1995-3#44)(1995-4#10)(1995-5#23)(1995-6#12)(1995-7#2)(1995-8#20)(1995-9#12)(1996-1#51)(1996-10#13)(1996-11#31)(1996-12#35)(1996-2#43)(1996-3#41)(1996-4#13)(1996-5#35)(1996-6#31)(1996-7#16)(1996-8#17)(1996-9#47)(1997-1#36)(1997-2#39)(1997-3#46)(1997-4#25)(1997-5#33)(1997-6#26)(1997-7#19)(1997-8#35)(2003-12#1)(2004-1#2)(2004-10#9)(2004-11#5)(2004-12#19)(2004-2#3)(2004-3#9)(2004-4#18)(2004-7#3)(2004-8#2)(2004-9#21)(2005-1#1)(2005-10#54)(2005-11#51)(2005-12#32)(2005-3#1)(2005-4#7)(2005-5#6)(2005-6#18)(2005-7#63)(2005-8#76)(2005-9#14)(2006-1#11)(2006-10#349)(2006-11#25)(2006-12#66)(2006-2#68)(2006-3#34)(2006-4#44)(2006-5#60)(2006-6#55)(2006-7#66)(2006-8#96)(2006-9#29)(2007-1#26)(2007-10#102)(2007-11#513)(2007-12#662)(2007-2#86)(2007-3#33)(2007-4#68)(2007-5#37)(2007-6#59)(2007-7#158)(2007-8#242)(2007-9#76)(2008-1#212)(2008-10#899)(2008-11#402)(2008-12#122)(2008-2#638)(2008-3#905)(2008-4#310)(2008-5#265)(2008-6#147)(2008-7#260)(2008-8#163)(2008-9#211)(2009-1#12)(2009-10#51)(2009-11#40)(2009-12#45)(2009-2#54)(2009-3#41)(2009-4#56)(2009-5#71)(2009-6#34)(2009-7#79)(2009-8#48)(2009-9#32)(2010-1#18)(2010-10#32)(2010-11#65)(2010-12#103)(2010-2#84)(2010-3#41)(2010-4#58)(2010-5#54)(2010-6#42)(2010-7#49)(2010-8#99)(2010-9#60)(2011-1#153)(2011-10#2)(2011-12#61)(2011-2#311)(2011-3#10)(2011-7#9)(2012-1#105)(2012-10#1)(2012-11#51)(2012-12#225)(2012-2#237)(2012-3#234)(2012-7#1)(2012-8#2)(2013-1#517)(2013-7#66)(2013-8#203)
use&quot##5##1##(2006-7#1)(2008-10#1)(2012-12#1)(2013-1#2)
use'##3##1##(1996-1#1)(2012-12#2)
use) may##2##2##(1996-9#1)(2010-1#1)
use) were##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
use)##17##1##(1996-9#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-9#1)(2010-1#2)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
use-dependent block of##2##3##(2008-8#2)
use-dependent block##3##2##(1996-10#1)(2008-8#2)
use-dependent##8##1##(1996-10#1)(1997-5#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-8#2)(2013-1#1)
use/land##2##1##(2007-5#2)
use?##4##1##(2006-10#1)(2008-7#1)(2008-8#1)(2010-12#1)
use]##10##1##(1991-6#1)(1992-5#1)(1993-10#1)(1994-11#1)(1994-8#1)(1995-9#1)(1996-9#1)(1997-6#1)(2005-9#1)(2013-8#1)
useable##4##1##(1996-12#1)(2006-6#1)(2008-5#1)(2013-1#1)
used &quot##4##2##(2010-4#1)(2011-2#1)(2013-1#2)
used (0##2##2##(1993-12#1)(2008-5#1)
used (4##2##2##(1996-10#1)(2008-10#1)
used (5##2##2##(1996-5#1)(2010-12#1)
used (n##2##2##(1991-8#1)(1995-6#1)
used 10##3##2##(1997-2#1)(2007-7#1)(2008-12#1)
used 11##2##2##(2007-8#1)(2008-10#1)
used 2##2##2##(2007-11#1)(2008-3#1)
used 3##3##2##(1992-7#1)(2008-10#1)(2011-1#1)
used BAC transgenic##2##3##(2008-4#1)(2013-8#1)
used Beck's##2##2##(1992-2#1)(2007-7#1)
used DNA##4##2##(2006-8#1)(2008-11#1)(2008-7#1)(2010-5#1)
used IUDs##2##2##(1992-2#2)
used MRI##4##2##(2005-10#1)(2010-2#1)(2012-1#1)(2012-2#1)
used NMR##2##2##(2009-3#1)(2009-8#1)
used PCR##3##2##(1994-10#1)(2010-10#1)(2012-12#1)
used UV##3##2##(2006-12#1)(2008-10#1)(2008-5#1)
used a broad##2##3##(1993-11#1)(2009-4#1)
used a combination of##9##4##(1992-11#1)(1994-9#1)(1996-7#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-8#1)(2011-10#1)
used a condom##3##3##(2007-7#1)(2009-5#1)(2012-3#1)
used a crude##2##3##(1996-12#1)(1996-7#1)
used a femtosecond##2##3##(2007-12#2)
used a genetic approach##3##4##(1995-2#1)(1995-8#1)(1996-10#1)
used a large##3##3##(1992-9#1)(2008-9#1)(2011-2#1)
used a middle##2##3##(2008-9#1)(2010-2#1)
used a mix of##2##4##(2010-5#1)(2013-1#1)
used a modified version of the##3##6##(1997-3#1)(2008-2#1)(2009-4#1)
used a modified##4##3##(1997-3#1)(2008-11#1)(2008-2#1)(2009-4#1)
used a novel##7##3##(1991-12#1)(2007-12#3)(2008-10#1)(2012-3#1)(2013-1#1)
used a number of##2##4##(1992-9#1)(1995-8#1)
used a panel of##2##4##(1994-3#1)(2007-10#1)
used a pharmacological##2##3##(2008-8#1)(2011-1#1)
used a phenomenological approach##2##4##(2008-2#1)(2011-1#1)
used a questionnaire to##2##4##(2007-8#1)(2011-2#1)
used a questionnaire##3##3##(2004-7#1)(2007-8#1)(2011-2#1)
used a rabbit model##2##4##(1996-3#1)(2007-9#1)
used a rigid seat##2##4##(2006-11#2)
used a series of##2##4##(1993-6#1)(2012-3#1)
used a short##2##3##(2007-8#1)(2008-3#1)
used a simple##4##3##(1995-12#1)(2006-12#1)(2007-8#1)(2008-3#1)
used a single##2##3##(2008-9#1)(2013-1#1)
used a site-directed mutagenesis##2##4##(1994-9#1)(1996-5#1)
used a specific##2##3##(1993-7#1)(2010-8#1)
used a visual##3##3##(2008-11#1)(2011-1#1)(2013-1#1)
used a##280##2##(1990-11#1)(1990-2#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-6#1)(1991-7#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#2)(1992-8#3)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#2)(1993-7#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#4)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-5#1)(1997-7#2)(2004-1#1)(2004-11#2)(2004-7#1)(2004-9#1)(2006-10#1)(2006-11#4)(2006-12#3)(2006-2#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#10)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#12)(2008-12#3)(2008-2#15)(2008-3#20)(2008-4#2)(2008-5#6)(2008-6#2)(2008-8#7)(2008-9#10)(2009-1#1)(2009-10#2)(2009-11#1)(2009-4#4)(2009-5#2)(2009-7#2)(2009-8#2)(2010-10#1)(2010-2#3)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-10#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#3)(2013-1#23)(2013-7#1)(2013-8#2)
used according to the##4##4##(1994-1#1)(2007-11#1)(2008-2#1)(2011-2#1)
used across##3##2##(2008-7#1)(2008-8#1)(2011-1#1)
used adjunctively with##2##3##(2008-5#1)(2010-12#1)
used affinity##2##2##(1991-5#1)(1997-3#1)
used after validation##2##3##(2011-2#1)(2012-12#1)
used after##10##2##(1990-6#1)(1991-5#1)(1995-9#1)(2004-11#1)(2006-11#1)(2006-12#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-12#1)
used again in##2##3##(1997-2#1)(2006-4#1)
used against##4##2##(2006-4#1)(2007-5#1)(2008-5#1)(2012-2#1)
used all over the world##4##5##(2007-7#1)(2007-8#1)(2011-2#1)(2012-2#1)
used alone as a##2##4##(2008-10#1)(2008-12#1)
used alone or in combination with##2##6##(2009-5#1)(2013-1#1)
used alone or in combination##3##5##(1993-6#1)(2009-5#1)(2013-1#1)
used alone or in##5##4##(1993-6#1)(2006-10#1)(2007-12#1)(2009-5#1)(2013-1#1)
used alone or with##2##4##(1996-10#1)(2012-12#1)
used alone or##7##3##(1993-6#1)(1996-10#1)(2006-10#1)(2007-12#1)(2009-5#1)(2012-12#1)(2013-1#1)
used alone was##2##3##(2007-8#1)(2009-9#1)
used alone##31##2##(1990-2#1)(1991-1#1)(1993-12#1)(1993-6#1)(1995-5#1)(1996-10#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2009-5#1)(2009-9#1)(2011-2#2)(2012-12#1)(2013-1#1)
used along with the##2##4##(2008-2#1)(2008-3#1)
used along with##7##3##(1993-2#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-3#1)(2011-2#1)(2012-12#1)
used also##2##2##(2005-11#1)(2008-8#1)
used alternative##3##2##(1997-7#1)(2008-9#1)(2009-12#1)
used among##3##2##(2007-12#1)(2008-1#1)(2013-1#1)
used an in vitro##3##4##(1994-12#1)(1994-6#1)(2012-12#1)
used an in##5##3##(1994-12#1)(1994-6#1)(1995-3#1)(2008-7#1)(2012-12#1)
used an online##2##3##(2007-10#1)(2008-11#1)
used an##57##2##(1990-10#2)(1991-9#2)(1992-2#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-5#3)(1997-2#1)(1997-5#1)(1997-7#1)(2006-2#1)(2006-6#2)(2006-9#1)(2007-10#1)(2007-12#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#6)(2008-6#1)(2008-7#1)(2009-9#2)(2010-1#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
used analysis##2##2##(2007-7#1)(2008-3#1)
used analytical methods##2##3##(2008-10#1)(2010-11#1)
used analytical##4##2##(2008-10#1)(2008-3#1)(2008-4#1)(2010-11#1)
used and a##5##3##(1991-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-8#1)
used and also##2##3##(1995-11#1)(2007-9#1)
used and are##2##3##(2006-10#1)(2009-5#1)
used and compared##6##3##(2008-10#3)(2008-2#1)(2010-4#1)(2013-7#1)
used and evaluated##3##3##(1996-7#1)(2008-11#1)(2010-4#1)
used and how##2##3##(2006-10#1)(2008-3#1)
used and in the##2##4##(1992-6#1)(1995-6#1)
used and in##4##3##(1992-6#1)(1995-6#1)(2007-11#1)(2008-10#1)
used and is##2##3##(2008-3#1)(2013-1#1)
used and its##3##3##(2007-8#1)(2008-12#1)(2008-2#1)
used and the clinical##2##4##(1997-3#1)(2005-12#1)
used and the results##2##4##(1991-7#1)(1994-12#1)
used and the##26##3##(1990-10#1)(1990-8#1)(1991-2#1)(1991-7#1)(1994-12#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-3#1)(2005-12#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#10)(2008-6#1)(2008-8#1)(2009-10#1)
used and their side effects##2##5##(2007-12#1)(2008-10#1)
used and their##4##3##(2007-12#1)(2008-10#1)(2008-5#1)(2012-2#1)
used and##125##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#3)(1990-8#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-6#1)(1992-9#2)(1993-4#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-8#1)(2005-11#2)(2005-12#1)(2005-8#1)(2006-10#4)(2006-2#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#20)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-5#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
used animal model for##2##4##(2010-12#1)(2011-2#1)
used animal##4##2##(2008-4#2)(2010-12#1)(2011-2#1)
used antibiotic##3##2##(1991-3#1)(2006-10#1)(2008-8#1)
used antibiotics##4##2##(1996-12#1)(1996-3#1)(2007-11#1)(2008-12#1)
used antibodies##3##2##(1991-7#1)(1995-12#1)(2008-4#1)
used anticancer drugs##2##3##(2008-11#1)(2008-5#1)
used anticancer##3##2##(2008-11#1)(2008-5#1)(2011-2#1)
used antiepileptic##2##2##(1990-12#1)(1997-3#1)
used approach for##2##3##(2008-10#1)(2012-2#1)
used approach##4##2##(2008-10#1)(2012-2#2)(2012-3#1)
used approaches##2##2##(2009-5#1)(2013-1#1)
used appropriately##8##2##(1994-12#1)(2005-8#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-11#1)(2012-2#1)
used are the##2##3##(2008-1#1)(2008-3#1)
used are##29##2##(1993-11#1)(1995-3#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-8#1)(2011-1#1)(2013-1#2)(2013-7#1)
used around the world##3##4##(2008-4#1)(2011-2#1)(2012-1#1)
used as a DNA##3##4##(1990-5#1)(1991-5#1)(2005-11#1)
used as a basis for##10##5##(1991-6#1)(1993-12#1)(1994-2#1)(1996-1#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2012-12#1)
used as a basis##12##4##(1991-6#1)(1993-12#1)(1994-2#1)(1996-1#1)(1997-6#1)(2005-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-12#1)
used as a biological##5##4##(1991-7#1)(2008-10#2)(2009-4#1)(2010-3#1)
used as a biomarker##2##4##(2008-10#1)(2012-2#1)
used as a biosensor##2##4##(2008-10#1)(2008-4#1)
used as a blocking##2##4##(1991-3#1)(2008-10#1)
used as a candidate##2##4##(2008-12#1)(2012-3#1)
used as a carrier##4##4##(1993-11#1)(1996-12#1)(2008-10#1)(2009-4#1)
used as a chemical##2##4##(2008-10#1)(2008-9#1)
used as a chiral##2##4##(2008-10#2)
used as a clinical and##2##5##(2007-6#1)(2013-1#1)
used as a clinical##3##4##(1993-3#1)(2007-6#1)(2013-1#1)
used as a component of##2##5##(2008-10#1)(2013-8#1)
used as a control##17##4##(1991-12#1)(1991-7#1)(1992-11#1)(1993-8#1)(1995-12#2)(2007-1#1)(2007-3#1)(2007-7#1)(2008-11#2)(2008-5#2)(2008-6#1)(2008-8#1)(2011-12#1)(2013-7#1)
used as a detector for##2##5##(2008-10#2)
used as a detector##4##4##(2008-10#4)
used as a diagnostic##5##4##(1997-3#1)(2005-12#1)(2007-11#1)(2008-3#1)(2008-9#1)
used as a drug##2##4##(2004-9#1)(2011-2#1)
used as a fast##2##4##(2008-12#1)(2008-3#1)
used as a fluorescent probe##2##5##(1991-5#1)(2006-10#1)
used as a fluorescent##3##4##(1991-5#1)(2006-10#1)(2008-10#1)
used as a functional test##2##5##(1997-7#1)(2008-10#1)
used as a functional##4##4##(1997-7#1)(2008-10#1)(2010-4#1)(2010-6#1)
used as a general##3##4##(2008-10#1)(2008-11#1)(2008-4#1)
used as a guide to##2##5##(2009-10#1)(2011-2#1)
used as a guide##4##4##(1996-3#1)(2009-10#1)(2011-2#1)(2012-2#1)
used as a light source##3##5##(2007-12#2)(2008-2#1)
used as a marker for the##2##6##(2008-7#1)(2009-2#1)
used as a marker for##9##5##(1993-2#1)(1994-2#1)(2006-4#1)(2007-10#1)(2008-11#1)(2008-7#1)(2009-2#1)(2010-10#1)(2010-7#1)
used as a marker of##4##5##(1997-6#1)(2005-9#1)(2009-12#1)(2012-2#1)
used as a marker##13##4##(1993-2#1)(1994-2#1)(1997-6#1)(2005-9#1)(2006-4#1)(2007-10#1)(2008-11#1)(2008-7#1)(2009-12#1)(2009-2#1)(2010-10#1)(2010-7#1)(2012-2#1)
used as a mask##2##4##(1992-7#1)(2008-1#1)
used as a matrix for the##2##6##(2008-11#1)(2008-4#1)
used as a matrix##3##4##(2008-11#1)(2008-4#1)(2008-7#1)
used as a means of##3##5##(1992-3#1)(1997-1#1)(1997-2#1)
used as a measure of the##3##6##(2008-10#1)(2008-2#1)(2008-8#1)
used as a measure of##12##5##(1990-2#1)(1990-4#1)(1991-4#1)(2006-6#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-2#1)(2011-2#1)
used as a method for##2##5##(2008-10#1)(2009-5#1)
used as a method##4##4##(2007-11#1)(2008-10#1)(2009-5#1)(2013-8#1)
used as a mode##2##4##(2007-12#1)(2013-7#1)
used as a model for developing##2##6##(2006-5#1)(2008-4#1)
used as a model for studying##2##6##(1996-12#1)(2008-9#1)
used as a model for##12##5##(1992-5#1)(1993-3#1)(1994-2#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-5#1)(2006-5#1)(2008-4#2)(2008-9#1)(2011-1#1)
used as a model of##4##5##(1991-10#1)(1991-5#1)(2010-1#1)(2010-4#1)
used as a model protein##2##5##(1997-1#1)(2009-9#1)
used as a model system for##3##6##(1994-9#1)(1995-3#1)(2008-10#1)
used as a model system to##2##6##(2008-10#1)(2008-7#1)
used as a model system##6##5##(1994-9#1)(1995-3#1)(2008-10#2)(2008-7#1)(2008-9#1)
used as a model to##3##5##(1990-7#1)(1993-12#1)(1993-9#1)
used as a model##39##4##(1990-12#1)(1990-4#1)(1990-7#1)(1991-10#1)(1991-5#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-3#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-5#1)(2005-11#1)(2006-5#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-9#2)(2010-1#1)(2010-4#1)(2010-8#1)(2011-1#2)(2012-11#1)
used as a negative control##3##5##(2008-10#1)(2013-1#2)
used as a new##11##4##(2005-10#1)(2008-10#4)(2008-2#1)(2008-5#3)(2008-9#1)(2011-2#1)
used as a non-invasive##3##4##(2006-10#1)(2008-7#1)(2009-8#1)
used as a nonlinear##2##4##(2007-12#1)(2008-3#1)
used as a novel##5##4##(1994-8#1)(2008-10#3)(2008-9#1)
used as a paradigm##2##4##(1993-9#1)(2008-11#1)
used as a parameter of##2##5##(1991-10#1)(1991-2#1)
used as a part of##2##5##(2008-11#1)(2010-7#1)
used as a pharmacological##2##4##(1992-1#1)(2006-12#1)
used as a photoaffinity##3##4##(1990-8#1)(1992-6#1)(1995-1#1)
used as a platform for##2##5##(2010-4#1)(2010-5#1)
used as a platform##3##4##(2008-7#1)(2010-4#1)(2010-5#1)
used as a positive##3##4##(1992-12#1)(1996-12#1)(2008-3#1)
used as a potential##4##4##(2004-4#1)(2005-11#1)(2008-10#1)(2013-1#1)
used as a preservative##2##4##(1995-1#1)(2011-2#1)
used as a primary##2##4##(2006-12#2)
used as a probe for##3##5##(1994-9#1)(2005-11#1)(2008-10#1)
used as a probe to screen a##2##7##(1990-6#1)(1994-12#1)
used as a probe to##6##5##(1990-6#1)(1991-2#1)(1993-2#1)(1993-3#1)(1994-12#1)(1997-1#1)
used as a probe##17##4##(1990-10#2)(1990-6#1)(1991-2#2)(1991-6#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-9#1)(1997-1#1)(1997-4#1)(2005-11#1)(2008-10#1)(2008-5#1)(2008-8#1)
used as a prototype##3##4##(2007-11#1)(2008-10#1)(2008-2#1)
used as a pump##3##4##(2007-11#1)(2007-12#2)
used as a quality##2##4##(1997-1#1)(2007-8#1)
used as a quantitative##3##4##(1996-6#1)(2007-8#1)(2008-4#1)
used as a reagent for##2##5##(2008-10#1)(2008-9#1)
used as a reference source in##2##6##(2008-2#2)
used as a reference##22##4##(1993-8#1)(1994-3#1)(2008-10#4)(2008-12#1)(2008-2#4)(2008-3#2)(2008-5#2)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#1)
used as a replacement##2##4##(2006-2#1)(2012-6#1)
used as a reporter gene to##2##6##(1990-5#1)(1991-5#1)
used as a reporter gene##3##5##(1990-5#1)(1991-5#1)(1994-2#1)
used as a reporter##4##4##(1990-5#1)(1991-5#1)(1994-2#1)(1997-8#1)
used as a scaffold to##2##5##(1997-3#1)(2007-8#1)
used as a scaffold##3##4##(1997-3#1)(2007-8#1)(2010-7#1)
used as a screening system to##2##6##(1991-12#1)(2008-10#1)
used as a screening##4##4##(1991-12#1)(2005-11#1)(2006-9#1)(2008-10#1)
used as a selection##2##4##(2006-8#1)(2008-4#1)
used as a selective##4##4##(2005-11#1)(2006-3#1)(2008-10#1)(2012-12#1)
used as a sensitive##2##4##(1990-4#1)(2007-10#1)
used as a single##3##4##(2008-10#1)(2008-3#1)(2009-12#1)
used as a smooth##2##4##(2007-2#1)(2008-3#1)
used as a sole carbon source##2##6##(2008-10#1)(2008-4#1)
used as a solid support##2##5##(2008-10#2)
used as a solid##4##4##(2008-10#4)
used as a source of##9##5##(1993-8#1)(1995-12#1)(1996-5#1)(2007-6#2)(2008-10#2)(2008-4#1)(2011-1#1)
used as a source##11##4##(1993-8#1)(1995-12#1)(1996-5#1)(2007-12#1)(2007-6#2)(2008-10#2)(2008-3#1)(2008-4#1)(2011-1#1)
used as a specific##2##4##(1991-12#1)(1992-9#1)
used as a spice##2##4##(2007-3#1)(2012-12#1)
used as a standard##4##4##(2008-3#1)(2008-6#1)(2009-11#1)(2013-1#1)
used as a starting##5##4##(1995-11#1)(2006-12#1)(2007-1#1)(2007-11#1)(2010-4#1)
used as a substitute for##2##5##(2007-1#1)(2008-5#1)
used as a substitute##3##4##(2007-1#1)(2008-1#1)(2008-5#1)
used as a substrate for##2##5##(2006-8#1)(2008-10#1)
used as a substrate##7##4##(1993-6#1)(1995-10#1)(1996-8#1)(2006-8#1)(2008-10#2)(2009-3#1)
used as a surrogate for##2##5##(2009-6#1)(2010-8#1)
used as a surrogate##5##4##(2008-1#1)(2008-6#1)(2009-3#1)(2009-6#1)(2010-8#1)
used as a target for##2##5##(1997-7#1)(2008-8#1)
used as a target##3##4##(1997-7#1)(2008-10#1)(2008-8#1)
used as a template for##2##5##(2008-11#1)(2008-7#1)
used as a template##4##4##(1993-12#1)(1997-6#1)(2008-11#1)(2008-7#1)
used as a test##4##4##(1992-8#1)(2008-10#1)(2008-2#1)(2008-4#1)
used as a theoretical##2##4##(2008-12#1)(2011-2#1)
used as a therapeutic tool in##2##6##(2009-9#1)(2012-2#1)
used as a therapeutic##3##4##(2008-5#1)(2009-9#1)(2012-2#1)
used as a tool for##3##5##(2007-12#1)(2009-12#1)(2013-1#1)
used as a tool to##4##5##(1997-5#1)(2008-7#1)(2010-6#2)
used as a tool##8##4##(1997-5#1)(2007-12#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-6#2)(2013-1#1)
used as a traditional##2##4##(2008-10#1)(2009-3#1)
used as a tumor marker##2##5##(1995-2#1)(2005-12#1)
used as a tunable##2##4##(2007-11#1)(2008-3#1)
used as a vehicle##2##4##(1997-4#1)(2008-6#1)
used as a weaning##2##4##(1997-4#2)
used as a working electrode in##3##6##(2008-10#3)
used as a working electrode##5##5##(2008-10#5)
used as a working##6##4##(1992-11#1)(2008-10#5)
used as a##655##3##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-10#2)(1991-12#4)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#2)(1991-7#2)(1991-9#1)(1992-1#1)(1992-11#4)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#5)(1993-2#3)(1993-3#4)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#2)(1994-11#4)(1994-12#1)(1994-2#6)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#4)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#4)(1996-9#1)(1997-1#4)(1997-2#5)(1997-3#4)(1997-4#4)(1997-5#2)(1997-6#5)(1997-7#3)(1997-8#2)(2004-1#1)(2004-11#1)(2004-4#1)(2004-9#1)(2005-10#2)(2005-11#10)(2005-12#2)(2005-4#2)(2005-8#2)(2005-9#1)(2006-10#6)(2006-11#1)(2006-12#7)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#4)(2007-10#2)(2007-11#12)(2007-12#22)(2007-2#2)(2007-3#2)(2007-5#2)(2007-6#5)(2007-7#2)(2007-8#7)(2007-9#1)(2008-1#7)(2008-10#113)(2008-11#17)(2008-12#8)(2008-2#26)(2008-3#20)(2008-4#13)(2008-5#20)(2008-6#6)(2008-7#15)(2008-8#11)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#5)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#4)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#5)(2010-5#5)(2010-6#3)(2010-7#3)(2010-8#5)(2011-1#7)(2011-12#2)(2011-2#12)(2011-3#1)(2012-1#5)(2012-11#5)(2012-12#8)(2012-2#12)(2012-3#2)(2012-6#1)(2013-1#20)(2013-7#5)(2013-8#4)
used as additional##2##3##(2008-10#1)(2008-6#1)
used as additives##4##3##(2008-10#3)(2012-2#1)
used as adjuvant therapy##2##4##(2008-7#1)(2011-2#1)
used as adjuvant##3##3##(2008-4#1)(2008-7#1)(2011-2#1)
used as alternative##5##3##(2005-9#1)(2006-10#1)(2008-10#1)(2012-2#1)(2013-1#1)
used as an &quot##2##4##(1992-2#1)(2009-5#1)
used as an activator##2##4##(2008-10#1)(2008-5#1)
used as an active##2##4##(1992-3#1)(2008-10#1)
used as an additional##4##4##(2007-12#1)(2008-11#1)(2011-2#1)(2013-1#1)
used as an additive to##2##5##(1994-6#1)(2007-8#1)
used as an additive##4##4##(1994-6#1)(2007-8#1)(2008-5#1)(2010-4#1)
used as an adjunct to##9##5##(1991-7#1)(2007-11#1)(2008-2#1)(2008-7#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
used as an adjunct##10##4##(1991-7#1)(2007-11#1)(2008-2#1)(2008-7#2)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
used as an adjuvant in##3##5##(1990-2#1)(2007-7#1)(2007-8#1)
used as an adjuvant##4##4##(1990-2#1)(1996-10#1)(2007-7#1)(2007-8#1)
used as an aid to##3##5##(2006-10#1)(2006-6#1)(2010-4#1)
used as an aid##5##4##(1991-11#1)(2006-10#1)(2006-6#1)(2008-10#1)(2010-4#1)
used as an alternative method to##2##6##(2008-10#2)
used as an alternative method##3##5##(2007-5#1)(2008-10#2)
used as an alternative to##4##5##(1992-5#1)(2007-10#1)(2007-7#1)(2008-10#1)
used as an alternative##17##4##(1991-4#1)(1992-5#1)(1994-3#1)(1996-7#1)(2006-3#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-10#6)(2008-4#1)
used as an amperometric sensor for##2##6##(2008-10#2)
used as an amperometric##4##4##(2008-10#4)
used as an analytical##2##4##(2008-10#1)(2008-9#1)
used as an anthelmintic##2##4##(2007-1#1)(2008-10#1)
used as an antigen to##2##5##(1993-3#1)(2008-10#1)
used as an antigen##4##4##(1993-3#1)(2008-10#2)(2010-6#1)
used as an effective research##2##5##(2005-10#1)(2008-11#1)
used as an effective##8##4##(2005-10#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-4#1)(2009-6#1)(2010-7#1)
used as an efficient##4##4##(2007-6#1)(2008-2#1)(2011-2#1)(2012-2#1)
used as an enzymatic##2##4##(2008-10#2)
used as an example##6##4##(1992-11#1)(1994-2#1)(2007-11#2)(2008-1#1)(2008-11#1)
used as an excellent##2##4##(2008-10#2)
used as an experimental model to##2##6##(2008-10#1)(2008-8#1)
used as an important##2##4##(2007-12#1)(2008-10#1)
used as an index of##12##5##(1990-4#1)(1990-9#1)(1991-2#1)(1992-2#1)(1993-2#1)(1993-9#1)(1996-12#1)(1996-3#1)(1997-2#1)(2006-9#1)(2008-11#1)(2009-9#1)
used as an index##13##4##(1990-4#1)(1990-9#1)(1991-2#1)(1992-2#1)(1993-2#1)(1993-9#1)(1996-12#1)(1996-3#1)(1997-2#1)(2006-9#1)(2008-11#2)(2009-9#1)
used as an indicator electrode in potentiometric titration of##6##9##(2008-10#6)
used as an indicator electrode in the potentiometric titration of##3##10##(2008-10#3)
used as an indicator electrode in the potentiometric##4##8##(2008-10#4)
used as an indicator electrode in##10##6##(2008-10#10)
used as an indicator electrode##11##5##(2008-10#11)
used as an indicator for##3##5##(1991-2#1)(2008-11#1)(2008-7#1)
used as an indicator of the##5##6##(2007-3#1)(2008-10#3)(2012-12#1)
used as an indicator of##12##5##(1992-7#1)(2006-3#1)(2006-5#1)(2007-3#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#1)(2012-12#1)
used as an indicator##28##4##(1991-2#1)(1992-7#1)(2006-3#1)(2006-5#1)(2007-10#1)(2007-3#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2012-12#1)
used as an indirect##3##4##(1992-8#1)(1997-1#1)(2008-11#1)
used as an inhibitor of##2##5##(2006-8#1)(2012-2#1)
used as an internal control##2##5##(1990-4#1)(1996-12#1)
used as an internal standard##15##5##(1991-5#1)(1992-2#1)(1993-1#1)(1993-3#1)(1997-3#1)(2007-8#1)(2008-10#7)(2008-6#1)(2010-2#1)
used as an internal##19##4##(1990-4#1)(1991-5#1)(1992-2#1)(1993-1#1)(1993-3#1)(1996-12#1)(1997-3#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-6#1)(2010-2#1)
used as an optical##2##4##(2008-2#1)(2008-3#1)
used as an##228##3##(1990-2#1)(1990-4#2)(1990-5#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-7#1)(1993-9#2)(1994-2#2)(1994-3#1)(1994-6#2)(1994-9#1)(1995-1#2)(1996-10#1)(1996-12#2)(1996-3#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-3#2)(2006-5#1)(2006-6#3)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#7)(2008-1#3)(2008-10#61)(2008-11#9)(2008-12#1)(2008-2#9)(2008-3#6)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
used as analytical##2##3##(2008-10#2)
used as anchors##2##3##(2008-11#1)(2008-7#1)
used as another##3##3##(2006-10#1)(2008-10#1)(2008-5#1)
used as antibacterial##2##3##(2005-11#1)(2012-3#1)
used as antigen##3##3##(1997-3#1)(2008-10#1)(2008-5#1)
used as antigens to##2##4##(1990-12#1)(1990-5#1)
used as antigens##3##3##(1990-12#1)(1990-5#1)(2012-12#1)
used as biological##2##3##(2008-11#1)(2010-8#1)
used as both##3##3##(2007-12#1)(2008-10#2)
used as capture##2##3##(1992-7#1)(2005-9#1)
used as carbon##2##3##(2008-6#1)(2011-2#1)
used as carrier##2##3##(2008-10#2)
used as chemical modifier##5##4##(2008-10#5)
used as chemical##8##3##(2008-10#8)
used as chiral##3##3##(1995-6#1)(1996-5#1)(2008-10#1)
used as coating##2##3##(2008-2#1)(2011-1#1)
used as complementary##2##3##(1990-12#1)(2008-9#1)
used as components of##3##4##(1994-9#1)(2008-10#1)(2012-12#1)
used as components##4##3##(1994-9#1)(2008-10#1)(2008-11#1)(2012-12#1)
used as constraints in##2##4##(1993-11#1)(1994-11#1)
used as control##16##3##(1991-3#1)(1991-8#1)(1993-11#1)(1994-6#1)(1994-9#1)(2006-4#1)(2006-6#1)(2007-6#1)(2008-12#1)(2008-5#2)(2008-8#1)(2009-2#1)(2009-8#1)(2012-12#1)(2013-7#1)
used as controls##27##3##(1990-12#1)(1992-1#1)(1992-2#1)(1993-10#1)(1993-11#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-2#1)(1996-5#1)(2004-11#1)(2006-10#1)(2006-4#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-4#2)(2008-5#2)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
used as criteria to##2##4##(2008-10#1)(2013-1#1)
used as criteria##6##3##(2008-10#1)(2008-12#1)(2008-3#1)(2012-3#1)(2013-1#1)(2013-7#1)
used as detector##3##3##(2005-4#1)(2008-10#1)(2011-3#1)
used as discriminating factors##2##4##(2010-5#2)
used as donor##2##3##(1994-11#1)(2008-9#1)
used as drugs in##2##4##(2007-11#1)(2013-8#1)
used as drugs##4##3##(1997-2#1)(2007-11#1)(2008-10#1)(2013-8#1)
used as dual-purpose##2##3##(2008-12#1)(2009-7#1)
used as efficient##4##3##(2008-10#1)(2008-4#1)(2008-8#1)(2012-3#1)
used as either##2##3##(2006-5#1)(2008-3#1)
used as electron##2##3##(2006-8#1)(2008-10#1)
used as endpoints##2##3##(1992-9#1)(2007-11#1)
used as excitation##2##3##(2008-10#2)
used as experimental##6##3##(1993-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2012-3#1)
used as exposure##3##3##(1995-5#1)(2006-12#1)(2011-2#1)
used as external##2##3##(2008-10#1)(2013-8#1)
used as first choice##2##4##(1990-1#1)(2013-8#1)
used as first##3##3##(1990-1#1)(2007-7#1)(2013-8#1)
used as first-line therapy##2##4##(2005-12#1)(2013-8#1)
used as first-line##5##3##(1993-2#1)(1997-3#1)(2005-12#1)(2009-8#1)(2013-8#1)
used as fluorescent##3##3##(2007-8#1)(2008-10#1)(2010-3#1)
used as food and##2##4##(2007-8#2)
used as food##3##3##(2007-8#2)(2008-5#1)
used as fuel##2##3##(2008-10#1)(2009-8#1)
used as host##4##3##(2004-2#1)(2008-10#1)(2008-3#1)(2009-10#1)
used as in##3##3##(1997-6#1)(2004-1#1)(2008-3#1)
used as independent variables##3##4##(2008-3#1)(2008-8#1)(2012-2#1)
used as independent##4##3##(2008-11#1)(2008-3#1)(2008-8#1)(2012-2#1)
used as indicator##3##3##(2007-3#1)(2008-10#2)
used as indicators of##5##4##(1992-3#1)(2008-4#1)(2008-8#1)(2010-11#1)(2010-4#1)
used as indicators##6##3##(1992-3#1)(2006-1#1)(2008-4#1)(2008-8#1)(2010-11#1)(2010-4#1)
used as indices for##2##4##(1997-6#1)(2008-10#1)
used as indices##3##3##(1992-3#1)(1997-6#1)(2008-10#1)
used as inoculum##2##3##(2008-10#2)
used as input for##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2012-12#1)
used as input##7##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-12#1)(2012-2#1)
used as inputs##2##3##(2007-8#1)(2012-1#1)
used as internal standard##11##4##(1990-10#1)(1990-11#1)(1996-8#1)(2007-8#1)(2008-10#7)
used as internal standards##4##4##(2008-10#3)(2012-3#1)
used as internal##17##3##(1990-10#1)(1990-11#1)(1996-8#1)(2007-8#1)(2008-10#11)(2008-8#1)(2012-3#1)
used as ionophores##2##3##(2008-10#2)
used as irrigation water##2##4##(2012-2#2)
used as ligands##3##3##(1996-11#1)(2008-3#1)(2008-5#1)
used as marker compounds##2##4##(1990-3#1)(1996-5#1)
used as marker##3##3##(1990-3#1)(1996-5#1)(2008-12#1)
used as markers in##2##4##(2007-6#1)(2008-10#1)
used as markers of##2##4##(1996-8#1)(2007-1#1)
used as markers to##3##4##(2006-9#1)(2007-11#1)(2008-7#1)
used as markers##10##3##(1996-8#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-6#1)(2008-10#3)(2008-7#1)(2011-1#1)
used as matrix modifiers##3##4##(2008-10#3)
used as medicines##2##3##(2008-8#1)(2010-10#1)
used as mirrors##2##3##(2007-12#1)(2008-2#1)
used as mobile phase##2##4##(2008-10#2)
used as mobile##3##3##(1991-3#1)(2008-10#2)
used as model##11##3##(1990-12#1)(1994-11#1)(1996-7#1)(1997-6#1)(2008-10#5)(2010-9#1)(2013-7#1)
used as models##3##3##(1994-2#1)(2006-9#1)(2008-7#1)
used as monotherapy##2##3##(2010-5#1)(2012-12#1)
used as much as##2##4##(2007-2#1)(2008-7#1)
used as new##2##3##(1996-12#1)(2008-3#1)
used as novel##3##3##(2008-10#1)(2010-1#1)(2010-2#1)
used as one of the##4##5##(2008-10#1)(2008-2#1)(2008-9#1)(2010-10#1)
used as one of##5##4##(1993-8#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-10#1)
used as outcome measures##2##4##(2006-7#1)(2007-12#1)
used as outgroups in##2##4##(1995-11#2)
used as outgroups##3##3##(1995-11#2)(2008-10#1)
used as part of a##6##5##(2008-2#1)(2008-3#1)(2009-3#1)(2009-4#1)(2010-5#1)(2010-6#1)
used as part of an##3##5##(2008-10#1)(2011-1#1)(2012-12#1)
used as part of the##4##5##(2008-2#1)(2008-4#1)(2012-12#2)
used as part of##14##4##(2005-10#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-3#1)(2009-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-12#3)
used as positive controls##2##4##(1994-6#1)(2013-1#1)
used as positive##3##3##(1993-9#1)(1994-6#1)(2013-1#1)
used as primary therapy##2##4##(1990-11#1)(2008-1#1)
used as primary##8##3##(1990-11#1)(2007-12#1)(2008-1#2)(2010-1#1)(2010-8#1)(2012-2#1)(2012-3#1)
used as probes##5##3##(1990-7#1)(1991-10#1)(1993-11#2)(2008-10#1)
used as prophylactic##2##3##(2009-5#1)(2010-12#1)
used as prophylaxis##3##3##(2006-10#1)(2007-11#1)(2012-11#1)
used as query##2##3##(1994-9#1)(2008-8#1)
used as reference##14##3##(1996-7#1)(2004-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2009-5#1)(2010-10#1)(2011-1#1)(2012-3#1)(2013-1#1)
used as representative##2##3##(1990-2#1)(2009-7#1)
used as scaffolds##2##3##(2007-11#2)
used as screening##5##3##(2005-11#1)(2008-10#2)(2011-2#1)(2011-3#1)
used as selective##3##3##(2008-10#2)(2008-12#1)
used as sensing materials##2##4##(2008-10#1)(2011-1#1)
used as sensing##3##3##(2008-10#2)(2011-1#1)
used as solid phase##3##4##(1992-9#1)(2008-10#2)
used as sorbent##3##3##(2008-10#3)
used as sources of##3##4##(1993-12#1)(1997-4#1)(2008-4#1)
used as stabilizer##2##3##(1994-8#1)(2013-8#1)
used as standard##6##3##(2004-1#1)(2006-10#1)(2008-10#2)(2008-5#1)(2010-3#1)
used as standards##3##3##(2008-10#3)
used as starting values for##2##5##(1991-7#1)(2008-10#1)
used as starting##5##3##(1991-7#2)(2008-10#1)(2008-11#2)
used as subjects in##2##4##(2004-11#1)(2009-6#1)
used as substrate##5##3##(1991-5#1)(1993-12#1)(1996-5#1)(2004-12#1)(2008-4#1)
used as substrates for##2##4##(1990-2#1)(2005-11#1)
used as substrates##15##3##(1990-2#1)(1991-10#1)(1991-2#1)(1991-5#1)(1992-8#1)(1994-5#2)(1994-8#1)(1994-9#1)(1997-4#1)(2005-11#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-6#1)
used as such##2##3##(1995-4#1)(2010-12#1)
used as supporting##3##3##(2006-6#1)(2008-10#2)
used as target##2##3##(1995-10#1)(2008-9#1)
used as template for##2##4##(1996-10#1)(1997-7#1)
used as template##7##3##(1990-4#1)(1996-10#1)(1997-7#1)(2006-4#1)(2008-10#1)(2008-8#1)(2008-9#1)
used as templates for##2##4##(2008-5#1)(2009-11#1)
used as templates##4##3##(2007-12#1)(2008-10#1)(2008-5#1)(2009-11#1)
used as test##5##3##(1995-8#1)(1996-8#1)(2008-10#2)(2008-11#1)
used as texture features##2##4##(2008-2#2)
used as texture##3##3##(2008-2#2)(2008-6#1)
used as the active##2##4##(2007-8#1)(2008-10#1)
used as the additive##2##4##(2005-11#1)(2008-10#1)
used as the analytical##3##4##(2008-10#3)
used as the basic##2##4##(2007-12#1)(2008-2#1)
used as the basis for a##2##6##(2008-10#1)(2008-2#1)
used as the basis for##10##5##(1992-6#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#1)(2010-3#1)(2013-8#1)
used as the basis of a##2##6##(1994-3#1)(2011-1#1)
used as the basis##12##4##(1992-6#1)(1994-3#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#1)(2010-3#1)(2011-1#1)(2013-8#1)
used as the conditioned stimulus (CS) and##2##7##(1995-11#1)(1995-12#1)
used as the dependent variable##2##5##(2008-10#1)(2008-4#1)
used as the detection##2##4##(2007-12#1)(2008-10#1)
used as the detector##4##4##(2008-10#3)(2013-7#1)
used as the extraction##3##4##(2008-10#2)(2012-12#1)
used as the first##2##4##(1993-10#1)(2008-1#1)
used as the host##2##4##(1994-2#1)(2008-2#1)
used as the internal standard##8##5##(1992-2#1)(1993-2#1)(1996-8#1)(1997-3#1)(2007-8#1)(2008-10#2)(2008-6#1)
used as the internal##10##4##(1992-2#2)(1993-2#1)(1996-8#1)(1997-3#1)(2007-8#1)(2008-10#2)(2008-6#1)(2012-12#1)
used as the ion-pairing agent in##2##6##(1990-11#1)(2008-10#1)
used as the light source and the##2##7##(2008-10#2)
used as the light source##6##5##(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)
used as the mobile phase##7##5##(1990-8#2)(2007-8#1)(2008-10#2)(2011-1#2)
used as the model##4##4##(2008-10#1)(2008-7#1)(2008-8#1)(2012-12#1)
used as the only iodinating reagent##2##6##(2007-11#2)
used as the only##3##4##(1992-4#1)(2007-11#2)
used as the primary##3##4##(2008-3#1)(2008-5#1)(2011-1#1)
used as the probe##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
used as the pump##4##4##(2007-12#2)(2008-2#1)(2008-3#1)
used as the reference##5##4##(1996-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-1#1)
used as the response variable##2##5##(2008-10#2)
used as the sample##3##4##(1992-11#1)(2007-12#1)(2008-10#1)
used as the solvent##2##4##(2008-10#1)(2008-2#1)
used as the source##3##4##(1990-11#1)(2008-10#2)
used as the standard##2##4##(2008-10#1)(2011-1#1)
used as the stationary phase##3##5##(2008-10#1)(2011-1#2)
used as the target##2##4##(2008-10#1)(2012-2#1)
used as the working electrode##2##5##(2008-10#2)
used as the##245##3##(1990-11#2)(1990-12#1)(1990-8#4)(1991-12#1)(1991-3#2)(1991-7#1)(1991-8#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#1)(1993-10#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(2004-9#1)(2005-11#4)(2005-12#1)(2005-8#1)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#1)(2007-10#2)(2007-11#5)(2007-12#12)(2007-4#1)(2007-6#1)(2007-8#5)(2008-1#3)(2008-10#69)(2008-11#4)(2008-2#20)(2008-3#10)(2008-4#2)(2008-5#6)(2008-6#5)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2011-1#8)(2011-2#2)(2012-12#8)(2012-2#3)(2012-9#1)(2013-1#2)(2013-7#3)(2013-8#6)
used as therapeutic agents##5##4##(1990-9#1)(1992-12#1)(2008-11#1)(2010-5#1)(2013-8#1)
used as therapeutics##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
used as tools for##4##4##(1994-6#1)(2007-2#1)(2008-11#1)(2010-1#1)
used as tools##5##3##(1994-6#1)(2007-2#1)(2008-11#1)(2009-12#1)(2010-1#1)
used as tracer##2##3##(1991-12#1)(2008-10#1)
used as training set##2##4##(2007-8#1)(2008-10#1)
used as treatment##2##3##(2005-11#1)(2008-10#1)
used as well as the##2##5##(2006-11#1)(2012-2#1)
used as well as##7##4##(1991-6#1)(1993-5#1)(1995-4#1)(2006-11#1)(2011-1#1)(2012-12#1)(2012-2#1)
used as well##9##3##(1991-6#1)(1993-5#1)(1995-4#1)(2006-11#1)(2008-3#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
used as##1963##2##(1990-1#1)(1990-10#3)(1990-11#6)(1990-12#6)(1990-2#6)(1990-3#4)(1990-4#6)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#8)(1990-9#3)(1991-10#4)(1991-11#1)(1991-12#6)(1991-2#6)(1991-3#5)(1991-4#3)(1991-5#7)(1991-6#5)(1991-7#6)(1991-8#3)(1991-9#2)(1992-1#2)(1992-11#6)(1992-12#6)(1992-2#6)(1992-3#7)(1992-4#1)(1992-5#3)(1992-6#5)(1992-7#5)(1992-8#4)(1992-9#4)(1993-1#1)(1993-10#3)(1993-11#6)(1993-12#13)(1993-2#7)(1993-3#7)(1993-4#3)(1993-5#2)(1993-6#2)(1993-7#3)(1993-8#4)(1993-9#6)(1994-11#9)(1994-12#3)(1994-2#10)(1994-3#6)(1994-5#3)(1994-6#11)(1994-8#4)(1994-9#11)(1995-1#8)(1995-10#2)(1995-11#6)(1995-12#4)(1995-2#3)(1995-3#2)(1995-4#3)(1995-5#3)(1995-6#3)(1995-7#2)(1995-8#3)(1995-9#2)(1996-1#2)(1996-10#2)(1996-11#2)(1996-12#7)(1996-2#4)(1996-3#4)(1996-4#1)(1996-5#7)(1996-6#1)(1996-7#3)(1996-8#9)(1996-9#4)(1997-1#6)(1997-2#9)(1997-3#11)(1997-4#6)(1997-5#2)(1997-6#9)(1997-7#4)(1997-8#3)(2004-1#3)(2004-10#2)(2004-11#5)(2004-12#2)(2004-2#1)(2004-4#3)(2004-9#4)(2005-10#5)(2005-11#24)(2005-12#4)(2005-4#3)(2005-7#2)(2005-8#4)(2005-9#3)(2006-1#1)(2006-10#17)(2006-11#3)(2006-12#13)(2006-2#4)(2006-3#4)(2006-4#7)(2006-5#4)(2006-6#9)(2006-7#3)(2006-8#7)(2006-9#5)(2007-1#10)(2007-10#9)(2007-11#35)(2007-12#50)(2007-2#6)(2007-3#7)(2007-4#3)(2007-5#4)(2007-6#10)(2007-7#10)(2007-8#36)(2007-9#5)(2008-1#18)(2008-10#424)(2008-11#49)(2008-12#20)(2008-2#71)(2008-3#55)(2008-4#37)(2008-5#58)(2008-6#23)(2008-7#38)(2008-8#27)(2008-9#21)(2009-10#2)(2009-11#5)(2009-12#5)(2009-2#6)(2009-3#8)(2009-4#7)(2009-5#5)(2009-6#7)(2009-7#6)(2009-8#6)(2009-9#6)(2010-1#5)(2010-10#4)(2010-11#3)(2010-12#10)(2010-2#5)(2010-3#7)(2010-4#13)(2010-5#13)(2010-6#6)(2010-7#8)(2010-8#12)(2010-9#2)(2011-1#27)(2011-12#5)(2011-2#31)(2011-3#4)(2012-1#7)(2012-11#6)(2012-12#33)(2012-2#38)(2012-3#14)(2012-6#2)(2012-7#1)(2012-9#1)(2013-1#37)(2013-7#14)(2013-8#26)
used at 1##2##3##(1994-5#1)(2008-10#1)
used at a##3##3##(1991-10#1)(2008-10#2)
used at all##3##3##(2006-8#1)(2008-10#1)(2008-3#1)
used at different##4##3##(1991-9#1)(2004-9#1)(2006-5#1)(2010-2#1)
used at high##3##3##(1996-9#1)(2007-5#1)(2010-1#1)
used at least##2##3##(2008-10#2)
used at low##2##3##(1996-9#1)(2010-11#1)
used at our institution##3##4##(2006-10#1)(2006-3#1)(2011-2#1)
used at present##3##3##(2006-2#1)(2007-11#1)(2010-6#1)
used at the##10##3##(1991-2#1)(1993-3#1)(2005-3#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2009-10#1)(2013-1#2)
used at##61##2##(1991-10#1)(1991-2#1)(1991-9#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-5#1)(1996-12#1)(1996-2#1)(1996-8#1)(1996-9#2)(2004-9#1)(2005-3#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-5#2)(2006-8#1)(2007-11#3)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-11#1)(2009-4#1)(2010-1#1)(2010-11#2)(2010-2#3)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#2)
used autologous##2##2##(2005-7#1)(2010-11#1)
used because it##2##3##(1997-2#1)(2008-10#1)
used because of its##2##4##(2008-5#1)(2013-1#1)
used because of their##2##4##(2007-2#1)(2008-3#1)
used because of##5##3##(1997-1#1)(2007-2#1)(2008-3#1)(2008-5#1)(2013-1#1)
used because the##2##3##(2007-12#1)(2010-8#1)
used because##13##2##(1997-1#1)(1997-2#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2010-8#1)(2013-1#1)(2013-8#1)
used before##7##2##(1992-8#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)
used behavioral##3##2##(2008-4#1)(2009-10#1)(2010-6#1)
used both for##3##3##(1993-9#1)(2008-4#1)(2009-8#1)
used both##17##2##(1990-2#1)(1993-11#1)(1993-9#1)(1995-1#1)(2005-11#1)(2007-1#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-8#1)(2012-2#2)(2013-7#1)
used but##6##2##(1990-12#1)(1995-11#1)(2006-6#1)(2007-11#1)(2007-4#1)(2008-1#1)
used by Canadian##2##3##(1996-2#1)(2007-3#1)
used by Medicare and##3##4##(1993-3#1)(1997-3#2)
used by P##2##3##(2008-10#1)(2011-2#1)
used by a number of##3##5##(1995-2#1)(2008-1#1)(2010-12#1)
used by a trained##2##4##(2006-10#1)(2007-2#1)
used by a##8##3##(1995-2#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-7#1)(2010-12#1)(2012-12#1)(2012-3#1)
used by all##2##3##(2010-3#1)(2013-8#1)
used by an##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
used by anaesthetists##2##3##(2006-10#1)(2010-2#1)
used by both##3##3##(1995-12#1)(2006-3#1)(2008-12#1)
used by clinical##4##3##(2008-4#1)(2011-1#1)(2013-1#2)
used by clinicians to##5##4##(1991-1#1)(2005-10#1)(2006-10#1)(2013-1#2)
used by clinicians##7##3##(1991-1#1)(1996-2#1)(2005-10#1)(2006-10#1)(2008-4#1)(2013-1#2)
used by data##2##3##(2008-7#2)
used by different##3##3##(1996-7#1)(2005-8#1)(2009-3#1)
used by general practitioners##2##4##(1997-4#2)
used by health care organizations##2##5##(1994-2#1)(2008-11#1)
used by health care##3##4##(1994-2#1)(2008-11#1)(2010-7#1)
used by health##6##3##(1994-2#1)(2006-8#1)(2008-11#1)(2008-8#1)(2010-7#1)(2012-12#1)
used by human##2##3##(1995-2#1)(2007-11#1)
used by individuals with##2##4##(2007-7#1)(2013-1#1)
used by individuals##3##3##(2007-7#1)(2008-12#1)(2013-1#1)
used by investigators to##2##4##(2006-8#1)(2009-8#1)
used by many##6##3##(2005-11#1)(2008-11#3)(2008-8#1)(2012-2#1)
used by medical##3##3##(2008-10#1)(2009-6#2)
used by most##6##3##(1990-11#1)(1997-9#1)(2006-12#1)(2007-7#1)(2011-1#1)(2011-2#1)
used by nurses##3##3##(2010-10#1)(2013-1#2)
used by one##2##3##(1992-2#1)(2008-11#1)
used by only##3##3##(2007-7#2)(2008-2#1)
used by other##2##3##(2006-10#1)(2009-11#1)
used by participants##2##3##(1990-1#1)(2010-7#1)
used by patients with##2##4##(1990-4#1)(2011-12#1)
used by patients##3##3##(1990-4#1)(2008-7#1)(2011-12#1)
used by people##4##3##(2008-10#1)(2008-6#1)(2012-2#1)(2012-3#1)
used by practitioners##2##3##(2007-12#1)(2008-12#1)
used by pregnant women##2##4##(2007-2#1)(2008-7#1)
used by radiologists##2##3##(1996-2#1)(2007-4#1)
used by the National##2##4##(1997-1#1)(2008-7#1)
used by the authors##3##4##(2006-2#1)(2007-12#1)(2007-9#1)
used by the elderly##2##4##(1993-3#2)
used by the##58##3##(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-4#2)(1993-11#1)(1993-3#2)(1995-1#1)(1995-12#1)(1997-1#1)(2004-9#1)(2006-10#1)(2006-2#1)(2006-3#2)(2006-4#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-7#2)(2009-11#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#2)
used by their##3##3##(2004-8#1)(2007-4#1)(2010-4#1)
used by them##2##3##(1990-9#1)(2008-3#1)
used by these##5##3##(1992-5#1)(1994-6#1)(1995-12#1)(2008-7#1)(2013-1#1)
used by this##3##3##(1990-12#1)(2010-8#1)(2011-2#1)
used by##320##2##(1990-1#1)(1990-11#2)(1990-12#5)(1990-4#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-1#3)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#1)(1993-10#1)(1993-11#1)(1993-3#4)(1993-5#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#4)(1995-2#3)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-5#1)(1996-7#1)(1997-1#2)(1997-2#3)(1997-3#4)(1997-4#3)(1997-9#1)(2004-12#1)(2004-8#2)(2004-9#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#3)(2006-10#8)(2006-12#3)(2006-2#2)(2006-3#3)(2006-4#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#4)(2007-2#5)(2007-3#3)(2007-4#4)(2007-5#1)(2007-7#5)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#17)(2008-11#10)(2008-12#6)(2008-2#7)(2008-3#7)(2008-4#8)(2008-5#4)(2008-6#4)(2008-7#11)(2008-8#5)(2008-9#3)(2009-10#1)(2009-11#3)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#3)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#5)(2010-4#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#7)(2012-2#7)(2012-3#6)(2013-1#12)(2013-7#2)(2013-8#5)
used can##4##2##(2005-11#1)(2006-12#1)(2008-10#1)(2008-3#1)
used cardiac##2##2##(1992-11#1)(2012-3#1)
used classifications##3##2##(2007-11#1)(2007-8#2)
used clinical periodontal parameters##2##4##(2008-6#2)
used clinical##4##2##(2006-6#1)(2008-6#2)(2011-2#1)
used clinically in##2##3##(2010-12#1)(2012-2#1)
used clinically to##5##3##(1996-12#1)(1997-4#1)(2007-11#1)(2008-8#1)(2010-7#1)
used clinically##13##2##(1996-12#1)(1997-4#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2012-2#2)
used commercially as##3##3##(2007-3#1)(2008-10#2)
used commercially##7##2##(1992-11#1)(2007-3#1)(2008-10#3)(2008-12#1)(2008-5#1)
used commonly##3##2##(2007-11#1)(2008-4#1)(2008-8#1)
used compared##2##2##(1996-5#1)(2012-2#1)
used compounds##2##2##(1996-12#1)(2005-11#1)
used computer##3##2##(1993-2#1)(2007-12#1)(2009-10#1)
used computers##3##2##(2013-8#3)
used condom##3##2##(2007-7#1)(2008-8#1)(2012-12#1)
used condoms##7##2##(2007-3#2)(2007-7#2)(2010-8#1)(2012-12#1)(2013-1#1)
used consisted of##3##3##(2006-4#1)(2008-3#1)(2008-8#1)
used contained##2##2##(1991-6#1)(2007-11#1)
used conventional pesticide##2##3##(2008-10#2)
used conventional##3##2##(2007-7#1)(2008-10#2)
used correctly##4##2##(1991-9#1)(1995-12#1)(2007-1#1)(2013-8#1)
used could##3##2##(1996-2#1)(2006-11#1)(2013-7#1)
used criteria for##2##3##(2006-9#1)(2007-11#1)
used crop##2##2##(2008-12#2)
used currently##2##2##(2004-11#1)(2010-12#1)
used data from the##6##4##(1995-12#1)(1996-3#1)(2007-3#1)(2009-7#1)(2010-10#1)(2010-8#1)
used data from##13##3##(1995-12#1)(1996-3#1)(2006-7#1)(2007-2#1)(2007-3#1)(2008-11#1)(2008-8#2)(2009-7#1)(2010-10#1)(2010-8#1)(2013-1#1)(2013-8#1)
used data of##2##3##(2007-11#1)(2007-8#1)
used data##19##2##(1995-12#1)(1996-3#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-8#2)(2009-7#1)(2010-10#1)(2010-8#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
used dental##2##2##(2010-4#1)(2011-1#1)
used detection technique##2##3##(2008-10#2)
used detection##3##2##(2008-10#2)(2008-9#1)
used device##2##2##(1996-1#1)(2010-7#1)
used devices##2##2##(2009-6#1)(2013-7#1)
used diagnostic##2##2##(1990-7#1)(1992-3#1)
used did not##3##3##(1990-2#1)(2007-7#1)(2008-9#1)
used different##7##2##(2006-6#1)(2006-8#1)(2007-10#1)(2007-9#1)(2008-11#1)(2012-12#1)(2012-3#1)
used direct##2##2##(2008-5#1)(2008-9#1)
used directly for##6##3##(1995-6#1)(2007-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-2#1)
used directly in##3##3##(1993-6#1)(1997-8#1)(2008-2#1)
used directly to##2##3##(2008-10#1)(2008-3#1)
used directly##14##2##(1993-6#1)(1995-6#1)(1997-8#1)(2007-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2011-1#1)
used display##2##2##(1991-3#1)(1995-2#1)
used doses##3##2##(1990-1#1)(1996-3#1)(2012-2#1)
used drug in the##2##4##(2004-10#1)(2008-1#1)
used drug in##3##3##(2004-10#1)(2008-1#1)(2008-7#1)
used drug##11##2##(2004-10#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
used drugs in##5##3##(1994-6#1)(2006-10#2)(2007-10#1)(2011-12#1)
used drugs##17##2##(1994-12#1)(1994-6#1)(1996-9#1)(1997-6#1)(2006-10#2)(2006-4#1)(2007-10#1)(2007-2#1)(2008-11#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-1#1)(2013-1#1)(2013-8#1)
used due to the##3##4##(2005-4#1)(2006-11#1)(2007-4#1)
used during the##8##3##(1992-10#1)(1994-1#1)(2005-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-2#1)
used during##44##2##(1992-10#1)(1993-12#2)(1994-1#1)(1994-2#1)(1996-9#1)(2005-10#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-9#1)(2011-12#1)(2012-1#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
used earlier##2##2##(1990-5#2)
used early##3##2##(2006-12#1)(2008-9#1)(2011-2#1)
used easily##2##2##(1991-2#1)(2008-3#1)
used effectively in##3##3##(2007-4#1)(2009-10#1)(2011-2#1)
used effectively##11##2##(2006-7#1)(2007-4#1)(2008-2#1)(2008-4#1)(2009-10#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#2)
used either for##3##3##(2006-5#1)(2008-4#1)(2010-12#1)
used either##12##2##(1994-4#1)(1994-5#1)(1996-8#1)(2005-10#1)(2006-5#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-4#1)
used electron##2##2##(1994-11#1)(1994-8#1)
used electronic##3##2##(2011-2#1)(2013-1#2)
used elsewhere##2##2##(1996-5#1)(2006-12#1)
used emergency##2##2##(2004-10#1)(2006-10#1)
used emotion-focused coping##2##3##(2011-2#2)
used evaluation##2##2##(1996-7#1)(2013-7#1)
used event-related##2##2##(2008-11#1)(2010-2#1)
used exclusively##2##2##(1994-3#1)(2009-6#1)
used experimental##2##2##(2008-11#1)(2012-12#1)
used experimentally##4##2##(2007-8#1)(2008-3#1)(2008-5#2)
used expression##3##2##(1997-4#1)(2008-7#1)(2011-1#1)
used extensively for##6##3##(1994-3#1)(2004-1#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)
used extensively in the##5##4##(2006-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2013-8#1)
used extensively in##16##3##(1990-10#1)(1995-12#1)(1997-3#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-6#1)(2013-8#1)
used extensively to##7##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-9#1)
used extensively##35##2##(1990-10#1)(1992-3#1)(1994-3#1)(1995-12#1)(1997-3#1)(2004-1#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-5#1)(2010-9#1)(2013-8#1)
used extraction##2##2##(2008-10#2)
used fMRI to##4##3##(2008-11#2)(2010-2#1)(2012-2#1)
used factor##2##2##(2005-12#1)(2010-6#1)
used fewer##2##2##(1991-12#1)(1995-3#1)
used flow cytometry##2##3##(2006-6#1)(2008-9#1)
used fluorescence##2##2##(1991-2#1)(2008-5#1)
used fluorophores##2##2##(1995-5#1)(2008-9#1)
used focus group##2##3##(2010-12#1)(2011-2#1)
used focus groups to##2##4##(1994-12#1)(2009-5#1)
used focus groups##3##3##(1994-12#1)(2007-2#1)(2009-5#1)
used focus##5##2##(1994-12#1)(2007-2#1)(2009-5#1)(2010-12#1)(2011-2#1)
used following##3##2##(1996-12#1)(2011-2#1)(2012-12#1)
used for DNA##5##3##(1996-4#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-10#1)
used for MRI##2##3##(2008-6#1)(2013-1#1)
used for MT##2##3##(2008-10#2)
used for Ophthalmic operation##2##4##(2013-1#2)
used for PCR##3##3##(1996-7#1)(2008-5#1)(2011-1#1)
used for RAPD##2##3##(2008-10#1)(2008-5#1)
used for a highly##2##4##(2008-10#2)
used for a long time in##2##6##(2008-10#1)(2008-3#1)
used for a long time##4##5##(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)
used for a period of##4##5##(2008-10#4)
used for a variety of##7##5##(1991-7#1)(2005-7#1)(2008-11#1)(2008-4#1)(2008-7#1)(2013-1#1)(2013-7#1)
used for a##50##3##(1990-2#1)(1991-7#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-2#1)(1996-8#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#2)(2007-1#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-1#2)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#2)(2008-7#1)(2008-9#1)(2010-10#1)(2010-12#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
used for ab initio##2##4##(2006-4#1)(2008-7#1)
used for absorbance##2##3##(2008-10#1)(2008-3#1)
used for affinity##2##3##(1996-11#1)(2008-4#1)
used for all##7##3##(1990-8#1)(1996-1#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-3#1)(2010-12#1)
used for an##4##3##(1990-11#1)(2005-11#1)(2008-1#1)(2008-5#1)
used for anaesthesia##2##3##(2010-12#1)(2011-2#1)
used for analysing##3##3##(1994-3#1)(2011-2#1)(2012-12#1)
used for analysis of##9##4##(2005-3#1)(2007-2#1)(2008-10#4)(2009-3#1)(2010-1#1)(2013-1#1)
used for analysis##17##3##(2005-3#1)(2007-10#1)(2007-12#1)(2007-2#2)(2008-10#5)(2009-3#1)(2010-1#1)(2010-6#1)(2012-12#1)(2013-1#3)
used for analytical##3##3##(2008-10#1)(2008-2#1)(2010-3#1)
used for analyzing the##2##4##(2007-2#1)(2008-4#1)
used for analyzing##4##3##(1996-12#1)(2007-2#1)(2008-4#1)(2009-5#1)
used for animal##2##3##(2008-10#1)(2010-1#1)
used for antibody##4##3##(1992-7#1)(1994-3#1)(2008-9#1)(2012-1#1)
used for assessing the##3##4##(1995-7#1)(2008-10#1)(2008-7#1)
used for assessment of##3##4##(2008-10#1)(2008-12#1)(2012-3#1)
used for assessment##4##3##(2008-10#1)(2008-12#1)(2012-3#1)(2013-8#1)
used for at least##16##4##(2007-8#1)(2008-10#15)
used for automated##3##3##(2008-10#1)(2013-1#2)
used for biological##3##3##(1994-6#1)(2008-10#1)(2008-7#1)
used for biomass##2##3##(2008-11#1)(2009-3#1)
used for biomedical##3##3##(2006-5#1)(2008-7#1)(2010-9#1)
used for blood##2##3##(2008-1#1)(2012-11#1)
used for both the diagnosis##2##5##(2006-10#1)(2008-6#1)
used for both the##5##4##(2006-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)
used for both##36##3##(1997-4#1)(2006-10#1)(2006-12#3)(2007-11#2)(2007-12#2)(2007-2#1)(2007-6#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#6)(2008-4#3)(2008-6#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-1#1)(2013-8#1)
used for bowel##2##3##(2006-6#1)(2011-2#1)
used for breast##2##3##(2010-9#1)(2011-2#1)
used for building##2##3##(2008-10#2)
used for calculating##3##3##(2007-12#1)(2007-7#1)(2008-2#1)
used for calculations of##2##4##(2007-8#1)(2008-2#1)
used for calibration##8##3##(1992-4#1)(2008-10#6)(2008-9#1)
used for carrying out##3##4##(2008-10#1)(2008-4#1)(2008-9#1)
used for cell##7##3##(1994-5#2)(1995-1#1)(2005-8#1)(2008-11#1)(2011-2#1)(2013-7#1)
used for challenge##3##3##(1997-6#1)(2008-10#2)
used for characterization of##6##4##(1992-8#1)(2006-8#1)(2007-12#1)(2008-10#1)(2009-3#2)
used for characterizing##4##3##(1992-4#1)(2007-12#1)(2008-1#1)(2008-10#1)
used for chemical##2##3##(1997-3#1)(2008-10#1)
used for chest wall reconstruction##2##5##(2012-2#2)
used for chronic##2##3##(2006-12#1)(2007-2#1)
used for classification##4##3##(2008-2#2)(2013-1#2)
used for clinical##10##3##(2008-7#1)(2010-11#2)(2010-2#1)(2010-8#1)(2012-12#2)(2013-1#2)(2013-8#1)
used for collecting##3##3##(2006-8#1)(2011-2#1)(2013-1#1)
used for column##2##3##(2008-10#2)
used for commercial##2##3##(2010-8#1)(2012-2#1)
used for comparison##17##3##(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-5#1)(2009-8#1)(2010-4#1)(2010-8#2)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
used for constructing the##2##4##(1997-6#1)(2009-10#1)
used for constructing##7##3##(1993-9#1)(1997-6#1)(2008-10#3)(2009-10#1)(2010-12#1)
used for construction of##2##4##(2008-10#1)(2012-11#1)
used for control##2##3##(2008-4#1)(2008-5#1)
used for controlling the##2##4##(2007-12#1)(2008-2#1)
used for controlling##3##3##(2007-12#1)(2008-2#1)(2010-12#1)
used for coronary artery bypass grafting##2##6##(2007-8#2)
used for creating##4##3##(2005-8#1)(2008-10#1)(2008-3#1)(2008-8#1)
used for data analysis##6##4##(2006-10#1)(2007-7#1)(2008-10#1)(2010-11#1)(2010-12#1)(2011-1#1)
used for data collection##8##4##(1993-2#1)(2005-12#1)(2007-10#1)(2008-3#1)(2008-8#1)(2009-11#1)(2011-1#1)(2013-8#1)
used for data##19##3##(1993-2#1)(2005-12#1)(2006-10#1)(2007-10#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-11#1)(2010-11#1)(2010-12#1)(2011-1#2)(2013-1#1)(2013-8#1)
used for designing a##2##4##(2008-4#1)(2012-12#1)
used for designing and##2##4##(2008-2#1)(2008-3#1)
used for designing##7##3##(2008-2#1)(2008-3#2)(2008-4#1)(2012-1#1)(2012-12#1)(2012-2#1)
used for detecting##5##3##(1995-8#1)(2007-9#1)(2008-10#1)(2008-9#1)(2010-3#1)
used for detection of##5##4##(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)
used for detection##12##3##(1996-2#1)(1997-3#1)(2005-3#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#1)(2011-1#1)
used for determination of the##3##5##(2007-12#1)(2008-3#2)
used for determination of##27##4##(1997-1#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#19)(2008-3#2)(2008-7#1)(2008-8#1)
used for determining DNA##2##4##(1995-2#1)(2008-10#1)
used for determining the##10##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#5)(2008-5#1)(2013-7#1)
used for determining##18##3##(1995-2#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2013-7#1)
used for diagnosis and treatment##3##5##(1990-3#1)(2008-3#1)(2011-2#1)
used for diagnosis and##6##4##(1990-3#1)(1991-6#1)(2007-7#1)(2007-8#1)(2008-3#1)(2011-2#1)
used for diagnosis##12##3##(1990-3#1)(1991-6#1)(1992-6#1)(1997-2#1)(2005-10#1)(2007-7#1)(2007-8#1)(2008-3#1)(2009-10#1)(2010-8#1)(2011-2#2)
used for diagnostic purposes##2##4##(1996-12#1)(2008-10#1)
used for diagnostic##6##3##(1990-10#1)(1996-12#1)(2008-10#1)(2011-2#1)(2012-1#1)(2012-12#1)
used for differential##2##3##(2008-2#1)(2012-3#1)
used for digestion##2##3##(1994-12#1)(1997-3#1)
used for direct determination of##2##5##(2008-10#2)
used for direct##7##3##(1994-6#1)(2008-10#4)(2008-4#1)(2010-8#1)
used for drinking##2##3##(2008-10#1)(2008-5#1)
used for drug##4##3##(2008-10#1)(2010-11#2)(2010-5#1)
used for each##7##3##(1990-5#1)(2007-12#2)(2008-10#3)(2008-8#1)
used for early##2##3##(2010-12#1)(2012-1#1)
used for effective##2##3##(2008-10#1)(2008-3#1)
used for efficient##5##3##(1996-7#1)(2007-12#1)(2008-2#2)(2008-3#1)
used for electrochemical##3##3##(2008-10#1)(2012-11#2)
used for electrophysiology##2##3##(2008-11#2)
used for elution##2##3##(2008-10#1)(2008-4#1)
used for enhancing##2##3##(2008-10#2)
used for enrichment##2##3##(2008-10#2)
used for equilibrium and##2##4##(2005-11#1)(2008-5#1)
used for estimating the##3##4##(2007-9#1)(2008-10#1)(2008-4#1)
used for estimating treatment effects in##2##6##(2009-9#1)(2010-6#1)
used for estimating##6##3##(2007-7#1)(2007-9#1)(2008-10#1)(2008-4#1)(2009-9#1)(2010-6#1)
used for estimation of##5##4##(2007-2#1)(2008-2#1)(2008-3#1)(2010-4#1)(2013-1#1)
used for evaluating the##2##4##(2008-10#1)(2011-2#1)
used for evaluating##5##3##(2004-11#1)(2008-10#2)(2011-2#2)
used for evaluation of##8##4##(1996-3#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-9#1)
used for evaluation##16##3##(1996-3#1)(1996-9#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-7#2)(2008-9#1)(2011-2#3)
used for examination##2##3##(1991-4#1)(2007-8#1)
used for examining##2##3##(2008-10#1)(2008-11#1)
used for extraction and##2##4##(2008-10#1)(2013-7#1)
used for extraction##4##3##(2008-10#3)(2013-7#1)
used for fabricating##2##3##(2008-10#1)(2008-2#1)
used for fabrication of##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
used for fitting##3##3##(2007-12#1)(2008-10#1)(2008-4#1)
used for fixation##3##3##(2008-10#2)(2009-3#1)
used for flow##2##3##(2007-8#1)(2008-9#1)
used for food##2##3##(2006-12#1)(2011-12#1)
used for frequency##2##3##(2007-12#2)
used for further##6##3##(2007-8#1)(2008-10#2)(2008-2#1)(2008-9#1)(2009-3#1)
used for gene##2##3##(2009-10#1)(2013-1#1)
used for generating##3##3##(2007-12#1)(2008-4#1)(2008-5#1)
used for genetic studies##2##4##(2008-10#1)(2008-12#1)
used for genetic##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
used for growth##2##3##(2008-4#1)(2008-6#1)
used for heart##2##3##(2007-8#1)(2013-1#1)
used for hemodialysis##4##3##(2006-8#1)(2007-7#3)
used for high-speed##2##3##(2010-4#1)(2011-1#1)
used for histological##3##3##(2006-12#1)(2011-2#1)(2012-2#1)
used for home##2##3##(2010-8#1)(2011-1#1)
used for identification of##6##4##(2004-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2011-1#1)
used for identification##9##3##(1990-8#1)(1997-7#1)(2004-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2011-1#1)
used for identifying##4##3##(2008-10#1)(2008-4#2)(2010-2#1)
used for image##7##3##(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2010-4#1)(2011-1#1)
used for imaging##5##3##(2007-11#1)(2007-12#2)(2009-7#1)(2012-12#1)
used for immunization##2##3##(1992-8#1)(2010-12#1)
used for in situ##3##4##(1995-11#1)(2008-10#1)(2010-2#1)
used for in vitro##9##4##(1993-9#1)(1994-3#1)(2008-11#1)(2008-4#2)(2008-5#3)(2010-5#1)
used for in##13##3##(1993-9#1)(1994-3#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#3)(2010-2#2)(2010-5#1)
used for infection##2##3##(2008-11#2)
used for initial##3##3##(2007-4#1)(2010-3#1)(2011-2#1)
used for insulation##2##3##(2010-8#1)(2010-9#1)
used for intra-articular administration##2##4##(2006-10#2)
used for investigating##3##3##(1990-4#1)(1996-5#1)(2007-10#1)
used for investigation of the##2##5##(1990-5#1)(2008-10#1)
used for investigation of##4##4##(1990-5#1)(2008-10#1)(2008-2#1)(2009-8#1)
used for irrigation##4##3##(2008-10#1)(2009-6#1)(2011-12#1)(2012-10#1)
used for isolation of##4##4##(1991-3#1)(2008-9#1)(2010-12#1)(2011-2#1)
used for isolation##5##3##(1991-3#1)(2007-11#1)(2008-9#1)(2010-12#1)(2011-2#1)
used for its determination##4##4##(1997-2#2)(2008-10#2)
used for its##9##3##(1997-2#2)(2005-4#1)(2008-10#2)(2011-1#1)(2011-2#2)(2013-8#1)
used for local##2##3##(1992-8#1)(2008-3#1)
used for long-term##2##3##(2007-11#1)(2008-10#1)
used for longer##2##3##(2008-1#1)(2009-5#1)
used for maintenance therapy##2##4##(2008-4#2)
used for making##2##3##(1994-3#1)(2008-5#1)
used for mammalian##2##3##(2008-11#1)(2008-9#1)
used for management of##3##4##(2005-12#1)(2007-12#1)(2012-12#1)
used for management##4##3##(2005-12#1)(2007-12#1)(2008-11#1)(2012-12#1)
used for many years to##4##5##(2007-12#1)(2009-5#1)(2012-10#1)(2013-8#1)
used for many years##11##4##(1992-5#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-5#1)(2009-5#1)(2009-8#1)(2012-10#1)(2013-8#1)
used for many##18##3##(1992-5#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-8#1)(2012-10#1)(2012-12#1)(2013-8#1)
used for material ablation##2##4##(2008-2#2)
used for measurement of the##2##5##(2007-12#1)(2013-8#1)
used for measurement of##4##4##(2007-12#2)(2008-3#1)(2013-8#1)
used for measurement##6##3##(2007-12#2)(2008-10#1)(2008-3#1)(2008-5#1)(2013-8#1)
used for measuring the##10##4##(1994-11#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-3#4)(2008-8#1)(2013-1#1)
used for measuring##17##3##(1990-11#1)(1992-1#1)(1994-11#1)(1996-6#1)(2007-12#1)(2008-10#2)(2008-3#6)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
used for medical purposes##2##4##(1996-9#1)(2013-8#1)
used for medical##3##3##(1996-9#1)(2008-8#1)(2013-8#1)
used for metal##2##3##(2008-10#1)(2008-8#1)
used for microbial##2##3##(2008-11#2)
used for modeling the##3##4##(2008-10#1)(2013-1#2)
used for modeling##4##3##(2008-10#1)(2013-1#3)
used for molecular##5##3##(1990-11#1)(1991-9#1)(2008-7#1)(2009-3#1)(2012-12#1)
used for monitoring the##2##4##(1993-12#1)(2008-10#1)
used for monitoring##9##3##(1993-12#1)(1993-7#1)(2004-4#1)(2007-12#1)(2008-10#4)(2013-1#1)
used for more than 100##2##5##(2008-10#1)(2008-7#1)
used for more than 50##2##5##(1995-12#1)(2008-10#1)
used for more than##13##4##(1995-12#1)(2008-10#10)(2008-7#1)(2011-2#1)
used for more##16##3##(1995-12#1)(1997-2#1)(2008-10#11)(2008-7#1)(2011-2#1)(2012-12#1)
used for multiple##3##3##(1990-4#1)(2008-9#1)(2012-11#1)
used for numerical##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
used for obtaining##4##3##(2006-5#1)(2008-1#1)(2008-10#1)(2010-7#1)
used for off-line##2##3##(2008-10#1)(2009-6#1)
used for on-line##2##3##(2008-10#2)
used for optical##5##3##(2007-11#2)(2007-12#2)(2008-2#1)
used for optimizing##2##3##(2007-6#1)(2008-10#1)
used for other##6##3##(1992-9#1)(1996-3#1)(2007-10#1)(2008-11#1)(2008-2#1)(2009-8#1)
used for pain##2##3##(2007-11#1)(2007-7#1)
used for parallel##2##3##(2008-2#1)(2008-4#1)
used for patients with celiac disease##2##6##(2011-2#2)
used for patients with##4##4##(1992-3#1)(2008-6#1)(2011-2#2)
used for patients##9##3##(1992-3#1)(1995-3#1)(2006-1#1)(2007-8#1)(2008-4#1)(2008-6#1)(2009-7#1)(2011-2#2)
used for personal##2##3##(1992-3#1)(2008-8#1)
used for precise##2##3##(2010-7#1)(2013-7#1)
used for preconcentration of##4##4##(2008-10#4)
used for predicting##4##3##(2005-12#1)(2007-3#1)(2011-12#1)(2013-8#1)
used for preparation of##4##4##(2005-10#1)(2008-10#1)(2008-11#1)(2008-9#1)
used for preparation##6##3##(1990-9#1)(2005-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)
used for preparing the##3##4##(2005-11#1)(2006-5#1)(2008-5#1)
used for prevention of##3##4##(2006-8#1)(2007-8#1)(2012-3#1)
used for prevention##5##3##(1996-11#1)(1997-2#1)(2006-8#1)(2007-8#1)(2012-3#1)
used for primary##3##3##(2004-9#2)(2008-10#1)
used for producing##2##3##(2004-8#1)(2011-2#1)
used for propagating##2##3##(2008-3#1)(2008-4#1)
used for prophylactic##2##3##(2007-11#1)(2011-1#1)
used for protein##4##3##(1997-3#1)(2008-10#1)(2008-4#1)(2012-1#1)
used for providing##2##3##(1997-3#1)(2012-12#1)
used for quantification and##2##4##(2008-11#1)(2008-7#1)
used for quantification of##3##4##(2008-10#3)
used for quantification##8##3##(1996-9#1)(2008-10#5)(2008-11#1)(2008-7#1)
used for quantitation##2##3##(1996-8#1)(2008-10#1)
used for quantitative analysis##6##4##(2004-9#1)(2008-10#3)(2008-5#2)
used for quantitative measurement##2##4##(2008-10#1)(2008-3#1)
used for quantitative##10##3##(2004-9#1)(2008-10#6)(2008-3#1)(2008-5#2)
used for rapid##10##3##(1996-8#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-5#2)(2010-6#1)
used for real-time monitoring of##2##5##(2008-10#1)(2010-5#1)
used for recording##4##3##(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#1)
used for relaxation purposes##2##4##(2007-6#2)
used for reliable##3##3##(1993-12#1)(1993-2#1)(2008-10#1)
used for removal##2##3##(2006-5#1)(2007-8#1)
used for repair##2##3##(2006-12#1)(2010-9#1)
used for research and##4##4##(1996-12#1)(2005-12#2)(2007-10#1)
used for research##7##3##(1996-12#1)(1996-6#1)(2005-12#2)(2007-10#1)(2007-11#1)(2008-7#1)
used for resolving##2##3##(2007-8#1)(2008-10#1)
used for root##2##3##(2008-11#1)(2013-1#1)
used for routine##6##3##(1994-3#1)(1997-3#1)(2005-4#1)(2007-7#1)(2008-10#1)(2008-12#1)
used for sample##4##3##(2008-10#3)(2011-1#1)
used for sampling##3##3##(2007-6#1)(2008-10#1)(2008-2#1)
used for screening of##2##4##(2008-7#1)(2012-2#1)
used for screening##8##3##(1995-4#1)(2007-11#1)(2007-7#1)(2008-7#2)(2008-8#1)(2010-8#1)(2012-2#1)
used for segmentation##2##3##(2008-2#1)(2008-3#1)
used for selecting##3##3##(1992-2#1)(2008-10#1)(2008-9#1)
used for selection of##6##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-2#1)(2011-2#1)
used for selection##8##3##(1997-4#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-2#1)(2011-2#1)(2013-8#1)
used for sensing##2##3##(2008-10#1)(2008-3#1)
used for sensitive and selective##3##5##(2007-8#1)(2008-10#1)(2009-3#1)
used for sensitive and##4##4##(2007-8#1)(2008-10#1)(2008-5#1)(2009-3#1)
used for sensitive##8##3##(2007-8#3)(2008-10#2)(2008-3#1)(2008-5#1)(2009-3#1)
used for sensor##3##3##(2007-11#1)(2008-10#2)
used for separation##2##3##(2008-10#1)(2008-6#1)
used for several##5##3##(2008-2#1)(2008-4#1)(2010-10#1)(2010-2#1)(2013-8#1)
used for short-term##3##3##(2008-1#1)(2010-7#2)
used for signal##2##3##(2006-6#1)(2007-12#1)
used for simulations and##2##4##(2008-2#1)(2012-1#1)
used for simulations##3##3##(2006-10#1)(2008-2#1)(2012-1#1)
used for simultaneous determination##2##4##(2008-10#2)
used for simultaneous##6##3##(2007-12#1)(2008-10#3)(2008-9#1)(2011-3#1)
used for solid-phase##2##3##(1993-2#1)(1994-6#1)
used for some##3##3##(1992-8#1)(2008-3#1)(2008-7#1)
used for spatial##2##3##(1993-3#1)(2008-10#1)
used for spatially##2##3##(1995-4#1)(2005-11#1)
used for species##3##3##(1996-12#1)(2008-10#1)(2011-12#1)
used for specific##3##3##(1997-6#1)(2006-10#1)(2008-4#1)
used for statistical analysis##7##4##(1994-9#1)(1996-12#1)(2006-7#2)(2007-11#1)(2012-2#1)(2012-3#1)
used for statistical##10##3##(1994-9#1)(1996-12#1)(2006-7#2)(2007-11#1)(2008-10#1)(2008-6#1)(2008-9#1)(2012-2#1)(2012-3#1)
used for studying the##3##4##(2006-5#1)(2008-10#1)(2008-2#1)
used for studying##11##3##(1994-11#1)(1996-2#1)(2005-11#1)(2006-5#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-8#1)
used for such##4##3##(2008-2#2)(2008-8#1)(2012-2#1)
used for surface##2##3##(2008-10#2)
used for surveillance##2##3##(1997-6#1)(2008-1#1)
used for synthesis of##2##4##(2008-4#2)
used for testing the##2##4##(2013-1#1)(2013-8#1)
used for testing##8##3##(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#2)(2013-1#1)(2013-8#1)
used for the amplification of##3##5##(1993-2#1)(2008-10#1)(2009-5#1)
used for the analyses##2##4##(2008-10#1)(2011-12#1)
used for the analysis of the##2##6##(1997-3#1)(2006-7#1)
used for the analysis of##9##5##(1993-2#1)(1997-3#1)(2006-7#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-4#1)
used for the analysis##14##4##(1993-2#1)(1997-3#3)(2006-7#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-9#1)(2011-2#1)
used for the application##2##4##(2005-11#1)(2010-5#1)
used for the assay of##7##5##(1997-8#1)(2008-10#6)
used for the assay##10##4##(1991-9#1)(1993-9#1)(1996-12#1)(1997-8#1)(2008-10#6)
used for the assessment of##5##5##(2006-4#1)(2007-8#1)(2008-10#2)(2008-8#1)
used for the biological##2##4##(2007-10#1)(2008-10#1)
used for the calculation of##3##5##(2005-11#1)(2008-10#1)(2008-2#1)
used for the calculations##2##4##(2008-10#2)
used for the calibration##2##4##(2008-10#2)
used for the characterization of##6##5##(1994-2#1)(1994-3#1)(1996-5#1)(2005-11#1)(2008-3#1)(2010-12#1)
used for the classification##2##4##(2010-8#1)(2012-12#1)
used for the construction of the##2##6##(2005-11#1)(2008-10#1)
used for the construction of##5##5##(2005-11#1)(2008-10#2)(2008-7#1)(2008-9#1)
used for the control of##4##5##(1997-6#1)(2008-10#3)
used for the control##5##4##(1997-6#1)(2008-10#3)(2013-1#1)
used for the design of##5##5##(2006-12#1)(2007-12#1)(2008-11#1)(2009-3#1)(2011-2#1)
used for the detection of##16##5##(1992-8#1)(1997-8#1)(2005-7#1)(2006-8#1)(2008-10#8)(2008-3#1)(2008-4#1)(2011-1#1)(2012-3#1)
used for the determination of Cu(II)##2##6##(2008-10#2)
used for the determination of Se##2##6##(2008-10#2)
used for the determination of the##8##6##(1996-5#1)(2008-10#5)(2008-5#1)(2012-12#1)
used for the determination of these##2##6##(2008-10#2)
used for the determination of trace##10##6##(2005-4#2)(2007-8#2)(2008-10#6)
used for the determination of##90##5##(1990-2#1)(1990-8#1)(1991-5#1)(1993-9#1)(1996-5#1)(1997-8#1)(2005-4#4)(2007-12#1)(2007-8#3)(2008-10#67)(2008-2#2)(2008-5#1)(2008-7#2)(2010-4#1)(2012-12#1)(2013-1#1)(2013-7#1)
used for the determination##91##4##(1990-2#1)(1990-8#1)(1991-5#1)(1993-9#1)(1996-5#1)(1997-8#1)(2005-4#4)(2007-12#1)(2007-8#3)(2008-10#68)(2008-2#2)(2008-5#1)(2008-7#2)(2010-4#1)(2012-12#1)(2013-1#1)(2013-7#1)
used for the development of##7##5##(2006-12#1)(2008-10#3)(2008-3#1)(2008-9#1)(2013-1#1)
used for the diagnosis and##3##5##(2006-10#1)(2008-4#1)(2010-12#1)
used for the diagnosis of##2##5##(1997-8#1)(2006-8#1)
used for the diagnosis##6##4##(1997-8#1)(2005-9#1)(2006-10#1)(2006-8#1)(2008-4#1)(2010-12#1)
used for the direct##4##4##(1990-12#1)(2007-8#1)(2008-10#1)(2012-12#1)
used for the estimation of the##3##6##(2005-11#1)(2008-10#1)(2013-1#1)
used for the estimation of##8##5##(2005-11#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-4#1)(2010-2#1)(2013-1#1)
used for the evaluation of the##4##6##(1997-3#1)(2008-10#1)(2012-1#1)(2012-2#1)
used for the evaluation of##13##5##(1990-11#1)(1991-2#1)(1996-5#1)(1997-3#1)(2004-9#1)(2008-10#4)(2010-12#1)(2010-3#1)(2012-1#1)(2012-2#1)
used for the evaluation##14##4##(1990-11#1)(1991-2#1)(1996-5#1)(1997-3#1)(2004-9#1)(2008-10#4)(2010-12#1)(2010-3#1)(2012-1#1)(2012-2#1)(2013-8#1)
used for the excitation and##2##5##(2007-12#1)(2008-2#1)
used for the excitation##3##4##(2007-12#1)(2008-2#1)(2008-5#1)
used for the experiments##3##4##(2008-2#1)(2008-5#1)(2012-1#1)
used for the expression##3##4##(1990-3#1)(2005-11#1)(2009-4#1)
used for the extraction of##3##5##(2008-10#3)
used for the extraction##4##4##(2008-10#4)
used for the fabrication of a##2##6##(2008-10#1)(2008-3#1)
used for the fabrication of##5##5##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-11#1)
used for the final##2##4##(2008-10#1)(2008-3#1)
used for the first time to study##2##7##(2008-10#2)
used for the first time to##5##6##(2008-10#3)(2010-1#1)(2013-8#1)
used for the first time##8##5##(2007-10#1)(2008-10#4)(2008-2#1)(2010-1#1)(2013-8#1)
used for the formation of##2##5##(2008-10#1)(2008-5#1)
used for the formulation of##2##5##(2008-10#1)(2010-5#1)
used for the generation of##2##5##(1992-7#1)(1997-7#1)
used for the identification of##5##5##(2007-6#1)(2008-10#3)(2008-9#1)
used for the identification##7##4##(2007-6#1)(2008-10#4)(2008-9#1)(2013-1#1)
used for the initial##2##4##(2006-12#1)(2008-10#1)
used for the investigation of the##2##6##(2008-10#1)(2010-12#1)
used for the investigation of##3##5##(2008-10#1)(2008-3#1)(2010-12#1)
used for the isolation of##4##5##(1994-12#1)(2008-1#1)(2008-11#1)(2011-1#1)
used for the isolation##5##4##(1994-12#1)(2008-1#1)(2008-11#1)(2008-4#1)(2011-1#1)
used for the localization of##2##5##(2008-3#1)(2008-7#1)
used for the management of##2##5##(2007-2#1)(2007-7#1)
used for the measurement of##3##5##(2008-10#1)(2008-2#1)(2008-4#1)
used for the measurements##2##4##(2008-3#2)
used for the model##2##4##(2007-4#1)(2008-4#1)
used for the optimization of##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
used for the preconcentration and separation of##2##7##(2008-10#2)
used for the preconcentration and##3##5##(2008-10#3)
used for the preconcentration of##4##5##(2007-8#1)(2008-10#3)
used for the preconcentration##7##4##(2007-8#1)(2008-10#6)
used for the prediction of##2##5##(2007-11#1)(2010-4#1)
used for the preparation of##5##5##(1994-2#1)(1994-6#1)(2008-3#1)(2008-8#1)(2012-3#1)
used for the production of recombinant proteins##3##7##(2008-11#3)
used for the production of##9##5##(2008-11#5)(2008-6#2)(2008-8#1)(2012-2#1)
used for the purification of##2##5##(1991-11#1)(2008-10#1)
used for the purification##3##4##(1991-11#1)(2008-10#2)
used for the purpose of##3##5##(1993-11#1)(2012-2#1)(2013-1#1)
used for the purpose##4##4##(1993-11#1)(2008-8#1)(2012-2#1)(2013-1#1)
used for the quantification of##3##5##(1990-12#1)(2008-10#2)
used for the quantification##4##4##(1990-12#1)(2008-10#2)(2012-12#1)
used for the quantitation##2##4##(1996-8#1)(2008-4#1)
used for the quantitative determination of##4##6##(2008-10#4)
used for the quantitative##8##4##(2007-8#1)(2008-10#5)(2008-3#1)(2013-8#1)
used for the rapid##5##4##(2005-11#1)(2006-8#1)(2007-7#1)(2008-10#1)(2010-9#1)
used for the reconstruction##3##4##(1996-11#1)(2005-11#1)(2011-1#1)
used for the research##2##4##(2005-10#1)(2008-11#1)
used for the same purpose##3##5##(2007-12#1)(2007-7#1)(2008-10#1)
used for the same##6##4##(2007-12#1)(2007-7#2)(2008-10#2)(2012-12#1)
used for the selective##4##4##(2008-10#4)
used for the sensitive determination of##2##6##(2008-10#2)
used for the sensitive##3##4##(1990-8#1)(2008-10#2)
used for the separation and##3##5##(2008-10#2)(2008-2#1)
used for the separation of##4##5##(2008-10#2)(2008-11#1)(2012-12#1)
used for the separation##10##4##(1997-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-7#1)(2012-12#1)
used for the simultaneous determination of the##2##7##(2008-10#2)
used for the simultaneous determination of##6##6##(2008-10#5)(2012-12#1)
used for the simultaneous##9##4##(2008-1#1)(2008-10#7)(2012-12#1)
used for the spectrophotometric determination of##2##6##(2008-10#2)
used for the study of the##3##6##(2006-9#1)(2008-10#2)
used for the study of##8##5##(1990-8#1)(1996-2#1)(1996-8#1)(2006-9#1)(2008-10#3)(2008-4#1)
used for the study##14##4##(1990-8#1)(1994-3#1)(1996-2#1)(1996-8#1)(2006-9#1)(2008-1#1)(2008-10#3)(2008-4#2)(2009-5#2)(2011-2#1)
used for the synthesis of##6##5##(1990-2#1)(2007-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)
used for the treatment of breast cancer##2##7##(1993-1#1)(2005-10#1)
used for the treatment of breast##3##6##(1992-9#1)(1993-1#1)(2005-10#1)
used for the treatment of diabetes##3##6##(2007-5#1)(2008-4#1)(2010-4#1)
used for the treatment of different##2##6##(2008-1#1)(2010-12#1)
used for the treatment of osteoporosis##2##6##(2005-1#1)(2005-3#1)
used for the treatment of various##2##6##(2005-3#1)(2006-12#1)
used for the treatment of##36##5##(1992-9#1)(1993-1#1)(1994-11#1)(1996-9#1)(2005-1#1)(2005-10#1)(2005-3#2)(2006-10#1)(2006-12#1)(2006-7#1)(2006-9#2)(2007-11#2)(2007-5#1)(2007-6#1)(2007-8#3)(2008-1#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-9#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#2)(2013-7#1)(2013-8#1)
used for the treatment##37##4##(1992-9#1)(1993-1#1)(1994-11#1)(1996-9#1)(2005-1#1)(2005-10#1)(2005-3#2)(2006-10#1)(2006-12#1)(2006-7#1)(2006-9#2)(2007-11#2)(2007-5#1)(2007-6#1)(2007-8#3)(2008-1#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-9#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#2)(2013-7#1)(2013-8#1)
used for the vanadium##2##4##(2008-10#2)
used for the##616##3##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#1)(1990-8#3)(1991-11#2)(1991-2#2)(1991-3#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-2#2)(1993-6#1)(1993-9#5)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#3)(1994-6#2)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#5)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#4)(1997-6#1)(1997-7#2)(1997-8#6)(2004-9#1)(2005-1#1)(2005-10#3)(2005-11#9)(2005-3#2)(2005-4#4)(2005-7#1)(2005-9#1)(2006-10#3)(2006-11#2)(2006-12#8)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#3)(2006-8#4)(2006-9#4)(2007-10#2)(2007-11#8)(2007-12#8)(2007-2#2)(2007-4#1)(2007-5#2)(2007-6#4)(2007-7#4)(2007-8#15)(2008-1#6)(2008-10#237)(2008-11#17)(2008-12#1)(2008-2#14)(2008-3#16)(2008-4#15)(2008-5#11)(2008-6#5)(2008-7#11)(2008-8#6)(2008-9#8)(2009-10#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#8)(2010-5#5)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#5)(2012-1#3)(2012-11#3)(2012-12#9)(2012-2#3)(2012-3#3)(2013-1#9)(2013-7#3)(2013-8#8)
used for their separation and##2##5##(2008-10#2)
used for their##9##3##(2006-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-9#1)
used for therapeutic##2##3##(2008-10#1)(2008-11#1)
used for these studies##4##4##(1991-12#1)(1994-9#1)(2008-10#1)(2008-8#1)
used for these##11##3##(1991-12#1)(1991-8#1)(1994-9#1)(2006-4#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-11#2)(2012-2#1)(2012-3#1)
used for this purpose##17##4##(1995-5#1)(1996-12#1)(2005-9#1)(2007-11#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-3#2)(2008-5#1)(2012-2#1)
used for this study##9##4##(1990-7#1)(1990-8#1)(1993-12#1)(1993-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-2#1)
used for this##46##3##(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-12#1)(1993-12#1)(1993-3#1)(1995-5#1)(1996-12#2)(1996-7#1)(2005-9#2)(2007-11#3)(2007-12#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#2)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
used for three-dimensional##2##3##(2008-3#1)(2013-8#1)
used for tissue engineering##3##4##(2007-9#1)(2012-11#2)
used for topical##2##3##(1993-11#1)(2006-12#1)
used for total##2##3##(2011-2#1)(2012-12#1)
used for traditional##2##3##(1997-2#1)(2009-5#1)
used for training##4##3##(2008-10#1)(2008-11#1)(2010-8#2)
used for transformation##2##3##(2008-10#1)(2008-11#1)
used for transient expression experiments##2##5##(1994-9#1)(1997-6#1)
used for transient##3##3##(1994-9#1)(1997-6#1)(2008-11#1)
used for transplantation##3##3##(1995-12#1)(2008-9#1)(2012-12#1)
used for transport##2##3##(1991-11#1)(2008-3#1)
used for trapping##2##3##(2008-10#1)(2008-2#1)
used for treating##14##3##(1992-3#1)(2005-8#1)(2006-10#1)(2006-12#2)(2007-4#1)(2008-10#1)(2009-8#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
used for treatment of patients with##2##6##(1993-9#1)(2007-8#1)
used for treatment of various##3##5##(1996-11#1)(2007-8#1)(2010-8#1)
used for treatment of##27##4##(1992-1#1)(1993-9#1)(1996-11#1)(2004-2#1)(2004-4#1)(2006-10#3)(2007-11#3)(2007-8#2)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-8#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-12#1)
used for treatment##29##3##(1992-1#1)(1993-9#1)(1996-11#1)(2004-2#1)(2004-4#1)(2006-10#3)(2007-11#3)(2007-8#2)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
used for tumor##2##3##(2008-8#1)(2010-2#1)
used for two##3##3##(1995-8#1)(2006-4#1)(2008-3#1)
used for validation##2##3##(2006-11#1)(2011-1#1)
used for various##3##3##(2006-10#1)(2008-5#2)
used for viral inactivation##2##4##(2008-1#1)(2011-3#1)
used for viral##3##3##(2008-1#1)(2008-8#1)(2011-3#1)
used for wave-front##2##3##(2008-3#2)
used for years##2##3##(2007-9#1)(2012-12#1)
used for##2532##2##(1990-10#1)(1990-11#5)(1990-12#6)(1990-2#5)(1990-3#2)(1990-4#2)(1990-5#6)(1990-7#2)(1990-8#8)(1990-9#2)(1991-10#2)(1991-11#3)(1991-12#4)(1991-2#2)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#3)(1991-8#2)(1991-9#3)(1992-1#5)(1992-12#4)(1992-2#3)(1992-3#5)(1992-4#5)(1992-5#4)(1992-6#3)(1992-7#4)(1992-8#7)(1992-9#5)(1993-1#2)(1993-11#4)(1993-12#3)(1993-2#5)(1993-3#4)(1993-4#3)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#9)(1994-1#1)(1994-11#5)(1994-12#2)(1994-2#5)(1994-3#9)(1994-5#4)(1994-6#8)(1994-7#1)(1994-8#2)(1994-9#6)(1995-1#1)(1995-11#3)(1995-12#7)(1995-2#5)(1995-3#2)(1995-4#3)(1995-5#2)(1995-6#1)(1995-7#2)(1995-8#4)(1995-9#1)(1996-1#3)(1996-11#4)(1996-12#11)(1996-2#6)(1996-3#5)(1996-4#3)(1996-5#8)(1996-6#4)(1996-7#6)(1996-8#6)(1996-9#5)(1997-1#3)(1997-2#10)(1997-3#11)(1997-4#6)(1997-5#2)(1997-6#7)(1997-7#3)(1997-8#8)(2004-10#1)(2004-11#2)(2004-12#1)(2004-2#1)(2004-4#5)(2004-8#1)(2004-9#9)(2005-1#1)(2005-10#8)(2005-11#19)(2005-12#7)(2005-3#4)(2005-4#8)(2005-7#3)(2005-8#5)(2005-9#3)(2006-1#1)(2006-10#27)(2006-11#4)(2006-12#30)(2006-2#2)(2006-3#1)(2006-4#7)(2006-5#10)(2006-6#10)(2006-7#8)(2006-8#12)(2006-9#6)(2007-1#4)(2007-10#14)(2007-11#51)(2007-12#76)(2007-2#14)(2007-3#4)(2007-4#7)(2007-5#3)(2007-6#11)(2007-7#29)(2007-8#53)(2007-9#11)(2008-1#34)(2008-10#594)(2008-11#69)(2008-12#19)(2008-2#95)(2008-3#121)(2008-4#92)(2008-5#53)(2008-6#20)(2008-7#40)(2008-8#35)(2008-9#35)(2009-1#1)(2009-10#10)(2009-11#4)(2009-12#3)(2009-2#7)(2009-3#12)(2009-4#3)(2009-5#7)(2009-6#4)(2009-7#3)(2009-8#13)(2009-9#4)(2010-1#3)(2010-10#4)(2010-11#9)(2010-12#28)(2010-2#13)(2010-3#6)(2010-4#18)(2010-5#14)(2010-6#6)(2010-7#6)(2010-8#20)(2010-9#9)(2011-1#36)(2011-12#5)(2011-2#49)(2011-3#2)(2012-1#16)(2012-10#2)(2012-11#20)(2012-12#40)(2012-2#26)(2012-3#15)(2013-1#63)(2013-7#15)(2013-8#27)
used form of##3##3##(1997-1#1)(2006-10#1)(2008-1#1)
used four##5##2##(2008-10#2)(2010-6#1)(2013-1#1)(2013-8#1)
used from a##2##3##(2009-12#1)(2009-7#1)
used from##6##2##(2008-10#1)(2008-5#1)(2009-12#1)(2009-7#1)(2010-6#1)(2013-8#1)
used functional magnetic resonance imaging (fMRI)##3##6##(2008-11#2)(2010-2#1)
used functional magnetic resonance imaging##4##5##(2008-11#2)(2008-9#1)(2010-2#1)
used functional magnetic##5##3##(2008-11#3)(2008-9#1)(2010-2#1)
used fungicide##2##2##(2007-8#1)(2008-10#1)
used gave##2##2##(1993-9#1)(2008-10#1)
used gene targeting##2##3##(1995-2#1)(1997-6#1)
used genetic and biochemical##2##4##(1995-8#1)(1996-9#1)
used globally##2##2##(2007-12#1)(2013-1#1)
used government health services##2##4##(2012-3#2)
used government health##3##3##(2012-3#3)
used had##3##2##(2008-10#1)(2009-7#1)(2012-3#1)
used has been##2##3##(2008-2#1)(2008-3#1)
used has##4##2##(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
used have##3##2##(2007-11#1)(2008-10#1)(2011-2#1)
used herbal medicines##2##3##(2006-8#1)(2007-11#1)
used herbal##3##2##(2006-8#2)(2007-11#1)
used herbs##2##2##(2006-12#1)(2008-10#1)
used here are##2##3##(2008-10#1)(2010-2#1)
used here for##2##3##(2007-8#1)(2008-3#1)
used here is##2##3##(2008-1#1)(2008-4#1)
used here to explore##2##4##(2006-2#1)(2010-8#1)
used here to##9##3##(1993-9#1)(2006-2#1)(2006-5#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-8#1)(2012-12#1)
used here was##2##3##(1993-1#1)(2012-3#1)
used here were##4##3##(2005-11#1)(2008-10#1)(2012-11#2)
used here##38##2##(1990-12#1)(1990-2#1)(1993-1#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-5#1)(2005-11#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2009-4#1)(2010-2#1)(2010-8#1)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#1)
used high##3##2##(2008-9#1)(2012-12#1)(2012-3#1)
used host##2##2##(1997-4#1)(2005-11#1)
used if the##2##3##(2010-12#1)(2011-2#1)
used if##7##2##(2008-1#1)(2008-2#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#2)
used illicit drug##4##3##(2006-8#1)(2008-1#1)(2008-4#1)(2013-7#1)
used illicit##5##2##(2006-8#1)(2008-1#1)(2008-4#1)(2013-7#1)(2013-8#1)
used imaging equipment##2##3##(1995-11#2)
used imaging##3##2##(1995-11#2)(2010-12#1)
used immunocytochemistry##2##2##(1995-11#1)(2008-7#1)
used implant##2##2##(2011-2#2)
used implants##2##2##(2011-2#2)
used in 24##2##3##(2007-8#1)(2008-8#1)
used in 7##3##3##(2007-7#1)(2008-7#1)(2012-2#1)
used in Ayurvedic##2##3##(2008-10#1)(2010-5#1)
used in CE##2##3##(1996-5#1)(2008-10#1)
used in India##5##3##(2007-6#1)(2007-7#2)(2008-4#1)(2011-1#1)
used in Indian##2##3##(2008-11#1)(2010-5#1)
used in Japan for##2##4##(2005-7#1)(2008-11#1)
used in Japan##8##3##(2005-7#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2010-12#1)(2010-6#1)
used in New Zealand##2##4##(2011-1#1)(2013-8#1)
used in PVC pipe production##2##5##(2008-10#2)
used in Study 1##2##4##(2005-10#1)(2007-9#1)
used in Western##2##3##(1995-12#1)(2007-2#1)
used in a cell##2##4##(1996-2#1)(2008-10#1)
used in a model for##2##5##(1996-3#1)(2008-7#1)
used in a model##5##4##(1996-3#1)(1996-4#1)(2007-10#1)(2008-3#1)(2008-7#1)
used in a multiplex##2##4##(2008-10#2)
used in a new##4##4##(2007-12#1)(2008-10#2)(2008-2#1)
used in a number of##3##5##(2008-4#1)(2008-7#1)(2012-11#1)
used in a simple##2##4##(1996-11#1)(2008-10#1)
used in a standard##2##4##(1996-12#1)(2007-12#1)
used in a study of##2##5##(2008-6#1)(2009-4#1)
used in a study##3##4##(2008-2#1)(2008-6#1)(2009-4#1)
used in a variety of applications##2##6##(1996-1#1)(2007-8#1)
used in a variety of##8##5##(1996-1#1)(1997-3#1)(2006-8#1)(2007-8#1)(2008-2#1)(2008-4#1)(2010-1#1)(2010-4#1)
used in a##121##3##(1993-6#1)(1994-3#1)(1994-5#2)(1995-2#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-3#1)(2004-10#1)(2004-2#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-8#2)(2007-10#2)(2007-11#3)(2007-12#8)(2007-8#1)(2007-9#1)(2008-10#30)(2008-11#1)(2008-12#1)(2008-2#9)(2008-3#8)(2008-4#6)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-4#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-11#2)(2012-12#1)(2012-2#2)(2013-7#4)(2013-8#1)
used in about##2##3##(2006-2#1)(2007-7#1)
used in acute##2##3##(2005-10#1)(2007-10#1)
used in addition to the##2##5##(2008-2#1)(2012-1#1)
used in addition to##5##4##(2007-7#1)(2008-2#1)(2008-5#2)(2012-1#1)
used in adults##3##3##(2006-10#1)(2008-8#1)(2009-4#1)
used in advanced##2##3##(2007-10#1)(2008-7#1)
used in agriculture##3##3##(1995-11#1)(2008-5#1)(2009-3#1)
used in all cases##3##4##(1994-2#1)(1996-2#1)(2006-6#1)
used in all patients##3##4##(2006-8#1)(2008-4#1)(2011-12#1)
used in all##22##3##(1994-10#1)(1994-2#1)(1996-2#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-4#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-9#1)(2011-12#1)(2011-2#2)(2011-7#1)
used in an attempt to##2##5##(1994-5#1)(2011-1#1)
used in an##23##3##(1990-3#1)(1992-8#1)(1993-4#1)(1994-11#1)(1994-5#1)(1995-2#1)(1996-9#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-4#1)(2008-10#6)(2008-3#3)(2010-12#1)(2011-1#1)(2012-3#1)
used in analysis##2##3##(1997-1#1)(2013-1#1)
used in apple breeding programs##2##5##(2008-10#2)
used in approximately##3##3##(2007-11#1)(2008-1#1)(2010-1#1)
used in assessing##2##3##(2007-7#1)(2008-7#1)
used in association with##5##4##(2008-10#1)(2008-5#1)(2008-6#1)(2010-4#1)(2013-8#1)
used in association##6##3##(2008-10#2)(2008-5#1)(2008-6#1)(2010-4#1)(2013-8#1)
used in attenuated##2##3##(2005-11#1)(2007-11#1)
used in basic##2##3##(1997-4#1)(2013-1#1)
used in biochemical##2##3##(1992-2#1)(2011-3#1)
used in biological##3##3##(1995-12#1)(2008-4#1)(2008-9#1)
used in biomedical applications##2##4##(2007-12#1)(2010-2#1)
used in biomedical##5##3##(1994-8#1)(2007-12#1)(2010-2#1)(2010-8#1)(2013-7#1)
used in bone##3##3##(2008-5#1)(2010-12#1)(2013-7#1)
used in both the##2##4##(1995-6#1)(1996-4#1)
used in both##9##3##(1992-12#1)(1993-1#1)(1995-6#1)(1996-4#1)(2006-10#1)(2007-12#1)(2008-10#1)(2012-2#1)(2013-1#1)
used in cancer##3##3##(1995-8#1)(2007-11#1)(2008-8#1)
used in case of##3##4##(1993-7#1)(1996-3#1)(2009-2#1)
used in cases of##3##4##(1991-4#1)(2004-10#1)(2008-2#1)
used in cases##4##3##(1990-11#1)(1991-4#1)(2004-10#1)(2008-2#1)
used in cell##2##3##(2008-9#1)(2012-1#1)
used in clinical practice for##2##5##(2008-9#1)(2011-1#1)
used in clinical practice in##3##5##(2008-1#1)(2008-2#1)(2009-10#1)
used in clinical practice##17##4##(2007-11#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-12#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
used in clinical studies##3##4##(2010-7#1)(2010-8#1)(2012-2#1)
used in clinical trials and##2##5##(2008-5#1)(2010-12#1)
used in clinical trials for##4##5##(1993-11#1)(2006-10#1)(2012-11#2)
used in clinical trials in##2##5##(2007-11#1)(2008-8#1)
used in clinical trials##11##4##(1993-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)(2012-11#2)(2012-3#1)
used in clinical##46##3##(1990-10#1)(1992-3#1)(1993-11#1)(1994-6#1)(1996-2#1)(2006-10#2)(2006-8#2)(2007-10#1)(2007-11#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2010-11#1)(2010-12#3)(2010-7#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)
used in clinics##3##3##(2010-5#1)(2012-11#2)
used in cognitive##2##3##(2011-12#1)(2013-7#1)
used in combination to##4##4##(2007-11#2)(2010-11#1)(2013-8#1)
used in combination with a##6##5##(2007-12#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)
used in combination with bisphosphonates##2##5##(2008-8#1)(2010-4#1)
used in combination with other##6##5##(2005-7#1)(2005-8#1)(2009-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
used in combination with the##5##5##(1992-1#1)(1996-10#1)(2008-2#1)(2010-12#1)(2013-8#1)
used in combination with##52##4##(1991-4#1)(1991-7#1)(1992-1#1)(1993-11#1)(1993-3#1)(1993-9#1)(1996-10#1)(1996-12#1)(1996-9#1)(2005-7#1)(2005-8#2)(2007-11#2)(2007-12#3)(2008-10#4)(2008-2#4)(2008-5#2)(2008-7#2)(2008-8#2)(2009-6#2)(2010-1#1)(2010-12#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2013-1#4)(2013-7#1)(2013-8#3)
used in combination##68##3##(1991-4#1)(1991-7#1)(1992-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-11#2)(1996-10#1)(1996-12#1)(1996-9#1)(2005-7#2)(2005-8#2)(2006-9#1)(2007-11#7)(2007-12#3)(2008-10#5)(2008-11#1)(2008-2#4)(2008-5#2)(2008-7#2)(2008-8#3)(2009-6#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2013-1#4)(2013-7#1)(2013-8#4)
used in comparative##2##3##(2008-10#1)(2012-1#1)
used in complementary##2##3##(2006-7#1)(2008-10#1)
used in conducting##2##3##(2010-3#1)(2013-8#1)
used in conjunction with a##6##5##(1992-9#1)(2008-10#2)(2008-3#2)(2012-1#1)
used in conjunction with an##4##5##(1996-2#1)(2007-12#1)(2008-3#1)(2008-4#1)
used in conjunction with other##6##5##(2005-11#1)(2007-8#1)(2008-4#2)(2008-8#1)(2010-12#1)
used in conjunction with the##7##5##(1992-5#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)
used in conjunction with##66##4##(1990-12#1)(1991-11#1)(1992-5#1)(1992-9#1)(1994-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#6)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#4)(2009-12#1)(2010-12#1)(2010-2#2)(2012-1#1)(2012-2#1)
used in connection with##3##4##(2008-10#3)
used in conventional##6##3##(2004-9#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)
used in cosmetics##3##3##(2008-5#3)
used in current##3##3##(2008-2#2)(2011-2#1)
used in daily practice##2##4##(2011-1#1)(2013-1#1)
used in daily##3##3##(2006-3#1)(2011-1#1)(2013-1#1)
used in dental##2##3##(2006-2#1)(2009-2#1)
used in dentistry##3##3##(2009-12#1)(2009-8#1)(2012-12#1)
used in designing##3##3##(2008-3#2)(2012-3#1)
used in detection##2##3##(2004-2#1)(2010-3#1)
used in determination of nickel and##2##6##(2008-10#2)
used in determination of##4##4##(2007-8#1)(2008-10#3)
used in developing and##2##4##(1997-3#1)(1997-7#1)
used in developing the##2##4##(1994-2#1)(2012-3#1)
used in developing##6##3##(1994-2#1)(1997-3#1)(1997-7#1)(2008-10#1)(2009-5#1)(2012-3#1)
used in diabetes##2##3##(2010-7#2)
used in diagnosing##2##3##(2012-12#1)(2012-2#1)
used in different studies##3##4##(2010-5#1)(2012-2#2)
used in different##10##3##(2007-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-2#2)
used in differential##2##3##(2008-2#1)(2012-3#1)
used in digital##2##3##(2008-2#1)(2008-9#1)
used in diverse##2##3##(1992-11#1)(2008-9#1)
used in dot blot##2##4##(2008-10#1)(2008-5#1)
used in drug##2##3##(2005-10#1)(2008-11#1)
used in each case##2##4##(2006-8#1)(2007-5#1)
used in each of##2##4##(2007-6#1)(2008-10#1)
used in each##11##3##(1994-3#1)(2006-8#1)(2007-5#1)(2007-6#1)(2008-10#4)(2008-2#1)(2008-6#1)(2010-6#1)
used in elderly##2##3##(1991-4#1)(1997-5#1)
used in epidemiology##2##3##(1994-3#1)(1997-6#1)
used in estimating the##2##4##(2008-2#1)(2012-2#1)
used in estimating##3##3##(2008-2#1)(2008-4#1)(2012-2#1)
used in evaluating##2##3##(2007-4#1)(2008-4#1)
used in evaluation of##2##4##(1992-2#1)(2011-1#1)
used in every##5##3##(1990-3#1)(2007-10#1)(2007-12#2)(2008-8#1)
used in everyday##2##3##(1997-3#2)
used in experimental studies##2##4##(2008-5#1)(2008-8#1)
used in experimental##3##3##(2008-5#1)(2008-8#1)(2008-9#1)
used in fermentation##3##3##(2008-6#2)(2008-8#1)
used in flow##3##3##(2008-10#1)(2008-9#2)
used in folk medicine##3##4##(2007-1#1)(2007-12#1)(2008-10#1)
used in folklore medicine##2##4##(2012-2#1)(2013-7#1)
used in food##7##3##(1994-3#1)(2005-7#1)(2008-10#1)(2008-6#1)(2012-1#1)(2012-2#1)(2012-3#1)
used in four##2##3##(2007-2#1)(2008-4#1)
used in general##2##3##(2007-8#1)(2008-9#1)
used in generation of##2##4##(1992-12#2)
used in health care##3##4##(1996-12#1)(2008-11#1)(2008-2#1)
used in health##7##3##(1996-12#1)(2008-11#1)(2008-2#1)(2011-1#1)(2012-3#1)(2013-1#2)
used in hemodialysis##2##3##(2007-7#1)(2008-10#1)
used in high##4##3##(2007-11#1)(2008-12#1)(2012-12#1)(2013-7#1)
used in human##3##3##(2006-3#1)(2011-1#1)(2011-2#1)
used in identifying##2##3##(1992-1#1)(2012-3#1)
used in image##3##3##(2008-2#2)(2008-3#1)
used in immunoassays##2##3##(2008-10#1)(2008-5#1)
used in immunohistochemical##2##3##(1990-7#1)(1992-8#1)
used in immunology##2##3##(2008-4#2)
used in in##2##3##(2008-3#1)(2008-4#1)
used in industrial##2##3##(2008-1#1)(2008-6#1)
used in industry##5##3##(1994-12#1)(1994-3#1)(2008-11#1)(2008-9#1)(2011-1#1)
used in infants and children##2##5##(1992-3#1)(2010-5#1)
used in integrated##2##3##(2008-3#2)
used in interventional##2##3##(2006-8#1)(2008-11#1)
used in isolation##5##3##(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-6#1)
used in its##6##3##(1991-4#1)(2005-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2012-1#1)
used in laboratory##3##3##(2008-10#1)(2008-4#2)
used in less##2##3##(2006-9#1)(2007-10#1)
used in low##2##3##(1996-9#1)(2007-8#1)
used in managing##2##3##(2006-8#1)(2007-7#1)
used in many fields##2##4##(2009-7#1)(2010-5#1)
used in many##13##3##(1996-9#1)(1997-4#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-7#1)(2010-2#1)(2010-5#1)(2010-8#1)(2013-7#1)
used in mate##3##3##(2008-8#1)(2008-9#1)(2009-4#1)
used in measuring##4##3##(1997-1#1)(2008-10#1)(2008-4#1)(2008-7#1)
used in mechanical##2##3##(2007-4#1)(2009-7#1)
used in medical##5##3##(1993-1#1)(1997-4#1)(2008-1#1)(2012-2#1)(2013-1#1)
used in medicine##4##3##(1995-2#1)(2004-9#1)(2007-3#1)(2009-2#1)
used in modern##3##3##(1996-2#1)(2008-2#1)(2008-3#1)
used in molecular biology##2##4##(1994-6#1)(2008-2#1)
used in molecular##3##3##(1994-6#1)(2008-2#1)(2012-3#1)
used in monitoring##2##3##(1997-6#1)(2007-2#1)
used in more##3##3##(2006-10#1)(2007-11#1)(2011-12#1)
used in most##4##3##(2006-11#1)(2007-8#1)(2010-3#1)(2012-3#1)
used in multiple##2##3##(2008-10#1)(2009-6#1)
used in nuclear##2##3##(2008-7#1)(2008-9#1)
used in oncology##3##3##(2010-2#1)(2011-1#2)
used in one##4##3##(2006-2#1)(2007-7#1)(2012-12#1)(2013-8#1)
used in ophthalmology##2##3##(2008-3#1)(2009-2#1)
used in optical##9##3##(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#2)(2010-12#1)
used in order to assess##2##5##(2007-2#1)(2008-12#1)
used in order to prevent##2##5##(1991-6#1)(2007-7#1)
used in order to##31##4##(1990-12#1)(1991-6#1)(1994-6#2)(1995-1#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#1)(2009-10#1)
used in other industries##2##4##(1995-12#2)
used in other##10##3##(1992-8#1)(1993-2#1)(1995-12#2)(2005-10#1)(2007-11#1)(2007-12#1)(2008-5#1)(2010-8#1)(2013-8#1)
used in our hospital##2##4##(1992-5#1)(2010-6#1)
used in our studies##2##4##(2008-11#1)(2011-1#1)
used in our study##2##4##(2006-8#1)(2008-3#1)
used in our##17##3##(1992-5#1)(1995-1#1)(2005-10#1)(2006-8#2)(2007-11#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-8#1)
used in paranasal sinus surgery##2##5##(2007-5#2)
used in part to##2##4##(1992-1#1)(2009-11#1)
used in patients undergoing##2##4##(2006-10#1)(2007-9#1)
used in patients with##15##4##(1990-3#1)(1993-2#1)(1995-6#1)(1996-11#1)(2005-12#1)(2006-10#3)(2007-11#3)(2007-7#1)(2008-1#1)(2009-8#1)(2011-1#1)
used in patients##20##3##(1990-3#1)(1991-4#1)(1993-2#1)(1995-6#1)(1996-11#1)(2005-12#1)(2006-10#4)(2007-11#3)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#1)(2009-8#1)(2010-12#1)(2011-1#1)
used in periodontal therapy##2##4##(2013-7#2)
used in pictorial works of art prior to conservation or restoration##2##11##(2008-10#2)
used in pictorial works of art##3##6##(2008-10#3)
used in place of the##3##5##(1990-4#1)(2008-10#1)(2012-2#1)
used in place of##5##4##(1990-4#1)(1994-12#1)(1994-9#1)(2008-10#1)(2012-2#1)
used in practice##7##3##(1994-9#1)(1996-2#1)(2007-12#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
used in pregnancy##5##3##(2006-10#2)(2008-8#2)(2010-2#1)
used in preparing the##2##4##(2007-5#1)(2008-10#1)
used in prevention of##3##4##(2008-1#1)(2011-3#1)(2012-3#1)
used in previous studies##4##4##(1994-12#1)(2010-4#1)(2012-12#1)(2012-2#1)
used in previous##5##3##(1994-12#1)(2008-9#1)(2010-4#1)(2012-12#1)(2012-2#1)
used in primary##3##3##(1996-9#1)(2012-12#1)(2013-8#1)
used in programs##2##3##(1996-12#1)(2008-11#1)
used in prophylaxis##2##3##(2007-2#1)(2013-8#1)
used in protein##3##3##(1996-8#1)(1997-6#1)(2008-4#1)
used in public health##2##4##(1995-6#1)(2012-12#1)
used in reaction##2##3##(2008-10#1)(2011-12#1)
used in reconstruction##2##3##(1992-5#1)(2008-2#1)
used in remote##2##3##(2007-5#1)(2008-2#1)
used in research and##2##4##(1995-12#1)(2010-8#1)
used in research##9##3##(1995-12#1)(1997-3#1)(2008-4#1)(2008-8#2)(2009-1#1)(2010-8#1)(2012-2#1)(2012-3#1)
used in restoration##2##3##(1991-1#1)(2008-5#1)
used in revision##2##3##(2009-3#1)(2009-7#1)
used in rice##3##3##(2008-10#1)(2008-4#1)(2009-10#1)
used in routine##3##3##(1997-2#1)(2007-11#1)(2013-1#1)
used in scientific##2##3##(2007-11#1)(2008-5#1)
used in selected cases##2##4##(2007-11#1)(2010-12#1)
used in several##8##3##(1995-4#1)(1997-7#1)(2007-3#1)(2007-8#1)(2008-7#2)(2011-2#1)(2013-1#1)
used in simulations##2##3##(2006-10#1)(2007-12#1)
used in situ hybridization##2##4##(1995-12#1)(1997-4#1)
used in situ##3##3##(1995-12#1)(1996-12#1)(1997-4#1)
used in six##2##3##(2006-6#1)(2007-8#1)
used in skin##2##3##(2009-6#1)(2012-3#1)
used in social##2##3##(1993-5#1)(2008-5#1)
used in solid##3##3##(1993-3#1)(2008-10#1)(2008-7#1)
used in some##3##3##(2008-10#1)(2011-2#2)
used in studies of the##2##5##(2007-11#1)(2008-4#1)
used in studies of##7##4##(1993-3#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-4#2)(2012-2#1)
used in studies##9##3##(1993-3#1)(1994-3#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-4#2)(2012-2#1)(2013-7#1)
used in subsequent##4##3##(2005-9#1)(2007-12#1)(2008-10#1)(2013-1#1)
used in such##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
used in surgery for##2##4##(1992-11#1)(2012-3#1)
used in surgery##4##3##(1992-11#1)(2007-8#1)(2009-2#1)(2012-3#1)
used in survey##2##3##(1994-2#1)(2008-10#1)
used in tandem##2##3##(2007-10#1)(2010-11#1)
used in that##2##3##(2007-12#1)(2008-2#1)
used in the ELISA##2##4##(1997-3#1)(2008-10#1)
used in the European##2##4##(2006-10#1)(2008-10#1)
used in the HI test##2##5##(2008-5#2)
used in the USA##3##4##(2008-2#1)(2010-12#1)(2011-2#1)
used in the United States to##2##6##(1993-7#1)(2006-10#1)
used in the United States##8##5##(1993-7#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-2#1)(2010-8#1)(2011-2#1)(2012-3#1)
used in the analysis of the##2##6##(1995-5#1)(2008-2#1)
used in the analysis of##8##5##(1990-2#1)(1995-5#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-12#1)
used in the analysis##17##4##(1990-2#1)(1992-3#1)(1994-2#2)(1995-5#1)(1997-8#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-12#1)(2012-6#1)
used in the application of##3##5##(1994-4#1)(2008-2#1)(2009-11#1)
used in the assay##6##4##(1990-11#1)(1991-4#1)(1992-4#1)(1992-6#1)(2008-10#1)(2008-4#1)
used in the calibration of##2##5##(2008-3#2)
used in the calibration##6##4##(2008-10#4)(2008-3#2)
used in the care of##2##5##(2006-1#1)(2006-10#1)
used in the case of##3##5##(1997-8#1)(2009-4#1)(2013-8#1)
used in the classification##2##4##(1993-7#1)(1994-3#1)
used in the clinic##4##4##(1992-3#1)(2008-11#1)(2008-7#1)(2009-2#1)
used in the clinical practice##3##5##(2008-10#1)(2010-3#1)(2013-1#1)
used in the clinical##5##4##(1992-7#1)(1994-6#1)(2008-10#1)(2010-3#1)(2013-1#1)
used in the community##3##4##(2008-11#1)(2008-2#1)(2009-3#1)
used in the construction of##5##5##(1990-3#1)(1995-2#1)(1997-4#1)(2007-11#1)(2008-8#1)
used in the context of##3##5##(2009-6#1)(2010-11#1)(2011-2#1)
used in the control of##3##5##(1990-11#1)(2007-11#1)(2013-7#1)
used in the creation of the##2##6##(1993-9#1)(2006-10#1)
used in the data analysis##3##5##(1990-3#1)(2008-10#1)(2008-6#1)
used in the design of##4##5##(2008-3#3)(2010-12#1)
used in the design##5##4##(2008-3#4)(2010-12#1)
used in the determination of##8##5##(2007-8#1)(2008-10#7)
used in the development of##6##5##(2005-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2010-8#1)
used in the diagnosis and##4##5##(1996-1#1)(2007-8#1)(2008-9#1)(2012-2#1)
used in the diagnosis of##10##5##(1990-10#1)(1992-10#1)(1994-2#1)(1995-12#1)(1996-12#1)(1997-8#1)(2007-7#1)(2010-12#1)(2011-2#1)(2012-12#1)
used in the diagnosis##14##4##(1990-10#1)(1992-10#1)(1994-2#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
used in the estimation##2##4##(2008-3#1)(2009-7#1)
used in the evaluation of the##2##6##(1990-5#1)(2010-9#1)
used in the evaluation of##6##5##(1990-5#1)(1993-2#1)(2010-10#1)(2010-9#1)(2013-1#2)
used in the examination##2##4##(1995-6#1)(2006-10#1)
used in the experiment##4##4##(2007-11#1)(2008-1#1)(2008-5#1)(2008-6#1)
used in the experiments##5##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-12#1)
used in the fabrication##2##4##(2008-10#1)(2008-2#1)
used in the field of##6##5##(2008-10#3)(2011-2#1)(2012-12#1)(2012-3#1)
used in the field##8##4##(1995-12#1)(2006-5#1)(2008-10#3)(2011-2#1)(2012-12#1)(2012-3#1)
used in the final##2##4##(1996-1#1)(2013-1#1)
used in the form of##2##5##(2010-8#1)(2013-8#1)
used in the future##6##4##(2006-10#1)(2006-12#1)(2008-10#1)(2008-3#1)(2012-12#1)(2012-6#1)
used in the hidden##6##4##(2008-10#4)(2010-8#2)
used in the human##2##4##(2007-4#1)(2008-10#1)
used in the identification of##3##5##(1995-11#1)(2011-2#1)(2012-2#1)
used in the identification##5##4##(1995-11#1)(2007-11#1)(2008-10#1)(2011-2#1)(2012-2#1)
used in the implementation##2##4##(2006-4#1)(2008-2#1)
used in the literature to describe##2##6##(2006-6#1)(2008-7#1)
used in the literature##4##4##(2006-6#1)(2008-7#1)(2008-9#1)(2011-1#1)
used in the majority of##2##5##(2008-4#1)(2011-2#1)
used in the management of##13##5##(1990-12#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-3#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#2)
used in the manufacture of##5##5##(1996-10#1)(1996-9#1)(2007-12#1)(2008-11#1)(2008-5#1)
used in the measurement##4##4##(2007-12#1)(2008-2#1)(2008-3#1)(2012-3#1)
used in the measurements##2##4##(2005-11#1)(2008-10#1)
used in the model##4##4##(2008-10#2)(2008-2#2)
used in the optimization##2##4##(2008-10#1)(2008-3#1)
used in the original##2##4##(2008-2#1)(2008-6#1)
used in the past to##2##5##(2006-10#1)(2008-3#1)
used in the past##7##4##(2006-10#1)(2006-3#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2010-3#1)
used in the polymerase chain reaction##2##6##(1991-9#1)(1996-11#1)
used in the potentiometric titration of Cu(2+) with EDTA##2##9##(2008-10#2)
used in the potentiometric titration of##4##6##(2008-10#4)
used in the preparation of##6##5##(2006-10#1)(2007-11#1)(2008-10#2)(2008-12#1)(2010-12#1)
used in the present study##4##5##(1991-9#1)(1992-9#1)(2008-5#1)(2013-8#1)
used in the present##8##4##(1991-9#1)(1992-9#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-5#1)(2013-8#1)
used in the prevention and treatment of##2##7##(2006-10#2)
used in the procedure##2##4##(2008-4#1)(2012-3#1)
used in the processing of##2##5##(2005-11#1)(2008-10#1)
used in the production of##6##5##(1994-6#1)(2005-11#1)(2008-5#1)(2008-8#1)(2008-9#2)
used in the recording##4##4##(2007-12#1)(2008-1#1)(2008-3#2)
used in the research##2##4##(2005-10#1)(2008-9#1)
used in the same sample treatment)##2##6##(2008-10#2)
used in the same##5##4##(2008-1#1)(2008-10#2)(2008-2#1)(2009-12#1)
used in the sample##2##4##(2008-10#1)(2012-12#1)
used in the second step##2##5##(1994-3#1)(2008-10#1)
used in the separation##2##4##(2008-10#2)
used in the solid-phase##2##4##(1991-10#1)(2008-1#1)
used in the statistical##2##4##(1990-8#1)(2011-2#1)
used in the studies##2##4##(1996-5#1)(1996-9#1)
used in the study of##7##5##(1996-3#1)(2005-4#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-4#2)
used in the study##24##4##(1990-6#1)(1996-1#1)(1996-3#1)(1996-8#1)(2005-4#1)(2006-10#1)(2007-10#3)(2007-11#1)(2007-7#1)(2008-10#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-3#1)(2010-5#1)(2010-8#1)(2013-1#1)
used in the surgery##3##4##(1996-11#1)(2008-6#1)(2009-2#1)
used in the synthesis of##3##5##(1990-8#1)(2007-11#1)(2009-3#1)
used in the system##3##4##(2007-12#1)(2013-1#2)
used in the traditional medicine in##2##6##(2008-10#2)
used in the traditional##3##4##(2008-10#3)
used in the treatment of Parkinson's disease##4##7##(1992-3#1)(1995-12#1)(1996-3#1)(2008-10#1)
used in the treatment of acute##4##6##(1992-2#1)(1996-3#1)(2006-9#1)(2007-10#1)
used in the treatment of postmenopausal osteoporosis##2##7##(2008-8#1)(2012-2#1)
used in the treatment of schizophrenia##2##6##(2010-7#1)(2011-1#1)
used in the treatment of several##3##6##(2008-12#1)(2009-10#1)(2010-11#1)
used in the treatment of##77##5##(1990-3#2)(1990-9#1)(1992-2#1)(1992-3#1)(1992-6#2)(1993-4#1)(1994-5#1)(1995-11#2)(1995-12#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-3#3)(1997-1#1)(1997-2#1)(2005-10#3)(2005-7#1)(2006-10#1)(2006-12#2)(2006-3#1)(2006-9#2)(2007-10#3)(2007-11#5)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-10#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
used in the treatment##78##4##(1990-3#2)(1990-9#1)(1992-2#1)(1992-3#1)(1992-6#2)(1993-4#1)(1994-5#1)(1995-11#2)(1995-12#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-3#3)(1997-1#1)(1997-2#1)(2005-10#3)(2005-7#1)(2006-10#1)(2006-12#2)(2006-3#1)(2006-9#2)(2007-10#3)(2007-11#5)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-10#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
used in the two##2##4##(1990-4#1)(2008-7#1)
used in the vehicles##2##4##(2010-5#2)
used in the##643##3##(1990-10#1)(1990-11#4)(1990-12#5)(1990-2#2)(1990-3#6)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#4)(1992-4#1)(1992-6#5)(1992-7#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#2)(1994-4#1)(1994-5#2)(1994-6#4)(1994-7#1)(1995-1#1)(1995-11#3)(1995-12#3)(1995-2#1)(1995-5#2)(1995-6#4)(1995-7#1)(1995-8#1)(1996-1#3)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#4)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#4)(2004-7#1)(2004-9#1)(2005-10#4)(2005-11#8)(2005-12#1)(2005-4#2)(2005-7#1)(2005-9#2)(2006-1#1)(2006-10#12)(2006-12#4)(2006-3#2)(2006-4#7)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#3)(2007-1#1)(2007-10#8)(2007-11#21)(2007-12#10)(2007-2#2)(2007-4#2)(2007-6#3)(2007-7#6)(2007-8#13)(2007-9#2)(2008-1#8)(2008-10#104)(2008-11#14)(2008-12#6)(2008-2#22)(2008-3#32)(2008-4#14)(2008-5#16)(2008-6#8)(2008-7#7)(2008-8#6)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#4)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#8)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#6)(2010-6#2)(2010-7#1)(2010-8#13)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#18)(2012-1#1)(2012-11#1)(2012-12#11)(2012-2#7)(2012-3#10)(2012-6#2)(2013-1#16)(2013-7#4)(2013-8#8)
used in their##2##3##(1997-9#1)(2007-11#1)
used in therapy##3##3##(1994-12#1)(2011-2#1)(2012-2#1)
used in these experiments##5##4##(1994-9#1)(1995-9#1)(2008-10#2)(2008-3#1)
used in these patients##3##4##(2006-10#1)(2007-9#1)(2011-2#1)
used in these studies##6##4##(1992-11#1)(1992-5#1)(1996-10#1)(2008-11#1)(2008-9#1)(2009-8#1)
used in these trials##2##4##(2006-10#1)(2007-11#1)
used in these##28##3##(1992-11#1)(1992-5#1)(1994-9#1)(1995-9#1)(1996-10#1)(2006-10#2)(2006-7#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
used in this experiment##5##4##(1996-3#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
used in this field##5##4##(2008-10#2)(2010-11#1)(2012-12#2)
used in this investigation to##2##5##(1991-10#1)(2008-10#1)
used in this investigation##5##4##(1991-10#1)(1991-4#1)(2008-10#1)(2008-11#1)(2008-8#1)
used in this manual##6##4##(2008-4#3)(2008-9#3)
used in this method##4##4##(2008-10#2)(2008-2#1)(2008-4#1)
used in this paper##2##4##(2005-4#1)(2013-1#1)
used in this research##3##4##(2008-3#1)(2009-7#1)(2010-4#1)
used in this study is##2##5##(2008-5#1)(2009-12#1)
used in this study should##2##5##(1996-8#1)(2006-12#1)
used in this study to##3##5##(1996-12#1)(2005-11#1)(2011-2#1)
used in this study was##5##5##(2006-8#1)(2008-12#1)(2008-5#2)(2010-9#1)
used in this study were##5##5##(1990-10#1)(1995-11#1)(1997-8#1)(2007-3#1)(2008-5#1)
used in this study##84##4##(1990-10#1)(1990-7#1)(1992-10#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-5#2)(1996-8#2)(1997-8#2)(2005-11#3)(2006-11#1)(2006-12#1)(2006-5#2)(2006-8#1)(2007-1#2)(2007-11#1)(2007-2#1)(2007-3#1)(2007-6#1)(2008-10#7)(2008-11#1)(2008-12#5)(2008-2#1)(2008-3#3)(2008-5#8)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-2#2)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-11#2)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#2)
used in this unit##2##4##(2008-1#1)(2008-4#1)
used in this work and##2##5##(1996-11#1)(2008-10#1)
used in this work##9##4##(1992-7#1)(1996-11#1)(2006-8#1)(2008-10#6)
used in this##143##3##(1990-10#1)(1990-7#1)(1991-10#1)(1991-4#1)(1992-10#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-8#2)(1997-8#2)(2005-11#4)(2005-4#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#2)(2006-8#3)(2007-1#2)(2007-11#3)(2007-12#2)(2007-2#1)(2007-3#2)(2007-6#1)(2008-1#1)(2008-10#20)(2008-11#2)(2008-12#6)(2008-2#4)(2008-3#5)(2008-4#5)(2008-5#8)(2008-7#3)(2008-8#4)(2008-9#4)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-11#1)(2010-2#2)(2010-4#3)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-10#1)(2012-11#2)(2012-12#4)(2012-3#3)(2013-1#3)(2013-7#2)
used in those##2##3##(1990-3#1)(2006-10#1)
used in three##2##3##(2007-8#1)(2008-11#1)
used in tissue engineering##2##4##(2008-5#1)(2012-2#1)
used in traditional Chinese medicine##2##5##(1992-2#1)(2008-10#1)
used in traditional medicine##2##4##(2010-2#1)(2013-1#1)
used in traditional##4##3##(1992-2#1)(2008-10#1)(2010-2#1)(2013-1#1)
used in transmission##2##3##(2008-2#1)(2008-3#1)
used in treatment of##6##4##(2007-11#2)(2008-4#1)(2010-12#1)(2011-2#1)(2012-3#1)
used in treatment##8##3##(2007-11#2)(2008-4#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
used in two##5##3##(2004-1#1)(2006-4#1)(2008-2#1)(2008-5#1)(2010-8#1)
used in typical##3##3##(1994-6#1)(2004-9#1)(2010-5#1)
used in vaccine##2##3##(2004-12#1)(2012-2#1)
used in various##10##3##(2006-6#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-9#2)(2009-3#1)(2012-12#1)
used in vascular##2##3##(1990-9#1)(2007-10#1)
used in vitro transcription##3##4##(1990-12#1)(1993-5#1)(1994-9#1)
used in vitro##10##3##(1990-12#1)(1992-8#1)(1993-5#1)(1994-9#1)(1997-5#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-3#1)(2012-2#1)
used in vivo##6##3##(1991-6#1)(1995-2#1)(2008-6#1)(2010-7#1)(2012-2#2)
used in which##4##3##(1992-6#1)(1995-3#1)(2008-2#1)(2008-3#1)
used in##2472##2##(1990-10#4)(1990-11#7)(1990-12#8)(1990-2#2)(1990-3#12)(1990-4#3)(1990-5#1)(1990-6#5)(1990-7#2)(1990-8#3)(1990-9#5)(1991-1#2)(1991-10#3)(1991-11#3)(1991-12#5)(1991-2#2)(1991-3#2)(1991-4#11)(1991-5#1)(1991-6#2)(1991-7#3)(1991-9#3)(1992-1#3)(1992-10#2)(1992-11#5)(1992-12#5)(1992-2#8)(1992-3#6)(1992-4#3)(1992-5#6)(1992-6#9)(1992-7#3)(1992-8#9)(1992-9#3)(1993-1#4)(1993-10#1)(1993-11#4)(1993-12#5)(1993-2#6)(1993-3#7)(1993-4#2)(1993-5#5)(1993-6#3)(1993-7#3)(1993-8#1)(1993-9#3)(1994-1#2)(1994-10#1)(1994-11#4)(1994-12#9)(1994-2#8)(1994-3#12)(1994-4#1)(1994-5#6)(1994-6#10)(1994-7#1)(1994-8#3)(1994-9#5)(1995-1#5)(1995-11#5)(1995-12#12)(1995-2#7)(1995-3#2)(1995-4#2)(1995-5#2)(1995-6#10)(1995-7#1)(1995-8#5)(1995-9#2)(1996-1#5)(1996-10#3)(1996-11#6)(1996-12#10)(1996-2#10)(1996-3#9)(1996-4#3)(1996-5#6)(1996-6#7)(1996-7#2)(1996-8#6)(1996-9#8)(1997-1#6)(1997-2#6)(1997-3#10)(1997-4#7)(1997-5#3)(1997-6#4)(1997-7#6)(1997-8#11)(1997-9#1)(2004-1#1)(2004-10#2)(2004-12#1)(2004-2#3)(2004-4#1)(2004-7#1)(2004-9#5)(2005-1#1)(2005-10#15)(2005-11#16)(2005-12#3)(2005-4#3)(2005-5#1)(2005-7#8)(2005-8#4)(2005-9#4)(2006-1#1)(2006-10#44)(2006-11#9)(2006-12#11)(2006-2#5)(2006-3#6)(2006-4#11)(2006-5#7)(2006-6#10)(2006-7#8)(2006-8#21)(2006-9#7)(2007-1#7)(2007-10#24)(2007-11#76)(2007-12#54)(2007-2#11)(2007-3#5)(2007-4#7)(2007-5#6)(2007-6#9)(2007-7#30)(2007-8#43)(2007-9#10)(2008-1#25)(2008-10#320)(2008-11#54)(2008-12#23)(2008-2#90)(2008-3#112)(2008-4#75)(2008-5#69)(2008-6#27)(2008-7#48)(2008-8#45)(2008-9#43)(2009-1#1)(2009-10#5)(2009-11#3)(2009-12#9)(2009-2#13)(2009-3#10)(2009-4#8)(2009-5#6)(2009-6#8)(2009-7#11)(2009-8#7)(2009-9#5)(2010-1#7)(2010-10#5)(2010-11#14)(2010-12#28)(2010-2#15)(2010-3#10)(2010-4#14)(2010-5#16)(2010-6#7)(2010-7#11)(2010-8#23)(2010-9#3)(2011-1#31)(2011-12#6)(2011-2#60)(2011-3#3)(2011-7#1)(2012-1#14)(2012-10#1)(2012-11#13)(2012-12#36)(2012-2#50)(2012-3#40)(2012-6#2)(2013-1#63)(2013-7#21)(2013-8#31)
used include##5##2##(1997-1#1)(2006-10#1)(2007-11#1)(2010-12#1)(2011-2#1)
used included##5##2##(1996-8#1)(2008-12#2)(2009-7#1)(2012-3#1)
used increasingly as a##2##4##(1994-7#1)(2008-7#1)
used increasingly for##5##3##(1992-5#1)(2006-6#1)(2007-10#1)(2011-2#1)(2012-1#1)
used increasingly in##2##3##(2006-10#1)(2008-10#1)
used increasingly##12##2##(1992-3#1)(1992-5#1)(1994-7#1)(1995-3#1)(2006-10#1)(2006-6#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-1#1)
used individually or in##2##4##(1996-1#1)(2009-4#1)
used individually or##3##3##(1996-1#1)(2008-10#1)(2009-4#1)
used individually##6##2##(1996-1#1)(2008-10#2)(2008-8#1)(2009-3#1)(2009-4#1)
used initially##2##2##(2004-2#1)(2010-12#1)
used instead of a##2##4##(2008-3#2)
used instead of the##3##4##(1990-11#1)(2008-3#1)(2011-2#1)
used instead of##28##3##(1990-11#1)(1995-12#1)(1997-7#1)(1997-8#2)(2005-8#1)(2006-2#1)(2006-5#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-3#4)(2008-4#3)(2008-7#1)(2008-8#1)(2010-12#1)(2010-7#1)(2011-2#3)(2013-8#1)
used instead##34##2##(1990-11#1)(1994-9#1)(1995-12#1)(1996-11#1)(1997-7#1)(1997-8#2)(2005-8#1)(2006-2#1)(2006-5#1)(2007-11#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-7#1)(2008-8#1)(2010-12#1)(2010-7#1)(2011-2#3)(2012-2#1)(2013-8#1)
used interchangeably##5##2##(2007-2#1)(2008-10#1)(2008-7#1)(2010-5#1)(2012-3#1)
used internal##2##2##(1991-2#1)(2008-9#1)
used intravenous##3##2##(1992-9#1)(2006-12#1)(2006-4#1)
used intravenously##2##2##(1990-4#1)(2008-4#1)
used is a##8##3##(2006-12#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#1)
used is based on the##2##5##(2007-12#1)(2008-10#1)
used is presented##2##3##(2008-2#1)(2008-3#1)
used is the##4##3##(1994-3#1)(2007-11#1)(2007-9#1)(2008-3#1)
used is##35##2##(1990-10#1)(1994-3#1)(1995-4#1)(1997-1#1)(2006-10#1)(2006-12#2)(2006-6#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#6)(2008-3#7)(2008-7#1)(2009-12#1)(2010-2#1)(2011-2#1)
used isolation##2##2##(1992-8#1)(2013-1#1)
used it as##2##3##(1994-6#1)(2008-8#1)
used it for##2##3##(1992-8#1)(2008-11#1)
used it to##10##3##(1991-12#1)(2007-12#1)(2007-3#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-12#1)(2010-8#1)(2012-3#1)
used it##17##2##(1991-12#1)(1992-8#1)(1993-3#1)(1994-6#1)(2007-12#1)(2007-3#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)
used laboratory##3##2##(1996-10#1)(2009-2#1)(2013-1#1)
used laser##2##2##(2008-2#1)(2008-9#1)
used less##3##2##(1991-10#1)(2006-6#1)(2011-2#1)
used local##3##2##(2006-12#1)(2012-3#2)
used logistic regression to##3##4##(1996-3#1)(2008-6#1)(2013-1#1)
used logistic regression##4##3##(1996-3#1)(2008-6#1)(2012-3#1)(2013-1#1)
used low##4##2##(2005-11#1)(2007-10#1)(2007-7#1)(2008-10#1)
used lubricating oil##2##3##(2008-10#2)
used lubricating oils by##3##4##(2008-10#3)
used lubricating oils##5##3##(2008-10#5)
used lubricating##7##2##(2008-10#7)
used mainly##5##2##(2007-11#1)(2008-5#1)(2008-8#1)(2009-2#1)(2011-2#1)
used male##2##2##(1990-5#1)(2011-2#1)
used many##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
used may##3##2##(2008-1#1)(2008-3#1)(2012-2#1)
used measures of##6##3##(2008-10#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-11#1)
used measures##8##2##(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-11#1)(2010-2#1)
used medications##3##2##(1996-7#1)(2007-8#1)(2008-3#1)
used medicinal##2##2##(1992-2#1)(2007-1#1)
used medicines classified##2##3##(2008-11#2)
used medicines##3##2##(2008-11#2)(2008-3#1)
used mental##2##2##(2009-7#1)(2013-8#1)
used method for the##2##4##(2008-4#1)(2011-1#1)
used method for##4##3##(2005-11#1)(2006-5#1)(2008-4#1)(2011-1#1)
used method in##2##3##(1995-2#1)(2008-2#1)
used method##13##2##(1995-1#1)(1995-2#1)(2004-11#1)(2005-11#1)(2005-7#1)(2006-12#1)(2006-5#1)(2008-2#1)(2008-4#2)(2008-9#1)(2011-1#1)(2013-8#1)
used methods and##3##3##(1997-8#1)(2008-10#2)
used methods for the analysis of##3##6##(1992-6#1)(1996-11#1)(1997-2#1)
used methods for##9##3##(1990-3#1)(1992-2#1)(1992-6#1)(1996-11#1)(1997-2#1)(2008-1#2)(2008-3#1)(2008-4#1)
used methods of##5##3##(2005-7#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-11#1)
used methods that##2##3##(2008-10#1)(2008-2#1)
used methods to##5##3##(2008-2#1)(2008-4#2)(2008-9#1)(2010-1#1)
used methods##33##2##(1990-3#1)(1991-9#1)(1992-2#1)(1992-6#1)(1996-11#1)(1997-2#1)(1997-8#1)(2004-9#1)(2005-7#1)(2006-12#1)(2008-1#2)(2008-10#7)(2008-2#3)(2008-3#1)(2008-4#4)(2008-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-2#1)
used mice##2##2##(1993-8#1)(2009-5#1)
used microdialysis##3##2##(1993-12#1)(1993-7#1)(1994-2#1)
used misoprostol##2##2##(2008-11#2)
used modalities##3##2##(1995-12#1)(2008-7#1)(2012-2#1)
used modality##3##2##(2006-7#1)(2012-12#1)(2012-3#1)
used model of##3##3##(1996-10#1)(2008-5#1)(2010-12#1)
used model##5##2##(1996-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-12#1)
used models##3##2##(1993-12#1)(2008-8#1)(2011-12#1)
used molecular##5##2##(1992-9#1)(2008-10#2)(2008-2#1)(2013-8#1)
used more and more in##2##5##(1996-9#1)(2008-5#1)
used more frequently in the##2##5##(2009-6#1)(2013-8#1)
used more frequently##5##3##(1991-2#1)(2008-4#1)(2009-6#1)(2010-6#1)(2013-8#1)
used more often##3##3##(2007-8#1)(2008-11#1)(2009-12#1)
used more recently##2##3##(2007-7#1)(2010-6#1)
used more than##2##3##(1994-6#1)(2006-2#1)
used more##22##2##(1991-2#1)(1994-6#1)(1996-9#1)(2006-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#2)(2009-6#1)(2010-6#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
used most commonly##2##3##(1995-3#1)(2010-2#1)
used most often##4##3##(1994-11#1)(1996-1#1)(1997-5#1)(2006-10#1)
used most##8##2##(1990-8#1)(1994-11#1)(1995-3#1)(1996-1#1)(1997-5#1)(2006-10#1)(2010-2#1)(2013-1#1)
used mouse strains##2##3##(2008-4#2)
used multiple##5##2##(1992-2#1)(2006-7#1)(2008-10#1)(2010-11#1)(2010-2#1)
used must be##2##3##(2010-12#1)(2011-2#1)
used new##2##2##(2008-10#1)(2011-2#1)
used next##2##2##(2007-9#1)(2008-10#1)
used no##5##2##(1992-2#1)(2011-2#1)(2013-1#3)
used nonsteroidal##2##2##(2006-10#1)(2012-1#1)
used not only as##7##4##(2008-10#1)(2008-2#1)(2008-8#1)(2013-8#4)
used not only for##2##4##(2011-1#1)(2011-2#1)
used not only in##3##4##(1990-5#1)(2006-6#1)(2007-11#1)
used not only to##4##4##(1991-5#1)(1995-1#1)(2008-10#1)(2008-4#1)
used not only##16##3##(1990-5#1)(1991-5#1)(1995-1#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-8#4)
used nuclear##3##2##(1993-11#1)(1997-5#1)(2008-7#1)
used of##4##2##(2004-1#1)(2005-9#1)(2008-8#1)(2013-1#1)
used on a regional basis##2##5##(2007-5#1)(2008-3#1)
used on a##13##3##(1991-8#1)(1994-12#1)(1997-3#1)(2007-12#1)(2007-5#1)(2008-12#1)(2008-2#2)(2008-3#2)(2010-4#1)(2012-12#1)(2013-7#1)
used on different##2##3##(1996-11#1)(2008-4#1)
used on each##3##3##(1996-12#1)(2007-6#1)(2013-1#1)
used on more##2##3##(2007-12#1)(2007-2#1)
used on the basis of##2##5##(2008-6#1)(2013-8#1)
used on the##8##3##(1992-12#1)(1994-12#1)(2006-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-6#1)(2013-8#1)
used on##62##2##(1990-3#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-4#1)(1993-2#1)(1994-12#2)(1994-5#1)(1995-5#1)(1996-11#1)(1996-12#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-12#2)(2006-5#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#2)(2009-6#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-12#1)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#2)
used once##2##2##(2008-11#1)(2008-5#1)
used one##6##2##(2006-6#1)(2008-10#2)(2010-1#1)(2011-2#1)(2012-1#1)
used ones##2##2##(1997-6#1)(2010-8#1)
used only a##2##3##(2009-10#1)(2012-2#1)
used only as##2##3##(1994-12#1)(2008-5#1)
used only for##6##3##(1990-12#2)(1993-6#1)(2008-1#1)(2008-10#1)(2011-2#1)
used only in the##2##4##(2007-11#2)
used only in##4##3##(1993-2#1)(2004-12#1)(2007-11#2)
used only##25##2##(1990-12#2)(1991-10#1)(1991-4#1)(1992-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1996-11#1)(2004-12#1)(2006-8#1)(2007-11#3)(2007-7#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-10#1)(2011-2#2)(2012-2#2)
used or##11##2##(2005-1#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-8#1)(2010-5#1)(2012-12#2)(2012-3#1)(2013-1#1)
used organic##2##2##(2008-10#1)(2008-5#1)
used our##3##2##(2007-8#1)(2011-2#1)(2012-12#1)
used over a period of 4 months with good reproducibility##2##10##(2008-10#2)
used over a period of##5##5##(2008-10#4)(2011-2#1)
used over a##9##3##(2007-11#1)(2008-10#6)(2008-3#1)(2011-2#1)
used over the##2##3##(1993-9#1)(2008-4#1)
used over##13##2##(1993-9#1)(2007-11#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-4#1)(2011-2#1)(2013-7#1)
used pacemakers##2##2##(1992-6#1)(1994-11#1)
used pesticides##2##2##(2008-10#2)
used plant##2##2##(2012-1#1)(2013-8#1)
used plants##3##2##(2007-11#1)(2012-12#1)(2013-8#1)
used polyacrylamide##3##2##(1990-5#1)(1991-10#1)(2008-10#1)
used polymerase chain reaction (PCR)##3##5##(1992-2#1)(1992-7#1)(2006-10#1)
used polymerase chain reaction##4##4##(1992-2#1)(1992-7#1)(1993-8#1)(2006-10#1)
used polystyrene##2##2##(2008-10#1)(2008-6#1)
used preoperatively##2##2##(1990-5#1)(1992-6#1)
used previously for##5##3##(1995-8#1)(1997-7#1)(2005-11#1)(2007-12#1)(2008-10#1)
used previously to##3##3##(2006-11#1)(2006-4#1)(2008-10#1)
used previously##14##2##(1992-8#1)(1993-2#1)(1995-8#1)(1997-7#1)(2005-11#1)(2006-11#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#1)(2011-3#1)
used primarily as a##2##4##(2008-8#1)(2008-9#1)
used primarily as##3##3##(2008-7#1)(2008-8#1)(2008-9#1)
used primarily for##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
used primarily in##2##3##(2004-1#1)(2008-5#1)
used primarily to##3##3##(1991-6#1)(2008-10#1)(2013-1#1)
used primarily##14##2##(1991-6#1)(1994-2#1)(1995-1#1)(2004-1#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
used prior to##6##3##(1992-2#1)(2007-8#1)(2008-10#3)(2010-8#1)
used procedure##2##2##(2008-10#1)(2008-4#1)
used productively##2##2##(1994-2#1)(1996-6#1)
used prophylactically in##2##3##(2007-11#1)(2013-1#1)
used protein##4##2##(2008-1#1)(2008-4#2)(2012-2#1)
used protocols##2##2##(2008-4#1)(2008-9#1)
used provides##2##2##(1992-8#1)(1996-12#1)
used psilocybin##2##2##(2013-8#2)
used qualitative methods to##2##4##(2008-6#1)(2012-3#1)
used qualitative##7##2##(2008-4#1)(2008-6#1)(2009-5#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
used quality##3##2##(1994-3#1)(1996-3#2)
used quantitative##5##2##(1995-11#1)(1996-4#1)(2008-12#1)(2008-8#1)(2012-3#1)
used random##2##2##(1991-1#1)(2011-1#1)
used rapidly##2##2##(1996-7#1)(2008-6#1)
used rat strains##2##3##(2008-4#2)
used rat##3##2##(1991-7#1)(2008-4#2)
used recently##2##2##(2008-3#1)(2013-8#1)
used recombinant##3##2##(1992-2#1)(2007-10#1)(2012-3#1)
used reference##2##2##(1996-10#1)(2008-5#1)
used repeatedly for the##2##4##(2008-10#1)(2008-6#1)
used repeatedly for##3##3##(2008-10#2)(2008-6#1)
used repeatedly##6##2##(2007-12#1)(2008-10#2)(2008-3#1)(2008-6#1)(2012-3#1)
used reverse transcription##2##3##(1994-6#1)(2010-5#1)
used reverse##4##2##(1994-11#1)(1994-6#1)(2010-5#1)(2013-8#1)
used rockwool##6##2##(2008-10#6)
used rodent##3##2##(2008-11#1)(2011-1#1)(2012-3#1)
used routinely in the##3##4##(1995-3#1)(2007-8#1)(2008-3#1)
used routinely in##7##3##(1992-1#1)(1995-3#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-9#1)(2012-12#1)
used routinely to##2##3##(2008-7#1)(2013-1#1)
used routinely##11##2##(1992-1#1)(1995-3#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#1)
used safely and##3##3##(2007-7#1)(2007-8#1)(2010-6#1)
used safely##6##2##(1995-7#1)(1995-8#1)(2007-7#1)(2007-8#1)(2010-6#1)(2012-12#1)
used satisfactorily for##2##3##(1996-2#1)(2008-10#1)
used scales##2##2##(2006-11#1)(2007-11#1)
used scanning##3##2##(1992-2#1)(2007-12#2)
used seem##2##2##(2007-8#1)(2011-1#1)
used selectively##3##2##(1993-1#1)(1996-3#1)(2007-8#1)
used separately##3##2##(2006-1#1)(2008-12#1)(2010-9#1)
used several complementary##2##3##(1995-3#1)(1997-8#1)
used several##6##2##(1994-9#1)(1995-3#1)(1995-6#1)(1997-8#1)(2007-12#1)(2009-9#1)
used should##2##2##(1995-12#1)(2007-4#1)
used showed##2##2##(2006-8#1)(2007-7#1)
used significantly##2##2##(2008-10#1)(2008-7#1)
used similar##3##2##(1990-10#1)(2006-2#1)(2008-5#1)
used simple##2##2##(2008-9#1)(2010-4#1)
used simulated##2##2##(1994-5#1)(2008-2#1)
used simulation##2##2##(2008-2#1)(2008-9#1)
used simultaneously##2##2##(2008-10#1)(2008-8#1)
used since an##2##3##(2007-10#1)(2011-2#1)
used since the early##2##4##(1995-4#1)(2007-11#1)
used since the##6##3##(1995-4#1)(2005-10#1)(2007-11#1)(2008-10#1)(2008-8#1)(2011-2#1)
used since##14##2##(1994-6#1)(1995-2#1)(1995-4#1)(2005-10#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#2)(2013-1#1)
used single##4##2##(1993-9#1)(2006-8#1)(2008-12#1)(2011-1#1)
used singly##2##2##(1994-11#1)(2008-2#1)
used site-directed mutagenesis to identify##2##5##(1994-11#1)(1994-9#1)
used site-directed mutagenesis to##3##4##(1994-11#1)(1994-9#1)(1995-5#1)
used site-directed mutagenesis##4##3##(1991-5#1)(1994-11#1)(1994-9#1)(1995-5#1)
used small##3##2##(2007-12#1)(2013-7#1)(2013-8#1)
used so far##2##3##(2006-2#1)(2007-11#1)
used so that##2##3##(2008-10#1)(2008-4#1)
used so##5##2##(2006-2#1)(2007-11#1)(2008-10#2)(2008-4#1)
used sodium##2##2##(1990-6#1)(1996-11#1)
used software##2##2##(2007-5#1)(2008-4#1)
used solely##3##2##(2008-9#1)(2011-2#1)(2011-3#1)
used solid##2##2##(2008-10#2)
used some##2##2##(2008-8#1)(2009-2#1)
used specific##3##2##(1996-5#1)(1997-5#2)
used specifically##2##2##(1996-8#1)(2006-10#1)
used spectral##2##2##(2007-11#1)(2008-3#1)
used standard##2##2##(2008-10#1)(2012-12#1)
used statistical##2##2##(2007-11#1)(2008-4#1)
used stereological morphometric methods to investigate##2##6##(2007-12#2)
used successfully for the##6##4##(1997-2#1)(2008-10#3)(2008-7#1)(2012-1#1)
used successfully for##13##3##(1996-12#1)(1997-2#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-7#1)(2009-3#1)(2012-1#1)
used successfully in the##8##4##(2007-11#1)(2007-2#1)(2008-10#3)(2008-4#1)(2009-10#1)(2009-4#1)
used successfully in##15##3##(1992-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#5)(2008-4#1)(2008-6#1)(2009-10#1)(2009-4#1)(2010-11#1)(2010-7#1)
used successfully to##21##3##(1996-4#1)(2005-10#1)(2005-7#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2010-2#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-7#1)
used successfully##55##2##(1992-10#1)(1992-12#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-5#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#11)(2008-11#1)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-2#1)(2010-7#1)(2010-8#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
used such##2##2##(2008-10#1)(2009-8#1)
used surface##2##2##(2005-11#1)(2008-6#1)
used synonymously##2##2##(2005-8#1)(2006-12#1)
used synthetic##3##2##(1990-12#1)(1993-4#1)(2008-6#1)
used systems##2##2##(2008-4#1)(2008-7#1)
used technique for measuring the##2##5##(2008-2#1)(2008-3#1)
used technique for##6##3##(2008-2#1)(2008-3#2)(2010-5#1)(2013-1#1)(2013-7#1)
used technique in##3##3##(2008-11#1)(2008-2#1)(2012-12#1)
used technique##15##2##(1996-8#1)(1997-6#1)(2007-7#1)(2008-11#1)(2008-2#2)(2008-3#2)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
used techniques##11##2##(1990-12#1)(2004-9#1)(2006-10#1)(2008-10#1)(2008-4#3)(2009-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
used test##4##2##(2008-5#2)(2009-4#1)(2012-12#1)
used tests to##2##3##(2008-10#1)(2008-8#1)
used tests##5##2##(1990-11#1)(1994-5#1)(2008-10#1)(2008-8#1)(2012-2#1)
used than##2##2##(2005-11#1)(2007-7#1)
used that##8##2##(2006-4#1)(2007-12#1)(2008-1#1)(2008-2#3)(2008-3#1)(2008-4#1)
used the comet assay##2##4##(1997-4#2)
used the emergency##2##3##(1995-9#1)(2007-2#1)
used the following##3##3##(2004-4#1)(2008-11#1)(2008-2#1)
used the in##2##3##(1994-8#1)(1996-2#1)
used the method of##3##4##(2005-4#1)(2011-2#1)(2012-3#1)
used the model system##2##4##(2008-11#1)(2008-9#1)
used the model to##2##4##(2007-12#1)(2010-6#1)
used the model##5##3##(1991-7#1)(2007-12#1)(2008-11#1)(2008-9#1)(2010-6#1)
used the polymerase chain reaction (PCR) to##2##7##(1991-6#1)(1993-4#1)
used the polymerase chain reaction (PCR)##4##6##(1991-6#1)(1993-4#1)(1994-7#1)(1997-4#1)
used the polymerase chain reaction##5##5##(1991-6#1)(1992-2#1)(1993-4#1)(1994-7#1)(1997-4#1)
used the radiolabelled##2##3##(1990-12#1)(1991-4#1)
used the results##2##3##(2008-8#1)(2012-3#1)
used the right##2##3##(1990-4#1)(1992-11#1)
used the same##11##3##(1994-1#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#1)(2011-2#1)(2013-7#1)(2013-8#1)
used the system in##2##4##(2007-8#1)(2012-1#1)
used the system##5##3##(1996-5#1)(2006-12#1)(2007-8#1)(2008-2#1)(2012-1#1)
used the##217##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#2)(1991-9#2)(1992-11#2)(1992-2#2)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-1#2)(1994-12#2)(1994-2#4)(1994-5#3)(1994-7#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#3)(1995-9#1)(1996-11#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-4#5)(1997-5#2)(1997-6#1)(1997-7#1)(2004-4#1)(2005-10#3)(2005-11#1)(2005-4#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#2)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#19)(2008-11#9)(2008-12#2)(2008-2#8)(2008-3#7)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#10)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#7)
used their##8##2##(1991-10#1)(2007-7#2)(2007-8#1)(2009-4#1)(2010-8#1)(2010-9#1)(2013-8#1)
used them to##2##3##(2010-7#1)(2013-1#1)
used them##6##2##(1991-3#1)(2007-7#1)(2008-7#1)(2008-8#1)(2010-7#1)(2013-1#1)
used therapeutic##3##2##(1990-6#1)(1995-2#1)(2007-7#1)
used therapeutically to##2##3##(1992-10#1)(2008-1#1)
used therapeutically##4##2##(1992-10#1)(1995-2#1)(2008-1#1)(2012-12#1)
used these data to##2##4##(1995-3#1)(2008-8#1)
used these methods##2##3##(1994-12#1)(2007-11#1)
used these results to##3##4##(1990-7#1)(1994-3#1)(2008-3#1)
used these##15##2##(1990-7#2)(1994-12#1)(1994-3#2)(1995-3#1)(1997-7#1)(2005-10#1)(2006-9#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-1#1)
used this information to##3##4##(1996-6#1)(2007-12#1)(2008-3#1)
used this method to##3##4##(1997-2#1)(1997-3#2)
used this method##5##3##(1997-2#1)(1997-3#2)(2007-8#1)(2008-3#1)
used this technique to##4##4##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
used this technique##6##3##(1990-6#1)(1991-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
used this##44##2##(1990-12#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-5#1)(1994-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-4#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-7#1)(2012-2#4)(2013-1#1)
used three different##2##3##(1996-3#1)(2005-11#1)
used three##7##2##(1992-12#1)(1995-1#1)(1996-3#1)(2005-11#1)(2008-10#1)(2013-8#2)
used three-dimensional##3##2##(2012-1#1)(2012-12#2)
used through the##2##3##(1992-1#1)(1995-1#1)
used through##4##2##(1992-1#1)(1995-1#1)(2008-7#1)(2013-1#1)
used throughout the##5##3##(1990-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)
used throughout##13##2##(1990-12#1)(1995-6#1)(1996-5#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#2)(2011-2#1)
used time##2##2##(2007-4#1)(2010-5#1)
used to &quot##3##3##(1993-5#1)(2013-1#2)
used to ablate##4##3##(1991-2#1)(2006-12#1)(2013-1#2)
used to absorb##2##3##(2007-4#1)(2008-9#1)
used to access##3##3##(2008-7#1)(2012-3#1)(2013-8#1)
used to account for##5##4##(1990-8#1)(2008-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
used to accurately##4##3##(1994-3#1)(2008-10#1)(2009-3#1)(2010-3#1)
used to achieve a##6##4##(1997-2#1)(2005-9#1)(2007-12#1)(2008-3#1)(2013-1#2)
used to achieve high##2##4##(2008-10#1)(2008-3#1)
used to achieve the##4##4##(2008-11#1)(2010-3#1)(2013-8#2)
used to achieve##32##3##(1991-6#1)(1995-3#1)(1997-2#1)(2005-11#1)(2005-9#1)(2007-1#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-10#5)(2008-11#2)(2008-3#3)(2008-8#1)(2009-3#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
used to acquire##3##3##(2006-2#1)(2008-3#1)(2008-5#1)
used to activate##2##3##(1990-8#1)(1997-1#1)
used to adapt##2##3##(2008-2#1)(2008-5#1)
used to address the##2##4##(2006-4#1)(2008-10#1)
used to address these problems##2##5##(2006-10#1)(2008-12#1)
used to address##11##3##(1994-2#1)(1995-8#1)(2006-10#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
used to adjust for##4##4##(2008-2#1)(2008-3#2)(2012-2#1)
used to adjust##7##3##(1992-6#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-3#2)(2012-2#1)
used to administer##3##3##(1991-3#2)(2006-7#1)
used to aid in##5##4##(2006-7#1)(2008-3#1)(2010-11#1)(2012-2#1)(2013-1#1)
used to aid##8##3##(2006-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-11#1)(2012-2#1)(2013-1#1)
used to alleviate the##2##4##(2007-8#1)(2008-11#1)
used to allow the##2##4##(2008-10#1)(2008-3#1)
used to allow##4##3##(2007-10#1)(2008-10#1)(2008-3#2)
used to alter the##2##4##(2008-3#1)(2008-7#1)
used to alter##3##3##(2008-3#1)(2008-7#1)(2009-2#1)
used to ameliorate the##2##4##(2008-5#1)(2010-7#1)
used to amplify a##5##4##(1992-8#1)(1993-8#1)(1995-3#1)(2008-10#2)
used to amplify the##8##4##(1991-7#1)(1996-5#1)(2008-10#3)(2008-8#1)(2009-4#1)(2012-12#1)
used to amplify##27##3##(1991-7#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-5#1)(1996-6#1)(2006-10#1)(2006-5#2)(2007-6#1)(2008-10#8)(2008-4#1)(2008-8#2)(2009-4#1)(2012-12#1)
used to analyse the##15##4##(1991-12#1)(1991-7#1)(1993-2#1)(1993-5#2)(1995-11#1)(1997-1#1)(1997-4#1)(2004-9#1)(2007-3#1)(2008-12#1)(2010-11#1)(2010-2#1)(2011-1#1)(2012-3#1)
used to analyse##28##3##(1991-12#1)(1991-7#1)(1993-2#1)(1993-5#3)(1995-11#1)(1997-1#1)(1997-4#1)(2004-9#1)(2006-10#1)(2007-3#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-3#1)
used to analyze 24##2##4##(2008-10#2)
used to analyze a##2##4##(2008-10#1)(2010-8#1)
used to analyze gene##2##4##(2010-1#1)(2012-11#1)
used to analyze the activity of##2##6##(1994-12#1)(2011-1#1)
used to analyze the data##6##5##(2007-10#1)(2008-10#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-1#1)
used to analyze the##40##4##(1991-8#1)(1992-1#1)(1993-6#1)(1994-12#1)(1995-3#1)(2007-10#2)(2007-12#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-8#4)(2009-4#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
used to analyze this##2##4##(2007-11#1)(2009-10#1)
used to analyze##91##3##(1990-11#1)(1991-8#1)(1992-1#1)(1993-6#1)(1994-12#1)(1995-3#1)(1996-2#1)(1996-5#1)(2006-10#1)(2006-3#1)(2006-4#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#16)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#10)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-12#2)(2010-2#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
used to answer##2##3##(1990-10#1)(2012-1#1)
used to apply##4##3##(2006-6#1)(2007-8#1)(2008-10#1)(2008-5#1)
used to approximate the##3##4##(1992-12#1)(2006-10#1)(2008-10#1)
used to argue##2##3##(1997-8#1)(2008-9#1)
used to articulate##2##3##(2008-5#1)(2012-2#1)
used to ascertain the##4##4##(1996-11#1)(2005-11#1)(2008-10#1)(2010-2#1)
used to ascertain##9##3##(1990-12#1)(1996-11#1)(2005-11#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-2#2)
used to assay the##2##4##(1997-4#1)(2008-4#1)
used to assay##6##3##(1996-12#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-4#1)
used to assemble the##3##4##(1990-9#1)(2007-12#1)(2008-4#1)
used to assess a##3##4##(2008-10#1)(2008-11#1)(2009-10#1)
used to assess and compare##2##5##(1993-5#1)(2007-4#1)
used to assess and##3##4##(1993-5#1)(2007-4#1)(2013-7#1)
used to assess differences in##3##5##(1995-1#1)(2008-10#1)(2013-1#1)
used to assess eating##2##4##(2006-7#1)(2009-2#1)
used to assess genetic##2##4##(2005-10#1)(2008-10#1)
used to assess its##2##4##(2008-11#2)
used to assess neuronal##2##4##(1990-7#1)(1996-12#1)
used to assess nutritional##2##4##(2007-7#1)(2013-1#1)
used to assess patterns of##2##5##(2007-8#1)(2008-11#1)
used to assess the ability of##2##6##(1991-12#1)(2008-11#1)
used to assess the effect of##6##6##(2007-8#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-12#2)
used to assess the growth of##2##6##(1996-3#1)(2008-10#1)
used to assess the impact of##7##6##(1990-5#1)(1992-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2013-1#2)
used to assess the presence of##2##6##(2007-2#1)(2010-1#1)
used to assess the##81##4##(1990-4#1)(1990-5#1)(1991-12#1)(1992-2#1)(1992-7#1)(1994-11#1)(1994-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-8#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-7#1)(2006-11#2)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#10)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2009-10#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#2)(2011-12#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
used to assess whether the##3##5##(2008-10#1)(2013-1#2)
used to assess##183##3##(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-6#1)(1992-2#1)(1992-7#1)(1993-1#1)(1993-2#1)(1993-4#1)(1993-5#1)(1994-11#1)(1994-2#1)(1995-1#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-7#1)(1997-2#1)(1997-8#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-5#1)(2005-7#1)(2006-10#1)(2006-11#2)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#2)(2007-4#3)(2007-7#4)(2007-8#3)(2007-9#3)(2008-1#2)(2008-10#19)(2008-11#9)(2008-3#3)(2008-4#4)(2008-5#11)(2008-6#3)(2008-7#6)(2008-9#3)(2009-10#2)(2009-11#1)(2009-2#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#3)(2010-5#4)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#4)(2012-3#4)(2013-1#10)(2013-7#3)(2013-8#2)
used to assign the##3##4##(1991-4#1)(1996-2#2)
used to assign##7##3##(1991-4#1)(1996-2#2)(1996-5#1)(2008-10#1)(2008-2#1)(2010-4#1)
used to assist in##2##4##(1996-2#1)(2008-10#1)
used to assist the##2##4##(2012-1#1)(2013-1#1)
used to assist##5##3##(1996-2#1)(2007-10#1)(2008-10#1)(2012-1#1)(2013-1#1)
used to attach##2##3##(2008-10#1)(2011-2#1)
used to attenuate##3##3##(2008-9#1)(2013-1#2)
used to attract##2##3##(2008-10#1)(2012-1#1)
used to augment the##3##4##(2006-3#1)(2013-1#2)
used to augment##4##3##(2006-3#1)(2010-8#1)(2013-1#2)
used to automatically##2##3##(2008-11#1)(2012-1#1)
used to avoid##5##3##(1991-9#1)(1995-7#1)(2007-11#1)(2010-7#2)
used to be considered##2##4##(2008-4#1)(2011-2#1)
used to be##9##3##(1990-7#1)(1996-11#1)(1996-3#1)(2007-8#1)(2008-12#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
used to better##7##3##(1994-2#1)(2006-12#1)(2008-6#1)(2009-7#1)(2011-1#1)(2013-1#2)
used to bind##4##3##(1992-6#1)(2008-10#1)(2008-5#1)(2008-8#1)
used to block##2##3##(2008-11#1)(2008-2#1)
used to both##4##3##(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
used to build a##2##4##(2006-5#1)(2008-10#1)
used to build thin##2##4##(2008-10#1)(2008-5#1)
used to build##7##3##(2006-5#1)(2008-10#3)(2008-5#1)(2010-5#1)(2011-1#1)
used to calculate the forces and##2##6##(2008-2#1)(2008-3#1)
used to calculate the relative##2##5##(1996-1#1)(2008-10#1)
used to calculate the##57##4##(1992-2#1)(1992-4#1)(1996-1#1)(1997-2#1)(1997-7#1)(2005-11#2)(2006-10#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#10)(2008-4#1)(2008-5#2)(2008-7#1)(2009-7#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#1)(2013-8#1)
used to calculate transition##2##4##(2008-2#1)(2008-3#1)
used to calculate##93##3##(1990-4#1)(1990-5#1)(1992-2#1)(1992-4#1)(1992-5#1)(1993-11#1)(1994-12#1)(1995-5#1)(1995-9#1)(1996-1#1)(1997-2#1)(1997-7#1)(2004-11#1)(2005-11#2)(2006-10#2)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#15)(2008-11#5)(2008-12#1)(2008-2#9)(2008-3#16)(2008-4#1)(2008-5#3)(2008-7#2)(2009-6#1)(2009-7#2)(2009-8#2)(2010-2#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#1)(2013-8#2)
used to calibrate a##2##4##(2009-3#1)(2012-2#1)
used to calibrate the##5##4##(1990-12#1)(1992-4#1)(2008-3#3)
used to calibrate##11##3##(1990-12#1)(1992-4#1)(2008-10#1)(2008-3#5)(2008-9#1)(2009-3#1)(2012-2#1)
used to capture##3##3##(1997-4#1)(2008-10#1)(2008-3#1)
used to carry out the##2##5##(2008-10#2)
used to carry out##4##4##(2008-10#2)(2008-4#1)(2012-2#1)
used to carry##5##3##(2008-10#3)(2008-4#1)(2012-2#1)
used to catalyze the##2##4##(2005-11#1)(2009-6#1)
used to catalyze##4##3##(2005-11#1)(2008-7#1)(2009-6#1)(2012-12#1)
used to cause##2##3##(2005-4#1)(2008-2#1)
used to challenge##2##3##(2005-11#1)(2008-10#1)
used to change the##3##4##(2008-3#1)(2010-11#1)(2010-5#1)
used to characterise the##3##4##(2008-10#2)(2010-4#1)
used to characterise##7##3##(1991-7#1)(2005-10#1)(2008-10#2)(2008-5#1)(2010-4#1)(2011-2#1)
used to characterize a##3##4##(1991-1#1)(1992-12#1)(2010-12#1)
used to characterize and##4##4##(1991-1#1)(2007-11#1)(2008-3#1)(2012-3#1)
used to characterize the expression##2##5##(1993-8#1)(2008-1#1)
used to characterize the##51##4##(1990-3#1)(1991-11#1)(1991-12#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-5#1)(1995-12#1)(1995-3#1)(1997-4#2)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#6)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#11)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2009-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-8#2)
used to characterize this##3##4##(1991-9#1)(2006-8#1)(2007-2#1)
used to characterize ultrashort##2##4##(2007-11#1)(2007-12#1)
used to characterize##100##3##(1990-3#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-7#1)(1991-9#2)(1992-12#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-3#1)(1997-4#2)(2004-9#1)(2005-11#1)(2006-12#2)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#9)(2007-2#2)(2007-8#1)(2008-1#5)(2008-10#18)(2008-11#3)(2008-2#4)(2008-3#4)(2008-4#4)(2008-5#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#2)
used to check the##8##4##(2005-11#1)(2007-4#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
used to check##12##3##(1995-8#1)(2005-11#1)(2007-4#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-4#1)
used to choose##2##3##(2008-12#1)(2012-3#1)
used to clarify##2##3##(2008-9#1)(2010-3#1)
used to classify subjects##2##4##(1994-2#1)(2012-12#1)
used to classify the##2##4##(2008-11#1)(2008-8#1)
used to classify##18##3##(1993-12#1)(1994-2#1)(1995-2#1)(2006-5#1)(2007-8#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-1#2)(2012-12#1)(2013-1#1)(2013-7#1)
used to clean##4##3##(2005-11#1)(2008-10#2)(2012-3#1)
used to cleave##2##3##(2008-11#1)(2008-8#1)
used to clone the##2##4##(1994-9#1)(2006-8#1)
used to clone##6##3##(1990-11#1)(1993-2#1)(1994-9#1)(1997-2#1)(2006-8#1)(2013-8#1)
used to close##2##3##(1992-3#1)(2012-8#1)
used to coat the##2##4##(1990-12#1)(2008-10#1)
used to code##2##3##(2008-2#1)(2008-3#1)
used to collect data from##2##5##(2008-11#1)(2013-1#1)
used to collect data##11##4##(1992-2#1)(2007-10#1)(2007-2#1)(2008-11#2)(2008-3#1)(2010-10#1)(2012-12#1)(2012-3#2)(2013-1#1)
used to collect the data##4##5##(2008-2#1)(2008-9#1)(2012-12#1)(2013-8#1)
used to collect the##6##4##(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2012-12#1)(2013-8#1)
used to collect##34##3##(1992-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#3)(2008-9#1)(2009-10#1)(2010-10#1)(2010-5#1)(2010-8#1)(2012-12#3)(2012-3#3)(2013-1#5)(2013-8#1)
used to combat##4##3##(2005-10#1)(2005-7#1)(2008-5#1)(2010-11#1)
used to combine these##3##4##(2009-9#1)(2013-1#2)
used to combine##4##3##(2008-2#1)(2009-9#1)(2013-1#2)
used to compare different##2##4##(1996-12#1)(1997-2#1)
used to compare the performance of##2##6##(2008-2#1)(2008-6#1)
used to compare the##36##4##(1990-7#1)(1991-5#1)(1992-1#1)(1993-12#1)(1993-9#1)(1994-5#1)(1995-4#1)(1995-5#2)(1996-10#1)(1996-7#1)(2005-11#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-6#1)(2011-1#4)(2013-7#2)
used to compare two##2##4##(2008-4#1)(2012-1#1)
used to compare with##3##4##(2005-9#1)(2008-1#1)(2008-10#1)
used to compare##66##3##(1990-7#1)(1991-5#1)(1992-1#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-5#3)(1995-4#1)(1995-5#2)(1996-10#1)(1996-12#1)(1996-7#1)(1997-2#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-11#2)(2007-9#1)(2008-1#4)(2008-10#6)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-5#1)(2009-7#1)(2010-6#2)(2010-9#2)(2011-1#4)(2012-1#2)(2012-12#1)(2012-2#1)(2013-7#2)
used to compensate for##3##4##(2005-4#1)(2008-3#2)
used to compensate##5##3##(2005-4#1)(2008-3#3)(2013-8#1)
used to complete the##2##4##(2008-7#1)(2008-8#1)
used to complete##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
used to compress##5##3##(2007-12#4)(2011-1#1)
used to compute a##4##4##(2006-12#1)(2008-2#1)(2008-6#1)(2008-8#1)
used to compute the##9##4##(2005-11#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-8#1)(2010-2#1)(2012-1#1)
used to compute##29##3##(1992-9#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-2#6)(2008-3#3)(2008-4#1)(2008-6#3)(2008-7#1)(2008-8#2)(2009-5#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-3#1)
used to concentrate and##2##4##(2008-10#1)(2008-2#1)
used to concentrate##6##3##(2008-10#5)(2008-2#1)
used to conduct the##3##4##(2008-9#1)(2010-3#1)(2013-8#1)
used to conduct##5##3##(2007-4#1)(2008-7#1)(2008-9#1)(2010-3#1)(2013-8#1)
used to confirm QTL associations detected in the##2##8##(2008-10#2)
used to confirm the diagnosis##4##5##(2007-10#1)(2008-7#1)(2012-2#1)(2013-1#1)
used to confirm the presence of##2##6##(2008-10#1)(2011-2#1)
used to confirm the##11##4##(1990-6#1)(2006-3#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
used to confirm##18##3##(1990-6#1)(1997-3#1)(2006-3#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
used to connect##2##3##(2007-8#1)(2009-3#1)
used to constrain##2##3##(2008-4#1)(2008-7#1)
used to construct a partial##3##5##(1990-8#1)(2006-10#1)(2008-10#1)
used to construct a simple##2##5##(2008-10#1)(2008-2#1)
used to construct a##25##4##(1990-11#1)(1990-7#1)(1990-8#1)(1991-4#1)(1992-3#1)(1992-6#1)(1994-5#1)(1994-9#1)(1995-3#1)(1996-6#1)(2006-10#1)(2008-10#7)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)(2012-2#1)
used to construct an##4##4##(1997-2#1)(2007-11#1)(2008-2#2)
used to construct the##6##4##(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-5#1)(2012-3#1)
used to construct##50##3##(1990-11#1)(1990-7#1)(1990-8#1)(1991-4#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-5#1)(1994-9#1)(1995-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#11)(2008-2#7)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)
used to control for the##2##5##(2008-9#1)(2012-2#1)
used to control for##3##4##(1996-10#1)(2008-9#1)(2012-2#1)
used to control the##11##4##(2006-10#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-5#1)(2012-2#1)(2013-8#1)
used to control##42##3##(1994-12#1)(1996-10#1)(1996-12#1)(2006-10#2)(2007-12#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#4)(2008-3#4)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#2)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#1)
used to convert##8##3##(1990-8#1)(1991-4#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-9#1)(2010-2#1)
used to convey##2##3##(1997-3#1)(2007-4#1)
used to cope with##2##4##(2009-9#1)(2013-8#1)
used to cope##3##3##(2007-3#1)(2009-9#1)(2013-8#1)
used to correct for##7##4##(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#2)(2008-8#1)(2012-3#1)
used to correct the##5##4##(2008-2#1)(2008-3#3)(2009-10#1)
used to correct##21##3##(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-2#3)(2008-3#6)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2012-2#1)(2012-3#1)
used to correlate the##3##4##(2007-10#1)(2008-6#1)(2009-4#1)
used to counteract##2##3##(2009-12#1)(2009-6#1)
used to cover the##2##4##(2008-11#1)(2010-9#1)
used to create a##6##4##(1996-4#1)(2006-12#1)(2008-2#2)(2009-11#1)(2011-2#1)
used to create the##6##4##(1992-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-7#1)(2012-2#1)
used to create##38##3##(1990-8#1)(1991-9#1)(1992-1#1)(1993-2#1)(1995-5#1)(1995-6#1)(1996-4#1)(2006-11#1)(2006-12#1)(2006-5#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-8#1)(2009-11#2)(2009-7#1)(2009-9#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
used to cultivate##5##3##(1991-9#1)(1992-12#1)(2008-11#1)(2008-12#1)(2008-4#1)
used to date##2##3##(2007-5#1)(2008-7#1)
used to deal with the##2##5##(1996-8#1)(2010-12#1)
used to deal with##5##4##(1996-8#1)(2006-10#1)(2007-10#1)(2010-12#1)(2011-1#1)
used to decide##3##3##(1996-2#1)(2008-10#1)(2009-9#1)
used to decrease the##2##4##(1996-11#1)(2007-8#1)
used to decrease##5##3##(1993-9#1)(1996-11#1)(1997-5#1)(2007-8#1)(2010-4#1)
used to deduce the##2##4##(2008-2#1)(2008-8#1)
used to deduce##4##3##(1997-6#1)(2008-2#1)(2008-7#1)(2008-8#1)
used to define biofidelity##2##4##(2006-11#1)(2007-1#1)
used to define new##2##4##(2008-10#1)(2008-2#1)
used to define the##18##4##(1994-2#1)(1995-6#1)(1996-7#1)(1997-3#1)(1997-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-10#1)(2011-1#1)(2012-2#1)
used to define##36##3##(1990-11#1)(1994-2#2)(1995-6#1)(1996-1#1)(1996-7#1)(1997-3#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)
used to delineate##2##3##(1997-7#1)(2008-2#1)
used to deliver##12##3##(1991-11#1)(2007-6#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#2)(2009-2#1)(2009-4#1)(2012-1#1)(2013-1#1)
used to demonstrate that both##2##5##(1991-4#1)(2008-5#1)
used to demonstrate that the##3##5##(1993-6#1)(1995-1#1)(2008-10#1)
used to demonstrate that##14##4##(1990-10#1)(1991-2#1)(1991-4#1)(1992-7#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)
used to demonstrate the feasibility of##3##6##(2008-10#2)(2008-11#1)
used to demonstrate the##18##4##(1994-11#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-9#1)
used to demonstrate##42##3##(1990-10#1)(1990-11#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-7#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#2)(1995-1#1)(1996-1#1)(1997-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#9)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-1#1)(2012-12#1)
used to deplete##2##3##(1997-6#1)(2008-4#1)
used to deposit##2##3##(2007-12#1)(2010-4#1)
used to derive a##6##4##(1992-12#1)(1995-8#1)(2007-8#1)(2008-2#1)(2008-3#1)(2011-2#1)
used to derive an##4##4##(2007-12#1)(2009-3#1)(2010-12#1)(2012-2#1)
used to derive the##9##4##(2006-10#2)(2007-7#1)(2008-11#1)(2008-2#2)(2008-3#3)
used to derive##32##3##(1992-12#1)(1994-3#1)(1995-8#1)(1996-12#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-2#5)(2008-3#6)(2008-5#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
used to describe a##5##4##(1990-9#1)(2007-6#1)(2008-9#1)(2009-3#1)(2012-1#1)
used to describe and##3##4##(2008-10#1)(2010-11#1)(2010-3#1)
used to describe the distribution##2##5##(1996-5#1)(2011-2#1)
used to describe the process##2##5##(2008-9#1)(2013-7#1)
used to describe the##32##4##(1992-6#1)(1993-9#1)(1994-2#1)(1995-11#1)(1996-5#1)(1997-2#2)(2006-10#2)(2006-2#1)(2006-8#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-9#2)(2010-12#1)(2011-2#2)(2012-1#1)(2013-7#1)
used to describe this##2##4##(2007-11#1)(2008-11#1)
used to describe##76##3##(1990-11#1)(1990-9#1)(1991-2#1)(1992-6#1)(1993-3#1)(1993-9#1)(1994-2#1)(1995-11#1)(1996-2#2)(1996-4#1)(1996-5#1)(1997-2#2)(1997-8#2)(2004-11#1)(2005-7#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-11#3)(2007-6#1)(2007-8#2)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#5)(2008-7#2)(2008-9#4)(2009-3#1)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
used to design a##5##4##(1995-3#1)(2008-10#1)(2008-3#1)(2010-12#1)(2012-2#1)
used to design and##2##4##(1993-12#1)(2007-11#1)
used to design primers for##2##5##(2008-10#1)(2008-11#1)
used to design primers##3##4##(2008-10#2)(2008-11#1)
used to design the##3##4##(1996-1#1)(2008-10#1)(2008-3#1)
used to design##29##3##(1993-12#1)(1995-3#1)(1996-1#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#10)(2008-11#1)(2008-3#5)(2008-5#1)(2008-9#1)(2009-5#1)(2010-12#1)(2012-1#1)(2012-2#1)
used to detect DNA damage##2##5##(1994-10#1)(2008-4#1)
used to detect DNA##3##4##(1994-10#1)(2008-4#2)
used to detect P##2##4##(2008-10#2)
used to detect a##4##4##(2007-11#1)(2008-2#1)(2008-5#1)(2008-9#1)
used to detect and##6##4##(1991-8#1)(2007-12#1)(2008-10#2)(2008-2#1)(2009-5#1)
used to detect genes##2##4##(2008-4#1)(2013-8#1)
used to detect microbial##2##4##(2008-11#2)
used to detect physical interactions between##2##6##(1992-7#1)(2008-2#1)
used to detect the##28##4##(1992-11#1)(1995-3#1)(1996-5#2)(1996-8#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-4#1)(2009-4#1)(2009-5#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
used to detect two##3##4##(1992-11#1)(2008-4#1)(2008-9#1)
used to detect##136##3##(1990-12#2)(1990-3#1)(1990-8#1)(1990-9#1)(1991-8#1)(1992-11#2)(1992-7#1)(1992-8#1)(1994-10#1)(1994-8#1)(1995-3#1)(1996-2#1)(1996-5#3)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-11#2)(2005-12#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#29)(2008-11#4)(2008-12#1)(2008-2#11)(2008-3#4)(2008-4#11)(2008-5#2)(2008-7#2)(2008-9#6)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
used to determination of##2##4##(2008-10#2)
used to determine a##4##4##(1993-12#1)(2007-11#1)(2008-3#1)(2010-4#1)
used to determine absolute##2##4##(2007-12#1)(2010-11#1)
used to determine antibody##2##4##(2007-2#1)(2008-10#1)
used to determine ascorbic acid in##2##6##(2007-8#1)(2008-10#1)
used to determine associations between##3##5##(2009-9#1)(2011-1#1)(2011-2#1)
used to determine both metals in##2##6##(2008-10#2)
used to determine both the##2##5##(2005-11#1)(2008-3#1)
used to determine both##4##4##(2005-11#1)(2008-10#2)(2008-3#1)
used to determine concentrations of##2##5##(2008-10#1)(2013-1#1)
used to determine differences between##2##5##(2006-10#1)(2007-7#1)
used to determine how##3##4##(2007-12#1)(2009-11#2)
used to determine if##3##4##(1993-4#1)(2007-2#1)(2008-8#1)
used to determine levels of##2##5##(1997-4#1)(2008-10#1)
used to determine that the##2##5##(1995-11#1)(2008-3#1)
used to determine that##4##4##(1993-8#1)(1995-11#1)(2008-10#1)(2008-3#1)
used to determine the composition of##4##6##(1990-9#1)(1992-1#1)(2007-11#1)(2007-8#1)
used to determine the concentration of##7##6##(1991-12#1)(2008-10#3)(2008-4#1)(2008-9#2)
used to determine the concentrations of##2##6##(1992-8#1)(2008-3#1)
used to determine the effect of##3##6##(1990-11#1)(2008-10#1)(2012-2#1)
used to determine the effects of a##2##7##(1996-11#1)(2008-1#1)
used to determine the effects of##5##6##(1996-11#1)(2006-10#1)(2008-1#1)(2008-2#1)(2011-2#1)
used to determine the extent of##3##6##(2005-11#1)(2008-7#1)(2011-1#1)
used to determine the extent##5##5##(1992-6#1)(2005-11#1)(2007-8#1)(2008-7#1)(2011-1#1)
used to determine the formation##2##5##(1991-9#1)(2008-10#1)
used to determine the frequency of##2##6##(2005-12#1)(2008-10#1)
used to determine the functional##2##5##(2008-10#1)(2008-4#1)
used to determine the impact of##2##6##(1997-5#1)(2012-1#1)
used to determine the impact##3##5##(1996-7#1)(1997-5#1)(2012-1#1)
used to determine the influence of##2##6##(2008-10#1)(2008-6#1)
used to determine the level of##2##6##(1990-8#1)(1995-7#1)
used to determine the low##2##5##(2008-10#2)
used to determine the nature of the##3##7##(1991-2#1)(1993-11#1)(2008-10#1)
used to determine the number of##5##6##(1995-11#1)(2006-10#1)(2008-10#2)(2008-4#1)
used to determine the optical##2##5##(2008-2#1)(2009-5#1)
used to determine the optimal##3##5##(2006-10#1)(2008-1#1)(2008-10#1)
used to determine the optimum##2##5##(2008-10#1)(2008-3#1)
used to determine the presence##4##5##(1995-5#1)(2004-11#1)(2005-8#1)(2008-7#1)
used to determine the prevalence##2##5##(2011-1#1)(2012-3#1)
used to determine the purity of##2##6##(1992-11#1)(2004-9#1)
used to determine the rate of##3##6##(1996-12#1)(2007-6#1)(2008-4#1)
used to determine the relationship between##2##6##(2007-9#1)(2011-1#1)
used to determine the relative##4##5##(1991-1#1)(2005-11#1)(2008-11#1)(2008-5#1)
used to determine the size##2##5##(1995-2#1)(2007-12#1)
used to determine the##197##4##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#3)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-7#1)(1995-10#1)(1995-11#4)(1995-2#2)(1995-5#3)(1995-6#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-7#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-11#1)(2004-9#1)(2005-11#3)(2005-12#1)(2005-8#1)(2006-10#5)(2006-2#2)(2006-5#2)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-6#2)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#34)(2008-11#2)(2008-12#1)(2008-2#13)(2008-3#6)(2008-4#11)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-5#2)(2009-6#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#1)
used to determine trace##2##4##(2008-10#2)
used to determine whether the##4##5##(1993-8#1)(2008-2#1)(2008-3#1)(2012-12#1)
used to determine whether##16##4##(1993-8#1)(1994-8#1)(2007-12#1)(2007-5#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
used to determine which##2##4##(1993-12#1)(2008-10#1)
used to determine##370##3##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#2)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-8#1)(1991-9#1)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#3)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-3#2)(1993-4#1)(1993-7#3)(1993-8#3)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-10#1)(1995-11#5)(1995-2#3)(1995-5#3)(1995-6#2)(1995-7#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-9#1)(2005-11#4)(2005-12#1)(2005-8#1)(2006-10#6)(2006-11#1)(2006-2#2)(2006-4#2)(2006-5#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#7)(2007-2#2)(2007-5#3)(2007-6#2)(2007-7#2)(2007-8#8)(2007-9#3)(2008-1#4)(2008-10#103)(2008-11#3)(2008-12#1)(2008-2#16)(2008-3#13)(2008-4#14)(2008-5#6)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#2)(2009-11#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-9#2)(2010-11#2)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#1)(2011-1#5)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
used to develop a comprehensive##2##5##(2007-9#1)(2008-3#1)
used to develop a simple##2##5##(2008-10#2)
used to develop a##26##4##(1990-12#1)(1990-8#1)(1991-6#1)(1991-8#1)(1992-4#1)(1994-5#1)(1996-3#1)(1997-4#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#4)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2010-4#1)(2012-12#1)
used to develop an##10##4##(1991-12#1)(1993-3#1)(1997-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2013-1#1)
used to develop and validate##2##5##(2007-4#1)(2010-11#1)
used to develop and##6##4##(1994-1#1)(2006-12#1)(2007-4#1)(2008-11#1)(2010-11#1)(2012-1#1)
used to develop the##11##4##(1996-2#1)(2007-4#1)(2008-10#4)(2008-11#1)(2008-12#1)(2013-1#2)(2013-8#1)
used to develop##83##3##(1990-12#1)(1990-8#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-4#1)(1993-3#2)(1994-1#1)(1994-5#2)(1995-1#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-4#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-12#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#3)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#18)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2010-11#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#1)(2011-12#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
used to devise a##2##4##(2005-8#1)(2008-10#1)
used to devise##3##3##(2005-8#1)(2008-10#1)(2008-2#1)
used to diagnose a##2##4##(2007-8#1)(2008-10#1)
used to diagnose and##2##4##(2008-10#1)(2011-2#1)
used to diagnose##16##3##(1991-5#1)(1997-2#1)(1997-3#2)(2004-2#1)(2006-10#1)(2007-10#2)(2007-8#1)(2008-10#2)(2009-3#2)(2011-2#1)(2013-1#2)
used to differentiate between##2##4##(2006-10#1)(2008-7#1)
used to differentiate##11##3##(2006-10#1)(2006-7#1)(2008-10#1)(2008-5#2)(2008-7#2)(2009-10#1)(2010-2#1)(2012-2#1)(2012-5#1)
used to digest##2##3##(1994-12#1)(2008-10#1)
used to direct the##3##4##(1990-12#1)(2008-7#2)
used to direct##4##3##(1990-12#1)(2008-5#1)(2008-7#2)
used to directly##8##3##(1992-11#1)(1995-1#1)(1995-3#1)(1996-8#1)(2008-10#3)(2008-7#1)
used to discover##3##3##(2006-5#1)(2008-10#1)(2008-9#1)
used to discriminate between##6##4##(1994-12#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-6#1)
used to discriminate##14##3##(1994-12#1)(1997-2#1)(1997-8#1)(2007-11#1)(2008-10#3)(2008-7#4)(2010-6#1)(2012-1#1)(2013-8#1)
used to displace##2##3##(1994-12#1)(2004-11#1)
used to display##5##3##(2007-12#1)(2008-2#2)(2008-3#1)(2010-2#1)
used to dissect##2##3##(1990-9#1)(2010-11#1)
used to dissociate##2##3##(1994-9#1)(2008-4#1)
used to distinguish among##3##4##(1993-6#1)(2008-10#1)(2008-8#1)
used to distinguish between##5##4##(1997-1#1)(2006-4#1)(2006-7#1)(2008-1#1)(2011-1#1)
used to distinguish the##2##4##(2008-10#1)(2010-8#1)
used to distinguish##20##3##(1992-8#1)(1993-6#1)(1997-1#2)(2006-2#1)(2006-4#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-4#2)(2008-8#1)(2009-12#1)(2010-8#1)(2011-1#1)(2013-8#1)
used to document##3##3##(1991-2#1)(1996-6#1)(2006-11#1)
used to draw##5##3##(1990-9#1)(2007-12#1)(2008-1#1)(2008-9#1)(2010-3#1)
used to drive the##5##4##(1995-8#1)(2006-12#1)(2008-10#1)(2008-8#1)(2009-8#1)
used to drive##10##3##(1993-5#1)(1995-8#1)(2006-12#2)(2006-6#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-4#1)(2009-8#1)
used to effectively##4##3##(2008-10#1)(2008-11#1)(2009-5#1)(2010-2#1)
used to efficiently##5##3##(2006-11#1)(2007-12#1)(2008-2#1)(2008-6#2)
used to elicit information##2##4##(2007-12#1)(2007-3#1)
used to elicit##3##3##(2007-12#1)(2007-3#1)(2008-11#1)
used to eliminate the##4##4##(2007-11#1)(2008-3#1)(2008-8#1)(2009-12#1)
used to eliminate##10##3##(1991-9#1)(1994-11#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-12#1)(2013-1#1)
used to elucidate the##9##4##(1990-3#1)(2006-12#1)(2007-6#1)(2008-10#2)(2008-4#1)(2009-7#1)(2010-9#1)(2012-1#1)
used to elucidate##14##3##(1990-3#1)(1993-3#1)(1994-8#1)(1997-4#1)(2006-12#1)(2007-6#1)(2008-10#3)(2008-4#1)(2009-7#1)(2010-9#1)(2011-12#1)(2012-1#1)
used to emulate##4##3##(1994-12#1)(2006-12#1)(2008-3#1)(2012-1#1)
used to enable##2##3##(2012-1#1)(2013-1#1)
used to encapsulate##2##3##(2005-11#1)(2010-1#1)
used to engineer the##2##4##(2006-5#1)(2012-2#1)
used to enhance the##20##4##(1990-11#1)(1990-3#2)(1991-9#1)(2008-10#5)(2008-2#2)(2008-3#4)(2008-6#1)(2008-7#1)(2009-10#1)(2012-1#1)(2012-2#1)
used to enhance##32##3##(1990-11#1)(1990-12#1)(1990-3#2)(1991-9#1)(2006-11#1)(2007-4#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-2#2)(2008-3#4)(2008-6#1)(2008-7#1)(2009-10#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
used to ensure that##2##4##(1994-2#1)(1996-9#1)
used to ensure##5##3##(1994-2#1)(1995-12#1)(1996-9#1)(2008-10#1)(2008-2#1)
used to establish a##7##4##(1991-6#1)(1995-3#1)(2007-4#1)(2008-11#2)(2008-2#1)(2008-4#1)
used to establish the calibration##2##5##(2008-10#2)
used to establish the diagnosis##2##5##(2007-5#1)(2010-6#1)
used to establish the##9##4##(1991-7#1)(2007-10#1)(2007-5#1)(2008-10#3)(2010-6#1)(2011-1#1)(2013-1#1)
used to establish##34##3##(1990-12#1)(1991-1#1)(1991-6#1)(1991-7#1)(1995-11#1)(1995-3#1)(1996-8#1)(2005-7#1)(2007-10#1)(2007-4#1)(2007-5#1)(2008-10#4)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#2)(2009-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#3)
used to established##2##3##(1993-1#1)(1997-4#1)
used to estimate the frequency of##2##6##(1994-3#2)
used to estimate the mean##2##5##(1993-5#1)(2008-3#1)
used to estimate the potential##4##5##(1991-3#1)(2008-10#2)(2011-2#1)
used to estimate the probability##2##5##(1994-11#1)(2008-10#1)
used to estimate the proportion of##2##6##(2008-4#1)(2011-2#1)
used to estimate the##74##4##(1990-8#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-8#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-3#3)(1995-1#1)(1995-8#1)(1996-3#1)(1996-9#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-12#2)(2007-1#2)(2007-8#2)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-2#8)(2008-3#8)(2008-4#2)(2008-6#1)(2008-7#3)(2009-10#2)(2009-12#1)(2009-8#1)(2010-6#1)(2011-1#2)(2011-2#2)
used to estimate##121##3##(1990-10#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-8#1)(1993-5#1)(1993-6#2)(1994-11#1)(1994-3#3)(1995-1#1)(1995-6#1)(1995-8#2)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-7#1)(2005-11#1)(2005-12#1)(2005-9#2)(2006-10#2)(2006-11#1)(2006-12#2)(2006-6#1)(2007-1#3)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#20)(2008-11#3)(2008-12#1)(2008-2#12)(2008-3#11)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#3)(2009-12#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#4)(2013-1#2)
used to evaluate a##3##4##(2008-10#1)(2008-4#1)(2008-6#1)
used to evaluate changes in##3##5##(1990-10#1)(2010-5#1)(2012-2#1)
used to evaluate differences##2##4##(1994-3#1)(2011-2#1)
used to evaluate the association between##2##6##(2013-1#2)
used to evaluate the effect of##2##6##(2004-12#1)(2012-2#1)
used to evaluate the effectiveness of##2##6##(2010-2#1)(2011-1#1)
used to evaluate the effects of##8##6##(1991-12#1)(1996-2#1)(1997-2#1)(2007-9#1)(2008-11#1)(2009-11#1)(2012-2#1)(2012-3#1)
used to evaluate the effects##9##5##(1991-12#1)(1996-2#1)(1997-2#1)(2006-12#1)(2007-9#1)(2008-11#1)(2009-11#1)(2012-2#1)(2012-3#1)
used to evaluate the efficacy of##2##6##(2004-3#1)(2013-1#1)
used to evaluate the proposed##2##5##(2012-1#1)(2012-12#1)
used to evaluate the purity of##2##6##(2008-4#1)(2008-8#1)
used to evaluate the quality of##2##6##(2007-11#1)(2007-8#1)
used to evaluate the relative##2##5##(2008-10#1)(2011-2#1)
used to evaluate the##107##4##(1991-1#1)(1991-12#1)(1991-9#1)(1993-1#1)(1993-3#1)(1994-3#1)(1994-5#1)(1995-10#1)(1996-11#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-12#3)(2004-3#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-4#4)(2007-7#2)(2007-8#4)(2007-9#1)(2008-10#16)(2008-11#2)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-8#2)(2010-11#2)(2010-2#1)(2010-8#2)(2011-1#3)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#1)
used to evaluate##175##3##(1990-10#1)(1990-12#2)(1991-1#1)(1991-12#3)(1991-3#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-3#1)(1994-12#1)(1994-3#3)(1994-5#2)(1995-10#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-6#1)(1997-8#1)(2004-12#3)(2004-2#2)(2004-3#1)(2005-11#1)(2006-10#1)(2006-11#3)(2006-12#3)(2006-2#1)(2006-3#1)(2006-8#3)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#5)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#21)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#6)(2008-4#3)(2008-5#3)(2008-6#4)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#2)(2009-5#1)(2009-8#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#2)(2011-1#4)(2011-12#2)(2011-2#7)(2012-1#3)(2012-12#4)(2012-2#5)(2012-3#4)(2013-1#6)(2013-8#2)
used to examine the associations between##2##6##(2011-2#1)(2012-3#1)
used to examine the effect of##6##6##(1991-10#2)(1996-12#1)(2007-5#1)(2008-10#1)(2012-12#1)
used to examine the effects of##3##6##(1990-2#1)(1994-2#1)(1995-11#1)
used to examine the extent of##2##6##(2009-5#1)(2012-1#1)
used to examine the relationships between##2##6##(2008-10#1)(2009-12#1)
used to examine the##61##4##(1990-2#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-6#1)(1993-12#1)(1994-11#1)(1994-2#2)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-4#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-4#1)(2004-10#1)(2005-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2007-12#1)(2007-5#1)(2008-10#9)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
used to examine whether##4##4##(1991-3#1)(1996-7#1)(2008-10#1)(2008-12#1)
used to examine##99##3##(1990-12#1)(1990-2#1)(1990-5#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-11#1)(1994-2#2)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-4#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-7#1)(1997-4#1)(1997-5#1)(2004-10#1)(2005-1#2)(2005-10#1)(2005-7#1)(2006-11#1)(2006-12#1)(2006-3#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#3)
used to excite the##4##4##(1991-3#1)(2007-9#2)(2008-3#1)
used to excite##5##3##(1991-3#1)(2007-9#2)(2008-3#1)(2011-1#1)
used to exclude other##2##4##(1990-4#1)(2008-3#1)
used to exclude##5##3##(1990-4#1)(1994-6#1)(2006-10#1)(2008-3#1)(2012-12#1)
used to expand##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
used to experimentally##2##3##(1995-10#1)(2013-1#1)
used to explain the##15##4##(2005-11#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2010-12#1)(2010-7#2)(2011-1#1)(2013-1#1)
used to explain##21##3##(1991-11#1)(1997-1#1)(2004-12#1)(2005-11#1)(2005-4#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2010-12#1)(2010-7#2)(2011-1#1)(2012-12#1)(2013-1#1)
used to explore how##2##4##(1997-3#1)(2008-10#1)
used to explore the##18##4##(1990-12#1)(1990-3#1)(1991-8#1)(1996-3#1)(2007-8#1)(2008-1#2)(2008-6#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
used to explore##28##3##(1990-12#1)(1990-3#1)(1991-8#1)(1994-6#1)(1996-3#1)(1997-3#1)(2005-12#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
used to express the##2##4##(1997-1#1)(2008-9#1)
used to express##13##3##(1993-6#1)(1995-8#1)(1997-1#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-7#2)(2008-9#2)(2010-12#1)
used to extend the##4##4##(2008-10#2)(2008-8#1)(2009-3#1)
used to extend##7##3##(1993-4#1)(2007-11#1)(2008-10#2)(2008-8#1)(2009-3#1)(2013-1#1)
used to extract the##6##4##(1997-2#1)(2006-5#1)(2008-10#2)(2008-3#1)(2012-3#1)
used to extract##32##3##(1990-12#1)(1990-9#1)(1995-2#1)(1995-5#1)(1997-2#1)(1997-3#1)(2006-12#1)(2006-4#1)(2006-5#1)(2008-10#13)(2008-3#2)(2008-6#1)(2008-9#1)(2009-3#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
used to fabricate the##3##4##(2007-8#1)(2008-12#2)
used to fabricate##20##3##(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#3)(2008-8#1)(2012-11#2)(2013-1#1)
used to facilitate the##3##4##(2006-12#1)(2006-7#1)(2012-2#1)
used to facilitate##9##3##(2006-12#1)(2006-7#1)(2007-3#1)(2008-12#1)(2008-4#2)(2008-6#1)(2012-1#1)(2012-2#1)
used to feed the##2##4##(2004-2#1)(2005-9#1)
used to feed##3##3##(2004-2#1)(2005-9#1)(2006-10#1)
used to fill##3##3##(2007-5#1)(2007-7#1)(2009-3#1)
used to find out##2##4##(2008-8#1)(2010-8#1)
used to find the##11##4##(1995-7#1)(2007-12#1)(2008-10#4)(2008-2#3)(2008-6#1)(2012-12#1)
used to find##28##3##(1994-6#1)(1995-1#1)(1995-7#1)(2006-8#1)(2006-9#1)(2007-12#1)(2008-10#9)(2008-2#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-8#1)(2011-2#1)(2012-12#1)
used to fit experimental##2##4##(2005-11#1)(2008-3#1)
used to fit the experimental data##2##6##(2008-10#1)(2008-3#1)
used to fit the models##2##5##(2008-9#2)
used to fit the##8##4##(1990-8#1)(2004-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#2)
used to fit##14##3##(1990-8#1)(2004-12#1)(2005-11#1)(2006-4#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#2)
used to follow individual##2##4##(2008-10#1)(2008-11#1)
used to follow the##9##4##(1991-12#1)(1992-2#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#2)
used to follow##18##3##(1990-11#1)(1991-12#1)(1991-3#1)(1992-2#1)(1996-12#1)(2005-11#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#2)
used to form a##5##4##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#2)
used to form an##3##4##(2007-12#1)(2008-10#1)(2010-5#1)
used to form the##5##4##(1995-4#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#1)
used to form##16##3##(1995-4#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#2)(2009-9#1)(2010-5#1)
used to formulate the##2##4##(2008-2#2)
used to formulate##4##3##(1991-4#1)(2008-10#1)(2008-2#2)
used to frequency##2##3##(2007-12#1)(2008-2#1)
used to further##13##3##(1992-2#1)(1996-12#1)(2006-1#1)(2007-2#1)(2007-4#1)(2008-10#3)(2008-3#1)(2008-7#1)(2010-5#1)(2012-12#1)(2012-3#1)
used to gain##7##3##(1995-11#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-4#1)(2009-5#1)(2010-9#1)
used to gather##5##3##(1996-2#1)(2006-10#1)(2007-7#2)(2008-3#1)
used to generalize the##3##4##(2008-2#1)(2013-1#2)
used to generalize##4##3##(2008-2#2)(2013-1#2)
used to generate a##13##4##(1990-8#1)(1993-3#1)(1994-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-1#1)
used to generate an##4##4##(2008-10#1)(2008-2#1)(2008-9#1)(2009-4#1)
used to generate genomic fingerprints of##2##6##(2008-10#2)
used to generate recombinant##2##4##(1994-3#1)(2010-7#1)
used to generate the##12##4##(1990-2#1)(1995-2#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-3#1)(2010-5#1)(2012-1#1)
used to generate transgenic##2##4##(1994-8#1)(2008-11#1)
used to generate##85##3##(1990-11#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-3#2)(2007-11#5)(2007-12#8)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#7)(2008-3#5)(2008-4#3)(2008-5#2)(2008-6#1)(2008-9#3)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
used to get##3##3##(2005-11#1)(2008-10#1)(2008-3#1)
used to give a##4##4##(1991-3#1)(1996-12#1)(2008-3#1)(2008-7#1)
used to give##5##3##(1991-3#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
used to group##2##3##(1995-12#1)(2008-8#1)
used to grow##6##3##(2007-5#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-9#1)
used to guide the choice of##2##6##(2008-10#1)(2013-1#1)
used to guide the##4##4##(1995-3#1)(2007-4#1)(2008-10#1)(2013-1#1)
used to guide##14##3##(1993-10#1)(1995-12#1)(1995-3#1)(2006-10#1)(2007-10#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2009-9#1)(2013-1#3)
used to handle##3##3##(2008-3#1)(2013-1#2)
used to help##14##3##(1992-1#1)(1992-2#1)(1992-8#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-8#1)(2012-2#1)
used to highlight##3##3##(2007-11#1)(2009-8#1)(2010-12#1)
used to identify a##14##4##(1990-11#1)(1992-2#1)(1993-6#1)(1994-9#1)(1995-12#1)(1995-8#1)(1997-2#1)(2006-11#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-1#1)
used to identify and to##2##5##(1991-2#1)(1994-8#1)
used to identify and##5##4##(1991-2#1)(1993-3#1)(1994-8#1)(2008-10#1)(2011-2#1)
used to identify areas##2##4##(2004-11#1)(2008-11#1)
used to identify candidate##2##4##(2008-10#1)(2008-7#1)
used to identify factors##2##4##(2011-1#1)(2013-1#1)
used to identify genes##5##4##(1996-5#1)(2007-6#1)(2008-10#1)(2008-7#1)(2012-1#1)
used to identify genetic##2##4##(2008-10#1)(2011-2#1)
used to identify molecular markers##2##5##(2008-10#2)
used to identify risk factors##3##5##(2008-7#1)(2013-1#2)
used to identify significant##2##4##(2007-1#1)(2010-2#1)
used to identify specific##8##4##(1990-2#1)(2008-2#2)(2008-4#3)(2010-11#1)(2013-1#1)
used to identify the best##2##5##(1995-2#1)(2008-4#1)
used to identify the most important##2##6##(2007-3#1)(2008-10#1)
used to identify the##52##4##(1990-11#1)(1990-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-4#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-5#1)(1997-2#1)(2005-10#1)(2007-1#1)(2007-12#1)(2007-3#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-4#3)(2008-9#1)(2009-10#1)(2009-12#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
used to identify unknown##2##4##(1991-12#1)(2008-10#1)
used to identify##219##3##(1990-11#3)(1990-12#2)(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-7#2)(1992-8#2)(1993-12#2)(1993-3#2)(1993-4#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#2)(1995-1#3)(1995-12#2)(1995-2#2)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(2004-11#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-1#2)(2007-10#1)(2007-12#3)(2007-2#1)(2007-3#3)(2007-6#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#32)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#14)(2008-5#2)(2008-6#2)(2008-7#9)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#2)(2009-7#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#6)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#14)(2013-7#1)(2013-8#4)
used to illustrate the##11##4##(1992-9#1)(1995-11#1)(1995-12#1)(1997-8#1)(2008-10#2)(2008-2#3)(2008-4#2)
used to illustrate##24##3##(1992-4#1)(1992-9#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-8#2)(2005-8#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-4#3)(2009-2#1)(2010-2#1)
used to image a##2##4##(1990-11#1)(2011-1#1)
used to image the##5##4##(2007-11#1)(2008-2#2)(2008-3#1)(2011-1#1)
used to image##15##3##(1990-11#1)(1996-5#1)(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#2)(2010-1#1)(2011-1#2)(2012-2#1)
used to immobilize##3##3##(2006-12#1)(2007-8#1)(2008-10#1)
used to immunize##2##3##(1993-8#1)(2011-2#1)
used to immunoprecipitate the##2##4##(1990-11#1)(1992-9#1)
used to immunoprecipitate##3##3##(1990-11#1)(1992-12#1)(1992-9#1)
used to implement a##3##4##(2007-11#2)(2008-2#1)
used to implement the##2##4##(1995-2#1)(2008-3#1)
used to implement##12##3##(1995-2#1)(2007-11#2)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#5)(2009-6#1)
used to improve the accuracy##2##5##(2008-10#1)(2008-3#1)
used to improve the sensitivity of##2##6##(2007-12#1)(2008-10#1)
used to improve the separation##3##5##(2005-12#2)(2008-10#1)
used to improve the##26##4##(1994-2#1)(1994-3#1)(2005-12#2)(2006-1#1)(2006-7#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#1)(2009-6#1)(2010-12#1)(2012-2#1)(2013-1#1)
used to improve##61##3##(1994-2#1)(1994-3#1)(1995-2#1)(1996-11#1)(1996-12#2)(1997-3#1)(2005-12#2)(2006-1#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#7)(2013-7#1)
used to in##2##3##(2008-2#1)(2010-4#1)
used to include##3##3##(1993-5#1)(2012-3#1)(2013-7#1)
used to incorporate##3##3##(2006-12#1)(2007-4#1)(2008-10#1)
used to increase the##10##4##(1997-3#1)(2005-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-7#1)
used to increase##21##3##(1994-6#1)(1996-3#1)(1997-3#1)(2004-10#1)(2005-10#1)(2006-12#1)(2006-4#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-11#2)(2010-4#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-7#1)
used to indicate the##4##4##(1992-6#1)(1992-8#1)(2008-12#1)(2012-3#1)
used to indicate##8##3##(1991-6#1)(1992-6#1)(1992-8#1)(2007-8#1)(2008-12#1)(2008-4#2)(2012-3#1)
used to induce##21##3##(1990-4#1)(1992-9#1)(1995-4#1)(2005-10#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-8#2)(2008-9#1)(2010-12#1)(2011-2#1)(2012-11#1)(2013-1#1)
used to infect Sf9##2##4##(1994-5#1)(1997-4#1)
used to infect##12##3##(1991-1#1)(1991-6#1)(1992-3#1)(1994-5#1)(1995-1#1)(1995-5#1)(1996-11#1)(1997-1#1)(1997-4#1)(2007-6#1)(2008-10#1)(2008-11#1)
used to infer the##9##4##(1992-1#1)(1992-12#1)(1994-3#1)(1995-5#1)(1997-2#1)(2006-12#1)(2008-1#1)(2010-8#1)(2012-3#1)
used to infer##14##3##(1992-1#1)(1992-12#1)(1994-3#1)(1995-5#1)(1997-2#1)(2006-12#1)(2008-1#2)(2008-3#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-8#1)
used to inform##8##3##(1996-1#1)(2007-12#1)(2008-7#1)(2012-12#2)(2013-1#2)(2013-8#1)
used to inhibit the##4##4##(1990-12#1)(1997-6#1)(2008-3#1)(2008-8#1)
used to inhibit##9##3##(1990-12#1)(1990-8#1)(1997-5#1)(1997-6#1)(2006-8#3)(2008-3#1)(2008-8#1)
used to initiate the##2##4##(2008-10#1)(2008-2#1)
used to initiate##4##3##(2007-3#1)(2008-10#2)(2008-2#1)
used to inoculate##6##3##(2008-10#5)(2008-4#1)
used to interpret the data##2##5##(2008-9#1)(2009-4#1)
used to interpret the##8##4##(1993-4#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-9#1)(2009-4#1)(2013-1#1)
used to interpret##11##3##(1993-4#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
used to interrogate##3##3##(2007-12#2)(2010-5#1)
used to interview##3##3##(2006-12#1)(2010-3#1)(2010-8#1)
used to introduce the##3##4##(1991-7#1)(1996-11#1)(2008-10#1)
used to introduce##12##3##(1991-7#1)(1994-5#2)(1996-11#1)(2005-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2009-11#1)(2010-10#1)
used to invert##3##3##(2008-2#1)(2008-3#1)(2009-3#1)
used to investigate how##2##4##(1996-5#1)(2010-8#1)
used to investigate in##2##4##(1990-4#1)(2008-10#1)
used to investigate the abuse potential of new compounds and to study the effects of candidate medications for the treatment of drug addiction##2##23##(2008-4#1)(2012-3#1)
used to investigate the adsorption##2##5##(2005-11#2)
used to investigate the cellular##2##5##(1993-12#1)(2008-4#1)
used to investigate the distribution of##2##6##(1991-9#1)(2008-10#1)
used to investigate the effect of the##2##7##(1996-3#1)(2008-3#1)
used to investigate the effect of##8##6##(1993-3#1)(1994-3#1)(1994-9#1)(1996-3#1)(1996-4#1)(2008-10#1)(2008-3#1)(2013-1#1)
used to investigate the effect##9##5##(1993-3#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-3#1)(1996-4#1)(2008-10#1)(2008-3#1)(2013-1#1)
used to investigate the effects of##7##6##(1995-12#1)(2005-11#1)(2007-9#1)(2008-2#1)(2008-8#1)(2009-8#1)(2010-4#1)
used to investigate the feasibility of##2##6##(2008-10#1)(2008-3#1)
used to investigate the formation of##2##6##(1996-3#1)(2007-12#1)
used to investigate the molecular basis of##2##7##(1990-8#1)(1996-12#1)
used to investigate the molecular##3##5##(1990-8#1)(1996-12#1)(2008-5#1)
used to investigate the possibility##2##5##(1994-6#1)(1996-6#1)
used to investigate the reaction##2##5##(2008-10#1)(2008-5#1)
used to investigate the relationship##2##5##(1996-12#1)(2010-6#1)
used to investigate the response##3##5##(1993-11#1)(1993-9#1)(2008-9#1)
used to investigate the role of##6##6##(1994-6#1)(1996-10#1)(2008-11#1)(2008-6#1)(2009-2#1)(2011-2#1)
used to investigate the structure and##2##6##(2006-12#1)(2008-2#1)
used to investigate the##108##4##(1990-11#1)(1990-2#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-9#1)(1995-10#2)(1995-11#2)(1995-12#2)(1995-2#2)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#3)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1997-3#1)(2005-11#5)(2005-12#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-10#14)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#4)
used to investigate whether##4##4##(1991-9#1)(1994-11#1)(1994-12#1)(2010-8#1)
used to investigate##156##3##(1990-11#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#3)(1993-12#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-6#3)(1994-9#1)(1995-10#3)(1995-11#2)(1995-12#3)(1995-2#2)(1995-7#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#1)(1997-3#1)(1997-8#1)(2005-11#5)(2005-12#1)(2006-11#1)(2006-12#2)(2006-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2007-9#2)(2008-10#19)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#4)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#4)
used to irradiate##2##3##(2008-10#1)(2009-8#1)
used to isolate a set of##2##6##(2008-10#1)(2008-2#1)
used to isolate a##8##4##(1991-2#1)(1991-5#1)(1993-11#1)(1994-6#1)(1995-2#1)(1997-4#1)(2008-10#1)(2008-2#1)
used to isolate the##3##4##(1994-12#1)(1995-2#1)(2008-4#1)
used to isolate##33##3##(1990-11#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-2#2)(1996-1#1)(1997-4#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-8#1)(2009-10#1)(2010-5#1)
used to judge##2##3##(2008-4#1)(2008-6#1)
used to justify##2##3##(2007-5#1)(2011-2#1)
used to kill##2##3##(1990-7#1)(2008-11#1)
used to know##2##3##(2008-10#1)(2008-11#1)
used to label cells##3##4##(1996-11#1)(2008-4#1)(2009-6#1)
used to label the##2##4##(1991-9#1)(2008-9#1)
used to label##11##3##(1991-9#1)(1992-1#2)(1996-11#1)(2008-10#1)(2008-4#2)(2008-9#1)(2009-6#1)(2010-4#1)(2012-2#1)
used to lengthen##3##3##(2007-11#1)(2007-8#2)
used to liberate##3##3##(1994-10#1)(2005-11#1)(2008-10#1)
used to limit the##2##4##(1993-3#1)(2006-8#1)
used to limit##3##3##(1993-3#1)(2006-8#1)(2008-2#1)
used to link##2##3##(2006-10#1)(2008-6#1)
used to load##2##3##(1993-11#1)(2011-1#1)
used to localize##10##3##(1990-4#1)(1993-5#1)(1994-10#1)(1994-2#1)(1995-12#1)(1997-6#1)(2008-11#1)(2009-10#1)(2010-4#1)(2011-1#1)
used to locate the##4##4##(1990-4#1)(2008-10#1)(2008-3#2)
used to locate##9##3##(1990-4#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#2)(2009-12#1)(2013-7#1)
used to lock##2##3##(2007-11#1)(2008-2#1)
used to look at##2##4##(1997-4#1)(2011-2#1)
used to look##3##3##(1992-3#1)(1997-4#1)(2011-2#1)
used to maintain##5##3##(2006-6#1)(2008-10#3)(2008-7#1)
used to make a##4##4##(2007-11#1)(2008-6#1)(2012-2#1)(2013-1#1)
used to make the##3##4##(1993-1#1)(2007-11#1)(2008-11#1)
used to make##35##3##(1991-2#1)(1993-1#1)(2005-10#1)(2005-11#1)(2006-5#2)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-7#1)(2010-10#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
used to manage##8##3##(1996-7#1)(2008-10#3)(2008-7#1)(2010-3#1)(2013-1#2)
used to manipulate##4##3##(2006-2#1)(2007-11#1)(2008-4#1)(2013-8#1)
used to manufacture##2##3##(2008-10#1)(2008-3#1)
used to map quantitative trait loci (QTL)##2##7##(2008-10#2)
used to map the##10##4##(1990-2#1)(1992-7#1)(1993-12#1)(1993-7#1)(1994-5#1)(2008-10#1)(2008-3#2)(2008-9#1)(2012-2#1)
used to map##18##3##(1990-2#1)(1992-7#1)(1993-12#1)(1993-7#1)(1994-5#1)(1996-4#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-9#1)(2012-2#1)
used to match##2##3##(1997-8#1)(2007-8#1)
used to maximize##3##3##(2007-12#1)(2008-3#1)(2008-5#1)
used to measure a##3##4##(1997-6#1)(2008-2#1)(2008-3#1)
used to measure and##3##4##(2008-11#1)(2008-9#1)(2009-11#1)
used to measure both##3##4##(2008-10#1)(2008-3#1)(2008-7#1)
used to measure changes in##4##5##(1990-4#1)(1991-5#1)(2008-7#1)(2012-3#1)
used to measure human##3##4##(2006-5#1)(2008-4#2)
used to measure relative##2##4##(1992-1#1)(2008-3#1)
used to measure temperature##2##4##(2008-3#2)
used to measure the ability##2##5##(2008-1#1)(2012-3#1)
used to measure the absorption##2##5##(2008-2#2)
used to measure the activity of##2##6##(1991-4#1)(2012-12#1)
used to measure the concentrations of##2##6##(2008-4#1)(2011-1#1)
used to measure the dispersion##2##5##(2008-2#2)
used to measure the effects of##2##6##(1995-12#1)(2008-9#1)
used to measure the extent of##2##6##(1994-5#1)(2008-4#1)
used to measure the rate of##3##6##(1993-11#1)(2008-4#1)(2009-12#1)
used to measure the surface##2##5##(1992-7#1)(2008-2#1)
used to measure the velocity##2##5##(2008-2#2)
used to measure the##88##4##(1990-12#1)(1990-2#1)(1991-4#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-11#1)(1994-5#1)(1994-9#2)(1995-12#1)(1995-6#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-8#1)(2004-9#1)(2005-11#2)(2006-7#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-2#13)(2008-3#13)(2008-4#6)(2008-5#1)(2008-7#2)(2008-9#2)(2009-12#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#4)(2012-3#2)
used to measure total##2##4##(2008-9#1)(2013-1#1)
used to measure two-dimensional##2##4##(2008-2#1)(2008-4#1)
used to measure##213##3##(1990-12#2)(1990-2#2)(1990-4#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-10#2)(1994-12#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#2)(1997-6#1)(1997-8#1)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#5)(2006-2#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#9)(2007-2#2)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#14)(2008-11#1)(2008-2#22)(2008-3#32)(2008-4#21)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#4)(2009-11#1)(2009-12#1)(2009-4#1)(2009-7#2)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#5)(2012-3#4)(2013-1#5)
used to mimic##2##3##(1994-5#1)(2008-10#1)
used to minimize the##6##4##(1992-12#1)(1995-2#1)(2007-12#1)(2008-11#1)(2008-2#2)
used to minimize##10##3##(1992-12#1)(1994-9#1)(1995-2#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#3)(2011-2#1)
used to mitigate the##4##4##(2008-2#1)(2012-11#2)(2013-1#1)
used to mitigate##5##3##(2007-7#1)(2008-2#1)(2012-11#2)(2013-1#1)
used to model the##19##4##(1992-12#1)(1994-5#1)(1994-8#1)(1997-1#1)(2005-11#1)(2006-11#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-6#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-5#1)
used to model##43##3##(1992-12#1)(1992-6#1)(1994-5#1)(1994-8#1)(1997-1#1)(2005-11#2)(2006-11#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-2#3)(2008-3#4)(2008-4#2)(2008-6#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2013-1#2)(2013-7#1)
used to modify the surface##2##5##(2008-10#1)(2009-7#1)
used to modify the##6##4##(1992-9#1)(2004-9#1)(2007-11#1)(2008-10#1)(2009-7#1)(2013-8#1)
used to modify##9##3##(1992-9#1)(2004-9#1)(2007-11#1)(2008-10#3)(2009-7#1)(2013-8#2)
used to modulate the##6##4##(2007-11#3)(2007-12#1)(2008-11#1)(2008-3#1)
used to modulate##9##3##(2007-11#3)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#1)(2011-1#1)
used to monitor and##2##4##(2008-10#1)(2009-4#1)
used to monitor the effect of##2##6##(1992-3#1)(1992-5#1)
used to monitor the effects of##2##6##(1993-2#1)(2008-10#1)
used to monitor the growth##2##5##(2008-10#1)(2008-11#1)
used to monitor the hydrolysis of##2##6##(2008-10#1)(2011-2#1)
used to monitor the hydrolysis##3##5##(2008-10#2)(2011-2#1)
used to monitor the reaction##2##5##(1994-5#1)(2008-10#1)
used to monitor the##44##4##(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-2#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-4#1)(1997-4#1)(1997-5#1)(2004-9#1)(2005-11#1)(2005-12#1)(2005-8#1)(2008-10#14)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-8#1)(2009-3#1)(2011-2#1)(2012-1#2)(2012-3#1)
used to monitor##91##3##(1990-2#1)(1990-3#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-2#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-4#1)(1994-5#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-4#2)(1995-5#1)(1996-5#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-4#1)(2004-9#1)(2005-11#3)(2005-12#1)(2005-8#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-10#26)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-5#1)(2011-2#2)(2012-1#2)(2012-3#1)(2013-8#1)
used to motivate##2##3##(2006-1#1)(2008-3#1)
used to narrow##2##3##(2008-2#1)(2008-8#1)
used to normalize##2##3##(2008-10#1)(2011-2#1)
used to observe and##2##4##(2008-10#1)(2011-1#1)
used to observe the effect##2##5##(2008-10#1)(2008-4#1)
used to observe the##6##4##(2007-10#1)(2008-10#3)(2008-4#1)(2010-8#1)
used to observe##14##3##(1991-9#1)(1993-3#1)(2006-6#1)(2007-10#1)(2007-3#1)(2008-10#4)(2008-4#1)(2008-5#1)(2010-8#1)(2011-1#1)(2013-1#1)
used to obtain a##9##4##(1991-4#1)(1995-3#1)(2004-12#1)(2005-11#2)(2008-2#2)(2008-3#1)(2009-11#1)
used to obtain an##4##4##(1994-5#1)(2007-12#1)(2008-2#1)(2008-3#1)
used to obtain both##2##4##(1997-8#1)(2008-10#1)
used to obtain estimates##2##4##(1991-4#1)(1992-8#1)
used to obtain highly##2##4##(1994-12#1)(1994-3#1)
used to obtain information about##2##5##(2005-11#1)(2008-2#1)
used to obtain the analytical##2##5##(2007-11#1)(2008-10#1)
used to obtain the##21##4##(1993-8#1)(1996-8#1)(2005-11#2)(2006-10#1)(2007-11#2)(2007-12#2)(2007-3#1)(2008-10#3)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2012-2#1)(2013-8#1)
used to obtain##98##3##(1990-9#1)(1991-11#1)(1991-4#2)(1992-7#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#3)(1994-5#1)(1994-6#1)(1995-10#1)(1995-2#2)(1995-3#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-5#1)(1997-8#1)(2004-12#1)(2005-11#6)(2006-10#1)(2006-12#2)(2006-2#1)(2006-3#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-3#2)(2008-10#12)(2008-12#1)(2008-2#8)(2008-3#8)(2008-4#2)(2008-5#6)(2008-7#2)(2008-8#2)(2009-11#2)(2009-3#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
used to offer##2##3##(2008-7#1)(2013-1#1)
used to optimize the##18##4##(1993-5#1)(1997-2#1)(2005-12#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2011-12#1)
used to optimize##23##3##(1993-5#1)(1997-2#1)(2005-12#1)(2007-11#2)(2007-12#2)(2008-10#6)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2009-11#1)(2011-12#1)
used to organize##2##3##(1993-12#1)(2009-4#1)
used to overcome the##4##4##(1991-11#1)(2007-11#1)(2009-11#1)(2012-3#1)
used to overcome these##2##4##(1996-3#1)(2007-5#1)
used to overcome##8##3##(1991-11#1)(1996-3#1)(2007-11#1)(2007-5#1)(2008-10#1)(2009-11#1)(2012-2#1)(2012-3#1)
used to overexpress##2##3##(1994-8#1)(2008-11#1)
used to oxidize##2##3##(2004-12#1)(2008-7#1)
used to package##2##3##(2008-3#1)(2012-1#1)
used to parameterize##2##3##(2008-8#1)(2009-11#1)
used to perform a##2##4##(2008-2#1)(2012-2#1)
used to perform an##2##4##(2006-6#1)(2010-3#1)
used to perform the##5##4##(1991-8#1)(1994-3#1)(2008-10#1)(2008-2#1)(2013-8#1)
used to perform##26##3##(1990-3#1)(1991-8#1)(1993-6#1)(1994-3#1)(2006-6#1)(2007-12#2)(2007-8#2)(2008-10#3)(2008-2#4)(2008-3#3)(2008-6#1)(2010-3#1)(2012-2#1)(2013-1#1)(2013-8#3)
used to permit##3##3##(2007-12#1)(2008-2#1)(2008-4#1)
used to photolabel##2##3##(1991-6#1)(1994-5#1)
used to place the PVA isolates into##2##7##(2008-10#2)
used to place##4##3##(2008-10#2)(2008-5#1)(2009-11#1)
used to plan##3##3##(1992-1#1)(2007-5#1)(2007-9#1)
used to plot calibration curves##2##5##(2008-10#2)
used to position a##2##4##(1994-3#1)(2007-5#1)
used to position##3##3##(1993-8#1)(1994-3#1)(2007-5#1)
used to precipitate the##2##4##(1996-6#1)(2008-2#1)
used to precipitate##6##3##(1996-6#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)
used to preconcentrate##2##3##(2008-10#2)
used to predict disease##2##4##(2005-8#1)(2008-10#1)
used to predict that##2##4##(1996-1#1)(2008-7#1)
used to predict the##33##4##(1990-2#1)(1992-4#1)(1992-6#1)(1993-9#1)(1995-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-9#1)(2005-10#1)(2005-11#1)(2007-10#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#2)(2009-3#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-8#1)(2012-3#1)(2013-8#1)
used to predict whether the##2##5##(2008-10#1)(2010-8#1)
used to predict##78##3##(1990-2#1)(1991-2#1)(1992-4#1)(1992-6#1)(1993-9#1)(1994-11#1)(1995-1#1)(1995-10#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-9#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-10#2)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-8#2)(2012-2#2)(2012-3#4)(2013-1#3)(2013-8#1)
used to prepare a##8##4##(1990-11#1)(1993-7#1)(1995-2#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#1)
used to prepare the##10##4##(1991-12#1)(2005-12#1)(2008-10#4)(2008-12#1)(2008-3#1)(2012-1#1)(2013-7#1)
used to prepare##40##3##(1990-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-8#1)(1992-12#2)(1993-3#1)(1993-7#1)(1994-5#1)(1994-6#1)(1995-2#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2012-1#1)(2012-2#2)(2013-7#1)
used to present the##3##4##(1996-3#1)(2008-10#2)
used to present##5##3##(1996-3#1)(2006-5#1)(2007-8#1)(2008-10#2)
used to preserve##2##3##(2009-3#1)(2010-4#1)
used to prevent and treat##2##5##(2010-4#1)(2013-1#1)
used to prevent and##3##4##(2006-1#1)(2010-4#1)(2013-1#1)
used to prevent##19##3##(1990-6#1)(1991-6#1)(1996-11#1)(1996-3#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
used to probe a##2##4##(1995-8#1)(2008-3#1)
used to probe the structural##2##5##(2006-3#1)(2006-6#1)
used to probe the##20##4##(1990-10#1)(1990-8#1)(1991-4#3)(1992-6#1)(1995-3#1)(1995-6#1)(1997-6#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#1)(2013-8#1)
used to probe##39##3##(1990-10#1)(1990-8#1)(1991-12#2)(1991-4#3)(1991-9#1)(1992-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-8#1)(2009-12#1)(2013-8#1)
used to process the##4##4##(2007-4#1)(2007-5#1)(2008-2#1)(2008-3#1)
used to process##6##3##(2007-4#1)(2007-5#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-7#1)
used to produce a##12##4##(1990-12#1)(1992-9#1)(1996-7#1)(2007-12#2)(2008-2#5)(2008-3#1)(2009-6#1)
used to produce high##2##4##(1992-1#1)(1997-4#1)
used to produce the##7##4##(1995-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-4#1)(2011-3#1)
used to produce##69##3##(1990-12#1)(1990-6#1)(1990-8#1)(1992-1#1)(1992-9#1)(1993-5#1)(1993-9#1)(1994-11#1)(1995-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-9#1)(2005-8#1)(2006-11#1)(2007-12#4)(2008-1#1)(2008-10#9)(2008-11#4)(2008-2#13)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-3#1)(2012-2#1)
used to profile##2##3##(2008-10#1)(2011-2#1)
used to promote the##2##4##(2007-6#1)(2008-2#1)
used to promote##6##3##(2007-6#1)(2008-10#1)(2008-12#1)(2008-2#1)(2011-12#1)(2012-3#1)
used to propose##3##3##(1995-3#1)(2008-1#1)(2008-10#1)
used to protect the##3##4##(1993-3#1)(2008-3#1)(2009-5#1)
used to protect##6##3##(1993-3#1)(1994-3#1)(2007-11#1)(2008-3#1)(2008-4#1)(2009-5#1)
used to prove the##2##4##(1993-11#1)(2007-11#1)
used to prove##4##3##(1993-11#1)(2007-11#1)(2008-10#1)(2008-5#1)
used to provide a##11##4##(1992-6#1)(1996-3#1)(1997-8#1)(2004-2#1)(2006-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2010-4#1)
used to provide the##3##4##(2006-12#1)(2007-12#1)(2008-3#1)
used to provide##35##3##(1991-12#1)(1992-6#1)(1996-3#2)(1997-8#1)(2004-11#1)(2004-2#1)(2006-12#3)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#3)(2008-4#3)(2008-8#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-1#2)(2012-1#1)(2013-1#1)
used to purify the##2##4##(1990-11#1)(1991-7#1)
used to purify##7##3##(1990-11#1)(1991-7#1)(1994-12#1)(1997-7#1)(1997-8#1)(2008-1#1)(2012-12#1)
used to qualitatively##2##3##(1992-9#1)(2008-10#1)
used to quantify and##3##4##(2006-11#1)(2010-5#1)(2012-2#1)
used to quantify the##13##4##(1990-7#1)(1993-7#1)(1997-8#1)(2006-10#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#3)(2011-1#1)(2012-1#1)
used to quantify##38##3##(1990-7#1)(1993-7#1)(1997-8#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#4)(2008-8#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)
used to quantitate the##2##4##(2008-10#1)(2009-10#1)
used to quantitate##12##3##(1990-12#1)(1991-9#1)(1992-12#1)(1994-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#3)(2008-9#1)(2009-10#1)
used to quantitatively assess##3##4##(2007-8#1)(2008-10#1)(2011-1#1)
used to quantitatively determine##3##4##(2007-5#1)(2008-10#2)
used to quantitatively measure##3##4##(2009-9#1)(2012-12#2)
used to quantitatively##14##3##(2005-11#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-9#1)(2009-7#1)(2009-9#1)(2010-2#1)(2011-1#1)(2012-12#2)
used to raise##3##3##(1991-5#1)(1993-9#1)(1996-8#1)
used to rank the##2##4##(1992-11#1)(2007-8#1)
used to rapidly##6##3##(1994-6#1)(2007-12#1)(2008-10#1)(2011-2#1)(2012-2#2)
used to rationalize##2##3##(1990-8#1)(1996-5#1)
used to re-estimate the sample size##2##6##(2012-2#2)
used to reach##2##3##(1994-12#1)(2005-5#1)
used to read##2##3##(2007-12#1)(2008-3#1)
used to realize##3##3##(2007-12#2)(2008-2#1)
used to reconstitute the##2##4##(1992-3#1)(2007-8#1)
used to reconstitute##3##3##(1992-3#1)(1997-4#1)(2007-8#1)
used to reconstruct the##13##4##(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#5)(2008-9#1)(2013-1#2)
used to reconstruct##22##3##(1992-1#1)(2007-11#1)(2007-12#4)(2007-7#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#5)(2008-8#1)(2008-9#1)(2009-8#1)(2010-6#1)(2011-1#1)(2013-1#2)
used to record the##7##4##(1994-2#1)(2007-1#1)(2007-10#1)(2008-3#1)(2009-4#1)(2009-8#1)(2010-6#1)
used to record##24##3##(1991-6#1)(1994-2#1)(1996-5#1)(1996-9#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-6#2)(2012-11#2)(2012-2#1)(2013-1#1)
used to recover the##4##4##(2007-11#1)(2007-12#1)(2008-3#1)(2008-4#1)
used to recover##6##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2013-1#1)
used to recruit##4##3##(2007-10#3)(2010-9#1)
used to reduce the incidence of##2##6##(2011-12#1)(2013-1#1)
used to reduce the number of##2##6##(2006-10#1)(2012-2#1)
used to reduce the##20##4##(1991-12#1)(1995-12#1)(1996-11#1)(1997-6#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#5)(2008-4#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
used to reduce##34##3##(1991-12#1)(1995-12#1)(1996-11#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-9#1)(2006-10#3)(2006-11#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#7)(2008-4#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
used to refer to a##3##5##(2011-2#1)(2013-1#2)
used to refer to##5##4##(2006-10#1)(2011-2#1)(2012-2#1)(2013-1#2)
used to refine the##3##4##(2008-6#1)(2009-10#1)(2009-4#1)
used to refine##6##3##(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-4#1)
used to reflect##3##3##(1996-12#1)(2008-3#1)(2011-1#1)
used to regulate##3##3##(2008-1#1)(2008-11#1)(2008-8#1)
used to relate##4##3##(2008-10#4)
used to reliably##5##3##(2008-10#1)(2008-3#1)(2008-8#1)(2009-4#1)(2010-3#1)
used to remove the##7##4##(2007-11#1)(2008-10#3)(2008-2#2)(2012-12#1)
used to remove traces of##2##5##(2007-6#1)(2008-10#1)
used to remove##20##3##(1990-12#1)(1991-6#1)(1995-2#1)(2005-5#1)(2007-11#1)(2007-6#2)(2008-10#6)(2008-2#2)(2008-5#1)(2008-6#1)(2010-2#1)(2011-2#1)(2012-12#1)
used to repair##4##3##(2007-11#2)(2007-8#1)(2010-8#1)
used to replace enamel in stratified composite restoration techniques##2##9##(2012-2#2)
used to replace the##2##4##(2008-8#1)(2013-8#1)
used to replace##9##3##(1994-12#1)(1995-1#1)(1996-2#1)(2008-2#1)(2008-8#1)(2012-2#2)(2013-7#1)(2013-8#1)
used to report##3##3##(1990-11#1)(2006-8#1)(2011-2#1)
used to represent the##6##4##(2008-10#1)(2008-12#1)(2008-2#2)(2008-6#1)(2008-7#1)
used to represent##13##3##(2007-12#2)(2008-10#3)(2008-12#1)(2008-2#3)(2008-4#1)(2008-6#2)(2008-7#1)
used to rescue##2##3##(2007-8#1)(2008-10#1)
used to resect##3##3##(1993-10#1)(2006-8#1)(2010-2#1)
used to resolve the##3##4##(1994-12#1)(1996-8#1)(2008-11#1)
used to resolve##11##3##(1990-8#1)(1991-7#1)(1994-12#1)(1996-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-1#1)(2013-7#1)
used to restore##3##3##(1996-3#1)(2007-12#1)(2008-4#1)
used to retrieve##4##3##(2008-2#2)(2008-3#1)(2013-1#1)
used to reveal##5##3##(1997-2#1)(1997-3#1)(2007-10#1)(2008-10#2)
used to sample the##2##4##(2008-10#1)(2008-7#1)
used to sample##6##3##(2008-10#4)(2008-7#1)(2012-12#1)
used to scale##3##3##(1991-1#1)(2008-11#1)(2008-2#1)
used to screen a cDNA library##2##6##(1993-5#1)(1994-6#1)
used to screen a##6##4##(1990-2#1)(1990-4#1)(1993-5#1)(1993-7#1)(1994-6#1)(2007-2#1)
used to screen for##9##4##(1991-3#1)(1995-5#1)(2006-10#1)(2008-10#1)(2008-2#1)(2010-12#1)(2010-5#1)(2010-6#1)(2012-11#1)
used to screen the##2##4##(1997-8#1)(2008-8#1)
used to screen##34##3##(1990-2#1)(1990-4#1)(1991-3#1)(1992-8#1)(1993-11#1)(1993-5#1)(1993-7#1)(1994-6#1)(1994-8#1)(1995-5#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-4#2)(2008-7#1)(2008-8#3)(2008-9#2)(2010-12#1)(2010-5#1)(2010-6#1)(2012-11#1)(2012-12#1)(2013-8#1)
used to search for##5##4##(2006-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2013-1#1)
used to search##8##3##(1993-8#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2013-1#1)
used to segment the##2##4##(2008-2#1)(2009-4#1)
used to select patients for##2##5##(1994-8#1)(2007-9#1)
used to select the##10##4##(1993-12#1)(2008-10#7)(2008-11#1)(2012-3#1)
used to select##30##3##(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-8#1)(1997-7#1)(2007-12#1)(2007-9#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-8#1)
used to selectively##7##3##(1994-6#1)(2007-11#2)(2008-10#2)(2008-12#1)(2011-1#1)
used to sense##2##3##(2008-2#1)(2008-3#1)
used to separate and##2##4##(2008-10#1)(2008-5#1)
used to separate##22##3##(1992-12#1)(2004-8#1)(2007-12#1)(2007-8#1)(2008-10#11)(2008-2#2)(2008-4#2)(2008-5#2)(2009-12#1)
used to separately##2##3##(2007-11#1)(2012-3#1)
used to set##6##3##(1991-2#1)(1992-2#1)(1997-3#1)(2005-5#1)(2007-8#1)(2012-2#1)
used to show that the##8##5##(1990-8#2)(1993-6#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-2#2)
used to show that this##3##5##(2007-11#1)(2007-12#1)(2008-2#1)
used to show that##19##4##(1990-8#2)(1991-3#1)(1993-6#1)(1994-2#1)(1994-9#1)(1996-1#1)(1997-1#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#4)(2008-8#1)
used to show the##8##4##(1995-10#1)(1997-7#1)(1997-8#1)(2006-12#1)(2008-10#1)(2008-3#1)(2012-2#1)(2012-3#1)
used to show##30##3##(1990-8#2)(1991-3#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-10#1)(1996-1#1)(1997-1#1)(1997-7#1)(1997-8#1)(2004-4#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#1)(2008-8#1)(2011-12#1)(2012-2#1)(2012-3#1)
used to simplify the heating cycles##2##6##(2008-10#2)
used to simplify the##6##4##(1992-2#1)(2005-11#1)(2008-10#2)(2008-2#2)
used to simplify##7##3##(1992-2#1)(2005-11#1)(2008-10#2)(2008-2#3)
used to simulate the##10##4##(1997-7#1)(2007-11#1)(2008-2#2)(2008-3#4)(2008-6#1)(2008-7#1)
used to simulate##22##3##(1990-11#1)(1997-7#1)(2006-11#1)(2007-11#1)(2007-4#2)(2008-2#3)(2008-3#6)(2008-6#2)(2008-7#2)(2008-8#1)(2010-1#1)(2010-5#1)
used to simultaneously##4##3##(2007-12#1)(2008-3#1)(2008-4#1)(2011-1#1)
used to solubilize##2##3##(2008-4#1)(2009-10#1)
used to solve for##2##4##(2007-12#1)(2008-3#1)
used to solve the##5##4##(2007-12#2)(2008-2#1)(2008-9#1)(2011-1#1)
used to solve##13##3##(2007-12#3)(2007-2#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-9#1)(2009-12#1)(2010-7#1)(2011-1#1)
used to sort##2##3##(2006-6#1)(2008-2#1)
used to split the data##2##5##(2008-10#1)(2009-2#1)
used to split the##3##4##(2008-10#1)(2008-2#1)(2009-2#1)
used to stabilize the##5##4##(1993-5#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-11#1)
used to stabilize##8##3##(1993-5#1)(1994-9#1)(2005-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)
used to stain##3##3##(1992-8#1)(1995-9#1)(2008-9#1)
used to stimulate##4##3##(1990-2#1)(1991-9#1)(1994-2#1)(2012-11#1)
used to store##2##3##(2008-4#1)(2008-5#1)
used to strengthen##3##3##(1995-5#1)(2006-12#1)(2008-10#1)
used to structure##2##3##(2006-12#1)(2007-10#1)
used to study a##2##4##(1991-11#1)(2008-10#1)
used to study and##2##4##(2007-11#1)(2008-7#1)
used to study basic##2##4##(2008-9#1)(2010-7#1)
used to study both the##3##5##(1993-6#1)(1994-10#1)(2009-4#1)
used to study mechanisms of##3##5##(1992-11#1)(2008-4#1)(2013-1#1)
used to study mechanisms##4##4##(1991-11#1)(1992-11#1)(2008-4#1)(2013-1#1)
used to study the association##2##5##(1993-12#1)(2008-10#1)
used to study the binding##3##5##(1991-8#1)(1993-11#1)(2006-10#1)
used to study the cellular##2##5##(1990-4#1)(2008-11#1)
used to study the distribution of##2##6##(1995-12#1)(1995-5#1)
used to study the effect of##14##6##(1990-11#1)(1990-2#1)(1991-7#1)(1992-3#1)(1993-8#1)(1997-1#1)(2007-10#1)(2008-7#3)(2008-8#1)(2010-6#1)(2013-7#2)
used to study the effects of exposure to##2##8##(1993-6#1)(2013-7#1)
used to study the effects of##8##6##(1993-6#1)(1997-5#1)(1997-7#1)(2007-11#1)(2008-2#1)(2008-5#1)(2010-4#1)(2013-7#1)
used to study the growth##2##5##(2008-3#1)(2013-8#1)
used to study the impact of##2##6##(2008-4#1)(2011-1#1)
used to study the influence of##2##6##(1993-9#1)(2008-5#1)
used to study the interaction between a##2##7##(2008-10#1)(2009-6#1)
used to study the interaction between##4##6##(2005-11#1)(2008-10#1)(2008-4#1)(2009-6#1)
used to study the interaction##5##5##(1990-4#1)(2005-11#1)(2008-10#1)(2008-4#1)(2009-6#1)
used to study the interactions of##2##6##(2008-9#2)
used to study the interactions##3##5##(2008-9#2)(2011-2#1)
used to study the kinetic##2##5##(2008-10#2)
used to study the kinetics of##2##6##(1990-12#1)(2008-4#1)
used to study the mechanisms by which##2##7##(2008-10#1)(2008-2#1)
used to study the molecular##3##5##(1990-7#1)(1992-8#1)(1995-10#1)
used to study the relationship##3##5##(2008-10#2)(2008-9#1)
used to study the role of##2##6##(1990-4#1)(2010-12#1)
used to study the stability##2##5##(1995-1#1)(2005-11#1)
used to study the##144##4##(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#4)(1990-7#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-6#2)(1993-8#3)(1993-9#1)(1994-3#1)(1994-5#1)(1995-1#2)(1995-10#1)(1995-12#2)(1995-5#1)(1996-1#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-5#2)(1997-6#1)(1997-7#1)(2005-11#4)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#26)(2008-11#3)(2008-2#5)(2008-3#3)(2008-4#6)(2008-5#3)(2008-7#4)(2008-8#5)(2008-9#4)(2009-11#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-9#3)(2010-12#1)(2010-4#2)(2010-6#1)(2010-7#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#3)(2013-8#1)
used to study this##3##4##(2006-2#1)(2008-10#1)(2013-8#1)
used to study various##2##4##(1990-9#1)(2012-2#1)
used to study##245##3##(1990-11#2)(1990-12#1)(1990-2#3)(1990-4#4)(1990-7#1)(1990-8#1)(1990-9#3)(1991-11#2)(1991-12#2)(1991-2#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-4#1)(1993-6#3)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-12#3)(1995-5#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#1)(2005-11#6)(2006-10#2)(2006-11#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#6)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#6)(2008-10#34)(2008-11#6)(2008-12#1)(2008-2#6)(2008-3#7)(2008-4#12)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#6)(2008-9#7)(2009-11#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#4)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#3)(2010-6#1)(2010-7#3)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#3)(2013-8#2)
used to substantiate##2##3##(1993-3#1)(2008-8#1)
used to substitute##3##3##(2008-10#1)(2008-9#1)(2010-11#1)
used to successfully##6##3##(2007-11#1)(2008-10#3)(2008-11#1)(2009-12#1)
used to suggest##2##3##(1991-2#1)(2010-8#1)
used to summarize##3##3##(1994-5#1)(2008-10#1)(2013-1#1)
used to supplement these##2##4##(1997-8#1)(2010-8#1)
used to supplement##3##3##(1997-8#1)(2008-3#1)(2010-8#1)
used to support an##2##4##(2005-9#1)(2006-2#1)
used to support the##3##4##(2007-9#1)(2008-10#2)
used to support##15##3##(1994-6#1)(1995-1#1)(2005-9#1)(2006-2#1)(2007-9#1)(2008-10#3)(2008-7#1)(2008-9#1)(2010-11#2)(2011-2#1)(2011-9#1)(2012-12#1)
used to suppress##4##3##(2007-11#1)(2008-10#2)(2011-2#1)
used to survey##2##3##(1994-9#1)(1996-7#1)
used to sustain##2##3##(2008-11#1)(2008-5#1)
used to synthesize##10##3##(1993-8#1)(1994-9#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2012-2#1)
used to tag##2##3##(2004-4#1)(2008-10#1)
used to tailor##3##3##(2009-12#1)(2010-4#1)(2013-1#1)
used to target##5##3##(1991-12#1)(2007-8#1)(2008-6#1)(2011-2#1)(2012-3#1)
used to teach##4##3##(2008-11#1)(2008-12#2)(2009-11#1)
used to test a##5##4##(1994-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)
used to test for differences##2##5##(1994-2#1)(2008-5#1)
used to test for##11##4##(1992-11#1)(1992-2#1)(1992-7#1)(1994-2#1)(1995-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-2#1)(2012-2#2)
used to test four##2##4##(2008-10#1)(2010-3#1)
used to test the effects of##2##6##(2008-11#2)
used to test the hypothesis that##2##6##(2008-5#1)(2011-2#1)
used to test the prediction##2##5##(2008-12#1)(2008-5#1)
used to test the##23##4##(1991-8#1)(1993-3#1)(2006-11#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#2)(2008-5#4)(2008-8#1)(2010-8#1)(2011-12#1)(2011-2#2)(2013-1#1)(2013-7#1)
used to test whether##5##4##(1992-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2013-1#1)
used to test##67##3##(1990-3#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-3#1)(1995-6#1)(2004-9#1)(2005-10#1)(2006-11#1)(2006-2#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#5)(2008-8#2)(2008-9#1)(2009-5#1)(2009-7#1)(2010-2#2)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#5)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)
used to tether##2##3##(1990-2#1)(1996-5#1)
used to the determination of##3##5##(2008-10#3)
used to the##8##3##(2005-4#1)(2008-10#6)(2009-4#1)
used to track the##4##4##(1994-3#1)(2005-11#1)(2008-10#2)
used to track##10##3##(1994-3#1)(2005-11#1)(2007-11#1)(2008-10#3)(2008-4#2)(2008-6#1)(2011-1#1)
used to train##9##3##(1995-2#1)(2008-10#2)(2008-4#1)(2009-8#1)(2011-2#1)(2012-1#2)(2012-2#1)
used to transfect##6##3##(1990-8#1)(1993-8#1)(2008-11#1)(2008-4#2)(2013-1#1)
used to transfer##6##3##(1990-5#1)(2006-5#1)(2007-12#2)(2008-10#2)
used to transform##9##3##(1990-5#2)(1995-2#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-4#2)(2008-8#1)
used to transiently##2##3##(1995-2#1)(2010-3#1)
used to treat a myriad of##2##6##(2008-10#1)(2008-8#1)
used to treat a variety of##2##6##(1992-1#1)(2006-9#1)
used to treat a##5##4##(1992-1#1)(1993-2#1)(2006-9#1)(2008-10#1)(2008-8#1)
used to treat bacterial infections##2##5##(2008-4#1)(2012-2#1)
used to treat chronic##3##4##(2007-11#1)(2012-12#1)(2012-3#1)
used to treat disorders##2##4##(2008-1#1)(2013-1#1)
used to treat hypertension because of##2##6##(1996-9#1)(2008-12#1)
used to treat hypertension##5##4##(1996-9#1)(2005-10#1)(2007-7#1)(2008-11#1)(2008-12#1)
used to treat inflammatory##2##4##(2007-8#1)(2008-10#1)
used to treat localized##2##4##(2008-7#1)(2012-1#1)
used to treat osteoporosis##4##4##(1993-11#1)(2007-11#1)(2007-8#1)(2008-3#1)
used to treat patients with##6##5##(2005-9#1)(2006-3#1)(2007-4#1)(2008-1#1)(2012-12#2)
used to treat patients##7##4##(1994-11#1)(2005-9#1)(2006-3#1)(2007-4#1)(2008-1#1)(2012-12#2)
used to treat schizophrenia##2##4##(2007-7#1)(2012-2#1)
used to treat selected##2##4##(1993-11#1)(2008-5#1)
used to treat the##11##4##(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-8#1)(2011-1#1)
used to treat this##4##4##(2006-10#1)(2008-1#1)(2011-1#1)(2013-8#1)
used to treat##139##3##(1990-3#1)(1991-12#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1993-11#2)(1993-2#1)(1994-11#2)(1994-5#1)(1995-4#1)(1995-9#1)(1996-11#1)(1996-9#1)(1997-6#1)(2005-10#2)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#6)(2006-12#3)(2006-2#1)(2006-3#1)(2006-6#1)(2006-7#6)(2006-8#2)(2006-9#2)(2007-10#1)(2007-11#6)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#5)(2007-8#3)(2008-1#3)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#7)(2008-7#5)(2008-8#9)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
used to trim##2##3##(2007-12#1)(2010-12#1)
used to understand the##5##4##(1996-11#1)(2006-11#1)(2007-10#1)(2008-10#1)(2012-3#1)
used to understand their##2##4##(2006-12#1)(2008-7#1)
used to understand##11##3##(1996-11#1)(2006-11#1)(2006-12#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-4#1)(2010-7#1)(2012-3#1)
used to unravel##2##3##(1993-9#1)(1995-11#1)
used to validate the model##6##5##(2007-4#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-2#1)(2013-8#1)
used to validate the##21##4##(1996-3#1)(2007-4#1)(2007-6#1)(2008-10#6)(2008-3#4)(2008-7#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#3)(2013-8#1)
used to validate##25##3##(1995-3#1)(1996-3#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-10#6)(2008-3#4)(2008-7#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#3)(2013-8#2)
used to verify that##4##4##(2006-7#1)(2008-4#1)(2008-9#2)
used to verify the##6##4##(1996-7#1)(1997-4#1)(2007-8#1)(2008-10#1)(2010-5#2)
used to verify##11##3##(1996-7#1)(1997-4#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#2)(2010-5#2)
used to visualise##2##3##(2008-8#1)(2012-2#1)
used to visualize the##10##4##(1993-4#1)(2007-12#1)(2008-3#1)(2008-4#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-11#2)
used to visualize##15##3##(1993-4#1)(1997-5#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-11#2)(2013-8#1)
used to##6240##2##(1990-10#6)(1990-11#25)(1990-12#26)(1990-2#18)(1990-3#13)(1990-4#14)(1990-5#12)(1990-6#5)(1990-7#10)(1990-8#22)(1990-9#12)(1991-1#8)(1991-10#2)(1991-11#11)(1991-12#21)(1991-2#23)(1991-3#14)(1991-4#13)(1991-5#12)(1991-6#14)(1991-7#13)(1991-8#14)(1991-9#24)(1992-1#17)(1992-10#1)(1992-11#9)(1992-12#21)(1992-2#16)(1992-3#13)(1992-4#8)(1992-5#2)(1992-6#17)(1992-7#12)(1992-8#14)(1992-9#10)(1993-1#6)(1993-10#2)(1993-11#17)(1993-12#20)(1993-2#11)(1993-3#21)(1993-4#7)(1993-5#13)(1993-6#15)(1993-7#8)(1993-8#16)(1993-9#14)(1994-1#1)(1994-10#7)(1994-11#16)(1994-12#24)(1994-2#20)(1994-3#24)(1994-4#2)(1994-5#27)(1994-6#20)(1994-7#2)(1994-8#13)(1994-9#19)(1995-1#22)(1995-10#12)(1995-11#16)(1995-12#18)(1995-2#26)(1995-3#17)(1995-4#7)(1995-5#17)(1995-6#12)(1995-7#5)(1995-8#13)(1995-9#4)(1996-1#14)(1996-10#5)(1996-11#15)(1996-12#26)(1996-2#22)(1996-3#24)(1996-4#5)(1996-5#25)(1996-6#7)(1996-7#11)(1996-8#10)(1996-9#8)(1997-1#18)(1997-2#25)(1997-3#20)(1997-4#24)(1997-5#10)(1997-6#18)(1997-7#15)(1997-8#22)(1997-9#1)(2004-10#2)(2004-11#7)(2004-12#8)(2004-2#5)(2004-3#1)(2004-4#4)(2004-8#1)(2004-9#8)(2005-1#2)(2005-10#17)(2005-11#65)(2005-12#11)(2005-4#4)(2005-5#4)(2005-7#8)(2005-8#8)(2005-9#9)(2006-1#5)(2006-10#71)(2006-11#25)(2006-12#47)(2006-2#19)(2006-3#11)(2006-4#11)(2006-5#21)(2006-6#13)(2006-7#17)(2006-8#21)(2006-9#7)(2007-1#17)(2007-10#41)(2007-11#119)(2007-12#173)(2007-2#24)(2007-3#15)(2007-4#33)(2007-5#16)(2007-6#17)(2007-7#36)(2007-8#96)(2007-9#25)(2008-1#73)(2008-10#914)(2008-11#158)(2008-12#42)(2008-2#330)(2008-3#350)(2008-4#211)(2008-5#122)(2008-6#55)(2008-7#136)(2008-8#103)(2008-9#105)(2009-10#27)(2009-11#25)(2009-12#20)(2009-2#11)(2009-3#20)(2009-4#29)(2009-5#23)(2009-6#13)(2009-7#26)(2009-8#24)(2009-9#22)(2010-1#10)(2010-10#10)(2010-11#26)(2010-12#36)(2010-2#35)(2010-3#30)(2010-4#31)(2010-5#38)(2010-6#18)(2010-7#20)(2010-8#31)(2010-9#13)(2011-1#90)(2011-12#15)(2011-2#104)(2011-3#5)(2011-9#1)(2012-1#46)(2012-11#18)(2012-12#68)(2012-2#98)(2012-3#73)(2012-5#1)(2012-8#1)(2013-1#157)(2013-7#25)(2013-8#66)
used today##10##2##(1991-6#1)(1992-6#1)(1994-5#1)(2006-10#1)(2006-6#1)(2007-12#2)(2008-4#1)(2008-5#2)
used together to##3##3##(2007-9#1)(2008-3#1)(2010-11#1)
used together with the##2##4##(2008-10#1)(2008-3#1)
used together with##7##3##(1996-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-7#1)(2011-12#1)
used together##14##2##(1996-2#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2010-11#1)(2010-7#1)(2011-12#2)(2012-12#1)(2013-7#1)
used tool for the##2##4##(2009-1#1)(2011-1#1)
used tool to##2##3##(2012-2#2)
used tool##6##2##(2006-10#1)(2009-1#1)(2011-1#1)(2012-2#2)(2012-3#1)
used topical##2##2##(1997-2#1)(2009-8#1)
used traditional##3##2##(2008-10#1)(2010-8#1)(2013-7#1)
used traditionally as##2##3##(2008-5#1)(2010-12#1)
used traditionally##6##2##(1996-4#1)(2007-6#1)(2008-1#1)(2008-5#1)(2010-12#1)(2012-2#1)
used transcranial##2##2##(1996-6#1)(2006-12#1)
used transformation##2##2##(2010-7#1)(2012-11#1)
used treatment for##3##3##(2006-11#1)(2008-5#1)(2008-7#1)
used treatment##7##2##(1994-2#1)(2006-11#1)(2007-7#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
used treatments##2##2##(2005-8#1)(2011-1#1)
used two different##3##3##(2008-11#1)(2008-2#1)(2012-1#1)
used two methods##3##3##(1994-11#1)(2008-5#1)(2009-9#1)
used two sets of##2##4##(1995-1#1)(2013-1#1)
used two##21##2##(1990-8#1)(1992-12#1)(1993-7#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-2#1)(1997-7#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2012-1#1)(2013-1#1)(2013-8#1)
used two-stage##2##2##(2008-2#1)(2012-12#1)
used type of##3##3##(2010-8#1)(2011-1#2)
used types of##2##3##(2007-8#1)(2010-6#1)
used under##8##2##(1990-2#1)(2007-11#1)(2008-1#1)(2008-10#3)(2011-2#1)(2013-1#1)
used until##3##2##(1995-2#1)(2006-2#1)(2006-4#1)
used up to##3##3##(2006-12#1)(2007-7#1)(2008-10#1)
used up##4##2##(1994-9#1)(2006-12#1)(2007-7#1)(2008-10#1)
used various##4##2##(1994-10#1)(2006-9#1)(2007-6#1)(2010-11#1)
used was a##9##3##(1997-5#1)(2006-4#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-3#1)(2010-2#2)(2010-5#1)
used was significantly##2##3##(1993-7#1)(2013-7#1)
used was the##4##3##(1991-4#1)(2004-12#1)(2012-12#1)(2013-8#1)
used was##63##2##(1990-12#1)(1991-4#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1993-7#1)(1997-1#1)(1997-2#1)(1997-5#1)(2004-12#1)(2006-4#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-12#1)(2009-3#2)(2010-2#5)(2010-3#1)(2010-5#1)(2010-6#1)(2011-12#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
used water##2##2##(2008-12#1)(2011-1#1)
used were the##4##3##(1997-4#1)(2005-11#1)(2007-7#1)(2011-1#1)
used were##47##2##(1990-3#1)(1990-8#1)(1992-8#1)(1993-11#1)(1993-6#1)(1996-3#1)(1996-5#1)(1997-4#1)(2005-10#1)(2005-11#1)(2006-7#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-5#1)(2008-6#2)(2010-12#1)(2010-4#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
used when a##3##3##(1996-12#1)(2005-8#1)(2008-10#1)
used when the##4##3##(1994-3#1)(2006-3#1)(2008-10#1)(2008-4#1)
used when there##2##3##(2008-10#1)(2010-12#1)
used when##37##2##(1991-12#1)(1993-8#1)(1994-3#1)(1996-12#1)(1996-4#1)(2005-8#1)(2006-10#1)(2006-3#1)(2007-12#2)(2008-1#2)(2008-10#7)(2008-12#1)(2008-2#2)(2008-4#3)(2008-7#2)(2008-9#2)(2009-10#1)(2010-12#2)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#1)
used where##2##2##(1992-12#1)(1997-2#1)
used which##6##2##(1992-3#1)(1992-7#1)(1994-12#1)(1996-9#1)(2008-10#1)(2012-12#1)
used while##3##2##(1994-12#1)(2007-8#1)(2011-2#1)
used widely as a##3##4##(2006-3#1)(2008-10#1)(2008-4#1)
used widely as##4##3##(2006-3#1)(2007-9#1)(2008-10#1)(2008-4#1)
used widely by##2##3##(1993-11#1)(2006-12#1)
used widely for##3##3##(2007-12#1)(2007-8#1)(2009-6#1)
used widely in##9##3##(1994-11#1)(1996-11#1)(1996-12#1)(2006-10#1)(2008-10#1)(2008-3#1)(2009-3#1)(2011-1#1)(2012-12#1)
used widely##23##2##(1993-11#1)(1994-11#1)(1996-11#1)(1996-12#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-3#1)(2009-6#1)(2010-10#1)(2011-1#1)(2012-12#1)(2013-8#1)
used with a plot of the dimensionless radii of the drop base##2##12##(2005-11#2)
used with a##22##3##(1991-2#1)(1992-2#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-12#1)(1996-6#1)(2005-11#2)(2005-12#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#3)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)
used with all##2##3##(2006-12#1)(2008-2#1)
used with an##6##3##(2006-5#1)(2008-10#2)(2008-2#1)(2008-5#2)
used with caution##12##3##(1990-5#1)(1995-9#1)(2005-10#1)(2006-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
used with different##2##3##(2008-9#1)(2009-3#1)
used with good##3##3##(1991-5#1)(2006-12#1)(2008-1#1)
used with heterodyne detection to measure##2##6##(2007-12#1)(2008-3#1)
used with light##2##3##(1997-6#1)(2005-7#1)
used with most##3##3##(1992-1#1)(2008-1#1)(2008-2#1)
used with regard to##2##4##(2008-7#1)(2010-4#1)
used with success for##3##4##(1992-11#1)(2007-11#1)(2009-2#1)
used with success##7##3##(1992-11#1)(2006-2#1)(2006-5#1)(2007-11#2)(2008-5#1)(2009-2#1)
used with the aim##2##4##(2008-10#1)(2011-2#1)
used with the##22##3##(1992-9#1)(1996-5#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-4#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#1)(2009-8#1)(2010-12#1)(2011-2#3)
used with this##2##3##(2008-12#1)(2011-12#1)
used with variable##3##3##(2008-11#1)(2013-1#2)
used with varying##2##3##(1990-2#1)(2005-8#1)
used with##199##2##(1990-2#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2005-10#2)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#3)(2006-8#1)(2007-1#1)(2007-11#6)(2007-12#6)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#7)(2008-10#18)(2008-11#4)(2008-12#1)(2008-2#11)(2008-3#16)(2008-4#7)(2008-5#6)(2008-6#1)(2008-7#5)(2008-9#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#8)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#1)
used within a##3##3##(2007-12#1)(2008-11#1)(2008-2#1)
used within the##3##3##(2007-12#1)(2010-2#1)(2013-7#1)
used within##9##2##(1997-8#1)(2006-11#1)(2007-12#2)(2008-11#1)(2008-2#1)(2010-2#1)(2011-2#1)(2013-7#1)
used without##6##2##(2006-6#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)
used worldwide##4##2##(2008-10#1)(2010-3#1)(2010-8#1)(2011-1#1)
used##18829##1##(1990-1#3)(1990-10#32)(1990-11#55)(1990-12#73)(1990-2#45)(1990-3#37)(1990-4#32)(1990-5#37)(1990-6#22)(1990-7#23)(1990-8#49)(1990-9#27)(1991-1#17)(1991-10#18)(1991-11#29)(1991-12#54)(1991-2#50)(1991-3#34)(1991-4#37)(1991-5#37)(1991-6#34)(1991-7#33)(1991-8#28)(1991-9#45)(1992-1#40)(1992-10#12)(1992-11#32)(1992-12#54)(1992-2#63)(1992-3#49)(1992-4#24)(1992-5#18)(1992-6#45)(1992-7#32)(1992-8#53)(1992-9#38)(1993-1#18)(1993-10#11)(1993-11#52)(1993-12#62)(1993-2#43)(1993-3#53)(1993-4#21)(1993-5#26)(1993-6#33)(1993-7#20)(1993-8#27)(1993-9#50)(1994-1#10)(1994-10#14)(1994-11#49)(1994-12#68)(1994-2#62)(1994-3#69)(1994-4#4)(1994-5#55)(1994-6#63)(1994-7#7)(1994-8#40)(1994-9#52)(1995-1#55)(1995-10#17)(1995-11#45)(1995-12#62)(1995-2#64)(1995-3#38)(1995-4#19)(1995-5#37)(1995-6#41)(1995-7#12)(1995-8#41)(1995-9#15)(1996-1#33)(1996-10#19)(1996-11#41)(1996-12#81)(1996-2#64)(1996-3#62)(1996-4#25)(1996-5#71)(1996-6#34)(1996-7#32)(1996-8#42)(1996-9#43)(1997-1#51)(1997-2#77)(1997-3#75)(1997-4#72)(1997-5#37)(1997-6#54)(1997-7#44)(1997-8#63)(1997-9#3)(2004-1#8)(2004-10#11)(2004-11#21)(2004-12#17)(2004-2#11)(2004-3#2)(2004-4#15)(2004-7#3)(2004-8#6)(2004-9#37)(2005-1#6)(2005-10#66)(2005-11#159)(2005-12#35)(2005-3#6)(2005-4#23)(2005-5#7)(2005-6#2)(2005-7#30)(2005-8#39)(2005-9#23)(2006-1#10)(2006-10#241)(2006-11#55)(2006-12#151)(2006-2#50)(2006-3#33)(2006-4#55)(2006-5#63)(2006-6#72)(2006-7#51)(2006-8#99)(2006-9#34)(2007-1#49)(2007-10#122)(2007-11#405)(2007-12#479)(2007-2#89)(2007-3#53)(2007-4#68)(2007-5#42)(2007-6#55)(2007-7#179)(2007-8#316)(2007-9#75)(2008-1#222)(2008-10#2844)(2008-11#481)(2008-12#164)(2008-2#763)(2008-3#887)(2008-4#566)(2008-5#435)(2008-6#180)(2008-7#363)(2008-8#293)(2008-9#294)(2009-1#5)(2009-10#65)(2009-11#48)(2009-12#54)(2009-2#54)(2009-3#68)(2009-4#70)(2009-5#57)(2009-6#50)(2009-7#58)(2009-8#72)(2009-9#53)(2010-1#31)(2010-10#35)(2010-11#72)(2010-12#157)(2010-2#105)(2010-3#72)(2010-4#106)(2010-5#105)(2010-6#59)(2010-7#62)(2010-8#127)(2010-9#43)(2011-1#257)(2011-10#3)(2011-12#49)(2011-2#413)(2011-3#19)(2011-7#1)(2011-9#1)(2012-1#121)(2012-10#3)(2012-11#70)(2012-12#276)(2012-2#320)(2012-3#226)(2012-5#1)(2012-6#5)(2012-7#1)(2012-8#1)(2012-9#1)(2013-1#520)(2013-7#119)(2013-8#240)
used) or##2##2##(2008-1#1)(2008-4#1)
used)##12##1##(1990-2#1)(1992-12#1)(1992-5#1)(1997-5#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-4#1)(2012-1#1)(2013-1#1)
usedfor##2##1##(2008-11#2)
useful adaptations##2##2##(2008-1#2)
useful addition to the therapeutic options available for##2##8##(2005-7#1)(2010-12#1)
useful addition to the##3##4##(2005-7#1)(2010-12#1)(2012-3#1)
useful addition to##8##3##(1993-12#1)(2005-7#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-12#1)(2012-3#1)
useful additional##2##2##(1991-9#1)(2007-2#1)
useful adjunct in##4##3##(1997-8#1)(2007-8#1)(2007-9#1)(2009-8#1)
useful adjunct to##9##3##(1993-2#1)(2005-9#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-8#1)(2009-10#1)(2010-11#1)(2012-3#1)
useful adjunct##14##2##(1993-2#1)(1997-8#1)(2005-9#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-11#1)(2012-3#1)
useful adjuncts##2##2##(2007-9#1)(2013-1#1)
useful against Alzheimer's##2##3##(1995-12#1)(2005-8#1)
useful against##3##2##(1995-12#1)(2005-7#1)(2005-8#1)
useful agent for##3##3##(2006-10#1)(2008-7#1)(2010-8#1)
useful agent in##2##3##(1993-3#1)(2007-11#1)
useful agent##6##2##(1993-3#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-7#1)(2010-8#1)
useful agents for the treatment##2##5##(2008-8#1)(2010-1#1)
useful agents for##3##3##(1992-2#1)(2008-8#1)(2010-1#1)
useful agents##5##2##(1992-2#1)(1992-6#1)(2008-8#1)(2009-6#1)(2010-1#1)
useful aid in##3##3##(1992-1#1)(2008-6#1)(2012-2#1)
useful alternative for the##2##4##(2008-10#1)(2012-2#1)
useful alternative for##4##3##(2008-10#3)(2012-2#1)
useful alternative to##7##3##(1995-9#1)(1997-3#1)(2007-3#1)(2008-3#1)(2008-5#1)(2010-7#1)(2012-2#1)
useful alternative##15##2##(1995-9#1)(1997-3#1)(2007-3#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-7#1)(2012-12#1)(2012-2#2)(2012-3#1)
useful analytical tools##4##3##(2008-10#3)(2010-12#1)
useful analytical##6##2##(2008-10#4)(2008-3#1)(2010-12#1)
useful and can be##2##4##(1991-3#1)(2012-1#1)
useful and effective##2##3##(1993-12#1)(2008-8#1)
useful and important##2##3##(1995-11#1)(2008-1#1)
useful and may##2##3##(2007-8#1)(2012-2#1)
useful and practical##2##3##(2005-4#1)(2008-12#1)
useful and safe##3##3##(1994-11#1)(2007-2#1)(2011-2#1)
useful and should not##2##4##(2006-7#1)(2007-1#1)
useful and should##3##3##(2006-7#1)(2007-1#1)(2011-12#1)
useful and##51##2##(1991-12#1)(1991-3#1)(1993-12#1)(1993-8#1)(1994-11#1)(1995-11#1)(1996-12#1)(1997-3#1)(1997-5#2)(2005-4#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-2#2)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#5)
useful animal##2##2##(1994-3#1)(2008-11#1)
useful application##2##2##(1996-3#1)(2006-6#1)
useful applications for##2##3##(2008-3#1)(2012-2#1)
useful applications in##5##3##(2007-12#2)(2008-3#1)(2008-4#1)(2008-7#1)
useful applications##10##2##(2007-12#2)(2008-1#1)(2008-3#3)(2008-4#1)(2008-7#1)(2012-2#1)(2012-3#1)
useful approach to##6##3##(1990-6#1)(1996-9#1)(1997-4#1)(2008-8#1)(2011-2#1)(2012-3#1)
useful approach##15##2##(1990-6#1)(1990-7#1)(1995-8#1)(1996-9#1)(1997-4#1)(2004-10#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-3#2)
useful are##2##2##(2008-11#1)(2008-4#1)
useful as a diagnostic##2##4##(2008-7#1)(2011-1#1)
useful as a means of##2##5##(1997-4#1)(2008-11#1)
useful as a model for##3##5##(1995-8#1)(2007-7#1)(2008-1#1)
useful as a##48##3##(1990-6#2)(1993-1#1)(1993-9#2)(1994-2#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-4#3)(1997-5#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#2)
useful as an index for##2##5##(1990-8#1)(1991-11#1)
useful as an initial screening##2##5##(2008-10#1)(2008-4#1)
useful as an##10##3##(1990-8#1)(1991-11#1)(1993-4#1)(2005-11#1)(2006-11#1)(2008-10#1)(2008-4#1)(2010-7#1)(2011-2#1)(2012-1#1)
useful as diagnostic##3##3##(2008-10#1)(2008-7#1)(2009-5#1)
useful as the##2##3##(2005-3#1)(2012-12#1)
useful as they##2##3##(2006-8#1)(2008-11#1)
useful as##105##2##(1990-3#1)(1990-6#2)(1990-8#2)(1991-1#1)(1991-11#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-9#2)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-7#1)(1996-8#1)(1997-4#3)(1997-5#1)(2005-10#1)(2005-11#2)(2005-3#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#19)(2008-11#5)(2008-3#2)(2008-4#6)(2008-5#4)(2008-7#2)(2008-8#2)(2009-5#2)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-10#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#1)
useful assay##2##2##(2007-2#1)(2008-4#1)
useful because it is##2##4##(2009-2#1)(2010-9#1)
useful because of the##2##4##(2007-7#1)(2009-3#1)
useful because##9##2##(1991-12#1)(1993-12#1)(1996-9#1)(2007-7#1)(2008-2#1)(2009-2#1)(2009-3#1)(2010-9#1)(2012-12#1)
useful bedside tool##2##3##(2009-6#1)(2012-2#1)
useful biochemical marker##2##3##(1990-4#1)(2008-10#1)
useful biological##4##2##(2005-8#1)(2008-5#1)(2010-11#1)(2011-1#1)
useful biomarkers##3##2##(2006-9#1)(2010-12#1)(2010-7#1)
useful both to##3##3##(2007-8#1)(2010-4#1)(2013-1#1)
useful both##4##2##(1992-12#1)(2007-8#1)(2010-4#1)(2013-1#1)
useful but##3##2##(1992-12#1)(2011-12#1)(2013-8#1)
useful by##2##2##(2008-1#1)(2008-2#1)
useful characteristics##3##2##(2008-10#2)(2008-2#1)
useful clinical information##2##3##(2006-6#1)(2010-7#1)
useful clinical tool##3##3##(1993-12#2)(2008-12#1)
useful clinical tools##2##3##(2007-11#1)(2008-12#1)
useful clinical##9##2##(1993-12#2)(2005-11#1)(2006-6#1)(2007-11#1)(2008-12#3)(2010-7#1)
useful comparisons##2##2##(1990-12#1)(1992-9#1)
useful complementary##4##2##(2007-11#1)(2007-5#1)(2009-12#1)(2012-12#1)
useful compounds##3##2##(1994-11#2)(2009-5#1)
useful criteria for##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
useful data to##2##3##(2011-1#2)
useful data##7##2##(1994-12#1)(1994-5#1)(2008-10#1)(2008-4#1)(2011-1#2)(2012-2#1)
useful diagnostic and##2##3##(1997-4#1)(2013-7#1)
useful diagnostic methods##2##3##(2005-12#1)(2008-8#1)
useful diagnostic tool in detecting##2##5##(2007-10#1)(2007-11#1)
useful diagnostic tool in##6##4##(2007-10#1)(2007-11#1)(2007-7#1)(2008-12#1)(2010-5#1)(2012-12#1)
useful diagnostic tool##7##3##(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-12#1)(2010-5#1)(2012-12#1)
useful diagnostic tools##3##3##(2007-2#1)(2010-7#1)(2012-12#1)
useful diagnostic##21##2##(1991-3#1)(1997-4#1)(2005-12#1)(2005-8#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
useful drug##6##2##(1990-9#1)(1996-9#1)(2007-11#1)(2007-2#1)(2008-5#1)(2011-2#1)
useful drugs##3##2##(1992-3#1)(2008-5#1)(2012-3#1)
useful even in##2##3##(1995-10#1)(2011-2#1)
useful even when##2##3##(2008-1#1)(2013-1#1)
useful even##4##2##(1995-10#1)(2008-1#1)(2011-2#1)(2013-1#1)
useful experimental##4##2##(1994-3#1)(1996-8#1)(2007-9#1)(2008-10#1)
useful for a better##2##4##(1990-12#1)(2008-7#1)
useful for a variety of##5##5##(1994-5#1)(2008-4#1)(2013-1#3)
useful for a##10##3##(1990-12#1)(1994-5#1)(1996-6#1)(1997-2#1)(2008-11#1)(2008-4#1)(2008-7#1)(2013-1#3)
useful for an##2##3##(1996-5#1)(2008-3#1)
useful for analysis of##4##4##(1997-2#1)(2007-11#1)(2008-10#1)(2008-4#1)
useful for analyzing the##4##4##(1993-6#1)(1997-6#1)(2008-2#1)(2008-4#1)
useful for analyzing##6##3##(1993-6#1)(1997-6#1)(2008-2#2)(2008-4#2)
useful for application in##2##4##(2005-12#1)(2008-5#1)
useful for application##3##3##(2005-12#1)(2008-10#1)(2008-5#1)
useful for applications in##2##4##(2007-11#1)(2009-8#1)
useful for applications such as##3##5##(2007-11#1)(2007-8#1)(2008-7#1)
useful for applications##5##3##(2007-11#2)(2007-8#1)(2008-7#1)(2009-8#1)
useful for assessing the##2##4##(2008-1#1)(2008-6#1)
useful for assessing##8##3##(1996-9#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-12#1)(2012-3#1)
useful for better##2##3##(2008-10#1)(2010-12#1)
useful for both##4##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-9#1)
useful for characterizing the##3##4##(1992-1#1)(1994-11#1)(2008-11#1)
useful for characterizing##4##3##(1992-1#1)(1994-11#1)(2008-10#1)(2008-11#1)
useful for classifying##2##3##(2008-10#1)(2012-12#1)
useful for controlling##3##3##(1992-2#1)(2008-10#1)(2008-2#1)
useful for designing##3##3##(2007-3#1)(2008-2#1)(2012-2#1)
useful for detecting##6##3##(1994-7#1)(2007-10#1)(2008-12#1)(2008-4#1)(2009-7#1)(2012-11#1)
useful for detection of##3##4##(2008-10#2)(2011-2#1)
useful for detection##4##3##(1992-8#1)(2008-10#2)(2011-2#1)
useful for determining the##2##4##(2007-12#1)(2008-10#1)
useful for determining##5##3##(2007-12#1)(2008-10#1)(2008-11#2)(2012-3#1)
useful for developing##6##3##(1994-3#1)(2006-7#1)(2008-12#1)(2008-5#1)(2011-12#1)(2012-2#1)
useful for diagnosing##3##3##(2008-9#1)(2011-2#2)
useful for diagnosis and##2##4##(1996-1#1)(2012-2#1)
useful for diagnosis of acute##2##5##(2007-10#1)(2008-4#1)
useful for diagnosis##5##3##(1991-2#1)(1996-1#1)(2007-10#1)(2008-4#1)(2012-2#1)
useful for different##2##3##(2005-11#1)(2008-4#1)
useful for differential diagnosis##3##4##(2007-12#1)(2010-11#1)(2012-1#1)
useful for differential##4##3##(2007-12#1)(2008-4#1)(2010-11#1)(2012-1#1)
useful for efficient##2##3##(2008-11#1)(2013-8#1)
useful for epidemiological##2##3##(2008-4#1)(2011-2#1)
useful for establishing##3##3##(1997-5#1)(2008-4#1)(2013-1#1)
useful for estimating##4##3##(1994-3#1)(1994-9#1)(2008-10#1)(2009-9#1)
useful for evaluating##6##3##(2008-5#2)(2008-7#1)(2010-4#1)(2010-9#1)(2013-1#1)
useful for examining the##2##4##(1995-2#1)(2008-4#1)
useful for examining##6##3##(1995-2#1)(2008-2#1)(2008-4#3)(2008-7#1)
useful for functional##2##3##(1991-8#1)(2008-2#1)
useful for further##6##3##(2005-11#1)(2007-8#1)(2008-10#2)(2008-8#1)(2011-1#1)
useful for future##3##3##(2007-11#1)(2008-12#1)(2010-10#1)
useful for gene##2##3##(2008-11#1)(2012-11#1)
useful for grouping##2##3##(2008-10#2)
useful for identification of##2##4##(1993-11#1)(2008-4#1)
useful for identification##3##3##(1993-11#1)(2008-4#1)(2010-8#1)
useful for identifying##10##3##(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#4)(2013-7#2)
useful for imaging##2##3##(2008-10#1)(2008-7#1)
useful for in vivo##5##4##(1997-4#1)(2008-4#2)(2012-11#1)(2012-12#1)
useful for in##9##3##(1996-12#1)(1997-4#1)(2004-9#1)(2008-3#1)(2008-4#2)(2008-5#1)(2012-11#1)(2012-12#1)
useful for investigating the##6##4##(1995-5#1)(1997-2#1)(2008-4#2)(2008-6#1)(2013-8#1)
useful for investigating##11##3##(1993-5#1)(1994-12#1)(1995-5#1)(1997-2#1)(2006-2#1)(2008-2#1)(2008-4#2)(2008-6#1)(2010-9#1)(2013-8#1)
useful for investigation of##3##4##(1995-12#1)(1996-9#1)(2008-10#1)
useful for making##6##3##(1994-6#1)(1995-10#1)(1997-8#2)(2007-12#1)(2008-3#1)
useful for managing##3##3##(2004-11#1)(2006-5#1)(2008-10#1)
useful for many##3##3##(2007-11#1)(2008-11#1)(2008-7#1)
useful for marker-assisted selection##2##4##(2008-10#2)
useful for measuring##7##3##(1992-3#1)(2008-1#1)(2008-3#1)(2008-4#2)(2008-8#1)(2010-7#1)
useful for monitoring the##3##4##(1992-2#1)(2008-10#1)(2011-2#1)
useful for monitoring##10##3##(1992-2#1)(1997-4#1)(2008-10#4)(2008-11#1)(2010-8#1)(2011-2#1)(2013-8#1)
useful for optical##2##3##(2007-12#1)(2008-2#1)
useful for patients##2##3##(2005-7#1)(2008-3#1)
useful for planning and##2##4##(2006-10#1)(2013-7#1)
useful for planning##3##3##(2006-10#1)(2008-8#1)(2013-7#1)
useful for predicting##4##3##(2006-9#1)(2008-10#1)(2008-8#1)(2010-8#1)
useful for prediction of##2##4##(1996-3#1)(2008-7#1)
useful for prevention of##3##4##(1991-11#1)(1996-12#1)(2007-10#1)
useful for producing##2##3##(2008-10#1)(2008-2#1)
useful for providing##2##3##(2008-2#1)(2012-3#1)
useful for quality control##2##4##(2007-8#1)(2008-11#1)
useful for rapid##3##3##(1995-8#1)(2008-10#1)(2008-5#1)
useful for reconstructing the##2##4##(2007-12#1)(2008-3#1)
useful for screening purposes##2##4##(1997-1#1)(2008-10#1)
useful for screening##5##3##(1997-1#1)(2006-2#1)(2008-10#3)
useful for simultaneous##2##3##(2006-12#1)(2008-5#1)
useful for studies of##7##4##(1991-1#1)(1992-3#1)(2008-1#1)(2008-4#2)(2008-7#1)(2010-12#1)
useful for studies##9##3##(1991-1#1)(1992-3#1)(1995-12#1)(2008-1#2)(2008-4#2)(2008-7#1)(2010-12#1)
useful for study of##2##4##(1995-2#1)(2008-10#1)
useful for studying the function of##2##6##(1990-10#1)(2008-8#1)
useful for studying the role of##2##6##(1991-8#1)(1992-12#1)
useful for studying the##15##4##(1990-10#1)(1990-2#1)(1991-8#1)(1992-12#1)(1995-11#1)(1995-2#1)(1996-10#1)(1997-8#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-8#1)(2008-9#1)
useful for studying##27##3##(1990-10#1)(1990-2#1)(1990-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-9#1)(1995-11#1)(1995-2#2)(1996-10#1)(1997-4#1)(1997-6#1)(1997-8#2)(2007-12#1)(2008-10#2)(2008-11#5)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)
useful for such##2##3##(1990-8#1)(2009-10#1)
useful for targeting##2##3##(2008-7#1)(2008-8#1)
useful for the analysis of##6##5##(1994-2#1)(1995-1#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-2#1)
useful for the detection of##2##5##(1992-8#1)(2008-10#1)
useful for the detection##3##4##(1992-8#1)(2008-10#2)
useful for the determination of the##2##6##(2008-3#1)(2010-2#1)
useful for the determination of##4##5##(2008-10#2)(2008-3#1)(2010-2#1)
useful for the development of##4##5##(2007-5#1)(2008-5#1)(2008-9#1)(2012-1#1)
useful for the diagnosis of##6##5##(1990-8#1)(1993-12#1)(1996-9#1)(2008-10#1)(2008-5#2)
useful for the diagnosis##7##4##(1990-8#1)(1993-12#1)(1996-9#1)(2008-10#1)(2008-4#1)(2008-5#2)
useful for the evaluation of##6##5##(2005-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#2)
useful for the investigation of##2##5##(1993-11#1)(1996-8#1)
useful for the measurement of##2##5##(2008-10#1)(2008-7#1)
useful for the measurement##3##4##(2008-10#2)(2008-7#1)
useful for the prevention of##2##5##(1992-11#1)(2008-10#1)
useful for the rapid##4##4##(1991-10#1)(2006-3#1)(2008-11#1)(2012-2#1)
useful for the study of the##2##6##(1994-3#1)(1996-12#1)
useful for the study of##5##5##(1992-8#1)(1994-3#1)(1996-12#1)(2008-2#1)(2008-4#1)
useful for the synthesis of##2##5##(1991-2#1)(2007-11#1)
useful for the treatment of patients##2##6##(2007-10#1)(2007-11#1)
useful for the treatment of##9##5##(1990-1#1)(1992-10#1)(2005-3#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-3#1)(2011-1#2)
useful for the treatment##10##4##(1990-1#1)(1992-10#1)(2005-3#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-3#1)(2011-1#2)
useful for the##111##3##(1990-1#1)(1990-3#2)(1990-8#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-8#3)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-5#1)(2005-3#2)(2006-10#2)(2006-11#1)(2006-12#2)(2006-3#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#13)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#2)(2008-4#5)(2008-5#5)(2008-7#3)(2008-9#2)(2009-2#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
useful for their##2##3##(2007-11#1)(2010-10#1)
useful for this##3##3##(2006-12#1)(2008-10#1)(2009-7#1)
useful for treatment##7##3##(2005-3#1)(2006-5#2)(2008-1#1)(2008-4#1)(2011-2#1)(2013-8#1)
useful for understanding the##4##4##(2007-12#1)(2008-4#1)(2008-8#1)(2010-3#1)
useful for understanding##8##3##(2007-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-4#1)(2010-3#1)(2013-8#1)
useful for visualizing##2##3##(1997-2#1)(2012-2#1)
useful for##677##2##(1990-1#1)(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-6#1)(1990-7#1)(1990-8#3)(1991-1#3)(1991-10#2)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#1)(1991-6#1)(1991-8#3)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-6#1)(1992-8#5)(1993-11#2)(1993-12#3)(1993-2#2)(1993-5#2)(1993-6#2)(1993-9#3)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#6)(1994-5#1)(1994-6#4)(1994-7#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#6)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#5)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#7)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#4)(1996-6#4)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#7)(1997-3#3)(1997-4#4)(1997-5#2)(1997-6#2)(1997-8#6)(2004-11#1)(2004-12#1)(2004-9#2)(2005-10#1)(2005-11#4)(2005-12#2)(2005-3#3)(2005-4#1)(2005-7#3)(2006-10#4)(2006-11#2)(2006-12#5)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#5)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#7)(2007-11#14)(2007-12#23)(2007-2#1)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#10)(2007-9#1)(2008-1#11)(2008-10#85)(2008-11#28)(2008-12#5)(2008-2#32)(2008-3#21)(2008-4#40)(2008-5#16)(2008-6#2)(2008-7#19)(2008-8#9)(2008-9#9)(2009-10#4)(2009-2#1)(2009-4#2)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#6)(2010-2#6)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#7)(2010-9#2)(2011-1#9)(2011-12#1)(2011-2#13)(2012-1#3)(2012-11#4)(2012-12#5)(2012-2#14)(2012-3#10)(2013-1#16)(2013-7#4)(2013-8#12)
useful frequency##2##2##(2008-2#1)(2008-3#1)
useful functions##2##2##(2008-7#1)(2010-8#1)
useful genes##2##2##(2009-10#1)(2011-1#1)
useful genetic##5##2##(1996-10#1)(2008-10#2)(2008-8#1)(2012-11#1)
useful guide for##3##3##(2007-10#1)(2008-11#1)(2011-1#1)
useful guide##6##2##(2007-10#1)(2008-10#1)(2008-11#1)(2009-4#1)(2011-1#1)(2013-7#1)
useful guides##2##2##(2008-5#1)(2012-2#1)
useful if##3##2##(2005-11#1)(2008-10#1)(2011-2#1)
useful in a variety of##6##5##(1990-12#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-3#1)
useful in a wide variety of##2##6##(1995-1#1)(2011-1#1)
useful in a wide##3##4##(1995-1#1)(1996-5#1)(2011-1#1)
useful in a##17##3##(1990-12#1)(1995-1#1)(1996-5#1)(1997-3#1)(2006-7#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2010-3#1)(2011-1#2)(2012-2#1)
useful in analysing##2##3##(1994-4#1)(2007-8#1)
useful in analyzing the##3##4##(2008-2#1)(2008-4#1)(2009-4#1)
useful in assessing the##5##4##(1994-2#1)(1996-12#1)(2007-6#1)(2008-2#1)(2010-10#1)
useful in assessing##8##3##(1994-2#1)(1996-12#1)(2007-6#1)(2008-2#1)(2008-7#1)(2010-10#1)(2010-8#1)(2011-2#1)
useful in assisting##4##3##(2008-12#1)(2008-5#1)(2010-5#1)(2012-12#1)
useful in both the##2##4##(1994-2#1)(2008-2#1)
useful in cancer##2##3##(2008-3#1)(2009-3#1)
useful in characterizing##2##3##(2007-2#1)(2008-9#1)
useful in clinical practice##2##4##(1995-1#1)(2008-3#1)
useful in clinical##6##3##(1990-8#1)(1995-1#1)(1996-11#1)(2008-3#1)(2008-5#1)(2013-1#1)
useful in combination with##2##4##(2008-3#2)
useful in comparative##2##3##(2008-7#1)(2011-12#1)
useful in creating##2##3##(2008-2#1)(2012-3#1)
useful in delineating##2##3##(1990-10#1)(1992-8#1)
useful in designing##3##3##(1994-2#1)(1996-6#1)(2008-3#1)
useful in detecting##7##3##(1991-4#1)(1997-6#1)(2007-9#1)(2010-7#1)(2010-8#1)(2012-2#2)
useful in determining the##6##4##(1991-7#1)(1992-2#1)(1997-6#1)(2004-11#1)(2005-6#1)(2006-2#1)
useful in determining##15##3##(1990-5#1)(1991-7#1)(1992-2#1)(1995-12#1)(1996-2#1)(1996-5#1)(1997-6#1)(2004-11#1)(2005-6#1)(2006-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-4#1)(2011-12#1)
useful in developing##8##3##(1994-11#1)(2008-10#3)(2009-9#1)(2011-2#1)(2011-3#1)(2013-8#1)
useful in differentiating between##2##4##(1994-6#1)(2012-2#1)
useful in differentiating##5##3##(1994-6#1)(2005-11#1)(2008-5#1)(2012-2#2)
useful in discriminating between##2##4##(2008-5#1)(2008-7#1)
useful in discriminating##3##3##(2008-12#1)(2008-5#1)(2008-7#1)
useful in distinguishing##3##3##(2010-12#1)(2013-1#1)(2013-8#1)
useful in early##2##3##(2006-10#1)(2011-2#1)
useful in establishing##2##3##(1997-4#1)(2006-1#1)
useful in evaluating##4##3##(2006-5#1)(2007-7#1)(2008-6#1)(2010-11#1)
useful in further studies on##2##5##(1993-1#1)(1993-8#1)
useful in further studies##3##4##(1993-1#1)(1993-8#1)(1994-9#1)
useful in further##5##3##(1993-1#1)(1993-8#1)(1994-8#1)(1994-9#1)(2012-3#1)
useful in future studies of##3##5##(2007-7#1)(2008-10#1)(2013-1#1)
useful in future##6##3##(2007-12#1)(2007-7#1)(2008-10#1)(2013-1#3)
useful in helping##3##3##(2008-10#2)(2008-4#1)
useful in identifying##12##3##(1992-5#1)(1994-6#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-8#1)(2008-11#1)(2008-9#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)
useful in imaging##2##3##(2007-11#1)(2007-12#1)
useful in indicating##2##3##(2008-11#1)(2013-1#1)
useful in inhibiting##3##3##(1991-12#1)(1991-5#1)(1992-1#1)
useful in investigating##2##3##(2006-5#1)(2008-3#1)
useful in maintaining##2##3##(2008-4#1)(2010-12#1)
useful in making##3##3##(1990-2#1)(2008-3#1)(2008-4#1)
useful in measuring##4##3##(1994-12#1)(2007-11#1)(2008-8#1)(2013-1#1)
useful in modeling##2##3##(2008-11#1)(2013-8#1)
useful in monitoring##4##3##(2006-10#1)(2008-10#1)(2008-2#1)(2008-7#1)
useful in most##2##3##(1992-11#1)(1996-12#1)
useful in patients with##4##4##(1990-10#1)(1991-8#1)(1992-12#1)(1997-1#1)
useful in patients##7##3##(1990-10#1)(1991-8#1)(1992-12#1)(1993-9#1)(1995-2#1)(1996-12#1)(1997-1#1)
useful in planning##5##3##(2006-10#1)(2006-2#1)(2006-5#1)(2008-9#1)(2009-8#1)
useful in predicting the##4##4##(2007-12#1)(2008-5#3)
useful in predicting##10##3##(1992-3#1)(1996-6#1)(2007-12#1)(2007-8#1)(2008-5#3)(2008-7#1)(2009-5#1)(2013-1#1)
useful in preventing and treating##2##5##(2007-11#1)(2013-7#1)
useful in preventing##8##3##(2006-10#1)(2006-7#1)(2007-11#1)(2008-11#1)(2010-1#1)(2010-7#1)(2010-8#1)(2013-7#1)
useful in providing##2##3##(2008-10#1)(2008-11#1)
useful in quantifying##2##3##(2008-1#1)(2008-10#1)
useful in quantitative##2##3##(1990-11#1)(2008-4#1)
useful in screening for##4##4##(1996-3#1)(2008-10#1)(2008-6#1)(2008-7#1)
useful in screening##5##3##(1996-3#1)(2008-10#1)(2008-6#1)(2008-7#1)(2012-3#1)
useful in selected##2##3##(2006-8#1)(2007-11#1)
useful in selecting a##2##4##(1995-9#1)(2008-10#1)
useful in selecting##4##3##(1992-2#1)(1995-9#1)(2008-10#1)(2008-8#1)
useful in some patients##3##4##(1997-1#1)(1997-8#1)(2006-10#1)
useful in some##5##3##(1997-1#1)(1997-8#1)(2004-1#1)(2006-10#1)(2008-1#1)
useful in studies of##3##4##(1993-11#1)(1994-3#1)(2006-10#1)
useful in studies##7##3##(1990-7#1)(1991-1#1)(1991-12#1)(1992-6#1)(1993-11#1)(1994-3#1)(2006-10#1)
useful in studying the##8##4##(1990-5#1)(1991-10#1)(1992-7#1)(1993-6#1)(1994-6#1)(1996-12#1)(1996-8#1)(2008-4#1)
useful in studying##12##3##(1990-5#1)(1991-10#1)(1992-7#1)(1993-6#1)(1994-6#1)(1996-12#1)(1996-8#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-9#1)
useful in that they##2##4##(2008-4#1)(2011-2#1)
useful in that##4##3##(2008-10#1)(2008-4#2)(2011-2#1)
useful in the analysis of##2##5##(2008-10#1)(2010-3#1)
useful in the assessment of##2##5##(1991-8#1)(2007-2#1)
useful in the design of##5##5##(1995-6#1)(2006-11#1)(2006-12#1)(2008-2#1)(2012-2#1)
useful in the detection and##2##5##(1996-6#1)(2008-10#1)
useful in the detection of##2##5##(1994-12#1)(2008-7#1)
useful in the detection##4##4##(1994-12#1)(1996-6#1)(2008-10#1)(2008-7#1)
useful in the development of##6##5##(1994-11#1)(1994-3#1)(1994-6#1)(2007-12#1)(2008-10#1)(2011-12#1)
useful in the diagnosis and##3##5##(1990-12#1)(2008-12#1)(2011-2#1)
useful in the diagnosis of##11##5##(1994-11#1)(1994-6#1)(1996-11#1)(2005-11#1)(2006-6#1)(2007-10#2)(2007-9#1)(2010-6#1)(2011-12#1)(2011-2#1)
useful in the diagnosis##14##4##(1990-12#1)(1994-11#1)(1994-6#1)(1996-11#1)(2005-11#1)(2006-6#1)(2007-10#2)(2007-9#1)(2008-12#1)(2010-6#1)(2011-12#1)(2011-2#2)
useful in the differential diagnosis##2##5##(1990-9#1)(2008-7#1)
useful in the early##2##4##(1995-2#1)(2008-8#1)
useful in the emergency##2##4##(2007-7#1)(2011-2#1)
useful in the evaluation of##2##5##(2007-10#1)(2008-9#1)
useful in the evaluation##3##4##(2007-10#1)(2008-2#1)(2008-9#1)
useful in the fabrication of##2##5##(2007-12#2)
useful in the field##2##4##(2008-10#1)(2013-1#1)
useful in the identification##2##4##(1995-1#1)(2007-1#1)
useful in the investigation of##3##5##(1994-6#1)(2008-2#1)(2012-8#1)
useful in the management of##10##5##(1994-6#1)(1996-6#1)(1997-8#1)(2004-1#1)(2004-2#1)(2005-4#1)(2005-7#1)(2005-9#1)(2009-11#1)(2010-9#1)
useful in the management##11##4##(1994-6#1)(1996-6#1)(1997-8#1)(2004-1#1)(2004-2#1)(2005-4#1)(2005-7#1)(2005-9#1)(2006-2#1)(2009-11#1)(2010-9#1)
useful in the prediction of##4##5##(1995-8#1)(1996-7#1)(2007-6#1)(2008-9#1)
useful in the study of the##3##6##(1991-5#1)(2008-1#1)(2008-2#1)
useful in the study of##7##5##(1990-1#1)(1991-5#1)(1993-4#1)(1995-5#1)(2008-1#1)(2008-2#1)(2008-3#1)
useful in the treatment of##13##5##(1991-11#1)(2005-7#1)(2006-7#1)(2007-11#2)(2007-6#1)(2007-8#2)(2008-10#1)(2008-5#3)(2009-5#1)
useful in the treatment##14##4##(1991-11#1)(2005-7#1)(2006-7#1)(2007-11#2)(2007-2#1)(2007-6#1)(2007-8#2)(2008-10#1)(2008-5#3)(2009-5#1)
useful in the##141##3##(1990-1#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-11#2)(1991-5#2)(1991-8#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-6#4)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-6#2)(1996-7#1)(1997-6#1)(1997-8#2)(2004-1#1)(2004-2#1)(2005-11#1)(2005-4#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-11#3)(2006-12#1)(2006-2#1)(2006-6#2)(2006-7#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#7)(2007-2#3)(2007-6#3)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#8)(2008-3#2)(2008-4#1)(2008-5#5)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-9#1)(2011-12#3)(2011-2#3)(2012-2#3)(2012-8#1)(2013-1#1)(2013-8#2)
useful in these patients##2##4##(2007-9#1)(2011-1#1)
useful in this##3##3##(2007-8#1)(2008-11#1)(2012-1#1)
useful in treating##6##3##(2006-10#1)(2006-5#1)(2007-11#1)(2007-9#1)(2008-4#1)(2013-1#1)
useful in understanding##9##3##(1990-4#1)(1995-11#1)(1996-12#1)(2007-4#1)(2008-10#2)(2008-7#1)(2010-12#1)(2012-2#1)
useful in vivo##2##3##(1995-7#1)(2008-11#1)
useful in##582##2##(1990-1#1)(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#3)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#3)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#3)(1994-2#3)(1994-3#2)(1994-4#1)(1994-6#8)(1994-7#1)(1994-8#2)(1994-9#4)(1995-1#4)(1995-11#3)(1995-12#1)(1995-2#3)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#6)(1996-2#2)(1996-3#2)(1996-5#2)(1996-6#6)(1996-7#1)(1996-8#3)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#3)(1997-7#1)(1997-8#4)(2004-1#2)(2004-11#3)(2004-2#1)(2005-10#2)(2005-11#3)(2005-4#1)(2005-6#2)(2005-7#2)(2005-8#3)(2005-9#3)(2006-1#2)(2006-10#14)(2006-11#3)(2006-12#3)(2006-2#4)(2006-3#2)(2006-5#4)(2006-6#4)(2006-7#5)(2006-8#3)(2007-1#1)(2007-10#4)(2007-11#15)(2007-12#11)(2007-2#6)(2007-3#2)(2007-4#1)(2007-6#4)(2007-7#5)(2007-8#9)(2007-9#6)(2008-1#3)(2008-10#40)(2008-11#12)(2008-12#6)(2008-2#23)(2008-3#20)(2008-4#17)(2008-5#19)(2008-6#5)(2008-7#15)(2008-8#7)(2008-9#10)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#2)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#4)(2010-4#5)(2010-5#2)(2010-6#3)(2010-7#4)(2010-8#5)(2010-9#1)(2011-1#6)(2011-12#5)(2011-2#9)(2011-3#1)(2011-7#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#13)(2012-3#4)(2012-8#1)(2013-1#21)(2013-7#2)(2013-8#9)
useful indicators for##2##3##(2004-4#1)(2007-12#1)
useful indicators of##3##3##(1992-8#1)(2004-4#1)(2010-4#1)
useful indicators##6##2##(1992-8#1)(1994-6#1)(2004-4#2)(2007-12#1)(2010-4#1)
useful information about the nature of##2##6##(2008-9#1)(2010-8#1)
useful information about the##8##4##(1991-2#1)(1992-8#1)(2007-10#1)(2007-11#1)(2008-9#1)(2009-7#1)(2010-8#1)(2012-3#1)
useful information about##13##3##(1991-2#1)(1992-8#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-7#1)
useful information and##5##3##(2007-11#1)(2008-4#1)(2008-7#1)(2009-12#1)(2013-7#1)
useful information concerning the##2##4##(1994-12#1)(2010-8#1)
useful information concerning##3##3##(1994-12#1)(2010-8#1)(2011-1#1)
useful information for further##2##4##(2008-10#1)(2012-3#1)
useful information for##16##3##(1992-10#1)(1992-5#1)(1996-3#1)(2005-4#1)(2008-10#4)(2008-2#1)(2009-11#1)(2010-10#1)(2010-5#2)(2012-12#1)(2012-3#1)(2013-1#1)
useful information from a##2##4##(2008-12#1)(2009-12#1)
useful information from##3##3##(1997-3#1)(2008-12#1)(2009-12#1)
useful information in##2##3##(2008-3#1)(2008-4#1)
useful information on the##4##4##(1996-6#1)(2008-5#1)(2009-5#1)(2012-2#1)
useful information on##6##3##(1996-6#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2012-2#1)
useful information to##3##3##(2007-10#1)(2010-7#1)(2012-12#1)
useful information##66##2##(1991-2#1)(1992-10#1)(1992-5#1)(1992-8#1)(1994-12#2)(1994-3#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(2005-4#1)(2007-10#2)(2007-11#2)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#2)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#2)
useful informations##2##2##(1995-8#1)(2013-1#1)
useful inhibitors##2##2##(1992-10#1)(2005-8#1)
useful insight into the##2##4##(2009-5#1)(2012-2#1)
useful insights for##2##3##(2006-2#1)(2007-12#1)
useful insights into##2##3##(2007-12#1)(2009-6#1)
useful insights on##2##3##(2008-11#1)(2012-1#1)
useful insights##8##2##(1997-3#1)(2006-2#1)(2007-12#2)(2008-11#1)(2009-12#1)(2009-6#1)(2012-1#1)
useful instrument##2##2##(1992-1#1)(1995-2#1)
useful intermediates in##2##3##(1996-5#1)(2007-11#1)
useful intermediates##3##2##(1996-5#1)(2007-11#2)
useful inventions##3##2##(2011-2#3)
useful is the##2##3##(1990-10#1)(2008-9#1)
useful is##5##2##(1990-10#1)(1993-8#1)(2008-9#1)(2011-12#1)(2012-3#1)
useful levels##2##2##(2008-3#1)(2009-5#1)
useful life of##2##3##(1990-8#1)(2008-10#1)
useful life##3##2##(1990-8#1)(2008-10#1)(2008-2#1)
useful lifetime of##4##3##(2008-10#3)(2009-11#1)
useful local##3##2##(2005-7#1)(2008-3#1)(2008-7#1)
useful marker for##6##3##(1994-6#1)(2008-4#2)(2008-6#1)(2010-8#1)(2011-2#1)
useful marker##18##2##(1990-5#1)(1990-8#1)(1991-11#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-9#1)(2006-9#1)(2007-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2010-5#1)(2010-8#1)(2011-2#2)(2013-1#1)
useful markers for##3##3##(1994-9#1)(1996-6#1)(2008-11#1)
useful markers of##2##3##(2009-5#1)(2009-6#1)
useful markers to##2##3##(2008-12#1)(2009-8#1)
useful markers##7##2##(1994-9#1)(1996-6#1)(2008-11#1)(2008-12#1)(2009-5#1)(2009-6#1)(2009-8#1)
useful material for##3##3##(2005-4#1)(2008-10#1)(2008-4#1)
useful material##4##2##(2005-4#1)(2008-10#1)(2008-4#1)(2013-1#1)
useful means for##4##3##(2008-10#1)(2008-12#1)(2008-9#2)
useful means##8##2##(1990-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#2)(2012-2#1)
useful measure##3##2##(1992-8#1)(2007-11#1)(2012-3#1)
useful measurements and data##2##4##(2008-2#2)
useful measurements##3##2##(2008-2#2)(2008-3#1)
useful measures##2##2##(1990-2#1)(2008-12#1)
useful medium##2##2##(2008-11#1)(2008-5#1)
useful method for##16##3##(1990-12#1)(1991-4#1)(1996-7#1)(1996-9#1)(2004-9#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2009-8#1)(2012-3#1)(2013-1#1)
useful method in the##2##4##(1995-4#1)(2004-11#1)
useful method of evaluating##2##4##(1995-6#1)(2008-2#1)
useful method of##11##3##(1994-5#1)(1995-6#1)(1996-5#1)(1996-6#1)(2005-11#1)(2006-5#1)(2007-3#1)(2007-9#2)(2008-2#1)(2010-6#1)
useful method to##7##3##(1992-8#1)(2006-10#1)(2008-1#2)(2008-11#1)(2008-4#1)(2010-6#1)
useful method##38##2##(1990-12#1)(1991-4#1)(1992-8#1)(1994-5#1)(1995-4#1)(1995-6#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(2004-11#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-5#1)(2007-3#1)(2007-7#1)(2007-9#3)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-4#3)(2008-6#1)(2009-8#1)(2010-6#2)(2012-3#1)(2013-1#1)
useful methods for##3##3##(1996-4#1)(2005-8#1)(2012-2#1)
useful methods of##3##3##(1993-2#1)(2007-11#1)(2007-7#1)
useful methods##9##2##(1993-2#1)(1996-4#1)(2005-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-4#1)(2012-2#1)(2013-8#1)
useful modality of treatment##2##4##(1994-12#1)(2006-5#1)
useful modality##4##2##(1994-12#1)(2006-3#1)(2006-5#1)(2011-2#1)
useful model for the study of##4##6##(1994-2#2)(1997-4#1)(2009-9#1)
useful model for##15##3##(1990-5#1)(1994-2#3)(1995-12#1)(1995-3#1)(1997-4#1)(2004-11#1)(2006-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2009-3#1)(2009-9#1)
useful model to##4##3##(1990-8#1)(1994-12#1)(2010-12#1)(2012-12#1)
useful model##25##2##(1990-5#1)(1990-7#1)(1990-8#1)(1994-12#1)(1994-2#3)(1995-12#1)(1995-3#2)(1997-4#1)(2004-11#1)(2006-2#1)(2007-10#1)(2008-10#1)(2008-11#3)(2008-4#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#1)
useful models for the##2##4##(1991-9#1)(1995-8#1)
useful models for##3##3##(1991-9#1)(1995-11#1)(1995-8#1)
useful models##4##2##(1991-9#1)(1995-11#1)(1995-8#1)(2007-11#1)
useful molecular##6##2##(1992-5#1)(1994-8#1)(2004-9#1)(2006-10#1)(2008-10#1)(2008-9#1)
useful new##2##2##(2005-7#1)(2006-2#1)
useful noninvasive##2##2##(2006-10#1)(2006-12#1)
useful nonnatural amino acids##2##4##(2009-9#2)
useful not only for##3##4##(1995-4#1)(1997-4#1)(2008-4#1)
useful optical##3##2##(2007-11#1)(2008-3#1)(2008-7#1)
useful option for##5##3##(2007-8#1)(2008-1#1)(2011-2#1)(2012-12#2)
useful option##8##2##(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-1#1)(2011-2#1)(2012-12#2)
useful or##4##2##(1995-8#1)(2008-12#1)(2009-6#1)(2013-8#1)
useful parameter to##3##3##(1992-12#1)(2008-10#1)(2010-7#1)
useful patterns##4##2##(2008-2#3)(2008-9#1)
useful pharmacological##2##2##(1996-10#1)(2009-12#1)
useful platform for##2##3##(1994-6#1)(2008-4#1)
useful predictive##2##2##(2008-8#1)(2010-8#1)
useful predictor variables##3##3##(2008-10#3)
useful predictor##5##2##(2008-10#3)(2008-3#1)(2013-1#1)
useful predictors of##4##3##(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)
useful probes for##2##3##(1994-8#1)(2004-4#1)
useful procedure##5##2##(1992-5#1)(2008-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
useful prognostic indicators##2##3##(1994-7#1)(2006-10#1)
useful prognostic##5##2##(1994-7#1)(2006-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
useful properties##3##2##(1991-12#1)(2008-7#2)
useful protein##2##2##(2006-6#1)(2011-1#1)
useful protocol##2##2##(2008-10#1)(2008-11#1)
useful range##4##2##(1995-1#1)(2008-2#1)(2008-7#2)
useful reagents for the##2##4##(1992-2#1)(1995-2#1)
useful reagents##3##2##(1992-2#1)(1995-2#1)(2008-9#1)
useful reference##2##2##(2007-4#1)(2008-4#1)
useful research##3##2##(1997-1#1)(2006-11#1)(2008-10#1)
useful resources##2##2##(2007-2#1)(2007-5#1)
useful results##4##2##(1995-3#1)(2004-12#1)(2008-12#1)(2012-2#1)
useful role in the##2##4##(1992-3#1)(2007-11#1)
useful role in##3##3##(1992-3#1)(2007-11#1)(2008-6#1)
useful role##4##2##(1992-3#1)(2005-7#1)(2007-11#1)(2008-6#1)
useful screening##4##2##(1993-10#1)(2008-10#1)(2008-11#1)(2009-10#1)
useful signals can be##2##4##(2008-10#1)(2008-2#1)
useful signals##5##2##(1990-8#2)(2008-10#2)(2008-2#1)
useful source of##3##3##(2006-4#1)(2007-5#1)(2008-10#1)
useful spatial resolution##2##3##(2008-2#1)(2009-8#1)
useful spatial##3##2##(2008-2#1)(2009-8#1)(2012-2#1)
useful strategies##2##2##(1994-3#1)(2008-8#1)
useful strategy for##4##3##(2006-10#1)(2008-10#1)(2010-10#1)(2012-3#1)
useful strategy##7##2##(2006-10#1)(2007-1#1)(2007-3#1)(2008-10#1)(2009-12#1)(2010-10#1)(2012-3#1)
useful substances##2##2##(1992-10#1)(2012-1#1)
useful technique for the##2##4##(2007-11#1)(2008-3#1)
useful technique for##13##3##(1992-12#1)(1995-6#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-9#2)(2012-2#1)(2013-8#2)
useful technique in the management of##2##6##(2007-12#1)(2010-12#1)
useful technique##19##2##(1991-5#1)(1992-12#1)(1995-6#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-9#2)(2010-12#1)(2010-7#1)(2012-2#1)(2013-8#2)
useful techniques##2##2##(1992-3#1)(2013-1#1)
useful technology##2##2##(2010-8#1)(2012-1#1)
useful test in##2##3##(1991-3#1)(2008-4#1)
useful test##9##2##(1990-1#1)(1991-2#1)(1991-3#1)(1995-5#1)(2005-12#1)(2006-8#2)(2008-2#1)(2008-4#1)
useful therapeutic##5##2##(1994-11#1)(1996-8#1)(2006-10#1)(2007-8#1)(2010-1#1)
useful therapy##2##2##(2010-5#1)(2011-2#1)
useful to assess the effect of##2##6##(1996-6#1)(1997-1#1)
useful to assess the##5##4##(1990-2#1)(1996-6#1)(1997-1#1)(2008-2#1)(2010-4#1)
useful to assess##10##3##(1990-2#1)(1995-1#1)(1996-6#2)(1997-1#1)(2008-10#1)(2008-2#2)(2008-4#1)(2010-4#1)
useful to characterize the##2##4##(2007-8#1)(2008-10#1)
useful to classify##2##3##(2008-10#1)(2013-8#1)
useful to clinicians and##2##4##(2005-10#1)(2007-2#1)
useful to control##2##3##(1990-12#1)(2008-10#1)
useful to detect##3##3##(1992-1#1)(2006-10#1)(2008-11#1)
useful to determine##5##3##(1992-2#1)(2008-10#1)(2008-11#2)(2010-8#1)
useful to develop##2##3##(2012-12#1)(2013-1#1)
useful to diagnose##2##3##(1997-1#1)(2009-5#1)
useful to examine##3##3##(1994-11#1)(2012-12#2)
useful to find##2##3##(1996-1#1)(2012-2#1)
useful to follow the##2##4##(1997-8#1)(2008-10#1)
useful to have an##2##4##(2006-5#1)(2011-1#1)
useful to have##5##3##(2005-12#1)(2006-5#1)(2007-2#1)(2009-2#1)(2011-1#1)
useful to identify##9##3##(2008-11#1)(2008-3#1)(2008-4#2)(2009-6#1)(2010-4#1)(2011-2#1)(2012-2#2)
useful to increase the##2##4##(2005-4#1)(2012-1#1)
useful to increase##3##3##(2005-4#1)(2008-10#1)(2012-1#1)
useful to measure##2##3##(2008-1#1)(2008-7#1)
useful to policy makers##3##4##(1994-1#2)(2011-2#1)
useful to predict the risk of##2##6##(2011-2#1)(2013-1#1)
useful to predict the##4##4##(1996-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
useful to predict##5##3##(1996-12#1)(2006-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
useful to prevent##2##3##(1992-5#1)(2007-7#1)
useful to review##3##3##(1991-4#1)(2008-10#1)(2008-4#1)
useful to study the##3##4##(1991-8#1)(2007-12#1)(2008-11#1)
useful to study##7##3##(1991-8#1)(1993-12#1)(1995-10#1)(2007-12#1)(2008-11#2)(2011-1#1)
useful to the##6##3##(1992-12#1)(1993-12#1)(1996-4#1)(1997-3#1)(2008-2#1)(2008-5#1)
useful to them##2##3##(2007-7#1)(2010-11#1)
useful to treat##2##3##(2008-7#1)(2011-2#1)
useful to##177##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-1#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#3)(1992-5#1)(1993-10#1)(1993-12#3)(1993-3#1)(1993-9#1)(1994-1#2)(1994-11#1)(1995-1#1)(1995-10#1)(1996-1#2)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#2)(1997-1#2)(1997-3#5)(1997-8#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-3#1)(2005-4#3)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#2)(2006-8#1)(2007-11#2)(2007-12#2)(2007-2#4)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#20)(2008-11#12)(2008-12#3)(2008-2#4)(2008-3#3)(2008-4#6)(2008-5#2)(2008-7#6)(2008-8#2)(2008-9#2)(2009-2#1)(2009-5#3)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-4#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#2)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#2)
useful tool for the##11##4##(1990-2#1)(1991-2#1)(1992-12#1)(1993-9#1)(1994-9#1)(2006-12#2)(2007-4#1)(2008-10#2)(2008-3#1)
useful tool for##70##3##(1990-10#1)(1990-2#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-8#1)(1993-3#1)(1993-9#2)(1994-3#1)(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-5#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-6#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-4#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
useful tool in the assessment of##3##6##(2005-10#1)(2006-9#1)(2008-7#1)
useful tool in the diagnosis##2##5##(1991-12#1)(2012-12#1)
useful tool in the treatment of##2##6##(1990-11#1)(1996-9#1)
useful tool in the##16##4##(1990-11#1)(1991-12#1)(1992-11#1)(1994-3#1)(1996-12#1)(1996-9#1)(2005-10#1)(2006-9#1)(2007-1#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-12#1)
useful tool in##39##3##(1990-11#1)(1991-11#1)(1991-12#1)(1992-1#1)(1992-11#1)(1992-3#1)(1994-2#1)(1994-3#1)(1995-11#1)(1996-12#1)(1996-9#1)(2005-10#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#2)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-8#1)
useful tool to investigate the##3##5##(2008-11#1)(2010-4#1)(2013-8#1)
useful tool to investigate##4##4##(2008-11#1)(2010-3#1)(2010-4#1)(2013-8#1)
useful tool to##18##3##(1991-1#1)(1993-3#1)(1993-9#1)(1997-8#1)(2006-2#2)(2007-10#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-8#1)
useful tool##131##2##(1990-10#1)(1990-11#1)(1990-2#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-3#2)(1993-9#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#3)(1995-12#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-9#1)(1997-5#1)(1997-8#1)(2005-10#1)(2006-10#5)(2006-12#2)(2006-2#3)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#2)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#3)(2009-10#1)(2009-2#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
useful tools for the##2##4##(2006-12#1)(2013-1#1)
useful tools for##12##3##(1990-9#1)(1995-12#1)(2006-12#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-1#1)(2013-7#1)
useful tools in##7##3##(1993-11#1)(1997-5#1)(2007-4#1)(2008-10#1)(2008-8#1)(2010-11#1)(2012-2#1)
useful tools to##6##3##(1994-6#1)(2007-11#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-1#1)
useful tools##25##2##(1990-9#1)(1993-11#1)(1994-6#1)(1995-12#1)(1997-5#1)(2006-12#2)(2007-11#1)(2007-4#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2010-11#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
useful way##3##2##(1991-4#1)(2008-9#1)(2011-2#1)
useful when a##2##3##(1996-1#1)(2007-7#1)
useful when the##2##3##(2008-2#1)(2008-4#1)
useful when there##4##3##(2008-10#1)(2008-4#3)
useful when##22##2##(1992-2#1)(1992-7#1)(1996-1#1)(1996-12#1)(1996-8#1)(2004-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-4#6)(2010-10#1)(2011-1#1)(2013-1#1)
useful with##2##2##(1991-12#1)(1995-12#1)
useful##2857##1##(1990-1#3)(1990-10#6)(1990-11#4)(1990-12#10)(1990-2#9)(1990-3#5)(1990-4#3)(1990-5#7)(1990-6#8)(1990-7#4)(1990-8#14)(1990-9#4)(1991-1#7)(1991-10#4)(1991-11#7)(1991-12#12)(1991-2#8)(1991-3#11)(1991-4#5)(1991-5#5)(1991-6#3)(1991-7#2)(1991-8#6)(1991-9#10)(1992-1#8)(1992-10#5)(1992-11#6)(1992-12#11)(1992-2#15)(1992-3#12)(1992-4#4)(1992-5#6)(1992-6#4)(1992-7#4)(1992-8#14)(1992-9#5)(1993-1#3)(1993-10#2)(1993-11#6)(1993-12#19)(1993-2#7)(1993-3#5)(1993-4#3)(1993-5#3)(1993-6#5)(1993-7#2)(1993-8#4)(1993-9#10)(1994-1#2)(1994-11#11)(1994-12#12)(1994-2#13)(1994-3#16)(1994-4#1)(1994-5#5)(1994-6#20)(1994-7#4)(1994-8#8)(1994-9#10)(1995-1#9)(1995-10#3)(1995-11#9)(1995-12#9)(1995-2#14)(1995-3#7)(1995-4#4)(1995-5#5)(1995-6#7)(1995-7#2)(1995-8#13)(1995-9#4)(1996-1#7)(1996-10#3)(1996-11#4)(1996-12#22)(1996-2#9)(1996-3#8)(1996-4#5)(1996-5#9)(1996-6#17)(1996-7#5)(1996-8#10)(1996-9#9)(1997-1#7)(1997-2#11)(1997-3#19)(1997-4#16)(1997-5#8)(1997-6#8)(1997-7#4)(1997-8#16)(2004-1#2)(2004-10#1)(2004-11#7)(2004-12#3)(2004-2#1)(2004-4#4)(2004-9#5)(2005-10#6)(2005-11#16)(2005-12#6)(2005-3#5)(2005-4#8)(2005-6#2)(2005-7#12)(2005-8#12)(2005-9#5)(2006-1#2)(2006-10#50)(2006-11#10)(2006-12#20)(2006-2#14)(2006-3#7)(2006-4#5)(2006-5#18)(2006-6#13)(2006-7#10)(2006-8#14)(2006-9#6)(2007-1#7)(2007-10#24)(2007-11#61)(2007-12#55)(2007-2#23)(2007-3#6)(2007-4#6)(2007-5#7)(2007-6#6)(2007-7#17)(2007-8#36)(2007-9#17)(2008-1#38)(2008-10#252)(2008-11#99)(2008-12#28)(2008-2#109)(2008-3#76)(2008-4#120)(2008-5#66)(2008-6#14)(2008-7#76)(2008-8#37)(2008-9#44)(2009-1#1)(2009-10#10)(2009-11#6)(2009-12#9)(2009-2#10)(2009-3#5)(2009-4#10)(2009-5#12)(2009-6#10)(2009-7#6)(2009-8#13)(2009-9#11)(2010-1#6)(2010-10#9)(2010-11#12)(2010-12#27)(2010-2#11)(2010-3#12)(2010-4#19)(2010-5#11)(2010-6#5)(2010-7#15)(2010-8#27)(2010-9#6)(2011-1#42)(2011-10#1)(2011-12#10)(2011-2#67)(2011-3#1)(2011-7#1)(2012-1#14)(2012-11#6)(2012-12#35)(2012-2#64)(2012-3#36)(2012-8#1)(2013-1#73)(2013-7#16)(2013-8#34)
usefull in##2##2##(2007-7#1)(2008-7#1)
usefully describing##2##2##(2010-2#1)(2011-1#1)
usefully##15##1##(1990-2#1)(1990-8#1)(1991-5#1)(2005-11#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2009-7#1)(2010-2#1)(2010-5#1)(2011-1#1)(2013-1#2)
usefulness and##16##2##(1990-2#2)(1992-5#1)(1996-11#1)(1996-7#1)(2006-8#1)(2008-10#2)(2008-3#1)(2008-4#2)(2011-2#1)(2012-12#1)(2013-1#3)
usefulness as markers of##2##4##(1994-3#1)(2005-11#1)
usefulness as##6##2##(1991-7#1)(1994-3#1)(2005-11#1)(2007-8#1)(2013-1#1)(2013-8#1)
usefulness for##16##2##(1992-11#1)(1994-3#1)(1995-3#1)(1996-3#1)(1996-6#1)(2007-3#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2010-8#1)(2013-8#1)
usefulness has been limited##2##4##(1996-3#1)(2008-6#1)
usefulness has##3##2##(1996-3#1)(2008-6#1)(2009-1#1)
usefulness in the##8##3##(1990-1#1)(1991-6#1)(1995-7#1)(2005-4#1)(2007-1#1)(2007-12#1)(2008-3#1)(2008-5#1)
usefulness in##29##2##(1990-1#1)(1990-3#1)(1991-3#1)(1991-6#1)(1991-9#1)(1994-2#1)(1994-3#1)(1995-7#1)(1996-9#1)(1997-2#1)(2005-4#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-12#2)(2010-8#1)(2012-12#1)(2013-1#2)
usefulness is##3##2##(1996-6#1)(2008-3#1)(2008-7#1)
usefulness of a##11##3##(1990-4#1)(1993-9#1)(1995-7#1)(1996-9#1)(2006-4#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-11#1)(2012-12#1)
usefulness of an##2##3##(2008-10#1)(2012-12#1)
usefulness of clinical signs##2##4##(2007-7#2)
usefulness of electrophysiological monitoring during##2##5##(2007-9#2)
usefulness of other##2##3##(1990-3#1)(2006-2#1)
usefulness of our##5##3##(2007-8#1)(2008-11#1)(2008-3#2)(2012-3#1)
usefulness of primary##2##3##(2007-9#1)(2008-3#1)
usefulness of procalcitonin in the diagnosis of appendicitis##2##8##(2013-1#2)
usefulness of serum##2##3##(1996-8#1)(2005-10#1)
usefulness of such##4##3##(1992-1#1)(1994-12#1)(2006-3#1)(2009-6#1)
usefulness of the method##2##4##(2006-10#1)(2008-10#1)
usefulness of the proposed methodology##2##5##(2007-8#1)(2008-10#1)
usefulness of the proposed##10##4##(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#3)(2008-3#1)(2013-1#2)
usefulness of the system##2##4##(2008-10#2)
usefulness of the##73##3##(1990-4#1)(1990-5#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-10#1)(1992-9#1)(1993-10#1)(1993-3#1)(1994-10#1)(1995-12#1)(1996-1#1)(1996-7#1)(1997-3#1)(2005-5#1)(2006-10#2)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-8#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#4)(2008-5#2)(2008-7#2)(2008-8#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#7)(2013-8#2)
usefulness of these##10##3##(1992-6#1)(1993-5#1)(1995-1#1)(1996-11#1)(2008-10#2)(2008-4#1)(2013-1#3)
usefulness of this approach##4##4##(1997-6#1)(2008-10#2)(2011-1#1)
usefulness of this drug##2##4##(1997-2#1)(2008-5#1)
usefulness of this method##5##4##(1993-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2012-3#1)
usefulness of this technique##3##4##(2007-8#1)(2008-10#1)(2008-5#1)
usefulness of this##26##3##(1993-12#1)(1993-9#1)(1994-9#1)(1997-2#1)(1997-6#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2011-1#1)(2011-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
usefulness of##297##2##(1990-3#1)(1990-4#3)(1990-5#2)(1990-9#1)(1991-1#1)(1991-3#3)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#3)(1992-11#1)(1992-6#6)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#2)(1993-9#3)(1994-10#1)(1994-12#2)(1994-3#1)(1994-6#2)(1994-7#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-4#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#4)(1997-5#1)(1997-6#1)(1997-7#2)(2004-10#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-5#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#8)(2007-12#4)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#5)(2007-8#5)(2007-9#4)(2008-10#37)(2008-11#9)(2008-12#4)(2008-2#10)(2008-3#11)(2008-4#5)(2008-5#10)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#3)(2009-1#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#5)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#19)(2013-7#3)(2013-8#5)
usefulness to##5##2##(1995-6#1)(2008-2#1)(2011-1#1)(2012-12#2)
usefulness##409##1##(1990-1#1)(1990-2#2)(1990-3#2)(1990-4#3)(1990-5#2)(1990-9#1)(1991-1#1)(1991-3#4)(1991-4#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#3)(1992-11#2)(1992-12#1)(1992-5#1)(1992-6#6)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#2)(1993-9#3)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#4)(1994-6#2)(1994-7#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#1)(1995-7#2)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#4)(1996-3#3)(1996-6#2)(1996-7#3)(1996-8#1)(1996-9#2)(1997-2#2)(1997-3#4)(1997-5#1)(1997-6#2)(1997-7#2)(2004-10#1)(2005-1#1)(2005-10#1)(2005-11#2)(2005-12#3)(2005-4#1)(2005-5#1)(2006-10#7)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#8)(2007-12#7)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#2)(2007-7#6)(2007-8#7)(2007-9#4)(2008-10#48)(2008-11#12)(2008-12#5)(2008-2#14)(2008-3#15)(2008-4#8)(2008-5#13)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#5)(2009-1#3)(2009-12#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#8)(2012-11#1)(2012-12#7)(2012-2#4)(2012-3#5)(2013-1#29)(2013-7#3)(2013-8#8)
useless in the##2##3##(1991-6#1)(2011-1#1)
useless in##4##2##(1991-6#1)(2005-7#1)(2011-1#1)(2011-2#1)
useless##18##1##(1991-6#1)(1992-2#1)(1995-12#1)(1997-3#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-11#1)(2008-11#1)(2009-6#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
user and non-user controls##3##4##(1996-10#1)(1996-7#2)
user and##12##2##(1991-11#1)(1991-3#1)(1996-10#2)(1996-7#2)(2007-4#1)(2008-12#2)(2008-6#1)(2009-6#1)(2012-3#1)
user can##4##2##(2008-2#1)(2008-4#2)(2008-6#1)
user capacity##3##2##(2008-2#2)(2008-3#1)
user commands##2##2##(2011-2#2)
user communities##2##2##(2008-7#1)(2012-3#1)
user engagement##2##2##(2011-2#1)(2012-1#1)
user facilities##3##2##(1993-3#2)(1997-3#1)
user facility for##2##3##(2006-5#2)
user friendly##6##2##(2007-6#2)(2008-10#1)(2008-3#2)(2011-2#1)
user group##2##2##(1997-1#1)(2012-12#1)
user groups##3##2##(1995-1#1)(2007-11#1)(2008-7#1)
user has##2##2##(2008-2#1)(2012-1#1)
user information##2##2##(2008-3#1)(2012-1#1)
user interface and##2##3##(2008-9#1)(2012-1#1)
user interface device##2##3##(2012-1#2)
user interface for##3##3##(2008-4#2)(2010-8#1)
user interface is##3##3##(2008-3#1)(2013-1#2)
user interface to##2##3##(2008-7#1)(2012-1#1)
user interface##24##2##(2006-2#1)(2007-5#3)(2008-3#1)(2008-4#4)(2008-7#1)(2008-9#1)(2010-8#5)(2011-1#1)(2012-1#5)(2013-1#2)
user interfaces and##2##3##(1994-3#1)(2008-7#1)
user interfaces##4##2##(1994-3#1)(2008-7#1)(2013-1#2)
user involvement and##2##3##(2008-12#2)
user involvement in##2##3##(2008-11#1)(2008-12#1)
user involvement##6##2##(2008-11#1)(2008-12#5)
user is##4##2##(1995-11#1)(2007-10#1)(2010-8#1)(2011-1#1)
user may##5##2##(1993-3#1)(2008-4#3)(2011-2#1)
user of##4##2##(1991-9#1)(1992-10#1)(1995-12#1)(2008-3#1)
user performance##3##2##(2013-1#3)
user satisfaction##5##2##(1996-2#1)(2011-1#1)(2011-2#1)(2013-1#2)
user to##30##2##(1993-3#1)(1994-4#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#5)(2008-6#3)(2008-7#1)(2008-9#2)(2009-12#1)(2011-2#1)(2012-1#3)(2013-1#2)(2013-8#1)
user##249##1##(1991-1#1)(1991-11#1)(1991-12#3)(1991-3#2)(1991-9#1)(1992-1#1)(1992-10#1)(1993-3#5)(1994-11#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-10#3)(1996-12#1)(1996-2#1)(1996-4#1)(1996-7#4)(1997-1#2)(1997-3#2)(1997-6#2)(2005-12#1)(2006-10#1)(2006-2#1)(2006-5#3)(2006-6#3)(2007-10#1)(2007-11#3)(2007-12#1)(2007-4#2)(2007-5#5)(2007-6#2)(2007-7#1)(2008-1#1)(2008-10#12)(2008-11#7)(2008-12#7)(2008-2#11)(2008-3#11)(2008-4#22)(2008-6#7)(2008-7#7)(2008-9#8)(2009-12#1)(2009-6#4)(2009-8#3)(2010-5#2)(2010-8#7)(2011-1#4)(2011-2#14)(2012-1#17)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#30)(2013-8#3)
user's hand##2##2##(2008-10#1)(2012-1#1)
user's##27##1##(1993-10#1)(1993-9#1)(2005-4#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2012-1#16)
user-defined##6##1##(2008-10#2)(2008-2#2)(2008-4#1)(2013-1#1)
user-friendly and##2##2##(2007-8#1)(2007-9#1)
user-friendly interface##2##2##(2011-1#1)(2013-8#1)
user-friendly##36##1##(1991-3#1)(1993-9#1)(1997-8#1)(2005-7#1)(2006-5#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#3)(2009-11#2)(2010-12#1)(2011-1#2)(2012-2#2)(2012-3#1)(2013-8#1)
user-generated##2##1##(2008-4#1)(2013-1#1)
user-specified##4##1##(2005-11#1)(2008-4#1)(2008-5#1)(2009-9#1)
users (AOR##2##2##(2012-3#2)
users (IDUs)##5##2##(1992-2#1)(2007-7#1)(2008-5#1)(2012-1#1)(2012-3#1)
users aged##2##2##(2012-2#1)(2013-8#1)
users and carers##4##3##(2009-6#4)
users and non-users##4##3##(1993-10#1)(2013-8#3)
users and of##2##3##(1993-3#1)(2008-9#1)
users and people with##2##4##(1994-4#1)(1996-6#1)
users and providers##2##3##(1993-12#1)(2012-11#1)
users and the##6##3##(1995-2#1)(1996-1#1)(1996-2#1)(2010-10#1)(2011-1#1)(2013-1#1)
users and their##3##3##(1996-4#1)(2008-11#1)(2008-12#1)
users and##56##2##(1990-9#1)(1991-5#1)(1992-2#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-3#1)(1994-4#1)(1995-2#1)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-6#1)(1996-7#1)(1997-6#1)(2005-7#2)(2007-8#1)(2008-1#1)(2008-11#6)(2008-12#2)(2008-3#1)(2008-7#1)(2008-9#2)(2009-6#4)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-1#2)(2012-11#3)(2013-1#4)(2013-8#4)
users are##11##2##(1991-3#1)(1992-12#1)(1994-3#1)(1994-4#1)(1997-6#1)(2005-10#1)(2008-11#1)(2009-2#1)(2010-9#1)(2012-1#1)(2013-1#1)
users as##4##2##(2008-12#2)(2008-4#1)(2012-3#1)
users at##5##2##(1992-12#1)(1993-3#1)(1996-5#1)(2007-10#1)(2008-10#1)
users by##3##2##(2007-6#1)(2008-11#1)(2012-11#1)
users can##6##2##(2008-2#2)(2008-9#1)(2013-1#3)
users compared to##3##3##(2007-2#1)(2013-8#2)
users do##2##2##(1991-3#1)(2008-9#1)
users for##3##2##(1995-1#1)(2007-10#1)(2008-9#1)
users from##3##2##(2006-1#1)(2006-6#1)(2010-12#1)
users had##3##2##(1996-9#1)(1997-6#1)(2007-11#1)
users have a##2##3##(1996-4#1)(2008-9#1)
users have##5##2##(1994-4#1)(1996-4#1)(2008-5#1)(2008-7#1)(2008-9#1)
users in an##2##3##(1991-1#1)(2009-6#1)
users in the United##2##4##(2006-8#1)(2007-1#1)
users in the##6##3##(2006-5#1)(2006-8#1)(2007-1#1)(2007-8#1)(2008-12#1)(2012-3#1)
users in##44##2##(1990-3#1)(1991-1#2)(1991-12#1)(1994-9#1)(1995-3#1)(1996-11#2)(1996-12#1)(2006-5#1)(2006-8#1)(2007-1#2)(2007-12#2)(2007-2#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-12#6)(2008-2#1)(2008-3#1)(2008-4#1)(2009-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#1)
users is##2##2##(2006-10#1)(2007-4#1)
users may##5##2##(2006-2#1)(2007-7#1)(2008-9#1)(2012-12#1)(2013-8#1)
users must##3##2##(1996-8#1)(2007-5#1)(2008-2#1)
users not##2##2##(1991-1#1)(2012-2#1)
users of CER##3##3##(2012-12#3)
users of NSAIDs##2##3##(2008-8#2)
users of a##3##3##(1992-5#1)(1995-5#1)(2012-12#1)
users of alcohol##2##3##(2009-12#2)
users of an##3##3##(1994-6#1)(2013-1#2)
users of benzodiazepines##2##3##(1991-1#1)(1996-9#1)
users of both##2##3##(2006-9#1)(2009-12#1)
users of meloxicam##3##3##(2008-11#3)
users of non-proven therapies##4##4##(1997-6#4)
users of other##2##3##(2007-3#1)(2010-12#1)
users of private##2##3##(2012-3#2)
users of such##2##3##(2008-11#1)(2009-5#1)
users of the##12##3##(1992-2#1)(1996-1#1)(1997-8#1)(2006-11#1)(2008-9#3)(2009-10#1)(2012-1#1)(2012-3#1)(2013-1#2)
users of these##2##3##(2006-10#1)(2008-11#1)
users of this##2##3##(1991-12#1)(2012-1#1)
users of##95##2##(1991-1#2)(1991-12#1)(1991-3#1)(1992-11#1)(1992-2#1)(1992-5#2)(1993-10#1)(1993-3#2)(1994-6#2)(1995-1#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-1#3)(1997-6#4)(1997-8#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-9#3)(2007-12#1)(2007-3#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#8)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#4)(2009-10#1)(2009-12#3)(2009-5#1)(2009-7#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#5)(2012-3#6)(2013-1#5)(2013-8#3)
users receive##3##2##(1994-2#1)(2006-2#1)(2008-9#1)
users reported##2##2##(2009-9#1)(2013-8#1)
users than##2##2##(1993-10#1)(1993-4#1)
users through##2##2##(2008-11#1)(2008-4#1)
users to##31##2##(1993-2#1)(1993-4#1)(2006-5#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#5)(2008-7#5)(2008-9#3)(2010-12#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)
users using##3##2##(1995-3#1)(2008-9#1)(2013-8#1)
users was##5##2##(1996-9#1)(2007-10#1)(2008-11#1)(2012-3#1)(2013-8#1)
users were more likely to##5##5##(2008-11#2)(2012-12#2)(2012-3#1)
users were more##6##3##(2008-11#2)(2012-12#2)(2012-3#2)
users were satisfied with##2##4##(1991-1#1)(2009-9#1)
users were##18##2##(1991-1#2)(2006-10#2)(2007-3#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-9#2)(2010-2#1)(2011-2#1)(2012-12#2)(2012-3#2)
users who are##3##3##(2008-11#1)(2012-1#1)(2012-11#1)
users who##14##2##(1995-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-5#1)(2011-12#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
users will##3##2##(1991-12#1)(1991-3#1)(1996-3#1)
users with a##2##3##(2004-4#1)(2008-11#1)
users with the##2##3##(2007-4#1)(2008-9#1)
users with##10##2##(2004-4#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-11#1)(2008-9#2)(2010-10#1)(2011-1#1)(2012-3#1)
users##639##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-1#13)(1991-10#1)(1991-12#7)(1991-3#6)(1991-5#1)(1992-1#2)(1992-11#1)(1992-12#5)(1992-2#5)(1992-5#3)(1992-9#3)(1993-1#1)(1993-10#5)(1993-12#1)(1993-2#1)(1993-3#10)(1993-4#3)(1994-2#2)(1994-3#1)(1994-4#7)(1994-6#2)(1994-9#2)(1995-1#5)(1995-2#1)(1995-3#7)(1995-5#1)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#4)(1996-12#4)(1996-2#5)(1996-3#3)(1996-4#3)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#4)(1997-1#4)(1997-3#1)(1997-5#2)(1997-6#11)(1997-8#1)(2004-4#2)(2005-10#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#7)(2006-11#1)(2006-12#1)(2006-2#2)(2006-3#3)(2006-5#4)(2006-6#1)(2006-8#1)(2006-9#3)(2007-1#7)(2007-10#7)(2007-11#4)(2007-12#6)(2007-2#4)(2007-3#4)(2007-4#4)(2007-5#1)(2007-6#2)(2007-7#7)(2007-8#6)(2007-9#5)(2008-1#3)(2008-10#9)(2008-11#36)(2008-12#15)(2008-2#13)(2008-3#6)(2008-4#15)(2008-5#6)(2008-7#15)(2008-8#3)(2008-9#51)(2009-10#3)(2009-12#4)(2009-2#2)(2009-4#1)(2009-5#2)(2009-6#7)(2009-7#2)(2009-8#1)(2009-9#7)(2010-1#2)(2010-10#4)(2010-12#10)(2010-2#2)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#14)(2011-12#2)(2011-2#14)(2011-3#1)(2012-1#19)(2012-11#12)(2012-12#18)(2012-2#12)(2012-3#25)(2013-1#31)(2013-7#2)(2013-8#24)
users' needs##3##2##(1991-9#1)(1996-2#1)(2011-2#1)
users' perspective##3##2##(1996-1#1)(1997-3#1)(2009-3#1)
users'##24##1##(1991-9#1)(1994-4#1)(1995-12#1)(1995-4#1)(1996-1#2)(1996-12#1)(1996-2#1)(1997-3#1)(2008-11#1)(2009-3#1)(2009-8#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#3)
users/sellers##2##1##(2007-8#2)
users]##5##1##(1995-2#1)(1995-9#1)(1996-9#1)(2009-10#1)(2013-8#1)
uses Duet Technologies'##2##3##(2008-2#2)
uses a CCD camera##2##4##(2007-12#2)
uses a CCD##3##3##(2007-12#2)(2008-10#1)
uses a binary##2##3##(2008-3#2)
uses a combination of##6##4##(1993-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-3#1)
uses a commercial##2##3##(2008-2#1)(2012-1#1)
uses a deformable##2##3##(2008-2#1)(2012-3#1)
uses a group##2##3##(1992-1#1)(2012-2#1)
uses a new##2##3##(1994-12#1)(2011-2#1)
uses a novel##6##3##(2007-11#1)(2007-12#3)(2013-1#2)
uses a phase##2##3##(2007-12#1)(2008-3#1)
uses a set of##2##4##(2008-2#1)(2008-3#1)
uses a simple##6##3##(2006-12#1)(2007-12#3)(2008-3#1)(2008-9#1)
uses a single##13##3##(2007-11#1)(2007-12#4)(2008-2#6)(2008-3#2)
uses a superluminescent diode light source with##2##7##(2007-12#2)
uses a thin##2##3##(2008-2#1)(2008-3#1)
uses a variety of##2##4##(1991-3#1)(2008-6#1)
uses a##231##2##(1990-12#1)(1991-3#2)(1992-1#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#1)(1994-12#1)(1994-3#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#3)(2005-11#2)(2005-5#1)(2006-12#2)(2007-11#10)(2007-12#30)(2007-4#2)(2007-5#1)(2008-1#2)(2008-10#16)(2008-11#1)(2008-2#38)(2008-3#49)(2008-4#9)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#5)(2012-1#4)(2012-2#3)(2012-3#5)(2013-1#11)(2013-7#1)(2013-8#1)
uses an optical##3##3##(2008-2#2)(2008-3#1)
uses an##49##2##(1993-12#1)(1995-1#1)(1996-12#1)(1996-2#1)(2005-10#1)(2006-8#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-4#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-2#7)(2008-3#14)(2008-4#2)(2009-7#1)(2010-11#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
uses analysis of##2##3##(2008-2#1)(2008-7#1)
uses and limitations of##2##4##(1996-1#1)(2007-5#1)
uses and limits##2##3##(2007-9#1)(2008-10#1)
uses and potential##2##3##(2006-10#1)(2010-12#1)
uses and usage of mechanical adjusting devices##2##7##(2007-6#2)
uses and usage##3##3##(2007-6#3)
uses and##13##2##(1993-2#1)(1996-1#1)(2006-10#1)(2007-11#1)(2007-5#1)(2007-6#3)(2007-9#1)(2008-10#1)(2009-9#1)(2010-12#2)
uses are##2##2##(2007-3#1)(2010-12#1)
uses as##2##2##(2007-12#1)(2012-1#1)
uses both##3##2##(2008-3#2)(2012-3#1)
uses classical##2##2##(2008-10#1)(2009-10#1)
uses data from the##2##4##(1995-6#1)(2010-8#1)
uses data##7##2##(1995-6#1)(1996-12#1)(2007-12#1)(2008-9#1)(2010-2#1)(2010-8#1)(2012-12#1)
uses different##2##2##(2008-6#1)(2008-9#1)
uses either the##2##3##(2008-3#1)(2009-5#1)
uses fluorescent##2##2##(1996-4#1)(2008-4#1)
uses for this##2##3##(1992-3#1)(2006-10#1)
uses for##16##2##(1992-3#1)(1992-5#1)(1997-3#1)(2005-11#1)(2006-10#2)(2006-8#1)(2007-12#1)(2008-5#2)(2008-6#1)(2009-4#1)(2010-3#1)(2011-1#2)(2012-1#1)
uses four##3##2##(1992-3#1)(2006-10#1)(2008-2#1)
uses geometric##2##2##(2008-10#1)(2008-2#1)
uses high-resolution##2##2##(2008-2#1)(2008-9#1)
uses his##2##2##(2004-12#1)(2006-10#1)
uses in##8##2##(1991-12#1)(2006-9#1)(2007-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2012-1#1)
uses it##3##2##(1997-2#1)(2010-12#1)(2011-2#1)
uses light##2##2##(2008-2#1)(2008-3#1)
uses may##2##2##(2006-10#1)(2008-7#1)
uses measurements##2##2##(2008-2#1)(2008-3#1)
uses mechanical##2##2##(2007-12#1)(2008-7#1)
uses multiple##3##2##(2008-3#1)(2008-4#1)(2008-7#1)
uses nonlinear##2##2##(2007-11#1)(2008-9#1)
uses of a##3##3##(1993-2#1)(2008-5#1)(2010-12#1)
uses of human tissue##2##4##(1996-11#1)(2008-8#1)
uses of the Internet##2##4##(1996-2#1)(2009-5#1)
uses of the##11##3##(1991-12#1)(1993-9#1)(1996-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-2#1)(2010-5#1)(2010-9#1)
uses of these##5##3##(1996-1#1)(2006-12#1)(2007-3#1)(2008-11#1)(2008-3#1)
uses of##81##2##(1990-12#2)(1991-11#1)(1991-12#2)(1991-2#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-9#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(2005-4#1)(2005-7#2)(2005-8#1)(2006-10#3)(2006-12#2)(2006-5#1)(2007-12#2)(2007-2#1)(2007-3#3)(2007-6#2)(2007-9#1)(2008-1#5)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-2#2)(2009-4#1)(2009-5#2)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#3)(2010-7#1)(2010-9#1)(2011-2#2)(2012-11#1)(2012-12#1)(2013-1#2)
uses off-axis##2##2##(2008-2#1)(2008-3#1)
uses one##3##2##(2007-12#1)(2008-5#1)(2012-3#1)
uses only a single##3##4##(1990-12#1)(2007-12#1)(2008-3#1)
uses only a##4##3##(1990-12#1)(1991-12#1)(2007-12#1)(2008-3#1)
uses only two##3##3##(2007-12#1)(2008-3#1)(2008-8#1)
uses only##12##2##(1990-12#1)(1991-12#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#1)
uses polarization##2##2##(2008-2#1)(2008-3#1)
uses second-order##2##2##(2008-10#1)(2008-3#1)
uses small##2##2##(2008-11#1)(2008-4#1)
uses standard##4##2##(1992-8#1)(2006-12#1)(2008-4#1)(2010-9#1)
uses such as##5##3##(2007-11#1)(2009-7#1)(2012-1#1)(2013-1#2)
uses that##3##2##(1997-8#1)(2013-1#2)
uses the polymerase chain reaction (PCR) to##3##7##(2008-2#2)(2008-4#1)
uses the same##3##3##(1995-2#1)(2008-2#1)(2008-4#1)
uses the##100##2##(1992-12#1)(1993-5#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1997-3#1)(1997-4#1)(2005-10#1)(2005-12#1)(2006-3#1)(2006-5#1)(2007-11#2)(2007-12#11)(2007-7#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-2#22)(2008-3#17)(2008-4#2)(2008-6#2)(2008-7#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-12#1)(2012-1#3)(2012-2#2)(2013-1#2)
uses this##6##2##(2007-12#1)(2008-11#2)(2008-2#1)(2013-1#2)
uses three##5##2##(1997-3#1)(2008-10#1)(2008-2#2)(2008-3#1)
uses to##2##2##(1997-3#1)(2006-10#1)
uses two monoclonal antibodies##2##4##(1992-12#1)(1993-2#1)
uses two##19##2##(1992-12#1)(1993-2#1)(1993-5#1)(2007-11#2)(2007-12#2)(2008-2#4)(2008-3#6)(2008-8#1)(2012-2#1)
uses very low##3##3##(2008-1#1)(2008-5#1)(2008-6#1)
uses video##2##2##(2006-10#1)(2008-3#1)
uses were obtainable in##2##4##(2007-6#2)
uses##1000##1##(1990-12#4)(1990-2#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#3)(1991-5#2)(1992-1#1)(1992-12#3)(1992-3#4)(1992-5#1)(1992-6#3)(1992-8#2)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#4)(1993-3#3)(1993-5#2)(1993-9#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#2)(1995-1#3)(1995-10#1)(1995-12#3)(1995-2#5)(1995-3#3)(1995-4#2)(1995-6#4)(1996-1#6)(1996-11#1)(1996-12#6)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#8)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-12#1)(2005-10#2)(2005-11#3)(2005-12#4)(2005-4#1)(2005-5#1)(2005-7#2)(2005-8#3)(2006-10#12)(2006-11#1)(2006-12#7)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#3)(2006-9#1)(2007-11#36)(2007-12#77)(2007-2#6)(2007-3#6)(2007-4#5)(2007-5#4)(2007-6#8)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#21)(2008-10#52)(2008-11#14)(2008-12#4)(2008-2#132)(2008-3#162)(2008-4#35)(2008-5#17)(2008-6#14)(2008-7#27)(2008-8#12)(2008-9#19)(2009-10#6)(2009-11#3)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#7)(2009-6#2)(2009-7#3)(2009-9#2)(2010-11#4)(2010-12#8)(2010-2#3)(2010-3#1)(2010-5#5)(2010-6#1)(2010-7#2)(2010-8#7)(2010-9#6)(2011-1#10)(2011-12#2)(2011-2#11)(2012-1#13)(2012-11#4)(2012-12#7)(2012-2#15)(2012-3#12)(2013-1#30)(2013-7#2)(2013-8#2)
usher in##4##2##(1991-5#1)(1995-6#1)(2009-5#1)(2011-7#1)
ushered in a##3##3##(1993-6#1)(2008-9#1)(2011-1#1)
ushered in the##3##3##(2006-4#1)(2007-9#1)(2012-2#1)
ushered in##8##2##(1993-6#1)(2006-4#1)(2007-9#1)(2008-9#2)(2010-12#1)(2011-1#1)(2012-2#1)
ushered##11##1##(1993-6#1)(2006-4#1)(2007-11#1)(2007-9#1)(2008-3#1)(2008-9#2)(2009-6#1)(2010-12#1)(2011-1#1)(2012-2#1)
ushering in##3##2##(2008-4#1)(2008-9#1)(2012-1#1)
using &quot##12##2##(1990-12#1)(1997-7#1)(2006-4#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-4#1)(2011-12#1)(2013-1#2)
using (1)##2##2##(2007-11#1)(2012-1#1)
using (1)D at##2##3##(2008-10#2)
using (1)H-##2##2##(2007-1#1)(2007-11#1)
using (14)C-labelled##2##2##(1996-2#1)(2007-1#1)
using (31)P##2##2##(2008-10#1)(2012-2#1)
using (7)Li##2##2##(2006-8#1)(2008-5#1)
using (i)##5##2##(1991-11#1)(2008-10#2)(2009-12#1)(2011-2#1)
using 0##25##2##(1990-6#1)(1990-8#1)(1992-2#1)(1997-1#1)(2006-2#1)(2007-8#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-5#1)(2009-12#1)(2013-1#1)
using 1 g##2##3##(2008-10#1)(2008-5#1)
using 1 ml of##2##4##(1993-2#1)(1996-6#1)
using 1##32##2##(1991-5#1)(1992-12#1)(1993-2#1)(1993-3#2)(1996-6#1)(1997-5#3)(2006-5#1)(2006-9#1)(2007-11#1)(2008-10#12)(2008-11#1)(2008-5#5)(2010-3#1)(2010-7#1)
using 1-(2-pyridylazo)-2-naphthol##2##2##(2008-10#2)
using 1-nitroso-2-naphthol##3##2##(2008-10#3)
using 10##12##2##(1992-1#1)(1994-11#1)(1997-4#1)(2004-3#1)(2007-1#1)(2007-4#1)(2008-10#3)(2008-5#1)(2012-2#1)(2012-3#1)
using 100##3##2##(1994-9#2)(1997-8#1)
using 11##3##2##(2008-10#2)(2013-8#1)
using 12##7##2##(1993-7#1)(1994-7#1)(2006-8#1)(2008-10#2)(2008-12#2)
using 125I-labelled##2##2##(1992-8#1)(1996-12#1)
using 15##5##2##(1997-3#1)(2008-10#1)(2008-12#1)(2008-5#2)
using 15N relaxation measurements##2##4##(1992-9#1)(1994-11#1)
using 15N##3##2##(1992-9#1)(1993-11#1)(1994-11#1)
using 16##4##2##(2008-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
using 16S rDNA sequence##2##4##(2006-8#1)(2007-12#1)
using 16S rRNA gene##2##4##(2011-1#1)(2011-2#1)
using 16S##5##2##(2006-8#1)(2007-12#1)(2011-1#2)(2011-2#1)
using 17##2##2##(1991-9#1)(2009-5#1)
using 18##5##2##(1991-2#1)(2008-10#2)(2008-5#1)(2013-1#1)
using 19##2##2##(2008-8#1)(2012-1#1)
using 19F##3##2##(1992-4#1)(1994-8#1)(1996-2#1)
using 1H and##2##3##(1990-3#1)(2008-12#1)
using 1H##4##2##(1990-3#1)(1996-5#1)(2006-11#1)(2008-12#1)
using 1H-NMR spectroscopy##2##3##(1990-5#1)(1991-12#1)
using 1M##2##2##(2005-11#1)(2008-10#1)
using 2 mM##2##3##(1994-9#1)(2008-10#1)
using 2 main##2##3##(2006-11#1)(2012-11#1)
using 2##24##2##(1990-2#1)(1991-10#1)(1992-3#1)(1994-9#1)(1996-12#1)(1997-3#1)(2006-11#2)(2006-6#1)(2007-11#1)(2008-10#8)(2008-6#2)(2008-8#1)(2010-6#1)(2011-2#1)(2012-11#1)
using 2-(5-bromo-2-pyridylazo)-5-diethylaminophenol##2##2##(2008-10#2)
using 2-D##2##2##(2008-2#1)(2008-4#1)
using 20##5##2##(2006-12#1)(2007-8#1)(2008-10#2)(2010-8#1)
using 200##4##2##(1996-5#1)(1997-3#1)(2007-1#1)(2012-3#1)
using 22##2##2##(2008-10#1)(2008-2#1)
using 237##2##2##(2008-7#1)(2012-12#1)
using 23Na nuclear magnetic resonance##2##5##(1994-3#2)
using 24##2##2##(1993-5#1)(2013-7#1)
using 241Am##2##2##(2007-8#2)
using 25 m2 quadrants##2##4##(2007-5#1)(2008-5#1)
using 25##3##2##(2007-5#1)(2008-10#1)(2008-5#1)
using 250##3##2##(2004-12#1)(2006-5#1)(2010-12#1)
using 26##2##2##(1992-8#1)(2011-2#1)
using 293T##2##2##(2008-11#1)(2008-4#1)
using 2D##5##2##(1991-7#1)(1995-1#1)(2010-4#2)(2012-2#1)
using 3##15##2##(1991-2#1)(1992-12#1)(1995-11#1)(1997-4#1)(1997-7#1)(2004-12#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-6#1)(2009-10#1)(2010-6#1)(2011-2#1)
using 30##3##2##(2006-8#1)(2008-8#1)(2008-9#1)
using 31P magnetic resonance spectroscopy##2##5##(1993-4#1)(2008-11#1)
using 31P##3##2##(1993-4#2)(2008-11#1)
using 3D##6##2##(2005-11#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-8#1)
using 4##6##2##(1992-5#1)(1996-11#1)(2006-10#1)(2008-10#2)(2010-3#1)
using 40##3##2##(1997-7#1)(2009-8#1)(2012-12#1)
using 400##2##2##(1991-3#1)(1994-9#1)
using 454##2##2##(2011-12#1)(2011-2#1)
using 4M aqueous HCl to yield##2##6##(2010-8#2)
using 5 ml of##2##4##(1996-8#1)(2008-10#1)
using 5 ml##4##3##(1996-8#1)(2008-10#3)
using 5##13##2##(1990-12#1)(1996-8#1)(2007-6#1)(2008-10#8)(2012-1#1)(2012-2#1)
using 50 mM##3##3##(1997-2#1)(1997-8#1)(2008-10#1)
using 50##6##2##(1997-2#1)(1997-8#1)(2007-5#1)(2008-10#1)(2008-9#1)(2012-3#1)
using 500##4##2##(1992-6#1)(1994-3#1)(2008-11#1)(2008-9#1)
using 6##2##2##(2005-4#1)(2013-1#1)
using 6%##2##2##(2006-12#1)(2008-10#1)
using 70%##3##2##(1990-7#1)(2008-5#1)(2013-8#1)
using 8##6##2##(2008-10#3)(2008-8#1)(2009-10#2)
using 9 different methods##2##4##(2007-7#2)
using 9##3##2##(2007-7#2)(2012-2#1)
using AAS##2##2##(2008-10#2)
using AFLP##2##2##(2008-10#2)
using AFM##2##2##(2008-10#2)
using ANOVA##5##2##(1990-8#1)(2004-3#1)(2006-11#1)(2007-6#1)(2010-8#1)
using AP##2##2##(2008-10#1)(2009-10#1)
using ATP##2##2##(1994-9#1)(2008-5#1)
using Adobe Flex##2##3##(2013-1#2)
using Advanced##2##2##(2008-5#1)(2013-8#1)
using Affymetrix##4##2##(2008-8#1)(2009-8#1)(2012-1#1)(2012-2#1)
using Akaike's##2##2##(2008-10#1)(2008-9#1)
using Amberlite XAD-16##2##3##(2008-10#2)
using Amberlite XAD-2##2##3##(2008-10#2)
using Amberlite##4##2##(2008-10#4)
using Amplatzer##2##2##(2008-4#2)
using Apache Foundation's Unstructured Information Management Architecture (UIMA) platform##2##9##(2013-1#2)
using B-mode##3##2##(1997-2#1)(2008-3#1)(2012-1#1)
using BAC##2##2##(2007-6#1)(2008-7#1)
using BALB/c##2##2##(1993-9#1)(2008-11#1)
using Bayesian##2##2##(2010-12#1)(2013-8#1)
using BrdU##2##2##(1996-11#1)(2007-2#1)
using C##5##2##(1993-9#1)(2007-12#2)(2008-10#1)(2008-6#1)
using C(18)##2##2##(2008-10#2)
using C-18##2##2##(2007-8#1)(2008-5#1)
using C18##5##2##(1996-8#1)(2007-8#2)(2008-10#2)
using C8 cartridges##2##3##(2008-10#2)
using CAT##2##2##(1993-10#1)(2008-9#1)
using CD##3##2##(1995-3#1)(1997-4#1)(2008-8#1)
using CDC light traps##2##4##(2005-8#1)(2011-1#1)
using CDC##3##2##(1997-2#1)(2005-8#1)(2011-1#1)
using CE##3##2##(1994-12#2)(2008-10#1)
using CEUS##2##2##(2008-7#1)(2012-2#1)
using CHO cell##2##3##(2008-2#1)(2010-1#1)
using CHO##3##2##(1996-5#1)(2008-2#1)(2010-1#1)
using COS-1 cells##2##3##(1994-11#1)(1995-6#1)
using COS-1##3##2##(1994-11#1)(1995-6#1)(2008-11#1)
using COSY##2##2##(1991-9#1)(2007-11#1)
using COX-2##3##2##(2010-2#1)(2011-2#1)(2013-8#1)
using CPB##3##2##(2007-8#2)(2007-9#1)
using CT scans##2##3##(2004-1#1)(2007-7#1)
using CT with##2##3##(2008-7#1)(2012-12#1)
using CT##12##2##(2004-1#1)(2006-6#1)(2007-5#1)(2007-7#1)(2008-7#2)(2008-9#1)(2012-1#1)(2012-12#3)(2012-2#1)
using CZ - II##2##4##(2007-11#2)
using Chelating Superose##3##3##(1991-11#3)
using Chinese hamster##2##3##(1995-3#1)(2011-1#1)
using Chinese##3##2##(1995-3#1)(2008-11#1)(2011-1#1)
using Coblation##4##2##(2006-7#1)(2006-8#3)
using Codessa Pro##2##3##(2009-3#2)
using Coomassie##2##2##(1992-8#1)(2008-10#1)
using Cox regression##2##3##(1996-2#1)(2007-10#1)
using Cox##3##2##(1996-2#1)(2007-10#1)(2011-2#1)
using Cox's proportional hazards##2##4##(1993-5#2)
using Cronbach's##3##2##(1996-3#1)(2007-10#1)(2010-12#1)
using DCT##2##2##(2010-1#2)
using DNA as##2##3##(1991-5#1)(2009-4#1)
using DNA from##2##3##(2008-10#2)
using DNA markers##2##3##(1996-12#1)(1997-4#1)
using DNA microarray##2##3##(2007-12#1)(2012-2#1)
using DNA microarrays##2##3##(2008-4#1)(2012-3#1)
using DNA##33##2##(1990-3#2)(1991-10#1)(1991-5#1)(1991-9#1)(1995-11#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-4#2)(2007-12#1)(2007-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#1)(2010-5#2)(2012-2#2)(2012-3#1)(2013-1#1)
using Dega and Salter##2##4##(2007-8#2)
using Doehlert##3##2##(2008-10#3)
using Doppler##3##2##(1990-6#1)(2010-10#1)(2013-1#1)
using Drosophila##3##2##(2007-10#1)(2008-2#1)(2010-4#1)
using Dsquame(R)##2##2##(2008-5#2)
using Dynalign on##2##3##(2008-4#2)
using Dynalign##3##2##(2008-4#3)
using E##3##2##(1997-6#1)(2006-12#1)(2011-1#1)
using EDTA as##3##3##(2008-10#3)
using EDXRF##2##2##(2008-10#1)(2012-12#1)
using ELISA##9##2##(2005-10#1)(2005-8#1)(2008-10#1)(2008-4#1)(2011-1#1)(2011-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
using ESI-MS##3##2##(2006-10#2)(2008-6#1)
using ESR##3##2##(1994-11#1)(1996-2#1)(1996-5#1)
using EST##2##2##(2008-7#1)(2008-9#1)
using Escherichia coli##2##3##(2008-5#1)(2008-9#1)
using Excel##2##2##(2006-11#1)(2011-2#1)
using FAAS##3##2##(2005-4#1)(2008-10#2)
using FBG##2##2##(2007-8#2)
using FCM##2##2##(1996-6#1)(2010-8#1)
using FT-IR spectroscopy##3##3##(2008-10#3)
using FT-IR##5##2##(2008-10#3)(2008-7#2)
using FTIR spectroscopy##4##3##(1995-1#2)(2008-10#1)(2009-1#1)
using FTIR##5##2##(1995-1#2)(2008-10#2)(2009-1#1)
using Fisher's exact test##2##4##(1995-12#1)(2008-12#1)
using Fourier Transform##2##3##(1991-3#1)(2010-5#1)
using Fourier transform infrared (FT-IR)##2##5##(2007-12#2)
using Fourier transform infrared (FTIR)##2##5##(2008-10#1)(2008-5#1)
using Fourier transform infrared spectroscopy##2##5##(1992-12#1)(2013-7#1)
using Fourier transform infrared##7##4##(1992-12#1)(2007-12#2)(2008-10#2)(2008-5#1)(2013-7#1)
using Fourier##12##2##(1991-3#1)(1992-12#1)(1993-11#1)(2007-1#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-5#1)(2010-5#1)(2013-7#1)
using Fourier-transform infrared##2##3##(2008-10#1)(2008-3#1)
using G##2##2##(2010-8#1)(2013-1#1)
using GAT and DCT##2##4##(2010-1#2)
using GAT and##3##3##(2010-1#3)
using GAT##4##2##(2010-1#4)
using GC-FID##3##2##(2008-10#2)(2012-1#1)
using GC-MS##3##2##(2007-11#1)(2008-10#1)(2008-11#1)
using GC/MS and##2##3##(1993-4#1)(2007-8#1)
using GC/MS##4##2##(1993-4#1)(2007-8#1)(2008-10#1)(2011-1#1)
using GFP##3##2##(2008-9#2)(2009-8#1)
using GIS##3##2##(2007-10#1)(2008-4#1)(2013-8#1)
using Gene-Fizz##2##2##(1996-12#2)
using Genetic##2##2##(2008-8#1)(2012-3#1)
using Gibbs sampling##4##3##(1993-9#1)(1994-4#1)(1997-7#1)(2011-2#1)
using Giemsa##2##2##(2008-12#2)
using Glide##2##2##(2010-12#1)(2012-2#1)
using GnRH##2##2##(2007-11#1)(2011-2#1)
using Goldman applanation tonometry##2##4##(2010-1#2)
using H(2)##3##2##(2008-7#1)(2012-11#2)
using H-point standard addition method##2##5##(2007-8#1)(2008-10#1)
using HIC##2##2##(2008-10#2)
using HIV##2##2##(2011-1#1)(2012-3#1)
using HPLC and##5##3##(1991-4#1)(2008-10#2)(2008-7#1)(2010-12#1)
using HPLC in combination with##2##5##(2008-10#1)(2012-2#1)
using HPLC separation##2##3##(2008-10#2)
using HPLC with##4##3##(1997-1#1)(1997-2#1)(2007-1#1)(2008-10#1)
using HPLC##25##2##(1990-12#1)(1990-8#1)(1991-4#1)(1992-2#2)(1994-8#1)(1997-1#1)(1997-2#1)(2007-1#3)(2008-10#8)(2008-11#1)(2008-4#2)(2008-7#1)(2010-12#1)(2012-2#1)
using HPTLC##2##2##(1991-9#1)(2010-2#1)
using HeLa##3##2##(1993-6#1)(1996-5#1)(2008-11#1)
using High##2##2##(2008-7#1)(2012-12#1)
using ICP-AES##2##2##(2008-10#2)
using ICP-MS##3##2##(2008-10#3)
using IMRT##2##2##(2008-6#2)
using IR##2##2##(2007-10#1)(2007-11#1)
using ISFETs##2##2##(2008-10#2)
using ITS sequence##2##3##(2008-10#1)(2012-11#1)
using ITS##3##2##(2008-10#2)(2012-11#1)
using JPEG##2##2##(2008-3#2)
using Jones##2##2##(2008-2#1)(2008-3#1)
using Kaplan-Meier##3##2##(2007-8#1)(2011-2#1)(2013-1#1)
using Kirchhoff##2##2##(2007-12#1)(2008-3#1)
using LC-MS/MS##2##2##(2010-11#1)(2013-1#1)
using Lactobacillus##2##2##(2008-12#1)(2008-6#1)
using Lipofectamine 2000##2##3##(2011-2#2)
using M##4##2##(2008-6#1)(2010-12#1)(2010-4#1)(2012-1#1)
using MALDI-MS##2##2##(2007-8#1)(2009-12#1)
using MATLAB##2##2##(2006-10#1)(2012-2#1)
using MEDLINE and##2##3##(1993-3#1)(2006-12#1)
using MEDLINE##5##2##(1993-3#1)(2004-3#1)(2006-12#1)(2010-4#1)(2013-1#1)
using MHC##2##2##(2008-9#1)(2009-12#1)
using MR imaging##2##3##(1997-8#1)(2011-2#1)
using MR##3##2##(1997-8#1)(2008-10#1)(2011-2#1)
using MRI##13##2##(1996-9#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-3#1)(2006-6#1)(2008-4#1)(2009-4#2)(2012-1#2)(2012-12#1)(2012-2#1)
using MS##3##2##(2007-1#1)(2008-10#1)(2008-6#1)
using MSCs##2##2##(2008-1#1)(2008-11#1)
using MTT##3##2##(1994-5#1)(1995-8#1)(2012-11#1)
using Machine Learning##4##3##(2013-1#4)
using Markov chain Monte Carlo##2##5##(2008-10#1)(2011-12#1)
using Markov##3##2##(2008-10#1)(2011-12#1)(2013-1#1)
using Maximum Likelihood##3##3##(1992-12#1)(2008-6#1)(2010-2#1)
using Medicare##4##2##(1994-1#1)(1995-3#1)(2005-9#1)(2007-12#1)
using Medline##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
using Microsoft##2##2##(1994-3#1)(1996-2#1)
using Mie##2##2##(2008-2#1)(2008-3#1)
using MoAbs##2##2##(1993-8#2)
using Monte Carlo simulation##2##4##(2011-2#2)
using Monte Carlo simulations of##2##5##(2007-11#1)(2010-9#1)
using Monte Carlo simulations##5##4##(2007-11#1)(2007-12#2)(2008-2#1)(2010-9#1)
using Monte Carlo##9##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2010-9#1)(2011-2#2)
using Msx1 and Msx2 conditional mutant alleles together with a Tie2-Cre transgene##2##12##(2012-12#2)
using N##8##2##(2008-10#8)
using N-methylpyridinium as##2##3##(2008-10#2)
using NADH##2##2##(1992-3#1)(1992-7#1)
using NMR##8##2##(1994-11#1)(1994-3#1)(2005-11#1)(2007-10#1)(2007-9#1)(2008-10#1)(2009-6#1)(2009-7#1)
using National##2##2##(2007-10#1)(2007-9#1)
using New Zealand White rabbits##2##5##(1994-3#2)
using Northern##5##2##(1991-3#1)(1994-2#1)(1994-5#1)(1997-8#1)(2006-12#1)
using Nuclear Magnetic Resonance (NMR)##2##5##(2009-11#1)(2012-1#1)
using OTC drugs##2##3##(2008-7#1)(2013-8#1)
using P##3##2##(2008-10#1)(2012-12#2)
using PBL in##3##3##(2008-12#3)
using PBMC##4##2##(2011-2#4)
using PCA##3##2##(2012-3#2)(2013-8#1)
using PCR amplification##2##3##(1993-12#1)(2008-4#1)
using PCR and##3##3##(1995-8#1)(2006-10#1)(2011-2#1)
using PCR method##2##3##(2008-9#1)(2012-12#1)
using PCR technique##2##3##(1992-11#1)(2008-4#1)
using PCR to determine##2##4##(2008-10#1)(2013-8#1)
using PCR with##2##3##(2006-3#1)(2012-2#1)
using PCR##25##2##(1992-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-8#1)(2006-10#1)(2006-3#1)(2008-10#1)(2008-2#1)(2008-4#5)(2008-8#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
using PCR-RFLP##6##2##(2008-10#1)(2008-12#2)(2008-8#1)(2011-2#2)
using PCR-amplified##2##2##(1993-3#1)(1997-4#1)
using PEG##2##2##(1997-7#1)(2008-10#1)
using PET##2##2##(1996-1#1)(1996-10#1)
using PLS##3##2##(2008-10#2)(2008-5#1)
using PLS-1##2##2##(2008-10#2)
using PTFE##2##2##(2008-10#2)
using PTH##2##2##(1991-12#1)(2006-7#1)
using PUF##2##2##(2008-11#2)
using Pavlik harness and Frejka pillow##2##6##(2007-8#2)
using Pd as a permanent modifier##2##6##(2008-10#2)
using Pearson correlation##3##3##(2008-12#1)(2009-3#1)(2012-11#1)
using Pearson##4##2##(2008-12#1)(2009-3#1)(2012-11#1)(2012-12#1)
using Percoll##2##2##(1994-8#1)(2008-1#1)
using Poisson regression##2##3##(2008-10#1)(2010-1#1)
using Protein##2##2##(1990-11#1)(2008-11#1)
using Pseudomonas##2##2##(2008-10#2)
using PubMed##4##2##(2008-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
using Quality Function Deployment##2##4##(2011-1#2)
using R##3##2##(2008-10#1)(2008-6#1)(2013-1#1)
using RAPD##5##2##(1994-8#1)(2008-10#2)(2008-8#1)(2008-9#1)
using RAPD-PCR##3##2##(2005-10#1)(2006-8#1)(2011-2#1)
using RFLP and##2##3##(2008-10#2)
using RFLP##3##2##(1996-12#1)(2008-10#2)
using RNA from the##2##4##(1991-9#1)(1993-12#1)
using RNA from##5##3##(1991-9#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)
using RNA isolated##2##3##(1992-11#1)(2008-5#1)
using RNA##11##2##(1991-8#1)(1991-9#1)(1992-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#2)(2008-5#1)(2009-9#1)(2010-2#1)
using RP HPLC##3##3##(2010-2#1)(2010-3#1)(2012-2#1)
using RP-HPLC with##2##3##(1997-3#1)(2007-11#1)
using RT-PCR and##2##3##(2007-9#1)(2009-3#1)
using RT-PCR##10##2##(1996-12#1)(1997-2#1)(2007-9#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-2#2)(2013-8#1)
using Raman spectroscopy##5##3##(2006-7#1)(2007-11#1)(2008-10#1)(2013-7#1)(2013-8#1)
using Rasch##2##2##(2012-2#2)
using Rat 1 fibroblasts##2##4##(1993-12#1)(1995-3#1)
using Real##2##2##(2007-2#1)(2013-1#1)
using S##2##2##(1996-6#1)(2008-8#1)
using SAS##3##2##(1995-2#1)(2007-4#1)(2011-2#1)
using SEM##2##2##(2008-7#1)(2008-8#1)
using SERS##2##2##(2008-2#1)(2010-7#1)
using SF-CO(2) at##2##3##(2008-10#2)
using SF-CO(2)##3##2##(2008-10#3)
using SMQ data resulted in a productive method of evaluating automated semantic relatedness and similarity scores##2##16##(2013-1#2)
using SPME##3##2##(2008-10#3)
using SPSS##9##2##(2007-10#1)(2009-6#1)(2010-11#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#2)
using SSCP##2##2##(1996-11#1)(2007-2#1)
using SVM##2##2##(2007-6#1)(2008-2#1)
using SYBR Green I##2##4##(2008-10#1)(2012-3#1)
using SYBR Green##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
using Saccharomyces cerevisiae##3##3##(1997-6#1)(2008-5#2)
using Sep Pac##2##3##(1991-12#2)
using Sephadex##4##2##(1997-2#1)(2006-10#1)(2007-8#1)(2008-10#1)
using South African##2##3##(2008-8#1)(2008-9#1)
using Soxhlet extraction##2##3##(2008-10#1)(2009-3#1)
using Soxhlet##3##2##(2008-10#1)(2009-3#1)(2009-5#1)
using Student's t test##2##4##(2005-10#1)(2012-2#1)
using Student's t-test##5##3##(2008-10#1)(2008-12#1)(2008-7#1)(2010-12#1)(2013-1#1)
using Student's##8##2##(2005-10#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
using T-matrix##2##2##(2008-2#1)(2008-3#1)
using TCA precipitation##2##3##(2008-3#1)(2008-4#1)
using TEM##3##2##(2005-11#1)(2010-2#1)(2012-2#1)
using TGS##2##2##(2008-10#2)
using TLC##2##2##(1990-5#1)(1997-4#1)
using TUNEL##2##2##(2008-4#1)(2010-12#1)
using TachoComb##2##2##(2007-8#2)
using TaqMan##4##2##(2008-10#3)(2008-12#1)
using Teflon##2##2##(2007-8#1)(2008-10#1)
using Thin##2##2##(2008-10#1)(2009-11#1)
using Tibone implants##3##3##(2007-8#3)
using Triton##4##2##(1991-8#1)(1997-2#1)(2008-10#2)
using TurboSEQUEST##2##2##(2008-4#2)
using UFuRT##2##2##(2013-1#2)
using USP##2##2##(2012-2#2)
using UV detection##3##3##(1997-3#1)(2008-10#2)
using UV##10##2##(1997-3#1)(1997-4#1)(2005-11#1)(2008-10#5)(2008-5#1)(2013-8#1)
using UV-Vis##2##2##(2008-10#1)(2009-9#1)
using UV-vis##2##2##(2005-11#1)(2008-10#1)
using UV-visible##2##2##(2007-9#1)(2008-10#1)
using Urea-PAGE##2##2##(2012-12#2)
using Visual Analog Scale (VAS)##2##5##(2012-12#1)(2012-2#1)
using Visual Analog##3##3##(2012-12#1)(2012-2#2)
using W-Rh##2##2##(2008-10#2)
using WHO##2##2##(2012-2#2)
using Waters##2##2##(2008-10#1)(2009-6#1)
using Web##2##2##(1996-12#1)(2008-11#1)
using Western blot##2##3##(2007-12#1)(2008-5#1)
using Western blotting##3##3##(1991-8#1)(1991-9#1)(1997-5#1)
using Western##5##2##(1991-8#1)(1991-9#1)(1997-5#1)(2007-12#1)(2008-5#1)
using Wilcoxon##2##2##(2006-10#1)(2009-2#1)
using Wisconsin Card Sorting Test##2##5##(1996-3#2)
using X-ray absorption##3##3##(2006-4#1)(2008-10#2)
using X-ray diffraction##5##3##(2005-4#1)(2008-10#3)(2010-4#1)
using X-ray fluorescence##3##3##(2005-4#2)(2008-10#1)
using X-ray##13##2##(2005-11#1)(2005-4#3)(2006-4#1)(2008-10#6)(2010-4#1)(2012-12#1)
using XCHF-B200##3##2##(2008-5#3)
using Zeeman effect background correction##2##5##(2008-10#2)
using [125I]##2##2##(1990-9#1)(1991-4#1)
using a &quot##7##3##(1995-8#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#1)(2012-3#1)
using a 0##6##3##(1995-11#1)(1996-5#1)(2007-12#1)(2008-10#2)(2013-7#1)
using a 1##11##3##(1993-7#1)(1997-3#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)
using a 10##2##3##(2006-4#1)(2008-10#1)
using a 10-point##2##3##(2007-7#1)(2013-1#1)
using a 100##2##3##(1997-8#1)(2007-5#1)
using a 2##4##3##(2007-1#1)(2008-10#1)(2010-2#1)(2013-1#1)
using a 2-stage##2##3##(1992-9#1)(2007-1#1)
using a 20 mM borate buffer (pH##2##7##(2008-10#2)
using a 200##2##3##(2007-8#1)(2010-6#1)
using a 3##4##3##(1991-8#1)(1995-1#1)(2006-5#1)(2008-10#1)
using a 32P-labeled##2##3##(1991-1#1)(1994-9#1)
using a 3D##2##3##(2005-12#1)(2006-11#1)
using a 4##3##3##(1990-12#1)(2006-11#1)(2008-10#1)
using a 4-mm-long##2##3##(2007-12#1)(2008-3#1)
using a 5##6##3##(2007-10#1)(2008-10#3)(2008-8#1)(2013-1#1)
using a 50##2##3##(2008-10#1)(2008-5#1)
using a 500 microm mesh##2##5##(2007-5#1)(2008-5#1)
using a 6##2##3##(2006-11#1)(2008-3#1)
using a 60 s preconcentration time##2##6##(2008-10#2)
using a 60##4##3##(2008-10#2)(2008-5#1)(2009-11#1)
using a 7##2##3##(2008-10#1)(2013-7#1)
using a Bayesian##5##3##(2008-10#1)(2008-2#1)(2008-8#1)(2012-3#1)(2013-1#1)
using a C(18) column##2##4##(2008-10#2)
using a C(18)##3##3##(2008-10#2)(2009-8#1)
using a C18 reversed-phase column##2##5##(1993-11#1)(1996-6#1)
using a C18##3##3##(1993-11#1)(1993-2#1)(1996-6#1)
using a CCD camera##2##4##(2008-10#1)(2008-2#1)
using a Fourier transform##3##4##(2006-12#1)(2008-3#1)(2010-4#1)
using a Fourier##4##3##(2006-12#1)(2008-10#1)(2008-3#1)(2010-4#1)
using a Markov##2##3##(1997-7#1)(2010-12#1)
using a Monte Carlo model of##2##6##(2010-9#1)(2012-2#1)
using a Monte##3##3##(2008-2#1)(2010-9#1)(2012-2#1)
using a Nd##3##3##(2008-2#3)
using a Neyman-Scott cluster process##2##5##(2008-10#2)
using a PCR thermocycler##2##4##(2011-2#2)
using a PCR##7##3##(1991-8#1)(1994-12#1)(1997-6#1)(2006-10#1)(2008-4#1)(2011-2#2)
using a PDMS##2##3##(2007-8#1)(2008-10#1)
using a PTFE##3##3##(2007-8#1)(2008-10#2)
using a Shimadzu##2##3##(2007-3#1)(2008-12#1)
using a TEA CO2##2##4##(2007-12#2)
using a Teflon##2##3##(1993-11#1)(2012-2#1)
using a UV detector at##2##5##(2008-10#2)
using a UV detector##5##4##(2008-10#3)(2010-12#1)(2010-2#1)
using a UV##7##3##(1995-11#1)(2008-10#4)(2010-12#1)(2010-2#1)
using a Waters##3##3##(1997-8#2)(2008-10#1)
using a baculovirus expression system##4##5##(1992-10#1)(1993-12#1)(1993-6#1)(1996-11#1)
using a baculovirus##5##3##(1992-10#1)(1993-12#1)(1993-6#1)(1994-12#1)(1996-11#1)
using a battery of##4##4##(1997-7#1)(2008-2#1)(2009-10#2)
using a beta-cyclodextrin##3##3##(2008-10#1)(2011-1#2)
using a binary##6##3##(1992-9#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-1#1)
using a biocompatible##2##3##(2010-7#1)(2012-1#1)
using a biolistic##2##3##(2006-12#1)(2010-2#1)
using a biological##2##3##(1990-12#1)(2008-1#1)
using a blend of##2##4##(1993-1#1)(2008-5#1)
using a bottom-up approach##5##4##(2012-2#1)(2013-1#4)
using a bottom-up##6##3##(1992-9#1)(2012-2#1)(2013-1#4)
using a broadband##2##3##(2012-2#2)
using a cDNA array##2##4##(2008-10#1)(2008-9#1)
using a cDNA probe##4##4##(1992-8#1)(1993-3#1)(1996-12#1)(1997-6#1)
using a cDNA##8##3##(1991-6#1)(1992-8#1)(1993-3#1)(1996-12#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-9#1)
using a calcium##3##3##(1991-4#1)(1992-6#1)(2007-1#1)
using a calculator##2##3##(2008-11#2)
using a canine##3##3##(2009-8#1)(2010-4#1)(2012-3#1)
using a capillary column##3##4##(1990-8#1)(1996-6#1)(2008-10#1)
using a capillary##7##3##(1990-8#1)(1994-5#1)(1996-6#1)(2007-12#1)(2008-10#3)
using a carbon paste electrode modified with##4##7##(2008-10#4)
using a carbon paste electrode modified##6##6##(2008-10#6)
using a carbon##8##3##(1997-3#1)(2008-10#7)
using a carrier##2##3##(2007-4#1)(2008-10#1)
using a case study##3##4##(1995-3#1)(2013-1#2)
using a cell##3##3##(1994-12#1)(1994-2#1)(2009-4#1)
using a central composite design##4##5##(2008-10#4)
using a central composite##5##4##(2008-10#4)(2008-11#1)
using a chemical##3##3##(2008-10#1)(2008-7#1)(2010-12#1)
using a chemically##2##3##(1996-2#1)(2008-10#1)
using a chimeric##2##3##(1995-3#1)(2008-1#1)
using a chromatographic##2##3##(2008-10#2)
using a chromogenic##2##3##(1994-11#1)(2008-10#1)
using a circular##3##3##(1991-2#1)(1995-1#1)(2006-6#1)
using a classical##2##3##(2008-10#1)(2008-2#1)
using a clinical##2##3##(2007-8#1)(2011-1#1)
using a closed##2##3##(2008-10#1)(2008-6#1)
using a closed-loop##2##3##(2007-11#1)(2010-5#1)
using a colorimetric##3##3##(1997-8#1)(2012-2#2)
using a column##6##3##(2008-10#4)(2008-2#1)(2008-4#1)
using a combination of X-ray##2##5##(2005-11#1)(2011-2#1)
using a combination of a##2##5##(2009-4#1)(2009-8#1)
using a combination of optical##2##5##(2008-11#1)(2008-2#1)
using a combination of the##3##5##(1994-8#1)(2008-10#1)(2008-3#1)
using a combination of##71##4##(1990-2#1)(1990-8#1)(1992-3#1)(1993-12#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-4#1)(1996-2#1)(1997-3#1)(1997-4#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-7#1)(2007-8#1)(2008-10#12)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-3#2)(2013-1#3)(2013-7#1)
using a combined##11##3##(1990-3#1)(1991-2#1)(1991-4#1)(1994-12#1)(2006-10#1)(2006-7#1)(2008-10#1)(2009-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
using a commercial ELISA##2##4##(2007-8#1)(2012-5#1)
using a commercial##13##3##(1991-10#1)(1993-2#1)(2007-8#1)(2008-10#2)(2008-5#3)(2008-6#1)(2008-9#1)(2009-10#1)(2012-12#1)(2012-5#1)
using a commercially available##8##4##(1993-9#1)(1994-2#1)(1995-2#1)(1995-7#1)(2008-10#3)(2011-1#1)
using a common spectrofluorometer##4##4##(2008-10#4)
using a common##13##3##(2005-11#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#2)(2009-12#1)(2009-5#1)
using a comparative##3##3##(2008-10#2)(2012-3#1)
using a competition binding assay##2##5##(1995-1#1)(1996-8#1)
using a competitive##4##3##(1991-9#1)(1994-5#1)(1997-4#1)(2008-10#1)
using a complete##6##3##(1993-11#1)(1994-11#1)(1997-7#1)(2006-11#1)(2008-12#1)(2012-3#1)
using a complex##3##3##(2008-10#2)(2008-8#1)
using a composite##5##3##(2007-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)
using a comprehensive##2##3##(2008-2#1)(2008-7#1)
using a computer program##2##4##(2007-7#1)(2008-10#1)
using a computer##6##3##(1990-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2010-8#1)(2012-2#1)
using a computer-based##3##3##(1992-12#1)(2008-2#1)(2008-9#1)
using a computerized##5##3##(1993-9#1)(1996-3#1)(1997-3#1)(2007-9#1)(2012-2#1)
using a confocal laser scanning microscope##2##6##(2008-5#1)(2008-9#1)
using a confocal laser##3##4##(1994-9#1)(2008-5#1)(2008-9#1)
using a confocal##4##3##(1994-9#1)(2008-5#1)(2008-9#1)(2010-9#1)
using a conjugate of##2##4##(2008-11#1)(2008-2#1)
using a conjugate##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
using a constant##9##3##(1991-8#2)(2004-12#2)(2006-10#1)(2008-10#2)(2008-11#1)(2012-1#1)
using a continuous glucose monitoring##2##5##(2008-1#1)(2012-4#1)
using a continuous##10##3##(1990-9#1)(1992-1#2)(2008-1#1)(2008-10#4)(2012-4#1)(2013-1#1)
using a controlled##3##3##(2013-1#2)(2013-8#1)
using a conventional##14##3##(1990-5#1)(1992-2#1)(2008-10#7)(2008-5#1)(2009-10#1)(2009-8#1)(2010-4#1)(2012-2#1)
using a critical##3##3##(2008-4#1)(2008-7#1)(2011-1#1)
using a cross-linked##2##3##(2008-10#1)(2008-5#1)
using a crude##2##3##(1992-12#1)(2008-10#1)
using a cryogenic surface coil##2##5##(2012-1#2)
using a cutoff##2##3##(1992-6#1)(2004-2#1)
using a cylindrical##2##3##(2008-10#1)(2008-3#1)
using a data##3##3##(1993-5#1)(2005-10#1)(2013-1#1)
using a dataset of##2##4##(2007-6#1)(2013-1#1)
using a deformable##3##3##(2007-11#1)(2008-2#2)
using a degenerate##2##3##(1997-2#1)(1997-6#1)
using a derivative of the##2##5##(1990-4#1)(2008-4#1)
using a different##3##3##(2006-6#1)(2007-2#1)(2008-3#1)
using a diffusion##3##3##(2008-10#1)(2008-2#2)
using a digital##6##3##(1993-11#1)(2007-2#1)(2008-12#1)(2008-2#1)(2008-7#1)(2012-6#1)
using a diode laser##2##4##(1997-8#1)(2007-8#1)
using a direct laryngoscope##3##4##(2008-5#3)
using a direct##10##3##(1990-10#1)(1996-6#1)(2008-10#3)(2008-5#3)(2010-6#1)(2013-8#1)
using a discrete##2##3##(2007-12#1)(2008-5#1)
using a disease##2##3##(2008-10#1)(2011-2#1)
using a disposable##2##3##(2008-10#1)(2008-11#1)
using a distributed##4##3##(2006-6#1)(2009-10#1)(2013-1#2)
using a domestic##3##3##(2005-12#1)(2007-8#1)(2008-10#1)
using a double##6##3##(1990-4#1)(1994-12#1)(2004-1#1)(2008-10#1)(2008-5#1)(2012-1#1)
using a dual##6##3##(1997-2#1)(2006-12#1)(2007-8#1)(2008-10#1)(2009-8#1)(2009-9#1)
using a dye##2##3##(2008-10#1)(2008-2#1)
using a dynamic##6##3##(1997-5#1)(2007-1#1)(2007-5#1)(2008-10#2)(2008-12#1)
using a factorial design to obtain the most relevant variables##2##10##(2007-8#1)(2008-10#1)
using a factorial design##3##4##(2007-8#1)(2008-10#1)(2010-4#1)
using a factorial##4##3##(2007-8#1)(2008-10#2)(2010-4#1)
using a fast##3##3##(2008-10#2)(2008-6#1)
using a fiber Bragg grating##2##5##(2007-12#1)(2008-1#1)
using a fiber optic##3##4##(2008-10#2)(2010-6#1)
using a fiber##6##3##(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2010-6#1)
using a fibrin-glue coated collagen patch##3##6##(2007-8#3)
using a first##2##3##(2006-6#1)(2011-1#1)
using a fixed##5##3##(2007-9#1)(2008-10#2)(2008-3#1)(2012-1#1)
using a flexible##3##3##(2006-6#1)(2008-10#1)(2012-1#1)
using a flow cytometer and##3##5##(1993-4#1)(1994-10#1)(2008-9#1)
using a flow cytometer##6##4##(1993-4#1)(1994-10#1)(1994-2#2)(2008-9#2)
using a flow injection on-line##2##5##(2005-4#1)(2008-10#1)
using a flow injection system with##3##6##(2008-10#3)
using a flow injection system##6##5##(2008-10#6)
using a flow injection##11##4##(2005-4#1)(2008-10#10)
using a flow system##2##4##(2008-10#2)
using a flow##24##3##(1993-4#1)(1994-10#1)(1994-2#2)(1997-7#1)(2005-4#1)(2008-1#1)(2008-10#13)(2008-4#1)(2008-9#2)(2011-2#1)
using a flow-injection system##2##4##(2008-10#2)
using a flow-injection##3##3##(2008-10#3)
using a flow-through##3##3##(1994-9#1)(2008-10#2)
using a fluorescence based##2##4##(1997-2#1)(2008-1#1)
using a fluorescence##7##3##(1990-5#1)(1993-11#1)(1995-11#1)(1996-7#1)(1997-2#1)(2007-2#1)(2008-1#1)
using a fluorescent probe##3##4##(1994-2#1)(1995-11#1)(2008-5#1)
using a fluorescent##4##3##(1994-2#1)(1995-11#1)(2006-12#1)(2008-5#1)
using a fluoride##2##3##(2008-10#2)
using a fluoride-selective electrode##2##4##(2008-10#2)
using a focalized##3##3##(2008-10#3)
using a focused microwave oven##2##5##(2008-10#2)
using a focused##3##3##(2008-10#2)(2013-1#1)
using a four-point scale##2##4##(1993-11#1)(2011-2#1)
using a free##4##3##(2006-11#1)(2006-3#2)(2011-1#1)
using a full##5##3##(2006-11#1)(2006-5#1)(2007-4#1)(2010-6#1)(2012-1#1)
using a fully automated##3##4##(2008-10#1)(2008-11#1)(2011-1#1)
using a fully##4##3##(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#1)
using a function##2##3##(2008-10#2)
using a gas##3##3##(2006-10#1)(2007-10#1)(2007-8#1)
using a gastric band cutter##2##5##(2012-12#2)
using a gastric##3##3##(1996-8#1)(2012-12#2)
using a general##3##3##(2008-10#1)(2009-3#1)(2013-1#1)
using a generalizable approach to ontology-based data access##2##8##(2013-1#2)
using a generalized##3##3##(2008-3#1)(2012-1#2)
using a genetic##3##3##(1990-3#1)(1995-6#1)(2008-10#1)
using a genome-wide##2##3##(2008-9#1)(2013-1#1)
using a geometric##2##3##(1996-2#1)(2008-10#1)
using a glassy carbon electrode##3##5##(2008-10#3)
using a glassy carbon##4##4##(2008-10#4)
using a global##4##3##(2007-11#1)(2008-2#1)(2010-12#1)(2012-7#1)
using a gold binding polypeptide##2##5##(2008-10#2)
using a gold##4##3##(2008-10#3)(2008-12#1)
using a gradient flow##2##4##(2008-10#2)
using a gradient of##2##4##(1990-2#1)(2007-11#1)
using a gradient##5##3##(1990-2#1)(2007-11#1)(2008-10#2)(2013-1#1)
using a graphical##2##3##(1992-8#1)(2011-2#1)
using a graphite##2##3##(2008-10#2)
using a grounded theory##2##4##(2013-1#1)(2013-8#1)
using a guide catheter##2##4##(2010-12#2)
using a guide##3##3##(2010-12#2)(2010-8#1)
using a hand##2##3##(2009-3#1)(2012-1#1)
using a hand-held##2##3##(2007-2#1)(2011-1#1)
using a handheld##2##3##(1997-6#1)(2007-8#1)
using a hanging mercury drop electrode (HMDE)##2##7##(2008-10#2)
using a hanging mercury drop electrode##5##6##(2008-10#5)
using a heated##2##3##(1996-3#1)(1997-3#1)
using a heating##2##3##(2008-10#2)
using a hemacytometer##7##3##(2008-11#1)(2008-2#1)(2008-4#4)(2008-9#1)
using a heterologous##3##3##(1994-8#2)(1997-4#1)
using a high frequency dielectric method##2##6##(2008-10#2)
using a high##15##3##(1990-12#1)(1993-9#1)(1994-5#1)(2004-9#1)(2005-7#1)(2006-4#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)
using a high-performance liquid chromatography##2##5##(1991-12#1)(1996-8#1)
using a high-performance##3##3##(1991-12#1)(1993-7#1)(1996-8#1)
using a high-resolution##4##3##(2006-10#1)(2008-10#1)(2008-7#1)(2013-1#1)
using a high-speed drill##2##4##(2007-1#1)(2011-2#1)
using a high-speed##5##3##(2005-12#1)(2007-1#2)(2007-4#1)(2011-2#1)
using a high-temperature##2##3##(1994-9#1)(2009-8#1)
using a high-volume sampler##2##4##(2008-10#2)
using a higher##2##3##(2006-8#1)(2008-7#1)
using a highly sensitive##3##4##(2008-5#1)(2011-2#1)(2013-1#1)
using a highly specific##2##4##(1992-11#1)(1994-5#1)
using a highly##10##3##(1992-11#1)(1994-11#1)(1994-5#1)(1994-8#1)(2007-12#1)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
using a hollow##2##3##(2007-12#1)(2007-8#1)
using a homogeneous##2##3##(2007-7#1)(2008-10#1)
using a horseradish##3##3##(1991-10#1)(1996-6#1)(2008-10#1)
using a human##9##3##(1993-12#1)(1993-5#1)(1993-9#1)(1994-9#1)(1995-1#1)(2006-12#1)(2007-3#1)(2008-11#1)(2012-3#1)
using a hybrid##4##3##(2007-11#1)(2007-8#1)(2008-3#1)(2011-2#1)
using a hydroxylapatite column##2##4##(1992-7#1)(2008-4#1)
using a kinetic##2##3##(2008-10#1)(2010-6#1)
using a known##2##3##(2008-10#1)(2010-5#1)
using a large##3##3##(2008-10#1)(2009-10#1)(2010-9#1)
using a larger sample##2##4##(1992-2#1)(2010-9#1)
using a larger##5##3##(1992-2#1)(2006-4#1)(2010-9#1)(2013-1#2)
using a laser scanning cytometer##2##5##(2008-9#2)
using a laser##10##3##(1990-10#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-9#2)(2009-7#1)(2011-1#1)(2013-8#2)
using a lateral flow##2##4##(2008-10#1)(2013-1#1)
using a lateral##4##3##(2007-11#1)(2008-10#1)(2009-10#1)(2013-1#1)
using a less##3##3##(1993-2#1)(1995-7#1)(2007-12#1)
using a library of##2##4##(1990-11#1)(2008-11#1)
using a life##2##3##(2009-9#1)(2011-2#1)
using a light microscope##3##4##(2008-4#1)(2008-9#1)(2011-2#1)
using a limited##3##3##(1990-12#1)(2006-6#1)(2009-8#1)
using a linear combination of##3##5##(2008-10#2)(2008-2#1)
using a linear gradient##2##4##(1990-8#1)(1997-8#1)
using a linear model##3##4##(2008-3#1)(2009-6#1)(2010-2#1)
using a linear##19##3##(1990-8#1)(1992-3#2)(1992-4#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-7#1)(2009-6#1)(2010-2#1)(2012-3#1)(2013-8#1)
using a liquid##2##3##(2008-10#2)
using a local##4##3##(1992-9#1)(1994-2#1)(2008-4#1)(2008-6#1)
using a locally##2##3##(2007-6#1)(2012-3#1)
using a locking plate system##3##5##(2010-3#3)
using a log-binomial model##2##4##(2010-12#2)
using a logarithmic##2##3##(2007-11#1)(2008-11#1)
using a logistic regression model##3##5##(1990-4#1)(2006-8#1)(2008-3#1)
using a long##4##3##(2006-12#1)(2007-12#1)(2008-3#1)(2010-11#1)
using a long-term##2##3##(2008-10#1)(2008-8#1)
using a low##4##3##(1992-6#1)(2005-7#1)(2008-10#1)(2008-11#1)
using a low-copy-number plasmid##2##4##(1992-9#1)(1997-2#1)
using a lower##2##3##(2006-10#1)(2009-8#1)
using a luciferase##2##3##(1993-12#1)(2008-9#1)
using a macroscopic##3##3##(1994-11#1)(1994-12#1)(2012-2#1)
using a magnetic##2##3##(2008-10#1)(2008-8#1)
using a mandelic acid dioxolanone as a synthetic equivalent##2##9##(2007-11#2)
using a manual##3##3##(1991-12#1)(2008-10#1)(2012-2#1)
using a marker##2##3##(1995-9#1)(2008-10#1)
using a mass spectrometer##2##4##(2008-4#1)(2010-6#1)
using a mass##5##3##(1996-1#1)(2007-8#1)(2008-4#1)(2009-10#1)(2010-6#1)
using a mathematical##2##3##(1992-2#1)(2008-10#1)
using a matrix##2##3##(2008-2#1)(2008-4#1)
using a mechanical stapler##2##4##(1992-9#2)
using a membrane##2##3##(1995-2#1)(2005-8#1)
using a mercury##2##3##(1995-3#1)(2007-8#1)
using a metal##4##3##(1993-5#1)(2008-3#1)(2012-1#1)(2013-1#1)
using a method of##4##4##(1995-3#1)(2008-12#1)(2008-5#1)(2008-9#1)
using a method##5##3##(1995-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)
using a micro-column packed with##3##5##(2008-10#2)(2008-3#1)
using a microfluidic##3##3##(2008-11#2)(2011-1#1)
using a microplate reader##2##4##(1996-12#1)(2008-11#1)
using a microwave##2##3##(1993-11#1)(2008-10#1)
using a mini##2##3##(2008-10#1)(2013-8#1)
using a mini-column##2##3##(2008-10#2)
using a minimal##3##3##(2008-2#1)(2012-11#1)(2013-8#1)
using a minimally invasive##3##4##(1996-12#1)(2006-3#1)(2006-6#1)
using a mixed WO(3)-based##2##4##(2008-10#2)
using a mixture of 0##3##5##(2008-10#2)(2012-12#1)
using a mixture of##21##4##(1992-2#1)(2008-10#16)(2008-2#1)(2008-6#1)(2012-12#1)(2013-1#1)
using a mobile phase of##3##5##(2005-12#1)(2008-10#1)(2010-12#1)
using a mobile phase##7##4##(2005-12#1)(2008-10#3)(2010-12#2)(2010-2#1)
using a model in which##2##5##(2008-8#1)(2008-9#1)
using a model of a##2##5##(2007-10#1)(2012-1#1)
using a model of##4##4##(1991-8#1)(2007-10#1)(2012-1#1)(2012-2#1)
using a model that##2##4##(2008-3#2)
using a model##17##3##(1991-8#1)(1994-8#1)(1995-9#1)(2006-12#1)(2007-10#1)(2008-10#3)(2008-3#2)(2008-8#1)(2008-9#2)(2012-1#2)(2012-12#1)(2012-2#1)
using a modification of a##2##5##(1997-2#1)(2012-12#1)
using a modification of##3##4##(1997-2#1)(2007-9#1)(2012-12#1)
using a modified American Orthopaedic Foot and Ankle Society##2##9##(2009-10#2)
using a modified commercial##2##4##(2007-11#1)(2008-10#1)
using a modified in##2##4##(1990-3#1)(1997-3#1)
using a modified version of the##4##6##(2008-1#1)(2008-10#1)(2008-4#1)(2012-1#1)
using a modified version of##5##5##(1993-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2012-1#1)
using a modified##40##3##(1990-3#1)(1992-7#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-11#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)
using a molecularly##2##3##(2007-6#2)
using a monoclonal antibody against human##2##6##(1995-2#1)(1996-3#1)
using a monoclonal antibody against##3##5##(1995-2#1)(1996-3#1)(1997-6#1)
using a monoclonal antibody directed against##2##6##(1993-12#1)(1996-11#1)
using a monoclonal antibody specific for##2##6##(1993-12#1)(2008-10#1)
using a monoclonal antibody##12##4##(1992-7#1)(1993-12#2)(1993-8#1)(1995-2#1)(1996-11#1)(1996-3#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
using a monoclonal##16##3##(1990-12#1)(1992-7#1)(1993-12#2)(1993-8#1)(1994-12#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-3#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)
using a more##4##3##(1994-12#1)(2007-3#1)(2008-11#1)(2008-4#1)
using a mouse##3##3##(1995-5#1)(2010-9#1)(2013-8#1)
using a moving##2##3##(2008-2#1)(2008-7#1)
using a multifunctional anaesthesia##2##4##(2011-2#2)
using a multifunctional##3##3##(2006-4#1)(2011-2#2)
using a multimodal##2##3##(2006-10#1)(2012-3#1)
using a multimode##2##3##(2008-10#1)(2010-4#1)
using a multisyringe##3##3##(2008-10#3)
using a multivariate logistic regression##2##5##(2012-12#1)(2012-3#1)
using a multivariate##6##3##(1991-3#1)(1993-12#1)(1995-8#1)(2008-10#1)(2012-12#1)(2012-3#1)
using a nested PCR##2##4##(2011-12#1)(2012-3#1)
using a nested##4##3##(2010-6#1)(2011-12#1)(2011-2#1)(2012-3#1)
using a network##2##3##(1997-6#1)(2008-11#1)
using a neutral##2##3##(1997-4#1)(2010-5#1)
using a new algorithm##2##4##(2008-10#1)(2010-12#1)
using a new approach##2##4##(1993-11#1)(1994-6#1)
using a new automated##2##4##(1997-2#1)(2010-11#1)
using a new chelating##2##4##(2008-10#2)
using a new method##2##4##(2008-5#1)(2008-8#1)
using a new particle-mediated immunoassay##2##5##(2008-10#2)
using a new##53##3##(1990-11#1)(1990-3#1)(1991-3#2)(1991-4#1)(1991-5#1)(1993-11#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-6#1)(1997-2#2)(2005-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#16)(2008-2#1)(2008-3#1)(2008-5#4)(2008-8#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
using a newly developed##8##4##(1994-11#2)(1994-12#1)(1995-4#1)(2007-11#2)(2010-12#1)(2012-3#1)
using a newly synthesized##3##4##(1996-8#1)(2008-10#2)
using a newly##14##3##(1994-11#2)(1994-12#1)(1994-8#1)(1995-4#1)(1996-8#1)(2007-11#2)(2008-10#2)(2010-12#1)(2011-2#2)(2012-3#1)
using a non-detachable balloon catheter to##2##6##(1997-3#2)
using a non-invasive##2##3##(2008-5#1)(2010-12#1)
using a non-linear##3##3##(1996-5#1)(2008-10#2)
using a nonionic##3##3##(2008-10#2)(2008-4#1)
using a normal##2##3##(1993-9#1)(2008-10#1)
using a novel fluorescence##2##4##(1997-7#1)(2007-11#1)
using a novel method of##2##5##(1997-7#1)(2009-4#1)
using a novel method##4##4##(1993-6#1)(1997-7#1)(2008-2#1)(2009-4#1)
using a novel##48##3##(1990-5#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-4#1)(1993-3#1)(1993-6#1)(1994-1#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-7#2)(2005-12#1)(2005-7#1)(2007-11#1)(2007-12#3)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#1)(2008-5#1)(2009-4#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#2)(2012-1#3)(2012-2#2)(2012-3#1)(2013-7#1)
using a number of##3##4##(1993-11#1)(2008-10#1)(2008-11#1)
using a one-pot##2##3##(1997-3#1)(2008-10#1)
using a p-value combination method##2##5##(2012-3#2)
using a pH 2##2##4##(2008-10#2)
using a pH##4##3##(2007-8#1)(2008-10#3)
using a pair of primers##2##5##(1990-2#1)(1997-6#1)
using a pair of##6##4##(1990-2#1)(1997-6#1)(2008-3#2)(2008-4#1)(2008-9#1)
using a panel of##9##4##(1991-12#1)(1993-1#1)(1995-11#1)(1995-2#2)(1997-5#1)(1997-6#1)(2006-2#1)(2007-7#1)
using a partial least##2##4##(2008-10#2)
using a partial least-squares##2##4##(2008-10#2)
using a partial##6##3##(1994-8#1)(2008-10#4)(2008-8#1)
using a particular##2##3##(2008-10#1)(2008-2#1)
using a pedicled##3##3##(2007-8#1)(2009-9#1)(2013-1#1)
using a perforated block of corticocancellous graft##2##7##(2007-7#2)
using a perforated##3##3##(2007-7#2)(2007-8#1)
using a peripheral##3##3##(1990-8#2)(2008-4#1)
using a peristaltic pump##2##4##(2008-10#1)(2008-11#1)
using a personal##2##3##(2008-10#1)(2011-2#1)
using a phenomenological##2##3##(2009-8#1)(2011-1#1)
using a photodiode array detector##4##5##(1991-8#1)(2008-10#2)(2013-7#1)
using a plasmid##3##3##(1991-3#1)(1996-7#1)(2007-7#1)
using a plastic##4##3##(1990-8#1)(1991-3#1)(1994-7#1)(2008-2#1)
using a polyclonal antibody against##2##5##(1996-9#1)(2010-12#1)
using a polyclonal antibody##4##4##(1993-12#1)(1996-9#1)(2008-6#1)(2010-12#1)
using a polyclonal##6##3##(1991-5#1)(1993-12#1)(1996-8#1)(1996-9#1)(2008-6#1)(2010-12#1)
using a polymer##3##3##(1995-3#1)(2010-1#1)(2010-12#1)
using a polymerase chain##3##4##(1991-5#1)(1994-9#1)(2011-2#1)
using a polyurethane foam##2##4##(2008-10#1)(2008-11#1)
using a polyvinyl##2##3##(2008-10#2)
using a pool of##3##4##(1992-8#1)(1992-9#1)(1995-2#1)
using a portable##5##3##(2007-6#1)(2008-10#2)(2009-1#1)(2013-1#1)
using a position laser system##2##5##(2008-7#2)
using a potentiometric sensor immobilized in a graphite matrix##2##9##(2008-10#2)
using a potentiometric##5##3##(2008-10#5)
using a preconcentration time of##4##5##(2008-10#4)
using a predesigned##2##3##(2008-2#1)(2013-8#1)
using a pressure##2##3##(2006-12#1)(2007-6#1)
using a previous preconcentration step##2##5##(2008-10#2)
using a previously##5##3##(1990-8#1)(1992-1#1)(2008-10#1)(2008-2#1)(2013-1#1)
using a priming##2##3##(1993-2#1)(2007-7#1)
using a principal component analysis##2##5##(2008-10#1)(2013-7#1)
using a principal component##3##4##(2008-10#2)(2013-7#1)
using a probe for##2##4##(1990-8#1)(1997-3#1)
using a probe##7##3##(1990-8#1)(1991-6#1)(1993-8#1)(1994-12#1)(1995-8#1)(1997-3#1)(2008-3#1)
using a procedure##2##3##(2006-6#1)(2009-3#1)
using a program##2##3##(2008-10#2)
using a proposed##4##3##(2007-8#1)(2008-2#1)(2008-7#1)(2013-7#1)
using a protein##2##3##(1990-12#1)(1990-8#1)
using a prototype##5##3##(2007-8#1)(2008-2#1)(2008-5#1)(2008-6#1)(2010-11#1)
using a pulse##2##3##(2006-10#1)(2007-1#1)
using a pulsed laser##2##4##(2008-10#1)(2012-2#1)
using a pulsed##5##3##(1990-2#1)(2008-10#2)(2008-2#1)(2012-2#1)
using a pump##2##3##(2007-12#1)(2008-10#1)
using a purge-and-trap system##2##4##(2008-10#2)
using a purified##3##3##(1990-4#1)(1991-2#1)(1994-9#1)
using a qualitative##2##3##(2008-11#1)(2013-1#1)
using a quantitative descriptive##2##4##(2008-10#1)(2010-4#1)
using a quantitative##6##3##(1992-5#1)(1994-6#1)(1997-2#1)(2006-7#1)(2008-10#1)(2010-4#1)
using a quartz crystal microbalance##3##5##(2005-11#1)(2008-10#2)
using a quartz crystal##4##4##(2005-11#1)(2008-10#3)
using a quartz##5##3##(2005-11#1)(2008-10#4)
using a quasi-experimental design##2##4##(2008-11#1)(2008-2#1)
using a questionnaire and##3##4##(1993-11#1)(2007-5#1)(2008-11#1)
using a questionnaire format##2##4##(1993-3#1)(2006-10#1)
using a questionnaire##21##3##(1992-1#1)(1992-12#1)(1993-11#1)(1993-3#1)(1993-6#1)(2004-10#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-10#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)
using a rabbit##3##3##(1991-10#1)(1992-7#1)(2008-10#1)
using a radial##2##3##(2008-9#1)(2009-11#1)
using a radioimmunoassay##3##3##(1990-2#1)(1991-8#1)(2008-3#1)
using a random##7##3##(1994-8#1)(2008-10#1)(2008-2#2)(2011-1#1)(2012-12#1)(2013-1#1)
using a randomized##4##3##(2007-2#1)(2008-8#1)(2013-1#2)
using a range of##10##4##(2006-11#1)(2006-5#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#2)(2011-1#1)(2013-1#1)
using a rapid##5##3##(1991-12#1)(1993-12#1)(1995-8#1)(2008-10#2)
using a rat model of##2##5##(1992-7#1)(1994-6#1)
using a rat model##3##4##(1992-7#1)(1994-6#1)(2012-12#1)
using a rat##6##3##(1992-3#1)(1992-7#1)(1992-8#1)(1993-7#1)(1994-6#1)(2012-12#1)
using a ray-tracing##2##3##(2008-2#2)
using a real##2##3##(2008-5#1)(2010-2#1)
using a real-time PCR##2##4##(2008-10#1)(2010-6#1)
using a real-time##3##3##(2008-10#1)(2010-6#1)(2011-2#1)
using a recently developed##3##4##(1991-5#1)(1992-6#1)(2008-10#1)
using a recently##7##3##(1991-5#1)(1992-6#1)(2007-8#1)(2008-10#4)
using a recombinant antigen##2##4##(1992-3#1)(2006-10#1)
using a recombinant inbred line##2##5##(2008-10#2)
using a recombinant inbred##3##4##(2008-10#2)(2012-11#1)
using a recombinant##9##3##(1992-3#2)(1994-3#1)(1996-11#1)(2006-10#1)(2008-10#2)(2010-4#1)(2012-11#1)
using a reference##3##3##(2007-8#1)(2008-10#1)(2008-2#1)
using a relatively small amount of##2##6##(2008-10#1)(2008-7#1)
using a relatively small number of##2##6##(1991-2#1)(1996-3#1)
using a relatively small##4##4##(1991-2#1)(1996-3#1)(2008-10#1)(2008-7#1)
using a relatively##5##3##(1991-2#1)(1996-3#1)(2008-10#1)(2008-6#1)(2008-7#1)
using a repeated##4##3##(1993-3#1)(1996-7#1)(2008-11#1)(2010-2#1)
using a rescaling factor##3##4##(1994-5#3)
using a response surface methodology##2##5##(2008-5#2)
using a retroviral vector##2##4##(1995-5#1)(2008-11#1)
using a reverse##3##3##(1995-10#1)(1996-10#1)(1996-11#1)
using a reversed##2##3##(1995-6#1)(2008-10#1)
using a reversed-phase##6##3##(1996-5#1)(2005-12#1)(2007-8#2)(2008-10#1)(2013-1#1)
using a rigorous##3##3##(2008-3#1)(2013-1#2)
using a robot##2##3##(2006-7#1)(2013-1#1)
using a robotic##3##3##(1994-6#1)(2012-1#2)
using a sample of##4##4##(1995-3#1)(2008-10#1)(2008-11#1)(2012-12#1)
using a sample volume of##2##5##(2008-10#2)
using a sample##10##3##(1994-11#1)(1994-2#1)(1995-3#1)(2008-10#4)(2008-11#1)(2009-5#1)(2012-12#1)
using a scanning##2##3##(2007-7#1)(2011-2#1)
using a second##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
using a secreted##2##3##(1995-2#2)
using a selective##4##3##(1991-5#1)(1992-2#1)(2008-4#1)(2011-1#1)
using a self-administered questionnaire##4##4##(2006-2#1)(2012-2#2)(2013-1#1)
using a semi-automated##2##3##(2009-10#1)(2010-12#1)
using a semi-quantitative##2##3##(1994-12#1)(2009-8#1)
using a semi-structured questionnaire##2##4##(2007-3#1)(2008-2#1)
using a semi-structured##3##3##(2007-3#1)(2008-2#1)(2011-1#1)
using a semiconductor##3##3##(2008-2#1)(2008-3#2)
using a semistructured guide##2##4##(2005-10#1)(2009-5#1)
using a semistructured interview##2##4##(2008-1#1)(2010-9#1)
using a semistructured questionnaire##2##4##(2004-12#1)(2007-11#1)
using a semistructured##7##3##(2004-12#1)(2005-10#1)(2007-11#1)(2008-1#1)(2009-5#1)(2010-9#1)(2011-1#1)
using a sensitive##8##3##(1991-9#1)(1994-2#1)(1994-6#1)(1996-5#1)(2008-10#2)(2008-2#1)(2010-12#1)
using a sequential injection analysis##2##5##(2008-10#2)
using a sequential injection system##3##5##(2008-10#3)
using a sequential injection##6##4##(2008-10#6)
using a sequential##11##3##(1997-4#1)(2008-10#9)(2009-10#1)
using a series of##16##4##(1990-8#4)(1992-11#1)(1995-4#1)(1995-8#1)(1996-2#1)(1996-5#3)(1997-6#1)(2008-10#1)(2008-8#1)(2009-8#1)(2010-2#1)
using a serum##2##3##(1990-4#1)(2007-6#1)
using a serum-free##3##3##(1993-8#1)(2008-11#1)(2008-7#1)
using a set of primers##2##5##(1994-5#1)(1995-8#1)
using a set of##16##4##(1992-1#1)(1994-5#1)(1995-8#1)(1996-9#1)(2006-3#1)(2006-5#1)(2008-10#4)(2008-8#1)(2009-10#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-3#1)
using a short##3##3##(1990-6#1)(2008-10#1)(2010-11#1)
using a shuttle vector##2##4##(1990-5#1)(1997-2#1)
using a silicon##2##3##(2006-12#1)(2008-10#1)
using a silicone##2##3##(1996-3#1)(2009-2#1)
using a similar technique##2##4##(1991-3#1)(2008-3#1)
using a similar##4##3##(1990-2#1)(1991-3#1)(2008-3#1)(2009-10#1)
using a simple and##3##4##(2008-10#2)(2012-12#1)
using a simple heterogeneous mixture of reagents##2##7##(2008-5#2)
using a simple model of the##2##6##(2008-2#1)(2008-7#1)
using a simple model of##3##5##(2007-12#1)(2008-2#1)(2008-7#1)
using a simple model##5##4##(1992-4#1)(1992-9#1)(2007-12#1)(2008-2#1)(2008-7#1)
using a simple system##2##4##(2008-5#2)
using a simple##42##3##(1990-5#1)(1990-8#1)(1991-3#1)(1992-4#1)(1992-9#1)(1995-7#1)(1997-8#1)(2006-2#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#6)(2008-6#2)(2008-7#2)(2009-10#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-8#1)
using a simplified##4##3##(2005-11#1)(2008-10#1)(2008-4#1)(2008-8#1)
using a simulation##2##3##(2006-10#1)(2013-1#1)
using a simultaneous##2##3##(2007-11#1)(2010-8#1)
using a single excitation##2##4##(2008-9#1)(2011-1#1)
using a single extraction##2##4##(2008-10#2)
using a single##38##3##(1990-11#1)(1990-8#1)(1991-5#1)(1992-3#1)(1994-4#1)(1995-12#1)(1996-2#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-2#2)(2011-1#1)
using a small number of##3##5##(1996-12#1)(2008-2#1)(2012-1#1)
using a small##10##3##(1996-12#1)(2004-9#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2012-1#1)(2012-12#1)(2013-7#1)
using a software program##2##4##(1995-6#1)(2011-2#1)
using a software##3##3##(1995-6#1)(2011-2#1)(2013-8#1)
using a solid phase##5##4##(1991-1#1)(1994-3#1)(1995-1#1)(2008-10#1)(2013-8#1)
using a solid##9##3##(1991-1#1)(1994-3#1)(1995-1#2)(2008-10#4)(2013-8#1)
using a solid-phase attachment##2##4##(2008-10#2)
using a solid-phase extraction (SPE)##2##5##(2008-10#2)
using a solid-phase extraction##4##4##(1990-9#1)(1997-3#1)(2008-10#2)
using a solid-phase##8##3##(1990-9#1)(1997-3#1)(2008-1#1)(2008-10#5)
using a solution hybridization##2##4##(1991-9#1)(1997-8#1)
using a solution##4##3##(1991-9#1)(1997-8#1)(2007-9#1)(2008-10#1)
using a spatial##3##3##(2007-12#1)(2008-2#1)(2012-1#1)
using a spatially##4##3##(2008-2#1)(2008-9#1)(2011-2#1)(2012-2#1)
using a special##12##3##(1993-4#1)(1994-6#1)(2005-12#1)(2006-3#1)(2006-6#2)(2007-11#1)(2007-9#1)(2008-11#1)(2008-2#2)(2011-2#1)
using a specially##4##3##(1991-11#1)(2007-10#1)(2008-5#1)(2010-3#1)
using a specific antibody##5##4##(1991-11#1)(1992-12#1)(1992-7#1)(1995-7#1)(1997-1#1)
using a specific monoclonal antibody##2##5##(1993-8#1)(2006-8#1)
using a specific##20##3##(1990-10#1)(1990-5#1)(1991-11#1)(1992-12#2)(1992-4#1)(1992-7#1)(1993-5#1)(1993-8#1)(1994-6#1)(1995-2#1)(1995-7#1)(1995-8#1)(1997-1#1)(1997-3#1)(2006-8#1)(2007-12#1)(2008-10#1)(2009-3#1)(2013-1#1)
using a spectral##2##3##(2008-10#1)(2008-4#1)
using a spectrophotometer##3##3##(2008-10#1)(2008-2#1)(2008-9#1)
using a spectrophotometric##2##3##(2008-10#2)
using a spin##3##3##(1990-3#1)(2005-11#1)(2008-10#1)
using a spontaneous##2##3##(2008-11#1)(2008-4#1)
using a square-wave##2##3##(2008-10#2)
using a standard curve##3##4##(1996-12#1)(2008-10#1)(2011-2#1)
using a standard protocol##4##4##(1991-7#1)(2006-5#1)(2008-10#1)(2012-2#1)
using a standard questionnaire##3##4##(1990-10#1)(2007-2#1)(2009-5#1)
using a standard test pattern##2##5##(2004-9#2)
using a standard##43##3##(1990-10#1)(1990-9#1)(1991-12#1)(1991-7#1)(1992-10#1)(1992-2#1)(1996-12#1)(1996-4#1)(1997-8#1)(2004-9#3)(2005-10#1)(2006-12#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-12#1)(2007-2#2)(2008-10#8)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)
using a standardized questionnaire##2##4##(1993-5#1)(2013-8#1)
using a standardized##11##3##(1993-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-9#1)(2010-6#1)(2012-12#1)(2013-1#1)(2013-8#1)
using a statistical##2##3##(2008-10#1)(2013-1#1)
using a step gradient##2##4##(1990-2#1)(2008-4#1)
using a stochastic##2##3##(2008-10#1)(2008-2#1)
using a strain of##2##4##(2008-5#1)(2013-8#1)
using a strong##3##3##(1997-3#1)(2007-12#1)(2007-8#1)
using a structured questionnaire##10##4##(2007-10#2)(2008-11#1)(2008-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)
using a structured##13##3##(2007-10#2)(2008-1#1)(2008-11#1)(2008-8#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#1)
using a subset of##3##4##(2012-3#1)(2013-1#2)
using a sucrose##2##3##(1995-2#1)(2008-1#1)
using a suitable##2##3##(2008-10#2)
using a surface plasmon resonance (SPR) biosensor##2##7##(2008-10#1)(2008-4#1)
using a surface plasmon resonance##3##5##(2008-10#2)(2008-4#1)
using a surface##7##3##(1994-11#1)(2008-10#3)(2008-4#1)(2008-5#1)(2013-7#1)
using a surgical##3##3##(1994-9#1)(2008-9#1)(2012-3#1)
using a survey##3##3##(1993-12#1)(2008-10#1)(2013-8#1)
using a synthetic##14##3##(1990-7#1)(1991-7#1)(1994-12#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-5#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#2)(2011-2#1)
using a system with##2##4##(2008-2#1)(2011-1#1)
using a system##5##3##(1994-2#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)
using a systematic##4##3##(1992-4#1)(1996-2#1)(2006-3#1)(2012-3#1)
using a target##2##3##(2008-10#1)(2008-3#1)
using a technique##8##3##(1990-5#1)(2006-10#1)(2007-9#1)(2008-10#2)(2008-7#1)(2009-11#1)(2010-3#1)
using a test pattern##2##4##(2004-9#2)
using a test set##4##4##(2007-4#1)(2009-3#1)(2013-1#2)
using a test##8##3##(2004-9#2)(2007-4#1)(2009-3#1)(2011-2#1)(2013-1#3)
using a tetrazolium salt##2##4##(1992-9#1)(1996-12#1)
using a thermodynamic##2##3##(1993-11#1)(2008-10#1)
using a thin##2##3##(2008-10#2)
using a three##2##3##(2008-10#1)(2008-5#1)
using a three-dimensional##3##3##(2006-3#1)(2008-5#1)(2010-12#1)
using a threshold##2##3##(2011-1#1)(2013-1#1)
using a titanium##2##3##(2007-11#1)(2007-8#1)
using a total of##4##4##(1990-11#1)(1994-5#1)(1995-1#1)(2008-7#1)
using a total##5##3##(1990-11#1)(1994-5#1)(1995-1#1)(2008-3#1)(2008-7#1)
using a traditional##2##3##(2008-10#2)
using a truncated##2##3##(1991-5#1)(2012-3#1)
using a two##2##3##(2008-10#1)(2011-11#1)
using a two-color##2##3##(1997-3#1)(2008-2#1)
using a two-dimensional##7##3##(1992-9#1)(2006-5#1)(2007-12#2)(2008-2#2)(2013-1#1)
using a two-stage##2##3##(2008-11#1)(2011-2#1)
using a two-step##6##3##(1991-5#1)(1991-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-7#1)
using a typical##4##3##(2007-10#1)(2008-3#1)(2008-7#1)(2009-5#1)
using a unique##6##3##(2006-4#1)(2008-10#1)(2012-12#1)(2012-3#1)(2013-1#2)
using a universal testing machine##2##5##(2009-8#1)(2013-8#1)
using a vaginal##2##3##(1992-12#1)(2011-1#1)
using a validated questionnaire##2##4##(2008-5#1)(2013-1#1)
using a validated##8##3##(2008-5#1)(2010-12#1)(2010-3#1)(2010-7#1)(2012-12#3)(2013-1#1)
using a variable##3##3##(1997-6#1)(2007-11#1)(2008-10#1)
using a variety of animal##2##5##(2006-10#1)(2012-1#1)
using a variety of methods##4##5##(1993-3#1)(2008-10#1)(2008-12#1)(2011-12#1)
using a variety of techniques##4##5##(2006-10#1)(2007-7#1)(2010-3#1)(2011-2#1)
using a variety of##32##4##(1992-1#1)(1992-11#1)(1992-9#1)(1993-11#2)(1993-3#1)(1994-11#1)(1995-3#1)(2005-11#1)(2006-10#2)(2006-4#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-3#1)
using a vector##3##3##(1991-4#1)(2006-6#1)(2012-11#1)
using a very##3##3##(1997-8#1)(2005-11#1)(2010-11#1)
using a video##3##3##(1993-12#1)(2007-11#1)(2013-1#1)
using a virtual learning environment (VLE)##2##6##(2008-12#2)
using a visible##2##3##(1991-4#1)(1994-2#1)
using a visual##4##3##(1996-12#1)(2008-10#1)(2010-2#1)(2012-1#1)
using a water mobile phase##3##5##(2008-10#3)
using a water soluble##2##4##(1993-4#1)(2008-5#1)
using a water##5##3##(1993-4#1)(2008-10#3)(2008-5#1)
using a water-soluble##4##3##(1990-4#1)(1996-5#1)(2008-10#2)
using a weakly##2##3##(2008-10#2)
using a well##2##3##(2008-7#1)(2013-1#1)
using a whole##3##3##(2011-1#1)(2011-2#2)
using a wide range of##2##5##(2007-12#1)(2012-1#1)
using a wide##3##3##(2007-12#1)(2009-10#1)(2012-1#1)
using a window##2##3##(2007-11#1)(2012-2#1)
using a yeast##4##3##(1994-12#1)(1995-1#1)(2008-5#1)(2008-9#1)
using a##3388##2##(1990-1#1)(1990-10#4)(1990-11#5)(1990-12#12)(1990-2#10)(1990-3#7)(1990-4#10)(1990-5#11)(1990-6#3)(1990-7#5)(1990-8#22)(1990-9#3)(1991-1#3)(1991-10#4)(1991-11#2)(1991-12#6)(1991-2#7)(1991-3#11)(1991-4#6)(1991-5#12)(1991-6#3)(1991-7#5)(1991-8#10)(1991-9#5)(1992-1#10)(1992-10#3)(1992-11#7)(1992-12#9)(1992-2#11)(1992-3#10)(1992-4#7)(1992-5#1)(1992-6#9)(1992-7#6)(1992-8#9)(1992-9#17)(1993-1#3)(1993-10#3)(1993-11#13)(1993-12#16)(1993-2#8)(1993-3#9)(1993-4#8)(1993-5#8)(1993-6#3)(1993-7#4)(1993-8#4)(1993-9#14)(1994-1#1)(1994-10#2)(1994-11#15)(1994-12#19)(1994-2#15)(1994-3#6)(1994-4#1)(1994-5#17)(1994-6#9)(1994-7#1)(1994-8#12)(1994-9#12)(1995-1#11)(1995-10#2)(1995-11#12)(1995-12#4)(1995-2#21)(1995-3#13)(1995-4#4)(1995-5#3)(1995-6#6)(1995-7#6)(1995-8#13)(1995-9#2)(1996-1#6)(1996-10#4)(1996-11#8)(1996-12#10)(1996-2#14)(1996-3#7)(1996-4#3)(1996-5#15)(1996-6#9)(1996-7#5)(1996-8#12)(1996-9#3)(1997-1#6)(1997-2#19)(1997-3#21)(1997-4#8)(1997-5#4)(1997-6#13)(1997-7#12)(1997-8#12)(2004-1#2)(2004-10#1)(2004-11#4)(2004-12#3)(2004-2#2)(2004-4#1)(2004-8#1)(2004-9#10)(2005-10#4)(2005-11#16)(2005-12#8)(2005-4#2)(2005-7#3)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#30)(2006-11#11)(2006-12#20)(2006-2#5)(2006-3#12)(2006-4#13)(2006-5#16)(2006-6#22)(2006-7#8)(2006-8#9)(2007-1#16)(2007-10#18)(2007-11#52)(2007-12#77)(2007-2#15)(2007-3#7)(2007-4#12)(2007-5#9)(2007-6#11)(2007-7#24)(2007-8#73)(2007-9#17)(2008-1#20)(2008-10#688)(2008-11#77)(2008-12#22)(2008-2#126)(2008-3#88)(2008-4#52)(2008-5#100)(2008-6#27)(2008-7#57)(2008-8#29)(2008-9#45)(2009-1#2)(2009-10#22)(2009-11#5)(2009-12#9)(2009-2#9)(2009-3#17)(2009-4#11)(2009-5#9)(2009-6#4)(2009-7#10)(2009-8#25)(2009-9#10)(2010-1#5)(2010-10#5)(2010-11#9)(2010-12#31)(2010-2#18)(2010-3#15)(2010-4#16)(2010-5#9)(2010-6#12)(2010-7#5)(2010-8#15)(2010-9#12)(2011-1#39)(2011-11#2)(2011-12#5)(2011-2#67)(2011-3#2)(2012-1#51)(2012-11#8)(2012-12#47)(2012-2#51)(2012-3#44)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#1)(2013-1#101)(2013-7#24)(2013-8#32)
using ab initio##2##3##(1994-7#1)(1997-2#1)
using abbreviated##2##2##(2007-7#1)(2008-7#1)
using absolute##3##2##(1990-4#1)(1993-3#1)(1993-5#1)
using absorbable##2##2##(1992-2#1)(2012-12#1)
using absorbance spectroscopy##2##3##(2008-4#1)(2010-11#1)
using absorbance##4##2##(2008-10#1)(2008-4#1)(2010-11#1)(2012-2#1)
using absorption##3##2##(2006-10#1)(2006-12#1)(2008-10#1)
using accelerated solvent extraction##2##4##(2008-10#2)
using accelerated##3##2##(2007-11#1)(2008-10#2)
using acellular dermis##2##3##(2008-9#2)
using acetic acid##2##3##(1991-3#1)(2008-10#1)
using acetic##3##2##(1991-3#1)(2008-10#1)(2008-6#1)
using acetone as a##2##4##(1992-8#1)(2007-6#1)
using acetone##3##2##(1992-8#1)(2007-6#1)(2008-7#1)
using acetonitrile and##4##3##(2008-10#1)(2011-1#1)(2012-12#2)
using acetonitrile as##2##3##(2007-11#1)(2010-12#1)
using acetonitrile##6##2##(2007-11#1)(2008-10#1)(2010-12#1)(2011-1#1)(2012-12#2)
using acid treatment##2##3##(2008-4#1)(2008-8#1)
using acid##4##2##(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)
using acidic##2##2##(2008-10#1)(2012-3#1)
using acidified##2##2##(2008-10#2)
using acoustic##2##2##(2007-12#1)(2007-5#1)
using actual##3##2##(2005-12#1)(2007-12#1)(2009-7#1)
using acute##3##2##(1995-2#1)(2007-11#1)(2007-7#1)
using adaptive##2##2##(2007-12#1)(2012-12#1)
using additional##6##2##(1991-3#1)(2008-4#2)(2008-7#1)(2010-3#1)(2012-3#1)
using adenovirus##2##2##(1994-8#1)(2007-3#1)
using adenoviruses##2##2##(2006-11#1)(2008-8#1)
using adequately-iodized salt##2##3##(2013-1#2)
using adjustable sutures##2##3##(1992-2#2)
using adjustable##3##2##(1992-2#3)
using administrative data##4##3##(1996-1#1)(2005-9#1)(2007-5#1)(2010-11#1)
using administrative##5##2##(1996-1#1)(1996-3#1)(2005-9#1)(2007-5#1)(2010-11#1)
using adsorption##3##2##(2005-11#1)(2007-10#1)(2008-10#1)
using adsorptive stripping voltammetry##2##4##(2008-10#2)
using adsorptive##3##2##(2008-10#3)
using adult##3##2##(2006-10#1)(2010-7#1)(2013-7#1)
using adults##2##2##(1996-12#1)(2012-12#1)
using advanced##2##2##(2008-11#2)
using affected sib pair##2##4##(1997-5#2)
using affinity chromatography##2##3##(1992-8#1)(1995-10#1)
using affinity##4##2##(1992-8#1)(1995-10#1)(2008-4#2)
using affinity-purified##2##2##(1996-6#1)(2008-4#1)
using agar##2##2##(2006-9#1)(2008-3#1)
using agarose gel##2##3##(1991-8#1)(2008-5#1)
using age as either last attained year or##2##8##(2007-7#2)
using age as##3##3##(2007-6#1)(2007-7#2)
using agents that##2##3##(2006-10#1)(2008-3#1)
using air##4##2##(2005-10#1)(2008-10#1)(2008-6#1)(2009-5#1)
using airborne##2##2##(2008-10#1)(2008-2#1)
using alkaline phosphatase##2##3##(1990-2#1)(1995-1#1)
using alkaline##6##2##(1990-2#1)(1994-10#1)(1995-1#1)(2008-10#2)(2008-5#1)
using alkyl##2##2##(2008-10#1)(2010-4#1)
using all the##4##3##(1992-1#1)(2008-2#1)(2009-2#1)(2013-8#1)
using all three##4##3##(2008-10#2)(2008-11#1)(2009-12#1)
using all##14##2##(1992-1#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-9#1)(2009-12#1)(2009-2#1)(2010-4#1)(2012-3#1)(2013-8#1)
using allele##2##2##(1990-7#1)(2010-2#1)
using allele-specific##4##2##(1992-1#1)(2006-4#1)(2008-4#1)(2010-12#1)
using allograft##3##2##(2009-10#2)(2012-3#1)
using alternating##2##2##(2008-2#1)(2009-2#1)
using alternative health##2##3##(2009-12#1)(2010-6#1)
using alternative##6##2##(1995-5#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-12#1)(2010-6#1)
using aluminium##2##2##(2008-10#1)(2013-7#1)
using aluminum##2##2##(2006-5#1)(2012-3#1)
using ambulatory##4##2##(1996-10#2)(1997-1#1)(2006-7#1)
using amino acid##2##3##(2009-5#1)(2012-2#1)
using amino##3##2##(2009-5#1)(2010-7#1)(2012-2#1)
using ammonia as##2##3##(1997-8#1)(2007-8#1)
using ammonia##3##2##(1997-8#1)(2007-8#1)(2008-6#1)
using ammonium##6##2##(1997-3#1)(1997-4#1)(2005-11#1)(2008-10#3)
using amniotic membranes##2##3##(1993-1#2)
using amperometric biosensors##2##3##(2008-10#2)
using amperometric##3##2##(2008-10#3)
using amperometry##2##2##(2008-10#2)
using amplified DNA##2##3##(1990-12#1)(1990-7#1)
using amplified fragment length polymorphism (AFLP) and##3##7##(2008-10#3)
using amplified fragment length polymorphism (AFLP) markers##2##7##(2008-10#2)
using amplified fragment length polymorphism (AFLP)##6##6##(2008-10#6)
using amplified fragment length polymorphism##9##5##(2008-10#9)
using amplified fragment length##10##4##(2008-10#10)
using amplified##13##2##(1990-12#1)(1990-7#1)(2008-10#10)(2008-11#1)
using amylose as a substrate##2##5##(1990-9#2)
using an Agrobacterium-mediated##2##3##(2006-12#1)(2008-10#1)
using an ELISA##7##3##(1993-1#1)(1997-6#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2013-8#1)
using an HPLC system with##2##5##(1997-8#1)(2008-10#1)
using an HPLC system##3##4##(1997-8#1)(2008-10#2)
using an HPLC##5##3##(1993-12#1)(1997-8#1)(2008-10#3)
using an NMR##2##3##(1991-5#1)(1997-4#1)
using an ODS column##2##4##(2008-10#2)
using an ODS##3##3##(1996-6#1)(2008-10#2)
using an Objective##2##3##(2008-11#1)(2009-4#1)
using an S-band EPR spectrometer##2##5##(1993-9#1)(1994-5#1)
using an XTT##2##3##(2011-2#1)(2013-1#1)
using an acetate buffer as a carrier##2##7##(2008-10#2)
using an acetonitrile-aqueous##2##3##(1992-1#1)(1992-2#1)
using an acid##3##3##(2008-10#3)
using an acidic##3##3##(2007-8#1)(2008-10#1)(2008-5#1)
using an action research approach##2##5##(2007-10#1)(2007-7#1)
using an adaptation of##2##4##(2010-2#1)(2012-1#1)
using an adequate##3##3##(2007-9#1)(2008-10#1)(2008-3#1)
using an adjustable##2##3##(2006-10#1)(2007-8#1)
using an affinity chromatography##2##4##(1997-7#1)(2008-10#1)
using an affinity##4##3##(1997-7#1)(2008-10#1)(2008-7#1)(2012-2#1)
using an alcohol##2##3##(1991-5#1)(2008-11#1)
using an allele-specific##3##3##(1995-12#1)(1996-11#1)(2008-4#1)
using an alternative##3##3##(1992-3#1)(2008-12#1)(2009-8#1)
using an amperometric##3##3##(2007-8#1)(2008-10#2)
using an analysis of##2##4##(2007-10#1)(2008-10#1)
using an analysis##3##3##(2007-10#1)(2008-10#2)
using an analytical##4##3##(1991-12#1)(2004-11#1)(2008-3#1)(2009-2#1)
using an angular##2##3##(2007-7#1)(2009-6#1)
using an anion exchange column##3##5##(1993-11#1)(2008-10#1)(2011-1#1)
using an anion##4##3##(1993-11#1)(1996-12#1)(2008-10#1)(2011-1#1)
using an anion-exchange##3##3##(2008-10#3)
using an antibody against##2##4##(1995-5#1)(2012-2#1)
using an antibody directed against##2##5##(1997-5#1)(2009-8#1)
using an antibody raised against##2##5##(1994-10#1)(2008-10#1)
using an antibody##7##3##(1994-10#1)(1995-5#1)(1997-5#1)(2008-10#1)(2008-4#1)(2009-8#1)(2012-2#1)
using an antigen##2##3##(1990-12#1)(2006-8#1)
using an antisense##2##3##(1991-2#1)(1997-7#1)
using an antiserum##2##3##(2008-10#1)(2008-5#1)
using an approach##2##3##(1991-1#1)(1997-7#1)
using an appropriate##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
using an aqueous solution of##2##5##(2007-8#1)(2008-10#1)
using an aqueous solution##3##4##(2007-8#1)(2008-10#2)
using an aqueous##5##3##(2007-8#1)(2008-10#4)
using an array of##4##4##(2006-5#1)(2007-11#1)(2008-10#1)(2012-2#1)
using an artificial neural network##2##5##(2008-10#1)(2008-8#1)
using an artificial##5##3##(2006-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)
using an assay##4##3##(1990-7#1)(1991-12#1)(1992-12#1)(1995-1#1)
using an atomic absorption##2##4##(2008-10#2)
using an atomic##4##3##(1994-11#1)(2008-10#2)(2010-4#1)
using an automated system##2##4##(2008-10#1)(2008-4#1)
using an automated##9##3##(2005-8#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-4#1)(2010-7#1)
using an automatic##3##3##(1991-12#1)(2008-1#1)(2008-10#1)
using an avocado##2##3##(2008-10#2)
using an efficient##2##3##(2008-3#1)(2013-1#1)
using an electrochemical##3##3##(2008-10#2)(2008-5#1)
using an electron##2##3##(2008-10#2)
using an electronic nose##3##4##(2008-10#1)(2008-11#1)(2008-6#1)
using an electronic portal imaging device##2##6##(1993-9#1)(2009-2#1)
using an electronic##8##3##(1993-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-2#1)(2013-1#1)
using an electrospray##2##3##(2008-10#1)(2009-6#1)
using an empirical##2##3##(2008-7#1)(2012-3#1)
using an endovascular##3##3##(1991-3#1)(2007-10#2)
using an enzymatic##5##3##(1992-11#1)(2008-10#4)
using an enzyme immunoassay##4##4##(1990-5#1)(1992-7#1)(1995-4#1)(2008-5#1)
using an enzyme linked immunosorbent assay##2##6##(2004-10#1)(2011-1#1)
using an enzyme##9##3##(1990-5#1)(1992-7#1)(1992-8#1)(1995-4#1)(1997-5#1)(2004-10#1)(2008-5#2)(2011-1#1)
using an enzyme-linked immunosorbent assay##5##5##(1995-2#1)(2005-8#1)(2008-10#2)(2012-2#1)
using an epidural##2##3##(1993-10#1)(2007-2#1)
using an established##2##3##(2007-6#1)(2009-4#1)
using an ethical decision-making##2##4##(2005-7#2)
using an evidence-based##2##3##(2011-2#1)(2012-3#1)
using an experimental design approach##2##5##(2008-10#2)
using an experimental design##4##4##(2008-10#4)
using an experimental##11##3##(1997-6#1)(2004-4#1)(2006-6#1)(2008-10#4)(2008-5#1)(2008-6#1)(2010-9#1)(2013-8#1)
using an exploratory##2##3##(2008-10#1)(2012-1#1)
using an expression vector##3##4##(1990-12#1)(1993-9#1)(1997-2#1)
using an extended##3##3##(1995-2#1)(2005-11#1)(2011-2#1)
using an extension of the##2##5##(2008-6#1)(2009-8#1)
using an external##7##3##(1990-9#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2009-2#1)(2012-3#1)
using an image analyzer##2##4##(1995-8#1)(2008-5#1)
using an image##4##3##(1991-6#1)(1995-8#1)(1996-5#1)(2008-5#1)
using an immobilized##3##3##(1995-3#1)(1997-8#1)(2004-8#1)
using an immunoaffinity##2##3##(1993-12#1)(2007-8#1)
using an improved##5##3##(1994-8#1)(2007-11#1)(2008-3#1)(2011-2#1)(2012-2#1)
using an in situ##3##4##(1995-3#1)(2004-4#1)(2008-10#1)
using an in vitro model##2##5##(2006-4#1)(2008-10#1)
using an in vitro##17##4##(1990-9#1)(1991-9#1)(1994-11#1)(1994-8#1)(1995-9#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-7#1)(2006-4#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-3#1)(2013-8#1)
using an in vivo assay##2##5##(1992-1#1)(2006-12#1)
using an in vivo##5##4##(1992-1#1)(1993-7#1)(1996-9#1)(2006-12#1)(2008-5#1)
using an in##27##3##(1990-9#1)(1991-9#1)(1992-1#1)(1993-7#1)(1994-11#1)(1994-4#1)(1994-8#1)(1995-3#1)(1995-9#1)(1996-4#1)(1996-5#1)(1996-9#2)(1997-7#1)(2004-4#1)(2006-12#1)(2006-4#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2009-3#1)(2012-2#1)(2013-8#1)
using an in-house##2##3##(2005-11#1)(2010-12#1)
using an indirect##2##3##(2008-10#1)(2008-11#1)
using an inductively coupled##2##4##(2008-10#1)(2008-2#1)
using an inexpensive##2##3##(2008-10#2)
using an information##2##3##(2006-10#1)(2008-6#1)
using an infrared##3##3##(2007-11#1)(2007-12#1)(2008-7#1)
using an innovative##2##3##(2009-3#1)(2010-3#1)
using an integrated##7##3##(1997-5#1)(2005-11#1)(2008-10#3)(2008-2#1)(2008-9#1)
using an interactive##2##3##(1994-2#1)(2006-5#1)
using an interdisciplinary##2##3##(1993-3#1)(2012-1#1)
using an internal standard##2##4##(1993-12#1)(1997-2#1)
using an interview##2##3##(2011-1#1)(2011-2#1)
using an inverse##3##3##(1993-5#1)(2006-11#1)(2008-2#1)
using an ion##4##3##(1996-9#1)(2008-10#3)
using an ion-selective electrode##2##4##(2008-10#1)(2013-8#1)
using an isocratic##2##3##(1996-3#1)(2008-10#1)
using an isolated##2##3##(1990-9#1)(1992-3#1)
using an iterative##2##3##(1997-6#1)(2008-3#1)
using an on-line##6##3##(1993-2#1)(2008-10#5)
using an online##2##3##(2008-10#1)(2011-2#1)
using an operational##2##3##(2006-6#1)(2008-10#1)
using an optical device##2##4##(2005-11#1)(2008-10#1)
using an optical##6##3##(1995-12#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-2#1)
using an optimally##2##3##(1990-12#1)(2012-2#1)
using an original##3##3##(1992-9#1)(2004-9#1)(2007-1#1)
using an osmotic minipump##2##4##(1996-10#1)(2011-2#1)
using an oxygen electrode##2##4##(1992-11#1)(2008-10#1)
using an ultrasonic##3##3##(2004-9#1)(2008-10#1)(2008-11#1)
using an ultraviolet detector##2##4##(1996-6#1)(1997-8#1)
using an ultraviolet##3##3##(1996-6#1)(1997-8#1)(2008-2#1)
using an uncemented##2##3##(2007-11#1)(2008-3#1)
using an##682##2##(1990-12#5)(1990-4#1)(1990-5#2)(1990-7#3)(1990-8#1)(1990-9#5)(1991-1#1)(1991-12#5)(1991-2#3)(1991-3#2)(1991-5#7)(1991-6#3)(1991-9#1)(1992-1#4)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#3)(1992-6#2)(1992-7#2)(1992-8#6)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#2)(1993-5#1)(1993-6#1)(1993-7#3)(1993-8#1)(1993-9#5)(1994-10#1)(1994-11#4)(1994-12#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#3)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#3)(1995-4#2)(1995-5#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-4#2)(1996-5#5)(1996-6#3)(1996-8#2)(1996-9#3)(1997-1#2)(1997-2#2)(1997-4#1)(1997-5#4)(1997-6#4)(1997-7#6)(1997-8#5)(2004-10#1)(2004-11#2)(2004-12#1)(2004-4#2)(2004-8#1)(2004-9#2)(2005-1#1)(2005-10#1)(2005-11#8)(2005-7#2)(2005-8#2)(2006-10#3)(2006-11#1)(2006-12#4)(2006-3#2)(2006-4#2)(2006-5#6)(2006-6#4)(2006-7#1)(2006-8#2)(2007-1#2)(2007-10#8)(2007-11#10)(2007-12#12)(2007-2#3)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#7)(2007-8#16)(2007-9#2)(2008-1#9)(2008-10#145)(2008-11#19)(2008-12#3)(2008-2#20)(2008-3#17)(2008-4#9)(2008-5#18)(2008-6#7)(2008-7#8)(2008-8#3)(2008-9#10)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#4)(2009-3#3)(2009-4#2)(2009-5#3)(2009-6#2)(2009-8#5)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#4)(2010-6#1)(2010-7#1)(2010-9#3)(2011-1#10)(2011-2#18)(2012-1#7)(2012-11#1)(2012-12#5)(2012-2#12)(2012-3#8)(2013-1#11)(2013-7#1)(2013-8#10)
using analgesics##2##2##(2006-6#1)(2010-11#1)
using analogues of##2##3##(1992-6#1)(1995-8#1)
using analysis of variance##2##4##(1993-12#1)(1995-2#1)
using analysis of##3##3##(1993-12#1)(1995-2#1)(2008-2#1)
using analytical##5##2##(1991-2#1)(1992-2#1)(1993-3#1)(2007-8#1)(2008-4#1)
using and##6##2##(1991-2#1)(1994-2#1)(2007-6#1)(2008-4#1)(2009-8#1)(2010-8#1)
using angiotensin##2##2##(2008-1#1)(2010-2#1)
using animal models##4##3##(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#1)
using animal##8##2##(1995-2#1)(2007-12#1)(2008-6#1)(2008-7#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#1)
using anion exchange##2##3##(1995-2#1)(2008-10#1)
using anion-exchange chromatography##3##3##(1992-5#1)(1996-8#1)(1997-5#1)
using anion-exchange##4##2##(1992-5#1)(1996-8#1)(1997-5#1)(2008-10#1)
using anisotropic##2##2##(2006-5#1)(2008-3#1)
using anodic stripping voltammetry##2##4##(2006-6#1)(2008-10#1)
using anodic##4##2##(2006-6#1)(2008-10#2)(2009-7#1)
using another##4##2##(2008-10#3)(2008-4#1)
using anterior##2##2##(2007-8#1)(2008-5#1)
using anthropometric##4##2##(2008-1#1)(2008-11#1)(2011-1#1)(2013-1#1)
using anti##2##2##(2008-12#1)(2008-5#1)
using anti-human##2##2##(1992-8#1)(1997-4#1)
using anti-inflammatory##3##2##(2008-5#1)(2008-7#1)(2009-12#1)
using anti-phosphotyrosine##2##2##(1993-6#2)
using anti-rat##2##2##(1991-4#1)(2008-4#1)
using antibiotics##4##2##(1993-2#1)(2005-11#1)(2006-10#1)(2012-3#1)
using antibodies against##12##3##(1990-6#1)(1991-9#1)(1992-9#1)(1995-12#1)(1996-3#1)(2008-10#2)(2011-2#1)(2012-12#3)(2012-3#1)
using antibodies raised against##4##4##(1992-11#1)(1992-8#1)(1994-3#1)(2008-5#1)
using antibodies specific for the##3##5##(1994-11#1)(1994-8#1)(1995-3#1)
using antibodies specific for##5##4##(1993-6#1)(1994-11#1)(1994-8#1)(1995-3#2)
using antibodies to##2##3##(1991-8#1)(1994-11#1)
using antibodies##35##2##(1990-11#1)(1990-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-11#2)(1994-3#1)(1994-8#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-8#2)(1996-3#1)(1996-8#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#2)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)
using antibody##9##2##(1990-4#1)(1993-12#1)(2008-3#1)(2008-4#2)(2008-8#1)(2010-11#1)(2010-6#1)(2011-2#1)
using antisense oligonucleotides##2##3##(1991-9#1)(1997-1#1)
using antisense##5##2##(1991-9#1)(1993-6#1)(1995-8#1)(1997-1#1)(2008-11#1)
using antisera against##3##3##(1991-12#1)(2005-9#1)(2008-10#1)
using antisera##8##2##(1991-12#1)(1993-3#1)(1993-9#1)(1996-4#1)(2005-9#1)(2007-8#1)(2008-10#2)
using antiserum##2##2##(1992-7#1)(2008-10#1)
using any of##2##3##(2006-6#1)(2008-9#1)
using any##18##2##(1995-2#1)(2006-10#1)(2006-6#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#1)(2008-9#3)(2010-4#1)(2010-5#2)(2011-2#1)
using appropriate equipment##2##3##(1992-7#1)(1997-3#1)
using appropriate statistical##4##3##(2008-10#1)(2012-12#1)(2012-2#2)
using appropriate##17##2##(1990-12#1)(1992-6#1)(1992-7#1)(1997-3#1)(2006-12#2)(2008-10#2)(2008-2#1)(2008-4#2)(2012-12#1)(2012-2#4)(2013-1#1)
using approximately##2##2##(1997-4#1)(2009-12#1)
using aqueous solutions of##2##4##(2008-10#1)(2010-5#1)
using aqueous standard solutions##2##4##(2007-8#1)(2008-10#1)
using aqueous##12##2##(2007-8#1)(2008-10#8)(2008-5#1)(2010-5#1)(2011-2#1)
using arbitrary##2##2##(2006-8#1)(2008-2#1)
using argon plasma##2##3##(1990-10#1)(2010-12#1)
using aromatic##3##2##(2007-11#1)(2008-10#1)(2008-7#1)
using artificial intelligence techniques##2##4##(2010-8#2)
using artificial neural networks (ANN)##2##5##(2008-10#1)(2010-8#1)
using artificial neural networks##10##4##(1995-5#2)(2008-10#6)(2010-4#1)(2010-8#1)
using artificial neural##11##3##(1995-5#2)(2008-10#7)(2010-4#1)(2010-8#1)
using artificial##15##2##(1994-6#1)(1995-5#2)(2008-10#7)(2008-2#1)(2010-4#1)(2010-8#3)
using artificially##3##2##(2010-12#1)(2011-1#1)(2012-2#1)
using as a substrate##2##4##(2008-10#1)(2011-2#1)
using as a##6##3##(1990-2#1)(1990-9#1)(1996-4#1)(2008-10#1)(2008-8#1)(2011-2#1)
using as little as##2##4##(1997-4#1)(2008-11#1)
using as mobile phase##2##4##(2008-10#2)
using as probes##2##3##(1993-2#1)(1994-11#1)
using as the##4##3##(1990-9#1)(1992-9#1)(1996-10#1)(2008-2#1)
using as##25##2##(1990-10#1)(1990-2#1)(1990-9#2)(1991-8#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-11#1)(1996-10#1)(1996-4#1)(1997-4#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-5#1)(2008-8#1)(2011-2#2)
using ascorbate##2##2##(1992-6#1)(2008-10#1)
using ascorbic acid##3##3##(2008-10#2)(2010-8#1)
using assays##2##2##(1991-4#1)(1992-1#1)
using asymmetric##2##2##(2007-12#1)(2007-6#1)
using asymptotic##2##2##(2008-3#2)
using at least##3##3##(2007-12#2)(2008-10#1)
using atmospheric##2##2##(2007-1#1)(2008-3#1)
using atom transfer radical polymerization##2##5##(2010-4#1)(2013-8#1)
using atom##3##2##(2008-10#1)(2010-4#1)(2013-8#1)
using atomic absorption spectrometry##5##4##(2008-10#3)(2009-6#1)(2013-8#1)
using atomic absorption##7##3##(2008-10#5)(2009-6#1)(2013-8#1)
using atomic force microscopy (AFM)##4##5##(2008-10#1)(2008-5#1)(2008-8#1)(2011-12#1)
using atomic force##5##3##(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-12#1)
using atomic##12##2##(2007-8#1)(2008-10#6)(2008-5#1)(2008-8#1)(2009-6#1)(2011-12#1)(2013-8#1)
using attenuated total##2##3##(2007-12#1)(2008-10#1)
using autogenic bone grafts##2##4##(2007-11#2)
using autogenic##3##2##(2007-11#3)
using autogenous##2##2##(2007-11#1)(2011-3#1)
using autologous rib##3##3##(2012-3#3)
using autologous##13##2##(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#3)(2007-8#1)(2008-11#1)(2011-2#1)(2012-3#3)(2013-1#1)
using automated##7##2##(1991-5#1)(1993-9#1)(1996-12#1)(1996-6#1)(1997-6#1)(2008-10#1)(2008-9#1)
using automatic##4##2##(1994-9#1)(2007-8#1)(2008-10#2)
using autoradiography##3##2##(1991-5#1)(1993-9#1)(2008-4#1)
using available##7##2##(2006-11#1)(2007-3#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-7#2)
using average blood##2##3##(2006-7#2)
using backscattered##3##2##(1996-9#1)(2007-1#1)(2009-4#1)
using bacteria and##2##3##(2006-2#1)(2008-9#1)
using bacterial luciferase##2##3##(1997-2#2)
using bacterial##4##2##(1997-2#2)(2008-10#1)(2008-4#1)
using bacteriophage##4##2##(1991-12#1)(1996-11#1)(1997-8#1)(2008-4#1)
using balloon angioplasty##2##3##(1994-11#1)(2012-3#1)
using balloon##4##2##(1994-11#1)(2008-1#1)(2008-7#1)(2012-3#1)
using basic##2##2##(2008-3#1)(2012-1#1)
using batch##3##2##(2006-11#1)(2008-10#2)
using bead##2##2##(2008-9#1)(2011-2#1)
using beads##2##2##(2011-2#2)
using behavioural##2##2##(1993-6#1)(2007-7#1)
using best##3##2##(2006-11#1)(2007-11#1)(2010-8#1)
using beta-correction##3##2##(2008-10#3)
using biased##2##2##(2008-9#1)(2012-3#1)
using bilateral##3##2##(2005-12#1)(2007-8#1)(2011-2#1)
using binding##3##2##(1990-10#1)(1995-3#1)(1995-5#1)
using biochemical and##3##3##(1990-7#2)(1995-5#1)
using biochemical methods##2##3##(2008-12#1)(2013-7#1)
using biochemical##6##2##(1990-7#2)(1995-5#1)(2008-10#1)(2008-12#1)(2013-7#1)
using bioinformatics##3##2##(2008-4#1)(2008-7#1)(2010-7#1)
using biological##4##2##(2005-11#1)(2007-11#1)(2008-6#1)(2008-7#1)
using biologically##2##2##(2007-11#1)(2008-3#1)
using bioluminescent##2##2##(1997-2#1)(2013-1#1)
using biotin##2##2##(1994-9#1)(2008-10#1)
using biotinylated estradiol##2##3##(2008-10#2)
using biotinylated##5##2##(1992-8#1)(1995-10#1)(1997-3#1)(2008-10#2)
using bismuth##2##2##(2007-8#1)(2013-8#1)
using bisphosphonates##3##2##(2008-1#1)(2008-6#1)(2013-1#1)
using bivariate##2##2##(2013-1#2)
using blackbody infrared radiative dissociation##3##5##(2006-1#1)(2006-3#1)(2006-4#1)
using blood##6##2##(2005-7#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
using blunt-end##2##2##(1990-3#1)(2008-5#1)
using body mass index##2##4##(2008-9#1)(2013-8#1)
using body##4##2##(2007-11#1)(2008-1#1)(2008-9#1)(2013-8#1)
using bone##4##2##(1996-11#1)(2007-11#1)(2007-8#1)(2008-7#1)
using borate##2##2##(2008-10#2)
using boron-doped diamond##2##3##(2008-10#2)
using both a##10##3##(1993-2#2)(2004-3#1)(2007-12#1)(2007-9#1)(2008-10#4)(2009-11#1)
using both an##2##3##(2008-2#1)(2010-11#1)
using both conventional##3##3##(2006-1#1)(2008-9#2)
using both fluorescence##2##3##(2007-8#1)(2008-3#1)
using both methods##6##3##(2006-8#1)(2007-3#1)(2007-8#1)(2008-10#1)(2009-3#1)(2012-1#1)
using both quantitative and qualitative approaches##2##6##(2007-7#1)(2008-12#1)
using both simulated and##3##4##(2008-10#1)(2013-1#2)
using both simulated##4##3##(2008-10#1)(2010-12#1)(2013-1#2)
using both simulations##2##3##(2008-3#1)(2010-2#1)
using both single##2##3##(1990-3#1)(2008-6#1)
using both the##13##3##(1994-9#1)(1995-2#1)(1997-5#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2010-12#1)(2010-6#1)
using both types of##2##4##(2008-10#1)(2013-1#1)
using both virulence##2##3##(2008-10#2)
using both##130##2##(1990-11#1)(1990-3#1)(1991-8#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-11#1)(1994-6#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-12#1)(1997-5#1)(1997-7#1)(2004-3#1)(2005-11#3)(2005-5#1)(2006-1#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-10#31)(2008-11#1)(2008-12#2)(2008-2#7)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)
using bovine##6##2##(1991-5#1)(1992-9#1)(1994-5#1)(1994-9#1)(2008-10#1)(2008-7#1)
using brain##3##2##(1996-1#1)(1996-12#1)(2007-7#1)
using bromate##2##2##(2008-10#2)
using bromocresol##2##2##(2008-10#2)
using bulk##2##2##(2008-10#1)(2008-3#1)
using bulked segregant analysis##5##4##(1995-6#1)(2006-9#1)(2008-10#2)(2008-5#1)
using bupivacaine 0##2##3##(2006-12#1)(2006-8#1)
using bupivacaine##4##2##(2006-12#2)(2006-8#1)(2007-8#1)
using cDNA microarray##2##3##(2006-10#1)(2008-10#1)
using cDNA##6##2##(1992-12#1)(1993-4#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-8#1)
using cDTPA and benzyl-EDTA derivatives as##2##6##(1996-8#2)
using calcium##2##2##(2008-10#1)(2010-9#1)
using calf##2##2##(1995-11#1)(2007-7#1)
using calibrated##4##2##(2006-6#1)(2008-3#1)(2008-5#1)(2009-11#1)
using calibration##2##2##(2008-10#2)
using camera##2##2##(2008-10#1)(2013-8#1)
using cannabis##3##2##(2005-10#1)(2008-12#1)(2012-12#1)
using capillary electrophoresis with laser-induced fluorescence detection##2##7##(1996-11#1)(1996-12#1)
using capillary electrophoresis with##6##4##(1994-9#1)(1996-11#1)(1996-12#1)(1996-5#1)(2008-10#2)
using capillary electrophoresis##14##3##(1994-9#2)(1996-11#1)(1996-12#1)(1996-5#3)(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#3)(2008-4#1)
using capillary gas chromatography##2##4##(1990-6#1)(1994-10#1)
using capillary zone electrophoresis (CZE)##5##5##(2005-12#1)(2008-10#4)
using capillary zone electrophoresis##6##4##(2005-12#1)(2007-8#1)(2008-10#4)
using capillary##24##2##(1990-6#1)(1990-9#1)(1994-10#1)(1994-9#2)(1996-11#1)(1996-12#1)(1996-5#3)(1997-2#1)(1997-8#1)(2005-12#1)(2007-8#2)(2008-10#8)(2008-4#1)
using carbodiimide##2##2##(1990-11#1)(2008-10#1)
using carbon dioxide##3##3##(2008-10#1)(2012-2#1)(2012-3#1)
using carbon monoxide##2##3##(1994-12#1)(2010-2#1)
using carbon##10##2##(1994-12#1)(2006-6#1)(2007-11#1)(2008-10#4)(2010-2#1)(2012-2#1)(2012-3#1)
using cardiopulmonary bypass##4##3##(2007-8#2)(2007-9#2)
using cardiopulmonary##5##2##(2006-10#1)(2007-8#2)(2007-9#2)
using carrageenan-induced paw edema##2##4##(2011-1#1)(2013-7#1)
using cascaded##2##2##(2007-12#1)(2008-2#1)
using case##2##2##(1995-2#1)(2008-11#1)
using cashew apple##2##3##(2008-5#2)
using cast##2##2##(2009-4#1)(2011-2#1)
using catalytic##3##2##(2008-10#2)(2012-2#1)
using cationic##4##2##(2008-1#2)(2008-10#1)(2009-2#1)
using cavity ringdown spectroscopy##2##4##(2008-3#2)
using celecoxib##2##2##(2006-10#1)(2008-11#1)
using celestial cues##2##3##(1994-3#2)
using cell culture##2##3##(2008-7#1)(2012-2#1)
using cell cultures##2##3##(2008-11#1)(2010-4#1)
using cell##10##2##(2006-3#1)(2008-11#2)(2008-7#3)(2010-12#2)(2010-4#1)(2012-2#1)
using cellophane tape##2##3##(2007-7#2)
using cells of##2##3##(1996-3#1)(2008-11#1)
using cells##8##2##(1996-3#1)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#1)(2010-10#1)(2012-12#1)
using cellular##6##2##(1992-11#1)(1995-3#1)(2005-8#1)(2007-2#1)(2007-8#1)(2008-11#1)
using cellulose##3##2##(1994-3#1)(2008-4#1)(2008-5#1)
using cellulose-azure##2##2##(2008-10#2)
using central composite design-response surface methodology##2##6##(2012-3#2)
using central composite design-response surface##3##5##(2012-12#1)(2012-3#2)
using central composite##5##3##(2008-10#2)(2012-12#1)(2012-3#2)
using central##6##2##(2007-7#1)(2008-10#2)(2012-12#1)(2012-3#2)
using centrifugation##2##2##(1995-11#1)(2008-4#1)
using ceramic implants##2##3##(2007-8#2)
using certain##2##2##(2007-7#1)(2009-10#1)
using certified##3##2##(2008-10#3)
using cervical##2##2##(2007-11#1)(2011-2#1)
using chaotic##2##2##(2007-12#1)(2008-11#1)
using chelating##3##2##(1990-2#1)(2008-10#2)
using chemical and cellular##2##4##(2008-11#2)
using chemical and##3##3##(2008-10#1)(2008-11#2)
using chemical##12##2##(1992-5#1)(2007-2#1)(2008-10#5)(2008-11#2)(2008-4#1)(2010-12#1)(2013-7#1)
using chemically modified##2##3##(2008-10#2)
using chemically##3##2##(1995-12#1)(2008-10#2)
using chemiluminescence##2##2##(1996-3#1)(2012-3#1)
using chemometric##2##2##(2008-10#2)
using chemometrics##3##2##(2008-10#3)
using chi-square analysis##2##3##(2006-10#1)(2013-1#1)
using chi-square##3##2##(2006-10#1)(2006-9#1)(2013-1#1)
using chimeric##3##2##(2006-12#1)(2008-10#1)(2013-1#1)
using chiral##3##2##(1997-3#1)(2007-11#1)(2010-6#1)
using chitin##2##2##(1997-4#1)(2006-6#1)
using chloramphenicol acetyltransferase##2##3##(1997-1#1)(1997-4#1)
using chloroquine##2##2##(1994-3#2)
using chromatographic##2##2##(2008-10#1)(2011-1#1)
using chromosomal##2##2##(1994-9#1)(2008-8#1)
using chromosome##2##2##(2008-5#1)(2013-1#1)
using cine##2##2##(2006-5#1)(2013-3#1)
using circular dichroism and##3##4##(1993-6#2)(1994-8#1)
using circular dichroism spectroscopy##2##4##(1995-5#1)(1997-7#1)
using circular dichroism##9##3##(1990-10#1)(1990-4#1)(1993-6#2)(1994-8#1)(1995-5#1)(1997-4#1)(1997-7#1)(2007-3#1)
using circular##10##2##(1990-10#1)(1990-4#1)(1991-8#1)(1993-6#2)(1994-8#1)(1995-5#1)(1997-4#1)(1997-7#1)(2007-3#1)
using claims data##5##3##(1996-1#1)(2007-10#1)(2009-9#1)(2013-1#2)
using classical methods##2##3##(2008-10#2)
using classical techniques##2##3##(2007-8#1)(2011-12#1)
using classical##10##2##(1990-2#1)(2007-8#1)(2008-10#4)(2008-5#1)(2009-5#1)(2011-12#1)(2012-3#1)
using clinical samples##2##3##(1997-5#1)(2007-7#1)
using clinical##15##2##(1993-6#1)(1993-9#2)(1994-5#1)(1997-5#1)(2004-9#1)(2005-7#1)(2007-7#2)(2007-9#1)(2008-11#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-1#1)
using cloned##5##2##(1990-6#1)(1995-11#1)(2008-10#2)(2008-9#1)
using closed##2##2##(1992-11#1)(2008-10#1)
using cluster analysis##3##3##(1992-11#1)(1994-9#1)(2008-11#1)
using co-immobilized##2##2##(2008-10#1)(2008-6#1)
using coagulation##2##2##(2006-4#1)(2006-7#1)
using coalescent-based##2##2##(2009-2#1)(2010-6#1)
using cochlear implants and##2##4##(2008-9#2)
using cochlear implants##9##3##(2008-9#9)
using cold##2##2##(2008-8#1)(2010-5#1)
using colloidal gold##2##3##(1992-8#1)(2008-10#1)
using colloidal radiopharmaceuticals##2##3##(2007-11#2)
using colloidal##9##2##(1992-8#1)(1996-11#1)(2005-11#1)(2007-11#2)(2008-10#4)
using colony##2##2##(2006-8#1)(2008-11#1)
using colorimetric##2##2##(2008-10#1)(2009-8#1)
using column##3##2##(1993-9#1)(1994-11#1)(2008-10#1)
using columns##3##2##(2007-8#1)(2008-10#1)(2011-2#1)
using combination therapy##3##3##(2007-10#1)(2010-11#1)(2012-12#1)
using combination##4##2##(2007-10#1)(2007-7#1)(2010-11#1)(2012-12#1)
using combinations of##6##3##(1993-11#1)(1997-4#1)(2008-1#1)(2010-10#1)(2012-12#2)
using combinatorial##2##2##(2008-1#1)(2008-4#1)
using combined##8##2##(2004-2#1)(2007-11#1)(2008-10#1)(2009-12#1)(2009-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
using commercial ELISA##2##3##(2007-12#1)(2008-4#1)
using commercial diagnostic kits##2##4##(2007-7#1)(2007-8#1)
using commercial##15##2##(1995-3#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2011-11#1)(2011-2#1)(2011-7#1)(2012-2#1)
using commercially available##13##3##(1991-3#1)(1992-1#1)(1996-6#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2011-2#1)
using common and rare##2##4##(2012-3#2)
using common##15##2##(1993-2#1)(2007-2#1)(2008-2#1)(2008-3#1)(2008-9#2)(2009-5#1)(2011-1#1)(2012-12#1)(2012-3#3)(2013-1#3)
using compact##2##2##(2007-8#1)(2011-1#1)
using comparable##4##2##(1992-8#1)(1994-12#1)(2006-10#1)(2011-2#1)
using comparative##2##2##(2010-12#1)(2013-1#1)
using competing##2##2##(2008-7#1)(2013-1#1)
using competition##4##2##(1994-12#1)(1995-3#1)(2008-4#1)(2012-3#1)
using competitive##2##2##(2008-10#2)
using complementary##4##2##(1992-9#1)(1997-2#1)(2004-11#1)(2005-11#1)
using complete##3##2##(2007-8#1)(2008-5#1)(2008-8#1)
using completely##2##2##(2008-10#1)(2008-5#1)
using complex##2##2##(2006-9#1)(2008-3#1)
using composite interval##2##3##(2008-10#2)
using composite##4##2##(2005-10#1)(2008-10#3)
using compound Gauss-Markov random fields##2##5##(2008-2#2)
using computational tools##3##3##(1993-9#1)(2008-7#2)
using computational##9##2##(1993-9#1)(2008-7#2)(2009-2#1)(2011-2#1)(2012-2#1)(2013-1#3)
using computed tomography (CT)##6##4##(2007-7#1)(2008-11#1)(2010-1#1)(2013-1#3)
using computed tomography and##2##4##(2008-3#1)(2011-2#1)
using computed tomography##11##3##(2007-7#2)(2008-11#2)(2008-3#1)(2010-1#1)(2011-2#2)(2013-1#3)
using computed##13##2##(2006-10#1)(2007-7#2)(2008-11#2)(2008-3#1)(2010-1#1)(2011-1#1)(2011-2#2)(2013-1#3)
using computer simulation##2##3##(2006-10#1)(2008-3#1)
using computer technology##2##3##(2008-9#2)
using computer##8##2##(2006-10#2)(2007-5#1)(2008-1#1)(2008-3#1)(2008-9#2)(2012-3#1)
using computer-assisted##4##2##(1991-12#1)(1993-2#1)(2008-10#1)(2013-1#1)
using computer-based image##2##3##(1997-8#1)(2013-1#1)
using computer-based##3##2##(1995-3#1)(1997-8#1)(2013-1#1)
using computerized##8##2##(1992-9#1)(1995-7#1)(2007-1#1)(2008-11#3)(2008-5#1)(2009-12#1)
using computers##3##2##(2008-11#1)(2013-8#2)
using concanavalin##2##2##(1993-11#1)(2006-5#1)
using concentrated##4##2##(2007-10#1)(2007-11#1)(2008-10#1)(2008-9#1)
using concentrations of##2##3##(1990-11#1)(2008-11#1)
using conditions##2##2##(2007-11#1)(2008-4#1)
using condoms during sexual##2##4##(2011-1#1)(2012-3#1)
using condoms during##4##3##(2010-7#2)(2011-1#1)(2012-3#1)
using condoms to##2##3##(1991-6#1)(1997-6#1)
using condoms##14##2##(1991-6#1)(1993-2#1)(1997-3#1)(1997-6#2)(2006-7#1)(2009-5#1)(2010-7#3)(2011-1#2)(2012-11#1)(2012-3#1)
using confirmatory factor analysis##2##4##(2008-11#1)(2012-1#1)
using confirmatory factor##3##3##(2008-11#1)(2008-3#1)(2012-1#1)
using confocal laser scanning microscopy (CLSM)##2##6##(2007-12#1)(2010-8#1)
using confocal laser##4##3##(1995-5#1)(2007-12#1)(2010-8#1)(2013-7#1)
using confocal microscopy##11##3##(1994-12#1)(1995-11#1)(1995-8#1)(1997-1#1)(2008-11#2)(2008-9#2)(2011-2#2)(2012-11#1)
using confocal##19##2##(1994-12#1)(1995-11#1)(1995-5#1)(1995-8#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-9#2)(2009-6#1)(2010-8#1)(2011-2#2)(2012-11#1)(2013-7#1)
using connected-component contours##2##3##(2008-6#2)
using conservative##2##2##(2008-10#1)(2013-1#1)
using conserved##3##2##(2007-6#1)(2008-10#2)
using constant##4##2##(2006-12#1)(2008-10#1)(2009-3#1)(2009-9#1)
using consumer##2##2##(1996-2#1)(2010-4#1)
using contact angle##2##3##(2005-11#1)(2008-10#1)
using contact##5##2##(1991-4#1)(1997-2#1)(2005-11#1)(2005-8#1)(2008-10#1)
using content analysis##2##3##(1990-12#1)(2007-2#1)
using content##4##2##(1990-12#1)(2007-2#1)(2008-2#1)(2012-3#1)
using continuous##10##2##(1994-12#2)(1994-3#1)(1995-11#1)(2005-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)
using contraception##2##2##(1991-6#1)(2012-12#1)
using contrast-enhanced ultrasound##2##3##(2008-7#1)(2010-12#1)
using contrast-enhanced##3##2##(2008-7#1)(2009-4#1)(2010-12#1)
using controlled##3##2##(2006-8#1)(2008-7#1)(2012-4#1)
using conventional and##2##3##(2008-10#1)(2008-9#1)
using conventional methods##2##3##(1991-7#1)(2011-2#1)
using conventional##41##2##(1990-12#1)(1991-2#1)(1991-7#1)(1993-12#2)(1993-8#1)(1995-5#1)(1996-11#1)(1997-3#1)(2004-2#1)(2005-7#1)(2006-10#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
using copper ions##2##3##(2008-10#2)
using copper##4##2##(2008-10#4)
using copper(II)-neocuproine##2##2##(2008-10#2)
using corn##2##2##(2008-6#1)(2011-2#1)
using corona discharge ion mobility spectrometry##2##6##(2008-10#2)
using coronally advanced flap with simultaneously performed frenotomy##2##8##(2013-7#2)
using coronally advanced flap##3##4##(2013-7#3)
using coronary##2##2##(2007-8#1)(2013-4#1)
using correlation##6##2##(1990-8#1)(1992-3#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-8#1)
using coupled##3##2##(2008-10#2)(2008-4#1)
using covalent##2##2##(2008-10#2)
using covalently closed circular##2##4##(1990-11#2)
using crash##2##2##(2006-11#1)(2007-4#1)
using cromolyn sodium##2##3##(1995-12#1)(2011-1#1)
using cross-sectional##2##2##(2006-12#1)(2008-2#1)
using cross-validation##2##2##(2009-3#1)(2010-3#1)
using crown ethers##2##3##(2008-10#2)
using crude##7##2##(1991-3#2)(1992-7#1)(1994-8#1)(1996-8#1)(2008-11#1)(2008-12#1)
using cryoablation##4##2##(2007-8#4)
using cryogenic##2##2##(1990-8#1)(2012-1#1)
using culture##4##2##(2008-7#1)(2010-4#1)(2011-2#1)(2012-3#1)
using cultured cells##2##3##(1994-12#1)(2008-11#1)
using cultured##7##2##(1990-12#1)(1992-12#1)(1992-8#1)(1994-12#1)(1994-5#1)(2006-6#1)(2008-11#1)
using current##9##2##(1992-2#1)(1993-12#1)(1996-12#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#1)(2010-3#1)(2012-12#1)
using currently available##2##3##(1993-11#1)(2010-11#1)
using currently##3##2##(1993-11#1)(2008-10#1)(2010-11#1)
using custom##2##2##(2010-7#1)(2012-2#1)
using cyanoacrylate##2##2##(2008-10#1)(2009-2#1)
using cyclic and differential pulse voltammetry##2##6##(2008-10#2)
using cyclic and square-wave voltammetry##2##5##(2008-10#2)
using cyclic and##4##3##(2008-10#4)
using cyclic voltammetry (CV) and##4##5##(2007-9#1)(2008-10#3)
using cyclic voltammetry (CV)##6##4##(2007-9#1)(2008-10#4)(2008-5#1)
using cyclic voltammetry and##3##4##(2008-10#3)
using cyclic voltammetry##20##3##(1991-10#1)(1995-6#1)(2007-9#1)(2008-10#13)(2008-4#1)(2008-5#1)(2008-6#1)(2009-9#1)
using cyclic##30##2##(1991-10#1)(1995-6#1)(1996-8#1)(2007-11#1)(2007-9#1)(2008-10#20)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-9#1)
using cylindrical##2##2##(1995-12#1)(2012-1#1)
using cytoreductive##2##2##(2006-6#1)(2010-12#1)
using cytotoxic##2##2##(2008-4#2)
using data collected from##5##4##(2008-10#4)(2008-12#1)
using data collected##10##3##(1994-11#1)(2008-10#4)(2008-12#1)(2008-7#1)(2012-3#1)(2013-1#2)
using data from a##8##4##(1992-9#1)(1993-9#1)(1996-1#1)(1996-7#1)(2007-7#1)(2008-8#1)(2008-9#1)(2009-10#1)
using data from an##2##4##(1991-5#1)(2011-1#1)
using data from the National Longitudinal Study of Adolescent Health##2##10##(2009-4#1)(2009-7#1)
using data from the National##3##5##(1995-12#1)(2009-4#1)(2009-7#1)
using data from the##19##4##(1990-2#1)(1992-6#1)(1993-5#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-9#1)(1997-6#1)(2005-10#1)(2007-6#1)(2008-10#1)(2008-2#1)(2009-4#1)(2009-7#1)(2011-2#3)(2012-1#1)(2012-2#1)
using data from##59##3##(1990-12#1)(1990-2#1)(1990-4#1)(1991-5#1)(1992-2#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-7#1)(1997-1#1)(1997-6#1)(2005-10#1)(2006-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-8#3)(2008-9#2)(2009-10#2)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
using data generated##3##3##(1992-8#1)(2008-8#1)(2010-6#1)
using data mining##3##3##(2008-10#1)(2013-1#2)
using data obtained##2##3##(2008-12#1)(2013-8#1)
using data of##5##3##(1992-9#1)(2007-7#1)(2013-1#2)(2013-8#1)
using data on##4##3##(1997-1#1)(2008-8#1)(2010-4#1)(2010-8#1)
using data##98##2##(1990-12#3)(1990-2#1)(1990-4#1)(1991-5#1)(1992-2#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-12#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-6#1)(2005-10#1)(2006-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#11)(2008-12#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-12#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#8)(2013-8#2)
using decitabine##2##2##(2005-7#1)(2013-8#1)
using deep##3##2##(2007-8#1)(2008-8#1)(2012-3#1)
using defined##2##2##(1993-3#1)(2008-8#1)
using degenerate oligonucleotide primers##2##4##(1994-12#1)(1997-6#1)
using degenerate oligonucleotides designed##2##4##(1996-8#1)(2008-10#1)
using degenerate oligonucleotides##3##3##(1993-8#1)(1996-8#1)(2008-10#1)
using degenerate primers##5##3##(2007-12#1)(2008-10#4)
using degenerate##13##2##(1993-8#1)(1994-12#2)(1994-8#1)(1996-8#1)(1997-6#1)(2007-12#2)(2008-10#5)
using deletion mutants of##2##4##(1994-3#1)(1997-6#1)
using deletion##3##2##(1994-3#1)(1997-6#1)(1997-7#1)
using demographic##2##2##(2008-8#1)(2011-2#1)
using denaturing gradient gel electrophoresis (DGGE)##2##6##(2006-8#1)(2008-9#1)
using denaturing##6##2##(1992-2#1)(2006-8#1)(2008-11#1)(2008-4#2)(2008-9#1)
using density functional theory (DFT)##2##5##(2010-5#1)(2013-8#1)
using density functional theory##4##4##(1996-2#1)(2007-11#1)(2010-5#1)(2013-8#1)
using density functional##5##3##(1996-2#1)(2007-10#1)(2007-11#1)(2010-5#1)(2013-8#1)
using density##7##2##(1996-2#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-5#1)(2013-8#1)
using dental##2##2##(2007-8#1)(2008-10#1)
using derivative spectrophotometry and##3##4##(2008-10#3)
using derivative spectrophotometry##4##3##(2008-10#4)
using derivative##7##2##(2008-10#7)
using descriptive and##2##3##(2012-12#1)(2013-1#1)
using descriptive statistics and##2##4##(2007-9#1)(2008-6#1)
using descriptive statistics##4##3##(2006-8#1)(2007-9#1)(2008-6#1)(2009-9#1)
using descriptive##7##2##(2006-8#1)(2007-9#1)(2008-6#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
using detailed##2##2##(2006-11#1)(2007-12#1)
using detergent##2##2##(1992-3#1)(2008-8#1)
using deuterium nuclear magnetic resonance##2##5##(1990-3#1)(1990-7#1)
using deuterium-labeled##2##2##(1994-8#1)(2008-10#1)
using diagnosis-related groups##2##3##(1991-1#1)(1991-12#1)
using diagnosis-related##3##2##(1991-1#1)(1991-12#1)(1995-2#1)
using diagnostic##3##2##(2010-6#1)(2013-1#2)
using dibutyl phthalate as##2##4##(2005-12#1)(2008-10#1)
using dichloromethane##2##2##(2008-10#1)(2010-4#1)
using dielectrophoresis##3##2##(2006-2#3)
using diethyl difluoromethylphosphonate##2##3##(2009-12#2)
using diethyl ether as##2##4##(2008-10#1)(2012-12#1)
using diethyl##5##2##(1994-9#1)(2008-10#1)(2009-12#2)(2012-12#1)
using diethyldithiocarbamate##2##2##(1994-5#1)(2005-12#1)
using different approaches##2##3##(2006-11#1)(2008-7#1)
using different cell##2##3##(2008-10#1)(2008-11#1)
using different combinations of##2##4##(2008-9#1)(2011-1#1)
using different conditions##2##3##(2009-6#1)(2011-2#1)
using different energy sources##2##4##(2007-8#2)
using different hand##2##3##(2007-4#1)(2010-8#1)
using different in vitro##3##4##(2008-5#1)(2008-9#1)(2011-1#1)
using different indicators##2##3##(2007-12#1)(2010-11#1)
using different methods##2##3##(1990-5#1)(2008-5#1)
using different models of##2##4##(1996-5#1)(2012-2#1)
using different techniques like##2##4##(2008-10#1)(2013-7#1)
using different techniques##3##3##(2006-10#1)(2008-10#1)(2013-7#1)
using different tests##2##3##(2008-10#1)(2008-4#1)
using different types of##3##4##(2008-10#1)(2008-3#1)(2011-2#1)
using different##123##2##(1990-10#1)(1990-12#1)(1990-5#2)(1990-7#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-4#1)(1994-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-11#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#2)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#28)(2008-11#5)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#2)(2009-2#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#5)(2013-1#1)(2013-7#1)(2013-8#1)
using differential display##2##3##(2008-8#1)(2010-12#1)
using differential pulse polarography##5##4##(2008-10#4)(2010-2#1)
using differential pulse##8##3##(1995-5#1)(2008-10#6)(2010-2#1)
using differential scanning calorimetry (DSC) and##2##6##(2007-11#1)(2008-5#1)
using differential scanning calorimetry##3##4##(2007-11#1)(2008-5#2)
using differential scanning##4##3##(2006-10#1)(2007-11#1)(2008-5#2)
using differential##22##2##(1994-5#1)(1995-5#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#8)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-2#1)(2011-1#1)
using diffraction##2##2##(2007-12#1)(2008-3#1)
using diffuse reflectance infrared##3##4##(2006-12#1)(2008-10#1)(2010-4#1)
using diffuse reflectance spectroscopy##2##4##(2008-10#2)
using diffuse reflectance##7##3##(2006-12#1)(2007-10#1)(2008-10#4)(2010-4#1)
using diffusion tensor imaging (DTI)##2##5##(2010-12#1)(2010-8#1)
using diffusion tensor imaging##4##4##(2007-5#1)(2010-12#1)(2010-8#1)(2011-12#1)
using diffusion##6##2##(2007-5#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-12#1)(2013-8#1)
using digital image analysis of light micrographs and##2##8##(2008-10#2)
using digital image analysis##3##4##(2005-11#1)(2008-10#2)
using digital image##5##3##(1993-11#1)(2005-11#1)(2008-10#2)(2012-2#1)
using digital imaging##2##3##(1996-8#1)(2008-1#1)
using digital signal processing techniques##3##5##(1990-9#1)(1994-12#1)(2010-8#1)
using digital##11##2##(1990-9#1)(1993-11#1)(1994-12#1)(1996-8#1)(2005-11#1)(2008-1#1)(2008-10#2)(2009-12#1)(2010-8#1)(2012-2#1)
using diiodine and ortho-periodic acid as the oxidant##2##8##(2007-11#2)
using dilute##3##2##(2007-8#1)(2008-10#1)(2013-1#1)
using diluted##2##2##(2008-10#2)
using dimethyl sulfate##2##3##(1992-9#1)(1995-8#1)
using dimethyl-beta-cyclodextrin##2##2##(2008-10#2)
using dimethylsulfoxide##3##2##(2008-10#2)(2008-5#1)
using diode lasers##2##3##(2008-3#1)(2008-5#1)
using diode##3##2##(2008-2#1)(2008-3#1)(2008-5#1)
using direct LA-ICP-MS##2##3##(2008-10#2)
using direct analysis##2##3##(2008-10#1)(2013-7#1)
using direct immunofluorescence##2##3##(2008-4#1)(2012-3#1)
using direct orthogonal signal##2##4##(2007-8#2)
using direct##24##2##(1992-3#1)(1994-5#1)(2007-1#3)(2007-7#1)(2007-8#2)(2008-10#6)(2008-4#1)(2008-5#1)(2010-2#1)(2010-4#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)
using discrete##2##2##(2008-10#1)(2013-8#1)
using disease##3##2##(1997-5#1)(2008-10#2)
using displacement##2##2##(1995-5#1)(2008-11#1)
using disposable##4##2##(1992-12#1)(2008-8#1)(2012-12#1)(2013-1#1)
using distance##3##2##(1992-9#1)(2008-11#1)(2012-3#1)
using distilled water##2##3##(1990-2#1)(2012-2#1)
using distinct##2##2##(2010-10#1)(2012-2#1)
using distorted##2##2##(2008-9#1)(2010-2#1)
using distraction##2##2##(1996-2#1)(2007-8#1)
using dithizone##3##2##(2008-10#3)
using donor##2##2##(1994-9#1)(2009-6#1)
using doses##2##2##(1991-2#1)(2008-7#1)
using dot blot hybridization##2##4##(1994-1#1)(2008-10#1)
using double##9##2##(1991-5#1)(1992-3#1)(2006-4#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-2#1)
using drug-eluting stents##2##3##(2009-5#1)(2010-5#1)
using drugs that##2##3##(2008-3#1)(2012-1#1)
using drugs##5##2##(1996-3#1)(2006-10#1)(2007-12#1)(2008-3#1)(2012-1#1)
using dry##2##2##(2008-10#1)(2010-4#1)
using dual##6##2##(1994-11#1)(1995-5#1)(2008-10#3)(2011-1#1)
using dual-energy X-ray absorptiometry##2##4##(2008-10#1)(2008-7#1)
using duplex oligomers containing##2##4##(2008-11#2)
using duplex##3##2##(2008-11#2)(2013-1#1)
using dynamic light scattering##2##4##(2005-11#1)(2008-2#1)
using dynamic##6##2##(2005-11#1)(2007-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)
using each of the##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
using each##8##2##(1990-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)
using early##2##2##(1994-6#1)(2009-8#1)
using echocardiography##2##2##(2010-12#1)(2012-12#1)
using ecological##2##2##(2010-1#1)(2011-2#1)
using eight primer##2##3##(2008-10#2)
using eight##6##2##(2007-11#1)(2008-10#3)(2010-12#1)(2011-2#1)
using either RNA or DNA##2##5##(1991-2#1)(2008-4#1)
using either a##6##3##(1992-5#1)(1996-11#1)(2008-10#2)(2008-9#1)(2011-1#1)
using either an##2##3##(1990-12#1)(2008-9#1)
using either suspension or adherent cells lysed by various means (e##2##11##(2008-4#2)
using either the##6##3##(1992-11#1)(1992-3#1)(2008-2#2)(2008-4#1)(2010-8#1)
using either their##2##3##(1997-1#1)(2009-2#1)
using either##87##2##(1990-11#2)(1990-12#2)(1990-3#1)(1991-12#1)(1991-2#3)(1991-5#2)(1991-9#1)(1992-11#1)(1992-3#2)(1992-5#1)(1992-8#2)(1993-11#1)(1993-6#1)(1994-3#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-3#1)(1997-6#1)(1997-8#1)(2004-12#1)(2005-8#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#2)(2008-4#9)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-4#2)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#4)(2013-7#1)
using electrical stimulation##4##3##(2006-7#2)(2008-5#1)(2009-10#1)
using electrical##6##2##(2006-7#2)(2008-12#1)(2008-5#1)(2009-10#1)(2013-1#1)
using electrochemical detection##2##3##(2007-8#1)(2008-10#1)
using electrochemical##6##2##(2007-8#1)(2008-10#3)(2008-5#1)(2009-10#1)
using electrodes##4##2##(2006-2#1)(2007-11#1)(2008-10#2)
using electrokinetic##2##2##(2006-2#1)(2007-8#1)
using electrolytic deposition##2##3##(2008-10#2)
using electromagnetic articulography##2##3##(2008-10#1)(2009-12#1)
using electromagnetic##4##2##(2008-10#1)(2008-3#1)(2009-12#1)(2012-3#1)
using electromyography##2##2##(2010-12#1)(2012-12#1)
using electron impact and##2##4##(1990-9#1)(1992-3#1)
using electron microscopy##7##3##(1997-7#1)(2004-12#1)(2005-11#1)(2007-6#1)(2008-11#2)(2013-8#1)
using electron paramagnetic resonance (EPR) spectroscopy##2##6##(1994-11#1)(2008-5#1)
using electron paramagnetic resonance##3##4##(1994-11#1)(2008-10#1)(2008-5#1)
using electron spin resonance (ESR)##2##5##(1993-7#1)(2008-9#1)
using electron spin resonance##4##4##(1992-11#1)(1993-7#1)(1994-12#1)(2008-9#1)
using electron##19##2##(1990-9#1)(1992-11#1)(1992-3#1)(1993-7#1)(1994-11#1)(1994-12#1)(1997-7#1)(2004-12#1)(2005-11#1)(2006-12#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2013-8#1)
using electronic health record##4##4##(2013-1#4)
using electronic media##2##3##(1993-12#1)(2012-1#1)
using electronic##9##2##(1993-12#1)(1996-1#1)(2005-11#1)(2012-1#1)(2013-1#4)(2013-8#1)
using electrophoresis##3##2##(2006-7#1)(2008-10#1)(2008-5#1)
using electrophoretic##2##2##(1993-12#1)(2008-12#1)
using electrospray ionization mass spectrometry##2##5##(1996-5#1)(2007-1#1)
using electrospray ionization##3##3##(1996-5#1)(2007-1#1)(2013-1#1)
using electrospray##5##2##(1996-5#1)(2007-1#1)(2008-10#2)(2013-1#1)
using electrostatic##2##2##(2005-11#1)(2008-5#1)
using electrothermal atomic absorption spectrometry (ETAAS)##2##6##(2008-10#2)
using electrothermal atomic absorption spectrometry with slurry##2##7##(2008-10#2)
using electrothermal atomic absorption spectrometry with##3##6##(2008-10#3)
using electrothermal atomic absorption spectrometry##6##5##(2008-10#6)
using electrothermal##7##2##(2008-10#7)
using elemental##2##2##(2007-11#1)(2008-10#1)
using embryonic stem cells##2##4##(1993-2#1)(2012-1#1)
using embryonic##4##2##(1993-2#1)(1996-5#1)(2008-8#1)(2012-1#1)
using emerging technologies##2##3##(2008-7#2)
using empirical equations##2##3##(2008-10#2)
using empirical##5##2##(1994-3#1)(2006-12#1)(2008-10#2)(2008-12#1)
using enantioselective##2##2##(2008-10#2)
using end-point##2##2##(1991-1#1)(1994-3#1)
using endogenous##2##2##(1997-7#1)(2008-4#1)
using endoscopic guidance##2##3##(2006-5#2)
using endoscopic techniques##4##3##(2006-2#1)(2006-5#2)(2006-6#1)
using endoscopic##11##2##(2006-2#1)(2006-5#4)(2006-6#1)(2007-5#1)(2008-10#2)(2009-4#1)(2013-1#1)
using enhanced chemiluminescence##2##3##(1994-2#2)
using environmental##2##2##(1996-3#1)(2008-9#1)
using enzymatic##6##2##(1992-8#1)(1994-11#1)(2006-10#1)(2007-1#1)(2008-5#1)(2010-5#1)
using enzyme##6##2##(1992-8#1)(2006-9#1)(2007-2#1)(2007-8#1)(2008-10#2)
using enzyme-linked immunosorbent assay##3##4##(1990-11#1)(2008-6#1)(2011-1#1)
using enzyme-linked##5##2##(1990-11#1)(2008-10#2)(2008-6#1)(2011-1#1)
using epidemiological##2##2##(2008-7#1)(2011-1#1)
using epidural##2##2##(1992-8#1)(2006-10#1)
using equipment##3##2##(2008-4#2)(2010-8#1)
using equivalent##2##2##(2005-11#1)(2006-10#1)
using error-prone PCR##2##3##(2008-8#1)(2011-1#1)
using essentially##3##2##(1994-2#1)(2008-10#1)(2008-4#1)
using established##5##2##(1997-2#1)(2006-5#1)(2007-8#1)(2008-2#1)(2008-7#1)
using estimated##2##2##(1990-10#1)(1996-11#1)
using estimating equations##2##3##(1994-6#1)(1997-4#1)
using ethanol##5##2##(2008-6#2)(2008-8#1)(2010-12#1)(2010-4#1)
using ethological##2##2##(1993-9#1)(2011-2#1)
using ethyl acetate##2##3##(1990-9#1)(2008-10#1)
using ethyl##5##2##(1990-9#1)(1991-8#1)(2008-10#1)(2008-4#1)(2011-2#1)
using ethylene##2##2##(2007-11#1)(2009-6#1)
using europium##2##2##(2008-10#2)
using event-related potentials##2##3##(2004-11#1)(2008-11#1)
using evidence##3##2##(2008-11#1)(2009-11#1)(2009-3#1)
using evidence-based##3##2##(2007-5#1)(2008-8#1)(2010-8#1)
using evoked field##2##3##(1995-5#2)
using evoked##3##2##(1995-5#2)(2007-8#1)
using examples from the literature##2##5##(2007-4#1)(2008-10#1)
using examples from the##3##4##(2007-4#1)(2008-10#1)(2008-7#1)
using examples from##6##3##(2006-2#1)(2007-4#1)(2008-10#2)(2008-7#1)(2010-7#1)
using examples##8##2##(2006-2#1)(2007-4#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-7#1)(2012-3#1)
using excess##2##2##(1994-2#1)(2013-1#1)
using excised inside-out membrane patches##2##5##(1995-5#1)(2008-8#1)
using excised##4##2##(1995-5#1)(2008-5#2)(2008-8#1)
using excision##2##2##(2008-10#1)(2008-9#1)
using excitation-emission matrix##2##3##(2008-10#2)
using exclusively##2##2##(2007-8#1)(2011-1#1)
using exfoliated graphite##2##3##(2008-10#2)
using existing##11##2##(1992-8#1)(2006-12#1)(2007-4#1)(2008-1#1)(2011-2#1)(2011-8#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
using experimental animal##2##3##(2008-1#1)(2010-12#1)
using experimental design methodology##4##4##(2008-10#4)
using experimental design##7##3##(2008-10#6)(2008-6#1)
using experimental##14##2##(2008-1#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-6#1)(2009-9#1)(2010-12#1)(2010-2#1)
using explicit##2##2##(1992-9#1)(2008-8#1)
using exploratory factor analysis##2##4##(2008-10#1)(2012-1#1)
using exploratory##3##2##(2008-10#1)(2008-11#1)(2012-1#1)
using expression##3##2##(1997-7#1)(2006-12#1)(2008-11#1)
using external calibration##3##3##(2008-10#3)
using external##9##2##(2004-11#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-6#1)(2008-9#1)
using extracellular recording techniques##2##4##(1995-12#1)(2009-10#1)
using extracellular recording##3##3##(1991-8#1)(1995-12#1)(2009-10#1)
using extracellular##4##2##(1991-8#1)(1995-12#1)(2008-11#1)(2009-10#1)
using extracorporeal circulation##2##3##(2006-10#1)(2007-8#1)
using extracts##2##2##(2008-10#1)(2009-6#1)
using eye##2##2##(2012-1#2)
using fMRI##4##2##(2008-1#1)(2008-11#1)(2010-2#1)(2011-2#1)
using factor analysis##2##3##(2008-10#1)(2011-2#1)
using factorial design and##2##4##(2008-10#2)
using factorial design for optimization##2##5##(2008-10#2)
using factorial design##7##3##(2007-8#1)(2008-10#6)
using factorial##10##2##(2007-8#1)(2008-10#9)
using fascia lata##2##3##(2007-8#1)(2008-12#1)
using fast##5##2##(1992-3#1)(1992-7#1)(2008-2#1)(2008-5#1)(2012-2#1)
using feature##2##2##(2008-11#1)(2008-2#1)
using femtosecond pulses##2##3##(2007-12#2)
using femtosecond##6##2##(2007-12#3)(2011-1#2)(2013-8#1)
using fermentation##2##2##(2007-7#1)(2012-2#1)
using fetal##3##2##(1994-3#1)(2006-8#1)(2012-2#1)
using fiber##2##2##(2007-12#1)(2008-2#1)
using fiber-optic##3##2##(2006-12#1)(2008-10#1)(2008-3#1)
using fibrin##2##2##(1996-12#1)(2009-4#1)
using fibronectin-coated dishes##2##3##(2008-11#2)
using field##4##2##(2007-5#1)(2008-2#1)(2011-2#2)
using film##2##2##(2008-2#1)(2008-3#1)
using filter##2##2##(2008-12#1)(2008-3#1)
using financial##2##2##(1992-12#1)(2009-2#1)
using finite##3##2##(2008-2#1)(2008-7#1)(2009-7#1)
using finite-difference time-domain##2##3##(2007-12#1)(2013-8#1)
using first generation##2##3##(2007-12#1)(2008-7#1)
using first##5##2##(1993-6#1)(2007-12#1)(2008-5#1)(2008-7#1)(2012-12#1)
using five different##3##3##(2007-8#1)(2008-11#1)(2012-12#1)
using five##10##2##(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2012-12#1)(2013-8#1)
using fixation##2##2##(2008-4#2)
using fixed##3##2##(2007-8#1)(2008-10#1)(2009-3#1)
using flame AAS##2##3##(2008-10#2)
using flame atomic absorption spectrometry (FAAS)##3##6##(2008-10#3)
using flame atomic absorption spectrometry##6##5##(2007-8#1)(2008-10#5)
using flame atomic absorption spectrophotometry##2##5##(2007-10#1)(2008-10#1)
using flame atomic absorption##10##4##(2007-10#1)(2007-8#1)(2008-10#7)(2011-2#1)
using flame##13##2##(2007-10#1)(2007-8#1)(2008-10#10)(2011-2#1)
using flow cytometric##5##3##(1994-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-12#1)
using flow cytometry and##3##4##(1991-10#1)(2008-9#1)(2011-2#1)
using flow cytometry##21##3##(1991-10#1)(1993-8#2)(1994-2#1)(1995-2#1)(1997-4#1)(2006-5#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-9#5)(2009-6#1)(2011-2#3)
using flow electroporation##2##3##(2008-11#2)
using flow injection (FI)##2##4##(2008-10#2)
using flow injection analysis (FIA)##2##5##(2008-10#2)
using flow injection analysis with tris(2##3##6##(2008-10#3)
using flow injection analysis with##8##5##(2008-10#8)
using flow injection analysis##17##4##(1997-2#1)(2008-10#16)
using flow injection##35##3##(1997-2#1)(2008-10#34)
using flow##64##2##(1991-10#1)(1993-8#2)(1994-2#1)(1994-3#1)(1995-2#1)(1997-2#1)(1997-4#1)(2006-5#1)(2008-10#36)(2008-11#4)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#5)(2009-6#1)(2011-2#3)(2012-12#1)
using flow-injection analysis##3##3##(2008-10#3)
using flow-injection##11##2##(2008-10#10)(2010-4#1)
using flowing##2##2##(2008-10#1)(2010-5#1)
using fluorescein isothiocyanate##2##3##(2008-10#1)(2008-4#1)
using fluorescein##3##2##(2008-10#2)(2008-4#1)
using fluorescein-labeled gamma##2##3##(1990-2#1)(1992-6#1)
using fluorescence and##3##3##(1995-5#1)(2004-11#1)(2008-10#1)
using fluorescence detection##3##3##(1992-11#1)(1996-5#1)(2008-10#1)
using fluorescence in situ hybridisation##3##5##(2006-8#1)(2008-12#2)
using fluorescence in situ hybridization (FISH)##2##6##(2007-5#1)(2008-11#1)
using fluorescence in situ hybridization##6##5##(1996-12#1)(1996-4#1)(1997-4#1)(2007-5#1)(2008-11#1)(2008-9#1)
using fluorescence in situ##9##4##(1996-12#1)(1996-4#1)(1997-4#1)(2006-8#1)(2007-5#1)(2008-11#1)(2008-12#2)(2008-9#1)
using fluorescence microscopy##9##3##(1990-4#2)(1991-9#1)(1994-5#1)(1997-6#1)(2008-11#1)(2009-12#1)(2012-11#2)
using fluorescence resonance energy transfer##4##5##(1993-8#2)(1994-5#1)(2008-4#1)
using fluorescence spectroscopy##6##3##(1991-3#1)(1991-7#1)(1992-6#1)(2006-10#1)(2008-10#1)(2008-5#1)
using fluorescence techniques##2##3##(1995-5#1)(2008-7#1)
using fluorescence##50##2##(1990-11#1)(1990-4#2)(1991-3#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-6#1)(1993-3#2)(1993-8#2)(1994-5#2)(1994-6#1)(1995-12#1)(1995-5#2)(1996-12#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-4#1)(1997-6#1)(2004-11#1)(2006-10#1)(2006-8#1)(2007-5#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-12#1)(2012-11#2)
using fluorescence-activated cell sorting (FACS)##2##5##(2008-4#1)(2012-12#1)
using fluorescent in situ hybridization##2##5##(1996-12#1)(2005-10#1)
using fluorescent##12##2##(1990-9#1)(1994-8#1)(1996-12#1)(1997-4#1)(2005-10#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)(2012-2#2)
using fluorimetric detection##4##3##(1996-3#1)(1997-3#1)(2008-10#2)
using fluorogenic##2##2##(1994-3#1)(2008-5#1)
using focus group discussions##2##4##(2008-11#1)(2008-12#1)
using focus group##3##3##(2008-11#1)(2008-12#1)(2010-10#1)
using focus groups##3##3##(2007-12#1)(2008-11#1)(2008-12#1)
using focus##6##2##(2007-12#1)(2008-11#2)(2008-12#2)(2010-10#1)
using focused##2##2##(2007-12#1)(2008-3#1)
using follistatin##2##2##(1992-6#2)
using food##2##2##(1994-12#1)(2013-1#1)
using forced##2##2##(1990-3#1)(2006-5#1)
using four different##5##3##(2008-10#1)(2009-11#1)(2010-4#1)(2012-1#1)(2012-12#1)
using four##28##2##(1991-10#1)(1991-9#1)(1996-12#1)(2005-11#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#2)(2009-11#1)(2010-4#2)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#2)(2013-1#1)
using fractional##2##2##(2007-11#1)(2013-1#1)
using free cells##2##3##(2008-5#1)(2008-7#1)
using free##8##2##(1991-3#1)(1996-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-2#1)(2012-12#1)
using free-flow electrophoresis##2##3##(2008-1#1)(2008-4#1)
using frequencies##7##2##(2006-10#1)(2007-11#1)(2007-12#2)(2012-12#2)(2013-1#1)
using frequency##2##2##(1991-2#1)(2008-7#1)
using frequency-domain##3##2##(1997-5#1)(1997-6#1)(2008-2#1)
using frequency-resolved optical gating##2##4##(2007-12#2)
using fresh##2##2##(1995-2#1)(2007-8#1)
using full cross validation (leave one##2##6##(2008-10#1)(2008-6#1)
using full##6##2##(2008-10#3)(2008-6#1)(2013-1#2)
using functional magnetic resonance imaging (fMRI)##3##6##(2007-4#1)(2008-11#1)(2011-1#1)
using functional magnetic resonance imaging##4##5##(1997-7#1)(2007-4#1)(2008-11#1)(2011-1#1)
using functional magnetic resonance##5##4##(1997-7#1)(2006-5#1)(2007-4#1)(2008-11#1)(2011-1#1)
using functional##11##2##(1997-7#1)(2006-5#1)(2007-4#1)(2008-11#2)(2008-4#1)(2008-5#1)(2010-7#1)(2011-1#3)
using fura-2##5##2##(1992-9#1)(1993-9#1)(1994-10#1)(1995-7#1)(2013-1#1)
using fuzzy##7##2##(2008-2#3)(2008-5#1)(2008-8#1)(2011-1#1)(2013-8#1)
using galvanostatic##2##2##(2008-10#1)(2009-10#1)
using gas chromatographic##2##3##(1996-8#1)(2008-5#1)
using gas chromatography and##2##4##(2005-8#1)(2008-10#1)
using gas chromatography with electron capture detection##2##7##(2008-10#2)
using gas chromatography with##3##4##(2008-10#3)
using gas chromatography##16##3##(1997-2#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-8#3)(2008-10#9)
using gas chromatography-mass spectrometry with##2##5##(1990-6#1)(1994-2#1)
using gas chromatography-mass spectrometry##6##4##(1990-6#1)(1992-8#1)(1994-2#1)(2008-10#1)(2011-1#2)
using gas chromatography-mass##7##3##(1990-6#1)(1992-8#1)(1994-2#1)(2008-10#1)(2011-1#3)
using gas##28##2##(1990-6#1)(1992-8#1)(1994-2#1)(1996-8#1)(1997-2#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-8#3)(2008-10#12)(2008-5#1)(2011-1#4)
using gel filtration##6##3##(1990-2#1)(1990-8#1)(1992-9#1)(2008-10#1)(2008-11#1)(2008-8#1)
using gel##12##2##(1990-2#1)(1990-8#1)(1991-7#1)(1992-9#1)(1994-9#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-8#2)
using gelatin##5##2##(1991-8#1)(2008-10#2)(2009-11#1)(2011-2#1)
using gene expression##2##3##(2008-4#1)(2010-12#1)
using gene specific##2##3##(1992-9#1)(1994-11#1)
using gene targeting##3##3##(1994-10#1)(1997-1#1)(2010-2#1)
using gene therapy##2##3##(2007-8#1)(2010-10#1)
using gene##17##2##(1991-12#1)(1992-9#1)(1994-10#1)(1994-11#1)(1995-8#1)(1997-1#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-8#2)(2008-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2012-12#1)
using general##2##2##(2008-10#1)(2008-4#1)
using generalized##4##2##(1990-12#1)(2007-4#1)(2008-10#1)(2010-7#1)
using generic##2##2##(2008-5#1)(2013-1#1)
using genes##2##2##(2008-10#1)(2012-1#1)
using genetic algorithm##2##3##(2008-8#1)(2008-9#1)
using genetic##13##2##(1990-10#1)(1993-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-2#2)(2012-3#2)(2013-8#1)
using genetically engineered##2##3##(1996-10#1)(2008-9#1)
using genetically modified##2##3##(2008-11#1)(2012-3#1)
using genetically##6##2##(1994-11#1)(1995-5#1)(1996-10#1)(2008-11#1)(2008-9#1)(2012-3#1)
using genomic##5##2##(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)
using geometric##3##2##(2008-2#2)(2012-1#1)
using glass beads##4##3##(2008-2#1)(2008-4#3)
using glass##7##2##(2004-9#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#1)
using glassy carbon##3##3##(2008-10#3)
using global##2##2##(1992-1#1)(2007-4#1)
using glucose##5##2##(1990-12#1)(2006-5#1)(2008-10#2)(2008-6#1)
using glutaraldehyde and fixed on a pretreated##2##7##(2008-10#2)
using glutaraldehyde and fixed on##3##5##(2008-10#3)
using glutaraldehyde##8##2##(1994-9#1)(1997-2#1)(2008-10#5)(2012-11#1)
using glutathione S-transferase fusion##2##4##(1994-12#1)(1996-4#1)
using glycerol as##2##3##(2008-6#1)(2008-7#1)
using gold##5##2##(2007-8#1)(2008-10#2)(2009-7#1)(2010-1#1)
using gradient elution with##3##4##(2007-8#1)(2008-10#1)(2011-1#1)
using gradient elution##6##3##(1997-8#1)(2007-8#1)(2008-10#2)(2011-1#1)(2013-7#1)
using gradient##7##2##(1997-8#1)(2007-8#1)(2008-10#3)(2011-1#1)(2013-7#1)
using graphite furnace atomic absorption spectrometry##4##6##(2005-4#1)(2008-10#3)
using graphite furnace atomic absorption##5##5##(2005-4#1)(2008-10#4)
using graphite##6##2##(2005-4#1)(2008-1#1)(2008-10#4)
using green tea##2##3##(2007-8#1)(2008-5#1)
using green##6##2##(2007-12#1)(2007-8#1)(2008-11#1)(2008-5#1)(2012-12#2)
using grounded theory methodology##2##4##(2011-2#2)
using grounded theory##3##3##(2011-2#2)(2012-2#1)
using group##6##2##(2006-4#1)(2008-10#2)(2008-2#1)(2011-1#1)(2011-2#1)
using hand-held##2##2##(2011-2#1)(2013-7#1)
using hanging mercury drop electrode##2##5##(2008-10#2)
using head space##2##3##(2008-5#1)(2012-2#1)
using headspace solvent microextraction##2##4##(2008-10#2)
using headspace##4##2##(2008-10#4)
using heart##2##2##(2011-2#1)(2012-2#1)
using heat##2##2##(2008-11#1)(2008-3#1)
using heat-inactivated##2##2##(2008-10#1)(2008-5#1)
using helper##2##2##(1997-4#1)(2008-4#1)
using hematoxylin and eosin staining##2##5##(2007-10#1)(2008-5#1)
using heparin##2##2##(1995-6#1)(2007-11#1)
using heteropolyacid montmorillonite clay-modified##2##4##(2008-10#2)
using hierarchical clustering##2##3##(2008-7#1)(2010-2#1)
using hierarchical linear##2##3##(2007-10#1)(2010-12#1)
using hierarchical##5##2##(2007-10#1)(2008-7#1)(2010-12#1)(2010-2#1)(2012-2#1)
using high doses of##3##4##(2007-10#1)(2007-8#1)(2010-1#1)
using high field##2##3##(2007-3#1)(2008-3#1)
using high frequency##3##3##(2007-11#1)(2011-2#1)(2012-12#1)
using high performance liquid chromatography (HPLC)##2##6##(1991-8#1)(2008-10#1)
using high performance liquid chromatography and the##2##7##(1990-7#1)(2013-8#1)
using high performance liquid chromatography and##4##6##(1990-7#1)(1995-5#1)(2008-10#1)(2013-8#1)
using high performance liquid chromatography with##2##6##(1993-2#1)(2008-10#1)
using high performance liquid chromatography##13##5##(1990-7#1)(1991-8#1)(1993-2#1)(1995-5#1)(2008-10#3)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
using high performance liquid##17##4##(1990-12#1)(1990-7#1)(1991-8#1)(1993-2#1)(1995-5#1)(2008-10#4)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
using high performance##18##3##(1990-12#1)(1990-7#1)(1991-8#1)(1993-2#1)(1995-5#1)(2008-10#4)(2010-9#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
using high pressure liquid chromatography##4##5##(1992-11#1)(1994-6#1)(2008-10#1)(2011-1#1)
using high resolution##4##3##(2008-10#2)(2008-8#1)(2010-4#1)
using high##49##2##(1990-12#1)(1990-7#1)(1991-8#1)(1992-11#1)(1993-2#1)(1994-6#1)(1995-12#1)(1995-5#1)(1997-2#1)(2006-11#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-8#2)(2008-10#9)(2008-11#1)(2008-3#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
using high-dimensional##3##2##(2012-12#1)(2013-1#2)
using high-flux filter systems is the only##2##7##(2007-11#1)(2009-8#1)
using high-frequency##2##2##(2012-12#1)(2013-1#1)
using high-level##2##2##(1996-8#1)(2011-1#1)
using high-molecular-mass polyethyleneimine##2##3##(1996-5#2)
using high-performance capillary##2##3##(1996-8#1)(2007-10#1)
using high-performance liquid chromatography (HPLC)##5##5##(1992-11#1)(1997-3#1)(2008-10#1)(2008-5#1)(2010-2#1)
using high-performance liquid chromatography and##2##5##(1997-3#1)(2007-1#1)
using high-performance liquid chromatography with fluorescence detection and##2##8##(2008-10#2)
using high-performance liquid chromatography with fluorescence detection##3##7##(1990-11#1)(2008-10#2)
using high-performance liquid chromatography with##9##5##(1990-11#1)(1992-2#1)(1993-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-3#1)(2008-10#2)
using high-performance liquid chromatography##25##4##(1990-11#2)(1990-12#1)(1990-7#1)(1991-12#1)(1991-4#1)(1992-11#1)(1992-2#1)(1993-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-3#4)(1997-8#1)(2007-1#1)(2008-10#5)(2008-5#1)(2010-2#1)
using high-performance liquid##27##3##(1990-11#2)(1990-12#1)(1990-7#1)(1991-12#1)(1991-4#1)(1992-11#1)(1992-2#1)(1993-2#1)(1996-5#1)(1996-7#1)(1996-8#2)(1997-3#4)(1997-8#1)(2007-1#1)(2008-10#6)(2008-5#1)(2010-2#1)
using high-performance##29##2##(1990-11#2)(1990-12#1)(1990-7#1)(1991-12#1)(1991-4#1)(1992-11#1)(1992-2#1)(1993-2#1)(1996-5#1)(1996-7#1)(1996-8#3)(1997-3#4)(1997-8#1)(2007-1#1)(2007-10#1)(2008-10#6)(2008-5#1)(2010-2#1)
using high-purity##2##2##(2008-10#2)
using high-resolution##7##2##(1992-3#1)(1993-3#1)(1994-3#1)(2006-12#1)(2008-1#1)(2008-10#1)(2011-1#1)
using high-sensitivity##2##2##(1997-6#1)(2010-12#1)
using high-speed counter-current##2##3##(2011-1#2)
using high-throughput methods##2##3##(2008-7#1)(2011-2#1)
using high-throughput technologies##3##3##(2008-8#1)(2010-9#1)(2012-2#1)
using high-throughput##10##2##(2008-7#2)(2008-8#1)(2009-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)
using higher##5##2##(1994-12#1)(2008-11#1)(2008-7#2)(2010-12#1)
using highly##10##2##(1991-8#1)(1995-3#1)(2004-11#1)(2005-12#1)(2006-12#1)(2006-4#1)(2008-10#2)(2008-5#1)(2013-8#1)
using his##2##2##(1996-12#1)(2007-1#1)
using histology##3##2##(1993-5#1)(2008-5#1)(2010-7#1)
using historical##4##2##(1994-1#1)(2008-10#1)(2013-1#2)
using home##2##2##(1991-1#1)(1992-2#1)
using homo- and heterooligomers##2##4##(1992-2#2)
using homo- and##3##3##(1990-5#1)(1992-2#2)
using homologous##3##2##(1990-2#1)(2008-4#1)(2008-5#1)
using homonuclear##2##2##(1994-5#1)(1995-3#1)
using hormonal##2##2##(2012-12#1)(2013-1#1)
using horseradish peroxidase and##3##4##(1990-12#1)(2007-8#1)(2008-9#1)
using horseradish peroxidase##5##3##(1990-12#1)(2007-8#1)(2008-4#1)(2008-9#1)(2010-2#1)
using horseradish##6##2##(1990-12#1)(2006-10#1)(2007-8#1)(2008-4#1)(2008-9#1)(2010-2#1)
using hospital##3##2##(2010-11#1)(2013-1#2)
using household survey data##3##4##(2005-9#1)(2010-3#1)(2010-8#1)
using household##4##2##(2005-9#1)(2010-3#1)(2010-8#1)(2011-2#1)
using human SMC##2##3##(1991-10#1)(1995-8#1)
using human##38##2##(1990-11#1)(1990-7#1)(1991-10#1)(1993-3#2)(1993-4#1)(1994-3#3)(1995-8#1)(1996-11#1)(1996-6#1)(1996-7#1)(1997-4#1)(2004-9#1)(2006-11#1)(2006-5#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#1)(2009-3#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2012-5#1)(2013-1#1)
using hydride##2##2##(2008-10#2)
using hydrogen##4##2##(1994-3#1)(2005-11#1)(2008-10#1)(2008-6#1)
using hydrophilic##2##2##(2012-2#2)
using hydroxyapatite##2##2##(1991-11#1)(2011-2#1)
using hydroxyl##2##2##(2005-11#1)(2009-3#1)
using hyphenated##2##2##(2008-10#2)
using hypoxanthine##2##2##(1994-6#1)(1997-5#1)
using identical##2##2##(2005-11#1)(2008-10#1)
using iliac##2##2##(2008-12#2)
using image analysis software##4##4##(1995-12#1)(2005-11#1)(2008-2#1)(2008-4#1)
using image analysis##8##3##(1995-12#1)(1997-3#1)(2005-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2011-2#1)
using image guidance system##2##4##(2011-2#2)
using image##13##2##(1995-12#1)(1997-3#1)(2005-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2010-8#1)(2011-2#3)(2013-7#1)
using imaging##2##2##(2007-4#1)(2008-2#1)
using immature##2##2##(2007-12#1)(2008-10#1)
using immobilised##2##2##(2008-10#2)
using immobilized cells##2##3##(2008-7#2)
using immobilized lipase##2##3##(2008-5#1)(2008-6#1)
using immobilized##20##2##(1990-8#1)(1995-2#1)(1996-8#1)(1997-6#1)(2007-8#2)(2008-10#3)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#1)(2012-11#1)
using immobilized-enzyme reactors##2##3##(2008-10#2)
using immunoaffinity##4##2##(1991-7#1)(1997-8#1)(2008-10#1)(2012-2#1)
using immunoassay##2##2##(2010-4#1)(2011-1#1)
using immunoblotting##2##2##(1995-2#1)(2013-8#1)
using immunocapture##2##2##(2011-2#2)
using immunochemical##2##2##(1992-4#1)(1995-12#1)
using immunocytochemical staining##2##3##(1993-9#1)(2008-8#1)
using immunocytochemical##4##2##(1993-9#1)(2007-12#2)(2008-8#1)
using immunocytochemistry and##6##3##(1991-11#1)(1992-6#1)(1992-8#1)(1994-11#1)(1996-7#1)(2008-9#1)
using immunocytochemistry##9##2##(1991-11#2)(1992-6#1)(1992-8#1)(1992-9#1)(1994-11#1)(1995-7#1)(1996-7#1)(2008-9#1)
using immunofluorescence##2##2##(2008-10#1)(2008-5#1)
using immunohistochemical and##2##3##(1992-8#1)(2007-12#1)
using immunohistochemical methods##3##3##(1993-6#1)(1994-2#1)(1994-5#1)
using immunohistochemical techniques##2##3##(1994-2#1)(2008-4#1)
using immunohistochemical##11##2##(1992-3#1)(1992-8#2)(1993-6#1)(1994-2#2)(1994-5#1)(2006-11#1)(2007-12#1)(2008-4#1)(2013-1#1)
using immunohistochemistry (IHC)##2##3##(1994-9#1)(2008-4#1)
using immunohistochemistry with##4##3##(1996-5#3)(1997-7#1)
using immunohistochemistry##20##2##(1993-11#1)(1994-5#1)(1994-9#1)(1996-4#1)(1996-5#3)(1997-7#1)(2004-2#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#2)(2010-3#1)(2011-2#1)(2013-7#1)(2013-8#1)
using immunological##2##2##(2008-4#2)
using immunosuppressive drugs##2##3##(1995-2#1)(2013-1#1)
using implantable##3##2##(2006-6#2)(2010-6#1)
using implicit##2##2##(1993-1#1)(2009-12#1)
using improved##2##2##(1991-8#1)(2009-5#1)
using in situ hybridisation##2##4##(1996-12#1)(1997-5#1)
using in situ hybridization and##4##5##(1991-12#1)(1995-10#1)(2008-10#1)(2008-8#1)
using in situ hybridization combined with##2##6##(1992-8#1)(1997-1#1)
using in situ hybridization histochemistry##4##5##(1991-3#1)(1992-8#1)(1995-11#1)(1996-5#1)
using in situ hybridization##13##4##(1991-12#1)(1991-3#1)(1992-8#2)(1995-10#1)(1995-11#2)(1995-12#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-4#1)(2008-8#1)
using in situ synthesized##2##4##(2008-10#2)
using in situ##21##3##(1991-12#1)(1991-3#1)(1992-8#2)(1995-10#1)(1995-11#2)(1995-12#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-5#1)(2007-7#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-8#1)
using in the##3##3##(2008-10#1)(2008-7#1)(2012-3#1)
using in vitro assays##3##4##(2008-10#1)(2009-3#1)(2010-4#1)
using in vitro receptor autoradiography##2##5##(1992-8#1)(1993-2#1)
using in vitro##22##3##(1990-7#1)(1991-9#1)(1992-8#1)(1993-2#1)(1994-3#1)(1995-3#2)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-4#1)
using in vivo and in vitro##2##6##(2008-10#1)(2008-11#1)
using in vivo and##3##4##(2008-10#1)(2008-11#2)
using in vivo microdialysis##2##4##(1993-4#1)(1996-1#1)
using in vivo##11##3##(1992-7#1)(1993-4#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-1#1)(1996-5#1)(1997-8#1)(2008-10#1)(2008-11#2)
using in##59##2##(1990-7#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-7#1)(1992-8#3)(1993-2#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-3#3)(1996-1#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-5#1)(1997-8#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#9)(2008-11#5)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2010-4#1)(2012-3#1)(2013-8#1)
using in-depth##3##2##(2006-11#1)(2013-1#2)
using inbred##2##2##(2012-3#2)
using increased##2##2##(2004-8#1)(2007-7#1)
using independent##3##2##(1995-4#1)(2005-11#1)(2009-5#1)
using indirect##6##2##(1995-3#1)(1997-2#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-9#1)
using indium##2##2##(2008-1#1)(2008-10#1)
using individual##9##2##(1992-6#1)(2007-10#1)(2008-12#1)(2008-7#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
using individual-based##2##2##(2008-8#1)(2008-9#1)
using inductively coupled plasma atomic emission spectrometry (ICP-AES)##5##8##(2008-10#5)
using inductively coupled plasma atomic emission spectrometry##6##7##(2008-10#6)
using inductively coupled plasma mass spectrometry (ICP-MS)##2##7##(2008-10#2)
using inductively coupled plasma mass spectrometry##4##6##(2008-10#4)
using inductively coupled plasma##11##4##(2008-10#11)
using inductively coupled plasma-optical emission spectrometry (ICP-OES)##2##7##(2008-10#2)
using inductively coupled##16##3##(1990-10#1)(2008-10#15)
using infliximab in combination with##2##5##(2008-8#2)
using information from##4##3##(1997-3#1)(1997-7#1)(2008-4#2)
using information obtained from##2##4##(2006-5#1)(2006-8#1)
using information##15##2##(1993-2#1)(1993-3#1)(1997-3#1)(1997-7#1)(2006-5#1)(2006-8#1)(2007-6#1)(2008-10#2)(2008-4#2)(2008-7#1)(2008-8#1)(2013-1#2)
using infrared spectroscopy and##2##4##(2008-10#2)
using infrared spectroscopy##4##3##(2008-10#3)(2010-12#1)
using infrared##12##2##(2007-8#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-5#1)(2011-1#1)
using initial##2##2##(1996-7#1)(2008-6#1)
using innovative##3##2##(1997-1#1)(2008-10#1)(2009-4#1)
using inorganic##2##2##(1996-7#1)(2013-1#1)
using intact##8##2##(1992-1#1)(1994-8#1)(2008-10#2)(2008-2#1)(2008-4#2)(2009-5#1)
using integrated##5##2##(2006-2#1)(2008-10#1)(2008-5#1)(2008-7#2)
using integrating##2##2##(2008-5#1)(2012-12#1)
using interaction##2##2##(2008-9#1)(2009-10#1)
using interactive##2##2##(2007-5#1)(2009-6#1)
using interbody##2##2##(2007-11#2)
using interleukin-12##2##2##(1996-10#2)
using internal standard##2##3##(2008-10#2)
using internal standardization##2##3##(2008-10#2)
using internal surface reversed-phase##2##4##(1990-11#1)(1991-5#1)
using internal##12##2##(1990-11#1)(1991-5#1)(1997-2#1)(2007-11#1)(2008-10#5)(2010-10#1)(2011-2#1)(2012-12#1)
using intracellular##4##2##(1991-5#1)(1993-2#1)(2007-11#1)(2008-11#1)
using intramedullary##2##2##(2007-7#1)(2013-1#1)
using intraoperative##2##2##(1993-10#1)(2006-10#1)
using intravenous##5##2##(2006-10#1)(2007-10#1)(2007-2#1)(2008-3#1)(2008-4#1)
using intravitreal##2##2##(2013-1#2)
using inverse##3##2##(1993-5#1)(2008-10#1)(2009-9#1)
using iodide##2##2##(2008-10#2)
using ion chromatography (IC)##2##4##(2008-10#2)
using ion chromatography with##2##4##(2008-10#2)
using ion chromatography##7##3##(2008-10#6)(2013-7#1)
using ion exchange chromatography##2##4##(1994-11#1)(1997-8#1)
using ion exchange##7##3##(1994-11#1)(1997-2#1)(1997-8#1)(2008-10#3)(2013-1#1)
using ion mobility spectrometry (IMS)##2##5##(2008-10#2)
using ion mobility spectrometry##5##4##(2008-10#5)
using ion pairing##2##3##(2008-10#2)
using ion##24##2##(1994-11#1)(1997-2#1)(1997-8#1)(2006-12#1)(2007-11#1)(2008-10#17)(2013-1#1)(2013-7#1)
using ion-pair##2##2##(1996-5#1)(2007-11#1)
using ion-selective electrodes (ISEs)##2##4##(2008-10#2)
using ion-selective electrodes##3##3##(2008-10#3)
using ion-spray mass spectrometry##2##4##(1994-5#2)
using ionic##2##2##(1996-5#1)(2008-10#1)
using iron(III)##2##2##(2008-10#1)(2010-2#1)
using isocratic##3##2##(1990-11#1)(1994-12#1)(2008-10#1)
using isolated rat##2##3##(1991-1#1)(1992-3#1)
using isolated##10##2##(1990-4#1)(1991-1#1)(1992-3#1)(1995-3#1)(1996-9#1)(1997-4#1)(2007-11#1)(2008-11#1)(2012-2#2)
using isolates##3##2##(2008-10#3)
using isotope dilution##2##3##(2008-10#2)
using it as a##3##4##(2008-10#1)(2012-2#1)(2013-8#1)
using it as##5##3##(2007-2#1)(2008-10#1)(2008-12#1)(2012-2#1)(2013-8#1)
using it to##2##3##(2010-2#1)(2010-8#1)
using it##11##2##(2007-10#1)(2007-2#1)(2008-10#1)(2008-12#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
using iterative##2##2##(2008-5#1)(2009-10#1)
using its knowledge base of resources and information needs##2##9##(2013-1#2)
using its##10##2##(1990-4#1)(2008-10#2)(2008-11#2)(2009-8#1)(2011-2#2)(2013-1#2)
using key##2##2##(1997-2#1)(2004-4#1)
using keywords##2##2##(2008-7#1)(2010-6#1)
using kinetic##2##2##(1992-7#1)(2008-10#1)
using knee arthroplasty and##2##4##(2008-8#2)
using knotted##2##2##(2008-10#2)
using known##5##2##(1990-5#1)(2008-8#1)(2010-7#1)(2012-12#1)(2012-3#1)
using labeled##2##2##(1994-9#1)(2008-6#1)
using labelled##3##2##(1996-1#1)(2006-10#1)(2008-7#1)
using laboratory##6##2##(1995-5#1)(2004-11#1)(2007-7#1)(2009-5#1)(2010-6#1)(2011-2#1)
using laccase##2##2##(2008-6#2)
using laminar##2##2##(2008-2#1)(2010-10#1)
using large##5##2##(1996-5#1)(2007-6#1)(2008-10#1)(2012-3#2)
using large-scale##2##2##(1991-8#1)(2009-8#1)
using larger##5##2##(2006-10#1)(2007-11#1)(2008-7#2)(2008-9#1)
using laser ablation inductively coupled plasma##2##6##(2008-10#2)
using laser ablation##3##3##(2008-1#1)(2008-10#2)
using laser induced##2##3##(2007-8#1)(2008-10#1)
using laser speckle imaging##2##4##(2013-1#2)
using laser##15##2##(1992-11#1)(1997-3#1)(2006-3#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2009-2#1)(2013-1#2)
using laser-Doppler flowmetry##2##3##(1993-11#1)(1997-7#1)
using laser-induced fluorescence##4##3##(1997-8#1)(2005-11#2)(2008-10#1)
using laser-induced##7##2##(1994-8#1)(1997-8#1)(2005-11#2)(2007-12#2)(2008-10#1)
using latent##2##2##(2010-3#1)(2012-3#1)
using layer-by-layer##3##2##(2008-10#2)(2008-7#1)
using lectin##3##2##(1993-1#1)(1996-5#1)(2005-7#1)
using lectins##2##2##(1992-6#1)(1994-11#1)
using less intrusive##2##3##(2010-8#1)(2011-2#1)
using less##3##2##(2008-10#1)(2010-8#1)(2011-2#1)
using lidocaine 1%##3##3##(2006-12#1)(2006-8#2)
using lidocaine##4##2##(2006-12#1)(2006-8#3)
using ligand##2##2##(1995-5#1)(1995-7#1)
using light and electron microscopy##5##5##(2007-12#1)(2008-10#3)(2008-7#1)
using light and electron##6##4##(1990-4#1)(2007-12#1)(2008-10#3)(2008-7#1)
using light and##7##3##(1990-4#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-7#1)
using light microscopy and scanning electron microscopy##2##7##(2007-5#1)(2008-10#1)
using light microscopy and##3##4##(2007-5#1)(2008-10#1)(2011-2#1)
using light microscopy##12##3##(1996-3#1)(2007-12#2)(2007-2#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#3)(2011-2#1)
using light scattering##2##3##(2005-11#1)(2008-10#1)
using light##29##2##(1990-4#1)(1996-3#1)(1997-6#1)(2005-11#1)(2007-12#3)(2007-2#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2009-7#1)(2011-2#1)
using light-scattering##2##2##(1991-2#1)(1995-1#1)
using likelihood##2##2##(1997-5#1)(2008-12#1)
using limited data sets##2##4##(2008-5#2)
using limited##5##2##(1995-3#1)(1996-8#1)(2008-5#2)(2012-3#1)
using linear and##2##3##(2007-4#1)(2008-2#1)
using linear interpolation##2##3##(2011-1#1)(2011-2#1)
using linear regression##2##3##(2010-8#1)(2013-7#1)
using linear sweep stripping##2##4##(2008-10#2)
using linear sweep##3##3##(2008-10#3)
using linear##20##2##(1996-3#1)(2006-10#1)(2007-4#2)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#1)(2009-12#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
using linked administrative databases##2##4##(2008-6#1)(2011-1#1)
using lipid##2##2##(2008-11#1)(2011-2#1)
using lipoprotein subclass analysis##2##4##(2008-3#2)
using liposomes##2##2##(2008-10#2)
using liquid chromatography and mass spectrometry##2##6##(2008-1#1)(2008-10#1)
using liquid chromatography and##3##4##(2008-1#1)(2008-10#2)
using liquid chromatography tandem mass spectrometry (LC-MS/MS)##2##7##(2011-1#2)
using liquid chromatography##9##3##(2008-1#1)(2008-10#4)(2010-4#1)(2011-1#2)(2012-12#1)
using liquid##19##2##(1991-1#1)(1996-8#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#7)(2010-4#1)(2011-1#3)(2012-12#3)
using liquid-liquid extraction##3##3##(1997-3#1)(2008-10#2)
using lithium##5##2##(1992-2#2)(2005-8#2)(2008-4#1)
using live cells##2##3##(2008-4#1)(2009-8#1)
using live##4##2##(2006-6#1)(2008-4#1)(2008-5#1)(2009-8#1)
using living##6##2##(2008-10#3)(2008-5#1)(2011-2#2)
using local and##2##3##(2008-10#1)(2008-2#1)
using local##8##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2010-10#1)(2011-12#1)(2012-2#1)
using logistic regression and##2##4##(1993-9#1)(2007-11#1)
using logistic regression with##2##4##(2007-2#1)(2011-2#1)
using logistic regression##10##3##(1993-9#2)(1995-5#1)(2007-11#1)(2007-2#1)(2007-7#1)(2011-1#1)(2011-2#1)(2012-12#2)
using logistic##11##2##(1993-9#2)(1995-5#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-12#2)
using long##3##2##(1993-3#1)(2008-10#1)(2008-6#1)
using longer##4##2##(1995-1#1)(2006-12#1)(2011-1#1)(2011-7#1)
using longitudinal data##2##3##(2012-12#1)(2013-1#1)
using longitudinal##4##2##(2008-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
using low melt agarose##2##4##(2008-11#2)
using low##12##2##(1990-5#1)(1991-8#1)(2004-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2010-1#1)(2010-4#1)(2011-1#1)(2013-8#1)
using low-cost##4##2##(2008-6#1)(2008-7#1)(2011-2#1)(2012-1#1)
using low-dose##2##2##(1996-9#1)(2013-1#1)
using low-temperature##2##2##(1991-12#1)(1993-11#1)
using lower##3##2##(1990-6#1)(1996-5#1)(2009-2#1)
using luminol##2##2##(1995-3#1)(2008-10#1)
using lung##3##2##(1996-12#1)(2008-5#1)(2012-12#1)
using lysozyme##2##2##(2006-5#1)(2008-12#1)
using mRNA differential display##2##4##(2008-8#1)(2008-9#1)
using macrocyclic##2##2##(2008-10#2)
using magnetic beads##2##3##(2008-4#2)
using magnetic cell##2##3##(2007-2#1)(2008-9#1)
using magnetic microbeads##2##3##(2008-10#2)
using magnetic nanoparticles##2##3##(2011-2#1)(2012-2#1)
using magnetic resonance (MR) imaging##3##5##(1996-2#1)(1997-8#1)(2008-8#1)
using magnetic resonance imaging (MRI)##3##5##(2007-8#1)(2007-9#1)(2008-5#1)
using magnetic resonance imaging##7##4##(1997-8#1)(2007-8#1)(2007-9#3)(2008-5#1)(2008-7#1)
using magnetic resonance##12##3##(1996-2#1)(1997-8#2)(2007-8#1)(2007-9#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)
using magnetic##26##2##(1996-2#1)(1997-8#2)(2005-11#2)(2007-2#1)(2007-8#1)(2007-9#3)(2008-10#3)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-2#1)
using mainly##4##2##(1994-6#1)(1995-6#1)(2006-1#1)(2012-12#1)
using mammalian##2##2##(1993-4#1)(2008-11#1)
using manual##3##2##(1991-3#1)(1993-1#1)(2009-6#1)
using many##2##2##(1996-5#1)(2008-11#1)
using maps##2##2##(2007-11#1)(2012-3#1)
using marker-assisted selection##2##3##(2008-10#1)(2012-11#1)
using markers##3##2##(2007-1#1)(2008-11#1)(2010-2#1)
using mass spectrometry##7##3##(1997-4#1)(1997-7#1)(2007-8#2)(2008-2#1)(2011-2#2)
using mass##9##2##(1997-4#2)(1997-7#1)(2007-8#2)(2008-11#1)(2008-2#1)(2011-2#2)
using material##4##2##(2007-12#1)(2007-6#1)(2008-11#1)(2008-9#1)
using mathematical##5##2##(1995-6#1)(2005-10#1)(2008-11#1)(2008-5#1)(2010-5#1)
using matrix##2##2##(2008-10#2)
using matrix-assisted laser desorption##3##4##(2008-5#1)(2012-3#2)
using matrix-assisted laser desorption/ionization##2##4##(2011-2#1)(2013-7#1)
using matrix-assisted laser##5##3##(2008-5#1)(2011-2#1)(2012-3#2)(2013-7#1)
using maximum parsimony##2##3##(2007-12#1)(2008-10#1)
using maximum##4##2##(2007-12#1)(2008-10#1)(2008-4#1)(2012-3#1)
using mean##3##2##(1992-9#1)(2008-10#2)
using measured##3##2##(2008-7#1)(2012-12#1)(2013-7#1)
using measurements of##3##3##(2008-4#1)(2010-8#2)
using measures of##3##3##(1993-9#1)(1994-2#1)(2008-10#1)
using mechanical##4##2##(2007-4#1)(2008-10#3)
using mechanisms##2##2##(1995-1#1)(2009-3#1)
using medical##5##2##(2007-2#1)(2008-6#1)(2012-3#1)(2013-1#2)
using medications##2##2##(2006-12#1)(2008-3#1)
using medium##2##2##(1992-6#1)(1994-5#1)
using melamine and##2##3##(2010-4#1)(2013-8#1)
using membrane mass spectrometry##2##4##(2008-11#2)
using membrane##11##2##(1992-1#1)(1993-2#1)(1994-2#1)(1995-3#1)(2008-11#3)(2009-10#1)(2010-4#1)(2012-3#2)
using membranes##4##2##(1992-12#1)(2007-12#2)(2007-8#1)
using mercaptosephadex##2##2##(2008-10#2)
using mercury##2##2##(2007-12#1)(2012-12#1)
using message-driven parallel quantum and classical dynamics##2##7##(2013-1#2)
using metal implants##2##3##(2007-8#2)
using metal##5##2##(2007-8#3)(2008-10#2)
using metallic##2##2##(2008-10#2)
using methanol and##2##3##(2007-8#1)(2008-10#1)
using methanol as##3##3##(2006-8#1)(2008-10#2)
using methanol##8##2##(1994-9#1)(2006-8#1)(2007-8#1)(2008-10#4)(2008-6#1)
using methods previously##2##3##(1997-3#1)(2007-1#1)
using methods##6##2##(1997-3#1)(2007-1#1)(2007-8#1)(2007-9#1)(2008-4#1)(2009-8#1)
using methyl tert-butyl ether##2##4##(2011-2#1)(2012-12#1)
using methyl##9##2##(1995-5#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2009-3#1)(2011-2#1)(2012-12#1)
using miRNAs as##2##3##(2009-12#1)(2009-5#1)
using mice as##2##3##(2008-12#1)(2008-6#1)
using mice##11##2##(1992-5#1)(1994-8#1)(1995-11#1)(2007-6#1)(2008-11#1)(2008-12#1)(2008-6#3)(2008-7#1)(2009-8#1)
using micellar electrokinetic capillary chromatography##2##5##(1992-2#1)(2008-10#1)
using micellar liquid chromatography##2##4##(2008-10#1)(2009-4#1)
using micellar##6##2##(1992-2#1)(2008-10#4)(2009-4#1)
using micro##2##2##(2008-6#1)(2009-12#1)
using micro-CT##2##2##(2010-9#1)(2011-1#1)
using microarray and##3##3##(2008-10#1)(2008-9#1)(2009-10#1)
using microarray technologies##2##3##(2008-4#1)(2009-12#1)
using microarray technology##2##3##(2008-7#1)(2012-3#1)
using microarray##9##2##(2006-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-1#1)(2012-3#1)
using microarrays##7##2##(2008-10#1)(2008-11#1)(2008-2#1)(2009-6#1)(2010-12#1)(2012-3#1)(2013-1#1)
using microbial##2##2##(2010-4#1)(2011-2#1)
using microcontact printing##2##3##(2006-12#1)(2010-4#1)
using microcrystalline cellulose##2##3##(2004-12#1)(2010-12#1)
using microdialysis##4##2##(1991-5#1)(1996-12#1)(2007-8#1)(2008-7#1)
using microelectrodes and##2##3##(2006-7#1)(2008-7#1)
using microelectrodes##3##2##(2006-7#1)(2008-10#1)(2008-7#1)
using microfluidics##2##2##(2008-10#1)(2008-11#1)
using microgravimetric quartz-crystal-microbalance##2##3##(2008-10#2)
using microhardness##2##2##(2012-2#1)(2013-8#1)
using microinjection of##2##3##(1993-6#1)(1996-6#1)
using microinjection##3##2##(1992-6#1)(1993-6#1)(1996-6#1)
using microsatellite DNA##2##3##(2008-11#1)(2011-2#1)
using microsatellite markers and##2##4##(2008-10#2)
using microsatellite markers##6##3##(2008-10#4)(2008-5#1)(2012-1#1)
using microsatellite##11##2##(1996-12#2)(2008-10#5)(2008-11#1)(2008-5#1)(2011-2#1)(2012-1#1)
using microscopy and##2##3##(2005-11#1)(2009-12#1)
using microscopy##3##2##(2005-11#1)(2009-12#1)(2011-1#1)
using microspectrofluorometry##2##2##(1993-6#2)
using microtiter##2##2##(2008-11#1)(2010-11#1)
using microwave heating##2##3##(2008-10#2)
using microwave irradiation##4##3##(1996-7#1)(2007-10#1)(2007-11#1)(2008-10#1)
using microwave##12##2##(1996-7#2)(2007-10#1)(2007-11#3)(2008-10#5)(2009-7#1)
using microwave-assisted##2##2##(2007-11#1)(2008-10#1)
using microwaves##2##2##(2008-10#2)
using mild conditions##3##3##(2007-10#1)(2008-10#2)
using mild##5##2##(1990-2#1)(1994-9#1)(2007-10#1)(2008-10#2)
using mineral##3##2##(2013-1#3)
using minimal##3##2##(1992-8#1)(2008-1#1)(2008-6#1)
using minimally invasive##3##3##(2004-1#1)(2011-2#1)(2013-1#1)
using mitochondrial##2##2##(2008-10#1)(2010-4#1)
using mixed ion-pairing##2##3##(2008-10#2)
using mixed##9##2##(2005-4#1)(2008-10#4)(2008-7#2)(2011-1#1)(2012-2#1)
using mixture models##2##3##(1995-4#1)(1996-7#1)
using mixtures of##7##3##(2008-10#5)(2009-9#1)(2011-1#1)
using mobile phase##2##3##(2008-10#1)(2011-1#1)
using mobile##3##2##(1992-5#1)(2008-10#1)(2011-1#1)
using model compounds##2##3##(2008-10#1)(2010-2#1)
using model##8##2##(1990-11#1)(1994-11#1)(2008-10#4)(2010-2#1)(2012-3#1)
using models of##2##3##(2008-10#1)(2008-2#1)
using models##3##2##(2008-10#1)(2008-2#1)(2008-8#1)
using moderate##2##2##(2007-8#1)(2008-5#1)
using modern scientific##2##3##(2011-1#1)(2013-1#1)
using modern technology##2##3##(2009-2#1)(2010-7#1)
using modern##16##2##(1991-4#1)(2005-11#1)(2006-12#2)(2007-5#1)(2007-8#2)(2008-10#1)(2008-6#1)(2009-12#1)(2009-2#1)(2010-7#1)(2011-1#2)(2012-12#1)(2013-1#1)
using modifications##2##2##(2005-9#1)(2012-3#1)
using modified versions of##2##4##(2008-11#1)(2008-4#1)
using modified##21##2##(1995-10#1)(1995-3#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#1)
using molecular beacons##2##3##(2008-10#1)(2008-9#1)
using molecular biology techniques##2##4##(2005-7#1)(2008-4#1)
using molecular docking##2##3##(2010-7#1)(2012-2#1)
using molecular dynamics##3##3##(1993-11#1)(1995-10#1)(2007-7#1)
using molecular markers##2##3##(1994-8#1)(2012-3#1)
using molecular modeling##2##3##(1992-9#1)(2008-5#1)
using molecular replacement##2##3##(1994-12#1)(1997-7#1)
using molecular##35##2##(1992-9#1)(1993-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-3#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-7#1)(2012-2#2)(2012-3#1)(2013-1#1)
using molecularly imprinted polymers as recognition elements##2##7##(2007-8#1)(2008-10#1)
using molecularly imprinted##3##3##(2007-8#2)(2008-10#1)
using molybdenum containing chemical modifiers##2##5##(2008-10#2)
using molybdenum##4##2##(2008-10#4)
using monoclonal antibodies against##2##4##(1993-6#1)(2005-8#1)
using monoclonal antibodies and##4##4##(1990-11#1)(1992-8#1)(1995-5#1)(2008-10#1)
using monoclonal antibodies in##2##4##(2008-10#1)(2008-7#1)
using monoclonal antibodies to##4##4##(1992-3#1)(1992-5#1)(1995-3#1)(1997-2#1)
using monoclonal antibodies##32##3##(1990-11#1)(1990-2#1)(1991-10#1)(1991-5#1)(1992-3#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-2#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-1#2)(1997-2#2)(1997-6#1)(2004-11#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)
using monoclonal antibody##5##3##(1990-11#1)(1991-10#1)(1995-6#1)(1997-4#1)(2007-6#1)
using monoclonal##45##2##(1990-11#3)(1990-2#1)(1991-10#2)(1991-5#1)(1991-8#1)(1992-3#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-6#1)(1997-2#2)(1997-4#1)(1997-6#1)(2004-11#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#1)(2012-3#1)
using monodisperse##2##2##(2010-12#1)(2010-8#1)
using monolithic column chromatography##2##4##(2008-10#2)
using monolithic silica##2##3##(2008-10#2)
using monolithic##4##2##(2008-10#4)
using monopolar##2##2##(2006-6#1)(2006-9#1)
using more sophisticated##2##3##(1994-12#1)(1995-12#1)
using more than one##3##4##(2006-4#1)(2007-10#1)(2008-9#1)
using more##12##2##(1993-3#1)(1994-12#1)(1995-12#1)(1997-3#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-4#1)(2008-9#1)(2009-7#1)(2012-7#1)
using morphological and molecular##2##4##(2010-8#1)(2011-1#1)
using morphological and##3##3##(2008-5#1)(2010-8#1)(2011-1#1)
using morphological criteria##2##3##(2008-10#2)
using morphological##11##2##(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#1)(2010-8#1)(2011-1#1)(2013-1#1)
using morphometric##3##2##(2008-6#1)(2009-2#1)(2009-4#1)
using mouse##10##2##(1990-10#1)(1994-8#1)(1997-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-1#1)(2012-12#3)
using multidimensional##3##2##(1995-12#1)(2008-4#1)(2013-7#1)
using multilayer##2##2##(2008-10#1)(2008-2#1)
using multilevel##3##2##(2007-4#1)(2009-6#1)(2013-1#1)
using multilocus##3##2##(2006-12#1)(2008-9#1)(2012-3#1)
using multiple linear regression##3##4##(2008-10#3)
using multiple logistic regression##3##4##(2011-2#1)(2012-3#1)(2013-7#1)
using multiple regression with##2##4##(2008-10#2)
using multiple regression##4##3##(2008-10#3)(2012-12#1)
using multiple sequence##2##3##(2010-4#1)(2013-1#1)
using multiple##48##2##(1993-12#1)(1995-3#1)(1996-6#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#12)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-4#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
using multiplex##2##2##(2008-8#1)(2013-1#1)
using multivariate analysis##2##3##(2008-5#1)(2008-7#1)
using multivariate calibration methods##3##4##(2008-10#3)
using multivariate calibration##6##3##(2008-10#6)
using multivariate regression##2##3##(1991-1#1)(2008-9#1)
using multivariate##18##2##(1991-1#1)(1997-4#1)(2007-10#1)(2008-10#9)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-8#1)
using multiwalled carbon nanotubes as##2##5##(2008-10#2)
using murine##4##2##(1995-2#1)(1996-6#1)(2008-5#2)
using mutants##3##2##(1990-9#1)(1994-3#1)(2013-7#1)
using myoglobin##2##2##(2008-10#1)(2013-8#1)
using nanoindentation##2##2##(2009-7#1)(2010-10#1)
using national##2##2##(2007-8#1)(2008-11#1)
using native##3##2##(1995-1#1)(1995-12#1)(2011-2#1)
using natural and##2##3##(1990-10#1)(1993-3#1)
using natural##12##2##(1990-10#1)(1993-3#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2013-1#2)
using naturally##2##2##(2008-10#2)
using near infrared spectroscopy##3##4##(1994-4#1)(2007-9#2)
using near infrared##5##3##(1994-4#1)(2007-9#2)(2011-1#1)(2013-8#1)
using near-infrared (NIR)##2##3##(2007-8#1)(2008-10#1)
using near-infrared spectroscopy in##2##4##(1997-6#1)(2008-10#1)
using near-infrared##7##2##(1997-6#1)(2007-11#1)(2007-8#1)(2008-10#3)(2011-1#1)
using needle##2##2##(1993-11#1)(2011-2#1)
using negative##2##2##(2008-10#2)
using nested##5##2##(1996-12#1)(1997-4#1)(2005-12#1)(2008-6#1)(2012-3#1)
using nets##2##2##(2007-2#2)
using network##3##2##(2008-11#1)(2008-4#1)(2008-9#1)
using neural network##2##3##(2008-8#1)(2010-8#1)
using neural networks##3##3##(1993-4#1)(2008-8#1)(2010-8#1)
using neural##5##2##(1993-4#1)(2008-8#2)(2010-8#2)
using neuroendoscopic techniques##2##3##(2006-11#1)(2012-12#1)
using neutral##4##2##(1991-7#1)(2007-2#1)(2008-10#1)(2009-11#1)
using neutralizing##2##2##(2004-12#1)(2013-1#1)
using new materials##3##3##(2007-11#1)(2012-3#1)(2013-1#1)
using new##17##2##(1990-3#1)(1991-10#1)(1991-2#1)(1992-6#1)(1995-9#1)(1996-12#1)(2005-8#1)(2006-4#1)(2007-11#2)(2007-5#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
using newer##4##2##(2008-3#1)(2011-2#2)(2013-8#1)
using newly##5##2##(1995-11#1)(1997-2#1)(2008-5#1)(2009-3#1)(2013-1#1)
using nine##2##2##(2008-10#1)(2013-8#1)
using nitrate##2##2##(2007-6#1)(2008-10#1)
using nitric acid##2##3##(2005-11#2)
using nitrogen adsorption##2##3##(2005-11#2)
using nitrogen and oxygen stable##2##5##(2013-8#2)
using nitrogen##7##2##(2005-11#3)(2008-10#1)(2013-8#3)
using no##4##2##(2005-11#1)(2007-2#1)(2008-1#1)(2013-1#1)
using non##3##2##(2008-10#3)
using non-invasive##2##2##(2008-10#1)(2010-12#1)
using non-linear##2##2##(2008-10#1)(2010-3#1)
using non-parametric statistics##2##3##(2012-12#1)(2013-1#1)
using non-parametric##4##2##(1996-5#1)(2007-8#1)(2012-12#1)(2013-1#1)
using noninvasive##4##2##(2006-10#1)(2007-4#1)(2010-12#1)(2010-5#1)
using nonlinear regression##2##3##(2008-10#1)(2008-4#1)
using nonlinear##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2011-1#1)
using nonparametric##2##2##(1997-5#1)(2008-10#1)
using normal##3##2##(1992-8#2)(2007-7#1)
using normalized##2##2##(2008-8#1)(2013-8#1)
using novel human##2##3##(2009-4#1)(2011-1#1)
using novel##13##2##(1993-8#1)(1994-12#1)(1995-12#1)(2005-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-2#1)(2009-4#1)(2011-1#1)(2012-12#2)
using nuclear extracts of##2##4##(1991-12#1)(1995-6#1)
using nuclear extracts##3##3##(1991-12#1)(1995-10#1)(1995-6#1)
using nuclear##9##2##(1991-12#1)(1994-3#1)(1994-5#1)(1995-10#1)(1995-3#1)(1995-6#1)(1996-9#1)(2010-10#1)(2010-3#1)
using nucleic##3##2##(2008-10#1)(2008-4#1)(2009-5#1)
using nucleoside phosphorylase##2##3##(1993-12#2)
using nude mice##2##3##(1994-11#1)(2010-1#1)
using numerical##5##2##(1996-4#1)(2006-11#1)(2007-11#1)(2007-8#1)(2008-7#1)
using nylon##2##2##(2008-4#2)
using o-phenylenediamine as##2##3##(2008-10#2)
using o-tolidine##2##2##(1996-9#1)(2008-10#1)
using objective##5##2##(2005-9#1)(2006-10#1)(2006-6#1)(2008-9#1)(2012-1#1)
using octadecyl silica membrane disks modified by##5##7##(2008-10#5)
using octadecyl##7##2##(2007-8#1)(2008-10#6)
using octadecylsilica##3##2##(1996-11#1)(2008-10#2)
using of##7##2##(2008-10#4)(2011-2#1)(2012-3#1)(2013-1#1)
using oligodeoxynucleotides##2##2##(1995-8#1)(2008-10#1)
using oligonucleotide probes##3##3##(1991-1#1)(1991-3#1)(1992-2#1)
using oligonucleotide##7##2##(1991-1#1)(1991-12#1)(1991-3#1)(1992-2#1)(1992-6#1)(1993-3#1)(2008-5#1)
using oligonucleotides##3##2##(1991-11#1)(1993-9#1)(1995-1#1)
using on##2##2##(2008-10#1)(2008-4#1)
using on-column##3##2##(1992-2#1)(2008-10#1)(2013-1#1)
using on-line electrogenerated##2##3##(2008-10#2)
using on-line radiochemical detection##2##4##(1991-5#2)
using on-line solid-phase extraction and##2##5##(1997-3#2)
using on-line solid-phase extraction##3##4##(1997-3#2)(2008-10#1)
using on-line##14##2##(1991-5#2)(1997-3#2)(2007-8#2)(2008-10#8)
using one of the##6##4##(1990-1#1)(1994-12#1)(1996-8#1)(1997-5#1)(2008-10#1)(2013-8#1)
using one of two##2##4##(2010-8#1)(2011-2#1)
using one of##9##3##(1990-1#1)(1994-12#1)(1996-8#1)(1997-5#1)(2008-10#1)(2008-2#1)(2010-8#1)(2011-2#1)(2013-8#1)
using one or##2##3##(2008-5#1)(2011-1#1)
using one##25##2##(1990-1#1)(1994-12#1)(1995-12#1)(1996-8#1)(1997-3#1)(1997-5#1)(2007-4#1)(2007-7#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2013-8#1)
using one-way ANOVA and##3##4##(2008-12#1)(2011-2#1)(2013-1#1)
using one-way ANOVA##5##3##(2008-12#2)(2011-2#1)(2013-1#1)(2013-8#1)
using one-way##6##2##(2008-10#1)(2008-12#2)(2011-2#1)(2013-1#1)(2013-8#1)
using online##4##2##(2008-10#1)(2008-11#1)(2008-4#1)(2010-12#1)
using only 1##2##3##(2010-2#1)(2011-2#1)
using only a##3##3##(1995-6#1)(2007-8#1)(2008-3#1)
using only one##4##3##(2008-10#3)(2008-3#1)
using only the##4##3##(2008-10#1)(2008-6#1)(2010-12#1)(2012-1#1)
using only##36##2##(1991-3#1)(1992-9#1)(1994-2#1)(1994-3#2)(1995-6#1)(2007-12#3)(2007-7#1)(2007-8#2)(2008-10#10)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
using ontologies##2##2##(2008-7#1)(2009-10#1)
using open##4##2##(1994-10#1)(2007-8#2)(2013-1#1)
using optical coherence tomography (OCT)##2##5##(2008-5#1)(2011-1#1)
using optical coherence tomography##5##4##(1997-4#1)(2007-3#1)(2008-1#1)(2008-5#1)(2011-1#1)
using optical emission spectroscopy##2##4##(2008-10#1)(2010-4#1)
using optical microscopy##2##3##(2008-5#2)
using optical##25##2##(1993-3#1)(1993-5#1)(1997-4#1)(2006-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-5#4)(2009-7#1)(2010-4#1)(2010-8#1)(2011-1#1)(2013-1#2)
using optically##2##2##(2007-12#1)(2008-9#1)
using optimized##4##2##(2008-10#1)(2008-2#1)(2010-4#1)(2011-1#1)
using or##2##2##(2006-3#1)(2012-12#1)
using oral##7##2##(1991-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-6#1)(2012-2#1)
using organic solvents##2##3##(2008-10#2)
using organic##3##2##(2008-10#2)(2013-1#1)
using ortho-periodic acid as the oxidant##2##6##(2007-11#2)
using orthogonal##2##2##(2008-10#1)(2010-11#1)
using orthopaedic##2##2##(2007-8#2)
using other methods##4##3##(1997-7#1)(2006-4#1)(2009-2#1)(2013-8#1)
using other surgical##2##3##(2006-10#1)(2007-8#1)
using other##31##2##(1990-11#1)(1991-5#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-5#1)(1997-3#1)(1997-7#1)(2005-12#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-2#2)(2013-8#1)
using our##15##2##(1993-4#1)(1997-4#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-3#1)
using outcome measures that are##2##5##(2006-2#1)(2008-11#1)
using outcome##3##2##(1995-2#1)(2006-2#1)(2008-11#1)
using outpatient##4##2##(1994-2#1)(1995-1#1)(1995-2#2)
using overlapping synthetic peptides##2##4##(1996-11#2)
using oxime##2##2##(2007-12#1)(2008-10#1)
using oxygen##3##2##(2008-6#1)(2008-7#1)(2011-2#1)
using p-aminoacetophenone and its application in environmental and biological samples##2##10##(2008-10#2)
using p-nitrophenyl##2##2##(1992-3#1)(1992-9#1)
using pUC18##2##2##(1991-9#1)(1993-11#1)
using packed column supercritical fluid chromatography (SFC)##2##7##(2008-10#2)
using packed column supercritical fluid chromatography##3##6##(2008-10#3)
using paired t-tests##2##3##(2008-5#1)(2012-1#1)
using paired##7##2##(1993-4#1)(2006-10#1)(2008-11#1)(2008-5#2)(2010-1#1)(2012-1#1)
using palm oil##2##3##(2008-6#2)
using pancreatic##3##2##(1991-5#1)(1991-9#1)(1997-7#1)
using parallel##2##2##(2008-10#1)(2013-1#1)
using paramagnetic##2##2##(1990-10#1)(2008-9#1)
using parameters##2##2##(2005-11#1)(2007-1#1)
using parsimony and Bayesian##2##4##(2010-4#1)(2010-6#1)
using parsimony##4##2##(2008-10#1)(2008-9#1)(2010-4#1)(2010-6#1)
using partial least squares (PLS) regression##2##6##(2008-10#2)
using partial least squares (PLS)##5##5##(2008-10#4)(2011-1#1)
using partial least squares multivariate calibration##2##6##(2008-10#2)
using partial least squares regression##2##5##(2008-10#2)
using partial least squares##16##4##(2008-10#13)(2008-6#1)(2010-4#1)(2011-1#1)
using partial least-squares (PLS)##2##4##(2008-10#2)
using partial least-squares##7##3##(2008-10#6)(2010-5#1)
using partial##28##2##(1991-4#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#19)(2008-6#1)(2008-7#1)(2010-4#1)(2010-5#1)(2011-1#1)
using partially##3##2##(1990-2#1)(1992-3#1)(2007-12#1)
using passive##5##2##(1993-11#1)(2006-10#1)(2007-11#1)(2008-2#1)(2012-1#1)
using patch-clamp recording##2##3##(2008-8#1)(2011-2#1)
using patch-clamp##4##2##(1994-11#1)(1997-7#1)(2008-8#1)(2011-2#1)
using path##2##2##(1994-2#1)(2012-3#1)
using pathways##2##2##(2008-3#2)
using patients##3##2##(1995-2#1)(2008-4#2)
using pattern recognition##2##3##(2008-10#2)
using pea##2##2##(2008-10#2)
using peak##6##2##(2007-4#1)(2008-10#4)(2012-1#1)
using pelletized##3##2##(2008-5#2)(2008-6#1)
using penalized regression##2##3##(2009-8#1)(2012-3#1)
using peptide##3##2##(1991-1#1)(1995-3#1)(1997-2#1)
using peptides##4##2##(1994-6#1)(1997-4#1)(2006-10#1)(2007-11#1)
using periacetabular osteotomy##3##3##(2007-7#2)(2007-8#1)
using periodically##3##2##(2007-12#1)(2008-1#2)
using peripheral blood mononuclear cells##3##5##(1994-2#1)(2008-11#1)(2011-2#1)
using peripheral##4##2##(1992-4#1)(1994-2#1)(2008-11#1)(2011-2#1)
using permanent modifiers##3##3##(2008-10#3)
using permanent##4##2##(2007-5#1)(2008-10#3)
using permanganate##2##2##(2008-10#2)
using phage##3##2##(1990-10#1)(1990-9#1)(1995-12#1)
using pharmacological##2##2##(1996-10#1)(2013-8#1)
using phase transfer catalytic##3##4##(2008-3#1)(2008-5#2)
using phase##5##2##(1997-7#1)(2008-10#1)(2008-3#1)(2008-5#2)
using phenol extraction and ethanol##2##5##(2008-2#1)(2008-4#1)
using phenol##3##2##(1990-6#1)(2008-2#1)(2008-4#1)
using phosphate buffer##2##3##(1990-8#1)(2012-2#1)
using phosphate##3##2##(1990-8#1)(2008-10#1)(2012-2#1)
using phosphoric##2##2##(2008-10#2)
using phosphorothioate##2##2##(1993-3#1)(1995-11#1)
using photo diode array##2##4##(2008-10#2)
using photoactivated##2##2##(2008-10#1)(2012-2#1)
using photobiotinylated DNA##2##3##(1994-3#2)
using photon##3##2##(1990-11#1)(1995-6#1)(2005-11#1)
using photons##2##2##(1995-4#1)(2006-4#1)
using photothermal OCT##2##3##(2011-1#2)
using phylogenetic##3##2##(1995-8#1)(2008-10#2)
using physical##5##2##(1995-4#2)(2006-10#1)(2008-10#2)
using pig##2##2##(2007-8#1)(2010-10#1)
using plasma##3##2##(2004-9#1)(2008-5#1)(2012-1#1)
using plasmid##3##2##(1995-8#1)(2008-8#1)(2008-9#1)
using plasmids##2##2##(1995-6#1)(2008-10#1)
using platelet##2##2##(1990-10#1)(2008-7#1)
using platelet-rich plasma##3##3##(1990-1#1)(2010-4#2)
using playback##2##2##(2008-8#2)
using pneumatic##2##2##(2006-10#1)(2008-10#1)
using polarization##2##2##(2008-2#1)(2008-3#1)
using polarized light microscopy##2##4##(2008-5#1)(2012-2#1)
using polarized##3##2##(1991-9#1)(2008-5#1)(2012-2#1)
using polyamine##2##2##(2008-10#1)(2008-12#1)
using polyclonal and##2##3##(1990-10#1)(1993-9#1)
using polyclonal antibodies##4##3##(1992-4#1)(1993-6#1)(1994-8#1)(1995-8#1)
using polyclonal antibody against##2##4##(1994-3#1)(1997-4#1)
using polyclonal antisera##2##3##(1990-8#1)(2008-10#1)
using polyclonal##13##2##(1990-10#1)(1990-8#1)(1992-4#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-8#1)(1997-4#1)(1997-8#1)(2008-10#2)(2008-5#1)
using polyethylene glycol##5##3##(1997-6#1)(2008-10#1)(2008-9#2)(2013-8#1)
using polyethylene##6##2##(1997-6#1)(2008-10#1)(2008-9#2)(2009-10#1)(2013-8#1)
using polyethylenimine##2##2##(2008-10#1)(2008-11#1)
using polymer##4##2##(2008-10#2)(2008-4#1)(2009-5#1)
using polymerase chain reaction (PCR)##6##5##(1990-7#1)(1994-3#1)(2008-10#4)
using polymerase chain reaction amplification##2##5##(2008-10#2)
using polymerase chain reaction and##5##5##(1990-3#1)(1993-11#1)(2008-12#1)(2013-1#1)(2013-7#1)
using polymerase chain reaction##23##4##(1990-2#1)(1990-3#1)(1990-7#1)(1991-8#2)(1993-11#1)(1994-2#1)(1994-3#1)(1995-11#1)(2006-10#1)(2006-8#1)(2008-10#8)(2008-12#1)(2010-4#1)(2013-1#1)(2013-7#1)
using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP)##2##8##(1997-8#1)(2008-10#1)
using polymerase chain reaction-restriction fragment length polymorphism##3##7##(1997-8#1)(2007-12#1)(2008-10#1)
using polymerase chain##30##3##(1990-2#1)(1990-3#1)(1990-7#1)(1991-8#2)(1993-11#1)(1994-2#1)(1994-3#1)(1995-11#1)(1997-8#4)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#10)(2008-12#1)(2010-4#1)(2013-1#1)(2013-7#1)
using polymeric##2##2##(2007-11#1)(2008-10#1)
using polymers##3##2##(2008-7#1)(2010-10#1)(2010-2#1)
using polymorphic##2##2##(1996-3#1)(2007-5#1)
using polystyrene latex particles##2##4##(2010-6#2)
using polystyrene##3##2##(2008-4#1)(2010-6#2)
using polytetrafluoroethylene##3##2##(2008-10#3)
using polyurethane membrane##2##3##(2008-10#2)
using polyurethane##3##2##(2008-10#3)
using pooled##2##2##(2008-10#1)(2008-6#1)
using population-based##3##2##(2012-3#1)(2013-1#2)
using porcine##3##2##(2006-11#1)(2008-3#1)(2013-1#1)
using porous graphitic carbon##2##4##(2008-10#2)
using porous##3##2##(2008-10#3)
using positive##5##2##(1992-9#1)(2008-10#1)(2008-9#1)(2011-1#2)
using positron emission tomography (PET)##4##5##(1993-9#1)(2005-9#1)(2006-11#1)(2006-9#1)
using positron emission tomography##5##4##(1990-2#1)(1993-9#1)(2005-9#1)(2006-11#1)(2006-9#1)
using post-column##3##2##(1990-6#1)(1991-5#1)(2008-7#1)
using postembedding##2##2##(1992-1#1)(1995-11#1)
using posterior##3##2##(1995-4#1)(2006-3#1)(2010-2#1)
using postoperative##3##2##(2004-1#1)(2011-1#1)(2011-3#1)
using potassium hydroxide##2##3##(1996-2#1)(2008-6#1)
using potassium##7##2##(1996-2#1)(1996-5#1)(2008-10#3)(2008-6#1)(2010-4#1)
using potentiometric and##4##3##(2008-10#2)(2008-3#1)(2010-5#1)
using potentiometric titration##3##3##(2008-10#3)
using potentiometric##11##2##(2008-10#9)(2008-3#1)(2010-5#1)
using powder##2##2##(2005-11#1)(2007-10#1)
using power##3##2##(2006-11#1)(2008-6#1)(2010-8#1)
using pre- and##2##3##(2005-10#1)(2007-8#1)
using pre-column derivatization with##2##4##(1990-6#1)(1996-6#1)
using pre-tested##2##2##(2011-1#1)(2012-12#1)
using prednisolone##2##2##(2007-8#1)(2011-12#1)
using preparative##2##2##(1991-11#1)(2007-8#1)
using prescription##2##2##(2008-3#1)(2013-1#1)
using pressure##2##2##(2006-10#1)(2007-4#1)
using primary cultured##3##3##(1990-10#1)(2007-11#1)(2008-5#1)
using primary cultures of rabbit corneal epithelial cells##2##8##(1992-11#2)
using primary cultures of##5##4##(1992-11#2)(1993-4#1)(1995-12#1)(1996-5#1)
using primary cultures##6##3##(1992-11#2)(1993-4#1)(1995-12#1)(1996-10#1)(1996-5#1)
using primary##14##2##(1990-10#1)(1990-5#1)(1992-11#2)(1993-4#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-5#1)(2007-11#1)(2008-11#1)(2008-5#1)(2009-12#1)(2010-8#1)
using primer pairs##2##3##(1991-9#1)(2007-2#1)
using primer##5##2##(1991-9#1)(2007-2#1)(2008-4#1)(2008-9#2)
using primers corresponding to##2##4##(1992-11#1)(1992-6#1)
using primers flanking the##4##4##(1997-7#1)(2008-11#1)(2008-7#1)(2010-4#1)
using primers specific for##6##4##(1991-9#1)(1992-9#1)(2008-10#2)(2008-5#2)
using primers##20##2##(1991-9#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-2#1)(1994-12#1)(1997-4#2)(1997-7#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-4#1)
using principal component analysis (PCA)##5##5##(2007-8#1)(2008-10#2)(2010-4#1)(2010-5#1)
using principal component analysis##10##4##(2007-8#1)(2008-10#6)(2008-11#1)(2010-4#1)(2010-5#1)
using principal component##11##3##(2007-8#1)(2008-10#7)(2008-11#1)(2010-4#1)(2010-5#1)
using principal components analysis (PCA)##4##5##(2008-10#2)(2008-6#1)(2013-1#1)
using principal components analysis##6##4##(1992-2#1)(2008-10#3)(2008-6#1)(2013-1#1)
using principal components##7##3##(1992-2#1)(2008-10#4)(2008-6#1)(2013-1#1)
using principal##18##2##(1992-2#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-6#1)(2010-4#1)(2010-5#1)(2013-1#1)
using private##2##2##(1994-2#1)(2008-7#1)
using probabilistic##3##2##(1997-8#1)(2009-12#1)(2013-1#1)
using probe RG57##2##3##(2008-10#2)
using probe##6##2##(1993-3#2)(1995-3#1)(2007-12#1)(2008-10#2)
using probes for##2##3##(1996-3#1)(2008-9#1)
using probes##4##2##(1992-8#1)(1996-3#1)(2008-4#1)(2008-9#1)
using propidium iodide##3##3##(2008-4#1)(2009-6#1)(2011-2#1)
using propofol##2##2##(2010-7#1)(2012-12#1)
using propolis##2##2##(2008-10#2)
using prospective##3##2##(2006-5#1)(2007-11#1)(2008-6#1)
using protamine##2##2##(2008-10#1)(2008-6#1)
using protective##2##2##(2010-3#1)(2011-2#1)
using protein##8##2##(1991-11#1)(1995-11#1)(1997-2#1)(2008-10#1)(2008-4#2)(2010-6#1)(2011-1#1)
using proteomics##3##2##(2007-12#1)(2008-10#2)
using protocol##2##2##(2008-4#1)(2012-12#1)
using proton##2##2##(1992-7#1)(2007-11#1)
using public##2##2##(2011-1#1)(2013-1#1)
using published##8##2##(1994-3#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
using pulmonary##2##2##(2007-8#1)(2010-2#1)
using pulse##7##2##(1992-12#1)(2005-4#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#1)
using pulsed amperometric detection##2##4##(1995-2#1)(2008-10#1)
using pulsed laser##3##3##(2008-10#2)(2008-2#1)
using pulsed##7##2##(1995-2#1)(1996-11#1)(2008-10#4)(2008-2#1)
using pure##7##2##(1992-7#1)(1994-10#1)(1995-3#1)(2008-10#1)(2008-4#1)(2010-2#1)(2012-2#1)
using purified protein##2##3##(1997-4#1)(2008-10#1)
using purified##22##2##(1990-9#1)(1991-12#1)(1991-8#1)(1992-4#1)(1992-8#1)(1993-11#1)(1994-9#1)(1995-1#1)(1996-10#1)(1997-4#1)(1997-7#2)(2007-7#1)(2008-10#3)(2008-11#1)(2008-4#2)(2011-1#1)(2012-12#1)(2012-2#1)
using pyrene as a##3##4##(2005-11#2)(2008-10#1)
using pyrene carboxylic acid##3##4##(2008-10#3)
using pyrene##8##2##(1990-11#1)(2005-11#3)(2008-10#4)
using pyridyl##2##2##(2008-10#1)(2010-5#1)
using pyrosequencing##3##2##(2009-8#1)(2011-2#1)(2012-2#1)
using qPCR##3##2##(2013-1#1)(2013-8#2)
using qualitative and quantitative##2##4##(2008-1#1)(2008-11#1)
using qualitative content analysis##3##4##(2008-12#1)(2010-10#2)
using qualitative##10##2##(2006-11#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-9#1)(2010-10#2)(2010-6#1)(2012-11#1)
using quality##3##2##(1996-2#1)(2007-2#1)(2008-5#1)
using quantitative autoradiography and##2##4##(1991-5#1)(1994-2#1)
using quantitative autoradiography of##2##4##(1991-9#1)(1994-3#1)
using quantitative autoradiography##5##3##(1991-5#1)(1991-9#1)(1994-2#1)(1994-3#1)(1996-4#1)
using quantitative data##2##3##(2008-8#1)(2009-5#1)
using quantitative polymerase chain reaction##2##5##(1995-6#1)(2009-6#1)
using quantitative real-time PCR##2##4##(2010-5#1)(2010-7#1)
using quantitative real-time##3##3##(2010-5#1)(2010-7#1)(2011-2#1)
using quantitative##31##2##(1990-2#2)(1991-4#1)(1991-5#1)(1991-9#1)(1992-9#1)(1994-2#1)(1994-3#1)(1995-6#1)(1996-4#1)(1997-8#1)(2007-1#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-6#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
using quantum##4##2##(2008-5#1)(2010-2#1)(2012-2#1)(2013-8#1)
using quartz crystal##3##3##(2008-10#2)(2009-6#1)
using quartz##5##2##(2007-8#1)(2008-10#2)(2008-6#1)(2009-6#1)
using questionnaires and##3##3##(2006-2#1)(2008-12#1)(2013-1#1)
using questionnaires##5##2##(2006-2#1)(2008-12#1)(2009-9#1)(2012-1#1)(2013-1#1)
using rDNA##2##2##(2008-10#1)(2013-7#1)
using rabbit##10##2##(1990-11#1)(1991-10#1)(1993-11#1)(1994-3#1)(1994-8#1)(1995-10#1)(1996-5#1)(1996-6#1)(1997-6#1)(2010-12#1)
using radial##3##2##(2006-4#1)(2013-1#2)
using radiation##2##2##(1990-4#1)(2006-5#1)
using radio##3##2##(1993-8#1)(2007-9#1)(2013-1#1)
using radioactively##2##2##(1996-2#1)(2008-4#1)
using radiofrequency ablation##2##3##(2007-8#2)
using radiofrequency##3##2##(2007-8#2)(2011-2#1)
using radioimmunoassay##5##2##(1996-1#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-9#1)
using radiolabeled##7##2##(1997-4#2)(2008-1#1)(2008-10#2)(2012-2#1)(2012-3#1)
using radiolabelled##2##2##(1992-12#1)(1992-8#1)
using radioligand binding assays##2##4##(1994-2#1)(1994-6#1)
using radioligand binding##3##3##(1994-2#1)(1994-6#1)(2008-4#1)
using radiotherapy##2##2##(2010-3#1)(2011-3#1)
using random amplified polymorphic DNA (RAPD) markers##2##7##(2008-10#2)
using random amplified polymorphic DNA (RAPD)##4##6##(2005-11#1)(2008-10#3)
using random amplified polymorphic DNA##5##5##(2005-11#1)(2007-1#1)(2008-10#3)
using random amplified polymorphic##6##4##(2005-11#2)(2007-1#1)(2008-10#3)
using random amplified##7##3##(2005-11#2)(2007-1#1)(2008-10#4)
using random##14##2##(1995-7#1)(2004-1#1)(2005-11#2)(2005-12#1)(2007-1#1)(2008-10#6)(2012-3#1)(2013-8#1)
using randomly##2##2##(2007-5#1)(2008-8#1)
using ranitidine##2##2##(1992-2#1)(2012-12#1)
using rapid##8##2##(1991-5#1)(1994-11#1)(1996-7#1)(2008-1#3)(2008-11#1)(2010-8#1)
using rat##12##2##(1991-12#1)(1993-3#1)(1994-8#1)(1995-10#1)(1996-4#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-4#1)(2010-12#1)
using rats##4##2##(1990-10#1)(1996-10#1)(2008-10#2)
using raw##2##2##(2004-8#1)(2008-10#1)
using ray##2##2##(2008-2#1)(2008-3#1)
using reaction cell and hydride generation##2##6##(2008-10#2)
using reaction##3##2##(2008-10#2)(2012-3#1)
using readily available microplate absorbance readers##2##6##(2012-12#2)
using readily available##6##3##(1992-9#1)(1996-2#1)(2008-4#1)(2008-6#1)(2012-12#2)
using real data##4##3##(2008-10#2)(2011-2#1)(2012-1#1)
using real##9##2##(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-3#1)
using real-time PCR##4##3##(2008-10#2)(2013-1#1)(2013-8#1)
using real-time polymerase chain reaction##3##5##(2008-10#2)(2013-1#1)
using real-time quantitative PCR##3##4##(2008-4#1)(2013-8#2)
using real-time quantitative polymerase chain reaction##2##6##(2008-10#1)(2010-7#1)
using real-time quantitative##7##3##(2008-10#2)(2008-4#1)(2010-7#1)(2013-1#1)(2013-8#2)
using real-time##20##2##(2007-7#1)(2007-8#1)(2008-10#7)(2008-4#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#3)(2013-8#4)
using realistic##5##2##(1996-4#1)(2006-10#1)(2008-10#1)(2009-10#1)(2010-12#1)
using receptor##5##2##(1992-11#1)(1992-7#1)(1993-11#1)(1995-3#1)(1996-10#1)
using recombinant adeno-associated virus##2##4##(2005-7#1)(2012-12#1)
using recombinant antigen##2##3##(2005-8#2)
using recombinant inbred lines##2##4##(2008-10#1)(2012-11#1)
using recombinant polymerase chain reaction##2##5##(1991-5#2)
using recombinant##23##2##(1991-2#1)(1991-5#2)(1992-7#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-3#1)(1997-4#1)(2005-7#2)(2005-8#2)(2008-1#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-9#1)(2009-9#1)(2012-11#1)(2012-12#1)
using rectal enemas##2##3##(2006-2#2)
using red##4##2##(2006-10#1)(2007-8#1)(2008-3#1)(2012-2#1)
using reduced##2##2##(2008-11#1)(2008-12#1)
using reference##5##2##(1994-6#1)(2008-10#3)(2008-2#1)
using reflection##3##2##(2008-12#2)(2008-2#1)
using regional techniques##2##3##(2006-10#2)
using regional##5##2##(1996-1#1)(2006-10#2)(2007-9#1)(2008-10#1)
using regression analyses##2##3##(2009-9#1)(2010-2#1)
using regression analysis##2##3##(2007-2#1)(2007-3#1)
using regression##7##2##(2007-2#1)(2007-3#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-9#1)(2010-2#1)
using relational databases##2##3##(2008-4#2)
using relational##3##2##(2008-12#1)(2008-4#2)
using relative##3##2##(2008-2#1)(2012-3#1)(2012-6#1)
using relatively##2##2##(1994-5#1)(2008-10#1)
using relaxation matrix##2##3##(1995-10#2)
using renewable##2##2##(2006-7#1)(2008-10#1)
using repeated measures ANOVA##2##4##(2008-5#1)(2009-3#1)
using repeated##4##2##(2008-10#1)(2008-5#1)(2009-3#1)(2010-12#1)
using repeated-measures##2##2##(2007-4#1)(2012-2#1)
using repetitive##2##2##(2008-10#2)
using resistant##2##2##(2008-10#1)(2011-2#1)
using resonance Rayleigh scattering (RRS)##3##5##(2007-8#1)(2008-10#2)
using resonance light scattering##2##4##(2008-10#2)
using resonance##6##2##(1993-2#1)(2007-8#1)(2008-10#4)
using resources##2##2##(2009-6#1)(2012-2#1)
using respiratory##3##2##(2006-8#1)(2009-10#1)(2013-1#1)
using response surface methodology##5##4##(2008-5#4)(2013-1#1)
using response surface##7##3##(2008-5#6)(2013-1#1)
using response##9##2##(2007-11#1)(2008-5#6)(2011-1#1)(2013-1#1)
using restriction fragment length polymorphism (RFLP)##2##6##(1996-12#1)(2008-10#1)
using restriction fragment length polymorphism markers##3##6##(2008-10#3)
using restriction fragment length polymorphism##7##5##(1996-12#1)(2008-10#6)
using restriction fragment length##8##4##(1996-12#1)(2008-10#7)
using restriction fragment##9##3##(1996-12#1)(2007-12#1)(2008-10#7)
using restriction##11##2##(1995-12#1)(1996-12#1)(2007-12#1)(2008-10#8)
using results from##2##3##(2007-7#1)(2008-10#1)
using results obtained from##2##4##(2005-12#1)(2008-1#1)
using results##6##2##(1995-4#1)(2005-11#1)(2005-12#1)(2007-7#1)(2008-1#1)(2008-10#1)
using retrograde##4##2##(1992-8#1)(1996-12#1)(2009-2#1)(2013-1#1)
using retroviral##2##2##(1993-2#1)(1996-1#1)
using reverse transcription##3##3##(1991-7#1)(1993-9#1)(1994-3#1)
using reverse transcription-polymerase chain reaction (RT-PCR)##3##6##(1994-9#1)(1997-7#1)(2008-10#1)
using reverse transcription-polymerase chain reaction##6##5##(1994-6#1)(1994-9#1)(1997-7#1)(2008-10#1)(2009-9#1)(2011-2#1)
using reverse##19##2##(1990-9#1)(1991-7#1)(1993-12#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-9#1)(1996-2#1)(1997-4#1)(1997-7#1)(2005-10#1)(2007-12#1)(2008-10#3)(2008-7#1)(2009-9#1)(2011-2#1)(2012-12#1)
using reverse-phase high performance liquid chromatography##2##6##(1992-7#1)(1992-8#1)
using reverse-phase##5##2##(1992-7#1)(1992-8#1)(1995-8#1)(2008-5#1)(2012-2#1)
using reversed phase##4##3##(1990-2#1)(1991-5#1)(2007-2#1)(2008-5#1)
using reversed##5##2##(1990-2#1)(1991-5#1)(2007-2#1)(2008-10#1)(2008-5#1)
using reversed-phase high performance liquid chromatography##2##6##(2008-10#1)(2011-1#1)
using reversed-phase high performance liquid##3##5##(2008-10#1)(2011-1#2)
using reversed-phase high-performance liquid chromatography##6##5##(1992-6#1)(1993-9#1)(1995-11#1)(1995-6#1)(1996-8#1)(2008-10#1)
using reversed-phase ion-pair##2##3##(2008-10#1)(2009-10#1)
using reversed-phase liquid chromatography##2##4##(2008-10#2)
using reversed-phase##16##2##(1990-9#1)(1992-6#1)(1993-9#1)(1995-11#1)(1995-6#1)(1996-8#1)(2008-10#7)(2009-10#1)(2011-1#2)
using rf##2##2##(2007-12#1)(2008-2#1)
using rhBMP-2##2##2##(2008-5#1)(2012-12#1)
using rhodamine S##2##3##(2008-10#2)
using rhodamine##4##2##(2008-10#4)
using ribonuclease##2##2##(1994-12#1)(1997-6#1)
using riboprobes##2##2##(2008-11#2)
using ridge##2##2##(2007-12#1)(2009-9#1)
using rigorous##2##2##(2007-12#1)(2012-2#1)
using rituximab##3##2##(2006-10#1)(2008-3#1)(2013-8#1)
using robust##3##2##(2008-2#1)(2008-4#1)(2008-6#1)
using role-play as##2##3##(2008-11#2)
using routine##5##2##(1995-2#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-2#1)
using routinely obtained blood specimens treated with##2##7##(2008-10#2)
using salicylate##2##2##(2008-10#2)
using salinized##2##2##(2008-12#2)
using sample##4##2##(2008-10#2)(2010-5#1)(2011-2#1)
using samples containing##2##3##(2012-12#2)
using samples from##2##3##(1993-7#1)(2012-2#1)
using samples of##4##3##(1993-9#1)(2008-10#2)(2013-8#1)
using samples##10##2##(1993-7#1)(1993-9#1)(2007-8#1)(2008-10#3)(2012-12#2)(2012-2#1)(2013-8#1)
using satellite##2##2##(2007-5#1)(2008-12#1)
using scale##3##2##(2008-2#3)
using scanning and transmission electron microscopy##2##6##(2007-6#1)(2008-7#1)
using scanning electron microscopy (SEM)##7##5##(2004-9#1)(2007-12#1)(2008-10#1)(2009-11#1)(2009-12#1)(2009-9#1)(2013-8#1)
using scanning electron microscopy and microradiography##2##6##(1995-6#2)
using scanning electron microscopy and##3##5##(1995-6#2)(2007-2#1)
using scanning electron microscopy##19##4##(1995-6#2)(1997-4#1)(2004-9#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-5#6)(2009-11#1)(2009-12#1)(2009-9#1)(2010-7#1)(2013-1#1)(2013-8#1)
using scanning electron##21##3##(1995-6#2)(1997-4#1)(2004-9#1)(2006-5#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-5#6)(2009-11#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-7#1)(2013-1#1)(2013-8#1)
using scanning##25##2##(1995-6#2)(1995-8#1)(1997-4#1)(2004-9#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-5#6)(2008-7#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-7#1)(2010-8#1)(2013-1#1)(2013-8#1)
using scenario-based design##2##3##(2010-8#2)
using selected ion monitoring##3##4##(1993-12#1)(1996-3#1)(2008-10#1)
using selected##7##2##(1993-12#1)(1996-3#1)(2008-10#4)(2008-8#1)
using selective##14##2##(1990-2#1)(1991-5#1)(1994-5#1)(1996-12#1)(1997-3#1)(2004-12#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-9#1)(2010-12#1)(2012-2#1)
using self-administered questionnaires##2##3##(2007-3#1)(2009-10#1)
using self-assembled##4##2##(2007-8#1)(2008-5#1)(2010-12#2)
using semi-quantitative RT-PCR##2##3##(1997-5#1)(2011-2#1)
using semi-quantitative##6##2##(1994-11#1)(1994-2#1)(1997-5#1)(2005-10#1)(2011-2#1)(2013-1#1)
using semi-structured##2##2##(2013-1#2)
using semiquantitative##3##2##(1991-4#1)(1992-11#1)(1995-11#1)
using sensitive##4##2##(2008-4#1)(2008-9#1)(2010-7#1)(2012-12#1)
using sensory##4##2##(2006-7#1)(2008-10#1)(2008-9#1)(2010-4#1)
using separate##4##2##(2007-12#1)(2008-10#1)(2008-5#1)(2009-8#1)
using sequence data from##2##4##(2010-4#1)(2012-3#1)
using sequence##5##2##(1994-3#1)(1995-6#1)(2008-8#1)(2010-4#1)(2012-3#1)
using sequence-specific##2##2##(1995-8#1)(1996-11#1)
using sequences of the##2##4##(2008-10#1)(2008-9#1)
using sequential injection analysis##2##4##(2008-10#2)
using sequential injection##4##3##(2008-10#4)
using sequential##12##2##(1992-9#1)(2008-10#7)(2008-11#1)(2010-4#1)(2012-2#2)
using serial##5##2##(1993-6#1)(2006-12#1)(2007-10#1)(2008-8#1)(2012-1#1)
using serological##2##2##(2008-10#1)(2011-2#1)
using serum samples##2##3##(2008-5#1)(2013-8#1)
using serum##8##2##(1991-12#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
using serum-free##3##2##(1997-3#1)(2008-11#1)(2008-7#1)
using seven##6##2##(1993-4#1)(1996-6#1)(2008-10#1)(2008-5#1)(2010-8#1)(2012-12#1)
using several different##8##3##(1990-12#1)(1994-5#1)(1996-8#1)(1997-6#1)(2006-12#1)(2008-10#1)(2011-2#2)
using several techniques including##2##4##(2007-12#1)(2010-8#1)
using several techniques##3##3##(1992-9#1)(2007-12#1)(2010-8#1)
using several##33##2##(1990-12#1)(1992-12#1)(1992-9#2)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-8#1)(1997-6#1)(2005-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2007-1#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#2)(2012-12#1)
using sevoflurane##2##2##(2006-10#1)(2011-2#1)
using sheep##2##2##(1997-2#1)(2013-1#1)
using short##10##2##(1990-12#1)(1991-2#1)(1993-7#1)(1996-9#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)
using shorter##2##2##(1993-11#1)(2006-8#1)
using silica gel column chromatography##2##5##(1997-8#1)(2008-11#1)
using silica gel loaded with##4##5##(2008-10#4)
using silica gel modified with##2##5##(2008-10#1)(2008-3#1)
using silica gel##10##3##(1997-8#1)(2007-1#1)(2008-10#6)(2008-11#1)(2008-3#1)
using silicon##3##2##(1997-6#1)(2006-2#1)(2008-2#1)
using silicone##3##2##(1996-3#1)(2008-2#1)(2011-2#1)
using silver and##2##3##(2008-10#2)
using silver##8##2##(1991-11#1)(2008-10#4)(2008-2#1)(2008-4#1)(2012-11#1)
using similar##8##2##(1990-11#1)(2005-11#1)(2006-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2012-12#1)(2012-2#1)
using simple sequence repeat polymorphisms##2##5##(1996-3#2)
using simple sequence repeat##3##4##(1996-3#2)(2008-9#1)
using simple##27##2##(1990-12#1)(1991-11#1)(1996-3#2)(1996-7#1)(2006-10#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-4#3)(2008-7#2)(2008-9#1)(2009-10#1)(2011-2#3)(2012-1#1)(2012-12#1)
using simulated annealing techniques##2##4##(1992-12#1)(2008-3#1)
using simulated annealing##5##3##(1992-12#1)(2008-2#3)(2008-3#1)
using simulated data##2##3##(2012-3#2)
using simulated##15##2##(1992-12#1)(1997-7#1)(2008-10#4)(2008-2#4)(2008-3#2)(2010-12#1)(2012-3#2)
using simulation studies##2##3##(2010-2#1)(2012-3#1)
using simulation##6##2##(2008-11#1)(2008-2#1)(2010-2#1)(2010-7#1)(2012-1#1)(2012-3#1)
using simulations##4##2##(2007-12#1)(2008-6#1)(2010-11#1)(2012-1#1)
using simultaneous##2##2##(2010-12#1)(2012-2#1)
using single cell##2##3##(1994-8#1)(2012-2#1)
using single nucleotide##2##3##(2008-7#1)(2009-8#1)
using single##14##2##(1990-9#1)(1991-6#1)(1994-8#2)(2007-2#1)(2008-3#1)(2008-7#2)(2009-8#1)(2010-11#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
using single-locus##2##2##(2010-6#1)(2012-3#1)
using singular value decomposition##2##4##(1994-11#1)(2008-10#1)
using singular##3##2##(1994-11#1)(2007-9#1)(2008-10#1)
using site-directed mutagenesis##11##3##(1990-2#1)(1990-5#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-2#2)(1996-8#1)(1997-3#1)(2008-9#1)
using six##6##2##(1997-5#1)(2007-4#1)(2008-10#1)(2008-12#1)(2009-10#1)(2010-5#1)
using size-exclusion chromatography##2##3##(1996-8#1)(2008-4#1)
using skin##2##2##(2007-8#1)(2011-2#1)
using slurry sampling##5##3##(2008-10#5)
using small molecules##2##3##(2009-7#1)(2010-2#1)
using small volumes##2##3##(2008-10#2)
using small##13##2##(1992-9#1)(1996-12#1)(1996-7#1)(2008-10#5)(2008-9#1)(2009-7#1)(2010-11#1)(2010-2#1)(2011-12#1)
using small-angle##2##2##(2005-11#1)(2008-5#1)
using so-called##2##2##(2008-4#1)(2009-4#1)
using sodium 3-(2-pyridyl)-5##2##3##(2008-10#2)
using sodium dodecyl sulphate##2##4##(1992-2#1)(1994-9#1)
using sodium dodecyl##3##3##(1992-2#1)(1994-9#1)(2011-12#1)
using sodium##20##2##(1991-7#1)(1992-2#1)(1994-3#1)(1994-9#2)(1997-2#1)(2005-12#1)(2007-9#1)(2008-10#9)(2008-12#1)(2008-5#1)(2011-12#1)
using soft##4##2##(2008-10#2)(2010-9#1)(2012-1#1)
using software##5##2##(2008-1#1)(2008-10#2)(2008-5#1)(2013-1#1)
using soil##2##2##(2006-3#1)(2008-10#1)
using sol-gel##3##2##(2008-10#1)(2009-3#1)(2009-8#1)
using solar energy##2##3##(2011-1#2)
using solid phase extraction (SPE)##2##5##(2008-10#1)(2008-11#1)
using solid phase extraction##8##4##(1990-9#1)(2008-10#5)(2008-11#1)(2013-7#1)
using solid phase##10##3##(1990-9#1)(2007-8#1)(2008-10#6)(2008-11#1)(2013-7#1)
using solid##18##2##(1990-9#1)(2005-11#1)(2007-8#1)(2008-10#11)(2008-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
using solid-phase extraction (SPE)##2##4##(2008-10#1)(2010-9#1)
using solid-phase extraction and##4##4##(1996-6#1)(2008-10#3)
using solid-phase extraction##13##3##(1991-8#1)(1996-11#1)(1996-6#1)(1997-3#1)(2007-8#1)(2008-10#4)(2010-4#1)(2010-9#1)(2013-7#1)(2013-8#1)
using solid-phase microextraction##3##3##(2008-10#3)
using solid-phase##18##2##(1991-8#1)(1995-1#1)(1996-11#1)(1996-6#1)(1997-3#1)(2007-8#1)(2008-10#8)(2010-4#1)(2010-9#1)(2013-7#1)(2013-8#1)
using soluble##4##2##(1994-3#1)(1994-8#1)(2008-10#1)(2009-12#1)
using solution##3##2##(2008-10#1)(2010-1#1)(2013-8#1)
using solutions##2##2##(2008-12#1)(2011-1#1)
using somatic##2##2##(1997-9#1)(2008-10#1)
using some of these##3##4##(2008-10#1)(2008-12#1)(2008-5#1)
using some of##5##3##(1995-11#1)(1995-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
using some##10##2##(1995-11#1)(1995-12#1)(1997-4#1)(2008-10#3)(2008-12#1)(2008-5#1)(2012-3#1)(2013-1#1)
using sonography##2##2##(1991-11#1)(2008-8#1)
using sorption##2##2##(1991-8#1)(2005-11#1)
using soybean##3##2##(2007-2#1)(2008-11#1)(2012-11#1)
using spatial##3##2##(2007-12#1)(2008-2#1)(2013-8#1)
using spatially##3##2##(2007-11#1)(2010-2#1)(2011-1#1)
using species-specific primers and##2##4##(2008-10#2)
using species-specific##3##2##(2008-10#2)(2011-2#1)
using specific antibodies raised against##2##5##(1990-7#1)(2008-6#1)
using specific antibodies##6##3##(1990-1#1)(1990-7#1)(1991-7#1)(1994-12#1)(2008-11#1)(2008-6#1)
using specific monoclonal antibodies##2##4##(2008-10#1)(2009-9#1)
using specific primers##6##3##(1994-11#1)(1996-2#1)(2007-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
using specific##39##2##(1990-1#1)(1990-11#1)(1990-7#1)(1991-7#1)(1991-8#1)(1992-11#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-2#1)(1997-6#1)(2005-12#1)(2006-10#1)(2007-3#1)(2007-8#2)(2008-10#6)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
using specifically designed##2##3##(2007-8#1)(2008-5#1)
using spectral##7##2##(1993-9#1)(2007-12#1)(2008-10#1)(2008-2#2)(2009-10#1)(2013-7#1)
using spectrophotometric method##3##3##(2007-8#1)(2008-10#2)
using spectrophotometric methods##4##3##(2008-10#2)(2010-7#1)(2010-8#1)
using spectrophotometric##11##2##(2007-2#1)(2007-8#1)(2008-10#7)(2010-7#1)(2010-8#1)
using spectrophotometry##2##2##(1990-6#1)(2008-10#1)
using spectroscopic optical coherence tomography##2##5##(2011-1#2)
using spectroscopic##3##2##(2008-9#1)(2011-1#2)
using speech##2##2##(2008-9#2)
using spiked##3##2##(2007-8#1)(2008-10#2)
using spin##2##2##(1991-9#1)(2006-10#1)
using spinach##2##2##(1994-12#1)(1995-8#1)
using spiro form rhodamine B hydrazide##2##6##(2008-10#2)
using spontaneous##2##2##(2008-12#1)(2011-1#1)
using spot##2##2##(2008-10#2)
using spray-drying technology##2##3##(2004-12#2)
using square wave voltammetry##3##4##(2008-10#3)
using square wave##6##3##(2008-10#6)
using square-wave##3##2##(2008-10#3)
using stabilized##4##2##(1996-12#1)(2008-10#2)(2008-6#1)
using stable##5##2##(1991-5#1)(1995-1#1)(2008-10#2)(2010-4#1)
using standard addition method##2##4##(2008-10#2)
using standard addition##4##3##(2007-8#1)(2008-10#3)
using standard bacteriological##3##3##(2008-12#3)
using standard methods##6##3##(1994-3#1)(2008-12#1)(2009-5#2)(2013-1#1)(2013-7#1)
using standard procedures##5##3##(1990-11#1)(1991-11#1)(2008-10#2)(2010-8#1)
using standard protocols##2##3##(2007-2#1)(2011-1#1)
using standard solid-phase##2##3##(1991-3#1)(2008-4#1)
using standard##78##2##(1990-11#2)(1990-6#1)(1991-11#1)(1991-3#1)(1992-1#1)(1992-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-7#1)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#1)(2005-10#1)(2007-12#1)(2007-2#3)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#13)(2008-11#1)(2008-12#5)(2008-4#4)(2008-7#2)(2008-8#2)(2009-2#1)(2009-5#3)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-12#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
using standardized##10##2##(1996-2#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
using state-of-the-art##2##2##(2008-8#1)(2009-7#1)
using statistical software##2##3##(2008-10#2)
using statistical##8##2##(1993-2#1)(1994-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-3#1)(2012-3#1)
using statistics##3##2##(2008-10#1)(2009-3#1)(2010-2#1)
using steady-state and time-resolved fluorescence##2##5##(2008-5#1)(2008-8#1)
using steady-state##5##2##(1992-9#1)(2008-10#2)(2008-5#1)(2008-8#1)
using stepwise##3##2##(1994-8#1)(1996-5#1)(2010-3#1)
using stereotactic##2##2##(2008-7#2)
using sterile##5##2##(1992-2#1)(1992-8#1)(2008-11#1)(2010-3#1)(2013-8#1)
using stimulant##2##2##(2010-11#1)(2011-2#1)
using stimulated##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
using stirred##2##2##(2006-8#1)(2008-11#1)
using stochastic dynamic programming##2##4##(2008-8#1)(2008-9#1)
using stochastic##5##2##(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)
using stopped-flow##6##2##(1990-5#1)(1992-8#1)(1994-11#1)(1997-4#1)(1997-7#1)(2008-10#1)
using strain##2##2##(2008-10#1)(2008-12#1)
using strain-specific monoclonal##2##3##(2008-10#2)
using strategy of gene disruption##2##5##(2008-8#2)
using streptavidin##2##2##(1995-11#1)(2008-10#1)
using stress relaxation##2##3##(2007-1#1)(2007-4#1)
using stringent##2##2##(1991-9#1)(1993-11#1)
using structural equation modeling##3##4##(2007-10#1)(2009-3#1)(2012-3#1)
using structural magnetic resonance imaging##2##5##(1997-2#1)(2008-9#1)
using structural##9##2##(1997-2#1)(2007-10#1)(2007-4#1)(2007-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-3#1)
using structured questionnaires##2##3##(2008-8#1)(2010-2#1)
using structured##5##2##(2008-1#1)(2008-11#1)(2008-8#1)(2010-2#1)(2010-3#1)
using student##2##2##(1997-2#2)
using such a##4##3##(1996-12#1)(2007-12#1)(2007-4#1)(2008-7#1)
using such##17##2##(1992-9#1)(1996-12#2)(2005-11#1)(2007-12#3)(2007-4#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-7#1)(2013-1#2)(2013-8#1)
using sucrose##2##2##(2008-10#1)(2011-1#1)
using suitable##3##2##(1991-8#1)(2008-1#1)(2008-10#1)
using sulfuric##2##2##(2005-11#1)(2013-1#1)
using supercritical fluid extraction##2##4##(2008-10#2)
using supercritical##4##2##(2008-10#3)(2012-2#1)
using support vector##2##3##(2008-11#1)(2010-8#1)
using surface characteristics##2##3##(2005-11#2)
using surface electromyography##2##3##(2007-1#1)(2010-6#1)
using surface enhanced##2##3##(2008-10#1)(2010-7#1)
using surface plasmon resonance (SPR)##2##5##(2008-10#2)
using surface plasmon resonance##5##4##(1996-7#1)(2008-10#3)(2008-2#1)
using surface##19##2##(1996-7#1)(1997-8#1)(2004-9#1)(2005-11#2)(2007-1#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2009-12#1)(2010-6#1)(2010-7#1)(2011-2#2)
using surfactant##2##2##(1990-12#1)(1997-1#1)
using surgical##2##2##(1992-12#1)(2010-12#1)
using survival##2##2##(2007-7#1)(2007-8#1)
using suture anchors##2##3##(2006-4#1)(2010-7#1)
using sweep##2##2##(2008-10#1)(2011-2#1)
using synchrotron radiation and##2##4##(2008-10#1)(2008-2#1)
using synchrotron radiation##11##3##(2006-5#6)(2008-10#2)(2008-2#2)(2008-5#1)
using synchrotron##15##2##(2006-4#2)(2006-5#6)(2008-10#2)(2008-2#2)(2008-5#3)
using synthesized data##2##3##(2008-2#2)
using synthetic and##2##3##(2008-10#1)(2008-6#1)
using synthetic data##2##3##(2008-2#1)(2008-3#1)
using synthetic fluorogenic substrates##2##4##(1992-2#1)(2008-4#1)
using synthetic oligonucleotides##2##3##(1990-5#1)(1995-12#1)
using synthetic peptides##7##3##(1990-12#1)(1990-4#1)(1991-12#1)(1991-8#1)(1994-9#1)(1995-11#1)(2008-4#1)
using synthetic##27##2##(1990-10#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-2#1)(1992-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-4#1)(1996-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-6#1)
using systematic##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
using systems##2##2##(1991-12#1)(2010-9#1)
using tandem mass spectrometry##2##4##(1990-1#1)(2009-11#1)
using tandem##3##2##(1990-1#1)(2008-11#1)(2009-11#1)
using target##3##2##(2008-10#1)(2010-5#1)(2013-1#1)
using targeted##3##2##(2005-10#1)(2008-5#1)(2010-12#1)
using technetium-99m##2##2##(2006-8#1)(2012-12#1)
using techniques that##2##3##(2008-7#1)(2010-12#1)
using techniques##9##2##(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)
using technology to##4##3##(2006-10#1)(2008-11#1)(2008-7#2)
using technology##8##2##(2006-10#1)(2008-11#3)(2008-7#2)(2010-3#2)
using telemedicine##2##2##(2005-10#1)(2008-5#1)
using temperature modulated SnO(2) gas sensor##2##6##(2008-10#2)
using temperature##4##2##(2008-10#3)(2011-2#1)
using templates##2##2##(1994-9#1)(2008-7#1)
using temporal##2##2##(2008-9#1)(2012-1#1)
using ten##2##2##(2008-2#1)(2008-5#1)
using tensile and##2##3##(2005-11#2)
using terms##2##2##(2009-4#1)(2013-1#1)
using test##2##2##(2008-10#1)(2009-10#1)
using testing##2##2##(2007-8#1)(2011-2#1)
using tests##3##2##(2005-10#1)(2008-3#1)(2009-4#1)
using tetanus toxoid##3##3##(1990-4#1)(2007-8#2)
using tetra-3##2##2##(2008-10#2)
using tetrazolium##2##2##(2008-10#1)(2008-11#1)
using that##2##2##(2007-7#1)(2008-7#1)
using the &quot##16##3##(1992-2#1)(1993-3#1)(2005-10#1)(2006-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-8#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#2)
using the 1##2##3##(1997-8#1)(2008-5#1)
using the 18F-labeled##2##3##(1990-5#2)
using the 2 methods##2##4##(2004-9#2)
using the 2##5##3##(2004-9#2)(2008-10#2)(2008-5#1)
using the 3-(4##2##3##(2008-4#1)(2010-8#1)
using the 3D##2##3##(2008-5#1)(2013-1#1)
using the API##2##3##(2007-8#2)
using the Affymetrix##3##3##(2009-10#1)(2010-11#1)(2010-2#1)
using the AmpFISTR Identifiler PCR Amplification Kit##2##7##(2008-12#1)(2010-9#1)
using the AmpFISTR Identifiler##3##4##(2008-12#1)(2010-9#2)
using the BDD electrode##2##4##(2008-10#2)
using the BIS##2##3##(2009-4#1)(2009-9#1)
using the Barthel Index##2##4##(2007-9#1)(2012-2#1)
using the Beads technique##2##4##(1996-12#2)
using the Bentall and##2##4##(2012-2#2)
using the Body##2##3##(2007-12#1)(2008-9#1)
using the Brief##4##3##(1997-8#1)(2008-7#1)(2010-2#1)(2010-3#1)
using the Burch-Schneider##2##3##(2007-7#2)
using the CARICOMP protocol##2##4##(2008-5#1)(2011-2#1)
using the CD Hopf##2##4##(2007-7#2)
using the CE##2##3##(2008-10#2)
using the CO 2 laser##4##5##(1992-1#3)(1992-3#1)
using the CO2 laser##2##4##(1994-12#2)
using the CO2-laser##2##3##(1992-3#1)(1993-8#1)
using the Cavitron##2##3##(1995-12#2)
using the Cochrane##2##3##(2008-6#1)(2012-12#1)
using the Cox proportional##2##4##(1997-3#1)(2007-10#1)
using the Cox##4##3##(1994-7#1)(1997-3#1)(2006-7#1)(2007-10#1)
using the DNA microarray##3##4##(2008-7#1)(2012-3#2)
using the DNA##5##3##(1997-6#1)(2008-7#1)(2010-5#1)(2012-3#2)
using the DualMesh 2-mm Gore-Tex##2##5##(2007-8#2)
using the ELISA technique##2##4##(2008-6#1)(2013-1#1)
using the ELISA##4##3##(1992-1#1)(2007-8#1)(2008-6#1)(2013-1#1)
using the EM algorithm##2##4##(1995-4#1)(2008-8#1)
using the Epworth Sleepiness Scale##2##5##(2007-2#1)(2008-8#1)
using the FOITS technique##2##4##(2008-5#2)
using the Food##2##3##(1991-2#1)(2008-1#1)
using the Frejka pillow##2##4##(2007-8#2)
using the Functional Assessment of Cancer##2##6##(2008-7#2)
using the GROC and##2##4##(2008-12#2)
using the Genetic Analysis Workshop 17 mini-exome##2##7##(2012-3#2)
using the Genetic Analysis Workshop 17##5##6##(2012-3#5)
using the HITRAN##2##3##(2008-2#1)(2008-3#1)
using the Herbert##2##3##(2006-3#2)
using the Hoechst 33342##2##4##(1991-6#1)(2008-9#1)
using the Hospital##2##3##(2007-11#1)(2009-3#1)
using the Hybrid III and THOR##2##6##(2006-11#2)
using the ICF##2##3##(2011-2#1)(2012-12#1)
using the Ilizarov method##2##4##(2007-11#1)(2008-8#1)
using the Ilizarov technique##2##4##(2007-8#1)(2009-3#1)
using the Ilizarov##5##3##(2007-11#1)(2007-8#1)(2008-8#1)(2009-3#1)(2009-4#1)
using the International##3##3##(2007-11#1)(2007-7#1)(2008-10#1)
using the Internet and other##2##5##(2006-5#1)(2007-4#1)
using the Internet to##2##4##(1997-1#1)(2008-10#1)
using the Internet##5##3##(1997-1#1)(2006-5#1)(2007-4#1)(2008-10#1)(2009-5#1)
using the Invitrogen##2##3##(2008-11#2)
using the Kaplan-Meier##2##3##(2005-5#1)(2007-6#1)
using the Keystone action plan criteria##2##6##(2011-1#2)
using the MTT assay##3##4##(1992-2#1)(2012-3#1)(2013-1#1)
using the MTT##4##3##(1992-2#1)(2012-11#1)(2012-3#1)(2013-1#1)
using the Mann-Whitney##3##3##(1997-3#1)(2009-3#1)(2013-8#1)
using the MeSH##2##3##(2008-1#1)(2013-1#1)
using the Mitsunobu reaction##2##4##(2008-4#1)(2008-6#1)
using the Monte Carlo method##2##5##(1994-3#1)(2008-10#1)
using the Morris water maze##2##5##(1994-6#1)(1997-2#1)
using the National##3##3##(2006-8#1)(2007-10#1)(2011-2#1)
using the PCR##3##3##(1997-6#1)(2008-11#1)(2008-4#1)
using the PCR-amplified##2##3##(1993-11#1)(1994-11#1)
using the Parafac2 model##2##4##(2013-1#2)
using the Peabody Developmental Motor Scales##2##6##(2006-10#2)
using the Premium CEEA##2##4##(1990-6#2)
using the PubMed##2##3##(2011-1#1)(2013-1#1)
using the Quality of##3##4##(2004-3#1)(2006-10#1)(2013-1#1)
using the RiceWrist##2##3##(2012-1#2)
using the Rose Bengal##2##4##(2013-8#2)
using the SF-36##2##3##(2009-10#1)(2013-8#1)
using the SPSS 11##2##4##(2011-1#1)(2012-3#1)
using the SPSS##5##3##(2010-6#1)(2011-1#1)(2012-3#1)(2013-8#2)
using the Saccharomyces cerevisiae##2##4##(1991-9#1)(2008-10#1)
using the Short##3##3##(1996-3#1)(2013-7#1)(2013-8#1)
using the Statistical Package for the Social Sciences (SPSS)##2##9##(2009-7#1)(2013-8#1)
using the Statistical Package for the Social Sciences##3##8##(2009-7#1)(2012-12#1)(2013-8#1)
using the Student's t test##2##5##(2007-8#1)(2013-8#1)
using the Student's t-test##4##4##(2004-1#1)(2008-10#1)(2012-12#1)(2013-8#1)
using the Student's##6##3##(2004-1#1)(2007-8#1)(2008-10#1)(2012-12#1)(2013-8#2)
using the Symptom Checklist##2##4##(2008-10#1)(2012-5#1)
using the T-cell##2##3##(2008-10#2)
using the T7##2##3##(1991-1#1)(1991-4#1)
using the TaqMan##2##3##(2008-10#1)(2012-2#1)
using the University of##2##4##(1996-3#1)(2008-11#1)
using the V-osteotomy##2##3##(2008-4#2)
using the Web Ontology Language (OWL)##4##6##(2013-1#4)
using the Web##6##3##(2008-4#1)(2008-9#1)(2013-1#4)
using the Western##2##3##(1990-7#1)(2007-12#1)
using the Wilcoxon signed rank test##2##6##(1997-8#1)(2010-6#1)
using the Wilcoxon##3##3##(1997-8#1)(2008-7#1)(2010-6#1)
using the World Health Organization##2##5##(2010-3#1)(2010-8#1)
using the Zeeman modulation technique##2##5##(2008-3#2)
using the above##7##3##(1992-8#2)(1997-2#1)(2004-4#1)(2007-5#1)(2008-11#1)(2008-2#1)
using the absolute##3##3##(2008-3#2)(2012-2#1)
using the agar diffusion##2##4##(2007-11#1)(2008-5#1)
using the agar dilution##2##4##(1994-11#1)(2012-12#1)
using the agar##4##3##(1994-11#1)(2007-11#1)(2008-5#1)(2012-12#1)
using the alkaline##4##3##(1992-3#1)(1997-1#1)(1997-4#1)(2005-11#1)
using the alternative##2##3##(2005-11#2)
using the analysis of variance##2##5##(1990-8#1)(2013-1#1)
using the anterior approach##2##4##(2007-11#2)
using the anterior##3##3##(2007-11#3)
using the antibodies against##2##4##(1990-8#1)(2008-8#1)
using the antibody##2##3##(2005-10#1)(2013-8#1)
using the antiserum##3##3##(1990-6#1)(1994-9#2)
using the approach##2##3##(2010-11#1)(2012-3#1)
using the appropriate##6##3##(1996-7#1)(2006-5#1)(2008-10#2)(2008-11#2)
using the area under the disease progress curve##2##8##(2008-10#2)
using the area under the##4##5##(2006-6#1)(2008-10#3)
using the asymptotic##2##3##(2008-2#1)(2009-10#1)
using the atomic absorption##2##4##(2008-10#1)(2011-12#1)
using the atomic force microscope##2##5##(2005-11#2)
using the atomic##4##3##(2005-11#2)(2008-10#1)(2011-12#1)
using the automated##3##3##(2006-12#1)(2008-10#1)(2012-2#1)
using the available##3##3##(1994-5#1)(2008-10#1)(2010-3#1)
using the avidin-biotin##2##3##(1990-12#1)(1995-7#1)
using the bacteriophage##3##3##(1994-3#1)(1996-2#1)(2008-2#1)
using the baculovirus expression system##2##5##(1992-8#1)(1993-8#1)
using the baculovirus expression##4##4##(1992-8#1)(1993-12#1)(1993-8#1)(1994-9#1)
using the baculovirus system##3##4##(1994-5#1)(2008-11#1)(2008-2#1)
using the baculovirus##8##3##(1990-4#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-5#1)(1994-9#1)(2008-11#1)(2008-2#1)
using the batch injection analysis (BIA) technique##2##7##(2008-10#2)
using the beam propagation method##2##5##(2008-3#2)
using the best##5##3##(2008-11#1)(2008-4#1)(2010-8#1)(2012-3#1)(2013-1#1)
using the biosensor developed##2##4##(2008-10#2)
using the bispectral index##2##4##(2006-10#1)(2006-4#1)
using the boundary##2##3##(2008-3#1)(2009-11#1)
using the cDNA##2##3##(1994-11#1)(1997-2#1)
using the carbon dioxide laser##2##5##(1991-12#2)
using the catalytic hydrogen wave##2##5##(2008-10#2)
using the catheter method##3##4##(2013-8#3)
using the cell##4##3##(2007-10#1)(2008-10#1)(2008-4#1)(2008-9#1)
using the chemical shift##2##4##(1991-1#1)(1992-4#1)
using the chemical##4##3##(1991-1#1)(1992-4#1)(2005-11#1)(2008-10#1)
using the chloramphenicol acetyltransferase (CAT) gene as##3##7##(1992-6#1)(1994-9#1)(1997-8#1)
using the chloramphenicol##4##3##(1992-12#1)(1992-6#1)(1994-9#1)(1997-8#1)
using the classic##2##3##(1994-3#1)(2006-8#1)
using the classical##4##3##(1996-12#1)(2008-10#1)(2008-4#1)(2008-8#1)
using the clinical##2##3##(2008-3#1)(2009-2#1)
using the cloned##3##3##(1990-3#1)(1994-11#2)
using the combination##3##3##(1992-4#1)(1995-9#1)(2007-11#1)
using the combined##2##3##(2011-2#1)(2013-1#1)
using the complete##2##3##(1991-4#1)(2007-12#1)
using the complexing agent##2##4##(2007-8#1)(2008-10#1)
using the computer program GenMark##2##5##(1995-12#2)
using the computer program##6##4##(1995-12#2)(1997-2#1)(2005-11#1)(2005-8#1)(2008-11#1)
using the computer##11##3##(1995-12#2)(1997-2#1)(2004-10#1)(2005-11#1)(2005-8#1)(2006-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2012-12#1)
using the concept of##2##4##(2007-4#1)(2008-5#1)
using the concept##3##3##(2007-4#1)(2008-5#1)(2008-9#1)
using the constant##2##3##(2008-10#1)(2008-11#1)
using the conventional method##2##4##(2008-10#2)
using the conventional##10##3##(1992-3#1)(1994-2#1)(1997-3#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-7#1)
using the coordinates##2##3##(1992-4#1)(1995-5#1)
using the correlation coefficient##2##4##(2008-10#1)(2011-3#1)
using the corresponding##4##3##(1993-2#1)(1997-4#1)(2007-2#1)(2008-10#1)
using the crude##2##3##(1995-7#1)(2005-11#1)
using the crystal structure of##2##5##(2008-8#1)(2013-1#1)
using the cuff method##4##4##(2013-8#4)
using the current##3##3##(1993-12#1)(1995-1#1)(2011-2#1)
using the daVinci telemanipulation system##2##5##(2007-8#2)
using the data##6##3##(1995-4#1)(2004-3#1)(2007-6#1)(2008-11#1)(2008-12#1)(2010-12#1)
using the density functional##2##4##(2010-5#1)(2013-1#1)
using the density##3##3##(1995-6#1)(2010-5#1)(2013-1#1)
using the described##2##3##(2008-3#1)(2010-8#1)
using the desirability function##2##4##(2008-10#2)
using the developed##8##3##(2005-11#1)(2007-8#1)(2008-10#6)
using the device for##2##4##(2006-6#1)(2007-7#1)
using the device##3##3##(2006-6#1)(2007-7#1)(2012-1#1)
using the different##5##3##(1992-12#1)(1995-3#1)(2007-8#1)(2008-10#1)(2008-9#1)
using the differential pulse##2##4##(2008-10#2)
using the dip stick and sedimentation methods##2##7##(2007-2#2)
using the direct##4##3##(2007-7#1)(2008-10#2)(2010-6#1)
using the discrete##2##3##(2008-2#1)(2008-6#1)
using the drug##2##3##(1991-4#1)(2007-11#1)
using the dual grid##2##4##(2013-1#2)
using the dye##2##3##(1994-6#1)(2012-2#1)
using the dynamic##5##3##(2007-10#1)(2008-10#2)(2008-5#1)(2011-2#1)
using the electrochemical quartz crystal microbalance##3##6##(2005-11#1)(2008-10#2)
using the electrode##3##3##(2008-10#2)(2008-9#1)
using the electron##2##3##(2008-6#1)(2009-7#1)
using the electrophoretic##2##3##(1993-12#1)(1995-8#1)
using the electrostatic##2##3##(2008-10#1)(2008-5#1)
using the elevated plus-maze##2##4##(1991-2#1)(1993-9#1)
using the embryo-larval stages##2##4##(1996-2#2)
using the entire##2##3##(1990-4#1)(2008-2#1)
using the enzyme##2##3##(1996-6#1)(2007-8#1)
using the epithet##2##3##(2008-10#1)(2013-7#1)
using the equation##3##3##(2008-10#1)(2009-8#1)(2011-2#1)
using the established##3##3##(2008-10#2)(2008-2#1)
using the example of##2##4##(2007-8#1)(2008-11#1)
using the existing##2##3##(2011-2#1)(2013-8#1)
using the experimental conditions##2##4##(2008-11#1)(2010-2#1)
using the experimental##8##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-2#1)
using the extended##2##3##(2008-3#1)(2009-3#1)
using the external##2##3##(2006-3#1)(2008-10#1)
using the extraction##3##3##(1993-1#1)(2008-10#2)
using the fast##2##3##(1992-11#1)(2012-3#1)
using the finite##2##3##(2006-10#1)(2013-8#1)
using the finite-difference time-domain##2##4##(2008-3#2)
using the finite-difference##3##3##(1996-8#1)(2008-3#2)
using the first derivative##2##4##(2008-10#2)
using the first##9##3##(1995-8#1)(2006-6#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-9#1)(2010-12#1)(2013-7#1)
using the fission yeast##2##4##(1993-9#1)(2009-3#1)
using the fluorescence##4##3##(2005-11#1)(2008-10#1)(2008-5#1)(2008-8#1)
using the fluorescent dye##2##4##(1990-2#1)(1990-9#1)
using the fluorescent probe##4##4##(1990-11#1)(1992-3#1)(1994-9#1)(1995-3#1)
using the fluorescent##11##3##(1990-11#1)(1990-2#1)(1990-9#1)(1992-3#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-3#1)(1996-6#1)(1997-6#1)(1997-7#1)
using the following##18##3##(1991-11#1)(1993-12#1)(1995-6#1)(2006-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-6#2)(2012-12#1)(2012-2#2)(2013-8#1)
using the formula##2##3##(2010-4#1)(2011-2#1)
using the full##2##3##(2007-8#1)(2010-8#1)
using the gene##2##3##(1992-3#1)(2008-11#1)
using the general##3##3##(2008-12#1)(2008-9#1)(2012-12#1)
using the generalized##3##3##(2007-1#1)(2011-2#1)(2012-12#1)
using the headspace##3##3##(2008-10#2)(2009-3#1)
using the heterologous##2##3##(1995-2#1)(1997-4#1)
using the high##2##3##(1991-6#1)(2006-5#1)
using the highly selective##4##4##(1990-10#1)(1995-7#1)(2007-1#1)(2007-11#1)
using the highly##5##3##(1990-10#1)(1995-1#1)(1995-7#1)(2007-1#1)(2007-11#1)
using the homology##2##3##(2007-12#1)(2012-2#1)
using the human##9##3##(1990-9#1)(1991-9#1)(1995-12#1)(1997-2#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-4#1)
using the image##5##3##(2005-11#1)(2006-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
using the imaging##2##3##(2006-12#1)(2010-4#1)
using the in##3##3##(1994-2#1)(1996-2#1)(2008-10#1)
using the in-situ##2##3##(2013-8#2)
using the independent##2##3##(2008-12#1)(2008-3#1)
using the information##3##3##(2010-8#1)(2011-2#1)(2011-3#1)
using the initial##2##3##(2008-10#2)
using the internal standard method##2##5##(2007-8#1)(2008-10#1)
using the internal##3##3##(2007-7#1)(2007-8#1)(2008-10#1)
using the isolated##3##3##(1993-3#1)(1996-12#1)(2008-5#1)
using the isotope-coded affinity tag##2##5##(2008-4#2)
using the iterative##2##3##(2005-11#1)(2008-3#1)
using the key words##3##4##(2006-12#1)(2008-1#1)(2011-1#1)
using the keywords &quot##2##4##(2008-7#1)(2011-2#1)
using the labeled##2##3##(1996-2#1)(2007-11#1)
using the laboratory##3##3##(1993-9#1)(2008-2#1)(2008-5#1)
using the lactate dehydrogenase##2##4##(2008-11#1)(2008-6#1)
using the laser##2##3##(1992-8#1)(2007-12#1)
using the latter##2##3##(2008-10#1)(2011-2#1)
using the least##3##3##(1995-12#1)(2008-3#1)(2008-5#1)
using the least-squares##2##3##(2008-3#1)(2012-3#1)
using the level of##2##4##(1997-8#1)(2008-4#1)
using the linear##4##3##(1992-9#1)(2008-10#2)(2013-1#1)
using the luciferase##2##3##(1996-5#1)(2008-11#1)
using the materials##2##3##(2007-8#1)(2008-1#1)
using the matrix##2##3##(2008-10#1)(2008-2#1)
using the measured##2##3##(1994-12#1)(2008-2#1)
using the median##2##3##(1994-8#1)(2006-10#1)
using the medical##2##3##(2008-11#1)(2013-8#1)
using the membrane##3##3##(1990-3#1)(2006-10#1)(2008-10#1)
using the metal##2##3##(2007-5#1)(2008-10#1)
using the method of constant stimuli##2##6##(1990-11#2)
using the method of high pressure liquid chromatography##2##8##(2008-6#2)
using the method of standard additions##3##6##(2008-10#3)
using the method of##20##4##(1990-11#3)(1990-3#1)(1992-9#1)(1995-5#1)(1997-3#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-6#2)(2010-12#1)(2011-2#2)(2013-1#1)
using the method##29##3##(1990-11#3)(1990-3#1)(1992-6#1)(1992-9#1)(1995-5#1)(1997-3#1)(2007-11#3)(2007-8#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-6#2)(2008-8#1)(2009-2#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
using the methodology of##2##4##(2008-10#1)(2010-8#1)
using the methodology##3##3##(2008-10#1)(2008-5#1)(2010-8#1)
using the methods of##2##4##(1994-8#1)(2009-2#1)
using the microdialysis technique##2##4##(1995-12#1)(1996-9#1)
using the microsatellite##2##3##(2008-10#1)(2012-2#1)
using the minimal##2##3##(1994-3#1)(2010-2#1)
using the mitochondrial##2##3##(2007-5#1)(2008-10#1)
using the mixture of##2##4##(2008-10#1)(2008-5#1)
using the model##10##3##(1996-2#1)(2005-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)
using the modified##15##3##(1996-12#2)(1997-4#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
using the monoclonal antibody##3##4##(1993-4#1)(1996-5#1)(1997-8#1)
using the monoclonal##4##3##(1993-4#1)(1996-5#1)(1997-8#1)(2009-2#1)
using the more##2##3##(2005-8#1)(2010-4#1)
using the most##5##3##(1992-2#1)(1992-5#1)(2006-10#1)(2007-12#1)(2008-4#1)
using the mouse##2##3##(2008-8#1)(2008-9#1)
using the multiple##2##3##(2008-10#1)(2008-11#1)
using the multivariate##2##3##(2008-10#1)(2012-3#1)
using the national##3##3##(2010-12#1)(2012-2#1)(2013-1#1)
using the natural##3##3##(1993-3#1)(1993-6#1)(2010-7#1)
using the neighbor-joining##2##3##(2008-10#1)(2008-6#1)
using the new primers##3##4##(2008-10#2)(2012-12#1)
using the new##17##3##(1991-9#1)(1994-9#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-6#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)
using the newly developed##2##4##(1990-12#1)(2008-10#1)
using the newly##3##3##(1990-12#1)(2007-8#1)(2008-10#1)
using the noise response##2##4##(2010-12#2)
using the novel##3##3##(1997-5#1)(2008-10#1)(2008-3#1)
using the nursing process in##2##5##(2008-12#1)(2010-3#1)
using the nursing##4##3##(2008-12#1)(2010-3#1)(2013-1#2)
using the open field##2##4##(1995-11#1)(2009-5#1)
using the open##4##3##(1990-5#1)(1995-11#1)(2009-5#1)(2010-3#1)
using the optical##4##3##(1997-4#1)(2008-10#1)(2008-2#1)(2008-3#1)
using the optimized##6##3##(2007-8#1)(2008-10#5)
using the original##2##3##(2006-6#1)(2013-1#1)
using the other##3##3##(1993-2#1)(2007-8#1)(2008-10#1)
using the oxygen radical absorbance capacity (ORAC) assay##2##8##(2008-10#1)(2008-7#1)
using the partial##2##3##(2007-11#1)(2008-10#1)
using the patch-clamp technique##4##4##(1990-3#1)(1994-9#1)(1995-5#1)(1996-2#1)
using the patch-clamp##6##3##(1990-3#1)(1994-9#1)(1995-5#1)(1996-12#1)(1996-2#1)(2008-11#1)
using the peak##3##3##(2008-10#2)(2008-7#1)
using the place conditioning paradigm##2##5##(1992-9#1)(1996-10#1)
using the plasma##2##3##(2008-12#1)(2008-3#1)
using the platform##2##3##(2008-10#1)(2008-5#1)
using the polyclonal##3##3##(1997-7#1)(2006-8#1)(2008-4#1)
using the polymerase chain reaction (PCR)##7##6##(1990-11#1)(1990-2#1)(1991-11#1)(1991-2#1)(1992-5#1)(1997-7#1)(2008-4#1)
using the polymerase chain reaction and degenerate primers##2##8##(1991-5#2)
using the polymerase chain reaction and##4##6##(1991-12#1)(1991-5#2)(1994-11#1)
using the polymerase chain reaction is##2##6##(1996-2#1)(2006-10#1)
using the polymerase chain reaction to##4##6##(1991-9#1)(1993-11#1)(2008-11#1)(2011-2#1)
using the polymerase chain reaction##37##5##(1990-11#2)(1990-2#3)(1990-3#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#2)(1991-9#3)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#2)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(1996-11#1)(1996-2#1)(1997-7#1)(2006-10#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
using the polymerase chain##38##4##(1990-11#2)(1990-2#3)(1990-3#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#2)(1991-9#3)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#2)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(1996-11#1)(1996-2#1)(1996-8#1)(1997-7#1)(2006-10#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
using the position##2##3##(1994-3#1)(2007-2#1)
using the potentiometric##2##3##(2005-11#1)(2008-10#1)
using the power##2##3##(2008-10#1)(2012-2#1)
using the prepared##2##3##(2005-12#1)(2008-10#1)
using the present##4##3##(2008-10#3)(2012-2#1)
using the previously##3##3##(1995-12#1)(1996-7#1)(2008-3#1)
using the primers##2##3##(1997-7#1)(2006-5#1)
using the principle##2##3##(2008-10#1)(2008-7#1)
using the principles of##3##4##(1994-1#1)(1995-6#1)(2006-3#1)
using the procedure##2##3##(2008-10#1)(2008-4#1)
using the program##6##3##(1990-11#1)(1993-11#1)(1995-5#1)(1996-2#1)(2008-4#1)(2010-12#1)
using the proposed biosensor##2##4##(2008-10#2)
using the proposed method##6##4##(2007-11#1)(2007-8#1)(2008-10#3)(2008-5#1)
using the proposed methodology##2##4##(2008-10#2)
using the proposed procedure##3##4##(2008-10#3)
using the proposed##28##3##(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#20)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)
using the protein##2##3##(1990-8#1)(2009-12#1)
using the pseudocontact shifts##2##4##(2007-10#2)
using the pulmonary##2##3##(2005-9#1)(2007-8#1)
using the pulse##2##3##(2007-7#1)(2008-10#1)
using the purified protein##2##4##(1995-2#1)(2005-11#1)
using the purified##5##3##(1995-2#1)(1996-5#1)(2005-11#1)(2007-12#1)(2008-10#1)
using the quality##2##3##(2011-1#1)(2011-2#1)
using the quantitative##2##3##(2007-8#1)(2010-8#1)
using the radial##3##3##(2008-4#1)(2010-12#1)(2011-2#1)
using the rat##5##3##(1990-5#1)(1990-7#1)(1992-10#1)(1995-2#1)(1996-12#1)
using the ratio##4##3##(1996-5#2)(2004-9#1)(2008-10#1)
using the reaction of##4##4##(2007-11#1)(2008-10#3)
using the reaction##6##3##(1991-5#1)(2007-11#1)(2008-10#4)
using the reactors##2##3##(2008-10#2)
using the real-time PCR##2##4##(2008-10#1)(2013-8#1)
using the recently##3##3##(1990-12#1)(1990-5#1)(2008-7#1)
using the redox##2##3##(2008-10#2)
using the reference##2##3##(2007-7#1)(2008-10#1)
using the relevant##3##3##(2004-9#1)(2008-2#1)(2011-2#1)
using the reported search of which 15 represented the best evidence on the topic##2##14##(2007-8#2)
using the reported search of which##5##6##(2007-8#5)
using the reported search##49##4##(2007-8#49)
using the restriction enzymes##2##4##(2008-10#1)(2009-10#1)
using the restriction##3##3##(2008-10#1)(2009-10#1)(2011-1#1)
using the results of##2##4##(2007-12#1)(2008-7#1)
using the results##4##3##(1992-12#1)(2007-12#1)(2008-6#1)(2008-7#1)
using the retroviral##2##3##(2006-12#1)(2008-9#1)
using the reverse transcription polymerase chain reaction (RT-PCR)##2##8##(2007-10#1)(2008-7#1)
using the reverse##4##3##(2007-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
using the right##2##3##(2007-7#1)(2007-8#1)
using the robot##3##3##(2007-5#1)(2012-1#2)
using the same approach##2##4##(2008-10#1)(2008-4#1)
using the same basic##3##4##(2008-2#2)(2008-5#1)
using the same experimental##2##4##(2008-10#1)(2008-7#1)
using the same instrument##3##4##(2008-10#1)(2008-6#1)(2011-2#1)
using the same procedures##2##4##(2006-4#1)(2007-1#1)
using the same protocol##2##4##(1993-9#1)(2008-7#1)
using the same set of##2##5##(2008-11#1)(2009-10#1)
using the same spectrometer##2##4##(2008-3#2)
using the same##59##3##(1990-12#1)(1990-6#1)(1992-12#1)(1993-2#1)(1993-9#2)(1994-12#1)(1994-9#1)(1995-2#2)(1996-3#1)(1997-6#1)(2004-9#1)(2006-10#2)(2006-4#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#3)(2009-10#1)(2009-11#1)(2009-4#1)(2010-12#1)(2011-11#1)(2011-2#1)(2013-7#1)
using the samples##3##3##(1991-1#1)(2008-10#2)
using the scanning##2##3##(1990-4#1)(2008-5#1)
using the search##3##3##(2007-8#1)(2008-6#1)(2011-2#1)
using the second##3##3##(2008-4#1)(2010-12#1)(2013-7#1)
using the selective##2##3##(1993-3#1)(1997-7#1)
using the sensor##2##3##(2007-8#1)(2008-10#1)
using the sequence of##3##4##(1992-11#1)(2008-10#2)
using the simulated##3##3##(2008-10#1)(2012-3#2)
using the single##2##3##(1997-4#1)(2008-6#1)
using the single-cell gel electrophoresis##2##5##(1996-2#1)(2009-4#1)
using the slope of the##2##5##(1993-12#1)(2005-11#1)
using the slope##3##3##(1993-12#1)(2005-11#2)
using the slurry##2##3##(2008-10#2)
using the soft##2##3##(2011-1#1)(2013-8#1)
using the software##4##3##(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
using the solvent##2##3##(2008-10#1)(2013-7#1)
using the spectral##2##3##(1993-3#1)(2013-7#1)
using the spectrophotometric##2##3##(2008-10#1)(2011-2#1)
using the spin##2##3##(1994-9#1)(2008-4#1)
using the square wave##2##4##(2008-10#1)(2011-2#1)
using the stabilization method##2##4##(1993-3#1)(2005-11#1)
using the standard addition method##3##5##(2008-10#3)
using the standard addition technique##2##5##(2008-10#1)(2010-4#1)
using the standard addition##5##4##(2008-10#4)(2010-4#1)
using the standard##21##3##(1992-12#1)(1994-1#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#8)(2008-11#1)(2008-2#1)(2008-7#1)(2010-4#1)(2011-1#1)(2013-8#2)
using the standardized##3##3##(1997-1#1)(2006-2#1)(2009-8#1)
using the statistical Student's t-test##2##5##(2007-10#1)(2008-10#1)
using the statistical##5##3##(2007-10#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
using the stopped-flow##3##3##(2008-10#3)
using the strategy##3##3##(2010-7#3)
using the substrate##2##3##(1990-8#1)(1996-7#1)
using the supero-medial##2##3##(2011-2#2)
using the supplemental##2##3##(2008-7#1)(2013-7#1)
using the synchronous##2##3##(2008-10#1)(2008-3#1)
using the synthetic##2##3##(1995-1#1)(2008-10#1)
using the system##4##3##(1994-12#1)(2008-10#2)(2013-1#1)
using the tagging reagent 1##2##5##(2008-10#2)
using the technique of##11##4##(1991-1#1)(1995-8#1)(1996-8#1)(2006-10#1)(2008-10#3)(2008-11#1)(2011-2#2)(2012-12#1)
using the technique##14##3##(1991-1#1)(1995-8#1)(1996-8#1)(2006-10#1)(2006-5#1)(2008-10#3)(2008-11#1)(2008-4#1)(2011-2#2)(2012-12#1)(2013-7#1)
using the techniques of##2##4##(1991-4#1)(2008-4#1)
using the techniques##3##3##(1991-4#1)(2008-4#1)(2012-3#1)
using the temperature##2##3##(1990-2#1)(2007-6#1)
using the temporal##2##3##(2007-11#1)(2008-10#1)
using the terms##3##3##(2011-2#1)(2012-2#1)(2013-1#1)
using the theory of##3##4##(2006-10#1)(2008-2#1)(2008-3#1)
using the therapy##2##3##(2007-11#1)(2012-2#1)
using the three##5##3##(2008-10#3)(2008-3#1)(2013-1#1)
using the total##3##3##(2005-11#1)(2008-6#1)(2013-1#1)
using the traditional##6##3##(2004-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-9#1)
using the transcriptional inhibitor actinomycin D##2##6##(1992-1#1)(1995-3#1)
using the two different##2##4##(2008-2#1)(2012-12#1)
using the two methods##2##4##(2011-2#1)(2012-7#1)
using the two##15##3##(1990-11#1)(1994-2#1)(1996-11#1)(1997-4#2)(2005-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-7#1)
using the two-dimensional##2##3##(2008-5#1)(2008-8#1)
using the variable##5##3##(1997-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
using the variables##2##3##(1995-10#1)(2008-11#1)
using the vector##4##3##(1990-9#1)(2008-2#2)(2008-5#1)
using the vein##2##3##(2007-8#1)(2010-12#1)
using the visual##2##3##(2008-10#1)(2009-2#1)
using the weighted##2##3##(2007-4#1)(2012-1#1)
using the white-ivory##2##3##(1996-2#2)
using the whole cell##3##4##(1993-2#1)(1993-3#1)(1997-5#1)
using the whole##8##3##(1993-2#1)(1993-3#1)(1996-6#1)(1997-5#1)(2004-11#1)(2007-1#1)(2008-4#1)(2013-8#1)
using the whole-cell patch-clamp method##2##5##(1990-7#1)(1996-9#1)
using the whole-cell patch-clamp technique##2##5##(1995-10#1)(1996-10#1)
using the whole-cell patch-clamp##5##4##(1990-5#1)(1990-7#1)(1995-10#1)(1996-10#1)(1996-9#1)
using the whole-cell voltage-clamp##2##4##(1997-1#1)(2009-12#1)
using the whole-cell##9##3##(1990-5#1)(1990-7#1)(1993-3#1)(1995-10#1)(1995-12#1)(1996-10#1)(1996-9#1)(1997-1#1)(2009-12#1)
using the yeast##3##3##(1996-2#1)(2008-7#1)(2008-8#1)
using the zero-crossing approach for determination of##2##7##(2008-10#2)
using the##2968##2##(1990-1#1)(1990-10#4)(1990-11#13)(1990-12#6)(1990-2#7)(1990-3#6)(1990-4#5)(1990-5#10)(1990-6#4)(1990-7#8)(1990-8#6)(1990-9#6)(1991-1#8)(1991-10#4)(1991-11#5)(1991-12#8)(1991-2#5)(1991-3#7)(1991-4#5)(1991-5#4)(1991-6#7)(1991-7#2)(1991-8#4)(1991-9#9)(1992-1#6)(1992-10#4)(1992-11#6)(1992-12#14)(1992-2#6)(1992-3#10)(1992-4#3)(1992-5#3)(1992-6#4)(1992-7#2)(1992-8#12)(1992-9#7)(1993-1#3)(1993-10#1)(1993-11#9)(1993-12#13)(1993-2#10)(1993-3#12)(1993-4#2)(1993-6#4)(1993-8#7)(1993-9#8)(1994-1#2)(1994-10#2)(1994-11#13)(1994-12#8)(1994-2#6)(1994-3#11)(1994-5#7)(1994-6#6)(1994-7#2)(1994-8#6)(1994-9#18)(1995-1#7)(1995-10#4)(1995-11#3)(1995-12#18)(1995-2#14)(1995-3#10)(1995-4#5)(1995-5#8)(1995-6#7)(1995-7#5)(1995-8#6)(1995-9#2)(1996-1#4)(1996-10#7)(1996-11#3)(1996-12#16)(1996-2#23)(1996-3#6)(1996-4#6)(1996-5#12)(1996-6#5)(1996-7#9)(1996-8#8)(1996-9#6)(1997-1#9)(1997-2#14)(1997-3#8)(1997-4#21)(1997-5#7)(1997-6#8)(1997-7#10)(1997-8#12)(2003-11#1)(2004-1#2)(2004-10#1)(2004-11#6)(2004-12#1)(2004-2#1)(2004-3#6)(2004-4#2)(2004-9#9)(2005-10#5)(2005-11#53)(2005-12#7)(2005-4#2)(2005-5#2)(2005-6#1)(2005-7#4)(2005-8#2)(2005-9#3)(2006-1#1)(2006-10#26)(2006-11#8)(2006-12#19)(2006-2#3)(2006-3#10)(2006-4#10)(2006-5#19)(2006-6#12)(2006-7#5)(2006-8#12)(2006-9#4)(2007-1#9)(2007-10#21)(2007-11#52)(2007-12#29)(2007-2#15)(2007-3#6)(2007-4#6)(2007-5#10)(2007-6#6)(2007-7#37)(2007-8#130)(2007-9#10)(2008-1#22)(2008-10#485)(2008-11#76)(2008-12#28)(2008-2#74)(2008-3#75)(2008-4#67)(2008-5#76)(2008-6#31)(2008-7#55)(2008-8#40)(2008-9#43)(2009-1#1)(2009-10#11)(2009-11#8)(2009-12#5)(2009-2#12)(2009-3#13)(2009-4#12)(2009-5#7)(2009-6#3)(2009-7#4)(2009-8#10)(2009-9#6)(2010-1#3)(2010-10#2)(2010-11#3)(2010-12#20)(2010-2#11)(2010-3#9)(2010-4#16)(2010-5#5)(2010-6#9)(2010-7#10)(2010-8#23)(2010-9#8)(2011-1#26)(2011-11#2)(2011-12#5)(2011-2#85)(2011-3#2)(2011-7#1)(2012-1#31)(2012-11#3)(2012-12#44)(2012-2#58)(2012-3#42)(2012-5#1)(2012-7#1)(2013-1#85)(2013-7#22)(2013-8#55)
using their own##2##3##(2011-1#1)(2012-12#1)
using their soluble recombinant proteins##2##5##(1996-2#2)
using their##15##2##(1991-2#1)(1993-2#1)(1995-6#1)(1995-9#1)(1996-2#2)(2006-3#1)(2006-6#1)(2008-10#2)(2009-10#1)(2011-1#1)(2012-12#1)(2013-1#2)
using them for##3##3##(2007-9#1)(2009-12#1)(2010-1#1)
using them to##2##3##(1997-4#1)(2008-6#1)
using them##14##2##(1995-6#1)(1997-4#1)(2007-12#2)(2007-4#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-6#1)(2009-12#1)(2010-1#1)(2010-2#1)(2011-2#2)
using thematic##3##2##(2008-11#1)(2009-12#1)(2012-12#1)
using therapeutic##3##2##(1995-4#1)(2007-7#1)(2012-2#1)
using therapy ion chambers##2##4##(2007-11#2)
using thermal##5##2##(2005-11#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-2#1)
using thermodynamic##2##2##(1994-11#1)(2008-10#1)
using thermoluminescence##2##2##(1997-8#1)(2008-10#1)
using these agents##3##3##(2007-11#2)(2008-7#1)
using these antigens##2##3##(2008-10#1)(2011-2#1)
using these cells##2##3##(1992-11#1)(2008-6#1)
using these compounds##2##3##(1992-1#1)(1993-11#1)
using these data##3##3##(1996-12#1)(2008-10#1)(2008-3#1)
using these markers##2##3##(2008-9#1)(2013-8#1)
using these measures##2##3##(2007-12#2)
using these methods##8##3##(1993-9#1)(2008-10#3)(2008-3#1)(2008-9#1)(2013-1#2)
using these modalities##2##3##(2007-4#1)(2008-1#1)
using these models##3##3##(1995-2#1)(2007-8#1)(2007-9#1)
using these new techniques##2##4##(2009-3#1)(2012-2#1)
using these new##4##3##(1990-5#1)(2007-11#1)(2009-3#1)(2012-2#1)
using these primers##2##3##(2008-10#2)
using these products##2##3##(2006-12#1)(2013-7#1)
using these techniques##5##3##(2006-10#1)(2006-5#1)(2008-10#1)(2008-9#1)(2009-11#1)
using these three##3##3##(2008-10#1)(2009-8#1)(2013-8#1)
using these two##3##3##(2007-12#1)(2007-8#1)(2012-3#1)
using these vectors##2##3##(1995-7#1)(2008-2#1)
using these##108##2##(1990-11#1)(1990-5#1)(1991-10#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-2#1)(1995-2#1)(1995-6#1)(1995-7#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-4#1)(2004-9#1)(2006-10#2)(2006-12#2)(2006-5#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#3)(2007-4#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#18)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#4)(2009-11#1)(2009-3#1)(2009-8#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
using thin layer chromatography (TLC)##2##5##(2008-2#1)(2010-9#1)
using thin##6##2##(2008-2#2)(2008-3#1)(2008-7#1)(2010-9#1)(2013-7#1)
using thin-layer chromatography##2##3##(1991-8#1)(1992-1#1)
using thiol-ene chemistry##2##3##(2010-12#2)
using this &quot##2##3##(2008-10#1)(2008-9#1)
using this DNA##2##3##(1991-5#1)(2012-3#1)
using this algorithm##2##3##(2008-2#1)(2010-12#1)
using this analytical##2##3##(2008-10#2)
using this approach to##2##4##(1992-2#1)(1993-11#1)
using this approach##16##3##(1992-10#1)(1992-2#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-6#1)(2005-6#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)
using this assay##4##3##(1993-2#1)(2008-10#2)(2008-7#1)
using this drug##2##3##(1996-9#1)(2006-10#1)
using this electrode##3##3##(2008-10#3)
using this information and##2##4##(1995-8#1)(2008-7#1)
using this material as##2##4##(2008-10#1)(2008-3#1)
using this method and##2##4##(2008-10#2)
using this method at##2##4##(1990-3#1)(2008-3#1)
using this method for the determination of##2##7##(2008-10#2)
using this method##27##3##(1990-3#1)(1990-8#1)(1992-2#1)(1993-1#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#8)(2008-2#2)(2008-3#1)(2008-7#1)(2012-3#1)(2013-8#1)
using this methodology##3##3##(2006-5#1)(2008-10#2)
using this model system##2##4##(2008-11#1)(2008-4#1)
using this model##6##3##(1992-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-5#1)(2011-1#1)
using this new##4##3##(2008-10#1)(2008-12#1)(2008-2#1)(2009-2#1)
using this novel##3##3##(1997-4#1)(2006-8#1)(2008-8#1)
using this principle##2##3##(2007-9#1)(2008-3#1)
using this probe##2##3##(2007-7#1)(2008-10#1)
using this procedure are##2##4##(1994-9#1)(2008-11#1)
using this procedure##6##3##(1994-9#1)(2005-4#1)(2008-10#2)(2008-11#1)(2008-5#1)
using this simple##2##3##(2007-8#2)
using this strategy##4##3##(2006-12#1)(2008-11#2)(2008-9#1)
using this substrate##2##3##(2008-10#2)
using this system##9##3##(1996-6#1)(1997-4#1)(1997-8#1)(2006-1#1)(2006-7#1)(2008-10#2)(2008-2#1)(2011-1#1)
using this technique to##4##4##(2007-12#1)(2008-2#1)(2008-4#1)(2013-8#1)
using this technique##18##3##(1991-10#1)(1994-5#1)(1996-5#1)(2006-6#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2011-12#1)(2012-1#1)(2013-8#1)
using this technology##2##3##(2008-11#1)(2008-6#1)
using this test##2##3##(1993-11#1)(2008-8#1)
using this type of##2##4##(1995-6#1)(2011-1#1)
using this voltammetric##2##3##(2008-10#2)
using this##207##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-8#1)(1991-10#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-5#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-5#2)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2005-11#1)(2005-4#1)(2005-6#2)(2006-1#1)(2006-10#3)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#4)(2007-7#2)(2007-8#6)(2007-9#1)(2008-10#47)(2008-11#12)(2008-12#3)(2008-2#9)(2008-3#9)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#3)(2009-2#1)(2009-4#1)(2009-5#1)(2010-12#5)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#4)(2011-12#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#3)(2013-7#1)(2013-8#2)
using thoracotomy##2##2##(1993-10#1)(2008-12#1)
using those##3##2##(1997-8#1)(2007-11#1)(2007-12#1)
using three different methods##2##4##(1995-1#1)(2008-10#1)
using three different tasks##2##4##(1993-3#1)(2008-11#1)
using three different##17##3##(1990-7#1)(1992-5#1)(1993-11#1)(1993-3#1)(1995-1#1)(2007-8#2)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2009-8#1)(2010-3#1)
using three##56##2##(1990-3#1)(1990-7#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(2005-11#1)(2005-7#1)(2006-11#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#3)(2007-8#5)(2008-10#14)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-2#1)(2012-1#1)
using three-dimensional##6##2##(2007-12#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-11#1)(2012-2#1)
using time##2##2##(2008-10#1)(2012-2#1)
using time-frequency methods##2##3##(2010-8#2)
using time-frequency##3##2##(2010-8#2)(2012-1#1)
using time-lapse microscopy##2##3##(2008-11#1)(2012-12#1)
using time-lapse##3##2##(2008-11#1)(2012-12#2)
using time-of-flight (TOF)##2##3##(2008-10#2)
using time-of-flight##3##2##(1997-1#1)(2008-10#2)
using time-resolved fluorescence##2##3##(2006-10#1)(2008-10#1)
using time-resolved##8##2##(1991-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)
using tissue culture##2##3##(2007-6#1)(2008-10#1)
using tissue engineering##2##3##(2010-8#1)(2012-3#1)
using tissue microarray##2##3##(2008-10#1)(2008-11#1)
using tissue##12##2##(1994-2#1)(1994-9#1)(1996-11#1)(1996-12#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-2#1)(2010-8#1)(2012-3#1)
using titanium cages##2##3##(2006-8#2)
using titanium mesh##2##3##(2007-8#1)(2011-2#1)
using titanium trichloride##2##3##(2008-10#2)
using titanium##8##2##(2006-8#3)(2007-8#1)(2008-10#3)(2011-2#1)
using tools from##2##3##(2008-11#1)(2011-2#1)
using tools of computational biology##2##5##(2012-2#2)
using tools##4##2##(2008-11#1)(2011-2#1)(2012-2#2)
using topical application##2##3##(2008-5#1)(2011-2#1)
using topical##12##2##(1992-8#1)(2006-10#1)(2006-12#3)(2007-11#1)(2007-8#1)(2008-5#2)(2011-12#1)(2011-2#2)
using topically applied##2##3##(1992-1#1)(2009-8#1)
using total##9##2##(1992-6#1)(1995-10#1)(1995-11#1)(1996-12#1)(1996-9#1)(2008-10#2)(2008-4#1)(2008-7#1)
using trace##2##2##(2008-10#1)(2008-7#1)
using tracer##3##2##(1993-4#1)(1994-9#1)(2008-10#1)
using traditional methods##3##3##(1993-10#1)(2008-10#1)(2008-5#1)
using traditional##18##2##(1993-10#3)(1994-3#1)(1996-12#1)(2006-12#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-6#2)(2009-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
using train-of-four stimulation##2##3##(1996-9#2)
using transcranial Doppler##3##3##(2006-10#1)(2007-10#2)
using transcranial##6##2##(2006-10#1)(2007-10#3)(2008-11#1)(2012-2#1)
using transcriptomics##2##2##(2011-2#1)(2012-12#1)
using transesophageal echocardiography##2##3##(1997-1#1)(2006-10#1)
using transesophageal##4##2##(1997-1#1)(2006-10#1)(2008-10#1)(2010-2#1)
using transgenic mice##2##3##(1994-6#1)(1995-8#1)
using transgenic##6##2##(1994-6#1)(1995-8#1)(1996-12#1)(2009-8#1)(2012-2#1)(2013-8#1)
using transient transfection assays in##2##5##(1991-5#1)(2008-3#1)
using transient transfection assays##3##4##(1991-5#1)(1996-10#1)(2008-3#1)
using transient##4##2##(1991-4#1)(1991-5#1)(1996-10#1)(2008-3#1)
using transition##2##2##(2006-4#1)(2013-8#1)
using transmission electron microscopy (TEM)##3##5##(2006-12#1)(2007-9#1)(2008-10#1)
using transmission electron microscopy and##2##5##(2007-12#1)(2009-2#1)
using transmission electron microscopy##8##4##(2006-12#1)(2007-12#1)(2007-9#1)(2008-10#3)(2009-2#1)(2012-2#1)
using transmission electron##9##3##(2006-12#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-2#1)(2009-2#1)(2012-2#1)
using transmission##11##2##(2006-12#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-2#1)(2009-2#1)(2011-2#1)(2012-2#1)
using transparent##2##2##(2008-5#1)(2009-12#1)
using transvaginal##2##2##(2010-12#1)(2011-2#1)
using tri-n-octylamine##2##2##(2008-10#2)
using tripod##2##2##(2008-10#1)(2008-5#1)
using tristimulus colorimetry and a quantitative##2##6##(2008-10#2)
using trypan blue exclusion##2##4##(2008-9#1)(2013-1#1)
using trypan blue##4##3##(2007-11#1)(2008-9#1)(2010-5#1)(2013-1#1)
using trypsin##2##2##(1995-3#1)(2008-10#1)
using tubular##2##2##(2008-10#1)(2013-1#1)
using tumor##2##2##(1990-5#1)(1996-3#1)
using twice daily##2##3##(2008-6#2)
using two certified reference materials##2##5##(2008-10#2)
using two different approaches##3##4##(1995-12#1)(2005-11#1)(2008-10#1)
using two different methods##2##4##(2008-10#1)(2008-4#1)
using two different##30##3##(1990-11#1)(1991-1#1)(1995-12#1)(1997-3#1)(2004-9#1)(2005-11#3)(2006-2#1)(2007-8#3)(2008-10#9)(2008-11#1)(2008-4#1)(2008-9#1)(2010-3#1)(2011-2#2)(2012-12#1)(2013-1#2)
using two independent##3##3##(1994-6#1)(2007-12#1)(2013-1#1)
using two level##2##3##(2008-10#2)
using two methods of##2##4##(2008-7#1)(2011-12#1)
using two methods##5##3##(2007-1#1)(2008-2#1)(2008-7#1)(2011-12#1)(2013-8#1)
using two monoclonal antibodies##2##4##(1991-4#1)(1995-3#1)
using two of##2##3##(2007-11#1)(2008-2#1)
using two samples##2##3##(2008-10#1)(2011-12#1)
using two sensors##2##3##(2007-11#1)(2010-4#1)
using two separate##2##3##(1990-10#1)(2009-5#1)
using two sets of##2##4##(2007-8#1)(2008-10#1)
using two techniques##2##3##(2008-10#1)(2008-2#1)
using two types of##4##4##(1994-12#1)(2008-5#1)(2008-7#1)(2009-2#1)
using two types##5##3##(1994-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)
using two##168##2##(1990-10#1)(1990-11#2)(1990-7#2)(1990-8#1)(1991-1#1)(1991-4#2)(1991-6#2)(1991-8#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#2)(1995-2#2)(1995-3#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#2)(2004-9#1)(2005-10#1)(2005-11#4)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#5)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#35)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#4)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#2)(2009-2#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#4)
using two- and three-dimensional##2##4##(1994-8#1)(2005-10#1)
using two- and##3##3##(1994-8#1)(2005-10#1)(2008-2#1)
using two-dimensional##11##2##(1990-4#1)(1990-6#1)(1991-4#1)(1992-11#1)(1992-9#1)(2005-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2013-8#1)
using two-photon##4##2##(2007-12#2)(2008-2#2)
using two-way##2##2##(2008-4#1)(2012-2#1)
using typical##2##2##(2008-10#1)(2010-10#1)
using tyrosinase##2##2##(2008-10#2)
using tyrosine hydroxylase (TH)##2##4##(1991-9#1)(1996-5#1)
using tyrosine hydroxylase##3##3##(1991-9#2)(1996-5#1)
using ultra##4##2##(2008-10#2)(2011-1#1)(2012-12#1)
using ultra-high##2##2##(2009-4#1)(2011-7#1)
using ultra-performance liquid chromatography coupled with##2##6##(2012-3#2)
using ultrafiltration##4##2##(2008-10#3)(2012-3#1)
using ultrasonic##6##2##(2007-4#1)(2008-10#3)(2009-7#1)(2013-8#1)
using ultrasonography##4##2##(1990-5#1)(1993-2#1)(2007-11#2)
using ultrasound guidance##2##3##(2007-7#2)
using ultrasound##11##2##(1992-5#1)(2005-11#1)(2007-7#4)(2008-10#2)(2010-1#1)(2012-12#1)(2012-3#1)
using ultraviolet (UV)##3##3##(2005-11#1)(2008-10#1)(2008-5#1)
using ultraviolet and visible##2##4##(2006-12#1)(2008-10#1)
using ultraviolet##7##2##(2005-11#1)(2006-12#1)(2008-10#4)(2008-5#1)
using ultraviolet-visible spectroscopy##2##3##(2008-10#2)
using uncoated##2##2##(2008-10#2)
using uniform##2##2##(1995-5#1)(2006-11#1)
using unipolar##2##2##(2007-8#2)
using univariate and multivariate##4##4##(1992-6#1)(2007-8#1)(2008-10#1)(2013-1#1)
using univariate##7##2##(1992-6#1)(2007-8#1)(2008-10#3)(2012-3#1)(2013-1#1)
using universal protein G-liposomal nanovesicles##2##5##(2008-10#2)
using unmodified##3##2##(1994-3#1)(2008-7#1)(2010-5#1)
using untreated##2##2##(1992-11#1)(2009-6#1)
using up to##5##3##(1990-11#1)(1993-11#1)(1995-3#1)(1996-10#1)(2006-4#1)
using urinary##2##2##(1992-8#1)(1993-9#1)
using urine##2##2##(1990-10#1)(1996-7#1)
using vacuum##2##2##(2008-10#1)(2013-8#1)
using validated##4##2##(2007-8#2)(2012-2#1)(2013-7#1)
using variable##6##2##(1992-7#1)(1993-12#1)(2005-11#2)(2008-2#1)(2008-3#1)
using variations of##2##3##(1992-9#1)(2011-1#1)
using various methods##4##3##(2008-1#1)(2009-2#1)(2010-9#1)(2012-11#1)
using various##57##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-7#1)(1991-3#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-5#1)(1997-3#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#2)(2009-2#1)(2009-5#1)(2010-2#2)(2010-4#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#2)
using varying##3##2##(2006-10#1)(2010-12#1)(2010-4#1)
using vascular##4##2##(2008-6#1)(2008-8#1)(2009-4#1)(2010-9#1)
using vector##2##2##(2008-2#1)(2008-9#1)
using vectors##3##2##(1990-6#1)(1990-9#1)(2008-1#1)
using vegetative compatibility##3##3##(2008-10#3)
using vertebral vectors##2##3##(2012-2#2)
using very##4##2##(1990-6#1)(1990-8#1)(2008-4#1)(2008-9#1)
using vibrational##2##2##(2007-8#1)(2008-3#1)
using video##3##2##(1994-4#1)(2008-8#1)(2012-12#1)
using viral##3##2##(2008-11#1)(2008-2#1)(2012-11#1)
using virtual##4##2##(2007-11#1)(2008-11#1)(2011-1#1)(2013-7#1)
using viruses##2##2##(2008-10#1)(2008-11#1)
using visible##2##2##(2005-11#1)(2010-2#1)
using visual and##2##3##(2008-10#1)(2012-1#1)
using visual##7##2##(2006-12#1)(2008-10#2)(2011-2#2)(2012-1#1)(2013-8#1)
using voice##2##2##(2006-6#1)(2010-12#1)
using voltammetric##2##2##(2008-10#2)
using volumetric##2##2##(2007-2#1)(2008-11#1)
using water and##2##3##(2008-10#2)
using water as solvent##2##4##(2008-10#1)(2011-1#1)
using water as##3##3##(2007-11#1)(2008-10#1)(2011-1#1)
using water or##2##3##(2009-3#1)(2009-7#1)
using water##16##2##(2005-11#1)(2007-11#1)(2008-10#7)(2009-3#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#2)
using water-soluble##2##2##(1997-2#1)(2008-10#1)
using wavelength##4##2##(2007-12#1)(2008-10#2)(2008-3#1)
using wavelet##6##2##(2007-1#1)(2008-10#4)(2011-1#1)
using wavelets##2##2##(2008-2#2)
using weather##3##2##(2008-10#3)
using web-based##2##2##(2006-10#1)(2011-2#1)
using weight##2##2##(1993-2#1)(2010-8#1)
using wet##3##2##(2008-10#1)(2011-2#2)
using what##3##2##(2004-1#1)(2008-3#1)(2013-1#1)
using wheat##2##2##(2008-10#1)(2008-5#1)
using which anomalies are detected in a supervised manner##2##9##(2013-1#2)
using which##3##2##(2012-2#1)(2013-1#2)
using white##3##2##(1991-11#1)(2009-4#1)(2012-2#1)
using whole blood##4##3##(1990-12#1)(2007-2#1)(2008-10#1)(2008-4#1)
using whole##10##2##(1990-12#1)(1993-7#1)(1996-1#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2012-3#1)
using whole-cell patch clamp techniques##2##5##(1996-10#1)(2011-2#1)
using whole-cell patch-clamp##3##3##(1995-12#1)(1997-5#1)(2008-4#1)
using whole-cell voltage-clamp##2##3##(1991-5#1)(2008-8#1)
using whole-cell##9##2##(1991-5#1)(1991-8#1)(1995-12#1)(1995-2#1)(1996-10#1)(1997-5#1)(2008-4#1)(2008-8#1)(2011-2#1)
using wide-field##3##2##(2008-8#1)(2011-1#2)
using wild-derived mouse stocks##2##4##(2009-5#2)
using winter wheat##2##3##(1992-3#1)(2008-10#1)
using winter##3##2##(1992-3#1)(2008-10#2)
using wireless##3##2##(2007-9#1)(2008-12#1)(2013-1#1)
using with##2##2##(2008-10#1)(2008-5#1)
using x-ray diffraction##2##3##(1991-6#1)(2008-5#1)
using x-ray##5##2##(1991-6#1)(2008-3#1)(2008-5#2)(2009-7#1)
using yeast one-hybrid system##3##4##(2008-8#1)(2008-9#2)
using yeast two-hybrid system##2##4##(2008-8#1)(2008-9#1)
using yeast two-hybrid##4##3##(2008-4#1)(2008-8#1)(2008-9#2)
using yeast##12##2##(1991-5#1)(1996-10#1)(2008-10#2)(2008-4#2)(2008-8#2)(2008-9#4)
using your##3##2##(2009-4#1)(2011-12#1)(2012-12#1)
using zero##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
using zinc##2##2##(2004-9#1)(2011-12#1)
using zirconium##2##2##(2008-10#1)(2010-12#1)
using zymography##2##2##(2008-11#1)(2011-2#1)
using##19933##1##(1990-1#6)(1990-10#34)(1990-11#69)(1990-12#74)(1990-2#54)(1990-3#32)(1990-4#33)(1990-5#56)(1990-6#28)(1990-7#43)(1990-8#60)(1990-9#35)(1991-1#27)(1991-10#25)(1991-11#27)(1991-12#50)(1991-2#35)(1991-3#47)(1991-4#31)(1991-5#65)(1991-6#27)(1991-7#26)(1991-8#47)(1991-9#50)(1992-1#39)(1992-10#13)(1992-11#46)(1992-12#57)(1992-2#55)(1992-3#55)(1992-4#20)(1992-5#18)(1992-6#48)(1992-7#37)(1992-8#90)(1992-9#65)(1993-1#19)(1993-10#14)(1993-11#59)(1993-12#66)(1993-2#59)(1993-3#57)(1993-4#32)(1993-5#23)(1993-6#39)(1993-7#20)(1993-8#32)(1993-9#63)(1994-1#6)(1994-10#14)(1994-11#78)(1994-12#74)(1994-2#72)(1994-3#84)(1994-4#8)(1994-5#58)(1994-6#44)(1994-7#8)(1994-8#60)(1994-9#79)(1995-1#46)(1995-10#26)(1995-11#48)(1995-12#69)(1995-2#91)(1995-3#71)(1995-4#26)(1995-5#45)(1995-6#48)(1995-7#28)(1995-8#61)(1995-9#17)(1996-1#36)(1996-10#41)(1996-11#36)(1996-12#92)(1996-2#82)(1996-3#50)(1996-4#30)(1996-5#85)(1996-6#44)(1996-7#38)(1996-8#68)(1996-9#30)(1997-1#47)(1997-2#92)(1997-3#79)(1997-4#92)(1997-5#47)(1997-6#61)(1997-7#69)(1997-8#74)(1997-9#1)(2003-11#2)(2004-1#10)(2004-10#6)(2004-11#23)(2004-12#18)(2004-2#6)(2004-3#15)(2004-4#11)(2004-7#1)(2004-8#4)(2004-9#34)(2005-1#2)(2005-10#39)(2005-11#190)(2005-12#34)(2005-3#1)(2005-4#25)(2005-5#5)(2005-6#5)(2005-7#28)(2005-8#26)(2005-9#13)(2006-1#11)(2006-10#182)(2006-11#58)(2006-12#124)(2006-2#40)(2006-3#36)(2006-4#61)(2006-5#96)(2006-6#79)(2006-7#42)(2006-8#80)(2006-9#21)(2007-1#74)(2007-10#115)(2007-11#323)(2007-12#329)(2007-2#86)(2007-3#32)(2007-4#82)(2007-5#60)(2007-6#57)(2007-7#163)(2007-8#496)(2007-9#82)(2008-1#161)(2008-10#3854)(2008-11#530)(2008-12#180)(2008-2#466)(2008-3#378)(2008-4#483)(2008-5#528)(2008-6#216)(2008-7#356)(2008-8#248)(2008-9#310)(2009-1#6)(2009-10#87)(2009-11#46)(2009-12#63)(2009-2#73)(2009-3#82)(2009-4#66)(2009-5#61)(2009-6#40)(2009-7#53)(2009-8#85)(2009-9#49)(2010-1#42)(2010-10#35)(2010-11#40)(2010-12#173)(2010-2#110)(2010-3#67)(2010-4#136)(2010-5#87)(2010-6#59)(2010-7#67)(2010-8#131)(2010-9#46)(2011-1#269)(2011-11#8)(2011-12#41)(2011-2#478)(2011-3#16)(2011-7#4)(2011-8#1)(2012-1#175)(2012-11#56)(2012-12#287)(2012-2#336)(2012-3#272)(2012-4#3)(2012-5#4)(2012-6#3)(2012-7#4)(2013-1#591)(2013-3#2)(2013-4#1)(2013-7#126)(2013-8#253)
usitata##2##1##(2008-10#2)
usp and the##2##3##(1997-7#2)
usp and##3##2##(1997-7#3)
usp##6##1##(1997-7#6)
usp/T3Rbeta heterodimers##3##2##(1997-7#3)
ussuricus##4##1##(2009-5#4)
usta##2##1##(2007-3#2)
ustekinumab (CNTO##2##2##(2009-11#1)(2010-12#1)
ustekinumab##5##1##(2009-11#4)(2010-12#1)
usual DBP##2##2##(1990-3#2)
usual activities##3##2##(2007-6#3)
usual and##3##2##(1991-2#1)(2006-10#1)(2007-12#1)
usual care (control##2##3##(2008-8#1)(2012-1#1)
usual care or##2##3##(2010-12#1)(2013-8#1)
usual care##15##2##(1990-5#1)(2005-12#1)(2008-11#1)(2008-4#2)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
usual cases##2##2##(1996-12#1)(2008-8#1)
usual cause##2##2##(2008-9#1)(2011-1#1)
usual clinical##3##2##(2006-8#1)(2007-3#1)(2008-5#1)
usual correction##2##2##(2005-10#2)
usual forms of##2##3##(2006-10#1)(2008-4#1)
usual health##2##2##(2008-10#1)(2010-5#1)
usual interstitial pneumonia (UIP)##4##4##(2005-8#4)
usual interstitial pneumonia##7##3##(2005-8#4)(2010-12#3)
usual method##5##2##(1996-9#1)(2005-11#1)(2007-7#1)(2008-10#1)(2008-12#1)
usual methods##5##2##(1993-5#1)(2008-10#2)(2008-5#2)
usual pain##2##2##(2007-2#2)
usual practice##5##2##(1993-12#1)(2008-1#1)(2009-4#1)(2010-12#1)(2012-1#1)
usual risk##2##2##(2008-10#1)(2010-7#1)
usual source of care##3##4##(1995-12#1)(2008-10#1)(2013-1#1)
usual source of##7##3##(1995-12#1)(2008-1#1)(2008-10#3)(2012-3#1)(2013-1#1)
usual source##8##2##(1995-12#2)(2008-1#1)(2008-10#3)(2012-3#1)(2013-1#1)
usual to##2##2##(1990-5#1)(2007-12#1)
usual treatment##5##2##(1992-5#1)(2007-11#1)(2007-12#1)(2013-1#2)
usual##308##1##(1990-10#1)(1990-11#2)(1990-3#3)(1990-5#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#4)(1991-3#2)(1991-4#1)(1991-7#1)(1991-9#1)(1992-11#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-5#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-8#2)(1995-12#3)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#3)(1996-4#3)(1996-7#2)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#4)(2005-10#3)(2005-11#6)(2005-12#1)(2005-3#1)(2005-6#1)(2005-8#8)(2006-1#1)(2006-10#8)(2006-11#1)(2006-12#1)(2006-4#2)(2006-6#2)(2006-7#3)(2006-8#2)(2007-1#2)(2007-11#9)(2007-12#11)(2007-2#3)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#3)(2007-7#5)(2007-8#2)(2007-9#2)(2008-1#5)(2008-10#22)(2008-11#3)(2008-12#4)(2008-2#13)(2008-3#12)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#7)(2009-10#1)(2009-12#2)(2009-2#2)(2009-4#1)(2009-5#3)(2009-7#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#6)(2010-3#1)(2010-4#5)(2010-5#3)(2010-6#1)(2010-7#2)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#9)(2013-8#1)
usual&quot##5##1##(1995-1#1)(1997-1#1)(2008-3#3)
usual-protein##2##1##(2007-8#2)
usually a combination of##3##4##(1990-9#1)(2011-2#1)(2012-1#1)
usually a major##2##3##(1991-3#1)(1997-6#1)
usually a##20##2##(1990-9#1)(1991-3#1)(1991-4#1)(1991-5#1)(1993-2#1)(1994-2#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-2#1)(2007-7#2)(2008-12#1)(2008-7#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-8#1)
usually accompanied by##6##3##(1993-10#1)(1995-6#1)(1997-8#1)(2008-10#1)(2010-2#1)(2012-2#1)
usually acquired##3##2##(2006-10#1)(2008-10#1)(2010-12#1)
usually administered##2##2##(2007-7#1)(2008-10#1)
usually affected##2##2##(2009-1#1)(2013-1#1)
usually affecting children##2##3##(2008-7#1)(2012-2#1)
usually affects##6##2##(1993-8#1)(2007-11#1)(2009-10#1)(2009-3#1)(2010-3#1)(2013-1#1)
usually after##2##2##(1992-5#1)(1993-9#1)
usually also##2##2##(1992-2#1)(1996-2#1)
usually an##8##2##(1991-5#1)(1997-7#1)(2004-4#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-6#1)(2013-8#1)
usually appear##2##2##(2006-10#1)(2010-4#1)
usually appears as a##2##4##(2009-3#1)(2013-1#1)
usually appears in the##2##4##(2007-8#1)(2008-3#1)
usually appears in##3##3##(2007-8#1)(2008-3#1)(2010-2#1)
usually appears##6##2##(2007-8#1)(2008-3#1)(2009-3#1)(2010-2#1)(2012-2#1)(2013-1#1)
usually applied##2##2##(2007-12#1)(2009-4#1)
usually are of##3##3##(1992-9#1)(2007-12#1)(2008-5#1)
usually are##17##2##(1992-9#1)(1995-4#1)(2004-11#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-3#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#3)
usually arises from##2##3##(2006-8#1)(2009-1#1)
usually arises##3##2##(2006-8#1)(2007-7#1)(2009-1#1)
usually around##2##2##(2007-2#1)(2008-10#1)
usually as##3##2##(1997-2#1)(2007-7#1)(2008-4#1)
usually asked##2##2##(1993-5#1)(1993-6#1)
usually assessed##2##2##(1990-11#1)(2008-3#1)
usually associated to##2##3##(2007-8#1)(2012-11#1)
usually associated with a##3##4##(2008-2#1)(2008-9#1)(2009-8#1)
usually associated with the##5##4##(1994-9#1)(1997-6#1)(2012-2#1)(2013-1#2)
usually associated with##37##3##(1992-10#1)(1993-10#1)(1993-11#1)(1994-7#1)(1994-9#1)(1997-6#1)(2006-1#1)(2007-11#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-9#1)(2011-2#2)(2012-2#5)(2013-1#3)(2013-8#1)
usually associated##39##2##(1992-10#1)(1993-10#1)(1993-11#1)(1994-7#1)(1994-9#1)(1997-6#1)(2006-1#1)(2007-11#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-9#1)(2011-2#2)(2012-11#1)(2012-2#5)(2013-1#3)(2013-8#1)
usually assumed##3##2##(1992-3#1)(2007-9#1)(2008-9#1)
usually asymptomatic##10##2##(1993-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#2)
usually at pH##2##3##(2008-10#2)
usually at the##2##3##(2008-11#1)(2012-2#1)
usually at##7##2##(2007-7#1)(2008-10#2)(2008-11#1)(2011-11#1)(2012-12#1)(2012-2#1)
usually attributed to##4##3##(1995-1#1)(2007-7#1)(2008-11#1)(2008-5#1)
usually based on the##2##4##(1995-12#1)(2008-3#1)
usually based on##6##3##(1995-12#1)(2007-9#1)(2008-11#1)(2008-3#1)(2009-8#1)(2011-2#1)
usually based##7##2##(1990-8#1)(1995-12#1)(2007-9#1)(2008-11#1)(2008-3#1)(2009-8#1)(2011-2#1)
usually be treated##2##3##(1990-12#1)(1993-10#1)
usually be##22##2##(1990-12#1)(1992-4#1)(1993-10#1)(1996-12#1)(1997-1#2)(2005-11#1)(2005-8#1)(2006-5#1)(2007-2#2)(2007-5#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-8#1)(2009-8#1)
usually begins##2##2##(2008-9#1)(2011-2#1)
usually believed to##2##3##(1991-9#1)(2008-8#1)
usually believed##3##2##(1991-9#1)(2008-8#1)(2013-8#1)
usually benign##7##2##(1992-9#1)(2004-11#1)(2007-10#1)(2008-11#1)(2010-3#1)(2013-1#2)
usually between##3##2##(2008-1#1)(2008-10#1)(2008-2#1)
usually by##6##2##(2005-7#1)(2007-2#1)(2008-3#2)(2008-7#1)(2012-2#1)
usually called##4##2##(1990-2#1)(2005-11#1)(2006-2#1)(2008-10#1)
usually can##2##2##(1995-3#1)(1997-4#1)
usually cause##3##2##(1992-11#1)(2007-10#1)(2012-3#1)
usually caused by##8##3##(1990-12#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-1#2)(2011-12#1)(2013-1#1)
usually causes##5##2##(1991-4#1)(2006-10#1)(2007-8#1)(2008-10#1)(2013-1#1)
usually characterised by##2##3##(2008-6#1)(2010-11#1)
usually characterised##3##2##(2008-10#1)(2008-6#1)(2010-11#1)
usually classified##2##2##(1993-8#1)(2013-1#1)
usually completely##2##2##(2007-2#1)(2008-8#1)
usually conducted##3##2##(2007-12#1)(2007-8#1)(2012-12#1)
usually confined to the##4##4##(1990-5#1)(1991-11#1)(2009-9#1)(2010-12#1)
usually connected with##2##3##(2007-7#1)(2011-3#1)
usually considered as a##2##4##(2008-10#1)(2012-3#1)
usually considered to be##4##4##(1991-5#1)(2008-4#1)(2008-7#1)(2009-2#1)
usually considered to##6##3##(1991-5#1)(2007-12#1)(2008-4#1)(2008-7#1)(2009-2#2)
usually considered##15##2##(1991-5#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-7#2)(2009-2#2)(2009-7#1)(2009-9#1)(2012-3#1)(2013-1#1)
usually consist##2##2##(1996-12#1)(2007-5#1)
usually consisting of##2##3##(1994-2#1)(2007-11#1)
usually consists of prolonged courses of antibiotics##2##7##(2008-5#1)(2008-6#1)
usually consists of##4##3##(2008-5#1)(2008-6#1)(2011-2#2)
usually consulted##2##2##(1996-6#1)(1997-4#1)
usually contain##6##2##(1993-9#1)(2006-12#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#1)
usually covered by##2##3##(1993-10#1)(2007-12#1)
usually cured##2##2##(2011-2#1)(2013-1#1)
usually described in##3##3##(2007-7#1)(2007-8#1)(2012-2#1)
usually described##5##2##(2007-7#1)(2007-8#1)(2008-9#1)(2010-5#1)(2012-2#1)
usually detected by##2##3##(2010-7#1)(2013-1#1)
usually detected in##2##3##(2008-10#1)(2013-8#1)
usually detected##5##2##(2008-10#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
usually developed##2##2##(2008-10#1)(2009-11#1)
usually develops in##3##3##(2008-5#1)(2008-7#1)(2013-8#1)
usually develops##9##2##(1990-1#1)(2008-10#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
usually diagnosed and treated##2##4##(1993-2#1)(2005-9#1)
usually diagnosed in##3##3##(2007-8#1)(2011-2#1)(2013-8#1)
usually diagnosed##10##2##(1993-2#1)(2005-9#1)(2006-2#1)(2007-8#1)(2008-10#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-8#1)
usually difficult to##4##3##(2006-12#1)(2006-6#1)(2007-12#1)(2008-10#1)
usually difficult##9##2##(2006-12#1)(2006-4#1)(2006-6#1)(2007-12#2)(2008-10#1)(2008-7#1)(2008-8#1)(2009-7#1)
usually do not require##3##4##(1996-3#1)(2006-1#1)(2008-6#1)
usually do not##7##3##(1990-9#1)(1991-8#1)(1996-3#1)(2006-1#1)(2006-10#1)(2008-6#1)(2010-4#1)
usually dominated by##2##3##(1997-6#1)(2008-3#1)
usually done##4##2##(1991-11#1)(2007-8#1)(2008-1#1)(2008-3#1)
usually due to##6##3##(2005-8#1)(2007-8#1)(2008-1#1)(2008-7#1)(2012-12#1)(2012-3#1)
usually during##2##2##(2007-2#1)(2012-3#1)
usually employed in##2##3##(2007-11#1)(2007-4#1)
usually employed##5##2##(2007-11#1)(2007-12#1)(2007-4#1)(2008-7#2)
usually encountered in##5##3##(1990-8#1)(2008-10#2)(2009-4#1)(2012-2#1)
usually established##3##2##(2004-12#1)(2007-11#1)(2007-9#1)
usually exhibit##2##2##(2008-10#1)(2013-8#1)
usually expressed##2##2##(1991-9#1)(2008-10#1)
usually follows##3##2##(2006-2#1)(2008-4#1)(2013-1#1)
usually found at##2##3##(1991-6#1)(1997-8#1)
usually found in the##6##4##(1993-11#1)(2007-8#1)(2008-5#1)(2009-3#1)(2010-12#1)(2013-8#1)
usually found in##12##3##(1992-10#1)(1993-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)(2009-3#1)(2010-12#1)(2011-1#1)(2013-7#1)(2013-8#1)
usually found to##2##3##(2005-12#1)(2009-10#1)
usually found##21##2##(1991-3#1)(1991-6#1)(1992-10#1)(1992-9#1)(1993-11#1)(1997-8#1)(2005-12#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-5#1)(2009-10#1)(2009-3#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
usually generate a##2##3##(2008-2#1)(2008-8#1)
usually has a##2##3##(2006-4#1)(2008-2#1)
usually has##5##2##(1997-3#1)(2006-4#1)(2006-6#1)(2008-2#1)(2013-8#1)
usually have the##2##3##(1991-5#1)(1997-6#1)
usually have##12##2##(1991-5#1)(1997-1#1)(1997-6#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-3#1)(2013-8#2)
usually higher in##2##3##(2008-10#1)(2008-5#1)
usually higher##6##2##(1997-3#1)(2006-12#1)(2008-10#1)(2008-5#1)(2010-5#1)(2011-2#1)
usually implies##2##2##(1992-3#1)(1992-8#1)
usually improves##2##2##(2007-10#1)(2008-7#1)
usually in a##3##3##(2006-10#1)(2013-7#1)(2013-8#1)
usually in association with##2##4##(1993-10#2)
usually in the##10##3##(2006-1#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2012-12#1)(2012-2#1)(2013-7#2)
usually in##25##2##(1992-1#1)(1993-10#2)(1994-6#1)(1997-6#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#3)(2007-7#2)(2008-1#1)(2008-10#2)(2008-3#1)(2009-9#1)(2012-12#1)(2012-2#2)(2013-7#3)(2013-8#1)
usually include##3##2##(2007-9#1)(2008-9#1)(2012-3#1)
usually included in##2##3##(2008-2#1)(2012-11#1)
usually included##3##2##(2008-10#1)(2008-2#1)(2012-11#1)
usually increased##2##2##(1992-5#1)(2012-2#1)
usually involve##4##2##(1990-12#1)(2007-11#1)(2010-10#1)(2010-8#1)
usually involves the##2##3##(2006-10#1)(2008-10#1)
usually involves##9##2##(2005-10#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-1#1)(2013-1#1)
usually is##12##2##(1997-6#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2009-6#1)(2010-12#1)(2011-3#1)(2012-3#1)(2013-8#1)
usually it##2##2##(1990-4#1)(2007-11#1)
usually known##2##2##(2005-10#1)(2008-2#1)
usually lasts##2##2##(1991-12#1)(2006-7#1)
usually lead to##3##3##(2008-10#1)(2011-1#1)(2013-8#1)
usually leads to##4##3##(1997-6#1)(2006-10#1)(2007-11#1)(2013-1#1)
usually less than##2##3##(1992-1#1)(2008-3#1)
usually less##5##2##(1992-1#1)(2007-11#1)(2008-3#1)(2008-7#1)(2008-9#1)
usually limited to##2##3##(2006-11#1)(2008-10#1)
usually limited##4##2##(2006-11#1)(2007-8#1)(2008-10#1)(2011-12#1)
usually linked to##2##3##(2007-9#1)(2008-2#1)
usually located in the##3##4##(2010-12#1)(2012-2#1)(2013-8#1)
usually located in##4##3##(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
usually located##10##2##(2007-8#1)(2008-7#1)(2009-9#1)(2010-12#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
usually manifests as a##2##4##(2007-12#1)(2010-6#1)
usually mild and##5##3##(1990-4#1)(2005-11#1)(2007-11#1)(2008-6#1)(2010-12#1)
usually mild##11##2##(1990-4#1)(1997-3#1)(2005-11#1)(2006-6#3)(2007-11#2)(2008-1#1)(2008-6#1)(2010-12#1)
usually modified##2##2##(1994-3#1)(2013-8#1)
usually more##10##2##(1991-11#1)(1995-5#1)(1996-4#1)(2006-11#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#2)(2013-1#1)
usually necessary for##3##3##(2007-8#1)(2008-10#1)(2010-11#1)
usually necessary##6##2##(1990-10#1)(2006-4#1)(2006-9#1)(2007-8#1)(2008-10#1)(2010-11#1)
usually negative##2##2##(2007-11#1)(2007-2#1)
usually no##4##2##(1990-1#1)(2008-3#1)(2009-4#1)(2012-2#1)
usually non-specific##2##2##(1992-4#1)(2010-4#1)
usually normal in##4##3##(1990-11#1)(2005-10#1)(2008-3#1)(2008-4#1)
usually normal##7##2##(1990-11#1)(2005-10#2)(2008-3#1)(2008-4#1)(2010-12#1)(2013-1#1)
usually not##16##2##(1990-12#1)(1992-3#1)(1993-6#1)(1996-1#1)(1997-3#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-6#1)(2012-12#1)(2013-1#1)
usually observed in##7##3##(1991-10#1)(2005-10#1)(2005-11#1)(2007-2#1)(2007-7#1)(2012-12#1)(2012-3#1)
usually observed##11##2##(1991-10#1)(1991-12#1)(1993-9#1)(1995-7#1)(2005-10#1)(2005-11#1)(2007-2#1)(2007-7#1)(2008-7#1)(2012-12#1)(2012-3#1)
usually obtained##2##2##(1996-3#1)(2007-11#1)
usually occur in##2##3##(2009-5#1)(2013-7#1)
usually occur##5##2##(2006-10#1)(2008-7#1)(2009-5#1)(2010-1#1)(2013-7#1)
usually occurring in##2##3##(2008-10#1)(2012-2#1)
usually occurs as a##2##4##(2007-8#1)(2008-6#1)
usually occurs as an isolated##2##5##(1996-3#1)(1996-6#1)
usually occurs as##5##3##(1990-5#1)(1996-3#1)(1996-6#1)(2007-8#1)(2008-6#1)
usually occurs at##2##3##(1995-2#1)(2010-7#1)
usually occurs due to##2##4##(2013-1#1)(2013-8#1)
usually occurs in the##3##4##(2006-10#1)(2009-10#1)(2012-12#1)
usually occurs in women##2##4##(2007-8#1)(2012-3#1)
usually occurs in##16##3##(1993-5#1)(2006-10#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-6#1)(2012-12#1)(2012-3#1)(2013-1#5)
usually occurs##35##2##(1990-5#1)(1990-6#1)(1993-5#1)(1995-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(2005-12#1)(2006-10#2)(2006-2#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#2)(2009-10#1)(2010-6#3)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#6)(2013-8#2)
usually of##10##2##(1990-10#1)(2005-10#1)(2006-10#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
usually on##2##2##(1990-3#1)(2007-2#1)
usually only##6##2##(1996-12#1)(2006-3#1)(2007-11#1)(2008-9#1)(2011-3#1)(2013-1#1)
usually originate from the##2##4##(1997-1#1)(2007-8#1)
usually originate from##3##3##(1997-1#1)(2007-8#1)(2011-2#1)
usually overcome##2##2##(1995-1#1)(2008-10#1)
usually overlooked##2##2##(2010-4#1)(2011-1#1)
usually performed as##2##3##(2008-7#1)(2010-3#1)
usually performed in##2##3##(1990-8#1)(2007-8#1)
usually performed##20##2##(1990-8#1)(1990-9#1)(1992-9#1)(1993-6#1)(1997-8#1)(2006-3#1)(2006-4#1)(2006-6#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-5#2)(2008-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#1)
usually present as##2##3##(2012-1#1)(2013-8#1)
usually present in##5##3##(2005-10#1)(2008-10#2)(2010-4#1)(2011-1#1)
usually present with##10##3##(1990-8#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-12#1)(2009-12#1)(2009-6#1)(2011-2#1)(2012-2#2)
usually present##24##2##(1990-8#1)(1995-11#1)(2005-10#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-12#1)(2009-6#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-8#1)
usually presenting##3##2##(2006-1#1)(2006-2#1)(2008-6#1)
usually presents as##2##3##(2008-4#1)(2012-3#1)
usually presents with##5##3##(2008-11#1)(2008-7#2)(2012-12#1)(2012-3#1)
usually presents##10##2##(2006-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2010-6#1)(2012-12#1)(2012-3#2)
usually prolonged##3##2##(2004-11#1)(2008-7#1)(2010-12#1)
usually provide##3##2##(2006-10#1)(2012-1#1)(2013-8#1)
usually provided by the lamp's manufacturer##2##6##(2008-3#2)
usually range##2##2##(1997-8#1)(2008-10#1)
usually recommended to##2##3##(2008-10#1)(2008-5#1)
usually recommended##6##2##(2006-10#1)(2008-10#1)(2008-5#1)(2010-11#1)(2010-7#1)(2013-7#1)
usually reduces##2##2##(2008-2#1)(2008-8#1)
usually referred to as##2##4##(1992-2#1)(2008-12#1)
usually refers to##2##3##(2008-11#1)(2008-5#1)
usually regarded as##3##3##(1990-8#1)(1995-11#1)(2007-12#1)
usually regarded##4##2##(1990-8#1)(1995-11#1)(2007-12#1)(2010-7#1)
usually related to##6##3##(1991-5#1)(1993-10#1)(2007-7#1)(2007-9#1)(2010-9#1)(2013-8#1)
usually reported##3##2##(1997-4#1)(2007-12#1)(2008-7#1)
usually represents##2##2##(1992-2#1)(2011-3#1)
usually require##6##2##(1997-3#1)(2007-11#2)(2008-10#1)(2013-1#2)
usually required to##3##3##(1995-3#1)(1995-5#1)(2010-9#1)
usually required##9##2##(1991-12#1)(1995-3#1)(1995-5#1)(2006-5#1)(2008-10#1)(2008-4#1)(2010-9#1)(2011-2#1)(2012-12#1)
usually requires a##3##3##(2006-10#1)(2008-1#1)(2011-2#1)
usually requires##12##2##(1995-9#1)(2006-10#1)(2006-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)
usually requiring##2##2##(2006-10#1)(2007-8#1)
usually resolve##2##2##(1995-9#1)(2008-7#1)
usually responds to##2##3##(2006-10#1)(2009-6#1)
usually responds well to##2##4##(2006-10#1)(2007-7#1)
usually responds##4##2##(2006-10#2)(2007-7#1)(2009-6#1)
usually restricted##2##2##(2008-4#1)(2010-4#1)
usually result from##2##3##(1996-6#1)(2008-2#1)
usually result in##3##3##(1997-6#1)(2005-2#1)(2007-8#1)
usually result##5##2##(1996-6#1)(1997-6#1)(2005-2#1)(2007-8#1)(2008-2#1)
usually results from##2##3##(2006-10#1)(2012-12#1)
usually results in##5##3##(2005-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-1#1)
usually results##7##2##(2005-7#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-12#1)(2013-1#1)
usually secondary to##7##3##(1991-5#1)(2006-3#1)(2006-5#1)(2007-12#1)(2008-10#1)(2012-2#2)
usually secondary##8##2##(1991-5#1)(2006-3#1)(2006-5#1)(2007-12#1)(2008-10#1)(2012-2#2)(2013-8#1)
usually seen in##6##3##(1996-3#1)(2008-10#2)(2009-2#1)(2009-9#1)(2011-2#1)
usually seen##12##2##(1996-3#1)(1997-5#1)(2006-12#1)(2006-3#1)(2008-10#2)(2008-11#1)(2009-11#1)(2009-2#1)(2009-9#1)(2011-2#1)(2012-2#1)
usually selected in##2##3##(1992-2#1)(2012-2#1)
usually self-limiting##2##2##(2008-8#1)(2011-1#1)
usually several##2##2##(2008-6#1)(2010-6#1)
usually show##2##2##(1997-6#1)(2010-8#1)
usually shows a##2##3##(1992-3#1)(1995-6#1)
usually shows##4##2##(1992-3#1)(1995-6#1)(2007-11#1)(2013-8#1)
usually small##2##2##(2012-12#1)(2013-1#1)
usually starting##2##2##(2006-1#1)(2013-1#1)
usually starts##3##2##(1995-5#1)(2008-3#1)(2008-5#1)
usually studied##3##2##(1995-5#1)(2008-10#1)(2012-12#1)
usually sufficient##4##2##(2006-10#1)(2008-1#1)(2009-4#1)(2010-11#1)
usually surgical##2##2##(1996-9#1)(2006-6#1)
usually suspected in##2##3##(2009-2#1)(2012-12#1)
usually takes##2##2##(1995-9#1)(2008-11#1)
usually tested##2##2##(1997-5#1)(2011-2#1)
usually the only##2##3##(1991-6#1)(2013-8#1)
usually the result of##2##4##(1995-1#1)(2008-6#1)
usually the##14##2##(1991-6#1)(1995-1#1)(1995-9#1)(2005-10#1)(2005-12#1)(2006-8#1)(2007-7#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-8#1)
usually to the##2##3##(1995-12#1)(2013-1#1)
usually to##4##2##(1995-12#1)(1996-3#1)(2008-2#1)(2013-1#1)
usually transient and##3##3##(2007-11#1)(2008-3#1)(2013-1#1)
usually treated as##3##3##(2006-7#1)(2008-2#1)(2008-9#1)
usually treated with##4##3##(1991-8#1)(2005-7#1)(2010-5#1)(2011-12#1)
usually treated##10##2##(1991-8#1)(2005-7#1)(2006-7#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-2#1)(2010-5#1)(2011-12#1)(2012-2#1)
usually uncomplicated##2##2##(1992-6#1)(2008-6#1)
usually undergo##2##2##(2005-2#1)(2006-10#1)
usually unknown##2##2##(2009-4#1)(2012-11#1)
usually unnecessary##2##2##(2007-7#2)
usually used as##2##3##(2008-5#1)(2009-3#1)
usually used for##2##3##(2008-10#1)(2008-2#1)
usually used in##2##3##(2008-10#2)
usually used to##2##3##(2008-10#1)(2008-3#1)
usually used##11##2##(1993-6#1)(2006-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-3#1)
usually very##6##2##(1996-4#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-2#1)
usually was##2##2##(2008-10#1)(2011-1#1)
usually were##4##2##(2008-10#3)(2008-8#1)
usually with SDS and reducing agents##2##6##(2008-2#1)(2008-4#1)
usually with##9##2##(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-7#1)(2011-2#1)
usually within##4##2##(1991-4#1)(1993-9#1)(2007-2#1)(2007-3#1)
usually without##3##2##(1991-2#1)(2008-3#1)(2008-8#1)
usually##1374##1##(1990-1#2)(1990-10#2)(1990-11#3)(1990-12#7)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#4)(1990-6#1)(1990-8#5)(1990-9#4)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#4)(1991-2#3)(1991-3#2)(1991-4#3)(1991-5#6)(1991-6#3)(1991-8#2)(1991-9#2)(1992-1#2)(1992-10#5)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#5)(1992-4#4)(1992-5#3)(1992-6#4)(1992-8#1)(1992-9#5)(1993-1#1)(1993-10#8)(1993-11#3)(1993-12#4)(1993-2#3)(1993-3#4)(1993-5#2)(1993-6#4)(1993-7#1)(1993-8#3)(1993-9#6)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#1)(1994-5#2)(1994-6#3)(1994-7#1)(1994-9#2)(1995-1#3)(1995-11#2)(1995-12#4)(1995-2#4)(1995-3#3)(1995-4#1)(1995-5#4)(1995-6#3)(1995-7#1)(1995-8#2)(1995-9#6)(1996-1#2)(1996-10#1)(1996-11#3)(1996-12#6)(1996-2#2)(1996-3#8)(1996-4#2)(1996-6#8)(1996-8#1)(1996-9#2)(1997-1#5)(1997-2#3)(1997-3#10)(1997-4#8)(1997-5#3)(1997-6#10)(1997-7#4)(1997-8#5)(2004-11#3)(2004-12#2)(2004-4#1)(2005-10#11)(2005-11#7)(2005-12#5)(2005-2#3)(2005-5#1)(2005-6#1)(2005-7#3)(2005-8#6)(2005-9#2)(2006-1#6)(2006-10#34)(2006-11#3)(2006-12#9)(2006-2#5)(2006-3#5)(2006-4#8)(2006-5#6)(2006-6#10)(2006-7#4)(2006-8#10)(2006-9#4)(2007-1#1)(2007-10#9)(2007-11#42)(2007-12#25)(2007-2#17)(2007-3#5)(2007-4#5)(2007-5#4)(2007-6#5)(2007-7#30)(2007-8#29)(2007-9#12)(2008-1#25)(2008-10#100)(2008-11#19)(2008-12#10)(2008-2#28)(2008-3#46)(2008-4#27)(2008-5#27)(2008-6#19)(2008-7#36)(2008-8#23)(2008-9#11)(2009-1#5)(2009-10#5)(2009-11#2)(2009-12#3)(2009-2#5)(2009-3#6)(2009-4#6)(2009-5#6)(2009-6#9)(2009-7#2)(2009-8#5)(2009-9#8)(2010-1#2)(2010-10#2)(2010-11#4)(2010-12#17)(2010-2#9)(2010-3#4)(2010-4#8)(2010-5#6)(2010-6#9)(2010-7#8)(2010-8#6)(2010-9#5)(2011-1#12)(2011-11#1)(2011-12#4)(2011-2#39)(2011-3#4)(2012-1#8)(2012-11#6)(2012-12#21)(2012-2#40)(2012-3#19)(2013-1#61)(2013-7#10)(2013-8#32)
usurped##2##1##(1992-5#1)(2009-2#1)
usyd##2##1##(2013-1#2)
utensils##5##1##(1994-4#1)(2008-10#1)(2008-4#2)(2012-1#1)
uteri from##2##2##(2006-5#1)(2013-7#1)
uteri of##2##2##(1996-5#1)(2006-5#1)
uteri##12##1##(1993-12#1)(1994-12#1)(1994-5#1)(1995-5#1)(1996-5#1)(2006-5#2)(2006-6#1)(2011-2#1)(2013-1#2)(2013-7#1)
uterine LMS##10##2##(2011-1#6)(2012-2#4)
uterine OT gene expression##3##4##(1995-10#3)
uterine adenocarcinoma##2##2##(2008-1#1)(2013-7#1)
uterine adnexa##4##2##(2007-12#4)
uterine and##4##2##(1990-11#1)(1990-5#1)(2011-2#1)(2012-12#1)
uterine arteries##3##2##(1994-9#2)(1995-3#1)
uterine artery##7##2##(1994-9#1)(2004-10#1)(2006-9#1)(2007-11#1)(2008-3#1)(2012-12#1)(2013-1#1)
uterine atony##5##2##(1995-12#2)(2011-2#3)
uterine bleeding (DUB)##2##3##(1994-9#1)(2008-10#1)
uterine bleeding is##2##3##(1994-9#2)
uterine bleeding##14##2##(1991-12#1)(1991-2#2)(1994-12#1)(1994-9#3)(1995-3#1)(2006-1#1)(2008-10#1)(2009-5#1)(2010-3#1)(2013-7#1)(2013-8#1)
uterine cancer##4##2##(1991-12#3)(2011-2#1)
uterine cancer]##2##2##(1990-10#1)(2006-6#1)
uterine carcinosarcoma##2##2##(2012-1#2)
uterine cavity##12##2##(1993-12#1)(1994-9#1)(1996-1#1)(2007-9#1)(2010-9#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-7#1)
uterine cells##7##2##(1990-8#1)(1994-8#1)(1994-9#2)(1996-8#2)(2007-12#1)
uterine cervical cancer patients##2##4##(2011-2#2)
uterine cervical cancer##4##3##(2011-2#4)
uterine cervical carcinoma##3##3##(1994-8#1)(2007-4#2)
uterine cervical neoplasms amongst females from##2##6##(2012-12#2)
uterine cervical neoplasms##3##3##(2012-12#3)
uterine cervical##14##2##(1990-7#1)(1994-8#1)(2007-4#2)(2011-2#6)(2012-12#3)(2012-2#1)
uterine cervix cancer##3##3##(1990-6#2)(1993-11#1)
uterine cervix##38##2##(1990-4#1)(1990-6#3)(1992-1#2)(1992-3#1)(1993-11#1)(1993-8#2)(1993-9#1)(1994-4#1)(1994-7#2)(2006-10#4)(2006-6#1)(2007-11#4)(2007-12#1)(2007-7#1)(2008-11#1)(2008-4#1)(2009-11#2)(2009-5#1)(2011-1#1)(2011-2#3)(2012-2#3)(2013-7#1)
uterine compression##2##2##(2011-2#2)
uterine contractions and##2##3##(1992-1#1)(2006-7#1)
uterine contractions##10##2##(1990-12#1)(1991-4#1)(1992-1#2)(1997-6#1)(2006-7#1)(2007-9#1)(2008-4#1)(2010-3#2)
uterine endometrial##2##2##(2006-8#1)(2008-3#1)
uterine epithelial cells##10##3##(2008-6#10)
uterine fibroids##5##2##(1993-12#2)(1994-9#1)(2007-2#1)(2010-6#1)
uterine horn cicatrix##2##3##(2012-1#2)
uterine horn##11##2##(1991-3#1)(1992-1#1)(1992-3#2)(1993-12#1)(1994-6#3)(2008-3#1)(2012-1#2)
uterine horns##5##2##(1995-7#3)(2008-11#2)
uterine incision##3##2##(1993-4#1)(1994-9#1)(2007-2#1)
uterine inertia##2##2##(2004-10#1)(2007-7#1)
uterine leiomyoma##3##2##(2005-3#1)(2012-3#2)
uterine leiomyomata##4##2##(2007-2#3)(2010-12#1)
uterine leiomyosarcoma##5##2##(2008-6#2)(2011-1#1)(2012-2#2)
uterine lipoma##4##2##(2013-7#4)
uterine metastasis##2##2##(2009-8#2)
uterine muscle##5##2##(1993-12#3)(2007-1#1)(2008-4#1)
uterine natural killer cells##2##4##(2013-1#2)
uterine prolapse##4##2##(2008-10#2)(2010-1#1)(2012-2#1)
uterine prostanoid synthesis##2##3##(1994-3#2)
uterine receptors##2##2##(1990-9#1)(2006-5#1)
uterine retention##2##2##(2008-8#2)
uterine rupture and##2##3##(1992-8#1)(2007-2#1)
uterine rupture##10##2##(1992-8#3)(1995-12#2)(2007-2#1)(2007-7#1)(2011-1#3)
uterine sarcoma##5##2##(1991-9#4)(2009-5#1)
uterine segment##2##2##(2009-1#1)(2011-2#1)
uterine smooth muscle activity##2##4##(1992-7#1)(1994-9#1)
uterine smooth muscle in both pregnant and non-pregnant mice##2##9##(2008-4#2)
uterine smooth muscle of pregnant and non-pregnant mice##3##8##(2008-4#3)
uterine smooth muscle##12##3##(1990-3#1)(1991-8#2)(1992-7#1)(1993-12#1)(1994-9#1)(2008-4#5)(2010-3#1)
uterine strips##2##2##(2008-4#2)
uterine tissue##6##2##(1994-8#1)(1996-12#1)(1997-6#3)(2006-10#1)
uterine tissues##5##2##(1995-7#1)(1997-6#2)(2010-3#1)(2012-2#1)
uterine torsion##2##2##(2006-1#1)(2011-2#1)
uterine tumor resembling##2##3##(2010-9#2)
uterine tumor##4##2##(1993-7#1)(2009-8#1)(2010-9#2)
uterine wall##4##2##(1993-1#1)(1994-9#1)(2007-9#1)(2010-2#1)
uterine weight##5##2##(1996-2#1)(2006-5#1)(2009-8#2)(2011-2#1)
uterine##391##1##(1990-10#2)(1990-11#3)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#5)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#3)(1991-9#5)(1992-1#7)(1992-12#2)(1992-3#3)(1992-4#4)(1992-7#1)(1992-8#4)(1993-1#2)(1993-11#1)(1993-12#13)(1993-4#3)(1993-6#1)(1993-7#1)(1993-8#4)(1993-9#1)(1994-12#3)(1994-3#3)(1994-4#2)(1994-6#5)(1994-7#3)(1994-8#5)(1994-9#22)(1995-1#1)(1995-10#5)(1995-11#1)(1995-12#4)(1995-3#2)(1995-4#1)(1995-5#1)(1995-7#4)(1996-1#2)(1996-12#2)(1996-2#1)(1996-5#1)(1996-8#4)(1997-6#6)(2004-10#3)(2005-3#1)(2006-1#2)(2006-10#9)(2006-5#8)(2006-6#4)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#7)(2007-2#7)(2007-3#1)(2007-4#2)(2007-7#3)(2007-9#4)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-3#4)(2008-4#12)(2008-5#1)(2008-6#13)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#2)(2009-2#2)(2009-5#3)(2009-8#8)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#6)(2010-6#1)(2010-9#4)(2011-1#14)(2011-2#28)(2011-8#1)(2012-1#6)(2012-12#6)(2012-2#19)(2012-3#4)(2013-1#5)(2013-7#10)(2013-8#1)
uterine-placental adherence##2##2##(1994-9#2)
utero##66##1##(1990-12#1)(1990-5#1)(1990-7#1)(1991-1#1)(1992-1#1)(1992-10#1)(1992-7#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-11#2)(1994-4#1)(1994-8#2)(1995-1#1)(1996-10#2)(1996-12#1)(1996-3#1)(1996-4#3)(1996-5#1)(1996-6#1)(1997-1#1)(1997-8#3)(2005-10#1)(2005-11#1)(2006-10#3)(2007-1#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
uteroferrin##6##1##(1990-4#2)(1991-8#2)(1994-9#1)(1995-3#1)
uteroglobin##2##1##(1993-11#1)(1994-5#1)
uteroplacental systolic/diastolic ratio##3##3##(1992-2#3)
uteroplacental##10##1##(1990-6#2)(1992-1#2)(1992-2#4)(1992-4#1)(1994-3#1)
uterotonic##2##1##(2008-3#1)(2008-8#1)
uterotrophic##2##1##(1997-5#1)(2008-10#1)
uterus also##2##2##(1993-1#1)(2008-10#1)
uterus and the##2##3##(2007-12#1)(2009-6#1)
uterus and vagina##2##3##(2007-7#1)(2013-1#1)
uterus and##15##2##(1992-11#1)(1992-3#1)(1993-1#1)(1993-8#1)(1995-10#1)(1995-3#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-11#1)(2009-4#1)(2009-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
uterus at##3##2##(1995-10#1)(2007-4#1)(2011-2#1)
uterus during pregnancy##3##3##(1994-8#2)(1996-11#1)
uterus epithelial cells and##2##4##(2008-9#2)
uterus has##2##2##(1995-10#1)(2008-8#1)
uterus in vivo##2##3##(1990-8#1)(1994-8#1)
uterus in##6##2##(1990-8#1)(1994-8#1)(1995-11#1)(2007-11#1)(2008-10#1)(2012-1#1)
uterus is##8##2##(1993-10#1)(1993-11#1)(2006-5#1)(2007-11#1)(2007-9#1)(2008-8#1)(2009-8#1)(2011-2#1)
uterus may be##3##3##(2007-9#1)(2013-1#2)
uterus or##2##2##(1995-11#1)(2006-6#1)
uterus was##5##2##(1992-7#1)(2006-10#1)(2007-9#1)(2008-7#1)(2012-2#1)
uterus with##3##2##(1994-2#1)(2011-1#1)(2013-1#1)
uterus##139##1##(1990-10#1)(1990-11#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#1)(1993-7#1)(1993-8#2)(1994-2#1)(1994-6#3)(1994-7#1)(1994-8#3)(1994-9#6)(1995-10#4)(1995-11#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(2006-10#3)(2006-12#1)(2006-5#3)(2006-6#2)(2006-9#1)(2007-11#6)(2007-12#2)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#6)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-2#1)(2009-4#2)(2009-6#2)(2009-8#2)(2010-12#2)(2010-3#2)(2011-1#2)(2011-2#4)(2012-1#2)(2012-2#6)(2012-3#3)(2013-1#9)(2013-7#3)
uterus]##6##1##(1992-3#1)(1993-6#1)(2006-10#1)(2007-8#1)(2008-8#1)(2010-6#1)
utexas##2##1##(2008-10#2)
utilis##6##1##(1996-9#3)(1997-2#2)(2008-11#1)
utilisation among##2##2##(2007-3#1)(2009-4#1)
utilisation and##2##2##(2008-11#1)(2008-7#1)
utilisation in##2##2##(2008-11#1)(2010-9#1)
utilisation is##3##2##(1994-12#1)(2008-11#2)
utilisation of the##4##3##(1993-8#1)(2007-11#1)(2007-6#1)(2008-11#1)
utilisation of##27##2##(1990-10#1)(1993-8#1)(2005-11#1)(2006-12#1)(2006-2#1)(2006-6#2)(2007-11#4)(2007-3#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#4)(2008-11#2)(2009-10#1)(2010-8#1)(2012-12#2)(2012-2#1)
utilisation was##2##2##(1993-4#1)(1996-9#1)
utilisation##57##1##(1990-10#1)(1993-4#1)(1993-8#1)(1994-12#1)(1996-9#3)(1997-2#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-6#2)(2007-11#4)(2007-3#3)(2007-6#1)(2007-7#3)(2008-1#1)(2008-10#8)(2008-11#9)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-8#1)(2010-9#1)(2012-12#4)(2012-2#2)
utilise the##3##2##(2006-10#1)(2008-11#1)(2008-4#1)
utilise##18##1##(1997-6#1)(2006-10#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2012-2#1)(2013-1#1)
utilised a##3##2##(1997-3#1)(2006-3#1)(2007-11#1)
utilised as##4##2##(2005-7#1)(2007-8#1)(2008-10#1)(2008-11#1)
utilised by##2##2##(2006-8#1)(2008-11#1)
utilised during##2##2##(2005-10#1)(2008-10#1)
utilised for the##2##3##(2006-8#1)(2008-10#1)
utilised for##7##2##(2006-8#1)(2006-9#1)(2008-10#4)(2008-11#1)
utilised in##5##2##(2006-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
utilised the##4##2##(2007-2#1)(2008-10#1)(2008-11#2)
utilised to investigate##2##3##(2006-8#1)(2008-11#1)
utilised to##17##2##(1993-12#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2012-2#2)
utilised##61##1##(1991-12#1)(1993-12#1)(1993-6#1)(1995-6#1)(1996-6#1)(1997-2#1)(1997-3#2)(2004-10#1)(2005-10#1)(2005-7#2)(2006-10#1)(2006-2#1)(2006-3#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#9)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#11)(2008-11#9)(2008-5#1)(2008-7#1)(2011-1#1)(2012-12#2)(2012-2#2)
utilises a##4##2##(2007-3#1)(2008-10#1)(2008-12#2)
utilises the##6##2##(1996-10#1)(2006-6#1)(2008-10#4)
utilises##18##1##(1991-9#1)(1996-10#1)(1997-2#1)(2006-6#1)(2007-11#3)(2007-3#1)(2008-10#5)(2008-12#2)(2008-5#1)(2011-1#1)(2012-2#1)
utilising a##6##2##(1997-3#1)(2007-8#1)(2008-10#1)(2008-7#1)(2013-1#2)
utilising an##2##2##(2005-7#1)(2007-8#1)
utilising the##4##2##(2006-3#1)(2008-10#1)(2008-12#1)(2008-2#1)
utilising##29##1##(1997-3#1)(1997-8#1)(2005-7#1)(2006-2#1)(2006-3#1)(2006-6#1)(2007-11#1)(2007-8#4)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-7#1)(2009-3#1)(2010-12#2)(2012-12#2)(2013-1#2)(2013-8#2)
utilitarian##6##1##(1997-1#1)(2006-4#2)(2006-7#1)(2008-10#1)(2008-11#1)
utilities of##4##2##(2008-10#1)(2008-4#1)(2010-12#1)(2012-3#1)
utilities##15##1##(1996-12#1)(1996-4#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-3#2)(2013-8#1)
utility and limitations of##2##4##(1995-1#1)(2008-9#1)
utility and limitations##3##3##(1995-1#1)(2008-9#1)(2010-4#1)
utility and the##2##3##(2005-7#1)(2012-3#1)
utility and##24##2##(1992-3#1)(1993-1#1)(1994-11#1)(1995-1#2)(1997-6#1)(2005-10#1)(2005-7#1)(2006-12#1)(2006-8#2)(2007-5#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-12#1)(2012-3#1)
utility as a novel##2##4##(1996-10#1)(2008-6#1)
utility as a##5##3##(1996-10#1)(2008-2#1)(2008-6#1)(2008-8#1)(2010-8#1)
utility as an alternative##2##4##(2006-10#1)(2006-12#1)
utility as an##4##3##(1997-4#1)(2006-10#1)(2006-12#1)(2008-7#1)
utility as well##2##3##(2009-4#1)(2010-12#1)
utility as##18##2##(1994-3#1)(1996-10#1)(1997-4#1)(2004-9#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-8#1)
utility for the##4##3##(2007-10#1)(2007-11#1)(2008-6#1)(2008-9#1)
utility for##30##2##(1990-10#1)(1990-5#1)(1991-7#1)(1993-12#2)(1993-3#1)(1995-2#1)(1995-3#1)(1997-8#1)(2005-7#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-4#3)(2008-5#1)(2008-6#1)(2008-9#2)(2013-1#1)
utility functions##4##2##(2013-1#4)
utility have been##2##3##(2007-4#1)(2009-9#1)
utility in clinical##2##3##(2008-9#1)(2012-1#1)
utility in identifying##2##3##(1992-1#1)(2012-3#1)
utility in studies##2##3##(2008-4#1)(2011-2#1)
utility in the diagnosis##2##4##(2007-10#1)(2008-5#1)
utility in the treatment of##2##5##(2008-10#1)(2013-1#1)
utility in the##11##3##(2006-10#1)(2006-7#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-5#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
utility in##43##2##(1992-1#2)(1995-3#1)(1995-5#1)(1997-4#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#4)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2010-10#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
utility is illustrated##2##3##(2008-10#1)(2011-1#1)
utility is##5##2##(2008-10#2)(2008-8#1)(2010-6#1)(2011-1#1)
utility may##2##2##(1997-7#1)(2013-8#1)
utility of a##10##3##(1996-7#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-7#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
utility of animal models of##2##5##(2005-7#1)(2011-1#1)
utility of animal models##3##4##(2005-7#1)(2007-11#1)(2011-1#1)
utility of both##3##3##(1993-5#1)(2007-12#2)
utility of carbon##2##3##(2008-10#1)(2012-2#1)
utility of information##2##3##(1995-12#1)(2010-3#1)
utility of new##3##3##(1997-6#1)(2007-11#1)(2008-6#1)
utility of our##4##3##(2007-12#1)(2009-12#1)(2009-5#1)(2013-1#1)
utility of such a##3##4##(1997-8#1)(2008-10#1)(2008-3#1)
utility of such##6##3##(1995-5#1)(1997-8#1)(2008-10#2)(2008-3#1)(2008-7#1)
utility of the method##6##4##(1993-2#1)(1994-9#1)(2008-2#1)(2008-3#2)(2009-12#1)
utility of the new##4##4##(2008-10#1)(2008-3#2)(2008-7#1)
utility of the proposed method##2##5##(2008-10#1)(2008-3#1)
utility of the proposed##5##4##(2008-10#3)(2008-3#2)
utility of the system##3##4##(1996-2#1)(2006-5#1)(2007-8#1)
utility of the##89##3##(1991-2#1)(1991-9#1)(1992-9#1)(1993-2#1)(1993-5#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-2#1)(2004-9#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#10)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#6)
utility of these##9##3##(1991-7#1)(1996-4#1)(1996-8#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2013-1#2)
utility of this method##8##4##(1990-4#1)(2006-7#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2010-2#1)
utility of this new##3##4##(1997-5#1)(2012-1#1)(2013-1#1)
utility of this##34##3##(1990-4#1)(1991-12#1)(1991-5#1)(1994-12#1)(1995-2#1)(1997-5#1)(1997-8#1)(2005-7#1)(2006-7#1)(2007-10#1)(2007-12#3)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-8#1)(2009-2#1)(2010-2#2)(2010-5#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#2)
utility of##341##2##(1990-10#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-9#2)(1993-2#2)(1993-4#1)(1993-5#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#2)(1996-1#1)(1996-2#1)(1996-4#2)(1996-5#1)(1996-7#1)(1996-8#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-12#1)(2004-9#1)(2005-10#1)(2005-7#5)(2005-8#6)(2006-10#11)(2006-11#1)(2006-12#3)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#12)(2007-12#15)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#7)(2007-9#2)(2008-1#3)(2008-10#32)(2008-11#10)(2008-12#4)(2008-2#6)(2008-3#16)(2008-4#4)(2008-5#2)(2008-6#4)(2008-7#12)(2008-8#3)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-8#3)(2009-9#2)(2010-11#1)(2010-12#2)(2010-2#6)(2010-3#3)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#9)(2012-1#3)(2012-12#8)(2012-2#7)(2012-3#10)(2013-1#16)(2013-7#1)(2013-8#5)
utility on##2##2##(2004-2#1)(2006-10#1)
utility scale##2##2##(2008-7#2)
utility to##6##2##(1992-1#1)(1994-8#1)(2007-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
utility values##3##2##(2006-12#1)(2013-1#2)
utility was##3##2##(1990-12#1)(2004-3#1)(2009-6#1)
utility##549##1##(1990-10#2)(1990-12#2)(1990-4#2)(1990-5#2)(1990-7#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#2)(1991-9#1)(1992-1#3)(1992-3#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#2)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#5)(1995-12#1)(1995-2#3)(1995-3#5)(1995-5#3)(1996-1#1)(1996-10#1)(1996-2#1)(1996-4#2)(1996-5#1)(1996-7#1)(1996-8#2)(1997-2#2)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#3)(2004-12#1)(2004-2#1)(2004-3#2)(2004-9#2)(2005-10#2)(2005-7#9)(2005-8#6)(2006-10#16)(2006-11#2)(2006-12#7)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#3)(2006-8#4)(2006-9#1)(2007-10#4)(2007-11#14)(2007-12#17)(2007-2#1)(2007-3#2)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#9)(2007-9#3)(2008-1#6)(2008-10#49)(2008-11#12)(2008-12#5)(2008-2#7)(2008-3#20)(2008-4#15)(2008-5#6)(2008-6#7)(2008-7#23)(2008-8#6)(2008-9#13)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#3)(2009-3#1)(2009-4#4)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#7)(2010-3#3)(2010-4#2)(2010-5#4)(2010-6#3)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#7)(2011-12#3)(2011-2#14)(2012-1#4)(2012-12#12)(2012-2#11)(2012-3#18)(2013-1#30)(2013-7#1)(2013-8#11)
utilization among##7##2##(1992-4#1)(2005-8#1)(2008-12#1)(2008-7#1)(2012-1#2)(2013-8#1)
utilization analysis##6##2##(2013-1#6)
utilization and access##3##3##(1994-1#1)(1994-2#1)(1995-12#1)
utilization and cost##3##3##(1995-3#1)(1997-2#2)
utilization and costs##2##3##(2008-11#1)(2009-11#1)
utilization and expenditure##2##3##(1992-1#1)(1994-1#1)
utilization and management##2##3##(2011-12#1)(2011-2#1)
utilization and program##3##3##(1991-3#2)(1992-1#1)
utilization and the##3##3##(2005-11#2)(2007-10#1)
utilization and to##2##3##(1993-3#1)(1995-3#1)
utilization and##57##2##(1991-1#1)(1991-10#1)(1991-11#1)(1991-3#2)(1992-1#3)(1992-6#1)(1993-12#1)(1993-3#2)(1994-1#2)(1994-2#2)(1994-3#1)(1994-8#1)(1995-10#1)(1995-12#3)(1995-2#1)(1995-3#4)(1996-12#1)(1997-2#2)(2005-11#2)(2006-10#2)(2007-10#2)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-4#1)(2010-1#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#2)(2012-3#1)
utilization are##5##2##(1990-12#1)(2007-4#1)(2007-9#2)(2012-1#1)
utilization as##7##2##(1997-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2011-2#1)
utilization between##2##2##(1995-12#1)(2010-11#1)
utilization by the##5##3##(1990-2#1)(1993-7#1)(1994-12#1)(2008-8#1)(2011-1#1)
utilization by##22##2##(1990-11#1)(1990-2#1)(1991-10#1)(1991-7#2)(1992-4#1)(1992-6#1)(1993-12#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1996-2#1)(1997-1#1)(2006-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-9#1)(2011-1#1)
utilization data##4##2##(1990-12#1)(1994-3#2)(2010-11#1)
utilization during##4##2##(1992-1#2)(1995-3#1)(2008-7#1)
utilization efficiencies##2##2##(2008-9#1)(2013-8#1)
utilization efficiency##5##2##(2013-8#5)
utilization for##13##2##(1991-1#1)(1993-1#1)(1993-2#1)(1994-2#1)(2005-12#1)(2006-12#1)(2008-1#1)(2008-7#1)(2011-2#1)(2012-2#2)(2013-1#2)
utilization groups##5##2##(1991-2#1)(1993-12#1)(1994-3#1)(2013-1#2)
utilization has been##2##3##(1990-2#1)(2011-2#1)
utilization has##3##2##(1990-2#1)(2010-11#1)(2011-2#1)
utilization in a##3##3##(1991-1#1)(1996-12#1)(2008-6#1)
utilization in an##2##3##(2007-11#1)(2008-3#1)
utilization in human##2##3##(1990-11#1)(1990-2#1)
utilization in the##5##3##(2007-7#1)(2008-6#1)(2008-8#1)(2011-12#1)(2013-1#1)
utilization in##47##2##(1990-11#2)(1990-2#3)(1990-7#2)(1991-1#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-8#2)(1996-12#1)(1997-8#1)(2006-8#1)(2007-11#3)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-8#3)(2009-11#1)(2009-5#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
utilization is##13##2##(1990-12#1)(1994-1#1)(1995-2#2)(1995-3#1)(2007-4#1)(2007-7#1)(2008-11#2)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
utilization management (UM)##2##3##(1996-1#1)(1997-2#1)
utilization management program##3##3##(1995-1#2)(1996-1#1)
utilization management##19##2##(1990-12#1)(1991-3#1)(1993-12#3)(1994-12#1)(1995-1#6)(1995-2#1)(1996-1#3)(1996-12#1)(1997-2#2)
utilization occurred##2##2##(2007-6#1)(2012-2#1)
utilization of a##7##3##(1994-5#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-3#1)
utilization of alternative##2##3##(1990-8#1)(1997-7#1)
utilization of amino acids for glutathione synthesis##2##7##(1996-11#2)
utilization of amino acids##3##4##(1996-11#2)(2013-8#1)
utilization of an##2##3##(1993-9#1)(2010-8#1)
utilization of beta-adrenergic##2##3##(2008-3#2)
utilization of biomass##2##3##(2008-5#1)(2013-8#1)
utilization of certain##2##3##(2008-10#1)(2008-11#1)
utilization of different##3##3##(2008-3#1)(2009-4#1)(2011-1#1)
utilization of drugs##2##3##(1995-1#1)(1997-2#1)
utilization of glucose##2##3##(2008-6#1)(2008-7#1)
utilization of health care services##4##5##(1993-2#1)(1993-3#1)(1994-1#2)
utilization of health care##5##4##(1993-2#1)(1993-3#1)(1994-1#2)(2008-8#1)
utilization of health##6##3##(1993-2#1)(1993-3#1)(1994-1#2)(1995-3#1)(2008-8#1)
utilization of medical services##2##4##(1996-2#1)(2007-6#1)
utilization of medical##4##3##(1996-12#1)(1996-2#1)(1996-6#1)(2007-6#1)
utilization of mental health##2##4##(1996-12#1)(1996-3#1)
utilization of occupational therapy services##2##5##(2013-7#2)
utilization of resources##2##3##(1995-3#1)(2006-8#1)
utilization of services##4##3##(1991-12#1)(1992-3#1)(1994-2#1)(1996-1#1)
utilization of surgical##2##3##(1995-3#1)(2006-8#1)
utilization of the initiator##2##4##(1993-11#1)(1995-6#1)
utilization of the system for##2##5##(2008-3#1)(2008-5#1)
utilization of the##37##3##(1990-5#1)(1991-4#1)(1991-5#1)(1992-10#1)(1992-7#1)(1993-11#1)(1994-1#3)(1994-5#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-3#1)(2005-4#1)(2006-8#2)(2006-9#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#4)(2009-7#1)(2010-9#1)(2011-2#1)(2012-11#1)
utilization of these##2##3##(1996-2#1)(2010-10#1)
utilization of this##4##3##(1991-7#1)(2007-11#1)(2008-7#1)(2013-1#1)
utilization of two##4##3##(1993-2#1)(2008-10#1)(2008-9#1)(2010-2#1)
utilization of very##2##3##(2008-10#1)(2008-11#1)
utilization of vitamin##2##3##(2010-12#1)(2011-1#1)
utilization of##254##2##(1990-12#3)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#3)(1991-4#1)(1991-5#2)(1991-7#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-3#2)(1992-4#2)(1992-5#1)(1992-7#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-1#7)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-9#1)(1995-1#2)(1995-3#7)(1995-6#1)(1996-1#2)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#2)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#3)(1997-5#1)(1997-7#1)(2005-10#4)(2005-4#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#2)(2006-8#8)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-4#2)(2007-6#2)(2007-7#3)(2007-9#1)(2008-1#3)(2008-10#20)(2008-11#7)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#7)(2008-5#8)(2008-6#7)(2008-7#13)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#2)(2009-2#5)(2009-4#2)(2009-5#1)(2009-7#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-8#3)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#3)(2013-1#6)(2013-7#2)(2013-8#5)
utilization on the##2##3##(1992-12#1)(2009-9#1)
utilization on##4##2##(1992-12#1)(2007-10#1)(2008-10#1)(2009-9#1)
utilization or##2##2##(1995-2#1)(2007-7#1)
utilization pattern##4##2##(1995-2#1)(2008-6#1)(2013-1#2)
utilization patterns in##3##3##(1994-2#1)(2006-5#1)(2008-7#1)
utilization patterns of##4##3##(2006-5#1)(2009-8#1)(2013-1#2)
utilization patterns##14##2##(1992-12#1)(1994-2#1)(1996-2#1)(1997-2#1)(2006-5#2)(2008-10#2)(2008-7#1)(2009-8#1)(2013-1#4)
utilization profiles##4##2##(1997-2#1)(2008-10#1)(2013-1#2)
utilization profiling and hot spotting##2##5##(2013-1#2)
utilization rate##8##2##(1991-10#1)(1993-1#1)(2007-6#1)(2008-11#1)(2008-6#1)(2008-7#3)
utilization rates of##2##3##(2007-4#1)(2013-8#1)
utilization rates##11##2##(1993-1#3)(1994-1#1)(2007-4#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-8#1)
utilization ratio##2##2##(1992-12#1)(2008-3#1)
utilization review and##2##3##(1991-4#1)(1992-12#1)
utilization review##14##2##(1991-3#2)(1991-4#1)(1992-1#2)(1992-12#1)(1994-1#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#2)
utilization study##3##2##(2006-8#2)(2008-4#1)
utilization to##2##2##(2008-10#1)(2008-7#1)
utilization under##3##2##(2008-2#1)(2013-1#2)
utilization was determined##2##3##(1990-2#1)(1995-10#1)
utilization was##14##2##(1990-2#1)(1990-7#1)(1992-6#1)(1994-8#1)(1995-10#1)(1995-3#1)(1997-8#2)(2004-11#1)(2005-10#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-3#1)
utilization were##4##2##(2010-10#1)(2011-1#1)(2012-12#1)(2012-2#1)
utilization when##2##2##(2008-6#1)(2012-2#1)
utilization will##2##2##(1996-3#1)(2006-2#1)
utilization##773##1##(1990-11#3)(1990-12#13)(1990-2#10)(1990-5#4)(1990-7#4)(1990-8#2)(1990-9#1)(1991-1#6)(1991-10#4)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#5)(1991-4#2)(1991-5#2)(1991-7#6)(1992-1#9)(1992-10#1)(1992-12#8)(1992-3#5)(1992-4#4)(1992-5#1)(1992-6#3)(1992-7#1)(1993-1#7)(1993-11#1)(1993-12#6)(1993-2#3)(1993-3#5)(1993-7#1)(1993-9#1)(1994-1#16)(1994-10#1)(1994-11#4)(1994-12#5)(1994-2#9)(1994-3#11)(1994-5#2)(1994-8#5)(1994-9#1)(1995-1#12)(1995-10#2)(1995-12#7)(1995-2#6)(1995-3#16)(1995-5#2)(1995-6#1)(1996-1#7)(1996-11#2)(1996-12#6)(1996-2#8)(1996-3#5)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#5)(1997-1#5)(1997-2#12)(1997-3#2)(1997-4#3)(1997-5#1)(1997-7#1)(1997-8#3)(2004-11#1)(2005-10#7)(2005-11#2)(2005-12#1)(2005-4#1)(2005-7#1)(2005-8#3)(2006-1#2)(2006-10#8)(2006-12#5)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#3)(2006-8#14)(2006-9#2)(2007-1#1)(2007-10#5)(2007-11#6)(2007-12#1)(2007-2#1)(2007-3#4)(2007-4#7)(2007-6#4)(2007-7#8)(2007-8#2)(2007-9#4)(2008-1#6)(2008-10#37)(2008-11#20)(2008-12#7)(2008-2#4)(2008-3#15)(2008-4#10)(2008-5#13)(2008-6#20)(2008-7#31)(2008-8#14)(2008-9#5)(2009-10#1)(2009-11#4)(2009-12#4)(2009-2#10)(2009-4#5)(2009-5#5)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#7)(2010-12#3)(2010-2#2)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#8)(2010-9#3)(2011-1#14)(2011-12#4)(2011-2#17)(2012-1#7)(2012-11#1)(2012-12#8)(2012-2#12)(2012-3#10)(2013-1#48)(2013-7#2)(2013-8#14)
utilization)##2##1##(2007-5#1)(2008-10#1)
utilize ATP##2##2##(2005-8#1)(2008-11#1)
utilize a##15##2##(1992-7#1)(1994-2#1)(1995-3#1)(1995-5#1)(1996-9#1)(1997-3#1)(2007-12#2)(2008-10#1)(2008-6#1)(2009-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
utilize an##2##2##(2006-5#1)(2008-2#1)
utilize available##2##2##(1996-12#1)(2008-4#1)
utilize both##3##2##(2008-11#1)(2008-4#1)(2008-9#1)
utilize data##2##2##(1997-7#1)(2013-1#1)
utilize different##2##2##(2007-12#1)(2013-8#1)
utilize electronic##4##2##(2013-1#4)
utilize individual##3##2##(2011-2#1)(2012-1#2)
utilize more##2##2##(1992-7#1)(2006-10#1)
utilize only##3##2##(1990-11#1)(2006-7#1)(2008-3#1)
utilize the##38##2##(1990-12#1)(1992-3#1)(1992-5#1)(1993-3#1)(1995-2#1)(1996-9#1)(1997-4#1)(1997-5#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
utilize these##3##2##(2006-10#1)(2013-1#2)
utilize this##6##2##(1994-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-1#1)
utilize to##2##2##(2008-11#1)(2012-1#1)
utilize##201##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#2)(1992-5#2)(1992-7#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#3)(1995-5#1)(1996-12#3)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#2)(2004-9#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-5#2)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-11#1)(2007-12#7)(2007-8#1)(2008-1#3)(2008-10#13)(2008-11#11)(2008-12#2)(2008-2#7)(2008-3#7)(2008-4#6)(2008-5#5)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#5)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#7)(2011-2#5)(2012-1#5)(2012-11#2)(2012-12#3)(2012-2#5)(2012-3#5)(2013-1#13)(2013-8#3)
utilized a modified##2##3##(1993-6#1)(2010-8#1)
utilized a novel##4##3##(1995-2#1)(2008-10#1)(2012-1#2)
utilized a##28##2##(1990-10#1)(1991-1#1)(1992-10#1)(1992-12#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-2#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-7#1)(2010-8#1)(2011-3#1)(2012-1#2)(2012-3#1)(2013-1#3)
utilized an##2##2##(1993-2#1)(1996-2#1)
utilized and##7##2##(1995-1#1)(1995-8#1)(2006-8#2)(2008-10#1)(2010-8#1)(2012-2#1)
utilized as a##16##3##(1991-4#1)(1992-3#1)(1992-5#1)(1994-9#1)(1996-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-4#1)(2009-11#1)
utilized as an effective##2##4##(2008-11#1)(2012-7#1)
utilized as an##10##3##(1991-9#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2012-7#1)
utilized as substrates##2##3##(1992-12#1)(2005-12#1)
utilized as the##4##3##(1996-5#1)(2007-12#1)(2008-6#1)(2010-7#1)
utilized as##50##2##(1990-10#1)(1991-11#1)(1991-4#1)(1991-9#2)(1992-12#1)(1992-3#1)(1992-5#1)(1993-3#1)(1994-11#1)(1994-9#1)(1996-5#3)(2005-12#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#10)(2008-11#3)(2008-2#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#1)(2010-4#1)(2010-7#1)(2012-7#1)(2013-1#1)
utilized at##2##2##(1997-2#1)(2008-3#1)
utilized by the students##2##4##(2007-10#2)
utilized by the##10##3##(1991-12#1)(1996-2#1)(2006-10#1)(2007-10#2)(2007-3#1)(2007-6#1)(2008-6#1)(2011-1#1)(2012-1#1)
utilized by##33##2##(1991-12#1)(1991-7#1)(1993-1#1)(1995-1#2)(1995-2#1)(1996-2#3)(1997-1#1)(1997-5#1)(2006-10#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-3#1)(2007-6#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-2#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-1#2)(2012-2#1)(2013-8#2)
utilized during the##2##3##(2008-1#1)(2013-1#1)
utilized during##4##2##(2007-12#1)(2008-1#1)(2008-5#1)(2013-1#1)
utilized either##2##2##(1993-4#1)(2009-5#1)
utilized epidemiologists##2##2##(2008-11#2)
utilized for a variety of##2##5##(2009-10#2)
utilized for a##3##3##(2005-11#1)(2009-10#2)
utilized for assessment of##2##4##(2008-9#1)(2012-2#1)
utilized for determining##2##3##(2008-10#1)(2008-2#1)
utilized for mass production##2##4##(2008-10#1)(2010-2#1)
utilized for monitoring##2##3##(1997-5#1)(2008-3#1)
utilized for the analysis of##2##5##(1990-12#1)(2008-10#1)
utilized for the study##2##4##(2004-9#1)(2012-2#1)
utilized for the synthesis of##2##5##(1994-3#1)(2008-5#1)
utilized for the##23##3##(1990-12#1)(1994-3#1)(2004-9#1)(2005-11#1)(2008-1#1)(2008-10#10)(2008-2#1)(2008-5#1)(2010-5#1)(2011-1#2)(2012-2#1)(2013-1#2)
utilized for##94##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-7#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-9#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-5#1)(2004-9#1)(2005-11#2)(2006-5#1)(2007-1#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#27)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#2)(2012-2#3)(2013-1#2)(2013-7#1)
utilized in a##6##3##(2008-10#2)(2008-5#1)(2010-5#1)(2012-2#2)
utilized in combination##2##3##(2007-6#1)(2009-4#1)
utilized in developing##3##3##(1996-3#1)(2008-10#1)(2013-8#1)
utilized in order to##2##4##(1991-3#1)(2004-9#1)
utilized in routine##2##3##(2008-10#1)(2008-12#1)
utilized in the experiments##2##4##(2008-10#1)(2008-9#1)
utilized in the treatment of##3##5##(1993-8#1)(2008-1#1)(2013-1#1)
utilized in the##23##3##(1991-9#1)(1992-2#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-9#2)(1995-12#1)(1997-4#1)(2004-9#1)(2006-10#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-10#1)(2011-2#1)(2013-1#1)
utilized in this study##2##4##(1996-2#1)(2005-4#1)
utilized in this##3##3##(1996-2#1)(2005-4#1)(2007-3#1)
utilized in treating##2##3##(2006-9#1)(2012-3#1)
utilized in vivo##2##3##(1993-9#1)(1995-3#1)
utilized in##101##2##(1990-7#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-2#1)(1992-8#1)(1992-9#2)(1993-3#2)(1993-8#1)(1993-9#2)(1994-9#3)(1995-12#1)(1995-3#2)(1995-5#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-4#1)(2004-9#2)(2005-4#1)(2005-8#1)(2006-10#6)(2006-11#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#13)(2008-12#4)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#1)(2010-10#1)(2010-5#3)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#1)
utilized significantly (p&lt##2##3##(2006-8#2)
utilized successfully##2##2##(2007-3#1)(2010-12#1)
utilized the##14##2##(1990-12#1)(1992-1#1)(1992-7#1)(1994-2#1)(1994-5#1)(1996-2#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#2)(2012-1#1)(2012-2#1)
utilized these##2##2##(1997-4#1)(2008-8#1)
utilized this##7##2##(1993-7#1)(2005-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-2#1)
utilized to achieve a##2##4##(2008-3#1)(2012-3#1)
utilized to achieve##3##3##(2008-3#1)(2009-6#1)(2012-3#1)
utilized to assess the##2##4##(1990-12#1)(2004-3#1)
utilized to assess##7##3##(1990-12#1)(1992-10#1)(1996-1#1)(2004-3#1)(2008-10#1)(2008-4#1)(2013-8#1)
utilized to calculate##2##3##(2007-4#1)(2008-3#1)
utilized to characterize##2##3##(2008-2#1)(2008-5#1)
utilized to construct a##2##4##(2008-9#1)(2010-5#1)
utilized to construct##4##3##(1995-5#1)(2008-9#2)(2010-5#1)
utilized to create##2##3##(2010-2#1)(2013-1#1)
utilized to detect##5##3##(2007-11#1)(2008-10#3)(2013-1#1)
utilized to determine the##5##4##(2006-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2010-4#1)
utilized to determine##7##3##(2006-11#1)(2006-2#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2010-4#1)
utilized to develop##3##3##(2008-10#1)(2013-1#2)
utilized to estimate the##4##4##(1996-4#1)(2006-10#1)(2008-11#1)(2010-3#1)
utilized to evaluate the##2##4##(1990-2#1)(1994-3#1)
utilized to evaluate##4##3##(1990-2#1)(1994-3#1)(2006-2#1)(2008-3#1)
utilized to examine##5##3##(2007-12#1)(2008-11#1)(2010-7#1)(2012-11#1)(2012-12#1)
utilized to identify the##2##4##(2007-12#1)(2012-2#1)
utilized to identify##7##3##(1990-12#1)(1993-3#1)(2007-12#1)(2012-12#2)(2012-2#1)(2013-8#1)
utilized to investigate the##3##4##(1990-4#1)(2004-11#1)(2008-10#1)
utilized to make##2##3##(1990-4#1)(2009-9#1)
utilized to measure##2##3##(1995-1#1)(2010-8#1)
utilized to model the##2##4##(2008-4#1)(2008-8#1)
utilized to monitor##2##3##(1990-2#1)(2006-5#1)
utilized to obtain##2##3##(1997-8#1)(2008-4#1)
utilized to prepare##2##3##(1994-5#1)(2008-10#1)
utilized to provide##3##3##(1992-2#1)(2013-1#2)
utilized to screen##2##3##(2008-4#1)(2008-9#1)
utilized to separate##2##3##(1991-8#1)(2008-10#1)
utilized to study the##2##4##(2008-10#1)(2008-3#1)
utilized to study##3##3##(2008-10#1)(2008-3#2)
utilized to support##2##3##(2013-1#1)(2013-8#1)
utilized to treat##3##3##(2006-8#1)(2006-9#1)(2008-11#1)
utilized to##147##2##(1990-12#2)(1990-2#3)(1990-4#2)(1990-5#1)(1990-6#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-3#1)(1994-1#1)(1994-3#1)(1994-5#1)(1995-1#2)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#1)(1996-1#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-8#2)(2004-11#1)(2004-12#1)(2004-3#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#2)(2006-5#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-4#1)(2007-8#3)(2008-1#1)(2008-10#19)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#4)(2008-5#2)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-6#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#11)(2013-8#4)
utilized with a##2##3##(1997-8#1)(2008-2#1)
utilized with##3##2##(1997-8#1)(2008-2#1)(2011-1#1)
utilized##673##1##(1990-10#3)(1990-11#3)(1990-12#6)(1990-2#4)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#2)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#5)(1992-1#1)(1992-10#2)(1992-12#3)(1992-2#4)(1992-3#4)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#5)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#3)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#3)(1994-8#3)(1994-9#8)(1995-1#8)(1995-10#1)(1995-12#1)(1995-2#6)(1995-3#6)(1995-4#1)(1995-5#4)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#9)(1996-3#2)(1996-4#1)(1996-5#7)(1996-6#2)(1996-7#3)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#3)(1997-5#3)(1997-7#1)(1997-8#3)(2004-11#1)(2004-12#2)(2004-3#1)(2004-9#3)(2005-10#3)(2005-11#3)(2005-12#1)(2005-4#1)(2005-8#4)(2006-1#1)(2006-10#13)(2006-11#4)(2006-12#4)(2006-2#2)(2006-5#2)(2006-7#1)(2006-8#16)(2006-9#3)(2007-1#2)(2007-10#5)(2007-11#11)(2007-12#14)(2007-2#2)(2007-3#3)(2007-4#2)(2007-5#3)(2007-6#4)(2007-7#6)(2007-8#7)(2007-9#1)(2008-1#11)(2008-10#91)(2008-11#14)(2008-12#7)(2008-2#21)(2008-3#14)(2008-4#14)(2008-5#12)(2008-6#8)(2008-7#6)(2008-8#5)(2008-9#9)(2009-1#1)(2009-10#4)(2009-11#5)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#4)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#5)(2010-3#3)(2010-4#3)(2010-5#6)(2010-6#2)(2010-7#3)(2010-8#6)(2011-1#8)(2011-12#3)(2011-2#8)(2011-3#1)(2012-1#8)(2012-11#1)(2012-12#7)(2012-2#11)(2012-3#9)(2012-7#1)(2013-1#28)(2013-7#1)(2013-8#8)
utilizes (12S)-HPETE##2##2##(1994-9#2)
utilizes a new##2##3##(1993-12#1)(2011-1#1)
utilizes a##39##2##(1990-12#1)(1991-7#1)(1992-8#1)(1993-12#3)(1994-6#1)(1995-5#1)(1996-8#1)(2004-1#1)(2006-10#1)(2006-11#1)(2006-3#1)(2007-11#1)(2007-12#4)(2007-3#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#7)(2008-4#2)(2009-10#1)(2009-7#1)(2011-1#2)
utilizes an##10##2##(1992-1#1)(1994-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-6#1)(2011-1#1)
utilizes four-wave mixing##2##3##(2008-1#1)(2008-3#1)
utilizes its##3##2##(1997-2#1)(1997-8#1)(2011-2#1)
utilizes multiple##2##2##(1995-10#1)(2010-2#1)
utilizes other##2##2##(2006-10#1)(2008-3#1)
utilizes sophisticated##2##2##(2008-3#1)(2011-1#1)
utilizes spatial##2##2##(2008-3#1)(2010-2#1)
utilizes the fact that##2##4##(2008-3#1)(2008-5#1)
utilizes the##45##2##(1990-11#1)(1990-12#1)(1990-4#1)(1993-12#1)(1994-5#1)(1995-6#1)(1996-7#1)(1997-3#1)(1997-4#1)(2005-11#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#2)(2011-1#2)(2012-2#3)(2013-1#1)
utilizes this information##2##3##(1995-5#1)(1997-5#1)
utilizes this##3##2##(1995-5#1)(1996-3#1)(1997-5#1)
utilizes two##3##2##(1996-8#1)(2008-4#2)
utilizes##190##1##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-7#1)(1992-1#1)(1992-6#1)(1992-8#1)(1993-12#4)(1993-3#2)(1994-12#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-10#1)(1995-3#1)(1995-5#3)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-1#1)(2004-11#1)(2005-11#2)(2005-12#1)(2006-10#3)(2006-11#1)(2006-3#1)(2007-1#2)(2007-10#2)(2007-11#5)(2007-12#10)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#14)(2008-11#5)(2008-12#1)(2008-2#18)(2008-3#16)(2008-4#14)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#4)(2009-10#2)(2009-12#2)(2009-2#1)(2009-6#1)(2009-7#1)(2010-2#3)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#5)(2012-2#3)(2012-3#2)(2013-1#1)
utilizing 0##2##2##(1991-7#1)(2008-10#1)
utilizing a redox reaction##2##4##(2008-10#2)
utilizing a simple##2##3##(2007-11#1)(2007-8#1)
utilizing a standard##2##3##(2007-7#1)(2011-2#1)
utilizing a##62##2##(1990-8#1)(1991-12#1)(1991-3#1)(1992-2#1)(1993-9#1)(1996-4#1)(1996-9#1)(1997-5#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#6)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-7#3)(2009-2#1)(2009-3#1)(2009-9#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-7#1)
utilizing aggressive##2##2##(2006-12#1)(2008-6#1)
utilizing an##12##2##(1992-1#1)(1993-2#1)(1995-5#1)(2006-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-12#2)
utilizing both##4##2##(1996-5#1)(2008-2#1)(2009-3#1)(2010-11#1)
utilizing either##2##2##(2008-11#1)(2008-5#1)
utilizing functional##2##2##(2012-3#1)(2013-1#1)
utilizing high-performance liquid chromatography##2##4##(1990-8#1)(1997-3#1)
utilizing in-line preconcentration/separation##2##3##(2008-10#2)
utilizing initial##2##2##(2008-10#1)(2009-7#1)
utilizing more than##2##3##(1996-3#1)(2008-4#1)
utilizing multiple##2##2##(1995-2#1)(2006-3#1)
utilizing optical##3##2##(2008-3#1)(2008-5#1)(2009-7#1)
utilizing six##2##2##(2013-1#1)(2013-8#1)
utilizing standard##3##2##(2008-1#1)(2008-10#1)(2008-9#1)
utilizing the beta-catenin##2##3##(2007-12#2)
utilizing the most##2##3##(2005-11#1)(2013-8#1)
utilizing the same##3##3##(1995-1#1)(2008-11#1)(2009-5#1)
utilizing the##59##2##(1990-11#1)(1992-1#1)(1992-12#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-6#1)(1995-1#1)(1995-8#1)(1996-2#1)(1997-1#1)(2005-11#1)(2005-4#1)(2006-3#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-2#5)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#2)
utilizing these##4##2##(1992-3#1)(1996-2#1)(2013-1#2)
utilizing this##9##2##(1991-5#1)(1992-9#1)(1996-2#1)(2006-4#1)(2008-7#1)(2010-12#1)(2013-1#2)(2013-8#1)
utilizing volunteers##2##2##(1994-3#1)(1995-12#1)
utilizing##396##1##(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#4)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-7#2)(1992-1#3)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#1)(1992-7#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#2)(1993-6#3)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#2)(1996-12#1)(1996-2#4)(1996-3#2)(1996-4#1)(1996-5#3)(1996-8#3)(1996-9#2)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-4#1)(2005-10#1)(2005-11#2)(2005-4#1)(2006-10#4)(2006-11#1)(2006-12#9)(2006-2#3)(2006-3#3)(2006-4#1)(2006-7#2)(2006-8#8)(2006-9#1)(2007-1#2)(2007-11#13)(2007-12#10)(2007-2#1)(2007-3#1)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#7)(2007-9#1)(2008-1#3)(2008-10#51)(2008-11#12)(2008-12#4)(2008-2#14)(2008-3#9)(2008-4#10)(2008-5#6)(2008-6#6)(2008-7#11)(2008-8#4)(2008-9#8)(2009-11#1)(2009-2#3)(2009-3#3)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#6)(2011-1#7)(2011-12#1)(2011-2#5)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#15)(2013-7#1)(2013-8#4)
utmost importance for the##5##4##(2006-10#2)(2008-10#1)(2011-1#1)(2012-12#1)
utmost importance for##7##3##(2006-10#2)(2007-8#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-12#1)
utmost importance to##5##3##(1990-12#1)(1991-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
utmost importance##30##2##(1990-12#1)(1990-9#1)(1991-6#1)(1993-3#1)(1996-10#1)(2006-10#3)(2006-4#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#2)(2010-12#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
utmost##36##1##(1990-12#2)(1990-9#1)(1991-6#1)(1993-3#1)(1996-10#1)(1997-8#1)(2006-10#3)(2006-4#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-8#1)(2010-12#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
utricle##5##1##(2010-2#4)(2012-2#1)
utter##2##1##(2005-10#1)(2007-11#1)
utterance and##3##2##(2008-2#1)(2008-4#2)
utterance##6##1##(2007-3#2)(2008-11#1)(2008-2#1)(2008-4#2)
utterances with strong##2##3##(2009-2#2)
utterances##10##1##(2007-10#2)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-2#2)(2012-2#1)(2013-8#1)
uttered##2##1##(1995-8#1)(2012-3#1)
utxA##3##1##(1990-11#3)
uv##4##1##(1991-6#1)(2008-10#1)(2008-5#2)
uv-LDL##3##1##(1997-2#3)
uveal effusion syndrome##2##3##(2009-2#1)(2013-8#1)
uveal melanoma##3##2##(1991-6#1)(2008-7#2)
uveal##10##1##(1991-6#2)(2008-7#3)(2009-2#2)(2013-8#3)
uveitic##2##1##(2008-4#1)(2009-2#1)
uveitides##2##1##(2007-11#2)
uveitis in a##2##3##(2006-10#1)(2007-2#1)
uveitis in##4##2##(2006-10#2)(2007-2#2)
uveitis is##5##2##(1993-11#1)(2006-10#1)(2007-11#1)(2009-2#1)(2013-7#1)
uveitis patients##4##2##(2012-12#1)(2013-7#3)
uveitis related##2##2##(2009-2#1)(2013-7#1)
uveitis were##2##2##(2006-10#1)(2013-7#1)
uveitis##72##1##(1991-12#1)(1993-11#3)(2006-1#1)(2006-10#17)(2007-11#4)(2007-2#3)(2007-3#1)(2008-4#1)(2008-5#1)(2009-2#5)(2010-12#1)(2011-2#1)(2012-12#9)(2012-3#1)(2013-1#2)(2013-7#21)
uveitis]##7##1##(2009-2#2)(2013-7#5)
uveoscleral outflow##3##2##(2009-8#2)(2011-2#1)
uveoscleral##5##1##(2009-8#2)(2011-2#3)
uvomorulin with##2##2##(1990-11#1)(1994-6#1)
uvomorulin##5##1##(1990-11#3)(1994-6#2)
uvs112##2##1##(1995-9#2)
uvsC##2##1##(1997-4#2)
uvsC114 mutant##2##2##(1997-4#2)
uvsX protein (a RecA-like##2##4##(1990-10#1)(1990-5#1)
uvsX protein##3##2##(1990-10#2)(1990-5#1)
uvsX##4##1##(1990-10#3)(1990-5#1)
uvula##2##1##(2007-8#1)(2009-10#1)
uxorilocal marriage##2##2##(2007-7#2)
uxpanapensis##2##1##(2008-5#2)
v 100%##2##2##(2007-10#2)
v 18%##2##2##(2007-9#2)
v = 0-0##2##3##(2008-2#2)
v =##3##2##(2008-2#3)
v and##3##2##(1991-9#1)(1997-7#1)(2008-5#1)
v beta 3##9##3##(1994-12#6)(1995-6#3)
v is##2##2##(2008-10#1)(2008-2#1)
v was##3##2##(1991-9#1)(1995-8#1)(2008-10#1)
v##570##1##(1990-10#1)(1990-11#3)(1990-12#8)(1990-2#8)(1990-3#4)(1990-5#4)(1990-6#2)(1990-7#11)(1991-1#4)(1991-10#8)(1991-12#5)(1991-2#8)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#11)(1991-7#1)(1991-9#10)(1992-1#3)(1992-10#5)(1992-12#8)(1992-2#4)(1992-3#28)(1992-6#2)(1992-7#6)(1992-8#11)(1992-9#2)(1993-1#4)(1993-11#13)(1993-12#8)(1993-2#1)(1993-3#13)(1993-4#7)(1993-6#1)(1993-7#5)(1993-8#4)(1993-9#2)(1994-1#1)(1994-10#2)(1994-11#2)(1994-12#7)(1994-2#10)(1994-3#6)(1994-5#1)(1994-6#4)(1994-7#2)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#18)(1995-2#5)(1995-3#6)(1995-5#8)(1995-6#8)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#4)(1996-12#20)(1996-2#6)(1996-4#2)(1996-6#2)(1996-7#1)(1996-8#4)(1996-9#3)(1997-1#6)(1997-2#1)(1997-4#11)(1997-5#10)(1997-6#1)(1997-7#10)(1997-8#4)(2004-1#3)(2005-1#1)(2005-10#4)(2005-11#3)(2005-7#1)(2006-1#1)(2006-10#2)(2006-12#5)(2006-5#2)(2006-6#4)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#8)(2007-11#1)(2007-2#7)(2007-3#12)(2007-4#1)(2007-6#9)(2007-7#10)(2007-8#1)(2007-9#18)(2008-1#10)(2008-10#7)(2008-11#3)(2008-2#7)(2008-3#2)(2008-4#2)(2008-5#7)(2008-6#4)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#4)(2010-3#1)(2010-7#1)(2010-8#7)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#5)
v&quot##2##1##(2008-3#2)
v(-1))##2##1##(2008-10#2)
v(S)##2##1##(2008-2#2)
v(i) and v(j)##3##3##(2008-10#3)
v(i) and##4##2##(2008-10#4)
v)##8##1##(1990-7#1)(2006-5#1)(2007-11#1)(2008-10#3)(2008-11#1)(2009-9#1)
v*ABS##2##1##(1991-7#2)
v-Crk##5##1##(1994-12#4)(2012-12#1)
v-Mos##2##1##(1995-2#2)
v-Mos-catalyzed phosphorylation sites##2##3##(1995-2#2)
v-SNARE##5##1##(1997-6#3)(2012-12#2)
v-Src##8##1##(1994-8#4)(1995-6#1)(2007-3#3)
v-abl##2##1##(1991-5#1)(1996-2#1)
v-crk##2##1##(1994-12#2)
v-jun##2##1##(1991-9#1)(2008-11#1)
v-myc##3##1##(1990-12#1)(1991-7#1)(2009-7#1)
v-ras-transformed##2##1##(1993-6#2)
v-src and##2##2##(1995-3#1)(1996-2#1)
v-src##8##1##(1994-6#1)(1995-3#1)(1995-6#1)(1996-2#4)(1997-7#1)
v-src-transformed##3##1##(1997-1#3)
v-vis##2##1##(2008-5#2)
v/v in##2##2##(1990-12#1)(2008-10#1)
v/v o-phosphoric acid in##2##4##(2012-12#2)
v/v of##3##2##(2008-10#1)(2008-4#2)
v/v or##2##2##(1996-10#1)(2009-3#1)
v/v##48##1##(1990-12#1)(1991-9#1)(1994-5#1)(1996-10#1)(1996-8#2)(1997-1#1)(1997-4#1)(2007-1#1)(2008-10#16)(2008-4#2)(2008-5#8)(2009-10#1)(2009-3#3)(2010-12#2)(2010-2#1)(2010-5#1)(2012-11#2)(2012-12#2)(2013-7#1)
v/v%)##2##1##(2008-11#1)(2012-12#1)
v/v) (pH 6##2##3##(1996-3#2)
v/v) and the##2##3##(1997-2#1)(2008-10#1)
v/v) and##14##2##(1990-8#1)(1996-8#1)(1997-2#1)(2007-8#1)(2008-10#9)(2008-7#1)
v/v) as mobile phase##3##4##(2008-10#1)(2011-2#1)(2012-12#1)
v/v) as the mobile phase at a flow rate of 0##2##11##(2011-1#1)(2012-12#1)
v/v) as the mobile phase at a##3##7##(1992-2#1)(2011-1#1)(2012-12#1)
v/v) as the mobile phase##6##5##(1990-12#1)(1990-6#1)(1992-2#1)(1997-8#1)(2011-1#1)(2012-12#1)
v/v) as##12##2##(1990-12#1)(1990-6#1)(1992-2#1)(1997-8#1)(2008-10#3)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#2)
v/v) at 121 degrees C##2##5##(2004-8#2)
v/v) at a flow rate of 1##2##7##(2010-2#1)(2012-12#1)
v/v) at a flow-rate of##2##5##(1997-3#2)
v/v) at a##4##3##(1997-3#2)(2010-2#1)(2012-12#1)
v/v) at the flow rate##2##5##(2008-10#2)
v/v) at##12##2##(1996-8#1)(1997-3#2)(2004-8#2)(2008-10#4)(2010-2#1)(2011-1#1)(2012-12#1)
v/v) by##2##2##(2008-10#1)(2008-5#1)
v/v) containing 0##4##3##(1996-9#1)(2007-8#1)(2008-10#1)(2011-2#1)
v/v) containing##10##2##(1996-5#1)(1996-9#1)(2007-8#1)(2008-10#6)(2011-2#1)
v/v) eluent containing the##2##4##(2008-10#2)
v/v) eluent containing##4##3##(1992-2#1)(2008-10#3)
v/v) in##2##2##(2008-10#2)
v/v) solution##4##2##(1997-8#1)(2008-10#2)(2012-12#1)
v/v) to##2##2##(1996-1#1)(2008-10#1)
v/v) was used as##2##4##(2008-10#1)(2013-7#1)
v/v) was##4##2##(1991-5#1)(2008-10#1)(2008-7#1)(2013-7#1)
v/v) with pH##2##3##(2010-12#1)(2010-2#1)
v/v) with##5##2##(2008-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2013-8#1)
v/v)##142##1##(1990-12#2)(1990-6#1)(1990-8#2)(1991-5#1)(1991-8#1)(1992-2#3)(1993-2#3)(1995-11#1)(1996-1#1)(1996-2#1)(1996-3#3)(1996-5#1)(1996-6#3)(1996-8#3)(1996-9#1)(1997-2#1)(1997-3#6)(1997-8#3)(2004-8#2)(2007-8#6)(2008-10#64)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#1)(2010-12#2)(2010-2#4)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#2)(2012-12#5)(2013-7#1)(2013-8#2)
v/v)] and##2##2##(1996-3#1)(2008-5#1)
v/v)]##3##1##(1996-3#1)(2008-5#2)
v/v--phase##2##1##(2008-6#2)
v/v/v) as mobile phase##3##4##(2008-10#2)(2010-12#1)
v/v/v) as the##2##3##(1992-2#1)(2008-2#1)
v/v/v) as##5##2##(1992-2#1)(2008-10#2)(2008-2#1)(2010-12#1)
v/v/v) at##3##2##(1990-12#2)(1997-8#1)
v/v/v) with a flow rate of 1##2##7##(2008-10#1)(2008-5#1)
v/v/v)##22##1##(1990-12#2)(1992-2#1)(1997-3#1)(1997-8#1)(2007-1#1)(2007-8#1)(2008-10#9)(2008-2#2)(2008-5#1)(2010-12#1)(2010-3#1)(2013-7#1)
v/v/v/v)##4##1##(2008-10#1)(2010-2#1)(2011-1#1)(2012-2#1)
v/w##2##1##(2008-10#1)(2012-11#1)
v/w)##3##1##(2010-12#2)(2012-2#1)
v1##3##1##(2008-11#1)(2011-12#2)
v1-1 088##2##2##(2005-4#2)
v1-1##5##1##(2005-4#5)
v3-1##5##1##(2005-4#5)
v4##2##1##(1990-10#2)
v4-720##2##1##(2005-4#2)
v? =##2##2##(2008-2#2)
v?) =##2##2##(2008-3#2)
vAcCMVBar##2##1##(2008-8#2)
vC = O##2##3##(1992-9#2)
vCJD##2##1##(2007-9#1)(2008-10#1)
vMCx##2##1##(2013-1#2)
vRNPs##2##1##(2013-1#2)
vSMC##6##1##(2008-10#6)
vV(nuc) were##2##2##(1996-9#2)
vV(nuc)##3##1##(1996-9#3)
vWA##6##1##(2008-12#5)(2012-12#1)
vWD##2##1##(1990-12#1)(2008-12#1)
vWF gene##3##2##(2008-12#3)
vWF in##3##2##(2007-10#1)(2013-8#2)
vWF multimers##2##2##(1990-12#1)(2007-12#1)
vWF##22##1##(1990-12#1)(1993-3#1)(2007-10#4)(2007-12#2)(2007-8#1)(2008-11#3)(2008-12#3)(2013-8#7)
vWd##3##1##(1990-11#3)
vWf activities##3##2##(2007-10#3)
vWf##12##1##(1990-11#3)(1992-1#5)(2007-10#4)
va region##3##2##(1995-8#3)
va##7##1##(1995-8#4)(2008-10#2)(2012-2#1)
vacancies in the##2##3##(1992-5#2)
vacancies in##4##2##(1992-5#2)(2010-4#1)(2011-2#1)
vacancies##9##1##(1992-5#2)(2008-9#4)(2010-4#1)(2011-2#1)(2012-12#1)
vacancy rates##2##2##(2007-4#1)(2012-12#1)
vacancy was##2##2##(1994-9#2)
vacancy##17##1##(1991-2#1)(1993-1#1)(1994-9#2)(2007-4#2)(2008-1#2)(2008-8#2)(2008-9#3)(2011-2#1)(2012-12#1)(2012-2#2)
vacant sites are##2##3##(1996-4#1)(2008-10#1)
vacant sites##4##2##(1996-4#1)(2007-11#1)(2008-10#2)
vacant##13##1##(1990-6#1)(1991-11#1)(1992-3#3)(1994-3#1)(1996-4#1)(2007-11#1)(2008-10#4)(2008-9#1)
vacated##2##1##(1996-12#1)(2008-7#1)
vacation##6##1##(1991-2#2)(1994-7#1)(2007-12#1)(2007-4#1)(2008-9#1)
vacations##3##1##(1991-3#1)(2006-12#1)(2008-10#1)
vaccae##2##1##(2007-11#1)(2012-2#1)
vaccinal strain##4##2##(1997-6#3)(2008-11#1)
vaccinal##6##1##(1990-6#1)(1997-6#3)(2005-7#1)(2008-11#1)
vaccinate was##2##2##(2009-4#2)
vaccinate##13##1##(1994-9#1)(1996-10#1)(1996-12#1)(2008-3#1)(2009-11#1)(2009-4#3)(2011-1#4)(2011-2#1)
vaccinated against##5##2##(2008-5#2)(2010-4#1)(2011-2#1)(2013-1#1)
vaccinated and non-vaccinated##4##3##(1997-3#1)(1997-6#1)(2008-5#2)
vaccinated and unvaccinated chickens##2##4##(2005-9#2)
vaccinated and unvaccinated groups##2##4##(1994-2#1)(2008-5#1)
vaccinated and unvaccinated##8##3##(1992-2#1)(1994-2#1)(1997-3#1)(1997-6#1)(2005-9#2)(2007-2#1)(2008-5#1)
vaccinated and##18##2##(1991-6#1)(1992-2#1)(1994-2#1)(1997-3#2)(1997-6#2)(2005-9#2)(2007-2#2)(2008-5#5)(2009-4#1)(2013-8#1)
vaccinated animals gave##2##3##(2010-4#2)
vaccinated animals##6##2##(1991-12#1)(1995-9#2)(2008-9#1)(2010-4#2)
vaccinated at##5##2##(1990-11#1)(2006-10#1)(2010-4#1)(2013-1#1)(2013-8#1)
vaccinated birds##3##2##(1997-3#1)(2008-5#1)(2013-8#1)
vaccinated broiler##2##2##(1992-10#2)
vaccinated broilers##2##2##(1997-3#2)
vaccinated cattle##3##2##(1994-3#1)(2007-2#2)
vaccinated chickens in##2##3##(1996-11#1)(2013-8#1)
vaccinated chickens were##2##3##(1997-6#1)(2008-5#1)
vaccinated chickens##13##2##(1996-11#1)(1997-6#1)(2008-5#5)(2013-8#6)
vaccinated children##3##2##(1997-6#1)(2012-12#2)
vaccinated group##2##2##(1994-2#1)(2005-11#1)
vaccinated groups##2##2##(2007-2#1)(2013-8#1)
vaccinated individuals##7##2##(1994-11#1)(1995-5#1)(1997-6#1)(2006-12#1)(2007-8#1)(2010-12#2)
vaccinated or infected##2##3##(1996-12#1)(2007-11#1)
vaccinated or##3##2##(1996-12#1)(2007-11#1)(2007-2#1)
vaccinated patients##2##2##(2005-7#1)(2011-1#1)
vaccinated population##2##2##(2006-4#1)(2013-8#1)
vaccinated with live##3##3##(2005-9#2)(2008-5#1)
vaccinated with three doses##2##4##(2005-11#1)(2013-1#1)
vaccinated with##33##2##(1991-3#1)(1997-3#1)(1997-6#2)(2005-11#1)(2005-7#1)(2005-9#2)(2006-10#1)(2007-2#3)(2008-5#5)(2008-8#3)(2010-2#1)(2010-4#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#6)
vaccinated##165##1##(1990-11#2)(1990-2#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-10#2)(1992-2#1)(1992-8#1)(1994-11#1)(1994-2#3)(1994-3#1)(1995-5#2)(1995-9#4)(1996-1#1)(1996-11#2)(1996-12#1)(1997-3#7)(1997-6#13)(2005-11#2)(2005-7#2)(2005-9#5)(2006-10#2)(2006-12#1)(2006-4#1)(2007-11#1)(2007-2#16)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#20)(2008-8#3)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#3)(2010-12#4)(2010-2#1)(2010-4#9)(2011-1#1)(2011-2#7)(2012-12#4)(2012-3#4)(2013-1#5)(2013-8#21)
vaccinating##5##1##(2007-11#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
vaccination against HAV##2##3##(2011-1#1)(2012-2#1)
vaccination against HBV##2##3##(1991-3#1)(2013-1#1)
vaccination against hepatitis B##4##4##(1992-8#1)(1993-6#1)(2006-2#1)(2013-1#1)
vaccination against hepatitis##5##3##(1992-8#1)(1993-6#1)(2006-10#1)(2006-2#1)(2013-1#1)
vaccination against infectious bronchitis##2##4##(2008-5#1)(2013-8#1)
vaccination against measles##2##3##(1993-3#1)(1997-6#1)
vaccination against##33##2##(1991-12#1)(1991-3#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-3#2)(1994-9#1)(1996-7#1)(1997-6#1)(2006-10#3)(2006-2#1)(2007-2#1)(2008-11#1)(2008-5#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#4)(2013-8#2)
vaccination among##5##2##(1997-6#1)(2011-2#3)(2012-3#1)
vaccination and prophylactic##2##3##(2007-2#1)(2008-7#1)
vaccination and the##3##3##(1990-9#1)(1993-2#1)(2008-7#1)
vaccination and##24##2##(1990-9#1)(1991-8#1)(1993-2#1)(1997-2#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-2#3)(2008-7#2)(2009-12#1)(2009-5#1)(2010-12#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#1)
vaccination appeared to be##2##4##(1991-12#1)(2007-2#1)
vaccination as a##2##3##(2007-11#1)(2011-1#1)
vaccination as##3##2##(2007-11#1)(2007-6#1)(2011-1#1)
vaccination attitude##2##2##(2011-2#2)
vaccination by##4##2##(1992-10#1)(1992-8#1)(1995-5#1)(2008-5#1)
vaccination campaign##3##2##(1992-8#2)(2007-8#1)
vaccination coverage among children##2##4##(1997-2#2)
vaccination coverage among##3##3##(1997-2#2)(2012-1#1)
vaccination coverage in##5##3##(1996-12#1)(2011-2#2)(2012-12#2)
vaccination coverage levels##2##3##(1997-2#2)
vaccination coverage rates##2##3##(1995-3#1)(2012-12#1)
vaccination coverage##22##2##(1994-9#1)(1995-3#2)(1996-12#2)(1997-2#4)(2008-9#2)(2010-12#3)(2011-2#3)(2012-1#1)(2012-12#4)
vaccination for##8##2##(1990-2#1)(1993-8#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-1#1)(2006-10#1)(2007-12#1)
vaccination had##3##2##(2008-7#1)(2010-12#1)(2013-1#1)
vaccination has been##2##3##(1997-8#1)(2006-8#1)
vaccination has##6##2##(1996-8#1)(1997-8#1)(2006-8#1)(2008-7#1)(2010-7#1)(2013-1#1)
vaccination have been##2##3##(2007-7#1)(2011-2#1)
vaccination have##3##2##(2007-11#1)(2007-7#1)(2011-2#1)
vaccination history of Bacille Calmette Guerin##2##6##(2011-1#2)
vaccination in The Netherlands]##2##4##(1993-7#1)(1994-4#1)
vaccination in a##2##3##(1995-2#1)(2008-3#1)
vaccination in high-risk##2##3##(1994-3#1)(2012-12#1)
vaccination in the United States##4##5##(1994-3#2)(2004-12#2)
vaccination in the elderly##2##4##(2007-11#1)(2009-12#1)
vaccination in the##13##3##(1990-6#1)(1994-3#2)(1996-9#1)(2004-12#2)(2006-10#1)(2006-8#1)(2007-11#1)(2009-12#1)(2010-4#1)(2012-3#1)(2013-1#1)
vaccination in##46##2##(1990-3#1)(1990-6#1)(1991-12#1)(1992-11#1)(1993-6#1)(1993-7#1)(1994-3#3)(1994-4#1)(1995-2#1)(1996-9#1)(1997-4#1)(2004-12#2)(2006-10#1)(2006-8#2)(2007-11#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#6)(2009-12#3)(2009-5#2)(2010-4#3)(2011-12#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#1)
vaccination is not##2##3##(2007-2#1)(2012-12#1)
vaccination is recommended for all##2##5##(2009-12#1)(2011-2#1)
vaccination is recommended##3##3##(1997-6#1)(2009-12#1)(2011-2#1)
vaccination is the##3##3##(1994-3#1)(1995-5#1)(2007-8#1)
vaccination is##19##2##(1994-3#3)(1995-5#1)(1996-3#2)(1997-6#1)(2006-8#1)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
vaccination may##4##2##(2005-7#1)(2009-4#1)(2012-2#1)(2013-8#1)
vaccination of children##5##3##(1991-3#2)(1994-8#1)(1997-1#1)(2010-12#1)
vaccination of commercial broilers##2##4##(2013-8#2)
vaccination of high-risk groups##2##4##(2006-10#1)(2009-11#1)
vaccination of the##2##3##(2010-12#1)(2013-1#1)
vaccination of##33##2##(1990-3#1)(1991-3#2)(1992-5#1)(1992-8#2)(1994-8#1)(1996-9#1)(1997-1#1)(1997-5#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-2#2)(2008-4#1)(2008-5#3)(2009-10#1)(2009-11#1)(2009-9#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#2)
vaccination on the##6##3##(1991-6#1)(1996-1#1)(1996-3#1)(2006-8#1)(2007-12#1)(2008-5#1)
vaccination on##7##2##(1991-6#1)(1996-1#1)(1996-3#2)(2006-8#1)(2007-12#1)(2008-5#1)
vaccination or##2##2##(2005-7#1)(2008-11#1)
vaccination policies##2##2##(2009-4#1)(2012-12#1)
vaccination policy##5##2##(2007-6#3)(2009-4#1)(2013-8#1)
vaccination program in##2##3##(2006-2#1)(2007-3#1)
vaccination program##6##2##(2006-2#1)(2007-3#1)(2007-9#2)(2011-2#2)
vaccination programme##4##2##(1990-2#1)(1997-3#1)(2008-9#1)(2011-1#1)
vaccination programmes##4##2##(2006-12#1)(2007-11#1)(2007-8#1)(2013-1#1)
vaccination programs##7##2##(2007-3#1)(2007-9#2)(2008-4#1)(2008-5#1)(2009-11#1)(2009-12#1)
vaccination protocol##2##2##(2007-2#1)(2012-3#1)
vaccination rates##5##2##(1994-3#1)(1997-6#1)(2008-4#2)(2009-5#1)
vaccination recommendations for travelers##2##4##(2011-2#2)
vaccination recommendations for##3##3##(2011-2#3)
vaccination recommendations##4##2##(2010-9#1)(2011-2#3)
vaccination regimens##3##2##(1994-3#1)(2007-11#2)
vaccination schedule##5##2##(1992-8#1)(1997-1#2)(2008-7#1)(2009-12#1)
vaccination schedules##3##2##(2007-2#1)(2008-4#1)(2008-7#1)
vaccination should be##2##3##(1995-3#1)(2012-12#1)
vaccination should##3##2##(1995-3#1)(2010-8#1)(2012-12#1)
vaccination started##2##2##(1993-6#1)(2008-9#1)
vaccination status in##2##3##(2006-10#1)(2008-8#1)
vaccination status of##2##3##(2007-2#1)(2007-3#1)
vaccination status##7##2##(1994-9#1)(2006-10#1)(2007-2#1)(2007-3#1)(2008-4#1)(2008-8#1)(2012-11#1)
vaccination strategies##9##2##(1997-3#1)(2006-10#1)(2007-2#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
vaccination strategy##3##2##(1995-9#1)(1997-8#1)(2013-1#1)
vaccination technique##2##2##(1994-11#1)(2010-1#1)
vaccination to prevent##2##3##(2007-12#1)(2009-11#1)
vaccination to##10##2##(2005-11#1)(2006-8#2)(2007-11#2)(2007-12#1)(2007-2#1)(2009-11#1)(2009-4#2)
vaccination trials##2##2##(1996-12#1)(2007-11#1)
vaccination using##3##2##(2011-2#1)(2013-8#2)
vaccination was also##3##3##(1991-12#1)(2012-12#1)(2013-1#1)
vaccination was associated with##2##4##(1995-12#1)(2006-8#1)
vaccination was##12##2##(1991-12#1)(1992-8#1)(1995-12#1)(2006-7#1)(2006-8#1)(2007-11#1)(2008-5#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-1#1)
vaccination were##5##2##(1991-12#1)(2008-5#1)(2011-2#2)(2013-1#1)
vaccination which##2##2##(2007-2#1)(2008-10#1)
vaccination with a live##2##4##(1995-9#1)(2013-8#1)
vaccination with a##5##3##(1995-9#1)(2008-9#1)(2013-1#2)(2013-8#1)
vaccination with killed-in-oil vaccine##2##4##(2005-9#2)
vaccination with the Rubini##2##4##(1997-6#2)
vaccination with the bivalent vaccine was estimated to##2##8##(2011-2#2)
vaccination with the##8##3##(1997-6#2)(2006-11#1)(2007-2#1)(2010-10#1)(2011-2#2)(2013-8#1)
vaccination with this##2##3##(2013-8#2)
vaccination with##43##2##(1991-12#1)(1991-5#1)(1992-8#2)(1995-2#1)(1995-3#1)(1995-9#1)(1996-11#1)(1997-3#1)(1997-6#3)(1997-8#1)(2005-7#1)(2005-9#3)(2006-10#1)(2006-11#1)(2006-7#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-4#1)(2008-5#5)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#3)(2013-1#2)(2013-8#5)
vaccination##609##1##(1990-11#1)(1990-2#6)(1990-3#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-12#6)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-10#2)(1992-11#1)(1992-5#5)(1992-8#10)(1992-9#1)(1993-2#1)(1993-3#6)(1993-6#5)(1993-7#4)(1993-8#2)(1994-11#1)(1994-2#1)(1994-3#11)(1994-4#1)(1994-8#1)(1994-9#7)(1995-12#2)(1995-2#3)(1995-3#6)(1995-4#1)(1995-5#11)(1995-6#1)(1995-8#1)(1995-9#4)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#3)(1996-3#4)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#4)(1997-2#5)(1997-3#5)(1997-4#2)(1997-5#1)(1997-6#11)(1997-8#4)(2004-1#1)(2004-12#2)(2005-11#5)(2005-7#5)(2005-9#4)(2006-10#15)(2006-11#1)(2006-12#3)(2006-2#4)(2006-4#2)(2006-7#4)(2006-8#11)(2007-10#1)(2007-11#21)(2007-12#5)(2007-2#33)(2007-3#4)(2007-6#5)(2007-7#4)(2007-8#5)(2007-9#5)(2008-10#7)(2008-11#9)(2008-3#4)(2008-4#22)(2008-5#28)(2008-7#8)(2008-8#3)(2008-9#8)(2009-10#1)(2009-11#4)(2009-12#8)(2009-4#11)(2009-5#7)(2009-6#2)(2009-7#1)(2009-9#1)(2010-1#3)(2010-10#1)(2010-12#17)(2010-2#1)(2010-4#8)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#43)(2012-1#5)(2012-11#2)(2012-12#24)(2012-2#11)(2012-3#8)(2013-1#26)(2013-8#18)
vaccination)##2##1##(1992-11#1)(2008-4#1)
vaccination-associated##2##1##(2005-11#2)
vaccination]##8##1##(1993-5#1)(1994-2#1)(1995-10#1)(1995-12#1)(1996-2#1)(1996-9#1)(2008-8#1)(2010-1#1)
vaccinations against##3##2##(2011-2#1)(2012-12#1)(2012-2#1)
vaccinations and##6##2##(1990-2#1)(1995-5#1)(2007-2#1)(2007-8#1)(2010-8#1)(2013-8#1)
vaccinations to##2##2##(2011-2#1)(2012-3#1)
vaccinations with##2##2##(1990-2#1)(2007-10#1)
vaccinations##33##1##(1990-2#2)(1992-8#2)(1993-3#1)(1995-5#2)(1996-12#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-8#1)(2008-4#2)(2008-5#2)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#1)
vaccine (IPV)##4##2##(1997-1#1)(2004-12#1)(2008-4#2)
vaccine (OPV)##8##2##(1994-9#1)(1995-3#1)(1997-1#1)(2004-12#1)(2007-2#1)(2008-4#2)(2008-8#1)
vaccine -##2##2##(2007-7#1)(2013-8#1)
vaccine acceptance##2##2##(2008-9#1)(2011-2#1)
vaccine adjuvant##7##2##(1995-12#1)(1995-5#1)(1996-10#1)(1996-9#1)(2007-11#1)(2008-7#1)(2013-1#1)
vaccine adjuvants##4##2##(1996-10#1)(2007-11#2)(2008-4#1)
vaccine administered##2##2##(2007-11#1)(2012-2#1)
vaccine administration##3##2##(2007-11#1)(2008-4#1)(2009-4#1)
vaccine against the##3##3##(1995-2#1)(1997-7#2)
vaccine against tuberculosis##2##3##(1995-2#1)(2008-7#1)
vaccine against##38##2##(1991-2#1)(1991-3#2)(1992-10#1)(1995-12#1)(1995-2#3)(1995-5#2)(1996-1#1)(1997-4#1)(1997-7#3)(2006-10#3)(2007-11#2)(2007-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#4)
vaccine alone##2##2##(2005-9#1)(2010-12#1)
vaccine among##4##2##(1996-1#1)(2008-9#3)
vaccine and a##2##3##(2006-10#1)(2007-11#1)
vaccine and the##3##3##(2007-10#1)(2007-11#1)(2011-2#1)
vaccine and##39##2##(1990-10#1)(1990-2#1)(1992-10#1)(1992-2#1)(1995-12#1)(1995-5#2)(1997-5#1)(2005-11#1)(2006-10#2)(2007-10#3)(2007-11#7)(2007-2#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
vaccine antigen##2##2##(2008-7#1)(2012-12#1)
vaccine antigens against##2##3##(2008-7#1)(2013-1#1)
vaccine antigens##10##2##(1995-5#3)(2006-10#1)(2008-7#3)(2012-12#1)(2013-1#2)
vaccine are##2##2##(2006-10#1)(2007-11#1)
vaccine as##2##2##(1994-9#1)(2006-10#1)
vaccine at##5##2##(1994-9#1)(2010-10#1)(2012-2#1)(2013-1#2)
vaccine availability##2##2##(2013-7#2)
vaccine available##2##2##(1997-2#1)(2005-7#1)
vaccine awareness##2##2##(2011-2#2)
vaccine bank##3##2##(2011-2#3)
vaccine banks##3##2##(2007-6#1)(2011-2#2)
vaccine being##2##2##(1994-2#1)(2010-10#1)
vaccine by##4##2##(1994-4#1)(1994-9#1)(2008-1#1)(2010-2#1)
vaccine can be##3##3##(2007-11#1)(2010-12#1)(2011-2#1)
vaccine can##6##2##(1990-10#1)(1996-12#1)(2006-10#1)(2007-11#1)(2010-12#1)(2011-2#1)
vaccine candidate for##3##3##(1993-2#1)(2013-1#2)
vaccine candidate##19##2##(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(2006-10#4)(2008-11#2)(2008-12#1)(2008-4#2)(2009-6#1)(2010-3#1)(2013-1#3)(2013-8#1)
vaccine candidates are##4##3##(2005-8#1)(2006-10#1)(2008-4#1)(2011-2#1)
vaccine candidates in##2##3##(1993-3#1)(2010-1#1)
vaccine candidates##13##2##(1993-3#1)(2005-8#1)(2006-10#2)(2008-4#1)(2008-7#1)(2009-5#2)(2010-1#1)(2010-12#1)(2011-2#1)(2013-1#2)
vaccine cold chain##2##3##(1993-2#1)(1997-8#1)
vaccine component##2##2##(1995-8#1)(2006-10#1)
vaccine components##5##2##(1995-5#2)(2005-11#1)(2007-11#1)(2008-4#1)
vaccine composed of##2##3##(1995-5#1)(2007-11#1)
vaccine comprising##2##2##(2008-4#2)
vaccine containing##4##2##(2005-9#2)(2008-10#1)(2008-11#1)
vaccine contains##2##2##(1992-6#1)(2007-11#1)
vaccine could##3##2##(1992-10#1)(2005-11#1)(2013-8#1)
vaccine coverage in##2##3##(1997-6#1)(2010-4#1)
vaccine coverage of##2##3##(1997-6#1)(2013-7#1)
vaccine coverage##7##2##(1997-6#2)(2007-2#1)(2008-4#2)(2010-4#1)(2013-7#1)
vaccine delivery##9##2##(1995-5#3)(2008-1#1)(2008-4#2)(2009-9#1)(2010-4#1)(2010-8#1)
vaccine derived from##2##3##(1996-11#1)(2008-5#1)
vaccine design##9##2##(1995-5#2)(2005-6#1)(2006-10#1)(2007-12#1)(2007-6#2)(2007-8#1)(2012-12#1)
vaccine development and##3##3##(1997-7#1)(2008-3#1)(2008-4#1)
vaccine development has##2##3##(2008-1#1)(2009-8#1)
vaccine development##40##2##(1992-12#1)(1993-3#1)(1994-8#1)(1995-5#1)(1995-8#2)(1997-7#1)(2005-12#1)(2005-7#2)(2006-10#8)(2007-11#2)(2007-7#1)(2008-1#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
vaccine does not##2##3##(1992-8#1)(2013-8#1)
vaccine dose##2##2##(2006-10#1)(2007-2#1)
vaccine doses##4##2##(2004-12#1)(2008-11#1)(2008-5#1)(2009-12#1)
vaccine effectiveness##6##2##(2010-4#5)(2012-12#1)
vaccine efficacy and##3##3##(1995-2#1)(2006-4#1)(2010-5#1)
vaccine efficacy##23##2##(1992-10#2)(1994-2#2)(1995-2#2)(1995-5#4)(1996-1#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-4#1)(2008-4#1)(2009-4#1)(2010-1#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
vaccine failure##2##2##(1997-6#1)(2008-1#1)
vaccine failures##4##2##(1991-2#2)(1997-6#2)
vaccine for 1##2##3##(2007-11#2)
vaccine for 2 of 3##2##5##(2007-11#2)
vaccine for children##3##3##(2008-11#2)(2008-5#1)
vaccine for human use##2##4##(2006-10#2)
vaccine for the prevention of##2##5##(1995-2#1)(2011-2#1)
vaccine for typhoid##3##3##(2010-12#3)
vaccine for##27##2##(1994-8#1)(1995-2#1)(1995-5#1)(2006-10#4)(2007-10#1)(2007-11#7)(2008-11#2)(2008-5#1)(2010-10#2)(2010-12#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
vaccine formulation##3##2##(1995-5#1)(1996-10#1)(2007-11#1)
vaccine formulations##7##2##(1995-5#2)(2007-11#2)(2008-3#1)(2008-4#1)(2012-2#1)
vaccine from##2##2##(1991-8#1)(2011-1#1)
vaccine given at##2##3##(1992-2#1)(2007-11#1)
vaccine has been shown to be safe##2##7##(2005-7#2)
vaccine has been shown to be##3##6##(2005-7#2)(2007-11#1)
vaccine has been shown to##4##5##(2005-7#2)(2007-11#2)
vaccine has been##14##3##(1992-10#1)(2005-7#2)(2006-10#2)(2007-11#5)(2008-4#1)(2008-8#1)(2012-12#1)(2012-2#1)
vaccine has proved##3##3##(2006-10#1)(2011-2#1)(2013-8#1)
vaccine has##24##2##(1992-10#1)(1993-3#1)(1994-3#1)(1995-5#1)(2005-7#2)(2006-10#3)(2007-11#5)(2007-12#1)(2007-7#1)(2008-4#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
vaccine have##2##2##(1993-6#1)(2007-11#1)
vaccine immunotherapy##2##2##(2005-10#2)
vaccine in a##2##3##(2007-7#1)(2008-6#1)
vaccine in healthy##2##3##(2009-5#1)(2011-2#1)
vaccine in the##4##3##(1995-5#1)(2007-2#1)(2009-9#1)(2013-8#1)
vaccine in##38##2##(1990-2#1)(1990-6#1)(1990-9#1)(1991-8#1)(1991-9#1)(1992-10#3)(1994-6#1)(1995-5#2)(1996-1#1)(1997-6#1)(2005-9#3)(2006-12#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-2#2)(2013-1#4)(2013-8#2)
vaccine induced##3##2##(2006-10#1)(2007-2#2)
vaccine introduction##2##2##(2007-12#1)(2012-12#1)
vaccine is also##2##3##(2005-7#1)(2007-11#1)
vaccine is currently##3##3##(2007-11#1)(2012-12#1)(2012-2#1)
vaccine is not yet##2##4##(2008-4#1)(2009-9#1)
vaccine is not##3##3##(2007-2#1)(2008-4#1)(2009-9#1)
vaccine is now##2##3##(2006-2#1)(2007-11#1)
vaccine is##34##2##(1993-6#1)(1994-2#1)(1994-9#1)(2005-7#2)(2006-10#4)(2006-2#1)(2007-11#10)(2007-2#3)(2007-8#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-12#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
vaccine made##2##2##(1997-6#1)(2013-1#1)
vaccine may be##3##3##(1990-2#1)(1992-10#1)(1995-5#1)
vaccine may##7##2##(1990-2#1)(1992-10#1)(1995-5#1)(2005-7#1)(2006-10#2)(2007-9#1)
vaccine of##4##2##(2005-6#1)(2010-1#1)(2011-2#2)
vaccine on##4##2##(1992-2#1)(1997-6#1)(2011-2#1)(2012-12#1)
vaccine or##8##2##(2006-10#1)(2007-11#1)(2007-12#1)(2008-4#2)(2008-8#1)(2011-2#1)(2013-1#1)
vaccine policy##2##2##(2006-2#2)
vaccine preparation##3##2##(1993-4#1)(2006-7#1)(2008-11#1)
vaccine preparations##2##2##(2008-1#1)(2008-11#1)
vaccine prepared##2##2##(1991-8#1)(1993-4#1)
vaccine preventable##2##2##(2006-10#1)(2007-2#1)
vaccine produced##2##2##(1997-6#1)(2012-3#1)
vaccine production##5##2##(2007-11#1)(2008-11#1)(2010-12#1)(2012-3#2)
vaccine program##2##2##(1994-9#1)(2006-10#1)
vaccine prophylaxis##2##2##(1997-6#1)(2008-5#1)
vaccine protection##6##2##(1994-2#1)(1997-6#1)(2007-2#1)(2007-8#1)(2013-8#2)
vaccine recipient##2##2##(2007-11#2)
vaccine recipients##2##2##(2008-1#1)(2010-12#1)
vaccine remains##2##2##(2008-5#1)(2010-2#1)
vaccine research may be##2##4##(2005-7#1)(2013-1#1)
vaccine research##4##2##(2005-7#1)(2008-5#1)(2010-3#1)(2013-1#1)
vaccine response##7##2##(2008-3#1)(2009-4#3)(2010-10#2)(2012-12#1)
vaccine responses##5##2##(2007-11#1)(2009-4#1)(2010-2#1)(2012-12#2)
vaccine resulted in##2##3##(2008-8#1)(2011-2#1)
vaccine resulted##4##2##(2008-5#1)(2008-8#2)(2011-2#1)
vaccine safety##8##2##(1995-5#3)(2007-2#1)(2008-8#2)(2010-11#1)(2012-1#1)
vaccine schedule##2##2##(2009-4#1)(2012-2#1)
vaccine serotypes##2##2##(2011-2#1)(2013-8#1)
vaccine should be##2##3##(1994-9#1)(2009-4#1)
vaccine strain and the##2##4##(1997-6#1)(2013-8#1)
vaccine strain in##2##3##(2011-1#1)(2012-3#1)
vaccine strain##18##2##(1992-10#1)(1997-6#2)(2007-2#1)(2008-11#1)(2008-9#1)(2011-1#1)(2012-3#4)(2013-8#7)
vaccine strains of##3##3##(1990-9#1)(1995-5#1)(2012-2#1)
vaccine strains were##2##3##(2011-1#1)(2013-1#1)
vaccine strains##14##2##(1990-3#1)(1990-9#3)(1995-5#1)(2008-11#1)(2008-5#2)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
vaccine strategies##8##2##(1996-10#1)(2005-7#2)(2006-10#1)(2007-11#2)(2008-1#2)
vaccine strategy##2##2##(2012-12#1)(2013-1#1)
vaccine target##2##2##(2008-11#1)(2012-2#1)
vaccine technologies are needed to##2##5##(2009-12#1)(2010-9#1)
vaccine technologies##3##2##(2009-12#2)(2010-9#1)
vaccine than##4##2##(2007-11#4)
vaccine that can##3##3##(2006-12#1)(2007-9#1)(2010-2#1)
vaccine that##9##2##(1994-8#1)(2006-10#1)(2006-12#1)(2007-8#1)(2007-9#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)
vaccine therapy in chronic hepatitis B infection##2##7##(1994-7#1)(2005-12#1)
vaccine therapy##7##2##(1994-7#1)(2004-12#1)(2005-12#1)(2005-8#1)(2006-9#3)
vaccine to be##2##3##(1993-5#1)(2012-2#1)
vaccine to prevent##2##3##(1995-12#1)(2008-5#1)
vaccine to protect against##3##4##(2007-2#1)(2007-6#1)(2013-8#1)
vaccine to##18##2##(1993-5#1)(1995-12#1)(1996-8#1)(1997-6#1)(2005-11#1)(2006-12#1)(2007-11#2)(2007-2#1)(2007-6#1)(2007-8#1)(2008-5#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
vaccine trial##2##2##(1993-12#1)(2012-12#1)
vaccine trials##7##2##(1994-9#1)(1995-5#1)(2005-8#1)(2006-10#1)(2008-11#1)(2008-7#1)(2012-12#1)
vaccine type##5##2##(1992-10#3)(2005-9#2)
vaccine types##3##2##(2005-9#1)(2009-4#2)
vaccine under##2##2##(1994-9#1)(2006-1#1)
vaccine uptake##3##2##(2007-11#1)(2010-9#1)(2012-3#1)
vaccine used##2##2##(2007-7#1)(2013-8#1)
vaccine using##4##2##(1993-3#1)(1995-5#1)(2005-7#1)(2008-5#1)
vaccine vector##5##2##(2008-1#2)(2008-11#2)(2013-8#1)
vaccine vehicle##2##2##(1995-5#1)(2011-2#1)
vaccine virus was##2##3##(2013-8#2)
vaccine virus##8##2##(1995-5#1)(1995-9#1)(2005-9#1)(2008-5#1)(2013-8#4)
vaccine viruses##2##2##(1997-6#1)(2005-9#1)
vaccine was administered to##2##4##(1992-2#1)(2012-2#1)
vaccine was administered##4##3##(1992-2#1)(1997-6#1)(2008-5#1)(2012-2#1)
vaccine was found##2##3##(2006-7#1)(2011-3#1)
vaccine was given##2##3##(1992-10#1)(2005-9#1)
vaccine was immunogenic##2##3##(2005-7#1)(2007-11#1)
vaccine was shown##2##3##(1991-2#1)(2011-2#1)
vaccine was##34##2##(1991-2#2)(1991-3#1)(1992-10#2)(1992-2#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-6#1)(2005-7#1)(2005-9#2)(2006-10#1)(2006-7#1)(2007-11#5)(2007-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-2#6)(2011-3#1)(2012-2#1)
vaccine were##4##2##(1992-6#1)(1996-1#1)(2008-4#1)(2010-12#1)
vaccine will be##2##3##(1990-11#1)(2008-11#1)
vaccine will##4##2##(1990-11#1)(2007-11#1)(2008-11#1)(2012-3#1)
vaccine with##7##2##(1994-3#2)(2004-1#1)(2007-10#1)(2012-12#1)(2013-1#2)
vaccine would##5##2##(1995-5#1)(2007-11#1)(2008-4#1)(2008-8#1)(2010-10#1)
vaccine##1156##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#4)(1990-6#3)(1990-8#2)(1990-9#5)(1991-11#1)(1991-12#1)(1991-2#6)(1991-3#3)(1991-5#2)(1991-8#4)(1991-9#1)(1992-10#18)(1992-12#2)(1992-2#4)(1992-4#1)(1992-6#4)(1992-8#2)(1993-12#2)(1993-2#2)(1993-3#8)(1993-4#3)(1993-5#2)(1993-6#3)(1993-9#1)(1994-11#1)(1994-2#6)(1994-3#4)(1994-4#1)(1994-6#1)(1994-7#1)(1994-8#4)(1994-9#13)(1995-11#1)(1995-12#5)(1995-2#6)(1995-3#6)(1995-5#57)(1995-8#3)(1995-9#3)(1996-1#5)(1996-10#7)(1996-11#1)(1996-12#6)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-8#4)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#22)(1997-7#6)(1997-8#1)(2004-1#1)(2004-12#6)(2005-10#2)(2005-11#6)(2005-12#2)(2005-5#1)(2005-6#2)(2005-7#21)(2005-8#4)(2005-9#20)(2006-1#2)(2006-10#71)(2006-12#9)(2006-2#3)(2006-4#1)(2006-7#7)(2006-8#1)(2006-9#3)(2007-1#1)(2007-10#7)(2007-11#119)(2007-12#9)(2007-2#27)(2007-3#4)(2007-4#1)(2007-6#4)(2007-7#10)(2007-8#7)(2007-9#3)(2008-1#16)(2008-10#7)(2008-11#27)(2008-12#2)(2008-3#7)(2008-4#46)(2008-5#31)(2008-6#2)(2008-7#13)(2008-8#15)(2008-9#12)(2009-11#2)(2009-12#5)(2009-4#12)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#4)(2009-9#6)(2010-1#5)(2010-10#17)(2010-11#2)(2010-12#30)(2010-2#5)(2010-3#2)(2010-4#8)(2010-5#1)(2010-8#4)(2010-9#5)(2011-1#12)(2011-12#1)(2011-2#60)(2011-3#1)(2012-1#2)(2012-12#32)(2012-2#18)(2012-3#16)(2013-1#47)(2013-7#3)(2013-8#48)
vaccine's##2##1##(2011-2#1)(2013-8#1)
vaccine)##8##1##(1991-8#2)(1992-8#1)(1997-6#1)(2006-1#1)(2008-10#1)(2013-8#2)
vaccine-associated paralytic poliomyelitis (VAPP)##2##4##(1997-1#1)(2004-12#1)
vaccine-associated paralytic##3##2##(1995-5#1)(1997-1#1)(2004-12#1)
vaccine-associated##5##1##(1995-5#1)(1997-1#1)(2004-12#1)(2007-2#1)(2013-8#1)
vaccine-derived##6##1##(2007-10#2)(2007-2#1)(2007-8#1)(2008-4#1)(2013-8#1)
vaccine-induced antibodies##2##2##(1995-9#1)(2008-5#1)
vaccine-induced immunity##2##2##(2007-12#1)(2007-9#1)
vaccine-induced protection##2##2##(2009-4#1)(2013-1#1)
vaccine-induced##9##1##(1995-5#1)(1995-9#1)(2007-12#1)(2007-9#1)(2008-5#1)(2009-4#3)(2013-1#1)
vaccine-preventable childhood##2##2##(1994-3#1)(2010-9#1)
vaccine-preventable disease##2##2##(2010-12#1)(2010-9#1)
vaccine-preventable diseases##6##2##(1995-3#2)(1996-12#1)(2010-9#2)(2013-1#1)
vaccine-preventable##11##1##(1994-3#1)(1995-3#2)(1996-12#1)(2010-12#1)(2010-9#5)(2013-1#1)
vaccine-related##4##1##(1993-12#1)(2006-10#1)(2012-1#1)(2013-1#1)
vaccine-vaccine interactions##4##2##(2007-11#4)
vaccine?##2##1##(2006-10#1)(2012-3#1)
vaccine]##5##1##(1992-6#1)(1994-9#1)(2007-10#1)(2007-6#1)(2010-1#1)
vaccinees and in##2##3##(2006-10#1)(2007-11#1)
vaccinees in##2##2##(1991-3#2)
vaccinees##8##1##(1991-3#2)(1995-4#1)(2006-10#1)(2007-11#2)(2008-4#1)(2010-12#1)
vaccines -##2##2##(2007-12#1)(2009-7#1)
vaccines a##2##2##(2008-5#2)
vaccines administered##2##2##(1991-5#1)(2008-10#1)
vaccines against Haemophilus influenzae type##2##5##(1995-6#1)(2008-11#1)
vaccines against leishmaniasis##2##3##(2005-8#1)(2006-10#1)
vaccines against the##3##3##(1992-8#1)(2007-11#1)(2012-12#1)
vaccines against##29##2##(1992-8#1)(1994-11#1)(1995-5#2)(1995-6#1)(1997-7#1)(2005-7#2)(2005-8#1)(2006-10#4)(2007-10#2)(2007-11#3)(2008-11#2)(2008-4#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#3)
vaccines and the##4##3##(2005-7#1)(2007-11#2)(2010-7#1)
vaccines and their##2##3##(2007-11#1)(2011-2#1)
vaccines and to##2##3##(1991-12#1)(2006-12#1)
vaccines and##37##2##(1991-12#1)(1995-5#1)(1995-6#1)(1996-6#1)(1997-7#1)(2005-5#1)(2005-7#2)(2005-8#3)(2005-9#1)(2006-10#2)(2006-12#2)(2007-11#5)(2007-12#1)(2007-6#1)(2008-1#1)(2008-11#2)(2008-5#1)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-10#1)(2012-12#2)(2013-8#2)
vaccines are also##2##3##(2007-11#1)(2010-3#1)
vaccines are available##2##3##(2007-11#1)(2007-8#1)
vaccines are derived from the Oka##2##6##(2007-11#1)(2008-4#1)
vaccines are effective##2##3##(2007-11#1)(2009-9#1)
vaccines are in development##2##4##(2007-2#1)(2011-1#1)
vaccines are not##3##3##(2010-12#1)(2013-1#2)
vaccines are recommended##2##3##(2007-8#1)(2011-2#1)
vaccines are##46##2##(1991-12#1)(1995-5#1)(1996-11#1)(1997-4#1)(1997-7#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#1)(2007-11#8)(2007-2#5)(2007-8#5)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#3)(2013-1#2)
vaccines as##2##2##(2007-10#1)(2008-5#1)
vaccines at the##2##3##(1992-5#1)(1995-5#1)
vaccines at##3##2##(1992-5#1)(1995-5#1)(2013-8#1)
vaccines available##3##2##(1997-8#1)(2008-1#1)(2011-1#1)
vaccines based on##2##3##(2009-8#1)(2012-2#1)
vaccines by##3##2##(2006-5#1)(2008-5#2)
vaccines can be used##2##4##(2005-10#1)(2007-11#1)
vaccines can be##3##3##(2005-10#1)(2007-11#1)(2013-8#1)
vaccines can##7##2##(1997-4#1)(1997-8#1)(2005-10#1)(2006-10#1)(2007-11#1)(2013-8#2)
vaccines containing##2##2##(2007-11#2)
vaccines currently##2##2##(2005-7#1)(2008-3#1)
vaccines during##2##2##(1996-3#1)(2007-10#1)
vaccines for##30##2##(1990-7#1)(1992-2#1)(1994-3#1)(1995-5#2)(1996-10#1)(1997-2#1)(1997-7#1)(2005-7#4)(2005-8#1)(2006-10#2)(2007-11#3)(2007-2#2)(2008-4#2)(2008-5#1)(2009-4#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)
vaccines from##3##2##(1991-8#1)(2007-11#1)(2008-5#1)
vaccines grown in QT35 cells and JBJ-1 cells##2##8##(2013-8#2)
vaccines has been##4##3##(1994-3#1)(2007-11#1)(2009-4#1)(2009-9#1)
vaccines has##5##2##(1994-3#1)(2007-11#2)(2009-4#1)(2009-9#1)
vaccines have been developed##4##4##(2007-11#3)(2008-7#1)
vaccines have been used##3##4##(2007-8#1)(2008-5#1)(2013-8#1)
vaccines have been##10##3##(2006-9#1)(2007-11#5)(2007-8#1)(2008-5#1)(2008-7#1)(2013-8#1)
vaccines have##16##2##(1991-5#1)(2006-10#2)(2006-9#1)(2007-11#5)(2007-8#1)(2008-11#2)(2008-5#1)(2008-7#1)(2010-12#1)(2013-8#1)
vaccines in children 18##2##4##(1991-2#2)
vaccines in children and adults##3##5##(2011-2#3)
vaccines in children##5##3##(1991-2#2)(2011-2#3)
vaccines in reducing##2##3##(1994-2#1)(2013-8#1)
vaccines in the##2##3##(1994-2#1)(2008-11#1)
vaccines in##27##2##(1991-2#2)(1994-2#2)(1994-9#1)(1995-5#2)(1997-6#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#4)(2007-6#1)(2007-8#1)(2008-11#1)(2008-4#2)(2009-4#1)(2011-2#3)(2013-1#2)(2013-8#1)
vaccines is##7##2##(1994-11#1)(1995-5#1)(2007-11#1)(2008-4#1)(2009-12#1)(2010-3#1)(2010-4#1)
vaccines may be##2##3##(2005-7#1)(2007-12#1)
vaccines must be##2##3##(1995-5#1)(2007-7#1)
vaccines must##3##2##(1995-5#2)(2007-7#1)
vaccines need to##2##3##(2007-11#1)(2008-3#1)
vaccines of##3##2##(1995-5#1)(2008-5#1)(2011-2#1)
vaccines offer##2##2##(1997-8#1)(2005-7#1)
vaccines or##4##2##(2006-12#1)(2007-11#3)
vaccines prepared from##2##3##(1991-5#1)(1991-8#1)
vaccines prepared##3##2##(1991-5#1)(1991-8#1)(2011-2#1)
vaccines produced##4##2##(2005-7#1)(2006-10#1)(2008-11#1)(2009-5#1)
vaccines requires##2##2##(1997-4#1)(2008-11#1)
vaccines should##4##2##(1995-5#2)(1997-7#1)(2007-11#1)
vaccines that have been##2##4##(2007-11#1)(2012-2#1)
vaccines that##11##2##(1990-12#1)(1995-5#1)(1996-10#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-11#2)(2008-3#1)(2012-2#1)
vaccines to fight##2##3##(2009-7#1)(2012-2#1)
vaccines to prevent##3##3##(2006-10#2)(2007-8#1)
vaccines to##17##2##(1991-7#1)(1995-5#1)(1997-4#1)(2006-10#3)(2007-11#1)(2007-8#1)(2008-11#1)(2008-5#2)(2008-9#1)(2009-7#1)(2009-9#1)(2011-2#2)(2012-2#1)
vaccines using##2##2##(1994-11#1)(2008-11#1)
vaccines were##9##2##(1991-8#1)(1995-5#2)(1996-3#1)(2007-2#1)(2008-4#1)(2008-5#2)(2012-2#1)
vaccines which##3##2##(1992-6#1)(2006-10#1)(2010-12#1)
vaccines will depend on##2##4##(1997-7#2)
vaccines will##5##2##(1995-5#1)(1996-12#1)(1997-7#2)(2009-9#1)
vaccines with##10##2##(1995-5#2)(1997-8#1)(2007-11#1)(2007-8#1)(2008-5#1)(2010-2#2)(2010-3#1)(2013-8#1)
vaccines without##2##2##(2007-2#1)(2008-11#1)
vaccines would##3##2##(1993-3#1)(2006-10#1)(2008-5#1)
vaccines##595##1##(1990-12#3)(1990-3#1)(1990-7#1)(1991-10#1)(1991-12#3)(1991-2#2)(1991-5#4)(1991-7#1)(1991-8#3)(1992-10#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-11#4)(1994-2#3)(1994-3#4)(1994-9#4)(1995-4#1)(1995-5#61)(1995-6#2)(1995-9#1)(1996-10#3)(1996-11#1)(1996-12#5)(1996-3#2)(1996-6#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#10)(1997-6#9)(1997-7#7)(1997-8#5)(2005-10#1)(2005-5#1)(2005-7#19)(2005-8#10)(2005-9#3)(2006-1#2)(2006-10#35)(2006-12#6)(2006-2#4)(2006-5#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#4)(2007-11#78)(2007-12#5)(2007-2#12)(2007-6#3)(2007-7#1)(2007-8#15)(2008-1#5)(2008-10#3)(2008-11#20)(2008-3#6)(2008-4#19)(2008-5#30)(2008-7#4)(2008-8#3)(2008-9#2)(2009-12#4)(2009-3#1)(2009-4#4)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#7)(2010-1#1)(2010-10#1)(2010-12#6)(2010-2#2)(2010-3#6)(2010-4#4)(2010-5#1)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#11)(2011-2#25)(2012-1#1)(2012-10#1)(2012-12#9)(2012-2#13)(2012-3#1)(2013-1#6)(2013-8#27)
vaccines)##2##1##(1997-7#1)(2007-11#1)
vaccines?##2##1##(2008-12#2)
vaccines]##5##1##(1990-2#1)(1992-5#1)(1996-9#1)(2008-8#1)(2010-1#1)
vaccinia construct##3##2##(1991-7#3)
vaccinia viral vector##2##3##(2008-8#2)
vaccinia virus expression system##2##4##(2008-2#2)
vaccinia virus##30##2##(1991-12#1)(1991-5#2)(1991-7#3)(1991-9#2)(1994-12#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-5#2)(2004-1#1)(2007-11#2)(2007-2#1)(2007-3#1)(2008-11#1)(2008-2#4)(2008-8#3)(2013-1#2)(2013-7#1)
vaccinia##48##1##(1991-12#2)(1991-5#2)(1991-7#6)(1991-9#2)(1994-12#1)(1994-9#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-5#3)(1997-1#1)(1997-3#1)(2004-1#1)(2007-11#2)(2007-2#3)(2007-3#1)(2008-11#1)(2008-2#6)(2008-4#1)(2008-8#6)(2008-9#1)(2009-9#1)(2013-1#2)(2013-7#1)
vaccinii were##2##2##(2008-10#2)
vaccinii##4##1##(2008-10#4)
vaccinii-corymbosi and##2##2##(2008-10#2)
vaccinii-corymbosi##17##1##(2008-10#17)
vaccinology##7##1##(2010-8#6)(2012-2#1)
vacuma and transposa##2##3##(2008-10#2)
vacuma isolates##2##2##(2008-10#2)
vacuma##10##1##(2008-10#10)
vacuo##11##1##(1990-2#2)(1993-11#1)(2007-12#2)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-2#1)(2010-5#1)
vacuolar ATPase##4##2##(1990-2#1)(1995-6#3)
vacuolar H(+)-ATPase##10##2##(1990-3#4)(1993-11#1)(1994-9#2)(1995-3#3)
vacuolar Mg2+ stores##2##3##(1997-1#2)
vacuolar and##3##2##(1997-1#1)(2009-8#2)
vacuolar degeneration##3##2##(1990-3#1)(2008-10#1)(2008-5#1)
vacuolar membrane##9##2##(1991-12#1)(1994-9#1)(1995-3#3)(2008-11#1)(2009-10#2)(2012-2#1)
vacuolar proton ATPase##2##3##(1993-11#1)(1994-6#1)
vacuolar sorting##3##2##(2009-10#2)(2009-8#1)
vacuolar type##5##2##(1990-7#1)(1991-10#1)(1994-6#1)(1994-8#2)
vacuolar##63##1##(1990-2#1)(1990-3#5)(1990-7#1)(1991-10#1)(1991-12#2)(1991-2#4)(1992-8#1)(1993-11#2)(1994-6#2)(1994-8#2)(1994-9#4)(1995-3#10)(1995-6#3)(1996-5#1)(1996-6#1)(1997-1#3)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-10#6)(2009-8#6)(2011-2#1)(2012-2#1)
vacuolar-type H(+)-ATPase##2##2##(1995-3#1)(2008-5#1)
vacuolata##3##1##(1993-11#2)(1994-8#1)
vacuolated area##2##2##(2007-10#1)(2007-12#1)
vacuolated cytoplasm##2##2##(2008-5#1)(2008-9#1)
vacuolated lymphocytes##2##2##(1996-4#1)(2007-3#1)
vacuolated##10##1##(1996-4#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)
vacuolation of##3##2##(1995-11#1)(2007-12#1)(2008-10#1)
vacuolation##10##1##(1991-1#1)(1992-7#1)(1995-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-5#1)(2012-2#1)
vacuole in##2##2##(1997-6#1)(2009-12#1)
vacuole of##3##2##(1990-12#2)(2011-2#1)
vacuole##34##1##(1990-12#2)(1993-3#2)(1993-6#1)(1996-10#1)(1997-6#3)(2007-3#1)(2007-5#1)(2008-1#2)(2008-11#3)(2008-6#1)(2008-9#2)(2009-10#7)(2009-12#1)(2009-8#3)(2011-2#2)(2012-2#2)
vacuoles and##11##2##(1994-9#1)(2007-12#3)(2007-5#1)(2008-11#1)(2008-5#1)(2008-7#3)(2010-12#1)
vacuoles are##3##2##(2007-12#2)(2008-7#1)
vacuoles filled with##2##3##(2005-12#1)(2009-10#1)
vacuoles in chloroquine-induced myopathy-affected muscle##2##5##(1995-12#2)
vacuoles in the##2##3##(2006-8#1)(2008-12#1)
vacuoles in##6##2##(1995-12#2)(2006-8#1)(2007-9#1)(2008-12#1)(2013-1#1)
vacuoles of##4##2##(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)
vacuoles were##3##2##(1991-2#1)(2008-7#2)
vacuoles##75##1##(1990-6#1)(1991-2#3)(1991-5#1)(1994-8#1)(1994-9#3)(1995-12#3)(1996-3#1)(1996-9#1)(2005-12#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-12#13)(2007-5#1)(2007-9#4)(2008-10#5)(2008-11#6)(2008-12#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#13)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2010-12#2)(2012-7#1)(2013-1#1)
vacuolization and##3##2##(1995-7#1)(2008-10#1)(2008-8#1)
vacuolization of the##3##3##(1992-3#1)(2008-9#2)
vacuolization of##6##2##(1990-6#1)(1992-3#1)(2008-12#1)(2008-8#1)(2008-9#2)
vacuolization##19##1##(1990-6#1)(1992-3#1)(1995-7#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-8#2)(2008-9#8)
vacuous chewing movements##3##3##(1996-2#3)
vacuous chewing##5##2##(1993-3#2)(1996-2#3)
vacuous##7##1##(1993-3#2)(1996-2#3)(2006-3#1)(2011-12#1)
vacuum and forceps deliveries##3##4##(1991-6#3)
vacuum and##10##2##(1991-6#3)(1995-6#1)(1995-8#1)(2006-4#1)(2008-3#1)(2008-5#1)(2008-6#1)(2013-1#1)
vacuum arc##2##2##(2004-9#2)
vacuum aspiration##5##2##(1995-8#1)(1996-8#1)(2007-1#1)(2011-1#2)
vacuum assisted closure (VAC)##2##4##(2007-8#1)(2008-11#1)
vacuum assisted closure##3##3##(2007-8#1)(2008-11#2)
vacuum chamber##3##2##(2006-4#1)(2006-5#1)(2008-10#1)
vacuum conditions##4##2##(2007-11#1)(2010-4#1)(2012-1#1)(2013-8#1)
vacuum devices##2##2##(2006-12#2)
vacuum disc herniation##3##3##(2012-2#3)
vacuum disc##7##2##(2008-12#2)(2012-2#5)
vacuum heat pump dryer##2##4##(2011-2#2)
vacuum heat pump##3##3##(2011-2#3)
vacuum heating##2##2##(2008-10#2)
vacuum infiltration##2##2##(2008-9#1)(2013-8#1)
vacuum or##4##2##(1990-8#1)(1991-6#1)(1996-8#1)(2008-10#1)
vacuum packaging##3##2##(2011-2#3)
vacuum phenomenon##2##2##(2006-8#1)(2007-11#1)
vacuum pump##3##2##(2008-10#1)(2010-8#1)(2012-3#1)
vacuum ultraviolet (VUV)##2##3##(2008-2#1)(2010-4#1)
vacuum ultraviolet radiation##4##3##(2007-11#2)(2007-12#1)(2008-2#1)
vacuum ultraviolet##11##2##(2007-11#2)(2007-12#4)(2008-1#1)(2008-2#3)(2010-4#1)
vacuum was##2##2##(2008-10#1)(2011-2#1)
vacuum##138##1##(1990-11#1)(1990-8#1)(1991-6#5)(1992-8#1)(1994-2#1)(1995-11#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-12#1)(1996-8#3)(2004-9#2)(2005-11#1)(2006-12#2)(2006-4#3)(2006-5#2)(2006-8#3)(2007-1#2)(2007-11#6)(2007-12#7)(2007-4#1)(2007-8#2)(2008-1#3)(2008-10#14)(2008-11#3)(2008-12#2)(2008-2#12)(2008-3#8)(2008-5#7)(2008-6#1)(2008-7#4)(2008-9#1)(2009-2#1)(2009-8#1)(2010-1#3)(2010-12#1)(2010-4#4)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-2#6)(2012-3#1)(2013-1#3)(2013-8#2)
vacuum)##3##1##(2008-11#1)(2009-8#2)
vacuum-UV##2##1##(2007-12#1)(2008-2#1)
vacuum-assisted closure therapy##4##3##(2007-8#3)(2012-2#1)
vacuum-assisted closure##6##2##(2007-8#4)(2008-2#1)(2012-2#1)
vacuum-assisted socket##5##2##(2007-10#5)
vacuum-assisted therapy with a handcrafted system##2##6##(2007-8#2)
vacuum-assisted therapy##3##2##(2007-8#3)
vacuum-assisted wound##2##2##(2009-9#1)(2010-2#1)
vacuum-assisted##21##1##(2006-6#1)(2007-10#6)(2007-8#7)(2008-2#1)(2009-9#1)(2010-12#1)(2010-2#1)(2012-2#2)(2012-3#1)
vacuum-deposited##2##1##(2008-3#1)(2013-8#1)
vacuum-packaged##3##1##(2007-3#1)(2010-4#2)
vacuum-ultraviolet spectrograph##2##2##(2008-3#2)
vacuum-ultraviolet wavelengths##2##2##(2008-3#2)
vacuum-ultraviolet##12##1##(1990-12#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#5)
vacuums##2##1##(2008-10#1)(2008-11#1)
vadis##3##1##(1993-2#1)(2007-9#1)(2011-2#1)
vagal activity##3##2##(2009-10#1)(2011-12#1)(2013-1#1)
vagal afferent neurones##2##3##(1992-9#2)
vagal afferent pathway##2##3##(1993-11#1)(2006-10#1)
vagal afferent##11##2##(1991-11#2)(1992-9#2)(1993-11#1)(1993-7#4)(2006-10#1)(2010-11#1)
vagal afferent-mediated##2##2##(1992-7#2)
vagal afferents##2##2##(1990-7#1)(1992-9#1)
vagal control##2##2##(1991-4#1)(2013-7#1)
vagal lobe of goldfish##2##4##(2010-2#2)
vagal lobe##5##2##(2008-6#1)(2010-2#4)
vagal modulation and##2##3##(2012-2#2)
vagal modulation##4##2##(2012-2#4)
vagal nerve##3##2##(1996-1#1)(1997-8#1)(2009-7#1)
vagal nerves##2##2##(1991-2#1)(1995-3#1)
vagal reflex##2##2##(1995-3#2)
vagal regulation##4##2##(2013-1#4)
vagal stimulation##2##2##(1997-7#1)(2013-1#1)
vagal tone##6##2##(1990-2#1)(1991-1#1)(1991-10#1)(2006-4#1)(2009-10#1)(2011-2#1)
vagal transport of AVP receptors##2##5##(1992-9#2)
vagal##72##1##(1990-2#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-10#3)(1991-11#2)(1991-2#1)(1991-4#1)(1992-6#1)(1992-7#2)(1992-9#8)(1993-11#3)(1993-7#4)(1995-3#3)(1996-1#1)(1996-2#1)(1996-5#2)(1996-6#2)(1997-7#1)(1997-8#1)(2006-10#2)(2006-4#1)(2007-10#1)(2007-12#1)(2008-6#1)(2008-8#1)(2009-10#2)(2009-7#1)(2010-11#1)(2010-2#6)(2011-12#2)(2011-2#1)(2012-2#5)(2013-1#6)(2013-7#1)
vagally mediated##2##2##(2006-10#1)(2009-7#1)
vagally##7##1##(1990-2#1)(1990-5#1)(1991-11#2)(1996-9#1)(2006-10#1)(2009-7#1)
vagile##2##1##(2008-8#2)
vagina and rectum##2##3##(2006-7#2)
vagina and##8##2##(1990-10#1)(1996-12#2)(2006-7#2)(2008-9#2)(2012-2#1)
vagina and/or##2##2##(1996-12#2)
vagina at##2##2##(1991-12#1)(2006-10#1)
vagina is##3##2##(1992-2#1)(1996-12#1)(2013-1#1)
vagina or##2##2##(1992-3#1)(2009-2#1)
vagina syndrome after classical anterior##2##5##(2012-3#2)
vagina syndrome##3##2##(2012-3#3)
vagina##66##1##(1990-10#2)(1990-12#2)(1990-2#1)(1990-8#1)(1991-12#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1993-1#1)(1994-1#2)(1994-7#1)(1995-11#1)(1996-12#7)(1996-9#1)(1997-7#5)(2005-8#1)(2006-10#4)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#3)(2007-11#1)(2007-12#2)(2007-4#2)(2007-7#2)(2007-8#2)(2008-11#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-6#1)(2010-11#1)(2011-1#1)(2012-2#1)(2012-3#3)(2013-1#2)
vaginal HPV##2##2##(1992-3#2)
vaginal Lactobacillus##3##2##(2006-5#2)(2006-8#1)
vaginal TCC##2##2##(2008-9#2)
vaginal agenesis##5##2##(1991-4#3)(1993-1#2)
vaginal and external anogenital condylomas##3##5##(1996-1#3)
vaginal and##8##2##(1996-1#4)(2007-10#1)(2007-11#1)(2008-4#1)(2010-11#1)
vaginal approach to##2##3##(1991-3#1)(1996-12#1)
vaginal approach##5##2##(1991-3#1)(1996-12#2)(2004-10#1)(2013-1#1)
vaginal birth after caesarean section in##2##6##(2011-1#2)
vaginal birth after caesarean section##5##5##(2011-1#4)(2011-12#1)
vaginal birth after caesarean##6##4##(2011-1#5)(2011-12#1)
vaginal birth after cesarean##2##4##(2007-2#1)(2010-9#1)
vaginal birth after##9##3##(2007-2#1)(2010-9#2)(2011-1#5)(2011-12#1)
vaginal birth##14##2##(2007-2#5)(2010-9#2)(2011-1#5)(2011-12#1)(2013-1#1)
vaginal bleeding and##2##3##(1996-9#1)(2012-2#1)
vaginal bleeding##14##2##(1991-2#1)(1996-9#1)(2004-10#1)(2005-10#2)(2006-4#1)(2007-10#1)(2007-11#1)(2007-5#1)(2009-4#1)(2009-6#1)(2011-2#1)(2012-2#2)
vaginal cancer##2##2##(2006-10#1)(2007-11#1)
vaginal candidiasis##2##2##(2008-5#1)(2012-12#1)
vaginal cylinder##2##2##(1994-9#1)(2009-2#1)
vaginal cylinders##7##2##(2009-2#7)
vaginal deliveries##4##2##(2006-2#1)(2008-11#1)(2011-2#1)(2013-8#1)
vaginal delivery and##3##3##(1993-7#1)(1995-12#1)(2006-10#1)
vaginal delivery between##2##3##(2011-1#1)(2011-2#1)
vaginal delivery of##2##3##(2004-10#1)(2010-8#1)
vaginal delivery under epidural##2##4##(1992-8#2)
vaginal delivery##29##2##(1992-8#3)(1993-4#1)(1993-6#1)(1993-7#2)(1995-12#1)(2004-10#4)(2006-10#3)(2006-12#1)(2006-5#1)(2007-8#1)(2010-8#1)(2011-1#2)(2011-12#3)(2011-2#5)
vaginal discharge or##2##3##(2006-10#1)(2007-7#1)
vaginal discharge##18##2##(1996-12#1)(2006-10#5)(2007-2#1)(2007-7#9)(2010-2#1)(2011-2#1)
vaginal dryness##2##2##(1994-3#1)(2012-11#1)
vaginal dysplasia (VAIN##2##3##(1992-9#2)
vaginal examination##2##2##(1992-12#1)(2011-2#1)
vaginal exudates from##2##3##(2006-10#1)(2007-10#1)
vaginal flora##2##2##(2006-10#1)(2007-12#1)
vaginal fluid##13##2##(1993-1#1)(1995-11#1)(1996-12#7)(2006-5#4)
vaginal fluids##2##2##(1996-12#1)(2006-10#1)
vaginal hysterectomies performed by the senior##2##6##(1993-12#2)
vaginal hysterectomies##10##2##(1993-12#4)(1995-1#6)
vaginal hysterectomy in##3##3##(1993-12#2)(1995-12#1)
vaginal hysterectomy is##3##3##(1993-12#1)(2010-3#1)(2011-2#1)
vaginal hysterectomy was##2##3##(1995-12#1)(1996-2#1)
vaginal hysterectomy with or without##2##5##(1993-2#1)(1994-2#1)
vaginal hysterectomy with##3##3##(1993-2#1)(1994-2#1)(2010-3#1)
vaginal hysterectomy##39##2##(1991-3#2)(1993-12#11)(1993-2#3)(1993-3#1)(1994-2#4)(1995-1#1)(1995-12#2)(1995-3#2)(1996-2#3)(2008-12#1)(2010-3#3)(2011-2#5)(2012-2#1)
vaginal infections##2##2##(2006-10#1)(2007-7#1)
vaginal intercourse##2##2##(2007-12#1)(2011-1#1)
vaginal intraepithelial neoplasia##3##3##(1997-7#1)(2006-10#1)(2013-1#1)
vaginal isolates##2##2##(2006-8#2)
vaginal lavage##2##2##(1996-12#1)(2007-1#1)
vaginal mass##3##2##(1990-2#1)(2010-2#2)
vaginal mesh##3##2##(2013-1#3)
vaginal microbicides##2##2##(2007-7#1)(2011-1#1)
vaginal microflora##2##2##(1995-11#2)
vaginal misoprostol for##2##3##(2007-8#1)(2009-7#1)
vaginal misoprostol##3##2##(2007-8#2)(2009-7#1)
vaginal opening##5##2##(1995-1#2)(1995-11#3)
vaginal operations##2##2##(1992-1#2)
vaginal or##2##2##(2007-2#1)(2010-7#1)
vaginal procedures##2##2##(1993-12#1)(2010-1#1)
vaginal product##2##2##(2007-7#1)(2012-2#1)
vaginal prolapse##4##2##(2007-4#2)(2011-2#2)
vaginal ring##2##2##(1992-1#1)(1994-4#1)
vaginal rings##3##2##(1994-9#2)(2005-8#1)
vaginal route##3##2##(1994-2#1)(1995-1#1)(1995-12#1)
vaginal secretion##3##2##(1996-12#1)(2006-8#2)
vaginal secretions##5##2##(1990-12#1)(1992-2#3)(1994-8#1)
vaginal septum##6##2##(2006-6#4)(2011-1#2)
vaginal sex##5##2##(2010-7#2)(2013-1#3)
vaginal surface##2##2##(2009-11#1)(2009-2#1)
vaginal swab##2##2##(1993-1#1)(2010-2#1)
vaginal swabs taken##2##3##(2008-12#2)
vaginal swabs##5##2##(2006-10#1)(2007-7#2)(2008-12#2)
vaginal ultrasonography##2##2##(1991-11#1)(1992-3#1)
vaginal ultrasound##2##2##(1992-12#1)(1995-8#1)
vaginal vault##6##2##(1991-12#1)(2004-10#1)(2006-10#3)(2013-1#1)
vaginal wall##7##2##(1991-12#1)(1996-12#1)(2007-12#1)(2008-10#1)(2010-2#2)(2011-2#1)
vaginal washings##2##2##(1996-12#1)(2006-10#1)
vaginal##362##1##(1990-11#2)(1990-12#1)(1990-2#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#4)(1991-4#3)(1992-1#3)(1992-12#4)(1992-2#3)(1992-3#4)(1992-8#3)(1992-9#4)(1993-1#4)(1993-12#16)(1993-2#3)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#2)(1994-1#1)(1994-2#7)(1994-3#1)(1994-4#1)(1994-8#1)(1994-9#3)(1995-1#10)(1995-11#7)(1995-12#4)(1995-3#2)(1995-8#1)(1996-1#4)(1996-12#16)(1996-2#4)(1996-9#3)(1997-7#2)(2004-1#1)(2004-10#8)(2005-10#2)(2005-8#4)(2006-10#22)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#9)(2006-6#5)(2006-8#6)(2007-1#1)(2007-10#5)(2007-11#3)(2007-12#4)(2007-2#7)(2007-4#2)(2007-5#1)(2007-7#15)(2007-8#3)(2008-10#7)(2008-11#4)(2008-12#3)(2008-4#3)(2008-5#4)(2008-8#2)(2008-9#3)(2009-11#1)(2009-2#11)(2009-4#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#7)(2010-3#5)(2010-4#1)(2010-5#2)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#13)(2011-12#5)(2011-2#19)(2012-11#1)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#13)(2013-8#1)
vaginalis in##2##2##(2006-10#1)(2008-10#1)
vaginalis should##2##2##(1997-4#1)(2012-2#1)
vaginalis with##4##2##(2006-10#4)
vaginalis##34##1##(1997-4#6)(2006-10#13)(2007-12#1)(2007-7#1)(2008-10#4)(2008-4#1)(2008-7#5)(2012-12#1)(2012-2#2)
vaginally##9##1##(1990-12#2)(1991-2#1)(1994-2#1)(1994-9#1)(2004-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
vaginectomy##2##1##(1993-1#1)(1996-12#1)
vaginismus##4##1##(2004-10#4)
vaginitis##10##1##(1994-12#1)(1997-4#1)(2007-12#1)(2007-7#1)(2011-1#2)(2011-2#4)
vaginocervical stimulation##2##2##(1992-9#2)
vaginocervical##3##1##(1992-9#3)
vaginoplasty and##2##2##(2007-7#1)(2013-1#1)
vaginoscopy##2##1##(2006-10#2)
vaginosis (BV)##4##2##(2006-10#2)(2007-12#1)(2008-10#1)
vaginosis##31##1##(2006-10#13)(2006-4#1)(2006-7#1)(2007-12#4)(2007-7#5)(2008-10#1)(2008-12#1)(2008-8#1)(2011-1#1)(2011-2#3)
vagotomized and##2##2##(1997-6#1)(1997-8#1)
vagotomized##3##1##(1994-10#1)(1997-6#1)(1997-8#1)
vagotomy and drainage##2##3##(2006-8#2)
vagotomy and##4##2##(1990-6#1)(1991-11#1)(2006-8#2)
vagotomy with pyloroplasty##4##3##(1990-6#4)
vagotomy##25##1##(1990-6#5)(1990-7#1)(1991-1#1)(1991-11#3)(1991-2#1)(1993-2#1)(1993-7#1)(1994-6#4)(1995-12#1)(1995-3#1)(1996-5#1)(1996-9#1)(2006-6#1)(2006-8#2)(2008-4#1)
vague abdominal pain##2##3##(1993-3#1)(2011-2#1)
vague and non-specific symptoms##2##4##(1993-3#2)
vague and non-specific##3##3##(1993-3#2)(2008-3#1)
vague and##6##2##(1993-3#2)(2008-3#1)(2010-4#1)(2012-12#1)(2013-1#1)
vague##27##1##(1990-6#1)(1993-3#3)(1993-6#1)(1995-12#1)(1997-7#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-4#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
vaguely##2##1##(1991-1#1)(2007-9#1)
vagueness of##4##2##(2006-10#1)(2007-2#1)(2008-1#1)(2011-2#1)
vagus nerve in##3##3##(1992-3#1)(1994-6#1)(2008-4#1)
vagus nerve stimulation##7##3##(1995-12#1)(1996-1#2)(2008-1#1)(2008-7#1)(2011-1#1)(2011-2#1)
vagus nerve##34##2##(1991-10#1)(1992-3#2)(1993-12#2)(1994-6#4)(1995-12#2)(1995-3#1)(1996-1#4)(1997-3#1)(2006-10#1)(2006-12#1)(2006-6#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-7#2)(2009-10#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)
vagus nerves##5##2##(1992-8#3)(1995-6#1)(2008-4#1)
vagus##51##1##(1991-10#1)(1992-3#3)(1992-8#3)(1993-12#7)(1993-9#1)(1994-2#1)(1994-6#4)(1995-12#2)(1995-3#1)(1995-6#1)(1996-1#4)(1996-5#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-6#1)(2008-1#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-10#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-1#1)(2013-1#2)
vaillantii s##2##2##(2013-7#2)
vaillantii##3##1##(2013-7#3)
valaciclovir to acyclovir##2##3##(1995-6#2)
valaciclovir##8##1##(1995-6#6)(2007-11#1)(2012-2#1)
valdecoxib##3##1##(2006-10#2)(2007-12#1)
valence and##5##2##(1995-9#1)(2005-11#1)(2008-5#1)(2008-8#1)(2010-2#1)
valence of the##4##3##(2005-11#1)(2008-10#1)(2008-2#1)(2009-12#1)
valence of visual##2##3##(2009-4#1)(2012-11#1)
valence of##11##2##(2005-11#1)(2008-10#2)(2008-2#3)(2008-5#1)(2009-12#1)(2009-4#1)(2012-11#2)
valence states##3##2##(2006-4#1)(2007-5#1)(2008-10#1)
valence##55##1##(1991-5#2)(1992-8#2)(1995-10#1)(1995-3#1)(1995-9#2)(1997-7#3)(2005-11#6)(2006-4#2)(2007-10#1)(2007-11#2)(2007-5#1)(2008-10#6)(2008-11#5)(2008-2#3)(2008-4#2)(2008-5#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-2#1)(2012-11#3)(2012-12#1)
valency chlorine species##2##3##(2008-10#2)
valency##7##1##(1990-10#1)(2005-11#2)(2008-10#3)(2012-2#1)
valent##3##1##(1991-5#1)(2008-6#1)(2010-5#1)
valerate##9##1##(1990-12#2)(1995-1#1)(1996-12#2)(2007-11#2)(2009-2#1)(2009-6#1)
valeric acid was##2##3##(1991-5#1)(2008-6#1)
valeric acid##5##2##(1991-5#2)(2008-10#1)(2008-6#2)
valeric##9##1##(1991-5#3)(2005-11#1)(2008-10#1)(2008-6#3)(2011-2#1)
valganciclovir##3##1##(2010-12#2)(2013-1#1)
valgus and##2##2##(2007-2#1)(2012-2#1)
valgus angle##2##2##(2007-8#1)(2012-2#1)
valgus deformity##8##2##(2007-7#1)(2009-10#1)(2009-3#1)(2010-11#1)(2012-2#4)
valgus extension overload##2##3##(2008-8#2)
valgus malalignment##3##2##(2008-8#1)(2009-4#1)(2012-2#1)
valgus osteotomy##3##2##(2009-3#2)(2012-2#1)
valgus##45##1##(2007-2#1)(2007-7#1)(2007-8#2)(2008-12#1)(2008-7#2)(2008-8#6)(2009-10#3)(2009-3#3)(2009-4#3)(2009-5#2)(2010-11#1)(2010-3#1)(2010-7#2)(2012-2#9)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
valid alternative to the##3##4##(1990-2#1)(2006-6#1)(2008-7#1)
valid alternative to##8##3##(1990-10#1)(1990-2#1)(1992-5#1)(1995-3#1)(2006-6#1)(2007-8#1)(2008-3#1)(2008-7#1)
valid alternative##15##2##(1990-10#1)(1990-2#1)(1992-5#1)(1992-6#1)(1995-3#1)(2006-6#1)(2007-8#2)(2008-10#3)(2008-3#1)(2008-7#2)(2011-2#1)
valid and reliable measures of##2##5##(1996-2#1)(2006-2#1)
valid and reliable##18##3##(1993-12#1)(1993-2#1)(1996-2#1)(1997-1#1)(1997-8#1)(2006-12#1)(2006-2#2)(2007-12#1)(2007-5#1)(2008-12#1)(2008-7#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-11#1)(2013-1#2)
valid and that##2##3##(2006-3#1)(2008-10#1)
valid and useful##2##3##(2010-10#1)(2010-4#1)
valid and##38##2##(1990-8#1)(1992-10#1)(1993-12#1)(1993-2#1)(1996-2#1)(1997-1#1)(1997-8#1)(2006-12#1)(2006-2#2)(2006-3#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#2)(2007-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#3)
valid as long as the##2##5##(2007-11#1)(2008-2#1)
valid as##3##2##(2007-11#1)(2008-2#1)(2013-7#1)
valid assessment of##3##3##(1995-11#1)(2008-7#1)(2008-9#1)
valid assessment##4##2##(1995-11#1)(2008-7#1)(2008-9#1)(2011-12#1)
valid at##2##2##(2006-4#1)(2006-8#1)
valid cases##2##2##(2012-11#1)(2012-12#1)
valid comparisons##2##2##(1995-8#1)(2006-9#1)
valid concerns about##2##3##(1996-2#1)(2008-8#1)
valid concerns##3##2##(1996-2#1)(2008-8#1)(2012-1#1)
valid data for##2##3##(1996-9#1)(2008-2#1)
valid data##3##2##(1996-9#1)(2008-2#1)(2013-7#1)
valid evidence##3##2##(2007-8#1)(2008-7#1)(2013-1#1)
valid for any##2##3##(2008-2#2)
valid for both##2##3##(2005-10#1)(2008-2#1)
valid for the##6##3##(1997-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)
valid for##30##2##(1991-9#1)(1993-6#1)(1994-5#1)(1995-3#1)(1997-8#2)(2005-10#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#8)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)(2013-8#1)
valid if the##2##3##(1991-8#1)(2008-3#1)
valid if##3##2##(1991-8#1)(2008-3#1)(2012-11#1)
valid in the##3##3##(2006-6#1)(2007-11#1)(2007-8#1)
valid in##9##2##(1996-8#1)(2006-11#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-8#2)(2008-9#2)
valid indicator of##2##3##(1997-5#1)(2010-12#1)
valid information##3##2##(1990-2#1)(2005-10#1)(2007-2#1)
valid measures of##2##3##(1994-2#1)(2010-10#1)
valid measures##3##2##(1994-2#1)(2007-11#1)(2010-10#1)
valid methods##2##2##(2008-7#1)(2010-9#1)
valid model##3##2##(1992-12#1)(2009-4#1)(2010-2#1)
valid procedure##2##2##(2011-2#2)
valid reasons##2##2##(1991-6#1)(2006-8#1)
valid results##3##2##(2009-4#1)(2010-12#1)(2012-1#1)
valid scientific##2##2##(2007-4#1)(2008-7#1)
valid test##2##2##(2010-12#1)(2011-2#1)
valid than those##2##3##(1994-11#1)(1997-3#1)
valid than##3##2##(1994-11#1)(1997-3#1)(2010-2#1)
valid to##2##2##(1995-4#1)(2007-8#1)
valid tool for##3##3##(2008-7#1)(2010-10#1)(2011-1#1)
valid tool##4##2##(2008-3#1)(2008-7#1)(2010-10#1)(2011-1#1)
valid treatment##4##2##(2006-12#1)(2011-2#1)(2011-3#1)(2013-1#1)
valid when##3##2##(2006-2#1)(2008-2#1)(2010-9#1)
valid##322##1##(1990-10#2)(1990-11#1)(1990-2#2)(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-9#2)(1994-11#2)(1994-2#2)(1994-3#1)(1994-5#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#3)(1995-8#1)(1996-12#3)(1996-2#3)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-8#3)(2004-10#1)(2005-10#3)(2005-11#2)(2005-8#1)(2006-10#3)(2006-11#2)(2006-12#2)(2006-2#7)(2006-3#2)(2006-4#1)(2006-5#3)(2006-6#7)(2006-7#1)(2006-8#5)(2006-9#2)(2007-10#1)(2007-11#8)(2007-12#8)(2007-2#4)(2007-3#1)(2007-4#4)(2007-5#1)(2007-7#1)(2007-8#9)(2007-9#1)(2008-1#1)(2008-10#19)(2008-11#3)(2008-12#5)(2008-2#18)(2008-3#19)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#15)(2008-8#2)(2008-9#6)(2009-1#1)(2009-10#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#1)(2010-10#3)(2010-11#4)(2010-12#4)(2010-2#3)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#2)(2011-12#1)(2011-2#12)(2011-3#2)(2012-1#3)(2012-11#5)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#10)(2013-7#4)(2013-8#2)
valid? A##2##2##(1993-11#1)(2011-1#1)
valid?##4##1##(1993-11#1)(2006-8#1)(2009-11#1)(2011-1#1)
validate a##18##2##(1996-2#1)(2006-11#1)(2007-12#1)(2007-4#1)(2008-10#5)(2008-5#1)(2008-7#1)(2012-1#2)(2012-2#1)(2013-1#2)(2013-8#2)
validate an##4##2##(1995-12#1)(2008-10#1)(2010-11#1)(2011-1#1)
validate its use##2##3##(2007-8#1)(2011-1#1)
validate or##2##2##(2007-11#1)(2012-12#1)
validate our method##4##3##(2007-12#1)(2008-3#1)(2013-1#2)
validate our##11##2##(1992-12#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-3#1)(2009-12#2)(2009-9#1)(2012-3#1)(2013-1#2)
validate the measure##2##3##(1993-3#1)(2007-12#1)
validate the novel##2##3##(2008-2#1)(2008-5#1)
validate the proposed##3##3##(2008-2#1)(2008-7#1)(2013-1#1)
validate the technique##6##3##(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)
validate the use of##5##4##(1996-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)
validate the##106##2##(1990-10#2)(1991-5#1)(1992-4#1)(1992-6#1)(1993-3#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-12#2)(2007-4#2)(2007-6#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#19)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#13)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#2)(2010-8#2)(2011-1#3)(2011-2#9)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
validate their##3##2##(1994-3#1)(2006-12#1)(2010-12#1)
validate these results##2##3##(2010-12#1)(2013-1#1)
validate these##6##2##(2005-8#1)(2007-11#1)(2009-10#1)(2010-12#1)(2010-2#1)(2013-1#1)
validate this##8##2##(1994-2#1)(1995-1#1)(1995-3#1)(1995-5#1)(2008-1#1)(2008-10#2)(2013-1#1)
validate##211##1##(1990-10#2)(1991-5#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-11#2)(2006-12#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-4#5)(2007-5#2)(2007-6#1)(2007-8#7)(2007-9#1)(2008-1#3)(2008-10#32)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#17)(2008-5#4)(2008-6#5)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#4)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-4#2)(2010-7#2)(2010-8#3)(2011-1#6)(2011-2#11)(2012-1#5)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#10)(2013-8#4)
validated FE##2##2##(2006-11#1)(2007-4#1)
validated HPLC method##2##3##(1996-6#1)(2011-1#1)
validated a##7##2##(2004-12#1)(2007-8#1)(2008-3#1)(2009-8#1)(2011-2#2)(2013-7#1)
validated according to the##3##4##(1997-8#1)(2013-7#2)
validated against PMHS##2##3##(2006-11#2)
validated against experimental data##3##4##(2007-4#2)(2012-2#1)
validated against experimental##4##3##(2007-4#2)(2008-3#1)(2012-2#1)
validated against laboratory##2##3##(2008-10#1)(2008-7#1)
validated against the##4##3##(1997-8#1)(2006-11#2)(2007-4#1)
validated against##28##2##(1996-3#1)(1997-8#1)(2006-11#8)(2006-4#1)(2007-4#6)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#2)(2010-9#1)(2012-2#2)(2012-3#1)(2012-7#1)
validated and applied##2##3##(1996-5#1)(2007-1#1)
validated and is##2##3##(2007-8#1)(2008-10#1)
validated and##22##2##(1996-12#1)(1996-5#1)(2006-9#1)(2007-1#1)(2007-8#2)(2007-9#1)(2008-10#10)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
validated as##7##2##(2007-7#1)(2008-10#2)(2010-8#1)(2011-1#1)(2012-12#1)(2013-7#1)
validated at##2##2##(2006-11#1)(2008-10#1)
validated automatic##2##2##(2010-7#2)
validated both##2##2##(2006-3#1)(2008-5#1)
validated by Western##2##3##(2010-12#2)
validated by a##3##3##(2008-10#1)(2008-12#2)
validated by an##3##3##(2006-8#1)(2008-1#1)(2008-2#1)
validated by analysis of##3##4##(2008-10#3)
validated by analysis##4##3##(2008-10#4)
validated by analyzing a certified reference material##2##7##(2008-10#2)
validated by analyzing##4##3##(2008-10#4)
validated by comparing the##4##4##(2005-11#1)(2008-10#3)
validated by comparing##6##3##(2005-11#1)(2008-10#4)(2013-8#1)
validated by comparison with##7##4##(1992-2#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)
validated by comparison##8##3##(1992-2#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#3)
validated by determining the##4##4##(1991-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
validated by determining##5##3##(1991-8#1)(2008-10#2)(2008-5#1)(2013-1#1)
validated by means of##3##4##(2006-11#1)(2007-8#1)(2008-10#1)
validated by testing##2##3##(2008-10#1)(2013-8#1)
validated by the analysis of##3##5##(2008-10#3)
validated by the##9##3##(2007-4#1)(2008-10#5)(2008-3#1)(2011-2#1)(2012-1#1)
validated by using two##2##4##(2008-10#2)
validated by using##9##3##(2008-10#7)(2008-5#1)(2010-2#1)
validated by##102##2##(1990-9#1)(1991-11#1)(1991-8#1)(1992-2#1)(1993-4#1)(1996-3#1)(2005-11#1)(2005-8#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#46)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#8)(2008-5#2)(2008-7#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#3)(2013-8#4)
validated computer##2##2##(2004-9#1)(2008-7#1)
validated delirium##2##2##(2013-1#2)
validated experimentally##7##2##(2008-2#2)(2008-3#2)(2009-10#1)(2013-1#1)(2013-7#1)
validated following the##2##3##(2008-10#1)(2012-12#1)
validated for its##2##3##(2007-8#1)(2011-7#1)
validated for simultaneous determination of##2##5##(2007-8#1)(2010-2#1)
validated for specificity##4##3##(2010-12#2)(2010-4#1)(2012-12#1)
validated for the determination of##8##5##(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#2)(2010-12#2)(2011-2#1)
validated for the simultaneous##4##4##(2010-2#1)(2011-1#1)(2012-12#1)(2013-7#1)
validated for the##21##3##(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#4)(2010-12#3)(2010-2#4)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
validated for this##2##3##(1992-8#1)(2012-12#1)
validated for##50##2##(1992-8#1)(1992-9#1)(1997-3#1)(1997-8#1)(2007-8#4)(2008-10#10)(2008-12#1)(2008-6#1)(2008-7#1)(2010-11#1)(2010-12#6)(2010-2#5)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#2)(2011-7#1)(2012-12#3)(2013-1#2)(2013-7#1)(2013-8#3)
validated in a##7##3##(2007-10#1)(2007-8#1)(2008-10#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-2#1)
validated in terms of##8##4##(2008-10#2)(2010-2#3)(2010-3#1)(2012-2#1)(2013-1#1)
validated in the##4##3##(1997-3#1)(2007-5#1)(2008-10#2)
validated in this##3##3##(2007-12#1)(2008-10#2)
validated in##38##2##(1992-8#1)(1993-12#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#2)(2007-8#1)(2008-10#8)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-3#1)(2011-1#1)(2012-1#1)(2012-2#3)(2013-1#2)
validated instrument##4##2##(2006-12#1)(2013-1#3)
validated instruments##4##2##(2007-12#1)(2012-12#1)(2013-1#2)
validated measures##2##2##(2008-11#1)(2008-6#1)
validated method##4##2##(2008-10#1)(2011-2#1)(2012-12#1)(2013-7#1)
validated methods##2##2##(1997-4#1)(2008-10#1)
validated model##8##2##(2006-11#3)(2007-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)
validated models##3##2##(2007-4#1)(2008-3#1)(2010-8#1)
validated on a##5##3##(2007-4#2)(2008-3#1)(2008-8#1)(2012-1#1)
validated on the##2##3##(2007-8#1)(2008-10#1)
validated on##10##2##(2007-4#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-1#1)(2012-2#1)(2013-1#1)
validated our##3##2##(2010-11#1)(2010-8#1)(2012-12#1)
validated over the concentration range##2##5##(2008-10#1)(2011-3#1)
validated over the##3##3##(2008-10#2)(2011-3#1)
validated over##7##2##(2008-10#3)(2010-12#1)(2011-3#1)(2013-1#2)
validated questionnaire##6##2##(2008-11#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#2)
validated questionnaires##4##2##(1991-2#1)(2013-1#2)(2013-8#1)
validated resource for research on oncology care##2##7##(2013-1#2)
validated statistically and by recovery studies##6##6##(2010-12#1)(2010-2#2)(2010-5#3)
validated survey##2##2##(1995-2#1)(2006-2#1)
validated the concept##2##3##(2007-12#1)(2008-3#1)
validated the proposed method##2##4##(2008-10#2)
validated the##20##2##(1997-2#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)(2009-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
validated through comparison with##2##4##(2008-10#1)(2008-2#1)
validated through the analysis of##2##5##(2008-10#2)
validated through##6##2##(1995-12#1)(2008-10#4)(2008-2#1)
validated to be##2##3##(2012-11#1)(2012-12#1)
validated to##3##2##(2008-10#1)(2012-11#1)(2012-12#1)
validated using a##4##3##(1990-12#1)(1990-2#1)(2008-10#2)
validated using liquid##2##3##(2007-8#1)(2010-4#1)
validated using the##2##3##(1996-1#1)(2011-2#1)
validated using##30##2##(1990-12#1)(1990-2#1)(1996-1#1)(1996-2#1)(1997-2#1)(2004-11#1)(2005-5#1)(2007-8#1)(2008-10#14)(2008-8#1)(2009-7#1)(2010-10#1)(2010-4#1)(2010-7#2)(2011-2#1)(2013-1#1)
validated with a##8##3##(2007-12#1)(2008-10#6)(2012-1#1)
validated with respect to##2##4##(1996-3#1)(2008-12#1)
validated with the##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
validated with##32##2##(1994-3#1)(1996-3#1)(2006-5#1)(2007-12#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)
validated##587##1##(1990-12#2)(1990-2#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-2#1)(1992-8#2)(1992-9#2)(1993-12#1)(1993-3#1)(1993-4#1)(1994-10#1)(1994-3#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#6)(1996-5#1)(1996-6#2)(1996-8#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-8#3)(2004-11#1)(2004-12#1)(2004-9#1)(2005-11#2)(2005-12#1)(2005-5#2)(2005-8#2)(2005-9#1)(2006-10#4)(2006-11#16)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#2)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#8)(2007-2#1)(2007-3#1)(2007-4#13)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#20)(2007-9#3)(2008-1#1)(2008-10#155)(2008-11#10)(2008-12#5)(2008-2#10)(2008-3#22)(2008-4#1)(2008-5#11)(2008-6#3)(2008-7#16)(2008-8#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#5)(2010-12#13)(2010-2#12)(2010-3#7)(2010-4#4)(2010-5#6)(2010-7#6)(2010-8#3)(2010-9#2)(2011-1#12)(2011-2#17)(2011-3#1)(2011-7#1)(2012-1#8)(2012-11#1)(2012-12#17)(2012-2#13)(2012-3#2)(2012-7#1)(2013-1#43)(2013-7#10)(2013-8#10)
validates a##3##2##(1996-3#1)(2008-7#1)(2011-2#1)
validates the use of##2##4##(1997-2#1)(2007-2#1)
validates the##13##2##(1990-12#1)(1997-2#1)(2007-2#2)(2008-10#5)(2008-4#1)(2009-4#1)(2010-4#1)(2011-1#1)
validates##21##1##(1990-12#1)(1996-3#1)(1997-2#1)(2007-2#2)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
validating the use of##3##4##(1993-3#1)(2008-10#2)
validating the##17##2##(1993-3#1)(2007-4#1)(2008-10#7)(2008-2#1)(2008-7#1)(2008-8#1)(2013-1#5)
validating##34##1##(1993-3#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-2#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#6)
validation against##2##2##(2007-1#1)(2008-3#1)
validation and application of##2##4##(2006-11#1)(2010-11#1)
validation and reliability##2##3##(2006-5#1)(2007-12#1)
validation and updating of a prognostic model for kidney graft survival##2##11##(1995-9#2)
validation and##23##2##(1995-1#1)(1995-9#3)(1996-2#1)(2005-7#1)(2005-8#2)(2006-11#1)(2006-5#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-2#1)(2013-1#4)
validation as##2##2##(2006-9#1)(2008-7#1)
validation cases##2##2##(2008-10#2)
validation data set##2##3##(2008-10#2)
validation data##12##2##(1992-7#1)(1997-8#1)(2008-10#8)(2012-12#1)(2013-1#1)
validation errors of##2##3##(2008-10#2)
validation for the##3##3##(2006-11#1)(2008-4#1)(2012-2#1)
validation for##7##2##(2005-10#1)(2006-11#1)(2006-7#1)(2008-4#1)(2010-12#1)(2012-2#1)(2013-8#1)
validation has##2##2##(2005-8#1)(2006-10#1)
validation in the##3##3##(2008-10#2)(2008-2#1)
validation in##11##2##(1993-3#1)(1996-5#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2009-12#1)(2010-5#1)
validation is critical##2##3##(1995-4#1)(2008-11#1)
validation is provided by##3##4##(1997-7#1)(2008-2#1)(2010-5#1)
validation is provided##4##3##(1997-7#1)(2008-2#1)(2008-7#1)(2010-5#1)
validation is##12##2##(1995-4#1)(1997-7#1)(2006-5#1)(2007-1#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#3)(2009-11#1)(2010-5#1)
validation method##3##2##(2008-10#2)(2008-2#1)
validation mixtures##2##2##(2008-10#2)
validation of a capillary##3##4##(1997-2#1)(1997-8#1)(2008-3#1)
validation of a high##2##4##(2007-12#1)(2008-5#1)
validation of a new##2##4##(2007-12#1)(2012-1#1)
validation of a scale to measure##2##6##(2006-4#1)(2008-12#1)
validation of a scale##3##4##(2006-4#1)(2008-12#1)(2013-1#1)
validation of a specific##2##4##(2008-10#1)(2011-1#1)
validation of a##43##3##(1990-12#1)(1992-9#1)(1995-11#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-8#1)(2006-2#1)(2006-4#1)(2007-12#5)(2007-4#1)(2007-8#2)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-12#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#3)
validation of an automated##2##4##(1990-2#1)(2008-10#1)
validation of an innovative##2##4##(2012-12#1)(2013-1#1)
validation of an##10##3##(1990-2#1)(1996-12#1)(2008-10#3)(2008-6#1)(2009-12#1)(2012-12#2)(2013-1#1)
validation of analytical##3##3##(1992-8#1)(2008-10#2)
validation of molecular##3##3##(2008-5#1)(2009-4#1)(2010-10#1)
validation of new##3##3##(2005-7#1)(2008-10#1)(2009-7#1)
validation of the method is##2##5##(2007-12#1)(2008-10#1)
validation of the method##3##4##(2007-12#1)(2008-10#2)
validation of the model##3##4##(2007-1#1)(2007-4#1)(2008-7#1)
validation of the proposed##2##4##(1995-2#1)(2012-3#1)
validation of the results##2##4##(2008-10#1)(2012-12#1)
validation of the##52##3##(1995-2#1)(1996-3#1)(1997-8#1)(2006-1#2)(2006-12#1)(2006-5#1)(2007-1#2)(2007-11#1)(2007-12#6)(2007-3#1)(2007-4#3)(2007-8#1)(2008-1#2)(2008-10#8)(2008-2#1)(2008-3#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
validation of their##2##3##(2008-10#1)(2010-2#1)
validation of these##3##3##(2007-4#1)(2012-2#1)(2013-8#1)
validation of this method##3##4##(2007-12#1)(2008-10#1)(2012-12#1)
validation of this##5##3##(2007-12#1)(2008-10#2)(2008-5#1)(2012-12#1)
validation of##174##2##(1990-12#1)(1990-2#1)(1992-8#1)(1992-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-8#2)(2005-11#1)(2005-7#1)(2006-1#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#2)(2007-1#2)(2007-11#3)(2007-12#12)(2007-3#1)(2007-4#6)(2007-6#1)(2007-8#4)(2008-1#2)(2008-10#35)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#7)(2008-6#2)(2008-7#6)(2008-8#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#3)(2009-8#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#3)(2012-1#2)(2012-12#4)(2012-2#4)(2012-3#7)(2013-1#6)(2013-8#1)
validation on##2##2##(1996-5#1)(2008-10#1)
validation or##2##2##(2008-12#1)(2008-4#1)
validation parameters##9##2##(1996-3#1)(2007-1#1)(2007-8#2)(2008-10#4)(2012-2#1)
validation procedure that##2##3##(1996-2#1)(2008-5#1)
validation procedure##4##2##(1996-2#1)(1997-5#1)(2007-8#1)(2008-5#1)
validation procedures##3##2##(1993-10#1)(2007-11#1)(2008-7#1)
validation programs##2##2##(2007-4#2)
validation protocol##2##2##(2008-10#2)
validation protocols##2##2##(2008-10#1)(2009-7#1)
validation proved##2##2##(1996-7#1)(2013-1#1)
validation results##4##2##(2008-10#2)(2008-3#1)(2012-2#1)
validation samples##2##2##(1997-1#1)(2008-10#1)
validation scheme##3##2##(2008-10#3)
validation set##14##2##(1990-12#2)(1995-9#2)(2008-10#7)(2008-4#2)(2009-4#1)
validation sets##5##2##(2007-11#1)(2008-10#4)
validation studies and##2##3##(1990-2#1)(2006-6#1)
validation studies##16##2##(1990-2#1)(2004-1#1)(2006-12#1)(2006-6#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2009-10#1)(2012-1#1)(2012-12#1)(2012-2#1)
validation study for##2##3##(1994-3#1)(2008-3#1)
validation study##13##2##(1991-6#1)(1993-11#1)(1994-3#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-2#1)(2010-8#2)(2010-9#1)
validation test##2##2##(2006-12#1)(2008-3#1)
validation testing##3##2##(2006-12#2)(2008-7#1)
validation tests##2##2##(2006-11#1)(2008-3#1)
validation through##3##2##(2006-10#1)(2008-10#1)(2012-3#1)
validation using##4##2##(2007-4#1)(2008-10#1)(2011-1#1)(2012-3#1)
validation was carried out##2##4##(2007-11#1)(2008-10#1)
validation was performed##2##3##(1992-5#1)(2012-12#1)
validation was##7##2##(1992-5#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-8#1)(2012-1#1)(2012-12#1)
validation were##4##2##(1997-8#2)(2008-10#1)(2013-8#1)
validation with the##2##3##(2007-4#1)(2012-12#1)
validation with##8##2##(2007-12#2)(2007-4#1)(2009-11#1)(2011-2#1)(2012-12#1)(2013-1#2)
validation##521##1##(1990-12#3)(1990-2#2)(1991-6#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-3#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-9#5)(1996-11#1)(1996-12#2)(1996-2#5)(1996-3#3)(1996-5#3)(1996-7#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#2)(1997-8#5)(2004-1#1)(2005-10#1)(2005-11#1)(2005-7#2)(2005-8#3)(2006-1#2)(2006-10#3)(2006-11#6)(2006-12#6)(2006-2#1)(2006-4#1)(2006-5#4)(2006-6#4)(2006-7#2)(2006-9#1)(2007-1#6)(2007-11#8)(2007-12#21)(2007-3#1)(2007-4#15)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#12)(2007-9#1)(2008-1#3)(2008-10#131)(2008-11#11)(2008-12#2)(2008-2#10)(2008-3#20)(2008-4#6)(2008-5#12)(2008-6#3)(2008-7#20)(2008-8#5)(2008-9#1)(2009-10#2)(2009-11#3)(2009-12#4)(2009-2#2)(2009-3#1)(2009-4#2)(2009-7#4)(2009-8#1)(2010-10#2)(2010-11#7)(2010-12#4)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#5)(2010-9#3)(2011-1#8)(2011-2#8)(2011-3#1)(2012-1#6)(2012-11#1)(2012-12#10)(2012-2#15)(2012-3#9)(2013-1#19)(2013-7#2)(2013-8#6)
validation)##3##1##(2007-12#1)(2010-7#1)(2010-8#1)
validations##8##1##(1996-11#1)(2006-5#1)(2008-10#2)(2008-3#2)(2012-1#1)(2012-2#1)
validities and##2##2##(2007-9#1)(2013-1#1)
validities##3##1##(2007-9#2)(2013-1#1)
validity among##2##2##(2007-12#1)(2013-7#1)
validity and clinical utility of##2##5##(2006-11#1)(2008-4#1)
validity and clinical utility##3##4##(2006-11#1)(2008-4#2)
validity and limitations of##2##4##(1994-12#1)(2011-2#1)
validity and reliability for##3##4##(2007-12#1)(2011-2#1)(2012-12#1)
validity and reliability of a new##2##6##(2005-10#1)(2010-12#1)
validity and reliability of a##3##5##(2005-10#1)(2010-12#1)(2010-9#1)
validity and reliability of the##7##5##(1994-2#1)(1994-6#1)(2007-12#1)(2007-7#1)(2007-9#1)(2011-2#1)(2013-8#1)
validity and reliability of##13##4##(1994-2#1)(1994-6#1)(2005-10#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-9#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-8#2)
validity and reliability##23##3##(1994-2#1)(1994-6#1)(1995-2#1)(2004-8#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-12#2)(2007-7#2)(2007-9#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#2)
validity and the##3##3##(2005-11#1)(2008-3#1)(2012-2#1)
validity and##53##2##(1994-12#1)(1994-2#1)(1994-6#1)(1995-2#1)(2004-8#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-10#1)(2007-12#6)(2007-7#3)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-7#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#3)
validity as an##2##3##(2007-12#1)(2008-5#1)
validity as##7##2##(2007-12#1)(2008-5#1)(2010-8#1)(2013-1#4)
validity but##2##2##(2008-10#1)(2010-10#1)
validity for the use of##2##5##(1997-2#1)(2007-2#1)
validity for the##4##3##(1997-2#1)(2006-10#1)(2007-2#1)(2007-7#1)
validity for##12##2##(1993-12#1)(1995-5#1)(1996-7#1)(1997-2#1)(2006-10#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-2#1)(2010-2#1)
validity in the##2##3##(2008-11#1)(2011-1#1)
validity in##10##2##(1993-12#1)(1995-6#1)(1996-9#1)(2004-10#1)(2007-12#2)(2007-7#1)(2008-11#1)(2011-1#1)(2012-2#1)
validity is discussed##2##3##(2004-12#1)(2008-7#1)
validity is##6##2##(2004-12#1)(2006-12#1)(2008-1#1)(2008-2#1)(2008-7#1)(2013-1#1)
validity of a new##3##4##(1997-5#1)(2006-10#1)(2009-2#1)
validity of a##16##3##(1992-7#1)(1996-8#1)(1997-5#1)(2004-10#1)(2006-10#1)(2008-12#1)(2008-3#1)(2009-2#1)(2009-9#1)(2010-3#1)(2010-9#2)(2011-2#1)(2013-1#2)(2013-8#1)
validity of an##4##3##(2011-1#1)(2013-1#2)(2013-8#1)
validity of any##2##3##(2006-8#1)(2008-9#1)
validity of both##2##3##(2008-10#1)(2009-12#1)
validity of determination##2##3##(2008-10#1)(2011-2#1)
validity of diagnostic##2##3##(1990-9#1)(2006-8#1)
validity of different##2##3##(1991-12#1)(2008-12#1)
validity of disorganized##2##3##(2006-3#2)
validity of each##2##3##(2008-2#1)(2008-7#1)
validity of the LPIA##2##4##(2008-3#2)
validity of the instrument##2##4##(1993-3#1)(2009-12#1)
validity of the method is##2##5##(2007-12#1)(2008-10#1)
validity of the method was##2##5##(1990-8#1)(2008-10#1)
validity of the method##9##4##(1990-8#1)(2007-12#2)(2007-6#1)(2008-10#5)
validity of the model##8##4##(1994-2#1)(2005-11#1)(2007-12#1)(2007-4#1)(2008-2#1)(2008-3#2)(2008-7#1)
validity of the new##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
validity of the proposed method##4##5##(2008-10#2)(2008-3#2)
validity of the proposed##7##4##(1997-6#1)(2008-10#2)(2008-3#3)(2010-4#1)
validity of the system##2##4##(1994-1#1)(2008-10#1)
validity of the technique##4##4##(1990-10#1)(1993-10#1)(1993-12#1)(2010-2#1)
validity of the##154##3##(1990-10#1)(1990-5#1)(1990-6#1)(1990-8#3)(1991-8#1)(1992-6#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-1#2)(1995-12#1)(1995-4#1)(1996-1#1)(1996-11#1)(1996-5#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(2004-10#1)(2005-11#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-10#4)(2007-11#1)(2007-12#10)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#16)(2008-11#3)(2008-12#2)(2008-2#13)(2008-3#20)(2008-4#2)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2010-10#1)(2010-2#2)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#7)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
validity of these methods##2##4##(2004-9#1)(2009-11#1)
validity of these models##2##4##(1992-2#1)(2012-2#1)
validity of these##13##3##(1992-2#1)(1993-12#1)(2004-9#1)(2006-12#1)(2006-8#1)(2008-3#2)(2009-11#1)(2010-10#1)(2010-11#1)(2010-12#2)(2012-2#1)
validity of this approach##5##4##(1992-3#1)(2007-12#1)(2008-2#1)(2008-5#1)(2009-8#1)
validity of this concept##2##4##(2008-2#1)(2012-2#1)
validity of this method##4##4##(2006-10#1)(2008-10#1)(2008-3#1)(2009-2#1)
validity of this new##2##4##(2004-3#1)(2010-5#1)
validity of this##25##3##(1990-10#1)(1990-2#1)(1992-3#1)(1995-8#1)(2004-3#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-5#1)(2010-6#1)(2012-2#1)
validity of using##3##3##(1990-1#1)(2006-10#1)(2006-5#1)
validity of##336##2##(1990-1#1)(1990-10#3)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#3)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-7#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#2)(1993-3#2)(1994-1#1)(1994-2#3)(1994-3#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#1)(2004-10#2)(2004-3#1)(2004-9#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#9)(2006-11#1)(2006-12#2)(2006-2#2)(2006-3#2)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#2)(2007-10#6)(2007-11#5)(2007-12#17)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-10#31)(2008-11#8)(2008-12#7)(2008-2#20)(2008-3#32)(2008-4#7)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#3)(2009-2#3)(2009-5#2)(2009-8#1)(2009-9#2)(2010-10#3)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#10)(2011-2#8)(2012-1#4)(2012-11#2)(2012-12#3)(2012-2#4)(2013-1#10)(2013-7#1)(2013-8#4)
validity studies##2##2##(2013-7#2)
validity testing##3##2##(1996-3#1)(2007-10#1)(2011-1#1)
validity than##3##2##(2008-3#1)(2008-8#1)(2010-12#1)
validity to the##2##3##(1996-4#1)(2009-4#1)
validity to##4##2##(1996-4#1)(2006-8#1)(2009-4#1)(2011-2#1)
validity was confirmed##2##3##(2004-8#1)(2008-10#1)
validity was supported##2##3##(2010-11#1)(2010-9#1)
validity was##15##2##(1996-3#1)(2004-8#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-11#2)(2010-9#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-8#1)
validity were##4##2##(2007-10#1)(2007-12#1)(2010-2#1)(2012-2#1)
validity with##2##2##(1994-12#1)(2011-1#1)
validity##567##1##(1990-1#1)(1990-10#3)(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#3)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-7#1)(1991-8#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#4)(1993-3#2)(1994-1#1)(1994-12#2)(1994-2#5)(1994-3#2)(1994-5#1)(1994-6#1)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-4#2)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#1)(2004-10#3)(2004-12#1)(2004-3#2)(2004-8#2)(2004-9#1)(2005-10#2)(2005-11#3)(2005-4#2)(2006-1#2)(2006-10#12)(2006-11#3)(2006-12#3)(2006-2#5)(2006-3#2)(2006-5#4)(2006-6#1)(2006-7#1)(2006-8#7)(2006-9#2)(2007-10#15)(2007-11#6)(2007-12#33)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#4)(2007-9#5)(2008-1#1)(2008-10#40)(2008-11#16)(2008-12#8)(2008-2#26)(2008-3#36)(2008-4#11)(2008-5#4)(2008-6#4)(2008-7#12)(2008-8#3)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#4)(2009-12#3)(2009-2#3)(2009-4#2)(2009-5#2)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#5)(2010-11#4)(2010-12#5)(2010-2#4)(2010-3#3)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#6)(2011-1#19)(2011-2#17)(2012-1#10)(2012-11#6)(2012-12#10)(2012-2#11)(2012-3#4)(2013-1#24)(2013-7#6)(2013-8#9)
validity) and##2##2##(2006-2#1)(2008-4#1)
validity)##3##1##(2006-2#2)(2008-4#1)
validly published##2##2##(2011-2#2)
validly##11##1##(1990-3#1)(1993-5#1)(1993-9#1)(1996-6#1)(2005-8#1)(2006-10#1)(2008-5#1)(2010-8#1)(2011-2#3)
valine (branched-chain amino acid) dehydrogenase-encoding gene##2##6##(1995-8#2)
valine adducts##3##2##(1997-8#3)
valine and##8##2##(1990-11#1)(1993-11#1)(1996-2#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2010-8#1)
valine at position##2##3##(1992-8#1)(1996-5#1)
valine identity##4##2##(1992-9#4)
valine to##3##2##(2006-10#1)(2006-8#1)(2008-3#1)
valine##70##1##(1990-11#2)(1990-2#1)(1990-4#2)(1991-5#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#5)(1993-11#2)(1993-12#1)(1993-6#3)(1993-8#1)(1994-3#1)(1994-9#1)(1995-11#3)(1995-2#1)(1995-4#1)(1995-8#4)(1996-2#3)(1996-4#1)(1996-5#1)(1996-6#1)(1997-8#7)(2006-10#1)(2006-8#3)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2010-4#1)(2010-8#1)
valine-328##2##1##(1990-11#2)
valinomycin and##2##2##(1992-4#1)(2008-10#1)
valinomycin##18##1##(1990-2#2)(1992-12#3)(1992-4#2)(1993-11#2)(1994-12#1)(1994-5#1)(1994-9#1)(1996-5#1)(1996-9#1)(2008-10#4)
vallate papillae##3##2##(2011-2#3)
valley from##2##2##(2008-11#1)(2011-2#1)
valley oak (Quercus lobata)##2##4##(2008-10#2)
valley##37##1##(2007-7#1)(2008-10#16)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2009-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#3)
valleys of the##2##3##(2008-10#1)(2008-8#1)
valleys of##3##2##(2008-10#1)(2008-8#1)(2009-5#1)
valleys##17##1##(2006-4#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-8#2)(2009-5#7)(2013-7#1)
valorization of##4##2##(2007-5#2)(2008-7#1)(2011-2#1)
valproate (VPA)##4##2##(1991-3#1)(1995-7#1)(2007-11#1)(2008-7#1)
valproate and##2##2##(2006-4#1)(2008-8#1)
valproate doses##3##2##(2008-3#3)
valproate for##2##2##(2010-12#1)(2010-7#1)
valproate in##5##2##(1996-6#2)(2008-3#1)(2010-12#1)(2010-7#1)
valproate on##2##2##(1995-12#1)(1997-4#1)
valproate##54##1##(1990-5#6)(1991-3#1)(1992-8#3)(1995-12#4)(1995-7#2)(1996-1#2)(1996-5#1)(1996-6#2)(1997-4#4)(1997-5#2)(2006-4#8)(2007-11#1)(2008-3#7)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#2)(2010-12#2)(2010-7#3)
valproic Acid##2##2##(2011-1#1)(2011-2#1)
valproic acid (VPA) and##2##4##(1996-5#1)(2011-1#1)
valproic acid (VPA)##7##3##(1996-5#2)(2008-11#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
valproic acid and##3##3##(1996-6#1)(2010-3#1)(2011-12#1)
valproic acid has##2##3##(2007-10#1)(2013-1#1)
valproic acid##28##2##(1990-5#1)(1996-5#2)(1996-6#1)(2007-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-10#2)(2010-3#3)(2011-1#1)(2011-12#3)(2011-2#2)(2013-1#3)
valproic##30##1##(1990-5#1)(1996-5#2)(1996-6#1)(2007-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-10#2)(2010-3#3)(2011-1#2)(2011-12#3)(2011-2#3)(2013-1#3)
valsartan and##2##2##(2010-2#2)
valsartan has##2##2##(2005-6#1)(2007-1#1)
valsartan in bulk##2##3##(2011-1#2)
valsartan in##3##2##(2010-3#1)(2011-1#2)
valsartan##24##1##(2005-6#1)(2007-1#12)(2008-3#2)(2009-9#1)(2010-2#3)(2010-3#1)(2011-1#4)
valuable additional information##2##3##(1996-12#1)(2006-5#1)
valuable aid in##2##3##(1991-3#1)(1993-5#1)
valuable aid##3##2##(1991-3#1)(1993-5#1)(1995-8#1)
valuable alternatives to##2##3##(2006-10#1)(2008-10#1)
valuable alternatives##3##2##(2006-10#1)(2008-10#1)(2010-4#1)
valuable and##14##2##(1990-3#1)(1991-2#1)(1991-3#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2011-12#1)(2013-8#1)
valuable as##2##2##(1990-3#1)(1995-12#1)
valuable assets##3##2##(1995-12#1)(2013-1#2)
valuable baseline##3##2##(2007-10#1)(2008-7#1)(2013-1#1)
valuable because##3##2##(1993-2#1)(1994-5#1)(2008-11#1)
valuable cell##2##2##(2006-10#1)(2009-12#1)
valuable clinical##2##2##(2006-3#1)(2007-7#1)
valuable complementary##2##2##(2008-1#1)(2008-12#1)
valuable component of##2##3##(2008-9#1)(2009-3#1)
valuable component##4##2##(2008-9#1)(2009-3#1)(2013-1#2)
valuable contribution to##2##3##(2008-11#1)(2010-12#1)
valuable contribution##4##2##(1992-2#1)(1997-3#1)(2008-11#1)(2010-12#1)
valuable cultural##2##2##(2008-10#2)
valuable data##6##2##(1990-12#1)(1992-4#1)(2008-10#1)(2008-7#2)(2010-2#1)
valuable feedback##2##2##(1991-10#1)(2012-2#1)
valuable for assessing##2##3##(1992-8#1)(2012-5#1)
valuable for studying##2##3##(2008-11#1)(2008-4#1)
valuable for the##6##3##(1993-2#1)(2007-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2011-3#1)
valuable for##39##2##(1992-8#1)(1993-2#1)(1994-5#1)(1994-7#1)(1996-3#1)(1996-5#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#3)
valuable guidance##2##2##(2013-8#2)
valuable in determining##2##3##(2008-10#1)(2008-7#1)
valuable in the evaluation##2##4##(1990-3#1)(2012-12#1)
valuable in the##14##3##(1990-3#1)(1992-1#1)(1997-8#1)(2007-11#2)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2011-7#1)(2012-12#1)(2013-8#1)
valuable in their##2##3##(1992-2#1)(2007-11#1)
valuable in##38##2##(1990-11#1)(1990-3#1)(1991-1#1)(1992-1#1)(1992-2#1)(1992-7#1)(1995-11#1)(1996-2#1)(1997-1#1)(1997-8#1)(2006-10#3)(2007-11#3)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
valuable information about the##5##4##(2007-9#1)(2008-8#1)(2009-4#1)(2012-1#1)(2012-2#1)
valuable information about##16##3##(2005-11#1)(2007-12#2)(2007-9#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-4#1)(2010-8#1)(2010-9#1)(2012-1#1)(2012-2#2)(2013-7#1)
valuable information for##11##3##(1990-12#1)(1992-1#1)(1996-8#1)(1997-4#1)(2005-11#1)(2008-10#1)(2008-8#1)(2012-1#1)(2012-12#1)(2013-1#2)
valuable information in##3##3##(2006-10#1)(2007-10#1)(2011-2#1)
valuable information on the##8##4##(2008-10#3)(2008-4#1)(2008-5#1)(2012-1#1)(2012-2#2)
valuable information on##15##3##(1993-3#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-8#1)(2009-5#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#3)
valuable information regarding##2##3##(1993-3#1)(2010-4#1)
valuable information that##3##3##(1996-12#1)(2006-7#1)(2007-3#1)
valuable information to the##2##4##(2008-1#1)(2013-8#1)
valuable information to##7##3##(2008-1#1)(2008-12#1)(2008-9#1)(2012-11#1)(2012-12#2)(2013-8#1)
valuable information##65##2##(1990-12#1)(1992-1#1)(1993-3#2)(1994-5#1)(1996-12#1)(1996-8#1)(1997-4#1)(2004-4#1)(2005-11#2)(2006-10#1)(2006-7#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-4#2)(2009-5#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#6)(2013-1#3)(2013-7#1)(2013-8#1)
valuable insight into the##4##4##(2008-11#1)(2009-2#1)(2013-1#2)
valuable insight into##6##3##(2006-10#1)(2008-11#1)(2009-2#1)(2011-2#1)(2013-1#2)
valuable insight##8##2##(2006-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-2#1)(2011-2#1)(2013-1#2)
valuable insights for##2##3##(2008-5#1)(2010-8#1)
valuable insights into the##5##4##(1994-10#1)(2007-8#1)(2008-2#1)(2012-2#1)(2013-8#1)
valuable insights into##7##3##(1994-10#1)(2007-8#1)(2008-2#1)(2008-8#1)(2010-11#1)(2012-2#1)(2013-8#1)
valuable insights##12##2##(1994-10#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-11#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
valuable lessons##2##2##(1995-2#1)(2007-7#1)
valuable management##2##2##(1994-3#1)(1995-1#1)
valuable members##2##2##(1992-12#1)(2005-11#1)
valuable method for the##3##4##(2007-11#1)(2009-1#1)(2011-2#1)
valuable method for##4##3##(2007-11#1)(2009-1#1)(2011-2#1)(2013-8#1)
valuable method##5##2##(2007-11#2)(2009-1#1)(2011-2#1)(2013-8#1)
valuable model for##6##3##(1992-4#1)(1996-8#1)(2007-12#1)(2008-4#1)(2011-1#1)(2013-8#1)
valuable model##14##2##(1992-4#1)(1993-9#1)(1995-8#1)(1996-3#1)(1996-8#1)(1996-9#1)(2007-12#2)(2008-4#2)(2008-5#1)(2009-5#1)(2011-1#1)(2013-8#1)
valuable new insights in the field of comparative genomics##2##9##(2009-5#1)(2011-2#1)
valuable new insights##3##3##(2009-5#1)(2011-1#1)(2011-2#1)
valuable new##6##2##(2006-5#1)(2008-4#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#1)
valuable pharmacological tools##2##3##(2006-10#1)(2009-12#1)
valuable prognostic information##2##3##(1994-7#1)(2010-5#1)
valuable prognostic##3##2##(1994-7#1)(2008-6#1)(2010-5#1)
valuable quantitative##3##2##(2010-5#1)(2011-1#1)(2013-8#1)
valuable resource##7##2##(1992-1#1)(2006-3#1)(2008-11#2)(2008-12#1)(2012-2#1)(2012-3#1)
valuable role in##4##3##(2008-11#1)(2008-5#1)(2010-7#1)(2012-1#1)
valuable role##6##2##(2005-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-7#1)(2012-1#1)
valuable services##2##2##(1992-2#2)
valuable source for##4##3##(2008-10#1)(2008-9#1)(2012-2#1)(2012-3#1)
valuable source##9##2##(1993-11#1)(1995-12#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-7#1)(2012-2#1)(2012-3#2)
valuable sources of##3##3##(2008-4#1)(2013-1#2)
valuable sources##4##2##(2008-4#1)(2009-10#1)(2013-1#2)
valuable supplement to##5##3##(1990-2#1)(2007-11#2)(2007-8#1)(2008-11#1)
valuable supplement##6##2##(1990-2#1)(2007-11#3)(2007-8#1)(2008-11#1)
valuable techniques##2##2##(2006-1#1)(2008-9#1)
valuable therapeutic##7##2##(1990-5#1)(1993-2#1)(2007-10#1)(2007-11#1)(2008-4#1)(2011-3#1)(2012-2#1)
valuable time##2##2##(1992-3#1)(2008-11#1)
valuable to the##4##3##(1993-2#1)(2007-3#1)(2008-9#1)(2009-4#1)
valuable to##16##2##(1993-2#1)(1994-2#1)(1995-12#1)(1995-5#1)(1997-5#1)(2007-3#1)(2008-10#1)(2008-6#1)(2008-9#4)(2009-4#1)(2010-2#1)(2010-4#1)(2013-1#1)
valuable tool for the##8##4##(1992-8#1)(1995-7#1)(2006-11#1)(2007-1#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-7#1)
valuable tool for##35##3##(1991-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#1)(1995-7#1)(2005-8#1)(2006-11#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-11#3)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#4)(2009-10#1)(2009-12#1)(2009-4#1)(2010-11#1)(2012-12#1)
valuable tool##66##2##(1990-4#1)(1991-6#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-4#1)(1995-7#1)(1996-8#1)(1997-2#1)(1997-4#1)(2005-8#1)(2006-11#1)(2006-2#1)(2007-1#2)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#2)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#3)(2008-11#5)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-11#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)
valuable tools for studying##2##4##(2008-4#1)(2008-8#1)
valuable tools for##13##3##(1995-6#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-3#1)
valuable tools in##2##3##(2008-10#1)(2010-5#1)
valuable tools##20##2##(1991-2#1)(1995-6#1)(1997-2#1)(1997-8#1)(2005-7#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2010-5#1)(2011-2#1)(2012-3#1)
valuable##600##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#4)(1990-4#1)(1990-5#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#2)(1991-6#1)(1992-1#5)(1992-12#3)(1992-2#5)(1992-3#2)(1992-4#2)(1992-5#1)(1992-7#3)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#6)(1993-3#3)(1993-4#1)(1993-5#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#4)(1994-6#3)(1994-7#3)(1995-1#3)(1995-11#1)(1995-12#4)(1995-2#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#2)(1997-8#4)(2004-4#1)(2005-10#2)(2005-11#5)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#18)(2006-11#2)(2006-12#1)(2006-2#2)(2006-3#4)(2006-5#5)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#3)(2007-1#2)(2007-10#5)(2007-11#16)(2007-12#12)(2007-2#5)(2007-3#3)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#8)(2007-8#9)(2007-9#6)(2008-1#12)(2008-10#33)(2008-11#26)(2008-12#7)(2008-2#11)(2008-3#11)(2008-4#21)(2008-5#10)(2008-6#7)(2008-7#14)(2008-8#11)(2008-9#16)(2009-1#2)(2009-10#6)(2009-11#3)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#7)(2009-5#4)(2009-6#1)(2009-8#1)(2009-9#2)(2010-11#3)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#5)(2010-5#6)(2010-7#4)(2010-8#5)(2010-9#1)(2011-1#7)(2011-12#2)(2011-2#17)(2011-3#2)(2011-7#1)(2012-1#6)(2012-11#3)(2012-12#9)(2012-2#18)(2012-3#8)(2012-5#1)(2013-1#27)(2013-7#5)(2013-8#10)
valuation of GAP##3##3##(2013-1#3)
valuation of the##3##3##(2008-10#1)(2008-9#1)(2009-11#1)
valuation of##10##2##(1990-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-11#1)(2013-1#4)
valuation##18##1##(1990-6#1)(2007-4#1)(2007-7#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-9#1)(2009-11#1)(2013-1#5)(2013-8#1)
valuations of##2##2##(2006-7#1)(2007-6#1)
value &gt##2##2##(1993-8#1)(2007-8#1)
value &lt##7##2##(1995-12#1)(2007-7#1)(2008-4#2)(2008-7#1)(2008-9#1)(2013-1#1)
value (0##3##2##(1993-6#1)(2006-10#1)(2006-9#1)
value (2##3##2##(2008-10#1)(2008-6#2)
value (5##2##2##(1990-7#1)(2007-7#1)
value (6##2##2##(1995-3#1)(2008-10#1)
value (9##2##2##(1992-10#1)(2012-2#1)
value (approximately##2##2##(1995-3#1)(2008-3#1)
value (p##2##2##(2008-3#2)
value (the##2##2##(1993-12#1)(2009-10#1)
value 0##2##2##(1991-9#1)(2011-2#1)
value 1##5##2##(1996-9#2)(2005-11#1)(2006-10#1)(2009-6#1)
value 3##2##2##(1996-9#1)(2008-10#1)
value = 0##3##3##(2008-3#1)(2011-1#1)(2013-8#1)
value =##7##2##(2007-10#1)(2008-10#1)(2008-3#1)(2009-4#2)(2011-1#1)(2013-8#1)
value above##2##2##(2008-10#1)(2011-2#1)
value achieved##2##2##(2007-11#1)(2008-3#1)
value added profile##2##3##(1996-1#1)(1997-1#1)
value added##3##2##(1996-1#1)(1997-1#1)(2010-2#1)
value added&quot##2##2##(1996-1#2)
value after##2##2##(2008-10#2)
value along##4##2##(1995-12#1)(1996-10#3)
value among the##2##3##(1993-7#1)(2013-8#1)
value among##3##2##(1993-7#1)(2008-2#1)(2013-8#1)
value and its##3##3##(1994-11#1)(2008-3#1)(2011-1#1)
value and peroxide value##2##4##(2007-3#1)(2008-10#1)
value and positive##3##3##(1993-1#1)(2007-8#2)
value and that##2##3##(1995-2#1)(2008-3#1)
value and the##12##3##(1990-6#1)(1990-7#1)(1991-5#1)(1992-12#1)(1993-3#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-3#1)(2010-9#1)(2012-1#1)
value and##79##2##(1990-3#1)(1990-6#1)(1990-7#2)(1991-2#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-12#2)(1997-2#2)(1997-4#1)(2005-7#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#2)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-9#3)(2011-1#4)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
value are##4##2##(2006-9#1)(2008-11#1)(2008-2#1)(2013-8#1)
value as a##7##3##(1991-12#1)(2008-11#1)(2009-8#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-8#1)
value as an indicator of##2##5##(1994-6#1)(2007-10#1)
value as an##4##3##(1994-6#1)(2006-10#1)(2007-10#1)(2008-2#1)
value as the##2##3##(1997-3#1)(2008-5#1)
value as##24##2##(1991-12#1)(1991-4#2)(1994-2#1)(1994-6#1)(1995-6#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#3)(2012-1#1)(2012-2#1)(2013-8#1)
value assigned to##2##3##(1991-8#1)(2006-10#1)
value at least##2##3##(1990-2#1)(1997-7#1)
value at only##2##3##(2010-12#1)(2010-4#1)
value at the##4##3##(1996-10#1)(2007-8#1)(2008-5#1)(2012-1#1)
value at##35##2##(1990-2#1)(1990-5#1)(1990-7#2)(1991-9#1)(1992-5#1)(1992-7#1)(1993-4#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-2#1)(1997-7#3)(2005-1#1)(2005-11#1)(2007-1#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-5#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-1#1)
value based##2##2##(1992-2#1)(2012-2#1)
value because of the##2##4##(1993-8#1)(2008-5#1)
value because##4##2##(1993-8#1)(1995-11#1)(1995-3#1)(2008-5#1)
value below##5##2##(1992-11#1)(1994-3#1)(2007-11#1)(2007-12#1)(2008-2#1)
value between##7##2##(1990-9#1)(1991-8#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-1#1)(2013-1#1)
value but##4##2##(2007-8#1)(2008-12#1)(2009-4#1)(2012-2#1)
value by themselves##2##3##(2006-3#1)(2008-6#1)
value by##8##2##(1990-7#1)(1996-7#1)(2006-3#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)
value calculated##2##2##(2008-10#1)(2013-8#1)
value can be obtained##2##4##(2008-10#2)
value can be##7##3##(1994-11#1)(2008-10#3)(2008-2#1)(2008-3#2)
value can##9##2##(1994-11#1)(2008-10#4)(2008-2#1)(2008-3#3)
value chain##4##2##(1997-3#2)(2004-11#1)(2008-10#1)
value characteristic##2##2##(1991-8#1)(2008-10#1)
value close to##2##3##(1990-4#1)(1992-3#1)
value comparable to##2##3##(1992-5#1)(2008-10#1)
value comparable##3##2##(1992-5#1)(2008-10#1)(2008-3#1)
value compared with##3##3##(2006-10#1)(2007-12#1)(2008-10#1)
value compared##5##2##(2006-10#1)(2007-12#1)(2008-10#2)(2011-1#1)
value composite resins##2##3##(2012-2#2)
value corresponding to the##2##4##(1994-3#1)(2008-10#1)
value corresponding to##3##3##(1994-3#1)(2005-11#1)(2008-10#1)
value corresponds##2##2##(1994-9#1)(2007-8#1)
value could##2##2##(2010-9#1)(2013-8#1)
value creation##2##2##(1995-1#1)(2008-10#1)
value detected##3##2##(1996-2#1)(2013-1#1)(2013-7#1)
value determination##3##2##(2008-10#1)(2008-2#1)(2010-5#1)
value determined for the##2##4##(2006-12#1)(2008-3#1)
value determined for##5##3##(1991-12#1)(1994-9#1)(1997-5#1)(2006-12#1)(2008-3#1)
value determined in##2##3##(2005-11#1)(2008-4#1)
value determined##9##2##(1991-12#1)(1993-11#1)(1994-9#1)(1997-5#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-4#1)
value dropped##2##2##(1994-8#1)(1995-6#1)
value during##5##2##(1996-6#1)(2005-10#1)(2007-3#1)(2007-8#1)(2008-2#1)
value for 10a/b##2##3##(2009-12#2)
value for Group 3 (CAb) mares was##2##7##(2006-5#2)
value for Group 3##3##4##(2006-5#3)
value for [3H]flunitrazepam binding##2##4##(1996-2#2)
value for a##4##3##(1995-9#1)(2007-12#1)(2008-3#1)(2008-5#1)
value for all##2##3##(1993-8#1)(2004-12#1)
value for clinical##2##3##(2007-2#1)(2008-10#1)
value for money##4##3##(1993-2#1)(1994-2#1)(2006-2#1)(2008-9#1)
value for patients##2##3##(2007-9#1)(2008-7#1)
value for the development of##2##5##(1997-2#1)(2006-10#1)
value for the preconcentration##3##4##(2008-10#3)
value for the##57##3##(1990-8#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-2#1)(1992-6#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-9#1)(1996-11#1)(1997-2#1)(1997-4#2)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#2)(2007-1#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#9)(2008-2#5)(2008-3#4)(2008-5#2)(2009-3#1)(2011-1#5)(2011-2#1)(2013-1#1)
value for their##3##3##(1993-3#1)(1994-3#1)(1997-1#1)
value for this##3##3##(2006-10#1)(2008-11#1)(2011-1#1)
value for use##2##3##(2006-10#1)(2008-10#1)
value for young##2##3##(1994-6#1)(2008-11#1)
value for##229##2##(1990-12#3)(1990-2#1)(1990-3#2)(1990-8#3)(1990-9#3)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#4)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1995-1#2)(1995-11#1)(1995-12#1)(1995-6#2)(1995-8#1)(1995-9#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#2)(2004-12#5)(2004-2#1)(2005-10#1)(2005-11#3)(2005-8#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#3)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#2)(2007-7#2)(2007-9#1)(2008-1#3)(2008-10#31)(2008-11#4)(2008-12#2)(2008-2#5)(2008-3#12)(2008-4#1)(2008-5#3)(2008-7#5)(2008-9#1)(2009-12#2)(2009-3#1)(2009-6#1)(2009-7#3)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#10)(2011-12#1)(2011-2#7)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#7)
value found for##2##3##(1990-8#1)(1995-8#1)
value from##4##2##(1991-9#1)(1994-12#1)(2007-12#1)(2008-3#1)
value greater than##2##3##(1990-10#1)(1996-12#1)
value has been##3##3##(1996-4#1)(2008-10#2)
value has##4##2##(1996-4#1)(2004-4#1)(2008-10#2)
value higher than##2##3##(1997-3#1)(2008-10#1)
value in a##3##3##(2006-12#1)(2008-10#1)(2008-3#1)
value in about##2##3##(2008-10#1)(2008-5#1)
value in both##3##3##(2008-11#1)(2012-2#1)(2013-1#1)
value in colorectal##2##3##(2006-6#2)
value in comparison to##3##4##(1993-7#1)(2008-11#1)(2012-3#1)
value in detecting##3##3##(1993-11#1)(2007-9#1)(2008-4#1)
value in each##2##3##(2010-9#1)(2011-2#1)
value in evaluating##3##3##(1991-7#1)(2006-8#1)(2010-4#1)
value in health##2##3##(1995-12#1)(2006-2#1)
value in patients with##2##4##(2008-1#1)(2010-8#1)
value in predicting the##3##4##(2008-12#1)(2008-9#1)(2013-1#1)
value in routine administration of outcome questionnaires##2##7##(2012-12#2)
value in routine administration of outcome##3##6##(2012-12#3)
value in seeds##2##3##(2006-11#1)(2010-2#1)
value in terms of the##2##5##(2010-4#1)(2012-2#1)
value in terms of##4##4##(1992-3#1)(1995-8#1)(2010-4#1)(2012-2#1)
value in the choice of##2##5##(2008-5#2)
value in the detection of##2##5##(1991-8#1)(1995-12#1)
value in the diagnosis of##2##5##(2007-2#1)(2008-7#1)
value in the diagnosis##3##4##(2007-2#1)(2008-7#1)(2012-2#1)
value in the management of##4##5##(1991-2#1)(2006-7#1)(2007-11#2)
value in the treatment of##8##5##(1991-4#1)(1996-2#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-9#1)(2009-1#1)
value in the##58##3##(1990-12#1)(1991-2#1)(1991-4#2)(1991-8#1)(1992-2#1)(1992-6#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-12#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-8#1)(2004-11#1)(2005-11#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#4)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-9#2)(2009-1#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
value in##185##2##(1990-12#1)(1990-5#2)(1991-2#1)(1991-4#3)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-11#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-6#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-4#1)(1997-7#1)(1997-8#2)(2004-11#1)(2005-11#3)(2005-5#1)(2005-9#1)(2006-10#3)(2006-11#3)(2006-12#3)(2006-2#1)(2006-5#2)(2006-6#3)(2006-7#4)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#2)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#6)(2007-9#2)(2008-1#3)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#5)(2008-9#4)(2009-1#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#5)(2010-6#1)(2010-8#4)(2010-9#2)(2011-1#2)(2011-2#6)(2012-12#5)(2012-2#6)(2012-3#4)(2013-1#5)(2013-8#4)
value increased to##2##3##(2006-9#1)(2013-7#1)
value increased##7##2##(1995-5#1)(2006-10#1)(2006-9#1)(2008-10#2)(2008-11#1)(2013-7#1)
value is 2##2##3##(1992-2#1)(1992-6#1)
value is about##2##3##(1995-5#1)(2013-8#1)
value is first##2##3##(2008-2#1)(2008-3#1)
value is##40##2##(1990-4#1)(1990-5#1)(1992-2#1)(1992-6#2)(1992-7#1)(1994-3#1)(1994-5#1)(1995-10#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-5#2)(1996-7#1)(2005-11#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
value judgments##3##2##(1994-3#1)(2005-11#1)(2007-5#1)
value less than##4##3##(1990-4#1)(2008-2#1)(2008-5#1)(2012-12#1)
value makes##2##2##(2008-10#1)(2010-12#1)
value measured##4##2##(1992-3#1)(1996-5#1)(1997-2#1)(2008-2#1)
value most##2##2##(2008-10#1)(2010-2#1)
value observed in##3##3##(1996-1#1)(2008-10#2)
value observed##4##2##(1996-1#1)(2008-10#2)(2008-8#1)
value obtained for the##3##4##(1995-11#1)(2008-10#1)(2008-2#1)
value obtained for##4##3##(1995-11#1)(2008-10#2)(2008-2#1)
value obtained from##3##3##(1993-11#1)(2008-10#1)(2012-2#1)
value obtained was##2##3##(2008-10#2)
value obtained##16##2##(1990-8#1)(1990-9#1)(1993-11#1)(1995-11#1)(1995-6#1)(1997-4#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-2#1)
value of &gt##3##3##(2005-10#1)(2008-3#1)(2012-2#1)
value of &lt##3##3##(1994-8#1)(2007-10#1)(2013-8#1)
value of (kH/kT)disc##2##3##(1995-10#2)
value of -0##2##3##(1992-7#1)(2008-10#1)
value of 0##64##3##(1990-11#1)(1990-12#2)(1990-5#1)(1990-8#2)(1991-12#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-7#1)(1992-8#1)(1993-2#2)(1993-4#1)(1994-11#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-7#2)(2005-8#1)(2006-10#1)(2006-12#2)(2006-6#2)(2007-8#3)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#5)(2008-5#4)(2008-8#2)(2009-3#2)(2009-4#1)(2009-8#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
value of 1##22##3##(1990-7#1)(1991-2#1)(1991-8#1)(1994-12#1)(1994-2#1)(1995-6#2)(1996-10#1)(1996-12#1)(1997-2#1)(1997-3#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-2#1)
value of 100%##2##3##(2007-12#1)(2008-5#1)
value of 11##2##3##(2006-12#1)(2008-12#1)
value of 12##3##3##(1997-1#1)(2007-1#1)(2008-10#1)
value of 13##2##3##(2008-11#1)(2013-8#1)
value of 14##2##3##(2008-10#1)(2008-8#1)
value of 15 microM##2##4##(1990-5#1)(1991-2#1)
value of 15##3##3##(1990-5#1)(1991-2#1)(1997-2#1)
value of 16##2##3##(1992-5#1)(2007-11#1)
value of 18##2##3##(1990-11#1)(1995-2#1)
value of 2##10##3##(1991-2#1)(1991-9#1)(1994-4#1)(2006-5#1)(2008-10#2)(2008-2#1)(2008-6#1)(2009-12#1)(2010-4#1)
value of 20 nM##2##4##(1995-3#1)(1996-2#1)
value of 22##2##3##(1990-9#1)(1994-8#1)
value of 23##2##3##(2008-10#1)(2011-1#1)
value of 28##2##3##(1996-8#1)(2008-12#1)
value of 3##8##3##(1991-1#1)(1991-5#1)(1994-11#1)(1994-9#1)(1995-11#1)(1996-9#1)(2006-12#1)(2009-4#1)
value of 35% and##2##4##(2006-2#1)(2006-4#1)
value of 4##10##3##(1990-11#2)(1992-11#1)(1993-8#1)(1995-2#1)(1997-5#1)(2007-2#1)(2008-10#1)(2008-3#2)
value of 5##9##3##(1991-11#1)(1993-3#1)(1994-8#1)(1995-7#1)(1996-1#1)(1997-1#1)(1997-2#1)(2006-9#1)(2008-3#1)
value of 50%##2##3##(2007-11#2)
value of 51##2##3##(2007-11#1)(2008-10#1)
value of 6##10##3##(1991-12#1)(1992-6#1)(1994-5#1)(2007-9#2)(2008-10#2)(2008-12#1)(2011-1#1)(2012-3#1)
value of 60 +/-##2##4##(1996-6#1)(2008-4#1)
value of 60##3##3##(1996-6#2)(2008-4#1)
value of 67##2##3##(1991-9#1)(2008-10#1)
value of 7##14##3##(1991-1#1)(1991-7#1)(1991-9#1)(1994-9#1)(1996-10#1)(1996-2#2)(1997-2#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2011-12#1)
value of 71##2##3##(2007-7#1)(2013-1#1)
value of 8##3##3##(1991-11#1)(1991-12#1)(1995-3#1)
value of 80##2##3##(1994-8#1)(2008-4#1)
value of 88%##2##3##(1992-3#1)(2006-2#1)
value of 9##5##3##(1990-2#1)(1990-7#1)(1996-10#1)(2008-10#1)(2012-12#1)
value of 95%##2##3##(2006-1#1)(2010-7#1)
value of AKBR##2##3##(2007-8#2)
value of Bcl-2##2##3##(2009-4#2)
value of CT##3##3##(1992-9#1)(2007-11#1)(2008-1#1)
value of EMG activity##4##4##(2010-2#4)
value of Km##3##3##(1990-3#1)(1990-7#1)(1996-1#1)
value of LND for RCC##2##5##(2006-9#2)
value of MRI in the##2##5##(1996-11#1)(2010-12#1)
value of MRI##3##3##(1996-11#1)(2007-11#1)(2010-12#1)
value of N##2##3##(2008-10#2)
value of Q and##3##4##(2007-11#1)(2008-10#2)
value of R##3##3##(2008-10#2)(2008-5#1)
value of SPECT##2##3##(2009-2#1)(2012-1#1)
value of a single##2##4##(1994-7#1)(2008-7#1)
value of a##31##3##(1990-3#1)(1990-7#1)(1991-6#2)(1991-7#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-5#2)(1994-2#1)(1994-7#1)(1995-3#1)(1996-4#1)(1997-1#1)(2006-2#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-1#1)(2013-8#1)
value of about 0##2##4##(1992-9#1)(1996-5#1)
value of about##7##3##(1990-12#1)(1990-4#1)(1990-7#2)(1992-9#1)(1996-5#1)(2012-2#1)
value of alternative##2##3##(1993-1#1)(2007-2#1)
value of an immunohistochemical##2##4##(1991-4#1)(1997-7#1)
value of an##6##3##(1991-4#1)(1997-7#1)(2007-11#1)(2008-4#1)(2013-1#2)
value of approximately##7##3##(1992-3#1)(1994-8#1)(1997-7#1)(2005-11#1)(2008-11#1)(2009-5#1)(2009-7#1)
value of blood##2##3##(2006-6#1)(2012-3#1)
value of bone##3##3##(1992-6#1)(2005-1#1)(2007-11#1)
value of both##2##3##(2005-11#1)(2008-10#1)
value of carotid##2##3##(2010-10#1)(2012-3#1)
value of cathepsin D##2##4##(2008-7#2)
value of clinical##5##3##(1995-11#1)(2008-10#1)(2008-7#1)(2009-3#1)(2012-12#1)
value of combining##2##3##(2010-2#1)(2013-8#1)
value of computed tomography##2##4##(2008-11#1)(2011-1#1)
value of contrast-enhanced MR mammography in patients with breast cancer##2##10##(1997-8#2)
value of contrast-enhanced##4##3##(1997-8#2)(2012-2#1)(2013-8#1)
value of correlation coefficient##2##4##(2008-10#2)
value of diagnostic##2##3##(2005-12#1)(2007-4#1)
value of different##5##3##(1991-6#1)(2005-10#1)(2011-1#1)(2012-3#1)(2013-1#1)
value of disease##2##3##(2008-10#2)
value of dynamic##2##3##(1992-11#1)(2008-4#1)
value of each##4##3##(2006-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
value of early##2##3##(1994-4#1)(2012-2#1)
value of eta(h)##2##3##(2008-3#2)
value of haemostatic##2##3##(2007-8#1)(2008-7#1)
value of imaging##2##3##(1995-5#1)(2007-4#1)
value of including##2##3##(2008-8#1)(2010-2#1)
value of intrathecal narcotic trials for long-term##2##7##(2006-12#2)
value of isolated##2##3##(1990-10#1)(2006-10#1)
value of less than##2##4##(2008-3#1)(2012-12#1)
value of magnetic resonance imaging##2##5##(2008-7#1)(2010-12#1)
value of magnetic resonance##5##4##(1996-11#1)(2005-12#1)(2006-12#1)(2008-7#1)(2010-12#1)
value of medical##3##3##(1992-5#1)(1997-8#1)(2012-2#1)
value of monitoring##3##3##(1994-7#1)(1995-3#1)(2013-1#1)
value of n##2##3##(1994-8#1)(2009-12#1)
value of neonatal screening for congenital dysplasia of the hip##2##10##(2007-11#2)
value of neuron-specific enolase##2##4##(1990-6#1)(2011-2#1)
value of non-invasive##3##3##(1996-3#1)(2008-1#1)(2013-1#1)
value of our##3##3##(2006-12#1)(2007-11#1)(2010-8#1)
value of patient##3##3##(1993-3#1)(2008-6#1)(2010-8#1)
value of preoperative##3##3##(1992-12#1)(2006-10#1)(2011-1#1)
value of procalcitonin in##2##4##(2008-5#1)(2013-1#1)
value of procalcitonin##4##3##(2008-5#1)(2013-1#3)
value of pull-out strength##2##4##(2007-11#2)
value of repeated##2##3##(1990-8#1)(2004-12#1)
value of rho##3##3##(2008-10#1)(2008-3#2)
value of role modelling##3##4##(2008-12#3)
value of screening##3##3##(2007-12#1)(2007-4#1)(2008-1#1)
value of selected##2##3##(1996-1#1)(2012-3#1)
value of sequence##2##3##(2008-10#1)(2008-8#1)
value of serum##5##3##(1991-8#1)(2007-5#1)(2008-8#1)(2013-1#2)
value of studying##3##3##(2007-9#1)(2008-2#1)(2008-4#1)
value of such##4##3##(1995-2#1)(2008-1#1)(2008-10#1)(2008-12#1)
value of tau##2##3##(1996-7#1)(1996-8#1)
value of the Hubble constant##2##5##(2006-7#2)
value of the absorption coefficient##2##5##(2007-12#1)(2008-3#1)
value of the absorption##3##4##(2007-12#1)(2008-3#1)(2013-1#1)
value of the applied voltage##2##5##(2013-8#2)
value of the daily evaporation##2##5##(2013-8#2)
value of the intervention##2##4##(1993-1#1)(2006-12#1)
value of the method##4##4##(1992-8#1)(2007-3#1)(2007-5#1)(2008-10#1)
value of the phase##3##4##(2007-11#1)(2008-3#2)
value of the response##2##4##(1990-7#1)(1993-3#1)
value of the test##4##4##(1990-6#1)(1991-12#2)(2008-7#1)
value of the wall##2##4##(2008-3#1)(2009-6#1)
value of the##227##3##(1990-11#1)(1990-2#2)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#3)(1991-12#3)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#2)(1993-9#2)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#2)(1997-2#1)(1997-3#1)(1997-7#2)(1997-8#1)(2005-10#1)(2005-11#5)(2006-12#2)(2006-4#1)(2006-5#3)(2006-7#2)(2007-1#1)(2007-11#6)(2007-12#9)(2007-2#2)(2007-3#3)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#20)(2008-11#3)(2008-2#7)(2008-3#25)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-6#2)(2009-7#2)(2009-9#1)(2010-11#1)(2010-2#2)(2010-4#3)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#3)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#6)(2013-8#6)
value of their##5##3##(1996-2#1)(2007-11#1)(2009-10#1)(2010-4#1)(2011-1#1)
value of these##8##3##(1992-6#1)(1994-3#1)(2007-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-2#1)(2011-2#1)
value of this approach##3##4##(1993-11#1)(2006-6#1)(2008-2#1)
value of this assay##2##4##(1991-12#1)(2008-10#1)
value of this##21##3##(1990-6#1)(1990-7#1)(1991-12#1)(1991-7#1)(1992-12#2)(1993-11#1)(1994-8#1)(1995-3#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)
value of transrectal##2##3##(2007-6#1)(2011-2#1)
value of tumor##3##3##(1995-9#1)(2005-5#1)(2011-2#1)
value of ultrasonography in the diagnosis of palpable breast##2##9##(2006-1#2)
value of ultrasonography##3##3##(1993-5#1)(2006-1#2)
value of using##7##3##(1992-2#1)(1995-12#1)(1995-2#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-2#1)
value of v##3##3##(1995-8#1)(2008-10#1)(2008-5#1)
value of various##2##3##(2006-10#1)(2007-4#1)
value of##1301##2##(1990-10#4)(1990-11#6)(1990-12#6)(1990-2#6)(1990-3#5)(1990-4#1)(1990-5#4)(1990-6#5)(1990-7#10)(1990-8#9)(1990-9#3)(1991-1#4)(1991-11#4)(1991-12#9)(1991-2#6)(1991-3#3)(1991-4#3)(1991-5#1)(1991-6#4)(1991-7#9)(1991-8#4)(1991-9#6)(1992-1#3)(1992-10#5)(1992-11#4)(1992-12#6)(1992-2#5)(1992-3#4)(1992-5#9)(1992-6#5)(1992-7#3)(1992-8#2)(1992-9#5)(1993-1#2)(1993-10#4)(1993-11#5)(1993-12#3)(1993-2#4)(1993-3#5)(1993-4#1)(1993-5#2)(1993-6#3)(1993-7#1)(1993-8#7)(1993-9#4)(1994-1#2)(1994-10#1)(1994-11#3)(1994-12#6)(1994-2#3)(1994-3#5)(1994-4#3)(1994-5#1)(1994-6#4)(1994-7#3)(1994-8#9)(1994-9#5)(1995-1#3)(1995-10#3)(1995-11#3)(1995-12#4)(1995-2#8)(1995-3#12)(1995-4#3)(1995-5#2)(1995-6#5)(1995-7#1)(1995-8#2)(1995-9#4)(1996-1#7)(1996-10#4)(1996-11#4)(1996-12#4)(1996-2#6)(1996-3#2)(1996-4#4)(1996-5#2)(1996-6#3)(1996-7#6)(1996-8#2)(1996-9#4)(1997-1#5)(1997-2#6)(1997-3#4)(1997-4#4)(1997-5#4)(1997-7#8)(1997-8#8)(2004-1#1)(2004-12#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-1#1)(2005-10#10)(2005-11#21)(2005-12#6)(2005-5#1)(2005-8#3)(2006-1#4)(2006-10#18)(2006-11#1)(2006-12#12)(2006-2#10)(2006-3#1)(2006-4#4)(2006-5#4)(2006-6#5)(2006-7#8)(2006-8#8)(2006-9#4)(2007-1#7)(2007-10#3)(2007-11#31)(2007-12#25)(2007-2#11)(2007-3#9)(2007-4#9)(2007-5#6)(2007-6#2)(2007-7#9)(2007-8#28)(2007-9#9)(2008-1#9)(2008-10#113)(2008-11#28)(2008-12#20)(2008-2#28)(2008-3#61)(2008-4#16)(2008-5#28)(2008-6#14)(2008-7#23)(2008-8#27)(2008-9#9)(2009-1#1)(2009-10#4)(2009-11#2)(2009-12#3)(2009-2#2)(2009-3#4)(2009-4#9)(2009-5#2)(2009-6#6)(2009-7#4)(2009-8#5)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#7)(2010-2#14)(2010-3#1)(2010-4#11)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#19)(2011-12#1)(2011-2#28)(2011-3#1)(2012-1#6)(2012-11#1)(2012-12#13)(2012-2#21)(2012-3#20)(2013-1#36)(2013-7#7)(2013-8#17)
value on the##4##3##(1992-5#1)(1996-8#1)(2009-5#1)(2013-8#1)
value on##9##2##(1990-8#1)(1992-5#1)(1992-8#1)(1993-11#1)(1996-8#1)(2006-7#1)(2008-9#1)(2009-5#1)(2013-8#1)
value or##2##2##(1997-7#1)(2008-12#1)
value over time##2##3##(1997-6#1)(2005-11#1)
value over##8##2##(1995-1#1)(1997-6#1)(2005-11#2)(2008-10#1)(2008-3#1)(2011-1#1)(2012-3#1)
value placed on##2##3##(2006-8#1)(2012-2#1)
value predicted by##2##3##(2008-6#1)(2011-2#1)
value ranges##3##2##(2008-10#3)
value recorded##2##2##(1991-2#1)(1992-4#1)
value relative to##2##3##(1996-9#1)(1997-2#1)
value relative##3##2##(1996-9#1)(1997-2#1)(2007-8#1)
value remained##2##2##(1990-8#1)(1992-5#1)
value remains##3##2##(2004-4#1)(2006-10#1)(2008-1#1)
value respectively##2##2##(2010-12#1)(2011-1#1)
value should be##2##3##(2005-11#1)(2012-12#1)
value significantly##3##2##(1993-3#1)(2007-12#1)(2013-8#1)
value similar to that##2##4##(1991-4#1)(1992-9#1)
value since##2##2##(1995-3#1)(2007-3#1)
value species conservation##2##3##(2006-7#2)
value stream##4##2##(2010-8#3)(2012-2#1)
value streams##3##2##(2010-8#3)
value structures and##2##3##(1995-1#2)
value system##4##2##(1991-12#2)(2007-4#1)(2010-2#1)
value than ALT##2##3##(1996-9#1)(2006-6#1)
value than those##2##3##(1996-5#1)(2006-10#1)
value than##10##2##(1990-10#1)(1990-9#1)(1994-11#1)(1996-5#1)(1996-9#1)(2006-10#1)(2006-6#1)(2007-4#1)(2008-2#1)(2013-8#1)
value that is##5##3##(1990-3#1)(1995-11#1)(2007-12#2)(2007-8#1)
value that the##2##3##(2007-4#1)(2008-1#1)
value that##16##2##(1990-3#1)(1992-8#2)(1993-2#1)(1995-11#1)(2007-12#3)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)
value the##10##2##(1990-12#1)(1990-6#1)(1991-4#1)(1992-7#1)(1994-2#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-12#1)(2008-4#1)
value theorem##3##2##(1995-2#1)(2008-2#2)
value they##2##2##(1996-1#1)(2012-2#1)
value to both##2##3##(1992-8#1)(2008-12#1)
value to forensic scientists##2##4##(2008-10#1)(2013-7#1)
value to predict the presence of##2##6##(2012-3#2)
value to the##13##3##(1990-3#1)(1992-3#1)(1994-1#1)(1995-6#1)(1997-2#1)(1997-4#1)(2005-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-3#2)(2011-2#1)
value to##58##2##(1990-3#1)(1990-4#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-10#1)(1994-1#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#1)(2004-12#1)(2005-8#1)(2007-12#2)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
value towards##2##2##(1993-3#1)(1995-7#1)
value under##2##2##(2010-1#2)
value units (RVUs)##3##3##(1991-12#1)(2012-2#1)(2013-1#1)
value units##7##2##(1991-12#2)(1992-3#1)(1994-1#1)(2012-2#1)(2013-1#2)
value using##3##2##(2006-12#1)(2008-6#1)(2012-2#1)
value was 0##6##3##(1990-12#1)(1990-9#1)(2008-5#1)(2011-2#2)(2013-8#1)
value was below##2##3##(1993-8#1)(2013-1#1)
value was calculated##2##3##(2008-3#1)(2010-2#1)
value was decreased##2##3##(1996-7#1)(2007-8#1)
value was found to be##2##5##(1992-7#1)(2008-12#1)
value was found##4##3##(1992-7#1)(2008-10#1)(2008-12#1)(2009-3#1)
value was higher than##2##4##(1996-6#1)(2008-10#1)
value was higher##4##3##(1996-6#1)(2008-10#1)(2008-4#1)(2008-5#1)
value was not##2##3##(1996-2#1)(2008-3#1)
value was observed in the##2##5##(2008-5#1)(2011-1#1)
value was observed in##3##4##(2008-3#1)(2008-5#1)(2011-1#1)
value was observed##4##3##(1997-4#1)(2008-3#1)(2008-5#1)(2011-1#1)
value was obtained for##4##4##(1994-3#1)(2008-10#2)(2008-3#1)
value was obtained##9##3##(1994-3#1)(1995-2#1)(2006-1#1)(2008-10#4)(2008-3#1)(2012-12#1)
value was only##2##3##(2007-8#1)(2008-10#1)
value was related to##3##4##(2005-11#1)(2008-5#1)(2011-1#1)
value was significantly##5##3##(1991-9#1)(2006-8#1)(2007-8#1)(2011-2#1)(2013-7#1)
value was then##2##3##(2008-10#1)(2008-11#1)
value was##96##2##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-9#1)(1992-7#1)(1993-1#3)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-6#3)(1996-7#2)(1997-4#1)(1997-8#2)(2005-11#2)(2005-8#1)(2006-1#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-8#5)(2008-1#1)(2008-10#17)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#5)(2008-6#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
value were##4##2##(2007-9#1)(2008-10#2)(2012-2#1)
value when the##3##3##(2007-10#1)(2008-3#1)(2010-7#1)
value when used##2##3##(2008-1#1)(2010-2#1)
value when##9##2##(2007-10#1)(2008-1#2)(2008-3#1)(2010-2#1)(2010-7#1)(2011-2#1)(2013-1#2)
value with the##4##3##(2008-10#2)(2008-3#1)(2012-2#1)
value with##8##2##(1992-11#1)(2008-10#2)(2008-3#2)(2009-6#1)(2012-2#2)
value within the##3##3##(2006-10#1)(2008-2#2)
value within##7##2##(1992-6#1)(2006-10#1)(2008-10#2)(2008-2#2)(2012-12#1)
value##3091##1##(1990-10#8)(1990-11#9)(1990-12#17)(1990-2#10)(1990-3#11)(1990-4#8)(1990-5#14)(1990-6#7)(1990-7#18)(1990-8#21)(1990-9#12)(1991-1#6)(1991-11#5)(1991-12#22)(1991-2#17)(1991-3#8)(1991-4#13)(1991-5#5)(1991-6#7)(1991-7#11)(1991-8#11)(1991-9#16)(1992-1#8)(1992-10#6)(1992-11#11)(1992-12#13)(1992-2#12)(1992-3#13)(1992-4#1)(1992-5#16)(1992-6#19)(1992-7#8)(1992-8#8)(1992-9#10)(1993-1#8)(1993-10#6)(1993-11#13)(1993-12#8)(1993-2#13)(1993-3#11)(1993-4#3)(1993-5#2)(1993-6#8)(1993-7#3)(1993-8#11)(1993-9#7)(1994-1#4)(1994-10#2)(1994-11#11)(1994-12#20)(1994-2#11)(1994-3#13)(1994-4#4)(1994-5#7)(1994-6#8)(1994-7#6)(1994-8#15)(1994-9#10)(1995-1#12)(1995-10#5)(1995-11#9)(1995-12#18)(1995-2#16)(1995-3#21)(1995-4#4)(1995-5#7)(1995-6#16)(1995-7#3)(1995-8#8)(1995-9#6)(1996-1#15)(1996-10#10)(1996-11#6)(1996-12#11)(1996-2#15)(1996-3#6)(1996-4#7)(1996-5#10)(1996-6#11)(1996-7#13)(1996-8#7)(1996-9#12)(1997-1#9)(1997-2#21)(1997-3#17)(1997-4#13)(1997-5#6)(1997-6#1)(1997-7#16)(1997-8#19)(2004-1#1)(2004-11#4)(2004-12#8)(2004-2#2)(2004-4#3)(2004-9#1)(2005-1#2)(2005-10#14)(2005-11#52)(2005-12#7)(2005-5#2)(2005-7#4)(2005-8#9)(2005-9#2)(2006-1#5)(2006-10#53)(2006-11#5)(2006-12#20)(2006-2#15)(2006-3#2)(2006-4#6)(2006-5#13)(2006-6#11)(2006-7#22)(2006-8#16)(2006-9#14)(2007-1#13)(2007-10#13)(2007-11#56)(2007-12#60)(2007-2#19)(2007-3#18)(2007-4#22)(2007-5#10)(2007-6#4)(2007-7#20)(2007-8#61)(2007-9#16)(2008-1#33)(2008-10#324)(2008-11#55)(2008-12#35)(2008-2#74)(2008-3#144)(2008-4#27)(2008-5#76)(2008-6#28)(2008-7#45)(2008-8#36)(2008-9#26)(2009-1#3)(2009-10#9)(2009-11#6)(2009-12#7)(2009-2#9)(2009-3#12)(2009-4#17)(2009-5#5)(2009-6#10)(2009-7#9)(2009-8#12)(2009-9#3)(2010-1#4)(2010-10#5)(2010-11#3)(2010-12#16)(2010-2#24)(2010-3#3)(2010-4#27)(2010-5#13)(2010-6#3)(2010-7#8)(2010-8#21)(2010-9#8)(2011-1#54)(2011-12#4)(2011-2#84)(2011-3#2)(2012-1#12)(2012-11#2)(2012-12#33)(2012-2#55)(2012-3#35)(2013-1#74)(2013-7#14)(2013-8#42)
value&quot##4##1##(2007-4#2)(2007-8#1)(2008-1#1)
value) and##3##2##(2008-10#1)(2010-1#1)(2013-1#1)
value) was##5##2##(1990-10#1)(2007-3#1)(2008-10#1)(2008-7#1)(2011-2#1)
value)##23##1##(1990-10#1)(1993-1#1)(1997-3#1)(2005-11#1)(2007-3#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-11#1)(2010-1#1)(2011-2#2)(2012-1#1)(2013-1#2)
value-added products##3##2##(2008-5#1)(2008-6#1)(2013-1#1)
value-added##10##1##(1993-1#1)(1993-2#2)(1996-3#1)(2008-10#1)(2008-5#1)(2008-6#2)(2010-6#1)(2013-1#1)
value-based##5##1##(2006-10#2)(2008-6#2)(2012-3#1)
value?##2##1##(1996-1#1)(2009-4#1)
valued as##2##2##(1991-12#1)(2010-4#1)
valued being##2##2##(2006-4#1)(2007-7#1)
valued by the##2##3##(1994-1#1)(2012-2#1)
valued by##4##2##(1993-12#1)(1994-1#1)(2012-12#1)(2012-2#1)
valued highly by the##2##4##(1997-1#2)
valued in##3##2##(2007-7#1)(2008-11#1)(2012-3#1)
valued##35##1##(1990-5#1)(1991-12#1)(1993-12#1)(1994-1#1)(1994-2#1)(1995-7#1)(1996-3#1)(1997-1#2)(2005-10#1)(2006-4#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-11#1)(2008-6#2)(2009-2#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)
values &gt##6##2##(1994-11#1)(1995-7#1)(2007-11#1)(2007-8#2)(2008-10#1)
values &lt##12##2##(1993-9#1)(1994-11#1)(2005-10#1)(2007-1#1)(2008-10#3)(2008-3#3)(2011-1#1)(2011-2#1)
values (##4##2##(2008-10#3)(2008-11#1)
values (&gt##3##2##(2008-4#1)(2009-3#1)(2011-12#1)
values (&lt##2##2##(1994-12#1)(2008-10#1)
values (0##8##2##(1995-6#1)(1996-11#1)(1997-3#1)(2006-9#1)(2008-10#3)(2010-11#1)
values (2##3##2##(2008-10#2)(2008-7#1)
values (5##2##2##(1990-2#1)(1990-7#1)
values (56##2##2##(2011-2#1)(2012-2#1)
values (6##2##2##(2008-10#2)
values (P &lt##3##3##(1994-3#1)(2008-10#1)(2008-5#1)
values (P##5##2##(1991-12#1)(1994-3#1)(2008-10#1)(2008-5#1)(2010-8#1)
values (R##2##2##(2008-10#2)
values (mean##2##2##(1994-12#1)(2008-10#1)
values (n =##2##3##(1995-7#1)(1996-8#1)
values (p &lt##3##3##(1994-6#2)(2013-8#1)
values (p##5##2##(1992-4#1)(1994-6#2)(2008-3#1)(2013-8#1)
values (range##2##2##(1995-7#2)
values (the##3##2##(1991-6#1)(2008-10#1)(2008-8#1)
values 0##5##2##(1993-12#1)(2005-10#2)(2005-11#1)(2008-10#1)
values 2##2##2##(1990-3#1)(1995-12#1)
values =##3##2##(1990-2#1)(2008-9#2)
values a##2##2##(2008-10#1)(2008-9#1)
values above the##3##3##(1990-4#1)(1996-7#1)(2007-12#1)
values above##7##2##(1990-2#1)(1990-4#1)(1994-6#1)(1996-7#1)(2007-12#1)(2008-5#1)(2012-2#1)
values according to##3##3##(2010-9#2)(2012-2#1)
values achieved##2##2##(2008-10#1)(2009-4#1)
values across##3##2##(2010-12#1)(2010-4#1)(2012-1#1)
values after##10##2##(1995-5#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-8#1)(2006-1#1)(2006-11#1)(2007-7#1)(2010-4#1)(2013-1#1)
values against##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
values agree##2##2##(2008-10#1)(2011-1#1)
values agreed##2##2##(2008-10#2)
values allows##2##2##(2005-10#1)(2008-3#1)
values among##4##2##(1990-8#1)(2008-10#3)
values and a##2##3##(1995-8#1)(2008-10#1)
values and attitudes##2##3##(2009-10#1)(2011-2#1)
values and beliefs##6##3##(1995-1#2)(2007-3#1)(2008-12#2)(2010-5#1)
values and can##2##3##(2008-10#1)(2008-8#1)
values and concentrations##2##3##(2007-8#1)(2009-4#1)
values and different##2##3##(1994-2#1)(2008-9#1)
values and have##2##3##(2008-10#1)(2008-3#1)
values and in##2##3##(1993-11#1)(2008-3#1)
values and increased##2##3##(1994-9#1)(2009-3#1)
values and lower##2##3##(2010-4#1)(2013-7#1)
values and percentage of##2##4##(2008-12#1)(2013-8#1)
values and standard##2##3##(2008-10#1)(2013-1#1)
values and the##20##3##(1991-4#1)(1994-12#1)(1995-12#1)(1995-3#1)(2005-11#1)(2007-11#3)(2007-8#1)(2008-10#8)(2011-2#1)(2012-2#1)(2012-3#1)
values and their##4##3##(1992-10#1)(2007-4#1)(2009-4#1)(2011-2#1)
values and then##2##3##(2008-3#1)(2008-4#1)
values and those##2##3##(2008-10#2)
values and to##2##3##(2007-2#1)(2008-9#1)
values and was##2##3##(1991-10#1)(2007-8#1)
values and with##2##3##(2008-10#2)
values and##171##2##(1990-10#1)(1990-3#1)(1990-7#2)(1991-10#1)(1991-4#1)(1992-10#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-7#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-7#2)(1994-8#3)(1994-9#4)(1995-1#3)(1995-12#3)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#2)(1996-12#1)(1997-3#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#2)(2006-4#1)(2007-10#1)(2007-11#3)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#5)(2008-1#4)(2008-10#36)(2008-11#1)(2008-12#5)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#2)(2009-3#1)(2009-4#2)(2009-6#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#4)
values are 3##2##3##(1990-5#1)(2008-10#1)
values are always##2##3##(2008-10#1)(2008-2#1)
values are as follows##2##4##(1997-7#1)(2010-12#1)
values are based on##2##4##(1995-8#1)(2008-10#1)
values are compared with##2##4##(2008-10#1)(2008-11#1)
values are compared##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
values are determined##2##3##(1990-8#1)(2005-4#1)
values are estimated##2##3##(2008-3#1)(2012-1#1)
values are exceeded##2##3##(2008-10#1)(2008-3#1)
values are found to##2##4##(1994-6#1)(2010-4#1)
values are found##3##3##(1994-6#1)(2008-4#1)(2010-4#1)
values are generally##2##3##(2008-10#1)(2012-12#1)
values are given##2##3##(2008-10#2)
values are in agreement with##2##5##(2005-11#1)(2008-10#1)
values are in the range##2##5##(2008-10#2)
values are in the##4##4##(1993-4#1)(2008-10#3)
values are in##9##3##(1993-4#1)(1995-10#1)(2005-11#1)(2008-10#4)(2008-2#1)(2008-3#1)
values are less than##2##4##(1995-4#1)(2006-12#1)
values are lower than##3##4##(1993-11#1)(2008-10#1)(2008-3#1)
values are not##3##3##(2008-10#2)(2009-6#1)
values are reported for##3##4##(2007-2#2)(2008-2#1)
values are reported##4##3##(2007-2#2)(2008-2#1)(2010-12#1)
values are similar to the##2##5##(1992-3#1)(1993-3#1)
values are similar##3##3##(1992-3#1)(1993-3#1)(2009-6#1)
values are the highest reported##2##5##(2008-2#2)
values are the##3##3##(2008-10#1)(2008-2#2)
values are then##2##3##(2006-11#1)(2007-12#1)
values are##113##2##(1990-5#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-4#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-10#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-2#2)(1997-7#1)(2005-11#1)(2005-4#2)(2005-7#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-5#1)(2007-10#1)(2007-12#3)(2007-2#2)(2007-4#1)(2007-8#1)(2008-10#31)(2008-11#1)(2008-2#8)(2008-3#11)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#2)(2010-12#2)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
values as a function of##3##5##(2008-10#1)(2008-3#1)(2008-5#1)
values as compared to##2##4##(2008-10#2)
values as high as##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
values as the##3##3##(2005-11#1)(2011-2#2)
values as##29##2##(1992-9#1)(2005-11#1)(2006-1#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#10)(2008-2#1)(2008-3#2)(2008-5#2)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#1)
values associated with##4##3##(1994-2#1)(2008-10#1)(2008-2#1)(2008-3#1)
values associated##5##2##(1994-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
values at 2##2##3##(1990-3#1)(2007-11#1)
values at 298##2##3##(2005-11#1)(2008-10#1)
values at day##2##3##(2007-9#1)(2008-5#1)
values at the##4##3##(2005-11#1)(2005-12#1)(2008-10#1)(2008-3#1)
values at##54##2##(1990-11#1)(1990-3#1)(1990-7#2)(1991-6#1)(1991-7#1)(1992-11#1)(1992-3#1)(1992-9#1)(1995-11#1)(1995-6#1)(1995-7#1)(1996-6#1)(1997-1#1)(1997-4#2)(2005-11#3)(2005-12#1)(2006-11#1)(2006-12#1)(2007-11#3)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#13)(2008-3#5)(2008-5#3)(2010-4#2)(2011-1#1)(2011-2#2)
values available for##2##3##(2009-3#1)(2013-1#1)
values available##3##2##(1992-9#1)(2009-3#1)(2013-1#1)
values based on##5##3##(2006-5#1)(2006-7#1)(2008-2#1)(2010-2#1)(2013-1#1)
values became##6##2##(1990-6#1)(1991-5#2)(1995-5#1)(1996-2#1)(2013-1#1)
values before##4##2##(1991-2#1)(2007-12#1)(2007-8#1)(2011-2#1)
values being##8##2##(1993-11#2)(1996-8#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-4#1)
values below 0##2##3##(1990-2#1)(2008-10#1)
values below 5##4##3##(1992-11#1)(1994-5#1)(2008-5#2)
values below the##3##3##(1996-7#1)(2008-10#1)(2008-2#1)
values below##18##2##(1990-10#1)(1990-2#1)(1992-11#1)(1992-4#1)(1993-9#1)(1994-5#1)(1995-5#1)(1996-7#1)(1997-4#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-5#2)(2010-2#1)(2012-3#1)
values between 0##7##3##(1994-4#1)(2008-10#4)(2008-5#1)(2010-8#1)
values between 4##2##3##(1993-9#1)(2008-5#1)
values between 8##2##3##(1992-12#1)(1993-3#1)
values between the##5##3##(1995-1#1)(1996-9#1)(2005-7#1)(2008-10#1)(2012-3#1)
values between##44##2##(1992-12#1)(1992-7#1)(1993-3#1)(1993-9#1)(1994-4#1)(1995-1#1)(1995-11#1)(1996-3#1)(1996-7#1)(1996-9#1)(2004-9#1)(2005-7#1)(2005-8#1)(2007-11#2)(2008-10#15)(2008-2#1)(2008-5#6)(2008-7#1)(2010-8#1)(2011-2#3)(2012-3#1)(2012-9#1)
values but both##2##3##(1994-12#1)(2008-12#1)
values but##5##2##(1994-12#1)(1994-6#1)(1995-8#1)(2008-10#1)(2008-12#1)
values by +##2##3##(1991-3#2)
values by the##3##3##(2005-12#1)(2008-10#2)
values by##16##2##(1991-3#2)(1994-11#1)(1997-1#1)(2005-12#1)(2007-4#1)(2008-10#7)(2008-2#1)(2010-9#1)(2012-3#1)
values calculated from the##2##4##(1995-3#1)(1997-2#1)
values calculated from##3##3##(1992-7#1)(1995-3#1)(1997-2#1)
values calculated with##3##3##(2008-10#1)(2008-2#1)(2008-6#1)
values calculated##11##2##(1992-7#1)(1995-3#1)(1997-2#1)(2005-10#1)(2005-11#1)(2008-10#3)(2008-2#2)(2008-6#1)
values can be##5##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-2#1)
values can##7##2##(1992-8#1)(1997-2#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-2#1)
values characterizing##2##2##(2008-2#1)(2012-2#1)
values comparable to##3##3##(2006-11#1)(2006-12#1)(2008-5#1)
values comparable with##2##3##(1992-1#1)(2008-10#1)
values comparable##5##2##(1992-1#1)(2006-11#1)(2006-12#1)(2008-10#1)(2008-5#1)
values compare##2##2##(2006-5#1)(2008-5#1)
values compared to##2##3##(2010-4#1)(2012-12#1)
values compared with##2##3##(2008-3#1)(2008-5#1)
values compared##6##2##(1991-8#1)(2008-3#1)(2008-5#1)(2010-4#1)(2012-12#1)(2012-3#1)
values computed##2##2##(2005-11#1)(2008-2#1)
values correlated well with##2##4##(1991-2#1)(2008-1#1)
values correlated##5##2##(1991-2#1)(1996-12#1)(1996-7#1)(2006-10#1)(2008-1#1)
values corresponding to the##2##4##(2006-11#1)(2011-1#1)
values corresponding to##5##3##(1994-5#1)(2006-11#1)(2008-5#1)(2011-1#1)(2013-8#1)
values declined##2##2##(2008-10#1)(2010-8#1)
values decreased from##2##3##(2005-12#1)(2008-4#1)
values decreased##7##2##(1993-2#1)(1995-11#1)(1995-8#1)(2005-12#1)(2008-4#1)(2009-11#1)(2013-8#1)
values depend##2##2##(1990-2#1)(2008-10#1)
values derived from the##6##4##(1997-2#1)(2008-10#2)(2008-3#1)(2008-7#1)(2012-2#1)
values derived##8##2##(1997-2#1)(2006-10#1)(2008-10#2)(2008-3#2)(2008-7#1)(2012-2#1)
values despite##2##2##(1991-9#1)(2007-11#1)
values determined by##8##3##(1990-4#4)(2006-2#1)(2008-10#1)(2008-2#1)(2008-3#1)
values determined from##3##3##(1990-7#1)(1996-2#1)(1996-8#1)
values determined in##2##3##(1991-5#1)(1994-3#1)
values determined##19##2##(1990-4#4)(1990-7#1)(1991-5#1)(1992-6#1)(1994-3#1)(1996-2#1)(1996-8#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-7#1)
values did not change during the##2##6##(1992-1#1)(1996-11#1)
values did not change##3##4##(1992-1#1)(1996-11#1)(2008-5#1)
values did not differ##2##4##(1991-2#1)(2010-8#1)
values did not##7##3##(1991-2#1)(1992-1#1)(1996-11#1)(1997-4#1)(2008-10#1)(2008-5#1)(2010-8#1)
values did##8##2##(1991-2#1)(1992-1#1)(1996-11#1)(1996-2#1)(1997-4#1)(2008-10#1)(2008-5#1)(2010-8#1)
values do not##3##3##(1994-8#1)(2007-8#1)(2008-3#1)
values do##4##2##(1994-8#1)(2007-8#1)(2008-10#1)(2008-3#1)
values due to the##2##4##(2008-10#1)(2013-1#1)
values due to##4##3##(2006-12#1)(2008-10#1)(2012-12#1)(2013-1#1)
values during the##5##3##(1994-2#1)(1994-8#1)(2008-5#1)(2010-5#1)(2011-1#1)
values during##11##2##(1992-8#1)(1994-2#2)(1994-8#1)(1997-5#1)(2006-9#2)(2007-9#1)(2008-5#1)(2010-5#1)(2011-1#1)
values education##3##2##(1992-2#2)(2007-4#1)
values equal##2##2##(1997-2#1)(2011-2#1)
values established##2##2##(1993-3#1)(2008-10#1)
values estimated by##2##3##(2007-10#1)(2010-6#1)
values estimated from the##2##4##(1996-4#1)(2008-2#1)
values estimated from##3##3##(1996-4#1)(2005-11#1)(2008-2#1)
values estimated##5##2##(1996-4#1)(2005-11#1)(2007-10#1)(2008-2#1)(2010-6#1)
values evaluated##2##2##(2008-10#1)(2011-2#1)
values even##4##2##(1993-2#1)(2006-4#1)(2007-12#1)(2008-10#1)
values exceeding##2##2##(1995-2#1)(2007-10#1)
values far##3##2##(2005-11#1)(2008-10#2)
values fell to##2##3##(1995-7#1)(1996-11#1)
values fell##6##2##(1995-6#1)(1995-7#1)(1996-11#1)(2007-1#2)(2008-8#1)
values fit##2##2##(1997-2#1)(2008-2#1)
values for Gly-Pro of the##2##5##(1990-1#2)
values for IMP##2##3##(1994-11#1)(1995-6#1)
values for K(ijk)##2##3##(2008-10#2)
values for S and##2##4##(2008-2#1)(2008-3#1)
values for a##8##3##(1994-9#1)(2008-10#3)(2008-2#2)(2008-3#1)(2011-2#1)
values for all##8##3##(1995-5#1)(1997-2#1)(2007-10#2)(2007-6#1)(2008-9#1)(2009-11#1)(2013-7#1)
values for both##7##3##(1991-2#1)(1993-11#1)(1994-6#1)(1996-7#1)(2007-11#1)(2008-3#1)(2008-5#1)
values for calcium##2##3##(2008-10#1)(2008-5#1)
values for each##10##3##(1990-12#1)(1990-3#1)(1996-9#1)(2006-7#1)(2008-10#2)(2008-2#1)(2013-1#2)(2013-8#1)
values for free##3##3##(1997-7#3)
values for human##2##3##(1990-12#1)(2008-3#1)
values for inhibition of##2##4##(1991-9#1)(1996-11#1)
values for inhibition##4##3##(1991-9#1)(1992-6#1)(1996-11#1)(1997-1#1)
values for isolated##2##3##(1993-8#1)(1994-8#1)
values for odour perception than those##2##6##(2008-7#2)
values for other##4##3##(1990-7#1)(1990-8#1)(1997-1#1)(2008-5#1)
values for serum##2##3##(1990-11#1)(2013-8#1)
values for spermine##2##3##(1995-2#1)(1996-12#1)
values for the beta (1##2##5##(1994-11#2)
values for the calculated##2##4##(1992-12#1)(2008-5#1)
values for the determination of##2##5##(1993-12#1)(2008-2#1)
values for the first##2##4##(2007-12#1)(2008-10#1)
values for the three##4##4##(1990-9#1)(2008-10#1)(2008-4#1)(2008-5#1)
values for the two##2##4##(1992-5#1)(2008-10#1)
values for the##123##3##(1990-10#2)(1990-2#1)(1990-8#3)(1990-9#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-7#3)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#1)(1993-11#5)(1993-12#1)(1993-4#1)(1994-11#4)(1994-5#3)(1994-8#1)(1995-11#1)(1995-2#3)(1995-6#1)(1995-9#1)(1996-12#2)(1996-3#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#2)(2007-10#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#21)(2008-2#9)(2008-3#4)(2008-4#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#5)
values for these##6##3##(1992-11#1)(1996-2#1)(2008-10#2)(2008-6#1)(2013-3#1)
values for this##7##3##(1990-2#1)(1991-7#1)(1994-5#1)(1994-8#1)(2008-3#1)(2010-12#1)(2011-2#1)
values for various##3##3##(1990-1#1)(1997-8#1)(2008-3#1)
values for##473##2##(1990-1#3)(1990-10#5)(1990-11#4)(1990-12#4)(1990-2#6)(1990-3#1)(1990-5#1)(1990-7#4)(1990-8#5)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#8)(1991-8#2)(1991-9#5)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#4)(1992-5#1)(1992-6#3)(1992-7#5)(1992-8#2)(1993-1#2)(1993-11#6)(1993-12#4)(1993-2#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#6)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#5)(1994-6#2)(1994-8#5)(1994-9#5)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#7)(1995-4#1)(1995-5#2)(1995-6#8)(1995-7#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#3)(1996-5#2)(1996-7#4)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#7)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#5)(1997-8#2)(2004-1#2)(2004-4#3)(2005-10#1)(2005-11#2)(2005-12#1)(2005-7#2)(2006-10#5)(2006-11#1)(2006-12#3)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#2)(2007-1#2)(2007-10#5)(2007-11#3)(2007-12#9)(2007-2#3)(2007-3#3)(2007-4#4)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#71)(2008-11#2)(2008-12#2)(2008-2#18)(2008-3#20)(2008-4#3)(2008-5#14)(2008-6#5)(2008-7#7)(2008-8#6)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#2)(2010-3#2)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#11)(2013-3#2)(2013-7#2)(2013-8#5)
values found for##6##3##(1993-6#1)(2006-12#1)(2008-10#3)(2013-1#1)
values found in the literature##2##5##(2008-3#1)(2009-4#1)
values found in the##3##4##(2008-10#1)(2008-3#1)(2009-4#1)
values found in##4##3##(1990-2#1)(2008-10#1)(2008-3#1)(2009-4#1)
values found##13##2##(1990-2#1)(1993-2#1)(1993-6#1)(2006-12#1)(2008-10#4)(2008-2#1)(2008-3#2)(2009-4#1)(2013-1#1)
values from 0##3##3##(1992-12#1)(1993-12#1)(2008-5#1)
values from a##3##3##(2005-11#1)(2006-5#1)(2013-8#1)
values from data##2##3##(1997-2#1)(2008-10#1)
values from the##11##3##(1990-12#1)(1991-8#1)(1996-11#1)(1997-2#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-3#1)(2011-2#1)(2013-1#1)
values from##46##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-8#3)(1991-9#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#1)(1996-11#1)(1996-3#1)(1996-4#1)(1997-2#2)(2005-11#1)(2006-1#1)(2006-5#1)(2006-7#1)(2007-7#1)(2008-10#11)(2008-2#1)(2008-3#3)(2008-5#3)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
values generated##2##2##(2008-10#1)(2008-3#1)
values given##3##2##(1995-7#1)(2007-10#1)(2008-7#1)
values gives the##2##3##(1994-11#1)(2008-3#1)
values greater than 0##2##4##(1990-12#1)(1996-6#1)
values greater than 100##2##4##(1991-8#1)(1993-1#1)
values greater than##11##3##(1990-12#1)(1990-5#1)(1991-8#1)(1993-1#1)(1993-6#1)(1996-6#1)(2007-12#1)(2008-10#2)(2008-3#2)
values had##2##2##(2008-5#1)(2013-8#1)
values has been##2##3##(1996-3#1)(2008-10#1)
values have been calculated##3##4##(1993-6#1)(2008-10#1)(2008-5#1)
values have been##4##3##(1993-6#1)(2008-10#2)(2008-5#1)
values have##7##2##(1993-6#1)(2006-11#1)(2008-10#3)(2008-5#2)
values higher than##5##3##(1993-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2012-12#1)
values in February##2##3##(2008-5#1)(2013-7#1)
values in a##8##3##(1993-2#1)(1994-8#1)(1997-8#1)(2008-10#3)(2008-3#1)(2009-12#1)
values in all##2##3##(1997-3#1)(2008-9#1)
values in both##4##3##(1995-3#1)(2008-11#1)(2013-1#1)(2013-8#1)
values in children##3##3##(2008-3#1)(2013-1#2)
values in excess of##2##4##(1992-4#1)(2009-7#1)
values in human##2##3##(1990-12#1)(1995-12#1)
values in patients##3##3##(1992-8#1)(1996-8#1)(1997-2#1)
values in relation to##2##4##(1990-5#1)(2013-1#1)
values in the case of##2##5##(2007-8#1)(2008-3#1)
values in the low nanomolar##2##5##(1996-8#1)(2012-2#1)
values in the micromolar range##2##5##(2006-12#1)(2008-4#1)
values in the micromolar##3##4##(1990-2#1)(2006-12#1)(2008-4#1)
values in the nanomolar##2##4##(1994-9#1)(2006-12#1)
values in the range 0##6##5##(1993-4#2)(2008-10#2)(2008-5#2)
values in the range of##5##5##(1996-12#1)(2004-4#1)(2006-8#1)(2008-10#1)(2010-5#1)
values in the range##14##4##(1993-4#2)(1996-12#1)(1997-7#1)(2004-4#1)(2006-8#1)(2008-10#5)(2008-5#2)(2010-5#1)
values in the##80##3##(1990-2#4)(1990-3#1)(1990-5#1)(1991-4#2)(1992-11#1)(1992-4#1)(1992-9#1)(1993-4#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-6#1)(1996-12#2)(1996-8#1)(1997-1#1)(1997-7#1)(2004-4#1)(2005-11#1)(2006-12#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-8#2)(2007-9#2)(2008-10#12)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#1)(2009-12#1)(2009-4#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
values in this case##2##4##(1997-1#1)(1997-4#1)
values in this##4##3##(1994-8#1)(1997-1#1)(1997-4#1)(2013-7#1)
values in three##2##3##(1992-12#1)(2008-10#1)
values in##192##2##(1990-12#1)(1990-2#4)(1990-3#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-4#2)(1992-11#1)(1992-12#4)(1992-2#1)(1992-4#2)(1992-8#1)(1992-9#1)(1993-2#1)(1993-4#2)(1993-6#1)(1993-7#1)(1993-9#2)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#2)(1995-7#1)(1996-12#3)(1996-2#1)(1996-8#2)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#2)(2004-4#1)(2005-11#3)(2005-7#1)(2006-10#1)(2006-12#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#5)(2007-11#1)(2007-12#2)(2007-2#4)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#30)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#8)(2008-4#4)(2008-5#10)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#3)(2009-6#1)(2009-7#2)(2010-10#1)(2010-5#1)(2010-8#2)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#8)(2013-7#3)(2013-8#1)
values increase##2##2##(1996-2#1)(2005-11#1)
values increased as##2##3##(2010-4#1)(2013-8#1)
values increased from##2##3##(1993-12#1)(2010-5#1)
values increased in##2##3##(1993-9#1)(2008-9#1)
values increased with##3##3##(2005-11#1)(2007-1#1)(2008-6#1)
values increased##12##2##(1991-6#1)(1993-12#1)(1993-9#1)(1995-11#1)(2005-11#1)(2007-1#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-4#1)(2010-5#1)(2013-8#1)
values indicate that##8##3##(1990-10#1)(1992-12#1)(1993-8#1)(1995-11#1)(1996-2#1)(2008-10#1)(2010-12#1)(2013-8#1)
values indicated that##3##3##(1992-1#1)(2005-12#1)(2008-10#1)
values indicated##4##2##(1992-1#1)(2005-12#1)(2008-10#2)
values indicating##2##2##(2013-1#2)
values induced by##2##3##(2006-8#1)(2013-1#1)
values instead of##4##3##(2008-10#3)(2008-8#1)
values is##14##2##(1995-10#1)(1996-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-6#2)(2009-7#1)(2011-1#1)(2013-1#2)
values larger##2##2##(2007-12#1)(2008-5#1)
values less than 10##3##4##(1990-12#1)(2005-11#1)(2008-1#1)
values less than 4##2##4##(2008-10#1)(2008-5#1)
values less than##10##3##(1990-12#1)(1991-4#1)(2005-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)
values lower than those##2##4##(1990-8#1)(2008-10#1)
values lower than##8##3##(1990-8#1)(1994-12#1)(1994-9#1)(2008-10#4)(2011-1#1)
values make##2##2##(2006-7#1)(2011-2#1)
values may be##2##3##(2005-7#1)(2008-3#1)
values may##6##2##(1990-7#1)(2005-11#1)(2005-7#1)(2008-10#1)(2008-3#1)(2011-2#1)
values measured for##4##3##(1990-9#1)(1992-1#1)(1994-8#1)(2008-3#1)
values measured in##3##3##(1995-10#1)(1995-4#1)(2007-11#1)
values measured##12##2##(1990-9#1)(1992-1#1)(1994-8#1)(1995-10#1)(1995-4#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-2#1)
values more##2##2##(1996-10#1)(2008-10#1)
values near##8##2##(1990-5#1)(1992-3#1)(1995-3#1)(2006-11#1)(2008-10#2)(2008-3#1)(2008-5#1)
values observed at the##2##4##(2008-2#1)(2009-6#1)
values observed for the##2##4##(1990-11#1)(1992-3#1)
values observed for##4##3##(1990-11#1)(1992-1#1)(1992-3#1)(2008-5#1)
values observed in##4##3##(1994-12#1)(2005-10#1)(2008-10#1)(2010-12#1)
values observed with##2##3##(1990-2#1)(1992-6#1)
values observed##14##2##(1990-11#1)(1990-2#1)(1992-1#1)(1992-3#1)(1992-6#1)(1994-12#1)(2005-10#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-6#1)(2010-12#1)(2012-2#1)
values obtained after##2##3##(1996-12#1)(2008-10#1)
values obtained are in good agreement with the##2##8##(2008-10#1)(2008-2#1)
values obtained are##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
values obtained by the##3##4##(1996-7#1)(2008-10#1)(2010-4#1)
values obtained by##20##3##(1990-2#1)(1990-4#1)(1990-8#1)(1996-7#1)(2006-1#1)(2006-5#1)(2008-10#11)(2008-3#1)(2010-4#1)(2013-1#1)
values obtained for model##2##4##(2007-8#1)(2008-2#1)
values obtained for the##5##4##(2005-10#1)(2006-4#1)(2008-10#3)
values obtained for##19##3##(1990-12#1)(1993-3#1)(1996-5#1)(2005-10#1)(2006-4#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#1)(2012-12#3)(2012-2#1)
values obtained from 10##2##4##(1996-6#1)(2008-10#1)
values obtained from a##2##4##(2008-10#1)(2013-1#1)
values obtained from the##6##4##(1991-9#1)(1992-2#1)(1994-8#1)(1996-5#1)(2007-8#1)(2012-3#1)
values obtained from##28##3##(1990-6#1)(1991-10#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1994-8#1)(1995-10#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-7#1)(2007-8#1)(2008-10#5)(2008-3#2)(2008-6#1)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
values obtained in the##3##4##(2008-10#2)(2008-5#1)
values obtained in##12##3##(1990-10#1)(1997-6#1)(2005-10#1)(2006-5#2)(2007-3#1)(2008-10#3)(2008-12#1)(2008-5#1)(2012-3#1)
values obtained using the cuff method##2##6##(2013-8#2)
values obtained using the##3##4##(2013-8#3)
values obtained using##4##3##(2007-4#1)(2013-8#3)
values obtained were##5##3##(1991-8#1)(1995-6#1)(2008-10#3)
values obtained with a##3##4##(1993-4#1)(2007-12#1)(2008-3#1)
values obtained with the two##2##5##(2004-12#1)(2008-10#1)
values obtained with##15##3##(1992-6#1)(1993-4#2)(1995-4#1)(1996-12#1)(1996-7#1)(1997-5#1)(2004-12#1)(2007-12#1)(2008-10#4)(2008-3#1)(2009-3#1)
values obtained##124##2##(1990-1#1)(1990-10#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#2)(1993-11#1)(1993-3#1)(1993-4#2)(1994-8#1)(1995-10#1)(1995-4#2)(1995-6#1)(1996-11#1)(1996-12#2)(1996-5#2)(1996-6#1)(1996-7#3)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-12#1)(2005-10#2)(2006-1#1)(2006-4#1)(2006-5#3)(2007-1#1)(2007-10#1)(2007-12#3)(2007-3#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#39)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#2)(2008-6#1)(2009-3#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#4)
values occurred##2##2##(2008-9#2)
values of % A##4##4##(2008-5#4)
values of &lt##3##3##(2008-10#3)
values of 0##45##3##(1990-5#1)(1991-8#1)(1992-8#1)(1993-8#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-7#1)(1995-8#1)(1997-2#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-12#1)(2007-5#1)(2008-10#6)(2008-11#2)(2008-12#4)(2008-3#4)(2008-5#1)(2008-6#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-7#1)
values of 1##13##3##(1990-8#1)(1991-2#1)(1991-7#1)(1992-11#1)(1992-12#1)(1993-3#1)(1996-5#1)(1997-7#2)(2005-9#1)(2008-10#2)(2008-3#1)
values of 10##2##3##(1994-11#1)(1996-6#1)
values of 11 and##3##4##(1997-1#2)(2008-5#1)
values of 11##6##3##(1997-1#3)(2008-10#1)(2008-5#1)(2013-1#1)
values of 129##2##3##(1992-3#1)(1995-11#1)
values of 13##2##3##(1995-8#1)(2008-10#1)
values of 14##2##3##(1995-11#1)(1997-8#1)
values of 16##3##3##(1990-3#1)(2010-6#1)(2013-1#1)
values of 2##13##3##(1991-7#1)(1992-11#1)(1994-8#1)(1995-1#1)(1995-12#1)(2006-12#3)(2008-1#1)(2008-10#3)(2008-7#1)
values of 3 and##2##4##(1991-2#1)(2008-10#1)
values of 3##6##3##(1991-2#1)(1992-3#1)(1995-8#1)(2008-10#3)
values of 300##2##3##(1994-12#1)(1996-9#1)
values of 310 and##2##4##(1996-5#1)(2008-10#1)
values of 4##7##3##(1995-1#1)(1995-2#1)(1995-3#1)(2007-8#1)(2008-11#2)(2013-1#1)
values of 44##2##3##(1991-8#1)(2008-10#1)
values of 49##2##3##(1990-2#1)(2008-11#1)
values of 5 microM##2##4##(1990-7#1)(1995-5#1)
values of 5##4##3##(1990-7#1)(1994-11#1)(1995-5#1)(2008-10#1)
values of 50##2##3##(1991-2#1)(1994-12#1)
values of 6##6##3##(1990-8#1)(1992-12#1)(1993-4#1)(1994-11#1)(1997-2#1)(2008-3#1)
values of 7##3##3##(1995-11#1)(1995-3#1)(2008-5#1)
values of 8##4##3##(1994-3#2)(1997-7#1)(2007-1#1)
values of 89##2##3##(1995-5#1)(2008-10#1)
values of 95##2##3##(1995-2#1)(2006-1#1)
values of CLr##2##3##(1990-9#2)
values of DeltaH##2##3##(2005-11#1)(2007-8#1)
values of K(obs) for##2##4##(1997-4#2)
values of LDL alpha-tocopherol##2##4##(1991-12#2)
values of P##4##3##(2011-2#2)(2012-2#2)
values of R##2##3##(1995-6#1)(2008-10#1)
values of V##2##3##(1994-11#1)(2010-3#1)
values of Y##2##3##(2008-7#2)
values of Young's modulus##2##4##(2009-4#1)(2009-7#1)
values of a##5##3##(1996-2#1)(2008-11#1)(2008-2#1)(2008-4#1)(2013-8#1)
values of aPS##2##3##(2008-7#2)
values of about##4##3##(1991-11#1)(1993-2#1)(1997-2#1)(2008-12#1)
values of absorption##2##3##(2008-2#1)(2008-3#1)
values of all the##2##4##(2005-11#1)(2009-6#1)
values of all##11##3##(1990-11#1)(2005-11#1)(2008-10#2)(2009-6#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
values of alpha##2##3##(1991-2#1)(2008-3#1)
values of antibodies to Tamm-Horsfall protein were##2##7##(1996-12#2)
values of apparent##2##3##(2006-10#2)
values of beta##2##3##(1992-2#1)(2008-10#1)
values of both the##2##4##(2005-11#2)
values of both##5##3##(1993-12#1)(2005-11#2)(2007-11#1)(2007-3#1)
values of creatinine##3##3##(2008-1#2)(2008-4#1)
values of delta##2##3##(1990-7#1)(1995-4#1)
values of dihydroetorphine for the##2##5##(1995-11#2)
values of disease##2##3##(2008-10#2)
values of each of the##2##5##(2008-10#1)(2008-5#1)
values of each##3##3##(2008-10#2)(2008-5#1)
values of electron##2##3##(2008-2#1)(2009-10#1)
values of five##2##3##(1997-1#1)(2008-7#1)
values of genetic diversity##2##4##(2008-10#2)
values of genetic##4##3##(2008-10#3)(2008-5#1)
values of human##2##3##(1990-1#1)(2008-7#1)
values of k(t)w(0)##2##3##(2008-2#2)
values of kcat##2##3##(1994-9#1)(1995-11#1)
values of lambda##3##3##(1992-2#1)(2010-2#2)
values of less than##2##4##(1994-7#1)(1995-1#1)
values of log##3##3##(2005-10#1)(2007-11#1)(2007-6#1)
values of optical##2##3##(2006-2#1)(2008-3#1)
values of parameters##2##3##(2008-3#1)(2012-12#1)
values of plasma##2##3##(1995-7#1)(1996-6#1)
values of protein##2##3##(2007-3#1)(2008-4#1)
values of raw##2##3##(2010-4#2)
values of recoveries##2##3##(2008-10#2)
values of reflectivity##2##3##(2008-3#2)
values of sensitivity##3##3##(2006-10#1)(2008-10#1)(2008-3#1)
values of serum##4##3##(2006-4#2)(2007-3#1)(2012-12#1)
values of some##3##3##(2007-11#1)(2008-2#1)(2013-1#1)
values of specific##2##3##(2006-12#1)(2007-3#1)
values of stability##2##3##(2008-10#2)
values of stress##2##3##(2007-11#1)(2008-2#1)
values of t(1)##2##3##(2008-10#2)
values of the Darcy number the##2##6##(2005-11#2)
values of the F(1) generation were##2##6##(2008-10#2)
values of the FAPP##2##4##(2008-2#2)
values of the compounds##2##4##(1994-11#1)(2008-10#1)
values of the control group##2##5##(2006-9#1)(2008-4#1)
values of the control sera##2##5##(1990-12#1)(1992-12#1)
values of the control##7##4##(1990-12#1)(1990-7#2)(1992-12#1)(2006-9#1)(2008-12#1)(2008-4#1)
values of the different##2##4##(1990-11#1)(1997-2#1)
values of the dissociation constants##2##5##(1994-9#1)(2005-11#1)
values of the dissociation##3##4##(1994-9#1)(2005-11#2)
values of the equilibrium##2##4##(1992-10#1)(2008-10#1)
values of the explanatory##2##4##(1995-6#1)(2010-8#1)
values of the samples##2##4##(2008-10#2)
values of the scattering##3##4##(2008-2#2)(2008-3#1)
values of the second##2##4##(1991-4#1)(2008-10#1)
values of the second-order##3##4##(1993-8#1)(2007-11#1)(2007-12#1)
values of the shear##2##4##(2006-11#2)
values of the significant variables##2##5##(2008-10#2)
values of the spectral##2##4##(2008-3#2)
values of the surface##2##4##(2005-11#1)(2008-10#1)
values of the three##2##4##(2007-6#1)(2009-7#1)
values of the two##6##4##(1990-2#1)(2004-12#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
values of the variables##2##4##(2008-2#1)(2011-2#1)
values of the##220##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#1)(1991-10#2)(1991-2#1)(1991-4#2)(1991-7#1)(1992-10#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-1#2)(1997-2#3)(1997-6#1)(1997-8#1)(2004-12#1)(2005-11#12)(2006-11#2)(2006-4#1)(2006-5#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#6)(2007-3#1)(2007-6#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#35)(2008-11#3)(2008-12#2)(2008-2#20)(2008-3#24)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-8#3)(2011-1#1)(2011-11#1)(2011-2#6)(2012-2#1)(2013-1#8)(2013-8#6)
values of these constants##3##4##(2005-11#1)(2008-10#2)
values of these##12##3##(1991-2#1)(1992-11#1)(1997-5#1)(2005-11#1)(2007-6#1)(2008-10#3)(2008-12#2)(2008-3#1)(2010-3#1)
values of this##3##3##(1991-6#1)(2006-5#1)(2008-5#1)
values of tilt##2##3##(2008-2#2)
values of total bilirubin##2##4##(2013-1#2)
values of total##3##3##(1991-12#1)(2013-1#2)
values of up to##3##4##(2007-12#1)(2009-11#1)(2012-1#1)
values of various##2##3##(2007-12#1)(2008-5#1)
values of vital##2##3##(1994-7#1)(2012-12#1)
values of volume##3##3##(2005-11#1)(2008-2#1)(2011-1#1)
values of |beta| for selection##2##5##(2008-8#2)
values of##980##2##(1990-1#2)(1990-10#2)(1990-11#3)(1990-12#3)(1990-2#5)(1990-3#3)(1990-4#5)(1990-5#3)(1990-6#2)(1990-7#6)(1990-8#5)(1990-9#3)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#8)(1991-2#8)(1991-4#3)(1991-5#2)(1991-6#2)(1991-7#6)(1991-8#6)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#5)(1992-2#4)(1992-3#3)(1992-4#1)(1992-5#4)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-1#4)(1993-11#4)(1993-12#3)(1993-2#1)(1993-3#3)(1993-4#3)(1993-5#1)(1993-6#1)(1993-8#5)(1993-9#1)(1994-1#1)(1994-11#5)(1994-12#6)(1994-2#1)(1994-3#7)(1994-5#2)(1994-6#1)(1994-7#4)(1994-8#6)(1994-9#6)(1995-1#5)(1995-10#1)(1995-11#8)(1995-12#6)(1995-2#4)(1995-3#8)(1995-4#1)(1995-5#8)(1995-6#5)(1995-7#3)(1995-8#6)(1996-1#2)(1996-10#2)(1996-11#3)(1996-12#4)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#6)(1996-6#5)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#9)(1997-2#8)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#3)(2004-10#1)(2004-12#2)(2004-2#1)(2004-9#2)(2005-10#3)(2005-11#28)(2005-12#2)(2005-9#1)(2006-1#1)(2006-10#7)(2006-11#4)(2006-12#7)(2006-2#1)(2006-4#3)(2006-5#4)(2006-6#2)(2006-7#2)(2006-8#2)(2006-9#4)(2007-1#5)(2007-10#8)(2007-11#20)(2007-12#16)(2007-2#2)(2007-3#5)(2007-4#2)(2007-5#2)(2007-6#5)(2007-7#4)(2007-8#7)(2007-9#5)(2008-1#6)(2008-10#143)(2008-11#19)(2008-12#14)(2008-2#53)(2008-3#61)(2008-4#9)(2008-5#33)(2008-6#4)(2008-7#21)(2008-8#13)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#3)(2009-4#4)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#2)(2010-2#6)(2010-3#2)(2010-4#12)(2010-5#1)(2010-6#2)(2010-8#7)(2010-9#2)(2011-1#11)(2011-11#1)(2011-12#6)(2011-2#16)(2012-1#1)(2012-11#3)(2012-12#10)(2012-2#4)(2012-3#4)(2013-1#23)(2013-7#5)(2013-8#11)
values on the##6##3##(1992-1#1)(1995-6#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-3#1)
values on##15##2##(1990-1#1)(1992-1#1)(1992-3#1)(1995-6#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-7#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-3#1)
values only##4##2##(1990-2#2)(2006-7#1)(2010-12#1)
values or##5##2##(2008-1#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-8#1)
values outside##2##2##(1990-12#1)(1991-9#1)
values over all##2##3##(2008-2#1)(2008-9#1)
values over the##2##3##(2007-8#1)(2008-10#1)
values over##9##2##(2007-11#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-7#1)(2008-9#1)(2010-11#1)
values predicted by the##2##4##(2008-3#1)(2008-5#1)
values predicted by##5##3##(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)
values predicted from the##2##4##(1993-12#1)(2007-11#1)
values predicted from##3##3##(1993-12#1)(2007-11#1)(2011-1#1)
values predicted##8##2##(1993-12#1)(2007-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)
values present in##2##3##(1990-7#1)(1996-1#1)
values present##3##2##(1990-7#1)(1996-1#1)(2008-10#1)
values provided##2##2##(2012-3#1)(2013-1#1)
values published##3##2##(1994-2#1)(2008-3#1)(2008-4#1)
values range from##4##3##(1990-3#1)(1991-8#1)(1996-2#2)
values ranged between##4##3##(1994-11#1)(2008-10#2)(2008-5#1)
values ranged from 0##8##4##(1993-6#1)(1994-5#1)(1996-3#1)(2008-10#4)(2008-5#1)
values ranged from 1##2##4##(1992-8#1)(2008-12#1)
values ranged from##17##3##(1992-8#1)(1993-6#1)(1994-5#1)(1995-3#1)(1996-3#1)(2006-8#1)(2007-10#1)(2007-4#1)(2008-10#4)(2008-12#1)(2008-5#2)(2008-7#1)(2012-2#1)
values ranged##22##2##(1991-5#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-3#1)(1996-3#1)(2006-8#1)(2007-10#1)(2007-4#1)(2008-10#6)(2008-12#1)(2008-5#3)(2008-7#1)(2012-2#1)
values ranging between##4##3##(1992-5#1)(1993-4#1)(2007-8#1)(2013-1#1)
values ranging from 0##6##4##(2006-1#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-5#1)
values ranging from 1##5##4##(2006-1#1)(2007-11#1)(2008-10#3)
values ranging from 6 to##2##5##(2007-11#1)(2010-4#1)
values ranging from 6##3##4##(2007-11#1)(2008-10#1)(2010-4#1)
values ranging from##29##3##(1993-9#1)(1996-10#1)(2005-10#1)(2006-1#2)(2006-12#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#9)(2008-3#1)(2008-5#3)(2009-2#1)(2009-7#2)(2010-4#1)
values ranging##34##2##(1992-5#1)(1993-4#1)(1993-9#1)(1996-10#1)(2005-10#1)(2006-1#2)(2006-12#2)(2006-5#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-3#1)(2008-5#3)(2009-2#1)(2009-7#2)(2010-4#1)(2013-1#1)
values recorded in##2##3##(1993-9#1)(2006-5#1)
values recorded##6##2##(1991-9#1)(1993-9#1)(2006-5#1)(2007-1#1)(2007-5#1)(2008-7#1)
values reduced##2##2##(2006-5#1)(2013-8#1)
values referred to##2##3##(1990-5#1)(2007-2#1)
values regarding##2##2##(2008-9#1)(2009-4#1)
values remained##7##2##(1992-12#1)(1993-7#1)(1996-11#1)(2006-5#1)(2008-10#1)(2011-2#1)(2013-8#1)
values reported elsewhere##2##3##(1997-4#1)(2008-10#1)
values reported for##4##3##(2007-11#2)(2008-3#1)(2012-12#1)
values reported in the literature##3##5##(1991-3#1)(2008-10#1)(2008-6#1)
values reported in##5##3##(1991-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)
values reported##13##2##(1991-3#1)(1997-4#1)(2007-11#2)(2008-10#3)(2008-3#3)(2008-5#1)(2008-6#1)(2012-12#1)
values resulted in a##2##4##(1994-7#1)(2008-3#1)
values returned to normal##2##4##(1997-6#1)(2004-9#1)
values returned to##3##3##(1995-2#1)(1997-6#1)(2004-9#1)
values seen in##2##3##(1990-9#1)(1996-5#1)
values seen##3##2##(1990-9#1)(1991-2#1)(1996-5#1)
values should be##4##3##(1990-2#2)(2006-1#1)(2008-3#1)
values should##5##2##(1990-2#2)(2006-1#1)(2008-3#1)(2008-5#1)
values show a significant##2##4##(1995-2#1)(2008-5#1)
values show##6##2##(1995-11#1)(1995-2#1)(1995-4#1)(1996-2#1)(2007-11#1)(2008-5#1)
values showed a good##2##4##(2007-5#1)(2008-10#1)
values showed a##3##3##(2007-1#1)(2007-5#1)(2008-10#1)
values showed##8##2##(1993-11#1)(2006-9#1)(2007-1#2)(2007-5#1)(2008-10#2)(2013-8#1)
values significantly##5##2##(1995-11#1)(1997-6#1)(2008-10#1)(2010-2#1)(2011-2#1)
values similar to##4##3##(1991-2#1)(2004-4#1)(2005-11#1)(2007-11#1)
values similar##5##2##(1991-2#1)(2004-4#1)(2005-11#1)(2007-11#1)(2008-11#1)
values specified##2##2##(2008-11#1)(2008-3#1)
values studied##2##2##(2008-10#1)(2013-1#1)
values suggest that##2##3##(2010-10#1)(2010-6#1)
values suggested##2##2##(1990-7#1)(2008-10#1)
values suggests##2##2##(1996-5#1)(2008-9#1)
values tend to##2##3##(2008-10#1)(2009-6#1)
values than the##3##3##(1994-3#1)(2007-10#1)(2007-12#1)
values than those obtained##2##4##(1995-12#1)(1997-7#1)
values than those of##2##4##(2008-5#1)(2011-2#1)
values than those##6##3##(1995-12#1)(1997-7#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
values than##22##2##(1991-5#1)(1994-3#1)(1995-12#1)(1996-3#1)(1997-7#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-5#2)(2008-6#1)(2009-4#1)(2010-4#1)(2011-2#4)(2012-12#1)(2012-2#1)
values that are##7##3##(1991-7#1)(1995-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-4#2)
values that correspond to the##2##5##(2008-2#1)(2010-2#1)
values that varied from##2##4##(1994-11#2)
values that were##3##3##(1994-11#1)(2008-10#1)(2008-5#1)
values that##25##2##(1991-7#1)(1994-11#3)(1995-12#1)(1996-2#1)(2006-11#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2010-2#1)(2010-4#2)
values the##4##2##(1991-3#1)(2007-12#1)(2008-10#1)(2008-7#1)
values through##3##2##(2008-3#1)(2009-10#1)(2011-2#1)
values throughout the##2##3##(1990-11#1)(2012-3#1)
values to be##3##3##(1991-7#1)(1995-6#1)(2008-1#1)
values to characterize the##2##4##(1997-7#1)(2008-3#1)
values to the original##2##4##(2004-9#1)(2008-12#1)
values to the##6##3##(2004-9#1)(2007-12#1)(2008-10#1)(2008-12#2)(2008-7#1)
values to those of##2##4##(1997-1#1)(2007-10#1)
values to##33##2##(1991-7#1)(1992-3#1)(1992-7#1)(1993-8#1)(1995-11#2)(1995-12#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-7#1)(2004-9#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-8#1)(2013-1#3)
values under##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
values up to##3##3##(2004-9#1)(2008-5#1)(2009-8#1)
values used##2##2##(2005-7#1)(2008-3#1)
values using##4##2##(2006-8#1)(2008-10#3)
values varied between##2##3##(2008-10#1)(2008-5#1)
values varied##3##2##(1992-4#1)(2008-10#1)(2008-5#1)
values versus##2##2##(2008-5#1)(2012-3#1)
values was found##3##3##(1993-9#1)(1996-5#1)(2008-7#1)
values was good##2##3##(2008-10#2)
values was noted in##2##4##(2005-11#1)(2012-1#1)
values was observed##5##3##(1992-8#1)(1995-1#1)(1997-5#1)(2005-11#1)(2006-10#1)
values was obtained for##2##4##(2005-11#1)(2008-10#1)
values was##35##2##(1990-1#1)(1991-2#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-9#1)(1995-1#1)(1996-5#1)(1997-5#1)(2004-12#1)(2005-11#3)(2005-12#1)(2006-10#1)(2007-1#1)(2008-10#8)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#1)(2010-2#1)(2012-1#1)(2012-12#1)
values well##2##2##(1992-6#1)(2008-10#1)
values were &gt##3##3##(2007-2#2)(2008-10#1)
values were &lt##3##3##(2007-2#1)(2011-1#1)(2011-2#1)
values were 0##7##3##(1990-2#1)(1990-3#1)(1993-11#1)(2008-10#1)(2008-12#1)(2010-4#1)(2012-12#1)
values were 1##4##3##(1994-8#1)(2008-10#2)(2008-7#1)
values were 2##2##3##(2006-8#1)(2009-4#1)
values were 3##2##3##(1994-5#1)(2006-8#1)
values were 4##4##3##(2008-10#2)(2008-11#1)(2009-4#1)
values were 5##2##3##(1997-7#1)(2013-8#1)
values were 6##2##3##(2008-10#1)(2008-5#1)
values were adjusted##3##3##(1990-10#1)(2011-2#2)
values were also##6##3##(1995-5#1)(1997-4#1)(2007-10#1)(2008-10#2)(2009-6#1)
values were approximately##2##3##(1990-2#1)(2008-10#1)
values were as follows##2##4##(2007-10#1)(2007-7#1)
values were associated with##2##4##(1996-8#1)(2010-12#1)
values were below##2##3##(1995-8#1)(2012-1#1)
values were calculated and compared##2##5##(2007-11#1)(2013-1#1)
values were calculated for##3##4##(2007-11#1)(2008-10#1)(2008-5#1)
values were calculated##11##3##(2007-11#2)(2007-4#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-6#1)(2011-1#1)(2011-3#1)(2013-1#2)
values were comparable##3##3##(1997-7#1)(2008-7#1)(2013-1#1)
values were compared to those of##2##6##(1990-9#1)(1997-8#1)
values were compared to##3##4##(1990-9#1)(1997-8#1)(2008-10#1)
values were compared with##3##4##(2007-11#1)(2008-10#2)
values were compared##8##3##(1990-9#1)(1992-8#1)(1997-8#1)(2007-11#1)(2008-10#3)(2013-1#1)
values were determined by##2##4##(2008-1#1)(2008-10#1)
values were determined for##3##4##(1995-8#1)(2007-11#2)
values were determined using##2##4##(2006-8#1)(2011-2#1)
values were determined##12##3##(1995-8#1)(2006-8#1)(2007-1#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-5#2)(2009-9#1)(2011-2#1)
values were established##3##3##(1996-12#1)(2008-10#1)(2008-5#1)
values were estimated##2##3##(2007-11#1)(2008-10#1)
values were found for##2##4##(1991-2#1)(2008-10#1)
values were found in the range of##2##7##(2007-10#2)
values were found in the##3##5##(1997-2#1)(2007-10#2)
values were found in##9##4##(1990-6#1)(1997-2#1)(2007-10#2)(2007-5#1)(2007-8#2)(2008-5#1)(2008-7#1)
values were found to be##5##5##(1991-12#1)(1994-5#1)(2005-11#1)(2008-10#2)
values were found to##8##4##(1990-12#1)(1991-12#1)(1991-4#1)(1994-5#1)(2005-11#1)(2008-10#3)
values were found##23##3##(1990-12#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-4#1)(1994-5#1)(1997-2#1)(2005-11#1)(2007-10#2)(2007-5#1)(2007-8#2)(2008-10#7)(2008-5#1)(2008-7#2)
values were generally##2##3##(1995-1#1)(1996-8#1)
values were higher in##4##4##(1990-11#1)(2011-2#3)
values were higher than##2##4##(1996-8#1)(2012-1#1)
values were higher##10##3##(1990-11#1)(1992-9#1)(1996-8#1)(2007-7#1)(2009-3#1)(2010-4#1)(2011-2#3)(2012-1#1)
values were identical to those observed##2##6##(1992-12#1)(2009-2#1)
values were in good agreement with##2##6##(2008-3#1)(2009-4#1)
values were in good agreement##3##5##(2008-10#1)(2008-3#1)(2009-4#1)
values were in the range##2##5##(2005-11#1)(2008-10#1)
values were in the##5##4##(1991-5#1)(1993-11#1)(2005-11#1)(2008-10#1)(2008-8#1)
values were in##8##3##(1991-5#1)(1993-11#1)(2005-11#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-4#1)
values were increased##2##3##(1997-8#1)(2013-1#1)
values were investigated##3##3##(2006-8#1)(2008-5#1)(2011-2#1)
values were less than##2##4##(2007-8#1)(2008-10#1)
values were less##4##3##(2007-8#1)(2008-10#1)(2008-8#1)(2012-2#1)
values were low##3##3##(1995-3#1)(1995-8#1)(2006-9#1)
values were lower in##3##4##(1997-5#1)(2007-8#1)(2008-7#1)
values were lower##6##3##(1997-2#1)(1997-5#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-8#1)
values were measured for##2##4##(1995-11#1)(1996-5#1)
values were measured in##2##4##(2006-10#1)(2008-2#1)
values were measured##10##3##(1992-3#1)(1995-11#1)(1996-5#1)(2006-10#1)(2008-10#2)(2008-2#1)(2012-2#1)(2013-8#2)
values were normal##2##3##(1990-9#1)(1995-11#1)
values were not significantly different between patients##2##7##(1996-7#1)(2007-12#1)
values were not significantly different##6##5##(1990-9#1)(1994-2#1)(1996-7#1)(2007-12#1)(2008-10#2)
values were not##9##3##(1990-9#1)(1991-11#1)(1992-6#1)(1994-2#1)(1996-7#1)(1996-9#1)(2007-12#1)(2008-10#2)
values were noted##2##3##(2007-2#1)(2009-3#1)
values were observed during##2##4##(1993-9#1)(2008-5#1)
values were observed for##4##4##(1990-12#1)(1993-6#1)(1996-5#1)(2008-10#1)
values were observed in##8##4##(1993-8#1)(1996-7#1)(2007-10#1)(2007-8#2)(2008-1#1)(2008-10#1)(2010-4#1)
values were observed##17##3##(1990-12#1)(1990-5#1)(1991-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1996-5#1)(1996-7#1)(2006-8#1)(2007-10#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-5#1)(2010-4#1)
values were obtained at##2##4##(2008-6#2)
values were obtained for##5##4##(1990-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
values were obtained from##2##4##(2006-8#1)(2007-2#1)
values were obtained in##3##4##(1996-11#1)(2007-3#1)(2008-10#1)
values were obtained##16##3##(1990-8#1)(1995-1#1)(1996-11#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-6#2)(2011-2#1)
values were recorded##3##3##(1992-1#1)(2011-1#1)(2013-8#1)
values were reduced##3##3##(1990-11#1)(1994-2#1)(1996-11#1)
values were seen##3##3##(1996-5#1)(2007-2#1)(2008-5#1)
values were significantly (P &lt##2##5##(1993-1#1)(2008-5#1)
values were significantly different##2##4##(2008-10#1)(2013-1#1)
values were significantly higher in##3##5##(1990-7#1)(2008-11#1)(2012-3#1)
values were significantly higher than those##2##6##(1990-8#1)(1991-8#1)
values were significantly higher than##3##5##(1990-8#1)(1991-8#1)(2009-8#1)
values were significantly higher##9##4##(1990-7#1)(1990-8#1)(1991-8#1)(2007-10#1)(2008-11#1)(2008-6#1)(2009-1#1)(2009-8#1)(2012-3#1)
values were significantly lower##3##4##(1995-11#2)(2004-9#1)
values were significantly##23##3##(1990-7#1)(1990-8#1)(1991-8#1)(1993-1#1)(1994-3#1)(1995-11#2)(2004-9#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-1#1)(2009-8#1)(2012-3#2)(2013-1#2)
values were similar in##2##4##(1997-2#1)(2008-7#1)
values were similar to##2##4##(1996-12#1)(2008-7#1)
values were similar##6##3##(1992-7#1)(1996-12#1)(1997-2#1)(2008-3#1)(2008-7#2)
values were still##3##3##(1996-12#1)(2006-4#1)(2008-6#1)
values were used to##2##4##(1993-11#1)(2008-3#1)
values were used##3##3##(1993-11#1)(2008-3#1)(2011-2#1)
values were##342##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#5)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#2)(1991-5#1)(1991-8#1)(1992-1#2)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#3)(1993-2#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-7#2)(1994-8#3)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#5)(1995-3#1)(1995-5#1)(1995-8#3)(1996-11#3)(1996-12#3)(1996-5#4)(1996-6#1)(1996-7#3)(1996-8#4)(1996-9#2)(1997-1#1)(1997-2#4)(1997-4#1)(1997-5#1)(1997-7#3)(1997-8#2)(2004-9#2)(2005-11#2)(2006-1#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-8#6)(2006-9#2)(2007-1#2)(2007-10#6)(2007-11#6)(2007-12#2)(2007-2#6)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#7)(2008-1#3)(2008-10#64)(2008-11#4)(2008-12#4)(2008-2#2)(2008-3#4)(2008-5#16)(2008-6#4)(2008-7#9)(2008-8#2)(2009-1#1)(2009-2#2)(2009-3#3)(2009-4#3)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#1)(2010-12#1)(2010-4#4)(2010-6#1)(2011-1#3)(2011-2#12)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#12)(2013-8#4)
values when##6##2##(1994-5#1)(2006-12#1)(2008-10#1)(2008-3#1)(2013-1#1)(2013-7#1)
values where##4##2##(1995-2#1)(2005-11#1)(2006-10#1)(2008-3#1)
values which are##4##3##(1990-12#1)(1995-3#1)(1997-1#1)(2008-11#1)
values which were lower##2##4##(1996-9#1)(2008-10#1)
values which were##6##3##(1996-9#2)(2004-12#1)(2008-10#2)(2008-7#1)
values which##16##2##(1990-12#1)(1993-12#1)(1995-3#1)(1996-9#2)(1997-1#1)(1997-7#1)(2004-12#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-7#1)(2011-1#2)
values while##3##2##(1994-12#1)(1994-4#1)(2007-11#1)
values will be##2##3##(1992-3#1)(2008-11#1)
values with the##5##3##(1990-9#1)(1991-5#1)(2005-11#1)(2006-12#1)(2008-3#1)
values with##21##2##(1990-12#1)(1990-9#1)(1991-5#1)(1995-8#1)(1997-2#1)(2005-11#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#1)
values within 8##2##3##(1991-4#1)(1994-9#1)
values within##10##2##(1991-4#1)(1992-2#1)(1993-11#1)(1994-9#1)(1996-7#1)(2008-10#2)(2008-2#1)(2009-2#1)(2012-2#1)
values##4478##1##(1990-1#9)(1990-10#15)(1990-11#14)(1990-12#28)(1990-2#33)(1990-3#13)(1990-4#14)(1990-5#18)(1990-6#8)(1990-7#24)(1990-8#26)(1990-9#15)(1991-1#5)(1991-10#8)(1991-11#7)(1991-12#18)(1991-2#26)(1991-3#7)(1991-4#16)(1991-5#12)(1991-6#7)(1991-7#17)(1991-8#20)(1991-9#11)(1992-1#18)(1992-10#3)(1992-11#11)(1992-12#23)(1992-2#15)(1992-3#21)(1992-4#11)(1992-5#8)(1992-6#19)(1992-7#10)(1992-8#23)(1992-9#9)(1993-1#9)(1993-11#27)(1993-12#16)(1993-2#11)(1993-3#8)(1993-4#13)(1993-5#5)(1993-6#10)(1993-7#3)(1993-8#16)(1993-9#20)(1994-1#4)(1994-11#30)(1994-12#21)(1994-2#12)(1994-3#20)(1994-4#2)(1994-5#20)(1994-6#11)(1994-7#9)(1994-8#29)(1994-9#23)(1995-1#14)(1995-10#12)(1995-11#31)(1995-12#25)(1995-2#23)(1995-3#25)(1995-4#8)(1995-5#16)(1995-6#24)(1995-7#18)(1995-8#21)(1995-9#2)(1996-1#6)(1996-10#5)(1996-11#14)(1996-12#26)(1996-2#19)(1996-3#16)(1996-4#6)(1996-5#22)(1996-6#9)(1996-7#25)(1996-8#15)(1996-9#18)(1997-1#23)(1997-2#41)(1997-3#9)(1997-4#20)(1997-5#12)(1997-6#7)(1997-7#22)(1997-8#16)(2004-1#2)(2004-10#1)(2004-12#7)(2004-2#1)(2004-4#7)(2004-9#10)(2005-10#16)(2005-11#70)(2005-12#10)(2005-4#6)(2005-5#1)(2005-7#8)(2005-8#3)(2005-9#1)(2006-1#12)(2006-10#31)(2006-11#17)(2006-12#30)(2006-2#3)(2006-4#10)(2006-5#23)(2006-6#11)(2006-7#12)(2006-8#16)(2006-9#14)(2007-1#22)(2007-10#39)(2007-11#62)(2007-12#62)(2007-2#25)(2007-3#14)(2007-4#17)(2007-5#8)(2007-6#10)(2007-7#17)(2007-8#55)(2007-9#17)(2008-1#35)(2008-10#802)(2008-11#52)(2008-12#43)(2008-2#152)(2008-3#215)(2008-4#27)(2008-5#161)(2008-6#33)(2008-7#80)(2008-8#46)(2008-9#25)(2009-1#1)(2009-10#9)(2009-11#8)(2009-12#3)(2009-2#11)(2009-3#17)(2009-4#26)(2009-5#1)(2009-6#13)(2009-7#16)(2009-8#5)(2009-9#6)(2010-1#3)(2010-10#12)(2010-11#9)(2010-12#18)(2010-2#21)(2010-3#7)(2010-4#46)(2010-5#7)(2010-6#6)(2010-7#1)(2010-8#25)(2010-9#12)(2011-1#43)(2011-11#1)(2011-12#8)(2011-2#93)(2011-3#3)(2012-1#19)(2012-11#4)(2012-12#37)(2012-2#38)(2012-3#35)(2012-9#1)(2013-1#97)(2013-3#2)(2013-7#14)(2013-8#48)
values) and##6##2##(1992-2#1)(1992-8#1)(2006-10#1)(2007-8#1)(2008-10#1)(2011-1#1)
values) are##2##2##(1997-7#1)(2008-10#1)
values) had##2##2##(1997-7#1)(2013-1#1)
values) is##2##2##(1997-1#1)(2008-10#1)
values) of##3##2##(2008-10#3)
values) were##2##2##(1992-11#1)(1996-9#1)
values)##45##1##(1991-7#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-8#2)(1994-5#1)(1994-9#1)(1995-8#1)(1996-9#1)(1997-1#1)(1997-6#1)(1997-7#2)(2004-3#1)(2006-10#5)(2007-8#1)(2008-10#17)(2008-12#1)(2009-2#1)(2010-4#1)(2011-1#1)(2012-11#1)(2013-1#2)
values/principles##2##1##(2009-3#2)
values?##2##1##(1991-12#1)(2008-8#1)
values]##4##1##(1996-2#1)(2008-2#1)(2010-12#1)(2011-2#1)
valuing each other and the##2##5##(2011-1#2)
valuing in##2##2##(2007-12#1)(2007-7#1)
valuing##9##1##(1991-12#1)(1992-10#1)(2007-12#1)(2007-7#1)(2008-11#1)(2009-4#1)(2011-1#2)(2011-2#1)
valué of##2##2##(2013-8#2)
valvar tissue##2##2##(2007-8#2)
valvar##3##1##(2006-8#1)(2007-8#2)
valve (MV)##2##2##(2007-8#1)(2009-4#1)
valve and the##4##3##(2006-8#1)(2007-7#1)(2008-10#1)(2013-1#1)
valve and##28##2##(1994-5#1)(2005-12#1)(2006-8#4)(2007-7#1)(2007-8#4)(2008-10#8)(2008-4#1)(2010-12#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)
valve annulus##4##2##(2007-8#2)(2011-2#1)(2012-1#1)
valve areas##3##2##(2011-1#2)(2013-1#1)
valve as##2##2##(2008-12#1)(2013-1#1)
valve assembly##2##2##(2006-8#2)
valve at##2##2##(2007-12#1)(2008-4#1)
valve bladder syndrome##2##3##(2008-10#2)
valve by##3##2##(2007-8#1)(2007-9#1)(2008-4#1)
valve closure##2##2##(1995-6#1)(2005-9#1)
valve cusps##2##2##(1990-11#1)(2008-5#1)
valve degeneration##3##2##(2008-5#3)
valve design##2##2##(2007-8#1)(2010-8#1)
valve disease##16##2##(1990-3#1)(1990-6#2)(1994-3#1)(2006-10#1)(2007-8#3)(2007-9#1)(2008-12#1)(2008-4#1)(2009-10#2)(2009-5#1)(2010-12#1)(2011-2#1)
valve dysfunction in##2##3##(2008-4#1)(2010-12#1)
valve dysfunction##5##2##(2008-4#2)(2010-12#1)(2012-2#1)(2012-3#1)
valve endocarditis##12##2##(1991-10#1)(2005-12#2)(2007-12#2)(2007-8#3)(2010-7#2)(2011-2#2)
valve failure##4##2##(2007-8#3)(2008-4#1)
valve for##2##2##(2008-3#1)(2008-5#1)
valve function##6##2##(1993-5#1)(2007-8#4)(2008-10#1)
valve has##2##2##(2009-10#1)(2012-2#1)
valve in 3##2##3##(2007-8#1)(2010-6#1)
valve in a##3##3##(2007-8#2)(2008-10#1)
valve in the aortic position##2##5##(2007-8#2)
valve in the##3##3##(2007-8#2)(2008-10#1)
valve in##14##2##(1991-3#1)(2006-8#1)(2007-12#1)(2007-8#6)(2008-10#2)(2010-12#1)(2010-6#1)(2010-8#1)
valve insufficiency in##3##3##(1993-5#1)(1997-5#1)(2011-2#1)
valve insufficiency##11##2##(1993-5#1)(1997-5#1)(1997-8#1)(2007-8#4)(2008-4#1)(2011-2#1)(2012-2#2)
valve interventions##2##2##(2007-8#2)
valve is a##3##3##(2007-8#1)(2008-11#1)(2012-3#1)
valve is the##3##3##(2006-8#1)(2007-8#1)(2013-1#1)
valve is##14##2##(1996-1#2)(2005-12#1)(2006-8#2)(2007-12#1)(2007-8#4)(2008-1#1)(2008-11#1)(2012-3#1)(2013-1#1)
valve leaflet##3##2##(2006-1#2)(2007-12#1)
valve leaflets##3##2##(2006-1#1)(2007-8#1)(2013-1#1)
valve lesion##2##2##(2009-4#1)(2013-1#1)
valve lesions##3##2##(2005-12#1)(2008-5#2)
valve of##2##2##(2008-10#2)
valve or##2##2##(2010-8#1)(2011-2#1)
valve papillary fibroelastoma##3##3##(2007-8#2)(2009-9#1)
valve pathology##3##2##(2007-8#1)(2011-1#1)(2012-2#1)
valve position in relation to##2##5##(2006-8#2)
valve position in##3##3##(2006-8#3)
valve position##4##2##(2006-8#3)(2008-10#1)
valve pressure##5##2##(2006-8#5)
valve prolapse and##2##3##(1993-6#1)(2013-8#1)
valve prolapse##20##2##(1991-8#1)(1992-11#1)(1993-6#1)(1995-6#5)(1997-1#4)(2007-8#2)(2008-4#1)(2008-5#1)(2009-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
valve prostheses##8##2##(1990-12#2)(1995-9#1)(2007-8#1)(2010-12#1)(2010-8#3)
valve prostheses]##2##2##(1990-12#1)(2010-8#1)
valve prosthesis##4##2##(1994-3#1)(1997-5#1)(2007-8#1)(2009-12#1)
valve regurgitation due to##2##4##(2007-8#2)
valve regurgitation##8##2##(2006-8#1)(2007-8#5)(2010-4#1)(2013-1#1)
valve repair and##2##3##(2005-12#1)(2011-2#1)
valve repair in##2##3##(2007-8#1)(2009-10#1)
valve repair using##3##3##(2007-8#3)
valve repair##25##2##(2005-12#1)(2007-8#9)(2007-9#1)(2008-10#3)(2009-10#2)(2009-7#1)(2011-2#5)(2013-1#3)
valve replaced##3##2##(1993-5#3)
valve replacement and coronary revascularization##2##5##(2007-8#2)
valve replacement and coronary##4##4##(2007-8#4)
valve replacement and##9##3##(2007-8#8)(2007-9#1)
valve replacement due to##3##4##(2007-8#1)(2008-4#1)(2010-7#1)
valve replacement for infective endocarditis##2##5##(2008-1#1)(2009-4#1)
valve replacement for##8##3##(2007-8#2)(2007-9#2)(2008-1#1)(2009-4#1)(2009-5#1)(2013-1#1)
valve replacement in##8##3##(2006-12#1)(2007-8#3)(2007-9#1)(2008-12#1)(2011-2#2)
valve replacement is##3##3##(2007-8#1)(2009-5#2)
valve replacement plus##2##3##(1996-8#1)(2007-8#1)
valve replacement surgery##5##3##(2005-12#1)(2007-9#3)(2012-3#1)
valve replacement were##2##3##(1994-3#1)(2007-9#1)
valve replacement with a bioprosthesis##3##5##(2007-8#3)
valve replacement with a##5##4##(2007-8#4)(2012-2#1)
valve replacement with##7##3##(2006-12#1)(2007-8#5)(2012-2#1)
valve replacement##110##2##(1990-3#1)(1994-3#1)(1996-8#2)(1996-9#1)(1997-5#2)(2005-12#1)(2006-12#3)(2006-4#1)(2007-8#45)(2007-9#14)(2008-1#2)(2008-12#1)(2008-4#3)(2009-12#1)(2009-4#3)(2009-5#6)(2010-7#1)(2010-8#1)(2011-2#5)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#7)(2013-8#2)
valve replacements##4##2##(1993-5#1)(2007-8#2)(2010-5#1)
valve ring##2##2##(1996-9#1)(1997-5#1)
valve rupture##3##2##(2006-4#1)(2012-2#2)
valve sizes##3##2##(2007-8#3)
valve stenosis is##2##3##(1993-12#1)(2009-5#1)
valve stenosis or##2##3##(1993-10#1)(1993-12#1)
valve stenosis##15##2##(1992-5#1)(1993-10#1)(1993-12#3)(1996-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-4#1)(2009-5#3)(2010-5#1)
valve substitute##2##2##(2007-8#1)(2013-1#1)
valve surgery and##4##3##(1993-12#1)(2007-8#1)(2011-2#2)
valve surgery through##2##3##(2007-8#1)(2007-9#1)
valve surgery##30##2##(1993-12#1)(2006-1#1)(2006-4#1)(2007-5#1)(2007-8#17)(2007-9#2)(2008-4#1)(2009-10#1)(2009-5#1)(2010-6#1)(2010-8#1)(2011-2#2)
valve tissue##4##2##(2008-4#1)(2009-8#1)(2011-2#1)(2012-2#1)
valve to##2##2##(2008-10#1)(2008-4#1)
valve vegetations##4##2##(1990-11#1)(1990-6#1)(2007-12#1)(2007-9#1)
valve was switched##2##3##(1997-3#1)(2008-10#1)
valve was used##2##3##(2008-10#2)
valve was##16##2##(1991-3#2)(1993-5#1)(1997-3#1)(2006-2#1)(2006-8#2)(2007-8#1)(2008-10#5)(2008-4#1)(2013-1#1)(2013-8#1)
valve were##2##2##(2008-5#1)(2009-8#1)
valve with a##2##3##(1990-6#1)(2012-3#1)
valve with##11##2##(1990-6#1)(1991-2#1)(1992-3#1)(2006-4#1)(2007-8#2)(2008-10#1)(2008-11#1)(2011-2#2)(2012-3#1)
valve##684##1##(1990-11#2)(1990-12#3)(1990-3#4)(1990-6#10)(1990-8#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#5)(1991-8#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#6)(1993-5#7)(1993-6#1)(1994-3#5)(1994-5#1)(1994-6#1)(1995-6#7)(1995-9#1)(1996-1#2)(1996-12#1)(1996-8#2)(1996-9#2)(1997-1#5)(1997-2#2)(1997-3#2)(1997-5#6)(1997-8#1)(2005-12#10)(2005-9#2)(2006-1#4)(2006-10#3)(2006-12#3)(2006-2#2)(2006-4#4)(2006-8#35)(2007-10#1)(2007-11#1)(2007-12#16)(2007-5#1)(2007-7#4)(2007-8#173)(2007-9#21)(2008-1#5)(2008-10#52)(2008-11#4)(2008-12#3)(2008-2#4)(2008-3#4)(2008-4#23)(2008-5#12)(2008-6#1)(2008-7#2)(2008-8#5)(2009-10#8)(2009-12#4)(2009-2#1)(2009-4#7)(2009-5#15)(2009-7#2)(2009-8#2)(2009-9#4)(2010-12#14)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#10)(2010-9#1)(2011-1#8)(2011-11#1)(2011-12#1)(2011-2#35)(2012-1#2)(2012-12#9)(2012-2#20)(2012-3#8)(2013-1#30)(2013-7#1)(2013-8#4)
valve)##6##1##(2005-12#2)(2006-8#1)(2007-8#2)(2011-1#1)
valve-in-valve&quot##2##1##(2013-1#2)
valve-related##3##1##(2007-8#3)
valved catheters##2##2##(2007-7#2)
valved conduit##2##2##(2007-8#2)
valved stent implanted##2##3##(2007-8#2)
valved stent was##2##3##(2007-8#2)
valved stent##5##2##(2007-8#5)
valved##16##1##(1996-2#1)(2007-7#4)(2007-8#8)(2008-12#1)(2013-1#2)
valves and##13##2##(1996-2#1)(1996-8#1)(1997-1#1)(2005-12#1)(2006-10#1)(2006-8#1)(2007-8#2)(2008-10#4)(2008-4#1)
valves are##8##2##(2006-8#1)(2007-8#1)(2008-10#2)(2009-10#1)(2010-8#1)(2013-1#2)
valves as##2##2##(2007-8#1)(2008-7#1)
valves at##2##2##(1990-8#1)(2007-8#1)
valves by##2##2##(2006-6#1)(2007-8#1)
valves for##3##2##(1990-10#1)(2008-10#2)
valves in the##2##3##(1994-11#1)(1996-12#1)
valves in##7##2##(1994-11#1)(1996-12#1)(1997-1#1)(2006-8#1)(2007-10#1)(2007-3#1)(2011-2#1)
valves is##4##2##(1997-2#1)(2006-10#1)(2010-12#1)(2010-8#1)
valves or##3##2##(1991-11#1)(1993-10#1)(2008-8#1)
valves was##3##2##(2006-8#1)(2008-5#1)(2011-1#1)
valves were##12##2##(2006-2#1)(2006-8#2)(2007-8#3)(2008-10#3)(2008-3#1)(2010-12#2)
valves##148##1##(1990-10#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#4)(1991-5#3)(1993-10#1)(1994-11#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-8#1)(1997-1#3)(1997-2#1)(2004-9#2)(2005-12#1)(2006-10#4)(2006-2#1)(2006-6#1)(2006-8#13)(2007-10#3)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#21)(2007-9#1)(2008-1#1)(2008-10#30)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#2)(2009-10#1)(2009-11#1)(2009-5#1)(2010-12#6)(2010-5#1)(2010-6#1)(2010-8#5)(2010-9#1)(2011-1#4)(2011-2#1)(2012-12#1)(2013-1#2)
valves)##2##1##(2006-8#1)(2011-2#1)
valves]##2##1##(1997-4#1)(2005-9#1)
valvotomies##2##1##(1997-8#1)(2007-9#1)
valvotomy and##2##2##(2007-9#1)(2008-11#1)
valvotomy##11##1##(2004-10#1)(2007-9#8)(2008-11#2)
valvula cerebelli##4##2##(1993-12#3)(1995-5#1)
valvula##5##1##(1993-12#4)(1995-5#1)
valvulae and##2##2##(2007-12#2)
valvulae##7##1##(2007-12#7)
valvular abnormalities##3##2##(1990-6#1)(2008-7#1)(2010-12#1)
valvular damage##3##2##(2012-12#1)(2013-1#2)
valvular disease##5##2##(2006-10#1)(2010-11#1)(2011-2#2)(2012-3#1)
valvular dysfunction##3##2##(2007-8#2)(2008-1#1)
valvular heart disease##18##3##(1990-6#1)(2005-12#2)(2006-1#1)(2006-10#1)(2007-8#2)(2008-10#2)(2008-5#2)(2009-10#1)(2011-2#5)(2012-2#1)
valvular heart diseases##3##3##(2010-7#1)(2013-1#2)
valvular heart##27##2##(1990-6#1)(2005-12#2)(2006-1#1)(2006-10#1)(2007-8#2)(2008-10#2)(2008-5#2)(2009-10#1)(2010-7#1)(2011-2#5)(2012-2#1)(2013-1#8)
valvular insufficiency##4##2##(1994-3#2)(1995-8#1)(2013-1#1)
valvular lesions##3##2##(1990-6#2)(2008-3#1)
valvular regurgitation##2##2##(2006-10#1)(2008-4#1)
valvular replacement##3##2##(2006-10#1)(2006-12#1)(2007-8#1)
valvular##74##1##(1990-11#1)(1990-6#4)(1991-10#1)(1991-12#1)(1993-5#1)(1994-3#2)(1995-8#1)(1997-1#1)(2005-12#2)(2005-9#2)(2006-1#1)(2006-10#4)(2006-12#1)(2006-6#1)(2007-12#2)(2007-8#10)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#8)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#13)
valvulopathy##2##1##(2006-10#2)
valvuloplasty and##3##2##(1990-8#2)(2011-2#1)
valvuloplasty for mitral##3##3##(1990-3#1)(1990-5#1)(2011-2#1)
valvuloplasty for##4##2##(1990-3#1)(1990-5#1)(2011-2#2)
valvuloplasty of##3##2##(1990-3#1)(1993-10#2)
valvuloplasty##20##1##(1990-3#2)(1990-5#1)(1990-8#2)(1993-10#2)(1994-3#1)(2007-8#1)(2008-11#1)(2008-12#1)(2009-4#2)(2009-8#1)(2010-12#1)(2011-2#5)
valyl-tRNA synthetase has##2##3##(1990-2#1)(1992-9#1)
valyl-tRNA synthetase##8##2##(1990-12#1)(1990-2#2)(1992-9#4)(1993-2#1)
valyl-tRNA synthetases##2##2##(1990-12#1)(1992-9#1)
valyl-tRNA##10##1##(1990-12#2)(1990-2#2)(1992-9#5)(1993-2#1)
valylation##4##1##(1992-9#4)
vampire bat##2##2##(2008-5#2)
van Cittert-Zernike##6##2##(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#1)
van Deemter##3##2##(2005-12#2)(2013-8#1)
van Gogh's case##2##3##(1996-3#2)
van Gogh's##4##2##(1992-2#1)(1996-3#3)
van Manen's##2##2##(2010-10#1)(2010-7#1)
van de Hulst's##2##3##(2007-12#1)(2008-2#1)
van de zorgbehoefte van##2##4##(2012-12#2)
van de zorgbehoefte##3##3##(2012-12#3)
van de##8##2##(1997-3#1)(1997-5#1)(2007-12#1)(2008-2#1)(2012-12#4)
van den Berg##2##3##(2007-12#2)
van den Berghe's##3##3##(2006-7#3)
van den##7##2##(1994-9#1)(2006-7#4)(2007-12#2)
van der Waals and electron-donor/acceptor##2##5##(2005-11#2)
van der Waals and##3##4##(2005-11#2)(2008-3#1)
van der Waals contact##3##4##(1991-4#1)(1994-5#1)(1995-6#1)
van der Waals contacts##2##4##(1992-6#1)(1996-2#1)
van der Waals forces##5##4##(1993-4#1)(2005-11#2)(2007-11#1)(2009-11#1)
van der Waals interaction##6##4##(1992-3#1)(2005-11#1)(2006-10#3)(2008-5#1)
van der Waals interactions between##3##5##(1993-8#1)(2008-10#2)
van der Waals interactions##7##4##(1991-3#1)(1993-8#1)(1996-4#1)(1996-8#1)(2008-10#2)(2010-2#1)
van der Waals space##2##4##(2007-11#2)
van der Waals##47##3##(1991-3#1)(1991-4#1)(1991-5#1)(1992-3#1)(1992-6#2)(1993-4#1)(1993-8#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-4#2)(1996-8#1)(2005-11#8)(2006-10#3)(2007-11#6)(2008-10#4)(2008-3#1)(2008-5#2)(2009-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2013-1#3)
van der##56##2##(1991-3#1)(1991-4#1)(1991-5#1)(1992-3#1)(1992-6#2)(1993-4#1)(1993-6#1)(1993-8#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-4#2)(1996-8#1)(1997-3#1)(2005-11#8)(2006-10#3)(2007-11#6)(2007-9#2)(2008-10#5)(2008-3#1)(2008-5#2)(2008-7#1)(2009-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-11#1)(2013-1#3)
van##113##1##(1991-3#1)(1991-4#1)(1991-5#1)(1992-10#1)(1992-2#1)(1992-3#2)(1992-6#2)(1993-4#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-2#1)(1996-3#5)(1996-4#2)(1996-8#1)(1997-3#2)(1997-5#1)(2005-11#8)(2005-12#2)(2006-10#3)(2006-4#1)(2006-7#4)(2007-11#6)(2007-12#8)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#8)(2008-2#3)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-11#1)(2012-12#10)(2013-1#3)(2013-7#1)(2013-8#1)
van't Hoff plots of##2##4##(1996-11#1)(1997-2#1)
van't Hoff plots##9##3##(1990-3#1)(1996-11#1)(1996-12#2)(1997-2#3)(2008-10#2)
van't Hoff##17##2##(1990-3#1)(1991-2#1)(1995-1#1)(1996-11#1)(1996-12#2)(1996-4#1)(1997-2#7)(2008-10#3)
vanA gene##2##2##(2007-12#1)(2008-5#1)
vanA##4##1##(1995-2#1)(2006-10#1)(2007-12#1)(2008-5#1)
vanZ##2##1##(1995-2#2)
vanadate and##2##2##(1990-8#1)(1997-1#1)
vanadate increased##2##2##(1997-1#2)
vanadate is##2##2##(1992-5#1)(1994-6#1)
vanadate species##2##2##(1994-11#2)
vanadate##56##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#3)(1990-7#1)(1990-8#1)(1991-9#2)(1992-10#1)(1992-5#5)(1994-11#6)(1994-12#3)(1994-5#4)(1994-6#5)(1995-10#1)(1995-2#1)(1995-6#1)(1995-7#1)(1997-1#9)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#4)
vanadate)##2##1##(1994-6#1)(1995-6#1)
vanadium (IV)##2##2##(1990-5#1)(2008-10#1)
vanadium (V)##8##2##(1993-12#1)(1996-3#1)(2004-4#1)(2008-10#3)(2008-5#1)(2011-2#1)
vanadium adsorption from the NH(4)VO(3) solution##2##6##(2008-10#2)
vanadium adsorption##3##2##(2008-10#3)
vanadium and molybdenum bearing geological##2##5##(2008-10#2)
vanadium and molybdenum##5##3##(2008-10#5)
vanadium and##19##2##(2004-4#1)(2005-4#1)(2007-11#1)(2008-10#14)(2008-11#1)(2011-2#1)
vanadium at##3##2##(2008-10#3)
vanadium by##6##2##(2008-10#6)
vanadium can be determined##2##4##(2008-10#2)
vanadium can be##3##3##(2008-10#3)
vanadium content in##2##3##(2008-10#2)
vanadium contents##2##2##(2008-10#2)
vanadium determination##3##2##(2008-10#3)
vanadium from##5##2##(2008-10#3)(2008-5#1)(2008-6#1)
vanadium in a##4##3##(1992-4#1)(1996-3#1)(2008-10#2)
vanadium in natural waters##3##4##(2008-10#3)
vanadium in the range##3##4##(2008-10#3)
vanadium in the##6##3##(2008-10#5)(2008-5#1)
vanadium in##38##2##(1992-4#2)(1996-3#1)(2007-8#1)(2008-10#32)(2008-3#1)(2008-5#1)
vanadium is##2##2##(2008-10#1)(2008-5#1)
vanadium oxide##2##2##(2009-2#2)
vanadium pentoxide##3##2##(1992-4#1)(1996-2#2)
vanadium species in##3##3##(2008-10#3)
vanadium species##5##2##(2008-10#5)
vanadium was determined##2##3##(1990-5#1)(1992-4#1)
vanadium was##6##2##(1990-5#1)(1992-4#1)(2008-10#3)(2008-3#1)
vanadium##167##1##(1990-2#2)(1990-5#5)(1992-4#7)(1992-6#1)(1993-12#1)(1994-11#1)(1996-2#3)(1996-3#2)(2004-4#2)(2005-4#1)(2007-11#3)(2007-8#1)(2008-10#120)(2008-11#1)(2008-3#3)(2008-5#7)(2008-6#1)(2009-2#2)(2011-2#4)
vanadium(IV) and (V)##2##3##(2008-10#2)
vanadium(IV) and vanadium(V)##3##3##(2008-10#3)
vanadium(IV) and##8##2##(2008-10#8)
vanadium(IV) in##2##2##(2008-10#2)
vanadium(IV)##13##1##(2008-10#12)(2010-5#1)
vanadium(V) and##3##2##(2008-10#3)
vanadium(V) with##4##2##(2008-10#4)
vanadium(V)##23##1##(2008-10#23)
vanadocytes##3##1##(2008-5#3)
vanadyl ion##3##2##(2006-2#1)(2008-10#1)(2008-3#1)
vanadyl ions##4##2##(1990-2#1)(2008-10#1)(2008-3#2)
vanadyl sulfate##4##2##(1990-2#1)(1993-12#2)(1994-6#1)
vanadyl sulphate intoxication in mice##2##5##(1990-5#2)
vanadyl was##2##2##(1990-2#2)
vanadyl##21##1##(1990-2#8)(1990-5#2)(1993-12#2)(1994-6#1)(2006-2#1)(2008-10#3)(2008-3#4)
vancomycin and##15##2##(1991-6#1)(2005-8#1)(2006-10#1)(2007-12#2)(2007-3#1)(2007-6#1)(2007-7#1)(2008-10#4)(2008-12#1)(2010-8#1)(2011-2#1)
vancomycin as##3##2##(1996-3#1)(2007-7#1)(2008-1#1)
vancomycin has been the##2##4##(2007-12#1)(2008-5#1)
vancomycin hydrochloride##2##2##(2008-10#1)(2010-4#1)
vancomycin in##4##2##(2007-7#1)(2008-10#1)(2008-5#1)(2013-1#1)
vancomycin resistance in the##2##4##(2006-10#1)(2007-7#1)
vancomycin resistance in##5##3##(1995-2#1)(2006-10#2)(2007-7#2)
vancomycin resistance##9##2##(1991-2#1)(1995-2#2)(2006-10#3)(2007-7#2)(2008-2#1)
vancomycin were##3##2##(2006-5#1)(2007-7#1)(2008-12#1)
vancomycin while##2##2##(2007-7#1)(2008-5#1)
vancomycin##95##1##(1991-2#2)(1991-6#1)(1994-6#1)(1995-2#3)(1996-3#1)(2005-8#3)(2006-10#5)(2006-5#2)(2006-7#1)(2007-12#14)(2007-3#1)(2007-6#1)(2007-7#10)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#5)(2009-8#1)(2010-4#2)(2010-8#3)(2011-1#1)(2011-2#12)(2012-12#6)(2012-2#1)(2013-1#5)(2013-8#1)
vancomycin-##2##1##(2005-9#1)(2008-10#1)
vancomycin-based##2##1##(2005-8#1)(2008-10#1)
vancomycin-resistant enterococci (VRE)##4##3##(2005-7#2)(2005-8#1)(2006-12#1)
vancomycin-resistant enterococci##10##2##(1996-3#1)(2005-7#3)(2005-8#1)(2006-10#2)(2006-12#1)(2009-5#1)(2011-1#1)
vancomycin-resistant##15##1##(1996-3#1)(2005-7#3)(2005-8#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-5#2)(2011-1#1)
vancomycine##2##1##(1991-3#1)(2011-2#1)
vandalism##4##1##(1994-2#1)(1995-2#1)(1996-12#1)(2011-12#1)
vane##3##1##(2007-9#3)
vanes##4##1##(2008-3#2)(2008-5#1)(2008-8#1)
vanilla beans from##2##3##(2008-10#2)
vanilla beans##3##2##(2008-10#3)
vanilla##9##1##(2008-10#9)
vanillic acid##3##2##(1990-7#1)(2007-8#1)(2008-10#1)
vanillic##6##1##(1990-7#1)(2004-2#1)(2007-8#2)(2008-10#1)(2011-2#1)
vanillin and PHB##3##3##(2008-10#3)
vanillin and##6##2##(2008-10#6)
vanillin was##2##2##(1993-2#2)
vanillin##16##1##(1993-2#3)(1993-9#1)(2005-12#1)(2007-1#1)(2008-10#10)
vanilloid receptor##4##2##(1997-5#1)(2008-11#2)(2010-3#1)
vanilloid receptors##3##2##(1997-5#2)(2005-8#1)
vanilloid##11##1##(1997-5#3)(1997-6#1)(2005-8#1)(2008-11#2)(2008-4#1)(2009-12#1)(2010-3#1)(2011-2#1)
vanillylmandelic acid (VMA)##3##3##(1995-4#1)(1997-8#1)(2006-9#1)
vanillylmandelic acid##5##2##(1995-4#2)(1997-8#2)(2006-9#1)
vanilmandelic acid##3##2##(1990-7#1)(2008-10#1)(2012-2#1)
vanish##6##1##(1990-5#1)(1996-6#1)(2005-10#1)(2007-9#1)(2008-3#1)(2009-2#1)
vanished##10##1##(1992-12#1)(1992-2#1)(1994-8#1)(2007-9#1)(2008-2#1)(2008-5#1)(2009-8#1)(2010-2#1)(2011-12#1)(2013-8#1)
vanishes##8##1##(1990-3#1)(1992-8#1)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#1)
vanishing bone disease##4##3##(2007-7#2)(2009-3#2)
vanishing of##2##2##(2006-6#1)(2008-10#1)
vanishing##16##1##(1997-3#1)(2004-11#1)(2005-11#1)(2006-6#1)(2007-12#1)(2007-7#4)(2008-1#1)(2008-10#1)(2009-3#2)(2009-8#1)(2010-12#1)(2011-12#1)
vannamei##11##1##(2007-3#1)(2008-5#10)
vantage point of##2##3##(1992-12#1)(2008-3#1)
vantage point##4##2##(1992-12#1)(2008-2#1)(2008-3#1)(2011-1#1)
vantage##5##1##(1992-12#1)(2008-2#1)(2008-3#1)(2011-1#2)
vap##3##1##(1995-8#3)
vapor and##10##2##(2008-10#2)(2008-2#2)(2008-3#6)
vapor at##6##2##(2007-12#3)(2008-2#1)(2008-3#2)
vapor atomic##11##2##(2008-10#11)
vapor cell##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
vapor concentrations##3##2##(1991-5#1)(1996-11#1)(2008-2#1)
vapor deposited onto##2##3##(2007-11#1)(2009-2#1)
vapor deposited##4##2##(2007-11#1)(2008-2#2)(2009-2#1)
vapor deposition and##3##3##(2007-9#1)(2008-10#2)
vapor deposition##36##2##(2005-4#1)(2006-12#1)(2006-4#2)(2007-11#2)(2007-9#1)(2008-10#7)(2008-2#7)(2008-3#7)(2009-11#2)(2009-2#1)(2009-7#1)(2010-4#4)
vapor detection##3##2##(2007-12#1)(2007-8#1)(2008-10#1)
vapor diffusion techniques##2##3##(2007-5#1)(2008-8#1)
vapor diffusion##3##2##(2007-5#1)(2008-8#1)(2008-9#1)
vapor exposure time##2##3##(2005-11#1)(2008-10#1)
vapor exposure##3##2##(1995-3#1)(2005-11#1)(2008-10#1)
vapor flux##2##2##(2008-10#1)(2013-8#1)
vapor from##3##2##(2007-8#1)(2008-3#2)
vapor generation atomic absorption spectrometry##2##5##(2007-12#1)(2008-10#1)
vapor generation##5##2##(2007-12#1)(2008-10#4)
vapor generator##2##2##(2005-4#1)(2008-10#1)
vapor in##10##2##(2008-10#1)(2008-2#3)(2008-3#6)
vapor inhalation##4##2##(1991-1#1)(1991-5#1)(2008-4#2)
vapor is##5##2##(2008-10#1)(2008-2#1)(2008-3#3)
vapor laser##6##2##(1992-9#2)(2008-2#2)(2008-3#2)
vapor mixture##2##2##(2005-11#1)(2008-10#1)
vapor of##4##2##(2005-11#1)(2007-12#2)(2008-2#1)
vapor on##5##2##(2005-11#3)(2008-10#1)(2008-3#1)
vapor phase##11##2##(1991-7#1)(2004-9#1)(2005-11#1)(2007-11#2)(2008-10#3)(2008-7#1)(2008-8#1)(2013-7#1)
vapor pressure deficit and##2##4##(2008-10#2)
vapor pressure##5##2##(2005-11#1)(2008-10#3)(2008-5#1)
vapor pressures##2##2##(1992-3#1)(2008-10#1)
vapor sources are##2##3##(2008-2#1)(2008-3#1)
vapor sources##3##2##(2008-2#2)(2008-3#1)
vapor to##2##2##(2007-12#1)(2008-3#1)
vapor transmission rate##2##3##(2008-5#2)
vapor was##5##2##(2007-12#1)(2008-10#3)(2008-3#1)
vapor were##2##2##(2007-12#1)(2008-10#1)
vapor with a##2##3##(2007-8#1)(2008-3#1)
vapor with##5##2##(1991-6#1)(2007-8#1)(2008-3#3)
vapor##274##1##(1990-2#1)(1991-1#1)(1991-3#2)(1991-5#4)(1991-6#1)(1991-7#1)(1992-3#1)(1992-9#2)(1995-3#1)(1996-11#1)(1997-1#1)(2004-9#1)(2005-11#12)(2005-4#4)(2006-12#2)(2006-4#2)(2007-11#15)(2007-12#20)(2007-5#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#66)(2008-11#1)(2008-2#34)(2008-3#60)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#2)(2009-2#2)(2009-3#1)(2009-7#1)(2010-4#4)(2011-2#1)(2012-11#1)(2013-1#3)(2013-7#1)(2013-8#3)
vapor)##2##1##(2007-12#1)(2008-10#1)
vapor-deposited films##4##2##(2007-11#1)(2007-12#3)
vapor-deposited##5##1##(2007-11#1)(2007-12#3)(2008-3#1)
vapor-induced##2##1##(2005-11#2)
vapor-liquid-solid##2##1##(2006-12#1)(2010-7#1)
vapor-phase##3##1##(2007-12#1)(2008-10#2)
vapor-solid##2##1##(2006-12#2)
vapor/aqueous##2##1##(2012-1#2)
vaporariorum in##2##2##(2011-12#2)
vaporariorum##10##1##(2007-6#1)(2008-10#2)(2011-12#7)
vaporisation##4##1##(1991-2#1)(2008-10#3)
vaporised##2##1##(2006-6#1)(2008-10#1)
vaporization and##5##2##(1991-2#1)(1992-3#2)(2007-8#1)(2008-10#1)
vaporization behavior of##3##3##(2008-10#3)
vaporization for##2##2##(1991-2#1)(2010-4#1)
vaporization in##3##2##(1996-1#1)(2008-10#1)(2008-3#1)
vaporization inductively coupled plasma atomic emission spectrometry##3##7##(2005-4#1)(2008-10#2)
vaporization inductively coupled plasma##7##4##(2005-4#1)(2008-10#6)
vaporization is a##2##3##(1990-12#1)(2008-2#1)
vaporization is##3##2##(1990-12#1)(2008-2#1)(2008-3#1)
vaporization of the##2##3##(1992-3#1)(2008-5#1)
vaporization of##12##2##(1990-12#1)(1992-3#2)(2005-4#2)(2007-12#2)(2007-4#1)(2008-10#3)(2008-5#1)
vaporization temperature of##4##3##(2008-10#4)
vaporization temperature##5##2##(2008-10#5)
vaporization##78##1##(1990-12#3)(1991-2#3)(1992-3#7)(1996-1#1)(2005-4#3)(2006-10#1)(2007-1#1)(2007-12#4)(2007-4#2)(2007-8#1)(2007-9#1)(2008-10#36)(2008-2#8)(2008-3#5)(2008-5#1)(2010-4#1)
vaporized and##2##2##(1991-2#1)(2008-10#1)
vaporized at##4##2##(1991-2#1)(2008-10#3)
vaporized with##2##2##(1991-2#1)(2007-8#1)
vaporized##14##1##(1991-2#3)(1992-1#2)(1992-3#2)(2007-8#1)(2008-10#5)(2008-5#1)
vaporizer##5##1##(2007-11#1)(2008-10#4)
vaporizing##2##1##(1991-2#1)(2008-2#1)
vapors of##2##2##(2008-10#1)(2008-3#1)
vapors##28##1##(2005-11#4)(2007-12#2)(2008-10#15)(2008-2#2)(2008-3#5)
vapour and##3##2##(1993-4#1)(2008-10#1)(2009-11#1)
vapour atomic absorption##10##3##(2007-5#1)(2008-10#9)
vapour atomic fluorescence spectrometry##3##4##(2008-10#3)
vapour atomic fluorescence##5##3##(2008-10#5)
vapour atomic##15##2##(2007-5#1)(2008-10#14)
vapour by##2##2##(2008-10#2)
vapour diffusion method##2##3##(1994-9#1)(2008-8#1)
vapour diffusion##4##2##(1992-11#1)(1994-9#1)(2008-8#1)(2013-7#1)
vapour generation and atomic##2##4##(2008-10#2)
vapour generation and##3##3##(2008-10#3)
vapour generation atomic fluorescence spectrometry##2##5##(2008-10#2)
vapour generation##7##2##(2008-10#7)
vapour phase decomposition (VPD) of quartz powder##2##7##(2008-10#2)
vapour phase##8##2##(2007-8#1)(2008-10#7)
vapour pressure and##2##3##(1990-9#1)(1992-1#1)
vapour pressure of##7##3##(2008-5#6)(2009-11#1)
vapour pressure##12##2##(1990-9#1)(1992-1#1)(2008-5#7)(2009-11#3)
vapour pressures##2##2##(2008-5#2)
vapour##79##1##(1990-9#1)(1992-1#1)(1992-11#1)(1993-4#4)(1994-9#1)(1995-6#2)(1996-12#1)(2006-5#1)(2007-1#1)(2007-5#1)(2007-8#1)(2008-10#39)(2008-4#1)(2008-5#10)(2008-7#3)(2008-8#2)(2009-11#4)(2009-6#3)(2013-7#1)(2013-8#1)
vapour-liquid-solid##2##1##(2008-7#2)
vapour-phase catalyst delivery##2##3##(2008-7#2)
vapour-phase##4##1##(2007-8#1)(2008-10#1)(2008-7#2)
vapours were##2##2##(2008-10#2)
vapours##17##1##(1991-6#3)(1993-4#1)(1996-12#1)(1997-3#1)(2008-10#11)
vapreotide##3##1##(2005-7#3)
var genes##3##2##(2012-3#3)
var##230##1##(1990-7#5)(1991-11#1)(1991-5#1)(1993-3#1)(1995-6#1)(1997-5#1)(2004-2#2)(2005-11#2)(2005-12#2)(2005-9#1)(2006-12#2)(2006-9#1)(2007-1#19)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#12)(2008-10#117)(2008-11#5)(2008-12#8)(2008-3#2)(2008-4#2)(2008-5#17)(2008-6#1)(2009-10#1)(2009-2#3)(2011-1#1)(2011-12#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#2)(2013-8#2)
varanid##2##1##(2013-1#2)
varanids##5##1##(2013-1#5)
varenicline##4##1##(2011-2#3)(2013-1#1)
varenidine##3##1##(2013-8#3)
vari (Lemur macaco##2##3##(2007-2#2)
variabilis were collected##2##3##(2004-11#2)
variabilis##11##1##(1990-9#1)(1996-9#3)(2004-11#3)(2007-7#2)(2008-1#1)(2008-8#1)
variabilities of##2##2##(2008-10#1)(2008-8#1)
variabilities##6##1##(1993-12#1)(2007-8#2)(2008-10#1)(2008-8#1)(2008-9#1)
variability (HRV) in##4##3##(1995-3#1)(2008-12#1)(2008-6#1)(2012-12#1)
variability (HRV)##11##2##(1995-3#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-10#1)(2009-11#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
variability across##2##2##(2009-12#1)(2010-2#1)
variability among isolates##2##3##(2008-10#2)
variability among the##3##3##(2008-10#3)
variability among##15##2##(1990-2#1)(2008-10#11)(2008-5#2)(2013-7#1)
variability amongst##2##2##(1992-9#1)(2006-12#1)
variability analysis##3##2##(2012-2#1)(2013-1#1)(2013-8#1)
variability and a##2##3##(2008-10#1)(2010-8#1)
variability and relationship##2##3##(1994-4#1)(2008-11#1)
variability and the##3##3##(1991-4#1)(2008-3#2)
variability and uncertainty##2##3##(1993-3#1)(2008-10#1)
variability and##51##2##(1990-11#1)(1991-4#1)(1993-3#1)(1993-5#1)(1994-4#1)(1994-5#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-4#1)(2007-3#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2009-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-7#2)(2013-8#2)
variability are##7##2##(2007-11#1)(2007-4#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)
variability as a##3##3##(1991-2#1)(2006-10#1)(2009-11#1)
variability as##4##2##(1991-2#1)(1996-12#1)(2006-10#1)(2009-11#1)
variability associated with##4##3##(1993-3#1)(2006-10#1)(2008-3#1)(2008-8#1)
variability at##5##2##(2008-10#1)(2010-8#2)(2012-12#1)(2013-8#1)
variability between different##3##3##(2008-10#2)(2010-9#1)
variability between the##4##3##(1991-12#1)(1993-12#2)(2007-10#1)
variability between##21##2##(1990-7#1)(1991-12#1)(1993-12#2)(1994-11#1)(1997-3#1)(2006-10#1)(2007-10#1)(2008-10#7)(2008-5#1)(2009-2#1)(2009-6#1)(2010-9#1)(2012-2#1)(2012-3#1)
variability both##2##2##(2005-12#1)(2007-3#1)
variability by##5##2##(1995-7#1)(2008-10#1)(2008-11#2)(2009-5#1)
variability can##3##2##(2006-7#1)(2008-6#1)(2012-5#1)
variability coefficient for the exercise was nearby to the average value for##2##12##(2008-10#2)
variability coefficient##3##2##(2008-10#3)
variability could be##4##3##(1993-5#1)(2008-10#1)(2012-1#1)(2012-3#1)
variability described##2##2##(1996-7#1)(1997-1#1)
variability due to##5##3##(1996-12#1)(1997-6#1)(2008-4#1)(2008-5#1)(2010-2#1)
variability during the##3##3##(2007-8#1)(2011-2#1)(2012-2#1)
variability exists in##2##3##(2008-8#1)(2012-12#1)
variability exists##3##2##(2008-8#2)(2012-12#1)
variability for##7##2##(1994-5#2)(2008-10#1)(2008-7#1)(2010-12#1)(2010-2#1)(2011-2#1)
variability found in##2##3##(2008-10#1)(2012-2#1)
variability from##2##2##(2008-8#1)(2012-2#1)
variability has##3##2##(2006-7#1)(2008-11#1)(2012-4#1)
variability have##3##2##(2006-10#1)(2008-9#1)(2011-12#1)
variability in HIV##2##3##(1996-1#1)(1996-6#1)
variability in clinical##3##3##(2007-11#1)(2008-8#1)(2009-11#1)
variability in disease incidence##2##4##(2008-10#2)
variability in disease##5##3##(2008-10#4)(2012-12#1)
variability in drug##2##3##(2008-8#1)(2010-12#1)
variability in enzyme activity##4##4##(2010-2#4)
variability in enzyme##5##3##(2010-2#5)
variability in its##3##3##(1993-3#1)(1997-7#1)(2010-8#1)
variability in lesion##2##3##(2007-10#2)
variability in normal##2##3##(2009-4#1)(2013-1#1)
variability in patients with##2##4##(2006-12#1)(2012-4#1)
variability in patients##3##3##(2006-12#1)(2010-12#1)(2012-4#1)
variability in per capita population growth rates##2##7##(2008-8#2)
variability in performance##3##3##(1990-11#1)(2008-2#1)(2009-6#1)
variability in response to##3##4##(2005-10#1)(2008-7#1)(2009-5#1)
variability in response##5##3##(2005-10#1)(2005-9#1)(2008-7#1)(2009-5#2)
variability in sag##2##3##(2012-2#2)
variability in seed output##2##4##(2008-9#2)
variability in seed production##2##4##(2008-9#2)
variability in seed##4##3##(2008-9#4)
variability in species'##2##3##(2008-8#2)
variability in such##3##3##(2008-7#1)(2013-1#2)
variability in the Indian##2##4##(2006-7#2)
variability in the clinical##2##4##(1994-11#2)
variability in the response to##2##5##(2006-9#1)(2008-10#1)
variability in the##65##3##(1990-8#1)(1991-12#2)(1991-4#1)(1991-6#3)(1992-11#1)(1993-12#1)(1994-11#2)(1994-2#2)(1994-4#1)(1994-9#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-5#1)(1997-8#1)(2004-12#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-3#1)(2006-7#2)(2006-9#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#2)(2010-2#2)(2010-7#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
variability in these##2##3##(2006-10#1)(2010-10#1)
variability in tumor delineation##2##4##(2009-11#2)
variability in virulence##2##3##(2008-10#2)
variability in##266##2##(1990-10#1)(1990-11#1)(1990-8#1)(1991-11#1)(1991-12#3)(1991-4#1)(1991-6#6)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-4#1)(1994-9#1)(1995-11#4)(1995-2#2)(1995-3#3)(1995-6#2)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-5#1)(1997-7#1)(1997-8#2)(2004-12#1)(2005-10#3)(2005-11#1)(2005-8#2)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-7#2)(2006-9#2)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-9#4)(2008-1#2)(2008-10#31)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#2)(2008-7#6)(2008-8#13)(2008-9#7)(2009-11#4)(2009-12#2)(2009-2#4)(2009-4#2)(2009-5#3)(2009-6#3)(2009-7#2)(2009-9#1)(2010-10#2)(2010-12#4)(2010-2#15)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#4)(2012-3#4)(2012-4#1)(2013-1#13)(2013-7#3)(2013-8#1)
variability indicators##2##2##(2012-4#2)
variability is##9##2##(1991-12#1)(2008-10#2)(2008-5#1)(2009-2#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)
variability maintained in a finite population due to mutational production of neutral and nearly neutral##2##15##(2008-11#2)
variability maintained##3##2##(2008-11#2)(2008-9#1)
variability may##2##2##(1993-12#1)(2008-10#1)
variability observed##3##2##(1997-4#1)(2007-4#1)(2012-12#1)
variability of BP##2##3##(2008-11#2)
variability of a##2##3##(1997-2#1)(2008-10#1)
variability of human##2##3##(1991-11#1)(2007-12#1)
variability of motor neuron spike timing##2##6##(2008-6#2)
variability of oceanic phycoerythrin spectral types##2##6##(2008-2#2)
variability of real samples##2##4##(2008-10#2)
variability of the clinical##3##4##(2006-7#1)(2006-8#1)(2007-7#1)
variability of the pathogen##3##4##(2008-10#3)
variability of the results##2##4##(1996-3#1)(2007-8#1)
variability of the##49##3##(1990-11#2)(1991-11#1)(1991-2#1)(1991-9#1)(1992-7#1)(1994-10#1)(1994-11#1)(1994-9#1)(1995-4#2)(1996-3#2)(1996-6#1)(1996-9#1)(1997-7#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#10)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#3)(2008-7#3)(2009-11#1)(2009-2#1)(2009-7#1)(2012-12#1)(2013-1#2)
variability of this##3##3##(2008-10#1)(2008-5#1)(2008-6#1)
variability of##161##2##(1990-11#2)(1990-8#1)(1990-9#1)(1991-11#2)(1991-2#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#3)(1993-2#1)(1993-6#2)(1994-10#1)(1994-11#1)(1994-9#2)(1995-11#1)(1995-3#1)(1995-4#2)(1995-6#1)(1996-11#2)(1996-12#3)(1996-3#3)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#4)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#27)(2008-11#6)(2008-12#2)(2008-2#6)(2008-3#4)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-7#1)(2009-8#4)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#6)
variability on the##3##3##(1992-9#1)(2010-11#1)(2011-2#1)
variability on##7##2##(1990-3#1)(1992-9#1)(2008-10#1)(2008-3#1)(2010-11#1)(2011-2#2)
variability over the##2##3##(2006-7#1)(2007-11#1)
variability over##4##2##(2006-7#1)(2007-11#1)(2008-12#1)(2008-9#1)
variability present##2##2##(2008-10#2)
variability relative to##2##3##(2010-12#1)(2010-7#1)
variability than##6##2##(1990-8#1)(1996-2#1)(2006-10#1)(2008-10#1)(2010-2#1)(2010-3#1)
variability that##3##2##(1995-1#1)(2006-7#1)(2008-3#1)
variability through##2##2##(2008-10#1)(2009-4#1)
variability to##2##2##(2010-2#1)(2010-4#1)
variability was attributable to##2##4##(2008-10#1)(2008-7#1)
variability was due##2##3##(1991-2#1)(2008-10#1)
variability was found##2##3##(2006-9#1)(2009-6#1)
variability was measured##2##3##(2005-10#1)(2008-2#1)
variability was observed##3##3##(1996-1#1)(2006-11#1)(2008-10#1)
variability was predicted by##2##4##(2007-12#2)
variability was##21##2##(1991-2#1)(1992-5#1)(1992-6#1)(1996-1#1)(2005-10#1)(2006-11#1)(2006-9#1)(2007-12#2)(2008-10#5)(2008-2#1)(2008-7#1)(2008-8#2)(2009-6#1)(2010-12#1)(2010-2#1)
variability were##7##2##(1991-10#1)(2005-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#1)(2013-8#1)
variability which##3##2##(1993-3#1)(2008-10#1)(2013-7#1)
variability with a##2##3##(2008-10#1)(2010-2#1)
variability with##6##2##(2006-7#1)(2008-10#1)(2008-9#1)(2010-2#1)(2011-12#1)(2013-1#1)
variability within a##2##3##(1993-2#1)(2008-9#1)
variability within and##2##3##(2007-1#1)(2008-10#1)
variability within this##2##3##(2007-2#1)(2008-10#1)
variability within##12##2##(1993-2#1)(1994-3#1)(2007-1#1)(2007-2#1)(2008-10#3)(2008-5#1)(2008-9#1)(2010-10#1)(2011-12#1)(2012-2#1)
variability##909##1##(1990-10#1)(1990-11#5)(1990-2#2)(1990-3#1)(1990-7#1)(1990-8#4)(1990-9#1)(1991-10#1)(1991-11#3)(1991-12#7)(1991-2#4)(1991-4#4)(1991-6#9)(1991-8#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#5)(1992-6#5)(1992-7#1)(1992-9#7)(1993-12#7)(1993-2#3)(1993-3#4)(1993-5#4)(1993-6#2)(1993-7#1)(1994-10#1)(1994-11#4)(1994-2#2)(1994-3#3)(1994-4#2)(1994-5#3)(1994-8#2)(1994-9#4)(1995-1#1)(1995-11#5)(1995-2#2)(1995-3#5)(1995-4#4)(1995-6#4)(1995-7#2)(1996-1#2)(1996-11#3)(1996-12#7)(1996-2#3)(1996-3#5)(1996-4#2)(1996-5#1)(1996-6#2)(1996-7#3)(1996-8#4)(1996-9#4)(1997-1#2)(1997-2#2)(1997-3#5)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#5)(2004-12#1)(2005-10#4)(2005-11#1)(2005-12#3)(2005-8#2)(2005-9#1)(2006-10#13)(2006-11#2)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#11)(2006-8#3)(2006-9#3)(2007-1#1)(2007-10#4)(2007-11#7)(2007-12#10)(2007-2#3)(2007-3#3)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#5)(2008-1#3)(2008-10#145)(2008-11#23)(2008-12#9)(2008-2#19)(2008-3#26)(2008-4#5)(2008-5#20)(2008-6#7)(2008-7#21)(2008-8#31)(2008-9#22)(2009-10#4)(2009-11#14)(2009-12#5)(2009-2#9)(2009-4#5)(2009-5#4)(2009-6#5)(2009-7#3)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#14)(2010-2#30)(2010-3#4)(2010-4#4)(2010-5#3)(2010-6#3)(2010-7#4)(2010-8#14)(2010-9#6)(2011-1#9)(2011-12#5)(2011-2#22)(2011-3#2)(2012-1#9)(2012-12#13)(2012-2#15)(2012-3#11)(2012-4#7)(2012-5#4)(2013-1#27)(2013-7#9)(2013-8#9)
variability) to##2##2##(1994-5#1)(2008-8#1)
variability)##5##1##(1994-5#1)(2008-11#1)(2008-8#3)
variable (V) region##2##3##(1990-11#1)(1997-2#1)
variable (V) regions##2##3##(2008-4#2)
variable (V)##7##2##(1990-11#1)(1997-1#1)(1997-2#1)(2008-4#3)(2012-1#1)
variable DNA##3##2##(1994-11#1)(2008-10#1)(2008-7#1)
variable Ig##2##2##(1994-11#1)(1995-2#1)
variable Zagreb##3##2##(2007-11#3)
variable aberration generators##2##3##(2008-2#2)
variable according to##2##3##(2004-2#1)(2009-5#1)
variable across##2##2##(2008-10#1)(2009-8#1)
variable affecting##2##2##(2008-10#1)(2008-5#1)
variable aggregation##2##2##(1992-6#1)(2009-3#1)
variable also##2##2##(2008-2#1)(2013-1#1)
variable amino##2##2##(1990-5#1)(1994-9#1)
variable among##7##2##(1997-8#1)(2008-10#1)(2008-3#2)(2008-9#1)(2010-8#1)(2012-12#1)
variable amount of##3##3##(1990-10#1)(2012-2#1)(2013-1#1)
variable amount##4##2##(1990-10#1)(2007-8#1)(2012-2#1)(2013-1#1)
variable amounts of##7##3##(1993-4#1)(1994-8#1)(1995-6#1)(1996-4#1)(2007-1#1)(2008-1#1)(2008-10#1)
variable amounts##9##2##(1993-4#1)(1994-8#1)(1995-6#1)(1996-4#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)
variable analysis##2##2##(2008-8#1)(2011-2#1)
variable and depends on##2##4##(2006-8#1)(2011-2#1)
variable and the##5##3##(1994-6#1)(2006-5#1)(2008-10#1)(2012-12#1)(2013-8#1)
variable and##48##2##(1990-5#1)(1994-11#1)(1994-6#1)(1995-3#1)(1996-11#1)(1996-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-8#2)(2007-11#4)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#4)(2012-2#1)(2013-8#2)
variable angle-of-incidence##2##2##(2008-2#1)(2008-3#1)
variable as a function of##2##5##(2008-10#2)
variable as##4##2##(1997-8#1)(2008-10#2)(2008-7#1)
variable associated with##3##3##(2008-10#1)(2009-6#1)(2013-1#1)
variable at the##2##3##(2008-7#1)(2010-3#1)
variable at##5##2##(1994-4#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-3#1)
variable between##3##2##(2008-10#2)(2013-8#1)
variable bias##2##2##(1992-6#2)
variable but##3##2##(1992-3#1)(2007-11#1)(2007-7#1)
variable can##3##2##(2008-8#1)(2011-2#1)(2012-1#1)
variable cellular##2##2##(1992-1#1)(2012-11#1)
variable charge soils##3##3##(2005-11#3)
variable charge##4##2##(2005-11#4)
variable clinical course##3##3##(2006-10#1)(2008-8#1)(2008-9#1)
variable clinical expression##2##3##(2011-2#1)(2013-8#1)
variable clinical manifestations##3##3##(2006-10#1)(2008-4#1)(2013-1#1)
variable clinical presentation##3##3##(2011-2#2)(2013-1#1)
variable clinical##15##2##(1997-1#1)(2006-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#3)(2013-1#3)(2013-4#1)(2013-8#1)
variable clustering##2##2##(1995-8#1)(2009-3#1)
variable composition##2##2##(2011-2#2)
variable connectivity index##2##3##(2007-11#2)
variable costs##2##2##(2007-4#1)(2008-5#1)
variable curvature##2##2##(2012-1#2)
variable degree of##6##3##(1992-6#1)(2007-12#1)(2009-8#1)(2011-2#2)(2012-3#1)
variable degree##8##2##(1992-6#1)(1994-11#1)(1997-3#1)(2007-12#1)(2009-8#1)(2011-2#2)(2012-3#1)
variable degrees of##4##3##(1993-9#1)(2007-10#1)(2008-1#1)(2011-1#1)
variable degrees##5##2##(1993-9#1)(1997-6#1)(2007-10#1)(2008-1#1)(2011-1#1)
variable deletions##2##2##(1993-11#1)(1997-3#1)
variable density##3##2##(1995-5#1)(2008-2#2)
variable depending on the##4##4##(1996-9#1)(1997-8#1)(2005-11#1)(2008-5#1)
variable depending on##6##3##(1996-9#1)(1997-8#1)(2005-11#1)(2008-12#1)(2008-5#1)(2009-8#1)
variable depth##2##2##(2007-9#1)(2008-3#1)
variable disease##3##2##(2010-12#1)(2012-2#1)(2013-1#1)
variable domain##5##2##(1996-6#2)(1997-2#1)(1997-4#2)
variable domains##5##2##(1991-9#1)(1992-6#1)(1994-3#1)(1994-9#1)(1995-3#1)
variable effect##3##2##(1994-6#1)(2008-10#1)(2008-11#1)
variable effects on##2##3##(2007-11#1)(2008-4#1)
variable effects##4##2##(1992-7#1)(2007-11#1)(2008-4#1)(2008-7#1)
variable environments##2##2##(2008-8#2)
variable expression##5##2##(1996-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)
variable extent##3##2##(1990-4#1)(2007-9#1)(2009-8#1)
variable factors##2##2##(2007-2#1)(2008-10#1)
variable focal##2##2##(2007-12#1)(2008-2#1)
variable for the##5##3##(1996-8#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-7#1)
variable for##14##2##(1993-2#1)(1994-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(2006-5#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-4#1)(2009-8#1)(2011-2#1)
variable fragment##4##2##(2008-10#4)
variable frequency of##2##3##(1990-10#1)(2012-3#1)
variable frequency##4##2##(1990-10#1)(2012-3#1)(2013-1#2)
variable from a##2##3##(2007-12#1)(2008-1#1)
variable from##7##2##(2006-8#1)(2007-12#2)(2008-1#1)(2008-5#1)(2008-7#1)(2013-1#1)
variable gene##2##2##(2008-4#2)
variable grating##2##2##(2008-2#2)
variable growth##2##2##(2008-12#2)
variable had##2##2##(1995-10#1)(2008-10#1)
variable hypogammaglobulinemia##3##2##(1993-10#1)(2006-2#2)
variable image##2##2##(2007-12#2)
variable immunodeficiency##9##2##(1992-8#1)(2007-11#2)(2007-2#3)(2007-7#2)(2012-3#1)
variable importance##2##2##(2007-12#1)(2012-11#1)
variable in the##8##3##(1995-2#1)(1997-7#1)(2006-4#1)(2007-12#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#1)
variable in##31##2##(1993-11#1)(1993-2#1)(1993-7#1)(1994-2#1)(1994-7#1)(1994-9#1)(1995-2#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-7#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-4#1)(2011-11#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
variable incidence##2##2##(1990-8#1)(2006-2#1)
variable interval##3##2##(1992-12#1)(1993-6#1)(2012-1#1)
variable is the##3##3##(2009-1#1)(2010-2#1)(2011-2#1)
variable is##11##2##(1994-6#1)(1994-8#1)(1995-12#1)(1995-4#1)(2005-10#1)(2006-12#1)(2008-8#1)(2009-1#1)(2010-2#1)(2011-2#2)
variable latency##2##2##(1991-11#1)(2011-2#1)
variable length and##2##3##(1992-6#1)(1993-3#1)
variable length##6##2##(1992-6#1)(1993-3#1)(1996-2#1)(2008-10#3)
variable levels of##5##3##(1992-6#1)(2008-8#2)(2011-2#2)
variable levels##7##2##(1992-11#1)(1992-6#1)(1995-3#1)(2008-8#2)(2011-2#2)
variable life##2##2##(2007-8#1)(2008-8#1)
variable linking##2##2##(2011-2#1)(2012-12#1)
variable local##4##2##(2010-1#3)(2013-7#1)
variable measurement variances##2##3##(2008-7#2)
variable methods##2##2##(2006-8#1)(2012-3#1)
variable number of tandem repeat##2##5##(2008-10#1)(2008-11#1)
variable number of tandem repeats (VNTR)##2##6##(1991-7#1)(2008-4#1)
variable number of tandem repeats##3##5##(1991-7#1)(2004-10#1)(2008-4#1)
variable number of tandem##5##4##(1991-7#1)(2004-10#1)(2008-10#1)(2008-11#1)(2008-4#1)
variable number of##12##3##(1991-7#1)(1996-11#1)(1997-2#1)(2004-10#1)(2005-10#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2010-2#1)(2012-2#1)
variable number tandem repeat (VNTR)##2##5##(2008-10#1)(2010-12#1)
variable number tandem repeat##4##4##(2007-10#1)(2008-10#1)(2008-7#1)(2010-12#1)
variable number##16##2##(1991-7#1)(1996-11#1)(1997-2#1)(2004-10#1)(2005-10#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-2#1)(2012-2#1)
variable numbers of##4##3##(1990-12#1)(1993-11#1)(1997-6#2)
variable of##6##2##(1990-11#1)(1990-12#1)(1990-8#1)(1995-6#1)(2006-4#1)(2012-3#1)
variable on the##2##3##(2008-10#2)
variable on##4##2##(2008-10#3)(2010-2#1)
variable outcomes##3##2##(2008-5#1)(2013-1#2)
variable part##2##2##(2008-2#1)(2008-5#1)
variable phase##2##2##(2007-11#1)(2008-2#1)
variable phenotype##4##2##(1991-5#1)(1997-3#1)(2008-4#1)(2009-12#1)
variable proportion of##4##3##(1994-12#1)(2008-10#1)(2008-5#1)(2013-7#1)
variable pulse##2##2##(1990-10#1)(2008-1#1)
variable radius mirror##2##3##(2008-2#1)(2008-3#1)
variable range##2##2##(1992-6#1)(2008-2#1)
variable rates##2##2##(1992-5#1)(2008-12#1)
variable reflectivity##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
variable refractive index##2##3##(2008-2#1)(2008-3#1)
variable region 1##2##3##(1995-5#2)
variable region genes of##2##4##(1993-5#1)(1994-12#1)
variable region genes##7##3##(1993-5#1)(1994-12#1)(1995-2#4)(2008-4#1)
variable region of##6##3##(2006-4#1)(2007-2#1)(2008-10#1)(2008-8#1)(2011-12#1)(2012-12#1)
variable region was##2##3##(2008-8#1)(2012-12#1)
variable region##38##2##(1990-12#1)(1990-5#2)(1992-6#1)(1992-7#2)(1992-8#1)(1993-11#1)(1993-5#1)(1994-12#1)(1994-9#2)(1995-1#1)(1995-2#4)(1995-5#3)(1996-5#1)(2006-4#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#2)(2009-10#1)(2009-5#1)(2011-12#1)(2012-12#3)(2012-2#1)
variable regions from##2##3##(1996-11#1)(2008-8#1)
variable regions of both##2##4##(1993-5#1)(1994-3#1)
variable regions of the##2##4##(1990-5#1)(1992-7#1)
variable regions of##4##3##(1990-5#1)(1992-7#1)(1993-5#1)(1994-3#1)
variable regions##16##2##(1990-5#1)(1992-11#1)(1992-7#5)(1993-5#1)(1994-3#1)(1995-11#1)(1996-11#2)(1997-2#1)(2007-11#1)(2008-10#1)(2008-8#1)
variable resistance to##2##3##(2011-10#1)(2012-11#1)
variable resistance##3##2##(1991-5#1)(2011-10#1)(2012-11#1)
variable response##3##2##(2008-9#1)(2010-12#1)(2013-8#1)
variable responses##3##2##(1994-2#1)(2008-11#1)(2008-4#1)
variable results##8##2##(1994-3#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-9#1)(2009-5#1)(2012-3#1)
variable retarder##2##2##(2008-3#2)
variable sample volume##2##3##(2008-10#2)
variable screening##2##2##(2012-1#2)
variable selection and##3##3##(1997-2#1)(2007-8#1)(2010-1#1)
variable selection methods##4##3##(1995-2#1)(2008-10#2)(2008-7#1)
variable selection principle##2##3##(1994-9#2)
variable selection was##2##3##(2008-10#1)(2013-8#1)
variable selection##31##2##(1993-1#2)(1994-9#8)(1995-2#2)(1997-2#2)(2007-8#1)(2008-10#4)(2008-7#1)(2009-12#1)(2010-1#3)(2010-7#1)(2012-1#1)(2012-12#2)(2012-3#2)(2013-8#1)
variable sensitivity to##2##3##(1992-6#1)(2010-8#1)
variable sensitivity##3##2##(1992-6#1)(2010-8#1)(2011-2#1)
variable severity of##2##3##(2007-12#1)(2007-7#1)
variable severity##5##2##(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2013-1#1)
variable sites##3##2##(2008-10#3)
variable spatial##2##2##(2008-2#1)(2008-3#1)
variable stars##3##2##(2006-7#2)(2007-9#1)
variable structural equation modeling##3##4##(2007-12#1)(2009-7#1)(2012-3#1)
variable success##4##2##(1991-6#1)(2010-10#1)(2010-5#1)(2011-1#1)
variable such as##2##3##(1996-7#1)(2013-1#1)
variable symptoms and##2##3##(2008-10#1)(2010-4#1)
variable symptoms##4##2##(2006-10#1)(2008-10#1)(2008-4#1)(2010-4#1)
variable temperature (1)H##2##3##(1996-2#1)(1996-5#1)
variable temperature##7##2##(1994-9#1)(1996-2#1)(1996-5#1)(2008-10#1)(2009-11#1)(2009-4#1)(2010-5#1)
variable than those##2##3##(2008-10#1)(2008-9#1)
variable than##10##2##(1990-9#1)(1993-3#1)(1995-4#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-9#1)(2012-12#2)
variable that##7##2##(1991-8#1)(1997-6#1)(2008-9#1)(2009-5#1)(2012-12#1)(2013-1#2)
variable thickness##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
variable time##3##2##(2008-11#1)(2008-3#1)(2008-9#1)
variable to describe##2##3##(1994-7#1)(2005-10#1)
variable to##6##2##(1994-7#1)(2005-10#1)(2008-10#3)(2008-8#1)
variable use##2##2##(2005-11#1)(2012-11#1)
variable used##2##2##(1997-6#1)(2008-10#1)
variable values)##2##2##(2008-10#2)
variable vertex-connectivity index##2##3##(2007-11#2)
variable was##10##2##(1992-1#1)(1993-3#1)(1994-3#1)(2007-9#1)(2008-10#1)(2008-11#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-3#1)
variable wavelength epi-fluorescence microscope##2##4##(2008-10#2)
variable when##3##2##(1990-12#1)(1993-7#1)(2011-2#1)
variable with##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
variable##1161##1##(1990-10#3)(1990-11#3)(1990-12#5)(1990-3#2)(1990-4#2)(1990-5#6)(1990-8#3)(1990-9#4)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#3)(1991-8#1)(1991-9#1)(1992-1#4)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#7)(1992-4#1)(1992-5#2)(1992-6#12)(1992-7#8)(1992-8#3)(1993-1#2)(1993-10#2)(1993-11#8)(1993-12#5)(1993-2#3)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#2)(1993-7#4)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#9)(1994-12#2)(1994-2#3)(1994-3#5)(1994-4#3)(1994-6#5)(1994-7#2)(1994-8#5)(1994-9#16)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#10)(1995-3#7)(1995-4#2)(1995-5#5)(1995-6#8)(1995-8#3)(1996-1#2)(1996-10#1)(1996-11#7)(1996-12#2)(1996-2#6)(1996-3#5)(1996-4#2)(1996-5#2)(1996-6#3)(1996-7#3)(1996-8#5)(1996-9#1)(1997-1#2)(1997-2#10)(1997-3#10)(1997-4#5)(1997-5#1)(1997-6#9)(1997-7#4)(1997-8#9)(2004-10#1)(2004-11#1)(2004-2#1)(2004-9#1)(2005-10#5)(2005-11#17)(2005-8#1)(2005-9#1)(2006-10#12)(2006-11#3)(2006-12#4)(2006-2#7)(2006-4#4)(2006-5#4)(2006-7#2)(2006-8#7)(2006-9#1)(2007-1#4)(2007-10#7)(2007-11#24)(2007-12#28)(2007-2#11)(2007-3#4)(2007-4#3)(2007-6#3)(2007-7#11)(2007-8#10)(2007-9#8)(2008-1#15)(2008-10#124)(2008-11#21)(2008-12#9)(2008-2#43)(2008-3#36)(2008-4#22)(2008-5#22)(2008-6#5)(2008-7#20)(2008-8#43)(2008-9#16)(2009-1#1)(2009-10#3)(2009-11#3)(2009-12#6)(2009-2#1)(2009-3#4)(2009-4#5)(2009-5#6)(2009-6#3)(2009-7#2)(2009-8#10)(2009-9#4)(2010-1#7)(2010-10#1)(2010-11#1)(2010-12#8)(2010-2#9)(2010-3#2)(2010-4#4)(2010-5#3)(2010-6#4)(2010-7#4)(2010-8#6)(2010-9#1)(2011-1#8)(2011-10#1)(2011-11#1)(2011-12#5)(2011-2#44)(2012-1#13)(2012-11#4)(2012-12#26)(2012-2#16)(2012-3#18)(2013-1#25)(2013-4#1)(2013-7#11)(2013-8#17)
variable) and##2##2##(2008-10#1)(2008-7#1)
variable)##6##1##(2004-3#1)(2008-10#2)(2008-3#1)(2008-7#2)
variable-angle screws##4##2##(2006-8#4)
variable-angle spectroscopic ellipsometry##2##3##(2008-2#2)
variable-angle##6##1##(2006-8#4)(2008-2#2)
variable-focal-length##2##1##(2007-12#1)(2008-3#1)
variable-line-spaced grating##3##2##(2008-3#3)
variable-line-spaced##4##1##(2008-3#4)
variable-reflectivity signal##2##2##(2007-11#2)
variable-reflectivity##3##1##(2007-11#2)(2008-3#1)
variable-retardance##2##1##(2007-12#1)(2008-3#1)
variable-size##3##1##(2008-2#1)(2008-3#2)
variable-sized##2##1##(1996-1#1)(2012-12#1)
variable-temperature##3##1##(1995-5#1)(1996-2#1)(2005-8#1)
variable-term computer leases##2##3##(1993-2#2)
variable-tone long calls##2##3##(2008-8#2)
variables &quot##2##2##(1994-6#1)(2008-5#1)
variables (age##3##2##(1993-12#1)(2008-10#1)(2008-11#1)
variables (e##13##2##(2007-12#3)(2007-7#1)(2007-9#1)(2008-7#3)(2010-2#1)(2013-1#4)
variables (pH##2##2##(2008-10#2)
variables (sample##3##2##(2008-10#3)
variables (temperature##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
variables 1##2##2##(2008-7#2)
variables according to##3##3##(2008-10#1)(2008-5#1)(2013-7#1)
variables accounted for a##2##4##(2008-10#1)(2010-3#1)
variables accounted for##3##3##(2008-10#1)(2008-8#1)(2010-3#1)
variables across##2##2##(1993-5#1)(2012-11#1)
variables affect##3##2##(2008-10#1)(2009-3#1)(2012-3#1)
variables affected##2##2##(2006-12#1)(2012-3#1)
variables affecting the fluorescence##4##4##(2008-10#4)
variables affecting the##24##3##(2007-4#1)(2007-8#2)(2008-10#20)(2012-12#1)
variables affecting##29##2##(2007-4#1)(2007-8#2)(2008-10#23)(2012-1#1)(2012-12#1)(2012-2#1)
variables after##2##2##(2007-9#1)(2009-11#1)
variables also##4##2##(1995-2#1)(1997-4#1)(2008-10#2)
variables analysed##2##2##(1997-3#1)(2012-1#1)
variables and body##2##3##(2008-7#1)(2008-9#1)
variables and parameters##3##3##(2006-10#1)(2008-10#2)
variables and surgical management of foot melanoma##2##7##(2012-3#2)
variables and the##18##3##(1995-10#1)(2006-3#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-3#1)(2008-9#1)(2009-2#1)(2009-4#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#2)
variables and their##4##3##(1994-6#1)(1996-9#1)(2008-10#2)
variables and##77##2##(1992-12#1)(1994-2#1)(1994-6#2)(1995-10#1)(1995-2#1)(1995-9#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-12#4)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-7#5)(2008-8#1)(2008-9#3)(2009-2#1)(2009-4#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#2)
variables are associated with##2##4##(2006-7#1)(2012-12#1)
variables are in##2##3##(2005-11#1)(2010-1#1)
variables are most##2##3##(2008-5#1)(2010-2#1)
variables are the##4##3##(2008-10#1)(2008-4#1)(2013-1#2)
variables are##43##2##(1992-1#1)(1992-3#2)(1992-6#3)(1992-7#1)(1993-1#1)(1993-9#1)(1995-6#1)(1996-1#1)(1996-8#1)(1997-4#1)(1997-5#1)(2005-11#1)(2006-7#1)(2007-6#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-2#3)(2011-1#1)(2012-12#3)(2012-3#1)(2013-1#3)
variables as independent##3##3##(1990-9#1)(2007-10#1)(2008-10#1)
variables as well as##9##4##(2007-12#2)(2007-3#1)(2008-10#5)(2009-8#1)
variables as well##10##3##(2007-12#2)(2007-3#1)(2008-10#5)(2008-5#1)(2009-8#1)
variables as##17##2##(1990-9#1)(1996-7#1)(2007-10#1)(2007-12#3)(2007-3#1)(2008-10#7)(2008-5#1)(2009-8#1)(2012-2#1)
variables associated with the##2##4##(2006-10#1)(2008-2#1)
variables associated with treatment##2##4##(1995-9#1)(2008-11#1)
variables associated with##14##3##(1995-9#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
variables at the##2##3##(2008-10#1)(2009-7#1)
variables at##6##2##(2008-10#4)(2009-7#1)(2012-12#1)
variables based on##4##3##(1994-6#1)(2008-10#2)(2008-3#1)
variables being##2##2##(2008-10#2)
variables between##4##2##(1993-11#1)(2010-3#1)(2012-12#1)(2013-1#1)
variables by the##2##3##(2008-10#1)(2008-3#1)
variables by##4##2##(1992-6#1)(2008-10#1)(2008-3#1)(2013-1#1)
variables can be##4##3##(1992-6#1)(2008-2#1)(2008-3#1)(2008-8#1)
variables can##5##2##(1992-6#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)
variables chosen##2##2##(2006-3#1)(2008-5#1)
variables corresponding##2##2##(1997-7#1)(2008-10#1)
variables could be##2##3##(2008-10#1)(2009-11#1)
variables could##3##2##(2008-10#1)(2009-11#1)(2011-2#1)
variables did not##6##3##(1991-2#1)(1993-8#1)(2008-8#1)(2009-7#1)(2011-1#1)(2011-2#1)
variables during##2##2##(2008-11#1)(2010-9#1)
variables examined##5##2##(1991-7#1)(1993-8#1)(2006-7#1)(2008-10#1)(2011-2#1)
variables explained##2##2##(2007-10#1)(2008-7#1)
variables for a##4##3##(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)
variables for each##2##3##(2012-3#1)(2013-7#1)
variables for the##6##3##(2007-8#1)(2008-10#3)(2010-5#1)(2013-1#1)
variables for##32##2##(1991-3#1)(1992-2#1)(1993-12#1)(1993-9#1)(2006-1#1)(2007-11#1)(2007-8#3)(2008-10#10)(2008-2#1)(2008-5#2)(2009-12#1)(2009-4#1)(2010-5#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
variables from the##3##3##(2007-7#2)(2010-3#1)
variables from##10##2##(2007-7#2)(2008-10#1)(2008-2#1)(2010-2#1)(2010-3#2)(2010-8#1)(2012-12#1)(2013-1#1)
variables had##6##2##(1991-3#1)(2004-10#1)(2008-10#3)(2013-1#1)
variables have been optimized##3##4##(2008-10#3)
variables have been##6##3##(1991-2#1)(2008-10#4)(2008-3#1)
variables have##8##2##(1991-2#1)(1996-11#1)(2006-10#1)(2008-10#4)(2008-3#1)
variables identified in##2##3##(1994-3#1)(2006-2#1)
variables in a group of##2##5##(1996-6#1)(2006-2#1)
variables in a##4##3##(1996-6#1)(2006-2#1)(2006-6#1)(2008-8#1)
variables in both##2##3##(1996-12#1)(2010-8#1)
variables in determining##2##3##(1995-6#1)(2007-2#1)
variables in order to##2##4##(2008-3#1)(2010-8#1)
variables in the model##4##4##(1992-6#1)(2007-12#1)(2008-10#1)(2008-11#1)
variables in the##15##3##(1991-6#1)(1992-6#1)(1993-5#1)(2007-12#1)(2007-3#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2013-1#1)
variables in##64##2##(1991-2#1)(1991-3#1)(1991-6#1)(1992-6#1)(1993-1#1)(1993-10#1)(1993-5#1)(1994-1#1)(1994-7#1)(1994-8#1)(1995-2#2)(1995-4#2)(1995-6#1)(1996-12#1)(1996-5#1)(1996-6#1)(2004-2#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-11#1)(2009-4#1)(2010-12#1)(2010-8#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
variables include##3##2##(2010-12#1)(2010-6#1)(2011-2#1)
variables included##5##2##(1990-12#1)(2006-6#1)(2007-9#1)(2008-12#1)(2012-3#1)
variables including##7##2##(1995-11#1)(2007-11#1)(2008-12#1)(2008-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
variables influence##2##2##(1996-1#1)(2008-12#1)
variables influenced##2##2##(2008-11#1)(2008-9#1)
variables influencing the##2##3##(2008-10#2)
variables influencing##5##2##(1994-2#1)(1996-8#1)(2008-10#2)(2013-8#1)
variables investigated##4##2##(2007-7#1)(2010-9#1)(2011-2#1)(2012-12#1)
variables is##12##2##(1997-1#1)(2008-10#2)(2008-11#2)(2008-3#2)(2009-4#2)(2011-2#1)(2012-2#1)(2013-7#1)
variables like##7##2##(2008-10#3)(2009-10#1)(2009-9#1)(2011-1#1)(2012-12#1)
variables may##10##2##(2005-10#1)(2006-1#1)(2007-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
variables measured##4##2##(1996-7#1)(2008-1#1)(2013-1#2)
variables of each##2##3##(2011-2#1)(2013-7#1)
variables of the system##3##4##(2008-10#1)(2008-5#1)(2008-6#1)
variables of the##17##3##(1996-11#1)(1997-1#1)(2004-9#2)(2007-3#1)(2008-10#5)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#2)(2010-8#1)
variables of##37##2##(1990-2#1)(1993-12#1)(1995-1#1)(1995-8#1)(1996-11#1)(1997-1#1)(2004-9#2)(2006-1#1)(2007-3#1)(2007-7#1)(2008-10#7)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
variables often##2##2##(2006-4#1)(2012-12#1)
variables on each##2##3##(1997-7#1)(2007-12#1)
variables on the determination of##2##5##(2008-10#2)
variables on the##13##3##(1990-8#1)(1991-2#1)(1992-12#1)(2004-12#1)(2007-12#1)(2008-10#6)(2011-2#1)(2012-11#1)
variables on these##2##3##(2008-10#1)(2008-4#1)
variables on##26##2##(1990-8#1)(1991-2#1)(1992-12#1)(1992-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2007-12#2)(2008-10#9)(2008-4#1)(2008-5#4)(2011-2#2)(2012-11#1)
variables or##5##2##(1995-12#1)(1995-9#1)(1996-8#1)(2008-4#2)
variables potentially##2##2##(1996-1#1)(2012-3#1)
variables related to##11##3##(1993-1#1)(1995-1#1)(1995-2#1)(2006-12#1)(2007-1#1)(2007-4#1)(2008-10#3)(2013-1#1)(2013-8#1)
variables related##12##2##(1993-1#1)(1995-1#1)(1995-2#1)(2006-12#1)(2007-1#1)(2007-4#1)(2008-10#3)(2011-1#1)(2013-1#1)(2013-8#1)
variables relating to##2##3##(2007-6#1)(2008-10#1)
variables representing##2##2##(1995-10#1)(2012-1#1)
variables required##2##2##(2008-3#2)
variables revealed that##2##3##(2004-11#1)(2010-8#1)
variables should be##3##3##(2008-11#1)(2012-12#1)(2012-2#1)
variables showed that##3##3##(1996-5#1)(1997-1#1)(2008-5#1)
variables showed##5##2##(1996-5#1)(1997-1#1)(2006-3#1)(2008-10#1)(2008-5#1)
variables showing the##2##3##(1996-5#1)(2008-10#1)
variables significantly related to##2##4##(2007-2#1)(2008-10#1)
variables significantly##4##2##(2007-10#1)(2007-2#1)(2008-10#1)(2012-1#1)
variables studied included##2##3##(1994-3#1)(2007-8#1)
variables studied were##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
variables studied##9##2##(1994-3#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-1#1)
variables such as age##3##4##(1992-4#1)(2007-8#1)(2008-12#1)
variables such as nationality##2##4##(2009-8#1)(2011-2#1)
variables such as pH##2##4##(2008-10#2)
variables such as the##6##4##(2008-10#5)(2009-7#1)
variables such as type##2##4##(1994-6#1)(2008-4#1)
variables such as##45##3##(1990-2#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-11#1)(1993-9#1)(1994-2#2)(1994-6#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
variables such##46##2##(1990-2#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-11#1)(1993-9#1)(1994-2#2)(1994-6#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
variables than##2##2##(2004-3#1)(2010-12#1)
variables that affect the##3##4##(1995-4#1)(2008-10#2)
variables that affect##5##3##(1995-4#1)(2008-10#3)(2008-8#1)
variables that appeared to##2##4##(2007-9#1)(2008-4#1)
variables that are associated with##2##5##(2008-8#1)(2010-2#1)
variables that are##10##3##(1995-1#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-2#1)(2011-12#1)
variables that can##4##3##(2008-1#1)(2008-4#1)(2010-10#1)(2011-2#1)
variables that characterize##3##3##(2008-10#1)(2013-1#2)
variables that contribute to##2##4##(1991-12#1)(2009-5#1)
variables that contributed##2##3##(2008-10#1)(2008-8#1)
variables that could affect the performance of this system were investigated as well as the possible interferents##2##17##(2008-10#2)
variables that could##3##3##(1994-7#1)(2008-10#2)
variables that have##2##3##(1992-3#1)(2009-10#1)
variables that influence the##2##4##(2008-10#2)
variables that influence##4##3##(2008-10#3)(2009-8#1)
variables that may be##2##4##(2007-12#1)(2013-7#1)
variables that may##4##3##(2006-10#1)(2007-12#1)(2008-12#1)(2013-7#1)
variables that significantly##2##3##(1995-5#1)(2006-1#1)
variables that were##4##3##(2008-11#1)(2011-2#1)(2012-12#1)(2013-7#1)
variables that##60##2##(1991-12#1)(1992-2#1)(1992-3#1)(1994-7#1)(1995-1#1)(1995-4#1)(1995-5#1)(1996-7#1)(2006-1#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-9#2)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-8#4)(2009-10#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#2)
variables the##6##2##(1990-3#1)(1994-2#1)(1996-7#1)(2008-10#2)(2010-4#1)
variables there##2##2##(2008-12#1)(2009-4#1)
variables to be studied##2##4##(2008-10#2)
variables to be##6##3##(2008-10#4)(2008-11#1)(2008-2#1)
variables to determine##2##3##(2010-8#1)(2011-2#1)
variables to the##2##3##(2008-10#1)(2008-8#1)
variables to##30##2##(1990-7#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-6#1)(2007-4#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#3)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-8#2)
variables typically##2##2##(2010-8#1)(2012-1#1)
variables used in the##2##4##(2008-5#1)(2010-5#1)
variables used to##2##3##(1994-2#1)(2010-2#1)
variables used##4##2##(1994-2#1)(2008-5#1)(2010-2#1)(2010-5#1)
variables using a##2##3##(2008-10#1)(2008-11#1)
variables using##5##2##(1990-12#1)(2008-10#2)(2008-11#1)(2008-5#1)
variables was assessed##2##3##(2012-2#1)(2013-8#1)
variables was completely studied by factorial design analysis##2##8##(2008-10#2)
variables was studied##2##3##(2008-10#2)
variables was##15##2##(1992-2#1)(1996-5#1)(2007-2#1)(2008-10#7)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
variables were analyzed using##2##4##(2008-10#1)(2012-2#1)
variables were assessed##4##3##(2008-10#2)(2009-12#1)(2013-8#1)
variables were collected##4##3##(2008-10#1)(2011-1#2)(2011-2#1)
variables were compared##5##3##(2006-10#1)(2006-12#2)(2007-5#1)(2008-10#1)
variables were considered##2##3##(2008-10#1)(2008-11#1)
variables were determined##2##3##(1995-3#1)(1996-3#1)
variables were examined##3##3##(1994-4#1)(2008-4#1)(2010-9#1)
variables were found to##2##4##(2007-12#1)(2007-2#1)
variables were found##4##3##(2004-11#1)(2007-12#1)(2007-2#1)(2011-2#1)
variables were included in##2##4##(2008-9#1)(2011-2#1)
variables were investigated##2##3##(2008-9#1)(2013-1#1)
variables were measured in##4##4##(1993-2#1)(2008-10#1)(2012-12#1)(2013-7#1)
variables were measured using the##2##5##(2006-7#1)(2010-3#1)
variables were measured##9##3##(1993-2#1)(1994-1#1)(2006-7#1)(2008-10#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
variables were measures##2##3##(1997-1#1)(2008-12#1)
variables were not##5##3##(1991-8#1)(1992-3#1)(1994-9#1)(1995-1#1)(2013-1#1)
variables were obtained##2##3##(2011-2#1)(2012-3#1)
variables were optimized##2##3##(2008-10#2)
variables were selected##3##3##(2008-10#1)(2013-1#2)
variables were significant##2##3##(1991-2#1)(2008-10#1)
variables were statistically##2##3##(2008-8#1)(2012-2#1)
variables were studied and optimized##3##5##(2008-10#3)
variables were studied in order to##2##6##(2008-10#2)
variables were studied in##3##4##(2008-10#2)(2011-2#1)
variables were studied##8##3##(2008-10#6)(2008-8#1)(2011-2#1)
variables were tested##2##3##(2008-10#1)(2011-1#1)
variables were the##2##3##(2008-10#1)(2012-3#1)
variables were then##2##3##(2008-12#1)(2011-2#1)
variables were used##2##3##(2008-10#2)
variables were##120##2##(1991-12#1)(1991-2#1)(1991-8#1)(1992-3#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-4#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-3#1)(1997-1#1)(2004-11#1)(2004-12#1)(2006-10#1)(2006-12#2)(2006-7#1)(2006-9#1)(2007-10#3)(2007-12#1)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#29)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#5)(2011-2#11)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#7)(2013-7#3)(2013-8#3)
variables which are##2##3##(1997-4#1)(1997-6#1)
variables which##10##2##(1991-12#1)(1996-12#1)(1997-4#1)(1997-6#1)(2005-10#1)(2008-10#1)(2008-7#1)(2012-2#2)(2013-7#1)
variables will##3##2##(1993-1#1)(2008-5#1)(2009-12#1)
variables with the##2##3##(1991-4#1)(2007-8#1)
variables with##18##2##(1990-9#1)(1991-4#1)(1993-2#1)(1995-12#1)(2004-12#1)(2005-10#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-8#1)(2009-4#1)(2010-1#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-2#1)
variables within##2##2##(2008-2#1)(2011-2#1)
variables##1465##1##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#4)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-12#3)(1991-2#8)(1991-3#3)(1991-4#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#2)(1992-1#2)(1992-12#2)(1992-2#5)(1992-3#6)(1992-4#1)(1992-5#1)(1992-6#8)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#7)(1993-10#1)(1993-11#6)(1993-12#7)(1993-2#4)(1993-3#1)(1993-5#5)(1993-8#4)(1993-9#10)(1994-1#2)(1994-12#1)(1994-2#8)(1994-3#4)(1994-4#1)(1994-6#9)(1994-7#3)(1994-8#2)(1994-9#1)(1995-1#5)(1995-10#2)(1995-11#2)(1995-12#5)(1995-2#10)(1995-3#3)(1995-4#4)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#2)(1995-9#3)(1996-1#4)(1996-11#2)(1996-12#4)(1996-2#2)(1996-3#3)(1996-5#5)(1996-6#1)(1996-7#7)(1996-8#6)(1996-9#1)(1997-1#5)(1997-2#2)(1997-3#4)(1997-4#4)(1997-5#2)(1997-6#3)(1997-7#3)(1997-8#4)(2004-10#3)(2004-11#3)(2004-12#5)(2004-2#1)(2004-3#1)(2004-9#2)(2005-10#11)(2005-11#5)(2005-8#1)(2005-9#3)(2006-1#6)(2006-10#18)(2006-12#7)(2006-2#3)(2006-3#4)(2006-4#3)(2006-6#5)(2006-7#4)(2006-9#3)(2007-1#4)(2007-10#9)(2007-11#11)(2007-12#32)(2007-2#8)(2007-3#6)(2007-4#3)(2007-5#1)(2007-6#6)(2007-7#8)(2007-8#23)(2007-9#10)(2008-1#7)(2008-10#312)(2008-11#29)(2008-12#17)(2008-2#36)(2008-3#23)(2008-4#13)(2008-5#44)(2008-6#7)(2008-7#41)(2008-8#28)(2008-9#18)(2009-10#6)(2009-11#5)(2009-12#6)(2009-2#3)(2009-3#2)(2009-4#10)(2009-5#5)(2009-6#1)(2009-7#8)(2009-8#9)(2009-9#2)(2010-1#3)(2010-10#5)(2010-11#1)(2010-12#8)(2010-2#19)(2010-3#8)(2010-4#7)(2010-5#3)(2010-6#6)(2010-7#2)(2010-8#12)(2010-9#3)(2011-1#23)(2011-11#2)(2011-12#2)(2011-2#50)(2012-1#19)(2012-11#3)(2012-12#34)(2012-2#32)(2012-3#33)(2013-1#61)(2013-7#20)(2013-8#22)
variables)##11##1##(1992-2#1)(1996-9#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-7#2)(2009-5#1)(2010-1#1)(2013-1#1)(2013-7#1)
variably associated with##2##3##(2004-10#1)(2006-8#1)
variably expressed in##3##3##(1993-9#1)(2007-12#1)(2012-3#1)
variably expressed##5##2##(1991-9#1)(1993-9#1)(1996-12#1)(2007-12#1)(2012-3#1)
variably sized##3##2##(2007-7#1)(2008-12#1)(2009-4#1)
variably##38##1##(1990-5#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-11#3)(1996-12#1)(2004-10#1)(2006-8#3)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-11#2)(2008-12#1)(2008-7#2)(2009-4#1)(2009-8#2)(2010-12#1)(2012-1#1)(2012-12#1)(2012-3#2)
variamine blue##3##2##(2008-10#3)
variance (I)##2##2##(2008-8#2)
variance = 4##2##3##(2011-1#2)
variance =##3##2##(2011-1#3)
variance analysis and##2##3##(1996-12#1)(2008-10#1)
variance analysis of##2##3##(1995-1#1)(2008-2#1)
variance analysis##7##2##(1992-2#1)(1995-1#1)(1996-12#1)(2008-10#3)(2008-2#1)
variance and the##2##3##(1993-5#1)(2008-8#1)
variance and##21##2##(1990-3#1)(1992-9#1)(1993-5#2)(1997-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-9#1)(2011-2#1)(2013-1#2)
variance associated with##3##3##(2007-12#1)(2009-9#1)(2013-1#1)
variance assumption##2##2##(1997-2#1)(2012-3#1)
variance between##5##2##(2008-3#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
variance can##4##2##(2008-10#1)(2008-8#2)(2010-6#1)
variance components##6##2##(1994-8#1)(1994-9#1)(1996-12#1)(2008-7#1)(2010-2#1)(2012-3#1)
variance contributed by##3##3##(2008-8#2)(2013-8#1)
variance could be##2##3##(1993-2#1)(2007-12#1)
variance estimate##5##2##(1996-7#2)(2008-2#2)(2008-6#1)
variance explained by##3##3##(2008-12#1)(2008-2#1)(2012-3#1)
variance explained##6##2##(2008-12#1)(2008-2#1)(2010-9#1)(2011-1#2)(2012-3#1)
variance for the##2##3##(2004-11#1)(2008-3#1)
variance for##9##2##(2004-11#1)(2008-10#6)(2008-3#2)
variance from##2##2##(2008-8#1)(2009-3#1)
variance in exercise##4##3##(2007-10#2)(2007-6#1)(2010-3#1)
variance in gain##2##3##(2008-9#2)
variance in perceived learning outcome##2##5##(2011-2#2)
variance in population##2##3##(2008-8#2)
variance in the lognormal##2##4##(2008-8#2)
variance in the use of##2##5##(2006-8#1)(2007-10#1)
variance in the##30##3##(1990-8#1)(1991-12#1)(1995-12#1)(1995-3#1)(1995-7#1)(2005-12#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-8#2)(2008-9#3)(2009-12#1)(2010-8#1)(2010-9#1)(2012-12#2)(2012-3#2)
variance in##122##2##(1990-12#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-8#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-1#2)(1996-2#1)(1996-6#1)(2004-10#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-3#1)(2006-8#1)(2007-1#1)(2007-10#6)(2007-11#3)(2007-12#3)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-10#7)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#11)(2008-9#10)(2009-10#1)(2009-12#4)(2009-4#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#5)(2010-9#4)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#2)
variance indicated that##3##3##(1993-9#1)(2008-10#2)
variance indicated##4##2##(1993-9#1)(2008-10#3)
variance is due to##2##4##(2008-10#1)(2009-4#1)
variance is##10##2##(1992-2#1)(1993-3#1)(1995-12#1)(2008-10#1)(2008-3#1)(2008-8#2)(2009-4#1)(2010-12#1)(2010-2#1)
variance model##2##2##(1997-2#1)(2008-10#1)
variance observed##2##2##(2008-10#1)(2008-7#1)
variance of a##2##3##(1993-9#1)(2009-3#1)
variance of area estimates##3##4##(1997-3#3)
variance of area##4##3##(1997-3#3)(2008-10#1)
variance of outcome##2##3##(1992-9#1)(2006-9#1)
variance of the number of##3##5##(1996-1#1)(2008-10#2)
variance of the optical##2##4##(2008-2#1)(2008-3#1)
variance of the##37##3##(1992-6#1)(1993-12#1)(1995-4#1)(1996-1#1)(1997-6#1)(2005-11#1)(2006-11#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-2#10)(2008-3#4)(2009-3#1)(2010-2#1)(2010-3#1)(2010-8#2)(2012-1#1)(2012-3#1)
variance of##66##2##(1992-6#1)(1992-9#1)(1993-12#1)(1993-8#1)(1993-9#1)(1995-4#1)(1996-1#1)(1997-3#3)(1997-6#1)(2005-11#1)(2006-11#2)(2006-9#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#10)(2008-2#11)(2008-3#5)(2008-8#1)(2009-2#1)(2009-3#2)(2009-5#2)(2010-2#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
variance on the##3##3##(2006-12#1)(2008-10#1)(2008-3#1)
variance on##4##2##(2006-12#1)(2008-10#1)(2008-3#1)(2010-6#1)
variance over##5##2##(2008-2#3)(2008-9#1)(2010-8#1)
variance ratio##2##2##(2008-3#1)(2010-2#1)
variance reduction##4##2##(1993-12#1)(2008-2#1)(2008-3#1)(2009-12#1)
variance revealed that##4##3##(2008-10#3)(2013-1#1)
variance revealed##7##2##(2004-11#1)(2008-10#3)(2009-11#1)(2012-3#1)(2013-1#1)
variance tests##2##2##(2008-10#1)(2011-2#1)
variance than##2##2##(1994-10#1)(2009-3#1)
variance that##3##2##(2008-10#1)(2010-3#1)(2010-6#1)
variance to the##2##3##(2008-10#1)(2009-9#1)
variance to##7##2##(1994-6#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2009-7#1)(2009-9#1)
variance was##13##2##(1991-2#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-6#2)(2009-9#1)(2013-1#2)
variance with the##5##3##(1995-6#1)(2008-10#1)(2009-6#1)(2010-2#1)(2013-8#1)
variance with##20##2##(1990-12#1)(1990-3#1)(1990-8#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-5#1)(1996-6#1)(2007-12#1)(2008-10#4)(2008-4#1)(2008-8#1)(2009-6#1)(2010-2#1)(2013-7#1)(2013-8#1)
variance##552##1##(1990-10#1)(1990-12#4)(1990-2#1)(1990-3#3)(1990-6#1)(1990-8#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-2#3)(1992-6#2)(1992-9#2)(1993-12#4)(1993-2#4)(1993-3#1)(1993-5#2)(1993-8#1)(1993-9#3)(1994-10#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#4)(1994-6#2)(1994-8#6)(1994-9#3)(1995-1#1)(1995-10#1)(1995-12#4)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#4)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#3)(1996-7#3)(1996-9#1)(1997-2#4)(1997-3#4)(1997-5#3)(1997-6#2)(2004-10#1)(2004-11#4)(2005-10#1)(2005-11#2)(2005-12#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-3#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#9)(2007-11#7)(2007-12#11)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#6)(2007-9#7)(2008-1#4)(2008-10#100)(2008-11#3)(2008-12#7)(2008-2#27)(2008-3#23)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#30)(2008-9#22)(2009-10#2)(2009-11#1)(2009-12#5)(2009-2#3)(2009-3#5)(2009-4#5)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#6)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#8)(2010-3#4)(2010-5#2)(2010-6#6)(2010-8#8)(2010-9#6)(2011-1#11)(2011-12#1)(2011-2#9)(2011-3#1)(2012-1#7)(2012-11#1)(2012-12#6)(2012-2#5)(2012-3#14)(2013-1#15)(2013-7#2)(2013-8#7)
variance)##8##1##(1997-2#1)(2006-9#1)(2007-10#1)(2008-10#2)(2008-3#2)(2008-8#1)
variance-covariance matrix##2##2##(2013-1#2)
variance-covariance##3##1##(2013-1#3)
variance-mean relationship##2##2##(2008-10#2)
variance-mean##3##1##(2008-10#3)
variance-to-mean##2##1##(2008-10#2)
variances and##2##2##(2008-8#1)(2013-1#1)
variances are##3##2##(1993-5#1)(2008-3#1)(2012-1#1)
variances as well as##2##4##(2008-2#1)(2008-7#1)
variances for##2##2##(2008-10#1)(2012-1#1)
variances in##6##2##(1992-2#1)(1994-9#1)(1995-7#1)(2006-2#1)(2008-11#1)(2008-9#1)
variances of##11##2##(1995-5#1)(1997-2#1)(2005-11#1)(2007-12#1)(2008-10#2)(2012-1#4)(2012-3#1)
variances using##3##2##(2012-1#3)
variances were##3##2##(2008-10#1)(2010-3#1)(2013-8#1)
variances##69##1##(1992-2#1)(1993-5#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-12#4)(1995-2#1)(1995-5#1)(1995-6#2)(1995-7#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#13)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-2#2)(2010-3#1)(2010-6#2)(2010-7#1)(2011-2#1)(2012-1#12)(2012-3#4)(2013-1#1)(2013-8#1)
varians##6##1##(2007-12#2)(2013-7#4)
variant (Met352----Arg)##2##2##(1990-8#2)
variant A##9##2##(1991-9#1)(1992-12#7)(2009-10#1)
variant Creutzfeldt-Jakob disease##2##3##(1997-3#1)(2006-4#1)
variant Creutzfeldt-Jakob##4##2##(1997-3#1)(2006-4#1)(2007-9#2)
variant D19S433*7 allele was##2##4##(2010-9#2)
variant FVII##3##2##(1994-11#3)
variant Na(V) 1##2##3##(2013-1#2)
variant allele##9##2##(1997-2#1)(2007-2#3)(2010-9#1)(2011-2#1)(2012-12#2)(2012-3#1)
variant alleles##6##2##(2008-10#1)(2008-4#1)(2010-2#3)(2010-9#1)
variant anatomy##3##2##(2011-2#1)(2013-1#2)
variant and normal##2##3##(1994-11#1)(1994-12#1)
variant and##11##2##(1990-7#1)(1994-11#1)(1994-12#1)(1997-7#1)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
variant associated with##2##3##(2007-12#1)(2013-1#1)
variant at##2##2##(1991-10#1)(2008-10#1)
variant cDNA for the##2##4##(1991-10#2)
variant cells##3##2##(1992-9#2)(1996-2#1)
variant data##9##2##(2010-8#1)(2012-3#8)
variant exhibited##2##2##(1990-8#1)(1994-12#1)
variant for##2##2##(1993-11#1)(2012-11#1)
variant form of the##4##4##(1991-10#1)(1996-12#1)(1996-2#1)(2009-10#1)
variant form of##7##3##(1991-10#1)(1991-3#1)(1992-6#1)(1996-12#1)(1996-2#1)(2005-8#1)(2009-10#1)
variant form##8##2##(1991-10#1)(1991-3#1)(1992-6#1)(1994-8#1)(1996-12#1)(1996-2#1)(2005-8#1)(2009-10#1)
variant forms of human##2##4##(1994-12#1)(1995-3#1)
variant forms of##4##3##(1994-12#1)(1995-3#1)(2008-3#1)(2008-7#1)
variant fractional##2##2##(2007-12#1)(2008-3#1)
variant genes##3##2##(2011-2#3)
variant genotypes##5##2##(2008-8#1)(2012-3#4)
variant had##4##2##(1992-9#1)(1993-8#1)(1994-11#1)(2012-3#1)
variant has a##2##3##(1991-12#1)(1994-12#1)
variant has been##3##3##(1991-12#1)(1993-8#1)(2011-2#1)
variant has##6##2##(1991-12#2)(1993-8#1)(1994-11#1)(1994-12#1)(2011-2#1)
variant hepatic##2##2##(2012-2#2)
variant human##2##2##(1993-4#1)(1994-11#1)
variant hypothesis##3##2##(2012-3#3)
variant in the##4##3##(1990-11#1)(2004-10#1)(2008-7#1)(2010-9#1)
variant in##16##2##(1990-11#1)(1990-7#1)(1992-2#1)(1992-8#1)(1992-9#1)(1994-12#1)(1994-8#2)(1996-11#1)(1996-3#1)(2004-10#1)(2007-6#1)(2008-2#1)(2008-7#1)(2010-9#1)(2012-3#1)
variant is a##2##3##(1997-5#1)(2009-10#1)
variant is associated with##3##4##(2010-12#1)(2012-12#1)(2012-2#1)
variant is##9##2##(1995-5#1)(1997-5#1)(2008-10#1)(2008-5#1)(2009-10#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
variant isolates##3##2##(2008-10#3)
variant lines##2##2##(2008-8#2)
variant number##2##2##(2008-8#1)(2008-9#1)
variant of 3beta-HSD deficiency CAH##2##5##(2008-4#2)
variant of Bartter syndrome##2##4##(2007-7#2)
variant of Cantrell's pentalogy?##2##4##(2009-6#2)
variant of GGCX##4##3##(2009-4#4)
variant of PPV HC-Pro##2##4##(2008-10#2)
variant of Wegener's granulomatosis##3##4##(2010-11#3)
variant of a##2##3##(2007-2#1)(2012-3#1)
variant of bovine pancreatic trypsin inhibitor##2##6##(1997-2#1)(1997-5#1)
variant of breast##2##3##(2005-12#1)(2007-11#1)
variant of cloacal exstrophy##2##4##(2006-12#1)(2008-10#1)
variant of glaucoma##3##3##(2012-3#3)
variant of green fluorescent protein##2##5##(2008-1#1)(2008-11#1)
variant of lichen planopilaris##2##4##(2005-11#1)(2010-12#1)
variant of renal cell carcinoma##2##5##(2007-2#1)(2010-12#1)
variant of serous cystadenoma of the pancreas##3##7##(2012-2#3)
variant of serous cystadenoma##4##4##(2012-2#4)
variant of squamous cell carcinoma##2##5##(2008-9#1)(2009-5#1)
variant of the gene##2##4##(1996-10#1)(2009-4#1)
variant of the human##5##4##(1994-12#2)(1996-5#1)(2006-9#2)
variant of the##39##3##(1990-10#1)(1992-10#1)(1992-2#1)(1992-7#1)(1994-12#2)(1994-5#1)(1994-6#1)(1995-1#1)(1995-11#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-1#1)(1997-4#1)(2005-8#1)(2006-12#1)(2006-9#2)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
variant of this##4##3##(1997-1#1)(2008-12#1)(2011-2#1)(2012-11#1)
variant of urothelial carcinoma##2##4##(2012-2#2)
variant of##174##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#2)(1990-7#2)(1991-12#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#3)(1992-4#1)(1992-7#2)(1993-6#1)(1993-7#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#2)(1995-1#1)(1995-11#2)(1995-2#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#3)(1996-5#3)(1997-1#3)(1997-2#1)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#2)(2004-2#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-8#1)(2006-10#3)(2006-12#3)(2006-7#2)(2006-9#2)(2007-10#1)(2007-11#2)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#1)(2008-1#3)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#3)(2009-4#7)(2009-5#2)(2009-6#2)(2009-8#2)(2010-10#1)(2010-11#3)(2010-12#4)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#8)(2012-3#4)(2013-1#5)(2013-8#2)
variant on##3##2##(2005-9#1)(2008-9#1)(2012-3#1)
variant protein##2##2##(1993-4#1)(1995-8#1)
variant that##4##2##(1994-8#1)(1997-7#1)(2005-10#1)(2010-6#1)
variant to##2##2##(1992-11#1)(2008-7#1)
variant was found##3##3##(1990-11#1)(2004-10#1)(2011-1#1)
variant was not##4##3##(1992-2#1)(2004-10#2)(2010-12#1)
variant was##16##2##(1990-11#1)(1992-2#1)(1992-3#1)(1992-9#1)(1994-11#1)(1994-3#1)(1996-3#1)(2004-10#3)(2009-3#1)(2010-12#2)(2010-2#1)(2011-1#1)(2012-3#1)
variant which##3##2##(1990-11#1)(1997-7#1)(2013-8#1)
variant with different##2##3##(1990-8#1)(2008-9#1)
variant with##8##2##(1990-8#2)(1991-2#1)(1994-3#1)(1995-6#1)(1996-5#1)(2008-9#1)(2012-2#1)
variant##619##1##(1990-10#2)(1990-11#5)(1990-12#1)(1990-4#3)(1990-5#2)(1990-6#2)(1990-7#5)(1990-8#10)(1991-10#5)(1991-11#1)(1991-12#13)(1991-2#1)(1991-3#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-10#3)(1992-11#2)(1992-12#10)(1992-2#10)(1992-3#4)(1992-4#2)(1992-6#4)(1992-7#3)(1992-8#3)(1992-9#7)(1993-11#3)(1993-12#2)(1993-3#4)(1993-4#4)(1993-6#3)(1993-7#3)(1993-8#4)(1994-1#2)(1994-11#11)(1994-12#13)(1994-2#5)(1994-3#4)(1994-5#1)(1994-6#2)(1994-8#5)(1995-1#2)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#2)(1995-8#7)(1995-9#1)(1996-10#1)(1996-11#5)(1996-12#3)(1996-2#3)(1996-3#5)(1996-4#2)(1996-5#11)(1996-7#1)(1997-1#3)(1997-2#4)(1997-3#1)(1997-4#1)(1997-5#4)(1997-6#1)(1997-7#8)(1997-8#1)(2004-10#6)(2004-2#1)(2005-10#2)(2005-11#2)(2005-12#2)(2005-5#1)(2005-8#4)(2005-9#2)(2006-10#4)(2006-11#1)(2006-12#4)(2006-2#1)(2006-4#1)(2006-7#2)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#5)(2007-5#1)(2007-6#2)(2007-7#7)(2007-8#4)(2007-9#3)(2008-1#3)(2008-10#22)(2008-11#3)(2008-12#4)(2008-2#2)(2008-3#6)(2008-4#9)(2008-5#9)(2008-6#4)(2008-7#7)(2008-8#12)(2008-9#10)(2009-10#7)(2009-12#1)(2009-3#3)(2009-4#9)(2009-5#3)(2009-6#2)(2009-8#4)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#13)(2010-2#8)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#5)(2011-1#8)(2011-11#1)(2011-2#19)(2012-1#3)(2012-11#3)(2012-12#9)(2012-2#15)(2012-3#64)(2013-1#18)(2013-7#2)(2013-8#4)
variant)##2##1##(1995-5#1)(2008-10#1)
variants and common##3##3##(2012-3#3)
variants and isoforms##2##3##(1997-2#2)
variants and their association with##2##5##(2009-3#1)(2012-3#1)
variants and their##3##3##(2009-11#1)(2009-3#1)(2012-3#1)
variants and to##2##3##(1994-2#1)(2012-3#1)
variants and##39##2##(1991-7#1)(1992-9#2)(1994-2#1)(1994-6#1)(1996-4#1)(1996-8#2)(1997-2#2)(2006-6#1)(2008-10#2)(2009-11#2)(2009-3#2)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#3)(2012-3#15)
variants are enriched in##2##4##(2012-3#2)
variants are involved in##2##4##(1997-1#1)(2012-3#1)
variants are not##2##3##(2012-3#2)
variants are presented##2##3##(1996-9#1)(2012-2#1)
variants are##27##2##(1992-9#1)(1996-9#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-6#1)(2009-4#1)(2012-12#1)(2012-2#2)(2012-3#15)(2013-1#1)
variants as##4##2##(1991-4#1)(1994-3#1)(1995-6#1)(1995-8#1)
variants associated with##10##3##(2012-3#9)(2013-8#1)
variants at the##3##3##(2012-3#3)
variants at##8##2##(1990-7#1)(1993-9#1)(2008-12#1)(2012-2#1)(2012-3#4)
variants based on##4##3##(2008-10#2)(2012-3#2)
variants by##8##2##(1992-7#1)(1994-2#1)(1995-6#1)(2008-9#1)(2012-3#4)
variants can##8##2##(2008-3#1)(2008-9#1)(2009-2#1)(2012-2#1)(2012-3#3)(2013-1#1)
variants compared to##2##3##(2009-3#1)(2012-3#1)
variants could##2##2##(1992-6#1)(2012-3#1)
variants differ##2##2##(1990-6#2)
variants for the##2##3##(1991-12#1)(1991-8#1)
variants for##6##2##(1991-12#1)(1991-8#1)(2008-8#1)(2012-3#3)
variants from##5##2##(1992-2#1)(2008-4#2)(2012-3#2)
variants has been##2##3##(1997-2#1)(2007-6#1)
variants has##3##2##(1997-2#1)(2007-6#1)(2012-3#1)
variants have been##8##3##(2008-4#1)(2008-7#1)(2008-9#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
variants have##16##2##(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#2)(2012-11#1)(2012-2#1)(2012-3#7)(2013-1#1)
variants in a##4##3##(2012-3#4)
variants in all##2##3##(1992-10#1)(1993-5#1)
variants in an##2##3##(1991-12#1)(2012-3#1)
variants in genome-wide association studies##2##5##(2012-3#2)
variants in human##2##3##(2010-12#1)(2012-2#1)
variants in the calmodulin-binding domain of RC3/neurogranin##2##7##(1996-11#2)
variants in the data##3##4##(2012-3#3)
variants in the nicotinic receptor genes CHRNA5(rs16969968) and CHRNA3(rs3743078)##2##9##(2010-9#2)
variants in the##16##3##(1996-11#2)(2008-7#1)(2009-4#1)(2010-9#2)(2011-2#1)(2012-3#8)(2013-1#1)
variants in this##2##3##(1992-9#1)(2009-5#1)
variants in which##4##3##(1990-2#1)(1996-5#1)(1997-2#1)(1997-4#1)
variants in##83##2##(1990-2#1)(1991-12#3)(1992-10#1)(1992-9#1)(1993-5#1)(1994-12#1)(1994-8#1)(1996-11#3)(1996-3#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-4#3)(2008-7#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-1#2)(2010-12#3)(2010-2#1)(2010-4#1)(2010-9#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#30)(2013-1#6)(2013-7#1)
variants into a##2##3##(2012-3#2)
variants into##4##2##(2012-3#4)
variants is##7##2##(1990-2#1)(1991-12#1)(1997-7#1)(2010-1#1)(2010-2#1)(2012-3#2)
variants leads to an##2##4##(1994-2#1)(1995-6#1)
variants may be##2##3##(1995-2#1)(2008-12#1)
variants may have a##2##4##(2008-9#1)(2013-1#1)
variants may##11##2##(1992-10#1)(1995-2#1)(2007-11#1)(2008-12#1)(2008-9#1)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#1)
variants of Forsyth's gamut-mapping method##2##5##(2008-2#2)
variants of a##3##3##(1990-7#1)(1991-5#1)(2008-4#1)
variants of cytochrome##2##3##(1990-5#1)(1997-2#1)
variants of human T-lymphoblastoid CCRF-CEM##2##5##(1991-9#2)
variants of human trace amine-associated receptor 5##2##7##(2012-2#2)
variants of human##9##3##(1991-8#1)(1991-9#2)(1994-12#1)(1996-8#1)(1997-9#1)(2006-12#1)(2012-2#2)
variants of satellite tobacco mosaic virus##2##6##(2008-10#2)
variants of the anterosuperior glenoid labrum##2##6##(2009-3#2)
variants of the##37##3##(1990-11#1)(1990-7#1)(1992-1#1)(1992-4#1)(1992-6#1)(1992-7#2)(1993-3#1)(1993-9#1)(1994-10#1)(1996-11#1)(1996-3#1)(1996-7#2)(1996-8#1)(1997-3#1)(1997-7#1)(2005-9#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-3#2)(2009-4#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-7#1)
variants of this##4##3##(1990-4#1)(2008-3#1)(2008-9#1)(2011-1#1)
variants of transthyretin##2##3##(1990-6#2)
variants of##116##2##(1990-11#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-4#1)(1992-6#2)(1992-7#2)(1992-9#1)(1993-3#1)(1993-9#2)(1994-10#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-7#2)(1996-8#4)(1996-9#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-9#1)(2004-10#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-9#2)(2007-11#2)(2007-8#3)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#2)(2009-4#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-2#2)(2013-1#4)(2013-7#1)
variants on##7##2##(2009-12#1)(2009-7#1)(2012-2#1)(2012-3#4)
variants or##7##2##(1990-11#1)(2006-3#1)(2008-7#1)(2012-3#3)(2013-8#1)
variants play a##2##3##(1997-7#1)(2011-2#1)
variants required##2##2##(2012-3#2)
variants reveals##2##2##(1994-11#1)(1996-12#1)
variants showed##3##2##(1992-2#1)(1993-7#1)(2012-3#1)
variants tested##2##2##(2008-11#1)(2011-1#1)
variants that are responsible for##3##5##(2009-5#1)(2012-3#2)
variants that are##4##3##(2009-5#1)(2012-3#3)
variants that contribute to##4##4##(2012-3#4)
variants that differ##2##3##(1996-9#1)(2008-10#1)
variants that may##3##3##(2008-10#1)(2012-3#2)
variants that were##3##3##(2012-3#2)(2013-1#1)
variants that##30##2##(1992-12#1)(1996-2#1)(1996-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2009-11#1)(2009-5#1)(2011-1#1)(2012-3#18)(2013-1#1)
variants to##5##2##(1996-11#1)(2005-11#1)(2006-11#1)(2008-10#1)(2012-3#1)
variants using##11##2##(2012-3#11)
variants was##7##2##(1990-7#2)(1997-3#1)(2008-11#1)(2008-5#1)(2009-3#1)(2010-12#1)
variants were characterized##2##3##(1994-2#1)(2008-6#1)
variants were classified as##2##4##(2009-3#1)(2012-3#1)
variants were collapsed##3##3##(2012-3#3)
variants were genotyped in##2##4##(2004-10#1)(2009-4#1)
variants were identified##2##3##(1996-5#1)(2013-1#1)
variants were more##2##3##(1991-2#1)(2013-8#1)
variants were purified##2##3##(1992-2#1)(2012-2#1)
variants were##34##2##(1990-4#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#2)(1996-11#1)(1996-5#1)(2004-10#1)(2008-10#3)(2008-3#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#5)(2013-1#1)(2013-8#1)
variants with a##2##3##(2008-10#1)(2011-1#1)
variants with increased##2##3##(2008-8#1)(2013-1#1)
variants with##25##2##(1992-6#1)(1995-12#1)(1996-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#3)(2008-9#1)(2009-3#2)(2009-9#1)(2010-12#2)(2011-1#1)(2011-3#1)(2012-3#7)(2013-1#1)
variants within a##3##3##(2008-10#1)(2012-3#2)
variants within##8##2##(2008-10#1)(2009-4#1)(2012-3#6)
variants##809##1##(1990-11#2)(1990-2#3)(1990-4#3)(1990-5#1)(1990-6#8)(1990-7#6)(1990-8#1)(1991-10#4)(1991-11#1)(1991-12#6)(1991-2#2)(1991-4#3)(1991-5#3)(1991-6#1)(1991-7#3)(1991-8#7)(1991-9#5)(1992-1#1)(1992-10#3)(1992-12#1)(1992-2#5)(1992-4#2)(1992-6#4)(1992-7#5)(1992-9#8)(1993-3#1)(1993-5#1)(1993-6#3)(1993-7#1)(1993-9#5)(1994-10#2)(1994-11#5)(1994-12#7)(1994-2#8)(1994-3#6)(1994-6#3)(1994-8#6)(1994-9#2)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#5)(1995-7#1)(1995-8#3)(1996-11#8)(1996-12#2)(1996-2#1)(1996-3#6)(1996-4#4)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#7)(1996-9#3)(1997-1#7)(1997-2#7)(1997-3#2)(1997-4#2)(1997-7#3)(1997-9#1)(2004-10#2)(2005-10#1)(2005-11#2)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#2)(2007-10#1)(2007-11#6)(2007-12#1)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#43)(2008-11#9)(2008-12#3)(2008-2#4)(2008-3#5)(2008-4#11)(2008-5#4)(2008-6#8)(2008-7#8)(2008-8#9)(2008-9#13)(2009-10#2)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#11)(2009-4#6)(2009-5#2)(2009-6#2)(2009-7#1)(2009-9#1)(2010-1#5)(2010-12#13)(2010-2#6)(2010-3#2)(2010-4#4)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#5)(2011-1#9)(2011-2#12)(2011-3#1)(2012-1#7)(2012-11#1)(2012-12#8)(2012-2#19)(2012-3#274)(2013-1#26)(2013-7#2)(2013-8#6)
variants)##4##1##(1996-3#2)(2007-12#1)(2012-3#1)
variate##4##1##(2007-1#1)(2008-10#1)(2008-4#1)(2013-7#1)
variates##4##1##(1992-12#1)(1992-9#1)(2008-10#2)
variation &lt##5##2##(2008-10#3)(2008-7#2)
variation (CNV)##4##2##(1995-6#1)(1996-1#1)(2008-5#1)(2009-5#1)
variation Dkappa##2##2##(2008-3#2)
variation across the##2##3##(1995-8#1)(2005-11#1)
variation across##7##2##(1994-12#1)(1994-3#1)(1995-8#1)(2005-11#1)(2008-3#1)(2008-9#1)(2012-3#1)
variation along##3##2##(2008-3#3)
variation among different##2##3##(1997-3#1)(2009-8#1)
variation among individual##2##3##(2008-7#1)(2010-8#1)
variation among strains was##2##4##(2008-10#2)
variation among strains##3##3##(2008-10#3)
variation among the strains##2##4##(1991-4#1)(2005-11#1)
variation among the##6##3##(1991-4#1)(1991-5#1)(1996-8#1)(2005-11#1)(2008-10#1)(2008-5#1)
variation among waggle runs##4##4##(2012-12#4)
variation among##52##2##(1991-4#1)(1991-5#1)(1994-2#1)(1994-5#2)(1995-5#1)(1996-12#1)(1996-8#1)(1997-3#1)(1997-9#1)(2004-10#1)(2005-10#2)(2005-11#1)(2006-5#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-12#2)(2008-2#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#5)
variation and effect of##2##4##(1997-2#1)(2008-10#1)
variation and population structure##2##4##(2008-10#1)(2012-11#1)
variation and population##3##3##(2007-12#1)(2008-10#1)(2012-11#1)
variation and the##7##3##(1994-3#1)(2006-5#1)(2008-10#1)(2008-2#2)(2008-8#1)(2013-8#1)
variation and variation in##2##4##(2008-10#2)
variation and##70##2##(1992-12#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-6#2)(1996-8#1)(1997-2#1)(2005-11#2)(2006-1#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#13)(2008-11#2)(2008-2#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#7)(2009-5#2)(2009-7#1)(2010-1#1)(2010-2#2)(2010-3#2)(2010-5#1)(2010-8#2)(2011-2#1)(2012-11#1)(2012-2#2)(2012-3#1)(2012-6#1)(2012-9#1)(2013-1#2)(2013-8#2)
variation appears##2##2##(1990-5#1)(2008-10#1)
variation are##7##2##(1991-2#1)(1996-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-2#1)(2011-1#1)
variation as a function of##2##5##(2008-5#1)(2012-2#1)
variation as well as##3##4##(2008-11#1)(2008-8#1)(2009-7#1)
variation as##7##2##(1994-4#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-7#1)(2012-2#1)(2013-1#1)
variation associated with##7##3##(1995-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-5#1)(2012-1#1)
variation at concentrations##2##3##(1996-6#1)(2008-2#1)
variation at the##3##3##(1994-3#1)(2009-12#1)(2010-10#1)
variation at##25##2##(1991-1#2)(1993-2#1)(1994-3#2)(1996-6#1)(1997-4#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-5#1)(2012-3#3)(2013-1#1)
variation between 1##2##3##(2008-10#1)(2012-2#1)
variation between individuals##2##3##(1990-7#1)(2009-7#1)
variation between the##4##3##(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)
variation between##33##2##(1990-7#1)(1991-10#1)(1991-9#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-9#1)(1996-11#1)(1996-2#1)(2006-8#1)(2007-1#1)(2007-12#1)(2008-10#7)(2008-3#1)(2008-5#3)(2008-6#1)(2009-7#2)(2009-8#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
variation both within##2##3##(2008-5#1)(2012-3#1)
variation by##6##2##(1994-12#1)(1996-6#1)(2008-10#2)(2008-8#1)(2011-1#1)
variation can be##3##3##(2008-3#1)(2008-8#2)
variation can##8##2##(1993-3#1)(1993-5#1)(2006-1#1)(2008-12#1)(2008-3#1)(2008-8#2)(2009-9#1)
variation characteristics of##2##3##(2011-12#1)(2013-8#1)
variation coefficient of the##2##4##(2008-10#2)
variation coefficient of##4##3##(1993-9#1)(2008-10#3)
variation coefficient were##3##3##(2008-10#3)
variation coefficient##11##2##(1992-1#2)(1993-9#1)(2008-10#8)
variation coefficients of##2##3##(2008-10#2)
variation coefficients##5##2##(1997-7#1)(2008-10#3)(2008-7#1)
variation compared to##2##3##(2008-8#1)(2009-2#1)
variation compared##3##2##(2008-10#1)(2008-8#1)(2009-2#1)
variation continues to##2##3##(1991-12#1)(1996-3#1)
variation depending on##2##3##(2008-10#1)(2010-5#1)
variation detected in##2##3##(2006-4#1)(2008-5#1)
variation detected##3##2##(2006-4#1)(2008-10#1)(2008-5#1)
variation does##2##2##(1990-2#1)(2008-5#1)
variation due to the##5##4##(1992-2#1)(2005-11#1)(2008-10#1)(2010-12#1)(2011-1#1)
variation due to##8##3##(1992-2#1)(2005-11#1)(2008-10#2)(2008-2#1)(2009-5#1)(2010-12#1)(2011-1#1)
variation during the##2##3##(2006-10#1)(2007-8#1)
variation during##6##2##(1995-9#1)(1997-4#1)(2006-10#1)(2007-8#1)(2008-3#1)(2012-2#1)
variation episodes##3##2##(2011-1#3)
variation exists##6##2##(1990-5#1)(1996-12#1)(2007-10#1)(2008-10#1)(2008-3#1)(2009-9#1)
variation for components of aggressiveness##2##5##(2008-10#2)
variation for resistance in##5##4##(2008-10#5)
variation for resistance to##2##4##(2008-10#2)
variation for resistance##8##3##(2008-10#8)
variation for the##8##3##(1996-6#1)(1996-9#1)(2008-10#3)(2008-5#1)(2012-12#2)
variation for this##3##3##(1994-12#1)(1996-9#1)(2008-9#1)
variation for##51##2##(1990-2#1)(1990-6#1)(1991-8#1)(1992-12#1)(1993-8#1)(1994-12#2)(1994-3#1)(1996-3#1)(1996-6#1)(1996-9#2)(1997-3#1)(1997-8#2)(2004-11#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#23)(2008-5#2)(2008-9#3)(2012-12#2)(2012-2#1)(2012-3#1)
variation from the##2##3##(1995-8#1)(2010-7#1)
variation from##6##2##(1995-8#1)(1996-3#1)(2008-7#1)(2008-8#1)(2010-7#1)(2012-2#1)
variation has been##5##3##(2007-12#1)(2008-10#1)(2008-7#1)(2010-12#1)(2012-2#1)
variation has##6##2##(1997-6#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-12#1)(2012-2#1)
variation in Bragg wavelength##3##4##(2013-8#3)
variation in H##2##3##(2008-10#1)(2009-11#1)
variation in a population##2##4##(1993-11#1)(2009-2#1)
variation in a##10##3##(1991-3#1)(1993-11#1)(1995-3#1)(1997-8#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-2#1)(2012-11#1)
variation in aggressiveness##3##3##(1995-11#1)(2008-10#2)
variation in an##2##3##(1993-1#1)(2008-3#1)
variation in body size and##5##5##(2008-9#1)(2009-2#1)(2010-3#1)(2010-8#1)(2013-7#1)
variation in body##6##3##(2008-9#1)(2009-2#1)(2010-3#1)(2010-8#1)(2013-7#2)
variation in both##4##3##(1991-4#1)(2008-4#1)(2008-5#1)(2009-4#1)
variation in brain##2##3##(1991-9#1)(2004-3#1)
variation in cancer##4##3##(2008-10#1)(2009-9#1)(2012-1#2)
variation in cell size##2##4##(2008-7#1)(2013-1#1)
variation in cell##3##3##(2007-7#1)(2008-7#1)(2013-1#1)
variation in clinical practice##2##4##(1991-9#1)(2006-10#1)
variation in clinical##4##3##(1991-9#1)(2006-10#1)(2007-7#1)(2008-5#1)
variation in competitive##2##3##(2008-8#1)(2008-9#1)
variation in condition##2##3##(2010-8#2)
variation in disease severity##3##4##(2008-10#3)
variation in disease##6##3##(2008-10#6)
variation in egg size##4##4##(2008-8#4)
variation in epicuticular##2##3##(2008-8#2)
variation in fitness##4##3##(2008-8#4)
variation in genetic##2##3##(2008-10#1)(2011-2#1)
variation in glucose homeostasis##2##4##(2008-1#2)
variation in growth rate##2##4##(2007-1#1)(2008-8#1)
variation in growth##5##3##(2007-1#1)(2007-11#1)(2008-8#2)(2010-8#1)
variation in health care utilization and##2##6##(2007-10#2)
variation in health care##3##4##(2007-10#2)(2008-1#1)
variation in health##5##3##(2007-10#2)(2008-1#1)(2008-7#1)(2009-4#1)
variation in hospital##2##3##(1992-12#1)(1994-5#1)
variation in host##2##3##(2008-10#1)(2008-9#1)
variation in human##2##3##(1992-11#1)(2006-1#1)
variation in individual##2##3##(1996-2#1)(2008-8#1)
variation in its##2##3##(2004-10#1)(2008-2#1)
variation in larval growth##2##4##(2007-5#2)
variation in larval##5##3##(1995-2#1)(2007-5#2)(2007-6#1)(2008-9#1)
variation in level##2##3##(1990-5#1)(1996-3#1)
variation in levels of##4##4##(1992-3#1)(1993-10#1)(1993-11#1)(2009-6#1)
variation in male##2##3##(2007-12#1)(2012-3#1)
variation in mammary thermography##2##4##(1990-2#2)
variation in meat quality##2##4##(2010-4#2)
variation in mechanical##2##3##(2013-1#1)(2013-8#1)
variation in mortality##2##3##(1994-5#1)(2013-8#1)
variation in number of Bs##2##5##(2008-5#2)
variation in one##2##3##(2008-12#1)(2008-8#1)
variation in parasitic fitness##2##4##(2008-10#2)
variation in patch density##2##4##(2008-8#2)
variation in patch##4##3##(2008-8#3)(2008-9#1)
variation in pathogenicity##3##3##(2008-10#3)
variation in patients##2##3##(2013-8#2)
variation in phenotypic##3##3##(2008-10#1)(2012-1#1)(2013-1#1)
variation in plasma##3##3##(1995-7#1)(1997-4#2)
variation in population density##4##4##(2008-8#2)(2013-1#2)
variation in population##7##3##(2008-8#3)(2008-9#1)(2012-3#1)(2013-1#2)
variation in presentation##2##3##(2009-10#1)(2012-2#1)
variation in quantitative traits##2##4##(2008-8#1)(2009-2#1)
variation in rectal and bladder doses##2##6##(2009-11#2)
variation in resistance##3##3##(2006-10#1)(2008-10#1)(2011-2#1)
variation in response to##3##4##(2005-10#1)(2010-12#2)
variation in response##4##3##(2005-10#1)(2008-10#1)(2010-12#2)
variation in risk##2##3##(1991-12#1)(1993-11#1)
variation in seed##2##3##(2007-3#1)(2008-9#1)
variation in selection##2##3##(2010-3#1)(2013-1#1)
variation in sensitivity##2##3##(1990-5#1)(2008-10#1)
variation in several##3##3##(1995-3#1)(2008-1#1)(2010-4#1)
variation in sex##2##3##(2008-8#2)
variation in skin surface##2##4##(2008-5#2)
variation in soil##2##3##(2008-10#1)(2013-7#1)
variation in species richness##4##4##(2008-8#4)
variation in species##5##3##(2008-5#1)(2008-8#4)
variation in the elastic anisotropy##2##5##(2009-7#2)
variation in the environment##3##4##(2008-10#1)(2012-3#1)(2013-1#1)
variation in the extent##2##4##(2006-5#1)(2008-7#1)
variation in the inhibitory##2##4##(1995-11#1)(1996-9#1)
variation in the magnitude and##2##5##(2009-7#1)(2010-8#1)
variation in the magnitude##3##4##(2006-10#1)(2009-7#1)(2010-8#1)
variation in the prevalence of##3##5##(1991-11#1)(2007-2#1)(2008-8#1)
variation in the relationship between the##2##6##(2007-3#1)(2008-10#1)
variation in the relationship between##3##5##(2007-3#1)(2008-10#1)(2010-2#1)
variation in the relative##2##4##(2007-12#1)(2008-2#1)
variation in the sensitivity##2##4##(2007-12#1)(2008-2#1)
variation in the##140##3##(1990-1#1)(1990-2#1)(1990-4#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-4#1)(1995-9#1)(1996-9#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-3#1)(2006-5#2)(2006-8#1)(2007-11#1)(2007-12#6)(2007-2#4)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#7)(2008-9#2)(2009-12#2)(2009-5#2)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-2#2)(2010-4#1)(2010-8#8)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#3)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#3)
variation in their##7##3##(1990-9#1)(1994-5#1)(1996-8#1)(1997-2#1)(2008-9#1)(2010-12#1)(2013-8#1)
variation in these##2##3##(1992-3#1)(2008-8#1)
variation in thickness of the##2##5##(2008-3#2)
variation in this region##2##4##(1991-12#1)(2008-10#1)
variation in this##3##3##(1991-12#1)(2008-10#1)(2008-9#1)
variation in time##4##3##(1996-12#1)(2008-10#1)(2008-9#1)(2013-1#1)
variation in urinary cytokine levels in##2##6##(1996-12#2)
variation in virulence and##2##4##(1991-8#1)(2008-10#1)
variation in virulence##4##3##(1991-8#1)(2008-10#3)
variation in virus titer##2##4##(1994-8#2)
variation in##677##2##(1990-1#2)(1990-12#3)(1990-2#3)(1990-4#1)(1990-5#3)(1990-7#1)(1990-8#1)(1990-9#3)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#4)(1991-7#1)(1991-8#3)(1991-9#2)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#3)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#5)(1993-12#1)(1993-2#3)(1993-3#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#5)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-11#4)(1995-12#2)(1995-2#3)(1995-3#2)(1995-4#2)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#5)(1995-9#2)(1996-1#1)(1996-12#5)(1996-2#1)(1996-3#2)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#4)(1997-5#1)(1997-7#3)(1997-8#3)(2004-10#1)(2004-11#2)(2004-2#1)(2004-3#1)(2005-10#3)(2005-11#2)(2005-8#1)(2006-1#1)(2006-10#6)(2006-12#2)(2006-3#3)(2006-5#5)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#3)(2007-10#5)(2007-11#5)(2007-12#14)(2007-2#5)(2007-3#6)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#7)(2008-10#75)(2008-11#11)(2008-12#11)(2008-2#13)(2008-3#15)(2008-4#3)(2008-5#14)(2008-6#4)(2008-7#11)(2008-8#66)(2008-9#20)(2009-10#2)(2009-11#3)(2009-12#5)(2009-2#6)(2009-4#4)(2009-5#4)(2009-6#2)(2009-7#8)(2009-8#3)(2009-9#5)(2010-1#3)(2010-10#3)(2010-11#1)(2010-12#5)(2010-2#4)(2010-3#7)(2010-4#6)(2010-7#1)(2010-8#26)(2010-9#2)(2011-1#9)(2011-12#2)(2011-2#15)(2011-3#2)(2012-1#7)(2012-11#2)(2012-12#6)(2012-2#7)(2012-3#19)(2013-1#26)(2013-7#5)(2013-8#12)
variation influences##3##2##(2010-12#1)(2011-2#1)(2012-3#1)
variation into##3##2##(2008-10#1)(2012-12#1)(2012-3#1)
variation is essential##2##3##(2008-10#1)(2008-7#1)
variation is found##2##3##(2008-1#1)(2011-2#1)
variation is not##2##3##(1992-5#1)(2008-5#1)
variation is very##2##3##(2008-7#1)(2011-12#1)
variation is##42##2##(1990-10#1)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#1)(1992-3#1)(1992-4#1)(1992-5#1)(1994-9#1)(1995-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(2006-1#1)(2006-9#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
variation limits##2##2##(2007-10#1)(2007-12#1)
variation makes##2##2##(1995-9#1)(2012-2#1)
variation may##5##2##(2008-12#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-5#1)
variation method##3##2##(1992-7#1)(2008-10#2)
variation not##2##2##(1995-11#1)(2010-5#1)
variation observed in the##2##4##(1990-4#1)(2010-3#1)
variation observed in##6##3##(1990-4#1)(1995-3#1)(2005-10#1)(2010-3#1)(2010-7#1)(2012-1#1)
variation observed##13##2##(1990-4#1)(1995-3#1)(2004-11#1)(2005-10#1)(2008-10#3)(2009-12#1)(2010-3#1)(2010-7#1)(2010-8#2)(2012-1#1)
variation of DNA##2##3##(1991-7#1)(1992-11#1)
variation of a quantitative trait##2##5##(2012-3#2)
variation of a##7##3##(1996-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-5#1)(2012-3#2)
variation of both##2##3##(2006-10#1)(2012-1#1)
variation of different##2##3##(2011-3#1)(2013-1#1)
variation of influenza##2##3##(2013-8#2)
variation of leaf##2##3##(2011-10#1)(2012-5#1)
variation of less than##3##4##(1996-11#1)(2008-10#1)(2008-2#1)
variation of one##2##3##(2008-3#1)(2009-10#1)
variation of rDNA##2##3##(2008-5#2)
variation of results##2##3##(2008-12#1)(2010-8#1)
variation of the assay##2##4##(1997-8#1)(2008-10#1)
variation of the light##6##4##(2008-10#1)(2008-2#2)(2008-3#3)
variation of the mean##2##4##(2008-10#1)(2008-2#1)
variation of the pH##2##4##(2008-10#2)
variation of the relative##2##4##(2008-3#2)
variation of the source##2##4##(2008-3#2)
variation of the spectral##2##4##(2008-2#2)
variation of the##136##3##(1990-2#1)(1990-8#2)(1990-9#2)(1991-9#1)(1992-11#1)(1993-1#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-9#1)(1995-3#1)(1995-9#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-5#1)(1997-7#1)(1997-8#2)(2005-11#3)(2007-12#15)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#19)(2008-12#1)(2008-2#19)(2008-3#20)(2008-5#6)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#4)
variation of these##5##3##(2007-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2012-1#1)
variation of this##2##3##(1996-6#1)(2008-3#1)
variation of##339##2##(1990-11#2)(1990-2#1)(1990-6#1)(1990-8#3)(1990-9#2)(1991-10#1)(1991-11#1)(1991-7#1)(1991-9#1)(1992-11#4)(1992-12#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-9#2)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-4#1)(2004-9#1)(2005-11#5)(2006-1#1)(2006-10#1)(2006-12#1)(2006-6#2)(2006-7#1)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#4)(2007-12#20)(2007-2#1)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#8)(2008-1#1)(2008-10#52)(2008-11#1)(2008-12#3)(2008-2#34)(2008-3#33)(2008-4#1)(2008-5#15)(2008-7#3)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#3)(2011-10#1)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#4)(2012-2#7)(2012-3#4)(2012-5#2)(2013-1#7)(2013-7#5)(2013-8#11)
variation often##2##2##(1991-9#1)(2008-12#1)
variation on the##5##3##(1990-11#1)(1991-4#1)(2012-2#1)(2013-8#2)
variation on##13##2##(1990-11#1)(1991-4#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2009-2#1)(2012-2#1)(2013-8#2)
variation or##4##2##(2008-9#1)(2010-11#1)(2010-5#1)(2012-2#1)
variation over all four campaigns##2##5##(2010-5#2)
variation over##4##2##(2008-3#1)(2010-5#2)(2010-8#1)
variation plays a##2##3##(2007-10#1)(2013-1#1)
variation plays##3##2##(2007-10#1)(2012-3#1)(2013-1#1)
variation present in the##2##4##(2006-12#1)(2010-4#1)
variation present##3##2##(1993-9#1)(2006-12#1)(2010-4#1)
variation remains##2##2##(1997-4#1)(2005-10#1)
variation resulting##2##2##(1997-3#1)(2008-3#1)
variation seems to##2##3##(1991-9#1)(2008-10#1)
variation showed##4##2##(1993-8#2)(2008-10#1)(2011-2#1)
variation shows##3##2##(1995-8#1)(2008-10#1)(2008-8#1)
variation than##6##2##(1991-11#1)(2007-12#1)(2008-5#1)(2008-8#2)(2009-2#1)
variation that is##5##3##(2006-1#1)(2008-2#1)(2008-4#1)(2010-4#1)(2012-3#1)
variation that##8##2##(2006-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)(2010-4#1)(2012-3#1)
variation through##2##2##(2006-12#1)(2010-7#1)
variation to##14##2##(1990-8#1)(1991-9#1)(1993-5#1)(1993-9#1)(1994-9#1)(2005-10#1)(2006-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-12#1)(2010-3#1)(2013-7#1)
variation under##3##2##(2008-2#1)(2012-3#2)
variation was 0##2##3##(2007-5#1)(2008-10#1)
variation was also##2##3##(1994-3#1)(2008-3#1)
variation was detected in the##2##5##(2006-5#1)(2010-2#1)
variation was detected##4##3##(2006-5#1)(2010-2#1)(2010-3#1)(2010-8#1)
variation was due to##2##4##(2008-10#2)
variation was found in the##4##5##(1997-7#1)(2007-1#1)(2012-3#1)(2013-7#1)
variation was found in##6##4##(1997-7#1)(2007-1#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
variation was found##11##3##(1994-5#1)(1997-7#1)(2007-1#1)(2008-10#3)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
variation was greatest##2##3##(2008-10#2)
variation was less than##5##4##(1994-9#1)(2007-8#1)(2008-3#2)(2012-12#1)
variation was less##6##3##(1994-9#1)(2005-11#1)(2007-8#1)(2008-3#2)(2012-12#1)
variation was observed in the##2##5##(1990-4#1)(2013-7#1)
variation was observed in##4##4##(1990-4#1)(2006-12#1)(2012-3#1)(2013-7#1)
variation was observed##13##3##(1990-4#1)(1996-1#1)(2006-12#1)(2006-3#1)(2008-10#2)(2009-3#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
variation was##78##2##(1990-2#1)(1990-4#1)(1991-8#1)(1992-8#1)(1993-11#1)(1994-3#3)(1994-5#2)(1994-9#1)(1996-1#1)(1996-8#1)(1997-2#1)(1997-7#1)(2004-2#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-1#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#23)(2008-12#1)(2008-3#4)(2008-5#2)(2009-3#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#3)
variation were##21##2##(1990-12#1)(1990-6#1)(1993-2#1)(1995-12#1)(1996-4#1)(1996-8#1)(1997-3#1)(2006-3#1)(2008-10#10)(2008-3#1)(2009-4#1)(2010-5#1)
variation while##2##2##(1991-9#1)(2008-2#1)
variation with a##2##3##(2007-10#1)(2008-10#1)
variation with temperature##2##3##(2007-11#1)(2007-3#1)
variation with the##2##3##(1990-6#1)(2010-5#1)
variation with##24##2##(1990-6#1)(1991-9#1)(1994-4#2)(1994-9#1)(1997-5#1)(2005-11#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-6#1)(2010-5#1)(2010-8#2)(2011-1#1)(2012-3#1)
variation within a##6##3##(2008-10#2)(2008-4#1)(2008-9#1)(2011-2#1)(2012-3#1)
variation within and among##2##4##(2008-10#2)
variation within and between##4##4##(1995-8#1)(2008-10#1)(2008-8#1)(2009-6#1)
variation within and##8##3##(1995-8#1)(2008-10#4)(2008-8#1)(2009-6#1)(2013-1#1)
variation within the population##2##4##(2008-8#1)(2012-3#1)
variation within the##8##3##(2008-10#3)(2008-12#1)(2008-8#1)(2010-2#1)(2010-3#1)(2012-3#1)
variation within##39##2##(1993-9#1)(1994-3#1)(1995-11#1)(1995-5#1)(1995-8#1)(2008-10#15)(2008-12#3)(2008-4#1)(2008-6#1)(2008-8#4)(2008-9#1)(2009-6#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
variation##2050##1##(1990-1#3)(1990-10#1)(1990-11#4)(1990-12#6)(1990-2#7)(1990-3#2)(1990-4#4)(1990-5#5)(1990-6#7)(1990-7#4)(1990-8#6)(1990-9#5)(1991-1#2)(1991-10#2)(1991-11#3)(1991-12#3)(1991-2#5)(1991-3#4)(1991-4#4)(1991-5#5)(1991-6#1)(1991-7#3)(1991-8#7)(1991-9#16)(1992-1#4)(1992-11#6)(1992-12#5)(1992-2#4)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#3)(1992-9#1)(1993-1#5)(1993-10#1)(1993-11#7)(1993-12#3)(1993-2#6)(1993-3#5)(1993-5#3)(1993-6#1)(1993-7#1)(1993-8#5)(1993-9#9)(1994-10#1)(1994-11#2)(1994-12#9)(1994-2#4)(1994-3#15)(1994-4#6)(1994-5#10)(1994-6#2)(1994-8#3)(1994-9#7)(1995-1#5)(1995-10#1)(1995-11#7)(1995-12#3)(1995-2#8)(1995-3#6)(1995-4#2)(1995-5#6)(1995-6#5)(1995-7#2)(1995-8#9)(1995-9#6)(1996-1#5)(1996-11#2)(1996-12#9)(1996-2#3)(1996-3#10)(1996-4#2)(1996-5#4)(1996-6#12)(1996-7#1)(1996-8#10)(1996-9#4)(1997-1#2)(1997-2#5)(1997-3#10)(1997-4#8)(1997-5#3)(1997-6#2)(1997-7#6)(1997-8#9)(1997-9#1)(2004-10#2)(2004-11#4)(2004-2#2)(2004-3#1)(2004-4#2)(2004-9#1)(2005-10#8)(2005-11#19)(2005-12#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-1#7)(2006-10#13)(2006-11#1)(2006-12#10)(2006-3#6)(2006-4#2)(2006-5#9)(2006-6#3)(2006-7#1)(2006-8#2)(2006-9#4)(2007-1#11)(2007-10#11)(2007-11#18)(2007-12#47)(2007-2#7)(2007-3#9)(2007-4#3)(2007-5#7)(2007-6#4)(2007-7#9)(2007-8#18)(2007-9#1)(2008-1#11)(2008-10#338)(2008-11#18)(2008-12#26)(2008-2#68)(2008-3#85)(2008-4#10)(2008-5#71)(2008-6#14)(2008-7#38)(2008-8#111)(2008-9#36)(2009-1#1)(2009-10#6)(2009-11#4)(2009-12#7)(2009-2#16)(2009-3#3)(2009-4#7)(2009-5#12)(2009-6#4)(2009-7#13)(2009-8#7)(2009-9#8)(2010-1#7)(2010-10#5)(2010-11#2)(2010-12#18)(2010-2#12)(2010-3#15)(2010-4#12)(2010-5#17)(2010-6#1)(2010-7#5)(2010-8#49)(2010-9#3)(2011-1#27)(2011-10#1)(2011-12#7)(2011-2#40)(2011-3#5)(2012-1#13)(2012-11#4)(2012-12#23)(2012-2#35)(2012-3#56)(2012-5#2)(2012-6#1)(2012-9#1)(2013-1#54)(2013-7#20)(2013-8#39)
variation) was##2##2##(1993-1#1)(1995-2#1)
variation)##6##1##(1991-5#1)(1993-1#1)(1995-2#1)(2007-11#1)(2008-8#1)(2008-9#1)
variational analysis##2##2##(2007-12#1)(2008-3#1)
variational approach##6##2##(1990-12#1)(2007-12#2)(2008-2#1)(2009-9#2)
variational method##2##2##(2007-11#1)(2007-12#1)
variational##25##1##(1990-12#1)(2007-11#2)(2007-12#7)(2007-8#1)(2008-1#1)(2008-2#3)(2008-3#1)(2008-7#1)(2009-9#5)(2010-2#2)(2012-3#1)
variations (SVs)##2##2##(2012-11#1)(2012-3#1)
variations across the##2##3##(2008-2#1)(2013-1#1)
variations across##3##2##(1997-1#1)(2008-2#1)(2013-1#1)
variations after##2##2##(1991-5#1)(1996-5#1)
variations among##4##2##(2008-10#1)(2009-10#1)(2012-2#1)(2013-7#1)
variations and pathologic##2##3##(1996-6#2)
variations and##26##2##(1992-8#1)(1996-6#2)(2006-7#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2009-10#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-8#1)(2010-9#1)(2011-1#1)(2012-3#2)
variations are##19##2##(1990-9#1)(1992-6#1)(1996-3#1)(1997-2#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-7#2)
variations around##2##2##(2008-2#1)(2012-3#1)
variations as a function of##2##5##(2008-3#2)
variations as a result of##2##5##(1991-2#1)(2010-12#1)
variations as a##4##3##(1991-2#1)(2008-3#2)(2010-12#1)
variations as##7##2##(1991-2#1)(1996-12#1)(2007-11#1)(2008-2#1)(2008-3#2)(2010-12#1)
variations at##2##2##(1992-4#1)(2012-1#1)
variations between different##2##3##(1992-3#1)(1995-7#1)
variations between the##2##3##(1997-2#1)(2008-7#1)
variations between##12##2##(1990-8#1)(1991-12#1)(1992-3#1)(1993-2#1)(1995-7#1)(1997-2#1)(2008-7#2)(2009-2#1)(2009-5#1)(2011-2#1)(2013-1#1)
variations by##3##2##(2008-11#1)(2008-3#1)(2010-11#1)
variations can##2##2##(2005-10#1)(2008-7#1)
variations caused by##2##3##(2008-10#1)(2008-2#1)
variations contribute to##3##3##(2008-7#1)(2013-1#2)
variations could##2##2##(2008-3#2)
variations exist in the##2##4##(2009-7#1)(2010-8#1)
variations exist##4##2##(2006-5#1)(2009-7#1)(2010-12#1)(2010-8#1)
variations for##2##2##(2008-3#1)(2008-5#1)
variations found##2##2##(2008-8#1)(2008-9#1)
variations from##3##2##(2008-3#2)(2011-2#1)
variations have been##2##3##(2007-12#1)(2009-11#1)
variations have##3##2##(2006-7#1)(2007-12#1)(2009-11#1)
variations in BCC##2##3##(2011-12#2)
variations in a##4##3##(2007-7#1)(2008-2#1)(2008-3#2)
variations in all##3##3##(1992-8#1)(1995-11#1)(2008-12#1)
variations in both optical##2##4##(1997-6#1)(2008-3#1)
variations in both##5##3##(1994-2#1)(1995-5#1)(1997-6#1)(2005-11#1)(2008-3#1)
variations in care##2##3##(1993-7#1)(2008-6#1)
variations in cell##2##3##(1991-11#1)(2007-9#1)
variations in dermatophytosis in HIV infected patients##2##7##(2007-7#2)
variations in disease##3##3##(2005-11#1)(2008-10#2)
variations in gene##2##3##(2008-10#1)(2012-3#1)
variations in its##3##3##(2008-2#1)(2010-8#1)(2012-1#1)
variations in maternal##2##3##(1995-8#1)(2008-8#1)
variations in morphology##2##3##(2007-7#2)
variations in pH and temperature##2##5##(2008-11#1)(2008-5#1)
variations in pH##3##3##(2008-11#1)(2008-5#1)(2009-6#1)
variations in practice##2##3##(2008-11#1)(2012-1#1)
variations in primary##3##3##(1996-7#1)(1997-3#1)(2008-5#1)
variations in shape and##2##4##(2008-5#1)(2009-5#1)
variations in small##2##3##(2008-2#1)(2009-6#1)
variations in some##3##3##(1993-5#1)(2007-1#1)(2008-8#1)
variations in temperature##2##3##(2008-10#1)(2013-8#1)
variations in the amino acid sequence##2##6##(1992-9#1)(2011-2#1)
variations in the angle of##2##5##(2006-8#1)(2008-2#1)
variations in the cell##2##4##(2008-11#1)(2008-5#1)
variations in the context of##2##5##(2008-8#1)(2011-2#1)
variations in the immune response##2##5##(2006-8#1)(2010-10#1)
variations in the input##2##4##(2008-1#1)(2008-2#1)
variations in the intensity of##2##5##(2008-10#1)(2008-3#1)
variations in the levels of##2##5##(1995-12#1)(2004-12#1)
variations in the patterns##2##4##(1993-12#1)(2009-12#1)
variations in the photosensitizer##2##4##(2009-4#2)
variations in the plasma##2##4##(1992-3#1)(2008-1#1)
variations in the refractive index##2##5##(2008-1#1)(2008-3#1)
variations in the sequences of##2##5##(1990-7#1)(1997-5#1)
variations in the thickness##2##4##(2008-5#1)(2008-9#1)
variations in the##138##3##(1990-7#1)(1990-8#1)(1991-10#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-3#3)(1992-6#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(2004-12#1)(2004-4#1)(2005-10#1)(2005-7#1)(2006-10#5)(2006-12#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#4)(2007-5#1)(2007-8#1)(2008-1#4)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#10)(2008-3#10)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#3)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#1)(2013-8#4)
variations in their##2##3##(1994-8#1)(2011-2#1)
variations in this##2##3##(1994-3#1)(2008-10#1)
variations in##369##2##(1990-12#2)(1990-2#2)(1990-4#1)(1990-6#1)(1990-7#2)(1990-8#2)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#1)(1993-5#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#2)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#5)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-1#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-12#1)(2004-4#1)(2005-10#1)(2005-11#2)(2005-5#1)(2005-7#2)(2006-1#1)(2006-10#6)(2006-12#4)(2006-5#1)(2006-6#1)(2006-8#5)(2006-9#2)(2007-1#3)(2007-10#1)(2007-11#6)(2007-12#6)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#25)(2008-11#4)(2008-12#4)(2008-2#21)(2008-3#22)(2008-4#6)(2008-5#17)(2008-6#5)(2008-7#10)(2008-8#5)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#4)(2009-5#5)(2009-6#3)(2009-7#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#2)(2011-12#6)(2011-2#8)(2012-1#8)(2012-11#3)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#8)(2013-7#2)(2013-8#9)
variations into account##2##3##(1990-8#1)(2006-6#1)
variations is##3##2##(2007-3#1)(2009-8#1)(2010-9#1)
variations may be##4##3##(2008-3#1)(2008-7#1)(2009-11#1)(2011-12#1)
variations may##9##2##(1990-11#1)(2006-10#1)(2007-9#1)(2008-3#1)(2008-7#1)(2009-11#1)(2011-12#1)(2011-2#1)(2012-2#1)
variations occur in##2##3##(1997-4#1)(2007-1#1)
variations occur##3##2##(1993-2#1)(1997-4#1)(2007-1#1)
variations occurred in##2##3##(2007-6#1)(2008-9#1)
variations of a##3##3##(2008-2#1)(2008-3#1)(2011-2#1)
variations of approximately##2##3##(2008-3#1)(2009-2#1)
variations of its##2##3##(1997-8#1)(2013-1#1)
variations of the absorption coefficient##2##5##(2007-12#1)(2008-3#1)
variations of the method##3##4##(2008-10#2)(2010-4#1)
variations of the optical##2##4##(2008-2#2)
variations of the##49##3##(1990-2#1)(1990-8#1)(1992-8#2)(1992-9#1)(1993-3#1)(1995-9#1)(1996-1#1)(1996-2#1)(1997-6#1)(2005-10#3)(2005-11#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#6)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-4#1)(2010-9#1)(2013-1#1)(2013-8#2)
variations of this##2##3##(2007-12#1)(2009-5#1)
variations of##137##2##(1990-12#2)(1990-2#1)(1990-4#1)(1990-8#2)(1990-9#2)(1991-11#1)(1992-3#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#1)(1994-11#1)(1995-1#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-5#1)(1997-6#2)(1997-8#1)(2005-10#5)(2005-11#2)(2005-4#2)(2005-8#1)(2006-1#1)(2006-10#2)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-2#12)(2008-3#9)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#8)
variations on the##12##3##(1990-10#1)(1990-7#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-7#1)(2011-1#1)(2013-8#1)
variations on##25##2##(1990-10#1)(1990-7#1)(1991-4#1)(1993-6#1)(2007-11#1)(2007-12#3)(2007-4#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#4)(2008-4#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#2)
variations ranging from##2##3##(2008-10#1)(2009-7#1)
variations should be taken into##2##5##(2009-4#1)(2013-7#1)
variations should be##3##3##(2009-4#1)(2011-1#1)(2013-7#1)
variations such##2##2##(2008-2#1)(2011-2#1)
variations that occur##2##3##(2007-12#1)(2010-5#1)
variations that##5##2##(2007-12#1)(2008-10#1)(2008-3#1)(2009-12#1)(2010-5#1)
variations to##2##2##(2007-12#1)(2008-3#1)
variations was##3##2##(2005-10#1)(2012-12#2)
variations were also##3##3##(1990-1#1)(2007-3#1)(2008-11#1)
variations were found for##2##4##(1991-5#1)(1993-11#1)
variations were found in the##2##5##(1993-5#1)(2008-10#1)
variations were found##5##3##(1991-5#1)(1993-11#1)(1993-5#1)(2008-10#1)(2013-7#1)
variations were investigated##2##3##(2007-8#1)(2008-5#1)
variations were not##2##3##(1994-4#1)(2008-7#1)
variations were observed among##3##4##(2008-10#2)(2013-1#1)
variations were observed for##2##4##(1990-8#1)(1991-5#1)
variations were observed##6##3##(1990-8#1)(1991-5#1)(1994-3#1)(2008-10#2)(2013-1#1)
variations were##33##2##(1990-1#1)(1990-8#1)(1991-5#2)(1993-11#1)(1993-5#1)(1994-3#2)(1994-4#2)(1995-11#1)(1996-12#1)(2006-10#1)(2006-8#1)(2007-10#2)(2007-3#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-10#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
variations will##2##2##(1993-1#1)(2011-1#1)
variations with respect to##2##4##(2008-11#1)(2009-5#1)
variations with##8##2##(1990-2#1)(1997-7#1)(2004-9#1)(2007-1#1)(2008-11#1)(2008-5#1)(2009-5#1)(2012-3#1)
variations within the##2##3##(1997-8#1)(2010-9#1)
variations within##6##2##(1997-8#1)(2008-10#1)(2008-5#1)(2009-7#1)(2010-11#1)(2010-9#1)
variations##860##1##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#6)(1990-2#4)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#7)(1990-9#3)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#6)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-12#4)(1992-2#2)(1992-3#5)(1992-4#3)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#6)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#5)(1993-2#6)(1993-3#2)(1993-5#3)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#5)(1994-2#1)(1994-3#4)(1994-4#3)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#6)(1995-2#1)(1995-3#1)(1995-5#2)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#2)(1996-7#2)(1997-1#2)(1997-2#5)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#2)(2004-12#1)(2004-4#1)(2004-9#1)(2005-10#10)(2005-11#4)(2005-4#2)(2005-5#1)(2005-7#2)(2005-8#1)(2006-1#2)(2006-10#12)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#3)(2006-8#6)(2006-9#2)(2007-1#7)(2007-10#5)(2007-11#18)(2007-12#28)(2007-3#4)(2007-4#3)(2007-5#1)(2007-6#2)(2007-7#11)(2007-8#8)(2007-9#4)(2008-1#5)(2008-10#58)(2008-11#13)(2008-12#8)(2008-2#53)(2008-3#54)(2008-4#14)(2008-5#41)(2008-6#7)(2008-7#22)(2008-8#11)(2008-9#9)(2009-10#3)(2009-11#4)(2009-12#4)(2009-2#3)(2009-3#1)(2009-4#6)(2009-5#9)(2009-6#3)(2009-7#8)(2009-8#4)(2010-1#2)(2010-10#3)(2010-11#5)(2010-12#7)(2010-2#3)(2010-3#1)(2010-4#3)(2010-5#2)(2010-7#1)(2010-8#10)(2010-9#6)(2011-1#11)(2011-12#9)(2011-2#20)(2012-1#13)(2012-11#4)(2012-12#5)(2012-2#11)(2012-3#15)(2012-9#1)(2013-1#21)(2013-7#14)(2013-8#21)
variations)##2##1##(2005-10#1)(2008-2#1)
variceal bleeding##15##2##(1995-8#1)(1995-9#5)(2006-10#3)(2008-12#2)(2009-8#3)(2012-2#1)
variceal hemorrhage##3##2##(2006-10#1)(2011-2#2)
variceal rebleeding##2##2##(1995-9#1)(2013-1#1)
variceal sclerotherapy##2##2##(1996-9#1)(2009-4#1)
variceal upper gastrointestinal bleeding##2##4##(2007-5#1)(2011-2#1)
variceal##32##1##(1995-8#1)(1995-9#6)(1996-9#1)(2006-10#7)(2007-5#1)(2008-12#2)(2008-8#1)(2009-4#1)(2009-8#3)(2011-2#6)(2012-2#2)(2013-1#1)
varicella and##5##2##(2007-9#1)(2008-4#4)
varicella cases##2##2##(2007-9#2)
varicella in##3##2##(2007-11#1)(2007-9#1)(2010-8#1)
varicella infection and##2##3##(2008-12#1)(2010-8#1)
varicella infection##5##2##(1992-1#1)(1994-3#1)(2008-12#1)(2008-5#1)(2010-8#1)
varicella is##2##2##(2007-7#1)(2010-8#1)
varicella vaccination##4##2##(2007-9#3)(2008-4#1)
varicella vaccine in##2##3##(2007-12#1)(2009-5#1)
varicella vaccine##6##2##(2007-11#1)(2007-12#2)(2008-11#1)(2009-5#1)(2010-10#1)
varicella virus##2##2##(2008-11#2)
varicella zoster infection##5##3##(2008-7#3)(2010-8#2)
varicella zoster virus (VZV)##3##4##(1996-12#1)(2007-11#1)(2008-5#1)
varicella zoster virus##8##3##(1992-11#1)(1994-2#1)(1996-12#1)(1996-2#1)(2007-11#1)(2008-5#1)(2008-7#1)(2013-1#1)
varicella zoster##14##2##(1992-11#1)(1994-2#1)(1995-9#1)(1996-12#1)(1996-2#1)(2007-11#1)(2008-5#1)(2008-7#4)(2010-8#2)(2013-1#1)
varicella##63##1##(1990-6#1)(1992-1#1)(1992-11#1)(1994-2#1)(1994-3#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-5#1)(2006-10#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-7#2)(2007-9#8)(2008-11#8)(2008-12#3)(2008-4#7)(2008-5#3)(2008-7#4)(2009-5#1)(2010-10#1)(2010-8#6)(2010-9#1)(2013-1#1)
varicella-related##3##1##(2008-11#2)(2008-12#1)
varicella-zoster virus (VZV)##3##3##(2008-7#1)(2011-1#1)(2013-8#1)
varicella-zoster virus##8##2##(1994-3#1)(2008-12#2)(2008-4#1)(2008-7#1)(2011-1#2)(2013-8#1)
varicelle##5##1##(2013-1#5)
varices and##2##2##(1996-11#1)(2010-12#1)
varices in the##2##3##(1992-4#1)(2011-2#1)
varices in##6##2##(1991-5#1)(1992-4#1)(2011-1#1)(2011-2#1)(2013-1#2)
varices is##2##2##(2006-6#1)(2009-8#1)
varices were##2##2##(2013-1#2)
varices with##3##2##(2011-2#3)
varices##60##1##(1991-11#1)(1991-5#2)(1992-4#1)(1995-9#1)(1996-11#3)(2004-11#1)(2005-7#1)(2006-10#4)(2006-4#1)(2006-6#1)(2006-8#2)(2007-2#1)(2008-12#2)(2009-8#8)(2009-9#2)(2010-12#1)(2011-1#1)(2011-2#9)(2012-1#3)(2013-1#14)(2013-8#1)
varices]##4##1##(1992-2#1)(1992-4#1)(2006-6#1)(2013-1#1)
varicocele after##2##2##(1990-3#1)(2008-7#1)
varicocele and##3##2##(1990-3#1)(2006-9#1)(2007-7#1)
varicocele in##3##2##(1990-3#2)(2006-9#1)
varicocele treatment##2##2##(2006-10#2)
varicocele##23##1##(1990-3#8)(1990-9#1)(2006-10#3)(2006-7#1)(2006-9#4)(2007-7#1)(2008-7#3)(2009-6#1)(2010-12#1)
varicocele]##2##1##(1990-9#1)(2008-7#1)
varicoceles##2##1##(1990-9#1)(2008-1#1)
varicophlebitis of the lower##2##4##(1990-6#2)
varicophlebitis##3##1##(1990-6#3)
varicose fibers##3##2##(1994-5#2)(1995-3#1)
varicose haemorrhage##3##2##(2006-6#3)
varicose nerve##2##2##(1990-5#1)(1997-3#1)
varicose terminals##5##2##(1992-8#1)(1994-5#3)(1996-5#1)
varicose veins##8##2##(2005-10#1)(2006-6#4)(2009-4#1)(2011-3#2)
varicose##25##1##(1990-5#1)(1992-8#1)(1993-12#1)(1994-5#5)(1994-6#1)(1995-3#2)(1995-5#1)(1996-5#1)(1997-3#1)(2005-10#1)(2006-6#7)(2009-4#1)(2011-3#2)
varicosis##7##1##(2010-5#7)
varicosities formed##2##2##(2007-10#2)
varicosities were closely##2##3##(1991-11#1)(1991-5#1)
varicosities were##4##2##(1991-11#1)(1991-5#1)(1995-5#1)(1996-9#1)
varicosities##15##1##(1991-11#3)(1991-5#2)(1995-5#1)(1996-6#1)(1996-9#1)(1997-3#1)(2007-10#5)(2008-4#1)
varicosity##3##1##(1996-6#1)(2006-6#2)
varied according to age##2##4##(1996-7#1)(2006-8#1)
varied according to brain##2##4##(1997-5#1)(2012-3#1)
varied according to the##9##4##(1993-12#1)(1994-11#1)(2004-10#1)(2007-6#1)(2007-7#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#1)
varied according to##17##3##(1993-12#1)(1994-11#1)(1996-7#1)(1997-5#1)(2004-10#1)(2006-8#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-5#2)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#2)
varied across the##7##3##(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-1#1)(2011-1#1)(2013-8#1)
varied across##13##2##(1994-3#1)(1995-12#1)(2006-10#1)(2007-1#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#1)(2010-1#1)(2011-1#1)(2013-8#1)
varied among experiments##2##3##(2008-10#2)
varied among strains##2##3##(2008-10#1)(2009-5#1)
varied among the strains tested from strongly adherent##2##8##(2006-8#2)
varied among the##8##3##(1993-3#1)(1996-5#1)(2004-11#1)(2006-8#2)(2008-10#1)(2008-9#1)(2009-8#1)
varied among tissues##2##3##(2008-11#2)
varied among##27##2##(1993-3#1)(1994-12#1)(1996-5#1)(2004-11#1)(2006-8#2)(2007-2#1)(2008-10#11)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#1)(2013-7#1)
varied and include##2##3##(1996-2#1)(2005-8#1)
varied and were##3##3##(2006-9#1)(2008-10#1)(2008-12#1)
varied and##14##2##(1990-8#1)(1994-7#1)(1996-2#1)(2005-8#1)(2006-9#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-12#1)(2009-4#1)(2013-1#2)(2013-8#1)
varied approaches##2##2##(2008-1#1)(2008-10#1)
varied as##11##2##(1993-9#1)(1997-3#1)(2004-11#1)(2007-11#1)(2008-2#1)(2009-2#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
varied at##3##2##(2007-12#1)(2008-6#1)(2008-8#1)
varied based on##2##3##(2009-7#1)(2013-8#1)
varied between 0 and##2##4##(2008-2#1)(2008-6#1)
varied between 0##13##3##(1997-6#1)(2007-10#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)
varied between 1 and##2##4##(2008-10#2)
varied between 1##8##3##(1992-2#1)(1994-2#1)(2006-12#1)(2008-10#3)(2008-2#1)(2011-1#1)
varied between 23 and##2##4##(1992-12#1)(2013-8#1)
varied between 3##2##3##(1993-1#1)(2011-1#1)
varied between 5 and##3##4##(1993-8#1)(1996-2#1)(2008-10#1)
varied between 5##4##3##(1993-8#1)(1996-2#1)(2008-10#1)(2011-2#1)
varied between the##2##3##(2008-10#1)(2012-12#1)
varied between##71##2##(1992-1#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-1#2)(1993-8#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-2#2)(1997-6#1)(2004-9#1)(2005-10#1)(2006-12#1)(2006-4#1)(2007-10#4)(2007-7#2)(2007-8#2)(2008-10#18)(2008-11#2)(2008-12#5)(2008-2#2)(2008-5#2)(2008-6#3)(2009-12#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#2)(2013-7#2)(2013-8#3)
varied both the##2##3##(2008-2#1)(2010-2#1)
varied both##3##2##(2008-2#1)(2009-8#1)(2010-2#1)
varied but##3##2##(1990-11#1)(1991-10#1)(2007-8#1)
varied by a factor of##2##5##(1994-12#1)(1995-3#1)
varied by age##3##3##(1992-10#1)(1995-2#1)(2009-7#1)
varied by changing the##3##4##(1992-6#1)(1994-9#1)(2005-11#1)
varied by controlling the##2##4##(2007-11#1)(2009-11#1)
varied by the##6##3##(1990-11#1)(1994-11#1)(2007-12#1)(2008-3#1)(2009-4#1)(2010-4#1)
varied by##37##2##(1990-11#1)(1992-10#1)(1992-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-3#2)(2004-12#1)(2005-11#1)(2006-11#1)(2006-2#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#2)(2009-4#2)(2009-7#2)(2010-4#1)(2011-1#1)(2012-1#1)(2013-1#2)(2013-7#1)
varied clinical presentations##2##3##(2005-10#1)(2009-5#1)
varied clinical##7##2##(2005-10#1)(2007-11#1)(2007-7#1)(2008-8#1)(2009-5#1)(2011-2#1)(2013-8#1)
varied considerably between##4##3##(1992-3#1)(1992-6#1)(2008-11#1)(2008-5#1)
varied considerably in size and##2##5##(1994-2#1)(2008-5#1)
varied considerably in##4##3##(1994-2#1)(2007-10#1)(2007-7#1)(2008-5#1)
varied considerably with##3##3##(1994-9#1)(1997-4#1)(2009-9#1)
varied considerably##22##2##(1992-3#1)(1992-6#1)(1994-2#1)(1994-9#1)(1995-5#1)(1996-1#1)(1996-8#1)(1997-4#1)(2005-9#1)(2006-12#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#1)(2009-12#1)(2009-9#1)(2011-2#1)(2012-3#1)
varied continuously from##2##3##(1992-5#1)(2008-8#1)
varied depending on the##5##4##(1993-12#1)(1995-5#2)(2007-2#1)(2008-12#1)
varied depending on##8##3##(1993-12#1)(1994-6#1)(1995-5#2)(1997-7#1)(2007-2#1)(2008-12#1)(2011-2#1)
varied depending##9##2##(1993-12#1)(1994-6#1)(1995-5#2)(1996-9#1)(1997-7#1)(2007-2#1)(2008-12#1)(2011-2#1)
varied directly with##2##3##(1991-1#1)(1995-9#1)
varied directly##3##2##(1991-1#1)(1991-5#1)(1995-9#1)
varied dramatically##3##2##(1991-1#1)(1995-5#1)(2013-8#1)
varied during the##3##3##(1992-4#1)(1997-2#1)(2007-4#1)
varied during##4##2##(1992-4#1)(1997-2#1)(2007-4#1)(2008-2#1)
varied effects##3##2##(1992-8#1)(2013-1#2)
varied etiology##2##2##(2006-10#1)(2007-7#1)
varied for the##2##3##(1990-2#1)(2007-12#1)
varied for##6##2##(1990-2#1)(1992-7#1)(2007-12#1)(2007-9#1)(2008-10#1)(2012-1#1)
varied from &lt##4##3##(1995-2#1)(2007-8#1)(2008-10#2)
varied from 0 to##6##4##(1995-8#1)(2004-11#1)(2008-10#2)(2008-7#1)(2011-2#1)
varied from 0##31##3##(1991-10#1)(1993-1#1)(1995-8#1)(1996-5#1)(1996-6#1)(2004-11#1)(2006-12#1)(2006-5#1)(2007-1#1)(2008-10#7)(2008-12#4)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-7#1)(2011-2#3)(2012-2#3)
varied from 1 to##2##4##(2008-10#2)
varied from 1##12##3##(2006-2#1)(2006-8#1)(2007-12#1)(2007-8#2)(2008-10#4)(2011-2#1)(2012-2#2)
varied from 10##2##3##(1993-1#1)(2008-10#1)
varied from 120 to##3##4##(2006-9#2)(2007-12#1)
varied from 17 to##2##4##(2007-1#1)(2008-5#1)
varied from 2 to##3##4##(2008-10#1)(2009-2#1)(2011-1#1)
varied from 2##15##3##(1997-2#1)(1997-8#1)(2004-11#1)(2007-1#1)(2008-1#1)(2008-10#4)(2008-5#2)(2009-2#2)(2010-4#1)(2011-1#1)
varied from 20 to##2##4##(1997-3#1)(2011-2#1)
varied from 20##4##3##(1997-3#1)(2007-12#1)(2008-10#1)(2011-2#1)
varied from 3 months to##2##5##(2007-7#1)(2011-1#1)
varied from 3##4##3##(2007-2#1)(2007-7#1)(2008-10#1)(2011-1#1)
varied from 4 to##2##4##(1997-7#1)(2013-8#1)
varied from 4##3##3##(1997-7#1)(2007-12#1)(2013-8#1)
varied from 5##5##3##(1991-1#1)(2005-4#1)(2008-10#1)(2008-6#1)(2012-1#1)
varied from 6##5##3##(1995-3#1)(2008-10#1)(2008-5#1)(2009-3#1)(2010-4#1)
varied from 8 to##2##4##(2007-7#1)(2008-10#1)
varied from 8%##2##3##(2006-8#1)(2007-3#1)
varied from 85##3##3##(1997-8#1)(2008-10#2)
varied from 95##2##3##(2008-10#2)
varied from 97 to##2##4##(1990-6#1)(2008-10#1)
varied from 97##3##3##(1990-6#1)(2008-10#2)
varied from two##2##3##(2005-12#1)(2008-11#1)
varied from##181##2##(1990-4#1)(1990-6#1)(1991-1#1)(1991-10#1)(1991-9#1)(1992-4#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#3)(1994-11#2)(1994-3#1)(1994-9#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#2)(2004-11#2)(2004-9#1)(2005-11#1)(2005-12#1)(2005-4#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#7)(2006-9#2)(2007-1#3)(2007-10#1)(2007-12#4)(2007-2#1)(2007-3#2)(2007-7#2)(2007-8#5)(2008-1#5)(2008-10#46)(2008-11#3)(2008-12#6)(2008-2#1)(2008-3#1)(2008-5#7)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#2)(2009-3#2)(2009-7#1)(2010-4#2)(2010-8#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#6)(2013-1#3)(2013-8#1)
varied greatly among##2##3##(2008-10#1)(2010-8#1)
varied greatly between##2##3##(1992-4#1)(1995-5#1)
varied greatly from##3##3##(2007-6#1)(2008-10#1)(2010-5#1)
varied greatly over##2##3##(2008-10#1)(2008-8#1)
varied greatly##15##2##(1991-12#1)(1992-4#1)(1995-5#1)(1996-6#1)(2007-6#1)(2008-10#4)(2008-8#1)(2010-2#1)(2010-5#1)(2010-8#1)(2012-3#1)(2013-8#1)
varied in a##9##3##(1997-1#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)
varied in both##3##3##(2008-3#1)(2008-7#1)(2012-2#1)
varied in different##2##3##(2008-3#1)(2013-8#1)
varied in size from##2##4##(2008-5#1)(2012-3#1)
varied in size##6##3##(2008-10#1)(2008-5#1)(2012-12#1)(2012-3#1)(2013-1#2)
varied in terms of their##2##5##(2007-10#1)(2009-5#1)
varied in the different##3##4##(1993-12#1)(1995-2#1)(2011-12#1)
varied in the level of##2##5##(2007-6#1)(2008-8#1)
varied in the range##3##4##(2008-10#3)
varied in the##14##3##(1993-12#1)(1993-4#1)(1995-2#1)(2007-11#1)(2007-6#1)(2008-10#3)(2008-2#1)(2008-8#2)(2010-11#1)(2010-4#1)(2011-12#1)
varied in their ability to##3##5##(1993-12#1)(2008-10#1)(2013-1#1)
varied in their##10##3##(1992-1#1)(1993-12#1)(1994-5#1)(2008-10#4)(2008-8#1)(2010-4#1)(2013-1#1)
varied in##74##2##(1992-1#1)(1992-3#2)(1992-5#1)(1993-12#2)(1993-4#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-2#1)(1996-7#1)(1997-1#2)(1997-7#1)(1997-8#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-6#1)(2008-10#18)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#2)(2009-7#1)(2010-11#1)(2010-4#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
varied independently##2##2##(2007-10#1)(2009-2#1)
varied inversely with the##2##4##(1992-11#1)(1995-9#1)
varied inversely with##3##3##(1992-11#1)(1992-8#1)(1995-9#1)
varied linearly with the##2##4##(1997-6#1)(2009-6#1)
varied linearly with##4##3##(1996-12#1)(1997-3#1)(1997-6#1)(2009-6#1)
varied linearly##6##2##(1996-12#1)(1997-3#1)(1997-6#1)(2008-10#2)(2009-6#1)
varied markedly between##2##3##(2007-8#1)(2012-3#1)
varied markedly##3##2##(2006-8#1)(2007-8#1)(2012-3#1)
varied more##3##2##(1991-1#1)(2006-6#1)(2008-10#1)
varied much more##2##3##(1992-3#1)(2010-2#1)
varied much##3##2##(1992-3#1)(2008-10#1)(2010-2#1)
varied needs##2##2##(2010-2#1)(2013-1#1)
varied outcomes##2##2##(2012-1#1)(2012-12#1)
varied over a wide range##2##5##(2007-8#1)(2008-2#1)
varied over a##3##3##(2007-8#1)(2008-11#1)(2008-2#1)
varied over several orders of magnitude##2##6##(2008-1#1)(2008-3#1)
varied over##10##2##(1994-11#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2009-5#1)
varied positively with##2##3##(2005-11#1)(2011-2#1)
varied presentations##2##2##(2007-12#1)(2008-7#1)
varied quantitatively##2##2##(2008-10#2)
varied significantly among##2##3##(2008-10#1)(2011-2#1)
varied significantly between##2##3##(2011-2#1)(2012-3#1)
varied significantly by##2##3##(1991-12#1)(2013-1#1)
varied significantly for##2##3##(2007-10#1)(2007-11#1)
varied significantly from##4##3##(2008-10#2)(2012-2#1)(2013-8#1)
varied significantly with##4##3##(1996-8#1)(2007-10#1)(2007-4#1)(2008-12#1)
varied significantly##22##2##(1991-11#1)(1991-12#1)(1996-8#1)(1997-7#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-10#4)(2008-12#1)(2008-5#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
varied somewhat between##2##3##(2007-12#1)(2013-1#1)
varied somewhat##3##2##(2007-12#1)(2008-9#1)(2013-1#1)
varied spatially and seasonally##2##4##(2007-5#2)
varied substantially##7##2##(1992-5#2)(1994-2#1)(1995-3#1)(2009-5#1)(2011-1#1)(2012-3#1)
varied the##6##2##(1993-8#1)(2004-11#1)(2007-12#2)(2008-1#1)(2008-11#1)
varied through##2##2##(1997-7#1)(2007-11#1)
varied throughout the##2##3##(2007-4#1)(2008-5#1)
varied to##14##2##(1991-11#1)(1994-9#1)(2005-11#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2010-8#1)(2012-3#1)
varied widely between##5##3##(1994-3#1)(2007-6#1)(2008-10#1)(2008-11#1)(2010-12#1)
varied widely from##2##3##(1990-12#1)(2008-10#1)
varied widely in their##2##4##(1991-2#1)(2008-11#1)
varied widely with##2##3##(2007-5#2)
varied widely##24##2##(1990-12#1)(1990-3#1)(1991-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1997-3#1)(2006-5#1)(2007-2#1)(2007-5#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2010-12#1)(2010-4#1)(2012-11#1)(2012-12#1)(2013-1#1)
varied with pH##2##3##(2008-10#2)
varied with species##2##3##(1992-8#1)(2011-1#1)
varied with the species##2##4##(1996-11#1)(1996-12#1)
varied with the##23##3##(1992-11#1)(1992-3#1)(1993-12#1)(1994-12#1)(1994-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(2004-2#1)(2004-4#1)(2006-3#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-5#1)(2012-11#1)(2013-1#1)
varied with##48##2##(1991-6#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-6#1)(2004-2#1)(2004-4#3)(2006-11#1)(2006-3#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2013-1#2)
varied within a##2##3##(2005-11#1)(2008-2#1)
varied within and between##2##4##(2006-5#1)(2009-2#1)
varied within the##2##3##(2008-10#1)(2009-2#1)
varied within##9##2##(2005-11#1)(2006-12#1)(2006-5#1)(2008-10#3)(2008-2#1)(2009-2#2)
varied##891##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#2)(1990-8#1)(1990-9#3)(1991-1#4)(1991-10#2)(1991-11#5)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#5)(1992-4#3)(1992-5#4)(1992-6#2)(1992-7#1)(1992-8#5)(1993-1#4)(1993-11#1)(1993-12#7)(1993-3#5)(1993-4#1)(1993-6#1)(1993-8#3)(1993-9#5)(1994-10#1)(1994-11#6)(1994-12#3)(1994-2#4)(1994-3#5)(1994-5#1)(1994-6#3)(1994-7#1)(1994-9#5)(1995-1#2)(1995-12#2)(1995-2#4)(1995-3#7)(1995-4#1)(1995-5#6)(1995-8#1)(1995-9#2)(1996-1#2)(1996-11#1)(1996-12#5)(1996-2#5)(1996-3#3)(1996-5#3)(1996-6#2)(1996-7#4)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#4)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#7)(1997-8#3)(2004-10#1)(2004-11#5)(2004-12#1)(2004-2#2)(2004-3#1)(2004-4#3)(2004-9#3)(2005-10#2)(2005-11#9)(2005-12#2)(2005-4#1)(2005-7#3)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#4)(2006-11#3)(2006-12#6)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#3)(2006-7#2)(2006-8#12)(2006-9#3)(2007-1#8)(2007-10#12)(2007-11#10)(2007-12#23)(2007-2#8)(2007-3#4)(2007-4#4)(2007-5#6)(2007-6#4)(2007-7#9)(2007-8#12)(2007-9#4)(2008-1#12)(2008-10#142)(2008-11#22)(2008-12#15)(2008-2#23)(2008-3#20)(2008-4#2)(2008-5#30)(2008-6#8)(2008-7#10)(2008-8#15)(2008-9#11)(2009-11#2)(2009-12#3)(2009-2#8)(2009-3#3)(2009-4#6)(2009-5#7)(2009-6#1)(2009-7#7)(2009-8#2)(2009-9#2)(2010-1#1)(2010-11#2)(2010-12#2)(2010-2#4)(2010-3#2)(2010-4#8)(2010-5#4)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#11)(2011-12#1)(2011-2#21)(2012-1#8)(2012-11#3)(2012-12#9)(2012-2#13)(2012-3#11)(2013-1#33)(2013-7#4)(2013-8#16)
variegata##5##1##(2006-12#2)(2007-2#1)(2007-3#1)(2008-4#1)
variegated##9##1##(1993-10#1)(2008-10#6)(2008-6#1)(2011-2#1)
variegatus##14##1##(2007-3#1)(2007-5#6)(2008-10#6)(2008-8#1)
varies according to the##8##4##(1994-5#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-4#1)(2009-2#1)(2013-1#2)
varies according to##13##3##(1994-5#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-10#1)(2011-2#1)(2013-1#2)
varies across the##4##3##(2007-11#1)(2007-12#2)(2009-10#1)
varies across##8##2##(1995-1#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-7#1)(2009-10#1)(2009-4#1)
varies along the##2##3##(1992-9#1)(2008-2#1)
varies among different##2##3##(1997-4#1)(2008-3#1)
varies among##7##2##(1991-10#1)(1991-9#1)(1997-4#1)(2008-3#1)(2011-1#1)(2012-1#1)(2012-3#1)
varies and##3##2##(1992-9#1)(2008-5#1)(2010-2#1)
varies as##2##2##(1997-6#1)(2008-3#1)
varies between 0##5##3##(1992-12#1)(2007-12#1)(2008-2#1)(2008-8#1)(2012-2#1)
varies between 2##2##3##(2008-1#1)(2011-1#1)
varies between 5 and##3##4##(2008-9#2)(2013-8#1)
varies between 5##4##3##(2006-1#1)(2008-9#2)(2013-8#1)
varies between##29##2##(1992-12#1)(1994-12#1)(1994-2#1)(1995-10#1)(1995-11#1)(1997-7#1)(2006-1#1)(2006-11#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2010-2#2)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
varies by##7##2##(1997-1#1)(2007-11#1)(2008-2#1)(2008-4#1)(2009-9#1)(2012-3#1)(2013-8#1)
varies considerably##11##2##(1990-2#1)(1991-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-6#1)(1996-11#2)(2012-12#2)(2012-2#1)
varies continuously##2##2##(1995-8#1)(2008-2#1)
varies depending on the##10##4##(1993-8#1)(2005-7#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-5#1)(2010-3#1)(2011-1#1)(2013-1#1)
varies depending on##13##3##(1991-4#1)(1993-8#1)(1995-1#1)(2005-7#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-1#1)(2013-1#1)
varies dramatically##2##2##(2007-12#1)(2008-12#1)
varies for##2##2##(1995-8#1)(2004-9#1)
varies from 0##4##3##(1990-9#1)(2007-5#1)(2008-10#2)
varies from 2##3##3##(1992-11#1)(2007-11#1)(2007-7#1)
varies from 6 to##2##4##(2007-11#1)(2008-10#1)
varies from one##4##3##(1992-4#1)(1995-1#1)(2007-12#1)(2010-8#1)
varies from place to place##2##5##(2007-8#2)
varies from##37##2##(1990-10#1)(1990-9#1)(1992-11#1)(1992-4#1)(1993-2#1)(1995-1#1)(1995-11#1)(1995-2#1)(2007-11#3)(2007-12#4)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-8#2)
varies greatly depending on the##2##5##(2009-3#1)(2013-1#1)
varies greatly from##2##3##(1992-3#1)(2006-9#1)
varies greatly##8##2##(1992-3#1)(1995-2#1)(1995-9#1)(2006-10#1)(2006-9#1)(2009-3#1)(2009-4#1)(2013-1#1)
varies in a density-dependent manner##2##5##(2008-10#1)(2008-9#1)
varies in different##4##3##(1994-12#1)(2008-5#1)(2009-9#1)(2010-7#1)
varies in frequency##2##3##(2009-5#1)(2013-1#1)
varies in individuals##2##3##(2009-4#1)(2010-7#1)
varies in severity##2##3##(2007-12#1)(2008-11#1)
varies in size##2##3##(1990-12#1)(1993-9#1)
varies in the##2##3##(2003-11#1)(2007-11#1)
varies in##29##2##(1990-12#1)(1993-9#1)(1994-12#2)(1995-12#1)(1996-12#1)(2003-11#1)(2004-2#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-11#1)(2010-7#2)(2011-2#1)(2013-1#2)
varies inversely with the##2##4##(2008-10#1)(2009-7#1)
varies linearly with the concentration of##2##6##(2008-10#2)
varies linearly with the##4##4##(2008-10#3)(2008-6#1)
varies markedly##2##2##(1990-7#1)(2008-7#1)
varies on##2##2##(2009-4#1)(2010-8#1)
varies over a##2##3##(2005-11#1)(2008-2#1)
varies over time##2##3##(1996-7#1)(1997-7#1)
varies over##7##2##(1995-6#1)(1996-7#1)(1997-7#1)(2005-11#1)(2007-6#1)(2008-10#1)(2008-2#1)
varies periodically##3##2##(2007-12#1)(2008-3#2)
varies significantly##6##2##(1996-2#1)(2005-8#1)(2007-8#1)(2008-3#1)(2009-6#1)(2012-3#1)
varies substantially##3##2##(2008-2#1)(2010-12#1)(2012-1#1)
varies widely among##3##3##(2009-5#1)(2010-12#1)(2011-1#1)
varies widely between##4##3##(2005-8#1)(2006-10#1)(2008-2#1)(2011-1#1)
varies widely in##2##3##(2007-11#1)(2012-3#1)
varies widely##16##2##(2005-8#2)(2006-10#1)(2007-11#2)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-1#2)(2012-1#1)(2012-3#1)(2013-1#1)
varies with the developmental stage at the time of administration##2##10##(1993-3#1)(1995-2#1)
varies with the developmental##3##4##(1990-5#1)(1993-3#1)(1995-2#1)
varies with the structure of the##2##6##(2005-11#1)(2010-12#1)
varies with the type of##2##5##(1996-3#1)(2008-6#1)
varies with the##22##3##(1990-5#1)(1990-6#2)(1990-8#1)(1993-3#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-5#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-6#1)(2009-9#1)(2010-12#1)
varies with##67##2##(1990-5#2)(1990-6#2)(1990-8#1)(1991-7#1)(1992-12#1)(1993-11#1)(1993-3#2)(1994-10#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-11#3)(2006-10#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-12#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-7#1)
varies within the##2##3##(2008-2#1)(2009-2#1)
varies within##4##2##(2008-2#1)(2008-3#1)(2008-5#1)(2009-2#1)
varies##341##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#3)(1990-6#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-3#2)(1992-4#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-5#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-12#4)(1994-2#3)(1994-5#1)(1994-6#1)(1995-1#4)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#2)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#4)(1996-3#1)(1996-5#1)(1996-7#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2003-11#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#6)(2005-3#1)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#6)(2006-11#1)(2006-5#1)(2006-6#1)(2006-9#3)(2007-1#1)(2007-11#11)(2007-12#19)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#4)(2008-10#17)(2008-11#2)(2008-12#2)(2008-2#15)(2008-3#22)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#5)(2008-8#9)(2008-9#5)(2009-10#1)(2009-2#3)(2009-3#2)(2009-4#5)(2009-5#3)(2009-6#1)(2009-7#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#5)(2011-12#1)(2011-2#5)(2012-1#3)(2012-12#3)(2012-2#5)(2012-3#5)(2012-8#1)(2013-1#11)(2013-7#2)(2013-8#4)
varietal differences##3##2##(2011-12#3)
varietal##8##1##(2008-10#5)(2011-12#3)
varieties and##8##2##(2008-1#1)(2008-10#3)(2008-12#2)(2008-5#1)(2011-2#1)
varieties are##5##2##(2005-9#1)(2006-12#1)(2008-10#1)(2008-12#2)
varieties as##2##2##(1996-8#1)(2013-8#1)
varieties could##2##2##(2010-7#1)(2013-8#1)
varieties have been##2##3##(2008-10#1)(2008-9#1)
varieties in farms##3##3##(2008-12#3)
varieties in##9##2##(2008-10#1)(2008-12#4)(2008-4#1)(2011-1#1)(2013-8#2)
varieties of D##3##3##(2008-10#3)
varieties of apples##2##3##(2008-10#1)(2008-3#1)
varieties of the##4##3##(2006-12#1)(2008-1#1)(2008-12#1)(2011-12#1)
varieties of##42##2##(1991-8#1)(1993-2#1)(1996-11#1)(1996-3#1)(1997-3#2)(1997-4#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-12#2)(2008-3#1)(2008-5#2)(2008-9#1)(2009-10#2)(2010-3#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#4)(2013-8#1)
varieties or##3##2##(2008-10#2)(2008-8#1)
varieties that##4##2##(1995-6#1)(2008-10#2)(2012-11#1)
varieties were##4##2##(2008-10#2)(2013-8#2)
varieties which##2##2##(1996-8#1)(2008-12#1)
varieties with contrasting##2##3##(2009-8#2)
varieties with##6##2##(2006-4#1)(2008-12#2)(2008-8#1)(2009-8#2)
varieties##155##1##(1991-8#1)(1993-2#1)(1993-9#1)(1995-6#1)(1996-11#2)(1996-3#1)(1996-8#3)(1997-3#2)(1997-4#1)(2004-4#1)(2005-9#1)(2006-12#4)(2006-4#3)(2006-5#1)(2006-9#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#47)(2008-12#22)(2008-3#1)(2008-4#1)(2008-5#4)(2008-8#6)(2008-9#3)(2009-10#3)(2009-3#2)(2009-6#1)(2009-8#2)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#4)(2011-12#2)(2011-2#10)(2012-11#2)(2013-1#1)(2013-8#10)
variety and##8##2##(1990-6#1)(1991-9#1)(1996-1#1)(2007-2#1)(2008-10#1)(2008-6#1)(2010-8#1)(2012-11#1)
variety in the##2##3##(2007-2#1)(2011-2#1)
variety in##7##2##(1993-2#1)(2007-2#1)(2008-10#1)(2010-6#1)(2011-2#2)(2012-11#1)
variety is##2##2##(1995-11#1)(2008-2#1)
variety of CNS disorders##2##4##(2008-1#1)(2008-5#1)
variety of CNS##3##3##(2007-11#1)(2008-1#1)(2008-5#1)
variety of DNA##4##3##(1994-5#1)(2005-11#1)(2008-3#1)(2008-4#1)
variety of PCR##2##3##(2006-10#1)(2008-4#1)
variety of abnormalities in##2##4##(1997-8#1)(2004-11#1)
variety of activities##4##3##(1997-3#1)(2006-12#1)(2007-11#1)(2010-8#1)
variety of adaptive responses##4##4##(1996-12#2)(1997-4#2)
variety of adaptive##5##3##(1996-12#2)(1997-4#2)(2012-12#1)
variety of agents##11##3##(1993-3#1)(1994-2#1)(1995-12#1)(1995-6#1)(2005-10#1)(2005-8#1)(2006-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2013-1#1)
variety of alternative##3##3##(1996-1#1)(1996-6#1)(2009-12#1)
variety of anatomic##2##3##(1993-4#1)(2009-5#1)
variety of anatomical and##2##4##(1990-7#1)(2013-1#1)
variety of anatomical##3##3##(1990-7#1)(2008-5#1)(2013-1#1)
variety of animal##10##3##(1992-6#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-8#1)(2011-1#1)(2012-1#2)(2012-12#1)
variety of anions##2##3##(2008-10#2)
variety of antimicrobial agents##2##4##(1991-12#1)(2007-8#1)
variety of antimicrobial##3##3##(1991-12#1)(2007-8#1)(2008-4#1)
variety of applications in##2##4##(2008-3#1)(2008-9#1)
variety of applications##26##3##(1991-4#1)(1993-12#1)(1995-1#1)(1996-1#1)(1997-4#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2011-1#1)(2012-1#1)(2013-1#1)
variety of approaches to##4##4##(2008-10#1)(2008-9#1)(2009-3#1)(2010-11#1)
variety of approaches##7##3##(2008-10#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-11#1)(2010-8#1)
variety of areas##2##3##(2006-10#1)(2009-4#1)
variety of atmospheric##2##3##(2008-2#1)(2008-3#1)
variety of bacterial##3##3##(2007-12#1)(2009-8#1)(2010-4#1)
variety of behavioral##5##3##(1993-11#1)(1993-12#1)(1994-3#1)(2008-4#1)(2008-8#1)
variety of biliary##2##3##(2006-10#1)(2010-12#1)
variety of biological effects##2##4##(1994-11#1)(2012-3#1)
variety of biological processes##2##4##(1993-6#1)(2011-2#1)
variety of biological##19##3##(1990-11#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-2#1)(1996-10#1)(2007-11#1)(2008-10#3)(2008-4#3)(2008-7#1)(2009-2#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-3#1)
variety of biomolecules that##2##4##(2006-10#1)(2012-2#1)
variety of cancers and##2##4##(2008-8#1)(2010-11#1)
variety of cancers##7##3##(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2013-8#1)
variety of cardiac##2##3##(1990-11#1)(2007-9#1)
variety of cases##2##3##(1993-11#1)(2010-2#1)
variety of cell lines##5##4##(1990-6#1)(1991-6#1)(1994-5#1)(2008-11#1)(2008-7#1)
variety of cell types in##2##5##(1996-9#1)(2008-4#1)
variety of cell types##18##4##(1990-3#1)(1992-3#1)(1995-10#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-9#1)(2005-12#1)(2008-1#1)(2008-11#2)(2008-4#5)(2008-9#1)
variety of cell##31##3##(1990-3#1)(1990-6#1)(1991-6#1)(1992-12#1)(1992-3#1)(1994-5#2)(1995-1#1)(1995-10#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-4#1)(2005-12#1)(2008-1#1)(2008-11#3)(2008-4#5)(2008-7#2)(2008-9#2)(2012-12#1)
variety of cells and##2##4##(1993-4#1)(2012-2#1)
variety of cells##14##3##(1992-7#1)(1992-9#1)(1993-4#1)(1994-11#1)(1994-2#1)(1995-6#1)(1996-10#1)(1996-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-8#1)(2012-2#1)
variety of cellular activities##2##4##(2008-7#1)(2009-11#1)
variety of cellular##15##3##(1993-12#1)(1994-12#1)(1995-3#1)(1996-10#1)(2006-10#1)(2007-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-12#1)(2011-1#2)
variety of changes in##2##4##(2007-10#1)(2011-1#1)
variety of chemical##3##3##(2007-12#1)(2008-3#1)(2009-3#1)
variety of chromatographic##2##3##(1991-1#1)(2008-10#1)
variety of clinical conditions##2##4##(1994-11#1)(2008-4#1)
variety of clinical manifestations##2##4##(2008-1#2)
variety of clinical settings##2##4##(2010-5#1)(2011-9#1)
variety of clinical##24##3##(1992-9#1)(1993-4#1)(1993-9#1)(1994-11#1)(2005-10#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-2#2)(2008-4#3)(2008-5#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-9#1)(2012-11#1)(2013-1#1)
variety of complex biological##2##4##(1991-11#1)(1994-3#1)
variety of complex##9##3##(1991-11#1)(1992-11#1)(1994-3#1)(1997-2#1)(2006-10#1)(2006-2#1)(2007-5#1)(2008-2#1)(2009-11#1)
variety of compounds##6##3##(1992-11#1)(2006-10#1)(2008-10#2)(2009-4#1)(2009-7#1)
variety of conditions##20##3##(1990-2#1)(1990-7#1)(1992-2#1)(1993-4#1)(1994-11#1)(1996-3#1)(2006-10#2)(2006-9#1)(2007-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-9#1)(2010-3#2)(2011-12#1)(2011-2#1)(2012-1#1)(2013-8#1)
variety of cultured##2##3##(1997-5#1)(2008-9#1)
variety of cytokines##6##3##(1991-10#2)(2008-4#1)(2008-9#1)(2009-3#1)(2012-1#1)
variety of defects in##2##4##(1997-2#1)(2007-12#1)
variety of defects##3##3##(1997-2#1)(2007-12#1)(2009-8#1)
variety of definitions##3##3##(2010-7#1)(2013-1#2)
variety of different##25##3##(1991-8#1)(1996-11#1)(1996-12#1)(1996-4#1)(1997-4#2)(1997-8#1)(2005-7#1)(2006-10#1)(2006-12#3)(2007-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-8#1)(2010-4#2)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
variety of disciplines##2##3##(2011-2#1)(2013-8#1)
variety of disease##4##3##(2008-10#1)(2008-4#1)(2010-12#1)(2010-2#1)
variety of diseases has been##2##5##(1992-9#1)(2012-3#1)
variety of diseases in humans and animals##2##7##(2011-1#1)(2012-3#1)
variety of diseases##20##3##(1992-9#1)(1995-12#1)(1997-5#1)(2005-6#2)(2005-7#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-7#1)(2009-10#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#2)
variety of disorders##5##3##(2006-10#1)(2006-5#1)(2007-10#1)(2008-1#1)(2008-11#1)
variety of diverse##2##3##(1996-5#1)(2007-11#1)
variety of drugs##4##3##(1990-11#1)(1992-3#1)(2006-10#1)(2008-11#1)
variety of effects##2##3##(2005-10#1)(2008-11#1)
variety of environmental##8##3##(1993-4#1)(1995-6#1)(2008-10#3)(2008-3#1)(2009-8#1)(2012-2#1)
variety of environments##2##3##(2008-3#1)(2008-9#1)
variety of etiologies##5##3##(2009-5#2)(2010-6#3)
variety of eukaryotic##4##3##(1995-1#1)(1996-2#1)(1996-3#1)(2008-4#1)
variety of examples##2##3##(1990-12#1)(1994-5#1)
variety of existing##3##3##(2007-1#1)(2008-11#1)(2012-1#1)
variety of experimental##16##3##(1993-11#1)(1994-11#1)(1995-10#1)(1996-3#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-2#3)(2008-4#1)(2008-6#1)(2008-7#2)(2011-1#1)
variety of extracellular##2##3##(1997-2#1)(2009-3#1)
variety of factors##12##3##(1995-1#1)(2004-12#1)(2007-1#1)(2008-1#1)(2008-7#2)(2009-8#1)(2010-2#1)(2010-5#1)(2011-1#1)(2013-8#2)
variety of features##2##3##(2008-6#1)(2011-2#1)
variety of findings##2##3##(1991-5#1)(2009-9#1)
variety of food products##2##4##(2008-10#1)(2011-2#1)
variety of food##4##3##(1996-2#1)(2008-1#1)(2008-10#1)(2011-2#1)
variety of foods##3##3##(2008-5#1)(2010-12#1)(2012-2#1)
variety of forms##5##3##(1997-3#1)(2005-7#1)(2008-6#1)(2009-2#1)(2009-3#1)
variety of functions##9##3##(1996-9#1)(1997-6#1)(2007-12#1)(2008-11#2)(2008-7#1)(2009-5#1)(2012-2#1)(2013-8#1)
variety of gastrointestinal##4##3##(2006-10#2)(2010-10#1)(2012-2#1)
variety of genes##9##3##(1993-3#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-4#1)(2006-10#1)(2008-10#1)(2010-12#1)(2011-2#1)
variety of genetic##3##3##(2005-8#1)(2009-3#1)(2011-2#1)
variety of graft materials##2##4##(2006-9#1)(2012-8#1)
variety of growth##4##3##(1994-8#1)(2008-4#2)(2011-2#1)
variety of health##5##3##(1993-9#1)(1995-3#1)(1996-12#1)(2006-2#1)(2009-10#1)
variety of hosts##2##3##(1992-1#1)(2011-2#1)
variety of human cancers##5##4##(1990-8#1)(1992-4#1)(2008-8#1)(2012-12#1)(2013-1#1)
variety of human diseases##2##4##(1995-2#1)(2011-2#1)
variety of human malignancies##2##4##(1994-10#1)(2011-2#1)
variety of human##21##3##(1990-11#1)(1990-8#2)(1990-9#1)(1992-4#1)(1992-7#1)(1994-10#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(2007-11#1)(2007-9#1)(2008-5#1)(2008-8#1)(2011-2#3)(2012-12#1)(2013-1#1)
variety of imaging##2##3##(2008-2#1)(2009-10#1)
variety of in##3##3##(1994-8#1)(2005-8#1)(2008-2#1)
variety of inflammatory##4##3##(2005-8#1)(2007-2#1)(2010-4#1)(2012-3#1)
variety of insects##2##3##(2007-12#1)(2008-6#1)
variety of interests##2##3##(1992-1#1)(2010-2#1)
variety of interventions##3##3##(2006-7#1)(2006-8#1)(2012-2#1)
variety of intracellular##2##3##(2007-12#1)(2008-8#1)
variety of kidney diseases##2##4##(2008-1#2)
variety of kidney##3##3##(2008-1#2)(2008-7#1)
variety of laboratory##6##3##(1997-5#1)(2005-7#1)(2006-10#1)(2008-4#1)(2008-7#1)(2012-12#1)
variety of local##3##3##(2006-8#1)(2011-12#2)
variety of malignant##4##3##(1995-6#1)(2008-1#1)(2008-9#1)(2010-11#1)
variety of mammalian##2##3##(1994-9#1)(2008-4#1)
variety of materials##7##3##(1995-3#1)(1996-4#1)(2007-11#1)(2007-4#1)(2009-2#1)(2010-4#1)(2012-2#1)
variety of mechanisms##8##3##(2005-11#1)(2005-8#1)(2007-5#1)(2008-3#1)(2008-8#1)(2011-2#2)(2012-12#1)
variety of medical##8##3##(2007-12#1)(2008-10#1)(2008-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
variety of methods for##3##4##(2008-1#1)(2008-4#2)
variety of methods##12##3##(1993-3#1)(1995-1#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#4)(2008-5#1)(2011-12#1)(2012-2#1)
variety of molecular##4##3##(1992-7#1)(2008-10#1)(2010-10#2)
variety of musculoskeletal##3##3##(1997-3#1)(2009-5#1)(2012-2#1)
variety of mutations in the##2##5##(1993-9#1)(2008-4#1)
variety of mutations##3##3##(1993-9#1)(2008-4#2)
variety of naturally occurring##2##4##(1996-7#1)(2008-10#1)
variety of neuropsychiatric##3##3##(2007-11#1)(2008-8#1)(2011-1#1)
variety of new##10##3##(1995-3#1)(2005-7#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2010-10#1)(2010-9#1)(2011-12#1)(2012-3#1)
variety of normal##4##3##(1990-2#1)(1994-5#1)(2008-4#1)(2008-6#1)
variety of observations##2##3##(1993-7#1)(2007-9#1)
variety of optical devices##2##4##(2008-3#1)(2008-9#1)
variety of optical##7##3##(2007-12#2)(2008-2#1)(2008-3#3)(2008-9#1)
variety of options for##2##4##(2007-12#1)(2011-2#1)
variety of options##4##3##(2007-12#1)(2007-9#1)(2010-2#1)(2011-2#1)
variety of optoelectronic##2##3##(2008-2#1)(2010-4#1)
variety of organisms and##3##4##(1990-11#1)(2008-6#1)(2008-7#1)
variety of organisms can##2##4##(1994-6#1)(2008-2#1)
variety of organisms##12##3##(1990-11#1)(1994-6#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-3#1)(2010-7#1)(2012-3#1)
variety of organs and##2##4##(1991-2#1)(2006-10#1)
variety of organs##3##3##(1991-2#1)(2006-10#1)(2007-3#1)
variety of other anions and##2##5##(2008-10#2)
variety of other anions##4##4##(1990-5#1)(2008-10#3)
variety of other cancers##2##4##(2011-2#1)(2011-3#1)
variety of other##37##3##(1990-5#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-8#2)(1994-9#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-4#1)(2008-10#13)(2008-4#1)(2008-9#2)(2009-1#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
variety of pain##4##3##(1996-7#1)(2007-2#1)(2009-7#1)(2010-2#1)
variety of parameter##2##3##(2008-2#1)(2008-3#1)
variety of pathological conditions##2##4##(1997-6#1)(2006-8#1)
variety of pathological##3##3##(1997-6#1)(2006-8#2)
variety of pathologies##4##3##(2006-12#1)(2010-4#1)(2012-1#1)(2012-2#1)
variety of patient- and##3##4##(2008-7#1)(2010-8#1)(2011-2#1)
variety of patients with##2##4##(1995-3#1)(2011-2#1)
variety of patients##3##3##(1995-3#1)(2006-11#1)(2011-2#1)
variety of pharmacological treatments##2##4##(2006-10#1)(2009-7#1)
variety of physiological and##4##4##(2005-8#1)(2008-1#1)(2008-2#1)(2008-4#1)
variety of physiological functions##5##4##(1990-3#1)(1995-5#1)(2006-10#1)(2008-5#1)(2008-7#1)
variety of physiological##12##3##(1990-3#1)(1991-8#1)(1995-5#1)(2005-8#1)(2006-10#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)
variety of possible##3##3##(2006-7#1)(2008-7#1)(2008-8#1)
variety of potential##8##3##(2007-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-6#1)(2011-1#1)(2012-2#1)
variety of potentially##2##3##(2006-11#1)(2007-9#1)
variety of practice##3##3##(2004-3#1)(2006-5#1)(2008-11#1)
variety of problems##2##3##(2006-10#1)(2013-1#1)
variety of procedures##2##3##(2006-10#1)(2012-3#1)
variety of products##2##3##(1990-8#1)(2008-10#1)
variety of protein##2##3##(2008-4#2)
variety of proteins##10##3##(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(2007-8#1)(2008-4#3)(2008-8#1)(2011-1#1)
variety of psychiatric##4##3##(1996-12#1)(2007-7#1)(2011-2#1)(2012-12#1)
variety of purposes##4##3##(1991-7#1)(2008-4#1)(2010-12#1)(2012-3#1)
variety of quality##2##3##(2006-2#1)(2008-11#1)
variety of reactions##3##3##(2004-11#1)(2005-11#1)(2008-9#1)
variety of real##2##3##(1997-6#1)(2008-10#1)
variety of reasons##9##3##(1990-5#1)(1993-6#1)(1995-12#1)(2006-1#1)(2007-4#2)(2008-1#1)(2008-9#1)(2011-1#1)
variety of recombinant##3##3##(1993-2#1)(1997-4#1)(2013-8#1)
variety of research##5##3##(2008-10#1)(2008-4#1)(2009-10#1)(2009-2#1)(2010-10#1)
variety of responses##4##3##(1992-4#1)(1993-6#1)(2007-4#1)(2013-7#1)
variety of sample types##2##4##(2008-10#1)(2008-3#1)
variety of sample##5##3##(1993-1#1)(2005-11#1)(2008-10#2)(2008-3#1)
variety of samples##3##3##(2008-10#1)(2008-2#1)(2008-9#1)
variety of secondary metabolites##2##4##(2009-3#1)(2009-8#1)
variety of sensing##2##3##(2008-10#1)(2008-3#1)
variety of services##2##3##(2008-2#1)(2011-1#1)
variety of signals##4##3##(1997-5#1)(2005-10#1)(2008-3#1)(2008-4#1)
variety of signs##2##3##(1993-2#1)(2008-9#1)
variety of situations##7##3##(1994-8#1)(1996-12#1)(1996-3#1)(2005-11#1)(2008-2#1)(2008-9#1)(2011-2#1)
variety of skin##2##3##(2008-5#2)
variety of sources##8##3##(1992-6#1)(1995-1#1)(1995-5#1)(1997-4#1)(2006-9#1)(2010-10#1)(2010-8#1)(2012-3#1)
variety of species##4##3##(1993-2#1)(2005-7#1)(2008-11#1)(2008-3#1)
variety of specimens##2##3##(2008-9#1)(2010-1#1)
variety of spectroscopic##2##3##(2008-4#1)(2009-2#1)
variety of spinal##4##3##(2006-8#2)(2007-1#1)(2008-8#1)
variety of stakeholders##4##3##(1997-2#1)(2007-12#1)(2008-11#1)(2012-12#1)
variety of standard##3##3##(2008-2#1)(2008-4#1)(2008-5#1)
variety of strategies##2##3##(1996-5#1)(2008-10#1)
variety of studies##5##3##(1990-12#1)(1995-11#1)(1996-5#1)(2008-11#1)(2010-11#1)
variety of substituents##2##3##(1993-4#1)(1994-9#1)
variety of substrate##2##3##(2009-7#1)(2010-4#1)
variety of substrates##6##3##(1994-8#1)(1996-5#1)(2005-8#1)(2007-12#1)(2008-2#1)(2010-4#1)
variety of such##2##3##(1991-3#1)(2013-8#1)
variety of systems##3##3##(1994-8#1)(2008-2#1)(2008-3#1)
variety of targets in##2##4##(2008-10#1)(2009-12#1)
variety of techniques and##2##4##(2007-7#1)(2009-10#1)
variety of techniques for##2##4##(2008-5#1)(2009-9#1)
variety of techniques##18##3##(1990-9#1)(1991-3#1)(1993-6#1)(1994-1#1)(1995-5#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#2)
variety of temporal##2##3##(2006-10#1)(2008-11#1)
variety of the##8##3##(1997-8#1)(2006-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
variety of tissues##15##3##(1990-9#1)(1992-2#1)(1993-3#1)(1994-10#1)(1994-11#2)(1995-11#1)(1996-10#1)(1997-3#1)(1997-4#2)(1997-8#1)(2005-8#1)(2008-4#1)(2010-12#1)
variety of treatment modalities##4##4##(2006-10#1)(2007-11#2)(2008-7#1)
variety of treatment##5##3##(2006-10#1)(2007-11#2)(2008-7#1)(2008-8#1)
variety of tumors and##2##4##(2006-4#1)(2009-3#1)
variety of tumors##3##3##(2005-9#1)(2006-4#1)(2009-3#1)
variety of tumour##2##3##(2008-6#1)(2011-12#1)
variety of ways##20##3##(1991-11#1)(1992-12#1)(1992-3#1)(1994-1#1)(1994-12#1)(1997-2#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
variety of##1844##2##(1990-10#1)(1990-11#5)(1990-12#3)(1990-2#4)(1990-3#4)(1990-4#2)(1990-5#3)(1990-6#2)(1990-7#3)(1990-8#5)(1990-9#5)(1991-1#6)(1991-10#4)(1991-11#3)(1991-12#5)(1991-2#3)(1991-3#5)(1991-4#2)(1991-5#5)(1991-6#3)(1991-7#4)(1991-8#4)(1991-9#3)(1992-1#5)(1992-11#7)(1992-12#3)(1992-2#4)(1992-3#6)(1992-4#3)(1992-5#2)(1992-6#7)(1992-7#6)(1992-9#4)(1993-1#1)(1993-11#8)(1993-12#8)(1993-2#6)(1993-3#7)(1993-4#8)(1993-5#1)(1993-6#5)(1993-7#2)(1993-8#1)(1993-9#4)(1994-1#3)(1994-10#3)(1994-11#12)(1994-12#11)(1994-2#6)(1994-3#8)(1994-5#8)(1994-6#5)(1994-8#14)(1994-9#12)(1995-1#9)(1995-10#4)(1995-11#4)(1995-12#11)(1995-2#7)(1995-3#13)(1995-4#2)(1995-5#7)(1995-6#7)(1995-8#4)(1996-1#6)(1996-10#8)(1996-11#4)(1996-12#14)(1996-2#9)(1996-3#9)(1996-4#3)(1996-5#9)(1996-6#1)(1996-7#4)(1996-8#4)(1996-9#2)(1997-1#4)(1997-2#11)(1997-3#8)(1997-4#16)(1997-5#7)(1997-6#4)(1997-7#8)(1997-8#7)(2004-11#3)(2004-12#3)(2004-3#3)(2004-9#1)(2005-10#8)(2005-11#10)(2005-12#3)(2005-3#1)(2005-5#1)(2005-6#3)(2005-7#15)(2005-8#15)(2005-9#1)(2006-1#2)(2006-10#56)(2006-11#4)(2006-12#15)(2006-2#7)(2006-3#2)(2006-4#2)(2006-5#7)(2006-6#2)(2006-7#7)(2006-8#12)(2006-9#6)(2007-1#6)(2007-10#6)(2007-11#36)(2007-12#33)(2007-2#10)(2007-3#10)(2007-4#12)(2007-5#8)(2007-7#11)(2007-8#15)(2007-9#18)(2008-1#26)(2008-10#104)(2008-11#56)(2008-12#16)(2008-2#43)(2008-3#37)(2008-4#83)(2008-5#41)(2008-6#18)(2008-7#54)(2008-8#32)(2008-9#38)(2009-1#1)(2009-10#16)(2009-11#7)(2009-12#10)(2009-2#9)(2009-3#15)(2009-4#5)(2009-5#16)(2009-6#1)(2009-7#10)(2009-8#15)(2009-9#10)(2010-1#2)(2010-10#8)(2010-11#9)(2010-12#18)(2010-2#13)(2010-3#6)(2010-4#17)(2010-5#4)(2010-6#12)(2010-7#6)(2010-8#12)(2010-9#8)(2011-1#27)(2011-12#12)(2011-2#44)(2011-3#2)(2011-8#1)(2011-9#1)(2012-1#13)(2012-11#3)(2012-12#25)(2012-2#34)(2012-3#20)(2012-8#1)(2013-1#27)(2013-7#3)(2013-8#29)
variety on##2##2##(2008-10#1)(2011-2#1)
variety was##2##2##(2008-12#1)(2008-5#1)
variety were##4##2##(2008-12#2)(2011-2#1)(2012-11#1)
variety##1937##1##(1990-10#1)(1990-11#5)(1990-12#3)(1990-2#5)(1990-3#4)(1990-4#2)(1990-5#3)(1990-6#3)(1990-7#3)(1990-8#5)(1990-9#5)(1991-1#6)(1991-10#4)(1991-11#3)(1991-12#5)(1991-2#4)(1991-3#5)(1991-4#2)(1991-5#5)(1991-6#3)(1991-7#4)(1991-8#4)(1991-9#4)(1992-1#5)(1992-11#7)(1992-12#3)(1992-2#4)(1992-3#6)(1992-4#3)(1992-5#2)(1992-6#7)(1992-7#6)(1992-9#4)(1993-1#1)(1993-11#8)(1993-12#8)(1993-2#10)(1993-3#7)(1993-4#8)(1993-5#1)(1993-6#5)(1993-7#2)(1993-8#1)(1993-9#4)(1994-1#3)(1994-10#3)(1994-11#12)(1994-12#11)(1994-2#7)(1994-3#8)(1994-5#8)(1994-6#5)(1994-8#14)(1994-9#12)(1995-1#9)(1995-10#4)(1995-11#5)(1995-12#11)(1995-2#7)(1995-3#13)(1995-4#2)(1995-5#7)(1995-6#7)(1995-8#4)(1996-1#7)(1996-10#8)(1996-11#6)(1996-12#14)(1996-2#9)(1996-3#9)(1996-4#3)(1996-5#9)(1996-6#1)(1996-7#4)(1996-8#4)(1996-9#2)(1997-1#4)(1997-2#12)(1997-3#8)(1997-4#16)(1997-5#7)(1997-6#4)(1997-7#8)(1997-8#7)(2004-1#1)(2004-11#3)(2004-12#3)(2004-3#3)(2004-9#1)(2005-10#8)(2005-11#10)(2005-12#3)(2005-3#1)(2005-5#1)(2005-6#3)(2005-7#15)(2005-8#15)(2005-9#1)(2006-1#2)(2006-10#56)(2006-11#4)(2006-12#15)(2006-2#8)(2006-3#2)(2006-4#2)(2006-5#7)(2006-6#2)(2006-7#7)(2006-8#12)(2006-9#6)(2007-1#6)(2007-10#6)(2007-11#38)(2007-12#33)(2007-2#12)(2007-3#11)(2007-4#13)(2007-5#8)(2007-7#18)(2007-8#16)(2007-9#18)(2008-1#27)(2008-10#111)(2008-11#58)(2008-12#32)(2008-2#44)(2008-3#37)(2008-4#84)(2008-5#47)(2008-6#19)(2008-7#55)(2008-8#32)(2008-9#42)(2009-1#1)(2009-10#16)(2009-11#7)(2009-12#10)(2009-2#9)(2009-3#15)(2009-4#5)(2009-5#16)(2009-6#1)(2009-7#10)(2009-8#17)(2009-9#10)(2010-1#2)(2010-10#8)(2010-11#9)(2010-12#18)(2010-2#13)(2010-3#6)(2010-4#17)(2010-5#4)(2010-6#13)(2010-7#6)(2010-8#13)(2010-9#8)(2011-1#27)(2011-12#13)(2011-2#53)(2011-3#2)(2011-8#1)(2011-9#1)(2012-1#14)(2012-11#7)(2012-12#25)(2012-2#34)(2012-3#21)(2012-8#1)(2013-1#29)(2013-7#3)(2013-8#30)
varifocal lens##3##2##(2007-12#1)(2008-2#2)
varimax rotation##3##2##(1992-1#1)(1996-5#1)(2013-1#1)
varimax##4##1##(1992-1#1)(1996-5#1)(2008-7#1)(2013-1#1)
variogram##2##1##(1997-6#1)(2012-2#1)
variola##6##1##(2009-9#6)
various &quot##4##2##(1995-3#1)(1997-4#1)(2010-12#1)(2011-1#1)
various C11-substituents##2##2##(1996-8#2)
various DNA##6##2##(1995-1#1)(1997-6#1)(1997-7#1)(2008-11#1)(2008-8#2)
various P2Y##2##2##(2008-4#2)
various PTMs##2##2##(2012-3#2)
various SH-reagents on p60v-src##2##4##(1990-11#2)
various abnormalities##3##2##(1995-2#1)(2008-8#1)(2011-12#1)
various acid##2##2##(1996-5#1)(2008-1#1)
various activities of the##4##4##(2007-2#3)(2011-2#1)
various activities of##5##3##(1996-5#1)(2007-2#3)(2011-2#1)
various activities##8##2##(1996-5#1)(2007-2#3)(2009-10#2)(2011-2#1)(2013-1#1)
various actors##2##2##(1993-3#1)(1997-3#1)
various advantages##3##2##(2008-10#1)(2008-2#1)(2012-3#1)
various adverse effects##2##3##(1997-5#1)(2012-3#1)
various adverse##4##2##(1993-12#1)(1997-5#1)(2009-5#1)(2012-3#1)
various aetiologies##2##2##(1991-5#1)(2010-10#1)
various age groups##8##3##(1994-11#1)(2006-2#1)(2007-6#1)(2010-12#3)(2012-12#1)(2012-2#1)
various agents##11##2##(1990-3#1)(1991-12#1)(1992-4#1)(1992-5#1)(2007-11#1)(2007-2#1)(2008-5#1)(2008-6#1)(2009-8#2)(2011-2#1)
various ages##10##2##(1991-10#1)(1992-5#1)(1993-7#1)(1993-9#1)(1995-9#1)(1996-1#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-5#1)
various agricultural##2##2##(2008-10#1)(2013-1#1)
various ailments##4##2##(2007-6#1)(2008-4#1)(2008-7#1)(2011-2#1)
various air##2##2##(1995-3#1)(2008-10#1)
various alcohols##2##2##(1994-9#1)(2007-12#1)
various algorithms##3##2##(2008-2#1)(2008-3#2)
various alloys and biological samples##2##5##(2008-10#2)
various alterations of##2##3##(1991-7#1)(1994-2#1)
various alterations##4##2##(1991-7#1)(1994-2#1)(2006-6#1)(2007-10#1)
various amino acids were##2##4##(1997-8#2)
various amino acids##5##3##(1996-5#1)(1997-8#2)(2008-10#1)(2012-2#1)
various amounts of##14##3##(1990-8#1)(1991-5#1)(1992-11#1)(1992-6#1)(1992-9#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2012-2#1)
various analytes##4##2##(2008-10#3)(2013-7#1)
various analytical##6##2##(2005-11#1)(2008-10#3)(2008-7#1)(2010-11#1)
various anatomic##2##2##(1994-3#1)(2012-1#1)
various anatomical##3##2##(1990-4#1)(1995-1#1)(2008-10#1)
various angles of incidence##2##4##(2006-7#1)(2007-12#1)
various angles of##4##3##(2006-7#1)(2007-12#1)(2007-7#2)
various angles##6##2##(2006-6#1)(2006-7#1)(2007-12#1)(2007-7#2)(2008-2#1)
various animal models##3##3##(2007-8#1)(2008-4#1)(2008-7#1)
various animal##8##2##(1990-6#1)(1995-6#1)(2007-8#1)(2008-4#2)(2008-7#1)(2011-1#1)(2013-7#1)
various animals##4##2##(1992-8#1)(1993-11#1)(2007-2#1)(2008-7#1)
various anti-inflammatory##2##2##(1994-11#1)(2009-11#1)
various antibiotics in##2##3##(2008-12#1)(2011-2#1)
various antibiotics##6##2##(1990-5#1)(2007-11#1)(2008-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
various antibody##2##2##(1997-2#1)(2007-7#1)
various anticancer##3##2##(1994-3#1)(1997-4#1)(2008-7#1)
various antigens##4##2##(1995-5#1)(2008-11#2)(2008-4#1)
various antihypertensive drug##2##3##(1996-9#2)
various application##3##2##(2009-11#1)(2009-3#1)(2012-12#1)
various applications of##3##3##(1994-6#1)(2008-3#1)(2008-8#1)
various applications##18##2##(1993-3#1)(1994-6#1)(2004-9#1)(2005-11#1)(2006-12#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-12#1)
various approaches to the##2##4##(1990-9#1)(2008-3#1)
various approaches to##8##3##(1990-9#1)(1993-2#1)(1995-2#1)(1997-6#1)(2005-5#1)(2008-3#1)(2008-4#1)(2010-5#1)
various approaches##16##2##(1990-9#1)(1993-2#1)(1995-2#1)(1997-6#1)(2005-5#1)(2005-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#3)(2009-11#1)(2009-12#1)(2010-3#1)(2010-5#1)
various approximations for computing the absorption efficiency and single-scattering albedo of##2##11##(2008-3#2)
various areas of##7##3##(1991-12#1)(1994-8#1)(2005-8#1)(2007-11#1)(2007-8#1)(2008-9#2)
various arrangements##2##2##(1996-2#1)(2012-12#1)
various aspects in##2##3##(2007-12#1)(2010-6#1)
various aspects of drug##2##4##(2005-7#1)(2006-8#1)
various aspects of gene##2##4##(1995-2#1)(2012-3#1)
various aspects of the##15##4##(1990-5#1)(1990-9#1)(1996-12#1)(1997-2#1)(2005-8#1)(2006-8#1)(2007-1#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-9#1)(2009-10#1)(2009-12#1)(2011-2#2)
various aspects of their##2##4##(1992-6#1)(2007-3#1)
various aspects of this##2##4##(2007-7#1)(2011-2#1)
various aspects of##64##3##(1990-5#1)(1990-9#1)(1992-4#1)(1992-6#2)(1994-5#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#1)(1997-2#2)(2005-7#2)(2005-8#2)(2006-10#2)(2006-5#2)(2006-8#8)(2007-1#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-9#1)(2010-10#2)(2010-8#2)(2010-9#1)(2011-2#4)(2012-1#1)(2012-3#2)(2013-1#1)
various aspects##75##2##(1990-5#1)(1990-9#1)(1992-4#1)(1992-6#2)(1993-5#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#1)(1997-2#2)(2005-7#2)(2005-8#2)(2006-10#2)(2006-5#2)(2006-8#8)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-5#1)(2009-9#1)(2010-10#2)(2010-2#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
various atmospheric##2##2##(2006-12#1)(2008-10#1)
various attempts##3##2##(1991-3#1)(2007-11#1)(2011-1#1)
various authors have##3##3##(1997-2#1)(2009-10#1)(2011-2#1)
various authors##7##2##(1996-3#1)(1997-2#1)(2006-6#1)(2009-10#1)(2010-7#1)(2011-2#1)(2013-1#1)
various autoimmune##3##2##(2006-10#1)(2007-11#1)(2010-5#1)
various available##3##2##(2006-1#1)(2008-4#1)(2010-12#1)
various bacterial proteinases##2##3##(1997-2#2)
various bacterial##7##2##(1990-9#1)(1993-2#1)(1993-9#1)(1997-2#2)(2007-11#1)(2013-1#1)
various base##3##2##(1995-6#1)(2008-10#2)
various batches of##2##3##(2009-6#1)(2010-4#1)
various behavioral##4##2##(1991-2#1)(1992-9#1)(1996-5#1)(2008-8#1)
various behavioural##2##2##(2005-10#1)(2008-11#1)
various binary##2##2##(2008-10#1)(2008-2#1)
various binding##2##2##(2008-4#1)(2013-1#1)
various biochemical parameters##4##3##(1997-8#1)(2008-5#1)(2010-12#1)(2012-2#1)
various biochemical##8##2##(1991-10#1)(1997-8#1)(2008-11#2)(2008-5#1)(2010-12#1)(2012-2#1)(2013-1#1)
various biologic##3##2##(1995-12#1)(2006-10#1)(2011-2#1)
various biological activities##3##3##(1997-6#1)(2008-10#1)(2008-5#1)
various biological and##2##3##(2012-12#1)(2013-8#1)
various biological fluids##3##3##(1995-11#1)(1996-12#1)(1996-2#1)
various biological functions##2##3##(1992-11#1)(2008-9#1)
various biological processes##3##3##(1990-12#1)(2008-7#1)(2012-11#1)
various biological##24##2##(1990-12#1)(1991-5#1)(1992-11#1)(1992-6#1)(1993-7#1)(1994-8#1)(1995-11#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2013-8#1)
various biomedical applications##4##3##(2008-5#2)(2009-3#1)(2011-1#1)
various biomedical##6##2##(2008-5#2)(2009-3#1)(2010-1#1)(2010-4#1)(2011-1#1)
various biomolecules##6##2##(1996-1#1)(2008-10#1)(2008-9#1)(2010-5#2)(2011-2#1)
various biopolymers##2##2##(2006-10#1)(2006-12#1)
various blood##6##2##(1992-3#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-3#1)
various body fluids of##2##4##(1991-9#1)(1995-1#1)
various body fluids##3##3##(1991-9#1)(1995-1#2)
various body systems##4##3##(2006-1#1)(2008-12#1)(2009-10#1)(2013-1#1)
various body##11##2##(1991-9#1)(1992-3#1)(1995-1#2)(2006-1#1)(2006-11#1)(2007-12#1)(2008-12#1)(2009-10#1)(2013-1#2)
various bone##2##2##(1992-7#1)(2008-5#1)
various brain regions##4##3##(1991-4#1)(1995-6#1)(1996-2#1)(2006-7#1)
various brain##7##2##(1991-12#1)(1991-4#1)(1994-2#1)(1995-5#1)(1995-6#1)(1996-2#1)(2006-7#1)
various branches of##4##3##(2007-7#1)(2008-7#1)(2012-2#2)
various brands of##4##3##(1996-8#1)(2007-11#1)(2008-10#1)(2013-1#1)
various business##2##2##(1993-1#1)(2007-4#1)
various calcium##2##2##(2005-3#1)(2012-2#1)
various cancer cell lines##3##4##(2007-1#1)(2008-11#2)
various cancer##6##2##(1993-8#1)(2007-1#1)(2008-1#1)(2008-11#2)(2012-3#1)
various cancers##5##2##(2008-9#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
various carbohydrates##5##2##(2007-7#1)(2008-10#3)(2008-6#1)
various carbon##5##2##(1990-9#1)(2008-10#2)(2008-5#1)(2008-8#1)
various cardiac glycosides##2##3##(2007-1#2)
various cardiac##4##2##(2007-1#3)(2008-4#1)
various cardiovascular diseases##2##3##(1993-5#1)(1997-7#1)
various cardiovascular##5##2##(1993-5#1)(1993-9#1)(1997-7#1)(2008-1#1)(2013-1#1)
various cases of##2##3##(2008-2#1)(2008-3#1)
various cases##5##2##(1997-6#1)(2005-11#1)(2007-11#1)(2008-2#1)(2008-3#1)
various caspases##2##2##(2008-1#1)(2008-11#1)
various categories of##3##3##(1992-8#1)(2011-2#1)(2012-12#1)
various categories##7##2##(1992-8#1)(2006-9#1)(2007-11#2)(2011-2#2)(2012-12#1)
various cationic##7##2##(2008-10#6)(2008-11#1)
various causes of##6##3##(2005-8#1)(2007-7#3)(2008-11#1)(2012-2#1)
various causes##16##2##(1994-6#1)(1996-3#1)(2005-8#2)(2007-11#1)(2007-7#3)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
various cell lines##8##3##(1990-10#1)(1990-11#1)(1992-11#1)(1993-3#1)(1996-1#1)(2007-2#1)(2008-11#1)(2008-6#1)
various cell types and##2##4##(1995-3#1)(2012-12#1)
various cell types of##4##4##(1991-10#3)(1994-3#1)
various cell types with##2##4##(1991-10#1)(2008-7#1)
various cell types##21##3##(1991-10#4)(1994-11#1)(1994-3#1)(1995-1#1)(1995-3#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-7#2)(2011-1#1)(2012-11#2)(2012-12#1)(2012-3#1)(2013-8#1)
various cell##41##2##(1990-10#1)(1990-11#1)(1991-10#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-1#1)(1997-6#1)(1997-7#1)(2007-2#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-8#1)(2010-7#2)(2011-1#1)(2012-11#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
various cells and tissues##2##4##(1993-6#1)(1995-6#1)
various cells##7##2##(1992-11#1)(1993-6#1)(1995-6#1)(2006-10#1)(2007-2#1)(2008-11#1)(2008-9#1)
various cellular and##2##3##(1990-3#1)(2008-11#1)
various cellular##12##2##(1990-3#1)(1994-8#1)(1995-11#1)(2007-8#1)(2008-11#1)(2008-6#1)(2009-12#1)(2009-8#2)(2010-11#1)(2010-12#1)(2012-3#1)
various cerebral##3##2##(1997-2#2)(1997-3#1)
various challenges##3##2##(2009-9#1)(2011-1#1)(2011-2#1)
various changes in##2##3##(2008-10#1)(2009-4#1)
various characteristics of##3##3##(1992-1#1)(1992-5#1)(2008-2#1)
various characteristics##4##2##(1992-1#1)(1992-4#1)(1992-5#1)(2008-2#1)
various chemical and##2##3##(1996-1#1)(2011-2#1)
various chemical elements##2##3##(2008-10#1)(2008-5#1)
various chemical modifiers##4##3##(2008-10#4)
various chemical##18##2##(1990-2#1)(1992-2#1)(1992-4#1)(1996-1#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#8)(2008-3#1)(2008-5#1)(2011-2#1)
various chemistries##2##2##(2008-5#1)(2008-7#1)
various chemotherapeutic agents##2##3##(2007-12#1)(2012-2#1)
various chemotherapeutic##3##2##(1996-6#1)(2007-12#1)(2012-2#1)
various chromatographic##2##2##(2008-10#1)(2011-2#1)
various chronic##7##2##(1990-12#1)(1990-8#1)(1991-3#1)(2008-3#1)(2008-8#1)(2009-12#1)(2013-7#1)
various circumstances##2##2##(2008-9#1)(2012-2#1)
various classes of##5##3##(1990-3#2)(1996-2#1)(2012-12#1)(2013-8#1)
various classes##8##2##(1990-3#2)(1991-8#1)(1995-10#1)(1996-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
various cleavage##2##2##(1993-6#1)(1997-3#1)
various clinical and##4##3##(2008-7#1)(2012-11#2)(2013-1#1)
various clinical aspects##2##3##(2006-8#1)(2009-8#1)
various clinical conditions##3##3##(1992-4#1)(2007-8#1)(2008-4#1)
various clinical manifestations##2##3##(1993-8#1)(2007-5#1)
various clinical specimens##3##3##(2007-8#3)
various clinical syndromes##2##3##(2006-8#1)(2008-11#1)
various clinical##35##2##(1991-3#1)(1992-4#1)(1993-2#1)(1993-8#1)(1997-3#1)(2005-12#1)(2005-9#1)(2006-8#5)(2007-1#1)(2007-12#1)(2007-5#1)(2007-7#3)(2007-8#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-8#1)(2010-8#1)(2011-2#1)(2012-11#2)(2013-1#3)
various cognitive##2##2##(2006-7#1)(2012-2#1)
various collapsing##2##2##(2012-3#2)
various combination##2##2##(2008-3#1)(2011-2#1)
various combinations by##2##3##(1994-9#1)(2008-11#1)
various combinations of##22##3##(1992-3#1)(1993-8#1)(1996-12#3)(1997-2#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-8#1)(2007-1#1)(2007-11#1)(2007-9#2)(2008-10#1)(2008-2#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#1)
various combinations##34##2##(1992-3#1)(1993-11#1)(1993-8#1)(1994-9#1)(1996-12#3)(1997-2#1)(1997-4#2)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-1#2)(2007-11#1)(2007-9#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#1)(2010-6#1)(2013-1#1)
various commercially available##4##3##(2008-3#1)(2008-6#1)(2012-2#1)(2013-7#1)
various common##2##2##(1990-8#1)(2013-1#1)
various complex##5##2##(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)
various complexes##4##2##(1994-12#1)(2005-11#1)(2008-10#1)(2011-1#1)
various complications##4##2##(1990-5#1)(2007-8#1)(2007-9#1)(2013-1#1)
various component##3##2##(2006-3#1)(2008-2#1)(2011-2#1)
various components in##2##3##(2007-12#1)(2009-10#1)
various components of the cell##2##5##(1996-4#1)(2008-4#1)
various components of the##12##4##(1990-4#1)(1993-6#1)(1995-3#1)(1996-4#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2012-2#1)
various components of##24##3##(1990-12#1)(1990-4#1)(1991-2#1)(1992-12#1)(1993-6#1)(1994-8#1)(1995-3#2)(1996-3#1)(1996-4#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)
various components##34##2##(1990-12#1)(1990-4#1)(1991-2#1)(1992-12#1)(1993-6#1)(1994-8#1)(1995-3#2)(1996-3#1)(1996-4#1)(2006-10#1)(2006-4#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-10#1)(2011-2#1)(2012-2#1)
various compositions##5##2##(1991-3#1)(2005-11#1)(2008-10#2)(2012-2#1)
various compounds##14##2##(1990-7#1)(1992-5#1)(1992-6#1)(1993-12#1)(2005-10#1)(2006-12#1)(2006-2#1)(2007-11#1)(2008-10#3)(2008-11#1)(2010-6#1)(2013-1#1)
various concentration of##3##3##(2005-4#1)(2008-11#1)(2008-12#1)
various concentration##5##2##(2005-4#1)(2008-10#2)(2008-11#1)(2008-12#1)
various concentrations (0##5##3##(1992-8#1)(1995-12#1)(2008-10#1)(2011-12#1)(2012-2#1)
various concentrations of NaCl##2##4##(1994-12#1)(2012-7#1)
various concentrations of standard##2##4##(2008-10#2)
various concentrations of the##3##4##(1991-6#1)(1996-12#1)(1996-5#1)
various concentrations of##44##3##(1990-4#1)(1990-9#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-5#1)(1992-7#1)(1992-8#2)(1993-3#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-8#1)(2005-11#1)(2006-5#2)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#1)(2011-2#2)(2012-2#1)(2012-7#1)(2013-8#2)
various concentrations##57##2##(1990-4#1)(1990-9#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-5#1)(1992-7#1)(1992-8#3)(1993-12#1)(1993-3#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-11#2)(2006-5#2)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#2)(2008-8#1)(2011-12#1)(2011-2#2)(2012-2#2)(2012-7#1)(2013-8#2)
various conditions have been##4##4##(1996-6#1)(2007-7#1)(2007-9#1)(2008-10#1)
various conditions##26##2##(1990-11#1)(1990-8#1)(1992-6#1)(1993-9#1)(1994-12#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-3#1)(2005-11#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2011-3#1)(2012-1#1)(2012-3#1)(2013-7#1)
various configurations of the##2##4##(2007-12#2)
various configurations of##3##3##(2007-12#2)(2008-2#1)
various configurations##5##2##(2007-12#2)(2008-2#2)(2008-3#1)
various congenital##2##2##(1990-6#1)(2010-12#1)
various contexts##2##2##(2008-2#1)(2009-5#1)
various control##4##2##(1990-2#1)(1993-10#1)(2007-8#1)(2008-11#1)
various conventional##2##2##(2008-10#1)(2010-5#1)
various cosmetic##3##2##(2008-5#2)(2008-7#1)
various countries of the##2##4##(2011-1#1)(2013-8#1)
various countries##10##2##(1993-3#1)(1994-5#1)(2006-2#1)(2008-1#1)(2008-10#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
various criteria##5##2##(1994-2#1)(2007-6#1)(2008-2#1)(2008-6#1)(2011-2#1)
various crops##4##2##(2008-10#4)
various cultural##3##2##(2008-8#1)(2009-6#1)(2011-2#1)
various culture##5##2##(2006-5#1)(2007-12#1)(2008-11#1)(2008-7#1)(2012-2#1)
various cytokines##7##2##(1990-3#1)(1993-6#1)(1993-8#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-4#1)
various cytotoxic##3##2##(1997-7#1)(2008-1#1)(2008-3#1)
various data##5##2##(1995-2#1)(1995-3#1)(2008-7#2)(2009-10#1)
various days##2##2##(1995-12#1)(2010-10#1)
various defense##2##2##(2005-1#1)(2009-6#1)
various definitions of##2##3##(2008-5#1)(2009-7#1)
various definitions##3##2##(2007-3#1)(2008-5#1)(2009-7#1)
various degenerative##2##2##(2007-11#1)(2008-1#1)
various degrees of occlusion##2##4##(2010-4#2)
various degrees of##15##3##(1995-9#1)(2006-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#2)(2010-4#2)(2012-3#1)
various degrees##23##2##(1991-12#1)(1993-3#1)(1995-6#1)(1995-9#1)(2005-10#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#2)(2010-4#2)(2012-2#1)(2012-3#1)
various deletions##2##2##(1990-12#1)(2008-7#1)
various demographic##6##2##(2006-8#1)(2007-10#1)(2012-2#3)(2013-1#1)
various design##2##2##(1997-4#1)(2008-2#1)
various detergents##3##2##(1990-2#1)(1990-7#1)(1996-5#1)
various developmental stages of##2##4##(2008-10#1)(2008-8#1)
various developmental stages##5##3##(1995-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
various developmental##6##2##(1995-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-9#1)
various devices##2##2##(2008-5#1)(2012-12#1)
various diagnoses##2##2##(1997-1#1)(2011-2#1)
various diagnostic##3##2##(1992-3#1)(2007-8#1)(2012-3#1)
various dietary##6##2##(1990-5#1)(1993-5#1)(2006-10#1)(2006-9#1)(2008-5#2)
various different##5##2##(1997-4#1)(2007-4#1)(2007-8#1)(2008-7#1)(2012-1#1)
various differentiation##2##2##(1991-7#1)(1992-8#1)
various diffraction orders##2##3##(2008-2#1)(2008-3#1)
various diluents having low dielectric constants##2##6##(2008-10#2)
various diluents of low dielectric##2##5##(2008-10#2)
various diluents##6##2##(2008-10#6)
various dimensions of##4##3##(1992-3#1)(1993-1#1)(2008-11#1)(2008-2#1)
various dipeptides##3##2##(1993-12#1)(1994-8#1)(2011-2#1)
various disciplines##8##2##(1992-2#1)(1994-2#1)(1997-3#1)(2007-11#2)(2008-3#1)(2008-8#1)(2009-5#1)
various disease processes##2##3##(1995-10#1)(2007-1#1)
various disease states##8##3##(1992-12#1)(1993-11#1)(2005-8#1)(2006-10#2)(2008-9#1)(2010-12#1)(2011-2#1)
various disease##12##2##(1992-12#1)(1993-11#1)(1995-10#1)(2005-8#1)(2006-10#2)(2007-1#1)(2007-9#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)
various diseases in##3##3##(1991-11#1)(1997-2#1)(2013-8#1)
various diseases such as##3##4##(2006-10#1)(2009-8#1)(2012-12#1)
various diseases##39##2##(1990-10#1)(1991-11#1)(1991-12#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-6#1)(2005-3#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#2)(2009-3#1)(2009-8#1)(2010-1#1)(2010-2#1)(2011-1#2)(2012-1#1)(2012-12#3)(2012-3#2)(2013-8#2)
various disorders##7##2##(2007-3#1)(2008-10#2)(2009-11#1)(2009-2#1)(2011-2#1)(2012-12#1)
various domains of the##2##4##(1995-3#1)(1996-12#1)
various domains of##4##3##(1995-3#1)(1996-12#1)(2008-7#1)(2012-2#1)
various dosage##2##2##(2007-11#1)(2012-12#1)
various dose levels##3##3##(1994-5#1)(2008-6#1)(2009-5#1)
various dose##4##2##(1994-3#1)(1994-5#1)(2008-6#1)(2009-5#1)
various doses and##3##3##(1990-3#1)(2008-3#1)(2009-3#1)
various doses of##13##3##(1991-10#1)(1993-6#1)(1994-3#1)(1995-8#1)(1996-4#1)(1996-6#1)(2006-4#1)(2008-11#2)(2008-5#2)(2008-7#2)
various doses##17##2##(1990-3#1)(1991-10#1)(1993-6#1)(1994-3#1)(1995-8#1)(1996-4#1)(1996-6#1)(1997-8#1)(2006-4#1)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#2)(2009-3#1)
various dosing##2##2##(2009-8#1)(2011-2#1)
various drug##3##2##(1993-9#1)(2005-9#1)(2010-8#1)
various drugs and##2##3##(2008-10#1)(2012-2#1)
various drugs in##2##3##(2007-11#1)(2008-2#1)
various drugs used in##2##4##(2010-11#1)(2010-2#1)
various drugs##16##2##(1990-8#1)(1991-12#1)(1994-8#1)(2005-12#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-2#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
various ecological##2##2##(2008-8#1)(2013-8#1)
various effects of##3##3##(1992-7#1)(2007-11#1)(2009-1#1)
various effects##5##2##(1992-7#1)(1994-8#1)(2007-11#1)(2009-1#1)(2013-1#1)
various electrolyte##2##2##(2005-11#1)(2010-4#1)
various electron##3##2##(1995-3#1)(2009-11#1)(2012-3#1)
various electrophiles##2##2##(2009-9#1)(2010-5#1)
various elements of the##2##4##(1993-3#1)(2008-3#1)
various elements of##4##3##(1993-3#1)(2006-8#1)(2008-3#1)(2008-4#1)
various elements##9##2##(1993-3#1)(1994-3#2)(2006-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2011-2#1)
various endoscopic##3##2##(2006-5#1)(2007-3#1)(2010-9#1)
various environmental and##2##3##(2006-12#1)(2008-10#1)
various environmental conditions##5##3##(2005-12#1)(2008-10#1)(2008-3#1)(2010-2#2)
various environmental samples##4##3##(2008-10#3)(2008-6#1)
various environmental stresses##2##3##(2008-9#1)(2012-1#1)
various environmental##19##2##(1994-3#1)(1996-12#1)(2005-12#1)(2006-12#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-2#2)(2012-1#1)
various enzymatic assays##2##3##(1990-2#1)(2008-10#1)
various enzymatic##4##2##(1990-2#2)(2008-10#1)(2010-10#1)
various enzyme##2##2##(1990-12#1)(1996-1#1)
various enzymes involved in##2##4##(1993-5#1)(2011-2#1)
various enzymes##5##2##(1992-6#1)(1993-12#1)(1993-5#1)(2009-2#1)(2011-2#1)
various epithelial##3##2##(1992-7#1)(1993-3#1)(2008-4#1)
various established##2##2##(1990-5#1)(2011-2#1)
various ethnic groups##2##3##(2008-5#1)(2012-2#1)
various etiologies##2##2##(2006-8#1)(2010-6#1)
various etiology##2##2##(2008-4#1)(2008-6#1)
various eucaryotic##2##2##(1992-2#1)(1995-3#1)
various events##2##2##(2008-6#1)(2010-10#1)
various excitation##2##2##(2008-1#1)(2008-3#1)
various exogenous##2##2##(1990-5#1)(2008-5#1)
various experimental conditions##4##3##(1991-2#1)(1997-8#1)(2007-6#1)(2008-10#1)
various experimental parameters##3##3##(2008-10#2)(2010-4#1)
various experimental##14##2##(1991-2#1)(1997-8#1)(2005-11#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#1)(2010-4#1)
various experts##2##2##(1993-12#1)(2008-6#1)
various explanations##3##2##(2005-9#1)(2008-8#1)(2010-1#1)
various exposure##4##2##(2008-10#2)(2008-7#1)(2009-4#1)
various expression##4##2##(1995-2#1)(1997-8#1)(2008-7#1)(2008-9#1)
various extended##2##2##(1992-9#1)(2008-2#1)
various extents##5##2##(1990-5#1)(1992-9#1)(1994-2#1)(1996-7#1)(2008-8#1)
various external##3##2##(1991-5#1)(1993-11#1)(2008-5#1)
various extractants##2##2##(2007-8#1)(2008-10#1)
various extracts##2##2##(2008-5#1)(2010-7#1)
various facets of##2##3##(1993-5#1)(2007-12#1)
various factors affecting the##2##4##(2008-10#1)(2008-5#1)
various factors affecting##4##3##(2008-10#1)(2008-2#1)(2008-5#1)(2012-12#1)
various factors are##2##3##(1997-3#1)(2013-8#1)
various factors in##3##3##(1990-9#1)(1996-2#1)(2013-8#1)
various factors involved in##4##4##(2005-10#1)(2006-5#1)(2007-7#1)(2008-3#1)
various factors such as##2##4##(2006-7#1)(2010-5#1)
various factors that##6##3##(1990-3#1)(1992-2#1)(1994-4#1)(2007-10#1)(2008-2#1)(2013-1#1)
various factors##48##2##(1990-3#1)(1990-9#1)(1992-2#2)(1992-8#1)(1994-4#1)(1996-2#1)(1996-3#1)(1997-3#1)(2005-10#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-10#4)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#1)(2008-5#3)(2008-7#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#5)
various fatty acids##2##3##(1991-5#1)(2013-8#1)
various features##3##2##(2005-10#1)(2008-3#1)(2010-2#1)
various fields##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
various filamentous fungi##2##3##(1994-5#1)(1997-2#1)
various findings##2##2##(1994-2#1)(2013-1#1)
various fish species##2##3##(2008-10#1)(2009-5#1)
various flow##2##2##(1991-3#1)(2010-8#1)
various food##3##2##(2008-10#2)(2011-2#1)
various foods##2##2##(2008-6#1)(2013-7#1)
various foodstuffs##2##2##(2008-10#1)(2012-2#1)
various foreign ions have been investigated##2##6##(2008-10#2)
various foreign ions have been##3##5##(2008-10#3)
various foreign ions##4##3##(2008-10#4)
various foreign##9##2##(1997-4#1)(2008-10#7)(2008-5#1)
various forms of stress##2##4##(1997-6#1)(2013-7#1)
various forms of##45##3##(1990-1#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-3#1)(1996-12#2)(1996-8#1)(1997-5#1)(1997-6#1)(2004-12#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-5#1)(2007-10#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
various forms##53##2##(1990-1#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-3#1)(1996-12#2)(1996-8#1)(1997-5#1)(1997-6#1)(2004-12#1)(2005-2#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-3#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#3)
various formulations##5##2##(2005-8#1)(2006-12#1)(2008-5#1)(2011-1#1)(2012-12#1)
various fractions of##2##3##(2008-10#1)(2008-7#1)
various fractions##4##2##(1996-8#1)(2008-10#2)(2008-7#1)
various fragments of##2##3##(1992-4#1)(1996-6#1)
various fragments##4##2##(1992-4#1)(1994-3#1)(1996-6#1)(2008-6#1)
various freshwaters##2##2##(2008-5#2)
various functional domains##3##3##(1994-6#2)(1997-1#1)
various functional groups##2##3##(1990-9#1)(2008-11#1)
various functional##9##2##(1990-9#1)(1994-6#2)(1997-1#2)(2008-11#2)(2010-5#1)(2012-11#1)
various functions of##2##3##(2008-2#1)(2012-1#1)
various functions##8##2##(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-1#1)(2012-2#1)
various fungal##2##2##(2012-2#2)
various fungi##2##2##(2008-10#2)
various gastrointestinal##2##2##(1991-3#1)(2013-1#1)
various gene##3##2##(2008-11#2)(2011-1#1)
various genes involved in##2##4##(2008-4#1)(2011-2#1)
various genes##5##2##(1995-8#1)(2008-4#1)(2009-8#1)(2011-2#2)
various genetic backgrounds##2##3##(1997-4#1)(2011-2#1)
various genetic##5##2##(1997-4#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
various genomic##3##2##(1996-3#1)(2008-7#1)(2009-5#1)
various geographic##3##2##(1997-6#1)(2008-10#2)
various geographical##2##2##(2008-10#1)(2013-8#1)
various geometries##4##2##(2008-10#1)(2008-7#1)(2011-1#1)(2012-11#1)
various glycolytic enzymes##2##3##(1997-4#2)
various group##3##2##(1992-9#1)(1994-2#1)(2011-7#1)
various groups have##2##3##(2006-8#1)(2009-6#1)
various groups of##10##3##(1991-2#1)(1994-11#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-7#1)(2008-8#2)(2010-12#1)(2012-2#1)
various groups##15##2##(1991-2#1)(1994-11#1)(1994-3#1)(2004-9#1)(2006-10#1)(2006-8#2)(2006-9#1)(2007-7#1)(2008-7#1)(2008-8#2)(2009-6#1)(2010-12#1)(2012-2#1)
various growth and##3##3##(2006-12#1)(2008-4#1)(2011-12#1)
various growth##12##2##(1990-10#1)(1993-9#1)(1994-9#1)(1996-6#1)(1997-1#1)(2006-12#1)(2008-4#1)(2008-5#2)(2009-4#1)(2011-12#1)(2013-1#1)
various habitats##3##2##(2005-11#1)(2009-6#1)(2011-1#1)
various hair##4##2##(2007-8#1)(2008-5#3)
various hard surfaces##2##3##(2013-1#2)
various health conditions and diseases##2##5##(2013-7#2)
various health problems##2##3##(1992-3#1)(2008-8#1)
various health services##3##3##(1996-1#1)(2005-5#2)
various health states##3##3##(1995-8#1)(2007-7#2)
various health##14##2##(1990-8#1)(1992-3#1)(1993-2#1)(1995-8#1)(1996-1#1)(2005-5#2)(2007-3#1)(2007-7#2)(2008-8#1)(2010-10#1)(2013-7#2)
various histological types of##3##4##(1996-9#2)(2011-2#1)
various histological types##4##3##(1996-9#2)(2008-6#1)(2011-2#1)
various histological##5##2##(1996-9#2)(2008-6#1)(2011-2#1)(2012-1#1)
various histopathological indexes##2##3##(2011-1#1)(2011-2#1)
various histopathological##4##2##(1996-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
various hormones##3##2##(1991-7#1)(1996-2#1)(2008-1#1)
various host##6##2##(2006-10#1)(2007-12#1)(2008-10#3)(2011-2#1)
various hosts and##3##3##(2008-10#3)
various hosts in##2##3##(2008-10#1)(2012-3#1)
various hosts##9##2##(1990-10#1)(2008-10#5)(2008-5#1)(2011-1#1)(2012-3#1)
various human and##2##3##(1993-12#2)
various human cell lines##2##4##(1992-12#1)(2007-11#1)
various human diseases##2##3##(1991-12#1)(2008-11#1)
various human tissues##9##3##(1990-12#1)(1991-5#1)(1991-7#1)(1991-9#1)(1993-6#1)(1995-2#1)(1995-6#1)(2008-8#2)
various human##32##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-12#2)(1993-3#2)(1993-6#1)(1995-2#1)(1995-6#1)(1997-7#2)(2005-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#1)(2013-1#1)
various humic##2##2##(2005-11#1)(2008-10#1)
various hydrocarbons##2##2##(2008-6#1)(2010-3#1)
various hypotheses##4##2##(2005-10#1)(2009-12#1)(2009-8#1)(2009-9#1)
various imaging##2##2##(1992-2#1)(2008-2#1)
various immune responses##2##3##(2008-11#1)(2010-5#1)
various immune##6##2##(2007-11#1)(2008-10#2)(2008-11#1)(2010-5#1)(2011-2#1)
various immunological##7##2##(1990-12#1)(1991-5#1)(1993-9#1)(2005-8#1)(2007-2#1)(2007-5#1)(2010-7#1)
various impact speeds##2##3##(2006-11#1)(2007-4#1)
various impact##5##2##(2006-11#2)(2007-1#1)(2007-4#2)
various impacts##2##2##(2006-11#1)(2008-2#1)
various important##3##2##(2008-3#2)(2012-2#1)
various in##5##2##(1994-10#1)(2008-10#1)(2009-11#1)(2009-12#1)(2009-4#1)
various indications##5##2##(1990-8#1)(2008-1#1)(2008-11#2)(2008-8#1)
various indicators of##3##3##(2007-2#1)(2008-11#1)(2013-7#1)
various indices of##3##3##(1995-12#1)(1996-1#1)(2010-8#1)
various indices##4##2##(1995-12#1)(1996-1#1)(2008-8#1)(2010-8#1)
various industrial##2##2##(2007-10#1)(2008-11#1)
various industries##2##2##(2010-12#1)(2011-12#1)
various infections##5##2##(2006-7#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-12#1)
various infectious##3##2##(2007-1#1)(2007-2#1)(2007-7#1)
various inflammatory cytokines##2##3##(2009-9#1)(2012-3#1)
various inflammatory joint diseases##2##4##(1994-3#1)(2010-5#1)
various inflammatory##14##2##(1990-2#1)(1994-3#1)(2006-10#1)(2006-12#1)(2008-4#1)(2008-5#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)
various inhibitors##2##2##(1991-10#1)(1992-2#1)
various inorganic##5##2##(2008-10#4)(2009-10#1)
various insulin##2##2##(1991-3#1)(2010-11#1)
various intensities of##2##3##(1990-7#1)(2008-7#1)
various interactions between##3##3##(2008-10#1)(2013-1#2)
various internal and external##2##4##(1992-12#1)(1996-1#1)
various internal and##3##3##(1992-12#1)(1996-1#1)(2008-5#1)
various internal##4##2##(1992-12#1)(1996-1#1)(2008-5#2)
various intervals##5##2##(2004-11#1)(2008-5#1)(2009-4#1)(2011-12#1)(2013-1#1)
various intervention##2##2##(2007-12#1)(2012-12#1)
various interventions##6##2##(1994-5#1)(2005-9#1)(2007-1#1)(2007-7#1)(2008-10#1)(2010-10#1)
various intracellular##3##2##(1996-7#1)(2008-4#1)(2008-5#1)
various ion##2##2##(2006-12#1)(2008-10#1)
various ionic strengths##5##3##(1992-6#1)(1992-9#1)(1997-7#1)(2008-10#2)
various ions##6##2##(2007-8#1)(2008-10#5)
various isolates of##2##3##(2008-10#1)(2008-12#1)
various isolates##6##2##(2007-7#2)(2008-10#2)(2008-12#1)(2008-5#1)
various issues##3##2##(1994-6#1)(2005-8#2)
various key##2##2##(1991-8#1)(2008-7#1)
various kinases##2##2##(1994-12#1)(1995-1#1)
various kinds of human##2##4##(1991-4#1)(1993-9#1)
various kinds of##22##3##(1991-4#2)(1991-5#1)(1992-5#1)(1993-9#2)(1994-6#1)(1995-11#1)(1995-2#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-1#1)(2012-2#1)(2013-1#2)
various kinds##23##2##(1991-4#2)(1991-5#1)(1992-5#1)(1993-9#2)(1994-6#1)(1995-11#1)(1995-2#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-6#1)(2010-1#1)(2012-2#1)(2013-1#2)
various known##2##2##(2008-5#1)(2010-12#1)
various laboratories##4##2##(1994-3#1)(2008-10#2)(2008-7#1)
various laser##2##2##(2007-12#1)(2008-2#1)
various learning##2##2##(1994-2#1)(2013-8#1)
various legal##2##2##(1993-12#1)(2007-10#1)
various lengths of the##2##4##(1992-12#1)(1996-5#1)
various lengths of##6##3##(1991-3#1)(1992-12#1)(1994-3#2)(1996-5#1)(2008-6#1)
various lengths##9##2##(1991-3#1)(1992-12#1)(1994-3#2)(1995-8#1)(1996-5#1)(2008-6#1)(2008-9#1)(2012-12#1)
various levels of rhIL-4##2##4##(2006-11#2)
various levels of suppressiveness##2##4##(2008-10#2)
various levels of##20##3##(1991-11#1)(1996-3#1)(2006-11#2)(2007-11#1)(2008-1#1)(2008-10#5)(2008-2#5)(2008-5#1)(2009-2#1)(2012-12#1)(2012-2#1)
various levels##31##2##(1991-11#1)(1992-3#1)(1993-7#2)(1996-3#1)(2006-11#2)(2007-11#2)(2008-1#2)(2008-10#5)(2008-2#5)(2008-5#1)(2009-10#1)(2009-2#1)(2009-4#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-8#1)
various ligands##4##2##(1993-7#1)(1996-6#1)(2008-10#1)(2008-4#1)
various lineages##2##2##(2010-3#1)(2012-12#1)
various linear##4##2##(1995-3#1)(2008-3#3)
various lipids##2##2##(1994-5#1)(2008-5#1)
various liver##4##2##(1991-10#1)(1996-4#2)(2008-11#1)
various local##2##2##(1992-11#1)(2005-7#1)
various locations in the##2##4##(2007-12#1)(2008-10#1)
various locations of##2##3##(1994-10#1)(2008-7#1)
various locations on##2##3##(2008-10#1)(2010-4#1)
various locations##16##2##(1991-5#1)(1994-10#1)(1994-8#1)(2007-10#2)(2007-12#2)(2008-10#3)(2008-5#1)(2008-7#2)(2010-12#1)(2010-4#1)(2010-8#1)
various lung##2##2##(2006-10#1)(2012-12#1)
various macromolecules##2##2##(2007-12#1)(2009-11#1)
various malignancies##6##2##(1990-1#1)(2008-6#1)(2010-10#1)(2010-12#2)(2011-2#1)
various malpositions and##2##3##(2010-7#2)
various mammalian##3##2##(1994-11#1)(1995-2#1)(2008-9#1)
various mammals##3##2##(1992-11#1)(1993-3#1)(2008-7#1)
various management options##2##3##(2008-6#1)(2008-8#1)
various management##3##2##(1994-3#1)(2008-6#1)(2008-8#1)
various manifestations of##3##3##(1990-12#1)(1993-9#1)(2007-2#1)
various manifestations##4##2##(1990-12#1)(1993-9#1)(2007-2#1)(2013-7#1)
various markers##3##2##(1995-9#1)(2008-10#1)(2010-12#1)
various materials##5##2##(2006-12#1)(2007-3#1)(2008-10#2)(2008-3#1)
various matrices##3##2##(2008-10#2)(2008-2#1)
various matrixes##2##2##(2008-10#1)(2008-5#1)
various matters##3##2##(1995-12#3)
various measures of##2##3##(2008-12#1)(2011-2#1)
various measures##5##2##(1992-11#1)(2008-12#1)(2008-4#1)(2010-6#1)(2011-2#1)
various mechanisms of##4##3##(1990-4#1)(1990-6#1)(2006-10#1)(2011-1#1)
various mechanisms##8##2##(1990-4#1)(1990-6#1)(2006-10#2)(2007-11#1)(2008-11#1)(2008-4#1)(2011-1#1)
various media##6##2##(2007-12#1)(2007-4#1)(2008-10#2)(2008-3#1)(2011-2#1)
various mediators of##2##3##(1990-5#1)(2007-9#1)
various medical and##2##3##(2008-7#1)(2013-8#1)
various medical conditions##4##3##(2007-8#1)(2012-3#1)(2013-1#2)
various medical##9##2##(2007-7#1)(2007-8#1)(2008-7#1)(2012-3#1)(2013-1#3)(2013-8#2)
various medicinal##2##2##(2008-11#1)(2012-11#1)
various membranes##2##2##(2008-10#1)(2008-7#1)
various mental##3##2##(1992-8#1)(1997-6#1)(2007-8#1)
various metabolic##7##2##(1993-3#1)(1997-5#1)(1997-6#1)(2005-3#1)(2008-1#1)(2011-1#1)(2012-2#1)
various metabolites##2##2##(2008-10#1)(2008-11#1)
various metal ions on the##2##5##(2008-10#2)
various metal ions##5##3##(1997-4#1)(2005-11#1)(2008-10#3)
various metal##7##2##(1997-4#1)(2005-11#1)(2008-10#5)
various metalloproteinase inhibitors##2##3##(1994-5#1)(2008-8#1)
various methodologies##6##2##(1994-9#1)(1995-2#1)(2008-10#1)(2008-3#1)(2010-10#1)(2011-1#1)
various methods and##2##3##(2007-9#1)(2008-2#1)
various methods are##3##3##(1994-6#1)(2007-11#1)(2012-2#1)
various methods for##4##3##(2005-10#1)(2008-12#1)(2008-4#1)(2012-3#1)
various methods in##3##3##(2007-7#1)(2007-8#1)(2008-2#1)
various methods of##16##3##(1991-11#1)(1992-9#1)(1995-11#1)(1995-9#1)(1996-3#1)(1997-2#1)(2004-3#1)(2007-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-7#1)(2012-1#1)
various methods that##2##3##(2004-10#1)(2008-5#1)
various methods to##3##3##(1993-10#1)(2008-3#1)(2011-12#1)
various methods with##2##3##(2008-2#1)(2012-11#1)
various methods##53##2##(1991-11#1)(1992-9#1)(1993-10#1)(1994-6#1)(1995-11#1)(1995-9#1)(1996-3#1)(1997-2#1)(1997-4#1)(2004-10#1)(2004-3#1)(2005-10#1)(2005-11#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#4)(2007-9#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-2#1)(2009-7#2)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
various modalities##5##2##(2006-10#1)(2007-12#1)(2008-8#1)(2009-4#1)(2010-2#1)
various model##4##2##(1990-2#1)(1992-2#1)(1997-3#1)(2008-11#1)
various models of##3##3##(2007-9#1)(2008-11#1)(2008-2#1)
various models##12##2##(1990-12#1)(1994-11#1)(1996-9#1)(2004-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)
various modes of##8##3##(1992-1#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2013-8#1)
various modes##9##2##(1992-1#1)(2005-8#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2013-8#1)
various modifications##5##2##(1996-6#1)(1997-3#1)(2006-10#1)(2007-9#1)(2009-8#1)
various molar ratios##2##3##(1990-2#1)(2008-5#1)
various molecular##10##2##(1990-8#1)(2007-9#1)(2008-10#5)(2009-1#1)(2010-11#1)(2013-1#1)
various molecules##3##2##(1990-8#1)(2006-10#1)(2008-7#1)
various mouse strains##2##3##(1990-11#1)(2008-10#1)
various mouse tissues##4##3##(1993-8#1)(1994-12#1)(2008-11#2)
various mouse##8##2##(1990-11#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-9#1)(2008-10#1)(2008-11#2)
various multilayer##2##2##(2007-11#1)(2008-2#1)
various muscle##2##2##(1995-5#1)(2012-2#1)
various mutant proteins##2##3##(1994-9#1)(1995-3#1)
various mutants##4##2##(1993-2#1)(1994-11#2)(1994-8#1)
various mutations in the##2##4##(1992-1#1)(1996-3#1)
various mutations in##3##3##(1992-1#1)(1996-3#1)(2009-5#1)
various natriuretic##2##2##(1990-12#2)
various natural and##2##3##(1995-2#1)(2008-10#1)
various natural##5##2##(1995-2#1)(1997-4#1)(2006-12#1)(2008-10#1)(2010-8#1)
various neuroendocrine##2##2##(1992-11#1)(2005-7#1)
various neurological##5##2##(1993-8#2)(1995-9#1)(2008-5#1)(2012-2#1)
various neuropeptides##3##2##(1994-11#1)(2004-3#1)(2013-8#1)
various neuropsychiatric disorders##5##3##(2012-2#5)
various neuropsychiatric##6##2##(2008-7#1)(2012-2#5)
various neurotransmitter##3##2##(1991-10#1)(1993-11#1)(2008-4#1)
various neurotransmitters##3##2##(2006-10#2)(2008-10#1)
various new##2##2##(2007-10#1)(2007-11#1)
various nf harmonics of the background signals##2##7##(2008-3#2)
various nf harmonics of##3##4##(2008-3#3)
various nuclear##2##2##(1991-2#1)(2007-9#1)
various nucleosides##2##2##(2006-3#1)(2008-4#1)
various nutritional##2##2##(1993-6#1)(2008-3#1)
various occupations##2##2##(1990-12#1)(2008-8#1)
various of##2##2##(2008-2#1)(2013-8#1)
various operating conditions##2##3##(2008-3#1)(2012-3#1)
various operational##2##2##(2007-8#1)(2008-3#1)
various operations##2##2##(2006-10#1)(2008-2#1)
various optical devices##2##3##(2008-2#2)
various optical elements##3##3##(2008-1#1)(2008-3#2)
various optical##12##2##(1992-9#1)(1994-6#1)(2008-1#1)(2008-2#4)(2008-3#5)
various options for##2##3##(2005-10#1)(2008-2#1)
various options##7##2##(1990-8#1)(1993-9#1)(2005-10#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#1)
various organ systems##2##3##(2008-8#1)(2011-2#1)
various organic acids##2##3##(2008-10#2)
various organic and inorganic##3##4##(2007-8#1)(2008-10#1)(2008-11#1)
various organic compounds##3##3##(2008-10#2)(2009-8#1)
various organic solvents##4##3##(2008-10#3)(2008-7#1)
various organic##16##2##(2007-8#1)(2008-10#11)(2008-11#1)(2008-7#1)(2009-10#1)(2009-8#1)
various organisms##6##2##(1995-2#1)(2006-10#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-11#1)
various organizations##4##2##(1991-12#1)(1995-9#1)(2008-2#1)(2012-3#1)
various organs and tissues##3##4##(2005-8#1)(2010-10#1)(2012-3#1)
various organs and##6##3##(2005-8#1)(2008-9#1)(2009-11#1)(2010-10#1)(2012-3#2)
various organs of##5##3##(1991-5#1)(1991-8#1)(1992-6#1)(1992-9#1)(1996-12#1)
various organs##32##2##(1990-12#2)(1991-12#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-6#1)(1992-9#3)(1994-4#1)(1994-6#1)(1996-12#1)(1997-4#1)(1997-8#1)(2005-8#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-9#2)(2009-11#1)(2010-10#1)(2010-9#1)(2012-12#4)(2012-2#1)(2012-3#2)
various origins##4##2##(2005-11#1)(2008-5#1)(2009-9#1)(2012-2#1)
various other types of cells##2##5##(1995-3#1)(2008-4#1)
various other types of##3##4##(1995-3#1)(2008-4#1)(2010-9#1)
various other##35##2##(1990-3#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-8#1)(1993-9#1)(1995-1#2)(1995-3#2)(1996-11#1)(1996-4#1)(1997-1#1)(1997-3#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-12#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#2)
various outcomes##3##2##(2005-8#1)(2007-11#1)(2008-11#1)
various oxidative##3##2##(1997-4#1)(2008-10#1)(2010-4#1)
various pH##5##2##(1991-8#1)(2008-10#2)(2008-4#1)(2008-5#1)
various pHs##4##2##(1990-10#1)(1992-12#1)(2008-10#2)
various pain##2##2##(2006-7#1)(2008-5#1)
various palliative##2##2##(2007-4#1)(2008-4#1)
various pancreatic##2##2##(2006-10#1)(2008-1#1)
various parameter##2##2##(2008-3#1)(2010-9#1)
various parameters such as##6##4##(2006-12#1)(2007-8#1)(2008-10#1)(2008-5#2)(2011-2#1)
various parameters that##2##3##(2008-10#1)(2008-5#1)
various parameters##27##2##(1990-6#1)(2006-12#1)(2007-8#1)(2008-10#9)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-6#1)(2011-2#2)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
various parts of the body##2##5##(1992-6#1)(2007-11#1)
various parts of the world##6##5##(2007-12#1)(2008-10#1)(2008-6#1)(2009-6#1)(2010-9#1)(2011-2#1)
various parts of the##16##4##(1992-11#1)(1992-6#1)(1994-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2009-6#1)(2009-9#1)(2010-9#1)(2011-2#1)(2012-1#1)
various parts of##24##3##(1992-11#1)(1992-6#1)(1994-10#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-6#1)(2009-9#1)(2010-7#2)(2010-9#1)(2011-2#3)(2012-1#1)
various parts##25##2##(1992-11#1)(1992-6#1)(1994-10#1)(1996-11#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-6#1)(2009-9#1)(2010-7#2)(2010-9#1)(2011-2#3)(2012-1#1)
various pathogenic##4##2##(1993-3#1)(2008-10#1)(2012-2#1)(2013-1#1)
various pathogens and##2##3##(2008-10#1)(2012-2#1)
various pathogens##6##2##(2006-10#1)(2008-10#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-2#1)
various pathologic##2##2##(2006-9#1)(2008-9#1)
various pathological conditions##6##3##(1992-2#1)(2005-12#1)(2006-9#1)(2007-8#1)(2011-2#1)(2012-2#1)
various pathological parameters of colon carcinoma##2##6##(2006-8#2)
various pathological parameters##3##3##(2006-8#3)
various pathological##12##2##(1992-2#1)(1996-4#1)(2005-12#1)(2006-8#3)(2006-9#1)(2007-8#1)(2008-8#1)(2009-3#1)(2011-2#1)(2012-2#1)
various pathologies##6##2##(2009-2#1)(2009-9#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)
various pathology##2##2##(1991-3#1)(1993-5#1)
various pathophysiological##2##2##(2012-1#1)(2013-8#1)
various pathways##4##2##(2007-5#1)(2008-11#1)(2009-1#1)(2011-2#1)
various patient groups##2##3##(2008-10#1)(2008-6#1)
various patient##5##2##(2006-10#2)(2008-10#1)(2008-6#1)(2011-2#1)
various patients##2##2##(2010-8#1)(2012-11#1)
various pattern##2##2##(1994-2#1)(2008-10#1)
various patterns of##4##3##(2006-6#1)(2007-12#1)(2011-2#1)(2012-3#1)
various patterns##5##2##(1996-9#1)(2006-6#1)(2007-12#1)(2011-2#1)(2012-3#1)
various people##2##2##(2007-3#1)(2008-2#1)
various peptide##3##2##(1992-6#1)(1994-8#1)(1995-6#1)
various peptides##5##2##(1991-3#1)(1991-4#1)(1991-5#3)
various periods of time##9##4##(1990-12#1)(1992-1#1)(1996-2#1)(1996-5#2)(1997-3#1)(1997-7#1)(2006-7#1)(2009-6#1)
various periods of##11##3##(1990-12#1)(1990-2#1)(1992-1#1)(1996-2#1)(1996-5#2)(1997-3#1)(1997-7#1)(2006-7#1)(2009-6#1)(2010-12#1)
various periods##13##2##(1990-12#1)(1990-2#1)(1992-1#1)(1996-2#1)(1996-5#2)(1997-3#1)(1997-7#1)(2006-7#1)(2006-8#1)(2008-10#1)(2009-6#1)(2010-12#1)
various perspectives##2##2##(1996-1#1)(2012-11#1)
various pharmaceutical##4##2##(2005-9#1)(2008-10#3)
various pharmacological agents##2##3##(1993-7#1)(2010-6#1)
various pharmacological##6##2##(1993-7#1)(2005-11#1)(2008-10#1)(2008-4#1)(2010-6#1)(2012-2#1)
various pharmacopoeias are responding with monographs or informational chapters addressing excipient functionality##2##12##(2012-2#2)
various phases of the##2##4##(1992-9#1)(1995-3#1)
various phases of##3##3##(1992-9#1)(1995-3#1)(1996-7#1)
various phases##5##2##(1992-9#1)(1995-3#1)(1996-7#1)(2007-11#1)(2008-4#1)
various phenotypic##2##2##(2007-12#1)(2008-8#1)
various phospholipids##2##2##(1991-4#2)
various physical##9##2##(1993-3#1)(1995-8#1)(1997-2#1)(2007-11#1)(2008-3#1)(2009-11#1)(2013-1#3)
various physico-chemical##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
various physicochemical studies##2##3##(2008-5#2)
various physicochemical##6##2##(2004-12#1)(2006-12#1)(2008-10#1)(2008-5#2)(2012-2#1)
various physiologic##2##2##(2008-10#1)(2010-12#1)
various physiological responses##2##3##(1993-2#1)(2008-4#1)
various physiological##7##2##(1990-10#1)(1993-2#1)(1993-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-4#1)
various plant species##4##3##(2008-10#2)(2009-8#1)(2010-12#1)
various plant##13##2##(1992-4#1)(1993-11#1)(1995-6#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-9#1)(2009-8#1)(2010-12#1)
various plasticizers##3##2##(2008-10#3)
various points##3##2##(1990-11#1)(2007-10#1)(2008-10#1)
various polymer##2##2##(2007-12#2)
various polymers##3##2##(2007-12#1)(2008-5#1)(2009-11#1)
various populations of##4##3##(1992-7#1)(2007-1#1)(2010-3#1)(2012-2#1)
various populations##10##2##(1991-1#1)(1992-7#1)(1997-8#1)(2006-10#1)(2006-9#1)(2007-1#2)(2008-1#1)(2010-3#1)(2012-2#1)
various portions of the##3##4##(1992-6#1)(2008-5#1)(2009-8#1)
various portions of##5##3##(1992-6#1)(1993-8#1)(2008-5#2)(2009-8#1)
various positions of##2##3##(2007-11#1)(2010-6#1)
various positions##6##2##(1995-5#1)(1997-5#1)(2007-11#1)(2007-12#1)(2010-6#1)(2011-2#1)
various possible##2##2##(1990-3#1)(2013-1#1)
various potential##4##2##(1997-2#1)(2008-1#1)(2008-12#1)(2008-5#1)
various poultry manure fractions##2##4##(2008-5#2)
various practical##3##2##(1991-12#1)(1995-6#1)(2012-2#1)
various presentations##2##2##(2008-5#1)(2011-1#1)
various preventive##2##2##(2007-7#1)(2009-3#1)
various primary##3##2##(1993-6#1)(2005-7#1)(2011-1#1)
various primates revealed##2##3##(1993-8#1)(2008-7#1)
various problems##6##2##(1990-9#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-12#1)
various procedures##9##2##(1990-10#1)(2006-8#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-5#1)(2012-3#1)(2013-1#1)
various processes involved in##3##4##(1994-11#1)(1994-8#1)(2007-11#1)
various processes##7##2##(1991-10#1)(1994-11#1)(1994-8#1)(2007-11#1)(2009-8#2)(2011-2#1)
various processing##4##2##(1992-8#1)(2008-10#1)(2008-5#2)
various products##2##2##(2007-6#1)(2013-7#1)
various professional##2##2##(1991-12#1)(2008-2#1)
various properties of the##3##4##(1990-1#1)(2006-10#1)(2008-2#1)
various properties of##4##3##(1990-1#1)(1997-6#1)(2006-10#1)(2008-2#1)
various properties##5##2##(1990-1#1)(1997-6#1)(2006-10#1)(2008-2#1)(2008-3#1)
various proportions of##3##3##(2008-10#2)(2009-6#1)
various proportions##6##2##(2007-12#1)(2008-10#4)(2009-6#1)
various proteases##2##2##(1991-1#1)(1994-6#1)
various protein kinase C##2##4##(1993-6#1)(2010-12#1)
various protein kinases##2##3##(1990-8#1)(2007-11#1)
various protein##5##2##(1990-8#1)(1993-6#1)(2007-11#1)(2008-2#1)(2010-12#1)
various proteins in##3##3##(1991-12#1)(1997-2#1)(2010-12#1)
various proteins including##2##3##(2008-8#2)
various proteins##15##2##(1991-12#1)(1991-9#1)(1993-3#1)(1995-5#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)(2012-2#1)
various proteomic techniques##2##3##(2010-12#2)
various proteomic##3##2##(2009-4#1)(2010-12#2)
various protocols##5##2##(1997-1#1)(2008-1#1)(2008-4#1)(2008-9#1)(2013-8#1)
various psychiatric disorders##4##3##(1996-6#1)(2007-7#1)(2009-4#1)(2012-2#1)
various psychiatric##5##2##(1996-6#1)(2007-7#1)(2009-10#1)(2009-4#1)(2012-2#1)
various public##2##2##(1995-6#1)(2011-2#1)
various public-private mix projects##2##4##(2013-7#2)
various published reports##2##3##(2004-3#1)(2006-5#1)
various published##4##2##(2004-3#1)(2006-5#1)(2006-8#1)(2008-7#1)
various pump##2##2##(2007-11#1)(2008-2#1)
various rat tissues##7##3##(1990-8#1)(1991-9#1)(1993-3#1)(1995-11#1)(1997-2#1)(2008-5#2)
various rates of##2##3##(2008-2#1)(2010-1#1)
various ratios of##4##3##(1991-9#1)(1993-8#1)(2008-2#1)(2008-5#1)
various ratios##6##2##(1991-9#1)(1993-8#1)(2008-2#1)(2008-5#2)(2010-4#1)
various reaction##2##2##(2008-3#1)(2011-1#1)
various reactions##4##2##(2008-5#1)(2009-7#1)(2010-11#1)(2011-2#1)
various reasons for##3##3##(2009-5#1)(2012-2#1)(2013-8#1)
various reasons##14##2##(1993-3#1)(1994-5#1)(1995-5#1)(2007-10#1)(2008-5#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
various recent##3##2##(2008-11#1)(2009-10#1)(2012-2#1)
various receptor##2##2##(1992-10#1)(1992-7#1)
various receptors##3##2##(1994-8#1)(2006-12#1)(2011-2#1)
various recombinant proteins##3##3##(2006-2#1)(2008-11#1)(2008-7#1)
various recombinant##4##2##(1994-8#1)(2006-2#1)(2008-11#1)(2008-7#1)
various reference materials##2##3##(2008-10#2)
various reference##3##2##(2007-8#1)(2008-10#2)
various regimens##2##2##(2008-6#1)(2010-3#1)
various regimes of##3##3##(1997-2#1)(2008-10#2)
various regions in##2##3##(2007-6#1)(2011-1#1)
various regions of the##10##4##(1994-12#1)(1997-2#1)(1997-7#1)(2005-5#1)(2007-12#1)(2008-3#1)(2008-7#2)(2009-8#1)(2011-1#1)
various regions of##13##3##(1994-12#1)(1995-12#1)(1996-5#1)(1997-2#1)(1997-7#1)(2005-5#1)(2007-12#2)(2008-3#1)(2008-7#2)(2009-8#1)(2011-1#1)
various regions##21##2##(1991-9#1)(1994-12#1)(1994-5#1)(1995-12#1)(1996-5#1)(1997-2#1)(1997-7#1)(2005-5#1)(2006-9#1)(2007-1#1)(2007-12#2)(2007-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-8#1)(2011-1#2)
various regression diagnostics##2##3##(2008-10#2)
various regression##3##2##(2007-9#1)(2008-10#2)
various regulatory and##2##3##(2008-8#1)(2010-5#1)
various regulatory##3##2##(1991-2#1)(2008-8#1)(2010-5#1)
various religious##2##2##(2008-12#1)(2008-9#1)
various renal##2##2##(2007-7#1)(2013-8#1)
various reports##4##2##(2006-10#1)(2006-12#1)(2007-11#1)(2008-7#1)
various reproductive##2##2##(1993-1#1)(2004-11#1)
various research##5##2##(2008-10#1)(2008-2#1)(2008-5#1)(2011-1#1)(2012-12#1)
various respiratory##2##2##(2010-12#1)(2012-12#1)
various responses##2##2##(2008-6#1)(2012-2#1)
various retinal##2##2##(2008-3#1)(2011-7#1)
various rewarming##2##2##(2005-8#2)
various rheumatic##2##2##(1991-5#1)(2006-10#1)
various risk factors associated with##2##5##(1993-11#1)(2012-12#1)
various risk factors for##2##4##(2008-3#1)(2008-7#1)
various risk factors##9##3##(1991-6#1)(1993-11#1)(2006-6#1)(2007-11#1)(2007-2#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-12#1)
various risk groups##2##3##(2007-7#1)(2008-8#1)
various risk##12##2##(1991-6#1)(1993-11#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-1#1)(2012-12#1)
various rural populations##2##3##(1996-7#2)
various salts##3##2##(1990-2#1)(2005-11#1)(2008-10#1)
various sample##2##2##(2007-12#1)(2012-3#1)
various samples of##2##3##(2007-1#1)(2008-10#1)
various samples##8##2##(2007-1#1)(2008-10#7)
various sampling schemes##2##3##(2008-10#2)
various sampling##3##2##(2008-10#2)(2012-2#1)
various scales##3##2##(2008-3#1)(2008-8#1)(2011-1#1)
various scattering##4##2##(2008-2#1)(2008-3#3)
various scenarios of##2##3##(2008-8#1)(2010-7#1)
various scenarios##4##2##(2008-2#1)(2008-8#1)(2010-7#1)(2010-8#1)
various scientific##2##2##(2006-4#1)(2007-10#1)
various sectors of##2##3##(1993-2#1)(2008-6#1)
various sectors##3##2##(1993-2#1)(2006-10#1)(2008-6#1)
various separation##3##2##(2007-8#1)(2008-10#1)(2013-1#1)
various sequence##2##2##(2005-9#1)(2008-4#1)
various sets of##2##3##(2006-10#1)(2008-11#1)
various settings in which##2##4##(1991-12#1)(2005-6#1)
various settings##6##2##(1991-12#1)(2005-6#1)(2006-8#1)(2008-2#1)(2010-5#1)(2010-9#1)
various shapes and##2##3##(2009-2#1)(2010-6#1)
various shapes##5##2##(2008-10#2)(2008-3#1)(2009-2#1)(2010-6#1)
various side effects##2##3##(2008-11#1)(2008-8#1)
various side##3##2##(1990-11#1)(2008-11#1)(2008-8#1)
various signal transduction pathways##3##4##(1994-3#1)(1995-3#1)(2008-5#1)
various signal transduction##4##3##(1994-3#1)(1995-3#1)(2008-11#1)(2008-5#1)
various signal##5##2##(1991-12#1)(1994-3#1)(1995-3#1)(2008-11#1)(2008-5#1)
various signaling pathways##6##3##(2008-1#1)(2008-4#1)(2008-8#1)(2009-5#1)(2009-8#1)(2012-2#1)
various signaling##7##2##(2008-1#2)(2008-4#1)(2008-8#1)(2009-5#1)(2009-8#1)(2012-2#1)
various signals##4##2##(2005-8#1)(2006-10#1)(2008-10#1)(2008-2#1)
various simulations##2##2##(2011-1#1)(2012-1#1)
various sites##14##2##(1990-3#1)(1990-8#1)(1991-12#1)(1993-6#1)(2006-12#1)(2006-3#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-12#1)(2011-2#1)
various situations of##2##3##(1990-3#1)(2008-1#1)
various situations##4##2##(1990-3#1)(1995-5#1)(2008-1#1)(2013-8#1)
various size of##2##3##(2013-8#2)
various size##4##2##(1993-9#1)(2008-1#1)(2013-8#2)
various sizes and##4##3##(1997-3#1)(1997-6#1)(2006-11#1)(2013-1#1)
various sizes of##3##3##(1991-12#1)(2008-11#1)(2008-3#1)
various sizes##19##2##(1991-12#1)(1993-3#1)(1993-9#1)(1995-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-11#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#2)(2008-9#1)(2012-2#1)(2013-1#1)
various skin##4##2##(1991-6#1)(2005-11#1)(2006-12#1)(2007-8#1)
various social##2##2##(1996-4#1)(2008-9#1)
various soil##3##2##(1997-4#1)(2008-10#2)
various soilborne##2##2##(2008-10#2)
various solutions##2##2##(2010-10#1)(2013-1#1)
various solvents##9##2##(1990-12#1)(2007-11#3)(2008-10#2)(2008-2#1)(2008-3#1)(2010-5#1)
various sorts of##2##3##(1997-8#1)(2012-12#1)
various sources of##5##3##(2008-10#1)(2008-3#1)(2010-2#1)(2011-2#1)(2013-7#1)
various sources##17##2##(1991-7#1)(1993-8#1)(1997-1#1)(2005-8#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-9#1)(2010-2#1)(2011-2#1)(2013-1#1)(2013-7#1)
various spatial profiles##2##3##(2007-12#2)
various spatial##4##2##(2007-12#2)(2008-10#1)(2009-12#1)
various specialists##3##2##(1992-4#1)(2009-7#1)(2012-2#1)
various species formed##2##3##(2008-10#2)
various species of##4##3##(1990-12#1)(1992-1#1)(2007-8#1)(2010-3#1)
various species##23##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#1)(1993-2#2)(1995-12#1)(1996-2#1)(1996-4#1)(1997-7#1)(2005-7#1)(2006-11#1)(2007-8#1)(2008-10#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-3#1)(2012-12#1)
various specific##7##2##(1996-5#1)(2005-9#1)(2006-8#1)(2008-1#1)(2008-3#1)(2008-9#1)(2011-12#1)
various spectral##6##2##(1997-6#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)
various spectroscopic##2##2##(2008-10#1)(2010-5#1)
various speech and language disturbances##2##5##(2007-8#2)
various speeds##2##2##(2008-3#1)(2012-1#1)
various stages in the##3##4##(1990-8#1)(2005-7#1)(2007-11#1)
various stages in##6##3##(1990-8#1)(1994-11#1)(1996-6#1)(2005-7#1)(2007-11#1)(2007-9#1)
various stages of cell##2##4##(2008-8#1)(2012-12#1)
various stages of development##5##4##(1991-7#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-5#1)
various stages of the##4##4##(2007-11#1)(2008-2#1)(2008-4#1)(2008-7#1)
various stages of##41##3##(1991-7#1)(1993-11#2)(1994-2#1)(1994-9#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-4#2)(1997-8#1)(2004-11#1)(2006-10#3)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
various stages##57##2##(1990-3#1)(1990-8#1)(1991-5#1)(1991-7#1)(1993-11#2)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#3)(1997-5#1)(1997-8#1)(2004-11#1)(2005-7#1)(2006-10#3)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
various stakeholders##4##2##(1993-12#1)(1995-1#1)(1996-3#1)(2010-8#1)
various standard alloys and environmental samples##4##6##(2008-10#4)
various standard alloys and##5##4##(2008-10#5)
various standard##6##2##(2008-10#6)
various states##3##2##(1992-10#1)(2011-2#1)(2013-8#1)
various statistical measures and the limitations of our experiments##2##9##(2013-1#2)
various statistical measures##3##3##(2008-10#1)(2013-1#2)
various statistical##4##2##(2008-10#1)(2008-7#1)(2013-1#2)
various stem##2##2##(2009-4#1)(2010-11#1)
various stent##2##2##(2008-7#1)(2010-8#1)
various steps involved in##2##4##(2007-8#1)(2008-10#1)
various steps of##2##3##(2006-5#1)(2008-11#1)
various steps##6##2##(1993-8#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-10#1)
various stimuli in##3##3##(1994-11#1)(1995-12#1)(2010-12#1)
various stimuli##12##2##(1991-2#1)(1993-6#1)(1994-11#1)(1995-12#1)(1995-8#2)(2008-4#3)(2009-3#1)(2010-12#1)(2010-2#1)
various stimulus##2##2##(1995-5#1)(2009-5#1)
various strains of##6##3##(1994-2#1)(1994-8#1)(1995-8#1)(1997-7#1)(2008-8#1)(2013-7#1)
various strains##7##2##(1994-2#1)(1994-8#1)(1995-8#1)(1997-7#1)(2008-4#1)(2008-8#1)(2013-7#1)
various strategies for##4##3##(1996-9#1)(2006-2#1)(2008-10#1)(2012-3#1)
various strategies to##2##3##(2007-12#1)(2012-12#1)
various strategies##11##2##(1996-9#1)(2006-2#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-6#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
various stress responses##3##3##(2009-8#2)(2012-1#1)
various stress##6##2##(2008-11#1)(2009-6#1)(2009-8#2)(2012-1#1)(2013-7#1)
various stresses##2##2##(1995-12#1)(2007-12#1)
various stressors##2##2##(1995-12#2)
various structural##4##2##(1992-6#1)(2008-1#1)(2008-2#1)(2012-2#1)
various structures of##3##3##(2008-10#1)(2008-8#1)(2012-1#1)
various structures##8##2##(1994-3#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-12#1)(2012-1#1)(2012-12#1)
various studies have been##2##4##(2010-7#1)(2011-1#1)
various studies have##3##3##(2010-7#1)(2011-1#1)(2013-1#1)
various studies on##2##3##(2010-12#1)(2012-2#1)
various studies##16##2##(1990-11#1)(1990-6#1)(1994-2#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
various subgroups of##2##3##(2007-11#1)(2012-1#1)
various subgroups##5##2##(1992-4#1)(1994-1#1)(1996-2#1)(2007-11#1)(2012-1#1)
various subpopulations##2##2##(2007-7#1)(2008-9#1)
various subsites##2##2##(1991-6#1)(1992-12#1)
various substances##4##2##(1997-8#1)(2006-9#1)(2008-5#1)(2010-12#1)
various substituents##2##2##(1996-8#1)(2010-6#1)
various substitutions##4##2##(1994-12#1)(1994-9#1)(1996-7#1)(2012-11#1)
various substrates and##2##3##(1997-6#1)(2011-12#1)
various substrates##11##2##(1990-1#1)(1992-6#1)(1994-8#1)(1997-6#1)(2004-9#1)(2005-11#1)(2006-6#1)(2008-10#1)(2008-6#1)(2011-12#1)(2012-3#1)
various subtypes of RCC##2##4##(2007-2#2)
various subtypes of##4##3##(2007-2#2)(2008-4#1)(2011-2#1)
various subunits##3##2##(1994-9#2)(1997-2#1)
various surface##6##2##(2005-11#1)(2005-12#1)(2008-10#1)(2008-5#1)(2010-4#1)(2013-8#1)
various surgical approaches have##2##4##(2006-12#1)(2006-2#1)
various surgical approaches##4##3##(2006-12#1)(2006-2#1)(2006-7#1)(2009-5#1)
various surgical procedures##7##3##(1990-9#1)(2006-10#1)(2006-3#1)(2007-5#1)(2008-8#1)(2010-7#1)(2013-1#1)
various surgical techniques##3##3##(1992-6#1)(2006-10#1)(2006-7#1)
various surgical##20##2##(1990-9#1)(1991-3#1)(1992-1#1)(1992-6#1)(1993-4#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-7#2)(2007-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-7#1)(2010-8#1)(2013-1#1)
various symptoms##5##2##(1990-6#1)(2006-9#1)(2008-10#1)(2008-2#1)(2008-7#1)
various synthetic##4##2##(1990-2#1)(1990-4#1)(1990-7#1)(2007-11#1)
various systems##7##2##(2006-10#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-9#1)(2012-11#1)
various target##2##2##(1996-9#1)(2006-1#1)
various targets##3##2##(1992-10#1)(2004-12#1)(2005-8#1)
various tasks##3##2##(2005-11#1)(2008-8#1)(2012-3#1)
various teaching##2##2##(2008-12#1)(2013-8#1)
various technical##5##2##(1993-10#1)(1997-5#1)(2007-4#1)(2008-9#1)(2010-2#1)
various techniques for##2##3##(1991-1#1)(2006-12#1)
various techniques have been##4##4##(1996-3#1)(2006-10#1)(2008-10#1)(2008-5#1)
various techniques of##4##3##(2006-10#1)(2007-11#1)(2012-3#2)
various techniques to##2##3##(1991-2#1)(2006-5#1)
various techniques##34##2##(1990-7#1)(1991-1#1)(1991-2#1)(1994-9#1)(1996-3#1)(2006-10#3)(2006-12#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-5#1)(2008-9#1)(2009-1#1)(2009-5#3)(2010-12#1)(2010-2#1)(2010-7#1)(2010-9#2)(2012-2#1)(2012-3#2)
various technological##2##2##(2006-6#1)(2008-3#1)
various temperature##2##2##(2006-10#1)(2011-12#1)
various temperatures##20##2##(1990-2#1)(1990-9#1)(1992-6#1)(1995-11#1)(2005-11#2)(2007-12#2)(2007-6#1)(2008-10#5)(2008-12#1)(2008-2#1)(2011-12#1)(2011-2#1)(2012-2#2)
various tests##8##2##(1990-8#1)(1991-5#1)(2006-10#1)(2007-11#2)(2008-11#1)(2011-2#1)(2012-2#1)
various themes##2##2##(2005-8#1)(2008-2#1)
various theoretical##2##2##(1991-12#1)(2008-2#1)
various theories##2##2##(2006-8#1)(2010-9#1)
various therapeutic options##4##3##(1990-9#1)(1992-6#1)(1993-10#1)(2008-3#1)
various therapeutic techniques##2##3##(1990-12#1)(2008-7#1)
various therapeutic##12##2##(1990-12#1)(1990-9#1)(1992-6#1)(1993-10#1)(2005-8#2)(2006-8#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2013-8#1)
various thicknesses of##2##3##(2008-2#1)(2008-3#1)
various thicknesses##3##2##(2008-2#1)(2008-3#1)(2012-2#1)
various time periods##2##3##(1990-10#1)(2007-8#1)
various time##21##2##(1990-10#1)(1997-5#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#5)(2010-2#1)(2013-7#1)
various times after##5##3##(1997-3#1)(2008-10#2)(2011-2#1)(2012-1#1)
various times##24##2##(1990-10#2)(1990-5#1)(1990-7#1)(1992-1#1)(1992-9#1)(1994-8#1)(1995-1#1)(1997-3#1)(2004-2#1)(2007-12#1)(2007-3#1)(2008-10#6)(2008-2#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-1#1)
various tissue##3##2##(1995-3#1)(2008-4#2)
various tissues and organs##2##4##(2008-5#1)(2013-1#1)
various tissues and##6##3##(1993-3#1)(2008-5#1)(2009-4#1)(2010-10#1)(2012-1#1)(2013-1#1)
various tissues of the##3##4##(1992-8#1)(1994-5#1)(2007-4#1)
various tissues of##8##3##(1990-10#1)(1992-6#1)(1992-8#1)(1994-5#1)(1996-3#1)(1997-5#1)(2007-4#1)(2008-11#1)
various tissues##45##2##(1990-10#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-6#2)(1992-8#2)(1993-12#1)(1993-3#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-3#1)(1996-4#2)(1997-2#1)(1997-5#1)(1997-8#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-2#1)(2009-4#1)(2010-10#2)(2010-12#1)(2011-1#2)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
various total##2##2##(2008-10#1)(2009-7#1)
various toxic##3##2##(1992-2#1)(1997-4#1)(2009-6#1)
various traits##4##2##(2008-8#2)(2009-4#1)(2012-11#1)
various treatment groups##2##3##(2008-10#1)(2008-5#1)
various treatment options##3##3##(2006-12#1)(2006-9#1)(2007-12#1)
various treatment strategies##2##3##(2008-7#1)(2009-8#1)
various treatment##13##2##(1997-3#1)(2006-10#3)(2006-12#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-6#1)(2009-8#1)(2012-2#1)
various treatments for##2##3##(2006-11#1)(2012-2#1)
various treatments##12##2##(1992-8#1)(1994-8#1)(2005-11#1)(2006-11#1)(2006-12#1)(2006-7#1)(2007-12#1)(2008-5#2)(2012-2#1)(2013-1#2)
various tumor##4##2##(1991-2#1)(1991-9#1)(1995-4#1)(2012-2#1)
various tumors##3##2##(1990-6#1)(2011-1#1)(2012-2#1)
various tumour##2##2##(1995-12#1)(2008-8#1)
various types and##3##3##(2004-12#1)(2005-8#1)(2008-10#1)
various types of biases##2##4##(1996-12#1)(2008-12#1)
various types of cancer##4##4##(1995-1#1)(2008-8#1)(2010-9#1)(2013-8#1)
various types of cancers##4##4##(2008-5#1)(2009-10#1)(2011-2#1)(2012-2#1)
various types of cells##3##4##(1993-3#1)(2008-4#2)
various types of innovative##2##4##(2010-3#2)
various types of interactions##2##4##(2005-11#1)(2011-1#1)
various types of medical##4##4##(1995-10#1)(1995-3#1)(1997-1#1)(1997-3#1)
various types of optical##2##4##(2007-12#1)(2008-2#1)
various types of sexual##2##4##(2012-2#1)(2012-3#1)
various types of stress##2##4##(2008-10#1)(2008-3#1)
various types of tumors##2##4##(2008-11#2)
various types of vitreous silica at 1064##2##7##(2008-3#2)
various types of##127##3##(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-10#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#2)(1997-4#1)(2004-9#1)(2005-11#2)(2006-10#5)(2006-8#2)(2006-9#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#4)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#4)(2009-4#1)(2009-9#2)(2010-10#1)(2010-3#3)(2010-4#2)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
various types##138##2##(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-10#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-9#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#2)(1997-4#1)(2004-12#1)(2004-9#1)(2005-11#2)(2005-8#1)(2006-10#5)(2006-8#2)(2006-9#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#4)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#4)(2009-4#1)(2009-9#2)(2010-10#1)(2010-3#3)(2010-4#2)(2010-7#2)(2010-9#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
various values of##2##3##(2008-2#1)(2008-3#1)
various values##3##2##(2008-2#1)(2008-3#2)
various vectors containing##2##3##(2007-6#1)(2008-9#1)
various vertebrate species##2##3##(1993-8#1)(2008-5#1)
various vertebrate##4##2##(1991-6#1)(1993-12#1)(1993-8#1)(2008-5#1)
various viral infections##2##3##(2008-1#1)(2010-2#1)
various viral##4##2##(1995-2#1)(2008-1#1)(2009-7#1)(2010-2#1)
various visual##4##2##(2008-10#1)(2008-3#1)(2008-6#1)(2011-2#1)
various vitamins##2##2##(2007-11#1)(2008-11#1)
various water samples##7##3##(2008-10#6)(2008-5#1)
various water##10##2##(1996-8#1)(2008-1#1)(2008-10#7)(2008-5#1)
various wave##3##2##(2008-10#1)(2012-12#2)
various ways of##2##3##(2007-11#2)
various ways that##3##3##(1994-2#1)(2013-1#2)
various ways to##3##3##(2008-11#1)(2010-2#1)(2012-3#1)
various ways##21##2##(1990-8#1)(1994-2#1)(1996-2#1)(1997-7#1)(2004-12#1)(2007-11#2)(2008-1#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
various wheat##2##2##(1991-12#1)(2008-10#1)
various workers##3##2##(2006-10#1)(2007-1#2)
various yeast##2##2##(1993-12#1)(1997-4#1)
various##4975##1##(1990-1#4)(1990-10#12)(1990-11#15)(1990-12#26)(1990-2#18)(1990-3#17)(1990-4#6)(1990-5#16)(1990-6#9)(1990-7#13)(1990-8#28)(1990-9#14)(1991-1#6)(1991-10#12)(1991-11#7)(1991-12#28)(1991-2#21)(1991-3#14)(1991-4#12)(1991-5#19)(1991-6#7)(1991-7#10)(1991-8#7)(1991-9#16)(1992-1#11)(1992-10#5)(1992-11#16)(1992-12#14)(1992-2#17)(1992-3#12)(1992-4#11)(1992-5#10)(1992-6#28)(1992-7#11)(1992-8#19)(1992-9#18)(1993-1#4)(1993-10#5)(1993-11#15)(1993-12#25)(1993-2#14)(1993-3#28)(1993-4#1)(1993-5#9)(1993-6#18)(1993-7#6)(1993-8#19)(1993-9#26)(1994-1#3)(1994-10#7)(1994-11#19)(1994-12#17)(1994-2#20)(1994-3#32)(1994-4#3)(1994-5#13)(1994-6#18)(1994-7#2)(1994-8#22)(1994-9#22)(1995-1#14)(1995-10#6)(1995-11#10)(1995-12#20)(1995-2#21)(1995-3#27)(1995-4#3)(1995-5#17)(1995-6#16)(1995-7#1)(1995-8#14)(1995-9#7)(1996-1#16)(1996-10#2)(1996-11#5)(1996-12#26)(1996-2#20)(1996-3#18)(1996-4#15)(1996-5#22)(1996-6#15)(1996-7#10)(1996-8#10)(1996-9#11)(1997-1#11)(1997-2#31)(1997-3#20)(1997-4#32)(1997-5#10)(1997-6#18)(1997-7#20)(1997-8#25)(2004-10#2)(2004-11#4)(2004-12#8)(2004-2#1)(2004-3#3)(2004-4#1)(2004-8#1)(2004-9#6)(2005-1#1)(2005-10#14)(2005-11#42)(2005-12#8)(2005-2#2)(2005-3#4)(2005-4#3)(2005-5#5)(2005-6#1)(2005-7#11)(2005-8#33)(2005-9#10)(2006-1#3)(2006-10#77)(2006-11#17)(2006-12#37)(2006-2#12)(2006-3#6)(2006-4#7)(2006-5#19)(2006-6#18)(2006-7#15)(2006-8#43)(2006-9#22)(2007-1#28)(2007-10#29)(2007-11#95)(2007-12#85)(2007-2#26)(2007-3#12)(2007-4#16)(2007-5#14)(2007-6#15)(2007-7#50)(2007-8#76)(2007-9#29)(2008-1#57)(2008-10#527)(2008-11#122)(2008-12#33)(2008-2#128)(2008-3#177)(2008-4#102)(2008-5#164)(2008-6#41)(2008-7#101)(2008-8#76)(2008-9#52)(2009-1#6)(2009-10#23)(2009-11#16)(2009-12#14)(2009-2#16)(2009-3#13)(2009-4#22)(2009-5#18)(2009-6#19)(2009-7#13)(2009-8#32)(2009-9#16)(2010-1#10)(2010-10#24)(2010-11#14)(2010-12#54)(2010-2#20)(2010-3#17)(2010-4#23)(2010-5#20)(2010-6#11)(2010-7#22)(2010-8#17)(2010-9#17)(2011-1#60)(2011-12#17)(2011-2#108)(2011-3#6)(2011-7#3)(2012-1#27)(2012-11#18)(2012-12#64)(2012-2#114)(2012-3#62)(2012-7#2)(2012-8#1)(2013-1#106)(2013-7#26)(2013-8#63)
variously treated##2##2##(1991-8#1)(1994-12#1)
variously##19##1##(1990-7#1)(1991-8#2)(1992-12#1)(1992-3#1)(1993-11#1)(1994-12#1)(1995-12#1)(1995-4#1)(1997-3#1)(2005-8#1)(2006-4#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2013-1#1)
varium##2##1##(2006-8#1)(2010-2#1)
varix##5##1##(1996-9#1)(2007-9#4)
varnish is##2##2##(2008-3#2)
varnish on the##2##3##(1995-2#1)(2010-3#1)
varnish or##2##2##(2008-3#2)
varnish removal##2##2##(2008-3#2)
varnish##20##1##(1995-2#1)(2008-3#9)(2010-2#5)(2010-3#1)(2011-2#2)(2012-2#2)
varnishes or##2##2##(2006-10#1)(2008-3#1)
varphi##4##1##(2006-5#1)(2010-7#3)
varroa##2##1##(2008-6#2)
varsigma##2##1##(2008-2#2)
varsigma-polarized emission##2##2##(2008-3#2)
varus and valgus tibiofemoral malalignment##2##5##(2008-8#2)
varus and##3##2##(2008-7#1)(2008-8#2)
varus deformity##6##2##(2005-7#1)(2007-7#1)(2007-8#1)(2009-3#1)(2009-9#1)(2013-1#1)
varus in##2##2##(2008-7#1)(2010-3#1)
varus malalignment##2##2##(2008-8#2)
varus or valgus##4##3##(2012-2#1)(2013-8#3)
varus or##5##2##(2012-2#1)(2013-8#4)
varus##28##1##(1991-12#1)(2005-7#2)(2007-7#2)(2007-8#2)(2008-4#1)(2008-7#2)(2008-8#4)(2009-3#1)(2009-4#2)(2009-9#1)(2010-3#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#4)
vary according to the type of##2##6##(1993-9#1)(2008-1#1)
vary according to the##11##4##(1993-9#1)(1994-9#1)(1995-1#1)(1996-11#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-5#1)(2010-2#1)(2012-12#1)(2012-2#1)
vary according to##18##3##(1990-6#1)(1992-11#1)(1993-9#1)(1994-9#1)(1995-1#1)(1996-11#1)(1996-3#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-9#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
vary across the##2##3##(2008-10#1)(2011-2#1)
vary across##11##2##(1994-1#1)(1996-7#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
vary along##2##2##(2008-2#1)(2008-6#1)
vary among different##2##3##(2009-6#1)(2010-3#1)
vary among the##3##3##(1994-9#1)(2004-10#1)(2008-10#1)
vary among##14##2##(1991-10#1)(1994-9#1)(1996-3#1)(2004-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-6#1)(2009-7#1)(2010-3#1)(2011-11#1)(2013-1#1)
vary and##3##2##(1992-2#1)(1993-6#1)(2008-11#1)
vary as a function of##4##5##(2007-12#1)(2008-2#1)(2009-4#1)(2009-7#1)
vary as the##2##3##(2008-3#1)(2008-7#1)
vary as##8##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-4#1)(2009-7#1)(2011-1#1)
vary based on##2##3##(2007-10#1)(2010-8#1)
vary between 80 and 100%##2##5##(1992-11#1)(2008-10#1)
vary between different##2##3##(2007-7#1)(2008-7#1)
vary between individuals##2##3##(2007-11#1)(2010-11#1)
vary between##21##2##(1990-9#1)(1991-9#1)(1992-11#1)(1996-3#1)(1996-9#1)(1997-5#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-7#1)(2010-11#1)(2010-8#1)(2012-3#1)
vary by age##3##3##(1997-2#1)(2010-11#1)(2011-12#1)
vary by as much as##2##5##(1995-3#1)(2007-11#1)
vary by gender##4##3##(2007-1#1)(2011-12#1)(2011-2#2)
vary by more than##2##4##(1997-2#1)(2005-9#1)
vary by##25##2##(1994-1#1)(1995-3#1)(1995-6#1)(1996-1#1)(1997-2#2)(2005-9#1)(2007-1#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-3#1)(2009-12#1)(2009-7#1)(2010-11#1)(2011-12#2)(2011-2#3)(2012-12#1)(2013-1#3)
vary considerably among##2##3##(2008-7#1)(2008-9#1)
vary considerably depending on##2##4##(2007-7#1)(2008-5#1)
vary considerably in##4##3##(1991-3#1)(1992-10#1)(2008-3#1)(2008-4#1)
vary considerably##17##2##(1991-3#1)(1992-10#1)(1994-9#1)(1995-6#1)(1996-8#1)(1997-1#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-1#1)(2013-1#2)
vary depending on the cell##2##5##(2008-2#1)(2008-9#1)
vary depending on the specific##2##5##(2010-5#1)(2011-2#1)
vary depending on the##10##4##(2005-3#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-9#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
vary dramatically##2##2##(1997-8#1)(2010-7#1)
vary during##2##2##(1991-11#1)(1991-2#1)
vary extensively in##3##3##(2007-11#1)(2008-7#1)(2008-8#1)
vary for the different##2##4##(2008-10#1)(2009-3#1)
vary for##4##2##(1994-1#1)(2008-10#1)(2009-3#1)(2009-4#1)
vary from 1##2##3##(1992-11#1)(2013-1#1)
vary from 20 to##2##4##(2007-12#1)(2008-10#1)
vary from a mild##2##4##(2007-9#1)(2011-2#1)
vary from a##5##3##(2007-9#1)(2008-10#1)(2010-12#1)(2011-2#1)(2012-12#1)
vary from one##6##3##(1990-5#1)(1991-4#1)(1992-2#1)(2006-10#1)(2008-5#1)(2013-1#1)
vary from the##3##3##(1997-3#1)(2006-8#1)(2010-6#1)
vary from##49##2##(1990-5#1)(1991-4#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-3#1)(1996-7#1)(1997-2#1)(1997-3#1)(2004-10#1)(2005-11#1)(2006-10#2)(2006-8#2)(2007-12#2)(2007-4#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#2)(2008-5#1)(2009-12#1)(2009-7#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
vary greatly in##2##3##(2008-2#1)(2010-8#1)
vary greatly##8##2##(2005-7#1)(2007-7#1)(2008-2#1)(2009-4#1)(2010-8#1)(2012-2#1)(2013-1#2)
vary in a##5##3##(1995-11#1)(1995-8#1)(2007-10#1)(2008-12#1)(2008-3#1)
vary in both##2##3##(1990-8#1)(1994-8#1)
vary in different##8##3##(1995-7#1)(2005-10#1)(2007-2#1)(2008-10#2)(2010-10#1)(2010-6#1)(2011-1#1)
vary in shape##2##3##(1992-7#1)(2011-2#1)
vary in size and##2##4##(2012-3#2)
vary in size##3##3##(1991-8#1)(2012-3#2)
vary in the order of##2##5##(2008-10#2)
vary in the order##4##4##(2008-10#4)
vary in the##10##3##(1992-3#1)(1997-1#1)(2005-10#1)(2008-10#6)(2008-8#1)
vary in their##11##3##(1993-9#1)(1994-12#1)(2005-8#1)(2006-12#1)(2007-1#1)(2008-10#1)(2008-8#2)(2010-11#1)(2010-7#1)(2012-1#1)
vary in##71##2##(1990-8#1)(1991-8#2)(1992-3#1)(1992-7#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-7#1)(1995-8#1)(1997-1#2)(2005-10#2)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#10)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#2)
vary inversely##2##2##(1992-8#1)(1995-2#1)
vary linearly with##3##3##(2006-10#1)(2008-10#2)
vary linearly##4##2##(2006-10#1)(2008-10#2)(2008-3#1)
vary little##3##2##(1996-4#1)(2008-10#2)
vary markedly##2##2##(1997-2#1)(2012-3#1)
vary over a##4##3##(1991-10#1)(2007-12#1)(2008-2#1)(2011-12#1)
vary over##9##2##(1991-10#1)(1992-8#1)(1993-5#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-12#1)
vary significantly across##2##3##(2007-5#1)(2009-7#1)
vary significantly at##2##3##(2008-8#1)(2011-2#1)
vary significantly between##4##3##(1992-12#1)(2006-4#1)(2008-8#1)(2013-7#1)
vary significantly in##4##3##(1992-8#1)(2008-10#1)(2008-3#1)(2010-7#1)
vary significantly##24##2##(1992-12#1)(1992-8#1)(1993-3#1)(1996-1#1)(1997-8#1)(2005-10#1)(2006-4#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-3#2)(2008-8#3)(2009-2#1)(2009-7#2)(2010-7#1)(2011-2#1)(2013-1#2)(2013-7#1)
vary slightly from those reported from other countries##2##8##(2008-1#1)(2010-4#1)
vary slightly##3##2##(2008-1#1)(2008-3#1)(2010-4#1)
vary slowly##2##2##(2008-2#1)(2008-3#1)
vary somewhat##2##2##(1993-2#1)(2008-1#1)
vary substantially among##2##3##(2008-9#1)(2013-8#1)
vary substantially between##2##3##(2008-10#1)(2008-11#1)
vary substantially##7##2##(1993-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-3#1)(2012-3#1)(2013-8#1)
vary the##17##2##(1990-2#1)(2005-11#1)(2007-4#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-2#4)(2008-3#3)(2008-7#1)(2010-4#1)(2013-1#1)
vary widely across##3##3##(1994-2#1)(2009-4#1)(2013-7#1)
vary widely in the##2##4##(1991-7#1)(2008-11#1)
vary widely in##7##3##(1991-7#1)(1992-7#1)(1993-11#1)(1993-5#1)(2008-11#1)(2008-6#1)(2012-2#1)
vary widely with##2##3##(1991-11#1)(2011-12#1)
vary widely##27##2##(1991-11#1)(1991-7#1)(1992-7#1)(1993-11#2)(1993-5#1)(1994-2#1)(1995-3#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-11#1)(2010-8#1)(2011-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
vary with respect to the##2##5##(1997-3#1)(2007-9#1)
vary with respect to##3##4##(1994-12#1)(1997-3#1)(2007-9#1)
vary with the##16##3##(1990-12#1)(1991-5#2)(1992-9#1)(1993-6#1)(1995-5#1)(1997-1#1)(2005-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-9#1)(2010-2#1)(2010-4#1)
vary with##49##2##(1990-12#1)(1991-4#1)(1991-5#2)(1992-9#1)(1993-6#2)(1994-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#2)(1997-7#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-10#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-5#2)(2008-8#5)(2008-9#5)(2009-12#1)(2010-2#1)(2010-4#1)(2013-1#2)(2013-7#1)
vary within the##4##3##(2006-8#1)(2007-12#1)(2008-5#1)(2008-7#1)
vary within##5##2##(2006-8#1)(2007-12#1)(2008-5#1)(2008-7#1)(2010-8#1)
vary worldwide##2##2##(2009-3#1)(2012-12#1)
vary##495##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#2)(1991-10#2)(1991-11#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#3)(1992-10#1)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#2)(1992-7#2)(1992-8#3)(1992-9#2)(1993-11#2)(1993-2#1)(1993-3#1)(1993-5#4)(1993-6#3)(1993-9#2)(1994-1#4)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-4#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#4)(1997-3#3)(1997-5#1)(1997-7#1)(1997-8#2)(2004-10#2)(2004-11#1)(2005-10#3)(2005-11#5)(2005-3#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#8)(2006-11#1)(2006-12#2)(2006-2#2)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#5)(2006-9#1)(2007-1#4)(2007-10#5)(2007-11#5)(2007-12#10)(2007-2#3)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#7)(2007-8#8)(2007-9#4)(2008-1#9)(2008-10#35)(2008-11#12)(2008-12#7)(2008-2#16)(2008-3#17)(2008-4#4)(2008-5#11)(2008-6#2)(2008-7#9)(2008-8#18)(2008-9#13)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#5)(2009-6#2)(2009-7#7)(2009-8#1)(2010-10#1)(2010-11#4)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#4)(2010-5#2)(2010-6#3)(2010-7#4)(2010-8#9)(2011-1#3)(2011-11#1)(2011-12#6)(2011-2#12)(2012-1#3)(2012-12#6)(2012-2#6)(2012-3#8)(2013-1#27)(2013-7#5)(2013-8#2)
varying affinity##2##2##(1995-3#1)(2006-12#1)
varying amounts of the##2##4##(1992-3#1)(1993-11#1)
varying amounts of##13##3##(1991-4#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-11#1)(1995-1#1)(1995-3#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-1#1)
varying amounts##16##2##(1991-4#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-11#1)(1995-1#1)(1995-3#1)(2007-10#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-1#1)
varying between 0##2##3##(1992-12#1)(2008-10#1)
varying between##16##2##(1990-8#1)(1991-9#1)(1992-12#2)(1994-12#1)(2006-5#1)(2007-3#2)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#1)(2013-8#2)
varying by as much as##2##5##(1992-9#1)(1995-11#1)
varying by##6##2##(1992-2#1)(1992-9#1)(1993-3#1)(1995-11#1)(2008-10#2)
varying chemical##2##2##(2007-10#1)(2008-10#1)
varying chloride##2##2##(1997-7#1)(2008-10#1)
varying coefficient##2##2##(2011-1#1)(2013-1#1)
varying composition##4##2##(1995-5#1)(1996-12#1)(2008-10#1)(2008-11#1)
varying concentration of##2##3##(2011-1#1)(2011-2#1)
varying concentrations of##19##3##(1991-9#1)(1994-12#1)(1995-10#1)(1995-5#2)(1996-12#1)(2006-1#1)(2008-10#5)(2008-11#1)(2009-10#1)(2009-11#1)(2009-9#1)(2011-1#2)(2013-1#1)
varying concentrations##22##2##(1991-9#1)(1994-12#1)(1995-10#1)(1995-5#2)(1995-7#1)(1996-12#1)(2006-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2009-10#1)(2009-11#1)(2009-9#1)(2011-1#2)(2013-1#1)
varying conditions and##2##3##(2008-3#1)(2009-5#1)
varying conditions##8##2##(1995-3#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-5#1)
varying contents of##2##3##(1991-2#1)(2008-10#1)
varying degree in##2##3##(2007-12#1)(2008-10#1)
varying degree of##6##3##(1996-2#1)(2007-12#1)(2008-3#1)(2008-7#1)(2013-1#2)
varying degree##9##2##(1994-8#1)(1996-2#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#2)
varying degrees of fecal incontinence##2##5##(2006-10#2)
varying degrees of resistance##4##4##(2008-10#3)(2011-1#1)
varying degrees of sequence##2##4##(1992-11#1)(2008-10#1)
varying degrees of severity##3##4##(2006-2#1)(2007-2#1)(2010-12#1)
varying degrees of success##6##4##(2005-8#2)(2006-10#1)(2006-9#1)(2008-11#1)(2008-9#1)
varying degrees of##60##3##(1990-4#1)(1991-6#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-2#1)(1997-2#1)(1997-3#1)(2005-7#1)(2005-8#2)(2006-10#4)(2006-2#1)(2006-9#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-12#1)(2011-1#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
varying degrees##73##2##(1990-4#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-11#1)(1997-2#1)(1997-3#1)(2005-7#1)(2005-8#2)(2006-10#4)(2006-2#1)(2006-7#1)(2006-9#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#6)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
varying doses of##7##3##(1994-11#1)(1997-4#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)
varying doses##8##2##(1994-11#1)(1996-9#1)(1997-4#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)
varying environment##3##2##(1994-6#2)(2008-9#1)
varying environmental##2##2##(1992-12#1)(2008-10#1)
varying environments##2##2##(1991-10#1)(2012-12#1)
varying ethnic##2##2##(2010-8#2)
varying fatty acid##2##3##(1993-9#1)(1997-5#1)
varying frequencies##2##2##(1994-12#1)(1996-12#1)
varying frequency##2##2##(2008-2#1)(2008-7#1)
varying from 0 to##2##4##(1995-8#1)(2010-2#1)
varying from 0##5##3##(1995-8#1)(2006-12#1)(2007-8#1)(2010-2#1)(2012-12#1)
varying from 1##4##3##(2008-10#3)(2011-1#1)
varying from 10##3##3##(2007-8#1)(2008-10#1)(2010-8#1)
varying from 2##3##3##(1996-5#1)(1996-7#1)(2005-11#1)
varying from 3 to##2##4##(2008-10#1)(2010-5#1)
varying from a##2##3##(1991-12#1)(2008-8#1)
varying from##44##2##(1990-9#1)(1991-12#1)(1992-2#1)(1993-11#1)(1995-1#1)(1995-6#1)(1995-8#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-4#1)(2007-8#2)(2008-10#13)(2008-2#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
varying impacts of factors##2##4##(2010-11#2)
varying in length##2##3##(1990-3#1)(2012-1#1)
varying in the##2##3##(2007-11#1)(2008-10#1)
varying in their##2##3##(1991-2#1)(2008-10#1)
varying in##15##2##(1990-3#1)(1991-2#1)(1993-11#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-6#1)(2009-2#1)(2011-2#1)(2012-1#1)
varying inbreeding depression##2##3##(2008-8#2)
varying initial##2##2##(2008-10#1)(2008-5#1)
varying intensity##4##2##(2007-10#1)(2009-3#1)(2012-2#1)(2013-8#1)
varying its##2##2##(2006-7#1)(2008-10#1)
varying lag times##2##3##(2008-5#2)
varying laser##2##2##(2008-2#1)(2008-3#1)
varying lengths of##3##3##(1991-12#1)(2007-8#1)(2008-10#1)
varying lengths##7##2##(1991-12#1)(1993-4#1)(1994-6#1)(1995-6#1)(2007-8#1)(2008-10#1)(2008-11#1)
varying levels in##2##3##(1992-2#1)(2007-10#1)
varying levels of##24##3##(1991-12#1)(1994-2#1)(1996-2#1)(1997-5#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#5)
varying levels##28##2##(1991-12#1)(1992-2#1)(1994-2#1)(1996-2#1)(1997-5#1)(2007-10#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#5)
varying local##2##2##(2008-12#1)(2008-9#1)
varying molecular##2##2##(1992-12#1)(2009-9#1)
varying outcomes##2##2##(2007-4#1)(2008-1#1)
varying pH##4##2##(1990-1#1)(2008-10#3)
varying period##2##2##(2008-10#1)(2008-3#1)
varying periods of time##4##4##(1994-5#1)(1995-2#1)(2008-1#1)(2008-10#1)
varying periods of##5##3##(1994-5#1)(1995-2#1)(2007-8#1)(2008-1#1)(2008-10#1)
varying periods##6##2##(1990-3#1)(1994-5#1)(1995-2#1)(2007-8#1)(2008-1#1)(2008-10#1)
varying perspectives##2##2##(2007-2#1)(2012-2#1)
varying phase##2##2##(2008-2#1)(2008-3#1)
varying potential##2##2##(1995-11#1)(1996-6#1)
varying proportions##5##2##(1993-8#1)(2007-12#1)(2008-10#2)(2008-7#1)
varying ranges##2##2##(2008-1#1)(2008-10#1)
varying rates##3##2##(2006-12#1)(2010-8#1)(2011-2#1)
varying refractive index##2##3##(2008-2#1)(2008-3#1)
varying results##9##2##(1990-2#1)(2006-8#2)(2008-10#1)(2008-4#1)(2009-7#1)(2010-2#1)(2010-5#1)(2012-12#1)
varying several##2##2##(2008-10#2)
varying size##4##2##(1994-6#1)(1995-3#1)(2008-10#1)(2010-5#1)
varying sources##2##2##(1996-8#1)(2008-3#1)
varying stability##2##2##(2008-10#2)
varying stages of##5##3##(1993-9#1)(2007-11#1)(2008-4#1)(2008-9#1)(2012-2#1)
varying substrate##2##2##(2006-12#1)(2007-11#1)
varying success##2##2##(2006-10#1)(2007-12#1)
varying surface##2##2##(1993-3#1)(2007-2#1)
varying temperature##2##2##(2008-10#1)(2009-3#1)
varying temperatures##4##2##(1997-4#1)(2007-10#1)(2008-10#1)(2012-4#1)
varying the amount of##3##4##(2008-10#2)(2009-8#1)
varying the conditions##2##3##(1995-12#1)(2009-12#1)
varying the core##2##3##(2010-1#2)
varying the metallic##2##3##(2010-6#2)
varying the refractive index of the##2##6##(2008-1#1)(2009-6#1)
varying the thickness of the##2##5##(2008-2#1)(2008-3#1)
varying the thickness of##3##4##(2008-2#1)(2008-3#2)
varying the##93##2##(1990-6#1)(1991-1#1)(1992-2#1)(1992-8#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(2005-11#3)(2005-12#1)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#12)(2008-1#1)(2008-10#18)(2008-12#2)(2008-2#5)(2008-3#10)(2008-5#2)(2008-7#4)(2008-8#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#4)(2010-6#2)(2010-8#1)(2011-2#2)(2012-1#2)(2012-2#1)
varying types and##2##3##(1997-3#1)(2009-1#1)
varying visual##2##2##(1992-9#1)(2008-11#1)
varying widely in##2##3##(1995-8#1)(2008-7#1)
varying with the##3##3##(1997-2#1)(2008-2#1)(2009-5#1)
varying with##4##2##(1997-2#1)(2007-12#1)(2008-2#1)(2009-5#1)
varying##750##1##(1990-1#1)(1990-11#1)(1990-12#5)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#2)(1990-6#1)(1990-8#2)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#3)(1991-4#1)(1991-6#2)(1991-8#2)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#4)(1992-3#2)(1992-5#1)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#2)(1993-11#4)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#1)(1993-8#5)(1993-9#2)(1994-11#4)(1994-12#6)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#4)(1994-8#3)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#4)(1995-3#5)(1995-4#2)(1995-5#4)(1995-6#3)(1995-7#1)(1995-8#4)(1996-11#1)(1996-12#5)(1996-2#3)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#3)(1996-9#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#3)(1997-6#3)(1997-7#5)(2004-11#2)(2004-8#1)(2004-9#1)(2005-11#9)(2005-12#1)(2005-7#2)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#9)(2006-11#1)(2006-12#5)(2006-2#2)(2006-5#1)(2006-7#2)(2006-8#3)(2006-9#2)(2007-10#6)(2007-11#21)(2007-12#35)(2007-2#5)(2007-3#3)(2007-4#3)(2007-5#1)(2007-7#3)(2007-8#9)(2008-1#7)(2008-10#107)(2008-11#18)(2008-12#8)(2008-2#28)(2008-3#38)(2008-4#12)(2008-5#18)(2008-6#6)(2008-7#16)(2008-8#9)(2008-9#14)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#2)(2009-2#2)(2009-3#7)(2009-4#3)(2009-5#5)(2009-6#2)(2009-7#6)(2009-8#1)(2009-9#5)(2010-1#4)(2010-11#3)(2010-12#5)(2010-2#7)(2010-4#3)(2010-5#6)(2010-6#3)(2010-7#1)(2010-8#8)(2010-9#1)(2011-1#9)(2011-12#2)(2011-2#15)(2012-1#7)(2012-12#6)(2012-2#12)(2012-3#6)(2012-4#2)(2013-1#16)(2013-7#1)(2013-8#7)
varying-coefficient models##4##2##(1997-7#3)(2010-1#1)
varying-coefficient##6##1##(1997-7#3)(2010-1#1)(2010-2#1)(2013-1#1)
vas deferens and##5##3##(1992-5#1)(1995-11#1)(1997-2#1)(1997-5#1)(1997-8#1)
vas deferens in##2##3##(1996-12#1)(2008-10#1)
vas deferens##34##2##(1990-12#1)(1990-5#2)(1990-7#2)(1991-1#1)(1992-3#1)(1992-5#1)(1993-3#2)(1994-8#2)(1995-11#1)(1996-11#2)(1996-12#3)(1997-2#1)(1997-5#3)(1997-7#1)(1997-8#2)(2007-12#1)(2007-9#2)(2008-10#5)(2013-8#1)
vas##44##1##(1990-12#1)(1990-5#2)(1990-7#2)(1991-1#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-3#3)(1994-8#7)(1995-11#1)(1996-11#2)(1996-12#3)(1997-2#1)(1997-5#3)(1997-7#1)(1997-8#2)(2007-12#1)(2007-9#2)(2008-10#5)(2010-4#2)(2011-3#1)(2013-8#1)
vasa nervorum##4##2##(1993-11#2)(1993-12#2)
vasa vasorum##3##2##(1997-8#1)(2010-4#1)(2010-9#1)
vasa##10##1##(1993-11#2)(1993-12#2)(1995-6#1)(1997-8#1)(2006-12#2)(2010-4#1)(2010-9#1)
vasal##3##1##(2006-2#1)(2010-4#2)
vascular abnormalities##7##2##(2007-10#1)(2008-1#1)(2012-12#3)(2012-3#1)(2013-1#1)
vascular access (VA)##3##3##(2007-7#3)
vascular access and##4##3##(2007-7#3)(2013-1#1)
vascular access failure##3##3##(2007-7#1)(2007-8#2)
vascular access for chronic hemodialysis##3##5##(2007-7#3)
vascular access for chronic##4##4##(2007-7#3)(2010-4#1)
vascular access for hemodialysis##9##4##(1991-6#1)(2007-7#7)(2008-1#1)
vascular access for##17##3##(1991-6#1)(2007-7#13)(2008-1#1)(2010-4#1)(2013-8#1)
vascular access in hemodialysis##2##4##(2007-7#2)
vascular access in patients##2##4##(2007-7#2)
vascular access in the##2##4##(2007-7#1)(2011-2#1)
vascular access in##12##3##(1990-10#1)(2007-7#10)(2011-2#1)
vascular access is the##2##4##(2007-7#2)
vascular access is##3##3##(2007-7#3)
vascular access plays##3##3##(2007-7#3)
vascular access site##4##3##(2007-11#1)(2007-7#1)(2011-2#2)
vascular access thrombosis and##3##4##(2006-5#1)(2007-7#2)
vascular access thrombosis##4##3##(2006-5#1)(2007-7#3)
vascular access was##2##3##(2007-7#2)
vascular access##116##2##(1990-10#1)(1990-8#1)(1991-6#1)(2006-5#1)(2007-11#1)(2007-3#1)(2007-7#82)(2007-8#6)(2008-1#7)(2008-4#1)(2010-4#1)(2011-1#3)(2011-2#5)(2012-1#1)(2013-1#3)(2013-8#1)
vascular accesses##3##2##(2007-7#1)(2008-1#1)(2008-4#1)
vascular accident##3##2##(1993-10#1)(2007-7#1)(2009-5#1)
vascular action of##3##3##(1991-7#3)
vascular actions##2##2##(2008-1#1)(2009-5#1)
vascular addressin##2##2##(1991-2#1)(1993-12#1)
vascular alterations##6##2##(2005-7#1)(2007-3#1)(2008-1#1)(2008-7#1)(2009-3#1)(2013-8#1)
vascular anastomosis##3##2##(2007-7#1)(2008-1#1)(2012-12#1)
vascular anatomy of the##3##4##(2006-3#2)(2008-7#1)
vascular anatomy of##4##3##(2006-3#2)(2007-7#1)(2008-7#1)
vascular anatomy##8##2##(1993-6#1)(2006-3#2)(2007-10#1)(2007-7#1)(2008-7#1)(2011-2#1)(2012-2#1)
vascular and bladder##2##3##(2006-5#2)
vascular and cardiac##2##3##(1993-11#1)(2006-10#1)
vascular and coronary##2##3##(2008-5#1)(2013-1#1)
vascular and nervous##2##3##(2007-11#1)(2008-5#1)
vascular and neurological complications##3##4##(2013-1#3)
vascular and neurological##4##3##(2008-7#1)(2013-1#3)
vascular and non-vascular##3##3##(1992-12#1)(1995-4#1)(2012-2#1)
vascular and##38##2##(1990-3#1)(1990-6#1)(1990-9#1)(1991-12#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-3#1)(1995-4#1)(2004-3#1)(2006-10#2)(2006-5#2)(2007-11#2)(2007-12#1)(2007-6#1)(2008-1#2)(2008-5#2)(2008-7#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#6)
vascular anomalies which##2##3##(2007-8#1)(2013-1#1)
vascular anomalies##6##2##(2007-6#3)(2007-8#1)(2010-2#1)(2013-1#1)
vascular architecture##3##2##(1991-2#1)(1997-6#1)(2008-1#1)
vascular assess##2##2##(2007-10#2)
vascular assessment##2##2##(1996-7#1)(2013-1#1)
vascular barrier##3##2##(2008-4#3)
vascular basement membrane##2##3##(1992-12#2)
vascular bed lesion##3##3##(2008-6#3)
vascular bed of the cat##2##5##(1991-2#1)(1993-3#1)
vascular bed of the##4##4##(1990-10#1)(1990-6#1)(1991-2#1)(1993-3#1)
vascular bed of##5##3##(1990-10#1)(1990-6#1)(1991-2#1)(1993-3#1)(2008-3#1)
vascular bed##22##2##(1990-10#1)(1990-6#1)(1991-2#4)(1991-8#1)(1992-1#1)(1993-3#4)(1997-1#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#3)
vascular beds##10##2##(1991-3#1)(1993-3#4)(1994-12#1)(2006-10#1)(2007-7#1)(2010-9#2)
vascular benefits##2##2##(2009-11#1)(2009-8#1)
vascular biology##6##2##(1994-5#1)(2008-1#2)(2008-3#1)(2009-4#1)(2012-12#1)
vascular brain perfusion model##2##4##(1993-12#1)(1994-5#1)
vascular brain##3##2##(1993-12#1)(1994-5#1)(2009-2#1)
vascular bundle##4##2##(2008-10#1)(2009-3#2)(2013-7#1)
vascular bundles##6##2##(2008-10#6)
vascular calcification##10##2##(2005-3#1)(2007-8#4)(2009-1#2)(2011-1#1)(2012-12#2)
vascular calcifications##3##2##(2007-8#2)(2012-12#1)
vascular catheters##3##2##(2006-9#1)(2007-7#2)
vascular cause##2##2##(2007-8#1)(2009-4#1)
vascular cell adhesion##4##3##(1995-12#1)(1995-8#2)(2012-2#1)
vascular cell##9##2##(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-1#1)(2009-8#1)(2012-2#2)
vascular cells and##2##3##(2008-1#1)(2011-1#1)
vascular cells##15##2##(1991-2#1)(1992-3#2)(1993-3#1)(1994-5#1)(1994-9#1)(2006-5#1)(2007-11#1)(2008-1#2)(2008-11#1)(2008-5#1)(2011-1#1)(2012-4#1)(2013-1#1)
vascular changes##7##2##(1992-6#1)(1996-2#1)(1996-7#1)(2008-1#1)(2008-7#1)(2012-12#2)
vascular channels and##3##3##(1992-10#1)(2008-5#1)(2009-3#1)
vascular channels##6##2##(1992-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#2)
vascular chymase##2##2##(2007-1#2)
vascular colonization by##2##3##(2008-10#2)
vascular complication##7##2##(1993-2#2)(1994-3#1)(2007-8#1)(2008-1#3)
vascular complications and##3##3##(1997-2#1)(2011-2#2)
vascular complications in##9##3##(2007-1#1)(2007-8#2)(2007-9#1)(2008-1#3)(2011-1#1)(2012-12#1)
vascular complications of##3##3##(1993-12#1)(2009-4#1)(2013-8#1)
vascular complications##33##2##(1991-12#1)(1992-8#1)(1993-12#2)(1997-2#1)(2005-7#1)(2007-1#1)(2007-8#3)(2007-9#1)(2008-1#7)(2008-12#1)(2008-3#1)(2008-7#1)(2009-4#1)(2009-5#1)(2011-1#2)(2011-2#4)(2012-12#2)(2013-1#1)(2013-8#1)
vascular component##2##2##(1996-11#1)(2008-4#1)
vascular compromise##4##2##(2007-12#1)(2007-3#1)(2008-12#2)
vascular conductance##4##2##(1990-9#1)(1991-8#1)(1995-12#1)(1997-8#1)
vascular congestion##3##2##(1997-6#1)(2008-8#1)(2010-3#1)
vascular connective tissue##2##3##(2007-11#1)(2008-5#1)
vascular contraction##5##2##(1992-1#2)(1997-6#1)(2011-2#2)
vascular contrast##2##2##(2008-7#1)(2009-4#1)
vascular control##2##2##(1990-3#1)(2007-7#1)
vascular damage##13##2##(1992-12#1)(1996-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-3#3)(2008-4#3)(2009-11#1)
vascular dementia (VD)##3##3##(1996-11#1)(1996-5#1)(2008-7#1)
vascular dementia (VaD)##2##3##(1997-7#1)(2008-7#1)
vascular dementia and Alzheimer's disease##3##5##(1997-7#1)(2007-9#1)(2008-3#1)
vascular dementia and##4##3##(1997-7#1)(2007-9#1)(2008-3#1)(2008-7#1)
vascular dementia##24##2##(1994-11#1)(1995-9#1)(1996-11#2)(1996-5#2)(1997-7#2)(2005-8#1)(2007-10#3)(2007-9#2)(2008-3#1)(2008-7#9)
vascular density##4##2##(2008-11#2)(2009-12#1)(2011-2#1)
vascular deposits##2##2##(1996-5#2)
vascular development##7##2##(1992-4#2)(1997-4#1)(2006-11#1)(2008-3#1)(2009-6#1)(2009-7#1)
vascular disease and the##2##4##(1992-9#1)(2005-7#1)
vascular disease and##6##3##(1992-6#1)(1992-9#1)(2005-10#1)(2005-7#1)(2007-11#1)(2008-1#1)
vascular disease by##2##3##(1992-8#1)(2005-10#1)
vascular disease in##7##3##(1995-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-6#1)(2011-1#1)
vascular disease is##2##3##(2005-7#1)(2008-1#1)
vascular disease of##3##3##(1990-5#1)(1991-4#1)(2008-10#1)
vascular disease or##2##3##(2008-1#1)(2008-3#1)
vascular disease##100##2##(1990-3#1)(1990-5#1)(1990-9#1)(1991-4#1)(1992-4#2)(1992-6#1)(1992-8#1)(1992-9#4)(1993-2#2)(1993-3#1)(1994-10#1)(1995-3#1)(1997-2#1)(1997-8#1)(2005-10#4)(2005-12#2)(2005-7#5)(2006-10#4)(2006-12#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#9)(2008-10#2)(2008-3#8)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-1#2)(2010-10#1)(2010-12#4)(2010-4#3)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#4)(2012-2#3)(2013-1#1)(2013-8#1)
vascular diseases and##2##3##(2008-5#1)(2011-2#1)
vascular diseases##31##2##(1990-4#1)(1991-11#1)(1991-9#1)(1992-10#1)(1995-2#1)(2004-12#1)(2005-11#1)(2005-7#1)(2006-10#2)(2007-10#1)(2007-9#1)(2008-1#2)(2008-5#1)(2008-7#1)(2009-10#4)(2010-12#1)(2010-4#4)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#3)
vascular diseases]##3##2##(1995-11#1)(1996-11#1)(2006-4#1)
vascular disorder##6##2##(1992-5#1)(2007-4#1)(2008-10#1)(2008-9#1)(2009-4#1)(2012-2#1)
vascular disorders in other organs##2##5##(2010-12#2)
vascular disorders##6##2##(1994-3#1)(2005-9#1)(2007-11#1)(2008-9#1)(2010-12#2)
vascular disruption##5##2##(1996-10#2)(1997-3#3)
vascular dysfunction##2##2##(2005-10#1)(2011-2#1)
vascular dysplasia##2##2##(2008-12#1)(2008-7#1)
vascular ectasias##2##2##(1991-3#1)(2006-10#1)
vascular effect of##2##3##(1997-6#1)(2013-1#1)
vascular effect##4##2##(1997-6#1)(2005-10#1)(2008-3#1)(2013-1#1)
vascular effects of endothelin-1##2##4##(1995-12#1)(1996-12#1)
vascular effects of##6##3##(1990-4#1)(1995-12#1)(1996-10#1)(1996-12#3)
vascular effects##11##2##(1990-4#1)(1993-11#1)(1995-12#1)(1996-10#1)(1996-12#4)(2005-7#1)(2008-1#1)(2009-8#1)
vascular endothelial and MCF-7 cells##2##5##(1990-4#2)
vascular endothelial cell growth factor##4##5##(1991-2#1)(1992-9#1)(1994-5#2)
vascular endothelial cell##12##3##(1990-4#1)(1991-2#1)(1991-9#1)(1992-9#1)(1994-5#2)(1994-9#1)(1995-3#1)(1996-12#1)(2008-1#1)(2009-7#1)(2013-1#1)
vascular endothelial cells and in##2##5##(1990-4#1)(1997-7#1)
vascular endothelial cells and##3##4##(1990-4#1)(1996-12#1)(1997-7#1)
vascular endothelial cells##57##3##(1990-2#2)(1990-3#2)(1990-4#1)(1991-12#1)(1991-2#1)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-12#1)(1992-6#1)(1993-11#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-9#3)(1995-11#1)(1996-12#3)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#2)(2004-12#1)(2005-8#1)(2007-9#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-3#2)(2009-7#2)(2010-1#2)(2010-12#1)(2010-2#1)(2012-2#1)
vascular endothelial damage##2##3##(2007-10#1)(2011-2#1)
vascular endothelial growth factor (VEGF) and##3##6##(2008-6#1)(2008-7#1)(2009-5#1)
vascular endothelial growth factor (VEGF) expression##2##6##(2009-8#1)(2013-8#1)
vascular endothelial growth factor (VEGF) has been##3##7##(2005-7#1)(2008-8#1)(2012-12#1)
vascular endothelial growth factor (VEGF) in the##2##7##(1997-7#1)(2013-1#1)
vascular endothelial growth factor (VEGF) in##5##6##(1997-7#1)(2007-11#1)(2008-2#1)(2008-9#1)(2013-1#1)
vascular endothelial growth factor (VEGF) is##2##6##(1995-1#1)(2008-3#1)
vascular endothelial growth factor (VEGF)##44##5##(1992-3#1)(1994-12#1)(1995-1#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-7#2)(2006-11#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#2)(2009-5#1)(2009-8#2)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#3)
vascular endothelial growth factor expression##2##5##(1995-1#1)(2011-2#1)
vascular endothelial growth factor in##5##5##(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)(2013-1#1)
vascular endothelial growth factor pathway##2##5##(2008-5#1)(2012-3#1)
vascular endothelial growth factor receptor##6##5##(2005-7#1)(2008-6#1)(2008-8#1)(2010-3#1)(2012-1#1)(2012-12#1)
vascular endothelial growth factor##90##4##(1992-3#2)(1994-12#2)(1995-1#2)(1995-3#1)(1996-5#1)(1997-4#1)(1997-5#1)(1997-7#3)(2005-7#3)(2006-11#1)(2006-12#1)(2006-4#1)(2006-9#1)(2007-11#2)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#3)(2009-11#3)(2009-3#1)(2009-5#2)(2009-8#3)(2010-1#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#5)(2012-3#1)(2013-1#5)(2013-8#3)
vascular endothelial growth factor/vascular permeability factor (VEGF/VPF)##2##7##(1994-3#1)(1995-1#1)
vascular endothelial growth factor/vascular##3##4##(1994-3#1)(1995-1#1)(2010-12#1)
vascular endothelial growth factors##2##4##(2007-12#1)(2009-8#1)
vascular endothelial growth##97##3##(1992-3#2)(1994-12#2)(1994-3#1)(1995-1#3)(1995-3#1)(1996-5#1)(1997-4#1)(1997-5#1)(1997-7#4)(2005-7#3)(2006-11#1)(2006-12#1)(2006-4#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#3)(2009-11#3)(2009-3#1)(2009-5#2)(2009-8#4)(2010-1#1)(2010-12#4)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#5)(2012-3#1)(2013-1#5)(2013-8#3)
vascular endothelial##174##2##(1990-2#2)(1990-3#2)(1990-4#4)(1991-12#1)(1991-2#2)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#3)(1992-12#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-6#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#1)(1994-9#4)(1995-1#3)(1995-11#1)(1995-3#2)(1996-12#4)(1996-5#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#6)(2004-12#1)(2005-7#3)(2005-8#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#2)(2007-9#2)(2008-1#6)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#3)(2009-3#3)(2009-5#2)(2009-7#3)(2009-8#4)(2010-1#3)(2010-12#5)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#4)
vascular endothelium and##2##3##(1992-12#1)(2008-3#1)
vascular endothelium##20##2##(1990-10#1)(1990-4#1)(1992-12#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-2#1)(1996-3#1)(2005-11#1)(2006-5#1)(2008-1#1)(2008-3#2)(2009-3#1)(2009-5#1)(2009-6#1)(2012-1#2)(2012-2#1)(2013-8#1)
vascular event##3##2##(2008-7#1)(2008-8#1)(2010-3#1)
vascular events associated with##2##4##(2004-12#1)(2009-5#1)
vascular events in##3##3##(2005-10#1)(2008-1#1)(2012-1#1)
vascular events##18##2##(1993-9#1)(2004-12#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-10#4)(2008-1#1)(2008-7#2)(2008-8#2)(2009-5#1)(2010-12#1)(2012-1#1)(2013-1#1)
vascular exclusion##3##2##(1991-6#1)(1995-9#1)(2013-7#1)
vascular flow##2##2##(2012-3#1)(2013-1#1)
vascular function and##2##3##(2012-12#1)(2013-8#1)
vascular function in##3##3##(2005-10#1)(2008-3#1)(2008-4#1)
vascular function##10##2##(1993-6#1)(2005-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-6#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-8#1)
vascular functional##3##2##(2005-7#1)(2012-12#2)
vascular functions##2##2##(1997-6#1)(2010-1#1)
vascular geometry##4##2##(2013-1#4)
vascular graft materials##2##3##(2009-11#1)(2011-3#1)
vascular graft##11##2##(1990-10#1)(2005-10#1)(2007-10#2)(2007-7#1)(2007-8#1)(2008-5#1)(2009-11#2)(2011-3#2)
vascular grafts##13##2##(1990-10#1)(1990-11#1)(1994-7#1)(2004-9#1)(2006-6#1)(2007-10#1)(2007-7#2)(2008-5#1)(2010-8#3)(2011-3#1)
vascular growth##6##2##(1994-12#1)(1995-8#1)(2006-10#1)(2008-1#1)(2008-11#1)(2013-1#1)
vascular imaging##11##2##(2007-10#2)(2008-8#1)(2009-10#3)(2010-8#1)(2011-1#2)(2013-1#1)(2013-8#1)
vascular inflammation and##2##3##(2005-11#1)(2008-5#1)
vascular inflammation##9##2##(2005-11#1)(2006-10#1)(2008-1#2)(2008-5#1)(2013-1#4)
vascular injuries##10##2##(1992-3#3)(2006-10#1)(2006-8#1)(2007-8#1)(2008-9#1)(2009-9#1)(2011-12#1)(2011-2#1)
vascular injury and##2##3##(2008-9#1)(2009-8#1)
vascular injury is##2##3##(1992-9#1)(2007-9#1)
vascular injury##25##2##(1992-12#2)(1992-9#2)(1994-11#1)(1994-12#1)(1994-5#1)(1995-8#1)(1996-8#1)(2006-5#1)(2007-10#4)(2007-9#1)(2008-9#3)(2009-3#1)(2009-8#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
vascular insufficiency##6##2##(2008-9#3)(2009-3#1)(2011-1#1)(2012-3#1)
vascular intimal hyperplasia after balloon injury in rabbits fed on a high-cholesterol diet##2##13##(1996-12#2)
vascular invasion##13##2##(1990-10#1)(1990-6#1)(1993-9#1)(1994-5#1)(2006-6#2)(2007-8#2)(2011-1#1)(2011-12#1)(2011-2#2)(2013-1#1)
vascular involvement##2##2##(2006-10#1)(2008-6#1)
vascular leakage and##2##3##(2008-1#1)(2012-12#1)
vascular leakage##3##2##(2006-10#1)(2008-1#1)(2012-12#1)
vascular lesion##8##2##(1997-8#2)(2006-4#1)(2007-7#1)(2007-9#1)(2008-7#1)(2010-12#1)(2011-2#1)
vascular lesions and##2##3##(2005-9#1)(2007-6#1)
vascular lesions are##2##3##(2007-11#1)(2008-7#1)
vascular lesions for##2##3##(2006-12#1)(2007-5#1)
vascular lesions is##2##3##(2006-10#1)(2007-9#1)
vascular lesions##32##2##(1990-4#1)(1992-4#1)(1992-8#1)(1996-11#1)(1997-2#1)(1997-8#2)(2005-9#1)(2006-10#1)(2006-12#2)(2006-2#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#7)(2007-8#1)(2007-9#2)(2008-1#1)(2008-12#1)(2008-7#1)(2012-2#1)(2013-8#1)
vascular malformation of##2##3##(2012-3#2)
vascular malformation##8##2##(2006-6#1)(2008-4#1)(2008-6#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-3#2)
vascular malformations and##2##3##(1992-10#1)(2007-7#1)
vascular malformations in##2##3##(2008-7#1)(2012-3#1)
vascular malformations with##2##3##(2007-9#1)(2008-7#1)
vascular malformations##29##2##(1992-10#2)(1992-5#1)(2006-1#2)(2007-6#4)(2007-7#1)(2007-9#4)(2008-10#1)(2008-7#3)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#3)(2013-7#1)
vascular mapping##3##2##(2007-7#1)(2013-1#2)
vascular modifications##2##2##(2008-10#1)(2009-6#1)
vascular morbidity##3##2##(1995-6#1)(2006-9#1)(2013-1#1)
vascular muscle alpha##2##3##(1991-6#2)
vascular muscle##4##2##(1991-6#4)
vascular narrowing##2##2##(2009-2#2)
vascular natriuretic peptide##2##3##(1994-12#2)
vascular neoplasm##2##2##(2009-5#1)(2010-6#1)
vascular network##12##2##(1996-1#1)(2007-7#1)(2008-11#4)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#2)
vascular networks##3##2##(2009-4#1)(2010-9#1)(2012-12#1)
vascular obstruction##3##2##(2008-10#1)(2012-2#1)(2013-8#1)
vascular occlusion##6##2##(1992-6#1)(1995-3#1)(2007-9#1)(2008-4#1)(2009-1#1)(2011-2#1)
vascular occlusions##3##2##(2009-4#2)(2009-7#1)
vascular occlusive##2##2##(2007-10#1)(2009-4#1)
vascular or##6##2##(1992-8#1)(2007-12#1)(2008-3#1)(2008-6#1)(2011-3#1)(2012-12#1)
vascular organization##2##2##(1991-6#2)
vascular pathogen##2##2##(2008-10#2)
vascular pathologies##2##2##(2010-3#1)(2013-8#1)
vascular pathology##5##2##(1991-1#1)(2008-10#2)(2012-1#1)(2013-8#1)
vascular pattern##3##2##(2008-5#1)(2010-6#2)
vascular pedicle##3##2##(1991-4#1)(2007-12#1)(2008-6#1)
vascular permeability factor were##3##4##(1991-9#3)
vascular permeability factor##12##3##(1991-10#1)(1991-2#1)(1991-9#8)(1992-9#1)(2008-9#1)
vascular permeability in##2##3##(2006-10#1)(2008-1#1)
vascular permeability induced by##2##4##(1992-12#1)(2011-2#1)
vascular permeability##33##2##(1990-12#1)(1990-4#1)(1991-10#1)(1991-2#1)(1991-8#1)(1991-9#8)(1992-12#1)(1992-6#2)(1992-9#1)(1994-12#2)(1994-8#1)(2004-3#1)(2006-10#1)(2008-1#3)(2008-9#2)(2009-2#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-7#1)
vascular permeation##2##2##(2012-1#1)(2013-8#1)
vascular physiology and##2##3##(1995-3#1)(2008-7#1)
vascular plant##8##2##(2004-4#1)(2008-10#2)(2008-11#1)(2008-8#2)(2008-9#1)(2009-8#1)
vascular plants##11##2##(1995-3#1)(2008-8#4)(2008-9#3)(2009-6#1)(2009-8#2)
vascular plug##3##2##(2010-5#3)
vascular pressure##3##2##(1997-1#1)(2006-5#1)(2010-7#1)
vascular procedures##3##2##(1994-2#1)(2005-10#1)(2006-6#1)
vascular production of##2##3##(1994-11#1)(1997-7#1)
vascular proliferation of##2##3##(2008-8#2)
vascular proliferation##6##2##(2007-8#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-3#1)
vascular prostacyclin synthesis##2##3##(1991-5#2)
vascular prostacyclin##7##2##(1991-5#4)(1992-1#1)(1994-5#2)
vascular prostheses##4##2##(1993-10#2)(2007-2#1)(2011-3#1)
vascular prosthesis##5##2##(1993-10#3)(2008-11#1)(2011-3#1)
vascular prosthetic graft##2##3##(2011-3#2)
vascular reactivity in##5##3##(1994-11#2)(1995-12#1)(2006-10#1)(2012-2#1)
vascular reactivity##15##2##(1990-3#1)(1992-1#1)(1994-11#2)(1994-2#1)(1995-12#2)(2005-7#1)(2006-10#1)(2008-1#1)(2008-3#2)(2012-2#3)
vascular reconstruction##5##2##(1991-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-3#1)
vascular relaxation##2##2##(1992-6#2)
vascular remodeling and##2##3##(1994-9#1)(1996-6#1)
vascular remodeling##14##2##(1994-9#1)(1996-6#1)(2008-1#2)(2008-11#1)(2009-4#1)(2009-7#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)
vascular remodelling of##2##3##(2010-6#2)
vascular remodelling##3##2##(2010-10#1)(2010-6#2)
vascular repair##5##2##(2008-9#2)(2009-11#1)(2009-3#2)
vascular reserve##4##2##(2007-9#3)(2008-12#1)
vascular resistance and##6##3##(1993-12#1)(1995-4#1)(2005-11#1)(2007-11#1)(2007-8#1)(2010-10#1)
vascular resistance from##2##3##(2007-9#1)(2008-12#1)
vascular resistance index##3##3##(2007-8#3)
vascular resistance of##3##3##(1997-5#1)(2007-9#1)(2009-5#1)
vascular resistance was##3##3##(1992-1#1)(2007-8#2)
vascular resistance##47##2##(1990-11#1)(1991-2#1)(1991-3#1)(1991-9#2)(1992-1#3)(1993-11#1)(1993-12#3)(1995-12#1)(1995-4#1)(1996-6#1)(1997-5#1)(2005-1#1)(2005-11#1)(2006-4#1)(2007-11#1)(2007-8#8)(2007-9#4)(2008-1#1)(2008-11#1)(2008-12#3)(2008-4#1)(2008-7#1)(2009-5#1)(2010-10#3)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)
vascular response of##2##3##(2010-3#1)(2013-8#1)
vascular response to##4##3##(1996-12#1)(2008-1#1)(2008-6#1)(2013-8#1)
vascular response##10##2##(1992-2#1)(1993-3#1)(1996-12#1)(1997-5#1)(2008-1#1)(2008-6#1)(2010-3#1)(2011-1#1)(2013-8#2)
vascular responses to##5##3##(1990-10#1)(1991-2#1)(1993-3#2)(1996-10#1)
vascular responses##6##2##(1990-10#1)(1991-2#1)(1993-3#3)(1996-10#1)
vascular ring due to double aortic arch##2##7##(2008-4#2)
vascular ring##3##2##(2008-4#2)(2013-1#1)
vascular rings##3##2##(2008-4#1)(2010-12#1)(2011-2#1)
vascular risk factors and##4##4##(2007-10#2)(2008-7#2)
vascular risk factors##10##3##(2007-10#5)(2007-9#1)(2008-3#1)(2008-7#2)(2010-9#1)
vascular risk##21##2##(2005-10#3)(2007-10#11)(2007-9#1)(2008-3#3)(2008-7#2)(2010-9#1)
vascular rupture##2##2##(2007-7#2)
vascular scaffold production##2##3##(2010-9#2)
vascular scaffolds were##3##3##(2010-12#3)
vascular scaffolds##11##2##(2010-12#11)
vascular screening##3##2##(2007-7#3)
vascular smooth muscle and##4##4##(1990-8#1)(1992-3#1)(1992-4#1)(1997-4#1)
vascular smooth muscle cell (SMC)##2##5##(1991-10#1)(1993-11#1)
vascular smooth muscle cell growth##2##5##(1994-12#1)(1996-9#1)
vascular smooth muscle cell proliferation##2##5##(2008-1#1)(2008-11#1)
vascular smooth muscle cell##9##4##(1991-10#1)(1991-9#1)(1993-11#1)(1994-12#1)(1996-9#1)(2008-1#1)(2008-11#2)(2008-9#1)
vascular smooth muscle cell]##2##4##(2010-12#1)(2012-12#1)
vascular smooth muscle cells (VSMC) and##4##6##(1990-11#1)(1992-3#1)(1995-3#1)(2008-1#1)
vascular smooth muscle cells (VSMC) was##2##6##(1991-12#1)(1993-2#1)
vascular smooth muscle cells (VSMC)##13##5##(1990-11#1)(1990-12#1)(1991-12#1)(1991-7#1)(1992-3#1)(1992-9#1)(1993-2#1)(1994-9#1)(1995-3#1)(1996-2#1)(2008-1#1)(2008-5#1)(2008-8#1)
vascular smooth muscle cells (VSMCs)##9##5##(1993-4#1)(1994-6#1)(1994-8#1)(2008-11#1)(2012-12#4)(2012-2#1)
vascular smooth muscle cells and fibroblasts##3##6##(1990-2#2)(1997-2#1)
vascular smooth muscle cells and##6##5##(1990-2#2)(1990-7#1)(1995-2#1)(1997-2#1)(2008-1#1)
vascular smooth muscle cells in##3##5##(1991-10#2)(2009-1#1)
vascular smooth muscle cells to##2##5##(1990-12#1)(1995-11#1)
vascular smooth muscle cells were studied##2##6##(1992-8#1)(1996-8#1)
vascular smooth muscle cells were##3##5##(1990-8#1)(1992-8#1)(1996-8#1)
vascular smooth muscle cells##87##4##(1990-11#2)(1990-12#3)(1990-2#3)(1990-7#1)(1990-8#3)(1991-10#4)(1991-12#2)(1991-2#1)(1991-7#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-8#2)(1992-9#2)(1993-2#1)(1993-3#1)(1993-4#2)(1994-11#3)(1994-6#1)(1994-8#3)(1994-9#4)(1995-11#3)(1995-12#2)(1995-2#4)(1995-3#2)(1996-2#2)(1996-6#1)(1996-8#4)(1997-1#1)(1997-2#3)(1997-5#2)(1997-7#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-1#1)(2009-2#1)(2012-12#4)(2012-2#1)
vascular smooth muscle relaxation##2##4##(1990-5#1)(1991-9#1)
vascular smooth muscle##136##3##(1990-10#1)(1990-11#4)(1990-12#5)(1990-2#3)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#6)(1991-1#2)(1991-10#5)(1991-12#3)(1991-2#1)(1991-6#1)(1991-7#2)(1991-9#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#3)(1992-9#2)(1993-11#1)(1993-2#1)(1993-3#3)(1993-4#2)(1993-8#2)(1994-11#4)(1994-12#1)(1994-6#1)(1994-8#4)(1994-9#4)(1995-1#2)(1995-11#3)(1995-12#4)(1995-2#4)(1995-3#2)(1996-2#2)(1996-6#1)(1996-8#4)(1996-9#1)(1997-1#1)(1997-2#3)(1997-4#2)(1997-5#2)(1997-7#1)(2008-1#3)(2008-10#1)(2008-11#4)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-2#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#7)(2012-2#1)
vascular smooth muscles##4##3##(1992-4#1)(1995-12#2)(2005-1#1)
vascular smooth##141##2##(1990-10#1)(1990-11#4)(1990-12#5)(1990-2#3)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#6)(1991-1#2)(1991-10#5)(1991-12#3)(1991-2#1)(1991-6#1)(1991-7#2)(1991-9#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#2)(1992-6#1)(1992-8#3)(1992-9#2)(1993-11#1)(1993-2#1)(1993-3#3)(1993-4#2)(1993-8#2)(1994-11#4)(1994-12#1)(1994-6#1)(1994-8#4)(1994-9#4)(1995-1#2)(1995-11#3)(1995-12#6)(1995-2#4)(1995-3#2)(1996-2#2)(1996-6#1)(1996-8#4)(1996-9#1)(1997-1#1)(1997-2#3)(1997-4#2)(1997-5#2)(1997-7#1)(2005-1#1)(2008-1#3)(2008-10#1)(2008-11#4)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-2#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#7)(2012-2#1)(2013-1#1)
vascular space##4##2##(1990-2#2)(1994-6#1)(2011-1#1)
vascular stent##2##2##(2006-6#1)(2009-7#1)
vascular stents##4##2##(2011-1#1)(2012-2#3)
vascular stretch##2##2##(1990-12#2)
vascular structure##5##2##(2004-12#1)(2007-9#1)(2008-7#1)(2009-5#1)(2012-12#1)
vascular structures of the##2##4##(1997-8#1)(2007-9#1)
vascular structures with##2##3##(1993-10#1)(2011-2#1)
vascular structures##12##2##(1993-10#1)(1995-2#2)(1997-8#1)(2006-6#1)(2007-8#1)(2007-9#2)(2008-3#1)(2010-6#1)(2010-9#1)(2011-2#1)
vascular studies##2##2##(1993-7#1)(2012-12#1)
vascular supply to the##3##4##(2006-6#1)(2007-11#1)(2007-12#1)
vascular supply##9##2##(1992-1#1)(2005-11#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#3)(2009-8#1)
vascular surgeon##3##2##(2007-7#1)(2008-8#2)
vascular surgeons##4##2##(1991-3#1)(1993-9#1)(2007-7#1)(2011-1#1)
vascular surgery##24##2##(1990-10#1)(1993-10#1)(1994-2#3)(2004-7#1)(2006-10#4)(2006-11#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#2)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)
vascular surgery]##4##2##(1991-3#1)(1994-2#1)(2009-5#1)(2011-3#1)
vascular surgical##3##2##(1990-7#1)(2007-7#1)(2009-7#1)
vascular system and##3##3##(2008-7#1)(2008-9#1)(2009-10#1)
vascular system##24##2##(1990-8#1)(1991-4#1)(2005-10#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-6#1)(2007-3#1)(2008-10#5)(2008-7#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)
vascular systems that##2##3##(1995-3#1)(2005-9#1)
vascular systems##5##2##(1995-3#1)(2005-9#1)(2008-4#1)(2008-7#1)(2008-9#1)
vascular tension##3##2##(1990-4#1)(1991-11#1)(2008-11#1)
vascular territories##2##2##(2006-10#1)(2007-9#1)
vascular territory was##2##3##(2007-9#2)
vascular territory##5##2##(2007-10#2)(2007-9#2)(2012-3#1)
vascular thrombosis and##2##3##(2008-10#1)(2009-8#1)
vascular thrombosis##5##2##(2006-10#1)(2007-11#1)(2008-10#1)(2009-8#1)(2012-12#1)
vascular tissue and their##2##4##(1997-2#1)(2007-11#1)
vascular tissue and##6##3##(1994-2#1)(1997-2#1)(2006-12#2)(2007-11#1)(2008-10#1)
vascular tissue##17##2##(1994-2#1)(1997-2#1)(2006-12#2)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#1)(2009-10#1)(2009-11#1)(2009-8#1)
vascular tissues of##2##3##(2008-10#1)(2008-8#1)
vascular tissues##19##2##(1992-9#1)(1993-8#1)(1995-12#1)(2006-12#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-9#1)
vascular tone and blood pressure##2##5##(2008-1#1)(2009-4#1)
vascular tone and blood##3##4##(2008-1#1)(2009-4#1)(2013-1#1)
vascular tone and##4##3##(2008-1#1)(2009-4#1)(2010-10#1)(2013-1#1)
vascular tone##15##2##(1990-6#1)(1993-6#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-10#1)(2008-1#2)(2008-5#1)(2009-10#1)(2009-4#1)(2010-10#2)(2012-4#1)(2013-1#1)
vascular tree scaffolding##2##3##(2010-9#2)
vascular tree##12##2##(1994-9#1)(2005-11#1)(2006-10#1)(2007-7#1)(2008-1#1)(2010-9#4)(2012-12#2)(2012-2#1)
vascular tumor##8##2##(2005-12#1)(2006-12#1)(2007-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#1)(2011-1#1)
vascular tumors in##2##3##(2010-6#1)(2013-1#1)
vascular tumors##7##2##(2005-12#1)(2006-2#1)(2007-6#1)(2010-6#1)(2013-1#2)(2013-8#1)
vascular tumour##2##2##(2008-5#1)(2008-6#1)
vascular tumours like##2##3##(2007-10#2)
vascular tumours##4##2##(2007-10#2)(2007-9#1)(2008-12#1)
vascular volume of##2##3##(2010-8#2)
vascular volume##4##2##(1997-6#1)(2010-8#3)
vascular wall cells##2##3##(1995-3#1)(1997-2#1)
vascular wall##18##2##(1990-12#1)(1990-8#1)(1992-9#1)(1993-12#1)(1995-3#1)(1997-2#1)(2005-6#1)(2005-7#1)(2006-6#2)(2008-11#1)(2008-7#1)(2009-2#1)(2009-7#1)(2010-12#1)(2010-5#1)(2012-12#1)(2013-1#1)
vascular walls##6##2##(1991-6#1)(1992-9#1)(1993-9#1)(1996-9#1)(2012-1#1)(2012-3#1)
vascular wilt##3##2##(2008-10#3)
vascular##2030##1##(1990-10#11)(1990-11#7)(1990-12#12)(1990-2#7)(1990-3#6)(1990-4#12)(1990-5#5)(1990-6#4)(1990-7#2)(1990-8#9)(1990-9#3)(1991-1#3)(1991-10#7)(1991-11#3)(1991-12#7)(1991-2#16)(1991-3#8)(1991-4#5)(1991-5#7)(1991-6#13)(1991-7#8)(1991-8#4)(1991-9#17)(1992-1#9)(1992-10#4)(1992-11#1)(1992-12#12)(1992-2#2)(1992-3#10)(1992-4#8)(1992-5#3)(1992-6#12)(1992-8#9)(1992-9#16)(1993-10#8)(1993-11#7)(1993-12#8)(1993-2#6)(1993-3#22)(1993-4#2)(1993-5#1)(1993-6#6)(1993-7#1)(1993-8#4)(1993-9#4)(1994-10#1)(1994-11#10)(1994-12#14)(1994-2#10)(1994-3#3)(1994-4#1)(1994-5#12)(1994-6#4)(1994-7#1)(1994-8#7)(1994-9#17)(1995-1#6)(1995-11#5)(1995-12#16)(1995-2#11)(1995-3#11)(1995-4#2)(1995-6#1)(1995-8#4)(1995-9#2)(1996-1#2)(1996-10#7)(1996-11#7)(1996-12#11)(1996-2#4)(1996-3#1)(1996-5#5)(1996-6#3)(1996-7#2)(1996-8#6)(1996-9#4)(1997-1#7)(1997-2#10)(1997-3#11)(1997-4#5)(1997-5#5)(1997-6#8)(1997-7#10)(1997-8#8)(2004-12#5)(2004-3#2)(2004-4#1)(2004-7#1)(2004-9#1)(2005-1#3)(2005-10#14)(2005-11#6)(2005-12#5)(2005-3#1)(2005-6#1)(2005-7#19)(2005-8#3)(2005-9#3)(2006-1#3)(2006-10#33)(2006-11#7)(2006-12#11)(2006-2#3)(2006-3#3)(2006-4#5)(2006-5#9)(2006-6#14)(2006-8#7)(2006-9#4)(2007-1#3)(2007-10#52)(2007-11#19)(2007-12#11)(2007-2#4)(2007-3#6)(2007-4#2)(2007-5#6)(2007-6#17)(2007-7#124)(2007-8#42)(2007-9#36)(2008-1#75)(2008-10#66)(2008-11#26)(2008-12#12)(2008-2#2)(2008-3#39)(2008-4#24)(2008-5#25)(2008-6#16)(2008-7#54)(2008-8#28)(2008-9#32)(2009-1#6)(2009-10#14)(2009-11#10)(2009-12#1)(2009-2#8)(2009-3#19)(2009-4#14)(2009-5#14)(2009-6#7)(2009-7#10)(2009-8#22)(2009-9#1)(2010-1#7)(2010-10#8)(2010-12#32)(2010-2#2)(2010-3#8)(2010-4#9)(2010-5#10)(2010-6#14)(2010-7#4)(2010-8#12)(2010-9#14)(2011-1#27)(2011-12#4)(2011-2#57)(2011-3#10)(2012-1#14)(2012-11#2)(2012-12#60)(2012-2#31)(2012-3#15)(2012-4#2)(2013-1#56)(2013-7#7)(2013-8#29)
vascular-type vasopressin receptor##2##3##(1994-8#2)
vascular-type##3##1##(1994-8#2)(2008-7#1)
vascularisation##4##1##(1991-5#1)(2008-1#1)(2012-2#2)
vascularised##4##1##(2005-7#1)(2008-3#1)(2009-2#1)(2012-12#1)
vascularity and##3##2##(2004-1#1)(2006-11#1)(2013-1#1)
vascularity of the##4##3##(1991-8#1)(1996-3#1)(1996-8#1)(2006-3#1)
vascularity of##7##2##(1991-8#1)(1996-3#1)(1996-8#1)(2006-3#1)(2007-6#1)(2009-5#1)(2010-8#1)
vascularity##21##1##(1991-8#1)(1996-3#2)(1996-8#1)(2004-1#1)(2005-8#2)(2006-1#1)(2006-11#1)(2006-3#2)(2007-6#1)(2008-7#3)(2009-5#1)(2010-8#1)(2011-2#3)(2013-1#1)
vascularization and##5##2##(1990-5#1)(2008-1#1)(2009-4#1)(2010-12#2)
vascularization in##2##2##(2008-11#1)(2011-2#1)
vascularization is##2##2##(2008-1#1)(2008-11#1)
vascularization of the##5##3##(1990-5#1)(2007-11#1)(2007-7#1)(2008-1#1)(2011-1#1)
vascularization of##10##2##(1990-5#1)(1990-6#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-4#1)(2010-11#1)(2011-1#1)(2013-7#1)
vascularization##43##1##(1990-5#2)(1990-6#1)(1993-10#1)(1993-9#1)(2005-9#1)(2006-5#2)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#1)(2008-11#6)(2008-4#3)(2009-3#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-8#1)(2013-7#1)
vascularized and##3##2##(2008-1#1)(2008-5#1)(2011-2#1)
vascularized bone graft##2##3##(2006-3#1)(2007-11#1)
vascularized bone##6##2##(1996-8#1)(2006-3#2)(2007-11#2)(2010-6#1)
vascularized fibula##4##2##(2006-3#1)(2008-1#1)(2008-6#2)
vascularized flaps##2##2##(2009-5#1)(2012-2#1)
vascularized grafts##2##2##(2007-11#1)(2009-3#1)
vascularized muscle##2##2##(2007-8#1)(2008-9#1)
vascularized tissue##2##2##(2010-9#1)(2012-2#1)
vascularized##50##1##(1995-11#1)(1995-12#1)(1995-2#2)(1996-8#3)(2006-3#4)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#3)(2007-8#1)(2008-1#4)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-9#2)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#2)
vascularly perfused##3##2##(1992-12#1)(1992-6#1)(1997-6#1)
vascularly##5##1##(1992-12#1)(1992-6#1)(1995-12#1)(1997-5#1)(1997-6#1)
vasculature and the##4##3##(1993-10#1)(1994-9#1)(1996-2#1)(2010-10#1)
vasculature and##10##2##(1991-9#1)(1993-10#1)(1994-9#1)(1995-1#1)(1996-2#1)(2005-12#1)(2008-3#1)(2010-10#1)(2011-1#1)(2013-1#1)
vasculature are##2##2##(1994-5#1)(2007-10#1)
vasculature by##2##2##(2006-10#1)(2012-2#1)
vasculature could##2##2##(2007-1#1)(2008-3#1)
vasculature for##4##2##(1996-5#1)(2005-9#1)(2008-7#1)(2008-9#1)
vasculature in the##3##3##(2008-9#1)(2013-1#2)
vasculature in##12##2##(1993-11#1)(1993-9#1)(2007-11#1)(2008-2#1)(2008-7#1)(2008-9#3)(2009-8#1)(2011-2#1)(2013-1#2)
vasculature is##4##2##(1994-12#1)(2008-7#1)(2009-4#1)(2012-2#1)
vasculature of the##4##3##(1997-3#1)(2006-11#1)(2012-12#1)(2013-1#1)
vasculature of##5##2##(1997-3#1)(2006-11#1)(2009-2#1)(2012-12#1)(2013-1#1)
vasculature on the##3##3##(2006-11#1)(2012-12#2)
vasculature or##2##2##(2005-8#1)(2007-7#1)
vasculature to##6##2##(1991-2#1)(1996-2#1)(2005-10#2)(2007-10#1)(2013-1#1)
vasculature was##3##2##(1995-10#1)(1996-11#1)(2007-9#1)
vasculature##127##1##(1990-2#1)(1991-2#1)(1991-9#2)(1993-10#1)(1993-11#1)(1993-9#5)(1994-12#1)(1994-2#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-10#1)(1996-11#1)(1996-2#2)(1996-5#2)(1997-1#6)(1997-3#1)(1997-8#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-11#7)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#6)(2008-9#5)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#5)(2009-6#1)(2009-8#1)(2010-10#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#5)(2012-2#8)(2012-3#2)(2013-1#9)(2013-8#2)
vasculitic leg ulcers associated with hepatitis C virus infection##4##9##(2013-1#4)
vasculitic##10##1##(1997-2#1)(2006-10#1)(2006-4#1)(2010-6#1)(2012-1#2)(2013-1#4)
vasculitides and##3##2##(1996-1#1)(2007-11#1)(2012-3#1)
vasculitides##14##1##(1996-1#1)(2005-8#4)(2007-11#1)(2007-8#1)(2008-7#1)(2010-4#2)(2012-1#2)(2012-3#2)
vasculitis and glomerulonephritis##3##3##(1996-1#2)(2007-2#1)
vasculitis and##14##2##(1993-10#1)(1996-1#2)(2005-9#1)(2006-10#5)(2007-1#1)(2007-2#1)(2007-7#1)(2010-6#1)(2011-2#1)
vasculitis associated with##2##3##(2008-5#1)(2010-7#1)
vasculitis have##2##2##(1997-4#1)(2007-2#1)
vasculitis in a patient with##2##5##(2006-10#1)(2011-1#1)
vasculitis in a##3##3##(2006-10#1)(2011-1#2)
vasculitis in the##4##3##(1991-3#1)(1997-5#1)(2006-10#1)(2007-8#1)
vasculitis in##20##2##(1991-3#2)(1996-3#1)(1997-5#1)(1997-8#2)(2005-9#1)(2006-10#4)(2007-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2011-1#2)
vasculitis involving##2##2##(2006-10#1)(2012-2#1)
vasculitis is##5##2##(1990-8#1)(2007-7#1)(2011-1#1)(2012-1#1)(2012-3#1)
vasculitis limited to the##2##4##(1992-8#1)(2006-10#1)
vasculitis of the cervix##2##4##(2006-10#2)
vasculitis of the##4##3##(1990-8#1)(2006-10#2)(2010-12#1)
vasculitis of##8##2##(1990-8#1)(2006-10#4)(2007-7#1)(2007-8#1)(2010-12#1)
vasculitis or##2##2##(2006-10#1)(2009-5#1)
vasculitis that is##2##3##(2006-10#1)(2011-1#1)
vasculitis that##6##2##(2006-10#1)(2007-2#1)(2008-1#1)(2008-8#1)(2011-1#1)(2013-1#1)
vasculitis was##2##2##(2006-10#1)(2007-3#1)
vasculitis with##6##2##(2006-10#6)
vasculitis##184##1##(1990-8#6)(1991-3#2)(1991-6#1)(1992-2#1)(1992-5#1)(1992-8#3)(1993-10#2)(1993-2#2)(1994-5#1)(1995-5#1)(1996-1#3)(1996-3#3)(1996-8#1)(1997-4#5)(1997-5#1)(1997-8#8)(2005-11#1)(2005-8#3)(2005-9#2)(2006-10#54)(2006-12#1)(2006-2#1)(2007-1#2)(2007-10#2)(2007-11#4)(2007-2#4)(2007-3#1)(2007-7#7)(2007-8#10)(2007-9#4)(2008-1#6)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#2)(2009-2#1)(2009-5#1)(2010-12#3)(2010-2#1)(2010-4#3)(2010-6#2)(2010-7#1)(2011-1#6)(2011-2#2)(2012-1#1)(2012-2#4)(2012-3#5)(2013-1#2)
vasculitis]##5##1##(1990-8#1)(1993-10#1)(1994-3#2)(2007-9#1)
vasculogenesis and angiogenesis##2##3##(2012-12#2)
vasculogenesis##4##1##(2010-9#1)(2012-12#3)
vasculogenic##6##1##(2006-10#1)(2009-3#2)(2009-5#1)(2012-12#1)(2012-3#1)
vasculopathies##2##1##(1990-5#1)(2010-12#1)
vasculopathy and##2##2##(2011-2#1)(2013-1#1)
vasculopathy is##2##2##(1995-12#1)(2007-10#1)
vasculopathy##24##1##(1995-12#4)(1995-2#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-7#1)(2008-4#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-5#1)(2010-6#1)(2011-2#2)(2012-12#1)(2013-1#1)
vasculosum laminae terminalis (OVLT)##2##4##(1993-7#2)
vasculosum##5##1##(1991-8#1)(1993-2#1)(1993-7#2)(2008-4#1)
vase##2##1##(2008-12#1)(2008-3#1)
vasectomies##5##1##(1996-1#5)
vasectomised##3##1##(1991-8#1)(1993-7#1)(2006-4#1)
vasectomized men##2##2##(1990-9#2)
vasectomized##6##1##(1990-9#2)(1993-7#1)(1994-12#2)(2008-12#1)
vasectomy##12##1##(1990-9#4)(1992-5#1)(1993-7#1)(1994-7#1)(1996-1#1)(2006-10#2)(2008-7#1)(2008-8#1)
vasinfectum from##2##2##(2008-10#2)
vasinfectum race 1##2##3##(2008-10#2)
vasinfectum##10##1##(2008-10#10)
vaso-occlusive##4##1##(1991-6#2)(1997-6#1)(2012-2#1)
vasoactive agents in##3##3##(1993-3#2)(2009-8#1)
vasoactive agents##7##2##(1993-3#3)(2006-10#3)(2009-8#1)
vasoactive drug##2##2##(1995-9#1)(2008-8#1)
vasoactive drugs##7##2##(1990-3#1)(1991-12#1)(1995-9#1)(1997-1#1)(2006-10#2)(2013-1#1)
vasoactive effects##2##2##(1996-2#1)(2006-2#1)
vasoactive factors and##2##3##(2009-6#1)(2012-12#1)
vasoactive intestinal contractor (VIC)##2##4##(1991-2#1)(1991-5#1)
vasoactive intestinal contractor##3##3##(1991-2#2)(1991-5#1)
vasoactive intestinal peptide (VIP) receptors##2##5##(1990-10#1)(1994-3#1)
vasoactive intestinal peptide (VIP)##9##4##(1990-10#1)(1990-6#1)(1994-11#1)(1994-3#1)(1997-1#1)(2006-10#1)(2006-6#1)(2006-7#1)(2010-12#1)
vasoactive intestinal peptide##15##3##(1990-10#1)(1990-6#1)(1994-11#1)(1994-3#3)(1994-9#1)(1995-12#1)(1995-5#1)(1997-1#1)(2006-10#2)(2006-6#1)(2006-7#1)(2010-12#1)
vasoactive intestinal polypeptide (VIP) immunoreactive##2##5##(1993-9#1)(1997-8#1)
vasoactive intestinal polypeptide (VIP)##11##4##(1990-4#1)(1990-7#1)(1992-9#1)(1993-3#1)(1993-9#1)(1995-11#1)(1995-5#1)(1995-9#1)(1997-5#1)(1997-8#1)(2008-4#1)
vasoactive intestinal polypeptide##20##3##(1990-4#1)(1990-5#1)(1990-7#1)(1992-9#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-3#2)(1995-11#1)(1995-5#1)(1995-6#1)(1995-9#1)(1997-1#1)(1997-5#1)(1997-8#4)(2008-4#1)
vasoactive intestinal##43##2##(1990-10#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-2#2)(1991-5#1)(1992-9#1)(1993-3#1)(1993-7#2)(1993-9#1)(1994-11#1)(1994-3#6)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#2)(1995-6#1)(1995-9#1)(1997-1#2)(1997-5#1)(1997-8#4)(2006-10#2)(2006-6#1)(2006-7#1)(2008-1#1)(2008-4#1)(2010-12#1)(2012-3#1)
vasoactive mediators and##4##3##(1996-2#1)(2006-10#1)(2006-8#1)(2008-1#1)
vasoactive mediators##6##2##(1994-12#1)(1996-2#1)(2006-10#2)(2006-8#1)(2008-1#1)
vasoactive peptide##3##2##(1992-3#1)(1993-3#1)(2011-2#1)
vasoactive peptides##5##2##(1994-9#4)(2005-8#1)
vasoactive substances##7##2##(1993-12#1)(1994-9#1)(2006-10#2)(2008-1#1)(2010-12#1)(2011-2#1)
vasoactive##101##1##(1990-10#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-2#2)(1991-5#2)(1991-6#1)(1992-3#1)(1992-9#1)(1993-12#2)(1993-3#5)(1993-7#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#6)(1994-8#1)(1994-9#6)(1995-11#1)(1995-12#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-9#4)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#3)(1997-5#1)(1997-8#4)(2004-12#1)(2005-8#1)(2006-10#11)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2008-1#3)(2008-4#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-12#3)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
vasoactivity##2##1##(1993-12#1)(2007-8#1)
vasoconstricting##5##1##(1990-3#1)(1994-11#1)(2006-10#1)(2007-9#1)(2008-7#1)
vasoconstriction and##7##2##(1992-4#1)(1993-12#1)(1993-3#1)(1994-2#1)(2006-10#1)(2006-8#1)(2010-2#1)
vasoconstriction by##4##2##(1990-6#1)(1993-10#1)(1995-12#1)(2008-2#1)
vasoconstriction effect##2##2##(2011-2#2)
vasoconstriction evoked by##4##3##(1990-6#1)(1992-8#2)(1995-12#1)
vasoconstriction in guinea-pig vena cava##2##5##(1995-12#2)
vasoconstriction in response to##2##4##(1995-12#1)(2006-10#1)
vasoconstriction in##9##2##(1992-3#1)(1995-12#3)(1996-10#1)(1997-4#1)(1997-8#1)(2006-10#1)(2008-7#1)
vasoconstriction is##2##2##(1993-3#1)(2006-10#1)
vasoconstriction of the##2##3##(1993-3#1)(2007-10#1)
vasoconstriction of##5##2##(1991-6#1)(1992-2#1)(1992-6#1)(1993-3#1)(2007-10#1)
vasoconstriction was##2##2##(1993-3#1)(1995-12#1)
vasoconstriction##89##1##(1990-1#1)(1990-10#1)(1990-2#1)(1990-4#2)(1990-5#2)(1990-6#2)(1990-9#1)(1991-11#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#4)(1993-10#1)(1993-12#1)(1993-3#6)(1994-2#1)(1994-9#1)(1995-12#11)(1995-5#1)(1996-10#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#1)(2005-10#1)(2006-10#10)(2006-2#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#1)(2010-12#3)(2010-2#1)(2010-7#1)(2011-2#2)(2012-3#1)
vasoconstrictions were##5##2##(1993-3#5)
vasoconstrictions##9##1##(1990-9#1)(1993-3#6)(2010-12#2)
vasoconstrictive##7##1##(1991-5#1)(1992-7#1)(1995-12#2)(1995-2#1)(2006-10#1)(2011-1#1)
vasoconstrictor activity##3##2##(1990-2#1)(1991-2#1)(1992-2#1)
vasoconstrictor and mitogen that##2##4##(2008-1#1)(2009-10#1)
vasoconstrictor and##7##2##(1991-9#1)(1995-12#1)(1996-2#1)(1997-5#1)(1997-7#1)(2008-1#1)(2009-10#1)
vasoconstrictor effect##4##2##(1991-9#1)(1993-3#2)(2008-12#1)
vasoconstrictor peptide##4##2##(1990-3#1)(1991-8#1)(1993-3#1)(1995-11#1)
vasoconstrictor response##2##2##(1992-8#1)(1996-10#1)
vasoconstrictor responses##4##2##(1992-8#1)(1994-6#1)(1996-10#1)(2010-10#1)
vasoconstrictor##41##1##(1990-2#1)(1990-3#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#2)(1993-1#4)(1993-3#4)(1994-6#1)(1995-11#1)(1995-12#1)(1996-10#3)(1996-2#1)(1996-9#1)(1997-1#1)(1997-5#1)(1997-7#1)(2007-10#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-12#1)(2009-10#1)(2010-10#2)
vasoconstrictors in##3##2##(1994-2#1)(1994-9#1)(2013-8#1)
vasoconstrictors##9##1##(1990-5#1)(1991-3#1)(1994-11#1)(1994-2#1)(1994-9#1)(2007-11#1)(2008-3#1)(2009-8#1)(2013-8#1)
vasocontractile##2##1##(1990-3#1)(1995-12#1)
vasocontraction##2##1##(1992-5#1)(1995-12#1)
vasodepressor activity##3##2##(1990-7#3)
vasodepressor response##2##2##(1997-1#1)(1997-2#1)
vasodepressor##6##1##(1990-7#3)(1996-12#1)(1997-1#1)(1997-2#1)
vasodilatation and the hyperdynamic circulation are hemodynamic abnormalities typical of cirrhosis and portal hypertension##2##14##(2006-10#2)
vasodilatation and the##3##3##(1997-7#1)(2006-10#2)
vasodilatation and##9##2##(1991-8#1)(1997-7#1)(2005-12#1)(2006-10#5)(2009-8#1)
vasodilatation in man##2##3##(1994-11#2)
vasodilatation in##7##2##(1990-7#1)(1994-11#2)(1995-11#3)(2005-11#1)
vasodilatation may##2##2##(1990-12#1)(1992-3#1)
vasodilatation of the##2##3##(1990-12#1)(1992-8#1)
vasodilatation of##3##2##(1990-12#1)(1992-8#2)
vasodilatation##50##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-7#3)(1990-8#1)(1990-9#1)(1991-5#1)(1991-8#1)(1992-3#2)(1992-6#1)(1992-8#2)(1994-11#2)(1994-9#1)(1995-11#3)(1995-12#1)(1996-3#2)(1997-5#1)(1997-7#3)(2005-1#1)(2005-11#1)(2005-12#1)(2006-10#8)(2008-10#1)(2008-11#5)(2008-8#1)(2009-8#2)
vasodilatatory##2##1##(2011-1#1)(2013-8#1)
vasodilating effects##2##2##(2006-10#1)(2007-9#1)
vasodilating##13##1##(1992-6#1)(1995-12#1)(2006-10#2)(2006-11#1)(2007-10#1)(2007-9#1)(2008-5#5)(2010-12#1)
vasodilation after##2##2##(1995-12#1)(2004-12#1)
vasodilation and##4##2##(1995-12#1)(2008-5#1)(2008-8#1)(2011-1#1)
vasodilation by##2##2##(1990-7#1)(2009-4#1)
vasodilation in rat##2##3##(1992-3#1)(1997-7#1)
vasodilation in the CAD##2##4##(1997-2#2)
vasodilation in the##3##3##(1997-2#2)(2008-12#1)
vasodilation in##7##2##(1992-3#1)(1997-2#2)(1997-7#1)(2006-10#1)(2008-12#1)(2008-7#1)
vasodilation of##4##2##(1992-8#1)(2007-9#2)(2008-3#1)
vasodilation was##2##2##(1992-3#1)(2011-2#1)
vasodilation with##2##2##(2006-9#1)(2013-8#1)
vasodilation##44##1##(1990-7#1)(1991-5#1)(1991-9#2)(1992-3#2)(1992-8#1)(1992-9#1)(1993-3#1)(1995-12#2)(1996-10#1)(1997-2#3)(1997-5#1)(1997-7#1)(2004-12#3)(2005-10#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-9#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#5)(2013-8#1)
vasodilator and##2##2##(1994-3#1)(2008-12#1)
vasodilator effect of##4##3##(1990-2#1)(1991-5#1)(1993-3#1)(2011-2#1)
vasodilator effect##6##2##(1990-2#1)(1991-2#1)(1991-5#1)(1993-3#1)(2010-6#1)(2011-2#1)
vasodilator response of##2##3##(1996-12#1)(2011-2#1)
vasodilator response##3##2##(1996-12#2)(2011-2#1)
vasodilator responses to##3##3##(1994-7#1)(1996-10#1)(2009-9#1)
vasodilator responses##5##2##(1993-3#1)(1994-7#1)(1996-10#1)(2004-12#1)(2009-9#1)
vasodilator therapy has##2##3##(1991-2#1)(2006-10#1)
vasodilator therapy##6##2##(1991-2#1)(2006-10#3)(2007-8#1)(2008-12#1)
vasodilator##58##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-9#3)(1991-12#1)(1991-2#3)(1991-3#3)(1991-5#1)(1991-9#1)(1992-5#1)(1993-11#1)(1993-3#3)(1994-11#1)(1994-3#1)(1994-6#2)(1994-7#1)(1996-10#1)(1996-12#6)(1996-6#1)(1996-8#1)(1997-7#1)(2004-12#1)(2006-10#4)(2007-8#3)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#3)(2008-4#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-6#1)(2011-2#2)(2012-3#1)
vasodilators and##8##2##(1990-8#1)(1996-5#1)(1997-8#1)(2004-3#1)(2006-10#1)(2008-10#1)(2010-12#1)(2010-6#1)
vasodilators in the##2##3##(2006-10#1)(2008-3#1)
vasodilators in##3##2##(2006-10#1)(2007-8#1)(2008-3#1)
vasodilators##32##1##(1990-12#2)(1990-8#4)(1993-10#1)(1994-7#1)(1995-11#1)(1996-11#1)(1996-5#1)(1997-1#1)(1997-5#1)(1997-8#1)(2004-12#1)(2004-3#1)(2006-10#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#3)(2009-5#1)(2010-10#1)(2010-12#2)(2010-6#1)
vasodilatory action##2##2##(1992-5#1)(2008-5#1)
vasodilatory actions##2##2##(1997-5#1)(2010-4#1)
vasodilatory effect of##2##3##(1990-11#1)(1990-7#1)
vasodilatory effect##3##2##(1990-11#1)(1990-7#1)(2008-1#1)
vasodilatory effects##3##2##(1995-2#1)(1996-9#1)(2013-8#1)
vasodilatory properties##2##2##(1990-11#1)(1991-8#1)
vasodilatory shock after##2##3##(2007-9#2)
vasodilatory##23##1##(1990-11#3)(1990-7#1)(1991-8#1)(1992-1#1)(1992-5#1)(1995-2#1)(1996-9#1)(1997-1#1)(1997-5#1)(2004-11#1)(2005-10#1)(2007-9#2)(2008-1#1)(2008-3#1)(2008-4#3)(2008-5#1)(2010-4#1)(2013-8#1)
vasogenic edema and##2##3##(2007-10#1)(2013-7#1)
vasogenic edema##5##2##(2007-10#3)(2011-2#1)(2013-7#1)
vasogenic##7##1##(1996-6#1)(2007-10#3)(2010-12#1)(2011-2#1)(2013-7#1)
vasography##2##1##(1997-8#2)
vasomotor activity##2##2##(2008-4#1)(2011-2#1)
vasomotor reactions##2##2##(1991-3#1)(2009-6#1)
vasomotor rhinitis##2##2##(2011-1#2)
vasomotor symptoms##4##2##(2007-6#1)(2008-11#1)(2013-1#2)
vasomotor tone##2##2##(1992-9#1)(2008-3#1)
vasomotor##25##1##(1990-7#1)(1991-12#1)(1991-3#1)(1992-3#1)(1992-9#1)(2006-12#1)(2007-6#2)(2007-8#1)(2007-9#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-5#1)(2009-6#1)(2011-1#2)(2011-2#1)(2013-1#3)
vasopressin (40##2##2##(1997-4#2)
vasopressin (AVP) and##2##3##(1993-12#1)(2013-8#1)
vasopressin (AVP) binding##2##3##(1991-3#1)(1994-8#1)
vasopressin (AVP) in##2##3##(1990-9#1)(1993-4#1)
vasopressin (AVP)##12##2##(1990-11#1)(1990-9#1)(1991-3#1)(1991-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-4#1)(1994-8#1)(1995-5#1)(2008-4#1)(2013-8#1)
vasopressin (VP)##3##2##(1994-9#1)(1996-8#1)(1997-8#1)
vasopressin V1 receptor antagonist##3##4##(1995-12#3)
vasopressin V1 receptors##2##3##(1992-9#1)(1995-12#1)
vasopressin V1##5##2##(1992-9#1)(1995-12#4)
vasopressin V1A receptor##2##3##(1996-10#2)
vasopressin V1A##3##2##(1996-10#3)
vasopressin V2 receptor##5##3##(1994-11#2)(1994-12#1)(1996-8#2)
vasopressin V2 receptor-related##2##3##(1996-10#2)
vasopressin V2##7##2##(1994-11#2)(1994-12#1)(1996-10#2)(1996-8#2)
vasopressin also##2##2##(1995-5#1)(1997-4#1)
vasopressin and angiotensin II stimulate the phosphorylation of##2##8##(1996-2#2)
vasopressin and angiotensin II##3##4##(1996-2#3)
vasopressin and oxytocin##2##3##(1993-4#1)(1994-9#1)
vasopressin and##11##2##(1991-9#1)(1992-5#2)(1993-4#1)(1994-9#2)(1995-12#1)(1996-2#3)(2013-8#1)
vasopressin are##2##2##(1995-12#1)(1995-9#1)
vasopressin but not##2##3##(1993-11#1)(1995-5#1)
vasopressin but##3##2##(1993-11#1)(1995-5#2)
vasopressin cells in##2##3##(1994-10#2)
vasopressin cells##3##2##(1990-5#1)(1994-10#2)
vasopressin from##3##2##(1994-10#2)(2013-1#1)
vasopressin immunoreactivity in##2##3##(1994-2#2)
vasopressin immunoreactivity##3##2##(1994-2#3)
vasopressin in the##2##3##(2007-9#2)
vasopressin in##10##2##(1990-12#1)(1990-9#1)(1991-7#1)(1993-12#1)(1993-7#2)(1995-12#1)(2006-4#1)(2007-9#2)
vasopressin is a##2##3##(1993-11#1)(1996-10#1)
vasopressin levels in##2##3##(1995-12#1)(2008-2#1)
vasopressin levels##3##2##(1995-12#2)(2008-2#1)
vasopressin neurons##3##2##(1993-4#1)(1994-10#1)(1996-9#1)
vasopressin on sodium intake##2##4##(1997-4#2)
vasopressin on##4##2##(1990-11#1)(1995-5#1)(1997-4#2)
vasopressin receptor antagonists##3##3##(2005-7#1)(2008-2#2)
vasopressin receptor gene##2##3##(1993-6#1)(1996-11#1)
vasopressin receptor##13##2##(1993-11#1)(1993-6#2)(1994-8#4)(1995-5#1)(1996-11#1)(2005-7#1)(2008-2#2)(2013-8#1)
vasopressin receptors##9##2##(1991-3#1)(1991-8#1)(1993-11#1)(1994-2#3)(1994-9#1)(1995-12#1)(1996-11#1)
vasopressin release##3##2##(1995-12#2)(1996-8#1)
vasopressin secretion##2##2##(1995-12#1)(2005-7#1)
vasopressin to##2##2##(1995-9#1)(1996-10#1)
vasopressin type 2 receptor##2##4##(1994-8#2)
vasopressin were##2##2##(1990-7#2)
vasopressin##186##1##(1990-11#3)(1990-12#2)(1990-5#4)(1990-7#3)(1990-9#4)(1991-3#3)(1991-5#1)(1991-7#3)(1991-8#1)(1991-9#2)(1992-11#1)(1992-5#5)(1992-8#2)(1992-9#2)(1993-11#5)(1993-12#2)(1993-2#1)(1993-4#7)(1993-6#2)(1993-7#3)(1994-10#9)(1994-11#2)(1994-12#1)(1994-2#10)(1994-8#7)(1994-9#7)(1995-12#18)(1995-5#10)(1995-7#1)(1995-9#2)(1996-10#8)(1996-11#2)(1996-12#1)(1996-2#4)(1996-8#4)(1996-9#1)(1997-3#1)(1997-4#7)(1997-8#1)(2005-10#1)(2005-7#2)(2006-10#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-3#1)(2007-8#1)(2007-9#4)(2008-12#1)(2008-2#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-1#1)(2012-1#1)(2012-12#2)(2013-1#4)(2013-8#3)
vasopressin- and##3##2##(1995-8#2)(2012-12#1)
vasopressin-containing cells##3##2##(1993-12#3)
vasopressin-immunoreactive##2##1##(1993-12#1)(1995-7#1)
vasopressin-induced##2##1##(1995-5#1)(1996-10#1)
vasopressin-labeled cells##2##2##(1993-12#1)(1996-9#1)
vasopressin-secreting neurons##2##2##(1993-4#2)
vasopressin-secreting##3##1##(1993-4#3)
vasopressinergic##4##1##(1990-5#1)(1993-2#3)
vasopressor##10##1##(1993-2#1)(1997-5#1)(2008-4#1)(2009-8#2)(2010-5#1)(2012-12#1)(2013-1#2)(2013-7#1)
vasopressors##7##1##(2006-10#2)(2008-3#1)(2009-9#1)(2012-3#1)(2013-1#2)
vasoproliferative tumor##3##2##(2007-3#3)
vasoreactivity##4##1##(1994-9#1)(2012-1#1)(2012-3#2)
vasoregulatory##2##1##(1992-12#1)(2008-1#1)
vasorelaxant effect of Viscum album##2##5##(2009-5#2)
vasorelaxant effect of##3##3##(2009-5#3)
vasorelaxant material##2##2##(1990-11#2)
vasorelaxant properties##2##2##(2009-5#2)
vasorelaxant##12##1##(1990-11#2)(1992-9#1)(1994-11#1)(1994-5#2)(2009-5#6)
vasorelaxation##6##1##(1991-9#1)(1992-9#1)(1993-6#2)(2013-8#2)
vasorum and##2##2##(1993-12#1)(2010-9#1)
vasorum##4##1##(1993-12#1)(1997-8#1)(2010-4#1)(2010-9#1)
vasospasm after AVM rupture##3##4##(2012-3#3)
vasospasm after subarachnoid hemorrhage##4##4##(2006-11#1)(2007-11#1)(2007-9#1)(2011-2#1)
vasospasm after##9##2##(2006-11#2)(2007-10#1)(2007-11#1)(2007-9#1)(2011-2#1)(2012-3#3)
vasospasm and diminished coronary blood flow reserve##2##7##(2008-7#2)
vasospasm and##8##2##(2006-11#1)(2007-10#1)(2007-9#1)(2008-7#4)(2011-2#1)
vasospasm in coronary artery bypass grafts##2##6##(2011-2#2)
vasospasm in##5##2##(1991-3#1)(2006-11#1)(2011-2#2)(2012-3#1)
vasospasm is##2##2##(2007-8#1)(2008-7#1)
vasospasm was##6##2##(2006-11#1)(2007-10#2)(2007-8#1)(2007-9#1)(2012-3#1)
vasospasm##76##1##(1991-3#1)(1992-5#1)(1992-9#1)(1994-11#1)(1995-11#1)(1996-3#1)(1996-8#1)(1997-3#1)(2006-11#12)(2007-10#14)(2007-11#1)(2007-8#3)(2007-9#6)(2008-3#2)(2008-7#8)(2008-8#1)(2008-9#3)(2009-8#2)(2010-12#2)(2010-7#1)(2011-2#5)(2012-3#7)(2013-8#1)
vasospasms##3##1##(1991-3#1)(1995-5#1)(2006-10#1)
vasospastic angina##2##2##(1996-9#1)(2008-4#1)
vasospastic##4##1##(1993-12#2)(1996-9#1)(2008-4#1)
vasotocin##9##1##(1993-4#6)(2008-7#2)(2012-1#1)
vasovagal syncope##5##2##(2006-9#5)
vasovagal##8##1##(1997-1#1)(2006-9#6)(2007-8#1)
vast amount of information##7##4##(1993-12#1)(2006-1#1)(2006-5#1)(2008-10#1)(2008-7#1)(2013-1#2)
vast amount of##12##3##(1993-12#1)(2006-1#1)(2006-10#1)(2006-5#1)(2007-7#1)(2008-10#1)(2008-7#2)(2009-12#1)(2012-3#1)(2013-1#2)
vast amounts of data##3##4##(1995-12#1)(2008-9#1)(2012-3#1)
vast amounts of##5##3##(1995-12#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-3#1)
vast areas##2##2##(1992-2#1)(2008-10#1)
vast array of##6##3##(2006-10#1)(2006-2#1)(2007-9#1)(2008-11#1)(2008-5#1)(2011-1#1)
vast geographic range##2##3##(2008-5#2)
vast literature on##2##3##(1996-8#1)(2009-7#1)
vast majority of cases##3##4##(1995-7#1)(2008-12#1)(2009-8#1)
vast majority of patients##7##4##(1997-1#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-7#1)(2009-3#1)(2012-2#1)
vast majority of the##5##4##(1997-6#1)(2006-8#1)(2007-6#1)(2008-1#1)(2011-2#1)
vast majority of these##7##4##(2007-12#1)(2008-11#1)(2009-5#1)(2010-12#1)(2012-11#2)(2013-7#1)
vast majority of women##2##4##(1994-12#1)(2008-9#1)
vast majority of##68##3##(1991-11#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-3#1)(1995-7#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#1)(2006-10#2)(2006-12#1)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#2)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#5)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#2)(2010-12#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-11#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
vast majority##76##2##(1991-11#1)(1991-8#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-3#1)(1995-7#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#1)(2006-10#2)(2006-12#1)(2006-7#1)(2006-8#3)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#2)(2007-6#1)(2007-7#2)(2008-1#2)(2008-10#3)(2008-11#5)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#2)(2010-12#2)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#3)(2012-11#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
vast number of##7##3##(1995-8#1)(2006-10#1)(2008-2#1)(2008-7#1)(2010-11#1)(2012-1#1)(2012-12#1)
vast pool of##2##3##(1995-7#1)(2012-12#1)
vast quantities of##2##3##(2006-10#1)(2008-9#1)
vast range of##2##3##(2011-1#1)(2012-2#1)
vast##166##1##(1990-3#1)(1990-7#1)(1991-11#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-7#2)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#2)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-11#1)(2006-1#1)(2006-10#6)(2006-12#1)(2006-2#2)(2006-5#1)(2006-7#1)(2006-8#3)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#3)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#7)(2008-11#8)(2008-12#1)(2008-2#3)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#9)(2008-8#4)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#3)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-2#6)(2012-1#3)(2012-11#2)(2012-12#5)(2012-2#6)(2012-3#2)(2013-1#4)(2013-7#2)
vastly improved##4##2##(1995-8#1)(2006-5#1)(2010-3#1)(2011-2#1)
vastly##15##1##(1994-6#1)(1995-8#1)(2006-2#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#2)(2009-3#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#1)
vastus lateralis muscle##3##3##(2008-1#1)(2008-5#2)
vastus lateralis##13##2##(1994-12#1)(2005-1#1)(2006-3#1)(2007-6#2)(2008-1#1)(2008-5#2)(2010-4#5)
vastus medialis oblique##3##3##(2006-3#1)(2007-6#2)
vastus medialis##7##2##(2006-3#1)(2007-6#4)(2008-2#1)(2008-6#1)
vastus##20##1##(1994-12#1)(2005-1#1)(2006-3#2)(2007-6#6)(2008-1#1)(2008-2#1)(2008-5#2)(2008-6#1)(2010-4#5)
vaterite##3##1##(2008-10#3)
vault and##2##2##(2007-12#1)(2008-5#1)
vault prolapse is##2##3##(2013-1#2)
vault prolapse##7##2##(2013-1#7)
vault##42##1##(1991-12#1)(1994-12#2)(2004-10#2)(2006-10#3)(2006-11#1)(2006-7#1)(2007-11#1)(2007-12#7)(2007-7#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#5)(2009-3#1)(2010-8#1)(2011-2#3)(2013-1#8)(2013-8#2)
vav##3##1##(1995-3#2)(2008-6#1)
vcr1##2##1##(2008-10#2)
vcr2##3##1##(2008-10#3)
vdW parameters##3##2##(2008-10#3)
vdW##4##1##(2008-10#4)
vdh##3##1##(1995-8#3)
ve HGV-E2##2##2##(2008-8#2)
ve##3##1##(2008-11#1)(2008-8#2)
vectabone##2##1##(2008-5#2)
vector Aedes aegypti##3##3##(2005-12#1)(2008-5#2)
vector Aedes##4##2##(2004-11#1)(2005-12#1)(2008-5#2)
vector DNA##8##2##(1990-3#1)(1993-9#1)(1994-12#1)(1995-1#1)(1997-6#1)(2006-12#1)(2008-2#1)(2012-3#1)
vector Polymyxa graminis##2##3##(2008-10#2)
vector administration##3##2##(1997-4#2)(2013-7#1)
vector amplification##3##2##(2008-2#1)(2008-4#1)(2011-2#1)
vector and expressed##3##3##(1997-4#1)(2005-11#1)(2008-8#1)
vector and its##2##3##(1994-8#1)(2005-10#1)
vector and nonvector whiteflies##2##4##(2008-10#2)
vector and nonvector##3##3##(2008-10#3)
vector and the cDNA##2##4##(1994-11#1)(1994-12#1)
vector and the overall##2##4##(1994-6#1)(1996-7#1)
vector and the##16##3##(1990-7#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-6#1)(1997-7#1)(2006-4#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-8#2)(2008-9#1)
vector and##53##2##(1990-3#1)(1990-7#1)(1991-5#1)(1991-9#1)(1992-8#2)(1992-9#1)(1993-4#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-7#1)(1997-4#2)(1997-6#1)(1997-7#1)(2005-10#1)(2005-11#2)(2006-4#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#4)(2008-3#1)(2008-4#1)(2008-8#5)(2008-9#1)(2010-5#1)(2011-1#1)(2013-7#1)
vector are##2##2##(2006-6#1)(2007-12#1)
vector as##3##2##(1995-12#1)(1997-4#1)(2005-11#1)
vector at##3##2##(1991-1#1)(2007-12#1)(2007-7#1)
vector based on##2##3##(2008-11#1)(2008-3#1)
vector but##5##2##(2008-1#1)(2008-10#2)(2009-10#2)
vector by##10##2##(1994-12#1)(1996-1#1)(1996-10#1)(1997-8#1)(2005-10#1)(2008-2#1)(2008-4#3)(2008-9#1)
vector can be used##3##4##(1990-9#1)(1995-2#1)(2013-1#1)
vector can be##7##3##(1990-5#1)(1990-9#1)(1991-9#1)(1995-2#1)(2008-2#1)(2008-4#1)(2013-1#1)
vector carrying a##3##3##(1995-8#1)(2010-5#1)(2011-1#1)
vector carrying the cDNA##2##4##(1990-5#1)(1992-7#1)
vector carrying the human tissue inhibitor of##2##7##(2010-1#2)
vector carrying the##6##3##(1990-5#1)(1991-12#1)(1991-7#1)(1992-7#1)(2010-1#2)
vector carrying##13##2##(1990-5#1)(1991-12#1)(1991-7#1)(1992-7#1)(1995-8#1)(2008-8#1)(2008-9#1)(2010-1#4)(2010-5#1)(2011-1#1)
vector competence##3##2##(2008-10#1)(2008-11#1)(2012-12#1)
vector competency##2##2##(2008-10#2)
vector constructed##2##2##(1990-12#1)(2008-8#1)
vector construction##3##2##(1990-9#1)(1995-2#1)(2008-5#1)
vector constructs##2##2##(1991-12#1)(2007-12#1)
vector containing a##2##3##(1997-2#1)(1997-4#1)
vector containing the##12##3##(1990-5#1)(1991-9#1)(1993-3#1)(1994-6#1)(1995-5#1)(1996-1#1)(2007-3#2)(2008-10#1)(2008-11#2)(2012-3#1)
vector containing##26##2##(1990-5#1)(1991-1#1)(1991-9#1)(1993-3#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-4#1)(1997-2#1)(1997-4#1)(2007-12#1)(2007-3#2)(2008-10#1)(2008-11#2)(2008-8#4)(2008-9#2)(2012-1#1)(2012-3#1)
vector contains two##2##3##(1991-7#2)
vector contains##4##2##(1990-5#2)(1991-7#2)
vector control and##3##3##(2007-6#1)(2010-1#1)(2013-1#1)
vector control in##2##3##(2006-4#1)(2008-4#1)
vector control##25##2##(1990-6#2)(2005-8#2)(2006-12#1)(2006-4#5)(2007-2#1)(2007-6#2)(2008-4#1)(2008-8#2)(2010-1#3)(2011-1#1)(2012-12#3)(2013-1#2)
vector could##2##2##(1996-2#1)(1996-7#1)
vector dark-soliton##2##2##(2007-12#2)
vector designed##2##2##(1991-12#1)(1993-6#1)
vector diffraction theory##4##3##(2007-11#2)(2008-3#2)
vector diffraction##7##2##(2007-11#2)(2008-2#1)(2008-3#4)
vector direction##4##2##(2008-2#4)
vector driven##3##2##(1993-12#1)(2008-11#1)(2010-11#1)
vector during the##3##3##(1996-10#1)(2008-10#1)(2010-8#1)
vector during##4##2##(1996-10#1)(2008-10#1)(2010-8#1)(2011-2#1)
vector ecology##2##2##(2008-10#1)(2010-1#1)
vector expressed##2##2##(1994-5#1)(2008-2#1)
vector expressing##5##2##(1994-5#1)(2008-11#2)(2008-7#1)(2008-8#1)
vector expression##3##2##(1990-10#1)(1994-3#1)(2008-2#1)
vector field##5##2##(2007-12#1)(2008-6#4)
vector fields##2##2##(2008-6#2)
vector flow##2##2##(2009-8#1)(2010-3#1)
vector for human##3##3##(2007-3#2)(2008-9#1)
vector for the##7##3##(1996-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)
vector for##40##2##(1990-10#1)(1990-5#1)(1991-7#1)(1991-8#1)(1993-11#1)(1994-12#1)(1994-2#1)(1995-8#1)(1996-2#2)(1997-4#2)(1997-8#1)(2005-10#1)(2007-11#1)(2007-3#2)(2008-1#1)(2008-10#2)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-10#1)(2010-1#1)(2011-1#1)(2011-2#3)(2012-1#2)(2013-1#1)
vector formalism##2##2##(2007-11#1)(2008-3#1)
vector from##4##2##(1991-9#1)(2008-10#1)(2008-11#2)
vector generation##2##2##(2008-2#2)
vector has##4##2##(1996-10#1)(2008-11#1)(2008-9#1)(2009-10#1)
vector in a##3##3##(1994-3#1)(1995-8#1)(2008-9#1)
vector in the##4##3##(1990-12#1)(2008-3#1)(2008-8#1)(2012-3#1)
vector in which##3##3##(1994-12#1)(2006-12#1)(2008-9#1)
vector in##27##2##(1990-12#1)(1990-5#1)(1992-8#1)(1993-6#1)(1994-12#2)(1994-3#1)(1995-2#1)(1995-8#1)(1997-4#1)(2006-12#1)(2007-3#1)(2007-6#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#2)(2012-3#1)
vector inoculation##3##2##(2007-2#1)(2008-10#2)
vector insects##2##2##(2008-10#2)
vector integration##2##2##(2008-11#1)(2012-12#1)
vector into the##2##3##(1991-7#1)(2006-8#1)
vector into##6##2##(1991-1#1)(1991-7#1)(1992-11#1)(1993-8#1)(1996-4#1)(2006-8#1)
vector is##18##2##(1997-1#1)(1997-4#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2011-2#1)(2013-1#4)
vector laryngotracheitis vaccine)##2##3##(2013-8#2)
vector machine##16##2##(2007-8#2)(2008-2#6)(2010-7#2)(2010-8#2)(2012-2#1)(2012-3#1)(2013-1#2)
vector may##2##2##(1997-6#1)(1997-8#1)
vector measurement##2##2##(2007-12#2)
vector moment##4##2##(1990-5#1)(2004-11#3)
vector moments##2##2##(1990-5#1)(2004-11#1)
vector mosquito##2##2##(2008-1#1)(2009-2#1)
vector mosquitoes##4##2##(2011-1#1)(2012-12#3)
vector of Lyme disease in##2##5##(2004-11#1)(2008-11#1)
vector of a##3##3##(2007-12#1)(2008-8#1)(2010-10#1)
vector of choice##2##3##(1996-10#1)(2008-1#1)
vector of dengue##2##3##(2008-1#1)(2008-5#1)
vector of the##6##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-1#1)(2011-12#1)
vector of visceral leishmaniasis in##2##5##(2004-11#2)
vector of visceral leishmaniasis##3##4##(2004-11#3)
vector of##44##2##(1992-8#1)(1995-1#1)(1995-4#1)(1996-10#1)(1997-2#1)(1997-3#1)(2004-11#7)(2005-8#1)(2006-5#1)(2007-12#3)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#3)(2010-1#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-2#1)
vector or##4##2##(2006-12#1)(2006-6#1)(2008-10#1)(2008-2#1)
vector packaging##2##2##(2008-11#1)(2008-8#1)
vector particles##2##2##(2008-2#1)(2008-4#1)
vector perturbation##2##2##(2007-11#1)(2008-1#1)
vector plasmid##5##2##(1990-3#1)(1994-12#1)(1995-5#1)(2008-4#1)(2008-9#1)
vector population##5##2##(2004-11#1)(2008-10#2)(2011-2#1)(2011-3#1)
vector populations and##2##3##(2008-10#1)(2008-11#1)
vector populations##6##2##(2008-10#3)(2008-11#2)(2008-8#1)
vector produced##2##2##(1995-2#1)(2008-2#1)
vector production##2##2##(2007-6#1)(2008-11#1)
vector provides a##2##3##(1995-5#1)(2007-10#1)
vector quantization of migratory##2##4##(2008-2#2)
vector quantization##17##2##(2008-2#14)(2008-3#3)
vector quantizer##3##2##(2008-2#1)(2008-3#2)
vector quantizers##2##2##(2008-2#2)
vector radiative transfer##2##3##(2008-3#2)
vector radiative##3##2##(2007-11#1)(2008-3#2)
vector relationships are##2##3##(2008-10#2)
vector represents the##2##3##(1993-9#1)(2012-3#1)
vector resistance##3##2##(2008-10#2)(2013-7#1)
vector results in##2##3##(1995-2#1)(2008-3#1)
vector sequences##3##2##(1990-9#1)(1997-8#1)(2008-11#1)
vector sequential projection##2##3##(2008-10#2)
vector soliton##4##2##(2007-11#3)(2007-12#1)
vector solitons and##3##3##(2007-11#2)(2007-12#1)
vector solitons##14##2##(2007-11#7)(2007-12#7)
vector space model##4##3##(2013-1#4)
vector space##8##2##(2008-11#2)(2008-2#1)(2011-1#1)(2013-1#4)
vector spatial solitons##2##3##(2007-12#2)
vector species of##2##3##(2008-10#1)(2013-1#1)
vector species##13##2##(1990-3#1)(2008-10#9)(2008-8#2)(2013-1#1)
vector specificity##4##2##(2008-10#4)
vector spherical##2##2##(2007-12#1)(2008-2#1)
vector status##2##2##(2008-10#2)
vector suitable for the##2##4##(1996-11#1)(1996-2#1)
vector suitable for##4##3##(1991-7#1)(1994-12#1)(1996-11#1)(1996-2#1)
vector system and##2##3##(1990-5#1)(1997-7#1)
vector system for efficient##2##4##(2008-11#1)(2011-1#1)
vector system for##5##3##(1991-6#1)(1997-1#1)(1997-2#1)(2008-11#1)(2011-1#1)
vector system in##3##3##(1997-4#2)(2008-11#1)
vector system##32##2##(1990-3#2)(1990-5#1)(1990-9#1)(1991-5#1)(1991-6#2)(1993-12#1)(1994-12#1)(1994-9#2)(1995-3#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-4#4)(1997-7#1)(2008-11#4)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-1#1)(2011-3#1)(2012-12#1)
vector systems##8##2##(1993-12#1)(1997-1#1)(1997-4#1)(2005-8#1)(2008-2#1)(2008-4#2)(2013-1#1)
vector than##2##2##(2007-3#1)(2007-6#1)
vector that allows##3##3##(1997-8#1)(2008-4#1)(2008-9#1)
vector that##13##2##(1990-8#1)(1992-8#1)(1993-12#1)(1997-1#1)(1997-8#1)(2007-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)
vector the##2##2##(2008-11#1)(2010-12#1)
vector theory to##2##3##(2008-2#1)(2008-3#1)
vector theory##6##2##(2007-11#1)(2008-2#3)(2008-3#2)
vector to a##2##3##(2008-2#1)(2008-9#1)
vector to##7##2##(1990-3#1)(2006-4#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)
vector transformation##4##2##(2013-1#4)
vector transmission of##2##3##(2008-10#2)
vector transmission##5##2##(2008-10#5)
vector transmitted##2##2##(2008-2#1)(2011-2#1)
vector under the control of##3##5##(1995-6#1)(1995-8#1)(1997-4#1)
vector under the control##4##4##(1995-6#1)(1995-8#1)(1997-4#1)(2008-11#1)
vector under##5##2##(1995-6#1)(1995-8#1)(1997-3#1)(1997-4#1)(2008-11#1)
vector vaccine##2##2##(2011-2#1)(2013-8#1)
vector vaccines##3##2##(2007-11#1)(2013-8#2)
vector via##3##2##(2008-4#1)(2008-8#1)(2010-7#1)
vector was constructed##7##3##(1991-7#1)(1994-12#1)(1994-5#1)(1995-8#1)(2005-10#1)(2008-9#1)(2011-1#1)
vector was##28##2##(1990-5#1)(1991-1#1)(1991-7#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-8#2)(2005-10#1)(2005-11#1)(2008-11#1)(2008-8#3)(2008-9#3)(2010-1#1)(2011-1#1)
vector which##3##2##(1990-3#1)(1992-7#1)(2008-5#1)
vector with a##2##3##(1990-3#1)(2008-8#1)
vector with##11##2##(1990-3#2)(1992-8#1)(1994-12#1)(1995-2#1)(2008-2#2)(2008-4#1)(2008-8#1)(2008-9#1)(2010-7#1)
vector##1246##1##(1990-10#5)(1990-11#5)(1990-12#6)(1990-2#1)(1990-3#15)(1990-4#1)(1990-5#23)(1990-6#2)(1990-7#2)(1990-8#2)(1990-9#10)(1991-1#5)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#5)(1991-6#4)(1991-7#23)(1991-8#3)(1991-9#13)(1992-11#2)(1992-12#4)(1992-3#2)(1992-6#1)(1992-7#3)(1992-8#8)(1992-9#1)(1993-11#3)(1993-12#14)(1993-2#1)(1993-3#4)(1993-4#2)(1993-5#3)(1993-6#6)(1993-8#7)(1993-9#6)(1994-11#1)(1994-12#19)(1994-2#1)(1994-3#8)(1994-5#11)(1994-6#2)(1994-8#2)(1994-9#5)(1995-1#4)(1995-11#3)(1995-12#3)(1995-2#15)(1995-3#1)(1995-4#1)(1995-5#4)(1995-6#2)(1995-8#11)(1995-9#1)(1996-1#3)(1996-10#8)(1996-11#3)(1996-12#3)(1996-2#8)(1996-3#1)(1996-4#3)(1996-7#6)(1996-8#2)(1997-1#5)(1997-2#11)(1997-3#4)(1997-4#20)(1997-6#7)(1997-7#4)(1997-8#14)(2004-1#1)(2004-11#14)(2005-10#6)(2005-11#11)(2005-12#1)(2005-6#1)(2005-7#1)(2005-8#5)(2006-10#5)(2006-11#1)(2006-12#7)(2006-4#10)(2006-5#3)(2006-6#4)(2006-8#1)(2007-1#1)(2007-10#7)(2007-11#25)(2007-12#42)(2007-2#2)(2007-3#7)(2007-6#11)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#9)(2008-10#124)(2008-11#64)(2008-2#89)(2008-3#50)(2008-4#28)(2008-5#18)(2008-6#14)(2008-7#8)(2008-8#58)(2008-9#38)(2009-10#13)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-8#2)(2010-1#13)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#5)(2010-6#1)(2010-7#4)(2010-8#11)(2011-1#13)(2011-12#1)(2011-2#18)(2011-3#2)(2012-1#4)(2012-11#1)(2012-12#16)(2012-2#7)(2012-3#6)(2013-1#28)(2013-7#4)(2013-8#10)
vector)##4##1##(2008-2#2)(2008-9#1)(2013-7#1)
vector-based##6##1##(2007-12#1)(2008-6#1)(2009-10#1)(2012-11#1)(2012-12#2)
vector-borne disease##2##2##(2008-8#1)(2012-2#1)
vector-borne diseases##6##2##(2007-2#1)(2007-8#1)(2008-11#2)(2010-1#1)(2011-1#1)
vector-borne parasite systems##2##3##(2006-10#2)
vector-borne##12##1##(2006-10#3)(2007-2#1)(2007-8#1)(2008-11#2)(2008-4#1)(2008-8#1)(2010-1#1)(2011-1#1)(2012-2#1)
vector-diffraction effects##2##2##(2008-3#2)
vector-diffraction theory##3##2##(2008-3#3)
vector-diffraction##6##1##(2008-3#6)
vector-encoded##2##1##(1995-2#1)(1995-5#1)
vector-field##3##1##(2008-2#2)(2009-8#1)
vector-matrix multiplier##3##2##(2008-2#1)(2008-3#2)
vector-mediated##4##1##(1994-5#1)(2006-10#1)(2012-3#1)(2013-1#1)
vector-phytoplasma-plant##2##1##(2008-10#2)
vector-specific##2##1##(2008-11#1)(2008-4#1)
vectored by the##3##3##(2008-10#2)(2012-3#1)
vectored by##6##2##(2008-10#5)(2012-3#1)
vectored##8##1##(2008-10#7)(2012-3#1)
vectorial effects##2##2##(2007-11#2)
vectorial status for##2##3##(2012-12#2)
vectorial theory##2##2##(2007-11#1)(2008-3#1)
vectorial##36##1##(1993-6#1)(1995-3#1)(1997-6#2)(2007-11#10)(2007-12#5)(2007-3#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#6)(2009-10#2)(2012-12#4)(2012-2#1)
vectorially##2##1##(1994-11#1)(2005-11#1)
vectoring ability##2##2##(2008-10#2)
vectoring##4##1##(2008-10#4)
vectors allow##2##2##(2008-11#1)(2012-2#1)
vectors and a##2##3##(2008-10#2)
vectors and the##4##3##(1992-1#1)(1994-12#1)(2007-12#1)(2013-7#1)
vectors and their##5##3##(1997-4#2)(2006-10#1)(2008-10#1)(2008-9#1)
vectors and##41##2##(1990-5#1)(1991-8#1)(1992-1#1)(1993-3#1)(1994-12#1)(1996-10#1)(1997-4#4)(2005-8#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-2#4)(2008-4#3)(2008-8#1)(2008-9#2)(2010-1#2)(2012-12#3)(2013-7#1)
vectors are designed to##2##4##(1990-3#1)(1992-7#1)
vectors are particularly##2##3##(1993-12#1)(2008-4#1)
vectors are suitable for##2##4##(1994-12#1)(2010-12#1)
vectors are##33##2##(1990-3#1)(1990-9#1)(1991-7#1)(1991-9#1)(1992-7#1)(1993-12#3)(1994-12#3)(1994-5#1)(1995-12#1)(1995-2#1)(1995-8#2)(1997-1#1)(1997-2#1)(1997-4#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
vectors as the##2##3##(2008-11#1)(2008-2#1)
vectors bearing##2##2##(1995-2#1)(2011-2#1)
vectors can be used##2##4##(1991-7#1)(2008-4#1)
vectors can be##6##3##(1990-11#1)(1991-7#1)(1993-12#1)(2008-3#1)(2008-4#1)(2008-9#1)
vectors can##7##2##(1990-11#1)(1991-7#1)(1993-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)
vectors carry the##3##3##(1991-4#1)(1994-12#1)(1995-8#1)
vectors carrying the##3##3##(1994-5#1)(1995-1#1)(2008-11#1)
vectors carrying##6##2##(1994-12#1)(1994-5#1)(1995-1#1)(2008-10#1)(2008-11#2)
vectors contain##6##2##(1991-8#1)(1995-8#1)(2008-11#2)(2008-4#1)(2008-7#1)
vectors containing the##4##3##(1990-9#1)(1994-12#1)(2008-11#2)
vectors containing##17##2##(1990-5#1)(1990-9#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-5#2)(1995-2#1)(1996-4#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2012-11#2)
vectors derived from##3##3##(2007-6#1)(2008-4#1)(2008-9#1)
vectors described##2##2##(2008-10#1)(2008-2#1)
vectors designed to##2##3##(1995-8#1)(2008-1#1)
vectors encoding the##2##3##(1992-8#1)(2008-9#1)
vectors encoding##4##2##(1992-8#1)(2008-11#1)(2008-7#1)(2008-9#1)
vectors expressing##2##2##(1995-8#2)
vectors for constructing##2##3##(1990-5#1)(1993-2#1)
vectors for direct cloning##2##4##(1991-7#1)(1997-4#1)
vectors for each##2##3##(2008-11#1)(2013-7#1)
vectors for gene delivery##2##4##(2007-11#1)(2008-2#1)
vectors for gene therapy##6##4##(1994-5#1)(2008-11#3)(2008-4#1)(2008-5#1)
vectors for gene##11##3##(1994-5#1)(2007-11#1)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-9#1)(2012-1#1)
vectors for human##2##3##(2008-11#1)(2008-8#1)
vectors for in vivo##3##4##(1994-12#1)(2005-7#1)(2008-6#1)
vectors for protein##2##3##(2008-11#1)(2008-2#1)
vectors for streptavidin-containing chimeric proteins##2##5##(1991-4#2)
vectors for the production of##2##5##(1995-8#1)(1996-8#1)
vectors for the##8##3##(1990-5#1)(1992-7#1)(1995-8#1)(1996-8#1)(2008-11#1)(2008-3#1)(2013-1#2)
vectors for use in##6##4##(1990-3#1)(1990-5#1)(1990-9#1)(1993-12#1)(1994-5#1)(2012-2#1)
vectors for use##7##3##(1990-3#1)(1990-5#1)(1990-9#2)(1993-12#1)(1994-5#1)(2012-2#1)
vectors for viral##2##3##(2007-11#2)
vectors for##81##2##(1990-3#2)(1990-5#5)(1990-9#3)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#3)(1992-7#1)(1992-9#1)(1993-12#2)(1993-2#3)(1993-5#1)(1994-12#4)(1994-3#1)(1994-5#3)(1994-6#1)(1995-8#1)(1996-10#2)(1996-8#1)(1997-4#3)(1997-6#1)(2005-7#1)(2005-8#1)(2007-11#5)(2007-6#1)(2008-10#1)(2008-11#8)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2010-1#1)(2011-3#1)(2012-1#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
vectors from##5##2##(1990-9#1)(2012-12#4)
vectors has been constructed##2##4##(1990-5#1)(1995-8#1)
vectors has been##3##3##(1990-5#1)(1992-7#1)(1995-8#1)
vectors has##6##2##(1990-5#1)(1992-7#1)(1995-8#1)(1997-4#1)(2013-1#2)
vectors have been##7##3##(1990-5#1)(1994-5#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)
vectors have##17##2##(1990-3#1)(1990-5#2)(1994-5#1)(1995-2#1)(1997-1#1)(1997-4#1)(2005-7#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2012-3#1)
vectors in clinical##2##3##(2006-6#1)(2008-8#1)
vectors in combination with##2##4##(2008-11#1)(2008-9#1)
vectors in gene therapy##2##4##(1995-12#1)(2007-6#1)
vectors in the##2##3##(2005-7#1)(2008-1#1)
vectors in which##2##3##(1991-7#1)(2008-8#1)
vectors in##33##2##(1990-3#2)(1991-6#1)(1991-7#1)(1993-12#1)(1995-12#1)(1996-11#1)(2005-7#1)(2006-6#1)(2007-11#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#1)(2008-8#4)(2008-9#1)(2009-5#1)(2009-9#1)(2012-1#1)(2012-3#2)(2013-1#2)
vectors into a##2##3##(1994-5#1)(1995-3#1)
vectors into the##2##3##(1990-6#1)(1991-8#1)
vectors into##8##2##(1990-3#1)(1990-6#1)(1991-8#1)(1993-12#1)(1994-5#1)(1995-3#1)(1997-4#1)(2008-9#1)
vectors is described##3##3##(1991-7#1)(1993-9#1)(1994-12#1)
vectors is##11##2##(1991-7#1)(1993-11#1)(1993-9#1)(1994-12#1)(1995-2#1)(2008-10#1)(2008-2#2)(2008-8#1)(2009-10#1)(2012-3#1)
vectors made##2##2##(1990-9#1)(2010-12#1)
vectors may be useful for##2##5##(1994-5#1)(1997-4#1)
vectors may be##4##3##(1994-5#1)(1995-5#1)(1997-4#1)(2008-10#1)
vectors may##6##2##(1993-12#1)(1994-5#1)(1995-5#1)(1997-4#2)(2008-10#1)
vectors of malaria in##2##4##(2007-8#1)(2012-12#1)
vectors of malaria##4##3##(2006-4#1)(2007-11#1)(2007-8#1)(2012-12#1)
vectors of the##5##3##(1996-2#1)(2007-11#1)(2008-3#2)(2010-11#1)
vectors of##41##2##(1990-6#2)(1991-12#1)(1993-6#1)(1996-2#1)(1997-2#1)(2004-11#2)(2006-4#2)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#9)(2008-2#2)(2008-3#4)(2010-11#1)(2011-2#1)(2012-12#5)(2012-2#2)
vectors offer##2##2##(1997-4#1)(2008-1#1)
vectors or intermediate hosts##2##4##(2008-8#1)(2013-1#1)
vectors or##8##2##(1990-10#1)(2007-11#1)(2008-10#2)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
vectors such as##3##3##(1990-3#2)(2007-11#1)
vectors than##3##2##(1991-9#1)(2008-10#1)(2008-2#1)
vectors that are derived from##2##5##(1997-2#1)(2008-9#1)
vectors that##10##2##(1990-3#1)(1994-5#1)(1995-5#1)(1997-2#2)(2008-11#1)(2008-9#1)(2009-10#1)(2010-1#1)(2012-12#1)
vectors to transfer##2##3##(1994-11#1)(2007-6#1)
vectors to##16##2##(1991-7#1)(1993-11#1)(1994-11#1)(1994-5#1)(1996-12#1)(1997-2#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-9#2)(2012-12#1)(2012-3#1)(2013-1#2)
vectors using##4##2##(1994-12#1)(2008-11#2)(2008-9#1)
vectors was##7##2##(1993-5#1)(1995-8#1)(1996-10#1)(1997-4#1)(2007-6#1)(2008-11#1)(2011-3#1)
vectors were constructed##7##3##(1990-9#1)(1993-12#1)(1993-3#1)(1997-4#1)(2008-8#1)(2008-9#2)
vectors were##22##2##(1990-3#1)(1990-5#1)(1990-9#1)(1993-12#2)(1993-3#2)(1994-12#1)(1997-4#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-10#1)(2012-1#1)(2013-1#1)(2013-8#2)
vectors which##7##2##(1990-3#1)(1990-9#1)(1993-6#1)(1995-8#1)(1996-6#1)(1997-4#1)(2013-8#1)
vectors with kanamycin##2##3##(1995-8#2)
vectors with##11##2##(1991-8#1)(1992-7#1)(1993-12#1)(1993-2#1)(1995-8#2)(2006-11#1)(2008-11#2)(2008-9#1)(2009-10#1)
vectors##724##1##(1990-10#2)(1990-11#2)(1990-3#15)(1990-5#13)(1990-6#5)(1990-9#11)(1991-12#5)(1991-2#1)(1991-4#3)(1991-5#2)(1991-6#2)(1991-7#13)(1991-8#6)(1991-9#7)(1992-1#1)(1992-12#1)(1992-7#6)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#26)(1993-2#6)(1993-3#6)(1993-4#1)(1993-5#2)(1993-6#4)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#26)(1994-3#2)(1994-5#14)(1994-6#4)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#6)(1995-3#1)(1995-5#5)(1995-7#1)(1995-8#15)(1996-1#1)(1996-10#6)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#7)(1997-4#26)(1997-6#1)(1997-7#1)(1997-8#3)(2004-11#3)(2005-10#1)(2005-11#1)(2005-7#4)(2005-8#3)(2005-9#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-4#4)(2006-6#1)(2007-11#17)(2007-12#9)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#10)(2007-7#2)(2007-8#3)(2008-1#7)(2008-10#55)(2008-11#57)(2008-12#1)(2008-2#35)(2008-3#13)(2008-4#32)(2008-5#10)(2008-6#1)(2008-7#2)(2008-8#13)(2008-9#23)(2009-10#15)(2009-5#1)(2009-9#1)(2010-1#5)(2010-11#1)(2010-12#2)(2010-8#4)(2011-1#1)(2011-2#3)(2011-3#5)(2012-1#4)(2012-11#4)(2012-12#21)(2012-2#11)(2012-3#11)(2013-1#19)(2013-7#6)(2013-8#9)
vecuronium bromide##2##2##(2009-6#1)(2010-7#1)
vecuronium##11##1##(1993-1#2)(1997-5#2)(2006-10#1)(2006-8#1)(2009-6#1)(2010-7#3)(2012-2#1)
vecuronium-induced tetanic fade##3##3##(1997-5#3)
ved##3##1##(2012-12#3)
vegetable and fruit##2##3##(1991-5#1)(2009-8#1)
vegetable and##7##2##(1991-5#1)(1994-3#1)(1994-6#1)(2006-7#1)(2006-9#1)(2009-8#1)(2011-2#1)
vegetable consumption##7##2##(1990-8#1)(1991-5#1)(1992-5#1)(2008-7#1)(2009-4#1)(2009-5#1)(2011-1#1)
vegetable crops##5##2##(1997-6#1)(2008-10#3)(2011-2#1)
vegetable dietary guidelines (p &lt##2##5##(2009-5#2)
vegetable intake##7##2##(1991-5#1)(1992-10#1)(2008-10#1)(2010-3#2)(2011-2#1)(2013-1#1)
vegetable matrices##2##2##(2008-10#2)
vegetable matter##2##2##(2007-2#1)(2008-5#1)
vegetable oil##8##2##(2005-7#1)(2006-10#1)(2008-10#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
vegetable oils and##2##3##(2008-7#1)(2009-3#1)
vegetable oils##22##2##(1990-8#1)(1991-12#1)(1997-8#1)(2006-12#1)(2007-8#1)(2008-10#8)(2008-7#2)(2009-3#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#3)
vegetable protein##3##2##(2011-2#1)(2013-8#2)
vegetable samples with satisfactory results##2##5##(2008-10#1)(2012-12#1)
vegetable samples##11##2##(2008-10#9)(2012-12#1)(2013-8#1)
vegetable shortening##2##2##(2008-4#2)
vegetable tanning residue##3##3##(2007-10#3)
vegetable tanning##5##2##(2007-10#5)
vegetable##115##1##(1990-2#1)(1990-8#2)(1991-12#1)(1991-5#3)(1992-10#1)(1992-5#1)(1993-12#2)(1994-3#1)(1994-6#1)(1997-4#3)(1997-6#1)(1997-8#1)(2005-7#2)(2006-10#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-10#5)(2007-2#1)(2007-8#1)(2008-10#34)(2008-12#3)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#3)(2009-3#2)(2009-4#1)(2009-5#3)(2009-8#2)(2010-3#2)(2010-4#1)(2011-1#3)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#4)
vegetables (AR =##2##3##(1992-5#2)
vegetables and fruit##2##3##(1991-5#1)(2011-2#1)
vegetables and fruits##6##3##(1991-5#2)(2008-12#1)(2008-7#1)(2009-8#1)(2012-2#1)
vegetables and soils from##2##4##(1993-9#2)
vegetables and whole grains##3##4##(2012-12#3)
vegetables and##26##2##(1990-8#1)(1991-5#3)(1993-9#3)(1994-2#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)
vegetables by##4##2##(2005-4#1)(2008-10#2)(2012-12#1)
vegetables grown##2##2##(1992-12#1)(2008-10#1)
vegetables has##2##2##(1997-2#1)(2008-10#1)
vegetables have##2##2##(1997-2#1)(2009-3#1)
vegetables in the##2##3##(1992-5#1)(2006-10#1)
vegetables in##7##2##(1992-5#1)(2006-10#1)(2008-10#1)(2011-12#1)(2012-2#3)
vegetables is##3##2##(2008-10#2)(2012-2#1)
vegetables may##2##2##(1994-2#2)
vegetables on##2##2##(1990-11#1)(2012-12#1)
vegetables was##5##2##(2005-4#1)(2008-1#1)(2011-1#1)(2012-12#2)
vegetables were##2##2##(2008-10#1)(2013-8#1)
vegetables with satisfactory##2##3##(2007-8#1)(2008-10#1)
vegetables with##5##2##(2005-4#2)(2007-8#1)(2008-10#2)
vegetables##142##1##(1990-11#1)(1990-8#3)(1991-2#1)(1991-5#4)(1992-10#2)(1992-12#2)(1992-5#3)(1992-8#1)(1993-12#2)(1993-9#3)(1994-2#3)(1996-1#1)(1997-1#1)(1997-2#4)(2005-10#1)(2005-4#5)(2006-10#2)(2007-12#1)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#29)(2008-12#1)(2008-4#4)(2008-7#1)(2009-11#1)(2009-3#4)(2009-4#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#6)(2011-12#1)(2011-2#12)(2012-1#4)(2012-12#9)(2012-2#10)(2013-1#3)(2013-8#1)
vegetal and##3##2##(2007-8#1)(2008-2#1)(2008-5#1)
vegetal extracts##2##2##(2008-5#2)
vegetal##18##1##(1993-6#1)(1997-6#1)(2005-10#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-4#3)(2008-5#4)(2009-12#1)
vegetalizing factor##2##2##(1992-3#2)
vegetans##4##1##(2007-8#2)(2011-2#2)
vegetarian diet##2##2##(1991-5#1)(2007-5#1)
vegetarian##6##1##(1990-9#1)(1991-5#1)(1992-9#1)(2007-3#1)(2007-5#1)(2007-8#1)
vegetated##6##1##(2008-11#1)(2008-8#4)(2010-8#1)
vegetation and##6##2##(1997-4#1)(2008-10#1)(2008-3#1)(2008-9#1)(2013-7#1)(2013-8#1)
vegetation at a##2##3##(2008-11#1)(2011-2#1)
vegetation at##3##2##(2007-3#1)(2008-11#1)(2011-2#1)
vegetation change##2##2##(2008-8#1)(2008-9#1)
vegetation cover data##2##3##(2008-12#2)
vegetation cover##6##2##(2008-12#6)
vegetation coverage##3##2##(2011-1#3)
vegetation density##2##2##(2010-8#1)(2013-8#1)
vegetation dynamics in##2##3##(1990-8#1)(2008-9#1)
vegetation had##2##2##(2008-5#1)(2009-8#1)
vegetation in##2##2##(2008-8#1)(2008-9#1)
vegetation index##4##2##(2008-8#4)
vegetation indices##2##2##(2013-8#2)
vegetation of##3##2##(2008-12#1)(2008-5#1)(2013-8#1)
vegetation on the##2##3##(1990-11#1)(2013-8#1)
vegetation on##5##2##(1990-11#1)(2008-5#1)(2008-8#1)(2011-12#1)(2013-8#1)
vegetation type##4##2##(2008-5#1)(2008-9#1)(2011-12#1)(2013-8#1)
vegetation types##4##2##(2007-3#1)(2008-5#1)(2008-9#1)(2013-8#1)
vegetation was##3##2##(2008-5#1)(2008-8#1)(2011-1#1)
vegetation##127##1##(1990-11#1)(1990-8#1)(1992-1#1)(1992-5#1)(1995-8#1)(1997-4#1)(2004-11#4)(2004-4#1)(2005-12#1)(2006-4#1)(2006-6#2)(2007-12#1)(2007-3#4)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#7)(2008-3#6)(2008-4#1)(2008-5#12)(2008-7#2)(2008-8#20)(2008-9#11)(2009-12#1)(2009-8#2)(2010-8#3)(2011-1#4)(2011-12#4)(2011-2#2)(2012-2#1)(2013-1#4)(2013-7#3)(2013-8#15)
vegetation)##2##1##(2007-3#1)(2008-3#1)
vegetations were##2##2##(2007-7#1)(2008-4#1)
vegetations##10##1##(1990-11#1)(1990-6#1)(1996-4#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-4#1)(2009-8#1)(2010-12#1)
vegetative and reproductive##5##3##(2008-10#1)(2008-5#1)(2008-8#1)(2009-10#1)(2012-8#1)
vegetative and##9##2##(1990-10#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-10#2)(2010-9#1)(2012-8#1)(2013-8#1)
vegetative cell##4##2##(1993-3#1)(2007-4#1)(2008-12#1)(2013-1#1)
vegetative cells of##3##3##(1991-8#1)(2008-10#1)(2008-11#1)
vegetative cells##9##2##(1991-8#2)(1997-3#2)(2008-10#2)(2008-11#2)(2011-2#1)
vegetative compatibility and##2##3##(2008-10#2)
vegetative compatibility group (VCG)##7##4##(2008-10#7)
vegetative compatibility group##9##3##(2008-10#9)
vegetative compatibility grouping (VCG)##2##4##(2008-10#2)
vegetative compatibility groups (VCGs)##11##4##(2008-10#11)
vegetative compatibility groups##18##3##(2008-10#18)
vegetative compatibility##42##2##(2008-10#42)
vegetative condition##2##2##(2007-8#2)
vegetative forms and B##2##4##(2007-7#2)
vegetative growth and##3##3##(2008-10#1)(2008-5#1)(2012-12#1)
vegetative growth stage of reed##2##5##(2008-5#2)
vegetative growth##11##2##(1990-10#1)(1996-6#1)(1997-4#1)(2008-10#2)(2008-5#3)(2011-12#2)(2012-12#1)
vegetative hyphae##2##2##(2008-10#1)(2011-1#1)
vegetative incompatibility (vic) genes##2##4##(2008-10#2)
vegetative incompatibility##6##2##(1995-8#2)(2008-10#4)
vegetative patients##2##2##(2006-5#1)(2012-1#1)
vegetative phase##2##2##(2008-8#2)
vegetative plant parts##2##3##(1991-11#2)
vegetative shoots##2##2##(2008-10#2)
vegetative stage##2##2##(2012-2#1)(2013-1#1)
vegetative state is##2##3##(1997-5#1)(2012-1#1)
vegetative state##18##2##(1990-11#1)(1990-9#1)(1991-12#1)(1992-12#1)(1993-2#2)(1995-4#2)(1997-5#1)(2005-12#1)(2006-10#1)(2006-11#1)(2008-11#2)(2008-2#2)(2012-1#2)
vegetative tissues##7##2##(1994-3#1)(1997-4#1)(2006-12#2)(2009-10#1)(2009-8#2)
vegetative trichomes##4##2##(2008-5#4)
vegetative##161##1##(1990-10#2)(1990-11#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#1)(1991-7#1)(1991-8#2)(1992-12#1)(1992-8#2)(1993-2#2)(1993-3#1)(1994-3#1)(1995-2#1)(1995-4#2)(1995-8#2)(1996-6#1)(1996-7#2)(1997-3#2)(1997-4#2)(1997-5#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-5#1)(2007-1#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-10#64)(2008-11#4)(2008-12#1)(2008-2#3)(2008-5#10)(2008-8#7)(2009-10#3)(2009-12#1)(2009-7#1)(2009-8#2)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#1)(2012-8#2)(2013-1#2)(2013-8#2)
vegetative&quot##2##1##(2008-10#1)(2012-1#1)
vegetatively compatible##5##2##(2008-10#5)
vegetatively incompatible##4##2##(2008-10#4)
vegetatively##15##1##(1993-6#1)(1997-6#1)(2008-10#11)(2008-5#2)
vehicle (0##3##2##(1997-2#1)(1997-5#1)(2008-5#1)
vehicle accident##10##2##(2006-4#3)(2008-12#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-4#1)(2012-3#1)
vehicle accidents##10##2##(1990-9#1)(1994-3#1)(2006-11#1)(2007-4#1)(2009-3#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-12#2)
vehicle alone##2##2##(1990-2#1)(2005-7#1)
vehicle and##7##2##(1996-12#1)(2007-1#1)(2008-5#1)(2009-11#1)(2012-12#2)(2012-2#1)
vehicle by##2##2##(2008-2#1)(2009-7#1)
vehicle contact##2##2##(2006-11#1)(2012-12#1)
vehicle control and##2##3##(2008-9#1)(2010-4#1)
vehicle control group##6##3##(2008-5#2)(2008-9#4)
vehicle control groups##11##3##(2008-5#1)(2008-9#10)
vehicle control##27##2##(1994-9#1)(1996-11#1)(2008-10#1)(2008-5#4)(2008-9#16)(2010-1#1)(2010-4#1)(2010-5#1)(2013-1#1)
vehicle controls##48##2##(1990-7#1)(1991-1#1)(1993-3#2)(2008-10#1)(2008-9#43)
vehicle crash tests##2##3##(2006-11#2)
vehicle crash##5##2##(2006-11#2)(2007-1#1)(2007-7#1)(2009-4#1)
vehicle crashes##3##2##(1997-3#1)(2006-11#1)(2007-1#1)
vehicle effects##2##2##(2008-5#2)
vehicle for oral delivery##2##4##(2007-11#1)(2011-1#1)
vehicle for the##6##3##(1992-12#1)(1993-3#1)(1993-6#1)(1995-2#1)(2008-12#1)(2008-5#1)
vehicle for##40##2##(1990-12#1)(1990-3#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-1#1)(1995-2#2)(1995-5#2)(1996-3#1)(1997-3#1)(2005-12#1)(2005-8#1)(2006-2#1)(2007-11#2)(2007-2#1)(2008-1#2)(2008-12#1)(2008-2#2)(2008-5#3)(2008-9#1)(2009-10#1)(2009-11#1)(2010-10#1)(2010-2#2)(2010-6#1)(2011-1#1)(2012-11#1)(2013-1#2)
vehicle group##6##2##(1993-12#1)(1995-3#1)(2008-5#1)(2011-2#1)(2013-8#2)
vehicle groups##2##2##(1991-2#2)
vehicle in which##3##3##(2008-5#3)
vehicle in##9##2##(1991-8#1)(1994-8#1)(1996-11#1)(1996-8#1)(1997-7#1)(2006-11#1)(2008-5#3)
vehicle injection##3##2##(1992-11#1)(1994-8#1)(2012-3#1)
vehicle injections##2##2##(1992-9#1)(1993-6#1)
vehicle into the##2##3##(1995-11#1)(2008-7#1)
vehicle is##2##2##(2008-5#1)(2011-2#1)
vehicle manufacturers##2##2##(2006-11#1)(2007-4#1)
vehicle on the##2##3##(1996-2#1)(2005-11#1)
vehicle on##5##2##(1996-2#1)(2005-11#1)(2008-2#1)(2008-5#2)
vehicle only##4##2##(1994-9#1)(1995-2#1)(2008-10#1)(2009-8#1)
vehicle or##11##2##(1992-11#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-9#1)(2008-10#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)
vehicle physical damage insurance##3##4##(2012-12#3)
vehicle seat##3##2##(2006-11#1)(2007-1#1)(2007-4#1)
vehicle that##2##2##(2008-1#1)(2009-11#1)
vehicle to##11##2##(1992-12#1)(1993-3#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)
vehicle treated##2##2##(2006-10#1)(2009-3#1)
vehicle treatment##4##2##(1991-10#1)(2009-8#2)(2013-1#1)
vehicle used##4##2##(2005-11#1)(2007-11#1)(2008-5#2)
vehicle was##5##2##(1993-2#1)(1995-10#1)(1995-5#1)(2007-4#1)(2012-12#1)
vehicle were##3##2##(1992-11#1)(1995-12#1)(2008-5#1)
vehicle with##2##2##(1996-11#1)(2008-2#1)
vehicle##374##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-7#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#4)(1991-8#2)(1992-1#1)(1992-11#3)(1992-12#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#4)(1993-4#1)(1993-6#3)(1994-1#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#5)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#6)(1995-3#3)(1995-5#4)(1996-1#3)(1996-11#4)(1996-12#2)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#2)(2005-10#1)(2005-11#3)(2005-12#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-11#13)(2006-2#1)(2006-4#3)(2006-5#2)(2007-1#6)(2007-11#5)(2007-12#1)(2007-2#1)(2007-4#7)(2007-7#2)(2007-9#2)(2008-1#4)(2008-10#12)(2008-11#2)(2008-12#4)(2008-2#6)(2008-3#3)(2008-4#5)(2008-5#36)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#61)(2009-10#2)(2009-11#3)(2009-3#3)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#5)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#13)(2012-1#1)(2012-11#3)(2012-12#14)(2012-2#5)(2012-3#2)(2013-1#8)(2013-8#4)
vehicle)##2##1##(1995-12#1)(2007-9#1)
vehicle-controlled##3##1##(2008-5#2)(2010-8#1)
vehicle-treated animals##4##2##(1993-12#1)(1996-11#1)(1996-12#2)
vehicle-treated control##3##2##(1992-3#1)(2008-5#1)(2008-7#1)
vehicle-treated controls##3##2##(1992-10#1)(1993-4#1)(1996-10#1)
vehicle-treated mice##5##2##(1991-2#1)(1994-3#1)(1995-12#1)(2008-5#2)
vehicle-treated rats##3##2##(1990-7#1)(1996-11#1)(2007-9#1)
vehicle-treated##22##1##(1990-12#1)(1990-7#1)(1991-2#1)(1992-10#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-11#2)(1996-12#2)(2007-9#1)(2008-5#4)(2008-7#1)
vehicles and##8##2##(1994-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)(2013-1#1)
vehicles can##2##2##(1996-3#1)(2012-1#1)
vehicles for anti-HIV##2##3##(2009-6#2)
vehicles for gene delivery##2##4##(1995-12#1)(2005-11#1)
vehicles for gene therapy and##2##5##(2008-11#1)(2008-4#1)
vehicles for gene therapy##3##4##(2008-11#1)(2008-4#1)(2012-1#1)
vehicles for gene##6##3##(1995-12#1)(2005-11#1)(2006-10#1)(2008-11#1)(2008-4#1)(2012-1#1)
vehicles for##20##2##(1991-3#1)(1994-5#1)(1995-12#1)(1995-5#1)(1996-11#1)(2005-11#1)(2006-10#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-2#1)(2009-6#2)(2010-4#1)(2012-1#1)(2012-11#2)(2012-12#1)
vehicles have##2##2##(1994-6#1)(2007-12#1)
vehicles on the release and##2##5##(2008-3#1)(2008-5#1)
vehicles on the##4##3##(2007-4#1)(2008-3#1)(2008-5#2)
vehicles to##2##2##(1994-3#1)(1996-1#1)
vehicles was##3##2##(2005-8#1)(2008-5#1)(2010-5#1)
vehicles were characterized##2##3##(2008-11#1)(2008-5#1)
vehicles were examined##2##3##(2010-5#2)
vehicles were##9##2##(2005-8#1)(2007-4#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-5#2)(2011-1#1)
vehicles##104##1##(1990-6#1)(1991-3#1)(1993-1#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-12#1)(1995-5#1)(1996-1#1)(1996-11#4)(1996-3#1)(2004-4#2)(2005-10#2)(2005-11#1)(2005-7#2)(2005-8#2)(2006-10#1)(2006-11#5)(2007-11#1)(2007-12#3)(2007-3#1)(2007-4#4)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#8)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#3)(2009-4#1)(2009-6#3)(2010-10#2)(2010-12#2)(2010-4#1)(2010-5#8)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
vehicles)##2##1##(1997-6#1)(2008-5#1)
vehicular##9##1##(2006-11#1)(2007-10#2)(2007-4#1)(2007-7#1)(2008-10#1)(2012-12#2)(2012-2#1)
veiling glare##4##2##(2008-3#4)
veiling##5##1##(2008-3#5)
vein ablation##3##2##(2006-8#2)(2009-10#1)
vein and Dacron##2##3##(2005-10#2)
vein and inferior vena cava##2##5##(2008-11#1)(2011-2#1)
vein and the##8##3##(1992-12#1)(2006-6#1)(2007-7#2)(2008-7#1)(2011-2#1)(2013-1#2)
vein and##28##2##(1992-12#1)(1993-2#1)(1997-7#1)(2005-10#2)(2006-10#1)(2006-6#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-11#2)(2008-4#1)(2008-7#1)(2009-9#1)(2010-10#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)
vein are##3##2##(2007-7#1)(2008-11#1)(2012-12#1)
vein as##3##2##(2007-7#1)(2007-8#1)(2011-2#1)
vein at the##3##3##(1996-9#1)(2007-7#1)(2011-2#1)
vein blood##2##2##(1997-2#1)(2013-8#1)
vein bypass##5##2##(1990-9#1)(1996-2#1)(2005-12#2)(2007-8#1)
vein cannulation##5##2##(2007-7#3)(2008-1#2)
vein catheter##2##2##(2007-9#1)(2012-12#1)
vein catheterization##6##2##(2007-7#4)(2007-9#1)(2012-12#1)
vein damage##2##2##(2007-8#1)(2008-3#1)
vein during##3##2##(2007-7#1)(2007-9#1)(2008-1#1)
vein endothelial cells in##2##4##(1991-1#1)(2008-11#1)
vein endothelial cells were##2##4##(1993-9#1)(2008-11#1)
vein endothelial cells##59##3##(1990-11#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#5)(1994-3#2)(1994-8#3)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-3#1)(1997-1#2)(1997-7#1)(2008-10#4)(2008-11#6)(2008-7#1)(2008-8#2)(2008-9#3)(2009-8#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-2#2)(2013-7#1)(2013-8#1)
vein endothelial##63##2##(1990-11#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#5)(1994-3#2)(1994-8#3)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-3#1)(1997-1#2)(1997-7#1)(2008-10#4)(2008-11#8)(2008-7#1)(2008-8#2)(2008-9#3)(2009-8#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-2#2)(2013-7#1)(2013-8#2)
vein entrapment is##2##3##(2005-10#2)
vein entrapment##4##2##(2005-10#4)
vein fistula##7##2##(1996-9#1)(2007-7#5)(2008-4#1)
vein for##9##2##(1990-2#1)(1990-4#1)(2007-7#4)(2008-3#1)(2011-3#1)(2013-7#1)
vein formation##3##2##(2009-6#3)
vein graft aneurysms##3##3##(2007-8#3)
vein graft patency##3##3##(2007-8#3)
vein graft to the##2##4##(1991-3#1)(2007-8#1)
vein graft to##3##3##(1991-3#1)(2007-8#1)(2008-12#1)
vein graft##32##2##(1990-3#2)(1991-3#1)(1996-2#1)(2005-10#1)(2006-4#1)(2006-6#1)(2007-8#16)(2008-10#1)(2008-12#2)(2008-9#2)(2009-5#2)(2011-3#1)(2012-2#1)
vein grafts or##2##3##(2005-10#2)
vein grafts##18##2##(1990-4#1)(1991-3#1)(1993-7#1)(2005-10#3)(2005-12#1)(2006-8#1)(2007-8#6)(2007-9#1)(2008-7#1)(2008-9#1)(2011-2#1)
vein harvest##2##2##(2009-7#1)(2011-3#1)
vein in a##3##3##(2005-12#2)(2008-12#1)
vein in the##2##3##(1993-5#1)(2013-8#1)
vein in##15##2##(1993-5#1)(2005-12#2)(2007-7#1)(2007-8#1)(2008-12#1)(2008-7#1)(2009-2#1)(2009-3#1)(2011-2#1)(2012-3#4)(2013-8#1)
vein is a rare##2##4##(2008-11#1)(2010-11#1)
vein is described##2##3##(2008-7#1)(2009-9#1)
vein is##18##2##(1991-10#1)(1991-6#1)(1992-12#1)(2006-6#1)(2007-3#1)(2007-7#6)(2007-8#1)(2008-11#2)(2008-7#1)(2009-9#1)(2010-11#1)(2012-2#1)
vein isolation##6##2##(2007-8#1)(2008-10#2)(2009-10#1)(2011-2#2)
vein necrosis##2##2##(2008-10#2)
vein occlusion and##3##3##(1991-5#1)(1992-10#1)(2011-1#1)
vein occlusion is##2##3##(2006-10#1)(2009-4#1)
vein occlusion##26##2##(1991-5#1)(1992-10#1)(2006-10#1)(2007-2#1)(2009-2#1)(2009-4#11)(2009-8#2)(2011-1#3)(2011-2#2)(2012-12#1)(2013-1#2)
vein occlusions##3##2##(2009-4#1)(2011-1#2)
vein of Galen malformation##4##4##(1996-6#4)
vein of Galen##5##3##(1996-6#4)(1996-9#1)
vein of a##2##3##(2008-11#1)(2008-3#1)
vein of the##4##3##(1990-10#1)(1993-9#1)(2007-7#1)(2007-8#1)
vein of##23##2##(1990-10#1)(1993-12#1)(1993-9#1)(1995-2#1)(1995-8#1)(1996-6#5)(1996-9#3)(2006-12#2)(2007-7#1)(2007-8#2)(2008-11#1)(2008-3#1)(2011-2#1)(2011-3#1)(2013-1#1)
vein or artery##3##3##(1996-3#1)(2008-4#2)
vein or in the##2##4##(2007-7#2)
vein or in##3##3##(2007-7#2)(2011-2#1)
vein or##11##2##(1991-6#1)(1996-3#1)(2007-7#5)(2008-1#1)(2008-4#2)(2011-2#1)
vein pH##3##2##(1993-4#1)(1993-7#2)
vein patched CEA developed &gt##3##5##(2005-10#3)
vein patched CEA##8##3##(2005-10#8)
vein patched##9##2##(2005-10#9)
vein pouch technique##2##3##(2010-12#2)
vein pouch##3##2##(2010-12#3)
vein segments##2##2##(1993-11#1)(2007-8#1)
vein stenosis##6##2##(2008-1#6)
vein thromboses##4##2##(1990-6#1)(2006-10#1)(2010-1#1)(2010-2#1)
vein thrombosis (DVT)##10##3##(1993-7#1)(1997-8#1)(2005-7#1)(2006-2#1)(2007-10#1)(2007-11#1)(2008-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
vein thrombosis after##2##3##(1990-12#1)(2007-7#1)
vein thrombosis and##5##3##(1993-5#1)(1997-5#1)(2007-10#1)(2011-2#1)(2013-1#1)
vein thrombosis in the##3##4##(1996-4#1)(1997-5#1)(2011-2#1)
vein thrombosis in##11##3##(1992-9#1)(1996-4#1)(1997-5#2)(2006-12#1)(2007-11#1)(2009-1#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
vein thrombosis is##4##3##(1992-9#1)(2007-7#1)(2011-1#1)(2013-1#1)
vein thrombosis with##3##3##(1990-12#2)(1997-8#1)
vein thrombosis##69##2##(1990-10#1)(1990-12#4)(1992-9#2)(1993-5#1)(1993-7#1)(1995-4#1)(1996-4#2)(1997-5#8)(1997-8#3)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-3#1)(2007-10#4)(2007-11#3)(2007-12#1)(2007-7#3)(2008-1#1)(2008-3#3)(2008-5#2)(2009-1#1)(2009-11#1)(2010-1#1)(2010-2#1)(2011-1#3)(2011-2#3)(2012-2#2)(2013-1#5)(2013-8#3)
vein to the##2##3##(2007-8#2)
vein to##4##2##(1991-10#1)(2007-8#3)
vein transposition##4##2##(2007-7#2)(2008-1#2)
vein tumor thrombus##2##3##(2012-2#2)
vein was accidentally cannulated during##2##5##(2007-9#1)(2012-12#1)
vein was performed##2##3##(2007-7#2)
vein was##15##2##(1993-5#1)(2006-6#1)(2006-9#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-12#1)
vein were found in##2##4##(2012-3#2)
vein were##8##2##(1991-2#1)(1993-6#1)(2007-7#1)(2007-8#2)(2008-7#1)(2012-3#2)
vein with##6##2##(1994-9#1)(2007-7#2)(2008-1#1)(2008-7#1)(2012-2#1)
vein yellowing##2##2##(2008-10#2)
vein##698##1##(1990-10#4)(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#6)(1990-4#4)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#4)(1991-1#1)(1991-10#4)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#4)(1991-6#3)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#3)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#3)(1993-6#2)(1993-7#5)(1993-9#2)(1994-11#1)(1994-2#6)(1994-3#2)(1994-6#3)(1994-8#5)(1994-9#3)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-4#1)(1995-6#1)(1995-8#1)(1996-2#4)(1996-3#3)(1996-4#2)(1996-6#6)(1996-9#5)(1997-1#3)(1997-2#2)(1997-4#1)(1997-5#11)(1997-7#2)(1997-8#5)(2004-9#1)(2005-10#24)(2005-12#6)(2005-7#1)(2005-8#1)(2006-10#6)(2006-12#3)(2006-2#4)(2006-3#1)(2006-4#1)(2006-6#8)(2006-7#2)(2006-8#4)(2006-9#1)(2007-10#5)(2007-11#3)(2007-12#3)(2007-2#2)(2007-3#1)(2007-7#95)(2007-8#57)(2007-9#7)(2008-1#21)(2008-10#32)(2008-11#21)(2008-12#8)(2008-3#9)(2008-4#5)(2008-5#5)(2008-6#2)(2008-7#15)(2008-8#3)(2008-9#7)(2009-1#1)(2009-10#4)(2009-11#3)(2009-2#2)(2009-3#2)(2009-4#12)(2009-5#4)(2009-6#6)(2009-7#2)(2009-8#4)(2009-9#4)(2010-1#2)(2010-10#1)(2010-11#5)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#12)(2011-2#30)(2011-3#7)(2011-8#1)(2012-12#8)(2012-2#18)(2012-3#12)(2013-1#14)(2013-2#2)(2013-7#2)(2013-8#12)
vein)##2##1##(1994-7#2)
vein-graft occlusion##2##2##(1993-7#2)
vein-graft patency##2##2##(1993-7#2)
vein-graft##4##1##(1993-7#4)
veinal mottle virus##4##3##(2008-10#4)
veinal necrosis##3##2##(2008-10#3)
veinal##7##1##(2008-10#7)
veins and the##2##3##(2006-6#1)(2008-7#1)
veins and##22##2##(1990-12#1)(1990-7#1)(1991-9#1)(1995-11#1)(2006-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-7#4)(2009-2#1)(2010-5#2)(2012-2#1)(2012-3#2)(2013-1#2)
veins are##6##2##(1996-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-3#1)
veins as##2##2##(2008-10#1)(2008-7#1)
veins but##2##2##(2005-10#1)(2007-7#1)
veins during##2##2##(2006-9#1)(2010-11#1)
veins had##2##2##(2006-6#1)(2007-8#1)
veins in the##2##3##(2009-6#1)(2011-2#1)
veins in##6##2##(1995-12#2)(2009-6#1)(2011-2#1)(2012-3#2)
veins is##5##2##(1993-5#1)(2006-8#1)(2007-8#1)(2011-3#1)(2013-7#1)
veins of both##2##3##(2004-9#1)(2007-2#1)
veins of the##3##3##(2004-9#1)(2006-6#1)(2008-7#1)
veins of##9##2##(1991-5#1)(1995-12#1)(2004-9#2)(2006-6#1)(2007-2#1)(2008-7#1)(2012-3#1)(2013-1#1)
veins or##2##2##(2008-8#1)(2012-9#1)
veins that##2##2##(2006-5#1)(2008-10#1)
veins to##2##2##(1997-1#1)(2006-6#1)
veins were##9##2##(1994-6#1)(1995-12#1)(2006-11#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-4#1)(2010-8#1)(2013-7#1)
veins with##3##2##(2007-8#1)(2008-10#1)(2012-3#1)
veins without endothelium##2##3##(1995-12#2)
veins without##3##2##(1995-12#2)(2011-2#1)
veins##176##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-7#1)(1991-10#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-6#1)(1995-11#1)(1995-12#12)(1996-2#1)(1996-8#1)(1996-9#3)(1997-1#2)(1997-3#1)(1997-8#1)(2004-9#2)(2005-10#2)(2005-11#1)(2006-10#2)(2006-11#3)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#8)(2006-8#2)(2006-9#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-7#10)(2007-8#16)(2008-1#2)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#13)(2008-8#3)(2008-9#3)(2009-10#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#3)(2010-8#2)(2011-1#2)(2011-2#6)(2011-3#3)(2012-2#1)(2012-3#9)(2012-9#1)(2013-1#7)(2013-7#3)(2013-8#1)
veins)##3##1##(2005-11#1)(2006-12#1)(2007-8#1)
velifer##2##1##(2010-12#2)
veliger stage##2##2##(2007-3#2)
vellus hair cysts##3##3##(2010-6#3)
velocimeter based on##2##3##(2008-3#2)
velocimeter has been##2##3##(2008-2#1)(2008-3#1)
velocimeter that##2##2##(2008-3#2)
velocimeter##20##1##(2007-11#1)(2008-2#6)(2008-3#13)
velocimetry (PIV)##3##2##(2008-2#2)(2008-3#1)
velocimetry and##7##2##(1994-3#1)(2008-2#2)(2008-3#4)
velocimetry at##2##2##(2008-3#1)(2011-2#1)
velocimetry by##2##2##(2008-1#1)(2008-3#1)
velocimetry for turbulent flows##2##4##(2008-2#1)(2008-3#1)
velocimetry in##4##2##(1996-12#1)(2007-11#1)(2008-3#2)
velocimetry of##2##2##(2007-12#2)
velocimetry with a compact##2##4##(2008-2#2)
velocimetry with##6##2##(2007-12#1)(2008-2#3)(2008-3#2)
velocimetry##59##1##(1992-2#1)(1994-11#1)(1994-3#3)(1996-12#1)(2007-11#2)(2007-12#7)(2008-1#1)(2008-2#14)(2008-3#24)(2009-10#1)(2011-2#4)
velocities and##3##2##(1996-6#1)(2008-11#1)(2012-1#1)
velocities are determined##2##3##(1992-3#1)(2008-3#1)
velocities between the##2##3##(2005-11#1)(2008-2#1)
velocities between##3##2##(1996-9#1)(2005-11#1)(2008-2#1)
velocities can##2##2##(1992-3#1)(2008-3#1)
velocities in the range##3##4##(2007-12#2)(2008-2#1)
velocities in the##9##3##(1996-2#1)(1996-6#1)(2006-11#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)
velocities in##12##2##(1996-2#1)(1996-6#1)(2005-9#1)(2006-11#1)(2007-12#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
velocities may##2##2##(2008-9#1)(2009-5#1)
velocities of pandemic spread##2##4##(2008-10#2)
velocities of the##7##3##(1991-10#1)(1996-8#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)
velocities of##17##2##(1990-12#1)(1991-10#1)(1991-6#1)(1996-4#1)(1996-8#1)(2005-11#2)(2006-4#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-7#1)
velocities that are##3##3##(1997-7#1)(2007-9#1)(2008-2#1)
velocities that##4##2##(1997-7#1)(2007-9#1)(2008-2#2)
velocities were found##2##3##(1996-9#1)(2011-2#1)
velocities were##8##2##(1996-9#2)(2005-11#2)(2007-11#1)(2008-3#1)(2008-7#1)(2011-2#1)
velocities##101##1##(1990-12#1)(1990-3#1)(1990-7#1)(1991-10#1)(1991-4#1)(1991-6#1)(1992-3#2)(1992-7#2)(1992-8#1)(1993-3#2)(1993-8#1)(1995-2#1)(1996-2#1)(1996-4#1)(1996-6#3)(1996-8#2)(1996-9#3)(1997-3#1)(1997-7#1)(2005-11#6)(2005-9#1)(2006-10#1)(2006-11#4)(2006-4#1)(2007-11#4)(2007-12#10)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#6)(2008-5#2)(2008-6#3)(2008-7#3)(2008-9#2)(2009-5#1)(2009-7#1)(2010-8#1)(2011-2#2)(2012-1#3)(2012-2#1)(2012-3#3)(2013-1#1)
velocity (EDV)##2##2##(2008-1#1)(2013-8#1)
velocity (Vmax)##3##2##(1993-8#1)(1995-11#1)(1995-5#1)
velocity and length##2##3##(2008-3#2)
velocity and temperature##2##3##(2008-2#2)
velocity and the##12##3##(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#6)(2008-6#1)(2011-2#1)
velocity and##53##2##(1991-5#2)(1994-12#1)(1994-4#1)(1995-10#1)(2006-10#2)(2006-11#1)(2007-10#4)(2007-11#4)(2007-12#3)(2007-3#1)(2007-4#2)(2008-10#2)(2008-11#3)(2008-2#5)(2008-3#8)(2008-5#2)(2008-6#1)(2008-7#1)(2009-3#1)(2010-10#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-1#2)(2013-1#1)
velocity are##7##2##(2005-11#1)(2008-2#1)(2008-3#4)(2010-1#1)
velocity at the##2##3##(2007-10#1)(2013-1#1)
velocity at##5##2##(1990-8#1)(1996-4#1)(1997-2#1)(2007-10#1)(2013-1#1)
velocity breakpoint##2##2##(2008-7#2)
velocity by##3##2##(1994-7#1)(2008-3#1)(2011-2#1)
velocity c##2##2##(2010-8#2)
velocity changes##4##2##(2006-6#1)(2007-12#1)(2008-7#1)(2011-2#1)
velocity component##2##2##(2007-11#1)(2008-2#1)
velocity components##2##2##(2008-3#2)
velocity did not change##2##4##(1990-3#1)(2008-11#1)
velocity did not##3##3##(1990-3#1)(2008-11#1)(2012-3#1)
velocity difference##5##2##(1990-8#1)(2008-2#2)(2008-3#2)
velocity distribution in##2##3##(2007-8#1)(2008-3#1)
velocity during the first##2##4##(1990-2#1)(1991-9#1)
velocity during##3##2##(1990-2#1)(1991-9#1)(2009-1#1)
velocity error##2##2##(1996-1#2)
velocity estimates##3##2##(2008-2#2)(2008-3#1)
velocity estimators##2##2##(2008-2#2)
velocity experiments##5##2##(1993-3#1)(2006-10#2)(2008-4#2)
velocity field##12##2##(2007-12#1)(2007-9#1)(2008-2#3)(2009-5#4)(2012-1#3)
velocity fields in##2##3##(2007-11#1)(2008-3#1)
velocity fields##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
velocity flow##2##2##(2008-4#1)(2008-7#1)
velocity for the##3##3##(2008-3#1)(2008-8#1)(2010-8#1)
velocity for##5##2##(2006-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-8#1)
velocity from##3##2##(2007-11#1)(2007-12#1)(2008-5#1)
velocity gradient##4##2##(2008-3#4)
velocity in a##2##3##(1995-7#1)(2007-12#1)
velocity in heterogenous biofilms##2##4##(2008-7#2)
velocity in microchannels##2##3##(2005-11#2)
velocity in the ipsilateral middle cerebral artery##2##7##(2007-10#2)
velocity in the##10##3##(1992-7#1)(1996-6#1)(2006-8#1)(2007-10#2)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2013-8#1)
velocity in##29##2##(1992-7#1)(1995-5#1)(1995-7#1)(1996-3#1)(1996-6#1)(2005-11#2)(2006-10#1)(2006-8#1)(2007-10#3)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
velocity increase in##2##3##(2007-8#1)(2008-10#1)
velocity increase##3##2##(1992-10#1)(2007-8#1)(2008-10#1)
velocity increased##4##2##(1994-4#1)(1997-7#1)(2008-6#1)(2012-1#1)
velocity information##4##2##(2008-3#4)
velocity is derived##2##3##(2008-2#1)(2008-3#1)
velocity is##14##2##(1991-5#1)(2005-11#4)(2007-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-9#1)(2009-6#1)
velocity mapping in turbid media##2##5##(2007-12#2)
velocity mapping##3##2##(2007-12#2)(2008-4#1)
velocity may be##2##3##(1991-2#1)(2012-1#1)
velocity may##3##2##(1991-2#1)(2008-7#1)(2012-1#1)
velocity measurement##6##2##(1996-2#1)(2007-11#1)(2008-2#1)(2008-3#3)
velocity measurements of##2##3##(2008-3#2)
velocity measurements##8##2##(1991-12#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)
velocity mismatch##2##2##(2007-11#1)(2008-2#1)
velocity near the##2##3##(1994-6#1)(2008-3#1)
velocity of 3##2##3##(1991-11#1)(2013-8#1)
velocity of a##8##3##(1991-5#1)(2005-11#1)(2008-3#3)(2011-1#1)(2011-2#2)
velocity of contraction##2##3##(1997-7#2)
velocity of pandemic spread##2##4##(2008-10#2)
velocity of sperm##2##3##(1992-7#2)
velocity of such##2##3##(2005-11#2)
velocity of the red cells##2##5##(2008-3#2)
velocity of the##23##3##(1990-2#1)(1990-7#1)(1991-12#1)(1991-8#1)(1995-4#1)(1996-3#1)(1996-6#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-3#4)(2008-8#1)(2010-12#1)(2011-2#6)
velocity of water##2##3##(2005-11#1)(2011-2#1)
velocity of##99##2##(1990-2#1)(1990-7#2)(1991-11#1)(1991-12#2)(1991-5#1)(1991-8#1)(1992-11#1)(1992-7#2)(1993-12#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-4#1)(1995-7#1)(1996-3#2)(1996-4#1)(1996-6#2)(1997-7#2)(2005-1#2)(2005-11#5)(2007-1#1)(2007-11#2)(2007-12#6)(2007-4#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#14)(2008-4#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#11)(2012-1#2)(2012-2#1)(2013-8#1)
velocity on the##2##3##(2008-2#1)(2009-7#1)
velocity on##3##2##(1995-6#1)(2008-2#1)(2009-7#1)
velocity or##2##2##(2007-10#1)(2011-2#1)
velocity peaks##2##2##(2007-8#1)(2008-11#1)
velocity precision##2##2##(2007-12#1)(2008-1#1)
velocity profile of##2##3##(1996-3#1)(2005-11#1)
velocity profile##7##2##(1996-3#1)(2005-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)
velocity profiles##4##2##(1993-5#1)(1997-2#1)(2008-7#2)
velocity range##4##2##(1992-7#1)(2007-11#1)(2007-12#1)(2008-2#1)
velocity sedimentation##6##2##(1990-11#1)(1990-12#1)(1992-11#1)(1993-8#1)(1994-8#1)(2008-1#1)
velocity still##2##2##(1991-9#1)(2008-8#1)
velocity studies##2##2##(1991-9#1)(1992-11#1)
velocity than##2##2##(1993-3#1)(2011-2#1)
velocity that##2##2##(1991-9#1)(2008-2#1)
velocity to be##2##3##(2008-3#1)(2008-4#1)
velocity to##8##2##(1993-9#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#1)(2010-12#1)
velocity up##2##2##(1993-12#1)(2008-11#1)
velocity vector##2##2##(2009-4#1)(2011-2#1)
velocity vectors##2##2##(2007-5#1)(2008-3#1)
velocity was##9##2##(1993-5#1)(1995-3#1)(1997-4#1)(2006-11#1)(2008-7#3)(2008-8#1)(2010-9#1)
velocity were##6##2##(1993-11#1)(2006-5#1)(2006-6#1)(2007-11#1)(2013-1#2)
velocity with the##2##3##(1993-7#1)(2007-11#1)
velocity with##5##2##(1993-7#1)(2007-11#2)(2008-1#1)(2008-3#1)
velocity without##2##2##(1993-11#1)(2007-11#1)
velocity##614##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#1)(1990-7#3)(1990-8#2)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#2)(1991-5#5)(1991-8#1)(1991-9#6)(1992-1#1)(1992-10#1)(1992-11#3)(1992-2#1)(1992-3#2)(1992-6#1)(1992-7#4)(1992-9#2)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#2)(1993-5#4)(1993-6#2)(1993-7#2)(1993-8#2)(1993-9#3)(1994-12#1)(1994-2#1)(1994-4#3)(1994-5#1)(1994-6#1)(1994-7#2)(1994-8#1)(1995-10#1)(1995-11#4)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#6)(1995-7#2)(1995-8#1)(1996-1#4)(1996-2#1)(1996-3#6)(1996-4#3)(1996-5#3)(1996-6#6)(1996-7#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-7#4)(2005-1#2)(2005-10#1)(2005-11#20)(2006-10#12)(2006-11#4)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-8#1)(2006-9#2)(2007-1#5)(2007-10#17)(2007-11#26)(2007-12#29)(2007-3#2)(2007-4#9)(2007-5#3)(2007-7#1)(2007-8#8)(2007-9#3)(2008-1#6)(2008-10#17)(2008-11#13)(2008-12#2)(2008-2#43)(2008-3#85)(2008-4#9)(2008-5#12)(2008-6#5)(2008-7#18)(2008-8#8)(2008-9#3)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#3)(2009-4#1)(2009-5#5)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-7#2)(2010-8#6)(2010-9#4)(2011-1#8)(2011-2#25)(2012-1#14)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#7)(2013-3#1)(2013-7#2)(2013-8#6)
velocity)##5##1##(1997-2#1)(2008-10#2)(2008-9#1)(2010-8#1)
velocity-dependent permeability##2##2##(2005-11#2)
velocity-dependent##6##1##(1993-9#1)(1997-5#1)(2005-11#2)(2007-7#1)(2012-1#1)
velogenic##6##1##(1997-3#1)(2005-9#2)(2007-6#2)(2008-11#1)
velvet##8##1##(1997-3#1)(2005-7#1)(2007-12#1)(2008-2#4)(2008-5#1)
velvetleaf leaves##2##2##(2008-10#2)
velvetleaf##3##1##(2008-10#3)
vena cava (IVC)##5##3##(1993-12#1)(2007-8#1)(2011-2#2)(2013-1#1)
vena cava =##2##3##(2007-7#2)
vena cava after##3##3##(2007-8#1)(2008-11#2)
vena cava and##15##3##(1995-12#1)(1996-3#3)(2007-8#3)(2008-11#7)(2010-4#1)
vena cava blood##2##3##(1996-3#2)
vena cava disease##2##3##(2008-7#2)
vena cava in a##2##4##(2007-8#1)(2013-1#1)
vena cava in##4##3##(1992-9#1)(2007-8#1)(2010-10#1)(2013-1#1)
vena cava is a##3##4##(2008-12#1)(2008-7#1)(2013-1#1)
vena cava may##2##3##(1992-9#1)(2007-7#1)
vena cava or##2##3##(1997-8#1)(2008-6#1)
vena cava syndrome##11##3##(1993-9#1)(1995-8#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-7#1)(2010-8#1)(2013-1#4)
vena cava was##5##3##(1992-1#1)(2007-7#1)(2007-8#2)(2010-4#1)
vena cava with##3##3##(2007-8#1)(2008-11#2)
vena cava##132##2##(1991-8#1)(1992-1#1)(1992-7#1)(1992-8#2)(1992-9#3)(1993-12#1)(1993-5#1)(1993-9#1)(1995-12#4)(1995-8#1)(1996-3#6)(1997-3#1)(1997-8#1)(2006-6#1)(2006-8#1)(2007-7#7)(2007-8#34)(2008-1#2)(2008-11#17)(2008-12#3)(2008-4#3)(2008-6#1)(2008-7#7)(2008-8#1)(2010-10#2)(2010-11#3)(2010-4#3)(2010-8#1)(2010-9#2)(2011-2#7)(2012-2#3)(2013-1#10)
vena caval compression##2##3##(2006-6#2)
vena caval##4##2##(2006-6#2)(2007-8#1)(2011-2#1)
vena##143##1##(1991-8#1)(1992-1#1)(1992-5#1)(1992-7#1)(1992-8#2)(1992-9#3)(1993-12#1)(1993-5#1)(1993-9#1)(1995-12#4)(1995-6#1)(1995-8#1)(1996-3#6)(1997-3#1)(1997-8#1)(2006-6#3)(2006-8#1)(2007-7#7)(2007-8#35)(2008-1#2)(2008-11#19)(2008-12#3)(2008-4#3)(2008-6#1)(2008-7#7)(2008-8#1)(2009-5#1)(2010-10#2)(2010-11#3)(2010-4#3)(2010-8#1)(2010-9#2)(2011-2#8)(2011-3#1)(2012-2#4)(2013-1#10)
venation##2##1##(2007-12#1)(2013-7#1)
vending machines##3##2##(1996-1#1)(1996-11#2)
vending##5##1##(1996-1#1)(1996-11#3)(2007-12#1)
vendor##20##1##(1991-1#1)(1991-3#1)(1992-12#1)(1993-12#1)(1995-12#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-3#1)(2004-9#1)(2005-9#2)(2007-4#1)(2008-10#3)(2009-10#1)(2009-3#1)(2011-2#1)(2013-1#1)
vendor's##2##1##(2004-9#1)(2008-7#1)
vendors and users##2##3##(1991-3#2)
vendors and##5##2##(1990-7#1)(1991-3#2)(2009-9#1)(2010-8#1)
vendors who##2##2##(1994-3#1)(2006-8#1)
vendors##36##1##(1990-5#2)(1990-7#1)(1991-3#2)(1993-12#2)(1994-1#2)(1994-2#1)(1994-3#2)(1995-1#1)(1996-11#1)(1997-3#1)(2004-9#1)(2005-12#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-4#4)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-7#1)
veneer##13##1##(2009-8#2)(2011-1#1)(2012-12#6)(2013-1#4)
veneering composites##2##2##(2004-9#2)
veneering porcelain##4##2##(2010-12#1)(2013-8#3)
veneering##9##1##(1991-1#1)(2004-9#2)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#3)
veneers over discolored backgrounds##2##4##(2009-8#2)
veneers##6##1##(2009-8#4)(2011-1#1)(2012-12#1)
venepuncture##3##1##(2008-11#1)(2009-5#1)(2012-2#1)
venereal diseases##4##2##(1991-6#1)(1992-2#2)(2010-2#1)
venereal##9##1##(1991-6#2)(1992-2#2)(2007-7#1)(2009-12#1)(2010-2#1)(2013-1#2)
venerealis##7##1##(2006-10#1)(2011-1#3)(2013-1#3)
venereum##7##1##(1991-9#1)(2005-11#2)(2007-7#2)(2008-12#1)(2011-2#1)
venezuelensis##2##1##(2012-12#2)
venipuncture and##2##2##(1997-7#1)(2007-7#1)
venipuncture##8##1##(1994-12#1)(1997-7#1)(2007-7#3)(2008-4#1)(2010-11#1)(2011-2#1)
venlafaxine XR##6##2##(2007-4#1)(2007-6#1)(2008-3#4)
venlafaxine and mirtazapine##2##3##(2010-5#2)
venlafaxine and##3##2##(2010-5#2)(2011-1#1)
venlafaxine##20##1##(2007-4#2)(2007-6#1)(2008-11#1)(2008-3#4)(2008-8#1)(2008-9#1)(2010-5#2)(2011-1#3)(2011-2#2)(2012-2#2)(2013-1#1)
veno-occlusive disease##5##2##(2005-11#1)(2010-10#3)(2012-10#1)
veno-venous##6##1##(2006-4#3)(2007-8#2)(2013-8#1)
venoconstriction##4##1##(1993-2#1)(1995-12#2)(1996-9#1)
venocuff##2##1##(2013-1#2)
venographic##3##1##(2008-1#1)(2012-3#2)
venography##17##1##(1990-12#1)(1992-3#1)(1993-9#1)(1997-5#1)(2006-8#1)(2007-10#1)(2007-7#4)(2007-8#1)(2010-12#1)(2011-1#1)(2012-3#3)(2013-1#1)
venom and##6##2##(1990-3#1)(2008-5#2)(2010-12#1)(2012-2#1)(2013-1#1)
venom apparatus##4##2##(2007-12#4)
venom contains##2##2##(1990-11#1)(2008-8#1)
venom gland##5##2##(2007-12#3)(2008-7#2)
venom glands##4##2##(1993-6#1)(1994-12#2)(1997-7#1)
venom is##2##2##(2008-8#1)(2012-2#1)
venom of Agkistrodon halys Pallas##2##5##(2008-8#2)
venom of Agkistrodon##3##3##(1992-12#1)(2008-8#2)
venom of Trimeresurus albolabris##2##4##(1993-3#1)(1996-2#1)
venom of the spider##3##4##(1993-11#1)(1996-11#2)
venom of the##14##3##(1990-12#2)(1990-2#1)(1990-5#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-5#1)(1994-8#1)(1995-5#1)(1996-11#2)(2011-2#1)
venom of##36##2##(1990-12#2)(1990-2#3)(1990-5#1)(1991-7#1)(1992-12#3)(1992-5#2)(1993-11#1)(1993-3#2)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-5#2)(1995-8#1)(1996-11#2)(1996-2#1)(2008-5#2)(2008-8#3)(2011-2#1)
venom on##6##2##(2007-2#3)(2013-1#3)
venom peptide##2##2##(1994-12#1)(1996-5#1)
venom proteins##2##2##(1993-3#2)
venom was##3##2##(1992-8#1)(1994-3#1)(2008-5#1)
venom were##2##2##(1994-6#1)(2007-2#1)
venom##144##1##(1990-11#4)(1990-12#2)(1990-2#4)(1990-3#1)(1990-5#1)(1990-7#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#4)(1992-3#2)(1992-5#3)(1992-8#1)(1993-11#1)(1993-3#5)(1993-5#1)(1993-6#2)(1993-7#1)(1994-11#2)(1994-12#8)(1994-2#2)(1994-3#4)(1994-5#2)(1994-6#2)(1994-8#2)(1995-1#1)(1995-5#4)(1995-8#1)(1996-11#2)(1996-2#3)(1996-5#1)(1997-2#1)(1997-7#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-12#10)(2007-2#9)(2008-10#2)(2008-12#1)(2008-5#12)(2008-7#4)(2008-8#7)(2009-3#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-2#4)(2012-2#5)(2012-3#1)(2013-1#8)(2013-7#1)
venomous snake##2##2##(2008-5#1)(2009-6#1)
venomous snakes##2##2##(2012-2#1)(2013-7#1)
venomous##7##1##(2007-12#1)(2008-5#1)(2009-6#2)(2012-2#2)(2013-7#1)
venoms##13##1##(1990-2#1)(1990-5#3)(1992-8#1)(1993-11#1)(1994-5#1)(1996-2#1)(2007-2#1)(2008-5#1)(2008-8#1)(2011-2#2)
venosus##5##1##(1996-12#1)(1996-9#1)(2007-1#1)(2008-11#1)(2008-5#1)
venous &quot##3##2##(2007-7#3)
venous abnormalities##3##2##(2008-7#1)(2012-3#2)
venous access can##2##3##(2011-2#2)
venous access in##2##3##(2007-7#2)
venous access systems were used in##2##6##(2007-7#2)
venous access##17##2##(2006-12#1)(2006-6#1)(2007-7#7)(2008-4#1)(2009-4#1)(2011-2#4)(2012-2#1)(2013-1#1)
venous anastomosis##2##2##(2007-7#1)(2013-1#1)
venous and arterial##5##3##(2005-7#1)(2007-7#2)(2008-10#1)(2011-3#1)
venous and##11##2##(1990-12#1)(2005-7#1)(2007-10#1)(2007-7#2)(2008-10#1)(2010-12#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
venous anomalies##4##2##(2008-9#1)(2010-11#1)(2012-12#1)(2012-3#1)
venous anomaly of##2##3##(2010-11#1)(2012-2#1)
venous anomaly##4##2##(2010-11#2)(2011-2#1)(2012-2#1)
venous blood and##2##3##(1994-7#1)(2011-2#1)
venous blood flow##2##3##(1992-1#1)(2008-9#1)
venous blood samples were taken before and##2##7##(1995-1#1)(2013-8#1)
venous blood samples were taken before##3##6##(1990-3#1)(1995-1#1)(2013-8#1)
venous blood samples were taken##4##5##(1990-3#1)(1995-1#1)(2013-1#1)(2013-8#1)
venous blood samples were##8##4##(1990-3#1)(1991-6#1)(1995-1#1)(2007-8#1)(2011-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
venous blood samples##9##3##(1990-3#1)(1991-6#1)(1995-1#1)(2007-8#1)(2008-7#1)(2011-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
venous blood was##2##3##(1994-7#1)(2008-9#1)
venous blood with##2##3##(1993-12#1)(2008-2#1)
venous blood##40##2##(1990-3#1)(1991-1#1)(1991-6#1)(1992-1#1)(1992-8#1)(1993-12#1)(1994-7#2)(1995-1#1)(1995-7#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-5#1)(2006-7#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-12#1)(2008-2#2)(2008-7#1)(2008-9#3)(2009-4#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
venous cannulation##9##2##(1997-3#1)(2007-7#3)(2007-8#1)(2008-1#1)(2010-11#1)(2012-12#2)
venous catheter (CVC)##3##3##(2007-7#2)(2008-7#1)
venous catheter and##2##3##(2007-7#2)
venous catheter in the##2##4##(2009-9#1)(2013-8#1)
venous catheter in##5##3##(2007-7#2)(2009-4#1)(2009-9#1)(2013-8#1)
venous catheter insertion##3##3##(2007-7#1)(2008-1#1)(2010-6#1)
venous catheter placement##3##3##(2007-7#2)(2012-12#1)
venous catheter system##2##3##(2007-7#2)
venous catheter##63##2##(1990-8#2)(1991-5#1)(2006-10#2)(2006-6#1)(2006-7#3)(2007-7#29)(2007-8#1)(2008-1#1)(2008-7#7)(2008-9#1)(2009-4#1)(2009-8#1)(2009-9#2)(2010-6#1)(2011-2#3)(2012-12#3)(2013-1#1)(2013-7#2)(2013-8#1)
venous catheter-associated bloodstream infections##3##4##(2007-12#1)(2008-4#2)
venous catheter-associated##4##2##(2007-12#1)(2008-4#2)(2011-2#1)
venous catheterization##9##2##(1990-6#1)(2007-7#2)(2007-9#1)(2008-4#2)(2008-7#1)(2010-10#1)(2012-12#1)
venous catheterizations##2##2##(2007-7#1)(2013-1#1)
venous catheters are##2##3##(2008-1#1)(2012-12#1)
venous catheters##31##2##(1990-3#1)(1992-1#1)(1992-2#1)(2004-11#1)(2005-10#1)(2005-8#1)(2006-6#1)(2007-7#14)(2008-1#2)(2008-7#4)(2012-12#3)(2013-8#1)
venous channels##2##2##(2008-7#1)(2012-3#1)
venous circulation##5##2##(1990-12#1)(1993-2#1)(2006-3#1)(2007-8#1)(2009-8#1)
venous conduits##2##2##(2007-8#1)(2008-8#1)
venous congestion##6##2##(1997-6#1)(2007-7#5)
venous connection##12##2##(2007-8#5)(2008-10#1)(2008-11#4)(2010-5#1)(2010-9#1)
venous dialysis##3##2##(2007-7#3)
venous disorders##4##2##(2008-3#1)(2010-7#3)
venous drainage and##2##3##(1996-9#1)(2008-7#1)
venous drainage in##2##3##(2007-8#1)(2008-7#1)
venous drainage is##2##3##(1996-9#1)(2010-8#1)
venous drainage of the##2##4##(1996-9#2)
venous drainage##22##2##(1996-9#4)(2007-10#1)(2007-8#6)(2008-7#6)(2010-12#1)(2010-8#1)(2012-12#1)(2012-3#2)
venous dysfunction##2##2##(2010-7#2)
venous embolization##4##2##(1997-8#2)(2008-7#1)(2012-12#1)
venous endothelial##2##2##(2004-11#1)(2008-1#1)
venous extension##3##2##(2006-10#3)
venous flow##7##2##(2007-8#4)(2008-7#1)(2011-2#1)(2012-2#1)
venous graft##3##2##(2007-8#2)(2011-2#1)
venous grafts##4##2##(2005-10#1)(2007-7#1)(2007-8#1)(2013-1#1)
venous hypertension##4##2##(1990-5#1)(2007-10#1)(2008-7#2)
venous infarction##4##2##(1992-7#1)(1996-9#1)(2007-10#1)(2007-9#1)
venous insufficiency and##2##3##(2008-5#1)(2011-3#1)
venous insufficiency may##4##3##(2013-1#4)
venous insufficiency using##2##3##(2009-2#1)(2012-3#1)
venous insufficiency with##2##3##(2005-10#1)(2011-3#1)
venous insufficiency##38##2##(1990-3#2)(2005-10#5)(2006-12#1)(2006-9#1)(2007-8#1)(2008-5#1)(2009-2#1)(2011-3#2)(2012-12#1)(2012-3#8)(2013-1#15)
venous ischemia by dural##2##4##(2007-10#2)
venous ischemia##3##2##(2007-10#3)
venous leg ulcer##2##3##(1997-3#2)
venous leg ulcer]##2##3##(1997-3#1)(2012-12#1)
venous leg ulcers##4##3##(1990-6#1)(1997-3#2)(2006-9#1)
venous leg##8##2##(1990-6#1)(1997-3#5)(2006-9#1)(2012-12#1)
venous line##3##2##(1994-9#1)(2007-7#1)(2013-1#1)
venous long-term##2##2##(2007-7#2)
venous malformations##2##2##(2007-7#1)(2012-1#1)
venous obstruction in##2##3##(2009-4#1)(2011-2#1)
venous obstruction##11##2##(2005-10#1)(2007-8#5)(2008-4#2)(2009-4#1)(2011-2#1)(2012-3#1)
venous occlusion##8##2##(1990-11#3)(1994-4#1)(2007-7#1)(2012-3#1)(2013-1#1)(2013-7#1)
venous or arterial##4##3##(1996-3#1)(2007-12#1)(2008-10#1)(2012-12#1)
venous or##6##2##(1996-3#2)(1997-6#1)(2007-12#1)(2008-10#1)(2012-12#1)
venous outflow##5##2##(2006-4#1)(2006-6#1)(2008-7#1)(2009-8#1)(2012-3#1)
venous outlet##2##2##(1996-9#2)
venous oxygen saturation##4##3##(2006-10#1)(2006-7#1)(2008-4#1)(2008-7#1)
venous oxygen##5##2##(2006-10#1)(2006-7#1)(2008-2#1)(2008-4#1)(2008-7#1)
venous patch##2##2##(2007-7#2)
venous perfusion##2##2##(1990-10#1)(2008-7#1)
venous phase##3##2##(2008-7#1)(2010-5#1)(2013-1#1)
venous phases##2##2##(2010-12#1)(2013-1#1)
venous plasma concentration of##2##4##(1990-11#1)(1990-5#1)
venous plasma##10##2##(1990-11#3)(1990-5#3)(1993-7#2)(1994-3#1)(1994-5#1)
venous plexus##16##2##(1996-12#1)(1996-9#2)(2006-6#1)(2009-6#2)(2011-2#10)
venous plexuses##3##2##(2011-2#3)
venous port##3##2##(2005-1#1)(2007-7#2)
venous pressure and##2##3##(1990-9#1)(1992-1#1)
venous pressure measurements##3##3##(1991-10#1)(2007-7#2)
venous pressure of##3##3##(1996-9#1)(2007-7#1)(2007-8#1)
venous pressure##23##2##(1990-9#1)(1991-10#1)(1991-5#1)(1992-1#3)(1993-2#2)(1996-9#1)(2007-7#7)(2007-8#5)(2008-7#1)(2010-8#1)
venous puncture##2##2##(1992-5#1)(2011-1#1)
venous resistance##3##2##(1997-5#3)
venous resistances##2##2##(1997-5#2)
venous return and##2##3##(1996-3#1)(2013-7#1)
venous return##6##2##(1996-3#1)(1997-1#1)(2007-8#3)(2013-7#1)
venous sampling##3##2##(2008-2#2)(2010-11#1)
venous saturation##2##2##(1997-6#1)(2008-7#1)
venous sinus thrombosis##4##3##(1997-6#2)(2007-10#1)(2007-9#1)
venous sinus##7##2##(1996-9#2)(1997-6#2)(2006-4#1)(2007-10#1)(2007-9#1)
venous stasis ulcers##2##3##(2005-7#1)(2008-5#1)
venous stasis##6##2##(2005-7#1)(2008-5#1)(2009-8#1)(2010-6#3)
venous stenosis##7##2##(1997-8#1)(2007-7#5)(2008-1#1)
venous stroke##4##2##(2007-10#4)
venous system in##2##3##(2008-9#1)(2013-2#1)
venous system##16##2##(1990-6#1)(1993-7#1)(2005-12#1)(2007-7#2)(2007-8#2)(2008-12#1)(2008-6#1)(2008-9#1)(2009-3#1)(2011-2#2)(2011-3#2)(2013-2#1)
venous systems##2##2##(2007-9#1)(2012-3#1)
venous thromboembolic disease##4##3##(1996-3#1)(1996-9#1)(2007-8#2)
venous thromboembolic events##3##3##(2012-3#1)(2013-1#2)
venous thromboembolic##10##2##(1995-4#1)(1996-3#1)(1996-9#1)(2005-7#1)(2007-8#2)(2010-6#1)(2012-3#1)(2013-1#2)
venous thromboembolism (VTE)##7##3##(2006-2#1)(2007-10#2)(2007-2#1)(2011-2#1)(2013-1#2)
venous thromboembolism after##3##3##(2007-10#1)(2013-1#2)
venous thromboembolism and##2##3##(2008-3#1)(2008-7#1)
venous thromboembolism in##6##3##(1993-5#2)(2006-2#2)(2010-11#2)
venous thromboembolism##53##2##(1993-5#4)(1996-11#2)(1997-2#1)(1997-3#1)(1997-5#4)(2005-10#2)(2006-2#3)(2006-4#1)(2007-10#8)(2007-12#1)(2007-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2010-11#3)(2010-12#2)(2010-2#2)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#6)
venous thromboses##2##2##(1996-4#1)(2007-8#1)
venous thrombosis after##3##3##(1990-6#1)(1997-5#1)(2007-10#1)
venous thrombosis and pulmonary embolism##6##5##(1997-2#1)(2005-1#1)(2008-12#1)(2012-3#1)(2013-1#2)
venous thrombosis and##10##3##(1997-2#1)(2005-1#1)(2006-4#1)(2008-12#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
venous thrombosis in the##2##4##(1992-10#1)(2006-6#1)
venous thrombosis in##13##3##(1992-10#2)(1996-6#1)(2005-10#1)(2006-10#2)(2006-6#1)(2007-9#1)(2008-7#1)(2008-9#1)(2010-11#2)(2012-3#1)
venous thrombosis of##2##3##(2007-7#1)(2011-2#1)
venous thrombosis should##2##3##(1993-5#1)(2007-10#1)
venous thrombosis was##3##3##(1992-3#1)(2006-2#1)(2008-8#1)
venous thrombosis with##3##3##(2007-9#1)(2008-10#1)(2008-8#1)
venous thrombosis##89##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-6#2)(1991-9#1)(1992-10#3)(1992-3#2)(1993-5#2)(1993-9#1)(1994-12#1)(1994-7#1)(1994-9#1)(1996-6#2)(1997-2#1)(1997-3#2)(1997-5#1)(2005-1#1)(2005-10#1)(2006-10#5)(2006-2#1)(2006-4#1)(2006-6#2)(2006-8#1)(2007-10#7)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-9#7)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#1)(2010-11#2)(2010-12#3)(2010-2#1)(2011-2#3)(2012-11#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#4)(2013-8#3)
venous thrombosis]##4##2##(1990-10#1)(1991-3#1)(1992-2#1)(1992-3#1)
venous thrombus##3##2##(2007-8#1)(2008-9#1)(2013-1#1)
venous tumour##3##2##(2008-6#2)(2009-7#1)
venous ulcers of##2##3##(1990-3#1)(2012-12#1)
venous ulcers##3##2##(1990-3#1)(2006-9#1)(2012-12#1)
venous varix##3##2##(2007-9#3)
venous vascular##4##2##(2007-7#2)(2013-8#2)
venous vessels##7##2##(1990-10#4)(1990-3#1)(1997-6#1)(2006-11#1)
venous wall##4##2##(2007-8#2)(2009-7#2)
venous##828##1##(1990-10#9)(1990-11#8)(1990-12#4)(1990-3#9)(1990-4#1)(1990-5#4)(1990-6#6)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-3#2)(1991-5#3)(1991-6#1)(1991-9#1)(1992-1#5)(1992-10#3)(1992-2#2)(1992-3#4)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#6)(1993-5#9)(1993-7#3)(1993-9#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-5#2)(1994-7#4)(1994-9#3)(1995-1#2)(1995-11#1)(1995-4#1)(1995-7#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#7)(1996-4#3)(1996-6#2)(1996-8#1)(1996-9#19)(1997-1#3)(1997-2#2)(1997-3#9)(1997-5#14)(1997-6#7)(1997-8#3)(2004-11#2)(2005-1#2)(2005-10#16)(2005-12#1)(2005-7#4)(2005-8#1)(2006-10#14)(2006-11#1)(2006-12#5)(2006-2#4)(2006-3#1)(2006-4#6)(2006-5#1)(2006-6#9)(2006-7#7)(2006-8#2)(2006-9#3)(2007-10#27)(2007-11#1)(2007-12#4)(2007-2#4)(2007-7#117)(2007-8#53)(2007-9#18)(2008-1#9)(2008-10#4)(2008-11#4)(2008-12#4)(2008-2#5)(2008-3#7)(2008-4#10)(2008-5#5)(2008-6#4)(2008-7#41)(2008-8#6)(2008-9#10)(2009-2#2)(2009-3#1)(2009-4#6)(2009-6#4)(2009-7#3)(2009-8#5)(2009-9#2)(2010-10#1)(2010-11#10)(2010-12#12)(2010-2#3)(2010-5#3)(2010-6#6)(2010-7#8)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#37)(2011-3#6)(2012-1#3)(2012-11#1)(2012-12#19)(2012-2#8)(2012-3#25)(2013-1#39)(2013-2#1)(2013-7#9)(2013-8#10)
venous-venous anastomoses##2##2##(2008-9#2)
venovenous##8##1##(2006-4#2)(2007-8#4)(2008-4#1)(2009-7#1)
vent##14##1##(1991-3#6)(2008-10#3)(2008-3#2)(2008-9#1)(2011-2#1)(2012-2#1)
ventilate##3##1##(1995-5#1)(1997-4#1)(2006-10#1)
ventilated and##3##2##(2008-3#1)(2008-7#1)(2010-7#1)
ventilated for##4##2##(1990-12#1)(1993-7#1)(2011-2#1)(2012-2#1)
ventilated patient##2##2##(2008-6#1)(2008-8#1)
ventilated patients##12##2##(1993-10#1)(1996-9#1)(2005-8#2)(2006-10#3)(2008-1#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
ventilated rats##4##2##(1994-10#1)(1994-11#1)(1995-3#1)(1997-5#1)
ventilated##59##1##(1990-12#1)(1991-3#1)(1992-6#1)(1993-10#1)(1993-12#1)(1993-7#1)(1994-10#2)(1994-11#1)(1994-12#1)(1994-6#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-9#2)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-8#2)(2006-10#4)(2007-3#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-6#1)(2010-12#2)(2010-7#2)(2011-1#1)(2011-2#3)(2012-2#2)(2013-7#1)
ventilation after##2##2##(2005-8#1)(2007-8#1)
ventilation and perfusion##2##3##(1997-1#1)(2008-1#1)
ventilation and the##3##3##(1995-2#1)(1996-9#1)(2007-11#1)
ventilation and##33##2##(1992-12#1)(1992-5#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-9#2)(1997-1#1)(1997-4#2)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-5#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-8#1)
ventilation by##2##2##(1997-4#1)(2006-10#1)
ventilation can##3##2##(1997-4#1)(2008-6#1)(2010-7#1)
ventilation during##2##2##(2006-10#1)(2007-8#1)
ventilation equipment##2##2##(1994-6#1)(2006-4#1)
ventilation for##12##2##(1996-12#1)(1997-4#1)(2005-8#1)(2006-10#2)(2006-4#2)(2007-9#1)(2008-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
ventilation has been shown to##2##5##(2006-10#1)(2008-6#1)
ventilation has been##4##3##(2006-10#2)(2008-6#2)
ventilation has##5##2##(2006-10#3)(2008-6#2)
ventilation have been##5##3##(1997-4#1)(2005-8#1)(2006-10#1)(2008-5#1)(2010-5#1)
ventilation in acute respiratory insufficiency]##2##5##(1997-4#2)
ventilation in acute respiratory##4##4##(1997-4#2)(2006-10#1)(2006-9#1)
ventilation in acute##5##3##(1997-4#2)(2006-10#2)(2006-9#1)
ventilation in children##3##3##(2006-10#1)(2009-3#1)(2013-8#1)
ventilation in patients with##4##4##(1997-4#2)(2006-10#1)(2012-1#1)
ventilation in the postoperative##2##4##(1997-4#1)(2013-1#1)
ventilation in the##7##3##(1995-2#1)(1997-4#2)(2005-9#1)(2007-6#1)(2011-12#1)(2013-1#1)
ventilation in##40##2##(1994-6#1)(1994-7#1)(1995-2#1)(1995-7#1)(1996-2#1)(1996-3#1)(1997-4#11)(2005-9#1)(2006-10#6)(2006-4#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-6#2)(2007-9#1)(2008-6#1)(2009-3#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
ventilation is##10##2##(1993-10#2)(1994-6#1)(2005-11#1)(2005-8#2)(2006-10#2)(2010-2#1)(2013-7#1)
ventilation may##4##2##(1997-4#3)(2005-8#1)
ventilation of patients##2##3##(2005-8#1)(2007-11#1)
ventilation of##9##2##(1990-3#1)(1993-3#1)(1994-6#2)(1997-4#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-4#1)
ventilation on##7##2##(1996-12#1)(1997-4#2)(2006-10#3)(2009-3#1)
ventilation requirements in patients undergoing mitral valve##2##7##(2007-9#2)
ventilation should be##2##3##(1997-4#1)(2010-2#1)
ventilation strategies##2##2##(2008-6#1)(2009-6#1)
ventilation systems##2##2##(1992-4#1)(2006-6#1)
ventilation time##2##2##(2007-8#1)(2013-1#1)
ventilation to##4##2##(2006-10#1)(2007-9#1)(2008-6#1)(2013-1#1)
ventilation using##2##2##(2005-8#1)(2006-4#1)
ventilation via a##2##3##(1997-4#2)
ventilation via##4##2##(1997-4#3)(2006-2#1)
ventilation was##10##2##(1990-12#1)(1992-10#1)(1994-4#1)(1994-6#1)(1997-4#1)(2007-8#2)(2007-9#1)(2009-6#1)(2010-7#1)
ventilation were##5##2##(1992-12#1)(1996-6#1)(2008-8#1)(2010-2#1)(2012-2#1)
ventilation while on cardiopulmonary bypass##2##5##(2007-8#2)
ventilation with the##2##3##(1991-1#1)(2009-6#1)
ventilation with##10##2##(1991-1#1)(1991-6#1)(1995-4#1)(1996-1#1)(1996-3#1)(1997-4#1)(2006-10#1)(2009-2#1)(2009-6#1)(2010-7#1)
ventilation within##2##2##(1997-4#1)(2007-2#1)
ventilation##380##1##(1990-12#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-5#1)(1991-6#1)(1992-10#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-10#6)(1993-2#1)(1993-3#1)(1993-5#1)(1994-1#1)(1994-3#1)(1994-4#3)(1994-6#15)(1994-7#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#2)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#9)(1996-2#1)(1996-3#3)(1996-6#1)(1996-9#2)(1997-1#2)(1997-4#43)(1997-8#1)(2005-1#1)(2005-11#5)(2005-8#18)(2005-9#2)(2006-10#57)(2006-11#1)(2006-12#1)(2006-2#2)(2006-4#11)(2006-6#3)(2006-9#2)(2007-10#3)(2007-11#6)(2007-2#2)(2007-6#4)(2007-7#1)(2007-8#19)(2007-9#9)(2008-1#3)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#9)(2008-7#2)(2008-8#4)(2008-9#1)(2009-2#1)(2009-3#2)(2009-6#5)(2009-7#1)(2009-9#1)(2010-2#4)(2010-5#5)(2010-6#1)(2010-7#7)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#5)(2012-2#17)(2012-3#1)(2013-1#16)(2013-7#6)(2013-8#5)
ventilation)##4##1##(2006-10#1)(2008-7#1)(2009-10#1)(2013-1#1)
ventilation-perfusion##6##1##(1994-7#1)(2005-11#1)(2006-10#1)(2010-6#2)(2013-7#1)
ventilation/perfusion ratio##3##2##(2005-9#1)(2006-10#2)
ventilation/perfusion##6##1##(2005-9#2)(2006-10#4)
ventilation]##4##1##(1993-10#1)(1994-6#1)(1997-4#2)
ventilator and##5##2##(1997-3#1)(2009-6#1)(2010-9#1)(2012-2#2)
ventilator associated##3##2##(2008-10#1)(2010-7#1)(2013-8#1)
ventilator dependence##2##2##(1997-4#1)(2012-2#1)
ventilator induced lung injury##2##4##(2008-6#2)
ventilator settings##2##2##(1991-9#2)
ventilator support##2##2##(2012-12#1)(2012-2#1)
ventilator to##2##2##(2011-1#2)
ventilator treatment##4##2##(1995-5#1)(1996-12#1)(2006-10#2)
ventilator##47##1##(1991-9#2)(1993-10#1)(1993-3#1)(1995-12#2)(1995-5#1)(1996-12#1)(1997-3#1)(1997-4#3)(2005-11#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-6#2)(2009-6#2)(2010-5#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#9)(2013-8#1)
ventilator-associated lung injury##2##3##(2005-8#1)(2006-10#1)
ventilator-associated pneumonia after##2##3##(2012-2#1)(2013-1#1)
ventilator-associated pneumonia##5##2##(2005-8#1)(2006-10#1)(2012-2#1)(2013-1#2)
ventilator-associated##8##1##(2005-8#2)(2006-10#2)(2012-2#1)(2013-1#2)(2013-8#1)
ventilator-dependent patients##2##2##(2005-8#1)(2007-8#1)
ventilator-dependent##5##1##(2005-8#1)(2007-8#3)(2010-8#1)
ventilator-induced lung injury##2##3##(2005-11#1)(2005-8#1)
ventilator-induced##3##1##(2005-11#1)(2005-8#1)(2012-1#1)
ventilators and##2##2##(2010-8#1)(2010-9#1)
ventilators##17##1##(1991-9#1)(1993-10#1)(1994-6#1)(2006-10#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#3)(2013-8#1)
ventilatory and##2##2##(2010-7#1)(2013-8#1)
ventilatory assistance##3##2##(1997-4#3)
ventilatory capacity##3##2##(2013-1#1)(2013-7#2)
ventilatory defect##2##2##(1994-6#1)(2005-8#1)
ventilatory drive##3##2##(1992-2#1)(1997-4#2)
ventilatory failure##6##2##(1992-2#1)(1993-10#1)(1997-4#4)
ventilatory function##5##2##(1993-10#1)(1994-6#2)(2006-10#2)
ventilatory management##3##2##(2005-8#1)(2007-9#1)(2008-6#1)
ventilatory modes##3##2##(1993-10#1)(2006-10#1)(2012-2#1)
ventilatory parameters##2##2##(2005-8#1)(2012-2#1)
ventilatory rhythm and##2##3##(2009-10#2)
ventilatory strategies##3##2##(2005-8#1)(2006-10#1)(2007-8#1)
ventilatory support and##5##3##(2007-2#1)(2007-8#1)(2009-3#1)(2010-7#1)(2012-2#1)
ventilatory support at home##2##4##(2006-10#2)
ventilatory support can##2##3##(2005-8#1)(2006-9#1)
ventilatory support for##2##3##(2006-9#1)(2007-8#1)
ventilatory support is##3##3##(1993-10#1)(1997-4#1)(2005-8#1)
ventilatory support##28##2##(1993-10#1)(1995-4#1)(1997-4#1)(2005-11#2)(2005-8#3)(2006-10#4)(2006-4#1)(2006-9#3)(2007-2#1)(2007-8#4)(2009-3#1)(2009-6#2)(2010-7#1)(2012-2#3)
ventilatory techniques##3##2##(1997-4#1)(2006-10#1)(2012-2#1)
ventilatory treatment##3##2##(1993-2#1)(2006-10#2)
ventilatory##100##1##(1991-4#1)(1992-2#2)(1993-10#7)(1993-12#1)(1993-2#1)(1994-12#1)(1994-6#3)(1995-12#1)(1995-4#1)(1995-7#2)(1996-2#2)(1997-1#1)(1997-4#13)(2005-10#2)(2005-11#2)(2005-8#8)(2006-10#14)(2006-4#1)(2006-9#3)(2007-2#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-6#2)(2008-7#2)(2009-10#3)(2009-3#1)(2009-6#2)(2010-7#2)(2012-2#7)(2012-3#1)(2013-1#1)(2013-7#4)(2013-8#1)
venting##4##1##(1996-12#1)(2006-5#1)(2008-10#1)(2013-1#1)
ventral abdominal##3##2##(2004-2#1)(2006-2#1)(2009-7#1)
ventral and lateral##2##3##(2008-6#1)(2012-12#1)
ventral and##7##2##(2006-12#1)(2006-5#1)(2007-12#1)(2007-5#1)(2008-6#1)(2012-12#1)(2012-2#1)
ventral approaches##2##2##(2006-7#2)
ventral cochlear nucleus##2##3##(1996-2#1)(2012-2#1)
ventral cochlear##4##2##(1993-12#1)(1996-12#1)(1996-2#1)(2012-2#1)
ventral decompressive procedure##2##3##(2006-5#1)(2006-9#1)
ventral decompressive##3##2##(2006-5#1)(2006-9#2)
ventral endoderm##4##2##(2012-12#4)
ventral epidural adhesiolysis##3##3##(2006-8#3)
ventral epidural##5##2##(2006-5#1)(2006-8#4)
ventral eyespots##2##2##(2008-9#2)
ventral ganglia##2##2##(1994-2#1)(2008-5#1)
ventral half of the##2##4##(1991-1#1)(1997-3#1)
ventral half##3##2##(1991-1#1)(1994-12#1)(1997-3#1)
ventral hernia##6##2##(1996-12#4)(2010-12#1)(2010-8#1)
ventral hernias##2##2##(1991-4#1)(2010-12#1)
ventral horn##10##2##(1990-7#1)(1991-5#1)(1992-7#2)(1995-11#1)(1995-5#1)(1995-7#1)(1996-6#1)(1996-9#1)(2010-5#1)
ventral keels##2##2##(2008-5#2)
ventral mesencephalic grafts##3##3##(1996-2#3)
ventral mesencephalic##5##2##(1995-7#2)(1996-2#3)
ventral mesencephalon (VM)##2##3##(1996-5#1)(2012-12#1)
ventral mesencephalon##7##2##(1995-9#4)(1996-12#1)(1996-5#1)(2012-12#1)
ventral mesh rectopexy##2##3##(2013-7#2)
ventral midline##3##2##(1990-5#1)(1994-12#1)(1996-12#1)
ventral nerve cord in##2##4##(2007-12#2)
ventral nerve cord##8##3##(1997-7#1)(2007-12#5)(2008-5#1)(2008-9#1)
ventral nerve cords##2##3##(2007-12#1)(2008-5#1)
ventral nerve##10##2##(1997-7#1)(2007-12#6)(2008-5#2)(2008-9#1)
ventral pallidum##4##2##(1992-7#1)(1993-6#1)(1997-2#1)(2009-2#1)
ventral part of the##5##4##(1992-9#1)(1994-12#1)(1995-8#1)(1996-11#1)(2007-3#1)
ventral posteromedial##3##2##(1990-4#1)(2007-10#2)
ventral prefrontal cortex##2##3##(2009-10#1)(2010-8#1)
ventral premammillary nucleus##2##3##(1997-3#2)
ventral prostate nuclei##2##3##(1990-7#1)(1990-8#1)
ventral prostate##10##2##(1990-7#3)(1990-8#1)(1993-3#1)(1995-6#2)(1996-11#3)
ventral prostatic##2##2##(1990-7#2)
ventral receptacle##2##2##(2007-12#2)
ventral root afferents into the spinal cord##2##7##(1991-6#2)
ventral root depolarization##2##3##(1994-2#2)
ventral root of the##2##4##(1993-12#2)
ventral root of##3##3##(1993-12#3)
ventral root##17##2##(1991-6#5)(1992-8#1)(1993-12#7)(1994-2#2)(1996-12#1)(2006-8#1)
ventral roots of the##3##4##(1992-8#1)(1996-12#2)
ventral roots##6##2##(1992-8#1)(1993-12#2)(1996-12#3)
ventral somite##2##2##(1994-12#2)
ventral spinal##2##2##(2006-5#2)
ventral striatal##6##2##(1992-10#1)(1993-6#2)(2011-1#2)(2012-1#1)
ventral striatum##20##2##(1992-10#1)(1993-6#8)(1994-2#3)(1994-8#1)(1997-8#1)(2009-2#2)(2010-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
ventral subiculum and##2##3##(1993-6#2)
ventral subiculum lesions##2##3##(1993-6#2)
ventral subiculum##6##2##(1993-6#5)(1997-7#1)
ventral surface of the##4##4##(2006-8#1)(2007-3#1)(2008-5#1)(2009-6#1)
ventral surface##6##2##(2006-8#1)(2007-3#1)(2008-5#2)(2009-6#1)(2011-2#1)
ventral tegmental area (VTA) and##4##5##(1994-12#1)(1996-12#1)(1996-5#1)(2009-8#1)
ventral tegmental area (VTA)##15##4##(1991-8#1)(1993-12#3)(1993-2#1)(1993-6#1)(1994-12#1)(1996-12#2)(1996-5#1)(1997-5#1)(2008-7#2)(2009-2#1)(2009-8#1)
ventral tegmental area##49##3##(1990-4#1)(1991-11#3)(1991-8#1)(1992-10#1)(1993-12#6)(1993-2#1)(1993-6#2)(1994-12#2)(1994-2#4)(1995-12#1)(1996-10#1)(1996-12#3)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-7#3)(1997-8#8)(2008-4#1)(2008-7#3)(2009-2#2)(2009-8#1)
ventral tegmental##53##2##(1990-4#1)(1991-11#3)(1991-8#1)(1991-9#1)(1992-10#2)(1993-12#6)(1993-2#1)(1993-6#2)(1994-12#2)(1994-2#4)(1995-12#1)(1996-10#1)(1996-12#3)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-7#3)(1997-8#8)(2008-4#1)(2008-7#3)(2009-2#2)(2009-8#1)(2010-12#1)
ventral temporal##2##2##(2008-11#1)(2008-9#1)
ventral thalamic nucleus##2##3##(1997-3#2)
ventral to the##2##3##(1993-7#1)(2008-5#1)
ventral wing##2##2##(2008-9#2)
ventral##393##1##(1990-11#1)(1990-4#3)(1990-5#1)(1990-7#8)(1990-8#1)(1991-1#1)(1991-11#3)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#5)(1991-6#5)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#5)(1992-7#3)(1992-8#4)(1992-9#3)(1993-12#21)(1993-2#4)(1993-3#2)(1993-5#1)(1993-6#19)(1993-7#4)(1993-9#2)(1994-12#8)(1994-2#12)(1994-5#1)(1994-8#1)(1995-11#5)(1995-12#7)(1995-3#1)(1995-5#6)(1995-6#3)(1995-7#3)(1995-8#2)(1995-9#5)(1996-10#1)(1996-11#5)(1996-12#19)(1996-2#5)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-2#3)(1997-3#8)(1997-5#2)(1997-6#2)(1997-7#7)(1997-8#10)(2004-2#2)(2005-5#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#6)(2006-7#4)(2006-8#8)(2006-9#4)(2007-1#2)(2007-10#2)(2007-12#29)(2007-3#2)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#19)(2008-6#3)(2008-7#5)(2008-9#6)(2009-10#1)(2009-12#2)(2009-2#6)(2009-5#6)(2009-6#1)(2009-7#1)(2009-8#2)(2010-12#3)(2010-4#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#3)
ventralis##7##1##(1992-7#2)(1997-6#1)(2008-6#2)(2010-8#2)
ventralizing##4##1##(1994-12#1)(1997-4#1)(2008-6#2)
ventrally and##2##2##(1993-12#1)(2006-12#1)
ventrally in the##2##3##(2007-12#2)
ventrally into##2##2##(2007-12#2)
ventrally to the##2##3##(2006-7#1)(2007-12#1)
ventrally##13##1##(1993-12#1)(1993-2#1)(1994-12#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-12#5)(2007-3#1)(2011-2#1)
ventricle (LV)##4##2##(1991-3#1)(1992-8#1)(1997-4#1)(2010-12#1)
ventricle after##2##2##(1996-1#1)(2007-8#1)
ventricle and the##4##3##(1997-5#1)(2006-5#1)(2007-8#1)(2009-10#1)
ventricle and##23##2##(1992-3#1)(1996-2#1)(1997-5#1)(1997-8#1)(2006-5#3)(2007-8#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-11#1)(2011-1#2)(2012-1#2)(2012-2#1)(2013-8#1)
ventricle anterior##2##2##(2011-2#2)
ventricle are##2##2##(2008-7#1)(2009-12#1)
ventricle assistance##4##2##(2012-3#4)
ventricle causing##2##2##(2005-1#1)(2007-2#1)
ventricle cysticercal cysts##2##3##(2006-5#2)
ventricle ejection fraction##3##3##(2006-6#1)(2011-2#1)(2013-1#1)
ventricle free##2##2##(2008-7#2)
ventricle in##14##2##(1993-12#1)(1997-1#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-10#1)(2011-2#1)(2013-1#2)
ventricle is##5##2##(1993-10#1)(1996-5#1)(2006-5#1)(2006-6#1)(2008-10#1)
ventricle of anesthetized##2##3##(1994-11#1)(1996-9#1)
ventricle of the##5##3##(1990-7#1)(1991-3#1)(1996-3#1)(2007-7#1)(2008-9#1)
ventricle of##13##2##(1990-7#2)(1991-2#1)(1991-3#1)(1994-11#1)(1995-12#1)(1996-3#1)(1996-9#1)(2007-7#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-3#1)
ventricle or##2##2##(1991-12#1)(2007-8#1)
ventricle presenting##2##2##(2008-7#2)
ventricle through##2##2##(1993-12#1)(2008-7#1)
ventricle to##2##2##(1996-4#1)(2007-8#1)
ventricle wall##2##2##(1996-6#1)(2009-12#1)
ventricle was##3##2##(2006-5#1)(2011-2#1)(2013-1#1)
ventricle were##2##2##(1995-5#1)(2008-5#1)
ventricle who##2##2##(2007-8#1)(2009-4#1)
ventricle with##5##2##(1992-9#1)(2009-3#1)(2010-10#1)(2010-8#1)(2012-2#1)
ventricle##259##1##(1990-7#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-8#3)(1991-9#1)(1992-3#1)(1992-7#2)(1992-8#1)(1992-9#3)(1993-10#1)(1993-12#4)(1993-4#1)(1993-7#1)(1993-9#3)(1994-11#1)(1994-2#1)(1994-3#2)(1994-7#1)(1995-11#1)(1995-12#3)(1995-5#1)(1995-7#1)(1996-1#1)(1996-2#1)(1996-3#3)(1996-4#3)(1996-5#1)(1996-6#1)(1996-7#3)(1996-9#1)(1997-1#2)(1997-4#1)(1997-5#2)(1997-8#4)(2005-1#2)(2005-12#1)(2006-2#1)(2006-5#17)(2006-6#10)(2006-8#2)(2007-1#1)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#26)(2007-9#1)(2008-10#12)(2008-11#4)(2008-4#3)(2008-5#5)(2008-7#21)(2008-8#4)(2008-9#4)(2009-10#2)(2009-12#5)(2009-3#1)(2009-4#3)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#10)(2012-1#8)(2012-12#2)(2012-2#6)(2012-3#6)(2013-1#14)(2013-7#2)(2013-8#2)
ventricle]##3##1##(2008-10#2)(2013-1#1)
ventricles and##6##2##(1991-12#1)(1994-3#1)(1996-5#1)(1997-8#1)(2005-10#1)(2010-9#1)
ventricles is##3##2##(2008-7#1)(2009-10#1)(2011-2#1)
ventricles of the##3##3##(1992-11#1)(2008-11#2)
ventricles of##8##2##(1992-11#1)(1992-3#1)(1997-5#1)(2008-11#2)(2008-5#1)(2008-7#1)(2013-1#1)
ventricles were##2##2##(1996-5#1)(2007-8#1)
ventricles with##2##2##(1991-2#1)(1992-7#1)
ventricles##73##1##(1990-5#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-12#1)(1994-3#2)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1997-5#1)(1997-6#1)(1997-8#2)(2005-10#1)(2006-5#10)(2006-9#1)(2007-8#5)(2007-9#2)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2010-2#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#1)(2012-1#3)(2012-12#1)(2013-1#4)(2013-7#2)
ventricular (LV)##19##2##(1992-4#1)(1993-12#1)(2005-10#1)(2007-8#6)(2009-10#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#2)
ventricular CSF seeps into the parenchyma##2##6##(2007-9#2)
ventricular CSF##3##2##(2007-9#3)
ventricular action potential##3##3##(2008-8#2)(2010-11#1)
ventricular activation time##3##3##(2008-7#3)
ventricular activation##4##2##(1995-6#1)(2008-7#3)
ventricular anaplastic##2##2##(2007-2#1)(2011-1#1)
ventricular and##8##2##(1990-11#1)(1990-2#1)(1992-5#1)(1995-12#1)(1995-6#1)(1996-12#1)(2008-8#1)(2012-12#1)
ventricular aneurysm##4##2##(1996-8#1)(2007-8#3)
ventricular apex##4##2##(1991-8#1)(2006-9#2)(2013-1#1)
ventricular apical##6##2##(2006-9#2)(2009-6#1)(2009-8#1)(2010-5#1)(2012-2#1)
ventricular arrhythmia was##2##3##(1990-11#1)(2005-1#1)
ventricular arrhythmia##6##2##(1990-11#2)(1995-4#1)(2005-1#1)(2012-3#1)(2013-7#1)
ventricular arrhythmias and sudden cardiac death##2##6##(1997-8#2)
ventricular arrhythmias and sudden##3##4##(1997-8#2)(2009-10#1)
ventricular arrhythmias and##4##3##(1997-8#2)(2008-12#1)(2009-10#1)
ventricular arrhythmias are##2##3##(1990-6#1)(1993-10#1)
ventricular arrhythmias has been##2##4##(1996-4#1)(2007-2#1)
ventricular arrhythmias in patients with##2##5##(1992-6#1)(1997-8#1)
ventricular arrhythmias in##3##3##(1992-6#1)(1997-8#2)
ventricular arrhythmias resulting##2##3##(1996-9#1)(2011-2#1)
ventricular arrhythmias##36##2##(1990-11#1)(1990-6#1)(1991-8#1)(1992-6#1)(1993-10#1)(1993-8#1)(1996-12#1)(1996-3#1)(1996-4#3)(1996-9#1)(1997-8#4)(2005-12#1)(2005-7#2)(2006-10#1)(2006-9#1)(2007-2#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-10#5)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
ventricular assist device implantation##2##4##(2007-8#1)(2010-5#1)
ventricular assist device in##2##4##(2007-8#1)(2009-4#1)
ventricular assist device##16##3##(2007-8#8)(2009-10#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-3#1)
ventricular assist devices (VADs)##3##4##(2010-6#2)(2012-3#1)
ventricular assist devices and##2##4##(2006-9#1)(2011-2#1)
ventricular assist devices##11##3##(2006-9#1)(2007-8#1)(2008-8#1)(2010-6#4)(2011-2#2)(2012-3#1)(2013-7#1)
ventricular assist##28##2##(2006-9#1)(2007-8#10)(2008-8#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-6#4)(2010-8#1)(2011-2#4)(2012-3#2)(2013-7#1)
ventricular cardiomyocytes in##2##3##(2008-7#1)(2011-1#1)
ventricular cardiomyocytes##4##2##(1994-12#1)(2008-11#1)(2008-7#1)(2011-1#1)
ventricular cavity and##3##3##(2008-11#1)(2008-5#1)(2012-2#1)
ventricular cavity##6##2##(1991-10#1)(1993-10#1)(2006-5#1)(2008-11#1)(2008-5#1)(2012-2#1)
ventricular cell models##2##3##(2008-11#2)
ventricular cell##4##2##(2008-11#4)
ventricular cells##3##2##(1993-3#1)(2008-11#2)
ventricular cerebrospinal fluid##5##3##(1992-4#1)(1995-6#2)(2006-7#1)(2011-2#1)
ventricular chamber##2##2##(2009-10#1)(2012-12#1)
ventricular chambers##2##2##(2007-8#1)(2008-10#1)
ventricular conduction##3##2##(1997-1#1)(2012-3#2)
ventricular contractility##4##2##(1992-5#1)(1997-8#1)(2012-1#1)(2012-2#1)
ventricular contraction and##3##3##(2006-9#1)(2007-8#1)(2008-10#1)
ventricular contraction##8##2##(1991-2#1)(2006-9#1)(2007-8#4)(2008-10#2)
ventricular depolarization##2##2##(1993-1#1)(2010-11#1)
ventricular diastolic function##2##3##(1995-6#2)
ventricular diastolic##8##2##(1993-12#1)(1995-6#3)(2006-10#1)(2006-2#1)(2010-12#2)
ventricular dilatation and##3##3##(1994-3#1)(2006-2#2)
ventricular dilatation##11##2##(1990-1#1)(1993-10#1)(1994-3#1)(1995-3#1)(1997-3#1)(2006-2#2)(2007-9#1)(2008-12#1)(2010-12#1)(2012-3#1)
ventricular dilation##8##2##(2007-8#1)(2008-5#4)(2012-12#1)(2013-1#1)(2013-7#1)
ventricular disorders of the cardiac rhythm##2##6##(2011-1#2)
ventricular disorders of##3##3##(2011-1#3)
ventricular disorders##4##2##(2011-1#4)
ventricular drainage##3##2##(2006-5#2)(2008-7#1)
ventricular dysfunction and##6##3##(1990-1#1)(1994-7#1)(2005-7#1)(2008-4#1)(2008-8#1)(2012-2#1)
ventricular dysfunction following##2##3##(1992-12#1)(1994-3#1)
ventricular dysfunction in##3##3##(1994-3#1)(1994-6#1)(2008-4#1)
ventricular dysfunction is##3##3##(1993-2#1)(2010-5#1)(2013-8#1)
ventricular dysfunction##52##2##(1990-1#1)(1990-12#1)(1992-12#1)(1992-5#1)(1993-2#6)(1994-3#4)(1994-6#1)(1994-7#1)(1995-6#1)(1996-6#1)(1996-9#1)(1997-1#4)(2005-10#1)(2005-12#1)(2005-7#1)(2006-10#2)(2007-8#5)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#2)(2009-1#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-2#1)(2013-7#1)(2013-8#1)
ventricular dysplasia##12##2##(1993-8#6)(1996-3#3)(2008-12#1)(2012-2#1)(2012-3#1)
ventricular dysrhythmias and##2##3##(1992-8#1)(2008-3#1)
ventricular dysrhythmias##5##2##(1992-8#2)(2008-3#3)
ventricular early potentials##2##3##(1995-6#2)
ventricular ectopy##2##2##(1992-8#1)(1996-3#1)
ventricular ejection fraction (LVEF)##6##4##(2007-8#3)(2008-10#1)(2010-11#1)(2013-7#1)
ventricular ejection fraction and##2##4##(1993-8#1)(2007-8#1)
ventricular ejection fraction was significantly lower in the preoperative group##2##10##(1997-1#2)
ventricular ejection fraction was##7##4##(1993-8#1)(1997-1#3)(1997-5#1)(2008-12#1)(2012-2#1)
ventricular ejection fraction##40##3##(1993-8#2)(1995-3#1)(1995-6#1)(1997-1#5)(1997-4#1)(1997-5#2)(1997-8#3)(2007-11#1)(2007-8#8)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-10#4)(2010-10#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
ventricular ejection##43##2##(1993-8#2)(1995-3#1)(1995-6#1)(1997-1#5)(1997-4#1)(1997-5#2)(1997-8#3)(2007-11#1)(2007-8#9)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2009-1#1)(2009-10#4)(2010-10#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
ventricular end-diastolic##10##2##(1993-3#1)(1996-10#2)(1997-8#1)(2007-8#1)(2008-12#2)(2008-7#1)(2012-2#1)(2013-1#1)
ventricular end-systolic volume##2##3##(2007-8#1)(2012-12#1)
ventricular end-systolic##3##2##(2007-8#1)(2012-12#1)(2013-1#1)
ventricular endomyocardial fibrosis##2##3##(2007-8#1)(2009-5#1)
ventricular endomyocardial##3##2##(2007-8#2)(2009-5#1)
ventricular enlargement and##3##3##(1996-7#1)(2006-9#1)(2008-5#1)
ventricular enlargement##5##2##(1996-7#2)(2006-9#1)(2008-5#1)(2011-2#1)
ventricular extra##2##2##(2011-1#2)
ventricular extrasystoles##4##2##(1992-5#1)(1996-3#2)(2012-1#1)
ventricular failure##12##2##(1990-9#1)(1996-3#1)(2005-8#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-5#2)(2010-10#1)(2010-3#1)(2010-5#1)(2010-6#1)
ventricular fibrillation and##2##3##(2006-10#1)(2010-12#1)
ventricular fibrillation during##3##3##(1990-12#1)(1995-12#1)(2008-12#1)
ventricular fibrillation in##2##3##(1995-12#1)(2010-12#1)
ventricular fibrillation or##2##3##(2006-10#1)(2010-1#1)
ventricular fibrillation was##2##3##(1992-6#1)(1993-8#1)
ventricular fibrillation##39##2##(1990-11#1)(1990-12#4)(1992-6#1)(1993-8#3)(1995-12#3)(1995-3#1)(1996-3#2)(2004-11#1)(2005-1#3)(2006-10#4)(2006-4#1)(2006-9#3)(2008-10#1)(2008-12#1)(2008-8#1)(2009-10#1)(2010-1#2)(2010-12#5)(2010-2#1)
ventricular free wall rupture##7##4##(2007-8#5)(2011-2#1)(2012-2#1)
ventricular free wall##8##3##(2007-8#6)(2011-2#1)(2012-2#1)
ventricular function and##6##3##(2005-10#1)(2006-8#1)(2008-8#1)(2009-10#1)(2010-11#1)(2010-5#1)
ventricular function in patients with##4##5##(1997-1#1)(2007-6#1)(2008-10#1)(2009-10#1)
ventricular function in the##4##4##(2005-1#2)(2006-10#1)(2010-11#1)
ventricular function in##14##3##(1992-9#1)(1997-1#1)(2005-1#2)(2006-10#1)(2006-6#1)(2007-6#1)(2007-8#1)(2008-10#1)(2009-10#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-2#1)
ventricular function##63##2##(1990-9#2)(1991-3#1)(1992-9#1)(1993-10#1)(1993-8#2)(1994-3#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-1#3)(1997-3#1)(1997-6#2)(1997-8#1)(2005-1#2)(2005-10#1)(2006-10#5)(2006-6#1)(2006-8#1)(2006-9#1)(2007-6#1)(2007-8#6)(2007-9#5)(2008-10#1)(2008-3#1)(2008-8#1)(2009-10#2)(2009-5#1)(2010-11#2)(2010-4#2)(2010-5#1)(2010-7#2)(2011-2#2)(2012-2#2)(2013-1#2)(2013-7#1)
ventricular geometry##2##2##(1993-10#1)(2012-2#1)
ventricular hypertrophy (LVH)##5##3##(1992-4#1)(1992-8#2)(2010-12#1)(2010-8#1)
ventricular hypertrophy and##8##3##(1993-3#1)(1996-9#1)(2007-7#1)(2008-1#1)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
ventricular hypertrophy in##7##3##(1990-6#1)(1991-6#1)(1995-11#1)(1995-9#1)(2005-10#1)(2008-12#1)(2012-12#1)
ventricular hypertrophy is##3##3##(2006-2#1)(2008-7#1)(2009-1#1)
ventricular hypertrophy##53##2##(1990-5#2)(1990-6#1)(1991-6#1)(1992-4#2)(1992-8#5)(1993-12#1)(1993-3#2)(1995-11#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-9#1)(2005-10#1)(2005-9#1)(2006-2#3)(2006-6#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-1#2)(2009-12#1)(2010-12#3)(2010-8#4)(2011-1#1)(2011-2#1)(2012-12#3)(2013-1#3)(2013-8#1)
ventricular infarction##3##2##(1993-9#1)(1997-3#1)(2008-4#1)
ventricular inflow obstruction##2##3##(2008-4#1)(2012-1#1)
ventricular lead##2##2##(2007-8#1)(2011-2#1)
ventricular loading##2##2##(2006-10#1)(2008-4#1)
ventricular mass index##3##3##(1995-6#1)(2007-8#2)
ventricular mass##33##2##(1990-5#10)(1992-4#1)(1993-3#2)(1995-3#2)(1995-6#1)(1997-8#1)(2005-12#1)(2006-2#1)(2006-6#1)(2007-8#2)(2007-9#1)(2008-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#4)
ventricular membranes##4##2##(1990-2#2)(1990-3#2)
ventricular morphology##2##2##(2008-9#1)(2009-2#1)
ventricular muscle##5##2##(1991-2#1)(1993-11#1)(1994-3#1)(2008-5#1)(2008-7#1)
ventricular myocardial##5##2##(1990-11#1)(2008-12#3)(2008-8#1)
ventricular myocardium and##2##3##(2005-1#1)(2012-1#1)
ventricular myocardium##12##2##(1990-11#1)(1990-2#3)(1991-4#1)(1992-6#1)(1993-8#1)(1996-9#1)(2005-1#1)(2012-1#3)
ventricular myocytes were studied using##2##5##(1991-2#1)(1996-10#1)
ventricular myocytes were##4##3##(1991-2#1)(1994-12#1)(1994-3#1)(1996-10#1)
ventricular myocytes##24##2##(1991-2#2)(1991-9#1)(1993-3#2)(1994-12#2)(1994-3#2)(1994-6#1)(1994-8#3)(1995-5#1)(1996-10#2)(1996-2#3)(1997-4#1)(1997-5#1)(2008-8#2)(2013-1#1)
ventricular myosin##4##2##(1991-9#2)(1994-12#1)(1996-9#1)
ventricular or##4##2##(2008-3#1)(2009-6#1)(2012-3#1)(2013-8#1)
ventricular outflow tract and##2##4##(2006-9#1)(2007-9#1)
ventricular outflow tract obstruction in##3##5##(2006-4#1)(2007-8#1)(2007-9#1)
ventricular outflow tract obstruction##7##4##(2006-4#1)(2007-8#2)(2007-9#1)(2011-1#1)(2012-2#2)
ventricular outflow tract##22##3##(1992-9#1)(1997-1#1)(2006-4#1)(2006-9#2)(2007-8#4)(2007-9#2)(2008-4#2)(2011-1#3)(2012-1#1)(2012-2#2)(2013-2#1)(2013-8#2)
ventricular outflow##24##2##(1992-9#1)(1997-1#1)(2006-4#1)(2006-9#2)(2007-8#5)(2007-9#2)(2008-4#3)(2011-1#3)(2012-1#1)(2012-2#2)(2013-2#1)(2013-8#2)
ventricular pacing##10##2##(1992-5#2)(1996-12#1)(1996-9#3)(2007-8#1)(2008-2#1)(2009-11#1)(2013-1#1)
ventricular penetration##2##2##(2007-8#2)
ventricular performance##3##2##(1994-12#1)(2008-5#1)(2009-10#1)
ventricular potentials##2##2##(1996-4#1)(2008-1#1)
ventricular premature beats##2##3##(1996-3#1)(2007-9#1)
ventricular premature depolarizations##2##3##(1995-12#2)
ventricular premature##4##2##(1995-12#2)(1996-3#1)(2007-9#1)
ventricular pressure (LVP)##2##3##(1993-1#1)(2007-8#1)
ventricular pressure and##2##3##(1991-8#1)(1993-3#1)
ventricular pressure##8##2##(1990-11#1)(1991-8#1)(1993-1#1)(1993-3#1)(2007-4#1)(2007-8#3)
ventricular rate##10##2##(1990-9#1)(1991-3#2)(1992-2#1)(2007-8#1)(2010-12#2)(2010-2#2)(2012-3#1)
ventricular remodeling and##3##3##(2009-10#2)(2012-12#1)
ventricular remodeling##9##2##(2005-10#1)(2009-10#2)(2011-2#2)(2012-12#3)(2013-8#1)
ventricular remodelling##2##2##(2008-4#1)(2012-2#1)
ventricular repolarization##5##2##(1997-8#3)(2009-10#1)(2012-3#1)
ventricular restoration procedures and the##2##5##(2010-11#2)
ventricular restoration##11##2##(2007-8#4)(2010-11#5)(2010-5#1)(2011-2#1)
ventricular rupture##2##2##(1991-6#1)(2008-4#1)
ventricular septal defect (VSD)##5##4##(2006-8#1)(2007-8#3)(2012-2#1)
ventricular septal defect in the##2##5##(1992-2#1)(2012-12#1)
ventricular septal defect in##3##4##(1992-2#1)(2012-1#1)(2012-12#1)
ventricular septal defect secondary to##2##5##(2006-4#2)
ventricular septal defect##29##3##(1992-10#1)(1992-2#1)(2005-12#1)(2006-12#1)(2006-4#2)(2006-8#1)(2007-8#7)(2008-4#3)(2008-7#1)(2009-10#1)(2009-4#1)(2009-9#2)(2012-1#1)(2012-12#2)(2012-2#3)(2013-8#1)
ventricular septal defects and##2##4##(2008-4#1)(2012-12#1)
ventricular septal defects##8##3##(1993-10#1)(2007-9#1)(2008-4#2)(2010-9#2)(2012-12#1)(2013-1#1)
ventricular septal rupture##4##3##(2007-8#3)(2013-7#1)
ventricular septal##46##2##(1992-10#1)(1992-2#1)(1993-10#1)(2005-12#1)(2006-12#1)(2006-4#2)(2006-8#1)(2007-8#10)(2007-9#1)(2008-4#5)(2008-7#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-9#2)(2010-9#2)(2012-1#1)(2012-12#3)(2012-2#6)(2013-1#2)(2013-7#1)(2013-8#1)
ventricular septum##2##2##(2006-4#1)(2008-4#1)
ventricular shunts##4##2##(1996-11#1)(2005-10#2)(2010-6#1)
ventricular size##2##2##(1997-4#1)(2011-1#1)
ventricular system volume##2##3##(1996-3#2)
ventricular system##9##2##(1996-3#2)(2006-5#5)(2008-7#1)(2010-9#1)
ventricular systole##2##2##(2005-9#1)(2007-8#1)
ventricular systolic and##2##3##(2007-9#1)(2012-2#1)
ventricular systolic function##15##3##(1997-1#1)(1997-8#2)(2006-6#1)(2007-8#2)(2008-11#1)(2008-4#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
ventricular systolic pressure##2##3##(2007-8#1)(2012-2#1)
ventricular systolic##26##2##(1997-1#1)(1997-3#1)(1997-8#2)(2006-6#1)(2007-10#1)(2007-8#3)(2007-9#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-4#1)(2009-9#1)(2010-11#2)(2010-6#1)(2011-2#1)(2012-2#3)(2013-1#2)(2013-8#1)
ventricular tachyarrhythmia##6##2##(1992-6#1)(2005-1#2)(2006-9#1)(2008-3#1)(2010-7#1)
ventricular tachyarrhythmias in##3##3##(2006-9#2)(2012-2#1)
ventricular tachyarrhythmias##7##2##(1993-2#1)(2006-9#5)(2012-2#1)
ventricular tachycardia and fibrillation##3##4##(1995-12#3)
ventricular tachycardia and ventricular fibrillation##2##5##(1995-12#1)(1996-3#1)
ventricular tachycardia and##10##3##(1995-12#4)(1996-3#1)(2004-11#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-4#1)
ventricular tachycardia in##4##3##(1993-12#1)(1996-4#1)(2005-1#1)(2008-4#1)
ventricular tachycardia induction##2##3##(1990-3#2)
ventricular tachycardia of left bundle branch block type##2##8##(1993-8#2)
ventricular tachycardia of torsade de pointes type##2##7##(2008-7#2)
ventricular tachycardia of##4##3##(1993-8#2)(2008-7#2)
ventricular tachycardia was##4##3##(1990-3#1)(1993-8#1)(1995-12#1)(2007-8#1)
ventricular tachycardia were##2##3##(1997-1#1)(2006-10#1)
ventricular tachycardia##62##2##(1990-3#6)(1991-2#1)(1993-12#2)(1993-7#1)(1993-8#4)(1994-11#1)(1995-12#5)(1995-6#2)(1996-3#1)(1996-4#1)(1997-1#2)(2004-11#1)(2005-1#2)(2006-10#2)(2006-4#3)(2006-9#5)(2007-8#3)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#3)(2008-7#2)(2008-8#1)(2009-10#2)(2009-2#1)(2009-4#1)(2009-5#1)(2011-2#1)(2013-1#1)(2013-8#2)
ventricular tachycardia)##2##2##(1995-12#1)(2007-9#1)
ventricular tissue##3##2##(1991-8#1)(1996-9#1)(2008-8#1)
ventricular tumors##4##2##(1993-12#1)(2006-5#1)(2006-8#2)
ventricular tunnel##5##2##(2005-12#2)(2008-11#2)(2009-8#1)
ventricular volume and##2##3##(2005-12#1)(2011-2#1)
ventricular volume##14##2##(1996-3#3)(2005-12#1)(2005-9#1)(2008-10#1)(2008-4#1)(2011-2#7)
ventricular volumes##2##2##(1994-3#1)(1995-5#1)
ventricular wall motion##8##3##(1997-1#3)(1997-3#2)(1997-6#1)(1997-8#2)
ventricular wall stress##2##3##(2008-7#1)(2009-1#1)
ventricular wall thickness##2##3##(1993-12#1)(2012-2#1)
ventricular wall##18##2##(1991-12#1)(1993-12#2)(1997-1#3)(1997-3#2)(1997-5#1)(1997-6#1)(1997-8#2)(2007-9#1)(2008-1#1)(2008-7#1)(2009-1#1)(2010-7#1)(2012-2#1)
ventricular weight##3##2##(1993-3#2)(2005-9#1)
ventricular zone##4##2##(1996-2#1)(1996-4#1)(1996-5#1)(2008-11#1)
ventricular##1123##1##(1990-1#2)(1990-11#8)(1990-12#5)(1990-2#6)(1990-3#11)(1990-5#12)(1990-6#2)(1990-9#4)(1991-10#1)(1991-12#2)(1991-2#5)(1991-3#3)(1991-4#2)(1991-5#1)(1991-6#4)(1991-7#1)(1991-8#4)(1991-9#8)(1992-10#1)(1992-12#2)(1992-2#4)(1992-4#5)(1992-5#6)(1992-6#4)(1992-8#9)(1992-9#3)(1993-1#4)(1993-10#11)(1993-11#1)(1993-12#14)(1993-2#7)(1993-3#12)(1993-7#1)(1993-8#23)(1993-9#1)(1994-11#2)(1994-12#8)(1994-3#11)(1994-6#2)(1994-7#1)(1994-8#4)(1995-11#2)(1995-12#14)(1995-3#9)(1995-4#1)(1995-5#2)(1995-6#18)(1995-8#2)(1995-9#1)(1996-10#4)(1996-11#2)(1996-12#4)(1996-2#4)(1996-3#19)(1996-4#9)(1996-5#2)(1996-6#2)(1996-7#4)(1996-8#1)(1996-9#9)(1997-1#20)(1997-3#7)(1997-4#4)(1997-5#4)(1997-6#5)(1997-8#20)(2004-11#2)(2005-1#14)(2005-10#8)(2005-12#8)(2005-7#3)(2005-8#1)(2005-9#5)(2006-10#18)(2006-12#1)(2006-2#8)(2006-4#10)(2006-5#9)(2006-6#5)(2006-7#1)(2006-8#7)(2006-9#28)(2007-10#2)(2007-11#1)(2007-2#3)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#107)(2007-9#20)(2008-1#4)(2008-10#15)(2008-11#19)(2008-12#21)(2008-2#2)(2008-3#10)(2008-4#28)(2008-5#11)(2008-6#2)(2008-7#23)(2008-8#18)(2008-9#1)(2009-1#6)(2009-10#30)(2009-11#1)(2009-12#2)(2009-2#3)(2009-4#6)(2009-5#5)(2009-6#3)(2009-8#2)(2009-9#3)(2010-1#2)(2010-10#3)(2010-11#15)(2010-12#18)(2010-2#4)(2010-3#2)(2010-4#3)(2010-5#7)(2010-6#9)(2010-7#6)(2010-8#8)(2010-9#4)(2011-1#16)(2011-2#38)(2012-1#13)(2012-12#17)(2012-2#35)(2012-3#17)(2013-1#18)(2013-2#1)(2013-7#10)(2013-8#11)
ventriculi and##2##2##(1992-5#1)(2008-5#1)
ventriculi##3##1##(1992-5#1)(2008-5#2)
ventriculitis##4##1##(2006-5#1)(2008-3#1)(2010-9#2)
ventriculo-peritoneal##4##1##(2007-2#1)(2008-7#2)(2012-12#1)
ventriculo-pulmonary shunt##3##2##(2007-8#3)
ventriculography in##2##2##(1991-11#1)(2011-2#1)
ventriculography##6##1##(1991-11#1)(1991-2#2)(1996-4#1)(1997-1#1)(2011-2#1)
ventriculomegaly##7##1##(1997-3#2)(2006-8#3)(2012-3#1)(2013-8#1)
ventriculoperitoneal shunt was##2##3##(2006-12#1)(2011-2#1)
ventriculoperitoneal shunt##9##2##(2006-12#1)(2006-6#1)(2008-5#1)(2010-11#1)(2011-2#1)(2012-12#3)(2012-2#1)
ventriculoperitoneal shunting##2##2##(2006-12#1)(2011-2#1)
ventriculoperitoneal##13##1##(2006-12#2)(2006-6#1)(2008-5#2)(2010-11#1)(2011-2#2)(2012-12#4)(2012-2#1)
ventriculostomy in##4##2##(2006-5#2)(2006-8#1)(2007-10#1)
ventriculostomy or##2##2##(2006-5#1)(2006-8#1)
ventriculostomy##30##1##(2006-11#1)(2006-5#19)(2006-8#3)(2007-10#5)(2008-2#1)(2011-2#1)
ventro-lateral##6##1##(1992-8#2)(1995-6#1)(2008-5#2)(2008-9#1)
ventrobasal thalamus##4##2##(1997-1#3)(1997-3#1)
ventrobasal##10##1##(1992-8#1)(1994-2#2)(1995-6#1)(1996-12#1)(1997-1#3)(1997-3#1)(2008-1#1)
ventrolateral medulla of the##2##4##(1991-6#1)(1997-8#1)
ventrolateral medulla##14##2##(1991-5#1)(1991-6#2)(1993-12#1)(1994-2#1)(1996-5#1)(1997-2#2)(1997-6#2)(1997-8#2)(2007-10#2)
ventrolateral orbital cortex##3##3##(1994-3#2)(1995-5#1)
ventrolateral pons##2##2##(1993-3#2)
ventrolateral prefrontal cortex##2##3##(2008-12#1)(2012-2#1)
ventrolateral thalamus in##2##3##(2006-3#1)(2010-10#1)
ventrolateral thalamus##3##2##(1992-11#1)(2006-3#1)(2010-10#1)
ventrolateral##50##1##(1990-7#1)(1991-11#1)(1991-5#2)(1991-6#2)(1992-11#1)(1993-12#2)(1993-3#2)(1993-7#1)(1993-9#2)(1994-2#3)(1994-3#2)(1995-5#3)(1995-6#1)(1996-1#1)(1996-11#1)(1996-4#2)(1996-5#1)(1996-6#2)(1997-2#2)(1997-6#4)(1997-8#2)(2006-3#1)(2006-8#1)(2007-10#2)(2007-12#3)(2008-12#1)(2010-10#3)(2012-2#1)
ventrolaterally on the second and third abdominal##2##7##(2007-12#2)
ventrolaterally##4##1##(2006-12#2)(2007-12#2)
ventromedial TE##2##2##(1996-9#2)
ventromedial and##5##2##(1990-7#2)(1991-2#1)(1991-5#1)(1994-2#1)
ventromedial hypothalamic stimulation##3##3##(1994-6#3)
ventromedial hypothalamic##7##2##(1994-6#4)(1995-11#1)(1995-5#1)(1996-9#1)
ventromedial hypothalamus (VMH)##4##3##(1991-6#1)(1993-2#1)(1993-9#1)(1995-10#1)
ventromedial hypothalamus##9##2##(1991-6#1)(1991-8#1)(1993-2#1)(1993-9#1)(1994-6#2)(1995-10#1)(1997-5#2)
ventromedial medulla##3##2##(1993-2#2)(1993-7#1)
ventromedial nuclei of the hypothalamus##2##5##(1993-12#1)(1995-1#1)
ventromedial nucleus##7##2##(1990-4#1)(1993-7#1)(1994-2#2)(1996-1#1)(2008-4#1)(2008-9#1)
ventromedial prefrontal cortex and##2##4##(2008-11#2)
ventromedial prefrontal cortex##7##3##(2008-11#6)(2013-1#1)
ventromedial prefrontal##8##2##(2008-11#6)(2008-12#1)(2013-1#1)
ventromedial thalamic##2##2##(1996-1#1)(1997-7#1)
ventromedial##51##1##(1990-4#1)(1990-7#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#2)(1993-12#1)(1993-2#3)(1993-7#2)(1993-9#1)(1994-2#4)(1994-6#6)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-5#1)(1996-1#2)(1996-9#4)(1997-5#2)(1997-7#1)(2008-11#6)(2008-12#1)(2008-4#2)(2008-9#1)(2013-1#1)
ventromedialis##2##1##(1990-4#1)(2008-6#1)
ventroposterolateral##2##1##(1992-2#2)
vents and##2##2##(2007-2#1)(2011-2#1)
vents##4##1##(1990-4#1)(2007-2#1)(2008-7#1)(2011-2#1)
venture capital##2##2##(2007-4#1)(2008-11#1)
venture in##2##2##(1995-2#1)(2008-5#1)
venture into##4##2##(1993-12#1)(2007-5#1)(2009-2#1)(2013-7#1)
venture of##2##2##(2008-3#1)(2008-5#1)
venture with##2##2##(1991-2#1)(2005-8#1)
venture##35##1##(1990-4#1)(1991-12#1)(1991-2#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-5#1)(1994-1#1)(1994-3#4)(1995-2#1)(1995-7#1)(2005-8#2)(2006-5#1)(2007-1#2)(2007-4#2)(2007-5#1)(2008-11#3)(2008-3#1)(2008-5#3)(2008-9#1)(2009-2#2)(2010-2#1)(2013-7#1)
ventures##19##1##(1991-1#1)(1991-2#1)(1991-9#1)(1992-3#1)(1993-1#2)(1993-12#1)(2007-1#1)(2007-4#2)(2008-11#8)(2010-9#1)
venturing into the##2##3##(2006-5#1)(2008-9#1)
venturing into##3##2##(2006-5#1)(2007-7#1)(2008-9#1)
venturing##5##1##(1993-1#1)(1995-10#1)(2006-5#1)(2007-7#1)(2008-9#1)
venue##8##1##(2005-8#1)(2006-10#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-7#1)(2012-2#1)(2013-8#1)
venues in##5##2##(2007-9#1)(2008-1#1)(2008-12#1)(2009-5#1)(2010-9#1)
venues##8##1##(2006-10#1)(2007-9#2)(2008-1#1)(2008-12#1)(2009-5#1)(2010-5#1)(2010-9#1)
venular resistance##4##2##(2008-3#4)
venular##9##1##(1993-11#2)(1995-12#1)(2008-3#6)
venules and##2##2##(1997-1#1)(2008-7#1)
venules##17##1##(1991-5#1)(1993-11#4)(1993-12#1)(1995-12#1)(1997-1#2)(1997-7#2)(2007-12#1)(2008-7#1)(2009-2#1)(2009-4#1)(2011-2#1)(2012-3#1)
venus##3##1##(1990-8#1)(1991-5#1)(1993-7#1)
vera##19##1##(1993-9#1)(1994-8#1)(1996-3#1)(2005-11#1)(2007-7#1)(2007-9#1)(2009-7#1)(2010-12#1)(2010-4#4)(2012-2#7)
veracity##3##1##(1997-1#1)(2010-3#1)(2012-3#1)
veraison##2##1##(2008-10#1)(2012-11#1)
verapamil and Schering 28080##2##4##(1997-1#2)
verapamil and diltiazem##4##3##(1990-7#1)(1993-3#2)(1993-4#1)
verapamil and nifedipine##5##3##(1990-8#1)(1995-1#4)
verapamil and##16##2##(1990-7#1)(1990-8#1)(1993-3#2)(1993-4#1)(1994-8#1)(1995-1#4)(1995-11#1)(1996-11#1)(1996-3#1)(1997-1#2)(2011-3#1)
verapamil in##5##2##(1990-6#1)(1991-8#2)(1993-10#1)(1993-7#1)
verapamil##86##1##(1990-10#2)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#3)(1991-9#2)(1992-1#1)(1992-11#2)(1992-8#1)(1993-10#1)(1993-3#9)(1993-4#1)(1993-7#4)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#4)(1995-11#4)(1995-3#1)(1996-1#4)(1996-11#2)(1996-3#1)(1996-5#2)(1997-1#2)(1997-5#2)(2005-12#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-5#1)(2011-2#2)(2011-3#1)(2012-2#1)
veratridine##12##1##(1992-3#2)(1992-7#1)(1992-8#1)(1994-3#2)(1995-11#1)(1995-12#3)(1996-1#2)
veratridine-induced##4##1##(1995-11#1)(1995-12#1)(1996-1#2)
veratrine##2##1##(1996-9#2)
veratrine-induced##2##1##(1993-9#1)(1996-9#1)
veratryl alcohol and##2##3##(1993-3#1)(2005-12#1)
veratryl alcohol##4##2##(1993-3#2)(2005-12#2)
verb inflection##2##2##(2012-1#2)
verb naming##2##2##(2010-2#2)
verb phrase ellipsis##2##3##(2007-8#2)
verb phrase##5##2##(2007-8#5)
verb production##4##2##(2010-2#2)(2012-11#2)
verb type##2##2##(2012-11#2)
verb##32##1##(1991-2#1)(2007-8#6)(2008-11#2)(2008-4#4)(2010-2#5)(2012-1#6)(2012-11#6)(2013-1#2)
verbal ability##2##2##(2009-1#1)(2012-11#1)
verbal abuse##2##2##(2007-3#1)(2013-1#1)
verbal aggression##4##2##(2008-2#4)
verbal and non-verbal communication##2##4##(2006-8#1)(2007-11#1)
verbal and non-verbal##7##3##(1990-3#1)(1997-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2009-2#1)(2009-4#1)
verbal and nonverbal##4##3##(2004-12#1)(2008-11#2)(2009-4#1)
verbal and physical##3##3##(2009-7#1)(2011-2#1)(2012-11#1)
verbal and visual##2##3##(2007-6#1)(2009-6#1)
verbal and##23##2##(1990-3#1)(1992-8#1)(1997-6#1)(2004-12#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-6#1)(2007-9#1)(2008-11#2)(2009-2#2)(2009-4#3)(2009-6#1)(2009-7#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
verbal communication##5##2##(2004-9#1)(2008-2#1)(2011-2#2)(2012-12#1)
verbal description ability##2##3##(2008-7#2)
verbal episodic memory##2##3##(1993-11#1)(2012-11#1)
verbal fluency and##2##3##(2007-9#1)(2008-9#1)
verbal fluency tests##2##3##(2013-8#2)
verbal fluency##9##2##(2007-9#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#2)(2013-8#2)
verbal intelligence and##2##3##(2008-11#1)(2012-1#1)
verbal interaction##3##2##(2007-10#3)
verbal language##2##2##(2008-9#1)(2009-4#1)
verbal learning##5##2##(1997-8#3)(2006-4#1)(2012-12#1)
verbal memory in##3##3##(1995-11#1)(2006-4#1)(2008-4#1)
verbal memory##10##2##(1995-11#2)(1996-3#1)(2006-4#2)(2007-8#1)(2008-4#1)(2008-9#1)(2010-7#1)(2011-1#1)
verbal numerical##2##2##(1993-4#2)
verbal or non-verbal##2##3##(1990-11#1)(2008-7#1)
verbal or##3##2##(1990-11#1)(2004-3#1)(2008-7#1)
verbal rating scale##2##3##(1996-12#1)(2013-8#1)
verbal rating##3##2##(1996-12#2)(2013-8#1)
verbal recall##2##2##(1997-8#1)(2008-9#1)
verbal self-monitoring mechanisms##2##3##(2008-9#2)
verbal short-term memory##3##3##(1995-11#1)(2008-4#2)
verbal short-term##4##2##(1995-11#1)(2008-4#3)
verbal span##3##2##(2007-8#3)
verbal translations##2##2##(2011-1#2)
verbal versus##2##2##(2007-8#1)(2010-7#1)
verbal working memory##6##3##(1995-12#2)(2008-11#1)(2009-9#1)(2012-3#2)
verbal##175##1##(1990-11#2)(1990-3#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-4#2)(1995-11#5)(1995-12#4)(1995-8#1)(1996-12#2)(1996-2#3)(1996-3#1)(1997-5#1)(1997-6#1)(1997-8#4)(2004-10#1)(2004-12#1)(2004-3#1)(2004-9#1)(2005-10#3)(2006-3#2)(2006-4#4)(2006-7#3)(2006-8#1)(2007-10#3)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-6#3)(2007-8#6)(2007-9#4)(2008-10#5)(2008-11#5)(2008-2#5)(2008-4#5)(2008-7#6)(2008-8#3)(2008-9#10)(2009-1#3)(2009-11#2)(2009-2#2)(2009-4#4)(2009-6#1)(2009-7#1)(2009-9#2)(2010-2#1)(2010-7#5)(2011-1#8)(2011-2#6)(2012-1#1)(2012-11#3)(2012-12#8)(2012-2#1)(2012-3#5)(2013-1#6)(2013-7#3)(2013-8#5)
verbalization##2##1##(2008-4#2)
verbally or##2##2##(2007-11#1)(2008-8#1)
verbally##5##1##(2007-11#1)(2008-8#1)(2009-4#1)(2011-1#1)(2012-12#1)
verbascoside##6##1##(2007-1#1)(2008-8#5)
verbatim##14##1##(2006-2#1)(2007-11#1)(2008-1#1)(2008-11#3)(2009-3#1)(2009-7#1)(2010-7#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
verbenone##3##1##(2011-2#3)
verbs and##3##2##(1996-2#1)(2008-11#1)(2008-4#1)
verbs compared to##2##3##(2008-11#1)(2012-11#1)
verbs in##3##2##(1991-2#2)(2008-11#1)
verbs were##2##2##(2010-2#1)(2012-11#1)
verbs with greater##3##3##(2010-2#2)(2012-11#1)
verbs##24##1##(1991-2#2)(1996-2#1)(2008-11#3)(2008-4#2)(2010-2#6)(2012-1#1)(2012-11#5)(2013-1#4)
verbs)##2##1##(2007-7#1)(2008-10#1)
verdict of##2##2##(1990-6#1)(1993-7#1)
verdict on the##2##3##(2009-2#1)(2012-11#1)
verdict on##3##2##(1997-3#1)(2009-2#1)(2012-11#1)
verdict##13##1##(1990-6#1)(1993-7#2)(1995-12#2)(1997-3#1)(1997-5#2)(2007-3#1)(2007-9#1)(2009-2#1)(2012-11#1)(2012-2#1)
verdicts##2##1##(2007-4#1)(2011-1#1)
veredas&quot##2##1##(2008-6#2)
verge##7##1##(1992-10#1)(1997-6#1)(2007-9#1)(2008-11#1)(2008-4#1)(2012-12#2)
veridical##3##1##(1992-10#1)(2008-11#2)
verifiable##7##1##(1994-6#2)(2006-12#1)(2008-3#1)(2012-12#1)(2013-1#2)
verification and theory##2##3##(2008-2#2)
verification and##6##2##(2008-2#4)(2008-7#1)(2009-2#1)
verification are##2##2##(2008-2#1)(2008-3#1)
verification for the##2##3##(1995-3#1)(2010-9#1)
verification for##3##2##(1995-3#1)(2010-9#1)(2012-3#1)
verification in##3##2##(2005-8#1)(2006-9#1)(2009-4#1)
verification of a##4##3##(2007-11#2)(2012-1#2)
verification of an##2##3##(2008-2#2)
verification of our##2##3##(2008-2#2)
verification of the model##2##4##(1996-12#1)(2008-3#1)
verification of the##21##3##(1996-12#1)(2005-4#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-9#3)(2009-2#1)(2010-9#1)(2011-2#1)
verification of this##3##3##(2008-2#2)(2008-8#1)
verification of##62##2##(1993-12#1)(1996-12#1)(2005-10#1)(2005-4#1)(2006-3#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-7#3)(2008-10#3)(2008-11#1)(2008-2#10)(2008-3#9)(2008-4#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-2#2)(2009-7#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#2)(2013-1#3)
verification or##2##2##(2008-11#1)(2011-12#1)
verification procedure##3##2##(2010-9#3)
verification protocol##2##2##(2006-7#1)(2012-12#1)
verification set##2##2##(1995-6#1)(2008-10#1)
verification that##2##2##(2007-1#1)(2012-12#1)
verification was##2##2##(1991-2#1)(2007-9#1)
verification with##3##2##(2007-12#1)(2008-2#1)(2012-11#1)
verification##145##1##(1990-12#1)(1991-2#2)(1991-5#1)(1993-12#1)(1994-12#1)(1994-6#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#2)(1996-3#1)(1997-6#1)(2004-2#1)(2005-10#1)(2005-11#1)(2005-4#1)(2005-8#1)(2006-3#2)(2006-7#1)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#3)(2007-12#4)(2007-7#3)(2007-9#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#25)(2008-3#17)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#5)(2009-10#4)(2009-2#4)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-9#6)(2011-1#1)(2011-12#2)(2011-2#4)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#3)(2013-7#1)
verifications of##2##2##(1995-2#1)(2008-7#1)
verifications##6##1##(1995-2#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-12#2)
verified a##3##2##(1991-9#1)(2008-10#1)(2009-9#1)
verified also##2##2##(1994-7#1)(2008-10#1)
verified and##5##2##(1993-9#1)(2008-10#2)(2008-2#1)(2011-12#1)
verified as##2##2##(2008-10#1)(2008-9#1)
verified at##5##2##(1990-4#1)(2007-8#1)(2008-3#1)(2008-6#1)(2013-1#1)
verified breast##2##2##(1994-3#1)(2004-2#1)
verified by DNA sequencing##3##4##(2008-10#1)(2008-8#1)(2010-12#1)
verified by RT-PCR and##2##4##(2008-9#1)(2010-10#1)
verified by a##6##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)
verified by comparing##2##3##(1995-8#1)(2009-3#1)
verified by comparison of##2##4##(2008-3#1)(2010-12#1)
verified by comparison##3##3##(2008-2#1)(2008-3#1)(2010-12#1)
verified by direct##4##3##(1992-3#1)(2007-12#1)(2008-1#1)(2008-3#1)
verified by experiment##2##3##(2008-3#2)
verified by experimental##2##3##(1995-7#1)(2008-3#1)
verified by measurement of##2##4##(1991-8#1)(2008-3#1)
verified by the analysis of##3##5##(2008-10#3)
verified by the##18##3##(1990-5#1)(1995-3#1)(2008-10#9)(2008-2#2)(2008-3#3)(2010-12#1)(2010-4#1)
verified by transmission##2##3##(2005-11#1)(2006-2#1)
verified by use of##2##4##(2007-11#1)(2008-3#1)
verified by use##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
verified by##115##2##(1990-5#1)(1990-6#1)(1990-8#1)(1991-5#2)(1991-8#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-2#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-8#1)(1997-2#1)(2004-2#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-7#1)(2008-1#1)(2008-10#23)(2008-11#1)(2008-2#9)(2008-3#13)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2010-10#1)(2010-12#3)(2010-4#2)(2010-5#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-4#1)
verified cases##2##2##(2008-7#2)
verified experimentally for##2##3##(1997-6#1)(2008-7#1)
verified experimentally that the##2##4##(2008-2#1)(2008-3#1)
verified experimentally with a##2##4##(2007-12#1)(2008-2#1)
verified experimentally##15##2##(1997-1#1)(1997-6#1)(2007-12#3)(2008-2#5)(2008-3#4)(2008-7#1)
verified for both##2##3##(2008-3#1)(2008-4#1)
verified for##11##2##(1997-6#1)(2005-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2010-2#1)
verified histologically##2##2##(1990-12#1)(1990-8#1)
verified in a##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
verified in the##7##3##(1990-2#1)(1992-9#1)(2008-10#3)(2008-2#1)(2012-1#1)
verified in##21##2##(1990-2#1)(1992-9#1)(1993-6#1)(1994-2#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2010-6#1)(2010-9#1)(2012-1#1)(2013-8#1)
verified its##2##2##(1992-7#1)(2008-2#1)
verified on##6##2##(1992-12#1)(2006-8#1)(2008-10#2)(2008-2#1)(2010-8#1)
verified or##2##2##(2008-7#1)(2009-4#1)
verified that the##15##3##(1991-4#1)(2005-10#1)(2006-5#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-12#1)(2013-8#1)
verified that##24##2##(1991-4#1)(1994-2#1)(1996-7#1)(1997-4#1)(2005-10#2)(2006-5#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#2)(2009-12#1)(2013-1#1)(2013-8#1)
verified the diagnosis of##2##4##(1991-11#1)(1997-3#1)
verified the effectiveness of the##2##5##(2008-3#2)
verified the##21##2##(1991-11#1)(1991-8#1)(1995-8#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#7)(2009-2#2)(2009-9#1)(2013-1#1)(2013-7#1)
verified through##6##2##(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)
verified to be##5##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#1)
verified to##9##2##(1993-3#1)(2006-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
verified using##4##2##(2006-11#1)(2008-10#1)(2012-2#1)(2013-1#1)
verified with the##2##3##(2005-11#1)(2009-2#1)
verified with##12##2##(2005-11#2)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#2)(2009-2#1)(2010-4#1)(2012-3#1)
verified##342##1##(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-11#1)(1991-4#2)(1991-5#2)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#3)(1993-2#1)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#3)(1994-3#3)(1994-7#1)(1995-2#1)(1995-3#2)(1995-7#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(2004-2#2)(2004-9#1)(2005-10#3)(2005-11#4)(2005-3#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-2#2)(2006-5#2)(2006-6#1)(2006-8#1)(2007-10#3)(2007-11#10)(2007-12#15)(2007-4#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#62)(2008-11#4)(2008-12#2)(2008-2#30)(2008-3#38)(2008-4#4)(2008-5#4)(2008-6#3)(2008-7#10)(2008-8#2)(2008-9#6)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#6)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2012-4#1)(2013-1#7)(2013-7#1)(2013-8#2)
verifier##2##1##(2010-8#2)
verifies that the##2##3##(2008-2#1)(2012-2#1)
verifies that##5##2##(2004-11#1)(2007-8#1)(2008-2#1)(2008-3#1)(2012-2#1)
verifies the##4##2##(2008-3#2)(2009-8#1)(2012-2#1)
verifies##9##1##(2004-11#1)(2007-8#1)(2008-2#1)(2008-3#3)(2009-8#1)(2012-2#2)
verify experimentally##2##2##(2007-12#1)(2008-2#1)
verify if##10##2##(2006-11#1)(2007-7#1)(2008-10#3)(2008-9#1)(2010-3#1)(2011-12#1)(2012-2#1)(2012-3#1)
verify it experimentally##2##3##(2007-12#2)
verify its##8##2##(2007-7#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2013-1#1)
verify or##2##2##(2007-9#1)(2008-11#1)
verify our##8##2##(1993-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2009-2#1)(2011-2#1)
verify that the##9##3##(1997-3#1)(1997-8#1)(2006-7#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#2)(2012-12#1)
verify that this##2##3##(1992-6#1)(2008-2#1)
verify that##27##2##(1992-6#1)(1993-7#1)(1993-9#1)(1997-3#1)(1997-8#2)(2006-7#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2011-1#1)(2011-2#2)(2012-12#1)
verify the accuracy of##4##4##(2008-10#2)(2008-2#1)(2012-12#1)
verify the accuracy##5##3##(2008-10#3)(2008-2#1)(2012-12#1)
verify the applicability of the##2##5##(2006-10#1)(2008-10#1)
verify the concept of##2##4##(2006-6#1)(2007-12#1)
verify the effectiveness of the##2##5##(2006-6#1)(2008-2#1)
verify the effectiveness of##3##4##(1991-6#1)(2006-6#1)(2008-2#1)
verify the effectiveness##4##3##(1991-6#1)(2006-6#1)(2008-2#1)(2008-5#1)
verify the efficacy of##2##4##(2007-8#1)(2008-11#1)
verify the existence of##3##4##(1992-12#1)(1992-3#1)(2008-2#1)
verify the feasibility of##4##4##(2007-8#1)(2008-6#1)(2013-1#1)(2013-8#1)
verify the feasibility##5##3##(2007-8#2)(2008-6#1)(2013-1#1)(2013-8#1)
verify the influence of##3##4##(2006-8#1)(2008-7#1)(2013-7#1)
verify the method##2##3##(2007-12#1)(2008-1#1)
verify the new##2##3##(2007-8#1)(2008-3#1)
verify the numerical results##2##4##(2006-10#1)(2008-3#1)
verify the numerical##3##3##(2006-10#1)(2008-3#1)(2008-9#1)
verify the occurrence of##3##4##(1991-9#1)(2008-10#1)(2008-6#1)
verify the theoretical##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2010-5#1)
verify the usefulness of##2##4##(2008-3#2)
verify the validity of##2##4##(2008-2#1)(2008-7#1)
verify the value of##2##4##(2007-7#1)(2008-2#1)
verify the##130##2##(1990-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-9#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-6#2)(2006-8#2)(2007-11#3)(2007-12#7)(2007-2#1)(2007-7#5)(2007-8#5)(2008-1#2)(2008-10#15)(2008-11#2)(2008-12#1)(2008-2#12)(2008-3#13)(2008-4#1)(2008-5#1)(2008-6#6)(2008-7#6)(2008-8#2)(2008-9#2)(2009-2#1)(2009-3#1)(2009-7#1)(2010-12#3)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#4)
verify their##3##2##(2008-10#1)(2008-2#1)(2013-7#1)
verify these results##2##3##(2008-10#1)(2008-2#1)
verify these##6##2##(2005-11#1)(2007-1#1)(2008-10#2)(2008-2#1)(2010-12#1)
verify this##7##2##(2007-11#3)(2008-2#1)(2008-3#1)(2010-10#1)(2012-1#1)
verify whether the##4##3##(1997-1#1)(2005-11#1)(2007-3#1)(2010-9#1)
verify whether##7##2##(1997-1#1)(2005-11#1)(2007-3#1)(2008-10#1)(2008-11#1)(2010-9#1)(2011-2#1)
verify##249##1##(1990-5#1)(1990-6#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-7#1)(1993-9#1)(1994-3#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#3)(2005-11#3)(2005-9#1)(2006-10#3)(2006-11#1)(2006-6#2)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#8)(2007-12#14)(2007-2#1)(2007-3#1)(2007-7#8)(2007-8#6)(2007-9#2)(2008-1#3)(2008-10#29)(2008-11#4)(2008-12#2)(2008-2#22)(2008-3#20)(2008-4#4)(2008-5#5)(2008-6#8)(2008-7#8)(2008-8#3)(2008-9#5)(2009-2#2)(2009-3#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-12#4)(2010-3#2)(2010-5#3)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#3)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#3)(2013-8#4)
verifying and##2##2##(1991-8#1)(1994-6#1)
verifying its##3##2##(2008-10#1)(2008-4#1)(2008-6#1)
verifying that##7##2##(1994-2#1)(1995-1#1)(1995-8#1)(1996-12#1)(1996-5#1)(2008-3#2)
verifying the##12##2##(1991-11#1)(1992-8#1)(2005-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2013-7#1)
verifying##33##1##(1991-11#1)(1991-8#1)(1992-8#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-8#1)(1996-12#1)(1996-5#1)(2005-9#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#3)(2008-2#2)(2008-3#5)(2008-4#3)(2008-6#1)(2008-7#1)(2013-1#2)(2013-7#1)
vermal##2##1##(1994-2#1)(1995-11#1)
vermicompost##2##1##(2008-12#1)(2008-5#1)
vermicomposting process##2##2##(2008-12#2)
vermicomposting##4##1##(2008-12#4)
vermicularis##2##1##(2011-1#1)(2012-2#1)
vermiculite##4##1##(2008-10#4)
vermiform appendix##5##2##(2008-12#3)(2010-6#2)
vermilion##4##1##(1991-11#1)(1995-8#2)(2009-9#1)
vermis##9##1##(1995-12#2)(1996-10#3)(2008-5#1)(2008-7#1)(2010-11#1)(2011-1#1)
vernakalant##2##1##(2009-10#2)
vernal keratoconjunctivitis##4##2##(2009-10#1)(2009-8#1)(2012-3#1)(2013-7#1)
vernal##6##1##(2007-11#1)(2009-10#1)(2009-8#1)(2010-12#1)(2012-3#1)(2013-7#1)
vernalization##5##1##(2009-8#2)(2012-3#2)(2013-8#1)
vernalized##3##1##(2008-10#1)(2009-8#2)
vernicifera##3##1##(1992-12#1)(2008-10#2)
vernix caseosa##2##2##(2007-2#1)(2008-5#1)
vernix is##2##2##(2008-5#2)
vernix##5##1##(2007-2#1)(2008-5#4)
vero##3##1##(2008-8#1)(2012-2#1)(2013-8#1)
verocytotoxin##2##1##(1992-12#1)(1993-10#1)
verotoxin##3##1##(1990-3#1)(2008-11#2)
verotoxin-producing Escherichia##2##2##(1990-3#1)(2007-12#1)
verrucae seborrhoicae##2##2##(2011-2#2)
verrucae vulgares##2##2##(2011-2#2)
verrucae##4##1##(2011-2#4)
verrucosa##5##1##(2007-8#1)(2008-5#1)(2010-3#1)(2010-6#2)
verrucous carcinoma##4##2##(1991-9#2)(2009-10#1)(2013-8#1)
verrucous hemangioma##2##2##(2010-6#2)
verrucous leukoplakia##2##2##(1991-5#1)(2012-11#1)
verrucous##21##1##(1991-5#1)(1991-9#2)(2005-11#1)(2007-11#2)(2007-7#4)(2009-10#1)(2010-6#6)(2010-7#1)(2012-11#1)(2012-3#1)(2013-8#1)
vers##4##1##(2009-10#1)(2009-4#1)(2012-2#1)(2013-1#1)
versa##56##1##(1990-5#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-2#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-1#1)(1996-1#2)(1996-5#2)(1997-1#1)(1997-3#1)(2005-11#3)(2006-1#1)(2007-1#2)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#7)(2008-2#1)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#1)(2009-11#1)(2009-7#1)(2009-8#1)(2009-9#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#2)
versant of##2##2##(2007-3#1)(2013-7#1)
versatile and##17##2##(1994-2#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-12#1)(2012-2#2)
versatile approach to##2##3##(2005-8#1)(2010-12#1)
versatile approach##4##2##(2005-8#1)(2008-7#1)(2010-12#1)(2010-4#1)
versatile building blocks##2##3##(1996-5#1)(2007-11#1)
versatile building##3##2##(1996-5#1)(2007-11#2)
versatile derivatization##2##2##(2008-10#2)
versatile drug##2##2##(2010-2#1)(2013-8#1)
versatile in##3##2##(1991-7#1)(2008-10#1)(2009-3#1)
versatile method that##2##3##(2007-11#1)(2008-4#1)
versatile method##4##2##(2007-11#1)(2008-10#1)(2008-4#1)(2010-1#1)
versatile methods for##2##3##(2007-12#1)(2008-2#1)
versatile methods##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
versatile scaffold##2##2##(1997-3#1)(2007-10#1)
versatile system##2##2##(1990-3#1)(2012-1#1)
versatile technique##2##2##(2008-8#1)(2009-9#1)
versatile tools##3##2##(2006-12#1)(2008-7#1)(2010-4#1)
versatile##163##1##(1990-12#1)(1990-3#1)(1991-5#1)(1991-7#1)(1992-3#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-7#1)(1996-5#2)(1997-2#3)(1997-3#2)(2004-2#2)(2005-8#1)(2006-12#2)(2006-4#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#6)(2007-8#2)(2008-1#1)(2008-10#28)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#14)(2008-4#6)(2008-7#9)(2008-8#3)(2008-9#2)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#1)(2010-2#4)(2010-4#6)(2011-1#4)(2011-12#2)(2011-2#1)(2012-1#1)(2012-11#4)(2012-2#6)(2012-3#3)(2013-1#2)(2013-8#2)
versatility and reliability##2##3##(2007-12#1)(2009-10#1)
versatility and##11##2##(2007-12#1)(2008-10#2)(2008-2#1)(2009-10#3)(2009-11#2)(2010-6#1)(2013-1#1)
versatility in##2##2##(2008-4#1)(2011-2#1)
versatility is##3##2##(2008-3#1)(2008-5#1)(2008-7#1)
versatility of sol-gel##2##3##(2008-10#1)(2010-7#1)
versatility of the##15##3##(1996-5#1)(2007-5#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#2)(2009-10#1)(2012-1#1)(2012-6#1)
versatility of these##2##3##(2008-2#1)(2008-7#1)
versatility of this##2##3##(2007-12#2)
versatility of##32##2##(1996-5#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#14)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#2)(2009-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2012-1#1)(2012-6#1)
versatility##69##1##(1990-9#1)(1996-2#1)(1996-5#1)(2004-9#1)(2006-6#1)(2006-9#1)(2007-12#3)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#17)(2008-11#2)(2008-2#4)(2008-3#5)(2008-4#5)(2008-5#1)(2008-7#4)(2009-10#4)(2009-11#2)(2009-12#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#2)(2011-2#3)(2012-1#1)(2012-2#1)(2012-6#1)(2013-1#1)
verses##3##1##(1992-10#1)(2006-12#1)(2007-12#1)
versican and##2##2##(2008-9#1)(2012-1#1)
versican gene locus##2##3##(1990-9#2)
versican gene##5##2##(1990-9#4)(1994-12#1)
versican proteoglycan##3##2##(1990-9#1)(2008-11#2)
versican##25##1##(1990-9#7)(1991-10#1)(1994-12#9)(2008-11#4)(2008-9#1)(2012-1#3)
versicolor 550##2##2##(1994-3#2)
versicolor and##5##2##(1990-4#1)(1991-8#1)(2008-5#2)(2011-2#1)
versicolor in##2##2##(1996-11#1)(2008-9#1)
versicolor is##2##2##(2007-7#1)(2008-5#1)
versicolor##49##1##(1990-4#1)(1991-8#3)(1994-3#2)(1996-11#3)(1997-7#5)(2007-7#10)(2007-8#3)(2008-11#3)(2008-5#8)(2008-6#2)(2008-9#2)(2009-3#1)(2009-9#1)(2011-2#5)
versicolor)##4##1##(2008-7#1)(2009-9#2)(2011-2#1)
version 1##3##2##(2008-10#1)(2008-11#1)(2011-12#1)
version 11##3##2##(2009-7#2)(2013-1#1)
version 15##2##2##(2011-1#1)(2013-8#1)
version 16##3##2##(2011-2#1)(2013-1#1)(2013-8#1)
version 2##6##2##(2005-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#2)
version 3##2##2##(2008-4#1)(2012-12#1)
version according to the##2##4##(2010-9#1)(2013-1#1)
version and##2##2##(2007-8#1)(2008-8#1)
version for##4##2##(2007-5#1)(2008-9#1)(2011-1#2)
version guarantees##2##2##(1995-6#2)
version has##2##2##(1995-6#1)(2012-1#1)
version is##8##2##(1994-3#1)(2005-7#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-9#1)(2010-2#1)
version of a##10##3##(1993-3#1)(2006-7#1)(2007-7#1)(2007-9#2)(2008-12#1)(2008-2#1)(2008-3#1)(2011-1#1)(2013-7#1)
version of it##3##3##(1995-2#1)(2009-4#1)(2012-1#1)
version of the Copenhagen Psychosocial Questionnaire##3##6##(2011-1#3)
version of the Functional##2##4##(2007-7#1)(2011-2#1)
version of the Hydrolight computer program##2##6##(2008-3#2)
version of the Hydrolight##3##4##(2008-3#3)
version of the Job Content Questionnaire##2##6##(2008-10#1)(2012-1#1)
version of the Morris water maze##5##6##(1993-12#4)(1995-12#1)
version of the Morris water##6##5##(1993-12#5)(1995-12#1)
version of the PBCM##2##4##(2006-5#2)
version of the Stroop##3##4##(1995-1#1)(1997-2#1)(2007-1#1)
version of the WorldSID dummy##2##5##(2007-4#2)
version of the algorithm##2##4##(2008-2#2)
version of the experiment##2##4##(2008-4#2)
version of the instrument was##2##5##(2008-11#1)(2011-1#1)
version of the model##5##4##(1997-8#1)(2007-10#1)(2008-10#1)(2008-8#1)(2009-4#1)
version of the modified##2##4##(1995-4#1)(1996-7#1)
version of the ontology##2##4##(2008-7#2)
version of the original##4##4##(2007-9#1)(2008-1#1)(2008-2#1)(2008-6#1)
version of the protocol##2##4##(1997-2#1)(2008-4#1)
version of the questionnaire##2##4##(2012-1#1)(2013-1#1)
version of the standard##2##4##(1997-3#1)(2008-2#1)
version of the task##3##4##(1995-1#1)(2008-4#1)(2011-2#1)
version of the test##2##4##(1997-3#1)(2006-11#1)
version of the##171##3##(1991-9#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-12#5)(1993-3#1)(1993-8#1)(1993-9#1)(1994-2#2)(1994-3#1)(1994-5#2)(1995-1#2)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-7#2)(1997-2#2)(1997-3#3)(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#5)(2006-11#1)(2006-3#1)(2006-5#3)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-3#2)(2007-4#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#16)(2008-3#11)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-9#2)(2011-1#10)(2011-2#7)(2012-1#5)(2012-11#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
version of this task##2##4##(1994-3#1)(2009-10#1)
version of this##37##3##(1994-3#1)(1996-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-1#2)(2010-12#6)(2011-1#3)(2011-2#2)(2012-1#3)(2012-11#2)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#1)
version of##272##2##(1991-1#1)(1991-12#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-12#6)(1993-3#2)(1993-8#1)(1993-9#1)(1994-2#3)(1994-3#2)(1994-5#2)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-4#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-7#3)(1996-8#1)(1997-2#3)(1997-3#3)(1997-7#1)(1997-8#1)(2004-10#1)(2005-10#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#3)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#2)(2007-3#2)(2007-4#3)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#3)(2008-1#5)(2008-10#13)(2008-11#3)(2008-12#2)(2008-2#22)(2008-3#14)(2008-4#10)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#5)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#4)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#3)(2010-12#7)(2010-2#1)(2010-3#1)(2010-4#1)(2010-9#2)(2011-1#14)(2011-2#10)(2012-1#9)(2012-11#5)(2012-12#5)(2012-2#9)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#4)
version was##4##2##(2007-12#1)(2009-10#1)(2012-1#2)
version with##4##2##(2006-3#1)(2008-10#2)(2008-2#1)
version##389##1##(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-12#6)(1993-3#2)(1993-8#1)(1993-9#1)(1994-2#4)(1994-3#4)(1994-5#2)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-4#1)(1995-5#1)(1995-6#4)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-7#3)(1996-8#1)(1997-2#3)(1997-3#3)(1997-7#2)(1997-8#1)(2004-10#1)(2005-10#1)(2005-6#1)(2005-7#4)(2006-10#8)(2006-11#1)(2006-12#1)(2006-3#2)(2006-5#3)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#3)(2007-3#2)(2007-4#5)(2007-5#3)(2007-7#2)(2007-8#4)(2007-9#3)(2008-1#7)(2008-10#19)(2008-11#6)(2008-12#2)(2008-2#30)(2008-3#16)(2008-4#13)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#8)(2008-9#14)(2009-10#5)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#5)(2009-6#1)(2009-7#3)(2009-8#1)(2010-1#5)(2010-12#7)(2010-2#2)(2010-3#2)(2010-4#1)(2010-9#3)(2011-1#20)(2011-12#1)(2011-2#16)(2012-1#13)(2012-11#5)(2012-12#11)(2012-2#11)(2012-3#4)(2013-1#14)(2013-7#2)(2013-8#10)
version)##6##1##(2006-4#1)(2010-5#1)(2011-1#2)(2012-11#1)(2013-7#1)
versions and##3##2##(1996-9#1)(2007-5#1)(2008-5#1)
versions are##2##2##(1997-8#1)(2008-4#1)
versions in##2##2##(2007-4#1)(2008-3#1)
versions of a scene perturbed##2##5##(2008-3#2)
versions of a##5##3##(2007-8#1)(2008-3#2)(2008-6#1)(2010-1#1)
versions of the device##2##4##(2006-6#1)(2012-1#1)
versions of the task##2##4##(1995-12#1)(2012-1#1)
versions of the##40##3##(1991-11#1)(1991-9#1)(1992-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-8#1)(1997-8#1)(2006-11#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-12#3)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#4)(2008-3#3)(2008-7#1)(2009-10#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-1#2)(2012-2#2)(2013-8#1)
versions of this##5##3##(1996-10#1)(1997-7#1)(2007-10#1)(2008-2#1)(2011-2#1)
versions of##81##2##(1990-11#1)(1991-10#1)(1991-11#1)(1991-9#1)(1992-2#1)(1993-5#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-10#1)(1996-4#1)(1996-7#2)(1996-8#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-11#1)(2006-6#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-4#2)(2007-8#3)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#6)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#1)
versions were##2##2##(2008-10#1)(2010-5#1)
versions##112##1##(1990-11#1)(1991-10#1)(1991-11#1)(1991-9#1)(1992-2#1)(1993-1#1)(1993-5#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-6#2)(1996-10#1)(1996-4#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-7#1)(1997-8#2)(2005-7#2)(2006-10#2)(2006-11#1)(2006-3#2)(2006-6#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-4#4)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#6)(2008-3#7)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-7#1)(2010-1#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#7)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#1)(2013-8#1)
versus &gt##3##2##(1997-5#3)
versus &quot##6##2##(1996-4#2)(2007-12#1)(2008-1#1)(2008-3#1)(2009-12#1)
versus (1##3##2##(2008-3#2)(2008-8#1)
versus 0##25##2##(1990-3#1)(1990-7#1)(1994-8#1)(1995-2#4)(1995-9#1)(1997-2#1)(2006-3#2)(2006-7#1)(2006-8#3)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-3#1)
versus 0%##2##2##(2007-8#2)
versus 1##15##2##(1990-5#1)(1992-11#1)(1993-4#1)(1994-6#1)(1997-2#1)(2006-10#2)(2007-7#3)(2007-8#3)(2011-2#1)(2013-1#1)
versus 10##7##2##(2006-7#1)(2007-8#1)(2008-3#1)(2009-4#1)(2011-1#1)(2012-3#1)(2013-1#1)
versus 11##3##2##(1997-2#1)(2007-7#1)(2008-8#1)
versus 12##5##2##(1997-2#1)(2008-10#1)(2010-7#3)
versus 13##4##2##(1997-5#2)(2007-8#1)(2008-5#1)
versus 14##5##2##(1993-6#1)(1997-5#1)(2007-7#1)(2008-10#1)(2013-1#1)
versus 149##2##2##(1997-2#1)(2008-1#1)
versus 15##4##2##(1994-12#1)(1997-2#1)(2011-1#1)(2012-12#1)
versus 16##5##2##(2008-10#2)(2008-12#1)(2008-3#1)(2013-1#1)
versus 17##3##2##(1993-9#1)(2006-8#1)(2012-12#1)
versus 18##4##2##(1995-6#1)(2008-3#1)(2008-7#1)(2011-2#1)
versus 2##8##2##(1994-12#1)(1996-8#1)(2006-10#1)(2007-7#2)(2008-1#1)(2010-11#1)(2011-2#1)
versus 20##4##2##(1993-1#1)(1994-9#1)(1997-2#1)(1997-6#1)
versus 21##7##2##(1994-6#1)(1997-2#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-9#1)(2011-2#1)
versus 22%##3##2##(1992-6#1)(2008-1#1)(2009-6#1)
versus 23##3##2##(1991-11#1)(2009-3#1)(2013-1#1)
versus 24##2##2##(2008-10#1)(2008-6#1)
versus 26##2##2##(2007-8#1)(2013-1#1)
versus 28##4##2##(1992-2#1)(1993-1#1)(2007-8#1)(2011-2#1)
versus 29##4##2##(1991-6#1)(2008-3#1)(2008-8#1)(2013-1#1)
versus 3##8##2##(1992-2#1)(1997-5#1)(2007-8#1)(2008-1#1)(2008-4#1)(2011-2#2)(2013-1#1)
versus 30##2##2##(1995-3#1)(2007-7#1)
versus 33##2##2##(1995-3#1)(2013-1#1)
versus 36##3##2##(1997-6#1)(2007-8#1)(2011-2#1)
versus 38##2##2##(1990-6#1)(2008-1#1)
versus 38%##2##2##(2008-1#1)(2008-7#1)
versus 4##5##2##(1992-11#1)(2007-8#1)(2008-6#1)(2008-7#2)
versus 44%##2##2##(2004-1#1)(2008-4#1)
versus 47##2##2##(2007-8#1)(2008-3#1)
versus 48##2##2##(2010-7#1)(2013-1#1)
versus 5##8##2##(1996-12#1)(1996-5#1)(1997-2#1)(2008-4#1)(2011-1#1)(2011-2#2)(2013-1#1)
versus 50%##2##2##(1993-7#1)(2013-1#1)
versus 51##2##2##(2007-10#1)(2011-2#1)
versus 54##2##2##(1993-5#1)(2007-8#1)
versus 57##2##2##(1997-6#1)(2013-1#1)
versus 6##6##2##(2007-7#1)(2007-8#3)(2008-12#1)(2008-3#1)
versus 6%##2##2##(2007-8#1)(2008-3#1)
versus 62% in##2##3##(1995-1#1)(2008-2#1)
versus 64##2##2##(2008-7#1)(2013-1#1)
versus 65##3##2##(2008-8#1)(2011-2#1)(2013-1#1)
versus 67##2##2##(1997-2#1)(2007-8#1)
versus 7##6##2##(1991-9#1)(1994-11#1)(1996-12#1)(2007-9#1)(2008-3#1)(2008-7#1)
versus 70##2##2##(1995-3#1)(2013-7#1)
versus 74##2##2##(2007-8#1)(2013-1#1)
versus 8##9##2##(1993-7#1)(1997-8#1)(2007-3#1)(2007-8#1)(2011-1#1)(2011-2#3)(2013-1#1)
versus 89%##2##2##(2008-10#1)(2008-3#1)
versus 9##2##2##(2007-3#1)(2013-7#1)
versus 94##2##2##(2011-2#2)
versus Ag/AgCl electrode##2##3##(2008-10#2)
versus Ag/AgCl for##2##3##(2007-8#1)(2008-10#1)
versus Ag/AgCl in##5##3##(2007-8#1)(2008-10#4)
versus Ag/AgCl to##3##3##(2007-8#1)(2008-10#2)
versus Ag/AgCl using##2##3##(2008-10#2)
versus Ag/AgCl##38##2##(2007-8#3)(2008-10#35)
versus Ag/AgCl)##7##2##(2007-12#1)(2007-8#1)(2008-10#5)
versus D2 receptors##3##3##(1997-1#3)
versus DNA##2##2##(2008-10#1)(2008-2#1)
versus E(1/2)]##2##2##(2009-11#2)
versus G-CSF##2##2##(2008-7#2)
versus Low Dose##2##3##(1994-7#1)(2012-3#1)
versus SCE in##2##3##(2008-10#2)
versus SCE##10##2##(2007-8#1)(2008-10#9)
versus SIMVA##2##2##(2008-3#2)
versus a control group##2##4##(2008-7#1)(2012-12#1)
versus a reference##2##3##(2008-10#1)(2008-12#1)
versus a##26##2##(1991-11#1)(1991-8#1)(1992-7#1)(2006-10#3)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-7#2)(2008-8#1)(2009-12#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
versus acute##3##2##(2008-10#2)(2012-12#1)
versus all other##2##3##(1992-8#1)(2008-10#1)
versus alpha##2##2##(1993-4#1)(2005-11#1)
versus an##6##2##(2005-8#1)(2006-11#1)(2006-3#1)(2008-10#1)(2008-3#1)(2013-1#1)
versus analgesic##2##2##(1994-2#1)(2006-10#1)
versus asexual##3##2##(2008-10#1)(2009-5#1)(2010-12#1)
versus bare-metal stents##3##3##(2009-12#1)(2009-5#2)
versus biatrial approaches##2##3##(2007-8#2)
versus bifocal glasses on somatic##2##5##(2007-4#2)
versus bilateral##2##2##(2006-10#1)(2008-9#1)
versus both##2##2##(1990-11#1)(1996-8#1)
versus capecitabine##2##2##(2008-7#2)
versus chronic##2##2##(1996-10#1)(2009-12#1)
versus clinical##2##2##(1993-8#1)(2006-3#1)
versus concentration is##2##3##(2007-8#1)(2008-10#1)
versus concentration of##4##3##(2008-10#4)
versus concentration plot##2##3##(2005-11#1)(2008-10#1)
versus concentration##13##2##(1992-2#1)(2005-11#1)(2007-8#1)(2008-10#10)
versus conservative##4##2##(2007-8#1)(2008-12#1)(2009-4#1)(2011-12#1)
versus continuous##2##2##(2008-11#1)(2008-2#1)
versus control in##2##3##(2008-10#1)(2008-5#1)
versus control##9##2##(1991-12#1)(2004-2#1)(2008-10#2)(2008-5#2)(2010-2#2)(2013-8#1)
versus controls##9##2##(1996-12#1)(2009-12#1)(2009-4#4)(2010-2#1)(2011-12#1)(2013-7#1)
versus conventional##12##2##(1991-9#1)(2006-6#1)(2007-8#1)(2007-9#1)(2008-3#2)(2008-5#1)(2009-9#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-7#1)
versus current##2##2##(2008-10#2)
versus delayed loading of##2##4##(2013-1#2)
versus delayed loading##3##3##(2008-4#1)(2013-1#2)
versus delayed##9##2##(2007-7#1)(2008-4#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-7#1)(2012-3#1)(2013-1#2)
versus delta plot##2##3##(2008-10#2)
versus direct##5##2##(2007-7#1)(2008-8#4)
versus distal##2##2##(2007-7#2)
versus endovascular##2##2##(2007-10#1)(2009-8#1)
versus environmental##2##2##(1997-5#1)(2008-4#1)
versus external##3##2##(1991-2#1)(2004-12#1)(2013-8#1)
versus female##3##2##(2007-12#1)(2008-8#2)
versus females##2##2##(2012-11#2)
versus free##3##2##(2008-3#1)(2008-9#1)(2010-11#1)
versus full##2##2##(2008-10#1)(2011-2#1)
versus fusion##4##2##(2008-11#2)(2012-12#2)
versus general anesthesia##3##3##(2006-10#1)(2013-8#2)
versus general##4##2##(2006-10#2)(2013-8#2)
versus haloperidol##2##2##(2006-12#1)(2009-10#1)
versus high##2##2##(1994-8#1)(2010-12#1)
versus hollow##2##2##(2007-12#1)(2007-4#1)
versus host disease (GVHD)##3##4##(2007-11#2)(2010-6#1)
versus host disease##14##3##(2005-12#2)(2005-8#1)(2005-9#1)(2007-11#3)(2007-4#1)(2008-5#1)(2008-7#1)(2010-6#2)(2012-12#1)(2013-8#1)
versus host disease]##2##3##(1994-3#1)(2013-8#1)
versus host##18##2##(1994-3#1)(2005-12#3)(2005-8#1)(2005-9#1)(2007-11#3)(2007-4#1)(2008-5#1)(2008-7#1)(2010-6#2)(2012-12#1)(2013-8#3)
versus human##4##2##(1992-11#1)(1995-1#1)(2007-7#1)(2009-12#1)
versus individual##2##2##(1991-12#1)(2009-4#1)
versus inpatient##3##2##(1991-1#1)(2006-7#1)(2007-8#1)
versus intensity##3##2##(2007-11#1)(2007-12#1)(2012-12#1)
versus intravenous##3##2##(2006-10#1)(2008-1#1)(2012-12#1)
versus its##2##2##(2007-6#1)(2008-1#1)
versus large##3##2##(1993-6#1)(2010-6#1)(2011-12#1)
versus log##3##2##(2008-10#2)(2008-8#1)
versus long##2##2##(1993-5#1)(1993-9#1)
versus low##8##2##(1990-4#1)(2007-4#4)(2008-4#2)(2009-1#1)
versus manual##2##2##(1995-1#1)(2010-1#1)
versus no treatment##2##3##(1992-12#1)(1995-12#1)
versus no##6##2##(1992-12#1)(1995-12#1)(1995-8#1)(2008-5#1)(2008-8#1)(2013-1#1)
versus noise##2##2##(2009-5#2)
versus none in the##2##4##(1990-11#1)(2008-3#1)
versus none##3##2##(1990-11#1)(2008-3#1)(2013-1#1)
versus normal##3##2##(1997-8#1)(2008-5#1)(2012-2#1)
versus not##2##2##(2011-1#1)(2013-7#1)
versus observed##3##2##(1994-3#1)(2008-10#1)(2008-8#1)
versus old##2##2##(2008-7#2)
versus older##4##2##(1995-2#1)(2006-6#2)(2010-12#1)
versus open surgery for##2##4##(2013-1#1)(2013-7#1)
versus open##6##2##(2009-6#1)(2010-1#1)(2013-1#1)(2013-7#2)(2013-8#1)
versus oral##3##2##(1991-8#1)(2006-10#1)(2007-8#1)
versus ordinary##2##2##(2011-1#2)
versus other##9##2##(1996-8#1)(2006-3#1)(2007-1#1)(2008-10#2)(2008-12#1)(2009-10#1)(2009-11#1)(2009-12#1)
versus outpatient##2##2##(2007-8#1)(2009-9#1)
versus pH##3##2##(2008-10#3)
versus patients with##2##3##(2012-12#1)(2012-3#1)
versus patients##3##2##(1990-6#1)(2012-12#1)(2012-3#1)
versus performance##2##2##(1994-2#1)(2008-3#1)
versus placebo in a##2##4##(2008-2#1)(2008-5#1)
versus placebo in##5##3##(1992-11#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-5#1)
versus placebo##24##2##(1992-11#1)(1993-12#1)(2006-10#1)(2007-11#2)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#6)(2011-2#3)(2012-2#1)(2013-8#1)
versus postoperative##2##2##(1994-8#2)
versus primary##2##2##(2010-12#1)(2011-2#1)
versus product##2##2##(2007-12#1)(2013-8#1)
versus quantum##2##2##(1993-3#1)(2008-10#1)
versus reality##3##2##(2007-12#1)(2007-8#1)(2008-7#1)
versus resistant##2##2##(1996-2#1)(2010-5#1)
versus saline##2##2##(2012-11#1)(2013-1#1)
versus sample##3##2##(2008-10#3)
versus saturated calomel##2##3##(2008-10#2)
versus secondary##4##2##(1994-2#1)(2006-5#1)(2012-12#1)(2012-2#1)
versus serotonergic cells##4##3##(1997-3#4)
versus short-term##2##2##(1992-1#1)(1996-10#1)
versus single##2##2##(1996-3#1)(2008-8#1)
versus skin##2##2##(2008-3#1)(2010-9#1)
versus slow##3##2##(2006-5#1)(2008-10#1)(2011-2#1)
versus small##3##2##(2006-10#1)(2007-10#1)(2008-9#1)
versus standard##4##2##(1993-9#1)(1995-12#1)(2008-10#1)(2011-12#1)
versus standardized patient satisfaction surveys##2##5##(1996-3#2)
versus sterile technique for##2##4##(2009-5#2)
versus surgery and##2##3##(1991-4#1)(2008-6#1)
versus surgery in##2##3##(2011-2#1)(2012-3#1)
versus surgery##5##2##(1991-4#1)(2008-6#1)(2011-2#2)(2012-3#1)
versus surgical##2##2##(2008-4#1)(2013-1#1)
versus temperature profiles##2##3##(1991-2#1)(2006-10#1)
versus temperature##4##2##(1991-2#1)(2006-10#1)(2008-10#1)(2008-3#1)
versus that of##2##3##(2007-11#1)(2007-9#1)
versus that##4##2##(1996-8#1)(2007-11#1)(2007-9#1)(2008-11#1)
versus the &quot##2##3##(1990-6#1)(2011-2#1)
versus the concentration of##2##4##(1992-3#1)(2008-4#1)
versus the concentration##3##3##(1992-3#1)(2008-10#1)(2008-4#1)
versus the control group##3##4##(2008-12#1)(2008-7#1)(2011-2#1)
versus the relative##2##3##(2007-11#1)(2010-1#1)
versus the##83##2##(1990-6#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-12#1)(2005-12#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#2)(2007-5#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#1)(2008-9#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-12#1)(2013-1#1)(2013-7#1)
versus their##3##2##(1990-12#1)(2006-10#1)(2007-5#1)
versus those who##2##3##(1993-3#1)(2008-7#1)
versus those without##2##3##(1993-3#1)(1997-3#1)
versus those##6##2##(1993-3#2)(1997-3#1)(2008-7#1)(2011-1#1)(2013-1#1)
versus time##14##2##(1990-11#1)(1991-12#1)(1995-1#1)(2005-11#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-6#1)(2008-7#1)(2010-11#2)
versus total parenteral nutrition##2##4##(2005-10#1)(2006-10#1)
versus total##6##2##(2005-10#1)(2006-10#1)(2008-10#2)(2008-4#1)(2011-2#1)
versus traditional##4##2##(2008-2#1)(2008-3#1)(2009-9#1)(2011-2#1)
versus tumor##2##2##(1991-12#1)(2009-10#1)
versus unfractionated heparin##3##3##(2007-10#3)
versus untreated##2##2##(1992-9#1)(2007-7#1)
versus water##3##2##(1996-8#1)(2006-8#2)
versus wavelength##4##2##(2007-12#1)(2008-10#2)(2008-3#1)
versus written##2##2##(1993-2#1)(2004-10#1)
versus##1711##1##(1990-10#2)(1990-11#4)(1990-12#4)(1990-2#1)(1990-3#3)(1990-4#2)(1990-5#2)(1990-6#4)(1990-7#3)(1990-8#3)(1990-9#2)(1991-1#5)(1991-11#5)(1991-12#5)(1991-2#12)(1991-3#5)(1991-4#2)(1991-6#2)(1991-7#1)(1991-8#7)(1991-9#3)(1992-1#4)(1992-10#1)(1992-11#5)(1992-12#3)(1992-2#4)(1992-3#8)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#2)(1993-1#3)(1993-12#5)(1993-2#3)(1993-3#5)(1993-4#2)(1993-5#3)(1993-6#5)(1993-7#6)(1993-8#1)(1993-9#8)(1994-1#3)(1994-10#1)(1994-11#3)(1994-12#5)(1994-2#8)(1994-3#7)(1994-4#1)(1994-5#1)(1994-6#3)(1994-7#4)(1994-8#7)(1994-9#5)(1995-1#10)(1995-11#1)(1995-12#5)(1995-2#10)(1995-3#12)(1995-4#4)(1995-5#3)(1995-6#3)(1995-8#9)(1995-9#2)(1996-1#3)(1996-10#2)(1996-11#1)(1996-12#11)(1996-2#3)(1996-3#4)(1996-4#4)(1996-5#7)(1996-6#3)(1996-7#2)(1996-8#7)(1996-9#5)(1997-1#6)(1997-2#16)(1997-3#15)(1997-4#9)(1997-5#11)(1997-6#4)(1997-7#1)(1997-8#6)(2004-1#7)(2004-10#4)(2004-12#1)(2004-2#2)(2004-3#2)(2005-10#5)(2005-11#8)(2005-12#6)(2005-6#1)(2005-8#2)(2005-9#5)(2006-10#38)(2006-11#2)(2006-12#4)(2006-2#3)(2006-3#7)(2006-4#3)(2006-5#6)(2006-6#8)(2006-7#6)(2006-8#12)(2006-9#5)(2007-1#5)(2007-10#16)(2007-11#23)(2007-12#32)(2007-2#5)(2007-3#3)(2007-4#15)(2007-5#3)(2007-6#9)(2007-7#34)(2007-8#68)(2007-9#8)(2008-1#13)(2008-10#208)(2008-11#18)(2008-12#13)(2008-2#25)(2008-3#50)(2008-4#25)(2008-5#24)(2008-6#12)(2008-7#47)(2008-8#30)(2008-9#21)(2009-1#1)(2009-10#8)(2009-11#7)(2009-12#16)(2009-2#4)(2009-3#7)(2009-4#20)(2009-5#12)(2009-6#5)(2009-7#5)(2009-8#8)(2009-9#10)(2010-1#7)(2010-10#2)(2010-11#8)(2010-12#5)(2010-2#14)(2010-3#5)(2010-4#4)(2010-5#5)(2010-6#5)(2010-7#12)(2010-8#7)(2010-9#4)(2011-1#24)(2011-12#11)(2011-2#67)(2011-3#1)(2011-7#1)(2012-1#9)(2012-11#7)(2012-12#32)(2012-2#25)(2012-3#18)(2012-6#1)(2013-1#71)(2013-4#1)(2013-7#18)(2013-8#19)
versuta##4##1##(2008-10#4)
vertebra and the##2##3##(1992-1#1)(2007-11#1)
vertebra and##8##2##(1992-1#1)(2006-1#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-4#1)(2010-12#1)(2012-2#1)
vertebra in the##2##3##(2007-11#1)(2013-1#1)
vertebra in##3##2##(2007-11#1)(2009-3#1)(2013-1#1)
vertebra was##3##2##(1991-11#1)(2007-2#1)(2007-7#1)
vertebra were##2##2##(2008-5#1)(2013-1#1)
vertebra with##2##2##(2006-10#1)(2011-12#1)
vertebra##53##1##(1991-11#1)(1992-1#3)(1994-7#1)(1996-6#1)(1997-4#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-8#1)(2007-10#1)(2007-11#9)(2007-12#1)(2007-2#1)(2007-4#4)(2007-5#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-3#3)(2010-12#2)(2011-12#1)(2012-2#2)(2013-1#2)
vertebrae and##15##2##(1992-1#1)(1995-8#1)(2006-11#1)(2007-1#1)(2007-11#5)(2007-4#2)(2007-7#1)(2007-8#2)(2009-2#1)
vertebrae are##3##2##(1992-1#1)(2006-8#1)(2007-4#1)
vertebrae at##3##2##(2006-8#1)(2007-11#1)(2013-1#1)
vertebrae by##2##2##(2008-4#1)(2012-1#1)
vertebrae decreased with age in##2##5##(2008-5#2)
vertebrae decreased with age##3##4##(2008-5#3)
vertebrae from the##2##3##(2007-8#1)(2009-3#1)
vertebrae from##3##2##(2007-5#1)(2007-8#1)(2009-3#1)
vertebrae in##8##2##(1993-11#1)(1995-8#1)(2006-8#1)(2007-7#2)(2007-8#1)(2008-5#2)
vertebrae with##2##2##(2008-7#1)(2010-12#1)
vertebrae##96##1##(1990-10#1)(1991-11#1)(1992-1#2)(1993-11#1)(1993-3#1)(1994-12#1)(1995-8#2)(1996-6#1)(1997-4#2)(2005-5#1)(2006-11#1)(2006-2#1)(2006-8#7)(2006-9#2)(2007-1#2)(2007-11#21)(2007-2#1)(2007-4#4)(2007-5#2)(2007-7#9)(2007-8#7)(2008-11#1)(2008-4#1)(2008-5#7)(2008-7#2)(2009-2#1)(2009-3#1)(2009-4#1)(2010-12#3)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#3)(2013-8#2)
vertebral and hip fractures##3##4##(2008-8#3)
vertebral and nonvertebral fractures##2##4##(2008-3#2)
vertebral and##9##2##(2008-3#3)(2008-7#2)(2008-8#3)(2012-2#1)
vertebral arteries##8##2##(1995-3#3)(1997-6#1)(2007-10#1)(2007-9#1)(2010-8#1)(2012-1#1)
vertebral artery (VA) occlusive##2##4##(2006-11#1)(2008-7#1)
vertebral artery (VA)##4##3##(2006-11#1)(2008-7#2)(2012-3#1)
vertebral artery and##3##3##(1997-6#1)(2006-12#1)(2007-9#1)
vertebral artery dissecting aneurysm##2##4##(2008-7#2)
vertebral artery dissection##10##3##(1991-8#2)(2006-4#1)(2008-7#4)(2008-8#1)(2011-2#1)(2013-8#1)
vertebral artery occlusive##2##3##(2006-11#1)(2008-7#1)
vertebral artery stenosis##2##3##(2007-10#1)(2012-3#1)
vertebral artery##53##2##(1990-7#1)(1991-8#3)(1992-6#1)(1993-3#2)(1996-12#1)(1996-2#1)(1996-9#2)(1997-6#1)(2005-9#1)(2006-11#3)(2006-12#3)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-9#1)(2008-12#4)(2008-5#1)(2008-7#11)(2008-8#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#3)
vertebral bodies and##3##3##(2006-9#1)(2007-11#1)(2007-8#1)
vertebral bodies in the##2##4##(2007-7#1)(2011-2#1)
vertebral bodies in##3##3##(1997-3#1)(2007-7#1)(2011-2#1)
vertebral bodies were##2##3##(2007-8#1)(2010-10#1)
vertebral bodies##23##2##(1995-9#1)(1996-12#1)(1997-3#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-2#1)(2007-7#1)(2007-8#4)(2008-7#1)(2010-10#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)
vertebral body and intervertebral discs wedging in##2##7##(2007-8#2)
vertebral body and##6##3##(2006-2#1)(2006-8#1)(2007-11#2)(2007-8#2)
vertebral body height##3##3##(2007-8#2)(2012-2#1)
vertebral body heights##2##3##(2006-11#2)
vertebral body metastases##2##3##(2007-11#1)(2008-6#1)
vertebral body or##2##3##(2007-11#2)
vertebral body was##2##3##(2006-8#1)(2009-3#1)
vertebral body wedging factor in the##2##6##(2007-8#2)
vertebral body wedging factors##2##4##(2007-8#2)
vertebral body wedging##4##3##(2007-8#4)
vertebral body with##6##3##(2006-8#3)(2008-6#1)(2009-3#1)(2012-2#1)
vertebral body##56##2##(1995-12#2)(1996-8#1)(2005-10#1)(2006-11#3)(2006-2#1)(2006-6#1)(2006-8#9)(2007-1#1)(2007-11#9)(2007-8#12)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#4)(2009-3#2)(2009-6#1)(2012-1#1)(2012-2#3)(2013-8#1)
vertebral bone##5##2##(1991-11#1)(2009-4#1)(2011-2#2)(2012-12#1)
vertebral canal haematoma##2##3##(2006-10#2)
vertebral canal##17##2##(1995-3#1)(2006-10#2)(2006-12#1)(2007-11#9)(2007-7#1)(2007-8#1)(2008-12#1)(2008-7#1)
vertebral column resection##3##3##(2008-8#3)
vertebral column##25##2##(1990-10#1)(1997-2#1)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#4)(2007-8#2)(2008-4#2)(2008-7#1)(2008-8#3)(2009-2#2)(2009-4#1)(2011-2#2)(2013-1#2)
vertebral compression fracture##4##3##(2006-10#1)(2006-8#1)(2008-12#1)(2009-5#1)
vertebral compression fractures secondary to##2##5##(2008-7#2)
vertebral compression fractures treated with surgical (kyphoplasty) or non surgical approach##2##11##(2013-1#2)
vertebral compression fractures##15##3##(2006-3#1)(2006-6#1)(2006-8#2)(2007-8#1)(2008-7#5)(2008-8#1)(2010-9#1)(2013-1#3)
vertebral compression##20##2##(2006-10#1)(2006-3#1)(2006-6#1)(2006-8#3)(2007-8#1)(2008-12#1)(2008-7#5)(2008-8#1)(2009-5#1)(2010-9#2)(2013-1#3)
vertebral corpus defects##2##3##(2007-8#2)
vertebral corpus##3##2##(2007-8#3)
vertebral crush##2##2##(1991-11#2)
vertebral dimensions##2##2##(2007-1#2)
vertebral disc##2##2##(2007-11#1)(2012-2#1)
vertebral fracture in##3##3##(1991-11#1)(1993-2#1)(2012-12#1)
vertebral fracture rate##2##3##(1991-11#1)(2007-11#1)
vertebral fracture##15##2##(1991-11#3)(1993-2#1)(2006-10#1)(2006-6#1)(2007-11#2)(2008-1#1)(2010-10#2)(2011-2#2)(2012-12#1)(2013-1#1)
vertebral fractures and##2##3##(1991-11#1)(1993-11#1)
vertebral fractures in##4##3##(1991-11#1)(1993-11#1)(2005-3#1)(2008-11#1)
vertebral fractures treatment##3##3##(2006-6#1)(2007-11#2)
vertebral fractures##31##2##(1991-11#3)(1992-10#1)(1993-11#2)(2005-3#1)(2006-10#1)(2006-6#1)(2007-11#4)(2007-8#3)(2008-11#6)(2008-4#1)(2008-7#1)(2008-8#3)(2010-10#3)(2013-1#1)
vertebral fusion##2##2##(2008-8#1)(2012-2#1)
vertebral growth##2##2##(2009-4#2)
vertebral involvement##2##2##(2007-7#1)(2008-7#1)
vertebral levels were##2##3##(2006-8#2)
vertebral levels##4##2##(2006-8#3)(2008-7#1)
vertebral metastases##3##2##(2009-5#1)(2011-2#1)(2012-2#1)
vertebral metastasis##2##2##(2006-8#1)(2010-12#1)
vertebral or##2##2##(2007-9#1)(2008-7#1)
vertebral osteonecrosis (Kummell's spondylitis)##3##4##(2006-8#3)
vertebral osteonecrosis##4##2##(2006-8#4)
vertebral rotation in##2##3##(2007-8#2)
vertebral rotation##8##2##(2007-7#3)(2007-8#4)(2012-2#1)
vertebral translation##3##2##(2007-7#3)
vertebral tumours##2##2##(2008-7#2)
vertebral vector##2##2##(2012-2#2)
vertebral vein##3##2##(1996-9#1)(2012-3#1)(2013-8#1)
vertebral venous plexus and##2##4##(2011-2#2)
vertebral venous plexus##10##3##(2011-2#10)
vertebral venous##12##2##(2011-2#12)
vertebral vessels##2##2##(1996-9#1)(2006-8#1)
vertebral##404##1##(1990-10#1)(1990-11#1)(1990-7#1)(1991-11#10)(1991-8#4)(1992-10#1)(1992-6#1)(1993-11#4)(1993-12#1)(1993-2#1)(1993-3#3)(1993-9#1)(1995-12#2)(1995-3#4)(1995-9#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-8#1)(1996-9#4)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#2)(2005-10#4)(2005-3#1)(2005-9#1)(2006-10#6)(2006-11#8)(2006-12#5)(2006-2#3)(2006-3#1)(2006-4#2)(2006-6#7)(2006-7#4)(2006-8#23)(2006-9#2)(2007-1#7)(2007-10#3)(2007-11#40)(2007-2#1)(2007-4#2)(2007-7#11)(2007-8#34)(2007-9#5)(2008-1#2)(2008-11#6)(2008-12#7)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#35)(2008-8#13)(2009-2#2)(2009-3#5)(2009-4#5)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#7)(2010-12#3)(2010-8#1)(2010-9#2)(2011-2#25)(2011-7#1)(2012-1#6)(2012-12#4)(2012-2#21)(2012-3#3)(2013-1#9)(2013-8#7)
vertebras##3##1##(2008-6#2)(2013-1#1)
vertebrate and invertebrate##8##3##(1990-11#1)(1991-4#1)(1992-12#1)(1993-12#1)(1996-7#1)(2007-12#1)(2008-10#1)(2008-9#1)
vertebrate and##10##2##(1990-11#1)(1990-2#1)(1991-4#1)(1992-12#1)(1993-12#1)(1996-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
vertebrate animal##2##2##(2008-2#1)(2008-9#1)
vertebrate animals##4##2##(1993-3#1)(2011-12#1)(2011-2#1)(2013-1#1)
vertebrate brain##3##2##(1994-12#1)(1996-4#1)(2008-4#1)
vertebrate cells##5##2##(1991-6#1)(1993-9#1)(1996-2#1)(2008-9#1)(2010-2#1)
vertebrate defensive##2##2##(1993-3#1)(1994-5#1)
vertebrate development##3##2##(1994-8#1)(1996-1#1)(1997-4#1)
vertebrate embryos##4##2##(1993-12#1)(2008-2#1)(2008-5#1)(2008-9#1)
vertebrate evolution##6##2##(1992-11#1)(1997-3#1)(1997-9#1)(2006-10#1)(2008-8#1)(2011-2#1)
vertebrate genome##3##2##(1995-2#1)(2008-8#1)(2011-2#1)
vertebrate genomes##6##2##(1991-6#1)(2007-6#1)(2008-8#2)(2010-3#1)(2011-2#1)
vertebrate groups##3##2##(1995-5#1)(2006-8#1)(2010-3#1)
vertebrate hard##3##2##(1992-5#3)
vertebrate hemoglobins##2##2##(1990-8#2)
vertebrate homolog##2##2##(1994-12#1)(2012-12#1)
vertebrate host##5##2##(1991-5#1)(2006-10#2)(2008-9#1)(2012-12#1)
vertebrate hosts##3##2##(1995-1#1)(2012-12#1)(2013-1#1)
vertebrate immune system##2##3##(2008-4#1)(2010-8#1)
vertebrate lineage##4##2##(1994-10#1)(2008-1#1)(2012-12#1)(2012-2#1)
vertebrate model##5##2##(2007-12#1)(2008-11#1)(2008-8#1)(2012-3#2)
vertebrate models##2##2##(2008-8#1)(2009-5#1)
vertebrate nervous system##3##3##(1991-3#1)(1996-3#1)(2008-7#1)
vertebrate nervous##4##2##(1991-3#1)(1996-3#1)(2008-7#2)
vertebrate neuromuscular##2##2##(1997-8#1)(2009-11#1)
vertebrate neurons##2##2##(1994-3#1)(2007-10#1)
vertebrate populations##2##2##(2008-8#1)(2012-3#1)
vertebrate proteins##3##2##(1991-5#1)(1997-2#1)(2012-12#1)
vertebrate retina##6##2##(1994-12#1)(1995-5#1)(2008-2#3)(2010-9#1)
vertebrate sequences##2##2##(1995-2#1)(1996-10#1)
vertebrate skeletal muscle##3##3##(1993-9#1)(2008-6#1)(2008-9#1)
vertebrate skeletal##4##2##(1991-3#1)(1993-9#1)(2008-6#1)(2008-9#1)
vertebrate species for which##2##4##(1993-12#1)(2008-8#1)
vertebrate species##17##2##(1992-12#1)(1993-12#1)(1993-8#1)(1996-6#2)(2007-8#1)(2008-3#1)(2008-5#1)(2008-8#2)(2011-12#1)(2012-12#4)(2012-2#2)
vertebrate tachykinins##2##2##(1990-2#2)
vertebrate##250##1##(1990-10#1)(1990-11#4)(1990-2#7)(1990-4#2)(1990-5#3)(1990-6#1)(1990-8#2)(1991-10#1)(1991-3#3)(1991-4#1)(1991-5#3)(1991-6#4)(1992-11#1)(1992-12#2)(1992-5#4)(1992-8#2)(1993-11#4)(1993-12#4)(1993-2#1)(1993-3#2)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#4)(1994-10#1)(1994-11#3)(1994-12#3)(1994-3#1)(1994-5#1)(1994-8#2)(1995-1#5)(1995-11#1)(1995-2#5)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#4)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#3)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-7#2)(1997-8#1)(1997-9#2)(2006-10#3)(2006-11#1)(2006-8#1)(2007-10#1)(2007-12#5)(2007-3#1)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#1)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#7)(2008-8#14)(2008-9#11)(2009-10#1)(2009-11#2)(2009-5#2)(2009-6#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-3#6)(2010-5#3)(2010-7#1)(2010-8#1)(2010-9#2)(2011-12#2)(2011-2#4)(2012-1#1)(2012-12#15)(2012-2#4)(2012-3#6)(2013-1#4)
vertebrates and invertebrates##4##3##(1991-3#1)(1995-3#1)(2008-9#1)(2009-6#1)
vertebrates and##16##2##(1991-3#1)(1991-5#1)(1993-6#1)(1995-11#1)(1995-2#1)(1995-3#1)(1997-2#1)(2007-12#2)(2008-1#1)(2008-7#3)(2008-9#1)(2009-6#1)(2009-7#1)
vertebrates are##3##2##(1996-5#1)(1996-7#1)(2007-12#1)
vertebrates have been##5##3##(1992-5#1)(2007-3#3)(2013-1#1)
vertebrates have##6##2##(1992-5#1)(2007-3#3)(2012-3#1)(2013-1#1)
vertebrates in Costa Rica##4##4##(2007-3#4)
vertebrates in Costa##5##3##(2007-3#5)
vertebrates in the##2##3##(2007-10#1)(2011-2#1)
vertebrates in##7##2##(2007-10#1)(2007-3#5)(2011-2#1)
vertebrates is the##2##3##(2010-9#1)(2011-1#1)
vertebrates is##6##2##(1994-11#1)(1995-8#1)(2007-7#1)(2010-4#1)(2010-9#1)(2011-1#1)
vertebrates were##2##2##(1992-1#2)
vertebrates##173##1##(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-11#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-9#3)(1992-1#3)(1992-5#2)(1993-2#2)(1993-5#1)(1993-6#2)(1994-11#2)(1994-12#2)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#2)(1995-10#1)(1995-11#4)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#3)(1996-10#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#3)(1996-7#2)(1996-9#1)(1997-2#3)(1997-4#3)(1997-5#2)(1997-7#1)(2006-5#2)(2007-10#1)(2007-12#18)(2007-2#1)(2007-3#11)(2007-5#1)(2007-7#2)(2008-1#3)(2008-11#2)(2008-12#2)(2008-4#3)(2008-5#1)(2008-7#12)(2008-8#8)(2008-9#5)(2009-10#1)(2009-2#2)(2009-5#1)(2009-6#2)(2009-7#1)(2010-3#3)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#1)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
vertebrectomy and##2##2##(2008-7#1)(2008-8#1)
vertebrectomy##6##1##(2006-8#1)(2008-7#3)(2008-8#2)
vertebro- and kyphoplasty in##2##4##(2007-8#2)
vertebro- and kyphoplasty##3##3##(2007-8#3)
vertebro-basilar##2##1##(1996-2#1)(2008-2#1)
vertebrobasilar and##2##2##(1991-3#1)(2008-7#1)
vertebrobasilar arterial system##2##3##(2007-10#1)(2008-7#1)
vertebrobasilar artery##6##2##(1997-3#1)(2008-7#1)(2010-8#1)(2012-3#3)
vertebrobasilar insufficiency##6##2##(1993-3#1)(2006-11#3)(2008-12#1)(2008-7#1)
vertebrobasilar lesions##2##2##(1996-2#2)
vertebrobasilar stroke##4##2##(1996-2#2)(2007-10#1)(2007-11#1)
vertebrobasilar system##6##2##(2006-1#1)(2007-9#3)(2008-7#1)(2011-2#1)
vertebrobasilar##37##1##(1991-3#1)(1993-3#1)(1996-2#6)(1997-3#1)(2006-1#1)(2006-11#3)(2006-4#1)(2007-10#2)(2007-11#2)(2007-9#3)(2008-12#1)(2008-2#1)(2008-7#5)(2010-8#2)(2011-1#1)(2011-2#1)(2012-3#5)
vertebroplasty and kyphoplasty##3##3##(2008-7#3)
vertebroplasty and##4##2##(2008-7#3)(2011-2#1)
vertebroplasty in the##2##3##(2006-2#1)(2007-8#1)
vertebroplasty in##6##2##(2006-2#3)(2006-8#1)(2007-8#1)(2008-7#1)
vertebroplasty is##6##2##(2007-11#2)(2007-8#2)(2008-7#2)
vertebroplasty with##3##2##(2006-8#1)(2007-11#1)(2007-8#1)
vertebroplasty##44##1##(2006-2#3)(2006-3#1)(2006-8#13)(2007-11#5)(2007-8#6)(2008-1#1)(2008-7#11)(2008-8#1)(2010-9#1)(2011-2#2)
verteporfin##2##1##(2007-11#2)
vertex of the##3##3##(1997-1#1)(2008-6#1)(2008-9#1)
vertex of##4##2##(1997-1#1)(2008-6#1)(2008-9#1)(2013-8#1)
vertex position update##2##3##(2008-6#2)
vertex##30##1##(1993-9#2)(1994-4#1)(1997-1#2)(2004-10#1)(2006-12#3)(2007-1#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#7)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
vertex-connectivity index##3##2##(2007-11#3)
vertical and horizontal cross-lines##2##4##(2008-5#2)
vertical and horizontal##10##3##(1995-11#1)(1997-6#1)(2006-5#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#1)
vertical and##18##2##(1992-2#1)(1995-11#1)(1997-6#1)(2006-5#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-8#1)(2009-9#1)(2011-12#1)(2013-8#1)
vertical array of##2##3##(2007-11#1)(2008-11#1)
vertical attenuation##2##2##(2008-2#1)(2008-3#1)
vertical axis##7##2##(1996-1#1)(2007-8#1)(2008-8#1)(2009-9#1)(2012-11#2)(2013-7#1)
vertical cavity surface emitting laser##2##5##(2007-12#1)(2007-8#1)
vertical cavity surface emitting##3##4##(2007-12#2)(2007-8#1)
vertical cavity surface-emitting laser##2##4##(2008-3#2)
vertical cavity surface-emitting##3##3##(2008-1#1)(2008-3#2)
vertical cavity##7##2##(2007-12#3)(2007-8#1)(2008-1#1)(2008-3#2)
vertical cell morphology##2##3##(2009-7#2)
vertical cell##3##2##(2009-7#3)
vertical components##4##2##(1990-5#1)(2007-4#1)(2008-11#1)(2008-9#1)
vertical coupler##2##2##(2007-12#1)(2008-3#1)
vertical dimension of##3##3##(2007-8#1)(2009-11#1)(2011-12#1)
vertical dimension##8##2##(2007-8#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-8#2)(2010-3#1)(2011-12#1)
vertical directions##5##2##(2008-2#1)(2008-3#3)(2009-11#1)
vertical disparities##3##2##(1991-1#3)
vertical displacement of the##2##4##(2005-10#1)(2008-5#1)
vertical distance##2##2##(2008-10#1)(2010-12#1)
vertical distribution of##9##3##(1993-2#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#2)
vertical distribution##14##2##(1993-2#1)(2007-3#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-5#2)(2013-8#1)
vertical force##4##2##(2009-7#1)(2013-7#3)
vertical gain component##2##3##(1992-10#2)
vertical gap is##2##3##(2008-7#2)
vertical incision##3##2##(1992-2#1)(2007-8#1)(2013-1#1)
vertical infection##4##2##(2011-3#4)
vertical integration##5##2##(1991-3#2)(1996-2#1)(1997-3#1)(2010-7#1)
vertical jump testing##2##3##(2010-12#2)
vertical mixing##2##2##(2008-11#1)(2008-3#1)
vertical movement of the##2##4##(2007-10#1)(2011-12#1)
vertical movement of##3##3##(2007-10#1)(2011-12#2)
vertical offset##2##2##(2007-12#1)(2007-7#1)
vertical or##4##2##(1991-2#1)(2008-2#1)(2008-7#1)(2011-12#1)
vertical orientation##3##2##(2006-12#1)(2008-2#1)(2009-5#1)
vertical plane##4##2##(2006-11#1)(2006-5#1)(2009-7#1)(2013-7#1)
vertical portion##2##2##(2010-12#2)
vertical profile of##2##3##(2008-3#1)(2013-8#1)
vertical profile##3##2##(2008-3#2)(2013-8#1)
vertical profiles are##2##3##(2008-3#2)
vertical profiles obtained##2##3##(2008-2#1)(2008-3#1)
vertical profiles of pressure and temperature##2##6##(2008-3#2)
vertical profiles of the##4##4##(2007-12#1)(2008-3#3)
vertical profiles of##12##3##(2007-12#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-3#8)
vertical profiles##20##2##(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#13)
vertical resolution of the##4##4##(2008-2#1)(2008-3#3)
vertical resolution of##6##3##(2008-2#1)(2008-3#5)
vertical resolution##17##2##(2007-12#2)(2008-2#3)(2008-3#12)
vertical scanning interferometry##3##3##(2008-3#3)
vertical scanning##4##2##(2008-3#4)
vertical section##3##2##(1996-6#1)(2009-7#2)
vertical separation##2##2##(2006-9#2)
vertical shear##2##2##(2011-2#1)(2012-2#1)
vertical structure of the water##2##5##(2007-5#2)
vertical structure of the##3##4##(2007-5#2)(2008-2#1)
vertical structure of##5##3##(2007-5#2)(2008-2#2)(2008-3#1)
vertical structure##9##2##(1990-12#1)(2007-5#2)(2008-2#3)(2008-3#3)
vertical substance and volume loss##2##5##(2011-2#2)
vertical surface##2##2##(2009-11#2)
vertical temperature##2##2##(2008-2#1)(2008-3#1)
vertical transmission in##3##3##(2008-9#1)(2011-3#2)
vertical transmission is not##2##4##(2008-8#1)(2011-3#1)
vertical transmission of HBV from HBsAg-positive father to infant##3##9##(2011-1#3)
vertical transmission of HBV##4##4##(2011-1#4)
vertical transmission of HIV-1##2##4##(1994-7#1)(2006-10#1)
vertical transmission of##12##3##(1994-7#1)(1995-3#3)(1996-3#1)(2006-10#2)(2008-10#1)(2011-1#4)
vertical transmission##35##2##(1994-7#1)(1995-3#3)(1996-3#1)(1996-5#2)(2006-10#3)(2006-8#2)(2007-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#7)(2009-1#1)(2011-1#4)(2011-3#4)(2012-3#1)(2013-1#1)
vertical##374##1##(1990-10#1)(1990-12#1)(1990-5#1)(1991-1#3)(1991-10#1)(1991-2#1)(1991-3#3)(1991-5#3)(1992-10#2)(1992-2#2)(1992-7#1)(1993-2#1)(1993-7#1)(1994-12#2)(1994-2#2)(1994-7#1)(1995-11#2)(1995-3#3)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(2004-3#1)(2005-10#1)(2005-11#2)(2005-5#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-5#2)(2006-8#3)(2006-9#5)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#18)(2007-2#1)(2007-3#3)(2007-4#2)(2007-5#8)(2007-7#3)(2007-8#10)(2008-1#3)(2008-10#12)(2008-11#10)(2008-2#34)(2008-3#68)(2008-4#2)(2008-5#12)(2008-6#1)(2008-7#7)(2008-8#9)(2008-9#9)(2009-1#1)(2009-11#5)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#7)(2009-8#3)(2009-9#2)(2010-12#7)(2010-2#2)(2010-3#3)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-12#6)(2011-2#6)(2011-3#8)(2012-1#1)(2012-11#4)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#7)(2013-8#3)
vertical) and##2##2##(2008-2#1)(2008-3#1)
vertical)##5##1##(1991-2#1)(2008-2#1)(2008-3#2)(2012-12#1)
vertical-cavity surface emitting laser##2##4##(2008-1#2)
vertical-cavity surface-emitting laser (VCSEL)##7##4##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)
vertical-cavity surface-emitting laser arrays##3##4##(2007-11#1)(2008-3#2)
vertical-cavity surface-emitting laser##17##3##(2007-11#2)(2007-12#5)(2008-2#4)(2008-3#6)
vertical-cavity surface-emitting lasers (VCSEL's)##3##4##(2008-3#3)
vertical-cavity surface-emitting lasers (VCSELs)##2##4##(2007-11#2)
vertical-cavity surface-emitting lasers and##2##4##(2008-2#1)(2008-3#1)
vertical-cavity surface-emitting lasers for##2##4##(2008-2#2)
vertical-cavity surface-emitting lasers##28##3##(2007-11#8)(2007-12#4)(2008-1#1)(2008-2#6)(2008-3#9)
vertical-cavity surface-emitting##47##2##(2007-11#10)(2007-12#11)(2008-1#1)(2008-2#10)(2008-3#15)
vertical-cavity##56##1##(2007-11#11)(2007-12#13)(2008-1#3)(2008-2#13)(2008-3#16)
vertical-external-cavity surface-emitting semiconductor lasers##2##4##(2007-12#2)
verticalia##3##1##(2008-5#3)
vertically aligned carbon nanofibers##2##4##(2009-2#2)
vertically aligned##7##2##(2007-12#1)(2008-7#3)(2009-2#2)(2010-4#1)
vertically and horizontally##4##3##(1994-1#1)(2008-1#2)(2008-2#1)
vertically and##5##2##(1994-1#1)(2007-5#1)(2008-1#2)(2008-2#1)
vertically displaced##2##2##(2007-12#1)(2009-5#1)
vertically homogeneous##2##2##(2008-2#1)(2008-3#1)
vertically in##2##2##(2008-12#1)(2008-9#1)
vertically integrated health##2##3##(1997-3#1)(2007-7#1)
vertically integrated##3##2##(1997-3#1)(2007-7#1)(2010-7#1)
vertically oriented##2##2##(2008-2#2)
vertically polarized##5##2##(2008-2#2)(2008-3#3)
vertically stratified water##2##3##(2008-2#2)
vertically stratified##3##2##(2008-2#2)(2010-8#1)
vertically to##4##2##(2007-1#1)(2007-12#1)(2008-10#1)(2008-2#1)
vertically transmitted##3##2##(2006-8#1)(2008-12#1)(2013-1#1)
vertically##63##1##(1994-1#1)(1994-2#1)(1995-9#1)(1996-9#1)(1997-3#1)(1997-5#1)(2004-11#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#12)(2008-3#9)(2008-5#2)(2008-7#3)(2008-9#2)(2009-2#2)(2009-5#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-3#1)(2013-1#2)
vertices and##2##2##(2007-6#1)(2009-12#1)
vertices##9##1##(1996-2#1)(2006-12#1)(2007-6#1)(2008-8#1)(2009-12#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-1#1)
verticillioides and F##2##3##(2008-10#2)
verticillioides and##5##2##(2008-10#4)(2008-12#1)
verticillioides in the##2##3##(2008-10#2)
verticillioides in##5##2##(2008-10#4)(2008-12#1)
verticillioides infection##2##2##(2008-10#2)
verticillioides on##2##2##(2008-10#2)
verticillioides##32##1##(2007-6#1)(2008-10#28)(2008-12#2)(2010-10#1)
verticillioides-inoculated rows##2##2##(2008-10#2)
verticis gyrata##2##2##(2007-7#2)
vertiginous symptomatology##2##2##(2008-2#2)
vertiginous syndromes##3##2##(2008-2#3)
vertiginous##9##1##(2008-2#7)(2009-5#1)(2013-1#1)
vertigo and migraine##4##3##(2012-2#4)
vertigo and##14##2##(1992-1#1)(2007-10#1)(2008-4#1)(2011-2#1)(2012-2#7)(2012-3#2)(2013-7#1)
vertigo is##6##2##(2008-4#1)(2011-1#1)(2012-2#3)(2012-3#1)
vertigo may##2##2##(1994-9#1)(2011-1#1)
vertigo or dizziness##2##3##(1993-8#1)(2007-9#1)
vertigo with a##2##3##(2008-4#1)(2012-2#1)
vertigo##52##1##(1990-5#2)(1992-1#1)(1993-8#1)(1994-9#1)(1997-8#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-2#2)(2008-4#5)(2011-1#8)(2011-2#1)(2012-12#1)(2012-2#16)(2012-3#7)(2013-1#1)(2013-7#1)
vertigo)##2##1##(1991-11#1)(2008-7#1)
vertigo]##3##1##(1993-5#1)(2012-2#1)(2013-1#1)
very abundant##5##2##(1991-9#1)(1992-12#1)(1996-9#1)(1997-4#1)(2006-12#1)
very accurate##7##2##(1992-9#1)(2006-5#1)(2008-10#2)(2008-3#1)(2008-4#2)
very acidic##6##2##(1997-1#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)
very active and##3##3##(2007-1#1)(2008-1#1)(2012-2#1)
very active on##2##3##(1990-2#1)(2008-4#1)
very active organ##2##3##(2008-10#1)(2008-5#1)
very active##24##2##(1990-2#1)(1991-12#1)(1991-9#1)(1993-8#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-3#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#3)(2009-10#1)(2010-3#1)(2012-2#1)(2013-8#2)
very actively##2##2##(1997-6#1)(2008-9#1)
very advanced and##2##3##(1994-4#1)(2008-9#1)
very advanced##5##2##(1994-4#1)(2008-12#1)(2008-9#3)
very aggressive##7##2##(2007-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2011-2#1)(2013-1#2)
very ancient##4##2##(1993-9#1)(1995-11#1)(1996-5#1)(2007-12#1)
very anisotropic##2##2##(1992-7#2)
very attractive alternative##2##3##(1996-9#1)(2006-2#1)
very attractive as##3##3##(2008-11#1)(2008-2#1)(2008-7#1)
very attractive in##3##3##(2007-12#1)(2007-8#1)(2008-1#1)
very attractive##23##2##(1992-12#1)(1994-5#1)(1996-9#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#3)(2008-7#1)(2010-10#1)(2010-12#1)(2012-2#1)
very atypical clinical##2##3##(2012-2#2)
very bad prognosis##2##3##(2007-11#2)
very basic##10##2##(2005-9#1)(2006-4#1)(2007-12#2)(2007-4#1)(2008-2#1)(2008-4#2)(2008-9#2)
very beginning##3##2##(2007-11#1)(2010-11#1)(2011-2#1)
very beneficial##2##2##(1993-12#1)(2010-4#1)
very bright##3##2##(1990-2#1)(2008-12#1)(2008-2#1)
very broad##12##2##(1991-4#1)(1994-2#1)(1994-5#1)(1995-3#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-8#1)(2011-2#1)
very busy##3##2##(2007-7#1)(2008-7#1)(2013-8#1)
very carefully##3##2##(2007-11#1)(2010-4#1)(2010-8#1)
very cautious##2##2##(2008-10#1)(2010-8#1)
very cautiously##2##2##(1994-2#1)(2008-7#1)
very challenging to##3##3##(2006-12#1)(2009-9#1)(2013-1#1)
very challenging##16##2##(1992-3#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-9#1)(2010-12#2)(2010-5#1)(2010-7#1)(2012-3#2)(2013-1#2)(2013-7#1)
very characteristic##3##2##(1995-5#1)(2006-12#1)(2007-11#1)
very clear##3##2##(1991-1#1)(2006-2#1)(2008-10#1)
very clearly##2##2##(1996-1#1)(2008-10#1)
very close proximity##3##3##(1993-11#1)(2005-11#1)(2008-10#1)
very close to each other##2##5##(2005-11#1)(2006-6#1)
very close to that of##2##5##(2008-2#1)(2008-5#1)
very close to that##3##4##(2008-2#2)(2008-5#1)
very close to the##15##4##(1992-1#1)(1992-9#1)(1993-3#1)(1996-11#1)(2006-6#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-11#1)(2012-12#1)(2012-3#2)(2013-8#1)
very close to##31##3##(1990-7#1)(1990-8#1)(1992-1#1)(1992-9#1)(1993-3#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-6#2)(2007-11#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-8#1)
very close##43##2##(1990-7#1)(1990-8#1)(1992-1#1)(1992-9#1)(1993-11#1)(1993-3#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#4)(2006-6#2)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-5#2)(2008-6#1)(2010-12#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
very closely related to##3##4##(2007-12#1)(2008-10#2)
very closely related##6##3##(2005-12#1)(2007-12#1)(2008-10#4)
very closely with##3##3##(1994-3#1)(1994-8#1)(2005-7#1)
very closely##15##2##(1992-6#1)(1994-3#1)(1994-8#1)(1995-3#1)(1997-4#1)(2005-12#1)(2005-7#1)(2007-12#1)(2008-10#5)(2008-9#1)(2010-2#1)
very common among##3##3##(1991-10#1)(1996-11#1)(2012-12#1)
very common and##5##3##(2006-10#2)(2008-10#1)(2008-11#1)(2010-11#1)
very common in this##3##4##(2008-12#1)(2008-5#1)(2010-12#1)
very common in##17##3##(1990-4#1)(1997-3#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-5#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-11#1)
very common##68##2##(1990-4#3)(1991-10#1)(1991-2#1)(1991-6#1)(1993-10#1)(1993-2#1)(1996-11#2)(1997-3#1)(2004-3#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2011-12#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2013-1#2)(2013-7#1)
very compact##5##2##(1996-6#1)(2007-11#1)(2007-12#2)(2008-3#1)
very competitive##4##2##(1995-12#1)(2008-2#1)(2013-1#2)
very complex and##3##3##(2006-8#1)(2008-9#1)(2012-2#1)
very complex structures##2##3##(2005-11#1)(2011-1#1)
very complex##38##2##(1990-3#1)(1992-5#1)(1992-9#2)(1993-5#1)(1994-11#1)(1996-12#1)(1996-5#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
very complicated##9##2##(2006-10#1)(2007-4#1)(2008-11#1)(2008-3#1)(2010-11#1)(2010-8#2)(2013-1#2)
very concrete##2##2##(2008-2#1)(2008-7#1)
very conserved##3##2##(1995-6#1)(2005-11#1)(2008-8#1)
very consistent##3##2##(2010-9#1)(2012-12#1)(2012-3#1)
very convenient for##4##3##(1996-2#1)(2008-10#1)(2008-3#1)(2010-4#1)
very convenient to##2##3##(2008-10#1)(2009-6#1)
very convenient##9##2##(1995-8#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-6#1)(2010-4#1)
very damaging##2##2##(1997-8#1)(2008-10#1)
very dangerous##2##2##(1990-8#1)(1993-3#1)
very deep##2##2##(2007-5#1)(2007-8#1)
very dense##2##2##(2012-1#2)
very dependent on##3##3##(1991-3#1)(2008-11#1)(2008-5#1)
very different DNA##2##3##(1994-12#1)(2010-12#1)
very different between##2##3##(1990-5#1)(2008-10#1)
very different effects on the##2##5##(1997-7#1)(2010-2#1)
very different from that of##2##5##(2008-10#1)(2008-8#1)
very different from that##4##4##(1990-9#1)(2006-10#1)(2008-10#1)(2008-8#1)
very different from the##5##4##(2008-8#1)(2009-12#1)(2009-6#1)(2010-4#1)(2011-2#1)
very different from those of##5##5##(1992-1#1)(1995-2#1)(1997-6#1)(2007-6#1)(2008-10#1)
very different from##16##3##(1990-9#1)(1992-1#1)(1995-2#1)(1997-6#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-8#2)(2009-12#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-3#1)
very different in the##2##4##(1995-8#1)(2007-9#1)
very different in##4##3##(1991-3#1)(1995-8#1)(2007-9#1)(2008-10#1)
very different medical##2##3##(1992-3#1)(2008-5#1)
very different nature##3##3##(1996-12#1)(2007-8#1)(2008-11#1)
very different##88##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-1#2)(1992-3#1)(1992-7#1)(1993-2#1)(1993-9#1)(1994-12#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-11#3)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#2)(2005-7#1)(2006-10#1)(2006-12#2)(2007-12#3)(2007-3#1)(2007-6#1)(2007-8#2)(2007-9#2)(2008-10#11)(2008-11#2)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-12#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
very differently##3##2##(1996-12#1)(2007-11#1)(2008-1#1)
very difficult to determine##2##4##(1994-11#1)(2010-12#1)
very difficult to diagnose##2##4##(2007-8#1)(2013-1#1)
very difficult to obtain##2##4##(2006-6#1)(2008-9#1)
very difficult to predict##2##4##(1994-3#1)(2006-10#1)
very difficult to##33##3##(1994-11#2)(1994-3#1)(1994-4#1)(1996-4#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-2#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-7#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
very difficult##55##2##(1990-4#1)(1990-8#1)(1992-10#1)(1993-1#1)(1994-11#2)(1994-3#1)(1994-4#1)(1996-2#1)(1996-4#2)(1997-7#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-6#2)(2007-10#1)(2007-11#1)(2007-2#2)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-7#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
very dilute solutions##2##3##(2008-10#1)(2010-4#1)
very dilute##3##2##(1990-7#1)(2008-10#1)(2010-4#1)
very disappointing##2##2##(1990-10#1)(2007-1#1)
very distinct##6##2##(1991-9#1)(1994-3#1)(2008-10#3)(2008-5#1)
very diverse##6##2##(1992-2#1)(1995-8#1)(2008-10#1)(2008-5#1)(2011-12#1)(2011-2#1)
very dry##2##2##(2008-5#2)
very early during##3##3##(1995-11#1)(1996-4#1)(2008-10#1)
very early in the process of##2##6##(2008-8#1)(2012-12#1)
very early in the##4##4##(1993-7#1)(1997-6#1)(2008-8#1)(2012-12#1)
very early in##11##3##(1990-11#1)(1990-9#1)(1993-7#1)(1997-6#1)(2007-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#1)
very early stage of##2##4##(2009-7#1)(2010-6#1)
very early stage##4##3##(2007-11#1)(2009-7#1)(2010-6#1)(2012-3#1)
very early stages of##3##4##(1995-11#1)(2008-10#1)(2009-8#1)
very early stages##5##3##(1995-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2009-8#1)
very early##51##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-9#2)(1993-7#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-11#3)(1995-8#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-6#1)(2006-10#3)(2006-9#1)(2007-11#1)(2007-2#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#2)(2009-7#2)(2009-8#1)(2010-6#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
very easily##2##2##(2008-5#2)
very easy to##4##3##(2004-9#1)(2008-10#1)(2008-11#1)(2010-9#1)
very easy##7##2##(2004-9#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-9#1)
very easy/easy&quot##2##2##(2012-3#2)
very effective against##4##3##(2006-8#1)(2007-7#1)(2008-10#1)(2013-8#1)
very effective and##6##3##(1994-2#1)(1995-5#1)(2007-11#1)(2007-8#1)(2008-3#1)(2009-5#1)
very effective for##6##3##(2005-11#1)(2008-10#1)(2010-4#1)(2012-1#1)(2013-1#2)
very effective in controlling##2##4##(2008-10#1)(2012-2#1)
very effective in reducing##2##4##(1990-12#1)(2007-11#1)
very effective in the treatment of##2##6##(2006-10#1)(2008-1#1)
very effective in the##3##4##(2006-10#1)(2008-1#1)(2008-7#1)
very effective in##26##3##(1990-12#1)(1991-6#1)(1992-3#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-5#1)(2005-9#1)(2006-10#1)(2006-5#1)(2007-11#2)(2007-7#4)(2008-1#1)(2008-10#1)(2008-7#1)(2010-9#1)(2012-11#2)(2012-12#1)(2012-2#2)(2013-1#1)
very effective to##3##3##(2008-10#1)(2011-2#1)(2013-7#1)
very effective##78##2##(1990-12#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-3#1)(1995-5#2)(1996-8#1)(1997-3#1)(2005-11#1)(2005-9#1)(2006-10#4)(2006-11#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#4)(2007-6#1)(2007-7#6)(2007-8#4)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-4#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#3)(2013-1#6)(2013-7#1)(2013-8#1)
very effectively in##2##3##(2008-10#1)(2008-7#1)
very effectively##6##2##(1992-9#2)(1995-5#1)(2007-10#1)(2008-10#1)(2008-7#1)
very efficacious in##2##3##(2008-10#1)(2008-3#1)
very efficient and##3##3##(1997-2#1)(2006-6#1)(2007-12#1)
very efficient in##2##3##(2007-8#1)(2008-12#1)
very efficient method##2##3##(1992-7#1)(1994-6#1)
very efficient##26##2##(1990-11#1)(1992-2#1)(1992-7#2)(1994-6#1)(1995-11#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-10#1)(2012-11#1)(2013-7#1)
very efficiently and##2##3##(2008-5#1)(2009-6#1)
very efficiently to##2##3##(1992-6#1)(1994-11#1)
very efficiently with##2##3##(1991-2#1)(2007-12#1)
very efficiently##12##2##(1991-2#1)(1992-6#1)(1994-11#1)(1995-12#1)(1996-10#1)(1996-11#1)(1996-7#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-5#1)(2009-6#1)
very elderly##4##2##(1993-12#1)(2006-10#3)
very elongate##2##2##(2007-12#1)(2008-7#1)
very encouraging with##2##3##(2007-7#1)(2008-10#1)
very encouraging##9##2##(1992-1#1)(2007-7#1)(2008-10#2)(2008-5#2)(2009-10#1)(2010-2#1)(2012-1#1)
very exceptional##2##2##(2007-11#1)(2011-12#1)
very exciting##3##2##(1991-7#1)(2006-12#1)(2009-12#1)
very expensive##6##2##(1994-3#1)(2006-2#2)(2008-10#1)(2008-11#1)(2008-7#1)
very experienced##2##2##(2006-2#1)(2010-12#1)
very extensive##3##2##(1993-12#1)(2008-8#1)(2011-2#1)
very familiar to##2##3##(1995-1#1)(2010-12#1)
very familiar##3##2##(1995-1#1)(2010-12#1)(2013-7#1)
very fast and##3##3##(2005-11#1)(2008-10#2)
very fast nonlinear scans##2##4##(2007-12#2)
very fast response##2##3##(2008-10#2)
very fast##31##2##(1990-2#2)(1992-9#1)(1995-1#1)(1996-8#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-9#1)(2007-12#8)(2008-1#1)(2008-10#8)(2008-2#2)(2008-3#2)(2010-5#1)
very favorable##4##2##(1992-3#1)(1993-9#1)(2008-10#1)(2011-2#1)
very favorably to##2##3##(2005-10#1)(2007-5#1)
very favorably##3##2##(2005-10#1)(2007-5#1)(2008-10#1)
very few case reports##2##4##(2012-12#1)(2013-8#1)
very few cases have been reported in##2##7##(1997-8#1)(2012-2#1)
very few cases have been##3##5##(1997-8#1)(2012-2#1)(2013-1#1)
very few cases have##4##4##(1990-12#1)(1997-8#1)(2012-2#1)(2013-1#1)
very few cases##5##3##(1990-12#1)(1997-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
very few complications##3##3##(1990-11#1)(1991-2#1)(2006-8#1)
very few of##2##3##(2010-12#1)(2012-1#1)
very few patients##3##3##(2008-5#1)(2010-2#1)(2011-1#1)
very few reported##2##3##(2009-10#1)(2012-3#1)
very few reports of##3##4##(2007-11#1)(2012-2#1)(2013-1#1)
very few reports##6##3##(2007-11#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
very few studies##3##3##(2009-7#1)(2012-2#2)
very few therapeutic##2##3##(2005-7#1)(2008-6#1)
very few##95##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-6#1)(1993-12#1)(1994-11#1)(1994-9#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-11#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-5#1)(2008-10#6)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
very fine##4##2##(2005-11#1)(2007-3#1)(2008-5#2)
very firm##2##2##(1992-1#1)(2006-5#1)
very first##7##2##(1990-7#1)(1994-1#1)(2008-10#1)(2008-12#1)(2010-12#1)(2010-8#1)(2012-1#1)
very flexible##6##2##(1990-3#1)(1992-9#1)(1994-12#1)(2008-10#1)(2008-6#1)(2010-1#1)
very fragile##2##2##(1994-11#1)(2008-11#1)
very frequent##12##2##(2006-1#1)(2006-10#2)(2006-6#1)(2008-2#1)(2008-8#2)(2009-10#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-2#1)
very frequently##5##2##(2006-4#1)(2007-11#1)(2007-7#1)(2008-10#1)(2011-1#1)
very fruitful##2##2##(2008-5#1)(2010-7#1)
very general##9##2##(1994-12#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2013-8#1)
very good agreement between the##2##5##(2008-10#2)
very good agreement between##3##4##(2008-10#3)
very good agreement with the##6##5##(1996-11#1)(2006-12#1)(2006-5#1)(2008-10#1)(2008-9#1)(2011-2#1)
very good agreement##11##3##(1996-11#1)(2006-12#1)(2006-5#1)(2008-10#4)(2008-3#2)(2008-9#1)(2011-2#1)
very good and good results##3##5##(2007-11#2)(2007-7#1)
very good and good##4##4##(2007-11#3)(2007-7#1)
very good and good)##2##4##(2007-8#2)
very good and##10##3##(1994-11#1)(1994-8#1)(2007-11#3)(2007-7#2)(2007-8#3)
very good correlation##2##3##(2008-10#2)
very good effect##3##3##(2008-11#2)(2008-7#1)
very good in##10##3##(1990-6#1)(1995-6#1)(2005-10#1)(2006-8#1)(2007-11#2)(2007-7#2)(2008-1#1)(2008-5#1)
very good or good results - no pain##2##8##(2007-11#2)
very good or good##6##4##(1991-3#1)(2006-8#1)(2007-11#2)(2007-7#2)
very good outcome##3##3##(2007-7#1)(2007-8#1)(2008-1#1)
very good outcomes##2##3##(2007-11#1)(2007-7#1)
very good quality##2##3##(2008-10#1)(2011-3#1)
very good reproducibility##2##3##(1996-6#1)(2008-10#1)
very good resolution##2##3##(2008-7#1)(2009-8#1)
very good results in##4##4##(2007-11#2)(2008-10#1)(2011-3#1)
very good results##13##3##(1990-7#1)(1990-9#1)(1993-3#1)(1996-11#1)(2006-3#1)(2007-11#3)(2008-10#1)(2008-11#1)(2009-5#1)(2011-3#1)(2013-1#1)
very good selectivity for##3##4##(2008-10#3)
very good selectivity##4##3##(2008-10#4)
very good sensitivity##2##3##(2008-10#2)
very good separation##2##3##(2006-4#1)(2008-10#1)
very good stability##2##3##(2007-11#1)(2008-10#1)
very good##158##2##(1990-6#1)(1990-7#1)(1990-9#1)(1991-3#4)(1993-2#2)(1993-3#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-11#2)(1996-6#1)(1996-8#1)(1997-1#1)(2004-2#1)(2005-10#2)(2005-11#1)(2005-8#2)(2006-10#3)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-11#18)(2007-12#2)(2007-7#10)(2007-8#6)(2007-9#2)(2008-1#2)(2008-10#36)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#5)(2008-7#2)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#3)(2012-1#1)(2012-12#3)(2013-1#2)(2013-8#4)
very great##2##2##(1992-3#1)(2008-12#1)
very hard##5##2##(1993-7#1)(2005-11#1)(2008-10#1)(2008-3#1)(2009-9#1)
very helpful in differentiating##2##4##(2009-5#1)(2012-12#1)
very helpful in##9##3##(2007-11#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-12#1)(2009-5#1)(2010-8#1)(2010-9#1)(2012-12#1)
very helpful##15##2##(2005-4#1)(2007-11#2)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-1#1)(2010-8#1)(2010-9#1)(2012-12#1)
very heterogeneous##10##2##(1990-3#1)(1992-6#1)(1997-6#1)(1997-8#1)(2005-8#1)(2010-12#2)(2010-4#1)(2011-12#1)(2011-2#1)
very high activity##4##3##(2008-5#1)(2008-8#1)(2010-11#1)(2010-12#1)
very high affinity##4##3##(1992-11#1)(1993-8#1)(1994-2#1)(1997-4#1)
very high and##6##3##(2008-10#2)(2010-12#2)(2012-2#1)(2013-1#1)
very high aspect ratio##2##4##(2007-12#2)
very high charge##2##3##(2005-11#1)(2009-10#1)
very high concentration of##4##4##(1994-11#1)(1995-1#1)(1997-8#1)(2008-10#1)
very high concentration##7##3##(1990-12#1)(1994-11#1)(1995-1#1)(1997-8#1)(2008-10#2)(2011-1#1)
very high concentrations of##4##4##(1990-5#1)(1997-4#1)(2012-3#1)(2013-7#1)
very high concentrations##7##3##(1990-5#1)(1990-9#1)(1991-1#1)(1996-12#1)(1997-4#1)(2012-3#1)(2013-7#1)
very high degree of##7##4##(1994-2#1)(2006-7#1)(2007-8#1)(2008-11#1)(2010-12#2)(2012-6#1)
very high doses##5##3##(1993-2#1)(1994-2#1)(1994-9#1)(2005-10#1)(2007-2#1)
very high expression##2##3##(1993-9#1)(2008-12#1)
very high frequency of##2##4##(2008-4#1)(2010-7#1)
very high frequency##3##3##(1992-9#1)(2008-4#1)(2010-7#1)
very high in comparison##2##4##(1997-4#1)(2008-4#1)
very high in the##3##4##(1990-5#1)(1992-5#1)(2008-1#1)
very high in##13##3##(1990-5#1)(1992-5#1)(1993-2#1)(1997-4#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)(2011-1#1)
very high incidence of##2##4##(2007-10#1)(2007-2#1)
very high incidence##3##3##(1990-1#1)(2007-10#1)(2007-2#1)
very high level of##7##4##(1990-2#1)(1991-9#1)(2008-10#2)(2011-1#2)(2013-1#1)
very high level##9##3##(1990-2#1)(1991-9#1)(1992-8#1)(1993-6#1)(2008-10#2)(2011-1#2)(2013-1#1)
very high levels in##2##4##(1997-4#1)(2008-10#1)
very high levels of##10##4##(1997-7#2)(2005-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)
very high levels##16##3##(1992-8#1)(1996-11#1)(1996-8#1)(1997-4#1)(1997-7#3)(2005-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)
very high molecular weight##5##4##(1990-7#1)(1991-12#1)(1991-2#1)(1996-6#1)(2008-5#1)
very high mortality##6##3##(1996-3#1)(2008-5#1)(2010-5#1)(2013-1#3)
very high or very low##4##5##(2008-1#1)(2013-1#2)(2013-8#1)
very high or##5##3##(2008-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
very high overall##3##3##(2008-10#1)(2013-1#2)
very high prevalence of##2##4##(1995-7#1)(2011-2#1)
very high prevalence##4##3##(1991-12#1)(1995-7#1)(2009-4#1)(2011-2#1)
very high rates##2##3##(2007-1#1)(2010-2#1)
very high risk for##2##4##(2006-10#1)(2011-2#1)
very high risk of##4##4##(1996-5#1)(2008-3#1)(2009-12#1)(2010-5#1)
very high risk##11##3##(1992-5#1)(1996-5#1)(2006-10#1)(2007-8#1)(2008-1#2)(2008-3#1)(2009-12#1)(2010-5#1)(2011-12#1)(2011-2#1)
very high selectivity##3##3##(2008-10#2)(2008-7#1)
very high serum##3##3##(1991-6#1)(1993-2#1)(2008-6#1)
very high specific radioactivity##2##4##(1990-12#2)
very high specificity##2##3##(2008-4#1)(2010-8#1)
very high##292##2##(1990-1#1)(1990-11#1)(1990-12#4)(1990-2#1)(1990-5#2)(1990-7#3)(1990-9#1)(1991-1#1)(1991-12#4)(1991-2#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-2#5)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#3)(1994-2#3)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-4#1)(1995-5#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#2)(1996-6#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#5)(1997-6#4)(1997-7#5)(1997-8#1)(2005-10#2)(2005-11#1)(2005-12#2)(2005-7#1)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#4)(2007-11#5)(2007-12#6)(2007-2#2)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#8)(2008-10#41)(2008-11#5)(2008-12#3)(2008-2#4)(2008-3#6)(2008-4#6)(2008-5#10)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#3)(2009-12#2)(2009-2#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#6)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#4)(2012-6#1)(2013-1#11)(2013-7#1)(2013-8#4)
very high-risk persons##2##3##(1993-9#2)
very high-risk##3##2##(1993-9#2)(1996-9#1)
very high-speed##3##2##(2007-11#2)(2008-2#1)
very highly significant##4##3##(2012-12#3)(2012-2#1)
very highly##7##2##(2008-4#2)(2012-12#3)(2012-2#1)(2013-8#1)
very homogeneous##2##2##(2008-10#1)(2013-8#1)
very hot##2##2##(1995-5#1)(1995-9#1)
very hydrophilic##2##2##(1997-2#1)(2008-10#1)
very hydrophobic##4##2##(1990-10#1)(1990-4#1)(1995-4#1)(2008-10#1)
very important and##4##3##(1990-5#1)(1990-8#1)(2012-2#1)(2012-3#1)
very important applications of##2##4##(2008-7#2)
very important factor##3##3##(2007-7#1)(2008-5#1)(2013-1#1)
very important factors in##3##4##(2007-11#1)(2007-8#1)(2011-2#1)
very important for the correct##3##5##(1993-8#1)(2008-1#1)(2009-2#1)
very important for the##13##4##(1993-8#1)(1995-6#1)(2005-11#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2012-2#1)
very important for##33##3##(1990-12#1)(1991-10#1)(1992-12#1)(1993-8#1)(1994-2#1)(1995-6#1)(1996-11#1)(2005-11#1)(2006-12#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#3)(2008-7#2)(2008-9#1)(2009-2#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
very important in the##4##4##(2007-11#1)(2008-1#3)
very important in##16##3##(1990-12#1)(1990-9#1)(1992-11#1)(1993-10#1)(1994-5#1)(1997-1#1)(2006-8#1)(2007-11#1)(2007-3#2)(2007-8#1)(2008-1#3)(2008-10#2)
very important part of the##2##5##(2006-6#1)(2007-11#1)
very important role in the##3##5##(2006-12#1)(2008-5#1)(2010-5#1)
very important role in##8##4##(1990-9#1)(2006-12#1)(2007-8#1)(2008-5#1)(2008-9#1)(2009-2#1)(2010-5#1)(2012-2#1)
very important role##11##3##(1990-9#1)(2005-10#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-2#1)(2010-5#1)(2012-2#1)
very important roles in##2##4##(1995-9#1)(2008-4#1)
very important roles##3##3##(1995-9#1)(2008-11#1)(2008-4#1)
very important since##3##3##(1992-10#1)(1993-12#1)(2007-12#1)
very important to the##2##4##(2010-7#1)(2013-8#1)
very important to##21##3##(1991-6#1)(2006-10#2)(2006-8#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#2)(2013-8#1)
very important##181##2##(1990-12#2)(1990-5#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-10#1)(1993-12#3)(1993-8#1)(1994-2#2)(1994-4#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#1)(1997-1#1)(2005-10#1)(2005-11#2)(2005-5#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#5)(2006-12#2)(2006-5#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-11#10)(2007-12#2)(2007-3#3)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#8)(2008-10#13)(2008-11#7)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#3)(2009-12#1)(2009-2#2)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#5)(2010-4#2)(2010-5#4)(2010-7#4)(2010-9#1)(2011-2#8)(2012-1#3)(2012-2#5)(2012-3#4)(2013-1#2)(2013-8#4)
very importantly##2##2##(2007-5#1)(2007-7#1)
very indirect##2##2##(2007-9#1)(2008-3#1)
very inert##2##2##(2008-10#1)(2009-2#1)
very inexpensive##3##2##(2008-10#3)
very informative##3##2##(2007-11#1)(2007-2#1)(2008-4#1)
very infrequent##3##2##(1992-5#1)(2007-11#1)(2008-8#1)
very intense##5##2##(2007-12#2)(2008-10#2)(2008-2#1)
very interesting and##2##3##(2005-10#1)(2012-2#1)
very interesting##18##2##(1993-9#1)(1994-2#1)(1996-5#1)(2005-10#1)(2006-12#1)(2006-4#1)(2008-10#3)(2008-5#3)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
very isolated##2##2##(2008-9#1)(2011-2#1)
very large amounts of##2##4##(2008-2#1)(2009-12#1)
very large and##8##3##(1995-12#1)(2007-12#1)(2008-2#2)(2008-8#2)(2010-7#1)(2012-2#1)
very large aperture##2##3##(2008-3#2)
very large coalesced LCA consisting##2##5##(1997-6#2)
very large groups##2##3##(1993-12#1)(2008-10#1)
very large molecular weight##2##4##(1996-1#2)
very large numbers of##3##4##(2007-11#1)(2008-7#1)(2011-2#1)
very large scale##4##3##(1991-11#1)(2007-11#1)(2008-2#1)(2010-4#1)
very large##86##2##(1990-8#1)(1991-11#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1993-12#2)(1994-12#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-12#1)(1996-3#1)(1996-8#1)(1997-6#2)(1997-8#1)(2004-12#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-11#5)(2007-12#8)(2007-2#1)(2007-4#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#8)(2008-3#7)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-6#2)(2010-1#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
very large-scale integration (VLSI) implementation of a##2##7##(2008-2#2)
very large-scale integration (VLSI) implementation of##3##6##(2008-2#3)
very large-scale integration (VLSI)##6##4##(2008-2#6)
very large-scale##7##2##(2008-2#7)
very late stent##2##3##(2008-11#1)(2008-12#1)
very late##14##2##(1991-4#1)(1997-3#2)(1997-4#5)(2007-7#1)(2008-11#1)(2008-12#1)(2009-12#1)(2009-5#1)(2012-1#1)
very less##3##2##(2007-10#1)(2008-12#1)(2009-6#1)
very lightly##2##2##(1990-7#1)(1997-2#1)
very likely a##3##3##(1990-12#1)(2008-3#1)(2008-5#1)
very likely that##4##3##(2008-1#1)(2008-3#1)(2008-9#1)(2013-1#1)
very likely to be##5##4##(2006-2#2)(2007-4#1)(2008-1#1)(2008-7#1)
very likely to##11##3##(1994-3#1)(1996-9#1)(2006-2#2)(2007-4#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-3#1)(2013-1#2)
very likely##27##2##(1990-12#1)(1990-4#1)(1990-5#1)(1991-12#1)(1992-5#1)(1992-8#1)(1994-3#1)(1994-8#1)(1996-9#1)(2005-12#1)(2005-2#1)(2006-2#2)(2007-4#1)(2008-1#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2012-3#1)(2013-1#3)
very limited and the##2##4##(2008-10#1)(2008-7#1)
very limited and##3##3##(2008-10#2)(2008-7#1)
very limited information on##2##4##(2005-7#1)(2006-12#1)
very limited sequence##2##3##(1990-5#1)(1994-11#1)
very limited##43##2##(1990-5#1)(1991-2#1)(1993-1#1)(1994-11#1)(1995-1#1)(1996-11#1)(1997-8#1)(2005-11#1)(2005-7#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-4#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-12#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2012-2#2)(2012-7#1)
very little about##2##3##(2006-4#1)(2009-11#1)
very little attention##3##3##(2006-8#1)(2007-8#1)(2008-6#1)
very little change in##2##4##(1991-2#1)(1992-6#1)
very little data##4##3##(2008-8#1)(2009-6#1)(2011-2#1)(2012-12#1)
very little evidence##2##3##(2006-2#1)(2007-8#1)
very little in the##2##4##(2007-10#1)(2007-8#1)
very little increase in##2##4##(2008-7#1)(2012-12#1)
very little information about##2##4##(2008-11#1)(2009-11#1)
very little information is##2##4##(2009-4#1)(2013-1#1)
very little information##6##3##(1994-3#1)(2008-1#1)(2008-11#1)(2009-11#1)(2009-4#1)(2013-1#1)
very little is known about the##8##6##(1995-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-5#1)
very little is known about##12##5##(1995-3#1)(1995-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-9#1)(2010-5#1)(2010-8#1)(2013-7#1)
very little of the##3##4##(2008-7#1)(2009-4#1)(2012-2#1)
very little or no##4##4##(1992-7#1)(1994-11#1)(1994-6#1)(2008-5#1)
very little or##5##3##(1992-7#1)(1994-11#1)(1994-6#1)(2008-5#1)(2009-6#1)
very little research has##3##4##(2007-6#1)(2008-11#1)(2008-9#1)
very little research##5##3##(2007-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)
very little response##2##3##(2008-10#1)(2008-9#1)
very little sequence identity##2##4##(1995-11#1)(1995-5#1)
very little work has been done##2##6##(2007-6#1)(2008-5#1)
very little work has been##4##5##(2007-6#1)(2008-5#2)(2013-8#1)
very little work has##5##4##(2007-6#1)(2008-5#2)(2009-7#1)(2013-8#1)
very little work##6##3##(2007-6#1)(2008-5#2)(2008-6#1)(2009-7#1)(2013-8#1)
very little##119##2##(1990-11#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-2#2)(1991-3#1)(1992-11#1)(1992-12#4)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-4#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-3#1)(1996-4#2)(1996-7#1)(1996-8#1)(1997-1#3)(1997-4#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-6#3)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#4)(2008-2#2)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#3)(2009-11#2)(2009-4#3)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
very long chain fatty acids##5##5##(1990-11#2)(1991-10#1)(1994-6#2)
very long chain fatty##7##4##(1990-11#2)(1991-10#1)(1992-3#1)(1994-12#1)(1994-6#2)
very long chain##8##3##(1990-11#2)(1991-10#1)(1992-3#1)(1994-12#1)(1994-6#2)(2012-2#1)
very long delays##2##3##(1990-12#1)(2009-11#1)
very long time##3##3##(1995-9#1)(2008-2#1)(2009-12#1)
very long##28##2##(1990-11#2)(1990-12#1)(1991-10#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-9#1)(1994-12#2)(1994-6#2)(1995-9#1)(1997-7#1)(2004-1#1)(2005-11#1)(2006-6#1)(2007-7#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2011-2#1)(2012-2#1)
very low (&lt##3##3##(2008-3#2)(2012-3#1)
very low (0##4##3##(1992-11#1)(2007-5#1)(2008-10#1)(2008-7#1)
very low activity##3##3##(1991-12#1)(1991-6#1)(1997-8#1)
very low affinity##4##3##(1996-6#1)(1997-2#1)(2008-1#1)(2008-10#1)
very low amounts of##2##4##(1992-3#1)(1997-2#1)
very low and##6##3##(1990-4#1)(1995-2#1)(2005-11#1)(2008-1#1)(2009-11#1)(2012-12#1)
very low as##2##3##(1993-3#1)(1994-6#1)
very low at##3##3##(1995-9#1)(2008-10#1)(2008-5#1)
very low birth weight infants##4##5##(1993-5#1)(1995-8#2)(2012-2#1)
very low birth weight##17##4##(1992-7#1)(1993-5#2)(1995-6#1)(1995-8#2)(2004-10#1)(2006-10#3)(2007-8#2)(2008-6#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-2#1)
very low birth weights##2##4##(1994-6#1)(2007-1#1)
very low birth##19##3##(1992-7#1)(1993-5#2)(1994-6#1)(1995-6#1)(1995-8#2)(2004-10#1)(2006-10#3)(2007-1#1)(2007-8#2)(2008-6#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-2#1)
very low birthweight infants##3##4##(1990-9#1)(2010-10#2)
very low birthweight##5##3##(1990-9#1)(1994-6#1)(2004-10#1)(2010-10#2)
very low compared with##3##4##(2007-2#1)(2008-11#1)(2013-1#1)
very low compared##5##3##(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-1#1)
very low concentration of##2##4##(2008-10#1)(2013-8#1)
very low concentration##9##3##(1994-2#1)(2005-12#1)(2008-10#4)(2008-7#1)(2013-1#1)(2013-8#1)
very low concentrations of##4##4##(1991-12#1)(1994-8#1)(2006-10#1)(2008-5#1)
very low concentrations##20##3##(1990-12#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-5#1)(1994-12#1)(1994-8#1)(1997-4#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-5#1)(2009-10#1)(2013-1#1)
very low content of##2##4##(1991-4#1)(1993-6#1)
very low density lipoprotein (VLDL) and##2##6##(1993-9#1)(2008-10#1)
very low density lipoprotein (VLDL) receptor##2##6##(1995-6#1)(1995-8#1)
very low density lipoprotein (VLDL)##5##5##(1993-9#1)(1995-6#1)(1995-8#1)(2004-11#1)(2008-10#1)
very low density lipoprotein receptor##2##5##(1995-6#1)(1995-8#1)
very low density lipoprotein##16##4##(1993-12#1)(1993-4#1)(1993-8#1)(1993-9#2)(1995-6#4)(1995-8#2)(2004-11#3)(2008-10#1)(2009-2#1)
very low density lipoprotein-cholesterol and triglycerides##2##6##(2010-5#2)
very low density lipoproteins (VLDL)##4##5##(1991-12#1)(1992-12#1)(1993-8#1)(1994-3#1)
very low density lipoproteins and##2##5##(1991-12#1)(2004-11#1)
very low density lipoproteins##12##4##(1991-12#2)(1992-12#2)(1992-2#1)(1992-3#1)(1993-8#1)(1994-3#1)(1995-2#1)(1995-4#1)(2004-11#2)
very low density##34##3##(1990-2#1)(1991-12#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-12#1)(1993-4#1)(1993-8#2)(1993-9#2)(1994-3#1)(1995-2#1)(1995-4#1)(1995-6#4)(1995-8#2)(2004-11#5)(2007-9#1)(2008-10#1)(2009-2#1)(2010-5#2)(2013-1#1)
very low detection limits##2##4##(2008-10#2)
very low dose##3##3##(2006-10#1)(2008-10#1)(2008-7#1)
very low doses of##3##4##(2008-7#2)(2009-7#1)
very low doses##5##3##(2008-7#2)(2009-7#1)(2010-12#2)
very low even##2##3##(1997-7#1)(2007-12#1)
very low frequencies##2##3##(2008-10#1)(2011-2#1)
very low frequency##4##3##(2008-5#1)(2008-8#1)(2010-7#1)(2013-8#1)
very low in comparison with##2##5##(2008-8#1)(2011-1#1)
very low in the##7##4##(1995-11#1)(2007-2#1)(2008-1#1)(2008-10#3)(2012-12#1)
very low in##13##3##(1995-11#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#5)(2008-5#1)(2008-8#1)(2011-1#1)(2012-12#1)
very low incidence of##5##4##(1990-6#1)(1991-3#1)(1996-4#1)(2006-1#1)(2006-10#1)
very low level of##4##4##(1996-7#1)(2007-7#1)(2007-8#1)(2008-10#1)
very low level##8##3##(1992-11#1)(1995-7#1)(1996-7#1)(2005-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2012-12#1)
very low levels and##2##4##(1994-2#1)(2008-9#1)
very low levels of##16##4##(1990-12#1)(1992-10#1)(1992-12#1)(1993-8#1)(1994-8#1)(1995-7#1)(1996-8#1)(2004-2#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-7#1)(2013-8#1)
very low levels##31##3##(1990-12#1)(1990-6#1)(1991-5#1)(1992-10#1)(1992-12#1)(1993-3#2)(1993-8#1)(1994-2#1)(1994-8#1)(1995-7#1)(1996-8#1)(1997-6#1)(2004-2#1)(2004-9#1)(2005-8#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-7#1)(2013-8#1)
very low limit of detection##2##5##(2008-10#2)
very low or undetectable##4##4##(1994-8#1)(1997-1#1)(2008-10#1)(2012-2#1)
very low or##7##3##(1994-8#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-2#1)
very low output##2##3##(1995-3#1)(2010-8#1)
very low rates##2##3##(2006-7#1)(2011-2#1)
very low risk##4##3##(2008-7#1)(2009-3#1)(2013-1#2)
very low signal##2##3##(1991-11#1)(2008-10#1)
very low solubility##2##3##(1997-1#1)(2008-7#1)
very low surface##3##3##(2005-11#1)(2009-7#1)(2010-4#1)
very low temperatures##4##3##(1991-2#1)(2008-5#1)(2008-9#1)(2012-2#1)
very low to##5##3##(1995-2#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
very low weight##2##3##(2007-8#1)(2012-2#1)
very low##444##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#2)(1990-8#2)(1990-9#2)(1991-11#4)(1991-12#4)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#5)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#5)(1992-12#4)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-10#1)(1993-12#3)(1993-3#5)(1993-4#3)(1993-5#2)(1993-6#1)(1993-8#3)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#1)(1994-6#3)(1994-8#4)(1995-1#1)(1995-10#2)(1995-11#3)(1995-2#4)(1995-3#2)(1995-4#2)(1995-5#1)(1995-6#5)(1995-7#3)(1995-8#6)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#2)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#2)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(1997-9#1)(2004-10#4)(2004-11#5)(2004-2#1)(2004-4#1)(2004-9#1)(2005-11#7)(2005-12#4)(2005-7#2)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#7)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#1)(2006-9#2)(2007-1#1)(2007-11#5)(2007-12#6)(2007-2#3)(2007-3#1)(2007-5#2)(2007-7#2)(2007-8#8)(2007-9#1)(2008-1#6)(2008-10#61)(2008-11#10)(2008-12#1)(2008-2#10)(2008-3#6)(2008-4#2)(2008-5#10)(2008-6#2)(2008-7#11)(2008-8#7)(2008-9#3)(2009-10#2)(2009-11#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#11)(2012-1#3)(2012-12#7)(2012-2#10)(2012-3#2)(2012-8#1)(2013-1#10)(2013-7#2)(2013-8#6)
very low-density lipoprotein (VLDL)##3##4##(1991-7#1)(2008-10#1)(2008-7#1)
very low-density lipoprotein##6##3##(1991-7#1)(1994-6#1)(2005-10#1)(2008-10#1)(2008-7#1)(2009-8#1)
very low-density lipoproteins##2##3##(2007-1#1)(2009-12#1)
very low-density##8##2##(1991-7#1)(1994-6#1)(2005-10#1)(2007-1#1)(2008-10#1)(2008-7#1)(2009-12#1)(2009-8#1)
very low-protein diet##2##3##(2007-8#2)
very marked##2##2##(1990-5#1)(2010-8#1)
very mild##8##2##(1991-2#1)(2007-11#4)(2008-10#1)(2009-11#1)(2012-12#1)
very mildly##2##2##(1994-9#1)(2008-3#1)
very minor##5##2##(1994-12#1)(1997-6#1)(2006-12#1)(2008-10#1)(2009-4#1)
very modest##7##2##(1994-12#1)(1995-8#1)(2008-1#2)(2008-11#1)(2009-4#1)(2012-3#1)
very much higher##2##3##(1994-11#1)(2008-8#1)
very much##18##2##(1990-9#1)(1994-11#1)(1996-11#1)(1997-1#1)(2004-3#1)(2005-8#1)(2006-6#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)
very narrow##6##2##(1991-7#1)(1991-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2010-8#1)
very nature##6##2##(2007-11#1)(2007-12#2)(2008-8#1)(2009-4#1)(2010-12#1)
very near##6##2##(1991-12#1)(1997-6#1)(2008-10#1)(2008-4#1)(2012-12#1)(2013-1#1)
very negative##4##2##(1992-8#1)(2007-12#2)(2009-11#1)
very nonpolar compounds##2##3##(2008-10#2)
very noticeable##2##2##(1992-2#1)(2007-9#1)
very obese women##4##3##(2008-3#4)
very obese##6##2##(1991-8#1)(2006-1#1)(2008-3#4)
very often is##2##3##(2007-8#1)(2011-2#1)
very often##20##2##(1992-4#1)(1995-12#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-3#1)(2011-2#2)(2013-8#1)
very old age##4##3##(1990-11#1)(2008-7#3)
very old##13##2##(1990-11#1)(1992-12#1)(1993-11#2)(1993-2#1)(1994-6#1)(1996-8#1)(2007-9#1)(2008-1#1)(2008-7#3)(2009-5#1)
very painful##3##2##(1990-7#1)(2005-7#1)(2012-12#1)
very peculiar##2##2##(1997-4#1)(2011-2#1)
very personal##2##2##(2006-2#1)(2007-7#1)
very polar##2##2##(1997-2#1)(1997-3#1)
very poor in##2##3##(1991-6#1)(2006-5#1)
very poor prognosis and##2##4##(2010-12#1)(2010-6#1)
very poor prognosis##9##3##(1991-11#1)(2006-6#1)(2007-10#1)(2007-2#2)(2010-1#1)(2010-12#1)(2010-6#1)(2010-9#1)
very poor substrates##2##3##(1991-4#1)(1991-5#1)
very poor##37##2##(1990-4#1)(1991-10#1)(1991-11#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-8#1)(1995-5#1)(1996-6#1)(2006-5#1)(2006-6#2)(2007-10#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-5#1)(2010-1#1)(2010-12#2)(2010-6#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#3)
very poorly##6##2##(1991-11#1)(1992-9#1)(2006-5#1)(2009-5#1)(2010-10#1)(2010-3#1)
very popular in##3##3##(2008-10#2)(2011-2#1)
very popular##10##2##(2004-11#1)(2007-8#2)(2008-10#3)(2010-7#1)(2011-12#1)(2011-2#1)(2012-3#1)
very positive and##2##3##(2008-11#1)(2011-7#1)
very positive##11##2##(1992-12#1)(1993-1#1)(1996-3#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-12#1)(2011-2#1)(2011-7#1)(2013-1#1)
very potent and##2##3##(1992-3#1)(2005-8#1)
very potent inhibitor of##3##4##(1990-10#1)(1991-8#1)(2008-11#1)
very potent series of compounds##2##5##(1995-3#1)(2008-3#1)
very potent##13##2##(1990-10#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-3#1)(1995-3#1)(1996-5#1)(1996-8#1)(2005-8#1)(2006-12#1)(2008-11#1)(2008-3#1)(2013-8#1)
very powerful##19##2##(1990-4#1)(1992-10#1)(1994-6#1)(1995-1#1)(1995-12#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-7#1)(2011-2#1)(2012-1#1)(2013-1#2)
very precise##7##2##(1991-8#1)(1993-8#1)(2008-10#3)(2008-11#1)(2008-9#1)
very precisely##6##2##(2006-5#1)(2007-11#1)(2008-10#1)(2009-4#1)(2012-1#1)(2012-12#1)
very preliminary in##2##3##(2008-5#1)(2008-6#1)
very preliminary results##2##3##(2008-1#1)(2011-2#1)
very preliminary##5##2##(1991-1#1)(2008-1#1)(2008-5#1)(2008-6#1)(2011-2#1)
very premature infants##4##3##(1993-5#2)(2007-11#1)(2011-2#1)
very premature##6##2##(1993-5#3)(2006-1#1)(2007-11#1)(2011-2#1)
very preterm infant##2##3##(1993-12#1)(2012-2#1)
very preterm##10##2##(1990-9#1)(1993-12#1)(1994-6#1)(1997-5#1)(2011-2#5)(2012-2#1)
very productive##2##2##(2006-4#1)(2011-2#1)
very prominent##4##2##(1995-9#1)(2007-2#1)(2008-10#1)(2008-9#1)
very promising for##4##3##(2007-9#1)(2008-5#1)(2008-7#1)(2011-2#1)
very promising in##3##3##(2008-1#1)(2008-10#1)(2008-5#1)
very promising##31##2##(1990-9#1)(1996-12#1)(1996-3#1)(2005-11#1)(2005-7#1)(2006-6#1)(2007-11#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#2)(2009-9#1)(2010-7#2)(2011-2#1)(2012-2#4)(2013-8#1)
very pure##4##2##(1996-8#1)(2008-11#1)(2008-4#1)(2012-10#1)
very quickly##9##2##(1990-6#1)(1991-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)(2012-1#1)
very rapid and simple##3##4##(1990-4#1)(2008-10#1)(2008-4#1)
very rapid effectiveness of##2##4##(1990-2#1)(1991-3#1)
very rapid##24##2##(1990-11#1)(1990-2#2)(1990-4#1)(1991-10#1)(1991-3#1)(1991-9#1)(1992-2#1)(1993-11#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1996-12#1)(2006-3#1)(2007-7#1)(2008-10#4)(2008-4#1)(2008-5#1)(2009-12#1)(2009-6#1)
very rapidly and##2##3##(2006-10#1)(2012-2#1)
very rapidly##15##2##(1990-8#1)(1991-5#1)(1995-3#1)(1995-7#1)(1996-11#1)(1997-6#1)(2006-10#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-3#1)(2012-12#1)(2012-2#2)
very rare and##17##3##(1991-3#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-7#2)(2010-12#2)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
very rare benign##3##3##(1992-2#1)(2011-2#1)(2013-7#1)
very rare case of##7##4##(1994-7#1)(2008-5#1)(2008-7#2)(2010-5#1)(2011-2#2)
very rare case##8##3##(1994-7#1)(2007-11#1)(2008-5#1)(2008-7#2)(2010-5#1)(2011-2#2)
very rare disease##3##3##(2006-8#1)(2008-9#1)(2013-8#1)
very rare in the##3##4##(1990-11#1)(2013-1#2)
very rare in##9##3##(1990-11#1)(1991-11#1)(1996-8#1)(2009-8#1)(2012-2#1)(2013-1#4)
very rare##160##2##(1990-10#1)(1990-11#1)(1990-6#1)(1991-11#1)(1991-3#3)(1991-9#2)(1992-2#1)(1992-5#1)(1993-9#1)(1994-7#1)(1995-4#1)(1996-10#1)(1996-8#1)(1996-9#1)(1997-5#1)(1997-6#2)(1997-8#1)(2005-12#2)(2006-10#5)(2006-12#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-8#8)(2008-10#3)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#3)(2008-7#9)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-4#2)(2009-6#1)(2009-7#3)(2009-8#2)(2010-11#2)(2010-12#4)(2010-5#2)(2010-6#5)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#10)(2012-1#2)(2012-12#7)(2012-2#6)(2012-3#1)(2013-1#15)(2013-7#2)(2013-8#7)
very rarely in the##2##4##(1994-10#1)(2012-12#1)
very rarely in##3##3##(1994-10#1)(2012-12#1)(2013-8#1)
very rarely##10##2##(1990-12#1)(1991-5#1)(1992-9#1)(1994-10#1)(2008-7#2)(2012-12#2)(2012-2#1)(2013-8#1)
very real##5##2##(1992-2#1)(1994-2#1)(1997-6#1)(2008-3#1)(2008-5#1)
very recent##5##2##(2005-7#1)(2006-5#1)(2008-8#1)(2008-9#1)(2013-1#1)
very recently##8##2##(1990-7#1)(1993-6#1)(1995-2#1)(2005-7#1)(2007-3#1)(2008-11#1)(2008-5#1)(2008-6#1)
very reduced##2##2##(2006-10#1)(2008-11#1)
very relevant##2##2##(1993-3#1)(2010-2#1)
very reliable and##3##3##(2007-5#1)(2008-10#1)(2011-2#1)
very reliable##7##2##(2006-3#1)(2007-5#1)(2008-10#2)(2011-2#1)(2012-2#2)
very resistant to##4##3##(1994-2#1)(2008-10#1)(2009-5#1)(2012-2#1)
very resistant##5##2##(1994-2#1)(2008-10#1)(2008-5#1)(2009-5#1)(2012-2#1)
very restricted##5##2##(1993-12#1)(1993-7#1)(2007-2#1)(2008-10#1)(2008-8#1)
very restrictive##2##2##(1995-4#1)(2008-11#1)
very rewarding##3##2##(1990-9#1)(1991-2#1)(1997-8#1)
very rich and##2##3##(2008-12#1)(2013-8#1)
very rich##4##2##(1991-1#1)(2008-12#1)(2008-3#1)(2013-8#1)
very rigid##3##2##(1991-5#1)(2005-11#1)(2006-10#1)
very robust##2##2##(2007-12#1)(2008-9#1)
very safe##3##2##(1994-9#1)(2008-7#1)(2012-2#1)
very same##4##2##(1992-4#1)(1997-8#1)(2008-7#1)(2009-4#1)
very satisfactory results##3##3##(2008-10#1)(2009-10#1)(2011-2#1)
very satisfactory##12##2##(1990-5#1)(1991-2#1)(1995-9#1)(2007-8#1)(2008-10#5)(2008-9#1)(2009-10#1)(2011-2#1)
very satisfied with push HIE##4##5##(2013-1#4)
very satisfied with the##3##4##(1992-5#1)(1994-1#1)(2008-9#1)
very satisfied with##11##3##(1992-5#1)(1993-3#1)(1994-1#1)(2008-9#1)(2011-2#1)(2013-1#6)
very scarce##2##2##(1994-2#1)(2006-1#1)
very seldom##3##2##(1992-12#1)(2011-2#1)(2013-1#1)
very selective for##2##3##(2008-10#1)(2010-5#1)
very selective##5##2##(1991-10#1)(2008-10#3)(2010-5#1)
very sensitive and##7##3##(1994-3#1)(2005-9#1)(2007-2#1)(2008-10#2)(2008-11#1)(2012-3#1)
very sensitive method for##2##4##(1996-1#1)(2008-10#1)
very sensitive method##4##3##(1996-1#1)(2008-10#3)
very sensitive to both compounds##2##5##(2004-4#1)(2007-3#1)
very sensitive to pH##2##4##(1990-9#1)(2013-8#1)
very sensitive to the##7##4##(1992-6#1)(2004-9#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-11#1)
very sensitive to##29##3##(1990-5#1)(1990-7#1)(1990-9#1)(1991-7#1)(1992-6#1)(1994-8#1)(2004-4#1)(2004-9#1)(2006-11#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-2#2)(2011-2#1)(2012-11#1)(2012-12#1)(2013-8#1)
very sensitive##66##2##(1990-12#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-7#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-5#1)(1994-3#1)(1994-8#2)(1996-1#1)(1996-9#1)(2004-4#1)(2004-9#1)(2005-9#1)(2006-11#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2010-11#1)(2010-2#2)(2010-3#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-3#1)(2013-8#1)
very sensitively##2##2##(2005-1#1)(2013-8#1)
very serious##13##2##(1993-12#1)(1995-3#1)(2005-1#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#1)
very seriously##2##2##(1994-3#1)(2010-8#1)
very severe##15##2##(1990-9#2)(1996-12#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-10#3)(2008-8#1)(2008-9#1)(2010-6#1)(2012-2#1)
very sharp##3##2##(1995-3#1)(1996-5#1)(2008-5#1)
very short (&lt##2##3##(2007-12#2)
very short and##2##3##(2008-5#2)
very short period##3##3##(1992-6#1)(2006-4#1)(2008-10#1)
very short response time##3##4##(2007-8#1)(2008-10#2)
very short time##6##3##(1995-7#1)(1996-8#1)(2006-2#1)(2008-10#1)(2008-11#2)
very short times##3##3##(1997-6#1)(2005-11#1)(2008-11#1)
very short##43##2##(1990-5#1)(1991-7#1)(1992-6#1)(1994-3#1)(1995-12#2)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-6#1)(2005-11#1)(2005-7#1)(2006-2#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#1)(2010-5#1)(2012-2#1)
very sick##2##2##(2008-8#1)(2012-3#1)
very significant decrease##2##3##(2010-3#1)(2011-2#1)
very significant##17##2##(1990-5#1)(1990-8#1)(1991-11#1)(1993-8#1)(1997-2#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-4#1)(2007-7#1)(2008-5#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-1#1)(2013-1#1)
very significantly##5##2##(1990-6#1)(2008-12#2)(2009-2#1)(2009-5#1)
very similar but##2##3##(1993-6#1)(2011-1#1)
very similar for##5##3##(1995-3#1)(1996-11#1)(1997-1#1)(2008-10#2)
very similar in the##3##4##(1992-8#1)(1993-11#1)(1995-2#1)
very similar in##13##3##(1990-11#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-12#1)(1995-2#1)(2005-7#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-4#1)(2012-2#1)
very similar properties##2##3##(1991-3#1)(2008-10#1)
very similar rates##2##3##(2008-11#1)(2013-1#1)
very similar to each other##3##5##(1991-5#1)(1994-6#1)(2008-10#1)
very similar to other##2##4##(1991-9#1)(2010-11#1)
very similar to that observed in##2##6##(1990-8#1)(1994-9#1)
very similar to that observed##4##5##(1990-2#1)(1990-8#1)(1994-9#1)(1995-8#1)
very similar to that of other##2##6##(1993-2#1)(1995-1#1)
very similar to that of the##7##6##(1990-3#1)(1991-7#1)(1994-2#1)(1996-11#1)(1997-4#1)(2008-5#1)(2008-8#1)
very similar to that of##20##5##(1990-3#1)(1991-7#1)(1992-8#1)(1993-2#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-11#1)(1996-11#1)(1996-12#1)(1997-4#1)(2005-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)
very similar to that reported for##2##6##(1995-1#1)(2008-7#1)
very similar to that##31##4##(1990-2#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-7#1)(1992-4#1)(1992-8#1)(1993-2#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-12#1)(1997-4#1)(2005-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
very similar to the##16##4##(1991-4#1)(1993-8#1)(1994-12#3)(1995-8#1)(1996-9#1)(2007-12#1)(2008-10#4)(2009-8#1)(2011-1#1)(2012-2#1)(2013-7#1)
very similar to those observed##2##5##(1997-8#1)(2006-10#1)
very similar to those obtained##2##5##(1993-11#1)(1993-8#1)
very similar to those of the##7##6##(1992-3#2)(1993-6#1)(1994-11#1)(1995-12#1)(1996-6#1)(1997-4#1)
very similar to those of##18##5##(1992-11#1)(1992-3#2)(1992-8#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-8#1)(1995-12#1)(1996-6#1)(1997-4#2)(2006-10#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-7#1)
very similar to those reported for##2##6##(1990-3#1)(1997-4#1)
very similar to those##36##4##(1990-3#1)(1991-4#1)(1992-11#2)(1992-3#2)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-6#2)(1997-4#3)(1997-8#1)(2006-10#2)(2006-12#1)(2008-10#1)(2008-2#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)
very similar to##116##3##(1990-2#1)(1990-3#2)(1990-4#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-3#3)(1992-4#1)(1992-8#3)(1993-11#2)(1993-2#2)(1993-6#1)(1993-8#4)(1994-11#3)(1994-12#3)(1994-2#2)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-6#2)(1996-9#1)(1997-4#4)(1997-8#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#9)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-8#1)(2010-11#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-7#1)
very similar##231##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#3)(1990-7#2)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#2)(1992-7#1)(1992-8#4)(1992-9#1)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#3)(1993-8#4)(1993-9#1)(1994-11#4)(1994-12#5)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#3)(1995-1#7)(1995-10#5)(1995-11#4)(1995-12#2)(1995-2#2)(1995-3#4)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-11#2)(1996-12#2)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#4)(1997-7#1)(1997-8#4)(2005-10#1)(2005-4#1)(2005-7#1)(2006-10#4)(2006-12#2)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-5#1)(2007-7#1)(2007-9#2)(2008-1#3)(2008-10#28)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-5#1)(2009-8#3)(2010-11#1)(2010-5#1)(2011-1#3)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)
very simple and fast##3##4##(2008-10#2)(2008-3#1)
very simple and sensitive##2##4##(2007-8#1)(2008-10#1)
very simple and##17##3##(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#3)(2008-10#7)(2008-2#1)(2008-3#1)(2008-4#1)
very simple##60##2##(1990-8#1)(1992-2#1)(1992-8#1)(1997-8#1)(2005-4#1)(2006-4#1)(2006-7#2)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#28)(2008-2#7)(2008-3#3)(2008-4#2)(2009-6#1)(2011-1#1)(2012-2#1)
very simply##2##2##(1992-9#1)(2008-10#1)
very slight or no##2##4##(2008-10#2)
very slight##5##2##(1995-1#1)(1995-6#1)(1996-2#1)(2008-10#2)
very slightly##5##2##(1994-3#1)(1994-5#1)(2008-10#2)(2008-5#1)
very slow in comparison to##2##5##(1991-10#1)(2013-1#1)
very slow##19##2##(1990-3#1)(1991-10#2)(1992-12#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-11#1)(1997-2#1)(1997-4#1)(2005-10#1)(2006-12#1)(2006-4#1)(2008-1#1)(2008-10#3)(2013-1#1)
very slowly between##2##3##(2005-10#1)(2008-2#1)
very slowly##14##2##(1990-1#1)(1991-6#1)(1993-5#2)(1994-12#1)(1996-2#1)(1997-6#1)(2005-10#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)
very small amounts of##4##4##(2008-10#2)(2008-6#1)(2008-9#1)
very small and##4##3##(2008-10#2)(2010-12#1)(2013-7#1)
very small fraction of##2##4##(1991-5#1)(2008-11#1)
very small lesions##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
very small number of##4##4##(1997-2#1)(2006-12#1)(2007-11#1)(2008-7#1)
very small number##6##3##(1995-5#1)(1997-2#1)(2006-12#1)(2007-11#1)(2008-7#1)(2010-2#1)
very small quantities##2##3##(2008-10#1)(2009-10#1)
very small sample volumes##2##4##(1990-6#1)(2011-2#1)
very small sample##3##3##(1990-6#1)(2011-2#2)
very small##110##2##(1990-3#1)(1990-6#1)(1990-7#1)(1991-12#3)(1991-5#2)(1991-7#1)(1992-10#1)(1992-11#1)(1992-9#2)(1993-11#1)(1993-3#2)(1993-6#1)(1993-7#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-10#3)(2006-12#2)(2006-3#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#4)(2008-10#20)(2008-11#3)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#5)(2009-10#1)(2009-6#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-2#2)(2013-1#1)(2013-7#2)
very smooth##2##2##(2007-12#1)(2008-5#1)
very soon after the##2##4##(2008-7#2)
very soon after##6##3##(2007-11#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#2)
very soon##8##2##(2007-11#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#2)(2010-1#1)(2011-2#1)
very sparse##3##2##(2007-12#1)(2008-7#1)(2012-12#1)
very special##2##2##(2009-4#1)(2011-12#1)
very specific and##2##3##(1997-2#1)(2007-11#1)
very specific##26##2##(1990-4#1)(1990-5#1)(1991-5#1)(1992-8#1)(1994-6#1)(1995-3#1)(1995-5#1)(1997-2#2)(2007-11#2)(2008-1#1)(2008-10#3)(2008-8#3)(2008-9#3)(2009-5#1)(2010-2#1)(2010-8#1)(2011-2#2)
very stable and homogeneous##2##4##(2008-10#2)
very stable and##7##3##(2005-4#1)(2007-8#1)(2008-10#4)(2008-11#1)
very stable even##2##3##(2008-10#1)(2013-8#1)
very stable to##3##3##(1995-1#1)(2007-12#1)(2008-7#1)
very stable##40##2##(1990-12#2)(1990-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-3#1)(1993-11#1)(1993-12#2)(1994-12#1)(1995-1#1)(1997-1#1)(2005-4#1)(2006-10#1)(2007-12#2)(2007-8#2)(2008-10#15)(2008-11#1)(2008-5#2)(2008-7#1)(2009-2#1)(2013-8#1)
very strict##2##2##(1992-11#1)(2008-1#1)
very strong and##3##3##(1995-8#1)(2008-3#1)(2012-3#1)
very strong correlation between##2##4##(2007-8#1)(2008-7#1)
very strong positive##2##3##(1994-12#1)(2009-2#1)
very strong##35##2##(1990-10#1)(1990-12#1)(1990-7#1)(1991-1#1)(1992-12#1)(1993-3#1)(1994-12#1)(1995-10#1)(1995-8#1)(1996-8#1)(1997-8#1)(2004-9#1)(2005-11#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-4#1)(2012-3#1)
very strongly##7##2##(1990-11#1)(1990-2#1)(1992-6#1)(1993-6#1)(2006-6#1)(2008-10#1)(2009-7#1)
very successful in the##2##4##(2006-5#1)(2007-8#1)
very successful in##4##3##(2006-4#1)(2006-5#1)(2007-8#1)(2008-4#1)
very successful when##2##3##(1993-8#1)(2006-8#1)
very successful##21##2##(1993-1#1)(1993-8#1)(1994-9#1)(1995-9#1)(1997-4#1)(2006-10#1)(2006-4#1)(2006-5#2)(2006-8#1)(2006-9#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#1)(2012-12#1)(2012-2#1)
very successfully##3##2##(2008-10#2)(2008-6#1)
very suggestive##2##2##(1993-3#1)(1997-8#1)
very suitable for the##4##4##(2005-4#1)(2006-12#1)(2008-10#2)
very suitable for##9##3##(1994-6#1)(2005-4#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-2#1)(2011-2#1)
very suitable##15##2##(1994-6#1)(2005-4#1)(2006-10#1)(2006-12#1)(2007-12#2)(2008-10#5)(2008-2#1)(2008-5#1)(2009-5#1)(2011-2#1)
very susceptible to##3##3##(2006-1#1)(2008-10#2)
very susceptible##6##2##(2006-1#1)(2008-10#5)
very thin##11##2##(2005-11#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#4)(2011-12#1)(2012-3#1)
very tight##3##2##(1992-6#1)(1995-1#1)(2008-3#1)
very tightly##4##2##(1990-7#1)(1991-5#1)(1996-4#1)(2008-9#1)
very time-consuming##3##2##(2005-10#1)(2008-2#1)(2008-5#1)
very toxic##2##2##(1990-5#1)(2005-8#1)
very unbalanced##3##2##(1995-12#1)(1995-8#1)(1996-12#1)
very uncommon##8##2##(1991-6#1)(2008-7#1)(2010-12#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
very unfavorable##2##2##(1993-2#1)(2012-12#1)
very unlikely that##2##3##(1994-12#1)(2006-5#1)
very unlikely##5##2##(1992-10#1)(1994-10#1)(1994-12#1)(2006-5#1)(2008-3#1)
very unstable and##2##3##(1992-12#1)(1996-2#1)
very unstable##8##2##(1990-12#1)(1991-5#1)(1992-12#1)(1995-1#1)(1995-5#1)(1996-2#1)(2008-10#1)(2013-8#1)
very unusual case##4##3##(2006-11#1)(2007-8#1)(2008-7#1)(2013-1#1)
very unusual##18##2##(1991-4#1)(1991-6#1)(1992-10#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-11#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-7#1)(2011-2#1)(2012-2#3)(2013-1#1)
very useful and##3##3##(1996-12#1)(2007-8#1)(2008-11#1)
very useful as a##3##4##(1993-9#1)(2008-11#1)(2008-4#1)
very useful as##4##3##(1993-9#1)(2008-11#1)(2008-4#1)(2011-2#1)
very useful for monitoring##3##4##(2008-10#2)(2011-2#1)
very useful for the##4##4##(1997-2#1)(2006-11#1)(2007-8#1)(2010-2#1)
very useful for##27##3##(1995-2#1)(1997-2#1)(1997-8#1)(2005-11#1)(2005-4#1)(2006-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#6)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-2#1)
very useful in identifying##2##4##(2008-11#1)(2012-2#1)
very useful in preventing##2##4##(2006-7#1)(2007-11#1)
very useful in studying##2##4##(1994-6#1)(2008-9#1)
very useful in##27##3##(1993-11#1)(1994-3#1)(1994-6#2)(1997-6#1)(1997-8#1)(2004-11#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-2#1)(2010-12#1)(2010-2#1)(2012-2#2)(2013-1#1)
very useful to##5##3##(1991-8#1)(1992-2#1)(1997-3#1)(2008-10#1)(2013-1#1)
very useful##102##2##(1990-11#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-6#2)(1995-2#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#3)(2004-11#1)(2005-11#1)(2005-4#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-3#1)(2006-5#3)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#3)(2007-8#3)(2008-10#11)(2008-11#6)(2008-12#2)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#3)
very valuable and##2##3##(2008-7#1)(2011-12#1)
very valuable for##2##3##(2008-2#1)(2008-9#1)
very valuable##10##2##(2005-8#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-12#1)(2011-2#1)
very variable##4##2##(2005-11#2)(2011-2#1)(2013-1#1)
very varied##3##2##(1990-11#1)(1997-8#1)(2007-12#1)
very versatile##4##2##(2008-3#1)(2008-4#1)(2008-7#1)(2013-8#1)
very virulent MDV strain##3##4##(2013-8#3)
very virulent MDV##4##3##(2013-8#4)
very virulent plus (vv+)##2##4##(2013-8#2)
very virulent plus MDV##2##4##(2013-8#2)
very virulent plus##6##3##(2013-8#6)
very virulent##17##2##(2005-9#1)(2008-5#3)(2013-8#13)
very weak and##4##3##(1995-12#1)(2005-11#1)(2006-10#1)(2007-1#1)
very weak in##3##3##(1990-10#1)(1993-11#1)(1997-7#1)
very weak##43##2##(1990-10#2)(1990-8#1)(1991-3#1)(1991-7#1)(1993-11#2)(1994-6#1)(1995-12#1)(1995-2#1)(1996-2#2)(1997-7#2)(2005-11#2)(2005-4#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-2#1)(2008-4#1)(2008-7#4)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#2)
very weakly##10##2##(1990-2#1)(1990-7#1)(1992-6#1)(1992-7#1)(1993-1#2)(1994-3#1)(1995-3#1)(2007-7#1)(2008-10#1)
very well be##3##3##(1995-5#1)(2008-10#1)(2012-2#1)
very well in##2##3##(2008-3#1)(2013-1#1)
very well known##2##3##(2007-12#1)(2012-2#1)
very well to##3##3##(1997-4#1)(2007-6#1)(2007-7#1)
very well tolerated and##3##4##(1990-10#1)(1990-5#1)(1992-10#1)
very well tolerated##7##3##(1990-10#1)(1990-5#1)(1991-7#1)(1992-10#1)(1992-11#1)(2007-11#1)(2008-5#1)
very well with the##8##4##(1992-6#1)(1995-2#1)(1997-1#1)(2007-8#1)(2008-10#2)(2010-12#1)(2011-1#1)
very well with those obtained##2##5##(2008-10#2)
very well with##19##3##(1992-2#2)(1992-6#1)(1993-3#1)(1994-11#1)(1995-2#1)(1995-7#1)(1997-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2009-9#1)(2010-12#1)(2011-1#1)
very well##66##2##(1990-10#1)(1990-5#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-7#2)(1997-1#1)(1997-4#1)(2006-1#1)(2006-12#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#10)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2009-7#1)(2009-9#1)(2010-12#2)(2010-7#2)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#4)(2013-1#1)
very wide range of##2##4##(2008-6#1)(2010-7#1)
very wide range##3##3##(2007-11#1)(2008-6#1)(2010-7#1)
very wide##13##2##(1992-12#1)(1995-3#1)(2005-1#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-6#1)(2010-5#1)(2010-7#1)
very widespread##3##2##(2007-11#1)(2008-10#1)(2010-1#1)
very young age##2##3##(2010-12#1)(2011-2#1)
very young and##2##3##(1994-9#1)(1995-3#1)
very young children##4##3##(2006-2#1)(2008-9#2)(2012-12#1)
very young##22##2##(1993-10#1)(1994-9#1)(1995-3#1)(1996-12#2)(1996-5#1)(1997-3#1)(2005-10#2)(2006-10#1)(2006-2#1)(2007-2#3)(2008-11#1)(2008-3#1)(2008-9#2)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
very##4500##1##(1990-1#3)(1990-10#8)(1990-11#16)(1990-12#22)(1990-2#13)(1990-3#10)(1990-4#15)(1990-5#17)(1990-6#9)(1990-7#19)(1990-8#13)(1990-9#17)(1991-1#7)(1991-10#11)(1991-11#11)(1991-12#18)(1991-2#16)(1991-3#15)(1991-4#9)(1991-5#22)(1991-6#12)(1991-7#14)(1991-8#12)(1991-9#13)(1992-1#10)(1992-10#10)(1992-11#13)(1992-12#24)(1992-2#14)(1992-3#16)(1992-4#4)(1992-5#12)(1992-6#17)(1992-7#12)(1992-8#13)(1992-9#24)(1993-1#6)(1993-10#4)(1993-11#13)(1993-12#20)(1993-2#16)(1993-3#18)(1993-4#4)(1993-5#9)(1993-6#10)(1993-7#5)(1993-8#16)(1993-9#16)(1994-1#2)(1994-10#3)(1994-11#21)(1994-12#25)(1994-2#23)(1994-3#16)(1994-4#3)(1994-5#9)(1994-6#24)(1994-7#1)(1994-8#16)(1994-9#12)(1995-1#23)(1995-10#11)(1995-11#18)(1995-12#13)(1995-2#15)(1995-3#20)(1995-4#9)(1995-5#15)(1995-6#14)(1995-7#8)(1995-8#18)(1995-9#10)(1996-1#7)(1996-10#3)(1996-11#19)(1996-12#22)(1996-2#10)(1996-3#9)(1996-4#12)(1996-5#12)(1996-6#11)(1996-7#7)(1996-8#15)(1996-9#7)(1997-1#18)(1997-2#21)(1997-3#13)(1997-4#29)(1997-5#2)(1997-6#23)(1997-7#15)(1997-8#28)(1997-9#1)(2004-1#1)(2004-10#4)(2004-11#8)(2004-12#2)(2004-2#2)(2004-3#2)(2004-4#3)(2004-9#4)(2005-1#3)(2005-10#18)(2005-11#40)(2005-12#10)(2005-2#1)(2005-4#7)(2005-5#1)(2005-6#1)(2005-7#19)(2005-8#14)(2005-9#8)(2006-1#7)(2006-10#72)(2006-11#8)(2006-12#33)(2006-2#18)(2006-3#8)(2006-4#15)(2006-5#21)(2006-6#24)(2006-7#9)(2006-8#19)(2006-9#10)(2007-1#11)(2007-10#18)(2007-11#117)(2007-12#95)(2007-2#27)(2007-3#13)(2007-4#16)(2007-5#17)(2007-6#7)(2007-7#51)(2007-8#82)(2007-9#25)(2008-1#69)(2008-10#539)(2008-11#102)(2008-12#36)(2008-2#92)(2008-3#76)(2008-4#72)(2008-5#133)(2008-6#39)(2008-7#122)(2008-8#61)(2008-9#69)(2009-10#16)(2009-11#13)(2009-12#12)(2009-2#12)(2009-3#5)(2009-4#19)(2009-5#16)(2009-6#20)(2009-7#17)(2009-8#17)(2009-9#11)(2010-1#8)(2010-10#11)(2010-11#20)(2010-12#50)(2010-2#16)(2010-3#12)(2010-4#20)(2010-5#20)(2010-6#12)(2010-7#23)(2010-8#22)(2010-9#10)(2011-1#38)(2011-12#11)(2011-2#116)(2011-3#4)(2011-7#1)(2012-1#26)(2012-10#1)(2012-11#8)(2012-12#57)(2012-2#93)(2012-3#39)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#111)(2013-7#20)(2013-8#68)
very-long-chain acyl-CoA##2##2##(1993-3#2)
very-long-chain fatty acid beta-oxidation system##2##5##(1994-6#2)
very-long-chain fatty acid##4##3##(1994-6#2)(1995-2#2)
very-long-chain fatty acids##3##3##(1991-10#1)(1993-9#1)(1995-2#1)
very-long-chain fatty##7##2##(1991-10#1)(1993-9#1)(1994-6#2)(1995-2#3)
very-long-chain##10##1##(1991-10#1)(1993-3#2)(1993-9#2)(1994-6#2)(1995-2#3)
very-low-birthweight infants##2##2##(1992-2#2)
very-low-carbohydrate##2##1##(2008-5#2)
very-low-contrast##2##1##(2008-2#2)
very-low-density lipoprotein (VLDL)##2##3##(1991-2#1)(2008-6#1)
very-low-density lipoprotein##3##2##(1991-2#2)(2008-6#1)
very-low-density##4##1##(1990-8#1)(1991-2#2)(2008-6#1)
vesamicol and AcCh##2##3##(1992-6#2)
vesamicol and##3##2##(1992-6#3)
vesamicol receptor (VR)##2##3##(1992-6#2)
vesamicol receptor##4##2##(1992-6#3)(1993-9#1)
vesamicol##11##1##(1992-6#9)(1993-9#2)
vesical fistula##2##2##(2008-1#1)(2008-10#1)
vesical##10##1##(1991-6#1)(1994-5#1)(1997-7#2)(2008-1#1)(2008-10#1)(2008-7#1)(2009-4#1)(2012-12#1)(2012-3#1)
vesicarium were exposed to##2##4##(2008-10#2)
vesicarium##8##1##(2008-10#8)
vesicatoria and##2##2##(1990-3#1)(2008-10#1)
vesicatoria be##2##2##(2008-10#2)
vesicatoria group##2##2##(2008-10#2)
vesicatoria in##2##2##(2008-10#2)
vesicatoria race T1##2##3##(2008-10#2)
vesicatoria##23##1##(1990-3#1)(2008-10#22)
vesicle aggregation##6##2##(1990-4#3)(1997-2#2)(1997-6#1)
vesicle and##3##2##(1995-8#1)(2007-12#1)(2007-9#1)
vesicle are##2##2##(2008-1#1)(2008-11#1)
vesicle assay##2##2##(1991-2#1)(1992-6#1)
vesicle clusters##4##2##(2007-10#4)
vesicle coat proteins##2##3##(2009-6#1)(2011-2#1)
vesicle coat##3##2##(1997-6#1)(2009-6#1)(2011-2#1)
vesicle concentration##2##2##(1992-3#1)(1995-8#1)
vesicle contents##5##2##(1994-2#1)(1996-7#3)(2008-9#1)
vesicle cycle##2##2##(2007-12#1)(2008-1#1)
vesicle exocytosis##5##2##(1996-9#1)(2008-4#3)(2011-2#1)
vesicle formation##8##2##(1992-11#1)(1997-4#1)(2008-10#1)(2008-3#1)(2009-8#1)(2012-2#2)(2013-1#1)
vesicle fusion##13##2##(1994-12#2)(1995-12#1)(1995-2#1)(1996-9#2)(1997-1#1)(1997-7#1)(2005-11#1)(2008-11#1)(2010-4#1)(2012-2#2)
vesicle is##4##2##(2007-12#1)(2008-11#1)(2011-2#2)
vesicle membrane##9##2##(1992-3#1)(1992-6#1)(1993-3#1)(1993-6#1)(1996-9#1)(1997-6#1)(2006-10#1)(2008-11#1)(2008-4#1)
vesicle membranes##6##2##(1990-2#1)(1991-2#2)(1993-11#3)
vesicle movement##3##2##(2008-11#3)
vesicle preparation##3##2##(1990-7#2)(2012-2#1)
vesicle protein##8##2##(1991-12#1)(1992-12#2)(1994-12#2)(1996-12#1)(1996-3#1)(2009-12#1)
vesicle proteins##7##2##(2007-10#1)(2008-4#6)
vesicle proteoglycan##3##2##(1992-6#3)
vesicle release##4##2##(1994-8#1)(2007-12#1)(2008-8#2)
vesicle size and##2##3##(1995-5#2)
vesicle size##6##2##(1991-4#1)(1992-3#2)(1995-5#3)
vesicle sizes##2##2##(1990-2#2)
vesicle structure##2##2##(1992-10#1)(2012-1#1)
vesicle systems##3##2##(1990-11#1)(1997-1#2)
vesicle traffic##2##2##(1991-5#1)(1994-6#1)
vesicle trafficking and exocytosis##2##4##(1995-2#1)(2009-8#1)
vesicle trafficking and##4##3##(1995-2#1)(2008-11#1)(2009-10#1)(2009-8#1)
vesicle trafficking##14##2##(1993-6#1)(1995-2#1)(1997-1#1)(2008-11#2)(2009-10#4)(2009-6#1)(2009-8#3)(2013-1#1)
vesicle transport##6##2##(1993-9#1)(1997-1#1)(1997-6#1)(2008-11#2)(2012-12#1)
vesicle turnover##2##2##(1997-7#2)
vesicle##230##1##(1990-10#1)(1990-11#3)(1990-2#7)(1990-4#3)(1990-7#3)(1991-10#1)(1991-12#1)(1991-2#4)(1991-4#1)(1991-5#1)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#7)(1992-6#9)(1993-11#3)(1993-3#2)(1993-6#2)(1993-9#2)(1994-11#2)(1994-12#7)(1994-2#1)(1994-6#1)(1994-8#2)(1995-10#3)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#3)(1995-6#2)(1995-8#2)(1996-12#1)(1996-3#1)(1996-7#3)(1996-9#4)(1997-1#6)(1997-2#3)(1997-4#1)(1997-6#4)(1997-7#3)(2005-11#6)(2006-10#3)(2006-7#1)(2007-1#1)(2007-10#6)(2007-11#1)(2007-12#4)(2007-5#1)(2007-9#2)(2008-1#4)(2008-10#6)(2008-11#22)(2008-3#1)(2008-4#11)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#4)(2009-12#1)(2009-6#2)(2009-8#7)(2010-4#1)(2010-6#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#9)(2012-3#1)(2013-1#3)(2013-8#1)
vesicle-associated##5##1##(1990-12#1)(1995-12#1)(1996-5#1)(1997-6#1)(2007-12#1)
vesicle-entrapped##2##1##(1994-8#1)(1996-7#1)
vesicle-mediated##2##1##(2008-10#2)
vesicle-specific##2##1##(1993-12#1)(1995-3#1)
vesicles (CCVs)##2##2##(2008-1#1)(2009-6#1)
vesicles (IOVs)##2##2##(1990-3#1)(1994-12#1)
vesicles (SUV)##4##2##(1991-9#1)(1992-3#1)(1997-1#1)(2008-10#1)
vesicles along##2##2##(1991-5#1)(2008-4#1)
vesicles also##2##2##(1992-12#1)(2008-1#1)
vesicles and a##3##3##(1990-4#1)(2007-12#1)(2008-8#1)
vesicles and to##3##3##(1992-6#3)
vesicles and were in##2##4##(1997-2#2)
vesicles and were##3##3##(1994-8#1)(1997-2#2)
vesicles and##50##2##(1990-3#1)(1990-4#1)(1990-5#1)(1991-5#1)(1991-9#2)(1992-12#1)(1992-6#4)(1993-12#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-12#2)(1995-7#1)(1996-8#1)(1997-2#2)(2006-10#1)(2007-10#2)(2007-12#2)(2007-9#1)(2008-10#7)(2008-4#1)(2008-7#3)(2008-8#2)(2010-7#1)(2012-11#1)(2012-2#1)
vesicles are##19##2##(1990-2#1)(1991-11#1)(1991-7#1)(1992-10#1)(1993-8#1)(1994-12#1)(1995-8#1)(1997-3#1)(1997-7#1)(2007-9#1)(2008-1#5)(2008-5#1)(2008-7#2)(2011-1#1)
vesicles as##6##2##(1990-2#1)(1991-5#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-12#1)
vesicles at the##3##3##(1991-1#1)(2008-4#1)(2008-7#1)
vesicles at##8##2##(1990-11#2)(1990-6#1)(1991-1#1)(1991-7#1)(1994-12#1)(2008-4#1)(2008-7#1)
vesicles but##4##2##(1991-5#1)(1994-5#1)(2008-7#1)(2011-2#1)
vesicles by a##2##3##(1992-6#1)(2008-10#1)
vesicles by detergent dialysis##2##4##(1990-3#1)(1991-2#1)
vesicles by the##2##3##(1994-3#1)(1995-6#1)
vesicles by##17##2##(1990-3#1)(1991-2#1)(1991-4#1)(1992-6#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-6#2)(1996-5#1)(1996-8#2)(1997-1#1)(2008-1#1)(2008-10#2)(2013-7#1)
vesicles can be##2##3##(1995-3#1)(2008-10#1)
vesicles can##4##2##(1994-5#1)(1995-3#1)(2008-10#1)(2013-8#1)
vesicles compared to##2##3##(1990-11#1)(1993-3#1)
vesicles composed of##6##3##(1990-2#1)(1990-3#1)(1991-4#2)(1991-5#1)(1994-8#1)
vesicles consisting of the##3##4##(1991-2#1)(1991-9#1)(1994-11#1)
vesicles consisting of##4##3##(1991-2#1)(1991-9#2)(1994-11#1)
vesicles contained##2##2##(1993-3#1)(1994-9#1)
vesicles containing 30 mol %##2##5##(1991-4#1)(1994-5#1)
vesicles containing GM1 ganglioside and cholesterol##2##6##(1997-7#2)
vesicles containing##22##2##(1990-2#1)(1990-4#1)(1991-4#2)(1991-7#1)(1992-12#7)(1993-9#1)(1994-5#1)(1995-10#1)(1997-6#1)(1997-7#2)(2007-10#1)(2007-12#1)(2008-11#1)(2008-8#1)
vesicles could be##2##3##(1991-2#1)(1992-6#1)
vesicles could##3##2##(1991-2#1)(1992-6#1)(1997-4#1)
vesicles depends##2##2##(1990-2#1)(1994-8#1)
vesicles deprived of##2##3##(1994-12#2)
vesicles derived from##2##3##(1995-8#1)(2013-8#1)
vesicles did not##3##3##(1992-10#1)(1994-9#2)
vesicles enriched in##2##3##(1995-11#1)(1995-2#1)
vesicles for##3##2##(1992-8#1)(2008-10#2)
vesicles form##2##2##(1997-4#1)(2012-2#1)
vesicles formed from##6##3##(1992-12#3)(1992-3#1)(2008-5#2)
vesicles formed##8##2##(1990-2#1)(1991-4#1)(1992-12#3)(1992-3#1)(2008-5#2)
vesicles from rat brain##2##4##(1990-9#1)(2008-4#1)
vesicles from rat##3##3##(1990-9#1)(1992-1#1)(2008-4#1)
vesicles from the##7##3##(1992-12#1)(1992-7#1)(1995-5#1)(1996-9#2)(2007-10#1)(2013-1#1)
vesicles from##28##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-7#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-5#1)(1996-1#1)(1996-9#2)(1997-5#1)(2007-1#1)(2007-10#1)(2008-1#1)(2008-11#2)(2008-4#1)(2012-3#1)(2013-1#1)
vesicles has been##5##3##(1990-2#1)(1991-9#1)(1993-3#1)(1996-9#1)(1997-6#1)
vesicles have##2##2##(1997-4#1)(2012-2#1)
vesicles in a##2##3##(1993-9#1)(1994-12#1)
vesicles in the presence of##2##5##(1990-11#1)(2005-11#1)
vesicles in the presence##3##4##(1990-11#1)(1990-3#1)(2005-11#1)
vesicles in the##7##3##(1990-11#1)(1990-3#1)(1991-9#1)(1995-11#1)(1996-1#1)(1997-1#1)(2005-11#1)
vesicles in##26##2##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-9#1)(1994-12#1)(1995-10#1)(1995-11#1)(1996-1#1)(1997-1#2)(1997-7#1)(2005-11#1)(2006-8#1)(2007-12#3)(2008-10#1)(2009-2#1)(2012-2#1)
vesicles increased##4##2##(1992-12#1)(1994-3#1)(2008-5#1)(2008-8#1)
vesicles induced by##2##3##(1990-11#1)(1996-1#1)
vesicles is##10##2##(1990-11#1)(1990-2#1)(1991-2#1)(1991-4#1)(1991-7#2)(1992-6#1)(1996-7#2)(2008-11#1)
vesicles isolated from the##3##4##(1992-6#2)(2008-11#1)
vesicles isolated from##6##3##(1991-6#1)(1992-6#2)(1994-12#2)(2008-11#1)
vesicles isolated##7##2##(1991-6#1)(1992-6#2)(1994-12#2)(2008-11#2)
vesicles labeled with##2##3##(1992-3#1)(2008-8#1)
vesicles made of##2##3##(1994-9#1)(2012-2#1)
vesicles made##3##2##(1994-9#1)(2008-8#1)(2012-2#1)
vesicles obtained by##2##3##(1991-5#1)(1993-8#1)
vesicles obtained##3##2##(1991-5#1)(1993-8#1)(1996-9#1)
vesicles of defined##2##3##(1990-2#1)(1992-6#1)
vesicles of different##3##3##(1990-2#1)(1994-5#1)(2013-7#1)
vesicles of the##4##3##(1991-4#2)(1993-6#1)(1994-2#1)
vesicles of##29##2##(1990-11#1)(1990-2#3)(1990-3#1)(1990-4#1)(1991-4#2)(1992-10#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#2)(1995-1#1)(2006-10#2)(2007-12#2)(2007-9#1)(2008-1#1)(2009-10#1)(2009-12#1)(2013-7#1)
vesicles or##9##2##(1991-2#2)(1991-8#1)(1995-7#1)(1997-4#1)(1997-7#1)(2007-7#1)(2008-5#1)(2008-9#1)
vesicles per##2##2##(1990-4#1)(1996-1#1)
vesicles prepared from cells##2##4##(1994-12#1)(1994-6#1)
vesicles prepared from rat##2##4##(1991-5#2)
vesicles prepared from##13##3##(1991-5#3)(1994-11#1)(1994-12#3)(1994-6#1)(1995-5#1)(1996-9#1)(1997-8#1)(2008-11#1)(2011-1#1)
vesicles prepared##14##2##(1990-7#1)(1991-5#3)(1994-11#1)(1994-12#3)(1994-6#1)(1995-5#1)(1996-9#1)(1997-8#1)(2008-11#1)(2011-1#1)
vesicles present in human##2##4##(1997-6#1)(2013-8#1)
vesicles pretreated##2##2##(1990-7#1)(1992-6#1)
vesicles purified from##2##3##(1992-6#1)(1992-8#1)
vesicles that are##2##3##(1990-9#1)(2008-11#1)
vesicles that##9##2##(1990-11#1)(1990-9#1)(1992-12#1)(1994-5#1)(2008-10#1)(2008-11#2)(2009-12#1)(2010-12#1)
vesicles to the##4##3##(1994-3#1)(1997-3#1)(1997-6#1)(2012-2#1)
vesicles to##16##2##(1992-3#1)(1993-6#1)(1994-3#1)(1994-5#1)(1995-5#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-11#2)(2008-8#1)(2009-10#1)(2012-2#1)
vesicles was found to##2##4##(2008-11#1)(2011-1#1)
vesicles was investigated by##2##4##(1990-4#1)(1990-8#1)
vesicles was investigated##3##3##(1990-4#1)(1990-8#1)(1992-6#1)
vesicles was observed##2##3##(1991-5#1)(1994-6#1)
vesicles was studied##3##3##(1990-6#1)(1992-3#1)(1994-2#1)
vesicles was##21##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-5#1)(1991-9#1)(1992-3#3)(1992-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-5#1)(1996-7#1)(2008-10#1)(2008-11#1)(2011-1#1)
vesicles were incubated##2##3##(1992-3#1)(1994-3#1)
vesicles were solubilized##2##3##(1990-11#1)(1990-2#1)
vesicles were##24##2##(1990-11#1)(1990-2#3)(1990-4#2)(1990-7#1)(1992-3#2)(1992-6#1)(1993-3#1)(1994-12#1)(1994-3#2)(1995-3#1)(1996-9#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-3#1)
vesicles which##7##2##(1991-2#1)(1995-6#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-6#1)
vesicles with a##3##3##(1990-11#1)(1996-5#1)(1997-3#1)
vesicles with an##2##3##(1992-8#1)(1994-5#1)
vesicles with the##5##3##(1990-11#1)(1990-2#1)(1992-6#1)(1997-6#1)(2009-2#1)
vesicles with##24##2##(1990-11#4)(1990-12#1)(1990-2#2)(1992-6#1)(1992-8#1)(1993-11#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-10#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-5#1)(2009-2#1)(2010-7#1)
vesicles##812##1##(1990-11#27)(1990-12#8)(1990-2#31)(1990-3#12)(1990-4#12)(1990-5#2)(1990-6#2)(1990-7#9)(1990-8#1)(1990-9#4)(1991-1#3)(1991-10#4)(1991-11#1)(1991-12#1)(1991-2#15)(1991-4#15)(1991-5#18)(1991-6#1)(1991-7#11)(1991-8#7)(1991-9#25)(1992-1#2)(1992-10#8)(1992-11#4)(1992-12#18)(1992-2#3)(1992-3#15)(1992-6#31)(1992-7#1)(1992-8#4)(1992-9#1)(1993-11#1)(1993-12#4)(1993-3#14)(1993-6#4)(1993-8#3)(1993-9#4)(1994-10#1)(1994-11#13)(1994-12#28)(1994-2#8)(1994-3#12)(1994-5#11)(1994-6#2)(1994-8#8)(1994-9#8)(1995-1#5)(1995-10#5)(1995-11#5)(1995-12#3)(1995-2#3)(1995-3#6)(1995-5#9)(1995-6#6)(1995-7#4)(1995-8#7)(1996-1#9)(1996-2#2)(1996-5#4)(1996-7#9)(1996-8#4)(1996-9#9)(1997-1#7)(1997-2#4)(1997-3#6)(1997-4#14)(1997-5#3)(1997-6#13)(1997-7#12)(1997-8#8)(2005-11#7)(2005-7#1)(2006-10#7)(2006-8#1)(2007-1#1)(2007-10#7)(2007-12#15)(2007-7#1)(2007-9#6)(2008-1#18)(2008-10#34)(2008-11#22)(2008-12#1)(2008-4#5)(2008-5#23)(2008-6#1)(2008-7#12)(2008-8#11)(2008-9#2)(2009-10#2)(2009-12#3)(2009-2#2)(2009-6#1)(2009-7#3)(2009-8#2)(2010-12#1)(2010-4#1)(2010-6#2)(2010-7#2)(2011-1#5)(2011-2#1)(2012-11#1)(2012-12#5)(2012-2#12)(2012-3#2)(2013-1#5)(2013-7#6)(2013-8#7)
vesicles)##3##1##(1991-10#1)(1994-2#1)(2008-9#1)
vesico-ureteral reflux##3##2##(2008-10#2)(2008-4#1)
vesico-ureteric junction##3##2##(2008-10#2)(2012-3#1)
vesico-ureteric reflux##3##2##(2007-7#1)(2008-4#2)
vesico-ureteric##6##1##(2007-7#1)(2008-10#2)(2008-4#2)(2012-3#1)
vesico-vaginal##3##1##(1992-2#1)(2004-10#1)(2009-4#1)
vesicocutaneous##2##1##(1993-2#1)(2011-2#1)
vesicolithotomy in##2##2##(2009-4#2)
vesicostomy##3##1##(2008-10#2)(2012-12#1)
vesicoureteral reflux in##3##3##(1991-5#1)(2008-10#1)(2012-2#1)
vesicoureteral reflux##24##2##(1991-5#3)(2006-10#1)(2006-9#3)(2007-9#1)(2008-1#1)(2008-10#10)(2008-7#2)(2012-11#2)(2012-2#1)
vesicoureteric reflux##6##2##(1990-8#1)(1991-11#1)(2008-1#1)(2008-6#1)(2008-7#1)(2009-5#1)
vesicoureteric##7##1##(1990-8#1)(1991-11#2)(2008-1#1)(2008-6#1)(2008-7#1)(2009-5#1)
vesicovaginal fistula##3##2##(1996-2#1)(2010-8#2)
vesicovaginal##4##1##(1993-2#1)(1996-2#1)(2010-8#2)
vesicular disease in##2##3##(2005-11#1)(2011-2#1)
vesicular disease##5##2##(2005-11#3)(2011-2#2)
vesicular fusion##2##2##(1995-2#1)(2008-5#1)
vesicular glutamate release during##2##4##(1994-2#1)(1997-5#1)
vesicular glutamate release##3##3##(1994-2#2)(1997-5#1)
vesicular glutamate transporter##2##3##(2008-7#1)(2009-8#1)
vesicular glutamate##5##2##(1994-2#2)(1997-5#1)(2008-7#1)(2009-8#1)
vesicular membrane##2##2##(1993-4#1)(2007-8#1)
vesicular membranes##3##2##(1990-11#1)(1991-10#1)(1994-2#1)
vesicular monoamine transporter is not##2##5##(1995-12#2)
vesicular monoamine transporter##9##3##(1995-12#6)(1996-12#2)(2008-11#1)
vesicular monoamine##11##2##(1995-12#7)(1996-12#2)(2008-11#1)(2010-6#1)
vesicular nuclei##3##2##(2004-2#1)(2008-9#1)(2010-12#1)
vesicular pathway##2##2##(2007-10#1)(2010-12#1)
vesicular stomatitis virus (VSV)##6##4##(1990-2#1)(1993-12#1)(1994-9#1)(1995-8#1)(2008-4#2)
vesicular stomatitis virus glycoprotein##2##4##(1991-2#1)(1997-4#1)
vesicular stomatitis virus##20##3##(1990-2#1)(1991-2#1)(1992-12#2)(1993-12#1)(1993-6#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-8#2)(1997-1#1)(1997-4#2)(2007-8#1)(2008-4#3)
vesicular stomatitis##23##2##(1990-2#1)(1991-2#1)(1992-12#2)(1993-12#1)(1993-6#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-8#2)(1997-1#2)(1997-4#2)(2005-5#1)(2007-8#1)(2008-1#1)(2008-4#3)
vesicular trafficking##5##2##(1996-5#1)(2009-10#2)(2009-7#1)(2011-2#1)
vesicular transport##6##2##(1995-2#1)(1995-8#1)(1996-12#1)(1997-6#2)(2008-11#1)
vesicular transporter##4##2##(1996-12#3)(2007-12#1)
vesicular##114##1##(1990-11#1)(1990-2#3)(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-2#1)(1992-10#1)(1992-12#2)(1992-7#1)(1992-8#1)(1993-12#1)(1993-4#1)(1993-6#2)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-12#7)(1995-2#3)(1995-7#1)(1995-8#3)(1996-1#1)(1996-12#6)(1996-5#2)(1997-1#2)(1997-4#2)(1997-5#2)(1997-6#3)(2004-2#1)(2005-11#3)(2005-5#1)(2007-10#1)(2007-12#2)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#4)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#4)(2010-11#1)(2010-12#2)(2010-6#2)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
vesiculated nerve endings##3##3##(1991-9#3)
vesiculated##7##1##(1991-9#5)(1995-11#1)(1996-3#1)
vesiculation and##5##2##(1990-4#2)(1992-11#2)(2007-9#1)
vesiculation##11##1##(1990-4#3)(1991-9#1)(1992-11#2)(1997-3#2)(2007-7#1)(2007-9#2)
vesnarinone##2##1##(1993-9#2)
vesosome is##2##2##(2008-9#2)
vesosome##3##1##(2008-9#3)
vespertinus##2##1##(2011-2#2)
vessel &quot##2##2##(2009-10#1)(2013-1#1)
vessel and the##2##3##(1993-8#1)(2008-10#1)
vessel and##14##2##(1993-8#1)(1994-11#2)(1996-6#1)(2008-10#6)(2011-1#2)(2011-12#1)(2012-3#1)
vessel avulsion model##2##3##(2007-10#2)
vessel coronary artery disease##4##4##(2007-8#1)(2007-9#2)(2012-2#1)
vessel coronary disease##2##3##(2007-8#2)
vessel coronary##6##2##(2007-8#3)(2007-9#2)(2012-2#1)
vessel density was##3##3##(1993-9#2)(2008-5#1)
vessel density##10##2##(1993-9#5)(2004-1#1)(2008-5#4)
vessel development##3##2##(2008-1#1)(2008-7#2)
vessel diameter##5##2##(2007-9#1)(2009-12#1)(2011-2#2)(2013-1#1)
vessel diameters##2##2##(2008-2#1)(2013-1#1)
vessel disease (0##2##3##(2013-8#2)
vessel disease and##3##3##(1994-11#1)(2007-8#1)(2008-8#1)
vessel disease##20##2##(1990-4#1)(1991-6#1)(1994-11#2)(2007-10#4)(2007-8#3)(2007-9#2)(2008-7#1)(2008-8#2)(2009-10#1)(2013-8#3)
vessel elements##2##2##(2008-10#2)
vessel endothelium##3##2##(1991-1#1)(2009-10#1)(2010-11#1)
vessel failure##2##2##(2008-11#1)(2009-10#1)
vessel for##2##2##(2008-7#1)(2010-5#1)
vessel formation##5##2##(1991-2#1)(2006-11#2)(2008-11#1)(2013-1#1)
vessel from the##2##3##(2007-8#1)(2008-3#1)
vessel geometry##2##2##(2007-7#1)(2009-4#1)
vessel grounding##2##2##(2011-2#2)
vessel growth##9##2##(1994-9#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-1#1)(2009-2#2)(2009-7#1)(2012-12#1)
vessel implantation##2##2##(2006-4#1)(2009-3#1)
vessel in the##2##3##(2008-3#2)
vessel injuries##3##2##(2007-8#1)(2013-1#2)
vessel invasion##5##2##(1990-10#1)(2006-8#1)(2013-1#1)(2013-8#2)
vessel is##3##2##(2008-10#2)(2008-12#1)
vessel lumen##3##2##(2008-5#1)(2011-1#1)(2012-1#1)
vessel occlusion and##2##3##(1992-9#1)(2012-2#1)
vessel occlusion##10##2##(1992-9#1)(1995-3#1)(1995-6#1)(2005-11#2)(2006-11#2)(2011-2#2)(2012-2#1)
vessel of##3##2##(2006-5#1)(2008-10#1)(2008-7#1)
vessel or##3##2##(1994-11#1)(2008-2#1)(2013-1#1)
vessel permeability##2##2##(1991-10#1)(1991-9#1)
vessel segmentation algorithm##2##3##(2013-1#2)
vessel segmentation##3##2##(2013-1#3)
vessel size##4##2##(2006-10#1)(2009-7#1)(2012-5#1)(2013-1#1)
vessel stroke##2##2##(2007-10#1)(2013-8#1)
vessel structure##2##2##(2007-5#1)(2008-1#1)
vessel surgery##2##2##(1991-12#1)(1994-3#1)
vessel tone##2##2##(1995-2#2)
vessel vasculitis in##3##3##(1997-8#2)(2006-10#1)
vessel vasculitis##8##2##(1997-8#2)(2006-10#2)(2008-10#1)(2011-1#1)(2012-2#1)(2012-3#1)
vessel wall remodeling##4##3##(2012-12#4)
vessel wall viability##2##3##(1996-1#2)
vessel wall##37##2##(1991-10#1)(1992-9#1)(1995-8#1)(1996-1#2)(1996-2#1)(1996-3#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#3)(2009-10#2)(2009-4#1)(2010-12#1)(2010-9#2)(2011-1#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#1)
vessel walls and##4##3##(1990-3#1)(2007-11#1)(2009-4#1)(2009-9#1)
vessel walls##17##2##(1990-3#1)(1990-8#1)(1991-3#1)(1992-3#1)(1994-9#1)(1995-3#1)(1996-1#1)(1996-6#1)(1997-7#1)(2007-11#1)(2008-11#1)(2008-4#1)(2009-4#1)(2009-8#1)(2009-9#1)(2011-1#1)(2012-3#1)
vessel was##12##2##(1990-6#1)(1996-9#3)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2012-12#3)
vessel were##3##2##(1992-10#1)(1995-3#1)(2007-8#1)
vessel##397##1##(1990-10#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-3#1)(1992-9#3)(1993-11#1)(1993-8#3)(1993-9#6)(1994-11#7)(1994-3#2)(1994-9#3)(1995-12#1)(1995-2#2)(1995-3#3)(1995-6#1)(1995-8#2)(1996-1#3)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#2)(1996-8#1)(1996-9#6)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#2)(2004-1#1)(2005-10#2)(2005-11#2)(2005-7#2)(2006-10#11)(2006-11#5)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-8#1)(2006-9#1)(2007-10#9)(2007-11#4)(2007-12#4)(2007-2#1)(2007-5#9)(2007-7#9)(2007-8#17)(2007-9#7)(2008-1#5)(2008-10#43)(2008-11#11)(2008-12#1)(2008-2#4)(2008-3#16)(2008-4#4)(2008-5#11)(2008-6#1)(2008-7#16)(2008-8#2)(2009-10#9)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#5)(2009-5#1)(2009-7#4)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#9)(2011-12#1)(2011-2#12)(2012-1#1)(2012-12#12)(2012-2#5)(2012-3#9)(2012-5#1)(2013-1#20)(2013-7#2)(2013-8#8)
vessel's##3##1##(2007-7#1)(2008-10#1)(2013-8#1)
vessel)##3##1##(2007-7#1)(2008-5#1)(2011-2#1)
vessel-resident cells##3##2##(2009-4#3)
vessel-resident##4##1##(2009-4#4)
vessels (2##2##2##(1994-2#1)(2007-9#1)
vessels and did not##2##4##(2005-10#1)(2012-12#1)
vessels and lymphatics##2##3##(2009-2#1)(2011-2#1)
vessels and nerves##3##3##(1996-3#1)(2004-12#1)(2011-1#1)
vessels and the##6##3##(1995-12#1)(1997-4#1)(2007-12#1)(2008-7#1)(2010-9#1)(2012-2#1)
vessels and##54##2##(1990-12#1)(1991-6#1)(1991-8#1)(1993-7#1)(1994-9#2)(1995-1#1)(1995-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-4#2)(1997-6#2)(2004-12#1)(2005-10#1)(2005-7#1)(2006-4#1)(2006-6#1)(2007-12#1)(2007-4#1)(2007-7#4)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
vessels are##11##2##(1992-1#1)(1993-9#1)(1994-9#1)(2004-4#1)(2005-11#1)(2006-11#1)(2007-1#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-4#1)
vessels around the##3##3##(2006-12#1)(2008-5#1)(2008-7#1)
vessels as##2##2##(2009-7#1)(2011-2#1)
vessels at##4##2##(1993-9#1)(2006-11#1)(2007-10#1)(2008-11#1)
vessels between##2##2##(2004-9#1)(2008-5#1)
vessels by##6##2##(1991-8#1)(1994-2#1)(2007-8#1)(2008-3#1)(2008-8#1)(2012-3#1)
vessels carrying##2##2##(2008-11#1)(2010-5#1)
vessels during##3##2##(2008-5#1)(2008-6#1)(2010-12#1)
vessels formed##2##2##(2008-7#1)(2011-2#1)
vessels from the##2##3##(2011-2#2)
vessels from##7##2##(1995-12#1)(1995-2#1)(2008-1#1)(2010-9#1)(2011-2#2)(2013-8#1)
vessels had##2##2##(1997-8#1)(2006-12#1)
vessels has##3##2##(1991-9#1)(2008-1#1)(2010-9#1)
vessels in a##4##3##(2006-11#1)(2007-8#1)(2008-10#1)(2011-2#1)
vessels in the##12##3##(1991-9#1)(1995-1#1)(2006-4#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-5#1)(2009-12#1)(2010-4#1)(2011-2#1)(2012-1#1)
vessels in##40##2##(1990-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1994-8#1)(1995-1#1)(1996-12#1)(1997-6#1)(2004-1#1)(2006-11#1)(2006-4#4)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#2)(2009-12#1)(2010-12#1)(2010-4#2)(2011-2#2)(2012-1#1)(2013-8#2)
vessels into##3##2##(2008-10#1)(2009-2#2)
vessels is##11##2##(1993-9#1)(1994-9#1)(1997-8#1)(2005-11#1)(2007-11#1)(2007-8#1)(2007-9#1)(2010-1#1)(2010-11#1)(2011-2#1)(2013-1#1)
vessels leads to##2##3##(1992-9#1)(2012-2#1)
vessels may##2##2##(2011-12#1)(2013-1#1)
vessels of animals##2##3##(2008-1#1)(2008-10#1)
vessels of the rat##2##4##(1990-10#1)(1995-1#1)
vessels of the##16##3##(1990-10#2)(1995-1#1)(1997-5#1)(2006-11#3)(2006-12#1)(2007-12#1)(2007-9#1)(2008-10#1)(2009-2#1)(2010-5#1)(2012-1#1)(2012-12#1)(2013-7#1)
vessels of##33##2##(1990-10#2)(1990-6#1)(1992-12#1)(1993-12#1)(1995-1#1)(1997-5#1)(2006-11#3)(2006-12#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-4#1)(2009-2#1)(2010-5#1)(2012-1#2)(2012-12#1)(2013-1#2)(2013-7#1)
vessels on the##3##3##(2006-11#1)(2007-1#2)
vessels or##5##2##(1990-2#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
vessels than##2##2##(1994-9#1)(2007-8#1)
vessels that##4##2##(1997-8#1)(2005-10#1)(2005-11#1)(2008-3#1)
vessels to the##3##3##(2011-2#1)(2012-12#1)(2012-3#1)
vessels to##8##2##(1990-10#1)(1995-12#1)(1996-3#1)(1997-6#1)(2007-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
vessels was##7##2##(1992-8#1)(2006-6#1)(2007-7#1)(2008-11#1)(2008-7#2)(2011-2#1)
vessels were##18##2##(1993-11#1)(1994-11#1)(1996-11#1)(1996-6#1)(2006-11#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-6#1)(2011-2#3)(2012-12#1)
vessels which##7##2##(1992-8#1)(1995-4#1)(2006-1#1)(2006-8#1)(2008-10#1)(2011-1#1)(2011-2#1)
vessels with##8##2##(1991-6#1)(2004-1#1)(2006-6#1)(2007-8#1)(2008-3#1)(2008-8#1)(2012-1#1)(2012-2#1)
vessels##573##1##(1990-10#5)(1990-11#1)(1990-12#1)(1990-2#4)(1990-3#4)(1990-6#1)(1990-7#1)(1990-8#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-8#3)(1991-9#2)(1992-1#2)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-10#2)(1993-11#2)(1993-12#5)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#3)(1994-11#3)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#8)(1995-1#3)(1995-11#1)(1995-12#6)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-11#3)(1996-12#1)(1996-3#2)(1996-5#1)(1996-6#3)(1996-8#1)(1996-9#4)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#5)(1997-8#7)(2004-1#4)(2004-12#2)(2004-4#1)(2004-9#1)(2005-10#7)(2005-11#6)(2005-12#1)(2005-7#2)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#9)(2006-11#18)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#6)(2006-6#5)(2006-7#2)(2006-8#3)(2007-1#4)(2007-10#9)(2007-11#6)(2007-12#8)(2007-2#1)(2007-4#2)(2007-5#4)(2007-6#1)(2007-7#12)(2007-8#17)(2007-9#11)(2008-1#15)(2008-10#27)(2008-11#13)(2008-12#2)(2008-2#2)(2008-3#7)(2008-4#9)(2008-5#10)(2008-6#2)(2008-7#17)(2008-8#6)(2008-9#5)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#6)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#3)(2009-8#2)(2010-1#3)(2010-11#1)(2010-12#12)(2010-4#6)(2010-5#3)(2010-6#4)(2010-7#2)(2010-8#4)(2010-9#5)(2011-1#11)(2011-12#1)(2011-2#32)(2011-3#1)(2012-1#7)(2012-12#14)(2012-2#10)(2012-3#9)(2013-1#15)(2013-7#3)(2013-8#8)
vest##3##1##(2006-6#1)(2008-8#2)
vested in the##2##3##(1991-12#1)(2012-3#1)
vested##7##1##(1991-12#1)(1994-12#1)(1994-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-3#1)
vestibular and pain##2##3##(2012-2#2)
vestibular and##6##2##(1991-2#2)(1996-5#1)(2012-2#3)
vestibular aqueduct syndrome##2##3##(2008-9#2)
vestibular aqueduct##3##2##(2008-9#3)
vestibular compensation in the goldfish##2##5##(1991-2#2)
vestibular compensation in##3##3##(1991-2#2)(1995-12#1)
vestibular compensation##7##2##(1991-2#2)(1995-12#2)(1996-9#1)(1997-7#2)
vestibular disorders##7##2##(1993-5#1)(2008-4#3)(2012-2#1)(2012-3#2)
vestibular function##4##2##(1993-2#1)(1997-7#1)(2011-1#1)(2012-3#1)
vestibular ganglion##3##2##(1995-5#1)(1997-7#2)
vestibular hypofunction##2##2##(2012-3#2)
vestibular loss##3##2##(2011-1#3)
vestibular migraine##8##2##(2012-2#8)
vestibular nerve##4##2##(1991-6#1)(1993-9#1)(2011-1#1)(2011-2#1)
vestibular neurons and Schwann cells##3##5##(2007-10#3)
vestibular neurons##4##2##(1991-2#1)(2007-10#3)
vestibular nuclei##6##2##(1995-10#1)(1996-12#1)(1996-9#4)
vestibular nucleus neurons in vitro##2##5##(1993-5#1)(1995-3#1)
vestibular nucleus##11##2##(1993-5#1)(1993-9#1)(1995-3#2)(1996-11#4)(1996-9#1)(1997-6#1)(1997-7#1)
vestibular rehabilitation##5##2##(2011-2#1)(2012-2#2)(2012-3#2)
vestibular response##2##2##(1993-2#1)(2011-1#1)
vestibular schwannoma and meningioma##2##4##(2010-11#2)
vestibular schwannoma hemorrhage##2##3##(2006-11#2)
vestibular schwannoma surgery##3##3##(2006-11#2)(2010-4#1)
vestibular schwannoma##13##2##(2005-5#1)(2006-11#5)(2010-11#2)(2010-4#3)(2011-2#2)
vestibular schwannomas##11##2##(2005-5#1)(2006-11#3)(2006-12#4)(2008-10#1)(2008-12#1)(2011-2#1)
vestibular signals##3##2##(1995-5#2)(1995-8#1)
vestibular stimulation##6##2##(1995-8#1)(1996-5#1)(1997-2#2)(2012-3#2)
vestibular symptoms##5##2##(2006-12#1)(2012-2#4)
vestibular system##5##2##(1994-10#1)(1995-8#2)(2008-4#1)(2009-9#1)
vestibular##161##1##(1990-10#1)(1990-6#1)(1991-2#8)(1991-5#1)(1991-6#1)(1991-9#1)(1993-12#1)(1993-2#2)(1993-5#2)(1993-9#4)(1994-10#2)(1995-10#1)(1995-12#6)(1995-3#2)(1995-5#4)(1995-8#5)(1996-11#4)(1996-12#1)(1996-3#2)(1996-5#2)(1996-9#8)(1997-2#2)(1997-6#3)(1997-7#7)(2005-5#2)(2006-11#8)(2006-12#7)(2007-10#5)(2007-3#1)(2008-10#1)(2008-12#1)(2008-4#5)(2008-9#3)(2009-5#1)(2009-9#1)(2010-11#2)(2010-4#3)(2011-1#9)(2011-2#7)(2012-1#2)(2012-2#20)(2012-3#9)(2013-1#2)(2013-7#1)
vestibule##10##1##(1993-4#1)(1993-9#1)(1995-8#1)(2007-7#1)(2008-8#5)(2013-1#1)
vestibulo-ocular reflex and optokinetic afternystagmus##4##5##(2008-4#4)
vestibulo-ocular reflex and optokinetic##5##4##(2008-4#5)
vestibulo-ocular reflex direction adaptation##2##4##(1991-5#2)
vestibulo-ocular reflex##13##2##(1991-5#3)(1992-9#2)(2008-4#8)
vestibulo-ocular##14##1##(1991-5#3)(1992-9#2)(2008-4#8)(2011-1#1)
vestibulo-postural rehabilitation##3##2##(2011-1#3)
vestiges##2##1##(1991-1#1)(1997-2#1)
vestigial##2##1##(2009-10#1)(2011-1#1)
vestimentiferans##2##1##(2009-8#2)
vet##4##1##(1991-8#1)(1997-6#1)(1997-8#1)(2010-8#1)
veteran##9##1##(1996-1#1)(2007-5#1)(2008-9#1)(2009-4#1)(2009-6#1)(2012-1#2)(2013-1#2)
veterans and##5##2##(2006-10#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
veterans from##3##2##(2012-1#1)(2013-1#2)
veterans in##2##2##(2012-1#1)(2012-3#1)
veterans of##6##2##(2004-7#1)(2007-10#1)(2011-1#1)(2012-1#1)(2013-1#2)
veterans were##3##2##(2007-7#1)(2013-1#2)
veterans who##4##2##(1995-4#1)(2007-7#1)(2008-4#1)(2013-1#1)
veterans with PTSD##3##3##(2005-10#1)(2007-7#1)(2008-9#1)
veterans with##12##2##(2005-10#1)(2006-4#1)(2007-10#2)(2007-5#2)(2007-7#2)(2008-9#2)(2012-2#1)(2013-1#1)
veterans##66##1##(1995-4#1)(1996-2#1)(1996-3#1)(2004-7#2)(2005-10#1)(2006-10#3)(2006-4#1)(2007-10#5)(2007-5#4)(2007-7#4)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#4)(2009-6#1)(2011-1#1)(2011-2#4)(2012-1#10)(2012-2#4)(2012-3#2)(2013-1#14)
veterans'##2##1##(2008-9#1)(2012-2#1)
veterinarian##8##1##(1995-9#1)(2005-7#1)(2007-1#1)(2007-4#2)(2010-2#1)(2011-2#1)(2012-3#1)
veterinarians and##7##2##(1997-7#1)(2005-5#2)(2008-12#1)(2010-4#1)(2013-1#2)
veterinarians have##4##2##(2004-2#1)(2012-2#1)(2013-8#2)
veterinarians in##2##2##(2005-7#2)
veterinarians##23##1##(1991-2#1)(1991-8#1)(1997-7#1)(2004-2#1)(2005-5#5)(2005-7#2)(2007-4#3)(2008-12#1)(2010-4#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
veterinary and##8##2##(2006-12#1)(2007-12#1)(2007-6#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
veterinary antibiotics##2##2##(2008-10#2)
veterinary care##3##2##(2005-5#1)(2008-3#2)
veterinary clinic##2##2##(2011-1#2)
veterinary drug residues##2##3##(1994-3#1)(2010-5#1)
veterinary drug##3##2##(1993-7#1)(1994-3#1)(2010-5#1)
veterinary health care settings##2##4##(2010-4#2)
veterinary importance##3##2##(1992-8#1)(2006-10#1)(2010-7#1)
veterinary laboratories##2##2##(1990-6#1)(2005-7#1)
veterinary medical##3##2##(2007-4#2)(2013-1#1)
veterinary medicine and##2##3##(2010-4#1)(2013-1#1)
veterinary medicine##8##2##(2007-9#1)(2008-3#1)(2009-3#1)(2010-4#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
veterinary parasitologists##2##2##(1997-7#2)
veterinary patients##2##2##(2012-3#1)(2013-1#1)
veterinary pharmaceuticals##2##2##(2008-10#2)
veterinary practitioners##2##2##(2005-7#1)(2011-2#1)
veterinary public health##2##3##(2005-5#2)
veterinary research##3##2##(1990-9#1)(1997-7#1)(2007-4#1)
veterinary science##3##2##(2005-5#1)(2005-7#1)(2010-3#1)
veterinary scientists##3##2##(2010-1#3)
veterinary services##5##2##(1997-7#1)(2005-5#1)(2007-8#2)(2008-3#1)
veterinary surgeon##3##2##(1990-9#1)(1992-10#1)(2004-2#1)
veterinary surgeons##2##2##(1990-6#1)(1995-9#1)
veterinary##118##1##(1990-6#2)(1990-9#3)(1992-10#1)(1992-8#1)(1993-2#1)(1993-7#1)(1994-1#1)(1994-3#1)(1995-9#1)(1996-11#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-7#6)(2004-2#1)(2005-5#8)(2005-7#5)(2006-10#1)(2006-12#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-4#15)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-3#5)(2008-8#4)(2009-3#2)(2009-4#1)(2010-1#4)(2010-11#1)(2010-3#1)(2010-4#5)(2010-5#1)(2010-7#2)(2011-1#6)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#6)
veterinary-assessed mobility##4##2##(2008-10#4)
vetispiradiene synthase##5##2##(1995-3#5)
veto the##2##2##(1991-10#1)(1996-5#1)
veto##5##1##(1991-10#1)(1991-3#1)(1992-11#1)(1995-6#1)(1996-5#1)
vetoed##3##1##(1991-10#1)(1996-5#2)
vexans##2##1##(2011-1#1)(2013-1#1)
vexed and##2##2##(2008-7#1)(2010-10#1)
vexing##7##1##(1996-2#1)(2006-3#1)(2008-11#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-3#1)
vgf gene expression##2##3##(1995-2#2)
vgf gene##5##2##(1995-2#3)(2008-10#2)
vgf##7##1##(1995-2#3)(2008-10#4)
via 16S##2##2##(2007-12#1)(2011-2#1)
via Agrobacterium tumefaciens##2##3##(2008-10#1)(2008-9#1)
via Ca2+##2##2##(1990-5#1)(1993-12#1)
via Charge##2##2##(1996-2#1)(1996-7#1)
via D1##2##2##(1992-9#1)(1994-8#1)
via DNA##2##2##(1991-9#1)(2010-7#1)
via L-type##2##2##(1996-12#1)(2010-12#1)
via NK1##2##2##(1992-10#1)(1995-12#1)
via P2Y receptors##3##3##(2008-4#3)
via PLSVC##2##2##(2012-2#2)
via RNA##2##2##(2010-5#1)(2012-2#1)
via Suzuki##2##2##(1996-5#1)(2007-11#1)
via a Knoevenagel##2##3##(2009-7#2)
via a catalytic##2##3##(1995-10#1)(2008-10#1)
via a cellular##2##3##(1994-12#1)(1996-4#1)
via a central##2##3##(2006-7#1)(2009-3#1)
via a combination of##2##4##(1995-2#1)(2009-2#1)
via a combined##4##3##(1997-4#1)(2005-2#1)(2006-12#1)(2006-5#1)
via a common##3##3##(1991-12#1)(1996-1#1)(2010-6#1)
via a complex##4##3##(1994-5#1)(2006-10#1)(2007-11#1)(2008-11#1)
via a concerted##2##3##(1996-2#2)
via a different##2##3##(1990-9#1)(1994-10#1)
via a direct##4##3##(1995-3#1)(2005-10#1)(2007-8#1)(2008-5#1)
via a disulfide##2##3##(1990-8#1)(1994-12#1)
via a facile##2##3##(2008-10#1)(2012-2#1)
via a hydrogen##2##3##(1990-2#1)(1993-6#1)
via a limited##2##3##(2008-7#2)
via a mechanism##4##3##(1991-1#1)(1992-3#1)(1993-9#1)(2008-5#1)
via a modified##3##3##(2008-10#1)(2008-8#2)
via a multidimensional##2##3##(2008-6#1)(2009-5#1)
via a novel##5##3##(1997-1#1)(2008-6#1)(2011-2#2)(2012-12#1)
via a patent##2##3##(2007-9#1)(2009-10#1)
via a pathway##3##3##(1993-7#1)(1993-8#1)(1995-8#1)
via a permanent##2##3##(2006-5#1)(2008-10#1)
via a pertussis toxin-sensitive G-protein##2##5##(1990-12#1)(1991-7#1)
via a pertussis toxin-sensitive##3##4##(1990-12#1)(1991-7#1)(1995-2#1)
via a pertussis##5##3##(1990-12#1)(1991-7#1)(1994-12#1)(1995-2#2)
via a programmed##2##3##(1997-1#1)(2011-1#1)
via a questionnaire##2##3##(1996-9#1)(2008-12#1)
via a receptor of the##2##5##(1997-5#2)
via a receptor##3##3##(1996-5#1)(1997-5#2)
via a reduction in##2##4##(2008-1#1)(2008-10#1)
via a reduction##3##3##(1990-1#1)(2008-1#1)(2008-10#1)
via a series of##3##4##(2008-4#1)(2008-7#1)(2010-5#1)
via a simple##6##3##(1997-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-2#1)(2010-7#1)
via a single##4##3##(1990-12#1)(1991-7#1)(2005-2#1)(2010-8#1)
via a specific##4##3##(1990-11#1)(1992-11#1)(1994-6#1)(1997-6#1)
via a syringe##2##3##(1990-8#1)(2008-10#1)
via a transient##2##3##(2008-11#1)(2009-11#1)
via a two-step##2##3##(1996-5#1)(2009-5#1)
via a type III secretion system##2##6##(2006-10#1)(2008-9#1)
via a variety of##2##4##(1994-9#1)(1997-7#1)
via a##337##2##(1990-1#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#1)(1991-1#4)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-7#2)(1991-8#1)(1991-9#3)(1992-11#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-4#2)(1993-6#5)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#6)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#8)(1995-5#1)(1995-8#3)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#3)(1996-5#5)(1996-8#4)(1996-9#2)(1997-1#4)(1997-3#1)(1997-4#5)(1997-5#4)(1997-6#1)(1997-7#4)(1997-8#3)(2004-11#1)(2004-12#1)(2005-10#3)(2005-11#2)(2005-2#3)(2005-5#1)(2005-9#1)(2006-10#3)(2006-12#2)(2006-2#3)(2006-4#2)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#5)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#7)(2007-9#2)(2008-1#3)(2008-10#22)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#1)(2008-4#11)(2008-5#8)(2008-6#5)(2008-7#8)(2008-8#5)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#3)(2010-1#1)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#10)(2012-10#1)(2012-12#9)(2012-2#4)(2013-1#8)(2013-7#2)(2013-8#3)
via actions at##2##3##(1996-5#1)(2007-10#1)
via activating##2##2##(2008-3#1)(2013-1#1)
via activation of the##5##4##(1994-6#1)(1994-8#2)(2008-3#1)(2008-4#1)
via activation of##18##3##(1990-2#1)(1990-8#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-3#1)(1995-8#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-3#2)
via addition of##2##3##(1996-11#1)(2009-3#1)
via adrenergic receptors of the beta 1-subtype##2##7##(1994-6#2)
via alpha##2##2##(1991-5#1)(1993-11#1)
via alternative splicing##3##3##(1992-6#1)(1993-8#1)(2009-5#1)
via alternative##4##2##(1992-6#1)(1993-8#1)(2009-12#1)(2009-5#1)
via an action at##2##4##(1994-11#1)(1994-2#1)
via an anterior approach##2##4##(2006-8#1)(2008-7#1)
via an anterior##3##3##(2006-12#1)(2006-8#1)(2008-7#1)
via an associative##3##3##(1996-2#1)(2013-1#2)
via an indwelling##2##3##(1991-2#1)(2008-11#1)
via an intermediate##3##3##(1991-8#1)(1995-3#1)(2010-5#1)
via an intramolecular##4##3##(1995-2#1)(1995-3#1)(2008-6#1)(2009-9#1)
via an optical##2##3##(2007-11#1)(2008-5#1)
via an oxidative##2##3##(2008-10#1)(2010-12#1)
via an##111##2##(1990-3#1)(1990-7#1)(1991-12#1)(1991-2#2)(1991-6#1)(1991-8#3)(1992-1#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-6#2)(1995-8#1)(1996-1#1)(1996-2#1)(1996-5#2)(1996-8#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-9#1)(2005-9#1)(2006-12#1)(2006-2#2)(2006-8#3)(2007-11#4)(2007-12#1)(2007-8#1)(2008-1#4)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-12#5)(2010-4#1)(2010-5#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
via analysis of##3##3##(1996-3#2)(2005-8#1)
via anion exchange chromatography##2##4##(1990-2#1)(1992-4#1)
via anion##3##2##(1990-2#1)(1992-4#1)(2008-4#1)
via anion-exchange##2##2##(2008-4#1)(2010-4#1)
via any##2##2##(2007-11#1)(2008-9#1)
via apoptosis##3##2##(1992-11#1)(1994-3#1)(2008-7#1)
via appropriate##2##2##(2011-1#1)(2011-2#1)
via aqueous Diels-Alder cycloaddition##2##4##(2008-4#2)
via aqueous##4##2##(1992-3#1)(2008-4#2)(2008-5#1)
via at least two different##2##5##(1992-8#1)(1997-7#1)
via at least##4##3##(1991-9#1)(1992-8#1)(1997-7#1)(2005-7#1)
via automated##2##2##(1992-4#1)(2008-10#1)
via batch##2##2##(1990-9#1)(2013-1#1)
via binding of##2##3##(1990-5#1)(1996-8#1)
via binding##4##2##(1990-5#1)(1996-8#1)(1997-8#1)(2006-10#1)
via biochemical##2##2##(2010-10#1)(2010-4#1)
via blood##2##2##(1991-5#1)(2012-12#1)
via both##9##2##(1991-9#1)(1992-12#2)(1994-5#2)(1995-6#1)(2007-12#1)(2008-1#1)(2008-10#1)
via breastfeeding##2##2##(2009-9#2)
via bronchoscopy##3##2##(1994-2#2)(2010-10#1)
via calcium##4##2##(1990-5#1)(2008-1#1)(2008-4#1)(2008-8#1)
via capillary##3##2##(2007-8#1)(2008-10#1)(2008-11#1)
via catalytic##2##2##(2006-12#1)(2011-2#1)
via catheter##2##2##(1994-5#1)(2007-7#1)
via catheters in the femoral artery##2##6##(1993-2#1)(1995-12#1)
via cellular##5##2##(2008-11#1)(2008-8#1)(2009-2#1)(2010-2#1)(2012-12#1)
via changes in##2##3##(1992-4#1)(2009-12#1)
via clinical trials##2##3##(2008-7#1)(2010-12#1)
via clinical##3##2##(2008-7#1)(2010-12#1)(2013-8#1)
via cognate interactions##2##3##(2006-10#2)
via collateral##2##2##(2008-7#1)(2012-2#1)
via comparative##2##2##(1993-12#1)(2008-7#1)
via complex formation with modifier##2##5##(2008-10#2)
via complex##6##2##(1990-5#1)(1995-12#1)(1997-4#1)(2008-10#2)(2008-8#1)
via contaminated##2##2##(1996-12#1)(2006-7#1)
via continuous##2##2##(2007-8#1)(2008-5#1)
via control of##2##3##(1990-2#1)(1991-3#1)
via conventional##5##2##(1990-7#1)(2008-10#2)(2009-5#1)(2010-6#1)
via cytochrome P-450##2##3##(1990-2#1)(2008-3#1)
via cytochrome##3##2##(1990-2#1)(1996-6#1)(2008-3#1)
via different mechanisms##4##3##(1993-6#1)(1994-6#1)(1997-1#1)(2010-7#1)
via different neural##2##3##(2008-8#1)(2012-12#1)
via different pathways##2##3##(1994-6#1)(2010-8#1)
via different routes##2##3##(2008-7#1)(2011-1#1)
via different##15##2##(1993-6#1)(1994-6#2)(1997-1#1)(2007-1#2)(2008-11#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)
via diffusion##4##2##(2008-10#2)(2009-9#1)(2011-1#1)
via direct effects on##2##4##(1996-4#1)(2008-10#1)
via direct injection##2##3##(1996-1#1)(2008-10#1)
via direct##17##2##(1993-7#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#1)(2005-7#1)(2006-11#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-7#1)
via distinct##4##2##(1992-3#1)(1993-6#1)(1994-9#1)(1996-2#1)
via dopamine##3##2##(1992-10#1)(1995-10#1)(2008-4#1)
via down-regulation of##2##3##(2013-1#2)
via downregulation of##2##3##(2013-1#2)
via drinking water##3##3##(1996-12#1)(2008-8#1)(2008-9#1)
via duplication and##2##3##(1992-3#1)(2008-2#1)
via either##6##2##(2005-11#1)(2005-7#1)(2006-10#1)(2008-10#2)(2012-12#1)
via electron beam##4##3##(2008-10#1)(2009-11#1)(2009-2#2)
via electron##6##2##(1995-3#1)(2008-10#1)(2008-8#1)(2009-11#1)(2009-2#2)
via endocytosis##4##2##(2011-2#1)(2012-12#3)
via endoscopic##3##2##(2008-7#2)(2009-5#1)
via energy##2##2##(2008-1#1)(2010-1#1)
via enhanced##3##2##(1990-3#1)(2008-5#1)(2012-12#1)
via enzyme##2##2##(1990-8#1)(1993-7#1)
via expression##2##2##(2008-4#1)(2012-1#1)
via flow##2##2##(2008-10#1)(2012-3#1)
via fluorescence##3##2##(1990-11#1)(2010-7#1)(2011-1#1)
via free radical polymerization##3##4##(2013-7#1)(2013-8#2)
via free radical##4##3##(2012-2#1)(2013-7#1)(2013-8#2)
via free radicals##2##3##(1993-3#1)(2005-8#1)
via free##6##2##(1993-3#1)(2005-8#1)(2012-2#1)(2013-7#1)(2013-8#2)
via gap junctions##2##3##(2006-10#1)(2008-11#1)
via gastric##4##2##(2008-11#1)(2008-4#3)
via genetic##2##2##(1991-12#1)(1994-12#1)
via glutaraldehyde##3##2##(2004-9#1)(2008-10#1)(2009-10#1)
via glycosylation##2##2##(2008-11#2)
via group##2##2##(1996-5#1)(2008-10#1)
via guide-wire##3##2##(2007-7#3)
via high##2##2##(1993-6#1)(1997-4#1)
via high-affinity##2##2##(1992-3#1)(1994-10#1)
via high-performance liquid chromatography##2##4##(1996-6#1)(1997-3#1)
via highly##2##2##(1993-9#1)(1996-5#1)
via homologous recombination##3##3##(1991-9#1)(1995-6#1)(2008-4#1)
via human##2##2##(1990-6#1)(1991-12#1)
via hybrid##2##2##(1991-9#1)(2008-4#1)
via hydrolysis of##3##3##(1992-4#1)(2005-11#2)
via hydrophobic##2##2##(2008-10#1)(2011-2#1)
via hyphal anastomosis##2##3##(2008-10#2)
via image##2##2##(1995-2#1)(2007-8#1)
via immobilized##2##2##(1994-11#1)(2007-8#1)
via immunogold##2##2##(2008-9#2)
via implantable##2##2##(1991-6#1)(2006-12#1)
via in##2##2##(2008-2#1)(2010-2#1)
via increased##6##2##(1991-11#1)(1997-1#1)(2007-11#1)(2008-3#1)(2012-12#1)(2012-3#1)
via induction of##6##3##(1991-12#1)(1992-6#1)(1995-10#1)(1996-10#1)(2005-11#1)(2008-10#1)
via ingestion##2##2##(2008-12#1)(2008-7#1)
via inhibition of the##2##4##(2008-3#1)(2011-3#1)
via inhibition of##9##3##(1990-3#1)(1990-9#1)(1994-8#1)(2005-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-3#1)(2012-2#1)
via inhibition##10##2##(1990-3#1)(1990-9#1)(1994-12#1)(1994-8#1)(2005-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-3#1)(2012-2#1)
via interaction with electronically excited metastable##2##6##(2009-12#2)
via interaction with##5##3##(1990-10#1)(1994-9#1)(2009-12#3)
via interaction##7##2##(1990-10#1)(1994-9#1)(1996-2#1)(2009-12#3)(2009-8#1)
via interactions with##2##3##(1994-12#1)(1994-5#1)
via interactive##2##2##(2008-10#1)(2012-3#1)
via intermediate##3##2##(2008-10#1)(2009-3#1)(2010-12#1)
via internal##2##2##(1992-9#1)(2006-6#1)
via interpolation##2##2##(2008-5#1)(2008-8#1)
via intracellular##2##2##(1994-9#1)(2008-1#1)
via intramolecular##2##2##(2006-12#1)(2007-1#1)
via intraperitoneal injection##2##3##(1996-9#1)(2012-2#1)
via introduction of a##2##4##(1996-8#1)(2011-1#1)
via ion exchange##2##3##(2007-8#1)(2008-10#1)
via ion pairing##2##3##(1992-4#1)(2008-5#1)
via ion##4##2##(1992-4#1)(2007-8#1)(2008-10#1)(2008-5#1)
via iterative##2##2##(1996-1#1)(2010-8#1)
via its specific##2##3##(1990-7#1)(1992-7#1)
via its##27##2##(1990-7#2)(1990-9#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#1)(1994-12#1)(1994-9#1)(1995-2#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-6#1)(2008-10#1)(2008-8#1)(2009-10#3)(2009-7#1)(2010-2#1)(2010-3#1)(2011-2#2)(2013-7#1)
via laparoscopy in##2##3##(1991-3#1)(1993-9#1)
via laparoscopy##5##2##(1991-3#3)(1993-9#1)(1996-2#1)
via layer-by-layer##2##2##(2008-10#2)
via lysosomal exocytosis##4##3##(2012-12#4)
via measurements of##2##3##(2008-4#1)(2010-9#1)
via mechanism##2##2##(1990-12#1)(1997-6#1)
via mechanisms that are##2##4##(1997-2#1)(2006-1#1)
via mechanisms##3##2##(1991-8#1)(1997-2#1)(2006-1#1)
via median sternotomy##3##3##(2007-8#2)(2008-10#1)
via median##4##2##(2007-8#2)(2008-10#2)
via metabolic##2##2##(1993-4#1)(2008-7#1)
via mitochondrial pathways##2##3##(1992-10#1)(2013-1#1)
via mitochondrial##3##2##(1992-10#2)(2013-1#1)
via mode-2##2##2##(2009-12#2)
via modulating##3##2##(2009-10#1)(2010-10#1)(2012-3#1)
via modulation of##4##3##(1997-1#1)(1997-7#1)(2008-5#1)(2013-1#1)
via molecular##3##2##(1997-3#1)(2009-11#1)(2009-2#1)
via monocytes##2##2##(1991-12#2)
via multiple##3##2##(2008-1#1)(2010-5#1)(2011-2#1)
via muscarinic##2##2##(1994-8#1)(2006-10#1)
via muscle metaboreflex##2##3##(2013-8#2)
via muscle##4##2##(2007-8#1)(2012-2#1)(2013-8#2)
via neuronal##2##2##(1997-4#1)(2007-10#1)
via neurotransmitter##2##2##(2007-12#1)(2008-9#1)
via new##2##2##(2005-8#1)(2008-10#1)
via nucleophilic##2##2##(1996-2#1)(2007-10#1)
via numerical##3##2##(2006-10#1)(2007-4#1)(2008-10#1)
via on-line##4##2##(1990-11#1)(2008-10#3)
via one-electron oxidation##2##3##(2006-3#2)
via open##2##2##(2007-8#1)(2010-2#1)
via oral route##5##3##(2008-4#3)(2009-5#2)
via oral##6##2##(1996-10#1)(2008-4#3)(2009-5#2)
via osmotic##2##2##(1995-5#1)(1996-11#1)
via other##3##2##(1991-2#1)(1992-6#1)(2005-7#1)
via our##3##2##(1992-2#1)(2008-11#1)(2008-9#1)
via oxidation##2##2##(1991-5#1)(2012-3#1)
via oxidative##2##2##(2007-11#1)(2009-3#1)
via p38##2##2##(2009-9#1)(2010-10#1)
via p53 in##2##3##(2011-2#2)
via p53##3##2##(2007-8#1)(2011-2#2)
via partial##2##2##(2008-2#1)(2010-6#1)
via particle bombardment##3##3##(2008-10#3)
via peripheral##2##2##(1994-3#1)(2006-10#1)
via pertussis toxin-sensitive##2##3##(1990-7#1)(1995-11#1)
via pharmacological##3##2##(2007-10#1)(2010-4#1)(2011-1#1)
via phospholipase##2##2##(1996-2#1)(2011-2#1)
via phosphorylation##3##2##(1991-12#1)(2005-12#1)(2008-8#1)
via pollen##2##2##(2005-10#1)(2008-10#1)
via positive##2##2##(1997-5#1)(2012-12#1)
via potentiometric titration##2##3##(2008-10#2)
via production of##3##3##(1994-5#1)(1994-9#1)(2011-2#1)
via production##4##2##(1994-5#1)(1994-9#1)(2008-7#1)(2011-2#1)
via promoter##2##2##(2008-7#1)(2008-8#1)
via protein-protein interactions##3##3##(1992-3#1)(1992-8#1)(2009-7#1)
via protonation##2##2##(2008-10#1)(2010-8#1)
via prunin##2##2##(2008-11#2)
via pyruvate##2##2##(1991-1#2)
via reaction of##4##3##(2007-10#1)(2007-11#1)(2009-2#1)(2012-11#1)
via reaction with##3##3##(1997-8#1)(2007-10#1)(2009-9#1)
via reaction##7##2##(1997-8#1)(2007-10#2)(2007-11#1)(2009-2#1)(2009-9#1)(2012-11#1)
via receptor-mediated endocytosis##3##3##(1994-11#1)(2008-11#2)
via reduction of##4##3##(1995-1#1)(2005-10#1)(2008-10#1)(2008-5#1)
via regulating##2##2##(2008-9#1)(2013-8#1)
via regulation of##2##3##(2012-12#1)(2012-3#1)
via release of##2##3##(1991-5#1)(1992-11#1)
via reverse Na-Ca+K exchange##2##4##(1995-5#2)
via reverse##3##2##(1995-5#3)
via reversed uptake##2##3##(1996-9#2)
via reversed##3##2##(1996-9#2)(2008-10#1)
via secretion of##2##3##(1991-9#1)(2008-11#1)
via selective##3##2##(1994-5#1)(1996-4#1)(2008-4#1)
via separate##3##2##(1993-6#1)(1996-11#1)(2006-10#1)
via sequential##4##2##(1992-11#1)(2007-11#1)(2008-10#1)(2012-12#1)
via several mechanisms##2##3##(1997-1#1)(2012-12#1)
via several##7##2##(1991-8#1)(1997-1#1)(2008-4#1)(2008-8#1)(2011-1#2)(2012-12#1)
via short##3##2##(2006-8#1)(2008-4#1)(2011-12#1)
via similar##4##2##(1990-5#1)(1991-9#1)(2009-6#2)
via simple##3##2##(1995-10#1)(2010-4#1)(2012-1#1)
via simulation studies##2##3##(2009-12#1)(2009-9#1)
via simulation##4##2##(1994-6#1)(2009-12#1)(2009-9#1)(2012-3#1)
via simulations##2##2##(2008-6#1)(2012-12#1)
via single##2##2##(2008-10#1)(2009-12#1)
via site-directed mutagenesis##2##3##(1992-6#1)(1995-8#1)
via slow##2##2##(1997-1#1)(2008-1#1)
via small##3##2##(1991-9#1)(2006-5#1)(2009-3#1)
via spatial##2##2##(2008-1#1)(2008-8#1)
via specialized##2##2##(2007-12#1)(2009-8#1)
via specific##5##2##(1991-2#1)(1996-11#1)(2008-11#1)(2008-8#1)(2012-12#1)
via sternotomy##5##2##(2007-8#4)(2009-8#1)
via stimulation of##6##3##(1995-12#2)(1996-1#1)(1996-2#1)(1996-5#1)(2009-6#1)
via successive##4##2##(1990-12#1)(1997-2#2)(2008-7#1)
via suppressing##2##2##(2008-10#1)(2008-11#1)
via surface##3##2##(2008-10#1)(2010-4#2)
via sustained##2##2##(2008-7#1)(2008-9#1)
via systemic##2##2##(1994-10#1)(1997-1#1)
via tail##2##2##(2005-10#1)(2008-8#1)
via tandem##2##2##(1996-7#1)(2007-11#1)
via targeted##3##2##(1991-6#1)(2006-12#1)(2008-6#1)
via telephone##4##2##(1996-12#1)(2006-10#1)(2008-1#1)(2013-1#1)
via text##2##2##(2012-1#1)(2013-1#1)
via the A1##3##3##(1993-6#1)(1994-11#1)(1994-6#1)
via the Hurd-Mori##2##3##(2007-11#2)
via the IL-5 receptor##2##4##(1990-12#2)
via the Internet and##2##4##(2005-10#1)(2013-7#1)
via the Internet in##2##4##(2007-12#1)(2008-1#1)
via the Internet##9##3##(2005-10#1)(2006-12#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-7#2)(2013-7#1)
via the LDL##2##3##(1991-8#1)(1992-5#1)
via the MT1##2##3##(2013-7#2)
via the Mitsunobu reaction##2##4##(2007-11#2)
via the Mitsunobu##3##3##(2007-11#3)
via the T cell##2##4##(1997-6#1)(2011-1#1)
via the action of##3##4##(1994-6#1)(2008-11#1)(2012-2#1)
via the activation of##4##4##(1994-10#1)(1994-2#1)(1995-6#1)(2009-8#1)
via the adenosine##2##3##(2008-10#1)(2008-4#1)
via the adenylate cyclase/cAMP pathway##2##5##(1996-5#2)
via the anterior##2##3##(2007-11#1)(2011-2#1)
via the bloodstream##2##3##(1992-11#2)
via the cAMP##3##3##(1992-6#1)(1994-8#1)(1996-5#1)
via the catecholamine extraneuronal uptake2 transporter##2##6##(1996-6#2)
via the central nervous system##2##5##(1997-7#1)(2013-7#1)
via the complex##2##3##(1993-8#1)(2008-10#1)
via the condensation##2##3##(2007-11#1)(2008-10#1)
via the constitutive pathway##2##4##(1992-12#1)(1996-4#1)
via the corresponding##2##3##(2007-11#2)
via the cytoplasmic domain of the interleukin 6 signal transducer gp130##2##11##(1996-5#2)
via the drinking water##2##4##(1990-4#1)(2008-10#1)
via the effects of##2##4##(2006-12#1)(2008-1#1)
via the external##2##3##(2007-9#1)(2008-10#1)
via the femoral##3##3##(2007-4#1)(2009-5#1)(2012-2#1)
via the formation of##4##4##(1990-12#1)(1994-10#1)(1995-5#1)(2006-10#1)
via the fusion of##2##4##(2008-9#1)(2010-9#1)
via the i##3##3##(1991-12#1)(2013-1#2)
via the induction of##4##4##(1995-6#1)(1996-10#1)(1996-9#1)(2010-5#1)
via the interaction of##2##4##(2008-10#1)(2012-2#1)
via the intrathymic##2##3##(2007-11#2)
via the intravenous route##2##4##(2007-11#1)(2008-4#1)
via the lateral##2##3##(1995-12#1)(1996-6#1)
via the layer-by-layer##2##3##(2009-2#1)(2010-4#1)
via the media##3##3##(2008-11#1)(2013-1#1)(2013-7#1)
via the normalization of##2##4##(1995-3#2)
via the penetrating arteries##2##4##(2006-5#2)
via the plasma membrane##2##4##(1996-8#1)(1997-1#1)
via the production of##2##4##(2006-10#1)(2008-11#1)
via the reaction of##3##4##(1993-6#1)(2008-10#1)(2008-5#1)
via the reaction##4##3##(1993-6#1)(2008-10#1)(2008-11#1)(2008-5#1)
via the regulation of##2##4##(2009-7#1)(2009-8#1)
via the release of##4##4##(1993-3#1)(1996-3#1)(1997-5#1)(2011-2#1)
via the same##5##3##(1990-3#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-6#1)
via the sol-gel##2##3##(2004-9#1)(2010-1#1)
via the stimulation of##3##4##(1992-9#1)(1994-12#1)(1997-5#1)
via the surrounding##2##3##(2010-2#2)
via the sympathetic innervation##2##4##(1994-5#1)(1995-3#1)
via the telephone##2##3##(2013-1#2)
via the trachea##3##3##(1994-5#1)(2008-10#1)(2008-5#1)
via the transarterial route##2##4##(1997-3#2)
via the ubiquitin-proteasome system##2##4##(2007-12#1)(2011-2#1)
via the use of##4##4##(2008-7#1)(2009-11#1)(2009-7#1)(2011-1#1)
via the##494##2##(1990-11#1)(1990-12#4)(1990-2#2)(1990-3#3)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#4)(1991-11#3)(1991-12#2)(1991-2#3)(1991-3#2)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#4)(1992-12#1)(1992-2#2)(1992-3#3)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#4)(1993-8#1)(1993-9#1)(1994-10#3)(1994-11#2)(1994-12#5)(1994-2#2)(1994-5#4)(1994-6#3)(1994-8#5)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#5)(1995-3#4)(1995-5#3)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#3)(1996-11#1)(1996-3#4)(1996-4#2)(1996-5#7)(1996-6#3)(1996-7#4)(1996-8#2)(1996-9#2)(1997-1#3)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#6)(1997-6#4)(1997-7#3)(1997-8#1)(2004-3#1)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#1)(2005-7#2)(2005-8#1)(2006-10#5)(2006-11#2)(2006-12#9)(2006-2#1)(2006-3#1)(2006-5#3)(2006-6#2)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#17)(2007-12#17)(2007-2#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#4)(2008-1#5)(2008-10#35)(2008-11#12)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#14)(2008-5#11)(2008-6#4)(2008-7#8)(2008-8#7)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#3)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#7)(2009-9#2)(2010-1#1)(2010-12#5)(2010-2#4)(2010-4#4)(2010-5#3)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#8)(2011-2#21)(2012-1#2)(2012-12#8)(2012-2#9)(2012-3#1)(2013-1#14)(2013-7#7)(2013-8#7)
via their 5'##2##3##(2008-4#2)
via their##15##2##(1994-3#1)(1995-10#1)(1996-2#1)(2006-10#1)(2006-2#1)(2007-12#2)(2008-4#3)(2008-5#1)(2010-1#1)(2010-7#1)(2012-2#2)
via these##5##2##(2004-12#1)(2008-5#1)(2009-2#2)(2010-1#1)
via this pathway##2##3##(1994-12#1)(2013-8#1)
via this receptor##2##3##(1995-6#1)(2008-5#1)
via this##11##2##(1993-11#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-6#1)(2005-8#1)(2006-9#1)(2008-10#1)(2008-5#1)(2012-2#1)(2013-8#1)
via thoracotomy##2##2##(2007-7#1)(2007-8#1)
via three##5##2##(1993-12#1)(1994-2#1)(1995-3#1)(2007-12#1)(2008-12#1)
via transferrin##3##2##(1993-11#2)(1994-5#1)
via transient##2##2##(1996-5#1)(2011-1#1)
via transition##2##2##(1995-11#1)(2009-7#1)
via transvaginal sonography##2##3##(1992-12#2)
via two##10##2##(1995-6#1)(1996-10#1)(2006-10#1)(2006-6#2)(2008-2#1)(2008-7#1)(2009-5#1)(2009-9#1)(2011-2#1)
via two-stage##2##2##(2006-12#1)(2009-10#1)
via use of##5##3##(2008-10#2)(2011-2#1)(2012-2#1)(2013-8#1)
via vaccination##2##2##(2008-9#1)(2010-7#1)
via viral##2##2##(1996-10#1)(2013-7#1)
via visual##2##2##(2006-8#1)(2008-6#1)
via which##5##2##(1995-1#1)(1996-1#1)(2006-1#1)(2013-1#2)
via wireless##4##2##(2008-10#2)(2008-9#1)(2010-8#1)
via##2594##1##(1990-1#2)(1990-10#1)(1990-11#8)(1990-12#10)(1990-2#9)(1990-3#10)(1990-4#6)(1990-5#9)(1990-6#3)(1990-7#11)(1990-8#9)(1990-9#6)(1991-1#7)(1991-10#4)(1991-11#7)(1991-12#17)(1991-2#14)(1991-3#9)(1991-4#1)(1991-5#11)(1991-6#5)(1991-7#3)(1991-8#9)(1991-9#17)(1992-1#3)(1992-10#5)(1992-11#10)(1992-12#10)(1992-2#5)(1992-3#16)(1992-4#5)(1992-5#1)(1992-6#14)(1992-7#4)(1992-8#5)(1992-9#6)(1993-1#1)(1993-11#11)(1993-12#7)(1993-2#3)(1993-3#9)(1993-4#6)(1993-5#3)(1993-6#18)(1993-7#5)(1993-8#5)(1993-9#10)(1994-10#10)(1994-11#9)(1994-12#21)(1994-2#13)(1994-3#9)(1994-4#1)(1994-5#13)(1994-6#13)(1994-8#17)(1994-9#15)(1995-1#11)(1995-10#7)(1995-11#6)(1995-12#19)(1995-2#18)(1995-3#24)(1995-5#11)(1995-6#10)(1995-7#5)(1995-8#13)(1995-9#3)(1996-1#9)(1996-10#9)(1996-11#10)(1996-12#8)(1996-2#19)(1996-3#11)(1996-4#11)(1996-5#29)(1996-6#8)(1996-7#11)(1996-8#13)(1996-9#10)(1997-1#16)(1997-2#18)(1997-3#6)(1997-4#22)(1997-5#16)(1997-6#10)(1997-7#14)(1997-8#9)(2004-10#1)(2004-11#3)(2004-12#3)(2004-3#3)(2004-9#6)(2005-1#2)(2005-10#9)(2005-11#16)(2005-12#1)(2005-2#3)(2005-4#1)(2005-5#1)(2005-7#10)(2005-8#10)(2005-9#3)(2006-1#4)(2006-10#40)(2006-11#4)(2006-12#26)(2006-2#9)(2006-3#3)(2006-4#4)(2006-5#7)(2006-6#12)(2006-7#5)(2006-8#16)(2006-9#4)(2007-1#9)(2007-10#13)(2007-11#53)(2007-12#46)(2007-2#1)(2007-3#2)(2007-4#6)(2007-5#5)(2007-6#1)(2007-7#7)(2007-8#39)(2007-9#9)(2008-1#33)(2008-10#197)(2008-11#60)(2008-12#15)(2008-2#24)(2008-3#19)(2008-4#88)(2008-5#51)(2008-6#24)(2008-7#53)(2008-8#47)(2008-9#26)(2009-1#1)(2009-10#15)(2009-11#11)(2009-12#20)(2009-2#21)(2009-3#19)(2009-4#8)(2009-5#13)(2009-6#9)(2009-7#12)(2009-8#18)(2009-9#18)(2010-1#11)(2010-10#10)(2010-11#6)(2010-12#17)(2010-2#15)(2010-3#5)(2010-4#21)(2010-5#17)(2010-6#9)(2010-7#17)(2010-8#13)(2010-9#3)(2011-1#41)(2011-12#4)(2011-2#74)(2011-3#3)(2012-1#15)(2012-10#1)(2012-11#2)(2012-12#57)(2012-2#44)(2012-3#23)(2013-1#75)(2013-7#23)(2013-8#32)
viabilities of##2##2##(2008-11#1)(2008-5#1)
viabilities##9##1##(2008-10#1)(2008-11#7)(2008-5#1)
viability after##8##2##(1994-2#1)(2006-12#1)(2006-5#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2013-7#1)
viability and body size##2##4##(2013-1#2)
viability and development##4##3##(2006-10#1)(2006-2#1)(2009-10#2)
viability and function##3##3##(2008-11#1)(2008-5#1)(2013-1#1)
viability and functionality##2##3##(2005-8#1)(2008-11#1)
viability and growth of##2##4##(1990-6#1)(2009-9#1)
viability and productivity##2##3##(2008-11#2)
viability and proliferation##5##3##(2008-11#1)(2008-5#2)(2010-8#1)(2012-6#1)
viability and sperm##2##3##(2009-5#1)(2009-6#1)
viability and survival##2##3##(2006-10#1)(2008-7#1)
viability and the##5##3##(1994-3#1)(2008-5#1)(2011-2#1)(2013-7#1)(2013-8#1)
viability and##103##2##(1990-6#1)(1991-1#2)(1991-10#2)(1991-11#1)(1991-6#1)(1992-2#1)(1993-4#2)(1993-7#1)(1994-1#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-7#1)(1996-12#1)(1997-1#1)(1997-4#1)(2004-9#1)(2005-8#2)(2006-10#3)(2006-2#1)(2006-5#3)(2007-1#1)(2007-6#2)(2007-8#1)(2008-10#6)(2008-11#14)(2008-12#1)(2008-4#2)(2008-5#8)(2008-7#6)(2008-9#3)(2009-10#2)(2009-3#1)(2009-5#1)(2009-6#4)(2009-7#1)(2009-9#2)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#3)(2012-6#1)(2013-1#4)(2013-7#2)(2013-8#2)
viability are##2##2##(1994-5#1)(2011-2#1)
viability as##5##2##(1992-6#1)(1997-3#1)(2008-11#1)(2010-5#1)(2013-1#1)
viability assay##4##2##(2011-2#1)(2012-2#3)
viability assessment##2##2##(2008-9#1)(2012-2#1)
viability at##7##2##(1996-1#1)(1997-6#1)(2004-11#1)(2009-6#1)(2011-12#1)(2012-11#2)
viability between##2##2##(2006-2#1)(2008-10#1)
viability by##2##2##(1993-12#1)(2008-5#1)
viability costs##2##2##(2008-8#2)
viability decreased##3##2##(2006-12#1)(2010-4#1)(2013-1#1)
viability during##3##2##(2008-10#1)(2008-11#2)
viability following##3##2##(1990-6#1)(1997-6#2)
viability for##2##2##(2007-5#1)(2008-8#1)
viability in both##2##3##(1994-5#1)(2010-8#1)
viability in the marketplace##2##4##(1996-12#1)(2007-2#1)
viability in the presence of##4##5##(1995-3#1)(2007-8#1)(2008-5#1)(2011-2#1)
viability in the##8##3##(1994-5#1)(1995-3#1)(1995-9#1)(1996-12#1)(2007-2#1)(2007-8#1)(2008-5#1)(2011-2#1)
viability in##42##2##(1992-12#1)(1994-5#2)(1994-6#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-4#1)(1997-6#1)(1997-8#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-2#2)(2007-8#1)(2008-10#5)(2008-11#7)(2008-5#2)(2010-8#1)(2011-2#2)(2012-11#1)(2013-1#3)
viability is##4##2##(1997-4#1)(2007-9#1)(2008-1#1)(2008-9#1)
viability losses##2##2##(2006-5#1)(2008-11#1)
viability of XO##2##3##(1991-5#2)
viability of a##5##3##(1992-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2013-8#1)
viability of cells##6##3##(2006-12#1)(2008-4#1)(2009-12#1)(2013-1#3)
viability of conidia##2##3##(2008-10#2)
viability of microsclerotia##2##3##(2008-10#2)
viability of the cells##2##4##(1995-2#1)(2009-7#1)
viability of the method##4##4##(2008-10#3)(2008-5#1)
viability of the##31##3##(1991-2#1)(1992-1#1)(1992-5#1)(1993-9#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-4#1)(2005-8#1)(2006-5#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#4)(2008-11#5)(2008-5#1)(2008-8#1)(2009-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2013-7#1)
viability of these##2##3##(1995-9#1)(2008-5#1)
viability of##127##2##(1990-12#1)(1990-6#1)(1991-1#1)(1991-2#1)(1991-5#2)(1992-1#2)(1992-5#1)(1992-7#1)(1993-9#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-7#1)(1995-9#3)(1996-12#1)(1996-8#1)(1997-2#2)(1997-4#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#20)(2008-11#14)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#3)(2008-8#2)(2008-9#6)(2009-12#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#2)(2012-2#1)(2012-3#3)(2013-1#6)(2013-7#2)(2013-8#1)
viability or proliferation##2##3##(1997-4#1)(2012-2#1)
viability or the##2##3##(1994-9#1)(2008-10#1)
viability or##9##2##(1994-9#3)(1997-4#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-9#1)(2012-2#1)
viability rates##3##2##(2006-5#2)(2011-12#1)
viability remained##2##2##(1992-12#1)(2008-11#1)
viability scores##2##2##(1995-7#2)
viability selection##7##2##(2008-8#1)(2008-9#1)(2013-1#5)
viability staining##2##2##(1996-1#1)(2008-10#1)
viability test##4##2##(1997-1#1)(2008-11#1)(2010-5#1)(2012-12#1)
viability than the##2##3##(2008-9#1)(2013-1#1)
viability than##3##2##(2006-5#1)(2008-9#1)(2013-1#1)
viability to##2##2##(1996-12#1)(2008-5#1)
viability traits##2##2##(2012-3#2)
viability under##2##2##(2008-7#1)(2010-8#1)
viability using##2##2##(2008-11#1)(2008-9#1)
viability was determined##3##3##(2008-11#1)(2010-5#1)(2012-12#1)
viability was estimated##2##3##(2006-8#1)(2011-12#1)
viability was greater##2##3##(2006-5#1)(2008-11#1)
viability was observed##3##3##(2004-9#1)(2008-10#1)(2008-11#1)
viability was##24##2##(1990-9#1)(1994-5#1)(1997-4#1)(2004-9#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-8#1)(2008-10#3)(2008-11#6)(2009-9#1)(2010-5#1)(2010-8#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
viability were##7##2##(1994-10#1)(2005-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-12#1)(2013-1#1)
viability with##3##2##(1996-12#1)(2008-10#1)(2009-10#1)
viability##630##1##(1990-12#1)(1990-5#1)(1990-6#4)(1990-9#1)(1991-1#4)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-1#3)(1992-11#2)(1992-12#2)(1992-2#1)(1992-5#2)(1992-6#2)(1992-7#1)(1993-12#2)(1993-4#3)(1993-7#3)(1993-8#1)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-5#5)(1994-6#1)(1994-9#4)(1995-10#1)(1995-12#3)(1995-2#5)(1995-3#2)(1995-6#1)(1995-7#5)(1995-8#3)(1995-9#6)(1996-1#5)(1996-10#1)(1996-12#9)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-7#5)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#5)(1997-4#6)(1997-5#2)(1997-6#11)(1997-7#1)(1997-8#2)(2004-11#1)(2004-12#1)(2004-9#2)(2005-11#1)(2005-12#3)(2005-8#6)(2006-10#5)(2006-12#3)(2006-2#3)(2006-5#19)(2006-7#1)(2006-8#3)(2007-1#3)(2007-11#3)(2007-12#3)(2007-2#5)(2007-4#1)(2007-5#1)(2007-6#4)(2007-7#3)(2007-8#6)(2007-9#4)(2008-1#5)(2008-10#52)(2008-11#77)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#10)(2008-5#21)(2008-6#1)(2008-7#16)(2008-8#15)(2008-9#29)(2009-10#4)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#7)(2009-7#2)(2009-8#1)(2009-9#6)(2010-1#2)(2010-10#2)(2010-4#2)(2010-5#6)(2010-7#1)(2010-8#9)(2010-9#7)(2011-1#5)(2011-12#7)(2011-2#14)(2012-1#1)(2012-11#7)(2012-12#8)(2012-2#13)(2012-3#10)(2012-6#1)(2013-1#33)(2013-7#9)(2013-8#7)
viability)##2##1##(1992-9#1)(2008-11#1)
viability/proliferation##2##1##(2010-7#2)
viable Escherichia coli O157##2##4##(2008-3#2)
viable Listeria##3##2##(2011-12#3)
viable Y##2##2##(2013-1#2)
viable alternative to##11##3##(1992-5#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-2#1)(2012-2#1)
viable alternative##22##2##(1992-2#1)(1992-5#1)(1996-3#1)(1997-4#1)(2006-10#2)(2006-11#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-5#1)(2009-7#1)(2011-2#2)(2012-2#1)
viable and nonviable##2##3##(2007-8#1)(2008-9#1)
viable and total cell##2##4##(2008-11#1)(2008-7#1)
viable and##25##2##(1992-7#1)(1995-6#2)(1995-8#1)(1996-5#1)(1996-8#1)(2006-5#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-7#3)(2008-9#2)(2009-10#1)(2009-4#1)(2010-2#1)(2011-1#1)(2013-1#1)
viable animal cells##2##3##(2008-11#2)
viable approach##4##2##(1994-10#1)(2007-5#1)(2008-4#1)(2012-3#1)
viable at##4##2##(1993-3#1)(2008-11#1)(2008-9#2)
viable bacteria##6##2##(1995-2#1)(2006-8#2)(2008-10#1)(2008-5#1)(2008-9#1)
viable bacterial counts##3##3##(2007-8#1)(2008-10#2)
viable biological##2##2##(1990-8#1)(2008-9#1)
viable biomass##2##2##(2008-11#2)
viable but asynergic##2##3##(1997-1#2)
viable but##7##2##(1995-8#1)(1997-1#2)(1997-4#1)(2008-10#1)(2008-9#1)(2011-1#1)
viable candidates for##2##3##(2010-10#1)(2012-12#1)
viable cell concentration##9##3##(1994-3#1)(2008-11#3)(2008-7#5)
viable cell concentrations##3##3##(1994-11#1)(1994-5#1)(2008-11#1)
viable cell counts##2##3##(2006-5#1)(2010-4#1)
viable cell density and##2##4##(2008-11#2)
viable cell density in##2##4##(2008-11#2)
viable cell density of##3##4##(2008-11#3)
viable cell density##18##3##(1994-5#1)(2008-11#17)
viable cell number##6##3##(2008-11#6)
viable cell##47##2##(1994-11#1)(1994-3#1)(1994-5#2)(1996-2#1)(1996-5#1)(2006-5#1)(2008-11#33)(2008-4#1)(2008-7#5)(2010-4#1)
viable cells and##2##3##(2006-5#1)(2008-10#1)
viable cells for##2##3##(1990-12#1)(2008-9#1)
viable cells in a culture##2##5##(1991-1#1)(2008-11#1)
viable cells in a##3##4##(1991-1#1)(2008-11#2)
viable cells in##8##3##(1991-1#1)(2008-11#6)(2012-12#1)
viable cells is##2##3##(2011-2#1)(2012-2#1)
viable cells were##2##3##(2006-11#1)(2013-1#1)
viable cells with a##2##4##(1994-2#1)(1995-4#1)
viable cells##40##2##(1990-12#1)(1991-1#1)(1994-2#1)(1995-1#3)(1995-4#1)(2006-11#1)(2006-5#1)(2007-7#1)(2008-10#3)(2008-11#10)(2008-2#2)(2008-4#4)(2008-7#1)(2008-9#2)(2009-4#2)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
viable cells) in##2##3##(2008-1#2)
viable colonies##2##2##(1995-8#1)(2008-10#1)
viable count##6##2##(2006-8#1)(2010-4#3)(2013-1#1)(2013-7#1)
viable counts dropped##2##3##(2012-2#2)
viable counts in the##2##4##(2008-10#1)(2013-1#1)
viable counts were##2##3##(1997-5#1)(2008-10#1)
viable counts##15##2##(1997-4#1)(1997-5#2)(2007-12#1)(2007-7#2)(2008-10#4)(2010-4#1)(2012-2#3)(2013-1#1)
viable fetus##2##2##(2006-8#2)
viable fetuses##2##2##(2005-7#1)(2006-5#1)
viable for##10##2##(1994-5#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2011-2#1)
viable hepatocytes##2##2##(2008-11#2)
viable in##7##2##(1993-9#1)(1994-12#1)(2004-4#1)(2008-1#1)(2010-11#1)(2010-3#1)(2010-9#1)
viable means of##4##3##(2004-3#1)(2007-12#1)(2008-2#1)(2013-7#1)
viable method##4##2##(1995-1#1)(2007-5#1)(2008-5#1)(2010-4#1)
viable microorganisms##2##2##(2008-5#1)(2011-2#1)
viable myocardium##8##2##(1997-1#1)(2007-8#6)(2008-10#1)
viable neurons##3##2##(2006-5#1)(2006-8#1)(2011-2#1)
viable offspring##2##2##(2011-12#1)(2013-8#1)
viable on##2##2##(1990-8#1)(2008-10#1)
viable option for the##3##4##(2008-10#1)(2008-3#1)(2009-10#1)
viable option for##11##3##(2005-7#1)(2005-8#1)(2007-7#1)(2008-10#2)(2008-3#1)(2009-10#1)(2011-2#2)(2012-2#2)
viable option##15##2##(2005-7#1)(2005-8#1)(2006-3#1)(2007-7#1)(2008-10#3)(2008-3#1)(2009-10#1)(2010-11#1)(2011-2#2)(2012-2#2)(2013-1#1)
viable over##2##2##(2006-2#1)(2008-5#1)
viable population##3##2##(1991-11#1)(2008-11#1)(2010-8#1)
viable populations##3##2##(2007-7#1)(2008-8#1)(2013-7#1)
viable solutions to##2##3##(1995-3#1)(2008-2#1)
viable spores##5##2##(2006-8#1)(2008-10#2)(2008-5#1)(2011-2#1)
viable technique for##3##3##(2008-10#1)(2008-4#1)(2012-4#1)
viable technique##4##2##(2008-10#1)(2008-11#1)(2008-4#1)(2012-4#1)
viable therapeutic##2##2##(2007-7#1)(2011-1#1)
viable tissue##3##2##(2007-8#1)(2013-7#2)
viable with##2##2##(1991-5#1)(2008-7#1)
viable without##2##2##(1991-1#1)(2009-4#1)
viable yeast##2##2##(2007-12#1)(2008-10#1)
viable##500##1##(1990-12#1)(1990-4#3)(1990-8#2)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-1#1)(1993-12#2)(1993-3#2)(1993-4#1)(1993-7#1)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#5)(1994-6#1)(1994-8#1)(1995-1#5)(1995-2#3)(1995-3#1)(1995-4#1)(1995-6#2)(1995-8#4)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#5)(1997-3#1)(1997-4#3)(1997-5#2)(1997-8#1)(2004-10#1)(2004-3#1)(2004-4#2)(2005-11#1)(2005-12#1)(2005-5#1)(2005-7#5)(2005-8#1)(2005-9#1)(2006-10#4)(2006-11#4)(2006-12#2)(2006-2#2)(2006-3#2)(2006-5#9)(2006-7#2)(2006-8#9)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#5)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#8)(2007-8#11)(2007-9#5)(2008-1#6)(2008-10#56)(2008-11#69)(2008-2#5)(2008-3#5)(2008-4#13)(2008-5#16)(2008-6#1)(2008-7#15)(2008-8#8)(2008-9#15)(2009-10#2)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#4)(2009-4#4)(2009-5#2)(2009-7#1)(2010-10#1)(2010-11#5)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#8)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#5)(2011-2#15)(2012-11#1)(2012-12#9)(2012-2#15)(2012-3#4)(2012-4#1)(2013-1#15)(2013-7#6)(2013-8#1)
vial and##3##2##(2008-10#1)(2008-8#1)(2012-12#1)
vial of##3##2##(1997-4#1)(2008-8#1)(2012-2#1)
vial##20##1##(1992-3#1)(1997-4#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-3#3)(2008-8#2)(2012-12#2)(2012-2#1)
vials of antivenom##2##3##(2006-4#2)
vials of##3##2##(1995-5#1)(2006-4#2)
vials##18##1##(1995-5#1)(1996-8#1)(2006-3#1)(2006-4#2)(2008-10#5)(2008-3#3)(2008-8#1)(2009-11#1)(2010-4#2)(2012-2#1)
vibrant Soundbridge middle-ear implant##2##4##(2008-9#2)
vibrant##5##1##(2008-10#1)(2008-12#1)(2008-9#2)(2009-10#1)
vibrate##4##1##(2007-3#1)(2008-2#1)(2008-3#2)
vibrated image##2##2##(2008-2#2)
vibrated images##2##2##(2008-2#1)(2008-3#1)
vibrated##5##1##(2005-11#1)(2008-2#3)(2008-3#1)
vibrates##2##1##(2008-2#1)(2008-3#1)
vibrating surfaces##2##2##(2008-2#2)
vibrating tool use##2##3##(2008-9#2)
vibrating##19##1##(1992-8#1)(2007-12#2)(2008-11#1)(2008-2#4)(2008-3#5)(2008-5#1)(2008-7#2)(2008-9#2)(2012-2#1)
vibration amplitude##2##2##(2008-2#1)(2008-3#1)
vibration amplitudes of a##3##4##(2008-3#3)
vibration amplitudes##5##2##(2008-2#1)(2008-3#4)
vibration and##8##2##(1991-12#1)(2008-10#1)(2008-2#4)(2008-3#1)(2012-3#1)
vibration are##3##2##(2007-5#1)(2008-3#1)(2011-1#1)
vibration effects##2##2##(2008-3#2)
vibration frequency##3##2##(2005-4#1)(2008-2#2)
vibration group##4##2##(2008-9#4)
vibration in a##2##3##(2005-11#1)(2009-11#1)
vibration in##7##2##(2005-11#1)(2005-4#3)(2006-4#1)(2008-2#1)(2009-11#1)
vibration is##3##2##(2008-3#2)(2011-1#1)
vibration measurement##3##2##(2007-11#1)(2008-2#2)
vibration mode of##2##3##(2008-10#1)(2008-2#1)
vibration mode##3##2##(2008-10#2)(2008-2#1)
vibration of a##2##3##(2007-12#1)(2008-2#1)
vibration of the##13##3##(1992-9#1)(1995-5#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-2#2)(2008-3#3)(2008-8#1)(2011-1#1)(2013-8#1)
vibration of##20##2##(1992-9#1)(1994-11#1)(1995-12#1)(1995-5#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#3)(2008-3#3)(2008-8#1)(2011-1#1)(2013-8#1)
vibration sensing##2##2##(2007-12#1)(2008-3#1)
vibration to##3##2##(2008-3#3)
vibration##139##1##(1990-4#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-9#1)(1994-11#1)(1995-12#3)(1995-5#1)(1996-2#2)(2005-11#5)(2005-4#6)(2006-11#1)(2006-12#1)(2006-4#1)(2007-11#5)(2007-12#8)(2007-5#4)(2007-8#2)(2007-9#1)(2008-10#7)(2008-11#5)(2008-2#21)(2008-3#31)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#9)(2009-11#2)(2011-1#5)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#2)(2013-8#3)
vibration-blur impulse response##2##3##(2008-3#2)
vibrational CARS##2##2##(2008-2#1)(2008-3#1)
vibrational Raman scattering##2##3##(2008-2#1)(2008-3#1)
vibrational Raman##6##2##(2007-11#1)(2008-2#2)(2008-3#2)(2011-2#1)
vibrational and rotational Raman##2##4##(2007-11#1)(2008-10#1)
vibrational and rotational##3##3##(2007-11#1)(2008-10#1)(2009-8#1)
vibrational and##5##2##(1992-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2009-8#1)
vibrational band##4##2##(2008-3#3)(2008-8#1)
vibrational bands of##2##3##(1995-5#2)
vibrational bands##3##2##(1995-5#2)(2008-5#1)
vibrational changes##2##2##(1995-1#1)(2010-7#1)
vibrational echo##2##2##(2008-8#2)
vibrational energy##3##2##(2006-5#1)(2007-1#1)(2008-3#1)
vibrational frequencies##4##2##(1996-2#1)(2008-11#1)(2013-1#2)
vibrational frequency##2##2##(2008-6#1)(2009-12#1)
vibrational imaging##2##2##(2007-12#1)(2009-4#1)
vibrational levels of##2##3##(1992-6#1)(2005-4#1)
vibrational levels##3##2##(1992-6#1)(2005-4#1)(2007-12#1)
vibrational modes of the##4##4##(1991-9#1)(1992-6#1)(2007-11#1)(2008-4#1)
vibrational modes##12##2##(1991-9#1)(1992-6#1)(1995-10#1)(1995-5#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-6#1)(2013-7#1)
vibrational properties of##2##3##(1991-7#1)(1992-9#1)
vibrational relaxation##3##2##(2007-1#2)(2008-1#1)
vibrational spectra of Bis(melaminium) terephthalate dihydrate##2##6##(2013-1#2)
vibrational spectra of##6##3##(1993-11#1)(1994-11#1)(1996-2#1)(2006-12#1)(2013-1#2)
vibrational spectra with##2##3##(2006-12#1)(2013-1#1)
vibrational spectra##15##2##(1993-11#1)(1994-11#1)(1996-2#2)(2006-12#2)(2006-5#2)(2007-11#1)(2009-2#1)(2010-7#1)(2013-1#3)(2013-8#1)
vibrational spectroscopic##2##2##(2008-10#1)(2013-1#1)
vibrational spectroscopy##6##2##(1996-4#1)(2007-12#2)(2008-10#1)(2010-4#1)(2011-2#1)
vibrational spectrum of##3##3##(1993-11#1)(2010-7#1)(2012-2#1)
vibrational spectrum##5##2##(1993-11#1)(2007-11#1)(2009-9#1)(2010-7#1)(2012-2#1)
vibrational state##3##2##(1995-1#3)
vibrational structure##4##2##(1991-7#1)(2006-4#2)(2006-5#1)
vibrational transition of##2##3##(2007-11#1)(2008-2#1)
vibrational transition##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
vibrational##141##1##(1990-8#1)(1991-7#2)(1991-9#2)(1992-2#1)(1992-6#2)(1992-9#2)(1993-11#2)(1993-3#1)(1994-11#2)(1995-1#4)(1995-10#1)(1995-5#3)(1996-2#3)(1996-4#1)(2005-4#2)(2006-12#3)(2006-3#1)(2006-4#3)(2006-5#4)(2007-1#3)(2007-11#14)(2007-12#7)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#7)(2008-3#13)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#6)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-12#4)(2010-4#1)(2010-7#5)(2011-2#2)(2012-1#3)(2012-12#2)(2012-2#1)(2013-1#7)(2013-7#1)(2013-8#1)
vibrational-rotational Raman##4##2##(2008-2#2)(2008-3#2)
vibrational-rotational##6##1##(2008-2#2)(2008-3#4)
vibrationally excited NO##2##3##(2008-3#2)
vibrationally excited##7##2##(2006-3#1)(2007-1#1)(2008-10#1)(2008-2#1)(2008-3#3)
vibrationally##10##1##(1995-2#1)(2006-3#2)(2007-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
vibrations and##4##2##(1990-12#1)(2008-2#2)(2008-3#1)
vibrations are##3##2##(1994-12#1)(2008-2#2)
vibrations at##3##2##(2006-3#1)(2012-12#2)
vibrations for##2##2##(2007-11#1)(2008-3#1)
vibrations in the##2##3##(2007-12#1)(2010-2#1)
vibrations in##5##2##(2007-12#1)(2007-9#1)(2008-10#1)(2010-2#1)(2012-2#1)
vibrations is##3##2##(1994-3#1)(2008-2#1)(2008-3#1)
vibrations of the##7##3##(1995-10#1)(2005-11#1)(2007-11#2)(2007-12#1)(2008-2#1)(2012-2#1)
vibrations of##14##2##(1992-6#1)(1994-9#1)(1995-10#1)(2005-11#1)(2005-4#2)(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#1)(2009-9#1)(2012-2#1)
vibrations that##2##2##(2008-2#1)(2008-3#1)
vibrations to improve##2##3##(2008-2#2)
vibrations##74##1##(1990-12#1)(1990-3#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-6#1)(1993-4#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#1)(1996-2#1)(2005-11#2)(2005-4#2)(2006-3#1)(2007-11#3)(2007-12#3)(2007-9#2)(2008-10#5)(2008-2#18)(2008-3#14)(2008-8#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-12#2)(2012-2#3)
vibratome##4##1##(1993-7#1)(2008-11#1)(2008-4#1)(2008-8#1)
vibrator##3##1##(1997-7#1)(2010-12#2)
vibrators##2##1##(2008-7#1)(2012-2#1)
vibratory sensibility##2##2##(1992-8#2)
vibratory signaling differences predicted winners##2##5##(2009-9#2)
vibratory signaling##4##2##(2009-9#4)
vibratory##15##1##(1992-8#2)(1995-12#2)(1995-5#1)(1997-6#1)(2007-8#1)(2008-5#1)(2009-2#2)(2009-9#4)(2010-12#1)
vibrissa##2##1##(1992-7#1)(2013-1#1)
vibrissae##7##1##(1991-5#1)(1994-2#4)(2009-10#1)(2013-1#1)
vibrissal FSC##4##2##(2011-2#4)
vibrissal follicle-sinus complex##2##3##(2011-2#2)
vibrissal##11##1##(2011-2#11)
vibrometer##4##1##(2007-9#1)(2008-3#2)(2013-8#1)
vibrometry##5##1##(2007-11#1)(2007-9#2)(2008-2#2)
vibron Raman##2##2##(2008-10#2)
vibron##3##1##(2008-10#3)
vibronic##5##1##(1990-7#1)(2005-11#1)(2007-12#2)(2008-2#1)
vibrotactile sensor##2##2##(2006-6#2)
vibrotactile##5##1##(2006-6#2)(2010-6#2)(2012-1#1)
vic##2##1##(2008-10#2)
vicariance##4##1##(2008-9#2)(2009-2#2)
vicariant##3##1##(2008-10#1)(2009-2#1)(2013-7#1)
vicarious calibration experiments##3##3##(2008-3#3)
vicarious calibration of the##3##4##(2008-3#3)
vicarious calibration##8##2##(2008-3#8)
vicarious liability##3##2##(1991-3#2)(1995-1#1)
vicarious##14##1##(1991-3#2)(1995-1#1)(2008-3#10)(2012-12#1)
vicariously##2##1##(2008-3#1)(2010-12#1)
vice president and##3##3##(1996-6#1)(2006-7#2)
vice president##5##2##(1996-6#2)(2006-7#3)
vice versa##52##2##(1990-5#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-2#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-1#1)(1996-1#2)(1996-5#2)(1997-1#1)(1997-3#1)(2005-11#2)(2007-1#2)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#7)(2008-2#1)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#1)(2009-11#1)(2009-7#1)(2009-8#1)(2009-9#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#2)
vice versa)##2##2##(1994-5#1)(2007-12#1)
vice##68##1##(1990-5#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-2#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-5#1)(1995-1#1)(1996-1#2)(1996-5#2)(1996-6#2)(1997-1#1)(1997-3#1)(2005-11#2)(2006-6#1)(2006-7#3)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#8)(2008-2#1)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#1)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2011-12#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
viciae UPM791##2##2##(1996-7#2)
viciae strain 248##3##3##(1991-9#3)
viciae##6##1##(1991-9#3)(1996-7#2)(2008-8#1)
viciae-villosae##3##1##(2008-10#3)
vicinal##12##1##(1992-1#1)(1992-3#1)(1992-4#1)(1992-6#1)(1994-9#1)(1996-11#1)(1996-5#1)(2006-12#1)(2008-4#2)(2008-7#1)(2010-2#1)
vicinities##2##1##(1992-3#1)(2008-12#1)
vicinity of a##9##3##(1990-3#1)(1991-5#1)(1996-3#1)(1996-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-1#1)
vicinity of an##4##3##(1993-2#1)(2007-12#1)(2007-8#1)(2009-6#1)
vicinity of the retrofacial nucleus##2##5##(1990-7#1)(1993-12#1)
vicinity of the##74##3##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-7#2)(1990-8#1)(1991-4#2)(1991-5#1)(1991-6#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1994-11#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-6#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#6)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-2#3)(2008-3#4)(2008-5#2)(2008-7#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-7#2)(2012-12#1)(2013-8#1)
vicinity of##144##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-6#1)(1997-7#2)(2005-11#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#9)(2007-12#2)(2007-6#1)(2007-7#2)(2007-8#6)(2008-10#14)(2008-11#2)(2008-12#2)(2008-2#6)(2008-3#7)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-9#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
vicinity to##4##2##(1993-6#1)(1996-4#1)(1997-7#1)(2013-1#1)
vicinity##163##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-10#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-4#3)(1996-8#1)(1996-9#1)(1997-1#2)(1997-4#3)(1997-6#1)(1997-7#3)(2005-11#2)(2006-10#3)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#10)(2007-12#3)(2007-6#1)(2007-7#2)(2007-8#7)(2008-10#15)(2008-11#2)(2008-12#2)(2008-2#6)(2008-3#7)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#2)(2009-2#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-9#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
vicious circle##3##2##(2006-6#1)(2006-9#2)
vicious cycle of##4##3##(1994-2#1)(2007-12#1)(2008-9#1)(2012-12#1)
vicious cycle##7##2##(1994-2#1)(2007-12#1)(2008-9#1)(2010-3#1)(2010-5#1)(2012-12#1)(2012-2#1)
vicious##13##1##(1994-2#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-12#1)(2008-3#1)(2008-9#1)(2010-3#2)(2010-5#1)(2012-12#1)(2012-2#1)
vicosae##3##1##(2008-6#3)
victim may##2##2##(1996-12#1)(2008-12#1)
victim of##11##2##(1991-6#1)(1995-5#1)(1996-6#1)(2007-1#1)(2007-9#1)(2008-10#1)(2009-5#1)(2011-1#2)(2012-12#1)(2012-2#1)
victim to##4##2##(1993-9#1)(1994-3#1)(2008-7#1)(2012-1#1)
victim was##4##2##(1992-5#1)(1995-3#1)(2008-12#1)(2011-2#1)
victim were##2##2##(1995-6#1)(2008-2#1)
victim##46##1##(1991-6#1)(1992-5#2)(1992-6#1)(1993-5#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-12#2)(1996-6#1)(2005-8#1)(2005-9#1)(2006-4#1)(2007-1#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#2)(2009-5#1)(2010-4#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)
victim's##10##1##(1996-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-4#2)(2010-12#1)(2010-4#1)(2012-2#1)(2013-7#1)
victimization among##4##2##(2009-7#1)(2010-1#1)(2013-1#1)(2013-7#1)
victimization and offending##3##3##(2012-12#3)
victimization and##7##2##(2008-10#1)(2008-12#1)(2010-2#1)(2012-12#3)(2013-1#1)
victimization but##2##2##(2013-1#1)(2013-7#1)
victimization experiences##5##2##(2007-12#1)(2012-12#4)
victimization in adolescence##3##3##(2009-7#2)(2010-2#1)
victimization in##5##2##(2009-5#1)(2009-7#2)(2010-1#1)(2010-2#1)
victimization than##3##2##(2008-10#1)(2013-1#1)(2013-7#1)
victimization were##2##2##(2012-12#1)(2013-1#1)
victimization##67##1##(1991-3#1)(2007-12#6)(2008-10#5)(2008-12#4)(2008-4#1)(2008-7#2)(2009-5#6)(2009-7#6)(2010-1#3)(2010-2#4)(2010-4#2)(2011-2#1)(2012-12#13)(2013-1#8)(2013-7#3)(2013-8#2)
victimized##4##1##(2009-7#1)(2010-1#1)(2010-2#1)(2012-12#1)
victims and perpetrators##2##3##(2007-9#2)
victims and the##2##3##(1996-3#1)(2008-4#1)
victims and##11##2##(1996-3#1)(2007-10#1)(2007-9#2)(2008-11#1)(2008-2#2)(2008-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
victims are##4##2##(1996-3#1)(2008-2#2)(2012-3#1)
victims had##4##2##(1992-6#1)(2007-8#1)(2009-7#2)
victims in a##3##3##(1996-11#1)(2008-5#2)
victims in##6##2##(1996-11#1)(2005-8#1)(2008-5#2)(2010-2#1)(2012-2#1)
victims of a mass disaster##3##5##(1995-11#3)
victims of crime##4##3##(2011-1#4)
victims of domestic##3##3##(1995-12#1)(2007-2#1)(2011-2#1)
victims of intimate partner violence##2##5##(2012-12#2)
victims of penetrating cardiac injuries##2##5##(2007-8#2)
victims of penetrating##3##3##(2007-3#1)(2007-8#2)
victims of terrorism##2##3##(2007-9#2)
victims of the##4##3##(2006-9#1)(2008-2#1)(2009-6#1)(2011-2#1)
victims of violence in##2##4##(1991-12#1)(2011-2#1)
victims of violence##10##3##(1991-12#2)(1993-3#1)(2005-8#1)(2008-9#1)(2010-12#1)(2010-6#1)(2011-2#3)
victims of##59##2##(1990-5#1)(1991-12#3)(1992-1#1)(1992-12#1)(1993-3#1)(1993-6#1)(1993-7#1)(1995-11#3)(1995-12#1)(1996-11#1)(1997-4#2)(2005-8#3)(2006-9#3)(2007-2#1)(2007-3#2)(2007-4#1)(2007-8#2)(2007-9#4)(2008-11#1)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-6#1)(2009-9#2)(2010-12#1)(2010-6#2)(2011-1#4)(2011-2#5)(2012-1#1)(2012-12#3)(2013-1#1)
victims than##3##2##(1992-1#1)(1993-8#1)(2006-9#1)
victims to##4##2##(2005-8#1)(2008-2#3)
victims were reported to##2##4##(1993-3#1)(2007-2#1)
victims were##11##2##(1990-12#1)(1992-5#2)(1993-3#1)(1995-3#1)(1996-11#1)(1996-5#1)(2007-2#2)(2010-4#1)(2011-2#1)
victims with##2##2##(1993-3#1)(2008-7#1)
victims##191##1##(1990-12#1)(1990-5#1)(1991-12#3)(1991-2#2)(1992-1#2)(1992-12#1)(1992-2#1)(1992-5#2)(1992-6#1)(1993-3#7)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-4#1)(1994-5#1)(1995-11#3)(1995-12#1)(1995-3#1)(1995-5#1)(1996-11#5)(1996-3#3)(1996-5#1)(1996-6#1)(1997-4#4)(2004-3#1)(2005-8#9)(2006-10#5)(2006-12#1)(2006-9#5)(2007-1#1)(2007-10#2)(2007-12#2)(2007-2#3)(2007-3#3)(2007-4#1)(2007-7#2)(2007-8#6)(2007-9#6)(2008-10#1)(2008-11#4)(2008-2#16)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#3)(2008-9#4)(2009-6#4)(2009-7#4)(2009-9#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-6#2)(2010-8#1)(2011-1#6)(2011-2#9)(2012-1#2)(2012-12#6)(2012-2#7)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
victims'##6##1##(2009-7#4)(2012-3#1)(2013-1#1)
victoria##4##1##(1996-6#1)(1997-5#1)(2008-10#1)(2008-8#1)
victoriae##9##1##(2008-10#4)(2010-8#1)(2013-8#4)
victoriae)##2##1##(2008-10#2)
victoriensis##3##1##(2011-2#3)
victories##3##1##(1995-9#1)(2008-7#1)(2010-12#1)
victory in##4##2##(1997-7#1)(2005-11#1)(2006-5#1)(2008-5#1)
victory over##2##2##(1992-5#1)(1995-11#1)
victory##12##1##(1992-5#1)(1995-11#1)(1995-2#1)(1997-6#2)(1997-7#1)(2004-12#1)(2005-11#1)(2006-5#2)(2007-8#1)(2008-5#1)
video analysis##3##2##(2007-1#1)(2008-2#1)(2011-2#1)
video and confocal##2##3##(2008-3#2)
video and##14##2##(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-3#3)(2008-4#1)(2008-7#1)(2010-2#1)(2012-12#2)
video assisted thoracoscopy##2##3##(2006-10#2)
video assisted##6##2##(2006-10#2)(2007-8#1)(2013-1#3)
video at##2##2##(2004-11#1)(2006-11#1)
video camera systems##2##3##(2008-3#2)
video camera##11##2##(2004-9#2)(2007-11#1)(2007-12#1)(2007-5#1)(2008-3#4)(2008-5#2)
video cameras##5##2##(1995-12#1)(2008-3#2)(2012-12#1)(2012-2#1)
video capsule endoscopy##3##3##(2008-3#1)(2009-2#2)
video clips##2##2##(2008-12#2)
video coding and##2##3##(2008-2#2)
video coding##3##2##(2008-2#3)
video conversion##4##2##(2004-9#4)
video describes the##2##3##(2008-11#2)
video fluoroscopy##2##2##(2008-9#1)(2013-1#1)
video format##2##2##(2008-11#1)(2009-8#1)
video frame rates##2##3##(2008-3#2)
video frame##3##2##(2008-3#3)
video frames##2##2##(2007-11#1)(2008-2#1)
video game play##4##3##(2013-1#4)
video game playing##2##3##(2012-12#1)(2013-1#1)
video game##14##2##(2007-10#5)(2012-12#2)(2013-1#6)(2013-7#1)
video image##3##2##(2008-2#1)(2008-3#1)(2010-4#1)
video imagery##3##2##(1997-8#1)(2008-3#2)
video images of##2##3##(2008-11#1)(2008-3#1)
video images##6##2##(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#1)(2011-1#1)
video imaging##2##2##(1996-11#1)(2008-9#1)
video is##3##2##(2008-11#2)(2012-1#1)
video light/electron microscopy##2##3##(2008-1#2)
video microscope##3##2##(1992-8#1)(2008-3#1)(2008-9#1)
video microscopic system##2##3##(2005-11#2)
video microscopic##3##2##(2005-11#3)
video microscopy##3##2##(1995-1#1)(2008-10#1)(2008-3#1)
video monitor##3##2##(1991-5#1)(1993-12#1)(2008-12#1)
video monitoring##2##2##(1990-12#1)(2007-8#1)
video monitors##2##2##(2006-5#1)(2006-6#1)
video of##4##2##(1997-8#2)(2006-11#1)(2007-8#1)
video playback##2##2##(2008-10#1)(2008-11#1)
video protocol##11##2##(2008-10#1)(2008-11#10)
video rate of##2##3##(2007-12#1)(2008-3#1)
video rate##9##2##(2007-12#1)(2008-2#2)(2008-3#3)(2008-6#2)(2011-1#1)
video recording##3##2##(1993-3#1)(2008-3#1)(2008-5#1)
video recordings of##3##3##(1993-4#1)(2006-4#1)(2008-3#1)
video recordings##8##2##(1993-4#1)(1994-4#1)(2006-4#2)(2007-12#1)(2008-3#2)(2012-1#1)
video sequences and##2##3##(2008-2#1)(2008-3#1)
video sequences##12##2##(2008-2#5)(2008-3#2)(2008-6#2)(2008-9#1)(2012-12#2)
video signal##3##2##(2008-2#3)
video stimuli##2##2##(2009-6#1)(2012-2#1)
video surveillance of Munchausen##2##4##(1996-2#1)(2006-4#1)
video surveillance of##4##3##(1993-10#1)(1996-2#1)(2006-4#2)
video surveillance##8##2##(1993-10#1)(1996-2#1)(2005-7#1)(2006-4#3)(2012-2#1)(2013-1#1)
video system##4##2##(1995-11#1)(2008-3#1)(2009-8#1)(2010-8#1)
video systems##2##2##(2010-5#1)(2011-2#1)
video tape##2##2##(2008-11#1)(2008-2#1)
video techniques to##2##3##(1996-12#1)(2008-8#1)
video techniques##4##2##(1996-12#2)(1996-9#1)(2008-8#1)
video technology##4##2##(1991-6#1)(1995-12#1)(2006-6#1)(2012-12#1)
video##333##1##(1990-12#1)(1990-3#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-4#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-6#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-9#2)(1997-6#1)(1997-8#4)(2004-11#1)(2004-9#15)(2005-11#3)(2005-7#1)(2006-10#4)(2006-11#2)(2006-12#1)(2006-4#6)(2006-5#3)(2006-6#4)(2007-1#1)(2007-10#7)(2007-11#3)(2007-12#7)(2007-4#1)(2007-5#2)(2007-8#5)(2008-1#3)(2008-10#8)(2008-11#53)(2008-12#7)(2008-2#38)(2008-3#36)(2008-4#2)(2008-5#4)(2008-6#10)(2008-7#1)(2008-8#4)(2008-9#5)(2009-10#1)(2009-2#2)(2009-3#2)(2009-6#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-2#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#3)(2012-1#4)(2012-12#8)(2012-2#7)(2012-3#2)(2013-1#16)(2013-7#1)(2013-8#1)
video-EEG##2##1##(1991-11#1)(1997-3#1)
video-assisted resternotomy##2##2##(2007-8#2)
video-assisted surgical techniques##2##3##(2006-6#2)
video-assisted surgical##3##2##(2006-6#3)
video-assisted technique of resternotomy##2##4##(2007-8#2)
video-assisted technique of##3##3##(2007-8#3)
video-assisted thoracic surgery (VATS) in##3##5##(2007-8#1)(2008-10#1)(2008-5#1)
video-assisted thoracic surgery (VATS) were##2##5##(2008-1#1)(2010-8#1)
video-assisted thoracic surgery (VATS)##10##4##(2007-8#2)(2008-1#1)(2008-10#1)(2008-5#1)(2010-8#1)(2012-12#2)(2013-7#2)
video-assisted thoracic surgery##20##3##(2004-2#1)(2007-8#7)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-8#2)(2012-1#1)(2012-12#2)(2013-7#3)
video-assisted thoracoscopic extended thymectomy##2##4##(2007-8#2)
video-assisted thoracoscopic resection##4##3##(2007-8#4)
video-assisted thoracoscopic surgery (VATS)##4##4##(2007-8#2)(2012-2#1)(2013-7#1)
video-assisted thoracoscopic surgery##8##3##(2006-10#2)(2007-8#3)(2012-2#1)(2013-1#1)(2013-7#1)
video-assisted thoracoscopic##22##2##(2006-10#2)(2006-8#1)(2007-8#13)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)
video-assisted thoracoscopy##4##2##(2006-10#1)(2007-8#3)
video-assisted##65##1##(2004-2#1)(2006-10#4)(2006-6#3)(2006-7#1)(2006-8#1)(2007-8#30)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-8#3)(2011-2#1)(2012-1#1)(2012-12#8)(2012-2#2)(2013-1#2)(2013-7#4)
video-based##4##1##(2007-11#1)(2008-3#1)(2009-10#1)(2012-12#1)
video-enhanced##3##1##(1992-5#1)(1994-2#1)(2007-3#1)
video-mediastinoscopy##3##1##(2007-8#3)
video-rate##5##1##(2007-11#1)(2008-3#2)(2011-1#2)
video-recorded##5##1##(2008-11#1)(2008-5#1)(2009-5#1)(2012-1#1)(2012-3#1)
video-teleconferencing##2##1##(2008-6#2)
videoconference##3##1##(2008-11#1)(2010-9#2)
videoconferencing##7##1##(2008-11#6)(2010-9#1)
videoendoscope##3##1##(2008-5#2)(2010-12#1)
videoendoscopic##3##1##(2007-8#3)
videofluorography##2##1##(1993-2#2)
videofluoroscopic swallow investigations##2##3##(2009-8#2)
videofluoroscopic swallow##3##2##(2009-8#2)(2011-12#1)
videofluoroscopic##5##1##(2007-10#1)(2009-8#2)(2011-12#2)
videographic##2##1##(2007-10#1)(2012-12#1)
videomicroscopy##2##1##(2007-9#1)(2008-1#1)
videos of##2##2##(2008-9#1)(2009-9#1)
videos##17##1##(1993-12#1)(1997-1#1)(1997-6#1)(2006-6#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-9#2)(2009-9#1)(2010-2#2)(2011-2#2)
videos)##2##1##(2012-2#2)
videotape##16##1##(1991-1#2)(1993-2#1)(1994-3#1)(1995-12#2)(2008-4#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-7#1)(2012-12#1)
videotaped and##3##2##(1993-9#1)(2008-11#1)(2012-2#1)
videotaped consultations##2##2##(1992-3#1)(2008-8#1)
videotaped##18##1##(1991-6#1)(1992-3#1)(1992-5#1)(1993-2#2)(1993-9#1)(1995-1#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-2#2)
videotapes of##3##2##(1991-6#1)(1996-2#1)(2011-2#1)
videotapes##13##1##(1991-6#1)(1993-12#1)(1993-2#5)(1994-6#1)(1996-2#1)(2004-9#1)(2006-8#1)(2007-2#1)(2011-2#1)
videotaping##3##1##(1995-12#2)(2004-9#1)
videothoracoscopic pulmonary##2##2##(2011-2#2)
videothoracoscopic##4##1##(2007-8#2)(2011-2#2)
vidicon##2##1##(2007-11#1)(2008-2#1)
vie##2##1##(2009-4#2)
vies##2##1##(1995-5#1)(2011-2#1)
view a##2##2##(1994-8#1)(2008-2#1)
view and a##3##3##(2007-8#1)(2008-3#1)(2011-2#1)
view and the##2##3##(2007-11#1)(2008-5#1)
view and##24##2##(1992-6#1)(1995-3#1)(2004-2#1)(2005-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#3)(2008-11#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#2)(2012-1#1)
view angle and##2##3##(2008-3#1)(2011-2#1)
view are##5##2##(1997-8#1)(2004-3#2)(2008-3#1)(2008-4#1)
view as##3##2##(1991-5#1)(2008-12#1)(2008-3#1)
view but##2##2##(1993-10#1)(2012-11#1)
view by##2##2##(1991-8#1)(2008-2#1)
view can be##2##3##(2006-5#1)(2012-2#1)
view condition-specific performance measures##2##4##(1997-3#2)
view for the##2##3##(1991-2#1)(2009-9#1)
view for##3##2##(1991-2#1)(2009-9#1)(2013-7#1)
view from the##8##3##(1991-1#1)(1993-1#1)(1995-2#1)(2006-4#1)(2008-11#1)(2008-3#1)(2010-12#1)(2013-8#1)
view from##15##2##(1990-12#1)(1991-1#1)(1993-1#1)(1994-1#1)(1995-2#1)(2006-4#1)(2007-10#1)(2007-4#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-12#1)(2013-8#1)
view in the##3##3##(2007-7#1)(2008-2#1)(2011-1#1)
view in##11##2##(1990-3#1)(1991-1#1)(1991-2#1)(1991-6#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#2)(2011-1#1)(2013-1#1)
view into the##4##3##(1994-3#1)(2010-8#1)(2011-7#1)(2012-2#1)
view into##5##2##(1994-3#1)(2008-4#1)(2010-8#1)(2011-7#1)(2012-2#1)
view is that##3##3##(1993-11#1)(1994-3#1)(1995-5#1)
view is##17##2##(1992-9#1)(1993-11#1)(1994-3#1)(1995-5#1)(1995-6#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-9#1)(2010-4#1)(2013-1#1)
view may##2##2##(2006-5#1)(2007-11#1)
view of B##2##3##(2008-10#1)(2011-1#1)
view of a##13##3##(1991-3#1)(1992-3#1)(1993-5#1)(1994-1#1)(1995-2#2)(2006-11#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-6#2)(2008-7#1)
view of an##7##3##(2006-6#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2013-1#2)
view of both##2##3##(1990-2#1)(2009-12#1)
view of current##2##3##(1994-12#1)(2007-10#1)
view of gene##3##3##(1995-6#1)(2010-1#1)(2010-5#1)
view of genes##2##3##(2008-7#2)
view of health care##2##4##(1993-1#1)(1994-6#1)
view of how to##2##4##(1993-2#1)(1997-7#1)
view of how##6##3##(1993-2#1)(1997-7#1)(2006-6#1)(2008-11#1)(2008-12#1)(2008-9#1)
view of its##6##3##(1990-12#1)(1990-5#1)(1992-11#1)(2008-11#1)(2008-7#1)(2009-6#1)
view of life and death##2##5##(1993-11#2)
view of reported##2##3##(1993-4#1)(2008-1#1)
view of statistical##2##3##(2008-11#1)(2013-8#1)
view of the above##3##4##(1990-12#1)(2011-1#1)(2013-1#1)
view of the effect of##2##5##(2006-10#1)(2011-2#1)
view of the fact that##5##5##(1991-4#1)(1997-1#1)(1997-5#1)(2006-6#1)(2008-10#1)
view of the future##2##4##(2013-1#2)
view of the genome##2##4##(2008-4#1)(2012-2#1)
view of the high prevalence##2##5##(1996-2#1)(2007-7#1)
view of the high##6##4##(1991-7#1)(1996-2#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-9#1)
view of the history of##2##5##(1993-11#1)(1994-12#1)
view of the impact##2##4##(1995-12#1)(2008-10#1)
view of the importance of this##2##6##(2008-10#2)
view of the importance of##3##5##(2008-1#1)(2008-10#2)
view of the increasing##5##4##(1990-11#1)(1990-4#1)(1993-11#1)(2010-5#1)(2012-1#1)
view of the other##2##4##(1994-3#1)(1994-8#1)
view of the population##2##4##(1991-5#1)(1994-3#1)
view of the potential##3##4##(1992-1#1)(2006-10#1)(2013-1#1)
view of the role of##2##5##(1994-2#1)(2010-9#1)
view of the role##3##4##(1994-2#1)(2007-10#1)(2010-9#1)
view of the small##2##4##(1995-11#1)(2009-8#1)
view of the world##2##4##(2005-7#1)(2008-12#1)
view of the##190##3##(1990-11#2)(1990-12#2)(1990-3#1)(1990-4#1)(1990-7#2)(1990-9#2)(1991-11#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-2#2)(1992-3#3)(1993-10#1)(1993-11#2)(1993-12#1)(1993-3#3)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#4)(1994-6#2)(1994-8#2)(1994-9#1)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#4)(1996-12#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-10#2)(2005-10#1)(2005-11#1)(2005-7#2)(2006-10#4)(2006-12#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#15)(2008-12#3)(2008-2#4)(2008-3#3)(2008-4#3)(2008-5#4)(2008-7#10)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-9#2)(2011-1#2)(2011-11#1)(2011-2#7)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#6)(2013-8#1)
view of their##14##3##(1990-1#1)(1991-8#1)(1994-3#1)(1996-1#1)(2005-7#1)(2005-8#1)(2006-4#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-1#1)(2010-12#1)(2012-2#1)
view of these##9##3##(1990-12#1)(1991-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#1)
view of this##13##3##(1991-10#2)(1991-3#1)(1996-5#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#1)
view of what##2##3##(2010-4#1)(2010-5#1)
view of##427##2##(1990-1#1)(1990-11#2)(1990-12#5)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#2)(1990-9#3)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#2)(1992-1#1)(1992-10#1)(1992-11#3)(1992-2#2)(1992-3#6)(1993-1#2)(1993-10#1)(1993-11#4)(1993-12#1)(1993-2#2)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#7)(1994-6#4)(1994-8#2)(1994-9#1)(1995-1#2)(1995-10#2)(1995-11#3)(1995-12#4)(1995-2#4)(1995-3#1)(1995-4#1)(1995-5#5)(1995-6#1)(1996-1#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#1)(2004-10#2)(2004-9#1)(2005-10#1)(2005-11#4)(2005-7#3)(2005-8#3)(2006-10#6)(2006-11#1)(2006-12#1)(2006-2#4)(2006-3#1)(2006-4#1)(2006-6#5)(2006-8#2)(2006-9#1)(2007-10#4)(2007-11#8)(2007-12#5)(2007-2#4)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#6)(2008-1#11)(2008-10#27)(2008-11#11)(2008-12#7)(2008-2#10)(2008-3#10)(2008-4#4)(2008-5#9)(2008-6#5)(2008-7#17)(2008-8#4)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#1)(2009-4#2)(2009-6#2)(2009-7#2)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#4)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#3)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#6)(2011-11#1)(2011-12#1)(2011-2#9)(2012-1#4)(2012-11#1)(2012-12#2)(2012-2#12)(2012-3#5)(2013-1#11)(2013-8#4)
view on the##6##3##(1993-6#1)(1994-5#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-8#1)
view on##23##2##(1993-6#1)(1994-5#1)(1996-7#1)(2005-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-5#2)(2010-1#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#2)
view over##2##2##(2008-2#1)(2013-1#1)
view point##5##2##(1994-3#1)(1995-4#1)(2005-3#1)(2007-8#1)(2008-7#1)
view provides##2##2##(1990-6#1)(2008-5#1)
view suggests that##2##3##(1997-4#1)(2012-11#1)
view that it##2##3##(2005-12#1)(2013-8#1)
view that the##22##3##(1990-10#1)(1990-12#2)(1990-5#2)(1992-12#1)(1993-5#1)(1994-11#1)(1995-1#1)(1995-12#1)(1995-5#1)(1997-6#1)(1997-9#1)(2006-10#1)(2007-8#2)(2008-1#2)(2008-12#2)(2008-5#1)(2009-9#1)
view that there##2##3##(2007-8#1)(2012-3#1)
view that these##2##3##(1993-6#1)(2011-12#1)
view that##118##2##(1990-10#1)(1990-12#2)(1990-2#3)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-6#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#1)(1994-6#2)(1994-9#1)(1995-1#2)(1995-12#1)(1995-3#1)(1995-5#2)(1995-8#2)(1996-10#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#2)(1997-9#1)(2004-3#1)(2004-9#1)(2005-10#1)(2005-12#1)(2005-9#1)(2006-10#2)(2006-4#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-6#1)(2007-8#5)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#3)(2009-7#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-12#1)(2012-11#1)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#1)
view the##28##2##(1990-4#1)(1993-1#1)(1994-7#1)(2006-10#3)(2006-11#2)(2006-9#1)(2007-5#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#2)(2009-9#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-8#2)
view their##4##2##(1993-2#1)(1994-3#1)(1996-1#1)(2009-7#1)
view this##4##2##(2008-6#2)(2010-5#1)(2012-3#1)
view through the##3##3##(2006-8#1)(2008-11#2)
view through##5##2##(2005-9#1)(2006-8#1)(2008-11#2)(2012-3#1)
view to identifying##4##3##(2006-10#1)(2008-1#1)(2009-9#1)(2011-1#1)
view to study##2##3##(1992-12#1)(2007-7#1)
view to the##4##3##(1991-5#1)(1992-7#1)(2008-2#1)(2008-5#1)
view to##66##2##(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-5#1)(1995-12#1)(1997-4#1)(2005-10#1)(2006-10#2)(2006-5#1)(2006-9#1)(2007-11#2)(2007-3#2)(2007-6#2)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#6)(2008-11#2)(2008-2#1)(2008-5#4)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-3#3)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#3)(2012-12#3)(2012-2#1)(2013-8#1)
view was##6##2##(1997-5#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-10#1)(2012-12#1)
view with##5##2##(1996-3#1)(1997-1#1)(2008-3#1)(2010-3#1)(2012-2#1)
view##1149##1##(1990-1#1)(1990-10#3)(1990-11#4)(1990-12#9)(1990-2#7)(1990-3#4)(1990-4#2)(1990-5#5)(1990-6#4)(1990-7#3)(1990-8#1)(1990-9#3)(1991-1#3)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#4)(1991-3#3)(1991-4#2)(1991-5#3)(1991-6#6)(1991-7#1)(1991-8#5)(1992-1#2)(1992-10#2)(1992-11#5)(1992-12#6)(1992-2#5)(1992-3#7)(1992-4#1)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#1)(1993-1#6)(1993-10#2)(1993-11#6)(1993-12#3)(1993-2#9)(1993-3#6)(1993-4#2)(1993-5#5)(1993-6#3)(1993-7#4)(1993-8#2)(1993-9#1)(1994-1#3)(1994-11#2)(1994-12#4)(1994-2#8)(1994-3#13)(1994-5#2)(1994-6#6)(1994-7#1)(1994-8#5)(1994-9#2)(1995-1#6)(1995-10#2)(1995-11#3)(1995-12#7)(1995-2#7)(1995-3#3)(1995-4#3)(1995-5#8)(1995-6#2)(1995-7#1)(1995-8#3)(1996-1#4)(1996-10#1)(1996-11#3)(1996-12#3)(1996-2#5)(1996-3#6)(1996-4#2)(1996-5#6)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#7)(1997-4#5)(1997-5#3)(1997-6#2)(1997-7#4)(1997-8#6)(1997-9#1)(2004-10#2)(2004-12#2)(2004-2#2)(2004-3#4)(2004-4#1)(2004-9#3)(2005-10#5)(2005-11#8)(2005-12#1)(2005-3#1)(2005-4#1)(2005-5#2)(2005-7#8)(2005-8#3)(2005-9#3)(2006-10#15)(2006-11#3)(2006-12#7)(2006-2#6)(2006-3#2)(2006-4#4)(2006-5#4)(2006-6#9)(2006-7#3)(2006-8#7)(2006-9#5)(2007-1#2)(2007-10#9)(2007-11#23)(2007-12#13)(2007-2#6)(2007-3#4)(2007-4#2)(2007-5#6)(2007-6#6)(2007-7#11)(2007-8#20)(2007-9#2)(2008-1#18)(2008-10#56)(2008-11#28)(2008-12#15)(2008-2#41)(2008-3#51)(2008-4#11)(2008-5#26)(2008-6#15)(2008-7#32)(2008-8#13)(2008-9#20)(2009-1#1)(2009-10#11)(2009-11#5)(2009-12#4)(2009-2#4)(2009-3#4)(2009-4#6)(2009-5#5)(2009-6#4)(2009-7#6)(2009-8#7)(2009-9#5)(2010-1#2)(2010-10#6)(2010-12#12)(2010-2#7)(2010-3#10)(2010-4#6)(2010-5#7)(2010-7#7)(2010-8#4)(2010-9#4)(2011-1#16)(2011-11#1)(2011-12#3)(2011-2#27)(2011-3#1)(2011-7#1)(2012-1#7)(2012-11#8)(2012-12#10)(2012-2#23)(2012-3#12)(2013-1#30)(2013-7#3)(2013-8#15)
view)##11##1##(2006-6#1)(2007-10#1)(2007-11#2)(2008-10#4)(2008-2#1)(2013-8#2)
view-dependent##4##1##(2008-6#4)
view-point##2##1##(2006-6#1)(2010-10#1)
view]##5##1##(1990-5#1)(1991-6#1)(1993-5#1)(2009-2#1)(2011-2#1)
viewed a##4##2##(1994-3#1)(1996-5#1)(2006-3#1)(2009-11#1)
viewed and##2##2##(2007-5#1)(2008-11#1)
viewed areas##2##2##(2008-3#1)(2010-3#1)
viewed as a &quot##2##4##(2007-3#1)(2011-2#1)
viewed as a problem##2##4##(1991-8#1)(2010-2#1)
viewed as a##38##3##(1990-12#1)(1991-8#1)(1991-9#1)(1992-3#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-8#1)(2004-11#1)(2005-8#1)(2006-1#1)(2006-4#2)(2006-8#2)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-3#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
viewed as an##14##3##(1992-12#1)(1993-9#1)(1996-5#1)(1997-3#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#2)(2010-12#1)(2011-2#1)
viewed as being##2##3##(2009-9#1)(2010-7#1)
viewed as the##7##3##(2005-8#1)(2006-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2010-4#2)
viewed as##110##2##(1990-12#1)(1991-12#1)(1991-3#2)(1991-8#2)(1991-9#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-5#2)(1997-3#1)(1997-8#1)(2004-11#1)(2005-8#2)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-7#2)(2006-8#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#3)(2008-7#6)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#6)
viewed at##2##2##(2008-3#2)
viewed by##9##2##(1991-2#2)(2006-12#1)(2008-1#1)(2008-2#1)(2008-7#1)(2009-7#1)(2012-3#1)(2013-1#1)
viewed differently##2##2##(2006-9#1)(2008-7#1)
viewed from the##6##3##(2006-12#1)(2007-11#1)(2008-3#2)(2008-4#1)(2010-12#1)
viewed from##11##2##(2006-12#2)(2007-11#2)(2008-10#1)(2008-3#2)(2008-4#1)(2009-4#1)(2010-12#1)(2011-3#1)
viewed in terms of the##2##5##(1992-6#1)(2006-10#1)
viewed in the context of##2##5##(1991-3#1)(2012-1#1)
viewed in the##4##3##(1991-3#1)(2006-12#1)(2008-2#1)(2012-1#1)
viewed in##13##2##(1991-3#1)(1992-6#1)(1996-1#1)(1997-8#2)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-2#1)(2009-3#1)(2012-1#1)
viewed photographs of##2##3##(2007-4#1)(2008-11#1)
viewed the##9##2##(1996-2#1)(2006-7#1)(2006-8#1)(2007-12#1)(2008-8#1)(2009-4#1)(2010-3#1)(2010-9#1)(2012-1#1)
viewed their##3##2##(1990-12#1)(2009-5#1)(2009-7#1)
viewed through a##2##3##(2007-3#1)(2008-2#1)
viewed through the##2##3##(2008-11#1)(2012-2#1)
viewed through##6##2##(2007-3#1)(2008-11#1)(2008-2#2)(2011-7#1)(2012-2#1)
viewed to##2##2##(1996-12#1)(2008-11#1)
viewed under##2##2##(2008-3#1)(2008-9#1)
viewed with a##3##3##(1991-9#1)(2008-10#1)(2008-3#1)
viewed with##8##2##(1991-2#1)(1991-9#1)(1993-11#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-8#1)
viewed##242##1##(1990-12#2)(1991-12#1)(1991-2#4)(1991-3#3)(1991-8#2)(1991-9#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-4#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-5#3)(1996-9#1)(1997-3#2)(1997-5#1)(1997-8#3)(2004-11#1)(2005-8#2)(2006-1#1)(2006-10#3)(2006-11#2)(2006-12#5)(2006-2#1)(2006-3#2)(2006-4#2)(2006-5#3)(2006-7#4)(2006-8#4)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#9)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#8)(2008-11#11)(2008-12#5)(2008-2#10)(2008-3#13)(2008-4#7)(2008-5#4)(2008-6#1)(2008-7#10)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#3)(2010-2#2)(2010-3#3)(2010-4#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2011-3#1)(2011-7#2)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#7)
viewer##4##1##(2008-11#1)(2008-3#1)(2008-7#1)(2009-3#1)
viewers do not##2##3##(2009-3#2)
viewers##7##1##(2009-3#6)(2010-11#1)
viewing a##2##2##(2009-8#1)(2012-2#1)
viewing and##8##2##(1996-8#1)(2006-6#1)(2008-4#2)(2008-6#2)(2009-3#1)(2012-12#1)
viewing angle and##3##3##(2008-1#1)(2010-4#1)(2010-8#1)
viewing angle of the##3##4##(2007-11#1)(2008-2#2)
viewing angle of##5##3##(2007-11#2)(2008-2#3)
viewing angle##15##2##(2007-11#3)(2008-1#1)(2008-2#5)(2008-3#3)(2008-4#1)(2010-4#1)(2010-8#1)
viewing angles of##2##3##(2006-11#1)(2008-2#1)
viewing angles##14##2##(1995-5#1)(2006-11#1)(2007-5#1)(2008-2#4)(2008-3#5)(2008-4#1)(2012-1#1)
viewing as##2##2##(2008-3#1)(2011-2#1)
viewing conditions##2##2##(1997-8#1)(2008-6#1)
viewing direction##4##2##(2007-5#1)(2008-3#3)
viewing directions##3##2##(2008-3#2)(2008-6#1)
viewing distance##4##2##(1991-1#3)(2008-3#1)
viewing geometry##4##2##(2008-3#4)
viewing of the##3##3##(2007-11#1)(2007-8#1)(2010-12#1)
viewing of##5##2##(2007-11#1)(2007-8#1)(2010-12#1)(2010-7#1)(2012-3#1)
viewing physique slides##2##3##(2006-7#2)
viewing resolution##3##2##(2007-11#3)
viewing sleep disturbance as an##2##5##(2010-12#2)
viewing the patient in an EMR-like view enables a natural-feeling medical review process for each patient##2##16##(2013-1#2)
viewing the##22##2##(1991-12#1)(1992-9#1)(1995-8#1)(2006-10#1)(2006-7#3)(2007-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-8#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#2)
viewing zenith##2##2##(2008-3#2)
viewing##153##1##(1990-9#1)(1991-1#3)(1991-11#1)(1991-12#1)(1992-9#3)(1993-2#1)(1994-3#1)(1994-8#2)(1995-5#1)(1995-8#1)(1996-8#2)(1997-8#2)(2004-10#2)(2004-12#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-7#5)(2007-11#8)(2007-12#7)(2007-2#2)(2007-4#2)(2007-5#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-2#14)(2008-3#32)(2008-4#7)(2008-6#6)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#3)(2009-8#1)(2010-12#4)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
viewing-angle##2##1##(2008-3#2)
viewpoint and##2##2##(2005-11#1)(2005-4#1)
viewpoint is##2##2##(1994-12#1)(2012-12#1)
viewpoint of##37##2##(1990-6#1)(1991-2#1)(1991-3#1)(1992-3#1)(1993-5#1)(1993-8#1)(1994-6#1)(1995-7#1)(1996-5#1)(1996-9#1)(1997-3#2)(1997-4#2)(2003-11#1)(2005-11#1)(2005-3#2)(2006-10#2)(2006-7#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
viewpoint that##2##2##(2006-6#1)(2008-8#1)
viewpoint##103##1##(1990-2#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-5#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-7#1)(1996-5#1)(1996-9#1)(1997-3#2)(1997-4#2)(2003-11#1)(2005-11#2)(2005-3#2)(2005-4#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#22)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#3)(2008-8#2)(2008-9#2)(2009-1#1)(2009-7#2)(2010-12#1)(2010-9#1)(2011-1#1)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#4)
viewpoint]##7##1##(1991-6#1)(1993-10#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-6#1)(2005-9#1)
viewpoints are##3##2##(2008-6#1)(2008-9#1)(2009-8#1)
viewpoints of##6##2##(1995-10#1)(2007-6#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-8#1)
viewpoints within##2##2##(2008-6#2)
viewpoints##25##1##(1991-6#1)(1993-2#1)(1995-10#1)(1995-4#1)(1997-2#3)(1997-8#1)(2005-7#1)(2005-8#1)(2007-6#1)(2008-11#1)(2008-3#1)(2008-6#4)(2008-7#2)(2008-9#1)(2009-4#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-2#1)
views about the##5##3##(1994-1#1)(2008-6#1)(2009-7#1)(2010-12#1)(2013-8#1)
views about##9##2##(1994-1#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
views and experience of##3##4##(2012-3#3)
views and experience##4##3##(2012-3#4)
views and experiences##4##3##(1997-8#1)(2010-9#1)(2011-1#1)(2012-3#1)
views and##25##2##(1990-5#1)(1992-4#1)(1994-1#1)(1997-8#1)(2004-10#1)(2007-12#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#7)(2013-1#2)
views are##7##2##(1990-12#1)(1990-9#1)(2006-2#1)(2008-12#1)(2008-5#1)(2009-10#1)(2010-12#1)
views as##3##2##(2007-7#1)(2009-3#1)(2010-4#1)
views concerning##2##2##(2005-11#1)(2007-7#1)
views from the##2##3##(1994-1#1)(2007-12#1)
views have been##2##3##(1995-5#1)(2009-3#1)
views have##3##2##(1995-5#1)(2009-3#2)
views in relation to##2##4##(2006-8#1)(2008-11#1)
views in##4##2##(2006-8#1)(2008-11#1)(2008-12#1)(2013-1#1)
views of a##3##3##(2007-12#1)(2008-11#1)(2008-2#1)
views of an##2##3##(2008-3#1)(2012-3#1)
views of health##3##3##(1993-1#1)(2012-3#2)
views of men##2##3##(2011-1#1)(2012-3#1)
views of the##28##3##(1991-1#1)(1991-2#1)(1992-2#1)(1995-5#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#2)(2007-3#1)(2008-1#2)(2008-3#1)(2008-5#1)(2008-9#2)(2009-10#1)(2009-2#2)(2009-5#1)(2009-9#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
views of their##3##3##(2007-12#1)(2008-11#1)(2011-1#1)
views of##81##2##(1990-12#1)(1991-1#1)(1991-2#1)(1992-2#1)(1993-1#1)(1993-2#1)(1994-12#1)(1995-5#1)(1996-3#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-10#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-12#4)(2007-2#1)(2007-3#1)(2008-1#2)(2008-11#3)(2008-12#5)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#3)(2009-10#2)(2009-2#2)(2009-4#2)(2009-5#1)(2009-9#2)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#8)(2013-1#2)(2013-7#2)(2013-8#1)
views on medical##2##3##(1991-2#1)(2005-12#1)
views on the##19##3##(1992-5#1)(1992-9#1)(1994-11#1)(1996-3#1)(1997-6#1)(2006-11#1)(2006-12#1)(2007-11#2)(2007-8#2)(2008-12#2)(2008-6#1)(2010-3#1)(2012-11#1)(2012-2#2)(2013-8#1)
views on##57##2##(1990-6#1)(1991-2#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-9#2)(1994-11#1)(1995-1#1)(1995-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-10#1)(2005-12#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2007-11#4)(2007-2#1)(2007-8#6)(2008-11#1)(2008-12#3)(2008-4#1)(2008-6#1)(2009-4#1)(2010-10#1)(2010-12#2)(2010-3#2)(2011-1#2)(2011-2#3)(2012-11#1)(2012-2#2)(2012-3#2)(2013-8#1)
views that##5##2##(2005-7#1)(2007-1#1)(2008-12#1)(2008-5#1)(2009-8#1)
views to##2##2##(2007-8#1)(2008-5#1)
views were##4##2##(2005-5#1)(2007-10#1)(2008-12#1)(2011-2#1)
views within the##2##3##(2008-11#1)(2008-2#1)
views##284##1##(1990-12#4)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-2#3)(1991-3#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-9#2)(1993-1#2)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-1#3)(1994-11#1)(1994-12#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-3#3)(1996-9#1)(1997-2#2)(1997-3#2)(1997-6#1)(1997-8#3)(2004-10#3)(2005-10#2)(2005-11#1)(2005-12#1)(2005-5#1)(2005-7#4)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#2)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#6)(2007-2#2)(2007-3#3)(2007-7#2)(2007-8#10)(2007-9#1)(2008-1#4)(2008-11#10)(2008-12#17)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#5)(2008-6#9)(2008-7#6)(2008-9#3)(2009-10#4)(2009-11#1)(2009-2#2)(2009-3#3)(2009-4#6)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#3)(2010-12#5)(2010-2#2)(2010-3#2)(2010-4#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#12)(2011-2#7)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#8)(2012-3#23)(2013-1#11)(2013-7#2)(2013-8#3)
views]##2##1##(1993-10#1)(1993-6#1)
vigabatrin##11##1##(1992-3#5)(1996-8#1)(2007-11#2)(2013-1#3)
vigilance and performance##2##3##(2006-10#2)
vigilance and##9##2##(1992-10#1)(1992-3#1)(1993-2#1)(2006-10#4)(2009-7#1)(2013-8#1)
vigilance for##3##2##(2009-12#1)(2010-2#1)(2012-11#1)
vigilance in##4##2##(2008-10#1)(2008-9#1)(2009-10#1)(2011-1#1)
vigilance is##2##2##(1995-9#1)(2006-10#1)
vigilance of##2##2##(2009-2#1)(2012-12#1)
vigilance regarding##2##2##(2008-10#1)(2011-2#1)
vigilance##39##1##(1992-10#1)(1992-3#1)(1993-2#1)(1995-9#1)(2004-11#1)(2006-10#8)(2006-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-7#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
vigilant in##3##2##(2010-9#1)(2011-2#2)
vigilant toward##2##2##(2006-8#1)(2008-6#1)
vigilant##19##1##(1993-1#1)(1996-8#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-7#1)(2009-9#3)(2010-11#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#4)(2012-12#1)
vigintioctopunctata##3##1##(2008-6#3)
vignette##10##1##(1996-2#1)(2005-7#1)(2006-10#2)(2007-12#3)(2008-2#1)(2011-2#1)(2012-12#1)
vignettes that##2##2##(2006-7#1)(2009-4#1)
vignettes to##2##2##(1997-8#1)(2010-2#1)
vignettes##12##1##(1993-12#1)(1996-12#1)(1997-8#1)(2006-7#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-4#1)(2010-2#2)(2010-5#1)
vigor and##2##2##(2007-5#1)(2008-10#1)
vigor index and seedling dry weight##2##6##(2008-12#2)
vigor of##2##2##(2008-10#1)(2008-8#1)
vigor were##2##2##(2006-10#1)(2008-10#1)
vigor##23##1##(1996-1#1)(2006-10#2)(2007-5#1)(2008-10#9)(2008-12#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-10#1)(2011-12#2)
vigorous activities##3##2##(2009-12#1)(2013-1#2)
vigorous and##2##2##(2008-4#1)(2013-1#1)
vigorous physical activity##11##3##(1991-5#1)(2007-10#1)(2007-7#1)(2010-1#1)(2010-11#5)(2013-1#2)
vigorous physical##13##2##(1991-5#1)(2007-10#1)(2007-7#1)(2010-1#1)(2010-11#5)(2011-1#1)(2012-1#1)(2013-1#2)
vigorous shaking##3##2##(2005-11#1)(2008-10#1)(2008-7#1)
vigorous##52##1##(1990-12#1)(1991-5#1)(1992-3#1)(1992-8#1)(1993-4#1)(1994-3#1)(1995-3#1)(1996-12#1)(1997-1#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-4#1)(2007-6#2)(2007-7#2)(2008-10#3)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#2)(2009-12#1)(2010-1#1)(2010-10#3)(2010-11#5)(2010-2#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#5)(2013-8#1)
vigorously##9##1##(1991-1#1)(1991-3#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2010-9#1)(2011-2#1)(2012-2#1)
vigour##7##1##(2008-12#2)(2008-7#1)(2010-1#1)(2011-12#1)(2012-1#2)
viii##2##1##(1990-3#1)(1990-9#1)
village (p &lt##2##3##(2007-8#2)
village chickens##3##2##(1997-3#1)(2008-5#1)(2013-8#1)
village in##8##2##(1990-12#1)(1992-10#1)(1993-2#1)(2006-4#2)(2006-5#1)(2006-8#1)(2011-2#1)
village level##2##2##(2008-8#1)(2010-8#1)
village of##6##2##(2006-4#1)(2007-2#1)(2008-10#1)(2010-12#1)(2012-12#2)
village to##2##2##(1997-1#1)(2008-10#1)
village##48##1##(1990-12#1)(1992-10#2)(1992-12#2)(1993-2#1)(1994-3#1)(1995-3#1)(1995-9#2)(1997-1#1)(1997-3#1)(2005-8#1)(2006-2#1)(2006-4#3)(2006-5#1)(2006-8#1)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#4)(2009-7#1)(2010-12#2)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#2)(2013-8#2)
villagers and##2##2##(2008-10#1)(2013-1#1)
villagers##9##1##(1994-3#2)(2007-7#2)(2008-10#2)(2011-12#1)(2012-2#1)(2013-1#1)
villages and##6##2##(1994-9#1)(1996-12#2)(2008-2#1)(2008-3#1)(2012-3#1)
villages around##2##2##(2008-12#1)(2012-12#1)
villages at##2##2##(2007-7#1)(2008-2#1)
villages in the##6##3##(1995-9#1)(2006-4#1)(2008-1#1)(2008-4#1)(2008-8#1)(2012-1#1)
villages in##21##2##(1992-8#1)(1995-9#1)(2006-10#1)(2006-2#1)(2006-4#2)(2007-10#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#3)(2008-8#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-1#2)
villages near##2##2##(2011-1#1)(2012-12#1)
villages of##14##2##(1991-3#1)(1997-6#1)(2006-2#1)(2007-10#2)(2007-2#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2012-12#1)(2013-1#1)
villages received##2##2##(1995-9#2)
villages were##2##2##(2008-5#1)(2013-1#1)
villages with no infection##2##4##(2010-8#2)
villages with##4##2##(2009-4#1)(2010-8#2)(2011-2#1)
villages##98##1##(1991-12#3)(1991-3#1)(1992-12#2)(1992-8#2)(1994-9#3)(1995-9#5)(1996-12#2)(1997-6#1)(2006-10#2)(2006-2#3)(2006-4#4)(2007-10#6)(2007-2#5)(2007-4#1)(2007-6#3)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#6)(2008-5#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-8#5)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#6)(2012-2#1)(2012-3#1)(2013-1#6)
villages)##2##1##(1994-2#1)(2007-8#1)
villi and crypts##2##3##(1997-8#2)
villi and##3##2##(1997-8#2)(2011-1#1)
villi in the##3##3##(2009-2#1)(2011-1#2)
villi in##4##2##(2009-2#2)(2011-1#2)
villi were##3##2##(1993-6#2)(1995-3#1)
villi##35##1##(1990-12#1)(1990-3#2)(1991-9#1)(1992-1#1)(1992-6#1)(1993-10#1)(1993-6#3)(1994-9#1)(1995-3#1)(1997-8#3)(2007-12#1)(2008-4#1)(2009-2#7)(2011-1#8)(2012-2#1)(2013-1#2)
villin##5##1##(1991-11#4)(1997-2#1)
villoglandular##2##1##(1993-8#1)(2011-2#1)
villonodular synovitis of the##2##4##(2010-3#1)(2013-1#1)
villonodular synovitis##7##2##(2010-3#2)(2011-2#2)(2013-1#3)
villosa##6##1##(1990-7#1)(1995-2#1)(2007-11#2)(2008-8#2)
villosum##2##1##(2007-1#1)(2013-1#1)
villous adenoma of the##2##4##(1990-10#1)(2010-2#1)
villous adenoma##5##2##(1990-10#2)(2010-2#3)
villous atrophy##5##2##(1991-11#1)(1991-4#1)(1995-3#1)(2013-1#2)
villous height in##2##3##(2013-1#2)
villous height##7##2##(2013-1#7)
villous##24##1##(1990-10#2)(1991-11#1)(1991-4#1)(1992-10#1)(1995-3#1)(2007-2#1)(2007-6#2)(2009-3#1)(2010-2#3)(2010-3#1)(2011-2#1)(2013-1#9)
villus and crypt##2##3##(1990-12#1)(1997-8#1)
villus and##3##2##(1990-12#1)(1997-8#2)
villus samples##2##2##(1997-8#2)
villus sampling (CVS)##3##3##(1991-3#1)(2007-3#1)(2008-4#1)
villus sampling##9##2##(1991-11#1)(1991-2#1)(1991-3#2)(1993-10#1)(2007-3#2)(2007-7#1)(2008-4#1)
villus tips##2##2##(1997-2#1)(1997-8#1)
villus##25##1##(1990-12#3)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#2)(1993-10#1)(1997-2#1)(1997-8#5)(2006-10#1)(2007-2#1)(2007-3#2)(2007-7#1)(2008-4#1)
villus-crypt junctional##3##2##(1997-8#3)
villus-crypt##4##1##(1997-8#4)
vim##4##1##(2007-7#2)(2008-8#1)(2008-9#1)
vimentin and desmin##2##3##(2007-6#2)
vimentin and##18##2##(1990-4#2)(1991-5#1)(1991-6#1)(2004-2#1)(2007-6#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-12#1)(2011-1#1)(2012-12#2)(2012-3#1)
vimentin antibodies##2##2##(1997-7#1)(2012-3#1)
vimentin expression##2##2##(2012-2#2)
vimentin was found##2##3##(2009-2#1)(2012-2#1)
vimentin was##4##2##(2007-2#1)(2007-9#1)(2009-2#1)(2012-2#1)
vimentin##74##1##(1990-4#3)(1991-3#4)(1991-4#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-5#4)(1993-8#1)(1994-11#1)(1994-8#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-7#4)(2004-2#2)(2007-12#1)(2007-2#1)(2007-6#3)(2007-9#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#6)(2009-10#1)(2009-2#4)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#8)(2012-3#2)(2013-1#1)
viminalis##5##1##(2012-3#5)
vinblastine treatment##2##2##(1991-9#1)(1994-2#1)
vinblastine was##2##2##(1993-7#1)(1994-2#1)
vinblastine##26##1##(1990-2#2)(1991-6#2)(1991-7#1)(1991-9#1)(1993-6#1)(1993-7#2)(1993-8#1)(1994-11#5)(1994-2#3)(1994-6#2)(2008-5#2)(2008-6#2)(2011-1#2)
vinca alkaloid##2##2##(1994-8#1)(2008-5#1)
vinca alkaloids##5##2##(1994-6#2)(1995-5#2)(2008-6#1)
vinca site agents##5##3##(1995-5#5)
vinca site##6##2##(1995-5#6)
vinca##14##1##(1994-6#2)(1994-8#1)(1995-5#9)(2008-5#1)(2008-6#1)
vinclozolin##21##1##(2008-10#21)
vincristine (1##2##2##(1990-10#1)(2008-6#1)
vincristine (VCR)##2##2##(1990-12#1)(1992-11#1)
vincristine and adriamycin##2##3##(1993-8#1)(2009-8#1)
vincristine and##8##2##(1993-8#2)(1994-12#1)(1994-6#1)(2008-6#1)(2008-7#1)(2009-8#1)(2013-8#1)
vincristine plus etoposide##2##3##(1993-8#2)
vincristine plus##3##2##(1993-8#3)
vincristine##50##1##(1990-10#2)(1990-11#1)(1990-12#2)(1991-6#1)(1991-7#2)(1992-11#1)(1993-8#6)(1993-9#4)(1994-12#1)(1994-6#1)(1995-3#2)(1995-4#1)(1995-9#1)(1997-4#1)(1997-5#3)(2004-1#1)(2005-10#1)(2007-6#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#3)(2008-7#1)(2009-11#1)(2009-6#1)(2009-8#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2013-8#1)
vinculin and##2##2##(1991-5#1)(1994-9#1)
vinculin##8##1##(1991-5#2)(1994-9#3)(2009-7#2)(2010-4#1)
vindesine (VDS)##2##2##(1992-12#1)(1993-2#1)
vindesine##9##1##(1990-2#2)(1991-7#1)(1992-12#2)(1993-2#1)(2009-6#3)
vindicated##2##1##(1992-3#1)(2006-9#1)
vindication##3##1##(2006-3#1)(2007-3#1)(2010-3#1)
vine decline##2##2##(2008-10#2)
vine##14##1##(2008-10#12)(2008-6#2)
vinegar and##2##2##(2008-10#2)
vinegar##13##1##(1997-3#2)(2008-10#9)(2008-5#1)(2008-6#1)
vinegars and##2##2##(2008-10#2)
vinegars##7##1##(2008-10#6)(2008-3#1)
vinelandii hydrogenase##2##2##(1990-11#1)(1992-3#1)
vinelandii##26##1##(1990-11#4)(1991-5#3)(1992-3#2)(1994-5#2)(1994-8#1)(1995-6#2)(1995-8#4)(2008-7#6)(2009-7#2)
vines in##2##2##(2008-10#2)
vines infected with##3##3##(2008-10#3)
vines infected##5##2##(2008-10#5)
vines showing esca symptoms in##2##5##(2008-10#2)
vines that had been inoculated##2##5##(2008-10#2)
vines that##3##2##(2008-10#3)
vines were##3##2##(2008-10#3)
vines##32##1##(2008-10#32)
vineyard in##2##2##(2008-10#2)
vineyard soil##3##2##(2008-10#3)
vineyard##14##1##(2004-2#1)(2008-10#12)(2011-12#1)
vineyards and##2##2##(2008-10#1)(2012-2#1)
vineyards in the##2##3##(2008-10#2)
vineyards in##6##2##(2008-10#6)
vineyards with##2##2##(2008-10#1)(2011-12#1)
vineyards##30##1##(2008-10#25)(2011-12#3)(2011-2#1)(2012-2#1)
vinflunine tartrate##2##2##(2012-3#2)
vinifera 'Chardonnay'##3##2##(2008-10#3)
vinifera L##5##2##(2008-10#1)(2008-5#1)(2009-8#2)(2013-1#1)
vinifera cultivars##4##2##(2008-10#4)
vinifera cv##2##2##(2008-10#2)
vinifera##25##1##(2008-10#19)(2008-5#2)(2008-8#1)(2009-8#2)(2013-1#1)
vinifera) and##2##2##(2008-10#2)
vinifera)##7##1##(2008-10#7)
vinorelbine as a single agent##2##5##(1994-8#2)
vinorelbine as##3##2##(1994-2#1)(1994-8#2)
vinorelbine chemotherapy##2##2##(1994-8#1)(2009-5#1)
vinorelbine in##3##2##(1994-12#1)(2004-1#1)(2010-8#1)
vinorelbine##16##1##(1994-12#1)(1994-2#1)(1994-4#1)(1994-8#4)(2003-11#1)(2004-1#5)(2007-4#1)(2009-5#1)(2010-8#1)
vinosum##7##1##(1993-8#2)(1994-8#1)(1995-2#1)(1996-7#3)
vinpocetine##4##1##(1995-12#1)(2010-12#3)
vintage##5##1##(2007-8#3)(2011-2#2)
vintages were##2##2##(2008-10#2)
vintages##3##1##(2008-10#3)
vinyl acetate copolymer (EVA)##2##4##(2008-11#2)
vinyl acetate copolymer##3##3##(1994-6#1)(2008-11#2)
vinyl acrylate##2##2##(2007-6#1)(2008-5#1)
vinyl alcohol##2##2##(2008-10#1)(2008-5#1)
vinyl and##2##2##(1990-7#1)(2007-11#1)
vinyl carbamate and##2##3##(1990-6#1)(1994-2#1)
vinyl carbamate epoxide##3##3##(1990-6#2)(1994-2#1)
vinyl carbamate##9##2##(1990-6#5)(1994-2#4)
vinyl chloride (VC)##3##3##(1992-1#1)(2006-3#1)(2012-12#1)
vinyl chloride##13##2##(1992-1#2)(1993-11#1)(2006-3#2)(2008-10#2)(2008-3#1)(2008-5#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-2#1)
vinyl ether##4##2##(1996-5#3)(2008-5#1)
vinyl ethers##4##2##(1996-5#1)(2007-11#2)(2008-10#1)
vinyl group##5##2##(1994-9#1)(2008-10#2)(2008-5#1)(2013-1#1)
vinyl groups##5##2##(2005-11#1)(2008-10#4)
vinyl phosphonates##2##2##(2011-12#2)
vinyl pyrrolidone##3##2##(2008-5#2)(2011-2#1)
vinyl sulfones##5##2##(1993-9#5)
vinyl##81##1##(1990-6#5)(1990-7#1)(1991-9#1)(1992-1#2)(1993-11#2)(1993-9#5)(1994-2#4)(1994-6#1)(1994-9#1)(1995-11#1)(1996-5#5)(2005-11#2)(2005-7#1)(2006-3#2)(2006-4#1)(2007-11#5)(2007-6#1)(2008-10#12)(2008-11#2)(2008-3#2)(2008-5#8)(2008-9#1)(2009-12#3)(2009-5#1)(2010-12#1)(2010-2#1)(2011-12#3)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)
vinylic##6##1##(1996-5#1)(2004-9#1)(2007-11#2)(2009-6#2)
vinylidene##3##1##(1996-12#2)(2007-12#1)
vinylogous##2##1##(2008-4#1)(2010-7#1)
vinylpyrrolidone##2##1##(1994-9#1)(2008-5#1)
violacea##3##1##(1993-12#2)(1995-2#1)
violaceous##6##1##(2005-11#1)(2006-10#1)(2007-7#1)(2008-5#3)
violaceus##5##1##(2007-3#1)(2008-8#2)(2008-9#2)
violate the Americans with Disabilities##2##5##(1996-5#1)(2005-10#1)
violate the##9##2##(1990-12#1)(1992-12#1)(1995-8#1)(1995-9#1)(1996-5#1)(1996-9#1)(2005-10#1)(2010-3#1)(2012-2#1)
violate##23##1##(1990-12#1)(1991-7#1)(1992-12#1)(1993-1#1)(1993-3#1)(1993-6#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-5#2)(1996-9#1)(1997-1#1)(2005-10#1)(2006-5#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-3#1)(2012-12#1)(2012-2#1)
violated and##3##2##(1996-12#1)(2007-10#1)(2008-1#1)
violated by##6##2##(1991-6#1)(1993-5#1)(1995-2#1)(1996-12#1)(2008-8#1)(2010-10#1)
violated the Americans with Disabilities Act (ADA)##2##7##(1995-6#1)(1997-5#1)
violated the Fair Housing Act##2##5##(1995-12#1)(1996-6#1)
violated the constitutional rights##2##4##(1991-6#1)(1997-5#1)
violated the##15##2##(1991-10#1)(1991-6#1)(1992-9#1)(1993-5#1)(1993-6#1)(1995-12#2)(1995-6#1)(1996-11#1)(1996-6#1)(1997-1#1)(1997-5#2)(2007-4#2)
violated##50##1##(1990-5#2)(1991-10#2)(1991-6#3)(1992-9#1)(1993-5#2)(1993-6#1)(1994-11#1)(1995-12#4)(1995-2#1)(1995-6#1)(1996-11#2)(1996-12#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-5#3)(1997-7#1)(2006-8#1)(2007-10#1)(2007-4#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-10#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#2)
violates the##4##2##(2008-10#1)(2008-8#1)(2010-12#1)(2011-2#1)
violates##6##1##(1995-6#1)(2007-11#1)(2008-10#1)(2008-8#1)(2010-12#1)(2011-2#1)
violating the##5##2##(1992-12#1)(1993-6#1)(1997-1#1)(2008-7#2)
violating##8##1##(1992-12#1)(1993-6#1)(1996-11#2)(1997-1#1)(2008-4#1)(2008-7#2)
violation of LG inequalities##2##4##(2012-2#2)
violation of the##16##3##(1993-1#1)(1993-3#1)(1994-2#1)(1994-7#1)(1995-6#2)(1996-11#1)(2005-11#1)(2006-8#1)(2008-3#3)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
violation of##31##2##(1991-6#1)(1992-5#1)(1993-1#1)(1993-3#1)(1994-2#1)(1994-7#1)(1995-6#2)(1996-11#1)(2005-11#1)(2006-7#1)(2006-8#2)(2007-12#1)(2008-3#4)(2008-8#1)(2008-9#1)(2009-2#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-8#2)
violation##46##1##(1990-12#1)(1991-10#1)(1991-6#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-3#1)(1994-2#1)(1994-7#1)(1995-12#1)(1995-6#2)(1996-11#1)(2005-11#1)(2006-7#1)(2006-8#3)(2007-12#1)(2007-3#3)(2007-5#1)(2008-3#4)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#3)(2009-9#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#5)(2012-3#1)(2013-8#2)
violation-of-expectation tasks##3##2##(2012-1#3)
violation-of-expectation##4##1##(2012-1#4)
violations and##2##2##(2007-5#1)(2011-2#1)
violations are##2##2##(2009-9#1)(2012-1#1)
violations in##3##2##(2007-5#1)(2008-11#1)(2010-3#1)
violations of the##5##3##(1994-9#1)(1995-6#1)(2008-3#1)(2008-4#1)(2010-2#1)
violations of##14##2##(1990-8#1)(1994-9#2)(1995-6#1)(2006-8#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-2#1)(2010-5#1)(2012-1#1)(2013-1#1)(2013-8#1)
violations##46##1##(1990-2#1)(1990-6#1)(1990-8#1)(1991-1#1)(1993-12#2)(1993-3#1)(1993-5#1)(1994-9#2)(1995-6#1)(2004-5#1)(2006-6#1)(2006-8#1)(2007-5#2)(2007-8#1)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#1)(2008-8#4)(2009-4#1)(2009-9#2)(2010-2#1)(2010-3#2)(2010-5#1)(2010-7#2)(2011-2#1)(2012-1#3)(2013-1#1)(2013-8#1)
violence against the person##2##4##(2005-8#2)
violence against the##3##3##(2005-8#2)(2008-4#1)
violence against women in##3##4##(2011-2#1)(2012-3#1)(2013-7#1)
violence against women##7##3##(1995-9#1)(2009-2#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-7#2)
violence against##15##2##(1993-2#1)(1995-9#1)(2005-6#1)(2005-8#3)(2008-12#1)(2008-4#1)(2008-9#1)(2009-2#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-7#2)
violence among##4##2##(2008-9#1)(2009-9#1)(2013-1#1)(2013-8#1)
violence and general aggression##3##4##(2009-7#3)
violence and general##4##3##(2009-7#3)(2011-2#1)
violence and sexual##2##3##(1996-1#1)(2010-6#1)
violence and the health##2##4##(1993-3#1)(2010-3#1)
violence and the##5##3##(1991-6#1)(1993-3#1)(2008-11#1)(2010-3#1)(2013-8#1)
violence and their##2##3##(2006-9#1)(2008-2#1)
violence and##43##2##(1991-12#1)(1991-6#1)(1993-3#1)(1995-12#1)(1995-8#2)(1996-1#1)(1996-3#1)(2006-9#2)(2007-12#1)(2007-2#2)(2007-7#3)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-12#1)(2009-7#5)(2009-9#1)(2010-12#1)(2010-3#2)(2010-6#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#1)
violence are##6##2##(1990-6#1)(1994-3#1)(2005-8#2)(2007-2#1)(2011-1#1)
violence as a##3##3##(1995-12#1)(1997-8#1)(2006-7#1)
violence as well as##2##4##(2008-2#2)
violence as##5##2##(1995-12#1)(1997-8#1)(2006-7#1)(2008-2#2)
violence during pregnancy##2##3##(2008-2#2)
violence during##5##2##(2008-2#2)(2008-9#1)(2011-1#2)
violence exposure##4##2##(2009-12#2)(2009-9#2)
violence from##2##2##(1996-12#1)(2011-1#1)
violence has been##2##3##(2007-7#1)(2008-12#1)
violence has##5##2##(2005-8#1)(2007-7#1)(2008-12#1)(2008-7#1)(2010-3#1)
violence have##2##2##(2011-1#1)(2013-7#1)
violence in a##5##3##(1994-2#1)(2007-2#1)(2008-4#1)(2009-2#1)(2011-2#1)
violence in early##2##3##(2008-8#1)(2009-7#1)
violence in the media##2##4##(2008-11#1)(2009-7#1)
violence in the workplace##3##4##(1991-12#1)(1995-2#1)(2007-9#1)
violence in the##12##3##(1991-12#2)(1995-2#1)(2006-9#1)(2007-3#1)(2007-9#1)(2008-11#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
violence in##31##2##(1991-1#1)(1991-12#2)(1993-3#2)(1994-2#1)(1995-2#2)(2006-7#1)(2006-9#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#2)(2009-2#1)(2009-7#2)(2009-9#1)(2010-12#1)(2011-1#2)(2011-2#2)(2013-1#3)
violence involvement##2##2##(2013-1#2)
violence is a##6##3##(1991-6#1)(2006-7#1)(2007-8#1)(2008-2#1)(2011-2#1)(2013-8#1)
violence is##17##2##(1991-12#1)(1991-3#1)(1991-6#1)(2005-8#1)(2006-7#1)(2007-7#1)(2007-8#2)(2008-2#1)(2008-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#2)
violence of##2##2##(2007-7#1)(2008-11#1)
violence perpetration and victimization##4##4##(2009-7#3)(2013-1#1)
violence perpetration##7##2##(2009-7#4)(2010-4#1)(2013-1#2)
violence prevention##3##2##(1995-12#1)(2006-9#1)(2007-2#1)
violence screening tools##2##3##(2013-7#2)
violence such as##3##3##(2005-8#1)(2007-3#1)(2013-8#1)
violence victimization##8##2##(2009-5#1)(2013-1#6)(2013-8#1)
violence was in the form of##2##6##(2011-1#1)(2012-11#1)
violence was##5##2##(1991-9#1)(2007-9#1)(2009-7#1)(2011-1#1)(2012-11#1)
violence were##2##2##(2008-7#1)(2012-12#1)
violence##356##1##(1990-2#1)(1990-6#2)(1991-1#1)(1991-12#4)(1991-3#1)(1991-4#1)(1991-6#5)(1991-9#2)(1992-12#2)(1993-12#4)(1993-2#1)(1993-3#6)(1994-1#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#2)(1994-9#2)(1995-12#5)(1995-2#6)(1995-3#1)(1995-8#2)(1995-9#2)(1996-1#1)(1996-12#3)(1996-2#6)(1996-3#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-12#1)(2004-3#1)(2005-10#1)(2005-6#1)(2005-8#12)(2006-7#8)(2006-9#8)(2007-10#1)(2007-12#2)(2007-2#8)(2007-3#2)(2007-7#11)(2007-8#8)(2007-9#4)(2008-10#1)(2008-11#10)(2008-12#8)(2008-2#9)(2008-4#5)(2008-6#2)(2008-7#8)(2008-8#5)(2008-9#8)(2009-10#1)(2009-11#2)(2009-12#3)(2009-2#3)(2009-4#1)(2009-5#11)(2009-7#17)(2009-9#8)(2010-10#1)(2010-11#2)(2010-12#7)(2010-2#4)(2010-3#6)(2010-4#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#13)(2011-12#3)(2011-2#11)(2012-1#1)(2012-11#5)(2012-12#10)(2012-3#8)(2013-1#23)(2013-7#7)(2013-8#9)
violence)##2##1##(2009-4#1)(2009-7#1)
violence-related##2##1##(2008-7#1)(2009-9#1)
violence?##2##1##(2006-9#1)(2008-5#1)
violent actions##2##2##(1995-2#1)(2013-1#1)
violent acts##3##2##(1991-6#2)(1993-4#1)
violent and delinquent##2##3##(2009-7#2)
violent and psychopathic individuals is##2##5##(2008-11#2)
violent and##10##2##(1990-6#1)(1995-11#1)(1997-8#1)(2008-11#2)(2008-7#1)(2009-5#1)(2009-7#3)
violent behavior##7##2##(1996-2#1)(2007-8#1)(2008-8#1)(2009-5#2)(2009-7#2)
violent behaviors##3##2##(2004-3#1)(2009-5#1)(2012-2#1)
violent behaviour##5##2##(1997-8#2)(2006-9#2)(2012-11#1)
violent causes##2##2##(1990-6#1)(2013-1#1)
violent crime##4##2##(1995-2#1)(2008-11#1)(2008-12#1)(2012-12#1)
violent crimes##3##2##(1994-12#1)(2005-8#1)(2007-10#1)
violent death##5##2##(1991-6#1)(2009-7#2)(2011-1#2)
violent deaths##2##2##(1991-6#1)(1993-9#1)
violent incidents##3##2##(1993-12#1)(2007-2#1)(2012-3#1)
violent media##6##2##(2009-7#6)
violent or##2##2##(1996-2#1)(2011-2#1)
violent patients were##2##3##(1991-9#2)
violent patients##7##2##(1991-9#3)(1995-11#1)(1996-2#2)(2008-7#1)
violent situations##3##2##(1991-1#1)(2008-7#2)
violent##92##1##(1990-2#2)(1990-6#2)(1990-8#1)(1991-1#1)(1991-6#4)(1991-9#3)(1993-12#1)(1993-4#1)(1993-9#1)(1994-12#1)(1995-11#2)(1995-2#4)(1996-2#5)(1996-5#1)(1997-7#1)(1997-8#7)(2004-3#1)(2005-8#1)(2006-7#1)(2006-9#2)(2007-10#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-11#3)(2008-12#1)(2008-7#5)(2008-8#2)(2009-3#1)(2009-5#4)(2009-7#14)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
violently##4##1##(1991-9#2)(2007-9#1)(2008-9#1)
violet (CV)##4##2##(2005-4#1)(2008-10#3)
violet (PCV)##3##2##(2008-10#3)
violet and##14##2##(1996-3#1)(2005-4#6)(2008-10#4)(2008-3#1)(2008-5#1)(2009-2#1)
violet as a##2##3##(2008-10#2)
violet by potassium periodate##2##4##(2008-10#2)
violet by##3##2##(2008-10#3)
violet colored##2##2##(2008-10#2)
violet colour##2##2##(2008-10#1)(2010-2#1)
violet dye##2##2##(2008-10#2)
violet is##2##2##(2008-10#1)(2008-2#1)
violet laser acupuncture##4##3##(2012-12#4)
violet light##4##2##(2008-3#1)(2008-5#2)(2009-4#1)
violet method##2##2##(2008-10#1)(2008-9#1)
violet modified carbon paste electrode##2##5##(2008-10#2)
violet or##2##2##(2008-3#1)(2013-7#1)
violet radiation##3##2##(2007-12#1)(2008-1#1)(2008-9#1)
violet staining##3##2##(1990-12#1)(1996-12#1)(2008-8#1)
violet to##2##2##(2008-10#1)(2008-9#1)
violet##96##1##(1990-12#1)(1991-8#1)(1992-11#4)(1994-5#1)(1996-12#1)(1996-3#1)(2005-4#9)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#44)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#3)(2008-8#1)(2008-9#3)(2009-2#2)(2009-4#1)(2010-2#1)(2010-5#1)(2010-7#1)(2012-12#4)(2012-2#1)(2013-7#1)
violet)##2##1##(1992-11#1)(2008-10#1)
violet-colored##2##1##(2007-4#1)(2008-11#1)
violinists##5##1##(2013-8#5)
viologen##12##1##(1990-3#2)(1991-5#1)(1992-12#1)(1992-8#1)(1995-8#1)(1997-7#1)(2005-12#1)(2008-10#3)(2010-12#1)
violuric acid##2##2##(2007-8#1)(2008-10#1)
violuric##3##1##(2007-8#2)(2008-10#1)
viper bite##3##2##(1997-8#1)(2012-2#2)
viper##16##1##(1990-11#1)(1990-12#2)(1990-5#1)(1991-7#1)(1994-6#2)(1997-8#1)(2005-8#1)(2012-2#6)(2013-7#1)
vir##2##1##(1990-11#1)(2006-3#1)
virE1##2##1##(2008-10#2)
virVf##2##1##(2008-10#2)
viraemia and##3##2##(1991-3#1)(2007-3#1)(2009-12#1)
viraemia##8##1##(1991-3#1)(1994-5#1)(2007-3#1)(2008-5#2)(2009-12#2)(2013-1#1)
viraemic##3##1##(1991-3#1)(1994-4#1)(2008-5#1)
viral DNA detection##2##3##(1997-4#1)(2011-12#1)
viral DNA in##2##3##(2011-2#1)(2013-8#1)
viral DNA is##2##3##(1991-5#1)(2009-10#1)
viral DNA polymerase##6##3##(1990-7#3)(1997-3#1)(1997-5#2)
viral DNA replication##9##3##(1990-6#1)(1990-9#1)(1995-6#1)(1997-1#2)(1997-3#2)(1997-5#1)(2008-2#1)
viral DNA##51##2##(1990-6#1)(1990-7#3)(1990-9#1)(1991-5#1)(1992-11#2)(1992-9#1)(1993-8#1)(1994-8#1)(1995-6#1)(1996-11#1)(1996-2#1)(1997-1#2)(1997-3#3)(1997-4#1)(1997-5#5)(2006-10#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-4#5)(2008-5#1)(2009-10#1)(2009-11#2)(2009-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
viral DNA)##2##2##(2008-10#2)
viral G protein##4##3##(1993-6#4)
viral G##5##2##(1993-6#4)(2012-12#1)
viral LTR##2##2##(1992-6#1)(1994-11#1)
viral RNA and##2##3##(1994-9#1)(1997-3#1)
viral RNA by##2##3##(1990-2#1)(2008-10#1)
viral RNA from##2##3##(2007-6#1)(2008-9#1)
viral RNA genome##3##3##(1990-9#1)(2008-10#1)(2009-11#1)
viral RNA genomes##2##3##(2008-9#1)(2010-7#1)
viral RNA in##2##3##(1996-11#1)(2010-5#1)
viral RNA is##3##3##(2008-10#1)(2008-9#2)
viral RNA was##7##3##(1995-2#1)(1997-2#1)(1997-3#1)(2004-11#1)(2008-10#2)(2012-3#1)
viral RNA##58##2##(1990-10#1)(1990-2#2)(1990-6#1)(1990-7#1)(1990-9#1)(1993-5#1)(1994-9#2)(1995-2#1)(1996-11#1)(1996-4#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(2004-11#1)(2007-6#1)(2008-10#14)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#11)(2009-11#1)(2009-2#1)(2010-5#4)(2010-7#1)(2011-1#1)(2012-3#1)
viral RNAs from plant protoplasts##2##5##(2008-9#2)
viral RNAs in##2##3##(2008-10#1)(2008-9#1)
viral RNAs using##2##3##(2008-9#2)
viral RNAs##15##2##(1996-4#1)(1997-3#1)(2008-10#5)(2008-9#8)
viral S##3##2##(2008-10#3)
viral UTIs##2##2##(2008-6#2)
viral accumulation##2##2##(1997-3#1)(2008-10#1)
viral activity##3##2##(1993-3#1)(2008-10#2)
viral aetiology##2##2##(1990-8#1)(2008-4#1)
viral agents##2##2##(2005-7#1)(2011-2#1)
viral and bacterial infections##2##4##(2009-9#1)(2010-12#1)
viral and bacterial##7##3##(1992-11#1)(1992-8#1)(2006-2#1)(2009-4#1)(2009-9#1)(2010-12#1)(2013-1#1)
viral and cell##2##3##(2008-4#1)(2011-3#1)
viral and cellular##7##3##(1994-3#1)(2007-11#2)(2008-10#1)(2008-9#2)(2009-2#1)
viral and fungal##2##3##(2007-7#1)(2011-3#1)
viral and host##2##3##(2006-10#1)(2007-11#1)
viral and parasitic##3##3##(2008-1#2)(2010-4#1)
viral and viral-like agents##2##4##(2008-11#2)
viral and##37##2##(1992-11#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-2#3)(2006-10#1)(2006-11#1)(2006-2#1)(2007-11#4)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-4#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-3#2)(2013-1#1)
viral antigen in the##2##4##(1997-6#1)(2007-8#1)
viral antigen in##3##3##(1997-6#2)(2007-8#1)
viral antigen##5##2##(1990-5#1)(1997-6#3)(2007-8#1)
viral antigens##9##2##(1990-5#1)(1990-8#1)(1997-4#2)(2005-9#1)(2007-11#3)(2011-2#1)
viral assembly and##2##3##(2011-3#1)(2013-1#1)
viral assembly##7##2##(1991-5#2)(1997-1#1)(2011-1#1)(2011-3#2)(2013-1#1)
viral binding##2##2##(1993-9#1)(2011-1#1)
viral breakthrough##3##2##(2009-8#1)(2012-2#1)(2013-1#1)
viral bronchiolites##2##2##(2008-4#2)
viral capsid antigen##2##3##(1991-9#1)(1995-2#1)
viral capsid protein##3##3##(2008-10#2)(2009-8#1)
viral capsid proteins##2##3##(1997-1#1)(2009-2#1)
viral capsid##10##2##(1991-9#1)(1995-2#3)(1997-1#1)(2007-2#1)(2008-10#2)(2009-2#1)(2009-8#1)
viral capsids##4##2##(1994-9#1)(1995-1#1)(2009-10#2)
viral causes of##2##3##(2009-7#1)(2010-5#1)
viral causes##3##2##(2007-5#1)(2009-7#1)(2010-5#1)
viral clearance##3##2##(1992-3#1)(1995-2#1)(2008-2#1)
viral coat protein (CP)##2##4##(2008-10#2)
viral coat protein##7##3##(1992-9#1)(1993-5#1)(2008-10#4)(2008-8#1)
viral coat##9##2##(1992-9#1)(1993-5#1)(1994-9#2)(2008-10#4)(2008-8#1)
viral complementary##4##2##(2008-10#4)
viral components##2##2##(2008-10#1)(2008-4#1)
viral concentration##2##2##(2007-11#1)(2008-5#1)
viral contamination##4##2##(1990-2#1)(2008-11#2)(2008-4#1)
viral contaminations as##2##3##(2008-11#2)
viral contaminations in##3##3##(2008-11#3)
viral contaminations##6##2##(2008-11#6)
viral copy number##2##3##(2013-8#2)
viral detection##2##2##(2008-10#1)(2010-5#1)
viral diarrhea virus##3##3##(2008-11#1)(2012-3#2)
viral diarrhea##4##2##(2006-10#1)(2008-11#1)(2012-3#2)
viral diarrhoea##6##2##(1993-2#1)(1994-4#1)(1997-5#2)(2006-10#1)(2008-1#1)
viral disease in the##3##4##(2006-10#2)(2008-10#1)
viral disease in##4##3##(2006-10#2)(2008-10#1)(2008-3#1)
viral disease of##4##3##(2007-7#1)(2008-10#3)
viral disease that##2##3##(2006-2#1)(2010-4#1)
viral disease##20##2##(2005-8#1)(2006-10#3)(2006-2#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
viral diseases in##2##3##(2007-7#1)(2008-10#1)
viral diseases of##2##3##(2008-10#1)(2008-8#1)
viral diseases##18##2##(1991-9#1)(1992-2#1)(1994-8#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-8#1)(2007-12#1)(2007-7#2)(2008-10#2)(2008-8#1)(2009-7#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
viral double-stranded RNA##2##3##(1993-3#1)(2008-10#1)
viral early##4##2##(1995-2#2)(1997-1#2)
viral encephalitis##3##2##(2007-8#1)(2008-7#1)(2011-1#1)
viral entry##7##2##(1990-4#1)(1993-3#1)(2005-7#1)(2007-11#1)(2008-1#1)(2008-11#1)(2011-1#1)
viral envelope##5##2##(1994-8#2)(2008-4#1)(2008-8#1)(2009-12#1)
viral epitopes##3##2##(1995-8#1)(1996-12#1)(2006-10#1)
viral ethiology of cirrhosis##3##4##(2006-6#3)
viral etiology of##4##3##(2013-1#3)(2013-7#1)
viral etiology##8##2##(2007-9#1)(2008-4#2)(2013-1#4)(2013-7#1)
viral factors##6##2##(1996-11#1)(1996-8#1)(2006-10#1)(2008-11#3)
viral fusion##6##2##(1991-5#1)(1994-12#1)(2008-1#2)(2009-8#1)(2011-1#1)
viral gastroenteritis##3##2##(1996-1#1)(2006-10#1)(2010-12#1)
viral gene expression and##3##4##(1991-12#1)(2008-10#1)(2013-1#1)
viral gene expression##9##3##(1991-12#1)(1997-6#1)(2008-10#1)(2008-8#2)(2009-2#2)(2012-12#1)(2013-1#1)
viral gene product##3##3##(1991-11#1)(1996-10#1)(2008-10#1)
viral gene products##3##3##(1995-2#1)(1997-4#1)(2012-2#1)
viral gene##19##2##(1991-11#1)(1991-12#1)(1995-2#1)(1996-10#1)(1996-8#1)(1997-1#1)(1997-4#2)(1997-6#1)(2008-10#2)(2008-8#2)(2009-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
viral genes and##2##3##(1995-2#1)(2008-9#1)
viral genes in##2##3##(2008-8#1)(2013-8#1)
viral genes##13##2##(1995-2#3)(1997-6#1)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#2)(2010-1#1)(2013-8#2)
viral genetic##2##2##(2011-2#1)(2013-1#1)
viral genetics##2##2##(2006-10#1)(2012-12#1)
viral genome and##4##3##(1995-8#1)(2008-9#2)(2012-12#1)
viral genome##36##2##(1990-7#1)(1991-6#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#1)(1995-8#3)(1997-2#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#5)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#3)
viral genome-associated protein##2##3##(2008-10#2)
viral genomes##13##2##(1994-11#3)(1995-2#1)(1996-2#1)(1996-4#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2012-2#1)
viral genomic RNA##3##3##(1992-6#1)(2008-10#1)(2008-11#1)
viral genomic##5##2##(1992-6#1)(2008-10#2)(2008-11#2)
viral genotypes##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
viral glycoproteins##2##2##(1990-10#1)(2007-11#1)
viral growth##3##2##(1990-11#1)(1991-10#1)(1993-12#1)
viral hemagglutinin##2##2##(1990-2#1)(2012-2#1)
viral hemorrhagic fever (VHF)##2##4##(1995-6#2)
viral hemorrhagic fever##3##3##(1995-6#2)(2011-1#1)
viral hemorrhagic septicemia virus##2##4##(2012-3#2)
viral hemorrhagic##9##2##(1995-6#4)(2011-1#2)(2012-3#2)(2013-8#1)
viral hepatitis B and##2##4##(2006-6#1)(2011-1#1)
viral hepatitis B##4##3##(1991-9#1)(2006-6#1)(2007-11#1)(2011-1#1)
viral hepatitis and##8##3##(2005-7#1)(2006-10#2)(2007-7#3)(2008-6#1)(2011-2#1)
viral hepatitis as##2##3##(2009-4#1)(2009-5#1)
viral hepatitis to##4##3##(2007-12#1)(2011-1#2)(2012-2#1)
viral hepatitis type##2##3##(2005-10#1)(2010-4#1)
viral hepatitis##56##2##(1991-9#1)(1992-1#1)(1992-2#1)(1996-8#2)(2005-10#1)(2005-6#2)(2005-7#1)(2005-8#1)(2006-10#9)(2006-2#2)(2006-6#4)(2007-11#2)(2007-12#3)(2007-7#5)(2008-4#1)(2008-6#1)(2008-7#2)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-4#1)(2011-1#4)(2011-2#2)(2012-2#2)(2013-1#1)
viral illness##2##2##(2008-1#1)(2008-10#1)
viral inactivation of##3##3##(1991-6#2)(2011-3#1)
viral inactivation##8##2##(1991-6#2)(1993-3#1)(2007-11#1)(2008-1#1)(2011-3#3)
viral infection and viral##2##4##(2008-9#1)(2011-1#1)
viral infection and##12##3##(1997-1#1)(2007-11#1)(2008-11#1)(2008-9#2)(2010-2#1)(2011-1#2)(2012-1#1)(2012-12#3)
viral infection in##7##3##(2006-7#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-7#1)(2012-2#1)
viral infection is##4##3##(2006-10#2)(2007-10#1)(2008-4#1)
viral infection of##5##3##(1996-10#1)(1997-7#1)(2007-8#1)(2009-9#1)(2012-3#1)
viral infection to##2##3##(2009-12#1)(2011-1#1)
viral infection when##2##3##(1993-12#1)(2010-6#1)
viral infection##82##2##(1990-6#1)(1990-8#1)(1991-1#1)(1991-2#1)(1992-12#2)(1992-3#1)(1993-12#1)(1993-2#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-7#1)(2006-10#4)(2006-7#2)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#2)(2008-1#4)(2008-10#1)(2008-11#3)(2008-4#3)(2008-5#2)(2008-7#3)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-6#2)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
viral infections and##2##3##(1994-12#1)(2013-1#1)
viral infections are##3##3##(1990-6#1)(2010-7#1)(2011-1#1)
viral infections has been##2##4##(2007-11#1)(2010-5#1)
viral infections induce##2##3##(1996-11#1)(2007-12#1)
viral infections may##2##3##(1992-11#1)(2005-9#1)
viral infections or##2##3##(2006-2#1)(2008-11#1)
viral infections such as##2##4##(2006-10#1)(2008-8#1)
viral infections##65##2##(1990-6#1)(1991-12#1)(1991-6#1)(1992-11#1)(1993-2#3)(1994-12#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-4#1)(1997-6#1)(2005-10#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#4)(2006-2#1)(2006-6#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-9#2)(2008-1#4)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-3#1)(2010-2#1)(2010-5#2)(2010-6#2)(2010-7#5)(2011-1#1)(2012-3#1)(2013-1#4)(2013-8#1)
viral infectious##2##2##(1992-6#1)(2008-5#1)
viral infectivity##2##2##(1993-3#1)(2006-4#1)
viral inhibitory substance##2##3##(1997-4#2)
viral inhibitory##4##2##(1997-4#4)
viral integration##3##2##(1991-12#1)(1994-9#1)(2012-12#1)
viral isolate##3##2##(2005-9#1)(2007-3#1)(2008-10#1)
viral isolates##4##2##(2008-10#1)(2008-5#1)(2013-8#2)
viral isolation in##2##3##(1992-10#1)(2011-2#1)
viral isolation##6##2##(1992-10#1)(2007-12#1)(2007-2#1)(2011-2#1)(2013-8#2)
viral labelling##2##2##(1993-9#2)
viral latency##4##2##(2012-2#3)(2013-8#1)
viral latent##2##2##(1992-12#1)(1995-8#1)
viral levels##2##2##(2006-10#1)(2008-5#1)
viral load and##10##3##(1995-9#1)(2006-10#1)(2007-12#1)(2007-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#3)
viral load have been##2##4##(2006-10#1)(2012-2#1)
viral load in##5##3##(2007-3#1)(2013-8#4)
viral load of##2##3##(1995-9#1)(2011-2#1)
viral load on##2##3##(2012-2#1)(2013-1#1)
viral load was##4##3##(2008-5#2)(2010-12#1)(2011-2#1)
viral load##73##2##(1995-9#8)(1996-2#1)(2005-8#1)(2006-1#1)(2006-10#5)(2007-1#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-7#1)(2008-5#4)(2008-6#2)(2008-8#2)(2009-11#1)(2009-5#1)(2009-6#2)(2010-11#1)(2010-12#5)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#9)(2012-3#1)(2013-1#7)(2013-8#8)
viral loads##16##2##(2005-8#1)(2006-10#2)(2007-1#1)(2007-11#1)(2007-8#1)(2008-11#2)(2009-10#2)(2009-5#1)(2010-12#3)(2012-3#1)(2013-1#1)
viral long terminal##3##3##(1993-4#1)(1995-2#1)(1997-6#1)
viral lysis and##3##3##(2005-12#3)
viral lysis##8##2##(2005-12#8)
viral mRNA##7##2##(1991-2#2)(1992-12#2)(1995-9#1)(2008-9#1)(2011-1#1)
viral mRNAs##4##2##(1996-4#2)(2011-1#2)
viral markers##3##2##(2007-7#2)(2008-10#1)
viral meningitis##4##2##(2007-3#3)(2007-8#1)
viral miRNA##2##2##(2013-1#1)(2013-8#1)
viral miRNAs are##2##3##(2013-8#2)
viral miRNAs##8##2##(2013-1#5)(2013-8#3)
viral movement##3##2##(2008-10#2)(2009-8#1)
viral myocarditis##5##2##(2007-1#1)(2010-5#1)(2010-7#2)(2011-2#1)
viral neurovirulence##2##2##(1990-11#1)(2013-8#1)
viral nucleic acid##2##3##(2008-10#1)(2011-2#1)
viral nucleic acids##3##3##(2007-11#1)(2010-2#1)(2011-1#1)
viral nucleic##6##2##(2007-11#1)(2008-10#1)(2009-10#1)(2010-2#1)(2011-1#1)(2011-2#1)
viral oncogene##3##2##(1992-9#1)(1993-7#1)(1995-2#1)
viral oncolysis##3##2##(1996-4#3)
viral or bacterial infections##2##4##(2005-11#1)(2008-8#1)
viral or bacterial##4##3##(1991-9#1)(1992-8#1)(2005-11#1)(2008-8#1)
viral or##9##2##(1991-9#1)(1992-8#1)(2005-11#1)(2008-10#1)(2008-4#2)(2008-8#1)(2010-11#1)(2011-2#1)
viral origin##3##2##(1992-12#1)(2008-5#1)(2011-1#1)
viral particle##2##2##(1995-9#1)(2009-10#1)
viral particles##13##2##(1991-10#1)(1991-12#1)(1991-2#1)(1992-12#1)(1994-5#1)(1997-3#2)(2005-7#1)(2008-4#1)(2009-4#1)(2011-3#2)(2012-3#1)
viral pathogen##4##2##(1995-5#1)(2007-12#1)(2008-1#1)(2008-4#1)
viral pathogens##12##2##(2005-11#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#2)(2008-6#1)(2008-8#1)(2010-12#1)(2012-2#1)(2013-1#1)
viral peptides##3##2##(1997-4#1)(2008-4#1)(2012-2#1)
viral persistence##3##2##(1997-6#1)(2006-10#2)
viral polyprotein##2##2##(1994-11#1)(2012-2#1)
viral population of##2##3##(2007-11#1)(2008-10#1)
viral population##3##2##(2007-11#1)(2008-10#2)
viral populations##4##2##(2008-10#1)(2012-2#1)(2013-1#2)
viral processes##2##2##(2008-11#1)(2013-1#1)
viral production in##2##3##(1994-5#1)(2008-11#1)
viral production##8##2##(1994-2#1)(1994-5#1)(1996-4#1)(2005-12#1)(2008-11#3)(2011-3#1)
viral promoter##5##2##(2008-3#1)(2012-12#4)
viral promoters##4##2##(1996-8#1)(1997-4#1)(1997-8#2)
viral protein and RNA##2##4##(1990-5#1)(2011-2#1)
viral protein and##4##3##(1990-5#1)(2008-11#1)(2011-2#1)(2013-1#1)
viral protein synthesis##2##3##(1992-12#1)(1993-12#1)
viral protein##21##2##(1990-11#1)(1990-5#1)(1990-9#1)(1992-12#1)(1993-12#1)(1994-8#1)(2005-8#1)(2006-6#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
viral proteins and##4##3##(1991-12#1)(1991-5#1)(1994-11#1)(2013-1#1)
viral proteins have##2##3##(2006-10#1)(2012-2#1)
viral proteins in##2##3##(1990-11#1)(2009-8#1)
viral proteins##21##2##(1990-11#1)(1991-12#1)(1991-5#1)(1994-11#2)(1994-3#1)(1995-2#1)(1997-5#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2009-8#2)(2012-2#2)(2013-1#1)
viral quasispecies##5##2##(2013-8#5)
viral reactivation##3##2##(2006-10#1)(2008-1#1)(2012-12#1)
viral reactivations##3##2##(2008-1#2)(2008-12#1)
viral replicase##2##2##(2008-10#2)
viral replication and##6##3##(1990-2#1)(1992-8#1)(2005-7#1)(2007-8#1)(2008-9#1)(2012-12#1)
viral replication in the##3##4##(1995-5#1)(2008-8#1)(2011-2#1)
viral replication in##5##3##(1995-5#1)(1997-3#1)(2008-8#1)(2011-2#1)(2013-8#1)
viral replication with##3##3##(2006-10#2)(2012-2#1)
viral replication##48##2##(1990-2#1)(1990-5#1)(1991-5#1)(1992-11#1)(1992-8#1)(1993-3#1)(1994-8#2)(1995-5#1)(1997-3#2)(2005-7#3)(2006-10#3)(2006-11#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-11#2)(2009-9#2)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
viral resistance in##2##3##(1991-2#2)
viral resistance to##2##3##(2006-10#1)(2009-6#1)
viral resistance##7##2##(1991-2#2)(1997-6#1)(2006-10#1)(2008-10#1)(2009-6#1)(2012-2#1)
viral respiratory infections##2##3##(1990-5#1)(2010-12#1)
viral respiratory##6##2##(1990-5#1)(2007-11#1)(2010-12#1)(2011-12#1)(2012-12#1)(2013-1#1)
viral response rate##2##3##(2007-11#2)
viral safety##2##2##(2007-8#2)
viral sequence##3##2##(1991-12#1)(1994-12#1)(2013-1#1)
viral sequences##3##2##(1992-2#1)(1993-12#1)(2006-2#1)
viral shedding##6##2##(1994-6#1)(2006-10#1)(2009-6#2)(2009-7#1)(2013-8#1)
viral species##3##2##(2008-10#3)
viral strain##4##2##(2006-10#1)(2007-11#2)(2010-4#1)
viral strains##4##2##(1992-8#1)(2008-10#1)(2012-12#2)
viral strand##2##2##(2008-10#2)
viral suppression##4##2##(2008-5#1)(2010-11#1)(2010-12#1)(2011-1#1)
viral titers##3##2##(2008-11#3)
viral titre##2##2##(2007-10#1)(2008-11#1)
viral transcription##3##2##(1990-6#1)(1995-2#1)(2012-12#1)
viral transcripts##5##2##(1994-8#1)(2008-9#3)(2011-3#1)
viral transduction##3##2##(2008-1#1)(2008-4#1)(2012-12#1)
viral transmission chains##2##3##(2010-1#1)(2013-8#1)
viral transmission##6##2##(1997-4#1)(2008-10#1)(2009-12#1)(2010-1#1)(2011-2#1)(2013-8#1)
viral uptake##3##2##(2008-10#1)(2008-6#2)
viral vaccine##3##2##(1997-6#1)(2008-11#2)
viral vaccines##5##2##(1995-5#1)(2008-11#3)(2011-2#1)
viral vector containing##2##3##(2008-8#1)(2008-9#1)
viral vector immunization##2##3##(2009-12#2)
viral vector##22##2##(1995-2#2)(1997-4#1)(2006-6#1)(2008-4#1)(2008-8#2)(2008-9#3)(2009-12#2)(2010-5#2)(2011-2#2)(2012-3#1)(2013-7#1)(2013-8#4)
viral vectors and##4##3##(2005-8#1)(2008-11#2)(2008-4#1)
viral vectors for##3##3##(2007-11#1)(2008-11#1)(2012-11#1)
viral vectors to##3##3##(2008-11#1)(2008-9#1)(2012-12#1)
viral vectors##26##2##(2005-8#1)(2007-11#5)(2007-6#1)(2008-11#4)(2008-4#5)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2012-11#2)(2012-12#1)(2013-1#1)(2013-7#1)
viral##1454##1##(1990-10#2)(1990-11#4)(1990-12#1)(1990-2#6)(1990-4#1)(1990-5#5)(1990-6#6)(1990-7#6)(1990-8#3)(1990-9#3)(1991-1#3)(1991-10#2)(1991-11#2)(1991-12#7)(1991-2#7)(1991-3#2)(1991-4#1)(1991-5#9)(1991-6#4)(1991-9#6)(1992-1#1)(1992-10#1)(1992-11#6)(1992-12#10)(1992-2#4)(1992-3#5)(1992-6#5)(1992-7#1)(1992-8#5)(1992-9#4)(1993-11#3)(1993-12#8)(1993-2#5)(1993-3#6)(1993-4#2)(1993-5#3)(1993-6#4)(1993-7#3)(1993-8#2)(1993-9#6)(1994-1#3)(1994-11#10)(1994-12#6)(1994-2#3)(1994-3#2)(1994-4#1)(1994-5#3)(1994-6#1)(1994-7#1)(1994-8#14)(1994-9#7)(1995-1#1)(1995-2#28)(1995-3#2)(1995-5#5)(1995-6#7)(1995-7#2)(1995-8#6)(1995-9#10)(1996-1#4)(1996-10#5)(1996-11#7)(1996-12#3)(1996-2#4)(1996-4#10)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#5)(1997-1#11)(1997-2#4)(1997-3#13)(1997-4#18)(1997-5#8)(1997-6#14)(1997-7#5)(1997-8#3)(2004-11#2)(2005-10#3)(2005-11#2)(2005-12#9)(2005-6#2)(2005-7#11)(2005-8#10)(2005-9#3)(2006-1#3)(2006-10#55)(2006-11#2)(2006-12#1)(2006-2#6)(2006-4#1)(2006-6#11)(2006-7#2)(2007-1#4)(2007-10#5)(2007-11#41)(2007-12#16)(2007-2#7)(2007-3#8)(2007-5#1)(2007-6#4)(2007-7#14)(2007-8#10)(2007-9#4)(2008-1#28)(2008-10#127)(2008-11#57)(2008-12#3)(2008-2#5)(2008-3#3)(2008-4#42)(2008-5#24)(2008-6#10)(2008-7#12)(2008-8#25)(2008-9#55)(2009-10#12)(2009-11#7)(2009-12#5)(2009-2#9)(2009-3#2)(2009-4#6)(2009-5#5)(2009-6#6)(2009-7#7)(2009-8#13)(2009-9#9)(2010-1#5)(2010-11#3)(2010-12#16)(2010-2#5)(2010-4#6)(2010-5#12)(2010-6#4)(2010-7#8)(2011-1#36)(2011-12#3)(2011-2#35)(2011-3#15)(2012-1#4)(2012-11#2)(2012-12#27)(2012-2#38)(2012-3#17)(2013-1#55)(2013-7#3)(2013-8#57)
viral-bacterial synergy##4##2##(2008-7#4)
viral-cellular##3##1##(2006-10#1)(2008-9#2)
viral-like##3##1##(2008-11#2)(2010-12#1)
viral-specific##3##1##(1990-10#1)(2006-10#1)(2008-10#1)
virally encoded##3##2##(1991-3#1)(1991-9#1)(2013-8#1)
virally transformed##3##2##(1994-3#1)(2008-4#1)(2008-5#1)
virally##10##1##(1990-8#1)(1991-3#1)(1991-9#1)(1994-3#1)(2008-4#2)(2008-5#1)(2009-12#2)(2013-8#1)
virchow##5##1##(1993-8#4)(2007-4#1)
viremia in##3##2##(2007-8#1)(2010-4#2)
viremia levels##2##2##(2013-8#2)
viremia was##2##2##(1993-12#1)(1995-2#1)
viremia##23##1##(1992-10#1)(1993-12#1)(1995-2#1)(1996-4#1)(2006-10#4)(2006-2#2)(2007-11#1)(2007-8#3)(2010-4#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
viremic##4##1##(2009-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
virens##12##1##(2006-12#2)(2008-10#10)
virescens and##6##2##(1994-8#3)(2007-12#1)(2008-11#1)(2013-8#1)
virescens##10##1##(1994-8#3)(2007-12#1)(2008-11#1)(2010-2#2)(2013-8#3)
virga##4##1##(2008-6#4)
virgal##2##1##(2008-6#2)
virgata##2##1##(2008-11#1)(2011-12#1)
virgaurin##2##1##(2007-1#2)
virgifera virgifera LeConte##3##3##(2010-12#1)(2011-2#2)
virgifera virgifera##5##2##(2010-12#2)(2011-12#1)(2011-2#2)
virgifera##13##1##(2010-12#7)(2011-12#2)(2011-2#4)
virgin and##3##2##(1991-12#1)(1996-3#1)(2008-8#1)
virgin female##3##2##(1994-3#1)(2008-5#1)(2009-5#1)
virgin females##8##2##(1994-3#1)(1995-1#3)(1997-4#1)(2007-12#1)(2008-8#1)(2013-8#1)
virgin hair##2##2##(2008-5#2)
virgin olive oil##5##3##(2007-8#3)(2009-3#1)(2012-2#1)
virgin olive oils##2##3##(2006-12#1)(2007-8#1)
virgin olive##7##2##(2006-12#1)(2007-8#4)(2009-3#1)(2012-2#1)
virgin or##2##2##(1994-3#2)
virgin##41##1##(1991-12#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-10#1)(1994-3#4)(1995-1#3)(1996-3#1)(1997-4#4)(2004-10#1)(2004-11#1)(2006-12#1)(2006-5#1)(2007-12#2)(2007-8#4)(2008-10#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#2)(2009-3#1)(2009-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
virginiana##12##1##(1994-9#1)(1996-5#2)(2007-1#2)(2008-10#6)(2008-8#1)
virginica##3##1##(2008-7#3)
virginica)##2##1##(2007-5#1)(2008-7#1)
virgo##6##1##(2004-4#3)(2008-10#2)(2008-8#1)
virial##3##1##(2007-12#1)(2008-10#1)(2009-6#1)
viridans group##3##2##(2006-10#1)(2007-12#2)
viridans streptococcus##2##2##(2007-12#2)
viridans##8##1##(1997-8#1)(2006-10#1)(2006-8#1)(2007-12#4)(2008-10#1)
viride S17A##5##2##(2008-10#5)
viride and##2##2##(1992-3#1)(2008-10#1)
viride##11##1##(1992-3#1)(2007-3#2)(2008-10#8)
viridiflorol##3##1##(2007-1#2)(2012-11#1)
viridis##16##1##(1991-3#3)(1993-11#2)(1993-8#3)(2008-12#4)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
virilis and##2##2##(1995-2#1)(1997-2#1)
virilis##7##1##(1994-9#1)(1995-2#5)(1997-2#1)
virilization of##2##2##(1995-11#1)(2008-4#1)
virilization##3##1##(1995-11#1)(2008-1#1)(2008-4#1)
virion RNA##5##2##(1997-3#3)(2008-4#2)
virion particles##2##2##(1996-11#1)(2008-9#1)
virion preparations##3##2##(2008-10#3)
virion proteins##2##2##(1991-12#1)(2013-8#1)
virion structural protein##2##3##(1993-12#2)
virion structural##3##2##(1993-12#3)
virion##40##1##(1990-11#1)(1991-12#2)(1991-5#1)(1991-6#1)(1992-5#1)(1992-8#2)(1993-12#5)(1994-9#1)(1995-5#1)(1996-10#1)(1996-11#1)(1997-3#6)(1997-4#1)(2006-12#1)(2008-10#6)(2008-4#3)(2008-9#3)(2011-1#1)(2011-12#1)(2013-8#1)
virions and##3##2##(1995-2#1)(2008-10#1)(2008-5#1)
virions in##2##2##(1997-3#1)(2013-8#1)
virions of##2##2##(2008-10#2)
virions were observed##2##3##(2008-10#2)
virions were##7##2##(1995-2#1)(2007-12#1)(2008-10#4)(2008-11#1)
virions##44##1##(1990-5#2)(1992-8#2)(1993-12#2)(1993-2#2)(1994-11#1)(1994-7#1)(1994-8#1)(1995-2#2)(1996-11#1)(1997-3#2)(2007-12#2)(2008-10#16)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2013-8#3)
viroid combinations##2##2##(2008-10#2)
viroid mixtures##2##2##(2008-10#2)
viroid replication##4##2##(2008-9#4)
viroid##33##1##(2008-10#28)(2008-9#5)
viroid-like##2##1##(2008-10#2)
viroids in coconut##2##3##(2008-10#2)
viroids in##4##2##(2008-10#4)
viroids were##2##2##(2008-10#2)
viroids##19##1##(2008-10#18)(2008-9#1)
virologic failure##3##2##(2007-1#3)
virologic response##8##2##(2009-5#1)(2010-12#2)(2010-2#1)(2012-1#1)(2013-1#3)
virologic##18##1##(1994-6#1)(2007-1#3)(2007-2#1)(2008-4#1)(2009-11#1)(2009-5#2)(2009-8#1)(2010-12#2)(2010-2#2)(2012-1#1)(2013-1#3)
virological and##2##2##(2008-4#1)(2012-3#1)
virological breakthrough##2##2##(2013-1#2)
virological breakthroughs##2##2##(2012-2#2)
virological response (SVR)##2##3##(2012-1#1)(2012-12#1)
virological response in##2##3##(2007-7#1)(2012-1#1)
virological response##12##2##(2005-6#1)(2007-11#1)(2007-7#1)(2009-7#1)(2009-8#2)(2012-1#2)(2012-12#2)(2012-2#1)(2013-7#1)
virological response)##2##2##(2007-7#2)
virological##30##1##(1996-2#1)(1997-3#1)(2005-6#1)(2007-11#3)(2007-7#3)(2007-8#1)(2008-4#1)(2008-5#1)(2009-7#1)(2009-8#2)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)
virologically##2##1##(2008-5#2)
virologists##5##1##(2005-8#1)(2007-8#1)(2008-9#2)(2010-10#1)
virology and##2##2##(2007-6#1)(2008-8#1)
virology##10##1##(1993-12#2)(1997-1#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-8#1)
virosomes##3##1##(1990-2#3)
virotherapy##5##1##(2008-1#3)(2013-1#1)(2013-8#1)
virtual and##5##2##(2008-10#1)(2008-3#1)(2008-7#1)(2012-3#1)(2013-1#1)
virtual colonoscopy##6##2##(2006-10#1)(2006-2#2)(2008-6#3)
virtual endoscopy##7##2##(2006-5#2)(2006-6#5)
virtual environments##2##2##(2008-3#1)(2008-6#1)
virtual hand was##2##3##(2008-11#2)
virtual hand##4##2##(2008-11#4)
virtual images##2##2##(2008-2#1)(2008-3#1)
virtual institute##2##2##(2007-9#2)
virtual laboratory for studying RNA secondary structures##2##7##(2009-11#2)
virtual laboratory for##4##3##(2008-2#2)(2009-11#2)
virtual lack of##2##3##(1996-4#1)(1997-7#1)
virtual lesion extension##2##3##(2008-10#2)
virtual lesion##4##2##(2008-10#4)
virtual libraries##2##2##(1996-1#1)(2006-5#1)
virtual memory##2##2##(2008-2#1)(2008-6#1)
virtual models##3##2##(2007-7#1)(2008-6#1)(2009-4#1)
virtual objects##2##2##(2006-6#1)(2008-3#1)
virtual point source##2##3##(2008-2#1)(2008-3#1)
virtual point##3##2##(2008-2#2)(2008-3#1)
virtual rat##3##2##(2005-10#2)(2013-8#1)
virtual reality (VR)##3##3##(2009-11#1)(2010-4#1)(2010-9#1)
virtual reality and##2##3##(1997-5#1)(2008-6#1)
virtual reality package##2##3##(2008-11#2)
virtual reality##29##2##(1997-5#1)(2006-10#1)(2006-6#4)(2008-11#3)(2008-6#1)(2008-7#1)(2009-11#2)(2009-12#1)(2009-6#1)(2010-1#1)(2010-4#3)(2010-8#1)(2010-9#1)(2011-7#2)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#2)
virtual screening and##2##3##(2011-3#1)(2013-7#1)
virtual screening##9##2##(2007-11#1)(2008-4#1)(2008-8#2)(2010-7#1)(2011-3#1)(2013-7#3)
virtual source##3##2##(2007-11#2)(2008-3#1)
virtual surgery##2##2##(2007-7#1)(2009-4#1)
virtual##191##1##(1990-5#1)(1991-4#1)(1993-12#1)(1993-6#1)(1996-1#3)(1996-2#1)(1996-4#1)(1997-3#1)(1997-5#1)(1997-7#1)(2005-10#3)(2005-7#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-5#5)(2006-6#12)(2007-11#4)(2007-12#3)(2007-4#2)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#10)(2008-11#9)(2008-12#4)(2008-2#9)(2008-3#12)(2008-4#2)(2008-5#1)(2008-6#11)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#4)(2009-12#1)(2009-3#1)(2009-4#2)(2009-6#1)(2010-1#1)(2010-3#1)(2010-4#4)(2010-7#1)(2010-8#5)(2010-9#3)(2011-1#1)(2011-12#1)(2011-2#4)(2011-3#1)(2011-7#2)(2012-1#12)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#7)(2013-7#3)(2013-8#4)
virtual-reality##2##1##(2006-6#2)
virtually absent from##4##3##(1991-12#1)(1992-7#1)(1994-10#1)(2009-11#1)
virtually absent in the##4##4##(1990-4#1)(1991-8#1)(1996-12#1)(2008-10#1)
virtually absent in##7##3##(1990-2#1)(1990-4#1)(1991-8#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-5#1)
virtually absent##18##2##(1990-2#1)(1990-4#1)(1991-12#1)(1991-8#1)(1992-7#1)(1992-8#1)(1994-10#1)(1995-2#1)(1996-12#1)(2006-2#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-11#1)(2012-1#1)(2012-3#1)
virtually all A beta##2##4##(1995-3#2)
virtually all cell types##2##4##(2008-4#1)(2009-12#1)
virtually all of##3##3##(1992-1#1)(1994-10#1)(2008-7#1)
virtually all the##3##3##(1996-12#1)(2008-10#1)(2012-1#1)
virtually all##44##2##(1991-12#1)(1992-1#1)(1992-3#1)(1992-9#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-9#2)(1995-3#3)(1996-12#2)(1996-6#1)(1997-2#2)(2006-10#3)(2006-12#1)(2006-6#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-12#1)(2009-8#2)(2010-10#1)(2010-2#1)(2012-1#1)(2012-2#2)
virtually and##2##2##(2009-4#1)(2013-1#1)
virtually any##13##2##(1994-3#1)(1996-12#1)(1997-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-2#1)(2008-3#1)(2010-4#1)(2011-2#1)(2013-1#2)
virtually complete##5##2##(1990-6#2)(1990-9#1)(1997-4#1)(2008-10#1)
virtually disappear##2##2##(1994-7#1)(2007-8#1)
virtually disappeared##3##2##(2006-2#1)(2008-5#1)(2008-7#1)
virtually eliminated the##2##3##(1992-7#1)(2009-4#1)
virtually eliminated##6##2##(1992-7#1)(1994-9#1)(1995-5#1)(2008-5#1)(2009-4#1)(2011-2#1)
virtually eliminates##2##2##(1990-6#1)(2008-3#1)
virtually every##9##2##(1996-12#1)(1997-1#1)(2005-7#1)(2007-2#1)(2008-10#3)(2008-12#1)(2009-7#1)
virtually free##2##2##(1991-3#1)(2007-2#1)
virtually identical to that of##3##5##(1992-8#1)(1996-7#1)(2008-10#1)
virtually identical to that##4##4##(1990-1#1)(1992-8#1)(1996-7#1)(2008-10#1)
virtually identical to the##2##4##(1991-6#1)(1996-8#1)
virtually identical to##8##3##(1990-1#1)(1991-4#1)(1991-6#1)(1992-8#1)(1994-12#1)(1996-7#1)(1996-8#1)(2008-10#1)
virtually identical with##2##3##(1995-3#1)(1996-2#1)
virtually identical##17##2##(1990-1#1)(1991-4#1)(1991-6#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-3#1)(1996-2#1)(1996-7#1)(1996-8#1)(2004-11#1)(2008-10#2)(2009-4#1)
virtually impossible to##2##3##(2006-6#1)(2011-1#1)
virtually impossible##5##2##(1992-6#1)(1994-1#1)(2006-6#1)(2008-1#1)(2011-1#1)
virtually inactive##5##2##(1990-10#1)(1991-11#1)(1993-11#1)(1995-8#1)(2008-4#1)
virtually no change in##2##4##(1991-10#1)(1993-3#1)
virtually no##17##2##(1990-5#1)(1991-10#1)(1992-10#1)(1992-2#1)(1992-5#1)(1993-3#1)(1994-4#2)(1997-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-5#1)
virtually pathognomonic##2##2##(2005-8#1)(2006-8#1)
virtually specific##2##2##(2008-10#2)
virtually the entire##3##3##(1991-5#1)(1992-11#1)(2011-1#1)
virtually the same##3##3##(1992-6#1)(1993-6#1)(2008-8#1)
virtually the##7##2##(1991-5#1)(1992-11#1)(1992-6#1)(1993-6#1)(2006-6#1)(2008-8#1)(2011-1#1)
virtually unaffected by##2##3##(1994-12#1)(1997-8#1)
virtually unaffected##3##2##(1990-3#1)(1994-12#1)(1997-8#1)
virtually unchanged##5##2##(1992-11#1)(1993-6#1)(1994-6#1)(2008-10#1)(2009-12#1)
virtually undetectable in##2##3##(1997-2#1)(2010-10#1)
virtually unlimited##5##2##(1994-3#1)(2006-9#1)(2007-11#1)(2008-11#1)(2012-12#1)
virtually##233##1##(1990-1#1)(1990-10#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#4)(1990-9#2)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-3#3)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#2)(1994-11#2)(1994-12#3)(1994-2#4)(1994-3#2)(1994-4#2)(1994-6#2)(1994-7#2)(1994-9#5)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#5)(1995-5#2)(1995-8#1)(1996-12#5)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#4)(1997-4#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#4)(2006-12#2)(2006-2#2)(2006-6#3)(2006-8#2)(2006-9#1)(2007-11#5)(2007-12#5)(2007-2#3)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#19)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#3)(2008-5#5)(2008-7#3)(2008-8#3)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#3)(2009-7#1)(2009-8#2)(2010-10#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#1)
virtue ethics##2##2##(2009-9#2)
virtue of a##2##3##(2006-10#1)(2008-10#1)
virtue of differential##2##3##(2006-10#1)(2008-4#1)
virtue of its##13##3##(1990-4#1)(1991-2#1)(1993-11#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2010-5#1)
virtue of the##10##3##(1995-2#2)(1996-1#1)(1997-8#1)(2006-12#1)(2007-12#2)(2008-3#1)(2009-3#1)(2011-2#1)
virtue of their##11##3##(1991-8#1)(1993-2#1)(1996-11#1)(2005-7#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-12#1)(2010-9#1)
virtue of##52##2##(1990-11#1)(1990-4#1)(1991-2#1)(1991-8#1)(1991-9#1)(1993-11#2)(1993-2#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-5#1)(1997-8#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
virtue##57##1##(1990-11#1)(1990-4#1)(1991-2#1)(1991-8#1)(1991-9#1)(1993-11#2)(1993-2#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-5#1)(1997-8#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#2)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-9#2)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
virtues and##3##2##(2006-10#1)(2007-5#1)(2012-12#1)
virtues of##3##2##(1995-6#1)(2006-10#1)(2007-4#1)
virtues##12##1##(1991-12#2)(1995-6#1)(2006-10#2)(2007-4#1)(2007-5#1)(2008-3#1)(2008-9#1)(2009-9#1)(2012-12#1)(2012-2#1)
virtuous##3##1##(1991-12#1)(2008-12#1)(2009-6#1)
virucidal##2##1##(1993-12#1)(2008-1#1)
virulence among##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
virulence and molecular##2##3##(2008-10#2)
virulence and pathogenicity##2##3##(1997-2#1)(2008-10#1)
virulence and resistance##7##3##(2008-10#4)(2011-10#1)(2012-3#1)(2013-1#1)
virulence and transmission##2##3##(2008-10#1)(2008-8#1)
virulence and##50##2##(1991-12#1)(1991-8#1)(1995-2#1)(1997-2#1)(1997-6#3)(2007-10#1)(2008-10#23)(2008-7#2)(2008-8#3)(2008-9#4)(2009-3#2)(2009-9#1)(2010-10#1)(2011-10#1)(2012-3#1)(2013-1#2)(2013-8#2)
virulence are##2##2##(2008-8#1)(2008-9#1)
virulence as##2##2##(2008-10#2)
virulence assays##3##2##(2008-10#2)(2009-3#1)
virulence associations##4##2##(2008-10#4)
virulence at##2##2##(2008-10#2)
virulence by##7##2##(2008-10#4)(2008-4#1)(2009-8#1)(2011-1#1)
virulence characteristics##2##2##(2008-10#1)(2010-12#1)
virulence complexity was##2##3##(2008-10#2)
virulence complexity##4##2##(2008-10#4)
virulence determinant##2##2##(1990-8#1)(2006-8#1)
virulence determinants##3##2##(1994-12#1)(2009-8#1)(2011-1#1)
virulence diversity##3##2##(2008-10#3)
virulence factor expression and##2##4##(2006-10#1)(2007-11#1)
virulence factor expression##7##3##(1996-8#1)(2006-10#1)(2007-11#1)(2009-2#1)(2009-8#1)(2010-12#2)
virulence factor of##6##3##(1994-12#1)(2005-11#2)(2008-10#2)(2013-1#1)
virulence factor##25##2##(1991-7#1)(1994-12#1)(1994-2#1)(1996-12#1)(1996-8#1)(2005-11#2)(2006-10#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#5)(2009-2#1)(2009-8#1)(2010-12#2)(2011-2#3)(2013-1#2)
virulence factors and host##2##4##(2006-10#1)(2010-12#1)
virulence factors and##5##3##(1995-8#1)(2006-10#1)(2008-10#1)(2010-12#1)(2013-1#1)
virulence factors in quest of a##2##6##(2006-10#2)
virulence factors in##8##3##(1994-3#1)(2006-10#3)(2007-12#1)(2007-8#1)(2008-4#1)(2013-1#1)
virulence factors including##2##3##(2009-2#1)(2013-8#1)
virulence factors of##6##3##(1990-8#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-8#1)
virulence factors such as##3##4##(2006-8#1)(2007-12#1)(2009-8#1)
virulence factors that##4##3##(2005-8#1)(2009-2#1)(2010-12#1)(2012-11#1)
virulence factors were##2##3##(2007-8#1)(2012-11#1)
virulence factors##62##2##(1990-8#1)(1993-12#1)(1994-3#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-12#2)(1996-8#2)(1997-2#1)(2005-8#1)(2006-10#6)(2006-8#2)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#3)(2008-10#6)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#2)(2009-2#3)(2009-6#1)(2009-8#1)(2010-12#4)(2011-1#2)(2012-11#2)(2012-12#1)(2013-1#5)(2013-8#2)
virulence for##6##2##(1991-8#1)(1997-6#1)(2008-10#3)(2008-5#1)
virulence frequency##3##2##(2008-10#3)
virulence gene##5##2##(1995-2#1)(2008-10#3)(2009-8#1)
virulence genes in the##2##4##(1995-2#1)(2008-10#1)
virulence genes##12##2##(1995-2#1)(1995-6#1)(1996-8#1)(2007-8#1)(2008-10#4)(2008-4#1)(2010-12#1)(2012-3#1)(2013-8#1)
virulence genotype frequencies##2##3##(2008-10#2)
virulence genotype##3##2##(2008-10#3)
virulence groups##3##2##(2008-10#3)
virulence in P##2##3##(2008-10#2)
virulence in the pathogen##3##4##(2008-10#3)
virulence in the##4##3##(2008-10#4)
virulence in##23##2##(1990-8#1)(2005-9#1)(2007-8#1)(2008-10#12)(2008-8#1)(2009-2#1)(2009-8#1)(2010-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
virulence is##4##2##(2008-10#3)(2008-8#1)
virulence level##2##2##(2008-10#2)
virulence markers like the ability to survive the serum bactericidal activity##2##11##(2013-8#2)
virulence markers##4##2##(2013-8#4)
virulence of C##3##3##(2007-7#1)(2008-10#1)(2009-2#1)
virulence of P##2##3##(1996-4#1)(2008-10#1)
virulence of Pseudomonas syringae##3##4##(2008-10#3)
virulence of bacterial##2##3##(1991-12#1)(2009-6#1)
virulence of isolates##4##3##(2008-10#4)
virulence of pathogens##3##3##(2008-10#1)(2008-8#1)(2010-12#1)
virulence of the organism##2##4##(2008-7#2)
virulence of the pathogen##2##4##(2008-10#2)
virulence of the##8##3##(2007-6#1)(2008-10#5)(2008-7#2)
virulence of these organisms##2##4##(2008-9#1)(2011-2#1)
virulence of these##3##3##(2005-8#1)(2008-9#1)(2011-2#1)
virulence of this##2##3##(1996-12#1)(2008-4#1)
virulence of##61##2##(1991-12#2)(1995-1#1)(1996-12#2)(1996-4#1)(2005-8#1)(2007-6#1)(2007-7#1)(2008-10#28)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-2#2)(2009-5#1)(2009-6#3)(2010-12#4)(2011-2#1)(2013-1#1)
virulence on a##2##3##(2008-10#2)
virulence on barley##2##3##(2008-10#2)
virulence on the##2##3##(2008-10#2)
virulence on tomato##2##3##(2008-10#2)
virulence on##30##2##(2008-10#28)(2008-5#1)(2008-9#1)
virulence or##7##2##(2008-10#5)(2011-2#1)(2013-8#1)
virulence patterns##2##2##(2008-10#2)
virulence phenotype##4##2##(2008-10#4)
virulence phenotypes and##2##3##(2008-10#2)
virulence phenotypes##10##2##(2008-10#10)
virulence polymorphism##2##2##(2008-10#2)
virulence proteins##3##2##(1990-8#1)(1993-12#1)(2008-10#1)
virulence spectrum##5##2##(2008-10#5)
virulence than##2##2##(2008-10#2)
virulence to Pc-45##2##3##(2008-10#2)
virulence to the##2##3##(2008-9#1)(2011-12#1)
virulence to##22##2##(2008-10#20)(2008-9#1)(2011-12#1)
virulence toward##2##2##(2008-10#2)
virulence under##2##2##(2008-10#1)(2013-1#1)
virulence using##2##2##(2008-8#1)(2010-12#1)
virulence variation##3##2##(2006-3#2)(2008-10#1)
virulence was##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
virulence were observed among##2##4##(2008-10#2)
virulence were##8##2##(1991-8#1)(2008-10#7)
virulence##550##1##(1990-8#5)(1991-12#3)(1991-7#1)(1991-8#4)(1992-12#3)(1993-12#2)(1993-3#1)(1994-12#2)(1994-2#2)(1994-3#1)(1995-1#1)(1995-2#5)(1995-6#3)(1995-8#1)(1996-12#5)(1996-4#1)(1996-5#1)(1996-8#5)(1997-2#3)(1997-6#4)(2005-11#2)(2005-7#3)(2005-8#2)(2005-9#3)(2006-10#9)(2006-3#3)(2006-8#4)(2007-10#3)(2007-11#2)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#6)(2008-10#275)(2008-11#4)(2008-12#1)(2008-4#8)(2008-5#8)(2008-7#5)(2008-8#23)(2008-9#18)(2009-2#7)(2009-3#4)(2009-5#1)(2009-6#4)(2009-8#8)(2009-9#1)(2010-10#2)(2010-12#20)(2011-1#6)(2011-10#1)(2011-12#1)(2011-2#10)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#14)(2013-8#22)
virulence-associated##4##1##(1995-8#1)(2008-5#1)(2011-1#1)(2013-8#1)
virulence-attenuated phenotype##2##2##(2012-2#2)
virulence-attenuated##3##1##(2012-2#3)
virulence/avirulence##2##1##(2008-10#2)
virulence?##2##1##(2008-9#1)(2010-12#1)
virulences in group 38##2##4##(2008-10#2)
virulences in group##3##3##(2008-10#3)
virulences in##5##2##(2008-10#5)
virulences were##4##2##(2008-10#4)
virulences##14##1##(2008-10#14)
virulent (causing lesions##2##3##(2008-10#2)
virulent (mean disease severity was##2##5##(2008-10#2)
virulent C##6##2##(1995-12#1)(1996-12#1)(2008-10#4)
virulent Listeria phage A511##2##4##(2011-12#1)(2012-2#1)
virulent M##2##2##(1995-2#1)(2010-12#1)
virulent MDV##8##2##(2013-8#8)
virulent Marek's disease virus##2##4##(2008-5#1)(2013-8#1)
virulent NDV strain##2##3##(2008-5#2)
virulent NDV##3##2##(2008-5#3)
virulent S##3##2##(1994-5#2)(2009-6#1)
virulent and avirulent##4##3##(2008-10#4)
virulent and##17##2##(2008-10#13)(2008-5#3)(2013-8#1)
virulent field strains##2##3##(2013-8#2)
virulent form##2##2##(2007-8#1)(2008-4#1)
virulent genotypes##2##2##(2008-10#2)
virulent in the##2##3##(2006-10#1)(2013-8#1)
virulent in##3##2##(2006-10#1)(2010-12#1)(2013-8#1)
virulent isolate##6##2##(2008-10#6)
virulent isolates alone##2##3##(2008-10#2)
virulent isolates of##2##3##(2008-10#2)
virulent isolates produced##2##3##(2008-10#2)
virulent isolates##18##2##(2008-10#18)
virulent on all##2##3##(2008-10#2)
virulent on##16##2##(2008-10#16)
virulent only on##2##3##(2008-10#2)
virulent pathogens##3##2##(2008-4#1)(2008-9#1)(2011-1#1)
virulent phages##2##2##(2011-12#1)(2012-1#1)
virulent plant##2##2##(2008-9#2)
virulent populations of##2##3##(2008-10#2)
virulent populations##6##2##(2008-10#6)
virulent strain of##3##3##(2008-10#2)(2008-5#1)
virulent strain##7##2##(1993-12#1)(1995-8#1)(2005-9#1)(2008-10#2)(2008-5#1)(2008-8#1)
virulent strains of the##4##4##(2008-10#3)(2008-4#1)
virulent strains of##6##3##(2005-8#1)(2008-10#4)(2008-4#1)
virulent strains##13##2##(1991-3#1)(2005-8#1)(2008-1#1)(2008-10#6)(2008-4#1)(2013-8#3)
virulent than the##5##3##(2008-10#2)(2008-5#3)
virulent than##15##2##(2008-10#10)(2008-5#3)(2013-1#1)(2013-8#1)
virulent to all##2##3##(2008-10#2)
virulent to avirulent##2##3##(2008-10#1)(2008-5#1)
virulent to##22##2##(2007-12#1)(2008-10#20)(2008-5#1)
virulent virus##4##2##(2008-10#3)(2008-8#1)
virulent wild-type##2##2##(2008-10#2)
virulent##257##1##(1990-11#2)(1991-3#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-5#2)(1995-12#1)(1995-2#1)(1995-7#1)(1995-8#1)(1996-12#2)(1996-2#1)(1997-6#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-6#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#152)(2008-12#1)(2008-4#3)(2008-5#23)(2008-8#2)(2008-9#7)(2009-6#1)(2009-9#2)(2010-12#4)(2011-1#1)(2011-12#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#28)
virulent/avirulent phenotypes##2##2##(2008-10#2)
viruliferous aphids##4##2##(2008-10#4)
viruliferous insects##2##2##(2008-10#2)
viruliferous mites##2##2##(2008-10#2)
viruliferous whiteflies##4##2##(2008-10#4)
viruliferous##20##1##(2008-10#20)
viruria##3##1##(2007-8#1)(2011-2#2)
virus (AAV)##4##2##(1994-6#1)(2005-7#1)(2008-8#1)(2011-3#1)
virus (BTV)##3##2##(1997-4#1)(2010-4#1)(2011-2#1)
virus (BVDV)##2##2##(1994-4#1)(2012-3#1)
virus (CAV)##9##2##(2005-9#1)(2007-6#1)(2008-5#6)(2013-8#1)
virus (DENV)##2##2##(2011-1#1)(2012-2#1)
virus (EBV) is##4##3##(1997-7#1)(2007-2#2)(2011-2#1)
virus (EBV)##29##2##(1990-5#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-2#1)(1997-3#1)(1997-7#1)(2005-8#1)(2006-8#1)(2007-11#2)(2007-2#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#3)(2009-12#1)(2010-6#1)(2011-2#1)
virus (EMCV)##3##2##(1990-2#1)(1997-8#1)(2007-2#1)
virus (HBV) and##5##3##(1993-7#1)(2008-1#1)(2008-10#1)(2013-1#1)(2013-8#1)
virus (HBV)##67##2##(1990-8#1)(1991-11#1)(1991-3#1)(1991-9#1)(1993-7#1)(1993-8#1)(1995-2#1)(1996-4#1)(1997-4#2)(1997-6#2)(2005-7#1)(2005-8#1)(2006-10#2)(2007-11#2)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#4)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#5)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#8)(2013-8#3)
virus (HCV) has##2##3##(2006-2#1)(2009-5#1)
virus (HCV) was used to test##2##6##(1990-3#1)(1991-9#1)
virus (HCV) was##3##3##(1990-3#1)(1991-9#1)(1995-1#1)
virus (HCV)##75##2##(1990-3#1)(1991-9#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-5#1)(2005-6#1)(2005-7#1)(2006-10#4)(2006-2#4)(2007-11#4)(2007-2#1)(2007-3#1)(2007-7#6)(2008-1#6)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-12#2)(2010-4#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#9)(2013-8#1)
virus (HDV)##3##2##(1991-9#1)(1992-5#1)(2009-8#1)
virus (HIV) and##6##3##(1992-2#1)(2007-2#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-12#1)
virus (HIV)##101##2##(1990-11#1)(1990-3#1)(1990-6#3)(1990-9#2)(1991-2#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-12#2)(1992-2#2)(1992-5#1)(1992-6#1)(1993-12#2)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1995-1#2)(1995-12#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-4#4)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-8#1)(2007-10#1)(2007-11#7)(2007-12#1)(2007-2#3)(2007-7#5)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#3)(2008-5#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
virus (HIV-1) DNA##2##3##(1990-11#1)(1994-12#1)
virus (HIV-1)##9##2##(1990-11#1)(1992-5#1)(1992-9#1)(1994-12#1)(2008-3#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-1#1)
virus (HPV)##8##2##(1991-2#2)(1996-12#1)(2008-10#1)(2008-3#1)(2009-12#1)(2010-7#1)(2011-2#1)
virus (IBV)##13##2##(1997-3#1)(1997-6#2)(2008-5#9)(2013-8#1)
virus (MDV)##24##2##(2005-9#1)(2007-6#1)(2008-5#2)(2013-8#20)
virus (MSV)##4##2##(1997-6#1)(2008-10#3)
virus (MV)##3##2##(1997-4#1)(1997-6#1)(2012-2#1)
virus (NDV)##10##2##(1997-6#1)(2007-6#1)(2008-11#1)(2008-5#4)(2008-9#1)(2013-8#2)
virus (PDV)##2##2##(2008-10#1)(2008-5#1)
virus (PHV)##4##2##(2008-10#2)(2008-5#2)
virus (PRV)##3##2##(1993-7#1)(1995-7#1)(2009-2#1)
virus (RSV)##15##2##(1992-10#1)(1993-12#1)(1996-3#1)(1997-8#1)(2005-8#1)(2007-11#1)(2008-11#1)(2009-8#2)(2010-10#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
virus (S-OIV)##2##2##(2011-1#2)
virus (SIV)##9##2##(1992-12#1)(1992-6#1)(1995-2#2)(1995-8#1)(1997-3#1)(1997-6#1)(2007-11#1)(2011-2#1)
virus (SPMV)##2##2##(2008-10#2)
virus (TTV)##2##2##(2006-2#1)(2008-10#1)
virus (VSV)##7##2##(1990-2#1)(1993-12#1)(1994-9#1)(1995-8#1)(2008-11#1)(2008-4#2)
virus (VZV)##9##2##(1996-12#1)(2007-11#1)(2007-2#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-1#1)(2011-1#1)(2013-8#1)
virus (WSMV)##4##2##(2008-10#4)
virus (strain)##4##2##(2008-10#4)
virus -##5##2##(2007-12#2)(2007-5#1)(2007-8#2)
virus 1 and##2##3##(1994-8#1)(2012-3#1)
virus 1##11##2##(1994-8#3)(2008-10#3)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
virus 2##4##2##(1993-2#1)(1997-4#1)(2008-10#1)(2011-1#1)
virus 40 DNA##3##3##(1990-12#1)(1994-8#1)(1997-1#1)
virus 40 T##2##3##(1995-6#2)
virus 40 T-antigen##2##3##(1996-5#1)(2008-11#1)
virus 40##20##2##(1990-12#1)(1990-6#1)(1993-4#1)(1994-3#1)(1994-6#2)(1994-8#3)(1995-2#1)(1995-6#2)(1996-5#1)(1997-1#1)(1997-7#1)(1997-8#1)(2008-11#2)(2011-2#1)(2013-1#1)
virus A##8##2##(2007-1#1)(2008-10#6)(2010-5#1)
virus B##6##2##(1991-6#1)(2008-10#1)(2008-12#1)(2008-4#2)(2013-8#1)
virus C##8##2##(1996-10#3)(2005-12#1)(2006-2#1)(2008-10#2)(2008-8#1)
virus D9964 strain##3##3##(2013-8#3)
virus D9964##4##2##(2013-8#4)
virus DNA polymerase##5##3##(1990-9#1)(1993-8#1)(1995-2#3)
virus DNA##15##2##(1990-8#1)(1990-9#2)(1993-8#1)(1994-11#1)(1995-2#3)(1997-1#1)(1997-4#1)(2005-10#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)
virus Helper##2##2##(2008-10#2)
virus Infecting##2##2##(2008-10#2)
virus Infection##2##2##(2008-10#2)
virus Is a Distinct##2##4##(2008-10#2)
virus Is##4##2##(2008-10#4)
virus Isolates##3##2##(2008-10#3)
virus M##3##2##(2005-11#2)(2008-10#1)
virus RNA##15##2##(1990-2#2)(1992-9#2)(1993-2#1)(1994-3#1)(1994-8#2)(1997-6#1)(2006-10#1)(2008-10#3)(2011-2#1)(2013-8#1)
virus Resistance in##3##3##(2008-10#3)
virus Resistance##5##2##(2008-10#5)
virus SH strain##2##3##(2005-11#2)
virus X (PVX) in##2##4##(1995-2#1)(2008-10#1)
virus X (PVX)##9##3##(1995-2#2)(1997-3#1)(2008-10#6)
virus X##15##2##(1995-2#2)(1996-8#1)(1997-3#1)(2005-8#1)(2008-10#8)(2010-9#1)(2012-12#1)
virus Y (PVY)##2##3##(2008-10#2)
virus Y##11##2##(2008-10#10)(2012-3#1)
virus a##3##2##(1994-12#1)(1997-6#1)(2008-10#1)
virus accumulated##3##2##(1997-1#1)(2008-10#2)
virus accumulation and##2##3##(2008-10#2)
virus accumulation in inoculated##2##4##(2008-10#2)
virus accumulation in##4##3##(2008-10#4)
virus accumulation##19##2##(2008-10#19)
virus acquisition##2##2##(2008-10#2)
virus activity in various##2##4##(1995-3#1)(1997-6#1)
virus activity in##3##3##(1995-3#1)(1997-6#1)(2007-8#1)
virus activity##7##2##(1995-3#1)(1996-2#3)(1997-6#1)(2007-8#1)(2008-8#1)
virus affects##3##2##(1997-6#1)(2007-1#1)(2007-2#1)
virus after##3##2##(1995-5#1)(1997-5#1)(2007-2#1)
virus alone##5##2##(2008-10#5)
virus also##3##2##(1990-4#1)(1993-11#1)(2008-10#1)
virus among##9##2##(1990-10#1)(1990-8#2)(2006-1#1)(2007-7#1)(2008-5#1)(2008-7#1)(2009-2#1)(2011-3#1)
virus amongst##2##2##(2005-7#1)(2007-7#1)
virus and Bean common mosaic##2##5##(2008-10#2)
virus and Pepper##2##3##(2008-10#2)
virus and Tomato##3##3##(2008-10#2)(2011-2#1)
virus and a##2##3##(1997-6#1)(2006-2#1)
virus and cellular##2##3##(1994-8#1)(1997-3#1)
virus and cytomegalovirus##2##3##(2006-10#1)(2011-12#1)
virus and hepatitis##3##3##(1997-6#1)(2007-7#1)(2010-12#1)
virus and host##3##3##(1995-3#1)(2008-10#1)(2009-2#1)
virus and human immunodeficiency virus##2##5##(1990-8#1)(2007-7#1)
virus and is##3##3##(1994-8#1)(2008-10#1)(2011-1#1)
virus and its##4##3##(2006-10#1)(2012-2#1)(2013-1#2)
virus and may##2##3##(2008-10#1)(2012-2#1)
virus and of##3##3##(1991-2#1)(2008-10#2)
virus and one##2##3##(1997-5#1)(2013-1#1)
virus and potato virus##2##4##(2008-10#2)
virus and the extent of##2##5##(1997-3#1)(2013-8#1)
virus and the##12##3##(1990-5#1)(1994-6#1)(1996-11#1)(1996-4#1)(1997-3#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-8#2)(2009-9#1)(2013-8#1)
virus and their##2##3##(2008-10#1)(2010-7#1)
virus and##145##2##(1990-11#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-12#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#2)(1995-1#1)(1995-3#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-1#2)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#1)(2006-10#4)(2006-2#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#3)(2008-10#47)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#7)(2008-7#1)(2008-8#4)(2009-2#1)(2009-9#3)(2010-12#1)(2010-4#1)(2010-7#2)(2011-1#6)(2011-12#1)(2011-2#2)(2011-3#1)(2012-12#4)(2012-2#5)(2013-1#4)(2013-7#1)(2013-8#2)
virus antibodies in##6##3##(1990-3#1)(1992-8#1)(1994-7#2)(1997-3#1)(2008-1#1)
virus antibodies##11##2##(1990-3#1)(1992-8#1)(1994-7#3)(1997-2#1)(1997-3#1)(2006-10#1)(2008-1#1)(2008-5#1)(2013-8#1)
virus antibody in##2##3##(2006-12#1)(2010-4#1)
virus antibody##7##2##(1991-9#1)(1994-7#1)(2006-12#1)(2007-2#1)(2007-7#1)(2010-12#1)(2010-4#1)
virus antigen##3##2##(1994-3#1)(1996-2#1)(2008-10#1)
virus antigens##3##2##(2006-10#1)(2008-11#1)(2008-5#1)
virus are available##2##3##(2008-4#1)(2008-9#1)
virus are provided##2##3##(2008-4#1)(2008-9#1)
virus are##14##2##(1994-2#1)(1997-2#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-4#2)(2008-9#3)(2010-1#1)(2013-1#1)
virus as a##7##3##(1990-11#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-8#2)
virus as##14##2##(1990-11#1)(1990-2#1)(2008-10#5)(2008-11#2)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#2)
virus assembly##4##2##(1995-2#1)(2013-1#3)
virus associated with##3##3##(1991-8#1)(2008-10#2)
virus associated##4##2##(1991-8#1)(2007-7#1)(2008-10#2)
virus at a##2##3##(2008-10#1)(2012-1#1)
virus at the##2##3##(2008-10#1)(2013-8#1)
virus at##11##2##(1997-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2010-4#1)(2012-1#1)(2013-8#1)
virus attachment##2##2##(1996-5#1)(2008-10#1)
virus based on##2##3##(2008-10#2)
virus based##3##2##(1990-12#1)(2008-10#2)
virus between##2##2##(2008-12#1)(2012-3#1)
virus binding##4##2##(1993-12#1)(2008-11#3)
virus bound to##2##3##(1993-9#1)(2006-2#1)
virus budding##6##2##(1997-1#3)(1997-3#1)(2011-1#1)(2013-1#1)
virus by reverse##2##3##(2004-11#1)(2012-2#1)
virus by the##2##3##(2008-10#2)
virus by##21##2##(1990-11#1)(1996-2#1)(1996-3#1)(1997-6#1)(2004-11#2)(2008-10#9)(2008-5#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
virus can be##2##3##(2007-2#1)(2008-10#1)
virus can##7##2##(1994-11#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-5#1)(2010-4#1)
virus capsid protein##2##3##(2008-10#1)(2009-7#1)
virus capsid##4##2##(2008-10#1)(2008-7#2)(2009-7#1)
virus caused##3##2##(2008-10#2)(2010-12#1)
virus challenge##5##2##(1992-6#3)(2005-11#1)(2013-1#1)
virus clone##3##2##(1995-2#3)
virus coat protein gene##2##4##(2008-10#2)
virus coat protein##5##3##(1990-5#1)(1992-9#1)(2008-10#2)(2011-2#1)
virus coat##6##2##(1990-5#1)(1992-9#1)(2008-10#3)(2011-2#1)
virus coinfection##2##2##(2008-10#1)(2013-1#1)
virus compared##2##2##(1995-2#1)(2012-2#1)
virus complex##3##2##(1994-8#1)(2008-10#2)
virus complexes##2##2##(2008-10#2)
virus concentration##2##2##(2008-10#2)
virus concentrations##2##2##(1997-4#1)(2008-10#1)
virus containing the##4##3##(1991-9#2)(1996-4#1)(1997-8#1)
virus containing##6##2##(1990-11#2)(1991-9#2)(1996-4#1)(1997-8#1)
virus contaminated##2##2##(2008-11#1)(2008-5#1)
virus contamination in##3##3##(1994-7#1)(2008-2#1)(2008-4#1)
virus contamination##5##2##(1990-11#1)(1994-7#2)(2008-2#1)(2008-4#1)
virus content##4##2##(2008-10#3)(2008-5#1)
virus core antigen##3##3##(1995-1#1)(1996-12#1)(2013-1#1)
virus core##5##2##(1994-7#1)(1995-1#1)(1996-12#1)(2008-8#1)(2013-1#1)
virus could be detected##2##4##(2008-10#1)(2013-8#1)
virus could be isolated##2##4##(2008-5#2)
virus could be##7##3##(2008-10#3)(2008-5#3)(2013-8#1)
virus could##10##2##(1991-5#1)(2008-10#5)(2008-5#3)(2013-8#1)
virus cultures##2##2##(1994-8#1)(2008-5#1)
virus decreased##2##2##(1990-11#1)(1990-5#1)
virus density##2##2##(2008-9#2)
virus derived from infectious##2##4##(2008-10#2)
virus derived from##8##3##(2008-10#7)(2013-8#1)
virus derived##9##2##(2008-10#7)(2012-2#1)(2013-8#1)
virus detection##6##2##(2004-11#1)(2006-2#1)(2008-10#2)(2008-4#1)(2008-9#1)
virus developed##2##2##(1995-8#1)(2004-11#1)
virus did not##4##3##(1991-3#1)(1992-10#1)(2008-10#1)(2013-8#1)
virus disease##8##2##(1995-2#1)(2005-12#1)(2006-10#1)(2008-10#5)
virus diseases##4##2##(1994-3#1)(1996-12#1)(2007-11#1)(2007-12#1)
virus displayed##2##2##(1996-4#1)(2008-10#1)
virus does not##5##3##(1992-6#1)(2006-10#1)(2008-10#1)(2008-8#1)(2009-2#1)
virus encoded##2##2##(2007-3#1)(2008-10#1)
virus entry##3##2##(1994-6#1)(2011-2#1)(2013-8#1)
virus envelope protein##3##3##(1995-8#1)(2009-7#1)(2011-1#1)
virus envelope##4##2##(1995-8#1)(2005-12#1)(2009-7#1)(2011-1#1)
virus evolution##3##2##(2011-2#1)(2013-8#2)
virus excretion##4##2##(1993-12#1)(2005-11#1)(2008-5#1)(2011-2#1)
virus exhibited##2##2##(1993-8#1)(2010-12#1)
virus exit process##3##3##(1997-1#3)
virus exposure##2##2##(1997-4#2)
virus expressing##5##2##(1991-7#1)(2007-2#1)(2008-10#2)(2008-7#1)
virus expression##4##2##(1992-7#1)(2008-2#2)(2008-4#1)
virus families have##2##3##(1997-6#1)(2013-1#1)
virus families##4##2##(1997-6#1)(2008-10#1)(2013-1#2)
virus family##2##2##(2009-11#1)(2009-7#1)
virus following##4##2##(1995-12#1)(2006-10#1)(2008-5#1)(2012-3#1)
virus for##12##2##(1993-2#1)(2005-11#1)(2007-9#1)(2008-10#6)(2008-4#2)(2010-12#1)
virus from a##2##3##(1992-11#1)(2008-10#1)
virus from the##4##3##(2008-10#2)(2011-1#1)(2013-8#1)
virus from##39##2##(1990-11#2)(1992-11#2)(1992-8#1)(1993-6#1)(1995-8#1)(1996-11#1)(1997-6#1)(2005-7#1)(2006-7#1)(2007-2#1)(2007-6#1)(2008-10#17)(2008-4#3)(2008-9#1)(2009-5#1)(2011-1#1)(2013-8#3)
virus fusion##3##2##(2007-6#1)(2008-1#1)(2009-9#1)
virus gene expression##2##3##(1990-6#1)(2007-11#1)
virus gene##6##2##(1990-6#1)(1991-9#1)(1997-3#1)(2007-11#1)(2008-9#1)(2013-8#1)
virus genome by##2##3##(1996-4#1)(2008-11#1)
virus genome##9##2##(1991-12#1)(1991-7#1)(1994-8#2)(1996-4#1)(2007-3#1)(2008-10#2)(2008-11#1)
virus genomes##4##2##(1997-3#1)(2008-4#1)(2008-9#1)(2013-8#1)
virus genotype##4##2##(2009-3#1)(2009-5#1)(2013-1#1)(2013-7#1)
virus genotypes##4##2##(2007-2#1)(2008-12#1)(2008-3#1)(2013-1#1)
virus genotyping##2##2##(2007-12#1)(2007-2#1)
virus glycoprotein##5##2##(1991-2#1)(1995-2#2)(1997-4#1)(2011-2#1)
virus grown in##3##3##(1990-5#1)(2008-5#1)(2013-8#1)
virus growth##2##2##(1994-8#1)(2013-8#1)
virus had not##2##3##(2005-11#2)
virus had##6##2##(1995-9#1)(2004-9#1)(2005-11#2)(2008-10#2)
virus has a##3##3##(2008-10#2)(2008-2#1)
virus has been##9##3##(1996-7#1)(2005-7#1)(2006-10#3)(2008-8#1)(2009-2#1)(2011-1#1)(2013-8#1)
virus has not##4##3##(1990-11#1)(2004-9#1)(2006-11#1)(2007-2#1)
virus has the##2##3##(1992-6#1)(2007-11#1)
virus has##24##2##(1990-11#1)(1992-6#1)(1996-7#1)(2004-9#1)(2005-7#1)(2006-10#3)(2006-11#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-2#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
virus hemagglutinin##4##2##(1990-2#1)(1993-6#1)(1995-6#1)(2011-1#1)
virus illness##2##2##(1993-1#1)(2009-10#1)
virus in Canada##2##3##(2010-9#1)(2012-2#1)
virus in China##2##3##(2008-9#1)(2010-1#1)
virus in Malaysia##2##3##(2005-12#1)(2011-1#1)
virus in Transgenic##2##3##(2008-10#2)
virus in a##11##3##(1993-6#1)(1995-5#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-5#1)(2012-3#1)
virus in both##2##3##(2007-11#1)(2008-3#1)
virus in chickens##3##3##(1997-6#1)(2008-5#1)(2013-8#1)
virus in different##3##3##(2007-2#1)(2010-12#1)(2013-8#1)
virus in laboratory##2##3##(2011-2#1)(2013-8#1)
virus in patients##2##3##(1993-2#1)(2008-10#1)
virus in serum##3##3##(2008-3#1)(2008-8#2)
virus in soybean##2##3##(2008-10#1)(2012-11#1)
virus in the pathogenesis##2##4##(2008-1#1)(2008-5#1)
virus in the##20##3##(1990-3#1)(1990-9#1)(1991-2#1)(1995-5#1)(1997-4#2)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-5#2)(2010-12#2)(2010-6#1)(2012-2#2)(2012-3#1)
virus in two##2##3##(2007-4#1)(2010-1#1)
virus in vitro##2##3##(1992-6#1)(1996-2#1)
virus in##168##2##(1990-11#1)(1990-3#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-6#1)(1993-12#1)(1993-2#3)(1993-6#1)(1993-7#1)(1993-9#1)(1994-3#1)(1995-12#2)(1995-5#2)(1995-8#1)(1996-2#3)(1997-3#2)(1997-4#2)(1997-6#4)(2004-11#1)(2005-11#5)(2005-12#1)(2005-6#1)(2006-10#2)(2006-2#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#47)(2008-11#4)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#11)(2008-8#2)(2008-9#3)(2009-3#1)(2009-4#2)(2009-5#2)(2009-9#1)(2010-1#2)(2010-12#4)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#5)(2011-2#1)(2012-11#2)(2012-2#3)(2012-3#5)(2013-1#3)(2013-8#7)
virus incidence##4##2##(2008-10#3)(2012-1#1)
virus induced##5##2##(1994-9#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-2#1)
virus infected##6##2##(1990-10#1)(1997-5#1)(2005-12#1)(2008-11#1)(2008-12#1)(2008-5#1)
virus infection after##2##3##(2006-10#1)(2007-11#1)
virus infection among##2##3##(2010-6#1)(2013-1#1)
virus infection and##11##3##(1993-7#1)(1997-6#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-2#1)(2013-1#2)
virus infection can##2##3##(2006-10#1)(2012-11#1)
virus infection has been##2##4##(1994-11#1)(2007-2#1)
virus infection in children##2##4##(2006-10#1)(2008-4#1)
virus infection in the##4##4##(2005-10#1)(2009-2#2)(2012-1#1)
virus infection in##26##3##(1991-2#1)(1991-3#1)(1993-6#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-6#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-9#1)(2007-12#1)(2007-2#2)(2008-10#1)(2008-11#1)(2008-4#1)(2009-11#1)(2009-2#3)(2011-2#1)(2012-1#2)(2012-12#1)
virus infection is##6##3##(2008-1#1)(2008-11#1)(2008-6#1)(2008-9#1)(2012-3#1)(2013-1#1)
virus infection may##3##3##(1995-1#1)(2006-10#1)(2008-10#1)
virus infection of the##2##4##(1997-4#1)(2008-10#1)
virus infection of##5##3##(1993-2#1)(1993-5#1)(1997-4#1)(2008-10#1)(2012-3#1)
virus infection on##4##3##(1997-6#1)(2007-7#1)(2009-2#1)(2012-3#1)
virus infection was##6##3##(2006-10#1)(2008-10#2)(2008-5#1)(2009-2#1)(2011-2#1)
virus infection who##5##3##(1997-7#1)(2006-10#1)(2010-2#1)(2013-1#2)
virus infection with##3##3##(2006-10#1)(2007-7#1)(2011-1#1)
virus infection##184##2##(1990-12#1)(1991-1#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-8#1)(1991-9#1)(1993-10#1)(1993-2#3)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#3)(1994-11#1)(1994-4#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-4#2)(1996-5#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#2)(2005-10#3)(2005-7#1)(2006-1#1)(2006-10#14)(2006-2#6)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#3)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#12)(2008-11#3)(2008-12#2)(2008-4#5)(2008-5#5)(2008-6#1)(2008-8#4)(2008-9#7)(2009-11#4)(2009-12#1)(2009-2#5)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-6#2)(2011-1#6)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#8)(2012-3#7)(2013-1#9)(2013-8#1)
virus infection]##10##2##(1990-6#1)(1991-6#1)(1992-2#1)(1993-2#1)(1993-5#1)(1996-11#1)(2006-4#1)(2009-2#1)(2013-1#1)(2013-7#1)
virus infections are##2##3##(1992-6#1)(2007-8#1)
virus infections in##2##3##(2006-10#1)(2008-7#1)
virus infections##24##2##(1990-6#1)(1990-9#1)(1992-6#1)(1996-9#1)(2005-7#1)(2006-10#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
virus infectious##2##2##(2006-8#1)(2012-1#1)
virus ingestion##2##2##(2008-10#2)
virus inoculum##4##2##(2005-9#1)(2008-11#3)
virus into the##5##3##(1992-3#1)(1992-8#1)(1993-6#1)(1997-2#1)(2008-4#1)
virus into##6##2##(1992-3#1)(1992-8#1)(1993-6#1)(1997-2#1)(2008-10#1)(2008-4#1)
virus is a##5##3##(2007-2#1)(2008-10#1)(2008-4#2)(2010-12#1)
virus is endemic in##2##4##(2007-2#1)(2008-1#1)
virus is highly##3##3##(1992-8#1)(2012-2#1)(2013-8#1)
virus is most##2##3##(2008-10#2)
virus is not##4##3##(1995-7#1)(2008-10#1)(2008-2#1)(2013-8#1)
virus is proposed##4##3##(2008-10#4)
virus is the##3##3##(2008-9#1)(2011-1#1)(2011-2#1)
virus is transmitted##4##3##(1992-2#1)(2007-2#2)(2008-10#1)
virus is##60##2##(1992-2#1)(1992-8#1)(1993-11#1)(1994-12#1)(1994-8#1)(1995-5#1)(1995-7#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-4#1)(2006-10#4)(2007-12#2)(2007-2#5)(2007-7#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-9#2)(2009-7#3)(2009-9#1)(2010-12#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#4)
virus isolate from##3##3##(1997-6#1)(2008-10#1)(2008-8#1)
virus isolate##9##2##(1997-6#1)(2007-6#3)(2008-10#3)(2008-8#1)(2008-9#1)
virus isolated from##7##3##(1992-10#1)(2008-5#3)(2008-8#1)(2008-9#1)(2012-2#1)
virus isolated in##2##3##(2005-9#1)(2008-5#1)
virus isolated##9##2##(1992-10#1)(2005-9#1)(2008-5#4)(2008-8#1)(2008-9#1)(2012-2#1)
virus isolates from##4##3##(2007-3#3)(2012-3#1)
virus isolates were##3##3##(2005-9#3)
virus isolates##17##2##(1990-9#1)(1995-5#1)(1997-6#1)(2005-9#3)(2007-3#3)(2008-10#4)(2008-8#1)(2011-1#1)(2012-3#1)(2013-8#1)
virus isolation and##5##3##(1993-12#1)(2008-4#1)(2008-5#2)(2013-8#1)
virus isolation was##2##3##(2012-3#1)(2013-1#1)
virus isolation##15##2##(1993-12#3)(1997-3#1)(2008-4#1)(2008-5#4)(2012-3#2)(2013-1#1)(2013-8#3)
virus isolations##2##2##(1992-6#1)(1997-6#1)
virus large##2##2##(1992-5#1)(2013-8#1)
virus latency##2##2##(2006-10#1)(2013-8#1)
virus levels##2##2##(2012-3#1)(2013-8#1)
virus life##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
virus long terminal repeat##7##4##(1990-12#2)(1992-8#2)(1995-6#2)(2013-8#1)
virus may##5##2##(2007-10#1)(2008-10#2)(2008-11#1)(2008-8#1)
virus models##2##2##(1994-11#2)
virus morphogenesis##3##2##(2012-2#1)(2013-1#1)(2013-8#1)
virus most##2##2##(1991-5#1)(2008-10#1)
virus movement##7##2##(2008-10#6)(2008-9#1)
virus multiplication##2##2##(2008-10#1)(2008-9#1)
virus mutants##2##2##(1994-8#1)(1995-7#1)
virus near##2##2##(1996-11#1)(2013-8#1)
virus neutralization (VN)##3##3##(1997-3#1)(2008-5#2)
virus neutralization test##2##3##(1997-6#1)(2008-12#1)
virus neutralization##9##2##(1992-6#4)(1997-3#1)(1997-6#1)(2008-12#1)(2008-5#2)
virus of Central/East African genotype##5##5##(2011-1#5)
virus of##20##2##(1991-12#1)(1991-6#1)(1993-5#2)(1995-2#1)(1996-4#1)(2005-9#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-8#1)(2011-1#7)(2012-1#1)
virus on mortality during the first##2##6##(2011-2#2)
virus on the##2##3##(1991-5#1)(1994-11#1)
virus on##6##2##(1991-5#1)(1993-10#1)(1994-11#1)(2008-12#1)(2011-2#2)
virus only##2##2##(1997-6#1)(2012-3#1)
virus or the##2##3##(2008-10#1)(2009-7#1)
virus or##18##2##(1991-8#1)(1992-2#1)(1993-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-4#1)(1997-3#1)(2005-12#1)(2006-10#1)(2007-11#1)(2008-10#3)(2009-2#1)(2009-7#1)(2011-2#1)
virus particle##4##2##(1997-3#1)(2008-10#1)(2011-2#1)(2011-3#1)
virus particles by##2##3##(1996-3#1)(1997-3#1)
virus particles were##7##3##(1994-8#1)(1995-8#1)(2008-10#5)
virus particles##27##2##(1990-2#1)(1990-5#1)(1991-5#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-3#1)(1996-4#1)(1997-3#3)(1997-4#3)(2008-10#13)
virus passage##2##2##(1994-10#1)(2008-11#1)
virus penetration##2##2##(2007-11#1)(2008-10#1)
virus per##3##2##(2008-10#2)(2008-12#1)
virus plus##2##2##(1990-5#1)(1991-2#1)
virus population##5##2##(1996-4#1)(2007-6#1)(2008-10#3)
virus populations##3##2##(2008-10#2)(2011-2#1)
virus positive##2##2##(2005-11#1)(2008-3#1)
virus preparations##4##2##(1992-12#1)(1997-3#1)(2008-10#2)
virus previously##2##2##(2008-10#1)(2012-2#1)
virus produced##3##2##(1992-6#1)(1997-3#1)(2006-10#1)
virus produces##4##2##(1994-11#1)(2006-10#1)(2012-12#1)(2012-2#1)
virus production in##4##3##(1992-9#1)(2007-11#1)(2008-11#2)
virus production##10##2##(1992-9#1)(2007-11#1)(2008-11#8)
virus progeny##2##2##(2008-10#1)(2008-4#1)
virus promoter##2##2##(2006-12#2)
virus protein##3##2##(1990-8#1)(1994-11#1)(1994-3#1)
virus proteins were##2##3##(2005-12#2)
virus proteins##6##2##(1990-2#1)(1996-4#1)(1997-6#1)(2005-12#3)
virus reactivation##4##2##(2006-10#4)
virus receptor##2##2##(1990-2#1)(1994-11#1)
virus recovered from##2##3##(2008-10#2)
virus related to##2##3##(1990-3#1)(2008-10#1)
virus related##3##2##(1990-3#1)(2007-11#1)(2008-10#1)
virus replication and##5##3##(1994-11#1)(2008-10#2)(2008-9#1)(2009-6#1)
virus replication by##3##3##(1995-2#1)(1997-4#1)(2013-7#1)
virus replication in the##2##4##(2007-6#1)(2010-7#1)
virus replication in##5##3##(2007-6#1)(2007-8#1)(2009-10#1)(2010-7#1)(2013-8#1)
virus replication was##4##3##(1997-3#1)(1997-6#1)(2008-10#2)
virus replication##39##2##(1990-12#1)(1992-12#1)(1994-11#5)(1995-2#3)(1996-4#2)(1996-5#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-6#1)(2007-8#1)(2008-10#7)(2008-5#3)(2008-9#2)(2009-10#1)(2009-6#1)(2010-7#1)(2011-1#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
virus research##2##2##(2007-6#1)(2008-9#1)
virus resistance genes##3##3##(2008-10#3)
virus resistance in wheat##2##4##(2008-10#2)
virus resistance in##4##3##(2008-10#4)
virus resistance##13##2##(2008-10#11)(2008-2#1)(2008-5#1)
virus responsible for##2##3##(1990-11#1)(2007-11#1)
virus results in##2##3##(1992-12#1)(2013-8#1)
virus retention##2##2##(2012-3#2)
virus reverse transcriptase##4##3##(1992-9#1)(1995-1#1)(1995-3#1)(1997-6#1)
virus sequences##2##2##(1996-2#1)(2008-10#1)
virus seropositivity##2##2##(1991-5#1)(2013-7#1)
virus serotype##6##2##(2008-10#1)(2008-5#3)(2013-8#2)
virus serotypes##6##2##(2005-12#3)(2008-1#1)(2008-10#1)(2013-8#1)
virus shedding##6##2##(1995-5#2)(2005-9#2)(2013-8#2)
virus should be##2##3##(2007-2#1)(2009-8#1)
virus source##2##2##(2008-10#2)
virus species in##2##3##(2008-10#2)
virus species##4##2##(2008-10#4)
virus spread##7##2##(1992-9#1)(2008-10#5)(2012-1#1)
virus status##2##2##(2007-12#1)(2008-10#1)
virus stocks##3##2##(2008-4#2)(2008-9#1)
virus strain##17##2##(1993-9#1)(1997-6#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-5#5)(2008-8#1)(2008-9#1)
virus strains from##2##3##(1993-3#1)(2009-2#1)
virus strains isolated in##2##4##(2008-5#1)(2012-2#1)
virus strains##15##2##(1993-3#1)(1994-6#1)(1997-6#1)(2005-9#1)(2008-10#5)(2008-5#1)(2009-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
virus structure##3##2##(2008-10#3)
virus surface##14##2##(1991-9#5)(1994-11#2)(1997-3#1)(1997-4#1)(1997-6#1)(2008-8#3)(2011-2#1)
virus system##3##2##(2007-11#1)(2008-9#2)
virus testing##3##2##(2007-12#1)(2013-1#2)
virus than##5##2##(1990-6#1)(1992-5#1)(2004-11#1)(2007-2#1)(2008-9#1)
virus that has##3##3##(2008-4#2)(2008-7#1)
virus that is##2##3##(2006-2#1)(2008-8#1)
virus that##16##2##(1991-5#1)(1994-3#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#2)(2008-8#1)(2009-8#1)(2010-10#1)(2011-3#1)(2013-8#2)
virus through##4##2##(1997-7#1)(2007-11#1)(2008-10#2)
virus throughout##2##2##(2007-12#1)(2009-2#1)
virus thymidine kinase##4##3##(1991-7#1)(1996-5#1)(2005-6#1)(2007-3#1)
virus titer##8##2##(1994-8#2)(2007-12#1)(2008-10#2)(2008-11#3)
virus titers by##3##3##(2008-11#2)(2013-8#1)
virus titers in##2##3##(2008-10#1)(2011-2#1)
virus titers##9##2##(2008-10#1)(2008-11#4)(2008-4#1)(2011-2#1)(2013-8#2)
virus titration experiment##4##3##(1992-6#4)
virus titration##6##2##(1992-6#5)(2007-6#1)
virus titres##2##2##(1997-6#1)(2008-5#1)
virus to##21##2##(1992-5#1)(1994-6#1)(1994-9#1)(1996-2#1)(1997-1#1)(2004-11#1)(2005-8#1)(2006-7#1)(2007-2#1)(2007-6#1)(2008-10#6)(2008-5#2)(2008-8#1)(2011-3#1)(2013-8#1)
virus transformed##5##2##(1991-9#1)(1994-3#2)(2007-2#1)(2008-5#1)
virus transmission in##2##3##(2008-10#1)(2008-9#1)
virus transmission was##2##3##(2008-10#2)
virus transmission##24##2##(1991-5#1)(1992-2#1)(1995-6#1)(2004-11#1)(2008-10#12)(2008-12#1)(2008-3#2)(2008-5#2)(2008-9#1)(2012-2#1)(2013-1#1)
virus transmitted##2##2##(2012-11#1)(2012-2#1)
virus type 1 and##3##4##(1991-2#1)(1992-9#1)(1997-3#1)
virus type 1 in##6##4##(1992-6#1)(1993-6#1)(1994-2#1)(1994-5#1)(2007-6#1)(2008-12#1)
virus type 1##98##3##(1990-2#1)(1990-5#1)(1991-1#1)(1991-10#1)(1991-2#4)(1991-3#2)(1991-9#2)(1992-11#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#3)(1994-8#3)(1994-9#1)(1995-1#5)(1995-2#1)(1995-3#3)(1995-5#1)(1995-7#2)(1995-8#3)(1996-1#1)(1996-10#2)(1996-11#1)(1996-4#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#5)(1997-3#1)(1997-6#1)(1997-7#2)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#7)(2008-4#1)(2008-9#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-2#1)
virus type 2##9##3##(1991-9#2)(1992-6#1)(2006-10#1)(2008-4#1)(2009-1#1)(2010-12#1)(2012-3#1)(2013-1#1)
virus type I (HTLV-I)##4##4##(1991-12#1)(1996-5#1)(2007-11#1)(2007-9#1)
virus type I##13##3##(1991-11#1)(1991-12#2)(1993-12#2)(1993-3#1)(1995-3#1)(1996-5#2)(2007-11#1)(2007-9#1)(2008-11#1)(2012-12#1)
virus type##126##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#3)(1991-9#4)(1992-11#2)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#3)(1994-8#3)(1994-9#1)(1995-1#5)(1995-2#1)(1995-3#4)(1995-5#1)(1995-7#2)(1995-8#3)(1996-1#1)(1996-10#2)(1996-11#1)(1996-4#1)(1996-5#2)(1996-7#2)(1996-8#2)(1997-1#1)(1997-2#5)(1997-3#1)(1997-6#1)(1997-7#2)(2006-10#2)(2006-4#1)(2007-11#2)(2007-12#2)(2007-6#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#2)(2008-2#7)(2008-4#2)(2008-9#1)(2009-1#1)(2010-12#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
virus type-1 DNA##4##3##(1990-2#1)(1990-7#1)(1996-8#2)
virus type-1##22##2##(1990-2#1)(1990-7#2)(1992-2#2)(1993-12#1)(1994-11#1)(1994-9#1)(1995-3#2)(1996-8#3)(1997-3#1)(1997-4#1)(2007-6#1)(2007-7#1)(2008-3#1)(2009-11#1)(2009-12#1)(2012-12#1)(2013-1#1)
virus types##6##2##(1991-12#1)(1991-9#1)(1993-12#1)(1995-5#1)(2004-11#1)(2007-2#1)
virus using##6##2##(2007-7#1)(2008-10#2)(2008-5#1)(2010-7#1)(2012-11#1)
virus vaccine and##3##3##(2005-11#1)(2007-10#1)(2008-9#1)
virus vaccine candidate##2##3##(2008-11#2)
virus vaccine for##3##3##(2007-10#1)(2007-11#2)
virus vaccine##21##2##(1992-12#1)(1995-8#1)(1995-9#2)(1997-6#1)(2004-1#1)(2005-11#1)(2007-10#3)(2007-11#3)(2007-2#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)
virus vaccines are##2##3##(2008-11#1)(2011-1#1)
virus vaccines for##3##3##(1992-2#1)(1997-2#1)(2008-5#1)
virus vaccines##14##2##(1992-2#1)(1994-2#1)(1995-5#2)(1997-2#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-11#2)(2008-5#1)(2011-1#1)(2011-2#1)
virus variant##2##2##(1993-8#1)(2007-12#1)
virus vector##7##2##(1992-12#1)(1996-12#1)(1996-8#1)(2007-11#1)(2008-8#1)(2008-9#1)(2012-2#1)
virus vectors in##2##3##(1995-12#1)(2008-8#1)
virus vectors##10##2##(1992-12#1)(1995-12#1)(2005-7#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2012-3#1)
virus viability##2##2##(1997-3#1)(2008-10#1)
virus was acquired##3##3##(2008-10#3)
virus was also##3##3##(1992-3#1)(2008-10#2)
virus was amplified##3##3##(1995-8#1)(2005-11#1)(2011-1#1)
virus was demonstrated##3##3##(1995-5#1)(2010-12#1)(2012-3#1)
virus was detected in##3##4##(2008-10#2)(2008-8#1)
virus was detected##4##3##(2008-10#3)(2008-8#1)
virus was evaluated##2##3##(2008-10#1)(2012-3#1)
virus was identified as an##2##5##(2007-2#1)(2008-11#1)
virus was identified as##3##4##(2007-2#1)(2008-1#1)(2008-11#1)
virus was identified##4##3##(2007-2#1)(2008-1#1)(2008-11#1)(2011-2#1)
virus was injected##4##3##(1992-8#1)(1996-4#1)(1997-2#1)(2007-1#1)
virus was isolated from##6##4##(2007-2#1)(2008-10#4)(2008-5#1)
virus was isolated##8##3##(2007-2#1)(2008-10#4)(2008-5#2)(2008-7#1)
virus was not##2##3##(2010-12#1)(2013-8#1)
virus was observed##2##3##(2008-10#1)(2012-3#1)
virus was obtained##2##3##(1997-6#1)(2005-9#1)
virus was readily transmitted##2##4##(2008-10#2)
virus was transmitted##5##3##(2008-10#5)
virus was used to infect##2##5##(1991-1#1)(1997-1#1)
virus was used to##3##4##(1991-1#1)(1995-8#1)(1997-1#1)
virus was used##4##3##(1991-1#1)(1995-8#1)(1997-1#1)(2008-10#1)
virus was whitefly-transmissible##2##3##(2008-10#2)
virus was##96##2##(1990-2#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-5#1)(1994-3#1)(1995-5#1)(1995-8#2)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#4)(2004-11#1)(2005-11#1)(2005-9#3)(2007-1#1)(2007-11#1)(2007-2#2)(2007-6#1)(2008-1#1)(2008-10#40)(2008-11#1)(2008-5#5)(2008-7#1)(2008-8#2)(2010-12#3)(2011-1#1)(2011-2#1)(2012-3#5)(2013-8#4)
virus were##14##2##(1990-11#1)(1992-10#1)(1992-8#1)(1997-3#1)(2004-11#1)(2005-9#1)(2006-10#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-3#1)(2012-3#1)(2013-8#2)
virus when##2##2##(2008-10#1)(2013-8#1)
virus which is##2##3##(1993-12#1)(2008-12#1)
virus which##5##2##(1993-12#1)(1996-6#1)(2006-10#1)(2008-12#1)(2008-8#1)
virus with a##3##3##(2008-10#1)(2008-12#1)(2008-6#1)
virus with the##3##3##(1990-11#1)(2010-2#1)(2012-11#1)
virus with##26##2##(1990-11#1)(1990-5#1)(1991-5#1)(1991-9#1)(2006-10#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-2#1)(2011-12#1)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#2)
virus within##3##2##(2008-5#3)
virus yields##3##2##(2007-11#1)(2008-11#2)
virus##4187##1##(1990-10#2)(1990-11#25)(1990-12#6)(1990-2#13)(1990-3#8)(1990-4#3)(1990-5#23)(1990-6#9)(1990-7#5)(1990-8#7)(1990-9#8)(1991-1#5)(1991-10#1)(1991-11#6)(1991-12#12)(1991-2#16)(1991-3#11)(1991-5#20)(1991-6#11)(1991-7#10)(1991-8#9)(1991-9#26)(1992-10#9)(1992-11#12)(1992-12#22)(1992-2#12)(1992-3#6)(1992-5#12)(1992-6#26)(1992-7#1)(1992-8#16)(1992-9#13)(1993-1#2)(1993-10#2)(1993-11#7)(1993-12#24)(1993-2#11)(1993-3#5)(1993-4#2)(1993-5#9)(1993-6#13)(1993-7#11)(1993-8#12)(1993-9#13)(1994-10#5)(1994-11#22)(1994-12#6)(1994-2#8)(1994-3#17)(1994-4#2)(1994-5#4)(1994-6#19)(1994-7#9)(1994-8#37)(1994-9#15)(1995-1#14)(1995-12#11)(1995-2#39)(1995-3#10)(1995-5#21)(1995-6#8)(1995-7#5)(1995-8#25)(1995-9#5)(1996-1#3)(1996-10#7)(1996-11#13)(1996-12#9)(1996-2#15)(1996-3#6)(1996-4#28)(1996-5#13)(1996-6#2)(1996-7#3)(1996-8#9)(1996-9#2)(1997-1#26)(1997-2#17)(1997-3#45)(1997-4#41)(1997-5#5)(1997-6#71)(1997-7#10)(1997-8#8)(2004-1#1)(2004-11#17)(2004-2#1)(2004-9#2)(2005-10#15)(2005-11#31)(2005-12#13)(2005-6#3)(2005-7#13)(2005-8#8)(2005-9#21)(2006-1#5)(2006-10#75)(2006-11#3)(2006-12#6)(2006-2#26)(2006-4#4)(2006-5#1)(2006-7#3)(2006-8#8)(2006-9#1)(2007-1#6)(2007-10#9)(2007-11#64)(2007-12#43)(2007-2#56)(2007-3#10)(2007-4#2)(2007-5#2)(2007-6#28)(2007-7#34)(2007-8#12)(2007-9#2)(2008-1#31)(2008-10#1093)(2008-11#109)(2008-12#37)(2008-2#18)(2008-3#19)(2008-4#71)(2008-5#159)(2008-6#5)(2008-7#22)(2008-8#82)(2008-9#84)(2009-1#2)(2009-10#6)(2009-11#14)(2009-12#11)(2009-2#19)(2009-3#4)(2009-4#10)(2009-5#11)(2009-6#5)(2009-7#12)(2009-8#22)(2009-9#15)(2010-1#10)(2010-10#4)(2010-11#1)(2010-12#37)(2010-2#8)(2010-3#1)(2010-4#17)(2010-5#2)(2010-6#6)(2010-7#7)(2010-8#3)(2010-9#3)(2011-1#69)(2011-12#8)(2011-2#72)(2011-3#13)(2012-1#16)(2012-11#17)(2012-12#50)(2012-2#64)(2012-3#61)(2013-1#91)(2013-7#11)(2013-8#139)
virus) and##2##2##(1992-12#1)(2008-4#1)
virus)##20##1##(1991-3#1)(1992-12#1)(1992-3#1)(1992-9#1)(1994-8#1)(1995-2#1)(1996-3#1)(1997-1#1)(1997-6#1)(2007-6#1)(2008-10#4)(2008-11#1)(2008-4#1)(2009-11#1)(2009-9#1)(2010-3#1)(2011-2#1)
virus-1 and##2##2##(2007-7#1)(2008-10#1)
virus-1##22##1##(1990-11#2)(1991-9#2)(1992-12#1)(1992-8#1)(1994-11#1)(1994-5#1)(1995-3#1)(2007-11#2)(2007-2#1)(2007-6#1)(2007-7#1)(2008-10#5)(2008-11#1)(2012-1#1)(2013-1#1)
virus-2##4##1##(2008-10#4)
virus-B2##2##1##(2008-9#2)
virus-associated hemophagocytic syndrome##3##3##(2007-2#1)(2009-6#2)
virus-associated##16##1##(1990-2#3)(2005-10#2)(2006-10#3)(2007-2#1)(2007-8#1)(2008-12#1)(2009-6#2)(2011-2#2)(2012-12#1)
virus-based##5##1##(1995-2#1)(1997-8#1)(2008-7#2)(2009-3#1)
virus-binding##2##1##(2008-10#2)
virus-containing##2##1##(1993-3#1)(2008-10#1)
virus-derived##5##1##(1995-2#1)(1997-4#1)(2008-10#1)(2008-9#2)
virus-encoded proteins##2##2##(2008-8#1)(2009-2#1)
virus-encoded##6##1##(1994-9#1)(2008-8#1)(2009-2#1)(2009-7#1)(2013-1#1)(2013-8#1)
virus-free counterparts##2##2##(2008-10#2)
virus-free fungal##2##2##(2008-10#2)
virus-free##15##1##(1993-3#1)(2008-10#11)(2008-11#2)(2008-4#1)
virus-host interactions##4##2##(2007-6#1)(2010-1#1)(2011-1#1)(2012-12#1)
virus-host protein interactions##2##3##(2013-8#2)
virus-host##8##1##(1991-1#1)(2007-6#1)(2010-1#1)(2011-1#1)(2012-12#1)(2013-8#3)
virus-induced##14##1##(1990-12#1)(1990-5#1)(1990-6#1)(1991-8#1)(1993-2#1)(1993-3#1)(1997-6#1)(2008-10#4)(2012-11#1)(2012-12#1)(2012-2#1)
virus-infected and##2##2##(1992-8#1)(2009-2#1)
virus-infected cell##2##2##(1990-3#1)(2005-12#1)
virus-infected cells with##2##3##(1994-11#1)(2008-4#1)
virus-infected cells##12##2##(1990-3#2)(1992-8#1)(1994-11#1)(1995-1#1)(1995-2#1)(1997-3#1)(2008-11#2)(2008-4#2)(2009-11#1)
virus-infected isolates##2##2##(2008-10#2)
virus-infected lettuce##2##2##(2008-10#2)
virus-infected plants##5##2##(2008-10#3)(2008-9#2)
virus-infected target cells##2##3##(1992-8#1)(1997-4#1)
virus-infected##39##1##(1990-3#3)(1992-8#3)(1994-10#1)(1994-11#1)(1995-1#2)(1995-2#2)(1997-3#1)(1997-4#2)(2004-11#1)(2005-12#1)(2007-12#1)(2008-10#10)(2008-11#3)(2008-4#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)
virus-like particles (VLP)##2##3##(2008-10#2)
virus-like particles (VLPs)##4##3##(1996-2#1)(2006-12#1)(2008-10#1)(2008-3#1)
virus-like particles##13##2##(1991-12#1)(1995-5#1)(1996-2#1)(1997-4#2)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#4)(2008-3#1)
virus-like##17##1##(1991-12#1)(1995-5#1)(1996-2#1)(1997-4#2)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#7)(2008-3#1)(2010-12#1)
virus-long terminal##3##2##(1993-12#2)(1996-5#1)
virus-mediated##3##1##(2006-10#1)(2008-8#1)(2008-9#1)
virus-neutralizing##2##1##(2008-5#1)(2010-12#1)
virus-producing cells##2##2##(1996-4#2)
virus-related hepatocellular carcinoma##2##3##(2013-8#2)
virus-related##6##1##(2006-7#1)(2007-11#1)(2007-12#1)(2011-2#1)(2013-8#2)
virus-resistant plants##2##2##(2008-10#2)
virus-resistant##6##1##(2008-10#6)
virus-retention region of##2##3##(2008-10#2)
virus-specific B cells##2##3##(1996-11#2)
virus-specific B##3##2##(1996-11#3)
virus-specific##23##1##(1991-12#1)(1992-8#1)(1996-11#5)(2005-11#1)(2007-11#1)(2008-10#10)(2008-5#2)(2010-5#2)
virus-transformed cells##2##2##(1990-7#1)(1991-1#1)
virus-transformed human##2##2##(1994-9#1)(1996-5#1)
virus-transformed##9##1##(1990-7#1)(1991-1#1)(1992-11#1)(1994-9#1)(1995-8#2)(1996-5#1)(2008-11#1)(2013-8#1)
virus-virus interactions##3##2##(1997-3#1)(2008-10#2)
virus]##16##1##(1990-3#1)(1991-6#1)(1992-10#1)(1992-11#1)(1993-10#1)(1994-4#1)(1996-6#1)(1996-9#1)(2004-9#1)(2007-11#1)(2010-12#1)(2010-4#2)(2012-3#1)(2013-7#1)(2013-8#1)
viruses (AIVs)##2##2##(2008-5#1)(2013-8#1)
viruses and a##3##3##(1995-2#1)(2008-10#1)(2013-8#1)
viruses and bacteria##2##3##(1991-12#1)(2008-1#1)
viruses and cells##2##3##(2010-7#1)(2012-2#1)
viruses and even##2##3##(1995-12#1)(2008-4#1)
viruses and other##4##3##(1993-3#1)(2007-11#2)(2010-12#1)
viruses and the##3##3##(2007-10#1)(2008-11#2)
viruses and viral##2##3##(1995-2#1)(2008-11#1)
viruses and##48##2##(1990-10#1)(1990-11#1)(1990-2#1)(1991-12#1)(1992-12#1)(1993-3#1)(1994-4#1)(1995-12#1)(1995-2#3)(1997-2#1)(2004-11#2)(2006-10#1)(2006-11#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-9#2)(2010-12#2)(2010-4#2)(2010-7#2)(2012-2#1)(2013-8#2)
viruses are currently##2##3##(2008-1#1)(2013-8#1)
viruses are##25##2##(1992-2#2)(1994-7#1)(1996-4#1)(1997-4#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#3)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
viruses as##5##2##(1990-2#1)(2005-8#1)(2007-2#1)(2008-10#1)(2008-11#1)
viruses belonging to the##3##4##(2008-10#1)(2008-9#1)(2013-8#1)
viruses but##3##2##(1990-5#1)(1996-8#1)(2008-10#1)
viruses by multiplex##2##3##(2008-10#2)
viruses by##7##2##(2008-10#5)(2008-5#1)(2013-1#1)
viruses can##5##2##(2006-10#1)(2007-11#1)(2008-10#1)(2010-1#1)(2013-8#1)
viruses carrying##2##2##(1990-11#1)(2008-10#1)
viruses causing##3##2##(1997-6#1)(2008-10#1)(2013-8#1)
viruses contain##2##2##(1992-5#1)(2008-10#1)
viruses containing##2##2##(1994-12#2)
viruses could be##2##3##(1990-2#1)(2005-8#1)
viruses could##3##2##(1990-2#1)(2005-8#1)(2008-10#1)
viruses depend on##2##3##(2008-10#1)(2008-9#1)
viruses displayed##2##2##(1995-2#1)(2008-10#1)
viruses during##2##2##(1996-6#1)(2006-10#1)
viruses exhibit increased##2##3##(1991-1#1)(2009-9#1)
viruses for the##2##3##(1995-2#1)(2013-8#1)
viruses for which##2##3##(2005-8#1)(2008-10#1)
viruses for##7##2##(1995-2#1)(1997-1#1)(2005-8#1)(2008-10#1)(2008-4#1)(2008-9#1)(2013-8#1)
viruses from a##2##3##(2008-10#1)(2008-5#1)
viruses from infected##2##3##(2007-12#1)(2007-9#1)
viruses from the##3##3##(2006-2#1)(2008-10#2)
viruses from##19##2##(1990-11#1)(1997-3#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-6#1)(2007-9#2)(2008-10#4)(2008-5#1)(2008-9#1)(2011-2#2)(2013-1#1)
viruses had##6##2##(1991-9#1)(2012-3#1)(2013-8#4)
viruses has been##4##3##(1994-9#1)(1997-6#1)(2006-10#1)(2008-7#1)
viruses has##6##2##(1994-9#1)(1997-6#1)(2006-10#1)(2008-7#1)(2013-1#2)
viruses have been##5##3##(1997-2#1)(1997-6#1)(2008-8#1)(2011-3#1)(2012-2#1)
viruses have##7##2##(1997-2#1)(1997-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-3#1)(2012-2#1)
viruses in a##5##3##(2008-10#1)(2008-9#1)(2010-7#1)(2011-2#1)(2013-1#1)
viruses in both##2##3##(1997-8#1)(2013-1#1)
viruses in humans##3##3##(2011-2#2)(2013-1#1)
viruses in layer##2##3##(2013-1#1)(2013-8#1)
viruses in marine##2##3##(2006-3#1)(2008-9#1)
viruses in patients##3##3##(2007-7#1)(2013-1#2)
viruses in the plant##2##4##(2008-10#2)
viruses in the##16##3##(1997-4#1)(1997-6#1)(2006-10#1)(2008-10#11)(2008-5#1)(2013-1#1)
viruses in various##2##3##(2008-10#1)(2008-6#1)
viruses in vitro##2##3##(1994-8#1)(2009-10#1)
viruses in vivo##2##3##(2007-11#1)(2013-1#1)
viruses in##80##2##(1990-12#1)(1991-5#1)(1994-8#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#23)(2008-11#1)(2008-5#3)(2008-6#1)(2008-9#3)(2009-10#1)(2009-5#2)(2010-1#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#12)(2013-8#5)
viruses including##2##2##(2013-1#1)(2013-8#1)
viruses infect##2##2##(2008-10#2)
viruses infecting##3##2##(2006-10#1)(2008-10#1)(2013-1#1)
viruses is##12##2##(1992-8#1)(1994-9#1)(1995-2#2)(1996-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-5#1)(2012-2#1)(2013-8#1)
viruses isolated from##5##3##(1997-3#1)(2007-6#1)(2008-10#2)(2011-1#1)
viruses isolated in##3##3##(1992-6#1)(2008-4#1)(2009-5#1)
viruses isolated##11##2##(1992-6#1)(1997-3#1)(2005-9#2)(2007-6#1)(2008-10#2)(2008-4#1)(2009-5#1)(2011-1#1)(2011-2#1)
viruses may##4##2##(1991-5#1)(1995-12#1)(2007-7#2)
viruses must##2##2##(1994-6#1)(2008-10#1)
viruses of the##9##3##(1992-9#3)(2006-10#3)(2008-4#1)(2011-1#1)(2011-2#1)
viruses of this##2##3##(2008-10#1)(2012-12#1)
viruses of##23##2##(1992-9#3)(1995-9#1)(2005-9#1)(2006-10#3)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#2)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#2)
viruses on##2##2##(2009-6#2)
viruses or virus strains##3##4##(2008-10#3)
viruses or##8##2##(1995-2#1)(1996-11#1)(1996-9#1)(2008-10#4)(2012-11#1)
viruses predominated during##2##3##(1994-9#1)(1996-6#1)
viruses responsible##2##2##(1997-6#1)(2010-4#1)
viruses share##2##2##(2008-10#1)(2011-2#1)
viruses should##2##2##(1994-8#1)(1996-2#1)
viruses showed##3##2##(2008-10#2)(2013-8#1)
viruses simultaneously##2##2##(2008-10#2)
viruses such as##3##3##(1997-4#1)(2011-3#2)
viruses tested##4##2##(1997-1#2)(2008-5#1)(2013-1#1)
viruses that cause barley yellow dwarf disease##2##7##(2008-10#2)
viruses that cause##7##3##(1995-6#1)(2008-10#5)(2013-8#1)
viruses that##18##2##(1994-8#1)(1995-6#1)(1995-9#1)(1997-6#1)(2008-1#1)(2008-10#7)(2008-5#1)(2009-2#1)(2011-1#2)(2012-12#1)(2013-8#1)
viruses there##2##2##(1997-6#1)(2008-11#1)
viruses to##9##2##(1995-12#1)(2008-1#1)(2008-10#2)(2009-12#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-8#1)
viruses transmitted by##2##3##(2008-10#1)(2012-2#1)
viruses using quartz crystal##2##4##(2008-10#1)(2009-6#1)
viruses was observed##3##3##(1996-6#2)(2008-10#1)
viruses was##14##2##(1996-6#2)(2007-11#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
viruses were found##2##3##(2008-11#1)(2011-1#1)
viruses were identified##2##3##(1992-12#1)(2013-1#1)
viruses were isolated from##3##4##(2008-5#1)(2011-2#1)(2013-8#1)
viruses were isolated##4##3##(2008-5#1)(2011-2#1)(2013-8#2)
viruses were mechanically##2##3##(2008-10#2)
viruses were most##3##3##(1996-6#1)(2008-10#2)
viruses were##39##2##(1990-11#1)(1991-6#1)(1992-12#1)(1996-6#2)(1997-4#1)(2005-7#1)(2007-12#3)(2008-10#13)(2008-11#3)(2008-5#2)(2009-6#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#6)
viruses with##4##2##(1994-6#1)(2006-10#1)(2007-6#1)(2009-5#1)
viruses within the##2##3##(2008-10#2)
viruses within##3##2##(2008-10#3)
viruses##807##1##(1990-10#2)(1990-11#5)(1990-12#1)(1990-2#6)(1990-5#1)(1991-1#2)(1991-12#2)(1991-5#2)(1991-6#1)(1991-9#2)(1992-12#4)(1992-2#4)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#4)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#1)(1994-4#3)(1994-6#4)(1994-7#1)(1994-8#8)(1994-9#5)(1995-12#5)(1995-2#14)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#2)(1995-9#4)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#2)(1996-5#1)(1996-6#8)(1996-8#2)(1996-9#5)(1997-1#7)(1997-2#5)(1997-3#5)(1997-4#6)(1997-6#13)(1997-8#1)(2004-11#2)(2005-10#2)(2005-11#2)(2005-7#4)(2005-8#7)(2005-9#9)(2006-10#20)(2006-11#1)(2006-12#2)(2006-2#3)(2006-3#1)(2006-5#1)(2006-6#2)(2006-7#2)(2007-10#4)(2007-11#19)(2007-12#10)(2007-2#4)(2007-3#1)(2007-6#11)(2007-7#5)(2007-8#1)(2007-9#6)(2008-1#6)(2008-10#190)(2008-11#25)(2008-2#1)(2008-3#1)(2008-4#15)(2008-5#24)(2008-6#4)(2008-7#12)(2008-8#2)(2008-9#33)(2009-10#1)(2009-12#7)(2009-2#4)(2009-3#1)(2009-5#4)(2009-6#6)(2009-7#2)(2009-8#3)(2009-9#6)(2010-1#5)(2010-10#1)(2010-12#4)(2010-4#9)(2010-5#2)(2010-7#6)(2011-1#11)(2011-2#21)(2011-3#4)(2012-11#1)(2012-12#5)(2012-2#13)(2012-3#3)(2013-1#40)(2013-8#50)
viruses)##5##1##(1996-6#1)(2008-4#1)(2008-9#1)(2011-2#1)(2013-8#1)
viruses]##7##1##(2007-9#2)(2010-1#1)(2010-10#1)(2010-4#1)(2013-8#2)
vis a vis the##2##4##(2007-12#1)(2009-12#1)
vis a vis##4##3##(1992-6#1)(2007-12#1)(2008-8#1)(2009-12#1)
vis##10##1##(1992-6#2)(2004-10#1)(2007-11#1)(2007-12#2)(2008-8#2)(2009-12#2)
vis-a-vis##7##1##(1991-12#1)(1992-8#1)(1993-4#1)(1995-12#1)(1997-2#1)(1997-3#1)(2008-5#1)
vis-à-vis the##2##2##(1990-5#1)(2008-1#1)
vis-à-vis##8##1##(1990-5#1)(2008-1#1)(2008-10#2)(2010-2#1)(2010-8#1)(2011-12#1)(2012-2#1)
visas##3##1##(1992-1#1)(2007-4#1)(2007-8#1)
viscera and##3##2##(2008-1#1)(2008-6#1)(2010-12#1)
viscera##22##1##(1990-2#1)(1990-5#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-2#1)(1993-10#1)(1994-8#1)(2006-9#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-6#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
visceral Trichobilharzia species##2##3##(2006-8#2)
visceral adipose tissue in##2##4##(2008-5#2)
visceral adipose tissue##5##3##(2008-3#2)(2008-5#3)
visceral adiposity and##3##3##(1995-12#1)(2008-1#2)
visceral adiposity##5##2##(1995-12#1)(2006-1#1)(2008-1#2)(2009-3#1)
visceral afferent##4##2##(1992-2#1)(1992-6#1)(1993-11#1)(2013-8#1)
visceral afferents##3##2##(1991-9#1)(2008-4#2)
visceral and somatic##2##3##(2006-10#1)(2008-5#1)
visceral and subcutaneous##2##3##(2008-1#1)(2010-4#1)
visceral and the##2##3##(2007-8#1)(2008-1#1)
visceral and##14##2##(1991-8#1)(1995-1#1)(1997-4#1)(2006-10#1)(2006-6#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-5#3)(2010-4#1)
visceral anomalies##2##2##(1997-1#1)(2009-3#1)
visceral arteries##2##2##(2006-6#1)(2011-2#1)
visceral cells##3##2##(2012-1#3)
visceral disease##4##2##(1995-1#1)(2006-10#1)(2008-7#1)(2013-7#1)
visceral endoderm##3##2##(2008-1#1)(2012-12#2)
visceral fat accumulation and##3##4##(2006-6#1)(2008-3#2)
visceral fat accumulation##9##3##(2006-6#1)(2008-1#3)(2008-3#4)(2008-4#1)
visceral fat area (VFA)##3##4##(2008-3#3)
visceral fat area##4##3##(2008-3#4)
visceral fat to##4##3##(2008-3#1)(2012-11#1)(2012-2#2)
visceral fat##29##2##(2005-10#1)(2006-6#1)(2008-1#6)(2008-11#3)(2008-3#10)(2008-4#1)(2010-4#1)(2010-6#1)(2012-11#1)(2012-2#4)
visceral hypersensitivity and##2##3##(2006-10#1)(2008-5#1)
visceral hypersensitivity##8##2##(2006-10#3)(2006-2#1)(2008-5#3)(2010-12#1)
visceral information##2##2##(1992-2#1)(1992-6#1)
visceral involvement##7##2##(1997-8#1)(2007-10#1)(2010-11#1)(2012-2#2)(2013-1#1)(2013-7#1)
visceral larva migrans##4##3##(2010-12#1)(2011-2#1)(2012-2#2)
visceral leishmaniasis in##9##3##(2004-11#2)(2005-8#1)(2007-12#2)(2008-4#1)(2008-7#1)(2008-8#1)(2012-2#1)
visceral leishmaniasis is##3##3##(2006-10#2)(2007-12#1)
visceral leishmaniasis##42##2##(1990-7#2)(1990-9#1)(1992-2#1)(1996-12#1)(2004-11#3)(2005-8#3)(2005-9#1)(2006-10#7)(2007-12#5)(2007-7#2)(2008-12#2)(2008-4#1)(2008-7#6)(2008-8#2)(2010-12#1)(2012-12#2)(2012-2#1)(2013-1#1)
visceral lesions##3##2##(1992-10#1)(1992-6#1)(1997-6#1)
visceral location##2##2##(2007-8#1)(2012-2#1)
visceral malignancies##3##2##(2008-7#1)(2010-8#2)
visceral manifestations of##2##3##(1990-2#1)(1992-11#1)
visceral metastases##4##2##(1996-6#1)(2012-2#1)(2013-7#2)
visceral obesity was##2##3##(2013-8#2)
visceral obesity##21##2##(2005-10#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-12#1)(2012-11#1)(2013-1#1)(2013-8#13)
visceral organs##5##2##(1990-10#1)(1996-11#1)(2008-5#1)(2011-2#1)(2013-8#1)
visceral pain##5##2##(1997-3#1)(2006-10#2)(2006-11#1)(2008-5#1)
visceral pleural invasion##5##3##(2007-8#5)
visceral pleural##6##2##(1991-12#1)(2007-8#5)
visceral sensory##2##2##(1993-12#1)(2008-4#1)
visceral stimuli##4##2##(1991-8#3)(1991-9#1)
visceral stimulus##3##2##(1991-9#1)(1992-2#1)(1992-7#1)
visceral yolk sac##3##3##(1995-1#2)(2012-1#1)
visceral##266##1##(1990-10#4)(1990-2#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-8#6)(1991-9#3)(1992-10#1)(1992-11#2)(1992-2#5)(1992-6#4)(1992-7#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-5#1)(1995-1#4)(1995-11#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(2004-11#3)(2005-10#4)(2005-12#1)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#16)(2006-11#2)(2006-12#1)(2006-2#1)(2006-6#3)(2006-8#4)(2006-9#1)(2007-10#1)(2007-12#8)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#10)(2007-9#1)(2008-1#12)(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#16)(2008-4#6)(2008-5#15)(2008-7#10)(2008-8#5)(2008-9#1)(2009-2#1)(2009-3#2)(2009-7#1)(2010-11#2)(2010-12#4)(2010-4#4)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#4)(2012-1#4)(2012-11#2)(2012-12#5)(2012-2#14)(2013-1#4)(2013-7#5)(2013-8#17)
viscero-somatic##2##1##(1996-5#1)(2005-8#1)
viscerum inversus totalis##3##3##(2007-3#1)(2012-12#2)
viscid##2##1##(1996-2#1)(2012-2#1)
visco-supplementation##3##1##(2006-10#3)
viscoelastic and##2##2##(2007-12#1)(2009-12#1)
viscoelastic behavior of##2##3##(2007-1#1)(2009-7#1)
viscoelastic behavior##5##2##(2007-1#1)(2007-4#1)(2009-7#2)(2012-1#1)
viscoelastic behaviour##2##2##(2008-5#1)(2008-7#1)
viscoelastic constitutive model##2##3##(2006-11#2)
viscoelastic constitutive##5##2##(2006-11#3)(2007-4#1)(2009-4#1)
viscoelastic material##2##2##(2006-11#2)
viscoelastic parameters##2##2##(2008-2#1)(2009-9#1)
viscoelastic properties of##6##3##(1994-9#1)(2005-11#1)(2008-3#1)(2009-9#1)(2012-2#1)(2013-1#1)
viscoelastic properties##13##2##(1994-9#2)(2005-11#3)(2007-4#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-9#1)(2012-11#1)(2012-2#1)(2013-1#1)
viscoelastic solid for##2##3##(2006-11#1)(2007-4#1)
viscoelastic solid##3##2##(2006-11#1)(2007-4#1)(2012-2#1)
viscoelastic##58##1##(1991-7#1)(1994-9#2)(2005-11#8)(2006-11#7)(2006-7#1)(2007-1#2)(2007-12#2)(2007-4#4)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#6)(2008-7#1)(2008-9#1)(2009-12#1)(2009-4#3)(2009-7#4)(2009-9#2)(2010-7#1)(2012-1#1)(2012-11#1)(2012-2#4)(2013-1#1)
viscoelasticity of the##2##3##(2008-10#1)(2010-4#1)
viscoelasticity of##3##2##(2007-11#1)(2008-10#1)(2010-4#1)
viscoelasticity##11##1##(1992-11#1)(2005-11#2)(2007-11#1)(2008-10#2)(2008-5#2)(2009-11#1)(2009-4#1)(2010-4#1)
viscometric studies##2##2##(1991-12#1)(2005-11#1)
viscometric##4##1##(1991-12#1)(1992-3#1)(2005-11#1)(2007-11#1)
viscometry##4##1##(1992-11#1)(1997-1#1)(1997-6#1)(2005-11#1)
viscosa leaves##2##2##(2008-10#2)
viscosa##14##1##(2007-1#1)(2008-10#9)(2010-12#3)(2010-2#1)
viscosities and##2##2##(2008-5#1)(2008-7#1)
viscosities of##2##2##(2008-5#1)(2010-2#1)
viscosities##12##1##(2007-6#1)(2008-10#3)(2008-5#5)(2008-6#1)(2008-7#1)(2010-2#1)
viscosity and density of##2##4##(2008-10#2)
viscosity and density##5##3##(2008-10#5)
viscosity and physical stability##2##4##(2008-5#2)
viscosity and systolic##2##3##(2007-1#2)
viscosity and the##3##3##(2008-10#1)(2008-5#1)(2010-1#1)
viscosity and water content##2##4##(2008-5#2)
viscosity and##37##2##(1991-1#1)(1991-12#1)(1991-9#1)(1992-12#1)(1995-3#1)(1996-9#1)(1997-6#1)(2005-11#1)(2007-1#4)(2008-1#1)(2008-10#7)(2008-3#1)(2008-5#9)(2008-6#1)(2008-7#1)(2010-1#1)(2010-2#1)(2011-2#1)(2011-3#1)(2012-2#1)
viscosity as##2##2##(2010-9#1)(2012-1#1)
viscosity associated with##2##3##(2005-9#1)(2007-10#1)
viscosity at##2##2##(2008-5#1)(2010-9#1)
viscosity effects##3##2##(2005-11#2)(2008-10#1)
viscosity has##2##2##(1991-12#1)(2009-4#1)
viscosity in the##5##3##(1991-12#1)(1994-8#2)(2005-11#1)(2011-2#1)
viscosity in##7##2##(1991-12#1)(1994-8#3)(2005-11#2)(2011-2#1)
viscosity measurements##3##2##(1991-7#1)(1996-1#1)(2008-5#1)
viscosity of shampoo##4##3##(2008-5#4)
viscosity of the continuous phase##2##5##(2005-11#1)(2012-11#1)
viscosity of the liquid##3##4##(2005-11#1)(2008-2#1)(2008-3#1)
viscosity of the##23##3##(1990-2#1)(1991-7#2)(2005-11#3)(2006-6#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-7#1)(2010-1#1)(2012-11#1)(2013-1#1)(2013-8#1)
viscosity of##46##2##(1990-2#1)(1991-7#2)(1992-3#1)(1994-11#3)(2004-1#1)(2005-11#4)(2005-4#1)(2006-12#1)(2006-6#1)(2008-1#1)(2008-10#7)(2008-2#2)(2008-3#1)(2008-5#8)(2008-6#2)(2008-7#1)(2008-8#1)(2009-7#1)(2010-1#2)(2012-11#1)(2013-1#2)(2013-8#2)
viscosity on the##2##3##(2008-10#1)(2009-10#1)
viscosity on##6##2##(1991-7#2)(2005-11#1)(2006-12#1)(2008-10#1)(2009-10#1)
viscosity ratios##4##2##(2005-11#4)
viscosity reduction##2##2##(2008-10#1)(2013-1#1)
viscosity was##4##2##(1992-12#1)(2004-12#1)(2007-1#1)(2008-5#1)
viscosity with##2##2##(2007-11#1)(2008-8#1)
viscosity##240##1##(1990-2#2)(1991-1#2)(1991-10#1)(1991-12#6)(1991-7#6)(1991-9#1)(1992-12#2)(1992-3#1)(1994-11#4)(1994-12#1)(1994-8#4)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-5#1)(1997-6#1)(1997-7#3)(2004-1#1)(2004-12#2)(2005-10#1)(2005-11#26)(2005-4#1)(2005-8#1)(2005-9#2)(2006-12#3)(2006-4#1)(2006-6#1)(2007-1#5)(2007-10#1)(2007-11#5)(2007-6#4)(2007-7#2)(2008-1#2)(2008-10#26)(2008-2#2)(2008-3#4)(2008-5#39)(2008-6#4)(2008-7#6)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#2)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#1)(2010-1#3)(2010-2#1)(2010-4#1)(2010-7#1)(2010-9#4)(2011-1#3)(2011-2#4)(2011-3#1)(2012-1#6)(2012-11#1)(2012-12#3)(2012-2#1)(2013-1#4)(2013-8#2)
viscosity)##3##1##(2008-5#1)(2009-8#1)(2012-1#1)
viscosity-enhancing agents##2##2##(1990-2#1)(2008-5#1)
viscosupplementation##5##1##(2006-12#1)(2007-11#1)(2013-1#3)
viscotoxin composition##2##2##(2007-1#2)
viscous criterion##2##2##(2006-11#1)(2007-4#1)
viscous liquid##2##2##(1995-3#1)(2008-12#1)
viscous triangular elements##2##3##(2008-7#2)
viscous##48##1##(1990-4#1)(1991-12#1)(1992-1#3)(1994-11#1)(1995-3#1)(1997-1#2)(2005-11#11)(2006-10#1)(2006-11#2)(2006-12#3)(2007-11#1)(2007-4#2)(2008-10#2)(2008-12#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-10#5)(2009-11#1)(2009-6#1)(2010-4#1)(2010-9#1)(2011-1#1)
viscouse##2##1##(2005-11#1)(2008-11#1)
visfatin##2##1##(2008-1#1)(2013-8#1)
visibilities##2##1##(2008-2#1)(2008-3#1)
visibility and##4##2##(1994-2#1)(1996-12#1)(2008-11#1)(2008-3#1)
visibility decrease##2##2##(2008-2#1)(2012-3#1)
visibility factor##2##2##(2007-12#2)
visibility in##2##2##(1991-4#1)(2008-2#1)
visibility is##4##2##(1994-3#1)(2007-12#2)(2008-2#1)
visibility measurements##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
visibility of the##13##3##(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(2007-11#1)(2007-7#2)(2008-2#1)(2008-3#3)(2009-11#1)(2009-6#1)
visibility of##25##2##(1994-12#1)(1994-3#2)(1995-1#1)(1995-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#3)(2008-2#2)(2008-3#5)(2009-11#1)(2009-6#1)(2010-7#1)(2012-1#1)(2012-3#1)(2013-1#1)
visibility on##2##2##(2008-2#1)(2009-10#1)
visibility to##3##2##(2007-5#1)(2008-5#1)(2013-8#1)
visibility##81##1##(1991-4#1)(1994-12#1)(1994-2#1)(1994-3#3)(1995-1#1)(1995-3#1)(1996-12#1)(2007-10#1)(2007-11#1)(2007-12#7)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#4)(2008-10#1)(2008-11#1)(2008-2#15)(2008-3#21)(2008-5#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-7#1)(2010-8#3)(2012-1#2)(2012-3#2)(2013-1#2)(2013-8#1)
visible absorbance##3##2##(1995-2#1)(2008-5#1)(2008-8#1)
visible absorption##9##2##(1992-1#1)(1993-11#1)(1994-2#1)(1995-10#1)(2006-12#1)(2006-3#1)(2007-12#1)(2008-10#1)(2010-5#1)
visible after##3##2##(1992-11#1)(2006-12#1)(2008-10#1)
visible and infrared##3##3##(2008-2#1)(2008-3#1)(2013-8#1)
visible and invisible##4##3##(1991-11#1)(2008-1#3)
visible and near infrared##3##4##(2007-12#1)(2010-4#2)
visible and near##4##3##(2007-12#1)(2008-3#1)(2010-4#2)
visible and near-IR##2##3##(2008-2#2)
visible and near-infrared channels##2##4##(2008-2#2)
visible and near-infrared##11##3##(2007-11#1)(2007-12#1)(2008-2#6)(2008-3#2)(2013-8#1)
visible and near-ultraviolet##3##3##(2007-12#1)(2008-3#2)
visible and palpable##3##3##(2005-11#1)(2012-12#2)
visible and the##13##3##(1994-3#1)(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#6)
visible and##52##2##(1991-11#1)(1992-5#1)(1994-3#1)(1995-4#1)(2005-11#1)(2007-11#2)(2007-12#5)(2008-1#3)(2008-10#2)(2008-2#14)(2008-3#12)(2008-6#1)(2010-2#1)(2010-4#2)(2012-12#3)(2013-8#2)
visible as##2##2##(1992-11#1)(2007-12#1)
visible at the##3##3##(1993-12#1)(2008-7#1)(2010-10#1)
visible at##5##2##(1993-12#1)(2008-3#1)(2008-7#1)(2010-10#1)(2012-2#1)
visible band##3##2##(2008-2#1)(2008-3#2)
visible bands##2##2##(2008-3#2)
visible by##8##2##(2007-12#3)(2008-10#3)(2008-5#1)(2008-7#1)
visible changes in##2##3##(2007-9#1)(2008-11#1)
visible changes##4##2##(2005-10#1)(2007-11#1)(2007-9#1)(2008-11#1)
visible clinical##2##2##(2008-10#1)(2008-5#1)
visible color##2##2##(2008-2#1)(2010-4#1)
visible damage##2##2##(2008-10#1)(2008-11#1)
visible detection at##2##3##(1997-3#1)(2008-10#1)
visible detection##3##2##(1992-1#1)(1997-3#1)(2008-10#1)
visible disease##2##2##(2008-10#1)(2013-1#1)
visible effect##2##2##(2007-1#1)(2008-10#1)
visible emission##2##2##(2008-3#1)(2009-2#1)
visible fluorescence##4##2##(2005-4#1)(2012-11#2)(2012-2#1)
visible fluorescent##2##2##(1990-5#1)(2008-1#1)
visible frequencies##2##2##(2007-12#2)
visible from space##2##3##(2012-2#2)
visible from##4##2##(2008-1#1)(2008-10#1)(2012-2#2)
visible in the##15##3##(1990-7#1)(1994-10#1)(1994-12#1)(2005-11#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
visible in##30##2##(1990-7#3)(1993-12#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-12#1)(1996-4#1)(2005-11#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#2)(2009-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
visible injury to hosts##2##4##(2011-12#2)
visible injury to##3##3##(2011-12#3)
visible laser beam##2##3##(2007-12#1)(2008-2#1)
visible laser light##2##3##(2008-3#2)
visible laser##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
visible light absorption##2##3##(1994-5#1)(2006-10#1)
visible light and##2##3##(2007-1#1)(2011-1#1)
visible light by##2##3##(2006-7#1)(2007-12#1)
visible light irradiation##5##3##(1993-8#2)(2009-3#2)(2013-8#1)
visible light##41##2##(1992-1#1)(1993-8#2)(1994-5#1)(1995-10#1)(1995-6#1)(1996-7#1)(2006-10#1)(2006-7#2)(2007-1#1)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#5)(2008-8#1)(2009-3#2)(2010-2#1)(2010-7#3)(2011-1#2)(2011-2#1)(2013-8#2)
visible necrosis##2##2##(2008-10#2)
visible nucleoli##2##2##(1993-12#2)
visible on the##2##3##(1992-8#1)(2008-10#1)
visible on##8##2##(1992-8#1)(1992-9#1)(2007-10#1)(2008-10#1)(2010-12#1)(2011-12#1)(2012-2#1)(2013-1#1)
visible or ultraviolet##2##3##(2007-12#1)(2008-2#1)
visible or##6##2##(1993-10#1)(1997-7#1)(2007-12#1)(2008-2#1)(2010-12#1)(2011-2#1)
visible platform##2##2##(1992-9#1)(1994-2#1)
visible pulse##2##2##(2007-12#1)(2008-1#1)
visible pulses##2##2##(2007-12#1)(2008-1#1)
visible quiescent infections##2##3##(2008-10#2)
visible radiation##2##2##(2007-12#2)
visible range##15##2##(1990-3#1)(1993-11#1)(1995-1#1)(2007-11#2)(2007-12#1)(2008-2#4)(2008-3#2)(2008-6#1)(2008-7#1)(2009-11#1)
visible reflector##2##2##(2007-12#2)
visible region of the spectrum is presented##2##7##(2007-11#1)(2008-10#1)
visible region of the spectrum##5##5##(2007-10#1)(2007-11#2)(2008-10#1)(2011-1#1)
visible region of the##7##4##(1990-3#1)(2007-10#1)(2007-11#2)(2008-10#1)(2008-2#1)(2011-1#1)
visible region##33##2##(1990-3#1)(1992-9#1)(1995-10#1)(2007-10#1)(2007-11#6)(2007-12#1)(2008-10#7)(2008-2#7)(2008-3#2)(2008-5#1)(2010-4#2)(2010-5#1)(2011-1#1)(2013-1#1)
visible regions##2##2##(2008-1#1)(2008-3#1)
visible results##3##2##(2011-2#1)(2013-1#2)
visible scar##3##2##(2012-12#3)
visible scarring##2##2##(2006-12#1)(2013-1#1)
visible solid-state##3##2##(2007-12#3)
visible spectra##2##2##(2005-4#2)
visible spectral##6##2##(2007-11#1)(2008-3#3)(2009-12#1)(2013-8#1)
visible spectrophotometric##7##2##(2005-8#1)(2008-10#5)(2010-2#1)
visible spectrophotometry##7##2##(2004-9#1)(2008-10#3)(2010-5#2)(2013-7#1)
visible spectroscopy##6##2##(1990-12#1)(2005-11#1)(2008-10#1)(2008-5#1)(2010-1#1)(2013-8#1)
visible spectrum of##3##3##(1993-3#1)(2008-10#2)
visible spectrum##15##2##(1990-3#1)(1993-3#1)(2006-7#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#4)(2009-4#1)
visible symptoms of##2##3##(2009-9#1)(2011-12#1)
visible symptoms##8##2##(2008-10#6)(2009-9#1)(2011-12#1)
visible through##2##2##(2007-12#1)(2007-9#1)
visible to the##4##3##(2007-12#2)(2008-2#1)(2008-5#1)
visible to##9##2##(2007-12#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-2#1)
visible tumors##2##2##(2007-7#1)(2013-1#1)
visible under##2##2##(1994-5#1)(2008-9#1)
visible vessel##2##2##(1992-10#1)(2007-5#1)
visible wavelength##6##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
visible wavelengths##11##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#2)(2008-7#2)(2010-5#2)
visible with the##2##3##(2006-5#1)(2007-11#1)
visible with##6##2##(2006-5#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)
visible within the##2##3##(2008-11#1)(2008-7#1)
visible##581##1##(1990-12#1)(1990-3#3)(1990-5#1)(1990-7#3)(1991-11#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-1#3)(1992-10#1)(1992-11#3)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#3)(1993-10#2)(1993-11#2)(1993-12#5)(1993-2#2)(1993-3#1)(1993-7#3)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#3)(1994-7#1)(1995-1#1)(1995-10#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-4#1)(1996-7#1)(1997-3#1)(1997-7#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-4#3)(2005-8#2)(2005-9#1)(2006-10#4)(2006-12#8)(2006-3#1)(2006-5#1)(2006-7#3)(2006-8#1)(2007-1#2)(2007-10#4)(2007-11#26)(2007-12#72)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#12)(2008-10#72)(2008-11#9)(2008-2#58)(2008-3#67)(2008-4#1)(2008-5#20)(2008-6#4)(2008-7#9)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#4)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#5)(2010-2#5)(2010-3#1)(2010-4#5)(2010-5#7)(2010-6#1)(2010-7#4)(2011-1#4)(2011-12#7)(2011-2#6)(2012-1#3)(2012-11#2)(2012-12#8)(2012-2#7)(2012-3#1)(2012-9#1)(2013-1#8)(2013-7#1)(2013-8#8)
visible)##3##1##(1991-11#1)(1993-12#1)(2008-2#1)
visible-light##8##1##(2008-2#3)(2008-3#2)(2010-11#1)(2010-5#1)(2013-7#1)
visible-near-IR##2##1##(2007-11#1)(2008-2#1)
visible-wavelength##2##1##(2008-3#1)(2010-4#1)
visibly##11##1##(1992-6#1)(2005-12#1)(2006-11#1)(2008-10#4)(2008-2#1)(2008-5#1)(2012-1#1)(2012-3#1)
visinin##3##1##(1992-11#1)(1992-5#1)(1992-8#1)
vision after##2##2##(2012-12#1)(2013-1#1)
vision among##5##2##(1995-1#1)(2010-8#4)
vision and artificial##2##3##(1997-8#1)(2008-9#1)
vision and in##2##3##(1995-1#1)(1996-1#1)
vision and##35##2##(1991-3#1)(1993-12#1)(1994-1#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-12#1)(1997-8#3)(2005-11#1)(2006-3#1)(2007-11#1)(2007-2#2)(2007-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2009-8#3)(2010-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
vision applications##2##2##(2008-2#1)(2008-3#1)
vision are##3##2##(1991-2#1)(1991-8#1)(1997-8#1)
vision as a##2##3##(2007-11#1)(2008-7#1)
vision as##3##2##(2007-11#1)(2008-11#1)(2008-7#1)
vision at##5##2##(1994-8#1)(1995-1#1)(2007-12#1)(2007-5#1)(2011-2#1)
vision by##2##2##(2007-8#2)
vision care and vision science##5##5##(2009-10#5)
vision care##7##2##(2009-10#7)
vision changes##2##2##(2007-7#1)(2013-1#1)
vision deficiency##5##2##(2011-1#5)
vision disorders##2##2##(1996-11#1)(1996-2#1)
vision during##2##2##(1992-9#1)(2008-11#1)
vision for the future##3##4##(1997-1#1)(2011-1#1)(2012-11#1)
vision for the##9##3##(1994-3#1)(1997-1#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-6#1)(2010-9#1)(2011-1#1)(2012-11#1)
vision for##18##2##(1994-3#1)(1995-1#1)(1997-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-4#1)(2010-6#1)(2010-9#1)(2011-1#2)(2012-11#1)(2013-1#1)(2013-8#1)
vision has##2##2##(1997-8#1)(2010-10#1)
vision in his right eye##2##5##(2010-10#2)
vision in one eye##3##4##(2007-8#1)(2008-7#1)(2009-2#1)
vision in one##4##3##(2007-8#1)(2008-7#1)(2009-2#1)(2013-7#1)
vision in the##2##3##(2008-1#1)(2011-1#1)
vision in##25##2##(1994-8#1)(1995-5#2)(1997-8#1)(2005-12#1)(2005-9#1)(2006-11#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-7#2)(2009-2#1)(2010-10#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#3)(2013-7#1)
vision is a##2##3##(2006-5#1)(2010-8#1)
vision is##8##2##(1995-8#1)(1997-8#2)(2006-5#1)(2008-1#1)(2008-12#1)(2010-11#1)(2010-8#1)
vision less than##2##3##(2010-8#1)(2012-3#1)
vision loss##15##2##(2004-8#1)(2005-11#1)(2007-11#2)(2008-1#3)(2008-3#1)(2011-1#2)(2011-2#2)(2012-1#2)(2013-1#1)
vision of a##2##3##(1996-1#1)(2011-1#1)
vision of birth##2##3##(2007-2#2)
vision of public health##2##4##(1996-3#1)(2013-1#1)
vision of the##12##3##(1995-12#1)(1996-3#1)(1997-1#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-2#2)(2008-4#1)(2011-2#1)(2012-1#1)(2012-3#1)
vision of##43##2##(1992-12#1)(1993-7#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-1#1)(2005-12#1)(2006-1#1)(2006-8#1)(2007-12#2)(2007-2#3)(2008-1#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#2)(2009-12#1)(2009-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
vision on##4##2##(1994-1#1)(1994-6#1)(1995-1#1)(2011-3#1)
vision or##3##2##(1994-12#1)(1997-8#1)(2011-2#1)
vision plays a##2##3##(1994-6#1)(2007-1#1)
vision science##6##2##(2009-10#6)
vision system based on the##2##5##(2008-2#1)(2008-3#1)
vision system for##2##3##(2010-8#1)(2012-1#1)
vision system##8##2##(1997-8#1)(2008-2#3)(2008-3#2)(2010-8#1)(2012-1#1)
vision systems##6##2##(1992-9#2)(1997-8#4)
vision technology##2##2##(2012-1#1)(2012-3#1)
vision that##3##2##(2008-3#2)(2013-8#1)
vision to##3##2##(1993-1#1)(1997-3#1)(2008-11#1)
vision was##10##2##(2008-1#1)(2008-12#2)(2010-10#1)(2010-8#2)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
vision were##2##2##(2011-2#1)(2012-3#1)
vision with a##2##3##(2007-4#1)(2007-8#1)
vision with##4##2##(2007-4#1)(2007-8#1)(2011-2#2)
vision##429##1##(1990-10#1)(1990-6#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-6#1)(1991-8#3)(1992-1#1)(1992-12#2)(1992-7#4)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#3)(1993-3#3)(1993-6#1)(1993-7#1)(1994-1#4)(1994-12#1)(1994-3#3)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#5)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#3)(1995-9#2)(1996-1#5)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#3)(1996-6#1)(1996-9#1)(1997-1#2)(1997-3#2)(1997-5#1)(1997-8#26)(2004-7#3)(2004-8#1)(2004-9#1)(2005-11#3)(2005-12#3)(2005-5#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-11#3)(2006-12#2)(2006-3#1)(2006-5#2)(2006-6#2)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#7)(2007-12#7)(2007-2#8)(2007-3#2)(2007-4#4)(2007-5#2)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#13)(2008-10#2)(2008-11#8)(2008-12#6)(2008-2#14)(2008-3#17)(2008-4#4)(2008-6#4)(2008-7#12)(2008-8#3)(2008-9#3)(2009-10#13)(2009-12#2)(2009-2#5)(2009-3#4)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#6)(2010-10#6)(2010-11#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#19)(2010-9#2)(2011-1#28)(2011-2#21)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#9)(2012-2#7)(2012-3#5)(2013-1#9)(2013-7#1)(2013-8#4)
vision)##2##1##(2009-3#1)(2012-12#1)
vision-based##4##1##(2008-3#1)(2012-1#3)
visionaries##2##1##(2008-1#1)(2009-11#1)
visionary##6##1##(1996-1#1)(2006-7#1)(2008-1#1)(2008-7#1)(2010-1#1)(2013-1#1)
visions and##4##2##(1996-1#1)(2008-4#1)(2009-10#1)(2010-11#1)
visions of##2##2##(1992-3#1)(2007-2#1)
visions##12##1##(1992-3#1)(1993-7#1)(1994-1#1)(1995-11#1)(1996-1#1)(2005-8#1)(2007-2#1)(2008-1#2)(2008-4#1)(2009-10#1)(2010-11#1)
visit after##2##2##(1993-2#1)(2004-2#1)
visit all##2##2##(1994-8#1)(2008-7#1)
visit and at##2##3##(1996-1#1)(2007-9#1)
visit and were##2##3##(2006-10#1)(2007-8#1)
visit and##13##2##(1995-12#1)(1996-1#1)(2005-10#2)(2006-10#1)(2007-8#1)(2007-9#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-8#1)(2013-1#1)
visit by##2##2##(2006-10#1)(2011-1#1)
visit duration##2##2##(1994-6#1)(2006-7#1)
visit endodontic##2##2##(2011-12#1)(2013-8#1)
visit for##3##2##(2006-10#1)(2007-2#1)(2010-5#1)
visit from##2##2##(1996-2#1)(2006-8#1)
visit in##4##2##(1991-3#1)(2006-7#1)(2010-8#1)(2011-2#1)
visit is##2##2##(2006-10#1)(2010-12#1)
visit of##5##2##(1992-2#1)(2006-10#1)(2006-8#1)(2008-7#1)(2012-12#1)
visit the##7##2##(1991-5#1)(1992-2#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#2)
visit time##2##2##(2010-8#1)(2011-1#1)
visit to the next##2##4##(1990-10#1)(2007-12#1)
visit to the##8##3##(1990-10#1)(1994-8#1)(1996-2#1)(2007-12#1)(2007-7#1)(2009-10#1)(2010-12#1)(2011-12#1)
visit to##18##2##(1990-10#1)(1992-10#1)(1994-8#1)(1995-3#1)(1996-1#1)(1996-2#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-12#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
visit volume##2##2##(2010-10#2)
visit was##7##2##(1991-12#1)(1994-12#1)(1995-12#1)(2007-6#1)(2012-3#1)(2013-1#2)
visit were##3##2##(2006-10#1)(2009-4#1)(2013-1#1)
visit##194##1##(1990-10#1)(1990-6#2)(1990-7#2)(1991-1#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#4)(1992-6#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-8#2)(1995-12#2)(1995-3#5)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#3)(1996-11#1)(1996-2#3)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#1)(2003-11#1)(2004-2#1)(2005-10#4)(2006-10#9)(2006-11#1)(2006-12#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#5)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#3)(2008-11#2)(2008-12#4)(2008-3#6)(2008-4#4)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#3)(2009-11#1)(2009-3#1)(2009-4#7)(2009-8#2)(2009-9#1)(2010-10#3)(2010-12#2)(2010-5#2)(2010-8#5)(2010-9#1)(2011-1#6)(2011-12#2)(2011-2#7)(2012-12#5)(2012-2#4)(2012-3#3)(2013-1#16)(2013-8#5)
visitation and##3##2##(1994-2#1)(2008-5#1)(2008-8#1)
visitation in the##2##3##(1994-2#2)
visitation program##2##2##(1993-2#1)(2009-11#1)
visitation##16##1##(1993-2#1)(1994-2#3)(1997-7#1)(2005-11#1)(2008-5#1)(2008-8#6)(2009-11#1)(2011-1#1)(2012-2#1)
visited a##5##2##(2008-1#1)(2012-12#1)(2012-2#1)(2012-3#2)
visited by the Pastorate of the Child##2##7##(2011-1#2)
visited by the Pastorate of the##3##6##(2011-1#3)
visited by the##4##3##(2011-1#4)
visited by##7##2##(2011-1#6)(2011-2#1)
visited daily##2##2##(2005-8#2)
visited in##3##2##(1990-3#1)(1992-12#1)(2009-7#1)
visited on##2##2##(1997-4#1)(2010-12#1)
visited only##2##2##(1992-12#1)(2008-8#1)
visited our clinic##2##3##(1996-6#1)(2011-2#1)
visited our department with##2##4##(2008-12#1)(2012-3#1)
visited our department##3##3##(1995-4#1)(2008-12#1)(2012-3#1)
visited our hospital for##2##4##(2007-8#1)(2010-12#1)
visited our hospital with##4##4##(2008-5#1)(2010-12#1)(2013-1#2)
visited our hospital##7##3##(2006-4#1)(2007-8#1)(2008-5#1)(2010-12#2)(2013-1#2)
visited our##12##2##(1995-4#1)(1996-6#1)(2006-4#1)(2007-8#1)(2008-12#1)(2008-5#1)(2010-12#2)(2011-2#1)(2012-3#1)(2013-1#2)
visited the##17##2##(1992-2#1)(1996-3#1)(2007-10#2)(2007-2#1)(2007-3#2)(2007-9#1)(2008-10#1)(2008-2#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-8#2)
visited their##2##2##(1994-2#1)(2008-1#1)
visited weekly##2##2##(1994-7#1)(2005-8#1)
visited##88##1##(1990-3#1)(1990-7#1)(1990-8#1)(1992-12#3)(1992-2#1)(1993-9#1)(1994-2#2)(1994-3#1)(1994-7#1)(1994-8#1)(1995-4#1)(1995-9#2)(1996-2#1)(1996-3#1)(1996-6#1)(1997-4#1)(1997-6#1)(2005-8#3)(2006-4#2)(2006-5#1)(2007-10#2)(2007-2#4)(2007-3#3)(2007-5#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#2)(2009-7#1)(2010-12#4)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#8)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#3)
visiting a##5##2##(1990-9#1)(1994-2#1)(2009-5#1)(2012-11#1)(2012-2#1)
visiting and involvement##2##3##(1990-6#2)
visiting and##3##2##(1990-6#2)(1991-10#1)
visiting nurses##2##2##(1992-2#1)(2007-11#1)
visiting scientists##2##2##(1992-12#1)(2007-8#1)
visiting the Department of##2##4##(2013-1#1)(2013-8#1)
visiting the outpatient##2##3##(1996-12#1)(2012-12#1)
visiting the##9##2##(1992-12#1)(1996-12#1)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
visiting##52##1##(1990-6#2)(1990-9#1)(1991-10#1)(1992-12#2)(1992-2#2)(1993-12#2)(1994-2#1)(1994-7#1)(1996-12#1)(1996-5#1)(1997-5#2)(2007-11#1)(2007-12#2)(2007-2#2)(2007-8#2)(2008-1#3)(2008-11#3)(2008-12#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-12#2)(2010-5#1)(2011-2#3)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
visiting-specialist services##2##2##(2009-4#2)
visitor##9##1##(1993-12#1)(1993-9#2)(1996-11#1)(2008-12#1)(2008-5#1)(2013-1#2)(2013-8#1)
visitors to##4##2##(1992-2#1)(1996-1#1)(2011-2#1)(2013-1#1)
visitors were##2##2##(2006-8#1)(2010-9#1)
visitors##36##1##(1990-12#1)(1990-6#1)(1991-5#1)(1992-11#1)(1992-2#7)(1993-12#1)(1994-12#1)(1995-2#2)(1996-1#1)(1996-12#1)(2004-11#1)(2006-8#2)(2007-3#3)(2008-1#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-9#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#5)
visits after##2##2##(1997-4#1)(2009-12#1)
visits and##22##2##(1990-12#1)(1992-6#2)(1995-12#1)(1995-3#1)(1996-2#1)(1996-3#1)(2006-10#2)(2007-11#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-9#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
visits are##5##2##(1992-6#1)(1994-2#1)(2007-8#1)(2009-4#1)(2012-3#1)
visits as##2##2##(1992-3#1)(1995-3#1)
visits by a##4##3##(1996-11#1)(2010-12#1)(2010-3#2)
visits by##14##2##(1996-11#1)(1996-2#1)(2006-8#2)(2008-1#1)(2008-3#1)(2009-4#1)(2010-12#3)(2010-2#1)(2010-3#2)(2012-2#1)
visits can##2##2##(1997-2#1)(2008-10#1)
visits during the##2##3##(1992-3#1)(1996-1#1)
visits during##3##2##(1992-3#2)(1996-1#1)
visits for##9##2##(1996-3#1)(2007-2#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-3#1)
visits from##7##2##(1995-1#1)(2006-2#2)(2006-8#1)(2008-7#1)(2009-3#1)(2010-2#1)
visits in the United States and##2##6##(2011-2#1)(2013-1#1)
visits in the United States##3##5##(2006-10#1)(2011-2#1)(2013-1#1)
visits in the##5##3##(2006-10#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
visits in##10##2##(1992-6#1)(2006-10#2)(2008-7#1)(2009-4#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
visits may##3##2##(2006-10#1)(2008-7#1)(2008-8#1)
visits on##4##2##(1993-6#1)(2005-8#2)(2006-10#1)
visits or##3##2##(2007-12#1)(2008-11#1)(2008-3#1)
visits per##2##2##(1991-12#1)(2008-10#1)
visits than##3##2##(1992-2#1)(1994-2#1)(2009-12#1)
visits the##7##2##(1991-6#1)(1994-6#1)(2006-7#1)(2008-1#1)(2011-1#1)(2013-1#2)
visits to physicians##2##3##(2008-7#1)(2010-7#1)
visits to primary care##2##4##(2004-3#1)(2008-7#1)
visits to the##8##3##(1990-10#1)(1992-5#2)(2007-2#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)
visits to##30##2##(1990-10#1)(1990-9#1)(1991-12#1)(1991-9#1)(1992-5#2)(1993-1#1)(1995-12#1)(1996-2#1)(1997-2#1)(2004-3#1)(2006-2#1)(2006-7#1)(2007-2#1)(2007-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
visits was##2##2##(1992-3#1)(2005-10#1)
visits were made to##2##4##(2008-12#1)(2008-5#1)
visits were##8##2##(1995-2#1)(2006-5#1)(2008-12#1)(2008-5#1)(2010-3#1)(2012-2#1)(2013-1#2)
visits with##5##2##(1995-2#1)(2006-8#1)(2008-12#2)(2012-3#1)
visits##245##1##(1990-10#1)(1990-12#2)(1990-9#1)(1991-1#1)(1991-12#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#5)(1992-5#2)(1992-6#5)(1993-1#2)(1993-6#3)(1994-1#1)(1994-2#5)(1994-6#2)(1995-1#3)(1995-12#4)(1995-2#3)(1995-3#4)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#2)(1996-6#1)(1997-2#4)(1997-4#1)(2004-3#2)(2005-10#1)(2005-8#3)(2006-10#8)(2006-2#3)(2006-5#1)(2006-7#3)(2006-8#8)(2007-11#2)(2007-12#2)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#11)(2008-10#2)(2008-11#4)(2008-12#9)(2008-3#5)(2008-5#3)(2008-6#3)(2008-7#7)(2008-8#2)(2008-9#2)(2009-12#5)(2009-3#1)(2009-4#4)(2009-6#1)(2009-8#3)(2010-11#1)(2010-12#5)(2010-2#4)(2010-3#4)(2010-5#1)(2010-7#4)(2010-8#5)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#6)(2011-9#1)(2012-1#4)(2012-11#1)(2012-12#2)(2012-2#7)(2012-3#5)(2013-1#14)
visits)##2##1##(1991-3#1)(2005-10#1)
vismodegib and##2##2##(2013-7#2)
vismodegib##4##1##(2013-7#4)
vison##3##1##(2008-6#2)(2011-1#1)
visors##2##1##(2010-1#2)
vistas in##3##2##(2008-2#1)(2012-2#2)
vistas##5##1##(1993-2#1)(2008-1#1)(2008-2#1)(2012-2#2)
visual abnormalities##2##2##(1992-2#1)(2008-10#1)
visual access to the##2##4##(2007-9#2)
visual acuities##4##2##(2007-2#1)(2011-2#1)(2013-1#2)
visual acuity (BCVA)##3##3##(2011-2#3)
visual acuity (VA)##3##3##(2009-8#1)(2011-2#1)(2013-1#1)
visual acuity and##9##3##(1992-7#1)(2008-1#1)(2008-3#1)(2008-7#1)(2011-12#1)(2012-12#3)(2013-1#1)
visual acuity improved##4##3##(2010-10#1)(2011-2#1)(2012-12#2)
visual acuity improvement##2##3##(2010-9#1)(2011-2#1)
visual acuity in##4##3##(1992-7#2)(2005-11#1)(2011-2#1)
visual acuity loss in##2##4##(2011-2#1)(2012-12#1)
visual acuity of 20/60##2##4##(2007-2#1)(2011-2#1)
visual acuity of PLR##2##4##(1992-7#2)
visual acuity of the##4##4##(2007-12#1)(2010-8#1)(2011-1#1)(2013-8#1)
visual acuity of##13##3##(1992-7#3)(2007-12#1)(2007-2#1)(2010-10#1)(2010-8#1)(2011-1#2)(2011-2#2)(2013-7#1)(2013-8#1)
visual acuity was##5##3##(1996-3#1)(2007-3#1)(2009-8#1)(2011-1#1)(2011-2#1)
visual acuity##87##2##(1992-7#10)(1993-11#1)(1994-2#1)(1996-3#2)(1997-8#1)(2005-10#1)(2005-11#5)(2006-12#1)(2006-4#1)(2007-1#2)(2007-12#2)(2007-2#1)(2007-3#5)(2008-1#1)(2008-3#1)(2008-4#2)(2008-7#2)(2009-2#1)(2009-3#2)(2009-8#3)(2010-10#2)(2010-8#1)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#15)(2012-12#7)(2013-1#5)(2013-7#1)(2013-8#2)
visual aids##2##2##(1993-11#2)
visual analog pain##2##3##(2006-8#1)(2007-12#1)
visual analog scale (VAS)##7##4##(2006-12#1)(2006-8#1)(2007-2#1)(2008-6#1)(2009-3#1)(2010-5#1)(2012-2#1)
visual analog scale and##2##4##(2005-9#1)(2010-7#1)
visual analog scale##20##3##(1993-9#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-8#1)(2007-2#2)(2008-10#1)(2008-6#1)(2009-3#2)(2010-3#1)(2010-5#1)(2010-7#1)(2012-2#2)(2013-1#1)
visual analog scales##6##3##(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2011-1#1)(2012-2#1)
visual analog score##3##3##(1996-12#1)(2008-7#2)
visual analog##33##2##(1993-9#1)(1996-12#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-3#1)(2006-8#2)(2007-12#1)(2007-2#3)(2008-1#2)(2008-10#2)(2008-6#1)(2008-7#2)(2009-3#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-2#3)(2013-1#1)
visual analogue pain score##2##4##(2007-11#1)(2013-1#1)
visual analogue pain##3##3##(2007-11#2)(2013-1#1)
visual analogue scale (VAS)##5##4##(2007-7#2)(2008-7#1)(2012-1#1)(2013-1#1)
visual analogue scale##12##3##(1995-12#1)(2006-10#1)(2007-7#2)(2008-7#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
visual analogue scales##6##3##(1996-3#1)(2007-11#1)(2007-6#1)(2008-10#2)(2008-7#1)
visual analogue##24##2##(1995-12#1)(1996-12#1)(1996-3#1)(2006-10#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-7#2)(2008-10#2)(2008-7#2)(2009-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#3)
visual analysis of##2##3##(1996-6#2)
visual analysis##3##2##(1996-6#2)(2007-12#1)
visual anatomic##2##2##(2006-8#2)
visual and auditory##3##3##(1991-3#1)(2007-5#1)(2008-8#1)
visual and digital assessments##2##4##(2008-10#2)
visual and quantitative analysis of different tastes##3##7##(2008-10#3)
visual and seismic courtship##2##4##(2009-6#2)
visual and somatosensory##2##3##(1991-2#1)(1994-2#1)
visual and##33##2##(1990-8#1)(1991-2#1)(1991-3#1)(1994-2#1)(2005-5#1)(2007-5#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#2)(2009-9#1)(2010-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#2)
visual area V4##3##3##(1992-11#1)(1992-9#1)(1993-2#1)
visual area in##2##3##(1996-3#1)(2008-9#1)
visual area of the##2##4##(1992-2#1)(2007-8#1)
visual area##8##2##(1992-11#1)(1992-2#1)(1992-9#1)(1993-2#1)(1996-3#1)(2007-8#1)(2008-9#2)
visual areas may##2##3##(1992-5#1)(1996-9#1)
visual areas of##2##3##(1990-2#1)(1992-9#1)
visual areas##15##2##(1990-2#1)(1992-5#1)(1992-9#1)(1995-11#2)(1995-12#1)(1995-5#1)(1996-1#1)(1996-9#3)(2008-1#1)(2008-11#2)(2009-1#1)
visual arts##2##2##(2005-12#1)(2012-2#1)
visual assessment of disease##2##4##(2008-10#2)
visual assessment of##5##3##(2008-10#3)(2008-11#1)(2008-5#1)
visual assessment##12##2##(1996-7#1)(2007-10#1)(2008-10#6)(2008-11#1)(2008-5#2)(2011-2#1)
visual assessments of##2##3##(2008-10#1)(2008-5#1)
visual association area##2##3##(1992-8#1)(1996-2#1)
visual association##4##2##(1992-8#1)(1996-2#2)(2011-2#1)
visual attention in##2##3##(1995-12#1)(2008-4#1)
visual attention to##2##3##(1997-1#1)(1997-2#1)
visual attention with##2##3##(2008-9#2)
visual attention##22##2##(1992-9#1)(1995-12#1)(1997-1#2)(1997-2#4)(2007-4#1)(2008-11#4)(2008-4#3)(2008-6#1)(2008-9#3)(2010-5#1)(2012-12#1)
visual autocatalytic##2##2##(2008-10#2)
visual axis##4##2##(1991-2#1)(2007-3#1)(2009-2#1)(2009-8#1)
visual basic##2##2##(2008-10#1)(2010-5#1)
visual blurring##3##2##(1990-10#3)
visual censuses##2##2##(2008-5#1)(2011-2#1)
visual communication##2##2##(2008-11#1)(2008-3#1)
visual complications##3##2##(2012-3#3)
visual concepts##2##2##(2008-2#2)
visual confluency##3##2##(2008-11#3)
visual content##2##2##(2008-2#2)
visual control##6##2##(1990-10#1)(1994-2#1)(1996-1#1)(2007-12#1)(2010-12#1)(2013-1#1)
visual cortex activity##2##3##(2012-2#2)
visual cortex and##6##3##(1993-7#1)(1995-11#1)(1995-12#1)(2008-8#1)(2011-2#1)(2013-7#1)
visual cortex have##2##3##(1997-7#1)(2009-10#1)
visual cortex in the ferret##2##5##(2008-1#2)
visual cortex in##5##3##(1992-8#1)(1996-3#1)(1997-3#1)(2008-1#2)
visual cortex is##3##3##(1990-2#1)(1990-8#1)(1995-11#1)
visual cortex lesions##2##3##(1993-2#2)
visual cortex of adult##4##4##(1992-10#1)(1993-12#1)(1995-12#2)
visual cortex of##10##3##(1990-2#1)(1991-8#1)(1992-10#1)(1992-9#1)(1993-12#1)(1995-12#2)(1996-9#1)(2008-11#1)(2008-8#1)
visual cortex was##2##3##(1990-2#1)(1997-7#1)
visual cortex were##2##3##(1990-8#1)(1995-1#1)
visual cortex with##3##3##(1993-12#1)(1995-12#1)(2008-7#1)
visual cortex##111##2##(1990-2#3)(1990-4#1)(1990-5#1)(1990-8#3)(1991-6#1)(1991-8#4)(1991-9#2)(1992-10#2)(1992-2#1)(1992-8#1)(1992-9#1)(1993-12#3)(1993-2#3)(1993-7#2)(1994-2#1)(1994-3#1)(1994-8#5)(1995-1#1)(1995-11#7)(1995-12#8)(1995-8#2)(1996-1#1)(1996-2#1)(1996-3#4)(1996-9#2)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-11#9)(2008-4#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#1)(2009-5#1)(2011-2#5)(2012-2#7)(2013-7#2)(2013-8#1)
visual cortical areas##4##3##(1992-9#1)(2008-8#1)(2009-10#1)(2009-3#1)
visual cortical##13##2##(1990-2#1)(1990-4#1)(1991-5#1)(1992-9#1)(1994-3#2)(1997-8#1)(2008-8#2)(2009-10#1)(2009-3#1)(2011-2#1)(2012-2#1)
visual cue##5##2##(2008-1#1)(2008-8#3)(2010-5#1)
visual cueing for##2##3##(2007-6#2)
visual cues to##2##3##(2006-5#1)(2008-9#1)
visual cues##10##2##(1990-10#1)(1991-2#1)(1997-8#1)(2006-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-6#1)(2010-8#1)(2012-1#1)
visual culture##2##2##(2012-2#2)
visual cycle retinoids##2##3##(1995-9#2)
visual defenses against##2##3##(1994-3#2)
visual deficits##2##2##(2011-2#1)(2012-3#1)
visual demonstration of##2##3##(2008-11#2)
visual deprivation##5##2##(1992-3#1)(1994-1#1)(2010-9#3)
visual detection and discrimination##2##4##(2012-2#2)
visual detection##4##2##(1995-12#1)(2009-6#1)(2012-2#2)
visual deterioration##2##2##(2007-1#1)(2008-7#1)
visual development##4##2##(1990-2#1)(1992-7#2)(2012-2#1)
visual direction and orientation disparity##2##5##(2008-9#2)
visual discrimination and##2##3##(1993-6#1)(1996-2#1)
visual discrimination learning##2##3##(1993-7#2)
visual discrimination task##2##3##(1990-7#1)(1995-12#1)
visual discrimination tasks##2##3##(1990-10#1)(1993-7#1)
visual discrimination##13##2##(1990-10#2)(1990-7#1)(1991-1#1)(1991-2#1)(1992-9#1)(1993-2#1)(1993-6#1)(1993-7#3)(1995-12#1)(1996-2#1)
visual discriminations##3##2##(1993-12#3)
visual display##8##2##(2007-4#1)(2008-11#1)(2008-6#2)(2009-4#1)(2010-8#1)(2013-1#2)
visual disturbance and##2##3##(2006-12#1)(2012-12#1)
visual disturbance##6##2##(1990-7#1)(1996-3#1)(2006-12#1)(2008-7#1)(2012-12#1)(2013-8#1)
visual disturbances with##2##3##(2006-12#1)(2008-8#1)
visual disturbances##10##2##(2006-12#1)(2008-3#1)(2008-8#1)(2011-2#5)(2012-3#2)
visual dyslexia##3##2##(2012-1#3)
visual effects##2##2##(2008-3#2)
visual environment##4##2##(1992-9#1)(1995-5#1)(2008-2#1)(2008-9#1)
visual environments##3##2##(1992-9#2)(2008-4#1)
visual errors##2##2##(2012-1#2)
visual estimation of##2##3##(2008-10#2)
visual estimation##3##2##(2008-10#3)
visual evaluation##9##2##(1994-11#1)(1996-12#1)(2007-10#5)(2008-2#1)(2008-5#1)
visual evidence of##3##3##(1991-12#1)(1997-1#1)(2005-11#1)
visual evidence##4##2##(1991-12#1)(1997-1#1)(2005-11#1)(2008-11#1)
visual evoked potential (VEP)##3##4##(1992-7#1)(1995-12#1)(2009-8#1)
visual evoked potential##9##3##(1992-7#1)(1995-12#2)(1997-3#1)(1997-7#1)(2006-12#1)(2009-8#1)(2012-1#1)(2013-8#1)
visual evoked potentials (VEPs)##2##4##(1996-1#1)(1997-7#1)
visual evoked potentials##4##3##(1990-3#1)(1996-1#1)(1996-2#1)(1997-7#1)
visual evoked##13##2##(1990-3#1)(1992-7#1)(1995-12#2)(1996-1#1)(1996-2#1)(1997-3#1)(1997-7#2)(2006-12#1)(2009-8#1)(2012-1#1)(2013-8#1)
visual examination of##3##3##(2008-10#1)(2008-9#1)(2011-1#1)
visual experience before##2##3##(1992-7#1)(2011-2#1)
visual experience##9##2##(1992-7#2)(1992-9#1)(2008-4#2)(2011-2#4)
visual fatigue measure##2##3##(2013-7#2)
visual fatigue##6##2##(2013-7#6)
visual feedback on##2##3##(2008-11#1)(2008-6#1)
visual feedback##12##2##(1992-10#3)(2007-5#2)(2007-9#1)(2008-11#1)(2008-4#2)(2008-6#1)(2009-12#1)(2012-1#1)
visual field and##7##3##(1996-3#1)(2007-6#1)(2011-2#4)(2012-11#1)
visual field damage in children##2##5##(2011-2#2)
visual field defect##2##3##(1995-8#1)(2008-7#1)
visual field defects in##4##4##(1993-2#1)(1996-2#1)(2008-7#2)
visual field defects##9##3##(1993-2#1)(1994-5#1)(1996-2#1)(2007-10#1)(2007-3#2)(2008-7#2)(2009-2#1)
visual field in##3##3##(1992-6#1)(2006-8#1)(2011-2#1)
visual field loss##2##3##(2007-6#1)(2011-2#1)
visual field progression##2##3##(2007-6#2)
visual field than##2##3##(1996-2#1)(2008-4#1)
visual field was##3##3##(2008-4#2)(2011-2#1)
visual field##68##2##(1990-4#1)(1992-6#2)(1992-7#2)(1992-9#1)(1993-2#1)(1993-7#4)(1994-2#1)(1994-5#1)(1995-8#1)(1996-2#6)(1996-3#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-3#2)(2007-6#9)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#5)(2008-7#3)(2008-9#1)(2009-2#1)(2009-4#2)(2010-2#1)(2011-2#13)(2012-11#1)(2012-2#1)(2012-3#1)
visual fields and##2##3##(2009-10#1)(2011-2#1)
visual fields##7##2##(1994-5#1)(2007-6#2)(2009-10#1)(2011-2#1)(2013-1#2)
visual form##3##2##(1997-8#1)(2008-9#2)
visual function##16##2##(1990-6#1)(1992-7#1)(2005-10#1)(2006-12#1)(2007-6#3)(2011-1#1)(2011-2#1)(2011-7#1)(2012-12#1)(2013-1#5)
visual guidance for##2##3##(1993-2#1)(2010-12#1)
visual guidance##5##2##(1993-2#1)(2007-12#1)(2008-1#2)(2010-12#1)
visual hallucinations##10##2##(2004-8#1)(2006-4#1)(2006-8#1)(2007-7#1)(2011-2#3)(2012-2#1)(2013-7#1)(2013-8#1)
visual identity##3##2##(2008-12#3)
visual imagery##5##2##(1996-9#1)(2007-2#1)(2008-11#3)
visual images##2##2##(1992-1#1)(1996-2#1)
visual impaired children##2##3##(1992-7#1)(2012-12#1)
visual impairment in childhood##3##4##(2011-2#3)
visual impairment in##7##3##(2007-1#3)(2011-2#3)(2013-1#1)
visual impairment was##2##3##(2008-10#1)(2011-12#1)
visual impairment##30##2##(1992-7#2)(1996-1#1)(2005-10#2)(2006-12#1)(2007-1#7)(2008-10#1)(2010-10#1)(2011-12#1)(2011-2#5)(2012-11#2)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#2)
visual impression of##2##3##(1995-12#1)(2012-2#1)
visual improvement##3##2##(2011-2#1)(2012-3#1)(2013-1#1)
visual information can##2##3##(1995-11#1)(2008-1#1)
visual information processing##6##3##(1996-2#1)(2004-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2013-7#1)
visual information##19##2##(1994-6#1)(1995-11#1)(1996-2#1)(2004-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2009-12#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-7#1)
visual input and##2##3##(2008-6#1)(2010-10#1)
visual input##13##2##(1991-2#7)(1992-9#1)(1993-12#1)(2008-6#1)(2010-10#1)(2012-2#1)(2013-8#1)
visual inputs##2##2##(1995-12#1)(1995-8#1)
visual inspection and##2##3##(2008-10#1)(2009-4#1)
visual inspection of the##4##4##(2004-2#1)(2007-11#1)(2009-2#1)(2009-8#1)
visual inspection of##5##3##(2004-2#1)(2007-11#1)(2008-7#1)(2009-2#1)(2009-8#1)
visual inspection##20##2##(1994-3#1)(1994-6#1)(2004-2#1)(2004-3#1)(2007-11#1)(2008-10#2)(2008-12#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-9#3)(2011-1#1)(2012-12#1)(2012-2#1)
visual latencies##2##2##(1996-2#2)
visual learning##6##2##(1993-2#1)(2008-11#1)(2008-8#2)(2009-4#1)(2012-12#1)
visual loss and##4##3##(2006-4#1)(2008-4#1)(2013-7#2)
visual loss due to##4##4##(2009-2#1)(2011-2#2)(2013-1#1)
visual loss in##6##3##(2006-11#1)(2008-1#1)(2008-7#1)(2009-2#1)(2009-8#1)(2012-2#1)
visual loss is##2##3##(2008-1#1)(2011-1#1)
visual loss##33##2##(2005-10#1)(2006-11#2)(2006-4#1)(2007-10#1)(2007-3#1)(2008-1#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#2)(2009-4#1)(2009-8#5)(2010-3#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
visual memory of##2##3##(2008-6#2)
visual memory performance##2##3##(2010-7#2)
visual memory##10##2##(1991-11#1)(1993-12#1)(1995-11#1)(2008-11#1)(2008-4#1)(2008-6#2)(2009-6#1)(2010-7#2)
visual method##3##2##(2008-10#2)(2008-9#1)
visual methods##2##2##(1991-8#1)(2011-2#1)
visual modality##2##2##(2008-8#2)
visual morbidity##2##2##(2006-11#1)(2007-11#1)
visual motion detection##2##3##(2011-2#2)
visual motion##9##2##(1992-2#1)(1992-9#2)(1993-2#1)(1996-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
visual naming activated##2##3##(1996-2#2)
visual naming##3##2##(1996-2#3)
visual neurons##2##2##(1993-2#1)(1996-2#1)
visual object##3##2##(1991-3#1)(1993-9#1)(2012-1#1)
visual objects##2##2##(1993-7#1)(1996-2#1)
visual obscurations and headache##2##4##(2008-7#2)
visual observation##4##2##(2008-10#1)(2008-11#1)(2008-5#2)
visual observations##5##2##(1992-3#1)(2005-11#2)(2008-11#1)(2008-3#1)
visual offline sample stacking##2##4##(2012-12#2)
visual ontology##10##2##(2013-1#10)
visual optical##2##2##(2008-3#2)
visual or##2##2##(2008-10#1)(2008-6#1)
visual organs##4##2##(2007-12#4)
visual outcome##3##2##(2011-2#2)(2013-1#1)
visual pain scale##2##3##(2006-9#1)(2007-7#1)
visual paradox##2##2##(2013-7#2)
visual pathway##8##2##(1990-7#2)(1991-2#1)(1991-8#1)(2007-3#2)(2008-2#1)(2011-1#1)
visual pathways of##2##3##(1995-5#1)(2013-7#1)
visual pathways##9##2##(1992-7#1)(1992-9#1)(1995-11#1)(1995-12#1)(1995-5#2)(2007-12#1)(2007-3#1)(2013-7#1)
visual pattern##2##2##(1991-2#1)(2012-2#1)
visual perception and##3##3##(2007-8#1)(2008-3#1)(2010-9#1)
visual perception of##3##3##(2008-2#1)(2009-10#1)(2010-6#1)
visual perception##16##2##(1994-8#1)(1995-1#1)(1997-5#1)(2007-8#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-10#1)(2010-6#1)(2010-9#1)(2012-11#1)(2013-1#1)
visual perturbation##2##2##(1992-9#1)(1996-2#1)
visual pigment##6##2##(1990-10#2)(1990-12#1)(1991-9#1)(1993-3#1)(1997-4#1)
visual pigments in##2##3##(1990-10#2)
visual pigments##5##2##(1990-10#3)(1990-12#2)
visual preferences##2##2##(2008-10#1)(2008-8#1)
visual presentation##4##2##(2008-1#1)(2008-3#1)(2009-4#1)(2010-7#1)
visual problems##2##2##(1992-7#1)(2004-7#1)
visual processing areas##4##3##(1997-8#2)(2008-11#1)(2012-2#1)
visual processing##20##2##(1994-2#1)(1995-11#1)(1995-5#1)(1995-8#1)(1997-8#6)(2006-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#2)(2012-2#4)
visual prognosis##4##2##(2010-7#1)(2012-12#1)(2013-7#2)
visual projection##2##2##(1993-12#1)(2008-3#1)
visual pursuit##2##2##(1992-7#1)(2009-8#1)
visual quality##7##2##(2008-2#3)(2008-3#3)(2008-6#1)
visual ratings##2##2##(1991-12#1)(2008-10#1)
visual reaction##2##2##(2006-3#1)(2012-1#1)
visual reactions and critical flicker frequency##2##6##(2012-1#2)
visual receptive fields expanded##2##4##(1994-2#2)
visual receptive fields##4##3##(1994-2#4)
visual recognition memory##4##3##(1996-1#3)(1996-7#1)
visual recognition##11##2##(1996-1#3)(1996-7#1)(1997-8#1)(2006-4#1)(2008-11#1)(2008-4#1)(2011-12#2)(2012-2#1)
visual representation of the##2##4##(2007-5#1)(2008-3#1)
visual resolution##3##2##(1992-7#2)(2007-12#1)
visual responses of##2##3##(2008-8#2)
visual responses##6##2##(1991-3#3)(2008-1#1)(2008-8#2)
visual scanning##2##2##(2012-12#1)(2013-8#1)
visual scene##5##2##(1996-2#1)(2008-4#1)(2009-12#1)(2009-4#2)
visual scenes##2##2##(2009-4#1)(2012-2#1)
visual search in##2##3##(2008-1#1)(2012-2#1)
visual search##11##2##(1997-7#1)(2008-1#5)(2009-10#1)(2009-2#2)(2012-2#1)(2012-3#1)
visual selection##2##2##(2006-12#2)
visual sense##3##2##(2007-12#3)
visual sensitivity##3##2##(2008-10#2)(2012-2#1)
visual short-term memory##2##3##(2008-11#1)(2011-2#1)
visual signal##2##2##(2008-11#1)(2009-6#1)
visual signals##2##2##(2008-11#1)(2008-8#1)
visual space to##2##3##(1995-11#1)(2008-3#1)
visual space##4##2##(1994-2#1)(1995-11#1)(2008-1#1)(2008-3#1)
visual span and reading speed##2##5##(2008-1#2)
visual span and##3##3##(2008-1#3)
visual span##5##2##(2008-1#5)
visual stimulation were##2##3##(1997-7#1)(2010-12#1)
visual stimulation##5##2##(1991-5#1)(1992-9#1)(1997-6#1)(1997-7#1)(2010-12#1)
visual stimuli alone##2##3##(2010-2#2)
visual stimuli and##3##3##(1993-2#1)(2008-5#1)(2008-6#1)
visual stimuli in##3##3##(1993-2#1)(1997-1#1)(2006-5#1)
visual stimuli may##2##3##(1993-6#1)(1996-5#1)
visual stimuli##36##2##(1990-10#1)(1990-4#4)(1992-10#1)(1993-2#2)(1993-6#5)(1995-11#1)(1995-8#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-8#1)(2006-5#2)(2006-7#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-11#1)(2010-12#1)(2010-2#2)(2011-2#1)(2012-1#1)(2012-2#1)
visual stimulus has##2##3##(2009-10#1)(2009-4#1)
visual stimulus was##2##3##(1991-11#1)(1992-11#1)
visual stimulus##12##2##(1991-11#1)(1991-12#1)(1992-11#2)(1993-2#2)(1995-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2009-10#1)(2009-4#1)
visual suppression in the rabbit##2##5##(1997-8#2)
visual symptoms resolved##2##3##(2011-2#1)(2012-3#1)
visual symptoms##8##2##(2008-10#5)(2011-2#1)(2012-3#1)(2013-8#1)
visual system and##4##3##(2007-12#2)(2008-1#1)(2008-3#1)
visual system development##2##3##(1994-3#1)(2007-12#1)
visual system in##3##3##(1996-1#1)(2008-2#1)(2008-8#1)
visual system is a##2##4##(1997-8#1)(2008-9#1)
visual system is##5##3##(1996-10#2)(1997-8#1)(2008-9#1)(2011-2#1)
visual system of Drosophila##2##4##(1994-3#1)(2008-3#1)
visual system of the##2##4##(2007-12#1)(2008-11#1)
visual system of##6##3##(1994-3#1)(1996-1#1)(2007-12#2)(2008-11#1)(2008-3#1)
visual system##67##2##(1991-11#1)(1991-6#1)(1992-6#1)(1992-7#3)(1992-9#1)(1993-12#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-5#7)(1996-1#2)(1996-10#4)(1996-2#1)(1997-3#1)(1997-8#2)(2007-12#14)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#5)(2008-8#1)(2008-9#3)(2009-12#2)(2009-6#1)(2011-2#2)(2012-1#1)(2012-2#1)
visual systems are##2##3##(2007-12#2)
visual systems##7##2##(1991-2#1)(2006-7#1)(2007-12#4)(2008-3#1)
visual target##7##2##(1994-8#1)(1995-5#2)(2009-8#1)(2012-1#2)(2012-2#1)
visual targets##5##2##(1992-10#1)(1993-2#1)(1995-5#1)(1995-8#1)(2009-8#1)
visual task##5##2##(1997-7#1)(2008-9#1)(2012-1#1)(2013-8#2)
visual textures##2##2##(1994-8#2)
visual thalamus##2##2##(1992-8#2)
visual tracking##2##2##(1995-4#1)(2008-9#1)
visual training##2##2##(1993-2#1)(2013-8#1)
visual transduction##4##2##(1990-10#1)(1990-2#1)(1993-4#1)(1995-9#1)
visual vertical##2##2##(2013-1#2)
visual word recognition##2##3##(2008-4#2)
visual word##4##2##(1990-8#1)(1995-12#1)(2008-4#2)
visual##1506##1##(1990-10#18)(1990-12#4)(1990-2#7)(1990-3#1)(1990-4#7)(1990-5#1)(1990-6#1)(1990-7#4)(1990-8#6)(1991-1#1)(1991-11#4)(1991-12#4)(1991-2#21)(1991-3#5)(1991-4#1)(1991-5#2)(1991-6#4)(1991-8#6)(1991-9#3)(1992-1#1)(1992-10#7)(1992-11#5)(1992-12#2)(1992-2#4)(1992-3#4)(1992-5#1)(1992-6#3)(1992-7#32)(1992-8#4)(1992-9#22)(1993-11#3)(1993-12#12)(1993-2#22)(1993-3#1)(1993-4#2)(1993-6#6)(1993-7#14)(1993-9#3)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#14)(1994-3#9)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#11)(1994-9#1)(1995-1#3)(1995-11#16)(1995-12#24)(1995-2#1)(1995-4#1)(1995-5#18)(1995-8#11)(1995-9#3)(1996-1#11)(1996-10#5)(1996-11#1)(1996-12#4)(1996-2#25)(1996-3#10)(1996-5#2)(1996-6#3)(1996-7#2)(1996-9#6)(1997-1#4)(1997-2#5)(1997-3#5)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#7)(1997-8#22)(2004-11#1)(2004-2#1)(2004-3#1)(2004-7#2)(2004-8#1)(2005-10#6)(2005-11#8)(2005-12#1)(2005-5#1)(2005-9#1)(2006-10#5)(2006-11#3)(2006-12#11)(2006-3#4)(2006-4#4)(2006-5#4)(2006-6#2)(2006-7#5)(2006-8#6)(2006-9#1)(2007-1#13)(2007-10#10)(2007-11#7)(2007-12#42)(2007-2#7)(2007-3#12)(2007-4#2)(2007-5#6)(2007-6#17)(2007-7#5)(2007-8#9)(2007-9#7)(2008-1#40)(2008-10#63)(2008-11#47)(2008-12#7)(2008-2#21)(2008-3#31)(2008-4#32)(2008-5#16)(2008-6#18)(2008-7#24)(2008-8#31)(2008-9#24)(2009-1#1)(2009-10#12)(2009-11#3)(2009-12#5)(2009-2#10)(2009-3#7)(2009-4#13)(2009-5#1)(2009-6#7)(2009-7#1)(2009-8#14)(2009-9#4)(2010-10#5)(2010-12#6)(2010-2#6)(2010-3#2)(2010-4#1)(2010-5#6)(2010-6#5)(2010-7#6)(2010-8#7)(2010-9#12)(2011-1#21)(2011-12#4)(2011-2#80)(2011-7#2)(2012-1#23)(2012-11#11)(2012-12#24)(2012-2#43)(2012-3#16)(2013-1#53)(2013-7#24)(2013-8#25)
visual)##3##1##(1994-3#1)(1995-11#1)(2010-12#1)
visual-auditory task##2##2##(2012-2#2)
visual-auditory##3##1##(2012-2#3)
visual-span##2##1##(2008-1#2)
visual-spatial##4##1##(1997-1#1)(2007-8#1)(2007-9#2)
visual-vestibular integration##2##2##(1991-2#2)
visual-visual##2##1##(2012-2#2)
visualisation and##2##2##(2008-10#1)(2011-3#1)
visualisation of the##6##3##(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2012-2#1)
visualisation of##13##2##(2005-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-7#1)(2011-3#1)(2012-2#2)
visualisation##25##1##(2005-12#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#2)(2011-3#3)(2012-2#3)
visualise the##4##2##(1996-5#1)(2008-3#1)(2012-2#2)
visualise##10##1##(1996-5#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-2#4)
visualised by##4##2##(1994-8#1)(1996-3#1)(2007-7#1)(2007-8#1)
visualised in##4##2##(1996-5#1)(2007-8#1)(2008-11#1)(2012-2#1)
visualised##14##1##(1994-8#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-3#1)(2006-6#2)(2007-7#1)(2007-8#2)(2008-11#2)(2008-8#1)(2012-2#1)
visualising##3##1##(2006-10#1)(2007-8#1)(2008-8#1)
visualization allows##2##2##(2006-12#1)(2008-4#1)
visualization and analysis in##2##4##(2008-5#1)(2010-9#1)
visualization and analysis##6##3##(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#2)(2010-9#1)
visualization and mapping of articular cartilage in##2##7##(2006-5#2)
visualization and mapping of##3##4##(2006-5#2)(2008-7#1)
visualization and##27##2##(1991-11#1)(2006-12#1)(2006-5#2)(2006-8#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-10#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2012-12#1)(2013-7#1)(2013-8#1)
visualization as##2##2##(2008-3#1)(2008-9#1)
visualization by##4##2##(1990-12#1)(1995-6#1)(2007-12#1)(2008-1#1)
visualization compared##2##2##(2005-5#1)(2008-7#1)
visualization during##2##2##(2006-5#1)(2009-1#1)
visualization for##3##2##(1990-12#1)(2006-5#1)(2011-2#1)
visualization in bone specimens fixed with##2##6##(2010-2#2)
visualization in##7##2##(2006-7#1)(2006-9#1)(2008-2#1)(2010-2#2)(2011-7#1)(2012-12#1)
visualization of a##2##3##(2008-2#1)(2011-2#1)
visualization of cardiac##2##3##(2010-6#1)(2010-8#1)
visualization of complex##3##3##(2008-7#1)(2011-2#1)(2011-7#1)
visualization of natural gas leaks##2##5##(2008-2#2)
visualization of phase changes in##2##5##(2008-2#2)
visualization of phase##3##3##(2008-2#2)(2008-3#1)
visualization of protein##2##3##(2008-4#2)
visualization of surface##2##3##(2007-11#1)(2008-2#1)
visualization of the condylar##2##4##(2012-12#2)
visualization of the data##2##4##(2008-10#1)(2008-6#1)
visualization of the##48##3##(1991-9#1)(1992-9#1)(1994-3#1)(1995-12#1)(1995-4#1)(1996-1#1)(1997-4#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-7#2)(2007-9#4)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-7#1)(2012-12#2)(2012-2#1)(2013-1#2)
visualization of this##2##3##(2006-12#1)(2008-11#1)
visualization of three-dimensional##2##3##(2008-3#1)(2008-6#1)
visualization of urinary##2##3##(2006-7#1)(2008-1#1)
visualization of##150##2##(1990-12#1)(1990-4#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-5#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-4#1)(1996-1#1)(1997-4#1)(1997-6#2)(1997-8#1)(2005-11#1)(2005-5#1)(2006-12#3)(2006-6#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#5)(2007-4#1)(2007-7#2)(2007-8#2)(2007-9#5)(2008-1#5)(2008-10#3)(2008-11#2)(2008-2#16)(2008-3#6)(2008-4#10)(2008-5#3)(2008-6#4)(2008-7#7)(2008-8#5)(2008-9#3)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#2)(2010-7#2)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#5)(2011-7#2)(2012-12#3)(2012-2#2)(2013-1#3)
visualization on the##2##3##(1992-12#1)(2008-6#1)
visualization or##2##2##(2006-10#1)(2006-5#1)
visualization technique##2##2##(2008-3#1)(2013-8#1)
visualization techniques##6##2##(2008-3#1)(2008-6#2)(2010-9#1)(2013-1#2)
visualization through##2##2##(2008-2#1)(2011-2#1)
visualization tools##3##2##(2006-6#1)(2008-4#1)(2010-2#1)
visualization was##2##2##(2005-5#1)(2007-8#1)
visualization with##3##2##(2006-10#1)(2006-5#1)(2008-10#1)
visualization##299##1##(1990-12#5)(1990-4#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-5#1)(1994-2#1)(1994-3#2)(1995-12#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-1#1)(1997-4#1)(1997-6#2)(1997-8#1)(2004-2#1)(2005-11#2)(2005-5#4)(2006-10#2)(2006-12#5)(2006-5#10)(2006-6#4)(2006-7#3)(2006-8#2)(2006-9#1)(2007-1#4)(2007-10#1)(2007-11#8)(2007-12#7)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#5)(2007-9#5)(2008-1#6)(2008-10#8)(2008-11#5)(2008-2#23)(2008-3#10)(2008-4#23)(2008-5#5)(2008-6#15)(2008-7#14)(2008-8#5)(2008-9#7)(2009-1#1)(2009-10#2)(2009-11#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-12#2)(2010-2#4)(2010-4#1)(2010-5#1)(2010-6#6)(2010-7#3)(2010-8#3)(2010-9#3)(2011-1#5)(2011-12#1)(2011-2#9)(2011-7#3)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#12)(2013-7#2)(2013-8#2)
visualization-based##4##1##(2013-1#4)
visualizations of##2##2##(2008-2#1)(2009-3#1)
visualizations##10##1##(2008-2#2)(2008-4#1)(2008-6#2)(2009-3#1)(2009-9#1)(2010-12#1)(2013-1#2)
visualize DNA##2##2##(2008-4#1)(2008-7#1)
visualize and analyze##2##3##(1992-10#1)(2008-4#1)
visualize and quantify##3##3##(2007-8#1)(2012-2#2)
visualize and##8##2##(1992-10#1)(2006-9#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-6#1)(2012-2#2)
visualize phylogenetic##2##2##(2008-4#2)
visualize the pancreas##2##3##(2010-12#2)
visualize the##36##2##(1990-5#1)(1991-12#1)(1992-12#1)(1993-4#1)(1994-5#1)(1996-11#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-8#1)(2009-7#1)(2010-1#2)(2010-12#2)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-11#2)(2012-12#1)(2013-1#2)(2013-8#2)
visualize##93##1##(1990-10#1)(1990-12#1)(1990-5#1)(1991-12#1)(1992-10#1)(1992-12#1)(1993-4#1)(1994-5#1)(1995-11#1)(1996-11#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#2)(2005-11#3)(2006-6#2)(2006-9#2)(2007-1#1)(2007-11#2)(2007-12#4)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#11)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-11#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#3)
visualized and##6##2##(1993-11#1)(2006-8#1)(2007-12#1)(2008-5#1)(2010-8#1)(2010-9#1)
visualized as##3##2##(1996-5#1)(2008-10#1)(2010-5#1)
visualized by autoradiography##2##3##(1990-7#1)(1991-7#1)
visualized by confocal microscopy##2##4##(2008-10#1)(2008-7#1)
visualized by digital infrared thermography##2##5##(2008-10#2)
visualized by electron##2##3##(1991-9#1)(2010-4#1)
visualized by fluorescence##2##3##(2008-10#1)(2008-5#1)
visualized by gold particles##2##4##(2007-9#1)(2008-9#1)
visualized by means of##2##4##(2008-11#1)(2008-9#1)
visualized by positron emission tomography##2##5##(1992-3#1)(1996-5#1)
visualized by silver staining##4##4##(1990-11#1)(1992-8#1)(1995-12#1)(2010-9#1)
visualized by staining##2##3##(2008-8#1)(2013-1#1)
visualized by##48##2##(1990-11#1)(1990-7#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-12#1)(1995-12#1)(1995-6#1)(1995-7#1)(1996-5#1)(1997-1#1)(2005-12#1)(2005-8#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-6#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-11#2)(2013-1#1)
visualized directly##3##2##(1993-4#1)(2007-1#1)(2008-4#1)
visualized from##2##2##(2008-11#1)(2008-3#1)
visualized in the##4##3##(1991-9#1)(1995-7#1)(2008-9#1)(2011-12#1)
visualized in##30##2##(1990-7#1)(1991-9#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-11#1)(1994-9#1)(1995-10#1)(1995-12#2)(1995-7#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#1)(2010-12#1)(2011-12#1)(2012-12#1)(2012-2#2)
visualized on the##2##3##(2008-10#1)(2008-7#1)
visualized on##6##2##(2007-10#1)(2008-10#3)(2008-7#1)(2013-1#1)
visualized the##2##2##(2008-10#1)(2011-1#1)
visualized under##2##2##(2006-8#1)(2013-8#1)
visualized using##9##2##(1992-1#1)(1992-8#1)(1995-11#1)(1996-6#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-12#1)
visualized with##7##2##(1996-12#1)(1996-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)
visualized within##2##2##(2007-12#1)(2008-9#1)
visualized##163##1##(1990-11#1)(1990-7#2)(1991-7#1)(1991-9#3)(1992-1#1)(1992-3#2)(1992-7#1)(1992-8#3)(1993-10#1)(1993-11#3)(1993-12#2)(1993-4#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-6#1)(1995-7#2)(1995-8#1)(1996-12#1)(1996-2#2)(1996-5#2)(1996-6#2)(1997-1#2)(1997-4#1)(1997-8#2)(2005-11#1)(2005-12#1)(2005-5#1)(2005-8#1)(2006-10#2)(2006-3#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-12#6)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#21)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#8)(2008-7#2)(2008-8#2)(2008-9#9)(2009-10#3)(2009-11#1)(2009-4#1)(2009-6#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#1)
visualizes##4##1##(1997-8#1)(2007-5#1)(2008-3#1)(2008-4#1)
visualizing a##3##2##(2008-7#1)(2013-1#2)
visualizing the##9##2##(1996-1#1)(1997-2#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-2#1)(2010-2#1)
visualizing##37##1##(1996-1#1)(1997-2#1)(1997-4#1)(2006-6#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#6)(2008-6#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#4)
visually and##9##2##(2007-10#1)(2008-10#2)(2008-2#4)(2008-5#2)
visually distinguishable##2##2##(2008-1#1)(2008-11#1)
visually evoked potential##2##3##(1992-8#2)
visually evoked##7##2##(1990-4#3)(1992-8#2)(1992-9#1)(1994-3#1)
visually for##4##2##(2006-6#1)(2007-2#1)(2008-10#2)
visually guided##4##2##(1993-2#2)(1995-12#1)(2010-10#1)
visually impaired##9##2##(1992-7#1)(2005-10#4)(2007-1#3)(2013-8#1)
visually mediated##2##2##(2008-11#2)
visually or##3##2##(2008-10#1)(2008-4#1)(2012-2#1)
visually presented##5##2##(1990-8#1)(1995-2#1)(2008-9#1)(2009-4#1)(2012-2#1)
visually selected##2##2##(1996-6#1)(2008-12#1)
visually##106##1##(1990-12#1)(1990-4#3)(1990-8#1)(1992-10#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-12#1)(1993-2#3)(1993-8#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-1#1)(1996-3#1)(1996-6#1)(2005-10#4)(2006-10#1)(2006-11#1)(2006-6#1)(2007-1#4)(2007-10#1)(2007-2#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#16)(2008-11#3)(2008-12#3)(2008-2#11)(2008-3#2)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2010-10#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-7#2)(2013-8#2)
visually)##2##1##(2006-9#1)(2008-10#1)
visuals##2##1##(2009-9#1)(2013-1#1)
visuo-motor coordination##4##2##(2008-7#4)
visuo-motor##7##1##(1992-9#1)(2008-1#1)(2008-7#4)(2011-2#1)
visuo-proprioceptive vestibulo-postural rehabilitation##2##3##(2011-1#2)
visuo-proprioceptive##3##1##(2011-1#3)
visuo-spatial and##2##2##(2008-7#1)(2011-1#1)
visuo-spatial memory##2##2##(1997-2#2)
visuo-spatial##7##1##(1993-7#1)(1995-12#1)(1996-1#1)(1997-2#2)(2008-7#1)(2011-1#1)
visuomotor##5##1##(1996-2#1)(2005-10#1)(2007-8#3)
visuospatial configural##3##2##(1993-9#3)
visuospatial processing##4##2##(1993-9#1)(2011-2#1)(2012-2#2)
visuospatial skills##2##2##(2008-6#2)
visuospatial##21##1##(1992-1#1)(1993-9#5)(1997-7#1)(2005-10#1)(2006-3#1)(2008-11#1)(2008-6#2)(2008-7#1)(2009-10#2)(2009-6#1)(2011-2#1)(2012-2#4)
vital activity##3##2##(2008-8#1)(2010-9#2)
vital and##2##2##(1993-3#1)(2007-8#1)
vital biological##3##2##(2008-10#1)(2010-9#1)(2012-1#1)
vital calves##2##2##(1994-7#2)
vital capacity (VC)##2##3##(2012-2#1)(2013-1#1)
vital capacity in supine##2##4##(2012-3#2)
vital capacity##22##2##(1993-7#1)(1997-3#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-7#1)(2009-6#1)(2011-2#1)(2012-2#3)(2012-3#4)(2013-1#2)
vital clinical##2##2##(1996-3#1)(2008-11#1)
vital component of##3##3##(2010-12#1)(2012-1#1)(2012-12#1)
vital components##4##2##(1990-5#1)(2005-8#1)(2007-4#1)(2012-2#1)
vital disability##2##2##(2010-9#2)
vital dyes##2##2##(2008-11#1)(2008-9#1)
vital events##2##2##(1993-2#1)(2013-1#1)
vital exhaustion##3##2##(2008-11#3)
vital for patients##2##3##(2007-10#1)(2013-1#1)
vital for the##4##3##(1994-2#1)(1994-3#1)(2005-5#1)(2012-2#1)
vital for##24##2##(1994-2#1)(1994-3#1)(1997-6#1)(2005-5#1)(2007-10#1)(2007-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-8#2)(2009-9#1)(2010-10#1)(2011-1#2)(2012-12#1)(2012-2#2)(2012-5#1)(2013-1#1)(2013-8#1)
vital function##2##2##(1991-7#1)(2012-2#1)
vital functions were acutely threatened##2##5##(1993-5#2)
vital functions##6##2##(1993-5#3)(2006-10#1)(2009-10#1)(2013-8#1)
vital if##2##2##(1994-7#1)(2008-12#1)
vital importance##9##2##(1993-1#1)(1993-3#1)(1994-10#1)(1994-2#1)(2008-5#2)(2009-6#1)(2009-8#1)(2012-12#1)
vital in##5##2##(2007-5#1)(2007-9#1)(2008-6#1)(2012-1#1)(2012-12#1)
vital link##2##2##(1997-3#1)(2008-11#1)
vital organs and##2##3##(1994-3#1)(2007-9#1)
vital organs##7##2##(1994-3#1)(2006-10#1)(2007-9#1)(2010-12#2)(2010-8#1)(2012-2#1)
vital pulp##2##2##(2012-12#1)(2012-2#1)
vital records##6##2##(2012-12#4)(2013-1#2)
vital registration##2##2##(2008-11#1)(2012-12#1)
vital role in the regulation of##2##6##(2006-10#1)(2008-4#1)
vital role in the##9##4##(2006-10#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-3#1)(2012-12#2)
vital role in##25##3##(1990-12#2)(2006-10#1)(2006-4#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#5)
vital role of##2##3##(1990-12#1)(2009-4#1)
vital role##33##2##(1990-11#1)(1990-12#3)(1993-1#1)(1993-12#1)(2006-10#1)(2006-4#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#6)
vital sign##3##2##(2005-9#1)(2008-2#1)(2012-12#1)
vital signs and##2##3##(2008-7#1)(2010-8#1)
vital signs are##2##3##(2005-8#1)(2012-3#1)
vital signs monitoring##2##3##(2006-1#1)(2010-8#1)
vital signs of##3##3##(2013-1#3)
vital signs##26##2##(1993-3#1)(1995-1#1)(1995-3#1)(1996-1#1)(2004-4#1)(2005-8#1)(2006-1#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-7#1)(2010-10#1)(2010-8#5)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
vital statistics systems##5##3##(2012-12#5)
vital statistics##14##2##(1991-12#1)(1992-6#1)(1997-3#1)(1997-8#1)(2012-12#9)(2013-1#1)
vital status##4##2##(1995-12#1)(2008-7#1)(2011-2#1)(2012-12#1)
vital structures##4##2##(2007-12#1)(2008-7#1)(2012-12#1)(2012-2#1)
vital systems##2##2##(1996-12#1)(2007-8#1)
vital that radiologists##2##3##(2007-4#1)(2012-2#1)
vital that the##4##3##(2007-11#1)(2008-1#1)(2008-11#1)(2013-1#1)
vital that##11##2##(1990-12#1)(1997-1#1)(2007-11#2)(2007-4#1)(2008-1#1)(2008-11#1)(2012-2#1)(2013-1#3)
vital to ensure##2##3##(2009-1#1)(2012-11#1)
vital to the success of##2##5##(2012-2#1)(2013-8#1)
vital to the##11##3##(1993-9#1)(1995-3#1)(2006-5#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-10#1)(2010-4#1)(2012-2#1)(2013-8#1)
vital to their##3##3##(1996-2#1)(2007-2#1)(2008-5#1)
vital to##39##2##(1990-7#1)(1991-1#1)(1993-9#1)(1995-3#1)(1996-2#1)(2005-12#1)(2006-5#1)(2006-7#1)(2007-2#1)(2007-4#2)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-8#3)
vital##374##1##(1990-11#2)(1990-12#4)(1990-2#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-12#1)(1993-2#2)(1993-3#3)(1993-5#3)(1993-7#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-2#4)(1994-3#2)(1994-6#1)(1994-7#3)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#4)(1997-6#1)(1997-8#1)(2004-2#1)(2004-4#2)(2005-12#1)(2005-5#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#3)(2007-11#4)(2007-12#2)(2007-2#2)(2007-4#4)(2007-5#2)(2007-7#3)(2007-8#5)(2007-9#4)(2008-1#6)(2008-10#11)(2008-11#19)(2008-12#5)(2008-2#6)(2008-3#2)(2008-4#4)(2008-5#10)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#10)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#6)(2010-12#7)(2010-3#2)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#7)(2010-9#7)(2011-1#5)(2011-2#13)(2012-1#4)(2012-11#1)(2012-12#30)(2012-2#17)(2012-3#7)(2012-5#1)(2013-1#22)(2013-7#4)(2013-8#12)
vitalba##2##1##(2010-3#2)
vitality and##2##2##(2008-1#1)(2011-1#1)
vitality of##8##2##(1990-3#1)(1991-5#2)(1994-7#1)(2007-8#1)(2008-11#1)(2011-2#2)
vitality##28##1##(1990-3#1)(1990-9#1)(1991-5#2)(1994-7#2)(2005-11#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-11#2)(2011-1#3)(2011-2#6)(2012-12#1)(2012-2#1)(2013-1#4)
vitally important in##2##3##(1991-11#1)(1993-2#1)
vitally important##4##2##(1991-11#1)(1993-2#1)(2007-11#1)(2008-4#1)
vitally##5##1##(1991-11#1)(1991-12#1)(1993-2#1)(2007-11#1)(2008-4#1)
vitals and haematology##2##3##(2012-2#2)
vitamin A (retinol)##2##3##(1992-2#1)(2008-8#1)
vitamin A acetate##7##3##(2008-11#7)
vitamin A and E##3##4##(2008-4#2)(2011-2#1)
vitamin A and iodine deficiencies##3##5##(1993-6#1)(2006-10#2)
vitamin A and##9##3##(1993-12#1)(1993-3#1)(1993-6#1)(2006-10#2)(2008-4#2)(2011-2#2)
vitamin A concentrations##2##3##(2008-7#2)
vitamin A deficiency among##2##4##(1991-8#2)
vitamin A deficiency and##3##4##(1991-2#1)(2007-11#2)
vitamin A deficiency disorders##2##4##(2006-10#2)
vitamin A deficiency##29##3##(1991-2#2)(1991-8#6)(1992-9#2)(1993-10#1)(2006-10#3)(2007-1#1)(2007-11#2)(2008-1#3)(2008-7#4)(2012-1#4)(2013-7#1)
vitamin A deficient rats##2##4##(1995-3#2)
vitamin A deficient##7##3##(1995-3#3)(2006-10#1)(2008-7#3)
vitamin A derivatives##3##3##(2006-12#1)(2008-4#1)(2009-8#1)
vitamin A in##4##3##(1992-9#1)(1993-12#2)(2012-1#1)
vitamin A intake##3##3##(1996-3#1)(2011-1#2)
vitamin A intestinal absorption##2##4##(2006-10#2)
vitamin A is##3##3##(1995-9#3)
vitamin A status##4##3##(1991-2#1)(1994-12#1)(2006-10#1)(2007-11#1)
vitamin A stores##2##3##(1995-3#1)(2013-1#1)
vitamin A sufficient##2##3##(1995-3#1)(2008-7#1)
vitamin A supplementation##3##3##(2006-10#1)(2007-11#1)(2010-5#1)
vitamin A treatment##3##3##(1992-2#1)(1997-8#1)(2006-10#1)
vitamin A##143##2##(1990-5#3)(1991-11#1)(1991-2#3)(1991-8#6)(1992-2#2)(1992-8#1)(1992-9#4)(1993-10#1)(1993-12#5)(1993-3#2)(1993-6#1)(1993-9#1)(1994-12#5)(1995-1#2)(1995-3#5)(1995-9#4)(1996-3#1)(1996-5#2)(1997-8#1)(2004-11#1)(2006-10#20)(2006-12#1)(2006-4#3)(2006-5#2)(2007-1#1)(2007-11#8)(2007-7#2)(2008-1#4)(2008-11#7)(2008-12#1)(2008-4#4)(2008-5#4)(2008-7#11)(2008-8#4)(2009-5#1)(2009-6#1)(2009-8#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-1#8)(2013-1#3)(2013-7#1)
vitamin A)##2##2##(2007-11#2)
vitamin A-deficient rats##3##3##(1992-9#1)(1993-12#1)(1994-12#1)
vitamin A-deficient##4##2##(1992-9#1)(1993-12#1)(1994-12#1)(2012-1#1)
vitamin B(12##2##2##(2008-11#2)
vitamin B(12) and##3##3##(2008-10#1)(2008-3#2)
vitamin B(12) deficiency##2##3##(2008-7#2)
vitamin B(12) did not promote##2##5##(2008-11#2)
vitamin B(12)##14##2##(2007-10#1)(2008-10#1)(2008-11#4)(2008-3#3)(2008-7#2)(2011-1#3)
vitamin B(2)##3##2##(2008-10#2)(2008-3#1)
vitamin B(6)##6##2##(2004-11#2)(2007-10#1)(2008-3#2)(2008-8#1)
vitamin B1 and##2##3##(2008-1#1)(2011-2#1)
vitamin B12 absorption##2##3##(1992-12#1)(2008-8#1)
vitamin B12 and folate##2##4##(1990-5#1)(1996-4#1)
vitamin B12 and iron##2##4##(2010-12#2)
vitamin B12 and##17##3##(1990-5#1)(1991-2#3)(1993-12#1)(1996-4#6)(2005-7#1)(2008-5#1)(2010-1#1)(2010-12#3)
vitamin B12 concentration##2##3##(1990-3#2)
vitamin B12 concentrations##3##3##(2005-7#3)
vitamin B12 deficiencies##2##3##(2013-8#2)
vitamin B12 deficiency in##2##4##(2013-7#2)
vitamin B12 deficiency were##2##4##(1990-3#1)(2013-8#1)
vitamin B12 deficiency##18##3##(1990-3#5)(1990-5#1)(1991-2#1)(1993-12#1)(1995-11#1)(2006-2#1)(2007-9#1)(2010-12#1)(2013-7#5)(2013-8#1)
vitamin B12 in##4##3##(2005-7#1)(2006-2#1)(2010-12#1)(2013-8#1)
vitamin B12 is not##2##4##(1992-12#1)(2009-9#1)
vitamin B12 is##3##3##(1992-1#1)(1992-12#1)(2009-9#1)
vitamin B12 level##3##3##(1990-3#1)(2010-1#1)(2013-7#1)
vitamin B12 levels##4##3##(1990-3#2)(1993-12#1)(2007-1#1)
vitamin B12 or B-complex##2##4##(2010-1#2)
vitamin B12 or##3##3##(1992-9#1)(2010-1#2)
vitamin B12 routine fortification##2##4##(2010-1#2)
vitamin B12 status##3##3##(1993-12#1)(2012-1#1)(2012-3#1)
vitamin B12##105##2##(1990-3#13)(1990-5#2)(1991-2#7)(1992-1#4)(1992-12#4)(1992-9#2)(1993-12#11)(1994-6#1)(1995-11#3)(1996-4#7)(1997-2#1)(2005-10#1)(2005-7#5)(2006-12#1)(2006-2#3)(2007-1#1)(2007-9#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-1#10)(2010-12#6)(2012-1#1)(2012-3#1)(2013-7#7)(2013-8#10)
vitamin B6 compounds##2##3##(2006-12#2)
vitamin B6 deficiency##3##3##(1991-5#1)(1994-12#2)
vitamin B6##21##2##(1991-2#1)(1991-5#2)(1991-8#4)(1992-9#2)(1993-7#2)(1994-12#2)(2004-11#1)(2005-10#1)(2006-12#2)(2008-4#1)(2013-1#3)
vitamin B6-deficient##2##2##(1991-5#1)(1994-12#1)
vitamin C (2g/L)##2##3##(2013-8#2)
vitamin C administration##5##3##(1997-3#1)(2008-8#1)(2011-1#3)
vitamin C and E##2##4##(2008-5#1)(2010-11#1)
vitamin C and##10##3##(1992-9#1)(1995-7#1)(2006-12#1)(2007-11#1)(2008-5#2)(2010-11#1)(2010-6#1)(2010-7#1)(2011-1#1)
vitamin C as well as##2##5##(1992-9#1)(2012-2#1)
vitamin C as##3##3##(1992-9#1)(2008-5#1)(2012-2#1)
vitamin C can##2##3##(1992-9#1)(1994-2#1)
vitamin C concentrations##2##3##(1994-10#1)(2012-2#1)
vitamin C from##3##3##(2010-12#1)(2011-1#2)
vitamin C in the##2##4##(2008-8#1)(2010-12#1)
vitamin C in##9##3##(1995-7#1)(2006-1#2)(2008-10#3)(2008-8#1)(2010-12#2)
vitamin C is##5##3##(1992-9#1)(2012-2#3)(2013-7#1)
vitamin C level was##2##4##(1996-1#1)(2011-1#1)
vitamin C level##3##3##(1992-9#1)(1996-1#1)(2011-1#1)
vitamin C levels in different brain areas of##2##8##(2011-1#2)
vitamin C levels in##3##4##(2011-1#3)
vitamin C levels of##3##4##(1996-1#3)
vitamin C levels were##2##4##(1996-1#1)(2011-1#1)
vitamin C levels##9##3##(1992-9#1)(1996-1#4)(2011-1#4)
vitamin C on##6##3##(1992-9#1)(2008-8#1)(2012-1#1)(2013-7#1)(2013-8#2)
vitamin C or E##2##4##(1992-9#1)(2008-1#1)
vitamin C supplementation##5##3##(1992-9#1)(1996-12#2)(1997-3#1)(2011-2#1)
vitamin C tablet##4##3##(2008-10#4)
vitamin C tablets##2##3##(2008-10#2)
vitamin C to the##2##4##(1997-3#1)(2013-8#1)
vitamin C##149##2##(1990-5#1)(1991-5#2)(1992-9#12)(1993-9#1)(1994-10#3)(1994-2#3)(1995-5#1)(1995-7#4)(1996-1#5)(1996-12#2)(1996-6#1)(1997-3#4)(1997-4#1)(1997-8#1)(2005-10#1)(2006-1#2)(2006-10#3)(2006-12#2)(2006-6#1)(2007-1#1)(2007-11#1)(2007-9#2)(2008-1#3)(2008-10#16)(2008-12#1)(2008-3#1)(2008-5#7)(2008-8#6)(2009-9#1)(2010-11#1)(2010-12#7)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#17)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#11)(2013-7#5)(2013-8#11)
vitamin C)##5##2##(1991-2#1)(2006-10#1)(2010-8#1)(2013-7#1)(2013-8#1)
vitamin D 24-hydroxylase##2##3##(1994-11#2)
vitamin D and calcium##2##4##(1990-11#1)(2008-5#1)
vitamin D and thyroid hormone##2##5##(1993-3#2)
vitamin D and##9##3##(1990-11#1)(1993-3#2)(2006-12#1)(2008-10#1)(2008-5#1)(2010-10#1)(2012-3#1)(2013-7#1)
vitamin D as a##2##4##(2010-12#1)(2011-2#1)
vitamin D compounds##3##3##(1991-8#2)(1992-9#1)
vitamin D deficiency (VDD)##2##4##(2010-3#1)(2011-1#1)
vitamin D deficiency and##2##4##(2008-11#1)(2013-7#1)
vitamin D deficiency has been associated with a lower pain threshold which increases when vitamin D deficiency is corrected##2##19##(2013-1#2)
vitamin D deficiency has been##3##5##(2011-2#1)(2013-1#2)
vitamin D deficiency has##4##4##(2011-2#1)(2012-2#1)(2013-1#2)
vitamin D deficiency in##8##4##(1993-8#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
vitamin D deficiency is##4##4##(2005-1#1)(2010-7#1)(2013-1#2)
vitamin D deficiency rickets##2##4##(2011-1#2)
vitamin D deficiency was##2##4##(2011-2#1)(2012-12#1)
vitamin D deficiency##36##3##(1993-8#1)(2005-1#2)(2007-2#1)(2008-11#1)(2010-3#1)(2010-7#2)(2011-1#4)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#2)
vitamin D derivatives##3##3##(1991-1#2)(2013-8#1)
vitamin D endocrine system##3##4##(2008-4#2)(2008-7#1)
vitamin D has##4##3##(1992-9#1)(2010-12#1)(2010-6#1)(2013-7#1)
vitamin D in reducing##2##4##(2010-7#2)
vitamin D in the prevention##2##5##(1997-6#1)(2012-12#1)
vitamin D in##7##3##(1997-6#1)(2010-10#1)(2010-7#2)(2012-12#2)(2012-2#1)
vitamin D insufficiency and##3##4##(1993-11#1)(2008-7#1)(2012-3#1)
vitamin D insufficient##2##3##(2012-2#1)(2012-3#1)
vitamin D intake##2##3##(2005-12#1)(2008-3#1)
vitamin D is also##2##4##(2005-3#1)(2008-4#1)
vitamin D levels are##2##4##(2012-2#1)(2012-3#1)
vitamin D levels in##2##4##(2010-12#1)(2013-1#1)
vitamin D levels##19##3##(2005-12#1)(2006-12#1)(2008-1#1)(2010-12#1)(2012-12#5)(2012-2#3)(2012-3#3)(2013-1#4)
vitamin D may##3##3##(1994-3#1)(2010-6#1)(2012-12#1)
vitamin D metabolism##2##3##(2008-4#1)(2012-12#1)
vitamin D metabolite##2##3##(1992-1#1)(2010-7#1)
vitamin D metabolites##5##3##(1993-11#1)(2005-1#2)(2007-8#1)(2012-12#1)
vitamin D on##2##3##(1992-1#1)(1993-9#1)
vitamin D or##2##3##(2005-1#1)(2005-3#1)
vitamin D receptor (VDR) and##2##5##(2010-7#1)(2012-12#1)
vitamin D receptor (VDR)##12##4##(1992-6#1)(1993-6#1)(1994-11#1)(1995-2#1)(2005-11#1)(2008-4#1)(2008-7#1)(2010-7#1)(2012-12#3)(2012-2#1)
vitamin D receptor##19##3##(1992-6#1)(1993-6#1)(1994-11#1)(1995-2#2)(2005-11#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-3#1)(2010-7#2)(2012-12#4)(2012-2#2)(2013-1#1)
vitamin D receptors##2##3##(1994-11#1)(2008-3#1)
vitamin D response element (VDRE)##3##5##(1992-12#1)(1994-11#1)(2012-12#1)
vitamin D response##5##3##(1992-12#1)(1994-11#1)(1995-8#1)(2008-1#1)(2012-12#1)
vitamin D status of##4##4##(1990-4#2)(2011-2#1)(2012-1#1)
vitamin D status with##2##4##(2012-2#1)(2013-7#1)
vitamin D status##14##3##(1990-4#2)(2010-6#1)(2010-7#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-7#3)
vitamin D supplementation##3##3##(2008-8#1)(2010-11#1)(2010-9#1)
vitamin D supplements##3##3##(2010-3#2)(2012-1#1)
vitamin D synthesis##5##3##(2008-10#2)(2010-9#1)(2011-2#1)(2012-3#1)
vitamin D treatment##2##3##(2010-10#1)(2011-1#1)
vitamin D was##2##3##(1991-11#1)(2012-3#1)
vitamin D were##3##3##(1992-1#1)(2013-1#2)
vitamin D with##4##3##(2006-10#1)(2008-1#1)(2010-12#2)
vitamin D##254##2##(1990-11#1)(1990-4#3)(1991-1#2)(1991-11#2)(1991-5#1)(1991-7#2)(1991-8#2)(1992-1#5)(1992-12#1)(1992-6#1)(1992-9#3)(1993-11#4)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#5)(1994-3#4)(1994-8#1)(1994-9#2)(1995-2#3)(1995-4#1)(1995-8#2)(1997-6#1)(2005-1#6)(2005-11#1)(2005-12#2)(2005-3#4)(2006-10#5)(2006-12#4)(2007-11#2)(2007-2#1)(2007-8#1)(2008-1#8)(2008-10#4)(2008-11#1)(2008-3#5)(2008-4#7)(2008-5#4)(2008-7#6)(2008-8#1)(2009-12#1)(2009-2#2)(2010-10#4)(2010-11#1)(2010-12#6)(2010-3#4)(2010-6#4)(2010-7#13)(2010-9#4)(2011-1#9)(2011-2#6)(2012-1#4)(2012-12#20)(2012-2#19)(2012-3#16)(2013-1#17)(2013-7#6)(2013-8#4)
vitamin D(2) into##3##3##(2008-10#3)
vitamin D(2)##8##2##(2008-10#8)
vitamin D(3) derivative##2##3##(2010-12#2)
vitamin D(3)##6##2##(2008-10#2)(2008-11#1)(2010-12#2)(2012-12#1)
vitamin D-dependent##2##2##(1991-9#1)(2012-12#1)
vitamin D-fortified doogh##2##3##(2013-7#2)
vitamin D/250 mL)##3##2##(2013-7#3)
vitamin D3 and##2##3##(1993-11#1)(2005-1#1)
vitamin D3 receptor##2##3##(1993-3#1)(1994-9#1)
vitamin D3##20##2##(1991-10#1)(1991-12#1)(1991-5#2)(1992-5#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-9#2)(1996-11#1)(1996-5#1)(1997-5#1)(1997-7#2)(2005-1#3)(2008-8#1)
vitamin E analogue##2##3##(1995-6#1)(2013-1#1)
vitamin E and C##2##4##(2008-10#1)(2011-2#1)
vitamin E and beta-carotene##5##4##(1991-2#2)(1995-3#3)
vitamin E and##14##3##(1991-2#2)(1994-5#1)(1995-3#4)(2004-12#1)(2005-9#1)(2008-10#1)(2008-7#1)(2010-4#1)(2011-2#1)(2013-8#1)
vitamin E are##3##3##(1991-2#1)(2007-2#1)(2008-10#1)
vitamin E by##2##3##(2008-10#1)(2008-5#1)
vitamin E deficiency##4##3##(1994-5#3)(2004-11#1)
vitamin E deficient##4##3##(1994-5#3)(2004-11#1)
vitamin E in the##3##4##(1994-6#1)(1995-6#1)(2008-10#1)
vitamin E in##17##3##(1992-9#6)(1994-5#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-3#1)(2007-11#1)(2008-10#3)(2008-5#1)(2010-8#1)
vitamin E is##4##3##(1992-9#1)(1995-8#1)(1996-3#1)(2008-10#1)
vitamin E levels##4##3##(1993-2#1)(2007-8#1)(2008-5#1)(2008-7#1)
vitamin E on##6##3##(1990-2#1)(1992-9#1)(1993-12#1)(1993-6#1)(2008-8#1)(2011-1#1)
vitamin E or##3##3##(1995-3#1)(2007-8#2)
vitamin E quinone##3##3##(1995-8#3)
vitamin E sufficient##7##3##(1994-5#7)
vitamin E to##2##3##(1991-12#1)(1993-6#1)
vitamin E was##2##3##(1990-8#2)
vitamin E##148##2##(1990-2#2)(1990-8#3)(1991-12#3)(1991-2#6)(1991-9#1)(1992-7#1)(1992-9#11)(1993-12#1)(1993-2#1)(1993-6#4)(1994-2#3)(1994-5#15)(1994-6#2)(1995-12#1)(1995-3#5)(1995-6#3)(1995-8#5)(1996-3#5)(2004-11#2)(2004-12#1)(2005-9#1)(2006-10#2)(2007-11#1)(2007-2#2)(2007-8#4)(2007-9#3)(2008-1#2)(2008-10#11)(2008-12#2)(2008-4#1)(2008-5#11)(2008-6#1)(2008-7#6)(2008-8#4)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#7)(2013-8#2)
vitamin E-deficient##2##2##(1991-2#1)(1995-6#1)
vitamin E-modified##8##2##(2007-7#4)(2008-1#4)
vitamin E-supplemented diet##2##3##(1991-2#2)
vitamin K cycle##3##3##(1995-1#1)(2009-11#2)
vitamin K deficiency in##2##4##(1992-12#1)(1996-6#1)
vitamin K deficiency##5##3##(1990-11#1)(1992-12#1)(1996-6#1)(1997-7#1)(2008-8#1)
vitamin K responsiveness##2##3##(1990-11#2)
vitamin K##30##2##(1990-11#8)(1990-5#1)(1990-6#4)(1992-12#1)(1995-1#3)(1995-4#1)(1996-6#1)(1997-7#2)(2004-12#1)(2006-4#1)(2008-7#1)(2008-8#1)(2009-11#3)(2013-1#2)
vitamin K(1)##4##2##(2008-10#4)
vitamin K-dependent carboxylase##2##3##(1991-5#1)(1995-8#1)
vitamin K-dependent coagulation factors##2##4##(1994-4#1)(1995-1#1)
vitamin K-dependent gamma-glutamyl carboxylase##2##4##(1990-5#1)(2009-4#1)
vitamin K-dependent proteins##5##3##(1997-4#5)
vitamin K-dependent##19##2##(1990-5#1)(1991-5#1)(1992-12#3)(1992-9#1)(1994-11#2)(1994-4#1)(1995-1#2)(1995-8#1)(1997-4#5)(2009-11#1)(2009-4#1)
vitamin K-treated cells##2##3##(1995-1#2)
vitamin K1##2##2##(1992-11#1)(1992-12#1)
vitamin K2##7##2##(2008-8#7)
vitamin K3 in##2##3##(1991-12#1)(2005-4#1)
vitamin K3##7##2##(1991-12#4)(2005-4#1)(2008-10#2)
vitamin and mineral supplements##2##4##(2008-11#2)
vitamin and mineral##7##3##(1990-3#2)(1997-3#2)(2004-4#1)(2008-11#2)
vitamin and##12##2##(1990-3#2)(1997-3#2)(2004-4#1)(2008-10#3)(2008-11#2)(2011-2#1)(2012-11#1)
vitamin content##2##2##(2006-4#1)(2011-2#1)
vitamin d##5##2##(2008-4#1)(2008-5#1)(2011-1#2)(2011-2#1)
vitamin deficiencies##3##2##(1997-8#1)(2004-11#1)(2010-12#1)
vitamin deficiency##3##2##(1992-9#1)(2005-9#1)(2006-10#1)
vitamin for##2##2##(2009-4#1)(2010-6#1)
vitamin pills##4##2##(1996-8#1)(2008-10#3)
vitamin status##3##2##(1992-9#2)(2006-10#1)
vitamin supplements##7##2##(1992-9#1)(2005-10#3)(2008-11#1)(2013-1#2)
vitamin tablets##5##2##(2008-10#5)
vitamin##1111##1##(1990-11#10)(1990-2#2)(1990-3#16)(1990-4#4)(1990-5#8)(1990-6#4)(1990-8#4)(1991-1#2)(1991-10#1)(1991-11#3)(1991-12#9)(1991-2#21)(1991-5#9)(1991-7#2)(1991-8#13)(1991-9#2)(1992-1#9)(1992-11#1)(1992-12#10)(1992-2#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#43)(1993-10#1)(1993-11#6)(1993-12#18)(1993-2#2)(1993-3#6)(1993-6#7)(1993-7#2)(1993-8#1)(1993-9#3)(1994-10#3)(1994-11#7)(1994-12#10)(1994-2#6)(1994-3#5)(1994-4#1)(1994-5#15)(1994-6#4)(1994-8#1)(1994-9#5)(1995-1#9)(1995-11#4)(1995-12#1)(1995-2#3)(1995-3#10)(1995-4#2)(1995-5#1)(1995-6#4)(1995-7#4)(1995-8#8)(1995-9#5)(1996-1#5)(1996-11#1)(1996-12#2)(1996-3#6)(1996-4#7)(1996-5#3)(1996-6#5)(1996-8#1)(1997-2#1)(1997-3#6)(1997-4#6)(1997-5#2)(1997-6#1)(1997-7#5)(1997-8#3)(2004-11#8)(2004-12#2)(2004-4#1)(2005-1#10)(2005-10#6)(2005-11#2)(2005-12#2)(2005-3#4)(2005-4#1)(2005-7#5)(2005-8#2)(2005-9#3)(2006-1#2)(2006-10#35)(2006-12#14)(2006-2#3)(2006-4#5)(2006-5#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#14)(2007-2#4)(2007-7#9)(2007-8#6)(2007-9#6)(2008-1#24)(2008-10#67)(2008-11#19)(2008-12#4)(2008-3#13)(2008-4#14)(2008-5#37)(2008-6#1)(2008-7#28)(2008-8#27)(2009-11#5)(2009-12#1)(2009-2#2)(2009-4#2)(2009-5#2)(2009-6#2)(2009-8#1)(2009-9#5)(2010-1#10)(2010-10#5)(2010-11#2)(2010-12#24)(2010-3#4)(2010-4#1)(2010-5#2)(2010-6#6)(2010-7#14)(2010-8#3)(2010-9#9)(2011-1#37)(2011-12#2)(2011-2#15)(2012-1#17)(2012-11#1)(2012-12#26)(2012-2#31)(2012-3#18)(2013-1#35)(2013-7#26)(2013-8#28)
vitamins A and E##7##4##(2006-10#1)(2007-7#2)(2008-10#1)(2008-4#3)
vitamins A##11##2##(2004-11#1)(2006-10#1)(2007-11#2)(2007-7#2)(2008-10#1)(2008-11#1)(2008-4#3)
vitamins C and E##5##4##(1991-5#1)(1992-9#2)(2006-12#1)(2008-5#1)
vitamins C##6##2##(1991-5#1)(1992-9#3)(2006-12#1)(2008-5#1)
vitamins E and C caused a significant##3##7##(2008-6#3)
vitamins E and C##11##4##(2008-6#10)(2009-6#1)
vitamins E and##13##3##(1992-9#1)(2008-11#1)(2008-6#10)(2009-6#1)
vitamins E##14##2##(1992-9#1)(2006-10#1)(2008-11#1)(2008-6#10)(2009-6#1)
vitamins and minerals##4##3##(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
vitamins and minerals)##2##3##(2011-1#1)(2013-8#1)
vitamins and##18##2##(1992-9#1)(1994-9#1)(1995-6#1)(2006-10#1)(2006-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#2)(2010-6#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#2)
vitamins have been used in the treatment of liver diseases##2##10##(2005-10#2)
vitamins have##3##2##(2005-10#2)(2006-10#1)
vitamins in pharmaceutical preparations##2##4##(2008-10#2)
vitamins in the##5##3##(1992-9#1)(2011-2#3)(2013-7#1)
vitamins in##11##2##(1992-9#1)(2004-11#1)(2007-11#1)(2008-10#3)(2008-5#1)(2011-2#3)(2013-7#1)
vitamins including##2##2##(1994-4#1)(2008-10#1)
vitamins is##2##2##(2011-2#2)
vitamins on##4##2##(1992-9#1)(1994-2#1)(2008-10#1)(2008-5#1)
vitamins to##2##2##(1994-3#1)(2007-11#1)
vitamins was##2##2##(2008-10#2)
vitamins were##2##2##(2008-5#1)(2009-8#1)
vitamins##145##1##(1990-10#1)(1990-4#1)(1990-8#1)(1991-5#1)(1992-9#12)(1994-2#1)(1994-3#1)(1994-4#1)(1994-9#1)(1995-6#2)(1997-3#2)(1997-6#1)(1997-8#1)(2004-11#4)(2005-10#2)(2006-10#10)(2006-11#1)(2006-12#1)(2006-8#2)(2007-11#6)(2007-7#3)(2007-8#4)(2008-1#1)(2008-10#23)(2008-11#6)(2008-12#2)(2008-3#2)(2008-4#5)(2008-5#11)(2008-6#10)(2008-7#1)(2008-8#2)(2009-2#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#2)
vitegnus##2##1##(2008-12#2)
vitellarium##2##1##(2007-12#2)
vitellin cleavage products##5##3##(2007-12#5)
vitellin##8##1##(2007-12#6)(2008-6#2)
vitelline coat of##3##3##(1993-6#3)
vitelline coat##5##2##(1993-6#4)(2008-6#1)
vitelline envelope and the chorion##2##5##(2008-12#2)
vitelline envelope and##3##3##(2007-12#1)(2008-12#2)
vitelline envelope##5##2##(1994-5#1)(2007-12#1)(2008-12#3)
vitelline##14##1##(1993-6#4)(1994-5#2)(2007-12#2)(2007-3#1)(2008-10#1)(2008-12#3)(2008-6#1)
vitellogenesis##12##1##(2007-12#4)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)
vitellogenic stage##3##2##(2008-5#1)(2008-6#2)
vitellogenic##6##1##(2007-3#1)(2008-5#1)(2008-6#3)(2010-5#1)
vitellogenin (Vg)##3##2##(1996-11#1)(2008-10#2)
vitellogenin and##2##2##(1995-8#1)(2010-4#1)
vitellogenin gene B1##2##3##(1994-12#2)
vitellogenin gene##5##2##(1994-12#3)(1996-11#1)(2010-5#1)
vitellogenin in##2##2##(2008-6#2)
vitellogenin is##2##2##(1995-8#2)
vitellogenin mRNA levels##2##3##(2008-6#2)
vitellogenin mRNA##3##2##(1995-10#1)(2008-6#2)
vitellogenin receptor##3##2##(1995-2#3)
vitellogenin synthesis##3##2##(1995-10#1)(2007-12#1)(2008-6#1)
vitellogenin using##2##2##(2008-10#2)
vitellogenin was##3##2##(2007-12#1)(2008-6#1)(2010-4#1)
vitellogenin##46##1##(1992-6#2)(1994-12#3)(1994-9#2)(1995-10#2)(1995-2#3)(1995-8#9)(1996-11#2)(2007-12#5)(2008-10#4)(2008-6#7)(2009-4#2)(2010-4#3)(2010-5#2)
vitellogenins##3##1##(1990-2#2)(1995-2#1)
vitians strains##6##2##(2008-10#6)
vitians##11##1##(2008-10#11)
viticola DNA in##2##3##(2008-10#2)
viticola DNA##4##2##(2008-10#4)
viticola and##2##2##(2008-10#2)
viticola was##2##2##(2008-10#2)
viticola##30##1##(2008-10#30)
vitiliginous##2##1##(2007-7#1)(2010-6#1)
vitiligo and alopecia areata##2##4##(2007-7#1)(2007-8#1)
vitiligo and psoriasis##4##3##(2006-12#1)(2010-6#3)
vitiligo and##11##2##(1996-1#1)(2006-12#1)(2007-7#2)(2007-8#1)(2008-4#1)(2009-6#1)(2010-6#4)
vitiligo has not been##2##4##(2009-6#1)(2010-12#1)
vitiligo has##3##2##(2009-6#1)(2010-12#1)(2013-1#1)
vitiligo in##3##2##(2007-7#1)(2009-1#1)(2010-12#1)
vitiligo is##2##2##(2007-7#1)(2007-8#1)
vitiligo on##2##2##(2010-6#1)(2013-1#1)
vitiligo patients##7##2##(1992-6#1)(2007-2#2)(2007-7#2)(2007-8#1)(2009-6#1)
vitiligo was##3##2##(2007-7#1)(2013-1#2)
vitiligo##92##1##(1992-6#2)(1996-1#1)(1996-3#1)(1997-8#1)(2006-12#5)(2007-2#3)(2007-5#2)(2007-7#39)(2007-8#9)(2008-4#1)(2008-8#1)(2009-1#1)(2009-6#8)(2010-12#4)(2010-6#5)(2011-2#1)(2012-12#1)(2013-1#7)
vitiligo-like depigmentation##4##2##(2010-6#4)
vitiligo-like##6##1##(2007-7#2)(2010-6#4)
vitis##12##1##(2008-10#12)
vitrectomy and##3##2##(2007-7#1)(2011-1#1)(2013-1#1)
vitrectomy##13##1##(2006-1#2)(2007-3#1)(2007-7#2)(2008-1#2)(2009-4#1)(2011-1#2)(2011-2#1)(2013-1#2)
vitreomacular##3##1##(2011-7#1)(2013-1#2)
vitreoretinal surgery##3##2##(2009-2#1)(2009-4#1)(2011-7#1)
vitreoretinal##4##1##(2009-2#1)(2009-4#1)(2011-2#1)(2011-7#1)
vitreous and##5##2##(1994-8#1)(2007-7#1)(2008-1#1)(2008-10#1)(2011-2#1)
vitreous body##4##2##(2006-11#1)(2012-1#2)(2013-1#1)
vitreous carbon (RVC)##2##3##(2008-10#2)
vitreous carbon##5##2##(2008-10#5)
vitreous cavity##2##2##(2007-11#1)(2011-1#1)
vitreous detachment##2##2##(2009-2#1)(2013-8#1)
vitreous fluid##3##2##(2007-12#2)(2008-1#1)
vitreous humor##4##2##(1996-9#1)(2006-1#1)(2009-3#2)
vitreous potassium level##2##3##(2006-1#2)
vitreous silica##3##2##(2008-2#1)(2008-3#2)
vitreous type IX collagen##2##4##(1992-5#2)
vitreous##61##1##(1992-5#4)(1994-8#6)(1996-9#2)(1997-7#3)(2006-1#3)(2006-11#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#2)(2007-7#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#3)(2009-2#1)(2009-3#2)(2009-4#2)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#2)(2013-1#1)(2013-7#1)(2013-8#1)
vitrification and one-step dilution##2##4##(2006-5#2)
vitrification and##3##2##(2006-5#2)(2009-6#1)
vitrification##10##1##(2006-10#1)(2006-5#3)(2008-10#2)(2009-6#1)(2012-2#1)(2012-3#1)(2013-8#1)
vitrified wastes##2##2##(2008-10#2)
vitrified##7##1##(1991-3#1)(1994-2#1)(2006-10#1)(2006-5#1)(2008-10#3)
vitrinus##2##1##(1996-12#2)
vitripennis##7##1##(2008-6#3)(2011-12#4)
vitro DNA##10##2##(1990-11#1)(1990-4#1)(1991-7#1)(1993-3#1)(1993-9#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-5#1)(2008-9#1)
vitro Evaluation of##6##3##(2008-10#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-2#1)
vitro T cell activation##2##4##(1996-7#2)
vitro T##3##2##(1996-7#2)(2009-9#1)
vitro absorption of##3##3##(1994-3#2)(2008-5#1)
vitro absorption##6##2##(1994-3#2)(2006-10#1)(2008-10#1)(2008-5#1)(2010-6#1)
vitro activities of##9##3##(1991-5#1)(1994-9#1)(1997-1#1)(1997-7#1)(2005-7#1)(2006-8#1)(2008-7#1)(2008-8#1)(2011-3#1)
vitro activities##12##2##(1991-5#1)(1994-9#1)(1996-10#1)(1997-1#1)(1997-7#1)(2005-7#1)(2006-12#1)(2006-8#1)(2008-7#1)(2008-8#1)(2011-3#1)(2012-2#1)
vitro activity of colistin or sulbactam in combination with fosfomycin or imipenem against##2##13##(2012-2#2)
vitro activity of##24##3##(1990-10#1)(1994-11#1)(1994-9#1)(1995-3#1)(1997-1#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#2)(2007-7#2)(2007-9#1)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#1)(2009-3#1)(2012-2#3)
vitro activity##54##2##(1990-10#1)(1990-6#1)(1991-12#2)(1992-4#1)(1993-1#2)(1993-5#1)(1994-11#1)(1994-9#1)(1995-3#2)(1995-5#1)(1996-2#1)(1997-1#2)(2005-8#2)(2006-10#1)(2006-12#2)(2006-5#1)(2006-8#5)(2007-11#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#9)(2008-7#1)(2009-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)
vitro affinity##2##2##(1991-12#1)(2010-7#1)
vitro agar##3##2##(1990-11#1)(1995-2#1)(2008-10#1)
vitro analyses##2##2##(2008-5#1)(2008-9#1)
vitro analysis##11##2##(1990-4#1)(1994-12#1)(1994-7#1)(1995-2#1)(1996-4#1)(2008-1#3)(2008-10#1)(2010-7#2)
vitro and animal studies##2##4##(2008-10#1)(2008-8#1)
vitro and animal##3##3##(2007-5#1)(2008-10#1)(2008-8#1)
vitro and ex vivo##12##4##(1991-8#1)(1993-4#1)(2008-10#1)(2008-11#4)(2008-9#1)(2012-1#2)(2012-12#1)(2013-7#1)
vitro and in vivo data##7##5##(1997-5#1)(2005-10#1)(2005-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
vitro and in vivo determinations of sun protection factors##2##9##(2008-5#2)
vitro and in vivo determinations##3##5##(2008-5#3)
vitro and in vivo evaluation##3##5##(2008-5#1)(2011-2#1)(2012-2#1)
vitro and in vivo evidence##3##5##(2008-5#1)(2011-2#1)(2012-12#1)
vitro and in vivo experiments##5##5##(1994-6#1)(1995-5#1)(2007-8#2)(2010-2#1)
vitro and in vivo results##3##5##(1991-2#1)(2008-5#1)(2012-12#1)
vitro and in vivo studies##20##5##(1990-9#1)(1992-11#1)(1993-5#1)(1995-10#1)(1996-12#1)(1996-3#1)(2005-10#1)(2007-11#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-2#1)(2011-2#1)(2013-1#2)(2013-8#1)
vitro and in vivo toxicity##2##5##(2010-2#1)(2013-1#1)
vitro and in vivo##288##4##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#2)(1992-2#1)(1992-5#3)(1992-6#2)(1992-8#3)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#3)(1993-5#2)(1993-6#1)(1993-9#2)(1994-11#4)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#3)(1995-10#2)(1995-12#7)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#4)(1996-8#2)(1997-1#2)(1997-2#2)(1997-4#1)(1997-5#4)(1997-6#2)(1997-8#1)(2004-9#1)(2005-10#2)(2005-7#2)(2005-8#3)(2006-12#1)(2006-5#2)(2007-1#1)(2007-10#1)(2007-11#8)(2007-7#2)(2007-8#4)(2008-1#5)(2008-10#13)(2008-11#8)(2008-2#4)(2008-3#4)(2008-4#4)(2008-5#29)(2008-7#6)(2008-8#5)(2008-9#4)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#3)(2010-2#5)(2010-3#2)(2010-6#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-11#2)(2012-12#9)(2012-2#5)(2012-3#1)(2013-1#15)(2013-7#2)(2013-8#5)
vitro and in##340##3##(1990-10#4)(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#2)(1992-2#1)(1992-5#3)(1992-6#2)(1992-8#3)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#3)(1993-3#1)(1993-5#2)(1993-6#1)(1993-7#1)(1993-9#2)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#5)(1995-1#1)(1995-10#2)(1995-12#7)(1995-2#1)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#6)(1996-8#3)(1997-1#2)(1997-2#2)(1997-4#1)(1997-5#4)(1997-6#3)(1997-7#1)(1997-8#1)(2004-1#1)(2004-9#1)(2005-10#2)(2005-7#2)(2005-8#3)(2006-1#1)(2006-12#1)(2006-5#2)(2007-1#1)(2007-10#1)(2007-11#10)(2007-12#1)(2007-7#2)(2007-8#4)(2008-1#6)(2008-10#22)(2008-11#10)(2008-2#4)(2008-3#6)(2008-4#5)(2008-5#31)(2008-7#6)(2008-8#7)(2008-9#4)(2009-10#3)(2009-11#1)(2009-12#4)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#5)(2010-2#5)(2010-3#2)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-11#2)(2012-12#11)(2012-2#5)(2012-3#2)(2013-1#15)(2013-7#2)(2013-8#5)
vitro and##476##2##(1990-10#7)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#4)(1991-5#5)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#4)(1992-11#2)(1992-12#1)(1992-2#1)(1992-5#4)(1992-6#4)(1992-7#2)(1992-8#5)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#3)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#3)(1994-6#3)(1994-8#2)(1994-9#8)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#8)(1995-2#4)(1995-3#9)(1995-4#1)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#3)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#7)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#3)(1997-2#3)(1997-4#3)(1997-5#4)(1997-6#3)(1997-7#1)(1997-8#2)(2004-1#1)(2004-9#1)(2005-10#2)(2005-11#1)(2005-7#2)(2005-8#5)(2006-1#1)(2006-11#1)(2006-12#1)(2006-5#2)(2006-6#3)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#12)(2007-12#1)(2007-5#1)(2007-7#3)(2007-8#4)(2008-1#6)(2008-10#33)(2008-11#16)(2008-2#4)(2008-3#6)(2008-4#8)(2008-5#35)(2008-7#7)(2008-8#11)(2008-9#7)(2009-10#7)(2009-11#1)(2009-12#4)(2009-2#1)(2009-4#3)(2009-5#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#5)(2010-2#6)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#3)(2012-11#2)(2012-12#19)(2012-2#8)(2012-3#2)(2013-1#17)(2013-7#3)(2013-8#5)
vitro andin vivo##5##3##(2008-11#2)(2008-8#3)
vitro andin##6##2##(2008-11#2)(2008-8#4)
vitro anergized T##2##3##(2008-11#2)
vitro antagonistic activity##2##3##(2008-12#2)
vitro anti-tumor##2##2##(2008-11#1)(2008-3#1)
vitro antibacterial##4##2##(2007-11#1)(2008-11#1)(2010-2#1)(2011-12#1)
vitro antifungal resistance in##2##4##(2008-5#2)
vitro antifungal susceptibility of clinical isolates##2##6##(2008-5#2)
vitro antifungal susceptibility of##4##4##(2007-7#2)(2008-5#2)
vitro antifungal susceptibility##7##3##(2007-7#2)(2008-5#5)
vitro antifungal##15##2##(2007-7#2)(2008-10#1)(2008-5#10)(2010-5#2)
vitro antimicrobial activity of##6##4##(2008-11#1)(2008-5#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
vitro antimicrobial activity##7##3##(2008-11#1)(2008-5#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
vitro antimicrobial##10##2##(2008-11#1)(2008-5#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
vitro antioxidant activity and in vivo photoprotective effect of a##2##10##(2008-5#2)
vitro antioxidant activity and##3##4##(2008-10#1)(2008-5#2)
vitro antioxidant activity of##2##4##(1994-9#1)(2008-10#1)
vitro antioxidant activity##6##3##(1994-9#1)(2008-10#2)(2008-5#2)(2010-5#1)
vitro antioxidant##8##2##(1994-9#1)(2006-12#1)(2008-10#2)(2008-5#2)(2010-5#1)(2011-1#1)
vitro as well##5##3##(1992-9#1)(2008-11#1)(2009-5#1)(2010-12#1)(2012-3#1)
vitro as##13##2##(1990-11#1)(1991-6#1)(1992-9#1)(1993-5#1)(1993-9#1)(1994-12#1)(1995-2#1)(2007-9#1)(2008-11#1)(2008-3#1)(2009-5#1)(2010-12#1)(2012-3#1)
vitro assay systems##4##3##(1992-11#1)(2008-11#1)(2008-4#1)(2008-7#1)
vitro assay##18##2##(1990-12#1)(1992-11#1)(1992-9#1)(1993-11#1)(1993-4#1)(1994-12#1)(1994-9#1)(1995-6#1)(2006-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
vitro assays of##2##3##(1992-5#1)(2010-4#1)
vitro assays##29##2##(1990-3#1)(1990-8#1)(1992-4#1)(1992-5#2)(1994-12#1)(1995-2#1)(1995-3#1)(1996-7#1)(1997-2#1)(1997-3#1)(2008-10#8)(2008-4#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#1)
vitro assembly of##4##3##(1994-9#1)(1995-8#2)(2004-12#1)
vitro assembly##5##2##(1994-9#1)(1995-1#1)(1995-8#2)(2004-12#1)
vitro assessment of##3##3##(2007-2#1)(2008-5#2)
vitro assessment##7##2##(2006-7#1)(2007-2#1)(2008-11#1)(2008-5#2)(2009-10#1)(2009-11#1)
vitro binding of##5##3##(1995-2#1)(1996-6#1)(1997-4#1)(1997-6#1)(2009-12#1)
vitro binding##17##2##(1991-11#1)(1992-11#1)(1993-12#1)(1993-4#1)(1995-2#1)(1995-6#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(2008-10#1)(2008-9#1)(2009-12#1)(2010-5#2)
vitro bioactivity of##2##3##(2009-7#1)(2010-8#1)
vitro bioactivity##3##2##(1994-11#1)(2009-7#1)(2010-8#1)
vitro bioassays##3##2##(1994-3#1)(1994-9#1)(2008-8#1)
vitro biological##9##2##(1990-2#1)(1993-8#1)(1993-9#1)(1995-3#1)(2007-11#1)(2008-5#1)(2008-8#2)(2008-9#1)
vitro biosynthesis of##2##3##(1992-11#2)
vitro cell culture##6##3##(1992-2#1)(2007-2#1)(2008-11#1)(2012-11#3)
vitro cell##17##2##(1990-1#1)(1992-2#1)(1994-9#1)(1995-3#1)(2006-10#1)(2007-2#1)(2008-11#2)(2008-7#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-8#1)(2012-1#1)(2012-11#3)
vitro characterization of##3##3##(1996-6#1)(2008-10#1)(2013-1#1)
vitro closure time##4##3##(2004-12#1)(2011-1#3)
vitro closure##6##2##(2004-12#1)(2011-1#5)
vitro comparison of##4##3##(2007-7#1)(2008-5#2)(2011-3#1)
vitro comparison##6##2##(1991-3#1)(2007-7#1)(2008-5#2)(2009-4#1)(2011-3#1)
vitro conditions##11##2##(1993-2#1)(1996-5#1)(1996-9#1)(1997-4#1)(2007-1#1)(2007-11#1)(2008-11#2)(2008-2#1)(2008-5#1)(2011-1#1)
vitro culture conditions##2##3##(2008-11#1)(2010-12#1)
vitro culture of human##2##4##(2008-11#2)
vitro culture of##10##3##(1992-9#1)(1994-3#1)(1996-10#1)(1996-6#1)(2006-5#1)(2008-11#2)(2008-5#2)(2011-1#1)
vitro culture##35##2##(1990-4#1)(1990-5#1)(1992-9#1)(1994-3#1)(1995-3#2)(1996-10#1)(1996-2#1)(1996-6#1)(2006-5#1)(2006-6#1)(2007-11#1)(2008-11#4)(2008-2#1)(2008-4#1)(2008-5#9)(2008-9#2)(2009-10#1)(2009-11#1)(2009-6#1)(2010-12#1)(2011-1#1)(2013-1#1)
vitro cultured##6##2##(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2012-2#1)
vitro culturing of##3##3##(2008-11#1)(2009-9#2)
vitro culturing##4##2##(2008-11#1)(2009-9#2)(2012-1#1)
vitro cytotoxic activities##2##3##(2008-5#1)(2011-2#1)
vitro cytotoxic##8##2##(1991-2#1)(1992-3#1)(2008-10#1)(2008-4#1)(2008-5#2)(2011-2#1)(2013-1#1)
vitro cytotoxicity of##2##3##(1997-2#1)(2008-5#1)
vitro cytotoxicity##12##2##(1992-11#1)(1995-3#2)(1997-1#1)(1997-2#1)(2007-11#1)(2008-3#2)(2008-5#2)(2009-3#1)(2011-2#1)
vitro degradation##4##2##(1993-8#1)(2008-5#2)(2008-6#1)
vitro development and##2##3##(1996-3#1)(2012-3#1)
vitro development of##7##3##(1996-2#1)(2006-5#1)(2008-11#2)(2008-5#1)(2011-12#1)(2012-2#1)
vitro development##11##2##(1996-2#2)(1996-3#1)(2006-5#1)(2008-11#2)(2008-5#1)(2009-12#1)(2011-12#1)(2012-2#1)(2012-3#1)
vitro differentiation##9##2##(1992-5#1)(1995-3#1)(1995-6#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#2)(2012-12#1)
vitro diffusion##2##2##(2004-12#1)(2010-2#1)
vitro dilution##2##2##(1993-12#2)
vitro dissolution studies##2##3##(2010-12#2)
vitro dissolution##8##2##(2008-5#2)(2010-12#3)(2012-2#2)(2012-3#1)
vitro drug interaction of glimepride with atorvastatin and rosuvastatin##2##9##(2011-1#2)
vitro drug release profile##2##4##(2010-12#1)(2011-1#1)
vitro drug release##20##3##(2004-9#1)(2010-12#3)(2010-2#2)(2010-3#4)(2010-5#2)(2011-1#2)(2011-2#2)(2012-11#2)(2012-2#1)(2013-7#1)
vitro drug##24##2##(1995-7#1)(2004-9#1)(2010-12#3)(2010-2#2)(2010-3#4)(2010-5#2)(2011-1#4)(2011-2#2)(2012-11#2)(2012-2#1)(2013-7#1)(2013-8#1)
vitro effect of##5##3##(1991-12#1)(1992-5#1)(1993-12#1)(1996-11#1)(2006-5#1)
vitro effects of##19##3##(1990-11#1)(1991-10#1)(1991-12#1)(1992-5#1)(1993-12#1)(1993-9#1)(1995-12#2)(1995-9#1)(1996-10#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-8#2)(2008-4#1)(2011-1#1)(2013-1#1)
vitro effects on##3##3##(1995-6#1)(2008-10#1)(2010-12#1)
vitro effects##26##2##(1990-11#3)(1991-10#1)(1991-12#1)(1992-5#1)(1993-12#1)(1993-9#1)(1995-12#2)(1995-5#2)(1995-6#1)(1995-9#1)(1996-10#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-8#2)(2008-10#1)(2008-4#1)(2010-12#1)(2011-1#1)(2013-1#1)
vitro efficacy of##3##3##(2006-7#1)(2010-5#1)(2013-8#1)
vitro efficacy##7##2##(2006-7#1)(2008-12#1)(2008-5#3)(2010-5#1)(2013-8#1)
vitro evaluation of##13##3##(2006-8#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#2)
vitro evaluation##14##2##(2006-8#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#2)
vitro evidence##6##2##(1993-11#1)(1995-1#1)(1995-6#1)(1996-10#1)(2008-10#1)(2008-5#1)
vitro evolution##3##2##(1992-11#1)(1992-7#1)(1997-6#1)
vitro experiments demonstrated that##2##4##(2008-10#1)(2012-2#1)
vitro experiments indicate##2##3##(1995-8#1)(2011-12#1)
vitro experiments were##3##3##(1991-5#1)(1995-6#1)(2011-2#1)
vitro experiments with##5##3##(1992-8#1)(1993-12#1)(1995-2#2)(2007-10#1)
vitro experiments##40##2##(1991-5#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-5#1)(1994-12#2)(1994-5#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-3#1)(1997-4#1)(2004-9#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#4)(2008-11#2)(2008-5#2)(2008-7#2)(2009-8#1)(2009-9#1)(2010-11#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-8#1)
vitro expression##5##2##(1993-6#1)(1995-8#1)(2007-7#1)(2008-10#2)
vitro fermentation of##2##3##(2006-8#2)
vitro fermentation##3##2##(2006-8#3)
vitro fertilization (IVF)##6##3##(2006-5#1)(2008-1#1)(2008-3#1)(2009-6#1)(2011-1#1)(2013-1#1)
vitro fertilization and##8##3##(1996-9#1)(1997-5#1)(2006-3#1)(2006-5#1)(2010-7#1)(2013-1#3)
vitro fertilization center##2##3##(2011-1#2)
vitro fertilization is##2##3##(2010-7#2)
vitro fertilization##49##2##(1990-6#1)(1991-11#1)(1992-7#1)(1992-9#1)(1993-1#1)(1994-12#1)(1994-9#1)(1995-6#4)(1995-8#2)(1996-9#1)(1997-2#1)(1997-5#1)(1997-8#1)(2006-3#1)(2006-5#5)(2008-1#1)(2008-3#2)(2008-9#1)(2009-2#2)(2009-6#1)(2010-12#1)(2010-7#3)(2011-1#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)
vitro findings##8##2##(1992-11#1)(1992-12#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-6#1)(2012-12#1)
vitro for##26##2##(1990-11#1)(1991-2#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-3#1)(2006-11#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#2)(2010-12#1)(2012-3#1)
vitro functional assays##3##3##(1993-11#1)(1993-8#1)(2008-8#1)
vitro functional##4##2##(1992-7#1)(1993-11#1)(1993-8#1)(2008-8#1)
vitro gene##2##2##(1995-2#1)(2008-7#1)
vitro genotoxicity##2##2##(1993-9#1)(2013-1#1)
vitro glycation of##2##3##(1991-12#1)(2007-2#1)
vitro glycation##3##2##(1991-12#1)(1992-12#1)(2007-2#1)
vitro growth kinetics of two Trypanosoma cruzi (Kinetoplastida##2##8##(2008-5#2)
vitro growth##17##2##(1990-3#1)(1991-10#1)(1991-3#1)(1991-9#2)(1992-8#2)(1993-11#1)(1993-8#1)(2007-11#1)(2008-10#4)(2008-5#2)(2009-8#1)
vitro human##9##2##(1993-9#1)(2005-7#1)(2008-1#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-12#1)(2012-12#1)
vitro hydrolysis of##2##3##(1990-4#1)(1991-3#1)
vitro identification of##2##3##(1991-11#1)(2012-2#1)
vitro immune##2##2##(1995-12#1)(2008-5#1)
vitro immunization (IVI)##3##3##(1992-8#1)(2008-11#2)
vitro immunization can##2##3##(1995-2#1)(2008-11#1)
vitro immunization##24##2##(1991-8#1)(1992-1#1)(1992-8#4)(1995-2#3)(2008-11#15)
vitro import##4##2##(1992-11#2)(1996-7#1)(2008-1#1)
vitro in the presence##5##4##(1991-5#1)(1992-8#1)(2008-4#1)(2008-8#1)(2012-2#1)
vitro in the##15##3##(1991-5#1)(1992-7#1)(1992-8#1)(1993-9#1)(1996-1#1)(1997-6#1)(2005-8#1)(2006-5#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-2#1)
vitro in##60##2##(1990-5#1)(1991-2#2)(1991-5#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-2#2)(1994-3#1)(1994-8#2)(1995-12#2)(1995-6#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-2#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#1)(2012-1#2)(2012-12#2)(2012-2#2)
vitro incorporation of##2##3##(1994-6#1)(2012-1#1)
vitro incubation of##8##3##(1990-2#1)(1990-4#1)(1991-2#1)(1994-11#1)(1994-9#1)(1996-5#1)(1997-8#1)(2007-12#1)
vitro incubation##14##2##(1990-11#1)(1990-2#1)(1990-4#1)(1991-2#1)(1991-7#1)(1992-4#1)(1994-11#1)(1994-9#2)(1996-5#1)(1997-8#1)(2006-9#1)(2007-12#1)(2008-10#1)
vitro inhibition of##7##3##(1993-7#1)(1995-3#1)(1996-11#1)(1997-7#1)(2006-12#1)(2008-10#1)(2008-5#1)
vitro inhibition##8##2##(1993-7#1)(1995-3#1)(1996-11#1)(1997-7#1)(2006-12#1)(2008-10#1)(2008-5#1)(2009-12#1)
vitro inhibitory##5##2##(1994-11#1)(2005-7#1)(2006-12#1)(2008-5#1)(2013-1#1)
vitro invasion##4##2##(2008-11#2)(2008-8#1)(2008-9#1)
vitro investigation of the##2##4##(2009-8#1)(2010-2#1)
vitro investigation##4##2##(1997-8#1)(2009-11#1)(2009-8#1)(2010-2#1)
vitro mRNA##2##2##(1992-12#1)(2008-4#1)
vitro measurement of##2##3##(1992-1#1)(1994-3#1)
vitro metabolism of LVV-hemorphin-7 in human plasma##2##7##(1996-8#2)
vitro metabolism of PTB##2##4##(1996-4#2)
vitro metabolism of##9##3##(1990-6#2)(1993-11#1)(1996-3#2)(1996-4#2)(1996-8#2)
vitro metabolism##12##2##(1990-11#1)(1990-6#2)(1993-11#1)(1993-7#1)(1996-3#2)(1996-4#2)(1996-8#2)(1997-1#1)
vitro models of##5##3##(1992-12#1)(2008-4#3)(2013-8#1)
vitro models to study##3##4##(2006-10#1)(2008-11#1)(2012-12#1)
vitro models to##5##3##(2006-10#1)(2008-11#1)(2010-12#1)(2011-1#1)(2012-12#1)
vitro models##24##2##(1992-12#1)(1994-9#1)(1996-4#2)(2006-10#1)(2008-11#2)(2008-4#4)(2008-5#5)(2008-7#2)(2008-8#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-8#1)
vitro motility##6##2##(1990-8#1)(1995-2#1)(1995-5#2)(1996-4#1)(1997-7#1)
vitro mutagenesis##2##2##(1991-8#1)(1992-11#1)
vitro mycelial growth of##2##4##(2008-10#2)
vitro mycelial growth##3##3##(2008-10#3)
vitro permeation##3##2##(2008-10#1)(2008-5#1)(2012-12#1)
vitro pharmacology of##2##3##(1993-3#1)(1995-12#1)
vitro pharmacology##3##2##(1993-3#1)(1995-12#1)(1996-12#1)
vitro phosphorylation of the##3##4##(1992-3#1)(1995-6#1)(1997-2#1)
vitro phosphorylation of##11##3##(1990-11#1)(1990-8#1)(1991-3#4)(1992-3#1)(1995-6#1)(1997-2#3)
vitro phosphorylation##17##2##(1990-11#1)(1990-8#1)(1991-3#4)(1992-3#1)(1993-12#1)(1993-3#1)(1993-8#1)(1995-10#1)(1995-5#1)(1995-6#1)(1997-2#4)
vitro photodynamic##2##2##(2012-3#2)
vitro platelet##4##2##(1994-2#1)(1997-7#1)(2004-12#1)(2007-6#1)
vitro processing##4##2##(1993-12#2)(1996-11#1)(2008-11#1)
vitro production of##7##3##(1994-12#1)(1994-8#1)(2007-2#1)(2008-10#1)(2008-11#2)(2011-12#1)
vitro production##8##2##(1994-12#1)(1994-8#1)(2007-2#1)(2008-10#1)(2008-11#2)(2009-3#1)(2011-12#1)
vitro proliferative response of##4##4##(1991-1#1)(2007-2#1)(2008-7#2)
vitro proliferative response##6##3##(1991-1#1)(2007-2#1)(2008-4#1)(2008-7#3)
vitro propagation##4##2##(1995-2#1)(2007-1#3)
vitro protein biosynthesis##4##3##(1995-3#1)(1995-7#3)
vitro protein##10##2##(1992-7#1)(1993-12#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-7#3)(2007-2#1)(2011-2#1)
vitro quantitative autoradiography##3##3##(1991-9#1)(1992-8#1)(1995-5#1)
vitro quantitative##4##2##(1991-9#2)(1992-8#1)(1995-5#1)
vitro reactivation##2##2##(1995-1#2)
vitro receptor##5##2##(1990-12#1)(1991-9#1)(1992-8#1)(1993-2#1)(1994-10#1)
vitro reconstitution##5##2##(1993-6#1)(1995-2#1)(2008-4#1)(2009-9#1)(2012-2#1)
vitro regeneration##2##2##(2007-1#1)(2013-1#1)
vitro release characteristics##2##3##(2008-11#1)(2010-2#1)
vitro release##14##2##(1992-3#1)(1994-10#1)(2004-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-1#2)(2010-2#3)(2011-1#1)(2012-12#1)(2013-7#1)
vitro resistance to##4##3##(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#1)
vitro results##8##2##(1994-6#1)(1997-6#1)(2004-12#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-12#1)
vitro selection of##3##3##(1990-8#1)(2008-4#1)(2010-5#1)
vitro selection using modified##2##4##(2008-4#2)
vitro selection using##3##3##(2008-4#3)
vitro selection##20##2##(1990-8#2)(1991-11#1)(1995-2#1)(1997-2#2)(1997-4#1)(1997-6#1)(2008-11#1)(2008-4#7)(2010-5#1)(2011-3#1)(2012-12#1)(2013-8#1)
vitro skin##6##2##(1996-6#1)(2008-5#5)
vitro slice##3##2##(1992-8#1)(1994-2#1)(1995-3#1)
vitro splicing##3##2##(1993-12#2)(1995-1#1)
vitro stimulation of##2##3##(1994-12#1)(2008-5#1)
vitro stimulation##6##2##(1994-12#1)(1996-10#1)(1996-11#1)(2008-5#2)(2011-2#1)
vitro studies demonstrated that##5##4##(2008-10#1)(2008-11#1)(2009-12#1)(2011-2#1)(2013-1#1)
vitro studies demonstrated##7##3##(1994-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-12#1)(2011-2#1)(2013-1#1)
vitro studies have shown that##7##5##(1992-12#1)(1992-4#1)(1994-10#1)(1996-8#1)(1997-1#1)(2008-5#1)(2009-11#1)
vitro studies have shown##10##4##(1992-12#1)(1992-4#1)(1994-10#1)(1996-8#1)(1997-1#1)(2005-6#1)(2007-2#1)(2008-5#2)(2009-11#1)
vitro studies have##14##3##(1991-10#1)(1992-12#1)(1992-4#1)(1994-10#1)(1996-8#1)(1997-1#1)(2005-6#1)(2007-11#1)(2007-2#1)(2008-5#3)(2009-11#1)(2013-1#1)
vitro studies in##4##3##(1992-11#1)(2007-11#1)(2008-11#1)(2008-5#1)
vitro studies of##7##3##(1993-3#1)(1994-11#1)(1995-12#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-5#1)
vitro studies on breast##2##4##(1994-12#1)(2007-11#1)
vitro studies on##5##3##(1994-12#1)(2006-3#1)(2007-11#1)(2008-11#1)(2012-2#1)
vitro studies show##2##3##(1997-5#1)(2009-1#1)
vitro studies showed that##4##4##(1992-12#1)(1994-8#1)(1996-5#1)(2008-5#1)
vitro studies showed##5##3##(1992-12#1)(1994-8#1)(1996-5#1)(2008-5#1)(2010-11#1)
vitro studies##93##2##(1990-10#1)(1991-10#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-4#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-8#2)(1994-9#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-6#1)(2005-8#1)(2006-10#1)(2006-3#1)(2007-11#9)(2007-12#1)(2007-2#1)(2008-10#6)(2008-11#7)(2008-3#1)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#1)(2009-1#1)(2009-11#2)(2009-12#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#2)
vitro study of the##3##4##(1990-5#1)(2010-12#1)(2012-1#1)
vitro study of##9##3##(1990-5#1)(1996-11#1)(2007-2#1)(2008-11#1)(2008-4#1)(2010-12#1)(2012-1#2)(2013-8#1)
vitro study on##2##3##(1997-5#1)(2012-3#1)
vitro study##48##2##(1990-11#1)(1990-5#2)(1991-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-6#1)(1994-8#1)(1996-11#1)(1997-5#1)(2004-9#1)(2006-8#1)(2007-2#1)(2007-5#1)(2008-11#2)(2008-4#1)(2008-5#3)(2008-8#1)(2009-3#1)(2010-12#1)(2010-6#2)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#8)(2013-8#1)
vitro susceptibilities##2##2##(2007-12#1)(2008-7#1)
vitro susceptibility of##5##3##(1991-8#1)(2006-4#1)(2006-8#1)(2008-5#1)(2011-12#1)
vitro susceptibility##19##2##(1991-8#1)(1992-5#2)(2006-4#2)(2006-8#1)(2007-7#3)(2008-11#1)(2008-5#3)(2011-12#1)(2011-2#2)(2012-12#2)(2013-7#1)
vitro synthesis of##2##3##(1992-9#1)(2008-4#1)
vitro synthesized##13##2##(1990-11#2)(1990-2#1)(1994-2#1)(1994-9#1)(1995-2#1)(1996-5#1)(1996-9#3)(1997-4#2)(2009-6#1)
vitro system##46##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-9#2)(1991-10#2)(1991-12#1)(1991-9#3)(1992-8#1)(1993-3#2)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-10#1)(1995-11#3)(1995-3#1)(1995-7#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-4#1)(2008-10#2)(2008-11#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-9#1)(2013-8#1)
vitro systems for##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
vitro systems##15##2##(1990-3#1)(1991-9#1)(1995-11#1)(1997-2#1)(2004-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#2)(2009-12#1)(2009-3#1)(2011-1#1)
vitro testing##15##2##(1993-9#1)(1994-2#1)(2004-9#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-5#4)(2008-8#1)(2009-7#1)(2011-2#1)(2012-12#1)
vitro tests##13##2##(1992-5#1)(1992-9#1)(2007-4#1)(2007-6#1)(2008-10#3)(2008-5#3)(2008-8#1)(2009-7#1)(2012-3#1)
vitro the##10##2##(1990-7#1)(1994-12#1)(1995-12#1)(1995-5#1)(2007-1#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)
vitro this##2##2##(1992-12#1)(1992-2#1)
vitro transcribed##8##2##(1992-8#3)(1993-3#1)(1993-6#1)(1993-8#2)(1994-9#1)
vitro transcription and translation##5##4##(1990-11#1)(1990-12#1)(1990-3#1)(1994-3#1)(1996-10#1)
vitro transcription and##6##3##(1990-11#1)(1990-12#1)(1990-3#1)(1994-3#1)(1996-10#1)(2008-11#1)
vitro transcription from##4##3##(1992-1#3)(1993-9#1)
vitro transcription##52##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-5#2)(1991-8#1)(1992-1#4)(1992-12#2)(1992-2#1)(1992-7#2)(1993-3#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#2)(1994-9#2)(1995-5#1)(1995-8#1)(1996-10#1)(1996-4#1)(1996-8#1)(1997-6#2)(2006-12#1)(2008-10#1)(2008-11#1)(2008-4#5)(2008-9#3)
vitro transcripts of the##2##4##(1991-6#1)(2008-10#1)
vitro transcripts of##4##3##(1991-6#1)(2008-10#3)
vitro transcripts##9##2##(1991-6#1)(2008-10#7)(2008-9#1)
vitro translated##6##2##(1991-7#1)(1993-12#1)(1993-8#1)(1994-8#1)(1995-1#1)(1995-2#1)
vitro translation in##2##3##(1995-5#1)(1995-8#1)
vitro translation of##14##3##(1990-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1993-5#1)(1993-9#1)(1995-2#1)(1995-3#3)(1995-6#1)(1997-3#1)(2008-9#2)
vitro translation##38##2##(1990-10#1)(1990-2#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-5#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-9#2)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#1)(1995-8#1)(1997-2#2)(1997-3#2)(1997-6#1)(2008-1#2)(2008-10#2)(2008-4#1)(2008-9#2)
vitro treatment of##6##3##(1990-2#1)(1992-6#1)(1996-5#1)(1996-6#1)(2012-12#2)
vitro treatment##9##2##(1990-2#1)(1992-6#1)(1996-5#1)(1996-6#1)(2008-10#1)(2009-8#1)(2011-1#1)(2012-12#2)
vitro tyrosine##2##2##(1991-11#1)(1993-3#1)
vitro with the##2##3##(1991-7#1)(2008-8#1)
vitro with##54##2##(1990-11#2)(1990-5#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-4#1)(1993-8#1)(1993-9#2)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-5#2)(1997-4#3)(1997-8#1)(2006-5#2)(2007-1#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#1)(2010-1#1)(2010-4#1)(2010-6#1)(2011-3#1)(2012-1#1)
vitro##4445##1##(1990-1#4)(1990-10#17)(1990-11#49)(1990-12#26)(1990-2#24)(1990-3#19)(1990-4#21)(1990-5#24)(1990-6#14)(1990-7#17)(1990-8#21)(1990-9#22)(1991-1#7)(1991-10#19)(1991-11#13)(1991-12#35)(1991-2#20)(1991-3#30)(1991-4#11)(1991-5#25)(1991-6#7)(1991-7#20)(1991-8#17)(1991-9#41)(1992-1#10)(1992-10#1)(1992-11#27)(1992-12#33)(1992-2#18)(1992-3#17)(1992-4#10)(1992-5#29)(1992-6#15)(1992-7#24)(1992-8#44)(1992-9#31)(1993-1#8)(1993-11#22)(1993-12#40)(1993-2#7)(1993-3#29)(1993-4#15)(1993-5#10)(1993-6#15)(1993-7#9)(1993-8#25)(1993-9#43)(1994-10#13)(1994-11#32)(1994-12#41)(1994-2#28)(1994-3#42)(1994-5#23)(1994-6#20)(1994-7#5)(1994-8#49)(1994-9#74)(1995-1#31)(1995-10#10)(1995-11#18)(1995-12#40)(1995-2#43)(1995-3#67)(1995-4#7)(1995-5#20)(1995-6#35)(1995-7#21)(1995-8#25)(1995-9#6)(1996-1#6)(1996-10#17)(1996-11#21)(1996-12#18)(1996-2#28)(1996-3#17)(1996-4#22)(1996-5#46)(1996-6#11)(1996-7#13)(1996-8#17)(1996-9#14)(1997-1#19)(1997-2#37)(1997-3#16)(1997-4#44)(1997-5#24)(1997-6#44)(1997-7#39)(1997-8#19)(2004-1#2)(2004-11#1)(2004-12#15)(2004-2#1)(2004-3#2)(2004-4#1)(2004-9#12)(2005-10#10)(2005-11#2)(2005-12#3)(2005-6#1)(2005-7#11)(2005-8#16)(2005-9#1)(2006-1#3)(2006-10#19)(2006-11#7)(2006-12#27)(2006-2#1)(2006-3#4)(2006-4#4)(2006-5#42)(2006-6#9)(2006-7#6)(2006-8#30)(2006-9#6)(2007-1#20)(2007-10#5)(2007-11#60)(2007-12#15)(2007-2#15)(2007-3#9)(2007-4#3)(2007-5#4)(2007-6#7)(2007-7#17)(2007-8#15)(2007-9#6)(2008-1#41)(2008-10#250)(2008-11#202)(2008-12#13)(2008-2#15)(2008-3#31)(2008-4#99)(2008-5#275)(2008-6#20)(2008-7#62)(2008-8#70)(2008-9#62)(2009-1#1)(2009-10#20)(2009-11#8)(2009-12#29)(2009-2#5)(2009-3#15)(2009-4#11)(2009-5#5)(2009-6#14)(2009-7#11)(2009-8#15)(2009-9#12)(2010-1#11)(2010-10#4)(2010-11#17)(2010-12#45)(2010-2#29)(2010-3#22)(2010-4#4)(2010-5#23)(2010-6#10)(2010-7#9)(2010-8#11)(2010-9#5)(2011-1#61)(2011-11#1)(2011-12#11)(2011-2#50)(2011-3#11)(2012-1#18)(2012-11#14)(2012-12#73)(2012-2#59)(2012-3#30)(2012-5#1)(2012-6#2)(2013-1#80)(2013-7#13)(2013-8#26)
vitro)##13##1##(1990-9#1)(1994-6#1)(1996-6#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#2)(2011-2#1)(2012-3#1)
vitronectin and##3##2##(1992-8#1)(2007-11#1)(2008-11#1)
vitronectin blood types##2##3##(1990-3#2)
vitronectin blood##3##2##(1990-3#3)
vitronectin gene##3##2##(1990-3#3)
vitronectin receptor (VNR)##2##3##(1991-10#1)(1991-12#1)
vitronectin receptor##4##2##(1991-10#1)(1991-12#1)(1994-6#1)(2009-9#1)
vitronectin##26##1##(1990-11#1)(1990-3#9)(1991-10#2)(1991-12#1)(1991-5#1)(1992-8#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-5#2)(2004-9#1)(2007-11#1)(2008-11#3)(2009-9#1)
vitronectin-bound PAI-1 and latent PAI-1##2##5##(1995-8#2)
vittatus##3##1##(2008-6#3)
vivax circumsporozoite protein##2##3##(2004-11#1)(2011-1#1)
vivax infection##3##2##(2009-9#1)(2012-12#2)
vivax malaria in##3##3##(2012-12#3)
vivax malaria##22##2##(2005-8#4)(2007-2#3)(2007-7#1)(2009-9#1)(2011-2#2)(2012-12#9)(2012-2#1)(2013-8#1)
vivax was##2##2##(2006-2#1)(2011-2#1)
vivax##54##1##(1990-9#1)(1992-4#3)(1993-4#1)(2004-11#2)(2005-8#4)(2006-2#3)(2007-1#1)(2007-12#1)(2007-2#4)(2007-7#4)(2008-4#3)(2009-9#3)(2010-12#2)(2011-1#1)(2011-2#5)(2012-12#13)(2012-2#2)(2013-8#1)
vivax) malaria##2##2##(2007-2#1)(2011-2#1)
vivesi##3##1##(2010-12#3)
vivid##7##1##(2007-2#1)(2007-5#1)(2008-5#1)(2011-2#3)(2012-3#1)
vividly##2##1##(2007-3#1)(2009-2#1)
viviparae and nymphs##2##3##(2008-9#2)
viviparity##5##1##(2008-8#2)(2010-3#3)
viviparous##8##1##(1991-11#1)(2007-12#2)(2007-3#2)(2008-5#1)(2008-7#1)(2008-8#1)
viviparum##3##1##(2009-5#3)
vivo DTI##3##2##(2008-11#2)(2012-1#1)
vivo EPR dosimetry##2##3##(2008-7#2)
vivo EPR##7##2##(1994-5#1)(2008-7#6)
vivo absorption##3##2##(2008-3#1)(2010-1#1)(2010-12#1)
vivo activities##6##2##(1990-2#1)(1990-7#1)(1992-5#1)(1992-6#2)(1994-9#1)
vivo administration of##11##3##(1990-12#1)(1990-2#1)(1994-6#1)(1995-10#2)(1996-10#1)(2008-3#1)(2010-12#1)(2012-11#1)(2012-12#1)(2013-8#1)
vivo administration##14##2##(1990-12#1)(1990-2#1)(1994-6#1)(1995-10#2)(1996-10#1)(1996-12#1)(2008-3#1)(2008-4#1)(2010-12#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-8#1)
vivo also##3##2##(1990-9#1)(1993-12#1)(1997-7#1)
vivo and in vitro experiments##4##5##(1993-5#1)(1995-8#1)(2007-12#1)(2009-9#1)
vivo and in vitro studies##8##5##(1991-9#1)(1992-11#1)(1994-8#1)(1995-9#1)(2007-11#1)(2009-1#1)(2010-5#1)(2013-1#1)
vivo and in vitro##141##4##(1990-11#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-8#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-11#2)(1992-3#1)(1992-4#2)(1992-5#1)(1992-8#1)(1993-11#1)(1993-3#4)(1993-5#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-12#2)(1994-3#2)(1994-5#3)(1994-8#5)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#4)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#2)(2004-11#1)(2004-12#1)(2004-9#1)(2005-7#1)(2006-12#1)(2007-11#4)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#6)(2008-4#3)(2008-5#6)(2008-6#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#3)(2010-11#3)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-11#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
vivo and in vivo##5##4##(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-2#1)
vivo and in##154##3##(1990-11#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-8#1)(1990-9#3)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-11#2)(1992-3#1)(1992-4#2)(1992-5#1)(1992-8#1)(1993-11#1)(1993-3#4)(1993-5#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-12#2)(1994-3#3)(1994-5#3)(1994-8#5)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#4)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#1)(1996-2#1)(1996-3#3)(1996-5#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#2)(2004-11#1)(2004-12#1)(2004-9#1)(2005-7#1)(2006-12#1)(2006-7#1)(2007-11#4)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#6)(2008-3#1)(2008-4#4)(2008-5#7)(2008-6#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#3)(2010-11#3)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-11#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
vivo and##225##2##(1990-11#2)(1990-3#1)(1990-4#3)(1990-5#2)(1990-8#2)(1990-9#3)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-11#4)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#4)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#5)(1994-9#2)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#7)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#2)(1996-5#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#3)(1997-5#2)(1997-6#3)(2004-11#1)(2004-12#1)(2004-9#2)(2005-10#1)(2005-7#2)(2006-10#1)(2006-12#3)(2006-6#2)(2006-7#1)(2007-11#5)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#9)(2008-3#2)(2008-4#5)(2008-5#11)(2008-6#5)(2008-7#5)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#3)(2010-11#3)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-11#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#1)
vivo antibody##2##2##(2007-11#1)(2008-4#1)
vivo antifungal##2##2##(2008-11#2)
vivo approaches##3##2##(2008-10#1)(2008-11#1)(2010-2#1)
vivo assay systems##2##3##(2008-11#1)(2008-4#1)
vivo assay##16##2##(1990-5#1)(1991-12#1)(1992-1#1)(1992-7#1)(1995-2#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#4)(2008-5#2)(2008-7#1)
vivo assays of##2##3##(2008-10#1)(2008-4#1)
vivo assays##12##2##(1995-3#1)(2008-10#6)(2008-11#1)(2008-4#1)(2009-9#1)(2010-7#1)(2011-2#1)
vivo at##7##2##(1993-9#1)(1995-6#1)(1996-3#1)(1996-5#1)(2006-10#1)(2007-7#1)(2010-12#1)
vivo binding##2##2##(1993-11#1)(2013-1#1)
vivo biodistribution and##2##3##(2008-7#1)(2012-2#1)
vivo biodistribution##4##2##(2008-5#1)(2008-7#1)(2012-2#1)(2013-7#1)
vivo by using##2##3##(2008-8#1)(2008-9#1)
vivo by##42##2##(1990-12#1)(1990-5#1)(1991-3#1)(1991-9#1)(1992-3#1)(1992-4#2)(1992-9#1)(1993-12#2)(1993-4#1)(1994-6#2)(1994-8#1)(1995-1#2)(1995-2#1)(1995-3#2)(1995-7#2)(1996-11#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#2)(2008-9#1)(2009-12#1)(2011-2#1)(2013-1#1)
vivo characterization of##3##3##(2008-5#1)(2010-12#1)(2011-2#1)
vivo chemical##2##2##(1990-2#1)(2008-7#1)
vivo comparison##2##2##(2008-4#1)(2009-5#1)
vivo confocal##4##2##(2008-2#1)(2008-3#1)(2008-5#1)(2013-1#1)
vivo could##3##2##(1995-5#1)(2008-8#1)(2011-12#1)
vivo cytokine production##4##3##(2008-10#1)(2008-4#3)
vivo cytokine##8##2##(2008-10#1)(2008-4#7)
vivo cytotoxicity##4##2##(1990-4#2)(1993-1#1)(2010-1#1)
vivo data for##2##3##(1993-3#1)(2008-11#1)
vivo data##17##2##(1990-7#1)(1992-11#1)(1993-3#1)(1995-3#1)(1995-5#1)(1997-5#1)(2005-10#1)(2005-8#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#3)(2011-2#1)
vivo delivery##3##2##(1995-2#1)(2008-4#1)(2008-8#1)
vivo detection of##3##3##(1992-6#1)(1993-9#1)(1994-8#1)
vivo detection##4##2##(1992-6#1)(1993-9#1)(1994-8#1)(2008-10#1)
vivo effect of##3##3##(1991-1#1)(1994-9#1)(2005-6#1)
vivo effect##6##2##(1991-1#1)(1994-9#1)(2004-1#1)(2005-6#1)(2005-8#1)(2008-6#1)
vivo effects of the##2##4##(2008-10#1)(2013-8#1)
vivo effects of##10##3##(1991-10#1)(1995-12#2)(1995-3#2)(2005-8#1)(2008-10#2)(2008-11#1)(2013-8#1)
vivo effects##15##2##(1991-1#1)(1991-10#1)(1995-1#1)(1995-12#3)(1995-3#2)(1996-10#1)(2005-8#1)(2008-10#2)(2008-11#1)(2010-12#1)(2013-8#1)
vivo electrochemistry##2##2##(1993-2#1)(1996-12#1)
vivo evaluation of##9##3##(1994-9#1)(1995-3#1)(2008-5#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
vivo evaluation##10##2##(1994-9#1)(1995-3#1)(2008-5#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
vivo evidence for the involvement of##2##6##(1995-1#1)(1996-1#1)
vivo evidence for the##3##4##(1992-10#1)(1995-1#1)(1996-1#1)
vivo evidence for##6##3##(1992-10#1)(1992-3#1)(1995-1#1)(1996-1#1)(2012-12#2)
vivo evidence that##7##3##(1990-8#1)(1994-11#1)(1994-2#1)(1996-8#1)(2008-10#1)(2008-11#1)(2012-12#1)
vivo evidence##18##2##(1990-8#1)(1992-10#1)(1992-3#1)(1994-11#1)(1994-2#1)(1995-1#1)(1996-1#2)(1996-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#4)
vivo expansion##5##2##(1996-11#1)(2008-1#1)(2008-11#2)(2008-4#1)
vivo experiment showed that##2##4##(2008-8#1)(2012-3#1)
vivo experiment##4##2##(2006-6#1)(2008-8#2)(2012-3#1)
vivo experiments##23##2##(1993-8#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-6#1)(2006-6#1)(2007-8#2)(2008-10#1)(2008-5#5)(2010-11#1)(2010-2#1)(2011-2#1)(2013-7#1)(2013-8#1)
vivo expression of##4##3##(1990-8#1)(1991-2#1)(2007-7#1)(2011-1#1)
vivo expression##9##2##(1990-8#2)(1991-2#1)(1994-12#1)(1995-1#1)(2007-12#1)(2007-7#1)(2008-7#1)(2011-1#1)
vivo fluorescence##2##2##(2007-12#1)(2011-3#1)
vivo footprinting##4##2##(1991-11#1)(1993-12#1)(1996-7#1)(1997-3#1)
vivo for their##2##3##(1993-4#1)(1994-9#1)
vivo for##19##2##(1990-4#1)(1991-2#1)(1991-3#1)(1991-8#1)(1993-12#1)(1993-4#1)(1994-10#1)(1994-6#1)(1994-9#1)(1995-11#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-2#1)
vivo functional interaction between phencyclidine##2##5##(1996-12#2)
vivo gene therapy##4##3##(1991-12#1)(1994-5#1)(2005-7#1)(2006-10#1)
vivo gene transfer##5##3##(1994-5#3)(1997-4#2)
vivo gene##13##2##(1991-12#1)(1994-12#1)(1994-5#5)(1997-4#2)(2005-7#1)(2006-10#1)(2008-11#1)(2008-4#1)
vivo glycation of##2##3##(1995-1#2)
vivo hepatic##2##2##(1991-1#1)(1997-4#1)
vivo histological##2##2##(2011-7#1)(2013-1#1)
vivo imaging of the##2##4##(1994-11#1)(2012-11#1)
vivo imaging of##9##3##(1994-11#1)(1996-9#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-5#1)(2009-8#1)(2012-11#1)
vivo imaging##28##2##(1994-11#1)(1996-9#1)(1997-5#1)(2005-7#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-12#4)(2009-5#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-7#1)(2012-11#1)(2012-2#2)
vivo immunomodulatory effects##2##3##(1997-8#2)
vivo in this##2##3##(1996-1#1)(2008-10#1)
vivo in##58##2##(1990-11#1)(1990-12#2)(1990-6#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-9#1)(1993-9#1)(1994-2#1)(1994-5#3)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2006-6#2)(2007-8#1)(2008-10#2)(2008-4#3)(2008-5#1)(2009-9#1)(2010-12#2)(2011-1#1)(2011-2#1)(2013-8#1)
vivo incubation of the SC resulted in##2##7##(2008-5#2)
vivo inhibition of##3##3##(1992-7#1)(1996-10#1)(2008-11#1)
vivo insulin##2##2##(1990-12#1)(2011-1#1)
vivo investigations##4##2##(2007-8#1)(2008-10#1)(2008-8#1)(2010-12#1)
vivo is##31##2##(1990-7#1)(1990-9#1)(1992-10#1)(1994-11#2)(1995-1#1)(1995-3#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-4#1)(1997-7#2)(2005-8#1)(2006-10#2)(2006-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-3#1)(2010-11#1)(2010-12#1)(2012-12#2)
vivo luminescence##3##2##(1997-2#3)
vivo magnetic resonance imaging##2##4##(1994-5#1)(2008-6#1)
vivo magnetic resonance##3##3##(1994-5#1)(2008-6#1)(2012-2#1)
vivo measurement##3##2##(2008-4#1)(2008-7#1)(2009-10#1)
vivo measurements of##4##3##(1996-2#1)(2007-1#1)(2008-2#1)(2008-7#1)
vivo measurements##12##2##(1993-9#1)(1996-2#1)(1997-6#1)(2006-6#2)(2007-1#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2011-1#1)
vivo mechanical##2##2##(2008-11#1)(2010-8#1)
vivo metabolism of##3##3##(1990-11#1)(1991-10#1)(1991-5#1)
vivo metabolism##4##2##(1990-11#1)(1991-10#1)(1991-5#1)(2010-2#1)
vivo method for##6##3##(1991-12#1)(2007-11#1)(2012-12#4)
vivo method##10##2##(1991-12#1)(1997-5#1)(2007-11#1)(2007-6#1)(2008-5#2)(2012-12#4)
vivo microdialysis##29##2##(1991-3#1)(1991-6#2)(1992-7#1)(1993-4#2)(1993-6#1)(1993-7#1)(1993-9#2)(1994-8#1)(1995-12#5)(1995-3#1)(1996-1#1)(1996-10#2)(1996-6#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(2008-10#2)
vivo model of##4##3##(1991-5#1)(1996-5#1)(2006-6#1)(2009-12#1)
vivo model##11##2##(1991-5#1)(1992-1#1)(1994-10#1)(1996-2#1)(1996-5#1)(2006-6#1)(2008-10#1)(2008-3#1)(2009-12#1)(2010-12#1)(2012-12#1)
vivo models for##2##3##(1992-2#1)(2012-12#1)
vivo models##15##2##(1992-2#1)(1994-10#1)(2006-5#1)(2006-6#1)(2007-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2011-1#1)(2012-12#3)(2013-1#2)
vivo monitoring of##8##3##(1991-5#1)(1993-9#1)(1996-12#1)(2008-10#3)(2009-5#1)(2012-1#1)
vivo murine##2##2##(2006-10#1)(2007-3#1)
vivo on##5##2##(1990-2#1)(1992-11#1)(1994-9#1)(2008-5#2)
vivo optical##4##2##(2007-11#2)(2009-4#1)(2010-2#1)
vivo or in vitro##12##4##(1990-4#1)(1995-2#1)(1996-12#1)(1997-1#2)(1997-4#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-9#1)(2011-1#1)
vivo or in##14##3##(1990-4#1)(1990-8#1)(1995-2#1)(1996-12#1)(1997-1#2)(1997-4#1)(2008-1#1)(2008-11#1)(2008-4#3)(2008-9#1)(2011-1#1)
vivo or##20##2##(1990-4#1)(1990-8#1)(1992-11#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-12#1)(1997-1#2)(1997-4#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#3)(2008-9#1)(2010-11#1)(2010-4#1)(2011-1#1)
vivo oxidation##2##2##(2005-7#1)(2006-12#1)
vivo pharmacology of##2##3##(1995-12#2)
vivo phenotyping with##2##3##(2010-2#1)(2012-2#1)
vivo plaque##2##2##(1995-12#1)(2010-9#1)
vivo platelet##6##2##(1990-12#2)(1993-6#1)(2006-6#1)(2009-8#2)
vivo processing##3##2##(1991-12#1)(1997-1#2)
vivo production of##3##3##(1992-3#2)(1994-5#1)
vivo proton magnetic resonance spectroscopy##2##5##(1991-1#1)(2008-7#1)
vivo rat##4##2##(1995-2#1)(1995-7#1)(1997-5#1)(2010-7#1)
vivo regulation of##4##3##(1991-12#1)(1992-8#1)(2008-4#1)(2011-1#1)
vivo release of##5##3##(1990-7#1)(1992-3#2)(1994-12#1)(1994-2#1)
vivo response to##2##3##(1991-9#1)(2008-11#1)
vivo response##3##2##(1991-9#1)(1994-8#1)(2008-11#1)
vivo results suggest##3##3##(1992-11#1)(2008-11#1)(2010-12#1)
vivo results##12##2##(1991-2#1)(1992-11#2)(1992-5#1)(1994-12#1)(2004-12#1)(2008-11#1)(2008-5#2)(2010-12#1)(2012-12#1)(2013-8#1)
vivo spin trapping##2##3##(1993-9#1)(1995-1#1)
vivo studies have##5##3##(1992-4#1)(2005-10#1)(2006-10#1)(2008-7#1)(2013-1#1)
vivo studies in##2##3##(2009-8#1)(2012-3#1)
vivo studies indicate that##2##4##(1995-10#1)(2007-11#1)
vivo studies of##5##3##(1996-12#1)(2005-8#1)(2010-7#1)(2012-1#1)(2013-7#1)
vivo studies on FIV##2##4##(2007-11#2)
vivo studies on the##3##4##(2007-11#1)(2007-12#1)(2008-11#1)
vivo studies on##7##3##(2007-11#3)(2007-12#1)(2008-11#1)(2008-9#1)(2013-8#1)
vivo studies##63##2##(1990-7#1)(1990-9#1)(1992-11#2)(1992-4#1)(1993-4#1)(1993-5#1)(1993-7#1)(1994-11#1)(1995-10#2)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-8#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-11#5)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
vivo study of the##2##4##(1994-10#1)(2008-5#1)
vivo study of##7##3##(1993-1#1)(1994-10#1)(2004-9#1)(2008-5#1)(2010-1#1)(2012-11#1)(2012-3#1)
vivo study##35##2##(1990-5#1)(1993-1#2)(1994-10#1)(1995-12#1)(2004-9#2)(2007-8#1)(2008-5#6)(2008-7#1)(2008-8#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-12#3)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)
vivo systems##2##2##(2008-7#2)
vivo technique##3##2##(1996-2#1)(2008-5#2)
vivo techniques##2##2##(2005-7#1)(2008-5#1)
vivo tests##6##2##(1995-12#2)(1996-12#1)(2007-6#1)(2008-10#1)(2008-3#1)
vivo the##16##2##(1990-11#1)(1991-12#1)(1991-6#1)(1992-4#1)(1993-6#1)(1994-11#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-12#1)(1997-5#1)(2006-6#1)(2008-5#2)(2009-2#1)
vivo thrombocyte activation##2##3##(2007-10#2)
vivo tissue##3##2##(1992-12#1)(2008-4#1)(2011-1#1)
vivo transfer##3##2##(1995-12#1)(2008-4#1)(2008-5#1)
vivo translation##2##2##(2006-12#1)(2008-9#1)
vivo treatment with##2##3##(1990-2#1)(1997-1#1)
vivo treatment##6##2##(1990-2#1)(1992-8#1)(1992-9#1)(1997-1#1)(1997-7#1)(2009-9#1)
vivo tritium contamination##2##3##(1991-5#2)
vivo tumor##13##2##(1991-4#1)(1991-9#2)(1995-5#1)(1997-1#1)(2007-8#1)(2008-8#1)(2009-6#2)(2010-10#1)(2010-2#1)(2011-2#1)(2012-3#1)
vivo under##2##2##(2008-5#1)(2008-7#1)
vivo using##16##2##(1993-9#1)(1994-5#1)(1995-11#1)(1996-12#1)(1996-2#2)(1997-6#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
vivo was studied##3##3##(1992-7#1)(2008-5#1)(2008-9#1)
vivo was##15##2##(1990-3#1)(1991-2#1)(1992-3#1)(1992-4#1)(1992-7#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-4#1)(1997-6#2)(2008-5#1)(2008-9#1)
vivo with a##4##3##(1990-12#1)(1991-7#1)(1991-8#1)(2010-1#1)
vivo with an##2##3##(2008-2#1)(2010-12#1)
vivo with##30##2##(1990-12#1)(1991-1#1)(1991-12#2)(1991-3#1)(1991-7#1)(1991-8#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-10#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-11#1)(2006-7#1)(2008-2#3)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-12#1)
vivo##3029##1##(1990-10#8)(1990-11#19)(1990-12#16)(1990-2#15)(1990-3#10)(1990-4#18)(1990-5#18)(1990-6#8)(1990-7#13)(1990-8#19)(1990-9#14)(1991-1#8)(1991-10#11)(1991-11#7)(1991-12#25)(1991-2#14)(1991-3#14)(1991-4#7)(1991-5#21)(1991-6#9)(1991-7#11)(1991-8#10)(1991-9#26)(1992-1#12)(1992-10#4)(1992-11#19)(1992-12#12)(1992-2#8)(1992-3#15)(1992-4#11)(1992-5#14)(1992-6#15)(1992-7#15)(1992-8#23)(1992-9#11)(1993-1#5)(1993-11#15)(1993-12#23)(1993-2#5)(1993-3#12)(1993-4#16)(1993-5#4)(1993-6#8)(1993-7#7)(1993-8#12)(1993-9#21)(1994-10#13)(1994-11#28)(1994-12#25)(1994-2#20)(1994-3#31)(1994-4#2)(1994-5#31)(1994-6#19)(1994-7#1)(1994-8#21)(1994-9#36)(1995-1#28)(1995-10#9)(1995-11#17)(1995-12#47)(1995-2#34)(1995-3#41)(1995-4#7)(1995-5#19)(1995-6#18)(1995-7#15)(1995-8#17)(1995-9#4)(1996-1#12)(1996-10#26)(1996-11#10)(1996-12#25)(1996-2#21)(1996-3#22)(1996-4#9)(1996-5#26)(1996-6#4)(1996-7#5)(1996-8#15)(1996-9#5)(1997-1#21)(1997-2#33)(1997-3#10)(1997-4#44)(1997-5#25)(1997-6#23)(1997-7#20)(1997-8#8)(2004-1#1)(2004-11#2)(2004-12#5)(2004-2#1)(2004-3#1)(2004-9#14)(2005-10#5)(2005-12#2)(2005-6#2)(2005-7#14)(2005-8#15)(2005-9#2)(2006-1#1)(2006-10#23)(2006-11#5)(2006-12#20)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#9)(2006-6#22)(2006-7#2)(2006-8#3)(2007-1#12)(2007-10#6)(2007-11#46)(2007-12#30)(2007-3#4)(2007-5#4)(2007-6#3)(2007-7#5)(2007-8#15)(2007-9#4)(2008-1#40)(2008-10#84)(2008-11#92)(2008-12#3)(2008-2#25)(2008-3#38)(2008-4#90)(2008-5#159)(2008-6#15)(2008-7#66)(2008-8#37)(2008-9#41)(2009-1#1)(2009-10#20)(2009-11#5)(2009-12#27)(2009-2#4)(2009-3#15)(2009-4#6)(2009-5#16)(2009-6#7)(2009-7#4)(2009-8#12)(2009-9#10)(2010-1#13)(2010-10#5)(2010-11#20)(2010-12#32)(2010-2#20)(2010-3#7)(2010-4#1)(2010-5#4)(2010-6#8)(2010-7#8)(2010-8#3)(2010-9#5)(2011-1#40)(2011-11#1)(2011-12#7)(2011-2#30)(2011-3#5)(2011-7#2)(2012-1#16)(2012-11#16)(2012-12#69)(2012-2#52)(2012-3#20)(2013-1#57)(2013-7#9)(2013-8#26)
vivo) and##2##2##(2007-11#1)(2008-5#1)
vivo)##4##1##(1991-5#1)(2007-1#1)(2007-11#1)(2008-5#1)
viz##113##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-8#3)(1993-11#1)(1993-8#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-4#1)(2004-11#1)(2005-11#2)(2005-12#1)(2006-12#2)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#3)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#23)(2008-11#4)(2008-12#7)(2008-3#1)(2008-5#6)(2008-7#1)(2008-8#2)(2009-10#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#3)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#6)(2013-8#2)
vm1AchR##2##1##(1997-4#2)
vocabularies and##2##2##(2008-2#1)(2013-8#1)
vocabularies are##3##2##(2008-7#2)(2008-9#1)
vocabularies in the##2##3##(2008-7#1)(2008-9#1)
vocabularies in##3##2##(2008-7#2)(2008-9#1)
vocabularies that##2##2##(2008-7#2)
vocabularies used##2##2##(2008-7#2)
vocabularies##22##1##(2008-2#1)(2008-4#1)(2008-7#12)(2008-9#4)(2010-8#1)(2013-1#2)(2013-8#1)
vocabulary and comprehension##2##3##(2008-12#1)(2010-2#1)
vocabulary and##8##2##(2007-9#1)(2008-12#2)(2008-9#2)(2010-2#1)(2011-2#2)
vocabulary intervention##4##2##(2011-2#4)
vocabulary knowledge##4##2##(2007-9#4)
vocabulary of##5##2##(2008-5#1)(2008-7#2)(2013-1#2)
vocabulary that##2##2##(2007-6#1)(2008-7#1)
vocabulary words##3##2##(2011-2#3)
vocabulary##49##1##(1992-1#1)(1993-2#1)(2007-3#1)(2007-6#1)(2007-8#1)(2007-9#6)(2008-12#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#8)(2008-9#3)(2010-2#1)(2010-4#1)(2011-2#10)(2013-1#6)(2013-7#1)
vocal behaviour##3##2##(1991-5#1)(1994-6#1)(2010-2#1)
vocal center (HVC)##2##3##(1997-2#1)(2008-9#1)
vocal center##5##2##(1997-2#1)(2008-9#4)
vocal communication##2##2##(2008-9#1)(2012-1#1)
vocal control##3##2##(1994-6#1)(1996-7#1)(2008-9#1)
vocal cord palsy##4##3##(2008-8#1)(2010-7#1)(2011-12#1)(2012-2#1)
vocal cord##14##2##(1990-4#1)(1991-4#2)(2007-9#1)(2008-2#1)(2008-8#1)(2009-10#1)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-2#1)(2013-8#1)
vocal cord)##2##2##(1991-4#1)(1997-4#1)
vocal cords##5##2##(1990-4#1)(2007-9#1)(2008-11#1)(2008-8#1)(2009-2#1)
vocal cues##2##2##(2009-10#1)(2013-8#1)
vocal exchanges##3##2##(2012-2#3)
vocal fold in##2##3##(2012-2#2)
vocal fold vibration##2##3##(2009-11#2)
vocal fold##11##2##(2008-5#1)(2009-10#1)(2009-11#3)(2011-2#1)(2012-2#5)
vocal folds atrophy##3##3##(2007-9#3)
vocal folds##6##2##(2007-9#4)(2012-2#2)
vocal learning##3##2##(2009-2#2)(2012-2#1)
vocal ligament##2##2##(2008-5#1)(2009-2#1)
vocal music##2##2##(1991-12#1)(2007-6#1)
vocal performance and##2##3##(2010-2#2)
vocal performance in##2##3##(2010-2#2)
vocal performance##7##2##(2010-2#7)
vocal polyps##2##2##(2009-2#1)(2011-1#1)
vocal utterances##3##2##(2008-1#1)(2008-6#1)(2012-2#1)
vocal versus instrumental##2##3##(2007-6#2)
vocal##111##1##(1990-4#2)(1991-12#1)(1991-4#3)(1991-5#1)(1992-9#1)(1994-6#2)(1996-11#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-5#3)(2005-5#1)(2007-6#3)(2007-9#6)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#2)(2008-8#4)(2008-9#10)(2009-10#4)(2009-11#3)(2009-2#16)(2009-9#3)(2010-2#9)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#14)(2013-8#3)
vocalization from##2##2##(1994-8#1)(2009-2#1)
vocalization in##2##2##(1994-8#1)(2008-9#1)
vocalization of##2##2##(2010-2#2)
vocalization threshold##2##2##(1994-6#1)(1996-12#1)
vocalization was##2##2##(2008-9#1)(2010-2#1)
vocalization##26##1##(1993-9#1)(1994-6#3)(1994-8#5)(1995-12#2)(1996-1#1)(1996-12#2)(2008-4#1)(2008-9#2)(2009-2#1)(2010-2#6)(2012-12#2)
vocalizations and##2##2##(2008-9#2)
vocalizations in##3##2##(1992-9#1)(1994-2#1)(2008-4#1)
vocalizations##14##1##(1992-9#1)(1994-2#2)(1996-1#1)(2008-3#1)(2008-4#1)(2008-9#3)(2009-2#2)(2009-4#2)(2012-2#1)
vocalizing##2##1##(2009-4#1)(2010-2#1)
vocally and morphologically##2##3##(2008-8#2)
vocation##3##1##(2008-1#1)(2010-2#1)(2011-2#1)
vocational and##2##2##(2008-12#1)(2010-1#1)
vocational education##3##2##(1992-2#1)(2008-11#1)(2011-2#1)
vocational functioning##2##2##(2006-9#1)(2010-9#1)
vocational rehabilitation counselors##2##3##(2010-2#2)
vocational rehabilitation organized by the State Social Security Institute of Iceland##2##11##(2006-8#2)
vocational rehabilitation organized by the##3##5##(2006-8#3)
vocational rehabilitation programs##2##3##(1993-3#1)(2008-2#1)
vocational rehabilitation##22##2##(1992-3#2)(1993-3#2)(2006-8#12)(2008-2#1)(2009-10#1)(2010-12#1)(2010-2#3)
vocational status##2##2##(2007-11#1)(2008-1#1)
vocational training schemes##3##3##(1990-3#1)(1996-8#2)
vocational training##7##2##(1990-3#1)(1995-5#1)(1996-10#1)(1996-8#2)(2009-7#1)(2011-2#1)
vocational##50##1##(1990-3#1)(1990-5#1)(1992-2#1)(1992-3#2)(1993-3#2)(1994-12#1)(1995-1#1)(1995-5#3)(1996-10#1)(1996-8#2)(2006-2#1)(2006-8#12)(2006-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-9#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-12#1)(2010-2#4)(2010-9#1)(2011-2#2)
vogue for##3##2##(1991-6#1)(2008-9#1)(2009-2#1)
vogue##6##1##(1991-6#1)(2007-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)
voice analysis##2##2##(2011-1#2)
voice and speech##4##3##(2009-2#1)(2011-1#3)
voice and##9##2##(1995-2#1)(2007-9#1)(2009-10#1)(2009-2#1)(2009-9#1)(2010-5#1)(2011-1#3)
voice concerns about##2##3##(1992-3#1)(1996-5#1)
voice control##3##2##(2006-6#1)(2007-8#1)(2008-4#1)
voice disorders##2##2##(2013-8#2)
voice for##2##2##(2012-2#1)(2012-3#1)
voice in health professional education?##2##5##(2008-12#2)
voice in##6##2##(2008-12#2)(2008-5#1)(2009-9#1)(2013-1#2)
voice is##2##2##(2011-1#1)(2013-7#1)
voice or##2##2##(2006-6#1)(2012-1#1)
voice quality##3##2##(2007-9#2)(2008-9#1)
voice response##2##2##(2007-1#1)(2008-11#1)
voice that##2##2##(1996-5#1)(2008-12#1)
voice their##2##2##(1992-5#1)(1993-1#1)
voice to##3##2##(1991-6#1)(2008-1#1)(2011-1#1)
voice##98##1##(1991-6#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-1#1)(1995-12#2)(1995-2#1)(1996-11#1)(1996-12#1)(1996-5#2)(1996-6#1)(2004-9#1)(2006-10#1)(2006-3#2)(2006-6#2)(2007-1#1)(2007-2#1)(2007-7#2)(2007-8#3)(2007-9#3)(2008-1#3)(2008-11#5)(2008-12#3)(2008-2#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#6)(2009-10#3)(2009-2#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-9#3)(2010-12#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#1)(2012-1#5)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#4)
voice?##2##1##(1996-3#1)(2012-2#1)
voiced speech##2##2##(2008-2#2)
voiced##7##1##(1990-12#1)(1991-2#1)(1995-2#1)(2008-2#2)(2008-5#1)(2011-12#1)
voiceless##2##1##(2008-5#1)(2009-10#1)
voices heard##2##2##(2004-5#1)(2009-5#1)
voices in##2##2##(2006-3#2)
voices of the##2##3##(2008-11#1)(2011-1#1)
voices of##7##2##(2008-11#2)(2008-8#1)(2009-4#2)(2010-3#1)(2011-1#1)
voices that##2##2##(2006-3#1)(2008-11#1)
voices##40##1##(1992-3#1)(1997-8#5)(2004-5#1)(2006-3#12)(2007-11#1)(2008-11#3)(2008-12#1)(2008-8#1)(2009-4#5)(2009-5#1)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#4)(2013-8#1)
voicing##5##1##(2008-12#1)(2008-5#2)(2008-9#1)(2010-7#1)
void volume##6##2##(1990-12#2)(1991-2#2)(1993-6#1)(2008-10#1)
void##26##1##(1990-12#2)(1991-2#2)(1991-4#1)(1992-12#1)(1993-1#1)(1993-6#1)(1994-11#1)(2005-11#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-1#1)(2010-4#1)(2012-12#1)(2013-1#1)
voided urine was##2##3##(1990-12#1)(2006-8#1)
voided urine##6##2##(1990-12#4)(2006-8#1)(2007-8#1)
voided##7##1##(1990-12#4)(1995-7#1)(2006-8#1)(2007-8#1)
voiding cystourethrogram##4##2##(2008-10#3)(2012-3#1)
voiding dysfunction##3##2##(2006-10#1)(2008-10#1)(2008-6#1)
voiding##27##1##(1990-5#2)(1994-3#1)(2006-1#1)(2006-10#1)(2006-9#2)(2007-7#1)(2007-8#1)(2008-10#7)(2008-4#1)(2008-6#1)(2009-5#1)(2010-8#3)(2012-11#2)(2012-3#2)(2013-8#1)
voids formed##2##2##(2007-12#2)
voids in##3##2##(2007-12#1)(2012-2#1)(2013-1#1)
voids##19##1##(1993-11#1)(1995-6#1)(2005-11#1)(2007-12#6)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-2#2)(2013-1#2)
voie##5##1##(2008-11#1)(2008-6#1)(2011-2#1)(2013-1#2)
vol##52##1##(1990-11#1)(1990-3#1)(1996-2#1)(1996-8#1)(2005-11#4)(2005-12#3)(2005-7#1)(2006-3#3)(2008-11#3)(2008-12#2)(2008-2#2)(2008-6#1)(2008-7#5)(2009-3#6)(2009-5#2)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#4)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
vol% HA##2##2##(2009-7#2)
vol%##8##1##(2005-11#1)(2008-5#1)(2009-7#4)(2010-7#2)
vol/vol)##4##1##(2008-10#3)(2012-12#1)
volant##3##1##(1997-4#3)
volar and dorsal##3##3##(2008-9#3)
volar fixed-angle##2##2##(2008-9#2)
volar forearm##12##2##(2008-5#11)(2013-1#1)
volar locking plate##2##3##(2008-9#1)(2011-2#1)
volar locking##5##2##(2008-9#2)(2011-2#3)
volar plate##3##2##(2006-3#1)(2008-9#2)
volar plating##2##2##(2008-9#2)
volar surface of the forearm of##2##6##(1994-4#1)(1996-7#1)
volar surface of the forearm##3##5##(1994-4#1)(1996-7#1)(2008-10#1)
volar##50##1##(1994-4#1)(1996-7#1)(2006-3#4)(2006-6#1)(2008-10#1)(2008-5#11)(2008-9#24)(2011-2#5)(2013-1#1)(2013-7#1)
volatile anaesthetic##2##2##(1992-11#1)(1996-1#1)
volatile anaesthetics##4##2##(1990-9#1)(2006-10#1)(2007-9#1)(2010-12#1)
volatile and##9##2##(1993-1#1)(2006-10#1)(2008-10#5)(2008-11#1)(2009-8#1)
volatile anesthetic agents##2##3##(2006-10#2)
volatile anesthetics##4##2##(1990-2#2)(1994-2#1)(2006-10#1)
volatile blend##2##2##(2007-6#2)
volatile carbonyl compounds##3##3##(1997-8#3)
volatile chlorination by-products##3##3##(2008-10#3)
volatile components##4##2##(2008-11#1)(2008-8#1)(2012-3#1)(2013-7#1)
volatile compound##2##2##(2008-10#1)(2013-7#1)
volatile compounds and##2##3##(2008-10#2)
volatile compounds emitted by##2##4##(2009-8#1)(2011-10#1)
volatile compounds from wine##2##4##(2008-10#2)
volatile compounds from##3##3##(2008-10#2)(2009-8#1)
volatile compounds of the infusion##2##5##(2010-12#2)
volatile compounds of##5##3##(2004-2#1)(2006-12#1)(2008-10#1)(2010-12#2)
volatile compounds were isolated##3##4##(2008-10#3)
volatile compounds were##4##3##(2008-10#4)
volatile compounds##33##2##(2004-2#1)(2006-12#1)(2008-10#23)(2009-8#3)(2010-12#2)(2010-4#1)(2011-1#1)(2011-10#1)
volatile constituents of##3##3##(2005-12#1)(2007-11#1)(2008-4#1)
volatile constituents##5##2##(2005-12#1)(2006-12#1)(2007-1#1)(2007-11#1)(2008-4#1)
volatile element##2##2##(2008-10#2)
volatile elements##3##2##(2008-10#3)
volatile emissions##3##2##(2009-8#2)(2011-10#1)
volatile fatty acid##3##3##(2006-8#1)(2008-10#1)(2012-3#1)
volatile fatty acids (VFAs)##2##4##(2008-10#1)(2008-5#1)
volatile fatty acids##7##3##(2006-10#1)(2006-8#1)(2008-10#1)(2008-5#2)(2008-7#1)(2013-1#1)
volatile fatty##10##2##(2006-10#1)(2006-8#2)(2008-10#2)(2008-5#2)(2008-7#1)(2012-3#1)(2013-1#1)
volatile flavour compounds were##2##4##(2008-10#2)
volatile flavour compounds##3##3##(2008-10#3)
volatile fractions##2##2##(2007-1#1)(2007-11#1)
volatile halogenated organic compounds##2##4##(2008-10#2)
volatile halogenated##3##2##(2008-10#2)(2009-8#1)
volatile hydrocarbons##2##2##(2008-10#2)
volatile issue##2##2##(1994-3#1)(1995-12#1)
volatile odor##4##2##(2008-10#2)(2008-5#2)
volatile oil from##2##3##(2007-3#1)(2013-8#1)
volatile oil##5##2##(2007-1#1)(2007-3#1)(2008-11#1)(2011-1#1)(2013-8#1)
volatile oils##7##2##(2007-1#1)(2008-11#4)(2012-1#1)(2013-1#1)
volatile organic compound##2##3##(1992-4#1)(2008-3#1)
volatile organic compounds (VOCs) in##2##5##(2008-10#1)(2011-1#1)
volatile organic compounds (VOCs)##7##4##(2006-12#1)(2008-10#5)(2011-1#1)
volatile organic compounds in air##3##5##(2008-10#1)(2013-1#2)
volatile organic compounds in##7##4##(1992-4#1)(2008-10#2)(2008-11#1)(2011-1#1)(2013-1#2)
volatile organic compounds##32##3##(1992-4#1)(1995-6#1)(2006-12#2)(2006-5#1)(2008-10#19)(2008-11#1)(2008-3#2)(2011-1#3)(2013-1#2)
volatile organic solvents##5##3##(2012-12#5)
volatile organic sulfur compounds##2##4##(2008-3#2)
volatile organic##44##2##(1992-4#2)(1995-6#1)(2006-12#2)(2006-5#1)(2008-10#22)(2008-11#1)(2008-3#5)(2011-1#3)(2012-12#5)(2013-1#2)
volatile organochlorine compounds##2##3##(2008-10#2)
volatile products##4##2##(2007-8#1)(2008-10#2)(2008-5#1)
volatile sesquiterpene##2##2##(2008-11#2)
volatile signals##2##2##(2009-8#2)
volatile solids##3##2##(2008-12#1)(2008-6#1)(2009-6#1)
volatile species##3##2##(2007-12#2)(2008-10#1)
volatile steroids##3##2##(2008-5#3)
volatile substances##2##2##(2008-10#2)
volatile sulfide##4##2##(2008-10#4)
volatile sulfides##2##2##(2008-10#2)
volatile sulfur compounds##2##3##(2006-12#1)(2008-10#1)
volatile sulfur##4##2##(2005-9#1)(2006-12#1)(2008-10#2)
volatile sulphur-containing compounds##2##3##(1997-4#2)
volatile##288##1##(1990-2#2)(1990-9#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-4#2)(1993-1#1)(1993-2#2)(1994-2#1)(1994-3#2)(1995-1#1)(1995-12#1)(1995-6#1)(1996-1#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#5)(2004-2#1)(2005-12#1)(2005-9#1)(2006-10#8)(2006-12#5)(2006-2#1)(2006-5#2)(2006-8#4)(2007-1#7)(2007-10#1)(2007-11#4)(2007-12#4)(2007-3#1)(2007-6#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#115)(2008-11#11)(2008-12#1)(2008-3#6)(2008-4#1)(2008-5#11)(2008-6#1)(2008-7#3)(2008-8#2)(2009-6#1)(2009-8#14)(2010-12#8)(2010-4#1)(2010-8#1)(2011-1#6)(2011-10#6)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#6)(2012-2#1)(2012-3#4)(2013-1#4)(2013-7#3)(2013-8#2)
volatiles and semivolatiles in##2##4##(2008-10#2)
volatiles and##5##2##(2008-10#4)(2011-2#1)
volatiles are##2##2##(2008-10#1)(2009-8#1)
volatiles emitted by##2##3##(2008-10#2)
volatiles from 'Isabella' grapes##2##4##(2008-10#2)
volatiles from##7##2##(2007-6#1)(2008-10#4)(2009-8#1)(2013-8#1)
volatiles in##7##2##(1990-11#2)(2005-12#1)(2007-12#1)(2008-10#1)(2009-8#1)(2011-12#1)
volatiles of##4##2##(2005-12#1)(2007-1#2)(2007-7#1)
volatiles on the growth of##2##5##(2008-10#1)(2009-8#1)
volatiles on the sporulation##2##4##(2008-10#2)
volatiles on the##4##3##(2008-10#3)(2009-8#1)
volatiles on##6##2##(2008-10#5)(2009-8#1)
volatiles or##2##2##(2009-8#2)
volatiles that##2##2##(2007-6#2)
volatiles to##2##2##(1990-11#1)(2009-8#1)
volatiles were##3##2##(2004-2#1)(2007-12#1)(2009-6#1)
volatiles##68##1##(1990-11#4)(1992-1#1)(2004-2#3)(2005-12#2)(2006-12#1)(2007-1#3)(2007-11#1)(2007-12#3)(2007-6#4)(2007-7#1)(2008-10#25)(2009-6#1)(2009-8#13)(2011-10#1)(2011-12#1)(2011-2#2)(2013-7#1)(2013-8#1)
volatilities##2##1##(2008-10#1)(2012-12#1)
volatility and##3##2##(2006-5#1)(2012-12#1)(2013-7#1)
volatility matrix##4##2##(2012-12#4)
volatility of##3##2##(1991-12#1)(2008-10#2)
volatility##28##1##(1991-12#1)(1991-2#1)(1995-1#1)(1997-7#1)(2006-5#3)(2007-1#1)(2008-10#7)(2008-2#1)(2012-12#11)(2013-7#1)
volatilization from##2##2##(2008-10#2)
volatilization##11##1##(2007-10#1)(2008-10#10)
volatilized##2##1##(2005-11#1)(2008-10#1)
volcanic aerosols##2##2##(2008-2#1)(2008-3#1)
volcanic centers##2##2##(1993-7#2)
volcanic dust##3##2##(2008-2#3)
volcanic eruption##3##2##(2008-2#2)(2008-9#1)
volcanic eruptions##3##2##(1992-3#2)(2007-9#1)
volcanic##26##1##(1990-6#1)(1992-3#2)(1992-7#1)(1993-7#3)(1996-3#1)(1996-4#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#9)(2008-3#1)(2008-9#1)(2010-5#1)
volcanism##4##1##(1991-6#1)(1993-4#2)(1993-7#1)
volcano##4##1##(1997-3#1)(2007-3#2)(2008-10#1)
vole (Microtus##2##2##(1991-8#1)(2013-1#1)
vole##11##1##(1991-8#2)(1992-9#1)(1994-3#1)(2008-10#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-1#2)
voles (Microtus##3##2##(1991-8#1)(2008-9#2)
voles and##2##2##(2012-1#1)(2013-1#1)
voles born into a##2##4##(1994-8#2)
voles did##3##2##(2008-9#2)(2009-6#1)
voles mounted##3##2##(2008-9#3)
voles##36##1##(1991-8#3)(1994-3#3)(1994-8#6)(1995-12#3)(1996-6#1)(2008-9#9)(2009-6#4)(2012-1#1)(2012-3#2)(2013-1#4)
volition##4##1##(1991-12#1)(1991-5#1)(2008-6#1)(2011-2#1)
volitional control##4##2##(2012-1#4)
volitional travel speed##2##3##(2010-8#2)
volitional##10##1##(2005-10#1)(2009-12#1)(2010-8#2)(2010-9#1)(2012-1#4)(2013-1#1)
volley##2##1##(1991-8#1)(1996-1#1)
volleyball##2##1##(2006-3#1)(2007-8#1)
volleys##6##1##(1990-7#1)(1991-11#4)(1992-9#1)
volt##2##1##(2007-9#1)(2008-3#1)
voltae##3##1##(1990-2#3)
voltage (&lt##2##2##(2008-10#1)(2010-4#1)
voltage V(c)##2##2##(2008-10#2)
voltage across##2##2##(2007-11#1)(2008-5#1)
voltage activated##4##2##(1994-5#1)(2008-11#1)(2008-8#2)
voltage and phase compensation##4##4##(2013-8#4)
voltage and the##3##3##(1997-2#1)(2006-5#1)(2007-11#1)
voltage and##34##2##(1990-2#1)(1991-5#1)(1992-11#1)(1993-2#1)(1993-9#1)(1996-10#1)(1997-2#2)(2005-11#1)(2006-5#1)(2007-11#2)(2007-12#1)(2008-10#9)(2008-2#3)(2008-4#1)(2008-5#1)(2009-7#2)(2010-2#1)(2013-8#4)
voltage applied to the##8##4##(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#3)
voltage applied to##9##3##(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#3)(2008-3#1)
voltage change##2##2##(1991-5#1)(2007-10#1)
voltage clamp technique##3##3##(1993-12#1)(1995-12#1)(2008-8#1)
voltage clamp##17##2##(1990-7#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-1#1)(1993-12#1)(1993-2#2)(1995-12#1)(1995-7#1)(1996-11#1)(1997-1#1)(1997-7#1)(2008-1#1)(2008-8#2)(2009-12#1)
voltage dependence of activation and##3##5##(1992-11#1)(1993-12#1)(2008-8#1)
voltage dependence of##6##3##(1992-11#1)(1993-12#1)(1997-7#1)(1997-8#1)(2008-8#2)
voltage dependence##12##2##(1991-2#1)(1992-11#1)(1993-12#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-4#1)(2008-8#3)(2009-11#1)(2009-8#1)
voltage dependent##7##2##(1990-11#1)(1993-12#1)(1994-11#1)(1997-4#1)(2008-1#1)(2008-11#1)(2009-12#1)
voltage dynamic range##2##3##(2009-5#2)
voltage for the##3##3##(1995-6#1)(2005-11#1)(2008-10#1)
voltage for##5##2##(1995-6#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-7#1)
voltage gated##2##2##(1991-1#1)(1992-7#1)
voltage gradients##2##2##(2012-11#2)
voltage in the##2##3##(1991-2#1)(2008-2#1)
voltage in##3##2##(1991-2#1)(2007-12#1)(2008-2#1)
voltage is applied across a##2##5##(2008-10#1)(2008-7#1)
voltage is applied to a##2##5##(1996-11#1)(2008-3#1)
voltage is applied to##4##4##(1996-11#1)(2008-2#1)(2008-3#2)
voltage is applied##7##3##(1996-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)
voltage is##11##2##(1995-3#1)(1996-11#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-7#1)(2013-8#1)
voltage noise##2##2##(1990-7#2)
voltage of 1##2##3##(2007-11#1)(2010-12#1)
voltage of 100 V##2##4##(2007-12#1)(2008-2#1)
voltage of 15##2##3##(2007-11#1)(2008-10#1)
voltage of the##2##3##(2006-5#1)(2007-12#1)
voltage of##34##2##(1997-3#1)(2005-12#1)(2006-5#1)(2007-11#3)(2007-12#6)(2007-8#2)(2008-1#1)(2008-10#13)(2008-2#3)(2008-3#1)(2010-12#1)(2010-4#1)
voltage on the##7##3##(1991-5#1)(2008-10#1)(2008-3#3)(2008-9#1)(2010-12#1)
voltage on##8##2##(1991-5#1)(2008-10#2)(2008-3#3)(2008-9#1)(2010-12#1)
voltage or##2##2##(2005-7#1)(2009-8#1)
voltage probe##2##2##(2008-3#2)
voltage ratio##2##2##(2008-2#1)(2008-3#1)
voltage sensitive Ca2+ channels##2##4##(1996-8#1)(1997-2#1)
voltage sensitive Ca2+##3##3##(1996-8#1)(1997-2#2)
voltage sensitive Na(+)-channels##2##3##(1996-11#2)
voltage sensitive##8##2##(1990-10#1)(1995-3#1)(1996-11#2)(1996-8#1)(1997-2#2)(2008-5#1)
voltage sensor based on##2##4##(2008-3#2)
voltage sensor for##2##3##(2008-3#2)
voltage sensor##12##2##(1993-12#1)(1996-9#1)(2008-3#4)(2008-8#2)(2010-12#4)
voltage steps##5##2##(1993-2#2)(1994-2#1)(1995-12#1)(2008-8#1)
voltage than##2##2##(2009-5#1)(2013-7#1)
voltage to##4##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#1)
voltage transients##2##2##(2010-2#2)
voltage tuning##2##2##(2008-3#1)(2011-1#1)
voltage was##5##2##(1991-9#1)(1996-5#1)(2008-10#2)(2012-12#1)
voltage were investigated##2##3##(2008-10#1)(2008-3#1)
voltage were##6##2##(1993-12#1)(2008-10#2)(2008-3#3)
voltage##358##1##(1990-10#2)(1990-11#1)(1990-2#1)(1990-3#2)(1990-7#3)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#5)(1991-6#2)(1991-8#1)(1991-9#5)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-12#6)(1993-2#9)(1993-3#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-12#3)(1995-3#4)(1995-6#2)(1995-7#1)(1996-1#1)(1996-10#2)(1996-11#4)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#7)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#3)(2005-11#2)(2005-12#1)(2005-7#1)(2006-2#1)(2006-5#3)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#16)(2007-12#29)(2007-8#4)(2007-9#2)(2008-1#5)(2008-10#68)(2008-11#5)(2008-2#22)(2008-3#21)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#12)(2008-9#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-5#4)(2009-6#1)(2009-7#3)(2009-8#3)(2010-10#2)(2010-12#7)(2010-2#4)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#2)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#3)(2013-8#8)
voltage- and ligand-gated##2##3##(1993-9#1)(2008-8#1)
voltage- and##4##2##(1993-2#1)(1993-9#1)(1994-2#1)(2008-8#1)
voltage-activated Ca2+ currents##2##3##(1994-3#1)(1996-1#1)
voltage-activated Ca2+##4##2##(1990-2#1)(1994-3#2)(1996-1#1)
voltage-activated calcium##6##2##(1993-12#2)(1996-3#1)(1996-5#1)(1997-5#1)(2008-8#1)
voltage-activated##28##1##(1990-2#1)(1993-12#2)(1993-9#1)(1994-3#2)(1994-8#3)(1995-11#3)(1995-12#1)(1996-1#5)(1996-3#2)(1996-5#1)(1997-5#1)(1997-7#2)(2008-8#4)
voltage-biased superconducting##2##2##(2008-2#1)(2008-3#1)
voltage-biased##4##1##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
voltage-clamp condition##2##2##(1991-8#1)(1993-2#1)
voltage-clamp conditions##2##2##(1995-6#1)(1997-2#1)
voltage-clamp recording##4##2##(1991-7#1)(1992-5#1)(1997-1#1)(1997-3#1)
voltage-clamp##15##1##(1991-5#1)(1991-7#1)(1991-8#1)(1992-5#1)(1993-2#1)(1995-11#1)(1995-6#1)(1995-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2008-8#1)(2009-12#1)
voltage-controlled##6##1##(2007-11#1)(2007-12#1)(2008-3#3)(2012-1#1)
voltage-dependency##2##1##(1995-12#1)(2009-3#1)
voltage-dependent Ca(2+)##3##2##(2008-4#1)(2008-8#1)(2009-12#1)
voltage-dependent Ca2+ channel##2##3##(1993-11#1)(1995-12#1)
voltage-dependent Ca2+ channels in##2##4##(1996-10#1)(1996-5#1)
voltage-dependent Ca2+ channels##8##3##(1990-7#1)(1992-7#1)(1993-3#1)(1994-11#1)(1995-12#1)(1996-10#1)(1996-5#1)(2008-8#1)
voltage-dependent Ca2+##12##2##(1990-7#1)(1992-7#2)(1993-11#1)(1993-3#1)(1994-11#1)(1995-12#2)(1996-10#1)(1996-5#1)(1997-5#1)(2008-8#1)
voltage-dependent K+##2##2##(1991-9#1)(1994-12#1)
voltage-dependent L-type Ca2+##5##3##(1992-7#1)(1995-12#3)(1997-5#1)
voltage-dependent Na+ channels##2##3##(1992-7#1)(1995-11#1)
voltage-dependent and##2##2##(1996-8#1)(2009-2#1)
voltage-dependent calcium channel##2##3##(1990-12#1)(1991-9#1)
voltage-dependent calcium channels##3##3##(1990-3#1)(1996-2#1)(2008-8#1)
voltage-dependent calcium current##2##3##(1995-10#2)
voltage-dependent calcium##8##2##(1990-12#1)(1990-3#1)(1991-9#1)(1995-10#2)(1996-2#1)(1997-7#1)(2008-8#1)
voltage-dependent inactivation##2##2##(1996-2#1)(2008-8#1)
voltage-dependent inward##2##2##(1993-3#1)(2009-12#1)
voltage-dependent potassium channels##2##3##(1996-10#1)(1996-2#1)
voltage-dependent potassium##6##2##(1996-10#1)(1996-2#1)(1996-5#4)
voltage-dependent sodium channels and##2##4##(2005-8#1)(2008-8#1)
voltage-dependent sodium channels##3##3##(2005-8#1)(2008-8#2)
voltage-dependent sodium##10##2##(1994-9#5)(1995-12#1)(2004-11#1)(2005-8#1)(2008-8#2)
voltage-dependent##85##1##(1990-12#1)(1990-3#1)(1990-7#1)(1991-5#1)(1991-9#3)(1992-4#1)(1992-7#4)(1993-11#1)(1993-2#1)(1993-3#6)(1994-11#1)(1994-12#1)(1994-9#5)(1995-10#3)(1995-11#1)(1995-12#6)(1995-2#1)(1996-10#3)(1996-11#1)(1996-2#3)(1996-5#6)(1996-8#3)(1997-1#1)(1997-2#3)(1997-5#2)(1997-7#4)(2004-11#1)(2005-11#1)(2005-8#1)(2007-11#2)(2007-9#1)(2008-4#2)(2008-8#7)(2009-12#2)(2009-2#1)(2009-8#1)(2012-2#2)
voltage-driven##2##1##(1993-12#1)(2008-8#1)
voltage-gated Ca(2+) channels##2##3##(2007-10#1)(2008-8#1)
voltage-gated Ca(2+)##3##2##(2007-10#1)(2008-4#1)(2008-8#1)
voltage-gated Ca2+ channels##5##3##(1994-10#1)(1994-5#1)(1996-2#1)(1996-9#1)(2009-7#1)
voltage-gated Ca2+##8##2##(1992-12#1)(1994-10#2)(1994-5#2)(1996-2#1)(1996-9#1)(2009-7#1)
voltage-gated Cl- channel##2##3##(1994-9#2)
voltage-gated Na(+) and##2##3##(2008-7#1)(2009-12#1)
voltage-gated Na(+) channel##3##3##(2008-8#3)
voltage-gated Na(+)##5##2##(2008-7#1)(2008-8#3)(2009-12#1)
voltage-gated Na+ and Ca2+##2##4##(1996-1#2)
voltage-gated and##2##2##(2008-4#1)(2008-8#1)
voltage-gated calcium channel currents##2##4##(1993-12#2)
voltage-gated calcium channel##5##3##(1990-7#1)(1993-12#2)(2008-8#1)(2009-5#1)
voltage-gated calcium channels##9##3##(1994-2#1)(1995-7#1)(1996-1#1)(1997-7#1)(2008-12#1)(2008-8#2)(2008-9#1)(2012-3#1)
voltage-gated calcium##15##2##(1990-7#1)(1993-12#2)(1993-9#1)(1994-2#1)(1995-7#1)(1996-1#1)(1997-7#1)(2008-12#1)(2008-8#3)(2008-9#1)(2009-5#1)(2012-3#1)
voltage-gated channels and##2##3##(1991-2#1)(1991-6#1)
voltage-gated channels##3##2##(1991-2#1)(1991-6#1)(1995-8#1)
voltage-gated ion channel##2##3##(2008-4#1)(2008-8#1)
voltage-gated ion##3##2##(2008-4#1)(2008-8#2)
voltage-gated potassium channels##2##3##(1993-9#1)(2010-12#1)
voltage-gated potassium##5##2##(1993-9#1)(1997-4#1)(2006-2#1)(2010-12#2)
voltage-gated sodium channel that##2##4##(2008-8#1)(2010-2#1)
voltage-gated sodium channel##7##3##(2006-10#1)(2008-8#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-3#2)
voltage-gated sodium channels##8##3##(2006-10#3)(2006-12#1)(2008-5#1)(2008-8#1)(2012-3#2)
voltage-gated sodium##18##2##(1992-11#1)(2006-10#4)(2006-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2010-12#1)(2010-2#1)(2012-12#1)(2012-3#4)
voltage-gated##76##1##(1990-7#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1993-12#2)(1993-9#3)(1994-10#2)(1994-2#2)(1994-5#3)(1994-9#3)(1995-7#1)(1995-8#1)(1996-1#3)(1996-10#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-4#2)(1997-7#1)(2006-10#4)(2006-12#1)(2006-2#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#13)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-12#3)(2010-2#1)(2011-1#1)(2012-12#1)(2012-3#5)
voltage-independent##7##1##(1991-3#1)(1995-6#1)(1996-8#1)(1997-7#1)(2008-8#2)(2009-8#1)
voltage-insensitive##2##1##(1996-9#2)
voltage-operated calcium channels##2##3##(1992-12#2)
voltage-operated calcium##4##2##(1991-5#1)(1992-12#3)
voltage-operated##5##1##(1991-5#1)(1992-12#3)(2010-2#1)
voltage-sensitive Ca2+ channel##2##3##(1994-3#2)
voltage-sensitive Ca2+ channels##3##3##(1990-7#1)(1993-11#1)(1996-6#1)
voltage-sensitive Ca2+ release pathway##2##4##(1995-3#2)
voltage-sensitive Ca2+##7##2##(1990-7#1)(1993-11#1)(1994-3#2)(1995-3#2)(1996-6#1)
voltage-sensitive Na##2##2##(1993-11#2)
voltage-sensitive calcium channel (VSCC)##2##4##(1990-7#1)(1993-2#1)
voltage-sensitive calcium channel##4##3##(1990-7#1)(1993-2#3)
voltage-sensitive calcium channels in##2##4##(1990-7#1)(2007-9#1)
voltage-sensitive calcium channels##7##3##(1990-7#2)(1995-11#3)(2007-9#2)
voltage-sensitive calcium##11##2##(1990-7#3)(1993-2#3)(1995-11#3)(2007-9#2)
voltage-sensitive dye##4##2##(1996-12#1)(1996-5#1)(2008-4#2)
voltage-sensitive dyes##5##2##(1994-12#1)(1996-12#3)(2008-4#1)
voltage-sensitive sodium channel gene##4##4##(1994-3#4)
voltage-sensitive sodium channels##2##3##(1994-3#1)(1995-3#1)
voltage-sensitive sodium##6##2##(1994-3#5)(1995-3#1)
voltage-sensitive##39##1##(1990-7#4)(1991-9#1)(1993-11#3)(1993-2#3)(1994-12#1)(1994-3#7)(1995-11#3)(1995-3#4)(1996-12#4)(1996-5#1)(1996-6#1)(2007-9#3)(2008-4#3)(2008-8#1)
voltages and##2##2##(1997-2#1)(2007-11#1)
voltages as low as##2##4##(2007-12#2)
voltages in the range##2##4##(2005-11#1)(2009-2#1)
voltages of##3##2##(2008-2#1)(2010-4#1)(2010-8#1)
voltages ranging from##2##3##(2008-2#1)(2009-2#1)
voltages to##2##2##(2007-12#1)(2008-2#1)
voltages##34##1##(1991-2#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-4#1)(2005-11#2)(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#8)(2008-3#3)(2008-4#1)(2008-8#1)(2009-2#2)(2010-4#1)(2010-8#1)(2012-1#1)(2012-11#1)(2013-7#1)(2013-8#1)
voltametric##3##1##(2008-10#2)(2010-2#1)
voltametry##4##1##(2008-10#2)(2009-5#2)
voltammetric (SWV)##3##2##(2008-10#3)
voltammetric analysis of##5##3##(2008-10#5)
voltammetric analysis##8##2##(2008-10#7)(2010-4#1)
voltammetric analyzer##2##2##(2008-10#2)
voltammetric approach##2##2##(2008-10#2)
voltammetric behavior of the##2##4##(2008-10#2)
voltammetric behavior of##7##3##(2008-10#7)
voltammetric behavior##9##2##(2008-10#9)
voltammetric behaviour of##7##3##(2008-10#7)
voltammetric behaviour##9##2##(2008-10#9)
voltammetric biosensor##2##2##(2008-10#2)
voltammetric characteristics##2##2##(2008-10#2)
voltammetric conditions##2##2##(2008-10#2)
voltammetric curves##2##2##(2008-10#2)
voltammetric data##4##2##(1997-1#1)(2008-10#3)
voltammetric detection of##4##3##(2008-10#4)
voltammetric detection##10##2##(2008-10#10)
voltammetric determination at##2##3##(2008-10#2)
voltammetric determination in##2##3##(2008-10#2)
voltammetric determination of copper##2##4##(2008-10#2)
voltammetric determination of the##3##4##(2008-10#3)
voltammetric determination of trace amount##3##5##(2008-10#3)
voltammetric determination of trace##4##4##(2008-10#4)
voltammetric determination of traces of nickel(II)##2##6##(2008-10#2)
voltammetric determination of##35##3##(2007-8#1)(2008-10#34)
voltammetric determination##40##2##(2007-8#1)(2008-10#39)
voltammetric enzyme-linked immunoassay system##3##4##(2008-10#3)
voltammetric enzyme-linked immunoassay##4##3##(2008-10#4)
voltammetric experiments##5##2##(2008-10#5)
voltammetric measurement##3##2##(2008-10#3)
voltammetric measurements##8##2##(2008-10#8)
voltammetric method for the determination of##2##6##(2008-10#2)
voltammetric method for the##3##4##(2008-10#3)
voltammetric method for##7##3##(2007-8#1)(2008-10#6)
voltammetric method is##4##3##(2008-10#4)
voltammetric method was##2##3##(2008-10#2)
voltammetric method##23##2##(2007-8#1)(2008-10#22)
voltammetric methods##4##2##(2006-6#1)(2008-10#3)
voltammetric oxidation##2##2##(2008-10#2)
voltammetric peak and##2##3##(2008-10#2)
voltammetric peak at potential of -0##2##6##(2008-10#2)
voltammetric peak at##3##3##(2008-10#3)
voltammetric peak current##2##3##(2008-10#2)
voltammetric peak##11##2##(2008-10#11)
voltammetric peaks##3##2##(2008-10#3)
voltammetric procedure for##3##3##(2008-10#3)
voltammetric procedure##8##2##(2008-10#8)
voltammetric reduction##2##2##(2008-10#2)
voltammetric response in##2##3##(2008-10#2)
voltammetric response of##3##3##(2008-10#3)
voltammetric response was##2##3##(2008-10#2)
voltammetric response##12##2##(2008-10#12)
voltammetric responses of##2##3##(2008-10#2)
voltammetric responses##5##2##(2008-10#3)(2009-3#2)
voltammetric results##3##2##(2008-10#3)
voltammetric scan##6##2##(2008-10#6)
voltammetric scans##2##2##(2007-8#1)(2008-10#1)
voltammetric sensor for##2##3##(2008-10#2)
voltammetric sensor##4##2##(2008-10#4)
voltammetric signals##5##2##(2008-10#5)
voltammetric stripping##3##2##(2007-8#1)(2008-10#2)
voltammetric studies##4##2##(2008-10#1)(2008-3#1)(2009-9#2)
voltammetric study##3##2##(2005-11#1)(2008-10#1)(2010-5#1)
voltammetric system##2##2##(2008-10#2)
voltammetric systems##2##2##(2008-10#2)
voltammetric technique for the##2##4##(2008-10#2)
voltammetric technique for##4##3##(2008-10#4)
voltammetric technique##5##2##(2008-10#5)
voltammetric techniques##8##2##(1992-3#1)(2008-10#7)
voltammetric waveform##2##2##(2008-10#2)
voltammetric##273##1##(1992-3#1)(1997-1#1)(2005-11#2)(2006-2#1)(2006-6#2)(2007-8#5)(2008-10#253)(2008-3#1)(2009-3#2)(2009-9#2)(2010-4#1)(2010-5#1)(2010-6#1)
voltammetrically##3##1##(2008-10#3)
voltammetry (CV) and##10##3##(2007-9#1)(2008-10#9)
voltammetry (CV)##26##2##(2005-11#1)(2007-9#1)(2008-10#20)(2008-5#2)(2010-4#1)(2010-5#1)
voltammetry (LSV)##2##2##(2008-10#2)
voltammetry after##2##2##(2008-10#1)(2009-3#1)
voltammetry and chronoamperometry##3##3##(2007-8#1)(2008-10#2)
voltammetry and chronocoulometry##2##3##(2008-10#2)
voltammetry and##31##2##(2005-11#2)(2007-8#2)(2008-10#23)(2010-11#1)(2013-1#3)
voltammetry at a carbon paste electrode##2##6##(2008-10#2)
voltammetry at a##11##3##(2008-10#11)
voltammetry at the##2##3##(2008-10#2)
voltammetry at##20##2##(1995-5#1)(2008-10#19)
voltammetry based on the adsorption collection##2##6##(2008-10#2)
voltammetry data##2##2##(2007-11#1)(2008-10#1)
voltammetry determination of##2##3##(2008-10#2)
voltammetry experiments##4##2##(2008-10#3)(2008-4#1)
voltammetry for the##2##3##(1994-8#1)(2008-10#1)
voltammetry for##4##2##(1994-8#1)(2008-10#3)
voltammetry has been##2##3##(2008-10#2)
voltammetry have been##2##3##(2008-10#2)
voltammetry in a flow injection system##2##6##(2008-10#2)
voltammetry in a##3##3##(2008-10#2)(2008-3#1)
voltammetry in##8##2##(2005-11#1)(2008-10#6)(2008-3#1)
voltammetry is##4##2##(2008-10#3)(2010-2#1)
voltammetry measurement##2##2##(2005-11#1)(2008-10#1)
voltammetry methods##3##2##(2008-10#2)(2008-4#1)
voltammetry of the##5##3##(2008-10#5)
voltammetry of##22##2##(2005-11#1)(2008-10#18)(2008-12#1)(2008-5#1)(2010-5#1)
voltammetry on a##6##3##(2008-10#6)
voltammetry on##9##2##(1997-8#1)(2008-10#8)
voltammetry technique##2##2##(2008-10#2)
voltammetry to the##2##3##(2008-10#2)
voltammetry using a##2##3##(2008-10#2)
voltammetry using##14##2##(2007-8#2)(2008-10#12)
voltammetry was used to study the##2##6##(2008-10#1)(2008-8#1)
voltammetry was used to##5##4##(2008-10#4)(2008-8#1)
voltammetry was used##6##3##(2008-10#5)(2008-8#1)
voltammetry was##11##2##(2008-10#10)(2008-8#1)
voltammetry were##4##2##(2008-10#4)
voltammetry with a##6##3##(2008-10#6)
voltammetry with the##2##3##(2008-10#2)
voltammetry with##16##2##(2008-10#14)(2008-4#1)(2009-9#1)
voltammetry##419##1##(1991-10#1)(1992-7#3)(1993-7#1)(1994-8#1)(1995-5#1)(1995-6#1)(1997-8#1)(2005-11#7)(2006-12#2)(2006-6#2)(2007-11#3)(2007-8#8)(2007-9#2)(2008-10#357)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#4)(2008-5#4)(2008-6#1)(2008-8#2)(2009-3#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#4)(2013-1#3)(2013-7#1)
voltammetry)##4##1##(2008-10#4)
voltammogram of the##3##3##(1992-7#1)(2005-11#1)(2008-3#1)
voltammogram of##6##2##(1992-7#1)(2005-11#1)(2008-10#2)(2008-3#1)(2009-9#1)
voltammogram was##2##2##(2008-10#2)
voltammogram##13##1##(1992-7#1)(2005-11#1)(2008-10#9)(2008-3#1)(2009-9#1)
voltammograms (CV)##2##2##(2007-8#1)(2008-10#1)
voltammograms in##2##2##(2008-10#1)(2010-6#1)
voltammograms of the##2##3##(2008-10#2)
voltammograms of##8##2##(1996-5#1)(2008-10#7)
voltammograms recorded##3##2##(2008-10#3)
voltammograms##29##1##(1996-5#1)(2007-8#1)(2008-10#26)(2010-6#1)
voltamograms##2##1##(1990-5#1)(2007-8#1)
voltinism##2##1##(2011-12#2)
volts##4##1##(1995-3#1)(1997-4#1)(2008-3#1)(2010-2#1)
volts)##2##1##(1990-11#1)(1995-3#1)
volume &gt##3##2##(2008-6#1)(2011-2#2)
volume (&lt##2##2##(2010-10#1)(2010-11#1)
volume (0##3##2##(2008-3#1)(2010-11#1)(2012-12#1)
volume (1##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
volume (100##2##2##(2008-10#2)
volume (GTV)##3##2##(2008-2#2)(2009-2#1)
volume (MCV)##5##2##(2005-10#1)(2006-2#1)(2008-10#1)(2008-7#1)(2011-12#1)
volume (P##2##2##(2007-10#1)(2009-5#1)
volume (PTV)##9##2##(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#2)(2009-10#1)(2009-5#1)(2012-12#1)
volume (ca##2##2##(2008-10#2)
volume (chi2 =##2##3##(2007-8#2)
volume (e##2##2##(2008-7#1)(2010-2#1)
volume 0##2##2##(1990-8#1)(2008-10#1)
volume 1##2##2##(2006-10#1)(2008-4#1)
volume 100##2##2##(2006-4#1)(2008-10#1)
volume 48##3##2##(2008-11#1)(2010-9#2)
volume IRBs##2##2##(2009-4#2)
volume after##7##2##(1992-6#1)(2006-6#1)(2007-9#1)(2008-1#1)(2011-2#1)(2012-12#2)
volume analysis##3##2##(1991-12#1)(1994-12#1)(2010-11#1)
volume and a##5##3##(2007-9#1)(2008-10#1)(2008-6#1)(2013-7#1)(2013-8#1)
volume and better##2##3##(2008-7#1)(2013-8#1)
volume and cell##2##3##(1993-2#1)(2007-8#1)
volume and cristae##2##3##(2012-3#2)
volume and flow##3##3##(1997-6#1)(2008-10#1)(2010-5#1)
volume and function##2##3##(1992-12#1)(2005-12#1)
volume and in##2##3##(2008-10#2)
volume and intensity of##2##4##(1991-2#2)
volume and intensity##3##3##(1991-2#3)
volume and is##5##3##(2007-12#2)(2008-10#1)(2011-2#2)
volume and limit of detection##4##5##(2008-10#4)
volume and surface area##2##4##(1996-5#2)
volume and surface##3##3##(1996-5#2)(2008-2#1)
volume and the##14##3##(1991-12#1)(1991-2#1)(1994-12#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-11#2)(2011-2#1)(2013-1#1)
volume and thus##2##3##(1997-1#1)(2007-2#1)
volume and##161##2##(1990-12#1)(1991-12#1)(1991-2#4)(1991-9#1)(1992-12#2)(1992-5#1)(1992-6#1)(1993-2#2)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-5#3)(1995-2#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#2)(1997-6#3)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#7)(2007-11#4)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#3)(2007-6#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#20)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#1)(2010-1#1)(2010-11#2)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#9)(2012-12#6)(2012-2#1)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#3)
volume are##9##2##(1990-3#1)(1997-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-6#1)(2012-12#2)
volume as a##2##3##(1995-2#1)(2013-7#1)
volume as##6##2##(1992-8#1)(1995-2#1)(2008-10#1)(2008-12#1)(2010-12#1)(2013-7#1)
volume at##8##2##(1992-1#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-4#1)
volume before##3##2##(2007-10#1)(2008-8#1)(2011-3#1)
volume being##2##2##(1996-5#1)(2010-7#1)
volume between##3##2##(1995-3#1)(2007-10#1)(2012-2#1)
volume but##2##2##(2008-10#1)(2008-3#1)
volume by##8##2##(1993-12#1)(1996-9#1)(2006-10#1)(2006-4#1)(2006-6#1)(2008-3#1)(2010-12#2)
volume can be##7##3##(1993-11#1)(1994-9#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-3#2)
volume change##4##2##(1990-7#1)(1991-2#1)(2005-11#1)(2007-12#1)
volume changes during##2##3##(2007-11#1)(2011-1#1)
volume changes of##2##3##(2007-12#1)(2008-4#1)
volume changes##17##2##(1990-8#2)(1993-7#2)(1996-12#1)(1997-4#1)(1997-6#1)(2005-11#2)(2006-10#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-8#1)(2009-1#1)(2011-1#2)
volume column system was##2##4##(2008-10#2)
volume column system##3##3##(2008-10#3)
volume compressibility##2##2##(1991-5#1)(2008-10#1)
volume concentration##3##2##(1996-11#1)(2007-12#1)(2008-3#1)
volume concentrations##4##2##(2008-2#2)(2008-3#2)
volume consumption for##2##3##(2008-3#2)
volume consumption is##2##3##(2008-3#2)
volume consumption##5##2##(2008-3#5)
volume correction##2##2##(1992-1#1)(2008-3#1)
volume data##3##2##(2008-6#1)(2008-7#1)(2009-5#1)
volume decrease##11##2##(1990-2#2)(1991-1#1)(1992-6#3)(1992-8#1)(1997-5#1)(2006-10#1)(2008-8#1)(2013-8#1)
volume decreased from##2##3##(2007-6#1)(2012-2#1)
volume decreased##5##2##(1995-8#1)(2006-9#1)(2007-6#1)(2008-6#1)(2012-2#1)
volume density of syncytiotrophoblast##2##4##(2011-1#2)
volume density of##6##3##(2008-3#1)(2009-11#1)(2009-2#1)(2011-1#2)(2012-1#1)
volume density##14##2##(1995-8#1)(2008-3#2)(2009-11#2)(2009-2#1)(2010-10#2)(2011-1#4)(2012-1#1)(2012-3#1)
volume depletion##2##2##(2007-7#1)(2010-7#1)
volume determination##3##2##(1996-7#1)(2008-10#2)
volume distribution##3##2##(2008-3#2)(2009-8#1)
volume dose##2##2##(1993-4#1)(2008-3#1)
volume during##7##2##(2011-2#6)(2013-7#1)
volume effect##4##2##(2007-10#1)(2008-2#1)(2009-7#1)(2011-1#1)
volume effects##2##2##(2008-3#1)(2009-7#1)
volume efficient than##2##3##(2008-3#2)
volume element of a highly diffusing medium##2##7##(2007-12#2)
volume element##4##2##(2007-12#3)(2009-7#1)
volume estimation of the hippocampus##2##5##(1996-9#2)
volume eventually##2##2##(2006-9#1)(2008-11#1)
volume expansion##5##2##(2005-10#1)(2007-5#1)(2008-12#1)(2009-8#1)(2011-1#1)
volume flow increased##2##3##(2006-10#1)(2008-11#1)
volume flow was measured##2##4##(2006-10#1)(2007-7#1)
volume flow was##3##3##(2006-10#2)(2007-7#1)
volume flow##13##2##(2006-10#5)(2007-10#1)(2007-7#1)(2007-9#3)(2008-11#3)
volume for the##4##3##(1994-4#1)(2005-11#1)(2008-10#1)(2012-12#1)
volume for##13##2##(1992-9#1)(1993-9#2)(1994-4#1)(1994-9#1)(2005-11#1)(2006-4#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-1#1)(2012-12#1)
volume fraction and##6##3##(2005-11#1)(2008-2#1)(2008-3#2)(2009-6#1)(2009-7#1)
volume fraction in##2##3##(2004-9#1)(2008-3#1)
volume fraction occupied by the##2##5##(2008-11#1)(2012-11#1)
volume fraction of the##4##4##(2007-12#1)(2008-11#1)(2009-5#2)
volume fraction of##15##3##(1995-3#1)(2005-12#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-12#1)(2009-5#2)(2010-9#1)(2011-1#1)(2012-12#1)
volume fraction##44##2##(1994-8#1)(1995-3#1)(1996-11#1)(1996-9#1)(2004-9#1)(2005-10#1)(2005-11#8)(2005-12#1)(2007-12#3)(2008-10#1)(2008-11#2)(2008-2#5)(2008-3#7)(2009-11#1)(2009-12#1)(2009-5#2)(2009-6#1)(2009-7#2)(2010-9#1)(2011-1#1)(2012-11#1)(2012-12#1)
volume fraction)##2##2##(2008-10#2)
volume fractions of the##3##4##(2008-2#1)(2008-3#2)
volume fractions were measured##2##4##(2010-9#1)(2013-8#1)
volume fractions##15##2##(2005-11#1)(2008-2#2)(2008-3#3)(2009-7#1)(2010-9#5)(2013-8#3)
volume from##4##2##(1996-1#1)(2007-8#1)(2008-10#1)(2008-3#1)
volume grating coupler##3##3##(2007-12#1)(2008-2#2)
volume grating is##2##3##(2007-12#2)
volume grating##12##2##(2007-12#4)(2008-2#4)(2008-3#4)
volume gratings written##2##3##(2007-12#1)(2008-3#1)
volume gratings##7##2##(2007-12#4)(2008-3#3)
volume group##2##2##(2009-7#2)
volume has##3##2##(1992-12#1)(1995-2#1)(2007-12#1)
volume hologram recording##2##3##(2007-12#2)
volume hologram was##3##3##(2007-12#3)
volume hologram##11##2##(2007-12#9)(2008-3#2)
volume holograms recorded##2##3##(2008-2#2)
volume holograms##9##2##(2008-1#1)(2008-2#3)(2008-3#5)
volume holographic data storage##7##4##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#4)
volume holographic data##8##3##(2007-11#2)(2007-12#1)(2008-1#1)(2008-3#4)
volume holographic memories##3##3##(2008-2#2)(2008-3#1)
volume holographic memory##3##3##(2008-1#1)(2008-2#2)
volume holographic storage##3##3##(2007-12#2)(2008-3#1)
volume holographic system are presented##2##5##(2007-11#2)
volume holographic##32##2##(2007-11#6)(2007-12#9)(2008-1#2)(2008-2#4)(2008-3#11)
volume immediately##2##2##(2008-3#1)(2013-8#1)
volume in a##4##3##(2007-8#1)(2008-10#1)(2008-3#1)(2009-9#1)
volume in breast cancer survivors##2##5##(2010-9#2)
volume in breast##3##3##(2010-9#2)(2012-12#1)
volume in the##15##3##(1990-5#1)(2006-10#1)(2006-5#1)(2007-10#2)(2007-8#1)(2007-9#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
volume in##57##2##(1990-5#1)(1992-1#1)(1992-7#1)(1992-8#1)(1994-5#2)(1996-2#1)(1996-5#1)(1996-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#3)(2007-8#5)(2007-9#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-9#2)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
volume increase##3##2##(1991-1#1)(1992-6#1)(1992-8#1)
volume increased with##3##3##(1996-1#1)(2007-8#1)(2008-7#1)
volume increased##10##2##(1994-4#1)(1996-1#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-9#1)(2013-1#2)(2013-7#1)
volume increases and##2##3##(2006-10#1)(2006-2#1)
volume increases##4##2##(2006-10#1)(2006-2#1)(2007-12#1)(2008-10#1)
volume index gratings in##2##4##(2007-11#1)(2007-12#1)
volume index gratings##3##3##(2007-11#2)(2007-12#1)
volume index##5##2##(2007-11#2)(2007-12#1)(2007-8#2)
volume injected##3##2##(2008-10#3)
volume injection loop##2##3##(2007-8#1)(2008-10#1)
volume integral equation simulations of##2##5##(2008-2#2)
volume integral equation##4##3##(2008-2#2)(2008-3#2)
volume integral##6##2##(2007-12#1)(2008-2#2)(2008-3#3)
volume is associated with##2##4##(2008-7#2)
volume is not##2##3##(1994-3#1)(1995-6#1)
volume is occupied by##2##4##(1996-2#1)(2007-11#1)
volume is related to##2##4##(2007-10#1)(2007-8#1)
volume is##36##2##(1991-2#1)(1992-12#2)(1994-3#1)(1994-6#1)(1994-9#2)(1995-6#1)(1996-2#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-7#1)(2010-10#1)(2012-12#1)(2013-1#1)
volume limitation##3##2##(2006-10#2)(2012-3#1)
volume loss##8##2##(2007-10#2)(2007-12#1)(2007-6#1)(2009-2#1)(2011-2#3)
volume measurements and##2##3##(2007-8#1)(2008-4#1)
volume measurements##7##2##(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-3#1)(2010-8#1)
volume median droplet diameter d(v50)##2##5##(2008-5#2)
volume mixing ratio##4##3##(2008-3#4)
volume mixing ratio) with##2##4##(2008-2#2)
volume mixing##6##2##(2008-2#2)(2008-3#4)
volume needed for##2##3##(2007-9#1)(2013-1#1)
volume observed##2##2##(1991-2#1)(2008-10#1)
volume occupied by##5##3##(1995-11#1)(2007-3#2)(2007-9#2)
volume of 0##5##3##(1990-11#1)(2008-10#3)(2010-4#1)
volume of 1##5##3##(2007-11#1)(2007-8#1)(2008-10#2)(2013-1#1)
volume of 100 mul##4##4##(2008-10#4)
volume of 100##8##3##(2008-10#8)
volume of 10ml##2##3##(2008-10#2)
volume of 20 mul##2##4##(2008-10#2)
volume of 20##6##3##(1991-2#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-5#1)
volume of 200##2##3##(2008-10#2)
volume of 25 ml##2##4##(2008-10#2)
volume of 25##4##3##(2008-10#3)(2008-5#1)
volume of 50 ml##2##4##(2008-10#2)
volume of 50##3##3##(2008-10#3)
volume of CO(2)##2##3##(2008-10#2)
volume of a##8##3##(1990-12#1)(1992-12#1)(1996-2#1)(2005-11#1)(2008-10#2)(2008-11#1)(2009-9#1)
volume of about##2##3##(1995-6#1)(2007-7#1)
volume of air##2##3##(2008-10#1)(2008-2#1)
volume of an##5##3##(2007-12#1)(2008-10#3)(2008-3#1)
volume of aqueous phase and interference of a number of metal ions on the determination of##3##16##(2008-10#3)
volume of aqueous phase and interference of a##4##8##(2008-10#4)
volume of aqueous phase and##5##5##(2008-10#5)
volume of aqueous phase##6##4##(2008-10#6)
volume of aqueous##9##3##(2008-10#9)
volume of blood and##2##4##(2007-2#1)(2011-1#1)
volume of blood##4##3##(2007-2#1)(2007-7#1)(2009-6#1)(2011-1#1)
volume of cells##2##3##(2008-10#1)(2008-11#1)
volume of clinical##2##3##(2006-10#1)(2013-1#1)
volume of contrast##2##3##(2006-8#2)
volume of distilled water##2##4##(2006-4#1)(2012-3#1)
volume of distribution (V(d))##2##4##(2007-1#1)(2011-1#1)
volume of distribution (Vd)##2##4##(2004-12#1)(2009-4#1)
volume of distribution and##4##4##(1990-11#1)(1996-11#1)(2007-2#1)(2008-3#1)
volume of distribution of##3##4##(1992-8#1)(2005-7#1)(2006-4#1)
volume of distribution##18##3##(1990-11#1)(1990-2#1)(1991-12#1)(1992-8#1)(1995-4#1)(1996-11#1)(2004-12#1)(2005-7#2)(2006-4#1)(2007-1#1)(2007-2#1)(2008-3#1)(2009-4#4)(2011-1#1)
volume of each##2##3##(2008-10#2)
volume of eluent##5##3##(2006-12#1)(2008-10#4)
volume of fresh##3##3##(1995-2#1)(2008-11#1)(2008-8#1)
volume of gas##2##3##(1995-3#2)
volume of injection##2##3##(1990-5#1)(2008-10#1)
volume of mitochondria##2##3##(2006-12#1)(2007-12#1)
volume of oil##2##3##(2008-10#1)(2008-5#1)
volume of organic solvent and##3##5##(2008-10#3)
volume of plasma##2##3##(1996-8#1)(1997-8#1)
volume of procedures##5##3##(1994-1#1)(1994-2#1)(1994-3#1)(1995-3#1)(2006-10#1)
volume of research##2##3##(1992-2#1)(2007-6#1)
volume of saline##5##3##(1990-7#1)(1991-12#1)(1995-3#1)(2011-2#1)(2012-2#1)
volume of sample and##2##4##(2008-10#2)
volume of sample##6##3##(2008-10#6)
volume of samples and##2##4##(2008-10#2)
volume of samples##3##3##(2008-10#3)
volume of services##3##3##(1992-2#3)
volume of syncytiotrophoblast in resorption villi of##3##7##(2011-1#3)
volume of syncytiotrophoblast in resorption villi##4##6##(2011-1#4)
volume of the glandular##2##4##(2012-12#2)
volume of the hippocampus##2##4##(1993-2#2)
volume of the protein##2##4##(2008-4#2)
volume of the sample##4##4##(1990-12#1)(2006-12#1)(2008-10#2)
volume of the system##4##4##(1990-5#1)(1996-4#1)(1997-8#1)(2005-11#1)
volume of the water##2##4##(2008-10#2)
volume of the##90##3##(1990-11#3)(1990-12#1)(1990-5#2)(1990-7#1)(1991-11#1)(1992-6#1)(1993-2#4)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-4#1)(1996-6#1)(1996-7#2)(1997-5#1)(1997-8#2)(2005-11#1)(2005-5#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-10#4)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#3)(2008-10#19)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#5)(2013-1#1)
volume of this##2##3##(1997-2#1)(2008-3#1)
volume of tissue##4##3##(1991-2#2)(1996-5#2)
volume of water##2##3##(1997-2#1)(2011-1#1)
volume of##478##2##(1990-10#1)(1990-11#5)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#3)(1990-7#2)(1990-8#1)(1991-1#1)(1991-11#3)(1991-12#2)(1991-2#4)(1991-5#1)(1991-9#2)(1992-12#4)(1992-2#4)(1992-3#1)(1992-6#3)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#6)(1994-1#2)(1994-11#2)(1994-2#1)(1994-3#3)(1994-4#3)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#7)(1995-4#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#3)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#4)(1996-8#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#8)(2004-12#1)(2005-10#1)(2005-11#4)(2005-5#1)(2005-7#3)(2006-10#9)(2006-12#6)(2006-4#3)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#6)(2007-11#5)(2007-12#6)(2007-2#4)(2007-3#6)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#13)(2008-10#139)(2008-11#14)(2008-12#3)(2008-2#9)(2008-3#7)(2008-4#4)(2008-5#5)(2008-6#4)(2008-7#5)(2008-8#7)(2008-9#1)(2009-11#2)(2009-12#3)(2009-2#3)(2009-3#2)(2009-4#4)(2009-5#3)(2009-6#2)(2009-8#1)(2009-9#3)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#3)(2010-5#1)(2010-8#6)(2011-1#10)(2011-12#1)(2011-2#12)(2012-1#1)(2012-12#9)(2012-2#6)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#2)
volume on a##2##3##(2006-5#1)(2007-12#1)
volume on the##4##3##(1992-1#1)(1997-3#1)(2008-10#2)
volume on##16##2##(1992-1#1)(1994-9#1)(1996-7#1)(1997-3#1)(2005-11#1)(2006-5#1)(2007-12#1)(2008-10#4)(2008-12#1)(2009-7#1)(2012-1#1)(2012-3#1)(2013-8#1)
volume only##2##2##(2008-7#1)(2009-3#1)
volume or##8##2##(1990-12#1)(2006-8#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2012-1#1)
volume overload and##5##3##(1994-9#2)(2010-8#1)(2012-1#1)(2013-1#1)
volume overload##11##2##(1994-9#2)(2005-9#1)(2007-1#1)(2007-8#3)(2008-10#1)(2010-8#1)(2012-1#1)(2013-1#1)
volume per testis##2##3##(1992-12#2)
volume per##7##2##(1992-12#2)(1996-8#1)(2008-11#1)(2008-3#1)(2008-6#1)(2011-2#1)
volume percentage##2##2##(2005-11#1)(2011-2#1)
volume performance##2##2##(1992-2#1)(1993-12#1)
volume phase##4##2##(1993-6#1)(2007-12#1)(2008-2#2)
volume ratio of the##2##4##(2008-10#1)(2009-5#1)
volume ratio of##3##3##(2008-10#1)(2008-11#1)(2009-5#1)
volume ratio##10##2##(2008-10#6)(2008-11#1)(2009-5#3)
volume ratio)##4##2##(2005-12#3)(2008-7#1)
volume ratios##2##2##(2008-10#1)(2008-4#1)
volume reduction and##2##3##(1997-8#1)(2007-8#1)
volume reduction surgery (LVRS) has##2##5##(2007-8#1)(2008-9#1)
volume reduction surgery (LVRS)##4##4##(2005-11#1)(2007-8#1)(2008-9#1)(2010-5#1)
volume reduction surgery in##2##4##(2007-8#1)(2008-9#1)
volume reduction surgery##11##3##(2005-11#1)(2006-10#3)(2007-8#2)(2008-9#2)(2010-5#2)(2013-1#1)
volume reduction##17##2##(1997-8#1)(2005-11#1)(2006-10#4)(2007-1#1)(2007-8#3)(2008-10#1)(2008-9#3)(2010-5#2)(2013-1#1)
volume reflection##2##2##(2008-2#1)(2008-3#1)
volume regulation by##2##3##(1992-5#2)
volume regulation in##2##3##(1991-1#1)(2008-8#1)
volume regulation of##4##3##(1990-2#2)(2008-4#1)(2013-8#1)
volume regulation##12##2##(1990-2#3)(1991-1#1)(1992-5#2)(1995-8#1)(2005-10#1)(2008-4#1)(2008-8#2)(2013-8#1)
volume rendering##6##2##(2007-11#3)(2008-6#2)(2012-1#1)
volume replacement##4##2##(1996-12#2)(2007-12#1)(2007-9#1)
volume requirements##2##2##(2007-9#1)(2008-10#1)
volume restoration##3##2##(2007-12#2)(2011-2#1)
volume samples##2##2##(2008-10#1)(2008-6#1)
volume scattering function is##2##4##(2008-2#1)(2008-3#1)
volume scattering function##4##3##(2008-2#2)(2008-3#2)
volume scattering##5##2##(2008-2#3)(2008-3#2)
volume shrinkage##3##2##(2013-8#3)
volume substitution##2##2##(2008-7#2)
volume than##3##2##(1994-3#1)(2008-12#1)(2010-8#1)
volume that is##2##3##(2008-3#1)(2012-12#1)
volume that##6##2##(2006-10#1)(2008-3#2)(2010-4#1)(2012-12#1)(2012-3#1)
volume the##2##2##(1991-12#1)(2008-2#1)
volume to the##2##3##(1992-3#1)(2008-2#1)
volume to##15##2##(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1994-5#1)(1996-2#1)(1996-7#1)(1997-8#1)(2005-11#1)(2008-10#3)(2008-2#1)(2008-7#1)(2010-8#1)
volume transmission##3##2##(1994-10#2)(2008-7#1)
volume up to##3##3##(2008-10#2)(2008-7#1)
volume using##2##2##(1990-12#1)(2011-1#1)
volume variations of##2##3##(1992-8#1)(2008-7#1)
volume variations##3##2##(1992-8#2)(2008-7#1)
volume ventilation##2##2##(2007-8#1)(2009-6#1)
volume was 0##3##3##(1997-4#1)(2007-8#1)(2011-1#1)
volume was 20##3##3##(2005-12#1)(2008-10#1)(2012-12#1)
volume was found to be##2##5##(1996-1#1)(2010-4#1)
volume was found##3##3##(1993-2#1)(1996-1#1)(2010-4#1)
volume was increased##2##3##(2009-10#1)(2009-12#1)
volume was not##2##3##(1991-6#1)(1992-12#1)
volume was observed##2##3##(2007-1#1)(2007-10#1)
volume was reduced##3##3##(1995-3#1)(1995-8#1)(2006-12#1)
volume was seen##2##3##(2006-12#1)(2007-1#1)
volume was significantly higher##2##4##(2012-12#1)(2012-3#1)
volume was significantly##5##3##(1996-7#1)(2007-8#1)(2008-7#1)(2012-12#1)(2012-3#1)
volume was used##2##3##(2008-1#1)(2008-10#1)
volume was##62##2##(1990-2#1)(1991-12#1)(1991-6#1)(1992-12#1)(1993-2#1)(1994-3#1)(1994-5#2)(1995-3#1)(1995-8#1)(1996-1#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-1#1)(2005-12#1)(2006-12#3)(2007-1#3)(2007-10#2)(2007-12#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-7#5)(2008-9#1)(2009-10#3)(2009-12#1)(2009-7#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-3#3)(2013-1#1)
volume were investigated##2##3##(2008-10#2)
volume were##16##2##(1996-3#2)(1997-8#1)(2007-10#1)(2008-10#8)(2008-2#1)(2008-4#1)(2009-2#1)(2012-12#1)
volume when the pressure##2##4##(1991-6#2)
volume when##3##2##(1991-6#2)(2008-10#1)
volume will##2##2##(1997-1#1)(2008-11#1)
volume with a##3##3##(2006-6#1)(2008-10#1)(2008-2#1)
volume with the##2##3##(1992-1#1)(1996-7#1)
volume with##9##2##(1992-1#1)(1996-7#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2011-2#1)
volume##2167##1##(1990-10#2)(1990-11#8)(1990-12#7)(1990-2#7)(1990-3#4)(1990-4#3)(1990-5#5)(1990-7#4)(1990-8#5)(1991-1#5)(1991-11#4)(1991-12#6)(1991-2#14)(1991-3#2)(1991-4#1)(1991-5#5)(1991-6#3)(1991-9#3)(1992-1#7)(1992-11#4)(1992-12#16)(1992-2#6)(1992-3#2)(1992-4#1)(1992-5#4)(1992-6#14)(1992-7#4)(1992-8#10)(1992-9#4)(1993-11#3)(1993-12#6)(1993-2#13)(1993-3#2)(1993-4#8)(1993-6#2)(1993-7#3)(1993-8#1)(1993-9#4)(1994-1#3)(1994-10#2)(1994-11#2)(1994-12#4)(1994-2#3)(1994-3#7)(1994-4#10)(1994-5#9)(1994-6#1)(1994-8#1)(1994-9#11)(1995-1#2)(1995-11#5)(1995-12#3)(1995-2#4)(1995-3#11)(1995-4#1)(1995-5#1)(1995-6#3)(1995-8#7)(1995-9#2)(1996-1#5)(1996-10#1)(1996-11#3)(1996-12#4)(1996-2#11)(1996-3#6)(1996-4#2)(1996-5#8)(1996-6#4)(1996-7#13)(1996-8#4)(1996-9#11)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#6)(1997-5#5)(1997-6#7)(1997-8#22)(2004-1#1)(2004-12#2)(2004-9#2)(2005-10#7)(2005-11#42)(2005-12#9)(2005-4#1)(2005-5#1)(2005-7#7)(2005-8#4)(2005-9#2)(2006-10#50)(2006-11#2)(2006-12#15)(2006-2#4)(2006-4#10)(2006-5#4)(2006-6#8)(2006-7#2)(2006-8#5)(2006-9#8)(2007-1#7)(2007-10#40)(2007-11#34)(2007-12#80)(2007-2#11)(2007-3#16)(2007-4#7)(2007-5#5)(2007-6#4)(2007-7#5)(2007-8#42)(2007-9#38)(2008-1#8)(2008-10#348)(2008-11#51)(2008-12#11)(2008-2#99)(2008-3#137)(2008-4#20)(2008-5#22)(2008-6#29)(2008-7#58)(2008-8#16)(2008-9#13)(2009-1#1)(2009-10#5)(2009-11#7)(2009-12#10)(2009-2#12)(2009-3#7)(2009-4#12)(2009-5#12)(2009-6#11)(2009-7#17)(2009-8#7)(2009-9#5)(2010-1#2)(2010-10#8)(2010-11#6)(2010-12#12)(2010-2#11)(2010-3#1)(2010-4#9)(2010-5#5)(2010-7#3)(2010-8#14)(2010-9#17)(2011-1#31)(2011-11#1)(2011-12#3)(2011-2#53)(2011-3#2)(2011-4#1)(2012-1#14)(2012-11#4)(2012-12#44)(2012-2#17)(2012-3#22)(2012-4#1)(2013-1#49)(2013-7#9)(2013-8#22)
volume) and##2##2##(2008-11#1)(2009-5#1)
volume) of the##2##3##(1993-6#1)(2010-2#1)
volume) of##3##2##(1993-6#1)(2007-8#1)(2010-2#1)
volume) was##2##2##(2008-10#1)(2013-7#1)
volume) were##2##2##(2008-10#1)(2013-1#1)
volume)##29##1##(1991-12#1)(1993-6#1)(1995-1#1)(1996-1#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#2)(2008-9#1)(2009-5#1)(2010-2#1)(2010-5#1)(2013-1#2)(2013-7#1)
volume-activated Cl- secretion##2##3##(1994-12#2)
volume-activated##3##1##(1994-12#2)(2008-8#1)
volume-equivalent##4##1##(2008-2#2)(2008-3#2)
volume-fraction##3##1##(1992-12#2)(2008-2#1)
volume-holographic correlator##2##2##(2008-3#2)
volume-holographic##4##1##(2007-11#2)(2008-3#2)
volume-index grating##2##2##(2007-12#2)
volume-mediated##2##1##(2007-9#2)
volume-mixing ratio for a 1-m path##2##6##(2008-3#2)
volume-mixing##3##1##(2008-3#3)
volume-regulatory##4##1##(1990-3#2)(1994-12#2)
volume-sensitive##2##1##(2007-9#1)(2008-8#1)
volume-type##2##1##(2008-3#2)
volumes (&lt##3##2##(2007-8#1)(2008-2#1)(2008-4#1)
volumes and solubility parameters of##3##5##(2008-10#3)
volumes and the##2##3##(2006-10#1)(2008-10#1)
volumes and##27##2##(1990-6#1)(1992-5#1)(1994-3#1)(2004-11#1)(2004-4#1)(2006-10#2)(2007-11#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-4#3)(2008-7#2)(2009-7#1)(2010-11#1)(2011-1#3)(2011-2#1)
volumes are##15##2##(1991-2#1)(1993-3#1)(2005-11#1)(2006-10#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2010-10#1)(2012-12#1)
volumes as##2##2##(1992-11#1)(1997-2#1)
volumes at##2##2##(2007-10#1)(2008-3#1)
volumes by using##2##3##(2007-8#1)(2012-2#1)
volumes by##4##2##(1991-6#1)(1995-12#1)(2007-8#1)(2012-2#1)
volumes for##9##2##(1990-3#1)(1995-11#1)(2006-10#1)(2007-8#1)(2008-2#2)(2008-3#1)(2011-2#1)(2012-12#1)
volumes has been##2##3##(1993-4#1)(2009-7#1)
volumes have##3##2##(2006-10#1)(2008-10#1)(2009-7#1)
volumes in the##2##3##(1997-6#1)(2013-1#1)
volumes in##15##2##(1990-10#1)(1992-6#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-11#1)(2007-8#2)(2008-10#1)(2008-2#2)(2008-3#1)(2011-2#1)(2013-1#2)
volumes increased##3##2##(1997-3#1)(2005-11#1)(2013-8#1)
volumes into a##2##3##(2008-10#1)(2008-9#1)
volumes into##4##2##(2008-10#3)(2008-9#1)
volumes is##4##2##(2008-10#1)(2008-2#2)(2010-12#1)
volumes of 2##2##3##(1991-3#1)(2008-10#1)
volumes of 40##2##3##(2012-3#2)
volumes of 50##2##3##(1991-3#1)(2008-10#1)
volumes of aqueous solutions##2##4##(2008-10#1)(2008-11#1)
volumes of aqueous##3##3##(2006-5#1)(2008-10#1)(2008-11#1)
volumes of sample and##2##4##(1992-2#1)(2008-10#1)
volumes of sample##8##3##(1992-2#1)(2007-8#1)(2008-10#5)(2008-9#1)
volumes of the##15##3##(1990-5#2)(1991-12#1)(1991-2#1)(1994-3#1)(1995-8#1)(1996-10#1)(1997-8#1)(2005-11#1)(2006-10#1)(2008-10#3)(2008-2#1)(2013-8#1)
volumes of##108##2##(1990-3#1)(1990-5#3)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-8#2)(1992-2#1)(1994-3#1)(1995-11#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#2)(1997-8#1)(2005-11#1)(2005-8#2)(2006-10#7)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2007-10#1)(2007-11#1)(2007-3#1)(2007-8#3)(2008-1#1)(2008-10#29)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-7#3)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#6)(2013-8#3)
volumes ranging from##2##3##(2008-10#2)
volumes showed##2##2##(2009-2#1)(2010-8#1)
volumes than##3##2##(2004-11#2)(2012-3#1)
volumes to##3##2##(2005-11#1)(2008-5#1)(2008-9#1)
volumes using##2##2##(2008-1#1)(2008-9#1)
volumes were measured##3##3##(1995-5#1)(2011-1#1)(2011-2#1)
volumes were not##2##3##(2004-11#1)(2004-12#1)
volumes were##23##2##(1993-3#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-9#1)(1997-8#1)(2004-11#2)(2004-12#1)(2007-10#2)(2007-12#1)(2008-10#1)(2008-2#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#3)(2013-8#1)
volumes when##2##2##(2009-10#1)(2009-7#1)
volumes while##2##2##(1997-8#1)(2006-2#1)
volumes with a##2##3##(2006-6#1)(2007-12#1)
volumes with##6##2##(2006-2#1)(2006-6#1)(2007-12#1)(2008-3#1)(2009-10#1)(2012-12#1)
volumes##386##1##(1990-10#1)(1990-12#2)(1990-3#2)(1990-5#4)(1990-6#1)(1990-8#2)(1990-9#1)(1991-11#2)(1991-12#3)(1991-2#3)(1991-3#2)(1991-6#2)(1991-8#3)(1992-1#1)(1992-11#3)(1992-2#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-2#2)(1993-3#2)(1993-4#1)(1993-9#1)(1994-12#1)(1994-3#3)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#3)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#2)(1996-3#2)(1996-9#1)(1997-2#1)(1997-3#2)(1997-6#2)(1997-8#9)(2004-11#7)(2004-12#1)(2004-4#1)(2005-11#7)(2005-8#2)(2006-10#20)(2006-11#1)(2006-2#4)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#2)(2006-9#1)(2007-10#7)(2007-11#3)(2007-12#5)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#13)(2008-1#3)(2008-10#70)(2008-11#6)(2008-12#1)(2008-2#15)(2008-3#17)(2008-4#7)(2008-5#4)(2008-6#5)(2008-7#6)(2008-9#7)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#10)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#8)(2012-1#2)(2012-12#13)(2012-2#2)(2012-3#5)(2013-1#10)(2013-8#5)
volumes)##3##1##(2008-10#1)(2008-4#1)(2012-12#1)
volumetric Karl Fischer titration##2##4##(2008-10#2)
volumetric Karl Fischer##4##3##(2008-10#4)
volumetric analysis##2##2##(1994-5#1)(2006-12#1)
volumetric and##3##2##(2008-10#1)(2008-9#1)(2010-4#1)
volumetric brain images##4##3##(2013-1#4)
volumetric brain##5##2##(2010-9#1)(2013-1#4)
volumetric changes##3##2##(1997-8#1)(2011-2#2)
volumetric density##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
volumetric flow rate##3##3##(1995-3#2)(2008-10#1)
volumetric flow##5##2##(1995-3#2)(2008-10#1)(2009-11#1)(2013-8#1)
volumetric images##3##2##(2010-12#1)(2011-1#1)(2011-7#1)
volumetric infusion##2##2##(1990-8#1)(2012-10#1)
volumetric lung depth##2##3##(1996-2#2)
volumetric productivities##2##2##(2004-8#1)(2008-11#1)
volumetric productivity of##5##3##(2008-11#2)(2008-5#1)(2008-6#1)(2012-3#1)
volumetric productivity was##2##3##(2008-11#1)(2008-6#1)
volumetric productivity##8##2##(2008-11#3)(2008-5#1)(2008-6#3)(2012-3#1)
volumetric protein productivity##2##3##(2008-11#1)(2008-7#1)
volumetric reductions##3##2##(2006-9#3)
volumetric spore trap##3##3##(2008-10#2)(2008-5#1)
volumetric spore traps##3##3##(2008-10#2)(2010-5#1)
volumetric spore##6##2##(2008-10#4)(2008-5#1)(2010-5#1)
volumetric titers##3##2##(2008-11#3)
volumetric titration##3##2##(2008-10#3)
volumetric wear##2##2##(2004-9#2)
volumetric##120##1##(1990-5#1)(1990-8#1)(1994-2#1)(1994-5#1)(1995-3#2)(1995-5#1)(1996-2#2)(1997-8#1)(2004-8#1)(2004-9#2)(2005-10#1)(2005-11#2)(2006-10#2)(2006-12#1)(2006-9#4)(2007-11#4)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#26)(2008-11#13)(2008-2#3)(2008-3#3)(2008-5#5)(2008-6#4)(2008-7#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-9#2)(2011-1#4)(2011-2#2)(2011-7#1)(2012-10#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#7)(2013-8#1)
volumetry##2##1##(2008-11#1)(2010-12#1)
voluminous literature##2##2##(2008-11#1)(2010-8#1)
voluminous##11##1##(1991-6#1)(1993-9#1)(1996-11#1)(1996-5#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-3#1)(2010-8#1)(2012-2#1)
voluntarily##23##1##(1990-8#1)(1991-10#1)(1991-2#1)(1992-2#1)(1994-3#2)(1995-1#1)(1996-10#1)(2006-5#2)(2006-9#1)(2007-2#1)(2008-11#2)(2008-9#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#1)
voluntary abortion##2##2##(2013-1#2)
voluntary alcohol intake in##2##4##(1993-12#1)(2008-2#1)
voluntary alcohol intake##3##3##(1993-12#2)(2008-2#1)
voluntary alcohol##5##2##(1993-12#4)(2008-2#1)
voluntary and involuntary##2##3##(2008-10#1)(2012-1#1)
voluntary and##6##2##(1993-9#1)(1996-2#1)(2008-10#1)(2012-1#1)(2013-1#1)(2013-8#1)
voluntary blood donors##4##3##(2013-8#4)
voluntary blood##5##2##(2013-8#5)
voluntary board##2##2##(1994-2#2)
voluntary consortium##2##2##(1993-12#1)(2008-6#1)
voluntary contraction (MVC)##3##3##(2010-6#1)(2012-1#1)(2013-8#1)
voluntary contraction##13##2##(1994-4#1)(1995-10#1)(2005-1#2)(2007-8#1)(2010-6#3)(2010-9#1)(2012-1#1)(2012-12#1)(2013-8#2)
voluntary contractions##2##2##(1993-9#1)(1996-5#1)
voluntary counseling and testing##2##4##(1991-3#1)(2013-1#1)
voluntary counselling and testing (VCT)##3##5##(2007-2#1)(2007-7#2)
voluntary counselling and testing##5##4##(2007-2#1)(2007-7#2)(2009-7#1)(2013-1#1)
voluntary disenrollment rates##2##3##(2007-2#2)
voluntary ethanol consumption##2##3##(1992-1#1)(1996-10#1)
voluntary health##3##2##(1996-3#1)(2008-11#1)(2012-1#1)
voluntary hospital##2##2##(1990-12#1)(1994-12#1)
voluntary isometric contraction##2##3##(1993-12#2)
voluntary liability insurance coverage##3##4##(2012-12#3)
voluntary motor##2##2##(1994-2#1)(2006-3#1)
voluntary movement##4##2##(2008-11#1)(2009-2#1)(2010-8#1)(2012-1#1)
voluntary movements##2##2##(1994-3#1)(2007-10#1)
voluntary organisations##2##2##(2008-11#2)
voluntary organizations##3##2##(1991-12#1)(1996-2#2)
voluntary physical activity##3##3##(2010-9#3)
voluntary regulation##3##2##(2007-7#2)(2009-6#1)
voluntary sector##3##2##(1993-7#1)(1994-12#1)(1996-3#1)
voluntary use##3##2##(2011-2#1)(2013-1#2)
voluntary work##2##2##(2008-1#1)(2010-8#1)
voluntary##163##1##(1990-10#1)(1990-12#2)(1990-6#2)(1991-12#1)(1991-3#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-12#8)(1993-7#1)(1993-9#2)(1994-12#2)(1994-2#3)(1994-3#3)(1994-4#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-4#1)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#5)(1996-3#5)(1996-5#1)(1996-6#1)(1996-9#1)(2005-1#2)(2006-11#1)(2006-12#1)(2006-3#2)(2006-4#1)(2006-7#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#4)(2007-4#1)(2007-7#6)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#9)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#3)(2010-8#2)(2010-9#4)(2011-1#2)(2011-2#2)(2012-1#5)(2012-12#8)(2012-2#1)(2012-3#2)(2013-1#13)(2013-8#8)
voluntary&quot##2##1##(1996-12#1)(1997-2#1)
volunteer administration##4##2##(1992-1#1)(1994-3#1)(1996-12#1)(1997-2#1)
volunteer administrator##2##2##(1993-1#1)(1994-1#1)
volunteer administrators to##2##3##(1993-1#1)(1995-2#1)
volunteer administrators##5##2##(1991-3#1)(1993-1#1)(1993-2#2)(1995-2#1)
volunteer agency##2##2##(1991-12#1)(1997-2#1)
volunteer and##10##2##(1991-3#1)(1993-2#1)(1994-2#2)(1996-2#1)(2006-11#3)(2007-4#1)(2009-7#1)
volunteer blood donors##4##3##(2008-12#2)(2011-1#2)
volunteer donors##2##2##(2008-10#2)
volunteer experience##3##2##(1992-3#2)(1994-3#1)
volunteer group##3##2##(1993-2#2)(2012-12#1)
volunteer input##2##2##(1993-2#1)(2008-12#1)
volunteer management##5##2##(1991-12#1)(1991-2#1)(1993-1#1)(1994-3#2)
volunteer organizations##3##2##(1992-12#1)(1993-12#2)
volunteer program##9##2##(1990-12#1)(1991-1#1)(1992-1#1)(1992-2#1)(1993-2#1)(1994-2#1)(1995-12#1)(1997-2#1)(2007-2#1)
volunteer programs##7##2##(1991-3#1)(1994-2#3)(1994-3#1)(1996-12#1)(1997-2#1)
volunteer recruitment##3##2##(1992-3#1)(1993-12#1)(1994-2#1)
volunteer service##2##2##(1996-3#2)
volunteer services##3##2##(1993-1#1)(1994-3#1)(2007-2#1)
volunteer students##2##2##(2008-11#1)(2008-4#1)
volunteer studies##2##2##(2006-11#1)(2008-5#1)
volunteer study##4##2##(2008-10#1)(2008-3#1)(2008-5#2)
volunteer tests##2##2##(2006-11#2)
volunteer to##4##2##(1994-10#1)(2006-10#2)(2013-1#1)
volunteer work##4##2##(1991-12#1)(1994-2#1)(1995-2#2)
volunteer##196##1##(1990-12#1)(1991-1#3)(1991-12#4)(1991-2#4)(1991-3#3)(1992-1#4)(1992-12#2)(1992-2#1)(1992-3#8)(1993-1#7)(1993-12#5)(1993-2#7)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#16)(1994-3#16)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#8)(1996-1#1)(1996-11#2)(1996-12#4)(1996-2#3)(1996-3#10)(1996-6#1)(1996-9#1)(1997-2#5)(1997-5#1)(2004-11#1)(2005-8#1)(2006-10#2)(2006-11#11)(2006-3#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#3)(2007-4#1)(2007-8#1)(2008-10#10)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#5)(2008-7#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-1#3)(2011-2#3)(2012-12#4)(2013-1#4)
volunteer's##5##1##(1991-2#1)(2005-12#1)(2007-1#2)(2012-3#1)
volunteered for the study##3##4##(2008-5#1)(2011-2#2)
volunteered for##6##2##(2008-5#1)(2008-8#1)(2009-10#1)(2011-2#2)(2013-1#1)
volunteered to##5##2##(2008-11#1)(2008-12#2)(2008-5#1)(2012-2#1)
volunteered##15##1##(1993-12#1)(2008-11#1)(2008-12#2)(2008-5#3)(2008-8#1)(2009-10#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
volunteering##3##1##(1994-1#1)(1994-2#1)(2010-12#1)
volunteerism in##3##2##(1991-3#1)(1996-3#2)
volunteerism##20##1##(1991-2#1)(1991-3#1)(1992-3#1)(1993-2#2)(1993-3#1)(1994-2#5)(1996-3#3)(2008-12#1)(2008-4#1)(2008-5#2)(2012-12#1)(2012-2#1)
volunteers (mean age##2##3##(1995-11#1)(2008-7#1)
volunteers (mean##3##2##(1995-11#1)(2008-7#1)(2012-12#1)
volunteers (n =##6##3##(1992-8#3)(1996-7#1)(2008-5#1)(2010-9#1)
volunteers a##2##2##(1994-2#1)(2008-5#1)
volunteers after oral administration of##3##5##(1991-12#1)(1996-5#1)(2008-10#1)
volunteers after##10##2##(1990-6#1)(1991-12#1)(1996-5#1)(1997-3#1)(2006-12#1)(2008-10#1)(2008-5#2)(2011-2#1)(2013-1#1)
volunteers and compared##2##3##(2008-2#1)(2010-5#1)
volunteers and patients##4##3##(2007-11#2)(2008-8#1)(2010-8#1)
volunteers and the##3##3##(1994-3#1)(1997-8#1)(2013-8#1)
volunteers and their##2##3##(1993-12#1)(1994-3#1)
volunteers and##33##2##(1990-1#1)(1991-12#1)(1992-3#3)(1993-12#1)(1993-9#1)(1994-3#3)(1995-12#1)(1996-3#1)(1996-7#1)(1997-3#1)(1997-6#1)(1997-8#2)(2005-8#1)(2006-1#1)(2006-4#1)(2006-8#1)(2007-11#3)(2008-2#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
volunteers are##5##2##(1993-2#1)(1994-2#1)(1994-3#1)(1996-12#1)(1996-3#1)
volunteers as##6##2##(1992-2#1)(1994-3#1)(2007-1#1)(2007-7#1)(2008-10#1)(2008-5#1)
volunteers at the##2##3##(2007-4#1)(2008-5#1)
volunteers at##7##2##(1994-3#1)(1995-11#1)(2006-2#1)(2007-4#1)(2008-5#2)(2008-7#1)
volunteers before and after##2##4##(1991-1#1)(1996-2#1)
volunteers by##3##2##(1990-3#1)(2008-5#1)(2013-1#1)
volunteers can##4##2##(1991-3#1)(1994-2#1)(2013-1#2)
volunteers during##3##2##(1992-3#1)(1995-11#1)(1995-7#1)
volunteers following##2##2##(1996-6#1)(2008-10#1)
volunteers for##8##2##(1991-2#1)(1992-12#1)(1992-3#1)(1994-5#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)
volunteers from the##2##3##(2008-5#1)(2011-1#1)
volunteers from##6##2##(1995-11#1)(2004-12#1)(2007-6#1)(2008-5#1)(2011-1#1)(2012-12#1)
volunteers had##2##2##(1995-11#1)(1997-4#1)
volunteers has##3##2##(2005-8#1)(2007-11#1)(2008-5#1)
volunteers have##2##2##(1992-1#1)(2007-7#1)
volunteers in a##3##3##(2007-4#1)(2008-12#1)(2008-5#1)
volunteers in the##2##3##(2007-10#1)(2008-4#1)
volunteers in##16##2##(1990-4#1)(1991-5#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-2#1)(1996-3#1)(2007-10#1)(2007-4#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-4#1)(2012-1#1)(2012-12#1)(2012-3#1)
volunteers is##3##2##(1993-12#1)(1994-3#1)(2008-5#1)
volunteers make##2##2##(1994-3#1)(1997-2#1)
volunteers of##5##2##(2006-5#1)(2007-2#1)(2008-5#2)(2013-8#1)
volunteers on the##2##3##(2008-10#1)(2008-5#1)
volunteers on##4##2##(1996-3#1)(2004-11#1)(2008-10#1)(2008-5#1)
volunteers participated in the study##2##5##(2004-12#1)(2013-8#1)
volunteers participated in the##3##4##(1996-2#1)(2004-12#1)(2013-8#1)
volunteers performed##2##2##(2008-10#1)(2012-2#1)
volunteers received##2##2##(2005-8#1)(2008-5#1)
volunteers revealed##2##2##(2007-11#1)(2008-5#1)
volunteers tested##2##2##(2007-7#1)(2008-10#1)
volunteers that##2##2##(2007-10#1)(2008-2#1)
volunteers the##2##2##(1995-6#1)(2007-4#1)
volunteers to##8##2##(1992-3#1)(1992-6#1)(1994-3#1)(1996-2#1)(1997-1#1)(2006-7#1)(2008-6#1)(2009-5#1)
volunteers under##2##2##(2008-3#1)(2010-12#1)
volunteers underwent##2##2##(2007-10#1)(2013-8#1)
volunteers using a##2##3##(1996-1#1)(2008-5#1)
volunteers was##8##2##(1992-8#1)(1994-10#1)(1996-7#1)(2006-8#1)(2008-5#1)(2008-6#1)(2009-1#1)(2013-1#1)
volunteers were randomly assigned to##2##5##(2008-3#1)(2010-4#1)
volunteers were reexamined after##2##4##(1996-5#2)
volunteers were selected and##2##4##(2009-6#1)(2011-2#1)
volunteers were used##3##3##(1993-11#1)(2008-5#2)
volunteers were##35##2##(1990-11#1)(1991-2#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-9#1)(1996-5#2)(1996-8#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-7#1)(2007-8#3)(2008-12#1)(2008-3#1)(2008-5#7)(2009-6#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
volunteers while they##2##3##(1996-2#1)(1996-7#1)
volunteers while##3##2##(1996-2#1)(1996-3#1)(1996-7#1)
volunteers who received##2##3##(2007-11#2)
volunteers who##8##2##(1992-3#1)(1996-3#1)(1997-4#1)(2006-6#1)(2007-11#2)(2009-6#1)(2012-1#1)
volunteers with history of cutaneous leishmaniasis (P&lt##2##7##(2007-2#2)
volunteers with history of cutaneous leishmaniasis##3##6##(2007-2#3)
volunteers with history of##4##4##(2007-2#4)
volunteers with increased##2##3##(1990-4#1)(2007-10#1)
volunteers with##19##2##(1990-4#1)(1996-3#1)(1996-5#1)(2004-11#1)(2007-10#1)(2007-12#1)(2007-2#4)(2007-8#1)(2008-1#1)(2008-5#3)(2008-7#1)(2009-6#1)(2010-10#1)(2013-1#1)
volunteers##523##1##(1990-1#3)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#2)(1990-6#3)(1990-7#1)(1991-1#4)(1991-12#5)(1991-2#3)(1991-3#2)(1991-5#1)(1991-8#1)(1992-1#3)(1992-10#1)(1992-12#3)(1992-2#3)(1992-3#10)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#5)(1993-11#2)(1993-12#5)(1993-2#5)(1993-4#1)(1993-5#2)(1993-8#1)(1993-9#2)(1994-10#1)(1994-2#8)(1994-3#20)(1994-4#3)(1994-5#2)(1994-6#2)(1994-8#1)(1995-1#2)(1995-11#10)(1995-12#7)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#5)(1996-12#2)(1996-2#10)(1996-3#11)(1996-5#6)(1996-6#1)(1996-7#10)(1996-8#7)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#6)(1997-6#4)(1997-7#3)(1997-8#7)(2004-11#5)(2004-12#3)(2005-11#1)(2005-7#4)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#2)(2006-12#5)(2006-2#3)(2006-4#1)(2006-5#6)(2006-6#1)(2006-7#2)(2006-8#3)(2007-1#1)(2007-10#10)(2007-11#12)(2007-12#2)(2007-2#7)(2007-3#1)(2007-4#3)(2007-6#1)(2007-7#5)(2007-8#11)(2008-1#1)(2008-10#17)(2008-11#5)(2008-12#4)(2008-2#3)(2008-3#8)(2008-4#3)(2008-5#58)(2008-6#2)(2008-7#10)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#6)(2009-8#1)(2010-10#2)(2010-12#4)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#8)(2011-2#15)(2012-1#4)(2012-12#6)(2012-2#8)(2012-3#3)(2013-1#13)(2013-7#1)(2013-8#4)
volunteers'##5##1##(1991-12#1)(2008-10#1)(2008-5#2)(2013-1#1)
volunteers)##4##1##(1993-11#1)(2004-12#1)(2007-8#1)(2011-2#1)
volunteers?##2##1##(1994-3#1)(1997-2#1)
volutrauma##2##1##(2006-10#1)(2010-8#1)
volvolus##2##1##(2011-2#2)
volvulus in the##2##3##(1991-12#1)(2010-12#1)
volvulus in##6##2##(1991-12#1)(2009-4#2)(2010-12#1)(2013-1#2)
volvulus##35##1##(1990-6#2)(1991-12#1)(1991-3#3)(1991-9#1)(1993-5#2)(2006-9#1)(2007-3#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-8#1)(2009-4#5)(2010-1#3)(2010-12#1)(2011-11#2)(2012-2#1)(2012-3#4)(2013-1#2)
vomeronasal axons##2##2##(1997-7#2)
vomeronasal organ##2##2##(1993-2#1)(1994-2#1)
vomeronasal system##3##2##(1993-2#1)(1997-7#1)(2012-2#1)
vomeronasal##13##1##(1992-8#1)(1993-2#2)(1994-2#2)(1997-7#4)(2008-6#1)(2012-2#3)
vomifoliol##2##1##(2007-11#2)
vomit and pain##2##3##(1990-8#2)
vomit##4##1##(1990-8#2)(2011-1#1)(2012-2#1)
vomiting after##4##2##(2007-5#1)(2011-12#1)(2012-12#2)
vomiting and abdominal##2##3##(1995-7#1)(2008-1#1)
vomiting and weight loss##5##4##(1996-8#1)(2005-12#1)(2009-6#1)(2011-1#1)(2013-1#1)
vomiting and##36##2##(1990-4#2)(1990-6#1)(1992-10#1)(1995-7#1)(1996-8#1)(1996-9#1)(1997-8#1)(2005-12#1)(2006-10#3)(2006-4#1)(2006-6#1)(2007-11#1)(2007-2#2)(2008-1#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#5)(2009-6#1)(2010-1#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
vomiting as##5##2##(1996-1#2)(2006-10#1)(2006-8#1)(2008-7#1)
vomiting by##3##2##(1994-10#1)(1995-6#1)(2010-9#1)
vomiting caused by##3##3##(1991-11#2)(2006-4#1)
vomiting during##3##2##(2008-7#3)
vomiting episodes##3##2##(1990-12#2)(1990-8#1)
vomiting in children##2##3##(2008-5#1)(2009-4#1)
vomiting in patients##2##3##(1990-6#1)(2011-12#1)
vomiting in the##2##3##(1990-6#1)(2008-5#1)
vomiting in##15##2##(1990-12#1)(1990-6#2)(1991-10#1)(1991-11#1)(1993-11#1)(1995-6#1)(2006-10#1)(2007-2#1)(2008-5#2)(2009-4#1)(2009-5#1)(2011-12#1)(2012-12#1)
vomiting is##3##2##(2006-10#2)(2010-9#1)
vomiting of##5##2##(2005-12#1)(2006-12#1)(2006-2#1)(2007-12#1)(2013-8#1)
vomiting or##5##2##(1991-12#1)(2006-10#1)(2007-8#1)(2008-8#1)(2011-12#1)
vomiting was##3##2##(1990-6#1)(1991-5#1)(2013-7#1)
vomiting##244##1##(1990-10#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#3)(1990-6#5)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#3)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-10#2)(1992-12#1)(1992-5#1)(1993-11#2)(1993-2#2)(1993-4#1)(1993-6#1)(1994-10#1)(1995-6#3)(1995-7#3)(1995-9#3)(1996-1#4)(1996-12#1)(1996-8#1)(1996-9#2)(1997-7#6)(1997-8#3)(2004-1#1)(2004-10#1)(2004-12#1)(2005-12#2)(2006-1#1)(2006-10#31)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#4)(2006-6#1)(2006-7#3)(2006-8#3)(2007-11#3)(2007-12#2)(2007-2#5)(2007-5#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#5)(2008-12#2)(2008-5#9)(2008-6#2)(2008-7#21)(2008-8#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-9#3)(2011-1#6)(2011-12#6)(2011-2#6)(2012-12#5)(2012-2#4)(2012-3#4)(2013-1#5)(2013-7#2)(2013-8#8)
vomiting)##5##1##(1990-10#1)(1990-6#1)(1991-11#1)(2006-10#1)(2008-1#1)
von Bertalanffy##9##2##(2008-5#1)(2010-8#5)(2013-7#3)
von Frey##3##2##(1996-8#1)(1997-2#1)(2009-12#1)
von Hippel-Lindau disease##3##3##(1993-7#1)(2008-1#1)(2012-3#1)
von Hippel-Lindau tumor suppressor##2##4##(2009-11#1)(2011-1#1)
von Hippel-Lindau##11##2##(1993-7#1)(2008-1#1)(2008-6#1)(2008-7#1)(2009-11#2)(2011-1#2)(2012-12#2)(2012-3#1)
von Kármán##2##2##(2008-2#1)(2008-3#1)
von Recklinghausen's disease##6##3##(1991-2#1)(1992-9#1)(2006-10#2)(2008-10#1)(2013-7#1)
von Recklinghausen's neurofibromatosis##3##3##(2006-12#1)(2008-10#2)
von Recklinghausen's##9##2##(1991-2#1)(1992-9#1)(2006-10#2)(2006-12#1)(2008-10#3)(2013-7#1)
von Willebrand Factor (vWF)##4##4##(1990-12#1)(1997-2#1)(2008-11#1)(2008-12#1)
von Willebrand Factor and##2##4##(1990-5#1)(1994-11#1)
von Willebrand Factor##7##3##(1990-12#1)(1990-5#1)(1994-11#1)(1997-2#1)(2008-11#2)(2008-12#1)
von Willebrand factor (vWF)##4##4##(1990-12#1)(1993-3#1)(2007-10#1)(2013-8#1)
von Willebrand factor (vWf)##2##4##(1992-1#1)(2007-10#1)
von Willebrand factor and##4##4##(1991-10#1)(1994-11#1)(2007-10#1)(2007-11#1)
von Willebrand factor antigen##3##4##(1990-11#3)
von Willebrand factor##35##3##(1990-11#3)(1990-12#3)(1990-5#1)(1991-10#1)(1992-1#2)(1992-11#1)(1992-12#3)(1993-3#2)(1993-5#1)(1993-9#2)(1994-11#1)(1996-2#1)(2005-10#1)(2007-10#4)(2007-11#3)(2007-12#1)(2008-7#1)(2009-7#1)(2012-1#1)(2012-2#1)(2013-8#1)
von Willebrand##48##2##(1990-11#4)(1990-12#4)(1990-5#2)(1991-10#1)(1992-1#2)(1992-11#1)(1992-12#3)(1993-3#2)(1993-5#1)(1993-9#4)(1994-11#2)(1996-2#1)(1997-2#1)(1997-7#1)(2005-10#1)(2005-7#1)(2007-10#4)(2007-11#3)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-7#1)(2012-1#1)(2012-2#1)(2013-8#1)
von Willebrand's Disease##2##3##(2008-12#2)
von Willebrand's disease##9##3##(1990-11#2)(1990-12#1)(1991-6#1)(1992-11#2)(1993-3#1)(1993-9#1)(2011-1#1)
von Willebrand's##13##2##(1990-11#2)(1990-12#1)(1991-6#1)(1992-11#2)(1993-3#1)(1993-9#1)(2008-12#2)(2010-12#1)(2011-1#2)
von hippel-lindau##2##2##(2011-2#1)(2013-8#1)
von##120##1##(1990-11#6)(1990-12#5)(1990-5#2)(1991-10#1)(1991-2#1)(1991-6#1)(1992-1#2)(1992-11#3)(1992-12#3)(1992-9#2)(1993-3#3)(1993-5#1)(1993-7#1)(1993-9#5)(1994-11#2)(1994-3#2)(1995-1#1)(1996-2#1)(1996-8#1)(1997-2#2)(1997-7#1)(1997-8#2)(2005-10#2)(2005-7#1)(2006-10#3)(2006-12#2)(2006-7#1)(2007-10#4)(2007-11#3)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-9#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-7#1)(2010-12#2)(2010-8#5)(2011-1#5)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-7#5)(2013-8#2)
voor##6##1##(1991-6#1)(1995-12#2)(1995-9#1)(1996-11#1)(2012-12#1)
voriconazole for##3##2##(2008-4#1)(2009-5#1)(2012-2#1)
voriconazole with miconazole##2##3##(2009-8#2)
voriconazole##15##1##(2007-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-12#1)(2012-12#2)(2012-2#1)
vortex and##3##2##(2005-10#2)(2008-2#1)
vortex structure##5##2##(1992-12#1)(1995-7#1)(2007-11#1)(2007-12#2)
vortex##53##1##(1991-12#2)(1991-5#2)(1992-12#2)(1994-5#1)(1995-10#1)(1995-5#1)(1995-7#2)(2005-10#4)(2007-11#7)(2007-12#12)(2007-7#2)(2008-1#3)(2008-10#3)(2008-2#3)(2008-6#1)(2009-5#2)(2010-7#1)(2012-2#3)(2013-8#1)
vortex-screening solitons##2##2##(2008-1#2)
vortices in a##3##3##(1993-8#1)(1994-10#1)(2007-12#1)
vortices in##6##2##(1990-4#1)(1993-8#1)(1994-10#1)(1995-10#1)(2007-11#1)(2007-12#1)
vortices of electromagnetic##2##3##(2007-12#2)
vortices##28##1##(1990-4#1)(1993-8#2)(1994-10#1)(1995-10#1)(2007-11#6)(2007-12#12)(2008-11#1)(2008-2#4)
vorticity##8##1##(1995-5#1)(2005-11#1)(2007-12#2)(2008-3#3)(2009-9#1)
vote of confidence##2##3##(1994-5#1)(1996-2#1)
vote of##4##2##(1994-5#1)(1996-2#1)(2013-1#1)(2013-7#1)
vote on May##2##3##(1995-6#1)(1996-5#1)
vote on Proposal B##2##4##(2006-7#2)
vote on##9##2##(1991-9#1)(1995-6#1)(1995-9#1)(1996-5#1)(1997-2#1)(2006-7#4)
vote##24##1##(1991-9#1)(1993-1#1)(1993-5#1)(1994-5#1)(1995-6#2)(1995-9#1)(1996-2#1)(1996-5#2)(1996-6#1)(1997-2#1)(2006-7#7)(2007-8#1)(2008-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
voted to##2##2##(1991-12#1)(1995-11#1)
voted##8##1##(1991-12#1)(1995-11#1)(1995-6#1)(1996-11#1)(1996-5#1)(1997-5#1)(2006-7#1)(2009-4#1)
voters##7##1##(1997-5#1)(2004-3#1)(2006-7#2)(2008-11#1)(2008-6#1)(2008-7#1)
votes to##3##2##(1990-7#1)(1995-6#1)(2010-9#1)
votes##7##1##(1990-7#1)(1991-1#1)(1995-10#1)(1995-6#1)(1996-6#1)(1997-5#1)(2010-9#1)
voting in##2##2##(1993-6#1)(2008-6#1)
voting##9##1##(1993-6#1)(2008-6#6)(2008-7#1)(2009-10#1)
voucher##2##1##(1996-12#1)(2008-6#1)
vouchers##2##1##(2008-4#1)(2008-9#1)
vowel deviants##2##2##(2009-2#2)
vowel inventory##2##2##(2013-8#2)
vowel space##2##2##(2013-8#2)
vowel##20##1##(2009-11#1)(2009-2#5)(2010-12#4)(2012-1#1)(2012-12#2)(2013-8#7)
vowel-to-vowel coarticulation##5##2##(2010-12#1)(2013-8#4)
vowel-to-vowel##6##1##(2010-12#1)(2013-8#5)
vowels ([i##3##2##(2012-12#3)
vowels ([o##3##2##(2012-12#3)
vowels and consonants by##2##4##(2013-8#2)
vowels##20##1##(2009-11#4)(2010-12#1)(2012-1#1)(2012-12#6)(2013-8#8)
voxel pairs in##2##3##(2008-2#2)
voxel surface##2##2##(2008-2#2)
voxel surfaces##4##2##(2008-2#4)
voxel##18##1##(2008-10#2)(2008-11#1)(2008-2#11)(2008-7#2)(2010-8#1)(2011-1#1)
voxel-based morphometry##6##2##(2008-11#2)(2009-4#1)(2009-9#2)(2013-1#1)
voxel-based##11##1##(2008-11#2)(2009-4#1)(2009-9#2)(2010-10#1)(2012-1#2)(2013-1#1)(2013-7#2)
voxel-wise##3##1##(2008-11#2)(2012-12#1)
voxelized##2##1##(2010-9#1)(2011-2#1)
voxels##10##1##(2007-11#3)(2008-10#1)(2008-11#1)(2008-2#2)(2008-7#1)(2009-10#1)(2012-2#1)
voyage##3##1##(2008-1#1)(2008-9#1)(2012-2#1)
vpr nonsense mutation##2##3##(1994-10#2)
vpr##8##1##(1994-10#6)(1997-4#1)(1997-6#1)
vrn-B1##2##1##(2012-3#2)
vs &gt##2##2##(1994-9#1)(2006-5#1)
vs +2##2##2##(2012-12#2)
vs -0##3##2##(2007-10#3)
vs 0##22##2##(1990-12#1)(1990-4#1)(1996-12#1)(1997-1#1)(1997-3#1)(2007-10#1)(2007-9#2)(2009-11#2)(2009-7#1)(2010-1#2)(2011-2#3)(2013-1#3)(2013-8#3)
vs 0%)##3##2##(2006-5#1)(2010-4#2)
vs 1##19##2##(1991-6#1)(1991-7#2)(1992-5#1)(1993-2#1)(2006-7#1)(2007-10#1)(2007-7#1)(2008-9#1)(2010-12#1)(2011-11#1)(2012-3#1)(2013-1#7)
vs 10##4##2##(1995-8#1)(2008-3#1)(2011-2#1)(2013-7#1)
vs 10%)##3##2##(2010-4#3)
vs 100%##2##2##(2007-7#2)
vs 11##4##2##(1993-4#2)(1994-7#1)(2011-2#1)
vs 13##6##2##(2007-10#1)(2007-7#1)(2010-4#3)(2011-2#1)
vs 137 +/-##2##3##(1995-7#1)(2007-10#1)
vs 14##5##2##(1990-9#1)(1994-8#1)(2007-7#1)(2008-3#1)(2008-4#1)
vs 15##4##2##(1990-11#1)(1990-3#1)(1992-2#1)(2007-10#1)
vs 16##7##2##(2007-3#1)(2008-8#1)(2010-4#4)(2011-2#1)
vs 17##5##2##(1992-10#1)(1993-2#2)(2007-10#1)(2008-5#1)
vs 19##4##2##(1997-3#1)(2007-10#1)(2007-4#1)(2011-2#1)
vs 19%)##2##2##(1990-6#1)(2011-2#1)
vs 2##15##2##(1990-3#1)(1991-6#1)(1991-7#2)(1992-2#1)(1994-8#1)(1995-7#1)(1997-2#1)(2005-10#1)(2006-10#1)(2006-4#1)(2007-9#1)(2008-7#2)(2011-2#1)
vs 20##5##2##(1993-4#1)(1994-7#1)(2004-1#1)(2010-1#1)(2012-12#1)
vs 20%)##2##2##(2008-6#1)(2010-4#1)
vs 21##2##2##(1996-2#1)(2008-8#1)
vs 23##4##2##(2006-8#1)(2008-8#1)(2010-4#2)
vs 24##2##2##(1990-12#1)(1995-9#1)
vs 25##3##2##(1991-5#1)(1992-10#1)(1994-2#1)
vs 25%)##3##2##(1990-6#2)(2011-2#1)
vs 26##3##2##(2010-4#3)
vs 27##2##2##(2008-4#1)(2010-4#1)
vs 28##2##2##(1997-2#1)(2005-10#1)
vs 29##2##2##(1990-12#1)(1994-7#1)
vs 3##9##2##(1992-5#1)(2005-10#1)(2008-1#1)(2008-7#2)(2009-2#1)(2010-11#1)(2010-4#2)
vs 30##4##2##(1993-8#1)(1994-11#1)(1997-2#1)(1997-8#1)
vs 33##5##2##(2007-7#1)(2007-9#1)(2008-4#1)(2010-4#1)(2012-2#1)
vs 36##2##2##(2010-4#2)
vs 37##3##2##(1991-8#1)(2008-1#1)(2011-2#1)
vs 38##4##2##(2007-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
vs 4##11##2##(1992-2#1)(1992-5#1)(1994-1#1)(1996-2#2)(1997-2#2)(2006-6#1)(2007-9#1)(2010-4#1)(2012-12#1)
vs 40##5##2##(2006-7#1)(2008-4#1)(2012-1#2)(2012-2#1)
vs 41##3##2##(2006-6#1)(2011-1#1)(2012-1#1)
vs 42##3##2##(1994-2#1)(1994-6#1)(2006-6#1)
vs 45##2##2##(2004-8#1)(2011-2#1)
vs 46##2##2##(1996-2#1)(2008-4#1)
vs 5##8##2##(1990-3#1)(1990-4#1)(1992-10#1)(1994-11#1)(1995-12#1)(2007-9#1)(2008-8#1)(2008-9#1)
vs 50%##2##2##(2008-3#1)(2011-2#1)
vs 57##2##2##(1990-6#1)(2005-10#1)
vs 59##3##2##(1992-6#1)(1997-7#1)(2005-10#1)
vs 6##10##2##(1991-5#1)(1995-9#1)(2005-10#1)(2006-6#1)(2008-5#1)(2009-8#1)(2010-4#3)(2013-1#1)
vs 7##4##2##(1993-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
vs 75%)##2##2##(1990-6#1)(1994-3#1)
vs 78##2##2##(2008-4#1)(2011-2#1)
vs 79##2##2##(2011-2#2)
vs 8##4##2##(1994-11#1)(2004-8#1)(2005-10#1)(2007-9#1)
vs 80##2##2##(1996-2#1)(2011-2#1)
vs 82##2##2##(2006-10#1)(2007-10#1)
vs 83##2##2##(2008-9#1)(2011-2#1)
vs 92%##2##2##(2007-10#2)
vs 93##2##2##(1991-6#2)
vs A1 receptors##3##3##(1994-9#1)(1995-3#2)
vs A1##4##2##(1994-9#1)(1995-3#3)
vs Ag/AgCl##2##2##(2008-10#2)
vs MCF-7 cells)##2##3##(1991-8#2)
vs SCE in##2##3##(1997-7#1)(2008-10#1)
vs SCE##3##2##(1996-5#1)(1997-7#1)(2008-10#1)
vs T##2##2##(1990-11#1)(1996-2#1)
vs a##2##2##(1995-3#1)(2008-6#1)
vs baseline)##2##2##(2007-11#2)
vs control group##2##3##(2006-6#2)
vs conventional##2##2##(1997-2#1)(2011-12#1)
vs external##2##2##(2008-11#1)(2008-8#1)
vs low-fat##2##2##(1991-2#2)
vs no##3##2##(2008-10#1)(2010-6#2)
vs normal##2##2##(1997-8#1)(2010-4#1)
vs pH for##2##3##(1991-9#2)
vs pH##4##2##(1991-9#3)(2005-11#1)
vs peers##2##2##(2008-12#2)
vs pethidine##2##2##(2008-7#1)(2010-7#1)
vs power##2##2##(2008-5#1)(2009-5#1)
vs the##9##2##(1990-2#1)(1991-11#1)(1996-2#1)(1997-2#1)(1997-7#1)(2007-7#1)(2008-4#1)(2008-8#1)(2011-1#1)
vs time curves##2##3##(2005-11#1)(2010-5#1)
vs time##7##2##(1997-4#1)(2005-11#3)(2008-5#2)(2010-5#1)
vs##1515##1##(1990-10#3)(1990-11#4)(1990-12#8)(1990-2#7)(1990-3#6)(1990-4#6)(1990-5#2)(1990-6#7)(1990-7#7)(1990-8#1)(1990-9#2)(1991-1#7)(1991-10#3)(1991-11#4)(1991-12#6)(1991-2#3)(1991-4#6)(1991-5#9)(1991-6#5)(1991-7#6)(1991-8#3)(1991-9#13)(1992-1#2)(1992-10#7)(1992-11#5)(1992-12#12)(1992-2#10)(1992-3#2)(1992-4#4)(1992-5#4)(1992-6#1)(1992-7#2)(1992-9#6)(1993-1#7)(1993-11#3)(1993-12#3)(1993-2#10)(1993-3#3)(1993-4#10)(1993-7#5)(1993-8#7)(1993-9#4)(1994-1#2)(1994-10#2)(1994-11#5)(1994-12#6)(1994-2#8)(1994-3#5)(1994-5#2)(1994-6#9)(1994-7#3)(1994-8#5)(1994-9#10)(1995-1#3)(1995-10#4)(1995-12#16)(1995-2#12)(1995-3#9)(1995-4#5)(1995-6#21)(1995-7#12)(1995-8#2)(1995-9#3)(1996-1#10)(1996-11#4)(1996-12#11)(1996-2#16)(1996-3#4)(1996-5#5)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#15)(1997-2#15)(1997-3#5)(1997-4#7)(1997-5#6)(1997-6#1)(1997-7#6)(1997-8#16)(2004-1#6)(2004-10#1)(2004-11#4)(2004-12#6)(2004-3#1)(2004-5#1)(2004-8#2)(2005-1#6)(2005-10#8)(2005-11#7)(2005-12#2)(2005-8#1)(2006-1#1)(2006-10#20)(2006-12#4)(2006-2#4)(2006-4#1)(2006-5#16)(2006-6#15)(2006-7#6)(2006-8#10)(2006-9#19)(2007-1#8)(2007-10#35)(2007-11#11)(2007-12#3)(2007-2#11)(2007-3#12)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#15)(2007-8#56)(2007-9#14)(2008-1#11)(2008-10#44)(2008-11#19)(2008-12#7)(2008-3#29)(2008-4#19)(2008-5#29)(2008-6#9)(2008-7#46)(2008-8#23)(2008-9#10)(2009-10#3)(2009-11#11)(2009-12#2)(2009-2#5)(2009-3#2)(2009-4#4)(2009-5#4)(2009-6#6)(2009-7#3)(2009-8#16)(2009-9#3)(2010-1#4)(2010-10#1)(2010-11#5)(2010-12#5)(2010-2#6)(2010-3#13)(2010-4#38)(2010-5#8)(2010-6#5)(2010-7#4)(2010-8#10)(2010-9#1)(2011-1#23)(2011-11#1)(2011-12#3)(2011-2#70)(2011-7#6)(2012-1#12)(2012-11#4)(2012-12#34)(2012-2#25)(2012-3#41)(2013-1#46)(2013-7#9)(2013-8#29)
vti1-1 cells##2##2##(1997-6#2)
vti1-1##3##1##(1997-6#3)
vti1-11##3##1##(1997-6#3)
vu##3##1##(1990-3#1)(2011-2#1)(2012-2#1)
vuittenezi##3##1##(2008-10#3)
vulE and vulF##2##3##(2007-12#2)
vulF cells##2##2##(2007-12#2)
vulF##3##1##(2007-12#3)
vulcanization##3##1##(2008-10#3)
vulgare and##3##2##(2007-1#1)(2011-2#2)
vulgare var##3##2##(2007-1#3)
vulgare##25##1##(1993-12#1)(1994-10#1)(1995-6#1)(2007-1#9)(2008-10#5)(2008-11#1)(2008-5#3)(2008-8#1)(2008-9#1)(2011-2#2)
vulgare)##5##1##(2006-9#1)(2008-10#2)(2008-5#1)(2008-8#1)
vulgaris (PV)##2##2##(1991-11#1)(2013-8#1)
vulgaris ESP6 could##2##3##(2013-1#2)
vulgaris ESP6##5##2##(2013-1#5)
vulgaris Hildenborough##6##2##(1992-3#2)(1994-5#2)(2006-8#2)
vulgaris L##11##2##(2008-12#5)(2008-5#1)(2011-2#1)(2012-3#2)(2013-8#2)
vulgaris and##10##2##(1991-12#1)(2005-11#1)(2006-8#1)(2007-7#1)(2007-8#2)(2008-5#1)(2009-4#1)(2010-3#1)(2011-1#1)
vulgaris cytochrome c3##2##3##(1994-8#2)
vulgaris flavodoxin##2##2##(1990-4#1)(1994-8#1)
vulgaris in the##2##3##(1992-12#1)(2004-2#1)
vulgaris in##3##2##(1992-12#1)(2004-2#1)(2004-4#1)
vulgaris is##5##2##(1992-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-8#1)
vulgaris on##2##2##(2007-7#2)
vulgaris tissue homogenate##2##3##(2008-10#2)
vulgaris to##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
vulgaris was##5##2##(1990-8#1)(1993-11#3)(2005-11#1)
vulgaris were##3##2##(1993-11#1)(2007-7#1)(2010-8#1)
vulgaris with##2##2##(2008-10#1)(2008-5#1)
vulgaris##199##1##(1990-4#3)(1990-8#5)(1991-11#5)(1991-12#4)(1991-5#1)(1992-12#3)(1992-3#2)(1992-9#1)(1993-11#5)(1994-2#1)(1994-5#3)(1994-8#7)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-6#1)(1997-8#1)(2004-2#3)(2004-4#7)(2005-11#2)(2006-12#3)(2006-4#1)(2006-8#10)(2007-1#1)(2007-7#18)(2007-8#10)(2008-1#1)(2008-10#20)(2008-11#3)(2008-12#7)(2008-4#1)(2008-5#12)(2008-7#2)(2008-8#2)(2008-9#2)(2009-4#2)(2009-5#1)(2010-3#2)(2010-4#1)(2010-5#3)(2010-8#8)(2011-1#2)(2011-12#2)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#8)(2013-8#8)
vulgaris) seedlings##2##2##(2008-10#1)(2009-3#1)
vulgaris)##28##1##(1991-5#1)(1993-12#1)(2004-4#1)(2008-10#19)(2009-3#1)(2010-5#1)(2011-1#2)(2012-2#2)
vulgaris-leucoagglutinin and##2##2##(1993-12#1)(1994-2#1)
vulgaris-leucoagglutinin##5##1##(1991-9#1)(1993-12#1)(1994-2#1)(1995-11#1)(1997-3#1)
vulgaris]##3##1##(1997-8#1)(2005-11#1)(2012-3#1)
vulgatus##3##1##(1997-2#3)
vulnerabilities of##3##2##(1997-3#1)(2011-1#1)(2011-2#1)
vulnerabilities##27##1##(1990-6#1)(1995-12#1)(1997-3#2)(2007-12#1)(2008-11#2)(2008-12#4)(2008-8#1)(2009-4#1)(2009-5#1)(2011-1#2)(2011-12#3)(2011-2#1)(2012-1#5)(2013-1#2)
vulnerability and##11##2##(1994-2#1)(1996-1#1)(2006-9#1)(2007-7#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2011-1#1)(2012-11#1)
vulnerability assessment##2##2##(2004-4#1)(2012-1#1)
vulnerability factors##2##2##(1994-2#1)(2008-11#1)
vulnerability for##6##2##(1994-8#1)(2007-2#1)(2007-8#1)(2008-2#1)(2010-7#1)(2013-1#1)
vulnerability in##3##2##(2007-2#1)(2009-5#1)(2013-1#1)
vulnerability indicators##3##2##(1997-2#2)(2008-9#1)
vulnerability is##5##2##(1990-2#1)(1995-1#1)(2004-4#1)(2010-4#1)(2011-2#1)
vulnerability locus##2##2##(1997-5#2)
vulnerability of the##12##3##(1995-11#1)(1995-3#1)(1996-10#1)(1996-5#1)(2006-10#1)(2006-5#1)(2007-1#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-7#1)
vulnerability of##31##2##(1990-5#1)(1990-7#1)(1992-7#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-12#1)(2007-9#2)(2008-10#1)(2008-5#2)(2008-7#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-7#1)
vulnerability score was##3##3##(2008-5#3)
vulnerability to a##2##3##(2007-7#1)(2008-8#1)
vulnerability to alcoholism##5##3##(1994-2#2)(2007-8#2)(2008-6#1)
vulnerability to different##2##3##(1996-6#1)(2006-5#1)
vulnerability to##38##2##(1994-2#2)(1994-6#1)(1995-11#1)(1995-12#1)(1996-6#1)(1996-7#1)(1997-5#2)(1997-8#2)(2005-10#1)(2006-5#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
vulnerability##157##1##(1990-2#1)(1990-5#2)(1990-7#1)(1991-2#1)(1992-10#1)(1992-7#1)(1993-11#1)(1994-2#4)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-3#1)(1995-5#1)(1996-1#3)(1996-10#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#2)(1997-2#3)(1997-5#4)(1997-7#1)(1997-8#2)(2004-4#2)(2005-10#3)(2006-10#2)(2006-5#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-2#4)(2007-7#4)(2007-8#3)(2007-9#3)(2008-1#2)(2008-10#2)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#8)(2008-9#4)(2009-10#2)(2009-4#6)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#8)(2013-7#2)(2013-8#1)
vulnerable adolescent population##2##3##(2007-1#1)(2008-4#1)
vulnerable and##5##2##(1997-8#1)(2007-11#1)(2008-11#1)(2010-7#1)(2013-1#1)
vulnerable because##2##2##(2008-7#1)(2012-1#1)
vulnerable beneficiaries##2##2##(2007-2#2)
vulnerable coronary plaques##2##3##(2007-11#1)(2008-5#1)
vulnerable families##2##2##(2008-7#1)(2012-3#1)
vulnerable group##3##2##(2011-1#1)(2012-1#1)(2013-1#1)
vulnerable groups such as##2##4##(2005-11#1)(2008-7#1)
vulnerable groups##6##2##(2005-11#1)(2007-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2013-8#1)
vulnerable in##7##2##(1991-1#1)(1995-11#1)(1996-9#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
vulnerable individuals##3##2##(2007-5#1)(2008-12#1)(2010-4#1)
vulnerable infant##2##2##(2013-1#2)
vulnerable patients##4##2##(2008-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
vulnerable period of##2##3##(1991-4#1)(2007-3#1)
vulnerable plaque##7##2##(2008-10#2)(2012-2#5)
vulnerable plaques in##2##3##(2008-1#1)(2008-10#1)
vulnerable plaques##8##2##(2008-1#1)(2008-10#4)(2008-7#1)(2012-2#2)
vulnerable population##12##2##(1993-2#1)(2008-12#1)(2009-4#1)(2009-5#1)(2009-9#3)(2010-8#3)(2011-1#1)(2013-1#1)
vulnerable populations such as##2##4##(1997-2#1)(2007-1#1)
vulnerable populations##25##2##(1991-1#1)(1995-12#2)(1995-2#1)(1997-2#1)(2007-1#2)(2007-2#1)(2007-8#1)(2008-11#3)(2008-8#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-1#2)(2011-1#2)(2011-2#2)(2012-2#3)
vulnerable prey##2##2##(2008-8#2)
vulnerable regions##2##2##(1995-12#1)(1997-8#1)
vulnerable segments of the##2##4##(2008-9#1)(2012-12#1)
vulnerable segments of##3##3##(1996-1#1)(2008-9#1)(2012-12#1)
vulnerable subgroups##2##2##(1995-12#1)(2007-2#1)
vulnerable time##2##2##(2011-2#2)
vulnerable to HIV infection##5##4##(1997-7#1)(2007-3#1)(2007-7#1)(2008-7#1)(2009-5#1)
vulnerable to HIV##6##3##(1996-11#1)(1997-7#1)(2007-3#1)(2007-7#1)(2008-7#1)(2009-5#1)
vulnerable to PM10##2##3##(2010-9#2)
vulnerable to a##4##3##(2007-11#1)(2008-3#1)(2011-9#1)(2013-1#1)
vulnerable to any##3##3##(1991-1#1)(2013-1#2)
vulnerable to extinction##2##3##(2013-1#1)(2013-7#1)
vulnerable to fracture##2##3##(2006-11#1)(2013-1#1)
vulnerable to infection##2##3##(2008-10#1)(2013-8#1)
vulnerable to mechanical and##2##4##(1995-7#1)(2006-10#1)
vulnerable to mechanical##3##3##(1995-7#1)(2006-10#1)(2007-9#1)
vulnerable to natural and##2##4##(2007-5#1)(2008-8#1)
vulnerable to the development of##3##5##(2006-11#1)(2006-3#1)(2012-2#1)
vulnerable to the effects of##2##5##(2010-9#1)(2013-1#1)
vulnerable to the##11##3##(1995-2#1)(2006-11#1)(2006-3#1)(2007-11#1)(2007-12#1)(2008-8#1)(2010-9#1)(2012-2#2)(2013-1#2)
vulnerable to##95##2##(1991-1#1)(1992-2#1)(1992-8#1)(1993-6#1)(1994-6#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-11#1)(1997-7#1)(2004-3#1)(2004-9#1)(2005-6#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-11#2)(2006-12#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-5#3)(2007-7#3)(2007-8#1)(2007-9#3)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#4)(2008-8#3)(2009-10#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-4#2)(2010-9#4)(2011-1#2)(2011-2#1)(2011-9#1)(2012-1#1)(2012-11#1)(2012-2#5)(2012-3#2)(2013-1#11)(2013-7#2)(2013-8#1)
vulnerable##272##1##(1990-2#2)(1991-1#3)(1991-4#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#7)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-7#2)(1997-8#4)(2004-3#1)(2004-9#1)(2005-11#1)(2005-6#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-11#2)(2006-12#1)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-1#3)(2007-10#1)(2007-11#6)(2007-12#4)(2007-2#10)(2007-3#3)(2007-5#4)(2007-7#5)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#16)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#3)(2008-7#9)(2008-8#8)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#2)(2010-12#1)(2010-4#3)(2010-7#1)(2010-8#3)(2010-9#6)(2011-1#6)(2011-2#9)(2011-9#1)(2012-1#4)(2012-11#2)(2012-12#7)(2012-2#19)(2012-3#6)(2013-1#20)(2013-7#3)(2013-8#3)
vulnerable&quot##2##1##(2007-3#1)(2011-1#1)
vulnificus are##2##2##(1995-5#2)
vulnificus##10##1##(1995-5#2)(2007-12#7)(2008-4#1)
vulpecula##3##1##(1997-8#3)
vulpia residues##6##2##(2004-2#6)
vulpia##9##1##(2004-2#9)
vultures##10##1##(1995-11#10)
vulva and##5##2##(1993-1#2)(2007-12#1)(2007-7#1)(2008-10#1)
vulva formation##2##2##(2007-11#1)(2007-12#1)
vulva in##2##2##(1996-12#1)(2006-10#1)
vulva##44##1##(1992-3#4)(1993-1#2)(1993-6#1)(1993-8#1)(1994-1#2)(1996-12#4)(1997-7#2)(2004-10#1)(2005-11#2)(2005-7#1)(2006-10#9)(2007-11#1)(2007-12#6)(2007-7#3)(2007-8#1)(2008-10#2)(2008-7#2)
vulval cell##2##2##(2007-12#2)
vulval cells##3##2##(1993-6#1)(2007-12#2)
vulval development##3##2##(1993-6#1)(2007-12#2)
vulval fates)##2##2##(1990-11#2)
vulval induction##7##2##(1990-11#4)(1993-6#3)
vulval##27##1##(1990-11#7)(1993-6#6)(2004-10#1)(2007-12#9)(2007-7#1)(2008-5#1)(2012-2#1)(2013-1#1)
vulvar Paget disease is##2##4##(2006-10#2)
vulvar Paget disease##5##3##(2006-10#5)
vulvar and vaginal##2##3##(2008-10#1)(2013-1#1)
vulvar cancer##3##2##(1992-3#1)(1993-9#1)(1994-7#1)
vulvar carcinoma##3##2##(1990-10#1)(1992-3#1)(1993-9#1)
vulvar intraepithelial neoplasia##3##3##(1991-2#1)(2006-10#2)
vulvar lesions##2##2##(1992-3#1)(2006-10#1)
vulvar squamous-cell##2##2##(1993-9#2)
vulvar##31##1##(1990-10#1)(1991-2#1)(1992-3#5)(1993-9#8)(1994-1#1)(1994-7#1)(1996-12#1)(2006-10#9)(2008-10#1)(2010-9#1)(2011-1#1)(2013-1#1)
vulvovaginal candidiasis##10##2##(1994-12#1)(2005-11#1)(2007-7#1)(2008-5#4)(2011-1#2)(2012-3#1)
vulvovaginal##13##1##(1994-12#1)(2005-11#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-5#4)(2011-1#2)(2011-2#1)(2012-3#1)
vulvovaginitis##5##1##(2006-10#1)(2006-8#1)(2011-2#3)
vv##2##1##(2013-8#2)
vv+##5##1##(2013-8#5)
vvCCL19##3##1##(2013-1#3)
vvMDV##3##1##(2008-5#3)
vvm##3##1##(2008-5#2)(2008-8#1)
vying for##3##2##(2006-10#1)(2008-10#1)(2010-4#1)
vying##4##1##(2006-10#1)(2006-2#1)(2008-10#1)(2010-4#1)
vésicules##2##1##(2012-2#1)(2013-1#1)
w of##2##2##(1991-4#1)(1995-6#1)
w v(-1)##2##2##(2008-10#2)
w##44##1##(1990-7#3)(1991-3#1)(1991-4#2)(1991-5#3)(1991-8#1)(1991-9#5)(1992-11#1)(1992-12#1)(1993-7#1)(1994-8#1)(1995-6#1)(2007-10#3)(2007-2#1)(2007-8#1)(2008-10#4)(2008-3#1)(2010-12#1)(2010-3#1)(2010-4#2)(2011-1#6)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
w(m##3##1##(2007-11#3)
w(w) decreased##2##2##(2008-12#2)
w)##2##1##(1991-3#1)(1991-4#1)
w-3 fatty acids##2##3##(2006-10#2)
w-3##8##1##(2006-10#3)(2008-9#5)
w/o emulsion##2##2##(2008-5#1)(2011-2#1)
w/o##8##1##(2005-11#1)(2007-5#1)(2008-5#5)(2011-2#1)
w/o/w##2##1##(2010-1#1)(2010-12#1)
w/v and##2##2##(2012-11#2)
w/v of##2##2##(2010-2#2)
w/v##18##1##(2004-12#1)(2008-10#7)(2008-12#1)(2008-5#2)(2008-6#1)(2010-2#2)(2012-11#3)(2012-2#1)
w/v) and##2##2##(2008-10#1)(2010-1#1)
w/v) as##2##2##(2012-11#2)
w/v) or##2##2##(2010-4#1)(2011-2#1)
w/v)##23##1##(1993-11#1)(1996-12#1)(1996-5#1)(2004-8#1)(2008-10#5)(2008-12#2)(2008-6#1)(2010-1#1)(2010-4#3)(2011-2#2)(2011-3#1)(2012-11#2)(2012-3#1)(2013-1#1)
w/w (C(4##6##2##(2008-5#6)
w/w acacia##2##2##(2004-12#2)
w/w carrier in##2##3##(2008-10#2)
w/w fat)##2##2##(2004-11#2)
w/w for##2##2##(1992-11#1)(2008-10#1)
w/w of##13##2##(2008-10#2)(2008-3#1)(2010-2#8)(2010-3#2)
w/w sodium##2##2##(2010-2#1)(2010-3#1)
w/w##50##1##(1992-11#1)(2004-1#3)(2004-11#2)(2004-12#4)(2008-10#9)(2008-3#2)(2008-5#11)(2008-7#1)(2008-8#1)(2010-2#9)(2010-3#5)(2010-4#1)(2011-2#1)
w/w% Ag-zeolite could show a sufficient antimicrobial effect against##2##9##(2008-5#2)
w/w% Ag-zeolite##3##2##(2008-5#3)
w/w%##6##1##(2005-11#1)(2008-5#5)
w/w) along with##2##3##(2008-8#1)(2010-2#1)
w/w) and##3##2##(1993-11#2)(2010-2#1)
w/w) in##6##2##(2008-10#2)(2009-3#1)(2009-6#1)(2010-12#2)
w/w) of##3##2##(2008-5#2)(2012-11#1)
w/w) using##2##2##(1991-2#1)(2008-10#1)
w/w) with##2##2##(2009-3#1)(2010-4#1)
w/w)##44##1##(1991-2#2)(1993-11#6)(1993-6#1)(1996-1#1)(1996-5#1)(1996-8#1)(2004-1#1)(2006-8#1)(2008-10#13)(2008-5#3)(2008-6#1)(2008-8#1)(2009-3#2)(2009-6#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2012-11#1)(2012-12#1)(2013-1#1)
w19##2##1##(1994-12#2)
w5##2##1##(1994-12#2)
wR = 0##2##3##(2006-5#2)
wR(2) = 0##4##3##(1996-2#4)
wa##3##1##(1990-7#1)(2008-8#1)(2009-7#1)
wa-2 EGF##2##2##(1995-2#2)
wa-2 mice##2##2##(1995-2#2)
wa-2##7##1##(1995-2#7)
wac##3##1##(1994-9#3)
wading##2##1##(2006-8#1)(2007-2#1)
wadsworthia to##3##2##(2006-8#3)
waf1/p21##2##1##(2008-9#2)
wafer and##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
wafer by##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
wafer that##2##2##(2008-3#2)
wafer was##2##2##(1992-6#1)(2008-11#1)
wafer with##2##2##(2007-12#2)
wafer##42##1##(1992-6#2)(2005-11#2)(2006-4#1)(2007-11#1)(2007-12#8)(2008-10#4)(2008-11#2)(2008-2#4)(2008-3#11)(2008-5#2)(2008-7#1)(2009-5#1)(2009-7#1)(2010-4#1)(2012-11#1)
wafer-scale##2##1##(2007-12#1)(2008-7#1)
wafers and##3##2##(1992-6#1)(2008-3#1)(2008-7#1)
wafers of##3##2##(2008-3#2)(2008-7#1)
wafers with##4##2##(2007-2#1)(2008-3#1)(2012-11#2)
wafers##30##1##(1992-6#2)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-2#4)(2008-3#11)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-5#1)(2012-11#2)(2012-2#1)
wage and price controls##3##4##(1994-12#3)
wage and salary##2##3##(1994-3#1)(2012-12#1)
wage and##5##2##(1994-12#3)(1994-3#1)(2012-12#1)
wage in##2##2##(1992-12#1)(2007-2#1)
wage index##2##2##(1992-12#1)(1992-2#1)
wage rates##2##2##(1992-1#2)
wage##21##1##(1990-5#1)(1990-8#1)(1992-1#2)(1992-12#3)(1992-2#1)(1993-6#1)(1994-12#3)(1994-3#1)(2006-4#1)(2007-2#1)(2008-9#1)(2011-2#2)(2012-12#2)(2013-8#1)
wages and salaries##2##3##(1992-1#1)(1994-1#1)
wages and##3##2##(1992-1#1)(1994-1#1)(1996-2#1)
wages##14##1##(1992-1#1)(1992-12#1)(1992-3#2)(1992-5#1)(1994-1#1)(1995-10#1)(1996-11#1)(1996-2#1)(1996-3#1)(2006-4#1)(2008-11#1)(2008-9#1)(2012-3#1)
waggle runs##12##2##(2012-12#12)
waggle##17##1##(2012-12#16)(2013-8#1)
waist and hip circumference##2##4##(2010-2#1)(2011-2#1)
waist and hip##6##3##(2006-2#1)(2008-3#1)(2008-5#1)(2010-2#1)(2011-2#1)(2013-7#1)
waist and##8##2##(2006-2#1)(2007-11#2)(2008-3#1)(2008-5#1)(2010-2#1)(2011-2#1)(2013-7#1)
waist circumference (WC)##3##3##(2008-12#1)(2011-1#1)(2013-1#1)
waist circumference (r =##2##4##(2008-3#1)(2010-4#1)
waist circumference and##6##3##(2006-4#2)(2008-3#1)(2010-8#1)(2011-1#1)(2013-1#1)
waist circumference to##2##3##(1996-8#1)(2008-11#1)
waist circumference##47##2##(1996-8#1)(2006-4#5)(2008-1#1)(2008-11#4)(2008-12#3)(2008-3#10)(2008-4#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-8#3)(2011-1#3)(2011-2#6)(2012-12#2)(2013-1#3)
waist is##2##2##(2007-12#1)(2008-2#1)
waist obesity was independently associated with abnormal ALT levels##2##9##(2013-1#2)
waist obesity##3##2##(2013-1#3)
waist of##4##2##(2008-1#1)(2008-2#1)(2008-3#2)
waist radius of##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
waist to hip ratio##2##4##(2006-9#1)(2011-2#1)
waist##95##1##(1996-8#1)(2006-2#1)(2006-4#5)(2006-9#1)(2007-11#5)(2007-12#7)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#4)(2008-12#4)(2008-2#4)(2008-3#16)(2008-4#2)(2008-5#1)(2008-9#5)(2010-12#1)(2010-2#2)(2010-4#4)(2010-8#3)(2011-1#4)(2011-11#1)(2011-2#9)(2012-12#2)(2013-1#6)(2013-7#1)(2013-8#1)
waist-hip ratio##3##2##(2011-2#2)(2013-1#1)
waist-hip##4##1##(2008-12#1)(2011-2#2)(2013-1#1)
waist-to-hip ratio (WHR)##5##3##(2007-12#3)(2008-3#1)(2011-1#1)
waist-to-hip ratio and##2##3##(1990-9#1)(1991-10#1)
waist-to-hip ratio##16##2##(1990-9#6)(1991-10#3)(2007-12#3)(2008-11#1)(2008-3#1)(2008-7#1)(2011-1#1)
waist-to-hip ratios##2##2##(1990-9#1)(2007-12#1)
waist-to-hip##19##1##(1990-9#8)(1991-10#3)(2007-12#4)(2008-11#1)(2008-3#1)(2008-7#1)(2011-1#1)
waist/hip ratio##5##2##(1994-12#2)(1997-7#1)(2006-6#1)(2008-5#1)
wait and##2##2##(2008-8#1)(2009-5#1)
wait for the##2##3##(2008-10#1)(2009-1#1)
wait for##10##2##(1994-1#1)(1996-11#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#1)(2008-7#1)(2009-1#1)
wait listing##2##2##(1995-12#2)
wait time was##2##3##(2010-8#1)(2011-2#1)
wait time##4##2##(2009-3#1)(2010-8#2)(2011-2#1)
wait times and##2##3##(2009-3#2)
wait times##4##2##(2009-3#3)(2010-8#1)
wait to##2##2##(2008-8#1)(2008-9#1)
wait until##3##2##(1993-3#1)(2006-9#1)(2013-7#1)
wait while##2##2##(1991-3#1)(1996-3#1)
wait##45##1##(1991-3#1)(1992-2#2)(1993-3#1)(1994-1#1)(1995-12#3)(1995-9#2)(1996-11#1)(1996-3#1)(2006-2#3)(2006-9#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-10#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-3#4)(2009-4#3)(2009-5#1)(2009-9#1)(2010-8#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
wait-list##4##1##(2010-6#1)(2011-1#1)(2012-2#1)(2013-8#1)
wait-listed##2##1##(2007-8#2)
waited for more than##2##4##(1992-5#1)(2007-7#1)
waited until##2##2##(1994-12#1)(1995-6#1)
waited##6##1##(1992-5#1)(1994-12#1)(1995-6#1)(2007-7#1)(2008-8#1)(2012-3#1)
waiting and##3##2##(1996-2#1)(2006-2#1)(2012-3#1)
waiting for a##4##3##(1996-2#1)(2006-10#1)(2007-8#1)(2009-12#1)
waiting for the##5##3##(1995-5#1)(1996-4#1)(2006-9#1)(2008-6#1)(2010-12#1)
waiting for##38##2##(1990-10#1)(1990-5#1)(1990-8#1)(1991-4#2)(1991-7#2)(1992-1#1)(1992-10#1)(1994-8#1)(1995-1#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-4#1)(2005-12#1)(2006-10#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-12#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-12#1)(2010-8#1)(2013-1#1)(2013-8#1)
waiting in the##2##3##(1991-12#1)(1996-1#1)
waiting in##3##2##(1991-12#1)(1996-1#1)(2007-10#1)
waiting list as##2##3##(1993-2#1)(2007-8#1)
waiting list for reduction##2##4##(1990-5#2)
waiting list for##3##3##(1990-5#2)(1991-4#1)
waiting list##32##2##(1990-5#3)(1991-11#6)(1991-4#2)(1993-2#3)(1996-11#1)(1997-1#6)(2006-8#1)(2007-7#2)(2007-8#3)(2008-5#1)(2010-9#1)(2011-2#1)(2011-3#2)
waiting lists and##2##3##(1991-11#1)(1993-2#1)
waiting lists are##2##3##(1996-8#1)(2006-12#1)
waiting lists in##2##3##(1991-11#2)
waiting lists##23##2##(1990-12#1)(1991-11#7)(1992-12#1)(1993-2#5)(1996-8#1)(2006-10#1)(2006-12#2)(2006-8#3)(2007-12#1)(2011-3#1)
waiting period##6##2##(1990-8#1)(1991-4#1)(1993-2#1)(1994-2#1)(2006-8#1)(2008-5#1)
waiting room for operation##2##4##(1990-8#2)
waiting room##5##2##(1990-8#2)(2006-8#1)(2008-7#1)(2010-4#1)
waiting time and##3##3##(1991-11#1)(1992-2#1)(2012-2#1)
waiting time for##9##3##(1990-8#1)(1991-11#3)(1992-12#1)(2006-7#2)(2006-8#1)(2008-5#1)
waiting time on##2##3##(2006-8#1)(2007-8#1)
waiting time to see##2##4##(1994-2#1)(2007-8#1)
waiting time to##4##3##(1994-2#1)(2006-10#1)(2007-8#1)(2012-12#1)
waiting time was##4##3##(2006-2#1)(2006-8#2)(2011-1#1)
waiting time##37##2##(1990-8#1)(1991-11#10)(1991-4#2)(1992-12#1)(1992-2#1)(1993-12#1)(1994-2#2)(2006-10#1)(2006-2#1)(2006-7#2)(2006-8#5)(2007-8#3)(2008-5#3)(2008-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
waiting times and the##2##4##(2006-2#1)(2006-8#1)
waiting times and##3##3##(2006-2#2)(2006-8#1)
waiting times between##2##3##(2008-7#1)(2008-9#1)
waiting times were##2##3##(2006-8#1)(2008-7#1)
waiting times##20##2##(1991-11#1)(1995-12#1)(1997-5#1)(1997-6#1)(2006-2#3)(2006-8#3)(2008-11#2)(2008-5#1)(2008-7#2)(2008-9#2)(2011-1#2)(2012-12#1)
waiting to##3##2##(1996-2#1)(2006-9#1)(2012-2#1)
waiting##190##1##(1990-10#1)(1990-12#1)(1990-5#4)(1990-8#5)(1991-10#1)(1991-11#27)(1991-12#1)(1991-4#7)(1991-7#2)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1993-12#1)(1993-2#9)(1994-2#4)(1994-8#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-4#1)(1996-8#2)(1997-1#6)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-12#1)(2006-10#5)(2006-12#2)(2006-2#5)(2006-7#3)(2006-8#15)(2006-9#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#4)(2007-8#10)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#3)(2011-3#4)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
waiting)##2##1##(2010-10#1)(2011-3#1)
waiting-list##3##1##(1997-8#1)(2007-12#1)(2009-2#1)
waitlist control##2##2##(2009-10#1)(2013-1#1)
waitlist##4##1##(2009-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
waive##2##1##(1996-6#1)(2008-2#1)
waiver is##2##2##(1992-2#1)(1997-2#1)
waiver of##3##2##(1993-9#1)(1997-1#1)(2006-10#1)
waiver patients and##2##3##(1997-2#2)
waiver program is##3##3##(1991-1#1)(1993-1#1)(1997-2#1)
waiver program##4##2##(1991-1#1)(1993-1#2)(1997-2#1)
waiver programs##2##2##(1994-2#1)(1996-2#1)
waiver to##2##2##(1996-12#1)(2005-6#1)
waiver##38##1##(1991-1#4)(1992-2#5)(1992-6#1)(1993-1#4)(1993-3#1)(1993-9#2)(1994-2#1)(1996-1#2)(1996-12#2)(1996-2#3)(1997-1#1)(1997-2#9)(2005-6#1)(2006-10#1)(2012-3#1)
waivers##9##1##(1991-3#1)(1994-12#1)(1996-1#7)
wake in##2##2##(1992-1#1)(2005-11#1)
wake onset time##2##3##(1996-7#2)
wake up##2##2##(2006-4#1)(2013-1#1)
wake##34##1##(1990-7#1)(1991-3#1)(1992-1#1)(1993-11#1)(1993-2#1)(1994-2#1)(1995-1#1)(1996-7#3)(2005-10#3)(2005-11#1)(2005-8#1)(2006-4#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-9#3)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#2)
wake-up##5##1##(1993-2#1)(2006-10#1)(2011-2#2)(2013-7#1)
wakefulness or##2##2##(1994-12#1)(2012-2#1)
wakefulness##19##1##(1992-1#2)(1992-8#1)(1993-11#1)(1994-12#1)(1994-2#1)(1996-1#1)(1996-6#3)(1997-3#2)(2007-1#2)(2007-6#2)(2010-10#1)(2012-2#2)
wakening from##2##2##(1993-2#1)(2013-7#1)
wakening##3##1##(1993-2#1)(2008-3#1)(2013-7#1)
waking MW##2##2##(2013-8#2)
waking and sleep##3##3##(1990-11#1)(2007-8#2)
waking and##5##2##(1990-11#2)(1993-5#1)(2007-8#2)
waking effect##2##2##(1990-11#2)
waking in##2##2##(1990-11#1)(2008-12#1)
waking##29##1##(1990-11#6)(1991-5#2)(1992-10#2)(1992-5#1)(1993-12#1)(1993-5#1)(1994-12#1)(1994-2#1)(1997-3#1)(2007-1#2)(2007-8#2)(2008-11#1)(2008-12#3)(2013-1#1)(2013-8#4)
waking-up##2##1##(2006-10#2)
walk and##2##2##(2006-10#1)(2009-3#1)
walk distance##7##2##(2010-10#2)(2011-2#1)(2012-12#2)(2013-1#2)
walk of##3##2##(2007-12#2)(2010-7#1)
walk on the##3##3##(2009-9#1)(2012-1#1)(2012-3#1)
walk on##5##2##(1991-4#1)(2009-9#1)(2012-1#1)(2012-2#1)(2012-3#1)
walk test##9##2##(2007-7#4)(2008-10#1)(2011-2#1)(2012-12#3)
walk time##2##2##(2007-10#2)
walk towards##2##2##(2012-2#1)(2013-8#1)
walk with##3##2##(2007-11#1)(2007-7#1)(2011-12#1)
walk##87##1##(1991-3#1)(1991-4#1)(1991-9#1)(1995-5#1)(1995-9#1)(1996-3#1)(1996-9#3)(2005-7#1)(2006-10#1)(2006-12#2)(2006-7#1)(2007-10#6)(2007-11#3)(2007-12#6)(2007-2#1)(2007-7#10)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-6#1)(2008-9#1)(2009-3#2)(2009-4#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#1)(2011-12#1)(2011-2#3)(2012-1#6)(2012-12#6)(2012-2#6)(2012-3#1)(2013-1#3)(2013-8#1)
walk-in##2##1##(2007-5#1)(2010-11#1)
walk-off in##3##2##(2007-11#1)(2007-12#2)
walk-off##21##1##(2007-11#9)(2007-12#12)
walk-off-compensated##4##1##(2007-12#3)(2008-1#1)
walk-off-free nonlinear optical loop mirror##2##5##(2007-11#2)
walk-off-free##3##1##(2007-11#3)
walked##13##1##(1990-4#1)(1992-5#1)(1995-4#1)(1996-3#1)(2004-11#1)(2007-7#2)(2013-1#6)
walker##14##1##(2008-12#1)(2010-12#1)(2010-5#1)(2012-1#3)(2012-11#2)(2013-1#1)(2013-7#5)
walkeri##11##1##(2008-10#11)
walkers##10##1##(2006-10#1)(2008-7#1)(2013-1#6)(2013-7#2)
walking a##2##2##(2007-9#1)(2013-1#1)
walking abilities##3##2##(2006-8#1)(2009-4#1)(2010-12#1)
walking ability##10##2##(1991-12#1)(1996-9#3)(2007-10#2)(2007-7#1)(2010-10#1)(2012-1#2)
walking aids##2##2##(2008-8#2)
walking and jogging)##2##3##(2013-1#2)
walking and##17##2##(1993-12#1)(2006-10#1)(2007-10#1)(2007-5#1)(2007-9#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-7#1)(2012-1#2)(2013-1#6)
walking assistance device##2##3##(2012-1#2)
walking assistance##3##2##(2012-1#3)
walking at similar speeds##2##4##(2007-10#2)
walking at##5##2##(1991-1#1)(2007-10#4)
walking behavior##3##2##(1993-7#1)(2011-12#1)(2012-1#1)
walking behaviour##4##2##(2007-12#1)(2010-2#3)
walking cycle##2##2##(2007-12#1)(2012-1#1)
walking distance##8##2##(1990-11#1)(1995-2#1)(2006-9#1)(2007-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2012-12#1)
walking frequency##2##2##(2013-1#2)
walking in##5##2##(1997-2#1)(2007-10#2)(2012-1#1)(2013-1#1)
walking legs of##3##3##(2007-12#3)
walking legs##5##2##(2007-12#5)
walking on a treadmill##3##4##(2012-1#3)
walking on a##5##3##(1997-2#1)(1997-4#1)(2012-1#3)
walking on the##4##3##(1992-10#1)(2012-1#3)
walking on##11##2##(1992-10#1)(1997-2#1)(1997-4#1)(2008-6#1)(2011-1#1)(2012-1#6)
walking over ground##2##3##(2012-1#2)
walking over##3##2##(2010-3#1)(2012-1#2)
walking patterns##4##2##(1993-12#1)(2012-1#3)
walking primers##2##2##(1995-7#2)
walking soliton##2##2##(2007-12#2)
walking speed after stroke##3##4##(2007-10#3)
walking speed##12##2##(1990-11#1)(1991-3#1)(2006-10#1)(2007-10#5)(2010-9#1)(2012-1#2)(2013-1#1)
walking speeds##2##2##(2007-10#1)(2012-1#1)
walking test##4##2##(1997-4#1)(2007-8#1)(2013-1#2)
walking to##3##2##(1996-6#1)(2011-2#1)(2012-1#1)
walking trail located in##2##4##(2004-11#2)
walking trail##3##2##(2004-11#3)
walking up##2##2##(2008-7#2)
walking velocity##2##2##(2012-1#1)(2012-2#1)
walking was##4##2##(1993-12#1)(1995-7#1)(2008-10#1)(2012-1#1)
walking with the exoskeleton##3##4##(2012-1#3)
walking with##9##2##(2006-10#1)(2010-3#1)(2012-1#6)(2012-12#1)
walking within##2##2##(2010-2#1)(2012-1#1)
walking without##2##2##(2007-9#1)(2008-6#1)
walking##257##1##(1990-11#3)(1990-6#2)(1991-1#1)(1991-12#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-10#1)(1993-12#7)(1993-7#1)(1994-6#1)(1994-8#1)(1995-2#3)(1995-7#4)(1996-6#1)(1996-9#3)(1997-2#3)(1997-4#2)(2004-11#3)(2005-10#1)(2005-9#1)(2006-10#6)(2006-3#1)(2006-4#1)(2006-8#3)(2006-9#1)(2007-10#17)(2007-11#4)(2007-12#21)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#4)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#9)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#4)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#9)(2010-3#4)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#1)(2012-1#66)(2012-11#2)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#22)(2013-7#1)(2013-8#1)
walking&quot##2##1##(2006-8#1)(2010-7#1)
walks and##3##2##(2006-8#2)(2007-3#1)
walks of life##3##3##(1994-9#1)(2008-4#1)(2008-7#1)
walks##21##1##(1993-1#1)(1993-12#2)(1994-6#1)(1994-9#1)(1995-2#1)(2006-4#1)(2006-8#3)(2006-9#1)(2007-3#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-4#1)
walkway length##3##2##(2012-12#3)
walkway##6##1##(2012-12#6)
wall after##4##2##(1995-3#1)(2007-8#1)(2012-1#1)(2012-2#1)
wall and a##3##3##(2006-6#1)(2011-1#1)(2013-8#1)
wall and in##2##3##(1996-12#1)(2010-3#1)
wall and right##2##3##(2009-5#1)(2010-12#1)
wall and the##9##3##(1990-10#1)(1994-10#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-8#2)(2012-2#1)
wall and##57##2##(1990-10#2)(1990-5#1)(1992-12#1)(1992-5#1)(1993-4#1)(1993-9#1)(1994-10#1)(1996-12#1)(1997-8#1)(2005-1#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-2#1)(2007-5#1)(2007-8#4)(2008-10#4)(2008-3#1)(2008-4#4)(2008-6#2)(2008-7#1)(2008-9#3)(2009-10#1)(2009-5#1)(2009-8#3)(2010-12#3)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#4)(2013-8#2)
wall apposition##2##2##(2008-10#2)
wall appositions and##4##3##(2008-10#4)
wall appositions##11##2##(2008-10#11)
wall are##5##2##(2007-12#1)(2007-8#1)(2008-12#1)(2008-4#1)(2013-1#1)
wall around##3##2##(2006-7#1)(2008-10#2)
wall as##6##2##(1990-9#1)(2008-10#1)(2008-8#1)(2009-2#1)(2009-7#1)(2010-8#1)
wall assembly##2##2##(2009-10#1)(2012-1#1)
wall at the##2##3##(2007-8#1)(2008-10#1)
wall at##4##2##(2007-10#1)(2007-8#1)(2008-10#1)(2009-4#1)
wall by a##2##3##(1990-12#1)(2008-5#1)
wall by##5##2##(1990-12#1)(1994-9#1)(2008-10#1)(2008-5#1)(2008-7#1)
wall caused##2##2##(2005-11#1)(2012-2#1)
wall cell##2##2##(1996-11#1)(2008-11#1)
wall cells##3##2##(1995-3#1)(1997-2#1)(2008-10#1)
wall components##11##2##(2006-10#1)(2006-12#1)(2007-2#1)(2008-10#2)(2008-5#3)(2009-3#1)(2010-12#1)(2011-2#1)
wall could##2##2##(1997-7#1)(2011-2#1)
wall defect was repaired##2##4##(2007-8#1)(2011-2#1)
wall defect##7##2##(2006-2#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-6#1)(2011-2#1)(2013-1#1)
wall defects##4##2##(1996-6#1)(2007-8#2)(2012-2#1)
wall deformity in the##2##4##(2007-8#2)
wall deposition##2##2##(2008-10#1)(2009-10#1)
wall dissolution around invading hyphae##2##5##(2008-10#2)
wall during##7##2##(1993-8#1)(2007-5#1)(2008-5#1)(2008-9#2)(2011-2#1)(2012-12#1)
wall dynamics in##2##3##(2009-6#2)
wall following##3##2##(1991-5#1)(2008-10#1)(2009-3#1)
wall formation##4##2##(1990-7#1)(2006-12#1)(2008-10#1)(2011-2#1)
wall from##2##2##(2008-10#1)(2009-7#1)
wall has been##3##3##(2011-2#2)(2012-12#1)
wall has##8##2##(1992-12#1)(2005-11#3)(2007-8#1)(2011-2#2)(2012-12#1)
wall hematoma##3##2##(2010-7#3)
wall hydatidosis##2##2##(2007-12#2)
wall imaging##2##2##(2010-9#2)
wall in a##3##3##(2005-11#1)(2008-7#1)(2012-12#1)
wall in the##3##3##(1990-3#1)(1992-9#1)(2005-7#1)
wall in##16##2##(1990-3#1)(1990-9#1)(1991-1#2)(1991-8#1)(1992-9#1)(1997-8#1)(2005-1#2)(2005-11#1)(2005-3#1)(2005-7#1)(2008-11#1)(2008-7#1)(2012-12#1)(2013-7#1)
wall injuries##3##2##(1991-4#1)(2006-4#1)(2006-6#1)
wall injury##2##2##(2005-10#1)(2011-2#1)
wall invasion##3##2##(1990-9#2)(2009-2#1)
wall is a rare##4##4##(1997-8#1)(2007-12#1)(2007-8#2)
wall is a##6##3##(1997-8#1)(2006-4#1)(2006-7#1)(2007-12#1)(2007-8#2)
wall is observed##2##3##(2008-7#1)(2012-3#1)
wall is##25##2##(1990-5#1)(1991-9#1)(1993-5#1)(1994-7#1)(1997-8#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-12#2)(2007-8#5)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2009-6#1)(2011-1#1)(2012-3#1)
wall jet##2##2##(2008-10#2)
wall materials##4##2##(2008-10#3)(2009-8#1)
wall may##3##2##(1992-9#1)(2008-7#1)(2011-2#1)
wall metabolism##2##2##(2008-10#1)(2013-8#1)
wall motion abnormalities (with##2##4##(1997-6#1)(2011-2#1)
wall motion abnormalities##11##3##(1993-12#2)(1997-6#1)(1997-8#1)(2006-9#1)(2007-8#2)(2010-9#1)(2011-2#1)(2013-1#2)
wall motion abnormality##4##3##(1997-3#3)(2012-2#1)
wall motion analysis##3##3##(1997-1#2)(1997-8#1)
wall motion at##2##3##(1993-2#1)(1997-8#1)
wall motion in##2##3##(2007-8#2)
wall motion##32##2##(1993-12#2)(1993-2#2)(1997-1#5)(1997-3#3)(1997-6#1)(1997-8#4)(2006-9#1)(2007-2#1)(2007-8#5)(2009-4#1)(2009-6#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#3)
wall normal##3##2##(1995-7#1)(2009-11#2)
wall occurred##2##2##(2006-6#1)(2007-8#1)
wall oedema##3##2##(1991-8#1)(2007-3#1)(2011-2#1)
wall of a##3##3##(2005-11#1)(2008-10#1)(2008-9#1)
wall of both##2##3##(2008-5#1)(2011-2#1)
wall of left ventricle##4##4##(2006-6#1)(2008-7#3)
wall of left##5##3##(2006-6#1)(2008-7#4)
wall of the C6 segment##2##5##(2005-5#2)
wall of the bladder##2##4##(2007-12#1)(2008-10#1)
wall of the inferior vena cava and##4##7##(2008-11#4)
wall of the left ventricle##3##5##(2008-10#2)(2013-1#1)
wall of the right##2##4##(2007-8#2)
wall of the urinary bladder##4##5##(1992-8#1)(1997-2#1)(2011-2#1)(2012-2#1)
wall of the##72##3##(1990-11#1)(1992-8#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-8#1)(1996-11#1)(1997-2#1)(1997-8#4)(2005-5#3)(2006-10#1)(2006-12#4)(2006-4#1)(2007-11#2)(2007-12#2)(2007-8#8)(2008-10#7)(2008-11#4)(2008-12#2)(2008-5#2)(2008-7#3)(2008-9#1)(2009-2#2)(2011-1#1)(2011-12#1)(2011-2#4)(2011-7#1)(2012-12#4)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
wall of##106##2##(1990-11#1)(1991-5#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-8#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-8#4)(2005-11#1)(2005-5#3)(2006-10#1)(2006-12#5)(2006-4#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-8#9)(2008-10#13)(2008-11#4)(2008-12#2)(2008-5#5)(2008-7#7)(2008-9#3)(2009-2#3)(2009-4#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#8)(2011-7#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
wall on the##2##3##(2005-11#1)(2007-12#1)
wall on##4##2##(1993-8#1)(2005-11#1)(2007-12#1)(2007-9#1)
wall or##3##2##(2008-10#1)(2011-1#1)(2011-2#1)
wall painting##4##2##(2007-8#2)(2008-10#2)
wall paintings found in##2##4##(2008-10#2)
wall paintings##5##2##(2008-10#5)
wall permeability##2##2##(2008-9#1)(2010-12#1)
wall pore sensilla##2##3##(2007-12#2)
wall pore##3##2##(2007-12#3)
wall proteins and##2##3##(2006-10#1)(2008-5#1)
wall proteins##3##2##(2005-7#1)(2006-10#1)(2008-5#1)
wall reconstruction##13##2##(2008-9#1)(2012-2#12)
wall reflectivity##2##2##(2008-3#2)
wall region##3##2##(2008-5#1)(2008-9#2)
wall remodeling##6##2##(2009-8#2)(2012-12#4)
wall resection##4##2##(2006-6#1)(2007-8#1)(2009-3#2)
wall revealed##2##2##(1991-12#1)(2008-10#1)
wall sarcoma##2##2##(2008-6#2)
wall shear rate##3##3##(2008-9#3)
wall shear stress (WSS)##2##4##(2011-2#1)(2013-1#1)
wall shear stress and##2##4##(2008-5#1)(2010-9#1)
wall shear stress##12##3##(1992-12#1)(2007-9#1)(2008-11#1)(2008-5#1)(2009-11#1)(2009-4#1)(2009-7#1)(2010-9#2)(2011-2#1)(2012-3#1)(2013-1#1)
wall shear stresses##2##3##(2008-11#1)(2009-4#1)
wall shear##17##2##(1992-12#1)(2007-9#1)(2008-11#2)(2008-5#1)(2008-9#3)(2009-11#1)(2009-4#2)(2009-7#1)(2010-9#2)(2011-2#1)(2012-3#1)(2013-1#1)
wall stress of the##2##4##(2006-10#1)(2008-7#1)
wall stress##12##2##(1996-3#1)(2005-9#1)(2006-10#2)(2006-2#1)(2007-11#1)(2008-7#3)(2009-1#1)(2009-4#1)(2009-7#1)
wall surface##3##2##(2008-10#2)(2008-7#1)
wall synthesis##7##2##(1997-4#2)(2006-11#2)(2007-6#1)(2008-3#1)(2009-10#1)
wall temperature##2##2##(2008-2#2)
wall tenderness##2##2##(1991-4#1)(1991-6#1)
wall that##3##2##(2008-10#1)(2008-3#1)(2013-8#1)
wall thickening and##2##3##(2007-7#1)(2008-10#1)
wall thickening##11##2##(1992-5#1)(1997-8#1)(2006-2#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-5#1)(2011-2#1)(2012-2#1)
wall thickness and##3##3##(2007-8#1)(2010-12#1)(2011-2#1)
wall thickness in##2##3##(1997-4#1)(2008-10#1)
wall thickness measurements in##2##4##(2005-10#2)
wall thickness measurements##3##3##(2005-10#3)
wall thickness was##2##3##(2007-8#1)(2011-2#1)
wall thickness##28##2##(1993-12#1)(1997-4#1)(1997-8#1)(2005-10#4)(2007-8#4)(2008-10#4)(2008-12#1)(2008-3#3)(2009-1#1)(2009-11#1)(2009-7#1)(2010-12#1)(2011-2#4)(2012-2#1)
wall thicknesses##2##2##(2008-10#1)(2009-7#1)
wall tissue##2##2##(2008-5#1)(2011-2#1)
wall to the##2##3##(2007-8#1)(2009-7#1)
wall to##12##2##(1997-6#1)(2004-9#1)(2006-6#1)(2007-8#2)(2008-10#2)(2009-12#1)(2009-7#3)(2011-2#1)
wall tuberculosis is##2##3##(2007-8#2)
wall tuberculosis##4##2##(2007-8#4)
wall tumor##3##2##(2006-10#1)(2007-8#1)(2009-3#1)
wall tumors##3##2##(2012-2#3)
wall velocity##3##2##(1995-7#1)(2009-6#2)
wall was performed##2##3##(2008-6#1)(2012-12#1)
wall was##17##2##(1992-12#1)(1995-3#1)(2007-1#1)(2007-8#1)(2008-10#3)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2010-4#1)(2012-12#2)(2012-2#1)
wall were##3##2##(2007-8#1)(2008-5#1)(2013-8#1)
wall which##3##2##(2011-2#1)(2012-2#1)(2013-1#1)
wall with##8##2##(1996-3#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-9#1)(2009-1#1)(2009-6#1)(2012-2#1)
wall without##2##2##(2007-8#1)(2013-8#1)
wall##1114##1##(1990-10#4)(1990-11#5)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#4)(1991-1#3)(1991-10#1)(1991-12#7)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#7)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#2)(1992-6#3)(1992-8#3)(1992-9#4)(1993-1#1)(1993-11#1)(1993-12#6)(1993-2#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#5)(1993-9#2)(1994-1#1)(1994-10#1)(1994-2#2)(1994-3#4)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-3#8)(1995-5#2)(1995-6#6)(1995-7#2)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#8)(1996-12#2)(1996-2#2)(1996-3#4)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#6)(1997-2#4)(1997-3#8)(1997-4#9)(1997-5#1)(1997-6#5)(1997-7#3)(1997-8#17)(2004-1#1)(2004-9#1)(2005-1#4)(2005-10#8)(2005-11#14)(2005-3#1)(2005-5#3)(2005-6#1)(2005-7#4)(2005-8#2)(2005-9#1)(2006-10#15)(2006-11#4)(2006-12#11)(2006-2#5)(2006-4#3)(2006-5#1)(2006-6#14)(2006-7#4)(2006-8#4)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#5)(2007-12#21)(2007-2#7)(2007-3#1)(2007-4#5)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#88)(2007-9#5)(2008-1#1)(2008-10#126)(2008-11#19)(2008-12#8)(2008-2#6)(2008-3#16)(2008-4#12)(2008-5#33)(2008-6#16)(2008-7#35)(2008-8#5)(2008-9#24)(2009-1#5)(2009-10#10)(2009-11#5)(2009-12#5)(2009-2#8)(2009-3#6)(2009-4#9)(2009-5#3)(2009-6#18)(2009-7#16)(2009-8#12)(2009-9#1)(2010-10#6)(2010-12#12)(2010-2#5)(2010-3#3)(2010-4#4)(2010-5#3)(2010-6#2)(2010-7#5)(2010-8#5)(2010-9#8)(2011-1#8)(2011-10#1)(2011-12#1)(2011-2#60)(2011-7#1)(2012-1#8)(2012-12#23)(2012-2#63)(2012-3#4)(2013-1#26)(2013-7#2)(2013-8#12)
wall)##3##1##(1993-3#1)(2007-5#1)(2008-10#1)
wall-bound##2##1##(2008-10#2)
wall-degrading enzymes##4##2##(2008-10#2)(2008-4#1)(2011-1#1)
wall-degrading##5##1##(2008-10#3)(2008-4#1)(2011-1#1)
wall-induced##2##1##(2007-9#1)(2008-5#1)
wall-jet (flow-onto)##2##2##(2008-10#2)
wall-jet amperometric detection##4##3##(1997-1#1)(2008-10#3)
wall-jet cell##3##2##(2008-10#3)
wall-jet configuration##3##2##(2008-10#3)
wall-jet detector##2##2##(2008-10#2)
wall-jet##15##1##(1997-1#1)(2008-10#14)
wall-less prokaryote##2##2##(1992-11#1)(2008-10#1)
wall-less##3##1##(1992-11#1)(2008-10#2)
wall-pore sensilla##3##2##(2008-7#3)
wall-pore##4##1##(2007-12#1)(2008-7#3)
wall-to-lumen ratio##2##2##(1996-7#2)
wall]##6##1##(1990-3#1)(1990-5#1)(1991-5#1)(1992-4#1)(2005-8#1)(2011-2#1)
wallaroos (Macropus robustus)##2##3##(2007-2#2)
walled carbon nanotube##2##3##(2010-7#1)(2010-8#1)
walled carbon nanotubes##4##3##(2010-3#1)(2010-7#2)(2010-8#1)
walled carbon##6##2##(2010-3#1)(2010-7#3)(2010-8#2)
walled##9##1##(2008-7#1)(2010-3#1)(2010-7#3)(2010-8#2)(2012-12#1)(2012-2#1)
walled-off pancreatic necrosis##2##3##(2010-12#1)(2013-1#1)
wallengreni n##3##2##(2013-8#3)
wallichiana##3##1##(2007-1#1)(2008-5#2)
walls after##2##2##(2010-8#1)(2013-7#1)
walls and##17##2##(1990-3#1)(1991-9#1)(1994-3#1)(1996-12#1)(1997-6#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-5#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
walls are##6##2##(1991-6#1)(2007-12#3)(2008-5#1)(2011-2#1)
walls around the##2##3##(2008-11#1)(2013-8#1)
walls by##4##2##(1997-6#1)(2008-11#1)(2008-5#1)(2013-8#1)
walls during##5##2##(2006-12#1)(2006-5#1)(2008-10#1)(2008-11#1)(2009-8#1)
walls in the##3##3##(1996-6#1)(2007-12#1)(2008-10#1)
walls in##10##2##(1995-10#1)(1996-6#1)(2007-12#3)(2007-7#1)(2008-10#3)(2009-6#1)
walls is##2##2##(2008-3#1)(2009-11#1)
walls of a##4##3##(1997-2#1)(2008-10#3)
walls of the##24##3##(1994-9#1)(1996-5#1)(2006-10#1)(2006-12#1)(2007-12#3)(2007-9#1)(2008-10#4)(2008-11#3)(2008-5#3)(2008-6#1)(2008-9#1)(2009-8#2)(2011-1#1)(2012-2#1)
walls of##65##2##(1993-4#1)(1994-9#1)(1996-5#1)(1997-2#1)(2005-10#1)(2006-10#3)(2006-12#2)(2007-12#8)(2007-8#1)(2007-9#1)(2008-10#24)(2008-11#4)(2008-4#1)(2008-5#4)(2008-6#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-8#3)(2011-1#1)(2011-2#1)(2012-2#2)
walls to##2##2##(1993-4#1)(2008-5#1)
walls were##5##2##(2008-10#4)(2012-2#1)
walls with##4##2##(2006-5#1)(2007-8#1)(2008-10#1)(2008-5#1)
walls##238##1##(1990-1#2)(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#5)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-4#2)(1993-9#1)(1994-3#2)(1994-6#1)(1994-9#2)(1995-10#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-9#1)(1997-2#1)(1997-6#3)(1997-7#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#21)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#63)(2008-11#8)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#13)(2008-6#1)(2008-7#6)(2008-9#5)(2009-10#2)(2009-11#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#5)(2009-9#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#2)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#6)
wan##2##1##(2008-4#2)
wand to##2##2##(2012-2#1)(2013-7#1)
wand##3##1##(2006-10#1)(2012-2#1)(2013-7#1)
wander##4##1##(2007-9#1)(2008-1#1)(2008-3#1)(2008-7#1)
wandering behavior##2##2##(1996-5#2)
wandering##11##1##(1995-4#1)(1996-5#3)(2006-12#1)(2007-2#2)(2008-9#1)(2013-8#3)
waned##3##1##(1994-2#1)(2006-4#1)(2013-8#1)
wanes##2##1##(1993-11#1)(2007-9#1)
waning and##2##2##(2006-8#1)(2009-5#1)
waning##5##1##(2006-8#1)(2007-9#1)(2008-2#1)(2008-5#1)(2009-5#1)
want him to##2##3##(1992-3#2)
want the##2##2##(2010-3#1)(2011-1#1)
want their##2##2##(2006-7#1)(2012-3#1)
want to be##10##3##(1991-11#1)(1991-6#1)(1995-12#1)(1997-5#1)(2004-4#1)(2008-1#1)(2009-2#1)(2012-2#2)(2013-8#1)
want to emphasize##2##3##(2012-2#2)
want to get##2##3##(2007-4#1)(2008-2#1)
want to give birth##2##4##(2010-12#1)(2010-9#1)
want to give##3##3##(2008-12#1)(2010-12#1)(2010-9#1)
want to know whether##2##4##(2009-5#1)(2012-3#1)
want to know##3##3##(2008-11#1)(2009-5#1)(2012-3#1)
want to learn##2##3##(1993-3#1)(1994-1#1)
want to lose##2##3##(2007-12#1)(2009-2#1)
want to make##4##3##(2007-9#1)(2008-1#1)(2013-1#2)
want to take##3##3##(1992-9#1)(1993-12#1)(2006-10#1)
want to use##2##3##(2008-4#1)(2011-1#1)
want to work##2##3##(1997-2#1)(2011-1#1)
want to##76##2##(1990-12#1)(1991-11#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-3#4)(1994-1#1)(1994-2#1)(1994-3#2)(1994-7#1)(1995-12#2)(1995-8#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-5#1)(2004-4#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-12#4)(2007-4#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#1)(2009-2#2)(2009-5#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#4)(2013-8#2)
want##112##1##(1990-12#1)(1991-11#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#3)(1992-9#1)(1993-10#1)(1993-12#1)(1993-3#4)(1993-4#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-7#1)(1995-12#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#3)(1997-1#2)(1997-2#2)(1997-4#1)(1997-5#1)(2004-4#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-12#5)(2007-4#2)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#3)(2009-2#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#4)(2013-8#2)
want?##3##1##(1994-12#1)(1995-3#1)(2007-9#1)
wanted more##3##2##(1993-3#1)(1994-8#1)(1997-5#1)
wanted to be##2##3##(2005-8#1)(2013-7#1)
wanted to compare the##3##4##(2008-11#1)(2011-2#1)(2013-1#1)
wanted to compare##4##3##(2008-11#1)(2011-2#2)(2013-1#1)
wanted to determine##4##3##(2005-10#1)(2008-10#1)(2008-4#1)(2013-7#1)
wanted to establish##2##3##(2007-12#1)(2011-12#1)
wanted to know the##2##4##(1993-5#1)(2013-1#1)
wanted to know##3##3##(1993-5#1)(2008-9#1)(2013-1#1)
wanted to pursue postgraduation##2##4##(2013-1#2)
wanted to##43##2##(1990-2#1)(1991-7#1)(1992-11#1)(1993-5#1)(1995-5#2)(1995-6#1)(2005-10#1)(2005-8#1)(2006-2#2)(2006-6#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#1)(2012-2#1)(2013-1#5)(2013-7#2)
wanted##55##1##(1990-2#1)(1991-7#1)(1992-11#1)(1992-4#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-8#1)(1995-5#2)(1995-6#1)(1996-11#1)(1997-5#1)(2005-10#1)(2005-8#1)(2006-2#2)(2006-6#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#1)(2012-2#1)(2013-1#5)(2013-7#2)
wanting the pregnancy##2##3##(2010-3#1)(2013-1#1)
wanting to be##2##3##(2006-10#1)(2010-3#1)
wanting to##8##2##(1992-8#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-7#1)(2008-12#1)(2008-9#1)(2010-3#1)
wanting##14##1##(1992-8#1)(2005-4#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-3#1)(2007-7#1)(2008-12#1)(2008-9#1)(2010-3#2)(2012-11#1)(2013-1#1)
wants to be##3##3##(2005-12#1)(2007-10#1)(2009-10#1)
wants to know what##2##4##(2006-7#1)(2007-7#1)
wants to##19##2##(1992-6#1)(1993-7#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-5#1)(1996-8#2)(2005-12#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2009-10#1)(2013-7#1)
wants##30##1##(1992-3#1)(1992-6#1)(1993-7#1)(1994-12#1)(1995-2#1)(1995-5#2)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-8#2)(1997-3#2)(2005-11#1)(2005-12#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2009-10#1)(2009-5#1)(2012-12#1)(2013-7#1)
war and the##3##3##(2008-8#1)(2010-12#1)(2013-8#1)
war and##12##2##(1990-12#1)(1994-9#1)(1995-4#1)(1997-6#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-12#1)(2013-1#2)(2013-8#1)
war but##2##2##(2008-4#1)(2013-8#1)
war in##6##2##(1993-10#1)(1993-9#1)(1995-4#1)(2005-9#1)(2008-11#1)(2011-1#1)
war of##2##2##(2007-9#1)(2008-6#1)
war on drugs##3##3##(1991-3#1)(2007-3#2)
war on the##2##3##(1993-1#1)(2006-10#1)
war on##9##2##(1991-3#1)(1992-3#1)(1993-1#1)(1996-11#1)(2006-10#1)(2006-8#1)(2007-3#2)(2009-9#1)
war related##2##2##(2004-7#1)(2012-1#1)
war veterans##2##2##(1995-4#1)(1996-3#1)
war##93##1##(1990-12#2)(1990-6#2)(1991-2#1)(1991-3#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-1#2)(1993-10#2)(1993-6#1)(1993-9#1)(1994-3#1)(1994-9#2)(1995-1#1)(1995-4#8)(1995-7#1)(1995-9#1)(1996-11#1)(1996-3#2)(1997-5#1)(1997-6#3)(2004-7#1)(2005-8#1)(2005-9#2)(2006-10#3)(2006-4#1)(2006-8#1)(2007-11#1)(2007-3#2)(2007-7#5)(2007-9#3)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-3#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
war)##2##1##(1994-3#1)(2007-11#1)
war]##2##1##(2011-1#2)
ward after##4##2##(2007-11#2)(2007-8#1)(2011-12#1)
ward and in##2##3##(1992-6#1)(2008-11#1)
ward and the##2##3##(2008-11#1)(2010-3#1)
ward and then##2##3##(2008-6#1)(2012-2#1)
ward and##9##2##(1992-6#1)(2005-1#1)(2008-11#2)(2008-6#1)(2008-7#2)(2010-3#1)(2012-2#1)
ward areas##3##2##(2006-1#1)(2007-9#1)(2008-11#1)
ward in the##2##3##(2007-12#1)(2011-2#1)
ward in##7##2##(1991-8#1)(1993-12#1)(2007-12#2)(2011-2#2)(2012-3#1)
ward of the##2##3##(1990-8#1)(2008-2#1)
ward of##7##2##(1990-8#1)(1993-2#1)(1995-9#1)(2007-2#1)(2008-2#1)(2009-7#1)(2011-2#1)
ward situations##2##2##(2011-1#2)
ward staff##6##2##(2007-10#1)(2011-1#2)(2012-2#2)(2013-8#1)
ward stay than##2##3##(2007-8#1)(2010-8#1)
ward stay##5##2##(2007-8#4)(2010-8#1)
ward stock##3##2##(2010-3#3)
ward visits by a pharmacist##2##5##(2010-3#2)
ward with##3##2##(2005-1#1)(2006-2#1)(2012-1#1)
ward##134##1##(1990-12#1)(1990-3#3)(1990-4#1)(1990-8#1)(1991-2#3)(1991-3#1)(1991-8#1)(1992-4#1)(1992-6#2)(1993-12#1)(1993-2#2)(1993-5#1)(1993-6#1)(1995-4#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1997-3#1)(2004-10#2)(2005-1#2)(2005-8#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-4#1)(2007-10#2)(2007-11#5)(2007-12#2)(2007-2#2)(2007-3#3)(2007-4#2)(2007-7#2)(2007-8#7)(2007-9#2)(2008-11#7)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-6#1)(2009-7#1)(2010-3#10)(2010-5#1)(2010-6#1)(2010-8#9)(2011-1#4)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#6)(2013-8#8)
ward-based guideline##4##2##(2007-9#4)
ward-based##5##1##(2007-9#4)(2010-8#1)
wards and in the##2##4##(2008-8#1)(2013-8#1)
wards and##7##2##(2007-3#1)(2008-8#1)(2009-4#1)(2010-3#1)(2013-8#3)
wards as##3##2##(1993-9#1)(2013-1#2)
wards for##2##2##(2007-8#1)(2008-6#1)
wards in a##2##3##(1992-10#1)(2007-10#1)
wards in##5##2##(1992-10#1)(2004-10#1)(2007-10#1)(2008-10#1)(2008-3#1)
wards of the##3##3##(2006-2#1)(2007-2#1)(2012-2#1)
wards of##9##2##(1995-9#1)(2006-1#1)(2006-2#1)(2007-2#1)(2008-10#1)(2010-8#1)(2011-2#2)(2012-2#1)
wards that##3##2##(2008-7#1)(2013-1#2)
wards were##4##2##(1997-8#1)(2013-1#2)(2013-8#1)
wards##86##1##(1990-10#1)(1990-4#1)(1990-8#1)(1992-10#2)(1992-6#5)(1993-9#1)(1995-9#1)(1996-2#1)(1997-8#2)(2004-10#1)(2005-8#1)(2006-1#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-8#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-3#9)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#5)(2013-1#14)(2013-8#6)
wards]##2##1##(1994-6#1)(2013-1#1)
wardship##2##1##(1991-8#1)(2008-8#1)
ware false##2##2##(2011-2#2)
ware##6##1##(2008-10#3)(2011-2#3)
warehouse for##2##2##(1997-3#1)(2007-5#1)
warehouse##17##1##(1997-3#1)(2007-12#5)(2007-5#1)(2008-2#2)(2013-1#8)
warehouses##4##1##(2009-5#1)(2010-4#1)(2013-1#2)
warehousing##4##1##(2008-4#2)(2008-7#2)
warfare agent##8##2##(2006-7#1)(2007-9#1)(2008-10#1)(2008-11#5)
warfare agents##7##2##(2008-10#1)(2008-11#5)(2008-4#1)
warfare in##2##2##(1993-12#1)(1995-1#1)
warfare##32##1##(1990-2#2)(1991-3#1)(1992-12#5)(1992-3#1)(1993-12#1)(1995-1#1)(1997-3#1)(2006-7#1)(2007-12#3)(2007-9#1)(2008-10#2)(2008-11#10)(2008-4#2)(2011-1#1)
warfarin and antiplatelets##5##3##(2007-10#5)
warfarin and##10##2##(1994-5#1)(1995-1#1)(2007-10#5)(2008-1#1)(2008-8#1)(2013-8#1)
warfarin anticoagulation##3##2##(2006-10#1)(2006-8#2)
warfarin dose##2##2##(2008-12#1)(2008-5#1)
warfarin for##2##2##(2007-10#1)(2012-12#1)
warfarin in patients with##2##4##(2006-8#1)(2007-8#1)
warfarin in patients##3##3##(1990-12#1)(2006-8#1)(2007-8#1)
warfarin in the##2##3##(2011-1#1)(2012-12#1)
warfarin in##8##2##(1990-12#2)(2006-8#1)(2007-10#1)(2007-8#1)(2010-4#1)(2011-1#1)(2012-12#1)
warfarin is##2##2##(1995-1#1)(2010-8#1)
warfarin on##2##2##(1990-12#1)(1995-1#1)
warfarin or antiplatelets##2##3##(2007-10#2)
warfarin or##6##2##(1992-3#1)(2007-10#3)(2008-3#1)(2013-1#1)
warfarin therapy for a##2##4##(2007-3#2)
warfarin therapy##8##2##(2006-9#1)(2007-10#2)(2007-3#2)(2010-12#1)(2012-1#2)
warfarin treatment##2##2##(2005-1#1)(2012-12#1)
warfarin was##4##2##(2007-10#1)(2008-10#1)(2008-5#1)(2011-1#1)
warfarin were##2##2##(2006-8#2)
warfarin##121##1##(1990-12#10)(1990-9#1)(1991-12#1)(1992-3#1)(1994-5#6)(1995-1#5)(1995-9#1)(2005-1#1)(2005-7#3)(2006-10#2)(2006-8#10)(2006-9#1)(2007-10#16)(2007-11#1)(2007-2#1)(2007-3#2)(2007-8#5)(2008-1#3)(2008-10#3)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#5)(2008-8#3)(2009-11#2)(2010-12#1)(2010-4#2)(2010-8#1)(2011-1#6)(2011-2#1)(2012-1#3)(2012-12#9)(2013-1#2)(2013-8#7)
warfarin-induced skin necrosis##2##3##(2011-2#2)
warfarin-induced##3##1##(2011-2#2)(2013-1#1)
warheads##2##1##(2007-9#2)
warm and dry##2##3##(2011-12#1)(2012-6#1)
warm and##10##2##(1991-8#1)(2005-12#1)(2008-10#1)(2008-9#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-6#1)(2013-8#1)
warm blood cardioplegia##6##3##(1991-3#2)(1996-9#3)(2007-8#1)
warm climates##2##2##(1995-9#1)(2005-11#1)
warm induction and##3##3##(2007-8#3)
warm on cold##2##3##(1990-2#2)
warm period##2##2##(2007-8#1)(2012-2#1)
warm season##4##2##(2008-10#3)(2011-12#1)
warm water##2##2##(2007-8#1)(2008-3#1)
warm winters##2##2##(2008-10#1)(2012-4#1)
warm##80##1##(1990-12#1)(1990-2#3)(1991-3#2)(1991-8#2)(1993-12#2)(1993-3#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-9#3)(1997-7#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-5#1)(2007-12#2)(2007-5#1)(2007-8#8)(2007-9#1)(2008-10#10)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-3#2)(2009-9#1)(2010-12#1)(2011-12#4)(2011-2#1)(2012-12#6)(2012-2#3)(2012-4#3)(2012-6#1)(2012-7#1)(2013-8#1)
warm-blooded##3##1##(1994-12#1)(2008-5#1)(2011-2#1)
warm-up##4##1##(2008-10#1)(2008-2#1)(2009-1#1)(2013-1#1)
warmed to##2##2##(1994-11#1)(1994-12#1)
warmed##4##1##(1990-7#1)(1994-11#1)(1994-12#1)(2006-5#1)
warmer and drier##3##3##(2008-10#2)(2012-7#1)
warmer and##5##2##(2008-10#3)(2012-7#2)
warmer locations##3##2##(2008-10#3)
warmer temperatures##3##2##(2008-10#2)(2008-5#1)
warmer than##2##2##(2007-2#1)(2008-8#1)
warmer##22##1##(2006-5#1)(2007-2#1)(2008-10#10)(2008-5#1)(2008-8#1)(2009-11#1)(2010-8#1)(2012-2#1)(2012-5#2)(2012-7#2)(2013-1#1)
warmest##2##1##(1990-3#1)(2013-7#1)
warming and##8##2##(1996-8#1)(2007-9#1)(2012-5#3)(2012-6#2)(2012-7#1)
warming had##2##2##(1994-12#1)(2012-5#1)
warming of the##3##3##(1994-12#1)(2007-8#2)
warming of##6##2##(1990-8#1)(1994-12#1)(2006-4#1)(2007-8#2)(2012-5#1)
warming to##3##2##(1994-12#1)(1996-2#1)(2013-8#1)
warming##77##1##(1990-3#2)(1990-8#2)(1992-1#1)(1992-3#3)(1993-4#1)(1994-12#7)(1995-3#1)(1996-1#1)(1996-2#1)(1996-8#1)(2005-1#1)(2006-4#1)(2006-5#1)(2007-12#1)(2007-8#6)(2007-9#6)(2008-12#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-5#8)(2012-6#11)(2012-7#2)(2012-8#1)(2012-9#4)(2013-7#1)(2013-8#4)
warmly##2##1##(1996-1#1)(2009-5#1)
warmth and competence##2##3##(2009-11#2)
warmth and##6##2##(2006-10#1)(2008-11#1)(2009-11#4)
warmth in##2##2##(2006-10#1)(2009-9#1)
warmth on the##2##3##(1997-5#1)(2012-3#1)
warmth on##3##2##(1997-5#1)(2010-1#1)(2012-3#1)
warmth##30##1##(1996-6#1)(1997-5#1)(2004-11#3)(2006-10#2)(2007-10#2)(2008-1#1)(2008-11#2)(2009-11#9)(2009-9#1)(2010-1#6)(2010-3#1)(2012-3#1)
warn of##2##2##(1990-3#1)(2013-1#1)
warn that##2##2##(1996-11#1)(2007-9#1)
warn us of##2##3##(2008-7#1)(2008-8#1)
warn##16##1##(1990-3#1)(1992-11#1)(1993-2#1)(1993-4#1)(1994-3#1)(1996-11#1)(1997-1#1)(2007-9#3)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
warned of##4##2##(1991-6#1)(2007-2#1)(2007-9#1)(2008-12#1)
warned##9##1##(1991-12#1)(1991-6#1)(1996-6#1)(2006-8#1)(2007-2#1)(2007-9#1)(2008-11#1)(2008-12#1)(2011-1#1)
warning about##3##2##(2007-1#1)(2008-10#1)(2013-1#1)
warning and##2##2##(2009-8#1)(2011-12#1)
warning in##2##2##(2008-10#1)(2010-8#1)
warning index##3##2##(2008-8#3)
warning of##3##2##(2005-5#1)(2006-7#1)(2008-10#1)
warning on##3##2##(2004-8#1)(2008-3#1)(2012-1#1)
warning sign of##2##3##(2006-7#1)(2010-12#1)
warning signs of##6##3##(1992-1#1)(2007-9#1)(2008-11#1)(2008-3#1)(2011-1#1)(2013-1#1)
warning signs##13##2##(1992-1#1)(1996-12#1)(1996-8#1)(2007-2#1)(2007-9#2)(2008-11#1)(2008-12#1)(2008-3#2)(2009-6#1)(2011-1#1)(2013-1#1)
warning system was##2##3##(2008-10#2)
warning system##9##2##(2008-10#6)(2008-8#1)(2012-12#1)(2012-2#1)
warning systems for##2##3##(2008-10#1)(2010-4#1)
warning systems##8##2##(1991-12#1)(2008-10#5)(2010-4#1)(2011-12#1)
warning to##2##2##(1990-12#1)(2008-3#1)
warning was##2##2##(2013-1#1)(2013-8#1)
warning##86##1##(1990-12#2)(1991-12#1)(1992-1#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-5#1)(1994-7#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-8#1)(2004-8#1)(2005-11#1)(2005-5#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-2#1)(2007-9#2)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#4)(2008-7#1)(2008-8#5)(2009-10#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#5)(2010-3#1)(2010-4#1)(2010-8#4)(2011-1#1)(2011-12#2)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#3)
warnings and##2##2##(2010-12#1)(2012-2#1)
warnings in the##2##3##(2006-10#1)(2006-2#1)
warnings##16##1##(2006-10#2)(2006-2#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#3)(2013-1#2)(2013-7#1)
warns about##3##2##(1992-8#1)(2007-1#1)(2013-1#1)
warns of##2##2##(1993-8#1)(2010-12#1)
warns the##2##2##(1992-2#1)(2013-1#1)
warns##9##1##(1992-2#1)(1992-8#1)(1993-8#1)(2007-1#1)(2008-5#1)(2010-12#1)(2013-1#3)
warp##2##1##(2008-12#1)(2012-1#1)
warping##3##1##(2006-11#1)(2008-6#1)(2010-8#1)
warps##2##1##(2008-3#1)(2009-7#1)
warrant a##4##2##(2006-9#1)(2010-8#1)(2011-2#2)
warrant an examination##2##3##(2007-5#1)(2008-1#1)
warrant extensive##2##2##(1991-4#1)(2007-7#1)
warrant further investigation##6##3##(1992-2#1)(2007-8#1)(2009-10#1)(2010-5#1)(2012-2#1)(2013-1#1)
warrant further research##3##3##(2006-10#1)(2010-10#1)(2010-2#1)
warrant further study##4##3##(2008-4#1)(2008-6#1)(2012-2#1)(2013-8#1)
warrant further##22##2##(1992-2#1)(1996-2#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-10#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2012-1#1)(2012-2#3)(2013-1#1)(2013-8#1)
warrant its##2##2##(2006-7#1)(2008-11#1)
warrant the##4##2##(1995-6#1)(2007-6#1)(2008-10#1)(2012-12#1)
warrant##68##1##(1991-10#1)(1991-4#1)(1992-2#1)(1993-10#1)(1994-3#3)(1994-9#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-3#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-9#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2009-10#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
warranted and##6##2##(1991-12#1)(1996-3#1)(2006-2#1)(2008-11#1)(2010-5#1)(2011-2#1)
warranted as##3##2##(2006-4#1)(2007-8#1)(2008-10#1)
warranted for a##2##3##(2012-1#1)(2012-2#1)
warranted for##9##2##(1996-2#1)(1996-3#1)(2006-10#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#2)
warranted in patients##2##3##(2007-9#1)(2008-7#1)
warranted in##12##2##(1990-10#1)(1992-11#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-9#1)(2012-1#1)
warranted to assess##4##3##(2006-10#1)(2006-9#1)(2007-5#1)(2012-1#1)
warranted to confirm##5##3##(2006-6#1)(2008-5#1)(2011-2#1)(2012-12#2)
warranted to determine##3##3##(2008-10#1)(2008-7#1)(2009-4#1)
warranted to elucidate the##3##4##(2005-8#1)(2006-10#1)(2007-8#1)
warranted to further##2##3##(2007-9#1)(2008-5#1)
warranted to improve##2##3##(2008-4#1)(2012-1#1)
warranted to investigate##2##3##(1995-12#1)(2008-6#1)
warranted to reduce##2##3##(2007-3#1)(2013-1#1)
warranted to##37##2##(1992-12#1)(1995-12#1)(2005-8#2)(2006-1#1)(2006-10#3)(2006-6#1)(2006-9#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2009-4#1)(2010-4#1)(2011-2#2)(2012-1#2)(2012-12#2)(2013-1#2)
warranted using##2##2##(2007-11#1)(2012-3#1)
warranted##171##1##(1990-10#1)(1990-12#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-4#1)(1994-3#1)(1994-9#1)(1995-10#2)(1995-12#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-2#1)(1997-8#1)(2004-10#1)(2004-3#1)(2005-10#1)(2005-8#2)(2006-1#1)(2006-10#8)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#2)(2006-7#2)(2006-8#3)(2006-9#1)(2007-10#3)(2007-11#4)(2007-12#2)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#6)(2007-9#2)(2008-10#6)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#11)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#4)(2012-12#5)(2012-2#5)(2012-3#4)(2013-1#8)(2013-7#1)
warranting a##2##2##(1992-12#1)(2008-9#1)
warranting##9##1##(1992-12#1)(2007-7#1)(2007-9#1)(2008-7#1)(2008-9#1)(2009-11#1)(2011-1#1)(2013-1#2)
warrants a##6##2##(2006-1#1)(2008-7#1)(2009-5#1)(2009-9#1)(2013-1#2)
warrants an examination of##2##4##(1991-12#1)(2008-11#1)
warrants consideration##5##2##(1990-12#1)(2007-2#1)(2008-7#1)(2010-11#1)(2013-1#1)
warrants further evaluation##2##3##(2007-8#1)(2010-7#1)
warrants further investigation##10##3##(2006-10#2)(2006-5#1)(2008-5#1)(2009-8#1)(2012-12#1)(2013-1#4)
warrants further study##4##3##(1996-8#1)(2008-10#1)(2008-5#1)(2012-2#1)
warrants further##22##2##(1993-4#1)(1996-8#1)(2005-11#2)(2006-10#2)(2006-5#1)(2007-8#1)(2008-10#1)(2008-5#2)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
warrants its##2##2##(2008-5#1)(2012-2#1)
warrants research##2##2##(2008-6#1)(2012-2#1)
warrants the development of novel approaches##2##6##(2007-6#1)(2013-8#1)
warrants the need for##2##4##(2010-7#1)(2013-8#1)
warrants the##6##2##(2007-6#1)(2007-8#1)(2010-7#1)(2011-1#1)(2013-8#2)
warrants urgent##2##2##(2007-8#1)(2011-2#1)
warrants##57##1##(1990-12#1)(1990-8#1)(1991-12#1)(1993-4#1)(1996-12#1)(1996-8#1)(1996-9#1)(2005-11#2)(2006-1#1)(2006-10#3)(2006-5#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-8#4)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#7)(2013-8#2)
warrior##4##1##(1991-11#1)(2006-7#1)(2010-12#2)
wars##27##1##(1991-10#1)(1991-3#2)(1992-8#1)(2004-3#1)(2005-10#1)(2006-4#1)(2006-7#2)(2007-4#7)(2007-7#5)(2008-3#2)(2008-4#1)(2008-7#2)(2011-1#1)
wart##4##1##(2007-11#2)(2007-7#1)(2010-12#1)
wartime##8##1##(1992-3#1)(1993-1#1)(2007-12#2)(2007-7#1)(2009-4#1)(2011-2#1)(2012-2#1)
warts and##2##2##(2005-7#1)(2008-4#1)
warts in##3##2##(1996-1#1)(2005-11#1)(2010-12#1)
warts##39##1##(1993-8#1)(1996-1#2)(2005-11#2)(2005-7#1)(2006-10#1)(2006-12#1)(2007-11#9)(2007-12#5)(2007-3#1)(2007-7#2)(2008-4#4)(2010-12#2)(2011-1#2)(2011-2#1)(2013-1#5)
warty##2##1##(2007-7#1)(2007-8#1)
was $5##2##2##(1994-9#1)(1995-1#1)
was &gt##42##2##(1993-1#1)(1994-8#1)(1994-9#1)(1995-7#1)(1996-2#1)(1996-7#1)(2005-10#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-11#2)(2008-10#9)(2008-11#1)(2008-12#2)(2008-5#6)(2008-6#1)(2009-2#2)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#5)(2012-1#1)
was &lt##47##2##(1994-2#1)(1994-9#2)(1995-1#1)(1996-12#1)(1996-7#1)(1997-8#1)(2005-10#2)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-8#3)(2008-10#19)(2008-3#1)(2008-9#1)(2010-4#3)(2010-8#1)(2011-2#1)(2013-1#3)(2013-8#1)
was &quot##18##2##(1990-2#2)(1990-6#1)(1991-4#1)(2006-10#1)(2006-12#1)(2008-11#1)(2008-2#2)(2008-5#1)(2009-10#1)(2010-1#1)(2011-12#1)(2011-2#3)(2012-3#1)(2013-7#1)
was (0##5##2##(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#2)
was (1)##2##2##(1990-11#1)(1991-3#1)
was (i)##4##2##(1997-8#2)(2008-5#1)(2011-2#1)
was (mean +/-##2##3##(1996-4#1)(2013-8#1)
was +/-0##3##2##(2008-10#3)
was +/-1##2##2##(2008-10#1)(2008-2#1)
was -0##9##2##(2007-11#1)(2008-10#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#2)
was -1##5##2##(2008-10#1)(2010-8#2)(2013-8#2)
was -18##2##2##(1992-10#1)(2006-10#1)
was -2##2##2##(2008-5#1)(2011-1#1)
was 0##647##2##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-9#2)(1991-1#4)(1991-11#3)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#3)(1991-7#5)(1991-8#3)(1991-9#1)(1992-1#1)(1992-10#3)(1992-11#1)(1992-2#6)(1992-6#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#3)(1994-3#5)(1994-9#2)(1995-1#3)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#3)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#2)(1996-6#4)(1996-7#2)(1996-8#4)(1997-1#2)(1997-3#3)(1997-4#2)(1997-7#1)(1997-8#3)(2004-1#1)(2004-10#2)(2005-10#1)(2005-11#3)(2005-12#6)(2005-3#1)(2005-4#8)(2006-10#3)(2006-12#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#3)(2006-8#1)(2006-9#1)(2007-1#3)(2007-10#3)(2007-11#5)(2007-12#8)(2007-2#2)(2007-3#5)(2007-4#2)(2007-5#3)(2007-7#5)(2007-8#23)(2007-9#1)(2008-1#5)(2008-10#222)(2008-11#4)(2008-12#6)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#9)(2008-6#2)(2008-7#5)(2008-8#6)(2008-9#5)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#3)(2009-9#2)(2010-1#1)(2010-12#6)(2010-2#2)(2010-4#5)(2010-5#1)(2010-7#1)(2010-8#4)(2010-9#5)(2011-1#20)(2011-11#1)(2011-12#1)(2011-2#14)(2011-3#1)(2012-1#4)(2012-11#3)(2012-12#14)(2012-2#6)(2012-3#6)(2013-1#26)(2013-7#3)(2013-8#18)
was 0%##7##2##(1990-2#1)(1991-2#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-6#1)(2011-1#1)
was 1 and##3##3##(2008-10#2)(2008-5#1)
was 1 fg##2##3##(1997-3#1)(2008-10#1)
was 1 h##2##3##(1993-11#1)(1995-3#1)
was 1 in##2##3##(2004-10#1)(2013-1#1)
was 1 microM##2##3##(1992-6#1)(1997-3#1)
was 1 mol of S-1 per##2##6##(1991-5#2)
was 1 mol of##3##4##(1991-5#2)(1994-9#1)
was 1 ng/ml##3##3##(1997-3#2)(2008-10#1)
was 1##383##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-4#1)(1990-5#3)(1990-6#1)(1990-8#2)(1991-12#1)(1991-2#4)(1991-3#3)(1991-5#4)(1991-7#4)(1991-8#3)(1991-9#5)(1992-10#1)(1992-2#4)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#2)(1992-9#1)(1993-11#2)(1993-3#3)(1993-8#4)(1993-9#2)(1994-11#1)(1994-12#3)(1994-3#1)(1994-8#1)(1994-9#5)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-6#2)(1995-7#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-8#4)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-6#1)(1997-7#3)(1997-8#2)(1997-9#1)(2004-10#1)(2005-10#2)(2005-11#3)(2005-12#3)(2005-4#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#3)(2007-11#5)(2007-2#4)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#8)(2007-8#17)(2007-9#3)(2008-1#2)(2008-10#91)(2008-11#3)(2008-12#4)(2008-2#4)(2008-3#4)(2008-5#7)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#1)(2010-12#6)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#1)(2011-1#8)(2011-11#1)(2011-12#2)(2011-2#10)(2011-3#1)(2012-1#1)(2012-12#8)(2012-2#4)(2012-3#11)(2013-1#11)(2013-7#1)(2013-8#6)
was 1%##3##2##(1990-5#1)(1997-8#1)(2011-3#1)
was 1-10##2##2##(2008-10#2)
was 10 mm##3##3##(2008-10#1)(2008-3#1)(2011-1#1)
was 10 months (range##2##4##(1990-8#1)(2013-8#1)
was 10 months##7##3##(1990-2#1)(1990-8#1)(1991-4#1)(2005-1#1)(2008-6#2)(2013-8#1)
was 10 ng##2##3##(1990-2#1)(2008-10#1)
was 10 ng/ml and the##2##5##(1991-2#1)(1997-8#1)
was 10 ng/ml for##2##4##(1993-2#1)(1996-6#1)
was 10 ng/ml##7##3##(1991-2#1)(1993-2#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-8#1)(2008-11#1)
was 10 times##2##3##(1994-12#1)(1994-9#1)
was 10 years##7##3##(1991-12#1)(1993-12#1)(2007-8#2)(2008-5#1)(2008-6#1)(2011-2#1)
was 10##103##2##(1990-2#2)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-10#1)(2005-1#1)(2005-12#1)(2006-1#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-3#4)(2008-5#2)(2008-6#4)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-9#1)(2011-1#2)(2011-2#4)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
was 10% in##2##3##(1996-9#1)(2011-2#1)
was 10%##9##2##(1991-8#1)(1993-2#1)(1996-9#1)(2005-10#1)(2007-12#1)(2009-9#1)(2010-6#1)(2011-12#1)(2011-2#1)
was 10(-5) M##2##3##(1992-6#1)(2008-10#1)
was 10(2)##2##2##(1991-10#1)(2013-8#1)
was 10(4)##2##2##(2007-11#1)(2007-12#1)
was 10(5)##2##2##(1992-7#1)(2008-10#1)
was 10-fold higher##2##3##(1992-2#1)(1995-10#1)
was 10-fold##5##2##(1991-3#1)(1992-2#1)(1995-10#1)(1995-5#1)(2011-2#1)
was 100##12##2##(1991-8#1)(1993-6#1)(1993-9#1)(1994-3#1)(2008-10#4)(2008-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
was 100% and##4##3##(2006-12#1)(2007-8#1)(2008-8#1)(2010-6#1)
was 100% at the##2##4##(1997-3#1)(2008-11#1)
was 100% at##3##3##(1997-3#1)(2008-11#1)(2008-2#1)
was 100% for##4##3##(1992-7#1)(2008-1#1)(2011-12#1)(2013-1#1)
was 100% higher than that##2##5##(2008-11#1)(2013-8#1)
was 100% in##3##3##(1994-12#1)(1997-3#1)(2012-3#1)
was 100% with##2##3##(2007-2#1)(2008-9#1)
was 100%##49##2##(1990-10#1)(1991-2#1)(1991-4#1)(1992-10#1)(1992-3#1)(1992-7#1)(1994-12#1)(1997-2#1)(1997-3#2)(2005-10#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-3#1)(2010-3#2)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#1)
was 101##5##2##(1992-11#1)(2007-8#2)(2008-10#1)(2013-1#1)
was 102##3##2##(1991-1#1)(2006-7#1)(2010-3#1)
was 105##3##2##(2004-11#1)(2007-1#1)(2007-12#1)
was 107##4##2##(1991-12#1)(1993-8#1)(2007-12#1)(2008-1#1)
was 11 months (range##3##4##(1990-8#1)(1991-6#1)(2008-10#1)
was 11 months##7##3##(1990-8#1)(1991-12#1)(1991-6#1)(1992-3#1)(1993-2#1)(2008-10#1)(2008-6#1)
was 11##50##2##(1990-11#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-6#2)(1992-3#1)(1992-5#1)(1992-7#1)(1993-2#1)(1994-11#1)(1995-3#1)(1996-9#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-6#1)(2007-7#4)(2007-8#3)(2008-10#6)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
was 11%##8##2##(1990-6#1)(1992-1#1)(1993-7#1)(1994-5#1)(1996-12#1)(2007-8#1)(2008-10#1)(2010-3#1)
was 110##3##2##(2005-10#1)(2007-8#1)(2012-3#1)
was 113##2##2##(2007-12#1)(2007-7#1)
was 117##2##2##(1990-7#1)(2006-6#1)
was 119##2##2##(1997-5#1)(2013-8#1)
was 12 months##8##3##(1990-2#1)(1991-9#1)(1994-11#1)(1996-4#1)(2007-11#1)(2007-2#1)(2007-7#1)(2010-12#1)
was 12 ng##2##3##(2008-10#2)
was 12##53##2##(1990-2#2)(1991-9#1)(1992-2#1)(1993-2#2)(1994-11#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-7#2)(2007-8#1)(2008-10#8)(2008-3#2)(2008-6#1)(2008-7#3)(2009-4#2)(2010-12#1)(2011-1#1)(2011-11#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#4)
was 12%##7##2##(1994-3#1)(1996-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-11#1)(2011-2#1)
was 120##3##2##(2008-10#2)(2008-8#1)
was 124##2##2##(1990-12#1)(2009-3#1)
was 126##3##2##(1995-3#1)(2007-7#1)(2013-1#1)
was 128##3##2##(2007-2#1)(2008-7#1)(2011-1#1)
was 129##3##2##(2004-2#1)(2007-12#1)(2007-8#1)
was 13 months##3##3##(1991-6#1)(2005-7#1)(2008-10#1)
was 13 ng##2##3##(2008-10#2)
was 13 years##2##3##(2007-7#1)(2013-8#1)
was 13##45##2##(1991-12#1)(1991-6#1)(1993-3#1)(1996-12#1)(1997-1#1)(2005-7#1)(2005-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#5)
was 13% and##2##3##(1990-6#1)(2005-9#1)
was 13%##8##2##(1990-6#1)(2005-9#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-6#1)(2008-9#1)(2013-1#1)
was 133##3##2##(1990-8#1)(2007-7#1)(2008-8#1)
was 134##2##2##(1990-11#1)(1993-7#1)
was 138##2##2##(2008-5#1)(2013-8#1)
was 14 days##3##3##(1993-1#1)(2007-2#1)(2007-7#1)
was 14 months##3##3##(1991-10#1)(2008-6#1)(2010-12#1)
was 14 years##2##3##(2006-4#1)(2007-7#1)
was 14##53##2##(1990-12#2)(1991-10#1)(1992-3#1)(1992-7#1)(1993-1#1)(1993-9#1)(1995-1#1)(1995-6#1)(1995-8#1)(1997-8#1)(2004-10#2)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-2#2)(2007-5#2)(2007-7#3)(2007-8#3)(2007-9#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-12#1)(2011-11#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
was 14%##7##2##(1990-12#1)(2005-10#1)(2007-10#2)(2007-12#1)(2007-8#1)(2011-1#1)
was 143##2##2##(1994-3#1)(2008-10#1)
was 149##2##2##(2007-7#1)(2007-9#1)
was 15 +/-##2##3##(2007-3#1)(2008-5#1)
was 15 days##2##3##(1990-12#1)(2013-1#1)
was 15 years##3##3##(2007-7#3)
was 15##53##2##(1990-12#1)(1991-1#1)(1992-3#2)(1992-4#2)(1994-9#1)(1995-11#1)(1995-6#1)(1997-3#1)(1997-4#1)(2005-1#1)(2006-11#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-7#4)(2007-8#2)(2008-10#6)(2008-5#4)(2008-6#2)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-2#2)(2013-1#6)(2013-8#1)
was 15%##5##2##(1991-11#1)(2006-8#1)(2007-2#1)(2013-1#1)(2013-8#1)
was 150##8##2##(2007-12#2)(2007-7#1)(2008-10#2)(2012-12#3)
was 1500##2##2##(2008-2#1)(2008-3#1)
was 151##4##2##(1997-5#2)(2011-12#1)(2013-1#1)
was 157##2##2##(1991-12#1)(2008-7#1)
was 16 and##2##3##(2006-9#1)(2013-1#1)
was 16 months##2##3##(1993-5#1)(2007-8#1)
was 16##46##2##(1990-8#1)(1991-1#1)(1991-8#2)(1992-7#1)(1993-5#1)(1994-6#1)(1997-5#1)(2004-9#1)(2006-1#1)(2006-11#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#2)(2009-10#1)(2009-5#2)(2009-6#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#3)
was 16% in##2##3##(2006-8#1)(2008-8#1)
was 16%##4##2##(2006-8#1)(2008-8#1)(2008-9#1)(2011-2#1)
was 160##3##2##(1990-7#1)(1991-12#1)(1991-8#1)
was 166##3##2##(2006-10#1)(2008-1#1)(2008-3#1)
was 17 months##4##3##(2007-7#1)(2007-8#2)(2008-10#1)
was 17 years old##2##4##(2006-1#1)(2008-6#1)
was 17##39##2##(1990-8#1)(1990-9#1)(1991-2#1)(1992-10#2)(1992-2#1)(1993-9#1)(1994-3#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-4#1)(2005-11#1)(2006-1#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-7#3)(2007-8#3)(2008-10#3)(2008-4#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-7#1)(2011-2#2)(2012-12#4)(2012-2#1)
was 17%##6##2##(1993-5#1)(1995-5#1)(2007-10#1)(2007-8#1)(2008-6#1)(2010-9#1)
was 170##3##2##(1991-9#1)(2008-10#1)(2008-12#1)
was 18 months old##2##4##(2010-6#1)(2011-2#1)
was 18 months##4##3##(2007-7#1)(2010-6#1)(2011-2#2)
was 18##36##2##(1991-6#1)(1992-4#1)(1995-3#1)(1995-6#1)(1997-1#1)(2006-10#1)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#4)(2008-10#5)(2008-12#1)(2008-6#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#7)(2013-8#2)
was 18%##9##2##(1991-12#1)(1997-6#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-7#1)(2011-2#1)
was 185##3##2##(2006-12#1)(2007-11#1)(2008-11#1)
was 19 months##2##3##(1990-9#1)(2011-2#1)
was 19##24##2##(1990-9#1)(1992-2#1)(1993-10#1)(1994-5#1)(1995-2#1)(1997-3#1)(2006-1#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-3#2)(2008-4#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
was 19%##2##2##(1991-6#1)(2008-3#1)
was 195##2##2##(1997-4#1)(2004-11#1)
was 1ngml(-1)##2##2##(2008-10#2)
was 2 and##2##3##(2008-10#1)(2012-2#1)
was 2 days##2##3##(1993-2#1)(2009-9#1)
was 2 mm##2##3##(2008-11#1)(2010-12#1)
was 2 ng/ml##2##3##(1996-3#1)(1996-8#1)
was 2 times##2##3##(2007-1#1)(2007-11#1)
was 2 to 3##2##4##(1991-7#1)(2008-10#1)
was 2 to##4##3##(1991-7#1)(2005-11#1)(2007-8#1)(2008-10#1)
was 2 years##2##3##(1993-12#1)(2010-12#1)
was 2##251##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#3)(1991-1#1)(1991-11#2)(1991-2#1)(1991-5#2)(1991-7#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-10#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-6#1)(2004-1#2)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-4#1)(2005-8#1)(2005-9#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#3)(2007-3#2)(2007-7#9)(2007-8#9)(2008-10#66)(2008-11#5)(2008-12#6)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#7)(2008-6#6)(2008-7#2)(2008-9#1)(2009-12#1)(2009-9#1)(2010-12#4)(2010-4#2)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#9)(2011-3#1)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#3)
was 2% and##2##3##(2005-12#1)(2007-11#1)
was 2% for##4##3##(1992-2#1)(2008-10#1)(2009-5#1)(2011-2#1)
was 2%##15##2##(1990-2#1)(1992-2#1)(1993-9#1)(1997-6#1)(2005-12#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-6#1)(2009-5#1)(2011-2#2)
was 2-3 times##2##3##(1992-8#1)(1993-12#1)
was 2-3##3##2##(1991-10#1)(1992-8#1)(1993-12#1)
was 2-fold more##2##3##(1992-9#1)(1996-8#1)
was 2-fold##5##2##(1992-9#1)(1995-3#1)(1996-8#1)(2008-10#1)(2012-2#1)
was 20 months##5##3##(2006-6#1)(2006-8#1)(2007-11#1)(2008-6#1)(2008-9#1)
was 20 times##2##3##(1995-12#1)(1996-2#1)
was 20 years##2##3##(2008-12#1)(2012-2#1)
was 20##56##2##(1990-8#1)(1991-2#1)(1991-4#1)(1992-3#1)(1992-4#1)(1994-8#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-6#2)(1997-8#1)(2005-11#1)(2005-12#1)(2005-4#1)(2006-10#1)(2006-6#1)(2006-8#2)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-9#1)(2009-3#1)(2009-5#1)(2010-11#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
was 20% in##2##3##(2008-10#1)(2008-5#1)
was 20%##7##2##(1990-6#1)(1993-10#1)(1993-5#1)(1995-2#1)(2008-10#1)(2008-5#1)(2008-9#1)
was 200##3##2##(1991-12#1)(2008-10#1)(2008-9#1)
was 203##2##2##(1995-12#1)(2011-2#1)
was 21 and##2##3##(1990-10#1)(2013-1#1)
was 21 months##3##3##(2008-6#1)(2010-11#1)(2011-1#1)
was 21##26##2##(1990-10#2)(1995-1#1)(1996-1#1)(2005-8#1)(2006-6#1)(2007-2#1)(2007-3#1)(2007-7#4)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
was 21%##3##2##(1997-1#1)(2006-7#1)(2008-6#1)
was 210##3##2##(1996-11#1)(2008-10#1)(2008-3#1)
was 213##4##2##(1993-7#1)(2007-11#1)(2008-3#1)(2008-5#1)
was 22##27##2##(1990-6#1)(1991-4#1)(1992-9#1)(1995-7#1)(1995-8#1)(1996-12#1)(2006-1#1)(2006-11#1)(2006-4#1)(2006-6#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-11#1)(2008-7#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)
was 22%##9##2##(1990-8#1)(1996-11#1)(1997-4#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-1#1)
was 23 months##2##3##(2007-8#1)(2008-4#1)
was 23##23##2##(1990-12#1)(1990-4#1)(1994-9#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#3)(2008-4#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-12#3)(2013-1#2)(2013-8#2)
was 23%##5##2##(2005-9#1)(2008-7#2)(2010-3#1)(2013-1#1)
was 237##2##2##(2008-10#1)(2012-12#1)
was 24 months##3##3##(2006-12#1)(2011-2#1)(2012-2#1)
was 24##30##2##(1991-11#2)(1992-3#1)(1992-4#1)(1994-6#1)(1996-11#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-6#1)(2011-11#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-8#1)
was 24%##3##2##(1990-11#1)(2007-7#1)(2008-6#1)
was 240##2##2##(2007-11#1)(2010-7#1)
was 25 degrees C##3##4##(2008-10#1)(2011-1#1)(2012-3#1)
was 25 degrees##5##3##(2007-7#2)(2008-10#1)(2011-1#1)(2012-3#1)
was 25 min##2##3##(1994-3#1)(2008-10#1)
was 25##26##2##(1992-11#1)(1992-4#1)(1994-3#1)(1995-8#1)(2004-9#1)(2006-12#1)(2007-7#2)(2007-8#2)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
was 25% higher in##2##4##(2008-10#1)(2008-11#1)
was 25%##8##2##(1995-7#1)(2004-11#1)(2006-7#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)
was 25-fold##2##2##(2008-10#2)
was 250##3##2##(1992-8#1)(2006-5#1)(2007-8#1)
was 254##2##2##(2007-12#1)(2008-10#1)
was 26 degrees##3##3##(2007-12#1)(2007-7#2)
was 26##17##2##(1991-12#1)(1991-6#1)(1993-11#1)(2006-6#1)(2006-9#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-2#1)(2008-3#1)(2009-5#2)(2011-2#1)(2012-12#1)(2013-8#1)
was 26%##3##2##(1993-12#1)(2007-11#1)(2008-1#1)
was 260##2##2##(1993-11#1)(2007-3#1)
was 27##23##2##(1991-12#1)(1997-2#1)(1997-8#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)(2011-11#1)(2012-12#1)(2013-1#1)(2013-8#2)
was 27%##6##2##(1993-8#1)(2006-7#1)(2008-5#1)(2011-2#3)
was 275##2##2##(2006-10#1)(2011-1#1)
was 28 (range##2##3##(2007-7#1)(2011-2#1)
was 28 years##2##3##(2004-10#1)(2007-7#1)
was 28##27##2##(1990-11#1)(1992-11#1)(1992-12#1)(1994-11#1)(1995-11#1)(1995-4#1)(1996-2#1)(1996-7#1)(2004-10#1)(2004-9#1)(2007-7#3)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#1)(2013-1#1)(2013-8#2)
was 280##3##2##(1993-7#1)(1994-8#1)(2012-3#1)
was 29 years##3##3##(1990-9#1)(2007-10#1)(2007-12#1)
was 29##22##2##(1990-4#1)(1990-9#1)(1996-6#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#1)(2009-5#1)(2010-1#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
was 29%##2##2##(2008-10#1)(2008-8#1)
was 2n =##2##3##(2008-8#1)(2013-7#1)
was 2x10(-6)##2##2##(2008-10#2)
was 3 cm##2##3##(2007-3#1)(2007-7#1)
was 3 days##5##3##(1997-3#1)(2007-8#1)(2008-10#2)(2013-8#1)
was 3 months##2##3##(1996-9#1)(2008-8#1)
was 3 x 10(-7)M for##2##5##(2008-10#2)
was 3 x##5##3##(1996-5#1)(2005-12#1)(2006-12#1)(2008-10#2)
was 3##216##2##(1990-11#1)(1990-2#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#4)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#1)(1993-1#1)(1993-2#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-7#1)(1995-3#1)(1995-6#2)(1995-9#2)(1996-3#1)(1996-5#2)(1996-6#2)(1996-9#2)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-1#2)(2004-3#1)(2004-9#1)(2005-11#2)(2005-12#2)(2006-10#4)(2006-11#1)(2006-12#2)(2006-7#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#1)(2007-5#2)(2007-7#9)(2007-8#10)(2007-9#1)(2008-1#2)(2008-10#54)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-7#3)(2009-9#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-9#1)(2011-1#3)(2011-11#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#8)(2012-2#3)(2012-3#2)(2012-7#1)(2013-1#4)(2013-8#4)
was 3%##7##2##(2007-2#1)(2007-8#1)(2008-10#4)(2013-8#1)
was 3+##2##2##(1992-9#1)(1993-6#1)
was 3-##2##2##(1991-9#1)(1996-4#1)
was 3-12##3##2##(1992-10#1)(1995-9#1)(2008-8#1)
was 3-fold greater##2##3##(1994-3#1)(1994-5#1)
was 3-fold##3##2##(1994-3#1)(1994-5#1)(1995-2#1)
was 30 degrees C##3##4##(1990-4#1)(1997-6#1)(2008-10#1)
was 30 degrees##5##3##(1990-4#1)(1997-6#1)(2007-7#1)(2008-10#1)(2012-2#1)
was 30##31##2##(1990-4#1)(1992-10#1)(1992-9#1)(1994-11#1)(1994-2#1)(1994-3#2)(1997-6#1)(2006-8#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
was 30% lower##2##3##(1991-12#1)(2008-10#1)
was 30% of##2##3##(1997-8#1)(2008-4#1)
was 30%##20##2##(1991-12#1)(1991-6#1)(1995-3#1)(1995-4#1)(1996-4#1)(1997-5#1)(1997-8#1)(2006-7#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-10#1)(2010-3#1)(2010-9#1)(2011-12#1)(2011-2#2)
was 30-fold##2##2##(1990-4#1)(2008-5#1)
was 300##8##2##(2004-9#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-5#1)
was 31##19##2##(1994-12#1)(2005-11#1)(2006-8#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-12#2)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#3)
was 31%##2##2##(1992-4#1)(2007-7#1)
was 32 months##2##3##(1991-11#1)(2006-5#1)
was 32 weeks##3##3##(1991-6#1)(2007-3#1)(2013-8#1)
was 32 years##2##3##(1993-5#1)(2006-5#1)
was 32##20##2##(1991-11#1)(1991-6#1)(1993-5#1)(1994-9#1)(2006-5#2)(2007-3#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-6#1)(2009-11#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
was 33 +/-##2##3##(2012-3#1)(2013-1#1)
was 33##22##2##(1990-8#1)(1992-11#1)(1994-3#1)(1994-6#1)(1995-3#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2010-1#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-3#2)(2013-1#2)
was 33%##13##2##(1990-6#1)(1991-2#2)(1993-5#1)(2005-7#1)(2007-7#2)(2008-10#1)(2009-10#1)(2011-2#2)(2012-3#1)(2013-8#1)
was 330##3##2##(1990-10#1)(1995-2#1)(2008-10#1)
was 339##2##2##(2008-4#1)(2009-3#1)
was 34 years##3##3##(2006-7#1)(2007-7#1)(2007-8#1)
was 34##19##2##(1992-1#1)(1993-6#1)(1993-8#1)(1993-9#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-10#2)(2007-3#2)(2007-7#2)(2007-8#1)(2008-10#1)(2008-4#2)(2011-1#1)(2013-1#1)
was 34%##8##2##(1994-6#1)(1997-4#1)(2006-8#1)(2008-2#1)(2008-8#1)(2010-8#1)(2012-12#1)(2013-1#1)
was 346##2##2##(1991-11#1)(1994-9#1)
was 35##13##2##(2006-2#1)(2006-7#1)(2006-8#1)(2007-2#2)(2007-7#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-1#1)(2012-3#1)
was 35%##5##2##(2007-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2013-8#1)
was 36 for##2##3##(2008-10#2)
was 36 months (range##2##4##(2008-11#1)(2010-3#1)
was 36 years##2##3##(2006-8#1)(2008-1#1)
was 36##25##2##(1990-10#1)(1990-8#1)(1992-6#1)(1993-5#1)(1996-12#1)(2006-2#1)(2006-8#2)(2007-3#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-7#1)
was 36%##9##2##(1990-2#1)(2005-8#1)(2006-8#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#1)(2012-2#1)
was 37 years##2##3##(2004-2#1)(2007-12#1)
was 37##20##2##(1991-10#1)(1991-11#1)(1993-8#1)(1994-12#1)(1995-6#1)(2004-2#1)(2005-10#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#2)(2009-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
was 37%##6##2##(1990-3#1)(1990-6#1)(1996-3#1)(2006-1#1)(2007-12#1)(2010-4#1)
was 38 months##3##3##(2006-5#1)(2006-8#1)(2009-3#1)
was 38##18##2##(1991-4#1)(1995-2#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#2)(2008-8#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
was 38%##7##2##(1990-4#1)(1996-12#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-2#1)
was 39 years##2##3##(2006-5#1)(2010-3#1)
was 39##23##2##(1990-9#1)(1991-12#1)(1991-8#1)(1992-2#1)(1997-6#1)(2005-1#1)(2006-5#1)(2007-12#3)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#2)(2010-3#1)(2010-4#1)(2011-1#3)(2013-1#1)(2013-8#1)
was 39%##6##2##(1994-3#1)(1996-12#1)(2006-7#1)(2007-9#1)(2008-6#1)(2013-1#1)
was 398##3##2##(1991-5#1)(2008-4#1)(2012-3#1)
was 4 (range##2##3##(1990-10#1)(2010-12#1)
was 4 and##2##3##(2005-11#1)(2012-3#1)
was 4 days##3##3##(2005-5#1)(2007-8#2)
was 4 months##9##3##(1990-10#1)(1990-2#1)(1990-6#1)(1991-12#1)(2007-2#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-12#1)
was 4 to##2##3##(1996-8#1)(2008-6#1)
was 4 weeks##3##3##(1990-10#1)(1993-6#1)(2007-7#1)
was 4 x##3##3##(1992-6#1)(1995-2#1)(2010-1#1)
was 4 years##4##3##(1997-8#1)(2007-8#1)(2008-4#1)(2008-6#1)
was 4##163##2##(1990-10#3)(1990-12#2)(1990-2#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#2)(1991-1#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-3#2)(1996-7#1)(1996-8#2)(1997-5#1)(1997-8#1)(2005-11#2)(2005-5#1)(2006-1#1)(2006-10#2)(2006-6#2)(2006-8#1)(2007-11#3)(2007-12#1)(2007-2#3)(2007-3#3)(2007-7#4)(2007-8#14)(2007-9#1)(2008-10#29)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#5)(2008-7#4)(2008-8#2)(2008-9#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-12#5)(2012-3#3)(2013-1#5)(2013-8#3)
was 4% and##2##3##(2007-1#1)(2008-11#1)
was 4% for##2##3##(2008-10#2)
was 4%##10##2##(2007-1#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2011-1#1)
was 4-fold##3##2##(1995-10#1)(1996-5#1)(2008-10#1)
was 40 +/-##2##3##(1994-9#1)(2011-2#1)
was 40##30##2##(1990-12#1)(1990-3#1)(1991-2#1)(1994-4#1)(1994-6#1)(1994-9#1)(1995-9#1)(1996-8#1)(1997-8#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-8#1)(2010-6#1)(2010-9#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#5)
was 40%##12##2##(1991-7#1)(1992-12#1)(1992-6#1)(1993-3#1)(1995-5#1)(2006-9#1)(2007-3#1)(2008-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
was 400##2##2##(2008-8#1)(2012-2#1)
was 41##15##2##(1993-8#1)(1994-7#1)(2006-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)
was 41%##7##2##(1993-5#1)(2008-3#1)(2008-8#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-1#1)
was 42##21##2##(1990-8#2)(1994-11#1)(1994-12#1)(1995-5#1)(2006-10#2)(2007-7#2)(2007-8#2)(2008-5#2)(2008-8#1)(2008-9#1)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
was 42%##3##2##(1992-1#1)(1992-8#1)(1994-3#1)
was 43 +/-##2##3##(1990-8#1)(1995-10#1)
was 43##13##2##(1990-8#2)(1995-10#1)(2005-10#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-6#1)(2011-2#2)
was 43%##5##2##(1991-8#1)(1997-6#1)(2008-2#1)(2009-2#1)(2012-2#1)
was 435##2##2##(1992-12#1)(2008-10#1)
was 439##2##2##(1996-5#1)(2013-8#1)
was 44 +/-##3##3##(2006-12#1)(2007-7#1)(2013-1#1)
was 44##15##2##(1992-4#1)(1993-2#1)(1994-9#1)(2006-12#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-6#1)(2009-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
was 44%##4##2##(1993-11#1)(2006-8#1)(2008-5#1)(2008-6#1)
was 45 kDa##2##3##(1991-8#1)(1993-1#1)
was 45##21##2##(1991-2#1)(1991-8#1)(1993-1#1)(1993-9#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-7#1)(1997-5#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2011-2#2)(2012-12#1)(2013-1#2)
was 45% in##2##3##(2006-7#1)(2008-3#1)
was 45%##6##2##(1991-12#1)(1992-8#1)(2006-10#1)(2006-7#1)(2008-3#1)(2008-8#1)
was 46 years##3##3##(1990-4#1)(2006-10#2)
was 46##23##2##(1990-4#1)(1991-4#1)(1993-9#1)(1997-2#1)(1997-3#2)(2006-10#2)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-7#2)(2008-10#1)(2008-7#1)(2010-9#1)(2011-1#1)(2011-2#1)
was 46%##3##2##(1991-4#1)(2008-12#1)(2009-2#1)
was 47##10##2##(1996-3#1)(2005-10#1)(2006-10#1)(2007-4#1)(2007-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
was 47% in the##2##4##(1990-2#1)(2004-1#1)
was 47% in##3##3##(1990-2#1)(2004-1#1)(2008-2#1)
was 47%##7##2##(1990-2#1)(1993-11#1)(2004-1#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
was 470##2##2##(1992-7#1)(2013-1#1)
was 472##2##2##(1993-4#1)(2007-11#1)
was 48 days##2##3##(2007-8#1)(2013-8#1)
was 48##19##2##(1991-9#1)(1992-5#1)(1994-6#1)(1996-9#1)(1997-5#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-6#1)(2011-2#2)(2013-1#1)(2013-8#1)
was 48%##2##2##(2005-7#1)(2008-7#1)
was 49 days##2##3##(1990-4#1)(2013-1#1)
was 49##19##2##(1990-4#1)(1992-10#1)(1993-5#1)(1993-8#1)(2005-11#1)(2007-11#2)(2007-9#1)(2008-1#1)(2008-5#1)(2008-6#1)(2009-5#1)(2009-8#1)(2010-4#1)(2012-3#1)(2013-1#3)(2013-8#1)
was 49%##2##2##(2008-11#1)(2010-12#1)
was 5 and##3##3##(1992-1#1)(2007-8#1)(2008-10#1)
was 5 cm##3##3##(2007-12#1)(2007-8#2)
was 5 days##4##3##(2006-6#1)(2007-7#2)(2009-9#1)
was 5 months##4##3##(1994-8#1)(2007-2#1)(2007-8#1)(2010-3#1)
was 5 to##2##3##(2008-10#1)(2013-1#1)
was 5 x##3##3##(2007-12#1)(2008-10#1)(2010-11#1)
was 5 years##4##3##(2007-2#2)(2007-7#1)(2011-2#1)
was 5##144##2##(1990-11#2)(1990-12#1)(1990-5#1)(1990-6#1)(1991-2#1)(1991-5#1)(1991-6#2)(1992-1#1)(1992-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(1996-10#1)(1996-11#1)(1996-2#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-11#2)(2005-6#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#2)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#5)(2007-3#2)(2007-6#1)(2007-7#6)(2007-8#9)(2008-1#1)(2008-10#25)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#4)(2012-2#1)(2012-3#4)(2013-1#4)(2013-8#2)
was 5%##13##2##(1990-9#1)(1991-8#1)(1991-9#1)(1992-1#1)(1994-3#1)(1995-3#1)(2007-10#1)(2008-10#3)(2008-5#2)(2010-4#1)
was 5-6##2##2##(2008-9#1)(2012-12#1)
was 5-fold##3##2##(1991-5#1)(1991-7#1)(1992-5#1)
was 50 degrees C##2##4##(1996-6#1)(2008-10#1)
was 50 min##2##3##(2008-10#1)(2008-11#1)
was 50 ng/ml##3##3##(1990-11#1)(1993-2#1)(2013-1#1)
was 50 times##2##3##(2007-11#1)(2008-10#1)
was 50##30##2##(1990-11#2)(1990-3#1)(1991-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-2#1)(1995-9#1)(1996-6#1)(1996-9#1)(2006-10#1)(2007-11#2)(2007-7#2)(2008-10#6)(2008-11#1)(2008-4#1)(2008-6#1)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
was 50% of the##2##4##(2007-12#1)(2013-1#1)
was 50% of##4##3##(1993-12#1)(2007-12#1)(2008-4#1)(2013-1#1)
was 50%##18##2##(1990-7#1)(1992-11#1)(1993-12#1)(1993-7#1)(1994-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#1)(2012-12#1)(2013-1#1)
was 500##3##2##(2007-12#1)(2008-10#2)
was 51##17##2##(1990-1#1)(1994-3#1)(1996-12#1)(1997-7#1)(2004-1#1)(2006-11#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-3#1)(2011-2#1)
was 51%##4##2##(1993-1#1)(2006-8#1)(2008-6#1)(2008-9#1)
was 52##18##2##(1991-6#1)(1992-4#1)(1995-9#1)(2005-1#1)(2006-2#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-7#1)(2011-2#1)(2012-2#1)
was 52%##3##2##(2006-10#1)(2007-9#2)
was 53##11##2##(1990-9#1)(1991-8#1)(1992-2#1)(1993-11#1)(1996-5#1)(2006-10#1)(2011-2#1)(2011-7#1)(2013-1#1)(2013-7#1)(2013-8#1)
was 53%##5##2##(1991-3#1)(2008-12#1)(2008-6#2)(2010-8#1)
was 54##13##2##(1992-12#1)(1995-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)
was 55 years##2##3##(1990-12#1)(1991-9#1)
was 55##18##2##(1990-12#1)(1990-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1993-2#1)(1993-8#1)(1997-3#1)(2005-11#1)(2006-2#1)(2007-8#1)(2007-9#2)(2008-10#1)(2010-3#1)(2011-2#1)(2012-1#1)(2013-1#1)
was 55% after##2##3##(1990-9#1)(2011-2#1)
was 55%##7##2##(1990-2#1)(1990-9#1)(1995-12#1)(2004-1#1)(2007-3#1)(2008-8#1)(2011-2#1)
was 56 years##3##3##(1995-4#1)(2008-11#1)(2011-2#1)
was 56##18##2##(1991-9#2)(1992-3#1)(1994-3#1)(1995-4#1)(1996-3#1)(1996-4#1)(1997-7#1)(2004-1#2)(2005-5#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-11#1)(2011-2#1)(2013-7#1)
was 56%##3##2##(1995-2#1)(2004-1#1)(2010-4#1)
was 57 years##2##3##(1992-4#1)(2007-3#1)
was 57##12##2##(1990-10#1)(1990-8#1)(1992-4#1)(1993-8#1)(1996-3#1)(2006-8#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-3#1)(2011-2#1)(2012-2#1)
was 57%##4##2##(1993-5#1)(2008-6#1)(2008-8#1)(2013-7#1)
was 58##15##2##(1990-3#1)(1991-8#1)(1992-4#1)(1993-3#1)(2004-10#1)(2006-8#1)(2007-7#1)(2007-8#2)(2008-11#2)(2008-7#1)(2010-9#1)(2011-2#1)(2013-1#1)
was 58%##4##2##(1993-1#1)(2007-7#1)(2008-10#1)(2008-12#1)
was 59 +/-##2##3##(2008-10#1)(2012-3#1)
was 59##15##2##(1991-3#1)(1992-3#1)(1992-5#1)(1992-8#1)(1995-10#1)(1996-1#1)(1997-7#1)(2006-5#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#1)(2012-2#1)(2012-3#1)(2013-8#1)
was 59%##3##2##(2006-8#1)(2008-1#1)(2008-10#1)
was 6 cm##3##3##(2007-8#2)(2008-10#1)
was 6 months##8##3##(1990-9#1)(2007-11#2)(2007-7#1)(2008-6#1)(2008-8#1)(2010-12#1)(2011-2#1)
was 6 weeks##2##3##(1990-10#1)(2008-8#1)
was 6 x##3##3##(2008-10#1)(2008-2#2)
was 6##123##2##(1990-10#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#2)(1991-9#1)(1993-10#1)(1993-5#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-10#2)(2006-11#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#4)(2007-8#9)(2007-9#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2010-12#4)(2010-2#1)(2011-1#3)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#4)
was 6% for##2##3##(1991-7#1)(1993-12#1)
was 6%##7##2##(1990-5#1)(1991-7#1)(1993-12#1)(2007-8#1)(2008-10#2)(2008-7#1)
was 6-10##2##2##(1990-10#1)(2011-2#1)
was 6-fold##2##2##(1991-12#1)(1991-3#1)
was 60 min##2##3##(1994-2#1)(2008-10#1)
was 60 years (range##2##4##(1992-8#1)(2006-7#1)
was 60 years##4##3##(1992-8#1)(2006-7#1)(2008-11#1)(2011-2#1)
was 60##20##2##(1990-12#1)(1991-2#1)(1992-8#1)(1994-2#1)(1994-5#1)(1997-8#1)(2006-7#1)(2007-8#2)(2008-10#4)(2008-11#1)(2009-11#1)(2011-1#1)(2011-2#3)(2012-2#1)
was 60%##9##2##(1990-8#1)(1991-9#1)(1992-2#1)(1994-12#1)(1994-5#1)(2004-1#1)(2008-1#1)(2008-3#1)(2010-8#1)
was 600##2##2##(1990-8#1)(2007-7#1)
was 61 years##2##3##(2006-10#1)(2011-2#1)
was 61##17##2##(1990-9#1)(1992-1#1)(1993-8#1)(1994-3#1)(2006-10#1)(2007-10#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2011-1#1)(2011-2#1)
was 61%##7##2##(1991-10#1)(1992-10#1)(1996-12#1)(1997-1#1)(2006-10#1)(2008-10#1)(2009-8#1)
was 62##7##2##(2007-11#1)(2009-3#2)(2010-3#1)(2011-2#1)(2013-8#2)
was 63 years##3##3##(1991-12#1)(1991-2#1)(2009-3#1)
was 63##22##2##(1990-4#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-8#1)(1993-2#1)(1994-3#1)(2004-1#1)(2005-11#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-3#1)(2011-1#1)(2011-2#2)
was 63%##7##2##(1990-10#1)(1993-5#1)(1997-7#1)(2004-1#1)(2004-10#1)(2008-10#2)
was 64##9##2##(1996-12#1)(1997-7#1)(2004-1#1)(2007-3#1)(2007-8#1)(2008-12#1)(2009-2#1)(2010-3#1)(2010-7#1)
was 64%##2##2##(1991-11#1)(2006-7#1)
was 643##2##2##(2007-9#1)(2011-1#1)
was 65 years##2##3##(2007-8#1)(2008-8#1)
was 65##14##2##(1990-2#1)(1990-9#1)(1992-1#1)(1996-6#1)(2006-6#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-8#1)(2012-12#1)(2013-1#3)
was 65% and##2##3##(2005-8#1)(2007-8#1)
was 65%##9##2##(1993-1#1)(1994-6#1)(1995-5#1)(2005-8#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-8#1)
was 650##2##2##(1993-3#1)(2008-4#1)
was 66 +/-##2##3##(2008-3#1)(2008-4#1)
was 66##16##2##(1990-11#1)(1991-12#1)(1995-6#1)(1997-8#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
was 66%##2##2##(2007-11#1)(2010-8#1)
was 67 years##2##3##(2008-3#1)(2012-2#1)
was 67##12##2##(1994-3#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-11#1)(2011-1#1)(2012-2#2)(2013-8#1)
was 67%##13##2##(1991-6#1)(1991-8#2)(2006-10#4)(2007-2#1)(2008-10#2)(2011-2#1)(2012-1#1)(2012-12#1)
was 68 years##2##3##(2007-7#1)(2012-3#1)
was 68##19##2##(1990-8#1)(1991-12#1)(1991-6#1)(1992-7#1)(2005-10#1)(2007-11#1)(2007-3#2)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-10#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
was 68%##8##2##(1995-8#1)(2005-10#1)(2006-4#1)(2006-8#1)(2007-12#1)(2008-5#1)(2008-6#1)(2009-9#1)
was 69 years##2##3##(1994-4#1)(2006-10#1)
was 69##9##2##(1994-4#1)(2006-10#2)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)
was 7 days##5##3##(2007-11#1)(2007-2#1)(2007-6#1)(2008-11#1)(2012-3#1)
was 7 months (range##4##4##(1990-2#1)(1991-2#1)(1992-2#1)(1992-8#1)
was 7 months##7##3##(1990-2#1)(1991-2#1)(1992-2#1)(1992-8#1)(1994-8#1)(2005-1#1)(2008-8#1)
was 7 years##2##3##(2007-7#1)(2008-6#1)
was 7##105##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-12#1)(1991-2#4)(1991-5#2)(1991-7#1)(1991-8#1)(1992-2#1)(1992-8#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#1)(1994-11#1)(1994-8#2)(1994-9#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(2004-9#2)(2005-1#2)(2005-8#1)(2006-10#1)(2006-12#2)(2006-6#1)(2007-10#1)(2007-11#6)(2007-2#2)(2007-6#1)(2007-7#4)(2007-8#6)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-9#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
was 7%##7##2##(1990-3#1)(1990-9#1)(1993-9#1)(2006-2#1)(2007-3#1)(2007-8#1)(2010-12#1)
was 7-fold##3##2##(1992-3#1)(1994-9#1)(1996-6#1)
was 70 years##2##3##(1996-1#1)(2013-8#1)
was 70##21##2##(1991-11#1)(1992-2#1)(1993-5#1)(1994-8#1)(1996-1#1)(1996-12#1)(1997-4#1)(2005-11#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-5#1)(2009-4#1)(2010-5#1)(2011-2#1)(2013-8#1)
was 70% higher##2##3##(1991-12#1)(1994-3#1)
was 70%##6##2##(1991-12#1)(1992-12#1)(1992-6#1)(1994-3#1)(2008-3#1)(2008-7#1)
was 71 years##3##3##(2007-8#1)(2007-9#2)
was 71##17##2##(1991-4#1)(1992-10#1)(1994-12#2)(1997-2#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-6#1)(2011-2#2)(2012-12#1)(2013-1#1)
was 71%##4##2##(1993-1#1)(2006-10#2)(2012-3#1)
was 72 +/-##2##3##(2007-7#1)(2008-3#1)
was 72##16##2##(1993-10#2)(1993-2#1)(1993-5#2)(2006-10#1)(2007-12#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-4#1)(2012-2#1)
was 72%##7##2##(1993-5#1)(1994-2#1)(2006-10#1)(2008-11#1)(2009-2#1)(2013-1#2)
was 73##12##2##(1991-6#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-5#1)(2011-1#2)(2011-3#1)(2012-12#1)(2013-1#1)
was 73%##5##2##(1992-11#1)(1994-9#1)(1995-3#1)(2008-8#1)(2013-8#1)
was 74 min##2##3##(2005-12#1)(2007-8#1)
was 74##12##2##(2005-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-7#2)(2009-12#1)(2012-2#2)(2013-1#2)
was 74%##3##2##(1992-10#1)(2006-10#1)(2008-6#1)
was 75##9##2##(1991-11#1)(1991-4#1)(1996-9#1)(2006-5#1)(2006-6#1)(2008-10#2)(2008-5#1)(2008-7#1)
was 75% and that##2##4##(2007-7#1)(2013-8#1)
was 75% and##3##3##(2007-7#1)(2008-6#1)(2013-8#1)
was 75% at##2##3##(2008-10#1)(2013-8#1)
was 75% for##2##3##(1990-6#1)(2008-8#1)
was 75%##12##2##(1990-6#1)(1992-11#1)(1997-8#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2013-8#2)
was 76##12##2##(1990-10#1)(1993-1#1)(1997-8#1)(2006-5#1)(2007-2#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-12#1)(2012-12#1)(2012-3#1)
was 76% in##2##3##(1990-8#1)(2008-5#1)
was 76%##9##2##(1990-8#1)(1992-3#1)(1993-1#1)(1996-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-2#1)(2011-2#1)
was 77##9##2##(1990-8#1)(1990-9#1)(1993-10#1)(1995-2#1)(1996-5#1)(1997-7#1)(2006-5#1)(2007-8#2)
was 77%##6##2##(1991-11#1)(1995-3#1)(1997-6#1)(2008-3#1)(2008-5#1)(2009-12#1)
was 78##14##2##(1993-1#1)(1993-5#1)(1996-3#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-8#2)(2008-10#1)(2008-5#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
was 78%##5##2##(1991-9#1)(1992-3#1)(2006-2#1)(2008-6#1)(2008-7#1)
was 79##11##2##(1990-6#1)(1992-6#1)(2007-8#2)(2008-3#1)(2008-4#1)(2008-6#2)(2010-8#1)(2012-3#1)(2013-8#1)
was 79%##2##2##(1993-4#1)(2007-8#1)
was 8 months##4##3##(1990-2#1)(2006-6#1)(2007-11#1)(2008-3#1)
was 8 years##2##3##(2008-7#1)(2013-1#1)
was 8##78##2##(1990-2#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-4#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-7#1)(1996-1#1)(1996-8#1)(1997-7#1)(2004-1#1)(2004-12#1)(2006-12#1)(2006-2#2)(2006-6#3)(2007-10#1)(2007-11#3)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#2)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#4)(2013-8#3)
was 8%##5##2##(1990-8#2)(1992-1#1)(2006-6#1)(2007-8#1)
was 80 samples per hour##2##5##(2008-10#2)
was 80 years##2##3##(2006-1#1)(2012-12#1)
was 80##17##2##(1991-2#1)(1993-1#1)(1996-12#1)(1996-8#1)(2006-1#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-8#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
was 80% and##3##3##(1996-3#1)(2007-1#1)(2010-5#1)
was 80%##12##2##(1991-2#1)(1994-6#1)(1996-3#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-6#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-5#1)
was 81##6##2##(1991-10#1)(2007-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
was 82##15##2##(1995-6#1)(1996-12#1)(2005-12#1)(2006-6#1)(2006-7#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-1#2)
was 82% and##4##3##(2005-1#1)(2006-10#1)(2006-4#1)(2013-8#1)
was 82%##8##2##(1990-10#1)(1997-5#1)(2005-1#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-7#1)(2013-8#1)
was 83##8##2##(1992-2#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-3#1)
was 83%##5##2##(1994-2#1)(1997-1#1)(2007-8#1)(2008-1#1)(2008-5#1)
was 84 points##2##3##(1991-12#1)(2007-7#1)
was 84##10##2##(1991-12#2)(1992-8#1)(2007-7#1)(2007-8#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
was 84% and##2##3##(2008-3#1)(2008-7#1)
was 84%##7##2##(1992-10#1)(1992-5#1)(1993-3#1)(2007-7#1)(2008-3#1)(2008-7#1)(2008-8#1)
was 85##18##2##(1990-8#1)(1992-6#1)(1993-1#1)(1993-7#1)(1996-3#1)(2006-5#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-8#2)(2011-1#1)(2011-2#1)(2012-12#2)
was 85%##7##2##(1993-4#1)(2007-8#1)(2008-6#2)(2008-8#1)(2012-2#1)(2013-7#1)
was 850##2##2##(2008-10#1)(2011-1#1)
was 86##12##2##(1990-11#1)(2005-5#1)(2006-10#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-4#1)
was 86%##6##2##(1993-12#1)(1996-12#1)(2007-7#1)(2007-9#1)(2008-3#1)(2008-8#1)
was 87##10##2##(1991-7#1)(1996-12#1)(2004-10#1)(2005-5#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#1)(2013-8#1)
was 87%##6##2##(2006-10#1)(2008-5#2)(2008-6#2)(2013-8#1)
was 88##9##2##(1990-10#1)(1992-4#1)(1992-8#1)(2005-9#1)(2007-3#1)(2007-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
was 88% and##2##3##(1991-5#1)(2008-7#1)
was 88%##9##2##(1991-2#2)(1991-5#1)(1991-6#1)(1994-9#1)(2005-10#1)(2008-6#1)(2008-7#1)(2010-5#1)
was 89##7##2##(1993-2#1)(1994-12#1)(1994-9#1)(1995-3#1)(2007-7#1)(2008-10#1)(2013-8#1)
was 89%##6##2##(1992-5#1)(1993-3#1)(2008-5#1)(2008-6#1)(2011-2#1)(2013-1#1)
was 9 days##2##3##(1996-4#1)(2007-8#1)
was 9 months##3##3##(1990-12#1)(1990-2#1)(2006-12#1)
was 9 to##2##3##(1991-11#1)(2008-10#1)
was 9 years##2##3##(2008-8#1)(2009-10#1)
was 9##77##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-9#3)(1992-2#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-6#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-4#1)(2005-9#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#4)
was 9%##5##2##(1992-5#1)(1996-3#1)(2007-9#1)(2008-10#2)
was 90##10##2##(1992-1#1)(1996-3#1)(1997-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2012-12#1)(2013-8#1)
was 90% in##2##3##(2007-8#1)(2008-5#1)
was 90%##11##2##(1993-5#1)(1995-2#1)(1996-6#1)(2007-2#1)(2007-8#2)(2008-5#2)(2008-6#2)(2013-1#1)
was 90s##2##2##(2008-10#2)
was 91##9##2##(1990-8#1)(1997-8#1)(2007-8#1)(2009-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
was 91%##11##2##(1990-12#1)(1990-2#1)(1994-1#1)(1994-3#1)(1997-6#1)(2004-2#1)(2005-1#1)(2006-12#1)(2007-8#1)(2008-3#1)(2008-6#1)
was 92##5##2##(1993-1#1)(1994-5#1)(2011-1#1)(2013-8#2)
was 92%##6##2##(1992-5#1)(2007-3#1)(2008-12#1)(2009-5#1)(2011-12#1)(2013-7#1)
was 93 +/-##2##3##(1996-3#1)(2008-2#1)
was 93##22##2##(1991-2#1)(1993-1#1)(1995-10#1)(1996-3#1)(2006-8#1)(2007-2#1)(2007-6#1)(2007-8#3)(2008-1#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-3#1)(2012-12#2)(2012-2#1)
was 93%##6##2##(2006-8#1)(2007-7#1)(2008-11#1)(2008-6#2)(2012-12#1)
was 94##7##2##(2008-10#1)(2008-3#1)(2010-3#1)(2011-2#2)(2012-3#1)(2013-1#1)
was 94%##7##2##(1991-8#1)(1996-12#1)(2007-7#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)
was 95 percent##2##3##(1993-10#1)(2007-2#1)
was 95##23##2##(1990-8#1)(1992-6#1)(1993-10#1)(1996-12#1)(1997-2#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-2#2)(2007-8#3)(2008-10#4)(2008-3#1)(2008-4#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-7#1)
was 95% and##3##3##(1994-2#1)(2005-1#1)(2006-7#1)
was 95% for##2##3##(1993-1#1)(1996-12#1)
was 95%##11##2##(1991-8#1)(1993-1#1)(1994-2#1)(1996-12#1)(2005-1#1)(2005-4#1)(2006-7#1)(2007-8#1)(2008-10#2)(2009-2#1)
was 96##16##2##(1990-12#1)(1992-3#1)(1995-8#1)(2005-10#1)(2005-5#1)(2007-8#3)(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
was 96% and##4##3##(1993-3#1)(1994-6#1)(2008-10#1)(2008-3#1)
was 96%##12##2##(1990-6#1)(1993-3#2)(1994-6#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-3#1)(2012-1#1)(2012-3#1)(2013-1#1)
was 97##10##2##(1993-9#1)(1997-8#1)(2005-11#1)(2007-10#1)(2007-8#2)(2008-10#1)(2009-3#1)(2009-4#1)(2009-5#1)
was 97%##10##2##(1990-2#1)(1991-3#1)(1993-2#1)(1995-11#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#2)
was 98##16##2##(1990-12#1)(1990-2#1)(1993-8#1)(1993-9#1)(1996-12#3)(1996-6#1)(2005-12#1)(2005-4#1)(2006-12#1)(2008-1#1)(2008-12#1)(2008-6#1)(2011-2#2)
was 98% and##2##3##(2007-2#1)(2009-5#1)
was 98%##9##2##(1992-8#1)(1996-6#1)(2006-11#1)(2007-2#2)(2007-9#1)(2008-6#1)(2009-5#1)(2010-5#1)
was 99##16##2##(1992-5#1)(2005-12#1)(2005-3#1)(2005-4#1)(2006-12#1)(2007-7#1)(2008-10#5)(2008-12#1)(2008-6#1)(2010-12#1)(2011-1#1)(2012-3#1)
was 99%##4##2##(2005-8#1)(2006-5#1)(2008-1#1)(2008-5#1)
was A##4##2##(1994-8#2)(1996-7#1)(2008-5#1)
was ADP-ribosylated##2##2##(1990-3#1)(1990-7#1)
was C##4##2##(1993-3#1)(1997-2#1)(2008-5#1)(2010-4#1)
was Ca(2+)-dependent and##2##3##(1992-12#1)(1994-8#1)
was Ca(2+)-dependent##3##2##(1992-12#1)(1993-4#1)(1994-8#1)
was Cs (x 10(6)) =##2##5##(2008-5#2)
was D(m) =##2##3##(2010-7#2)
was Dr##2##2##(2007-6#1)(2008-1#1)
was Gaussian##2##2##(1996-12#1)(2008-10#1)
was Gram-positive##2##2##(1991-3#1)(2012-2#1)
was H##2##2##(2007-3#1)(2011-2#1)
was HIV##2##2##(1991-7#1)(2008-11#1)
was HIV-positive and##2##3##(1991-7#1)(1996-6#1)
was HIV-positive##9##2##(1991-7#2)(1995-12#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#2)(1997-5#1)
was I##2##2##(1997-2#2)
was NADPH-dependent##2##2##(1991-5#1)(1991-8#1)
was NOK##4##2##(1990-4#1)(1995-2#2)(1997-4#1)
was P##2##2##(2006-8#1)(2010-4#1)
was PCR amplified##2##3##(1993-12#1)(1997-4#1)
was PCR##3##2##(1993-12#1)(1994-4#1)(1997-4#1)
was R = 0##2##4##(1990-9#1)(1993-5#1)
was R##4##2##(1990-9#1)(1993-5#1)(2008-10#1)(2011-1#1)
was Rs##2##2##(2010-12#1)(2011-1#1)
was S##3##2##(2008-5#1)(2011-1#1)(2013-8#1)
was SS##2##2##(2010-2#1)(2013-8#1)
was Staphylococcus aureus##2##3##(1991-3#1)(2011-2#1)
was Staphylococcus##3##2##(1991-3#1)(2008-2#1)(2011-2#1)
was T##4##2##(1993-3#1)(2007-3#2)(2011-1#1)
was a &quot##2##3##(2010-9#1)(2013-7#1)
was a 3##3##3##(1997-6#1)(2006-9#1)(2013-1#1)
was a 30##2##3##(1990-12#1)(1990-3#1)
was a 4##2##3##(1997-7#1)(2007-2#1)
was a 50%##2##3##(1993-3#1)(2008-10#1)
was a 54-year-old##2##3##(1995-9#1)(2007-8#1)
was a 62-year-old##2##3##(1995-9#1)(2008-5#1)
was a 69-year-old woman##2##4##(1993-11#1)(2007-8#1)
was a 74-year-old##2##3##(2011-2#1)(2013-1#1)
was a better predictor of##3##5##(2010-3#1)(2010-8#1)(2012-11#1)
was a better predictor##4##4##(2007-1#1)(2010-3#1)(2010-8#1)(2012-11#1)
was a better##12##3##(1993-12#1)(1995-2#1)(2006-12#1)(2007-1#1)(2007-8#1)(2008-10#2)(2010-3#2)(2010-8#1)(2011-12#1)(2012-11#1)
was a bilateral##3##3##(1994-5#2)(2009-3#1)
was a bit##2##3##(2004-12#1)(2013-7#1)
was a case of##4##4##(2006-1#1)(2008-1#1)(2011-1#1)(2013-8#1)
was a case##6##3##(2006-1#1)(2008-1#1)(2011-1#1)(2013-1#2)(2013-8#1)
was a causal##2##3##(2008-7#1)(2012-3#1)
was a change in##2##4##(1991-7#1)(2013-1#1)
was a characteristic##2##3##(1991-5#1)(2005-11#1)
was a clear##4##3##(1991-2#1)(2008-10#1)(2008-4#1)(2012-1#1)
was a clinical##2##3##(2005-12#1)(2007-11#1)
was a close##4##3##(1992-11#1)(1993-1#1)(1994-6#1)(2008-5#1)
was a combination of##2##4##(2004-10#1)(2009-8#1)
was a common feature##2##4##(2008-10#1)(2008-5#1)
was a common##5##3##(2008-10#1)(2008-5#1)(2010-12#1)(2010-4#1)(2011-1#1)
was a comparison of##3##4##(2007-11#1)(2008-4#1)(2008-7#1)
was a competitive inhibitor##2##4##(1991-3#1)(1995-1#1)
was a competitive##4##3##(1991-3#1)(1995-1#1)(2008-10#2)
was a complete##3##3##(2006-4#1)(2008-10#1)(2008-11#1)
was a component of##2##4##(1991-2#1)(2008-10#1)
was a concordance of##2##4##(2008-7#1)(2013-1#1)
was a consequence of##5##4##(1994-3#1)(2007-1#1)(2008-11#1)(2012-2#1)(2012-5#1)
was a consistent##6##3##(1991-5#1)(1993-7#1)(1997-8#1)(2008-10#1)(2008-3#1)(2010-5#1)
was a correlation##8##3##(1991-6#1)(1992-4#1)(1994-12#1)(1994-8#1)(2007-3#1)(2008-10#2)(2008-9#1)
was a corresponding##3##3##(2007-8#1)(2007-9#1)(2008-11#1)
was a critical##3##3##(1994-2#1)(2008-4#1)(2011-1#1)
was a cross-sectional study##7##4##(2011-2#3)(2012-12#2)(2013-1#1)(2013-8#1)
was a cross-sectional##13##3##(2008-5#1)(2011-1#1)(2011-2#4)(2012-12#4)(2013-1#2)(2013-8#1)
was a crucial##2##3##(2008-1#1)(2008-7#1)
was a decisive##3##3##(1992-3#1)(2010-1#1)(2013-1#1)
was a decline in##3##4##(1990-12#1)(1992-12#1)(2005-10#1)
was a decrease in##14##4##(1991-12#1)(1991-6#1)(1991-8#1)(1991-9#1)(1993-12#1)(1995-12#1)(2006-9#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-4#2)(2010-9#1)
was a decrease of##3##4##(1990-7#1)(1991-10#1)(2008-1#1)
was a decrease##19##3##(1990-7#1)(1991-10#1)(1991-12#1)(1991-6#1)(1991-8#1)(1991-9#1)(1993-12#1)(1995-12#1)(1997-5#1)(2006-9#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-4#2)(2010-9#1)
was a delayed##2##3##(1990-2#1)(1993-6#1)
was a descriptive study of##2##5##(2011-2#1)(2012-12#1)
was a descriptive study##4##4##(2011-2#1)(2012-12#2)(2013-1#1)
was a descriptive##8##3##(2009-7#1)(2010-10#1)(2011-2#2)(2012-12#3)(2013-1#1)
was a diabetic##2##3##(2007-7#1)(2012-3#1)
was a difference in the##2##5##(2005-11#1)(2007-8#1)
was a difference in##4##4##(1990-12#1)(2005-11#1)(2007-8#1)(2011-12#1)
was a difference##7##3##(1990-12#1)(1991-4#1)(2005-11#1)(2006-8#1)(2007-8#1)(2011-1#1)(2011-12#1)
was a dimer of##2##4##(1991-7#1)(1992-3#1)
was a direct##5##3##(1994-5#1)(2008-10#3)(2011-2#1)
was a distinct##4##3##(1990-10#1)(1996-3#1)(2008-10#1)(2009-2#1)
was a dose-response relationship between paternal serum HBV-DNA load levels and neonatal cord blood HBV-DNA positive##2##16##(2011-1#2)
was a double##2##3##(2007-12#1)(2011-2#1)
was a double-blind randomized##2##4##(2006-10#1)(2012-2#1)
was a dramatic##3##3##(1993-3#1)(1996-12#1)(2010-10#1)
was a factor##4##3##(2009-2#1)(2011-1#1)(2012-3#2)
was a fall in##3##4##(1992-2#1)(1997-1#1)(2008-7#1)
was a frequent##2##3##(1990-10#1)(2009-8#1)
was a function of the##2##5##(1991-4#1)(2008-11#1)
was a function of##4##4##(1991-4#1)(2008-10#1)(2008-11#1)(2010-9#1)
was a function##5##3##(1991-4#1)(2008-10#2)(2008-11#1)(2010-9#1)
was a general trend##2##4##(2008-10#2)
was a general##8##3##(1996-7#1)(1997-3#1)(2008-10#3)(2008-4#1)(2011-1#1)(2012-3#1)
was a glycoprotein##2##3##(1990-10#1)(2008-11#1)
was a good agreement between the two##3##7##(2007-8#1)(2008-10#1)(2008-5#1)
was a good agreement between the##4##6##(2007-8#1)(2008-10#2)(2008-5#1)
was a good correlation between the##5##6##(1990-7#2)(1995-12#1)(2007-8#1)(2008-5#1)
was a good correlation between##6##5##(1990-7#2)(1995-12#1)(1996-5#1)(2007-8#1)(2008-5#1)
was a good predictor of the##2##6##(2008-10#1)(2008-9#1)
was a good predictor of##4##5##(1997-5#1)(2008-10#1)(2008-8#1)(2008-9#1)
was a good predictor##5##4##(1997-5#1)(2008-10#2)(2008-8#1)(2008-9#1)
was a good##24##3##(1990-7#2)(1992-11#1)(1994-11#1)(1995-12#1)(1996-5#2)(1997-5#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#6)(2008-5#2)(2008-8#1)(2008-9#1)(2012-12#1)(2013-1#1)
was a great deal of##2##5##(1994-2#1)(2013-8#1)
was a great##8##3##(1994-2#1)(1994-3#1)(2006-12#1)(2006-4#1)(2008-10#1)(2010-11#1)(2010-12#1)(2013-8#1)
was a greater##4##3##(1995-1#1)(1997-6#1)(2008-10#1)(2008-11#1)
was a group of##2##4##(2007-7#1)(2008-11#1)
was a high incidence of##3##5##(1994-12#1)(2005-12#1)(2008-12#1)
was a high prevalence of##5##5##(1994-6#1)(2008-12#1)(2012-1#1)(2013-1#2)
was a high rate of##3##5##(1990-4#1)(1992-10#1)(2008-6#1)
was a high##22##3##(1990-4#1)(1990-5#1)(1992-10#1)(1994-12#1)(1994-6#1)(1995-3#1)(1995-5#1)(2004-9#1)(2005-12#1)(2007-2#2)(2007-3#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-9#1)(2011-1#1)(2012-1#1)(2013-1#2)
was a higher incidence of##6##5##(1990-6#1)(1996-3#1)(2004-10#1)(2007-8#1)(2008-9#1)(2013-8#1)
was a higher prevalence##2##4##(2011-2#1)(2012-3#1)
was a higher##21##3##(1990-6#1)(1991-11#1)(1992-4#1)(1993-11#1)(1996-3#1)(1996-5#1)(1996-6#1)(2004-10#1)(2005-8#1)(2007-2#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
was a highly significant##4##4##(1994-3#1)(2008-5#1)(2008-8#2)
was a highly##6##3##(1994-3#1)(2008-5#2)(2008-8#2)(2009-2#1)
was a hybrid##2##3##(2008-2#1)(2013-1#1)
was a key##4##3##(2008-5#2)(2008-9#1)(2012-12#1)
was a known##3##3##(1997-5#1)(2007-11#1)(2013-8#1)
was a lack of##4##4##(1997-7#1)(2008-10#1)(2008-8#1)(2012-2#1)
was a large##8##3##(1994-2#1)(1996-9#1)(2005-7#1)(2006-2#1)(2008-7#2)(2009-12#1)(2009-5#1)
was a later##2##3##(1995-8#1)(2006-9#1)
was a less##3##3##(1991-2#1)(1991-8#1)(2011-2#1)
was a linear increase in##3##5##(2006-1#1)(2007-1#1)(2008-12#1)
was a linear relationship between the##4##6##(2008-10#2)(2008-11#1)(2012-2#1)
was a linear relationship between##6##5##(2007-2#1)(2008-10#3)(2008-11#1)(2012-2#1)
was a linear##15##3##(1995-6#1)(1996-5#1)(2006-1#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2012-2#1)
was a little##5##3##(1992-3#1)(2008-11#2)(2008-5#1)(2013-8#1)
was a low##6##3##(1990-2#1)(1990-7#1)(1992-8#1)(1996-8#1)(2007-10#1)(2009-4#1)
was a major determinant of##2##5##(1990-11#1)(2013-1#1)
was a major factor##2##4##(2006-12#1)(2007-9#1)
was a major problem##2##4##(1990-10#1)(2013-8#1)
was a major##20##3##(1990-10#1)(1990-11#1)(1995-11#1)(1995-3#1)(2005-12#1)(2006-12#1)(2006-9#1)(2007-9#1)(2008-10#1)(2008-5#2)(2009-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
was a male##4##3##(2006-10#1)(2007-2#1)(2013-1#1)(2013-8#1)
was a marginal##2##3##(2008-5#1)(2009-2#1)
was a marked improvement in##2##5##(1997-1#2)
was a marked increase in##2##5##(1993-1#1)(1995-7#1)
was a marked reduction##4##4##(1994-4#1)(1997-5#1)(2005-7#1)(2007-12#1)
was a marked##13##3##(1991-2#1)(1993-1#1)(1994-4#1)(1995-7#1)(1997-1#2)(1997-4#1)(1997-5#1)(1997-6#1)(2005-7#1)(2007-12#1)(2008-11#1)(2008-6#1)
was a member of the##3##5##(1997-6#1)(2006-5#1)(2006-8#1)
was a member of##5##4##(1997-6#1)(2006-5#1)(2006-8#1)(2008-10#1)(2009-4#1)
was a metastasis##2##3##(1993-12#1)(2007-12#1)
was a mild##4##3##(1990-11#1)(1992-7#1)(1996-10#1)(2012-2#1)
was a minor##5##3##(1990-5#1)(1992-3#1)(1992-7#1)(1995-3#1)(2011-1#1)
was a mixture of##10##4##(1990-7#1)(1992-5#1)(1996-11#1)(1997-3#1)(1997-4#1)(2008-10#2)(2010-2#2)(2010-5#1)
was a moderate##4##3##(1991-2#1)(1991-8#1)(1992-7#1)(1997-7#1)
was a modest##4##3##(1990-11#1)(1992-4#1)(1995-8#1)(2008-9#1)
was a modification of the##2##5##(1994-2#1)(2008-10#1)
was a more effective##2##4##(1997-7#1)(2013-1#1)
was a more efficient##2##4##(1994-12#1)(2008-2#1)
was a more##10##3##(1994-12#1)(1995-1#1)(1995-3#1)(1997-7#1)(2007-4#1)(2008-10#1)(2008-2#1)(2013-1#1)(2013-8#2)
was a much##5##3##(1991-8#1)(1995-12#1)(1995-2#1)(2006-8#1)(2008-5#1)
was a negative correlation between##6##5##(1991-11#1)(1993-5#1)(1993-7#1)(1997-8#1)(2007-8#1)(2008-8#1)
was a negative correlation of##3##5##(2008-10#1)(2008-5#1)(2012-12#1)
was a negative correlation##10##4##(1991-11#1)(1993-5#1)(1993-7#1)(1997-8#1)(2006-3#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-12#1)
was a negative##14##3##(1991-11#1)(1993-5#1)(1993-7#1)(1995-5#1)(1997-8#1)(2006-10#1)(2006-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-12#1)
was a new member of##2##5##(1994-8#1)(2008-10#1)
was a new##10##3##(1993-8#1)(1994-8#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-8#2)(2009-10#1)(2011-3#1)
was a newly##2##3##(2008-10#1)(2008-8#1)
was a non-significant##2##3##(2006-9#1)(2013-8#1)
was a notable##2##3##(1995-11#1)(2012-3#1)
was a novel##4##3##(1991-12#1)(2008-10#1)(2008-5#1)(2012-3#1)
was a part of##3##4##(2006-10#3)
was a partial##2##3##(1990-10#1)(1991-8#1)
was a patient with##2##4##(2005-1#1)(2009-2#1)
was a patient##4##3##(1996-12#1)(2005-1#1)(2009-2#1)(2011-2#1)
was a permanent##3##3##(2007-7#1)(2008-11#1)(2008-9#1)
was a phase I##2##4##(2006-6#2)
was a phase##3##3##(2006-6#3)
was a pioneer in the##2##5##(2006-4#1)(2008-8#1)
was a poor substrate for##3##5##(1994-11#1)(1994-9#1)(1997-3#1)
was a poor substrate##5##4##(1991-8#1)(1994-11#1)(1994-9#1)(1995-8#1)(1997-3#1)
was a poor##12##3##(1991-4#1)(1991-8#1)(1994-11#1)(1994-12#1)(1994-9#2)(1995-8#1)(1996-4#1)(1997-3#1)(2007-2#1)(2010-11#1)(2011-1#1)
was a positive and significant##2##5##(1994-5#1)(1996-3#1)
was a positive correlation between the##5##6##(1990-10#1)(2006-5#1)(2008-10#1)(2012-2#1)(2013-8#1)
was a positive correlation between##9##5##(1990-10#1)(1997-2#1)(2006-5#1)(2006-6#2)(2008-10#1)(2012-2#1)(2013-7#1)(2013-8#1)
was a positive correlation##12##4##(1990-10#1)(1993-12#1)(1997-2#1)(2006-5#1)(2006-6#2)(2006-9#1)(2008-10#2)(2012-2#1)(2013-7#1)(2013-8#1)
was a positive##25##3##(1990-10#1)(1993-12#1)(1993-5#1)(1994-10#1)(1994-5#1)(1996-3#1)(1997-2#1)(2006-10#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#2)(2008-10#2)(2008-12#1)(2008-3#1)(2011-1#1)(2012-2#1)(2013-7#2)(2013-8#1)
was a possible solution##2##4##(2007-5#1)(2009-10#1)
was a possible##4##3##(2004-1#1)(2007-5#1)(2008-9#1)(2009-10#1)
was a potent inhibitor of the##4##6##(1991-1#1)(1991-3#1)(1991-8#1)(1995-8#1)
was a potent inhibitor of##8##5##(1990-10#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-8#1)(1994-8#1)(1995-11#1)(1995-8#1)
was a potent reversible inhibitor of##2##6##(1991-5#1)(1994-8#1)
was a potent##10##3##(1990-10#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1994-8#2)(1995-11#1)(1995-8#1)
was a potential##2##3##(2008-11#1)(2011-1#1)
was a powerful##2##3##(1993-2#1)(2010-1#1)
was a predictor of##2##4##(1990-12#1)(2007-10#1)
was a predominance of##2##4##(2008-7#1)(2012-3#1)
was a predominant##2##3##(1990-3#1)(2008-1#1)
was a preferred substrate##2##4##(1991-4#2)
was a preponderance of##2##4##(2005-8#1)(2006-10#1)
was a prevalence of##2##4##(2009-2#1)(2011-2#1)
was a previously healthy##2##4##(2009-8#1)(2012-2#1)
was a previously##4##3##(2006-8#1)(2009-8#1)(2010-6#1)(2012-2#1)
was a primary##6##3##(1992-2#1)(2005-7#1)(2006-9#1)(2007-2#1)(2008-7#1)(2010-3#1)
was a prominent##3##3##(2007-2#1)(2007-7#1)(2008-2#1)
was a prospective##8##3##(2006-6#1)(2007-11#1)(2009-6#1)(2012-12#2)(2012-2#1)(2013-8#2)
was a protein##3##3##(1990-5#1)(1991-10#1)(1993-9#1)
was a pure##2##3##(2007-8#1)(2008-10#1)
was a qualitative##3##3##(2006-10#1)(2008-11#1)(2013-1#1)
was a question##2##3##(1992-4#1)(2008-3#1)
was a randomized##6##3##(2005-8#1)(2006-10#2)(2008-4#1)(2008-8#1)(2010-8#1)
was a rapid increase in the##2##6##(1990-6#1)(1995-4#1)
was a rapid##6##3##(1990-6#1)(1993-12#1)(1993-4#1)(1993-6#1)(1995-4#1)(2006-5#1)
was a reduced##2##3##(1992-12#1)(2008-9#1)
was a reduction in the number of##2##7##(2010-8#1)(2011-1#1)
was a reduction in the##3##5##(1992-10#1)(2010-8#1)(2011-1#1)
was a reduction in##9##4##(1990-5#1)(1992-10#1)(1996-2#1)(1997-1#1)(2004-2#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-8#1)
was a reduction of##4##4##(2007-7#1)(2008-10#1)(2012-12#1)(2013-1#1)
was a reduction##13##3##(1990-5#1)(1992-10#1)(1996-2#1)(1997-1#1)(2004-2#1)(2007-7#1)(2008-10#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
was a reflection of the##2##5##(1993-2#1)(2008-1#1)
was a relationship between the##2##5##(2008-10#1)(2009-9#1)
was a relatively##4##3##(1991-12#1)(1992-12#1)(2008-10#1)(2013-1#1)
was a relevant##2##3##(1995-12#1)(2007-12#1)
was a reliable##3##3##(1995-10#1)(2007-2#1)(2007-8#1)
was a remarkable##5##3##(1990-6#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-3#1)
was a result of the##3##5##(2008-10#1)(2008-9#1)(2013-1#1)
was a result of##5##4##(2008-10#1)(2008-9#1)(2009-5#1)(2012-1#1)(2013-1#1)
was a retrospective review of##3##5##(2004-10#1)(2008-9#1)(2011-11#1)
was a retrospective review##5##4##(2004-10#1)(2005-12#1)(2006-6#1)(2008-9#1)(2011-11#1)
was a retrospective study of##4##5##(2007-3#2)(2011-1#1)(2012-12#1)
was a retrospective study##8##4##(2007-3#2)(2009-10#1)(2009-9#1)(2011-1#1)(2011-11#1)(2012-12#1)(2012-3#1)
was a retrospective##20##3##(2004-10#2)(2005-12#1)(2006-6#1)(2007-10#1)(2007-3#3)(2007-8#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-9#1)(2011-1#1)(2011-11#2)(2012-12#2)(2012-3#1)(2013-1#1)
was a rise in##2##4##(1994-6#1)(2008-4#1)
was a risk factor for##3##5##(1991-2#1)(2008-3#2)
was a risk##5##3##(1991-2#1)(1996-5#1)(2008-10#1)(2008-3#2)
was a robust##3##3##(2008-3#1)(2010-1#2)
was a safe and effective##2##5##(2008-9#1)(2011-2#1)
was a safe and##3##4##(2006-11#1)(2008-9#1)(2011-2#1)
was a selective##4##3##(1993-12#1)(1994-8#2)(2010-8#1)
was a sensitive and##2##4##(2005-10#1)(2008-10#1)
was a sensitive parameter##2##4##(2008-10#2)
was a sensitive##6##3##(1990-2#1)(2005-10#1)(2008-10#3)(2008-7#1)
was a severe##2##3##(2004-4#1)(2007-8#1)
was a shift of##2##4##(1991-12#1)(2008-10#1)
was a shift##4##3##(1990-4#1)(1991-12#1)(2008-1#1)(2008-10#1)
was a significant (P &lt##7##5##(1997-5#1)(2008-1#1)(2009-5#3)(2012-2#2)
was a significant (P##8##4##(1997-5#1)(2008-1#1)(2009-5#3)(2009-6#1)(2012-2#2)
was a significant and##2##4##(2008-12#1)(2011-2#1)
was a significant association between##5##5##(2008-10#1)(2011-2#2)(2012-12#1)(2012-2#1)
was a significant association##7##4##(2008-10#1)(2008-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
was a significant correlation between##17##5##(1992-11#1)(1992-8#1)(1994-5#1)(1996-12#1)(1997-2#1)(2007-10#2)(2007-7#3)(2008-1#1)(2008-6#2)(2010-10#1)(2011-2#1)(2013-1#2)
was a significant correlation of##2##5##(2011-2#1)(2013-1#1)
was a significant correlation##19##4##(1992-11#1)(1992-8#1)(1994-5#1)(1996-12#1)(1997-2#1)(2007-10#2)(2007-7#3)(2008-1#1)(2008-6#2)(2010-10#1)(2011-2#2)(2013-1#3)
was a significant decrease (P &lt##3##6##(2008-1#1)(2009-5#2)
was a significant decrease in the mean##2##7##(2007-7#1)(2007-9#1)
was a significant decrease in the##13##6##(1990-8#1)(1991-1#1)(1992-12#1)(1993-12#1)(2007-1#1)(2007-11#1)(2007-7#1)(2007-9#2)(2008-10#1)(2008-8#1)(2011-2#1)(2013-8#1)
was a significant decrease in##21##5##(1990-8#1)(1991-1#1)(1992-12#1)(1993-12#1)(1995-1#1)(2005-10#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-7#1)(2007-9#3)(2008-10#2)(2008-8#1)(2011-2#2)(2012-2#1)(2013-8#2)
was a significant decrease##29##4##(1990-4#1)(1990-8#1)(1991-1#1)(1992-12#1)(1993-12#1)(1995-1#1)(2004-11#1)(2005-10#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-7#1)(2007-9#3)(2008-1#1)(2008-10#2)(2008-12#1)(2008-8#2)(2009-5#2)(2010-4#1)(2011-2#2)(2012-2#1)(2013-8#2)
was a significant difference between the##6##6##(2006-8#1)(2007-5#1)(2007-7#1)(2008-7#1)(2008-8#1)(2009-8#1)
was a significant difference between##7##5##(1995-5#1)(2006-8#1)(2007-5#1)(2007-7#1)(2008-7#1)(2008-8#1)(2009-8#1)
was a significant difference in the##4##6##(2006-10#1)(2006-9#1)(2011-1#1)(2013-8#1)
was a significant difference in##14##5##(1990-10#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-9#1)(2010-9#1)(2011-1#1)(2012-2#2)(2013-8#1)
was a significant difference of##2##5##(2011-2#1)(2012-12#1)
was a significant difference##23##4##(1990-10#1)(1995-5#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
was a significant direct correlation between##2##6##(2006-8#2)
was a significant effect of##5##5##(1996-12#1)(2008-10#1)(2010-7#1)(2013-1#2)
was a significant effect##6##4##(1996-12#1)(2008-10#1)(2008-12#1)(2010-7#1)(2013-1#2)
was a significant fall in##2##5##(2008-3#1)(2008-7#1)
was a significant improvement in##6##5##(1991-2#1)(1995-6#1)(2004-2#1)(2007-12#1)(2008-10#1)(2012-12#1)
was a significant improvement##7##4##(1991-2#1)(1995-6#1)(2004-2#1)(2006-6#1)(2007-12#1)(2008-10#1)(2012-12#1)
was a significant increase (P &lt##4##6##(1994-7#1)(1997-2#1)(1997-5#1)(2009-5#1)
was a significant increase in the number of##2##8##(1994-5#1)(2012-3#1)
was a significant increase in the##10##6##(1994-5#1)(1997-8#1)(2006-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2012-3#1)(2013-8#2)
was a significant increase in##26##5##(1990-11#1)(1991-1#1)(1993-12#1)(1994-5#1)(1996-9#1)(1997-8#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
was a significant increase of##4##5##(1995-8#1)(2007-7#2)(2012-2#1)
was a significant increase##36##4##(1990-11#1)(1991-1#1)(1993-12#1)(1994-5#1)(1994-7#1)(1995-8#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-8#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#3)(2009-5#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
was a significant independent predictor of##2##6##(2007-10#1)(2012-12#1)
was a significant inverse##3##4##(1994-2#1)(1995-8#1)(1997-8#1)
was a significant negative correlation (R = -0##2##8##(1990-12#1)(2008-10#1)
was a significant negative correlation##12##5##(1990-12#1)(1992-11#1)(1994-2#1)(1994-6#1)(2005-10#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-7#1)(2012-2#1)(2012-6#1)
was a significant positive correlation between##6##6##(2004-11#1)(2007-7#3)(2008-8#1)(2011-1#1)
was a significant positive##8##4##(2004-11#1)(2007-7#3)(2008-10#1)(2008-8#2)(2011-1#1)
was a significant predictor of##7##5##(1995-6#1)(2005-8#1)(2008-5#1)(2010-6#1)(2012-3#2)(2013-1#1)
was a significant predictor##8##4##(1995-6#1)(2005-8#1)(2008-5#1)(2010-6#1)(2012-3#2)(2013-1#1)(2013-7#1)
was a significant reduction in the##5##6##(1993-12#1)(1993-7#1)(1996-1#1)(2007-5#1)(2008-10#1)
was a significant reduction in##9##5##(1993-1#1)(1993-12#1)(1993-7#1)(1995-12#1)(1996-1#1)(2007-5#1)(2008-10#1)(2008-5#1)(2013-1#1)
was a significant reduction of##2##5##(1996-12#1)(2012-2#1)
was a significant reduction##11##4##(1993-1#1)(1993-12#1)(1993-7#1)(1995-12#1)(1996-1#1)(1996-12#1)(2007-5#1)(2008-10#1)(2008-5#1)(2012-2#1)(2013-1#1)
was a significant trend##2##4##(1992-9#1)(2006-12#1)
was a significant##231##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-2#2)(1991-7#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-7#2)(1993-9#1)(1994-2#2)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-12#3)(1996-5#1)(1996-9#2)(1997-2#2)(1997-5#2)(1997-8#3)(2004-11#2)(2004-2#1)(2005-10#3)(2005-8#1)(2006-10#3)(2006-12#2)(2006-4#1)(2006-6#1)(2006-8#4)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#12)(2007-8#2)(2007-9#6)(2008-1#5)(2008-10#16)(2008-11#1)(2008-12#6)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#1)(2009-5#6)(2009-6#1)(2009-8#1)(2010-10#3)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#12)(2012-1#1)(2012-12#5)(2012-2#10)(2012-3#3)(2012-4#1)(2012-6#1)(2013-1#10)(2013-7#3)(2013-8#5)
was a significantly greater##2##4##(1996-12#1)(2008-4#1)
was a significantly##7##3##(1996-12#1)(2007-7#1)(2008-10#1)(2008-4#2)(2010-7#1)(2012-2#1)
was a simple##4##3##(1995-11#1)(2008-10#3)
was a single##10##3##(1992-12#1)(1993-12#1)(1996-12#1)(1997-4#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#1)
was a slight##4##3##(1992-6#1)(2007-2#1)(2008-10#1)(2010-8#1)
was a small##7##3##(1990-5#1)(1992-2#1)(1992-7#1)(1993-2#1)(2008-10#1)(2008-9#1)(2012-1#1)
was a specific##3##3##(1990-5#1)(1996-9#1)(2008-4#1)
was a statistical difference##3##4##(2006-6#1)(2007-6#1)(2012-12#1)
was a statistical##6##3##(1990-12#2)(2006-6#1)(2007-6#1)(2008-3#1)(2012-12#1)
was a statistically significant association between##2##6##(2004-1#1)(2008-1#1)
was a statistically significant difference between the##4##7##(2005-10#1)(2007-6#1)(2009-8#1)(2011-2#1)
was a statistically significant difference between##6##6##(2005-10#1)(2007-12#1)(2007-6#1)(2009-8#1)(2011-2#1)(2012-2#1)
was a statistically significant difference in##6##6##(1993-2#1)(2007-11#1)(2007-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
was a statistically significant difference##14##5##(1993-2#1)(2005-10#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-6#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
was a statistically significant##34##4##(1990-7#1)(1993-10#1)(1993-2#1)(1993-9#1)(1997-6#1)(2004-1#1)(2005-10#1)(2006-10#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#3)(2008-1#1)(2008-4#1)(2009-8#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
was a steady increase in##2##5##(2006-9#1)(2013-8#1)
was a strong association between##3##5##(1990-8#1)(2010-12#1)(2012-3#1)
was a strong correlation between the##3##6##(1990-11#1)(1991-6#1)(2012-2#1)
was a strong correlation between##5##5##(1990-11#1)(1990-8#1)(1991-6#1)(2008-10#1)(2012-2#1)
was a strong correlation##9##4##(1990-11#1)(1990-8#1)(1991-6#1)(1994-8#1)(1995-12#1)(2008-10#3)(2012-2#1)
was a strong relationship between##2##5##(2006-5#1)(2008-9#1)
was a strong structure##2##4##(2005-11#2)
was a strong##29##3##(1990-11#1)(1990-8#2)(1991-6#1)(1994-8#3)(1995-12#1)(1995-6#1)(1997-4#1)(2005-11#2)(2006-5#1)(2007-3#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#2)
was a stronger##2##3##(1994-12#1)(2009-7#1)
was a substantial##4##3##(1991-6#1)(1992-2#1)(2011-12#1)(2012-11#1)
was a suitable##3##3##(2008-10#1)(2008-5#1)(2010-4#1)
was a symptom##3##3##(1991-4#1)(2006-9#1)(2008-5#1)
was a temporary##2##3##(1990-4#1)(1996-2#1)
was a tendency for##4##4##(1991-2#1)(1995-7#1)(2007-12#1)(2010-12#1)
was a tendency to##2##4##(1992-8#1)(2008-11#1)
was a tendency##8##3##(1991-2#1)(1992-8#1)(1993-3#1)(1995-7#1)(2007-12#1)(2008-11#1)(2008-3#1)(2010-12#1)
was a thin##2##3##(1994-11#1)(2008-7#1)
was a time##3##3##(1994-11#1)(2006-12#1)(2009-10#1)
was a transition##2##3##(1990-12#1)(2007-12#1)
was a treatment##2##3##(2006-4#1)(2012-3#1)
was a trend for the##2##5##(1992-11#1)(2008-10#1)
was a trend for##6##4##(1990-2#1)(1992-11#1)(2005-10#1)(2008-10#1)(2008-11#1)(2008-6#1)
was a trend toward better##3##5##(1995-11#1)(2009-3#1)(2012-2#1)
was a trend toward more##2##5##(2008-7#1)(2011-2#1)
was a trend toward##12##4##(1995-11#1)(1995-2#1)(2007-2#1)(2008-10#2)(2008-7#2)(2009-2#1)(2009-3#1)(2011-2#2)(2012-2#1)
was a trend towards improvement in##2##6##(2008-3#1)(2009-3#1)
was a trend towards##11##4##(1992-8#1)(2005-1#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)
was a trend##34##3##(1990-2#1)(1992-11#1)(1992-5#1)(1992-8#1)(1995-11#1)(1995-2#1)(1996-6#1)(2005-1#1)(2005-10#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#3)(2009-2#1)(2009-3#2)(2011-2#2)(2012-2#1)
was a unique##6##3##(1995-2#1)(1996-1#1)(2007-2#1)(2007-8#1)(2013-1#1)(2013-7#1)
was a useful##3##3##(2008-11#1)(2012-12#1)(2013-1#1)
was a validated##2##3##(2010-4#1)(2012-2#1)
was a variant##2##3##(1991-10#1)(2005-9#1)
was a very poor##2##4##(1991-8#1)(1992-3#1)
was a very##12##3##(1990-7#1)(1991-8#2)(1992-3#1)(2005-8#1)(2006-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-1#1)(2011-2#1)(2012-2#1)
was a weak structure##2##4##(2005-11#2)
was a weak##6##3##(1992-6#1)(1994-9#1)(2005-11#2)(2008-10#1)(2008-9#1)
was a wide range##2##4##(1996-3#1)(2008-10#1)
was a wide##7##3##(1996-3#1)(1997-3#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
was a young##3##3##(2010-12#1)(2013-1#2)
was a##1695##2##(1990-10#10)(1990-11#10)(1990-12#13)(1990-2#5)(1990-3#4)(1990-4#7)(1990-5#12)(1990-6#3)(1990-7#8)(1990-8#5)(1990-9#2)(1991-1#3)(1991-10#4)(1991-11#3)(1991-12#5)(1991-2#12)(1991-3#3)(1991-4#8)(1991-5#4)(1991-6#5)(1991-7#3)(1991-8#12)(1991-9#4)(1992-1#3)(1992-10#3)(1992-11#8)(1992-12#9)(1992-2#9)(1992-3#7)(1992-4#5)(1992-5#3)(1992-6#4)(1992-7#6)(1992-8#8)(1992-9#2)(1993-1#5)(1993-10#2)(1993-11#2)(1993-12#15)(1993-2#6)(1993-3#6)(1993-4#1)(1993-5#2)(1993-6#4)(1993-7#5)(1993-8#3)(1993-9#5)(1994-10#1)(1994-11#6)(1994-12#6)(1994-2#6)(1994-3#5)(1994-4#2)(1994-5#6)(1994-6#5)(1994-7#1)(1994-8#12)(1994-9#6)(1995-1#5)(1995-10#3)(1995-11#7)(1995-12#8)(1995-2#5)(1995-3#9)(1995-4#1)(1995-5#4)(1995-6#9)(1995-7#4)(1995-8#6)(1995-9#5)(1996-1#5)(1996-10#2)(1996-11#2)(1996-12#9)(1996-2#4)(1996-3#8)(1996-4#1)(1996-5#10)(1996-6#8)(1996-7#2)(1996-8#1)(1996-9#6)(1997-1#7)(1997-2#4)(1997-3#8)(1997-4#6)(1997-5#8)(1997-6#8)(1997-7#5)(1997-8#6)(2004-1#3)(2004-10#7)(2004-11#3)(2004-12#2)(2004-2#2)(2004-4#1)(2004-9#1)(2005-1#2)(2005-10#8)(2005-11#15)(2005-12#5)(2005-4#2)(2005-6#1)(2005-7#7)(2005-8#6)(2005-9#2)(2006-1#2)(2006-10#20)(2006-11#4)(2006-12#8)(2006-2#4)(2006-3#3)(2006-4#6)(2006-5#11)(2006-6#12)(2006-7#2)(2006-8#18)(2006-9#12)(2007-1#6)(2007-10#9)(2007-11#13)(2007-12#25)(2007-2#24)(2007-3#8)(2007-4#6)(2007-5#7)(2007-6#3)(2007-7#26)(2007-8#35)(2007-9#10)(2008-1#23)(2008-10#139)(2008-11#28)(2008-12#23)(2008-2#8)(2008-3#23)(2008-4#15)(2008-5#38)(2008-6#12)(2008-7#35)(2008-8#30)(2008-9#26)(2009-10#6)(2009-12#2)(2009-2#10)(2009-3#6)(2009-4#5)(2009-5#10)(2009-6#4)(2009-7#7)(2009-8#7)(2009-9#4)(2010-1#6)(2010-10#6)(2010-11#2)(2010-12#11)(2010-2#3)(2010-3#6)(2010-4#8)(2010-5#2)(2010-6#6)(2010-7#3)(2010-8#10)(2010-9#7)(2011-1#32)(2011-11#2)(2011-12#4)(2011-2#56)(2011-3#2)(2012-1#11)(2012-11#3)(2012-12#39)(2012-2#45)(2012-3#23)(2012-4#1)(2012-5#1)(2012-6#2)(2013-1#54)(2013-7#13)(2013-8#35)
was abandoned due to##2##4##(2007-7#1)(2012-3#1)
was abdominal pain##3##3##(1990-9#1)(1991-8#1)(2009-6#1)
was ablated##4##2##(1991-2#1)(2008-11#2)(2008-3#1)
was able to account for##2##5##(1995-12#1)(2009-7#1)
was able to accumulate##2##4##(2006-12#1)(2008-10#1)
was able to achieve##2##4##(1996-3#1)(2012-2#1)
was able to activate the##2##5##(1992-12#1)(1994-8#1)
was able to activate##3##4##(1992-12#1)(1994-8#1)(1995-10#1)
was able to almost completely##2##5##(2005-8#1)(2008-4#1)
was able to amplify##3##4##(1995-2#1)(2008-10#1)(2009-7#1)
was able to assess##2##4##(1992-11#1)(2007-5#1)
was able to be##3##4##(2008-11#2)(2008-5#1)
was able to bind to##3##5##(1993-8#1)(1995-2#1)(1995-3#1)
was able to bind##4##4##(1993-8#1)(1994-8#1)(1995-2#1)(1995-3#1)
was able to capture##3##4##(2006-10#1)(2007-11#1)(2010-9#1)
was able to complement##3##4##(1990-5#1)(1990-9#1)(1995-4#1)
was able to complete the##2##5##(2008-6#1)(2010-8#1)
was able to control##2##4##(1996-1#1)(2011-1#1)
was able to describe##2##4##(2012-3#1)(2013-1#1)
was able to detect##7##4##(1994-2#1)(1995-2#1)(2007-12#1)(2008-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
was able to develop##2##4##(1993-1#1)(2008-1#1)
was able to differentiate##2##4##(1994-9#1)(2008-10#1)
was able to discriminate##2##4##(2008-12#1)(2010-12#1)
was able to disrupt##2##4##(1997-1#1)(2013-7#1)
was able to distinguish between##2##5##(1993-2#1)(2008-10#1)
was able to distinguish##3##4##(1993-2#1)(2007-5#1)(2008-10#1)
was able to down-regulate##2##4##(1994-6#1)(2011-1#1)
was able to enhance the##2##5##(1991-2#1)(1994-5#1)
was able to enhance##4##4##(1990-2#2)(1991-2#1)(1994-5#1)
was able to form##2##4##(1990-2#1)(2011-1#1)
was able to generate##3##4##(1995-2#1)(2008-10#1)(2008-9#1)
was able to grow in##2##5##(2008-11#1)(2008-7#1)
was able to grow on##2##5##(2008-10#1)(2008-5#1)
was able to grow##7##4##(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2012-2#1)
was able to identify the##2##5##(2008-10#1)(2008-4#1)
was able to identify##3##4##(2008-10#1)(2008-4#1)(2011-1#1)
was able to improve##2##4##(2008-5#1)(2013-1#1)
was able to increase##4##4##(1996-5#1)(2008-4#1)(2010-2#1)(2012-12#1)
was able to induce##9##4##(1993-4#1)(1994-12#1)(1994-2#1)(1996-12#1)(1996-4#1)(1997-7#1)(2006-9#1)(2008-10#1)(2008-11#1)
was able to infect##2##4##(2008-10#2)
was able to inhibit the##2##5##(1992-9#1)(2011-12#1)
was able to inhibit##3##4##(1990-11#1)(1992-9#1)(2011-12#1)
was able to maintain##4##4##(2005-12#1)(2008-11#1)(2010-2#1)(2012-1#1)
was able to make##2##4##(1993-2#1)(2008-2#1)
was able to potentiate##2##4##(1996-12#1)(2012-12#1)
was able to predict##2##4##(2008-10#2)
was able to promote the##2##5##(1996-4#1)(2008-3#1)
was able to promote##3##4##(1996-4#1)(2008-10#1)(2008-3#1)
was able to provide##2##4##(1994-12#1)(2008-7#1)
was able to reduce the##3##5##(1995-3#1)(2008-5#1)(2010-12#1)
was able to reduce##7##4##(1995-3#1)(2008-3#1)(2008-5#2)(2008-6#1)(2010-12#1)(2012-2#1)
was able to rescue the##2##5##(1995-11#1)(2008-10#1)
was able to rescue##3##4##(1995-11#1)(1995-3#1)(2008-10#1)
was able to resolve##2##4##(2010-12#1)(2013-1#1)
was able to reverse the##2##5##(1995-12#1)(2012-3#1)
was able to significantly reduce##3##5##(2007-9#1)(2008-10#1)(2008-4#1)
was able to significantly##5##4##(1994-11#1)(1996-5#1)(2007-9#1)(2008-10#1)(2008-4#1)
was able to stay##2##4##(1996-12#1)(1997-2#1)
was able to stimulate##2##4##(1994-2#1)(2008-11#1)
was able to substitute for##2##5##(1993-3#1)(1995-2#1)
was able to support the##2##5##(2008-10#2)
was able to support##5##4##(2008-10#3)(2008-5#2)
was able to suppress##2##4##(1995-3#1)(2007-3#1)
was able to##241##3##(1990-10#2)(1990-11#3)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-1#1)(1991-10#2)(1991-2#2)(1991-6#2)(1991-7#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-2#2)(1993-3#2)(1993-4#1)(1993-8#2)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#5)(1995-3#7)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#4)(1996-3#1)(1996-4#2)(1996-5#4)(1997-1#2)(1997-2#1)(1997-7#1)(1997-8#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-9#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-9#1)(2008-1#2)(2008-10#32)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#6)(2008-5#11)(2008-6#4)(2008-7#3)(2008-8#1)(2008-9#3)(2009-1#1)(2009-3#1)(2009-7#2)(2010-12#4)(2010-2#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#3)(2011-3#1)(2011-7#1)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#13)(2013-7#2)
was able##242##2##(1990-10#2)(1990-11#3)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-1#1)(1991-10#2)(1991-2#2)(1991-6#2)(1991-7#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-2#2)(1993-3#2)(1993-4#1)(1993-8#2)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#5)(1995-3#7)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#4)(1996-3#1)(1996-4#2)(1996-5#4)(1997-1#2)(1997-2#1)(1997-7#1)(1997-8#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-9#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-9#1)(2008-1#2)(2008-10#32)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#6)(2008-5#11)(2008-6#4)(2008-7#3)(2008-8#1)(2008-9#3)(2009-1#1)(2009-3#1)(2009-7#2)(2010-12#4)(2010-2#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-12#3)(2011-3#1)(2011-7#1)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#13)(2013-7#2)
was abnormal in##2##3##(1997-3#1)(2006-12#1)
was abnormal##8##2##(1994-8#1)(1997-3#1)(2006-10#1)(2006-12#1)(2007-2#1)(2008-8#1)(2012-12#1)(2013-1#1)
was abolished after##3##3##(1991-5#1)(2006-4#1)(2007-8#1)
was abolished by prior##2##4##(1992-7#1)(1995-5#1)
was abolished by tetrodotoxin##2##4##(1990-7#1)(1995-5#1)
was abolished by the addition of##4##6##(1992-7#1)(1992-8#1)(1994-6#1)(2013-1#1)
was abolished by the presence of serosal ouabain##2##8##(2008-6#2)
was abolished by the presence of##3##6##(1995-11#1)(2008-6#2)
was abolished by the##9##4##(1990-3#1)(1992-7#2)(1992-8#1)(1994-6#1)(1995-11#1)(2008-6#2)(2013-1#1)
was abolished by##46##3##(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-10#1)(1992-4#1)(1992-7#4)(1992-8#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-5#3)(1996-6#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-7#1)(2008-6#2)(2008-9#1)(2010-12#1)(2011-2#2)(2013-1#1)
was abolished following##2##3##(1992-7#1)(1997-5#1)
was abolished in the presence of##3##6##(1990-5#1)(1991-12#1)(1991-7#1)
was abolished in the##6##4##(1990-5#1)(1991-12#1)(1991-7#1)(1992-3#1)(1996-12#1)(2009-10#1)
was abolished in##12##3##(1990-12#1)(1990-5#1)(1991-12#1)(1991-7#1)(1992-3#1)(1993-2#1)(1995-11#2)(1995-3#1)(1996-12#1)(2008-10#1)(2009-10#1)
was abolished when##2##3##(1997-5#1)(2008-5#1)
was abolished##79##2##(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#2)(1991-12#1)(1991-5#2)(1991-6#1)(1991-7#2)(1991-9#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-7#5)(1992-8#2)(1993-11#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#3)(1995-11#4)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#3)(1996-12#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-5#3)(1997-7#2)(2006-4#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2011-2#2)(2013-1#1)
was about 0##5##3##(1990-9#1)(1991-5#1)(1995-12#1)(2007-3#1)(2008-10#1)
was about 1##11##3##(1990-3#1)(1992-2#1)(1992-6#1)(1996-8#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2010-12#1)(2013-8#1)
was about 10##2##3##(1996-12#1)(2007-8#1)
was about 10(-9) M##2##4##(1996-11#1)(1997-8#1)
was about 10-fold##2##3##(1990-6#1)(2008-5#1)
was about 100-fold##2##3##(1992-9#1)(1996-8#1)
was about 2 times##2##4##(2008-11#1)(2008-6#1)
was about 2##13##3##(1990-7#2)(1990-8#1)(1992-8#1)(1993-2#1)(1997-1#1)(2006-5#1)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#1)(2012-12#1)
was about 20##2##3##(2008-5#1)(2008-8#1)
was about 20% higher##2##4##(2008-11#1)(2009-4#1)
was about 20%##5##3##(1990-4#1)(1992-12#1)(1993-9#1)(2008-11#1)(2009-4#1)
was about 25##3##3##(2008-10#1)(2013-1#2)
was about 3##3##3##(1995-11#1)(2008-10#1)(2008-11#1)
was about 3-fold##2##3##(1997-4#1)(2008-11#1)
was about 30 min##2##4##(2008-10#2)
was about 30##7##3##(1990-10#1)(2008-10#6)
was about 30%##3##3##(1995-6#1)(1996-5#1)(2008-5#1)
was about 4##6##3##(1991-9#1)(1992-9#1)(1993-9#1)(2005-12#1)(2008-7#1)(2011-1#1)
was about 40% of##2##4##(1992-6#1)(2007-8#1)
was about 40%##3##3##(1992-6#1)(2007-8#1)(2011-3#1)
was about 400##2##3##(1990-11#1)(2008-10#1)
was about 44%##2##3##(2006-8#1)(2013-8#1)
was about 5##3##3##(2008-10#3)
was about 5% as##2##4##(1992-5#1)(1997-4#1)
was about 50##3##3##(1994-12#1)(2008-5#1)(2012-2#1)
was about 50% higher than the##2##6##(2008-10#1)(2013-1#1)
was about 50% of that##2##5##(1990-4#1)(1991-1#1)
was about 50% of##3##4##(1990-4#1)(1991-1#1)(1992-4#1)
was about 50%##5##3##(1990-4#1)(1991-1#1)(1992-4#1)(2008-10#1)(2013-1#1)
was about 6##5##3##(1990-5#1)(1991-8#1)(2007-5#1)(2009-11#1)(2011-1#1)
was about 60##2##3##(1996-7#1)(2008-10#1)
was about 60%##3##3##(1990-2#1)(1995-5#1)(2008-5#1)
was about 66##3##3##(1993-8#1)(2013-1#2)
was about 9##2##3##(1992-9#1)(2008-10#1)
was about one##4##3##(1991-7#1)(1993-9#1)(1997-2#1)(2008-8#1)
was about tenfold##2##3##(1997-3#1)(2008-5#1)
was about the same##2##4##(1995-4#1)(2008-10#1)
was about the##3##3##(1995-4#1)(2008-10#1)(2011-2#1)
was about three##3##3##(1992-1#1)(1996-2#1)(2008-10#1)
was about twice as high##3##5##(1993-4#1)(2008-11#2)
was about twice##4##3##(1992-1#1)(1993-4#1)(2008-11#2)
was about two-fold##2##3##(1992-2#1)(1993-6#1)
was about##192##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#3)(1990-5#2)(1990-6#1)(1990-7#4)(1990-8#4)(1990-9#1)(1991-1#2)(1991-2#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#4)(1993-11#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-1#2)(1995-11#1)(1995-12#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#1)(2004-4#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-8#2)(2007-11#2)(2007-3#1)(2007-5#1)(2007-8#3)(2008-10#31)(2008-11#14)(2008-12#1)(2008-5#7)(2008-6#2)(2008-7#2)(2008-8#7)(2008-9#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-12#3)(2011-1#4)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#6)(2013-8#2)
was above 0##3##3##(2007-10#2)(2008-5#1)
was above the##8##3##(1991-10#1)(1994-6#1)(2008-10#1)(2008-6#1)(2010-4#1)(2010-9#1)(2012-2#1)(2013-8#1)
was above##26##2##(1990-5#1)(1991-10#1)(1994-6#1)(1996-11#1)(2007-10#2)(2007-2#1)(2007-7#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-9#1)(2010-4#1)(2010-9#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-8#1)
was abrogated by the##2##4##(1991-12#1)(1992-6#1)
was abrogated by##6##3##(1991-12#1)(1992-6#1)(1992-9#1)(2009-9#1)(2012-12#1)(2012-2#1)
was abrogated##8##2##(1991-12#1)(1992-6#1)(1992-9#1)(1996-12#1)(2008-11#1)(2009-9#1)(2012-12#1)(2012-2#1)
was absence##2##2##(1997-4#1)(2012-2#1)
was absent and the##2##4##(1992-12#1)(2008-10#1)
was absent from the culture##2##5##(1993-9#1)(2009-10#1)
was absent from the##5##4##(1991-8#1)(1993-9#1)(1994-11#1)(1996-4#1)(2009-10#1)
was absent from##10##3##(1991-8#1)(1992-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-5#1)(1996-4#1)(2008-10#1)(2009-10#1)(2012-2#1)
was absent in all##2##4##(1990-3#1)(1992-2#1)
was absent in both##2##4##(2007-3#1)(2009-10#1)
was absent in the##4##4##(1994-11#1)(1997-4#1)(2006-8#1)(2013-8#1)
was absent in##25##3##(1990-12#1)(1990-3#1)(1992-2#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-4#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-10#3)(2008-4#2)(2009-10#1)(2009-5#1)(2012-12#1)(2013-8#1)
was absent when##2##3##(1991-5#1)(2013-1#1)
was absent##74##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-10#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-8#2)(1992-9#1)(1993-2#1)(1993-6#2)(1993-9#1)(1994-11#2)(1994-12#2)(1994-6#1)(1995-10#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-4#1)(1997-7#1)(1997-8#2)(2004-11#1)(2005-11#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#7)(2008-4#2)(2008-5#1)(2008-9#2)(2009-10#2)(2009-3#1)(2009-5#2)(2010-7#1)(2011-12#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
was absolutely##2##2##(1990-7#1)(1992-9#1)
was absorbed by##2##3##(1990-12#1)(2010-12#1)
was absorbed##10##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1992-11#1)(2008-10#3)(2010-12#1)
was abstracted##3##2##(2007-10#1)(2010-2#1)(2011-2#1)
was abundant in the##3##4##(1992-8#1)(2007-12#1)(2008-5#1)
was abundant in##6##3##(1992-5#1)(1992-8#1)(1995-2#1)(1996-5#1)(2007-12#1)(2008-5#1)
was abundant##9##2##(1992-3#1)(1992-5#1)(1992-8#1)(1995-2#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-7#1)
was abundantly expressed in lung##2##5##(1994-9#1)(1996-11#1)
was abundantly expressed in##4##4##(1994-11#2)(1994-9#1)(1996-11#1)
was abundantly##5##2##(1994-11#2)(1994-9#1)(1996-11#1)(2008-4#1)
was academic##2##2##(2012-1#1)(2012-2#1)
was accelerated by##3##3##(1994-3#1)(1996-1#1)(1996-12#1)
was accelerated in the presence of##2##6##(1996-10#1)(2008-9#1)
was accelerated##12##2##(1991-2#1)(1994-3#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#1)(2004-11#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-11#1)
was acceptable and##3##3##(2007-12#1)(2008-1#1)(2013-1#1)
was acceptable to##3##3##(2009-11#1)(2013-1#2)
was acceptable##15##2##(1991-8#1)(1992-11#1)(1992-6#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-11#1)(2011-2#1)(2013-1#3)
was accepted as##3##3##(2006-8#1)(2009-2#1)(2011-1#1)
was accepted at##2##3##(2008-5#1)(2010-8#1)
was accepted by##2##3##(1990-6#1)(2012-12#1)
was accepted##10##2##(1990-6#1)(2006-8#1)(2007-11#1)(2008-5#1)(2009-2#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
was accessed##5##2##(2007-7#1)(2008-10#1)(2008-7#1)(2009-8#1)(2013-1#1)
was accessible##3##2##(2005-10#1)(2012-11#2)
was accidentally##6##2##(1991-6#1)(2007-10#1)(2007-3#1)(2007-8#1)(2007-9#1)(2012-12#1)
was accompanied by a decrease in the##2##7##(1990-11#1)(1991-5#1)
was accompanied by a decrease in##3##6##(1990-11#1)(1991-5#1)(1996-4#1)
was accompanied by a decrease##4##5##(1990-11#1)(1991-5#1)(1992-9#1)(1996-4#1)
was accompanied by a decreased##2##5##(1992-3#1)(2008-11#1)
was accompanied by a large##2##5##(1997-4#2)
was accompanied by a lower##2##5##(1991-2#1)(2013-8#1)
was accompanied by a marked reduction##2##6##(1990-10#1)(1993-12#1)
was accompanied by a marked##4##5##(1990-10#1)(1993-12#1)(1993-9#1)(2012-3#1)
was accompanied by a quantitative##2##5##(1992-1#1)(1996-5#1)
was accompanied by a reduction in##2##6##(1993-3#1)(2012-12#1)
was accompanied by a significant##3##5##(1994-8#1)(2008-4#1)(2008-5#1)
was accompanied by a##45##4##(1990-10#1)(1990-11#2)(1990-3#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-4#2)(2005-10#1)(2006-11#1)(2006-12#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-8#2)(2012-12#1)(2012-3#1)(2013-8#1)
was accompanied by an increase in the##3##7##(1997-8#1)(2008-10#1)(2011-2#1)
was accompanied by an increase in##9##6##(1991-2#1)(1991-6#1)(1992-8#1)(1993-9#1)(1996-6#1)(1997-8#1)(2008-10#1)(2011-2#1)(2012-1#1)
was accompanied by an increase##10##5##(1991-2#1)(1991-6#1)(1992-8#1)(1993-9#1)(1996-6#1)(1997-8#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-1#1)
was accompanied by an##14##4##(1991-2#1)(1991-6#1)(1992-8#1)(1993-9#1)(1996-3#1)(1996-6#1)(1997-8#1)(2008-10#1)(2008-6#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
was accompanied by changes in the##3##6##(1990-3#1)(2007-9#1)(2009-6#1)
was accompanied by changes in##4##5##(1990-3#1)(2007-9#1)(2009-6#1)(2010-4#1)
was accompanied by enhanced##5##4##(1991-10#1)(1996-3#1)(2009-2#2)(2011-1#1)
was accompanied by increases in both##2##6##(2006-6#1)(2012-12#1)
was accompanied by inhibition of##2##5##(1991-5#1)(1992-6#1)
was accompanied by marked##2##4##(1990-3#1)(2011-2#1)
was accompanied by multiple##2##4##(2008-11#1)(2012-12#1)
was accompanied by reduced##2##4##(1992-7#1)(1995-12#1)
was accompanied by significant##2##4##(2008-5#1)(2012-1#1)
was accompanied by the appearance of##2##6##(2006-8#1)(2008-10#1)
was accompanied by the development of##2##6##(2010-3#1)(2012-1#1)
was accompanied by the formation of##2##6##(1995-3#1)(2004-9#1)
was accompanied by the##13##4##(1991-1#1)(1991-9#2)(1993-9#1)(1994-3#1)(1995-3#1)(2004-9#1)(2006-10#1)(2006-8#1)(2008-10#2)(2010-3#1)(2012-1#1)
was accompanied by##131##3##(1990-10#1)(1990-11#2)(1990-3#3)(1990-5#1)(1990-6#1)(1990-7#1)(1991-1#2)(1991-10#2)(1991-2#3)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-3#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-11#2)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#2)(2004-3#1)(2004-9#1)(2005-10#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-6#1)(2006-8#2)(2007-7#1)(2007-9#1)(2008-10#6)(2008-11#4)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#3)(2009-6#2)(2009-8#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#4)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
was accompanied with increased##2##4##(1990-8#1)(2011-2#1)
was accompanied with##5##3##(1990-8#1)(1997-1#1)(2010-6#1)(2011-2#1)(2012-1#1)
was accompanied##138##2##(1990-10#1)(1990-11#2)(1990-3#3)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-10#2)(1991-2#3)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-3#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-11#2)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#3)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#2)(2004-3#1)(2004-9#2)(2005-10#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-6#1)(2006-8#2)(2007-7#1)(2007-9#1)(2008-10#6)(2008-11#4)(2008-4#2)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#3)(2009-6#2)(2009-8#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#1)(2011-12#2)(2011-2#3)(2012-1#5)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
was accomplished after##2##3##(1995-2#1)(2008-9#1)
was accomplished by a##3##4##(1994-4#1)(2008-5#1)(2011-1#1)
was accomplished by the##4##4##(1996-8#1)(1997-2#1)(2007-10#1)(2010-4#1)
was accomplished by using##4##4##(2007-12#1)(2008-10#3)
was accomplished by##40##3##(1992-5#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-12#1)(1994-4#1)(1994-8#1)(1995-5#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(2004-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#2)(2008-10#13)(2008-5#3)(2008-6#1)(2010-4#1)(2011-1#1)
was accomplished in the##3##4##(2010-4#1)(2011-2#1)(2012-12#1)
was accomplished in##11##3##(1995-1#1)(2006-12#1)(2007-2#1)(2008-10#3)(2008-5#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
was accomplished through##4##3##(2006-10#1)(2007-8#1)(2008-2#1)(2009-7#1)
was accomplished using a##5##4##(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#2)
was accomplished using the##2##4##(2006-12#1)(2007-5#1)
was accomplished using##15##3##(1990-9#1)(1992-12#1)(2006-12#1)(2007-5#1)(2007-8#2)(2008-10#4)(2008-5#2)(2008-6#2)(2012-2#1)
was accomplished with a##3##4##(1990-8#1)(2008-10#1)(2008-3#1)
was accomplished with##11##3##(1990-8#1)(1993-4#1)(2007-12#1)(2008-10#4)(2008-3#2)(2008-8#1)(2012-12#1)
was accomplished without##4##3##(1996-8#1)(2007-11#1)(2009-10#1)(2009-8#1)
was accomplished##100##2##(1990-8#1)(1990-9#1)(1992-12#1)(1992-5#1)(1992-7#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-9#1)(1994-12#1)(1994-4#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-2#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-2#1)(2004-9#1)(2005-10#1)(2006-10#2)(2006-12#4)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#5)(2008-1#1)(2008-10#25)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#6)(2008-6#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)
was accounted for by##8##4##(1992-5#1)(1992-9#1)(1994-3#1)(1994-4#1)(1994-6#1)(1997-8#1)(2007-3#1)(2010-2#1)
was accounted for##12##3##(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#1)(1994-3#1)(1994-4#1)(1994-6#1)(1997-8#1)(2006-8#1)(2007-3#1)(2008-10#1)(2010-2#1)
was accounted##14##2##(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#1)(1994-3#1)(1994-4#1)(1994-6#1)(1997-8#1)(2006-8#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-2#1)
was accumulated by##2##3##(2006-10#1)(2008-10#1)
was accumulated in##3##3##(1990-10#1)(1997-5#1)(2010-12#1)
was accumulated on##2##3##(2008-10#2)
was accumulated##16##2##(1990-10#1)(1991-7#1)(1994-6#1)(1997-5#1)(2006-10#1)(2008-10#6)(2008-11#1)(2008-6#1)(2010-12#1)(2011-12#1)(2011-2#1)
was accurate in##3##3##(2007-3#1)(2013-8#2)
was accurate##5##2##(2007-3#1)(2010-2#1)(2011-1#1)(2013-8#2)
was accurately##6##2##(1991-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-8#1)(2013-1#1)
was acetonitrile##2##2##(2008-10#1)(2008-5#1)
was acetonitrile-water##2##2##(2008-10#1)(2010-4#1)
was acetylated with##2##3##(1996-8#1)(2008-10#1)
was acetylated##4##2##(1991-12#1)(1996-8#1)(2006-12#1)(2008-10#1)
was achieved after##9##3##(1995-8#1)(2006-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2009-7#1)(2012-12#1)(2012-2#1)
was achieved and maintained##2##4##(1991-4#1)(2008-11#1)
was achieved and the##3##4##(2005-4#1)(2006-9#1)(2010-12#1)
was achieved and##10##3##(1991-4#1)(2005-4#1)(2006-9#1)(2007-8#1)(2008-10#3)(2008-11#1)(2010-12#1)(2011-2#1)
was achieved as compared with the##2##6##(2008-10#2)
was achieved as compared##3##4##(2008-10#2)(2008-7#1)
was achieved as##6##3##(2007-8#1)(2008-10#3)(2008-7#1)(2011-2#1)
was achieved at a##4##4##(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
was achieved at the##3##4##(1990-6#1)(2008-10#1)(2008-6#1)
was achieved at##23##3##(1990-6#1)(1991-12#1)(1995-3#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-4#1)(2012-12#2)(2012-2#1)
was achieved between##2##3##(2007-11#1)(2008-1#1)
was achieved but##2##3##(2007-11#1)(2007-8#1)
was achieved by a combination of##3##6##(1991-5#1)(2007-11#1)(2008-11#1)
was achieved by a##13##4##(1991-5#1)(1996-12#1)(1996-2#1)(1996-5#2)(2006-8#1)(2007-1#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)
was achieved by an##2##4##(1991-3#1)(2012-2#1)
was achieved by applying##3##4##(2007-6#1)(2008-10#1)(2008-5#1)
was achieved by coupling##2##4##(1991-9#1)(1997-1#1)
was achieved by either##2##4##(1990-12#1)(2008-10#1)
was achieved by injection##2##4##(2007-12#1)(2008-10#1)
was achieved by ion exchange##2##5##(1995-6#1)(2009-9#1)
was achieved by microscopy##2##4##(2008-4#1)(2008-5#1)
was achieved by the##11##4##(2006-5#1)(2008-10#8)(2008-11#1)(2010-2#1)
was achieved by this##2##4##(2007-12#1)(2008-10#1)
was achieved by two##4##4##(1996-12#1)(2008-10#2)(2008-6#1)
was achieved by use of a##2##6##(1990-12#1)(2007-12#1)
was achieved by use of##4##5##(1990-12#1)(1990-4#1)(2007-12#2)
was achieved by using a##2##5##(2008-10#2)
was achieved by using the##3##5##(2007-9#1)(2008-10#1)(2011-2#1)
was achieved by using##14##4##(1990-8#1)(1994-12#1)(2007-9#1)(2008-10#8)(2008-12#1)(2011-2#1)(2013-8#1)
was achieved by##152##3##(1990-11#1)(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#3)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-8#2)(1991-9#2)(1992-2#2)(1993-1#1)(1993-12#1)(1994-11#3)(1994-12#2)(1994-3#1)(1995-1#1)(1995-11#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#3)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-1#4)(2007-11#4)(2007-12#6)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#42)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-4#2)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#1)(2013-8#2)
was achieved during the##2##4##(1996-1#1)(2008-10#1)
was achieved either by##2##4##(1994-3#1)(2008-10#1)
was achieved for a##2##4##(2007-11#1)(2007-12#1)
was achieved for the##3##4##(2007-12#1)(2008-10#2)
was achieved for##22##3##(1994-1#1)(1997-1#1)(2007-11#1)(2007-12#5)(2007-9#1)(2008-10#10)(2008-6#1)(2009-3#1)(2013-8#1)
was achieved from the##2##4##(2007-12#1)(2010-2#1)
was achieved from##5##3##(1996-6#1)(2007-12#1)(2008-10#1)(2010-2#1)(2013-1#1)
was achieved in 100% of##2##5##(2007-7#1)(2010-10#1)
was achieved in 17##4##4##(2004-10#1)(2005-5#1)(2008-6#2)
was achieved in 19##2##4##(2007-8#1)(2011-2#1)
was achieved in 22##2##4##(2007-8#1)(2008-5#1)
was achieved in 29##2##4##(1997-4#1)(2008-10#1)
was achieved in 39##2##4##(1992-1#2)
was achieved in 86%##2##4##(2006-12#1)(2007-7#1)
was achieved in a##6##4##(2007-12#2)(2008-10#1)(2008-3#1)(2009-9#1)(2010-9#1)
was achieved in about##2##4##(2008-10#2)
was achieved in all cases##5##5##(1995-5#1)(2007-8#1)(2008-8#1)(2009-3#1)(2011-2#1)
was achieved in all patients after##2##6##(2008-5#1)(2009-2#1)
was achieved in all patients##5##5##(2006-6#1)(2007-11#1)(2007-8#1)(2008-5#1)(2009-2#1)
was achieved in all##13##4##(1995-5#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2011-2#1)
was achieved in both##2##4##(2007-12#1)(2007-2#1)
was achieved in less than##3##5##(2008-10#3)
was achieved in six patients##2##5##(2006-12#1)(2008-6#1)
was achieved in the presence of##3##6##(1996-6#1)(1997-3#1)(2008-11#1)
was achieved in the##7##4##(1996-6#1)(1997-3#1)(2006-12#2)(2007-11#1)(2008-10#1)(2008-11#1)
was achieved in##128##3##(1990-10#1)(1990-6#1)(1991-6#1)(1991-8#1)(1992-1#2)(1992-12#1)(1992-4#2)(1995-1#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-3#3)(1997-4#2)(1997-8#1)(2004-10#1)(2005-10#1)(2005-5#2)(2005-9#1)(2006-12#7)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#4)(2007-2#1)(2007-7#11)(2007-8#11)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#6)(2008-7#4)(2008-8#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-9#1)(2011-2#6)(2012-12#2)(2012-3#1)(2013-1#2)
was achieved on a##11##4##(1990-8#1)(1994-5#1)(1995-6#1)(1996-3#1)(1996-8#1)(1997-8#1)(2008-10#2)(2009-10#1)(2010-12#1)(2012-12#1)
was achieved on an##6##4##(1996-8#1)(2008-10#2)(2012-12#1)(2013-7#2)
was achieved on the##3##4##(2008-10#1)(2008-11#1)(2013-1#1)
was achieved on##28##3##(1990-8#1)(1994-5#1)(1995-6#1)(1996-3#1)(1996-8#2)(1997-8#1)(2007-3#1)(2008-10#7)(2008-11#1)(2008-5#1)(2009-10#1)(2009-4#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-12#2)(2013-1#2)(2013-7#2)
was achieved only##4##3##(2007-2#1)(2008-10#1)(2008-11#1)(2013-1#1)
was achieved over##2##3##(2008-3#1)(2013-7#1)
was achieved successfully##2##3##(2007-8#1)(2008-10#1)
was achieved through a##2##4##(2008-5#1)(2010-3#1)
was achieved through the##5##4##(2005-8#1)(2007-11#1)(2008-10#2)(2008-2#1)
was achieved through##12##3##(2005-8#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#2)(2010-3#1)
was achieved to##2##3##(2010-6#1)(2011-2#1)
was achieved under##2##3##(2008-10#2)
was achieved using a single##2##5##(1997-3#1)(2008-10#1)
was achieved using a##17##4##(1991-4#1)(1993-2#1)(1996-6#1)(1997-3#1)(1997-8#1)(2006-6#1)(2007-8#2)(2008-10#4)(2008-5#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-12#1)
was achieved using an##2##4##(1996-6#1)(2008-10#1)
was achieved using##37##3##(1990-12#1)(1991-4#1)(1993-2#1)(1995-2#1)(1996-6#2)(1996-7#1)(1997-3#2)(1997-6#1)(1997-8#1)(2006-6#1)(2006-8#1)(2007-7#1)(2007-8#3)(2008-10#9)(2008-11#1)(2008-4#1)(2008-5#2)(2010-12#1)(2010-2#1)(2011-1#1)(2011-3#1)(2012-12#2)(2013-1#1)
was achieved via##3##3##(1996-5#1)(2008-10#1)(2013-1#1)
was achieved when the##6##4##(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-2#1)
was achieved when weather supported severe epidemics##2##7##(2008-10#2)
was achieved when weather supported##3##5##(2008-10#3)
was achieved when##18##3##(1995-6#1)(1996-9#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2010-2#1)
was achieved with 0##4##4##(1990-11#1)(2008-10#2)(2010-4#1)
was achieved with a##15##4##(1997-2#2)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
was achieved with an##2##4##(2005-11#1)(2008-5#1)
was achieved with high##3##4##(2008-10#1)(2008-5#1)(2010-12#1)
was achieved with no##2##4##(1997-7#1)(2008-7#1)
was achieved with the##13##4##(1991-9#1)(1992-8#1)(2005-11#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#4)(2011-2#1)(2012-12#1)
was achieved with##80##3##(1990-10#1)(1990-11#1)(1991-7#1)(1991-9#1)(1992-8#1)(1993-1#1)(1994-3#2)(1995-2#1)(1997-2#3)(1997-5#1)(1997-7#1)(2005-11#2)(2006-9#1)(2007-11#4)(2007-12#7)(2007-2#1)(2007-3#1)(2007-6#1)(2008-1#3)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#3)(2009-10#1)(2009-4#1)(2009-5#1)(2010-12#3)(2010-4#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)
was achieved within a few##2##5##(2005-10#1)(2008-10#1)
was achieved within##10##3##(1995-10#1)(2005-10#1)(2008-10#5)(2008-3#1)(2008-8#1)(2009-11#1)
was achieved without any##2##4##(2008-10#1)(2011-2#1)
was achieved without##7##3##(1993-1#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-1#2)
was achieved##712##2##(1990-10#2)(1990-11#3)(1990-12#4)(1990-2#1)(1990-4#1)(1990-5#4)(1990-6#2)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#3)(1992-1#2)(1992-12#2)(1992-2#2)(1992-4#2)(1992-5#1)(1992-7#1)(1992-8#1)(1993-1#4)(1993-12#3)(1993-2#1)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#4)(1994-3#4)(1994-5#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#4)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#3)(1997-2#4)(1997-3#8)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2004-10#1)(2004-9#1)(2005-10#2)(2005-11#2)(2005-2#1)(2005-4#1)(2005-5#2)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#1)(2006-11#1)(2006-12#10)(2006-4#1)(2006-5#3)(2006-6#6)(2006-8#5)(2006-9#3)(2007-1#5)(2007-10#2)(2007-11#22)(2007-12#37)(2007-2#3)(2007-3#3)(2007-5#1)(2007-6#2)(2007-7#15)(2007-8#26)(2007-9#4)(2008-1#7)(2008-10#168)(2008-11#16)(2008-12#5)(2008-2#7)(2008-3#20)(2008-4#6)(2008-5#17)(2008-6#12)(2008-7#15)(2008-8#8)(2008-9#2)(2009-10#4)(2009-11#1)(2009-2#1)(2009-3#4)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-10#2)(2010-11#1)(2010-12#8)(2010-2#5)(2010-3#3)(2010-4#5)(2010-5#1)(2010-6#1)(2010-9#2)(2011-1#3)(2011-2#19)(2011-3#1)(2012-1#3)(2012-12#14)(2012-2#7)(2012-3#4)(2013-1#18)(2013-7#4)(2013-8#6)
was achiewed in##2##3##(2007-11#2)
was acknowledged##3##2##(2008-7#1)(2009-4#1)(2010-12#1)
was acquired and##2##3##(1993-6#1)(2008-10#1)
was acquired by##7##3##(1994-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-8#1)
was acquired##20##2##(1993-6#1)(1994-8#1)(1995-2#1)(2007-3#1)(2007-8#1)(2008-10#7)(2008-2#3)(2008-5#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
was acting##2##2##(1992-1#1)(1993-2#1)
was activated by the##2##4##(1996-7#1)(2008-5#1)
was activated by##23##3##(1990-10#2)(1990-11#1)(1990-4#1)(1991-4#1)(1991-5#2)(1992-11#1)(1992-9#1)(1993-3#2)(1994-12#1)(1995-1#1)(1995-11#1)(1995-6#1)(1996-7#1)(1997-5#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-11#1)
was activated in the##2##4##(1993-12#1)(1994-12#1)
was activated in##4##3##(1993-12#1)(1994-12#1)(2012-2#2)
was activated to a##3##4##(1991-4#2)(1995-11#1)
was activated to##4##3##(1990-5#1)(1991-4#2)(1995-11#1)
was activated##45##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-4#1)(1990-5#1)(1991-4#3)(1991-5#2)(1992-11#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-3#2)(1994-12#2)(1994-8#1)(1995-1#1)(1995-11#3)(1995-2#1)(1995-6#1)(1996-7#1)(1997-5#1)(1997-6#2)(1997-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-6#1)(2012-2#2)(2012-7#1)
was active against##7##3##(1991-9#1)(1996-8#1)(1997-2#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-5#1)
was active as##2##3##(1990-2#1)(1993-4#1)
was active at##4##3##(1990-7#1)(1992-2#1)(1995-2#1)(2006-8#1)
was active in the##2##4##(1991-11#1)(2005-7#1)
was active in##10##3##(1990-10#1)(1990-12#1)(1991-11#1)(1993-9#1)(1994-2#1)(1997-2#1)(1997-6#1)(2005-7#1)(2008-8#1)(2009-2#1)
was active##39##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-7#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-4#1)(1993-9#1)(1994-2#1)(1995-2#4)(1995-3#1)(1996-8#1)(1997-2#3)(1997-6#1)(1997-8#1)(2004-2#1)(2005-7#1)(2006-8#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-3#1)(2012-12#1)(2012-2#1)(2013-7#1)
was actively##5##2##(1993-2#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-6#1)
was actually##11##2##(1990-7#1)(1991-2#1)(1991-3#1)(1991-7#1)(1995-12#1)(2006-7#1)(2007-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)
was acute##4##2##(1997-5#1)(2006-2#1)(2007-11#1)(2008-7#1)
was acutely##2##2##(2013-1#1)(2013-8#1)
was adapted for the##2##4##(2008-10#1)(2013-1#1)
was adapted for##9##3##(1992-1#1)(2006-8#1)(2008-10#3)(2008-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
was adapted to a##2##4##(2008-10#1)(2010-12#1)
was adapted to the##3##4##(1995-1#1)(2008-10#1)(2008-2#1)
was adapted to##13##3##(1990-8#1)(1991-1#1)(1991-5#1)(1993-12#1)(1995-1#1)(1995-2#1)(2008-10#3)(2008-2#1)(2009-10#1)(2010-12#1)(2012-3#1)
was adapted##27##2##(1990-8#1)(1991-1#1)(1991-5#1)(1992-1#1)(1993-12#1)(1995-1#1)(1995-2#1)(2006-8#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
was added after##2##3##(2008-10#2)
was added as an##2##4##(2008-10#1)(2010-2#1)
was added as##5##3##(1990-12#1)(1990-8#1)(2008-10#1)(2009-8#1)(2010-2#1)
was added at a##2##4##(1994-2#1)(2008-7#1)
was added at the##3##4##(1990-5#1)(1995-11#1)(1996-1#1)
was added at##7##3##(1990-5#1)(1994-2#1)(1995-11#1)(1996-1#1)(2008-10#2)(2008-7#1)
was added followed by##2##4##(1990-5#1)(1991-10#1)
was added for##2##3##(2008-5#1)(2012-3#1)
was added in the presence of low##2##7##(1994-11#2)
was added in the presence of##3##6##(1994-11#2)(1997-5#1)
was added in the second trial##2##6##(2013-1#2)
was added in the##6##4##(1994-11#2)(1997-5#1)(2008-10#1)(2013-1#2)
was added in##12##3##(1992-6#1)(1994-11#2)(1994-2#1)(1997-5#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-6#1)(2013-1#2)
was added into the solution##3##5##(2007-8#1)(2008-10#2)
was added into the##5##4##(2007-8#1)(2008-10#3)(2011-1#1)
was added into##7##3##(2007-8#1)(2008-10#4)(2008-11#1)(2011-1#1)
was added to a##4##4##(2008-10#1)(2008-11#1)(2008-2#1)(2009-6#1)
was added to an##2##4##(1997-2#1)(2008-10#1)
was added to isolated##2##4##(1994-6#1)(2012-2#1)
was added to plasma##2##4##(1996-3#1)(1996-5#1)
was added to prevent the##2##5##(1990-11#1)(2008-10#1)
was added to soil##2##4##(2006-3#1)(2008-10#1)
was added to the apical side of##2##7##(2008-11#2)
was added to the blood##2##5##(2010-5#1)(2013-8#1)
was added to the buffer##2##5##(1994-2#1)(1994-3#1)
was added to the culture##3##5##(1994-12#1)(2008-11#2)
was added to the medium##2##5##(1994-6#1)(2006-4#1)
was added to the patient's##2##5##(1994-6#1)(2008-7#1)
was added to the regimen##2##5##(2007-8#1)(2012-3#1)
was added to the sample solution##2##6##(2008-10#2)
was added to the sample##4##5##(2008-10#4)
was added to the solution##5##5##(2007-8#1)(2008-10#4)
was added to the test##2##5##(1992-9#1)(2008-10#1)
was added to the##77##4##(1990-4#1)(1991-2#2)(1991-3#1)(1992-5#1)(1992-9#2)(1993-12#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1996-5#1)(1996-7#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-2#1)(2007-8#3)(2007-9#1)(2008-10#23)(2008-11#6)(2008-3#1)(2008-5#5)(2008-6#3)(2008-7#1)(2008-9#1)(2010-5#1)(2010-8#1)(2012-3#1)(2013-8#2)
was added to this##2##4##(2008-10#1)(2011-2#1)
was added to##148##3##(1990-11#1)(1990-2#2)(1990-4#2)(1991-12#1)(1991-2#2)(1991-3#3)(1992-2#1)(1992-3#2)(1992-5#1)(1992-9#2)(1993-12#2)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#3)(1994-8#1)(1995-1#2)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-4#1)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#1)(2007-10#1)(2007-2#1)(2007-8#4)(2007-9#1)(2008-10#36)(2008-11#8)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#8)(2008-6#4)(2008-7#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#2)(2009-6#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
was added##248##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-4#2)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-12#1)(1991-2#2)(1991-3#3)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-9#2)(1993-12#2)(1993-3#3)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#2)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-4#1)(2006-3#1)(2006-4#2)(2006-5#4)(2006-6#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#2)(2007-8#6)(2007-9#1)(2008-10#62)(2008-11#14)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#13)(2008-6#8)(2008-7#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#2)(2009-6#1)(2009-8#1)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#3)
was additionally##11##2##(1993-12#1)(1997-7#2)(2006-6#1)(2007-11#1)(2007-7#1)(2008-10#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
was additive##5##2##(1990-4#1)(1993-6#1)(1995-8#1)(2008-10#2)
was addressed by a##2##4##(1995-3#1)(2012-3#1)
was addressed by##4##3##(1995-3#1)(2008-10#1)(2008-7#1)(2012-3#1)
was addressed to the##2##4##(1996-11#1)(2013-7#1)
was addressed##13##2##(1994-8#1)(1995-3#1)(1996-11#1)(2005-10#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
was adequate for the##2##4##(2008-10#1)(2008-6#1)
was adequate for##4##3##(2008-10#1)(2008-6#1)(2008-8#1)(2012-2#1)
was adequate in##2##3##(2008-7#2)
was adequate to##2##3##(2008-10#1)(2008-6#1)
was adequate##12##2##(1991-8#1)(2008-10#2)(2008-6#2)(2008-7#3)(2008-8#2)(2011-2#1)(2012-2#1)
was adhered to##2##3##(1990-4#1)(2007-2#1)
was adherent##2##2##(1991-9#1)(2007-8#1)
was adjusted for##3##3##(2008-11#1)(2008-3#1)(2013-8#1)
was adjusted from##2##3##(1991-4#1)(1994-3#1)
was adjusted to 3##2##4##(2008-10#2)
was adjusted to 6##3##4##(1990-8#1)(2008-10#2)
was adjusted to pH##3##4##(2008-10#2)(2008-7#1)
was adjusted to the##2##4##(2008-5#1)(2008-7#1)
was adjusted to##16##3##(1990-8#1)(2007-9#1)(2008-10#8)(2008-4#1)(2008-5#1)(2008-7#2)(2013-1#2)
was adjusted with a##2##4##(2008-10#1)(2008-2#1)
was adjusted##28##2##(1990-8#1)(1991-4#1)(1991-6#1)(1994-3#1)(1997-1#1)(2007-9#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
was administered Mao-to from day##2##5##(2010-7#2)
was administered alone or##2##4##(1993-12#1)(2007-11#1)
was administered and the##3##4##(2008-12#1)(2011-2#1)(2012-12#1)
was administered and##5##3##(2005-9#1)(2008-12#1)(2011-2#1)(2012-12#2)
was administered as a##2##4##(2007-9#1)(2011-1#1)
was administered as an##2##4##(2007-5#1)(2009-7#1)
was administered as##5##3##(2007-5#1)(2007-9#1)(2009-7#1)(2010-7#1)(2011-1#1)
was administered at a##3##4##(1991-2#1)(1994-2#1)(2013-1#1)
was administered at the beginning##2##5##(1990-3#1)(2007-9#1)
was administered at the##4##4##(1990-3#1)(1995-7#1)(2007-9#1)(2011-2#1)
was administered at##14##3##(1990-3#1)(1991-2#1)(1993-12#1)(1994-2#1)(1995-7#1)(1997-2#1)(2007-12#1)(2007-9#1)(2008-8#1)(2009-5#1)(2011-2#1)(2013-1#2)(2013-7#1)
was administered by##6##3##(1993-10#1)(1997-6#1)(2007-2#1)(2011-1#1)(2012-2#1)(2013-1#1)
was administered concurrently##2##3##(2007-9#1)(2008-7#1)
was administered during the last##2##5##(2008-1#1)(2010-12#1)
was administered during the##4##4##(1993-12#1)(2007-11#1)(2008-1#1)(2010-12#1)
was administered either##2##3##(1992-5#1)(2007-10#1)
was administered every 2##2##4##(2008-7#1)(2011-2#1)
was administered every##5##3##(1991-10#1)(1992-2#1)(2008-7#1)(2011-2#1)(2012-12#1)
was administered for 2##2##4##(1995-11#1)(2012-12#1)
was administered for five##2##4##(2007-7#1)(2013-8#1)
was administered for##15##3##(1990-2#1)(1990-5#1)(1990-9#1)(1992-12#1)(1992-7#1)(1993-2#1)(1995-11#1)(2007-4#1)(2007-7#2)(2008-2#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
was administered i##2##3##(1993-4#1)(1996-4#1)
was administered immediately##2##3##(1994-6#1)(2006-12#1)
was administered in the##2##4##(1991-4#1)(2007-1#1)
was administered in##12##3##(1990-6#2)(1991-4#1)(1991-9#1)(1997-6#1)(2007-1#1)(2007-9#1)(2008-12#1)(2010-7#1)(2010-9#1)(2011-2#1)(2013-1#1)
was administered into##2##3##(1996-3#1)(2008-9#1)
was administered intramuscularly##3##3##(2004-1#1)(2007-2#1)(2008-4#1)
was administered intraperitoneally (i##3##4##(1992-12#1)(1997-2#1)(2007-6#1)
was administered intraperitoneally##5##3##(1992-12#1)(1993-4#1)(1997-2#2)(2007-6#1)
was administered intravenously at the##2##5##(2008-11#1)(2013-1#1)
was administered intravenously##9##3##(1996-4#1)(1997-8#1)(2004-1#1)(2005-8#1)(2006-4#1)(2007-9#1)(2008-10#1)(2008-11#1)(2013-1#1)
was administered on##5##3##(1991-12#1)(1995-9#1)(2007-10#1)(2007-11#1)(2008-6#1)
was administered once##2##3##(1990-5#1)(2006-6#1)
was administered oral##2##3##(2010-7#2)
was administered orally at a dose of##2##7##(1993-7#1)(2013-1#1)
was administered orally at##4##4##(1993-7#1)(2008-5#1)(2009-5#1)(2013-1#1)
was administered orally in##2##4##(2008-5#1)(2011-2#1)
was administered orally to##4##4##(1991-5#1)(1997-3#1)(2008-4#1)(2008-6#1)
was administered orally##12##3##(1991-5#1)(1993-7#1)(1993-8#1)(1995-12#1)(1997-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-5#1)(2011-2#1)(2013-1#1)
was administered over##2##3##(1994-1#1)(2011-2#1)
was administered s##3##3##(1992-4#2)(1994-3#1)
was administered simultaneously with##2##4##(1990-2#1)(2007-2#1)
was administered subcutaneously##3##3##(1995-3#1)(2008-5#1)(2009-8#1)
was administered to 21##2##4##(1992-10#1)(2008-5#1)
was administered to a##5##4##(1994-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2011-12#1)
was administered to all##2##4##(1997-7#1)(2008-7#1)
was administered to mice##2##4##(1997-7#1)(2012-12#1)
was administered to rats##4##4##(1990-5#1)(1991-7#1)(1992-2#1)(1997-8#1)
was administered to the##2##4##(2008-1#1)(2008-3#1)
was administered to two##2##4##(2007-9#1)(2008-10#1)
was administered to##69##3##(1990-5#1)(1990-9#1)(1991-7#1)(1992-10#1)(1992-2#2)(1992-8#1)(1993-2#1)(1994-2#2)(1995-1#1)(1996-10#1)(1996-3#1)(1997-3#1)(1997-7#2)(1997-8#2)(2004-10#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-7#2)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-9#1)(2009-11#1)(2009-5#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
was administered via##2##3##(1996-11#1)(2008-1#1)
was administered with##7##3##(1990-4#1)(2006-5#1)(2008-11#1)(2008-4#1)(2008-8#1)(2013-1#1)(2013-8#1)
was administered##264##2##(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#2)(1990-8#2)(1990-9#2)(1991-10#1)(1991-12#1)(1991-2#4)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-12#4)(1993-2#2)(1993-4#2)(1993-7#1)(1993-8#1)(1994-1#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#3)(1995-7#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#1)(1997-2#3)(1997-3#3)(1997-6#2)(1997-7#2)(1997-8#3)(2004-1#2)(2004-10#1)(2005-10#1)(2005-8#2)(2005-9#1)(2006-10#1)(2006-12#2)(2006-4#2)(2006-5#3)(2006-6#1)(2006-7#3)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#8)(2007-12#2)(2007-2#6)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#9)(2008-1#3)(2008-10#3)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#8)(2008-6#4)(2008-7#6)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#4)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-7#6)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#15)(2012-12#6)(2012-2#3)(2012-3#3)(2013-1#11)(2013-7#4)(2013-8#3)
was administrated##4##2##(1996-7#1)(2008-12#1)(2011-1#1)(2012-3#1)
was admitted because of##6##4##(1993-12#1)(2007-8#2)(2008-7#1)(2009-1#1)(2009-4#1)
was admitted due to##3##4##(1991-8#1)(2009-4#1)(2011-12#1)
was admitted for elective##2##4##(2006-7#1)(2007-8#1)
was admitted for evaluation of##2##5##(2007-7#1)(2009-8#1)
was admitted for surgery##2##4##(2006-10#1)(2007-8#1)
was admitted for##23##3##(1991-6#1)(1992-5#1)(1994-9#1)(2006-10#1)(2006-7#1)(2007-7#1)(2007-8#4)(2008-10#1)(2008-5#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2011-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
was admitted in the ICU##2##5##(2013-1#2)
was admitted in the##5##4##(2011-2#1)(2013-1#4)
was admitted in##8##3##(2006-4#1)(2006-5#1)(2011-2#1)(2013-1#5)
was admitted to a##3##4##(2006-2#1)(2006-4#1)(2007-12#1)
was admitted to hospital because of##3##6##(1991-9#1)(1995-7#1)(2008-4#1)
was admitted to hospital for##2##5##(1993-9#1)(2007-2#1)
was admitted to hospital with acute##2##6##(1990-5#1)(2007-12#1)
was admitted to hospital with##5##5##(1990-5#1)(1993-3#1)(2005-12#1)(2007-12#1)(2012-2#1)
was admitted to hospital##15##4##(1990-5#1)(1990-8#1)(1991-9#1)(1993-3#1)(1993-9#1)(1995-7#1)(2005-12#1)(2007-12#1)(2007-2#1)(2008-4#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#2)
was admitted to our clinic with##2##6##(2005-12#1)(2010-2#1)
was admitted to our clinic##3##5##(2005-12#1)(2007-4#1)(2010-2#1)
was admitted to our department##5##5##(2007-8#1)(2008-12#1)(2011-2#2)(2012-3#1)
was admitted to our hospital because of##2##7##(2007-12#1)(2008-7#1)
was admitted to our hospital because##3##6##(2007-12#1)(2008-1#1)(2008-7#1)
was admitted to our hospital for##6##6##(1991-12#1)(2006-4#1)(2008-1#2)(2012-2#1)(2013-8#1)
was admitted to our hospital with##8##6##(1993-6#1)(2005-12#1)(2007-10#2)(2007-12#1)(2008-1#1)(2011-2#1)(2013-7#1)
was admitted to our hospital##19##5##(1991-12#1)(1993-6#1)(2005-12#1)(2006-4#1)(2007-10#2)(2007-12#2)(2008-1#4)(2008-7#1)(2010-2#1)(2011-2#1)(2012-2#2)(2013-7#1)(2013-8#1)
was admitted to our institution##2##5##(2008-12#1)(2012-2#1)
was admitted to our##32##4##(1991-12#1)(1993-6#1)(1996-1#1)(2005-12#2)(2006-4#1)(2006-9#1)(2007-10#2)(2007-12#2)(2007-4#1)(2007-8#1)(2008-1#4)(2008-12#2)(2008-7#1)(2010-2#2)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
was admitted to the Department of##2##6##(2012-2#1)(2013-8#1)
was admitted to the emergency##3##5##(2007-12#1)(2007-8#2)
was admitted to the hospital because of##4##7##(1993-6#1)(2006-2#1)(2006-4#1)(2008-10#1)
was admitted to the hospital because##5##6##(1993-6#1)(2006-2#1)(2006-4#1)(2008-10#1)(2012-3#1)
was admitted to the hospital##12##5##(1992-3#1)(1993-6#1)(2006-2#1)(2006-4#1)(2008-10#1)(2009-4#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#3)
was admitted to the intensive care unit##3##7##(2006-10#1)(2006-4#2)
was admitted to the##25##4##(1992-3#1)(1993-6#1)(1993-8#1)(2006-10#1)(2006-2#1)(2006-4#3)(2006-7#1)(2007-12#1)(2007-8#2)(2008-10#1)(2009-4#1)(2009-6#1)(2010-7#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
was admitted to##80##3##(1990-5#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1995-7#1)(1996-1#1)(2005-12#3)(2006-10#1)(2006-2#2)(2006-4#5)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#2)(2007-12#5)(2007-2#1)(2007-4#1)(2007-8#3)(2008-1#4)(2008-10#1)(2008-12#2)(2008-4#1)(2008-7#1)(2009-4#1)(2009-6#1)(2010-2#3)(2010-7#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#4)
was admitted with a##8##4##(2005-12#3)(2006-12#1)(2007-8#2)(2008-6#1)(2012-3#1)
was admitted with fever##3##4##(2009-3#1)(2010-12#1)(2011-2#1)
was admitted with##27##3##(1994-10#1)(1994-7#1)(1997-5#1)(2005-12#4)(2006-10#1)(2006-12#1)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-6#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
was admitted##158##2##(1990-5#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-7#1)(1994-9#1)(1995-7#2)(1996-1#1)(1997-5#1)(2005-10#1)(2005-12#7)(2005-5#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-4#7)(2006-5#2)(2006-7#2)(2006-9#1)(2007-10#2)(2007-12#5)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#12)(2008-1#6)(2008-10#3)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-1#1)(2009-12#1)(2009-3#2)(2009-4#4)(2009-6#2)(2009-8#1)(2010-12#2)(2010-2#3)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#9)(2012-1#2)(2012-12#2)(2012-2#8)(2012-3#3)(2013-1#16)(2013-7#2)(2013-8#6)
was adopted and##3##3##(2008-6#1)(2008-8#2)
was adopted as a##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
was adopted as##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
was adopted by##2##3##(2007-5#1)(2008-1#1)
was adopted for the##3##4##(2007-8#1)(2008-10#2)
was adopted for##7##3##(1991-4#1)(2007-8#2)(2008-10#2)(2011-2#2)
was adopted in##6##3##(1993-8#1)(2006-6#1)(2007-6#1)(2008-4#1)(2013-1#2)
was adopted to##8##3##(2008-10#1)(2008-3#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-11#1)(2012-3#1)
was adopted##53##2##(1991-4#1)(1993-10#1)(1993-8#1)(1996-3#1)(2005-5#1)(2006-4#1)(2006-6#1)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
was adsorbed on a small column packed with Sephadex G-25 gel##2##11##(2008-10#2)
was adsorbed on the##2##4##(2008-10#1)(2008-2#1)
was adsorbed on##7##3##(1990-10#1)(1991-5#1)(2008-10#4)(2008-2#1)
was adsorbed onto the##2##4##(2007-8#2)
was adsorbed to##2##3##(1992-9#1)(2006-8#1)
was adsorbed##14##2##(1990-10#1)(1991-5#1)(1992-9#1)(1993-6#1)(2006-8#1)(2007-8#2)(2008-10#4)(2008-2#1)(2008-7#1)(2012-11#1)
was adsorption##2##2##(2008-10#1)(2010-5#1)
was advanced to##2##3##(2007-5#1)(2010-7#1)
was advanced##5##2##(1992-8#1)(2005-9#1)(2007-5#1)(2010-7#1)(2013-1#1)
was advantageous##7##2##(1996-9#1)(2005-11#1)(2008-10#4)(2013-1#1)
was adversely affected by##2##4##(1996-3#1)(2008-6#1)
was adversely affected##3##3##(1996-3#1)(2008-10#1)(2008-6#1)
was advised##8##2##(1993-8#1)(2006-11#1)(2007-8#1)(2008-8#1)(2012-2#2)(2013-1#2)
was affected by both##2##4##(1996-1#1)(2011-2#1)
was affected by temperature##2##4##(2008-10#1)(2012-2#1)
was affected by the##14##4##(1990-8#1)(1991-3#1)(1991-5#1)(1992-1#1)(1995-2#1)(2004-4#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)
was affected by##49##3##(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-3#1)(1992-7#1)(1995-2#1)(1996-1#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-4#1)(2004-4#1)(2005-11#1)(2005-8#1)(2006-8#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#3)(2008-9#2)(2009-4#1)(2009-7#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-2#1)(2013-7#1)(2013-8#1)
was affected in the##2##4##(2011-1#1)(2013-8#1)
was affected in##6##3##(1995-12#1)(1996-3#1)(2007-2#1)(2008-9#1)(2011-1#1)(2013-8#1)
was affected mainly by##4##4##(2008-10#4)
was affected significantly (P &lt##2##5##(1996-6#1)(2008-10#1)
was affected significantly##3##3##(1996-6#1)(2008-10#2)
was affected##81##2##(1990-8#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-3#1)(1992-7#1)(1994-11#1)(1994-3#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#2)(1997-1#1)(1997-4#1)(1997-7#1)(2004-4#1)(2005-11#1)(2005-8#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-10#15)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#3)(2009-4#1)(2009-5#1)(2009-7#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#2)
was after##3##2##(1992-6#1)(2008-7#1)(2010-6#1)
was afterwards##2##2##(2008-10#2)
was again determined##2##3##(2008-9#1)(2010-2#1)
was again observed##2##3##(1993-7#1)(2007-6#1)
was again##15##2##(1991-2#1)(1992-10#2)(1993-11#1)(1993-7#1)(1993-8#1)(1994-12#1)(1995-3#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-6#1)(2008-3#1)(2008-9#1)(2010-2#1)
was against##3##2##(2013-1#3)
was age##2##2##(1995-8#1)(2008-7#1)
was aggregated##2##2##(1993-6#1)(2008-10#1)
was agreed##5##2##(1993-9#1)(2007-11#1)(2008-10#1)(2008-4#1)(2010-8#1)
was agreement##4##2##(2007-8#1)(2008-9#1)(2009-10#1)(2011-10#1)
was aimed at assessing the##3##5##(2007-8#1)(2008-7#1)(2013-8#1)
was aimed at characterizing##2##4##(1994-2#1)(2008-10#1)
was aimed at determining##2##4##(1994-8#1)(1995-12#1)
was aimed at the##3##4##(2008-3#1)(2009-2#1)(2012-12#1)
was aimed at##39##3##(1990-2#1)(1990-6#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-5#1)(1997-6#1)(2005-8#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-7#1)(2009-2#2)(2009-5#1)(2009-6#1)(2010-12#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-12#5)(2013-1#2)(2013-8#3)
was aimed to develop##3##4##(2010-12#1)(2010-5#1)(2012-3#1)
was aimed to##25##3##(1991-6#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#3)(2008-5#2)(2009-12#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
was aimed##64##2##(1990-2#1)(1990-6#1)(1991-6#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-5#1)(1997-6#1)(2005-8#1)(2006-6#1)(2007-7#2)(2007-8#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#2)(2008-7#1)(2009-12#1)(2009-2#2)(2009-5#1)(2009-6#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#8)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
was aligned##3##2##(1991-2#1)(1993-6#1)(2008-11#1)
was alive##4##2##(1994-12#1)(1996-12#1)(2008-6#1)(2013-1#1)
was all##3##2##(2008-10#1)(2010-4#1)(2013-1#1)
was alleviated by##2##3##(1991-12#1)(1996-3#1)
was alleviated##3##2##(1991-12#1)(1996-3#1)(2009-8#1)
was allocated##2##2##(1991-9#1)(2008-8#1)
was allowed to dry##2##4##(2008-10#2)
was allowed to oviposit 0##2##5##(2007-6#2)
was allowed to react with##2##5##(1992-9#1)(2009-9#1)
was allowed to##21##3##(1990-12#2)(1990-5#1)(1992-9#1)(1993-11#1)(1996-1#1)(2004-9#3)(2007-11#1)(2007-6#2)(2007-8#1)(2008-10#3)(2009-9#1)(2010-12#1)(2010-2#1)(2012-12#1)(2013-7#1)
was allowed##27##2##(1990-12#2)(1990-5#1)(1992-9#1)(1993-11#1)(1996-1#1)(1996-3#1)(1996-8#1)(2004-9#3)(2007-11#1)(2007-6#2)(2007-8#2)(2007-9#1)(2008-10#3)(2009-1#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2012-12#1)(2013-7#1)
was almost a##2##3##(1996-12#1)(2008-10#1)
was almost complete##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
was almost completely abolished##2##4##(1993-6#1)(1994-2#1)
was almost completely inhibited by##4##5##(1994-2#1)(1994-9#1)(1995-1#1)(2008-10#1)
was almost completely##15##3##(1991-4#1)(1992-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-6#1)(1997-8#1)(2005-11#1)(2008-10#1)(2008-6#1)
was almost equal to that of##2##6##(1992-5#1)(2007-4#1)
was almost equally##3##3##(1994-12#1)(2006-5#1)(2011-1#1)
was almost exclusively##2##3##(2006-8#1)(2008-10#1)
was almost fully##2##3##(1992-9#1)(1995-8#1)
was almost identical to##2##4##(1997-5#1)(2007-2#1)
was almost identical##4##3##(1995-7#1)(1997-5#1)(2007-2#1)(2007-7#1)
was almost independent of##2##4##(2005-11#1)(2008-10#1)
was almost lost##2##3##(2008-2#1)(2008-9#1)
was almost normal##2##3##(2007-2#1)(2012-1#1)
was almost the same as that of##2##7##(1992-3#1)(2008-5#1)
was almost the same as that##3##6##(1992-3#1)(2008-5#2)
was almost the same##4##4##(1992-3#1)(2008-10#1)(2008-5#2)
was almost totally##2##3##(2008-10#1)(2008-6#1)
was almost twice that##2##4##(2006-10#1)(2006-12#1)
was almost twice##3##3##(2006-10#1)(2006-12#1)(2008-7#1)
was almost uniformly##2##3##(1991-2#1)(1996-3#1)
was almost##80##2##(1990-10#1)(1990-5#2)(1991-2#1)(1991-4#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-12#1)(1994-2#2)(1994-6#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#2)(1997-4#1)(1997-5#1)(1997-8#1)(2005-11#3)(2006-10#1)(2006-12#1)(2006-5#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#2)(2008-1#1)(2008-10#10)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)
was already done##2##3##(1990-3#2)
was already evident##2##3##(1994-8#1)(1995-7#1)
was already in##3##3##(1990-11#1)(2008-10#1)(2008-11#1)
was already present in##3##4##(1990-4#1)(1991-12#1)(2009-2#1)
was already present##4##3##(1990-4#1)(1990-8#1)(1991-12#1)(2009-2#1)
was already shown##2##3##(1994-11#1)(2010-5#1)
was already well##2##3##(1990-4#1)(2006-7#1)
was already##32##2##(1990-11#1)(1990-2#1)(1990-3#2)(1990-4#2)(1990-8#1)(1991-12#2)(1991-3#1)(1992-5#1)(1994-11#1)(1994-8#1)(1995-7#1)(1997-7#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-2#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-8#1)(2009-2#2)(2009-6#1)(2010-5#1)(2013-1#2)
was also a significant##11##4##(1991-2#1)(1992-1#1)(1994-8#1)(1995-8#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-4#1)(2008-10#1)(2008-5#1)(2012-2#1)
was also a small but significant##2##6##(1997-3#1)(1997-5#1)
was also a##42##3##(1990-5#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-10#1)(1993-12#1)(1993-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-10#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-8#1)(2005-8#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-10#3)(2008-12#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-6#1)(2012-2#1)
was also able to increase the##2##6##(2008-4#1)(2011-1#1)
was also able to induce##3##5##(1992-8#1)(2006-8#1)(2009-10#1)
was also able to inhibit##2##5##(1992-8#1)(1996-12#1)
was also able to##12##4##(1992-3#1)(1992-7#1)(1992-8#2)(1994-12#1)(1995-12#1)(1996-12#1)(2006-8#1)(2008-10#1)(2008-4#1)(2009-10#1)(2011-1#1)
was also able##13##3##(1992-3#1)(1992-7#1)(1992-8#2)(1994-12#1)(1995-12#1)(1996-12#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-10#1)(2011-1#1)
was also accelerated##2##3##(1990-5#1)(1993-12#1)
was also accompanied by##4##4##(1991-5#1)(1991-9#1)(2008-10#1)(2009-5#1)
was also achieved with##3##4##(1994-5#1)(2007-11#1)(2011-1#1)
was also achieved##5##3##(1994-5#1)(2007-11#1)(2008-10#2)(2011-1#1)
was also active on rac1 p21##2##6##(1992-1#2)
was also active##6##3##(1991-10#1)(1992-1#2)(1993-6#1)(1994-8#1)(1995-7#1)
was also added to##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
was also adjusted##2##3##(2007-12#1)(2009-7#1)
was also administered##2##3##(1991-11#1)(2010-1#1)
was also affected by the##4##5##(1994-9#1)(2006-5#1)(2008-10#2)
was also affected by##10##4##(1994-11#1)(1994-9#1)(1995-5#1)(1995-6#2)(2006-5#1)(2008-10#2)(2009-2#1)(2011-2#1)
was also affected##11##3##(1993-3#1)(1994-11#1)(1994-9#1)(1995-5#1)(1995-6#2)(2006-5#1)(2008-10#2)(2009-2#1)(2011-2#1)
was also altered##3##3##(1994-3#1)(1996-4#2)
was also an increase in##4##5##(1997-1#1)(2006-8#1)(2007-12#1)(2013-1#1)
was also an##16##3##(1993-9#1)(1995-3#1)(1997-1#1)(1997-3#1)(2005-8#1)(2006-8#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-12#1)(2013-1#1)
was also analysed##6##3##(1991-6#1)(1993-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2010-4#1)
was also analyzed##11##3##(1992-2#1)(1995-6#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2009-3#1)(2012-2#1)(2013-1#1)
was also apparent in##2##4##(2008-10#1)(2012-1#1)
was also apparent##4##3##(1997-8#1)(2008-10#1)(2008-12#1)(2012-1#1)
was also applicable to other##2##5##(1992-2#1)(1993-2#1)
was also applicable to##4##4##(1991-8#1)(1992-2#1)(1993-2#1)(2010-5#1)
was also applicable##5##3##(1991-8#1)(1992-2#1)(1993-2#1)(1993-9#1)(2010-5#1)
was also applied for the##3##5##(2006-12#1)(2007-1#1)(2008-10#1)
was also applied for##4##4##(2006-12#1)(2007-1#1)(2008-10#2)
was also applied to estimate##2##5##(2007-8#1)(2008-10#1)
was also applied to the##5##5##(1996-3#1)(2008-10#2)(2008-5#2)
was also applied to##16##4##(1990-12#1)(1996-3#1)(2006-10#1)(2007-8#1)(2008-10#7)(2008-5#2)(2011-2#1)(2012-2#1)(2013-8#1)
was also applied##25##3##(1990-12#1)(1996-3#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-8#2)(2008-10#13)(2008-5#2)(2011-2#1)(2012-2#1)(2013-8#1)
was also assessed and##2##4##(2007-2#1)(2008-4#1)
was also assessed by##3##4##(2008-10#1)(2009-12#1)(2012-2#1)
was also assessed##31##3##(1991-10#1)(1991-2#1)(1993-1#1)(1993-2#1)(1994-12#2)(1997-4#1)(2004-11#1)(2006-9#1)(2007-12#1)(2007-2#2)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-2#1)
was also associated with a decrease in##2##7##(2005-10#1)(2007-9#1)
was also associated with a significant increase##2##7##(1990-9#1)(1994-6#1)
was also associated with a##12##5##(1990-9#1)(1994-6#1)(1996-8#1)(1997-5#1)(2005-10#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-7#1)(2013-1#1)
was also associated with an increased likelihood of##2##8##(2013-1#2)
was also associated with an##4##5##(1993-11#1)(1996-5#1)(2013-1#2)
was also associated with increased##2##5##(2012-2#1)(2012-6#1)
was also associated with the##5##5##(1990-5#1)(1994-6#1)(2006-9#1)(2008-8#1)(2012-2#1)
was also associated with##41##4##(1990-5#1)(1990-9#1)(1993-11#1)(1993-4#1)(1994-6#3)(1995-1#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-5#1)(1997-8#1)(2005-10#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-8#1)(2010-7#2)(2011-1#1)(2012-1#2)(2012-2#2)(2012-3#1)(2012-6#1)(2013-1#5)(2013-7#1)
was also associated##43##3##(1990-3#1)(1990-5#1)(1990-9#1)(1993-11#1)(1993-4#1)(1994-6#3)(1995-1#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-5#1)(1997-8#1)(2005-10#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-6#1)(2008-8#1)(2010-7#2)(2011-1#1)(2012-1#2)(2012-2#2)(2012-3#1)(2012-6#1)(2013-1#5)(2013-7#1)
was also attenuated##3##3##(1990-12#1)(1994-9#1)(2008-11#1)
was also blocked by##3##4##(1991-9#1)(1995-12#1)(2008-11#1)
was also bound##2##3##(1993-3#1)(2010-10#1)
was also briefly##2##3##(1994-9#1)(2009-10#1)
was also calculated##3##3##(2005-4#1)(2011-1#1)(2011-2#1)
was also capable of##2##4##(2008-6#1)(2013-1#1)
was also carried out and##2##5##(2005-11#1)(2008-10#1)
was also carried out by##2##5##(2007-8#1)(2008-10#1)
was also carried out in##2##5##(2007-5#1)(2008-2#1)
was also carried out with##2##5##(2011-1#1)(2013-1#1)
was also carried out##18##4##(1993-2#1)(1993-6#1)(2005-11#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2009-6#1)(2009-7#1)(2010-5#1)(2011-1#1)(2013-1#2)
was also changed##3##3##(1993-11#1)(2005-11#1)(2007-4#1)
was also characterized by##3##4##(1991-1#1)(2007-11#1)(2008-10#1)
was also characterized##6##3##(1991-1#1)(1991-8#1)(2005-4#1)(2007-11#1)(2008-10#1)(2012-1#1)
was also checked by##2##4##(2008-10#1)(2012-1#1)
was also compared with##2##4##(2007-8#1)(2008-10#1)
was also compared##9##3##(1993-9#1)(1995-5#1)(1995-8#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
was also conducted to##2##4##(2008-5#1)(2013-8#1)
was also conducted##4##3##(2008-5#1)(2013-1#1)(2013-8#2)
was also confirmed by##9##4##(1990-3#1)(1990-4#1)(1992-4#1)(1992-7#1)(1993-9#2)(2005-12#1)(2008-10#1)(2010-10#1)
was also confirmed in##3##4##(1990-7#1)(1993-2#1)(2008-5#1)
was also confirmed##20##3##(1990-3#1)(1990-4#1)(1990-7#1)(1992-4#1)(1992-7#1)(1993-2#1)(1993-9#2)(1996-5#1)(2005-12#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-7#1)(2010-10#1)(2010-8#1)
was also considered##5##3##(1990-10#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#1)
was also constructed and##2##4##(1992-7#1)(1995-8#1)
was also constructed##3##3##(1992-7#1)(1995-8#1)(2008-3#1)
was also correlated with the##2##5##(1995-7#1)(1996-3#1)
was also correlated with##3##4##(1991-11#1)(1995-7#1)(1996-3#1)
was also decreased by##2##4##(1994-11#1)(1995-2#1)
was also decreased in##2##4##(1994-2#1)(1996-1#1)
was also decreased##10##3##(1990-3#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-7#1)(1996-1#1)(1996-5#1)(1997-7#1)(2009-12#1)
was also delayed##2##3##(1997-3#1)(2013-1#1)
was also demonstrated by##3##4##(1995-3#1)(1995-8#1)(2008-10#1)
was also demonstrated for##2##4##(1994-12#1)(2008-10#1)
was also demonstrated in##5##4##(1991-5#1)(1991-9#1)(1995-12#1)(2007-9#1)(2008-5#1)
was also demonstrated##36##3##(1990-2#1)(1990-5#1)(1991-5#1)(1991-9#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#1)(1997-1#1)(2004-2#1)(2007-12#1)(2007-9#2)(2008-10#8)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2011-1#1)
was also dependent on the##6##5##(1994-10#1)(1994-9#1)(2008-10#1)(2008-4#2)(2008-7#1)
was also dependent on##10##4##(1991-4#1)(1994-10#1)(1994-2#1)(1994-9#1)(1995-1#1)(1996-9#1)(2008-10#1)(2008-4#2)(2008-7#1)
was also described in##2##4##(2006-12#1)(2007-11#1)
was also described##9##3##(2006-12#1)(2007-11#1)(2007-7#1)(2008-10#3)(2010-3#1)(2013-1#2)
was also detectable in the##2##5##(1990-10#1)(2008-4#1)
was also detectable in##5##4##(1990-10#1)(1991-5#1)(1992-11#1)(1993-5#1)(2008-4#1)
was also detectable##6##3##(1990-10#1)(1991-3#1)(1991-5#1)(1992-11#1)(1993-5#1)(2008-4#1)
was also detected for##3##4##(1996-6#1)(2008-10#2)
was also detected in cultured##2##5##(1991-3#1)(1992-9#1)
was also detected in some##4##5##(1995-11#1)(1996-12#1)(1997-8#1)(2003-11#1)
was also detected in the##10##5##(1991-12#1)(1993-3#1)(1993-7#1)(1994-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(2006-12#1)(2008-8#1)(2009-2#1)
was also detected in##32##4##(1990-8#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#1)(1997-8#1)(2003-11#1)(2006-12#1)(2008-1#1)(2008-10#6)(2008-5#1)(2008-8#1)(2009-2#1)
was also detected only in##2##5##(1990-11#1)(2012-12#1)
was also detected##50##3##(1990-10#1)(1990-11#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-12#2)(1996-2#2)(1996-4#1)(1996-5#1)(1996-6#1)(1997-8#1)(2003-11#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-4#1)(2012-12#1)
was also determined by##5##4##(1990-12#1)(1993-12#1)(2008-10#3)
was also determined in##4##4##(1991-12#1)(2007-10#1)(2008-10#1)(2008-5#1)
was also determined using##3##4##(2008-10#2)(2008-4#1)
was also determined##29##3##(1990-12#1)(1990-2#1)(1991-12#1)(1992-12#1)(1993-12#1)(1997-4#1)(2007-10#1)(2007-4#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-4#1)(2008-5#3)(2009-12#1)(2009-3#1)(2010-1#1)(2011-2#1)
was also developed for##3##4##(2008-10#3)
was also developed to##6##4##(1991-5#1)(2005-11#1)(2007-6#1)(2008-10#2)(2008-3#1)
was also developed##15##3##(1990-8#1)(1991-2#1)(1991-5#1)(2005-11#1)(2007-6#1)(2008-10#7)(2008-3#2)(2010-12#1)
was also diagnosed##2##3##(2006-4#1)(2011-2#1)
was also diminished##4##3##(1990-5#1)(1994-10#1)(1995-3#1)(2012-11#1)
was also directly##2##3##(1992-9#1)(2011-2#1)
was also discovered##2##3##(1994-3#1)(2006-10#1)
was also discussed##18##3##(1993-3#1)(2007-12#1)(2008-10#11)(2008-2#1)(2008-5#1)(2008-8#1)(2011-12#1)(2011-3#1)
was also documented by##2##4##(1996-2#1)(2008-5#1)
was also documented##4##3##(1996-2#1)(2007-9#1)(2008-5#1)(2011-2#1)
was also done with##3##4##(1992-6#1)(1994-12#1)(2007-7#1)
was also done##6##3##(1992-6#1)(1994-12#1)(2007-7#1)(2008-5#1)(2012-2#1)(2013-8#1)
was also effective in##7##4##(1990-3#1)(1990-5#1)(1991-11#1)(1994-10#1)(1994-8#1)(2007-11#1)(2008-11#1)
was also effective##10##3##(1990-3#1)(1990-5#1)(1991-11#1)(1994-10#1)(1994-8#1)(1997-4#1)(2007-11#2)(2008-11#1)(2012-11#1)
was also elevated##2##3##(1995-2#1)(2006-10#1)
was also employed to##2##4##(1993-8#1)(2005-11#1)
was also employed##3##3##(1993-8#1)(2005-11#1)(2008-8#1)
was also enhanced by##2##4##(1997-4#1)(2008-5#1)
was also enhanced in##4##4##(1993-12#1)(2007-11#1)(2008-11#1)(2008-3#1)
was also enhanced##8##3##(1991-3#1)(1993-12#1)(1994-2#1)(1997-4#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-5#1)
was also essentially##2##3##(1995-2#1)(1995-5#1)
was also estimated##6##3##(1996-8#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-9#1)(2012-2#1)
was also evaluated and##2##4##(2008-10#2)
was also evaluated in##5##4##(2008-10#1)(2008-12#2)(2008-5#1)(2009-9#1)
was also evaluated using##2##4##(2008-10#1)(2008-11#1)
was also evaluated with two##2##5##(1997-3#1)(1997-8#1)
was also evaluated with##3##4##(1997-3#1)(1997-8#1)(2010-2#1)
was also evaluated##38##3##(1995-11#1)(1997-3#2)(1997-8#1)(2004-12#1)(2005-11#1)(2006-10#1)(2007-8#1)(2008-10#18)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#1)(2009-2#1)(2009-9#1)(2010-2#1)(2010-4#2)(2012-3#1)
was also evidence for##2##4##(2008-11#1)(2008-9#1)
was also evidence##4##3##(1991-8#1)(1996-6#1)(2008-11#1)(2008-9#1)
was also evidenced##2##3##(2008-8#1)(2012-3#1)
was also evident in the##3##5##(1990-11#1)(1995-8#1)(2008-10#1)
was also evident##9##3##(1990-11#1)(1990-12#1)(1991-9#1)(1995-8#1)(2008-10#3)(2009-4#1)(2012-12#1)
was also examined and##3##4##(1991-2#1)(1994-11#1)(2008-10#1)
was also examined for##2##4##(2008-10#2)
was also examined in the##3##5##(1996-6#1)(1997-8#1)(2008-10#1)
was also examined in##5##4##(1994-9#1)(1995-12#1)(1996-6#1)(1997-8#1)(2008-10#1)
was also examined using##2##4##(1992-3#1)(2008-10#1)
was also examined##36##3##(1991-12#1)(1991-2#2)(1992-1#1)(1992-3#1)(1992-5#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-6#2)(1997-2#1)(1997-4#1)(1997-8#1)(2007-10#1)(2007-4#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-6#1)
was also explored##7##3##(2006-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2009-10#1)(2010-1#1)(2013-1#1)
was also expressed as a##2##5##(1991-8#1)(1992-9#1)
was also expressed as##3##4##(1991-8#1)(1992-9#1)(2008-4#1)
was also expressed in the##2##5##(1995-11#1)(1996-2#1)
was also expressed in##7##4##(1995-11#2)(1996-2#1)(1996-8#1)(1997-5#1)(2008-8#1)(2008-9#1)
was also expressed##13##3##(1990-9#1)(1991-8#1)(1992-9#1)(1995-11#2)(1996-2#1)(1996-8#1)(1997-2#1)(1997-5#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-11#1)
was also followed by##2##4##(1994-5#1)(1995-10#1)
was also followed##3##3##(1994-5#1)(1995-10#1)(2008-10#1)
was also formed##3##3##(1990-8#1)(1995-5#1)(2008-12#1)
was also found at##2##4##(1994-11#1)(2008-10#1)
was also found between##3##4##(1997-2#1)(2006-10#1)(2007-7#1)
was also found by##2##4##(1990-4#1)(2008-7#1)
was also found for the##2##5##(2008-10#1)(2009-7#1)
was also found for##5##4##(2007-6#1)(2008-10#2)(2008-3#1)(2009-7#1)
was also found in patients##2##5##(1995-2#1)(2012-3#1)
was also found in the##5##5##(1993-6#1)(1995-3#1)(2007-11#1)(2008-11#1)(2009-6#1)
was also found in##27##4##(1990-11#2)(1990-2#1)(1991-9#2)(1992-5#1)(1992-9#1)(1993-6#1)(1995-2#1)(1995-3#1)(1995-9#1)(1997-4#1)(1997-6#1)(2006-4#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-5#1)(2009-6#1)(2010-3#1)(2010-9#1)(2012-12#1)(2012-3#1)
was also found significantly##2##4##(2008-6#1)(2010-12#1)
was also found that this##2##5##(1993-5#1)(2010-5#1)
was also found that##30##4##(1990-2#1)(1992-9#1)(1993-4#1)(1993-5#1)(1995-2#1)(1996-9#1)(2005-11#1)(2007-12#1)(2007-6#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-5#5)(2008-7#2)(2008-8#2)(2010-5#2)(2011-2#1)(2012-11#1)
was also found to be a significant##2##7##(1996-3#1)(2006-8#1)
was also found to be a##3##6##(1996-3#1)(2006-8#1)(2007-12#1)
was also found to be effective##3##6##(1991-12#1)(2006-10#1)(2010-7#1)
was also found to be related to##2##7##(1997-1#1)(2008-2#1)
was also found to be##28##5##(1990-9#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-2#1)(1994-9#2)(1996-3#1)(1996-5#1)(1997-1#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-5#1)(2008-7#1)(2010-7#1)(2012-2#1)
was also found to decrease##2##5##(1990-5#1)(2011-2#1)
was also found to##41##4##(1990-5#1)(1990-9#1)(1991-12#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-9#2)(1995-6#1)(1995-8#1)(1996-3#2)(1996-5#1)(1996-8#1)(1997-1#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#3)(2008-5#2)(2008-7#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-2#1)
was also found with##2##4##(1995-1#1)(2008-3#1)
was also found##134##3##(1990-11#2)(1990-2#2)(1990-4#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-9#3)(1992-11#1)(1992-12#3)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#2)(1993-5#1)(1993-6#3)(1994-11#2)(1994-9#2)(1995-1#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2004-9#1)(2005-11#2)(2006-10#3)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-6#2)(2007-7#1)(2008-1#1)(2008-10#18)(2008-11#2)(2008-2#5)(2008-3#2)(2008-5#8)(2008-6#1)(2008-7#4)(2008-8#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
was also greater in##3##4##(1992-7#1)(2008-5#1)(2010-4#1)
was also greater##5##3##(1992-7#1)(1993-8#1)(2007-1#1)(2008-5#1)(2010-4#1)
was also high##2##3##(1990-10#1)(2012-3#1)
was also higher among##2##4##(1991-9#1)(1994-6#1)
was also higher in##9##4##(1991-12#1)(1996-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
was also higher##18##3##(1991-12#1)(1991-9#1)(1994-12#1)(1994-6#1)(1996-12#1)(2006-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
was also highly##4##3##(1990-1#1)(1991-7#1)(2008-5#1)(2009-6#1)
was also identical##2##3##(1993-3#1)(1994-6#1)
was also identified as a##3##5##(1995-5#1)(1996-5#1)(2008-1#1)
was also identified in##3##4##(1996-9#1)(2008-10#2)
was also identified##14##3##(1990-9#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-5#1)(1996-5#1)(1996-7#1)(1996-9#1)(2008-1#1)(2008-10#3)(2012-1#1)
was also impaired##3##3##(1992-9#1)(1997-4#1)(1997-5#1)
was also implemented##2##3##(2007-10#1)(2008-3#1)
was also improved##3##3##(1996-6#1)(2007-8#1)(2008-10#1)
was also in the##2##4##(1990-5#1)(1991-4#1)
was also in##5##3##(1990-5#1)(1991-4#2)(2005-10#1)(2008-10#1)
was also included in the##4##5##(1994-2#1)(2008-10#2)(2008-5#1)
was also included in##5##4##(1994-2#1)(2008-10#2)(2008-5#1)(2009-4#1)
was also included##9##3##(1992-8#1)(1994-2#1)(2006-11#1)(2007-4#1)(2008-10#2)(2008-5#1)(2009-3#1)(2009-4#1)
was also incorporated into##2##4##(2008-5#1)(2010-12#1)
was also incorporated##3##3##(2008-10#1)(2008-5#1)(2010-12#1)
was also increased by##9##4##(1990-9#1)(1991-11#1)(1991-2#1)(1995-12#1)(1995-3#1)(1997-6#1)(2008-10#1)(2011-2#1)(2013-1#1)
was also increased in##6##4##(1990-7#1)(1990-8#1)(1995-10#1)(1996-11#1)(2004-12#1)(2010-12#1)
was also increased##25##3##(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-7#1)(1993-12#1)(1994-11#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-3#1)(1996-11#1)(1997-2#1)(1997-6#1)(2004-12#1)(2008-10#2)(2008-11#1)(2010-12#2)(2011-2#2)(2013-1#1)
was also indicated##3##3##(1996-5#1)(2008-7#1)(2008-9#1)
was also induced by##5##4##(1992-12#1)(1993-8#1)(1996-11#1)(1996-8#1)(2008-4#1)
was also induced##11##3##(1991-11#1)(1992-12#1)(1993-8#1)(1994-8#1)(1996-11#1)(1996-12#1)(1996-8#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-4#1)
was also ineffective##3##3##(1992-8#1)(2007-8#1)(2010-2#1)
was also influenced by##2##4##(1992-6#1)(1996-8#1)
was also inhibited (IC50##2##4##(1991-1#1)(1991-8#1)
was also inhibited by##14##4##(1990-2#1)(1990-5#1)(1991-2#2)(1992-8#2)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-8#1)(1996-5#1)(2008-11#1)(2008-8#1)
was also inhibited##20##3##(1990-2#2)(1990-5#1)(1991-1#1)(1991-2#2)(1991-8#1)(1992-8#2)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-8#1)(1996-5#1)(1997-7#1)(2006-3#1)(2008-11#1)(2008-8#1)(2010-4#1)
was also investigated by##3##4##(2008-10#3)
was also investigated for##3##4##(2007-8#1)(2008-10#1)(2008-11#1)
was also investigated in order to##2##6##(1994-6#1)(2010-4#1)
was also investigated in##6##4##(1992-6#1)(1992-8#1)(1994-6#1)(1996-8#1)(2006-8#1)(2010-4#1)
was also investigated under##2##4##(1991-2#1)(1995-10#1)
was also investigated using##2##4##(2007-9#1)(2008-10#1)
was also investigated##60##3##(1990-12#1)(1990-4#1)(1991-2#1)(1991-5#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-7#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-10#1)(1996-2#1)(1996-7#1)(1996-8#1)(2005-4#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#19)(2008-11#2)(2008-2#2)(2008-5#6)(2009-10#1)(2010-1#1)(2010-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
was also involved##3##3##(1993-2#1)(1996-10#1)(2008-10#1)
was also isolated from the##3##5##(1990-7#1)(1992-9#1)(2008-8#1)
was also isolated from##4##4##(1990-7#1)(1992-9#1)(2008-10#1)(2008-8#1)
was also isolated##7##3##(1990-7#1)(1991-4#1)(1992-9#1)(1995-3#1)(2008-10#1)(2008-8#1)(2009-5#1)
was also labeled##2##3##(1991-8#1)(1995-6#1)
was also largely##2##3##(2010-12#1)(2013-1#1)
was also less##4##3##(1990-12#1)(1990-3#1)(2008-10#1)(2011-12#1)
was also localized##3##3##(1990-5#1)(1995-12#1)(1996-1#1)
was also low##2##3##(2008-12#1)(2008-4#1)
was also lower in##2##4##(1991-10#1)(2013-1#1)
was also lower than##2##4##(2008-3#1)(2008-9#1)
was also lower##6##3##(1991-10#1)(1993-9#1)(1995-7#1)(2008-3#1)(2008-9#1)(2013-1#1)
was also made##4##3##(2005-7#1)(2008-7#1)(2009-7#1)(2010-9#1)
was also markedly##3##3##(1995-7#1)(1997-1#1)(1997-4#1)
was also measured before##2##4##(2006-8#1)(2008-3#1)
was also measured by##4##4##(1996-11#1)(1997-1#1)(2004-9#1)(2008-2#1)
was also measured for##3##4##(2006-5#1)(2008-10#1)(2013-8#1)
was also measured using a##2##5##(1993-2#1)(2008-5#1)
was also measured##20##3##(1991-3#1)(1993-12#1)(1993-2#1)(1996-11#1)(1996-3#1)(1997-1#1)(2004-9#1)(2006-5#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-8#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
was also mentioned##2##3##(1991-10#1)(2013-1#1)
was also modified##2##3##(2008-10#1)(2011-1#1)
was also monitored##3##3##(1990-12#1)(1996-5#1)(1996-8#1)
was also more likely##2##4##(2007-8#1)(2010-7#1)
was also more##7##3##(1994-6#1)(1995-6#1)(1996-6#1)(2007-8#2)(2008-12#1)(2010-7#1)
was also necessary##3##3##(1996-6#1)(2007-7#1)(2008-5#1)
was also negatively associated with##2##5##(2008-11#1)(2010-3#1)
was also negatively##3##3##(2008-11#1)(2010-3#1)(2013-8#1)
was also no significant difference##3##5##(1990-7#1)(2004-3#1)(2009-5#1)
was also no##9##3##(1990-7#1)(2004-3#1)(2007-7#1)(2008-8#2)(2009-10#1)(2009-5#1)(2011-1#1)(2013-8#1)
was also normal##2##3##(1994-3#1)(2012-12#1)
was also not affected##3##4##(1993-5#1)(2008-10#1)(2008-12#1)
was also not significant##2##4##(2008-6#1)(2010-4#1)
was also not##8##3##(1993-5#1)(1994-10#1)(1995-12#1)(2008-10#2)(2008-12#1)(2008-6#1)(2010-4#1)
was also noted for##2##4##(1992-7#1)(1995-7#1)
was also noted in the##3##5##(1994-8#1)(1996-12#1)(2008-10#1)
was also noted in##6##4##(1994-2#1)(1994-8#1)(1996-12#1)(1997-1#1)(2006-2#1)(2008-10#1)
was also noted##15##3##(1992-7#1)(1994-2#1)(1994-8#1)(1995-7#1)(1996-12#1)(1996-5#1)(1997-1#1)(2006-2#1)(2007-7#1)(2008-10#2)(2008-8#1)(2009-9#1)(2010-7#2)
was also noticed##7##3##(1993-2#1)(1997-8#1)(2004-10#1)(2007-9#1)(2008-5#1)(2008-7#1)(2011-2#1)
was also observed after##4##4##(1994-11#1)(2008-5#1)(2009-4#1)(2010-4#1)
was also observed at the mRNA level##2##7##(1995-5#1)(1996-5#1)
was also observed at##4##4##(1995-5#1)(1996-5#1)(2008-5#1)(2008-6#1)
was also observed between##3##4##(2007-5#1)(2012-12#1)(2012-3#1)
was also observed by##2##4##(1993-6#1)(1997-1#1)
was also observed for the##3##5##(1991-1#1)(1992-6#1)(2012-2#1)
was also observed for##6##4##(1991-1#1)(1992-10#1)(1992-6#1)(1993-9#1)(2006-7#1)(2012-2#1)
was also observed in cells##2##5##(1993-4#1)(1996-5#1)
was also observed in the experiment##2##6##(2006-8#1)(2008-10#1)
was also observed in the##16##5##(1991-12#1)(1991-9#1)(1992-9#1)(1994-2#1)(1996-11#1)(1997-5#1)(2006-12#1)(2006-8#1)(2007-6#1)(2008-10#4)(2008-8#1)(2009-6#1)(2012-1#1)
was also observed in##41##4##(1990-5#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-9#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-5#1)(1997-6#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-6#1)(2007-8#1)(2008-10#7)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-1#1)
was also observed on##3##4##(1994-2#1)(1997-6#1)(2008-10#1)
was also observed that##16##4##(1990-4#1)(1992-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-9#1)(2009-7#1)(2012-6#1)(2013-7#1)(2013-8#1)
was also observed to##4##4##(1991-3#1)(1994-5#1)(2006-10#1)(2008-11#1)
was also observed when the##2##5##(1991-5#1)(1997-6#1)
was also observed when##8##4##(1991-11#1)(1991-5#1)(1993-12#1)(1993-7#1)(1994-5#1)(1995-5#1)(1997-6#1)(2008-10#1)
was also observed with##5##4##(1992-12#1)(1995-8#1)(1997-2#1)(2005-12#1)(2010-8#1)
was also observed within##4##4##(1991-12#1)(1992-8#1)(2008-10#1)(2012-1#1)
was also observed##135##3##(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-6#2)(1993-7#2)(1993-9#1)(1994-11#1)(1994-2#2)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-5#2)(1995-6#2)(1995-8#2)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#2)(1997-1#4)(1997-2#1)(1997-5#2)(1997-6#3)(1997-7#1)(2005-11#3)(2005-12#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#2)(2007-6#1)(2007-8#1)(2008-10#17)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#2)(2013-7#2)(2013-8#1)
was also obtained by##3##4##(1992-10#1)(1994-8#1)(2008-5#1)
was also obtained from the##2##5##(2005-7#1)(2008-7#1)
was also obtained from##3##4##(1993-3#1)(2005-7#1)(2008-7#1)
was also obtained in##4##4##(1990-9#1)(1996-6#1)(1997-7#1)(2008-5#1)
was also obtained with##3##4##(1990-2#1)(1994-11#1)(1994-9#1)
was also obtained##24##3##(1990-2#1)(1990-9#1)(1992-10#1)(1993-3#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-6#1)(1996-9#1)(1997-7#1)(2005-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#1)(2011-2#1)
was also one of the##3##5##(2008-10#2)(2008-3#1)
was also partially##2##3##(1991-1#1)(2008-11#1)
was also performed in##5##4##(1992-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-12#1)
was also performed on##4##4##(1994-8#1)(1995-2#1)(2006-5#1)(2008-10#1)
was also performed##32##3##(1992-10#1)(1992-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1997-2#1)(1997-3#1)(2004-4#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-10#7)(2008-2#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-12#1)(2012-2#1)(2013-1#2)
was also phosphorylated##2##3##(1996-2#1)(1997-6#1)
was also poor in##2##4##(1990-12#1)(2010-7#1)
was also positively##2##3##(1997-2#1)(2008-6#1)
was also possible##2##3##(2008-10#2)
was also posted##2##3##(2008-11#1)(2012-3#1)
was also potentiated by##2##4##(1990-5#1)(1997-5#1)
was also prepared##3##3##(1992-12#1)(1993-8#1)(2008-2#1)
was also present in cytosol##2##5##(1990-3#1)(1994-6#1)
was also present in other##2##5##(2008-10#1)(2008-7#1)
was also present in the##4##5##(1990-5#1)(1995-9#1)(2007-8#1)(2008-10#1)
was also present in##15##4##(1990-1#1)(1990-3#1)(1990-5#1)(1993-2#1)(1993-9#1)(1994-6#1)(1995-10#1)(1995-9#1)(1997-5#1)(2007-8#1)(2008-10#3)(2008-7#1)(2012-3#1)
was also present on the##2##5##(1995-3#1)(2012-2#1)
was also present##25##3##(1990-1#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-7#1)(1991-9#1)(1993-2#1)(1993-9#1)(1994-6#1)(1995-10#1)(1995-3#3)(1995-9#1)(1997-3#1)(1997-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-7#1)(2012-2#1)(2012-3#1)
was also presented##5##3##(1996-2#1)(2005-8#1)(2005-9#1)(2012-2#1)(2013-1#1)
was also prevented by##2##4##(1990-10#1)(1990-12#1)
was also prevented##5##3##(1990-10#1)(1990-12#1)(1994-2#1)(1997-1#1)(1997-5#1)
was also produced by##2##4##(1992-6#1)(2008-11#1)
was also produced##6##3##(1992-6#1)(1994-5#1)(1996-4#1)(2008-10#1)(2008-11#1)(2008-5#1)
was also prominent##2##3##(1995-7#1)(2007-7#1)
was also proposed##5##3##(1997-5#1)(1997-8#1)(2008-10#2)(2009-11#1)
was also proved to##2##4##(2008-10#1)(2008-11#1)
was also proved##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
was also provided by##2##4##(1990-5#1)(1994-3#1)
was also purified from##2##4##(1990-8#1)(1993-9#1)
was also recently##3##3##(1994-11#1)(2008-4#1)(2010-3#1)
was also recognized##3##3##(2005-12#1)(2005-7#1)(2008-5#1)
was also recorded in##3##4##(1995-12#1)(2007-3#1)(2010-4#1)
was also recorded##13##3##(1990-10#1)(1993-2#1)(1995-12#1)(2004-10#1)(2006-12#1)(2007-3#1)(2008-12#1)(2008-5#1)(2009-12#1)(2010-4#1)(2011-12#2)(2013-1#1)
was also reduced by##5##4##(1990-2#1)(1995-12#1)(1996-9#1)(2008-10#1)(2008-12#1)
was also reduced in the##4##5##(1991-9#1)(2006-12#1)(2012-12#2)
was also reduced in##7##4##(1990-12#1)(1991-9#1)(1993-12#1)(2006-12#1)(2006-7#1)(2012-12#2)
was also reduced##17##3##(1990-12#1)(1990-2#1)(1990-5#1)(1991-9#1)(1992-7#1)(1992-8#1)(1993-12#1)(1995-12#1)(1996-9#1)(2006-12#1)(2006-7#1)(2008-10#2)(2008-12#1)(2012-12#2)(2012-3#1)
was also reflected by##2##4##(1996-10#1)(2008-10#1)
was also reflected##3##3##(1996-10#1)(2008-10#1)(2011-1#1)
was also related to##3##4##(1994-3#1)(1996-1#1)(2007-12#1)
was also relatively##2##3##(1991-6#1)(1994-9#1)
was also removed##3##3##(1996-8#1)(2008-5#1)(2013-1#1)
was also reported##4##3##(1993-1#1)(2006-6#1)(2007-8#1)(2008-6#1)
was also restored##2##3##(2008-7#1)(2012-3#1)
was also revealed##4##3##(1991-3#1)(1994-5#1)(2007-1#1)(2008-10#1)
was also reviewed##2##3##(2008-7#1)(2013-8#1)
was also seen at##2##4##(1990-5#1)(1994-6#1)
was also seen in the##2##5##(1996-12#1)(2007-4#1)
was also seen in##8##4##(1991-11#1)(1994-6#1)(1995-11#1)(1996-12#1)(1996-5#1)(2007-2#1)(2007-4#1)(2009-4#1)
was also seen to be##2##5##(2008-10#1)(2012-11#1)
was also seen to##3##4##(1994-4#1)(2008-10#1)(2012-11#1)
was also seen with##2##4##(1990-9#1)(1995-8#1)
was also seen##21##3##(1990-5#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-8#1)(1994-4#1)(1994-6#2)(1995-11#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-6#1)(2006-8#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#1)(2009-4#1)(2012-11#1)
was also sensitive to##2##4##(1993-2#1)(1996-8#1)
was also shown by##2##4##(1993-2#1)(2008-7#1)
was also shown that the##3##5##(1992-12#1)(1995-2#1)(2008-10#1)
was also shown that##11##4##(1992-12#1)(1994-9#1)(1995-2#1)(1996-6#1)(1997-1#1)(2007-2#1)(2008-10#1)(2008-6#1)(2009-10#1)(2009-3#1)(2013-7#1)
was also shown to be expressed in##2##7##(2010-5#2)
was also shown to be present##2##6##(1991-5#1)(1994-8#1)
was also shown to be##6##5##(1991-5#1)(1994-8#1)(2006-12#1)(2007-5#1)(2010-5#2)
was also shown to##16##4##(1991-10#1)(1991-5#1)(1992-6#1)(1994-8#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-5#1)(2006-10#1)(2006-12#1)(2007-5#1)(2008-10#1)(2008-7#1)(2010-5#2)(2012-1#1)
was also shown##29##3##(1991-10#1)(1991-5#1)(1992-12#1)(1992-6#1)(1993-2#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-5#1)(2008-10#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-3#1)(2010-5#2)(2012-1#1)(2013-7#1)
was also significant##6##3##(1993-4#1)(1995-12#1)(1995-3#1)(2006-8#1)(2008-10#1)(2008-5#1)
was also significantly associated with##2##5##(2011-1#2)
was also significantly diminished##2##4##(1991-12#1)(2008-8#1)
was also significantly higher among##2##5##(2006-10#2)
was also significantly higher in##2##5##(1994-6#1)(2011-2#1)
was also significantly higher than that in##2##7##(2008-9#1)(2011-1#1)
was also significantly higher than##3##5##(1991-4#1)(2008-9#1)(2011-1#1)
was also significantly higher##7##4##(1991-4#1)(1994-6#1)(2006-10#2)(2008-9#1)(2011-1#1)(2011-2#1)
was also significantly increased##3##4##(1991-5#1)(2008-4#2)
was also significantly related to##2##5##(1996-3#1)(2008-8#1)
was also significantly##27##3##(1991-12#1)(1991-4#1)(1991-5#1)(1993-12#1)(1994-6#1)(1994-8#2)(1996-1#1)(1996-3#1)(1996-5#1)(2006-10#2)(2006-2#1)(2008-4#4)(2008-8#2)(2008-9#2)(2009-6#1)(2009-8#1)(2011-1#3)(2011-2#1)
was also statistically##2##3##(2008-8#1)(2008-9#1)
was also stimulated by##5##4##(1990-11#1)(1994-12#1)(1994-3#2)(1995-7#1)
was also stimulated##7##3##(1990-11#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-7#1)
was also studied and##4##4##(1990-4#1)(2008-10#2)(2012-1#1)
was also studied by##4##4##(1996-2#1)(2005-11#2)(2008-10#1)
was also studied for##3##4##(1993-12#1)(2005-11#1)(2007-10#1)
was also studied in##3##4##(1990-9#1)(1996-12#1)(2010-12#1)
was also studied on##2##4##(2008-10#1)(2009-12#1)
was also studied to##2##4##(2005-11#1)(2012-2#1)
was also studied using##3##4##(2008-10#1)(2009-3#1)(2010-5#1)
was also studied##70##3##(1990-11#1)(1990-2#1)(1990-4#1)(1990-9#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-3#1)(1995-12#1)(1995-7#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-5#1)(2005-11#5)(2005-12#1)(2005-4#3)(2006-10#1)(2007-10#1)(2007-8#1)(2008-10#23)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
was also subjected to##2##4##(2008-10#1)(2008-5#1)
was also successfully##3##3##(1993-2#1)(2008-10#2)
was also suggested##3##3##(1991-9#1)(2010-10#1)(2010-4#1)
was also superior to##2##4##(2005-7#1)(2007-11#1)
was also supported by##2##4##(1990-5#1)(2008-7#1)
was also supported##3##3##(1990-5#1)(2008-7#1)(2009-2#1)
was also suppressed##3##3##(1991-3#1)(2008-10#1)(2011-2#1)
was also suspected##2##3##(2008-10#1)(2013-1#1)
was also taken into account##2##5##(2007-7#1)(2010-4#1)
was also taken##3##3##(2007-7#1)(2010-4#1)(2012-12#1)
was also tested for##3##4##(1992-7#1)(1996-5#1)(2008-9#1)
was also tested in a##2##5##(2004-9#1)(2008-11#1)
was also tested in##4##4##(1997-7#1)(2004-9#1)(2008-11#1)(2012-3#1)
was also tested on##2##4##(1992-8#1)(2010-2#1)
was also tested##19##3##(1990-2#1)(1992-7#1)(1992-8#1)(1995-2#2)(1996-5#1)(1997-7#1)(2004-9#1)(2007-1#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-9#1)(2010-1#1)(2010-2#1)(2012-3#1)
was also the most##2##4##(2008-10#1)(2008-11#1)
was also the##4##3##(1992-7#1)(2007-12#1)(2008-10#1)(2008-11#1)
was also transcribed##2##3##(1994-6#1)(1995-3#1)
was also treated with##3##4##(1990-2#1)(2006-10#1)(2006-4#1)
was also unaffected##3##3##(1997-3#1)(2005-8#1)(2011-12#1)
was also under##2##3##(2005-7#1)(2010-12#1)
was also undertaken##3##3##(2007-2#1)(2008-10#1)(2012-3#1)
was also used as a##4##5##(1996-8#1)(2007-10#1)(2008-10#1)(2008-12#1)
was also used as##5##4##(1996-8#1)(2007-10#1)(2008-10#2)(2008-12#1)
was also used for the determination of##2##7##(2008-10#2)
was also used for the##3##5##(2008-10#3)
was also used for##11##4##(1991-12#1)(1996-3#1)(2004-9#1)(2008-10#8)
was also used in a##2##5##(2008-10#2)
was also used in##6##4##(1994-9#1)(2008-10#4)(2011-1#1)
was also used to analyze##2##5##(2007-8#1)(2008-10#1)
was also used to assess the##2##6##(1994-2#1)(2008-10#1)
was also used to calculate##2##5##(2008-10#1)(2008-3#1)
was also used to compare the##2##6##(1995-5#1)(2008-5#1)
was also used to determine##2##5##(1991-9#1)(2008-10#1)
was also used to evaluate the##2##6##(2007-8#1)(2011-1#1)
was also used to measure the##2##6##(2008-10#1)(2008-2#1)
was also used to produce##2##5##(1990-12#1)(2008-7#1)
was also used to screen##2##5##(2008-10#2)
was also used to##36##4##(1990-12#1)(1991-9#1)(1994-2#2)(1994-9#1)(1995-1#1)(1995-5#1)(2004-4#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#2)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
was also used##62##3##(1990-12#1)(1991-12#1)(1991-9#1)(1994-2#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-5#1)(1996-3#1)(1996-8#1)(2004-4#1)(2004-9#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#2)(2008-10#24)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2009-9#1)(2011-1#2)(2011-2#1)(2012-12#1)
was also utilized##2##3##(1995-8#1)(2012-2#1)
was also validated by##3##4##(2008-1#1)(2008-10#1)(2010-5#1)
was also validated##4##3##(2008-1#1)(2008-10#1)(2010-12#1)(2010-5#1)
was also verified##5##3##(2008-10#3)(2008-9#1)(2011-1#1)
was also very##4##3##(1994-12#1)(2008-10#1)(2008-5#1)(2013-1#1)
was also visible##2##3##(2008-10#1)(2011-12#1)
was also##1964##2##(1990-1#2)(1990-10#6)(1990-11#8)(1990-12#12)(1990-2#11)(1990-3#9)(1990-4#5)(1990-5#21)(1990-7#8)(1990-8#9)(1990-9#9)(1991-1#4)(1991-10#8)(1991-11#8)(1991-12#10)(1991-2#10)(1991-3#10)(1991-4#7)(1991-5#10)(1991-6#2)(1991-7#5)(1991-8#10)(1991-9#17)(1992-1#5)(1992-10#4)(1992-11#5)(1992-12#10)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#4)(1992-6#9)(1992-7#9)(1992-8#11)(1992-9#9)(1993-1#2)(1993-11#7)(1993-12#14)(1993-2#18)(1993-3#9)(1993-4#9)(1993-5#3)(1993-6#9)(1993-7#4)(1993-8#9)(1993-9#9)(1994-10#4)(1994-11#12)(1994-12#13)(1994-2#11)(1994-3#13)(1994-4#1)(1994-5#9)(1994-6#15)(1994-8#14)(1994-9#17)(1995-1#10)(1995-10#4)(1995-11#7)(1995-12#18)(1995-2#16)(1995-3#12)(1995-5#11)(1995-6#11)(1995-7#11)(1995-8#11)(1995-9#2)(1996-1#4)(1996-10#4)(1996-11#4)(1996-12#13)(1996-2#10)(1996-3#8)(1996-4#5)(1996-5#17)(1996-6#11)(1996-7#2)(1996-8#12)(1996-9#7)(1997-1#14)(1997-2#11)(1997-3#10)(1997-4#10)(1997-5#13)(1997-6#8)(1997-7#5)(1997-8#8)(2003-11#1)(2004-10#2)(2004-11#1)(2004-12#2)(2004-2#1)(2004-3#1)(2004-4#2)(2004-9#4)(2005-10#2)(2005-11#21)(2005-12#4)(2005-4#6)(2005-7#7)(2005-8#5)(2005-9#2)(2006-1#1)(2006-10#17)(2006-11#3)(2006-12#10)(2006-2#6)(2006-3#2)(2006-4#4)(2006-5#6)(2006-6#1)(2006-7#3)(2006-8#14)(2006-9#4)(2007-1#6)(2007-10#9)(2007-11#26)(2007-12#17)(2007-2#13)(2007-3#3)(2007-4#7)(2007-5#7)(2007-6#5)(2007-7#14)(2007-8#26)(2007-9#7)(2008-1#7)(2008-10#314)(2008-11#37)(2008-12#17)(2008-2#21)(2008-3#25)(2008-4#19)(2008-5#70)(2008-6#17)(2008-7#29)(2008-8#26)(2008-9#17)(2009-10#8)(2009-11#1)(2009-12#6)(2009-2#7)(2009-3#8)(2009-4#7)(2009-5#5)(2009-6#7)(2009-7#9)(2009-8#6)(2009-9#3)(2010-1#6)(2010-10#4)(2010-12#14)(2010-2#5)(2010-3#4)(2010-4#17)(2010-5#8)(2010-6#1)(2010-7#9)(2010-8#4)(2010-9#2)(2011-1#23)(2011-12#7)(2011-2#28)(2011-3#1)(2012-1#12)(2012-11#5)(2012-12#13)(2012-2#21)(2012-3#14)(2012-6#2)(2013-1#44)(2013-7#5)(2013-8#13)
was altered at##2##3##(2008-10#2)
was altered by site-directed mutagenesis##2##5##(1991-2#1)(1993-11#1)
was altered by##10##3##(1991-2#1)(1993-11#1)(1995-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2012-2#1)
was altered in##8##3##(1994-3#1)(1996-12#1)(1996-5#1)(1996-9#1)(2007-9#1)(2008-10#1)(2008-8#1)(2011-2#1)
was altered##33##2##(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-8#1)(1994-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-9#1)(1997-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-8#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-7#1)
was alternated with##2##3##(1990-10#1)(2012-3#1)
was alternated##3##2##(1990-10#1)(2008-3#1)(2012-3#1)
was always associated with##4##4##(2007-6#1)(2008-10#3)
was always found to be##3##5##(2007-11#1)(2008-10#1)(2008-12#1)
was always found##4##3##(2007-11#1)(2008-10#2)(2008-12#1)
was always higher than that##2##5##(1995-3#1)(2008-10#1)
was always higher than##4##4##(1994-2#1)(1995-3#1)(2008-10#2)
was always higher##5##3##(1994-2#1)(1995-3#1)(2008-10#2)(2013-8#1)
was always less than##3##4##(1990-12#1)(2008-2#1)(2008-3#1)
was always less##4##3##(1990-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
was always lower than##2##4##(1992-9#1)(1996-11#1)
was always observed##2##3##(2008-10#1)(2008-11#1)
was always##55##2##(1990-11#1)(1990-12#2)(1990-5#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-11#1)(1995-3#1)(1996-11#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-6#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#4)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
was ameliorated by##4##3##(1995-3#1)(2008-6#1)(2012-12#1)(2013-1#1)
was ameliorated##5##2##(1995-3#1)(2008-4#1)(2008-6#1)(2012-12#1)(2013-1#1)
was amended with##7##3##(2006-3#1)(2008-10#6)
was amended##8##2##(2006-3#1)(2006-8#1)(2008-10#6)
was among children##2##3##(2012-12#1)(2012-2#1)
was among the first to recognize that##2##7##(2006-2#2)
was among the first to##3##5##(2006-2#2)(2012-2#1)
was among the first##7##4##(1990-8#1)(1993-3#1)(1997-7#1)(2006-2#2)(2007-3#1)(2012-2#1)
was among the##10##3##(1990-8#1)(1993-3#1)(1997-7#1)(2006-10#1)(2006-2#2)(2007-3#1)(2008-10#1)(2008-12#1)(2012-2#1)
was among those who##2##4##(1993-3#2)
was among those##3##3##(1993-3#2)(2006-6#1)
was among##16##2##(1990-8#1)(1992-2#1)(1993-3#3)(1997-7#1)(2006-10#1)(2006-2#2)(2006-6#1)(2007-3#1)(2008-10#1)(2008-12#1)(2012-12#1)(2012-2#2)
was amplified and sequenced##2##4##(2008-10#2)
was amplified and##7##3##(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2012-12#1)
was amplified by PCR and cloned##2##6##(1997-8#1)(2008-8#1)
was amplified by PCR and##4##5##(1997-8#1)(2006-8#1)(2008-10#1)(2008-8#1)
was amplified by PCR with##2##5##(1991-12#1)(1992-3#1)
was amplified by PCR##12##4##(1990-12#1)(1991-12#1)(1992-3#1)(1993-12#1)(1997-8#1)(2005-11#1)(2006-6#1)(2006-8#1)(2008-10#1)(2008-8#2)(2011-1#1)
was amplified by RT-PCR from##2##5##(2005-11#1)(2008-8#1)
was amplified by RT-PCR##3##4##(2005-11#2)(2008-8#1)
was amplified by polymerase chain reaction (PCR) and##2##8##(2008-10#1)(2010-6#1)
was amplified by polymerase chain reaction (PCR)##4##7##(2006-8#1)(2008-10#1)(2008-4#1)(2010-6#1)
was amplified by polymerase chain reaction##7##6##(1994-12#1)(1996-10#1)(2006-8#1)(2008-10#2)(2008-4#1)(2010-6#1)
was amplified by reverse transcription-polymerase chain reaction (RT-PCR)##2##8##(1997-6#1)(2008-10#1)
was amplified by reverse transcription-polymerase chain reaction##3##7##(1994-12#1)(1997-6#1)(2008-10#1)
was amplified by reverse##4##4##(1994-12#1)(1997-6#1)(2005-11#1)(2008-10#1)
was amplified by the polymerase chain reaction##2##7##(1996-7#1)(1997-6#1)
was amplified by the##5##4##(1996-7#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-11#1)
was amplified by##35##3##(1990-12#1)(1990-3#1)(1991-12#1)(1992-3#1)(1993-12#1)(1994-12#2)(1996-10#1)(1996-7#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-11#4)(2006-6#1)(2006-8#2)(2007-12#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-8#4)(2010-6#1)(2011-1#1)
was amplified from the##2##4##(2005-11#1)(2008-10#1)
was amplified from##16##3##(1993-11#2)(1995-8#1)(1996-7#1)(1997-3#1)(1997-9#1)(2005-11#2)(2008-10#6)(2008-4#1)(2009-10#1)
was amplified through##2##3##(2008-5#1)(2011-1#1)
was amplified using the polymerase chain reaction##2##7##(1991-5#1)(2006-5#1)
was amplified using the##3##4##(1991-5#1)(2006-5#1)(2008-12#1)
was amplified using##5##3##(1991-5#1)(2006-5#1)(2006-8#1)(2008-12#1)(2009-5#1)
was amplified with##3##3##(1991-10#1)(1992-11#1)(2008-10#1)
was amplified##78##2##(1990-12#1)(1990-3#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-11#2)(1992-3#1)(1993-11#2)(1993-12#1)(1994-12#2)(1995-1#1)(1995-3#1)(1995-8#2)(1996-10#1)(1996-7#2)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#1)(1997-9#1)(2005-11#6)(2006-5#2)(2006-6#1)(2006-8#3)(2007-11#1)(2007-12#2)(2008-10#17)(2008-11#3)(2008-12#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#4)(2009-10#1)(2009-5#1)(2010-6#1)(2011-1#2)(2012-12#1)
was an active##2##3##(1991-1#1)(1995-5#1)
was an additional##2##3##(2008-10#1)(2011-2#1)
was an almost##3##3##(1996-9#1)(1997-3#2)
was an apparent##3##3##(1990-6#1)(2008-10#1)(2010-11#1)
was an approximately##2##3##(1996-10#1)(2008-10#1)
was an association between##4##4##(2007-12#1)(2007-5#1)(2011-2#1)(2013-8#1)
was an association of##2##4##(2007-10#1)(2008-10#1)
was an association##6##3##(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#1)(2011-2#1)(2013-8#1)
was an attempt##2##3##(1992-3#1)(2010-3#1)
was an average of##3##4##(2007-8#1)(2010-8#1)(2013-7#1)
was an average##4##3##(2007-8#1)(2008-1#1)(2010-8#1)(2013-7#1)
was an early##7##3##(1990-7#1)(1996-3#1)(1997-8#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#1)
was an effect of##3##4##(1991-3#1)(1996-5#1)(2009-4#1)
was an effective technique for##2##5##(2008-10#1)(2008-5#1)
was an effective technique##3##4##(2008-10#2)(2008-5#1)
was an effective tool to##2##5##(2008-10#1)(2010-10#1)
was an effective tool##3##4##(2006-10#1)(2008-10#1)(2010-10#1)
was an effective##12##3##(1993-12#1)(1995-6#1)(2004-12#1)(2006-10#1)(2008-10#5)(2008-5#1)(2008-7#1)(2010-10#1)
was an efficient##5##3##(1990-11#1)(1990-12#1)(1994-8#1)(2008-10#1)(2008-8#1)
was an excellent correlation between##2##5##(1992-2#1)(2008-10#1)
was an excellent##5##3##(1992-2#1)(1994-8#1)(2007-10#1)(2008-10#1)(2010-11#1)
was an extensive##2##3##(2007-9#1)(2010-5#1)
was an extremely##4##3##(2008-4#1)(2010-1#1)(2013-1#2)
was an immediate##3##3##(1994-8#1)(2007-7#1)(2008-7#1)
was an important factor in##2##5##(1993-5#1)(2008-5#1)
was an important factor##3##4##(1993-5#1)(2008-5#1)(2013-8#1)
was an important milestone in##2##5##(2007-7#1)(2013-1#1)
was an important risk factor##2##5##(2008-5#1)(2013-8#1)
was an important##20##3##(1993-5#1)(1994-8#1)(2005-10#1)(2005-8#1)(2007-7#1)(2008-5#5)(2008-7#1)(2008-9#1)(2010-4#1)(2010-7#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
was an improvement in##4##4##(2008-10#1)(2008-5#2)(2008-7#1)
was an improvement##5##3##(2008-10#1)(2008-5#3)(2008-7#1)
was an incidental finding during##3##5##(1992-9#1)(2008-12#1)(2013-8#1)
was an incidental finding##4##4##(1992-9#1)(1995-11#1)(2008-12#1)(2013-8#1)
was an increase in the number of##2##7##(1996-10#1)(2007-4#1)
was an increase in the total##2##6##(1990-5#1)(1992-2#1)
was an increase in the##12##5##(1990-5#1)(1992-2#1)(1994-11#1)(1996-10#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-9#1)(2009-8#1)(2010-7#1)(2013-8#2)
was an increase in##28##4##(1990-5#1)(1991-7#1)(1992-12#1)(1992-2#1)(1994-11#1)(1994-6#1)(1996-10#1)(1997-1#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-9#1)(2009-10#2)(2009-8#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
was an increase##29##3##(1990-5#1)(1991-7#1)(1992-12#1)(1992-2#1)(1994-11#1)(1994-6#1)(1996-10#1)(1997-1#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#4)(2008-11#3)(2008-9#1)(2009-10#2)(2009-8#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
was an increased##6##3##(1992-12#1)(1995-5#1)(1996-2#1)(2007-10#1)(2008-11#1)(2011-2#1)
was an increasing##3##3##(2008-10#1)(2008-7#1)(2012-1#1)
was an independent factor for##2##5##(2007-8#1)(2012-3#1)
was an independent predictor of a poor &quot##4##8##(2013-1#4)
was an independent predictor of##6##5##(1996-9#1)(2007-11#1)(2013-1#4)
was an independent risk factor for##2##6##(2007-8#1)(2007-9#1)
was an independent risk factor##3##5##(1994-12#1)(2007-8#1)(2007-9#1)
was an independent##16##3##(1994-12#2)(1995-4#1)(1996-11#1)(1996-9#1)(2007-10#1)(2007-11#1)(2007-8#2)(2007-9#1)(2011-2#1)(2012-3#1)(2013-1#4)
was an index of##2##4##(1996-12#1)(2008-10#1)
was an indication that##2##4##(2005-11#1)(2008-11#1)
was an indicator##2##3##(1993-9#1)(2008-10#1)
was an inverse correlation between##2##5##(2009-2#1)(2012-12#1)
was an inverse predictor##2##4##(2006-7#1)(2008-7#1)
was an inverse relationship between##3##5##(1991-5#1)(1996-7#1)(2008-10#1)
was an inverse##10##3##(1991-5#1)(1996-7#1)(2006-7#1)(2008-10#3)(2008-7#1)(2009-2#1)(2012-12#1)(2012-2#1)
was an isolated##2##3##(1996-3#1)(2007-8#1)
was an isoschizomer of##2##4##(1993-9#2)
was an order##2##3##(1991-1#1)(1997-5#1)
was an overall##5##3##(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2013-1#1)
was an uncommon##2##3##(2006-10#1)(2007-12#1)
was an unexpected finding##2##4##(1990-12#1)(2008-12#1)
was an unexpected##3##3##(1990-12#1)(2008-12#1)(2011-1#1)
was an unusual##2##3##(2008-7#1)(2010-5#1)
was an up-regulation of##3##4##(2010-11#1)(2010-4#1)(2013-1#1)
was an##306##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-7#1)(1991-8#2)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#2)(1992-9#1)(1993-10#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-9#4)(1994-11#1)(1994-12#3)(1994-6#1)(1994-8#4)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#2)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-7#2)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#2)(1997-8#2)(2004-12#1)(2004-2#1)(2004-8#1)(2005-10#1)(2005-11#2)(2005-8#2)(2006-10#4)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#3)(2007-10#6)(2007-11#6)(2007-12#6)(2007-2#3)(2007-4#2)(2007-5#3)(2007-7#5)(2007-8#6)(2007-9#3)(2008-1#4)(2008-10#28)(2008-11#10)(2008-12#4)(2008-3#1)(2008-4#3)(2008-5#12)(2008-7#9)(2008-8#5)(2008-9#5)(2009-10#4)(2009-2#2)(2009-3#1)(2009-4#2)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#4)(2011-1#3)(2011-2#7)(2011-3#1)(2012-1#3)(2012-12#6)(2012-2#3)(2012-3#5)(2013-1#16)(2013-7#1)(2013-8#8)
was analogous to that##2##4##(1992-1#1)(1993-2#1)
was analogous##3##2##(1992-1#1)(1993-2#1)(2009-10#1)
was analysed and##3##3##(1993-11#1)(1996-12#1)(2008-10#1)
was analysed as##2##3##(1997-1#1)(2009-7#1)
was analysed by the##3##4##(1990-5#1)(1997-3#1)(2008-5#1)
was analysed by##25##3##(1990-5#1)(1990-9#1)(1992-2#1)(1995-12#1)(1995-3#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-6#1)(2004-10#1)(2005-8#1)(2006-8#1)(2008-10#1)(2008-11#2)(2008-5#4)(2009-10#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
was analysed for##6##3##(2008-10#1)(2008-11#2)(2008-12#1)(2011-2#1)(2012-9#1)
was analysed in##7##3##(1996-1#1)(1996-5#1)(1997-1#1)(1997-7#1)(2006-8#1)(2008-5#2)
was analysed to##4##3##(1990-9#1)(1991-2#1)(2006-10#1)(2010-8#1)
was analysed using a##2##4##(2006-8#1)(2008-11#1)
was analysed using the##2##4##(2012-12#1)(2012-2#1)
was analysed using##12##3##(2005-11#1)(2006-4#1)(2006-8#3)(2008-11#1)(2008-12#1)(2009-1#1)(2010-3#1)(2012-12#1)(2012-2#2)
was analysed##91##2##(1990-5#1)(1990-6#1)(1990-9#2)(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-11#1)(1994-11#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#2)(2004-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#5)(2007-1#1)(2007-11#2)(2007-5#1)(2007-8#3)(2008-10#4)(2008-11#6)(2008-12#2)(2008-5#8)(2008-6#1)(2009-1#1)(2009-10#1)(2009-7#2)(2010-10#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#4)(2012-9#1)(2013-7#1)(2013-8#2)
was analysis of##2##3##(2007-8#1)(2008-7#1)
was analytically##2##2##(2008-3#1)(2011-2#1)
was analyzed after##5##3##(1994-4#1)(2008-10#2)(2009-4#1)(2012-12#1)
was analyzed and compared##2##4##(1996-11#1)(2007-3#1)
was analyzed and the##4##4##(1996-7#1)(1997-8#1)(2004-11#1)(2008-10#1)
was analyzed and##12##3##(1993-12#1)(1996-11#1)(1996-7#1)(1997-6#1)(1997-8#1)(2004-11#1)(2007-3#1)(2008-10#2)(2009-9#1)(2011-1#1)(2011-2#1)
was analyzed as a##3##4##(1992-9#1)(2007-8#1)(2008-10#1)
was analyzed as##5##3##(1992-9#1)(2007-3#1)(2007-8#1)(2008-10#1)(2010-8#1)
was analyzed at the##3##4##(1994-3#1)(2008-4#1)(2008-8#1)
was analyzed at##7##3##(1990-5#1)(1994-3#1)(1994-5#1)(2008-10#1)(2008-4#1)(2008-8#1)(2013-7#1)
was analyzed both##2##3##(2008-10#1)(2011-2#1)
was analyzed by GC and##2##5##(2007-1#1)(2007-11#1)
was analyzed by GC##3##4##(2007-1#1)(2007-11#1)(2007-8#1)
was analyzed by HPLC##2##4##(2008-10#1)(2012-12#1)
was analyzed by PCR##3##4##(1995-2#1)(2010-12#1)(2012-12#1)
was analyzed by SDS-PAGE##2##4##(2011-1#1)(2013-1#1)
was analyzed by a##3##4##(1997-8#1)(2006-10#1)(2008-10#1)
was analyzed by both##2##4##(1994-12#1)(2008-10#1)
was analyzed by immunoblotting and immunohistochemistry##2##6##(1991-2#1)(1994-2#1)
was analyzed by means of##2##5##(2008-5#1)(2013-8#1)
was analyzed by modified##2##4##(1995-12#1)(2008-2#1)
was analyzed by polymerase chain reaction##2##6##(1991-10#1)(2012-3#1)
was analyzed by the##10##4##(1990-2#1)(1992-11#1)(2005-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2010-12#1)(2010-4#1)(2011-1#1)(2013-7#1)
was analyzed by using##3##4##(1992-11#1)(2005-11#1)(2013-1#1)
was analyzed by##103##3##(1990-10#1)(1990-11#2)(1990-2#1)(1990-3#1)(1991-10#1)(1991-12#1)(1991-2#1)(1992-11#4)(1992-12#1)(1992-9#2)(1993-11#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-9#1)(1997-3#2)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#2)(2005-12#1)(2006-10#3)(2007-1#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#11)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-8#3)(2008-9#1)(2010-12#3)(2010-4#2)(2010-8#1)(2011-1#2)(2012-12#6)(2012-3#2)(2013-1#2)(2013-7#3)(2013-8#6)
was analyzed during two##2##4##(2007-12#1)(2009-10#1)
was analyzed for its##4##4##(1992-11#1)(2008-3#1)(2010-5#1)(2011-2#1)
was analyzed for the presence of##2##6##(2007-2#1)(2008-10#1)
was analyzed for the##5##4##(1997-1#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)
was analyzed for##27##3##(1992-10#2)(1992-11#1)(1993-1#1)(1993-9#1)(1995-2#1)(1997-1#1)(2004-1#1)(2007-12#1)(2007-2#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#1)(2009-11#1)(2009-2#1)(2010-1#1)(2010-5#2)(2011-2#1)(2012-12#1)(2012-2#1)
was analyzed in a##2##4##(1991-7#1)(1995-8#1)
was analyzed in detail##2##4##(2008-10#1)(2008-9#1)
was analyzed in order to##2##5##(1991-3#1)(1993-6#1)
was analyzed in relation to##2##5##(2005-11#1)(2012-1#1)
was analyzed in terms of##2##5##(1997-1#1)(2005-11#1)
was analyzed in the##6##4##(1990-2#1)(1995-8#1)(2006-8#1)(2008-10#2)(2008-5#1)
was analyzed in##42##3##(1990-2#1)(1991-3#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-6#1)(1993-8#3)(1994-11#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-8#2)(1996-7#1)(1997-1#2)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#2)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2011-2#1)(2012-1#1)(2013-1#1)
was analyzed on the basis of##4##6##(2007-8#1)(2008-3#1)(2008-6#1)(2012-2#1)
was analyzed on##7##3##(1994-5#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2011-1#1)(2012-2#1)
was analyzed to determine##2##4##(1995-12#1)(2008-10#1)
was analyzed to##3##3##(1995-12#1)(2008-10#2)
was analyzed under##2##3##(1990-11#1)(1997-2#1)
was analyzed using a##5##4##(2006-10#1)(2008-10#3)(2010-12#1)
was analyzed using an##2##4##(2007-10#1)(2008-10#1)
was analyzed using the##11##4##(1991-2#1)(1992-8#1)(2005-11#2)(2008-10#4)(2008-5#1)(2009-4#1)(2013-1#1)
was analyzed using##40##3##(1990-9#1)(1991-1#1)(1991-2#1)(1992-8#1)(1992-9#1)(1996-8#1)(1997-5#1)(1997-6#1)(2005-11#2)(2006-10#1)(2006-11#1)(2007-10#2)(2008-10#15)(2008-5#2)(2009-4#1)(2010-12#1)(2011-1#2)(2011-2#1)(2013-1#3)(2013-8#1)
was analyzed with a##2##4##(2006-10#1)(2012-2#1)
was analyzed with##13##3##(1992-11#1)(1993-11#1)(1993-4#1)(2005-10#1)(2005-11#1)(2006-10#1)(2008-2#1)(2008-6#1)(2008-8#1)(2010-5#1)(2011-3#1)(2012-2#1)(2013-8#1)
was analyzed##346##2##(1990-10#1)(1990-11#3)(1990-2#2)(1990-3#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-10#2)(1992-11#7)(1992-12#2)(1992-2#1)(1992-3#1)(1992-8#3)(1992-9#4)(1993-1#1)(1993-11#2)(1993-12#1)(1993-4#1)(1993-6#1)(1993-8#4)(1993-9#2)(1994-11#5)(1994-12#4)(1994-2#1)(1994-3#3)(1994-4#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#4)(1995-3#1)(1995-6#1)(1995-8#4)(1996-1#1)(1996-11#1)(1996-4#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#2)(2004-1#1)(2004-11#2)(2005-10#2)(2005-11#8)(2005-12#2)(2005-4#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#6)(2007-12#8)(2007-2#2)(2007-3#3)(2007-4#1)(2007-8#6)(2007-9#1)(2008-10#57)(2008-11#5)(2008-12#2)(2008-2#5)(2008-3#4)(2008-4#2)(2008-5#8)(2008-6#2)(2008-7#3)(2008-8#7)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#5)(2010-3#1)(2010-4#2)(2010-5#3)(2010-8#2)(2011-1#6)(2011-2#6)(2011-3#1)(2012-1#4)(2012-12#8)(2012-2#3)(2012-3#4)(2013-1#7)(2013-7#4)(2013-8#16)
was anaplastic##2##2##(2007-12#1)(2013-8#1)
was anchored##2##2##(1997-4#1)(2010-3#1)
was and##3##2##(2010-2#1)(2010-6#1)(2011-2#1)
was annealed at##2##3##(2013-8#2)
was annealed to##2##3##(1992-12#1)(1996-7#1)
was annealed##4##2##(1992-12#1)(1996-7#1)(2013-8#2)
was another##5##2##(2008-1#1)(2008-5#1)(2009-6#1)(2010-4#1)(2011-1#1)
was answered in##2##3##(2011-2#1)(2012-12#1)
was antagonized by SCH 23390##2##5##(1990-5#2)
was antagonized by##18##3##(1990-2#2)(1990-5#5)(1990-7#1)(1993-11#1)(1993-6#1)(1994-8#1)(1995-3#3)(1995-7#1)(1996-12#1)(1997-5#2)
was antagonized in##2##3##(1992-8#1)(1993-12#1)
was antagonized##21##2##(1990-2#2)(1990-5#5)(1990-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-3#3)(1995-7#1)(1996-12#1)(1997-5#2)
was anticipated that##2##3##(2010-7#1)(2013-1#1)
was anticipated to##2##3##(1997-7#1)(2008-4#1)
was anticipated##4##2##(1997-7#1)(2008-4#1)(2010-7#1)(2013-1#1)
was any##6##2##(1995-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-8#1)
was apoptosis##2##2##(2008-11#2)
was apparent between##2##3##(1994-9#1)(2006-7#1)
was apparent by##2##3##(1993-8#1)(2007-11#1)
was apparent following##2##3##(1995-5#1)(2013-8#1)
was apparent in the##5##4##(1991-3#1)(1997-3#1)(2007-5#1)(2008-1#1)(2010-12#1)
was apparent in##10##3##(1991-3#1)(1991-6#1)(1995-5#1)(1997-3#1)(2005-1#1)(2006-10#1)(2007-11#1)(2007-5#1)(2008-1#1)(2010-12#1)
was apparent that##2##3##(1995-8#1)(1996-12#1)
was apparent when##2##3##(1990-8#1)(1992-9#1)
was apparent with##2##3##(2005-11#1)(2010-8#1)
was apparent within##2##3##(1994-11#1)(1995-1#1)
was apparent##37##2##(1990-8#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-9#2)(1993-7#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-5#2)(1995-8#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-8#1)(2005-1#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-12#1)(2010-8#1)(2012-3#1)(2013-8#1)
was apparently not##3##3##(1991-10#1)(2009-2#1)(2013-1#1)
was apparently##26##2##(1990-12#1)(1990-5#1)(1991-10#1)(1991-11#1)(1992-4#1)(1992-6#1)(1993-6#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-11#1)(1996-1#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-2#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
was applicable to the analysis of##2##6##(2008-10#2)
was applicable to the##3##4##(2007-11#1)(2008-10#2)
was applicable to##6##3##(2007-11#1)(2008-10#4)(2013-8#1)
was applicable##11##2##(1993-12#1)(2007-11#1)(2007-8#1)(2008-10#7)(2013-8#1)
was applied after##3##3##(1992-9#1)(2007-8#1)(2008-5#1)
was applied and##13##3##(1993-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#1)
was applied as a##7##4##(2008-10#5)(2008-11#1)(2008-5#1)
was applied as an##4##4##(2007-2#1)(2008-10#2)(2010-4#1)
was applied as##17##3##(1997-7#1)(2007-2#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#1)(2010-4#1)
was applied at the##3##4##(2006-11#1)(2008-10#2)
was applied at##8##3##(1997-1#1)(2006-11#1)(2008-10#3)(2010-4#1)(2011-1#1)(2012-2#1)
was applied before##3##3##(1992-2#1)(2008-10#2)
was applied by##3##3##(2008-5#1)(2008-7#1)(2009-6#1)
was applied daily##2##3##(2007-7#1)(2012-2#1)
was applied directly##4##3##(1996-5#1)(2007-11#1)(2008-10#1)(2011-1#1)
was applied during##6##3##(1991-12#1)(1994-3#1)(1995-6#2)(2008-10#1)(2009-4#1)
was applied for copper determination in##2##6##(2008-10#2)
was applied for copper determination##3##5##(2008-10#3)
was applied for determination of##4##5##(1997-8#1)(2008-10#3)
was applied for simultaneous##3##4##(2007-10#1)(2008-10#1)(2008-2#1)
was applied for the analysis of##4##6##(1997-3#1)(2008-10#3)
was applied for the determination of drug##2##7##(2008-10#2)
was applied for the determination of the##4##7##(1991-7#1)(2008-10#3)
was applied for the determination of##25##6##(1991-7#1)(2008-10#24)
was applied for the determination##26##5##(1991-7#1)(2008-10#24)(2012-12#1)
was applied for the simultaneous##4##5##(2008-10#3)(2013-7#1)
was applied for the##54##4##(1991-7#1)(1993-12#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#45)(2008-11#1)(2011-2#1)(2012-12#1)(2013-7#1)
was applied for##102##3##(1991-7#1)(1993-12#1)(1997-3#1)(1997-8#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#4)(2008-10#73)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#4)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-7#1)
was applied from##2##3##(2006-8#1)(2013-8#1)
was applied in a##3##4##(2006-7#1)(2008-10#2)
was applied in order to determine the##2##7##(2008-10#2)
was applied in order to##4##5##(1996-5#1)(2008-10#3)
was applied in pharmacokinetic##2##4##(2008-10#1)(2011-3#1)
was applied in the##6##4##(1992-2#1)(2006-9#1)(2008-10#4)
was applied in two##2##4##(2008-3#1)(2008-9#1)
was applied in##33##3##(1992-2#1)(1996-5#1)(1997-6#1)(2005-12#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#13)(2008-11#1)(2008-3#1)(2008-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-3#1)
was applied on the##5##4##(1996-1#1)(2008-10#1)(2009-11#1)(2011-3#1)(2013-1#1)
was applied on##13##3##(1993-3#1)(1996-1#1)(2008-10#5)(2008-5#1)(2008-9#1)(2009-11#1)(2011-3#1)(2012-2#1)(2013-1#1)
was applied once##3##3##(2008-10#1)(2013-1#2)
was applied only##2##3##(1995-7#1)(2008-1#1)
was applied onto the##2##4##(1996-8#1)(2007-8#1)
was applied over the##2##4##(2008-10#1)(2008-9#1)
was applied over##4##3##(2008-10#2)(2008-11#1)(2008-9#1)
was applied satisfactorily to the##3##5##(2008-10#3)
was applied satisfactorily to##6##4##(2008-10#6)
was applied successfully for the determination of##3##7##(2008-10#3)
was applied successfully in##2##4##(2008-10#2)
was applied successfully to determine##3##5##(1996-6#1)(2008-10#2)
was applied successfully to the analysis of##2##7##(2007-8#1)(2008-10#1)
was applied successfully to the determination of##15##7##(2007-8#2)(2008-10#13)
was applied successfully to the##18##5##(1992-4#1)(2007-8#3)(2008-10#14)
was applied successfully to##22##4##(1991-5#1)(1992-4#1)(1996-6#1)(2007-8#3)(2008-10#16)
was applied successfully##27##3##(1991-5#1)(1992-4#1)(1996-6#1)(2007-8#3)(2008-10#21)
was applied through the##2##4##(2007-7#1)(2009-12#1)
was applied to 1##4##4##(2006-12#1)(2008-10#2)(2013-1#1)
was applied to a sample of##2##6##(2008-10#1)(2010-9#1)
was applied to a##28##4##(1990-5#1)(1991-12#1)(1995-2#1)(1997-1#1)(1997-4#1)(2006-5#1)(2007-11#2)(2007-12#1)(2008-10#11)(2008-2#1)(2008-3#4)(2010-9#1)(2011-1#1)(2012-1#1)
was applied to analyse##2##4##(2008-10#2)
was applied to analyze##2##4##(2008-10#1)(2013-8#1)
was applied to assay##2##4##(2008-10#2)
was applied to assess the associations##2##6##(2011-1#1)(2013-1#1)
was applied to assess the##4##5##(2007-11#1)(2011-1#1)(2012-12#1)(2013-1#1)
was applied to both##3##4##(2008-10#1)(2008-2#1)(2008-5#1)
was applied to characterize##2##4##(1996-2#1)(2008-10#1)
was applied to commercial##2##4##(2008-10#2)
was applied to detect the##3##5##(2007-8#1)(2008-10#1)(2011-1#1)
was applied to detect##8##4##(1997-7#1)(2007-8#1)(2008-10#3)(2011-1#1)(2011-2#1)(2013-1#1)
was applied to determination of##7##5##(2008-10#6)(2010-9#1)
was applied to determine the##10##5##(1992-2#1)(1994-12#1)(2005-11#1)(2008-10#5)(2009-12#1)(2011-1#1)
was applied to determine zinc##2##5##(2008-10#2)
was applied to determine##27##4##(1992-2#1)(1994-12#1)(1996-3#1)(2005-11#1)(2007-8#3)(2008-10#17)(2009-12#1)(2010-12#1)(2011-1#1)
was applied to different##4##4##(2008-10#4)
was applied to estimate the##2##5##(1994-6#1)(2008-3#1)
was applied to estimate##3##4##(1994-6#1)(2008-10#1)(2008-3#1)
was applied to evaluate##2##4##(2006-12#1)(2008-10#1)
was applied to extract##2##4##(2008-10#2)
was applied to generate##2##4##(1996-10#1)(2005-11#1)
was applied to identify##2##4##(2011-3#1)(2013-8#1)
was applied to investigate the##5##5##(1994-3#1)(2005-11#1)(2008-9#1)(2010-4#1)(2011-3#1)
was applied to investigate##6##4##(1994-3#1)(2005-11#1)(2008-9#1)(2010-4#1)(2011-3#1)(2013-7#1)
was applied to measure the##3##5##(1993-7#1)(2006-6#1)(2012-2#1)
was applied to measure##7##4##(1993-7#1)(2006-6#1)(2008-2#1)(2008-5#1)(2008-6#1)(2010-2#1)(2012-2#1)
was applied to measurements of##3##5##(1993-2#1)(2008-10#1)(2011-2#1)
was applied to obtain the##2##5##(2008-10#2)
was applied to obtain##3##4##(2008-10#2)(2008-5#1)
was applied to on-line##2##4##(2008-10#2)
was applied to one##2##4##(2006-11#1)(2008-10#1)
was applied to plasma##3##4##(1990-11#2)(1996-8#1)
was applied to predict##2##4##(2008-10#1)(2013-1#1)
was applied to quantitative analysis of##2##6##(2007-8#1)(2008-2#1)
was applied to select the##2##5##(2008-10#1)(2010-8#1)
was applied to select##3##4##(2008-10#1)(2010-8#1)(2012-12#1)
was applied to several##2##4##(2008-10#2)
was applied to study the##7##5##(1996-11#1)(1997-7#1)(2008-10#3)(2011-3#1)(2013-8#1)
was applied to study##8##4##(1996-11#1)(1997-7#1)(2008-10#4)(2011-3#1)(2013-8#1)
was applied to tap water##3##5##(2008-10#3)
was applied to the VMH##2##5##(1993-2#2)
was applied to the VTA##2##5##(1993-2#2)
was applied to the analysis of certified##2##7##(2008-10#2)
was applied to the analysis of the##3##7##(1997-8#1)(2007-8#1)(2008-10#1)
was applied to the analysis of##30##6##(1992-2#1)(1993-2#1)(1997-8#1)(2007-8#2)(2008-10#23)(2010-2#1)(2010-4#1)
was applied to the detection of##3##6##(2007-8#1)(2008-10#2)
was applied to the detection##4##5##(2007-8#1)(2008-10#2)(2010-2#1)
was applied to the determination of boron in##2##8##(2007-8#1)(2008-10#1)
was applied to the determination of cadmium in##3##8##(2008-10#3)
was applied to the determination of chloramphenicol##2##7##(2008-10#2)
was applied to the determination of copper in##2##8##(2008-10#2)
was applied to the determination of hydrazine in water samples##2##10##(2008-10#2)
was applied to the determination of molybdenum in##2##8##(2008-10#2)
was applied to the determination of silver in##2##8##(2008-10#2)
was applied to the determination of the drug in##2##9##(2008-10#2)
was applied to the determination of the##3##7##(2008-10#3)
was applied to the determination of these compounds in##3##9##(2008-10#3)
was applied to the determination of these##7##7##(2008-10#7)
was applied to the determination of##101##6##(1990-9#1)(1996-5#1)(1997-2#1)(2005-4#1)(2007-8#5)(2008-10#91)(2009-6#1)
was applied to the direct determination##2##6##(2008-10#2)
was applied to the direct##3##5##(2008-10#3)
was applied to the electrode##2##5##(2005-11#1)(2008-10#1)
was applied to the extraction##2##5##(2008-10#2)
was applied to the measurement of##2##6##(1990-8#1)(2008-10#1)
was applied to the separation of##2##6##(1991-11#1)(2013-8#1)
was applied to the separation##3##5##(1991-11#1)(2008-10#1)(2013-8#1)
was applied to the simultaneous determination of##2##7##(2008-10#2)
was applied to the simultaneous spectrophotometric determination of##2##8##(2008-10#2)
was applied to the simultaneous##6##5##(2008-10#6)
was applied to the speciation of##3##6##(2008-10#3)
was applied to the speciation##4##5##(2008-10#4)
was applied to the##237##4##(1990-2#1)(1990-3#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-5#1)(1992-2#1)(1992-9#1)(1993-2#5)(1994-3#1)(1995-6#1)(1996-1#2)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-11#2)(2005-4#2)(2006-11#1)(2007-12#1)(2007-8#10)(2008-1#1)(2008-10#169)(2008-11#2)(2008-12#1)(2008-3#3)(2008-6#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-2#2)(2010-4#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#5)(2013-8#2)
was applied to three##2##4##(2006-3#1)(2008-10#1)
was applied to two different##2##5##(2008-10#1)(2008-3#1)
was applied to two##7##4##(2008-10#4)(2008-3#3)
was applied to verify the##2##5##(2008-10#1)(2013-7#1)
was applied to water samples##2##5##(2008-10#1)(2010-5#1)
was applied to##531##3##(1990-11#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-9#2)(1992-10#1)(1992-2#2)(1992-8#1)(1992-9#1)(1993-2#7)(1993-7#1)(1993-9#1)(1994-12#1)(1994-3#3)(1994-6#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-7#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#1)(2005-11#5)(2005-4#2)(2006-10#2)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#3)(2007-12#6)(2007-6#1)(2007-8#21)(2007-9#1)(2008-1#1)(2008-10#303)(2008-11#4)(2008-12#1)(2008-2#7)(2008-3#18)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#2)(2009-4#1)(2009-6#3)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#4)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#7)(2011-3#3)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#13)(2013-7#2)(2013-8#7)
was applied using a##3##4##(1996-11#1)(2008-11#1)(2013-1#1)
was applied using##4##3##(1996-11#1)(2008-11#1)(2013-1#2)
was applied which##2##3##(2007-8#1)(2008-10#1)
was applied with##7##3##(2007-8#1)(2008-10#3)(2008-12#1)(2008-4#1)(2009-7#1)
was applied##897##2##(1990-11#2)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-5#3)(1991-7#1)(1991-9#2)(1992-10#1)(1992-2#4)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#8)(1993-3#2)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#4)(1994-6#1)(1995-2#4)(1995-3#1)(1995-6#3)(1995-7#2)(1996-1#3)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#3)(1996-6#2)(1996-8#3)(1997-1#2)(1997-2#1)(1997-3#5)(1997-4#3)(1997-6#2)(1997-7#3)(1997-8#2)(2004-9#1)(2005-11#5)(2005-12#1)(2005-4#2)(2006-10#3)(2006-11#3)(2006-12#3)(2006-2#1)(2006-3#3)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#12)(2007-12#8)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#44)(2007-9#2)(2008-1#3)(2008-10#477)(2008-11#12)(2008-12#5)(2008-2#9)(2008-3#21)(2008-4#3)(2008-5#18)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#6)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#4)(2009-7#2)(2009-8#1)(2010-10#2)(2010-12#5)(2010-2#3)(2010-3#1)(2010-4#8)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#10)(2011-2#14)(2011-3#5)(2012-1#3)(2012-11#1)(2012-12#9)(2012-2#7)(2012-3#2)(2012-5#1)(2013-1#23)(2013-7#5)(2013-8#8)
was appointed##8##2##(1993-11#1)(1993-3#2)(2010-1#1)(2010-12#2)(2011-1#1)(2011-2#1)
was apportioned into##2##3##(2008-10#1)(2010-5#1)
was appreciable##2##2##(1991-2#1)(1995-8#1)
was appreciably##6##2##(1990-3#1)(1990-4#1)(1991-2#1)(1993-3#1)(1995-1#1)(2008-5#1)
was appreciated##2##2##(2007-2#1)(2012-12#1)
was appressed##2##2##(2008-10#2)
was approached by##3##3##(1993-12#1)(1995-11#1)(2005-4#1)
was approached in##3##3##(1991-2#1)(1995-9#1)(2013-8#1)
was approached##9##2##(1990-2#1)(1991-2#1)(1992-3#1)(1993-12#1)(1995-11#1)(1995-9#1)(1996-3#1)(2005-4#1)(2013-8#1)
was appropriate for##6##3##(2008-1#1)(2008-10#2)(2009-10#1)(2011-12#1)(2013-8#1)
was appropriate##9##2##(2005-11#1)(2006-12#1)(2008-1#1)(2008-10#2)(2009-10#1)(2010-12#1)(2011-12#1)(2013-8#1)
was appropriately##4##2##(2005-11#1)(2007-11#1)(2008-4#1)(2008-5#1)
was approved by the US Food and Drug Administration##3##9##(2008-5#1)(2011-1#1)(2012-12#1)
was approved by the##5##4##(2008-5#1)(2008-9#1)(2010-4#1)(2011-1#1)(2012-12#1)
was approved by##9##3##(1996-7#1)(2008-5#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
was approved for the treatment of##2##6##(2008-5#1)(2008-7#1)
was approved for##5##3##(2008-11#1)(2008-5#3)(2008-7#1)
was approved in the##2##4##(2007-11#1)(2009-11#1)
was approved in##6##3##(2005-9#1)(2006-12#1)(2007-11#1)(2009-11#1)(2010-12#1)(2012-3#1)
was approved##24##2##(1996-7#1)(2005-9#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-5#5)(2008-7#1)(2008-9#1)(2009-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
was approx##5##2##(1990-5#1)(1993-12#1)(1993-9#1)(2008-5#2)
was approximately 0##6##3##(2008-10#3)(2008-3#3)
was approximately 1##10##3##(1991-10#1)(1992-11#1)(1995-2#1)(1995-6#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#1)
was approximately 1%##4##3##(2004-2#1)(2006-10#2)(2007-12#1)
was approximately 10##6##3##(1991-5#1)(1994-11#1)(1995-6#1)(2008-10#1)(2008-2#1)(2008-3#1)
was approximately 10-fold##2##3##(1993-3#1)(2008-10#1)
was approximately 13%##2##3##(2008-10#1)(2008-8#1)
was approximately 2 microM##2##4##(1994-3#2)
was approximately 2 times higher##2##5##(2010-2#1)(2011-2#1)
was approximately 2##9##3##(1990-8#1)(1992-12#1)(1994-3#2)(2008-10#1)(2008-4#1)(2008-7#1)(2010-2#1)(2011-2#1)
was approximately 2%##2##3##(2008-10#1)(2008-5#1)
was approximately 2-fold##2##3##(1991-5#1)(1993-11#1)
was approximately 20 times##2##4##(1997-4#1)(2008-10#1)
was approximately 20##3##3##(1997-4#1)(2008-10#1)(2009-9#1)
was approximately 200 times##2##4##(2008-10#1)(2010-5#1)
was approximately 200##3##3##(2008-10#1)(2009-7#1)(2010-5#1)
was approximately 3##2##3##(2008-3#2)
was approximately 4##3##3##(1991-2#1)(2007-12#1)(2008-10#1)
was approximately 4-fold##2##3##(1991-8#1)(1997-6#1)
was approximately 400##2##3##(1992-5#1)(2009-12#1)
was approximately 5##3##3##(1992-4#1)(1996-2#1)(2008-3#1)
was approximately 50% lower##2##4##(1997-8#1)(2008-7#1)
was approximately 50%##6##3##(1994-11#1)(1996-9#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-7#1)
was approximately 60%##2##3##(1993-11#1)(2011-2#1)
was approximately 70##3##3##(1991-6#1)(2008-10#1)(2008-3#1)
was approximately 8##2##3##(1991-3#1)(2008-10#1)
was approximately 80%##2##3##(2006-12#1)(2010-5#1)
was approximately equal to##2##4##(2008-10#1)(2013-1#1)
was approximately equal##3##3##(1994-11#1)(2008-10#1)(2013-1#1)
was approximately five##2##3##(2008-10#1)(2008-5#1)
was approximately one##3##3##(1993-4#1)(1996-12#1)(1997-4#1)
was approximately the same##2##4##(1997-7#1)(2008-3#1)
was approximately##153##2##(1990-11#1)(1990-2#1)(1990-8#2)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1993-11#2)(1993-3#3)(1993-4#1)(1994-10#2)(1994-11#3)(1994-2#2)(1994-3#2)(1994-9#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#3)(1995-8#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-9#2)(1997-2#1)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#2)(2004-2#1)(2004-9#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-7#1)(2007-9#2)(2008-10#29)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#13)(2008-4#1)(2008-5#5)(2008-7#2)(2008-8#4)(2009-12#1)(2009-3#1)(2009-7#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#3)
was arbitrarily defined as##2##4##(1993-12#1)(2011-2#1)
was arbitrarily##4##2##(1993-12#1)(2008-10#1)(2010-7#1)(2011-2#1)
was argued##3##2##(2008-12#1)(2010-8#1)(2013-7#1)
was around 0##2##3##(1990-10#1)(2008-10#1)
was around 10%##2##3##(1992-7#1)(2008-10#1)
was around 20##2##3##(2008-10#2)
was around##18##2##(1990-10#1)(1990-7#1)(1992-4#1)(1992-7#1)(2008-10#10)(2008-11#2)(2008-9#1)(2012-3#1)
was arranged for##2##3##(1995-4#1)(2010-9#1)
was arranged in##2##3##(2006-12#1)(2008-12#1)
was arranged##9##2##(1993-9#1)(1995-4#1)(2006-12#2)(2008-12#1)(2010-11#1)(2010-9#1)(2011-2#2)
was arrested and##2##3##(1995-12#1)(2011-2#1)
was arrested at##2##3##(2008-10#1)(2008-5#1)
was arrested##8##2##(1991-10#1)(1993-12#1)(1994-8#1)(1995-12#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-8#1)
was arrived at##3##3##(1990-3#1)(1995-6#1)(2009-5#1)
was artificially##2##2##(2007-11#1)(2010-8#1)
was as active as the##2##5##(1991-8#1)(2009-3#1)
was as active as##4##4##(1991-4#1)(1991-8#1)(1995-2#1)(2009-3#1)
was as effective as##12##4##(1990-2#1)(1991-8#1)(1993-9#1)(1995-10#1)(1997-5#1)(2007-11#1)(2008-10#1)(2008-3#3)(2008-8#1)(2013-8#1)
was as effective##13##3##(1990-2#1)(1991-8#1)(1993-9#1)(1995-10#1)(1997-5#1)(2007-11#1)(2008-10#2)(2008-3#3)(2008-8#1)(2013-8#1)
was as efficient as##2##4##(1990-12#1)(2008-10#1)
was as efficient##3##3##(1990-12#1)(2008-10#1)(2008-8#1)
was as follows##22##3##(1990-2#1)(1992-5#1)(1992-9#1)(1994-11#1)(1994-3#1)(1996-4#1)(1996-5#1)(2005-12#1)(2006-10#1)(2007-3#2)(2007-6#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-7#1)(2010-5#1)(2012-12#1)(2013-1#2)
was as good as##3##4##(2008-9#1)(2011-1#1)(2013-8#1)
was as high as##10##4##(1997-4#1)(2004-11#1)(2007-11#1)(2007-12#1)(2008-6#1)(2008-7#1)(2010-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
was as high##12##3##(1991-2#1)(1997-4#1)(2004-11#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-6#1)(2008-7#1)(2010-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
was as large as##5##4##(2007-12#2)(2008-2#1)(2008-3#1)(2009-11#1)
was as low as 0##4##5##(1992-8#1)(2006-5#1)(2008-10#1)(2008-2#1)
was as low as 1##2##5##(2008-10#1)(2011-1#1)
was as low as##10##4##(1992-8#1)(2006-5#1)(2008-10#6)(2008-2#1)(2011-1#1)
was as much as##2##4##(1994-6#1)(2008-5#1)
was as much##4##3##(1994-6#1)(2008-12#1)(2008-5#1)(2008-7#1)
was as potent as##2##4##(1990-2#1)(1995-12#1)
was as##95##2##(1990-12#2)(1990-2#3)(1990-4#1)(1990-6#1)(1991-2#1)(1991-4#1)(1991-8#2)(1992-5#2)(1992-8#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-4#1)(1996-5#1)(1997-4#1)(1997-5#1)(2004-11#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-3#2)(2007-6#1)(2007-8#2)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#2)(2010-1#1)(2010-5#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
was ascertained by##10##3##(1990-3#1)(1991-7#1)(1996-10#1)(2004-2#1)(2008-10#5)(2011-1#1)
was ascertained##21##2##(1990-3#1)(1991-4#1)(1991-7#1)(1993-9#1)(1994-8#1)(1996-10#1)(1997-2#1)(1997-3#1)(2004-2#1)(2008-10#5)(2008-3#1)(2008-6#2)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
was ascribed to the##2##4##(1994-3#1)(1997-7#1)
was ascribed to##3##3##(1992-6#1)(1994-3#1)(1997-7#1)
was asked by##2##3##(1995-2#1)(2012-2#1)
was asked to##6##3##(1990-11#1)(1991-3#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-8#1)
was asked##8##2##(1990-11#1)(1991-3#1)(1995-2#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-8#1)(2012-2#1)
was aspirated##7##2##(2008-10#3)(2008-7#1)(2010-12#1)(2011-1#1)(2012-2#1)
was assayed by##12##3##(1991-7#1)(1992-5#1)(1993-12#1)(1994-2#1)(1994-9#1)(1996-4#1)(2004-12#1)(2008-10#3)(2008-11#1)(2009-9#1)
was assayed for##4##3##(1990-4#1)(1991-3#1)(1993-5#1)(1995-3#1)
was assayed in the##2##4##(1993-7#1)(2008-10#1)
was assayed in##9##3##(1990-12#1)(1990-4#1)(1992-12#1)(1992-3#1)(1993-7#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-5#1)
was assayed on##5##3##(2007-11#2)(2008-10#1)(2008-7#1)(2011-2#1)
was assayed using##5##3##(1995-8#1)(1997-7#1)(2007-2#1)(2008-8#1)(2012-11#1)
was assayed with##3##3##(1996-8#1)(1996-9#1)(2008-11#1)
was assayed##47##2##(1990-12#1)(1990-4#2)(1990-7#1)(1991-3#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-4#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-7#1)(2004-12#1)(2007-11#2)(2007-2#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)(2012-11#1)
was assembled for##2##3##(2008-10#1)(2012-2#1)
was assembled in##3##3##(1991-6#1)(1994-3#1)(2010-5#1)
was assembled to##3##3##(2007-12#1)(2008-2#1)(2012-2#1)
was assembled with##4##3##(1997-4#1)(2007-8#1)(2008-10#2)
was assembled##21##2##(1991-6#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-6#1)(1997-4#1)(2007-12#2)(2007-8#1)(2008-10#8)(2008-2#1)(2010-5#1)(2012-2#2)
was assesed##2##2##(2007-11#1)(2008-7#1)
was assessed 2##2##3##(2004-12#1)(2008-10#1)
was assessed according to the##2##5##(1995-4#1)(2007-8#1)
was assessed according to##6##4##(1993-8#1)(1995-4#1)(2007-7#2)(2007-8#1)(2012-3#1)
was assessed after##3##3##(1990-12#1)(1991-5#1)(1994-12#1)
was assessed among##3##3##(1991-3#1)(2006-10#1)(2012-12#1)
was assessed and compared to##2##5##(2008-4#1)(2010-2#1)
was assessed and compared##3##4##(2008-10#1)(2008-4#1)(2010-2#1)
was assessed and##6##3##(2008-10#1)(2008-3#1)(2008-4#1)(2009-2#1)(2010-2#1)(2011-1#1)
was assessed as a##2##4##(1991-3#1)(2009-2#1)
was assessed as an##2##4##(1996-11#1)(2010-6#1)
was assessed as##9##3##(1991-3#1)(1996-11#1)(2007-2#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-6#1)(2012-2#1)
was assessed at##14##3##(1993-4#2)(2004-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
was assessed based on the##2##5##(2008-10#1)(2011-1#1)
was assessed based on##4##4##(2008-10#2)(2011-1#1)(2011-2#1)
was assessed before and after##2##5##(2007-9#1)(2013-7#1)
was assessed before and##3##4##(2005-5#1)(2007-9#1)(2013-7#1)
was assessed by a##7##4##(1996-5#1)(2006-3#1)(2007-11#1)(2008-10#1)(2010-7#1)(2011-2#1)(2013-7#1)
was assessed by analyzing##2##4##(1997-2#1)(2005-11#1)
was assessed by calculating the##2##5##(2007-8#1)(2008-5#1)
was assessed by changes in##2##5##(1997-2#1)(2007-11#1)
was assessed by comparing the##3##5##(1990-12#1)(1991-6#1)(2008-10#1)
was assessed by comparing##8##4##(1990-12#2)(1991-6#1)(1994-1#1)(1997-3#1)(2007-7#1)(2008-10#1)(2010-4#1)
was assessed by comparison with##2##5##(2008-10#1)(2008-5#1)
was assessed by counting colonies formed from spore-bearing splash droplets deposited in sheltered petri plates containing a selective medium##2##19##(2008-10#2)
was assessed by determining##2##4##(2008-10#1)(2008-5#1)
was assessed by enzyme-linked immunosorbent assay##2##6##(2008-10#1)(2011-2#1)
was assessed by evaluating the##2##5##(1993-6#1)(1996-11#1)
was assessed by evaluating##3##4##(1993-6#1)(1996-11#1)(2008-10#1)
was assessed by flow cytometry##2##5##(2008-4#1)(2013-7#1)
was assessed by fluorescent##2##4##(1993-7#1)(2008-10#1)
was assessed by means of the##2##6##(2008-7#1)(2013-1#1)
was assessed by means of##5##5##(2007-11#1)(2007-3#1)(2008-7#1)(2010-4#1)(2013-1#1)
was assessed by measurement of##3##5##(1993-2#1)(1994-4#2)
was assessed by measuring serum##2##5##(2008-10#1)(2012-2#1)
was assessed by measuring the##6##5##(1990-5#1)(1995-3#1)(1997-4#1)(2004-11#1)(2008-3#1)(2012-2#1)
was assessed by measuring##11##4##(1990-5#1)(1993-7#1)(1994-6#1)(1995-3#1)(1997-4#1)(2004-11#1)(2008-10#1)(2008-3#1)(2009-10#1)(2012-2#2)
was assessed by monitoring##2##4##(1997-3#1)(2007-10#1)
was assessed by quantitative##2##4##(2007-8#1)(2008-7#1)
was assessed by studying the##2##5##(2005-11#1)(2011-2#1)
was assessed by studying##3##4##(1991-5#1)(2005-11#1)(2011-2#1)
was assessed by the determination of##2##6##(2008-10#2)
was assessed by the##23##4##(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1997-8#1)(2004-11#1)(2006-6#1)(2008-10#4)(2008-5#1)(2008-9#1)(2009-3#2)(2009-6#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-1#3)(2013-8#1)
was assessed by use of##3##5##(1995-11#1)(2008-7#1)(2013-1#1)
was assessed by using a##3##5##(1990-7#1)(2006-6#1)(2013-8#1)
was assessed by using##7##4##(1990-7#1)(1993-7#1)(2006-6#1)(2007-9#1)(2008-10#2)(2013-8#1)
was assessed by##172##3##(1990-10#1)(1990-12#2)(1990-5#1)(1990-6#1)(1990-7#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-7#4)(1993-9#1)(1994-1#1)(1994-11#1)(1994-3#1)(1994-4#2)(1994-5#2)(1994-6#3)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-5#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#1)(1997-8#3)(2004-11#2)(2004-12#1)(2005-11#2)(2006-12#1)(2006-3#1)(2006-6#2)(2006-8#2)(2007-10#1)(2007-11#4)(2007-3#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-10#30)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#9)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-2#3)(2013-1#10)(2013-7#3)(2013-8#4)
was assessed during##2##3##(2008-10#1)(2013-8#1)
was assessed either by##2##4##(1992-1#1)(1995-6#1)
was assessed for 7##2##4##(1991-6#1)(2011-2#1)
was assessed for the##2##4##(2008-10#2)
was assessed for##11##3##(1991-6#1)(2006-10#1)(2007-2#1)(2008-10#3)(2008-9#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-11#1)
was assessed from the##5##4##(1997-4#1)(1997-6#1)(2006-8#1)(2008-10#1)(2008-11#1)
was assessed from##7##3##(1997-4#1)(1997-6#1)(2006-4#1)(2006-8#1)(2008-10#2)(2008-11#1)
was assessed in 20##2##4##(1992-3#1)(2008-10#1)
was assessed in a large##2##5##(1993-3#1)(2008-7#1)
was assessed in a sample of##2##6##(2006-4#1)(2010-7#1)
was assessed in a##11##4##(1990-8#1)(1993-3#1)(2006-4#1)(2006-8#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-7#1)(2011-1#1)(2013-1#1)
was assessed in all##2##4##(2008-7#1)(2012-2#1)
was assessed in field experiments##2##5##(2008-10#2)
was assessed in terms of##5##5##(2005-10#1)(2008-10#1)(2008-11#1)(2008-6#1)(2012-2#1)
was assessed in the##13##4##(1990-8#1)(1992-3#1)(1994-2#1)(1997-2#1)(1997-8#1)(2007-10#1)(2007-3#1)(2008-10#1)(2008-2#1)(2009-6#2)(2011-2#1)(2013-1#1)
was assessed in these##2##4##(1994-2#1)(2008-10#1)
was assessed in this##2##4##(1993-9#1)(2008-10#1)
was assessed in two##2##4##(2007-8#1)(2008-10#1)
was assessed in##87##3##(1990-12#1)(1990-2#1)(1990-8#2)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-3#3)(1993-3#1)(1993-9#2)(1994-2#3)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#3)(1997-1#1)(1997-2#2)(1997-7#1)(1997-8#1)(2004-11#1)(2004-3#1)(2005-10#1)(2005-9#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#3)(2009-6#2)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-5#1)(2013-1#3)
was assessed on the##2##4##(2007-8#1)(2008-10#1)
was assessed on##10##3##(1990-6#1)(1992-8#1)(2005-8#1)(2006-12#1)(2006-6#1)(2007-8#1)(2008-10#3)(2008-6#1)
was assessed over##3##3##(2004-1#1)(2008-9#1)(2009-4#1)
was assessed through analysis of##2##5##(1994-12#1)(2013-1#1)
was assessed through##12##3##(1994-12#1)(1996-12#1)(2008-10#6)(2009-12#1)(2010-8#1)(2011-12#1)(2013-1#1)
was assessed to##2##3##(2007-7#1)(2008-8#1)
was assessed using a##11##4##(1997-7#1)(2004-10#1)(2008-1#1)(2008-10#4)(2009-3#3)(2012-3#1)
was assessed using both##2##4##(1993-2#1)(2013-1#1)
was assessed using the##24##4##(1990-11#1)(1990-5#1)(1991-11#1)(1991-8#1)(1995-10#1)(2004-3#1)(2005-7#1)(2006-9#1)(2007-10#2)(2007-7#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-5#1)(2013-7#1)(2013-8#1)
was assessed using##77##3##(1990-11#1)(1990-5#1)(1991-11#1)(1991-8#1)(1992-1#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-10#1)(1996-7#1)(1997-3#1)(1997-7#1)(2004-10#1)(2004-3#1)(2005-7#1)(2006-5#1)(2006-9#1)(2007-10#3)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#10)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-3#4)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#4)(2013-7#3)(2013-8#4)
was assessed via##3##3##(2006-8#1)(2009-2#1)(2009-7#1)
was assessed with a##5##4##(1993-12#1)(2008-11#1)(2008-5#2)(2010-7#1)
was assessed with the##11##4##(1991-2#1)(1994-2#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2012-12#2)(2013-8#1)
was assessed with##30##3##(1991-2#1)(1993-12#1)(1994-2#1)(1994-8#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-3#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2010-7#1)(2012-12#2)(2013-1#4)(2013-8#1)
was assessed##551##2##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#1)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#3)(1992-1#4)(1992-11#1)(1992-3#4)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#3)(1993-7#5)(1993-8#1)(1993-9#4)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#5)(1994-3#1)(1994-4#2)(1994-5#4)(1994-6#3)(1994-8#4)(1994-9#1)(1995-1#2)(1995-10#2)(1995-11#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#5)(1996-2#1)(1996-3#4)(1996-5#4)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#4)(1997-3#6)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#5)(2004-1#1)(2004-10#1)(2004-11#3)(2004-12#2)(2004-2#1)(2004-3#2)(2004-4#1)(2005-10#1)(2005-11#2)(2005-5#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#4)(2006-12#2)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#5)(2006-8#7)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#6)(2007-12#2)(2007-2#3)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#9)(2007-8#11)(2007-9#2)(2008-1#2)(2008-10#90)(2008-11#4)(2008-12#4)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#24)(2008-6#10)(2008-7#12)(2008-8#3)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#6)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#1)(2010-12#3)(2010-2#1)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#5)(2010-8#3)(2010-9#2)(2011-1#9)(2011-12#1)(2011-2#13)(2012-1#5)(2012-11#1)(2012-12#10)(2012-2#11)(2012-3#4)(2012-5#2)(2013-1#27)(2013-7#8)(2013-8#11)
was assigned a##2##3##(1993-6#1)(2010-2#1)
was assigned as##3##3##(2007-1#1)(2008-5#1)(2010-4#1)
was assigned to the##5##4##(1991-8#1)(1994-11#1)(2005-11#1)(2006-8#1)(2008-8#1)
was assigned to##14##3##(1991-8#1)(1993-3#1)(1994-11#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-8#1)(2008-10#5)(2008-8#1)
was assigned using##2##3##(1992-3#1)(2008-10#1)
was assigned##26##2##(1990-12#1)(1991-8#1)(1992-3#1)(1993-3#1)(1993-6#1)(1994-11#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-8#1)(2007-1#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-8#1)(2010-2#1)(2010-4#1)
was associated only with##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
was associated to##4##3##(1992-6#1)(1992-9#1)(2008-10#2)
was associated with Buerger's disease##2##5##(1997-8#2)
was associated with a 1##2##5##(2008-11#1)(2013-1#1)
was associated with a 7##2##5##(1991-6#1)(1996-6#1)
was associated with a better outcome in##2##7##(2008-11#1)(2009-10#1)
was associated with a better##3##5##(2008-11#1)(2008-6#1)(2009-10#1)
was associated with a decrease in##4##6##(1994-5#1)(1995-3#1)(2008-7#1)(2010-8#1)
was associated with a decrease##5##5##(1994-5#1)(1995-3#1)(1996-6#1)(2008-7#1)(2010-8#1)
was associated with a decreased risk of##3##7##(2007-9#1)(2011-2#1)(2013-7#1)
was associated with a decreased##6##5##(1991-9#1)(1992-8#1)(2007-9#1)(2011-2#2)(2013-7#1)
was associated with a delay in##2##6##(1996-5#1)(2008-10#1)
was associated with a gradual##2##5##(2007-10#1)(2008-10#1)
was associated with a greater##2##5##(1991-1#1)(1995-6#1)
was associated with a high##5##5##(2007-11#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-7#1)
was associated with a higher incidence of##2##7##(2009-1#1)(2013-8#1)
was associated with a higher proportion of##2##7##(1996-2#1)(2008-9#1)
was associated with a higher##7##5##(1996-2#1)(2007-8#1)(2008-2#1)(2008-9#1)(2009-1#1)(2013-1#1)(2013-8#1)
was associated with a lower##4##5##(2007-10#1)(2007-8#1)(2008-10#1)(2013-8#1)
was associated with a reduction in the##2##7##(2006-4#1)(2008-10#1)
was associated with a reduction in##4##6##(2006-4#1)(2008-10#1)(2010-11#1)(2013-1#1)
was associated with a rise in##2##6##(1990-7#1)(2008-10#1)
was associated with a significant decrease of the##2##8##(2011-1#1)(2013-8#1)
was associated with a significant decrease##3##6##(1996-4#1)(2011-1#1)(2013-8#1)
was associated with a significant increase in##3##7##(1995-12#1)(2007-2#1)(2012-1#1)
was associated with a significant increase##4##6##(1990-12#1)(1995-12#1)(2007-2#1)(2012-1#1)
was associated with a significant reduction in##7##7##(2007-10#1)(2007-2#2)(2008-3#1)(2008-4#1)(2010-5#1)(2010-6#1)
was associated with a significant##16##5##(1990-12#1)(1993-7#1)(1995-12#1)(1996-4#1)(2007-10#1)(2007-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-1#1)(2013-8#1)
was associated with a significantly##2##5##(1992-10#1)(2012-12#1)
was associated with a similar##2##5##(1992-3#1)(1996-3#1)
was associated with a##114##4##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-4#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-10#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-12#3)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#1)(1997-1#1)(1997-4#2)(2005-11#1)(2006-12#2)(2006-4#2)(2006-6#1)(2006-9#1)(2007-10#4)(2007-11#1)(2007-2#3)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#2)(2013-1#4)(2013-7#1)(2013-8#5)
was associated with abnormal##2##4##(1990-8#1)(2008-9#1)
was associated with activation of##2##5##(2008-4#1)(2010-12#1)
was associated with age##4##4##(1996-2#1)(2008-5#1)(2012-3#1)(2013-1#1)
was associated with all##3##4##(1990-5#1)(2007-10#1)(2012-1#1)
was associated with an enhanced frequency of##2##7##(1993-4#1)(2011-2#1)
was associated with an enhanced##3##5##(1991-5#1)(1993-4#1)(2011-2#1)
was associated with an increase in the##3##7##(2007-8#1)(2008-5#1)(2011-2#1)
was associated with an increase in##15##6##(1990-7#1)(1993-12#1)(1994-6#1)(1995-10#1)(1996-1#1)(1996-10#1)(1997-5#1)(2007-8#2)(2008-10#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-2#2)
was associated with an increased risk of##5##7##(1993-11#1)(1995-5#1)(2007-9#1)(2010-6#1)(2012-2#1)
was associated with an increased##9##5##(1990-11#1)(1990-12#1)(1993-11#1)(1995-5#1)(2007-9#1)(2008-11#1)(2010-12#1)(2010-6#1)(2012-2#1)
was associated with an##40##4##(1990-11#1)(1990-12#1)(1990-6#1)(1990-7#1)(1991-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-4#1)(1994-2#1)(1994-6#1)(1995-10#1)(1995-5#1)(1996-1#1)(1996-10#1)(1997-5#1)(2007-8#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-9#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#1)(2013-8#1)
was associated with better##4##4##(2007-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
was associated with both##4##4##(1990-8#1)(1995-2#1)(2004-11#1)(2010-7#1)
was associated with boys'##2##4##(2007-12#2)
was associated with changes##2##4##(1994-3#1)(2008-12#1)
was associated with complications##2##4##(2011-2#1)(2012-12#1)
was associated with current##2##4##(2012-3#1)(2013-1#1)
was associated with decreased##8##4##(1993-9#1)(2007-11#2)(2008-10#1)(2008-9#1)(2009-12#1)(2010-8#1)(2013-8#1)
was associated with elevated levels of##2##6##(1990-12#1)(2008-10#1)
was associated with elevated##8##4##(1990-12#1)(1991-5#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-5#1)(2010-7#1)
was associated with enhanced##5##4##(1993-8#1)(2008-12#1)(2010-11#1)(2011-2#1)(2012-2#1)
was associated with fewer##3##4##(2005-12#1)(2007-7#1)(2011-2#1)
was associated with girls'##2##4##(2007-12#2)
was associated with good##2##4##(2005-5#1)(2012-2#1)
was associated with greater##9##4##(2007-10#1)(2007-12#1)(2008-4#2)(2009-11#1)(2009-5#1)(2010-4#1)(2010-9#1)(2013-8#1)
was associated with having##2##4##(2008-6#1)(2009-4#1)
was associated with high##7##4##(1994-8#1)(1996-1#1)(2004-9#1)(2007-7#1)(2008-10#1)(2009-4#1)(2013-8#1)
was associated with higher levels of##3##6##(2006-10#1)(2007-8#2)
was associated with higher##13##4##(1993-3#1)(1994-12#1)(2006-10#1)(2007-2#1)(2007-8#2)(2008-10#1)(2009-9#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
was associated with improved##3##4##(2008-6#1)(2010-4#1)(2012-3#1)
was associated with increased activation in##2##6##(1995-12#1)(2008-11#1)
was associated with increased expression of##2##6##(1991-3#1)(2012-12#1)
was associated with increased mortality##2##5##(2005-12#1)(2011-2#1)
was associated with increased risk of##2##6##(2005-12#1)(2008-6#1)
was associated with increased risk##4##5##(1993-9#1)(2005-12#1)(2008-6#1)(2012-3#1)
was associated with increased##36##4##(1991-3#1)(1992-8#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(2005-10#1)(2005-12#2)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-2#2)(2010-4#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#3)(2012-6#1)(2013-1#1)
was associated with increases in##2##5##(1993-3#1)(2008-10#1)
was associated with inhibition of##2##5##(1991-9#1)(2012-2#1)
was associated with less##6##4##(2006-6#1)(2007-3#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-9#1)
was associated with low##2##4##(2008-10#1)(2008-7#1)
was associated with lower HIV prevalence (AOR=0##2##7##(2012-3#2)
was associated with lower levels of##2##6##(2009-5#1)(2010-4#1)
was associated with lower rates of##2##6##(2008-10#1)(2013-1#1)
was associated with lower##13##4##(1993-3#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-4#1)(2012-1#1)(2012-3#2)(2013-1#2)
was associated with marked##4##4##(1991-5#1)(1992-8#1)(2007-10#1)(2008-10#1)
was associated with meeting##2##4##(2009-5#2)
was associated with more than one##2##6##(2008-10#2)
was associated with more##9##4##(1995-3#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#2)
was associated with no change in##2##6##(1992-2#1)(1995-12#1)
was associated with only##3##4##(1995-5#1)(1997-4#1)(2008-8#1)
was associated with poorer##5##4##(2005-7#1)(2007-12#1)(2008-9#1)(2009-9#1)(2012-1#1)
was associated with preventive attitudes (aOR =##2##7##(1992-4#2)
was associated with reduced##6##4##(1997-4#1)(2005-12#2)(2008-3#1)(2010-8#1)(2011-2#1)
was associated with schizophrenia##2##4##(1997-5#1)(2010-12#1)
was associated with shorter##2##4##(1993-10#1)(2007-11#1)
was associated with significant decreases in##3##6##(1993-12#1)(1996-12#1)(2007-8#1)
was associated with significant##7##4##(1993-12#1)(1996-12#1)(2005-8#1)(2007-8#1)(2008-10#1)(2010-12#1)(2010-6#1)
was associated with significantly##5##4##(1990-2#1)(1993-9#1)(2009-9#1)(2010-5#1)(2012-2#1)
was associated with stronger##2##4##(2010-6#1)(2012-2#1)
was associated with symptomatic##2##4##(1995-2#1)(2013-1#1)
was associated with the development of##2##6##(1993-6#1)(2008-4#1)
was associated with the highest##2##5##(2007-9#1)(2008-4#1)
was associated with the induction of##2##6##(2008-10#1)(2008-11#1)
was associated with the presence of##4##6##(1993-11#1)(1995-2#1)(2008-10#1)(2013-8#1)
was associated with the##51##4##(1990-12#1)(1990-2#1)(1991-2#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-2#1)(1996-6#1)(1997-5#1)(2004-2#1)(2005-10#1)(2007-12#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#2)(2010-6#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
was associated with younger age##2##5##(2007-10#1)(2010-12#1)
was associated with##636##3##(1990-11#1)(1990-12#5)(1990-2#3)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#3)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#4)(1991-9#3)(1992-10#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-8#4)(1992-9#2)(1993-10#2)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#6)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#4)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#4)(1994-8#5)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#6)(1995-2#4)(1995-3#3)(1995-5#3)(1995-6#3)(1995-8#2)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#3)(1996-3#4)(1996-4#1)(1996-5#2)(1996-6#3)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#6)(1997-5#3)(1997-8#2)(2004-1#1)(2004-10#1)(2004-11#1)(2004-2#1)(2004-9#1)(2005-10#5)(2005-11#1)(2005-12#6)(2005-5#2)(2005-7#1)(2005-8#4)(2006-10#3)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#3)(2006-6#2)(2006-8#1)(2006-9#1)(2007-10#10)(2007-11#8)(2007-12#9)(2007-2#8)(2007-3#1)(2007-6#3)(2007-7#9)(2007-8#20)(2007-9#5)(2008-1#3)(2008-10#59)(2008-11#11)(2008-12#8)(2008-2#1)(2008-3#6)(2008-4#9)(2008-5#7)(2008-6#8)(2008-7#15)(2008-8#6)(2008-9#14)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#4)(2009-2#2)(2009-3#2)(2009-4#7)(2009-5#9)(2009-7#3)(2009-8#3)(2009-9#5)(2010-11#3)(2010-12#10)(2010-2#3)(2010-3#1)(2010-4#8)(2010-5#3)(2010-6#5)(2010-7#3)(2010-8#4)(2010-9#2)(2011-1#8)(2011-12#2)(2011-2#18)(2012-1#9)(2012-12#14)(2012-2#19)(2012-3#15)(2012-5#1)(2012-6#1)(2013-1#30)(2013-7#2)(2013-8#17)
was associated##653##2##(1990-11#1)(1990-12#5)(1990-2#3)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#3)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#4)(1991-9#3)(1992-10#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#2)(1992-8#4)(1992-9#3)(1993-10#2)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#6)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#4)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#4)(1994-8#5)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#6)(1995-2#5)(1995-3#3)(1995-5#3)(1995-6#3)(1995-8#2)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#3)(1996-3#4)(1996-4#1)(1996-5#2)(1996-6#3)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#6)(1997-5#3)(1997-8#3)(2004-1#1)(2004-10#1)(2004-11#1)(2004-2#1)(2004-9#1)(2005-10#5)(2005-11#2)(2005-12#6)(2005-5#2)(2005-7#1)(2005-8#4)(2006-10#3)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#3)(2006-6#3)(2006-8#1)(2006-9#1)(2007-10#10)(2007-11#8)(2007-12#9)(2007-2#8)(2007-3#1)(2007-6#3)(2007-7#10)(2007-8#20)(2007-9#5)(2008-1#3)(2008-10#63)(2008-11#12)(2008-12#8)(2008-2#1)(2008-3#6)(2008-4#9)(2008-5#7)(2008-6#8)(2008-7#15)(2008-8#6)(2008-9#15)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#4)(2009-2#2)(2009-3#2)(2009-4#7)(2009-5#9)(2009-7#3)(2009-8#3)(2009-9#5)(2010-11#3)(2010-12#12)(2010-2#3)(2010-3#1)(2010-4#8)(2010-5#4)(2010-6#5)(2010-7#3)(2010-8#4)(2010-9#2)(2011-1#8)(2011-12#2)(2011-2#18)(2012-1#9)(2012-12#14)(2012-2#19)(2012-3#15)(2012-5#1)(2012-6#1)(2013-1#31)(2013-7#2)(2013-8#17)
was assumed that the##7##4##(2005-11#2)(2005-7#1)(2008-11#1)(2008-2#1)(2008-6#2)
was assumed that##16##3##(1994-9#1)(1996-8#1)(2005-11#2)(2005-7#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#2)(2008-8#1)(2011-12#1)(2012-12#1)
was assumed to be a##2##5##(1991-2#1)(2008-7#1)
was assumed to be##8##4##(1990-5#1)(1991-2#1)(1992-4#1)(2004-9#1)(2008-10#2)(2008-3#1)(2008-7#1)
was assumed to##10##3##(1990-5#1)(1991-2#1)(1992-4#1)(2004-9#1)(2008-10#3)(2008-3#1)(2008-7#1)(2013-1#1)
was assumed##36##2##(1990-5#1)(1991-2#1)(1992-4#1)(1994-9#1)(1996-8#1)(2004-9#1)(2005-11#2)(2005-7#2)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-2#2)(2009-4#1)(2010-4#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
was assured by##3##3##(1990-8#1)(2005-11#1)(2007-11#1)
was asymptomatic after##2##3##(2008-10#1)(2012-2#1)
was asymptomatic and##3##3##(2008-4#2)(2012-12#1)
was asymptomatic at##2##3##(1993-10#1)(2013-1#1)
was asymptomatic##21##2##(1990-8#1)(1993-10#1)(1996-3#1)(1997-1#1)(2006-9#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#4)
was at a##6##3##(2007-8#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-2#1)
was at all##2##3##(1990-12#1)(2013-7#1)
was at an##2##3##(2013-7#1)(2013-8#1)
was at approximately##3##3##(1993-8#1)(2007-11#1)(2008-10#1)
was at first##2##3##(2005-10#1)(2010-12#1)
was at its##2##3##(2006-6#1)(2010-8#1)
was at least 1##2##4##(2007-1#1)(2008-10#1)
was at least 5##2##4##(1995-9#1)(2006-8#1)
was at least as effective as##2##6##(2005-7#1)(2007-11#1)
was at least as good as##2##6##(2008-10#1)(2008-5#1)
was at least as##5##4##(2005-7#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)
was at least equivalent to##3##5##(2007-11#1)(2008-3#1)(2012-12#1)
was at least partly##3##4##(1994-8#1)(2008-10#2)
was at least##29##3##(1990-10#1)(1990-11#1)(1990-5#1)(1993-2#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-9#1)(2005-7#1)(2005-8#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-8#1)(2009-9#1)(2012-12#1)(2013-8#1)
was at most##2##3##(1994-8#1)(2008-10#1)
was at pH##4##3##(1991-2#2)(1992-9#1)(2008-10#1)
was at the same##2##4##(2008-5#1)(2008-9#1)
was at the##15##3##(2005-1#1)(2005-12#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2011-1#1)(2011-2#1)
was at##103##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-8#1)(1992-9#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-12#2)(1995-8#1)(1995-9#1)(1996-6#1)(1997-4#1)(2005-1#1)(2005-10#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#4)(2007-12#2)(2007-5#2)(2007-7#1)(2007-8#2)(2008-10#19)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#2)(2009-2#1)(2009-3#1)(2009-7#2)(2009-9#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#4)(2013-8#3)
was atrophied##2##2##(1995-11#1)(2008-5#1)
was attached to a##2##4##(1993-11#1)(2008-10#1)
was attached to the##13##4##(1992-5#1)(1994-2#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-10#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-2#1)
was attached to##17##3##(1992-5#1)(1993-11#1)(1994-2#1)(1997-2#1)(2006-8#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-7#1)(2009-10#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-2#1)
was attached##22##2##(1992-5#1)(1993-11#1)(1993-5#1)(1994-2#1)(1997-2#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-2#1)
was attained at##4##3##(1990-11#1)(1995-1#1)(2007-12#1)(2007-7#1)
was attained by##5##3##(1991-7#2)(2008-10#2)(2011-1#1)
was attained for##3##3##(1995-6#1)(2007-12#1)(2008-10#1)
was attained in 10##2##4##(1992-12#1)(2012-1#1)
was attained in the presence of##2##6##(1990-2#1)(1993-6#1)
was attained in the##3##4##(1990-2#1)(1993-6#1)(2008-11#1)
was attained in##10##3##(1990-2#1)(1991-3#1)(1992-12#1)(1993-6#1)(2007-11#2)(2008-10#2)(2008-11#1)(2012-1#1)
was attained when##2##3##(2007-8#1)(2008-6#1)
was attained with##3##3##(2007-4#1)(2008-3#1)(2008-7#1)
was attained within a##2##4##(2008-10#2)
was attained within##4##3##(1993-2#1)(2008-10#2)(2011-1#1)
was attained##45##2##(1990-11#1)(1990-2#1)(1991-3#1)(1991-4#1)(1991-7#2)(1992-12#1)(1993-2#1)(1993-6#1)(1995-1#1)(1995-6#1)(2005-11#1)(2006-10#1)(2007-11#4)(2007-12#3)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#13)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2010-8#1)(2011-1#2)(2012-1#1)
was attempted and##2##3##(2005-8#1)(2008-10#1)
was attempted by##2##3##(2008-10#1)(2013-7#1)
was attempted from##3##3##(1997-3#1)(2005-8#1)(2008-10#1)
was attempted in##8##3##(1991-8#1)(1993-8#1)(2007-11#1)(2007-3#2)(2007-7#1)(2007-8#1)(2008-1#1)
was attempted to##4##3##(1990-8#1)(2006-4#1)(2006-8#1)(2008-6#1)
was attempted##36##2##(1990-8#1)(1991-8#1)(1993-5#1)(1993-8#2)(1995-11#1)(1996-6#1)(1997-3#2)(2005-8#2)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-3#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2013-7#1)(2013-8#1)
was attended by approximately##6##4##(2005-8#3)(2008-5#3)
was attended by over 2000##2##5##(2005-8#1)(2010-5#1)
was attended by over##8##4##(2005-7#1)(2005-8#3)(2005-9#2)(2008-4#1)(2010-5#1)
was attended by##17##3##(1994-7#1)(2005-7#2)(2005-8#6)(2005-9#2)(2008-4#1)(2008-5#4)(2010-5#1)
was attended##18##2##(1994-7#1)(2005-7#2)(2005-8#6)(2005-9#2)(2008-4#1)(2008-5#4)(2010-5#1)(2012-3#1)
was attenuated by a##3##4##(1994-2#2)(2009-9#1)
was attenuated by pretreatment with##4##5##(1992-9#1)(1994-10#2)(2005-8#1)
was attenuated by##20##3##(1991-5#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-10#2)(1994-2#2)(1994-5#1)(1995-12#1)(1995-5#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(2005-8#1)(2009-2#1)(2009-9#2)
was attenuated for##2##3##(1996-9#1)(2013-8#1)
was attenuated in##5##3##(1993-12#1)(1996-5#1)(2008-10#1)(2008-4#2)
was attenuated or##2##3##(1991-5#1)(1993-2#1)
was attenuated##38##2##(1991-11#1)(1991-5#2)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#2)(1994-10#2)(1994-2#2)(1994-5#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(2005-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2009-2#1)(2009-5#1)(2009-9#2)(2010-2#1)(2013-8#1)
was attributable to##10##3##(1990-11#1)(1992-1#1)(1994-12#1)(1996-8#1)(2008-10#5)(2008-7#1)
was attributed to a reduction in##2##6##(2007-12#1)(2008-10#1)
was attributed to a##8##4##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2010-1#1)
was attributed to an##3##4##(1990-4#1)(1994-8#1)(2008-10#1)
was attributed to its##2##4##(1994-3#1)(1995-12#1)
was attributed to the accumulation of##2##6##(1990-5#1)(2008-10#1)
was attributed to the presence of##2##6##(1991-2#1)(2008-10#1)
was attributed to the##27##4##(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-7#1)(1994-3#2)(1994-5#1)(1995-5#2)(1996-5#1)(1997-4#1)(2004-9#1)(2005-11#1)(2006-9#1)(2008-10#7)(2008-5#1)(2008-7#2)(2010-12#1)(2012-11#1)
was attributed to their##2##4##(1994-12#1)(1994-3#1)
was attributed to##68##3##(1990-2#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-5#1)(1992-8#1)(1993-8#1)(1994-12#1)(1994-3#4)(1994-5#1)(1994-8#1)(1995-12#1)(1995-5#2)(1996-5#1)(1996-8#1)(1997-4#1)(2004-9#1)(2005-11#3)(2006-10#2)(2006-9#1)(2007-12#3)(2007-2#1)(2008-1#1)(2008-10#16)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-1#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-12#3)(2012-11#1)
was attributed##71##2##(1990-2#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-5#1)(1992-8#1)(1993-8#1)(1994-12#1)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-5#2)(1996-5#1)(1996-8#1)(1997-4#1)(2004-9#1)(2005-11#3)(2006-10#2)(2006-9#1)(2007-12#3)(2007-2#1)(2008-1#1)(2008-10#17)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-1#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-12#3)(2012-11#1)
was atypical##5##2##(2006-10#2)(2007-7#1)(2007-8#1)(2011-2#1)
was augmented by##8##3##(1993-7#1)(1995-2#2)(1995-5#1)(1995-7#1)(1996-5#1)(1997-8#1)(2007-8#1)
was augmented##14##2##(1993-11#1)(1993-7#1)(1994-3#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-7#1)(1996-5#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-11#1)(2012-2#1)
was authorised##2##2##(2009-6#1)(2011-2#1)
was autoclaved##2##2##(2008-10#1)(2008-11#1)
was autogenously##2##2##(1997-4#2)
was automated##2##2##(1997-2#1)(2008-10#1)
was automatically##2##2##(2007-8#1)(2008-11#1)
was available and##2##3##(2011-1#1)(2012-1#1)
was available for##8##3##(1991-8#1)(1993-9#1)(2006-10#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-9#1)
was available from##2##3##(2007-1#2)
was available in only##2##4##(2008-8#1)(2011-2#1)
was available in##10##3##(2004-2#1)(2007-10#1)(2007-2#2)(2007-7#2)(2007-9#1)(2008-8#1)(2011-2#1)(2012-2#1)
was available on##3##3##(1991-6#1)(2006-8#1)(2007-2#1)
was available to##2##3##(2006-8#1)(2011-12#1)
was available##47##2##(1991-12#2)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#2)(1993-3#1)(1993-9#1)(1994-3#1)(1996-8#1)(2004-2#1)(2004-4#1)(2004-9#1)(2006-10#3)(2006-8#2)(2007-1#2)(2007-10#1)(2007-2#3)(2007-3#1)(2007-7#4)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)
was average##3##2##(2007-10#1)(2012-12#2)
was avirulent to##3##3##(2008-10#3)
was avirulent##5##2##(2008-10#4)(2008-5#1)
was avoided by the##2##4##(2008-10#2)
was avoided by using##2##4##(2006-2#1)(2008-10#1)
was avoided by##4##3##(2006-2#1)(2008-10#3)
was avoided##12##2##(1990-11#1)(1992-3#1)(2005-5#1)(2006-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-8#1)
was awake##3##2##(2007-12#1)(2012-2#1)(2013-8#1)
was awarded the Nobel Prize##2##5##(2007-4#1)(2010-7#1)
was awarded the Nobel##3##4##(2007-4#1)(2007-9#1)(2010-7#1)
was awarded the##4##3##(2007-4#1)(2007-9#1)(2008-7#1)(2010-7#1)
was awarded to##3##3##(2007-9#1)(2008-10#1)(2013-1#1)
was awarded##13##2##(1995-12#1)(1997-5#1)(2005-6#2)(2007-4#1)(2007-9#2)(2008-10#1)(2008-7#1)(2010-12#1)(2010-7#1)(2012-3#1)(2013-1#1)
was aware of##4##3##(1995-12#1)(2009-10#1)(2013-1#2)
was aware that##2##3##(1996-12#1)(2013-8#1)
was aware##7##2##(1995-12#1)(1996-1#1)(1996-12#1)(2009-10#1)(2013-1#2)(2013-8#1)
was back-flushed with the##2##4##(1990-8#1)(2008-10#1)
was banned##2##2##(2007-8#1)(2008-1#1)
was barely detectable by##2##4##(1991-9#1)(1994-3#1)
was barely detectable##8##3##(1991-9#2)(1992-5#1)(1994-12#1)(1994-3#1)(1997-6#1)(2008-9#1)(2010-2#1)
was barely inhibited by inaperisone##2##5##(1992-3#2)
was barely##13##2##(1990-7#1)(1991-9#2)(1992-3#2)(1992-5#1)(1994-12#1)(1994-3#1)(1996-4#1)(1997-6#1)(2008-9#1)(2010-2#1)(2013-7#1)
was barred##2##2##(1996-6#1)(2013-7#1)
was based on a sample of##2##6##(2010-11#1)(2010-5#1)
was based on a##29##4##(1990-6#1)(1990-9#1)(1993-12#1)(1993-2#1)(1994-3#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-7#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
was based on an##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
was based on continuous##2##4##(2008-10#1)(2008-7#1)
was based on detection of##2##5##(1997-6#1)(2008-8#1)
was based on interviews##2##4##(2011-1#1)(2011-2#1)
was based on previous##2##4##(2007-8#1)(2010-2#1)
was based on the chemiluminescence##2##5##(2008-10#2)
was based on the criteria##2##5##(2006-10#1)(2008-5#1)
was based on the formation of##3##6##(2008-10#3)
was based on the measurement of##2##6##(2008-10#1)(2013-1#1)
was based on the presence of##2##6##(1991-9#1)(1997-8#1)
was based on the presence##3##5##(1991-9#1)(1997-8#1)(2008-10#1)
was based on the reaction##4##5##(2008-10#4)
was based on the reduction of the##2##7##(2008-10#2)
was based on the review of##2##6##(2006-2#1)(2008-4#1)
was based on the study of##2##6##(2009-10#1)(2010-8#1)
was based on the use of the##3##7##(1994-6#1)(2008-10#2)
was based on the use of##6##6##(1994-6#1)(1996-11#1)(2008-10#4)
was based on the##97##4##(1991-9#1)(1992-4#1)(1993-7#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-11#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-2#2)(2007-5#1)(2007-7#1)(2008-10#44)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#2)(2009-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#4)(2012-2#1)(2013-1#1)(2013-7#1)
was based on their##2##4##(2008-10#1)(2013-8#1)
was based on two##2##4##(2008-10#2)
was based on##238##3##(1990-12#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-9#2)(1992-12#1)(1992-4#2)(1993-12#1)(1993-2#1)(1993-7#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-12#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-11#2)(2006-12#3)(2006-2#2)(2006-6#1)(2006-8#3)(2007-10#3)(2007-11#10)(2007-12#1)(2007-2#2)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#76)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#4)(2009-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#3)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#8)(2011-3#2)(2012-11#1)(2012-12#10)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
was based upon the##3##4##(1990-12#1)(1997-1#1)(2008-10#1)
was based upon##9##3##(1990-12#1)(1993-12#1)(1993-5#1)(1993-7#1)(1997-1#1)(2007-2#1)(2007-8#1)(2008-10#2)
was based##253##2##(1990-12#3)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-9#2)(1992-12#1)(1992-4#2)(1993-12#2)(1993-2#1)(1993-5#1)(1993-7#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-12#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-11#2)(2006-12#3)(2006-2#3)(2006-6#1)(2006-8#3)(2007-10#3)(2007-11#10)(2007-12#1)(2007-2#3)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#4)(2007-9#3)(2008-1#3)(2008-10#80)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#4)(2009-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#3)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#8)(2011-3#2)(2012-11#1)(2012-12#10)(2012-2#6)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
was because of##2##3##(2011-12#2)
was because##5##2##(2008-10#2)(2008-3#1)(2011-12#2)
was been##2##2##(2008-10#1)(2011-2#1)
was begun in##2##3##(1991-6#1)(2005-8#1)
was begun##10##2##(1990-9#1)(1991-6#1)(1992-10#1)(2005-8#1)(2006-4#1)(2008-11#1)(2008-6#1)(2010-7#1)(2013-1#1)(2013-8#1)
was being developed##2##3##(2005-7#1)(2008-8#1)
was being treated with##2##4##(1991-11#1)(2010-10#1)
was being treated##3##3##(1991-11#1)(2010-10#1)(2012-3#1)
was being used##2##3##(2006-7#1)(2007-7#1)
was being##26##2##(1991-11#1)(1993-2#1)(1996-11#1)(2005-7#2)(2006-7#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-7#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#3)
was believed to be##2##4##(1993-2#1)(2006-8#1)
was believed to##7##3##(1993-2#1)(1996-2#1)(1997-2#1)(2006-8#2)(2007-7#1)(2010-8#1)
was believed##9##2##(1990-3#1)(1993-2#1)(1996-2#1)(1997-2#1)(2006-8#2)(2007-7#1)(2010-8#1)(2012-3#1)
was below 0##2##3##(2008-10#2)
was below 1##2##3##(2011-2#1)(2012-12#1)
was below 10%##2##3##(1995-2#1)(2013-1#1)
was below 15%##2##3##(1994-10#1)(2008-10#1)
was below 4##2##3##(1993-8#1)(2008-10#1)
was below 5##2##3##(1994-12#1)(2008-10#1)
was below that##2##3##(1992-10#1)(2008-10#1)
was below the detection##2##4##(1997-2#1)(2005-11#1)
was below the level of##2##5##(2008-10#1)(2008-5#1)
was below the##16##3##(1991-10#1)(1991-11#1)(1991-7#1)(1992-6#1)(1993-8#1)(1997-2#1)(2005-11#2)(2007-11#1)(2007-7#1)(2008-10#3)(2008-5#1)(2011-2#1)(2013-1#1)
was below##41##2##(1990-7#1)(1991-10#1)(1991-11#1)(1991-7#1)(1992-10#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-8#3)(1994-10#1)(1994-12#1)(1995-2#1)(1997-2#1)(1997-8#1)(2005-11#2)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#13)(2008-3#1)(2008-5#1)(2011-2#2)(2012-12#1)(2013-1#2)
was beneficial in reducing their transfusion requirements##2##7##(2007-2#2)
was beneficial in##5##3##(2007-2#2)(2008-10#1)(2008-12#1)(2008-5#1)
was beneficial##7##2##(2007-2#3)(2008-10#1)(2008-12#2)(2008-5#1)
was benign##3##2##(1990-4#1)(2013-1#2)
was best described by the##2##5##(2008-10#2)
was best described by##3##4##(2008-10#2)(2013-1#1)
was best described##4##3##(2008-10#3)(2013-1#1)
was best##19##2##(1990-12#1)(1990-5#1)(1990-8#1)(1997-2#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-7#1)(2009-8#1)(2010-8#1)(2013-1#1)(2013-8#1)
was beta##2##2##(1993-11#1)(1995-8#1)
was better at##2##3##(2007-5#1)(2008-10#1)
was better for##4##3##(1990-4#1)(2007-5#1)(2008-10#1)(2008-5#1)
was better in##5##3##(1991-2#1)(1994-7#1)(2007-8#1)(2011-2#1)(2013-1#1)
was better than that of controls##2##6##(2008-10#1)(2013-7#1)
was better than that of##4##5##(2008-10#2)(2008-5#1)(2013-7#1)
was better than that##7##4##(2006-4#1)(2008-10#2)(2008-3#1)(2008-5#2)(2013-7#1)
was better than the##4##4##(2008-10#1)(2008-5#1)(2012-12#1)(2013-7#1)
was better than##28##3##(1991-2#1)(1993-3#1)(1995-5#1)(1996-8#1)(2006-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-7#2)
was better tolerated##2##3##(2004-1#1)(2004-3#1)
was better with the##2##4##(1995-2#1)(2007-7#1)
was better with##3##3##(1995-2#1)(2007-12#1)(2007-7#1)
was better##63##2##(1990-4#1)(1991-2#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-7#1)(1995-2#1)(1995-5#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(2004-1#1)(2004-3#1)(2006-12#1)(2006-4#1)(2007-12#1)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#3)(2008-10#15)(2008-3#2)(2008-5#5)(2008-6#2)(2008-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#2)
was between 0##10##3##(1990-2#1)(2004-12#1)(2008-10#6)(2008-5#1)(2011-2#1)
was between 1 and##3##4##(2008-10#3)
was between 1##7##3##(1997-3#1)(2008-10#6)
was between 10 and##2##4##(2008-10#1)(2008-7#1)
was between 3 and 10##2##5##(1990-4#1)(2008-10#1)
was between 3##4##3##(1990-4#1)(1993-8#1)(2007-2#1)(2008-10#1)
was between 45 and##2##4##(1990-5#1)(1993-9#1)
was between 5 and##2##4##(2008-10#2)
was between 5##3##3##(2008-10#3)
was between 8##2##3##(1996-5#1)(2008-11#1)
was between 80 and##2##4##(2008-10#1)(2010-5#1)
was between 92##2##3##(2008-10#2)
was between 95##2##3##(2008-10#1)(2011-1#1)
was between the##3##3##(1990-7#1)(1990-9#1)(1991-3#1)
was between##81##2##(1990-2#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-3#1)(1991-9#1)(1992-7#1)(1993-8#1)(1993-9#1)(1995-7#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2004-10#1)(2004-12#1)(2005-11#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#30)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-1#1)(2013-1#3)(2013-7#1)(2013-8#1)
was bigger than the##2##4##(2008-10#1)(2008-7#1)
was bigger##3##2##(2007-1#1)(2008-10#1)(2008-7#1)
was bilateral##4##2##(1990-4#1)(2007-7#1)(2008-5#1)(2011-1#1)
was bilaterally symmetrical##2##3##(1993-2#1)(2007-2#1)
was bilaterally##6##2##(1993-2#1)(1996-1#1)(1996-12#1)(2007-1#1)(2007-2#1)(2012-2#1)
was bimodal##5##2##(1990-1#1)(1993-9#1)(1997-1#1)(2006-10#1)(2010-2#1)
was bioactivated##2##2##(1991-8#1)(1995-7#1)
was biologically active##3##3##(1991-7#1)(1993-3#1)(1994-12#1)
was biologically inactive##2##3##(1993-8#1)(1995-3#1)
was biologically##6##2##(1991-7#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-3#1)(2008-11#1)
was biopsied##3##2##(2005-9#1)(2008-10#2)
was biphasic##8##2##(1990-10#1)(1990-7#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-8#1)
was bleeding##2##2##(1992-6#1)(2007-10#1)
was blended with##2##3##(2008-5#2)
was blended##3##2##(2008-5#3)
was blocked at the##2##4##(1994-9#1)(1995-6#1)
was blocked at##3##3##(1994-9#1)(1995-6#1)(2005-11#1)
was blocked by 1##3##4##(1992-4#1)(1996-1#1)(2008-6#1)
was blocked by DuP##2##4##(1991-9#1)(1993-3#1)
was blocked by SCH 23390##2##5##(1992-9#1)(1996-10#1)
was blocked by a##3##4##(1992-9#1)(1995-2#1)(1997-7#1)
was blocked by addition of##2##5##(1995-6#1)(1996-6#1)
was blocked by atropine##2##4##(1996-12#1)(2010-4#1)
was blocked by inclusion of##2##5##(1995-12#1)(1995-6#1)
was blocked by monoclonal antibodies directed against##2##7##(1994-9#1)(1995-8#1)
was blocked by pretreatment##2##4##(1993-6#1)(1995-2#1)
was blocked by the 5-HT1A receptor##2##6##(1993-3#1)(1995-12#1)
was blocked by the NMDA##2##5##(1992-1#1)(1993-2#1)
was blocked by the##17##4##(1990-5#1)(1992-1#1)(1992-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-12#2)(1996-12#1)(1996-2#2)(1997-6#1)(2007-12#1)(2008-11#1)(2008-2#1)
was blocked by##98##3##(1990-2#2)(1990-5#1)(1990-7#1)(1991-10#1)(1991-12#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#3)(1992-1#2)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#4)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#8)(1995-2#3)(1995-3#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-6#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#2)(2005-8#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-6#1)(2008-8#3)(2009-12#1)(2009-4#1)(2010-4#1)(2012-2#1)(2013-1#1)
was blocked in the##2##4##(1991-2#1)(1993-12#1)
was blocked in##5##3##(1991-2#1)(1992-11#1)(1993-12#1)(1995-3#1)(1997-3#1)
was blocked with##5##3##(1990-11#1)(1990-12#1)(1990-7#1)(1994-9#1)(2008-11#1)
was blocked##130##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#2)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#3)(1992-1#2)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#1)(1992-9#4)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#3)(1993-9#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#4)(1995-11#1)(1995-12#8)(1995-2#3)(1995-3#3)(1995-6#4)(1995-8#2)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#2)(1997-7#2)(2004-4#1)(2005-11#1)(2005-8#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-11#4)(2008-2#1)(2008-4#2)(2008-6#1)(2008-8#3)(2008-9#1)(2009-12#2)(2009-4#1)(2010-10#1)(2010-4#1)(2012-2#1)(2013-1#1)
was blood##3##2##(2006-6#1)(2007-10#1)(2009-5#1)
was blunted##3##2##(1995-8#1)(1997-7#1)(2008-4#1)
was body##2##2##(1991-4#1)(2010-8#1)
was boiled##2##2##(2005-8#1)(2006-12#1)
was born in the##3##4##(2008-8#1)(2009-1#1)(2009-7#1)
was born in##7##3##(2007-5#1)(2007-9#2)(2008-1#1)(2008-8#1)(2009-1#1)(2009-7#1)
was born to##2##3##(2010-6#1)(2010-9#1)
was born##19##2##(1993-5#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-7#1)(2010-12#1)(2010-6#1)(2010-9#1)(2012-2#1)
was borne out##2##3##(1997-2#1)(2010-10#1)
was both time- and##2##4##(1994-3#1)(1995-6#1)
was both##14##2##(1990-2#1)(1992-5#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-9#1)(1997-6#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
was bound by##3##3##(1990-3#1)(1992-12#1)(1992-6#1)
was bound to the##7##4##(1991-7#1)(1992-6#1)(1992-8#1)(1997-1#1)(2006-8#1)(2008-10#2)
was bound to##14##3##(1990-12#1)(1991-7#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-12#1)(1994-11#1)(1997-1#1)(1997-4#1)(2006-8#1)(2008-10#2)
was bound##22##2##(1990-12#1)(1990-3#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-6#4)(1992-8#1)(1992-9#1)(1993-12#1)(1994-11#2)(1995-2#1)(1995-8#1)(1997-1#1)(1997-4#1)(2006-8#1)(2008-10#2)
was breast cancer##2##3##(2006-7#1)(2007-7#1)
was breast##3##2##(1992-8#1)(2006-7#1)(2007-7#1)
was bred##3##2##(1995-8#1)(2008-3#1)(2008-8#1)
was briefly##2##2##(2006-11#1)(2008-5#1)
was broad##4##2##(1997-5#1)(2008-10#2)(2011-10#1)
was broadened##2##2##(2007-12#1)(2008-8#1)
was broadest among##2##3##(2008-10#2)
was broadly tunable##2##3##(2007-12#1)(2008-1#1)
was broadly##6##2##(1996-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2013-8#1)
was broken##3##2##(1997-3#1)(2006-8#1)(2008-9#1)
was brought by##3##3##(1995-9#1)(2008-5#1)(2012-2#1)
was brought to the hospital##2##5##(2007-7#1)(2009-3#1)
was brought to the##8##4##(1992-6#1)(1993-10#1)(1995-4#1)(2006-3#1)(2007-7#2)(2009-3#1)(2010-12#1)
was brought to##11##3##(1990-10#1)(1992-6#1)(1993-10#1)(1995-4#1)(2006-3#1)(2007-7#2)(2008-10#1)(2009-3#2)(2010-12#1)
was brought##20##2##(1990-10#1)(1992-6#1)(1993-10#1)(1995-4#1)(1995-9#1)(1996-12#1)(2006-3#1)(2006-9#1)(2007-7#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-3#2)(2010-12#1)(2012-2#2)
was buffered##2##2##(1996-2#1)(2008-10#1)
was built and placed##2##4##(2008-2#1)(2009-10#1)
was built and tested##3##4##(2008-2#1)(2008-3#2)
was built and##10##3##(2007-11#1)(2008-2#3)(2008-3#3)(2008-7#1)(2009-10#1)(2012-2#1)
was built by##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
was built for##3##3##(2008-10#1)(2008-3#2)
was built from##3##3##(1990-7#1)(1994-11#1)(2008-11#1)
was built in##2##3##(1992-2#1)(2009-7#1)
was built to##6##3##(1993-9#1)(2006-10#1)(2006-4#1)(2008-10#1)(2013-1#2)
was built up##6##3##(1993-4#1)(2007-12#1)(2008-10#3)(2013-8#1)
was built with##3##3##(2008-10#3)
was built##53##2##(1990-3#1)(1990-7#1)(1992-2#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-6#1)(1996-2#1)(2005-12#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#11)(2008-11#1)(2008-2#5)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#1)(2012-2#2)(2013-1#4)(2013-8#2)
was bureaucratic##2##2##(1993-2#1)(2011-1#1)
was buried##2##2##(1992-6#1)(2011-1#1)
was by a##2##3##(2007-2#1)(2008-10#1)
was by far the##3##4##(2006-8#1)(2008-5#2)
was by##26##2##(1991-11#1)(1994-2#1)(1995-6#1)(1996-6#1)(1996-8#1)(2004-7#1)(2005-10#1)(2006-3#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#2)(2011-1#1)(2011-2#2)(2012-1#2)
was c(L)=0##3##2##(2007-8#1)(2008-10#2)
was ca##16##2##(1990-12#2)(1990-2#1)(1990-9#1)(1991-5#1)(1993-2#1)(1994-9#1)(1995-3#1)(2008-10#7)(2008-3#1)
was calculated after##4##3##(1996-9#1)(2007-7#1)(2008-8#1)(2012-12#1)
was calculated and analyzed##3##4##(1991-4#2)(2008-10#1)
was calculated and compared with the##2##6##(2007-9#1)(2008-5#1)
was calculated and compared##4##4##(2007-9#1)(2008-5#1)(2008-8#1)(2010-5#1)
was calculated and the##2##4##(2006-10#1)(2008-10#1)
was calculated and##13##3##(1991-4#2)(1995-3#1)(2006-10#1)(2007-9#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-8#1)(2010-5#1)
was calculated as 1##2##4##(2008-10#1)(2008-12#1)
was calculated as a function of##4##6##(1992-9#1)(2007-11#1)(2008-2#1)(2010-9#1)
was calculated as a##5##4##(1992-9#1)(2007-11#1)(2008-2#1)(2008-5#1)(2010-9#1)
was calculated as the difference between##2##6##(2007-8#1)(2008-10#1)
was calculated as the difference##3##5##(2007-8#1)(2008-10#2)
was calculated as the##7##4##(2007-10#1)(2007-8#1)(2008-10#2)(2008-7#1)(2012-3#1)(2013-7#1)
was calculated as##25##3##(1992-9#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-10#5)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-7#2)(2013-7#1)(2013-8#1)
was calculated at##9##3##(1991-7#1)(1994-6#1)(1995-6#1)(2008-10#2)(2008-12#1)(2008-3#1)(2011-1#1)(2011-2#1)
was calculated by employing##2##4##(2006-10#1)(2008-10#1)
was calculated by gender##2##4##(2008-3#1)(2008-9#1)
was calculated by the##2##4##(2005-4#1)(2011-3#1)
was calculated by use of##4##5##(2008-2#2)(2008-3#2)
was calculated by##27##3##(1993-9#1)(1994-8#1)(1996-8#1)(1997-8#1)(2005-11#1)(2005-4#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-12#2)(2008-2#3)(2008-3#3)(2008-5#1)(2008-9#1)(2011-2#1)(2011-3#1)(2013-1#2)
was calculated for all the##2##5##(2006-1#1)(2011-2#1)
was calculated for both##3##4##(1993-9#1)(2006-8#1)(2012-3#1)
was calculated for each group##2##5##(2011-2#1)(2012-2#1)
was calculated for each##8##4##(2008-10#4)(2008-5#1)(2010-3#1)(2011-2#1)(2012-2#1)
was calculated for the##2##4##(1993-2#1)(2008-1#1)
was calculated for##28##3##(1992-6#1)(1993-2#1)(1993-9#1)(1996-2#1)(2006-1#1)(2006-12#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#2)(2009-11#1)(2009-3#1)(2009-6#1)(2010-2#1)(2010-3#1)(2011-2#3)(2012-2#1)(2012-3#1)
was calculated from the frequency##2##5##(2008-10#1)(2008-3#1)
was calculated from the##20##4##(1990-4#1)(1992-6#1)(1992-9#1)(1993-2#1)(1994-8#1)(1995-10#1)(1996-3#1)(1997-7#1)(2004-12#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-3#2)(2012-2#1)
was calculated from##33##3##(1990-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-8#1)(1995-10#1)(1995-5#1)(1996-3#1)(1997-1#1)(1997-7#1)(2004-12#1)(2007-7#1)(2007-8#2)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2009-12#1)(2011-2#1)(2012-2#1)
was calculated in##3##3##(1991-10#1)(2010-8#1)(2012-2#1)
was calculated on a##2##4##(2007-7#1)(2008-10#1)
was calculated on##3##3##(2006-10#1)(2007-7#1)(2008-10#1)
was calculated over##2##3##(2008-10#1)(2009-12#1)
was calculated that##3##3##(1995-8#1)(2007-10#1)(2008-10#1)
was calculated to be 0##3##5##(1990-8#1)(2008-10#1)(2008-2#1)
was calculated to be 4##2##5##(2008-10#2)
was calculated to be 99##2##5##(1996-12#1)(2008-10#1)
was calculated to be approximately##3##5##(1991-12#1)(1995-6#1)(2008-3#1)
was calculated to be##29##4##(1990-5#1)(1990-8#1)(1991-12#2)(1992-12#1)(1993-11#1)(1993-12#1)(1993-9#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-6#1)(2005-11#1)(2007-12#1)(2008-10#9)(2008-2#1)(2008-3#2)(2008-5#1)(2009-12#1)(2013-8#1)
was calculated to evaluate the##2##5##(2008-10#1)(2012-3#1)
was calculated to##39##3##(1990-5#1)(1990-8#1)(1991-12#2)(1991-2#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-9#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-6#1)(2005-11#1)(2006-5#1)(2007-12#1)(2008-10#10)(2008-2#2)(2008-3#3)(2008-5#1)(2009-12#1)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
was calculated using the##14##4##(1995-5#1)(1996-10#1)(2004-11#1)(2005-11#1)(2005-4#1)(2006-9#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-2#2)(2011-2#2)(2012-2#1)
was calculated using##22##3##(1995-5#1)(1996-10#1)(2004-11#1)(2005-11#1)(2005-4#1)(2006-9#1)(2007-4#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#3)(2010-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-8#1)
was calculated when##2##3##(1990-4#1)(1996-6#1)
was calculated with a##2##4##(2008-3#2)
was calculated with the##2##4##(2008-5#1)(2012-1#1)
was calculated with##6##3##(2008-2#1)(2008-3#2)(2008-5#1)(2011-1#1)(2012-1#1)
was calculated##298##2##(1990-3#1)(1990-4#2)(1990-5#2)(1990-8#1)(1990-9#2)(1991-10#1)(1991-12#2)(1991-2#1)(1991-4#2)(1991-7#1)(1992-10#1)(1992-12#2)(1992-3#2)(1992-6#3)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#2)(1993-8#1)(1993-9#3)(1994-6#1)(1994-8#2)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#2)(2004-12#1)(2005-1#1)(2005-11#3)(2005-4#2)(2006-1#3)(2006-10#4)(2006-12#1)(2006-5#1)(2006-8#3)(2006-9#1)(2007-10#3)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#4)(2007-8#7)(2007-9#1)(2008-1#3)(2008-10#58)(2008-11#2)(2008-12#6)(2008-2#13)(2008-3#14)(2008-4#1)(2008-5#10)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#3)(2009-3#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#12)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#10)(2012-3#4)(2012-7#2)(2013-1#4)(2013-7#2)(2013-8#7)
was calibrated against##2##3##(2007-12#1)(2007-8#1)
was calibrated and##2##3##(2008-10#1)(2008-3#1)
was calibrated by##2##3##(2007-11#1)(2008-10#1)
was calibrated in the##3##4##(2008-10#2)(2008-3#1)
was calibrated in##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
was calibrated to the##2##4##(2006-6#1)(2010-9#1)
was calibrated using##2##3##(2008-10#2)
was calibrated with a##3##4##(2008-3#3)
was calibrated with##6##3##(1992-7#1)(2007-11#1)(2008-3#3)(2009-10#1)
was calibrated##21##2##(1992-7#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#6)(2008-2#2)(2008-3#5)(2009-10#1)(2010-9#1)
was called##7##2##(1990-8#1)(1992-9#1)(1996-7#1)(1997-2#1)(2008-10#1)(2011-2#1)(2012-2#1)
was canceled##2##2##(2011-2#1)(2012-2#1)
was cancelled by the##2##4##(2008-10#1)(2012-2#1)
was cancelled by##3##3##(1991-2#1)(2008-10#1)(2012-2#1)
was cancelled##4##2##(1991-2#1)(2008-1#1)(2008-10#1)(2012-2#1)
was cannulated##2##2##(2008-12#1)(2008-4#1)
was capable of a##2##4##(2005-11#1)(2011-1#1)
was capable of being##2##4##(1994-8#1)(2007-8#1)
was capable of inducing##3##4##(1990-11#1)(2004-8#1)(2008-5#1)
was capable of moving##2##4##(2008-10#2)
was capable of producing##2##4##(2008-9#1)(2013-1#1)
was capable of protecting##2##4##(1995-12#1)(2008-10#1)
was capable of##37##3##(1990-10#1)(1990-11#1)(1990-4#3)(1992-2#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-11#1)(1996-8#1)(2004-8#1)(2005-11#1)(2006-3#1)(2006-8#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-9#1)(2009-9#1)(2011-1#1)(2013-1#2)
was capable##38##2##(1990-10#1)(1990-11#1)(1990-4#3)(1992-2#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-11#1)(1996-8#1)(2004-8#1)(2005-11#1)(2006-3#1)(2006-8#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-9#1)(2009-9#1)(2011-1#2)(2013-1#2)
was captured in##2##3##(2008-12#1)(2008-6#1)
was captured with a##2##4##(2012-1#1)(2013-7#1)
was captured##8##2##(1996-3#1)(2007-8#1)(2008-12#1)(2008-6#2)(2010-8#1)(2012-1#1)(2013-7#1)
was cardiovascular##3##2##(1993-8#1)(2007-7#1)(2013-1#1)
was carefully##7##2##(1996-1#1)(2007-12#1)(2008-10#1)(2010-8#1)(2012-2#1)(2013-7#1)(2013-8#1)
was carried by a##2##4##(2008-1#1)(2008-10#1)
was carried by##4##3##(1996-12#1)(2008-1#1)(2008-10#2)
was carried on##3##3##(2005-11#1)(2007-9#1)(2013-8#1)
was carried out according to##2##5##(1993-12#1)(2012-2#1)
was carried out after 1##2##5##(2008-5#1)(2013-1#1)
was carried out after##3##4##(1993-12#1)(2008-5#1)(2013-1#1)
was carried out against##3##4##(2008-10#2)(2010-12#1)
was carried out among the##3##5##(2007-2#1)(2010-12#1)(2011-1#1)
was carried out among##9##4##(1991-11#1)(1994-6#2)(2005-9#1)(2007-2#1)(2010-12#1)(2011-1#2)(2013-7#1)
was carried out and showed##2##5##(2006-9#1)(2008-2#1)
was carried out and the##2##5##(2007-4#1)(2008-10#1)
was carried out and##11##4##(2005-8#1)(2006-9#1)(2007-4#1)(2008-10#3)(2008-2#2)(2010-4#1)(2012-2#1)(2012-3#1)
was carried out as a##2##5##(1990-12#1)(1995-5#1)
was carried out as##5##4##(1990-12#1)(1995-5#1)(2004-9#1)(2008-10#1)(2008-9#1)
was carried out at 25 degrees C and 25 kV##2##10##(2008-10#2)
was carried out at a##2##5##(1994-9#1)(2008-10#1)
was carried out at the##7##5##(2004-10#1)(2005-11#1)(2006-5#1)(2007-10#1)(2008-12#3)
was carried out at##42##4##(1990-10#1)(1991-3#1)(1992-7#1)(1994-9#1)(2004-10#1)(2005-11#2)(2006-5#1)(2007-10#1)(2007-3#1)(2007-7#1)(2008-10#11)(2008-12#3)(2008-5#3)(2008-6#1)(2008-7#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
was carried out based on##2##5##(1994-3#1)(2007-8#1)
was carried out before and after##2##6##(2006-2#1)(2010-12#1)
was carried out before##3##4##(2006-2#1)(2007-10#1)(2010-12#1)
was carried out between##4##4##(1990-10#1)(2005-8#1)(2007-3#1)(2013-1#1)
was carried out by a##7##5##(1990-8#1)(1993-3#1)(2007-1#1)(2007-7#1)(2008-1#1)(2008-10#2)
was carried out by employing##3##5##(1992-7#1)(2008-10#2)
was carried out by means of##2##6##(2008-10#1)(2011-2#1)
was carried out by standard##2##5##(2008-10#1)(2010-2#1)
was carried out by the##12##5##(1991-12#1)(2006-10#1)(2007-10#1)(2008-10#5)(2008-7#1)(2010-5#1)(2012-2#1)(2012-3#1)
was carried out by using a##4##6##(2007-9#1)(2008-10#3)
was carried out by using##10##5##(1992-12#1)(2007-9#1)(2008-10#6)(2010-5#1)(2011-1#1)
was carried out by##83##4##(1990-3#1)(1990-8#2)(1991-12#1)(1992-12#2)(1992-7#1)(1993-3#1)(1994-11#1)(1994-5#1)(1997-1#1)(1997-2#2)(2005-11#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-1#2)(2007-10#2)(2007-11#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#39)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-8#1)
was carried out during the##3##5##(1992-8#1)(2010-1#1)(2012-2#1)
was carried out during##7##4##(1992-8#1)(2006-4#1)(2007-11#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
was carried out employing##2##4##(2007-8#1)(2008-10#1)
was carried out for a##2##5##(2006-10#1)(2011-1#1)
was carried out for all patients##2##6##(2008-1#1)(2008-4#1)
was carried out for all##3##5##(2008-1#1)(2008-10#1)(2008-4#1)
was carried out for each##2##5##(1993-9#1)(2008-8#1)
was carried out for the##4##5##(1991-2#1)(1994-5#1)(2007-2#1)(2009-6#1)
was carried out for##28##4##(1990-12#1)(1991-2#1)(1993-9#1)(1994-5#1)(2006-10#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-6#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
was carried out from##3##4##(2006-4#1)(2008-10#1)(2008-4#1)
was carried out in 24##2##5##(1990-10#1)(2008-7#1)
was carried out in 61 patients##2##6##(1991-11#1)(2006-10#1)
was carried out in a##18##5##(1990-12#1)(1994-2#1)(1994-5#1)(1996-5#1)(2004-8#1)(2006-4#1)(2007-11#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2011-2#1)(2012-2#2)(2013-1#1)
was carried out in all##5##5##(1990-11#1)(1992-4#1)(2006-10#1)(2009-3#1)(2011-1#1)
was carried out in an##2##5##(2011-1#1)(2013-7#1)
was carried out in order to evaluate the##3##8##(1990-10#1)(2007-8#1)(2008-10#1)
was carried out in order to##9##6##(1990-10#1)(1991-9#1)(1993-11#1)(1995-5#1)(1997-8#1)(2005-11#1)(2007-8#1)(2008-10#2)
was carried out in six##2##5##(2008-5#1)(2012-12#1)
was carried out in the absorbance mode at##2##8##(2008-10#2)
was carried out in the laboratory##2##6##(2008-2#1)(2009-6#1)
was carried out in the presence of##4##7##(1991-1#1)(2007-10#1)(2007-11#1)(2008-10#1)
was carried out in the##26##5##(1991-1#1)(1992-10#1)(1992-4#1)(1993-6#1)(1994-10#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-8#2)(2008-10#5)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2009-6#1)(2010-12#1)(2013-1#1)
was carried out in three##3##5##(1995-7#1)(2008-7#1)(2011-2#1)
was carried out in two##8##5##(1994-6#1)(1997-8#1)(2006-8#1)(2007-11#1)(2008-10#2)(2011-1#2)
was carried out in##159##4##(1990-10#2)(1990-11#1)(1990-12#2)(1990-3#1)(1990-6#1)(1991-1#2)(1991-11#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-4#2)(1992-5#1)(1993-11#2)(1993-5#2)(1993-6#2)(1993-7#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#3)(1995-5#1)(1995-7#1)(1996-1#1)(1996-3#1)(1996-5#2)(1996-7#1)(1997-3#1)(1997-7#1)(1997-8#2)(2004-11#2)(2004-8#1)(2004-9#1)(2005-11#1)(2005-9#1)(2006-10#3)(2006-2#2)(2006-4#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#6)(2007-2#4)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-10#21)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-12#2)(2010-5#2)(2011-1#5)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#3)
was carried out of the##2##5##(1995-12#1)(1997-8#1)
was carried out on 12##2##5##(2008-10#1)(2008-3#1)
was carried out on 2##3##5##(2007-1#1)(2007-5#1)(2010-12#1)
was carried out on a C18##2##6##(1990-6#1)(2005-12#1)
was carried out on a sample of##2##7##(2006-2#1)(2008-6#1)
was carried out on a##18##5##(1990-6#1)(1991-10#1)(1992-2#1)(2005-12#1)(2006-2#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-6#1)(2008-7#1)(2010-12#1)(2010-2#1)(2012-12#1)(2013-1#1)
was carried out on an##5##5##(2006-8#1)(2008-6#1)(2010-9#1)(2011-1#2)
was carried out on the##8##5##(1994-6#1)(1997-1#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-2#2)
was carried out on##76##4##(1990-3#1)(1990-4#1)(1990-6#2)(1990-8#1)(1991-10#1)(1992-12#1)(1992-2#1)(1993-6#1)(1994-6#4)(1995-5#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-3#1)(2005-12#1)(2006-2#2)(2006-8#1)(2007-1#2)(2007-11#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2009-2#1)(2009-7#1)(2010-12#5)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-12#2)(2013-1#4)(2013-8#1)
was carried out only##2##4##(2007-7#1)(2008-10#1)
was carried out over##2##4##(2007-1#1)(2007-3#1)
was carried out the##2##4##(1991-8#1)(2008-10#1)
was carried out to assess the##4##6##(2008-2#1)(2008-4#1)(2008-6#1)(2013-1#1)
was carried out to assess##10##5##(1991-5#1)(1993-8#1)(1996-6#1)(1996-9#1)(2008-2#1)(2008-4#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
was carried out to characterize##2##5##(1990-7#1)(2007-11#1)
was carried out to compare the##2##6##(2007-7#1)(2008-6#1)
was carried out to confirm the##2##6##(2008-10#1)(2011-2#1)
was carried out to describe##3##5##(2008-1#1)(2008-10#1)(2008-4#1)
was carried out to determine community##2##6##(2012-2#2)
was carried out to determine the effects of##2##8##(2007-8#1)(2013-1#1)
was carried out to determine the prevalence of##3##8##(1996-12#1)(2010-8#1)(2011-2#1)
was carried out to determine the##15##6##(1990-8#1)(1994-3#1)(1996-12#1)(2004-9#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
was carried out to determine whether##4##6##(1993-7#1)(1993-8#1)(1997-5#1)(2012-2#1)
was carried out to determine##26##5##(1990-8#1)(1993-7#1)(1993-8#1)(1994-3#1)(1995-7#1)(1996-12#1)(1997-2#1)(1997-5#1)(2004-9#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)
was carried out to evaluate the##14##6##(1990-2#1)(1991-2#1)(1992-4#1)(1992-6#1)(1996-1#1)(2006-11#1)(2007-1#2)(2008-10#1)(2008-12#1)(2008-3#1)(2010-5#1)(2011-12#1)(2013-8#1)
was carried out to evaluate##18##5##(1990-11#1)(1990-2#1)(1991-2#1)(1992-4#1)(1992-6#1)(1996-1#1)(2006-11#1)(2007-1#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-5#1)(2011-12#1)(2013-8#1)
was carried out to find the##6##6##(1995-12#1)(2007-7#1)(2007-8#1)(2008-3#1)(2011-3#1)(2013-7#1)
was carried out to find##7##5##(1995-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2011-3#1)(2013-7#1)
was carried out to investigate the##12##6##(1990-3#1)(1991-6#1)(1996-4#1)(1997-5#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-5#2)(2009-12#1)(2009-7#1)(2012-11#1)
was carried out to investigate##17##5##(1990-3#1)(1991-6#1)(1996-4#1)(1997-5#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2009-12#1)(2009-7#1)(2011-2#1)(2012-11#2)(2013-8#1)
was carried out to study the##3##6##(1994-6#1)(2007-10#1)(2011-12#1)
was carried out to study##4##5##(1994-6#1)(2007-10#1)(2011-12#1)(2013-1#1)
was carried out to##124##4##(1990-11#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-4#1)(1992-6#1)(1993-7#1)(1993-8#2)(1994-3#2)(1994-6#1)(1995-12#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-5#2)(1997-6#1)(1997-8#1)(2004-9#1)(2006-11#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#2)(2011-12#2)(2011-2#5)(2011-3#1)(2012-11#3)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
was carried out under the##2##5##(2007-1#1)(2008-5#1)
was carried out under##6##4##(2007-1#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-5#1)(2011-1#1)
was carried out using a##8##5##(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-2#1)(2010-3#1)
was carried out using an##5##5##(1994-9#1)(1996-8#1)(2008-10#2)(2011-1#1)
was carried out using the##7##5##(1990-11#1)(1996-12#1)(2006-5#2)(2008-10#1)(2008-12#1)(2008-5#1)
was carried out using two##2##5##(2008-10#1)(2008-5#1)
was carried out using##54##4##(1990-11#1)(1991-5#1)(1991-9#1)(1992-2#1)(1994-9#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-8#1)(2005-12#1)(2006-10#1)(2006-5#2)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#21)(2008-11#1)(2008-12#3)(2008-5#5)(2008-9#1)(2009-3#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#1)
was carried out with a##5##5##(2007-11#1)(2008-2#1)(2008-3#1)(2009-11#1)(2012-12#1)
was carried out with the aim of##4##7##(1994-3#1)(1997-3#1)(2008-8#1)(2010-4#1)
was carried out with the##13##5##(1992-10#1)(1994-3#1)(1995-1#1)(1997-3#1)(2005-11#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#1)
was carried out with##38##4##(1990-10#1)(1991-12#1)(1992-10#1)(1993-2#1)(1994-3#1)(1995-1#1)(1997-3#1)(1997-6#1)(2005-11#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-11#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#3)(2013-1#1)
was carried out##808##3##(1990-10#5)(1990-11#3)(1990-12#4)(1990-2#1)(1990-3#6)(1990-4#1)(1990-5#1)(1990-6#4)(1990-7#2)(1990-8#4)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#3)(1991-8#4)(1991-9#3)(1992-10#2)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#3)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#3)(1993-6#3)(1993-7#3)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#6)(1994-5#3)(1994-6#10)(1994-9#2)(1995-1#3)(1995-12#2)(1995-3#1)(1995-5#3)(1995-7#2)(1996-1#3)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#3)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#4)(2004-10#1)(2004-11#2)(2004-4#1)(2004-8#1)(2004-9#3)(2005-11#6)(2005-12#2)(2005-8#2)(2005-9#3)(2006-10#7)(2006-11#1)(2006-12#1)(2006-2#7)(2006-4#4)(2006-5#5)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-1#11)(2007-10#6)(2007-11#13)(2007-12#2)(2007-2#10)(2007-3#5)(2007-4#5)(2007-5#1)(2007-6#2)(2007-7#9)(2007-8#16)(2007-9#5)(2008-1#9)(2008-10#155)(2008-11#9)(2008-12#11)(2008-2#12)(2008-3#15)(2008-4#6)(2008-5#30)(2008-6#11)(2008-7#12)(2008-8#9)(2008-9#7)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#3)(2009-5#4)(2009-6#3)(2009-7#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#14)(2010-2#7)(2010-3#1)(2010-4#4)(2010-5#6)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#19)(2011-12#3)(2011-2#32)(2011-3#1)(2012-1#3)(2012-11#3)(2012-12#21)(2012-2#17)(2012-3#8)(2013-1#32)(2013-7#4)(2013-8#12)
was carried to##2##3##(1997-8#1)(2008-12#1)
was carried##824##2##(1990-10#5)(1990-11#3)(1990-12#4)(1990-2#1)(1990-3#6)(1990-4#1)(1990-5#1)(1990-6#4)(1990-7#2)(1990-8#4)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#3)(1991-8#4)(1991-9#3)(1992-10#2)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#3)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#3)(1993-6#3)(1993-7#3)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#6)(1994-5#3)(1994-6#10)(1994-9#3)(1995-1#3)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#3)(1995-7#2)(1996-1#3)(1996-10#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#3)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#5)(2004-10#1)(2004-11#2)(2004-4#1)(2004-8#1)(2004-9#3)(2005-11#7)(2005-12#2)(2005-8#2)(2005-9#3)(2006-10#7)(2006-11#1)(2006-12#1)(2006-2#7)(2006-4#4)(2006-5#5)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-1#11)(2007-10#6)(2007-11#13)(2007-12#2)(2007-2#10)(2007-3#5)(2007-4#5)(2007-5#1)(2007-6#2)(2007-7#9)(2007-8#16)(2007-9#6)(2008-1#10)(2008-10#158)(2008-11#9)(2008-12#12)(2008-2#12)(2008-3#15)(2008-4#6)(2008-5#30)(2008-6#12)(2008-7#12)(2008-8#9)(2008-9#7)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#3)(2009-5#4)(2009-6#3)(2009-7#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#14)(2010-2#7)(2010-3#1)(2010-4#4)(2010-5#6)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#20)(2011-12#3)(2011-2#32)(2011-3#1)(2012-1#3)(2012-11#3)(2012-12#21)(2012-2#17)(2012-3#8)(2013-1#33)(2013-7#4)(2013-8#13)
was carrying##2##2##(2007-11#1)(2011-1#1)
was cast##2##2##(2006-5#1)(2008-11#1)
was catalytically active##2##3##(1992-8#1)(1994-6#1)
was catalytically##4##2##(1992-8#1)(1994-11#1)(1994-6#1)(2008-10#1)
was catalyzed by##3##3##(1995-10#1)(2012-2#1)(2013-1#1)
was catalyzed##4##2##(1995-10#1)(1997-2#1)(2012-2#1)(2013-1#1)
was categorized as##5##3##(2008-11#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
was categorized into##4##3##(2007-6#1)(2008-10#1)(2010-3#1)(2011-2#1)
was categorized##12##2##(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
was catheterized##2##2##(2007-9#1)(2012-3#1)
was caused by a##11##4##(1992-1#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-6#1)(2008-10#3)(2010-12#1)(2013-1#1)(2013-8#1)
was caused by an increase##2##5##(2008-11#1)(2008-8#1)
was caused by an##4##4##(1994-7#1)(2008-11#2)(2008-8#1)
was caused by the##18##4##(1991-8#1)(1993-12#1)(1997-4#1)(2005-11#2)(2007-11#1)(2007-12#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-2#1)(2012-3#1)(2013-8#2)
was caused by##63##3##(1991-2#1)(1991-8#1)(1992-1#1)(1993-11#1)(1993-12#2)(1994-2#1)(1994-7#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-4#1)(2005-11#2)(2007-11#1)(2007-12#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
was caused##69##2##(1990-9#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#1)(1993-11#1)(1993-12#2)(1994-2#1)(1994-7#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(2004-4#1)(2005-11#2)(2006-3#2)(2007-11#1)(2007-12#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
was centered around##2##3##(1996-2#1)(2008-10#1)
was centered at##2##3##(2008-2#1)(2009-5#1)
was centered##4##2##(1996-2#1)(2008-10#1)(2008-2#1)(2009-5#1)
was centrally##2##2##(2009-11#1)(2010-2#1)
was centrifuged##2##2##(1990-7#1)(2013-8#1)
was cervical##2##2##(2007-3#1)(2011-2#1)
was chaired by Dr##3##4##(2005-8#2)(2005-9#1)
was chaired by Professor##2##4##(2008-5#2)
was chaired by##6##3##(2005-8#3)(2005-9#1)(2008-5#2)
was challenged by the discovery##2##5##(2008-8#1)(2010-5#1)
was challenged by##4##3##(2004-3#1)(2008-8#1)(2010-4#1)(2010-5#1)
was challenged##5##2##(2004-3#1)(2008-8#1)(2010-4#2)(2010-5#1)
was challenging##2##2##(2008-9#1)(2013-8#1)
was change##2##2##(2008-7#1)(2011-2#1)
was changed by##6##3##(1994-11#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-7#1)(2012-1#1)
was changed from##7##3##(1990-5#1)(1993-8#1)(1997-3#1)(2008-10#2)(2008-3#1)(2009-9#1)
was changed in##3##3##(2007-11#1)(2008-10#1)(2009-6#1)
was changed to##13##3##(1991-10#1)(1991-2#1)(1992-6#1)(1993-12#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-8#1)(2010-6#1)(2011-1#1)(2012-11#1)(2013-8#2)
was changed with##3##3##(2005-4#1)(2008-5#1)(2012-2#1)
was changed##51##2##(1990-5#1)(1991-10#1)(1991-2#1)(1992-6#1)(1993-12#1)(1993-5#1)(1993-8#2)(1994-11#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-5#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-12#2)(2005-4#1)(2006-10#1)(2006-4#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-12#2)(2008-3#1)(2008-5#2)(2009-6#1)(2009-9#1)(2010-1#1)(2010-6#1)(2011-1#1)(2011-12#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
was characterised by elemental analysis##2##5##(2008-10#1)(2010-5#1)
was characterised by##12##3##(1990-3#1)(1991-3#1)(1992-8#1)(1993-11#1)(1997-8#1)(2005-7#1)(2008-10#2)(2008-6#1)(2008-7#1)(2010-5#1)(2011-2#1)
was characterised in##2##3##(1992-8#1)(2008-11#1)
was characterised##17##2##(1990-3#1)(1991-3#1)(1992-8#2)(1993-11#1)(1997-8#1)(2005-7#1)(2007-4#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#1)(2010-5#1)(2011-2#1)
was characteristic of a##2##4##(1992-11#1)(1996-10#1)
was characteristic of the##3##4##(1991-9#1)(2008-10#2)
was characteristic of##9##3##(1990-3#1)(1991-9#1)(1992-11#1)(1993-11#1)(1996-10#1)(1997-3#1)(2008-10#2)(2009-2#1)
was characteristic##12##2##(1990-3#1)(1991-9#2)(1992-11#1)(1992-8#1)(1993-11#2)(1996-10#1)(1997-3#1)(2008-10#2)(2009-2#1)
was characteristically##3##2##(1991-11#1)(1997-6#1)(2007-2#1)
was characterized after##2##3##(2007-6#1)(2011-1#1)
was characterized and found to be##2##6##(1997-2#1)(1997-4#1)
was characterized and found to##3##5##(1994-5#1)(1997-2#1)(1997-4#1)
was characterized and##8##3##(1993-6#1)(1994-5#1)(1995-3#1)(1997-2#1)(1997-4#1)(2005-11#1)(2007-12#1)(2008-10#1)
was characterized as a##2##4##(1993-11#1)(2008-10#1)
was characterized as##9##3##(1990-3#1)(1993-11#1)(1993-9#1)(2006-11#1)(2006-8#1)(2008-10#3)(2012-1#1)
was characterized by FTIR spectroscopy##2##5##(2008-5#1)(2013-7#1)
was characterized by Southern##2##4##(1991-7#1)(2008-10#1)
was characterized by UV##2##4##(1990-7#2)
was characterized by X-ray##2##4##(1996-2#1)(2008-10#1)
was characterized by XRD##2##4##(2005-11#2)
was characterized by a very high##2##6##(1997-4#1)(2007-2#1)
was characterized by a##14##4##(1991-2#1)(1992-12#1)(1992-9#1)(1994-9#2)(1995-12#1)(1997-4#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#2)(2012-2#1)
was characterized by an increase in##3##6##(1991-6#1)(1992-9#1)(1997-2#1)
was characterized by an increase##4##5##(1991-6#1)(1992-9#1)(1997-2#1)(2005-8#1)
was characterized by an##11##4##(1990-5#1)(1991-6#1)(1992-11#1)(1992-9#1)(1994-5#1)(1997-2#1)(2005-8#1)(2008-10#2)(2010-12#1)(2012-1#1)
was characterized by elemental analysis and##2##6##(2012-12#1)(2013-8#1)
was characterized by gel##2##4##(1990-2#1)(1992-8#1)
was characterized by high##2##4##(1997-4#1)(2013-1#1)
was characterized by its##3##4##(1990-6#1)(1994-9#1)(2007-1#1)
was characterized by large##2##4##(1997-6#1)(2010-4#1)
was characterized by low##2##4##(2008-10#1)(2012-1#1)
was characterized by means of##2##5##(2008-10#2)
was characterized by measuring##2##4##(2008-2#1)(2008-5#1)
was characterized by mild##2##4##(2006-10#1)(2007-12#1)
was characterized by restriction##2##4##(1991-12#1)(1997-2#1)
was characterized by scanning electron microscopy (SEM)##3##7##(2008-10#1)(2008-5#1)(2012-2#1)
was characterized by surface##2##4##(2008-10#1)(2011-2#1)
was characterized by the presence of##2##6##(2008-10#2)
was characterized by the##15##4##(1991-9#1)(1992-5#1)(1996-11#2)(2004-11#1)(2007-10#1)(2008-10#4)(2008-7#1)(2010-8#1)(2013-1#2)(2013-7#1)
was characterized by three##2##4##(1992-1#1)(1997-8#1)
was characterized by two##2##4##(2008-5#1)(2012-3#1)
was characterized by using##3##4##(2005-11#1)(2009-9#1)(2011-2#1)
was characterized by##151##3##(1990-11#2)(1990-2#2)(1990-5#2)(1990-6#1)(1990-7#2)(1991-10#1)(1991-12#1)(1991-2#2)(1991-6#2)(1991-7#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-12#3)(1993-3#1)(1993-9#1)(1994-3#1)(1994-5#3)(1994-9#3)(1995-12#1)(1995-2#1)(1996-11#2)(1996-2#3)(1997-2#2)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2004-11#1)(2005-11#6)(2005-12#1)(2005-8#2)(2006-10#2)(2006-12#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-9#1)(2008-10#34)(2008-2#2)(2008-3#2)(2008-5#6)(2008-7#2)(2008-8#1)(2009-9#1)(2010-12#5)(2010-4#1)(2010-7#1)(2010-8#2)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#1)
was characterized for##3##3##(1992-5#1)(1992-9#1)(2008-5#1)
was characterized in a##2##4##(2008-10#1)(2008-6#1)
was characterized in terms of##2##5##(2008-10#1)(2010-12#1)
was characterized in the##3##4##(2007-12#1)(2008-2#1)(2008-5#1)
was characterized in##13##3##(1990-5#1)(1994-12#1)(1994-9#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-6#1)(2010-12#1)(2010-8#1)(2012-1#1)
was characterized through##2##3##(2008-10#2)
was characterized using a##2##4##(2008-6#1)(2009-12#1)
was characterized using the##3##4##(1993-6#1)(2007-1#1)(2008-12#1)
was characterized using##18##3##(1991-5#1)(1991-8#1)(1993-6#1)(1994-5#1)(1995-5#1)(1996-9#1)(1997-8#1)(2005-11#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-10#1)(2009-12#1)(2009-7#1)(2012-2#1)
was characterized with respect to its##2##6##(1990-12#1)(1996-2#1)
was characterized with respect to the##2##6##(2008-10#1)(2008-11#1)
was characterized with respect to##5##5##(1990-12#1)(1996-2#1)(2008-10#2)(2008-11#1)
was characterized with the##2##4##(1994-3#1)(2008-2#1)
was characterized with##13##3##(1990-12#1)(1990-5#1)(1994-3#1)(1996-2#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-4#1)(2013-1#1)
was characterized##251##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#4)(1990-6#1)(1990-7#2)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#5)(1994-9#5)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-11#2)(1996-2#4)(1996-9#1)(1997-2#3)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#4)(2004-11#1)(2005-11#10)(2005-12#1)(2005-8#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-4#1)(2006-8#2)(2007-1#2)(2007-10#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#53)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#9)(2008-6#2)(2008-7#3)(2008-8#1)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#2)(2009-9#1)(2010-12#6)(2010-4#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#3)(2012-1#5)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#6)(2013-7#2)(2013-8#1)
was charged with##6##3##(1994-1#2)(1996-5#2)(2007-4#1)(2010-6#1)
was charged##11##2##(1992-5#1)(1994-1#2)(1994-9#2)(1996-5#2)(2007-4#1)(2008-10#1)(2010-6#1)(2011-2#1)
was checked by analysing##2##4##(2008-10#2)
was checked by analyzing##2##4##(2008-10#2)
was checked by measuring the##2##5##(2008-10#2)
was checked by performing##2##4##(1994-1#1)(2008-10#1)
was checked by the analysis of##2##6##(2008-10#2)
was checked by the use##2##5##(2008-10#2)
was checked by the##4##4##(2008-10#4)
was checked by##31##3##(1991-8#1)(1994-1#1)(1995-9#1)(2005-6#1)(2008-10#22)(2010-12#2)(2010-7#1)(2012-1#1)(2013-1#1)
was checked for##5##3##(1995-2#1)(2008-10#4)
was checked with##7##3##(1996-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2012-2#1)
was checked##58##2##(1991-8#1)(1994-1#1)(1995-2#1)(1995-9#1)(1996-11#1)(2005-11#1)(2005-6#1)(2007-2#1)(2008-10#39)(2008-11#1)(2008-3#1)(2008-5#1)(2010-12#2)(2010-3#1)(2010-7#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
was chemically modified with##2##4##(1993-11#1)(2008-6#1)
was chemically##5##2##(1992-6#1)(1993-11#1)(1993-12#1)(2008-10#1)(2008-6#1)
was chiefly##2##2##(2007-12#1)(2012-12#1)
was chose as the##2##4##(2007-11#1)(2011-1#1)
was chosen as a model system##2##6##(2006-12#1)(2008-7#1)
was chosen as a model##3##5##(2006-12#1)(2008-7#1)(2010-2#1)
was chosen as a##11##4##(1997-7#1)(2006-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2010-2#2)(2011-1#1)
was chosen as an##2##4##(1992-5#1)(2011-2#1)
was chosen as dependent##2##4##(2007-3#1)(2012-3#1)
was chosen as substrate##2##4##(1993-4#1)(2008-10#1)
was chosen as the##11##4##(1992-5#1)(2008-10#7)(2009-8#2)(2010-5#1)
was chosen as##38##3##(1992-5#2)(1993-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-12#2)(2007-3#1)(2008-10#16)(2008-11#1)(2008-2#1)(2008-7#1)(2009-8#2)(2010-2#2)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-3#1)
was chosen because it##2##4##(2006-8#1)(2010-12#1)
was chosen because of##2##4##(2006-12#1)(2007-1#1)
was chosen because##6##3##(2006-10#1)(2006-12#1)(2006-8#1)(2007-1#1)(2008-10#1)(2010-12#1)
was chosen by##2##3##(1994-3#1)(2007-12#1)
was chosen due to##2##4##(2008-10#1)(2008-3#1)
was chosen for the##2##4##(2008-10#2)
was chosen for this study##3##5##(1994-12#1)(2008-10#1)(2008-11#1)
was chosen for##14##3##(1990-12#1)(1991-12#1)(1992-9#1)(1993-3#1)(1994-12#1)(2006-11#1)(2006-3#1)(2007-8#1)(2008-10#3)(2008-11#1)(2011-12#1)(2012-12#1)
was chosen from the##3##4##(2006-10#1)(2006-8#1)(2007-10#1)
was chosen from##4##3##(2006-10#1)(2006-8#1)(2007-10#1)(2008-10#1)
was chosen in##3##3##(1990-6#1)(1993-8#1)(2008-2#1)
was chosen to examine##2##4##(2008-11#1)(2008-12#1)
was chosen to fill the##2##5##(2007-4#1)(2008-1#1)
was chosen to provide##2##4##(2008-5#1)(2008-7#1)
was chosen to##20##3##(1995-8#1)(1996-4#1)(1996-8#1)(2004-9#1)(2006-8#1)(2007-10#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-11#1)(2011-2#1)
was chosen##106##2##(1990-12#1)(1990-6#2)(1991-12#1)(1992-12#1)(1992-5#2)(1992-9#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-8#1)(1994-12#2)(1994-3#1)(1995-8#1)(1996-4#1)(1996-8#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#1)(2006-10#3)(2006-11#2)(2006-12#3)(2006-3#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#26)(2008-11#8)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#3)(2011-3#2)(2012-12#1)(2012-3#1)
was chromatographed on a##3##4##(1991-8#1)(1992-11#1)(1992-2#1)
was chromatographed on##4##3##(1991-8#1)(1992-11#1)(1992-2#1)(2008-6#1)
was chronic##3##2##(2004-10#1)(2008-1#1)(2009-10#1)
was chronically##2##2##(1992-9#1)(2006-10#1)
was cited as the##2##4##(2008-12#1)(2013-8#1)
was cited as##3##3##(2006-10#1)(2008-12#1)(2013-8#1)
was cited##4##2##(2006-10#1)(2008-12#1)(2010-4#1)(2013-8#1)
was clamped##2##2##(1993-12#1)(1995-12#1)
was clarified##3##2##(2007-12#1)(2008-10#1)(2009-6#1)
was classified according to##3##4##(2008-7#1)(2011-12#1)(2011-2#1)
was classified as a##5##4##(1997-2#1)(2005-5#1)(2007-2#1)(2008-5#2)
was classified as either##2##4##(2006-7#1)(2008-9#1)
was classified as##26##3##(1992-12#1)(1995-6#1)(1996-6#1)(1997-2#1)(2005-5#1)(2006-11#1)(2006-7#1)(2007-10#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#4)(2008-9#2)(2009-4#1)(2010-3#1)(2010-4#1)(2012-12#1)(2013-1#2)(2013-8#1)
was classified in the##2##4##(1994-3#1)(2008-10#1)
was classified in##3##3##(1990-2#1)(1994-3#1)(2008-10#1)
was classified into six##2##4##(2008-5#1)(2008-6#1)
was classified into the##2##4##(1996-2#1)(2007-10#1)
was classified into three##2##4##(1990-8#1)(2012-11#1)
was classified into two##2##4##(2007-12#1)(2010-8#1)
was classified into##11##3##(1990-8#1)(1996-2#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-8#1)(2011-1#1)(2012-11#1)(2012-2#1)
was classified##45##2##(1990-2#1)(1990-8#1)(1992-12#1)(1994-3#1)(1995-6#1)(1996-2#1)(1996-6#1)(1997-2#1)(2005-5#1)(2006-11#1)(2006-7#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
was cleaned##2##2##(1997-3#1)(2013-1#1)
was clear for##2##3##(2010-3#1)(2011-2#1)
was clear that##6##3##(1990-7#1)(1992-2#1)(1993-3#1)(1995-7#1)(2005-8#1)(2012-1#1)
was clear##12##2##(1990-7#1)(1992-2#1)(1993-3#2)(1995-7#1)(2005-8#1)(2008-6#1)(2008-9#2)(2010-3#1)(2011-2#1)(2012-1#1)
was cleared from the circulation##2##5##(1991-2#1)(1995-5#1)
was cleared from the##4##4##(1991-2#2)(1993-7#1)(1995-5#1)
was cleared from##5##3##(1991-2#2)(1993-7#1)(1995-5#1)(2009-3#1)
was cleared##10##2##(1991-2#3)(1993-7#1)(1995-5#1)(1997-8#1)(2006-12#1)(2008-5#1)(2009-3#1)(2013-1#1)
was clearly demonstrated that##3##4##(1994-2#1)(2005-6#1)(2005-8#1)
was clearly demonstrated##4##3##(1994-2#1)(2005-6#1)(2005-8#1)(2012-2#1)
was clearly evident##5##3##(1997-5#1)(2007-9#1)(2008-11#1)(2010-10#1)(2011-1#1)
was clearly not##2##3##(2008-10#1)(2009-10#1)
was clearly observed##4##3##(2006-5#1)(2008-10#1)(2008-11#1)(2013-8#1)
was clearly related to##2##4##(1991-9#1)(2007-6#1)
was clearly seen##2##3##(1992-11#1)(2007-10#1)
was clearly superior to##2##4##(1991-2#1)(1996-12#1)
was clearly superior##3##3##(1991-2#1)(1996-12#1)(2006-12#1)
was clearly suppressed##2##3##(2008-5#1)(2008-8#1)
was clearly##62##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-6#1)(1994-2#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-5#3)(2005-6#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-10#14)(2008-11#4)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-10#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
was cleaved at##5##3##(1991-2#3)(1994-12#1)(1995-6#1)
was cleaved by##4##3##(1990-11#1)(1991-2#1)(1992-3#1)(2008-5#1)
was cleaved in##2##3##(1991-8#1)(1995-1#1)
was cleaved into##2##3##(1995-2#1)(1997-4#1)
was cleaved with##2##3##(1995-8#1)(1996-5#1)
was cleaved##20##2##(1990-11#1)(1990-7#1)(1991-1#1)(1991-2#4)(1991-8#1)(1992-3#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-9#1)(1997-4#1)(2008-5#2)(2009-2#1)
was clinical and##2##3##(2007-7#1)(2008-6#1)
was clinical##7##2##(1994-12#1)(1995-12#1)(2007-7#2)(2008-6#1)(2008-7#1)(2011-2#1)
was clinically and##3##3##(1991-7#1)(1995-12#1)(1997-6#1)
was clinically diagnosed##4##3##(1993-8#1)(1996-5#1)(2006-8#1)(2007-7#1)
was clinically##13##2##(1991-5#1)(1991-7#1)(1993-8#1)(1995-12#1)(1996-5#1)(1997-6#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-6#1)(2009-2#1)(2012-3#1)
was cloned and analyzed##2##4##(2005-10#1)(2008-11#1)
was cloned and characterized##6##4##(1994-12#1)(1995-2#1)(1997-2#1)(2008-10#2)(2010-10#1)
was cloned and completely sequenced##2##5##(2008-10#2)
was cloned and expressed in Escherichia coli##6##7##(1990-4#2)(1990-9#1)(1991-10#1)(1991-9#1)(1993-12#1)
was cloned and expressed in##9##5##(1990-2#1)(1990-4#2)(1990-9#1)(1991-10#1)(1991-3#1)(1991-9#1)(1993-12#1)(2008-5#1)
was cloned and its nucleotide sequence##3##6##(1991-8#1)(1996-7#1)(1997-7#1)
was cloned and its nucleotide##4##5##(1991-8#1)(1994-12#1)(1996-7#1)(1997-7#1)
was cloned and its##8##4##(1990-11#1)(1990-9#1)(1991-12#1)(1991-8#1)(1994-12#1)(1996-7#1)(1997-7#1)(2008-10#1)
was cloned and overexpressed in Escherichia coli##2##7##(1992-3#1)(2008-10#1)
was cloned and sequenced from##6##5##(1992-2#1)(1992-3#1)(1997-2#1)(1997-4#1)(2005-11#1)(2008-10#1)
was cloned and sequenced##26##4##(1990-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-9#1)(1995-10#1)(1995-11#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-11#1)(2007-7#1)(2008-10#6)(2008-5#1)(2008-8#1)(2008-9#1)
was cloned and the sequence##2##5##(1996-9#1)(2008-8#1)
was cloned and the##5##4##(1993-3#1)(1994-8#1)(1996-9#1)(2008-8#2)
was cloned and##64##3##(1990-11#1)(1990-2#1)(1990-4#2)(1990-9#3)(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-11#1)(2007-7#1)(2008-10#12)(2008-11#1)(2008-5#3)(2008-8#3)(2008-9#1)(2010-10#1)(2013-1#1)
was cloned based on##3##4##(1993-9#1)(1994-12#1)(2010-5#1)
was cloned between##2##3##(1993-5#1)(2009-3#1)
was cloned by IPCR of 1##2##6##(1996-6#2)
was cloned by PCR using##2##5##(1993-9#1)(2007-12#1)
was cloned by PCR##3##4##(1993-9#1)(2007-12#1)(2008-8#1)
was cloned by a##2##4##(1993-2#1)(2009-2#1)
was cloned by complementation##2##4##(1994-12#1)(1995-6#1)
was cloned by functional##2##4##(1990-1#1)(1991-5#1)
was cloned by##20##3##(1990-1#1)(1991-5#1)(1991-9#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#1)(2007-12#1)(2008-11#1)(2008-8#2)(2009-2#1)
was cloned downstream from##2##4##(1997-4#2)
was cloned downstream##3##3##(1997-4#2)(2008-8#1)
was cloned from a bovine##2##5##(1994-9#1)(1997-2#1)
was cloned from a##9##4##(1990-2#1)(1994-8#1)(1994-9#2)(1996-10#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-6#1)
was cloned from human genomic DNA##2##6##(1992-9#1)(1994-12#1)
was cloned from human genomic##3##5##(1992-9#1)(1994-12#1)(1994-6#1)
was cloned from human##5##4##(1992-1#1)(1992-9#1)(1994-12#1)(1994-6#1)(1995-6#1)
was cloned from the##6##4##(1991-5#1)(1993-9#1)(1994-11#1)(2005-11#1)(2006-12#1)(2008-8#1)
was cloned from##27##3##(1990-2#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-9#2)(1993-9#2)(1994-11#2)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-6#1)(1996-10#2)(1996-9#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-12#1)(2008-11#1)(2008-8#1)
was cloned in a##2##4##(1992-8#1)(1997-3#1)
was cloned in the##3##4##(1990-1#1)(1995-11#1)(2008-9#1)
was cloned in##14##3##(1990-1#1)(1990-11#1)(1990-3#1)(1991-8#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-12#1)(1995-11#1)(1997-3#1)(2008-10#2)(2008-8#1)(2008-9#1)
was cloned into a##8##4##(1990-5#1)(1991-5#1)(1993-12#1)(1993-6#2)(1994-12#1)(2008-10#2)
was cloned into the##7##4##(1991-6#1)(1994-9#1)(1995-2#1)(2005-11#3)(2005-6#1)
was cloned into##26##3##(1990-5#1)(1991-5#1)(1991-6#1)(1993-12#2)(1993-6#2)(1994-12#1)(1994-9#1)(1995-2#1)(1995-8#1)(1997-4#1)(2005-11#7)(2005-6#1)(2008-10#2)(2008-8#3)(2008-9#1)
was cloned recently##2##3##(1992-3#1)(2008-5#1)
was cloned using##4##3##(1990-10#1)(1991-9#1)(1993-11#1)(2012-2#1)
was cloned##198##2##(1990-1#2)(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#2)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-9#4)(1991-1#1)(1991-10#1)(1991-12#2)(1991-3#1)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-8#1)(1992-9#2)(1993-11#4)(1993-12#4)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#4)(1993-7#1)(1993-8#1)(1993-9#5)(1994-11#2)(1994-12#7)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#4)(1995-10#1)(1995-11#2)(1995-2#2)(1995-6#2)(1995-8#2)(1996-10#3)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#3)(1996-7#3)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#9)(2005-6#1)(2006-10#1)(2006-12#2)(2007-12#1)(2007-7#1)(2008-10#22)(2008-11#3)(2008-5#4)(2008-8#11)(2008-9#4)(2009-2#1)(2009-3#1)(2010-10#1)(2010-5#1)(2012-2#1)(2013-1#1)
was close agreement between##2##4##(2008-10#1)(2008-5#1)
was close to 1##2##4##(2008-10#1)(2008-8#1)
was close to a##2##4##(1991-5#1)(2008-5#1)
was close to that##3##4##(1990-12#1)(2008-10#1)(2008-3#1)
was close to the Na+ equilibrium potential##2##7##(1991-8#1)(1994-2#1)
was close to the##17##4##(1990-6#1)(1991-8#1)(1994-2#2)(1994-8#1)(1997-4#1)(1997-6#1)(2006-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2013-1#1)(2013-8#1)
was close to##40##3##(1990-12#1)(1990-6#1)(1991-2#1)(1991-5#1)(1991-8#1)(1993-2#2)(1994-2#2)(1994-8#1)(1995-1#1)(1995-5#1)(1996-3#1)(1997-4#1)(1997-6#1)(2004-11#1)(2006-11#1)(2007-12#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#1)(2013-1#1)(2013-8#1)
was close##43##2##(1990-12#1)(1990-6#1)(1991-2#1)(1991-5#1)(1991-8#1)(1993-2#2)(1994-2#2)(1994-8#1)(1995-1#1)(1995-5#1)(1996-3#1)(1997-4#1)(1997-6#1)(2004-11#1)(2006-11#1)(2007-12#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#5)(2008-7#1)(2008-8#2)(2008-9#1)(2013-1#1)(2013-8#2)
was closed after##3##3##(2007-8#1)(2008-5#1)(2008-6#1)
was closed and##2##3##(1992-2#1)(2007-8#1)
was closed surgically##2##3##(2009-6#1)(2012-3#1)
was closed with##3##3##(2007-8#2)(2012-2#1)
was closed##23##2##(1990-12#1)(1991-12#1)(1992-2#1)(1996-9#1)(2004-1#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#7)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
was closely associated with##3##4##(1994-3#1)(1996-9#1)(2011-1#1)
was closely correlated with the##3##5##(1992-5#1)(1992-9#1)(2008-10#1)
was closely correlated with##5##4##(1992-5#1)(1992-9#1)(1994-6#1)(1997-4#1)(2008-10#1)
was closely linked to##2##4##(1994-10#1)(2010-12#1)
was closely related to the##7##5##(1991-11#1)(1994-9#1)(1995-1#1)(2008-10#2)(2008-11#1)(2008-9#1)
was closely related to##18##4##(1991-11#1)(1991-8#1)(1993-12#1)(1993-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2013-1#1)
was closely related##19##3##(1991-11#1)(1991-8#1)(1993-12#1)(1993-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
was closely##38##2##(1991-11#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1996-9#1)(1997-4#1)(1997-7#1)(2006-7#1)(2007-6#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
was closer to##2##3##(2008-10#2)
was closer##3##2##(2008-10#2)(2013-1#1)
was closest to the##2##4##(2008-9#1)(2012-12#1)
was closest to##3##3##(2008-10#1)(2008-9#1)(2012-12#1)
was co-chaired by Dr##2##4##(2008-5#2)
was co-expressed##2##2##(1993-12#1)(2008-8#1)
was co-immunoprecipitated with the##2##4##(1994-11#1)(1997-7#1)
was co-immunoprecipitated with##3##3##(1994-11#1)(1997-6#1)(1997-7#1)
was co-transfected##2##2##(1996-8#1)(1997-7#1)
was coated onto##2##3##(1990-12#1)(2008-10#1)
was coated with##5##3##(2005-11#1)(2008-10#2)(2008-2#1)(2012-12#1)
was coated##11##2##(1990-12#1)(2005-11#1)(2008-10#5)(2008-2#1)(2008-7#1)(2012-1#1)(2012-12#1)
was coded using##2##3##(2010-6#1)(2013-1#1)
was coded##4##2##(2010-6#1)(2013-1#3)
was coexpressed with the##2##4##(1995-8#1)(2008-8#1)
was coexpressed with##6##3##(1995-8#1)(1996-12#1)(1997-6#2)(2008-11#1)(2008-8#1)
was coexpressed##8##2##(1995-8#1)(1996-12#1)(1997-6#2)(2008-11#2)(2008-7#1)(2008-8#1)
was coincident with the##3##4##(1992-3#1)(1993-7#1)(1995-2#1)
was coincident with##5##3##(1992-3#1)(1993-7#1)(1995-2#1)(2008-8#1)(2010-12#1)
was coined by##2##3##(2006-8#1)(2007-11#1)
was coined in##2##3##(2013-8#2)
was coined##4##2##(2006-8#1)(2007-11#1)(2013-8#2)
was collated##2##2##(2008-12#1)(2012-2#1)
was collected and##8##3##(2008-10#1)(2008-12#1)(2010-12#1)(2012-11#1)(2012-2#1)(2012-5#1)(2013-1#1)(2013-8#1)
was collected at the##2##4##(2007-2#1)(2007-9#1)
was collected at##4##3##(2007-2#1)(2007-9#1)(2008-10#1)(2012-2#1)
was collected by a##2##4##(2007-10#1)(2008-2#1)
was collected by questionnaire##2##4##(2011-2#2)
was collected by##18##3##(1990-8#1)(1992-11#1)(2006-10#1)(2007-10#2)(2007-3#1)(2007-7#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-4#1)(2010-8#1)(2011-2#4)(2012-12#2)
was collected during##3##3##(2006-7#1)(2008-10#1)(2008-7#1)
was collected for##12##3##(1990-6#1)(1992-11#1)(1993-8#1)(1997-3#2)(1997-5#1)(2004-12#1)(2005-11#1)(2007-9#1)(2008-12#1)(2008-5#1)(2013-8#1)
was collected from each##3##4##(2008-10#2)(2008-9#1)
was collected from hospital##2##4##(2006-8#1)(2008-2#1)
was collected from the##6##4##(2006-7#3)(2008-10#1)(2013-1#1)(2013-8#1)
was collected from##38##3##(1991-2#1)(1994-1#1)(1996-6#1)(2006-1#1)(2006-12#1)(2006-7#3)(2006-8#1)(2007-3#1)(2007-7#1)(2008-10#8)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
was collected in a capillary of a sampling arm assembly##2##10##(2008-10#2)
was collected in a##5##4##(2008-10#3)(2008-11#1)(2011-1#1)
was collected in the##4##4##(2007-3#1)(2008-10#3)
was collected in##19##3##(1993-6#1)(1993-8#1)(2006-8#1)(2007-3#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-4#1)(2009-4#1)(2011-1#1)(2013-1#1)
was collected on activated carbon after##2##6##(2008-10#2)
was collected on activated carbon##3##5##(2008-10#3)
was collected on the##3##4##(2008-10#2)(2011-2#1)
was collected on##13##3##(1993-9#1)(1995-3#1)(1996-6#1)(2008-10#6)(2008-9#1)(2010-5#1)(2011-2#1)(2013-1#1)
was collected prospectively##2##3##(2004-10#1)(2006-10#1)
was collected retrospectively from##2##4##(2006-8#1)(2008-12#1)
was collected retrospectively##3##3##(2006-8#1)(2008-12#1)(2012-12#1)
was collected through a##3##4##(2008-12#1)(2008-2#1)(2008-7#1)
was collected through the##2##4##(2007-11#2)
was collected through##6##3##(2007-11#2)(2008-12#1)(2008-2#1)(2008-7#2)
was collected using a##2##4##(2011-2#1)(2013-1#1)
was collected using##4##3##(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
was collected via a##2##4##(2004-11#1)(2007-12#1)
was collected with a##3##4##(2010-9#1)(2011-1#1)(2013-1#1)
was collected with the help of##2##6##(2006-10#1)(2007-7#1)
was collected with the##3##4##(2006-10#1)(2007-7#1)(2010-3#1)
was collected with##8##3##(2006-10#1)(2007-7#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#2)(2013-1#1)
was collected##166##2##(1990-6#2)(1990-8#1)(1991-2#1)(1992-11#2)(1993-2#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-1#1)(1995-3#1)(1996-6#2)(1997-3#2)(1997-5#2)(2004-10#1)(2004-11#1)(2004-12#1)(2005-11#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-5#1)(2006-7#7)(2006-8#3)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#3)(2007-7#3)(2007-9#2)(2008-1#1)(2008-10#25)(2008-11#2)(2008-12#8)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#3)(2009-4#2)(2009-5#1)(2009-7#1)(2010-12#1)(2010-2#2)(2010-3#3)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#9)(2011-9#1)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#7)(2013-7#2)(2013-8#4)
was colonized by##2##3##(2005-1#1)(2010-8#1)
was combined in##2##3##(1993-2#1)(2008-3#1)
was combined with a##6##4##(2007-1#1)(2007-12#1)(2008-6#2)(2011-2#1)(2013-1#1)
was combined with the##4##4##(1994-12#1)(1997-5#1)(2008-10#2)
was combined with##41##3##(1990-10#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-6#1)(1997-5#1)(1997-6#1)(2004-11#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#3)(2008-10#12)(2008-3#1)(2008-4#1)(2008-6#3)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-7#1)(2013-1#2)
was combined##47##2##(1990-10#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-6#1)(1997-5#1)(1997-6#1)(2004-11#1)(2005-9#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#12)(2008-3#2)(2008-4#1)(2008-6#3)(2009-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-7#1)(2013-1#2)
was commenced at##2##3##(2007-7#1)(2011-2#1)
was commenced##9##2##(1990-4#1)(1990-9#1)(2007-11#1)(2007-7#3)(2007-8#1)(2011-2#1)(2012-2#1)
was committed to##2##3##(2006-10#1)(2009-4#1)
was committed##4##2##(2006-10#1)(2009-4#1)(2010-4#1)(2011-1#1)
was common among##2##3##(2006-8#1)(2008-2#1)
was common and##2##3##(2011-2#1)(2013-1#1)
was common but##2##3##(1996-12#1)(2008-3#1)
was common in this##2##4##(2007-12#1)(2008-5#1)
was common in##7##3##(1991-11#1)(1993-2#1)(2007-12#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-2#1)
was common to##4##3##(1990-8#1)(1992-5#1)(2008-10#1)(2008-9#1)
was common within a local area of influence that extended##2##10##(2008-10#2)
was common##32##2##(1990-8#1)(1991-11#1)(1991-2#1)(1992-5#1)(1993-10#1)(1993-2#1)(1996-12#1)(1997-3#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-8#2)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
was commonest##3##2##(2007-7#1)(2011-12#1)(2011-2#1)
was commonly detected##3##3##(1991-3#1)(1995-12#1)(2010-6#1)
was commonly##14##2##(1990-3#1)(1991-3#1)(1995-12#1)(1995-8#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-2#1)(2010-6#2)(2011-1#1)(2012-12#1)(2013-8#1)
was communicated at greater-than-chance levels only when a##2##8##(2011-2#2)
was communicated##4##2##(1997-8#1)(2011-2#3)
was comparable between the two##2##5##(2008-10#1)(2012-12#1)
was comparable for the##2##4##(1997-7#1)(2006-8#1)
was comparable for##3##3##(1997-7#1)(2006-8#1)(2013-1#1)
was comparable in the two groups##4##6##(1990-11#1)(2006-2#1)(2007-2#1)(2012-2#1)
was comparable in the two##5##5##(1990-11#1)(2006-2#1)(2007-2#1)(2008-7#1)(2012-2#1)
was comparable in the##8##4##(1990-11#1)(2006-2#1)(2006-8#2)(2007-2#1)(2008-7#1)(2011-2#1)(2012-2#1)
was comparable in##14##3##(1990-11#1)(1996-7#1)(1997-7#1)(2006-2#1)(2006-7#1)(2006-8#3)(2007-2#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
was comparable to that in##7##5##(1990-7#1)(1996-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2013-1#1)
was comparable to that observed in##2##6##(1995-2#1)(2011-2#1)
was comparable to that observed##3##5##(1991-10#1)(1995-2#1)(2011-2#1)
was comparable to that obtained in##2##6##(1997-7#1)(2008-11#1)
was comparable to that obtained##3##5##(1997-7#1)(2008-10#1)(2008-11#1)
was comparable to that of the##5##6##(1993-6#1)(1994-9#1)(1995-1#1)(2006-9#1)(2008-10#1)
was comparable to that of##16##5##(1991-1#2)(1992-9#1)(1993-6#1)(1993-7#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(2005-11#1)(2006-9#1)(2007-10#1)(2008-10#1)(2008-11#1)(2010-2#1)(2012-12#1)
was comparable to that##34##4##(1990-7#1)(1991-1#2)(1991-10#1)(1992-9#1)(1993-6#1)(1993-7#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-10#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-9#1)(2007-10#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
was comparable to the##7##4##(1990-12#1)(1991-3#1)(1993-12#1)(1995-3#1)(2008-1#1)(2008-10#1)(2008-4#1)
was comparable to those of##2##5##(1992-11#1)(2012-1#1)
was comparable to those##3##4##(1992-11#1)(2008-10#1)(2012-1#1)
was comparable to##54##3##(1990-12#1)(1990-7#1)(1991-1#2)(1991-10#1)(1991-3#1)(1992-11#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#2)(1996-10#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-9#1)(2007-10#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
was comparable with that of##5##5##(1990-8#2)(1991-3#1)(2008-5#1)(2010-8#1)
was comparable with that##7##4##(1990-8#2)(1991-3#1)(1993-1#1)(2007-12#1)(2008-5#1)(2010-8#1)
was comparable with the##4##4##(1992-3#1)(1996-5#1)(1997-2#1)(2007-11#1)
was comparable with##19##3##(1990-8#2)(1991-3#1)(1992-3#1)(1993-1#1)(1994-9#1)(1996-5#1)(1997-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-5#1)(2010-8#1)(2011-2#1)(2012-12#1)
was comparable##103##2##(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#2)(1991-1#2)(1991-10#1)(1991-3#2)(1992-11#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-9#2)(1995-1#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#2)(1996-10#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-7#3)(2005-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#13)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2009-8#1)(2010-2#1)(2010-8#3)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#5)(2013-8#1)
was comparatively higher##2##3##(1990-3#1)(2013-1#1)
was comparatively##9##2##(1990-3#1)(1992-2#1)(1992-5#1)(1992-9#1)(1995-12#1)(1995-3#1)(2008-3#1)(2010-2#1)(2013-1#1)
was compared against##4##3##(2005-12#1)(2006-11#1)(2008-7#1)(2009-5#1)
was compared before and##2##4##(2007-8#1)(2008-5#1)
was compared between the two groups##2##6##(1997-8#1)(2012-2#1)
was compared between the##5##4##(1997-8#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
was compared between##13##3##(1996-12#1)(1997-8#1)(2006-6#1)(2008-2#1)(2008-5#1)(2008-7#3)(2008-9#1)(2012-2#2)(2013-1#2)
was compared by##7##3##(1991-8#1)(1993-3#1)(1994-9#1)(1995-8#1)(1996-12#1)(1996-3#1)(2012-12#1)
was compared for##5##3##(1990-11#1)(1991-2#1)(1997-2#1)(2012-12#1)(2013-1#1)
was compared in four groups of##2##6##(1991-8#1)(2008-5#1)
was compared in the##4##4##(1994-8#1)(1996-4#1)(2008-4#1)(2011-2#1)
was compared in three##3##4##(1991-4#1)(2004-2#1)(2008-5#1)
was compared in##21##3##(1990-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-8#1)(1993-8#1)(1994-8#1)(1996-4#1)(1997-8#2)(2004-2#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
was compared on##2##3##(2008-7#1)(2010-12#1)
was compared over##3##3##(2007-12#1)(2011-2#1)(2012-2#1)
was compared to a##12##4##(1990-7#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-10#1)(2011-2#1)(2012-12#2)(2012-3#1)
was compared to other##2##4##(2007-8#1)(2010-2#1)
was compared to that in##2##5##(1993-2#1)(2008-11#1)
was compared to that obtained##2##5##(1992-12#2)
was compared to that of other##2##6##(1990-9#1)(2008-11#1)
was compared to that of the##3##6##(1992-1#1)(1997-4#1)(2009-12#1)
was compared to that of##13##5##(1990-9#1)(1991-3#1)(1991-9#1)(1992-1#1)(1993-12#1)(1997-1#1)(1997-3#1)(1997-4#1)(2006-8#2)(2008-10#1)(2008-11#1)(2009-12#1)
was compared to that##18##4##(1990-9#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-12#2)(1993-12#1)(1993-2#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(2006-8#2)(2008-10#1)(2008-11#2)(2009-12#1)
was compared to the##17##4##(1990-10#1)(1990-9#1)(1991-12#1)(1991-4#1)(1993-4#1)(1995-12#1)(1995-8#1)(1997-3#1)(1997-5#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-2#1)(2010-11#1)(2010-12#1)
was compared to##85##3##(1990-10#1)(1990-7#1)(1990-9#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-6#2)(1993-12#1)(1993-2#1)(1993-4#1)(1994-5#3)(1995-12#1)(1995-8#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#2)(2005-12#1)(2006-8#4)(2007-10#1)(2007-2#2)(2007-7#2)(2007-8#3)(2008-10#8)(2008-11#4)(2008-2#2)(2008-5#4)(2008-7#5)(2009-10#2)(2009-12#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#2)
was compared using##6##3##(1990-11#1)(1992-4#1)(1995-3#1)(2004-3#1)(2007-12#1)(2008-7#1)
was compared with 5##2##4##(1993-7#1)(2008-10#1)
was compared with a##8##4##(1991-2#1)(1991-3#1)(1991-8#1)(2008-10#3)(2008-5#1)(2011-2#1)
was compared with an##7##4##(1990-6#1)(2006-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-2#1)
was compared with conventional##2##4##(1990-12#1)(2008-5#1)
was compared with its##2##4##(1995-3#1)(2008-5#1)
was compared with other##3##4##(1990-12#1)(1991-11#1)(2008-10#1)
was compared with standard##4##4##(1992-1#1)(2010-12#1)(2010-2#1)(2013-8#1)
was compared with that in##3##5##(1995-2#1)(2009-2#1)(2013-8#1)
was compared with that of a##3##6##(1995-2#1)(2008-2#1)(2008-5#1)
was compared with that of the##13##6##(1991-12#1)(1991-2#1)(1991-6#1)(1995-1#1)(1995-10#1)(1995-6#1)(1996-8#1)(2007-12#1)(2008-10#1)(2009-8#1)(2010-12#1)(2010-7#1)(2012-1#1)
was compared with that of two##2##6##(1993-1#1)(2008-10#1)
was compared with that of##40##5##(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1993-1#1)(1993-11#1)(1995-1#2)(1995-10#2)(1995-2#1)(1995-6#3)(1996-4#1)(1996-8#1)(1997-4#1)(1997-8#1)(2004-10#1)(2006-4#1)(2006-5#2)(2006-6#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-5#3)(2008-7#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-7#1)(2012-1#1)(2013-8#1)
was compared with that##51##4##(1991-12#1)(1991-2#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-6#1)(1995-1#2)(1995-10#2)(1995-2#2)(1995-6#3)(1996-12#1)(1996-4#1)(1996-8#1)(1997-4#1)(1997-8#1)(2004-10#1)(2006-4#1)(2006-5#2)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#3)(2008-7#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-7#1)(2012-1#1)(2013-1#1)(2013-8#2)
was compared with the conventional##2##5##(2006-10#1)(2008-10#1)
was compared with the performance of##2##6##(2008-2#1)(2008-3#1)
was compared with the same##2##5##(1993-4#1)(2008-7#1)
was compared with the standard##3##5##(2005-9#1)(2008-10#1)(2008-3#1)
was compared with the volume of##2##6##(1992-2#1)(2011-2#1)
was compared with the##53##4##(1990-2#1)(1990-5#1)(1991-2#1)(1992-2#1)(1993-12#1)(1993-4#1)(1993-9#2)(1995-2#1)(1995-3#1)(1995-8#2)(1996-1#1)(1996-3#1)(1996-6#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-9#1)(2006-10#2)(2006-8#3)(2007-7#1)(2008-10#13)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#2)(2009-2#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)
was compared with those of##3##5##(1997-2#2)(2008-10#1)
was compared with those##4##4##(1997-2#2)(2006-12#1)(2008-10#1)
was compared with##190##3##(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-7#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-8#1)(1995-1#2)(1995-10#2)(1995-12#1)(1995-2#3)(1995-3#3)(1995-6#3)(1995-8#2)(1996-1#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-8#3)(2004-10#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-8#4)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#38)(2008-11#2)(2008-2#5)(2008-3#3)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-12#2)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
was compared##365##2##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-9#2)(1991-11#1)(1991-12#5)(1991-2#6)(1991-3#3)(1991-4#2)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#1)(1993-1#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-5#3)(1994-8#2)(1994-9#1)(1995-1#3)(1995-10#2)(1995-12#2)(1995-2#3)(1995-3#4)(1995-6#3)(1995-8#4)(1996-1#2)(1996-12#3)(1996-2#3)(1996-3#2)(1996-4#3)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#2)(1997-5#2)(1997-6#3)(1997-8#7)(2004-1#1)(2004-10#2)(2004-12#1)(2004-2#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#3)(2006-6#2)(2006-8#8)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#4)(2007-4#2)(2007-6#1)(2007-7#5)(2007-8#6)(2008-1#2)(2008-10#53)(2008-11#6)(2008-2#8)(2008-3#4)(2008-4#3)(2008-5#17)(2008-6#2)(2008-7#14)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#3)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#4)(2010-2#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#9)(2012-1#3)(2012-12#7)(2012-2#7)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#3)
was compatible with the##2##4##(1991-4#1)(2007-8#1)
was compatible with##9##3##(1991-4#1)(1992-1#1)(2007-8#1)(2008-10#2)(2008-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
was compensated by a##2##4##(2006-12#1)(2008-7#1)
was compensated for##2##3##(2008-10#1)(2008-3#1)
was compensated##5##2##(1996-3#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
was competed with##2##3##(1993-11#1)(2008-2#1)
was competed##5##2##(1991-7#2)(1993-11#1)(1997-4#1)(2008-2#1)
was competent##2##2##(1990-5#1)(1990-6#1)
was competing##2##2##(1991-3#1)(2012-12#1)
was competitive with##3##3##(1991-12#1)(1994-11#1)(1994-12#1)
was competitive##9##2##(1990-10#1)(1991-12#1)(1992-3#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(2008-11#1)(2008-5#1)
was competitively inhibited by##3##4##(1990-5#1)(1992-4#1)(1995-2#1)
was competitively inhibited##4##3##(1990-5#1)(1992-4#1)(1994-10#1)(1995-2#1)
was competitively##7##2##(1990-5#1)(1992-4#1)(1993-6#1)(1994-10#1)(1995-2#1)(1996-12#1)(2008-10#1)
was compiled to##3##3##(1993-12#1)(1997-5#1)(2012-1#1)
was compiled##13##2##(1993-12#1)(1997-1#1)(1997-5#1)(2006-10#1)(2006-4#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
was complemented by##2##3##(2008-10#1)(2010-2#1)
was complemented with##2##3##(2010-12#1)(2013-1#1)
was complemented##4##2##(2008-10#1)(2010-12#1)(2010-2#1)(2013-1#1)
was complete in##7##3##(1990-9#1)(1991-8#1)(1996-7#1)(2006-2#1)(2007-8#1)(2008-10#2)
was complete within##3##3##(1991-8#1)(1992-8#1)(2004-9#1)
was complete##25##2##(1990-9#1)(1991-4#1)(1991-8#3)(1992-11#1)(1992-8#1)(1993-3#1)(1994-11#1)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#1)(2004-9#1)(2005-12#1)(2006-2#1)(2007-8#3)(2008-10#4)(2008-11#1)(2008-5#1)
was completed and##3##3##(1992-2#1)(1993-3#1)(2013-1#1)
was completed at##2##3##(2004-3#1)(2013-8#1)
was completed by the##6##4##(1992-8#1)(2007-4#1)(2008-10#2)(2008-6#1)(2012-1#1)
was completed by##22##3##(1990-10#1)(1992-12#2)(1992-8#1)(1994-11#1)(1996-1#1)(1997-5#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-4#1)(2012-1#1)(2013-1#1)
was completed for each##2##4##(2006-2#1)(2010-3#1)
was completed for##3##3##(2006-10#1)(2006-2#1)(2010-3#1)
was completed in all##2##4##(2007-8#1)(2011-2#1)
was completed in less than##3##5##(1996-11#1)(2008-10#2)
was completed in##17##3##(1991-3#1)(1996-1#1)(1996-11#1)(2004-9#1)(2006-12#1)(2006-5#1)(2007-8#2)(2008-10#4)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#2)
was completed to##2##3##(1991-12#1)(2012-12#1)
was completed under##2##3##(1991-12#1)(2008-10#1)
was completed using##4##3##(2007-8#1)(2012-1#1)(2013-1#2)
was completed with##5##3##(1996-11#1)(2007-12#1)(2010-12#1)(2011-2#1)(2012-12#1)
was completed within##7##3##(1990-7#1)(1992-11#1)(1992-2#1)(2007-8#1)(2008-10#3)
was completed##91##2##(1990-10#1)(1990-7#1)(1991-12#2)(1991-3#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-8#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-1#2)(1996-11#2)(1996-6#1)(1997-5#1)(2004-3#1)(2004-9#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-2#2)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-8#6)(2008-10#12)(2008-11#3)(2008-12#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#3)(2012-1#3)(2012-12#2)(2012-2#1)(2013-1#5)(2013-8#1)
was completely abolished by##5##4##(1990-3#1)(1990-5#1)(1991-6#1)(1993-6#1)(1997-8#1)
was completely abolished in the presence of##2##7##(1990-2#1)(1994-2#1)
was completely abolished in the##3##5##(1990-2#1)(1994-2#1)(1997-7#1)
was completely abolished in##5##4##(1990-2#1)(1993-3#1)(1994-2#1)(1996-2#1)(1997-7#1)
was completely abolished##15##3##(1990-2#1)(1990-3#1)(1990-5#1)(1991-6#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#1)(1995-5#2)(1996-2#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-12#1)
was completely abrogated##2##3##(1990-11#1)(1993-11#1)
was completely absent in##2##4##(1991-2#1)(2011-2#1)
was completely asymptomatic and##2##4##(2007-7#1)(2011-2#1)
was completely blocked by 0##2##5##(1992-7#1)(1994-9#1)
was completely blocked by a##2##5##(1992-3#1)(1995-7#1)
was completely blocked by the##2##5##(1990-2#1)(1995-6#1)
was completely blocked by##15##4##(1990-2#1)(1990-5#1)(1992-3#1)(1992-7#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-6#1)(1995-7#1)(1996-10#1)(1996-12#1)(1997-2#1)(2008-5#1)(2008-9#1)(2012-2#1)
was completely blocked##18##3##(1990-2#1)(1990-5#1)(1992-2#1)(1992-3#1)(1992-7#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-6#1)(1995-7#1)(1996-10#1)(1996-12#1)(1997-2#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#1)
was completely disrupted##2##3##(2010-2#1)(2011-2#1)
was completely excised and##2##4##(2009-4#1)(2012-12#1)
was completely excised##4##3##(2007-11#1)(2009-4#1)(2012-12#1)(2013-1#1)
was completely identical to that of the##2##7##(1990-12#1)(1996-5#1)
was completely identical to that of##3##6##(1990-12#1)(1993-11#1)(1996-5#1)
was completely identical to##4##4##(1990-12#1)(1991-10#1)(1993-11#1)(1996-5#1)
was completely inactivated by##2##4##(1992-7#1)(2006-8#1)
was completely inactive in##2##4##(1992-6#1)(1996-9#1)
was completely inactive##3##3##(1992-6#1)(1996-9#1)(1997-8#1)
was completely inhibited by the##3##5##(1991-4#1)(1992-3#1)(1993-6#1)
was completely inhibited by##15##4##(1990-10#1)(1990-2#1)(1990-4#1)(1991-1#1)(1991-4#1)(1991-7#2)(1992-3#1)(1993-6#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-8#1)(1997-4#1)
was completely inhibited##21##3##(1990-10#1)(1990-2#1)(1990-4#1)(1991-1#1)(1991-4#1)(1991-7#2)(1992-11#1)(1992-3#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-7#1)(1997-4#2)(2008-7#1)
was completely lost##2##3##(1993-11#1)(1996-5#1)
was completely neutralized by##2##4##(1994-8#1)(2006-10#1)
was completely overcome##2##3##(1994-3#1)(2008-10#1)
was completely prevented by##3##4##(1997-2#1)(2006-9#1)(2007-10#1)
was completely prevented##4##3##(1994-12#1)(1997-2#1)(2006-9#1)(2007-10#1)
was completely removed##4##3##(2007-11#1)(2008-5#2)(2008-7#1)
was completely resected##4##3##(2008-7#1)(2009-5#1)(2012-2#1)(2013-8#1)
was completely resistant##2##3##(1992-12#1)(2008-10#1)
was completely reversed by##4##4##(1993-11#1)(1993-5#1)(1995-12#1)(1995-3#1)
was completely reversed##6##3##(1993-11#1)(1993-5#1)(1995-12#1)(1995-3#1)(1996-1#1)(2008-9#1)
was completely reversible##4##3##(1991-3#1)(1992-8#1)(1993-1#1)(1994-11#1)
was completely sequenced##3##3##(2008-10#1)(2008-5#1)(2012-11#1)
was completely stable##2##3##(1991-2#1)(2009-3#1)
was completely suppressed##2##3##(1991-2#1)(2008-6#1)
was completely##156##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#3)(1991-3#1)(1991-4#2)(1991-6#1)(1991-7#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#4)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#4)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#2)(1996-5#2)(1996-7#1)(1996-9#2)(1997-2#3)(1997-4#2)(1997-7#1)(1997-8#2)(2006-10#3)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#11)(2008-11#3)(2008-5#4)(2008-6#2)(2008-7#4)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
was complex##3##2##(1994-12#1)(2008-10#1)(2011-2#1)
was complexed with##10##3##(1992-11#1)(1992-5#1)(1996-5#1)(1996-8#1)(2007-11#1)(2008-10#4)(2013-1#1)
was complexed##11##2##(1992-11#1)(1992-5#1)(1993-12#1)(1996-5#1)(1996-8#1)(2007-11#1)(2008-10#4)(2013-1#1)
was complicated by a##2##4##(1995-1#1)(2010-1#1)
was complicated by the##2##4##(1991-2#1)(2008-10#1)
was complicated by##23##3##(1991-2#1)(1991-8#1)(1995-1#1)(2005-12#1)(2006-10#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#5)
was complicated with##2##3##(2013-1#1)(2013-8#1)
was complicated##28##2##(1991-2#1)(1991-8#1)(1995-1#1)(2005-12#1)(2006-10#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-7#1)(2008-9#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#6)(2013-8#1)
was composed by##5##3##(2007-12#1)(2008-10#3)(2011-2#1)
was composed mainly of##2##4##(2008-12#1)(2008-7#1)
was composed of 30##2##4##(2007-8#1)(2008-2#1)
was composed of a single##2##5##(1993-12#1)(1995-6#1)
was composed of a##9##4##(1993-12#1)(1995-6#1)(1997-6#1)(2005-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2013-1#1)(2013-8#1)
was composed of cells##2##4##(2007-12#1)(2012-1#1)
was composed of four##3##4##(1991-9#1)(1992-2#1)(1995-2#1)
was composed of the head##2##5##(2008-8#2)
was composed of the##4##4##(2008-8#2)(2010-6#1)(2013-1#1)
was composed of three##2##4##(1990-3#1)(1997-2#1)
was composed of two##6##4##(1990-1#2)(1990-7#1)(1993-3#1)(2007-8#1)(2008-10#1)
was composed of##81##3##(1990-1#2)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-2#1)(1995-2#1)(1995-5#1)(1995-6#3)(1996-10#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-10#1)(2005-11#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#3)(2008-10#9)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
was composed##89##2##(1990-1#2)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-2#1)(1995-2#1)(1995-5#1)(1995-6#3)(1996-10#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-10#1)(2005-11#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-8#3)(2008-10#13)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-6#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
was compound##2##2##(1994-9#1)(2008-3#1)
was comprehensively##2##2##(1993-2#1)(2013-8#1)
was compressed by##2##3##(2008-10#1)(2008-5#1)
was compressed##5##2##(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
was comprised of seven teams##2##5##(2012-2#2)
was comprised of seven##3##4##(2008-10#1)(2012-2#2)
was comprised of##12##3##(1992-3#2)(1994-6#1)(2004-10#1)(2008-10#3)(2008-3#1)(2008-6#1)(2012-2#2)(2013-1#1)
was comprised##14##2##(1992-3#2)(1994-3#1)(1994-6#1)(2004-10#1)(2008-10#3)(2008-3#1)(2008-6#1)(2012-2#2)(2013-1#1)(2013-7#1)
was compromised##2##2##(2007-11#1)(2012-2#1)
was computed for##2##3##(2008-5#1)(2008-6#1)
was computed from the##3##4##(2008-10#1)(2008-3#1)(2013-1#1)
was computed from##5##3##(1993-12#1)(2008-10#1)(2008-3#1)(2012-5#1)(2013-1#1)
was computed to##2##3##(2008-9#1)(2011-1#1)
was computed using##2##3##(2008-10#1)(2008-7#1)
was computed##26##2##(1990-12#1)(1990-5#1)(1990-8#1)(1992-12#1)(1993-12#1)(1993-9#1)(1997-7#1)(2006-7#1)(2007-10#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-4#3)(2011-1#1)(2011-2#2)(2012-5#1)(2013-1#1)
was concanavalin A##2##3##(1995-11#1)(1996-2#1)
was concealed##2##2##(2011-2#1)(2012-2#1)
was conceived in##2##3##(2010-11#1)(2012-1#1)
was conceived##6##2##(1991-1#1)(2007-2#1)(2008-10#1)(2010-11#1)(2010-5#1)(2012-1#1)
was concentrated by##3##3##(1996-4#1)(2008-10#2)
was concentrated in the##2##4##(1991-10#1)(2008-10#1)
was concentrated in##6##3##(1990-5#1)(1991-10#1)(1996-5#1)(1997-5#1)(2008-10#2)
was concentrated##15##2##(1990-5#1)(1991-10#1)(1995-2#1)(1996-4#1)(1996-5#1)(1997-5#1)(1997-8#1)(2005-11#1)(2008-10#6)(2012-3#1)
was concentration and##2##3##(1994-11#1)(2008-5#1)
was concentration dependent and##3##4##(1990-12#1)(1994-8#1)(2008-7#1)
was concentration dependent##4##3##(1990-12#1)(1992-7#1)(1994-8#1)(2008-7#1)
was concentration##6##2##(1990-12#1)(1992-7#1)(1994-11#1)(1994-8#1)(2008-5#1)(2008-7#1)
was concentration- and##2##3##(1992-7#1)(2008-4#1)
was concentration-dependent and##5##3##(1990-8#1)(1991-1#1)(1991-12#1)(1993-9#1)(1994-11#1)
was concentration-dependent with an IC50 of##2##6##(1990-2#1)(1994-8#1)
was concentration-dependent with##3##3##(1990-2#1)(1994-8#1)(2008-4#1)
was concentration-dependent##11##2##(1990-2#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1993-9#1)(1994-11#1)(1994-8#1)(2008-4#2)(2012-2#1)
was concerned with the##2##4##(2008-10#1)(2009-2#1)
was concerned with##7##3##(1991-5#1)(1993-3#1)(2008-10#1)(2008-8#1)(2009-2#1)(2012-1#1)(2012-12#1)
was concerned##13##2##(1991-2#1)(1991-5#1)(1993-3#1)(1994-3#1)(1997-8#1)(2005-4#1)(2006-12#1)(2008-10#1)(2008-8#1)(2009-2#1)(2010-8#1)(2012-1#1)(2012-12#1)
was concluded from##2##3##(1992-2#1)(2010-2#1)
was concluded in##2##3##(2005-7#1)(2010-6#1)
was concluded that a##3##4##(2006-6#1)(2009-10#1)(2013-1#1)
was concluded that for##2##4##(2008-10#1)(2008-11#1)
was concluded that one##2##4##(1997-3#1)(2008-10#1)
was concluded that the##59##4##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#2)(1990-6#2)(1990-7#1)(1991-12#1)(1991-3#1)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1994-2#2)(1994-6#1)(1996-8#1)(2005-11#1)(2006-2#1)(2006-5#3)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#6)(2008-7#1)(2010-4#2)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#1)
was concluded that there##4##4##(2005-12#1)(2008-5#1)(2009-3#1)(2010-4#1)
was concluded that these##3##4##(1996-5#1)(1996-8#1)(2009-4#1)
was concluded that##150##3##(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#2)(1990-6#4)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-3#1)(1991-5#3)(1991-7#1)(1991-8#2)(1991-9#3)(1992-12#2)(1992-3#1)(1992-6#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-5#1)(1996-8#3)(1996-9#1)(1997-3#1)(1997-8#1)(2005-11#3)(2005-12#1)(2006-2#1)(2006-5#5)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#19)(2008-11#4)(2008-12#3)(2008-3#2)(2008-4#3)(2008-5#7)(2008-7#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-7#1)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-1#2)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
was concluded to be##2##4##(1997-6#1)(2012-12#1)
was concluded to##4##3##(1997-6#1)(2008-10#1)(2012-1#1)(2012-12#1)
was concluded##161##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#2)(1990-6#4)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-3#1)(1991-5#3)(1991-7#1)(1991-8#2)(1991-9#3)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-5#1)(1996-8#3)(1996-9#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-11#3)(2005-12#1)(2005-7#1)(2006-2#1)(2006-5#5)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#20)(2008-11#4)(2008-12#3)(2008-3#2)(2008-4#3)(2008-5#7)(2008-7#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-7#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#8)(2012-1#3)(2012-12#6)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
was concomitant with a decrease in##2##6##(1994-11#1)(1994-12#1)
was concomitant with##3##3##(1994-11#1)(1994-12#1)(2008-10#1)
was concomitant##4##2##(1994-11#1)(1994-12#1)(2008-10#1)(2008-6#1)
was concomitantly##5##2##(1991-12#1)(1993-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
was condensed with##2##3##(1992-5#1)(1996-2#1)
was condensed##3##2##(1992-5#1)(1996-2#1)(2008-2#1)
was conditioned by a single dominant##2##6##(2008-10#1)(2012-11#1)
was conditioned##3##2##(1992-12#1)(2008-10#1)(2012-11#1)
was conducted among##14##3##(1992-5#1)(1992-6#1)(2006-10#1)(2007-3#1)(2008-12#1)(2009-10#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
was conducted and##4##3##(2005-10#1)(2007-2#1)(2013-8#2)
was conducted as##4##3##(2007-8#1)(2008-10#1)(2008-3#1)(2010-10#1)
was conducted at a##2##4##(1996-4#1)(2008-10#1)
was conducted at the Department of Hemato-Oncology##2##7##(2013-1#2)
was conducted at the Department of##3##6##(2011-2#1)(2013-1#2)
was conducted at the##16##4##(1994-1#1)(2007-10#1)(2007-3#1)(2007-7#1)(2008-12#3)(2008-9#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#2)
was conducted at##34##3##(1994-1#1)(1996-4#1)(2006-11#1)(2006-4#1)(2007-10#1)(2007-2#1)(2007-3#2)(2007-7#1)(2008-10#2)(2008-12#4)(2008-3#2)(2008-5#2)(2008-9#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
was conducted based on##2##4##(1993-2#1)(2012-12#1)
was conducted between April##3##4##(1993-2#1)(2011-2#1)(2012-12#1)
was conducted between##8##3##(1993-2#1)(2006-10#1)(2011-2#4)(2012-12#1)(2013-8#1)
was conducted both##2##3##(1991-1#1)(2008-3#1)
was conducted by a##3##4##(2004-10#1)(2006-12#1)(2008-10#1)
was conducted by the##2##4##(2006-7#1)(2010-3#1)
was conducted by##20##3##(1990-12#1)(1996-12#1)(2004-10#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-3#1)
was conducted during##7##3##(2005-10#1)(2007-11#1)(2007-5#1)(2008-12#1)(2008-5#1)(2012-1#1)(2013-7#1)
was conducted following##2##3##(1996-11#1)(2012-1#1)
was conducted for the##2##4##(2006-10#1)(2008-5#1)
was conducted for##8##3##(1994-6#1)(1996-12#1)(1996-2#1)(2006-10#2)(2007-2#1)(2008-12#1)(2008-5#1)
was conducted from October##3##4##(2006-7#1)(2007-7#1)(2010-12#1)
was conducted from##14##3##(1990-10#1)(2004-11#1)(2005-8#1)(2006-7#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#2)(2013-7#1)
was conducted in 2004##4##4##(2007-11#1)(2008-1#1)(2008-4#1)(2013-8#1)
was conducted in a##22##4##(1995-2#1)(2004-11#1)(2006-4#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#1)(2009-12#1)(2009-5#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
was conducted in an##2##4##(2006-8#1)(2013-1#1)
was conducted in different##2##4##(2006-8#1)(2012-2#1)
was conducted in order to##12##5##(1993-3#1)(1996-8#1)(1997-7#1)(1997-8#1)(2004-11#1)(2008-12#1)(2008-5#1)(2008-9#2)(2009-11#1)(2010-8#1)(2012-1#1)
was conducted in the Department of Microbiology##2##7##(2011-1#1)(2013-8#1)
was conducted in the Department of##4##6##(2011-1#1)(2013-8#3)
was conducted in the Federated States of Micronesia##4##8##(2013-8#4)
was conducted in the Republic of Palau##2##7##(2008-1#1)(2013-8#1)
was conducted in the Republic of##3##6##(2008-1#1)(2013-8#2)
was conducted in the##32##4##(1992-2#1)(1995-7#1)(2006-2#1)(2007-10#1)(2007-5#1)(2007-7#2)(2008-1#2)(2008-12#1)(2008-5#1)(2011-1#4)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#14)
was conducted in two phases##3##5##(2008-10#1)(2012-2#1)(2013-1#1)
was conducted in which##6##4##(1993-1#1)(1997-4#1)(2004-2#1)(2006-5#1)(2011-2#1)(2012-7#1)
was conducted in##160##3##(1990-10#1)(1990-12#1)(1990-3#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-10#1)(1992-2#1)(1993-1#1)(1993-10#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-3#1)(1995-2#1)(1995-7#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#1)(2004-11#2)(2004-2#1)(2006-1#1)(2006-10#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#4)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#4)(2008-1#5)(2008-10#6)(2008-11#3)(2008-12#6)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#4)(2008-9#5)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-5#1)(2010-8#2)(2011-1#6)(2011-12#2)(2011-2#11)(2012-1#2)(2012-12#4)(2012-2#6)(2012-3#2)(2012-7#1)(2013-1#6)(2013-7#1)(2013-8#19)
was conducted of##8##3##(1991-8#1)(1994-2#1)(2007-8#2)(2008-9#1)(2009-10#1)(2009-9#1)(2011-2#1)
was conducted on a##6##4##(1991-7#1)(2007-9#1)(2008-5#1)(2012-1#1)(2012-5#1)(2013-1#1)
was conducted on randomly##2##4##(2008-6#1)(2011-1#1)
was conducted on the##8##4##(1994-8#1)(1997-6#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-8#3)
was conducted on##78##3##(1991-5#1)(1991-7#1)(1994-8#1)(1995-10#1)(1997-5#1)(1997-6#1)(2004-12#1)(2006-10#1)(2006-2#1)(2006-3#1)(2007-12#1)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2009-11#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-12#3)(2010-2#1)(2011-1#4)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2012-5#1)(2012-6#1)(2013-1#5)(2013-7#1)(2013-8#5)
was conducted over a##3##4##(2007-8#1)(2008-10#1)(2012-12#1)
was conducted over##6##3##(2007-8#1)(2008-1#1)(2008-10#2)(2012-12#1)(2013-1#1)
was conducted to assess the##13##5##(2006-5#1)(2007-7#2)(2008-10#2)(2008-5#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#2)(2012-1#1)(2012-12#1)
was conducted to assess##15##4##(2006-5#1)(2007-7#2)(2008-10#3)(2008-2#1)(2008-5#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#2)(2012-1#1)(2012-12#1)
was conducted to compare the##6##5##(1993-1#1)(1994-7#1)(1995-4#1)(1997-2#1)(2012-12#1)(2012-2#1)
was conducted to compare##12##4##(1993-1#1)(1994-7#1)(1995-4#1)(1997-2#1)(2006-5#1)(2007-3#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)
was conducted to delineate##3##4##(1997-6#1)(2009-4#1)(2013-1#1)
was conducted to describe the##2##5##(2005-10#1)(2007-11#1)
was conducted to describe##3##4##(2005-10#1)(2007-11#1)(2012-11#1)
was conducted to determine how##2##5##(2008-10#1)(2008-5#1)
was conducted to determine if##5##5##(1992-3#1)(1995-3#1)(2008-10#3)
was conducted to determine the effect of##4##7##(2008-10#1)(2008-12#2)(2008-5#1)
was conducted to determine the effects of##4##7##(2007-4#1)(2008-10#1)(2008-7#1)(2012-2#1)
was conducted to determine the impact of the##2##8##(1995-1#1)(2006-11#1)
was conducted to determine the pattern of##2##7##(2007-12#1)(2010-8#1)
was conducted to determine the prevalence##3##6##(2007-2#1)(2011-1#1)(2013-8#1)
was conducted to determine the##36##5##(1992-12#1)(1994-6#1)(1995-1#1)(1995-11#1)(1997-6#1)(2004-10#1)(2006-11#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
was conducted to determine whether##6##5##(1995-8#1)(2008-10#2)(2008-7#1)(2012-1#1)(2013-7#1)
was conducted to determine##57##4##(1992-12#1)(1992-3#1)(1994-1#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-8#1)(1997-6#1)(2004-10#1)(2005-10#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#1)(2008-10#9)(2008-11#1)(2008-12#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
was conducted to elucidate##2##4##(1995-2#1)(2007-3#1)
was conducted to establish##3##4##(2007-3#1)(2008-10#1)(2011-2#1)
was conducted to estimate##2##4##(1994-3#1)(2008-9#1)
was conducted to evaluate the effect of##2##7##(2008-12#1)(2012-2#1)
was conducted to evaluate the effects of##4##7##(2008-12#2)(2010-4#1)(2012-12#1)
was conducted to evaluate the##20##5##(1992-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-6#1)(2009-6#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
was conducted to evaluate##30##4##(1992-2#1)(1997-8#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2013-8#1)
was conducted to examine the##6##5##(1990-4#1)(2007-10#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-12#1)
was conducted to examine whether##4##5##(1997-8#1)(2004-11#1)(2008-11#1)(2012-2#1)
was conducted to examine##15##4##(1990-4#1)(1994-1#1)(1995-1#1)(1997-8#1)(2004-11#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-4#1)(2012-2#1)
was conducted to explore the##2##5##(2008-11#1)(2008-12#1)
was conducted to explore##4##4##(2007-4#1)(2008-11#1)(2008-12#1)(2009-5#1)
was conducted to find out##2##5##(1990-6#1)(2007-3#1)
was conducted to find##5##4##(1990-6#1)(2004-3#1)(2007-3#1)(2007-6#1)(2013-8#1)
was conducted to identify the##7##5##(1995-10#1)(1995-12#1)(2008-10#1)(2009-10#1)(2009-6#1)(2011-1#1)(2012-2#1)
was conducted to identify##20##4##(1994-9#1)(1995-10#1)(1995-12#1)(1997-1#1)(2005-5#1)(2007-11#1)(2008-10#2)(2008-2#1)(2009-10#1)(2009-6#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#4)
was conducted to investigate the effect of different##2##8##(2008-12#2)
was conducted to investigate the effect of##3##7##(2008-12#2)(2011-2#1)
was conducted to investigate the effects of##3##7##(1992-2#1)(2010-2#1)(2011-2#1)
was conducted to investigate the relationship##2##6##(2007-4#1)(2008-10#1)
was conducted to investigate the##13##5##(1992-2#1)(2005-10#2)(2007-4#1)(2008-10#1)(2008-12#2)(2009-9#1)(2010-2#1)(2011-2#2)(2012-3#1)(2013-1#1)
was conducted to investigate##17##4##(1991-3#1)(1992-2#1)(1996-1#1)(2005-10#2)(2007-4#1)(2008-10#1)(2008-12#2)(2008-9#1)(2009-9#1)(2010-2#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
was conducted to obtain##5##4##(1993-8#1)(2007-6#1)(2008-3#1)(2013-1#2)
was conducted to study the effect of##2##7##(2008-10#1)(2011-12#1)
was conducted to study the effects of##2##7##(2010-4#1)(2013-8#1)
was conducted to study the##9##5##(2004-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-4#1)(2011-12#1)(2012-12#1)(2013-8#2)
was conducted to study##11##4##(2004-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-4#1)(2011-12#1)(2012-12#1)(2013-8#2)
was conducted to test the##4##5##(1991-2#1)(2009-10#1)(2009-11#1)(2012-2#1)
was conducted to test##6##4##(1991-2#1)(1997-8#1)(2008-10#1)(2009-10#1)(2009-11#1)(2012-2#1)
was conducted to##244##3##(1990-12#1)(1990-4#1)(1990-6#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-1#1)(1993-10#1)(1993-8#1)(1994-1#2)(1994-3#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#2)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-6#2)(1997-8#3)(2004-10#1)(2004-11#3)(2004-3#1)(2005-10#4)(2005-5#1)(2006-10#1)(2006-11#2)(2006-5#2)(2006-8#2)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#4)(2007-3#6)(2007-4#6)(2007-6#2)(2007-7#4)(2007-8#4)(2008-1#1)(2008-10#24)(2008-11#5)(2008-12#14)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#5)(2008-9#3)(2009-10#2)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#5)(2010-5#3)(2010-8#5)(2011-1#7)(2011-12#5)(2011-2#12)(2012-1#4)(2012-11#1)(2012-12#6)(2012-2#10)(2012-3#4)(2013-1#9)(2013-7#1)(2013-8#7)
was conducted under the##4##4##(2008-10#1)(2008-11#1)(2010-12#1)(2012-1#1)
was conducted under##5##3##(2008-1#1)(2008-10#1)(2008-11#1)(2010-12#1)(2012-1#1)
was conducted using a##7##4##(1991-12#1)(2008-10#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
was conducted using multiple##2##4##(2012-12#1)(2013-7#1)
was conducted using nondestructive##2##4##(2007-1#1)(2008-11#1)
was conducted using the##8##4##(2006-11#1)(2007-7#2)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
was conducted using##45##3##(1991-12#1)(1993-8#1)(1996-2#2)(1996-5#1)(1996-9#1)(2004-3#1)(2006-11#2)(2007-1#1)(2007-7#3)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-12#3)(2012-2#2)(2013-1#2)(2013-7#1)
was conducted via##3##3##(2005-2#1)(2009-12#1)(2013-1#1)
was conducted with the##6##4##(1997-2#1)(2007-11#1)(2007-7#1)(2011-2#1)(2012-12#1)(2013-7#1)
was conducted with##24##3##(1996-3#1)(1997-2#1)(2004-1#1)(2005-11#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-2#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#2)(2013-7#1)
was conducted without##2##3##(2007-10#1)(2012-3#1)
was conducted##799##2##(1990-10#2)(1990-12#3)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-5#1)(1992-6#1)(1993-1#2)(1993-10#2)(1993-11#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-8#2)(1993-9#1)(1994-1#3)(1994-2#1)(1994-3#2)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#3)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-7#1)(1995-8#1)(1996-1#3)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#6)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#3)(1997-8#4)(2004-1#1)(2004-10#2)(2004-11#6)(2004-12#1)(2004-2#1)(2004-3#3)(2005-10#6)(2005-11#1)(2005-2#1)(2005-5#1)(2005-8#1)(2006-1#1)(2006-10#8)(2006-11#5)(2006-12#1)(2006-2#4)(2006-3#1)(2006-4#2)(2006-5#4)(2006-6#1)(2006-7#2)(2006-8#9)(2007-1#1)(2007-10#7)(2007-11#8)(2007-12#5)(2007-2#16)(2007-3#13)(2007-4#9)(2007-5#3)(2007-6#4)(2007-7#20)(2007-8#15)(2007-9#2)(2008-1#10)(2008-10#59)(2008-11#12)(2008-12#31)(2008-2#6)(2008-3#15)(2008-4#5)(2008-5#22)(2008-6#6)(2008-7#15)(2008-8#3)(2008-9#12)(2009-10#5)(2009-11#3)(2009-12#3)(2009-2#2)(2009-4#2)(2009-5#4)(2009-6#4)(2009-7#3)(2009-9#6)(2010-10#2)(2010-11#1)(2010-12#8)(2010-2#4)(2010-3#1)(2010-4#6)(2010-5#6)(2010-6#1)(2010-8#10)(2010-9#3)(2011-1#26)(2011-12#10)(2011-2#48)(2012-1#12)(2012-11#1)(2012-12#25)(2012-2#27)(2012-3#16)(2012-5#1)(2012-6#1)(2012-7#1)(2013-1#40)(2013-7#7)(2013-8#38)
was conferred by a single##3##5##(2008-10#3)
was conferred by##5##3##(2008-10#5)
was conferred##7##2##(1997-3#1)(2008-10#5)(2008-8#1)
was configured##2##2##(2006-11#1)(2008-10#1)
was confined to the##11##4##(1990-5#1)(1993-12#1)(1994-3#1)(1995-8#1)(2006-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-4#1)(2012-2#1)
was confined to##22##3##(1990-5#1)(1991-11#1)(1993-12#1)(1994-3#1)(1995-12#1)(1995-8#2)(2006-12#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)
was confined##23##2##(1990-5#1)(1991-11#1)(1993-12#1)(1994-3#1)(1995-12#1)(1995-8#2)(2005-11#1)(2006-12#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)
was confirmed after##4##3##(1990-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
was confirmed and a##2##4##(1993-3#1)(2008-10#1)
was confirmed and##9##3##(1993-3#1)(1993-8#1)(1994-10#1)(1995-8#1)(2008-10#3)(2008-7#1)(2008-9#1)
was confirmed as a##2##4##(2011-1#1)(2013-7#1)
was confirmed as##5##3##(1990-6#1)(1991-12#1)(2008-10#1)(2011-1#1)(2013-7#1)
was confirmed at the##3##4##(1994-2#1)(1995-2#1)(2008-10#1)
was confirmed at##7##3##(1991-11#1)(1994-2#1)(1995-2#1)(2006-5#1)(2008-10#2)(2011-2#1)
was confirmed between##2##3##(2007-11#1)(2010-12#1)
was confirmed by FT-IR##2##4##(2005-11#1)(2007-11#1)
was confirmed by Northern##2##4##(1992-7#1)(1995-2#1)
was confirmed by PCR and##2##5##(1992-8#1)(2005-11#1)
was confirmed by PCR##4##4##(1992-8#1)(2005-11#1)(2011-2#1)(2012-2#1)
was confirmed by RT-PCR##3##4##(1996-9#1)(2008-10#1)(2008-8#1)
was confirmed by Southern##3##4##(1991-3#1)(1997-2#1)(2006-12#1)
was confirmed by Western blotting##2##5##(1996-1#1)(2008-11#1)
was confirmed by Western##3##4##(1991-8#1)(1996-1#1)(2008-11#1)
was confirmed by a##6##4##(1990-12#1)(1994-5#1)(1994-8#1)(2007-8#1)(2010-12#1)(2012-12#1)
was confirmed by an##4##4##(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)
was confirmed by analysis of##5##5##(2008-10#5)
was confirmed by biopsy##4##4##(2005-11#2)(2011-2#1)(2013-7#1)
was confirmed by comparing the##4##5##(1996-12#1)(1996-4#1)(2008-10#1)(2009-2#1)
was confirmed by comparison with the##2##6##(1993-9#1)(2008-2#1)
was confirmed by comparison with##3##5##(1990-6#1)(1993-9#1)(2008-2#1)
was confirmed by computed tomography (CT)##2##6##(2007-10#1)(2008-8#1)
was confirmed by computed tomography##3##5##(2007-10#1)(2008-7#1)(2008-8#1)
was confirmed by computed##4##4##(2007-10#1)(2008-7#1)(2008-8#1)(2010-10#1)
was confirmed by culture##4##4##(2007-7#1)(2009-11#1)(2011-2#1)(2012-2#1)
was confirmed by demonstrating##3##4##(1992-1#1)(1995-2#1)(1997-1#1)
was confirmed by direct##2##4##(1992-9#1)(1994-3#1)
was confirmed by experiments##3##4##(2007-11#1)(2008-11#2)
was confirmed by fluorescence##2##4##(1995-5#1)(2005-11#1)
was confirmed by histopathological examination##2##5##(1997-3#1)(2012-2#1)
was confirmed by histopathological##4##4##(1997-3#1)(2005-11#1)(2012-12#1)(2012-2#1)
was confirmed by histopathology##3##4##(2007-7#2)(2007-8#1)
was confirmed by hybridization##2##4##(1991-7#1)(2008-10#1)
was confirmed by immunoblot##2##4##(2008-1#1)(2013-1#1)
was confirmed by immunoblotting and##2##5##(1995-7#1)(2008-11#1)
was confirmed by immunofluorescence##2##4##(1995-3#1)(2007-7#1)
was confirmed by immunohistochemistry##3##4##(2008-7#1)(2009-5#1)(2013-8#1)
was confirmed by in vivo##2##5##(1990-5#1)(1995-12#1)
was confirmed by in##3##4##(1990-5#1)(1995-12#1)(1996-4#1)
was confirmed by its##2##4##(1990-5#1)(2004-11#1)
was confirmed by mass spectrometry##2##5##(1992-4#1)(1996-6#1)
was confirmed by mass##3##4##(1991-8#1)(1992-4#1)(1996-6#1)
was confirmed by matching##2##4##(1991-2#1)(2011-2#1)
was confirmed by means of##2##5##(2008-10#1)(2008-5#1)
was confirmed by measuring the##2##5##(1990-2#1)(1996-9#1)
was confirmed by northern blot##2##5##(1995-8#1)(2008-10#1)
was confirmed by polymerase chain reaction##3##6##(2008-10#3)
was confirmed by recombinant immunoblot assay##2##6##(1991-3#1)(2007-2#1)
was confirmed by recombinant##3##4##(1991-3#1)(1995-5#1)(2007-2#1)
was confirmed by repeated##2##4##(2006-8#1)(2007-7#1)
was confirmed by restriction##3##4##(1992-8#1)(1992-9#1)(2008-1#1)
was confirmed by sequencing##2##4##(1990-4#1)(2008-10#1)
was confirmed by showing that the##2##6##(1993-2#1)(1994-2#1)
was confirmed by simultaneous##2##4##(1991-8#1)(1995-2#1)
was confirmed by the demonstration of##2##6##(1994-8#1)(2007-7#1)
was confirmed by the detection of##2##6##(2005-11#1)(2007-8#1)
was confirmed by the good concordance between found and certified values in the analysis of certified reference materials##2##18##(2008-10#2)
was confirmed by the results of##2##6##(2008-4#1)(2010-12#1)
was confirmed by the##33##4##(1991-11#1)(1991-9#1)(1994-4#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-8#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-12#1)(2008-3#2)(2008-4#2)(2010-12#1)(2011-2#2)(2013-1#2)
was confirmed by using##2##4##(1996-3#1)(2008-10#1)
was confirmed by western blotting##2##5##(2008-10#1)(2008-11#1)
was confirmed by##301##3##(1990-10#1)(1990-12#5)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#3)(1990-8#1)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-7#2)(1991-8#3)(1991-9#2)(1992-1#1)(1992-10#1)(1992-2#2)(1992-4#2)(1992-6#3)(1992-7#2)(1992-8#2)(1992-9#2)(1993-12#2)(1993-2#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#1)(1995-5#2)(1995-6#6)(1995-7#1)(1995-8#2)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#3)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#4)(1997-1#3)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#2)(2004-11#1)(2005-11#11)(2005-12#2)(2006-12#4)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#2)(2007-3#2)(2007-7#9)(2007-8#8)(2007-9#1)(2008-1#2)(2008-10#43)(2008-11#11)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#6)(2008-7#6)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#4)(2010-4#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#13)(2012-11#1)(2012-12#4)(2012-2#7)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
was confirmed during##3##3##(1991-11#1)(2006-11#1)(2012-3#1)
was confirmed experimentally##3##3##(1996-2#1)(2004-8#1)(2008-7#1)
was confirmed for the##4##4##(1995-5#1)(2008-10#1)(2008-11#1)(2010-3#1)
was confirmed for##8##3##(1995-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2010-3#2)(2012-3#1)
was confirmed histologically##7##3##(1995-9#1)(2006-6#3)(2007-12#1)(2007-8#1)(2011-1#1)
was confirmed in a clinical##2##5##(1996-4#1)(2008-5#1)
was confirmed in a##4##4##(1994-12#1)(1996-4#1)(2008-10#1)(2008-5#1)
was confirmed in experiments in which##2##6##(1990-11#1)(1990-7#1)
was confirmed in the##5##4##(1995-11#1)(2005-11#1)(2008-10#3)
was confirmed in##38##3##(1990-11#1)(1990-5#1)(1990-7#1)(1991-5#2)(1993-12#1)(1993-7#1)(1994-12#2)(1995-11#1)(1996-4#1)(1996-8#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-4#1)(2008-5#2)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
was confirmed on CT scan##2##5##(2005-9#1)(2011-1#1)
was confirmed on magnetic resonance imaging##2##6##(2012-2#2)
was confirmed on##9##3##(2005-9#1)(2006-4#1)(2007-7#1)(2011-1#1)(2012-2#3)(2013-7#1)(2013-8#1)
was confirmed that the##3##4##(1991-9#1)(2005-11#1)(2008-8#1)
was confirmed that##9##3##(1991-9#1)(1994-5#1)(1995-12#1)(2005-10#1)(2005-11#2)(2008-10#2)(2008-8#1)
was confirmed through##4##3##(1995-12#1)(1996-7#1)(2008-5#1)(2013-1#1)
was confirmed to be##11##4##(1991-6#1)(1992-10#1)(1993-12#1)(1997-1#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2012-3#1)
was confirmed to have##2##4##(2007-12#1)(2008-11#1)
was confirmed to##17##3##(1991-6#1)(1992-10#1)(1993-12#1)(1994-2#1)(1997-1#1)(1997-4#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2012-3#1)
was confirmed using an##2##4##(1994-6#1)(1996-5#1)
was confirmed using##13##3##(1991-5#1)(1992-1#1)(1994-6#1)(1996-5#1)(2004-12#1)(2006-12#1)(2008-10#3)(2008-5#1)(2010-11#1)(2010-8#1)(2012-12#1)
was confirmed via##4##3##(1990-11#1)(2007-12#1)(2009-2#1)(2010-8#1)
was confirmed when##2##3##(1993-9#1)(2008-10#1)
was confirmed with a##3##4##(2007-11#1)(2007-3#1)(2011-2#1)
was confirmed with the##4##4##(1993-2#1)(1997-7#1)(2005-8#1)(2012-12#1)
was confirmed with##13##3##(1992-9#1)(1993-2#1)(1995-2#1)(1997-7#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-3#1)(2010-5#1)(2011-2#1)(2012-12#1)
was confirmed##505##2##(1990-10#1)(1990-11#3)(1990-12#5)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#4)(1990-6#5)(1990-7#2)(1990-8#2)(1990-9#3)(1991-1#2)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#4)(1991-6#2)(1991-7#2)(1991-8#3)(1991-9#3)(1992-1#2)(1992-10#2)(1992-2#2)(1992-4#2)(1992-6#4)(1992-7#2)(1992-8#2)(1992-9#3)(1993-12#5)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#2)(1993-7#3)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#5)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#2)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#4)(1995-2#7)(1995-3#1)(1995-5#3)(1995-6#6)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#1)(1996-12#4)(1996-2#4)(1996-3#2)(1996-4#4)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#4)(1997-1#4)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#4)(1997-8#2)(2004-11#1)(2004-12#1)(2004-8#1)(2004-9#1)(2005-10#2)(2005-11#14)(2005-12#2)(2005-8#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#5)(2006-3#2)(2006-4#1)(2006-5#2)(2006-6#4)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#8)(2007-12#5)(2007-2#3)(2007-3#3)(2007-7#13)(2007-8#11)(2007-9#1)(2008-1#3)(2008-10#74)(2008-11#14)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#4)(2008-5#11)(2008-7#9)(2008-8#5)(2008-9#2)(2009-1#1)(2009-11#1)(2009-2#3)(2009-3#2)(2009-5#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-3#3)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#17)(2012-11#1)(2012-12#9)(2012-2#10)(2012-3#8)(2013-1#10)(2013-7#3)(2013-8#5)
was confounded by##3##3##(2005-10#1)(2013-1#2)
was confounded##5##2##(2005-10#1)(2008-10#1)(2008-8#1)(2013-1#2)
was conjugated to the##3##4##(2008-10#1)(2012-11#2)
was conjugated to##10##3##(1991-2#1)(1992-8#1)(1993-3#1)(1997-2#1)(2008-10#3)(2012-11#2)(2012-2#1)
was conjugated with a##2##4##(2006-12#1)(2011-1#1)
was conjugated with##6##3##(1992-3#1)(2005-11#1)(2006-12#1)(2010-12#1)(2011-1#1)(2013-1#1)
was conjugated##16##2##(1991-2#1)(1992-3#1)(1992-8#1)(1993-3#1)(1997-2#1)(2005-11#1)(2006-12#1)(2008-10#3)(2010-12#1)(2011-1#1)(2012-11#2)(2012-2#1)(2013-1#1)
was connected to a##2##4##(2006-8#1)(2008-10#1)
was connected to the##4##4##(1990-8#1)(2007-8#1)(2008-4#1)(2010-5#1)
was connected to##8##3##(1990-8#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2010-5#1)
was connected##10##2##(1990-8#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-6#1)(2010-5#1)(2010-9#1)
was conscious and##2##3##(2006-4#1)(2009-6#1)
was conscious##3##2##(2006-4#1)(2008-1#1)(2009-6#1)
was consecutively##2##2##(1994-5#1)(2008-10#1)
was consequently##8##2##(1990-3#1)(1990-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2009-6#1)
was conserved at the##2##4##(1995-6#1)(2012-2#1)
was conserved in##2##3##(1997-6#1)(2012-12#1)
was conserved##8##2##(1994-11#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-6#1)(1997-6#1)(2012-12#1)(2012-2#1)
was considerable variation in##3##4##(1996-12#1)(2006-8#1)(2008-10#1)
was considerable##14##2##(1991-9#1)(1992-2#1)(1993-3#1)(1996-12#1)(1996-3#1)(2004-2#1)(2006-8#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-7#1)(2010-2#1)(2013-8#1)
was considerably decreased##2##3##(1993-6#1)(2005-11#1)
was considerably higher in the##2##5##(1994-9#1)(1995-12#1)
was considerably higher in##4##4##(1994-9#1)(1995-12#1)(1996-3#1)(2013-1#1)
was considerably higher than that##2##5##(1992-5#1)(1996-5#1)
was considerably higher than##4##4##(1992-5#1)(1992-8#1)(1994-6#1)(1996-5#1)
was considerably higher##12##3##(1992-5#1)(1992-8#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-5#1)(2007-11#1)(2008-11#1)(2013-1#1)
was considerably increased##2##3##(1994-11#1)(1997-6#1)
was considerably less##4##3##(1991-12#1)(1992-6#1)(1993-12#1)(1993-7#1)
was considerably lower than in the##2##6##(2007-11#1)(2007-9#1)
was considerably lower than##6##4##(1990-2#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-10#1)(2012-12#1)
was considerably lower##10##3##(1990-2#1)(1990-6#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-10#2)(2012-12#2)(2013-1#1)
was considerably more##2##3##(2008-10#1)(2008-6#1)
was considerably reduced by##2##4##(1990-2#1)(1993-2#1)
was considerably reduced in the##2##5##(2008-10#1)(2010-1#1)
was considerably reduced in##3##4##(2008-10#1)(2008-12#1)(2010-1#1)
was considerably reduced##8##3##(1990-2#1)(1993-2#1)(1993-4#1)(1994-8#1)(1997-4#1)(2008-10#1)(2008-12#1)(2010-1#1)
was considerably##57##2##(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#1)(1991-12#2)(1991-9#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-8#1)(2012-12#3)(2012-2#1)(2013-1#2)
was considered a##12##3##(1993-1#1)(1994-12#1)(2006-10#1)(2006-9#1)(2007-5#1)(2008-1#2)(2008-3#1)(2009-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
was considered an##3##3##(2006-6#2)(2010-4#1)
was considered and##2##3##(2008-10#1)(2012-12#1)
was considered as a##8##4##(1992-3#1)(1993-9#1)(2006-4#1)(2007-2#1)(2007-8#1)(2008-9#1)(2013-1#1)(2013-8#1)
was considered as statistically significant##2##5##(2011-2#1)(2013-1#1)
was considered as the##4##4##(2006-12#1)(2008-10#1)(2008-12#1)(2011-2#1)
was considered as##23##3##(1992-3#1)(1993-9#1)(2004-12#1)(2006-12#1)(2006-4#1)(2006-8#2)(2007-2#2)(2007-8#1)(2008-10#3)(2008-12#1)(2008-9#1)(2010-3#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
was considered by##6##3##(1992-1#1)(1997-7#1)(2007-11#1)(2008-7#2)(2011-2#1)
was considered in all##2##4##(2007-10#1)(2012-12#1)
was considered in##6##3##(1992-11#1)(2005-11#1)(2007-10#1)(2012-12#2)(2012-2#1)
was considered inappropriate##2##3##(2007-10#1)(2007-3#1)
was considered inoperable##2##3##(2007-10#1)(2010-3#1)
was considered most##3##3##(1995-10#1)(2005-11#1)(2005-7#1)
was considered necessary to##2##4##(1991-6#1)(2011-2#1)
was considered optimal##2##3##(2006-10#1)(2006-9#1)
was considered positive##4##3##(1995-4#1)(2006-8#1)(2008-12#1)(2012-12#1)
was considered safe##2##3##(1991-12#1)(2013-8#1)
was considered significant for##2##4##(2005-1#1)(2012-2#1)
was considered significant##7##3##(2005-1#1)(2006-8#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#2)
was considered successful##3##3##(2004-10#1)(2005-12#1)(2012-2#1)
was considered that the##4##4##(2004-9#1)(2005-7#1)(2008-7#1)(2013-8#1)
was considered that##8##3##(2004-9#1)(2005-7#1)(2008-5#1)(2008-7#1)(2012-1#1)(2013-8#3)
was considered the first sign of puberty in##2##8##(2006-10#2)
was considered the##8##3##(2006-10#2)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
was considered to be a##6##5##(2004-1#1)(2008-10#2)(2010-12#2)(2011-12#1)
was considered to be either##2##5##(1992-5#1)(1996-3#1)
was considered to be the##6##5##(1996-12#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-5#1)(2009-7#1)
was considered to be##32##4##(1992-5#1)(1996-1#1)(1996-12#1)(1996-3#1)(2004-1#1)(2005-11#1)(2006-10#3)(2007-1#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-5#3)(2008-7#1)(2009-12#1)(2009-2#1)(2009-7#1)(2010-12#2)(2010-7#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-7#1)(2013-8#1)
was considered to have##4##4##(1994-4#1)(2006-8#1)(2007-7#1)(2008-5#1)
was considered to##39##3##(1992-5#1)(1994-4#1)(1996-1#1)(1996-12#2)(1996-3#1)(2004-1#1)(2005-11#1)(2006-10#3)(2006-8#1)(2007-1#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-5#4)(2008-7#1)(2009-12#1)(2009-2#2)(2009-7#1)(2010-12#2)(2010-7#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-7#1)(2013-8#1)
was considered useful##2##3##(1990-6#1)(2008-5#1)
was considered##193##2##(1990-12#1)(1990-6#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-4#1)(1994-6#1)(1994-9#1)(1995-10#2)(1995-3#2)(1995-4#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#1)(2004-1#1)(2004-10#1)(2004-12#1)(2004-9#2)(2005-1#2)(2005-11#3)(2005-12#1)(2005-7#2)(2006-10#8)(2006-12#1)(2006-4#1)(2006-6#3)(2006-8#6)(2006-9#3)(2007-1#2)(2007-10#4)(2007-11#3)(2007-2#4)(2007-3#1)(2007-5#2)(2007-7#3)(2007-8#2)(2008-1#5)(2008-10#14)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#2)(2009-7#2)(2010-11#2)(2010-12#3)(2010-3#4)(2010-4#1)(2010-7#1)(2011-12#1)(2011-2#10)(2012-1#1)(2012-12#6)(2012-2#8)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#6)
was consisted of##3##3##(2008-3#1)(2011-2#1)(2013-1#1)
was consistent among##2##3##(1997-3#1)(2008-10#1)
was consistent for##3##3##(2011-1#1)(2011-2#1)(2012-3#1)
was consistent in##3##3##(1991-7#1)(1995-11#1)(1996-10#1)
was consistent with a single##2##5##(1991-3#1)(1993-2#1)
was consistent with a##15##4##(1990-2#1)(1991-3#2)(1992-3#1)(1993-2#1)(1995-3#1)(2005-5#1)(2006-10#1)(2007-12#1)(2008-10#2)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)
was consistent with one##2##4##(1992-12#1)(1994-5#1)
was consistent with our##2##4##(1995-11#1)(2008-2#1)
was consistent with the observed##3##5##(1996-7#1)(2008-10#1)(2008-5#1)
was consistent with the results of##2##6##(1992-7#1)(2008-9#1)
was consistent with the##27##4##(1990-8#1)(1991-7#1)(1992-7#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-7#1)(1997-5#1)(2005-11#1)(2007-11#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-12#1)(2012-1#1)
was consistent with what##2##4##(2007-12#1)(2008-7#1)
was consistent with##79##3##(1990-2#1)(1990-5#1)(1990-8#2)(1991-3#2)(1991-7#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-3#1)(1994-5#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#2)(1996-11#1)(1996-7#1)(1996-8#1)(1997-5#1)(1997-7#2)(2005-11#1)(2005-5#1)(2006-10#4)(2006-5#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#13)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#2)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
was consistent##91##2##(1990-2#1)(1990-5#1)(1990-8#2)(1991-3#2)(1991-7#2)(1992-12#1)(1992-3#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-3#1)(1994-5#2)(1995-10#1)(1995-11#2)(1995-12#2)(1995-3#1)(1995-5#2)(1996-10#1)(1996-11#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-7#2)(2005-11#1)(2005-5#1)(2006-10#4)(2006-5#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
was consistently associated with##3##4##(2006-9#1)(2008-10#1)(2012-12#1)
was consistently detected##2##3##(1994-2#1)(2008-10#1)
was consistently found in##2##4##(1996-4#1)(2008-5#1)
was consistently found##3##3##(1993-3#1)(1996-4#1)(2008-5#1)
was consistently higher in##2##4##(1991-12#1)(2011-12#1)
was consistently higher than that##2##5##(1993-7#1)(1997-1#1)
was consistently higher than##3##4##(1993-7#1)(1997-1#1)(2011-1#1)
was consistently higher##6##3##(1991-12#1)(1993-7#1)(1997-1#1)(2006-8#1)(2011-1#1)(2011-12#1)
was consistently isolated from##3##4##(1997-6#1)(2008-10#2)
was consistently larger##2##3##(2008-7#1)(2010-2#1)
was consistently lower##2##3##(1992-8#1)(1994-2#1)
was consistently observed##5##3##(1993-9#1)(1994-8#1)(1996-1#1)(1996-4#1)(2011-2#1)
was consistently present in##3##4##(2006-9#1)(2008-10#2)
was consistently##47##2##(1990-12#1)(1991-12#1)(1991-8#1)(1992-10#1)(1992-2#1)(1992-8#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-2#2)(1994-8#1)(1995-9#1)(1996-1#1)(1996-4#2)(1996-5#1)(1997-1#1)(1997-6#2)(2004-3#1)(2006-8#1)(2006-9#2)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
was consolidated##2##2##(2009-6#1)(2012-12#1)
was constant at##4##3##(2007-12#1)(2008-10#1)(2008-7#1)(2012-12#1)
was constant for##3##3##(1990-11#1)(1994-6#1)(2005-11#1)
was constant in##2##3##(2011-2#1)(2012-3#1)
was constant##20##2##(1990-11#2)(1990-12#1)(1993-8#1)(1994-6#1)(1996-5#1)(2005-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
was constantly##3##2##(2007-8#1)(2008-10#1)(2011-2#1)
was constituted by the##4##4##(2008-10#3)(2010-8#1)
was constituted by##6##3##(1993-11#1)(2008-10#3)(2010-8#1)(2011-1#1)
was constituted##7##2##(1993-11#1)(2008-10#3)(2008-9#1)(2010-8#1)(2011-1#1)
was constitutive and was##2##4##(1995-3#1)(1996-5#1)
was constitutive in##2##3##(1990-9#1)(1991-7#1)
was constitutive##5##2##(1990-9#1)(1991-7#1)(1994-2#1)(1995-3#1)(1996-5#1)
was constitutively##3##2##(1992-8#1)(1994-9#1)(1995-6#1)
was constrained##2##2##(2008-10#1)(2008-3#1)
was constructed and evaluated##2##4##(2008-10#1)(2008-5#1)
was constructed and is described##2##5##(2008-3#2)
was constructed and is##3##4##(2008-3#3)
was constructed and tested##4##4##(2008-10#3)(2008-2#1)
was constructed and the##2##4##(1992-3#1)(1994-9#1)
was constructed and used to##3##5##(1993-3#1)(2008-2#1)(2008-8#1)
was constructed and used##5##4##(1990-5#1)(1993-3#1)(2008-2#2)(2008-8#1)
was constructed and##33##3##(1990-5#1)(1991-7#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-9#2)(1995-6#1)(1995-8#1)(1996-10#1)(2005-11#2)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-8#5)(2008-9#1)
was constructed as a##2##4##(2008-10#2)
was constructed based on the##3##5##(2008-2#1)(2008-9#1)(2009-2#1)
was constructed based on##4##4##(2008-10#1)(2008-2#1)(2008-9#1)(2009-2#1)
was constructed by immobilizing##4##4##(2007-8#1)(2008-10#3)
was constructed by inserting the##2##5##(1995-1#1)(2008-8#1)
was constructed by inserting##4##4##(1995-1#1)(1995-8#1)(1996-8#1)(2008-8#1)
was constructed by the immobilization of##2##6##(2007-8#1)(2008-10#1)
was constructed by the##3##4##(1997-4#1)(2007-8#1)(2008-10#1)
was constructed by using##4##4##(2008-10#1)(2008-11#1)(2008-8#1)(2011-3#1)
was constructed by##36##3##(1990-5#1)(1991-7#1)(1992-4#1)(1995-1#1)(1995-2#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-8#1)(1997-4#1)(1997-8#1)(2005-11#2)(2007-8#2)(2008-10#10)(2008-11#1)(2008-3#1)(2008-8#4)(2008-9#1)(2009-5#1)(2011-1#1)(2011-3#2)
was constructed for the##5##4##(1997-2#1)(2008-10#2)(2008-5#1)(2010-4#1)
was constructed for##9##3##(1997-2#1)(2008-10#3)(2008-2#1)(2008-5#1)(2009-10#1)(2010-4#1)(2011-1#1)
was constructed from a##5##4##(1994-12#1)(1997-2#1)(2007-11#1)(2008-10#2)
was constructed from##11##3##(1994-12#2)(1994-6#1)(1997-2#2)(2007-11#2)(2008-10#3)(2010-8#1)
was constructed in Escherichia coli##2##5##(1991-9#1)(1994-2#1)
was constructed in order to##2##5##(1995-2#1)(2011-2#1)
was constructed in the##4##4##(1990-11#1)(1994-9#1)(1997-6#1)(1997-7#1)
was constructed in which##5##4##(1994-12#1)(1994-5#1)(1995-3#1)(2008-10#1)(2010-5#1)
was constructed in##18##3##(1990-11#1)(1990-5#1)(1991-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1997-6#1)(1997-7#2)(2005-11#1)(2008-10#2)(2010-5#1)(2011-2#1)
was constructed on the basis of##2##6##(2005-11#1)(2008-6#1)
was constructed that##3##3##(1990-11#1)(2008-3#1)(2011-1#1)
was constructed to determine##2##4##(1991-1#1)(1991-9#1)
was constructed to identify##2##4##(2008-10#1)(2013-1#1)
was constructed to##13##3##(1991-1#1)(1991-9#1)(2007-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-8#1)(2008-9#2)(2013-1#1)
was constructed using a##2##4##(1995-8#1)(2007-8#1)
was constructed using the##10##4##(1990-3#1)(1993-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-2#1)(2013-8#1)
was constructed using##23##3##(1990-3#1)(1993-8#1)(1995-8#1)(1996-6#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-8#4)(2008-9#2)(2012-2#2)(2013-8#1)
was constructed which##3##3##(1993-11#1)(1993-12#1)(1995-4#1)
was constructed with a##4##4##(1994-8#1)(2008-10#2)(2008-2#1)
was constructed with the##5##4##(1995-8#1)(2007-12#1)(2007-5#1)(2008-5#1)(2008-8#1)
was constructed with##16##3##(1990-11#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)
was constructed##243##2##(1990-11#3)(1990-3#1)(1990-5#3)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-7#3)(1991-9#2)(1992-3#1)(1992-4#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#5)(1996-10#2)(1996-12#1)(1996-2#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-4#1)(1997-6#3)(1997-7#3)(1997-8#1)(2005-10#1)(2005-11#9)(2005-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-5#1)(2007-8#5)(2008-10#47)(2008-11#5)(2008-12#2)(2008-2#7)(2008-3#8)(2008-4#1)(2008-5#5)(2008-6#3)(2008-8#21)(2008-9#12)(2009-10#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#1)(2011-3#2)(2012-2#2)(2013-1#1)(2013-8#5)
was consumed by##2##3##(1990-12#1)(2010-4#1)
was consumed in##2##3##(2008-11#1)(2013-7#1)
was consumed more rapidly##2##4##(1994-2#1)(2004-9#1)
was consumed##9##2##(1990-12#1)(1990-2#1)(1993-9#1)(1994-2#1)(2004-9#1)(2008-11#2)(2010-4#1)(2013-7#1)
was contacted##5##2##(1991-12#1)(1993-8#1)(1996-11#1)(2006-10#1)(2008-7#1)
was contagious##2##2##(2007-2#1)(2011-12#1)
was contained in a##2##4##(1992-2#1)(1997-8#1)
was contained in##5##3##(1992-2#1)(1995-8#1)(1996-5#1)(1997-8#1)(2008-11#1)
was contained within##3##3##(1995-5#1)(2013-1#2)
was contained##8##2##(1992-2#1)(1995-5#1)(1995-8#1)(1996-5#1)(1997-8#1)(2008-11#1)(2013-1#2)
was contaminated by##2##3##(2008-11#1)(2013-8#1)
was contaminated with##2##3##(1991-6#1)(2012-2#1)
was contaminated##6##2##(1991-6#1)(1996-12#2)(2008-11#1)(2012-2#1)(2013-8#1)
was contingent on##2##3##(2008-9#1)(2009-9#1)
was continued and she##2##4##(2012-2#2)
was continued at##3##3##(1990-2#1)(2008-6#1)(2011-1#1)
was continued for##6##3##(2007-8#1)(2008-5#3)(2008-6#1)(2012-2#1)
was continued till##2##3##(2007-7#1)(2008-1#1)
was continued until##5##3##(1991-3#1)(1992-4#1)(1993-7#1)(1994-8#1)(2013-8#1)
was continued with##3##3##(1997-2#1)(2008-10#1)(2011-1#1)
was continued##29##2##(1990-2#1)(1991-3#1)(1992-4#1)(1993-4#1)(1993-7#1)(1994-8#1)(1997-2#1)(1997-8#1)(2006-4#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-6#2)(2011-1#2)(2012-2#4)(2013-8#2)
was continuous##5##2##(1995-10#1)(1997-2#1)(2007-7#1)(2007-8#1)(2008-10#1)
was continuously infused##2##3##(1994-8#1)(1995-5#1)
was continuously monitored by##4##4##(1991-9#1)(2008-10#2)(2008-5#1)
was continuously monitored##6##3##(1991-9#1)(1995-6#1)(2008-10#2)(2008-5#1)(2011-1#1)
was continuously pumped through the##2##5##(2008-10#2)
was continuously pumped##3##3##(2007-8#1)(2008-10#2)
was continuously##30##2##(1990-12#1)(1991-9#1)(1992-10#1)(1994-8#1)(1995-5#1)(1995-6#1)(1996-6#1)(1997-2#1)(2004-9#1)(2006-2#1)(2007-12#3)(2007-8#1)(2008-10#6)(2008-2#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2010-5#1)(2011-1#1)(2012-2#1)
was contraindicated because of##2##4##(1990-11#1)(1991-4#1)
was contraindicated##3##2##(1990-11#1)(1991-4#1)(2012-12#1)
was contrasted with##2##3##(1997-7#1)(2008-10#1)
was contrasted##3##2##(1997-7#1)(2008-10#1)(2008-5#1)
was contributed by##2##3##(2008-10#1)(2009-9#1)
was controlled at the##2##4##(1994-3#1)(2006-12#1)
was controlled at##5##3##(1994-3#1)(2006-12#1)(2008-11#1)(2008-6#1)(2011-12#1)
was controlled by a single dominant locus##3##7##(2008-10#3)
was controlled by a single dominant##4##6##(2008-10#4)
was controlled by a##7##4##(1991-7#1)(2008-10#6)
was controlled by the##9##4##(2005-11#1)(2007-8#1)(2007-9#1)(2008-10#3)(2009-4#1)(2010-1#2)
was controlled by##32##3##(1990-6#1)(1991-7#1)(1994-3#1)(1996-5#1)(2005-11#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#14)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-1#2)(2010-12#1)(2010-5#1)(2013-8#1)
was controlled for##2##3##(1990-6#1)(1990-9#1)
was controlled in all patients##2##5##(1990-8#1)(1997-8#1)
was controlled in##7##3##(1990-12#1)(1990-6#1)(1990-8#1)(1992-11#1)(1997-8#1)(2008-1#1)(2008-10#1)
was controlled with##8##3##(1990-9#1)(1994-2#1)(1997-8#1)(2007-2#1)(2007-3#1)(2008-11#1)(2013-1#2)
was controlled##71##2##(1990-12#1)(1990-2#1)(1990-6#3)(1990-8#1)(1990-9#2)(1991-7#1)(1992-11#1)(1993-12#1)(1994-2#1)(1994-3#2)(1995-3#1)(1996-5#1)(1997-8#2)(2005-11#2)(2005-12#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#17)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-7#2)(2010-1#2)(2010-12#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-12#2)(2013-1#2)(2013-8#2)
was convened in##3##3##(1996-3#1)(2008-3#1)(2009-4#1)
was convened to discuss##2##4##(2007-4#1)(2008-3#1)
was convened to##4##3##(2007-2#1)(2007-4#1)(2008-3#1)(2008-6#1)
was convened##7##2##(1996-3#1)(2007-2#1)(2007-4#1)(2008-3#2)(2008-6#1)(2009-4#1)
was convenient##3##2##(2006-8#1)(2008-10#2)
was converted by##4##3##(1991-5#1)(1992-7#1)(1995-8#1)(2007-8#1)
was converted in##4##3##(1993-9#1)(1996-5#1)(2007-11#1)(2007-8#1)
was converted into 1##2##4##(1992-2#1)(2007-11#1)
was converted into a##2##4##(1991-2#1)(2006-9#1)
was converted into an##2##4##(1994-9#1)(2007-6#1)
was converted into the corresponding phenylhydrazone which was determined using reversed-phase high-performance liquid chromatography##2##14##(1992-6#1)(1993-9#1)
was converted into the##4##4##(1990-12#1)(1992-6#1)(1993-9#1)(2012-3#1)
was converted into##15##3##(1990-12#1)(1990-5#1)(1991-2#1)(1992-2#1)(1992-6#1)(1993-9#1)(1994-8#1)(1994-9#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-6#1)(2010-1#1)(2011-1#1)(2012-3#1)
was converted to a##4##4##(1993-8#1)(2005-11#1)(2008-10#2)
was converted to its##2##4##(1991-4#1)(2008-10#1)
was converted to the##4##4##(1990-8#1)(1993-4#2)(2007-11#1)
was converted to##43##3##(1990-8#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-7#1)(1991-8#1)(1992-3#3)(1992-9#1)(1993-11#1)(1993-4#2)(1993-8#2)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-3#1)(1996-5#1)(2005-11#3)(2005-12#1)(2007-1#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-6#2)(2009-9#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-8#1)
was converted##71##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#3)(1991-7#1)(1991-8#1)(1992-2#1)(1992-3#3)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-4#2)(1993-8#2)(1993-9#3)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-8#1)(1996-3#1)(1996-5#2)(2005-11#3)(2005-12#1)(2006-9#1)(2007-1#2)(2007-11#3)(2007-6#1)(2007-8#2)(2008-10#7)(2008-11#1)(2008-6#4)(2009-9#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
was cooled##2##2##(1994-11#1)(1995-10#1)
was coordinated to##2##3##(2008-5#1)(2013-1#1)
was coordinated##4##2##(2008-11#1)(2008-5#1)(2008-9#1)(2013-1#1)
was copolymerized with##5##3##(2007-8#1)(2008-5#1)(2009-10#3)
was copurified with##2##3##(1992-12#1)(1997-6#1)
was correct##2##2##(2008-6#1)(2008-8#1)
was corrected by using##2##4##(2005-4#1)(2008-7#1)
was corrected by##6##3##(2005-4#1)(2007-12#1)(2008-10#1)(2008-7#1)(2013-1#2)
was corrected for##2##3##(2008-10#2)
was corrected##17##2##(1993-12#2)(2005-4#1)(2006-6#1)(2007-12#2)(2007-7#1)(2008-10#3)(2008-7#1)(2009-3#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
was correctly##8##2##(1990-9#1)(1991-10#1)(1992-6#1)(1992-8#1)(1994-12#1)(2008-11#1)(2008-4#1)(2012-1#1)
was correlated closely with##2##4##(2008-10#2)
was correlated to a##3##4##(2007-5#1)(2008-9#1)(2011-2#1)
was correlated to the##5##4##(1992-12#1)(1995-8#1)(2008-7#1)(2009-10#1)(2009-9#1)
was correlated to##14##3##(1991-12#1)(1992-12#1)(1994-5#1)(1995-8#1)(2006-10#1)(2007-5#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-9#1)(2011-2#1)
was correlated with a##5##4##(1990-3#1)(1992-2#1)(1994-8#1)(1996-5#1)(2006-11#1)
was correlated with an increased##3##5##(1991-6#1)(2008-10#1)(2008-7#1)
was correlated with high##2##4##(1994-2#1)(2010-4#1)
was correlated with reduced##2##4##(2008-10#1)(2010-10#1)
was correlated with the presence of##2##6##(1996-6#1)(2008-10#1)
was correlated with the ratio##2##5##(1993-12#1)(2008-10#1)
was correlated with the severity of##3##6##(1997-8#1)(2008-10#1)(2008-7#1)
was correlated with the##36##4##(1992-1#1)(1993-12#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-4#2)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
was correlated with their##2##4##(1997-6#1)(2009-5#1)
was correlated with##92##3##(1990-3#1)(1990-4#1)(1991-6#1)(1992-1#1)(1992-2#1)(1993-12#1)(1993-7#1)(1994-10#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#3)(1996-6#1)(1997-2#1)(1997-4#3)(1997-6#1)(1997-8#2)(2004-10#1)(2006-11#1)(2006-9#1)(2007-12#1)(2007-8#3)(2008-10#22)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-3#2)(2009-5#1)(2009-7#1)(2010-10#1)(2010-4#4)(2012-1#1)(2012-12#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#2)
was correlated##119##2##(1990-3#1)(1990-4#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-7#1)(1994-10#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#3)(1996-6#1)(1997-2#1)(1997-4#3)(1997-6#1)(1997-8#2)(2004-10#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#3)(2008-10#31)(2008-11#3)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-3#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-4#4)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#2)
was corroborated by in vitro##3##5##(1993-9#1)(1995-2#1)(2007-12#1)
was corroborated by##11##3##(1993-9#1)(1995-12#1)(1995-2#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-6#1)(2008-8#1)(2012-2#1)
was corroborated##15##2##(1993-9#1)(1995-12#1)(1995-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-6#1)(2008-8#1)(2012-2#1)
was counted##11##2##(1990-10#1)(1992-6#1)(1994-5#1)(2008-10#3)(2008-12#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-12#1)
was counteracted by##2##3##(1990-2#1)(1991-3#1)
was coupled to a##3##4##(1991-5#1)(2008-10#1)(2008-11#1)
was coupled to the##7##4##(1990-12#1)(1992-12#1)(1995-10#1)(1996-11#1)(1996-8#1)(2008-10#1)(2013-8#1)
was coupled to##19##3##(1990-12#2)(1990-5#2)(1991-5#1)(1992-12#1)(1995-10#1)(1996-11#1)(1996-8#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2009-12#1)(2012-1#1)(2013-8#1)
was coupled with a##6##4##(1990-5#1)(1994-1#1)(1996-12#1)(2006-11#1)(2008-5#1)(2009-5#1)
was coupled with the##3##4##(1990-11#1)(1990-4#1)(1995-11#1)
was coupled with##15##3##(1990-11#1)(1990-4#1)(1990-5#1)(1994-1#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-12#1)(1997-8#1)(2006-11#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-4#1)
was coupled##36##2##(1990-11#1)(1990-12#2)(1990-4#1)(1990-5#3)(1991-5#1)(1992-12#1)(1993-12#1)(1994-1#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-8#1)(2006-11#1)(2007-11#2)(2007-8#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-4#1)(2012-1#1)(2013-8#1)
was covalently attached to the##3##5##(1992-6#1)(1995-5#1)(2008-10#1)
was covalently attached to##5##4##(1991-9#1)(1992-6#1)(1993-8#1)(1995-5#1)(2008-10#1)
was covalently attached##6##3##(1990-12#1)(1991-9#1)(1992-6#1)(1993-8#1)(1995-5#1)(2008-10#1)
was covalently bonded to##2##4##(1990-9#1)(2008-10#1)
was covalently bound to##4##4##(1990-8#2)(2008-10#1)(2009-5#1)
was covalently bound##7##3##(1990-8#2)(1994-5#1)(2008-10#3)(2009-5#1)
was covalently coupled##2##3##(1996-1#1)(2004-9#1)
was covalently immobilized on##2##4##(1997-2#1)(2008-10#1)
was covalently immobilized onto a##2##5##(2008-10#2)
was covalently immobilized##5##3##(1997-2#1)(2008-10#4)
was covalently linked to the##2##5##(1991-7#1)(2008-10#1)
was covalently linked to##4##4##(1991-7#2)(2008-10#2)
was covalently##32##2##(1990-12#1)(1990-8#3)(1990-9#1)(1991-7#2)(1991-9#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-5#1)(1995-5#1)(1996-1#1)(1996-7#1)(1997-2#1)(2004-9#1)(2008-10#13)(2009-5#1)
was covered by a##4##4##(2006-10#1)(2006-12#1)(2007-8#1)(2008-5#1)
was covered by##5##3##(1996-4#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-5#1)
was covered with##5##3##(2004-9#1)(2007-11#1)(2008-10#1)(2013-1#1)(2013-8#1)
was covered##11##2##(1996-4#1)(2004-9#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2013-1#1)(2013-8#1)
was created and##3##3##(1991-12#1)(1996-1#1)(2005-8#1)
was created at the##2##4##(1990-3#1)(1996-2#1)
was created by the##3##4##(2007-10#1)(2008-7#1)(2010-7#1)
was created by##9##3##(1997-2#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-7#1)(2010-7#1)(2011-2#2)
was created in the##3##4##(2007-11#1)(2011-1#1)(2013-1#1)
was created in##11##3##(1996-1#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-9#1)(2010-5#1)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
was created through##2##3##(2008-9#1)(2010-2#1)
was created to##12##3##(1992-2#1)(2006-8#1)(2007-1#1)(2007-10#1)(2008-10#2)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
was created using##2##3##(2008-10#1)(2008-5#1)
was created##63##2##(1990-11#1)(1990-3#1)(1991-12#1)(1992-2#1)(1995-2#1)(1996-1#2)(1996-2#1)(1996-3#1)(1997-2#1)(2004-3#1)(2004-9#1)(2005-8#1)(2006-3#1)(2006-5#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#3)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-2#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-9#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#4)
was critical for the##2##4##(2008-11#1)(2010-7#1)
was critical for##5##3##(1997-4#1)(2008-10#1)(2008-11#1)(2010-7#1)(2012-3#1)
was critical to the##2##4##(2007-12#1)(2010-4#1)
was critical to##5##3##(1993-5#1)(1995-3#1)(2007-12#1)(2010-4#1)(2013-8#1)
was critical##12##2##(1993-5#1)(1995-3#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-4#1)(2010-7#1)(2012-3#1)(2013-8#1)
was critically dependent on##2##4##(1994-9#1)(2013-8#1)
was critically reviewed##2##3##(2007-10#1)(2012-3#1)
was critically##9##2##(1994-9#1)(2007-10#1)(2008-10#3)(2009-4#1)(2011-1#1)(2012-3#1)(2013-8#1)
was cross-linked##5##2##(1993-11#1)(1996-7#1)(2005-11#1)(2008-10#2)
was cross-reactive##2##2##(1991-2#1)(1992-3#1)
was cross-resistant to##2##3##(1991-3#1)(1991-7#1)
was crossed to##3##3##(2008-10#3)
was crossed with an##2##4##(2008-10#2)
was crossed with two##2##4##(2006-12#1)(2008-10#1)
was crossed with##10##3##(2004-11#1)(2006-12#1)(2008-10#6)(2008-5#1)(2009-10#1)
was crossed##15##2##(1992-5#1)(2004-11#1)(2006-12#1)(2008-10#10)(2008-5#1)(2009-10#1)
was crosslinked with##2##3##(2008-10#2)
was crosslinked##4##2##(1993-3#1)(2008-10#2)(2008-5#1)
was crucial for the##2##4##(2006-2#1)(2013-7#1)
was crucial for##4##3##(2006-2#1)(2008-10#1)(2008-3#1)(2013-7#1)
was crucial in##2##3##(2013-1#2)
was crucial##8##2##(2006-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-3#1)(2013-1#2)(2013-7#1)
was crystallized and##2##3##(1991-3#1)(1991-8#1)
was crystallized in a##2##4##(2008-9#1)(2010-10#1)
was crystallized in##3##3##(2008-9#2)(2010-10#1)
was crystallized##5##2##(1991-3#1)(1991-8#1)(2008-9#2)(2010-10#1)
was cultivated in a##4##4##(1991-10#1)(2008-11#1)(2008-6#1)(2008-7#1)
was cultivated in##9##3##(1991-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#1)
was cultivated on a##2##4##(2006-12#1)(2008-6#1)
was cultivated on the##2##4##(2008-6#2)
was cultivated on##4##3##(2006-12#1)(2008-6#3)
was cultivated##16##2##(1991-10#1)(1992-11#1)(2006-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#3)(2008-6#4)(2008-7#1)(2013-7#1)
was cultured and##2##3##(2007-7#1)(2012-3#1)
was cultured at##2##3##(2010-2#1)(2013-7#1)
was cultured from##3##3##(1991-5#1)(2008-1#1)(2011-2#1)
was cultured in##4##3##(2006-8#1)(2007-7#1)(2008-11#1)(2013-7#1)
was cultured on##2##3##(2007-7#1)(2008-5#1)
was cultured##18##2##(1991-5#1)(1994-7#1)(2005-6#1)(2006-8#1)(2007-5#1)(2007-7#3)(2008-1#1)(2008-11#1)(2008-5#3)(2010-2#1)(2011-2#1)(2012-3#1)(2013-7#2)
was curative##3##2##(2007-2#2)(2013-1#1)
was cured by##3##3##(1990-9#1)(1996-9#1)(2007-7#1)
was cured##6##2##(1990-9#1)(1991-4#1)(1996-9#1)(2007-7#1)(2007-8#1)(2007-9#1)
was cut in##2##3##(1991-6#1)(2008-10#1)
was cut into##2##3##(2004-9#1)(2008-5#1)
was cut off##2##3##(2004-9#1)(2008-5#1)
was cut##13##2##(1991-6#1)(1992-11#1)(2004-9#2)(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-9#1)(2011-3#1)(2012-1#1)
was cyclized to##2##3##(1996-5#1)(2007-10#1)
was cyclized##3##2##(1992-9#1)(1996-5#1)(2007-10#1)
was cytotoxic##6##2##(1993-8#1)(1996-8#1)(1997-2#1)(2008-11#1)(2008-8#1)(2011-2#1)
was damaged##3##2##(2007-7#1)(2007-8#1)(2010-8#1)
was day 21##2##3##(1996-5#2)
was day##4##2##(1996-5#4)
was decided that the##2##4##(2007-12#1)(2008-11#1)
was decided that##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2011-4#1)
was decided to perform##2##4##(2012-2#1)(2013-7#1)
was decided to##14##3##(1990-2#1)(1994-2#1)(1996-5#1)(2006-10#3)(2006-2#1)(2007-11#1)(2007-7#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#1)
was decided##23##2##(1990-2#1)(1991-6#1)(1994-2#1)(1995-11#1)(1996-5#1)(2006-10#3)(2006-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-12#1)(2011-2#1)(2011-4#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
was decisive for##2##3##(2008-10#1)(2012-3#1)
was declared##3##2##(1991-1#1)(2008-1#1)(2008-10#1)
was declined##2##2##(2008-10#1)(2013-8#1)
was decomposed##2##2##(2008-10#2)
was decompressed##2##2##(2006-12#1)(2008-5#1)
was decreased (p##2##3##(1991-10#1)(2013-8#1)
was decreased after##5##3##(1992-12#1)(1994-5#1)(1996-12#1)(2008-10#1)(2010-7#1)
was decreased and the##4##4##(1991-7#1)(1993-2#1)(2008-10#1)(2013-8#1)
was decreased and##9##3##(1991-7#1)(1993-2#1)(1994-6#1)(2005-4#1)(2008-10#1)(2008-8#1)(2009-4#1)(2012-2#1)(2013-8#1)
was decreased at the##2##4##(1996-5#1)(1996-7#1)
was decreased at##7##3##(1994-11#1)(1994-5#1)(1995-5#1)(1996-5#1)(1996-7#1)(1996-8#1)(2005-11#1)
was decreased by 40%##2##4##(1995-3#1)(2008-10#1)
was decreased by a##2##4##(1996-8#1)(2008-10#1)
was decreased by castration in epididymal##2##6##(1994-12#2)
was decreased by the##4##4##(1994-6#1)(1996-12#1)(2005-11#1)(2008-10#1)
was decreased by##41##3##(1990-7#2)(1991-3#1)(1991-4#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-1#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-7#1)(1996-12#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(2005-11#1)(2006-3#1)(2006-8#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2010-5#1)(2011-1#2)(2011-3#1)(2012-3#2)
was decreased compared with##2##4##(1995-5#1)(2009-6#1)
was decreased compared##3##3##(1994-2#1)(1995-5#1)(2009-6#1)
was decreased for the##2##4##(1995-5#1)(2010-5#1)
was decreased for##3##3##(1991-9#1)(1995-5#1)(2010-5#1)
was decreased from##5##3##(1995-5#1)(1996-2#2)(2008-11#1)(2009-5#1)
was decreased in a##2##4##(1992-7#1)(2008-5#1)
was decreased in all##3##4##(2006-12#1)(2006-8#1)(2009-12#1)
was decreased in amplitude by MCh##2##6##(1997-5#2)
was decreased in comparison##2##4##(1993-3#1)(2008-8#1)
was decreased in involutive phase##2##5##(2013-1#2)
was decreased in the absence of##2##6##(1991-9#1)(1994-9#1)
was decreased in the presence of##3##6##(1990-7#1)(2008-10#2)
was decreased in the##11##4##(1990-7#1)(1991-9#1)(1994-5#1)(1994-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(2007-8#1)(2008-10#2)(2008-9#1)
was decreased in##38##3##(1990-7#2)(1991-12#1)(1991-9#3)(1992-7#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-5#2)(2005-8#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-8#2)(2008-10#4)(2008-5#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#1)(2012-12#1)(2013-1#2)
was decreased significantly in##4##4##(1992-8#1)(1993-8#1)(2012-2#2)
was decreased significantly##6##3##(1992-8#1)(1993-8#1)(2005-11#1)(2012-2#3)
was decreased to only##2##4##(1996-7#1)(2008-10#1)
was decreased to##13##3##(1990-5#1)(1990-8#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-10#1)(1996-7#1)(2007-4#1)(2008-10#1)(2008-8#1)(2010-4#1)(2011-12#1)(2013-8#1)
was decreased while the##3##4##(1990-12#1)(2008-9#1)(2011-2#1)
was decreased with aging##2##4##(1992-1#1)(1995-9#1)
was decreased with##4##3##(1992-1#1)(1995-9#1)(1997-7#1)(2010-6#1)
was decreased##179##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#4)(1990-8#1)(1991-10#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-7#1)(1991-9#4)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-7#2)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#3)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#4)(1994-6#3)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#2)(1995-5#4)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#3)(1996-12#4)(1996-2#3)(1996-4#1)(1996-5#3)(1996-7#3)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-7#1)(2005-11#5)(2005-12#1)(2005-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-8#3)(2008-10#14)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#5)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#4)
was decreasing##4##2##(1993-12#1)(1996-5#1)(2007-11#1)(2008-10#1)
was dedicated to the##3##4##(2005-8#2)(2008-8#1)
was dedicated to##6##3##(2005-7#2)(2005-8#2)(2008-5#1)(2008-8#1)
was dedicated##8##2##(2004-10#1)(2005-7#2)(2005-8#2)(2008-5#1)(2008-8#1)(2011-2#1)
was deduced by##2##3##(1991-9#1)(1994-8#1)
was deduced from the nucleotide sequence##3##6##(1992-1#1)(1992-7#1)(1997-4#1)
was deduced from the sequence of nucleotides in a recombinant cDNA##5##11##(1992-5#1)(1992-8#1)(1993-4#3)
was deduced from the sequence of nucleotides in two recombinant cDNAs##2##11##(1994-5#2)
was deduced from the sequence of nucleotides in##7##8##(1992-5#1)(1992-8#1)(1993-4#3)(1994-5#2)
was deduced from the sequence of##8##6##(1992-5#1)(1992-8#1)(1993-11#1)(1993-4#3)(1994-5#2)
was deduced from the##19##4##(1992-1#2)(1992-5#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-4#3)(1994-5#2)(1995-5#1)(1997-4#1)(2006-11#1)(2007-12#2)(2008-10#1)(2008-5#1)(2012-2#1)
was deduced from##23##3##(1990-12#1)(1991-7#1)(1992-1#2)(1992-5#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-4#3)(1994-5#2)(1995-5#1)(1997-4#1)(2005-7#1)(2006-11#1)(2007-12#2)(2008-10#1)(2008-5#1)(2010-5#1)(2012-2#1)
was deduced to be##6##4##(1990-4#1)(1990-7#1)(1994-8#1)(2008-10#1)(2008-8#1)(2009-2#1)
was deduced to##7##3##(1990-4#1)(1990-7#1)(1994-5#1)(1994-8#1)(2008-10#1)(2008-8#1)(2009-2#1)
was deduced##37##2##(1990-12#1)(1990-4#1)(1990-7#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-5#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-4#3)(1993-9#1)(1994-5#3)(1994-8#2)(1995-2#1)(1995-5#1)(1997-4#1)(2005-4#1)(2005-7#1)(2006-11#1)(2007-12#3)(2008-10#3)(2008-5#1)(2008-8#1)(2009-2#1)(2010-5#1)(2012-2#1)
was deducted##2##2##(1990-3#1)(1992-12#1)
was deemed to be##3##4##(2007-2#1)(2008-12#1)(2009-2#1)
was deemed to##4##3##(2007-2#1)(2008-12#1)(2008-3#1)(2009-2#1)
was deemed##12##2##(1995-11#1)(2007-2#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-12#2)(2008-3#1)(2009-2#1)(2011-1#2)(2012-3#1)
was deficient##2##2##(1991-9#1)(2007-3#1)
was defined according to##2##4##(2007-8#1)(2010-12#1)
was defined as &lt##2##4##(2007-10#1)(2007-8#1)
was defined as a##18##4##(1995-8#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-10#3)(2007-7#1)(2007-8#1)(2008-5#1)(2008-6#2)(2008-8#1)(2011-2#3)(2013-1#2)
was defined as an##6##4##(2004-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2013-1#1)(2013-8#1)
was defined as any##5##4##(1993-6#1)(2004-10#1)(2006-12#1)(2008-3#1)(2011-1#1)
was defined as the difference between the##2##7##(2009-11#1)(2011-2#1)
was defined as the presence of##2##6##(2006-10#1)(2008-4#1)
was defined as the ratio of##2##6##(2008-10#1)(2011-2#1)
was defined as the##21##4##(1992-6#1)(1993-12#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2011-2#3)(2012-2#2)(2012-3#1)
was defined as##81##3##(1990-4#1)(1992-6#1)(1993-11#2)(1993-12#1)(1993-6#2)(1995-10#1)(1995-8#1)(2004-10#1)(2004-2#1)(2005-10#1)(2005-11#1)(2006-10#4)(2006-12#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#6)(2007-11#2)(2007-12#1)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#1)(2011-1#2)(2011-12#1)(2011-2#9)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
was defined based on the##2##5##(2008-3#2)
was defined by a##2##4##(1993-2#2)
was defined by the##4##4##(1991-8#1)(1994-3#1)(1995-9#1)(2008-3#1)
was defined by##13##3##(1991-8#1)(1993-11#1)(1993-2#2)(1994-3#1)(1995-9#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-4#1)(2010-6#1)(2011-1#1)(2012-3#1)
was defined in terms of##2##5##(2008-10#1)(2008-2#1)
was defined in##3##3##(1997-2#1)(2008-10#1)(2008-2#1)
was defined to be##4##4##(1990-11#2)(2004-11#1)(2010-4#1)
was defined using##6##3##(2007-1#1)(2008-1#2)(2008-6#1)(2010-11#1)(2013-1#1)
was defined##122##2##(1990-11#2)(1990-4#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-11#3)(1993-12#1)(1993-2#2)(1993-6#2)(1994-3#1)(1995-10#1)(1995-8#1)(1995-9#1)(1997-2#1)(1997-5#1)(2004-10#1)(2004-11#1)(2004-2#1)(2005-10#1)(2005-11#1)(2006-10#4)(2006-12#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#6)(2007-11#2)(2007-12#1)(2007-7#5)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#2)(2008-6#4)(2008-7#2)(2008-8#4)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#10)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
was degraded in the##2##4##(2008-10#1)(2012-12#1)
was degraded in##4##3##(2008-10#1)(2008-11#1)(2011-12#1)(2012-12#1)
was degraded to##3##3##(1992-11#1)(1992-9#1)(1997-3#1)
was degraded##14##2##(1992-11#1)(1992-9#1)(1995-2#1)(1996-9#1)(1997-3#1)(2005-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-12#1)(2012-12#1)
was delayed and##2##3##(2008-5#1)(2012-3#1)
was delayed by##5##3##(1993-7#1)(1997-8#1)(2008-4#1)(2009-2#1)(2009-4#1)
was delayed due to##2##4##(1991-12#1)(2006-4#1)
was delayed for##5##3##(1992-12#1)(2006-5#1)(2008-10#2)(2010-11#1)
was delayed in##10##3##(1991-9#1)(1995-1#1)(1995-6#1)(2006-10#1)(2007-9#1)(2008-10#2)(2008-7#1)(2009-9#1)(2010-6#1)
was delayed to##2##3##(1995-1#1)(1996-5#1)
was delayed until##4##3##(1990-8#1)(2008-10#1)(2008-7#1)(2012-2#1)
was delayed##55##2##(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-4#1)(1993-6#1)(1993-7#2)(1995-1#2)(1995-6#1)(1996-1#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-8#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-5#1)(2007-9#1)(2008-10#9)(2008-4#1)(2008-5#1)(2008-7#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
was deleted and replaced by a##2##6##(1990-10#1)(2009-8#1)
was deleted and##3##3##(1990-10#1)(1990-4#1)(2009-8#1)
was deleted in the##3##4##(1991-2#1)(1996-4#1)(1996-7#1)
was deleted in##4##3##(1991-2#1)(1996-4#1)(1996-7#1)(1997-3#1)
was deleted##16##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1991-2#1)(1993-11#1)(1996-10#1)(1996-4#1)(1996-7#1)(1997-3#1)(1997-7#1)(2005-11#1)(2008-12#1)(2008-9#1)(2009-8#1)(2013-8#1)
was delimited##3##2##(1993-9#1)(2006-12#1)(2008-10#1)
was delineated in##2##3##(2009-8#1)(2011-2#1)
was delivered at##2##3##(2008-7#1)(2012-12#1)
was delivered by a##3##4##(1991-2#1)(2007-1#1)(2008-10#1)
was delivered by##6##3##(1991-2#1)(1997-8#1)(2007-1#1)(2008-10#1)(2008-4#1)(2012-2#1)
was delivered day 1##2##4##(2006-6#2)
was delivered every##2##3##(2006-6#1)(2010-12#1)
was delivered in##4##3##(1991-8#1)(2007-8#1)(2008-8#1)(2012-2#1)
was delivered into the##2##4##(2008-5#1)(2012-12#1)
was delivered through##2##3##(2011-2#1)(2012-2#1)
was delivered to the##4##4##(1994-12#1)(2007-11#1)(2008-6#1)(2011-2#1)
was delivered to##8##3##(1994-12#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-11#2)(2008-6#1)(2011-2#1)
was delivered via##2##3##(2012-3#1)(2013-1#1)
was delivered##48##2##(1990-12#3)(1991-2#1)(1991-8#2)(1992-10#1)(1992-8#1)(1993-7#1)(1994-12#1)(1996-12#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-6#3)(2007-1#1)(2007-11#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-12#1)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#2)
was demonstrable in##2##3##(1996-5#1)(2008-5#1)
was demonstrable##5##2##(1991-7#1)(1994-9#1)(1996-5#1)(1997-4#1)(2008-5#1)
was demonstrated after##4##3##(1991-3#1)(1995-12#1)(1997-5#1)(2012-3#1)
was demonstrated and the##2##4##(2008-10#1)(2012-11#1)
was demonstrated and##8##3##(1990-12#1)(1992-12#1)(2005-11#1)(2006-6#1)(2008-10#2)(2008-5#1)(2012-11#1)
was demonstrated as a typical##2##5##(2007-8#1)(2008-10#1)
was demonstrated as a##3##4##(2007-8#1)(2008-10#2)
was demonstrated at the##2##4##(1996-12#1)(2012-3#1)
was demonstrated at##7##3##(1993-11#1)(1996-12#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-2#1)(2012-3#1)
was demonstrated between relapsed and nonrelapsed##2##6##(1996-2#1)(1996-7#1)
was demonstrated between##7##3##(1994-9#1)(1995-6#1)(1996-2#1)(1996-7#1)(2007-11#1)(2007-8#1)(2009-8#1)
was demonstrated by Western blot##2##5##(1996-12#1)(1997-7#1)
was demonstrated by a##4##4##(1994-8#1)(1994-9#1)(1996-6#1)(2008-10#1)
was demonstrated by analyzing##7##4##(2007-8#1)(2008-10#6)
was demonstrated by detecting##3##4##(2008-11#2)(2013-1#1)
was demonstrated by determining##2##4##(1992-10#1)(2008-10#1)
was demonstrated by in##2##4##(1993-12#1)(1996-6#1)
was demonstrated by means of##3##5##(2007-10#1)(2008-3#1)(2008-5#1)
was demonstrated by monitoring##2##4##(2008-10#2)
was demonstrated by the ability of##3##6##(1995-3#2)(1997-7#1)
was demonstrated by the analysis of##3##6##(1992-2#1)(2006-10#1)(2008-10#1)
was demonstrated by the##21##4##(1990-11#1)(1990-9#1)(1991-10#1)(1992-11#1)(1992-2#1)(1992-7#1)(1995-3#2)(1996-2#1)(1997-7#1)(1997-8#1)(2004-11#1)(2006-10#1)(2007-9#1)(2008-10#5)(2012-2#1)(2013-7#1)
was demonstrated by their##3##4##(1990-7#1)(1994-6#1)(1995-5#1)
was demonstrated by transfection of##2##5##(1990-5#1)(1993-5#1)
was demonstrated by use of##4##5##(2007-12#1)(2008-3#3)
was demonstrated by using##2##4##(1990-12#1)(2005-12#1)
was demonstrated by##103##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-10#1)(1991-3#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-5#1)(1993-9#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-3#2)(1995-5#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-10#2)(2004-11#1)(2004-9#1)(2005-12#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#23)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#1)(2010-9#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
was demonstrated for the##7##4##(1990-7#1)(1992-11#1)(2005-11#1)(2008-10#4)
was demonstrated for##18##3##(1990-7#1)(1992-11#1)(1992-2#1)(1997-5#1)(2005-11#1)(2006-12#1)(2007-12#2)(2008-10#6)(2008-2#1)(2008-5#1)(2011-2#1)(2013-7#1)
was demonstrated in 6 of##2##5##(1990-3#1)(1993-2#1)
was demonstrated in a field##2##5##(2008-10#2)
was demonstrated in a##13##4##(1992-8#1)(1994-9#1)(2007-12#3)(2008-10#4)(2008-2#2)(2009-6#1)(2010-9#1)
was demonstrated in different##2##4##(1994-3#1)(2011-2#1)
was demonstrated in the presence of a##2##7##(1991-5#1)(2008-1#1)
was demonstrated in the##14##4##(1991-5#1)(1993-11#1)(1994-2#1)(1994-8#1)(1996-12#1)(1996-8#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-2#1)(2013-1#1)
was demonstrated in this study##2##5##(1997-2#1)(2008-9#1)
was demonstrated in this##3##4##(1997-2#1)(2008-10#1)(2008-9#1)
was demonstrated in##79##3##(1990-2#1)(1990-3#1)(1990-9#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#3)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-7#1)(2005-7#1)(2006-12#1)(2007-11#1)(2007-12#6)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#4)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
was demonstrated on a##2##4##(2008-2#2)
was demonstrated on the##3##4##(1996-3#1)(2008-10#2)
was demonstrated on##12##3##(1993-1#1)(1994-6#1)(1996-3#1)(2006-8#1)(2006-9#1)(2008-10#4)(2008-11#1)(2008-2#2)
was demonstrated that a##5##4##(1994-2#1)(1997-8#1)(2005-11#1)(2008-10#1)(2013-8#1)
was demonstrated that for##2##4##(2005-11#1)(2010-2#1)
was demonstrated that the##32##4##(1991-4#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-6#1)(1997-8#1)(2006-12#2)(2006-7#1)(2007-10#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-2#1)(2009-3#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
was demonstrated that##71##3##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1991-4#1)(1992-1#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1997-8#2)(2004-4#2)(2005-11#2)(2006-12#2)(2006-2#1)(2006-7#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
was demonstrated the##2##3##(2008-10#2)
was demonstrated through##2##3##(2011-1#1)(2012-2#1)
was demonstrated to be able to##2##6##(1991-8#1)(2012-1#1)
was demonstrated to be##19##4##(1991-8#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-5#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2008-10#2)(2008-5#1)(2009-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#2)
was demonstrated to have##2##4##(1993-9#1)(2007-11#1)
was demonstrated to##29##3##(1991-8#1)(1992-4#1)(1992-8#1)(1993-9#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-5#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#2)(2007-8#1)(2008-10#4)(2008-5#1)(2008-6#1)(2009-5#1)(2009-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#2)
was demonstrated using a##4##4##(1994-5#1)(2010-11#1)(2010-5#1)(2012-1#1)
was demonstrated using##13##3##(1994-5#1)(1994-9#2)(1996-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-1#1)
was demonstrated when##2##3##(2008-10#1)(2008-4#1)
was demonstrated with a##4##4##(2007-11#1)(2008-2#1)(2008-3#1)(2010-7#1)
was demonstrated with an##2##4##(1995-2#1)(1997-4#1)
was demonstrated with the##3##4##(1990-8#1)(2008-10#1)(2008-2#1)
was demonstrated with##18##3##(1990-8#1)(1995-2#1)(1997-4#1)(2006-7#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#3)(2010-2#1)(2010-7#2)(2011-2#1)
was demonstrated##486##2##(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#4)(1990-7#2)(1990-8#1)(1990-9#3)(1991-10#2)(1991-12#1)(1991-3#2)(1991-4#2)(1991-5#3)(1991-7#2)(1991-8#4)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#2)(1992-2#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#3)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-5#1)(1993-8#1)(1993-9#3)(1994-11#2)(1994-12#2)(1994-2#4)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#7)(1994-9#8)(1995-11#2)(1995-12#1)(1995-2#5)(1995-3#2)(1995-5#2)(1995-6#3)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#4)(1996-2#5)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#4)(1997-8#5)(2004-10#3)(2004-11#1)(2004-4#2)(2004-9#1)(2005-11#4)(2005-12#1)(2005-7#1)(2006-10#3)(2006-12#8)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#5)(2006-8#5)(2006-9#2)(2007-10#3)(2007-11#9)(2007-12#21)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#8)(2007-9#2)(2008-1#3)(2008-10#89)(2008-11#12)(2008-2#14)(2008-3#14)(2008-4#2)(2008-5#10)(2008-6#4)(2008-7#5)(2008-8#7)(2008-9#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#4)(2010-11#2)(2010-12#5)(2010-2#3)(2010-4#3)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#3)(2011-2#6)(2012-1#5)(2012-11#3)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#7)(2013-7#2)(2013-8#3)
was denied##4##2##(1995-12#1)(1996-11#1)(1996-12#1)(2010-10#1)
was dense##2##2##(1997-3#1)(2004-2#1)
was density dependent##3##3##(1991-12#1)(2008-8#1)(2008-9#1)
was dependant upon##2##3##(2008-12#1)(2010-12#1)
was dependant##3##2##(1997-3#1)(2008-12#1)(2010-12#1)
was dependent on Ca2+##3##4##(1990-7#1)(1996-6#1)(1997-7#1)
was dependent on both the##3##5##(1990-11#1)(2008-5#1)(2010-5#1)
was dependent on both##4##4##(1990-11#1)(1996-12#1)(2008-5#1)(2010-5#1)
was dependent on its##2##4##(1994-8#1)(1996-11#1)
was dependent on pH##3##4##(1990-7#1)(1991-9#1)(2010-5#1)
was dependent on plant##3##4##(2006-12#1)(2008-10#1)(2008-8#1)
was dependent on protein synthesis##2##5##(1990-11#1)(1993-9#1)
was dependent on the concentration of##6##6##(1991-1#1)(1991-4#1)(1991-8#1)(1992-12#1)(2010-3#1)(2013-1#1)
was dependent on the concentrations of##2##6##(1991-1#1)(2012-1#1)
was dependent on the level of##2##6##(1992-5#1)(2011-12#1)
was dependent on the pH##2##5##(1990-11#1)(2008-10#1)
was dependent on the presence of##6##6##(1993-6#1)(1995-2#2)(1996-10#1)(2008-4#1)(2012-12#1)
was dependent on the##57##4##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-1#2)(1991-12#1)(1991-4#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#2)(1993-6#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#3)(1995-5#1)(1996-10#1)(1996-5#1)(1997-7#1)(2005-12#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#2)(2010-3#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
was dependent on##98##3##(1990-11#3)(1990-12#1)(1990-2#2)(1990-5#2)(1990-7#3)(1991-1#3)(1991-10#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-7#2)(2005-12#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#1)(2008-8#3)(2008-9#1)(2009-9#2)(2010-3#1)(2010-5#3)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
was dependent upon a functional##2##5##(1993-6#1)(1994-8#1)
was dependent upon a##3##4##(1993-6#1)(1994-8#1)(1996-5#1)
was dependent upon the presence of##2##6##(1992-9#1)(2008-6#1)
was dependent upon the##12##4##(1990-5#1)(1992-9#1)(1994-3#1)(1995-11#1)(1995-3#1)(1996-5#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-6#1)(2012-3#1)
was dependent upon##20##3##(1990-5#1)(1992-12#1)(1992-9#2)(1993-6#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-4#1)(1996-5#2)(1996-9#1)(2006-10#1)(2008-10#2)(2008-11#2)(2008-6#1)(2012-3#1)
was dependent##120##2##(1990-11#3)(1990-12#1)(1990-2#2)(1990-5#3)(1990-7#3)(1991-1#3)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-12#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#2)(1996-5#3)(1996-6#1)(1996-9#1)(1997-2#1)(1997-7#2)(2005-12#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-10#8)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#2)(2008-8#3)(2008-9#1)(2009-9#2)(2010-3#1)(2010-5#3)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
was dephosphorylated##3##2##(1990-3#1)(1992-11#1)(1994-12#1)
was depleted##3##2##(1994-5#1)(2008-10#1)(2008-6#1)
was deployed##7##2##(2006-11#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-8#1)(2011-3#1)
was deposited at##3##3##(1991-3#1)(2008-10#2)
was deposited by##2##3##(2007-11#2)
was deposited in the##2##4##(1994-12#2)
was deposited in##3##3##(1994-12#2)(1995-3#1)
was deposited on the##3##4##(2008-10#2)(2009-5#1)
was deposited on##5##3##(2008-10#2)(2009-11#2)(2009-5#1)
was deposited onto##3##3##(2005-11#1)(2007-12#1)(2008-10#1)
was deposited##22##2##(1991-3#1)(1994-12#2)(1995-3#2)(2005-11#1)(2007-11#2)(2007-12#1)(2008-10#8)(2008-2#1)(2008-7#1)(2009-11#2)(2009-5#1)
was depressed by##3##3##(1993-2#1)(1994-2#1)(2004-9#1)
was depressed##9##2##(1990-10#1)(1990-4#1)(1991-6#1)(1993-2#1)(1994-2#1)(1994-5#1)(2004-9#1)(2008-12#1)(2008-8#1)
was deproteinized with##3##3##(1993-2#1)(2008-10#2)
was deproteinized##4##2##(1990-11#1)(1993-2#1)(2008-10#2)
was derivatized to##2##3##(1996-5#1)(2012-11#1)
was derivatized with##7##3##(1990-9#1)(1993-9#1)(1994-11#1)(1997-2#1)(2008-10#3)
was derivatized##10##2##(1990-9#1)(1992-9#1)(1993-9#1)(1994-11#1)(1996-5#1)(1997-2#1)(2008-10#3)(2012-11#1)
was derived as##2##3##(2008-2#1)(2008-7#1)
was derived by##7##3##(1990-9#1)(1991-5#1)(1992-12#1)(2008-10#3)(2012-2#1)
was derived for##3##3##(1993-2#1)(2005-11#1)(2007-11#1)
was derived from a##4##4##(1991-2#1)(1991-6#1)(1995-3#1)(2006-12#1)
was derived from the##18##4##(1990-5#1)(1992-5#1)(1993-2#1)(1994-11#1)(1996-2#1)(1997-2#1)(2004-11#1)(2005-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2011-1#1)(2011-2#2)(2013-8#1)
was derived from##44##3##(1990-5#2)(1991-12#1)(1991-2#1)(1991-6#1)(1992-5#1)(1992-9#2)(1993-2#1)(1993-9#2)(1994-11#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-7#1)(1997-2#1)(2004-11#1)(2005-11#2)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#3)
was derived to##4##3##(2008-10#1)(2008-3#1)(2013-1#2)
was derived##78##2##(1990-5#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-5#1)(1992-9#2)(1993-11#1)(1993-2#2)(1993-3#1)(1993-9#2)(1994-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-2#1)(2004-11#1)(2005-11#3)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-3#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#4)
was described and##4##3##(2008-10#3)(2011-7#1)
was described as a##4##4##(1995-12#1)(1995-5#1)(2005-8#1)(2011-2#1)
was described as##19##3##(1990-10#1)(1995-12#1)(1995-5#1)(1996-3#1)(1996-8#1)(2005-8#2)(2006-1#1)(2006-12#2)(2006-8#1)(2008-10#1)(2008-7#1)(2009-8#1)(2009-9#1)(2011-2#1)(2013-1#3)
was described by a##4##4##(1990-7#1)(1992-3#1)(1995-5#1)(2008-10#1)
was described by the##2##4##(2008-10#2)
was described by##12##3##(1990-5#1)(1990-7#1)(1992-3#1)(1995-5#1)(2008-10#4)(2008-8#1)(2011-1#1)(2013-1#2)
was described for determination of##2##5##(2008-10#2)
was described for the determination of##2##6##(2008-10#2)
was described for the##5##4##(2008-10#3)(2009-6#1)(2010-4#1)
was described for##8##3##(1997-4#1)(2008-10#5)(2009-6#1)(2010-4#1)
was described in 1899 by##2##5##(2006-7#1)(2011-2#1)
was described in a##2##4##(2006-9#1)(2008-11#1)
was described in patients with##2##5##(2006-2#1)(2012-3#1)
was described in this paper##2##5##(2007-11#2)
was described in##25##3##(1991-9#1)(1992-7#1)(1997-5#1)(2005-11#1)(2006-2#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)
was described on the##3##4##(2008-12#3)
was described over##2##3##(2007-10#1)(2012-3#1)
was described recently##2##3##(2008-3#1)(2008-7#1)
was described to##3##3##(2004-12#1)(2008-10#1)(2010-12#1)
was described##113##2##(1990-10#1)(1990-5#1)(1990-7#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-7#1)(1995-12#1)(1995-5#2)(1996-3#1)(1996-8#1)(1997-4#1)(1997-5#1)(2004-12#1)(2005-11#1)(2005-4#2)(2005-7#1)(2005-8#3)(2006-1#1)(2006-12#2)(2006-2#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#35)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#3)(2009-1#1)(2009-12#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#3)(2011-7#1)(2012-12#2)(2012-3#2)(2013-1#5)
was designated as the##2##4##(2007-9#1)(2008-10#1)
was designated as##17##3##(1994-2#1)(1995-3#1)(1996-2#1)(2005-11#1)(2006-9#1)(2007-8#1)(2007-9#2)(2008-10#6)(2008-8#2)(2008-9#1)
was designated the##2##3##(1995-5#1)(2012-2#1)
was designated##31##2##(1990-7#1)(1992-11#1)(1994-12#1)(1994-2#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-7#1)(2005-11#2)(2006-9#1)(2007-8#1)(2007-9#2)(2008-10#12)(2008-8#2)(2008-9#1)(2012-2#1)(2013-7#1)
was designed and built##3##4##(2006-5#1)(2008-11#1)(2008-2#1)
was designed and constructed##4##4##(2007-11#1)(2008-10#1)(2008-12#1)(2010-4#1)
was designed and developed##2##4##(2008-10#1)(2009-12#1)
was designed and fabricated##3##4##(2007-12#1)(2008-2#1)(2010-2#1)
was designed and proposed##2##4##(2010-8#2)
was designed and synthesized##7##4##(1996-4#1)(1996-8#1)(2005-11#1)(2007-8#1)(2008-8#2)(2008-9#1)
was designed and tested##3##4##(2008-11#1)(2008-3#2)
was designed and##41##3##(1994-12#1)(1996-4#1)(1996-8#1)(2005-11#2)(2006-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-8#3)(2008-9#1)(2009-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#3)(2012-1#1)(2012-3#1)(2013-1#2)
was designed as a##13##4##(1996-1#1)(2004-1#1)(2006-12#1)(2007-1#1)(2008-3#1)(2008-5#1)(2009-3#1)(2010-3#1)(2010-4#1)(2011-2#2)(2013-1#2)
was designed as an##3##4##(1990-11#1)(1993-3#1)(2009-12#1)
was designed as##17##3##(1990-11#1)(1993-3#1)(1996-1#1)(2004-1#1)(2006-12#1)(2006-6#1)(2007-1#1)(2008-3#1)(2008-5#1)(2009-12#1)(2009-3#1)(2010-3#1)(2010-4#1)(2011-2#2)(2013-1#2)
was designed based on the##3##5##(1993-8#1)(2007-10#1)(2008-10#1)
was designed based on##5##4##(1993-8#1)(2007-10#1)(2007-12#1)(2008-10#1)(2012-1#1)
was designed by##3##3##(2008-10#1)(2010-10#1)(2012-3#1)
was designed for evaluating##2##4##(2011-2#1)(2012-12#1)
was designed for operation##2##4##(2007-12#2)
was designed for the##6##4##(2007-2#1)(2008-10#3)(2010-5#1)(2013-1#1)
was designed for##22##3##(1993-9#1)(1994-8#1)(1996-12#1)(2005-11#1)(2007-12#2)(2007-2#1)(2008-10#7)(2008-2#1)(2008-3#1)(2009-2#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
was designed in order to##5##5##(1996-12#1)(2005-11#1)(2007-1#1)(2008-10#1)(2011-1#1)
was designed in##9##3##(1994-2#1)(1996-12#1)(2005-11#1)(2005-9#1)(2007-1#1)(2008-10#1)(2010-10#1)(2010-8#1)(2011-1#1)
was designed so that the##2##5##(2007-8#1)(2008-5#1)
was designed that##3##3##(2008-3#3)
was designed to address##2##4##(2008-1#1)(2008-3#1)
was designed to allow the##2##5##(1997-6#1)(2012-1#1)
was designed to assess the##13##5##(1991-9#1)(1992-12#1)(1994-6#1)(2005-5#1)(2007-2#2)(2009-4#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-2#1)
was designed to assess##19##4##(1991-9#1)(1992-12#1)(1994-3#1)(1994-6#1)(1996-3#1)(2005-5#1)(2006-5#1)(2007-10#1)(2007-2#3)(2008-8#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-2#1)
was designed to be##7##4##(1993-6#1)(1996-2#1)(1997-4#1)(2007-9#1)(2008-10#2)(2008-2#1)
was designed to compare##17##4##(1991-12#1)(1993-4#1)(1994-12#1)(1996-3#2)(2007-1#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
was designed to define the##3##5##(1995-2#1)(2006-8#1)(2009-3#1)
was designed to describe the##2##5##(2009-4#1)(2010-5#1)
was designed to detect##3##4##(2007-6#1)(2008-10#2)
was designed to determine if##7##5##(1991-1#1)(1994-2#1)(1997-8#1)(2006-12#1)(2006-5#1)(2008-11#1)(2008-7#1)
was designed to determine the##14##5##(1990-5#1)(1993-9#1)(1997-3#1)(2006-10#1)(2006-7#1)(2006-8#2)(2007-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-4#1)(2011-2#1)(2012-3#1)
was designed to determine whether##7##5##(1992-11#1)(1992-3#1)(1992-9#1)(1996-1#1)(1996-7#1)(2009-4#1)(2012-3#1)
was designed to determine##29##4##(1990-5#1)(1991-1#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-9#1)(1994-2#1)(1996-1#1)(1996-7#1)(1997-3#1)(1997-8#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-4#1)(2011-2#1)(2012-3#2)
was designed to develop a##2##5##(2011-2#1)(2012-1#1)
was designed to develop##4##4##(2008-10#1)(2009-10#1)(2011-2#1)(2012-1#1)
was designed to estimate the##3##5##(2008-12#1)(2010-3#1)(2013-1#1)
was designed to evaluate a##3##5##(1996-1#1)(2006-8#1)(2010-3#1)
was designed to evaluate the##20##5##(1994-9#1)(1995-8#1)(2006-6#1)(2007-11#1)(2007-7#4)(2007-9#1)(2008-5#1)(2008-6#2)(2009-10#1)(2009-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#3)
was designed to evaluate##33##4##(1993-12#1)(1994-9#1)(1995-8#1)(1996-1#1)(2006-6#1)(2006-8#6)(2007-11#1)(2007-7#4)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#2)(2009-10#1)(2009-12#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#5)
was designed to examine the##11##5##(1992-2#1)(1992-8#1)(1993-12#1)(1994-11#1)(1996-5#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-2#1)
was designed to examine##15##4##(1992-2#1)(1992-8#1)(1993-12#2)(1993-4#1)(1994-11#1)(1996-5#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
was designed to facilitate the##2##5##(2008-2#1)(2008-4#1)
was designed to facilitate##3##4##(1992-6#1)(2008-2#1)(2008-4#1)
was designed to help##2##4##(2008-9#1)(2012-12#1)
was designed to highlight the##2##5##(1992-8#1)(1994-2#1)
was designed to identify##3##4##(1993-12#1)(1994-9#1)(2013-8#1)
was designed to increase##2##4##(2007-11#1)(2008-9#1)
was designed to investigate the influence of##4##7##(1993-11#1)(2007-2#1)(2011-2#2)
was designed to investigate the##28##5##(1993-11#2)(1993-12#1)(1993-3#1)(1995-3#1)(1997-6#1)(1997-8#1)(2004-10#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-8#2)(2007-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-5#2)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#5)(2012-12#1)
was designed to investigate##37##4##(1990-12#1)(1993-11#2)(1993-12#1)(1993-3#1)(1995-11#1)(1995-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-10#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-8#2)(2007-2#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-5#3)(2009-8#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-2#6)(2012-12#1)
was designed to measure##4##4##(1993-9#1)(1995-2#1)(2008-6#1)(2012-3#1)
was designed to reduce##2##4##(1992-8#1)(2008-2#1)
was designed to stimulate##2##4##(2007-11#1)(2010-1#1)
was designed to study the##4##5##(2008-11#1)(2010-4#1)(2011-1#2)
was designed to study##8##4##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#2)(2012-3#1)
was designed to target##2##4##(2008-10#1)(2010-5#1)
was designed to test the importance of##2##7##(1991-4#2)
was designed to test the##9##5##(1991-4#2)(1992-1#2)(1995-8#1)(1997-8#1)(2006-8#1)(2008-10#1)(2008-7#1)
was designed to##275##3##(1990-12#1)(1990-5#1)(1991-1#2)(1991-12#1)(1991-3#1)(1991-4#2)(1991-7#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#3)(1993-12#7)(1993-3#1)(1993-4#2)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-2#2)(1995-3#2)(1995-8#3)(1996-1#2)(1996-2#2)(1996-3#3)(1996-5#2)(1996-7#2)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#2)(1997-7#1)(1997-8#3)(2004-10#1)(2005-11#1)(2005-5#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#3)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#12)(2007-1#3)(2007-10#3)(2007-11#6)(2007-12#1)(2007-2#6)(2007-6#1)(2007-7#6)(2007-8#2)(2007-9#3)(2008-1#3)(2008-10#17)(2008-11#5)(2008-12#2)(2008-2#6)(2008-3#4)(2008-4#4)(2008-5#5)(2008-6#5)(2008-7#6)(2008-8#4)(2008-9#5)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#3)(2011-1#4)(2011-12#1)(2011-2#14)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#7)(2013-1#7)(2013-8#2)
was designed using the##2##4##(2006-11#1)(2008-10#1)
was designed using##4##3##(2006-11#1)(2008-10#1)(2008-2#1)(2009-2#1)
was designed which##2##3##(1990-2#1)(2008-10#1)
was designed with a##3##4##(1992-1#1)(1992-7#1)(2008-3#1)
was designed with the##4##4##(2008-10#1)(2008-3#2)(2013-1#1)
was designed with##13##3##(1992-1#1)(1992-7#1)(2006-11#1)(2008-10#5)(2008-3#3)(2012-2#1)(2013-1#1)
was designed##425##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-1#2)(1991-12#1)(1991-3#1)(1991-4#2)(1991-7#1)(1991-9#1)(1992-1#3)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#3)(1993-12#7)(1993-3#2)(1993-4#2)(1993-6#2)(1993-8#2)(1993-9#3)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#2)(1995-3#2)(1995-8#3)(1996-1#3)(1996-12#2)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#2)(1996-7#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#2)(1997-7#1)(1997-8#3)(2004-1#1)(2004-10#1)(2005-11#6)(2005-5#1)(2005-9#2)(2006-10#5)(2006-11#3)(2006-12#4)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#12)(2007-1#5)(2007-10#4)(2007-11#9)(2007-12#6)(2007-2#7)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#4)(2007-9#3)(2008-1#4)(2008-10#43)(2008-11#8)(2008-12#4)(2008-2#12)(2008-3#21)(2008-4#5)(2008-5#7)(2008-6#5)(2008-7#6)(2008-8#8)(2008-9#6)(2009-10#2)(2009-12#4)(2009-2#3)(2009-3#2)(2009-4#3)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#5)(2010-4#4)(2010-5#4)(2010-8#5)(2011-1#6)(2011-12#1)(2011-2#18)(2012-1#5)(2012-12#4)(2012-2#5)(2012-3#11)(2013-1#14)(2013-8#4)
was desorbed##3##2##(2008-10#3)
was destroyed by##3##3##(1991-8#1)(1992-8#1)(2008-10#1)
was destroyed##7##2##(1991-6#1)(1991-8#1)(1992-10#1)(1992-8#1)(2007-11#1)(2008-10#1)(2008-11#1)
was detached from the##2##4##(2008-5#1)(2011-2#1)
was detached##3##2##(2008-5#1)(2011-2#1)(2013-1#1)
was detailed##2##2##(1992-1#1)(2008-10#1)
was detectable after##2##3##(1990-2#1)(1992-8#1)
was detectable as##2##3##(1990-7#1)(1996-6#1)
was detectable at 0##2##4##(1991-12#1)(2008-10#1)
was detectable by##6##3##(1990-5#1)(1990-7#1)(1991-5#1)(1996-3#1)(2005-11#1)(2006-4#1)
was detectable in the##4##4##(1992-11#1)(2006-10#1)(2006-8#1)(2008-4#1)
was detectable in##15##3##(1990-6#1)(1991-9#1)(1992-11#2)(1994-5#2)(1994-8#1)(1996-5#1)(2006-10#1)(2006-8#2)(2008-10#2)(2008-4#1)(2008-7#1)
was detectable##44##2##(1990-2#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-11#2)(1992-8#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-6#1)(2006-8#2)(2007-11#2)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-8#1)
was detected 2##2##3##(2008-10#1)(2012-2#1)
was detected after exposure##2##4##(1995-3#1)(2008-10#1)
was detected after##10##3##(1990-5#1)(1990-7#1)(1992-11#1)(1993-9#1)(1995-3#1)(2007-8#1)(2008-10#2)(2010-11#1)(2013-8#1)
was detected among all##2##4##(2008-10#2)
was detected among the##2##4##(2008-12#1)(2011-2#1)
was detected among##9##3##(2007-7#2)(2008-10#4)(2008-12#1)(2010-8#1)(2011-2#1)
was detected and quantitated##2##4##(1991-2#1)(1996-2#1)
was detected and the##2##4##(1991-10#1)(2006-8#1)
was detected and##14##3##(1991-10#1)(1991-2#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(2006-12#1)(2006-8#1)(2007-8#1)(2008-10#3)(2009-3#1)(2012-12#1)
was detected as a##3##4##(1991-6#1)(2007-8#1)(2008-10#1)
was detected as early as##6##5##(1990-12#1)(1994-12#1)(1996-4#1)(1997-5#1)(1997-8#1)(2008-5#1)
was detected as the predominant##2##5##(1995-3#2)
was detected as##17##3##(1990-12#1)(1991-6#1)(1992-2#1)(1994-12#1)(1994-3#1)(1995-3#2)(1996-4#1)(1997-5#1)(1997-8#1)(2007-8#1)(2008-10#3)(2008-5#2)(2009-6#1)
was detected at a##3##4##(1991-8#1)(1994-3#1)(1994-5#1)
was detected at higher##2##4##(2005-10#1)(2008-10#1)
was detected at pH##2##4##(2004-8#1)(2008-5#1)
was detected at the##6##4##(1991-12#1)(1992-3#2)(1994-12#1)(2008-10#1)(2008-5#1)
was detected at##29##3##(1991-12#1)(1991-4#1)(1991-8#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-7#1)(1993-12#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(2004-8#1)(2005-10#1)(2007-5#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#2)(2009-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
was detected before##3##3##(1992-6#1)(2006-12#1)(2008-10#1)
was detected between the two##2##5##(1993-1#1)(2008-1#1)
was detected between the##6##4##(1993-1#1)(1996-9#1)(2008-1#1)(2008-10#1)(2010-12#1)(2010-2#1)
was detected between##15##3##(1991-9#1)(1993-1#1)(1994-6#1)(1996-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-8#1)(2010-12#2)(2010-2#1)(2012-12#1)
was detected by HPLC##2##4##(1996-6#1)(1996-7#1)
was detected by PCR##2##4##(2008-5#1)(2010-1#1)
was detected by RT-PCR##2##4##(1993-4#1)(2008-6#1)
was detected by Southern##2##4##(1992-9#1)(2008-10#1)
was detected by Western blot##2##5##(2008-8#1)(2008-9#1)
was detected by Western blotting##2##5##(1990-3#1)(2005-11#1)
was detected by Western##4##4##(1990-3#1)(2005-11#1)(2008-8#1)(2008-9#1)
was detected by a##10##4##(1990-2#1)(1992-2#1)(1993-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-7#1)(2010-5#1)(2011-2#1)
was detected by both##3##4##(1992-4#1)(2008-10#1)(2012-3#1)
was detected by direct##2##4##(2012-2#1)(2012-3#1)
was detected by immunoblotting##2##4##(1992-1#1)(1992-12#1)
was detected by immunofluorescence##3##4##(1996-4#1)(2008-5#2)
was detected by immunohistochemical##2##4##(1997-8#1)(2010-12#1)
was detected by in vitro##2##5##(1997-3#1)(2011-1#1)
was detected by in##3##4##(1995-12#1)(1997-3#1)(2011-1#1)
was detected by polymerase chain reaction (PCR) in##2##8##(2008-10#2)
was detected by polymerase chain reaction##4##6##(2008-10#2)(2008-4#1)(2011-2#1)
was detected by the##10##4##(1991-3#1)(1993-11#1)(1995-2#1)(2006-8#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#1)
was detected by ultraviolet##2##4##(1997-8#1)(2012-12#1)
was detected by using##4##4##(1991-3#1)(2008-9#2)(2011-1#1)
was detected by##113##3##(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-3#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#3)(1996-7#1)(1997-3#1)(1997-8#3)(2005-11#1)(2005-4#1)(2006-8#1)(2007-1#1)(2007-12#2)(2007-8#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#5)(2009-3#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#2)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#2)
was detected during##6##3##(1991-12#1)(1991-4#1)(1991-8#1)(2006-10#1)(2010-12#1)(2012-12#1)
was detected even in##2##4##(1996-2#1)(2008-10#1)
was detected even##3##3##(1996-2#1)(2008-10#1)(2010-3#1)
was detected except for##2##4##(1994-9#1)(2008-10#1)
was detected following##2##3##(1994-2#1)(1996-10#1)
was detected for the first time in##2##7##(1991-10#1)(2008-4#1)
was detected for the##6##4##(1991-10#1)(1995-5#1)(1996-11#1)(1996-7#1)(2005-10#1)(2008-4#1)
was detected for##15##3##(1991-10#1)(1995-5#2)(1996-11#1)(1996-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-8#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2012-3#1)
was detected from the saliva of all five species##2##9##(2011-12#2)
was detected from the##4##4##(2008-10#1)(2008-6#1)(2011-12#2)
was detected from##10##3##(1996-6#1)(1997-2#1)(1997-6#1)(2008-10#3)(2008-6#1)(2009-5#1)(2011-12#2)
was detected immunohistochemically in##2##4##(1991-3#1)(2007-8#1)
was detected immunohistochemically##3##3##(1991-3#1)(1997-3#1)(2007-8#1)
was detected in 11##3##4##(2006-8#1)(2007-7#1)(2013-8#1)
was detected in 12##2##4##(2011-12#1)(2011-2#1)
was detected in 15##2##4##(2008-12#1)(2013-8#1)
was detected in 18##2##4##(1996-6#1)(2008-12#1)
was detected in 2##3##4##(2007-2#1)(2007-8#1)(2011-12#1)
was detected in 20##2##4##(1997-3#1)(2011-2#1)
was detected in 21##3##4##(1993-10#1)(1996-2#1)(2013-1#1)
was detected in 28##3##4##(2008-10#1)(2012-12#1)(2012-2#1)
was detected in 32##2##4##(2008-12#1)(2011-2#1)
was detected in 38##2##4##(2011-2#1)(2012-12#1)
was detected in 5##3##4##(1992-11#1)(2008-4#1)(2011-1#1)
was detected in 64##2##4##(2011-1#2)
was detected in 7##4##4##(1991-5#1)(2008-3#2)(2012-3#1)
was detected in 8##2##4##(1993-5#1)(1995-4#1)
was detected in 89##2##4##(2007-10#1)(2007-2#1)
was detected in a##11##4##(1990-9#1)(1992-8#1)(1993-9#1)(1996-12#1)(1997-8#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-9#1)(2012-2#2)
was detected in about##2##4##(2008-11#1)(2010-5#1)
was detected in all patients##2##5##(1996-4#1)(2008-8#1)
was detected in all the##4##5##(1996-2#1)(1996-6#1)(2008-11#1)(2012-12#1)
was detected in all##15##4##(1990-2#1)(1991-2#1)(1992-9#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-4#1)(2004-11#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#1)
was detected in an##2##4##(1991-9#1)(1995-11#1)
was detected in any of the##2##6##(1992-11#1)(2010-10#1)
was detected in both##9##4##(1991-8#1)(1994-6#1)(1994-9#1)(1996-12#1)(2007-2#1)(2008-10#2)(2008-2#1)(2011-12#1)
was detected in control##2##4##(1994-5#1)(2006-4#1)
was detected in cultured##3##4##(1994-11#1)(1994-6#1)(1994-8#1)
was detected in either##2##4##(1996-8#1)(1997-1#1)
was detected in four##2##4##(1991-12#1)(2008-5#1)
was detected in human##6##4##(1990-10#1)(1992-12#1)(1993-6#1)(1994-11#1)(1996-12#1)(2012-1#1)
was detected in minicells##2##4##(1990-11#1)(1990-3#1)
was detected in normal##2##4##(1991-9#1)(1994-11#1)
was detected in one##5##4##(1993-8#1)(2006-10#1)(2007-10#1)(2008-10#1)(2012-12#1)
was detected in only##4##4##(1996-4#1)(2008-11#1)(2011-2#2)
was detected in other##2##4##(1994-6#1)(2008-10#1)
was detected in plants##2##4##(2008-10#2)
was detected in plasma##2##4##(2008-8#1)(2009-4#1)
was detected in some##3##4##(1996-4#1)(1997-7#1)(2008-7#1)
was detected in the absence of##2##6##(1991-4#1)(2009-1#1)
was detected in the blood##2##5##(1991-2#1)(1997-3#1)
was detected in the brain##5##5##(1991-2#1)(1996-10#1)(2007-9#1)(2009-2#1)(2009-7#1)
was detected in the culture##2##5##(1993-4#1)(1994-12#1)
was detected in the cytoplasmic##2##5##(1990-10#1)(2006-3#1)
was detected in the inoculated##2##5##(2008-10#1)(2008-8#1)
was detected in the left##2##5##(1993-2#1)(2007-5#1)
was detected in the liver##2##5##(1990-11#1)(2008-10#1)
was detected in the membrane##2##5##(1992-11#1)(2007-12#1)
was detected in the right##2##5##(2008-1#2)
was detected in the same##2##5##(2008-10#1)(2010-10#1)
was detected in the third##2##5##(1993-3#1)(2007-6#1)
was detected in the##118##4##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1991-10#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1992-11#2)(1992-5#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-4#2)(1993-6#1)(1994-12#3)(1994-8#1)(1995-11#6)(1995-12#3)(1995-3#1)(1995-6#2)(1996-10#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#2)(2004-2#1)(2005-11#1)(2005-12#1)(2006-3#1)(2006-5#2)(2007-10#1)(2007-12#3)(2007-5#1)(2007-6#2)(2007-9#2)(2008-1#2)(2008-10#15)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2009-1#1)(2009-2#2)(2009-4#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#2)
was detected in these##2##4##(1997-4#1)(2008-5#1)
was detected in this##4##4##(1991-7#1)(1997-6#1)(2008-11#1)(2010-7#1)
was detected in turkeys##2##4##(1997-6#1)(2013-1#1)
was detected in two##2##4##(2004-11#1)(2006-4#1)
was detected in various##2##4##(1995-6#1)(1996-2#1)
was detected in##442##3##(1990-10#3)(1990-11#4)(1990-12#4)(1990-2#4)(1990-3#3)(1990-4#2)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#3)(1991-12#2)(1991-2#4)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#4)(1991-8#1)(1991-9#4)(1992-1#1)(1992-11#4)(1992-12#2)(1992-5#2)(1992-7#1)(1992-8#4)(1992-9#2)(1993-10#2)(1993-11#3)(1993-2#1)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#4)(1993-9#2)(1994-11#4)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#3)(1994-8#4)(1994-9#1)(1995-1#2)(1995-10#3)(1995-11#9)(1995-12#3)(1995-3#2)(1995-4#1)(1995-5#4)(1995-6#4)(1995-7#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#5)(1996-3#1)(1996-4#4)(1996-5#3)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#4)(1997-4#2)(1997-6#5)(1997-7#4)(1997-8#5)(2004-11#2)(2004-2#2)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-3#2)(2006-4#2)(2006-5#3)(2006-8#1)(2007-10#3)(2007-12#4)(2007-2#6)(2007-5#3)(2007-6#3)(2007-7#5)(2007-8#5)(2007-9#2)(2008-1#3)(2008-10#62)(2008-11#7)(2008-12#7)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#12)(2008-6#2)(2008-7#6)(2008-8#11)(2008-9#2)(2009-1#1)(2009-2#4)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#2)(2010-12#8)(2010-2#1)(2010-4#2)(2010-5#2)(2010-7#1)(2011-1#5)(2011-12#5)(2011-2#13)(2012-1#4)(2012-12#6)(2012-2#5)(2012-3#3)(2013-1#12)(2013-8#7)
was detected not only in##2##5##(1993-4#1)(2008-10#1)
was detected on a##2##4##(1991-2#1)(2008-10#1)
was detected on the##6##4##(2005-11#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-4#1)(2012-12#1)
was detected on##25##3##(1990-8#1)(1991-2#1)(1993-8#1)(1994-11#2)(1997-8#1)(2005-11#1)(2006-3#2)(2007-11#1)(2007-8#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-6#1)(2009-4#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)
was detected only at##3##4##(1990-7#1)(2006-4#1)(2012-11#1)
was detected only by##2##4##(1990-1#1)(1994-12#1)
was detected only in the##4##5##(1991-9#1)(1993-4#1)(1997-6#1)(2008-10#1)
was detected only in##10##4##(1991-9#1)(1992-1#1)(1993-4#1)(1994-3#1)(1996-12#1)(1997-6#2)(2008-10#3)
was detected only##22##3##(1990-1#1)(1990-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1993-4#1)(1994-12#2)(1994-3#1)(1995-1#1)(1996-12#1)(1997-6#2)(2006-4#1)(2007-6#1)(2008-10#5)(2012-11#1)
was detected over the##3##4##(1995-11#2)(2007-10#1)
was detected over##4##3##(1995-11#2)(2007-10#1)(2008-10#1)
was detected spectrophotometrically##2##3##(2008-10#2)
was detected throughout the##2##4##(2007-8#1)(2008-10#1)
was detected to##4##3##(2008-10#1)(2008-6#1)(2008-9#1)(2013-1#1)
was detected under conditions##2##4##(1995-8#1)(2008-2#1)
was detected up to##2##4##(2007-12#1)(2010-12#1)
was detected upon##2##3##(1994-8#1)(2007-8#1)
was detected using the##3##4##(1993-12#1)(2008-9#1)(2012-2#1)
was detected using##15##3##(1991-12#1)(1993-12#1)(1994-8#1)(1997-2#2)(2007-2#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-9#1)(2012-12#1)(2012-2#1)
was detected when the##4##4##(1992-11#1)(1997-6#1)(2007-7#1)(2008-10#1)
was detected when##10##3##(1992-11#1)(1993-12#1)(1993-3#1)(1995-2#1)(1997-4#1)(1997-6#1)(2007-7#1)(2008-10#2)(2010-5#1)
was detected which##2##3##(1991-9#1)(1993-3#1)
was detected with a##6##4##(1992-7#1)(1994-12#1)(1996-9#1)(2006-4#1)(2008-10#1)(2008-11#1)
was detected with an##3##4##(1990-5#1)(1991-5#1)(1992-2#1)
was detected with the##3##4##(1993-8#1)(2007-11#1)(2008-10#1)
was detected with##29##3##(1990-4#1)(1990-5#1)(1991-12#1)(1991-5#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-6#1)(1996-2#1)(1996-9#1)(1997-8#1)(2006-4#1)(2006-8#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-4#1)(2011-2#1)(2011-3#2)(2012-2#1)
was detected within the##3##4##(1995-5#1)(2008-10#1)(2008-7#1)
was detected within##6##3##(1995-5#1)(1996-4#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)
was detected##988##2##(1990-1#1)(1990-10#4)(1990-11#5)(1990-12#6)(1990-2#7)(1990-3#4)(1990-4#5)(1990-5#6)(1990-7#4)(1990-8#3)(1990-9#2)(1991-1#1)(1991-10#5)(1991-11#1)(1991-12#7)(1991-2#7)(1991-3#6)(1991-4#3)(1991-5#4)(1991-6#3)(1991-7#5)(1991-8#3)(1991-9#8)(1992-1#3)(1992-11#9)(1992-12#7)(1992-2#3)(1992-3#3)(1992-4#1)(1992-5#3)(1992-6#4)(1992-7#3)(1992-8#5)(1992-9#5)(1993-1#2)(1993-10#2)(1993-11#5)(1993-12#6)(1993-2#1)(1993-3#5)(1993-4#5)(1993-5#1)(1993-6#4)(1993-7#2)(1993-8#7)(1993-9#4)(1994-11#9)(1994-12#9)(1994-2#3)(1994-3#7)(1994-5#4)(1994-6#6)(1994-8#8)(1994-9#5)(1995-1#3)(1995-10#4)(1995-11#12)(1995-12#4)(1995-2#3)(1995-3#7)(1995-4#1)(1995-5#9)(1995-6#5)(1995-7#1)(1995-8#3)(1996-10#2)(1996-11#4)(1996-12#7)(1996-2#8)(1996-3#2)(1996-4#7)(1996-5#5)(1996-6#8)(1996-7#3)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#6)(1997-3#8)(1997-4#6)(1997-5#3)(1997-6#10)(1997-7#5)(1997-8#12)(2004-11#3)(2004-2#2)(2004-8#1)(2005-10#2)(2005-11#6)(2005-12#1)(2005-4#1)(2005-8#1)(2006-10#4)(2006-12#2)(2006-3#4)(2006-4#4)(2006-5#3)(2006-8#7)(2006-9#2)(2007-1#2)(2007-10#6)(2007-11#2)(2007-12#8)(2007-2#7)(2007-3#1)(2007-5#5)(2007-6#5)(2007-7#10)(2007-8#17)(2007-9#2)(2008-1#5)(2008-10#166)(2008-11#16)(2008-12#14)(2008-2#5)(2008-3#8)(2008-4#8)(2008-5#28)(2008-6#8)(2008-7#12)(2008-8#19)(2008-9#10)(2009-1#1)(2009-2#4)(2009-3#3)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#15)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#5)(2010-7#1)(2010-8#3)(2011-1#13)(2011-12#8)(2011-2#22)(2011-3#2)(2012-1#7)(2012-11#2)(2012-12#18)(2012-2#15)(2012-3#9)(2012-6#1)(2013-1#20)(2013-7#1)(2013-8#15)
was determinated##3##2##(1997-7#1)(2008-7#1)(2008-8#1)
was determined 1 h##2##4##(1994-2#1)(2004-10#1)
was determined according to the##3##5##(2005-10#1)(2008-10#2)
was determined according to##6##4##(1995-11#1)(2005-10#1)(2008-10#2)(2008-7#1)(2013-7#1)
was determined after##10##3##(1990-2#1)(1990-8#1)(1993-2#1)(1995-6#1)(2008-10#4)(2010-5#1)(2011-1#1)
was determined against##2##3##(2007-6#1)(2008-10#1)
was determined and a##3##4##(1997-2#1)(2005-4#1)(2006-8#1)
was determined and analyzed##3##4##(2005-11#1)(2008-3#1)(2008-8#1)
was determined and compared with##2##5##(1990-4#1)(1997-6#1)
was determined and its##2##4##(1992-8#1)(2008-10#1)
was determined and the##6##4##(1991-7#1)(1992-8#1)(1993-2#1)(2007-8#1)(2008-10#1)(2008-5#1)
was determined and turned out to be identical to##2##9##(1995-6#1)(1997-8#1)
was determined and##39##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1991-5#1)(1991-7#2)(1992-1#1)(1992-8#3)(1993-2#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-8#2)(2012-11#1)
was determined as a function of the##2##7##(1991-9#1)(2008-3#1)
was determined as a function of##5##6##(1991-9#1)(2005-11#1)(2008-10#2)(2008-3#1)
was determined as a##8##4##(1991-9#1)(1995-6#1)(1997-2#1)(1997-8#1)(2005-11#1)(2008-10#2)(2008-3#1)
was determined as the##4##4##(1992-11#1)(1992-12#1)(1996-1#1)(2009-8#1)
was determined as well##2##4##(1997-2#1)(2006-8#1)
was determined as##36##3##(1990-11#1)(1991-1#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-9#1)(1995-6#1)(1996-1#1)(1996-10#1)(1997-2#2)(1997-8#1)(2004-9#1)(2005-11#1)(2006-12#1)(2006-8#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-12#1)(2012-7#1)(2013-8#1)
was determined at 2##6##4##(1996-11#1)(1996-5#1)(1997-6#1)(2008-10#2)(2008-8#1)
was determined at various##2##4##(1995-8#1)(1996-7#1)
was determined at##22##3##(1991-1#1)(1991-4#1)(1992-3#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-4#1)(1997-6#1)(2007-3#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-7#2)(2008-8#1)
was determined based on the##3##5##(2007-8#1)(2008-10#1)(2013-8#1)
was determined based on##5##4##(2007-8#1)(2008-10#1)(2008-5#1)(2009-3#1)(2013-8#1)
was determined before##4##3##(2007-8#1)(2008-12#1)(2009-3#1)(2012-12#1)
was determined between##3##3##(1994-3#1)(2008-12#2)
was determined by ELISA##3##4##(1993-5#1)(2007-8#1)(2012-3#1)
was determined by GC/MS##2##4##(2008-10#1)(2011-1#1)
was determined by GF-AAS##2##4##(2008-10#2)
was determined by HPLC##3##4##(1993-3#1)(2008-10#1)(2008-7#1)
was determined by MTT assay##2##5##(2007-8#1)(2011-2#1)
was determined by NMR##2##4##(1995-2#1)(1996-6#1)
was determined by Northern##2##4##(1993-11#1)(2004-11#1)
was determined by PCR amplification of##2##6##(1997-4#1)(2007-7#1)
was determined by X-ray diffraction##2##5##(1997-5#1)(2007-11#1)
was determined by X-ray##5##4##(1990-2#1)(1996-5#1)(1997-5#1)(2006-4#1)(2007-11#1)
was determined by a combination of##3##6##(1991-9#1)(1992-12#1)(2008-10#1)
was determined by a##20##4##(1990-2#1)(1991-9#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-9#1)(1995-10#1)(1997-8#1)(2007-2#1)(2007-9#1)(2008-10#7)(2008-5#2)(2012-12#1)
was determined by adsorptive##4##4##(2008-10#4)
was determined by an##3##4##(1992-8#1)(1997-7#1)(2008-5#1)
was determined by analysis of##4##5##(1990-4#1)(1990-7#1)(1996-11#1)(2008-10#1)
was determined by atomic absorption spectrometry##4##6##(2008-10#4)
was determined by atomic absorption##5##5##(2004-12#1)(2008-10#4)
was determined by atomic##7##4##(2004-12#1)(2008-10#5)(2008-2#1)
was determined by both##4##4##(1992-4#1)(1993-11#1)(1994-8#1)(2008-10#1)
was determined by chemical##2##4##(1993-8#1)(2006-12#1)
was determined by comparing##2##4##(2008-12#1)(2010-8#1)
was determined by continuous##2##4##(1991-7#1)(2011-2#1)
was determined by counting the number of##2##7##(1990-3#1)(2008-4#1)
was determined by direct##3##4##(1990-5#1)(1991-6#1)(1994-12#1)
was determined by enzyme-linked immunosorbent assay##2##6##(2008-10#1)(2010-4#1)
was determined by enzyme-linked##3##4##(1997-5#1)(2008-10#1)(2010-4#1)
was determined by examining##2##4##(1994-12#1)(2007-3#1)
was determined by flow##2##4##(2008-10#2)
was determined by gel filtration##2##5##(1990-7#1)(2008-10#1)
was determined by gel##3##4##(1990-7#1)(1997-1#1)(2008-10#1)
was determined by graphite furnace atomic absorption spectrometry##2##8##(1995-6#1)(2008-10#1)
was determined by graphite furnace##3##5##(1992-3#1)(1995-6#1)(2008-10#1)
was determined by inoculating##2##4##(2008-10#2)
was determined by matrix-assisted##3##4##(2008-11#3)
was determined by means of##3##5##(2006-12#1)(2008-10#1)(2012-2#1)
was determined by measuring fluorescence using Indo-1 as##2##8##(1990-7#2)
was determined by measuring the##7##5##(1990-12#1)(1990-3#1)(1992-3#1)(1993-3#1)(2008-10#1)(2008-12#1)(2008-5#1)
was determined by measuring##13##4##(1990-12#1)(1990-3#1)(1990-7#2)(1990-8#1)(1992-3#1)(1992-6#1)(1993-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2012-1#1)
was determined by methylation##2##4##(1990-3#1)(1991-2#1)
was determined by monitoring the formation of 3H-citrulline from 3H-L-arginine##2##10##(1992-11#1)(1992-6#1)
was determined by monitoring the formation of##3##7##(1992-11#1)(1992-6#2)
was determined by primer extension##2##5##(1990-9#1)(1994-12#1)
was determined by protein sequencing##2##5##(1991-6#1)(1995-6#1)
was determined by single crystal X-ray diffraction##2##7##(2007-11#1)(2008-5#1)
was determined by single##4##4##(1995-11#1)(2007-11#1)(2008-5#1)(2009-12#1)
was determined by the difference##2##5##(1994-11#1)(2008-8#1)
was determined by the disk diffusion method##2##7##(2008-5#1)(2011-2#1)
was determined by the method##2##5##(1996-3#1)(2012-12#1)
was determined by the molecular##2##5##(2007-5#1)(2008-9#1)
was determined by the##50##4##(1990-3#1)(1990-5#1)(1992-10#1)(1992-12#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-3#1)(1996-3#1)(1996-4#1)(1997-4#2)(1997-8#1)(2004-9#1)(2005-11#1)(2005-4#1)(2006-5#1)(2007-10#1)(2007-5#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-8#2)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#2)
was determined by their##2##4##(1995-2#1)(2010-12#1)
was determined by titration##2##4##(1996-11#1)(2007-1#1)
was determined by use of##5##5##(1991-8#1)(2008-2#1)(2008-3#3)
was determined by using the##3##5##(1991-9#1)(2007-10#1)(2008-10#1)
was determined by using##6##4##(1991-9#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-9#1)
was determined by##374##3##(1990-12#3)(1990-2#4)(1990-3#4)(1990-4#2)(1990-5#3)(1990-7#6)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#4)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#3)(1994-3#4)(1994-5#1)(1994-8#3)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#4)(1995-3#4)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-4#4)(1997-5#2)(1997-7#1)(1997-8#6)(2004-11#2)(2004-12#1)(2004-2#1)(2004-9#1)(2005-11#2)(2005-4#4)(2006-10#1)(2006-12#6)(2006-4#3)(2006-5#1)(2006-8#1)(2007-1#4)(2007-10#3)(2007-11#5)(2007-12#1)(2007-2#3)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#79)(2008-11#8)(2008-12#2)(2008-2#5)(2008-3#8)(2008-4#3)(2008-5#10)(2008-6#5)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#2)(2009-2#1)(2009-8#2)(2010-12#4)(2010-2#1)(2010-4#2)(2010-8#4)(2011-1#4)(2011-12#1)(2011-2#7)(2012-1#5)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#6)(2013-1#5)(2013-7#2)(2013-8#2)
was determined directly from the##2##5##(1991-9#1)(2008-11#1)
was determined directly##4##3##(1991-9#1)(1992-6#1)(2008-10#1)(2008-11#1)
was determined either by##2##4##(2006-11#1)(2012-3#1)
was determined every##2##3##(2008-12#1)(2008-5#1)
was determined experimentally##3##3##(2004-12#1)(2007-12#1)(2008-3#1)
was determined following##2##3##(1997-2#1)(2008-11#1)
was determined for a##4##4##(1992-6#1)(1992-7#1)(1995-1#1)(1997-5#1)
was determined for all##2##4##(1996-6#1)(2009-7#1)
was determined for both##3##4##(2008-10#1)(2008-12#1)(2012-12#1)
was determined for each##6##4##(1993-12#1)(2004-11#1)(2004-12#1)(2007-10#1)(2007-7#1)(2008-10#1)
was determined for the##7##4##(1990-5#1)(1991-11#1)(1993-12#1)(2004-7#1)(2006-10#1)(2008-5#1)(2009-10#1)
was determined for three##2##4##(2007-5#1)(2008-10#1)
was determined for##42##3##(1990-5#1)(1991-11#1)(1992-1#1)(1992-6#1)(1992-7#1)(1993-12#2)(1994-9#1)(1995-1#1)(1996-6#1)(1997-5#1)(2004-11#1)(2004-12#1)(2004-7#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-5#3)(2009-10#2)(2009-7#2)(2011-2#3)(2012-1#1)(2012-12#1)(2013-8#1)
was determined from the measured##2##5##(2007-11#1)(2008-3#1)
was determined from the##19##4##(1991-2#1)(1991-8#1)(1993-12#1)(1994-8#1)(1996-7#1)(2004-12#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-3#3)(2011-2#1)
was determined from two overlapping##2##5##(1996-2#1)(1996-6#1)
was determined from##37##3##(1991-2#1)(1991-8#1)(1993-12#2)(1994-3#1)(1994-8#1)(1995-5#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-6#1)(2004-12#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#13)(2008-2#1)(2008-3#3)(2008-5#1)(2011-2#1)
was determined in 0##2##4##(2008-7#1)(2011-2#1)
was determined in a##5##4##(1992-5#1)(1992-8#1)(2007-10#1)(2008-10#1)(2012-12#1)
was determined in all##2##4##(1995-7#1)(2007-12#1)
was determined in order to##6##5##(1996-8#1)(2008-10#2)(2011-1#1)(2012-1#1)(2012-12#1)
was determined in plasma##3##4##(1990-2#1)(1994-2#1)(1997-3#1)
was determined in rat##5##4##(1990-2#1)(1991-5#1)(1994-5#1)(1996-6#1)(2008-8#1)
was determined in samples collected##2##5##(1992-3#1)(1994-6#1)
was determined in samples of##2##5##(1995-1#1)(1997-8#1)
was determined in samples##5##4##(1992-3#1)(1994-6#1)(1995-1#1)(1997-8#1)(2008-10#1)
was determined in the concentration range##2##6##(1995-1#1)(2008-10#1)
was determined in the presence of##3##6##(1990-8#1)(2008-10#1)(2008-5#1)
was determined in the same##2##5##(2008-10#1)(2009-11#1)
was determined in the##25##4##(1990-8#1)(1991-1#1)(1993-3#1)(1995-1#1)(1995-5#1)(1996-7#1)(1997-2#1)(2005-4#1)(2006-4#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-5#2)(2008-7#2)(2009-11#1)(2009-3#1)(2009-5#1)
was determined in this##2##4##(1997-2#1)(2008-10#1)
was determined in whole##2##4##(1991-3#1)(1992-4#1)
was determined in##126##3##(1990-2#3)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-3#3)(1992-4#2)(1992-5#1)(1992-7#1)(1992-8#3)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#3)(1994-5#2)(1994-6#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-7#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#2)(1997-8#2)(2005-4#2)(2006-4#1)(2006-5#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-10#26)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#6)(2008-8#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#4)(2012-4#1)(2013-3#1)(2013-8#1)
was determined mainly by##3##4##(2008-10#3)
was determined on a##2##4##(1996-5#2)
was determined on the basis of##2##6##(2005-11#1)(2007-1#1)
was determined on the##6##4##(1994-12#1)(2005-11#1)(2007-1#1)(2008-11#1)(2008-12#1)(2008-5#1)
was determined on##19##3##(1990-6#1)(1992-10#1)(1993-11#1)(1994-12#1)(1994-2#1)(1995-11#1)(1996-5#2)(1997-2#1)(1997-3#1)(2005-11#1)(2006-8#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-3#1)(2013-7#1)
was determined over a##2##4##(2008-3#1)(2008-8#1)
was determined over##8##3##(2007-1#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-8#1)
was determined radioimmunologically##2##3##(1995-12#2)
was determined spectrophotometrically##4##3##(1992-1#1)(2007-6#1)(2008-10#2)
was determined that the##4##4##(1991-4#1)(1991-9#1)(2007-12#1)(2012-2#1)
was determined that##20##3##(1991-4#1)(1991-9#1)(1992-5#1)(1992-6#1)(1995-2#1)(1996-6#1)(2005-11#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
was determined through##7##3##(1994-12#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-5#1)(2011-1#1)
was determined to be (3##2##5##(2008-10#2)
was determined to be 0##8##5##(1996-7#1)(2008-10#4)(2008-3#1)(2008-5#1)(2011-2#1)
was determined to be 1##2##5##(2008-11#1)(2011-2#1)
was determined to be 2##7##5##(1995-3#1)(1997-1#1)(1997-2#1)(2006-12#1)(2008-10#3)
was determined to be 3##4##5##(1993-8#1)(1996-7#1)(2008-10#2)
was determined to be 4##2##5##(1997-8#1)(2008-10#1)
was determined to be 7##2##5##(1996-7#1)(2007-12#1)
was determined to be 8##3##5##(1992-11#1)(1992-3#1)(1994-5#1)
was determined to be 9##2##5##(1995-11#1)(2008-10#1)
was determined to be a mean of##2##7##(2010-6#2)
was determined to be a##6##5##(1991-10#1)(1991-8#1)(1993-11#1)(1996-2#1)(2010-6#2)
was determined to be about##2##5##(1994-9#1)(2006-3#1)
was determined to be approximately##2##5##(1995-10#1)(2008-10#1)
was determined to be at the##2##6##(1991-5#1)(2008-10#1)
was determined to be at##3##5##(1991-5#1)(2008-10#1)(2008-11#1)
was determined to be the##2##5##(1992-7#1)(2007-1#1)
was determined to be##107##4##(1990-2#2)(1990-6#1)(1990-7#1)(1991-10#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-10#4)(1995-11#3)(1995-3#2)(1996-2#2)(1996-7#3)(1997-1#1)(1997-2#4)(1997-4#1)(1997-6#1)(1997-8#2)(2006-12#2)(2006-3#1)(2007-1#2)(2007-12#1)(2007-8#6)(2008-10#34)(2008-11#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#1)(2010-11#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#3)(2012-11#1)
was determined to have a##2##5##(1990-7#1)(2010-10#1)
was determined to have##4##4##(1990-7#1)(2006-10#1)(2008-10#1)(2010-10#1)
was determined to##127##3##(1990-2#2)(1990-6#1)(1990-7#2)(1991-10#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-9#2)(1995-10#4)(1995-11#4)(1995-3#2)(1996-2#2)(1996-7#3)(1997-1#1)(1997-2#5)(1997-4#1)(1997-6#1)(1997-8#2)(2005-11#1)(2006-10#1)(2006-12#2)(2006-3#1)(2007-1#2)(2007-12#1)(2007-2#1)(2007-8#6)(2008-1#1)(2008-10#37)(2008-11#3)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#3)(2010-11#1)(2010-5#2)(2010-6#2)(2011-1#1)(2011-2#4)(2012-11#1)(2012-2#1)
was determined together with##2##4##(1996-2#1)(2008-10#1)
was determined using RT-PCR##2##4##(2008-6#1)(2013-8#1)
was determined using a##11##4##(1992-2#1)(1996-5#1)(1996-7#1)(2005-4#1)(2007-1#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-2#1)
was determined using an##2##4##(1996-3#1)(1997-8#1)
was determined using standard##2##4##(2008-10#1)(2012-12#1)
was determined using the##12##4##(1994-11#1)(1995-11#1)(1995-8#1)(2006-5#1)(2006-7#1)(2007-8#1)(2008-10#4)(2008-9#1)(2013-7#1)
was determined using##62##3##(1990-8#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-2#1)(1993-9#2)(1994-11#1)(1995-11#1)(1995-8#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-4#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-6#1)(2007-8#1)(2008-10#13)(2008-11#3)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
was determined with a##6##4##(1990-11#1)(1996-5#1)(2005-12#1)(2008-10#1)(2008-3#1)(2010-3#1)
was determined with satisfactory results##2##5##(2008-10#2)
was determined with the##5##4##(1993-9#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-8#1)
was determined with##28##3##(1990-11#1)(1990-12#1)(1990-5#1)(1991-1#1)(1992-12#1)(1992-6#1)(1993-9#1)(1996-2#2)(1996-5#1)(1996-9#1)(2005-12#1)(2007-12#1)(2008-10#8)(2008-3#2)(2008-6#1)(2008-8#2)(2009-8#1)(2010-3#1)
was determined##1217##2##(1990-1#1)(1990-10#3)(1990-11#4)(1990-12#5)(1990-2#12)(1990-3#7)(1990-4#4)(1990-5#8)(1990-6#5)(1990-7#12)(1990-8#7)(1990-9#4)(1991-1#4)(1991-10#2)(1991-11#4)(1991-12#3)(1991-2#6)(1991-3#3)(1991-4#4)(1991-5#6)(1991-6#3)(1991-7#6)(1991-8#5)(1991-9#9)(1992-1#5)(1992-10#3)(1992-11#4)(1992-12#7)(1992-2#2)(1992-3#9)(1992-4#5)(1992-5#2)(1992-6#10)(1992-7#5)(1992-8#8)(1992-9#4)(1993-11#7)(1993-12#11)(1993-2#7)(1993-3#5)(1993-4#3)(1993-5#1)(1993-6#4)(1993-7#2)(1993-8#3)(1993-9#6)(1994-11#3)(1994-12#8)(1994-2#11)(1994-3#7)(1994-5#5)(1994-6#3)(1994-8#6)(1994-9#4)(1995-1#5)(1995-10#7)(1995-11#11)(1995-12#4)(1995-2#8)(1995-3#6)(1995-5#4)(1995-6#6)(1995-7#4)(1995-8#6)(1996-1#2)(1996-10#3)(1996-11#3)(1996-12#4)(1996-2#7)(1996-3#4)(1996-4#4)(1996-5#9)(1996-6#5)(1996-7#10)(1996-8#1)(1996-9#4)(1997-1#4)(1997-2#17)(1997-3#5)(1997-4#11)(1997-5#3)(1997-6#4)(1997-7#4)(1997-8#13)(2004-10#1)(2004-11#3)(2004-12#5)(2004-2#1)(2004-7#1)(2004-9#3)(2005-10#1)(2005-11#10)(2005-12#1)(2005-4#9)(2006-10#6)(2006-11#2)(2006-12#11)(2006-3#1)(2006-4#4)(2006-5#3)(2006-7#2)(2006-8#7)(2007-1#10)(2007-10#7)(2007-11#11)(2007-12#9)(2007-2#5)(2007-3#3)(2007-4#1)(2007-5#4)(2007-6#3)(2007-7#4)(2007-8#16)(2007-9#4)(2008-1#4)(2008-10#276)(2008-11#26)(2008-12#13)(2008-2#10)(2008-3#24)(2008-4#5)(2008-5#41)(2008-6#8)(2008-7#15)(2008-8#18)(2008-9#7)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#4)(2009-5#3)(2009-7#2)(2009-8#5)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#8)(2010-2#4)(2010-3#2)(2010-4#4)(2010-5#7)(2010-6#2)(2010-8#4)(2011-1#9)(2011-12#2)(2011-2#18)(2012-1#7)(2012-11#5)(2012-12#13)(2012-2#9)(2012-3#8)(2012-4#1)(2012-7#1)(2012-9#1)(2013-1#11)(2013-3#1)(2013-7#5)(2013-8#9)
was developed a##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
was developed and applied to the##2##6##(2007-11#1)(2008-10#1)
was developed and applied to##5##5##(2007-11#1)(2007-8#1)(2008-10#2)(2009-4#1)
was developed and characterized##3##4##(2008-10#1)(2008-11#1)(2010-9#1)
was developed and evaluated via##2##5##(2007-12#2)
was developed and evaluated##3##4##(2007-12#2)(2007-2#1)
was developed and implemented##7##4##(2007-3#1)(2007-5#1)(2008-12#1)(2008-5#1)(2010-2#1)(2011-1#1)(2013-1#1)
was developed and optimized##5##4##(1994-11#1)(2008-10#3)(2010-12#1)
was developed and tested in##2##5##(2008-2#1)(2009-3#1)
was developed and tested with##2##5##(2007-2#1)(2011-1#1)
was developed and tested##12##4##(1997-4#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-2#3)(2009-3#1)(2011-1#1)
was developed and the##2##4##(2008-10#1)(2011-2#1)
was developed and used for the##2##6##(2008-10#1)(2008-7#1)
was developed and used for##4##5##(2007-11#1)(2008-10#2)(2008-7#1)
was developed and used in##2##5##(2008-10#2)
was developed and used to detect##2##6##(1997-3#1)(2006-10#1)
was developed and used to investigate##2##6##(1991-9#1)(2008-10#1)
was developed and used to study the##2##7##(2008-10#1)(2008-8#1)
was developed and used to##12##5##(1991-5#1)(1991-9#1)(1997-3#1)(2006-10#1)(2008-10#5)(2008-7#1)(2008-8#1)(2012-12#1)
was developed and used##18##4##(1991-5#1)(1991-9#1)(1997-3#1)(2006-10#1)(2007-11#1)(2008-10#9)(2008-7#2)(2008-8#1)(2012-12#1)
was developed and utilized##2##4##(2008-10#2)
was developed and validated against##2##5##(2006-11#1)(2007-4#1)
was developed and validated by##2##5##(2008-10#2)
was developed and validated in##3##5##(2007-12#1)(2008-10#2)
was developed and validated using##2##5##(2008-10#2)
was developed and validated##21##4##(1995-12#1)(2006-11#1)(2007-12#1)(2007-4#1)(2007-8#3)(2008-10#9)(2008-11#1)(2008-6#1)(2010-2#1)(2011-2#1)(2013-7#1)
was developed and##101##3##(1990-5#1)(1991-5#1)(1991-9#1)(1992-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-12#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#2)(2007-3#1)(2007-4#3)(2007-5#1)(2007-8#5)(2007-9#1)(2008-10#34)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-12#2)(2013-1#1)(2013-7#1)
was developed as a##11##4##(1994-3#1)(1996-5#1)(2008-10#3)(2008-2#1)(2008-7#1)(2012-1#2)(2012-12#1)(2012-3#1)
was developed as an alternative to##2##6##(1997-2#1)(2008-2#1)
was developed as an##3##4##(1997-2#1)(2008-2#1)(2011-2#1)
was developed as##18##3##(1994-3#1)(1996-5#1)(1997-2#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#1)
was developed at the##2##4##(2007-5#1)(2008-12#1)
was developed at##6##3##(1992-2#1)(2007-5#1)(2008-1#1)(2008-12#2)(2012-1#1)
was developed based on a##2##5##(2008-10#2)
was developed based on its##2##5##(2007-8#1)(2008-10#1)
was developed based on mitochondrial##2##5##(2008-10#2)
was developed based on the##10##5##(2005-4#2)(2006-11#1)(2008-10#4)(2008-8#1)(2010-5#1)(2011-1#1)
was developed based on##23##4##(2005-4#2)(2006-11#1)(2007-8#1)(2008-10#13)(2008-12#1)(2008-8#1)(2010-5#1)(2011-1#1)(2012-1#1)(2013-1#1)
was developed by a combination of##2##6##(2007-8#1)(2008-10#1)
was developed by a##5##4##(1995-2#1)(1997-3#1)(2007-8#1)(2008-10#2)
was developed by coupling##6##4##(2007-6#1)(2008-10#5)
was developed by immobilizing##2##4##(2008-10#2)
was developed by the use of##2##6##(2005-12#1)(2008-10#1)
was developed by the##8##4##(1994-3#1)(2005-12#1)(2006-12#1)(2008-10#1)(2009-5#1)(2010-11#1)(2010-5#1)(2010-9#1)
was developed by use of##2##5##(2008-2#1)(2008-3#1)
was developed by using##4##4##(1996-8#1)(2008-10#3)
was developed by##48##3##(1990-12#1)(1990-8#1)(1991-2#1)(1994-3#1)(1995-2#1)(1996-8#1)(1997-3#1)(2005-12#1)(2006-12#1)(2006-6#1)(2007-6#1)(2007-8#1)(2008-10#20)(2008-2#1)(2008-3#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)
was developed following##2##3##(2008-10#1)(2011-12#1)
was developed for a##4##4##(1991-8#1)(1993-12#1)(2008-10#1)(2008-11#1)
was developed for an##2##4##(2008-2#1)(2008-3#1)
was developed for detecting##2##4##(1995-11#1)(2008-9#1)
was developed for detection of##2##5##(1992-8#1)(2008-10#1)
was developed for determination of##7##5##(2008-10#7)
was developed for evaluating the##2##5##(1996-9#1)(2008-10#1)
was developed for identification and##2##5##(1995-12#1)(2008-10#1)
was developed for measuring##5##4##(1995-3#1)(2008-5#1)(2008-7#1)(2009-10#2)
was developed for monitoring##2##4##(2008-10#2)
was developed for predicting##3##4##(1997-6#1)(2007-1#1)(2008-10#1)
was developed for producing##2##4##(2008-11#1)(2008-2#1)
was developed for quantifying##3##4##(2004-2#1)(2007-8#1)(2008-10#1)
was developed for quantitative analysis of##2##6##(2007-8#1)(2008-10#1)
was developed for quantitative##4##4##(1992-2#1)(2007-8#1)(2008-10#2)
was developed for rapid and##2##5##(2007-8#1)(2008-10#1)
was developed for sample##2##4##(2008-10#2)
was developed for simultaneous determination of##6##6##(2008-10#5)(2010-2#1)
was developed for simultaneous##8##4##(2008-10#7)(2010-2#1)
was developed for the analysis of organophosphorus pesticides##2##8##(2008-10#2)
was developed for the analysis of the##2##7##(1997-3#1)(2008-10#1)
was developed for the analysis of##10##6##(1991-8#1)(1996-6#1)(1997-3#1)(2007-11#1)(2008-10#5)(2012-12#1)
was developed for the detection and##2##6##(2007-1#1)(2012-3#1)
was developed for the detection of##6##6##(1990-12#2)(2008-10#4)
was developed for the detection##8##5##(1990-12#2)(2007-1#1)(2008-10#4)(2012-3#1)
was developed for the determination of cadmium in##2##8##(2008-10#2)
was developed for the determination of the##3##7##(1990-12#1)(2008-10#2)
was developed for the determination of trace levels of##2##9##(2008-10#2)
was developed for the determination of trace##3##7##(2008-10#3)
was developed for the determination of##60##6##(1990-10#1)(1990-12#1)(1990-8#1)(1990-9#1)(1991-9#1)(1996-5#1)(1996-8#2)(1997-8#1)(2006-12#1)(2007-8#3)(2008-10#38)(2008-11#1)(2008-3#1)(2009-3#1)(2011-1#3)(2011-3#1)(2012-1#1)(2012-12#1)
was developed for the direct##2##5##(2008-10#2)
was developed for the identification of##2##6##(1990-8#1)(2008-10#1)
was developed for the quantification##2##5##(2008-10#1)(2013-8#1)
was developed for the quantitation of##2##6##(2008-10#2)
was developed for the quantitative##3##5##(2007-8#1)(2008-10#1)(2012-12#1)
was developed for the rapid##3##5##(2008-10#3)
was developed for the selective determination of##2##7##(2007-8#1)(2013-8#1)
was developed for the sensitive##2##5##(2007-8#1)(2008-10#1)
was developed for the separation and##3##6##(2008-10#3)
was developed for the separation of##3##6##(2005-4#1)(2008-10#2)
was developed for the separation##6##5##(2005-4#1)(2008-10#5)
was developed for the simultaneous detection##2##6##(2008-10#1)(2013-1#1)
was developed for the simultaneous determination of##10##7##(1990-11#1)(2008-10#5)(2010-2#1)(2012-12#2)(2013-7#1)
was developed for the simultaneous spectrophotometric determination of##2##8##(2008-10#2)
was developed for the simultaneous##17##5##(1990-11#1)(1990-9#1)(2007-8#1)(2008-10#9)(2010-2#1)(2012-12#2)(2013-1#1)(2013-7#1)
was developed for the spectrophotometric determination of##3##7##(2008-10#3)
was developed for the##156##4##(1990-10#1)(1990-11#3)(1990-12#4)(1990-8#2)(1990-9#2)(1991-8#1)(1991-9#1)(1992-11#1)(1994-12#1)(1996-5#2)(1996-6#1)(1996-8#2)(1997-3#2)(1997-8#1)(2005-11#1)(2005-4#1)(2005-9#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-8#8)(2008-10#87)(2008-11#3)(2008-3#4)(2008-4#1)(2008-6#1)(2009-3#1)(2010-2#1)(2010-4#1)(2011-1#4)(2011-3#1)(2012-1#1)(2012-12#6)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
was developed for##262##3##(1990-10#1)(1990-11#4)(1990-12#4)(1990-2#1)(1990-3#1)(1990-8#2)(1990-9#2)(1991-8#2)(1991-9#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-12#2)(1995-11#1)(1995-12#2)(1995-3#1)(1996-11#1)(1996-5#2)(1996-6#2)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#3)(1997-6#1)(1997-8#1)(2004-2#1)(2005-11#1)(2005-4#1)(2005-9#1)(2006-12#2)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#1)(2007-12#2)(2007-8#12)(2008-10#133)(2008-11#6)(2008-12#2)(2008-2#5)(2008-3#10)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#2)(2010-12#1)(2010-2#2)(2010-4#2)(2011-1#4)(2011-3#1)(2012-1#2)(2012-12#6)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
was developed from a cross between##3##6##(2008-10#2)(2012-11#1)
was developed from a##7##4##(1992-2#1)(2008-10#5)(2012-11#1)
was developed from##14##3##(1991-2#1)(1992-2#1)(2004-9#1)(2006-4#1)(2008-10#6)(2008-6#1)(2011-2#1)(2012-11#1)(2012-3#1)
was developed in a##8##4##(1990-12#1)(2004-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-2#1)(2011-2#1)
was developed in combination with##2##5##(1990-3#1)(2008-10#1)
was developed in conjunction with the##2##6##(1996-2#1)(2007-2#1)
was developed in conjunction with##5##5##(1992-1#1)(1996-2#1)(2007-2#1)(2008-10#2)
was developed in order to##11##5##(1990-2#1)(1991-3#1)(1992-9#1)(1996-12#1)(1997-2#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-11#1)(2010-12#1)
was developed in order##12##4##(1990-2#1)(1991-3#1)(1992-9#1)(1996-12#1)(1997-2#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-11#1)(2010-12#1)(2011-2#1)
was developed in our##2##4##(2008-5#1)(2008-9#1)
was developed in the##7##4##(1992-11#1)(1994-3#1)(2006-8#1)(2008-10#3)(2012-7#1)
was developed in this study##2##5##(2007-8#1)(2008-10#1)
was developed in this work##3##5##(2008-10#3)
was developed in this##6##4##(2007-8#1)(2008-10#5)
was developed in which the##3##5##(2006-5#1)(2008-11#2)
was developed in which##6##4##(1992-3#1)(2006-5#1)(2008-10#1)(2008-11#2)(2008-3#1)
was developed in##62##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-9#1)(1994-3#1)(1995-4#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(2004-12#1)(2005-8#1)(2005-9#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#19)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-11#1)(2010-12#1)(2010-2#1)(2011-2#3)(2012-7#1)
was developed on the basis of##2##6##(2008-10#1)(2008-2#1)
was developed on the##4##4##(2008-10#1)(2008-2#1)(2008-3#2)
was developed on##7##3##(1992-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)
was developed over##2##3##(1997-6#1)(2008-7#1)
was developed prior to##2##4##(1993-12#1)(2008-10#1)
was developed recently##2##3##(2008-10#1)(2008-9#1)
was developed that included##2##4##(1997-1#1)(2010-7#1)
was developed that includes a##2##5##(1990-8#1)(2007-11#1)
was developed that##21##3##(1990-3#1)(1990-8#1)(1991-1#1)(1997-1#1)(1997-4#1)(2004-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-2#2)(2008-7#1)(2009-6#1)(2010-7#1)
was developed through##3##3##(1995-7#1)(2007-10#1)(2008-12#1)
was developed to address##4##4##(2006-1#1)(2008-12#1)(2008-3#1)(2008-7#1)
was developed to allow##2##4##(1994-3#1)(2008-4#1)
was developed to assess the##2##5##(1993-2#1)(2010-9#1)
was developed to assess##6##4##(1993-2#1)(1996-12#1)(1997-5#1)(2008-11#1)(2010-9#1)(2013-8#1)
was developed to characterize the##2##5##(2008-10#1)(2008-5#1)
was developed to characterize##3##4##(2008-10#2)(2008-5#1)
was developed to describe the##4##5##(1990-11#1)(2008-10#1)(2008-3#1)(2008-7#1)
was developed to detect the##3##5##(1991-12#1)(2008-2#1)(2013-1#1)
was developed to detect##7##4##(1991-12#1)(1997-4#1)(2008-10#1)(2008-2#1)(2011-1#1)(2012-12#1)(2013-1#1)
was developed to determine the##5##5##(2008-10#4)(2008-5#1)
was developed to determine##17##4##(1992-2#1)(1994-9#1)(2008-10#14)(2008-5#1)
was developed to differentiate##2##4##(2008-10#1)(2008-4#1)
was developed to enable##2##4##(2008-10#1)(2010-10#1)
was developed to ensure##2##4##(2007-7#1)(2012-2#1)
was developed to estimate##2##4##(1991-5#1)(2007-1#1)
was developed to evaluate##6##4##(1996-7#1)(1997-2#1)(2007-10#1)(2008-10#2)(2013-1#1)
was developed to examine##3##4##(1995-8#1)(2008-11#1)(2008-9#1)
was developed to generate##2##4##(2008-11#1)(2008-3#1)
was developed to guide##2##4##(2010-6#1)(2012-2#1)
was developed to improve##2##4##(2012-11#1)(2012-2#1)
was developed to investigate the##2##5##(1992-7#1)(2007-1#1)
was developed to isolate and##2##5##(1990-5#1)(2008-10#1)
was developed to isolate##3##4##(1990-5#1)(1992-7#1)(2008-10#1)
was developed to measure##8##4##(1993-6#1)(1996-3#1)(1997-8#1)(2004-4#1)(2006-12#1)(2006-9#1)(2008-3#1)(2009-9#1)
was developed to model##2##4##(2008-2#1)(2010-2#1)
was developed to monitor the##3##5##(2008-10#3)
was developed to monitor##4##4##(1991-8#1)(2008-10#3)
was developed to predict the##2##5##(2008-10#2)
was developed to predict##6##4##(1992-3#1)(2008-10#3)(2013-1#2)
was developed to produce##3##4##(2006-5#1)(2008-10#1)(2009-5#1)
was developed to provide##5##4##(2007-1#1)(2008-1#1)(2008-10#1)(2008-8#1)(2012-2#1)
was developed to quantify the##3##5##(2007-12#1)(2008-10#2)
was developed to quantify##7##4##(1996-3#1)(1997-3#1)(2007-12#1)(2008-10#4)
was developed to quantitate##2##4##(1992-12#1)(2007-1#1)
was developed to quantitatively measure##2##5##(1994-9#1)(2008-10#1)
was developed to separate##3##4##(2008-10#1)(2008-3#1)(2011-1#1)
was developed to simulate the##2##5##(2007-4#1)(2008-3#1)
was developed to simulate##4##4##(2007-4#1)(2008-10#2)(2008-3#1)
was developed to simultaneously##5##4##(1995-12#1)(2008-10#1)(2008-12#1)(2011-1#1)(2013-8#1)
was developed to study the effects of##2##7##(2007-11#1)(2008-10#1)
was developed to study the##10##5##(1996-8#1)(1997-8#1)(2006-11#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2010-12#1)
was developed to test the##2##5##(2007-1#1)(2011-1#1)
was developed to##192##3##(1990-11#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-7#2)(1992-9#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-3#2)(1994-9#2)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2004-3#1)(2004-4#1)(2005-10#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-1#5)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#3)(2008-1#2)(2008-10#57)(2008-11#7)(2008-12#6)(2008-2#5)(2008-3#9)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#5)(2013-1#6)(2013-8#2)
was developed under##2##3##(2005-12#1)(2007-3#1)
was developed using a##5##4##(1991-9#1)(1993-2#1)(1995-8#1)(2008-10#2)
was developed using an##3##4##(1992-1#1)(2008-10#2)
was developed using the##5##4##(1990-2#1)(1994-9#1)(1996-3#1)(2005-11#1)(2008-2#1)
was developed using##40##3##(1990-2#2)(1991-9#1)(1992-1#1)(1992-6#1)(1992-8#1)(1993-2#1)(1994-9#1)(1995-8#1)(1996-3#1)(2005-11#1)(2006-11#2)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#18)(2008-11#1)(2008-2#1)(2011-1#2)(2012-12#1)(2013-1#1)
was developed utilizing##3##3##(1993-4#1)(2006-12#1)(2009-2#1)
was developed which allows the##2##5##(1991-11#1)(1991-5#1)
was developed which##11##3##(1991-11#1)(1991-5#1)(1991-7#1)(1993-2#1)(1996-5#1)(1997-3#1)(2008-10#2)(2008-11#1)(2011-12#2)
was developed with a view to##2##6##(2008-10#1)(2008-11#1)
was developed with a##4##4##(2008-10#1)(2008-11#1)(2008-2#1)(2012-12#1)
was developed with the##4##4##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
was developed with##20##3##(1993-12#1)(2007-11#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2009-12#1)(2012-12#1)(2012-3#2)
was developed##1086##2##(1990-10#1)(1990-11#5)(1990-12#7)(1990-2#5)(1990-3#3)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#6)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#3)(1991-7#1)(1991-8#4)(1991-9#4)(1992-1#3)(1992-11#3)(1992-12#1)(1992-2#6)(1992-3#4)(1992-5#1)(1992-6#1)(1992-7#4)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#7)(1994-9#4)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#3)(1995-4#1)(1995-6#1)(1995-7#3)(1995-8#4)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#3)(1996-5#4)(1996-6#3)(1996-7#1)(1996-8#7)(1996-9#1)(1997-1#1)(1997-2#6)(1997-3#11)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2004-12#1)(2004-2#1)(2004-3#1)(2004-4#1)(2004-9#2)(2005-10#1)(2005-11#3)(2005-12#4)(2005-4#4)(2005-5#1)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#3)(2006-11#5)(2006-12#7)(2006-4#2)(2006-5#3)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#7)(2007-10#7)(2007-11#12)(2007-12#12)(2007-2#3)(2007-3#2)(2007-4#6)(2007-5#5)(2007-6#2)(2007-7#5)(2007-8#27)(2007-9#1)(2008-1#4)(2008-10#424)(2008-11#32)(2008-12#19)(2008-2#27)(2008-3#37)(2008-4#4)(2008-5#15)(2008-6#5)(2008-7#15)(2008-8#6)(2008-9#7)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#4)(2009-3#4)(2009-4#3)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#9)(2010-3#1)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#4)(2011-1#19)(2011-12#4)(2011-2#13)(2011-3#1)(2012-1#7)(2012-11#3)(2012-12#15)(2012-2#11)(2012-3#8)(2012-7#1)(2013-1#16)(2013-7#3)(2013-8#6)
was development##3##2##(2008-10#1)(2008-6#1)(2010-9#1)
was devised and##2##3##(2007-8#1)(2008-10#1)
was devised for the##3##4##(1990-6#1)(1990-8#1)(2007-12#1)
was devised for##5##3##(1990-6#1)(1990-8#1)(1991-7#1)(2007-12#1)(2008-5#1)
was devised to##5##3##(1990-11#1)(1994-3#1)(1994-6#1)(2008-10#1)(2012-2#1)
was devised##21##2##(1990-11#1)(1990-6#1)(1990-8#2)(1991-7#1)(1994-3#2)(1994-6#1)(2004-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-5#1)(2009-2#1)(2011-2#1)(2012-2#1)
was devoid of activity##2##4##(1991-11#1)(1991-9#1)
was devoid of any##3##4##(1992-2#1)(1996-12#1)(2006-12#1)
was devoid of##14##3##(1990-3#1)(1991-11#1)(1991-9#1)(1992-2#1)(1993-11#1)(1994-2#1)(1994-5#1)(1994-9#1)(1996-1#2)(1996-12#1)(1997-3#1)(2006-12#1)(2008-7#1)
was devoted to the##2##4##(2008-5#1)(2008-7#1)
was devoted to##6##3##(2005-8#1)(2006-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-1#1)
was diagnosed 3##2##3##(1994-7#1)(1996-3#1)
was diagnosed according to the##2##5##(1997-2#1)(2008-4#1)
was diagnosed after##7##3##(1992-3#2)(2005-5#1)(2007-5#1)(2007-8#1)(2008-7#1)(2013-1#1)
was diagnosed and treated##2##4##(2010-10#1)(2013-8#1)
was diagnosed and##13##3##(1990-8#1)(1996-6#2)(2006-12#1)(2007-12#1)(2007-6#1)(2007-8#1)(2010-10#1)(2010-12#1)(2011-1#2)(2011-2#1)(2013-8#1)
was diagnosed as a case of##4##6##(2007-7#1)(2008-11#1)(2011-1#1)(2013-7#1)
was diagnosed as a##10##4##(1995-4#1)(2007-7#2)(2008-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-7#1)
was diagnosed as having a##2##5##(1996-9#1)(2011-2#1)
was diagnosed as having##13##4##(1991-11#1)(1991-7#1)(1996-9#1)(2006-4#1)(2007-7#1)(2008-7#1)(2009-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#2)
was diagnosed as##55##3##(1990-6#2)(1991-11#1)(1991-12#1)(1991-7#1)(1994-7#1)(1995-2#1)(1995-4#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-9#1)(2005-12#1)(2006-4#2)(2007-11#1)(2007-12#1)(2007-7#6)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-8#4)(2010-12#1)(2010-2#2)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-1#2)(2012-2#5)(2013-1#2)(2013-7#2)(2013-8#1)
was diagnosed at a##2##4##(2007-8#2)
was diagnosed at the##3##4##(2006-10#1)(2006-4#1)(2007-7#1)
was diagnosed at##11##3##(2006-10#1)(2006-4#1)(2007-7#1)(2007-8#2)(2008-6#1)(2010-11#2)(2012-3#3)
was diagnosed based on the##2##5##(2012-2#1)(2013-7#1)
was diagnosed based on##8##4##(2005-9#1)(2006-10#2)(2006-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
was diagnosed by liver biopsy##2##5##(1993-7#1)(2010-8#1)
was diagnosed by##18##3##(1990-5#1)(1993-7#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
was diagnosed during##3##3##(2007-2#1)(2007-8#1)(2009-1#1)
was diagnosed in a##6##4##(1990-2#1)(1991-5#1)(1994-4#1)(1994-7#1)(2007-10#1)(2008-3#1)
was diagnosed in four##2##4##(1994-4#1)(1997-8#1)
was diagnosed in the##4##4##(2006-10#1)(2008-5#1)(2012-3#1)(2013-8#1)
was diagnosed in two##2##4##(1996-3#1)(2008-11#1)
was diagnosed in##50##3##(1990-2#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-5#2)(1994-4#2)(1994-7#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-8#2)(2005-10#1)(2005-12#1)(2005-9#1)(2006-10#5)(2006-2#1)(2007-10#1)(2007-11#4)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
was diagnosed more often##3##4##(2012-3#1)(2013-1#2)
was diagnosed of##2##3##(2007-12#1)(2013-1#1)
was diagnosed on the basis of##5##6##(1995-12#1)(2006-6#1)(2008-1#1)(2008-11#1)(2013-8#1)
was diagnosed on the##6##4##(1990-9#1)(1995-12#1)(2006-6#1)(2008-1#1)(2008-11#1)(2013-8#1)
was diagnosed on##9##3##(1990-9#1)(1992-8#1)(1995-12#1)(2006-6#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-5#1)(2013-8#1)
was diagnosed perioperatively##2##3##(1996-5#1)(2011-3#1)
was diagnosed preoperatively##2##3##(1991-5#1)(2013-7#1)
was diagnosed six##2##3##(1990-4#1)(2012-2#1)
was diagnosed to have##9##4##(1997-8#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-6#1)(2010-12#1)(2012-2#2)(2013-1#1)
was diagnosed to##11##3##(1990-10#1)(1997-8#1)(2007-7#2)(2007-8#1)(2008-12#1)(2008-6#1)(2010-12#1)(2012-2#2)(2013-1#1)
was diagnosed using##2##3##(2008-5#1)(2010-8#1)
was diagnosed with a##6##4##(1995-12#1)(2007-8#2)(2008-2#1)(2012-12#1)(2012-2#1)
was diagnosed with acute##3##4##(2007-4#1)(2012-12#1)(2013-1#1)
was diagnosed with left##3##4##(2006-4#1)(2013-1#2)
was diagnosed with multiple##2##4##(2006-10#1)(2006-8#1)
was diagnosed with severe##2##4##(2010-10#1)(2012-3#1)
was diagnosed with the##2##4##(2008-10#1)(2013-8#1)
was diagnosed with##70##3##(1994-1#1)(1995-12#1)(1996-11#1)(1996-5#1)(1997-3#2)(1997-5#1)(2004-2#1)(2005-10#1)(2006-10#2)(2006-4#1)(2006-6#1)(2006-8#3)(2007-12#2)(2007-2#2)(2007-4#1)(2007-8#4)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#2)(2011-1#2)(2011-2#3)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#10)(2013-8#1)
was diagnosed##330##2##(1990-10#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-5#2)(1991-7#1)(1991-8#1)(1992-3#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-5#4)(1993-7#1)(1994-1#1)(1994-4#2)(1994-7#4)(1995-12#2)(1995-2#1)(1995-4#1)(1995-6#1)(1996-11#1)(1996-12#3)(1996-3#3)(1996-5#2)(1996-6#5)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-5#4)(1997-8#4)(2004-2#2)(2005-10#2)(2005-12#2)(2005-5#1)(2005-9#3)(2006-1#1)(2006-10#12)(2006-12#3)(2006-2#1)(2006-4#4)(2006-6#2)(2006-7#1)(2006-8#3)(2007-10#1)(2007-11#5)(2007-12#6)(2007-2#7)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#13)(2007-8#12)(2008-1#7)(2008-10#2)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#8)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#1)(2009-1#1)(2009-12#1)(2009-3#1)(2009-8#4)(2009-9#1)(2010-10#3)(2010-11#3)(2010-12#5)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#4)(2010-8#3)(2010-9#2)(2011-1#10)(2011-2#13)(2011-3#1)(2012-1#4)(2012-12#4)(2012-2#20)(2012-3#9)(2013-1#21)(2013-7#5)(2013-8#10)
was diagnostic##2##2##(2006-9#1)(2011-2#1)
was diarrhea##3##2##(1992-10#1)(2007-2#1)(2008-7#1)
was different between the##2##4##(2008-10#2)
was different between##4##3##(2008-10#3)(2013-7#1)
was different for##3##3##(1991-2#1)(2008-10#2)
was different from any other##2##5##(1991-1#1)(2008-10#1)
was different from other##2##4##(2008-10#1)(2008-11#1)
was different from that of the##5##6##(1997-6#1)(1997-8#1)(2008-10#2)(2013-1#1)
was different from that of##9##5##(1994-9#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-2#1)(2008-10#3)(2013-1#1)
was different from that on##3##5##(1992-3#1)(2008-10#1)(2008-5#1)
was different from that##17##4##(1990-5#1)(1991-7#1)(1992-3#1)(1993-3#1)(1994-9#1)(1996-11#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-5#1)(2013-1#1)
was different from the##5##4##(1994-6#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-1#1)
was different from##32##3##(1990-1#1)(1990-5#1)(1991-1#2)(1991-7#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-6#1)(1994-9#1)(1996-11#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-2#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
was different in the##2##4##(2007-8#1)(2013-7#1)
was different in##3##3##(2007-8#1)(2009-12#1)(2013-7#1)
was different to##2##3##(2008-10#1)(2009-10#1)
was different##57##2##(1990-1#1)(1990-5#1)(1991-1#2)(1991-2#1)(1991-3#1)(1991-7#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-11#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#14)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#2)(2013-8#2)
was differentially expressed##2##3##(1991-3#1)(2007-12#1)
was differentially##4##2##(1991-3#1)(1994-6#1)(1995-2#1)(2007-12#1)
was differentiated from##2##3##(2007-7#1)(2008-5#1)
was differentiated##4##2##(2007-12#1)(2007-7#1)(2008-5#1)(2013-1#1)
was difficult because of##3##4##(1992-4#1)(2006-6#1)(2009-10#1)
was difficult due to##2##4##(2004-4#1)(2010-8#1)
was difficult to detect##3##4##(1991-1#1)(2008-10#1)(2012-12#1)
was difficult to identify##4##4##(1990-10#2)(2008-10#2)
was difficult to##22##3##(1990-10#2)(1990-2#1)(1990-8#1)(1991-1#1)(1993-7#1)(1995-4#1)(2005-11#1)(2007-2#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-12#2)(2013-1#2)
was difficult##31##2##(1990-10#2)(1990-2#1)(1990-8#1)(1991-1#1)(1992-4#1)(1993-7#1)(1995-4#1)(2004-4#1)(2005-11#1)(2006-6#1)(2007-2#1)(2007-4#1)(2007-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-10#2)(2009-4#1)(2010-8#1)(2011-2#1)(2012-12#2)(2013-1#2)
was diffuse##4##2##(1991-10#1)(1992-10#1)(1992-11#1)(2007-7#1)
was diffusely##2##2##(1992-9#1)(1995-2#1)
was digested by##2##3##(1993-9#1)(2013-8#1)
was digested with trypsin##3##4##(1990-2#2)(1994-11#1)
was digested with##15##3##(1990-2#2)(1990-5#1)(1992-11#1)(1992-4#1)(1994-11#2)(1994-12#1)(1996-12#1)(2006-5#1)(2006-8#1)(2008-10#3)(2008-8#1)
was digested##19##2##(1990-2#2)(1990-5#1)(1992-11#1)(1992-4#1)(1992-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1996-12#1)(2006-5#1)(2006-8#1)(2008-10#3)(2008-8#1)(2013-8#2)
was digitized##2##2##(1990-11#1)(2008-2#1)
was dilated##2##2##(2009-8#1)(2013-7#1)
was diluted in water##2##4##(2008-10#1)(2008-5#1)
was diluted in##5##3##(1994-8#1)(2008-10#1)(2008-5#1)(2011-12#1)(2013-1#1)
was diluted to##2##3##(2006-5#1)(2008-10#1)
was diluted with##4##3##(1997-3#1)(2005-4#1)(2006-5#1)(2013-8#1)
was diluted##17##2##(1990-2#1)(1992-3#1)(1994-8#1)(1997-3#1)(1997-8#1)(2005-4#1)(2006-5#2)(2008-10#4)(2008-5#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
was diminished and##2##3##(2010-12#1)(2011-2#1)
was diminished by##7##3##(1992-12#1)(1993-12#1)(1993-9#1)(1994-10#1)(1995-8#1)(2008-10#1)(2010-12#1)
was diminished or##2##3##(2007-10#1)(2008-10#1)
was diminished to##2##3##(1991-7#1)(1992-8#1)
was diminished when##2##3##(1991-1#1)(1993-7#1)
was diminished##28##2##(1991-1#1)(1991-10#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-5#2)(1993-7#1)(1993-9#1)(1994-10#1)(1995-12#1)(1995-3#1)(1995-7#1)(1995-8#1)(2004-11#1)(2007-10#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-12#2)(2011-2#1)(2012-12#1)
was direct##2##2##(2008-12#1)(2012-1#1)
was directed against##2##3##(1990-5#1)(2007-8#1)
was directed at##3##3##(1993-2#1)(2005-9#1)(2010-3#1)
was directed by the##2##4##(1993-3#1)(2008-9#1)
was directed by##3##3##(1993-3#1)(2008-9#1)(2010-1#1)
was directed to a##2##4##(2007-8#1)(2008-11#1)
was directed to##5##3##(1992-12#1)(1997-4#1)(2007-8#1)(2008-11#1)(2010-5#1)
was directed toward the##2##4##(1991-1#1)(1993-1#1)
was directed toward##3##3##(1991-1#1)(1993-1#1)(2008-9#1)
was directed towards##2##3##(2008-2#1)(2013-1#1)
was directed##23##2##(1990-5#1)(1991-1#1)(1992-12#1)(1992-5#1)(1993-1#1)(1993-2#1)(1993-3#1)(1997-3#1)(1997-4#1)(2005-9#1)(2007-4#1)(2007-8#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#2)(2010-1#1)(2010-3#1)(2010-5#1)(2013-1#1)
was directly attached to##2##4##(1991-9#2)
was directly correlated with##6##4##(1991-8#1)(1993-11#2)(1996-3#1)(2008-10#1)(2011-2#1)
was directly coupled##2##3##(2007-8#1)(2008-10#1)
was directly demonstrated by##2##4##(1995-8#1)(2012-2#1)
was directly dependent on##2##4##(2007-7#1)(2008-8#1)
was directly determined##2##3##(1993-6#1)(2008-10#1)
was directly injected##2##3##(2005-11#1)(2008-10#1)
was directly introduced into##2##4##(2008-10#1)(2008-6#1)
was directly introduced##4##3##(2008-10#2)(2008-6#1)(2008-9#1)
was directly involved##2##3##(1994-2#1)(2008-4#1)
was directly measured##2##3##(2008-10#1)(2008-3#1)
was directly proportional to the concentration of##2##7##(2005-12#1)(2008-10#1)
was directly proportional to the concentration##3##6##(1991-8#1)(2005-12#1)(2008-10#1)
was directly proportional to the##6##5##(1991-8#1)(2005-12#1)(2007-8#1)(2008-10#2)(2008-11#1)
was directly proportional to##8##4##(1991-8#1)(1992-7#1)(2005-12#1)(2007-8#1)(2008-10#3)(2008-11#1)
was directly related to incubation time and microsomal protein concentration##2##10##(1993-9#2)
was directly related to the##3##5##(1990-5#1)(2008-10#1)(2011-1#1)
was directly related to##9##4##(1990-5#2)(1993-9#2)(2005-11#1)(2008-10#2)(2011-1#2)
was directly related##10##3##(1990-5#2)(1993-9#2)(2005-11#1)(2008-10#2)(2008-3#1)(2011-1#2)
was directly##74##2##(1990-5#2)(1991-8#2)(1991-9#2)(1992-7#1)(1993-11#2)(1993-6#1)(1993-9#2)(1994-12#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-8#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-7#2)(2005-11#3)(2005-12#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#28)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
was disappointing##4##2##(1992-5#1)(2008-10#1)(2009-3#1)(2012-3#1)
was discarded##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
was discharged after##3##3##(1995-3#1)(2010-12#1)(2013-8#1)
was discharged from hospital##2##4##(2006-4#1)(2007-10#1)
was discharged from the hospital##4##5##(2009-3#1)(2010-12#1)(2011-2#1)(2012-12#1)
was discharged from the##5##4##(2006-4#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-12#1)
was discharged from##8##3##(2006-4#2)(2007-10#1)(2007-8#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-12#1)
was discharged home on the##3##5##(2008-12#1)(2012-12#2)
was discharged home##11##3##(1993-7#1)(2006-10#3)(2006-4#1)(2007-8#1)(2008-12#1)(2010-7#2)(2012-12#2)
was discharged in good##3##4##(2006-6#1)(2007-8#1)(2011-12#1)
was discharged on day##4##4##(2012-2#1)(2013-1#1)(2013-8#2)
was discharged on the##8##4##(2010-5#1)(2011-1#1)(2012-12#3)(2012-2#1)(2013-1#2)
was discharged on##14##3##(2010-12#1)(2010-5#1)(2011-1#1)(2012-12#3)(2012-2#2)(2013-1#3)(2013-8#3)
was discharged with##2##3##(2007-10#1)(2013-8#1)
was discharged##57##2##(1990-12#1)(1992-5#1)(1993-7#1)(1994-4#1)(1994-9#1)(1995-3#1)(1997-8#1)(2006-10#3)(2006-4#4)(2006-6#1)(2007-10#2)(2007-8#4)(2008-12#1)(2008-5#1)(2008-7#2)(2009-2#1)(2009-3#1)(2009-4#1)(2010-12#3)(2010-5#1)(2010-7#2)(2011-1#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#7)(2012-2#2)(2013-1#4)(2013-8#5)
was disclosed##5##2##(1993-11#1)(1995-3#1)(1997-3#2)(2008-8#1)
was discontinued after##6##3##(1992-5#1)(1995-7#1)(2007-5#1)(2008-9#2)(2011-1#1)
was discontinued and the##3##4##(2006-5#1)(2008-1#2)
was discontinued and##6##3##(2005-10#1)(2006-5#1)(2006-9#1)(2008-1#2)(2013-1#1)
was discontinued because of##2##4##(2005-11#1)(2006-12#1)
was discontinued in##4##3##(2005-8#2)(2007-5#1)(2011-2#1)
was discontinued on##2##3##(2006-2#1)(2012-12#1)
was discontinued##43##2##(1992-5#1)(1992-6#1)(1994-4#1)(1994-6#1)(1995-6#1)(1995-7#1)(2005-10#1)(2005-11#1)(2005-8#2)(2006-10#6)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-5#2)(2008-1#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#2)
was discovered about##2##3##(2008-10#1)(2008-4#1)
was discovered as a result of##2##6##(1991-11#1)(2008-10#1)
was discovered as a##3##4##(1991-11#1)(2008-10#1)(2011-2#1)
was discovered as##4##3##(1991-11#1)(2007-11#1)(2008-10#1)(2011-2#1)
was discovered at##2##3##(1990-2#1)(1995-2#1)
was discovered by##6##3##(1990-5#1)(1990-7#1)(2005-8#1)(2008-1#1)(2008-7#1)(2008-8#1)
was discovered for##2##3##(2008-3#1)(2011-1#1)
was discovered in a##7##4##(1990-8#1)(2005-8#2)(2007-6#1)(2008-7#1)(2011-1#1)(2012-12#1)
was discovered in the##3##4##(1995-1#1)(2008-9#1)(2010-7#1)
was discovered in##20##3##(1990-8#1)(1995-1#2)(1995-8#1)(1996-8#1)(2004-11#1)(2005-7#1)(2005-8#2)(2007-11#1)(2007-4#1)(2007-6#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)
was discovered on##5##3##(2010-7#1)(2012-2#1)(2013-1#2)(2013-8#1)
was discovered that##7##3##(1997-1#1)(2005-4#1)(2006-1#1)(2008-10#2)(2008-3#1)(2012-3#1)
was discovered to have##2##4##(2008-10#2)
was discovered##78##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-5#1)(1993-10#1)(1993-9#1)(1994-11#2)(1994-12#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-1#2)(2004-11#1)(2005-4#1)(2005-7#1)(2005-8#3)(2006-1#1)(2006-12#1)(2007-11#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-12#1)(2010-7#3)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
was discussed and the##3##4##(2005-4#1)(2008-10#2)
was discussed and##5##3##(2005-4#1)(2008-10#3)(2009-7#1)
was discussed in relation to the##2##6##(1991-7#1)(1997-8#1)
was discussed in##7##3##(1991-2#1)(1991-7#1)(1997-8#1)(2008-10#3)(2013-8#1)
was discussed##58##2##(1991-2#1)(1991-7#1)(1992-2#1)(1992-3#1)(1993-3#1)(1995-11#1)(1997-1#1)(1997-8#1)(2005-11#1)(2005-4#5)(2005-8#3)(2006-6#1)(2008-10#28)(2008-5#1)(2008-8#5)(2009-7#1)(2011-7#1)(2013-8#4)
was disease##4##2##(1994-8#1)(2007-11#1)(2008-10#2)
was dislocated##2##2##(2007-8#1)(2009-4#1)
was dislodged##3##2##(1997-6#1)(2011-2#1)(2013-8#1)
was disorganized and##2##3##(1996-7#1)(2009-10#1)
was dispensable for##3##3##(1996-8#1)(2008-10#1)(2012-3#1)
was dispersed in##2##3##(1990-3#1)(2010-7#1)
was dispersed into##2##3##(1994-12#1)(2008-10#1)
was dispersed##9##2##(1990-3#2)(1991-9#1)(1994-12#1)(2008-10#2)(2008-2#1)(2010-5#1)(2010-7#1)
was displaceable by the##2##4##(1990-2#1)(1993-9#1)
was displaced by the##2##4##(1995-10#1)(1997-2#1)
was displaced by##8##3##(1993-8#1)(1994-3#1)(1994-6#1)(1995-10#2)(1996-1#1)(1996-8#1)(1997-2#1)
was displaced with##3##3##(1993-7#1)(1994-12#1)(1996-8#1)
was displaced##16##2##(1990-4#1)(1993-1#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-10#2)(1996-1#2)(1996-3#1)(1996-8#2)(1997-2#1)
was displayed on##3##3##(1996-2#1)(2013-1#1)(2013-8#1)
was displayed##4##2##(1993-3#1)(1996-2#1)(2013-1#1)(2013-8#1)
was disproportionately##2##2##(2008-11#1)(2009-2#1)
was disrupted by##3##3##(1993-12#1)(1997-4#1)(2008-10#1)
was disrupted in##4##3##(1991-6#1)(1993-3#1)(2008-10#2)
was disrupted##13##2##(1991-1#1)(1991-6#1)(1991-9#1)(1993-12#1)(1993-3#1)(1997-4#1)(1997-7#1)(2008-10#4)(2008-7#1)(2012-2#1)
was dissected##5##2##(1996-5#1)(2006-12#1)(2010-12#1)(2010-4#1)(2012-3#1)
was dissociated from##4##3##(1991-7#1)(1992-2#1)(1992-6#1)(1992-7#1)
was dissociated into##3##3##(1990-9#1)(1994-3#1)(2008-11#1)
was dissociated##10##2##(1990-9#1)(1991-12#1)(1991-7#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-8#1)(1994-3#1)(1997-6#1)(2008-11#1)
was dissolved in the##3##4##(1994-11#1)(2008-5#1)(2008-6#1)
was dissolved in##13##3##(1994-11#1)(1997-3#1)(2005-4#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2012-12#1)
was dissolved with##8##3##(2008-10#7)(2012-12#1)
was dissolved##22##2##(1994-11#1)(1997-3#1)(2005-12#1)(2005-4#1)(2008-10#11)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2012-12#2)
was distinct from that of##3##5##(1992-10#1)(2008-10#1)(2008-6#1)
was distinct from##12##3##(1991-8#1)(1992-10#1)(1992-4#1)(1995-1#1)(1995-5#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-6#1)
was distinct##15##2##(1991-8#1)(1992-10#1)(1992-4#1)(1993-8#1)(1995-1#1)(1995-5#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-6#1)(2010-10#1)
was distinctly##7##2##(1992-1#1)(1993-12#1)(1994-12#1)(2005-8#1)(2008-10#1)(2009-8#1)(2012-2#1)
was distributed among fields within##2##5##(2008-10#2)
was distributed among fields##3##4##(2008-10#3)
was distributed among##9##3##(2008-10#9)
was distributed between##2##3##(1994-6#1)(2008-10#1)
was distributed by##2##3##(2007-3#1)(2009-2#1)
was distributed in the##5##4##(1997-3#3)(2008-10#2)
was distributed in##7##3##(1991-10#1)(1997-3#3)(2008-10#3)
was distributed throughout##2##3##(1995-11#1)(1996-1#1)
was distributed to##6##3##(1990-5#1)(1992-4#1)(1992-6#1)(1993-12#1)(1996-9#1)(2012-12#1)
was distributed within##7##3##(2008-10#7)
was distributed##41##2##(1990-5#1)(1991-10#1)(1992-3#1)(1992-4#1)(1992-6#2)(1993-12#1)(1993-6#1)(1994-6#1)(1995-11#1)(1996-1#1)(1996-9#1)(1997-3#3)(2007-3#1)(2008-10#22)(2009-2#1)(2011-12#1)(2012-12#1)
was disturbed##2##2##(2009-2#1)(2011-1#1)
was divided in##4##3##(2006-4#1)(2008-12#1)(2011-2#1)(2013-1#1)
was divided into five##2##4##(2008-10#1)(2008-7#1)
was divided into four##3##4##(2008-10#1)(2008-5#1)(2010-7#1)
was divided into three##12##4##(1991-3#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-10#1)(2010-8#2)(2012-3#1)
was divided into two subgroups##3##5##(2007-8#1)(2009-4#1)(2011-2#1)
was divided into two##9##4##(2005-11#1)(2007-7#1)(2007-8#2)(2009-4#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
was divided into##47##3##(1990-12#1)(1991-3#2)(1997-2#1)(2005-1#1)(2005-11#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
was divided on##2##3##(2008-6#1)(2013-1#1)
was divided##56##2##(1990-12#1)(1991-3#2)(1997-1#1)(1997-2#1)(2005-1#1)(2005-11#1)(2005-8#3)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-7#1)(2010-8#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)
was documented by##8##3##(1994-9#1)(1996-6#1)(1997-6#2)(2006-10#1)(2007-12#1)(2012-2#1)(2013-8#1)
was documented in 7##2##4##(1991-4#1)(2008-7#1)
was documented in##18##3##(1991-4#1)(1991-7#1)(1991-8#1)(1992-3#1)(1993-8#1)(1995-2#1)(2006-2#1)(2007-9#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)(2012-12#1)(2012-2#2)
was documented that##2##3##(2007-11#1)(2008-8#1)
was documented##45##2##(1991-10#1)(1991-12#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-8#1)(1994-4#1)(1994-9#1)(1995-2#1)(1996-6#1)(1997-6#2)(2006-10#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-2#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-8#2)
was domesticated from##3##3##(2008-6#1)(2012-11#2)
was domesticated##4##2##(2008-10#1)(2008-6#1)(2012-11#2)
was dominant in the##5##4##(1992-3#1)(1995-11#2)(2008-10#1)(2010-8#1)
was dominant in##7##3##(1990-6#1)(1992-3#1)(1995-11#2)(2008-10#2)(2010-8#1)
was dominant##10##2##(1990-6#1)(1991-3#1)(1992-3#1)(1994-12#1)(1995-11#2)(1997-7#1)(2008-10#2)(2010-8#1)
was dominated by a##2##4##(1990-7#1)(2005-6#1)
was dominated by##16##3##(1990-2#1)(1990-7#1)(1993-8#2)(2005-6#1)(2007-5#1)(2008-10#1)(2008-5#2)(2009-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#2)
was done after a##2##4##(2007-8#1)(2008-7#1)
was done after##5##3##(2007-7#1)(2007-8#1)(2008-3#1)(2008-7#1)(2012-12#1)
was done and the##3##4##(2008-8#1)(2009-10#1)(2012-12#1)
was done and##17##3##(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#1)(2013-8#2)
was done at the##2##4##(1990-3#1)(1995-9#1)
was done at##14##3##(1990-3#1)(1992-2#1)(1995-12#1)(1995-9#1)(1996-2#1)(2004-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-7#1)(2013-1#1)(2013-8#1)
was done before and##2##4##(2008-10#1)(2012-2#1)
was done before##3##3##(1997-3#1)(2008-10#1)(2012-2#1)
was done by ELISA##2##4##(1993-11#1)(2013-1#1)
was done by HPLC##2##4##(1997-1#1)(2008-10#1)
was done by a##4##4##(2008-6#1)(2010-1#1)(2010-12#1)(2013-1#1)
was done by comparison##2##4##(2008-10#2)
was done by studying their##2##5##(2008-10#1)(2013-1#1)
was done by studying##3##4##(1997-1#1)(2008-10#1)(2013-1#1)
was done by the##4##4##(1994-6#1)(2008-10#1)(2008-7#1)(2013-8#1)
was done by using the##8##5##(2008-10#1)(2008-11#1)(2008-4#1)(2013-8#5)
was done by using##11##4##(2008-10#3)(2008-11#1)(2008-4#1)(2013-8#6)
was done by##62##3##(1991-2#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-8#1)(1997-1#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#2)(2010-1#1)(2010-12#2)(2010-6#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#4)(2013-8#11)
was done during##2##3##(2005-10#1)(2010-6#1)
was done for a##2##4##(1996-12#1)(2013-8#1)
was done for the##3##4##(2011-1#1)(2012-3#1)(2013-1#1)
was done for##14##3##(1996-12#1)(2006-4#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-7#1)(2009-5#1)(2011-1#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
was done from##3##3##(2007-7#2)(2009-6#1)
was done in a##4##4##(2008-10#1)(2011-2#3)
was done in one##2##4##(1994-8#1)(2007-11#1)
was done in order to##4##5##(1990-10#2)(2007-5#1)(2008-10#1)
was done in the##5##4##(2007-8#1)(2008-10#3)(2008-4#1)
was done in##51##3##(1990-10#2)(1994-10#1)(1994-12#2)(1994-8#1)(1996-5#1)(1997-1#1)(1997-6#1)(1997-8#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#6)(2008-10#5)(2008-12#4)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-1#1)(2010-12#1)(2011-1#2)(2011-2#6)(2013-1#1)(2013-7#1)(2013-8#1)
was done of##5##3##(2005-8#1)(2008-9#2)(2011-2#1)(2012-1#1)
was done on the basis of##2##6##(2007-11#1)(2007-7#1)
was done on the##5##4##(1993-12#1)(1995-8#1)(2007-11#1)(2007-7#1)(2008-5#1)
was done on##17##3##(1990-5#1)(1993-12#1)(1993-6#1)(1995-8#1)(1997-7#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-5#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-8#2)
was done only##2##3##(2009-10#1)(2010-8#1)
was done through the##3##4##(2012-12#2)(2012-2#1)
was done through##4##3##(1993-3#1)(2012-12#2)(2012-2#1)
was done to compare the##3##5##(2007-7#1)(2008-10#1)(2010-7#1)
was done to confirm##2##4##(2008-5#1)(2012-12#1)
was done to detect##2##4##(2007-7#2)
was done to determine the##2##5##(2008-5#1)(2013-8#1)
was done to identify##3##4##(2012-12#1)(2012-2#1)(2013-8#1)
was done to see##2##4##(2006-4#1)(2007-8#1)
was done to##38##3##(2004-12#1)(2006-4#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-9#1)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#6)
was done under general##2##4##(2007-7#1)(2013-8#1)
was done under local anaesthesia##2##5##(2007-7#1)(2011-1#1)
was done under local##3##4##(1992-12#1)(2007-7#1)(2011-1#1)
was done under##7##3##(1992-12#1)(2007-4#1)(2007-7#2)(2007-9#1)(2011-1#1)(2013-8#1)
was done using the##2##4##(1997-8#1)(2008-6#1)
was done using##15##3##(1990-2#1)(1990-8#1)(1996-5#1)(1997-8#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-5#1)(2008-6#1)(2010-8#1)(2012-2#2)(2013-1#1)
was done with a##3##4##(2006-12#1)(2007-7#1)(2007-8#1)
was done with the##7##4##(1990-8#1)(2007-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2012-12#1)
was done with two##2##4##(2008-10#1)(2011-1#1)
was done with##26##3##(1990-12#1)(1990-8#1)(1994-11#1)(2006-12#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-9#1)(2010-12#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
was done within##3##3##(2012-3#1)(2013-1#2)
was done##360##2##(1990-10#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#2)(1991-2#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-1#2)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-1#3)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-1#1)(2004-12#1)(2004-2#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#3)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#7)(2007-12#4)(2007-2#2)(2007-3#3)(2007-4#1)(2007-5#3)(2007-7#20)(2007-8#22)(2007-9#4)(2008-1#1)(2008-10#30)(2008-11#2)(2008-12#6)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#15)(2008-6#6)(2008-7#12)(2008-8#2)(2008-9#4)(2009-10#2)(2009-11#1)(2009-5#4)(2009-6#5)(2009-8#1)(2010-1#2)(2010-12#4)(2010-4#1)(2010-6#2)(2010-7#3)(2010-8#3)(2011-1#11)(2011-12#2)(2011-2#16)(2011-3#1)(2012-1#3)(2012-12#11)(2012-2#18)(2012-3#3)(2013-1#19)(2013-7#1)(2013-8#30)
was dose dependent and##4##4##(1990-7#1)(1991-1#1)(1995-7#1)(1997-8#1)
was dose dependent##10##3##(1990-2#1)(1990-7#1)(1991-1#1)(1993-6#1)(1994-11#2)(1995-5#1)(1995-7#1)(1997-8#1)(2008-11#1)
was dose##14##2##(1990-2#1)(1990-7#1)(1991-1#1)(1993-6#1)(1994-11#2)(1995-12#1)(1995-2#1)(1995-5#2)(1995-7#1)(1997-5#1)(1997-8#1)(2008-11#1)
was dose-##2##2##(1990-11#1)(1997-3#1)
was dose-dependent and also##2##4##(1992-9#1)(2004-12#1)
was dose-dependent and##4##3##(1992-9#1)(1994-12#1)(1994-2#1)(2004-12#1)
was dose-dependent in##2##3##(2008-11#1)(2008-5#1)
was dose-dependent##25##2##(1990-10#1)(1991-12#1)(1992-11#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-4#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-8#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-1#1)(2004-12#1)(2008-11#1)(2008-5#1)(2010-10#1)
was dose-dependently inhibited by the##2##5##(1994-6#1)(1996-6#1)
was dose-dependently inhibited by##4##4##(1994-12#1)(1994-6#1)(1995-6#1)(1996-6#1)
was dose-dependently##6##2##(1994-12#1)(1994-6#1)(1995-3#1)(1995-6#1)(1996-6#1)(2012-3#1)
was dose-limiting##2##2##(2005-8#1)(2008-5#1)
was dose-related##3##2##(1990-5#1)(1992-10#1)(1994-6#1)
was doubled to##2##3##(2008-11#2)
was doubled##4##2##(1997-5#1)(2008-11#3)
was doubly##2##2##(1991-3#1)(2008-10#1)
was down to##4##3##(1997-4#1)(2008-10#2)(2008-11#1)
was down##7##2##(1997-4#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2012-12#1)
was down-regulated##10##2##(1992-5#1)(1992-9#1)(1993-8#1)(1995-11#1)(2006-9#1)(2008-8#2)(2009-4#1)(2010-12#1)(2011-1#1)
was downregulated in##4##3##(2009-8#1)(2010-1#1)(2010-12#1)(2012-2#1)
was downregulated##9##2##(1992-9#1)(1996-8#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2012-2#1)(2013-1#1)
was drafted##2##2##(2007-6#1)(2008-5#1)
was drained##7##2##(1990-5#1)(1992-1#1)(1993-10#1)(1993-12#1)(2006-8#1)(2008-1#1)(2012-2#1)
was dramatic##2##2##(2007-12#1)(2013-1#1)
was dramatically decreased##2##3##(1995-7#1)(2013-1#1)
was dramatically increased##5##3##(1997-7#1)(2007-11#1)(2008-10#1)(2008-3#1)(2013-8#1)
was dramatically induced##2##3##(1990-4#1)(1990-7#1)
was dramatically reduced##5##3##(1994-2#1)(1996-4#1)(1997-8#1)(2012-12#2)
was dramatically repressed##2##3##(1994-2#1)(2008-8#1)
was dramatically##22##2##(1990-4#1)(1990-7#2)(1994-2#2)(1995-1#1)(1995-7#1)(1996-4#1)(1997-7#1)(1997-8#1)(2004-4#1)(2007-11#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-8#1)(2012-12#2)(2013-1#1)(2013-8#1)
was drastically enhanced by##2##4##(2009-2#2)
was drastically reduced##3##3##(1995-7#1)(2008-10#1)(2012-11#1)
was drastically##8##2##(1995-7#1)(2008-10#2)(2009-2#2)(2010-12#1)(2011-2#1)(2012-11#1)
was drawn at##2##3##(2007-10#1)(2010-5#1)
was drawn before##2##3##(2007-11#1)(2010-6#1)
was drawn from the##2##4##(2006-8#1)(2010-2#1)
was drawn from##6##3##(2006-4#1)(2006-8#1)(2008-10#1)(2008-11#1)(2010-2#1)(2011-1#1)
was drawn into the syringe##3##5##(2008-10#3)
was drawn to the##3##4##(2005-8#1)(2006-10#1)(2009-7#1)
was drawn##20##2##(2005-8#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-11#1)(2009-7#1)(2010-2#1)(2010-5#2)(2010-6#1)(2011-1#1)(2013-1#1)
was dried and##3##3##(2008-10#2)(2008-5#1)
was dried##7##2##(2008-10#5)(2008-5#2)
was drilled##5##2##(2005-5#2)(2005-9#2)(2008-5#1)
was driven by a##2##4##(1994-12#1)(2008-11#1)
was driven by an##3##4##(2006-8#1)(2007-12#1)(2008-11#1)
was driven by the##3##4##(1997-6#1)(2009-2#1)(2013-1#1)
was driven by##11##3##(1994-12#1)(1997-6#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-11#2)(2009-11#1)(2009-2#1)(2010-11#1)(2013-1#1)
was driven##13##2##(1991-9#1)(1994-12#1)(1997-6#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-11#2)(2009-11#1)(2009-2#1)(2010-11#1)(2013-1#1)
was dropped from##2##3##(2007-1#1)(2008-2#1)
was dropped##4##2##(2007-1#1)(2007-8#1)(2008-2#1)(2009-8#1)
was drug##2##2##(1990-9#1)(2007-8#1)
was due in part to##2##5##(1990-2#1)(2007-7#1)
was due largely to##2##4##(2007-12#1)(2008-10#1)
was due mainly to##4##4##(1994-8#1)(1996-11#1)(2008-10#1)(2008-7#1)
was due only to##2##4##(1990-11#1)(2008-10#1)
was due primarily to the##2##5##(1996-9#1)(2008-10#1)
was due primarily to##3##4##(1992-6#1)(1996-9#1)(2008-10#1)
was due to a decrease in##2##6##(1992-8#1)(1993-8#1)
was due to a decrease##3##5##(1992-8#1)(1993-8#1)(1996-1#1)
was due to a##20##4##(1990-10#1)(1991-6#1)(1992-8#1)(1993-4#1)(1993-8#1)(1994-12#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-1#2)(1997-1#1)(1997-4#1)(1997-7#1)(2005-10#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)
was due to an increase in the##2##7##(1990-5#1)(2008-4#1)
was due to an increase##3##5##(1990-5#1)(1990-7#1)(2008-4#1)
was due to an##10##4##(1990-2#1)(1990-5#1)(1990-7#1)(1992-11#1)(1993-12#1)(1995-12#1)(1996-10#1)(1997-8#1)(2007-10#1)(2008-4#1)
was due to both##3##4##(1990-3#1)(1994-6#1)(2008-9#1)
was due to changes in##2##5##(1991-10#1)(1997-2#1)
was due to differences in isolates between groups##2##8##(2008-10#2)
was due to differences in##4##5##(1994-2#1)(1995-3#1)(2008-10#2)
was due to inhibition of the##2##6##(1993-6#1)(2008-10#1)
was due to inhibition of##3##5##(1993-6#1)(1995-3#1)(2008-10#1)
was due to its##2##4##(1992-6#1)(1995-10#1)
was due to the fact that##2##6##(1990-8#1)(2008-7#1)
was due to the formation of##2##6##(1991-9#1)(1996-12#1)
was due to the presence of##2##6##(1997-7#1)(2007-12#1)
was due to the##34##4##(1990-8#1)(1991-10#1)(1991-2#1)(1991-9#2)(1994-11#1)(1994-9#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-9#1)(2006-10#2)(2007-12#2)(2007-4#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)
was due to their##2##4##(1991-2#1)(1997-3#1)
was due to##169##3##(1990-10#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-10#2)(1991-2#4)(1991-4#1)(1991-6#1)(1991-9#2)(1992-11#1)(1992-6#1)(1992-8#1)(1993-10#2)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#2)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#3)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#2)(1997-7#2)(1997-8#2)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#18)(2008-11#5)(2008-2#1)(2008-3#9)(2008-4#4)(2008-5#3)(2008-7#2)(2008-9#2)(2009-4#1)(2010-3#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#7)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
was due##189##2##(1990-10#1)(1990-11#1)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-10#2)(1991-2#4)(1991-4#1)(1991-6#1)(1991-9#2)(1992-11#1)(1992-6#2)(1992-8#1)(1993-10#2)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#3)(1996-1#2)(1996-10#1)(1996-11#3)(1996-12#1)(1996-2#3)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#2)(1997-7#2)(1997-8#2)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-9#1)(2007-10#3)(2007-11#3)(2007-12#4)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#23)(2008-11#6)(2008-2#1)(2008-3#9)(2008-4#4)(2008-5#3)(2008-7#3)(2008-9#2)(2009-4#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#7)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
was during the##2##3##(2007-7#1)(2010-10#1)
was during##3##2##(1991-5#1)(2007-7#1)(2010-10#1)
was dynamically##4##2##(2006-11#1)(2008-10#2)(2009-10#1)
was earlier##4##2##(1993-2#1)(1996-1#1)(2008-10#1)(2013-1#1)
was early##2##2##(1997-8#1)(2008-10#1)
was easier to##4##3##(2008-10#1)(2008-11#1)(2012-1#1)(2012-2#1)
was easier##5##2##(2008-10#2)(2008-11#1)(2012-1#1)(2012-2#1)
was easily achieved##2##3##(2007-8#1)(2008-10#1)
was easily detected##3##3##(2007-1#1)(2008-10#1)(2011-1#1)
was easily removed##2##3##(2010-2#1)(2013-8#1)
was easily##31##2##(1992-12#2)(1993-3#1)(1994-11#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#8)(2008-11#3)(2008-3#1)(2008-5#2)(2008-6#1)(2009-3#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
was easy and##2##3##(1991-3#1)(2006-10#1)
was easy to perform##2##4##(1990-4#1)(2008-5#1)
was easy to##3##3##(1990-4#1)(2007-8#1)(2008-5#1)
was easy##8##2##(1990-4#1)(1991-3#1)(1992-11#1)(2006-10#1)(2007-12#1)(2007-8#2)(2008-5#1)
was eaten##2##2##(1991-11#2)
was effected by##6##3##(1991-11#1)(1992-2#1)(1993-9#1)(1994-2#1)(1995-1#1)(2007-11#1)
was effected with##2##3##(1990-8#1)(2008-10#1)
was effected##11##2##(1990-2#1)(1990-8#1)(1991-11#1)(1992-2#1)(1992-6#1)(1993-9#1)(1994-2#1)(1995-1#1)(2007-11#1)(2008-10#1)(2008-11#1)
was effective against##4##3##(2005-11#1)(2008-10#2)(2011-1#1)
was effective and well tolerated in##2##6##(2008-3#2)
was effective and well tolerated##3##5##(2008-3#2)(2011-2#1)
was effective and##5##3##(2006-2#1)(2008-3#2)(2008-5#1)(2011-2#1)
was effective at##5##3##(1990-2#1)(1991-12#1)(1993-3#1)(2008-10#1)(2012-2#1)
was effective for##7##3##(1991-3#1)(2005-12#1)(2006-8#1)(2007-8#2)(2008-10#2)
was effective in 88% of##2##5##(2007-11#1)(2011-2#1)
was effective in a##2##4##(2007-10#1)(2007-9#1)
was effective in achieving##2##4##(2008-12#1)(2012-2#1)
was effective in improving##3##4##(2004-9#1)(2007-8#1)(2010-3#1)
was effective in lowering the##2##5##(2007-10#1)(2008-1#1)
was effective in preventing##2##4##(1990-6#1)(2007-8#1)
was effective in reducing the##2##5##(2008-10#1)(2008-5#1)
was effective in reducing##5##4##(1990-5#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-5#1)
was effective in the treatment of##2##6##(2006-8#1)(2007-11#1)
was effective in the##3##4##(2006-8#1)(2007-11#1)(2008-11#1)
was effective in##53##3##(1990-12#1)(1990-5#1)(1990-6#1)(1992-2#1)(1993-8#1)(1994-10#2)(1994-5#1)(1994-9#1)(1995-12#2)(1997-1#1)(2004-9#1)(2005-11#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-2#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#3)(2008-7#1)(2009-12#1)(2009-6#1)(2010-1#1)(2010-3#1)(2011-2#3)(2012-11#1)(2012-2#1)(2013-1#1)
was effective on##2##3##(1990-5#1)(1993-12#1)
was effective to##4##3##(1996-1#1)(2007-8#1)(2008-10#1)(2008-8#1)
was effective##106##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-2#1)(1992-3#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-8#1)(1994-10#2)(1994-2#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#2)(1996-1#1)(1997-1#1)(1997-2#1)(2004-9#1)(2005-11#2)(2005-12#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#7)(2007-2#2)(2007-7#1)(2007-8#7)(2007-9#2)(2008-1#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2009-12#1)(2009-6#1)(2010-1#1)(2010-3#1)(2011-1#1)(2011-2#6)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)
was effectively inhibited by##2##4##(1996-2#1)(2008-8#1)
was effectively##20##2##(1992-6#1)(1993-2#1)(1994-11#1)(1995-6#1)(1996-2#1)(2004-11#1)(2006-10#1)(2008-10#4)(2008-11#3)(2008-5#1)(2008-8#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)
was efficacious in##2##3##(1994-11#1)(2006-8#1)
was efficacious##4##2##(1994-11#1)(1997-5#1)(2005-12#1)(2006-8#1)
was efficient and##2##3##(2007-8#1)(2012-2#1)
was efficient in##3##3##(1997-4#1)(2007-11#1)(2008-5#1)
was efficient##8##2##(1993-8#1)(1993-9#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-5#1)(2009-3#1)(2012-2#1)
was efficiently expressed in##2##4##(1990-4#1)(1992-3#1)
was efficiently##21##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-8#1)(1993-9#1)(1995-3#1)(1995-8#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-4#1)(2013-1#2)
was either a##3##3##(1991-5#1)(1996-1#1)(2012-1#1)
was either an##2##3##(2005-11#1)(2008-2#1)
was either increased or##2##4##(1991-9#1)(2008-10#1)
was either##50##2##(1990-11#1)(1990-2#1)(1990-6#2)(1990-7#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-8#1)(1993-12#1)(1994-10#1)(1995-2#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-8#1)(1997-1#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-9#2)(2005-11#1)(2005-4#1)(2006-12#1)(2006-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2011-1#1)(2012-1#1)(2012-2#4)(2013-1#1)
was elaborated for##2##3##(2007-3#1)(2011-2#1)
was elaborated from##2##3##(1990-11#1)(2007-11#1)
was elaborated##9##2##(1990-11#1)(1992-12#1)(1994-6#1)(2007-11#1)(2007-3#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-2#1)
was elderly##2##2##(1990-10#1)(2005-10#1)
was elected as##2##3##(2008-10#1)(2008-7#1)
was elected##6##2##(1995-1#2)(2008-10#1)(2008-7#1)(2009-7#1)(2013-8#1)
was electrically##3##2##(1996-12#1)(1997-5#1)(1997-6#1)
was electrochemically##5##2##(2007-9#1)(2008-10#3)(2009-3#1)
was electron##2##2##(1991-6#1)(2009-7#1)
was electroporated into##2##3##(2005-11#1)(2008-9#1)
was electrospun##2##2##(2008-5#2)
was electrostatically##2##2##(2008-10#2)
was elevated (P&lt##2##3##(2007-6#2)
was elevated above the normal range##2##6##(1995-10#2)
was elevated and##5##3##(1994-6#1)(1997-4#1)(2008-5#1)(2009-1#1)(2012-2#1)
was elevated at the##3##4##(1993-6#1)(2008-10#1)(2011-2#1)
was elevated at##6##3##(1990-5#1)(1993-6#1)(1995-5#1)(1996-5#1)(2008-10#1)(2011-2#1)
was elevated by DON##2##4##(2008-10#2)
was elevated by##8##3##(1993-6#1)(1993-8#1)(1994-8#1)(1997-8#1)(2008-10#3)(2012-2#1)
was elevated for##4##3##(2008-12#4)
was elevated from 0##2##4##(1994-7#1)(2006-8#1)
was elevated from##3##3##(1993-6#1)(1994-7#1)(2006-8#1)
was elevated in the##3##4##(1994-6#1)(1997-8#1)(2011-2#1)
was elevated in##18##3##(1990-11#1)(1990-2#1)(1993-6#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1997-8#1)(2007-9#2)(2008-3#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
was elevated significantly##3##3##(1994-8#1)(1995-5#1)(1996-9#1)
was elevated to##2##3##(2012-12#2)
was elevated with##2##3##(2008-9#1)(2013-1#1)
was elevated##76##2##(1990-11#1)(1990-2#2)(1990-5#1)(1991-4#1)(1991-7#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-6#4)(1993-8#1)(1994-2#1)(1994-6#2)(1994-7#1)(1994-8#3)(1995-1#2)(1995-10#2)(1995-2#1)(1995-3#1)(1995-5#2)(1996-5#1)(1996-7#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#3)(2006-8#1)(2007-6#2)(2007-9#2)(2008-10#5)(2008-11#1)(2008-12#5)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#2)(2013-8#1)
was elicited by the##2##4##(1991-2#1)(1993-12#1)
was elicited by##13##3##(1991-2#1)(1991-3#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-7#1)(1994-2#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-7#1)(2007-8#1)
was elicited using##2##3##(2012-1#1)(2013-8#1)
was elicited##25##2##(1991-2#1)(1991-3#1)(1991-9#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-7#1)(1994-2#1)(1995-5#1)(1997-5#2)(1997-7#1)(1997-8#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2009-10#1)(2012-1#1)(2012-12#1)(2013-8#1)
was eliminated after##2##3##(2008-10#1)(2008-8#1)
was eliminated and##2##3##(1990-2#1)(2008-10#1)
was eliminated by the##2##4##(1995-6#1)(2008-10#1)
was eliminated by##11##3##(1991-12#1)(1994-11#1)(1995-6#2)(1997-2#1)(1997-5#1)(2007-3#1)(2008-10#3)(2008-11#1)
was eliminated either by##2##4##(1992-8#1)(2008-10#1)
was eliminated from the##2##4##(1990-11#1)(2008-7#1)
was eliminated in##5##3##(1990-2#1)(1990-3#1)(1995-12#1)(2008-10#1)(2013-8#1)
was eliminated when##2##3##(1994-8#1)(2008-10#1)
was eliminated##37##2##(1990-11#1)(1990-2#2)(1990-3#1)(1991-1#1)(1991-12#1)(1991-5#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-6#2)(1996-2#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-5#1)(2007-3#1)(2008-10#10)(2008-11#1)(2008-7#1)(2008-8#1)(2009-9#1)(2012-2#1)(2013-8#2)
was elucidated as##4##3##(2007-1#3)(2008-4#1)
was elucidated by means of##3##5##(2006-12#2)(2007-1#1)
was elucidated by##10##3##(1990-4#1)(1994-8#1)(1996-2#1)(2006-12#2)(2007-1#3)(2007-11#1)(2012-3#1)
was elucidated on the basis of spectroscopic##2##7##(1994-3#1)(2007-11#1)
was elucidated##20##2##(1990-4#1)(1991-5#1)(1994-12#1)(1994-3#1)(1994-8#1)(1996-2#1)(2006-12#2)(2007-1#7)(2007-11#3)(2008-4#1)(2012-3#1)
was eluted at the##2##4##(1990-12#1)(2008-11#1)
was eluted from a##2##4##(1990-12#1)(1992-2#1)
was eluted from the column##2##5##(2008-10#2)
was eluted from the##4##4##(1997-8#1)(2008-10#3)
was eluted from##8##3##(1990-12#1)(1992-2#1)(1992-6#1)(1997-8#1)(2008-10#4)
was eluted with a##2##4##(2008-10#2)
was eluted with##9##3##(1990-11#1)(1993-6#1)(1995-2#2)(2005-4#1)(2007-8#1)(2008-10#3)
was eluted##26##2##(1990-11#3)(1990-12#2)(1990-8#1)(1992-2#1)(1992-6#1)(1993-3#1)(1993-6#1)(1995-2#2)(1995-7#1)(1997-8#2)(2005-4#1)(2007-8#2)(2008-10#7)(2008-11#1)
was embedded in the##2##4##(2007-1#1)(2008-8#1)
was embedded in##5##3##(2007-1#1)(2008-10#3)(2008-8#1)
was embedded##6##2##(2006-12#1)(2007-1#1)(2008-10#3)(2008-8#1)
was emitted in##2##3##(2007-8#1)(2008-2#1)
was emitted##4##2##(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)
was emphasized##2##2##(2005-7#1)(2013-1#1)
was empirically##3##2##(1997-3#1)(2010-12#1)(2012-2#1)
was employed and the##2##4##(1990-8#1)(2008-10#1)
was employed and##6##3##(1990-8#1)(1996-9#1)(2008-10#2)(2013-1#2)
was employed as a##3##4##(1990-2#1)(1991-12#1)(2008-2#1)
was employed as an##2##4##(2007-11#1)(2008-10#1)
was employed as the##9##4##(1997-3#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2012-3#1)
was employed as##17##3##(1990-2#1)(1991-12#1)(1997-3#1)(2007-11#1)(2008-10#7)(2008-2#2)(2008-3#2)(2008-5#1)(2012-3#1)
was employed for extraction##2##4##(2008-10#2)
was employed for quantitative determination##3##5##(2008-10#3)
was employed for quantitative measurement##2##5##(2008-10#2)
was employed for quantitative##5##4##(2008-10#5)
was employed for screening##2##4##(2008-10#1)(2008-5#1)
was employed for the determination of##7##6##(2008-10#6)(2011-1#1)
was employed for the quantitative##2##5##(1996-8#1)(2008-10#1)
was employed for the##16##4##(1994-11#1)(1996-8#1)(2007-8#2)(2008-10#9)(2008-12#1)(2008-3#1)(2011-1#1)
was employed for##39##3##(1994-11#1)(1996-3#1)(1996-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-10#24)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#2)
was employed in order to obtain##2##6##(2008-10#1)(2009-7#1)
was employed in order to##4##5##(1997-3#1)(2008-10#1)(2008-11#1)(2009-7#1)
was employed in the##3##4##(1991-12#1)(2007-8#1)(2013-1#1)
was employed in##16##3##(1990-12#1)(1991-12#1)(1993-1#1)(1997-3#1)(2006-6#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-11#1)(2009-7#1)(2010-4#1)(2012-12#1)(2013-1#1)
was employed to amplify##3##4##(1991-9#1)(1993-4#1)(1994-12#1)
was employed to analyze the##3##5##(2008-10#2)(2008-11#1)
was employed to build##2##4##(1994-12#1)(2007-11#1)
was employed to characterize the##2##5##(2008-10#2)
was employed to compare##2##4##(1991-1#1)(2008-10#1)
was employed to detect##4##4##(1995-2#1)(2005-11#1)(2008-10#2)
was employed to determine the##3##5##(1997-7#1)(2008-11#1)(2008-8#1)
was employed to determine##8##4##(1991-2#1)(1992-9#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-8#1)
was employed to drive the##2##5##(2007-8#1)(2008-10#1)
was employed to evaluate the effects of##2##7##(2008-6#1)(2013-8#1)
was employed to evaluate the##5##5##(1995-2#1)(2008-10#1)(2008-12#1)(2008-6#1)(2013-8#1)
was employed to evaluate##6##4##(1995-2#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-6#1)(2013-8#1)
was employed to generate##3##4##(1995-5#1)(2008-3#2)
was employed to identify##3##4##(1992-11#1)(1994-3#1)(2008-11#1)
was employed to investigate the##5##5##(1990-10#1)(1994-3#1)(2008-10#2)(2008-11#1)
was employed to measure the##2##5##(2008-10#1)(2008-3#1)
was employed to measure##3##4##(1991-8#1)(2008-10#1)(2008-3#1)
was employed to monitor##2##4##(2008-10#2)
was employed to obtain the optimum##2##6##(2008-10#1)(2013-1#1)
was employed to obtain##3##4##(2005-11#1)(2008-10#1)(2013-1#1)
was employed to produce##3##4##(1995-5#1)(2008-10#1)(2012-12#1)
was employed to study the##4##5##(2007-12#1)(2008-10#2)(2008-2#1)
was employed to study##6##4##(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2011-1#1)
was employed to##105##3##(1990-10#1)(1990-6#1)(1991-1#1)(1991-2#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-4#1)(1994-12#2)(1994-3#2)(1994-8#1)(1995-2#2)(1995-5#2)(1997-7#2)(2005-11#3)(2005-12#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-8#2)(2008-10#34)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-2#1)(2010-5#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#2)
was employed using##3##3##(2008-10#1)(2009-7#1)(2012-2#1)
was employed where##2##3##(2006-8#1)(2009-3#1)
was employed with##3##3##(1992-1#1)(2008-10#1)(2010-5#1)
was employed##234##2##(1990-10#1)(1990-12#3)(1990-2#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-8#1)(1995-2#2)(1995-5#2)(1995-9#1)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-7#2)(1997-8#1)(2005-11#3)(2005-12#2)(2005-3#1)(2005-9#1)(2006-12#2)(2006-6#1)(2006-8#2)(2007-11#6)(2007-12#5)(2007-4#1)(2007-8#8)(2008-10#86)(2008-11#7)(2008-12#2)(2008-2#6)(2008-3#8)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#4)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-5#3)(2011-1#3)(2011-12#2)(2011-2#3)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#2)
was enabled by a##2##4##(2007-5#1)(2008-7#1)
was enabled by the##2##4##(2011-3#1)(2013-8#1)
was enabled by##5##3##(2007-5#1)(2007-9#1)(2008-7#1)(2011-3#1)(2013-8#1)
was enabled##6##2##(1995-8#1)(2007-5#1)(2007-9#1)(2008-7#1)(2011-3#1)(2013-8#1)
was enacted##5##2##(1995-2#1)(2006-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
was encapsulated##2##2##(2008-10#1)(2008-12#1)
was enclosed##2##2##(1996-11#1)(2008-6#1)
was encoded by##4##3##(1995-3#1)(2007-11#2)(2007-12#1)
was encountered in##12##3##(1993-2#3)(1995-9#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-7#1)(2010-3#1)
was encountered that##2##3##(1990-9#1)(2013-1#1)
was encountered##21##2##(1990-9#1)(1992-8#1)(1993-2#3)(1994-3#1)(1995-5#1)(1995-9#1)(2006-8#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-7#2)(2010-3#1)(2010-9#1)(2012-2#1)(2013-1#1)
was encouraged##3##2##(2005-8#1)(2008-11#1)(2012-2#1)
was ended##2##2##(2006-11#1)(2013-1#1)
was enforced##2##2##(1990-4#1)(1992-6#1)
was engaged in##2##3##(2009-10#1)(2009-4#1)
was engaged##3##2##(1994-3#1)(2009-10#1)(2009-4#1)
was engineered##4##2##(1992-6#1)(1994-11#1)(1994-9#1)(2006-12#1)
was enhanced 10-fold by##2##4##(1991-6#1)(2008-10#1)
was enhanced 10-fold##3##3##(1991-6#2)(2008-10#1)
was enhanced after##4##3##(1992-6#1)(1995-3#1)(1995-7#1)(2008-6#1)
was enhanced and##5##3##(1996-9#1)(1997-4#1)(2004-4#1)(2008-10#1)(2008-12#1)
was enhanced at low##2##4##(1990-10#1)(1992-3#1)
was enhanced at##5##3##(1990-10#1)(1992-3#1)(1996-7#1)(2005-11#1)(2008-10#1)
was enhanced but##2##3##(1996-10#1)(2008-5#1)
was enhanced by a##5##4##(1990-12#1)(1993-9#1)(2006-3#2)(2008-10#1)
was enhanced by decreasing##2##4##(1991-8#1)(2006-3#1)
was enhanced by pretreatment##2##4##(1994-12#1)(2008-6#1)
was enhanced by the addition of##2##6##(1992-9#1)(2008-10#1)
was enhanced by the presence of##3##6##(2008-10#1)(2008-5#1)(2008-6#1)
was enhanced by the##10##4##(1992-9#2)(1994-12#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-5#1)
was enhanced by##55##3##(1990-11#1)(1990-12#1)(1990-7#1)(1991-1#1)(1991-8#1)(1992-1#1)(1992-9#2)(1993-12#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#4)(1995-12#1)(1995-2#1)(1995-3#3)(1996-12#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#1)(2006-3#4)(2006-6#2)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)
was enhanced further by##2##4##(1996-6#1)(2007-11#1)
was enhanced further##3##3##(1996-6#1)(2007-11#1)(2008-4#1)
was enhanced in the presence of##4##6##(1991-5#1)(1992-8#1)(1996-6#1)(2005-11#1)
was enhanced in the##8##4##(1991-5#1)(1992-8#1)(1993-12#1)(1993-4#1)(1996-6#1)(2005-11#1)(2008-10#1)(2008-2#1)
was enhanced in##23##3##(1991-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-4#1)(1995-2#1)(1995-6#1)(1996-1#2)(1996-6#1)(1997-7#1)(2005-11#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2009-9#1)(2010-11#1)
was enhanced more##2##3##(1990-11#1)(2008-10#1)
was enhanced only when##2##4##(2006-8#1)(2008-10#1)
was enhanced only##6##3##(1990-5#1)(1993-7#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
was enhanced significantly##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
was enhanced when##5##3##(1992-7#1)(1993-6#1)(1996-12#1)(1996-8#1)(2012-2#1)
was enhanced with##5##3##(1994-12#1)(1996-5#1)(1997-2#1)(2007-6#1)(2010-4#1)
was enhanced##166##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-5#2)(1990-7#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#3)(1993-4#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#5)(1995-12#2)(1995-2#2)(1995-3#4)(1995-6#1)(1995-7#1)(1996-1#2)(1996-10#3)(1996-12#3)(1996-3#1)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#2)(1997-4#1)(1997-7#2)(1997-8#1)(2004-11#1)(2004-4#1)(2005-11#3)(2005-4#1)(2006-12#1)(2006-3#4)(2006-6#2)(2006-8#1)(2007-11#3)(2007-12#2)(2007-6#1)(2007-8#1)(2008-10#22)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#4)(2008-7#3)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#2)(2009-9#1)(2010-11#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
was enlarged##3##2##(1996-9#1)(2007-8#1)(2009-6#1)
was enough to##3##3##(1995-6#1)(2008-10#2)
was enough##5##2##(1995-6#1)(1997-7#1)(2008-10#3)
was enriched approximately##2##3##(1990-12#1)(1995-11#1)
was enriched in##9##3##(1990-2#1)(1992-9#1)(1993-6#1)(1995-6#1)(1996-5#2)(1996-8#1)(2008-10#1)(2012-3#1)
was enriched with##4##3##(1996-2#1)(2006-4#1)(2007-8#1)(2008-10#1)
was enriched##22##2##(1990-12#1)(1990-2#1)(1991-1#1)(1991-10#1)(1991-2#1)(1992-9#1)(1993-6#1)(1993-9#1)(1994-11#1)(1995-11#1)(1995-6#1)(1996-2#1)(1996-5#2)(1996-8#1)(1997-7#1)(2006-4#1)(2007-8#1)(2008-10#2)(2008-7#1)(2012-3#1)
was ensured by##3##3##(1996-1#1)(2006-7#1)(2008-10#1)
was ensured##6##2##(1990-3#1)(1996-1#1)(2006-7#1)(2008-10#2)(2008-5#1)
was entered##2##2##(1990-2#1)(2013-8#1)
was entirely##11##2##(1990-4#1)(1991-12#1)(1992-4#1)(1994-12#1)(1995-8#2)(1996-12#1)(2005-11#1)(2006-1#1)(2009-9#1)(2012-2#1)
was entrapped in the##2##4##(2008-10#2)
was entrapped in##3##3##(2008-10#3)
was entrapped##4##2##(2008-10#4)
was envisaged##2##2##(2008-5#1)(2009-3#1)
was enzymatically active##3##3##(1990-12#1)(1994-8#1)(1995-8#1)
was enzymatically##7##2##(1990-11#1)(1990-12#1)(1994-2#1)(1994-8#1)(1995-8#1)(2008-10#1)(2008-5#1)
was equal among##2##3##(1997-1#2)
was equal or lower##2##4##(1996-7#1)(2007-8#1)
was equal or##3##3##(1996-7#1)(2007-8#1)(2008-10#1)
was equal to 0##2##4##(2008-10#1)(2008-5#1)
was equal to 1##3##4##(1993-12#1)(2008-10#1)(2012-3#1)
was equal to or greater##2##5##(1990-12#1)(1996-8#1)
was equal to or##5##4##(1990-12#1)(1996-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
was equal to the##3##4##(2007-11#1)(2008-9#1)(2012-12#1)
was equal to##21##3##(1990-12#2)(1993-12#1)(1996-8#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
was equal##30##2##(1990-12#2)(1993-12#1)(1996-7#1)(1996-8#1)(1997-1#2)(2006-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
was equally divided between##2##4##(1993-3#1)(2006-10#1)
was equally effective##2##3##(1992-12#1)(1996-10#1)
was equally potent in##2##4##(1992-3#2)
was equally##17##2##(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#2)(1993-3#1)(1996-10#1)(1996-7#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-9#2)(2008-11#2)(2008-8#1)
was equilibrated with##3##3##(1996-6#1)(2008-10#1)(2012-12#1)
was equipotent##4##2##(1992-5#1)(1994-11#1)(1994-9#1)(1996-2#1)
was equipped with##2##3##(2007-11#1)(2008-11#1)
was equivalent in##4##3##(1990-2#1)(1991-5#1)(2008-10#1)(2012-12#1)
was equivalent to a##3##4##(2008-10#2)(2013-7#1)
was equivalent to that of##2##5##(2008-10#1)(2010-7#1)
was equivalent to the##4##4##(1990-3#1)(1992-8#1)(1993-12#1)(2005-11#1)
was equivalent to##14##3##(1990-3#1)(1992-3#1)(1992-8#1)(1993-12#1)(2005-11#1)(2007-7#1)(2008-10#4)(2010-7#1)(2011-2#1)(2013-7#2)
was equivalent##23##2##(1990-2#1)(1990-3#2)(1991-5#1)(1992-3#1)(1992-8#1)(1993-12#1)(1995-10#1)(1995-11#1)(2005-11#1)(2007-7#1)(2008-10#5)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-7#2)
was eradicated in##2##3##(1990-2#1)(1993-9#1)
was eradicated##3##2##(1990-2#1)(1990-3#1)(1993-9#1)
was escalated from##2##3##(1990-12#1)(2010-3#1)
was escalated##3##2##(1990-12#1)(2007-7#1)(2010-3#1)
was especially evident##2##3##(1995-5#1)(1996-6#1)
was especially important##2##3##(2006-8#1)(2008-11#1)
was especially##12##2##(1995-5#2)(1996-6#1)(1997-8#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
was essential for the##6##4##(1994-9#1)(1997-2#2)(2008-8#1)(2011-2#1)(2013-1#1)
was essential for##18##3##(1990-6#1)(1991-9#1)(1994-9#1)(1995-10#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-2#2)(2007-7#1)(2008-10#2)(2008-7#1)(2008-8#3)(2011-2#1)(2013-1#1)
was essential to##2##3##(2008-10#1)(2008-8#1)
was essential##28##2##(1990-6#1)(1991-9#1)(1992-4#1)(1994-9#1)(1995-10#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-7#1)(2007-6#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#4)(2011-2#1)(2012-3#1)(2013-1#1)
was essentially identical##2##3##(1994-3#1)(2008-7#1)
was essentially inactive##3##3##(1991-8#1)(1992-12#1)(1995-2#1)
was essentially no##2##3##(1993-8#1)(2011-12#1)
was essentially the same as##2##5##(1992-2#1)(1995-6#1)
was essentially##28##2##(1990-5#1)(1991-2#1)(1991-3#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-8#2)(1994-11#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-12#2)(2011-2#1)
was established (genes##2##3##(2008-10#2)
was established after##7##3##(1990-10#1)(1992-4#1)(2007-8#1)(2008-10#2)(2008-3#1)(2012-12#1)
was established and the##2##4##(2010-1#1)(2011-1#1)
was established and##11##3##(1992-8#1)(1995-1#1)(2005-11#1)(2007-11#1)(2008-1#1)(2008-10#2)(2010-1#1)(2011-1#2)(2011-2#1)
was established as an##2##4##(2009-11#2)
was established as the##6##4##(1994-3#1)(1995-5#1)(1996-6#1)(2008-10#1)(2010-12#1)(2012-1#1)
was established as##18##3##(1991-7#1)(1992-11#1)(1994-3#1)(1995-5#1)(1996-6#1)(2007-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2009-11#2)(2010-12#1)(2012-1#1)(2013-1#1)
was established based on##4##4##(2007-1#1)(2008-10#1)(2008-4#1)(2013-1#1)
was established between the##3##4##(2008-10#2)(2008-4#1)
was established between##7##3##(1991-8#1)(1992-2#1)(2008-10#3)(2008-4#1)(2008-5#1)
was established both by##2##4##(1992-3#1)(2006-12#1)
was established by a##2##4##(1992-8#1)(2008-11#1)
was established by comparison##2##4##(1990-3#1)(2008-3#1)
was established by demonstrating##2##4##(1990-8#2)
was established by echocardiography and##2##5##(2010-7#1)(2012-3#1)
was established by the##3##4##(1995-12#1)(1995-2#1)(2006-4#1)
was established by##47##3##(1990-3#2)(1990-5#1)(1990-8#2)(1992-8#1)(1993-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-4#1)(2004-9#1)(2006-12#2)(2006-4#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#8)(2008-11#3)(2008-3#1)(2008-5#2)(2008-9#1)(2010-10#1)(2010-12#1)(2010-7#1)(2012-12#2)(2012-3#1)(2013-7#1)(2013-8#2)
was established for the##15##4##(1990-9#1)(1994-12#1)(2005-12#2)(2005-4#2)(2008-10#3)(2011-1#4)(2012-12#1)(2012-2#1)
was established for##25##3##(1990-9#1)(1991-2#1)(1994-12#1)(1995-1#1)(1995-6#1)(2005-12#2)(2005-4#2)(2008-10#5)(2008-11#1)(2010-2#1)(2011-1#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
was established from a##3##4##(1991-9#1)(1993-8#1)(1994-12#1)
was established from##7##3##(1991-9#1)(1993-8#1)(1994-11#1)(1994-12#1)(1996-5#1)(2007-1#1)(2008-11#1)
was established in 1986##2##4##(1993-3#1)(2006-2#1)
was established in 1999##2##4##(2007-6#1)(2008-7#1)
was established in all##2##4##(1996-10#1)(1997-3#1)
was established in both##2##4##(2011-1#1)(2011-2#1)
was established in order to##2##5##(2008-6#1)(2010-3#1)
was established in the##4##4##(1995-2#1)(1997-7#1)(2008-10#2)
was established in##50##3##(1991-2#1)(1991-4#1)(1991-8#1)(1992-8#1)(1993-3#1)(1995-2#1)(1995-4#1)(1996-1#1)(1996-10#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-5#1)(2005-6#1)(2006-2#1)(2006-3#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-1#2)(2008-10#3)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-3#2)(2010-9#1)(2011-1#1)(2011-2#3)(2011-7#1)(2012-2#1)(2012-8#1)
was established on a##3##4##(1993-6#1)(1996-6#1)(2008-5#1)
was established on the basis of the##2##7##(1994-6#1)(2011-12#1)
was established on the##3##4##(1992-8#1)(1994-6#1)(2011-12#1)
was established on##7##3##(1992-8#1)(1993-6#1)(1994-6#1)(1996-6#1)(2007-8#1)(2008-5#1)(2011-12#1)
was established only##2##3##(1992-11#1)(2007-12#1)
was established over##2##3##(2007-4#1)(2008-10#1)
was established prior to##2##4##(1992-10#1)(2008-10#1)
was established that the##4##4##(1992-3#1)(1995-9#1)(1996-3#1)(2008-10#1)
was established that##17##3##(1990-10#1)(1990-9#1)(1992-3#1)(1994-8#1)(1995-9#1)(1996-3#1)(2004-11#1)(2006-11#1)(2008-10#4)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
was established to assess the incidence of##2##7##(2012-2#2)
was established to assess the##3##5##(2012-2#3)
was established to determine##3##4##(2008-10#1)(2008-11#1)(2012-12#1)
was established to develop##2##4##(2007-10#1)(2008-5#1)
was established to promote##2##4##(1997-2#1)(2004-2#1)
was established to study##2##4##(1995-11#1)(2007-12#1)
was established to##24##3##(1990-6#1)(1994-1#1)(1994-9#1)(1995-11#1)(1996-2#1)(1996-3#2)(1997-2#1)(2004-2#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-11#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#3)
was established using a##2##4##(1996-8#1)(2008-11#1)
was established using two##2##4##(2007-8#1)(2013-1#1)
was established using##8##3##(1996-8#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2013-1#1)
was established via##2##3##(2006-12#1)(2007-1#1)
was established when it was used in##2##7##(2008-8#2)
was established when##5##3##(1992-2#1)(2008-8#4)
was established with a pair of monoclonal antibodies prepared against the##2##11##(1993-11#1)(1996-1#1)
was established with a##5##4##(1991-9#1)(1993-11#1)(1996-1#1)(2006-12#1)(2007-5#1)
was established with the##4##4##(2006-8#1)(2008-10#2)(2013-8#1)
was established with##14##3##(1991-9#1)(1992-3#1)(1993-11#1)(1995-9#1)(1996-1#1)(2006-12#1)(2006-8#1)(2007-5#1)(2008-10#3)(2011-2#1)(2012-2#1)(2013-8#1)
was established##358##2##(1990-10#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#2)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-10#2)(1992-11#3)(1992-2#3)(1992-3#3)(1992-4#1)(1992-8#4)(1993-1#1)(1993-11#1)(1993-3#3)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-9#2)(1996-1#2)(1996-10#1)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-7#2)(1997-8#1)(2004-11#1)(2004-2#1)(2004-9#1)(2005-11#2)(2005-12#2)(2005-4#4)(2005-5#2)(2005-6#1)(2006-11#1)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-1#6)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#11)(2008-1#3)(2008-10#62)(2008-11#12)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#15)(2008-6#3)(2008-7#6)(2008-8#11)(2008-9#5)(2009-11#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#8)(2011-12#2)(2011-2#11)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#8)(2012-2#11)(2012-3#2)(2012-8#1)(2013-1#4)(2013-7#2)(2013-8#8)
was esterified with##2##3##(1991-4#1)(1994-9#1)
was esterified##3##2##(1991-4#1)(1994-9#1)(2005-12#1)
was estimated according to##3##4##(1991-6#1)(2007-11#1)(2012-3#1)
was estimated among##2##3##(2008-10#1)(2008-4#1)
was estimated and a##2##4##(2008-6#1)(2011-2#1)
was estimated and##6##3##(2006-11#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-2#1)
was estimated as 0##5##4##(2008-10#3)(2008-12#1)(2008-5#1)
was estimated as##28##3##(1990-11#1)(1990-2#1)(1991-2#2)(1991-6#1)(1993-8#1)(1994-11#1)(1995-1#1)(1995-8#1)(1997-1#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)
was estimated at 0##2##4##(1997-6#1)(2008-10#1)
was estimated at 1##2##4##(2006-12#1)(2010-3#1)
was estimated at 10##2##4##(1992-12#1)(1994-3#1)
was estimated at 22##2##4##(2006-2#1)(2008-10#1)
was estimated at##27##3##(1991-10#1)(1991-4#1)(1992-11#1)(1992-12#1)(1992-2#1)(1994-11#1)(1994-3#1)(1994-5#1)(1997-6#2)(2006-12#1)(2006-2#1)(2008-1#2)(2008-10#5)(2008-9#1)(2009-5#1)(2009-9#1)(2010-3#1)(2011-2#2)(2012-12#1)(2013-7#1)
was estimated by a##2##4##(1993-3#1)(2008-10#1)
was estimated by analysis of##2##5##(2008-10#2)
was estimated by averaging##2##4##(1996-12#1)(2008-10#1)
was estimated by measuring the##2##5##(1994-2#1)(2008-10#1)
was estimated by quantitative##2##4##(2008-10#1)(2008-11#1)
was estimated by the##6##4##(1997-6#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-2#1)(2010-9#1)
was estimated by this##2##4##(2008-2#1)(2008-3#1)
was estimated by##46##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1991-5#1)(1992-7#1)(1993-2#1)(1993-3#1)(1994-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-6#1)(1997-8#1)(2006-8#1)(2007-8#1)(2008-10#13)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
was estimated for the##3##4##(1993-3#1)(2007-7#1)(2008-10#1)
was estimated for##7##3##(1993-3#1)(2007-1#1)(2007-5#1)(2007-7#1)(2008-10#2)(2011-1#1)
was estimated from the##7##4##(1991-6#1)(1995-11#1)(2005-11#1)(2008-10#2)(2008-7#1)(2013-8#1)
was estimated from##16##3##(1990-11#1)(1991-6#1)(1992-10#1)(1995-11#1)(2005-11#2)(2007-1#1)(2007-5#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#1)(2013-8#1)
was estimated in the presence of##2##6##(1997-4#1)(2011-2#1)
was estimated in the##3##4##(1996-3#1)(1997-4#1)(2011-2#1)
was estimated in##12##3##(1992-2#1)(1996-3#1)(1996-8#1)(1997-4#1)(1997-8#1)(2008-10#2)(2008-5#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
was estimated on##2##3##(1993-4#1)(2007-7#1)
was estimated that##2##3##(2007-7#1)(2008-11#1)
was estimated through##2##3##(2013-1#1)(2013-8#1)
was estimated to be 0##4##5##(2008-10#3)(2013-1#1)
was estimated to be 1##6##5##(1995-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2012-2#1)
was estimated to be 10##2##5##(1990-12#1)(1992-12#1)
was estimated to be 12##2##5##(2008-10#1)(2008-5#1)
was estimated to be 2##4##5##(1991-9#1)(2008-10#2)(2008-2#1)
was estimated to be 24##2##5##(2006-8#1)(2007-12#1)
was estimated to be 36##2##5##(1992-12#1)(2007-3#1)
was estimated to be 50##2##5##(1990-9#1)(1994-12#1)
was estimated to be 65##2##5##(1990-8#1)(1992-11#1)
was estimated to be about##4##5##(1992-12#1)(1995-5#1)(2005-11#1)(2008-10#1)
was estimated to be approximately##5##5##(1994-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
was estimated to be ca##2##5##(1990-10#1)(2008-10#1)
was estimated to be less than##4##6##(1991-1#1)(2008-10#1)(2008-3#2)
was estimated to be of the order of##2##8##(1990-4#1)(1992-3#1)
was estimated to be##83##4##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#4)(1992-3#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-5#1)(1995-1#1)(1995-11#2)(1995-5#1)(1997-6#2)(2004-11#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-3#2)(2007-7#2)(2008-10#17)(2008-11#1)(2008-2#4)(2008-3#5)(2008-5#2)(2009-10#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#3)
was estimated to have a molecular##2##6##(1994-8#1)(1996-5#1)
was estimated to have##6##4##(1990-5#1)(1991-5#1)(1994-8#1)(1996-5#1)(2006-8#1)(2011-2#1)
was estimated to range##2##4##(2008-10#1)(2010-3#1)
was estimated to##100##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#4)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-5#1)(1996-5#1)(1997-6#2)(2004-11#1)(2005-11#1)(2006-10#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#4)(2007-3#2)(2007-7#2)(2008-10#18)(2008-11#1)(2008-2#5)(2008-3#6)(2008-5#2)(2009-10#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#3)
was estimated using a##3##4##(1992-8#1)(1996-5#1)(2008-10#1)
was estimated using the##6##4##(1993-3#1)(1993-9#1)(2005-11#1)(2007-7#1)(2008-10#1)(2011-1#1)
was estimated using##17##3##(1992-8#1)(1993-3#1)(1993-9#1)(1996-5#1)(1997-2#1)(2005-11#1)(2007-7#1)(2008-10#6)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)
was estimated with a##2##4##(2006-10#1)(2007-8#1)
was estimated with the##3##4##(2007-8#1)(2008-5#1)(2008-6#1)
was estimated with##10##3##(2005-11#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-10#3)(2008-5#1)(2008-6#1)
was estimated##315##2##(1990-10#2)(1990-11#5)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#2)(1991-4#1)(1991-5#2)(1991-6#4)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#5)(1992-2#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-2#1)(1993-3#3)(1993-4#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#3)(1994-2#3)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#2)(1995-11#3)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#5)(1997-8#2)(2004-11#1)(2005-11#7)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-8#3)(2007-1#2)(2007-10#1)(2007-11#7)(2007-12#5)(2007-3#2)(2007-5#3)(2007-7#6)(2007-8#4)(2008-1#3)(2008-10#73)(2008-11#8)(2008-12#2)(2008-2#9)(2008-3#13)(2008-4#2)(2008-5#10)(2008-6#4)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#10)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#4)
was euthanized##4##2##(2007-2#3)(2009-4#1)
was evacuated##4##2##(1993-10#1)(2006-10#1)(2009-3#1)(2012-2#1)
was evaluated 24 h after##2##5##(1992-11#1)(1995-12#1)
was evaluated according to the##5##5##(1992-4#1)(2007-7#1)(2008-10#1)(2011-1#1)(2013-1#1)
was evaluated according to##10##4##(1990-12#1)(1992-4#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-3#1)(2011-1#1)(2013-1#1)(2013-8#1)
was evaluated after##8##3##(1992-4#1)(1995-2#1)(2004-9#1)(2006-2#1)(2007-3#1)(2008-10#2)(2009-3#1)
was evaluated against the##3##4##(1994-3#1)(2007-7#1)(2008-5#1)
was evaluated against##15##3##(1992-3#1)(1994-3#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-5#1)(2010-12#1)(2010-5#1)(2011-12#1)(2012-2#3)(2013-1#1)
was evaluated and compared with##2##5##(2008-10#2)
was evaluated and the##3##4##(2008-10#2)(2012-1#1)
was evaluated and##15##3##(1994-12#1)(2005-9#1)(2008-10#6)(2008-5#1)(2008-6#1)(2010-12#1)(2010-7#1)(2012-1#1)(2013-1#1)(2013-8#1)
was evaluated as a function of##5##6##(2008-10#3)(2008-11#1)(2010-2#1)
was evaluated as a tool to##2##6##(2008-10#1)(2010-4#1)
was evaluated as a##12##4##(1993-9#1)(2006-5#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2010-2#1)(2010-4#1)
was evaluated as the##4##4##(1997-8#1)(2008-10#1)(2011-1#1)(2011-2#1)
was evaluated as##24##3##(1993-9#1)(1994-9#1)(1997-8#1)(2005-10#1)(2006-5#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)
was evaluated at different##2##4##(2007-11#1)(2008-10#1)
was evaluated at the##5##4##(2007-9#1)(2008-10#3)(2013-8#1)
was evaluated at three##2##4##(2008-10#1)(2011-2#1)
was evaluated at##16##3##(2006-10#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-10#7)(2008-5#2)(2008-7#1)(2011-2#1)(2013-8#1)
was evaluated based on##2##4##(2007-8#1)(2008-10#1)
was evaluated before and after##3##5##(1996-6#1)(2006-12#1)(2007-9#1)
was evaluated before##4##3##(1996-6#1)(2006-12#1)(2007-9#1)(2012-1#1)
was evaluated by MRI##2##4##(2007-8#1)(2007-9#1)
was evaluated by MTT##2##4##(2007-2#1)(2011-3#1)
was evaluated by a##5##4##(2008-2#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
was evaluated by an##2##4##(1993-1#1)(2006-8#1)
was evaluated by analysis of##2##5##(2008-10#2)
was evaluated by analyzing##7##4##(1997-3#1)(2007-8#1)(2008-10#5)
was evaluated by applying##2##4##(2008-10#1)(2008-5#1)
was evaluated by assaying##3##4##(2008-10#1)(2008-5#1)(2010-5#1)
was evaluated by calculating##2##4##(2008-10#1)(2008-5#1)
was evaluated by comparing the##2##5##(1991-9#1)(2006-8#1)
was evaluated by comparing##7##4##(1991-9#1)(2004-3#1)(2006-8#2)(2007-4#1)(2008-10#2)
was evaluated by comparison of##2##5##(1993-7#1)(2006-10#1)
was evaluated by comparison with##4##5##(2008-10#3)(2008-2#1)
was evaluated by comparison##6##4##(1993-7#1)(2006-10#1)(2008-10#3)(2008-2#1)
was evaluated by determining##3##4##(1997-4#1)(2008-10#2)
was evaluated by exposing the##2##5##(1991-12#1)(1997-4#1)
was evaluated by light microscopy and##2##6##(1990-3#2)
was evaluated by light##3##4##(1990-3#2)(2004-9#1)
was evaluated by linear##2##4##(2008-10#1)(2010-2#1)
was evaluated by mass##2##4##(2011-2#2)
was evaluated by means of##8##5##(1991-12#1)(1993-9#1)(1996-12#1)(1997-3#1)(1997-4#1)(2008-10#2)(2008-5#1)
was evaluated by measuring the##5##5##(1990-11#1)(1993-4#1)(1994-8#1)(1997-2#1)(2008-5#1)
was evaluated by measuring##9##4##(1990-11#1)(1993-4#1)(1994-8#1)(1997-2#2)(2008-10#1)(2008-5#1)(2010-4#1)(2012-3#1)
was evaluated by performing##4##4##(2008-10#1)(2010-1#1)(2012-2#1)(2013-8#1)
was evaluated by standard##2##4##(2008-10#2)
was evaluated by testing##2##4##(2008-10#1)(2013-8#1)
was evaluated by the change in##2##6##(2007-2#1)(2007-8#1)
was evaluated by the same##2##5##(1996-11#1)(2012-1#1)
was evaluated by the##22##4##(1992-11#1)(1994-3#1)(1996-11#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#9)(2008-5#1)(2008-9#1)(2009-7#1)(2012-1#1)(2013-1#1)(2013-8#1)
was evaluated by two##2##4##(2008-5#1)(2012-12#1)
was evaluated by use of##2##5##(2008-2#1)(2008-3#1)
was evaluated by using different##2##5##(2011-1#1)(2012-12#1)
was evaluated by using the##3##5##(1992-3#1)(2008-10#1)(2012-12#1)
was evaluated by using##11##4##(1992-3#1)(2006-3#1)(2007-9#1)(2008-10#4)(2011-1#1)(2011-2#1)(2012-12#2)
was evaluated by##185##3##(1990-11#1)(1990-12#2)(1990-3#2)(1991-11#1)(1991-12#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-7#1)(1993-9#2)(1994-3#2)(1994-5#1)(1994-8#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-2#2)(1997-3#2)(1997-4#3)(1997-9#1)(2004-3#2)(2004-9#1)(2005-1#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-8#3)(2007-11#1)(2007-2#4)(2007-4#1)(2007-7#3)(2007-8#5)(2007-9#3)(2008-10#51)(2008-11#2)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#9)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#5)(2011-3#2)(2012-1#5)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#9)(2013-8#5)
was evaluated directly in##2##4##(1996-2#1)(2008-4#1)
was evaluated during##3##3##(2011-1#1)(2013-8#2)
was evaluated for its ability to##4##6##(2004-11#1)(2005-9#1)(2008-10#1)(2008-5#1)
was evaluated for its##13##4##(1993-2#1)(2004-11#1)(2005-9#1)(2007-8#2)(2008-10#5)(2008-5#1)(2009-2#1)(2010-12#1)
was evaluated for resistance to##2##5##(2008-10#2)
was evaluated for the determination of##4##6##(2008-10#3)(2010-5#1)
was evaluated for the extraction of##2##6##(1991-8#1)(2012-1#1)
was evaluated for the separation##2##5##(1997-8#1)(2007-8#1)
was evaluated for the treatment of##2##6##(1995-5#1)(2007-3#1)
was evaluated for the##23##4##(1991-8#1)(1994-5#1)(1995-5#1)(1997-2#1)(1997-8#1)(2006-6#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-5#1)(2010-5#1)(2010-9#1)(2012-1#1)(2012-12#1)(2013-1#2)
was evaluated for their##3##4##(2009-3#1)(2011-2#1)(2012-3#1)
was evaluated for use##2##4##(1992-6#1)(1997-1#1)
was evaluated for##72##3##(1991-8#1)(1992-6#1)(1993-2#1)(1993-9#1)(1994-5#2)(1995-5#1)(1997-1#1)(1997-2#1)(1997-8#1)(2004-11#1)(2005-8#1)(2005-9#1)(2006-6#1)(2007-3#1)(2007-7#1)(2007-8#3)(2008-10#24)(2008-5#4)(2008-7#1)(2009-10#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#4)
was evaluated from the##4##4##(1995-6#1)(2008-5#1)(2008-7#1)(2012-12#1)
was evaluated from##12##3##(1995-6#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)(2012-12#1)
was evaluated further##3##3##(1992-3#1)(2008-10#2)
was evaluated in 16##2##4##(1990-6#1)(2012-1#1)
was evaluated in 20##2##4##(1995-12#1)(2008-1#1)
was evaluated in 24##3##4##(2005-11#1)(2007-7#1)(2011-2#1)
was evaluated in a randomized##3##5##(1992-1#1)(2008-10#2)
was evaluated in a##15##4##(1991-4#1)(1992-1#1)(1992-8#1)(1993-2#1)(1996-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2011-2#2)(2012-1#1)(2012-12#1)
was evaluated in an experimental model of##2##7##(1997-5#1)(2008-5#1)
was evaluated in an##7##4##(1993-12#1)(1997-5#1)(2008-10#2)(2008-5#1)(2012-1#1)(2012-2#1)
was evaluated in bioassays##2##4##(2008-10#2)
was evaluated in greenhouse trials##2##5##(2008-10#2)
was evaluated in greenhouse##3##4##(2008-10#3)
was evaluated in mice##3##4##(1995-12#1)(2010-4#1)(2013-1#1)
was evaluated in order to##2##5##(2004-9#1)(2007-11#1)
was evaluated in patients with##2##5##(2008-3#1)(2012-12#1)
was evaluated in patients##3##4##(2008-3#1)(2012-12#2)
was evaluated in rats##4##4##(1996-12#1)(2005-11#1)(2008-10#1)(2009-3#1)
was evaluated in relation to##2##5##(2008-6#1)(2011-1#1)
was evaluated in terms of the##3##6##(2007-9#1)(2008-10#2)
was evaluated in terms of##6##5##(2005-5#1)(2007-9#1)(2008-10#3)(2008-2#1)
was evaluated in the current study##2##6##(2004-3#1)(2007-12#1)
was evaluated in the greenhouse##2##5##(2008-10#2)
was evaluated in the presence of##2##6##(1996-12#1)(2008-10#1)
was evaluated in the present study##2##6##(1993-4#1)(2008-7#1)
was evaluated in the##15##4##(1991-3#1)(1993-4#1)(1995-4#1)(1996-12#1)(2004-3#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-7#1)(2008-8#1)(2008-9#1)
was evaluated in this##2##4##(1991-2#1)(2007-9#1)
was evaluated in two##2##4##(2006-10#1)(2007-3#1)
was evaluated in vitro##5##4##(1993-3#1)(2007-3#1)(2007-8#1)(2008-10#1)(2010-4#1)
was evaluated in##138##3##(1990-3#2)(1990-4#1)(1990-6#1)(1990-7#1)(1991-2#2)(1991-3#1)(1991-4#2)(1992-1#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-8#1)(1994-1#1)(1994-9#2)(1995-10#1)(1995-12#2)(1995-2#1)(1995-4#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-3#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-8#1)(2004-3#1)(2004-4#1)(2004-8#1)(2004-9#1)(2005-11#2)(2005-5#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#3)(2007-4#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#31)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2010-4#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#4)(2012-12#6)(2012-2#1)(2013-1#4)(2013-7#1)
was evaluated on a##3##4##(2008-5#1)(2013-1#2)
was evaluated on the basis of the##2##7##(2006-4#1)(2007-11#1)
was evaluated on the basis of##6##6##(1993-11#1)(1994-10#1)(2006-4#1)(2007-11#1)(2007-8#2)
was evaluated on the##11##4##(1993-11#1)(1994-10#1)(1994-12#1)(1997-8#1)(2006-4#1)(2007-11#2)(2007-8#2)(2008-10#1)(2008-5#1)
was evaluated on##36##3##(1990-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-10#1)(1994-12#1)(1995-1#1)(1996-12#1)(1997-8#1)(2006-4#1)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#6)(2008-5#3)(2010-12#1)(2010-2#1)(2011-1#1)(2012-11#1)(2012-2#2)(2013-1#5)
was evaluated over a period of##2##6##(1990-3#1)(2008-10#1)
was evaluated over a##3##4##(1990-3#1)(2008-10#2)
was evaluated over##4##3##(1990-3#1)(2008-10#2)(2012-3#1)
was evaluated the##3##3##(2008-10#2)(2008-5#1)
was evaluated through the determination of##2##6##(2008-10#2)
was evaluated through the use of##2##6##(1991-12#1)(2012-3#1)
was evaluated through the##6##4##(1991-12#1)(2008-10#3)(2008-12#1)(2012-3#1)
was evaluated through##15##3##(1991-1#1)(1991-12#1)(2004-4#1)(2006-4#1)(2007-5#1)(2008-10#5)(2008-12#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
was evaluated to be 0##2##5##(1993-4#1)(2012-12#1)
was evaluated to be 1##3##5##(1993-4#1)(2008-10#1)(2008-3#1)
was evaluated to be##5##4##(1993-4#2)(2008-10#1)(2008-3#1)(2012-12#1)
was evaluated to determine##2##4##(1996-9#1)(2006-7#1)
was evaluated to##15##3##(1993-4#2)(1996-9#1)(2006-7#1)(2007-1#1)(2008-10#5)(2008-3#1)(2008-5#1)(2009-4#2)(2012-12#1)
was evaluated together with a##2##5##(2007-2#1)(2008-2#1)
was evaluated under##3##3##(2008-10#1)(2011-12#1)(2013-8#1)
was evaluated using a##12##4##(1995-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-8#1)(2010-12#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
was evaluated using an##2##4##(2010-9#1)(2011-2#1)
was evaluated using both##2##4##(2008-5#1)(2010-2#1)
was evaluated using crude acetic acid extracts##2##7##(1991-3#2)
was evaluated using different##2##4##(2007-11#1)(2008-10#1)
was evaluated using scanning electron microscopy##3##6##(2008-5#2)(2009-11#1)
was evaluated using the chi-square test##2##6##(2010-9#1)(2011-1#1)
was evaluated using the##17##4##(1992-12#1)(1993-9#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-3#1)
was evaluated using two##3##4##(2007-9#1)(2008-10#1)(2009-11#1)
was evaluated using##66##3##(1990-10#1)(1990-5#1)(1991-3#2)(1992-12#1)(1993-9#1)(1995-2#2)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#10)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#1)(2009-11#2)(2009-2#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#4)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#5)(2013-8#1)
was evaluated via##4##3##(2009-2#1)(2010-10#1)(2010-8#1)(2012-2#1)
was evaluated when##2##3##(2008-6#1)(2013-1#1)
was evaluated with a##5##4##(2008-10#1)(2008-11#1)(2008-3#1)(2012-3#1)(2013-7#1)
was evaluated with an##3##4##(2008-10#1)(2008-7#1)(2013-1#1)
was evaluated with reference##2##4##(2008-10#1)(2008-11#1)
was evaluated with regard to##2##5##(1996-9#1)(2006-5#1)
was evaluated with respect to the##2##6##(2008-10#2)
was evaluated with respect to##5##5##(1990-12#1)(1993-1#1)(2008-10#3)
was evaluated with the##8##4##(1990-5#1)(1990-7#1)(2007-1#1)(2007-2#1)(2007-8#1)(2008-10#2)(2013-1#1)
was evaluated with##40##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1993-1#1)(1996-9#1)(1997-7#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-2#1)(2007-8#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#3)(2013-7#1)
was evaluated##847##2##(1990-10#2)(1990-11#2)(1990-12#5)(1990-2#1)(1990-3#5)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#3)(1991-4#2)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#4)(1992-12#1)(1992-3#3)(1992-4#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#3)(1993-4#5)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#6)(1994-1#1)(1994-10#1)(1994-12#3)(1994-3#3)(1994-5#3)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-12#3)(1995-2#4)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-11#2)(1996-12#5)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#5)(1997-3#4)(1997-4#4)(1997-5#1)(1997-7#3)(1997-8#4)(1997-9#1)(2004-11#1)(2004-3#4)(2004-4#2)(2004-8#2)(2004-9#5)(2005-1#1)(2005-10#1)(2005-11#4)(2005-12#2)(2005-5#1)(2005-8#2)(2005-9#2)(2006-10#9)(2006-12#7)(2006-2#2)(2006-3#2)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#5)(2007-1#3)(2007-10#3)(2007-11#12)(2007-12#2)(2007-2#7)(2007-3#6)(2007-4#3)(2007-5#4)(2007-7#14)(2007-8#18)(2007-9#10)(2008-1#4)(2008-10#212)(2008-11#17)(2008-12#7)(2008-2#9)(2008-3#7)(2008-4#3)(2008-5#42)(2008-6#8)(2008-7#11)(2008-8#4)(2008-9#6)(2009-10#2)(2009-11#2)(2009-2#5)(2009-3#4)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#9)(2010-2#5)(2010-3#3)(2010-4#7)(2010-5#4)(2010-7#3)(2010-8#4)(2010-9#3)(2011-1#13)(2011-12#6)(2011-2#18)(2011-3#2)(2012-1#16)(2012-11#2)(2012-12#18)(2012-2#14)(2012-3#17)(2013-1#37)(2013-7#2)(2013-8#14)
was evaporated and the##2##4##(1992-7#1)(2008-10#1)
was evaporated to dryness and the residue##2##7##(1993-2#2)
was evaporated to dryness and the##3##6##(1993-2#2)(2008-10#1)
was evaporated to dryness and##4##5##(1993-2#2)(1996-8#1)(2008-10#1)
was evaporated to dryness##9##4##(1993-2#2)(1996-8#1)(1997-3#1)(2008-10#5)
was evaporated##15##2##(1991-8#1)(1992-7#1)(1993-2#2)(1996-8#1)(1997-3#1)(2008-10#7)(2008-11#1)(2008-5#1)
was even higher##4##3##(1992-9#1)(1996-2#1)(1996-3#2)
was even less##2##3##(1992-1#1)(2005-11#1)
was even more##5##3##(1995-3#1)(2007-12#1)(2008-5#1)(2010-3#1)(2011-1#1)
was even##22##2##(1990-5#2)(1991-11#1)(1992-1#1)(1992-9#1)(1993-10#1)(1993-3#1)(1993-6#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#2)(1997-4#1)(2005-11#1)(2007-12#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-1#1)(2012-2#1)
was evenly distributed##2##3##(2007-11#1)(2008-10#1)
was eventually diagnosed as##2##4##(2009-3#1)(2013-8#1)
was eventually diagnosed##3##3##(2007-2#1)(2009-3#1)(2013-8#1)
was eventually##10##2##(2007-2#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-3#1)(2010-12#1)(2013-8#3)
was ever##3##2##(1991-11#1)(1994-3#1)(2011-1#1)
was evidence for##4##3##(1991-9#1)(1992-2#1)(2005-10#1)(2007-10#1)
was evidence of construct validity##2##5##(2007-10#2)
was evidence of##16##3##(1992-5#1)(1993-12#1)(1994-3#1)(1995-5#1)(2004-4#1)(2005-7#1)(2006-8#2)(2007-10#2)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-3#1)
was evidence that the##2##4##(1994-11#1)(2008-5#1)
was evidence that##6##3##(1994-11#1)(2005-8#1)(2007-3#1)(2008-12#1)(2008-5#1)(2013-1#1)
was evidence##26##2##(1991-9#1)(1992-2#1)(1992-5#1)(1993-12#1)(1994-11#1)(1994-3#1)(1995-5#1)(2004-4#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-8#2)(2007-10#3)(2007-3#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-3#1)(2013-1#1)
was evidenced between##2##3##(1992-2#1)(2007-6#1)
was evidenced by its##2##4##(1997-5#1)(2010-3#1)
was evidenced by the##2##4##(2008-11#1)(2010-4#1)
was evidenced by##11##3##(1995-8#1)(1996-12#1)(1996-5#1)(1997-5#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-4#1)(2010-3#1)(2010-4#1)
was evidenced in the##2##4##(2008-10#1)(2010-9#1)
was evidenced in##4##3##(2008-10#1)(2010-9#1)(2011-2#1)(2013-1#1)
was evidenced##23##2##(1990-8#1)(1992-2#1)(1993-3#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-5#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2009-4#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#1)(2013-1#1)
was evident after##4##3##(1993-4#1)(1996-6#1)(2007-11#1)(2010-5#1)
was evident also in##2##4##(2004-9#1)(2008-3#1)
was evident at##4##3##(1994-3#1)(1995-9#1)(2008-8#1)(2011-2#1)
was evident by##2##3##(1997-3#1)(2012-1#1)
was evident for##7##3##(1994-3#1)(2008-10#2)(2008-5#1)(2008-6#1)(2012-3#1)(2013-7#1)
was evident from the##6##4##(2005-9#1)(2008-10#1)(2011-12#1)(2013-1#3)
was evident from##11##3##(1993-9#2)(1994-6#1)(1995-3#1)(2005-9#1)(2008-10#1)(2008-7#1)(2011-12#1)(2013-1#3)
was evident in both##3##4##(1993-12#1)(1993-2#1)(1996-10#1)
was evident in the##9##4##(1993-11#1)(1995-12#1)(1996-10#1)(1996-4#1)(1996-5#1)(2008-6#1)(2008-8#1)(2010-8#1)(2011-1#1)
was evident in##32##3##(1990-5#1)(1991-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-10#2)(1996-4#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-6#1)(2008-8#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-5#1)
was evident on##2##3##(1996-6#1)(2010-2#1)
was evident that the##2##4##(1993-12#1)(2008-10#1)
was evident that##4##3##(1993-12#1)(2007-5#1)(2008-1#1)(2008-10#1)
was evident throughout the##2##4##(1996-2#1)(2011-2#1)
was evident within##2##3##(1991-10#1)(2010-3#1)
was evident##99##2##(1990-10#1)(1990-12#1)(1990-5#2)(1991-10#1)(1991-12#1)(1991-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#2)(1993-9#2)(1994-10#1)(1994-3#3)(1994-6#2)(1994-9#1)(1995-12#2)(1995-3#2)(1995-8#1)(1995-9#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#3)(1996-6#2)(1996-8#1)(1996-9#1)(1997-3#3)(1997-4#1)(1997-6#1)(2004-4#1)(2004-9#1)(2005-9#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#4)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-3#1)(2012-5#1)(2013-1#3)(2013-7#1)
was evidently greater##2##3##(2004-4#1)(2008-10#1)
was evidently##3##2##(2004-4#1)(2008-10#1)(2009-10#1)
was evoked by##6##3##(1990-7#1)(1991-5#1)(1992-7#1)(1994-2#1)(1997-6#1)(2009-5#1)
was evoked##11##2##(1990-7#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-7#1)(1994-2#1)(1995-7#1)(1997-6#1)(2007-10#1)(2008-9#1)(2009-5#1)
was evolved##6##2##(1996-5#1)(1997-4#1)(2006-3#2)(2008-10#1)(2012-12#1)
was exacerbated by##3##3##(2005-12#1)(2008-10#1)(2011-10#1)
was exactly the same as##2##5##(1990-4#1)(1995-3#1)
was examined among##5##3##(2007-12#1)(2008-10#1)(2009-6#1)(2012-2#1)(2013-7#1)
was examined and an oral##2##5##(2008-5#2)
was examined and the##4##4##(1992-6#1)(1994-6#1)(2008-10#1)(2008-5#1)
was examined and##12##3##(1991-1#1)(1992-6#1)(1994-6#1)(1995-8#1)(1996-12#1)(2007-8#1)(2008-10#2)(2008-5#3)(2008-8#1)
was examined as a##7##4##(1994-5#1)(1997-2#1)(2007-12#1)(2008-10#2)(2010-1#1)(2012-2#1)
was examined as an##2##4##(2008-10#2)
was examined as well##2##4##(1996-11#1)(2008-5#1)
was examined as##14##3##(1991-12#1)(1994-5#1)(1996-11#1)(1997-2#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-5#1)(2010-1#1)(2012-2#1)
was examined at the##2##4##(1997-5#1)(2008-4#1)
was examined at##10##3##(1992-12#1)(1992-3#1)(1994-12#1)(1997-5#1)(1997-7#1)(2004-9#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-4#1)
was examined because of##3##4##(1993-7#1)(2011-2#1)(2012-3#1)
was examined because##4##3##(1993-7#1)(1994-5#1)(2011-2#1)(2012-3#1)
was examined both##2##3##(1993-4#1)(2008-10#1)
was examined by Northern blot analysis in##2##7##(1993-3#1)(1993-6#1)
was examined by Northern blot analysis##4##6##(1992-8#1)(1993-3#1)(1993-6#1)(1994-8#1)
was examined by Western##2##4##(1996-6#1)(2012-3#1)
was examined by a##2##4##(1990-3#1)(1991-2#1)
was examined by applying##2##4##(2004-4#1)(2008-10#1)
was examined by fitting##2##4##(2008-1#1)(2008-10#1)
was examined by flow cytometry##2##5##(2008-10#1)(2011-2#1)
was examined by immunohistochemistry##3##4##(1994-10#1)(1995-12#1)(1995-6#1)
was examined by manipulating whether##2##5##(2008-1#2)
was examined by manipulating##3##4##(2008-1#2)(2008-4#1)
was examined by means of##3##5##(1990-5#1)(2007-9#1)(2008-5#1)
was examined by measuring##3##4##(1992-11#1)(2008-10#1)(2008-11#1)
was examined by reverse##2##4##(1995-8#1)(2011-2#1)
was examined by the##3##4##(2008-10#2)(2010-2#1)
was examined by using##7##4##(1990-2#1)(1991-4#1)(1991-7#1)(2008-10#2)(2008-7#1)(2009-12#1)
was examined by##92##3##(1990-2#1)(1990-3#1)(1990-5#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-5#2)(1996-6#2)(1997-2#1)(1997-4#1)(1997-8#1)(2004-4#1)(2005-11#2)(2005-4#1)(2006-10#1)(2006-5#2)(2006-6#1)(2006-8#2)(2007-9#1)(2008-1#3)(2008-10#16)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#1)(2009-12#2)(2009-7#1)(2010-12#1)(2010-2#1)(2011-2#4)(2012-3#2)(2013-1#2)(2013-8#3)
was examined during the##2##4##(1990-10#1)(2008-5#1)
was examined during##5##3##(1990-10#1)(1990-5#1)(2008-10#1)(2008-5#1)(2012-8#1)
was examined following##3##3##(1990-7#1)(1993-3#1)(1997-6#1)
was examined for a##3##4##(2006-10#1)(2013-1#2)
was examined for its ability to##3##6##(2007-11#1)(2008-5#1)(2013-1#1)
was examined for its##10##4##(1990-4#1)(1992-5#1)(1994-3#1)(1995-2#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-5#1)(2010-12#1)(2013-1#1)
was examined for the##5##4##(1997-8#1)(2007-8#1)(2008-10#3)
was examined for##32##3##(1990-4#1)(1991-12#2)(1992-5#1)(1994-3#1)(1995-2#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-10#9)(2008-3#1)(2008-5#2)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#3)
was examined from##3##3##(1991-11#1)(1997-6#1)(2010-8#1)
was examined in 16##2##4##(1996-2#1)(2004-11#1)
was examined in a comprehensive population study##2##7##(1991-4#1)(1993-6#1)
was examined in a sample of##4##6##(2006-1#1)(2008-11#1)(2008-9#1)(2011-2#1)
was examined in a##21##4##(1991-1#1)(1991-4#1)(1991-8#1)(1993-6#2)(1994-8#1)(1996-11#1)(1996-7#1)(1997-2#1)(2006-1#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-2#2)(2013-1#2)
was examined in adult##2##4##(1996-12#1)(1997-2#1)
was examined in conscious##2##4##(1991-9#1)(1997-5#1)
was examined in cultured rat vascular smooth muscle cells (VSMC)##2##10##(1990-11#1)(1991-7#1)
was examined in cultured##5##4##(1990-11#1)(1990-8#1)(1991-7#1)(1994-6#1)(1997-6#1)
was examined in detail##2##4##(1992-8#1)(1996-8#1)
was examined in human##2##4##(1993-6#1)(2007-12#1)
was examined in liver##2##4##(1996-6#1)(2008-6#1)
was examined in male##2##4##(1990-7#1)(1994-2#1)
was examined in mice##2##4##(1995-11#1)(1996-4#1)
was examined in order to##3##5##(2007-3#1)(2008-10#2)
was examined in primary##2##4##(1990-7#1)(1993-12#1)
was examined in rat##2##4##(1993-3#1)(1993-6#1)
was examined in rats##5##4##(1992-11#1)(1993-2#1)(1993-7#1)(1994-5#1)(1995-12#1)
was examined in relation to##3##5##(1994-8#1)(2008-5#1)(2009-11#1)
was examined in the absence##2##5##(2008-10#1)(2011-2#1)
was examined in the presence of##3##6##(1990-2#1)(1991-7#1)(2008-11#1)
was examined in the present study##2##6##(1997-2#1)(1997-5#1)
was examined in the present##3##5##(1996-10#1)(1997-2#1)(1997-5#1)
was examined in the##31##4##(1990-2#1)(1990-5#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-8#1)(1993-7#1)(1995-12#1)(1996-10#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-7#1)(2004-2#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-6#2)(2008-8#1)(2010-8#1)(2011-2#1)
was examined in this study##3##5##(1997-8#1)(2008-10#1)(2008-5#1)
was examined in two##5##4##(1990-12#1)(1997-6#1)(2004-10#1)(2006-5#1)(2010-7#1)
was examined in vitro and in vivo##2##7##(1990-8#1)(2008-5#1)
was examined in vitro##4##4##(1990-8#1)(1991-10#1)(1993-4#1)(2008-5#1)
was examined in##165##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#3)(1990-8#2)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#2)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-4#1)(1993-6#6)(1993-7#2)(1993-8#2)(1993-9#2)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#3)(1995-10#1)(1995-11#2)(1995-12#5)(1995-6#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#5)(1996-9#2)(1997-2#3)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#1)(2004-10#1)(2004-11#1)(2004-2#1)(2004-9#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-5#3)(2007-12#4)(2007-3#1)(2007-9#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#5)(2008-6#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#2)(2009-4#1)(2010-7#2)(2010-8#5)(2011-2#4)(2013-1#2)(2013-8#1)
was examined on human##3##4##(1992-11#1)(1992-12#1)(1995-3#1)
was examined on##13##3##(1992-11#1)(1992-12#1)(1993-12#1)(1994-9#1)(1995-3#1)(1997-2#1)(1997-5#1)(2004-12#1)(2007-5#1)(2008-10#3)(2008-6#1)
was examined over a##2##4##(1991-9#1)(2013-7#1)
was examined through##2##3##(2006-10#1)(2010-8#1)
was examined to assess##2##4##(1994-6#1)(2008-5#1)
was examined to determine##3##4##(1990-10#1)(1994-12#1)(2005-8#1)
was examined to##12##3##(1990-10#1)(1994-12#1)(1994-6#1)(1995-11#1)(1997-7#1)(2005-8#1)(2008-10#3)(2008-5#1)(2010-8#2)
was examined using a##10##4##(1992-6#2)(1995-2#1)(1995-3#1)(2008-10#4)(2009-5#1)(2012-2#1)
was examined using an##6##4##(1991-9#1)(1992-3#1)(2004-11#1)(2008-11#1)(2008-5#1)(2011-2#1)
was examined using data from##2##5##(2008-12#1)(2009-10#1)
was examined using data##3##4##(2008-10#1)(2008-12#1)(2009-10#1)
was examined using light##3##4##(2007-12#1)(2008-10#1)(2009-7#1)
was examined using the fluorescent##2##5##(1990-2#1)(1995-3#1)
was examined using the##3##4##(1990-2#1)(1992-12#1)(1995-3#1)
was examined using treatments##2##4##(1990-5#1)(1994-2#1)
was examined using##58##3##(1990-2#3)(1990-5#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-9#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#1)(1994-2#3)(1994-3#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-5#1)(1997-4#1)(1997-5#1)(2004-11#1)(2004-4#1)(2005-11#1)(2006-11#1)(2007-12#3)(2007-4#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#2)(2009-10#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)
was examined whether##2##3##(2006-2#1)(2008-4#1)
was examined with a##2##4##(1996-2#1)(2008-9#1)
was examined with respect to##2##5##(1991-6#1)(1997-3#1)
was examined with the##3##4##(1995-5#1)(2008-10#1)(2009-10#1)
was examined with##15##3##(1991-6#1)(1992-12#1)(1993-11#1)(1995-5#1)(1995-9#1)(1996-2#1)(1997-3#1)(1997-7#1)(2005-11#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-10#1)
was examined##634##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#5)(1990-3#3)(1990-4#2)(1990-5#6)(1990-6#1)(1990-7#6)(1990-8#3)(1990-9#3)(1991-1#4)(1991-10#3)(1991-11#3)(1991-12#6)(1991-2#2)(1991-3#3)(1991-4#2)(1991-5#2)(1991-6#4)(1991-7#4)(1991-8#1)(1991-9#7)(1992-11#3)(1992-12#7)(1992-2#2)(1992-3#5)(1992-4#3)(1992-5#2)(1992-6#4)(1992-7#1)(1992-8#4)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#6)(1993-4#3)(1993-5#1)(1993-6#7)(1993-7#5)(1993-8#3)(1993-9#4)(1994-10#2)(1994-11#4)(1994-12#4)(1994-2#5)(1994-3#5)(1994-5#6)(1994-6#5)(1994-8#4)(1994-9#2)(1995-10#2)(1995-11#3)(1995-12#8)(1995-2#4)(1995-3#3)(1995-5#4)(1995-6#5)(1995-8#5)(1995-9#1)(1996-1#1)(1996-10#2)(1996-11#4)(1996-12#5)(1996-2#5)(1996-3#2)(1996-4#2)(1996-5#6)(1996-6#5)(1996-7#1)(1996-8#5)(1996-9#2)(1997-2#12)(1997-3#1)(1997-4#4)(1997-5#5)(1997-6#6)(1997-7#4)(1997-8#3)(2004-10#2)(2004-11#3)(2004-12#1)(2004-2#1)(2004-4#3)(2004-9#4)(2005-11#6)(2005-4#1)(2005-8#1)(2006-1#1)(2006-10#6)(2006-11#2)(2006-12#1)(2006-2#1)(2006-5#5)(2006-6#1)(2006-8#6)(2007-1#2)(2007-11#3)(2007-12#14)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-8#6)(2007-9#2)(2008-1#5)(2008-10#95)(2008-11#10)(2008-12#4)(2008-2#4)(2008-3#4)(2008-4#6)(2008-5#31)(2008-6#7)(2008-7#3)(2008-8#5)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2010-1#2)(2010-12#2)(2010-2#4)(2010-3#2)(2010-4#1)(2010-7#2)(2010-8#11)(2011-2#13)(2012-1#1)(2012-2#4)(2012-3#5)(2012-8#1)(2013-1#11)(2013-7#6)(2013-8#6)
was exceeded##2##2##(1991-3#1)(2013-8#1)
was excellent in##5##3##(1990-7#1)(1996-9#1)(2007-9#1)(2008-10#1)(2011-2#1)
was excellent with##3##3##(2007-8#1)(2008-10#2)
was excellent##36##2##(1990-7#1)(1991-8#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-9#1)(1996-8#1)(1996-9#1)(2004-9#1)(2006-8#1)(2007-3#1)(2007-6#1)(2007-8#2)(2007-9#2)(2008-10#8)(2008-5#2)(2008-7#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
was exceptionally##2##2##(1991-2#1)(2007-1#1)
was excessive##3##2##(1994-10#1)(2007-10#1)(2013-7#1)
was exchanged##2##2##(1995-5#1)(2008-10#1)
was excised and##3##3##(2007-10#1)(2009-1#1)(2011-2#1)
was excised by##2##3##(2007-8#1)(2011-12#1)
was excised through a##2##4##(2012-2#1)(2013-1#1)
was excised through##3##3##(2011-2#1)(2012-2#1)(2013-1#1)
was excised##24##2##(1992-12#1)(1997-6#1)(2005-10#1)(2005-11#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-1#1)(2009-3#1)(2010-12#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
was excited by##3##3##(1997-3#1)(2008-3#2)
was excited##5##2##(1997-3#1)(1997-7#1)(2008-3#3)
was excluded and##3##3##(1994-12#1)(2008-12#1)(2013-1#1)
was excluded by##3##3##(1991-6#1)(1993-7#1)(1995-2#1)
was excluded from the##3##4##(1994-7#1)(2007-9#1)(2008-10#1)
was excluded from##5##3##(1990-2#1)(1994-7#1)(1997-5#1)(2007-9#1)(2008-10#1)
was excluded in a##2##4##(1992-5#1)(1995-11#1)
was excluded in##3##3##(1992-5#1)(1995-11#1)(2011-1#1)
was excluded##20##2##(1990-2#1)(1991-6#1)(1992-5#1)(1993-7#1)(1994-12#1)(1994-7#1)(1995-11#1)(1995-2#1)(1997-5#1)(2006-9#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-3#1)(2011-1#1)(2012-12#2)(2013-1#1)
was exclusive of the##2##4##(1995-6#1)(1997-8#1)
was exclusive##3##2##(1994-3#1)(1995-6#1)(1997-8#1)
was exclusively present in##3##4##(2008-10#1)(2009-8#1)(2010-12#1)
was exclusively##13##2##(1991-12#1)(1992-8#1)(1994-9#1)(1995-6#1)(2006-8#1)(2007-8#2)(2008-10#2)(2009-7#1)(2009-8#1)(2010-12#1)(2011-1#1)
was excreted in##3##3##(1990-3#1)(1991-12#1)(1997-8#1)
was excreted##9##2##(1990-3#1)(1991-12#1)(1991-2#1)(1995-2#1)(1995-3#1)(1997-8#1)(2007-11#1)(2008-5#1)(2010-11#1)
was executed to##2##3##(2009-12#1)(2011-2#1)
was executed with##2##3##(1993-9#1)(2008-11#1)
was executed##10##2##(1993-2#1)(1993-9#1)(2005-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2009-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
was exerted by##2##3##(1992-12#1)(1994-12#1)
was exerted##3##2##(1990-11#1)(1992-12#1)(1994-12#1)
was exhausted##2##2##(2005-12#1)(2011-2#1)
was exhibited by##6##3##(1993-5#1)(2007-11#1)(2008-10#3)(2012-2#1)
was exhibited in##4##3##(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)
was exhibited##14##2##(1991-3#1)(1993-5#1)(1994-8#1)(2007-11#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-2#1)(2012-3#1)
was expanded by##2##3##(2007-12#1)(2008-8#1)
was expanded to include##2##4##(2008-10#1)(2012-2#1)
was expanded to##7##3##(2007-3#1)(2008-10#3)(2010-3#1)(2011-9#1)(2012-2#1)
was expanded##15##2##(1992-3#1)(1997-6#1)(1997-7#1)(2006-5#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-5#1)(2008-8#2)(2010-3#1)(2011-9#1)(2012-2#1)
was expected for##2##3##(1991-7#1)(1992-3#1)
was expected that##6##3##(1990-12#1)(1997-8#1)(2005-8#1)(2007-12#1)(2008-8#1)(2011-2#1)
was expected to be &lt##2##5##(2013-1#2)
was expected to be##6##4##(2005-8#1)(2006-12#1)(2008-10#1)(2013-1#3)
was expected to##13##3##(1997-4#1)(2005-11#2)(2005-8#2)(2006-12#1)(2008-10#2)(2008-7#1)(2012-12#1)(2013-1#3)
was expected##33##2##(1990-12#1)(1991-7#1)(1992-3#1)(1993-3#1)(1993-9#1)(1997-4#1)(1997-8#1)(2005-11#2)(2005-8#3)(2006-10#1)(2006-11#1)(2006-12#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#3)
was experienced as##2##3##(1992-5#1)(2010-8#1)
was experienced in##2##3##(2007-9#1)(2012-2#1)
was experienced##5##2##(1992-5#1)(2006-6#1)(2007-9#1)(2010-8#1)(2012-2#1)
was experimentally confirmed##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
was experimentally demonstrated by##2##4##(2007-12#1)(2008-3#1)
was experimentally demonstrated##5##3##(2007-12#1)(2008-3#4)
was experimentally determined to be##2##5##(2008-10#2)
was experimentally determined##5##3##(1994-3#1)(1997-3#1)(2008-10#2)(2011-2#1)
was experimentally evaluated##2##3##(2008-3#1)(2010-2#1)
was experimentally found to be##2##5##(2007-11#1)(2008-2#1)
was experimentally investigated##3##3##(2007-11#1)(2008-1#1)(2008-2#1)
was experimentally##33##2##(1994-3#1)(1995-11#1)(1997-3#1)(2005-11#1)(2005-12#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#7)(2008-7#2)(2008-9#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)
was explained by the##7##4##(1990-4#2)(1992-1#1)(1996-3#1)(2005-11#1)(2008-10#1)(2008-9#1)
was explained by##19##3##(1990-4#2)(1992-1#1)(1996-3#1)(2004-2#1)(2005-10#1)(2005-11#1)(2006-10#1)(2008-10#5)(2008-8#1)(2008-9#2)(2012-12#2)(2013-1#1)
was explained in terms of the##3##6##(2005-11#2)(2008-10#1)
was explained##27##2##(1990-4#2)(1992-1#1)(1996-3#1)(2004-2#1)(2005-10#1)(2005-11#4)(2006-10#1)(2008-10#9)(2008-12#1)(2008-8#1)(2008-9#2)(2012-12#2)(2013-1#1)
was explanted##5##2##(1997-8#1)(2007-7#1)(2007-8#1)(2012-2#1)(2013-1#1)
was explicitly##2##2##(2008-10#1)(2008-2#1)
was exploited for##4##3##(1992-11#1)(2007-11#1)(2008-10#1)(2009-6#1)
was exploited in order to##3##5##(2008-10#1)(2008-3#2)
was exploited to enhance##2##4##(2007-11#1)(2008-7#1)
was exploited to##5##3##(2007-11#1)(2008-10#2)(2008-7#1)(2008-8#1)
was exploited##13##2##(1992-11#1)(2007-11#2)(2008-1#1)(2008-10#4)(2008-3#2)(2008-7#1)(2008-8#1)(2009-6#1)
was explored as a##3##4##(1995-7#1)(2008-10#1)(2008-8#1)
was explored as##4##3##(1995-7#1)(2007-4#1)(2008-10#1)(2008-8#1)
was explored at the cellular level##2##6##(2008-10#2)
was explored by##6##3##(1991-10#1)(1995-8#1)(1997-4#2)(2008-10#2)
was explored for##3##3##(1995-5#1)(2008-10#1)(2008-3#1)
was explored in##4##3##(1990-12#1)(1996-6#1)(2008-3#1)(2009-10#1)
was explored to##2##3##(2008-10#1)(2008-3#1)
was explored using a##2##4##(1993-1#1)(2008-1#1)
was explored using##4##3##(1990-9#1)(1993-1#1)(2008-1#1)(2010-12#1)
was explored##51##2##(1990-12#1)(1990-9#1)(1991-10#1)(1992-3#1)(1993-1#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-6#1)(1997-2#1)(1997-4#2)(2005-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-3#4)(2008-8#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-7#1)(2013-1#3)(2013-8#1)
was exponentially##3##2##(1995-6#1)(2008-10#1)(2009-8#1)
was exposed directly onto##2##4##(2008-2#1)(2008-3#1)
was exposed to a##6##4##(1993-12#1)(1993-7#1)(1994-2#2)(2008-11#1)(2012-12#1)
was exposed to the##4##4##(1990-6#1)(1996-6#1)(2008-11#1)(2010-4#1)
was exposed to##27##3##(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1993-12#1)(1993-7#1)(1994-2#2)(1996-12#1)(1996-6#1)(1997-4#1)(1997-6#1)(2007-12#1)(2007-6#1)(2008-10#6)(2008-11#2)(2010-4#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-6#1)
was exposed with##2##3##(2005-9#1)(2007-8#1)
was exposed##37##2##(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1993-12#1)(1993-7#1)(1994-2#2)(1995-3#1)(1996-12#1)(1996-6#1)(1997-4#1)(1997-6#1)(2005-5#1)(2005-9#1)(2006-5#1)(2007-12#1)(2007-6#1)(2007-8#3)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#2)(2010-4#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-6#1)
was expressed abundantly##2##3##(1993-6#1)(1996-4#1)
was expressed alone##2##3##(1996-1#1)(1997-6#1)
was expressed and##3##3##(1990-9#1)(1991-10#1)(2012-2#1)
was expressed as a percentage of##2##6##(1997-2#1)(2008-5#1)
was expressed as a##8##4##(1991-12#1)(1992-6#1)(1997-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)
was expressed as the percentage of##2##6##(2006-6#1)(2008-10#1)
was expressed as the##5##4##(1994-12#1)(2006-6#1)(2008-10#2)(2008-5#1)
was expressed as##18##3##(1991-12#1)(1992-6#1)(1994-12#1)(1995-3#1)(1997-2#1)(2004-11#1)(2006-6#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#2)
was expressed at a##2##4##(1990-12#1)(1996-9#1)
was expressed at high levels##2##5##(1995-2#1)(1996-12#1)
was expressed at##6##3##(1990-12#1)(1995-2#1)(1996-12#1)(1996-9#1)(2008-10#1)(2008-8#1)
was expressed by a##4##4##(1991-4#1)(1996-9#1)(2008-10#1)(2008-11#1)
was expressed by all##2##4##(1993-3#1)(2008-7#1)
was expressed by the##3##4##(1993-3#1)(1994-12#1)(1996-5#1)
was expressed by##18##3##(1990-12#1)(1991-4#1)(1992-9#1)(1993-3#3)(1994-12#1)(1995-12#1)(1995-3#1)(1996-5#1)(1996-9#1)(2006-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2013-8#1)
was expressed from a##2##4##(1997-1#1)(2012-3#1)
was expressed from##5##3##(1994-3#1)(1997-1#1)(2007-7#1)(2012-3#2)
was expressed in COS-7 cells##2##5##(1997-7#1)(2008-9#1)
was expressed in E##13##4##(1991-4#1)(1991-9#1)(1992-11#1)(1992-6#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-2#1)(1996-10#1)(2005-11#1)(2008-9#1)(2011-1#1)
was expressed in Escherichia coli and purified to homogeneity##2##9##(1996-5#1)(1996-7#1)
was expressed in Escherichia coli as a##2##7##(1994-2#1)(1996-5#1)
was expressed in Escherichia coli to##2##6##(1990-12#1)(2009-3#1)
was expressed in Escherichia coli using the##2##7##(1993-8#1)(1993-9#1)
was expressed in Escherichia coli##16##5##(1990-11#2)(1990-12#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-4#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-2#1)(1996-5#2)(1996-7#1)(2009-3#1)
was expressed in Spodoptera frugiperda (Sf9) insect cells##2##8##(1992-3#1)(1993-12#1)
was expressed in Xenopus oocytes in##2##6##(1992-2#1)(1995-2#1)
was expressed in Xenopus oocytes##3##5##(1992-2#1)(1993-3#1)(1995-2#1)
was expressed in a##7##4##(1991-9#1)(1994-2#1)(1994-8#1)(1995-5#1)(1996-2#1)(1997-2#1)(2008-10#1)
was expressed in all##3##4##(2008-6#1)(2009-5#1)(2010-5#1)
was expressed in an##2##4##(1994-3#1)(1995-8#1)
was expressed in cells##2##4##(1993-3#1)(1994-8#1)
was expressed in human##2##4##(1990-8#1)(1995-2#1)
was expressed in insect##2##4##(1994-5#1)(1994-9#1)
was expressed in the##15##4##(1991-8#1)(1993-5#1)(1996-9#1)(1997-2#2)(2005-11#1)(2006-12#2)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#2)
was expressed in tobacco##2##4##(2006-12#1)(2008-10#1)
was expressed in transgenic##2##4##(2008-10#1)(2008-9#1)
was expressed in yeast##2##4##(1990-10#1)(1996-2#1)
was expressed in##120##3##(1990-10#1)(1990-11#2)(1990-12#2)(1990-8#1)(1991-12#2)(1991-2#1)(1991-4#4)(1991-8#1)(1991-9#3)(1992-11#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#3)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#4)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#2)(1995-2#6)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#2)(1997-2#3)(1997-4#2)(1997-7#2)(2005-11#2)(2006-12#4)(2007-6#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#4)(2009-3#2)(2009-5#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#2)
was expressed inE##2##3##(2008-8#1)(2008-9#1)
was expressed into##2##3##(1991-4#1)(1995-6#1)
was expressed on the cell surface##2##6##(1990-12#1)(1990-7#1)
was expressed on the##3##4##(1990-12#1)(1990-7#1)(1996-4#1)
was expressed on##9##3##(1990-12#1)(1990-2#1)(1990-7#1)(1991-3#1)(1991-9#2)(1992-8#1)(1996-4#1)(2007-10#1)
was expressed only in the##2##5##(1996-2#1)(1997-2#1)
was expressed only in##4##4##(1992-8#1)(1996-2#1)(1997-2#1)(2008-5#1)
was expressed only##6##3##(1992-4#1)(1992-8#1)(1996-12#1)(1996-2#1)(1997-2#1)(2008-5#1)
was expressed throughout the##3##4##(1991-5#1)(1992-12#1)(2006-12#1)
was expressed under the control of##3##6##(1990-8#1)(1992-12#1)(1997-4#1)
was expressed under the##4##4##(1990-8#1)(1992-12#1)(1997-2#1)(1997-4#1)
was expressed##234##2##(1990-10#1)(1990-11#2)(1990-12#6)(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#6)(1991-5#1)(1991-8#1)(1991-9#5)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#6)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#6)(1994-3#3)(1994-5#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#7)(1995-3#3)(1995-5#3)(1995-6#3)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#4)(1996-4#4)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#4)(1997-1#1)(1997-2#8)(1997-4#3)(1997-6#1)(1997-7#2)(2004-11#1)(2005-11#2)(2006-12#6)(2006-6#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#19)(2008-11#4)(2008-2#1)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#4)(2008-8#7)(2008-9#6)(2009-10#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#3)
was extended by##5##3##(1995-3#1)(1997-4#1)(2008-10#2)(2010-9#1)
was extended for the##2##4##(2008-10#1)(2008-3#1)
was extended for##3##3##(2008-10#2)(2008-3#1)
was extended from##3##3##(2008-10#1)(2008-11#2)
was extended into##2##3##(2007-5#1)(2009-4#1)
was extended to the##2##4##(2006-9#1)(2007-8#1)
was extended to##16##3##(1992-3#1)(1994-10#1)(1997-4#1)(2006-10#1)(2006-9#1)(2007-3#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-7#1)(2009-8#1)(2010-12#1)(2013-1#1)
was extended with##2##3##(1991-9#1)(2008-11#1)
was extended##37##2##(1991-9#1)(1992-3#1)(1994-10#1)(1995-3#1)(1997-4#2)(1997-5#1)(1997-8#3)(2006-10#1)(2006-9#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-3#3)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-9#1)(2013-1#1)
was extending##2##2##(2007-7#1)(2012-2#1)
was extensive##7##2##(1996-5#1)(1997-3#1)(1997-8#1)(2005-7#1)(2008-10#2)(2008-9#1)
was extensively and##2##3##(1996-5#1)(2008-5#1)
was extensively##13##2##(1990-4#1)(1992-1#1)(1995-8#1)(1996-5#1)(2006-5#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)(2010-11#1)(2013-1#1)
was extinguished##5##2##(1992-2#1)(2008-3#4)
was extracellular##2##2##(1991-4#1)(1996-6#1)
was extracted and##10##3##(1995-11#1)(1996-9#1)(1997-6#1)(1997-8#1)(2007-2#2)(2008-10#3)(2008-12#1)
was extracted by the##2##4##(2010-3#1)(2011-1#1)
was extracted by##7##3##(2008-10#1)(2008-12#1)(2008-8#1)(2010-3#1)(2011-1#2)(2012-12#1)
was extracted from soil##2##4##(2008-10#2)
was extracted from the blood##2##5##(2013-1#1)(2013-8#1)
was extracted from the##14##4##(1994-2#1)(2006-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-4#1)(2012-12#1)(2013-1#1)(2013-8#1)
was extracted from tissues##2##4##(1991-5#1)(2008-9#1)
was extracted from##62##3##(1990-2#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-12#1)(1994-2#1)(1994-3#1)(1996-5#1)(2004-11#1)(2006-10#1)(2006-8#2)(2007-8#2)(2008-10#16)(2008-11#1)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-11#1)(2010-6#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#4)
was extracted in##3##3##(2008-10#3)
was extracted into the##3##4##(2008-10#3)
was extracted into##6##3##(2008-10#6)
was extracted quantitatively with 10 ml of##2##7##(2008-10#2)
was extracted quantitatively##3##3##(2007-11#1)(2008-10#2)
was extracted to##3##3##(2008-10#2)(2009-6#1)
was extracted with TTCTOHA into octan-1-ol as##2##7##(2008-10#2)
was extracted with a##3##4##(1997-8#1)(2007-5#1)(2011-2#1)
was extracted with##25##3##(1995-6#1)(1996-4#1)(1996-6#1)(1997-8#1)(2005-12#1)(2006-3#1)(2007-1#1)(2007-5#1)(2008-10#8)(2008-11#2)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
was extracted##138##2##(1990-12#1)(1990-2#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-6#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-8#2)(2004-11#1)(2005-12#1)(2006-10#1)(2006-3#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-5#1)(2007-8#3)(2008-10#48)(2008-11#3)(2008-12#6)(2008-2#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#5)(2011-12#1)(2011-2#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#4)
was extremely high##2##3##(2008-6#1)(2009-5#1)
was extremely low in##2##4##(2009-7#1)(2012-12#1)
was extremely low##7##3##(1991-12#1)(1996-5#1)(2008-10#2)(2009-7#1)(2010-6#1)(2012-12#1)
was extremely##18##2##(1990-12#1)(1991-12#1)(1995-8#1)(1996-5#1)(2006-8#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-5#1)(2009-7#1)(2010-5#1)(2010-6#1)(2012-12#1)
was extubated the##2##3##(2007-8#1)(2012-2#1)
was extubated##4##2##(2006-4#1)(2007-8#1)(2012-2#2)
was fabricated and##6##3##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)
was fabricated as##2##3##(2008-3#1)(2008-5#1)
was fabricated by a##2##4##(2008-3#2)
was fabricated by coating a##2##5##(2008-10#2)
was fabricated by coating##4##4##(2008-10#3)(2013-1#1)
was fabricated by immobilizing##3##4##(1992-11#1)(2007-8#1)(2008-10#1)
was fabricated by use of##2##5##(2007-12#1)(2008-3#1)
was fabricated by##27##3##(1992-11#1)(2006-5#1)(2007-12#4)(2007-8#1)(2008-10#9)(2008-2#1)(2008-3#6)(2010-4#1)(2012-1#1)(2013-1#2)
was fabricated for##3##3##(2008-3#1)(2009-11#2)
was fabricated from a##2##4##(2008-10#1)(2008-2#1)
was fabricated from##4##3##(2008-10#2)(2008-2#1)(2009-2#1)
was fabricated in a##3##4##(2007-12#1)(2008-2#1)(2013-7#1)
was fabricated on##2##3##(2008-10#1)(2008-3#1)
was fabricated to investigate the characteristics of each component##2##9##(2008-3#2)
was fabricated using##5##3##(2006-12#1)(2006-5#1)(2008-10#2)(2008-2#1)
was fabricated##63##2##(1992-11#1)(2006-12#1)(2006-5#2)(2007-11#1)(2007-12#8)(2007-8#2)(2008-10#21)(2008-2#6)(2008-3#11)(2008-5#1)(2009-11#2)(2009-2#1)(2010-2#1)(2010-4#1)(2012-1#1)(2013-1#2)(2013-7#1)
was faced with the##2##4##(1997-1#1)(2008-11#1)
was faced with##3##3##(1993-1#1)(1997-1#1)(2008-11#1)
was facilitated by the##3##4##(1990-11#1)(2006-1#1)(2008-10#1)
was facilitated by##7##3##(1990-11#1)(1991-7#1)(1995-12#1)(2006-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
was facilitated##12##2##(1990-11#1)(1990-8#1)(1991-3#1)(1991-7#1)(1995-12#1)(1996-6#1)(1997-5#1)(2006-1#1)(2008-10#2)(2008-11#1)(2008-7#1)
was failure to achieve NED##2##5##(2013-1#2)
was fair##4##2##(1990-6#1)(2007-11#1)(2007-8#1)(2008-10#1)
was fairly rapid##2##3##(2008-10#1)(2008-5#1)
was fairly##6##2##(1992-1#1)(2005-11#1)(2008-10#1)(2008-5#1)(2010-7#1)(2013-8#1)
was far below##2##3##(1997-4#1)(2008-10#1)
was far from##2##3##(2007-3#1)(2009-10#1)
was far less##2##3##(2006-4#2)
was far more frequent than##2##5##(1997-3#1)(2007-2#1)
was far more##5##3##(1991-2#1)(1996-6#1)(1997-3#1)(2006-7#1)(2007-2#1)
was far##15##2##(1991-2#2)(1992-5#1)(1994-2#1)(1996-6#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-4#2)(2006-7#1)(2007-2#1)(2007-3#1)(2008-10#1)(2009-10#1)
was fast and##4##3##(2004-11#1)(2008-10#3)
was fast##5##2##(2004-11#1)(2008-10#4)
was faster and the##2##4##(2012-3#1)(2013-7#1)
was faster and##4##3##(1996-5#1)(2012-2#1)(2012-3#1)(2013-7#1)
was faster for##2##3##(1996-11#1)(2008-10#1)
was faster in the##3##4##(1991-5#1)(2008-11#1)(2008-8#1)
was faster in##7##3##(1991-5#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
was faster than that of 1-nitro-3-nitrosopyrene##2##6##(1992-7#2)
was faster than that of##3##5##(1992-7#2)(2008-10#1)
was faster than that##5##4##(1992-7#2)(2008-10#3)
was faster than##7##3##(1992-7#2)(1994-1#1)(1996-5#1)(2008-10#3)
was faster with##2##3##(1992-4#1)(2012-2#1)
was faster##28##2##(1990-7#1)(1991-5#1)(1992-4#1)(1992-7#2)(1994-1#1)(1996-11#1)(1996-5#2)(2004-11#1)(2007-12#1)(2007-9#2)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)(2012-2#2)(2012-3#1)(2013-7#1)
was fatal##4##2##(2007-12#1)(2007-2#1)(2010-8#1)(2012-2#1)
was favorable##11##2##(2005-10#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-8#1)(2009-6#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
was favored by a high##2##5##(2013-1#2)
was favored by##6##3##(1993-3#1)(2008-10#3)(2013-1#2)
was favored##7##2##(1993-3#1)(2008-10#3)(2008-12#1)(2013-1#2)
was favourable with##3##3##(2008-5#1)(2010-12#1)(2011-1#1)
was favourable##6##2##(2007-2#1)(2008-5#1)(2008-7#2)(2010-12#1)(2011-1#1)
was favoured by##2##3##(1990-5#1)(2006-9#1)
was favoured##4##2##(1990-5#1)(2006-9#1)(2010-12#1)(2010-9#1)
was feasible and##2##3##(2011-2#1)(2012-1#1)
was feasible##10##2##(2006-11#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-5#1)(2011-2#2)(2012-1#1)(2012-2#1)
was fed a vitamin##2##4##(1991-2#2)
was fed a##6##3##(1991-2#3)(1992-9#1)(1997-4#1)(2005-12#1)
was fed by##3##3##(2007-8#1)(2007-9#1)(2008-7#1)
was fed for##2##3##(1992-9#1)(2008-5#1)
was fed into the##2##4##(2008-10#1)(2008-5#1)
was fed on rat chow containing 15% (wt/wt)##2##8##(2009-5#2)
was fed on rat chow##3##5##(2009-5#3)
was fed to the##2##4##(2007-3#1)(2012-2#1)
was fed to##5##3##(1992-5#1)(1996-11#1)(2007-3#1)(2008-10#1)(2012-2#1)
was fed with a low-nutrition diet##2##6##(2011-2#2)
was fed with a normal diet##2##6##(2011-2#2)
was fed with a##7##4##(2008-5#2)(2011-2#5)
was fed with##9##3##(2007-1#2)(2008-5#2)(2011-2#5)
was fed##41##2##(1990-3#1)(1991-2#4)(1992-5#1)(1992-8#1)(1992-9#2)(1994-2#1)(1996-11#1)(1997-4#1)(2004-11#1)(2005-12#1)(2006-10#1)(2007-1#2)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-5#5)(2008-6#1)(2008-7#1)(2009-5#3)(2011-2#5)(2012-2#1)(2013-7#1)
was felt to be##3##4##(1997-8#1)(2007-12#1)(2009-5#1)
was felt to have##2##4##(2008-1#1)(2008-7#1)
was felt to##5##3##(1997-8#1)(2007-12#1)(2008-1#1)(2008-7#1)(2009-5#1)
was felt##9##2##(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-1#1)
was female##2##2##(1994-2#1)(2008-5#1)
was fermented##3##2##(2006-8#1)(2008-5#2)
was figured##2##2##(2008-3#1)(2011-3#1)
was filed by##2##3##(1995-12#1)(1996-12#1)
was filed in Japan in##2##5##(2005-8#2)
was filed in##3##3##(2005-8#2)(2005-9#1)
was filed##5##2##(1995-12#1)(1996-12#1)(2005-8#2)(2005-9#1)
was filled in##2##3##(2008-5#1)(2013-1#1)
was filled out##2##3##(2007-9#1)(2013-1#1)
was filled with a##2##4##(2008-6#1)(2009-6#1)
was filled with silicone gel##2##5##(2007-1#2)
was filled with##17##3##(1991-5#1)(1994-9#1)(1995-12#1)(2007-1#2)(2007-11#2)(2007-7#1)(2008-10#1)(2008-6#1)(2009-6#1)(2009-8#1)(2010-3#1)(2012-1#1)(2013-1#3)
was filled##23##2##(1991-5#1)(1994-9#1)(1995-12#1)(2007-1#2)(2007-11#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-6#1)(2009-8#1)(2010-3#1)(2011-12#1)(2012-1#1)(2013-1#6)
was filtered##3##2##(2008-11#1)(2008-3#1)(2013-7#1)
was finalized##2##2##(2006-8#1)(2008-1#1)
was finally diagnosed##3##3##(1994-3#1)(2007-11#1)(2012-12#1)
was finally##18##2##(1994-3#1)(1995-4#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-8#2)(2008-10#7)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
was finished with Amira 4##2##5##(2012-3#2)
was finished##4##2##(1995-3#1)(2008-10#1)(2012-3#2)
was fired because##2##3##(1996-11#1)(1997-5#1)
was fired##8##2##(1995-12#1)(1996-11#3)(1996-6#1)(1997-5#2)(2013-8#1)
was first analyzed##2##3##(1990-5#1)(2010-4#1)
was first applied to##3##4##(2006-12#1)(2008-10#2)
was first applied##4##3##(2006-12#1)(2008-10#3)
was first attributed to##2##4##(1993-3#1)(2007-6#1)
was first characterized##2##3##(2008-4#1)(2008-5#1)
was first demonstrated##4##3##(2005-7#1)(2007-11#1)(2008-11#1)(2008-7#1)
was first described by##7##4##(2006-12#1)(2007-8#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
was first described in 1986##2##5##(2008-3#1)(2008-6#1)
was first described in the##3##5##(2008-10#1)(2010-8#1)(2012-2#1)
was first described in##13##4##(1990-12#1)(1995-2#1)(1996-3#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-6#1)(2010-8#1)(2011-2#1)(2012-2#1)
was first described more than##2##5##(2008-3#1)(2011-12#1)
was first described over##2##4##(2007-11#1)(2008-10#1)
was first described##32##3##(1990-12#1)(1992-2#1)(1995-2#1)(1996-3#1)(1996-9#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-8#1)
was first detected at##2##4##(2008-10#1)(2009-6#1)
was first detected in the hemolymph##2##6##(2008-10#2)
was first detected in the##4##5##(2008-10#3)(2012-3#1)
was first detected in##8##4##(1997-2#1)(1997-4#1)(2008-10#3)(2011-2#1)(2012-2#1)(2012-3#1)
was first detected##14##3##(1997-2#1)(1997-4#1)(2008-10#5)(2009-6#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#1)
was first developed##5##3##(2005-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-12#1)
was first diagnosed##2##3##(2006-10#1)(2008-10#1)
was first discovered in##3##4##(2008-4#1)(2011-1#1)(2012-3#1)
was first discovered##5##3##(1993-8#1)(2004-12#1)(2008-4#1)(2011-1#1)(2012-3#1)
was first estimated##2##3##(2008-10#1)(2008-2#1)
was first found in##2##4##(2008-10#1)(2008-5#1)
was first identified as a##4##5##(1990-8#1)(1995-2#1)(1996-10#1)(2008-10#1)
was first identified as##5##4##(1990-8#1)(1995-2#1)(1996-10#1)(2008-10#1)(2011-1#1)
was first identified in 1994##2##5##(2004-12#1)(2007-11#1)
was first identified in##7##4##(1994-8#1)(1995-6#1)(2004-12#1)(2006-4#1)(2007-11#1)(2008-10#1)(2013-7#1)
was first identified##12##3##(1990-8#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-10#1)(2004-12#1)(2006-4#1)(2007-11#1)(2008-10#2)(2011-1#1)(2013-7#1)
was first introduced in##2##4##(2007-5#1)(2010-3#1)
was first introduced##7##3##(1991-3#1)(2006-8#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-3#1)
was first isolated##2##3##(1990-12#1)(2011-2#1)
was first noted in the##2##5##(1990-4#1)(1997-1#1)
was first noted##5##3##(1990-10#1)(1990-4#1)(1992-3#1)(1997-1#1)(2008-9#1)
was first noticed in##2##4##(2009-12#1)(2011-12#1)
was first observed at##2##4##(2006-5#1)(2008-10#1)
was first observed in##3##4##(2008-10#3)
was first observed##7##3##(2006-5#2)(2008-10#5)
was first performed##2##3##(1994-2#1)(2008-10#1)
was first proposed##3##3##(2008-10#1)(2009-12#1)(2012-1#1)
was first recognized in the##2##5##(2008-10#1)(2012-1#1)
was first recognized##5##3##(1992-9#1)(1997-8#1)(2008-10#1)(2011-1#1)(2012-1#1)
was first reported in##7##4##(1996-8#1)(2006-10#1)(2008-10#4)(2008-12#1)
was first reported##11##3##(1996-8#1)(2005-11#1)(2006-10#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-9#1)(2013-1#1)
was first seen in##2##4##(1995-5#1)(2008-8#1)
was first seen##5##3##(1995-5#1)(1996-12#1)(2006-8#1)(2008-8#1)(2011-2#1)
was first suggested by##2##4##(1992-9#1)(2008-4#1)
was first tested##2##3##(2008-3#1)(2008-6#1)
was first treated with##4##4##(1994-9#1)(2008-10#1)(2008-5#1)(2009-8#1)
was first used for##2##4##(2005-8#1)(2008-10#1)
was first used in##4##4##(2006-6#1)(2006-8#2)(2007-11#1)
was first used to##4##4##(2007-11#1)(2007-4#1)(2008-11#2)
was first used##11##3##(2005-8#1)(2006-6#1)(2006-8#2)(2007-11#2)(2007-4#1)(2008-10#2)(2008-11#2)
was first##218##2##(1990-10#2)(1990-12#4)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#2)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#2)(1994-9#1)(1995-2#2)(1995-5#1)(1995-6#3)(1995-7#1)(1996-10#1)(1996-12#1)(1996-3#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-12#2)(2005-11#3)(2005-6#1)(2005-7#1)(2005-8#2)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-8#4)(2007-11#6)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#50)(2008-11#7)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#8)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#6)(2009-12#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-3#3)(2010-4#2)(2010-8#1)(2011-1#6)(2011-12#4)(2011-2#6)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
was firstly developed for the##2##5##(2008-10#2)
was firstly developed##3##3##(2008-10#3)
was firstly##13##2##(2007-10#1)(2008-10#9)(2008-9#1)(2011-2#1)(2013-8#1)
was fit to the data##2##5##(2006-9#1)(2008-10#1)
was fit to##3##3##(2005-4#1)(2006-9#1)(2008-10#1)
was fitted in##2##3##(2005-11#1)(2008-10#1)
was fitted to data describing##2##5##(2008-10#2)
was fitted to data##3##4##(2008-10#3)
was fitted to the##3##4##(2005-11#1)(2008-10#2)
was fitted to##8##3##(2005-11#1)(2008-10#5)(2008-7#1)(2012-3#1)
was fitted with##3##3##(1992-12#1)(1994-8#1)(2008-10#1)
was fitted##14##2##(1992-12#2)(1994-8#1)(2005-11#2)(2008-10#7)(2008-7#1)(2012-3#1)
was five##4##2##(2006-10#1)(2008-1#1)(2008-10#1)(2009-9#1)
was fixed at##6##3##(2006-8#2)(2008-10#2)(2008-5#1)(2013-7#1)
was fixed in a##2##4##(2008-10#2)
was fixed in##3##3##(1994-6#1)(2008-10#2)
was fixed on##2##3##(2008-10#2)
was fixed to##2##3##(2006-11#1)(2008-12#1)
was fixed with##4##3##(2009-2#1)(2010-3#1)(2012-3#2)
was fixed##29##2##(1990-12#1)(1994-6#1)(1995-12#1)(2006-11#1)(2006-12#1)(2006-8#2)(2007-8#1)(2007-9#1)(2008-10#9)(2008-12#2)(2008-5#1)(2009-2#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-7#1)
was flat##2##2##(1991-2#1)(1997-2#1)
was flexed##4##2##(1995-3#1)(1997-8#3)
was flexible##2##2##(2007-9#1)(2008-10#1)
was focused into##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
was focused on the##5##4##(1990-9#1)(1992-10#1)(1996-5#1)(2011-1#1)(2012-12#1)
was focused on##7##3##(1990-9#1)(1992-10#1)(1996-5#1)(2005-8#1)(2008-10#1)(2011-1#1)(2012-12#1)
was focused##13##2##(1990-9#1)(1991-6#1)(1992-10#1)(1996-5#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-2#1)
was followed at##3##3##(1993-1#1)(1993-3#1)(2008-10#1)
was followed by a decrease in##3##6##(1993-3#1)(2008-4#1)(2009-9#1)
was followed by a decrease##5##5##(1993-12#1)(1993-3#1)(1993-9#1)(2008-4#1)(2009-9#1)
was followed by a rapid##2##5##(1990-2#1)(1991-6#1)
was followed by a reduction##3##5##(1992-4#1)(1992-9#1)(1993-3#1)
was followed by a second##2##5##(1994-2#1)(2008-12#1)
was followed by a significant increase in##2##7##(1994-3#1)(1997-6#1)
was followed by a significant##3##5##(1994-3#1)(1997-6#1)(2008-11#1)
was followed by a slow##2##5##(1990-2#1)(1990-3#1)
was followed by a##35##4##(1990-11#1)(1990-2#3)(1990-3#1)(1991-6#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-9#1)(1994-2#1)(1994-3#1)(1997-6#1)(2004-12#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-9#1)(2010-10#1)(2013-1#1)(2013-7#1)
was followed by formation of##2##5##(2008-10#2)
was followed by measuring##2##4##(1990-3#1)(2005-11#1)
was followed by the##5##4##(1992-8#1)(1994-11#1)(2006-10#1)(2008-8#1)(2012-2#1)
was followed by##112##3##(1990-10#1)(1990-11#1)(1990-2#3)(1990-3#2)(1990-4#1)(1991-1#2)(1991-10#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-7#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-12#1)(1996-6#1)(1997-2#2)(1997-6#1)(1997-8#1)(2004-12#1)(2004-9#1)(2005-11#1)(2006-10#3)(2006-7#1)(2006-8#1)(2007-7#3)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#4)(2008-7#1)(2008-8#1)(2009-2#1)(2009-9#2)(2010-10#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-1#3)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#2)
was followed during the##2##4##(1994-11#1)(2006-8#1)
was followed during##3##3##(1994-11#1)(2006-6#1)(2006-8#1)
was followed for##7##3##(1990-5#1)(2005-10#1)(2008-10#3)(2008-5#1)(2010-7#1)
was followed from##2##3##(2008-10#1)(2008-9#1)
was followed in the##4##4##(1990-3#1)(1992-5#1)(1994-9#1)(2008-10#1)
was followed in##12##3##(1990-3#1)(1992-5#1)(1994-9#1)(1996-12#1)(1996-3#1)(2005-8#1)(2006-10#1)(2006-8#1)(2008-10#3)(2013-1#1)
was followed over a##2##4##(1994-3#1)(2008-10#1)
was followed over##3##3##(1994-3#1)(2008-10#2)
was followed to##4##3##(2007-8#1)(2008-10#2)(2008-12#1)
was followed up for##4##4##(2005-11#1)(2008-8#1)(2009-4#1)(2011-1#1)
was followed up##11##3##(1997-8#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-8#1)(2009-4#1)(2011-1#1)(2013-1#3)
was followed using##2##3##(1997-7#1)(2008-10#1)
was followed with##2##3##(2011-2#2)
was followed##176##2##(1990-10#1)(1990-11#2)(1990-2#3)(1990-3#3)(1990-4#1)(1990-5#1)(1990-9#1)(1991-1#2)(1991-10#2)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#3)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-7#1)(1993-9#2)(1994-11#3)(1994-2#1)(1994-3#2)(1994-9#2)(1996-12#2)(1996-3#2)(1996-6#1)(1997-2#2)(1997-6#1)(1997-7#1)(1997-8#3)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-3#1)(2005-8#1)(2006-10#4)(2006-6#1)(2006-7#1)(2006-8#3)(2007-7#3)(2007-8#3)(2007-9#3)(2008-1#3)(2008-10#26)(2008-11#2)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#7)(2008-6#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-9#2)(2010-10#1)(2010-2#2)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#3)(2012-2#3)(2013-1#6)(2013-7#1)(2013-8#3)
was followed-up for##2##3##(2008-8#1)(2012-2#1)
was followed-up##3##2##(2008-8#1)(2011-2#1)(2012-2#1)
was following##2##2##(2006-8#1)(2007-11#1)
was for a##3##3##(1992-2#1)(1995-5#1)(2011-2#1)
was for its##2##3##(1993-3#2)
was for the first time##5##5##(2007-11#1)(2008-10#4)
was for the##6##3##(2007-11#1)(2008-10#5)
was for##32##2##(1991-5#1)(1992-2#1)(1993-11#2)(1993-3#2)(1994-3#1)(1994-8#1)(1995-5#1)(2005-8#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#8)(2008-12#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
was forced to##4##3##(1992-1#1)(1997-4#1)(2007-9#1)(2008-10#1)
was forced##6##2##(1992-1#1)(1997-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)
was forecasted##2##2##(2005-4#1)(2011-2#1)
was formed at the##6##4##(1997-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)
was formed at##9##3##(1997-7#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2013-8#1)
was formed by a##3##4##(2008-10#1)(2009-5#1)(2011-2#1)
was formed by mixing##2##4##(2008-5#1)(2012-1#1)
was formed by the##3##4##(1995-4#1)(2009-2#1)(2011-2#1)
was formed by##25##3##(1990-10#2)(1994-11#1)(1995-4#1)(2005-11#2)(2005-4#2)(2007-12#3)(2007-8#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-5#1)(2011-2#2)(2012-1#1)
was formed from the##2##4##(2007-11#1)(2011-2#1)
was formed from##4##3##(1991-12#1)(1995-8#1)(2007-11#1)(2011-2#1)
was formed in a##2##4##(2007-12#1)(2008-11#1)
was formed in##8##3##(1993-12#1)(1995-8#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
was formed on a##2##4##(2008-10#2)
was formed on##3##3##(1990-2#1)(2008-10#2)
was formed only##3##3##(1992-11#1)(2008-11#1)(2010-4#1)
was formed to##10##3##(1994-12#1)(2006-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-7#1)(2012-12#2)(2013-1#1)
was formed using##2##3##(1996-3#1)(2012-12#1)
was formed with a##2##4##(2007-11#1)(2007-12#1)
was formed with the##2##4##(1993-11#1)(2005-6#1)
was formed with##6##3##(1993-11#1)(1995-11#1)(2005-6#1)(2007-11#1)(2007-12#1)(2008-7#1)
was formed##104##2##(1990-10#2)(1990-2#2)(1990-3#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-6#2)(1991-7#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#3)(1995-1#1)(1995-11#1)(1995-4#1)(1995-6#1)(1995-8#2)(1996-3#1)(1996-5#1)(1997-7#1)(2004-9#1)(2005-11#2)(2005-4#2)(2005-6#1)(2006-12#3)(2007-11#3)(2007-12#9)(2007-8#4)(2008-1#1)(2008-10#16)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#2)(2013-1#1)(2013-8#2)
was formerly##2##2##(2007-8#1)(2010-2#1)
was formulated and##5##3##(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)
was formulated as##2##3##(1996-8#1)(2008-5#1)
was formulated in##2##3##(2009-6#1)(2010-12#1)
was formulated to##4##3##(1991-2#1)(1994-12#1)(2008-7#1)(2012-2#1)
was formulated##18##2##(1991-2#1)(1993-3#1)(1994-12#1)(1996-8#1)(2008-11#2)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-6#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
was found after the##3##4##(1996-7#1)(2008-10#1)(2012-2#1)
was found after##12##3##(1992-2#1)(1993-2#1)(1996-7#1)(1997-6#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#1)
was found also in##2##4##(1990-5#1)(1996-2#1)
was found also##3##3##(1990-5#1)(1996-2#1)(2010-4#1)
was found among the##11##4##(1991-10#1)(1992-8#1)(2006-1#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#1)
was found among##23##3##(1991-10#1)(1992-8#1)(1993-6#1)(1994-6#1)(2006-1#1)(2006-10#1)(2006-12#2)(2006-2#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
was found and##9##3##(1994-5#1)(1995-2#1)(2005-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2011-1#1)(2013-1#2)
was found around##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
was found as 0##2##4##(2008-10#2)
was found as##10##3##(1993-4#1)(2006-7#1)(2008-10#7)(2011-1#1)
was found associated with##2##4##(1990-5#1)(2006-10#1)
was found at 120 kDa upon gel filtration##2##8##(1992-1#2)
was found at 24h##2##4##(2010-4#2)
was found at a##3##4##(1991-1#1)(1995-6#1)(2006-7#1)
was found at all##3##4##(1992-8#1)(1996-12#1)(2008-4#1)
was found at low##2##4##(1991-9#1)(2008-10#1)
was found at pH##2##4##(1996-5#1)(2008-10#1)
was found at surgery##2##4##(1990-3#1)(2005-5#1)
was found at the##11##4##(1995-4#1)(1997-2#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2010-9#1)(2011-1#1)(2012-12#1)
was found at##57##3##(1990-3#1)(1990-5#1)(1991-1#3)(1991-12#1)(1991-9#2)(1992-1#2)(1992-8#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-7#1)(2004-10#1)(2005-11#1)(2005-5#1)(2006-12#1)(2006-3#1)(2006-7#1)(2007-1#2)(2007-11#1)(2007-3#3)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2010-12#1)(2010-4#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
was found being##2##3##(2005-11#1)(2008-10#1)
was found between both##2##4##(1993-4#1)(2008-10#1)
was found between groups##2##4##(2008-12#1)(2009-2#1)
was found between methods##2##4##(2008-10#1)(2008-6#1)
was found between number of##4##5##(1994-5#1)(2006-8#3)
was found between patients with##2##5##(2007-2#1)(2010-6#1)
was found between the degree of##3##6##(1990-4#1)(1996-11#1)(1996-3#1)
was found between the determined##2##5##(2008-10#2)
was found between the groups##3##5##(2007-2#1)(2007-5#1)(2007-8#1)
was found between the level of##2##6##(1992-2#1)(2012-12#1)
was found between the number of##2##6##(1995-12#1)(2011-2#1)
was found between the presence of##3##6##(1994-7#1)(2008-5#1)(2013-8#1)
was found between the two groups##3##6##(1996-11#1)(2010-12#1)(2013-1#1)
was found between the two##8##5##(1994-11#1)(1996-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2010-12#1)(2012-12#1)(2013-1#1)
was found between the##97##4##(1990-10#1)(1990-12#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-2#3)(1994-11#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-12#1)(1996-11#2)(1996-12#1)(1996-3#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-4#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#11)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#5)(2012-3#1)(2013-1#3)(2013-8#4)
was found between these##2##4##(1990-3#1)(2008-2#1)
was found between this##2##4##(1990-4#1)(2006-9#1)
was found between##240##3##(1990-10#2)(1990-12#3)(1990-3#1)(1990-4#2)(1990-6#1)(1990-8#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#4)(1993-4#1)(1994-11#1)(1994-2#1)(1994-5#3)(1994-6#1)(1994-7#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-5#2)(1995-8#2)(1996-11#3)(1996-12#3)(1996-2#1)(1996-3#3)(1996-7#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-4#3)(2005-10#1)(2006-10#4)(2006-11#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#9)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#3)(2007-12#4)(2007-2#4)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#33)(2008-11#3)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#4)(2008-7#5)(2008-8#2)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#4)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#12)(2012-12#6)(2012-2#1)(2012-3#2)(2012-6#1)(2013-1#7)(2013-7#1)(2013-8#5)
was found both in##2##4##(1995-11#1)(2008-9#1)
was found both##3##3##(1993-12#1)(1995-11#1)(2008-9#1)
was found by DNA sequencing##2##5##(1990-9#1)(2008-3#1)
was found by using##3##4##(2008-10#2)(2008-8#1)
was found by##27##3##(1990-12#1)(1990-6#1)(1990-9#2)(1991-12#1)(1993-12#1)(1994-8#1)(1995-8#1)(1997-2#1)(1997-7#1)(2008-10#8)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-12#1)
was found comparable##2##3##(2008-10#1)(2010-5#1)
was found dead in##2##4##(1995-3#1)(2005-9#1)
was found dead##3##3##(1995-11#1)(1995-3#1)(2005-9#1)
was found due to##2##4##(1996-2#2)
was found during the##2##4##(1990-3#1)(2008-3#1)
was found during##7##3##(1990-3#1)(1990-5#1)(1992-6#1)(2008-11#1)(2008-3#1)(2008-6#1)(2011-1#1)
was found effective##3##3##(1992-10#1)(2007-6#1)(2010-5#1)
was found especially##2##3##(1992-6#1)(2007-1#1)
was found even##2##3##(1992-6#1)(2008-5#1)
was found exclusively##2##3##(1996-8#1)(2008-5#1)
was found experimentally to be##3##5##(2007-12#1)(2008-3#1)(2008-5#1)
was found following##2##3##(1992-1#1)(2013-1#1)
was found for a##2##4##(1994-7#1)(2008-10#1)
was found for any##2##4##(2007-5#1)(2007-8#1)
was found for both##4##4##(1990-2#1)(2005-11#2)(2008-12#1)
was found for complete blood##2##5##(2008-10#2)
was found for professional##2##4##(1992-3#1)(2011-2#1)
was found for the##21##4##(1991-2#1)(1993-3#1)(1995-5#1)(1996-11#1)(1996-7#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-1#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)
was found for two##2##4##(1990-4#1)(1991-7#1)
was found for##87##3##(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-7#1)(1991-2#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-2#1)(1994-7#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-7#1)(2005-11#4)(2006-10#1)(2006-12#1)(2006-2#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#5)(2007-8#1)(2008-10#13)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#7)(2012-11#1)(2012-2#3)(2013-1#1)
was found from the##6##4##(2005-11#2)(2007-6#1)(2008-10#3)
was found from##9##3##(2005-11#3)(2007-6#1)(2008-10#3)(2008-2#1)(2012-12#1)
was found if the##2##4##(1992-6#1)(1996-11#1)
was found immediately##2##3##(1990-11#2)
was found in &gt##2##4##(2008-10#1)(2008-7#1)
was found in 1 patient##2##5##(2007-11#1)(2008-7#1)
was found in 10##3##4##(2007-11#1)(2007-9#1)(2013-7#1)
was found in 11##3##4##(2007-11#1)(2008-1#1)(2008-4#1)
was found in 12##6##4##(1990-6#1)(2006-6#1)(2007-7#2)(2008-9#1)(2012-3#1)
was found in 12% of##2##5##(1994-3#1)(2007-8#1)
was found in 13##3##4##(1995-2#1)(2007-7#1)(2008-7#1)
was found in 14##3##4##(1992-9#1)(2011-2#1)(2012-12#1)
was found in 18##2##4##(2011-2#1)(2013-8#1)
was found in 2##3##4##(1997-7#1)(2007-8#1)(2011-2#1)
was found in 20##2##4##(2008-6#1)(2013-1#1)
was found in 25##2##4##(2006-6#1)(2011-1#1)
was found in 28##2##4##(1993-1#1)(2008-3#1)
was found in 3##2##4##(2007-11#1)(2008-9#1)
was found in 32##2##4##(2006-10#1)(2011-11#1)
was found in 4 patients##2##5##(2005-10#1)(2007-11#1)
was found in 4##5##4##(2005-10#1)(2007-11#1)(2008-4#1)(2011-2#2)
was found in 44##2##4##(2006-10#1)(2006-6#1)
was found in 47##2##4##(2006-10#1)(2007-11#1)
was found in 5 cases##3##5##(1991-9#1)(1993-2#1)(2007-8#1)
was found in 5##4##4##(1991-9#1)(1993-2#1)(2006-6#1)(2007-8#1)
was found in 52##2##4##(2008-1#1)(2010-12#1)
was found in 6##4##4##(1994-7#1)(2008-1#1)(2011-1#1)(2011-2#1)
was found in 61% of##2##5##(1993-9#1)(2009-2#1)
was found in 7##2##4##(1994-12#1)(2007-11#1)
was found in 8##2##4##(2007-11#1)(2007-8#1)
was found in 9##2##4##(2007-8#1)(2013-1#1)
was found in 90% of the##2##6##(1992-4#1)(2012-12#1)
was found in C57BL/10 mice##2##5##(1990-3#2)
was found in a##21##4##(1990-11#2)(1990-3#1)(1990-7#1)(1991-10#1)(1994-12#1)(1994-2#1)(1995-3#2)(1995-8#1)(1996-12#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-5#3)(2008-9#1)(2012-2#1)(2013-1#2)
was found in all groups##3##5##(1990-11#1)(2006-8#1)(2008-7#1)
was found in all of the##2##6##(2008-11#1)(2008-5#1)
was found in all the##2##5##(1993-2#1)(2008-10#1)
was found in all##29##4##(1990-11#1)(1990-2#1)(1990-7#1)(1991-8#1)(1992-6#1)(1993-2#1)(1995-6#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-9#1)(2006-8#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-5#3)(2008-6#1)(2008-7#3)(2010-11#1)(2011-1#1)(2012-3#1)(2013-8#1)
was found in an##4##4##(1994-10#1)(1995-11#1)(1995-2#1)(2008-10#1)
was found in any of the##6##6##(1990-5#1)(1991-8#1)(2007-8#1)(2008-4#1)(2008-7#1)(2010-8#1)
was found in any##10##4##(1990-5#1)(1991-8#1)(1996-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-8#1)
was found in both the##2##5##(1993-2#1)(2009-4#1)
was found in both##9##4##(1990-12#1)(1992-3#1)(1993-2#1)(1996-10#1)(1996-4#1)(1997-6#1)(2009-4#1)(2011-2#1)(2012-2#1)
was found in bovine##2##4##(1992-11#1)(1994-6#1)
was found in children##3##4##(2008-10#1)(2008-12#1)(2012-2#1)
was found in eight##2##4##(1991-12#1)(1991-4#1)
was found in human##2##4##(1991-3#1)(1992-8#1)
was found in infected##2##4##(1993-9#1)(2008-10#1)
was found in membrane##2##4##(1991-5#1)(1994-12#1)
was found in most##3##4##(1991-2#1)(2011-12#1)(2011-2#1)
was found in one##4##4##(1990-5#1)(2005-1#1)(2008-9#1)(2011-2#1)
was found in only##5##4##(1992-10#1)(1993-10#1)(1995-4#1)(2008-1#1)(2011-2#1)
was found in other##4##4##(1991-2#1)(1993-11#1)(1993-6#1)(1994-6#1)
was found in our##2##4##(1995-11#1)(2008-10#1)
was found in patients with##3##5##(2005-1#1)(2008-7#1)(2011-2#1)
was found in patients##5##4##(2005-1#1)(2007-11#2)(2008-7#1)(2011-2#1)
was found in seven patients##2##5##(2007-8#1)(2008-1#1)
was found in seven##3##4##(2007-3#1)(2007-8#1)(2008-1#1)
was found in six##3##4##(1992-2#1)(2006-8#1)(2008-10#1)
was found in some##2##4##(2008-10#1)(2013-1#1)
was found in the SRY gene of##2##7##(1990-11#2)
was found in the areas##2##5##(2008-10#1)(2009-4#1)
was found in the cells##3##5##(1994-11#1)(1994-3#1)(2008-11#1)
was found in the central##3##5##(1992-8#1)(1993-11#1)(2007-1#1)
was found in the cytosol##2##5##(1997-6#2)
was found in the fraction##2##5##(2008-10#1)(2009-10#1)
was found in the frontal plane##2##6##(2007-7#2)
was found in the group##3##5##(1991-11#1)(1991-6#1)(1993-5#1)
was found in the medial##2##5##(1990-9#1)(1997-4#1)
was found in the nuclear##2##5##(1993-8#1)(2006-7#1)
was found in the number of patients##2##7##(1991-5#1)(2007-11#1)
was found in the number of##4##6##(1991-5#1)(2007-11#1)(2008-5#1)(2008-9#1)
was found in the range from##2##6##(2008-5#1)(2011-2#1)
was found in the range##5##5##(2007-8#1)(2008-10#2)(2008-5#1)(2011-2#1)
was found in the rate of##2##6##(1997-7#1)(2008-7#1)
was found in the right##4##5##(2006-10#2)(2011-1#2)
was found in the tumor##2##5##(1990-12#1)(1991-8#1)
was found in the##176##4##(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#2)(1990-5#2)(1990-9#3)(1991-10#1)(1991-11#3)(1991-12#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#2)(1994-6#3)(1994-7#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-5#1)(1996-6#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#3)(1997-8#1)(2006-1#1)(2006-10#3)(2006-12#2)(2006-3#1)(2006-5#1)(2006-7#1)(2007-1#3)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#1)(2007-7#4)(2007-8#3)(2008-1#2)(2008-10#13)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#6)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#3)(2013-8#2)
was found in this study##6##5##(2005-11#1)(2008-5#2)(2011-2#1)(2012-2#2)
was found in this##9##4##(1994-12#1)(2005-11#1)(2008-5#2)(2008-6#1)(2011-2#2)(2012-2#2)
was found in those##2##4##(1990-2#1)(1997-8#1)
was found in three##5##4##(1992-8#1)(2008-7#2)(2010-4#2)
was found in two of the##2##6##(1995-3#1)(2006-8#1)
was found in two##4##4##(1995-3#1)(2006-8#1)(2008-10#2)
was found in young##3##4##(1990-5#1)(1992-6#1)(1994-2#1)
was found in##617##3##(1990-10#1)(1990-11#5)(1990-12#5)(1990-2#5)(1990-3#6)(1990-4#1)(1990-5#7)(1990-6#3)(1990-7#4)(1990-9#4)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#3)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#2)(1991-8#4)(1991-9#6)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#5)(1992-4#2)(1992-5#2)(1992-6#4)(1992-8#3)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#8)(1993-2#6)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#5)(1994-1#1)(1994-10#2)(1994-11#3)(1994-12#8)(1994-2#4)(1994-3#3)(1994-5#2)(1994-6#5)(1994-7#4)(1994-8#3)(1995-1#1)(1995-10#1)(1995-11#5)(1995-12#5)(1995-2#3)(1995-3#5)(1995-4#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-1#1)(1996-10#3)(1996-11#2)(1996-12#6)(1996-2#5)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#3)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#6)(1997-7#5)(1997-8#2)(1997-9#1)(2005-1#3)(2005-10#4)(2005-11#1)(2005-6#1)(2005-8#1)(2006-1#1)(2006-10#7)(2006-12#3)(2006-3#3)(2006-5#1)(2006-6#6)(2006-7#2)(2006-8#5)(2007-1#3)(2007-10#7)(2007-11#15)(2007-12#2)(2007-2#2)(2007-3#5)(2007-5#2)(2007-7#13)(2007-8#20)(2007-9#2)(2008-1#8)(2008-10#44)(2008-11#12)(2008-12#9)(2008-3#5)(2008-4#5)(2008-5#25)(2008-6#4)(2008-7#18)(2008-8#3)(2008-9#9)(2009-10#1)(2009-11#1)(2009-2#5)(2009-3#1)(2009-4#3)(2009-6#3)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-3#2)(2010-4#3)(2010-8#3)(2011-1#8)(2011-11#1)(2011-12#1)(2011-2#23)(2012-11#3)(2012-12#15)(2012-2#12)(2012-3#4)(2013-1#14)(2013-7#6)(2013-8#6)
was found inside##2##3##(2005-8#1)(2007-9#1)
was found mainly in the##3##5##(1993-7#1)(2008-7#1)(2008-8#1)
was found mainly on Phaeophyta followed by##2##7##(2008-5#2)
was found mainly##5##3##(1993-7#1)(2008-5#2)(2008-7#1)(2008-8#1)
was found more sensitive##3##4##(2007-8#1)(2008-5#2)
was found more##9##3##(1992-8#1)(1993-9#1)(2007-8#1)(2008-10#1)(2008-5#4)(2011-1#1)
was found most##3##3##(1996-5#1)(2007-12#1)(2008-10#1)
was found near##2##3##(2007-12#1)(2010-7#1)
was found necessary##2##3##(1994-11#1)(2013-7#1)
was found neither in##2##4##(1991-9#1)(1992-1#1)
was found not only in##2##5##(1996-6#1)(2008-4#1)
was found not only##3##4##(1996-6#1)(1997-6#1)(2008-4#1)
was found not to be##3##5##(1990-8#1)(2007-8#1)(2009-12#1)
was found not to##5##4##(1990-8#1)(1991-2#1)(1993-12#1)(2007-8#1)(2009-12#1)
was found not##9##3##(1990-8#1)(1991-2#1)(1993-12#1)(1996-6#1)(1997-6#1)(2004-12#1)(2007-8#1)(2008-4#1)(2009-12#1)
was found of##3##3##(1990-2#1)(1994-8#1)(2007-11#1)
was found on follow-up##2##4##(1996-6#1)(2007-11#1)
was found on the##10##4##(1991-10#1)(1994-6#1)(1996-2#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-5#1)(2010-5#1)(2011-1#1)
was found on##29##3##(1990-8#1)(1991-10#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-6#1)(1996-2#1)(1996-6#1)(1997-6#1)(2004-11#1)(2006-10#2)(2006-12#1)(2006-8#2)(2007-11#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-5#1)(2011-1#1)(2013-8#1)
was found only in the##9##5##(1994-11#1)(1996-2#1)(1997-3#1)(2004-2#1)(2008-11#1)(2008-4#1)(2008-5#3)
was found only in two##2##5##(1991-2#1)(2008-8#1)
was found only in##22##4##(1990-8#1)(1991-2#1)(1992-1#1)(1992-11#1)(1994-1#1)(1994-11#1)(1996-2#1)(1997-3#1)(2004-2#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2013-8#1)
was found only##26##3##(1990-8#1)(1991-2#1)(1992-1#1)(1992-11#1)(1994-1#1)(1994-11#1)(1996-10#1)(1996-2#1)(1997-3#1)(2004-2#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2012-1#1)(2013-8#2)
was found out##2##3##(2006-6#1)(2011-1#1)
was found positive##2##3##(1996-12#1)(2007-5#1)
was found radiologically##2##3##(2007-7#2)
was found showing##3##3##(1995-11#1)(1996-2#1)(2013-1#1)
was found significantly higher than##2##5##(2007-8#1)(2008-12#1)
was found significantly##6##3##(2006-4#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)
was found suitable for the##2##5##(2007-1#1)(2008-11#1)
was found suitable for##3##4##(2007-1#1)(2008-11#1)(2008-12#1)
was found that a##9##4##(1992-1#1)(1994-12#1)(1997-6#1)(2007-11#1)(2007-4#1)(2008-12#1)(2008-3#1)(2011-1#1)(2012-3#1)
was found that all##4##4##(2008-12#1)(2008-3#1)(2008-7#1)(2011-12#1)
was found that although##5##4##(1991-12#1)(1991-5#1)(1996-8#1)(2008-12#1)(2008-5#1)
was found that at the##3##5##(1991-5#1)(1993-11#1)(2009-2#1)
was found that at##6##4##(1991-5#1)(1993-11#1)(1994-3#1)(2007-12#1)(2008-10#1)(2009-2#1)
was found that both the##4##5##(2006-10#1)(2008-10#2)(2008-5#1)
was found that both##8##4##(2005-11#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-5#1)
was found that exposure to##2##5##(2007-12#1)(2010-5#1)
was found that for##6##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
was found that in the presence of##3##7##(1993-8#1)(2008-10#2)
was found that in the##5##5##(1993-8#1)(1994-8#1)(2008-10#3)
was found that in##9##4##(1993-1#1)(1993-8#1)(1994-8#1)(1996-7#1)(2008-10#3)(2008-5#1)(2011-1#1)
was found that only the##2##5##(1994-8#1)(2007-4#1)
was found that only##7##4##(1991-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(2007-4#1)(2007-8#1)(2008-10#1)
was found that several##2##4##(1990-7#1)(2009-9#1)
was found that the addition of##2##6##(2005-11#1)(2008-10#1)
was found that the distribution of##2##6##(2008-8#2)
was found that the effect of##2##6##(2008-10#1)(2012-3#1)
was found that the electrode##2##5##(2007-8#1)(2008-10#1)
was found that the lower##2##5##(2007-11#1)(2008-2#1)
was found that the percentage of##2##6##(2005-11#1)(2007-2#1)
was found that the##231##4##(1990-10#2)(1990-2#1)(1990-3#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#2)(1992-1#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-7#2)(2004-9#1)(2005-11#14)(2005-4#1)(2006-10#1)(2006-11#2)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#2)(2007-11#8)(2007-12#3)(2007-2#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#56)(2008-11#4)(2008-12#1)(2008-2#10)(2008-3#9)(2008-5#11)(2008-6#2)(2008-7#4)(2008-8#9)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#2)(2010-1#2)(2010-2#2)(2010-4#3)(2010-5#2)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#3)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#7)
was found that their##2##4##(2008-10#2)
was found that there is##2##5##(2008-3#1)(2008-5#1)
was found that there was##2##5##(2008-10#1)(2008-5#1)
was found that there were##3##5##(1993-2#1)(2008-10#1)(2013-1#1)
was found that there##8##4##(1993-2#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-9#1)(2013-1#1)
was found that this##6##4##(1995-3#1)(2008-10#2)(2008-3#2)(2013-1#1)
was found that three##4##4##(1990-8#1)(1997-8#1)(2008-10#1)(2008-11#1)
was found that two##2##4##(1990-9#1)(1993-3#1)
was found that while##2##4##(2008-5#1)(2009-11#1)
was found that##565##3##(1990-10#3)(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#4)(1990-9#2)(1991-1#3)(1991-11#4)(1991-12#3)(1991-3#2)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#5)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-3#5)(1994-5#2)(1994-6#3)(1994-8#3)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#2)(1996-10#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#1)(2004-10#1)(2004-3#1)(2004-9#2)(2005-11#20)(2005-4#3)(2006-10#4)(2006-11#3)(2006-12#2)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#2)(2007-10#5)(2007-11#14)(2007-12#9)(2007-2#2)(2007-3#1)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#4)(2008-1#3)(2008-10#109)(2008-11#13)(2008-12#11)(2008-2#15)(2008-3#24)(2008-4#1)(2008-5#25)(2008-6#5)(2008-7#10)(2008-8#18)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#3)(2009-3#2)(2009-5#1)(2009-6#3)(2009-7#5)(2009-8#2)(2009-9#1)(2010-1#5)(2010-12#3)(2010-2#4)(2010-4#3)(2010-5#7)(2010-7#2)(2010-8#2)(2011-1#5)(2011-12#2)(2011-2#7)(2012-1#9)(2012-12#7)(2012-2#7)(2012-3#2)(2013-1#10)(2013-8#9)
was found the most##2##4##(2008-12#1)(2008-7#1)
was found the##4##3##(1996-2#1)(2008-12#1)(2008-7#1)(2013-7#1)
was found through the##2##4##(2008-10#2)
was found to account##2##4##(1994-3#1)(1994-9#1)
was found to accumulate##2##4##(2008-10#1)(2008-6#1)
was found to affect the##2##5##(2008-10#1)(2009-6#1)
was found to affect##3##4##(2008-10#1)(2008-7#1)(2009-6#1)
was found to afford##3##4##(1994-9#1)(2007-11#1)(2008-11#1)
was found to associate with##4##5##(1992-7#1)(1992-8#1)(1994-8#1)(2004-11#1)
was found to be &gt##3##5##(1996-7#1)(2007-7#1)(2008-10#1)
was found to be 0##24##5##(1990-6#1)(1991-10#1)(1995-4#1)(2008-10#14)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#3)
was found to be 1##14##5##(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#9)(2010-3#1)(2010-4#1)
was found to be 10##4##5##(1992-9#1)(1995-8#1)(1997-4#1)(2008-10#1)
was found to be 10-fold##2##5##(1990-11#1)(1995-11#1)
was found to be 100%##2##5##(1995-12#1)(2007-7#1)
was found to be 16##3##5##(2008-3#1)(2012-2#2)
was found to be 18##2##5##(2007-10#1)(2007-7#1)
was found to be 2##16##5##(1996-5#1)(1996-8#1)(2007-1#1)(2007-10#1)(2008-10#9)(2008-2#2)(2010-12#1)
was found to be 20##3##5##(2008-5#2)(2010-12#1)
was found to be 3##6##5##(1990-12#1)(2006-10#1)(2008-10#2)(2008-3#1)(2009-6#1)
was found to be 4##12##5##(1995-12#1)(1997-8#1)(2007-2#1)(2007-5#1)(2008-10#4)(2009-5#1)(2010-12#1)(2012-2#1)(2012-3#1)
was found to be 41%##2##5##(2007-7#1)(2009-11#1)
was found to be 5##6##5##(1990-5#1)(1993-3#1)(2006-4#1)(2007-8#1)(2008-10#2)
was found to be 50##2##5##(2006-12#1)(2011-2#1)
was found to be 51##2##5##(2007-12#1)(2007-8#1)
was found to be 6##3##5##(1992-2#1)(1992-7#1)(2008-10#1)
was found to be 7##4##5##(1991-5#1)(2008-10#2)(2013-1#1)
was found to be 8##3##5##(1992-2#1)(1996-4#1)(2008-10#1)
was found to be 80##2##5##(2008-8#1)(2010-8#1)
was found to be 9##2##5##(1991-5#1)(2009-6#1)
was found to be 99##3##5##(2010-1#1)(2010-2#1)(2013-1#1)
was found to be a better##2##6##(1996-8#1)(2008-10#1)
was found to be a competitive##2##6##(1995-10#1)(2011-2#1)
was found to be a critical factor##2##7##(1994-2#1)(1996-10#1)
was found to be a glycoprotein##2##6##(1990-7#1)(1992-12#1)
was found to be a good##3##6##(1991-4#1)(1994-12#1)(1994-5#1)
was found to be a linear function of the##2##9##(1990-11#1)(2006-10#1)
was found to be a major##2##6##(1990-7#1)(2008-4#1)
was found to be a more##3##6##(1990-2#1)(2008-10#2)
was found to be a potent##5##6##(1990-6#1)(1991-5#1)(1991-7#1)(1997-4#1)(2008-5#1)
was found to be a reliable##3##6##(2004-9#1)(2006-6#1)(2008-2#1)
was found to be a safe##2##6##(1990-11#1)(2010-7#1)
was found to be a significant factor for##2##8##(2007-2#1)(2008-6#1)
was found to be a significant##3##6##(2007-2#1)(2008-6#1)(2009-7#1)
was found to be a single##2##6##(1990-11#1)(1990-3#1)
was found to be a specific##2##6##(1990-7#1)(2010-1#1)
was found to be a suitable##2##6##(2008-11#1)(2013-8#1)
was found to be a useful##2##6##(2007-11#1)(2008-10#1)
was found to be a very##3##6##(1990-10#1)(1990-9#1)(1991-2#1)
was found to be a viable##2##6##(2008-10#1)(2013-1#1)
was found to be a##81##5##(1990-10#1)(1990-11#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#3)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-12#4)(1992-2#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#3)(1995-10#1)(1995-5#2)(1996-10#1)(1996-8#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
was found to be able to##2##6##(1994-9#1)(2008-10#1)
was found to be about##2##5##(1994-8#1)(2011-2#1)
was found to be acceptable##2##5##(2007-12#1)(2011-2#1)
was found to be accompanied by##2##6##(1991-6#1)(1992-8#1)
was found to be accurate##4##5##(2004-10#1)(2008-10#1)(2010-2#1)(2012-2#1)
was found to be active##2##5##(2008-11#1)(2010-2#1)
was found to be altered##2##5##(1990-6#1)(2008-1#1)
was found to be an effective##4##6##(1994-9#1)(1997-1#1)(2008-11#1)(2010-2#1)
was found to be an efficient##4##6##(1990-4#1)(1991-12#1)(2007-12#1)(2012-2#1)
was found to be an important##2##6##(1997-2#1)(2008-6#1)
was found to be an##21##5##(1990-4#1)(1991-12#1)(1991-7#1)(1992-2#1)(1992-7#1)(1993-10#1)(1994-9#1)(1995-4#2)(1997-1#1)(1997-2#1)(2007-12#2)(2007-7#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-2#1)(2012-2#1)(2013-1#1)
was found to be anomalous##2##5##(2011-2#2)
was found to be approximately##8##5##(1997-4#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)
was found to be around##2##5##(1995-2#1)(2008-10#1)
was found to be as##2##5##(1992-7#1)(2006-2#1)
was found to be associated with an increased risk of##2##10##(2010-12#1)(2013-1#1)
was found to be associated with##17##6##(1990-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1997-6#1)(2006-9#1)(2007-10#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-4#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
was found to be associated##18##5##(1990-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1997-6#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-4#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
was found to be at least 10-fold##2##7##(1991-2#1)(1994-6#1)
was found to be at least##5##6##(1991-2#1)(1994-6#1)(1996-5#1)(2008-2#1)(2008-4#1)
was found to be at##6##5##(1991-2#1)(1994-6#1)(1996-5#1)(2008-2#1)(2008-3#1)(2008-4#1)
was found to be best##2##5##(1996-5#1)(2007-7#1)
was found to be better than##2##6##(2008-10#1)(2012-1#1)
was found to be better##4##5##(2008-10#3)(2012-1#1)
was found to be between##8##5##(1991-9#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-4#1)(2013-7#1)
was found to be biphasic##2##5##(1992-3#1)(2004-9#1)
was found to be both##3##5##(1993-5#1)(2007-6#1)(2008-10#1)
was found to be caused by##2##6##(1992-1#1)(2006-10#1)
was found to be cleaved##2##5##(1990-10#1)(2009-12#1)
was found to be close to##5##6##(2005-11#1)(2008-10#2)(2008-9#1)(2012-12#1)
was found to be closely related to##2##7##(2008-10#1)(2008-8#1)
was found to be common##2##5##(1994-2#1)(2007-10#1)
was found to be comparable to that##2##7##(2007-2#1)(2008-10#1)
was found to be comparable to##3##6##(1990-10#1)(2007-2#1)(2008-10#1)
was found to be comparable##5##5##(1990-10#1)(2007-2#1)(2008-10#2)(2013-7#1)
was found to be composed of##2##6##(1992-12#1)(2006-8#1)
was found to be critical for##2##6##(2006-2#1)(2008-11#1)
was found to be critical to##2##6##(1994-9#1)(2005-11#1)
was found to be critical##4##5##(1994-9#1)(2005-11#1)(2006-2#1)(2008-11#1)
was found to be crucial to##2##6##(1997-3#1)(2012-2#1)
was found to be decreased##2##5##(1990-10#1)(2008-10#1)
was found to be deficient##2##5##(1990-10#1)(1995-12#1)
was found to be dependent on the presence of##2##9##(1991-3#1)(2011-1#1)
was found to be dependent on the##6##7##(1991-3#1)(2005-12#1)(2008-10#1)(2010-12#1)(2010-5#1)(2011-1#1)
was found to be dependent on##11##6##(1991-3#1)(1993-8#1)(2005-12#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)
was found to be dependent##12##5##(1991-3#1)(1993-8#1)(2005-12#1)(2006-11#1)(2008-10#2)(2008-11#1)(2008-6#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)
was found to be different in the##2##7##(1993-11#1)(2007-1#1)
was found to be different##3##5##(1993-11#1)(2007-1#1)(2012-2#1)
was found to be dose dependent##2##6##(2008-5#1)(2008-8#1)
was found to be due to the##3##7##(1990-12#1)(2008-5#1)(2008-9#1)
was found to be due to##9##6##(1990-12#1)(1993-11#1)(1993-9#1)(1994-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-2#1)
was found to be effective and##2##6##(1990-4#1)(2007-8#1)
was found to be effective for##2##6##(2008-7#1)(2012-2#1)
was found to be effective in##5##6##(2006-6#1)(2006-8#1)(2007-4#1)(2007-7#1)(2013-1#1)
was found to be effective##12##5##(1990-4#1)(1993-1#1)(1993-4#1)(2006-6#1)(2006-8#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-7#1)(2012-11#1)(2012-2#1)(2013-1#1)
was found to be either##2##5##(1990-5#1)(1997-1#1)
was found to be enhanced##2##5##(1994-6#1)(1997-8#1)
was found to be equal to##2##6##(1994-2#1)(2008-10#1)
was found to be essential for the##2##7##(2005-11#1)(2008-4#1)
was found to be essential for##6##6##(1994-12#1)(1995-2#1)(1997-1#1)(2005-11#1)(2007-11#1)(2008-4#1)
was found to be essential in##2##6##(1993-3#1)(2011-1#1)
was found to be essential##10##5##(1990-12#1)(1993-3#1)(1994-12#1)(1995-2#1)(1996-7#1)(1997-1#1)(2005-11#1)(2007-11#1)(2008-4#1)(2011-1#1)
was found to be expressed in##2##6##(1992-7#1)(2008-10#1)
was found to be expressed##6##5##(1991-6#1)(1991-7#1)(1992-7#1)(1992-9#1)(2008-10#1)(2008-11#1)
was found to be extremely##2##5##(1993-9#1)(2008-10#1)
was found to be feasible##2##5##(2010-7#1)(2013-1#1)
was found to be followed##2##5##(2008-10#2)
was found to be fragmented##2##5##(1994-8#1)(2012-3#1)
was found to be good##2##5##(2007-1#1)(2008-10#1)
was found to be greater than##2##6##(1990-12#1)(1992-1#1)
was found to be greater##4##5##(1990-12#1)(1992-1#1)(1993-12#1)(1993-6#1)
was found to be growth##2##5##(1994-5#1)(2008-11#1)
was found to be heat stable##2##6##(1991-9#1)(2008-10#1)
was found to be high##2##5##(2009-9#1)(2010-8#1)
was found to be higher in the##2##7##(1990-7#1)(1994-6#1)
was found to be higher in##4##6##(1990-7#1)(1994-6#1)(2012-2#1)(2013-8#1)
was found to be higher than that##2##7##(2006-8#1)(2008-11#1)
was found to be higher than##3##6##(2006-8#1)(2008-11#2)
was found to be higher##9##5##(1990-7#1)(1994-6#1)(2006-8#1)(2008-11#3)(2008-5#1)(2012-2#1)(2013-8#1)
was found to be highly conserved##2##6##(1990-11#1)(2006-8#1)
was found to be highly##15##5##(1990-11#1)(1992-12#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-8#1)(2006-8#1)(2007-10#1)(2008-10#4)(2008-6#1)(2011-1#1)(2012-3#1)
was found to be homologous##2##5##(1995-3#1)(2008-8#1)
was found to be identical to##2##6##(2008-10#2)
was found to be impaired in##2##6##(2008-1#1)(2011-2#1)
was found to be impaired##4##5##(1990-11#1)(1995-5#1)(2008-1#1)(2011-2#1)
was found to be important##2##5##(1993-12#1)(2008-4#1)
was found to be improved##2##5##(2009-3#2)
was found to be in the range of##5##8##(2008-10#3)(2008-3#1)(2010-12#1)
was found to be in the range##6##7##(1997-1#1)(2008-10#3)(2008-3#1)(2010-12#1)
was found to be in the##7##6##(1997-1#1)(2005-11#1)(2008-10#3)(2008-3#1)(2010-12#1)
was found to be in##15##5##(1990-3#1)(1990-7#1)(1991-7#1)(1992-11#1)(1997-1#1)(2004-11#1)(2005-11#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-7#1)(2010-12#1)
was found to be increased in##3##6##(1990-2#1)(1996-1#1)(1997-2#1)
was found to be increased##5##5##(1990-2#1)(1992-9#1)(1996-1#1)(1997-2#1)(1997-3#1)
was found to be independent of the##4##7##(1995-3#1)(2007-12#2)(2008-10#1)
was found to be independent of##5##6##(1991-9#1)(1995-3#1)(2007-12#2)(2008-10#1)
was found to be independent##6##5##(1990-12#1)(1991-9#1)(1995-3#1)(2007-12#2)(2008-10#1)
was found to be independently##2##5##(1992-9#1)(1995-8#1)
was found to be indistinguishable from the##2##7##(1991-9#1)(1995-2#1)
was found to be influenced by##2##6##(1994-5#1)(2008-11#1)
was found to be influenced##3##5##(1994-5#1)(2008-11#1)(2011-1#1)
was found to be inhibited by##2##6##(1992-6#1)(2008-8#1)
was found to be inhibited##3##5##(1992-6#1)(1996-6#1)(2008-8#1)
was found to be insensitive to##4##6##(2008-10#2)(2008-3#1)(2011-2#1)
was found to be inversely##2##5##(1997-8#1)(2004-12#1)
was found to be involved in the##2##7##(2008-10#1)(2010-2#1)
was found to be involved in##3##6##(2008-10#1)(2010-2#1)(2010-4#1)
was found to be irreversible##2##5##(1990-2#1)(2006-10#1)
was found to be less than 0##2##7##(2008-10#2)
was found to be less than##5##6##(2006-8#1)(2008-10#3)(2010-11#1)
was found to be less##8##5##(1995-6#1)(2006-8#1)(2007-4#1)(2008-10#3)(2008-9#1)(2010-11#1)
was found to be lethal##2##5##(1990-5#1)(2011-12#1)
was found to be linear in the range of##2##9##(2008-10#2)
was found to be linear##10##5##(1994-5#1)(2007-8#1)(2008-10#5)(2010-2#2)(2012-2#1)
was found to be linearly##4##5##(2007-4#2)(2008-10#1)(2008-7#1)
was found to be localized in the##2##7##(1990-2#1)(1992-7#1)
was found to be localized##4##5##(1990-2#1)(1992-7#1)(1997-6#1)(2008-5#1)
was found to be located##3##5##(1990-11#1)(1990-12#1)(2006-9#1)
was found to be low in##2##6##(2008-7#1)(2011-2#1)
was found to be low##3##5##(2008-7#1)(2010-5#1)(2011-2#1)
was found to be lower in##3##6##(1990-10#2)(2011-2#1)
was found to be lower than##2##6##(2011-2#2)
was found to be lower##5##5##(1990-10#2)(2011-2#3)
was found to be mainly##4##5##(1990-12#1)(1997-3#1)(2008-4#1)(2008-5#1)
was found to be mediated by##4##6##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)
was found to be mediated##5##5##(1992-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)
was found to be methylated##2##5##(2007-11#1)(2008-7#1)
was found to be more effective in##2##7##(2008-10#1)(2010-4#1)
was found to be more effective##5##6##(2004-12#1)(2008-10#1)(2008-7#1)(2010-4#1)(2012-2#1)
was found to be more sensitive than##2##7##(1990-12#1)(2012-1#1)
was found to be more sensitive##3##6##(1990-12#2)(2012-1#1)
was found to be more strongly##3##6##(2004-3#2)(2009-7#1)
was found to be more toxic than##3##7##(1990-6#1)(2004-2#1)(2007-6#1)
was found to be more##31##5##(1990-12#2)(1990-6#1)(1992-11#1)(1992-8#1)(1993-2#1)(1995-3#1)(1996-9#1)(1997-3#2)(2004-12#1)(2004-2#1)(2004-3#2)(2007-12#1)(2007-3#1)(2007-6#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-4#1)(2010-5#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
was found to be most effective##2##6##(2005-11#1)(2011-12#1)
was found to be most##6##5##(1993-3#1)(2005-11#1)(2008-10#1)(2008-5#1)(2011-12#1)(2013-8#1)
was found to be much higher than##2##7##(2008-7#1)(2009-7#1)
was found to be much##6##5##(1991-9#1)(1995-3#1)(2008-10#2)(2008-7#1)(2009-7#1)
was found to be nearly identical to##2##7##(1991-4#1)(1996-8#1)
was found to be nearly##3##5##(1991-4#1)(1996-8#1)(2008-2#1)
was found to be necessary##2##5##(1990-8#1)(2008-10#1)
was found to be negligible##3##5##(2008-10#3)
was found to be normal##3##5##(2005-12#2)(2008-10#1)
was found to be of##6##5##(1994-2#1)(2005-11#1)(2005-5#1)(2005-9#1)(2008-10#1)(2008-5#1)
was found to be only##3##5##(1997-1#1)(2007-12#1)(2008-10#1)
was found to be optimal for##2##6##(1991-10#1)(2008-8#1)
was found to be optimal##3##5##(1991-10#1)(1992-8#1)(2008-8#1)
was found to be optimum##2##5##(1997-4#1)(2008-5#1)
was found to be pH independent##2##6##(1990-7#1)(1993-3#1)
was found to be pH##3##5##(1990-7#1)(1993-3#1)(1997-3#1)
was found to be partially##4##5##(1993-9#1)(1995-1#1)(2004-9#1)(2013-1#1)
was found to be positive at##2##6##(2005-12#1)(2007-7#1)
was found to be positive for##4##6##(2005-12#1)(2007-7#1)(2013-1#2)
was found to be positive in##2##6##(2010-8#1)(2013-8#1)
was found to be positive##8##5##(2005-12#2)(2007-7#2)(2010-8#1)(2013-1#2)(2013-8#1)
was found to be positively##2##5##(1996-3#1)(2009-7#1)
was found to be predominantly##2##5##(1990-11#1)(1993-9#1)
was found to be preferable##3##5##(2008-10#2)(2008-11#1)
was found to be present in##4##6##(1991-6#1)(1992-11#1)(2008-1#1)(2008-12#1)
was found to be present mainly as##2##7##(2008-10#1)(2008-5#1)
was found to be present##6##5##(1991-6#1)(1992-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)
was found to be proportional to the##2##7##(2008-10#1)(2010-4#1)
was found to be protective##2##5##(2008-12#1)(2013-1#1)
was found to be quite##5##5##(2007-7#1)(2008-10#2)(2009-2#1)(2010-4#1)
was found to be rapid##2##5##(1992-2#1)(2008-10#1)
was found to be reduced##2##5##(1992-6#1)(1997-2#1)
was found to be regulated##2##5##(1990-12#1)(2008-8#1)
was found to be related to the##3##7##(1991-3#1)(2007-9#1)(2008-10#1)
was found to be related to##7##6##(1991-3#1)(1992-9#1)(2006-6#2)(2007-9#2)(2008-10#1)
was found to be relatively##4##5##(2005-10#1)(2007-7#1)(2008-10#2)
was found to be reliable##2##5##(1996-3#1)(2011-2#1)
was found to be required for the##2##7##(1992-5#1)(1996-4#1)
was found to be required for##3##6##(1992-5#1)(1996-4#1)(2009-8#1)
was found to be required##4##5##(1992-5#1)(1996-4#1)(2009-12#1)(2009-8#1)
was found to be responsible for##2##6##(2005-11#1)(2006-6#1)
was found to be safe and effective##2##7##(2006-5#1)(2008-11#1)
was found to be safe and well tolerated##2##8##(1992-8#1)(2010-5#1)
was found to be safe and##4##6##(1992-8#1)(2006-5#1)(2008-11#1)(2010-5#1)
was found to be satisfactory##3##5##(1996-1#1)(2008-10#1)(2012-12#1)
was found to be selective##2##5##(1991-9#1)(2008-10#1)
was found to be sensitive to the##2##7##(1995-11#1)(2007-12#1)
was found to be sensitive to##4##6##(1990-12#1)(1995-11#1)(2007-12#1)(2008-1#1)
was found to be sensitive##5##5##(1990-12#1)(1995-11#1)(2007-12#1)(2008-1#1)(2011-2#1)
was found to be significant##4##5##(1993-9#2)(2008-10#1)(2008-9#1)
was found to be significantly (P &lt##2##7##(2004-11#1)(2008-10#1)
was found to be significantly associated with##4##7##(2007-12#1)(2008-10#1)(2008-8#1)(2011-1#1)
was found to be significantly correlated with##2##7##(1994-3#1)(2008-5#1)
was found to be significantly elevated##2##6##(2008-7#1)(2011-12#1)
was found to be significantly greater##2##6##(1990-4#1)(2007-4#1)
was found to be significantly higher (p##2##7##(1990-7#1)(2006-8#1)
was found to be significantly higher in##4##7##(1996-2#1)(2007-1#1)(2008-10#1)(2010-12#1)
was found to be significantly higher##8##6##(1990-7#1)(1992-7#1)(1994-8#1)(1996-2#1)(2006-8#1)(2007-1#1)(2008-10#1)(2010-12#1)
was found to be significantly lower in the##2##8##(2013-7#1)(2013-8#1)
was found to be significantly lower in##3##7##(2008-10#1)(2013-7#1)(2013-8#1)
was found to be significantly lower##4##6##(2008-10#1)(2013-7#1)(2013-8#2)
was found to be significantly##33##5##(1990-4#1)(1990-7#1)(1992-7#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-10#1)(1996-2#1)(2004-11#1)(2005-11#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#2)(2013-7#1)(2013-8#2)
was found to be similar for##2##6##(2005-11#1)(2007-8#1)
was found to be similar to that of the##2##9##(1992-11#1)(2006-11#1)
was found to be similar to that of##3##8##(1992-11#1)(1996-6#1)(2006-11#1)
was found to be similar to that##4##7##(1990-2#1)(1992-11#1)(1996-6#1)(2006-11#1)
was found to be similar to##7##6##(1990-2#1)(1990-7#1)(1992-11#1)(1993-9#1)(1994-11#1)(1996-6#1)(2006-11#1)
was found to be similar##12##5##(1990-2#1)(1990-7#1)(1992-11#1)(1993-9#1)(1994-11#1)(1994-12#1)(1996-6#1)(1997-7#1)(2004-10#1)(2005-11#1)(2006-11#1)(2007-8#1)
was found to be slightly##2##5##(1990-12#1)(1993-2#1)
was found to be specific for##2##6##(1991-12#1)(1992-3#1)
was found to be specific##5##5##(1991-12#1)(1992-3#1)(2008-10#1)(2008-6#1)(2013-7#1)
was found to be stable##2##5##(1990-7#1)(1996-7#1)
was found to be statistically significant##3##6##(1990-2#2)(2007-8#1)
was found to be statistically##8##5##(1990-2#2)(1993-11#1)(2007-2#1)(2007-8#1)(2011-2#1)(2012-12#2)
was found to be stimulated by##2##6##(1995-6#1)(2009-8#1)
was found to be strongly dependent on the##2##8##(2008-7#1)(2011-2#1)
was found to be strongly##7##5##(1994-11#1)(2007-3#1)(2008-10#1)(2008-7#1)(2009-11#1)(2011-12#1)(2011-2#1)
was found to be sufficient##3##5##(1996-4#1)(2006-11#1)(2006-8#1)
was found to be suitable for the determination of##3##9##(1996-3#1)(2008-10#2)
was found to be suitable for the##5##7##(1996-3#1)(2008-10#3)(2011-1#1)
was found to be suitable for##7##6##(1991-8#1)(1996-3#1)(2008-10#4)(2011-1#1)
was found to be suitable##8##5##(1991-8#1)(1996-3#1)(2008-10#5)(2011-1#1)
was found to be superior to the##2##7##(1996-2#1)(2008-10#1)
was found to be superior to##4##6##(1996-2#1)(2008-10#1)(2008-5#2)
was found to be superior##7##5##(1992-12#1)(1996-2#1)(2008-10#2)(2008-5#2)(2010-8#1)
was found to be the best##5##6##(2008-10#1)(2008-7#1)(2009-7#1)(2010-2#1)(2011-2#1)
was found to be the main##4##6##(2007-10#1)(2008-8#1)(2011-1#2)
was found to be the major##7##6##(1990-4#1)(2006-12#1)(2007-8#1)(2008-10#4)
was found to be the most common##2##7##(2008-9#1)(2011-2#1)
was found to be the most effective##2##7##(2008-10#1)(2009-5#1)
was found to be the most efficient##4##7##(1990-3#1)(1990-9#1)(2006-2#1)(2008-10#1)
was found to be the most important##3##7##(1991-4#1)(2009-6#1)(2009-7#1)
was found to be the most sensitive##2##7##(2008-10#1)(2008-12#1)
was found to be the most significant##2##7##(2008-9#1)(2010-3#1)
was found to be the most suitable##3##7##(2007-8#1)(2008-10#1)(2012-2#1)
was found to be the most##26##6##(1990-3#1)(1990-9#1)(1991-4#1)(1992-1#1)(2006-2#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-6#2)(2009-7#1)(2010-3#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-7#1)
was found to be the same##3##6##(1993-3#1)(1997-1#1)(2008-8#1)
was found to be the##59##5##(1990-12#1)(1990-3#1)(1990-4#1)(1990-9#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-3#1)(1995-7#1)(1996-9#1)(1997-1#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-8#3)(2008-1#2)(2008-10#11)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#2)(2010-2#1)(2010-3#1)(2011-1#2)(2011-2#3)(2012-11#1)(2012-2#1)(2013-7#1)
was found to be unstable in##2##6##(1990-11#1)(1991-8#1)
was found to be unstable##3##5##(1990-11#1)(1991-2#1)(1991-8#1)
was found to be useful##2##5##(2008-10#1)(2008-9#1)
was found to be very high##2##6##(2010-2#1)(2012-3#1)
was found to be very sensitive to##3##7##(1990-5#1)(2006-11#1)(2013-8#1)
was found to be very useful##3##6##(2007-8#1)(2008-11#1)(2008-5#1)
was found to be very##16##5##(1990-5#1)(1992-12#1)(1997-4#1)(1997-8#1)(2006-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-2#1)(2010-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
was found to be within##3##5##(1997-3#1)(2008-10#1)(2013-1#1)
was found to be##1159##4##(1990-10#7)(1990-11#10)(1990-12#16)(1990-2#8)(1990-3#5)(1990-4#5)(1990-5#7)(1990-6#6)(1990-7#15)(1990-8#2)(1990-9#3)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#4)(1991-2#5)(1991-3#2)(1991-4#3)(1991-5#4)(1991-6#5)(1991-7#4)(1991-8#4)(1991-9#7)(1992-1#3)(1992-10#1)(1992-11#4)(1992-12#8)(1992-2#5)(1992-3#3)(1992-5#2)(1992-6#3)(1992-7#7)(1992-8#5)(1992-9#7)(1993-1#1)(1993-10#1)(1993-11#5)(1993-12#5)(1993-2#4)(1993-3#6)(1993-4#2)(1993-5#2)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#10)(1994-10#1)(1994-11#3)(1994-12#5)(1994-2#6)(1994-3#4)(1994-5#8)(1994-6#3)(1994-8#6)(1994-9#8)(1995-1#1)(1995-10#3)(1995-11#5)(1995-12#6)(1995-2#6)(1995-3#7)(1995-4#3)(1995-5#4)(1995-6#3)(1995-7#1)(1995-8#5)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#5)(1996-4#3)(1996-5#5)(1996-6#3)(1996-7#4)(1996-8#4)(1996-9#2)(1997-1#6)(1997-2#6)(1997-3#9)(1997-4#10)(1997-6#4)(1997-7#3)(1997-8#8)(2003-11#1)(2004-10#2)(2004-11#3)(2004-12#2)(2004-2#1)(2004-3#2)(2004-8#1)(2004-9#4)(2005-10#1)(2005-11#12)(2005-12#5)(2005-5#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#6)(2006-11#6)(2006-12#5)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#5)(2006-7#2)(2006-8#9)(2006-9#2)(2007-1#4)(2007-10#8)(2007-11#11)(2007-12#21)(2007-2#8)(2007-3#4)(2007-4#5)(2007-5#1)(2007-6#3)(2007-7#15)(2007-8#20)(2007-9#5)(2008-1#8)(2008-10#226)(2008-11#24)(2008-12#7)(2008-2#10)(2008-3#11)(2008-4#7)(2008-5#29)(2008-6#8)(2008-7#16)(2008-8#12)(2008-9#9)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#4)(2009-3#5)(2009-5#4)(2009-6#5)(2009-7#7)(2009-8#5)(2009-9#3)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#14)(2010-2#13)(2010-3#5)(2010-4#8)(2010-5#6)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#18)(2011-12#7)(2011-2#29)(2012-1#3)(2012-11#3)(2012-12#11)(2012-2#13)(2012-3#5)(2013-1#16)(2013-7#9)(2013-8#10)
was found to bind the##2##5##(2008-10#1)(2010-12#1)
was found to bind to the##2##6##(1994-3#1)(1995-8#1)
was found to bind to##4##5##(1990-9#1)(1992-12#1)(1994-3#1)(1995-8#1)
was found to bind##11##4##(1990-9#1)(1992-12#1)(1992-7#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-8#2)(2008-10#1)(2010-12#1)(2012-2#1)
was found to block the##2##5##(1993-3#1)(1996-2#1)
was found to block##3##4##(1993-3#1)(1994-12#1)(1996-2#1)
was found to catalyze the##2##5##(2007-10#1)(2009-12#1)
was found to cause##4##4##(1993-2#1)(1993-4#1)(2008-4#1)(2008-8#1)
was found to change dramatically##2##5##(1992-11#1)(1995-12#1)
was found to code##2##4##(1990-3#1)(1992-11#1)
was found to consist of two##2##6##(1991-10#1)(1996-9#1)
was found to consist of##3##5##(1991-10#1)(1993-6#1)(1996-9#1)
was found to contain a##4##5##(1991-1#1)(1993-11#1)(1994-9#1)(2009-2#1)
was found to contain less##2##5##(1993-6#1)(1994-5#1)
was found to contain two##4##5##(1990-5#1)(1993-11#1)(1996-10#1)(1996-7#1)
was found to contain##27##4##(1990-10#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-5#1)(1993-6#2)(1994-11#1)(1994-5#1)(1994-6#1)(1994-9#1)(1996-10#1)(1996-2#1)(1996-7#1)(1997-1#1)(2008-5#1)(2009-2#1)(2011-2#1)(2013-1#1)
was found to contribute to##2##5##(1996-10#1)(2007-12#1)
was found to correlate with the##2##6##(1992-6#1)(2008-3#1)
was found to correlate with##7##5##(1992-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(2008-3#1)(2011-2#1)(2013-7#1)
was found to correlate##8##4##(1992-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(2008-3#1)(2008-9#1)(2011-2#1)(2013-7#1)
was found to cosegregate with##2##5##(1995-8#1)(2008-10#1)
was found to cross-link##3##4##(1993-11#3)
was found to decay##2##4##(1994-9#1)(2008-2#1)
was found to decrease the rate of##2##7##(2010-4#1)(2011-1#1)
was found to decrease the##7##5##(1997-2#1)(2004-9#1)(2007-12#1)(2008-10#1)(2010-4#1)(2011-1#1)(2012-2#1)
was found to decrease with increasing##2##6##(2007-12#1)(2008-10#1)
was found to decrease##15##4##(1990-2#1)(1990-5#1)(1994-8#1)(1994-9#1)(1997-2#1)(2004-9#1)(2007-12#2)(2008-10#2)(2008-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-2#1)
was found to degrade in##2##5##(2008-10#1)(2010-2#1)
was found to degrade significantly under##2##6##(2012-12#2)
was found to degrade##4##4##(2008-10#1)(2010-2#1)(2012-12#2)
was found to depend on the##4##6##(1992-6#1)(2008-10#1)(2008-7#1)(2011-1#1)
was found to depend on##6##5##(1992-6#1)(2005-11#1)(2008-10#2)(2008-7#1)(2011-1#1)
was found to depend strongly on the##2##7##(2008-3#1)(2008-5#1)
was found to depend strongly on##4##6##(2007-11#1)(2008-11#1)(2008-3#1)(2008-5#1)
was found to depend##11##4##(1992-6#1)(2005-11#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)
was found to differ from##3##5##(1990-11#1)(1992-11#1)(1995-11#1)
was found to direct##2##4##(1991-9#1)(1996-10#1)
was found to display##4##4##(1994-8#1)(2008-10#1)(2008-7#1)(2012-2#1)
was found to dose dependently##2##5##(1995-12#1)(1995-6#1)
was found to effectively##2##4##(2008-10#1)(2013-1#1)
was found to encode a##3##5##(1992-4#1)(1996-9#1)(1997-7#1)
was found to encode##4##4##(1992-4#1)(1992-7#1)(1996-9#1)(1997-7#1)
was found to enhance the##4##5##(1993-12#1)(2008-10#1)(2008-11#1)(2009-11#1)
was found to enhance##6##4##(1993-12#1)(1995-12#1)(2008-10#1)(2008-11#1)(2009-11#1)(2009-6#1)
was found to exceed##4##4##(1990-10#1)(2010-2#1)(2012-11#2)
was found to exert##3##4##(1990-8#1)(1992-6#1)(2010-10#1)
was found to exhibit a##2##5##(2008-1#1)(2008-10#1)
was found to exhibit the##2##5##(1992-5#1)(2013-8#1)
was found to exhibit##6##4##(1992-5#1)(2008-1#1)(2008-10#1)(2010-10#1)(2010-12#1)(2013-8#1)
was found to exist between peak height and the concentration of the##2##12##(2008-10#2)
was found to exist in the##2##6##(2008-10#1)(2011-2#1)
was found to exist in##3##5##(1992-5#1)(2008-10#1)(2011-2#1)
was found to exist##6##4##(1992-3#1)(1992-5#1)(2008-10#3)(2011-2#1)
was found to express##2##4##(1996-5#1)(2008-5#1)
was found to extend the##2##5##(2008-8#1)(2010-5#1)
was found to extend##3##4##(2007-11#1)(2008-8#1)(2010-5#1)
was found to fall##2##4##(2008-10#1)(2012-12#1)
was found to follow##4##4##(2005-11#1)(2007-10#1)(2008-10#1)(2008-4#1)
was found to form##8##4##(1994-11#1)(1995-8#1)(1996-5#1)(1996-7#1)(2007-12#1)(2008-3#1)(2008-5#1)(2009-11#1)
was found to give satisfactory results##2##6##(2008-10#2)
was found to give the##2##5##(2008-10#1)(2008-11#1)
was found to give##15##4##(1991-8#1)(1996-3#1)(2005-11#1)(2007-10#1)(2007-8#1)(2008-10#9)(2008-11#1)
was found to have a high##3##6##(2008-10#1)(2010-8#1)(2013-7#1)
was found to have a highly##2##6##(2008-10#1)(2008-11#1)
was found to have a significant effect##2##7##(1994-3#1)(2008-3#1)
was found to have a significant##4##6##(1994-3#1)(2007-8#1)(2008-3#1)(2012-1#1)
was found to have a similar##2##6##(1991-8#1)(2008-10#1)
was found to have a##49##5##(1990-4#1)(1991-3#1)(1991-8#1)(1992-5#1)(1992-6#2)(1993-6#1)(1993-9#2)(1994-11#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-12#2)(1997-6#1)(1997-7#1)(2004-8#1)(2006-8#1)(2007-4#1)(2007-8#4)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2009-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-7#1)(2013-8#1)
was found to have an##13##5##(1991-8#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#2)(2009-2#1)(2009-7#1)(2010-9#1)(2011-2#1)
was found to have both##2##5##(1992-5#1)(2006-10#1)
was found to have good##3##5##(1994-9#1)(2006-6#1)(2008-6#1)
was found to have higher##3##5##(1996-7#1)(2008-5#1)(2011-2#1)
was found to have no##4##5##(1992-12#1)(1996-7#1)(2012-2#2)
was found to have pelvic##2##5##(1990-6#1)(2013-1#1)
was found to have significant##2##5##(1994-3#1)(2008-1#1)
was found to have significantly##2##5##(2008-2#1)(2008-3#1)
was found to have the following##2##6##(1991-12#1)(1993-3#1)
was found to have the##6##5##(1991-12#1)(1991-8#1)(1993-3#1)(1996-8#1)(1997-2#1)(2008-10#1)
was found to have two##3##5##(1994-9#1)(1997-6#1)(2008-7#1)
was found to have##144##4##(1990-4#1)(1990-6#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-8#3)(1991-9#1)(1992-12#1)(1992-5#2)(1992-6#2)(1993-3#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-3#1)(1995-6#1)(1996-12#3)(1996-5#1)(1996-7#2)(1996-8#2)(1997-2#1)(1997-6#2)(1997-7#1)(2004-8#1)(2006-10#5)(2006-12#1)(2006-6#2)(2006-8#1)(2006-9#2)(2007-10#1)(2007-12#1)(2007-4#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#11)(2008-11#2)(2008-12#4)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#6)(2009-11#1)(2009-2#1)(2009-3#4)(2009-7#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#5)(2013-1#5)(2013-7#1)(2013-8#4)
was found to include##2##4##(1993-2#1)(1994-9#1)
was found to increase by##2##5##(2008-5#1)(2013-7#1)
was found to increase in##2##5##(1990-7#1)(2008-4#1)
was found to increase sulfatide concentrations in##2##7##(1997-4#2)
was found to increase the##3##5##(1991-6#1)(1994-6#1)(2004-9#1)
was found to increase when##2##5##(2005-11#1)(2008-10#1)
was found to increase with increasing##4##6##(1995-6#1)(2004-9#1)(2005-11#1)(2008-7#1)
was found to increase with the##2##6##(2008-10#1)(2008-8#1)
was found to increase with##9##5##(1995-6#1)(2004-9#1)(2005-11#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#1)
was found to increase##31##4##(1990-10#1)(1990-2#1)(1990-7#1)(1991-6#1)(1992-8#1)(1994-3#1)(1994-6#1)(1995-6#1)(1997-4#2)(1997-6#1)(2004-9#2)(2005-11#2)(2007-5#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2012-2#1)(2013-7#1)
was found to induce a##2##5##(1994-12#1)(2008-4#1)
was found to induce##14##4##(1990-5#1)(1991-2#2)(1991-9#1)(1992-8#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-3#1)(2008-10#2)(2008-4#1)(2012-2#1)
was found to influence##3##4##(1992-8#1)(2006-11#1)(2011-1#1)
was found to inhibit the##7##5##(1990-7#1)(1990-9#1)(1993-4#1)(1993-6#1)(1994-5#1)(2008-10#1)(2011-2#1)
was found to inhibit##23##4##(1990-10#1)(1990-7#1)(1990-9#2)(1991-11#1)(1991-2#1)(1991-4#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-5#2)(1995-1#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-7#1)
was found to interact##2##4##(1997-6#1)(2009-10#1)
was found to interfere with##2##5##(2006-5#1)(2008-10#1)
was found to interfere##4##4##(2006-5#1)(2007-12#1)(2008-10#2)
was found to involve the##2##5##(2009-3#1)(2011-2#1)
was found to involve##3##4##(1993-9#1)(2009-3#1)(2011-2#1)
was found to lead to##3##5##(1993-3#1)(2005-11#1)(2010-2#1)
was found to lie##3##4##(1995-9#1)(2004-12#1)(2008-10#1)
was found to mediate##4##4##(1992-3#1)(1996-6#1)(2009-10#1)(2009-8#1)
was found to move##2##4##(1997-4#1)(2008-2#1)
was found to obey##2##4##(2008-10#2)
was found to occur in a##2##6##(1991-6#1)(1994-9#1)
was found to occur only##2##5##(1991-12#1)(1994-9#1)
was found to occur with age##2##6##(1990-11#1)(2009-2#1)
was found to occur with an##2##6##(1993-3#1)(2011-1#1)
was found to occur with##5##5##(1990-11#2)(1993-3#1)(2009-2#1)(2011-1#1)
was found to occur##15##4##(1990-11#2)(1991-12#1)(1991-6#1)(1992-9#1)(1993-3#1)(1994-2#1)(1994-9#3)(2007-11#1)(2008-10#1)(2008-3#1)(2009-2#1)(2011-1#1)
was found to possess##5##4##(1997-1#1)(2007-1#1)(2007-10#1)(2008-10#1)(2010-12#1)
was found to potentiate##2##4##(1991-4#1)(1997-4#1)
was found to produce a##5##5##(1994-2#1)(1997-1#1)(2006-9#1)(2008-10#2)
was found to produce##12##4##(1994-2#1)(1997-1#1)(2006-9#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2009-11#1)
was found to promote##2##4##(1992-8#1)(2007-8#1)
was found to protect##2##4##(1993-4#1)(1996-4#1)
was found to provide##5##4##(2008-10#3)(2008-3#1)(2009-12#1)
was found to range from##4##5##(1994-10#1)(1994-8#1)(2008-5#1)(2008-9#1)
was found to rapidly##3##4##(1992-10#1)(1995-12#1)(1997-1#1)
was found to reduce the##3##5##(1993-2#1)(2007-4#1)(2008-10#1)
was found to reduce##9##4##(1992-4#1)(1992-5#1)(1993-2#1)(1993-4#1)(1995-5#1)(1997-6#1)(2007-2#1)(2007-4#1)(2008-10#1)
was found to remain##3##4##(1992-8#1)(1994-4#1)(2008-10#1)
was found to respond##2##4##(1990-11#1)(2008-11#1)
was found to result from the##2##6##(1990-2#1)(2008-7#1)
was found to result from##4##5##(1990-2#1)(1991-9#1)(1997-1#1)(2008-7#1)
was found to result in the##3##6##(1992-3#1)(2005-11#1)(2006-11#1)
was found to result in##4##5##(1992-3#1)(1994-9#1)(2005-11#1)(2006-11#1)
was found to result##8##4##(1990-2#1)(1991-9#1)(1992-3#1)(1994-9#1)(1997-1#1)(2005-11#1)(2006-11#1)(2008-7#1)
was found to share##2##4##(1995-6#1)(1997-6#1)
was found to shift##3##4##(1991-8#1)(1992-9#1)(2005-11#1)
was found to show##2##4##(2005-11#1)(2008-11#1)
was found to significantly decrease##3##5##(1990-12#1)(1991-9#1)(2010-2#1)
was found to significantly improve##2##5##(1993-7#1)(1997-5#1)
was found to significantly##11##4##(1990-12#1)(1991-9#1)(1992-8#1)(1993-7#1)(1995-3#1)(1997-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-2#1)
was found to stimulate##5##4##(1990-3#1)(1990-8#1)(1992-3#1)(1994-2#1)(2006-7#1)
was found to strongly##2##4##(1990-11#1)(1995-6#1)
was found to support##3##4##(2008-10#1)(2008-11#2)
was found to suppress##2##4##(2007-11#1)(2011-1#1)
was found to take##2##4##(2008-10#1)(2008-7#1)
was found to the##3##4##(1997-7#1)(2008-10#1)(2009-2#1)
was found to undergo##2##4##(2008-10#1)(2008-5#1)
was found to vary from##3##5##(1992-11#1)(1992-3#1)(2005-11#1)
was found to vary significantly##2##5##(2008-10#1)(2009-7#1)
was found to vary##6##4##(1992-11#1)(1992-3#1)(2005-11#2)(2008-10#1)(2009-7#1)
was found to yield##4##4##(1991-7#1)(1997-3#1)(2008-2#2)
was found to##1807##3##(1990-10#11)(1990-11#17)(1990-12#17)(1990-2#12)(1990-3#8)(1990-4#7)(1990-5#12)(1990-6#7)(1990-7#19)(1990-8#4)(1990-9#7)(1991-1#3)(1991-10#3)(1991-11#4)(1991-12#6)(1991-2#11)(1991-3#4)(1991-4#7)(1991-5#4)(1991-6#7)(1991-7#6)(1991-8#9)(1991-9#12)(1992-1#4)(1992-10#3)(1992-11#9)(1992-12#14)(1992-2#5)(1992-3#9)(1992-4#3)(1992-5#7)(1992-6#10)(1992-7#12)(1992-8#14)(1992-9#11)(1993-1#1)(1993-10#1)(1993-11#10)(1993-12#8)(1993-2#7)(1993-3#12)(1993-4#6)(1993-5#3)(1993-6#10)(1993-7#2)(1993-8#2)(1993-9#15)(1994-10#3)(1994-11#7)(1994-12#9)(1994-2#10)(1994-3#13)(1994-4#1)(1994-5#11)(1994-6#8)(1994-8#12)(1994-9#24)(1995-1#4)(1995-10#4)(1995-11#6)(1995-12#12)(1995-2#8)(1995-3#10)(1995-4#3)(1995-5#5)(1995-6#8)(1995-7#1)(1995-8#9)(1995-9#1)(1996-1#2)(1996-10#5)(1996-11#1)(1996-12#4)(1996-2#4)(1996-3#6)(1996-4#4)(1996-5#8)(1996-6#4)(1996-7#9)(1996-8#7)(1996-9#4)(1997-1#12)(1997-2#8)(1997-3#10)(1997-4#14)(1997-5#1)(1997-6#11)(1997-7#6)(1997-8#9)(2003-11#1)(2004-10#2)(2004-11#4)(2004-12#3)(2004-2#1)(2004-3#2)(2004-4#1)(2004-8#2)(2004-9#7)(2005-10#1)(2005-11#24)(2005-12#5)(2005-5#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#11)(2006-11#9)(2006-12#8)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#7)(2006-7#3)(2006-8#11)(2006-9#5)(2007-1#6)(2007-10#13)(2007-11#21)(2007-12#29)(2007-2#9)(2007-3#4)(2007-4#7)(2007-5#2)(2007-6#4)(2007-7#18)(2007-8#28)(2007-9#6)(2008-1#12)(2008-10#301)(2008-11#45)(2008-12#12)(2008-2#19)(2008-3#23)(2008-4#14)(2008-5#42)(2008-6#14)(2008-7#31)(2008-8#17)(2008-9#12)(2009-10#3)(2009-11#7)(2009-12#4)(2009-2#9)(2009-3#11)(2009-5#4)(2009-6#8)(2009-7#11)(2009-8#6)(2009-9#4)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#17)(2010-2#18)(2010-3#5)(2010-4#10)(2010-5#7)(2010-6#1)(2010-7#2)(2010-8#6)(2010-9#3)(2011-1#29)(2011-12#7)(2011-2#38)(2011-3#1)(2012-1#5)(2012-11#5)(2012-12#15)(2012-2#23)(2012-3#6)(2013-1#23)(2013-7#13)(2013-8#16)
was found useful##2##3##(2007-12#1)(2008-10#1)
was found using##5##3##(1992-5#1)(2005-10#1)(2008-7#1)(2008-8#1)(2013-1#1)
was found when the##7##4##(1994-3#3)(2007-3#1)(2008-10#2)(2008-3#1)
was found when##19##3##(1990-2#1)(1992-12#1)(1992-6#1)(1994-3#3)(1996-2#1)(1996-5#1)(2006-11#1)(2007-3#1)(2008-10#3)(2008-3#1)(2008-5#2)(2009-2#1)(2011-2#2)
was found which is##2##4##(2008-10#2)
was found which was##2##4##(1990-11#1)(1994-9#1)
was found which##5##3##(1990-11#1)(1990-12#1)(1994-9#1)(2008-10#2)
was found with a##5##4##(1995-5#1)(2007-11#1)(2012-2#1)(2013-1#2)
was found with an##3##4##(1991-12#1)(1992-3#1)(2008-10#1)
was found with other##3##4##(1990-2#1)(1996-7#1)(2008-10#1)
was found with the##7##4##(1991-3#1)(1992-2#1)(1993-9#1)(1994-3#1)(1995-2#1)(2008-10#1)(2008-2#1)
was found with##49##3##(1990-10#1)(1990-2#1)(1990-3#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-6#2)(1993-9#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-7#1)(2005-11#1)(2006-1#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#5)(2008-12#3)(2008-2#2)(2008-6#1)(2008-7#4)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#4)
was found within a##2##4##(1992-9#1)(2008-10#1)
was found within and##2##4##(2008-10#2)
was found within the##4##4##(1991-2#1)(1994-10#1)(2008-10#2)
was found within##10##3##(1991-2#1)(1992-1#1)(1992-9#1)(1994-10#1)(2008-10#6)
was found##4094##2##(1990-10#18)(1990-11#31)(1990-12#37)(1990-2#25)(1990-3#22)(1990-4#14)(1990-5#25)(1990-6#16)(1990-7#26)(1990-8#14)(1990-9#15)(1991-1#10)(1991-10#8)(1991-11#15)(1991-12#21)(1991-2#23)(1991-3#10)(1991-4#10)(1991-5#9)(1991-6#13)(1991-7#8)(1991-8#14)(1991-9#26)(1992-1#16)(1992-10#8)(1992-11#18)(1992-12#25)(1992-2#15)(1992-3#18)(1992-4#8)(1992-5#11)(1992-6#26)(1992-7#14)(1992-8#21)(1992-9#19)(1993-1#5)(1993-10#3)(1993-11#16)(1993-12#29)(1993-2#20)(1993-3#19)(1993-4#10)(1993-5#5)(1993-6#15)(1993-7#6)(1993-8#8)(1993-9#25)(1994-1#3)(1994-10#7)(1994-11#14)(1994-12#22)(1994-2#16)(1994-3#26)(1994-4#1)(1994-5#23)(1994-6#21)(1994-7#7)(1994-8#22)(1994-9#31)(1995-1#7)(1995-10#6)(1995-11#17)(1995-12#23)(1995-2#18)(1995-3#22)(1995-4#7)(1995-5#11)(1995-6#13)(1995-7#3)(1995-8#20)(1995-9#3)(1996-1#5)(1996-10#11)(1996-11#11)(1996-12#18)(1996-2#20)(1996-3#15)(1996-4#7)(1996-5#15)(1996-6#12)(1996-7#17)(1996-8#11)(1996-9#8)(1997-1#20)(1997-2#17)(1997-3#19)(1997-4#23)(1997-5#6)(1997-6#23)(1997-7#23)(1997-8#15)(1997-9#1)(2003-11#1)(2004-1#1)(2004-10#4)(2004-11#5)(2004-12#5)(2004-2#2)(2004-3#3)(2004-4#5)(2004-8#2)(2004-9#10)(2005-1#3)(2005-10#9)(2005-11#59)(2005-12#5)(2005-4#4)(2005-5#3)(2005-6#1)(2005-7#1)(2005-8#3)(2005-9#2)(2006-1#5)(2006-10#35)(2006-11#15)(2006-12#21)(2006-2#6)(2006-3#5)(2006-4#3)(2006-5#7)(2006-6#17)(2006-7#12)(2006-8#33)(2006-9#10)(2007-1#17)(2007-10#37)(2007-11#70)(2007-12#56)(2007-2#20)(2007-3#17)(2007-4#12)(2007-5#9)(2007-6#13)(2007-7#48)(2007-8#67)(2007-9#9)(2008-1#25)(2008-10#613)(2008-11#87)(2008-12#50)(2008-2#45)(2008-3#71)(2008-4#27)(2008-5#130)(2008-6#34)(2008-7#90)(2008-8#52)(2008-9#34)(2009-1#5)(2009-10#7)(2009-11#12)(2009-12#8)(2009-2#21)(2009-3#18)(2009-4#6)(2009-5#7)(2009-6#14)(2009-7#22)(2009-8#11)(2009-9#6)(2010-1#7)(2010-10#5)(2010-11#3)(2010-12#31)(2010-2#24)(2010-3#8)(2010-4#22)(2010-5#17)(2010-6#3)(2010-7#5)(2010-8#14)(2010-9#6)(2011-1#57)(2011-11#1)(2011-12#13)(2011-2#110)(2011-3#3)(2012-1#17)(2012-11#9)(2012-12#48)(2012-2#53)(2012-3#17)(2012-6#1)(2013-1#71)(2013-7#24)(2013-8#48)
was founded by##4##3##(1990-9#1)(1993-2#1)(2005-9#1)(2008-10#1)
was founded in##9##3##(1990-10#1)(2006-10#1)(2006-4#1)(2006-6#1)(2008-11#1)(2008-4#1)(2010-3#1)(2011-2#1)(2012-1#1)
was founded##17##2##(1990-10#1)(1990-9#1)(1992-2#1)(1993-2#1)(2005-9#1)(2006-10#1)(2006-4#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-3#1)(2010-6#1)(2011-2#1)(2011-4#1)(2012-1#1)
was four months##2##3##(1990-9#1)(1993-3#1)
was four to##2##3##(1995-6#1)(2008-10#1)
was four##9##2##(1990-9#1)(1992-4#1)(1992-5#1)(1993-3#1)(1995-6#1)(2004-11#1)(2008-10#2)(2011-2#1)
was fractionated by gel##2##4##(1990-2#1)(2007-8#1)
was fractionated by##3##3##(1990-2#1)(1997-7#1)(2007-8#1)
was fractionated into##2##3##(1993-8#1)(2006-12#1)
was fractionated on##4##3##(1990-5#1)(1991-5#1)(1992-12#1)(2011-2#1)
was fractionated##13##2##(1990-2#1)(1990-5#1)(1991-1#1)(1991-5#1)(1992-12#1)(1993-8#1)(1997-3#1)(1997-7#1)(2006-12#1)(2007-8#2)(2008-12#1)(2011-2#1)
was free from##8##3##(1991-12#1)(1992-6#1)(2008-10#5)(2013-8#1)
was free of disease##2##4##(2006-9#1)(2009-1#1)
was free of##11##3##(1991-8#1)(1992-11#1)(1992-9#1)(1994-8#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-8#1)(2009-1#1)(2011-2#2)
was free##19##2##(1991-12#1)(1991-8#1)(1992-11#1)(1992-6#1)(1992-9#1)(1994-8#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-8#1)(2008-10#5)(2009-1#1)(2011-2#2)(2013-8#1)
was freely##3##2##(2007-12#1)(2008-10#1)(2012-2#1)
was frequency doubled##3##3##(2007-12#2)(2008-2#1)
was frequency##5##2##(2007-12#3)(2008-10#1)(2008-2#1)
was frequent in##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2010-12#1)
was frequent##8##2##(1991-4#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-7#2)(2010-12#1)(2012-2#1)
was frequently observed##4##3##(1991-5#1)(1992-6#1)(2007-11#1)(2013-1#1)
was frequently##13##2##(1991-5#1)(1992-6#1)(1997-3#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-7#1)(2013-1#2)
was from 0##5##3##(2007-8#1)(2008-10#3)(2010-12#1)
was from 1##6##3##(2008-10#6)
was from 3 to##2##4##(2008-10#1)(2008-7#1)
was from 3##3##3##(1990-2#1)(2008-10#1)(2008-7#1)
was from 4##2##3##(2007-7#1)(2012-12#1)
was from 5##4##3##(2008-10#3)(2011-2#1)
was from 7##2##3##(2007-2#1)(2008-10#1)
was from January##2##3##(2012-2#1)(2013-1#1)
was from a##3##3##(2007-12#1)(2008-10#1)(2012-3#1)
was from the##5##3##(1996-11#1)(1997-6#1)(2007-9#1)(2008-10#1)(2012-3#1)
was from##66##2##(1990-2#1)(1991-9#1)(1992-1#1)(1995-11#1)(1996-11#1)(1996-9#1)(1997-6#1)(2005-1#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-10#26)(2008-12#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#3)(2013-8#2)
was frozen in liquid nitrogen##3##5##(2008-5#3)
was frozen##4##2##(2006-6#1)(2008-5#3)
was full##3##2##(1994-3#1)(2007-7#1)(2008-3#1)
was fully activated by##2##4##(1995-2#1)(1997-2#1)
was fully active##4##3##(1990-10#1)(1993-9#1)(1996-5#1)(2008-7#1)
was fully automated##2##3##(1993-9#1)(2008-10#1)
was fully characterized##2##3##(1990-2#1)(2008-10#1)
was fully examined##2##3##(2006-7#1)(2010-2#1)
was fully inactivated##2##3##(1993-8#1)(1997-1#1)
was fully recovered##2##3##(2008-12#1)(2012-12#1)
was fully reversed by##2##4##(1994-3#1)(2009-9#1)
was fully reversible##2##3##(1995-10#1)(1997-7#1)
was fully##45##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-5#1)(1990-7#2)(1990-8#1)(1992-8#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#1)(1995-10#1)(1995-2#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-7#1)(2005-1#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
was functional and##3##3##(1992-5#1)(1993-5#1)(2007-7#1)
was functional in S##2##4##(1990-9#2)
was functional in##7##3##(1990-3#1)(1990-9#2)(1991-10#1)(1992-6#1)(1993-12#1)(2008-10#1)
was functional##16##2##(1990-3#1)(1990-9#2)(1991-10#1)(1992-11#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-5#1)(1994-8#2)(2007-7#1)(2008-10#2)(2008-4#1)(2008-8#1)
was functionalized##2##2##(2008-10#2)
was functionally expressed in##2##4##(1993-2#1)(1994-8#1)
was functionally##9##2##(1990-11#1)(1993-2#1)(1994-8#1)(1995-8#1)(1996-11#2)(1997-4#1)(2008-8#1)(2009-8#1)
was funded by the##3##4##(2008-10#1)(2008-2#1)(2012-2#1)
was funded by##4##3##(2008-1#1)(2008-10#1)(2008-2#1)(2012-2#1)
was funded##7##2##(1993-3#1)(1995-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2012-2#1)
was further analyzed by##3##4##(1992-6#1)(1992-7#1)(2008-10#1)
was further analyzed##4##3##(1992-6#1)(1992-7#1)(2008-10#1)(2013-7#1)
was further applied to##5##4##(1991-10#1)(1995-10#1)(1997-8#1)(2008-10#2)
was further assessed##2##3##(1996-8#1)(2010-3#1)
was further characterized by##3##4##(1992-2#1)(1994-11#1)(1994-6#1)
was further characterized##5##3##(1990-5#2)(1992-2#1)(1994-11#1)(1994-6#1)
was further confirmed by##8##4##(1990-12#1)(1990-5#1)(1994-5#1)(1996-4#1)(1997-2#1)(2008-7#1)(2008-8#1)(2011-2#1)
was further confirmed##10##3##(1990-12#1)(1990-5#1)(1994-5#1)(1996-4#1)(1997-2#1)(2005-12#1)(2007-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
was further converted to##2##4##(2010-5#1)(2012-11#1)
was further converted##3##3##(1992-11#1)(2010-5#1)(2012-11#1)
was further decreased##2##3##(1994-12#1)(2006-5#1)
was further defined by##2##4##(1995-6#1)(2006-10#1)
was further demonstrated by the##2##5##(1995-1#1)(2008-5#1)
was further demonstrated by##4##4##(1995-1#1)(1995-12#1)(2008-5#2)
was further demonstrated##8##3##(1992-6#1)(1995-1#1)(1995-12#1)(2008-10#1)(2008-5#2)(2008-9#1)(2009-11#1)
was further employed to##2##4##(2006-12#1)(2008-2#1)
was further enhanced by##5##4##(1995-2#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-2#1)
was further enhanced##7##3##(1995-2#1)(1996-10#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)
was further established##2##3##(1990-7#1)(1991-3#1)
was further evaluated##4##3##(1995-3#1)(2009-9#1)(2010-12#1)(2012-12#1)
was further examined in##2##4##(1996-8#1)(2008-10#1)
was further examined##5##3##(1996-5#1)(1996-8#1)(1997-1#1)(2008-10#1)(2008-9#1)
was further improved##2##3##(2007-11#1)(2008-9#1)
was further increased##2##3##(1991-1#1)(1994-3#1)
was further inhibited by##2##4##(1992-3#1)(1996-5#1)
was further investigated by##8##4##(1990-11#1)(1990-9#1)(1995-3#1)(1995-5#1)(2005-11#1)(2007-12#1)(2008-5#1)(2010-12#1)
was further investigated##13##3##(1990-11#1)(1990-9#1)(1995-3#1)(1995-5#1)(1996-11#1)(2005-11#2)(2007-12#1)(2008-1#1)(2008-5#1)(2010-12#1)(2012-11#2)
was further metabolized##2##3##(1996-5#1)(2006-8#1)
was further processed##3##3##(1996-3#1)(2006-12#1)(2012-2#1)
was further purified by##3##4##(1991-2#1)(1992-2#1)(1995-2#1)
was further purified##6##3##(1991-2#1)(1992-2#1)(1992-3#1)(1993-12#1)(1994-12#1)(1995-2#1)
was further reduced##5##3##(1991-5#1)(1997-5#1)(2008-10#2)(2008-11#1)
was further separated on a##2##5##(1992-1#1)(1993-2#1)
was further shown##2##3##(2009-10#1)(2010-2#1)
was further studied##3##3##(1994-3#1)(2008-10#1)(2008-11#1)
was further supported by the##8##5##(1990-2#1)(1992-2#1)(1995-6#1)(1996-2#1)(1997-4#1)(2008-10#1)(2011-12#1)(2012-2#1)
was further supported by##10##4##(1990-2#1)(1992-2#1)(1995-6#1)(1996-2#1)(1997-4#1)(2007-12#1)(2008-10#2)(2011-12#1)(2012-2#1)
was further supported##11##3##(1990-2#1)(1992-2#1)(1995-6#1)(1996-2#1)(1997-4#1)(2007-12#1)(2008-10#2)(2011-12#1)(2012-2#1)(2012-3#1)
was further tested##2##3##(2008-10#1)(2011-1#1)
was further treated##2##3##(2007-11#1)(2007-2#1)
was further used for the##2##5##(2008-10#1)(2008-5#1)
was further used for##3##4##(2008-10#2)(2008-5#1)
was further used##5##3##(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)
was further validated by##4##4##(2008-10#1)(2008-5#1)(2010-12#1)(2013-1#1)
was further validated##6##3##(2008-10#2)(2008-5#1)(2010-12#1)(2012-3#1)(2013-1#1)
was further verified by##2##4##(1993-11#1)(2008-2#1)
was further##177##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#3)(1990-7#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-11#3)(1992-12#1)(1992-2#4)(1992-3#2)(1992-6#2)(1992-7#1)(1993-11#2)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#3)(1994-3#2)(1994-5#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#4)(1996-8#4)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#2)(2005-12#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#21)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#1)(2008-5#6)(2008-7#2)(2008-8#2)(2008-9#6)(2009-10#1)(2009-11#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-5#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-11#4)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#1)
was fused in frame##2##4##(1995-3#1)(1996-3#1)
was fused to the transmembrane and cytoplasmic domains of T beta##2##11##(1995-3#2)
was fused to the##4##4##(1991-5#1)(1995-3#2)(2009-6#1)
was fused to##7##3##(1990-11#1)(1991-5#1)(1993-9#1)(1995-3#2)(2006-12#1)(2009-6#1)
was fused with##3##3##(1995-11#1)(1997-6#1)(2008-10#1)
was fused##15##2##(1990-11#1)(1991-5#1)(1991-7#1)(1993-9#1)(1995-11#1)(1995-3#3)(1996-3#1)(1997-6#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-6#1)
was gained by the##3##4##(1990-12#1)(1997-1#1)(2009-4#1)
was gained##7##2##(1990-12#1)(1991-6#1)(1993-10#1)(1997-1#1)(2007-11#1)(2009-10#1)(2009-4#1)
was gastrointestinal##3##2##(1990-6#1)(2006-6#1)(2007-7#1)
was gathered by##2##3##(2007-10#1)(2007-9#1)
was gathered from##5##3##(2005-10#1)(2006-7#1)(2006-8#2)(2009-9#1)
was gathered using a questionnaire##2##5##(1992-1#1)(1992-12#1)
was gathered##12##2##(1992-1#1)(1992-12#1)(2005-10#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-9#1)(2009-9#1)(2010-6#1)(2011-2#1)(2013-8#1)
was generalized##2##2##(2008-10#1)(2008-2#1)
was generally decreased##2##3##(1992-8#1)(2004-11#1)
was generally good##3##3##(1990-7#1)(1991-6#1)(2008-7#1)
was generally high##2##3##(2011-2#1)(2012-2#1)
was generally higher##4##3##(2004-4#1)(2007-10#1)(2008-10#1)(2008-12#1)
was generally less##3##3##(1995-10#1)(1997-8#1)(2008-11#1)
was generally low##3##3##(2007-11#1)(2010-4#1)(2012-3#1)
was generally lower##2##3##(1996-9#1)(2006-9#1)
was generally mild##5##3##(1990-2#1)(1991-10#1)(2007-9#1)(2008-3#1)(2008-6#1)
was generally not##2##3##(1997-4#1)(2010-4#1)
was generally observed##2##3##(1994-12#1)(2008-4#1)
was generally poor##4##3##(2008-1#1)(2008-10#1)(2009-4#1)(2013-8#1)
was generally reduced##2##3##(2009-4#1)(2009-6#1)
was generally similar to that##3##5##(1994-12#1)(2008-9#2)
was generally similar to##4##4##(1992-7#1)(1994-12#1)(2008-9#2)
was generally stronger##2##3##(2006-10#1)(2008-10#1)
was generally very##2##3##(1991-7#1)(2012-12#1)
was generally well tolerated##4##4##(2008-10#1)(2008-3#2)(2009-8#1)
was generally well##5##3##(2005-8#1)(2008-10#1)(2008-3#2)(2009-8#1)
was generally##92##2##(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-7#1)(1992-8#1)(1994-12#2)(1994-3#1)(1995-10#1)(1995-3#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-8#1)(2004-11#1)(2004-4#1)(2005-12#3)(2005-8#1)(2006-10#1)(2006-11#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-9#2)(2008-1#1)(2008-10#14)(2008-11#1)(2008-12#3)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-2#1)(2010-4#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-8#2)
was generated and##3##3##(1990-10#1)(1995-12#1)(2008-2#1)
was generated at a##4##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
was generated at##5##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
was generated by the##4##4##(2008-10#1)(2010-4#1)(2010-5#1)(2011-1#1)
was generated by##31##3##(1990-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-9#1)(1994-6#1)(1995-1#1)(1995-8#1)(1996-5#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#2)(2008-11#3)(2008-2#3)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-4#1)(2010-5#1)(2011-1#1)(2013-8#1)
was generated during##2##3##(1990-5#1)(1997-8#1)
was generated for the##2##4##(2008-10#1)(2013-7#1)
was generated for##3##3##(2007-12#1)(2008-10#1)(2013-7#1)
was generated from##10##3##(1992-8#1)(1994-11#1)(1996-5#1)(2008-10#4)(2008-2#1)(2008-3#2)
was generated in a##5##4##(2007-11#1)(2007-12#2)(2008-10#1)(2008-7#1)
was generated in rabbits##2##4##(1997-4#1)(2008-10#1)
was generated in##12##3##(1992-8#1)(1994-6#1)(1995-3#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-7#1)(2013-8#1)
was generated that##2##3##(1997-1#1)(2008-4#1)
was generated upon##2##3##(1992-3#1)(2012-12#1)
was generated using a##2##4##(1994-3#1)(2012-2#1)
was generated using##9##3##(1991-9#1)(1994-2#1)(1994-3#1)(1997-4#1)(2008-2#1)(2008-4#1)(2009-6#1)(2012-2#2)
was generated with a##3##4##(2007-12#1)(2008-2#2)
was generated with##11##3##(2007-11#1)(2007-12#3)(2007-8#1)(2008-2#4)(2008-8#1)(2013-8#1)
was generated##114##2##(1990-10#1)(1990-11#1)(1990-4#1)(1990-5#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-9#2)(1992-3#1)(1992-7#1)(1992-8#2)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#2)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#2)(1996-5#2)(1997-1#1)(1997-4#2)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#5)(2007-12#16)(2007-8#2)(2008-1#2)(2008-10#13)(2008-11#4)(2008-2#12)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#1)(2010-1#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#3)
was genetic##3##2##(2007-10#1)(2008-10#1)(2008-9#1)
was genetically mapped##2##3##(2008-9#2)
was genetically##8##2##(1995-1#1)(1997-6#1)(2005-11#1)(2008-10#1)(2008-9#2)(2010-2#1)(2011-1#1)
was genotyped##3##2##(1997-5#1)(2007-10#1)(2008-10#1)
was gentamicin##2##2##(1990-4#1)(1990-6#1)
was given 1##4##3##(1991-6#1)(1996-6#1)(2009-5#1)(2012-1#1)
was given a##5##3##(1995-2#1)(2006-4#1)(2008-1#1)(2008-3#1)(2009-6#1)
was given an##4##3##(1993-2#1)(2008-1#1)(2008-10#1)(2010-12#1)
was given as a 1-h##2##5##(2008-6#2)
was given as a##6##4##(1992-9#1)(1995-6#1)(2007-8#1)(2008-4#1)(2008-6#2)
was given as##14##3##(1990-5#1)(1991-6#1)(1991-9#1)(1992-8#1)(1992-9#1)(1995-6#1)(1997-6#1)(2006-9#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-6#2)
was given at a##2##4##(1991-6#1)(1994-8#1)
was given at##7##3##(1991-6#1)(1994-8#1)(2005-9#1)(2006-12#1)(2007-7#1)(2011-1#1)(2013-1#1)
was given bupivacaine 0##2##4##(2006-12#2)
was given by a##3##4##(2005-8#3)
was given by the##5##4##(2007-8#1)(2008-10#3)(2008-6#1)
was given by##13##3##(1990-4#1)(1992-10#1)(1993-11#1)(2005-8#3)(2006-11#1)(2007-8#1)(2008-10#3)(2008-6#1)(2009-10#1)
was given during##4##3##(1992-2#1)(1992-9#1)(1997-5#1)(2011-2#1)
was given for a##2##4##(1994-6#1)(2009-10#1)
was given for the##3##4##(1994-11#1)(2007-3#1)(2007-8#1)
was given for##9##3##(1993-7#1)(1994-11#1)(1994-6#1)(2005-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2009-10#1)
was given i##3##3##(1990-12#1)(2006-7#1)(2008-7#1)
was given in a##3##4##(1997-7#1)(2007-7#1)(2013-8#1)
was given in the##3##4##(1991-6#1)(1993-6#1)(2006-10#1)
was given in##15##3##(1990-10#1)(1991-6#1)(1991-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1995-3#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-7#1)(2007-9#1)(2010-12#1)(2011-1#1)(2013-8#1)
was given intramuscularly##2##3##(1990-2#1)(2007-2#1)
was given intraperitoneally##2##3##(2007-8#1)(2010-1#1)
was given intravenously at a dose of##2##7##(1991-6#1)(2008-6#1)
was given intravenously##3##3##(1991-6#1)(1996-12#1)(2008-6#1)
was given on days 10-12##2##5##(1993-3#1)(1995-2#1)
was given orally to##3##4##(2010-12#1)(2012-2#1)(2013-1#1)
was given orally##6##3##(2007-2#1)(2007-8#1)(2008-5#1)(2010-12#1)(2012-2#1)(2013-1#1)
was given the##5##3##(2008-10#3)(2009-2#1)(2011-2#1)
was given three##2##3##(2008-2#1)(2012-3#1)
was given to a##2##4##(2007-2#1)(2013-7#1)
was given to all##4##4##(2007-2#1)(2008-4#1)(2009-6#1)(2013-1#1)
was given to rats##2##4##(1993-4#1)(1997-2#1)
was given to the##12##4##(2005-11#1)(2005-8#1)(2007-5#1)(2008-12#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
was given to##49##3##(1990-10#1)(1990-4#1)(1992-10#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-9#1)(1994-12#1)(1995-10#1)(1995-12#1)(1996-3#1)(1997-2#1)(1997-8#1)(2004-10#1)(2004-11#1)(2005-11#1)(2005-8#2)(2007-2#2)(2007-5#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-6#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#3)(2013-8#1)
was given with##2##3##(1995-3#1)(2007-7#1)
was given##232##2##(1990-10#3)(1990-11#2)(1990-12#2)(1990-2#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-6#5)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-2#3)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#4)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#3)(1993-4#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1996-10#2)(1996-12#2)(1996-3#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2004-10#1)(2004-11#1)(2004-2#1)(2004-3#1)(2005-11#1)(2005-12#1)(2005-8#6)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#4)(2006-4#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-10#2)(2007-11#1)(2007-2#9)(2007-3#1)(2007-5#1)(2007-7#8)(2007-8#6)(2007-9#2)(2008-1#3)(2008-10#10)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#8)(2008-7#5)(2008-8#1)(2009-10#2)(2009-11#1)(2009-2#2)(2009-5#3)(2009-6#3)(2010-1#1)(2010-11#1)(2010-12#4)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#8)(2013-7#3)(2013-8#2)
was globally##2##2##(2005-10#1)(2007-4#1)
was glomerular##2##2##(1990-6#1)(1991-3#1)
was glucose##2##2##(2007-12#1)(2008-12#1)
was glycated in##3##3##(1992-12#1)(2007-2#2)
was glycated##4##2##(1991-5#1)(1992-12#1)(2007-2#2)
was glycosylated##2##2##(1992-12#1)(1993-11#1)
was going to##2##3##(1992-3#1)(1996-4#1)
was going##3##2##(1992-3#1)(1996-4#1)(2008-8#1)
was good agreement##8##3##(1992-1#2)(1996-12#1)(1997-3#1)(2007-10#1)(2008-7#1)(2012-2#1)(2012-3#1)
was good and##8##3##(1995-2#1)(2007-7#1)(2008-10#2)(2008-4#1)(2012-12#1)(2012-3#1)(2013-8#1)
was good for##2##3##(2008-1#1)(2008-5#1)
was good in all##2##4##(1994-9#1)(1996-6#1)
was good in##8##3##(1994-9#1)(1996-6#1)(2005-8#1)(2007-10#1)(2007-8#1)(2007-9#1)(2013-1#1)(2013-8#1)
was good linear##2##3##(2005-9#1)(2011-1#1)
was good or excellent##2##4##(1992-2#1)(2007-1#1)
was good or##3##3##(1992-2#1)(2007-1#1)(2007-8#1)
was good##63##2##(1990-12#1)(1990-6#1)(1991-11#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-2#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-8#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-3#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#8)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
was governed by##3##3##(2007-1#1)(2008-10#2)
was governed##5##2##(2004-4#1)(2007-1#1)(2007-4#1)(2008-10#2)
was grade##8##2##(2006-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-5#1)(2008-8#2)(2013-8#1)
was graded according to the##2##5##(2007-7#1)(2012-11#1)
was graded according to##3##4##(2007-7#1)(2008-7#1)(2012-11#1)
was graded as good##2##4##(1997-3#1)(2010-7#1)
was graded as##3##3##(1997-3#1)(2007-1#1)(2010-7#1)
was graded by##2##3##(2007-8#1)(2008-6#1)
was graded in the##2##4##(1995-2#1)(1996-6#1)
was graded in##3##3##(1990-3#1)(1995-2#1)(1996-6#1)
was graded using a##2##4##(2011-2#1)(2012-2#1)
was graded using the##2##4##(2009-3#1)(2010-8#1)
was graded using##4##3##(2009-3#1)(2010-8#1)(2011-2#1)(2012-2#1)
was graded##25##2##(1990-12#1)(1990-3#1)(1992-6#1)(1995-2#1)(1996-6#2)(1997-3#1)(2007-1#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-11#1)(2012-2#2)
was gradual##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
was gradually and##2##3##(2007-11#1)(2008-12#1)
was gradually converted##2##3##(1990-12#1)(2013-1#1)
was gradually decreased##3##3##(1997-6#1)(2012-1#1)(2012-2#1)
was gradually increased##4##3##(1990-5#1)(2008-11#1)(2008-5#1)(2011-2#1)
was gradually##26##2##(1990-12#1)(1990-5#1)(1991-2#1)(1992-8#1)(1995-1#1)(1995-11#1)(1997-6#1)(2006-4#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2009-4#1)(2010-10#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
was grafted##2##2##(1995-2#1)(1997-4#1)
was granted in##2##3##(1996-6#1)(2005-9#1)
was granted##5##2##(1995-6#1)(1996-6#1)(2005-9#1)(2007-9#1)(2013-8#1)
was great##3##2##(1994-3#1)(1994-7#1)(2009-7#1)
was greater (P&lt##3##3##(2009-4#3)
was greater after##2##3##(2007-10#1)(2008-5#1)
was greater among##2##3##(1995-1#1)(2008-9#1)
was greater at higher##2##4##(2008-2#1)(2008-8#1)
was greater at the##2##4##(2008-10#1)(2011-1#1)
was greater at##11##3##(1995-5#1)(1996-7#1)(2006-5#1)(2008-10#4)(2008-2#1)(2008-8#1)(2008-9#1)(2011-1#1)
was greater for producing##2##4##(2009-4#2)
was greater for the choice photographs than for the nonchoice photographs when the subjects##2##14##(2007-5#2)
was greater for the##4##4##(1996-7#1)(2007-5#2)(2011-2#1)
was greater for##19##3##(1991-12#1)(1996-7#1)(1997-3#1)(2004-1#1)(2007-5#2)(2008-10#2)(2008-9#4)(2009-4#2)(2009-8#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-2#1)
was greater in male##3##4##(1996-10#1)(1996-6#1)(2008-10#1)
was greater in the group##3##5##(1997-6#1)(2004-3#1)(2009-10#1)
was greater in the##21##4##(1991-5#1)(1992-6#2)(1993-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#2)(1997-6#1)(2004-11#1)(2004-3#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-10#1)(2011-2#1)(2013-8#1)
was greater in##61##3##(1990-2#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-6#2)(1992-7#2)(1993-11#1)(1993-6#2)(1994-2#1)(1994-5#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-5#3)(1996-1#1)(1996-10#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-6#1)(2004-11#1)(2004-3#1)(2007-1#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#12)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-10#1)(2009-11#1)(2009-3#2)(2010-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
was greater on the##2##4##(2008-10#1)(2010-2#1)
was greater on##4##3##(1997-6#1)(2008-10#2)(2010-2#1)
was greater than 1##2##4##(2007-12#1)(2008-10#1)
was greater than 95%##6##4##(2008-10#2)(2008-11#2)(2008-6#1)(2012-12#1)
was greater than 99%##4##4##(2008-10#3)(2012-3#1)
was greater than additive##2##4##(1996-1#1)(2008-10#1)
was greater than for the##2##5##(1994-9#1)(2008-10#1)
was greater than in##2##4##(2006-5#1)(2008-7#1)
was greater than or equal to 22##2##7##(1991-8#2)
was greater than or equal to##5##6##(1991-8#3)(2008-10#2)
was greater than that during##2##5##(1990-10#1)(2004-4#1)
was greater than that in the##2##6##(1997-3#1)(2008-5#1)
was greater than that of the##4##6##(1990-10#1)(2005-11#1)(2008-5#1)(2013-7#1)
was greater than that of##19##5##(1990-10#1)(1990-8#1)(1991-8#1)(1994-10#1)(1994-11#2)(1994-3#1)(1995-11#1)(1995-5#1)(1997-8#1)(2005-11#1)(2005-12#1)(2008-10#2)(2008-5#1)(2010-2#1)(2011-2#2)(2013-7#1)
was greater than that##28##4##(1990-10#2)(1990-8#1)(1991-12#1)(1991-3#1)(1991-8#1)(1994-10#1)(1994-11#2)(1994-3#1)(1995-11#1)(1995-5#1)(1997-3#1)(1997-8#1)(2004-4#1)(2005-11#2)(2005-12#1)(2008-10#3)(2008-2#1)(2008-5#2)(2010-2#1)(2011-2#2)(2013-7#1)
was greater than the##6##4##(1996-9#1)(2006-5#1)(2007-10#1)(2007-8#1)(2008-9#1)(2010-5#1)
was greater than with##3##4##(1990-12#1)(1993-4#1)(1994-12#1)
was greater than##85##3##(1990-10#2)(1990-11#1)(1990-12#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#4)(1992-2#1)(1992-6#1)(1993-4#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-1#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-4#1)(2004-9#1)(2005-11#2)(2005-12#1)(2005-2#1)(2006-10#1)(2006-11#1)(2006-5#2)(2007-10#1)(2007-12#4)(2007-2#2)(2007-8#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-12#2)(2012-3#2)(2013-7#1)
was greater when the##2##4##(2008-10#1)(2008-4#1)
was greater when##6##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-2#1)
was greater with##6##3##(1994-9#1)(1996-12#1)(2005-12#1)(2007-7#1)(2008-10#1)(2008-5#1)
was greater##228##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#4)(1991-9#2)(1992-12#1)(1992-2#1)(1992-6#3)(1992-7#2)(1993-11#1)(1993-4#2)(1993-6#2)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#3)(1995-3#2)(1995-5#5)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-6#2)(1996-7#2)(1996-9#2)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#3)(1997-8#1)(2004-1#1)(2004-11#1)(2004-3#1)(2004-4#1)(2004-9#1)(2005-11#2)(2005-12#2)(2005-2#1)(2006-10#2)(2006-11#1)(2006-5#3)(2007-1#1)(2007-10#2)(2007-12#4)(2007-2#3)(2007-3#1)(2007-5#2)(2007-7#3)(2007-8#2)(2008-10#46)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#9)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#8)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#5)(2009-8#1)(2010-2#4)(2010-3#1)(2010-5#1)(2010-7#2)(2011-1#2)(2011-12#1)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#2)(2013-7#1)(2013-8#2)
was greatest among the##2##4##(1992-6#1)(1996-4#1)
was greatest among##4##3##(1992-6#1)(1996-4#1)(2006-8#1)(2008-10#1)
was greatest at##2##3##(2008-10#2)
was greatest between##3##3##(2008-10#3)
was greatest following##2##3##(2008-10#2)
was greatest for 'Spanco'##2##4##(2008-10#2)
was greatest for the##2##4##(2006-5#1)(2013-1#1)
was greatest for##7##3##(2006-5#1)(2008-10#5)(2013-1#1)
was greatest in the##9##4##(1990-5#1)(1991-12#2)(1993-9#1)(1996-6#1)(2007-10#1)(2008-9#1)(2009-7#1)(2012-1#1)
was greatest in##19##3##(1990-3#1)(1990-5#1)(1991-12#2)(1993-11#1)(1993-9#1)(1996-6#1)(2007-10#1)(2007-2#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-2#2)(2011-2#1)(2012-1#1)
was greatest on the##2##4##(2008-10#1)(2010-2#1)
was greatest on##6##3##(2008-10#5)(2010-2#1)
was greatest when##4##3##(1990-12#1)(2008-10#3)
was greatest with##2##3##(1995-2#1)(2004-12#1)
was greatest##56##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-12#3)(1991-2#1)(1991-5#1)(1992-6#1)(1993-11#1)(1993-9#1)(1995-2#1)(1996-4#1)(1996-6#1)(2004-12#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#26)(2008-4#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-2#3)(2011-2#1)(2012-1#1)(2013-1#1)
was greatly attenuated in the presence of##2##7##(1993-2#1)(2013-8#1)
was greatly decreased##2##3##(1996-8#1)(2008-11#1)
was greatly diminished##3##3##(1990-6#1)(1991-11#1)(1996-8#1)
was greatly enhanced by##2##4##(1997-8#1)(2008-10#1)
was greatly enhanced##7##3##(1991-12#1)(1991-6#1)(1997-8#1)(2008-10#4)
was greatly impaired##2##3##(1990-2#1)(1996-7#1)
was greatly improved##5##3##(2007-8#1)(2008-10#2)(2008-11#1)(2012-3#1)
was greatly increased after##2##4##(2005-11#1)(2008-8#1)
was greatly increased##7##3##(1990-2#1)(1991-3#1)(1994-2#1)(1995-6#1)(2005-11#1)(2008-10#1)(2008-8#1)
was greatly influenced by the##2##5##(1992-1#1)(1993-6#1)
was greatly inhibited##2##3##(1991-12#1)(2011-2#1)
was greatly reduced and##2##4##(1992-1#1)(2008-5#1)
was greatly reduced at the neuromuscular junctions (NMJs)##2##8##(2012-12#2)
was greatly reduced by##2##4##(1992-8#1)(2006-5#1)
was greatly reduced in##3##4##(1990-7#1)(1997-7#1)(2008-7#1)
was greatly reduced when##2##4##(1996-5#1)(2008-10#1)
was greatly reduced##21##3##(1990-5#2)(1990-7#1)(1991-10#1)(1991-5#1)(1992-1#1)(1992-8#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-7#1)(2005-11#1)(2006-5#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2012-11#1)(2012-12#2)
was greatly##64##2##(1990-2#2)(1990-5#2)(1990-6#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-8#2)(1997-7#1)(1997-8#1)(2005-11#3)(2006-5#1)(2007-6#1)(2007-8#1)(2008-10#12)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-1#1)(2011-2#1)(2012-11#1)(2012-12#5)(2012-3#1)(2013-8#1)
was grossly##3##2##(1990-8#1)(1994-9#1)(2009-3#1)
was grounded##2##2##(1997-5#1)(2007-7#1)
was grouped as##2##3##(1994-6#1)(2008-1#1)
was grouped into one##2##4##(2006-11#1)(2008-5#1)
was grouped into##5##3##(2006-10#1)(2006-11#1)(2006-3#1)(2008-10#1)(2008-5#1)
was grouped##12##2##(1994-3#1)(1994-6#1)(2006-10#1)(2006-11#1)(2006-3#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-6#1)
was grown for##2##3##(2008-10#2)
was grown in a##3##4##(1991-10#1)(1997-6#1)(2012-2#1)
was grown in##16##3##(1990-5#1)(1991-10#1)(1997-6#1)(1997-7#1)(2006-8#1)(2008-10#7)(2008-5#1)(2011-2#1)(2012-2#1)(2012-5#1)
was grown on##6##3##(1992-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2013-1#2)
was grown##32##2##(1990-5#1)(1991-10#1)(1992-8#1)(1994-12#2)(1996-12#1)(1996-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-8#1)(2007-12#1)(2008-10#10)(2008-5#2)(2008-6#1)(2008-7#2)(2011-2#1)(2012-2#1)(2012-5#1)(2013-1#2)
was guided by the##3##4##(2009-3#1)(2010-3#2)
was guided by##7##3##(2008-9#1)(2009-11#1)(2009-3#1)(2010-11#1)(2010-3#2)(2010-9#1)
was half that##2##3##(1995-9#1)(2008-5#1)
was half##3##2##(1990-3#1)(1995-9#1)(2008-5#1)
was half-maximal at##2##3##(1990-4#1)(1991-2#1)
was half-maximal##3##2##(1990-4#1)(1991-2#1)(2004-11#1)
was halved##3##2##(1992-2#1)(2007-7#1)(2009-10#1)
was hampered by##2##3##(1995-6#1)(2008-10#1)
was hampered##3##2##(1995-6#1)(2006-4#1)(2008-10#1)
was hand##2##2##(2007-8#1)(2011-2#1)
was handed##2##2##(2006-10#1)(2008-12#1)
was handled in##2##3##(2008-11#1)(2008-3#1)
was handled##4##2##(1995-10#1)(2008-11#1)(2008-3#1)(2009-11#1)
was hardly affected##3##3##(1993-6#1)(1993-9#1)(1994-8#1)
was hardly changed##2##3##(1990-5#1)(1997-8#1)
was hardly extracted with##2##4##(2008-10#2)
was hardly##11##2##(1990-12#1)(1990-5#1)(1992-3#1)(1992-6#1)(1993-6#1)(1993-9#1)(1994-8#1)(1997-8#1)(2007-8#1)(2008-10#2)
was harvested and##4##3##(2008-10#1)(2008-4#3)
was harvested at##2##3##(1996-2#1)(2013-1#1)
was harvested from##4##3##(1991-12#1)(2007-7#1)(2008-11#1)(2012-2#1)
was harvested##21##2##(1991-12#1)(1995-12#1)(1996-2#2)(2006-6#1)(2007-7#2)(2008-10#1)(2008-11#4)(2008-4#3)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#3)
was having##5##2##(2006-2#1)(2007-7#3)(2007-8#1)
was health care##2##3##(2007-10#2)
was healthy##3##2##(2007-12#2)(2012-1#1)
was heard##2##2##(1992-3#1)(2008-8#1)
was heat stable##3##3##(1992-9#1)(2008-10#1)(2013-7#1)
was heat##5##2##(1992-9#1)(2006-8#1)(2008-10#2)(2013-7#1)
was heat-stable##2##2##(2008-10#1)(2008-11#1)
was heated at##6##3##(1995-6#1)(2005-11#2)(2008-10#1)(2008-3#1)(2008-7#1)
was heated on a##2##4##(2008-10#2)
was heated##12##2##(1995-6#1)(2005-11#2)(2008-10#4)(2008-2#2)(2008-3#2)(2008-7#1)
was heavily##5##2##(1990-6#1)(1993-6#1)(1994-12#1)(2007-5#1)(2008-10#1)
was held at the Royal Free##2##6##(2006-11#2)
was held at the Royal##3##5##(2006-11#3)
was held at the##8##4##(2006-11#5)(2006-9#1)(2008-1#1)(2008-8#1)
was held at##12##3##(2006-11#8)(2006-9#1)(2008-1#1)(2008-10#1)(2008-8#1)
was held constant at##4##4##(1991-4#1)(2008-10#1)(2008-6#1)(2008-9#1)
was held constant##7##3##(1991-4#1)(1995-12#1)(2008-10#3)(2008-6#1)(2008-9#1)
was held in October##2##4##(1991-10#1)(2007-7#1)
was held in Washington##3##4##(2006-10#1)(2008-10#1)(2008-5#1)
was held in the##2##4##(2005-8#1)(2013-7#1)
was held in##22##3##(1991-10#1)(1991-3#1)(1997-8#1)(2004-12#1)(2004-4#1)(2005-11#1)(2005-8#4)(2006-10#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-11#1)(2010-5#2)(2011-2#1)(2011-4#1)(2013-7#1)
was held on March##2##4##(1991-11#1)(2007-11#1)
was held on##6##3##(1991-11#1)(1996-12#1)(2005-7#1)(2007-11#1)(2008-7#1)(2009-8#1)
was held to##4##3##(1990-12#1)(2006-8#1)(2007-11#1)(2008-3#1)
was held##64##2##(1990-12#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-4#1)(1992-5#2)(1995-12#1)(1996-12#1)(1997-8#1)(2004-12#1)(2004-4#1)(2005-11#1)(2005-7#1)(2005-8#5)(2006-10#1)(2006-11#8)(2006-8#1)(2006-9#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-5#2)(2011-2#1)(2011-4#1)(2013-7#1)
was helpful in##2##3##(2008-12#2)
was helpful to##3##3##(1994-3#1)(1996-9#1)(2010-8#1)
was helpful##10##2##(1990-6#1)(1994-3#1)(1996-9#1)(2005-7#1)(2007-3#1)(2007-8#1)(2008-12#2)(2010-8#1)(2013-1#1)
was here##2##2##(1996-5#1)(2011-2#1)
was heritable##2##2##(2006-12#1)(2007-11#1)
was heterogeneous for the##2##4##(1992-9#1)(2008-7#1)
was heterogeneous##7##2##(1990-12#1)(1990-4#1)(1991-7#1)(1992-9#2)(2008-11#1)(2008-7#1)
was heterozygous for a##2##4##(1995-4#1)(2008-3#1)
was heterozygous for##3##3##(1992-2#1)(1995-4#1)(2008-3#1)
was heterozygous##5##2##(1992-2#1)(1993-6#1)(1995-4#1)(2006-7#1)(2008-3#1)
was high (&gt##2##3##(2013-1#2)
was high and##7##3##(2004-1#1)(2007-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-11#1)(2011-2#1)
was high at##3##3##(1990-11#1)(2008-10#2)
was high but##4##3##(1996-2#1)(1996-5#1)(2012-2#1)(2013-1#1)
was high compared to##2##4##(1996-1#1)(2006-8#1)
was high compared##3##3##(1995-3#1)(1996-1#1)(2006-8#1)
was high for##7##3##(1990-6#1)(1992-2#1)(2008-10#2)(2008-7#1)(2009-3#1)(2009-7#1)
was high in all##3##4##(2008-10#3)
was high in both##2##4##(2008-5#1)(2011-2#1)
was high in the##2##4##(2007-7#1)(2010-12#1)
was high in this##2##4##(1993-5#1)(2012-3#1)
was high in##22##3##(1993-5#1)(1994-12#1)(1995-8#1)(1997-6#1)(2007-10#1)(2007-7#3)(2008-1#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
was high while##2##3##(2005-12#1)(2008-9#1)
was high with##2##3##(2005-9#1)(2006-10#1)
was high##138##2##(1990-10#1)(1990-11#1)(1990-6#4)(1990-9#1)(1991-2#1)(1991-6#2)(1992-12#1)(1992-2#2)(1992-6#1)(1992-7#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-3#2)(1995-8#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-3#2)(1997-4#1)(1997-6#1)(2004-1#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-9#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-1#2)(2007-10#3)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#6)(2007-8#1)(2008-1#2)(2008-10#26)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#3)(2009-11#2)(2009-3#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-1#4)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#6)(2013-8#2)
was higher (0##2##3##(1991-1#1)(2008-10#1)
was higher (P &lt##12##4##(1994-6#1)(2006-5#3)(2007-8#2)(2008-4#1)(2010-2#5)
was higher (P less than 0##2##6##(1990-12#1)(1992-4#1)
was higher (P##14##3##(1990-12#1)(1992-4#1)(1994-6#1)(2006-5#3)(2007-8#2)(2008-4#1)(2010-2#5)
was higher (p &lt##4##4##(2008-3#3)(2008-5#1)
was higher after##2##3##(1991-12#1)(1995-11#1)
was higher among female subjects and higher##3##7##(1997-1#3)
was higher among girls in##2##5##(1991-8#1)(2008-9#1)
was higher among patients with versus without PPE##2##8##(2008-7#2)
was higher among patients with##3##5##(1992-5#1)(2008-7#2)
was higher among patients##4##4##(1992-5#1)(2007-8#1)(2008-7#2)
was higher among rural subjects##2##5##(1997-1#2)
was higher among rural##3##4##(1997-1#3)
was higher among the##4##4##(1996-8#1)(2008-5#1)(2011-2#1)(2013-1#1)
was higher among women##2##4##(2007-9#1)(2009-4#1)
was higher among##28##3##(1991-8#1)(1992-5#1)(1993-11#1)(1996-8#1)(1997-1#6)(2006-10#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-4#1)(2010-4#1)(2011-1#2)(2011-11#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
was higher and the##2##4##(2008-11#1)(2013-8#1)
was higher and##4##3##(2007-7#1)(2008-10#1)(2008-11#1)(2013-8#1)
was higher as##2##3##(1992-1#1)(2007-8#1)
was higher at##9##3##(2007-2#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-8#1)(2011-2#2)(2012-3#1)
was higher by##5##3##(1994-2#1)(2006-12#1)(2007-8#2)(2009-4#1)
was higher during##5##3##(1990-7#1)(1994-4#1)(2007-8#1)(2008-11#1)(2012-2#1)
was higher for the##7##4##(1993-12#1)(1995-7#1)(2004-8#1)(2008-10#2)(2008-11#1)(2013-8#1)
was higher for##20##3##(1991-9#1)(1992-5#1)(1993-12#1)(1994-3#1)(1995-7#1)(2004-8#1)(2005-7#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-7#1)(2010-4#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
was higher if##2##3##(1997-5#1)(2012-1#1)
was higher in OXE rats##2##5##(2004-11#2)
was higher in boys than##2##5##(2013-1#1)(2013-7#1)
was higher in comparison to##2##5##(2008-5#1)(2011-2#1)
was higher in females##3##4##(2006-10#1)(2006-9#1)(2008-4#1)
was higher in males than in females##2##7##(1995-5#1)(1995-6#1)
was higher in males than##3##5##(1995-5#1)(1995-6#1)(2006-2#1)
was higher in males##6##4##(1995-5#1)(1995-6#1)(2006-2#1)(2006-9#1)(2007-7#1)(2009-4#1)
was higher in patients with##7##5##(1990-7#1)(1990-8#1)(1994-12#1)(1995-6#1)(2006-11#1)(2008-7#1)(2012-12#1)
was higher in patients##12##4##(1990-7#1)(1990-8#1)(1991-4#1)(1994-12#1)(1995-6#1)(2006-11#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
was higher in subjects##2##4##(2008-7#1)(2011-2#1)
was higher in the dry season##2##6##(2007-5#1)(2007-8#1)
was higher in the group##3##5##(1991-10#1)(2010-2#1)(2012-2#1)
was higher in the##40##4##(1990-3#1)(1991-10#1)(1991-12#2)(1991-9#1)(1995-6#1)(1996-12#1)(1997-5#1)(1997-7#1)(2005-12#1)(2006-5#1)(2007-10#2)(2007-11#1)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#5)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#2)(2009-4#1)(2010-2#1)(2010-8#1)(2011-2#3)(2012-2#2)(2013-7#2)(2013-8#2)
was higher in those with##2##5##(2010-4#1)(2011-2#1)
was higher in women##4##4##(1993-11#1)(2007-7#1)(2008-10#1)(2013-3#1)
was higher in younger##2##4##(2011-2#2)
was higher in##146##3##(1990-3#1)(1990-7#1)(1990-8#3)(1991-10#2)(1991-12#3)(1991-4#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-7#2)(1993-11#1)(1993-3#1)(1994-12#3)(1994-4#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-6#3)(1995-7#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-5#1)(1997-7#2)(1997-8#1)(2004-1#1)(2004-10#1)(2004-11#2)(2005-10#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-5#2)(2006-9#2)(2007-10#2)(2007-11#1)(2007-2#3)(2007-5#2)(2007-7#5)(2007-8#6)(2007-9#2)(2008-10#8)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#4)(2008-5#6)(2008-7#2)(2008-8#3)(2009-4#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#12)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#7)(2013-3#1)(2013-7#3)(2013-8#7)
was higher on##2##3##(2008-10#1)(2008-5#1)
was higher than 0##2##4##(2008-10#1)(2010-4#1)
was higher than 301 var##2##5##(2008-12#2)
was higher than 301##4##4##(2008-12#4)
was higher than 4##2##4##(2008-10#1)(2010-4#1)
was higher than 60%##2##4##(2012-11#1)(2013-7#1)
was higher than for##5##4##(2006-5#1)(2007-8#1)(2008-8#1)(2008-9#1)(2010-12#1)
was higher than in the##6##5##(1993-4#1)(1996-10#1)(2006-8#1)(2008-10#1)(2008-5#1)(2009-2#1)
was higher than in##19##4##(1991-7#1)(1993-4#1)(1996-10#1)(1997-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-9#1)(2009-2#1)(2010-12#1)(2010-3#1)(2011-2#1)
was higher than that by##2##5##(1995-8#1)(2013-8#1)
was higher than that for##4##5##(1990-9#1)(1994-5#1)(2007-10#1)(2008-12#1)
was higher than that in##5##5##(1991-3#1)(2005-4#1)(2008-10#2)(2013-8#1)
was higher than that of the##6##6##(1992-10#1)(1994-11#1)(2008-5#2)(2009-5#1)(2009-7#1)
was higher than that of##31##5##(1990-5#1)(1991-4#1)(1992-10#1)(1994-11#1)(1994-8#1)(1996-5#2)(1997-8#1)(2005-11#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-5#3)(2008-6#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-3#1)(2012-3#1)(2013-1#2)
was higher than that reported in##2##6##(1990-12#1)(1994-12#1)
was higher than that reported##3##5##(1990-12#1)(1994-12#1)(2012-12#1)
was higher than that##52##4##(1990-12#1)(1990-5#1)(1990-9#1)(1991-3#1)(1991-4#1)(1992-10#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-8#1)(1996-5#2)(1997-8#1)(2005-11#1)(2005-4#1)(2007-10#1)(2007-2#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#2)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-3#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#4)
was higher than the control##2##5##(1992-4#1)(2008-8#1)
was higher than the##15##4##(1992-4#1)(2005-12#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#2)
was higher than those##3##4##(1992-3#1)(2010-11#1)(2012-3#1)
was higher than##145##3##(1990-12#3)(1990-5#1)(1990-9#1)(1991-3#2)(1991-4#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-4#1)(1993-10#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-5#2)(1996-6#1)(1997-2#3)(1997-8#1)(2005-11#2)(2005-12#1)(2005-4#1)(2006-5#2)(2006-7#1)(2006-8#2)(2007-10#2)(2007-2#3)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#14)(2008-11#7)(2008-12#10)(2008-2#3)(2008-3#1)(2008-5#7)(2008-6#2)(2008-8#3)(2008-9#4)(2009-2#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#3)(2011-3#2)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#3)(2012-6#1)(2013-1#5)(2013-7#2)(2013-8#6)
was higher under##2##3##(2006-8#1)(2008-10#1)
was higher when the##2##4##(2008-6#1)(2012-1#1)
was higher when##9##3##(1993-12#1)(2008-10#3)(2008-6#1)(2008-7#2)(2008-9#1)(2012-1#1)
was higher with##9##3##(1990-12#1)(1992-12#1)(1997-8#1)(2007-8#1)(2007-9#1)(2008-10#2)(2010-7#1)(2013-8#1)
was higher##441##2##(1990-12#5)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#4)(1991-3#2)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#3)(1992-7#2)(1993-10#1)(1993-11#2)(1993-12#2)(1993-3#2)(1993-4#1)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#1)(1994-4#2)(1994-5#1)(1994-6#1)(1994-8#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#3)(1995-7#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#6)(1997-2#4)(1997-4#1)(1997-5#2)(1997-7#2)(1997-8#3)(2004-1#1)(2004-10#1)(2004-11#2)(2004-2#1)(2004-8#1)(2005-10#1)(2005-11#2)(2005-12#2)(2005-4#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#8)(2006-7#2)(2006-8#4)(2006-9#2)(2007-10#5)(2007-11#1)(2007-12#1)(2007-2#7)(2007-4#1)(2007-5#3)(2007-7#7)(2007-8#19)(2007-9#4)(2008-1#1)(2008-10#38)(2008-11#12)(2008-12#13)(2008-2#4)(2008-3#6)(2008-4#5)(2008-5#17)(2008-6#4)(2008-7#8)(2008-8#6)(2008-9#7)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#5)(2010-2#8)(2010-3#2)(2010-4#6)(2010-5#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#6)(2011-11#1)(2011-2#22)(2011-3#2)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#9)(2012-3#7)(2012-6#1)(2013-1#17)(2013-3#1)(2013-7#5)(2013-8#18)
was highest among the##2##4##(2008-10#1)(2008-11#1)
was highest among##7##3##(2006-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-6#1)(2012-12#1)(2013-1#1)
was highest at##8##3##(1993-11#1)(1995-6#1)(1997-8#1)(2008-10#4)(2008-5#1)
was highest during the first##2##5##(1991-4#1)(2008-11#1)
was highest during##4##3##(1991-4#1)(2008-11#1)(2010-8#1)(2012-2#1)
was highest following corn##2##4##(2011-2#2)
was highest following##3##3##(2011-2#3)
was highest for the##3##4##(2007-2#1)(2008-10#1)(2013-7#1)
was highest for##12##3##(1992-6#1)(1996-6#1)(1997-6#1)(2007-2#2)(2008-10#2)(2008-4#1)(2011-2#3)(2013-7#1)
was highest in the first##2##5##(2004-11#1)(2006-7#1)
was highest in the##22##4##(1992-1#1)(1992-2#1)(1992-5#2)(1993-3#1)(1994-2#1)(1995-12#1)(1997-8#1)(2004-11#2)(2006-7#1)(2006-8#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-4#1)(2013-3#1)
was highest in##59##3##(1990-8#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-5#2)(1993-3#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-7#1)(1995-12#1)(1995-8#1)(1997-6#3)(1997-8#1)(2004-1#1)(2004-11#2)(2006-2#2)(2006-7#1)(2006-8#5)(2007-10#1)(2007-11#1)(2007-3#2)(2007-7#1)(2007-8#3)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#3)(2009-2#1)(2009-7#3)(2009-8#1)(2010-4#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-3#1)
was highest on##3##3##(2004-9#1)(2008-4#1)(2008-5#1)
was highest when the##2##4##(2004-11#1)(2008-2#1)
was highest with##2##3##(2007-5#1)(2008-10#1)
was highest##115##2##(1990-8#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-5#2)(1992-6#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-7#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-6#4)(1997-8#2)(2004-1#1)(2004-11#4)(2004-9#1)(2005-12#1)(2006-2#3)(2006-7#1)(2006-8#5)(2007-10#1)(2007-11#2)(2007-2#4)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#5)(2009-2#2)(2009-6#1)(2009-7#4)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-3#1)(2013-7#1)(2013-8#1)
was highlighted by##2##3##(2005-8#1)(2006-10#1)
was highlighted in the##2##4##(2007-2#1)(2012-12#1)
was highlighted##9##2##(1993-3#1)(2005-8#3)(2006-10#1)(2007-2#1)(2008-11#1)(2010-8#1)(2012-12#1)
was highly active in##2##4##(1992-7#1)(1996-8#1)
was highly active##5##3##(1990-11#1)(1992-7#1)(1996-8#1)(2007-11#2)
was highly associated with the##3##5##(2009-8#1)(2013-1#2)
was highly associated with##4##4##(2009-8#1)(2011-1#1)(2013-1#2)
was highly conserved##3##3##(1997-7#1)(2008-10#2)
was highly correlated to##2##4##(1990-2#1)(2008-10#1)
was highly correlated with##5##4##(1991-11#1)(1995-6#1)(1996-3#1)(2008-10#2)
was highly correlated##8##3##(1990-2#1)(1991-11#1)(1995-6#1)(1996-3#1)(2008-10#4)
was highly dependent on the##5##5##(1992-1#1)(1995-7#1)(1997-1#1)(1997-8#1)(2008-11#1)
was highly dependent on##6##4##(1992-1#1)(1995-7#1)(1997-1#1)(1997-8#1)(2005-11#1)(2008-11#1)
was highly dependent##7##3##(1992-1#1)(1995-7#1)(1997-1#1)(1997-8#1)(2005-11#1)(2008-11#1)(2012-3#1)
was highly effective at##2##4##(2008-10#1)(2010-4#1)
was highly effective in##4##4##(2008-10#3)(2008-5#1)
was highly effective##7##3##(1991-4#1)(2008-10#4)(2008-5#1)(2010-4#1)
was highly elevated##3##3##(1991-4#1)(2009-8#2)
was highly expressed in rat##2##5##(1992-11#1)(1994-6#1)
was highly expressed in##7##4##(1992-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-5#1)(2008-6#1)(2013-8#1)
was highly expressed##12##3##(1992-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-5#1)(2005-11#1)(2007-12#1)(2008-6#2)(2008-8#1)(2010-5#1)(2013-8#1)
was highly homologous to that of##2##6##(1991-9#1)(1995-3#1)
was highly homologous to the##2##5##(1990-4#1)(1994-12#1)
was highly homologous to##7##4##(1990-4#1)(1991-5#1)(1991-9#1)(1994-12#1)(1995-3#1)(1997-2#1)(1997-5#1)
was highly homologous##9##3##(1990-4#1)(1990-5#1)(1991-5#1)(1991-9#1)(1994-12#1)(1995-3#1)(1997-2#1)(1997-4#1)(1997-5#1)
was highly increased in##2##4##(1993-11#1)(2011-10#1)
was highly induced##2##3##(1997-8#1)(2008-10#1)
was highly predictive of improvement of##2##6##(2007-8#2)
was highly predictive of##3##4##(2007-8#2)(2008-6#1)
was highly predictive##4##3##(1993-11#1)(2007-8#2)(2008-6#1)
was highly purified from the##2##5##(1991-4#1)(1993-3#1)
was highly purified from##4##4##(1991-4#1)(1993-3#1)(2008-9#2)
was highly reproducible##2##3##(1993-2#1)(2008-10#1)
was highly resistant to##2##4##(2008-10#1)(2011-2#1)
was highly resistant##3##3##(2008-10#2)(2011-2#1)
was highly selective for##2##4##(1991-7#1)(2010-1#1)
was highly selective##4##3##(1991-7#1)(1997-6#1)(2010-1#1)(2013-8#1)
was highly sensitive to##5##4##(1992-8#2)(1997-4#1)(2008-10#1)(2012-2#1)
was highly sensitive##8##3##(1992-8#2)(1994-11#1)(1997-4#1)(2005-4#1)(2008-10#2)(2012-2#1)
was highly significant (P &lt##3##5##(1995-6#1)(1996-9#1)(2007-6#1)
was highly significant (P##4##4##(1992-7#1)(1995-6#1)(1996-9#1)(2007-6#1)
was highly significant##14##3##(1990-4#1)(1990-6#1)(1992-7#1)(1994-3#1)(1995-6#1)(1996-9#1)(2007-6#1)(2007-7#1)(2008-10#4)(2008-5#1)(2011-2#1)
was highly significantly##2##3##(1994-4#1)(2008-10#1)
was highly specific and##3##4##(1991-11#1)(1991-4#1)(2008-10#1)
was highly specific for##3##4##(1993-9#1)(1995-5#1)(2008-10#1)
was highly specific##10##3##(1991-11#1)(1991-4#1)(1993-9#1)(1995-5#1)(1996-9#1)(1997-4#1)(2006-10#1)(2008-10#3)
was highly susceptible##2##3##(2008-5#1)(2009-3#1)
was highly variable##7##3##(1994-4#1)(2006-8#1)(2008-10#2)(2008-9#2)(2010-8#1)
was highly##166##2##(1990-11#2)(1990-2#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1991-11#2)(1991-4#4)(1991-5#1)(1991-7#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-7#2)(1992-8#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-7#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-9#1)(2005-11#2)(2005-4#1)(2006-10#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-10#32)(2008-11#2)(2008-4#1)(2008-5#6)(2008-6#4)(2008-7#1)(2008-8#3)(2008-9#5)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#3)(2010-1#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#3)
was his##4##2##(1995-5#1)(2007-6#1)(2011-2#1)(2013-8#1)
was histologic##2##2##(1995-8#1)(2009-2#1)
was histological##3##2##(1991-11#1)(2007-8#1)(2008-6#1)
was histologically confirmed##3##3##(1990-10#1)(2007-6#1)(2007-8#1)
was histologically normal##2##3##(1993-12#1)(2008-3#1)
was histologically verified##2##3##(2008-10#1)(2008-7#1)
was histologically##10##2##(1990-10#1)(1993-12#1)(2007-6#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-9#1)
was historically##2##2##(1997-5#1)(2013-8#1)
was hitherto##4##2##(2007-3#2)(2009-8#1)(2010-12#1)
was homogenized in##2##3##(1995-3#1)(2008-10#1)
was homogenized##4##2##(1990-7#1)(1995-3#1)(2008-10#2)
was homologous to the##2##4##(1991-10#1)(1991-7#1)
was homologous to##7##3##(1991-10#1)(1991-7#1)(1992-9#1)(1993-9#1)(1995-8#1)(1997-7#1)(2008-8#1)
was homologous with the##2##4##(1990-10#2)
was homologous##9##2##(1990-10#2)(1991-10#1)(1991-7#1)(1992-9#1)(1993-9#1)(1995-8#1)(1997-7#1)(2008-8#1)
was homozygous for resistance to##2##5##(2008-10#2)
was homozygous for the##2##4##(1994-11#1)(2008-3#1)
was homozygous for##7##3##(1993-12#1)(1993-7#1)(1994-11#1)(2007-12#1)(2008-10#2)(2008-3#1)
was honored##3##2##(1996-12#1)(2005-8#2)
was hoped that##2##3##(2006-10#1)(2008-1#1)
was hospitalised in our##2##4##(2006-2#1)(2012-2#1)
was hospitalised##4##2##(2006-2#1)(2007-8#1)(2012-12#1)(2012-2#1)
was hospitalized because of##3##4##(1996-12#2)(2007-8#1)
was hospitalized for##6##3##(1990-8#1)(1991-10#1)(1993-10#1)(1995-9#1)(2011-2#1)(2013-8#1)
was hospitalized in##2##3##(2007-8#1)(2009-1#1)
was hospitalized with##2##3##(1996-3#1)(2005-12#1)
was hospitalized##16##2##(1990-8#1)(1991-10#1)(1993-10#1)(1993-6#1)(1995-4#1)(1995-9#1)(1996-12#2)(1996-3#1)(2005-12#1)(2007-8#2)(2009-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
was hosted by##2##3##(2005-7#1)(2008-11#1)
was hosted jointly by the##2##5##(2005-8#2)
was hosted##5##2##(2005-7#1)(2005-8#2)(2007-12#1)(2008-11#1)
was housed##2##2##(2007-2#1)(2008-5#1)
was however##7##2##(1990-5#1)(1993-9#1)(1996-12#1)(2007-1#1)(2008-10#1)(2008-6#1)(2009-9#1)
was hybridized to a##2##4##(1993-2#1)(1995-8#1)
was hybridized to##3##3##(1993-2#1)(1995-8#1)(2008-10#1)
was hybridized with a##2##4##(1990-2#1)(2008-8#1)
was hybridized with the##2##4##(1990-4#1)(1990-5#1)
was hybridized with##6##3##(1990-2#1)(1990-4#1)(1990-5#1)(2008-10#1)(2008-8#1)(2013-1#1)
was hybridized##9##2##(1990-2#1)(1990-4#1)(1990-5#1)(1993-2#1)(1995-8#1)(2008-10#2)(2008-8#1)(2013-1#1)
was hydrolysed by##2##3##(1997-8#1)(2006-11#1)
was hydrolysed to##2##3##(1991-2#1)(1994-3#1)
was hydrolysed##4##2##(1991-2#1)(1994-3#1)(1997-8#1)(2006-11#1)
was hydrolyzed with##2##3##(2010-2#1)(2012-3#1)
was hydrolyzed##10##2##(1990-7#1)(1992-3#2)(1995-3#1)(1996-3#1)(1996-5#1)(2008-10#2)(2010-2#1)(2012-3#1)
was hyperphosphorylated in##2##3##(2009-6#1)(2013-7#1)
was hyperphosphorylated##3##2##(1994-8#1)(2009-6#1)(2013-7#1)
was hypertension##2##2##(2007-7#1)(2012-12#1)
was hypophisiary##2##2##(2013-1#2)
was hypothesised##4##2##(1994-2#1)(2007-10#1)(2007-11#1)(2008-5#1)
was hypothesized that the##5##4##(1996-4#1)(2006-2#1)(2007-8#1)(2008-10#1)(2013-1#1)
was hypothesized that this##3##4##(2007-8#1)(2008-5#1)(2008-8#1)
was hypothesized that##29##3##(1991-1#1)(1992-2#1)(1995-1#1)(1996-3#1)(1996-4#1)(1997-5#2)(2004-12#1)(2004-9#1)(2006-2#1)(2007-8#3)(2008-10#3)(2008-12#1)(2008-4#2)(2008-5#1)(2008-8#3)(2008-9#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-7#1)
was hypothesized to##4##3##(1993-12#1)(2006-10#1)(2010-12#1)(2012-3#1)
was hypothesized##35##2##(1991-1#1)(1992-2#1)(1993-12#1)(1995-1#1)(1996-3#1)(1996-4#1)(1997-5#2)(2004-12#1)(2004-9#1)(2006-10#1)(2006-2#1)(2007-8#3)(2008-10#4)(2008-12#1)(2008-4#2)(2008-5#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-12#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
was identical for the##2##4##(1992-11#1)(1995-6#1)
was identical for##3##3##(1992-11#1)(1995-6#1)(2008-10#1)
was identical in all##3##4##(1990-4#1)(2009-9#1)(2012-12#1)
was identical in both##2##4##(1990-5#1)(1993-4#1)
was identical in the##2##4##(1992-1#1)(1994-12#1)
was identical in##9##3##(1990-4#1)(1990-5#1)(1990-8#1)(1992-1#1)(1993-4#1)(1994-12#1)(2008-10#1)(2009-9#1)(2012-12#1)
was identical to that of the##4##6##(1990-5#1)(1990-8#1)(1994-3#1)(1994-9#1)
was identical to that of##9##5##(1990-1#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1992-7#1)(1994-3#1)(1994-9#1)
was identical to that##15##4##(1990-1#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-8#1)(1992-7#1)(1993-12#1)(1994-3#1)(1994-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)
was identical to the##8##4##(1990-2#1)(1991-7#1)(1992-5#1)(1994-11#1)(1995-3#1)(1997-2#1)(2008-5#1)(2009-11#1)
was identical to##28##3##(1990-1#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-8#1)(1991-1#1)(1991-7#1)(1991-8#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-4#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-4#1)(1997-2#1)(1997-9#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2009-11#1)
was identical with that of##4##5##(1990-3#1)(1990-7#2)(1994-11#1)
was identical with that##8##4##(1990-3#1)(1990-7#2)(1991-2#2)(1994-11#1)(1995-3#1)(1996-11#1)
was identical with the##2##4##(1997-7#1)(2006-10#1)
was identical with##11##3##(1990-3#1)(1990-7#2)(1991-2#2)(1994-11#1)(1995-3#1)(1996-11#1)(1997-7#1)(2006-10#1)(2008-10#1)
was identical##59##2##(1990-1#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#3)(1991-1#1)(1991-2#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-4#2)(1994-11#2)(1994-12#1)(1994-3#1)(1994-9#1)(1995-3#2)(1995-6#1)(1996-11#1)(1996-4#1)(1997-2#1)(1997-7#1)(1997-9#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-2#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
was identifiable##2##2##(2008-7#2)
was identified adjacent to##2##4##(1991-7#1)(1995-6#1)
was identified among the##2##4##(2006-12#2)
was identified and characterized##2##4##(1993-3#1)(2008-10#1)
was identified and quantified##2##4##(2008-10#1)(2013-8#1)
was identified and shown to be##2##6##(1991-8#1)(1992-12#1)
was identified and shown to##3##5##(1991-8#1)(1992-12#1)(2006-8#1)
was identified and##16##3##(1990-5#1)(1990-8#1)(1991-8#1)(1992-12#1)(1993-3#1)(1994-8#1)(1994-9#1)(1997-2#1)(2006-8#1)(2007-8#2)(2008-10#3)(2009-4#1)(2013-8#1)
was identified as Bacillus##2##4##(2005-11#1)(2013-1#1)
was identified as P##2##4##(2006-8#1)(2008-10#1)
was identified as a new##3##5##(2006-9#1)(2008-10#1)(2013-1#1)
was identified as a promising##2##5##(2006-12#1)(2008-6#1)
was identified as a##39##4##(1990-12#2)(1990-3#1)(1990-8#1)(1991-11#1)(1991-8#1)(1992-12#1)(1992-8#2)(1993-3#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-6#1)(1996-10#1)(1996-11#1)(1997-1#1)(1997-4#1)(2006-12#1)(2006-9#1)(2008-10#5)(2008-5#3)(2008-6#1)(2008-7#1)(2009-8#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#2)
was identified as an important##2##5##(1994-4#1)(2008-10#1)
was identified as an##5##4##(1990-12#1)(1994-4#1)(2007-2#1)(2008-10#1)(2008-11#1)
was identified as being##2##4##(1991-11#1)(2011-2#1)
was identified as the best##2##5##(1996-6#1)(2008-6#1)
was identified as the cause of death##2##7##(2006-10#1)(2007-2#1)
was identified as the cause of##4##6##(2006-10#1)(2007-2#2)(2008-10#1)
was identified as the gene##2##5##(1997-4#1)(2013-8#1)
was identified as the main##2##5##(2005-10#1)(2007-1#1)
was identified as the major##4##5##(1994-1#1)(1994-9#1)(1997-3#1)(2007-1#1)
was identified as the most##5##5##(1995-12#1)(1995-7#1)(2008-10#1)(2011-2#1)(2012-12#1)
was identified as the##41##4##(1991-4#1)(1991-5#1)(1994-1#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-7#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-10#1)(2006-10#2)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2008-10#5)(2008-5#2)(2008-6#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#1)
was identified as##134##3##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-11#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#2)(1992-12#1)(1992-5#1)(1992-8#2)(1992-9#2)(1993-3#2)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-3#2)(1994-4#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-7#1)(1996-10#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#2)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#2)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#3)(2007-7#1)(2008-1#1)(2008-10#17)(2008-11#2)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
was identified at##4##3##(1993-3#1)(2008-3#1)(2009-1#1)(2011-2#1)
was identified between the##3##4##(2007-7#1)(2010-12#1)(2011-1#1)
was identified by Southern hybridization##2##5##(1995-8#1)(2008-8#1)
was identified by a##3##4##(2008-10#1)(2008-8#1)(2011-2#1)
was identified by its##2##4##(1994-8#1)(2008-10#1)
was identified by means of##4##5##(2005-10#1)(2008-10#1)(2008-11#1)(2008-5#1)
was identified by screening##2##4##(1990-5#1)(1991-10#1)
was identified by the##3##4##(1995-1#1)(2005-12#1)(2008-5#1)
was identified by##57##3##(1990-5#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#2)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-5#1)(2005-10#1)(2005-11#2)(2005-12#1)(2006-10#1)(2007-12#1)(2007-7#2)(2008-10#8)(2008-11#1)(2008-5#2)(2008-8#4)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
was identified for##5##3##(2008-11#1)(2008-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
was identified from a##2##4##(1994-12#1)(2005-11#1)
was identified from##6##3##(1994-12#2)(2005-11#1)(2006-6#1)(2008-10#1)(2008-9#1)
was identified in 16##2##4##(1991-2#1)(2013-1#1)
was identified in a##6##4##(1990-3#1)(1990-9#1)(1993-3#1)(1997-2#1)(2008-10#2)
was identified in all##2##4##(1990-8#1)(2006-10#1)
was identified in both##2##4##(2008-1#1)(2009-5#1)
was identified in exon 4##2##5##(1990-5#1)(2012-12#1)
was identified in exon##3##4##(1990-5#1)(1990-6#1)(2012-12#1)
was identified in patients with##2##5##(1994-9#1)(2007-10#1)
was identified in the##21##4##(1990-4#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-6#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-3#1)(1996-12#1)(1997-8#1)(2006-2#1)(2007-8#1)(2008-11#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-12#1)
was identified in three##2##4##(2008-10#1)(2012-3#1)
was identified in##91##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-11#2)(1994-2#2)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#3)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(2006-10#2)(2006-2#1)(2006-8#1)(2007-10#2)(2007-2#4)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#12)(2008-11#1)(2008-8#1)(2009-10#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-2#1)(2010-5#1)(2011-2#4)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#2)
was identified on chromosome##2##4##(2008-10#1)(2008-9#1)
was identified on the##2##4##(2008-10#2)
was identified on##7##3##(1992-3#1)(1995-2#1)(2006-10#1)(2008-10#3)(2008-9#1)
was identified that was##2##4##(1990-11#1)(2008-10#1)
was identified that##10##3##(1990-11#1)(1992-5#1)(1997-2#1)(2007-11#1)(2008-10#3)(2008-5#1)(2008-9#1)(2013-1#1)
was identified through##7##3##(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
was identified to be a##2##5##(1994-3#1)(2012-3#1)
was identified to be##6##4##(1993-8#2)(1994-3#1)(1994-8#1)(2008-9#1)(2012-3#1)
was identified to##8##3##(1990-10#1)(1993-8#2)(1994-3#1)(1994-8#1)(2008-9#1)(2012-3#1)(2013-1#1)
was identified using##5##3##(1994-5#1)(1995-1#1)(1997-4#1)(2008-10#1)(2010-8#1)
was identified which##4##3##(1991-2#2)(1995-2#1)(1997-1#1)
was identified whose##2##3##(1995-2#1)(2011-2#1)
was identified with##4##3##(1994-2#1)(1995-12#1)(2007-11#1)(2008-8#1)
was identified within the##3##4##(1995-8#1)(1996-3#1)(2013-8#1)
was identified within##4##3##(1991-5#1)(1995-8#1)(1996-3#1)(2013-8#1)
was identified##462##2##(1990-1#2)(1990-10#2)(1990-11#3)(1990-12#5)(1990-2#2)(1990-3#2)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#5)(1990-9#3)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#5)(1991-4#1)(1991-5#4)(1991-7#6)(1991-8#4)(1991-9#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#3)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#5)(1993-11#4)(1993-12#1)(1993-2#1)(1993-3#7)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#5)(1994-12#3)(1994-2#4)(1994-3#3)(1994-4#1)(1994-5#2)(1994-6#3)(1994-8#7)(1994-9#5)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#4)(1995-3#4)(1995-5#5)(1995-6#4)(1995-7#1)(1995-8#3)(1996-10#2)(1996-11#3)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#1)(1997-1#2)(1997-2#5)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#4)(2005-10#2)(2005-11#5)(2005-12#1)(2005-5#1)(2006-10#10)(2006-12#5)(2006-2#1)(2006-5#1)(2006-6#2)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#4)(2007-12#5)(2007-2#7)(2007-3#1)(2007-7#6)(2007-8#5)(2008-1#2)(2008-10#56)(2008-11#6)(2008-3#4)(2008-4#5)(2008-5#13)(2008-6#2)(2008-7#2)(2008-8#9)(2008-9#9)(2009-1#2)(2009-10#1)(2009-2#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#5)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#3)(2010-5#2)(2010-6#1)(2010-8#3)(2011-1#5)(2011-12#1)(2011-2#14)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#7)(2012-3#8)(2013-1#9)(2013-7#1)(2013-8#6)
was ignored##2##2##(2005-10#1)(2012-11#1)
was illuminated with##3##3##(2007-12#1)(2008-2#2)
was illuminated##4##2##(2007-12#1)(2008-1#1)(2008-2#2)
was illustrated by##3##3##(1991-9#1)(1997-6#1)(2009-2#1)
was illustrated in the##2##4##(1991-12#1)(2007-1#1)
was illustrated##12##2##(1991-12#1)(1991-9#1)(1997-6#1)(2007-1#1)(2008-10#6)(2009-2#1)(2012-3#1)
was imaged by##3##3##(1996-11#1)(1997-1#1)(2008-2#1)
was imaged##9##2##(1996-11#1)(1996-9#1)(1997-1#1)(2007-12#2)(2007-9#1)(2008-2#3)
was immediate##3##2##(1995-12#1)(2008-5#1)(2010-9#1)
was immediately##15##2##(1990-9#1)(1992-2#1)(2005-11#1)(2006-5#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-5#1)(2009-6#1)(2010-10#1)(2011-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
was immersed in##2##3##(2007-8#1)(2010-5#1)
was immersed##3##2##(2007-8#1)(2008-10#1)(2010-5#1)
was immobilised on a##2##4##(2008-10#2)
was immobilised on the##3##4##(2008-10#3)
was immobilised on##5##3##(2008-10#5)
was immobilised##8##2##(2007-11#1)(2008-10#7)
was immobilized at##2##3##(2008-10#1)(2009-3#1)
was immobilized by##6##3##(2004-9#1)(2007-8#1)(2008-10#4)
was immobilized in##6##3##(2008-10#3)(2008-6#2)(2010-3#1)
was immobilized on a##4##4##(2008-10#2)(2008-11#1)(2008-7#1)
was immobilized on porous silica beads (glass##2##7##(2008-10#2)
was immobilized on the biosensor surface##2##6##(2008-10#2)
was immobilized on the surface of the##3##7##(2007-8#1)(2008-10#1)(2008-11#1)
was immobilized on the surface of##4##6##(2007-8#1)(2008-10#2)(2008-11#1)
was immobilized on the##13##4##(2007-8#1)(2008-10#10)(2008-11#1)(2010-4#1)
was immobilized on##31##3##(1990-11#1)(1997-2#1)(2007-8#1)(2008-10#21)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-4#1)
was immobilized onto##6##3##(1991-5#1)(2005-12#1)(2008-10#4)
was immobilized to the##2##4##(2007-8#1)(2008-10#1)
was immobilized to##3##3##(1992-12#1)(2007-8#1)(2008-10#1)
was immobilized##64##2##(1990-11#1)(1991-5#1)(1992-12#1)(1993-12#1)(1997-2#1)(2004-9#1)(2005-12#1)(2007-8#3)(2008-10#42)(2008-11#3)(2008-12#1)(2008-6#3)(2008-7#1)(2009-10#1)(2009-3#1)(2010-3#1)(2010-4#1)
was immune##2##2##(1995-6#1)(2008-10#1)
was immunolocalized##2##2##(1995-12#2)
was immunologically##4##2##(1990-11#1)(1991-12#1)(1995-3#1)(1997-7#1)
was immunoprecipitated by a##2##4##(1992-6#1)(1995-6#1)
was immunoprecipitated from##2##3##(1991-5#1)(1996-8#1)
was immunoprecipitated with##4##3##(1990-11#2)(1991-12#1)(1991-5#1)
was immunoprecipitated##9##2##(1990-11#2)(1991-12#1)(1991-5#2)(1992-6#1)(1995-6#1)(1996-8#2)
was immunoreactive##2##2##(1991-2#1)(2009-7#1)
was impaired and##2##3##(2007-8#1)(2010-4#1)
was impaired by##5##3##(1993-12#1)(1995-3#1)(2012-12#2)(2013-1#1)
was impaired in##6##3##(1994-12#1)(1995-2#1)(1997-7#1)(2008-10#1)(2008-7#1)(2012-3#1)
was impaired when##3##3##(1990-11#1)(2008-7#1)(2012-2#1)
was impaired with##2##3##(1992-8#1)(2011-2#1)
was impaired##32##2##(1990-11#1)(1991-2#1)(1992-4#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-7#1)(1997-7#1)(2005-1#1)(2005-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
was implanted in the##3##4##(1992-4#1)(2011-3#1)(2013-1#1)
was implanted in##12##3##(1991-3#1)(1992-10#1)(1992-4#1)(1992-5#1)(2005-10#1)(2007-4#1)(2007-7#1)(2008-5#1)(2011-3#1)(2012-3#1)(2013-1#2)
was implanted into##3##3##(1996-10#1)(2004-9#2)
was implanted##28##2##(1991-3#2)(1992-10#1)(1992-4#1)(1992-5#1)(1995-9#1)(1996-10#1)(2004-9#3)(2005-10#1)(2007-1#1)(2007-4#1)(2007-7#2)(2007-8#4)(2008-5#1)(2009-4#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
was implemented and##2##3##(2008-3#1)(2008-6#1)
was implemented by##7##3##(1996-12#1)(2005-9#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-3#1)
was implemented for##4##3##(1992-4#1)(2008-8#1)(2010-8#1)(2012-3#1)
was implemented in a##6##4##(2008-10#2)(2008-2#1)(2008-3#1)(2010-12#1)(2013-8#1)
was implemented in##18##3##(2005-1#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2010-12#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
was implemented into a##2##4##(2008-7#1)(2012-2#1)
was implemented on a##2##4##(1992-3#1)(2008-3#1)
was implemented on##4##3##(1992-3#1)(2008-11#1)(2008-3#1)(2010-2#1)
was implemented that##2##3##(1997-1#1)(2005-10#1)
was implemented to evaluate##2##4##(1997-1#1)(2011-1#1)
was implemented to##10##3##(1990-12#1)(1990-7#1)(1997-1#1)(2008-10#1)(2011-1#1)(2012-3#1)(2013-1#3)(2013-8#1)
was implemented with##3##3##(2007-12#1)(2007-5#1)(2008-3#1)
was implemented##86##2##(1990-12#1)(1990-7#1)(1992-3#1)(1992-4#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#2)(2005-1#2)(2005-10#1)(2005-9#1)(2006-10#1)(2006-3#1)(2006-6#2)(2007-10#2)(2007-12#4)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-2#3)(2012-3#2)(2013-1#8)(2013-8#2)
was implicated as##3##3##(1992-2#1)(2006-4#1)(2006-8#1)
was implicated in the##3##4##(1997-8#1)(2007-2#1)(2007-7#1)
was implicated in##5##3##(1994-9#1)(1997-8#1)(2007-2#1)(2007-7#1)(2008-10#1)
was implicated##9##2##(1992-2#1)(1994-9#1)(1997-8#1)(2006-4#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-10#2)
was important for##5##3##(1991-8#1)(2006-5#1)(2008-8#1)(2009-6#1)(2011-2#1)
was important in##4##3##(1991-12#1)(1996-10#1)(2006-10#1)(2008-7#1)
was important to##3##3##(1992-11#1)(2006-12#1)(2008-9#1)
was important##19##2##(1991-12#1)(1991-8#1)(1992-11#1)(1995-2#1)(1996-10#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#2)(2011-2#2)
was imposed on the##2##4##(1992-7#1)(2008-2#1)
was imposed on##3##3##(1991-8#1)(1992-7#1)(2008-2#1)
was imposed##7##2##(1991-8#1)(1992-7#1)(1995-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2011-2#1)
was impossible##8##2##(1994-2#1)(1994-4#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)
was impractical##2##2##(1992-10#1)(2011-2#1)
was improved as well as##2##5##(2007-8#1)(2008-12#1)
was improved at##2##3##(1996-9#1)(1997-2#1)
was improved by a factor of##3##6##(1996-12#1)(2008-10#1)(2011-2#1)
was improved by increasing the##2##5##(1997-8#1)(2010-4#1)
was improved by the##3##4##(2008-10#2)(2008-7#1)
was improved by using##4##4##(1990-6#1)(1990-8#1)(2008-10#2)
was improved by##28##3##(1990-6#1)(1990-7#1)(1990-8#1)(1992-8#2)(1993-8#1)(1994-8#1)(1996-12#1)(1997-8#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
was improved for##2##3##(2007-8#1)(2008-12#1)
was improved from##2##3##(1994-11#1)(2008-8#1)
was improved in the##3##4##(2008-10#2)(2012-3#1)
was improved in##10##3##(1990-6#1)(1997-7#1)(2006-6#1)(2006-7#1)(2006-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-3#1)
was improved significantly##3##3##(1990-8#1)(2007-11#1)(2008-10#1)
was improved to##6##3##(2007-12#1)(2008-10#3)(2008-3#1)(2011-1#1)
was improved using##2##3##(2008-10#2)
was improved when##3##3##(2004-8#1)(2008-10#1)(2008-11#1)
was improved with##4##3##(1994-12#1)(1995-1#1)(2006-10#1)(2013-1#1)
was improved##85##2##(1990-6#2)(1990-7#1)(1990-8#2)(1992-11#1)(1992-3#1)(1992-8#2)(1993-2#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-8#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-8#1)(2006-10#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-8#3)(2008-1#1)(2008-10#18)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#2)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
was improvement in##2##3##(2006-8#1)(2008-3#1)
was improvement##3##2##(2006-8#1)(2008-3#1)(2008-4#1)
was in July##2##3##(2008-5#1)(2011-2#1)
was in a persistent vegetative state##2##6##(1990-11#1)(2008-2#1)
was in a ratio of##2##5##(2008-5#2)
was in a##13##3##(1990-11#1)(1990-2#1)(1991-8#1)(1993-2#1)(1995-10#1)(1996-9#1)(2007-6#1)(2008-10#2)(2008-2#1)(2008-5#2)(2009-7#1)
was in accordance with the##2##5##(2008-10#1)(2008-5#1)
was in accordance with##3##4##(2008-10#1)(2008-4#1)(2008-5#1)
was in accordance##4##3##(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)
was in addition##3##3##(2008-10#1)(2008-5#1)(2009-6#1)
was in agreement with the##4##5##(1991-9#1)(2007-10#1)(2008-10#2)
was in agreement with##9##4##(1991-9#1)(1992-10#1)(2006-12#1)(2007-10#1)(2008-10#4)(2008-4#1)
was in all##3##3##(1992-1#1)(1992-3#1)(2008-10#1)
was in an##2##3##(2006-10#1)(2012-11#1)
was in both##2##3##(2007-6#1)(2008-10#1)
was in contrast to the##2##5##(1994-12#1)(2011-9#1)
was in contrast to##3##4##(1994-12#1)(1994-9#1)(2011-9#1)
was in direct correlation to##2##5##(2008-11#2)
was in excellent##2##3##(1994-3#1)(2008-10#1)
was in excess##3##3##(1992-9#1)(2006-8#1)(2007-1#1)
was in fact##8##3##(1991-8#1)(1993-4#1)(1995-5#1)(1997-4#1)(2005-11#1)(2006-5#1)(2006-8#1)(2008-12#1)
was in general##2##3##(1997-4#1)(2008-7#1)
was in good agreement with the##2##6##(2008-11#1)(2009-5#1)
was in good agreement with##5##5##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-5#1)
was in good general##3##4##(1990-4#1)(2013-8#2)
was in good##12##3##(1990-4#1)(2005-4#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-5#1)(2011-2#1)(2013-8#2)
was in inverse proportion to the##2##6##(1990-8#1)(2008-10#1)
was in its##2##3##(2010-2#1)(2011-1#1)
was in keeping with##2##4##(1991-9#1)(1994-12#1)
was in many##2##3##(1997-6#1)(2010-4#1)
was in nonvertex presentation##2##4##(1992-12#2)
was in one##3##3##(2007-8#3)
was in parallel##2##3##(1990-4#1)(2011-12#1)
was in phase II trials##2##5##(2005-8#2)
was in phase##5##3##(2005-6#1)(2005-7#1)(2005-8#3)
was in place##6##3##(2004-2#1)(2009-4#1)(2011-1#1)(2012-2#1)(2013-1#2)
was in remission##3##3##(1994-12#2)(2006-10#1)
was in situ##2##3##(2008-10#1)(2013-8#1)
was in the case of##2##5##(1993-12#1)(2009-4#1)
was in the following order##2##5##(2004-9#1)(2008-10#1)
was in the following##3##4##(1996-6#1)(2004-9#1)(2008-10#1)
was in the normal range##4##5##(1991-10#1)(1993-7#1)(2006-12#1)(2007-8#1)
was in the normal##5##4##(1991-10#1)(1993-7#1)(2006-12#1)(2007-8#1)(2010-11#1)
was in the order of##6##5##(1991-1#1)(1994-2#1)(2005-11#1)(2008-10#1)(2013-8#2)
was in the order##12##4##(1991-1#1)(1994-12#1)(1994-2#1)(2005-11#1)(2008-10#4)(2012-2#2)(2013-8#2)
was in the presence of##2##5##(1997-7#1)(2009-6#1)
was in the range 0##3##5##(1996-6#2)(2004-9#1)
was in the range 1##2##5##(1996-6#1)(2008-10#1)
was in the range of 0##3##6##(2010-2#1)(2011-2#1)(2012-1#1)
was in the range of 2##4##6##(1996-8#1)(2005-4#1)(2008-10#2)
was in the range of##21##5##(1996-2#1)(1996-4#1)(1996-8#1)(2005-11#1)(2005-4#3)(2008-10#10)(2008-6#1)(2010-2#1)(2011-2#1)(2012-1#1)
was in the range##33##4##(1992-2#1)(1996-2#1)(1996-4#1)(1996-6#3)(1996-8#1)(2004-9#1)(2005-11#1)(2005-4#3)(2008-10#17)(2008-6#1)(2010-2#1)(2011-2#1)(2012-1#1)
was in the same##3##4##(1991-11#1)(1991-3#1)(2006-10#1)
was in the##105##3##(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#2)(1992-2#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#4)(1996-8#1)(1997-4#2)(1997-7#2)(2004-9#2)(2005-11#2)(2005-4#3)(2006-10#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#4)(2007-8#2)(2008-10#27)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-2#2)(2013-7#3)(2013-8#2)
was in##280##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#4)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#2)(1991-8#2)(1991-9#2)(1992-1#2)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-7#2)(1994-1#1)(1994-11#1)(1994-12#5)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#2)(1995-10#2)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#1)(1996-6#4)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#4)(1997-6#1)(1997-7#2)(2004-10#1)(2004-11#1)(2004-2#1)(2004-9#2)(2005-11#3)(2005-4#4)(2005-6#1)(2005-7#2)(2005-8#3)(2005-9#1)(2006-10#3)(2006-12#3)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#3)(2007-4#1)(2007-6#2)(2007-7#6)(2007-8#9)(2008-10#48)(2008-11#6)(2008-12#3)(2008-2#4)(2008-4#5)(2008-5#8)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-2#4)(2010-3#1)(2010-4#1)(2011-1#3)(2011-12#2)(2011-2#11)(2011-9#1)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#3)(2013-8#8)
was inactivated by##7##3##(1990-2#1)(1991-1#1)(1992-7#1)(1992-9#2)(1995-5#1)(2007-12#1)
was inactivated##16##2##(1990-2#1)(1991-1#1)(1992-5#1)(1992-7#1)(1992-9#2)(1993-2#1)(1994-11#1)(1995-11#1)(1995-5#2)(1996-2#1)(2007-12#1)(2008-6#1)(2012-12#1)(2012-2#1)
was inactive at##2##3##(1993-9#1)(2008-5#1)
was inactive in##2##3##(1995-5#1)(1997-6#1)
was inactive##20##2##(1990-10#1)(1990-5#1)(1991-5#3)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-9#1)(1994-12#1)(1995-3#1)(1995-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-4#1)(2008-5#1)
was inadequate and that##2##4##(1994-3#1)(1996-12#1)
was inadequate##13##2##(1994-3#1)(1996-12#1)(2007-6#1)(2007-7#2)(2008-11#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#2)(2013-7#1)
was inadequately##2##2##(1997-8#1)(2011-10#1)
was inappropriate##2##2##(1996-5#1)(2011-1#1)
was inaugurated##2##2##(2009-10#1)(2009-7#1)
was incapable of forming##2##4##(1992-8#1)(1997-3#1)
was incapable of##7##3##(1991-4#1)(1992-8#1)(1993-6#1)(1997-3#1)(1997-5#1)(1997-6#1)(2007-8#1)
was incident##2##2##(1992-7#1)(2007-12#1)
was incidentally found to have a##2##6##(2010-4#1)(2010-9#1)
was incidentally found##3##3##(2006-1#1)(2010-4#1)(2010-9#1)
was incidentally##6##2##(2006-1#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-9#1)(2013-8#1)
was inclined##2##2##(2007-4#2)
was included as a##6##4##(1993-7#1)(2004-11#1)(2008-11#2)(2010-1#1)(2010-12#1)
was included as an##2##4##(2008-10#2)
was included as##8##3##(1993-7#1)(2004-11#1)(2008-10#2)(2008-11#2)(2010-1#1)(2010-12#1)
was included in a##3##4##(2004-11#1)(2007-12#1)(2012-2#1)
was included in the study##2##5##(2008-11#1)(2008-5#1)
was included in the##16##4##(1990-12#1)(1990-9#1)(1992-2#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-6#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2010-4#1)
was included in this study##2##5##(2006-2#1)(2013-1#1)
was included in##28##3##(1990-10#1)(1990-12#1)(1990-9#1)(1991-6#1)(1992-2#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-6#1)(1997-1#1)(1997-2#1)(2004-11#1)(2006-2#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-6#1)(2010-4#1)(2010-9#1)(2012-2#1)(2013-1#1)
was included to##2##3##(1995-3#1)(2007-6#1)
was included##57##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-9#1)(1991-6#1)(1992-2#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-11#2)(2005-3#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-6#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
was incompatible with##2##3##(2007-12#1)(2008-10#1)
was incomplete##6##2##(1990-2#1)(1995-2#1)(1996-2#1)(1997-6#1)(2008-10#2)
was incompletely occluded##2##3##(1996-9#1)(2013-1#1)
was incompletely##3##2##(1995-2#1)(1996-9#1)(2013-1#1)
was inconclusive because of##2##4##(2006-2#1)(2008-3#1)
was inconclusive##11##2##(1995-6#1)(2006-2#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-12#1)(2011-2#1)(2013-1#2)
was inconsistency##3##2##(2008-11#1)(2008-12#1)(2011-2#1)
was inconsistent##8##2##(1995-2#1)(1995-3#1)(2008-10#2)(2008-8#2)(2010-4#1)(2013-8#1)
was incontinent##2##2##(2006-10#1)(2008-10#1)
was incorporated at the##2##4##(1996-5#1)(2008-3#1)
was incorporated at##4##3##(1992-1#1)(1996-5#1)(1997-3#1)(2008-3#1)
was incorporated in the##3##4##(2008-10#2)(2009-8#1)
was incorporated in##12##3##(1990-5#1)(1992-6#1)(1995-2#2)(2007-8#1)(2008-10#5)(2008-9#1)(2009-8#1)
was incorporated into a##5##4##(1991-1#1)(1994-11#1)(2004-9#1)(2008-10#1)(2010-11#1)
was incorporated into an##2##4##(2007-12#2)
was incorporated into the##15##4##(1990-2#1)(1991-10#1)(1991-5#1)(1994-9#1)(1995-1#1)(1995-6#1)(2008-1#1)(2008-10#2)(2008-5#3)(2008-8#1)(2010-1#1)(2012-12#1)
was incorporated into##42##3##(1990-2#1)(1991-1#1)(1991-10#1)(1991-3#1)(1991-5#1)(1992-10#1)(1992-5#1)(1993-11#1)(1993-3#1)(1994-11#2)(1994-5#2)(1994-9#1)(1995-1#1)(1995-6#1)(1997-7#1)(2004-9#1)(2006-3#1)(2007-12#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-5#5)(2008-8#3)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2012-12#1)
was incorporated per mole of##2##5##(1990-9#1)(1992-5#1)
was incorporated##69##2##(1990-2#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-10#1)(1992-5#2)(1992-6#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-5#2)(1994-9#1)(1995-1#1)(1995-2#3)(1995-6#1)(1996-1#1)(1996-5#1)(1997-3#1)(1997-7#1)(2004-9#1)(2006-3#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-3#1)(2008-5#5)(2008-8#4)(2008-9#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2012-12#1)
was incorrect and##2##3##(1996-12#1)(2007-12#1)
was incorrect##11##2##(1992-8#1)(1993-3#1)(1996-12#1)(2006-12#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2010-4#1)(2010-8#1)
was incorrectly##4##2##(1990-9#1)(1994-3#1)(2007-10#1)(2007-11#1)
was increase in##2##3##(2012-3#1)(2013-1#1)
was increased (P &lt##6##4##(1993-11#1)(1995-6#1)(1997-2#1)(2006-5#2)(2011-3#1)
was increased 10-fold##2##3##(1990-6#1)(2013-1#1)
was increased 2##2##3##(1991-2#1)(2008-6#1)
was increased 3-fold##3##3##(1991-6#1)(1995-1#1)(1995-6#1)
was increased about##7##3##(1990-3#1)(1994-6#1)(1996-7#1)(1997-4#2)(1997-6#1)(2007-12#1)
was increased after incubation##2##4##(1990-7#1)(1994-2#1)
was increased after the##2##4##(2008-10#1)(2013-8#1)
was increased after##8##3##(1990-7#1)(1993-6#1)(1993-9#1)(1994-2#1)(1996-5#1)(2005-11#1)(2008-10#1)(2013-8#1)
was increased and the##2##4##(1995-3#1)(2008-10#1)
was increased and##8##3##(1990-12#1)(1992-8#1)(1994-12#1)(1995-3#1)(2008-10#2)(2008-2#1)(2009-8#1)
was increased approximately##2##3##(2007-1#1)(2008-11#1)
was increased at##3##3##(1994-2#1)(2005-11#1)(2008-4#1)
was increased by 0##2##4##(1992-10#1)(1993-1#1)
was increased by 1##2##4##(1991-5#1)(2013-8#1)
was increased by 2##2##4##(1997-7#1)(2013-1#1)
was increased by 25%##2##4##(1991-1#1)(1991-7#1)
was increased by a factor of##2##6##(1993-9#1)(2008-10#1)
was increased by a##4##4##(1992-5#1)(1993-9#1)(1994-9#1)(2008-10#1)
was increased by about##3##4##(1997-3#1)(2008-10#1)(2008-11#1)
was increased by more than##2##5##(1994-11#1)(2006-10#1)
was increased by raising the##2##5##(1993-11#1)(2008-10#1)
was increased by the addition of##2##6##(1995-5#1)(1995-8#1)
was increased by the##10##4##(1990-12#1)(1991-10#1)(1991-2#1)(1995-5#1)(1995-8#1)(1996-5#1)(2008-10#1)(2008-5#1)(2010-4#1)(2010-7#1)
was increased by up to##2##5##(1996-2#1)(2011-12#1)
was increased by##95##3##(1990-12#2)(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#3)(2006-10#1)(2006-9#1)(2007-11#1)(2007-7#2)(2008-10#6)(2008-11#6)(2008-12#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#7)(2013-8#5)
was increased due to the##3##5##(1997-8#1)(2008-10#1)(2008-5#1)
was increased during the##2##4##(1991-12#1)(1997-3#1)
was increased during##5##3##(1991-12#2)(1997-2#1)(1997-3#1)(2008-10#1)
was increased following##3##3##(1992-7#1)(1993-12#1)(1994-2#1)
was increased from 0 to##2##5##(1994-3#1)(2005-12#1)
was increased from 0##7##4##(1991-2#1)(1991-4#1)(1994-3#1)(1996-5#1)(2005-12#1)(2007-1#2)
was increased from 1##3##4##(1991-7#1)(1993-8#1)(2008-4#1)
was increased from 12##2##4##(2008-10#1)(2013-1#1)
was increased from##23##3##(1991-1#1)(1991-2#2)(1991-4#1)(1991-7#1)(1993-8#1)(1994-3#1)(1995-5#1)(1996-5#1)(2005-12#1)(2006-6#1)(2007-1#2)(2007-12#1)(2008-10#4)(2008-4#1)(2008-5#1)(2013-1#2)(2013-8#1)
was increased gradually##2##3##(2013-8#2)
was increased immediately after##2##4##(1995-12#1)(2007-9#1)
was increased in M patients compared to##2##7##(2012-3#2)
was increased in a dose-dependent manner by##2##7##(1991-9#1)(1997-7#1)
was increased in a dose-dependent manner##3##6##(1991-9#1)(1996-9#1)(1997-7#1)
was increased in a##4##4##(1991-9#1)(1992-6#1)(1996-9#1)(1997-7#1)
was increased in patients with##2##5##(1995-6#1)(2012-3#1)
was increased in patients##3##4##(1995-6#1)(2008-7#1)(2012-3#1)
was increased in response to##3##5##(1990-5#1)(1991-5#1)(1993-12#1)
was increased in the hippocampus##2##5##(1991-12#1)(2010-12#1)
was increased in the presence of##5##6##(1990-5#1)(1990-7#1)(1992-1#1)(1997-1#1)(2005-4#1)
was increased in the##24##4##(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-9#2)(1992-1#2)(1992-8#1)(1993-2#1)(1993-7#1)(1994-11#1)(1994-12#2)(1996-10#1)(1996-4#1)(1996-7#1)(1997-1#1)(2005-4#1)(2008-9#2)(2010-12#1)
was increased in##79##3##(1990-2#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-5#2)(1991-9#3)(1992-1#2)(1992-3#1)(1992-6#2)(1992-8#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-10#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-5#2)(1997-7#1)(2004-11#1)(2005-4#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-3#3)(2013-1#2)
was increased linearly##2##3##(2008-10#2)
was increased more than##3##4##(1991-6#1)(1994-12#1)(1995-10#1)
was increased more##4##3##(1991-1#1)(1991-6#1)(1994-12#1)(1995-10#1)
was increased significantly in##3##4##(2007-10#1)(2008-3#1)(2011-1#1)
was increased significantly##7##3##(1991-3#1)(1992-3#1)(2007-10#1)(2008-11#1)(2008-3#1)(2011-1#1)(2012-2#1)
was increased the##2##3##(1990-11#1)(1997-2#1)
was increased to 100##2##4##(2008-7#1)(2013-8#1)
was increased to 30##2##4##(2006-10#1)(2008-10#1)
was increased to a##3##4##(1995-3#1)(1997-2#1)(2011-2#1)
was increased to##26##3##(1990-9#1)(1993-2#1)(1993-4#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-4#1)(1996-12#1)(1997-2#2)(1997-4#1)(2006-10#2)(2007-11#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
was increased twofold##2##3##(2008-11#1)(2008-8#1)
was increased under##3##3##(1997-2#2)(2007-12#1)
was increased up to##4##4##(1990-4#1)(1993-12#1)(1997-3#1)(2007-12#1)
was increased upon the##2##4##(1993-3#1)(1995-2#1)
was increased upon##3##3##(1992-5#1)(1993-3#1)(1995-2#1)
was increased when##4##3##(1993-8#1)(2008-5#2)(2008-8#1)
was increased with the##2##4##(1994-11#1)(2009-7#1)
was increased with##6##3##(1994-11#1)(2004-3#1)(2007-8#1)(2008-9#1)(2009-7#1)(2012-12#1)
was increased##415##2##(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#4)(1990-9#2)(1991-1#4)(1991-10#1)(1991-12#5)(1991-2#7)(1991-3#2)(1991-4#2)(1991-5#4)(1991-6#2)(1991-7#2)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#4)(1992-5#3)(1992-6#3)(1992-7#1)(1992-8#5)(1992-9#3)(1993-1#1)(1993-11#4)(1993-12#4)(1993-2#3)(1993-3#2)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#3)(1994-10#1)(1994-11#7)(1994-12#7)(1994-2#5)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#4)(1995-1#8)(1995-10#2)(1995-12#4)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#4)(1995-6#5)(1995-8#1)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#4)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#12)(1997-3#5)(1997-4#4)(1997-5#3)(1997-6#3)(1997-7#3)(1997-8#4)(2004-11#1)(2004-3#1)(2005-11#5)(2005-12#2)(2005-4#1)(2006-10#4)(2006-5#2)(2006-6#2)(2006-9#1)(2007-1#4)(2007-10#1)(2007-11#4)(2007-12#7)(2007-5#2)(2007-7#2)(2007-8#2)(2007-9#2)(2008-10#38)(2008-11#16)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#11)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#8)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-4#3)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#15)(2013-7#1)(2013-8#11)
was increasing during##3##3##(1991-10#1)(2007-2#1)(2008-9#1)
was increasing##10##2##(1991-10#1)(1991-2#1)(1993-12#3)(2006-8#1)(2007-2#1)(2008-12#1)(2008-9#1)(2011-1#1)
was incubated aerobically##2##3##(1995-6#1)(1996-4#1)
was incubated at pH##2##4##(1990-5#1)(2008-6#1)
was incubated at##4##3##(1990-5#1)(1992-6#1)(1994-3#1)(2008-6#1)
was incubated for##5##3##(1990-2#1)(1992-6#1)(1993-9#1)(2005-11#1)(2013-1#1)
was incubated in the presence of##3##6##(1990-4#1)(1992-11#1)(1995-4#1)
was incubated in##15##3##(1990-11#1)(1990-2#1)(1990-4#1)(1991-12#1)(1992-11#1)(1994-8#1)(1995-2#1)(1995-4#1)(1995-5#1)(2005-11#1)(2006-3#1)(2008-10#3)(2008-4#1)
was incubated on##2##3##(2008-8#1)(2010-3#1)
was incubated with a##2##4##(1990-2#1)(1995-2#1)
was incubated with glucose##2##4##(1996-9#1)(2008-7#1)
was incubated with the##2##4##(1990-2#1)(1990-7#1)
was incubated with##35##3##(1990-12#3)(1990-2#2)(1990-7#1)(1990-9#1)(1991-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-7#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-12#1)(2006-4#1)(2006-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
was incubated##67##2##(1990-1#1)(1990-11#1)(1990-12#3)(1990-2#4)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#3)(1992-7#1)(1993-9#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#2)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-12#1)(2005-11#2)(2006-3#1)(2006-4#1)(2006-8#1)(2008-10#5)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2010-3#1)(2013-1#1)
was indeed a##2##3##(1994-7#1)(2009-8#1)
was indeed found##2##3##(1991-1#1)(2008-5#1)
was indeed the##2##3##(1990-9#1)(2010-6#1)
was indeed##11##2##(1990-4#1)(1990-9#1)(1991-1#1)(1992-6#1)(1992-8#1)(1994-7#1)(2007-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-6#1)
was independent of its##2##4##(1996-8#1)(1997-6#1)
was independent of pH##4##4##(1990-7#1)(1991-12#1)(1991-5#1)(2008-10#1)
was independent of the presence of##3##6##(1994-3#1)(1997-5#1)(2008-10#1)
was independent of the##32##4##(1990-2#1)(1990-6#1)(1990-7#1)(1991-7#1)(1992-2#1)(1992-8#2)(1994-12#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-10#1)(1997-5#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-6#1)(2008-8#2)(2009-8#1)(2013-8#1)
was independent of##70##3##(1990-10#1)(1990-2#1)(1990-6#2)(1990-7#2)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#3)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2006-11#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#3)(2009-4#2)(2009-8#1)(2013-8#1)
was independent on the##2##4##(1995-12#1)(2008-10#1)
was independent##73##2##(1990-10#1)(1990-2#1)(1990-6#2)(1990-7#2)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#3)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2006-11#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#3)(2009-4#2)(2009-8#1)(2013-8#1)
was independently associated with##12##4##(2007-10#1)(2007-8#2)(2008-7#1)(2010-8#1)(2012-3#1)(2013-1#5)(2013-8#1)
was independently associated##13##3##(2007-10#1)(2007-8#3)(2008-7#1)(2010-8#1)(2012-3#1)(2013-1#5)(2013-8#1)
was independently related to##5##4##(1997-2#1)(2007-12#1)(2007-9#2)(2008-3#1)
was independently##26##2##(1992-7#1)(1993-6#1)(1994-2#1)(1997-2#1)(2007-10#1)(2007-12#1)(2007-8#3)(2007-9#2)(2008-3#1)(2008-7#1)(2010-5#1)(2010-8#1)(2012-11#2)(2012-12#1)(2012-3#2)(2013-1#5)(2013-8#1)
was indicated as##2##3##(2010-3#1)(2010-9#1)
was indicated by a##2##4##(2008-10#1)(2008-9#1)
was indicated by the low##2##5##(1993-4#1)(2008-10#1)
was indicated by the##8##4##(1990-2#1)(1993-4#1)(1994-8#1)(2004-4#1)(2007-1#1)(2008-10#2)(2011-1#1)
was indicated by##16##3##(1990-2#1)(1993-4#1)(1994-8#1)(1997-2#1)(1997-8#1)(2004-4#1)(2007-1#1)(2007-9#1)(2008-10#4)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)
was indicated for the##2##4##(2005-8#1)(2007-11#1)
was indicated for##3##3##(2005-8#1)(2007-11#1)(2008-12#1)
was indicated in##4##3##(1993-10#1)(1994-8#1)(1995-11#1)(2006-12#1)
was indicated that the##3##4##(2008-10#1)(2008-8#2)
was indicated that##4##3##(2008-10#1)(2008-8#3)
was indicated to##3##3##(1995-10#1)(2011-2#1)(2012-11#1)
was indicated##46##2##(1990-2#2)(1993-10#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-8#2)(1995-10#1)(1995-11#1)(1996-8#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-8#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-12#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-4#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-8#1)
was indicative of##2##3##(2006-5#1)(2008-12#1)
was indirect##2##2##(1991-2#1)(2008-10#1)
was indirectly related to##3##4##(2009-7#2)(2012-3#1)
was indirectly##6##2##(1992-5#1)(2008-10#2)(2009-7#2)(2012-3#1)
was indistinguishable from that##3##4##(1990-11#1)(1995-12#1)(1995-5#1)
was indistinguishable from the##3##4##(1995-3#1)(1996-8#1)(1996-9#1)
was indistinguishable from##10##3##(1990-11#1)(1992-12#1)(1992-7#1)(1993-12#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-8#1)(1996-9#1)(1997-7#1)
was indistinguishable##13##2##(1990-11#1)(1992-12#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-2#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-8#1)(1996-9#1)(1997-7#1)(2008-10#1)
was individual##2##2##(2008-11#1)(2010-8#1)
was individually replaced##2##3##(1993-11#1)(1995-3#1)
was individually##6##2##(1993-11#1)(1995-1#1)(1995-3#1)(2007-8#1)(2008-1#1)(2008-12#1)
was induced after##2##3##(1996-1#1)(2003-11#1)
was induced and##2##3##(1996-6#1)(2009-4#1)
was induced at##2##3##(1994-11#1)(1996-12#1)
was induced by a shift##2##5##(1996-11#1)(2008-4#1)
was induced by a single##3##5##(2008-10#1)(2008-5#1)(2010-12#1)
was induced by a##10##4##(1990-2#1)(1995-12#1)(1996-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-12#1)
was induced by an##4##4##(1991-2#1)(1997-5#1)(1997-8#1)(2012-2#1)
was induced by both##2##4##(1993-3#1)(1996-5#1)
was induced by exposing the##2##5##(1995-12#1)(2013-1#1)
was induced by injection##2##4##(1992-8#1)(2013-1#1)
was induced by insertion of##2##5##(1990-12#1)(1996-9#1)
was induced by permanent##2##4##(1997-2#1)(2007-10#1)
was induced by the##9##4##(1995-1#1)(1996-6#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-1#1)
was induced by##89##3##(1990-12#2)(1990-2#2)(1990-7#2)(1990-9#1)(1991-2#1)(1991-7#1)(1992-4#1)(1992-8#1)(1993-3#1)(1993-4#1)(1994-6#2)(1994-9#2)(1995-1#2)(1995-12#4)(1995-2#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-5#1)(1997-7#2)(1997-8#2)(2007-10#2)(2007-11#3)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#3)(2008-8#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-12#2)(2010-5#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#2)(2013-7#1)
was induced from##2##3##(2007-1#1)(2008-8#1)
was induced in Wistar##3##4##(2011-2#1)(2012-2#1)(2012-3#1)
was induced in a wheat cultivar-specific manner##2##7##(2008-10#2)
was induced in a##3##4##(1993-8#1)(2008-10#2)
was induced in adult##2##4##(2007-9#1)(2008-7#1)
was induced in both##2##4##(1994-12#1)(2008-10#1)
was induced in rats by##2##5##(1997-2#1)(2011-3#1)
was induced in the##11##4##(1990-7#1)(1991-5#1)(1992-5#1)(1992-8#1)(1994-12#1)(1995-3#1)(1996-12#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-7#1)
was induced in##52##3##(1990-10#1)(1990-3#1)(1990-7#2)(1991-2#1)(1991-5#1)(1991-8#1)(1992-5#1)(1992-8#1)(1993-8#1)(1994-12#3)(1995-12#1)(1995-2#2)(1995-3#1)(1996-12#3)(1996-6#1)(1997-2#2)(2006-2#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-7#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
was induced only by##5##4##(1990-9#1)(1991-11#1)(1992-12#1)(2008-11#1)(2008-8#1)
was induced only##7##3##(1990-9#1)(1991-11#1)(1991-6#1)(1992-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
was induced to##4##3##(1994-6#1)(1997-6#1)(2008-10#1)(2008-8#1)
was induced with##9##3##(1990-12#1)(1995-1#1)(1995-12#1)(1996-1#1)(2007-9#1)(2008-10#1)(2008-6#1)(2010-7#1)(2011-2#1)
was induced##205##2##(1990-10#1)(1990-12#3)(1990-2#2)(1990-3#2)(1990-4#1)(1990-7#4)(1990-9#2)(1991-11#1)(1991-2#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-8#2)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-3#1)(1994-6#5)(1994-8#1)(1994-9#3)(1995-1#3)(1995-12#7)(1995-2#3)(1995-3#2)(1995-6#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#9)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#3)(1996-9#1)(1997-1#1)(1997-2#5)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2003-11#1)(2006-2#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#3)(2008-1#1)(2008-10#24)(2008-11#6)(2008-3#1)(2008-4#6)(2008-5#4)(2008-6#4)(2008-7#3)(2008-8#6)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#2)(2010-5#2)(2010-7#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
was inducible by##3##3##(1992-6#1)(1993-9#1)(1994-8#1)
was inducible##4##2##(1992-6#1)(1993-9#1)(1994-11#1)(1994-8#1)
was ineffective against C##2##4##(2008-10#2)
was ineffective against##4##3##(2008-10#2)(2011-2#1)(2012-3#1)
was ineffective at all##2##4##(1992-4#1)(1993-3#1)
was ineffective at##4##3##(1990-8#1)(1992-12#1)(1992-4#1)(1993-3#1)
was ineffective compared to##2##4##(1993-2#1)(2008-4#1)
was ineffective in reducing the##2##5##(2008-10#1)(2008-7#1)
was ineffective in##8##3##(1990-7#1)(1993-7#1)(1995-3#1)(1997-1#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-7#1)
was ineffective on##2##3##(1990-10#1)(2008-10#1)
was ineffective##47##2##(1990-10#1)(1990-11#2)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-2#2)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-1#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-8#2)(2008-10#5)(2008-4#2)(2008-5#1)(2008-7#2)(2009-11#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
was inefficient and##2##3##(1990-6#1)(1996-10#1)
was inefficient##4##2##(1990-6#1)(1993-12#1)(1996-10#1)(2011-2#1)
was infected by##6##3##(1996-5#1)(1997-6#1)(2008-10#3)(2008-11#1)
was infected with##7##3##(1990-2#1)(1997-3#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-11#1)
was infected##21##2##(1990-2#2)(1996-11#1)(1996-5#1)(1997-3#1)(1997-6#1)(2004-9#1)(2005-11#1)(2006-10#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2010-12#1)(2012-11#1)
was infectious in##2##3##(2008-10#2)
was infectious##6##2##(1997-3#1)(2008-10#4)(2008-9#1)
was inferior to##3##3##(1995-4#1)(2008-11#1)(2008-7#1)
was inferred from##6##3##(1990-5#1)(1995-5#1)(2008-7#1)(2012-1#1)(2012-12#2)
was inferred that##3##3##(2008-10#2)(2008-8#1)
was inferred to be##3##4##(1991-7#1)(1995-3#1)(1995-6#1)
was inferred to##4##3##(1991-7#1)(1995-3#1)(1995-6#1)(2013-8#1)
was inferred##16##2##(1990-5#1)(1991-7#1)(1992-3#1)(1995-3#1)(1995-5#1)(1995-6#1)(2008-10#3)(2008-7#1)(2008-8#2)(2012-1#1)(2012-12#2)(2013-8#1)
was infested with##5##3##(2007-7#1)(2008-10#2)(2009-3#1)(2010-3#1)
was infiltrated by##2##3##(2009-1#1)(2011-1#1)
was infiltrated into##2##3##(2008-10#2)
was infiltrated with##2##3##(1996-8#1)(2006-8#1)
was infiltrated##6##2##(1996-8#1)(2006-8#1)(2008-10#2)(2009-1#1)(2011-1#1)
was inflated##6##2##(1997-3#1)(1997-6#1)(2007-6#3)(2013-8#1)
was influenced by the presence of##2##6##(1994-12#1)(2004-12#1)
was influenced by the##26##4##(1990-11#1)(1991-4#1)(1993-2#2)(1993-9#1)(1994-12#2)(2004-12#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#2)(2009-10#1)(2009-12#1)(2009-5#1)(2012-2#1)
was influenced by##44##3##(1990-11#1)(1991-3#1)(1991-4#1)(1993-2#2)(1993-9#1)(1994-12#2)(1995-3#1)(2004-12#1)(2004-2#1)(2005-11#1)(2006-5#1)(2006-7#1)(2007-8#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-4#1)(2010-7#1)(2012-2#1)
was influenced primarily by##2##4##(1991-6#1)(2008-10#1)
was influenced##50##2##(1990-11#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-7#1)(1993-2#2)(1993-9#1)(1994-12#2)(1995-3#1)(2004-12#1)(2004-2#1)(2005-11#1)(2006-5#1)(2006-7#1)(2007-8#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-4#1)(2010-7#1)(2012-2#2)
was informed by##3##3##(2007-10#1)(2011-1#1)(2012-3#1)
was infrequent##5##2##(2007-7#1)(2008-10#2)(2012-1#1)(2013-1#1)
was infrequently##2##2##(1991-7#1)(2007-8#1)
was infused directly into the##2##5##(1990-6#1)(1992-3#1)
was infused directly##3##3##(1990-6#1)(1992-3#1)(1996-6#1)
was infused into the##4##4##(1990-2#1)(1993-12#2)(2011-2#1)
was infused into##6##3##(1990-2#1)(1993-12#2)(1993-2#1)(1995-10#1)(2011-2#1)
was infused intravenously at##3##4##(1990-6#2)(2010-3#1)
was infused over##2##3##(2007-1#1)(2008-6#1)
was infused##26##2##(1990-2#1)(1990-6#3)(1990-7#1)(1991-2#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-12#2)(1993-2#1)(1995-10#2)(1996-6#1)(1997-8#1)(2007-1#1)(2007-9#1)(2008-6#2)(2010-3#2)(2011-12#1)(2011-2#1)(2012-2#1)
was inherited from##2##3##(2006-12#1)(2008-10#1)
was inherited##3##2##(2006-12#1)(2008-10#2)
was inhibited (by##4##3##(1994-6#1)(2008-2#3)
was inhibited about##2##3##(1990-5#1)(1997-2#1)
was inhibited almost##2##3##(1992-4#2)
was inhibited and##4##3##(1997-7#1)(2006-3#1)(2008-7#1)(2008-9#1)
was inhibited at##7##3##(1991-2#1)(1992-9#1)(2008-10#4)(2008-6#1)
was inhibited by 1 mM##2##5##(1991-1#1)(1992-4#1)
was inhibited by 50%##3##4##(1990-5#1)(1994-10#1)(1994-5#1)
was inhibited by DEPC##2##4##(1990-11#1)(1991-9#1)
was inhibited by EDTA##2##4##(1990-10#1)(1990-9#1)
was inhibited by a##4##4##(1990-7#1)(1992-6#1)(1997-6#1)(2006-3#1)
was inhibited by actinomycin D##2##5##(1994-9#1)(2008-4#1)
was inhibited by all the##2##5##(1991-2#1)(1995-6#1)
was inhibited by an excess of unlabeled##3##7##(1990-8#1)(1993-9#1)(1995-8#1)
was inhibited by an excess of##4##6##(1990-8#1)(1993-9#1)(1995-8#1)(1996-11#1)
was inhibited by an##6##4##(1990-5#1)(1990-8#1)(1992-6#1)(1993-9#1)(1995-8#1)(1996-11#1)
was inhibited by both##2##4##(1994-5#1)(1996-12#1)
was inhibited by cycloheximide##2##4##(1990-11#1)(1993-12#1)
was inhibited by indomethacin##3##4##(1991-3#1)(1995-3#1)(1997-1#1)
was inhibited by low concentrations of##2##6##(1991-3#1)(1991-7#1)
was inhibited by other##2##4##(1992-9#1)(1995-3#1)
was inhibited by oxypurinol##2##4##(1996-6#2)
was inhibited by pertussis toxin##2##5##(1990-8#1)(1992-6#1)
was inhibited by potassium##2##4##(1993-4#1)(1996-7#1)
was inhibited by preincubation of the cells with##2##8##(1996-5#1)(1997-1#1)
was inhibited by pretreatment with##2##5##(1994-12#1)(1994-3#1)
was inhibited by pretreatment##3##4##(1994-12#1)(1994-3#1)(2008-11#1)
was inhibited by rat##2##4##(1990-9#1)(1993-11#1)
was inhibited by sodium azide##2##5##(1990-1#1)(2008-8#1)
was inhibited by the addition of superoxide dismutase##2##8##(1994-6#1)(2006-12#1)
was inhibited by the addition of##7##6##(1993-4#1)(1993-8#1)(1994-3#1)(1994-6#1)(2006-12#1)(2008-8#1)(2011-12#1)
was inhibited by the removal of##2##6##(1990-2#1)(1992-11#1)
was inhibited by the same##2##5##(1993-3#1)(1994-8#1)
was inhibited by the##33##4##(1990-1#1)(1990-2#1)(1990-7#1)(1991-10#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-8#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#1)(1997-2#2)(1997-5#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2011-12#1)(2011-2#1)(2013-1#1)
was inhibited by wortmannin##2##4##(1994-11#1)(1995-3#1)
was inhibited by##244##3##(1990-1#3)(1990-10#6)(1990-11#3)(1990-12#3)(1990-2#7)(1990-3#3)(1990-4#1)(1990-5#3)(1990-7#4)(1990-8#3)(1990-9#3)(1991-1#3)(1991-10#3)(1991-12#1)(1991-2#3)(1991-3#4)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#2)(1991-9#1)(1992-11#4)(1992-12#3)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#5)(1992-7#2)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#1)(1993-3#5)(1993-4#4)(1993-6#2)(1993-7#1)(1993-8#4)(1993-9#2)(1994-10#1)(1994-11#5)(1994-12#6)(1994-3#5)(1994-5#3)(1994-6#4)(1994-8#4)(1994-9#4)(1995-1#2)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#7)(1995-6#2)(1995-7#1)(1995-8#3)(1996-11#1)(1996-12#5)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#4)(1996-7#1)(1996-9#1)(1997-1#4)(1997-2#3)(1997-3#1)(1997-5#2)(1997-6#3)(1997-7#3)(1997-8#2)(2006-12#1)(2006-3#1)(2006-6#1)(2008-10#10)(2008-11#7)(2008-3#1)(2008-4#8)(2008-5#1)(2008-8#4)(2008-9#1)(2009-2#1)(2009-3#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-2#2)(2013-1#3)
was inhibited completely##2##3##(1995-12#1)(2008-8#1)
was inhibited in a dose-dependent manner##2##6##(1992-6#1)(1993-9#1)
was inhibited in a##5##4##(1992-12#1)(1992-6#1)(1993-9#1)(1996-5#1)(2005-12#1)
was inhibited in the presence of##3##6##(2006-5#1)(2008-10#1)(2008-11#1)
was inhibited in the##4##4##(1995-12#1)(2006-5#1)(2008-10#1)(2008-11#1)
was inhibited in##16##3##(1992-12#1)(1992-6#1)(1993-9#1)(1994-5#1)(1995-12#1)(1996-10#1)(1996-5#1)(1997-2#1)(2004-4#1)(2005-12#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-5#2)(2011-2#1)
was inhibited markedly by##4##4##(1990-9#1)(1991-8#1)(1993-3#1)(1995-8#1)
was inhibited more##3##3##(1990-12#1)(1991-10#1)(2011-12#1)
was inhibited specifically by##2##4##(1990-2#1)(1993-6#1)
was inhibited to a##2##4##(1990-4#1)(2008-8#1)
was inhibited to##3##3##(1990-4#1)(1991-12#1)(2008-8#1)
was inhibited under##2##3##(1991-5#1)(1993-12#1)
was inhibited when##3##3##(1990-11#1)(1990-3#1)(1997-7#1)
was inhibited with##5##3##(1991-8#1)(1992-6#1)(2008-10#1)(2008-12#1)(2008-8#1)
was inhibited##349##2##(1990-1#3)(1990-10#8)(1990-11#4)(1990-12#4)(1990-2#8)(1990-3#5)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#5)(1990-8#3)(1990-9#5)(1991-1#3)(1991-10#4)(1991-12#3)(1991-2#6)(1991-3#4)(1991-4#1)(1991-5#4)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#4)(1992-12#4)(1992-3#6)(1992-4#3)(1992-5#1)(1992-6#7)(1992-7#2)(1992-8#3)(1992-9#3)(1993-11#2)(1993-12#2)(1993-3#6)(1993-4#4)(1993-6#5)(1993-7#2)(1993-8#4)(1993-9#3)(1994-10#1)(1994-11#7)(1994-12#8)(1994-3#6)(1994-5#5)(1994-6#5)(1994-8#6)(1994-9#5)(1995-1#3)(1995-10#2)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#7)(1995-6#4)(1995-7#2)(1995-8#4)(1996-10#1)(1996-11#1)(1996-12#6)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#2)(1996-6#4)(1996-7#1)(1996-9#1)(1997-1#5)(1997-2#5)(1997-3#1)(1997-5#2)(1997-6#3)(1997-7#5)(1997-8#2)(2004-4#1)(2005-12#1)(2006-12#1)(2006-3#2)(2006-5#1)(2006-6#1)(2006-8#1)(2008-10#19)(2008-11#9)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#8)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#3)(2009-2#1)(2009-3#1)(2010-5#1)(2011-12#2)(2011-2#5)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
was inhibition of##2##3##(2008-11#1)(2008-5#1)
was inhibition##3##2##(1991-6#1)(2008-11#1)(2008-5#1)
was inhibitory to conidial germination##2##5##(2008-10#2)
was inhibitory##5##2##(1992-2#1)(1995-2#1)(1997-3#1)(2008-10#2)
was initially demonstrated##2##3##(2008-10#2)
was initially described##2##3##(1991-2#1)(2008-9#1)
was initially developed as##2##4##(1996-2#1)(2010-12#1)
was initially developed for the##2##5##(2005-6#1)(2005-7#1)
was initially developed to##2##4##(2008-4#2)
was initially developed##7##3##(1996-2#1)(2005-6#1)(2005-7#1)(2008-11#1)(2008-4#2)(2010-12#1)
was initially diagnosed as##3##4##(2007-7#1)(2008-7#1)(2009-9#1)
was initially diagnosed with##4##4##(2010-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
was initially diagnosed##9##3##(2007-10#1)(2007-7#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
was initially identified as a##2##5##(2008-1#1)(2012-3#1)
was initially identified##3##3##(2008-1#1)(2008-12#1)(2012-3#1)
was initially low##2##3##(2008-8#1)(2010-10#1)
was initially misdiagnosed as##2##4##(2008-10#1)(2008-6#1)
was initially misinterpreted as##2##4##(1994-7#1)(2009-3#1)
was initially missed##2##3##(2006-10#1)(2008-12#1)
was initially observed##3##3##(1992-2#1)(1994-8#1)(2013-1#1)
was initially the##2##3##(1990-10#1)(2008-12#1)
was initially thought to be##3##5##(2008-10#1)(2013-1#2)
was initially thought##5##3##(2008-10#1)(2008-6#1)(2009-8#1)(2013-1#2)
was initially treated with##6##4##(2008-7#1)(2010-4#1)(2012-2#2)(2013-8#2)
was initially treated##7##3##(2008-7#1)(2010-4#1)(2011-12#1)(2012-2#2)(2013-8#2)
was initially very##2##3##(2008-1#1)(2008-10#1)
was initially##92##2##(1990-10#1)(1990-12#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-6#1)(1994-11#1)(1994-2#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#2)(1997-6#1)(2004-12#1)(2005-10#1)(2005-4#1)(2005-6#1)(2005-7#2)(2006-10#2)(2006-5#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#5)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#2)(2011-12#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#3)(2013-8#3)
was initiated and##4##3##(2005-12#1)(2006-4#1)(2012-3#1)(2013-8#1)
was initiated as a##2##4##(2006-10#1)(2008-7#1)
was initiated at the##4##4##(1990-5#1)(1991-3#1)(2006-4#1)(2007-10#1)
was initiated at##10##3##(1990-5#1)(1990-9#1)(1991-3#1)(2006-12#1)(2006-4#1)(2006-9#1)(2007-10#1)(2008-7#1)(2009-8#1)(2011-2#1)
was initiated before##2##3##(2007-12#1)(2007-3#1)
was initiated by addition of##2##5##(1993-11#1)(2013-1#1)
was initiated by##16##3##(1990-11#2)(1991-6#1)(1992-5#1)(1993-11#1)(1994-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2013-1#1)
was initiated in a##2##4##(1995-3#1)(2006-5#1)
was initiated in the##2##4##(1991-1#1)(2006-9#1)
was initiated in##20##3##(1990-2#1)(1991-1#1)(1993-12#1)(1995-2#1)(1995-3#1)(1997-1#1)(1997-3#1)(2006-5#1)(2006-9#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
was initiated on##5##3##(2008-1#1)(2009-2#1)(2010-12#3)
was initiated to investigate the##2##5##(2008-10#1)(2008-4#1)
was initiated to investigate##3##4##(1997-4#1)(2008-10#1)(2008-4#1)
was initiated to##9##3##(1997-4#1)(2008-10#4)(2008-11#1)(2008-4#1)(2009-4#1)(2010-12#1)
was initiated using##3##3##(1990-11#1)(2007-2#1)(2008-10#1)
was initiated with##3##3##(1992-2#1)(1995-11#1)(2013-1#1)
was initiated##108##2##(1990-11#3)(1990-2#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(2004-8#1)(2005-12#1)(2006-10#2)(2006-12#2)(2006-4#3)(2006-5#1)(2006-8#2)(2006-9#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#9)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#3)(2013-8#1)
was injected and##3##3##(2008-10#1)(2009-4#1)(2012-1#1)
was injected at##3##3##(1995-12#1)(2008-7#1)(2011-2#1)
was injected directly into the##3##5##(2006-5#1)(2008-10#1)(2011-2#1)
was injected directly into##4##4##(1991-12#1)(2006-5#1)(2008-10#1)(2011-2#1)
was injected directly onto the##2##5##(1990-8#1)(1997-3#1)
was injected directly##6##3##(1990-8#1)(1991-12#1)(1997-3#1)(2006-5#1)(2008-10#1)(2011-2#1)
was injected i##2##3##(1994-2#1)(1996-10#1)
was injected in the##4##4##(1993-12#1)(1993-2#1)(1997-2#1)(2008-10#1)
was injected in##8##3##(1993-12#1)(1993-2#1)(1994-12#1)(1997-2#1)(2007-11#1)(2008-10#3)
was injected into a semiconductor tapered##2##6##(2007-12#1)(2008-2#1)
was injected into a water carrier stream##2##7##(2008-10#2)
was injected into a##10##4##(2007-12#1)(2008-10#8)(2008-2#1)
was injected into an##2##4##(2008-10#2)
was injected into the carrier stream##2##6##(2008-10#2)
was injected into the##27##4##(1990-7#1)(1990-8#1)(1991-6#1)(1991-9#1)(1992-8#1)(1993-12#1)(1993-7#1)(1995-12#1)(1995-3#1)(1996-3#1)(1997-2#1)(2004-10#1)(2004-9#1)(2006-4#1)(2006-5#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2011-2#1)(2013-7#1)
was injected into##53##3##(1990-12#1)(1990-7#1)(1990-8#1)(1991-6#1)(1991-9#1)(1992-8#1)(1993-12#2)(1993-7#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-3#1)(1997-2#1)(2004-10#1)(2004-9#2)(2005-11#1)(2006-4#1)(2006-5#1)(2007-12#1)(2008-10#17)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#4)(2010-10#1)(2011-2#1)(2013-7#1)
was injected intraperitoneally##3##3##(2007-9#1)(2008-11#1)(2008-6#1)
was injected intravenously##5##3##(1993-12#1)(1996-9#1)(2007-10#1)(2011-2#1)(2013-1#1)
was injected on a##2##4##(1997-3#1)(2008-10#1)
was injected onto a##2##4##(1992-7#1)(1997-8#1)
was injected onto the##2##4##(1992-3#1)(2008-10#1)
was injected onto##5##3##(1992-3#1)(1992-7#1)(1997-8#1)(2008-10#2)
was injected percutaneously##2##3##(2007-1#1)(2008-7#1)
was injected subcutaneously##4##3##(1994-5#1)(1994-8#1)(2008-10#1)(2008-5#1)
was injected to##4##3##(1995-4#1)(2008-10#2)(2008-4#1)
was injected with 300 mug kg(-1) body wt of AFB1 once every 3 days for 15 days and##2##18##(2008-10#2)
was injected with a sample##2##5##(2008-10#2)
was injected with##9##3##(1991-8#1)(1994-5#1)(2007-11#1)(2008-10#4)(2008-12#1)(2011-2#1)
was injected##138##2##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-5#3)(1994-8#1)(1995-11#1)(1995-12#6)(1995-3#1)(1995-4#1)(1996-1#1)(1996-10#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-2#3)(1997-3#2)(1997-6#1)(1997-8#2)(2004-10#1)(2004-12#1)(2004-9#2)(2005-11#1)(2006-12#1)(2006-4#1)(2006-5#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#39)(2008-11#1)(2008-12#1)(2008-2#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#5)(2009-4#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-1#2)(2013-1#1)(2013-7#1)
was injured by##2##3##(1992-7#1)(2012-2#1)
was injured##4##2##(1991-3#1)(1992-7#1)(1996-11#1)(2012-2#1)
was inoculated in##3##3##(2008-1#1)(2008-10#1)(2008-5#1)
was inoculated onto##2##3##(2008-10#1)(2008-8#1)
was inoculated with 50##2##4##(2008-10#1)(2008-12#1)
was inoculated with a##2##4##(2006-10#1)(2008-10#1)
was inoculated with##13##3##(2006-10#1)(2007-1#1)(2007-8#1)(2008-10#9)(2008-12#1)
was inoculated##28##2##(2006-10#1)(2006-3#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-12#1)(2008-5#3)(2008-7#1)(2008-8#1)(2010-10#1)
was inorganic##2##2##(2005-4#1)(2008-10#1)
was insensitive to the##5##4##(1990-2#3)(2006-6#1)(2008-2#1)
was insensitive to##16##3##(1990-2#4)(1990-7#1)(1991-9#1)(1992-12#1)(1995-11#1)(1995-12#1)(1996-5#1)(1996-6#1)(2006-6#1)(2008-10#2)(2008-2#1)(2012-2#1)
was inserted after##2##3##(1992-10#1)(2008-4#1)
was inserted and the##2##4##(2006-10#1)(2008-7#1)
was inserted and##4##3##(2006-10#1)(2006-6#1)(2007-7#1)(2008-7#1)
was inserted by##2##3##(2006-5#1)(2008-11#1)
was inserted for##3##3##(2005-12#1)(2006-2#1)(2012-2#1)
was inserted in the##2##4##(1994-2#1)(2007-8#1)
was inserted in##6##3##(1990-4#1)(1994-2#1)(1997-2#1)(1997-3#1)(2007-8#1)(2008-10#1)
was inserted into a gene that encodes a##2##8##(2008-10#2)
was inserted into a##8##4##(1992-12#1)(1993-5#1)(1995-8#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-11#1)
was inserted into an##2##4##(1993-11#1)(2007-8#1)
was inserted into the genome of##2##6##(1991-1#1)(2011-12#1)
was inserted into the vector##2##5##(2008-8#1)(2010-5#1)
was inserted into the##21##4##(1990-5#1)(1990-9#1)(1991-1#1)(1991-9#1)(1993-3#1)(1993-9#1)(1997-2#1)(1997-4#1)(2005-11#1)(2007-8#3)(2008-10#1)(2008-11#2)(2008-8#2)(2010-5#1)(2011-12#1)(2011-2#1)(2013-1#1)
was inserted into##40##3##(1990-11#1)(1990-5#1)(1990-9#2)(1991-1#1)(1991-9#2)(1992-12#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-9#1)(1995-5#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-11#2)(2005-8#1)(2007-12#1)(2007-8#4)(2008-10#4)(2008-11#3)(2008-4#1)(2008-8#2)(2010-5#1)(2011-12#1)(2011-2#2)(2013-1#1)
was inserted under the##2##4##(1990-4#1)(2011-2#1)
was inserted##79##2##(1990-11#1)(1990-12#1)(1990-4#2)(1990-5#1)(1990-9#2)(1991-1#1)(1991-2#1)(1991-9#2)(1992-10#1)(1992-12#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-5#1)(1995-8#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#1)(2005-11#2)(2005-12#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-7#1)(2007-8#6)(2008-10#7)(2008-11#4)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
was insignificant for##2##3##(1997-8#1)(2008-10#1)
was insignificant##7##2##(1997-8#1)(2007-7#1)(2008-10#3)(2008-5#1)(2010-12#1)
was inspected##3##2##(2006-5#2)(2012-12#1)
was inspired by the##2##4##(2006-2#1)(2008-12#1)
was inspired by##3##3##(2006-2#1)(2008-12#1)(2008-9#1)
was installed at##2##3##(2007-5#1)(2007-7#1)
was installed by##2##3##(2008-6#1)(2012-12#1)
was installed on a##2##4##(2008-3#1)(2011-1#1)
was installed##8##2##(2007-5#1)(2007-7#1)(2008-3#1)(2008-6#1)(2010-4#1)(2011-1#1)(2012-12#2)
was instilled##3##2##(1996-2#1)(2012-11#1)(2012-3#1)
was instituted##16##2##(1991-1#1)(1991-6#1)(1994-12#1)(2006-10#2)(2006-11#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-7#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-2#1)
was instructed to##3##3##(2010-2#1)(2010-6#1)(2012-1#1)
was instrumental in##3##3##(1990-8#1)(1994-6#1)(2007-9#1)
was instrumented with##2##3##(2006-11#1)(2007-4#1)
was insufficient for##2##3##(1993-8#1)(1995-9#1)
was insufficient to##5##3##(1995-11#1)(1996-1#1)(1996-11#1)(2005-7#1)(2008-8#1)
was insufficient##15##2##(1993-8#2)(1995-11#1)(1995-9#1)(1996-1#1)(1996-11#1)(2005-7#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-9#1)(2008-11#1)(2008-8#1)(2010-8#1)(2012-12#1)
was insufficiently##3##2##(1997-6#1)(1997-7#1)(2011-2#1)
was intact and##2##3##(2011-1#1)(2012-12#1)
was intact##11##2##(1993-7#1)(1997-2#1)(2006-9#1)(2007-8#2)(2009-7#1)(2010-12#1)(2010-6#1)(2011-1#2)(2012-12#1)
was integrated into the##3##4##(1990-3#1)(1996-3#1)(2005-6#1)
was integrated into##8##3##(1990-3#1)(1994-12#1)(1996-3#1)(1997-4#1)(2005-6#1)(2008-8#1)(2012-1#1)(2012-2#1)
was integrated with the##3##4##(2008-11#1)(2008-2#1)(2008-7#1)
was integrated with##5##3##(2007-4#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)
was integrated##21##2##(1990-3#1)(1994-12#1)(1996-3#1)(1997-4#2)(2005-6#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2012-1#1)(2012-2#1)
was intended for##2##3##(2008-3#1)(2012-12#1)
was intended to provide##2##4##(2007-10#1)(2008-5#1)
was intended to##12##3##(1990-11#1)(1992-1#1)(1992-12#1)(2005-12#1)(2006-10#1)(2007-10#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)
was intended##15##2##(1990-11#1)(1992-1#1)(1992-12#1)(2005-12#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-12#1)
was intense##2##2##(1996-4#1)(2008-10#1)
was intensely expressed in##2##4##(1994-9#1)(2012-3#1)
was intensely expressed##3##3##(1994-2#1)(1994-9#1)(2012-3#1)
was intensified##2##2##(2008-10#1)(2013-7#1)
was intentional and##2##3##(2012-12#1)(2013-1#1)
was intercalated into the##3##4##(1990-2#1)(1997-4#1)(2008-10#1)
was intercalated##4##2##(1990-2#1)(1997-4#1)(2005-11#1)(2008-10#1)
was interconnected##2##2##(1991-11#1)(2007-5#1)
was interesting##4##2##(2007-12#1)(2008-11#1)(2008-12#1)(2008-5#1)
was interfered##2##2##(1996-2#1)(2008-10#1)
was intermediate to##3##3##(1995-5#1)(1995-6#1)(2008-5#1)
was intermediate##14##2##(1990-3#1)(1993-3#1)(1994-3#1)(1995-5#1)(1995-6#1)(2008-10#2)(2008-5#3)(2008-6#1)(2008-8#1)(2011-2#2)
was internalized in##2##3##(1991-9#1)(1994-8#1)
was internalized##5##2##(1991-12#1)(1991-9#1)(1994-8#2)(1995-10#1)
was interposed between##2##3##(2007-8#1)(2011-2#1)
was interpreted as##10##3##(1990-7#1)(1991-8#1)(2007-11#1)(2008-3#1)(2009-11#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-7#1)
was interpreted in terms of##3##5##(2005-11#1)(2007-12#1)(2008-10#1)
was interpreted to be due to##2##6##(1992-12#1)(2008-10#1)
was interpreted to##4##3##(1990-11#1)(1992-12#1)(2008-10#2)
was interpreted##22##2##(1990-11#1)(1990-7#1)(1991-8#1)(1992-12#1)(1996-7#1)(2005-11#2)(2007-11#1)(2007-12#2)(2008-10#5)(2008-3#1)(2009-11#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-7#1)
was interrupted by an intron##3##5##(1993-8#1)(1995-8#1)(1997-2#1)
was interrupted by##9##3##(1991-2#1)(1993-12#2)(1993-2#1)(1993-8#1)(1995-12#1)(1995-8#1)(1997-2#1)(1997-4#1)
was interrupted##14##2##(1990-7#1)(1991-2#1)(1991-3#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-4#1)(1995-12#1)(1995-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(2010-9#1)
was interviewed using##3##3##(2009-9#1)(2011-2#1)(2012-2#1)
was interviewed##7##2##(2006-4#1)(2008-5#1)(2009-5#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
was intraperitoneally##3##2##(2008-6#1)(2013-1#2)
was introduced and##5##3##(2008-10#2)(2008-3#1)(2012-1#1)(2012-3#1)
was introduced as a new##2##5##(2008-5#1)(2012-2#1)
was introduced as a tool for##2##6##(2008-10#1)(2012-1#1)
was introduced as a tool##3##5##(2008-10#1)(2009-10#1)(2012-1#1)
was introduced as a##7##4##(2008-10#2)(2008-5#1)(2009-10#1)(2012-1#1)(2012-10#1)(2012-2#1)
was introduced as##8##3##(2008-10#2)(2008-12#1)(2008-5#1)(2009-10#1)(2012-1#1)(2012-10#1)(2012-2#1)
was introduced at the##3##4##(1992-5#1)(2010-9#1)(2011-2#1)
was introduced at##4##3##(1992-5#1)(2008-12#1)(2010-9#1)(2011-2#1)
was introduced by a##2##4##(2007-10#1)(2008-5#1)
was introduced by##16##3##(1992-9#1)(1993-10#1)(1995-8#1)(2005-12#1)(2005-8#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#1)(2013-1#1)(2013-7#1)
was introduced for the##2##4##(1997-4#1)(2007-7#1)
was introduced for##5##3##(1991-9#1)(1997-4#1)(2007-7#1)(2008-10#1)(2012-12#1)
was introduced in a##5##4##(1992-11#1)(2008-10#2)(2008-5#1)(2012-12#1)
was introduced in the early##4##5##(1996-3#1)(2006-8#1)(2007-7#1)(2010-12#1)
was introduced in the##10##4##(1993-3#1)(1995-3#1)(1996-3#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2010-12#1)(2012-2#1)
was introduced in this##2##4##(2008-12#1)(2012-12#1)
was introduced in##34##3##(1990-12#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-3#1)(1995-3#1)(1996-3#1)(2005-8#1)(2006-8#1)(2007-11#1)(2007-7#2)(2008-10#4)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2011-7#1)(2012-12#2)(2012-2#2)(2013-1#1)
was introduced into a##6##4##(2006-12#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-9#1)
was introduced into the flow##2##5##(2008-10#2)
was introduced into the##29##4##(1990-11#1)(1990-6#1)(1991-12#2)(1991-4#1)(1992-2#1)(1992-6#1)(1994-3#1)(1994-8#1)(1995-6#1)(1997-3#1)(1997-6#2)(2005-11#1)(2006-12#1)(2008-10#8)(2008-11#3)(2008-2#1)(2010-8#1)(2011-2#1)
was introduced into tobacco plants##2##5##(1997-6#2)
was introduced into tobacco##3##4##(1997-6#2)(2008-9#1)
was introduced into##67##3##(1990-11#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-12#2)(1991-4#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-8#2)(1995-11#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#4)(1997-7#2)(1997-8#1)(2005-11#2)(2005-7#1)(2006-12#3)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#16)(2008-11#4)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#3)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
was introduced just##2##3##(1993-5#1)(1997-7#1)
was introduced recently##3##3##(1993-2#1)(2008-2#1)(2008-3#1)
was introduced that##2##3##(2008-2#1)(2008-3#1)
was introduced through a##2##4##(1990-2#1)(2007-8#1)
was introduced through##4##3##(1990-2#1)(1993-2#1)(1996-3#1)(2007-8#1)
was introduced to the market##2##5##(2006-10#1)(2009-8#1)
was introduced to the##6##4##(1993-4#1)(2006-10#1)(2007-8#1)(2008-6#1)(2009-8#1)(2013-1#1)
was introduced to##18##3##(1993-4#1)(1995-2#1)(2005-11#1)(2006-10#2)(2006-12#1)(2007-8#2)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-5#1)(2011-1#1)(2013-1#2)
was introduced using##2##3##(1994-7#1)(2008-10#1)
was introduced##201##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-8#1)(1994-3#1)(1994-7#1)(1994-8#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-3#4)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#4)(1997-7#3)(1997-8#2)(2005-11#3)(2005-12#1)(2005-7#1)(2005-8#2)(2006-10#4)(2006-12#4)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#2)(2007-7#6)(2007-8#5)(2007-9#1)(2008-10#33)(2008-11#10)(2008-12#5)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#7)(2011-3#1)(2011-7#1)(2012-1#2)(2012-10#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#1)
was introgressed from##2##3##(2008-10#2)
was introgressed into##2##3##(2008-10#1)(2009-5#1)
was introgressed##4##2##(2008-10#3)(2009-5#1)
was intubated##3##2##(2009-4#1)(2010-7#1)(2012-12#1)
was invaded##3##2##(1995-6#1)(2008-10#2)
was invariably associated with the##2##5##(1995-8#1)(1997-6#1)
was invariably##3##2##(1995-8#1)(1997-6#1)(2007-7#1)
was invariant across##2##3##(2007-12#1)(2008-10#1)
was invasive##3##2##(1997-3#1)(2008-10#1)(2013-1#1)
was inversely associated with the##2##5##(1995-12#1)(2011-1#1)
was inversely associated with##7##4##(1995-12#1)(2007-2#1)(2009-3#1)(2009-9#2)(2011-1#2)
was inversely correlated to##2##4##(1991-12#1)(1991-2#1)
was inversely correlated with the##3##5##(1990-5#1)(1995-3#1)(2010-4#1)
was inversely correlated with##15##4##(1990-5#1)(1993-11#1)(1995-3#1)(1995-6#1)(1996-6#1)(2008-10#2)(2008-7#1)(2010-3#2)(2010-4#2)(2011-2#1)(2012-2#2)
was inversely correlated##18##3##(1990-5#1)(1991-12#1)(1991-2#1)(1993-11#1)(1995-3#1)(1995-6#1)(1996-6#1)(2008-10#3)(2008-7#1)(2010-3#2)(2010-4#2)(2011-2#1)(2012-2#2)
was inversely proportional to the##3##5##(1990-12#1)(1991-7#1)(2011-1#1)
was inversely proportional to##5##4##(1990-12#1)(1991-7#1)(1993-8#1)(2011-1#2)
was inversely related to the##7##5##(1990-2#1)(1990-5#1)(1990-8#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-4#1)
was inversely related to##14##4##(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-9#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-4#1)(2007-8#1)(2008-10#1)(2008-4#1)(2010-8#1)(2012-11#1)
was inversely##49##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#1)(1991-12#2)(1991-2#1)(1991-7#1)(1991-9#1)(1993-11#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-4#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-6#1)(2005-5#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-7#1)(2009-3#1)(2009-9#2)(2010-3#2)(2010-4#2)(2010-8#1)(2011-1#4)(2011-2#1)(2011-3#1)(2012-11#1)(2012-2#2)(2013-1#1)(2013-8#1)
was invested in##2##3##(2011-2#2)
was investigated after##2##3##(2006-11#1)(2007-6#1)
was investigated against##3##3##(2010-5#1)(2012-2#1)(2012-3#1)
was investigated along the##2##4##(1990-12#1)(2012-2#1)
was investigated along##4##3##(1990-12#1)(2008-12#1)(2012-2#1)(2013-1#1)
was investigated and a##2##4##(1997-3#1)(2008-10#1)
was investigated and compared with##2##5##(2005-11#1)(2007-9#1)
was investigated and discussed##2##4##(2008-10#1)(2010-4#1)
was investigated and it##2##4##(1990-11#1)(1990-8#1)
was investigated and the results##2##5##(2008-10#2)
was investigated and the##7##4##(2008-10#5)(2008-6#1)(2013-1#1)
was investigated and##23##3##(1990-11#1)(1990-8#1)(1994-3#1)(1997-3#1)(2005-11#1)(2007-9#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-6#1)(2010-12#1)(2010-4#1)(2013-1#1)
was investigated as a method of##2##6##(2008-10#1)(2008-5#1)
was investigated as a##10##4##(1995-5#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-3#1)
was investigated as an##3##4##(1996-7#2)(2010-9#1)
was investigated as##18##3##(1995-5#1)(1996-7#2)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-5#4)(2008-7#1)(2009-3#1)(2010-9#1)
was investigated at a##2##4##(1996-3#1)(2008-10#1)
was investigated at pH 7##2##5##(1991-3#1)(2008-10#1)
was investigated at various##3##4##(2008-10#3)
was investigated at##20##3##(1990-9#1)(1991-3#1)(1992-1#1)(1996-3#1)(2005-11#2)(2005-12#1)(2007-12#2)(2008-10#9)(2008-11#1)(2008-5#1)
was investigated based on##3##4##(1995-11#1)(2005-11#1)(2008-10#1)
was investigated both##3##3##(2007-2#1)(2008-10#1)(2010-4#1)
was investigated by UV##2##4##(2005-11#2)
was investigated by a##5##4##(1991-6#1)(2005-11#1)(2008-10#1)(2009-8#1)(2012-2#1)
was investigated by analyzing##3##4##(1992-5#1)(2008-10#1)(2008-9#1)
was investigated by cyclic voltammetry (CV)##2##6##(2008-10#1)(2010-5#1)
was investigated by cyclic voltammetry##3##5##(2008-10#2)(2010-5#1)
was investigated by cyclic##6##4##(2008-10#5)(2010-5#1)
was investigated by determining the##3##5##(1992-4#1)(1995-10#1)(2008-10#1)
was investigated by electron##2##4##(1996-3#1)(2007-12#1)
was investigated by immunohistochemical##2##4##(1991-5#1)(1997-3#1)
was investigated by in vivo##2##5##(1992-6#1)(2008-8#1)
was investigated by in##3##4##(1992-6#1)(1996-3#1)(2008-8#1)
was investigated by light microscopy##2##5##(2007-12#2)
was investigated by means of##6##5##(1994-6#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-9#1)(2012-3#1)
was investigated by measuring the##3##5##(1991-9#1)(2006-10#1)(2008-10#1)
was investigated by measuring##9##4##(1990-5#1)(1991-1#1)(1991-9#1)(1993-5#1)(1994-10#1)(1996-9#1)(2006-10#1)(2008-10#1)(2008-11#1)
was investigated by performing##2##4##(2009-6#1)(2011-12#1)
was investigated by removing##2##4##(1992-9#1)(2009-9#1)
was investigated by studying the##4##5##(1992-7#1)(1995-1#1)(2005-11#1)(2008-5#1)
was investigated by testing##2##4##(2006-2#1)(2008-10#1)
was investigated by the##5##4##(1990-4#1)(1990-9#1)(2008-10#1)(2008-11#1)(2009-2#1)
was investigated by time-resolved##2##4##(1990-3#1)(1992-6#1)
was investigated by using a##2##5##(2008-10#1)(2008-7#1)
was investigated by using##18##4##(1990-2#1)(1990-3#2)(1990-7#1)(1992-11#1)(1993-3#1)(1996-2#1)(2005-11#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)
was investigated by##167##3##(1990-1#1)(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#4)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-5#1)(1995-7#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-8#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(2004-9#1)(2005-11#8)(2006-10#2)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#7)(2007-5#1)(2008-10#31)(2008-11#5)(2008-2#1)(2008-3#2)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-5#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
was investigated during##4##3##(1994-6#1)(1996-5#1)(2008-10#1)(2008-5#1)
was investigated employing##3##3##(1990-8#1)(1996-5#1)(2008-10#1)
was investigated experimentally##2##3##(2007-12#1)(2008-11#1)
was investigated following##4##3##(1993-5#1)(1995-3#1)(1995-5#1)(2008-11#1)
was investigated for different##2##4##(2008-2#1)(2012-1#1)
was investigated for its ability to##2##6##(2008-10#2)
was investigated for its ability##3##5##(2008-10#2)(2008-11#1)
was investigated for its##6##4##(1990-4#1)(1991-11#1)(2008-10#3)(2008-11#1)
was investigated for the##7##4##(1990-9#1)(2007-11#1)(2007-12#1)(2008-10#4)
was investigated for various##2##4##(2008-10#1)(2008-2#1)
was investigated for##34##3##(1990-4#1)(1990-5#1)(1990-9#1)(1991-11#1)(1994-11#1)(1995-6#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-2#3)(2008-3#1)(2008-7#1)(2010-1#1)(2011-2#1)(2012-1#2)(2012-2#2)
was investigated from the##3##4##(1993-12#1)(2006-10#1)(2007-12#1)
was investigated from##6##3##(1993-12#1)(1994-6#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#1)
was investigated further##3##3##(1994-6#1)(2008-10#2)
was investigated immunohistochemically in##2##4##(1993-12#1)(1996-9#1)
was investigated immunohistochemically##3##3##(1993-12#1)(1996-1#1)(1996-9#1)
was investigated in 25##2##4##(1992-6#1)(1993-12#1)
was investigated in 6 healthy##2##5##(1991-10#1)(1994-4#1)
was investigated in a prospective##2##5##(1992-12#1)(2008-7#1)
was investigated in a series of##4##6##(1990-10#1)(1991-8#1)(2008-10#2)
was investigated in a##22##4##(1990-10#2)(1990-12#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-4#1)(1993-12#1)(1993-5#1)(1993-6#1)(1995-3#1)(2006-8#1)(2007-4#1)(2008-10#3)(2008-5#1)(2008-7#2)(2009-6#1)(2012-2#1)
was investigated in adult##2##4##(1990-3#1)(1995-3#1)
was investigated in an##5##4##(1995-5#1)(2006-11#1)(2007-10#1)(2007-12#1)(2008-10#1)
was investigated in aqueous##3##4##(1997-1#1)(2008-10#2)
was investigated in cultured##2##4##(1990-2#1)(1995-8#1)
was investigated in cultures of##2##5##(1992-4#1)(1996-3#1)
was investigated in detail##5##4##(2005-11#1)(2008-10#3)(2013-1#1)
was investigated in different##4##4##(1994-3#1)(1994-9#1)(2008-10#2)
was investigated in human##6##4##(1991-5#1)(1993-8#1)(1993-9#1)(1994-8#1)(1997-7#1)(2013-1#1)
was investigated in isolated##2##4##(1990-5#1)(1992-3#1)
was investigated in laboratory##2##4##(2008-10#1)(2008-4#1)
was investigated in male##2##4##(1991-1#1)(1992-3#1)
was investigated in mice##6##4##(1991-6#1)(1993-3#1)(1994-2#1)(1996-1#1)(1996-2#1)(2013-8#1)
was investigated in mouse##2##4##(1992-1#1)(1996-12#1)
was investigated in normal##2##4##(2008-10#1)(2010-11#1)
was investigated in order to##6##5##(1997-3#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-5#1)
was investigated in order##7##4##(1997-3#1)(2006-12#1)(2008-10#2)(2008-11#2)(2008-5#1)
was investigated in patients with stable angina##2##7##(2007-9#2)
was investigated in patients with##3##5##(1990-3#1)(2007-9#2)
was investigated in patients##5##4##(1990-3#1)(1992-7#1)(2006-4#1)(2007-9#2)
was investigated in rat brain##2##5##(1993-4#1)(1996-12#1)
was investigated in rat##4##4##(1990-12#1)(1993-4#1)(1996-1#1)(1996-12#1)
was investigated in rats##4##4##(1990-4#1)(1992-7#1)(1997-4#1)(2008-4#1)
was investigated in relation to##2##5##(2005-11#1)(2011-1#1)
was investigated in terms of##5##5##(1994-8#1)(1996-2#1)(2008-10#3)
was investigated in the dentate gyrus of##2##7##(1995-12#1)(1997-5#1)
was investigated in the presence of##2##6##(1991-2#1)(2011-1#1)
was investigated in the presence##3##5##(1991-2#1)(1997-7#1)(2011-1#1)
was investigated in the present study##3##6##(1992-12#1)(1994-2#1)(2007-10#1)
was investigated in the rat##5##5##(1991-2#1)(1993-2#1)(1995-11#1)(2008-7#1)(2009-10#1)
was investigated in the##35##4##(1990-12#1)(1990-2#1)(1990-7#1)(1991-2#2)(1991-8#1)(1992-12#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-2#1)(1995-11#2)(1995-12#2)(1996-1#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-2#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#2)(2011-1#1)(2012-3#1)
was investigated in three##3##4##(1993-1#1)(2007-12#1)(2008-10#1)
was investigated in two##2##4##(1990-3#1)(2008-10#1)
was investigated in various##2##4##(1997-4#1)(2008-8#1)
was investigated in vitro##5##4##(1992-2#1)(1994-9#1)(1995-3#1)(2004-9#1)(2008-10#1)
was investigated in young##2##4##(1995-9#1)(1997-6#1)
was investigated in##237##3##(1990-10#2)(1990-11#1)(1990-12#5)(1990-2#3)(1990-3#3)(1990-4#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-10#3)(1991-2#4)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#4)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#3)(1992-4#3)(1992-6#1)(1992-7#2)(1993-1#1)(1993-12#4)(1993-2#1)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-2#3)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#4)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#3)(1996-12#3)(1996-2#2)(1996-3#3)(1996-5#1)(1996-6#2)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#3)(1997-6#2)(1997-7#4)(1997-8#2)(2004-2#1)(2004-9#1)(2005-11#4)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-10#2)(2007-12#2)(2007-4#1)(2007-7#1)(2007-9#2)(2008-10#39)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#3)(2009-10#2)(2009-2#1)(2009-6#1)(2010-11#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
was investigated on##15##3##(1990-2#1)(1990-5#1)(1991-2#2)(1993-1#1)(1997-3#1)(2007-1#1)(2008-10#4)(2008-6#1)(2010-4#1)(2011-1#1)(2012-12#1)
was investigated over the visible and near-infrared spectral##2##8##(2008-2#2)
was investigated over##4##3##(2008-10#1)(2008-2#2)(2008-5#1)
was investigated spectrophotometrically##2##3##(2008-10#2)
was investigated through the##2##4##(2007-11#1)(2008-7#1)
was investigated through##8##3##(1994-12#1)(2007-11#1)(2008-10#2)(2008-5#2)(2008-7#1)(2010-4#1)
was investigated to##10##3##(1996-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-8#1)(2009-12#1)(2013-8#1)
was investigated under controlled##2##4##(2008-10#2)
was investigated under##6##3##(1991-3#1)(2008-10#3)(2008-11#1)(2008-6#1)
was investigated using a##15##4##(1990-2#1)(1994-12#2)(1994-5#1)(2006-12#1)(2008-10#4)(2008-5#1)(2008-9#1)(2010-4#3)(2010-9#1)
was investigated using an assay##2##5##(1990-7#1)(1992-12#1)
was investigated using an##5##4##(1990-7#1)(1992-12#1)(1993-6#1)(2007-2#1)(2008-5#1)
was investigated using in vitro##2##5##(1990-7#1)(1993-2#1)
was investigated using the##13##4##(1990-12#1)(1990-4#1)(1992-7#1)(1995-1#1)(1995-5#1)(1995-7#1)(1996-12#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2012-1#1)(2012-3#1)
was investigated using##89##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#3)(1991-5#1)(1992-12#2)(1992-2#1)(1992-7#1)(1992-9#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#3)(1994-3#2)(1994-5#1)(1995-1#2)(1995-5#1)(1995-7#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-7#2)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-5#4)(2008-7#1)(2008-9#1)(2010-4#3)(2010-5#1)(2010-9#1)(2011-1#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
was investigated which##2##3##(1996-10#1)(1997-1#1)
was investigated with a##6##4##(1990-3#1)(1991-2#2)(1992-8#1)(1997-3#1)(2008-5#1)
was investigated with the use of##2##6##(1993-2#1)(2008-10#1)
was investigated with##26##3##(1990-2#1)(1990-3#1)(1990-5#1)(1991-2#2)(1991-5#1)(1992-8#1)(1993-2#2)(1995-6#1)(1996-5#1)(1997-3#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#2)(2010-2#1)(2012-1#1)
was investigated##1106##2##(1990-1#1)(1990-10#7)(1990-11#4)(1990-12#9)(1990-2#7)(1990-3#10)(1990-4#5)(1990-5#9)(1990-6#2)(1990-7#9)(1990-8#3)(1990-9#3)(1991-1#3)(1991-10#4)(1991-11#3)(1991-12#1)(1991-2#9)(1991-3#3)(1991-4#2)(1991-5#7)(1991-6#3)(1991-7#2)(1991-8#5)(1991-9#6)(1992-1#6)(1992-10#2)(1992-11#3)(1992-12#6)(1992-2#5)(1992-3#5)(1992-4#5)(1992-5#5)(1992-6#6)(1992-7#5)(1992-8#3)(1992-9#4)(1993-1#2)(1993-11#3)(1993-12#8)(1993-2#4)(1993-3#9)(1993-4#3)(1993-5#4)(1993-6#6)(1993-7#1)(1993-8#5)(1993-9#3)(1994-10#3)(1994-11#7)(1994-12#6)(1994-2#5)(1994-3#6)(1994-4#1)(1994-5#5)(1994-6#12)(1994-8#6)(1994-9#8)(1995-1#5)(1995-10#2)(1995-11#6)(1995-12#5)(1995-2#2)(1995-3#9)(1995-5#6)(1995-6#3)(1995-7#2)(1995-8#2)(1995-9#2)(1996-1#7)(1996-10#1)(1996-12#9)(1996-2#4)(1996-3#7)(1996-5#10)(1996-6#4)(1996-7#6)(1996-8#4)(1996-9#2)(1997-1#4)(1997-2#6)(1997-3#7)(1997-4#3)(1997-5#3)(1997-6#4)(1997-7#7)(1997-8#2)(2004-11#1)(2004-12#2)(2004-2#2)(2004-8#1)(2004-9#3)(2005-10#2)(2005-11#31)(2005-12#5)(2005-9#1)(2006-10#6)(2006-11#2)(2006-12#7)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#5)(2007-1#3)(2007-10#2)(2007-11#7)(2007-12#22)(2007-2#3)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#8)(2007-9#4)(2008-1#2)(2008-10#268)(2008-11#35)(2008-12#5)(2008-2#12)(2008-3#15)(2008-4#4)(2008-5#46)(2008-6#10)(2008-7#17)(2008-8#13)(2008-9#4)(2009-10#3)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#14)(2010-5#8)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#9)(2011-12#2)(2011-2#14)(2012-1#7)(2012-11#2)(2012-12#5)(2012-2#11)(2012-3#5)(2013-1#12)(2013-7#1)(2013-8#7)
was investigating##2##2##(2008-8#1)(2011-2#1)
was invited to##2##3##(2008-9#1)(2011-1#1)
was involved in a##5##4##(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#2)
was involved in the##10##4##(1993-8#1)(1994-12#1)(1994-9#1)(1997-3#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-8#1)(2013-1#1)
was involved in this##3##4##(1990-11#1)(1995-11#1)(2012-2#1)
was involved in##39##3##(1990-11#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1997-3#2)(2005-12#1)(2006-3#1)(2007-10#2)(2007-11#2)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#3)(2013-8#1)
was involved with##2##3##(2005-8#1)(2008-9#1)
was involved##47##2##(1990-10#1)(1990-11#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-5#1)(1997-3#2)(2005-12#1)(2005-8#1)(2006-3#1)(2007-10#2)(2007-11#2)(2007-7#2)(2007-8#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#3)(2013-8#1)
was irradiated by##2##3##(1991-1#1)(2008-10#1)
was irradiated using##2##3##(2005-11#1)(2008-7#1)
was irradiated##10##2##(1991-1#1)(2005-11#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)
was irregular##2##2##(2007-2#1)(2007-7#1)
was irrelevant##3##2##(1993-9#2)(1997-1#1)
was irreversible and##4##3##(1993-12#1)(2008-10#3)
was irreversible##7##2##(1991-8#1)(1993-12#2)(1994-11#1)(2008-10#3)
was irreversibly##4##2##(1991-2#1)(1993-12#1)(2008-10#1)(2008-5#1)
was isolated after##3##3##(1993-12#1)(2008-10#1)(2008-5#1)
was isolated and characterized from##2##5##(2008-8#1)(2013-7#1)
was isolated and characterized##12##4##(1990-4#1)(1990-7#1)(1991-1#1)(1991-3#1)(1993-2#1)(1994-11#1)(1995-3#1)(2005-8#1)(2008-11#1)(2008-5#1)(2008-8#1)(2013-7#1)
was isolated and found to contain##2##6##(1993-8#1)(1997-5#1)
was isolated and found to have##2##6##(1992-8#1)(1994-12#1)
was isolated and found to##7##5##(1990-2#1)(1992-1#1)(1992-8#1)(1993-8#1)(1994-12#1)(1995-2#1)(1997-5#1)
was isolated and identified##4##4##(2006-12#1)(2011-12#1)(2012-12#2)
was isolated and named##2##4##(1990-7#1)(1997-8#1)
was isolated and purified from##3##5##(1991-1#1)(1992-8#1)(1995-2#1)
was isolated and purified##5##4##(1991-1#1)(1992-8#1)(1994-8#1)(1995-2#1)(1996-5#1)
was isolated and sequenced##12##4##(1990-12#1)(1991-11#1)(1991-2#2)(1991-5#1)(1992-12#1)(1992-6#1)(1993-2#1)(1994-9#1)(1995-11#1)(1997-1#1)(2008-10#1)
was isolated and subjected to##2##5##(1994-9#1)(2012-11#1)
was isolated and the##4##4##(1990-9#1)(1991-2#1)(1991-9#1)(2007-7#1)
was isolated and##69##3##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-2#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-8#1)(1996-5#2)(1997-1#1)(1997-5#1)(1997-8#1)(2005-8#1)(2006-12#1)(2007-1#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-12#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-7#1)
was isolated as a##8##4##(1992-5#1)(1995-8#1)(1997-1#1)(2007-1#1)(2010-2#2)(2010-5#1)(2011-2#1)
was isolated as##11##3##(1991-5#1)(1992-5#1)(1995-10#1)(1995-8#1)(1996-10#1)(1997-1#1)(2007-1#1)(2010-2#2)(2010-5#1)(2011-2#1)
was isolated by complementation##2##4##(1995-3#1)(1997-6#1)
was isolated by culture##2##4##(2008-5#2)
was isolated by gel filtration and##2##6##(1990-2#1)(2008-6#1)
was isolated by ion-exchange##2##4##(1990-8#1)(1991-11#1)
was isolated by screening a human##4##6##(1993-12#1)(1994-3#1)(1996-10#1)(2008-8#1)
was isolated by screening a##5##5##(1993-12#1)(1994-3#1)(1995-1#1)(1996-10#1)(2008-8#1)
was isolated by screening##6##4##(1993-12#1)(1994-3#1)(1995-1#1)(1996-10#1)(1996-5#1)(2008-8#1)
was isolated by using##3##4##(1994-8#1)(1996-8#1)(2008-9#1)
was isolated by##37##3##(1990-11#1)(1990-2#2)(1990-3#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#1)(1992-4#1)(1993-12#1)(1993-3#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-10#3)(1996-5#1)(1996-8#1)(1997-6#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-12#1)(2012-2#1)(2013-1#1)
was isolated following##2##3##(1994-9#1)(2008-10#1)
was isolated for the first time from the leaves of Cichorium endivia##2##12##(2013-1#2)
was isolated for##4##3##(1997-4#1)(2008-9#1)(2013-1#2)
was isolated from Candida##2##4##(1995-8#1)(1997-4#1)
was isolated from a cDNA library##3##6##(1995-8#1)(1997-2#1)(2005-6#1)
was isolated from a cosmid##2##5##(1993-12#2)
was isolated from a genomic library##4##6##(1990-5#1)(1992-8#1)(1993-6#1)(2006-12#1)
was isolated from a genomic##5##5##(1990-4#1)(1990-5#1)(1992-8#1)(1993-6#1)(2006-12#1)
was isolated from a human liver cDNA library##5##8##(1991-5#1)(1991-8#1)(1992-8#1)(1993-4#1)(1994-11#1)
was isolated from a human##12##5##(1991-10#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-8#2)(1993-4#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-11#1)(2008-9#1)
was isolated from a lambda##2##5##(1993-4#1)(2008-11#1)
was isolated from a porcine##2##5##(1994-2#1)(1997-6#1)
was isolated from a rat brain cDNA library##2##8##(1994-12#1)(1996-12#1)
was isolated from a rat brain##3##6##(1991-12#1)(1994-12#1)(1996-12#1)
was isolated from a rat liver##2##6##(1991-12#1)(1993-2#1)
was isolated from a rat##9##5##(1991-1#1)(1991-12#2)(1991-9#1)(1993-2#1)(1994-12#1)(1996-10#1)(1996-12#1)(1996-2#1)
was isolated from a yeast##2##5##(1993-3#1)(1994-3#1)
was isolated from a##80##4##(1990-10#1)(1990-12#2)(1990-4#1)(1990-5#3)(1991-1#1)(1991-10#1)(1991-12#2)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-12#2)(1992-2#1)(1992-8#3)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#2)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-6#1)(2005-6#1)(2006-10#1)(2006-12#2)(2006-3#1)(2006-8#2)(2006-9#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#2)(2011-12#1)(2011-2#6)(2012-2#1)
was isolated from an anaerobic##2##5##(2006-8#2)
was isolated from an##6##4##(1991-4#1)(1997-7#1)(2005-10#1)(2006-8#2)(2011-2#1)
was isolated from blood##3##4##(1990-12#1)(1995-3#1)(2010-9#1)
was isolated from both##4##4##(1995-11#1)(2008-10#2)(2008-5#1)
was isolated from bovine##3##4##(1990-7#1)(1991-10#1)(1991-4#1)
was isolated from cerebrospinal fluid##2##5##(1995-3#1)(2009-3#1)
was isolated from culture##2##4##(2004-8#1)(2008-11#1)
was isolated from eel##2##4##(1990-7#1)(1991-10#1)
was isolated from fetal##2##4##(1991-7#1)(1994-11#1)
was isolated from human brain##2##5##(1994-10#1)(1994-2#1)
was isolated from human##6##4##(1991-12#1)(1992-3#1)(1994-10#1)(1994-2#1)(1996-8#1)(2011-2#1)
was isolated from mouse##2##4##(1996-8#1)(1997-2#1)
was isolated from one##2##4##(2008-4#1)(2008-5#1)
was isolated from rat##3##4##(1991-8#1)(1992-2#1)(1993-9#1)
was isolated from soil##3##4##(2005-11#1)(2007-12#1)(2013-1#1)
was isolated from the aerial parts of##2##7##(2006-12#1)(2008-4#1)
was isolated from the cDNA library of##2##7##(1992-12#1)(1992-2#1)
was isolated from the cDNA library##3##6##(1990-2#1)(1992-12#1)(1992-2#1)
was isolated from the genomic DNA library of##2##8##(1990-4#1)(1996-9#1)
was isolated from the leaves of##3##6##(2006-12#1)(2007-1#1)(2007-11#1)
was isolated from the liver and##2##6##(1995-9#1)(2007-2#1)
was isolated from the liver of the##2##7##(1992-12#1)(2010-5#1)
was isolated from the liver##4##5##(1992-12#1)(1995-9#1)(2007-2#1)(2010-5#1)
was isolated from the roots of##2##6##(1994-3#1)(2007-1#1)
was isolated from the soil##2##5##(2007-1#1)(2012-2#1)
was isolated from the stem bark of##2##7##(2007-1#1)(2007-11#1)
was isolated from the##61##4##(1990-2#2)(1990-4#1)(1990-5#1)(1991-12#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-5#2)(1995-9#2)(1996-7#1)(1996-9#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-12#5)(2007-1#8)(2007-11#4)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#3)(2010-5#1)(2011-12#1)(2012-2#2)
was isolated from two##3##4##(2006-10#1)(2011-2#1)(2012-11#1)
was isolated from##282##3##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#4)(1990-7#4)(1990-9#1)(1991-1#1)(1991-10#5)(1991-12#4)(1991-3#1)(1991-4#4)(1991-5#1)(1991-7#2)(1991-8#3)(1991-9#2)(1992-1#1)(1992-12#4)(1992-2#4)(1992-3#4)(1992-4#1)(1992-5#1)(1992-8#3)(1992-9#2)(1993-12#2)(1993-2#4)(1993-3#2)(1993-4#2)(1993-6#3)(1993-8#2)(1993-9#3)(1994-10#2)(1994-11#3)(1994-12#3)(1994-2#5)(1994-3#3)(1994-5#2)(1994-8#2)(1994-9#1)(1995-11#2)(1995-2#1)(1995-3#2)(1995-5#6)(1995-8#3)(1995-9#2)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-7#2)(1996-8#3)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#3)(1997-7#3)(1997-8#1)(1997-9#1)(2004-8#1)(2005-10#2)(2005-11#4)(2005-6#1)(2005-9#1)(2006-10#3)(2006-12#7)(2006-3#1)(2006-8#4)(2006-9#1)(2007-1#8)(2007-11#5)(2007-12#4)(2007-2#1)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#24)(2008-11#6)(2008-12#1)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-3#1)(2009-5#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-10#1)(2011-12#2)(2011-2#15)(2012-11#2)(2012-12#1)(2012-2#5)(2013-1#3)
was isolated in a##2##4##(1997-3#1)(2012-2#1)
was isolated in the##2##4##(2007-7#1)(2008-5#1)
was isolated in##17##3##(1994-2#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-8#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-5#4)(2008-9#1)(2012-2#1)
was isolated that##2##3##(1990-11#1)(2007-8#1)
was isolated through##2##3##(2008-9#1)(2010-5#1)
was isolated using the polymerase chain reaction##2##7##(1991-12#1)(1991-6#1)
was isolated using the##3##4##(1991-12#1)(1991-6#1)(1995-12#1)
was isolated using##7##3##(1990-2#1)(1991-12#1)(1991-6#1)(1994-2#1)(1995-12#2)(1995-2#1)
was isolated with##3##3##(1991-6#1)(1992-8#1)(2012-12#1)
was isolated##506##2##(1990-10#1)(1990-11#6)(1990-12#6)(1990-2#8)(1990-3#3)(1990-4#3)(1990-5#5)(1990-7#7)(1990-8#3)(1990-9#4)(1991-1#3)(1991-10#5)(1991-11#2)(1991-12#6)(1991-2#3)(1991-3#2)(1991-4#4)(1991-5#4)(1991-6#2)(1991-7#2)(1991-8#5)(1991-9#6)(1992-1#2)(1992-12#5)(1992-2#4)(1992-3#4)(1992-4#2)(1992-5#3)(1992-6#1)(1992-7#1)(1992-8#6)(1992-9#3)(1993-12#5)(1993-2#6)(1993-3#6)(1993-4#2)(1993-6#4)(1993-7#1)(1993-8#4)(1993-9#5)(1994-10#2)(1994-11#4)(1994-12#8)(1994-2#7)(1994-3#6)(1994-5#4)(1994-6#1)(1994-8#5)(1994-9#5)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#4)(1995-3#5)(1995-4#2)(1995-5#7)(1995-6#2)(1995-8#7)(1995-9#2)(1996-10#7)(1996-11#2)(1996-12#2)(1996-2#2)(1996-5#3)(1996-6#1)(1996-7#3)(1996-8#4)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#6)(1997-7#4)(1997-8#2)(1997-9#1)(2004-8#1)(2005-10#2)(2005-11#4)(2005-6#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-12#8)(2006-3#1)(2006-8#7)(2006-9#1)(2007-1#10)(2007-10#1)(2007-11#6)(2007-12#4)(2007-2#1)(2007-4#1)(2007-7#8)(2007-8#8)(2007-9#1)(2008-1#2)(2008-10#38)(2008-11#8)(2008-12#1)(2008-4#2)(2008-5#20)(2008-6#2)(2008-7#2)(2008-8#7)(2008-9#7)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#3)(2010-9#1)(2011-1#2)(2011-10#1)(2011-12#3)(2011-2#17)(2012-11#3)(2012-12#4)(2012-2#8)(2012-3#1)(2013-1#7)(2013-7#1)
was isolation##2##2##(2005-11#1)(2008-11#1)
was issued##4##2##(1993-12#1)(2005-7#1)(2013-1#1)(2013-8#1)
was it possible to##2##4##(1991-2#1)(1993-11#1)
was it##10##2##(1991-11#1)(1991-2#1)(1991-3#1)(1993-11#1)(1997-6#1)(2007-5#1)(2008-10#2)(2009-2#1)(2011-2#1)
was its##3##2##(1995-8#1)(2008-10#1)(2008-5#1)
was itself##2##2##(1992-7#1)(2012-12#1)
was joined##2##2##(1994-9#1)(2007-4#1)
was judged as##2##3##(1992-2#1)(2005-11#1)
was judged by the##2##4##(1991-7#1)(1992-9#1)
was judged by##4##3##(1991-7#1)(1992-9#1)(1997-2#1)(2007-10#1)
was judged to be a##2##5##(2004-7#1)(2008-10#1)
was judged to be equivocal##3##5##(2008-8#1)(2008-9#2)
was judged to be##7##4##(1993-9#1)(2004-7#1)(2006-11#1)(2008-10#1)(2008-8#1)(2008-9#2)
was judged##19##2##(1991-3#1)(1991-7#1)(1992-2#1)(1992-9#1)(1993-9#1)(1995-4#1)(1997-2#1)(2004-7#1)(2005-11#2)(2006-11#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-8#1)(2008-9#2)(2012-3#1)
was just as##4##3##(1994-12#1)(1997-8#1)(2007-8#1)(2008-9#1)
was just##11##2##(1994-11#1)(1994-12#1)(1997-8#1)(2005-10#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)(2013-1#2)
was justified##2##2##(1993-12#1)(2013-8#1)
was keeping##2##2##(2007-10#1)(2011-2#1)
was kept as##2##3##(2007-11#1)(2008-5#1)
was kept at##8##3##(1990-8#1)(1992-1#1)(2005-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2011-1#1)
was kept constant in all##2##5##(1991-10#1)(2010-12#1)
was kept constant##4##3##(1991-10#1)(1997-1#1)(2008-10#1)(2010-12#1)
was kept under##2##3##(2010-3#1)(2012-3#1)
was kept##21##2##(1990-8#1)(1991-10#1)(1992-1#1)(1997-1#2)(2005-12#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-1#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-3#1)
was killed##4##2##(1992-3#1)(1992-5#1)(1995-3#1)(2011-1#1)
was kinetically##9##2##(1990-2#1)(1990-7#1)(1994-8#1)(1995-2#2)(2008-10#3)(2009-10#1)
was knocked down##4##3##(2011-1#1)(2012-12#2)(2013-1#1)
was known about##3##3##(1992-10#1)(1993-3#1)(2011-2#1)
was known as##2##3##(2007-11#1)(2008-6#1)
was known to be##2##4##(1994-5#1)(2008-5#1)
was known to##6##3##(1994-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2012-1#1)
was known##23##2##(1990-12#1)(1992-10#1)(1993-3#1)(1993-9#1)(1994-5#1)(1995-6#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#2)(2010-12#1)(2011-2#2)(2012-1#1)(2012-12#3)
was labeled by##2##3##(1992-1#1)(2010-12#1)
was labeled with a##4##4##(1992-6#1)(1993-3#2)(2006-6#1)
was labeled with an##2##4##(1992-2#1)(2008-10#1)
was labeled with##18##3##(1992-2#1)(1992-6#1)(1993-3#2)(1993-4#1)(1994-11#2)(1997-1#1)(2006-10#1)(2006-3#2)(2006-6#1)(2007-5#1)(2008-10#3)(2008-12#1)(2008-9#1)
was labeled##26##2##(1990-11#1)(1992-1#1)(1992-2#1)(1992-6#1)(1993-3#2)(1993-4#1)(1993-7#1)(1994-11#2)(1994-9#1)(1995-6#1)(1997-1#1)(2006-10#1)(2006-3#2)(2006-6#1)(2007-2#1)(2007-5#1)(2008-10#4)(2008-12#1)(2008-9#1)(2010-12#1)
was labelled by the##2##4##(1994-2#1)(1995-12#1)
was lack of##2##3##(2006-10#1)(2007-11#1)
was lacking##6##2##(1994-9#1)(2007-2#2)(2010-8#1)(2011-2#2)
was laid##3##2##(2008-12#2)(2008-7#1)
was large and very##2##4##(2008-10#1)(2008-5#1)
was large and##4##3##(2008-10#1)(2008-5#1)(2008-9#1)(2011-1#1)
was large enough##2##3##(2008-10#1)(2008-9#1)
was large variation##2##3##(2008-3#1)(2013-1#1)
was large##15##2##(1990-12#1)(1997-8#1)(2006-3#1)(2006-4#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#2)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
was largely a##2##3##(1990-3#1)(2009-4#1)
was largely attributed to the##2##5##(1995-1#1)(2006-11#1)
was largely dependent on the##2##5##(1990-8#1)(1996-1#1)
was largely dominated by##2##4##(1996-7#1)(2008-10#1)
was largely due to##2##4##(1994-12#1)(2008-6#1)
was largely insensitive to##2##4##(1997-9#1)(2008-4#1)
was largely restricted to##2##4##(1990-3#1)(1997-3#1)
was largely##45##2##(1990-12#1)(1990-3#2)(1990-8#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-6#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#2)(1995-1#1)(1996-1#1)(1996-7#1)(1997-3#1)(1997-9#1)(2006-11#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-12#2)(2007-9#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#1)(2011-2#2)(2013-1#3)(2013-8#1)
was larger for##2##3##(2008-7#1)(2010-9#1)
was larger in##3##3##(1990-12#1)(2006-9#1)(2013-7#1)
was larger on##2##3##(1995-12#1)(2008-5#1)
was larger than that of the##2##6##(1992-9#1)(2008-3#1)
was larger than that of##3##5##(1992-9#1)(2008-10#1)(2008-3#1)
was larger than that##7##4##(1992-9#1)(1994-9#1)(1997-7#1)(2006-12#1)(2008-10#2)(2008-3#1)
was larger than the##2##4##(2008-10#1)(2012-12#1)
was larger than those (467##2##5##(2012-12#2)
was larger than##16##3##(1992-9#1)(1993-12#1)(1994-9#1)(1997-7#1)(2006-12#1)(2007-4#1)(2008-10#4)(2008-3#1)(2010-4#1)(2011-2#1)(2012-12#3)
was larger##30##2##(1990-12#1)(1992-9#1)(1993-12#1)(1993-7#2)(1994-9#1)(1995-12#1)(1996-2#1)(1997-7#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-4#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#3)(2013-7#2)(2013-8#1)
was largest at the##2##4##(2007-8#2)
was largest##3##2##(1994-2#1)(2007-8#2)
was last##2##2##(2007-3#1)(2011-2#1)
was later applied to##2##4##(2008-7#1)(2011-2#1)
was later confirmed by##4##4##(2006-10#1)(2006-2#1)(2008-4#1)(2011-2#1)
was later confirmed##7##3##(2006-10#1)(2006-2#1)(2008-4#1)(2009-9#1)(2010-2#1)(2011-2#1)(2013-1#1)
was later discovered##2##3##(2004-12#1)(2006-10#1)
was later found to##2##4##(2007-2#1)(2011-12#1)
was later identified##2##3##(1995-3#1)(2006-10#1)
was later##25##2##(1995-3#1)(1997-1#1)(2004-12#1)(2006-10#3)(2006-2#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-2#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
was launched as##2##3##(2005-7#1)(2012-2#1)
was launched by the##2##4##(1990-10#1)(1993-6#1)
was launched in##7##3##(1996-9#1)(2005-7#1)(2008-1#1)(2008-3#1)(2009-7#1)(2010-5#1)(2010-8#1)
was launched on##3##3##(2008-2#1)(2008-3#2)
was launched##25##2##(1990-10#1)(1993-6#1)(1996-9#1)(2005-5#1)(2005-7#2)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-8#1)(2009-7#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-10#1)(2012-2#1)
was leached##2##2##(1997-1#1)(2008-10#1)
was learned##4##2##(2010-5#1)(2010-6#1)(2013-1#2)
was least in##3##3##(1991-2#1)(2007-12#1)(2008-5#1)
was least##6##2##(1990-12#1)(1991-2#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-3#1)
was led by##2##3##(2008-10#1)(2010-11#1)
was left at##2##3##(1992-4#1)(2008-5#1)
was left in place##2##4##(1994-9#1)(2008-9#1)
was left in##3##3##(1994-9#1)(2008-9#1)(2013-1#1)
was left untreated##2##3##(2006-8#1)(2009-3#1)
was left##15##2##(1990-3#1)(1991-7#1)(1992-3#1)(1992-4#1)(1994-9#1)(1996-12#1)(1996-8#1)(2006-8#1)(2008-11#2)(2008-5#1)(2008-9#1)(2009-3#1)(2011-12#1)(2013-1#1)
was legalized##2##2##(2011-1#1)(2012-11#1)
was lesioned##2##2##(1992-10#1)(1995-11#1)
was less affected by##8##4##(1990-2#1)(1991-3#1)(1992-7#1)(2010-7#2)(2011-10#1)(2011-12#1)(2013-8#1)
was less affected##11##3##(1990-2#1)(1991-3#1)(1992-7#1)(1997-8#1)(2006-12#1)(2010-7#2)(2011-10#1)(2011-12#1)(2011-2#1)(2013-8#1)
was less at##5##3##(1991-8#1)(1995-5#1)(1997-6#1)(2008-10#1)(2008-9#1)
was less clear##3##3##(1992-2#1)(2008-10#1)(2012-3#1)
was less common##2##3##(1997-6#1)(2013-1#1)
was less consistent##3##3##(1996-7#1)(2005-10#1)(2008-6#1)
was less diverse##3##3##(2011-12#1)(2012-3#1)(2013-1#1)
was less effective and##2##4##(1992-12#1)(1995-6#1)
was less effective in preventing##2##5##(1991-3#1)(1993-12#1)
was less effective in##5##4##(1990-10#1)(1991-3#1)(1992-8#1)(1993-12#1)(1994-8#1)
was less effective than##6##4##(1994-11#1)(1995-6#1)(1996-9#1)(2008-10#2)(2011-2#1)
was less effective##17##3##(1990-10#1)(1991-3#1)(1992-12#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-6#2)(1996-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)
was less efficient than##2##4##(1995-5#1)(2008-9#1)
was less efficient##3##3##(1994-9#1)(1995-5#1)(2008-9#1)
was less frequent in##6##4##(1994-6#1)(2009-2#1)(2010-6#1)(2011-2#1)(2013-1#2)
was less frequent##9##3##(1994-6#1)(1994-7#1)(2009-2#1)(2009-6#1)(2010-6#1)(2011-12#1)(2011-2#1)(2013-1#2)
was less in the##2##4##(1997-6#1)(2012-12#1)
was less in##9##3##(1991-12#1)(1997-5#1)(1997-6#1)(2008-10#2)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
was less likely to##3##4##(1994-2#1)(2004-10#1)(2008-2#1)
was less marked##2##3##(1996-5#1)(2008-11#1)
was less potent than##5##4##(1991-2#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-6#1)
was less potent##6##3##(1991-2#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-6#1)(2008-5#1)
was less pronounced in the##2##5##(1994-2#1)(1997-7#1)
was less pronounced in##6##4##(1992-4#1)(1994-2#1)(1995-9#1)(1997-7#1)(2008-3#1)(2012-6#1)
was less pronounced than##2##4##(2010-4#1)(2012-1#1)
was less pronounced##12##3##(1990-2#1)(1992-4#1)(1994-2#1)(1995-9#1)(1997-7#1)(2006-5#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-4#1)(2012-1#1)(2012-6#1)
was less reactive##2##3##(1993-8#1)(2010-4#1)
was less satisfactory##2##3##(2008-10#1)(2008-9#1)
was less sensitive to the##2##5##(2005-11#1)(2008-2#1)
was less sensitive to##5##4##(1990-2#1)(1996-1#1)(1997-7#1)(2005-11#1)(2008-2#1)
was less sensitive##7##3##(1990-2#1)(1996-1#1)(1996-3#1)(1997-7#1)(2005-11#1)(2008-10#1)(2008-2#1)
was less severe and##2##4##(1994-6#1)(2012-1#1)
was less severe in##4##4##(1992-9#1)(1994-5#1)(1997-2#1)(2011-2#1)
was less severe##7##3##(1992-9#1)(1994-5#1)(1994-6#1)(1997-2#1)(2008-10#1)(2011-2#1)(2012-1#1)
was less significant##2##3##(2005-11#1)(2013-1#1)
was less so##2##3##(1991-8#1)(1996-3#1)
was less specific##2##3##(1991-4#1)(2008-10#1)
was less susceptible to the##2##5##(1997-6#1)(2011-2#1)
was less susceptible to##3##4##(1994-6#1)(1997-6#1)(2011-2#1)
was less than 0##9##4##(1996-7#1)(1997-8#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-9#1)(2011-3#1)
was less than 1##7##4##(1990-2#1)(2007-12#1)(2008-10#3)(2008-3#1)(2012-3#1)
was less than 10%##2##4##(2008-10#1)(2012-3#1)
was less than 100##2##4##(1990-9#1)(2012-12#1)
was less than 14##2##4##(2008-10#1)(2012-12#1)
was less than 15%##3##4##(1994-9#1)(2008-10#1)(2011-3#1)
was less than 2##5##4##(1991-8#1)(2006-12#1)(2008-10#2)(2008-2#1)
was less than 2%##2##4##(2005-4#1)(2008-11#1)
was less than 20##2##4##(2007-8#1)(2008-7#1)
was less than 24##2##4##(2007-8#1)(2007-9#1)
was less than 3##6##4##(1995-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)
was less than 30 min##2##5##(1990-6#1)(2007-8#1)
was less than 30##3##4##(1990-6#1)(2007-8#1)(2008-10#1)
was less than 4% for all##2##6##(2008-10#1)(2008-3#1)
was less than 4%##5##4##(2005-12#1)(2008-10#3)(2008-3#1)
was less than 40##2##4##(1996-6#1)(2008-10#1)
was less than 5##5##4##(1993-5#1)(1995-10#1)(2007-1#1)(2008-10#1)(2012-3#1)
was less than 5%##8##4##(1994-10#1)(2008-10#5)(2010-12#1)(2013-1#1)
was less than 50%##2##4##(2011-2#2)
was less than 6##2##4##(2008-10#1)(2011-2#1)
was less than 6% in##2##5##(1994-9#1)(2007-3#1)
was less than 6%##3##4##(1994-9#1)(2007-3#1)(2008-10#1)
was less than 8##3##4##(1995-3#1)(2008-10#2)
was less than one##5##4##(1991-6#1)(1997-8#1)(2006-10#1)(2007-7#1)(2008-1#1)
was less than that by the##2##6##(2008-9#2)
was less than that by##3##5##(2008-9#3)
was less than that of the vehicle##2##7##(2008-9#2)
was less than that of the##5##6##(1990-5#1)(1994-8#1)(2008-9#2)(2013-8#1)
was less than that of##7##5##(1990-5#1)(1992-6#1)(1994-8#1)(1997-4#1)(2008-9#2)(2013-8#1)
was less than that##15##4##(1990-5#1)(1992-6#1)(1994-6#1)(1994-8#2)(1995-2#1)(1997-4#1)(2006-3#1)(2006-8#1)(2008-9#5)(2013-8#1)
was less than the##4##4##(1992-1#1)(2008-11#1)(2008-3#1)(2008-7#1)
was less than##138##3##(1990-2#1)(1990-5#3)(1990-6#1)(1990-9#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-6#1)(1997-8#3)(2005-12#1)(2005-4#1)(2006-10#2)(2006-12#2)(2006-3#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#37)(2008-11#2)(2008-2#3)(2008-3#7)(2008-7#3)(2008-9#6)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-12#3)(2012-3#3)(2013-1#1)(2013-8#3)
was less then##2##3##(2008-10#1)(2008-2#1)
was less toxic than##2##4##(1990-10#1)(1996-6#1)
was less##312##2##(1990-10#2)(1990-2#4)(1990-5#3)(1990-6#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#2)(1991-6#2)(1991-8#3)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-5#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-5#2)(1994-6#5)(1994-7#1)(1994-8#3)(1994-9#4)(1995-1#2)(1995-10#2)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#3)(1995-7#1)(1995-9#1)(1996-1#1)(1996-3#2)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#5)(1997-7#2)(1997-8#5)(2004-10#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-4#1)(2006-10#2)(2006-12#3)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-1#2)(2007-10#3)(2007-11#4)(2007-12#2)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#3)(2007-8#7)(2007-9#1)(2008-1#2)(2008-10#56)(2008-11#5)(2008-2#6)(2008-3#8)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#10)(2009-2#1)(2009-3#2)(2009-6#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-10#1)(2011-12#3)(2011-2#9)(2011-3#2)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#6)(2012-6#1)(2013-1#11)(2013-8#5)
was lesser##2##2##(1990-10#1)(2011-2#1)
was lethal to##3##3##(1992-3#1)(1995-8#1)(2008-10#1)
was lethal##6##2##(1991-7#1)(1992-3#1)(1995-8#1)(2006-10#1)(2008-10#1)(2009-8#1)
was liberated##3##2##(1995-3#1)(1996-2#1)(2008-11#1)
was licensed##2##2##(2007-9#1)(2008-5#1)
was lifted##3##2##(1990-4#1)(2005-9#1)(2007-8#1)
was ligated##4##2##(1993-11#1)(1997-2#1)(2005-11#1)(2007-8#1)
was like##2##2##(2010-7#1)(2011-2#1)
was likely a##3##3##(2007-2#1)(2008-10#2)
was likely an##2##3##(1997-8#1)(2009-8#1)
was likely due to##2##4##(2008-10#1)(2013-8#1)
was likely related to##2##4##(1995-7#1)(2009-2#1)
was likely that##2##3##(1994-3#1)(2011-2#1)
was likely to be##4##4##(1992-12#1)(1995-6#1)(1995-7#1)(1997-7#1)
was likely to have##2##4##(1996-2#1)(2008-11#1)
was likely to##13##3##(1992-12#1)(1993-5#1)(1995-6#1)(1995-7#1)(1996-2#1)(1997-7#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2012-2#1)
was likely##32##2##(1992-12#1)(1992-2#1)(1993-5#1)(1994-3#1)(1994-8#1)(1995-6#1)(1995-7#2)(1996-2#1)(1996-3#1)(1997-7#1)(1997-8#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-7#1)(2009-10#1)(2009-2#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
was likewise##2##2##(1994-2#1)(2007-8#1)
was limited and the##2##4##(1996-1#1)(2008-10#1)
was limited and##4##3##(1992-8#1)(1996-1#1)(2008-10#1)(2012-2#1)
was limited by the##19##4##(1990-12#1)(1997-2#1)(2006-11#1)(2007-12#2)(2007-6#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-2#1)
was limited by##28##3##(1990-12#1)(1994-9#1)(1995-2#1)(1997-2#1)(2006-11#1)(2007-12#2)(2007-6#1)(2008-10#4)(2008-2#6)(2008-3#3)(2008-5#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-2#2)(2012-3#1)
was limited in all##2##4##(2007-11#1)(2008-10#1)
was limited in##4##3##(2007-11#1)(2007-7#1)(2008-10#2)
was limited only by##2##4##(2007-12#2)
was limited only to##2##4##(1994-9#1)(2007-7#1)
was limited only##4##3##(1994-9#1)(2007-12#2)(2007-7#1)
was limited or inconclusive##2##4##(2006-8#2)
was limited to a##7##4##(1992-5#1)(2006-12#1)(2007-12#1)(2008-10#2)(2009-8#1)(2010-8#1)
was limited to the##5##4##(1993-11#1)(2006-9#1)(2008-10#2)(2012-2#1)
was limited to##31##3##(1990-2#1)(1990-7#1)(1992-5#1)(1993-11#1)(1994-3#1)(2004-12#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-12#1)(2008-10#9)(2008-3#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
was limited##91##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-7#1)(1992-5#1)(1992-8#1)(1993-10#1)(1993-11#1)(1994-3#1)(1994-9#2)(1995-2#1)(1996-1#1)(1996-8#1)(1997-2#1)(2004-12#1)(2006-11#1)(2006-12#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-3#1)(2007-6#1)(2007-7#2)(2008-10#20)(2008-12#2)(2008-2#6)(2008-3#5)(2008-5#1)(2008-8#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
was limiting##2##2##(1996-11#1)(2008-10#1)
was linear and##2##3##(1992-10#1)(2008-10#1)
was linear between 0##2##4##(1992-1#1)(2008-10#1)
was linear between 10##2##4##(2008-10#2)
was linear between##7##3##(1992-1#1)(1995-2#1)(2008-10#5)
was linear for the range of concentrations between 0##2##9##(2008-10#2)
was linear for##8##3##(1992-6#1)(1994-10#1)(1996-12#1)(2007-8#1)(2008-10#3)(2010-2#1)
was linear from 0##8##4##(1997-2#1)(1997-8#1)(2008-10#6)
was linear from 1##2##4##(2008-10#2)
was linear from 20 to 200##2##6##(1993-2#1)(2008-10#1)
was linear from 20 to##3##5##(1993-2#1)(2008-10#2)
was linear from##18##3##(1993-2#1)(1997-2#1)(1997-8#2)(2008-10#14)
was linear in the concentration range from 5##2##8##(2008-10#2)
was linear in the concentration range of##4##7##(1997-3#1)(2008-10#3)
was linear in the concentration range##7##6##(1997-3#1)(2008-10#6)
was linear in the concentration##8##5##(1996-8#1)(1997-3#1)(2008-10#6)
was linear in the range 0##5##6##(2008-10#5)
was linear in the range 3##2##6##(2008-10#2)
was linear in the range of 0##3##7##(2008-10#3)
was linear in the range of 1##3##7##(1996-6#1)(2008-10#2)
was linear in the range of##12##6##(1992-1#1)(1996-6#1)(2005-12#1)(2007-8#1)(2008-10#8)
was linear in the range##29##5##(1992-1#1)(1993-2#1)(1996-6#1)(2005-12#1)(2007-8#1)(2008-10#24)
was linear in the##44##4##(1992-1#1)(1992-4#1)(1993-2#1)(1996-6#1)(1996-8#1)(1997-3#1)(2005-12#1)(2005-4#1)(2007-8#1)(2008-10#34)(2012-12#1)
was linear in##45##3##(1992-1#1)(1992-4#1)(1993-2#1)(1996-6#1)(1996-8#1)(1997-3#1)(2005-12#1)(2005-4#1)(2007-8#1)(2008-10#35)(2012-12#1)
was linear over a concentration range of##2##7##(2010-2#1)(2011-2#1)
was linear over a range of##4##6##(1993-12#1)(1997-3#1)(2007-8#1)(2008-10#1)
was linear over a range##5##5##(1993-12#1)(1993-9#1)(1997-3#1)(2007-8#1)(2008-10#1)
was linear over a##11##4##(1993-12#1)(1993-9#1)(1996-5#1)(1997-3#1)(2007-8#1)(2008-10#4)(2010-2#1)(2011-2#1)
was linear over about##2##4##(2008-10#2)
was linear over the concentration range 0##2##7##(1990-9#1)(2008-10#1)
was linear over the concentration range from##2##7##(2008-10#2)
was linear over the concentration range of##4##7##(2008-10#2)(2010-12#1)(2010-2#1)
was linear over the concentration range##11##6##(1990-12#1)(1990-9#1)(2008-10#7)(2010-12#1)(2010-2#1)
was linear over the range 0##4##6##(2008-10#4)
was linear over the range 1##3##6##(2008-10#3)
was linear over the range of 0##3##7##(1997-8#2)(2008-10#1)
was linear over the range of 2##2##7##(2008-10#2)
was linear over the range of##10##6##(1997-8#3)(2008-10#6)(2013-1#1)
was linear over the range##20##5##(1997-8#3)(2008-10#16)(2013-1#1)
was linear over the##34##4##(1990-12#1)(1990-9#1)(1997-8#3)(2008-10#26)(2010-12#1)(2010-2#1)(2013-1#1)
was linear over##51##3##(1990-12#1)(1990-9#1)(1993-12#1)(1993-9#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-8#3)(2007-8#1)(2008-10#35)(2010-12#1)(2010-2#2)(2011-2#1)(2013-1#1)
was linear to##8##3##(1996-6#1)(2008-10#7)
was linear up to 0##2##5##(2008-10#2)
was linear up to 100##2##5##(2008-10#2)
was linear up to 50##2##5##(1991-1#1)(2008-10#1)
was linear up to##15##4##(1991-1#1)(1992-3#1)(1993-2#1)(2007-10#1)(2008-10#11)
was linear with a correlation coefficient of 0##5##8##(2008-10#5)
was linear with a##7##4##(2008-10#7)
was linear with the##5##4##(2008-10#5)
was linear with time##2##4##(1990-2#1)(1990-4#1)
was linear with##17##3##(1990-2#1)(1990-4#1)(1996-6#1)(2008-10#14)
was linear within##2##3##(1993-12#1)(2008-10#1)
was linear##185##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-9#1)(1991-1#1)(1991-10#1)(1992-1#2)(1992-10#1)(1992-3#3)(1992-4#1)(1992-6#1)(1993-12#2)(1993-2#3)(1993-9#1)(1994-10#1)(1995-2#1)(1996-12#2)(1996-5#1)(1996-6#3)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-8#5)(2005-12#2)(2005-4#1)(2007-10#1)(2007-8#5)(2008-10#129)(2010-12#1)(2010-2#3)(2011-2#1)(2012-12#3)(2013-1#1)
was linearly correlated with##3##4##(2008-10#2)(2008-7#1)
was linearly dependent on the##3##5##(1990-11#1)(2008-10#2)
was linearly proportional to the##2##5##(1991-2#1)(2008-10#1)
was linearly related to the log of##2##7##(1991-2#1)(2008-10#1)
was linearly related to the logarithm of##2##7##(2008-10#2)
was linearly related to the##8##5##(1991-2#1)(1995-3#1)(2008-10#5)(2008-5#1)
was linearly related to##11##4##(1991-2#1)(1993-1#1)(1995-3#1)(2006-8#1)(2008-10#6)(2008-5#1)
was linearly##21##2##(1990-11#1)(1991-2#2)(1993-1#1)(1993-9#1)(1995-3#1)(2006-8#1)(2008-10#11)(2008-2#1)(2008-5#1)(2008-7#1)
was linked in##3##3##(2008-10#3)
was linked to a##2##4##(1990-3#1)(1993-6#1)
was linked to the##8##4##(1996-12#1)(1997-2#1)(1997-7#1)(2005-11#1)(2008-10#2)(2008-3#1)(2008-5#1)
was linked to##22##3##(1990-3#1)(1991-8#1)(1993-6#1)(1994-3#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-7#1)(2005-11#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
was linked with##5##3##(2007-2#1)(2008-10#2)(2009-10#1)(2012-1#1)
was linked##30##2##(1990-3#1)(1991-8#1)(1993-6#1)(1994-3#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-2#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
was little change##3##3##(1995-8#1)(2008-10#1)(2008-8#1)
was little difference##4##3##(1991-4#1)(1992-9#1)(1994-8#1)(2010-8#1)
was little evidence for##2##4##(2008-5#1)(2010-11#1)
was little evidence that##3##4##(1990-12#1)(2004-11#1)(2012-3#1)
was little evidence##6##3##(1990-12#1)(2004-11#1)(2008-5#1)(2010-11#1)(2012-2#1)(2012-3#1)
was little or no##5##4##(1994-12#1)(1997-2#1)(2007-12#1)(2007-9#1)(2008-6#1)
was little relationship between##2##4##(2008-4#1)(2008-8#1)
was little##40##2##(1990-11#1)(1990-12#1)(1991-4#1)(1992-9#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-2#2)(2004-11#1)(2005-8#1)(2006-7#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2010-11#1)(2010-8#1)(2012-2#1)(2012-3#1)
was living##3##2##(1995-1#1)(2006-10#1)(2008-7#1)
was loaded in##3##3##(2007-4#1)(2008-10#1)(2008-9#1)
was loaded into the##2##4##(1991-8#1)(2009-3#1)
was loaded on##4##3##(2008-10#3)(2010-12#1)
was loaded onto##2##3##(1997-8#1)(2012-12#1)
was loaded##12##2##(1991-8#1)(1997-8#1)(2007-4#1)(2008-10#5)(2008-9#1)(2009-3#1)(2010-12#1)(2012-12#1)
was local##2##2##(2010-9#1)(2011-2#1)
was localised to the##2##4##(1996-10#2)
was localised##3##2##(1993-12#1)(1996-10#2)
was localized at the##2##4##(1990-4#1)(1995-6#1)
was localized at##8##3##(1990-10#1)(1990-11#1)(1990-4#1)(1994-10#1)(1995-3#1)(1995-6#1)(1996-5#1)(2008-11#1)
was localized in a##2##4##(2009-10#1)(2013-1#1)
was localized in cell##2##4##(1995-3#1)(1996-6#1)
was localized in the##13##4##(1990-11#1)(1990-4#1)(1992-3#1)(1992-6#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-7#1)(2006-2#1)(2009-8#2)(2011-12#1)(2011-2#1)
was localized in##30##3##(1990-11#1)(1990-4#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-9#1)(1995-3#1)(1996-5#1)(1996-6#1)(1996-9#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#2)(2010-11#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
was localized mainly##2##3##(1997-4#1)(2009-10#1)
was localized on the##2##4##(1992-7#1)(2006-10#1)
was localized on##5##3##(1991-5#1)(1992-7#1)(1994-12#1)(1995-6#1)(2006-10#1)
was localized only in the##2##5##(2006-2#1)(2008-10#1)
was localized only in##3##4##(2006-2#1)(2008-10#2)
was localized specifically##2##3##(2008-7#1)(2010-11#1)
was localized to a##5##4##(1993-9#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-6#1)
was localized to the basolateral##2##5##(1993-6#1)(1994-3#1)
was localized to the nucleus##3##5##(1991-10#1)(1997-1#1)(2009-10#1)
was localized to the##13##4##(1990-12#1)(1990-6#1)(1991-10#1)(1991-11#1)(1992-7#1)(1993-6#2)(1994-3#1)(1994-8#1)(1996-5#1)(1997-1#1)(2008-11#1)(2009-10#1)
was localized to within##3##4##(1993-11#1)(1993-2#1)(1995-6#1)
was localized to##27##3##(1990-12#1)(1990-6#2)(1991-10#1)(1991-11#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-6#2)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-6#2)(1996-5#1)(1997-1#1)(1997-7#1)(2006-10#1)(2008-11#1)(2008-9#1)(2009-10#1)(2010-12#1)
was localized using##2##3##(1994-11#1)(2006-10#1)
was localized within##2##3##(1990-2#1)(1997-4#1)
was localized##97##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-4#2)(1990-6#3)(1991-10#2)(1991-11#2)(1991-5#2)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-3#2)(1995-6#4)(1996-5#4)(1996-6#2)(1996-9#2)(1997-1#1)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#1)(2004-9#1)(2006-10#3)(2006-2#2)(2007-11#2)(2007-8#2)(2008-10#4)(2008-11#3)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#3)(2009-8#2)(2010-11#2)(2010-12#2)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
was locally invasive##2##3##(2006-10#1)(2012-2#1)
was locally##5##2##(2006-10#1)(2008-4#1)(2008-6#2)(2012-2#1)
was located at the##6##4##(1991-8#1)(1991-9#1)(1994-9#1)(1995-8#1)(1996-9#1)(2013-8#1)
was located at##8##3##(1991-8#1)(1991-9#1)(1994-9#1)(1995-8#1)(1996-9#1)(1997-4#1)(2008-5#1)(2013-8#1)
was located below the##3##4##(2009-9#1)(2012-12#2)
was located between the##3##4##(1991-7#1)(2008-5#1)(2008-9#1)
was located between##6##3##(1991-7#1)(1995-10#1)(1997-2#1)(2008-5#1)(2008-9#1)(2012-2#1)
was located in a##2##4##(2008-10#1)(2012-2#1)
was located in the middle##2##5##(1996-1#1)(2013-8#1)
was located in the##30##4##(1990-2#1)(1990-5#1)(1991-3#1)(1991-6#1)(1991-7#1)(1993-9#1)(1994-12#1)(1996-1#1)(1997-6#1)(1997-8#1)(2006-11#3)(2006-12#1)(2006-7#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#2)(2012-12#1)(2013-8#5)
was located in##42##3##(1990-2#1)(1990-5#1)(1990-7#1)(1991-3#1)(1991-6#1)(1991-7#1)(1993-9#1)(1994-12#1)(1994-8#1)(1996-1#1)(1996-9#1)(1997-6#1)(1997-8#1)(2006-11#3)(2006-12#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#5)
was located near the##2##4##(1992-9#1)(2008-10#1)
was located near##4##3##(1992-9#1)(2008-10#1)(2012-3#2)
was located on a##2##4##(1992-3#1)(2008-5#1)
was located on chromosome##3##4##(1994-9#1)(1997-8#1)(2008-10#1)
was located on the##8##4##(1990-2#1)(1992-4#1)(1995-11#1)(2008-10#2)(2008-3#1)(2008-8#1)(2011-1#1)
was located on##17##3##(1990-2#1)(1992-3#1)(1992-4#1)(1993-4#1)(1994-9#1)(1995-11#1)(1997-8#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2011-1#1)
was located predominantly##2##3##(1995-7#1)(2007-11#1)
was located within a##2##4##(1990-9#1)(1997-6#1)
was located within the##4##4##(1990-3#1)(1997-7#1)(2007-8#1)(2013-1#1)
was located within##6##3##(1990-3#1)(1990-9#1)(1997-6#1)(1997-7#1)(2007-8#1)(2013-1#1)
was located##115##2##(1990-2#2)(1990-3#2)(1990-5#1)(1990-7#2)(1990-9#2)(1991-3#1)(1991-4#1)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-4#1)(1993-9#2)(1994-12#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-5#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#6)(1997-7#1)(1997-8#2)(2006-11#3)(2006-12#3)(2006-7#1)(2006-8#1)(2007-11#4)(2007-12#2)(2007-4#1)(2007-8#2)(2008-10#10)(2008-3#1)(2008-5#5)(2008-7#3)(2008-8#3)(2008-9#5)(2009-9#1)(2010-12#2)(2011-1#1)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#7)
was locked to##4##3##(2007-12#2)(2008-2#2)
was locked##6##2##(2007-12#3)(2008-2#2)(2008-3#1)
was long and##3##3##(2007-12#2)(2008-10#1)
was long##8##2##(1991-6#1)(2006-2#1)(2007-12#2)(2008-10#2)(2008-11#1)(2009-4#1)
was long-lasting##2##2##(1990-5#1)(1996-12#1)
was longer in patients##2##4##(2007-11#1)(2013-8#1)
was longer in the##2##4##(1996-1#1)(2007-8#1)
was longer in##6##3##(1991-5#1)(1996-1#1)(2007-11#1)(2007-8#1)(2013-8#2)
was longer than that##2##4##(1997-5#1)(2008-11#1)
was longer than##7##3##(1997-5#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2011-1#1)
was longer##22##2##(1990-10#1)(1991-5#1)(1992-3#1)(1996-1#1)(1996-3#1)(1997-5#2)(2006-6#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-4#1)(2009-9#1)(2011-1#1)(2013-8#2)
was looked##2##2##(1990-3#1)(2007-7#1)
was lost after##4##3##(1991-8#1)(2008-10#1)(2012-3#1)(2013-1#1)
was lost and##4##3##(1990-9#1)(2007-2#1)(2008-1#1)(2013-8#1)
was lost by##2##3##(2008-11#1)(2008-6#1)
was lost during##2##3##(1990-12#1)(1992-11#1)
was lost from##2##3##(1992-6#1)(1994-5#1)
was lost in all##2##4##(2008-1#1)(2008-7#1)
was lost in##6##3##(1991-9#1)(2008-1#1)(2008-10#1)(2008-7#2)(2013-7#1)
was lost to follow-up and##2##5##(2008-3#1)(2008-6#1)
was lost to the atmosphere##2##5##(1996-8#2)
was lost to the##3##4##(1992-6#1)(1996-8#2)
was lost to##5##3##(1992-6#1)(1996-8#2)(2008-3#1)(2008-6#1)
was lost upon##3##3##(1990-5#1)(1994-3#1)(1995-3#1)
was lost when##2##3##(1993-1#1)(1994-3#1)
was lost##45##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-6#2)(1993-1#1)(1994-11#1)(1994-3#2)(1994-5#1)(1995-3#1)(1996-8#2)(1996-9#1)(2006-10#1)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#2)(2008-9#1)(2010-11#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
was low (1##4##3##(2007-8#1)(2010-11#1)(2012-2#1)(2013-8#1)
was low among##3##3##(2008-11#1)(2008-2#1)(2011-1#1)
was low and similar##2##4##(2008-8#1)(2013-8#1)
was low and the##3##4##(1996-2#1)(2007-2#1)(2011-2#1)
was low and##16##3##(1991-12#1)(1992-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-8#1)(2011-2#2)(2012-3#1)(2013-8#1)
was low at##2##3##(1996-5#1)(2006-10#1)
was low but##2##3##(2007-7#1)(2012-3#1)
was low compared to##3##4##(1995-10#1)(1995-12#1)(2007-2#1)
was low compared with##3##4##(1993-8#1)(2012-2#1)(2013-7#1)
was low compared##6##3##(1993-8#1)(1995-10#1)(1995-12#1)(2007-2#1)(2012-2#1)(2013-7#1)
was low during the##2##4##(2008-5#1)(2008-9#1)
was low for##2##3##(2008-10#1)(2012-3#1)
was low if##2##3##(2008-10#1)(2012-1#1)
was low in all##4##4##(2004-12#1)(2008-10#1)(2012-3#1)(2013-1#1)
was low in the##3##4##(1990-5#1)(1993-9#1)(1997-4#1)
was low in##17##3##(1990-5#1)(1992-10#1)(1993-9#1)(1997-4#1)(2004-12#1)(2005-6#1)(2008-10#4)(2008-11#2)(2008-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
was low on##2##3##(1995-10#1)(2008-8#1)
was low throughout the##2##4##(2008-10#1)(2010-8#1)
was low when##3##3##(1992-8#1)(2008-10#1)(2013-7#1)
was low with##3##3##(1993-1#1)(2008-10#2)
was low##148##2##(1990-11#1)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#1)(1991-12#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-7#1)(1992-8#2)(1993-1#1)(1993-10#1)(1993-8#1)(1993-9#1)(1994-9#1)(1995-10#2)(1995-11#1)(1995-12#2)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#2)(1997-2#2)(1997-3#2)(1997-4#3)(1997-6#1)(1997-7#1)(2004-12#1)(2005-11#1)(2005-12#1)(2005-6#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-2#2)(2007-3#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#28)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-5#1)(2010-11#3)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#2)(2012-3#6)(2013-1#6)(2013-7#3)(2013-8#3)
was lower (0##5##3##(1995-1#1)(1997-3#1)(2008-10#1)(2013-8#2)
was lower (P &lt##2##4##(2010-2#2)
was lower (P##3##3##(2008-5#1)(2010-2#2)
was lower among##3##3##(1992-8#1)(1997-1#1)(2008-7#1)
was lower and##4##3##(1991-10#1)(1992-3#1)(2005-11#1)(2008-8#1)
was lower at the##2##4##(2008-11#1)(2010-4#1)
was lower at##5##3##(1995-6#1)(2008-10#1)(2008-11#1)(2010-4#1)(2012-1#1)
was lower by##4##3##(1995-9#1)(2008-2#1)(2008-7#1)(2013-8#1)
was lower compared##2##3##(2008-10#1)(2012-1#1)
was lower for the##3##4##(1994-11#2)(2008-10#1)
was lower for##11##3##(1994-11#2)(2008-10#6)(2008-9#1)(2010-4#1)(2012-2#1)
was lower in patients##3##4##(2012-12#1)(2012-2#1)(2013-1#1)
was lower in plants##2##4##(2008-10#1)(2009-2#1)
was lower in the less reproductively##2##6##(2009-12#1)(2012-3#1)
was lower in the orange juice phase compared with##2##9##(2007-8#2)
was lower in the patients than in##2##7##(1997-2#1)(2008-7#1)
was lower in the presence of##2##6##(1995-1#1)(2008-10#1)
was lower in the##29##4##(1990-4#1)(1991-11#1)(1992-10#1)(1993-10#1)(1994-2#2)(1995-1#1)(1995-9#1)(1997-2#1)(2004-11#1)(2004-9#1)(2006-11#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
was lower in##67##3##(1990-10#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#2)(1993-10#1)(1993-7#1)(1994-12#1)(1994-2#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-9#1)(1997-2#1)(2004-11#2)(2004-9#1)(2006-11#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-8#2)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
was lower than 0##2##4##(2008-10#2)
was lower than 2##2##4##(2008-6#1)(2012-11#1)
was lower than 3##3##4##(1990-2#1)(2008-10#1)(2012-12#1)
was lower than during##2##4##(1992-1#1)(1996-3#1)
was lower than in normal##2##5##(1990-5#1)(2011-2#1)
was lower than in the##3##5##(1992-10#1)(2006-8#1)(2008-11#1)
was lower than in##12##4##(1990-5#1)(1992-10#1)(1997-1#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#1)(2011-2#2)
was lower than normal in TT##3##6##(2007-7#3)
was lower than normal##4##4##(2007-2#1)(2007-7#3)
was lower than that for##2##5##(1991-9#1)(1992-3#1)
was lower than that found##2##5##(1990-6#1)(1997-7#1)
was lower than that observed in##2##6##(1994-2#1)(1995-8#1)
was lower than that of the##2##6##(1993-9#1)(1997-4#1)
was lower than that of##10##5##(1990-10#1)(1990-3#1)(1990-4#1)(1993-9#1)(1997-4#1)(2006-8#1)(2008-10#1)(2008-5#1)(2011-2#2)
was lower than that reported in Caucasian##2##7##(1997-8#1)(2009-5#1)
was lower than that reported##3##5##(1996-12#1)(1997-8#1)(2009-5#1)
was lower than that##21##4##(1990-10#1)(1990-3#1)(1990-4#1)(1990-6#1)(1991-9#1)(1992-3#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-8#1)(1996-12#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-5#1)(2011-2#2)
was lower than the##9##4##(1993-3#1)(1993-9#1)(1995-4#1)(2007-2#1)(2008-7#2)(2008-8#1)(2011-12#1)(2012-1#1)
was lower than those##4##4##(2007-12#1)(2008-10#1)(2008-12#1)(2008-9#1)
was lower than##91##3##(1990-10#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-9#2)(1994-2#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-2#2)(2006-8#4)(2007-12#1)(2007-2#2)(2007-7#4)(2007-9#1)(2008-10#16)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#2)
was lower when compared with##2##5##(2006-12#1)(2012-3#1)
was lower when compared##3##4##(2006-12#1)(2008-12#1)(2012-3#1)
was lower when##6##3##(1990-5#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-12#1)(2012-3#1)
was lower with the##2##4##(1995-2#1)(2011-2#1)
was lower with##5##3##(1995-2#1)(2007-11#1)(2009-4#1)(2009-6#1)(2011-2#1)
was lower##248##2##(1990-10#2)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-6#2)(1991-9#2)(1992-1#1)(1992-10#2)(1992-12#2)(1992-3#2)(1992-5#1)(1992-8#2)(1992-9#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-7#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#3)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#1)(1995-7#2)(1995-8#1)(1995-9#2)(1996-12#1)(1996-3#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-11#2)(2004-9#1)(2005-11#1)(2006-11#2)(2006-12#1)(2006-2#2)(2006-5#1)(2006-6#1)(2006-8#5)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#3)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#8)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#33)(2008-11#5)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#7)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-12#2)(2010-2#2)(2010-4#4)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#11)(2012-1#4)(2012-11#1)(2012-12#6)(2012-2#4)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#6)
was lowered by 50%##2##4##(1992-6#1)(1996-12#1)
was lowered by##5##3##(1991-6#1)(1992-6#1)(1996-12#1)(1997-8#1)(2013-8#1)
was lowered in##2##3##(2008-10#1)(2013-7#1)
was lowered to 5##2##4##(1990-6#1)(1996-3#1)
was lowered##16##2##(1990-6#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-4#1)(1992-6#1)(1994-3#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-8#1)(2006-5#1)(2008-10#1)(2013-7#1)(2013-8#2)
was lowest for##3##3##(1993-9#1)(2004-11#1)(2005-10#1)
was lowest in Iceland##2##4##(2006-8#2)
was lowest in the##3##4##(1994-11#1)(2007-8#1)(2008-10#1)
was lowest in##12##3##(1994-11#1)(1996-6#1)(2005-12#1)(2006-8#2)(2007-10#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)
was lowest with##2##3##(2008-10#1)(2012-3#1)
was lowest##27##2##(1993-9#1)(1994-11#1)(1996-6#1)(2004-11#1)(2005-10#1)(2005-12#1)(2006-8#2)(2007-10#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-12#3)(2008-5#3)(2010-4#1)(2012-2#1)(2012-3#1)
was lyophilized##2##2##(2008-5#1)(2013-7#1)
was made a##2##3##(2008-10#1)(2013-1#1)
was made according to the criteria##2##6##(2004-1#1)(2008-1#1)
was made according to##3##4##(2004-1#1)(2008-1#1)(2013-1#1)
was made after##5##3##(1992-12#1)(2006-10#1)(2007-12#1)(2011-2#1)(2013-1#1)
was made among##3##3##(2008-10#2)(2013-1#1)
was made and the##3##4##(2005-4#1)(2008-10#1)(2009-6#1)
was made and treatment##3##4##(1993-1#1)(2006-4#1)(2013-7#1)
was made and##11##3##(1993-1#1)(1997-4#1)(2005-4#1)(2006-4#1)(2008-10#1)(2008-9#1)(2009-6#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-7#1)
was made as##2##3##(1997-4#1)(2006-8#1)
was made at##7##3##(1990-2#1)(1991-12#1)(1993-12#1)(2006-2#1)(2008-3#1)(2009-6#1)(2011-12#1)
was made available in##2##4##(2006-5#1)(2007-8#1)
was made available to##2##4##(2007-2#1)(2013-7#1)
was made available##4##3##(2006-5#1)(2007-2#1)(2007-8#1)(2013-7#1)
was made based on the##3##5##(1991-6#1)(2006-8#1)(2011-2#1)
was made based on##8##4##(1991-6#1)(2006-12#1)(2006-8#1)(2007-7#1)(2008-11#1)(2011-2#2)(2012-3#1)
was made between the##6##4##(2006-2#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-6#1)(2008-10#1)
was made between##17##3##(1993-5#1)(1994-3#2)(2006-2#1)(2006-7#2)(2006-8#1)(2007-10#1)(2007-6#1)(2008-10#3)(2008-7#1)(2008-8#1)(2010-1#1)(2011-2#1)(2013-7#1)
was made but##2##3##(2007-2#1)(2009-5#1)
was made by CT##2##4##(1992-9#1)(2007-8#1)
was made by the##6##4##(2005-11#1)(2006-10#1)(2007-9#1)(2008-3#1)(2012-3#1)(2013-7#1)
was made by##47##3##(1990-12#1)(1992-12#1)(1992-9#1)(1993-9#1)(1994-9#1)(1996-1#1)(1996-8#1)(1997-3#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#7)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
was made easier##2##3##(1996-12#1)(2008-9#1)
was made for all the##2##5##(2007-8#1)(2008-10#1)
was made for the##2##4##(1992-11#1)(2006-8#1)
was made for##12##3##(1992-11#1)(1995-2#1)(2006-8#1)(2007-8#2)(2008-10#3)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)
was made from##7##3##(2008-10#3)(2010-12#1)(2010-2#1)(2012-3#1)(2013-1#1)
was made in some##3##4##(2007-9#1)(2008-11#2)
was made in the##2##4##(2007-3#1)(2008-5#1)
was made in##36##3##(1990-10#2)(1990-3#1)(1990-6#1)(1991-3#1)(1992-3#1)(1993-5#1)(1994-2#1)(1995-7#1)(1997-2#1)(2005-1#1)(2007-11#3)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2009-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
was made into the##2##4##(2006-6#1)(2008-2#1)
was made into##3##3##(2006-6#1)(2008-10#1)(2008-2#1)
was made of a##2##4##(1992-5#1)(2008-6#1)
was made of the##17##4##(1990-12#1)(1991-1#1)(1991-3#1)(1992-6#1)(1993-2#1)(1994-1#1)(1995-8#1)(1997-6#1)(2004-9#1)(2006-2#1)(2008-10#2)(2008-3#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
was made of##38##3##(1990-12#1)(1991-1#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-2#1)(1994-1#1)(1995-8#1)(1996-1#1)(1996-12#1)(1997-6#2)(2004-9#1)(2005-10#1)(2006-2#2)(2006-8#1)(2007-6#1)(2008-10#3)(2008-3#1)(2008-6#2)(2009-10#1)(2010-4#1)(2011-1#1)(2012-12#3)(2012-3#1)(2013-1#2)(2013-7#1)
was made on the basis of the##4##7##(2006-10#1)(2007-2#1)(2007-8#1)(2012-12#1)
was made on the basis of##11##6##(1992-4#1)(1992-7#1)(1994-11#1)(2006-10#1)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#1)(2012-12#1)
was made on the##18##4##(1990-11#1)(1992-4#1)(1992-7#1)(1994-11#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-8#1)(2012-12#1)(2013-8#3)
was made on##29##3##(1990-11#1)(1991-4#1)(1992-4#1)(1992-7#1)(1993-9#2)(1994-11#1)(1994-4#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-8#3)(2008-1#2)(2008-10#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2012-12#1)(2013-8#3)
was made possible by a##3##5##(2007-8#1)(2008-12#1)(2008-3#1)
was made possible by##8##4##(1994-3#1)(1996-7#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-6#1)
was made since##2##3##(2007-7#1)(2011-2#1)
was made to estimate the##2##5##(2006-8#1)(2007-1#1)
was made to find the##2##5##(2008-5#1)(2010-4#1)
was made to find##3##4##(2008-5#1)(2010-4#1)(2012-2#1)
was made to study##2##4##(2008-11#1)(2013-7#1)
was made to##35##3##(1990-6#1)(1991-11#1)(1992-8#1)(1993-12#1)(1995-4#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-4#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)
was made up of##8##4##(1996-1#1)(2004-2#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-3#1)
was made up##11##3##(1995-11#1)(1996-1#1)(2004-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-2#1)(2009-3#1)
was made using a##4##4##(2008-10#1)(2008-9#1)(2012-12#2)
was made using the##2##4##(2006-8#1)(2008-10#1)
was made using##14##3##(2006-4#1)(2006-8#1)(2008-10#6)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#2)(2013-1#1)
was made with a##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
was made with the##4##4##(1995-2#1)(2005-4#1)(2006-10#1)(2013-1#1)
was made with##21##3##(1990-10#1)(1992-12#1)(1995-2#1)(1995-6#1)(2005-4#1)(2006-10#2)(2006-8#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2009-7#1)(2010-12#1)(2011-1#2)(2011-2#1)(2013-1#1)
was made without##3##3##(2008-3#1)(2012-12#2)
was made##431##2##(1990-10#3)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-6#2)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-3#3)(1991-4#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#4)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-5#3)(1993-9#3)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-4#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#3)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-1#1)(2004-2#1)(2004-9#2)(2005-1#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-4#2)(2005-9#2)(2006-10#7)(2006-12#2)(2006-2#5)(2006-4#4)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#8)(2007-1#1)(2007-10#3)(2007-11#11)(2007-12#3)(2007-2#7)(2007-3#3)(2007-6#2)(2007-7#10)(2007-8#17)(2007-9#3)(2008-1#6)(2008-10#53)(2008-11#9)(2008-12#7)(2008-2#3)(2008-3#10)(2008-4#6)(2008-5#14)(2008-6#3)(2008-7#5)(2008-8#6)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#2)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#2)(2010-6#1)(2011-1#9)(2011-12#1)(2011-2#14)(2012-11#1)(2012-12#13)(2012-2#7)(2012-3#7)(2013-1#18)(2013-7#6)(2013-8#7)
was mailed to a random sample of##3##7##(1991-3#1)(2009-4#1)(2013-8#1)
was mailed to a##4##4##(1991-3#1)(1995-12#1)(2009-4#1)(2013-8#1)
was mailed to##14##3##(1991-3#1)(1993-8#1)(1994-1#1)(1995-12#1)(1996-3#2)(2006-10#2)(2006-7#1)(2007-10#1)(2008-4#2)(2009-4#1)(2013-8#1)
was mainly attributed to the##2##5##(2007-4#1)(2008-10#1)
was mainly composed of##2##4##(2008-10#1)(2008-8#1)
was mainly controlled by##2##4##(2007-6#1)(2013-8#1)
was mainly detected in##2##4##(1997-6#1)(2008-10#1)
was mainly determined by##2##4##(2005-11#1)(2008-10#1)
was mainly due to a decrease##2##6##(1997-2#1)(2009-8#1)
was mainly due to a##3##5##(1997-2#1)(2008-10#1)(2009-8#1)
was mainly due to the##2##5##(2004-11#1)(2008-9#1)
was mainly due to##18##4##(1991-2#1)(1993-5#1)(1994-6#1)(1997-2#1)(2004-1#1)(2004-11#1)(2006-10#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-9#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-12#2)(2012-2#1)
was mainly found in the##3##5##(1991-1#1)(1991-2#1)(1994-11#1)
was mainly found in##4##4##(1991-1#1)(1991-2#1)(1994-11#1)(1995-3#1)
was mainly in the##2##4##(1991-1#1)(1992-11#1)
was mainly localized in the##2##5##(1994-6#1)(2007-6#1)
was mainly localized in##3##4##(1992-2#1)(1994-6#1)(2007-6#1)
was mainly located on##2##4##(1991-12#1)(2008-9#1)
was mainly located##3##3##(1991-12#1)(2007-1#1)(2008-9#1)
was mainly observed##2##3##(2008-10#2)
was mainly on the##2##4##(1991-2#1)(2008-8#1)
was mainly specific for##2##4##(2008-7#2)
was mainly##87##2##(1990-12#1)(1990-4#1)(1991-1#2)(1991-12#1)(1991-2#3)(1991-7#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-5#1)(1994-6#2)(1995-1#1)(1995-3#1)(1995-6#1)(1996-1#2)(1996-5#1)(1997-2#2)(1997-6#2)(1997-8#1)(2004-1#1)(2004-11#1)(2005-11#2)(2005-12#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-3#2)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-2#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#3)
was maintained after the##2##4##(1991-2#1)(2009-6#1)
was maintained after##4##3##(1991-2#1)(2008-3#1)(2009-6#1)(2010-2#1)
was maintained and##2##3##(2005-11#1)(2010-8#1)
was maintained as##2##3##(2008-6#1)(2009-7#1)
was maintained at a##3##4##(1993-12#1)(2006-12#1)(2008-11#1)
was maintained at##21##3##(1993-12#1)(1993-9#1)(1994-11#1)(1995-9#1)(1996-2#1)(1997-6#1)(2006-12#1)(2006-8#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2009-2#1)(2010-12#1)(2012-12#2)(2013-7#1)
was maintained between##4##3##(2008-1#1)(2008-10#2)(2012-2#1)
was maintained by##5##3##(1990-11#1)(1994-3#1)(2007-8#1)(2012-2#1)(2013-7#1)
was maintained during##3##3##(1994-2#1)(1996-7#1)(2008-6#1)
was maintained for at least##2##5##(1993-4#1)(2013-7#1)
was maintained for the##3##4##(1993-11#1)(2007-10#1)(2011-2#1)
was maintained for up to##2##5##(2009-12#1)(2010-9#1)
was maintained for##14##3##(1993-11#1)(1993-4#1)(1995-12#1)(2004-11#1)(2006-7#1)(2007-10#1)(2008-1#1)(2008-5#1)(2009-12#1)(2010-9#1)(2011-2#3)(2013-7#1)
was maintained from##2##3##(1990-2#1)(2006-11#1)
was maintained in a##4##4##(1991-12#1)(2007-12#1)(2011-2#1)(2013-7#1)
was maintained in the##4##4##(2007-12#1)(2009-10#1)(2010-7#1)(2012-12#1)
was maintained in##11##3##(1991-12#1)(1996-8#1)(2004-9#1)(2007-12#2)(2009-10#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
was maintained on##5##3##(1991-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)
was maintained over the##3##4##(1995-6#1)(2008-5#1)(2011-2#1)
was maintained over##5##3##(1993-3#1)(1995-6#1)(2008-5#1)(2011-2#1)(2012-12#1)
was maintained throughout the##2##4##(1994-2#1)(2007-11#1)
was maintained throughout##3##3##(1990-3#1)(1994-2#1)(2007-11#1)
was maintained until the##2##4##(2007-2#1)(2008-3#1)
was maintained until##4##3##(1996-3#1)(2007-2#1)(2008-3#1)(2008-5#1)
was maintained with##6##3##(2007-9#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-7#1)
was maintained within##2##3##(1992-10#1)(2006-7#1)
was maintained##118##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-12#2)(1991-2#1)(1992-10#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-3#1)(1995-12#2)(1995-6#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-6#1)(2004-11#1)(2004-9#1)(2005-11#1)(2006-11#1)(2006-12#1)(2006-7#2)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#7)(2008-11#6)(2008-3#2)(2008-4#1)(2008-5#8)(2008-6#3)(2008-8#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#7)(2012-12#5)(2012-2#3)(2013-1#3)(2013-7#5)
was male##5##2##(1992-11#1)(2007-2#1)(2009-2#1)(2011-2#1)(2012-12#1)
was malignant in##2##3##(2004-2#1)(2013-8#1)
was malignant##5##2##(2004-2#2)(2008-12#1)(2008-6#1)(2013-8#1)
was manageable and##2##3##(2004-1#1)(2008-6#1)
was managed by##8##3##(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-6#1)(2009-7#1)
was managed conservatively with##2##4##(2008-12#1)(2013-8#1)
was managed conservatively##4##3##(2008-12#1)(2013-1#2)(2013-8#1)
was managed successfully by##2##4##(2008-7#1)(2012-2#1)
was managed successfully with##3##4##(2006-4#1)(2007-8#1)(2010-10#1)
was managed successfully##7##3##(2006-4#1)(2007-8#1)(2008-7#1)(2009-10#1)(2010-10#1)(2010-11#1)(2012-2#1)
was managed with a##2##4##(2009-3#1)(2012-12#1)
was managed with##10##3##(2006-10#1)(2006-4#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-3#1)(2009-3#1)(2009-5#1)(2011-2#1)(2012-12#1)
was managed##36##2##(2006-10#1)(2006-4#2)(2007-11#1)(2007-2#1)(2007-3#2)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#2)(2008-7#2)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#2)
was manifest##3##2##(2008-4#1)(2010-8#1)(2012-3#1)
was manifested by a##3##4##(2008-10#1)(2009-8#2)
was manifested by##5##3##(1995-8#1)(2008-10#1)(2009-8#2)(2011-12#1)
was manifested##8##2##(1995-8#1)(1997-3#1)(2007-11#1)(2008-10#2)(2009-8#2)(2011-12#1)
was manipulated by using##2##4##(1995-2#1)(2008-12#1)
was manipulated by##4##3##(1995-2#1)(1995-4#1)(2008-12#1)(2009-12#1)
was manipulated in##3##3##(1995-12#1)(2008-8#1)(2009-11#1)
was manipulated##12##2##(1992-10#1)(1995-12#1)(1995-2#1)(1995-4#1)(1996-9#1)(2008-1#1)(2008-12#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-8#1)(2011-2#1)
was manufactured on##2##3##(2008-1#1)(2008-3#1)
was manufactured##4##2##(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#1)
was mapped and##2##3##(1990-11#1)(2008-11#1)
was mapped at##3##3##(1993-3#1)(1994-8#1)(2008-8#1)
was mapped by##5##3##(1994-2#1)(1995-6#2)(2007-5#1)(2009-7#1)
was mapped in the##2##4##(2008-8#1)(2008-9#1)
was mapped in##3##3##(2008-8#1)(2008-9#1)(2012-3#1)
was mapped on chromosome##2##4##(2008-8#1)(2008-9#1)
was mapped on##6##3##(1995-6#1)(1996-9#1)(1997-4#1)(2008-10#1)(2008-8#1)(2008-9#1)
was mapped onto##3##3##(2008-9#1)(2012-1#2)
was mapped to a##5##4##(1994-11#1)(1994-6#1)(1995-8#1)(2008-10#1)(2012-11#1)
was mapped to chromosome##6##4##(1996-6#1)(1997-5#1)(1997-7#1)(2008-8#2)(2012-11#1)
was mapped to the proximal##2##5##(1993-2#1)(1997-7#1)
was mapped to the short arm of chromosome##2##8##(2008-10#2)
was mapped to the##11##4##(1990-8#1)(1991-10#1)(1993-2#1)(1994-9#1)(1996-5#1)(1997-7#1)(2008-10#5)
was mapped to##31##3##(1990-8#1)(1991-10#1)(1992-8#1)(1993-2#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-5#2)(1997-7#2)(2007-7#1)(2008-10#7)(2008-7#3)(2008-8#2)(2011-2#1)(2012-11#3)
was mapped using##2##3##(1992-9#1)(2008-8#1)
was mapped##59##2##(1990-11#1)(1990-8#1)(1991-10#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-6#3)(1995-8#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-5#2)(1997-7#2)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#10)(2008-11#1)(2008-7#3)(2008-8#6)(2008-9#3)(2009-7#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-11#3)(2012-3#1)
was marginal##2##2##(1993-3#1)(2012-2#1)
was marginally more resistant to##2##5##(2008-10#2)
was marginally##10##2##(1992-2#1)(1996-9#1)(1997-8#1)(2007-10#1)(2008-10#3)(2012-1#2)(2013-1#1)
was marked by the##2##4##(1995-6#1)(2008-12#1)
was marked by##7##3##(1995-6#1)(2007-9#1)(2008-10#1)(2008-12#1)(2009-1#1)(2012-2#1)(2013-1#1)
was marked##17##2##(1993-12#1)(1993-4#1)(1995-6#1)(1996-11#1)(2005-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-1#1)(2010-11#1)(2012-2#1)(2013-1#2)(2013-8#1)
was markedly attenuated in the##2##5##(1996-5#1)(2008-11#1)
was markedly attenuated##3##3##(1996-5#1)(1997-2#1)(2008-11#1)
was markedly augmented by##2##4##(1993-7#1)(1995-2#1)
was markedly better##2##3##(2008-10#1)(2008-9#1)
was markedly decreased in##2##4##(1991-6#1)(1994-9#1)
was markedly decreased##7##3##(1991-6#1)(1992-8#1)(1994-9#1)(1995-2#1)(1995-9#1)(1997-2#1)(2008-4#1)
was markedly delayed##2##3##(1994-8#1)(2012-2#1)
was markedly dependent on the##2##5##(1994-3#1)(2008-4#1)
was markedly depressed##2##3##(1992-3#1)(1997-2#1)
was markedly elevated##2##3##(1992-1#1)(2008-12#1)
was markedly enhanced by##4##4##(1992-4#1)(1992-8#1)(1993-8#1)(1995-2#1)
was markedly enhanced##9##3##(1990-11#1)(1992-4#1)(1992-8#2)(1993-12#1)(1993-8#1)(1994-9#1)(1995-2#1)(1997-4#1)
was markedly higher than##2##4##(1992-12#1)(2008-9#1)
was markedly higher##4##3##(1992-12#1)(1995-6#1)(1997-2#1)(2008-9#1)
was markedly increased by##2##4##(1992-12#1)(1997-2#1)
was markedly increased in the##3##5##(1991-4#2)(1991-6#1)
was markedly increased in##8##4##(1991-4#2)(1991-6#1)(1994-2#1)(1995-2#1)(1995-3#1)(2007-5#1)(2012-2#1)
was markedly increased##14##3##(1991-4#2)(1991-6#1)(1992-12#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-5#1)(2012-2#1)
was markedly induced in##2##4##(1992-12#1)(1996-3#1)
was markedly induced##3##3##(1990-9#1)(1992-12#1)(1996-3#1)
was markedly inhibited by##8##4##(1990-2#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-4#1)(1993-3#1)(1993-8#1)(1994-9#1)
was markedly inhibited##10##3##(1990-2#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-4#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-9#1)
was markedly less##2##3##(1993-3#1)(2008-10#1)
was markedly lower than that##2##5##(1997-1#1)(2008-11#1)
was markedly lower##3##3##(1993-9#1)(1997-1#1)(2008-11#1)
was markedly more##2##3##(2008-10#1)(2008-5#1)
was markedly reduced after##2##4##(1991-2#1)(2013-7#1)
was markedly reduced by##3##4##(1991-10#1)(1993-11#1)(2010-12#1)
was markedly reduced in comparison##2##5##(1994-12#2)
was markedly reduced in the##3##5##(1991-7#1)(2008-4#1)(2013-1#1)
was markedly reduced in##8##4##(1990-7#1)(1991-7#1)(1994-12#2)(2008-10#2)(2008-4#1)(2013-1#1)
was markedly reduced##21##3##(1990-12#1)(1990-3#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-7#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#2)(1997-2#1)(1997-5#2)(2008-10#2)(2008-4#1)(2010-12#1)(2013-1#1)(2013-7#1)
was markedly suppressed by phosphoramidon##2##5##(1991-6#1)(1992-6#1)
was markedly suppressed by##5##4##(1991-11#1)(1991-6#1)(1992-4#1)(1992-6#1)(1994-11#1)
was markedly suppressed##6##3##(1991-11#1)(1991-6#1)(1992-4#1)(1992-6#1)(1993-3#1)(1994-11#1)
was markedly##112##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#2)(1990-9#2)(1991-10#2)(1991-11#2)(1991-2#2)(1991-4#3)(1991-5#2)(1991-6#3)(1991-7#2)(1992-1#1)(1992-12#3)(1992-3#1)(1992-4#2)(1992-6#1)(1992-8#3)(1993-11#1)(1993-12#3)(1993-3#3)(1993-4#1)(1993-7#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-6#1)(1995-9#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#6)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2006-1#1)(2007-5#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
was masked by##3##3##(2007-11#1)(2008-10#2)
was masked##4##2##(1993-12#1)(2007-11#1)(2008-10#2)
was massive##2##2##(1993-10#1)(2008-5#1)
was massively##3##2##(1991-9#1)(2008-5#1)(2011-2#1)
was matched by##2##3##(1992-1#1)(2009-2#1)
was matched##6##2##(1991-3#1)(1992-1#1)(2005-10#3)(2009-2#1)
was maximal at##6##3##(1990-10#1)(1990-3#1)(1991-12#1)(1994-12#1)(2008-10#1)(2011-2#1)
was maximal in the##4##4##(1991-4#1)(1991-5#1)(1993-6#1)(1996-3#1)
was maximal in##5##3##(1991-4#1)(1991-5#1)(1993-6#1)(1996-3#1)(1997-1#1)
was maximal when##3##3##(1993-11#1)(1994-2#1)(1995-1#1)
was maximal##20##2##(1990-10#1)(1990-3#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#2)(1993-11#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-3#1)(1997-1#1)(1997-5#1)(2008-10#1)(2008-5#1)(2011-2#1)
was maximally expressed##2##3##(1990-5#1)(2008-11#1)
was maximally incorporated into##2##4##(1990-7#1)(1994-9#1)
was maximally##14##2##(1990-3#1)(1990-5#1)(1990-7#1)(1994-3#1)(1994-9#1)(1995-6#1)(1995-8#1)(1997-6#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
was maximized at##2##3##(2013-1#2)
was maximized##9##2##(1991-7#1)(1996-12#1)(2008-11#2)(2008-3#1)(2008-6#1)(2010-4#1)(2013-1#2)
was maximum during##2##3##(2008-5#1)(2012-1#1)
was maximum in##3##3##(2007-7#1)(2010-12#1)(2012-1#1)
was maximum when##2##3##(2008-10#2)
was maximum with##2##3##(1992-5#1)(1995-5#1)
was maximum##15##2##(1992-5#1)(1995-5#1)(1997-6#1)(2007-7#4)(2008-10#3)(2008-5#2)(2010-12#1)(2012-1#2)
was mean##4##2##(1992-6#1)(2008-3#1)(2009-6#1)(2013-1#1)
was measurable in##2##3##(2006-6#1)(2008-5#1)
was measured according to##2##4##(2007-9#1)(2011-3#1)
was measured after 24 h##2##5##(1997-4#1)(2013-1#1)
was measured after a propagation distance of##2##7##(2007-11#1)(2007-12#1)
was measured after a##3##4##(1995-7#1)(2007-11#1)(2007-12#1)
was measured after an##2##4##(2004-11#1)(2006-4#1)
was measured after staining##2##4##(2008-10#1)(2008-7#1)
was measured after##21##3##(1992-8#1)(1994-12#1)(1995-7#1)(1997-2#1)(1997-4#1)(2004-11#2)(2004-9#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#2)(2013-1#1)
was measured against##3##3##(2008-10#2)(2012-1#1)
was measured and compared with that of##3##7##(1991-3#1)(1994-12#1)(2009-6#1)
was measured and compared with that##4##6##(1991-3#1)(1994-12#1)(2005-5#1)(2009-6#1)
was measured and compared with##5##5##(1991-3#1)(1994-12#1)(2005-5#1)(2008-3#1)(2009-6#1)
was measured and compared##6##4##(1991-3#1)(1994-12#1)(1994-8#1)(2005-5#1)(2008-3#1)(2009-6#1)
was measured and found to be in##2##7##(2007-11#1)(2007-12#1)
was measured and the##4##4##(2005-11#1)(2005-4#1)(2008-12#1)(2011-1#1)
was measured and##20##3##(1990-11#1)(1991-3#1)(1994-12#1)(1994-8#1)(2005-11#1)(2005-4#1)(2005-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2009-6#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
was measured as a function of pH##2##7##(1993-11#1)(2005-11#1)
was measured as a function of the##10##7##(1990-4#1)(2005-11#1)(2008-2#4)(2008-3#3)(2009-10#1)
was measured as a function of##21##6##(1990-3#1)(1990-4#1)(1993-11#1)(1993-12#1)(1996-1#1)(2005-11#2)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#3)(2008-7#1)(2009-10#1)
was measured as a##22##4##(1990-3#1)(1990-4#1)(1993-11#1)(1993-12#1)(1996-1#1)(2005-11#2)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-2#5)(2008-3#3)(2008-7#1)(2009-10#1)
was measured as an index of##3##6##(1997-1#1)(2005-12#1)(2008-11#1)
was measured as an indicator of##2##6##(1994-11#1)(2008-10#1)
was measured as an##6##4##(1994-11#1)(1997-1#1)(2005-12#1)(2008-10#1)(2008-11#2)
was measured as the##6##4##(1990-10#1)(1990-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2009-9#1)
was measured as##45##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1992-11#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-11#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-1#1)(2005-11#2)(2005-12#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#6)(2008-3#4)(2008-7#2)(2009-10#1)(2009-9#1)
was measured at 1##2##4##(2008-3#2)
was measured at a##2##4##(2007-12#1)(2008-5#1)
was measured at each##3##4##(1997-6#1)(2008-2#1)(2009-2#1)
was measured at the##4##4##(2007-11#1)(2007-8#1)(2008-3#1)(2010-12#1)
was measured at two##2##4##(2007-5#1)(2008-9#1)
was measured at##54##3##(1990-2#1)(1991-12#1)(1992-12#1)(1992-7#1)(1992-8#1)(1995-8#1)(1996-2#1)(1997-6#1)(2007-11#2)(2007-12#6)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#16)(2008-2#2)(2008-3#6)(2008-5#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2010-12#2)(2010-4#1)(2012-2#1)(2013-1#1)
was measured based on##2##4##(2008-2#1)(2013-8#1)
was measured before and after##5##5##(1996-2#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-12#1)
was measured before and##6##4##(1996-2#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-12#1)
was measured before##8##3##(1991-10#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-12#1)
was measured between##2##3##(1994-10#1)(2008-12#1)
was measured by ELISA##3##4##(1990-3#1)(2007-10#1)(2008-10#1)
was measured by MTT assay##3##5##(2008-5#1)(2010-12#1)(2013-7#1)
was measured by Western blot##2##5##(2011-2#1)(2012-2#1)
was measured by a specific##2##5##(1992-2#1)(1992-3#1)
was measured by a##19##4##(1990-4#1)(1990-6#1)(1992-2#1)(1992-3#1)(1994-2#1)(1994-6#1)(1996-4#1)(1996-9#1)(2004-11#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-5#1)(2009-7#1)(2010-3#1)(2011-11#1)(2013-7#1)
was measured by an##3##4##(1991-5#1)(1995-5#1)(2007-8#1)
was measured by continuous##4##4##(1993-11#1)(2008-3#1)(2011-2#1)(2012-12#1)
was measured by flow##2##4##(1993-2#1)(1997-2#1)
was measured by means of##2##5##(2005-11#1)(2007-11#1)
was measured by microdialysis##2##4##(1991-2#1)(1997-2#1)
was measured by quantitative##2##4##(1992-5#1)(2013-1#1)
was measured by radioimmunoassay##3##4##(1990-5#1)(1991-5#1)(2011-1#1)
was measured by the use of##2##6##(1991-12#1)(1993-3#1)
was measured by the##30##4##(1990-2#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-7#1)(1993-12#1)(1993-3#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-1#1)(2004-12#1)(2005-8#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#3)(2012-2#1)(2013-1#2)
was measured by use of##3##5##(2007-11#1)(2008-2#1)(2009-1#1)
was measured by using##6##4##(1992-6#1)(1995-8#1)(2008-10#1)(2008-6#1)(2013-1#1)(2013-8#1)
was measured by##160##3##(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#3)(1991-5#4)(1991-6#1)(1991-9#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#1)(1994-10#1)(1994-11#2)(1994-2#1)(1994-6#1)(1995-1#3)(1995-2#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-2#2)(1996-4#2)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-5#2)(2004-11#1)(2004-12#2)(2005-1#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-4#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#1)(2007-6#1)(2007-8#4)(2008-1#1)(2008-10#14)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-7#1)(2010-9#1)(2011-1#3)(2011-11#1)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#3)
was measured compared##2##3##(2008-3#1)(2008-5#1)
was measured continuously##2##3##(2013-1#2)
was measured directly##5##3##(1993-6#1)(2008-10#2)(2008-3#1)(2008-6#1)
was measured during the##2##4##(2004-4#1)(2008-11#1)
was measured during##10##3##(1991-1#1)(1993-1#1)(1995-11#1)(1997-1#1)(1997-8#1)(2004-4#1)(2008-1#1)(2008-11#1)(2008-3#1)(2013-7#1)
was measured every##2##3##(1995-11#1)(2007-12#1)
was measured following##4##3##(1992-3#1)(2005-8#1)(2008-3#1)(2012-12#1)
was measured for a##3##4##(2007-11#2)(2008-2#1)
was measured for each##2##4##(2008-10#1)(2008-9#1)
was measured for the first time##2##6##(1995-6#1)(2009-4#1)
was measured for the##5##4##(1995-6#1)(2007-12#1)(2007-6#1)(2008-3#1)(2009-4#1)
was measured for##20##3##(1992-11#1)(1992-6#1)(1995-6#1)(1996-8#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-7#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-9#2)(2009-4#1)
was measured from the date of first##2##7##(1990-8#1)(2008-7#1)
was measured from the##7##4##(1990-8#1)(1997-8#1)(2006-12#1)(2007-2#2)(2008-7#1)(2011-2#1)
was measured from##9##3##(1990-8#1)(1991-2#1)(1997-8#1)(2006-12#1)(2007-2#2)(2008-12#1)(2008-7#1)(2011-2#1)
was measured in a##5##4##(1993-11#1)(2006-2#1)(2008-10#1)(2008-2#1)(2012-2#1)
was measured in an##2##4##(1993-2#1)(2008-5#1)
was measured in both##3##4##(1993-3#1)(1995-3#1)(2011-1#1)
was measured in four##2##4##(2008-10#1)(2008-5#1)
was measured in healthy##2##4##(1993-9#1)(2008-4#1)
was measured in liver##2##4##(1991-9#1)(2008-7#1)
was measured in rat##2##4##(1990-6#1)(1991-2#1)
was measured in rats##3##4##(1994-3#1)(2004-11#1)(2008-4#1)
was measured in sera##2##4##(1993-1#1)(1997-2#1)
was measured in seven##2##4##(1996-4#1)(2008-5#1)
was measured in situ##2##4##(2008-10#1)(2010-8#1)
was measured in suspended##2##4##(1991-2#1)(2013-1#1)
was measured in terms of##2##5##(1995-12#1)(2008-10#1)
was measured in the absence##3##5##(1991-10#1)(1995-5#1)(1996-7#1)
was measured in the##25##4##(1991-10#1)(1991-8#1)(1993-2#1)(1993-3#2)(1993-5#1)(1995-5#1)(1996-12#1)(1996-7#2)(1997-5#1)(1997-8#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
was measured in vas deferens DDT1 MF-2##2##7##(1990-7#2)
was measured in vitro by##3##5##(1992-5#1)(2006-3#1)(2008-9#1)
was measured in vitro in##2##5##(1991-2#1)(2008-10#1)
was measured in vitro##5##4##(1991-2#1)(1992-5#1)(2006-3#1)(2008-10#1)(2008-9#1)
was measured in vivo##2##4##(2008-2#1)(2008-3#1)
was measured in##133##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#3)(1990-6#1)(1990-7#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#3)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#5)(1992-1#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-2#2)(1993-3#3)(1993-5#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-3#1)(1995-5#3)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-11#2)(2005-7#1)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#2)(2008-10#12)(2008-2#5)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)
was measured on a##6##4##(1993-5#1)(2006-9#1)(2007-12#1)(2008-2#1)(2008-4#1)(2011-2#1)
was measured on the basis of##2##6##(1994-7#1)(2010-11#1)
was measured on the##6##4##(1994-7#1)(1995-6#1)(1997-7#1)(2007-11#1)(2009-2#1)(2010-11#1)
was measured on##19##3##(1993-5#1)(1993-7#1)(1994-7#1)(1995-6#1)(1996-5#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-9#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-4#1)(2009-2#1)(2010-11#1)(2011-2#1)(2012-2#1)
was measured over a##4##4##(2008-10#1)(2008-2#1)(2008-3#2)
was measured over##7##3##(1997-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-9#1)
was measured simultaneously in the##2##5##(1996-9#1)(2011-1#1)
was measured simultaneously##3##3##(1996-9#1)(2009-5#1)(2011-1#1)
was measured spatially##2##3##(2008-2#2)
was measured spectrophotometrically##2##3##(2008-10#1)(2013-8#1)
was measured through##3##3##(1990-12#1)(2008-10#1)(2008-3#1)
was measured to be 0##2##5##(2007-12#1)(2008-1#1)
was measured to be 5##2##5##(2008-3#1)(2009-11#1)
was measured to be approximately##2##5##(2008-2#1)(2008-3#1)
was measured to be##19##4##(2007-11#1)(2007-12#4)(2008-1#2)(2008-2#6)(2008-3#4)(2008-8#1)(2009-11#1)
was measured to determine the##4##5##(2008-10#2)(2008-7#1)(2010-2#1)
was measured to determine##8##4##(2006-5#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-2#1)
was measured to evaluate##3##4##(1990-11#1)(1996-6#1)(2007-9#1)
was measured to##34##3##(1990-11#1)(1996-6#1)(1996-9#1)(2006-5#1)(2007-11#2)(2007-12#4)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#6)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-2#1)
was measured under the##2##4##(2005-4#1)(2008-10#1)
was measured under##7##3##(1991-2#1)(2005-4#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-2#1)
was measured using a##9##4##(1991-3#1)(1992-4#1)(1994-3#1)(1994-8#1)(2007-6#1)(2008-5#1)(2008-7#1)(2009-7#1)(2012-2#1)
was measured using an##2##4##(1991-6#1)(2013-8#1)
was measured using in##2##4##(1991-3#1)(2008-3#1)
was measured using the##10##4##(1991-2#1)(1992-8#2)(2007-12#1)(2007-7#1)(2008-11#1)(2008-5#1)(2010-8#1)(2011-12#1)(2012-3#1)
was measured using##59##3##(1991-2#1)(1991-3#2)(1991-6#1)(1992-4#1)(1992-7#1)(1992-8#2)(1993-8#1)(1993-9#1)(1994-3#3)(1994-5#1)(1994-8#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-8#1)(2006-7#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
was measured via##2##3##(2008-10#1)(2008-12#1)
was measured when##4##3##(1990-11#1)(1992-2#1)(2007-8#1)(2012-12#1)
was measured with a laser##2##5##(1996-1#1)(2005-11#1)
was measured with a##18##4##(1991-2#1)(1996-1#1)(1996-3#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#1)(2009-11#1)(2010-2#1)(2010-4#1)
was measured with an##7##4##(2007-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)
was measured with both##3##4##(1990-12#1)(2008-3#1)(2008-5#1)
was measured with positron emission tomography##3##6##(1995-11#1)(1996-2#1)(1996-5#1)
was measured with the##10##4##(1991-4#1)(1997-2#1)(1997-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2010-7#1)(2010-8#1)(2013-8#1)
was measured with##59##3##(1990-12#1)(1990-2#1)(1991-2#1)(1991-4#1)(1995-11#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-8#2)(2005-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#2)(2008-8#2)(2009-11#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
was measured##818##2##(1990-10#1)(1990-11#5)(1990-12#4)(1990-2#7)(1990-3#6)(1990-4#3)(1990-5#1)(1990-6#3)(1990-7#4)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#10)(1991-3#3)(1991-4#3)(1991-5#6)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#6)(1992-1#1)(1992-11#5)(1992-12#3)(1992-2#2)(1992-3#3)(1992-4#3)(1992-5#3)(1992-6#4)(1992-7#4)(1992-8#5)(1993-1#3)(1993-10#2)(1993-11#6)(1993-12#3)(1993-2#8)(1993-3#5)(1993-4#3)(1993-5#2)(1993-6#1)(1993-7#3)(1993-8#1)(1993-9#2)(1994-10#2)(1994-11#4)(1994-12#3)(1994-2#2)(1994-3#4)(1994-4#1)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#2)(1995-1#4)(1995-11#5)(1995-12#2)(1995-2#1)(1995-3#4)(1995-5#7)(1995-6#3)(1995-7#1)(1995-8#3)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#5)(1996-3#2)(1996-4#3)(1996-5#4)(1996-6#1)(1996-7#3)(1996-8#2)(1996-9#7)(1997-1#6)(1997-2#7)(1997-3#4)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#7)(2004-11#6)(2004-12#3)(2004-2#1)(2004-4#1)(2004-9#1)(2005-1#1)(2005-10#3)(2005-11#8)(2005-12#2)(2005-4#2)(2005-5#1)(2005-7#1)(2005-8#3)(2006-10#3)(2006-12#2)(2006-2#1)(2006-3#2)(2006-4#4)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#3)(2007-10#8)(2007-11#20)(2007-12#32)(2007-2#5)(2007-3#4)(2007-4#1)(2007-5#2)(2007-6#3)(2007-7#7)(2007-8#11)(2007-9#6)(2008-1#9)(2008-10#92)(2008-11#12)(2008-12#7)(2008-2#37)(2008-3#43)(2008-4#12)(2008-5#25)(2008-6#4)(2008-7#12)(2008-8#6)(2008-9#5)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#3)(2010-1#2)(2010-11#1)(2010-12#4)(2010-2#4)(2010-3#2)(2010-4#6)(2010-5#2)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#7)(2011-11#1)(2011-12#2)(2011-2#14)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#5)(2012-2#7)(2012-3#3)(2012-5#1)(2013-1#19)(2013-7#4)(2013-8#11)
was mechanically##5##2##(1993-7#1)(2008-10#2)(2010-12#1)(2012-1#1)
was mediated by a##6##4##(1994-3#1)(1995-10#1)(1996-8#1)(2007-8#1)(2011-12#1)(2012-1#1)
was mediated by an##2##4##(1991-6#1)(2008-10#1)
was mediated by the##5##4##(1992-5#1)(1993-9#1)(2004-12#1)(2008-5#1)(2010-10#1)
was mediated by##29##3##(1991-2#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-5#1)(1993-9#1)(1994-3#1)(1995-10#1)(1996-12#1)(1996-8#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-12#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-7#1)(2010-10#1)(2010-12#1)(2011-12#1)(2012-1#1)(2013-1#1)
was mediated through the##2##4##(1995-10#1)(1995-12#1)
was mediated through##7##3##(1990-11#1)(1992-6#1)(1994-5#1)(1995-10#1)(1995-12#1)(1996-12#1)(2008-10#1)
was mediated via##3##3##(1992-5#1)(1994-12#1)(2009-9#1)
was mediated##40##2##(1990-11#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-5#2)(1992-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-10#2)(1995-11#1)(1995-12#1)(1996-12#2)(1996-8#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-12#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-12#1)(2012-1#1)(2013-1#1)
was mentioned in##3##3##(1993-8#2)(2009-12#1)
was mentioned##8##2##(1993-8#2)(2005-3#1)(2008-11#2)(2008-9#1)(2009-12#1)(2012-12#1)
was merged with an##2##4##(2007-12#1)(2008-10#1)
was merged with##5##3##(2007-12#1)(2008-10#3)(2011-2#1)
was meshed##2##2##(2006-11#1)(2007-7#1)
was met with##2##3##(1995-12#1)(2007-5#1)
was met##8##2##(1990-4#1)(1995-12#1)(2005-11#1)(2006-8#1)(2007-5#1)(2009-10#2)(2010-8#1)
was metabolically##3##2##(1990-11#1)(1993-4#1)(1994-6#1)
was metabolized by the##2##4##(1990-5#1)(2008-11#1)
was metabolized by##4##3##(1990-5#1)(1993-8#1)(1994-3#1)(2008-11#1)
was metabolized to##4##3##(1990-10#1)(1992-11#1)(1993-9#1)(2008-11#1)
was metabolized##11##2##(1990-10#2)(1990-5#1)(1992-11#1)(1993-8#1)(1993-9#1)(1994-3#1)(1996-8#1)(2008-11#2)(2013-8#1)
was methylated in##2##3##(1990-11#1)(2007-11#1)
was methylated##3##2##(1990-11#1)(1992-3#1)(2007-11#1)
was microinjected into##2##3##(1995-3#1)(1997-2#1)
was microinjected##3##2##(1990-7#1)(1995-3#1)(1997-2#1)
was microscopically##2##2##(1995-11#1)(2007-6#1)
was mild and##3##3##(1992-10#1)(1994-6#1)(1996-5#1)
was mild in##3##3##(1995-1#1)(2008-1#1)(2012-12#1)
was mild##11##2##(1992-10#1)(1994-6#1)(1995-1#1)(1995-9#1)(1996-5#1)(2005-7#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-7#1)(2012-12#1)
was milder##2##2##(1995-8#1)(2013-1#1)
was mimicked by nicotine##2##4##(1991-8#1)(1994-2#1)
was mimicked by##9##3##(1990-2#1)(1991-8#1)(1992-5#1)(1992-9#1)(1994-11#1)(1994-2#2)(1995-12#1)(1997-6#1)
was mineralized##3##2##(2005-12#1)(2008-10#1)(2009-11#1)
was minimal and##6##3##(1990-12#1)(1991-6#1)(1992-4#1)(2006-10#1)(2008-5#1)(2011-2#1)
was minimal in the##2##4##(1991-12#1)(2012-3#1)
was minimal in##4##3##(1991-12#1)(1991-2#1)(2009-2#1)(2012-3#1)
was minimal on##2##3##(2006-10#1)(2008-9#1)
was minimal##28##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-4#1)(1992-6#1)(1993-12#1)(1995-3#1)(1997-6#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-2#1)(2010-6#1)(2011-2#1)(2012-3#1)
was minimally##5##2##(1992-1#1)(1995-6#1)(2008-10#2)(2008-5#1)
was minimized by##4##3##(2007-11#1)(2008-10#2)(2008-5#1)
was minimized##11##2##(1991-8#1)(1995-5#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2009-5#1)
was minimum##3##2##(2008-10#1)(2010-5#1)(2012-1#1)
was mirrored by##2##3##(1997-7#1)(2008-10#1)
was mirrored##3##2##(1997-7#1)(2008-10#1)(2008-8#1)
was misdiagnosed as having##2##4##(2006-4#1)(2010-9#1)
was misdiagnosed as##5##3##(1997-8#1)(2006-4#1)(2007-12#1)(2010-9#1)(2011-2#1)
was misdiagnosed##7##2##(1997-8#1)(2006-4#1)(2007-12#1)(2008-7#1)(2009-4#1)(2010-9#1)(2011-2#1)
was missed##5##2##(1991-11#1)(1992-11#1)(2009-4#1)(2012-12#1)(2012-2#1)
was missing in##2##3##(2008-11#1)(2012-2#1)
was missing##3##2##(2008-11#1)(2012-2#1)(2013-1#1)
was misspelled##2##2##(1995-3#1)(2007-12#1)
was mixed on-line with##2##4##(2008-10#2)
was mixed with a##2##4##(1994-5#1)(2008-10#1)
was mixed with the##9##4##(1995-11#1)(2005-11#1)(2008-10#6)(2011-1#1)
was mixed with##26##3##(1990-12#1)(1991-5#1)(1992-2#1)(1992-6#1)(1994-5#1)(1995-11#1)(1997-6#1)(2004-1#1)(2005-11#1)(2008-10#13)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#1)
was mixed##36##2##(1990-12#1)(1991-5#1)(1992-2#1)(1992-6#1)(1993-12#1)(1994-5#1)(1995-11#1)(1997-6#1)(2004-1#1)(2005-11#1)(2007-12#1)(2008-10#17)(2008-2#1)(2008-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
was mobilized##4##2##(1997-4#1)(2007-11#1)(2007-8#1)(2012-3#1)
was mode locked##2##3##(2007-11#2)
was mode##3##2##(2007-11#2)(2013-8#1)
was modeled after##2##3##(2005-10#1)(2009-7#1)
was modeled as a##5##4##(2007-4#1)(2007-9#1)(2008-10#1)(2010-3#1)(2013-1#1)
was modeled as##6##3##(2007-4#1)(2007-9#1)(2008-10#2)(2010-3#1)(2013-1#1)
was modeled in##4##3##(1995-1#1)(2006-11#1)(2012-1#2)
was modeled using a##2##4##(1992-12#1)(2007-2#1)
was modeled using the##2##4##(2011-1#1)(2011-2#1)
was modeled using##7##3##(1992-12#1)(2007-2#1)(2008-10#2)(2011-1#1)(2011-2#1)(2013-1#1)
was modeled with##3##3##(2008-10#1)(2008-3#2)
was modeled##27##2##(1992-12#1)(1995-1#1)(2005-10#1)(2006-11#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-10#6)(2008-2#2)(2008-3#2)(2009-7#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#2)(2013-1#2)
was modelled by##3##3##(1995-12#1)(1997-3#1)(2008-10#1)
was modelled using##2##3##(1995-12#1)(2007-6#1)
was modelled##7##2##(1995-12#2)(1997-3#1)(2005-10#1)(2007-6#1)(2008-10#1)(2009-4#1)
was moderate evidence##2##3##(2012-12#1)(2013-1#1)
was moderate to high##2##4##(2010-10#1)(2012-2#1)
was moderate##19##2##(1990-10#1)(1990-2#1)(1993-2#1)(1994-3#1)(1995-10#1)(2004-12#1)(2006-12#1)(2006-8#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
was moderated by##2##3##(2013-1#1)(2013-7#1)
was moderately##11##2##(1990-11#1)(1991-6#1)(1992-12#1)(1992-5#1)(2007-8#1)(2008-10#2)(2008-6#1)(2009-10#1)(2010-2#1)(2013-1#1)
was modest##4##2##(2007-2#1)(2008-6#1)(2012-3#2)
was modified and adapted##2##4##(2005-11#1)(2008-10#1)
was modified and##5##3##(1997-8#1)(2005-11#1)(2008-10#2)(2008-5#1)
was modified by adding##2##4##(2008-5#1)(2010-3#1)
was modified by using##2##4##(1991-12#1)(1992-2#1)
was modified by##13##3##(1991-1#1)(1991-12#1)(1992-2#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-5#2)(2010-3#1)(2010-9#1)(2012-12#1)(2013-1#1)
was modified during the##2##4##(1992-1#1)(2006-12#1)
was modified from##2##3##(2007-12#1)(2011-12#1)
was modified in##6##3##(1991-3#2)(1992-2#1)(1995-5#1)(1996-8#1)(2007-4#1)
was modified so##3##3##(1990-10#1)(1993-3#1)(2008-10#1)
was modified to allow##3##4##(2006-5#1)(2008-2#2)
was modified to include##4##4##(2007-5#2)(2007-7#1)(2008-6#1)
was modified to represent the##2##5##(2007-4#1)(2008-10#1)
was modified to##24##3##(1990-12#1)(1991-4#1)(1992-8#1)(1993-11#1)(1995-1#1)(1995-10#1)(1996-2#1)(1997-6#1)(2006-11#1)(2006-5#1)(2007-11#1)(2007-4#1)(2007-5#2)(2007-7#1)(2008-10#3)(2008-2#2)(2008-6#1)(2008-7#2)(2008-8#1)
was modified using##3##3##(1990-3#1)(1993-11#1)(1993-6#1)
was modified with##9##3##(1990-12#1)(1994-2#1)(2005-11#1)(2007-8#1)(2008-10#3)(2008-3#1)(2010-4#1)
was modified##83##2##(1990-10#1)(1990-12#2)(1990-3#1)(1990-4#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1992-1#1)(1992-2#3)(1992-8#1)(1993-11#2)(1993-3#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-5#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(2005-11#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#14)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-7#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-12#1)(2012-12#1)(2013-1#2)
was modulated by the##3##4##(1991-2#1)(2008-11#1)(2010-12#1)
was modulated by##11##3##(1991-2#1)(1991-3#1)(1995-8#1)(1996-4#1)(2008-11#1)(2008-9#1)(2010-12#1)(2012-2#2)(2013-8#2)
was modulated##15##2##(1991-2#1)(1991-3#1)(1991-4#1)(1995-8#1)(1996-4#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-9#1)(2010-12#1)(2012-2#2)(2013-8#2)
was molecularly##2##2##(2007-6#1)(2012-12#1)
was monitored and##2##3##(2008-10#1)(2011-12#1)
was monitored as##2##3##(2005-11#1)(2008-10#1)
was monitored at 254 nm##2##5##(1996-6#1)(2008-6#1)
was monitored at the##2##4##(2008-10#2)
was monitored at##19##3##(1990-12#1)(1990-6#1)(1993-12#1)(1993-3#1)(1996-6#1)(1997-2#1)(2008-10#9)(2008-2#1)(2008-6#2)(2010-2#1)
was monitored both##2##3##(1992-2#1)(1997-1#1)
was monitored by a##5##4##(1993-2#1)(2007-10#1)(2008-10#1)(2008-2#2)
was monitored by collection##2##4##(2007-5#2)
was monitored by fluorescence##5##4##(1990-8#1)(1991-5#1)(1994-8#1)(2008-10#1)(2008-11#1)
was monitored by measuring the formation of the##2##8##(1991-1#1)(1996-8#1)
was monitored by measuring the##5##5##(1991-1#1)(1992-8#1)(1996-8#1)(2008-1#1)(2008-10#1)
was monitored by measuring##6##4##(1991-1#1)(1992-8#1)(1996-8#1)(2008-1#1)(2008-10#2)
was monitored by the##4##4##(1990-2#1)(1990-8#1)(1992-7#1)(2008-10#1)
was monitored by##55##3##(1990-2#2)(1990-8#4)(1991-1#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-8#1)(1995-2#1)(1996-4#1)(1996-8#2)(1996-9#1)(1997-6#1)(2004-12#1)(2007-10#1)(2007-5#2)(2007-6#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-6#1)(2010-5#1)(2010-8#1)
was monitored continuously##2##3##(1993-9#1)(2008-6#1)
was monitored directly##2##3##(1990-12#1)(1992-3#1)
was monitored during the##2##4##(1992-9#1)(2008-10#1)
was monitored during##4##3##(1992-9#1)(2008-10#2)(2008-7#1)
was monitored fluorometrically at 455nm (excitation at 340nm)##2##8##(2008-10#2)
was monitored fluorometrically##3##3##(2008-10#3)
was monitored for quantifying the##2##5##(2007-8#2)
was monitored for##6##3##(2007-8#3)(2008-10#3)
was monitored in real time##2##5##(2008-10#2)
was monitored in real-time##2##4##(2008-10#2)
was monitored in situ by##2##5##(2007-8#1)(2013-8#1)
was monitored in situ##4##4##(2007-8#1)(2008-10#1)(2009-7#1)(2013-8#1)
was monitored in the##4##4##(2007-8#1)(2007-9#1)(2008-10#2)
was monitored in##32##3##(1990-8#1)(1992-9#1)(1993-3#1)(1994-3#1)(1997-2#1)(2006-8#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-7#1)(2012-2#1)(2013-1#2)(2013-8#1)
was monitored over a##2##4##(2005-11#1)(2007-11#1)
was monitored simultaneously##2##3##(2008-3#1)(2009-12#1)
was monitored spectrophotometrically at##3##4##(2008-10#3)
was monitored spectrophotometrically by measuring the##5##6##(2008-10#5)
was monitored spectrophotometrically by##6##4##(2008-10#5)(2008-3#1)
was monitored spectrophotometrically##10##3##(2008-10#9)(2008-3#1)
was monitored through##5##3##(1997-2#1)(2008-10#1)(2008-4#1)(2008-6#1)(2012-7#1)
was monitored throughout the##5##4##(2007-3#1)(2007-9#1)(2008-10#2)(2008-3#1)
was monitored to determine the##2##5##(1995-11#1)(2008-10#1)
was monitored using a##2##4##(1993-2#1)(2011-1#1)
was monitored using the##4##4##(1996-2#1)(2008-10#1)(2008-5#1)(2010-4#1)
was monitored using##13##3##(1990-8#1)(1993-2#1)(1995-5#1)(1996-2#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-4#1)(2011-1#1)(2011-2#1)
was monitored via##2##3##(1992-11#1)(2010-2#1)
was monitored with a##2##4##(1993-7#1)(2008-2#1)
was monitored with the##4##4##(1994-2#2)(2006-8#1)(2008-2#1)
was monitored with##16##3##(1990-3#1)(1990-8#2)(1993-2#1)(1993-7#1)(1994-2#2)(2006-8#1)(2008-10#4)(2008-2#3)(2008-3#1)
was monitored##216##2##(1990-12#2)(1990-2#2)(1990-3#1)(1990-6#2)(1990-8#8)(1991-1#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#3)(1993-1#1)(1993-12#2)(1993-2#4)(1993-3#2)(1993-7#1)(1993-9#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#4)(1997-6#1)(1997-8#1)(2004-12#1)(2005-11#3)(2005-4#1)(2006-5#1)(2006-8#4)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#2)(2007-6#1)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#74)(2008-11#3)(2008-2#8)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#4)(2008-9#3)(2009-12#2)(2009-3#1)(2009-6#1)(2009-7#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#1)(2012-7#1)(2013-1#2)(2013-8#1)
was monomeric and##2##3##(1992-6#1)(1995-6#1)
was monophasic in##2##3##(1995-8#1)(1996-12#1)
was monophasic##4##2##(1990-10#1)(1995-8#1)(1996-12#1)(1996-8#1)
was monotonically##2##2##(2008-10#1)(2011-2#1)
was more abundant in the##2##5##(1994-3#1)(1995-5#1)
was more abundant##3##3##(1994-3#1)(1995-5#1)(2008-5#1)
was more accurate than##2##4##(2008-10#1)(2013-1#1)
was more accurate##4##3##(2004-2#1)(2006-5#1)(2008-10#1)(2013-1#1)
was more acidic than##2##4##(1990-5#1)(1991-8#1)
was more active in##4##4##(1994-12#1)(1996-7#1)(2008-11#1)(2010-8#1)
was more active than##3##4##(1992-10#1)(1995-1#1)(2007-6#1)
was more active##11##3##(1992-10#1)(1994-12#1)(1995-1#1)(1995-10#1)(1996-7#1)(1997-6#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-8#1)
was more affected by##2##4##(2011-2#2)
was more affected##3##3##(2010-11#1)(2011-2#2)
was more attractive than##3##4##(2011-12#3)
was more closely related to##2##5##(1992-2#1)(2011-2#1)
was more closely##3##3##(1992-2#1)(1993-7#1)(2011-2#1)
was more common among##3##4##(2008-1#1)(2008-3#1)(2012-1#1)
was more common in patients with##2##6##(1992-1#1)(2010-12#1)
was more common in patients##5##5##(1992-1#1)(2007-11#1)(2007-7#1)(2010-12#1)(2011-2#1)
was more common in women##2##5##(2006-8#1)(2009-11#1)
was more common in##13##4##(1990-2#1)(1992-1#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2009-11#1)(2010-12#1)(2011-2#2)(2013-8#1)
was more common than##2##4##(2008-4#1)(2011-2#1)
was more common##21##3##(1990-2#1)(1990-9#1)(1992-1#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-3#2)(2008-4#1)(2009-11#1)(2010-12#1)(2011-2#3)(2012-1#1)(2013-8#1)
was more commonly##2##3##(2007-7#1)(2007-8#1)
was more complex##3##3##(2005-11#1)(2005-12#1)(2007-3#1)
was more complicated##2##3##(1994-9#1)(2007-11#1)
was more dependent on##3##4##(2008-10#1)(2012-9#1)(2013-1#1)
was more difficult to##3##4##(1990-5#1)(2007-4#1)(2008-6#1)
was more difficult##4##3##(1990-5#1)(2007-3#1)(2007-4#1)(2008-6#1)
was more dominant##3##3##(1996-6#1)(2013-1#2)
was more dramatic##2##3##(2008-12#1)(2008-3#1)
was more effective at##7##4##(1991-5#1)(2005-11#1)(2008-10#2)(2008-4#1)(2010-4#1)(2012-3#1)
was more effective for##2##4##(2012-2#1)(2013-1#1)
was more effective in controlling##2##5##(2007-7#1)(2008-10#1)
was more effective in the##4##5##(1992-3#1)(1997-6#1)(2005-10#1)(2005-11#1)
was more effective in##14##4##(1992-3#1)(1992-5#1)(1996-10#1)(1996-12#1)(1996-9#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#1)(2007-7#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-2#1)
was more effective than placebo in relieving##2##7##(2007-11#1)(2012-1#1)
was more effective than placebo in##3##6##(2007-11#1)(2012-1#1)(2013-1#1)
was more effective than placebo##4##5##(1993-9#1)(2007-11#1)(2012-1#1)(2013-1#1)
was more effective than##24##4##(1992-9#1)(1993-9#1)(1995-1#2)(1995-11#1)(2005-7#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-8#1)(2012-1#1)(2012-12#2)(2013-1#1)
was more effective with##2##4##(2007-11#1)(2008-10#1)
was more effective##56##3##(1991-5#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-9#1)(1994-8#1)(1995-1#2)(1995-11#1)(1996-10#2)(1996-12#1)(1996-9#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#2)(2005-7#1)(2007-11#4)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-4#1)(2008-5#3)(2008-9#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)
was more efficacious##2##3##(2008-10#1)(2011-2#1)
was more efficient for##2##4##(2008-5#1)(2011-2#1)
was more efficient in##6##4##(1990-3#1)(2005-11#1)(2008-10#2)(2009-3#1)(2012-3#1)
was more efficient than the##2##5##(2007-10#1)(2008-10#1)
was more efficient than##6##4##(1994-12#1)(1994-5#1)(2007-10#1)(2008-10#2)(2012-3#1)
was more efficient##19##3##(1990-3#1)(1992-11#1)(1994-12#1)(1994-5#1)(1997-1#1)(2005-11#1)(2007-10#1)(2008-10#5)(2008-3#1)(2008-5#1)(2009-3#1)(2010-8#1)(2011-2#1)(2012-3#2)
was more efficiently##2##3##(1994-6#1)(1995-3#1)
was more evenly distributed##2##4##(1994-12#1)(2008-2#1)
was more evident in##4##4##(1992-12#1)(2007-7#1)(2008-10#1)(2012-1#1)
was more evident##6##3##(1992-12#1)(2007-7#1)(2008-10#1)(2009-7#1)(2011-1#1)(2012-1#1)
was more extensive##2##3##(2008-10#1)(2008-11#1)
was more favorable##2##3##(2006-8#1)(2010-12#1)
was more favourable##2##3##(2004-2#1)(2012-2#1)
was more frequent among##4##4##(1997-3#1)(2008-9#1)(2013-7#1)(2013-8#1)
was more frequent in patients##2##5##(2006-6#1)(2011-2#1)
was more frequent in the##3##5##(1995-11#1)(2007-10#1)(2007-3#1)
was more frequent in##16##4##(1991-12#1)(1994-7#1)(1995-11#1)(1997-7#1)(2006-6#1)(2007-10#1)(2007-3#1)(2007-7#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
was more frequent than##2##4##(2007-10#1)(2011-1#1)
was more frequent##25##3##(1991-12#1)(1994-7#1)(1995-11#1)(1997-3#1)(1997-7#1)(2006-6#1)(2007-10#2)(2007-3#1)(2007-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
was more frequently found##2##4##(2006-8#1)(2013-7#1)
was more frequently observed in##2##5##(2008-10#1)(2011-1#1)
was more frequently##10##3##(1990-6#1)(2005-10#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-10#1)(2011-1#1)(2013-7#1)(2013-8#1)
was more gradual##2##3##(1997-4#1)(1997-7#1)
was more highly##2##3##(1997-2#1)(2008-10#1)
was more homogeneous##2##3##(1997-1#1)(2008-10#1)
was more important in##4##4##(2007-7#1)(2008-4#1)(2009-9#1)(2011-2#1)
was more important than##2##4##(2008-10#1)(2008-8#1)
was more important##7##3##(2007-7#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-9#1)(2011-2#1)(2012-12#1)
was more in ETD##2##4##(2013-8#2)
was more in##7##3##(1994-7#1)(2007-7#1)(2008-1#1)(2010-7#1)(2013-1#1)(2013-8#2)
was more informative than##2##4##(2008-10#2)
was more intense##5##3##(1993-11#1)(1993-4#1)(1994-5#1)(2008-10#1)(2010-12#1)
was more likely to be##7##5##(1990-6#1)(2008-2#1)(2008-8#1)(2012-2#2)(2012-3#2)
was more likely to##9##4##(1990-6#1)(2008-11#1)(2008-2#1)(2008-8#1)(2012-12#1)(2012-2#2)(2012-3#2)
was more likely##13##3##(1990-6#1)(1996-12#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
was more marked in##3##4##(1990-11#1)(1991-12#1)(1995-3#1)
was more marked##7##3##(1990-11#1)(1990-2#1)(1991-12#1)(1995-3#1)(1996-11#1)(1997-8#1)(2008-11#1)
was more obvious##2##3##(2008-4#1)(2013-8#1)
was more often##3##3##(1993-8#1)(2008-10#1)(2008-4#1)
was more on##2##3##(2008-5#1)(2012-2#1)
was more or less##4##4##(1992-9#1)(2008-10#1)(2008-11#1)(2008-5#1)
was more potent in inhibiting the##2##6##(1992-3#1)(1996-12#1)
was more potent in##4##4##(1990-12#1)(1992-3#1)(1994-10#1)(1996-12#1)
was more potent than##9##4##(1992-8#1)(1994-6#1)(1995-12#2)(1995-6#1)(1996-2#1)(2005-7#1)(2006-12#1)(2006-8#1)
was more potent##14##3##(1990-12#1)(1992-3#1)(1992-8#1)(1994-10#1)(1994-6#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-2#1)(2005-7#1)(2006-12#2)(2006-8#1)
was more prevalent in##5##4##(2007-2#1)(2008-10#2)(2010-1#1)(2011-2#1)
was more prevalent##10##3##(2007-2#2)(2008-10#4)(2008-2#1)(2010-1#1)(2011-2#1)(2012-3#1)
was more prominent in##2##4##(1991-10#1)(1992-8#1)
was more prominent##5##3##(1991-10#1)(1992-8#1)(1994-8#1)(1996-6#1)(2012-3#1)
was more pronounced at##5##4##(1990-3#1)(1991-2#1)(2008-10#3)
was more pronounced in male##2##5##(1994-11#1)(2010-6#1)
was more pronounced in the##8##5##(1996-3#1)(1996-9#1)(1997-1#1)(2008-5#2)(2008-7#1)(2009-5#1)(2010-3#1)
was more pronounced in##16##4##(1993-2#2)(1993-5#1)(1994-11#1)(1995-5#1)(1996-3#1)(1996-9#1)(1997-1#1)(2008-10#1)(2008-5#3)(2008-7#1)(2009-5#1)(2010-3#1)(2010-6#1)
was more pronounced than##2##4##(2008-4#1)(2010-12#1)
was more pronounced with##2##4##(1991-2#1)(2006-5#1)
was more pronounced##35##3##(1990-11#1)(1990-3#1)(1991-2#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1994-11#1)(1994-12#1)(1995-5#1)(1995-7#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-1#2)(2006-5#1)(2006-8#1)(2008-10#4)(2008-4#1)(2008-5#4)(2008-7#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#1)
was more rapid##5##3##(1993-6#1)(1995-2#1)(1996-6#1)(1997-4#1)(2007-8#1)
was more rapidly##2##3##(1990-11#1)(1994-8#1)
was more readily##2##3##(1995-6#1)(1996-5#1)
was more reliable##2##3##(2005-7#1)(2007-8#1)
was more remarkable in the##3##5##(2007-6#1)(2008-11#1)(2010-10#1)
was more resistant to##4##4##(1990-11#1)(2008-10#1)(2008-3#1)(2008-5#1)
was more robust and##2##4##(2008-11#1)(2008-3#1)
was more robust than##3##4##(1990-4#1)(2008-11#1)(2008-3#1)
was more robust##5##3##(1990-4#1)(2008-11#2)(2008-3#2)
was more sensitive than the##4##5##(1991-9#1)(1994-12#1)(2008-10#1)(2013-8#1)
was more sensitive than##10##4##(1990-3#1)(1991-9#1)(1994-12#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-3#2)(2009-6#1)(2013-8#1)
was more sensitive to##12##4##(1992-7#1)(1993-12#1)(1995-2#1)(2007-10#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2012-2#1)
was more sensitive##28##3##(1990-3#1)(1991-9#1)(1992-7#1)(1993-12#1)(1993-9#1)(1994-1#1)(1994-12#1)(1995-2#1)(1996-6#1)(1996-9#1)(2006-2#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-3#3)(2008-5#1)(2008-6#1)(2009-6#1)(2012-2#1)(2013-8#1)
was more serious in##2##4##(1993-12#1)(2008-2#1)
was more severe in the##2##5##(1994-6#1)(2008-5#1)
was more severe in##3##4##(1994-6#1)(2008-5#1)(2011-2#1)
was more severe##6##3##(1994-6#1)(1996-10#1)(2008-10#2)(2008-5#1)(2011-2#1)
was more significant##4##3##(1996-3#1)(1997-5#1)(2008-10#1)(2011-2#1)
was more similar to##2##4##(1990-12#1)(2008-12#1)
was more specific than##2##4##(1997-1#1)(2008-3#1)
was more specific##4##3##(1997-1#1)(2008-3#1)(2008-5#1)(2011-2#1)
was more stable and##2##4##(1993-11#1)(2008-12#1)
was more stable than##3##4##(1994-11#1)(2008-5#2)
was more stable##10##3##(1990-12#1)(1990-4#1)(1993-11#1)(1994-11#1)(1995-5#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-5#2)
was more strongly correlated with##2##5##(2008-9#1)(2012-3#1)
was more strongly##4##3##(2008-9#1)(2009-7#1)(2010-2#1)(2012-3#1)
was more suitable##2##3##(2008-10#1)(2013-8#1)
was more susceptible to##4##4##(1991-12#1)(1994-8#1)(1996-6#1)(2004-11#1)
was more susceptible##5##3##(1991-12#1)(1994-12#1)(1994-8#1)(1996-6#1)(2004-11#1)
was more than 3##3##4##(1991-8#1)(2008-3#1)(2010-7#1)
was more than 50%##2##4##(2007-9#1)(2011-2#1)
was more than 98%##3##4##(1990-12#1)(2008-10#1)(2012-12#1)
was more than five times##2##5##(1994-5#1)(2008-10#1)
was more than in##3##4##(1994-7#1)(2008-6#1)(2012-3#1)
was more than one##2##4##(1997-7#1)(2008-6#1)
was more than that of alpha-pinene##2##6##(2010-5#2)
was more than that of##4##5##(1991-9#1)(2008-7#1)(2010-5#2)
was more than the##2##4##(2007-7#1)(2013-1#1)
was more than twice as##2##5##(1991-8#1)(2005-12#1)
was more than twice##4##4##(1990-11#1)(1991-8#1)(2005-12#1)(2008-5#1)
was more than##59##3##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1991-7#1)(1991-8#2)(1991-9#1)(1993-2#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-1#1)(1996-3#1)(1996-5#1)(1997-2#2)(1997-7#1)(2005-12#1)(2007-1#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-5#3)(2010-7#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
was more thermostable##2##3##(1993-3#1)(1995-12#1)
was more toxic##2##3##(1990-5#1)(1996-6#1)
was more with Group I##2##5##(2010-7#2)
was more with Group##3##4##(2010-7#3)
was more with##4##3##(2010-7#3)(2011-1#1)
was more##567##2##(1990-11#5)(1990-12#5)(1990-2#2)(1990-3#4)(1990-4#3)(1990-5#7)(1990-6#2)(1990-7#1)(1990-9#1)(1991-10#1)(1991-12#4)(1991-2#2)(1991-5#1)(1991-7#1)(1991-8#3)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#3)(1993-3#2)(1993-4#2)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#7)(1994-3#1)(1994-5#3)(1994-6#4)(1994-7#3)(1994-8#4)(1994-9#2)(1995-1#4)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#1)(1996-1#2)(1996-10#3)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#3)(1996-5#2)(1996-6#6)(1996-7#1)(1996-8#1)(1996-9#4)(1997-1#5)(1997-2#3)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#2)(2004-11#1)(2004-2#2)(2005-10#2)(2005-11#7)(2005-12#2)(2005-6#1)(2005-7#3)(2006-10#1)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#6)(2007-1#1)(2007-10#7)(2007-11#9)(2007-2#6)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#9)(2007-8#6)(2007-9#1)(2008-1#6)(2008-10#65)(2008-11#15)(2008-12#7)(2008-2#6)(2008-3#13)(2008-4#7)(2008-5#21)(2008-6#7)(2008-7#2)(2008-8#6)(2008-9#5)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#7)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#5)(2010-8#3)(2010-9#1)(2011-1#6)(2011-12#3)(2011-2#29)(2012-1#3)(2012-12#9)(2012-2#11)(2012-3#11)(2012-9#1)(2013-1#15)(2013-7#4)(2013-8#10)
was morphologically and##2##3##(2008-12#1)(2008-4#1)
was morphologically##5##2##(1997-2#1)(2007-9#1)(2008-12#1)(2008-4#1)(2008-5#1)
was most closely related to##8##5##(1997-8#1)(2008-10#5)(2008-5#1)(2008-9#1)
was most common followed by A##2##6##(2008-4#2)
was most common in male patients with##2##7##(2006-10#2)
was most common in##6##4##(2006-10#2)(2006-8#1)(2007-10#1)(2011-2#2)
was most common##14##3##(2006-10#2)(2006-4#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-4#2)(2008-6#2)(2011-2#2)(2012-12#1)
was most commonly isolated##2##4##(2006-5#1)(2008-10#1)
was most commonly##8##3##(2006-2#1)(2006-5#1)(2008-10#2)(2008-9#2)(2011-1#1)(2012-2#1)
was most consistent##3##3##(2007-12#1)(2007-3#1)(2009-4#1)
was most dramatic##2##3##(1995-8#1)(2008-10#1)
was most effective at##3##4##(1997-8#1)(2008-10#1)(2009-10#1)
was most effective in##6##4##(1992-6#1)(1997-1#1)(1997-8#1)(2008-4#2)(2011-2#1)
was most effective when##2##4##(2008-10#1)(2013-1#1)
was most effective##16##3##(1992-6#1)(1993-6#1)(1997-1#2)(1997-8#2)(2008-10#4)(2008-4#2)(2008-5#1)(2009-10#1)(2011-2#1)(2013-1#1)
was most efficient in##2##4##(2009-11#1)(2012-1#1)
was most frequent##3##3##(2008-3#1)(2008-5#1)(2008-6#1)
was most frequently##6##3##(1990-4#1)(1991-9#1)(2008-10#2)(2008-5#1)(2013-8#1)
was most highly expressed in##2##5##(2013-8#2)
was most important##2##3##(2007-11#1)(2008-10#1)
was most intensely##2##3##(1995-6#1)(1996-12#1)
was most likely caused by##2##5##(2008-10#1)(2008-5#1)
was most likely due to##2##5##(2007-10#1)(2008-10#1)
was most likely to##2##4##(2006-10#1)(2006-2#1)
was most likely##15##3##(1991-5#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#5)(2008-5#1)(2010-10#1)(2010-8#1)
was most often##5##3##(1993-3#1)(2006-10#1)(2006-8#1)(2008-5#1)(2010-12#1)
was most potent##2##3##(2010-12#1)(2013-1#1)
was most prevalent in##2##4##(2008-10#2)
was most prevalent##5##3##(1990-5#1)(2008-10#3)(2011-1#1)
was most probably##4##3##(1997-5#1)(2008-10#1)(2010-10#1)(2011-2#1)
was most prominent in##3##4##(1997-3#1)(2006-8#1)(2008-6#1)
was most prominent##5##3##(1991-3#1)(1997-3#1)(2006-8#1)(2008-2#1)(2008-6#1)
was most pronounced at##4##4##(1994-11#1)(1994-8#1)(1995-1#1)(2010-2#1)
was most pronounced in the##3##5##(1990-7#2)(2011-2#1)
was most pronounced in##9##4##(1990-7#2)(1993-8#1)(1995-2#1)(1995-7#1)(1996-5#1)(1997-7#1)(2008-8#1)(2011-2#1)
was most pronounced##19##3##(1990-7#2)(1993-8#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-7#1)(1996-5#1)(1997-7#2)(2006-5#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-12#1)(2010-2#1)(2011-2#1)(2013-8#1)
was most rapid during the first##2##6##(2004-4#1)(2008-12#1)
was most rapid##3##3##(2004-4#1)(2008-10#1)(2008-12#1)
was most severe in the##3##5##(1993-4#1)(1996-5#2)
was most significant##2##3##(2009-2#1)(2013-8#1)
was most similar to##2##4##(1992-9#1)(2008-10#1)
was most##167##2##(1990-4#3)(1990-5#2)(1990-7#2)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-1#2)(1995-2#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-5#3)(1996-7#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#2)(1997-8#3)(2004-11#1)(2004-4#2)(2005-11#1)(2006-10#4)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#2)(2006-8#3)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#30)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#9)(2008-6#5)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#2)(2009-7#1)(2010-10#2)(2010-12#3)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#5)
was mostly attributed to##2##4##(1997-3#1)(2008-12#1)
was mostly confined to the##2##5##(1993-12#2)
was mostly confined to##3##4##(1993-12#2)(1996-12#1)
was mostly due to a##2##5##(1990-11#1)(2010-5#1)
was mostly due to##3##4##(1990-11#1)(2010-5#1)(2011-3#1)
was mostly in the##2##4##(2008-10#2)
was mostly##30##2##(1990-10#1)(1990-11#1)(1991-1#1)(1991-2#1)(1991-4#1)(1992-1#1)(1993-12#2)(1996-12#1)(1996-2#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-12#2)(2008-10#6)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-5#1)(2011-3#1)(2012-2#2)(2013-8#1)
was motivated by the need for a##2##7##(2007-10#1)(2008-2#1)
was motivated by##5##3##(1991-12#1)(1995-6#1)(2005-11#1)(2007-10#1)(2008-2#1)
was mounted in##2##3##(2008-10#1)(2008-3#1)
was mounted on a##2##4##(2008-10#1)(2008-5#1)
was mounted onto a##2##4##(2007-3#1)(2012-1#1)
was mounted##8##2##(2006-6#1)(2007-3#1)(2007-4#1)(2008-10#2)(2008-3#1)(2008-5#1)(2012-1#1)
was moved##3##2##(2006-11#1)(2008-10#1)(2009-4#1)
was much better than##2##4##(1990-4#1)(2008-3#1)
was much better##4##3##(1990-4#1)(2007-11#1)(2008-3#1)(2012-12#1)
was much faster than that of##2##6##(1994-12#1)(2008-2#1)
was much faster than that##3##5##(1990-12#1)(1994-12#1)(2008-2#1)
was much faster than##5##4##(1990-12#1)(1994-12#1)(2007-8#1)(2008-2#1)(2009-10#1)
was much faster##8##3##(1990-12#1)(1992-6#1)(1994-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2009-10#2)
was much fewer##2##3##(2008-5#1)(2008-9#1)
was much greater for##2##4##(1995-5#1)(2004-9#1)
was much greater in the##2##5##(1996-2#1)(2008-5#1)
was much greater in##4##4##(1991-5#1)(1995-12#1)(1996-2#1)(2008-5#1)
was much greater than that##3##5##(1990-7#1)(2008-2#1)(2008-7#1)
was much greater than##6##4##(1990-7#1)(1991-1#1)(1994-11#1)(2008-10#1)(2008-2#1)(2008-7#1)
was much greater##14##3##(1990-7#1)(1991-1#1)(1991-5#1)(1994-11#1)(1995-12#1)(1995-5#1)(1996-2#1)(1997-7#1)(2004-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)
was much higher in##5##4##(1997-2#1)(1997-6#1)(2007-2#1)(2008-10#2)
was much higher than that in##2##6##(2008-10#1)(2011-1#1)
was much higher than that of##3##6##(2006-12#1)(2010-3#1)(2012-2#1)
was much higher than that##7##5##(2006-12#1)(2007-8#1)(2008-10#1)(2010-3#1)(2011-1#1)(2012-2#2)
was much higher than##12##4##(2006-12#1)(2007-8#1)(2008-10#3)(2008-8#1)(2009-2#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-2#2)
was much higher##21##3##(1997-2#1)(1997-6#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-10#6)(2008-8#1)(2009-2#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#2)
was much improved##2##3##(1996-12#1)(2008-10#1)
was much larger##4##3##(1995-6#1)(1997-2#1)(2008-10#1)(2012-1#1)
was much less pronounced##2##4##(1992-11#1)(1996-5#1)
was much less than that##3##5##(1990-12#1)(1992-2#1)(2010-2#1)
was much less than##5##4##(1990-12#1)(1990-4#1)(1992-1#1)(1992-2#1)(2010-2#1)
was much less##18##3##(1990-12#2)(1990-2#1)(1990-4#1)(1992-1#1)(1992-11#1)(1992-2#1)(1994-10#1)(1994-12#1)(1994-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(2006-2#1)(2006-4#1)(2008-10#1)(2010-2#1)
was much longer##2##3##(2008-3#1)(2011-1#1)
was much lower for##2##4##(1992-10#1)(2008-10#1)
was much lower in##3##4##(1990-4#1)(2008-10#1)(2012-12#1)
was much lower than that in##3##6##(1993-11#1)(1997-2#1)(2008-7#1)
was much lower than that of##7##6##(1990-7#1)(1994-2#1)(1995-2#1)(1996-9#1)(2008-8#2)(2012-2#1)
was much lower than that##11##5##(1990-7#1)(1993-11#1)(1994-2#1)(1995-2#1)(1996-9#1)(1997-2#1)(2008-10#1)(2008-7#1)(2008-8#2)(2012-2#1)
was much lower than##16##4##(1990-7#1)(1993-11#1)(1994-2#1)(1995-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#3)(2012-2#1)(2013-8#1)
was much lower##27##3##(1990-4#1)(1990-7#1)(1991-4#1)(1992-10#1)(1992-8#1)(1993-11#1)(1994-2#1)(1994-9#1)(1995-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(2008-10#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2011-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
was much more rapid##2##4##(2008-10#1)(2008-11#1)
was much more sensitive##2##4##(1997-2#1)(2013-1#1)
was much more than##2##4##(2007-2#1)(2008-8#1)
was much more##29##3##(1990-1#1)(1990-11#1)(1990-2#1)(1991-5#1)(1992-5#1)(1993-5#1)(1993-9#1)(1994-3#3)(1996-4#1)(1997-1#2)(1997-2#1)(1997-7#1)(2007-2#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-8#2)(2011-2#2)(2012-12#1)(2013-1#1)
was much reduced##2##3##(1990-12#1)(2008-10#1)
was much shorter than##2##4##(1991-12#1)(2008-10#1)
was much slower##6##3##(1992-6#1)(1993-6#1)(1993-8#1)(1995-2#1)(2008-4#1)(2008-8#1)
was much smaller than that of##2##6##(1996-5#1)(2008-6#1)
was much smaller than that##3##5##(1994-3#1)(1996-5#1)(2008-6#1)
was much smaller##4##3##(1994-3#1)(1996-5#1)(1997-6#1)(2008-6#1)
was much weaker##2##3##(1990-11#1)(1994-6#1)
was much##160##2##(1990-1#1)(1990-11#2)(1990-12#4)(1990-2#2)(1990-4#3)(1990-7#2)(1991-1#1)(1991-12#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-5#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#4)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-9#1)(1997-1#2)(1997-2#4)(1997-4#1)(1997-6#2)(1997-7#2)(2004-9#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-11#2)(2007-2#2)(2007-8#3)(2008-1#1)(2008-10#24)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#7)(2008-9#1)(2009-10#2)(2009-2#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#4)(2013-1#1)(2013-8#1)
was mutagenic##2##2##(1993-11#1)(2008-9#1)
was mutated to##4##3##(1994-12#1)(1995-2#1)(2008-4#1)(2013-8#1)
was mutated##9##2##(1990-8#1)(1991-2#1)(1994-12#1)(1995-2#1)(1996-9#1)(2008-12#1)(2008-4#1)(2013-8#2)
was named as##2##3##(2008-7#1)(2010-8#1)
was named##24##2##(1990-3#1)(1990-7#1)(1991-7#1)(1991-9#1)(1992-7#1)(1993-11#1)(1993-9#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-10#6)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#1)
was narrow##2##2##(1997-3#1)(2008-9#1)
was narrowed##4##2##(2007-12#1)(2008-10#1)(2008-7#1)(2009-10#1)
was near the##2##3##(2004-11#1)(2008-2#1)
was near##11##2##(1993-12#1)(1997-2#2)(1997-5#1)(2004-11#1)(2004-4#1)(2007-7#1)(2008-2#1)(2008-3#1)(2012-2#2)
was nearly 100%##2##3##(2008-11#1)(2012-2#1)
was nearly abolished##2##3##(1992-7#1)(2006-4#1)
was nearly as##2##3##(1991-4#1)(2008-10#1)
was nearly complete##2##3##(1990-9#1)(2008-10#1)
was nearly identical in##2##4##(2007-2#1)(2008-10#1)
was nearly identical to##2##4##(1997-2#1)(2008-10#1)
was nearly identical##6##3##(1997-2#1)(2007-2#1)(2008-10#3)(2011-2#1)
was nearly the same##2##4##(1993-4#1)(1996-11#1)
was nearly##38##2##(1990-5#1)(1990-9#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-4#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-2#1)(1997-2#1)(2006-12#1)(2006-4#1)(2007-2#1)(2007-4#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
was necessary for the##6##4##(1990-11#1)(1994-11#1)(1994-9#1)(1996-5#1)(2010-5#1)(2011-2#1)
was necessary for##21##3##(1990-10#1)(1990-11#1)(1990-5#1)(1992-4#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-2#2)(1996-5#1)(1996-9#1)(2007-10#1)(2008-10#2)(2008-4#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
was necessary in only##2##4##(1994-2#1)(2013-1#1)
was necessary in two cases##2##5##(1990-12#1)(2008-6#1)
was necessary in##15##3##(1990-12#1)(1991-12#1)(1992-10#1)(1994-2#1)(1994-9#1)(1996-11#1)(1997-1#1)(2006-11#1)(2007-8#2)(2007-9#1)(2008-6#1)(2011-2#2)(2013-1#1)
was necessary to achieve##2##4##(1992-2#1)(1997-1#1)
was necessary to confirm the diagnosis##2##6##(1990-9#1)(1994-6#1)
was necessary to remove the##2##5##(1997-6#1)(2008-10#1)
was necessary to remove##3##4##(1997-6#1)(2008-10#2)
was necessary to use##2##4##(1992-9#1)(2008-10#1)
was necessary to##35##3##(1990-2#2)(1990-5#1)(1990-9#1)(1991-2#1)(1992-10#1)(1992-2#2)(1992-6#1)(1992-9#1)(1993-6#1)(1994-6#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-4#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
was necessary##98##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-10#3)(1992-2#2)(1992-4#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-6#2)(1994-9#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#2)(1996-2#2)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#4)(2007-9#1)(2008-10#16)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#6)(2012-2#1)(2013-1#4)(2013-8#1)
was necrotizing##2##2##(1990-3#1)(2008-5#1)
was needed and##4##3##(1996-1#1)(2005-4#1)(2008-10#1)(2013-1#1)
was needed due to##2##4##(2007-11#1)(2008-10#1)
was needed for##9##3##(1990-5#1)(1990-8#1)(1992-12#2)(1995-5#1)(2007-8#1)(2008-7#1)(2012-12#2)
was needed in##4##3##(2007-3#1)(2007-9#1)(2008-10#1)(2008-11#1)
was needed to remove the##2##5##(2008-10#1)(2013-7#1)
was needed to##16##3##(1993-7#1)(1994-3#1)(1995-6#1)(1996-10#1)(1997-2#1)(2006-8#2)(2008-10#4)(2008-2#1)(2008-9#1)(2011-2#1)(2013-7#1)(2013-8#1)
was needed##45##2##(1990-5#1)(1990-8#1)(1992-12#2)(1992-2#1)(1993-7#1)(1994-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-4#1)(1997-2#1)(2005-4#1)(2006-8#2)(2007-11#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
was negative after##2##3##(1995-11#1)(2011-12#1)
was negative and##2##3##(2008-7#1)(2013-1#1)
was negative correlation##2##3##(1993-12#1)(2012-3#1)
was negative for##15##3##(1992-3#1)(1995-4#1)(2006-2#1)(2007-12#1)(2008-10#2)(2008-7#1)(2010-12#2)(2010-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
was negative in all##2##4##(1996-12#1)(2007-7#1)
was negative in##8##3##(1991-4#1)(1996-12#2)(2007-7#2)(2008-11#1)(2008-9#1)(2012-2#1)
was negative on##2##3##(1995-4#1)(1996-6#1)
was negative##73##2##(1990-2#1)(1990-6#1)(1991-10#1)(1991-2#1)(1991-4#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-12#2)(1995-11#1)(1995-4#2)(1996-12#3)(1996-6#2)(1997-6#1)(2006-2#2)(2006-9#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-5#2)(2007-7#6)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#2)(2010-12#2)(2010-2#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-2#4)(2012-3#3)(2013-1#6)
was negatively associated with##7##4##(2004-11#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
was negatively charged##2##3##(2008-10#1)(2009-12#1)
was negatively correlated to##2##4##(2008-10#1)(2012-2#1)
was negatively correlated with plant tissue nitrogen content and positively correlated with##2##12##(2008-10#2)
was negatively correlated with##18##4##(1990-4#1)(2008-10#9)(2008-9#1)(2009-4#1)(2009-7#1)(2010-8#2)(2011-2#2)(2013-7#1)
was negatively correlated##21##3##(1990-4#1)(2008-10#11)(2008-9#1)(2009-4#1)(2009-7#1)(2010-8#2)(2011-2#2)(2012-2#1)(2013-7#1)
was negatively related to later-life appraisals##2##6##(2013-1#2)
was negatively related to##3##4##(2007-3#1)(2013-1#2)
was negatively##36##2##(1990-4#1)(2004-11#1)(2007-3#1)(2008-10#12)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-7#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#1)
was neglected##2##2##(2008-5#1)(2008-8#1)
was negligent##2##2##(1991-7#1)(1995-6#1)
was negligible and##2##3##(1996-2#1)(1996-8#1)
was negligible for##3##3##(1991-5#1)(1991-9#1)(2008-10#1)
was negligible in##2##3##(1990-7#1)(2008-10#1)
was negligible##21##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-3#1)(1991-5#1)(1991-9#1)(1993-10#1)(1996-2#2)(1996-8#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-8#1)(2007-8#1)(2008-10#5)(2008-11#1)
was neither##18##2##(1990-10#1)(1990-2#1)(1991-11#1)(1991-12#1)(1992-3#1)(1994-11#1)(1995-3#1)(1995-6#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-6#1)(2009-3#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
was neurologically##2##2##(2008-7#1)(2011-2#1)
was neutralized by monoclonal antibodies##2##5##(1990-7#1)(1993-4#1)
was neutralized by##5##3##(1990-7#1)(1991-10#1)(1993-4#1)(1995-5#1)(1997-1#1)
was neutralized##7##2##(1990-7#1)(1991-10#1)(1993-4#1)(1995-5#1)(1997-1#1)(2008-10#2)
was never found##2##3##(2007-7#1)(2008-10#1)
was never observed##6##3##(1993-6#1)(1995-2#1)(2008-10#2)(2009-9#1)(2012-3#1)
was never recovered##2##3##(2008-10#1)(2008-5#1)
was never used##3##3##(2006-12#1)(2011-2#1)(2013-1#1)
was never##28##2##(1990-8#1)(1993-6#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-6#1)(2006-12#2)(2007-5#1)(2007-7#1)(2008-10#4)(2008-3#1)(2008-5#3)(2008-8#1)(2009-10#1)(2009-2#2)(2009-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
was nevertheless##4##2##(1994-9#1)(1995-3#1)(2006-8#1)(2008-10#1)
was newly synthesized##2##3##(2008-10#1)(2008-9#1)
was newly##4##2##(2008-10#1)(2008-9#1)(2010-7#1)(2013-8#1)
was nil##3##2##(1991-6#1)(2008-7#1)(2011-11#1)
was nine days##2##3##(2012-3#1)(2013-8#1)
was nine months##2##3##(1992-6#1)(1996-4#1)
was nine##7##2##(1992-6#1)(1996-4#1)(1997-8#1)(2007-3#1)(2012-3#1)(2013-8#2)
was no accumulation of##2##4##(1992-9#1)(1994-12#1)
was no apparent##7##3##(1994-8#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#1)(2010-6#1)
was no association between sex##2##5##(1994-6#1)(1995-11#1)
was no association between##9##4##(1993-1#1)(1994-6#1)(1995-11#1)(1995-12#1)(1997-8#1)(2008-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
was no association with##4##4##(1991-9#1)(2008-1#1)(2008-12#1)(2008-9#1)
was no association##15##3##(1991-9#1)(1993-1#1)(1994-6#1)(1995-11#1)(1995-12#1)(1997-8#1)(2008-1#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
was no better##3##3##(1990-10#1)(1993-1#1)(2006-10#1)
was no change in the##13##5##(1990-5#1)(1991-2#1)(1991-6#1)(1991-8#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-12#1)(2006-10#1)(2007-11#1)(2008-3#1)(2008-7#1)
was no change in##22##4##(1990-5#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-2#1)(1993-2#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-12#2)(2006-10#1)(2007-11#1)(2008-3#1)(2008-7#1)(2012-12#1)(2013-8#2)
was no change##23##3##(1990-5#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-2#1)(1993-2#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-12#2)(2006-10#1)(2007-11#1)(2008-3#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-8#2)
was no clear difference in##2##5##(1997-2#1)(2008-7#1)
was no clear evidence##2##4##(2008-11#1)(2013-8#1)
was no clear##8##3##(1992-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#2)(2011-1#1)(2013-8#1)
was no clinical##3##3##(2008-4#1)(2012-2#1)(2012-3#1)
was no consistent##5##3##(1990-12#1)(1994-5#1)(1995-2#1)(2008-10#2)
was no conversion##3##3##(2007-8#1)(2008-10#1)(2013-1#1)
was no correlation between the##13##5##(1992-4#1)(1994-6#1)(1995-6#1)(1996-1#1)(2007-7#2)(2008-10#3)(2008-5#1)(2012-2#3)
was no correlation between##36##4##(1990-12#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-5#1)(1991-8#2)(1992-4#1)(1993-1#1)(1993-2#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-2#1)(2005-8#1)(2007-10#1)(2007-3#1)(2007-7#4)(2008-1#2)(2008-10#3)(2008-5#1)(2009-3#1)(2011-2#2)(2012-2#3)
was no correlation in##2##4##(2007-9#1)(2011-2#1)
was no correlation##43##3##(1990-12#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-5#1)(1991-8#2)(1992-4#1)(1993-1#1)(1993-2#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-2#1)(2005-8#1)(2007-10#1)(2007-3#1)(2007-7#4)(2007-9#1)(2008-1#2)(2008-10#4)(2008-5#2)(2008-6#1)(2009-3#1)(2011-2#3)(2012-2#3)(2013-1#1)
was no decrease in##5##4##(1990-5#1)(1991-8#1)(1995-1#1)(2008-10#1)(2008-9#1)
was no detectable##3##3##(1991-10#1)(1994-11#1)(1996-12#1)
was no difference between patients with##2##6##(1993-12#1)(1994-4#1)
was no difference between patients##3##5##(1993-12#1)(1994-4#1)(2006-8#1)
was no difference between the##11##5##(1990-2#1)(1990-5#1)(1990-7#1)(1995-2#1)(1996-6#1)(2007-10#1)(2007-8#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
was no difference between##27##4##(1990-10#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-11#1)(1993-1#1)(1993-10#1)(1993-12#1)(1994-3#1)(1994-4#1)(1995-2#1)(1995-3#1)(1996-6#1)(1996-9#1)(2006-8#1)(2007-10#2)(2007-7#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-9#1)(2010-5#1)(2011-2#1)(2013-1#2)
was no difference in the##28##5##(1990-7#1)(1992-4#1)(1992-6#1)(1993-1#1)(1993-3#1)(1993-4#1)(1993-7#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-3#1)(2004-11#1)(2006-8#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
was no difference in##73##4##(1990-11#2)(1990-7#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#2)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-3#1)(2004-1#1)(2004-11#1)(2004-3#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#6)
was no difference##106##3##(1990-10#1)(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#2)(1991-11#1)(1991-3#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-6#1)(1993-1#2)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#1)(1994-12#1)(1994-3#1)(1994-4#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-12#2)(1996-5#1)(1996-6#3)(1996-8#1)(1996-9#2)(1997-3#2)(2004-1#1)(2004-11#1)(2004-3#1)(2006-8#2)(2007-10#3)(2007-2#1)(2007-7#2)(2007-8#6)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2009-3#1)(2009-6#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#6)
was no direct##2##3##(2008-10#2)
was no effect of##6##4##(1995-11#1)(1996-12#1)(1997-3#1)(2006-5#1)(2008-10#1)(2009-3#1)
was no effect on the##3##5##(1990-11#1)(1995-3#1)(2008-5#1)
was no effect on##7##4##(1990-11#1)(1992-2#1)(1994-12#1)(1995-2#1)(1995-3#1)(1997-6#1)(2008-5#1)
was no effect##16##3##(1990-11#1)(1990-5#1)(1992-2#1)(1992-8#1)(1993-4#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-3#1)(1997-6#1)(2006-5#1)(2008-10#1)(2008-5#1)(2009-3#1)
was no evidence for a##3##5##(1993-9#1)(2009-5#1)(2013-1#1)
was no evidence for the##3##5##(2009-2#1)(2011-2#1)(2012-12#1)
was no evidence for##12##4##(1990-3#1)(1990-9#1)(1992-12#1)(1992-9#1)(1993-9#1)(1996-7#1)(2009-2#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
was no evidence of a significant##3##6##(1996-7#1)(2011-2#1)(2013-1#1)
was no evidence of a##4##5##(1996-7#1)(2007-12#1)(2011-2#1)(2013-1#1)
was no evidence of any##2##5##(1990-3#1)(1996-3#1)
was no evidence of carcinogenic activity of##6##7##(2008-8#1)(2008-9#5)
was no evidence of carcinogenic##7##5##(2008-8#1)(2008-9#6)
was no evidence of excessive##3##5##(1992-5#1)(1996-8#1)(2010-3#1)
was no evidence of metastasis##2##5##(2008-1#1)(2013-8#1)
was no evidence of##55##4##(1990-3#1)(1990-5#1)(1991-1#1)(1991-6#1)(1991-7#1)(1992-2#2)(1992-5#1)(1993-1#1)(1993-7#1)(1994-3#1)(1996-1#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-2#1)(2006-5#2)(2007-10#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#7)(2009-5#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
was no evidence that##7##4##(1993-9#1)(1994-5#1)(1996-3#1)(2008-10#1)(2008-9#1)(2009-5#1)(2012-2#1)
was no evidence##77##3##(1990-3#2)(1990-5#1)(1990-9#1)(1991-1#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-9#1)(1993-1#1)(1993-7#1)(1993-9#2)(1994-3#1)(1994-5#1)(1996-1#1)(1996-3#2)(1996-7#2)(1996-8#1)(1997-2#1)(2006-5#2)(2007-10#1)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#8)(2009-2#1)(2009-5#3)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
was no further##4##3##(1992-5#1)(1997-1#1)(1997-3#1)(2008-5#1)
was no higher than##2##4##(2008-10#1)(2012-2#1)
was no improvement##4##3##(2006-8#1)(2008-12#1)(2009-8#1)(2011-1#1)
was no incidence of##2##4##(1996-3#1)(2008-7#1)
was no increase in##5##4##(1991-3#1)(1992-6#1)(1995-11#2)(2006-7#1)
was no increase##6##3##(1990-7#1)(1991-3#1)(1992-6#1)(1995-11#2)(2006-7#1)
was no increased##4##3##(1991-12#1)(1994-4#1)(2010-12#1)(2011-12#1)
was no indication of##3##4##(1990-5#1)(2008-10#1)(2008-5#1)
was no interaction between##2##4##(2008-10#1)(2008-4#1)
was no interference of##2##4##(2008-10#1)(2012-3#1)
was no interference##8##3##(1993-2#1)(2008-10#5)(2010-5#1)(2012-3#1)
was no longer apparent at##2##5##(1992-2#1)(2008-11#1)
was no longer detectable##2##4##(1994-6#1)(1996-1#1)
was no longer significant##3##4##(1991-2#1)(1996-7#1)(2007-11#1)
was no longer##22##3##(1990-11#1)(1990-5#1)(1990-8#1)(1991-2#2)(1992-2#1)(1992-4#1)(1993-11#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-1#1)(1996-7#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2011-2#1)
was no marked##3##3##(2008-11#1)(2011-2#1)(2013-8#1)
was no more##2##3##(1990-5#1)(2010-8#1)
was no mortality among##2##4##(1997-8#1)(2008-3#1)
was no mortality##10##3##(1990-10#1)(1991-6#1)(1997-8#1)(2006-12#1)(2006-6#1)(2007-2#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)
was no need to##4##4##(1992-2#1)(2006-5#1)(2007-11#2)
was no obvious##5##3##(1996-7#1)(1997-3#1)(2008-3#1)(2011-2#1)(2013-8#1)
was no occurrence of##2##4##(2007-8#1)(2008-9#1)
was no other##5##3##(2006-12#1)(2007-7#1)(2008-7#2)(2009-9#1)
was no preceding##3##3##(1994-7#1)(2009-4#1)(2013-1#1)
was no recurrence during##2##4##(2004-10#1)(2007-8#1)
was no recurrence of##6##4##(2006-8#1)(2007-11#2)(2007-7#1)(2008-4#1)(2009-3#1)
was no recurrence##13##3##(2004-10#1)(2006-8#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-12#1)(2008-4#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
was no relationship between the##5##5##(1990-2#1)(1991-11#1)(2008-12#1)(2008-8#1)(2013-1#1)
was no relationship between##19##4##(1990-2#1)(1991-11#1)(1994-6#1)(1997-2#1)(2004-12#1)(2005-7#1)(2006-7#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-8#2)(2011-2#2)(2013-1#1)
was no relationship##21##3##(1990-2#1)(1991-11#1)(1993-12#1)(1994-6#1)(1997-2#1)(2004-12#1)(2005-7#1)(2006-7#1)(2006-8#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-8#2)(2011-2#2)(2013-1#1)
was no residual##2##3##(1994-3#1)(2007-8#1)
was no response in##2##4##(2009-8#1)(2010-12#1)
was no response##5##3##(1992-8#1)(1997-2#1)(2008-10#1)(2009-8#1)(2010-12#1)
was no significant association with##3##5##(1995-8#2)(2008-12#1)
was no significant association##7##4##(1994-7#1)(1995-8#2)(1996-8#1)(2008-12#1)(2011-1#1)(2012-12#1)
was no significant change in the##9##6##(1990-3#1)(1994-3#1)(1995-12#1)(1997-1#1)(2005-10#1)(2006-10#1)(2008-1#1)(2008-7#1)(2009-4#1)
was no significant change in##18##5##(1990-12#1)(1990-3#1)(1992-8#1)(1993-3#1)(1994-3#1)(1995-12#1)(1997-1#1)(2004-3#1)(2005-10#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#1)(2011-2#1)(2013-1#1)
was no significant change##19##4##(1990-12#1)(1990-3#1)(1992-8#1)(1993-3#1)(1994-3#1)(1995-12#1)(1997-1#1)(2004-3#1)(2005-10#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
was no significant correlation between DNA##2##6##(1994-12#1)(2008-10#1)
was no significant correlation between the##7##6##(1995-10#1)(1997-2#1)(1997-8#1)(2007-10#1)(2007-2#1)(2008-10#1)(2010-3#1)
was no significant correlation between##21##5##(1992-9#1)(1994-12#1)(1995-10#1)(1997-2#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-6#1)(2009-10#1)(2010-3#1)(2012-2#1)
was no significant correlation##23##4##(1992-9#1)(1994-12#1)(1995-10#1)(1997-2#1)(1997-8#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-2#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-5#1)(2008-6#1)(2009-10#1)(2010-3#1)(2012-2#1)
was no significant difference among##7##5##(1990-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2012-12#1)(2013-1#1)
was no significant difference between the##24##6##(1990-9#1)(1991-6#1)(1992-12#1)(1993-4#1)(1993-8#1)(1996-10#1)(1997-8#1)(1997-9#1)(2005-8#1)(2006-2#1)(2007-2#1)(2007-9#2)(2008-10#2)(2008-8#1)(2008-9#2)(2009-5#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
was no significant difference between##59##5##(1990-5#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-6#1)(1991-8#3)(1992-12#1)(1992-8#1)(1993-10#1)(1993-2#2)(1993-4#1)(1993-8#1)(1994-4#1)(1996-10#1)(1997-2#1)(1997-8#1)(1997-9#1)(2004-3#1)(2005-8#1)(2006-2#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#3)(2008-9#2)(2009-5#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#3)(2013-8#2)
was no significant difference in attitude between##2##7##(2008-4#2)
was no significant difference in latency##2##6##(1992-9#1)(2011-2#1)
was no significant difference in overall##2##6##(2004-9#1)(2008-6#1)
was no significant difference in the mean##5##7##(2007-1#1)(2007-2#1)(2007-7#1)(2008-8#1)(2013-1#1)
was no significant difference in the percentage of isolates in each group##2##12##(1991-8#2)
was no significant difference in the proportion of##2##8##(2011-2#1)(2012-3#1)
was no significant difference in the##39##6##(1990-7#1)(1991-2#1)(1991-7#1)(1991-8#2)(1993-4#1)(1996-1#1)(1996-3#1)(1996-6#1)(2006-5#1)(2006-8#1)(2007-1#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#3)(2008-8#1)(2009-5#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#3)
was no significant difference in total##2##6##(2008-5#1)(2009-2#1)
was no significant difference in##89##5##(1990-12#1)(1990-7#1)(1991-10#2)(1991-2#1)(1991-7#1)(1991-8#2)(1992-9#1)(1993-11#1)(1993-4#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-10#1)(1995-11#1)(1995-4#1)(1996-1#1)(1996-3#1)(1996-6#1)(1997-8#1)(2004-9#1)(2005-7#1)(2006-11#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#3)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-2#1)(2009-5#3)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2012-7#1)(2013-1#3)
was no significant difference of##4##5##(1994-3#1)(2007-2#1)(2011-1#1)(2011-2#1)
was no significant difference##168##4##(1990-12#2)(1990-5#1)(1990-7#1)(1990-9#1)(1991-10#3)(1991-11#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#5)(1992-12#1)(1992-8#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-2#2)(1993-4#2)(1993-8#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-7#1)(1995-10#1)(1995-11#1)(1995-4#1)(1996-1#1)(1996-10#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-8#3)(1997-9#1)(2004-3#1)(2004-9#1)(2005-7#1)(2005-8#1)(2006-11#1)(2006-2#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-11#1)(2007-12#2)(2007-2#4)(2007-3#1)(2007-7#4)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#5)(2009-2#1)(2009-5#4)(2010-4#1)(2010-8#2)(2011-1#8)(2011-2#11)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#5)(2012-7#1)(2013-1#6)(2013-7#3)(2013-8#2)
was no significant differences##3##4##(1993-12#1)(2008-7#1)(2013-1#1)
was no significant improvement in##3##5##(1991-5#1)(1993-3#1)(2013-1#1)
was no significant improvement##4##4##(1991-5#1)(1993-3#1)(2005-9#1)(2013-1#1)
was no significant increase in##5##5##(1990-3#1)(1992-2#1)(1997-6#1)(2008-2#1)(2013-1#1)
was no significant increase##7##4##(1990-3#1)(1992-2#1)(1997-6#1)(2008-11#1)(2008-2#1)(2013-1#2)
was no significant interaction##4##4##(2007-12#1)(2008-10#2)(2008-12#1)
was no significant relationship between the##2##6##(1993-12#1)(2006-1#1)
was no significant relationship between##5##5##(1993-12#1)(2006-1#1)(2007-5#1)(2008-10#1)(2008-6#1)
was no significant relationship##6##4##(1993-12#1)(2006-1#1)(2007-5#1)(2008-10#2)(2008-6#1)
was no significant variation in the##2##6##(2007-8#1)(2008-11#1)
was no significant##269##3##(1990-12#3)(1990-3#2)(1990-5#1)(1990-7#1)(1990-9#1)(1991-10#4)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#5)(1992-12#1)(1992-2#1)(1992-8#3)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#2)(1993-7#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-4#1)(1994-7#2)(1995-10#3)(1995-11#2)(1995-12#2)(1995-2#1)(1995-4#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-6#1)(1997-8#4)(1997-9#1)(2004-3#2)(2004-9#1)(2005-10#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#2)(2006-5#2)(2006-6#2)(2006-8#3)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#6)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#7)(2007-9#2)(2008-1#7)(2008-10#20)(2008-11#6)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#7)(2008-6#6)(2008-7#5)(2008-8#5)(2008-9#5)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#4)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#10)(2011-2#14)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#5)(2012-7#1)(2013-1#11)(2013-7#3)(2013-8#2)
was no single##4##3##(1996-5#1)(2005-7#1)(2005-8#1)(2007-3#1)
was no statistical difference between##6##5##(1996-12#1)(1996-6#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#1)
was no statistical difference in the##2##6##(1991-5#1)(2011-1#1)
was no statistical difference in##5##5##(1990-12#1)(1991-5#1)(2008-8#1)(2010-2#1)(2011-1#1)
was no statistical difference##13##4##(1990-12#1)(1991-5#1)(1996-12#1)(1996-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-1#2)(2012-2#1)(2013-1#1)
was no statistical##18##3##(1990-12#1)(1991-5#1)(1996-12#1)(1996-6#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-1#2)(2012-2#1)(2013-1#3)(2013-8#1)
was no statistically significant difference between##6##6##(1996-3#1)(2005-10#1)(2006-5#1)(2007-2#1)(2007-7#1)(2009-12#1)
was no statistically significant difference in the##5##7##(1993-3#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-5#1)
was no statistically significant difference in##13##6##(1993-1#1)(1993-3#1)(1994-2#1)(1995-10#1)(1996-6#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-9#1)(2012-2#1)(2013-8#1)
was no statistically significant difference##26##5##(1993-1#1)(1993-3#1)(1994-2#1)(1995-10#1)(1996-3#1)(1996-6#1)(2005-10#1)(2006-10#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-12#1)(2010-12#1)(2010-9#1)(2011-1#2)(2012-2#2)(2013-1#1)(2013-8#1)
was no statistically significant##32##4##(1993-1#1)(1993-3#1)(1994-2#1)(1995-10#1)(1996-3#1)(1996-6#1)(1996-9#1)(2005-10#1)(2006-10#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-9#1)(2011-1#2)(2012-2#2)(2013-1#1)(2013-8#2)
was no statistically valid##2##4##(2007-8#1)(2011-2#1)
was no statistically##34##3##(1993-1#1)(1993-3#1)(1994-2#1)(1995-10#1)(1996-3#1)(1996-6#1)(1996-9#1)(2005-10#1)(2006-10#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#2)
was no such##2##3##(1996-2#1)(2012-2#1)
was no##982##2##(1990-10#4)(1990-11#5)(1990-12#7)(1990-2#2)(1990-3#4)(1990-4#2)(1990-5#9)(1990-6#1)(1990-7#4)(1990-8#3)(1990-9#3)(1991-1#1)(1991-10#6)(1991-11#5)(1991-12#1)(1991-2#6)(1991-3#3)(1991-5#3)(1991-6#5)(1991-7#3)(1991-8#9)(1991-9#3)(1992-1#1)(1992-12#6)(1992-2#9)(1992-3#2)(1992-4#3)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#7)(1992-9#4)(1993-1#7)(1993-10#2)(1993-11#2)(1993-12#5)(1993-2#8)(1993-3#4)(1993-4#6)(1993-5#1)(1993-7#3)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#6)(1994-2#2)(1994-3#8)(1994-4#3)(1994-5#2)(1994-6#4)(1994-7#3)(1994-8#2)(1995-1#1)(1995-10#4)(1995-11#8)(1995-12#5)(1995-2#10)(1995-3#4)(1995-4#1)(1995-6#3)(1995-8#3)(1995-9#1)(1996-1#5)(1996-10#1)(1996-12#9)(1996-2#5)(1996-3#9)(1996-5#2)(1996-6#6)(1996-7#4)(1996-8#3)(1996-9#4)(1997-1#2)(1997-2#9)(1997-3#6)(1997-6#3)(1997-8#8)(1997-9#1)(2004-1#1)(2004-10#1)(2004-11#1)(2004-12#1)(2004-3#3)(2004-9#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#4)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#9)(2006-11#1)(2006-12#4)(2006-2#2)(2006-4#2)(2006-5#9)(2006-6#6)(2006-7#4)(2006-8#13)(2006-9#1)(2007-1#2)(2007-10#13)(2007-11#9)(2007-12#6)(2007-2#13)(2007-3#5)(2007-5#2)(2007-6#3)(2007-7#23)(2007-8#29)(2007-9#8)(2008-1#17)(2008-10#78)(2008-11#20)(2008-12#12)(2008-2#4)(2008-3#9)(2008-4#12)(2008-5#23)(2008-6#9)(2008-7#22)(2008-8#12)(2008-9#21)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#5)(2009-4#4)(2009-5#8)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#3)(2010-12#4)(2010-2#2)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#4)(2010-7#2)(2010-8#9)(2010-9#3)(2011-1#20)(2011-12#2)(2011-2#36)(2012-1#3)(2012-11#2)(2012-12#15)(2012-2#22)(2012-3#13)(2012-7#1)(2012-8#1)(2013-1#36)(2013-7#6)(2013-8#22)
was nominated by##3##3##(2008-9#3)
was nominated for study by##2##5##(2008-9#2)
was nominated for##4##3##(2008-9#4)
was nominated##8##2##(2008-9#8)
was non##2##2##(2007-11#1)(2007-9#1)
was non-competitive##2##2##(1996-6#1)(1997-7#1)
was noncompetitive##4##2##(1992-3#3)(1993-11#1)
was nonetheless##2##2##(1995-12#1)(2011-2#1)
was nonreactive with##2##3##(1992-3#1)(1994-12#1)
was nonreactive##3##2##(1992-3#1)(1994-12#2)
was normal and the##2##4##(1994-12#1)(2012-2#1)
was normal and##4##3##(1994-12#1)(2007-12#1)(2008-6#1)(2012-2#1)
was normal at##2##3##(1991-6#1)(2013-1#1)
was normal but##2##3##(2005-12#1)(2008-7#1)
was normal in##8##3##(1990-3#1)(1991-10#1)(1991-3#1)(1992-12#1)(1994-8#1)(2010-12#1)(2011-1#1)(2013-1#1)
was normal on##2##3##(1995-1#1)(1997-8#1)
was normal or##2##3##(2007-1#1)(2013-8#1)
was normal##72##2##(1990-3#1)(1990-6#1)(1991-10#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#1)(1996-6#1)(1997-8#2)(2005-12#3)(2006-10#4)(2006-4#1)(2006-5#1)(2007-1#1)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-12#1)(2008-6#1)(2008-7#7)(2009-9#1)(2010-11#1)(2010-12#2)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#3)
was normalised##2##2##(1993-8#1)(2007-8#1)
was normalized to##3##3##(1991-12#1)(1993-12#1)(2008-10#1)
was normalized##8##2##(1990-10#1)(1991-12#1)(1993-12#1)(1995-6#1)(1995-7#1)(2008-10#2)(2009-8#1)
was not a good##3##4##(2007-11#1)(2008-10#2)
was not a major##3##4##(1994-1#2)(2008-10#1)
was not a prerequisite##2##4##(1991-9#1)(1993-4#1)
was not a significant##6##4##(1990-1#1)(1996-1#1)(2006-5#1)(2007-10#1)(2011-2#2)
was not a statistically significant##2##5##(2008-12#1)(2009-9#1)
was not a##50##3##(1990-1#1)(1990-6#1)(1991-2#1)(1991-9#1)(1992-9#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-1#2)(1994-12#2)(1994-2#1)(1994-7#1)(1994-8#2)(1995-10#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(2006-5#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-5#1)(2009-9#1)(2010-1#1)(2010-2#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-8#2)
was not able to##9##4##(1992-12#1)(1992-3#1)(1994-6#1)(1995-12#1)(2004-12#1)(2008-10#1)(2008-4#1)(2011-1#1)(2013-1#1)
was not abolished by##2##4##(1994-3#1)(1997-6#1)
was not abundant##2##3##(2008-6#1)(2009-7#1)
was not accompanied by a##2##5##(1994-3#1)(1997-4#1)
was not accompanied by an increase in##3##7##(1994-12#1)(1994-6#1)(1995-12#1)
was not accompanied by an##4##5##(1994-12#1)(1994-2#1)(1994-6#1)(1995-12#1)
was not accompanied by any change in##2##7##(1995-2#1)(1997-5#1)
was not accompanied by any##5##5##(1990-12#1)(1990-5#1)(1995-2#1)(1997-5#1)(2009-8#1)
was not accompanied by##17##4##(1990-12#1)(1990-5#1)(1992-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-5#1)(2008-11#1)(2009-8#1)(2010-12#1)(2013-7#1)
was not accompanied##18##3##(1990-12#1)(1990-5#1)(1991-12#1)(1992-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-5#1)(2008-11#1)(2009-8#1)(2010-12#1)(2013-7#1)
was not achieved in##2##4##(1996-5#1)(2011-2#1)
was not achieved##10##3##(1991-11#1)(1996-5#1)(1996-6#1)(2006-10#1)(2008-10#2)(2008-12#1)(2008-5#1)(2011-2#1)(2012-12#1)
was not active##2##3##(2008-11#1)(2011-3#1)
was not adequate##2##3##(2007-7#1)(2008-10#1)
was not affected at all##2##5##(1993-12#1)(1995-1#1)
was not affected at##5##4##(1993-12#1)(1993-4#1)(1995-1#1)(1997-4#1)(2013-1#1)
was not affected by any of the##3##7##(1994-9#1)(1995-5#1)(1997-5#1)
was not affected by any##4##5##(1994-9#1)(1995-5#1)(1997-5#1)(2007-9#1)
was not affected by diltiazem (10(-5) M)##2##7##(1990-7#2)
was not affected by either##3##5##(1990-10#1)(1997-5#1)(2010-8#1)
was not affected by the presence of##6##7##(1990-5#1)(1991-9#1)(1992-8#1)(1993-4#1)(2007-11#1)(2008-10#1)
was not affected by the##26##5##(1990-5#1)(1991-1#1)(1991-9#1)(1992-11#1)(1992-8#1)(1993-4#1)(1994-12#2)(1994-8#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-7#1)(2007-11#2)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#1)
was not affected by tillage##2##5##(2008-10#2)
was not affected by verapamil##2##5##(1992-11#1)(1994-6#1)
was not affected by##108##4##(1990-1#1)(1990-10#1)(1990-2#2)(1990-5#2)(1990-6#2)(1990-7#5)(1990-8#1)(1990-9#2)(1991-1#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#3)(1992-12#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#3)(1996-5#2)(1997-1#1)(1997-3#1)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#1)(2005-11#1)(2007-11#2)(2007-3#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-2#2)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
was not affected either##2##4##(1990-4#1)(2006-4#1)
was not affected in##4##4##(1994-12#1)(1997-5#1)(2008-10#1)(2011-1#1)
was not affected significantly by##2##5##(1991-2#1)(1997-7#1)
was not affected under##2##4##(1997-2#1)(2012-12#1)
was not affected when##2##4##(1994-5#1)(1994-8#1)
was not affected##151##3##(1990-1#1)(1990-10#1)(1990-11#1)(1990-2#3)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#5)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#3)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#4)(1993-2#2)(1993-3#1)(1993-4#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#6)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#4)(1995-11#1)(1995-2#2)(1995-3#2)(1995-5#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#4)(1997-6#1)(1997-7#4)(1997-8#1)(2004-2#1)(2004-4#1)(2005-11#1)(2006-4#1)(2007-11#2)(2007-3#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-2#3)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
was not altered by the##2##5##(1992-4#1)(1997-7#1)
was not altered by##16##4##(1990-1#1)(1990-7#2)(1990-9#1)(1992-4#1)(1992-7#1)(1993-4#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-3#2)(1996-12#1)(1996-5#1)(1997-7#1)
was not altered in the##3##5##(1995-5#1)(2008-12#1)(2010-7#1)
was not altered in##6##4##(1991-3#1)(1995-5#1)(1996-5#1)(2008-12#1)(2010-7#1)(2011-2#1)
was not altered##35##3##(1990-1#1)(1990-7#2)(1990-9#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#2)(1996-12#1)(1996-2#1)(1996-5#2)(1997-7#2)(2008-10#1)(2008-12#1)(2008-8#1)(2010-7#1)(2011-2#1)
was not always##11##3##(1991-12#1)(1992-10#1)(1994-12#1)(2007-3#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-7#1)
was not an important##2##4##(2008-10#1)(2013-7#1)
was not an independent##2##4##(1990-12#1)(2010-11#1)
was not an##10##3##(1990-12#1)(1995-9#1)(2005-7#1)(2008-10#2)(2008-9#1)(2010-11#1)(2012-3#1)(2013-1#1)(2013-7#1)
was not anticipated##2##3##(1995-5#1)(2009-10#1)
was not any##3##3##(1995-2#1)(2007-2#1)(2008-7#1)
was not apparent in the##2##5##(1994-2#1)(2006-9#1)
was not apparent in##4##4##(1994-2#1)(2006-9#1)(2007-5#1)(2012-12#1)
was not apparent##10##3##(1994-2#1)(1995-1#1)(1997-2#1)(2006-9#1)(2007-5#2)(2008-10#1)(2008-7#1)(2012-12#2)
was not as common as in##2##6##(2008-1#2)
was not as effective as##5##5##(2007-11#1)(2008-10#3)(2013-1#1)
was not as effective##7##4##(2007-11#1)(2008-10#3)(2008-5#1)(2013-1#2)
was not as great as##2##5##(1991-2#1)(1995-5#1)
was not as great##3##4##(1991-2#1)(1995-5#1)(2008-3#1)
was not as sensitive##2##4##(1991-3#1)(2011-2#1)
was not as##22##3##(1991-2#1)(1991-3#1)(1993-2#1)(1995-5#3)(2006-5#1)(2007-11#2)(2008-1#2)(2008-10#5)(2008-3#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
was not associated with a##4##5##(1992-4#1)(1992-8#1)(2008-12#1)(2012-2#1)
was not associated with an increased risk##2##7##(2010-4#1)(2012-2#1)
was not associated with an##3##5##(2009-10#1)(2010-4#1)(2012-2#1)
was not associated with any other##2##6##(2008-12#1)(2008-8#1)
was not associated with any##5##5##(2008-10#2)(2008-12#1)(2008-8#1)(2012-3#1)
was not associated with improved##2##5##(1997-1#1)(2005-12#1)
was not associated with increased##4##5##(1995-1#1)(1995-12#1)(2005-10#1)(2007-11#1)
was not associated with plasma##2##5##(1997-8#1)(2007-9#1)
was not associated with the##3##5##(2008-10#1)(2012-3#1)(2013-1#1)
was not associated with##64##4##(1991-9#1)(1992-4#1)(1992-8#1)(1993-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-5#1)(1996-11#1)(1997-1#1)(1997-6#1)(1997-8#1)(2004-2#1)(2005-10#1)(2005-12#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-6#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#3)(2009-11#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#1)
was not associated##66##3##(1991-9#1)(1992-4#1)(1992-8#1)(1993-9#1)(1994-5#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-5#1)(1996-11#1)(1997-1#1)(1997-6#1)(1997-8#1)(2004-2#1)(2005-10#1)(2005-12#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-6#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#3)(2009-11#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#1)
was not attached to any##2##5##(2013-1#2)
was not attempted##2##3##(2008-11#1)(2010-4#1)
was not attenuated by##3##4##(1996-6#1)(1997-5#1)(2007-8#1)
was not attributable to##3##4##(1992-7#1)(1993-9#1)(2013-1#1)
was not attributable##4##3##(1990-11#1)(1992-7#1)(1993-9#1)(2013-1#1)
was not available for##2##4##(2008-11#1)(2011-1#1)
was not available in##3##4##(2006-7#1)(2007-8#1)(2010-3#1)
was not available##13##3##(2005-7#2)(2006-10#1)(2006-2#1)(2006-7#1)(2007-8#1)(2008-11#1)(2008-7#2)(2010-3#3)(2011-1#1)
was not being##3##3##(2007-9#1)(2010-1#1)(2013-1#1)
was not blocked by##6##4##(1990-5#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-9#1)
was not blocked##7##3##(1990-5#1)(1990-7#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-9#1)
was not bound##2##3##(1990-3#1)(1994-8#1)
was not carried out##2##4##(2010-12#1)(2012-2#1)
was not caused by##4##4##(1995-8#1)(2005-11#1)(2006-4#1)(2008-5#1)
was not changed by##4##4##(1990-7#1)(1993-3#1)(1997-8#1)(2008-9#1)
was not changed in##3##4##(1994-12#1)(1997-2#1)(1997-6#1)
was not changed significantly##2##4##(1993-11#1)(2008-11#1)
was not changed##17##3##(1990-7#1)(1992-1#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-6#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-12#1)(2007-6#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#2)(2013-8#1)
was not clear##7##3##(1992-9#1)(1993-11#1)(1996-9#1)(2008-10#1)(2008-11#1)(2009-6#1)(2012-2#1)
was not clearly##4##3##(1992-9#1)(2007-9#1)(2011-2#1)(2012-12#1)
was not cleaved##3##3##(1991-9#1)(1994-11#1)(1995-10#1)
was not clinically##3##3##(2007-8#1)(2008-12#1)(2008-6#1)
was not closely related to##2##5##(2008-10#2)
was not common to##2##4##(2007-4#1)(2008-10#1)
was not common##6##3##(1991-6#1)(2006-10#1)(2007-4#1)(2008-10#2)(2010-12#1)
was not complete##2##3##(2008-6#1)(2012-2#1)
was not completely##5##3##(1990-2#1)(1994-11#1)(1996-4#1)(2007-8#1)(2008-10#1)
was not compromised##2##3##(2008-10#1)(2012-6#1)
was not confirmed by##5##4##(1990-6#1)(1991-4#1)(2008-4#1)(2008-7#1)(2010-12#1)
was not confirmed in the##2##5##(1992-2#1)(2008-1#1)
was not confirmed in##4##4##(1992-2#1)(2007-8#1)(2008-1#1)(2011-2#1)
was not confirmed##12##3##(1990-6#1)(1991-4#1)(1992-2#1)(2005-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-11#1)
was not considered##8##3##(1992-5#1)(1992-7#1)(1996-3#1)(2007-1#1)(2007-7#1)(2008-10#1)(2010-10#1)(2013-1#1)
was not consistent across##2##4##(1995-5#1)(2008-10#1)
was not consistent with the##2##5##(2008-1#1)(2008-10#1)
was not consistent##7##3##(1990-2#1)(1995-5#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-10#2)
was not consistently##6##3##(1990-3#1)(1991-3#1)(2008-10#2)(2010-11#1)(2012-2#1)
was not constant throughout the##2##5##(1993-3#1)(2008-7#1)
was not controlled##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
was not correlated to##2##4##(1994-6#1)(2008-10#1)
was not correlated with a##2##5##(1994-11#1)(2008-10#1)
was not correlated with host##2##5##(2008-10#1)(2008-4#1)
was not correlated with##21##4##(1990-3#1)(1991-7#1)(1991-8#1)(1992-7#1)(1992-9#1)(1994-11#1)(1994-6#1)(1996-11#2)(2008-10#5)(2008-4#1)(2008-5#1)(2008-9#1)(2010-6#1)(2010-8#1)(2011-1#1)(2013-8#1)
was not correlated##25##3##(1990-3#1)(1991-7#1)(1991-8#1)(1992-7#1)(1992-9#1)(1994-11#1)(1994-6#2)(1996-11#2)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-6#1)(2010-8#1)(2011-1#1)(2013-8#1)
was not cross-resistant to##2##4##(1990-10#1)(1991-7#1)
was not cytotoxic##4##3##(1994-8#1)(1996-6#1)(1997-4#1)(2013-1#1)
was not delayed##2##3##(1990-12#1)(2011-2#1)
was not demonstrated##3##3##(1995-5#1)(1997-8#1)(2007-8#1)
was not dependent on the concentration of##2##7##(1993-12#1)(2012-2#1)
was not dependent on the presence of##2##7##(1991-5#1)(1997-6#1)
was not dependent on the##6##5##(1991-5#1)(1993-12#1)(1997-6#1)(2010-4#1)(2012-2#1)(2013-8#1)
was not dependent on##9##4##(1991-5#1)(1993-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1997-6#1)(2010-4#1)(2012-2#1)(2013-8#1)
was not dependent upon##4##4##(1991-12#1)(1992-5#1)(2008-10#1)(2008-5#1)
was not dependent##13##3##(1991-12#1)(1991-5#1)(1992-5#1)(1993-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1997-6#1)(2008-10#1)(2008-5#1)(2010-4#1)(2012-2#1)(2013-8#1)
was not derived from##3##4##(1990-12#1)(1994-9#1)(2008-10#1)
was not described##3##3##(2007-11#1)(2008-5#1)(2009-2#1)
was not designed##2##3##(2006-5#1)(2006-8#1)
was not destroyed##2##3##(1990-5#1)(1990-6#1)
was not detectable by##2##4##(1997-3#1)(2008-9#1)
was not detectable in##9##4##(1990-8#1)(1991-5#1)(1992-4#1)(1992-8#1)(1994-11#1)(1995-3#1)(1995-4#1)(2008-10#1)(2011-2#1)
was not detectable##19##3##(1990-8#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-4#1)(1992-8#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-9#1)(1995-3#1)(1995-4#1)(1997-3#1)(1997-4#1)(2008-10#2)(2008-9#1)(2011-2#1)
was not detected at all in##2##6##(1995-11#1)(2008-10#1)
was not detected at##4##4##(1995-11#1)(2008-10#2)(2008-5#1)
was not detected by##5##4##(1993-4#1)(1994-11#1)(1996-6#1)(2006-12#1)(2008-10#1)
was not detected during the##3##5##(1997-2#1)(2006-4#1)(2008-10#1)
was not detected during##4##4##(1990-3#1)(1997-2#1)(2006-4#1)(2008-10#1)
was not detected either##2##4##(1991-2#1)(1997-3#1)
was not detected in all##2##5##(2008-10#2)
was not detected in any of the##2##7##(1995-2#1)(2006-8#1)
was not detected in any of##3##6##(1993-9#1)(1995-2#1)(2006-8#1)
was not detected in any sample##2##6##(2008-12#1)(2008-5#1)
was not detected in any##6##5##(1993-9#1)(1994-12#1)(1995-2#1)(2006-8#1)(2008-12#1)(2008-5#1)
was not detected in the##17##5##(1990-9#1)(1993-11#1)(1994-11#1)(1995-5#1)(1996-2#1)(1997-5#1)(2006-10#1)(2006-11#1)(2007-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
was not detected in##47##4##(1990-9#1)(1991-12#1)(1991-3#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-2#1)(1997-5#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-1#1)(2007-5#1)(2007-8#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#2)(2012-12#2)(2012-2#1)(2013-1#1)
was not detected##85##3##(1990-3#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-4#1)(1993-7#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#3)(1995-5#2)(1995-6#1)(1996-2#1)(1996-6#3)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-5#1)(2007-8#1)(2008-10#21)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#7)(2008-7#2)(2008-8#2)(2010-12#1)(2012-12#2)(2012-2#2)(2013-1#1)
was not determined##7##3##(1992-2#1)(1995-9#1)(1997-3#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-5#1)
was not different among the##2##5##(1997-4#1)(2007-10#1)
was not different among##3##4##(1997-4#1)(2007-10#1)(2013-8#1)
was not different between the two groups##3##7##(1991-10#1)(2006-10#1)(2008-4#1)
was not different between the##4##5##(1991-10#1)(1996-8#1)(2006-10#1)(2008-4#1)
was not different between##10##4##(1991-10#1)(1994-5#1)(1996-10#1)(1996-8#1)(1997-5#1)(2006-10#1)(2008-4#2)(2012-3#1)(2013-8#1)
was not different from that of##2##6##(1991-3#1)(1994-8#1)
was not different from that##3##5##(1991-3#1)(1994-8#1)(2011-1#1)
was not different from##7##4##(1991-3#1)(1994-8#1)(2004-12#1)(2007-8#1)(2008-10#1)(2010-8#1)(2011-1#1)
was not different in control##2##5##(1990-7#1)(1990-8#1)
was not different in##7##4##(1990-2#1)(1990-7#1)(1990-8#1)(1994-11#1)(2004-12#1)(2007-7#1)(2009-7#1)
was not different##34##3##(1990-2#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-3#1)(1991-6#1)(1994-11#1)(1994-5#1)(1994-8#1)(1996-10#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#1)(2004-11#1)(2004-12#2)(2004-2#1)(2006-10#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-4#2)(2009-7#1)(2010-8#1)(2011-1#1)(2012-11#1)(2012-3#1)(2013-8#2)
was not diminished##3##3##(1990-7#1)(1997-2#1)(2008-10#1)
was not directly##7##3##(1990-8#1)(1993-1#1)(1996-8#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-4#1)
was not disclosed##2##3##(1993-9#1)(2011-1#1)
was not displaced by##2##4##(1993-1#1)(2004-9#1)
was not done##5##3##(1992-2#1)(1994-8#1)(1995-4#1)(2007-8#1)(2008-7#1)
was not due to a##12##5##(1992-3#1)(1992-7#1)(1992-9#1)(1993-12#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-5#1)(2008-10#1)(2009-4#1)(2009-6#1)
was not due to an##5##5##(1990-8#1)(1991-1#1)(1992-4#1)(1997-1#1)(1997-7#1)
was not due to lack of##2##6##(1993-6#1)(2007-12#1)
was not due to the##7##5##(1990-3#1)(1991-7#1)(1995-12#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-7#1)
was not due to##47##4##(1990-11#1)(1990-3#1)(1990-8#1)(1991-1#1)(1991-7#1)(1991-9#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-6#2)(1994-10#1)(1994-2#2)(1995-1#2)(1995-12#1)(1995-2#2)(1996-1#1)(1996-10#1)(1996-12#2)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#1)(2005-12#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-6#1)(2013-1#1)
was not due##49##3##(1990-11#1)(1990-3#1)(1990-8#1)(1991-1#1)(1991-7#1)(1991-9#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-6#2)(1994-10#1)(1994-2#2)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-10#1)(1996-12#2)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#1)(2005-12#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-7#2)(2008-8#1)(2009-4#1)(2009-6#1)(2013-1#1)
was not easily##2##3##(1993-3#1)(2008-10#1)
was not effective in preventing##2##5##(1991-12#1)(2008-10#1)
was not effective in protecting##2##5##(1991-1#1)(1993-5#1)
was not effective in##12##4##(1990-12#1)(1991-1#1)(1991-12#1)(1993-5#1)(1994-5#1)(2005-12#1)(2007-6#1)(2008-1#1)(2008-10#2)(2009-10#1)(2010-1#1)
was not effective##17##3##(1990-12#1)(1991-1#1)(1991-12#1)(1992-12#1)(1993-5#1)(1994-5#1)(2005-12#1)(2007-6#2)(2008-1#1)(2008-10#3)(2008-11#1)(2009-10#1)(2010-1#1)(2012-12#1)
was not elevated##4##3##(1993-12#1)(1995-5#1)(2004-10#1)(2011-2#1)
was not eliminated##2##3##(1990-8#1)(2008-5#1)
was not enhanced by the##2##5##(2008-11#1)(2010-8#1)
was not enhanced by##5##4##(1990-7#1)(1994-9#1)(2008-10#1)(2008-11#1)(2010-8#1)
was not enhanced##7##3##(1990-7#1)(1991-6#1)(1994-9#1)(1995-3#1)(2008-10#1)(2008-11#1)(2010-8#1)
was not enough to##3##4##(1996-2#1)(2005-11#1)(2008-9#1)
was not enough##5##3##(1996-2#1)(2005-11#1)(2007-6#1)(2008-4#1)(2008-9#1)
was not essential##2##3##(1996-6#1)(2008-11#1)
was not established##4##3##(1990-12#1)(1990-5#1)(1994-4#1)(2005-11#1)
was not evident in##3##4##(1994-3#1)(2011-1#1)(2013-8#1)
was not evident##11##3##(1992-7#1)(1994-3#1)(1997-5#1)(2005-9#1)(2006-7#1)(2008-10#1)(2008-7#1)(2011-1#2)(2011-2#1)(2013-8#1)
was not exposed##2##3##(1995-12#1)(2008-8#1)
was not expressed by##2##4##(1996-2#1)(2007-9#1)
was not expressed in any##2##5##(1994-3#1)(1995-1#1)
was not expressed in##6##4##(1992-8#1)(1993-3#1)(1994-3#1)(1995-1#1)(2008-8#1)(2010-12#1)
was not expressed##11##3##(1990-12#1)(1990-4#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-1#1)(1996-2#1)(2007-9#1)(2008-8#1)(2010-12#1)
was not feasible##2##3##(1995-7#1)(2011-1#1)
was not followed by##3##4##(1992-12#1)(1997-3#1)(2010-12#1)
was not formed##2##3##(1995-1#1)(2012-2#1)
was not found in any of the##4##7##(1991-8#1)(1995-4#1)(2006-8#1)(2007-12#1)
was not found in any##7##5##(1991-4#1)(1991-8#1)(1992-7#1)(1995-4#1)(2006-8#1)(2007-12#1)(2008-10#1)
was not found in the##4##5##(1991-9#1)(1994-12#1)(2006-8#1)(2007-4#1)
was not found in##25##4##(1991-12#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-7#1)(1992-9#1)(1993-3#1)(1994-12#1)(1995-4#1)(1996-8#1)(2006-10#1)(2006-8#2)(2007-12#1)(2007-4#1)(2008-10#4)(2008-9#1)(2009-4#1)(2011-2#1)(2012-1#1)
was not found to be related to##2##7##(2008-9#1)(2013-1#1)
was not found to be##8##5##(1996-6#1)(2007-7#1)(2008-10#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
was not found to##16##4##(1991-2#1)(1992-11#1)(1992-5#1)(1993-12#1)(1996-6#1)(2006-4#1)(2007-7#1)(2008-10#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
was not found##57##3##(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-4#1)(1996-2#1)(1996-6#1)(1996-8#1)(1996-9#1)(2006-10#1)(2006-4#1)(2006-8#3)(2007-12#1)(2007-4#1)(2007-7#2)(2008-10#7)(2008-5#2)(2008-6#2)(2008-9#2)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
was not fully appreciated##2##4##(2007-12#1)(2011-1#1)
was not fully##6##3##(2007-12#1)(2007-8#1)(2008-10#1)(2011-1#1)(2012-2#1)(2012-3#1)
was not generally##2##3##(1994-2#2)
was not generated##3##3##(1993-12#1)(1995-7#1)(1996-9#1)
was not given##4##3##(1990-6#1)(1992-9#1)(1994-6#1)(2006-8#1)
was not greater##2##3##(2008-4#1)(2008-5#1)
was not higher in##2##4##(1995-6#1)(2010-2#1)
was not higher##4##3##(1995-6#1)(2007-10#1)(2008-10#1)(2010-2#1)
was not identical to##2##4##(1994-8#1)(1997-3#1)
was not identified in##2##4##(2011-2#1)(2012-3#1)
was not identified##4##3##(2008-11#1)(2011-2#1)(2012-3#2)
was not impaired in##3##4##(1993-11#1)(2006-6#1)(2008-7#1)
was not impaired##9##3##(1993-11#1)(1995-8#1)(1996-9#1)(1997-6#1)(2004-4#1)(2006-6#1)(2008-4#1)(2008-7#2)
was not implemented##3##3##(2007-7#1)(2008-10#1)(2010-10#1)
was not improved##5##3##(1992-8#1)(2006-10#1)(2006-6#1)(2008-10#2)
was not in itself##2##4##(1990-12#1)(2007-6#1)
was not in the##2##4##(2008-10#1)(2011-12#1)
was not in##8##3##(1990-12#1)(1993-6#1)(1995-6#1)(2007-5#1)(2007-6#1)(2008-10#1)(2011-12#1)(2011-2#1)
was not increased after##2##4##(1994-2#2)
was not increased by##2##4##(1992-9#1)(1997-1#1)
was not increased in##2##4##(1990-11#1)(2004-12#1)
was not increased with##2##4##(2007-7#1)(2007-9#1)
was not increased##14##3##(1990-11#1)(1991-10#1)(1992-9#1)(1994-2#2)(1996-1#2)(1997-1#1)(2004-12#1)(2006-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)
was not indicative of##3##4##(2006-11#1)(2010-4#1)(2013-1#1)
was not induced by the##2##5##(1997-3#1)(2006-5#1)
was not induced by##6##4##(1990-7#1)(1995-5#1)(1997-3#1)(2006-5#1)(2011-2#1)(2012-2#1)
was not induced##10##3##(1990-7#1)(1992-12#1)(1994-8#1)(1995-5#1)(1996-12#1)(1997-3#1)(2006-5#1)(2008-10#1)(2011-2#1)(2012-2#1)
was not inducible##2##3##(1991-2#1)(1997-2#1)
was not inferior to##2##4##(2008-11#1)(2010-12#1)
was not influenced by the##7##5##(1990-12#1)(1991-9#1)(1994-6#1)(2008-10#2)(2008-11#1)(2008-12#1)
was not influenced by##20##4##(1990-12#3)(1990-2#2)(1991-11#1)(1991-12#2)(1991-9#1)(1994-6#1)(1995-2#1)(1996-12#1)(1997-8#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2011-2#1)
was not influenced##23##3##(1990-12#3)(1990-2#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-9#1)(1994-6#1)(1995-2#1)(1996-12#1)(1997-8#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2010-2#1)(2011-2#1)
was not informed##2##3##(1990-2#1)(2011-12#1)
was not inhibited by the##2##5##(1996-1#1)(1997-3#1)
was not inhibited by##22##4##(1990-2#3)(1991-7#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-4#1)(1994-11#1)(1995-1#1)(1995-10#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2013-1#1)
was not inhibited in##2##4##(1996-12#1)(2008-10#1)
was not inhibited##33##3##(1990-2#3)(1990-3#1)(1990-7#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-9#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-11#1)(1995-1#1)(1995-10#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#3)(2008-4#1)(2008-5#1)(2013-1#1)
was not initially considered##3##4##(2007-12#1)(2008-12#1)(2013-1#1)
was not investigated##2##3##(2008-10#1)(2011-2#1)
was not involved in the##4##5##(1994-6#1)(1995-2#1)(2008-10#2)
was not involved in##8##4##(1994-6#1)(1995-2#1)(1996-2#1)(1997-4#1)(1997-5#1)(2008-10#3)
was not involved##9##3##(1994-6#1)(1995-2#1)(1996-2#1)(1997-4#1)(1997-5#1)(2008-10#3)(2008-11#1)
was not known##8##3##(1990-12#1)(1992-8#1)(2007-10#1)(2007-7#2)(2008-10#2)(2008-12#1)
was not large##2##3##(1996-9#1)(2006-12#1)
was not lethal to##2##4##(2008-10#1)(2013-1#1)
was not lethal##3##3##(2008-10#2)(2013-1#1)
was not likely to##3##4##(1995-3#1)(2005-11#1)(2008-10#1)
was not likely##4##3##(1995-3#1)(2005-11#1)(2008-10#2)
was not lower##3##3##(2007-12#1)(2008-10#1)(2012-12#1)
was not made##4##3##(1992-8#1)(2007-11#1)(2007-4#1)(2008-7#1)
was not maintained##3##3##(1994-6#1)(2008-4#1)(2009-12#1)
was not mentioned in any##2##5##(1993-8#1)(2007-12#1)
was not mentioned in##3##4##(1993-8#1)(2007-12#1)(2008-7#1)
was not mentioned##7##3##(1993-3#1)(1993-8#1)(2007-12#1)(2008-7#3)(2012-12#1)
was not mimicked by##2##4##(1993-3#1)(2008-5#1)
was not mitogenic for##2##4##(1990-2#1)(1995-3#1)
was not modified by##6##4##(1991-8#1)(1994-8#1)(1995-12#1)(1997-6#1)(2008-10#1)(2009-9#1)
was not modified##16##3##(1991-8#1)(1994-8#2)(1995-12#2)(1995-9#1)(1997-2#1)(1997-6#1)(2006-7#1)(2008-1#1)(2008-10#1)(2008-3#2)(2009-9#1)(2013-1#2)
was not more effective than##3##5##(2008-8#2)(2012-12#1)
was not more##5##3##(2007-8#1)(2008-10#1)(2008-8#2)(2012-12#1)
was not mutagenic in##4##4##(1995-11#1)(2008-9#3)
was not necessarily##2##3##(1996-9#1)(2008-10#1)
was not necessary for##5##4##(1990-10#1)(1990-3#1)(1994-12#1)(2008-10#1)(2009-6#1)
was not necessary to##2##4##(1993-8#1)(2008-10#1)
was not necessary##10##3##(1990-10#1)(1990-3#1)(1993-8#1)(1994-12#1)(1995-2#1)(2008-10#3)(2009-6#1)(2013-8#1)
was not needed##2##3##(2007-6#1)(2008-11#1)
was not noted##4##3##(1993-4#1)(1996-11#1)(2010-9#1)(2013-1#1)
was not observed after inhibition of##2##6##(2010-12#2)
was not observed after##3##4##(1996-5#1)(2010-12#2)
was not observed during the##2##5##(1994-12#1)(1996-5#1)
was not observed following##2##4##(1997-5#1)(2009-5#1)
was not observed for the##2##5##(2005-11#1)(2012-1#1)
was not observed for##7##4##(1991-8#1)(1995-3#1)(2005-11#1)(2007-10#1)(2008-10#1)(2008-12#1)(2012-1#1)
was not observed in a##2##5##(2009-4#1)(2012-11#1)
was not observed in any##3##5##(1995-3#1)(1996-5#1)(2009-5#1)
was not observed in control##2##5##(1991-8#1)(2008-10#1)
was not observed in the presence of ATP##2##8##(1994-5#1)(1995-3#1)
was not observed in the presence of##3##7##(1994-11#1)(1994-5#1)(1995-3#1)
was not observed in the present##2##6##(1991-12#1)(2008-11#1)
was not observed in the##19##5##(1990-3#1)(1991-1#1)(1991-12#1)(1992-2#1)(1993-11#1)(1994-11#2)(1994-5#1)(1995-11#1)(1995-3#1)(2003-11#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-4#1)(2010-10#1)(2011-1#1)
was not observed in##54##4##(1990-3#1)(1991-1#1)(1991-12#3)(1991-8#1)(1992-2#1)(1992-6#1)(1993-11#1)(1994-11#2)(1994-3#1)(1994-5#1)(1995-11#1)(1995-3#2)(1995-5#3)(1995-8#1)(1996-12#1)(1996-5#3)(1996-8#2)(1997-4#1)(1997-6#1)(1997-8#2)(2003-11#1)(2004-4#1)(2006-5#1)(2007-3#1)(2007-7#1)(2008-10#5)(2008-11#3)(2008-3#2)(2008-4#1)(2009-4#1)(2009-5#1)(2010-10#2)(2011-1#1)(2012-11#1)(2012-12#2)
was not observed on##2##4##(2008-10#1)(2013-8#1)
was not observed under##2##4##(2006-10#1)(2007-12#1)
was not observed up to##2##5##(2007-12#1)(2008-10#1)
was not observed when the##2##5##(1992-3#1)(1994-5#1)
was not observed when##7##4##(1991-7#1)(1992-3#1)(1994-5#2)(1995-3#1)(2008-6#1)(2010-12#1)
was not observed with the##2##5##(1990-3#1)(1995-2#1)
was not observed with##5##4##(1990-3#1)(1993-8#1)(1995-1#1)(1995-2#1)(1996-11#1)
was not observed##129##3##(1990-10#1)(1990-12#1)(1990-3#2)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-7#1)(1991-8#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1993-11#1)(1993-4#1)(1993-8#3)(1994-11#2)(1994-12#2)(1994-3#1)(1994-5#4)(1994-7#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#4)(1995-5#3)(1995-8#1)(1996-11#2)(1996-12#1)(1996-5#5)(1996-6#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2003-11#1)(2004-4#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-5#2)(2007-1#1)(2007-10#1)(2007-12#3)(2007-3#1)(2007-7#2)(2008-10#13)(2008-11#5)(2008-12#2)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#2)(2009-4#1)(2009-5#2)(2009-9#1)(2010-10#2)(2010-12#3)(2010-2#1)(2011-1#2)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
was not obtained and##2##4##(2008-12#1)(2013-1#1)
was not obtained for##2##4##(2008-10#1)(2009-4#1)
was not obtained when##2##4##(1990-10#1)(1994-9#1)
was not obtained##8##3##(1990-10#1)(1994-9#1)(2008-10#2)(2008-12#2)(2009-4#1)(2013-1#1)
was not obvious##4##3##(2005-7#1)(2010-12#1)(2012-3#1)(2013-1#1)
was not of##3##3##(1993-2#1)(2008-10#2)
was not only the##3##4##(1992-6#1)(2006-12#1)(2011-2#1)
was not only##15##3##(1992-6#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#2)(2009-2#1)(2011-2#2)(2012-12#2)(2013-7#1)
was not otherwise##2##3##(1990-10#1)(2010-11#1)
was not paralleled by an increase in##2##7##(1992-1#1)(1994-5#1)
was not part of##2##4##(2011-2#1)(2012-3#1)
was not performed##7##3##(1996-3#1)(2005-10#1)(2007-11#1)(2008-4#1)(2012-2#1)(2013-8#2)
was not phosphorylated by##3##4##(1991-8#1)(1993-12#1)(1994-9#1)
was not possible as##2##4##(2008-5#1)(2012-2#1)
was not possible because of##3##5##(1991-11#1)(2008-10#1)(2008-3#1)
was not possible due to##2##5##(2007-8#1)(2009-6#1)
was not possible in##2##4##(2007-8#1)(2011-12#1)
was not possible to derive##2##5##(1997-1#1)(2008-5#1)
was not possible to identify##2##5##(2007-3#1)(2008-10#1)
was not possible to##22##4##(1992-3#1)(1992-9#1)(1996-12#1)(1997-1#1)(2005-11#1)(2006-4#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-5#2)(2008-7#1)(2010-2#1)(2013-7#1)(2013-8#1)
was not possible with the##2##5##(2008-10#1)(2008-3#1)
was not possible##43##3##(1990-7#1)(1991-11#1)(1992-3#1)(1992-7#1)(1992-9#1)(1996-12#1)(1997-1#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-7#2)(2007-8#3)(2008-10#10)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#1)(2009-6#1)(2010-2#1)(2011-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
was not powered to##2##4##(2008-5#1)(2010-10#1)
was not powered##3##3##(2008-5#1)(2010-10#1)(2013-1#1)
was not predictive of##3##4##(2007-2#1)(2008-9#1)(2011-2#1)
was not predictive##4##3##(2007-2#1)(2008-9#1)(2009-7#1)(2011-2#1)
was not present in control##2##5##(1993-8#1)(2005-10#1)
was not present in patients##2##5##(1995-6#1)(1997-2#1)
was not present in the##2##5##(1990-11#1)(2011-2#1)
was not present in##13##4##(1990-11#1)(1990-12#1)(1991-2#1)(1992-12#1)(1993-8#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-2#1)(2005-10#1)(2008-11#1)(2011-2#2)
was not present##24##3##(1990-11#1)(1990-12#1)(1991-11#1)(1991-2#1)(1992-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-10#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-8#1)(2005-10#1)(2008-10#1)(2008-11#1)(2008-9#2)(2011-2#3)(2013-1#1)
was not prevented by##3##4##(1990-10#1)(1990-2#1)(2008-4#1)
was not previously##3##3##(1996-2#1)(2008-2#1)(2008-9#1)
was not processed##3##3##(1992-11#1)(1992-3#1)(1993-3#1)
was not produced##3##3##(1997-8#1)(2005-12#1)(2008-11#1)
was not properly##3##3##(1995-6#2)(2008-11#1)
was not proportional to the##3##5##(1991-8#1)(2008-10#1)(2010-12#1)
was not random##2##3##(2008-10#1)(2008-8#1)
was not reached in##2##4##(2004-1#1)(2012-12#1)
was not reached##6##3##(1993-12#1)(1997-7#1)(2004-1#1)(2006-6#1)(2008-10#1)(2012-12#1)
was not readily##2##3##(1995-10#1)(1997-2#1)
was not recognized##4##3##(1993-8#1)(1995-2#1)(2006-9#1)(2008-10#1)
was not reduced by##5##4##(1990-2#1)(1991-5#1)(1995-2#1)(2007-2#1)(2008-10#1)
was not reduced in##3##4##(1993-12#1)(1995-3#1)(2011-2#1)
was not reduced##16##3##(1990-2#1)(1991-10#1)(1991-5#2)(1993-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(2004-9#1)(2007-2#1)(2008-10#3)(2008-5#1)(2011-2#1)(2013-7#1)
was not regulated by##3##4##(1995-8#1)(1997-2#1)(2010-10#1)
was not related to age##2##5##(2007-3#1)(2013-1#1)
was not related to any##2##5##(1993-9#1)(2008-10#1)
was not related to the##10##5##(1992-2#1)(1993-10#1)(1994-9#1)(1995-1#1)(1996-1#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-9#1)(2011-1#1)
was not related to##39##4##(1991-12#2)(1991-5#1)(1992-2#1)(1993-10#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-9#1)(1995-1#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-6#1)(2004-4#1)(2006-10#2)(2006-12#1)(2007-1#1)(2007-2#1)(2007-3#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#1)
was not related##41##3##(1990-10#1)(1991-12#2)(1991-5#1)(1991-8#1)(1992-2#1)(1993-10#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-9#1)(1995-1#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-6#1)(2004-4#1)(2006-10#2)(2006-12#1)(2007-1#1)(2007-2#1)(2007-3#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#1)
was not reliable##3##3##(1991-4#1)(2010-11#1)(2010-3#1)
was not relieved##3##3##(2006-12#1)(2012-12#1)(2012-2#1)
was not removed##4##3##(1991-10#1)(1995-2#2)(2009-3#1)
was not replicated##2##3##(2006-3#1)(2008-7#1)
was not reported in##2##4##(2010-12#1)(2010-9#1)
was not reported##6##3##(1993-6#1)(1994-3#1)(2008-12#1)(2010-12#1)(2010-9#1)(2012-12#1)
was not required for binding##2##5##(1992-12#1)(2008-10#1)
was not required for the##3##5##(1992-10#1)(1994-8#1)(2008-11#1)
was not required for##12##4##(1992-10#1)(1992-12#1)(1992-5#1)(1992-7#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-2#1)
was not required##20##3##(1992-10#1)(1992-12#1)(1992-5#1)(1992-7#1)(1994-11#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-3#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2010-2#1)(2012-2#1)(2013-1#1)
was not resolved##2##3##(1991-3#1)(2008-4#1)
was not responsible for the##4##5##(1992-7#1)(1992-8#1)(1996-5#1)(1996-8#1)
was not responsive to##2##4##(1996-8#1)(2008-1#1)
was not restricted by the##2##5##(1990-4#1)(2008-8#1)
was not restricted to##2##4##(2008-10#1)(2008-11#1)
was not restricted##4##3##(1990-4#1)(2008-10#1)(2008-11#1)(2008-8#1)
was not retained##2##3##(1992-6#1)(2008-10#1)
was not revealed##2##3##(2008-5#1)(2008-7#1)
was not reversed by##3##4##(1992-3#1)(1996-8#1)(2013-1#1)
was not satisfactory##3##3##(2007-7#1)(2011-1#1)(2012-12#1)
was not secreted into##2##4##(1994-11#1)(1997-2#1)
was not seen in##9##4##(1992-7#1)(1993-12#1)(1993-7#1)(1994-5#1)(1996-10#1)(2005-12#1)(2006-11#1)(2008-1#1)(2009-9#1)
was not seen until##3##4##(1995-10#1)(1997-3#2)
was not seen with##2##4##(2008-6#1)(2008-8#1)
was not seen##20##3##(1990-12#1)(1991-9#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-7#1)(1994-5#1)(1995-10#1)(1996-10#1)(1997-3#2)(2005-12#1)(2006-11#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-9#1)
was not selective for the##2##5##(1990-11#1)(2008-10#1)
was not selective##3##3##(1990-11#1)(1997-5#1)(2008-10#1)
was not sensitive to##6##4##(1990-8#1)(1991-3#1)(1991-8#1)(1993-9#1)(2008-11#1)(2012-3#1)
was not shown##6##3##(1992-3#1)(1995-1#1)(2006-10#1)(2008-11#1)(2009-10#1)(2010-4#1)
was not significant (P = 0##2##6##(1996-3#1)(2008-10#1)
was not significant (p##4##4##(1992-7#1)(2008-10#1)(2010-9#1)(2013-1#1)
was not significant between the##3##5##(2007-8#1)(2008-6#1)(2010-12#1)
was not significant between##5##4##(2007-8#1)(2008-6#1)(2010-12#1)(2011-2#1)(2013-8#1)
was not significant but##2##4##(2008-5#1)(2011-2#1)
was not significant in##3##4##(1994-11#1)(1995-8#1)(2013-7#1)
was not significant when compared##2##5##(2007-1#2)
was not significant##63##3##(1990-6#1)(1990-8#1)(1991-1#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-12#2)(1993-4#1)(1994-11#1)(1995-8#1)(1996-3#1)(2006-2#2)(2006-5#1)(2007-1#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#2)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
was not significantly affected by any##2##6##(1991-8#1)(2008-10#1)
was not significantly affected by the##3##6##(1996-12#1)(2008-10#1)(2008-5#1)
was not significantly affected by##16##5##(1990-5#1)(1991-1#1)(1991-8#1)(1996-12#1)(1996-5#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#1)(2009-12#1)(2010-4#1)(2010-5#1)
was not significantly affected##22##4##(1990-5#1)(1991-1#1)(1991-8#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-7#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-5#1)(2008-6#1)(2009-12#1)(2010-11#1)(2010-4#1)(2010-5#1)(2012-2#1)
was not significantly altered by the##2##6##(1991-2#1)(2006-9#1)
was not significantly altered by##4##5##(1991-2#1)(1992-1#1)(1995-12#1)(2006-9#1)
was not significantly altered in##3##5##(1995-6#1)(2008-10#1)(2008-9#1)
was not significantly altered##8##4##(1991-2#1)(1992-1#1)(1995-12#2)(1995-6#1)(2006-9#1)(2008-10#1)(2008-9#1)
was not significantly associated with##5##5##(1997-7#1)(2008-8#1)(2009-4#1)(2011-11#1)(2012-2#1)
was not significantly associated##6##4##(1997-7#1)(2008-8#1)(2009-4#1)(2011-11#1)(2012-12#1)(2012-2#1)
was not significantly changed by the##2##6##(2008-10#1)(2011-1#1)
was not significantly changed by##3##5##(1996-4#1)(2008-10#1)(2011-1#1)
was not significantly changed##5##4##(1992-6#1)(1995-6#1)(1996-4#1)(2008-10#1)(2011-1#1)
was not significantly different (P##2##5##(2008-10#2)
was not significantly different among the##2##6##(2008-7#1)(2013-1#1)
was not significantly different among##4##5##(2004-11#1)(2008-10#1)(2008-7#1)(2013-1#1)
was not significantly different between the two groups##3##8##(1995-12#1)(2006-10#1)(2007-4#1)
was not significantly different between the two##4##7##(1995-12#1)(2006-10#1)(2007-4#1)(2013-1#1)
was not significantly different between the##6##6##(1995-12#1)(2005-8#1)(2006-10#1)(2007-4#1)(2011-2#1)(2013-1#1)
was not significantly different between##12##5##(1991-5#1)(1991-8#1)(1993-11#1)(1995-12#1)(2005-8#2)(2006-10#1)(2007-4#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
was not significantly different from that of the##3##8##(1992-4#1)(2006-8#1)(2008-5#1)
was not significantly different from that of##6##7##(1990-8#1)(1992-4#1)(1992-7#1)(2006-8#1)(2007-12#1)(2008-5#1)
was not significantly different from that##8##6##(1990-8#1)(1992-4#1)(1992-7#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-5#1)
was not significantly different from the control##2##7##(1993-1#1)(2007-8#1)
was not significantly different from the mean##2##7##(2007-7#2)
was not significantly different from the##8##6##(1993-1#1)(1993-6#1)(2007-7#2)(2007-8#1)(2008-6#1)(2010-3#1)(2012-12#1)
was not significantly different from##24##5##(1990-8#1)(1991-8#1)(1992-4#1)(1992-7#1)(1993-1#1)(1993-6#1)(1995-1#1)(1995-8#1)(1996-12#1)(1997-6#1)(2006-8#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-9#1)(2010-3#1)(2012-12#1)(2013-1#1)
was not significantly different in the##2##6##(2007-4#1)(2008-8#1)
was not significantly different in##3##5##(2007-4#1)(2008-10#1)(2008-8#1)
was not significantly different than##2##5##(2008-10#1)(2009-12#1)
was not significantly different##57##4##(1990-8#1)(1991-5#1)(1991-8#2)(1992-12#1)(1992-4#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-6#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-6#2)(2004-11#1)(2005-8#2)(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-4#2)(2007-7#2)(2007-8#2)(2008-10#8)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
was not significantly elevated in the##2##6##(1991-2#1)(2004-10#1)
was not significantly higher##2##4##(1991-5#1)(2007-6#1)
was not significantly influenced by##4##5##(1990-8#1)(1991-2#1)(1996-10#1)(2010-8#1)
was not significantly inhibited by##2##5##(1990-7#1)(1994-12#1)
was not significantly inhibited##3##4##(1990-5#1)(1990-7#1)(1994-12#1)
was not significantly reduced by##2##5##(2008-10#1)(2009-11#1)
was not significantly reduced##8##4##(1990-12#1)(1993-9#1)(1994-9#1)(1997-8#1)(2008-10#1)(2008-9#1)(2009-11#1)(2012-2#1)
was not significantly related to##6##5##(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2012-12#2)
was not significantly##142##3##(1990-12#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-2#3)(1991-5#2)(1991-8#3)(1992-1#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-9#2)(1995-1#1)(1995-12#3)(1995-6#2)(1995-8#1)(1996-10#1)(1996-12#3)(1996-4#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#2)(1997-8#2)(2004-10#1)(2004-11#1)(2005-11#1)(2005-8#2)(2006-10#2)(2006-5#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#3)(2007-6#1)(2007-7#3)(2007-8#3)(2008-1#2)(2008-10#18)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-11#1)(2011-12#2)(2011-2#1)(2012-12#4)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#1)
was not simply due to##2##5##(1992-7#1)(2008-11#1)
was not simply##3##3##(1992-7#1)(2007-11#1)(2008-11#1)
was not so##7##3##(1990-12#1)(1991-9#1)(1992-9#1)(1993-8#1)(2007-10#1)(2007-7#1)(2008-10#1)
was not solely##2##3##(2008-5#1)(2010-7#1)
was not solubilized##2##3##(1991-10#1)(1991-5#1)
was not specific to##3##4##(1994-3#1)(1995-1#1)(2008-10#1)
was not specifically##2##3##(1997-4#1)(2008-10#1)
was not stable##3##3##(1994-9#1)(2007-11#1)(2007-8#1)
was not stated##3##3##(1995-2#1)(1997-7#1)(2007-2#1)
was not statistically different between##2##5##(1990-3#1)(2012-2#1)
was not statistically different from that in##2##7##(1992-5#1)(1993-4#1)
was not statistically different from that##3##6##(1992-5#1)(1993-4#1)(2012-3#1)
was not statistically different from##5##5##(1992-5#1)(1993-4#1)(2008-10#1)(2011-1#1)(2012-3#1)
was not statistically different##8##4##(1990-3#1)(1991-12#1)(1992-5#1)(1993-4#1)(2008-10#1)(2011-1#1)(2012-2#1)(2012-3#1)
was not statistically significant (p = 0##5##7##(1991-4#1)(2006-12#1)(2007-2#1)(2008-9#1)(2012-2#1)
was not statistically significant at##3##5##(2006-7#1)(2007-1#1)(2008-12#1)
was not statistically significant in##2##5##(1992-1#1)(2008-7#1)
was not statistically significant##54##4##(1990-11#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#1)(1993-2#1)(1996-12#2)(1997-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-2#2)(2007-4#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#2)(2009-6#1)(2009-8#1)(2010-2#2)(2010-7#1)(2011-2#2)(2012-12#3)(2012-2#2)(2013-1#1)(2013-8#2)
was not statistically##65##3##(1990-11#1)(1990-3#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-5#1)(1993-2#1)(1993-4#1)(1996-12#2)(1997-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-2#2)(2007-4#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#2)(2009-6#1)(2009-8#1)(2010-2#3)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
was not stimulated by##6##4##(1990-11#1)(1991-10#1)(1991-2#1)(1992-3#1)(1995-10#1)(1996-5#1)
was not stimulated##10##3##(1990-11#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-3#1)(1993-11#1)(1995-10#1)(1996-5#1)
was not strong##2##3##(2009-7#1)(2010-8#1)
was not strongly##2##3##(2008-10#1)(2012-1#1)
was not subject to##2##4##(1991-7#1)(2008-10#1)
was not substantially influenced by the##2##6##(1994-1#1)(1994-6#1)
was not substantially##5##3##(1994-1#1)(1994-6#1)(1997-2#1)(2004-4#1)(2008-10#1)
was not successful##10##3##(1997-3#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-5#1)(2013-1#1)
was not sufficient for##3##4##(1991-12#1)(2008-10#1)(2012-2#1)
was not sufficient to##6##4##(1994-8#1)(1994-9#1)(1995-6#1)(1995-7#1)(1996-12#1)(1997-7#1)
was not sufficient##10##3##(1991-12#1)(1994-8#1)(1994-9#1)(1995-6#1)(1995-7#1)(1996-12#1)(1997-7#1)(2008-10#1)(2010-3#1)(2012-2#1)
was not sufficiently##2##3##(1997-8#1)(2007-1#1)
was not suitable##2##3##(1996-7#1)(2008-10#1)
was not superior to##2##4##(1997-8#1)(2010-12#1)
was not superior##3##3##(1997-8#1)(2010-12#1)(2013-1#1)
was not supported by##3##4##(1996-1#1)(1997-8#1)(2006-12#1)
was not supported##6##3##(1990-2#1)(1996-1#1)(1997-5#1)(1997-8#1)(2006-10#1)(2006-12#1)
was not suppressed##5##3##(1993-12#1)(1997-2#1)(2008-10#2)(2011-1#1)
was not suspected##4##3##(2006-4#1)(2007-12#1)(2007-7#2)
was not sustained##2##3##(1994-2#1)(1995-7#1)
was not synergistic##2##3##(1991-7#1)(1995-10#1)
was not taken up by##2##5##(1994-12#1)(2008-11#1)
was not taken##4##3##(1994-12#1)(1995-3#1)(2008-11#1)(2009-5#1)
was not the case for##5##5##(1991-4#1)(1993-4#1)(2006-7#1)(2008-11#1)(2011-2#1)
was not the case in##2##5##(1991-5#1)(2007-9#1)
was not the case##10##4##(1991-4#1)(1991-5#1)(1993-4#1)(1993-5#1)(1994-5#1)(2006-7#1)(2007-9#1)(2008-11#1)(2008-6#1)(2011-2#1)
was not the direct cause of##2##6##(2006-12#1)(2008-1#1)
was not the primary cause of##2##6##(1996-12#1)(2005-8#1)
was not the result of##5##5##(1990-11#1)(1992-1#1)(1996-2#1)(1997-1#1)(2008-12#1)
was not the same for##2##5##(1995-6#1)(1997-8#1)
was not the same##4##4##(1995-6#1)(1997-2#1)(1997-8#1)(2008-10#1)
was not the##32##3##(1990-11#1)(1990-4#1)(1991-4#1)(1991-5#1)(1992-1#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2011-2#1)(2013-8#1)
was not to##3##3##(1995-6#1)(2006-4#1)(2011-12#1)
was not tolerated##2##3##(1990-4#1)(2010-1#1)
was not toxic to the##2##5##(1996-6#1)(2008-7#1)
was not toxic to##3##4##(1996-6#1)(2008-10#1)(2008-7#1)
was not transmitted##3##3##(2008-10#3)
was not treated##2##3##(2006-4#1)(2006-7#1)
was not uniform##3##3##(1997-6#1)(2008-11#1)(2010-8#1)
was not until the##2##4##(2009-4#1)(2012-2#1)
was not until##6##3##(2008-1#1)(2008-7#1)(2009-4#1)(2012-2#3)
was not used to##4##4##(1990-4#1)(1992-3#1)(1996-12#1)(2008-3#1)
was not used##14##3##(1990-4#1)(1992-11#1)(1992-3#1)(1993-10#1)(1993-5#1)(1994-12#1)(1996-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-7#1)(2012-12#1)(2013-1#1)
was not utilized##3##3##(2007-7#2)(2010-11#1)
was not visible in##3##4##(2005-11#1)(2007-11#1)(2008-11#1)
was not visible##4##3##(1992-7#1)(2005-11#1)(2007-11#1)(2008-11#1)
was not voltage-dependent##2##3##(1996-8#2)
was not well separated from cytotoxicity##2##6##(1997-2#2)
was not well##5##3##(1997-2#2)(2008-10#1)(2012-3#1)(2013-1#1)
was not yet##4##3##(1993-3#1)(2008-2#1)(2012-2#1)(2013-1#1)
was not##2405##2##(1990-1#3)(1990-10#8)(1990-11#12)(1990-12#20)(1990-2#19)(1990-3#11)(1990-4#8)(1990-5#12)(1990-6#10)(1990-7#19)(1990-8#11)(1990-9#7)(1991-1#7)(1991-10#6)(1991-11#8)(1991-12#18)(1991-2#17)(1991-3#11)(1991-4#7)(1991-5#12)(1991-6#6)(1991-7#12)(1991-8#17)(1991-9#14)(1992-1#7)(1992-10#4)(1992-11#9)(1992-12#11)(1992-2#7)(1992-3#13)(1992-4#9)(1992-5#8)(1992-6#8)(1992-7#16)(1992-8#13)(1992-9#18)(1993-1#6)(1993-10#2)(1993-11#10)(1993-12#20)(1993-2#8)(1993-3#15)(1993-4#11)(1993-5#3)(1993-6#17)(1993-7#2)(1993-8#14)(1993-9#12)(1994-1#3)(1994-10#3)(1994-11#18)(1994-12#25)(1994-2#15)(1994-3#13)(1994-4#1)(1994-5#11)(1994-6#12)(1994-7#2)(1994-8#17)(1994-9#15)(1995-1#19)(1995-10#12)(1995-11#9)(1995-12#15)(1995-2#22)(1995-3#17)(1995-4#3)(1995-5#19)(1995-6#14)(1995-7#6)(1995-8#8)(1995-9#5)(1996-1#8)(1996-10#6)(1996-11#8)(1996-12#23)(1996-2#13)(1996-3#8)(1996-4#2)(1996-5#15)(1996-6#18)(1996-7#6)(1996-8#11)(1996-9#11)(1997-1#10)(1997-2#21)(1997-3#15)(1997-4#11)(1997-5#14)(1997-6#20)(1997-7#15)(1997-8#18)(2003-11#1)(2004-1#1)(2004-10#2)(2004-11#3)(2004-12#4)(2004-2#3)(2004-4#5)(2004-9#2)(2005-10#6)(2005-11#12)(2005-12#6)(2005-7#7)(2005-8#4)(2005-9#1)(2006-10#21)(2006-11#5)(2006-12#13)(2006-2#3)(2006-3#3)(2006-4#9)(2006-5#8)(2006-6#6)(2006-7#11)(2006-8#12)(2006-9#5)(2007-1#9)(2007-10#10)(2007-11#20)(2007-12#16)(2007-2#11)(2007-3#12)(2007-4#9)(2007-5#5)(2007-6#12)(2007-7#29)(2007-8#39)(2007-9#11)(2008-1#17)(2008-10#264)(2008-11#55)(2008-12#24)(2008-2#8)(2008-3#19)(2008-4#24)(2008-5#51)(2008-6#16)(2008-7#41)(2008-8#23)(2008-9#27)(2009-10#11)(2009-11#2)(2009-12#3)(2009-2#5)(2009-3#8)(2009-4#7)(2009-5#6)(2009-6#8)(2009-7#6)(2009-8#3)(2009-9#5)(2010-1#5)(2010-10#6)(2010-11#8)(2010-12#24)(2010-2#12)(2010-3#7)(2010-4#7)(2010-5#4)(2010-6#3)(2010-7#4)(2010-8#10)(2010-9#6)(2011-1#21)(2011-11#1)(2011-12#6)(2011-2#53)(2011-3#1)(2012-1#9)(2012-11#4)(2012-12#40)(2012-2#38)(2012-3#21)(2012-6#1)(2013-1#55)(2013-7#9)(2013-8#26)
was notable##4##2##(1992-8#1)(1995-12#1)(2005-7#1)(2011-2#1)
was notably##4##2##(2008-7#1)(2010-12#1)(2010-6#1)(2013-8#1)
was noted 3##2##3##(1990-5#1)(1991-5#1)
was noted after##2##3##(1990-2#1)(2006-10#1)
was noted among##4##3##(2007-2#1)(2007-7#2)(2013-8#1)
was noted and##2##3##(2008-7#1)(2012-12#1)
was noted as the##2##4##(1992-5#1)(2008-9#1)
was noted as##5##3##(1992-5#1)(1995-3#1)(2007-8#1)(2008-12#1)(2008-9#1)
was noted at the##4##4##(1990-3#1)(2006-4#1)(2008-7#1)(2013-1#1)
was noted at##11##3##(1990-3#1)(1993-12#1)(1994-2#1)(2005-7#1)(2006-10#1)(2006-4#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-7#1)(2013-1#1)
was noted between the##3##4##(2007-7#1)(2008-4#1)(2008-7#1)
was noted between##11##3##(2007-7#1)(2008-1#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#1)(2012-7#1)(2013-1#1)
was noted following##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
was noted for either##2##4##(1994-5#1)(1995-5#1)
was noted for the##4##4##(2008-10#1)(2008-9#1)(2010-3#1)(2013-8#1)
was noted for##11##3##(1993-3#1)(1994-5#1)(1995-5#1)(2006-8#2)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-3#1)(2013-8#1)
was noted in a##2##4##(1993-3#1)(2008-5#1)
was noted in all patients##2##5##(1997-1#1)(2006-7#1)
was noted in all##4##4##(1997-1#1)(2006-7#1)(2008-10#1)(2009-3#1)
was noted in both##5##4##(1990-10#1)(1995-11#1)(2008-10#1)(2012-1#1)(2013-8#1)
was noted in five##2##4##(2006-12#1)(2008-9#1)
was noted in patients with hypoalbuminemia##2##6##(2013-1#2)
was noted in patients with##3##5##(2012-12#1)(2013-1#2)
was noted in patients##6##4##(1993-9#1)(1997-1#1)(2007-9#1)(2012-12#1)(2013-1#2)
was noted in the presence of##2##6##(1992-3#1)(1993-12#1)
was noted in the##26##4##(1990-4#1)(1991-12#1)(1991-4#1)(1992-3#1)(1993-12#1)(1996-12#1)(1996-9#1)(1997-1#1)(2004-11#1)(2005-11#2)(2006-10#2)(2006-12#1)(2008-11#1)(2008-12#1)(2009-1#1)(2009-7#1)(2010-12#2)(2010-3#1)(2010-6#1)(2012-1#1)(2013-8#3)
was noted in three patients##3##5##(1990-8#1)(2006-12#1)(2008-6#1)
was noted in two other##2##5##(2007-7#1)(2007-8#1)
was noted in two##4##4##(2007-7#1)(2007-8#2)(2012-2#1)
was noted in##92##3##(1990-10#1)(1990-4#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#2)(1995-11#1)(1995-9#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-5#1)(2004-11#1)(2005-10#1)(2005-11#3)(2006-10#2)(2006-12#3)(2006-2#1)(2006-7#2)(2007-11#2)(2007-5#1)(2007-7#3)(2007-8#4)(2007-9#5)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#2)(2009-1#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-12#3)(2010-3#1)(2010-6#1)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#4)
was noted on the##3##4##(2006-11#1)(2009-12#1)(2010-7#1)
was noted on##5##3##(2006-11#1)(2006-12#1)(2009-12#1)(2010-7#1)(2012-8#1)
was noted that the##3##4##(1997-2#1)(2006-2#1)(2008-9#1)
was noted that##17##3##(1990-4#1)(1992-3#1)(1993-3#1)(1994-3#1)(1995-12#1)(1997-2#1)(2005-8#1)(2006-2#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-12#1)(2013-8#1)
was noted to be##6##4##(2005-12#1)(2006-10#1)(2011-2#1)(2012-2#2)(2013-1#1)
was noted to have##6##4##(2006-12#1)(2008-1#1)(2008-4#1)(2009-4#1)(2011-1#1)(2013-1#1)
was noted to##14##3##(2005-12#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-4#2)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
was noted when##7##3##(1992-3#1)(1995-5#1)(1996-3#1)(1996-4#1)(1997-2#1)(2008-10#1)(2009-2#1)
was noted with##8##3##(1994-8#1)(1995-3#1)(1995-5#1)(1997-3#1)(2007-1#1)(2007-7#2)(2008-6#1)
was noted within##2##3##(2006-7#1)(2007-2#1)
was noted##265##2##(1990-10#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-2#1)(1992-3#3)(1992-5#3)(1992-6#1)(1993-12#3)(1993-3#3)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#3)(1995-6#2)(1995-9#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(2004-11#1)(2005-10#2)(2005-11#4)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#7)(2006-11#1)(2006-12#5)(2006-2#2)(2006-4#1)(2006-7#3)(2006-8#3)(2007-1#1)(2007-11#3)(2007-12#3)(2007-2#4)(2007-5#1)(2007-7#12)(2007-8#10)(2007-9#6)(2008-1#4)(2008-10#10)(2008-11#2)(2008-12#4)(2008-3#1)(2008-4#5)(2008-5#4)(2008-6#4)(2008-7#4)(2008-9#9)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#5)(2009-3#3)(2009-4#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-6#1)(2010-7#1)(2011-1#4)(2011-12#1)(2011-2#10)(2012-1#2)(2012-12#3)(2012-2#7)(2012-3#4)(2012-7#1)(2012-8#1)(2013-1#10)(2013-7#2)(2013-8#8)
was noticeable in##2##3##(1994-6#1)(2008-5#1)
was noticeable##7##2##(1992-5#1)(1994-6#1)(1996-3#1)(1996-7#1)(2008-3#1)(2008-5#2)
was noticeably##4##2##(1994-2#1)(1997-1#1)(2005-11#1)(2008-10#1)
was noticed after##2##3##(2007-11#1)(2007-7#1)
was noticed for the##2##4##(2007-11#1)(2009-6#1)
was noticed for##3##3##(1990-12#1)(2007-11#1)(2009-6#1)
was noticed in the##2##4##(2007-11#1)(2013-1#1)
was noticed in##10##3##(2005-10#1)(2006-11#1)(2007-11#1)(2007-7#1)(2008-10#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
was noticed on the##3##4##(2008-11#1)(2010-12#1)(2010-8#1)
was noticed that the##2##4##(2007-11#1)(2012-3#1)
was noticed that##7##3##(2006-4#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#1)(2012-3#1)
was noticed to##2##3##(2007-12#1)(2007-7#1)
was noticed##43##2##(1990-12#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-4#2)(2006-9#1)(2007-11#4)(2007-12#1)(2007-7#4)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-6#2)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
was notified of##2##3##(1991-6#1)(1996-3#1)
was notified that##2##3##(1992-5#1)(1993-7#1)
was notified##5##2##(1991-6#1)(1992-5#1)(1993-7#1)(1995-5#1)(1996-3#1)
was now##7##2##(1991-9#1)(1992-11#1)(1994-9#1)(1995-5#1)(1997-3#1)(2005-4#1)(2008-6#1)
was numerically##2##2##(2007-12#1)(2008-10#1)
was obeyed over the range 0##2##6##(2008-10#2)
was obeyed over the range of 0##2##7##(2008-10#2)
was obeyed over the range##6##5##(2008-10#6)
was obeyed over the##8##4##(2008-10#8)
was obeyed##17##2##(2008-10#15)(2010-2#1)(2011-1#1)
was objectified by##2##3##(1992-12#1)(2007-8#1)
was obliterated##3##2##(2006-12#1)(2006-6#1)(2009-3#1)
was obscure##2##2##(2007-10#1)(2011-2#1)
was obscured##2##2##(1995-11#1)(2008-2#1)
was observed (P##2##3##(1992-1#1)(2013-1#1)
was observed (n =##2##4##(1996-5#1)(2008-5#1)
was observed 1##2##3##(2008-10#1)(2013-1#1)
was observed 4##2##3##(1995-12#1)(2008-11#1)
was observed a##7##3##(1991-6#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-11#2)(2011-2#1)
was observed about##2##3##(1991-8#1)(2012-2#1)
was observed above the##2##4##(1991-2#1)(2013-8#1)
was observed above##3##3##(1991-2#1)(2006-10#1)(2013-8#1)
was observed after 24##3##4##(2007-12#1)(2008-5#1)(2008-8#1)
was observed after 4##2##4##(1992-10#1)(2008-5#1)
was observed after 8 h with##2##6##(2008-7#2)
was observed after a##2##4##(1995-12#1)(1995-5#1)
was observed after addition of##3##5##(1993-8#1)(1994-4#1)(2013-1#1)
was observed after the##5##4##(1993-8#1)(1994-6#1)(1995-2#1)(1996-9#1)(2011-2#1)
was observed after treatment with##3##5##(1990-4#1)(1995-2#1)(1995-8#1)
was observed after treatment##4##4##(1990-4#1)(1992-6#1)(1995-2#1)(1995-8#1)
was observed after##51##3##(1990-3#1)(1990-4#2)(1990-5#1)(1990-9#1)(1991-12#1)(1992-10#1)(1992-6#1)(1993-12#1)(1993-4#1)(1993-8#2)(1994-4#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-7#1)(2003-11#1)(2004-3#1)(2006-1#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-10#1)(2008-5#5)(2008-7#2)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#1)
was observed against##5##3##(1997-1#2)(2008-10#1)(2008-5#1)(2012-12#1)
was observed along the##2##4##(1991-9#1)(2010-8#1)
was observed along with##2##4##(1995-5#1)(2008-10#1)
was observed along##4##3##(1991-9#1)(1995-5#1)(2008-10#1)(2010-8#1)
was observed among accessions of##2##5##(2008-5#1)(2012-2#1)
was observed among isolates of##2##5##(2008-10#1)(2012-2#1)
was observed among isolates##4##4##(2008-10#3)(2012-2#1)
was observed among patients##2##4##(1991-10#1)(2012-2#1)
was observed among strains##2##4##(2005-11#1)(2008-10#1)
was observed among the##3##4##(1996-8#1)(2008-10#1)(2012-2#1)
was observed among these##2##4##(2008-8#1)(2011-2#1)
was observed among##24##3##(1991-10#1)(1996-8#1)(2005-11#1)(2007-3#1)(2007-9#1)(2008-10#8)(2008-2#1)(2008-5#1)(2008-8#1)(2010-9#1)(2011-2#2)(2012-2#4)(2012-3#1)
was observed and correlated with##2##5##(2008-10#1)(2013-8#1)
was observed and no##2##4##(2006-8#1)(2008-10#1)
was observed and the detection##2##5##(2008-10#2)
was observed and the##6##4##(1994-3#1)(2008-10#2)(2008-8#1)(2012-1#1)(2013-8#1)
was observed and##21##3##(1992-6#1)(1994-3#1)(1995-10#1)(2006-8#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-8#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-8#2)
was observed around##2##3##(1994-5#1)(2008-10#1)
was observed as compared to##2##5##(2011-2#1)(2013-8#1)
was observed as compared##3##4##(1992-6#1)(2011-2#1)(2013-8#1)
was observed as early as##3##5##(1994-12#1)(1996-5#1)(2010-12#1)
was observed as the##3##4##(1991-8#1)(2007-11#1)(2008-5#1)
was observed as##12##3##(1991-2#1)(1991-8#1)(1992-6#1)(1994-12#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
was observed at -75mmHg when compared to##2##7##(2007-8#2)
was observed at 1##2##4##(2007-9#1)(2008-12#1)
was observed at 100##2##4##(1994-10#1)(1994-11#1)
was observed at 2##2##4##(2012-2#1)(2013-1#1)
was observed at 20##4##4##(1990-9#2)(1994-3#1)(2008-10#1)
was observed at 24##2##4##(1995-12#1)(2007-10#1)
was observed at 30 min##2##5##(1996-12#1)(2013-8#1)
was observed at 30##3##4##(1994-12#1)(1996-12#1)(2013-8#1)
was observed at 6##2##4##(1994-11#1)(1995-8#1)
was observed at 8##2##4##(1994-6#1)(1997-3#1)
was observed at a##5##4##(1992-8#1)(1994-12#1)(1995-1#1)(2007-11#1)(2008-8#1)
was observed at all##4##4##(1995-5#1)(2006-10#1)(2007-11#1)(2008-10#1)
was observed at approximately##2##4##(1990-2#1)(2008-10#1)
was observed at concentrations##3##4##(1991-9#1)(1997-1#1)(2008-10#1)
was observed at different##2##4##(2007-12#1)(2008-10#1)
was observed at high concentrations##3##5##(1991-2#1)(2008-12#2)
was observed at high##7##4##(1991-2#1)(1994-3#1)(1994-5#1)(2007-1#1)(2008-10#1)(2008-12#2)
was observed at higher##3##4##(1991-10#1)(2008-10#2)
was observed at low##2##4##(2007-12#1)(2008-10#1)
was observed at pH##3##4##(1992-2#1)(2007-10#1)(2008-10#1)
was observed at the##13##4##(1990-10#1)(1991-5#1)(1993-6#1)(1994-9#1)(1996-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-8#1)(2012-3#1)(2013-1#1)
was observed at##117##3##(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-9#2)(1991-10#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-12#2)(1993-6#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#3)(1995-8#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-5#1)(2003-11#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#1)(2007-8#3)(2007-9#1)(2008-10#25)(2008-11#3)(2008-12#4)(2008-3#1)(2008-4#2)(2008-6#3)(2008-7#2)(2008-8#2)(2009-12#1)(2009-6#4)(2010-11#1)(2010-8#2)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
was observed because of##3##4##(2008-12#1)(2009-4#1)(2012-12#1)
was observed because##4##3##(2008-10#1)(2008-12#1)(2009-4#1)(2012-12#1)
was observed before##2##3##(2004-9#1)(2007-2#1)
was observed between the different##2##5##(2006-5#1)(2008-10#1)
was observed between the two methods##2##6##(2008-10#1)(2011-2#1)
was observed between the two##6##5##(1990-2#1)(1992-10#1)(2008-10#1)(2008-5#1)(2011-12#1)(2011-2#1)
was observed between the##52##4##(1990-2#1)(1990-7#1)(1991-2#1)(1992-10#1)(1992-8#2)(1994-6#1)(1995-8#1)(1996-10#1)(1996-12#1)(1997-4#1)(1997-6#1)(2004-11#2)(2004-12#1)(2004-2#1)(2005-11#1)(2006-3#1)(2006-4#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-9#1)(2011-12#1)(2011-2#3)(2013-1#1)(2013-8#1)
was observed between##125##3##(1990-10#2)(1990-2#2)(1990-4#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-6#1)(1992-10#1)(1992-12#1)(1992-8#2)(1993-9#3)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-5#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-6#1)(2004-11#2)(2004-12#1)(2004-2#1)(2004-9#1)(2005-11#2)(2005-12#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#25)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#5)(2008-7#4)(2009-4#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-8#1)(2010-9#1)(2011-12#2)(2011-2#5)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#2)
was observed bilaterally in##2##4##(1996-1#1)(1996-12#1)
was observed both in##3##4##(1993-9#1)(1995-5#2)
was observed both##4##3##(1993-9#1)(1995-5#2)(2008-5#1)
was observed but##2##3##(1990-7#1)(2005-12#1)
was observed by means of the##2##6##(1994-5#1)(2008-6#1)
was observed by the addition of##3##6##(1992-6#1)(1994-12#1)(1997-2#1)
was observed by the##4##4##(1992-6#1)(1994-12#1)(1997-2#1)(2007-10#1)
was observed by transmission electron microscopy##2##6##(2005-11#2)
was observed by using##4##4##(2008-10#2)(2008-2#1)(2008-8#1)
was observed by##37##3##(1990-2#1)(1991-5#1)(1991-8#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-4#1)(1994-12#1)(1994-5#1)(1996-11#1)(1997-2#1)(2005-11#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#5)(2008-6#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-3#1)(2012-3#1)
was observed despite##2##3##(2010-12#1)(2012-3#1)
was observed due to the##2##5##(1997-1#1)(2008-10#1)
was observed due to##3##4##(1997-1#1)(2008-10#2)
was observed during the first##2##5##(2009-4#1)(2012-3#1)
was observed during the##18##4##(1990-3#2)(1993-4#1)(1994-5#1)(1997-3#1)(2005-12#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-5#1)(2011-1#1)(2012-3#1)
was observed during##36##3##(1990-3#2)(1993-4#1)(1994-5#1)(1996-3#1)(1996-6#1)(1997-3#1)(2005-12#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-4#1)(2010-5#1)(2011-1#2)(2011-12#1)(2012-2#1)(2012-3#1)
was observed either##2##3##(2009-4#1)(2012-2#1)
was observed even in the##2##5##(1994-5#1)(1996-5#1)
was observed even##3##3##(1994-5#1)(1996-5#1)(1997-2#1)
was observed experimentally##2##3##(2007-11#1)(2008-3#1)
was observed following microinjections of##2##5##(1990-7#1)(1993-12#1)
was observed following##10##3##(1990-7#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-1#1)(1996-9#1)(2008-5#1)
was observed for a##3##4##(1990-10#1)(1992-1#1)(1995-1#1)
was observed for all the##2##5##(1990-6#1)(2005-11#1)
was observed for all##9##4##(1990-6#1)(1991-8#1)(1997-4#1)(2005-11#1)(2006-7#1)(2008-9#1)(2010-2#1)(2011-12#1)(2012-1#1)
was observed for both##5##4##(1995-2#1)(2008-10#2)(2010-5#1)(2011-2#1)
was observed for each##3##4##(1996-12#1)(2007-12#1)(2007-6#1)
was observed for either##4##4##(2004-11#1)(2008-1#1)(2008-10#1)(2009-2#1)
was observed for mutant##2##4##(1994-11#1)(1995-1#1)
was observed for the first time##3##6##(2008-10#1)(2008-12#1)(2008-9#1)
was observed for the first##4##5##(2004-9#1)(2008-10#1)(2008-12#1)(2008-9#1)
was observed for the##34##4##(1990-10#1)(1990-11#1)(1991-9#1)(1992-11#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-5#1)(1995-11#1)(1997-7#1)(2004-9#1)(2005-11#2)(2007-12#1)(2007-9#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-1#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
was observed for##158##3##(1990-10#3)(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#3)(1990-6#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-9#1)(1993-12#1)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-5#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-12#2)(1996-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-11#2)(2004-9#1)(2005-11#4)(2006-7#1)(2006-8#1)(2007-1#2)(2007-12#4)(2007-2#1)(2007-6#3)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#21)(2008-11#8)(2008-12#3)(2008-2#2)(2008-3#4)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#3)(2011-12#1)(2011-2#4)(2012-1#3)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
was observed from the##6##4##(1991-9#1)(1992-5#1)(1994-2#1)(2008-10#2)(2012-3#1)
was observed from##23##3##(1991-9#1)(1992-5#1)(1994-2#1)(1995-2#1)(1997-2#1)(2007-12#1)(2007-8#2)(2008-10#10)(2008-11#2)(2008-12#2)(2012-3#1)
was observed if the##2##4##(2008-10#1)(2008-6#1)
was observed if##3##3##(1990-9#1)(2008-10#1)(2008-6#1)
was observed in 1##2##4##(1992-1#1)(2013-8#1)
was observed in 10##5##4##(1990-6#1)(1991-2#1)(1994-7#1)(2007-7#2)
was observed in 11##3##4##(2005-1#1)(2006-10#1)(2013-7#1)
was observed in 14 patients##2##5##(1991-4#1)(2013-1#1)
was observed in 14##4##4##(1991-4#1)(2007-11#1)(2007-8#1)(2013-1#1)
was observed in 15##2##4##(1993-10#1)(2008-7#1)
was observed in 16##3##4##(1990-2#1)(2007-11#1)(2008-5#1)
was observed in 2##3##4##(1992-12#1)(2007-6#1)(2008-9#1)
was observed in 23##2##4##(2008-5#1)(2008-7#1)
was observed in 28##2##4##(1991-8#1)(2005-8#1)
was observed in 29##2##4##(2007-8#1)(2011-2#1)
was observed in 3 patients##4##5##(1991-8#1)(1994-4#1)(1997-7#1)(2007-7#1)
was observed in 3##5##4##(1991-8#1)(1992-8#1)(1994-4#1)(1997-7#1)(2007-7#1)
was observed in 31 patients##2##5##(2011-2#2)
was observed in 35%##2##4##(1991-10#1)(2011-2#1)
was observed in 4 cases##5##5##(1991-2#1)(1995-10#1)(2007-11#1)(2007-7#2)
was observed in 40% of##2##5##(2006-7#1)(2008-5#1)
was observed in 50% of##2##5##(1991-6#1)(2008-5#1)
was observed in 50%##3##4##(1991-6#1)(2008-5#1)(2012-1#1)
was observed in 6##2##4##(1997-3#1)(2013-8#1)
was observed in 7 patients##2##5##(2007-10#1)(2007-7#1)
was observed in 7##3##4##(2007-10#1)(2007-7#1)(2008-5#1)
was observed in 70% of##2##5##(2006-6#1)(2008-4#1)
was observed in 8##2##4##(2007-9#1)(2013-1#1)
was observed in 9##2##4##(1991-11#1)(1993-5#1)
was observed in EMR-F and EMR-A groups##3##7##(2008-12#3)
was observed in a patient##2##5##(1992-11#1)(2006-2#1)
was observed in a range##2##5##(1993-9#1)(2010-4#1)
was observed in a variety of##2##6##(1990-6#1)(2012-12#1)
was observed in a##24##4##(1990-6#1)(1991-8#1)(1992-11#1)(1992-6#1)(1992-7#2)(1993-9#1)(1994-12#1)(1994-2#1)(1996-1#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-9#1)(2010-4#1)(2012-12#1)
was observed in about##3##4##(1990-10#1)(2008-11#2)
was observed in adults##2##4##(2006-4#1)(2008-10#1)
was observed in all cases##4##5##(2004-4#1)(2007-12#1)(2008-5#1)(2013-7#1)
was observed in all patients##3##5##(2007-11#1)(2007-7#1)(2007-8#1)
was observed in all the##3##5##(1996-8#1)(2007-8#1)(2011-1#1)
was observed in all three##2##5##(2008-10#2)
was observed in all##32##4##(1990-11#1)(1992-7#1)(1995-5#1)(1996-12#1)(1996-8#1)(1997-3#1)(2004-4#1)(2005-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-7#1)
was observed in an##3##4##(1993-12#1)(1993-9#1)(2008-10#1)
was observed in animals##4##4##(1993-6#1)(1994-7#1)(1994-9#1)(2009-10#1)
was observed in any##4##4##(1993-12#1)(2008-3#1)(2010-4#1)(2011-1#1)
was observed in both cases##3##5##(1992-11#1)(2008-7#1)(2013-8#1)
was observed in both groups##2##5##(1997-3#1)(2006-5#1)
was observed in both males and females##2##7##(1991-5#1)(1995-5#1)
was observed in both##20##4##(1991-5#1)(1992-11#2)(1992-12#1)(1995-5#1)(1996-10#1)(1996-12#2)(1996-8#1)(1997-3#1)(1997-6#1)(2006-5#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
was observed in cell##2##4##(1994-12#1)(1994-6#1)
was observed in cells expressing the##2##6##(1995-6#1)(2008-10#1)
was observed in cells expressing##3##5##(1995-6#1)(1997-2#1)(2008-10#1)
was observed in cells##6##4##(1990-8#1)(1995-6#1)(1997-2#1)(1997-4#1)(2008-10#1)(2013-8#1)
was observed in commercial##2##4##(2008-10#1)(2008-5#1)
was observed in comparison to##2##5##(1992-5#1)(2007-9#1)
was observed in control##3##4##(1991-9#1)(2007-2#1)(2009-12#1)
was observed in each##3##4##(2007-9#1)(2010-4#1)(2012-1#1)
was observed in either##4##4##(1990-7#1)(1991-7#1)(2008-9#1)(2011-2#1)
was observed in females##3##4##(1994-6#1)(1995-5#1)(2008-7#1)
was observed in five##2##4##(2008-10#1)(2012-3#1)
was observed in four cases##2##5##(1994-12#1)(2006-8#1)
was observed in four##3##4##(1994-12#1)(2006-8#1)(2008-8#1)
was observed in group##2##4##(2007-8#1)(2009-5#1)
was observed in groups##2##4##(2007-11#1)(2007-9#1)
was observed in heart##4##4##(1995-5#1)(1997-6#1)(1997-8#1)(2007-8#1)
was observed in intestinal##3##4##(1993-9#1)(1996-12#1)(2008-10#1)
was observed in liver##2##4##(1993-11#1)(1995-1#1)
was observed in most of the##3##6##(2006-4#1)(2008-6#1)(2011-2#1)
was observed in most##5##4##(1996-10#1)(2006-4#1)(2008-6#1)(2011-2#1)(2013-1#1)
was observed in one of##3##5##(2007-11#1)(2008-4#2)
was observed in one patient##2##5##(2006-8#1)(2008-6#1)
was observed in one##8##4##(1992-5#1)(2006-8#1)(2007-11#1)(2008-4#3)(2008-6#1)(2008-7#1)
was observed in only##3##4##(1992-6#1)(1995-2#1)(2004-3#1)
was observed in patients with##8##5##(1990-4#1)(1991-10#1)(1996-8#1)(2006-5#1)(2007-11#1)(2010-12#1)(2011-1#1)(2011-2#1)
was observed in patients##12##4##(1990-4#1)(1991-10#1)(1996-6#1)(1996-7#1)(1996-8#1)(2006-5#1)(2007-11#1)(2007-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-7#1)
was observed in peripheral blood##3##5##(1996-12#1)(2008-9#2)
was observed in peripheral##5##4##(1996-12#1)(1996-4#1)(2008-9#2)(2012-2#1)
was observed in plants##3##4##(2006-12#1)(2008-10#2)
was observed in response##2##4##(1996-5#1)(2008-10#1)
was observed in roots##2##4##(2008-12#1)(2009-5#1)
was observed in several##2##4##(2008-10#1)(2008-2#1)
was observed in six patients##2##5##(1994-6#1)(2008-5#1)
was observed in six##5##4##(1994-6#1)(1997-3#1)(2008-10#2)(2008-5#1)
was observed in some cases##2##5##(2007-11#1)(2008-10#1)
was observed in some##6##4##(1990-7#1)(1993-12#1)(2007-11#1)(2008-10#1)(2009-4#1)(2011-1#1)
was observed in the absence of##3##6##(2008-11#2)(2008-5#1)
was observed in the bilateral##2##5##(2008-9#1)(2013-7#1)
was observed in the blood##2##5##(1994-5#1)(2008-2#1)
was observed in the case of##3##6##(2005-11#1)(2008-11#1)(2011-1#1)
was observed in the cells##2##5##(1994-9#1)(2008-9#1)
was observed in the clinical##2##5##(2008-11#1)(2013-8#1)
was observed in the concentration range of##2##7##(2006-12#1)(2010-2#1)
was observed in the concentration range##3##6##(2006-12#1)(2008-10#1)(2010-2#1)
was observed in the concentration##4##5##(2006-12#1)(2008-10#1)(2010-2#1)(2013-7#1)
was observed in the cytoplasm of##2##6##(1995-8#1)(2008-11#1)
was observed in the experimental##3##5##(1991-8#1)(2008-10#1)(2008-4#1)
was observed in the first##3##5##(1996-3#1)(2007-7#1)(2008-10#1)
was observed in the flow##2##5##(2008-10#1)(2012-12#1)
was observed in the infected##2##5##(1994-2#1)(2008-10#1)
was observed in the nucleus accumbens##2##6##(1994-8#1)(1995-5#1)
was observed in the presence of##17##6##(1991-2#1)(1991-8#1)(1992-11#1)(1992-8#1)(1994-3#1)(1997-2#2)(2006-12#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-4#1)(2011-1#1)(2012-2#1)
was observed in the presence or absence of##2##8##(1992-3#1)(2009-11#1)
was observed in the presence##19##5##(1991-2#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-8#1)(1994-3#1)(1997-2#2)(2006-12#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-4#1)(2009-11#1)(2011-1#1)(2012-2#1)
was observed in the range##2##5##(2007-8#1)(2008-1#1)
was observed in the region##2##5##(1992-12#1)(1997-4#1)
was observed in the resistant##2##5##(2008-10#1)(2009-3#1)
was observed in the sample##2##5##(2006-4#1)(2007-11#1)
was observed in the two##2##5##(1994-6#1)(2008-8#1)
was observed in the##211##4##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-7#3)(1991-12#1)(1991-2#3)(1991-3#2)(1991-5#3)(1991-7#1)(1991-8#2)(1991-9#2)(1992-11#3)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#4)(1992-9#2)(1993-12#2)(1993-2#1)(1993-6#1)(1993-7#1)(1994-10#1)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#3)(1994-8#4)(1994-9#2)(1995-11#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#3)(1996-12#4)(1996-2#1)(1996-3#4)(1996-5#2)(1996-8#1)(1996-9#2)(1997-2#3)(1997-4#2)(1997-5#2)(1997-7#1)(1997-8#1)(2004-2#1)(2004-4#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-11#1)(2006-12#3)(2006-4#1)(2006-7#2)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#4)(2007-8#4)(2008-1#3)(2008-10#20)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#9)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#2)(2009-12#2)(2009-3#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#4)(2013-8#6)
was observed in these##3##4##(1994-3#1)(2008-11#1)(2008-6#1)
was observed in this##4##4##(1991-9#1)(2007-7#1)(2008-1#1)(2008-5#1)
was observed in three##4##4##(1990-8#1)(1992-3#1)(2008-10#1)(2010-7#1)
was observed in two cases##2##5##(1991-12#1)(2007-8#1)
was observed in two patients##3##5##(1991-10#1)(1992-3#1)(2008-4#1)
was observed in two##7##4##(1991-10#1)(1991-12#1)(1992-3#1)(1997-3#1)(2007-8#1)(2008-4#1)(2008-5#1)
was observed in vitro##3##4##(1990-2#1)(2009-8#1)(2010-11#1)
was observed in women##3##4##(1991-7#1)(1995-9#1)(2012-3#1)
was observed in##766##3##(1990-10#3)(1990-11#5)(1990-12#3)(1990-2#4)(1990-4#2)(1990-5#3)(1990-6#3)(1990-7#7)(1990-8#3)(1990-9#1)(1991-10#4)(1991-11#2)(1991-12#6)(1991-2#5)(1991-3#2)(1991-4#2)(1991-5#8)(1991-6#1)(1991-7#5)(1991-8#9)(1991-9#5)(1992-1#1)(1992-10#2)(1992-11#6)(1992-12#3)(1992-2#1)(1992-3#3)(1992-5#3)(1992-6#2)(1992-7#3)(1992-8#6)(1992-9#5)(1993-10#1)(1993-11#2)(1993-12#8)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#3)(1993-7#2)(1993-9#4)(1994-10#2)(1994-12#6)(1994-2#8)(1994-3#5)(1994-4#1)(1994-5#2)(1994-6#7)(1994-7#2)(1994-8#5)(1994-9#6)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#4)(1995-2#4)(1995-3#3)(1995-4#1)(1995-5#6)(1995-6#3)(1995-7#3)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#3)(1996-11#3)(1996-12#10)(1996-2#3)(1996-3#5)(1996-4#1)(1996-5#5)(1996-6#1)(1996-7#1)(1996-8#5)(1996-9#3)(1997-1#2)(1997-2#5)(1997-3#10)(1997-4#6)(1997-5#2)(1997-6#2)(1997-7#5)(1997-8#3)(2004-12#1)(2004-2#1)(2004-3#1)(2004-4#2)(2005-1#1)(2005-11#1)(2005-5#1)(2005-7#2)(2005-8#2)(2005-9#2)(2006-10#5)(2006-11#1)(2006-12#6)(2006-2#1)(2006-4#3)(2006-5#4)(2006-6#3)(2006-7#4)(2006-8#5)(2007-10#6)(2007-11#11)(2007-12#9)(2007-2#5)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#16)(2007-8#16)(2007-9#6)(2008-1#6)(2008-10#76)(2008-11#22)(2008-12#10)(2008-2#3)(2008-3#9)(2008-4#11)(2008-5#27)(2008-6#7)(2008-7#16)(2008-8#9)(2008-9#9)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#4)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#4)(2009-8#1)(2010-10#1)(2010-11#3)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#6)(2010-5#2)(2010-7#3)(2010-8#7)(2010-9#1)(2011-1#17)(2011-12#1)(2011-2#20)(2011-3#2)(2012-1#5)(2012-12#3)(2012-2#8)(2012-3#4)(2013-1#11)(2013-7#7)(2013-8#15)
was observed independent of##2##4##(2005-10#1)(2008-10#1)
was observed irrespective of##2##4##(1996-8#1)(2008-11#1)
was observed mainly##2##3##(1991-7#1)(2005-11#1)
was observed more frequently##2##4##(1996-9#1)(2008-12#1)
was observed more##4##3##(1990-7#1)(1996-9#1)(2008-12#1)(2011-2#1)
was observed of##2##3##(1994-2#1)(1995-6#1)
was observed on both##3##4##(1990-8#1)(1991-9#1)(2008-5#1)
was observed on day##4##4##(1990-12#1)(1992-3#1)(2006-6#1)(2012-1#1)
was observed on fibronectin and polystyrene##2##6##(2008-11#2)
was observed on the surface##3##5##(2005-11#1)(2008-10#1)(2008-11#1)
was observed on the##18##4##(1995-2#1)(1995-3#1)(1996-4#1)(2004-9#1)(2005-11#1)(2006-5#2)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2010-5#1)
was observed on##57##3##(1990-12#1)(1990-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-2#2)(1995-3#1)(1996-4#1)(1997-1#1)(1997-6#1)(1997-7#1)(2004-9#1)(2005-11#1)(2006-11#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#3)(2010-11#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)
was observed only at##4##4##(2008-1#1)(2008-3#1)(2012-12#2)
was observed only for the##2##5##(2008-10#1)(2008-5#1)
was observed only for##3##4##(1992-11#1)(2008-10#1)(2008-5#1)
was observed only in the##3##5##(1995-6#1)(2007-11#1)(2013-1#1)
was observed only in##18##4##(1990-8#1)(1991-2#1)(1991-3#1)(1993-2#1)(1994-5#1)(1995-6#2)(1996-8#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-3#1)(2008-5#2)(2009-5#1)(2009-6#1)(2011-1#1)(2013-1#1)
was observed only on##2##4##(2008-10#2)
was observed only under##3##4##(1992-8#1)(1996-5#1)(2006-12#1)
was observed only when##5##4##(1991-10#1)(1992-9#2)(2008-10#1)(2012-12#1)
was observed only##40##3##(1990-8#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-8#1)(1992-9#2)(1993-2#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-6#2)(1996-5#1)(1996-8#1)(1997-2#1)(1997-7#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#3)(2009-2#1)(2009-5#1)(2009-6#1)(2011-1#1)(2012-12#3)(2013-1#1)
was observed over a##2##4##(1995-5#1)(2008-10#1)
was observed over the##2##4##(2007-1#1)(2008-10#1)
was observed over##8##3##(1990-12#1)(1995-5#1)(1996-5#1)(2007-1#1)(2008-10#2)(2008-11#1)(2008-3#1)
was observed predominantly in the##2##5##(1991-8#1)(1996-1#1)
was observed that both##2##4##(2008-4#1)(2013-1#1)
was observed that in##2##4##(1990-12#1)(2009-10#1)
was observed that the##26##4##(1993-9#1)(1996-2#1)(2005-11#2)(2007-11#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-5#3)(2009-5#1)(2009-6#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
was observed that there##3##4##(1994-2#1)(1996-12#1)(2012-12#1)
was observed that these##2##4##(1996-2#1)(2008-10#1)
was observed that##91##3##(1990-12#1)(1990-4#1)(1990-5#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-7#1)(1993-3#1)(1993-9#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-4#1)(1997-5#1)(2005-11#6)(2005-4#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-7#1)(2011-1#2)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
was observed through the##2##4##(2005-8#1)(2009-2#1)
was observed through##3##3##(2004-9#1)(2005-8#1)(2009-2#1)
was observed throughout the##4##4##(1993-7#1)(2006-12#1)(2007-9#1)(2013-1#1)
was observed throughout##5##3##(1993-7#1)(2006-12#1)(2007-9#1)(2009-8#1)(2013-1#1)
was observed to be linear##2##5##(2008-10#2)
was observed to be significantly##2##5##(1997-5#1)(2006-10#1)
was observed to be##24##4##(1990-12#1)(1991-4#2)(1992-3#1)(1993-8#1)(1994-2#1)(1995-2#1)(1997-4#1)(1997-5#2)(2006-10#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#2)(2010-4#1)(2013-1#1)
was observed to coincide with##2##5##(2007-12#1)(2008-11#1)
was observed to decrease with the##2##6##(2007-11#1)(2008-3#1)
was observed to decrease##5##4##(2007-11#1)(2008-3#2)(2008-6#1)(2012-12#1)
was observed to increase##3##4##(2005-11#1)(2008-2#1)(2012-3#1)
was observed to occur##3##4##(1995-3#1)(1997-4#1)(2009-5#1)
was observed to reduce##2##4##(1990-7#1)(1991-4#1)
was observed to##65##3##(1990-12#2)(1990-7#1)(1991-12#1)(1991-2#1)(1991-4#4)(1992-3#1)(1993-4#1)(1993-8#3)(1994-2#1)(1995-2#1)(1995-3#1)(1996-7#1)(1997-4#2)(1997-5#2)(2004-11#1)(2005-11#1)(2006-10#3)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
was observed under the##3##4##(1993-6#1)(2007-12#1)(2008-10#1)
was observed under##9##3##(1993-1#1)(1993-6#1)(2006-5#1)(2007-12#1)(2008-10#4)(2008-11#1)
was observed up to 0##2##5##(1990-5#1)(2008-10#1)
was observed up to##6##4##(1990-5#1)(2007-3#1)(2008-1#1)(2008-10#2)(2013-8#1)
was observed upon##9##3##(1990-11#1)(1992-3#1)(1995-8#1)(1997-1#1)(2007-8#1)(2008-4#2)(2008-6#1)(2012-12#1)
was observed using the##2##4##(1992-5#1)(2011-2#1)
was observed using##13##3##(1990-2#1)(1991-9#1)(1992-5#1)(1993-6#1)(2004-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-2#1)(2011-2#1)
was observed was##3##3##(2004-4#1)(2013-8#2)
was observed when HGF was added##2##6##(2008-11#2)
was observed when a##4##4##(1997-4#1)(2008-10#1)(2008-2#2)
was observed when cells##2##4##(2008-11#2)
was observed when compared with##2##5##(2008-10#1)(2011-2#1)
was observed when compared##3##4##(1994-3#1)(2008-10#1)(2011-2#1)
was observed when it was##2##5##(1996-1#1)(2010-4#1)
was observed when the##17##4##(1990-12#1)(1990-5#1)(1990-8#1)(1991-2#2)(1991-5#2)(1992-9#1)(1994-11#2)(2007-11#1)(2008-10#4)(2008-5#1)(2010-4#1)
was observed when##76##3##(1990-10#3)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#3)(1990-8#1)(1991-12#1)(1991-2#2)(1991-5#2)(1991-6#1)(1992-2#1)(1992-9#1)(1993-4#1)(1994-11#5)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-4#1)(1997-4#1)(1997-6#1)(2004-9#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#12)(2008-11#7)(2008-2#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2010-4#2)(2010-5#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
was observed where##2##3##(2008-10#1)(2008-11#1)
was observed whereas##2##3##(2006-7#1)(2008-9#1)
was observed which##5##3##(1995-1#1)(1995-6#1)(1996-7#1)(2008-10#1)(2012-2#1)
was observed with a##11##4##(1990-5#1)(1992-7#2)(1993-9#1)(1994-3#1)(1994-8#1)(1995-6#1)(1996-1#1)(2007-12#1)(2008-10#1)(2008-2#1)
was observed with an##2##4##(1990-11#1)(1993-12#1)
was observed with either##2##4##(1993-4#1)(1995-3#1)
was observed with increasing##2##4##(2008-10#1)(2008-2#1)
was observed with normal##2##4##(1996-4#1)(2008-10#1)
was observed with purified##2##4##(1990-9#1)(1994-9#1)
was observed with respect to##2##5##(1994-11#1)(2009-3#1)
was observed with the control##2##5##(1994-9#1)(2008-5#1)
was observed with the##20##4##(1990-2#1)(1990-3#1)(1990-9#1)(1991-3#1)(1991-5#1)(1992-9#2)(1993-12#1)(1994-9#2)(1995-8#1)(1996-9#2)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#3)(2013-1#1)
was observed with##121##3##(1990-11#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-11#1)(1991-3#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#2)(1992-9#2)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#1)(1993-4#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#3)(1994-9#3)(1995-1#2)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#2)(2004-11#1)(2004-8#1)(2005-11#1)(2006-1#1)(2006-10#1)(2007-1#2)(2007-11#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#14)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#6)(2008-7#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
was observed within 3##2##4##(2006-8#1)(2007-11#1)
was observed within a##3##4##(1992-7#1)(2007-8#1)(2008-10#1)
was observed within the##6##4##(1991-12#1)(2006-3#1)(2007-11#1)(2007-12#1)(2008-10#2)
was observed within##22##3##(1990-10#1)(1991-12#1)(1992-7#1)(1994-11#1)(1995-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(2006-3#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#1)(2010-1#1)(2012-12#1)
was observed##2607##2##(1990-10#16)(1990-11#14)(1990-12#15)(1990-2#18)(1990-3#7)(1990-4#11)(1990-5#14)(1990-6#8)(1990-7#18)(1990-8#7)(1990-9#8)(1991-1#1)(1991-10#11)(1991-11#4)(1991-12#16)(1991-2#17)(1991-3#8)(1991-4#10)(1991-5#22)(1991-6#7)(1991-7#12)(1991-8#16)(1991-9#18)(1992-1#5)(1992-10#5)(1992-11#10)(1992-12#6)(1992-2#6)(1992-3#11)(1992-4#2)(1992-5#9)(1992-6#20)(1992-7#12)(1992-8#14)(1992-9#14)(1993-1#2)(1993-10#1)(1993-11#8)(1993-12#22)(1993-2#9)(1993-3#7)(1993-4#10)(1993-5#4)(1993-6#10)(1993-7#3)(1993-8#10)(1993-9#18)(1994-10#4)(1994-11#14)(1994-12#17)(1994-2#19)(1994-3#18)(1994-4#2)(1994-5#11)(1994-6#15)(1994-7#2)(1994-8#14)(1994-9#16)(1995-1#10)(1995-10#3)(1995-11#9)(1995-12#13)(1995-2#18)(1995-3#14)(1995-4#1)(1995-5#19)(1995-6#10)(1995-7#6)(1995-8#14)(1995-9#2)(1996-1#12)(1996-10#6)(1996-11#6)(1996-12#19)(1996-2#8)(1996-3#10)(1996-4#6)(1996-5#17)(1996-6#10)(1996-7#3)(1996-8#13)(1996-9#11)(1997-1#10)(1997-2#15)(1997-3#18)(1997-4#15)(1997-5#9)(1997-6#9)(1997-7#16)(1997-8#4)(2003-11#2)(2004-1#1)(2004-11#9)(2004-12#3)(2004-2#2)(2004-3#2)(2004-4#5)(2004-8#1)(2004-9#7)(2005-1#1)(2005-10#1)(2005-11#29)(2005-12#3)(2005-4#1)(2005-5#2)(2005-7#4)(2005-8#6)(2005-9#2)(2006-1#3)(2006-10#18)(2006-11#4)(2006-12#15)(2006-2#3)(2006-3#4)(2006-4#8)(2006-5#12)(2006-6#8)(2006-7#7)(2006-8#13)(2006-9#2)(2007-1#8)(2007-10#18)(2007-11#43)(2007-12#51)(2007-2#15)(2007-3#6)(2007-4#2)(2007-5#5)(2007-6#7)(2007-7#27)(2007-8#42)(2007-9#16)(2008-1#14)(2008-10#355)(2008-11#81)(2008-12#29)(2008-2#23)(2008-3#36)(2008-4#24)(2008-5#89)(2008-6#24)(2008-7#40)(2008-8#25)(2008-9#21)(2009-1#3)(2009-10#5)(2009-11#5)(2009-12#7)(2009-2#6)(2009-3#4)(2009-4#10)(2009-5#9)(2009-6#8)(2009-7#2)(2009-8#6)(2009-9#3)(2010-1#3)(2010-10#3)(2010-11#6)(2010-12#17)(2010-2#10)(2010-3#3)(2010-4#18)(2010-5#10)(2010-6#1)(2010-7#4)(2010-8#19)(2010-9#6)(2011-1#30)(2011-12#12)(2011-2#54)(2011-3#5)(2012-1#14)(2012-11#2)(2012-12#28)(2012-2#35)(2012-3#19)(2013-1#50)(2013-7#11)(2013-8#36)
was obstructed##2##2##(2004-10#1)(2008-5#1)
was obtained (r=0##2##3##(2008-10#2)
was obtained according to##2##4##(2011-2#1)(2013-8#1)
was obtained after a##3##4##(1995-1#1)(2008-10#1)(2008-8#1)
was obtained after##21##3##(1990-2#1)(1990-4#1)(1990-6#1)(1991-12#1)(1992-2#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-8#1)(1996-10#1)(1997-4#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-8#1)(2012-12#1)(2012-2#1)
was obtained and a##2##4##(1995-4#1)(2008-12#1)
was obtained and compared##2##4##(1990-6#1)(2006-10#1)
was obtained and the##6##4##(1994-3#1)(1997-5#1)(2005-11#1)(2008-10#2)(2009-6#1)
was obtained and##20##3##(1990-6#1)(1991-5#1)(1994-3#1)(1995-4#1)(1997-5#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#5)(2008-12#1)(2009-6#1)(2012-12#1)(2012-2#2)(2013-1#1)
was obtained around pH 7##2##5##(2008-10#2)
was obtained around##3##3##(1990-5#1)(2008-10#2)
was obtained as a##3##4##(1991-8#1)(2007-8#1)(2008-2#1)
was obtained as an##2##4##(1994-11#1)(2007-12#1)
was obtained as the##2##4##(2008-4#1)(2009-9#1)
was obtained as##11##3##(1990-12#1)(1991-8#1)(1994-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)(2009-9#1)
was obtained at 0##3##4##(1992-9#1)(2008-10#1)(2012-2#1)
was obtained at 1##5##4##(1993-12#1)(2005-12#1)(2007-11#1)(2007-12#1)(2008-1#1)
was obtained at a##11##4##(1992-5#1)(1994-3#2)(2007-12#3)(2008-10#3)(2008-3#1)(2008-6#1)
was obtained at an##2##4##(2006-8#1)(2008-2#1)
was obtained at pH##2##4##(2007-10#1)(2008-12#1)
was obtained at the##4##4##(2005-10#1)(2007-2#1)(2008-10#1)(2013-8#1)
was obtained at##45##3##(1990-7#1)(1991-9#1)(1992-5#2)(1992-9#1)(1993-12#1)(1994-3#2)(2005-10#1)(2005-12#2)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#1)(2008-1#2)(2008-10#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#3)(2010-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
was obtained between Vg concentration and##2##6##(2008-10#2)
was obtained between the##15##4##(1990-2#1)(1993-2#1)(2006-4#1)(2007-8#1)(2008-10#11)
was obtained between##28##3##(1990-2#1)(1993-11#1)(1993-2#2)(1995-1#1)(1995-2#1)(1996-1#2)(2006-4#1)(2007-12#1)(2007-8#1)(2008-10#16)(2008-2#1)
was obtained both##2##3##(2007-2#1)(2008-10#1)
was obtained by a##7##4##(1991-2#1)(1995-9#1)(1997-2#1)(2008-10#1)(2010-9#1)(2012-2#1)(2013-1#1)
was obtained by application of##2##5##(2007-12#1)(2008-2#1)
was obtained by both##2##4##(2008-10#1)(2011-2#1)
was obtained by collecting##3##4##(1996-10#1)(1996-2#1)(2007-8#1)
was obtained by comparing##2##4##(2007-1#1)(2008-10#1)
was obtained by detecting##2##4##(2005-4#1)(2008-2#1)
was obtained by increasing##2##4##(2007-8#1)(2008-10#1)
was obtained by means of##3##5##(1992-12#1)(2008-2#1)(2008-3#1)
was obtained by plotting##2##4##(1995-7#1)(2008-10#1)
was obtained by subtracting##2##4##(2008-2#1)(2008-8#1)
was obtained by the##8##4##(1991-7#1)(1995-12#1)(2007-10#1)(2008-10#4)(2010-12#1)
was obtained by use of a##3##6##(2007-11#1)(2007-12#1)(2008-3#1)
was obtained by use of##5##5##(1992-7#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
was obtained by using a##5##5##(2007-7#1)(2008-10#3)(2012-12#1)
was obtained by using an injected volume of##2##8##(2008-10#2)
was obtained by using the##3##5##(2005-11#1)(2008-10#1)(2010-7#1)
was obtained by using##18##4##(1997-4#1)(1997-8#1)(2005-11#1)(2007-11#1)(2007-7#1)(2008-10#8)(2008-8#2)(2008-9#1)(2010-7#1)(2012-12#1)
was obtained by##151##3##(1990-12#1)(1990-2#1)(1990-3#3)(1990-5#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-5#1)(1993-9#1)(1994-11#2)(1994-8#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#3)(1995-7#1)(1995-9#1)(1996-10#2)(1996-2#1)(1996-4#2)(1997-1#1)(1997-2#1)(1997-4#3)(1997-6#2)(1997-8#1)(2005-11#3)(2005-4#1)(2006-10#2)(2006-2#1)(2007-1#2)(2007-10#2)(2007-11#3)(2007-12#6)(2007-6#1)(2007-7#1)(2007-8#6)(2008-1#2)(2008-10#32)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#2)(2009-1#1)(2009-8#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
was obtained compared##3##3##(2008-10#2)(2008-8#1)
was obtained during##2##3##(1997-3#1)(2011-2#1)
was obtained either##2##3##(1990-12#1)(1997-5#1)
was obtained even##3##3##(1997-4#1)(2008-5#1)(2011-1#1)
was obtained experimentally##2##3##(2008-10#1)(2010-4#1)
was obtained following##4##3##(1991-2#3)(2008-6#1)
was obtained for a##7##4##(2007-12#2)(2008-1#1)(2008-10#4)
was obtained for all##6##4##(1991-4#1)(1992-10#1)(1995-11#1)(2008-10#3)
was obtained for arsenic determination between##2##6##(2008-10#2)
was obtained for both##2##4##(2008-10#2)
was obtained for each##2##4##(2007-8#1)(2008-12#1)
was obtained for the determination of##2##6##(2008-10#2)
was obtained for the same##2##5##(2005-11#1)(2013-8#1)
was obtained for the##28##4##(1991-2#1)(1991-5#1)(1994-8#1)(1994-9#1)(2005-11#3)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#11)(2008-12#2)(2008-3#1)(2011-1#1)(2013-8#1)
was obtained for##100##3##(1990-3#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-10#1)(1992-4#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1996-12#2)(1996-7#1)(1997-4#1)(1997-8#2)(2005-11#3)(2007-10#1)(2007-11#1)(2007-12#8)(2007-8#3)(2008-1#2)(2008-10#47)(2008-11#2)(2008-12#3)(2008-3#5)(2008-5#2)(2010-1#1)(2010-11#1)(2010-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
was obtained from 0##4##4##(2008-10#4)
was obtained from 1##2##4##(1991-12#1)(2008-2#1)
was obtained from 3##2##4##(2007-3#1)(2008-10#1)
was obtained from a genomic##2##5##(1990-12#1)(1993-2#1)
was obtained from a total of##2##6##(2006-10#1)(2007-3#1)
was obtained from a total##3##5##(1994-12#1)(2006-10#1)(2007-3#1)
was obtained from a##19##4##(1990-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-8#1)(2006-10#1)(2007-11#3)(2007-3#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)
was obtained from all##2##4##(2006-8#1)(2011-2#1)
was obtained from an##3##4##(1993-6#1)(2007-3#1)(2008-10#1)
was obtained from different##2##4##(2007-10#1)(2007-3#1)
was obtained from medical records##3##5##(2006-10#2)(2007-10#1)
was obtained from patients##2##4##(2013-1#1)(2013-8#1)
was obtained from the Icelandic##2##5##(2006-8#2)
was obtained from the##28##4##(1993-10#1)(1997-4#1)(2006-10#1)(2006-8#3)(2007-11#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-7#1)(2013-1#3)
was obtained from##114##3##(1990-12#2)(1991-12#1)(1991-8#1)(1992-12#1)(1993-10#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-8#1)(1996-3#1)(1997-1#1)(1997-4#2)(1997-8#1)(2005-11#2)(2005-9#2)(2006-10#4)(2006-7#1)(2006-8#4)(2006-9#1)(2007-10#2)(2007-11#7)(2007-12#1)(2007-3#4)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#16)(2008-11#5)(2008-12#1)(2008-2#6)(2008-3#4)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-2#2)(2010-4#1)(2011-1#1)(2011-2#5)(2012-2#1)(2012-7#2)(2013-1#5)(2013-7#1)(2013-8#3)
was obtained in 0##2##4##(2008-10#2)
was obtained in 11##3##4##(1990-6#1)(1992-12#1)(2013-8#1)
was obtained in 40%##2##4##(1991-6#1)(2012-2#1)
was obtained in 44##2##4##(1991-6#1)(1991-8#1)
was obtained in a##11##4##(1990-11#1)(1991-2#1)(1992-2#1)(1993-2#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#1)
was obtained in all cases##3##5##(2008-6#1)(2009-3#1)(2013-1#1)
was obtained in all patients##2##5##(2006-12#1)(2007-7#1)
was obtained in all##7##4##(2006-12#1)(2007-11#1)(2007-7#1)(2008-6#1)(2008-7#1)(2009-3#1)(2013-1#1)
was obtained in both##2##4##(2007-8#2)
was obtained in the absence of##2##6##(1991-2#1)(2013-1#1)
was obtained in the concentration range 2##2##7##(1992-2#1)(2008-10#1)
was obtained in the concentration range of 0##2##8##(2008-10#2)
was obtained in the concentration range of##4##7##(2008-10#3)(2010-5#1)
was obtained in the concentration range##8##6##(1992-2#1)(1996-5#1)(2008-10#5)(2010-5#1)
was obtained in the concentration##9##5##(1992-2#1)(1996-5#1)(2008-10#6)(2010-5#1)
was obtained in the presence of##4##6##(1991-2#1)(1997-2#1)(1997-4#1)(2008-10#1)
was obtained in the range of##4##6##(1996-8#1)(2008-10#2)(2008-12#1)
was obtained in the range##10##5##(1996-8#1)(2007-8#1)(2008-10#7)(2008-12#1)
was obtained in the##41##4##(1991-2#2)(1991-6#1)(1992-2#1)(1992-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#18)(2008-12#1)(2008-5#2)(2008-9#1)(2010-10#1)(2010-5#1)(2013-1#1)
was obtained in this##2##4##(2008-10#1)(2008-5#1)
was obtained in##126##3##(1990-10#1)(1990-11#2)(1990-3#1)(1990-4#1)(1990-6#3)(1991-2#3)(1991-6#4)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-12#1)(1995-6#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#2)(2005-11#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-4#1)(2006-9#1)(2007-11#3)(2007-12#4)(2007-7#1)(2007-8#11)(2008-10#28)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#1)(2008-5#7)(2008-6#1)(2008-7#3)(2008-9#1)(2009-2#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#3)
was obtained on a##2##4##(2008-10#2)
was obtained on the##5##4##(2006-7#1)(2007-10#1)(2008-10#2)(2010-12#1)
was obtained on##22##3##(1991-2#1)(1991-9#1)(1995-12#1)(1997-2#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-3#1)(2008-10#6)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2012-2#1)
was obtained only with the##3##5##(1991-6#1)(1992-9#1)(2008-3#1)
was obtained only with##4##4##(1991-6#1)(1992-9#1)(1994-3#1)(2008-3#1)
was obtained only##6##3##(1991-6#1)(1992-9#1)(1994-3#1)(2006-10#1)(2008-3#1)(2008-8#1)
was obtained over a##2##4##(2008-10#1)(2012-12#1)
was obtained over the range of 0##2##7##(2005-12#1)(2008-10#1)
was obtained over the range##3##5##(2005-12#1)(2008-10#2)
was obtained over the##7##4##(1997-3#1)(2005-12#1)(2008-10#5)
was obtained over##9##3##(1997-3#1)(2005-12#1)(2008-10#6)(2012-12#1)
was obtained than##2##3##(1995-10#1)(2008-10#1)
was obtained that was##2##4##(2007-12#1)(2008-3#1)
was obtained that##7##3##(1990-11#1)(1990-12#1)(1996-8#1)(2006-7#1)(2007-12#1)(2008-3#1)(2011-1#1)
was obtained through the##8##4##(1993-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#1)(2012-2#1)(2013-1#1)
was obtained through##21##3##(1990-10#1)(1991-7#1)(1992-1#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-9#1)(1997-6#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-2#2)(2013-1#1)(2013-8#2)
was obtained to##5##3##(2005-12#1)(2006-8#1)(2008-3#1)(2012-2#1)(2013-1#1)
was obtained under the##2##4##(2008-10#1)(2008-3#1)
was obtained under##7##3##(2005-11#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-3#2)
was obtained using a##3##4##(2006-1#1)(2007-3#1)(2008-10#1)
was obtained using an##3##4##(2008-5#1)(2010-11#1)(2012-12#1)
was obtained using the##3##4##(1996-4#1)(2010-4#1)(2011-12#1)
was obtained using##21##3##(1992-6#1)(1994-12#1)(1996-4#1)(1997-3#1)(2006-1#1)(2006-2#1)(2007-3#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2010-11#1)(2010-4#1)(2011-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
was obtained via##2##3##(2006-8#1)(2013-1#1)
was obtained when the##14##4##(1990-11#1)(1995-5#1)(1996-3#1)(2005-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-6#2)(2012-12#1)
was obtained when##26##3##(1990-11#1)(1990-3#1)(1991-2#1)(1992-9#1)(1995-2#1)(1995-5#1)(1996-3#1)(2005-11#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#4)(2010-4#1)(2012-12#1)
was obtained which##5##3##(1992-7#1)(1994-12#1)(2004-12#1)(2008-9#1)(2012-12#1)
was obtained with 0##2##4##(1990-5#1)(2008-5#1)
was obtained with 10 nM##2##5##(1990-10#1)(1993-3#1)
was obtained with a yield##2##5##(1994-6#1)(1996-11#1)
was obtained with a##30##4##(1990-9#1)(1991-4#1)(1993-4#1)(1993-6#1)(1994-3#1)(1994-6#1)(1996-11#1)(2006-5#1)(2007-12#4)(2007-8#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)
was obtained with an##2##4##(2007-8#1)(2008-1#1)
was obtained with the##19##4##(1990-11#1)(1990-3#1)(1995-1#1)(2006-5#1)(2007-10#2)(2007-12#2)(2007-4#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)
was obtained with##105##3##(1990-10#2)(1990-11#3)(1990-3#1)(1990-5#2)(1990-9#1)(1991-4#2)(1991-8#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-3#1)(1994-6#1)(1995-1#1)(1996-11#1)(1996-5#2)(1997-2#1)(1997-4#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-5#2)(2007-10#3)(2007-11#2)(2007-12#7)(2007-3#1)(2007-4#1)(2007-8#3)(2008-1#2)(2008-10#33)(2008-11#4)(2008-2#1)(2008-3#7)(2008-5#4)(2008-6#2)(2008-7#2)(2010-2#1)(2011-2#2)
was obtained within a##2##4##(2007-12#1)(2008-10#1)
was obtained within##9##3##(1991-2#1)(1992-2#1)(1997-3#1)(2005-12#1)(2007-12#1)(2008-10#4)
was obtained without##3##3##(2008-10#1)(2008-3#1)(2008-6#1)
was obtained##1137##2##(1990-10#4)(1990-11#9)(1990-12#8)(1990-2#4)(1990-3#7)(1990-4#4)(1990-5#4)(1990-6#6)(1990-7#2)(1990-8#1)(1990-9#3)(1991-11#1)(1991-12#4)(1991-2#12)(1991-4#3)(1991-5#4)(1991-6#5)(1991-7#2)(1991-8#6)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#5)(1992-12#5)(1992-2#6)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#4)(1992-9#4)(1993-10#1)(1993-11#2)(1993-12#4)(1993-2#4)(1993-3#5)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#5)(1994-12#7)(1994-3#6)(1994-5#1)(1994-6#3)(1994-8#6)(1994-9#4)(1995-1#5)(1995-10#2)(1995-11#4)(1995-12#4)(1995-2#2)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-10#3)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#3)(1996-4#3)(1996-5#8)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#4)(1997-4#10)(1997-5#2)(1997-6#3)(1997-8#8)(2004-11#1)(2004-12#1)(2005-10#1)(2005-11#16)(2005-12#9)(2005-4#2)(2005-8#3)(2005-9#3)(2006-1#2)(2006-10#14)(2006-11#1)(2006-12#2)(2006-2#2)(2006-3#2)(2006-4#2)(2006-5#4)(2006-6#1)(2006-7#4)(2006-8#9)(2006-9#2)(2007-1#3)(2007-10#10)(2007-11#27)(2007-12#48)(2007-2#2)(2007-3#8)(2007-4#1)(2007-6#1)(2007-7#6)(2007-8#30)(2007-9#1)(2008-1#14)(2008-10#302)(2008-11#22)(2008-12#10)(2008-2#29)(2008-3#37)(2008-4#5)(2008-5#32)(2008-6#18)(2008-7#14)(2008-8#10)(2008-9#11)(2009-1#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#5)(2010-2#6)(2010-4#5)(2010-5#4)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#9)(2011-12#1)(2011-2#17)(2012-12#10)(2012-2#15)(2012-3#1)(2012-7#2)(2012-8#1)(2013-1#26)(2013-7#2)(2013-8#16)
was obvious##7##2##(1994-10#1)(1994-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#1)(2013-8#1)
was obviously enhanced##2##3##(2008-11#1)(2013-1#1)
was obviously##9##2##(1990-11#1)(1995-12#1)(2007-1#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-1#1)(2013-1#1)
was occasionally##4##2##(1991-2#1)(2008-5#1)(2010-3#1)(2010-7#1)
was occluded with##2##3##(2006-12#1)(2008-4#1)
was occluded##4##2##(1994-6#1)(2006-12#1)(2007-10#1)(2008-4#1)
was occupied by a##3##4##(1990-7#1)(1994-9#1)(1996-9#1)
was occupied by##6##3##(1990-7#1)(1994-2#1)(1994-9#1)(1995-4#1)(1996-9#1)(2008-7#1)
was occupied##8##2##(1990-7#1)(1990-8#1)(1994-2#1)(1994-9#1)(1995-4#1)(1996-9#1)(2006-7#1)(2008-7#1)
was occurring##2##2##(1995-12#1)(2008-10#1)
was of 0##7##3##(2007-10#1)(2008-10#4)(2011-2#1)(2013-7#1)
was of 1##6##3##(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2012-2#1)(2013-7#1)
was of 12##2##3##(1993-9#1)(2008-10#1)
was of 4##4##3##(2006-6#1)(2008-10#2)(2012-2#1)
was of 5##3##3##(2007-8#1)(2008-10#2)
was of 50##2##3##(2007-8#2)
was of a##9##3##(1991-2#1)(2006-6#2)(2008-3#1)(2008-7#2)(2009-4#1)(2009-8#1)(2013-8#1)
was of average FSIQ##2##4##(2004-10#2)
was of benefit##2##3##(2004-2#1)(2007-8#1)
was of borderline statistical significance##2##5##(2008-11#2)
was of great##3##3##(2006-7#1)(2007-4#1)(2008-10#1)
was of high affinity##2##4##(1993-11#1)(1993-6#1)
was of high##5##3##(1993-11#1)(1993-6#1)(1996-4#1)(2005-4#1)(2012-12#1)
was of little##2##3##(2009-2#1)(2013-1#1)
was of moderate##2##3##(1990-12#1)(2008-6#1)
was of note##2##3##(1997-6#1)(2006-12#1)
was of particular interest##3##4##(1992-8#2)(2006-11#1)
was of significant##2##3##(2008-10#1)(2010-9#1)
was of the order of##4##5##(1994-3#1)(1996-7#1)(2008-3#2)
was of the order##5##4##(1994-3#1)(1996-7#1)(2008-3#2)(2010-4#1)
was of the same magnitude##2##5##(1994-5#1)(1997-5#1)
was of the same order of magnitude as that##2##9##(1991-2#1)(1994-11#1)
was of the same##4##4##(1991-2#1)(1994-11#1)(1994-5#1)(1997-5#1)
was of the##15##3##(1991-2#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1996-3#1)(1996-7#1)(1997-5#1)(2008-10#2)(2008-3#2)(2008-5#1)(2010-4#1)(2011-2#1)
was of##133##2##(1990-12#1)(1991-12#1)(1991-2#3)(1991-4#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-8#1)(2004-10#2)(2004-2#1)(2005-4#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#4)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#7)(2008-1#4)(2008-10#20)(2008-11#3)(2008-3#5)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#2)(2013-8#1)
was offered ad libitum##2##4##(2007-1#1)(2012-2#1)
was offered to the patient##2##5##(2007-8#1)(2009-3#1)
was offered to the##3##4##(1995-6#1)(2007-8#1)(2009-3#1)
was offered to##6##3##(1994-11#1)(1995-6#1)(2007-8#1)(2009-3#1)(2010-8#1)(2011-1#1)
was offered##16##2##(1994-11#1)(1995-6#1)(1995-8#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-6#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-7#1)
was offset by##2##3##(1992-12#1)(2007-1#1)
was often associated with##2##4##(1990-3#1)(2012-3#1)
was often found##2##3##(1990-10#1)(2008-5#1)
was often observed##3##3##(1996-6#1)(2004-11#1)(2012-2#1)
was often questionable##2##3##(1993-6#2)
was often the##2##3##(2006-12#1)(2013-1#1)
was often used##2##3##(2008-10#1)(2010-9#1)
was often##42##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-3#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-6#2)(1995-12#1)(1996-6#1)(2004-11#1)(2005-4#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-9#2)(2010-12#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
was older##2##2##(2007-10#1)(2011-2#1)
was omitted##4##2##(1993-7#1)(1994-9#1)(2007-8#1)(2011-2#1)
was on a##3##3##(1991-2#1)(1991-4#1)(2012-11#1)
was on average##2##3##(2010-8#1)(2012-3#1)
was on chronic steroid therapy##3##5##(2008-7#1)(2013-1#2)
was on day##2##3##(1996-12#1)(2006-10#1)
was on surface##2##3##(2004-9#1)(2008-10#1)
was on the left##3##4##(1993-9#1)(2011-2#2)
was on the right##3##4##(1993-9#1)(1996-2#1)(2011-2#1)
was on the##12##3##(1993-9#2)(1996-2#1)(2006-7#1)(2007-7#1)(2008-3#1)(2009-4#1)(2010-12#1)(2011-2#3)(2012-3#1)
was on##54##2##(1990-10#1)(1990-12#1)(1991-2#1)(1991-4#1)(1993-9#2)(1996-12#1)(1996-2#1)(2004-9#1)(2005-8#3)(2006-1#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-6#1)(2007-7#4)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-4#1)(2010-12#3)(2010-8#1)(2011-2#3)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#4)
was on-line detected##2##3##(2008-10#2)
was on-line electrogenerated by constant-current electrolysis##2##6##(2008-10#2)
was on-line electrogenerated##3##3##(2008-10#3)
was on-line##7##2##(2008-10#6)(2010-11#1)
was once##8##2##(1991-11#1)(1992-8#1)(1996-3#1)(2006-10#1)(2006-9#1)(2007-12#1)(2008-5#1)(2012-2#1)
was one case of##4##4##(2006-12#1)(2006-8#2)(2011-2#1)
was one case##5##3##(2006-12#1)(2006-6#1)(2006-8#2)(2011-2#1)
was one death##6##3##(2006-7#1)(2007-7#2)(2007-8#1)(2008-6#1)(2008-7#1)
was one of the first##4##5##(1995-2#1)(2005-7#1)(2007-5#1)(2008-2#1)
was one of the highest##2##5##(2008-11#1)(2011-2#1)
was one of the most important##2##6##(2010-7#1)(2013-1#1)
was one of the most##4##5##(2007-7#1)(2009-7#1)(2010-7#1)(2013-1#1)
was one of the##23##4##(1995-2#1)(1996-12#1)(1997-6#1)(2005-7#1)(2005-8#1)(2006-9#1)(2007-1#1)(2007-4#1)(2007-5#1)(2007-7#3)(2008-10#2)(2008-11#2)(2008-2#1)(2008-8#1)(2009-4#1)(2009-7#1)(2010-7#1)(2011-2#1)(2013-1#1)
was one of these##2##4##(2008-11#2)
was one of##28##3##(1995-2#1)(1996-12#1)(1997-6#1)(2004-2#1)(2005-7#1)(2005-8#1)(2006-9#1)(2007-1#1)(2007-4#1)(2007-5#1)(2007-7#3)(2008-10#3)(2008-11#4)(2008-2#1)(2008-8#1)(2009-4#1)(2009-7#1)(2010-7#1)(2011-2#2)(2013-1#1)
was one year##3##3##(1994-7#1)(2006-8#1)(2009-8#1)
was one##71##2##(1991-8#1)(1992-9#1)(1993-12#1)(1994-2#1)(1994-7#1)(1995-11#1)(1995-2#1)(1996-12#2)(1996-8#1)(1997-6#1)(2004-2#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#6)(2007-8#4)(2008-10#6)(2008-11#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#6)(2013-1#2)(2013-7#1)
was only 0##13##3##(1991-5#1)(1993-8#1)(1994-10#1)(1994-3#1)(1994-6#1)(1994-7#1)(1996-6#1)(1997-5#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)
was only 1##4##3##(1991-3#1)(1992-8#1)(1993-8#1)(1997-5#1)
was only 11##2##3##(1990-9#1)(1995-5#1)
was only 2##2##3##(1990-3#1)(2008-11#1)
was only 20%##3##3##(1990-8#1)(1994-5#1)(1995-5#1)
was only 30%##2##3##(1996-9#1)(2008-10#1)
was only 50% of##2##4##(1996-8#1)(2008-2#1)
was only 52%##2##3##(1992-3#1)(2011-2#1)
was only 8##2##3##(2008-11#1)(2008-5#1)
was only 9##2##3##(2008-10#2)
was only a minor##3##4##(2006-2#1)(2008-10#2)
was only a##16##3##(1990-7#1)(1991-11#1)(1993-6#1)(1995-3#1)(1996-5#1)(1997-1#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#1)
was only able to##2##4##(1991-1#1)(2008-5#1)
was only about##5##3##(2007-5#1)(2008-10#2)(2008-11#1)(2009-11#1)
was only active##2##3##(1996-7#1)(2008-5#1)
was only affected##2##3##(2004-9#1)(2008-5#1)
was only after##3##3##(1997-5#1)(2006-2#1)(2011-1#1)
was only associated with##4##4##(2007-7#1)(2009-8#1)(2011-1#1)(2013-1#1)
was only detectable##2##3##(1995-4#1)(2011-2#1)
was only detected in cells##2##5##(1991-5#1)(1994-12#1)
was only detected in the##2##5##(2008-10#1)(2008-3#1)
was only detected in##7##4##(1990-11#1)(1991-5#1)(1992-7#1)(1994-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
was only detected##8##3##(1990-11#1)(1991-5#1)(1992-7#1)(1994-12#1)(2004-4#1)(2008-10#1)(2008-3#1)(2011-2#1)
was only effective##3##3##(1990-7#1)(1995-2#1)(1997-1#1)
was only expressed in normal##2##5##(1996-2#2)
was only expressed in the##2##5##(2006-12#1)(2012-3#1)
was only expressed in##6##4##(1994-12#1)(1996-2#2)(2006-12#1)(2008-8#1)(2012-3#1)
was only expressed##7##3##(1994-12#1)(1996-2#2)(2006-12#1)(2008-10#1)(2008-8#1)(2012-3#1)
was only found in##6##4##(1997-6#1)(2007-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#1)
was only found##9##3##(1993-9#1)(1997-6#1)(2006-8#1)(2007-6#1)(2008-10#2)(2008-7#1)(2008-8#1)(2012-2#1)
was only half##2##3##(1990-11#1)(1992-6#1)
was only marginal##2##3##(1992-10#1)(2012-3#1)
was only marginally affected by##2##5##(1990-9#1)(1993-7#1)
was only marginally##4##3##(1990-5#1)(1990-9#1)(1993-7#1)(1995-2#1)
was only moderately##2##3##(1991-10#1)(1991-2#1)
was only modest##2##3##(1990-12#1)(1997-2#1)
was only observed at##2##4##(2008-10#1)(2008-7#1)
was only observed for the##2##5##(1991-5#1)(2012-2#1)
was only observed for##4##4##(1990-3#1)(1991-5#1)(1997-1#1)(2012-2#1)
was only observed in##5##4##(1996-6#1)(1996-8#1)(1997-1#1)(2011-1#1)(2012-5#1)
was only observed with##2##4##(2008-10#1)(2010-2#1)
was only observed##18##3##(1990-3#1)(1991-3#1)(1991-5#1)(1992-3#1)(1993-3#1)(1996-6#1)(1996-8#1)(1997-1#2)(2005-11#1)(2008-10#2)(2008-7#1)(2010-2#1)(2011-1#1)(2012-2#1)(2012-5#1)(2013-1#1)
was only one case##2##4##(1996-5#1)(2008-4#1)
was only one##12##3##(1991-12#1)(1991-3#1)(1993-8#1)(1996-12#1)(1996-5#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-8#1)(2011-1#1)(2013-7#1)
was only partially##13##3##(1990-3#1)(1990-5#1)(1992-1#1)(1993-2#1)(1994-6#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-11#1)(2009-4#1)(2012-11#2)
was only partly##3##3##(1992-12#1)(1994-12#1)(2006-8#1)
was only possible##4##3##(1996-7#1)(2007-11#1)(2008-1#1)(2008-10#1)
was only present in##2##4##(1991-9#1)(2008-5#1)
was only present##3##3##(1991-9#1)(1997-5#1)(2008-5#1)
was only recently##4##3##(2006-12#1)(2006-8#1)(2007-2#1)(2009-3#1)
was only seen##2##3##(1993-3#1)(1993-4#1)
was only significant for##2##4##(1996-3#1)(2011-2#1)
was only significant##4##3##(1996-3#1)(2008-11#1)(2011-2#1)(2012-2#1)
was only significantly##2##3##(2006-9#1)(2009-4#1)
was only slightly changed##2##4##(1995-2#1)(1995-7#1)
was only slightly impaired##2##4##(1993-11#1)(1995-5#1)
was only slightly increased##2##4##(1995-2#1)(2012-2#1)
was only slightly inhibited##2##4##(1990-11#1)(1996-2#1)
was only slightly##14##3##(1990-11#1)(1993-11#2)(1994-2#1)(1995-11#1)(1995-2#3)(1995-5#1)(1995-7#1)(1996-2#1)(2008-5#1)(2009-4#1)(2012-2#1)
was only the##2##3##(2008-10#1)(2012-2#1)
was only used##2##3##(1997-3#1)(2008-10#1)
was only##298##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#3)(1990-5#3)(1990-7#3)(1990-8#1)(1990-9#3)(1991-1#1)(1991-10#3)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#3)(1991-5#3)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-3#2)(1992-5#2)(1992-6#1)(1992-7#4)(1992-8#1)(1993-10#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#2)(1994-10#1)(1994-12#6)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#6)(1995-3#1)(1995-4#1)(1995-5#4)(1995-6#1)(1995-7#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#5)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#4)(1997-2#3)(1997-3#2)(1997-5#4)(1997-6#2)(1997-8#1)(2004-10#1)(2004-4#1)(2004-9#1)(2005-10#3)(2005-11#1)(2006-12#4)(2006-2#2)(2006-7#1)(2006-8#6)(2006-9#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#5)(2008-1#2)(2008-10#35)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#9)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#1)(2009-11#2)(2009-3#1)(2009-4#4)(2009-5#1)(2009-8#2)(2010-10#1)(2010-2#1)(2010-7#1)(2011-1#9)(2011-12#2)(2011-2#7)(2012-11#2)(2012-12#1)(2012-2#9)(2012-3#3)(2012-5#1)(2013-1#5)(2013-7#1)
was open##3##2##(1991-4#1)(1994-12#1)(2009-3#1)
was opened##6##2##(1991-3#1)(1993-1#1)(1996-6#1)(1997-6#1)(2009-2#1)(2011-2#1)
was operated at a##2##4##(2010-6#1)(2013-1#1)
was operated at##5##3##(2007-8#1)(2008-10#1)(2010-6#1)(2013-1#2)
was operated for a##2##4##(2005-11#1)(2008-6#1)
was operated in the##3##4##(2008-10#1)(2008-2#1)(2012-3#1)
was operated in##5##3##(2007-11#1)(2008-10#2)(2008-2#1)(2012-3#1)
was operated on##7##3##(1992-6#1)(1996-12#1)(2006-6#2)(2007-4#1)(2007-8#1)(2013-1#1)
was operated with##3##3##(1993-8#1)(2008-10#1)(2008-2#1)
was operated##35##2##(1992-6#1)(1993-8#1)(1996-12#1)(2004-9#1)(2005-11#1)(2006-6#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#3)(2007-9#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-6#1)(2009-1#1)(2010-6#1)(2012-3#1)(2013-1#5)(2013-7#1)
was opposite to that of##2##5##(1991-5#1)(2013-7#1)
was opposite to that##3##4##(1991-5#1)(2004-4#1)(2013-7#1)
was opposite##4##2##(1991-5#1)(2004-4#1)(2008-3#1)(2013-7#1)
was optically##6##2##(1994-9#1)(2007-12#4)(2008-3#1)
was optimal at pH##3##4##(1990-9#1)(2008-10#1)(2008-11#1)
was optimal at##9##3##(1990-9#1)(1995-11#1)(2006-2#1)(2008-10#4)(2008-11#1)(2009-8#1)
was optimal for the##2##4##(2008-10#1)(2009-2#1)
was optimal for##4##3##(1995-2#1)(2008-10#2)(2009-2#1)
was optimal##16##2##(1990-2#1)(1990-9#1)(1995-11#1)(1995-2#1)(2006-2#1)(2008-10#7)(2008-11#1)(2008-7#1)(2009-2#1)(2009-8#1)
was optimally##2##2##(1991-12#1)(1992-7#1)
was optimised for##3##3##(2008-10#3)
was optimised in##2##3##(2007-8#1)(2008-10#1)
was optimised##7##2##(2007-8#1)(2008-10#6)
was optimized after##2##3##(2008-10#1)(2013-1#1)
was optimized and the##3##4##(1990-9#1)(1996-6#1)(2008-10#1)
was optimized and##14##3##(1990-9#1)(1995-3#1)(1996-3#1)(1996-6#1)(1997-8#1)(2008-10#9)
was optimized as##2##3##(2008-10#2)
was optimized by##10##3##(2007-11#1)(2007-8#1)(2008-10#6)(2008-7#1)(2009-11#1)
was optimized for an##2##4##(2008-10#1)(2008-11#1)
was optimized for the##2##4##(2008-10#1)(2008-2#1)
was optimized for##12##3##(1990-9#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2010-10#1)(2010-5#1)
was optimized to##9##3##(2006-8#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2011-2#1)
was optimized using response surface##2##5##(2008-5#2)
was optimized using the##2##4##(2008-10#2)
was optimized using##8##3##(2008-10#4)(2008-5#2)(2012-3#1)(2013-1#1)
was optimized with respect to the##2##6##(1994-12#1)(2008-10#1)
was optimized with respect to##4##5##(1994-12#1)(2008-10#3)
was optimized with##5##3##(1994-12#1)(2008-10#3)(2011-1#1)
was optimized##77##2##(1990-9#2)(1994-12#1)(1995-3#1)(1996-3#1)(1996-6#1)(1997-8#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-8#3)(2008-10#39)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#3)(2008-7#2)(2009-11#1)(2010-1#1)(2010-10#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-3#2)(2013-1#2)
was optimum at##2##3##(1994-3#1)(2008-10#1)
was optimum##5##2##(1990-12#1)(1990-9#1)(1994-3#1)(2008-10#2)
was orally administered to##4##4##(2008-10#1)(2008-8#1)(2012-2#1)(2013-8#1)
was orally administered##5##3##(2008-10#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
was orally##6##2##(2008-10#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
was organised##3##2##(2006-11#2)(2008-5#1)
was organized as a##2##4##(2008-5#1)(2008-8#1)
was organized by the##3##4##(2008-10#1)(2008-5#1)(2008-8#1)
was organized by##13##3##(1990-5#1)(1996-7#1)(2005-8#2)(2008-10#1)(2008-5#5)(2008-8#1)(2009-11#1)(2010-5#1)
was organized in##4##3##(1992-8#1)(2005-9#1)(2010-11#1)(2012-12#1)
was organized to##2##3##(2011-2#1)(2013-1#1)
was organized##27##2##(1990-5#1)(1990-8#1)(1992-8#1)(1996-7#1)(2005-8#3)(2005-9#1)(2007-7#1)(2008-10#2)(2008-5#6)(2008-7#1)(2008-8#2)(2009-11#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
was originally based on##2##4##(2007-8#1)(2009-10#1)
was originally derived##2##3##(2008-2#1)(2008-3#1)
was originally described as a##2##5##(1993-9#1)(2008-5#1)
was originally described by##2##4##(1997-8#1)(2012-3#1)
was originally described##5##3##(1993-9#1)(1997-8#1)(2008-10#1)(2008-5#1)(2012-3#1)
was originally developed##2##3##(2008-3#1)(2008-5#1)
was originally identified in##2##4##(2008-1#1)(2012-12#1)
was originally identified##3##3##(1993-6#1)(2008-1#1)(2012-12#1)
was originally isolated from##5##4##(1996-2#1)(2009-3#1)(2011-2#3)
was originally presented##3##3##(2008-12#1)(2008-2#1)(2012-3#1)
was originally thought##3##3##(2006-10#1)(2008-4#1)(2010-12#1)
was originally##47##2##(1992-9#1)(1993-4#1)(1993-6#1)(1993-9#1)(1995-11#1)(1995-12#1)(1996-11#1)(1996-2#1)(1997-8#1)(2003-11#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-3#1)(2006-8#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2009-10#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#1)
was orthogonal to##2##3##(1997-8#1)(2009-4#1)
was otherwise##8##2##(1991-6#1)(1991-8#1)(2006-12#1)(2007-7#1)(2008-11#1)(2010-6#1)(2012-12#1)(2013-1#1)
was out of##2##3##(1994-12#1)(2009-2#1)
was outlined##3##2##(2008-10#1)(2008-6#1)(2009-12#1)
was outside##3##2##(1996-12#1)(2013-1#2)
was outward##2##2##(1993-12#1)(1996-1#1)
was over 90%##2##3##(2007-11#1)(2008-10#1)
was over##19##2##(1992-1#1)(1994-2#1)(1995-11#1)(1995-2#1)(2007-11#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#1)(2009-9#1)
was over-expressed in##3##3##(1991-8#1)(2008-11#1)(2010-11#1)
was overall survival##3##3##(1992-2#1)(2006-6#1)(2011-2#1)
was overall##5##2##(1992-1#1)(1992-2#1)(2006-6#1)(2008-10#1)(2011-2#1)
was overcome by##8##3##(1990-2#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-7#1)(2009-6#1)(2011-1#1)
was overcome##9##2##(1990-2#1)(1997-2#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-7#1)(2009-6#1)(2011-1#1)
was overestimated##2##2##(2007-11#1)(2013-8#1)
was overexpressed in E##2##4##(1991-11#1)(2008-7#1)
was overexpressed in Escherichia coli##4##5##(1991-8#1)(1994-12#1)(1995-8#1)(2011-2#1)
was overexpressed in##9##3##(1991-11#1)(1991-8#1)(1994-11#1)(1994-12#1)(1995-8#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-8#1)
was overexpressed##11##2##(1991-11#1)(1991-8#1)(1994-11#1)(1994-12#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2011-2#1)(2013-8#1)
was overlapped##2##2##(1990-3#1)(1996-12#1)
was overproduced in##2##3##(1997-1#1)(1997-4#1)
was overrepresented##3##2##(1997-2#1)(2010-5#1)(2012-2#1)
was overweight##2##2##(2009-4#1)(2013-8#1)
was oxidized and##2##3##(1990-5#1)(1995-11#1)
was oxidized by##6##3##(1992-5#1)(1992-6#1)(1993-4#1)(2008-10#3)
was oxidized to the##2##4##(1996-2#1)(1997-8#1)
was oxidized to##6##3##(1996-2#1)(1997-8#1)(2005-12#1)(2008-10#3)
was oxidized##24##2##(1990-12#1)(1990-5#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-4#1)(1993-9#1)(1994-2#1)(1995-11#2)(1995-7#1)(1996-2#1)(1997-6#1)(1997-8#1)(2005-12#1)(2008-10#8)(2010-5#1)
was pH 4##3##3##(2005-11#1)(2008-10#2)
was pH dependent##2##3##(1991-10#1)(1994-8#1)
was pH##9##2##(1991-10#1)(1991-12#1)(1994-8#1)(2005-11#1)(2008-10#4)(2013-1#1)
was packed in a##3##4##(2008-10#3)
was packed into##3##3##(1991-8#1)(2008-10#2)
was packed with##5##3##(2008-10#4)(2012-3#1)
was packed##12##2##(1991-8#1)(2008-10#10)(2012-3#1)
was pain##2##2##(2006-1#1)(2012-12#1)
was paired with##7##3##(1992-9#3)(1993-12#1)(1996-6#1)(2009-11#2)
was palpable##5##2##(1994-7#1)(2006-10#1)(2007-9#1)(2008-10#1)(2011-1#1)
was palpated in the##2##4##(1994-7#1)(2013-8#1)
was palpated##4##2##(1994-7#1)(1996-3#1)(2007-8#1)(2013-8#1)
was paralleled by a decrease in##2##6##(1990-3#1)(1995-12#1)
was paralleled by a##6##4##(1990-3#1)(1993-9#1)(1995-12#1)(2008-7#1)(2010-12#1)(2010-8#1)
was paralleled by changes in##2##5##(1995-10#1)(1996-5#1)
was paralleled by##16##3##(1990-3#1)(1991-5#1)(1992-8#1)(1993-3#1)(1993-9#1)(1995-10#1)(1995-12#2)(1996-5#1)(1996-8#1)(2008-4#1)(2008-7#1)(2010-12#3)(2010-8#1)
was paralleled##18##2##(1990-3#1)(1991-5#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-6#1)(1995-10#1)(1995-12#2)(1996-5#1)(1996-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-12#3)(2010-8#1)
was parameterized##2##2##(2008-10#1)(2008-9#1)
was part of a##11##4##(1990-7#1)(1996-12#1)(2005-7#1)(2005-8#1)(2006-7#1)(2006-8#1)(2007-9#1)(2010-10#1)(2010-7#1)(2013-1#2)
was part of an##3##4##(1996-11#1)(2008-10#1)(2008-7#1)
was part of the##8##4##(1996-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#1)
was part of##26##3##(1990-7#1)(1995-6#1)(1996-11#1)(1996-12#3)(1996-3#1)(2005-7#1)(2005-8#1)(2006-7#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-7#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
was partially blocked by##4##4##(1991-2#1)(1994-9#1)(1995-5#1)(1995-6#1)
was partially blocked##5##3##(1991-2#1)(1994-9#1)(1995-5#1)(1995-6#1)(2007-1#1)
was partially dependent on the presence of##2##7##(1990-2#1)(1994-12#1)
was partially dependent on##3##4##(1990-2#1)(1994-12#1)(1994-2#1)
was partially dominant##2##3##(2008-10#2)
was partially effective##2##3##(2008-10#2)
was partially inactivated##2##3##(1993-11#1)(1993-2#1)
was partially inhibited by the##3##5##(1990-2#1)(1994-11#1)(1997-7#1)
was partially inhibited by##10##4##(1990-2#1)(1990-3#1)(1990-7#1)(1994-11#1)(1994-3#1)(1995-5#1)(1997-4#1)(1997-7#1)(2005-12#1)(2009-9#1)
was partially inhibited##11##3##(1990-2#1)(1990-3#1)(1990-7#1)(1994-11#1)(1994-3#1)(1995-5#1)(1997-4#1)(1997-7#1)(2005-12#1)(2008-11#1)(2009-9#1)
was partially overcome##2##3##(1994-8#1)(2008-10#1)
was partially prevented##2##3##(1991-7#1)(1994-2#1)
was partially purified and characterized from##2##6##(1997-6#1)(2006-8#1)
was partially purified and##4##4##(1994-11#1)(1997-6#1)(2006-8#2)
was partially purified by##5##4##(1991-9#1)(1992-8#1)(1995-3#1)(2006-10#1)(2010-2#1)
was partially purified from the##2##5##(1991-4#1)(1996-8#1)
was partially purified from##10##4##(1990-9#1)(1991-2#1)(1991-4#1)(1993-8#1)(1994-8#2)(1996-8#1)(1997-7#1)(2008-10#1)(2008-8#1)
was partially purified##25##3##(1990-5#1)(1990-9#1)(1991-2#1)(1991-4#2)(1991-9#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#3)(1995-3#1)(1996-8#1)(1997-6#2)(1997-7#1)(2006-10#1)(2006-8#2)(2008-10#2)(2008-8#1)(2010-2#1)
was partially reactivated##2##3##(1993-11#1)(1993-6#1)
was partially resected##2##3##(2007-8#1)(2011-2#1)
was partially reversed by##3##4##(1990-10#1)(1992-5#1)(1997-5#1)
was partially reversed##4##3##(1990-10#1)(1990-3#1)(1992-5#1)(1997-5#1)
was partially sequenced##2##3##(1992-3#1)(1995-8#1)
was partially suppressed##2##3##(1992-7#1)(2008-8#1)
was partially##101##2##(1990-10#1)(1990-2#2)(1990-3#2)(1990-5#3)(1990-7#2)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-4#3)(1991-7#1)(1991-9#2)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#3)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#4)(1994-9#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-8#1)(1996-9#2)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#2)(2005-12#1)(2006-10#1)(2006-8#2)(2007-1#1)(2007-12#1)(2007-5#2)(2007-8#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#3)(2008-9#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-7#1)(2013-1#2)
was participating in##2##3##(2007-6#1)(2011-2#1)
was particular##3##2##(1992-5#1)(2008-7#1)(2008-9#1)
was particularly emphasized##2##3##(2005-8#1)(2006-12#1)
was particularly high##2##3##(1990-6#1)(1993-2#1)
was particularly marked##2##3##(1992-8#1)(1993-3#1)
was particularly striking##2##3##(2006-6#1)(2007-12#1)
was particularly strong in##2##4##(1995-11#1)(2008-8#1)
was particularly strong##4##3##(1995-11#1)(2008-7#1)(2008-8#2)
was particularly##40##2##(1990-11#1)(1990-2#1)(1990-6#1)(1991-6#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-5#1)(1996-12#2)(1996-5#1)(2005-8#1)(2006-12#2)(2006-6#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2009-4#1)(2009-5#1)(2010-4#2)(2010-8#1)
was partitioned##3##2##(1992-7#1)(2006-12#1)(2008-10#1)
was partly due to##3##4##(1996-5#1)(1997-7#1)(2008-11#1)
was partly restored by the addition of##2##7##(1992-8#1)(2008-10#1)
was partly##19##2##(1990-2#1)(1992-8#1)(1993-3#1)(1994-3#1)(1995-3#2)(1996-5#1)(1997-7#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-6#1)(2011-1#1)(2013-8#1)
was passed through a##7##4##(1991-2#1)(1992-12#1)(1997-8#1)(2008-10#2)(2008-2#1)(2008-5#1)
was passed through the##2##4##(2008-10#2)
was passed through##12##3##(1991-2#1)(1991-8#1)(1992-12#1)(1997-2#1)(1997-8#1)(2008-10#5)(2008-2#1)(2008-5#1)
was passed to##3##3##(1993-1#1)(2006-10#1)(2007-8#1)
was passed##23##2##(1990-3#1)(1991-1#1)(1991-2#1)(1991-8#1)(1992-12#1)(1993-1#1)(1997-1#1)(1997-2#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-5#1)(2008-8#1)(2013-8#1)
was passing##2##2##(2007-8#1)(2008-7#1)
was passively##2##2##(2007-12#1)(2009-3#1)
was patched##2##2##(2006-8#1)(2008-5#1)
was pathologically##2##2##(2010-5#1)(2012-12#1)
was patterned##2##2##(2007-12#1)(2008-11#1)
was per##2##2##(1993-8#1)(2007-10#1)
was perceived as##3##3##(1996-2#2)(2008-11#1)
was perceived to be##3##4##(1991-2#1)(2008-7#1)(2010-3#1)
was perceived to##4##3##(1991-2#1)(2008-11#1)(2008-7#1)(2010-3#1)
was perceived##10##2##(1991-2#1)(1994-3#1)(1996-12#1)(1996-2#2)(2008-11#2)(2008-7#2)(2010-3#1)
was perfectly##2##2##(2008-12#1)(2008-5#1)
was perforated##2##2##(2007-7#1)(2008-10#1)
was performad##2##2##(2007-11#2)
was performed 3##3##3##(2010-6#1)(2012-1#1)(2012-8#1)
was performed a##2##3##(2007-7#1)(2012-2#1)
was performed according to##3##4##(2008-4#1)(2008-9#1)(2009-1#1)
was performed after the##4##4##(1997-3#1)(2007-3#1)(2013-1#2)
was performed after##22##3##(1990-8#1)(1991-4#1)(1996-3#3)(1996-7#1)(1997-3#1)(2006-5#1)(2006-6#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)
was performed among##2##3##(2008-10#1)(2012-2#1)
was performed and a##2##4##(2008-10#1)(2011-2#1)
was performed and in##2##4##(2005-11#1)(2013-8#1)
was performed and the##19##4##(1990-3#1)(1991-7#1)(1991-9#1)(2006-9#1)(2007-11#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-6#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
was performed and##63##3##(1990-2#1)(1990-3#1)(1991-10#1)(1991-7#1)(1991-9#1)(1992-12#1)(1993-9#1)(1994-8#1)(1996-11#1)(1996-12#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-8#4)(2007-9#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-8#2)(2011-12#1)(2011-2#6)(2012-12#2)(2012-2#5)(2013-1#7)(2013-8#4)
was performed as a##5##4##(2007-11#1)(2008-10#1)(2008-8#1)(2012-12#1)(2013-1#1)
was performed as an##2##4##(2006-5#1)(2011-2#1)
was performed as the##3##4##(1996-5#1)(1996-6#2)
was performed as##15##3##(1991-2#1)(1995-11#1)(1996-5#1)(1996-6#2)(2005-1#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
was performed at 6 and##2##5##(2008-9#1)(2011-2#1)
was performed at a##6##4##(1991-2#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-9#1)
was performed at an##3##4##(1991-1#1)(1993-8#1)(2008-5#1)
was performed at the##6##4##(1996-6#1)(1997-8#1)(2005-10#1)(2006-10#1)(2007-11#1)(2013-8#1)
was performed at##47##3##(1990-3#1)(1991-1#1)(1991-2#1)(1992-1#1)(1992-2#1)(1993-8#1)(1994-3#1)(1996-3#1)(1996-6#2)(1997-8#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-11#3)(2007-3#1)(2007-7#1)(2007-8#3)(2008-10#7)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#1)
was performed because of##6##4##(1993-6#1)(2008-7#1)(2009-3#1)(2010-2#1)(2011-2#2)
was performed because##8##3##(1993-6#1)(2008-7#1)(2009-3#1)(2010-2#1)(2011-2#2)(2012-11#1)(2013-7#1)
was performed before and after##2##5##(1994-6#1)(2008-5#1)
was performed before##7##3##(1994-6#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-5#1)(2009-3#1)
was performed between a##2##4##(1992-11#1)(2008-10#1)
was performed between##9##3##(1992-11#1)(1992-7#1)(1994-11#1)(1996-12#1)(2006-10#1)(2007-2#1)(2008-10#2)(2011-2#1)
was performed by PCR##2##4##(1992-9#1)(2013-1#1)
was performed by a##14##4##(1990-10#1)(1991-10#1)(2005-8#1)(2006-6#1)(2007-8#1)(2008-10#6)(2010-4#1)(2012-2#1)(2013-1#1)
was performed by an##3##4##(2007-7#1)(2008-10#1)(2008-6#1)
was performed by combining##2##4##(2010-12#1)(2012-2#1)
was performed by comparing the##3##5##(1996-6#1)(1997-6#1)(2008-5#1)
was performed by comparison of##2##5##(2008-10#1)(2008-3#1)
was performed by direct##2##4##(1992-12#1)(2008-5#1)
was performed by gas##2##4##(2008-10#2)
was performed by laparoscopy##2##4##(1993-9#1)(1994-9#1)
was performed by means of##6##5##(1992-2#1)(1994-9#1)(2005-11#1)(2008-10#2)(2013-7#1)
was performed by measuring the##2##5##(2008-10#1)(2008-11#1)
was performed by measuring##3##4##(1992-5#1)(2008-10#1)(2008-11#1)
was performed by one##2##4##(1995-2#1)(2008-7#1)
was performed by the##14##4##(1997-2#1)(1997-4#1)(1997-7#1)(2006-11#1)(2006-5#1)(2007-8#1)(2008-10#2)(2008-8#1)(2009-10#1)(2010-8#1)(2011-1#2)(2012-2#1)
was performed by three##3##4##(2007-8#1)(2009-6#1)(2011-1#1)
was performed by use of##3##5##(2008-3#1)(2008-9#2)
was performed by using a##3##5##(2008-10#1)(2011-2#1)(2013-8#1)
was performed by using the##2##5##(2004-10#1)(2008-5#1)
was performed by using##9##4##(1995-12#1)(2004-10#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
was performed by##165##3##(1990-1#1)(1990-10#2)(1990-12#1)(1990-2#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-7#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#3)(1996-7#1)(1996-9#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-10#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-11#1)(2006-5#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-3#3)(2007-6#2)(2007-7#1)(2007-8#6)(2008-10#39)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-6#3)(2010-12#4)(2010-4#3)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
was performed directly##2##3##(1996-7#1)(2011-2#1)
was performed due to the absence of##2##7##(2007-7#1)(2011-2#1)
was performed due to the##3##5##(2007-7#2)(2011-2#1)
was performed due to##8##4##(2007-7#2)(2008-1#1)(2008-10#2)(2011-2#1)(2012-2#2)
was performed during the same##2##5##(2007-6#1)(2012-2#1)
was performed during the##6##4##(1992-12#1)(2007-6#1)(2007-8#1)(2008-2#1)(2008-5#1)(2012-2#1)
was performed during##8##3##(1992-12#1)(2007-6#1)(2007-8#1)(2008-2#1)(2008-5#2)(2012-2#1)(2013-7#1)
was performed employing##2##3##(1994-11#1)(2006-11#1)
was performed first##2##3##(2006-7#1)(2007-11#1)
was performed followed by##2##4##(1992-6#1)(2008-8#1)
was performed following a##2##4##(2008-10#1)(2010-4#1)
was performed following the##2##4##(2007-3#1)(2010-9#1)
was performed following##4##3##(2007-3#1)(2008-10#1)(2010-4#1)(2010-9#1)
was performed for a##3##4##(2007-12#1)(2008-5#1)(2010-4#1)
was performed for all##2##4##(1995-1#1)(2007-7#1)
was performed for each##4##4##(1996-2#1)(2008-1#1)(2008-10#1)(2008-7#1)
was performed for the##6##4##(2007-8#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
was performed for##42##3##(1990-10#1)(1993-10#1)(1995-1#1)(1996-2#1)(1996-8#1)(2006-7#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#4)(2008-12#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-10#2)(2010-12#2)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-3#1)(2013-8#2)
was performed from the##2##4##(2007-8#1)(2010-3#1)
was performed from##7##3##(1996-2#1)(2007-8#2)(2008-1#1)(2010-3#1)(2013-1#1)(2013-8#1)
was performed immediately after##2##4##(2010-12#1)(2013-1#1)
was performed immediately##3##3##(2009-9#1)(2010-12#1)(2013-1#1)
was performed in 1##3##4##(2007-10#1)(2008-10#1)(2009-10#1)
was performed in 11##2##4##(2008-5#1)(2013-1#1)
was performed in 13##2##4##(2008-6#1)(2008-7#1)
was performed in 14 patients##2##5##(1992-10#1)(2007-9#1)
was performed in 14##3##4##(1992-10#1)(2006-6#1)(2007-9#1)
was performed in 15 cases##3##5##(2007-2#1)(2008-7#1)(2011-2#1)
was performed in 15##4##4##(2006-11#1)(2007-2#1)(2008-7#1)(2011-2#1)
was performed in 17##3##4##(1994-9#1)(2006-11#1)(2011-2#1)
was performed in 18##2##4##(2007-2#1)(2007-8#1)
was performed in 2##2##4##(2007-8#1)(2009-10#1)
was performed in 20 patients##2##5##(1990-12#1)(2006-12#1)
was performed in 20##4##4##(1990-12#1)(1991-3#1)(2006-12#1)(2008-5#1)
was performed in 21 patients##3##5##(1995-6#1)(2006-12#1)(2008-1#1)
was performed in 24 patients with##3##6##(1994-11#1)(2007-10#1)(2008-7#1)
was performed in 27##2##4##(1992-9#1)(2007-11#1)
was performed in 30##2##4##(1992-2#1)(2009-2#1)
was performed in 31##2##4##(1990-8#1)(2010-12#1)
was performed in 33 patients##2##5##(2007-11#1)(2007-8#1)
was performed in 36 patients##2##5##(1994-3#1)(2012-12#1)
was performed in 37##2##4##(1992-8#1)(2007-9#1)
was performed in 4##3##4##(1990-6#1)(2008-10#1)(2012-2#1)
was performed in 42 patients with##2##6##(1992-6#1)(2007-8#1)
was performed in 46##2##4##(1996-1#1)(2008-5#1)
was performed in 49##2##4##(1990-8#1)(2007-8#1)
was performed in 7##2##4##(2007-11#1)(2013-1#1)
was performed in 8##2##4##(2007-8#1)(2008-10#1)
was performed in a##12##4##(1994-5#1)(1996-6#1)(2005-12#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-10#2)(2010-7#1)(2011-2#1)(2013-1#2)
was performed in all cases##3##5##(1991-4#1)(2007-8#1)(2008-5#1)
was performed in all patients##4##5##(1990-9#1)(1992-5#1)(1993-3#1)(1997-5#1)
was performed in all##11##4##(1990-9#1)(1991-4#1)(1991-9#1)(1992-5#1)(1993-3#1)(1997-5#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
was performed in an attempt to##2##6##(1996-8#1)(2013-7#1)
was performed in an##11##4##(1991-11#1)(1996-8#1)(2006-7#1)(2006-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2010-11#1)(2013-7#1)
was performed in both patients##2##5##(1997-6#1)(2006-12#1)
was performed in both##3##4##(1997-6#1)(2006-12#1)(2012-12#1)
was performed in combination with##2##5##(1992-1#1)(2008-10#1)
was performed in five cases##2##5##(1997-3#1)(1997-8#1)
was performed in five patients##2##5##(2006-8#1)(2007-7#1)
was performed in five##5##4##(1997-3#1)(1997-8#1)(2006-8#1)(2007-7#2)
was performed in four patients##2##5##(1991-5#1)(2006-11#1)
was performed in four##3##4##(1991-5#1)(2006-11#1)(2013-7#1)
was performed in one##3##4##(2006-6#1)(2008-10#1)(2011-2#1)
was performed in order to identify##3##6##(2006-10#1)(2007-8#1)(2008-10#1)
was performed in order to investigate##2##6##(1997-5#1)(2008-2#1)
was performed in order to##16##5##(1996-6#1)(1996-8#1)(1997-5#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-2#1)(2008-7#1)(2009-7#1)
was performed in patients with##2##5##(1996-9#1)(2007-7#1)
was performed in patients##3##4##(1996-3#1)(1996-9#1)(2007-7#1)
was performed in seven patients##2##5##(1993-2#1)(2006-12#1)
was performed in seven##3##4##(1993-2#1)(2006-12#1)(2013-7#1)
was performed in the area##2##5##(2005-8#1)(2008-12#1)
was performed in the operating##2##5##(2007-8#1)(2011-2#1)
was performed in the##29##4##(1991-12#1)(1992-3#1)(1996-11#1)(1996-12#1)(1997-8#3)(2005-8#1)(2007-11#2)(2007-8#3)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-8#1)(2011-2#3)(2012-3#1)(2013-8#2)
was performed in three##2##4##(2006-11#1)(2012-2#1)
was performed in two patients##2##5##(2006-11#1)(2007-7#1)
was performed in two stages##2##5##(1992-10#1)(2009-3#1)
was performed in two##6##4##(1992-10#1)(2006-11#1)(2007-7#1)(2008-5#1)(2009-3#1)(2009-4#1)
was performed in which##4##4##(1997-6#1)(2004-9#1)(2007-5#1)(2010-3#1)
was performed in##261##3##(1990-10#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-2#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#2)(1996-8#3)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#2)(1997-8#7)(2004-4#1)(2004-9#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#5)(2006-11#6)(2006-12#5)(2006-6#3)(2006-7#1)(2006-8#3)(2007-10#4)(2007-11#11)(2007-12#2)(2007-2#4)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#19)(2007-9#2)(2008-1#6)(2008-10#20)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#8)(2008-6#4)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#2)(2009-2#2)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#12)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#10)(2013-7#3)(2013-8#3)
was performed laparoscopically##3##3##(2008-10#1)(2012-12#1)(2012-2#1)
was performed of all##3##4##(2004-10#1)(2006-10#1)(2008-9#1)
was performed of patients##2##4##(2006-7#1)(2011-2#1)
was performed of the##3##4##(2007-8#1)(2008-2#1)(2012-2#1)
was performed of##13##3##(2004-10#2)(2006-10#1)(2006-6#1)(2006-7#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#2)(2011-2#1)(2012-2#1)
was performed on 10##2##4##(2006-5#1)(2010-12#1)
was performed on 13##2##4##(2007-8#1)(2009-12#1)
was performed on 35##2##4##(2005-5#1)(2007-7#1)
was performed on 50##2##4##(2006-8#1)(2013-8#1)
was performed on Wistar rats##2##5##(2005-10#2)
was performed on a C18##2##5##(1992-2#1)(2010-12#1)
was performed on a##27##4##(1992-2#1)(1992-7#1)(1997-3#2)(1997-5#1)(2005-10#1)(2005-3#1)(2007-8#3)(2007-9#2)(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2013-1#1)
was performed on all patients##4##5##(2007-7#3)(2008-6#1)
was performed on all##7##4##(1992-12#1)(2007-7#3)(2008-6#1)(2011-1#1)(2012-2#1)
was performed on an outpatient basis##2##6##(2006-8#2)
was performed on an##5##4##(2006-8#2)(2007-8#1)(2011-1#2)
was performed on day##4##4##(2008-1#1)(2008-11#1)(2013-8#2)
was performed on the same##2##5##(2007-8#1)(2008-5#1)
was performed on the##33##4##(1990-4#1)(1991-12#1)(1991-9#1)(1993-12#1)(1995-6#1)(1996-1#1)(1997-1#1)(1997-2#1)(2006-12#1)(2006-8#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-5#2)(2008-7#3)(2009-5#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
was performed on these##2##4##(2007-8#1)(2008-5#1)
was performed on##179##3##(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-12#2)(1991-6#1)(1991-9#1)(1992-12#3)(1992-2#2)(1992-4#1)(1992-7#3)(1993-11#1)(1993-12#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-5#2)(1997-6#1)(2004-1#1)(2005-10#3)(2005-3#1)(2005-5#1)(2006-12#3)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#4)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#4)(2007-6#1)(2007-7#7)(2007-8#14)(2007-9#4)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#6)(2013-8#9)
was performed once##3##3##(2006-5#1)(2007-9#1)(2011-2#1)
was performed only in##3##4##(2005-11#1)(2006-10#1)(2007-11#1)
was performed over a##2##4##(2007-3#1)(2010-4#1)
was performed over##3##3##(2007-3#1)(2010-4#1)(2013-1#1)
was performed simultaneously##3##3##(2006-6#1)(2007-9#1)(2008-10#1)
was performed subsequently##2##3##(2007-7#1)(2008-10#1)
was performed successfully in##3##4##(1996-12#1)(2006-6#2)
was performed successfully##6##3##(1996-12#1)(2006-6#2)(2007-8#1)(2008-11#1)(2008-5#1)
was performed through a##3##4##(2007-8#1)(2009-3#1)(2010-2#1)
was performed through the##2##4##(2008-9#1)(2013-1#1)
was performed through##10##3##(2007-8#1)(2007-9#1)(2008-10#1)(2008-9#1)(2009-3#1)(2010-2#1)(2012-12#2)(2013-1#1)(2013-7#1)
was performed to assess the effect of##2##7##(2007-6#1)(2008-5#1)
was performed to assess the##9##5##(2006-12#2)(2007-10#1)(2007-6#1)(2008-5#1)(2010-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
was performed to assess##12##4##(1997-8#1)(2006-12#2)(2007-10#1)(2007-6#1)(2008-10#1)(2008-5#1)(2010-10#1)(2010-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
was performed to better understand##2##5##(2010-12#1)(2011-2#1)
was performed to characterize##3##4##(1992-3#1)(1993-2#1)(1994-2#1)
was performed to compare the##2##5##(1991-8#1)(2013-1#1)
was performed to compare##4##4##(1990-12#1)(1991-8#1)(2008-7#1)(2013-1#1)
was performed to confirm##2##4##(2006-10#1)(2008-12#1)
was performed to detect the##3##5##(2008-8#1)(2012-12#1)(2013-8#1)
was performed to detect##5##4##(2008-3#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
was performed to determine if##3##5##(2006-12#1)(2008-10#2)
was performed to determine the prevalence##2##6##(2006-8#1)(2010-9#1)
was performed to determine the##11##5##(1994-9#1)(1995-2#1)(2006-11#1)(2006-8#1)(2007-10#1)(2008-10#2)(2008-7#1)(2010-9#1)(2011-2#1)(2013-8#1)
was performed to determine whether##4##5##(1990-11#1)(1994-8#1)(2008-7#1)(2011-2#1)
was performed to determine##22##4##(1990-11#1)(1994-8#1)(1994-9#1)(1995-2#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-10#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-9#1)(2011-2#2)(2013-8#2)
was performed to eliminate##2##4##(2007-11#1)(2007-8#1)
was performed to establish whether##2##5##(2007-2#1)(2007-5#1)
was performed to estimate the##3##5##(1990-12#1)(2008-10#1)(2013-8#1)
was performed to estimate##4##4##(1990-12#1)(2008-10#1)(2013-7#1)(2013-8#1)
was performed to evaluate the feasibility of##2##7##(1992-12#1)(2008-10#1)
was performed to evaluate the##12##5##(1992-12#1)(1992-6#1)(1994-9#1)(2005-9#1)(2006-6#1)(2008-1#1)(2008-10#1)(2011-2#3)(2012-1#1)(2013-1#1)
was performed to evaluate##17##4##(1992-12#1)(1992-3#1)(1992-6#1)(1994-9#1)(2005-9#1)(2006-6#1)(2008-1#2)(2008-10#1)(2011-2#4)(2012-1#1)(2013-1#1)(2013-8#2)
was performed to examine the##5##5##(1994-2#1)(1997-5#1)(2008-10#1)(2008-2#1)(2008-7#1)
was performed to examine##7##4##(1994-2#1)(1995-2#1)(1996-4#1)(1997-5#1)(2008-10#1)(2008-2#1)(2008-7#1)
was performed to identify##5##4##(2008-12#1)(2011-2#2)(2012-12#1)(2013-8#1)
was performed to investigate the##9##5##(1992-8#1)(1994-10#1)(1996-11#1)(1996-12#1)(1997-6#1)(2005-11#1)(2008-2#1)(2008-5#1)(2008-9#1)
was performed to investigate##11##4##(1992-8#1)(1994-10#1)(1996-11#1)(1996-12#1)(1997-6#1)(2005-11#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-5#1)(2008-9#1)
was performed to obtain##3##4##(1994-11#1)(2007-8#1)(2012-3#1)
was performed to optimize the##3##5##(2008-10#1)(2008-5#2)
was performed to optimize##4##4##(2008-10#1)(2008-5#3)
was performed to prevent##5##4##(2008-12#1)(2008-5#1)(2011-1#1)(2012-1#1)(2013-1#1)
was performed to remove##2##4##(2006-5#1)(2007-8#1)
was performed to retrieve##2##4##(1990-12#1)(2013-1#1)
was performed to test the##3##5##(1997-2#1)(2004-11#1)(2007-7#1)
was performed to treat##3##4##(2006-8#1)(2009-3#1)(2012-12#1)
was performed to##167##3##(1990-11#1)(1990-12#3)(1990-5#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-2#1)(1994-10#1)(1994-11#1)(1994-2#2)(1994-8#1)(1994-9#2)(1995-2#2)(1995-5#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#2)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#4)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#3)(2008-10#14)(2008-12#5)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#8)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-10#2)(2010-12#2)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#13)(2012-1#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#10)
was performed twice##5##3##(2006-8#2)(2008-12#2)(2008-7#1)
was performed under cardiopulmonary bypass##2##5##(2007-8#1)(2013-1#1)
was performed under##15##3##(1995-9#1)(1996-5#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-4#1)(2007-8#2)(2008-5#2)(2008-7#1)(2011-2#1)(2013-1#2)
was performed using a modified##2##5##(2008-10#1)(2013-1#1)
was performed using a##28##4##(1990-3#1)(1991-8#1)(1995-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#5)(2008-5#2)(2008-7#2)(2009-10#1)(2009-3#1)(2011-1#2)(2011-12#1)(2011-2#2)(2013-1#2)
was performed using an##4##4##(2005-8#1)(2007-10#1)(2007-3#1)(2007-7#1)
was performed using capillary##2##4##(1996-5#1)(2008-10#1)
was performed using factorial design##2##5##(2007-8#1)(2008-10#1)
was performed using medical records##2##5##(2013-1#2)
was performed using multiple##2##4##(2007-8#1)(2011-3#1)
was performed using the##25##4##(1992-3#2)(1997-8#1)(2006-3#1)(2007-1#1)(2007-11#1)(2007-3#1)(2008-10#3)(2008-7#3)(2009-2#1)(2009-3#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
was performed using##143##3##(1990-3#1)(1991-3#1)(1991-8#1)(1992-3#2)(1992-9#1)(1993-10#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-6#1)(1995-7#1)(1996-5#1)(1996-8#1)(1997-8#3)(2004-9#1)(2005-12#1)(2005-8#2)(2006-11#2)(2006-2#2)(2006-3#2)(2006-5#1)(2006-6#2)(2006-8#3)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#2)(2007-2#2)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#6)(2008-10#26)(2008-11#1)(2008-12#1)(2008-5#4)(2008-7#7)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-6#1)(2010-1#2)(2010-10#1)(2010-12#3)(2010-4#2)(2010-5#1)(2011-1#4)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#2)(2012-3#3)(2013-1#10)(2013-8#2)
was performed utilizing##2##3##(2007-8#1)(2013-1#1)
was performed via a##2##4##(2008-10#1)(2011-2#1)
was performed via##4##3##(2007-8#1)(2008-10#1)(2011-2#1)(2012-11#1)
was performed which showed##2##4##(1992-4#1)(2007-7#1)
was performed which##4##3##(1992-4#1)(1993-2#1)(2006-4#1)(2007-7#1)
was performed with a##19##4##(1991-3#1)(1995-3#1)(1996-9#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2009-2#1)(2009-3#1)(2011-2#2)(2012-7#1)
was performed with an##3##4##(2006-12#1)(2007-7#1)(2008-12#1)
was performed with measurement of##2##5##(2006-5#1)(2007-7#1)
was performed with the use of##2##6##(2007-7#1)(2007-8#1)
was performed with the##15##4##(1991-3#1)(1995-1#1)(1996-6#1)(1996-8#1)(2006-5#1)(2006-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-7#1)(2010-2#1)(2013-8#1)
was performed with##107##3##(1990-3#2)(1990-9#1)(1991-11#1)(1991-3#2)(1991-4#1)(1991-6#1)(1991-8#1)(1992-9#1)(1993-11#1)(1994-10#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-2#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-6#1)(2004-11#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-5#2)(2006-6#4)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#5)(2007-9#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#2)(2009-2#2)(2009-3#1)(2009-6#1)(2010-12#2)(2010-2#2)(2010-9#1)(2011-12#2)(2011-2#7)(2012-1#2)(2012-2#2)(2012-3#2)(2012-7#1)(2013-1#2)(2013-7#1)(2013-8#2)
was performed within the##2##4##(2010-11#1)(2011-2#1)
was performed within##5##3##(1990-8#1)(2008-10#1)(2010-11#1)(2011-2#1)(2012-1#1)
was performed without##6##3##(1994-3#1)(2005-12#1)(2007-2#1)(2008-7#1)(2009-8#1)(2012-3#1)
was performed##1755##2##(1990-1#1)(1990-10#6)(1990-11#1)(1990-12#8)(1990-2#5)(1990-3#7)(1990-4#2)(1990-5#4)(1990-6#4)(1990-8#5)(1990-9#3)(1991-1#1)(1991-10#4)(1991-11#5)(1991-12#4)(1991-2#4)(1991-3#5)(1991-4#4)(1991-5#4)(1991-6#6)(1991-7#2)(1991-8#5)(1991-9#4)(1992-1#3)(1992-10#3)(1992-11#1)(1992-12#9)(1992-2#6)(1992-3#6)(1992-4#5)(1992-5#5)(1992-6#7)(1992-7#5)(1992-8#5)(1992-9#4)(1993-1#3)(1993-10#2)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#3)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#6)(1994-10#2)(1994-11#8)(1994-12#3)(1994-2#3)(1994-3#4)(1994-5#3)(1994-6#5)(1994-7#3)(1994-8#2)(1994-9#8)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#6)(1995-3#1)(1995-5#1)(1995-6#5)(1995-7#1)(1995-9#1)(1996-1#4)(1996-11#6)(1996-12#10)(1996-2#5)(1996-3#9)(1996-4#1)(1996-5#7)(1996-6#14)(1996-7#3)(1996-8#7)(1996-9#4)(1997-1#1)(1997-2#9)(1997-3#7)(1997-4#3)(1997-5#5)(1997-6#9)(1997-7#3)(1997-8#14)(1997-9#1)(2004-1#2)(2004-10#3)(2004-11#3)(2004-12#1)(2004-4#1)(2004-9#4)(2005-1#2)(2005-10#7)(2005-11#9)(2005-12#3)(2005-3#1)(2005-5#1)(2005-8#4)(2005-9#1)(2006-10#23)(2006-11#13)(2006-12#17)(2006-2#5)(2006-3#2)(2006-4#3)(2006-5#14)(2006-6#18)(2006-7#6)(2006-8#20)(2006-9#3)(2007-1#5)(2007-10#12)(2007-11#32)(2007-12#20)(2007-2#20)(2007-3#11)(2007-4#4)(2007-5#4)(2007-6#7)(2007-7#35)(2007-8#94)(2007-9#17)(2008-1#20)(2008-10#185)(2008-11#18)(2008-12#29)(2008-2#10)(2008-3#27)(2008-4#13)(2008-5#54)(2008-6#23)(2008-7#44)(2008-8#20)(2008-9#16)(2009-1#1)(2009-10#7)(2009-11#1)(2009-12#1)(2009-2#9)(2009-3#11)(2009-4#5)(2009-5#4)(2009-6#6)(2009-7#2)(2009-8#4)(2009-9#4)(2010-1#3)(2010-10#7)(2010-11#2)(2010-12#24)(2010-2#8)(2010-3#5)(2010-4#9)(2010-5#5)(2010-6#3)(2010-7#3)(2010-8#5)(2010-9#9)(2011-1#29)(2011-12#7)(2011-2#88)(2011-3#2)(2011-7#1)(2012-1#16)(2012-11#3)(2012-12#32)(2012-2#32)(2012-3#18)(2012-5#1)(2012-7#1)(2012-8#2)(2013-1#72)(2013-7#14)(2013-8#48)
was perfused##5##2##(1990-12#1)(1993-4#1)(1994-8#1)(2008-11#2)
was periodically##3##2##(1997-4#1)(2007-12#2)
was permanent##3##2##(1990-9#1)(2011-1#1)(2011-2#1)
was permanently##2##2##(1991-6#1)(1995-12#1)
was permitted##2##2##(2012-2#1)(2013-8#1)
was perpendicular to the##2##4##(2007-11#1)(2008-3#1)
was perpendicular to##3##3##(2007-11#1)(2008-3#2)
was persistent##3##2##(1995-2#1)(1997-1#1)(2008-8#1)
was persistently##2##2##(2007-1#1)(2008-1#1)
was perturbed##4##2##(1991-7#1)(1997-4#1)(2008-10#1)(2008-11#1)
was petrolatum##2##2##(2008-5#2)
was phase##2##2##(2008-3#1)(2008-5#1)
was phenotypically##2##2##(2008-10#1)(2012-2#1)
was phosphorylated and##3##3##(1990-5#2)(2008-6#1)
was phosphorylated at##3##3##(1990-11#1)(1994-3#1)(1994-9#1)
was phosphorylated by both##2##4##(1990-4#1)(1991-7#1)
was phosphorylated by protein kinase C##2##6##(1990-3#1)(1991-8#1)
was phosphorylated by protein##3##4##(1990-3#1)(1991-8#1)(1994-9#1)
was phosphorylated by##9##3##(1990-3#1)(1990-4#1)(1991-7#2)(1991-8#1)(1992-3#1)(1994-12#1)(1994-9#1)(1995-1#1)
was phosphorylated in vitro by##4##5##(1990-11#1)(1992-7#1)(1993-8#1)(1995-2#1)
was phosphorylated in vitro##7##4##(1990-11#2)(1992-7#2)(1993-8#1)(1994-9#1)(1995-2#1)
was phosphorylated in##9##3##(1990-11#2)(1992-7#2)(1993-8#1)(1994-8#1)(1994-9#1)(1995-2#1)(1997-2#1)
was phosphorylated on##3##3##(1993-8#1)(1996-2#1)(1997-6#1)
was phosphorylated to 1##2##4##(1994-3#2)
was phosphorylated##34##2##(1990-11#3)(1990-3#1)(1990-4#1)(1990-5#2)(1991-10#1)(1991-7#2)(1991-8#1)(1992-3#1)(1992-7#2)(1993-8#2)(1994-12#1)(1994-3#3)(1994-8#2)(1994-9#6)(1995-1#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-6#1)(2008-6#1)
was photosynthetic##2##2##(2007-12#2)
was phylogenetically distinct from##2##4##(2008-10#2)
was phylogenetically##3##2##(2008-10#2)(2012-3#1)
was physically##5##2##(1991-8#1)(1995-6#1)(1997-7#1)(2008-10#1)(2013-1#1)
was picked up##2##3##(1995-3#1)(2008-4#1)
was picked##4##2##(1994-3#1)(1995-3#1)(1997-3#1)(2008-4#1)
was pilot tested##2##3##(2010-10#1)(2012-1#1)
was piloted##2##2##(2008-11#1)(2008-12#1)
was pioneered by##3##3##(1994-9#1)(2006-7#1)(2013-1#1)
was pivotal##2##2##(2008-8#1)(2010-10#1)
was placed at##3##3##(2008-2#1)(2008-3#1)(2008-4#1)
was placed between the##2##4##(2006-12#1)(2008-5#1)
was placed between##3##3##(2006-12#1)(2008-10#1)(2008-5#1)
was placed downstream from the##2##5##(1994-12#1)(1997-4#1)
was placed downstream##4##3##(1994-12#1)(1997-4#1)(2005-11#1)(2008-8#1)
was placed in a##4##4##(2008-10#1)(2009-3#1)(2012-2#1)(2012-3#1)
was placed in an##4##4##(2008-10#1)(2008-5#1)(2008-6#1)(2009-3#1)
was placed in the right##2##5##(1993-2#1)(2007-8#1)
was placed in the##12##4##(1993-11#1)(1993-2#1)(1994-6#1)(1997-4#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)
was placed in##32##3##(1992-5#1)(1993-11#1)(1993-2#1)(1994-6#1)(1994-9#1)(1995-8#1)(1997-4#2)(2004-9#2)(2007-11#2)(2007-7#1)(2007-8#2)(2008-10#7)(2008-3#1)(2008-5#2)(2008-6#1)(2009-3#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
was placed inside##3##3##(1997-6#1)(2008-10#2)
was placed into a##2##4##(2008-10#2)
was placed into the##2##4##(2007-7#1)(2012-12#1)
was placed into##4##3##(2007-7#1)(2008-10#2)(2012-12#1)
was placed just##2##3##(1997-4#1)(2006-11#1)
was placed on the##4##4##(2005-7#1)(2005-8#1)(2008-7#1)(2011-2#1)
was placed on##9##3##(1990-2#1)(2005-7#1)(2005-8#1)(2006-9#1)(2007-8#1)(2008-7#2)(2011-2#2)
was placed over the##3##4##(1994-6#1)(2008-3#1)(2012-2#1)
was placed to##2##3##(1990-3#1)(2006-12#1)
was placed under the control of the##2##7##(1994-11#1)(1997-5#1)
was placed under the control of##5##6##(1994-11#1)(1994-2#1)(1997-4#2)(1997-5#1)
was placed under the##8##4##(1993-12#2)(1994-11#1)(1994-2#1)(1996-7#1)(1997-4#2)(1997-5#1)
was placed under##9##3##(1993-12#2)(1994-11#1)(1994-2#1)(1995-8#1)(1996-7#1)(1997-4#2)(1997-5#1)
was placed within##2##3##(1993-11#1)(2012-2#1)
was placed##96##2##(1990-2#1)(1990-3#1)(1990-5#1)(1992-5#1)(1993-11#2)(1993-12#2)(1993-2#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-8#2)(1996-7#1)(1996-9#1)(1997-4#6)(1997-5#1)(1997-6#1)(2004-9#2)(2005-11#1)(2005-7#1)(2005-8#1)(2006-11#1)(2006-12#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-11#2)(2007-4#1)(2007-7#3)(2007-8#6)(2008-10#12)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#2)(2009-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
was planned as a##2##4##(2010-6#1)(2010-7#1)
was planned as##3##3##(1990-6#1)(2010-6#1)(2010-7#1)
was planned in##2##3##(2008-7#1)(2012-2#1)
was planned to##11##3##(1994-11#1)(1994-12#1)(1996-10#1)(2004-1#1)(2007-10#1)(2012-3#1)(2013-1#2)(2013-8#3)
was planned under##2##3##(2006-1#1)(2013-7#1)
was planned##31##2##(1990-3#1)(1990-6#1)(1991-5#1)(1993-3#1)(1994-11#1)(1994-12#1)(1996-10#1)(2004-1#1)(2006-1#1)(2006-8#1)(2007-10#1)(2007-6#1)(2007-8#1)(2008-7#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#4)
was planted in##2##3##(2008-10#2)
was planted##3##2##(2008-10#2)(2011-2#1)
was played##3##2##(1993-1#2)(2009-2#1)
was plotted against##3##3##(2006-8#1)(2008-10#1)(2008-8#1)
was plotted##5##2##(2006-8#1)(2008-10#2)(2008-8#1)(2013-8#1)
was pointed out##6##3##(1990-7#1)(1991-6#1)(2008-10#2)(2008-8#1)(2009-2#1)
was pointed##7##2##(1990-7#1)(1991-6#1)(2008-10#2)(2008-8#1)(2009-2#1)(2011-2#1)
was poisoned##2##2##(1990-5#1)(1991-11#1)
was polymerized in##2##3##(1990-12#1)(2012-2#1)
was polymerized##4##2##(1990-12#1)(1995-2#1)(2010-4#1)(2012-2#1)
was poor (r = 0##2##5##(1991-3#1)(1996-9#1)
was poor and##2##3##(1992-10#1)(2008-11#1)
was poor compared with##2##4##(1996-8#1)(2008-6#1)
was poor in##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
was poor##38##2##(1990-1#1)(1990-6#1)(1991-3#1)(1992-10#1)(1995-12#1)(1996-8#1)(1996-9#1)(1997-6#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-9#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
was poorer than##2##3##(2006-10#1)(2007-11#1)
was poorer##5##2##(1997-5#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)
was poorly##18##2##(1990-12#1)(1991-12#1)(1991-9#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-1#1)(1997-3#1)(2006-4#1)(2006-8#2)(2007-12#1)(2007-8#2)(2011-12#1)(2011-2#1)
was popular##2##2##(2011-1#1)(2012-2#1)
was posed##2##2##(1995-8#1)(2008-9#1)
was positioned on##2##3##(2008-10#2)
was positioned opposite##2##3##(1995-10#2)
was positioned##17##2##(1995-10#2)(1996-5#1)(1996-8#1)(1997-1#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-6#1)(2009-4#1)(2012-1#1)(2012-12#2)(2013-1#1)
was positive and##4##3##(2006-7#1)(2007-2#1)(2008-6#1)(2010-2#1)
was positive by PCR##3##4##(1991-9#1)(2005-7#1)(2008-5#1)
was positive by##4##3##(1991-9#1)(1992-6#1)(2005-7#1)(2008-5#1)
was positive correlation between##2##4##(1996-3#1)(2011-1#1)
was positive for anti-HCV##2##4##(1991-3#1)(1991-9#1)
was positive for##29##3##(1990-12#1)(1991-11#1)(1991-3#1)(1991-9#1)(1995-4#1)(1997-2#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-8#2)
was positive in 1##3##4##(2007-2#1)(2011-1#2)
was positive in all##2##4##(1995-11#1)(1996-8#1)
was positive in the##5##4##(1994-7#1)(2007-2#1)(2008-5#1)(2011-2#2)
was positive in two##2##4##(2007-7#1)(2008-1#1)
was positive in##35##3##(1990-2#1)(1992-10#1)(1992-6#1)(1993-10#1)(1994-1#1)(1994-7#1)(1995-11#1)(1996-1#1)(1996-8#1)(1996-9#3)(1997-7#1)(2006-8#1)(2007-2#4)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-8#2)
was positive with##5##3##(1991-2#1)(1994-12#1)(1995-12#1)(2008-7#1)(2012-2#1)
was positive##114##2##(1990-12#1)(1990-2#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-9#3)(1992-10#1)(1992-2#1)(1992-6#2)(1993-10#2)(1994-1#1)(1994-12#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-4#1)(1996-1#2)(1996-3#1)(1996-7#1)(1996-8#1)(1996-9#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#6)(2007-4#1)(2007-5#2)(2007-7#6)(2007-8#4)(2008-1#3)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#5)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#4)(2013-8#4)
was positively associated with the##3##5##(2008-8#2)(2010-12#1)
was positively associated with##24##4##(1993-12#1)(1996-3#1)(1996-9#1)(1997-2#1)(2006-7#1)(2007-2#1)(2008-12#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-7#1)(2009-9#2)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#3)
was positively correlated to the##3##5##(2006-10#1)(2008-10#1)(2011-2#1)
was positively correlated to##5##4##(2004-12#1)(2006-10#1)(2008-10#2)(2011-2#1)
was positively correlated with age##2##5##(1994-6#1)(2011-1#1)
was positively correlated with children's behavior problems##2##7##(2010-11#2)
was positively correlated with percentage of field area affected by FCRR##2##11##(2008-10#2)
was positively correlated with the##13##5##(1990-7#1)(1996-6#1)(2005-11#1)(2007-7#1)(2008-10#3)(2008-7#1)(2009-7#1)(2010-1#1)(2010-4#1)(2012-12#2)
was positively correlated with##51##4##(1990-7#1)(1991-12#1)(1991-2#1)(1991-8#1)(1994-1#1)(1994-12#1)(1994-6#2)(1995-12#1)(1996-6#1)(2004-11#1)(2005-11#1)(2007-12#2)(2007-7#1)(2008-10#16)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-11#2)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)
was positively correlated##58##3##(1990-7#1)(1991-12#1)(1991-2#1)(1991-8#1)(1994-1#1)(1994-12#1)(1994-6#2)(1995-12#1)(1996-6#1)(2004-11#1)(2004-12#1)(2005-11#1)(2006-10#1)(2007-12#2)(2007-7#1)(2008-10#19)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-11#2)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#1)
was positively identified as##2##4##(1995-6#1)(2008-10#1)
was positively related to the number of good##2##8##(2009-8#2)
was positively related to the##4##5##(1996-12#1)(2009-8#2)(2011-2#1)
was positively related to##18##4##(1995-12#1)(1996-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-4#3)(2009-7#1)(2009-8#2)(2011-2#2)(2012-12#2)
was positively related##19##3##(1995-12#1)(1996-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-4#3)(2009-7#1)(2009-8#2)(2010-8#1)(2011-2#2)(2012-12#2)
was positively##109##2##(1990-7#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-3#1)(1993-12#1)(1994-1#1)(1994-12#2)(1994-6#2)(1995-12#2)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(2004-11#1)(2004-12#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#23)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#3)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#2)(2010-1#1)(2010-11#2)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#4)(2013-1#4)
was possible after##2##3##(1991-11#1)(2010-10#1)
was possible by##4##3##(1990-11#1)(1996-5#1)(2008-10#2)
was possible for##5##3##(1995-8#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-9#1)
was possible from##3##3##(2007-8#1)(2008-11#1)(2013-1#1)
was possible in 31##2##4##(2007-9#1)(2008-5#1)
was possible in all##2##4##(2010-7#1)(2011-2#1)
was possible in##14##3##(1990-12#1)(1991-6#1)(1993-3#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-10#1)(2010-7#1)(2011-2#1)(2013-1#1)
was possible thanks to##2##4##(2009-12#1)(2012-12#1)
was possible to determine the##3##5##(1991-8#1)(1992-6#1)(1992-7#1)
was possible to determine##4##4##(1991-8#1)(1992-6#1)(1992-7#1)(2008-10#1)
was possible to identify##5##4##(1996-1#1)(2006-7#1)(2008-10#1)(2010-4#1)(2012-3#1)
was possible to observe##3##4##(1992-6#1)(1995-8#1)(1997-2#1)
was possible to obtain a##4##5##(2008-10#2)(2008-5#1)(2013-1#1)
was possible to obtain##10##4##(2005-11#1)(2008-10#6)(2008-5#1)(2013-1#2)
was possible to produce##2##4##(2008-11#1)(2008-5#1)
was possible to resolve and##2##5##(1990-11#1)(2008-10#1)
was possible to resolve##4##4##(1990-11#1)(2007-12#1)(2008-10#1)(2011-1#1)
was possible to select##2##4##(2004-9#1)(2012-11#1)
was possible to##118##3##(1990-10#2)(1990-11#2)(1990-3#1)(1990-6#1)(1990-8#1)(1991-3#2)(1991-8#1)(1992-10#1)(1992-11#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-8#2)(1995-1#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-9#1)(1997-2#3)(1997-5#1)(2004-8#1)(2004-9#1)(2005-11#3)(2005-9#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#4)(2008-10#30)(2008-11#5)(2008-2#1)(2008-3#3)(2008-5#4)(2008-6#1)(2008-7#5)(2008-9#1)(2009-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#4)
was possible using##4##3##(1990-10#1)(2008-10#3)
was possible with a##2##4##(2008-10#2)
was possible with the##2##4##(1995-6#1)(2008-3#1)
was possible with##6##3##(1994-3#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-3#1)
was possible##186##2##(1990-10#3)(1990-11#3)(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-3#2)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-8#2)(1995-1#2)(1995-2#1)(1995-4#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-2#4)(1997-5#1)(1997-7#1)(2004-8#1)(2004-9#1)(2005-11#4)(2005-9#1)(2006-12#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-7#1)(2007-8#8)(2007-9#1)(2008-10#46)(2008-11#8)(2008-2#2)(2008-3#5)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#2)(2009-12#1)(2009-2#2)(2010-10#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#4)(2012-3#1)(2013-1#7)
was possibly a##2##3##(1994-12#1)(2007-11#1)
was possibly due to##2##4##(2005-7#1)(2008-10#1)
was possibly##9##2##(1992-8#1)(1993-3#1)(1994-12#1)(2005-7#1)(2007-11#1)(2008-10#1)(2008-8#1)(2010-5#1)(2011-1#1)
was posted##4##2##(2005-10#1)(2008-7#1)(2010-12#1)(2010-5#1)
was postponed##3##2##(2006-7#1)(2010-5#1)(2013-1#1)
was postulated that##4##3##(1994-12#1)(2006-12#1)(2008-10#1)(2009-8#1)
was postulated to be##3##4##(1997-3#1)(2008-10#1)(2008-7#1)
was postulated to##5##3##(1997-3#1)(2008-10#3)(2008-7#1)
was postulated##11##2##(1994-12#1)(1994-2#1)(1997-3#1)(2006-12#1)(2008-10#5)(2008-7#1)(2009-8#1)
was potential##2##2##(2011-2#1)(2013-1#1)
was potentiated by superoxide dismutase##2##5##(1990-10#1)(1990-11#1)
was potentiated by the##2##4##(1990-7#1)(1995-12#1)
was potentiated by##14##3##(1990-10#1)(1990-11#1)(1990-7#1)(1991-9#1)(1992-11#1)(1993-6#1)(1994-11#1)(1994-5#2)(1995-12#1)(1996-12#1)(1997-2#1)(1997-5#1)(2012-12#1)
was potentiated in##2##3##(1996-2#1)(2007-1#1)
was potentiated##16##2##(1990-10#1)(1990-11#1)(1990-7#1)(1991-9#1)(1992-11#1)(1993-6#1)(1994-11#1)(1994-5#2)(1995-12#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-5#1)(2007-1#1)(2012-12#1)
was potently inhibited by##2##4##(1994-8#1)(1996-10#1)
was potently##3##2##(1993-7#1)(1994-8#1)(1996-10#1)
was powered##2##2##(2007-8#1)(2008-8#1)
was practically##7##2##(1991-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-12#1)
was practiced##2##2##(1994-12#1)(2012-1#1)
was practised##2##2##(1991-8#1)(2008-3#1)
was preceded by a##10##4##(1991-9#1)(1992-2#1)(1993-12#1)(1993-9#1)(1996-9#1)(1997-7#1)(2005-7#1)(2008-10#2)(2008-12#1)
was preceded by the##2##4##(1994-5#1)(2008-8#1)
was preceded by##15##3##(1991-9#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-5#1)(1996-9#1)(1997-7#1)(2005-7#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-8#1)(2011-2#1)
was precipitated and##2##3##(2008-10#1)(2008-6#1)
was precipitated by##5##3##(1990-1#1)(1990-12#1)(1990-2#1)(2008-10#1)(2008-9#1)
was precipitated in##2##3##(2008-10#2)
was precipitated with##3##3##(1991-5#1)(2008-10#2)
was precipitated##12##2##(1990-1#1)(1990-12#1)(1990-2#1)(1991-5#1)(2008-10#6)(2008-6#1)(2008-9#1)
was precisely##5##2##(1991-11#1)(2008-1#1)(2008-10#2)(2010-12#1)
was precluded##2##2##(2008-10#1)(2009-6#1)
was preconcentrated in a membrane cell##2##6##(2008-10#2)
was preconcentrated in a##3##4##(2008-10#3)
was preconcentrated in##5##3##(2008-10#5)
was preconcentrated on the##2##4##(2008-10#2)
was preconcentrated on##5##3##(2008-10#5)
was preconcentrated onto the##2##4##(2008-10#2)
was preconcentrated##17##2##(2008-10#17)
was predictable##2##2##(2007-12#1)(2008-11#1)
was predicted by##15##3##(2006-12#1)(2007-12#3)(2008-10#4)(2008-12#1)(2008-2#1)(2008-9#1)(2010-1#1)(2010-2#1)(2012-2#1)(2013-1#1)
was predicted for##2##3##(1990-5#1)(1992-2#1)
was predicted from##2##3##(1990-5#1)(2008-10#1)
was predicted that##2##3##(1996-8#1)(2009-4#1)
was predicted to be a##2##5##(1994-11#1)(2008-8#1)
was predicted to be##6##4##(1990-12#1)(1994-11#1)(1994-9#1)(2007-11#1)(2008-8#1)(2010-4#1)
was predicted to occur##2##4##(2006-5#1)(2007-4#1)
was predicted to##9##3##(1990-12#1)(1994-11#1)(1994-9#1)(1995-3#1)(2006-5#1)(2007-11#1)(2007-4#1)(2008-8#1)(2010-4#1)
was predicted##44##2##(1990-12#1)(1990-4#1)(1990-5#2)(1992-2#1)(1993-2#1)(1994-11#1)(1994-9#1)(1995-10#1)(1995-3#1)(1996-6#1)(1996-8#2)(2005-11#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#3)(2007-4#1)(2008-10#8)(2008-12#2)(2008-2#2)(2008-8#3)(2008-9#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-4#1)(2012-2#1)(2013-1#1)
was predictive of##8##3##(2007-12#2)(2007-8#2)(2008-10#1)(2008-6#1)(2009-5#1)(2010-5#1)
was predominant among##2##3##(2007-8#1)(2008-10#1)
was predominant in the##3##4##(2007-5#1)(2008-5#1)(2010-8#1)
was predominant in##12##3##(1991-9#1)(1994-2#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-5#3)(2008-7#1)(2010-8#1)(2013-8#1)
was predominant##22##2##(1991-9#1)(1992-11#1)(1994-2#3)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#5)(2008-7#1)(2010-8#1)(2011-2#1)(2013-8#1)
was predominantly due to##2##4##(1991-8#1)(1996-10#1)
was predominantly expressed in the##3##5##(1997-4#1)(1997-6#1)(2013-8#1)
was predominantly expressed in##4##4##(1992-8#1)(1997-4#1)(1997-6#1)(2013-8#1)
was predominantly##31##2##(1991-5#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-7#1)(1992-8#1)(1995-10#1)(1995-12#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-5#1)(1996-7#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-9#2)(2010-5#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
was preferential##3##2##(1997-2#1)(2007-11#1)(2008-5#1)
was preferentially##7##2##(1990-2#1)(1993-6#1)(1994-8#1)(1997-1#1)(1997-7#1)(2008-11#1)(2008-5#1)
was preferred in##2##3##(1991-6#1)(2007-12#1)
was preferred over##2##3##(1991-11#1)(2010-8#1)
was preferred##13##2##(1991-11#1)(1991-6#2)(1992-3#1)(1993-2#1)(1996-5#1)(2007-12#2)(2008-10#2)(2008-4#1)(2010-8#1)(2013-1#1)
was preformed to##2##3##(2008-5#1)(2011-2#1)
was preformed##4##2##(2008-5#1)(2009-5#1)(2011-2#1)(2012-12#1)
was pregnant##2##2##(2006-10#2)
was preincubated in##2##3##(1990-11#1)(1994-3#1)
was preincubated with##2##3##(1991-7#1)(1995-6#1)
was preincubated##4##2##(1990-11#1)(1991-7#1)(1994-3#1)(1995-6#1)
was preliminarily##2##2##(2012-2#1)(2013-1#1)
was preliminary##3##2##(1990-10#1)(1995-3#1)(2010-11#1)
was prepared and analyzed##2##4##(2007-11#1)(2013-7#1)
was prepared and characterized##2##4##(1995-1#1)(2009-11#1)
was prepared and evaluated##3##4##(1993-9#1)(1995-3#1)(2009-6#1)
was prepared and investigated##2##4##(2008-10#1)(2008-5#1)
was prepared and its##5##4##(2008-10#3)(2008-5#1)(2013-1#1)
was prepared and the##2##4##(2011-1#1)(2012-12#1)
was prepared and used to##4##5##(1994-10#1)(1995-8#1)(2008-10#1)(2008-11#1)
was prepared and used##7##4##(1994-10#1)(1995-8#1)(2008-10#4)(2008-11#1)
was prepared and##40##3##(1993-11#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1995-1#1)(1995-3#1)(1995-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-5#3)(2009-11#1)(2009-6#1)(2010-5#1)(2011-1#1)(2012-12#2)(2013-1#1)(2013-7#2)
was prepared as a##5##4##(1990-12#1)(1992-3#1)(2007-5#1)(2008-10#1)(2008-2#1)
was prepared as##8##3##(1990-12#2)(1992-3#1)(1994-9#1)(1997-6#1)(2007-5#1)(2008-10#1)(2008-2#1)
was prepared by a##6##4##(1994-2#1)(1994-9#1)(2008-10#2)(2008-5#1)(2013-1#1)
was prepared by coupling##2##4##(1990-2#1)(2007-8#1)
was prepared by dissolving##2##4##(2008-10#2)
was prepared by first##2##4##(1991-3#1)(2007-8#1)
was prepared by mixing##2##4##(2008-10#1)(2008-2#1)
was prepared by reacting##2##4##(2005-11#1)(2008-10#1)
was prepared by reaction of##2##5##(1990-2#1)(1997-7#1)
was prepared by sol-gel##2##4##(2008-10#2)
was prepared by the addition of##2##6##(2008-10#1)(2012-12#1)
was prepared by the##7##4##(1990-7#1)(1996-4#1)(1997-2#1)(2008-10#3)(2012-12#1)
was prepared by using##4##4##(2007-11#1)(2008-10#3)
was prepared by##85##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-7#1)(1991-3#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-2#2)(1994-3#1)(1994-9#2)(1995-5#1)(1995-7#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-7#2)(2004-11#1)(2004-9#2)(2005-11#6)(2005-7#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#3)(2008-10#25)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#5)(2009-7#1)(2010-1#1)(2010-12#1)(2010-4#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
was prepared for##4##3##(1995-2#1)(1997-3#1)(2005-12#1)(2008-10#1)
was prepared from the##5##4##(1994-2#1)(2005-11#2)(2010-7#1)(2011-2#1)
was prepared from##30##3##(1991-4#1)(1992-3#2)(1993-3#1)(1994-2#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-2#1)(1996-2#1)(1996-7#1)(1997-2#1)(2005-11#2)(2005-8#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-9#1)(2010-2#2)(2010-7#1)(2011-2#1)
was prepared in a##3##4##(1993-3#1)(2004-7#1)(2007-8#1)
was prepared in order to##3##5##(1996-2#1)(2005-8#1)(2008-10#1)
was prepared in##16##3##(1993-3#1)(1996-2#2)(2004-7#1)(2005-8#1)(2006-12#2)(2007-11#1)(2007-8#1)(2008-10#4)(2008-9#1)(2010-4#1)(2013-8#1)
was prepared successfully##2##3##(2009-11#1)(2010-12#1)
was prepared to##4##3##(1994-8#1)(1995-3#1)(1997-2#1)(2008-10#1)
was prepared using a##2##4##(2007-8#1)(2008-11#1)
was prepared using the##4##4##(1994-3#1)(1996-2#1)(2005-11#1)(2008-5#1)
was prepared using##12##3##(1994-3#1)(1996-2#2)(2005-11#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#3)(2009-8#1)
was prepared with the##2##4##(2007-8#1)(2011-3#1)
was prepared with##8##3##(1990-5#1)(1996-6#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-3#1)
was prepared##238##2##(1990-11#1)(1990-12#4)(1990-2#2)(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-3#3)(1992-8#1)(1993-11#2)(1993-3#2)(1993-6#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-2#3)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#8)(1995-1#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-7#1)(1995-8#1)(1996-2#5)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-6#2)(1997-7#2)(2004-11#1)(2004-12#1)(2004-7#1)(2004-9#2)(2005-11#9)(2005-12#1)(2005-7#1)(2005-8#2)(2006-12#2)(2007-10#2)(2007-11#5)(2007-12#3)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#9)(2008-10#59)(2008-11#6)(2008-12#2)(2008-2#5)(2008-3#2)(2008-5#13)(2008-8#1)(2008-9#3)(2009-11#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#2)(2010-4#4)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#3)
was preparing##2##2##(1996-6#1)(2004-3#1)
was prescribed in##2##3##(2008-6#1)(2010-12#1)
was prescribed to##7##3##(2006-12#1)(2006-2#1)(2006-8#1)(2009-5#2)(2010-2#1)(2011-2#1)
was prescribed##20##2##(1995-11#1)(1995-3#1)(1997-1#1)(2005-12#1)(2005-3#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-12#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-5#2)(2010-12#2)(2010-2#1)(2011-2#1)(2012-1#1)
was presence##2##2##(1990-11#1)(2013-1#1)
was present almost exclusively in##2##5##(1994-12#1)(1997-5#1)
was present among##2##3##(2008-5#1)(2012-12#1)
was present and##2##3##(2008-3#1)(2008-5#1)
was present as a##2##4##(1990-10#1)(2008-10#1)
was present as##6##3##(1990-10#1)(1990-2#1)(2007-8#1)(2008-10#2)(2010-2#1)
was present at a##6##4##(1991-12#1)(1993-8#1)(1996-5#1)(2008-10#2)(2010-7#1)
was present at high##2##4##(1991-8#1)(1997-3#1)
was present at significantly##2##4##(1990-10#1)(1993-3#1)
was present at the##3##4##(1996-5#1)(1996-6#1)(2008-10#1)
was present at##25##3##(1990-10#2)(1991-12#1)(1991-8#1)(1993-3#2)(1993-8#1)(1995-1#1)(1995-2#1)(1996-5#2)(1996-6#1)(1997-3#1)(1997-5#1)(2004-1#1)(2004-11#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-8#1)(2010-7#1)
was present between##2##3##(1990-4#1)(2011-1#1)
was present during##2##3##(1990-11#1)(1993-12#1)
was present for##7##3##(1990-9#1)(1997-1#1)(2005-11#1)(2006-8#1)(2007-10#1)(2008-9#1)(2010-6#1)
was present from##2##3##(1991-10#1)(2009-2#1)
was present in 10##4##4##(2006-12#1)(2008-5#1)(2011-12#1)(2011-2#1)
was present in 10%##2##4##(2007-3#1)(2007-8#1)
was present in 13##4##4##(1997-8#1)(2006-9#1)(2007-9#1)(2013-8#1)
was present in 14##2##4##(2008-7#1)(2011-11#1)
was present in 22##2##4##(1994-1#1)(2007-7#1)
was present in 22%##2##4##(2007-8#2)
was present in 38##3##4##(1991-11#1)(2007-7#1)(2013-1#1)
was present in 4##2##4##(1994-7#1)(2007-7#1)
was present in 46%##2##4##(2006-10#1)(2010-4#1)
was present in 60%##2##4##(1993-12#1)(2012-3#1)
was present in 8##2##4##(1991-5#1)(1992-12#1)
was present in a##9##4##(1992-11#1)(1993-3#2)(1994-2#1)(1994-9#1)(2008-10#3)(2008-4#1)
was present in all three##2##5##(2006-10#1)(2007-12#1)
was present in all##14##4##(1991-4#1)(1992-11#1)(1992-8#1)(1993-8#1)(1996-12#1)(1997-4#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2012-3#1)
was present in both the##3##5##(1997-4#1)(2010-5#1)(2013-7#1)
was present in both##11##4##(1990-10#1)(1992-8#1)(1993-4#1)(1994-2#1)(1997-4#2)(2006-6#1)(2006-9#1)(2007-2#1)(2010-5#1)(2013-7#1)
was present in cells##2##4##(1991-5#1)(1997-6#1)
was present in excess##2##4##(1992-6#1)(1994-11#1)
was present in most##2##4##(1992-1#1)(2008-10#1)
was present in normal##2##4##(1995-6#1)(2006-5#1)
was present in one##2##4##(2007-6#1)(2011-12#1)
was present in patients##2##4##(2007-12#1)(2008-5#1)
was present in the functional##2##5##(1991-2#1)(1992-3#1)
was present in the system##2##5##(1992-11#2)
was present in the##49##4##(1990-11#1)(1990-2#1)(1990-7#1)(1991-2#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-7#1)(1993-12#2)(1993-7#1)(1994-2#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-4#1)(2010-5#1)(2012-3#1)(2013-7#1)
was present in these##2##4##(1992-12#1)(1997-2#1)
was present in this##3##4##(1990-12#1)(1992-12#1)(2008-10#1)
was present in three##3##4##(1990-3#1)(1992-11#1)(2011-12#1)
was present in two patients##2##5##(1991-1#1)(2006-10#1)
was present in##228##3##(1990-10#2)(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#1)(1991-9#1)(1992-1#2)(1992-11#6)(1992-12#7)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#4)(1993-3#2)(1993-4#1)(1993-5#2)(1993-7#1)(1993-8#2)(1994-1#1)(1994-11#2)(1994-2#3)(1994-3#1)(1994-6#1)(1994-7#2)(1994-8#2)(1994-9#2)(1995-12#1)(1995-5#2)(1995-6#2)(1995-8#2)(1996-12#2)(1996-3#2)(1996-5#3)(1996-6#1)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#5)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#1)(2004-12#1)(2005-10#1)(2005-8#2)(2006-10#6)(2006-12#5)(2006-5#1)(2006-6#2)(2006-9#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#4)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#23)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#2)(2011-1#3)(2011-11#1)(2011-12#3)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#7)(2013-1#1)(2013-7#2)(2013-8#4)
was present mainly in##3##4##(2008-10#2)(2008-4#1)
was present mainly##5##3##(1991-8#1)(1993-11#1)(2008-10#2)(2008-4#1)
was present on the##2##4##(2008-5#1)(2010-5#1)
was present on##7##3##(1993-6#1)(2007-2#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-5#1)
was present only in##5##4##(1991-9#1)(1996-8#1)(2006-11#1)(2008-10#1)(2008-6#1)
was present only##6##3##(1991-9#1)(1996-8#1)(2006-11#1)(2008-10#2)(2008-6#1)
was present or##2##3##(1992-1#1)(2009-4#1)
was present throughout the##2##4##(2004-2#2)
was present which##2##3##(1991-3#1)(2010-12#1)
was present within##2##3##(2008-10#2)
was present##369##2##(1990-10#5)(1990-11#4)(1990-12#4)(1990-2#2)(1990-3#5)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#3)(1991-4#2)(1991-5#3)(1991-6#1)(1991-8#4)(1991-9#2)(1992-1#3)(1992-11#7)(1992-12#7)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#3)(1993-12#6)(1993-3#4)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#3)(1993-8#4)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#4)(1994-3#1)(1994-6#1)(1994-7#2)(1994-8#3)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-5#3)(1995-6#2)(1995-8#2)(1996-12#2)(1996-3#2)(1996-5#5)(1996-6#2)(1996-8#5)(1996-9#3)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#5)(1997-5#3)(1997-6#3)(1997-7#2)(1997-8#2)(2004-1#1)(2004-11#1)(2004-12#1)(2004-2#2)(2005-10#1)(2005-11#1)(2005-8#2)(2006-10#8)(2006-11#1)(2006-12#5)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#2)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#4)(2007-3#1)(2007-6#2)(2007-7#5)(2007-8#10)(2007-9#2)(2008-1#2)(2008-10#44)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#10)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#2)(2009-4#5)(2009-8#1)(2009-9#1)(2010-12#3)(2010-2#2)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#1)(2011-1#6)(2011-11#1)(2011-12#3)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#7)(2013-1#2)(2013-7#2)(2013-8#5)
was presented as a new##2##5##(2008-10#1)(2012-2#1)
was presented as a##4##4##(2008-10#1)(2008-12#1)(2012-2#2)
was presented as##6##3##(1997-8#1)(2008-10#2)(2008-12#1)(2012-2#2)
was presented at the##5##4##(1995-2#1)(1996-6#1)(2007-8#1)(2008-12#1)(2008-7#1)
was presented at##6##3##(1995-2#1)(1996-6#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)
was presented by##6##3##(2005-1#1)(2007-4#1)(2008-10#1)(2008-6#1)(2009-9#1)(2011-2#1)
was presented for##7##3##(2008-10#1)(2008-5#2)(2012-2#2)(2013-1#1)(2013-8#1)
was presented in the##2##4##(2007-9#1)(2008-4#1)
was presented in this paper##3##5##(2005-4#1)(2011-2#1)(2013-8#1)
was presented in##11##3##(1992-11#1)(1994-12#1)(2005-4#1)(2005-9#1)(2007-9#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-8#2)
was presented on##2##3##(2005-8#1)(2007-8#1)
was presented the##3##3##(2007-10#1)(2011-2#1)(2012-12#1)
was presented to the##2##4##(1995-5#1)(2012-12#1)
was presented to##9##3##(1995-5#1)(2005-8#1)(2006-5#1)(2006-8#1)(2008-5#1)(2008-7#1)(2012-12#2)(2013-1#1)
was presented with a history of##2##6##(2008-5#1)(2012-2#1)
was presented with a##3##4##(2008-5#1)(2012-12#1)(2012-2#1)
was presented with##14##3##(1996-2#1)(2005-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#2)
was presented##90##2##(1990-7#1)(1991-7#1)(1992-11#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-6#1)(1997-8#1)(2005-1#1)(2005-4#2)(2005-7#1)(2005-8#3)(2005-9#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-4#1)(2007-8#4)(2007-9#2)(2008-10#9)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#6)(2009-6#1)(2009-9#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#4)(2012-2#8)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#5)
was presently##2##2##(1994-8#1)(1995-9#1)
was preserved by addition of##2##5##(1994-11#1)(1996-3#1)
was preserved in the presence of##2##6##(1990-7#1)(2009-4#1)
was preserved in the##3##4##(1990-7#1)(2008-11#1)(2009-4#1)
was preserved in##10##3##(1990-7#1)(1994-12#1)(2006-11#1)(2006-12#2)(2008-11#1)(2009-1#1)(2009-4#1)(2010-11#1)(2012-3#1)
was preserved##22##2##(1990-5#1)(1990-7#1)(1991-10#1)(1994-11#1)(1994-12#1)(1996-3#1)(1996-8#1)(1997-7#1)(2006-11#1)(2006-12#4)(2008-11#1)(2008-4#1)(2008-9#1)(2009-1#1)(2009-4#1)(2010-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
was presumably##5##2##(1990-7#1)(1991-3#1)(1994-3#1)(2006-10#1)(2012-1#1)
was presumed to be##2##4##(2007-12#1)(2008-4#1)
was presumed to##4##3##(2007-12#1)(2008-4#1)(2009-10#1)(2012-1#1)
was pretreated with##2##3##(1991-9#1)(1994-4#1)
was pretreated##4##2##(1991-3#1)(1991-9#1)(1994-4#1)(2011-12#1)
was prevalent in##2##3##(2010-12#1)(2013-1#1)
was prevalent##5##2##(1994-6#1)(2008-10#2)(2010-12#1)(2013-1#1)
was prevented by a##3##4##(1992-8#1)(1993-3#1)(1994-3#1)
was prevented by pretreatment with##3##5##(1992-8#1)(1995-1#2)
was prevented by selective##2##4##(1991-3#1)(2010-12#1)
was prevented by testosterone##2##4##(1994-2#1)(1995-5#1)
was prevented by the addition of##3##6##(1997-1#2)(2008-5#1)
was prevented by the##10##4##(1993-5#1)(1993-9#1)(1994-2#1)(1994-8#2)(1995-5#1)(1996-11#1)(1997-1#2)(2008-5#1)
was prevented by##53##3##(1990-2#1)(1990-5#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-8#4)(1993-11#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-2#4)(1994-3#2)(1994-8#3)(1995-1#2)(1995-12#1)(1995-5#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#4)(1997-7#1)(1997-8#1)(2005-8#2)(2006-4#1)(2006-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-1#1)(2013-1#2)
was prevented in the presence of##3##6##(1990-6#1)(1995-2#1)(1996-9#1)
was prevented in the##4##4##(1990-6#1)(1995-2#1)(1996-9#1)(1997-1#1)
was prevented in##8##3##(1990-6#1)(1993-12#1)(1995-2#2)(1996-9#1)(1997-1#1)(1997-2#1)(2013-8#1)
was prevented only##2##3##(1994-5#1)(1995-2#1)
was prevented when##3##3##(1990-7#1)(1993-12#1)(1994-5#1)
was prevented##74##2##(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-8#4)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-9#1)(1994-2#4)(1994-3#2)(1994-5#2)(1994-8#3)(1995-1#2)(1995-12#1)(1995-2#4)(1995-5#3)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#2)(1997-1#5)(1997-2#1)(1997-7#2)(1997-8#1)(2005-8#2)(2006-4#1)(2006-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-1#1)(2013-1#3)(2013-8#1)
was previously characterized##2##3##(1997-3#1)(2008-10#1)
was previously described as a##2##5##(1994-2#1)(2008-12#1)
was previously described as##3##4##(1990-4#1)(1994-2#1)(2008-12#1)
was previously described##4##3##(1990-4#1)(1994-2#1)(2008-12#1)(2011-2#1)
was previously determined##2##3##(1991-11#1)(2008-10#1)
was previously established##2##3##(1994-8#1)(2008-10#1)
was previously found in##2##4##(1991-1#1)(1994-11#1)
was previously found to be##4##5##(1994-11#1)(1997-6#1)(2006-3#1)(2008-7#1)
was previously found##7##3##(1991-1#1)(1994-11#2)(1995-11#1)(1997-6#1)(2006-3#1)(2008-7#1)
was previously identified as##2##4##(1997-7#1)(2008-10#1)
was previously identified##3##3##(1990-12#1)(1997-7#1)(2008-10#1)
was previously observed##2##3##(1993-4#1)(1996-5#1)
was previously proposed to##2##4##(2007-9#1)(2011-2#1)
was previously proposed##3##3##(2007-9#2)(2011-2#1)
was previously purified from##2##4##(1991-1#1)(1994-9#1)
was previously reported to be##3##5##(1990-7#1)(1996-4#1)(2008-10#1)
was previously reported to##5##4##(1990-7#1)(1996-4#1)(1997-7#1)(2008-10#1)(2011-2#1)
was previously reported##10##3##(1990-7#1)(1996-4#2)(1997-3#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2011-2#1)
was previously shown that##2##4##(2011-2#1)(2012-3#1)
was previously shown to affect development of the somatic gonad##2##10##(2012-12#2)
was previously shown to be required for##2##7##(1993-9#1)(2008-9#1)
was previously shown to be##9##5##(1992-3#1)(1993-12#1)(1993-9#1)(1996-5#2)(1997-4#1)(2008-10#1)(2008-9#1)(2012-1#1)
was previously shown to##21##4##(1990-12#1)(1991-4#1)(1992-3#1)(1993-12#1)(1993-9#1)(1995-3#1)(1995-5#1)(1996-4#1)(1996-5#2)(1997-4#2)(2006-12#1)(2007-12#1)(2008-10#2)(2008-9#1)(2012-1#1)(2012-12#2)(2012-2#1)
was previously shown##23##3##(1990-12#1)(1991-4#1)(1992-3#1)(1993-12#1)(1993-9#1)(1995-3#1)(1995-5#1)(1996-4#1)(1996-5#2)(1997-4#2)(2006-12#1)(2007-12#1)(2008-10#2)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
was previously suggested##3##3##(1995-5#2)(2008-10#1)
was previously thought to be##2##5##(1996-11#1)(2007-9#1)
was previously thought to##5##4##(1993-8#1)(1995-6#1)(1996-11#1)(2007-9#1)(2010-12#1)
was previously thought##7##3##(1993-8#1)(1995-6#1)(1996-11#1)(2006-10#1)(2007-10#1)(2007-9#1)(2010-12#1)
was previously##109##2##(1990-12#2)(1990-4#1)(1990-7#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-3#1)(1993-12#2)(1993-4#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-2#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#4)(1995-6#1)(1995-8#1)(1996-11#1)(1996-4#4)(1996-5#3)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#3)(2004-11#1)(2005-11#1)(2006-10#3)(2006-12#2)(2006-3#1)(2006-5#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#1)(2007-9#3)(2008-10#18)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
was primarily a##2##3##(1993-3#1)(2006-12#1)
was primarily associated with the##2##5##(1994-10#1)(1995-9#1)
was primarily due to##3##4##(1991-12#1)(2007-4#1)(2010-8#1)
was primarily in##2##3##(1995-5#1)(2010-11#1)
was primarily influenced by##2##4##(2008-10#1)(2010-8#1)
was primarily used##2##3##(2005-11#1)(2010-12#1)
was primarily##31##2##(1991-12#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-6#1)(1995-5#1)(1995-9#1)(1997-1#1)(1997-6#1)(2004-2#1)(2004-9#1)(2005-11#1)(2006-12#2)(2006-8#1)(2007-12#1)(2007-4#1)(2008-10#5)(2008-11#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-12#1)
was primary##3##2##(2005-12#1)(2007-11#1)(2012-2#1)
was primed with oligo-dT##2##4##(1992-11#1)(1997-2#1)
was primed with##3##3##(1992-1#1)(1992-11#1)(1997-2#1)
was primed##4##2##(1992-1#1)(1992-11#1)(1997-2#1)(2009-3#1)
was principally##4##2##(1990-2#1)(1995-4#1)(1996-12#1)(1997-6#1)
was printed##3##2##(2007-11#1)(2008-1#1)(2008-2#1)
was probably a##3##3##(2005-11#1)(2008-10#1)(2008-7#1)
was probably an##2##3##(1994-8#1)(2008-9#1)
was probably caused by##2##4##(1992-8#1)(2008-10#1)
was probably caused##3##3##(1992-8#1)(2007-2#1)(2008-10#1)
was probably due to the high##3##6##(1993-1#1)(2008-10#1)(2010-5#1)
was probably due to the##8##5##(1993-1#1)(1996-1#1)(2005-11#2)(2008-10#1)(2009-10#1)(2010-5#1)(2010-8#1)
was probably due to##15##4##(1990-11#1)(1990-8#1)(1993-1#1)(1996-1#1)(1996-6#2)(2005-11#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-5#1)(2010-8#1)
was probably related to##2##4##(2008-4#1)(2012-1#1)
was probably the##5##3##(2007-4#1)(2008-10#2)(2009-5#1)(2012-3#1)
was probably##51##2##(1990-11#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-11#1)(1992-8#1)(1993-1#1)(1993-7#1)(1994-2#1)(1994-8#1)(1996-1#1)(1996-4#1)(1996-6#2)(1996-9#1)(2005-11#3)(2006-6#1)(2007-2#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)
was probed by##4##3##(1992-4#1)(1994-8#1)(1995-8#1)(1996-7#1)
was probed in##2##3##(2007-1#1)(2010-4#1)
was probed using##2##3##(1990-8#1)(1994-9#1)
was probed with a##2##4##(1993-8#1)(2005-11#1)
was probed##12##2##(1990-8#1)(1992-4#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-7#1)(1996-8#1)(1997-2#1)(2005-11#1)(2007-1#1)(2010-4#1)
was problematic##2##2##(2008-10#1)(2013-7#1)
was proceeded##2##2##(2008-10#1)(2008-5#1)
was processed by##3##3##(1996-12#1)(2008-10#1)(2010-11#1)
was processed for##2##3##(1994-2#1)(2010-4#1)
was processed in##2##3##(1991-9#1)(2008-3#1)
was processed to##3##3##(1995-8#1)(1997-1#1)(2008-3#1)
was processed under##2##3##(1992-8#1)(2013-1#1)
was processed##24##2##(1990-11#1)(1990-3#1)(1991-9#1)(1992-8#2)(1994-2#1)(1995-8#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(2004-8#2)(2008-10#4)(2008-3#2)(2008-7#1)(2010-11#1)(2010-4#1)(2013-1#1)(2013-8#1)
was produced against##5##3##(1996-12#1)(2008-10#4)
was produced and##8##3##(1993-8#1)(1994-9#1)(1996-3#1)(2005-4#1)(2006-8#1)(2008-10#1)(2008-11#1)(2011-1#1)
was produced as a##2##4##(1993-5#1)(2010-5#1)
was produced as##5##3##(1993-5#1)(2006-3#1)(2008-10#1)(2010-5#2)
was produced at##2##3##(1990-10#1)(1997-6#1)
was produced by a##4##4##(1993-12#1)(2008-10#2)(2013-7#1)
was produced by all##2##4##(1993-3#1)(2008-10#1)
was produced by four-vessel occlusion##2##5##(2007-9#1)(2010-1#1)
was produced by fusing##2##4##(2008-11#2)
was produced by the##5##4##(1991-2#1)(1995-8#1)(2006-10#1)(2008-10#1)(2008-6#1)
was produced by using##2##4##(1995-12#1)(2008-5#1)
was produced by##55##3##(1990-7#3)(1990-9#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#1)(1993-10#1)(1993-12#2)(1993-3#1)(1993-4#1)(1994-10#1)(1994-2#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-8#1)(1996-5#1)(1996-9#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-5#5)(2008-6#2)(2008-8#1)(2009-12#1)(2010-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
was produced for the##2##4##(1990-12#1)(2008-10#1)
was produced for##3##3##(1990-12#1)(2008-10#2)
was produced from the##2##4##(1995-3#1)(2008-5#1)
was produced from##9##3##(1991-1#1)(1991-5#1)(1995-3#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)
was produced in Escherichia coli##4##5##(1991-5#1)(1991-9#1)(1995-2#1)(2010-6#1)
was produced in a##4##4##(1990-5#1)(2008-11#2)(2008-6#1)
was produced in the##4##4##(2007-12#1)(2008-10#1)(2008-7#1)(2012-2#1)
was produced in##27##3##(1990-5#1)(1990-6#1)(1991-5#2)(1991-9#2)(1992-3#1)(1992-8#1)(1993-12#4)(1994-12#1)(1995-2#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-6#2)(2008-7#1)(2008-8#1)(2010-6#1)(2012-2#1)(2013-1#1)
was produced to##3##3##(1993-11#1)(1995-2#1)(1995-8#1)
was produced when##4##3##(1994-8#1)(1995-1#1)(2008-5#2)
was produced with the##2##4##(2008-6#1)(2012-2#1)
was produced with##6##3##(2005-11#1)(2008-10#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-2#1)
was produced##159##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#3)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-9#3)(1992-12#1)(1992-3#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#7)(1993-3#1)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-8#3)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#2)(1995-6#1)(1995-8#2)(1996-12#2)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-6#1)(1997-7#1)(2005-11#2)(2005-4#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-8#2)(2007-11#2)(2007-12#4)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#26)(2008-11#8)(2008-3#2)(2008-5#10)(2008-6#7)(2008-7#1)(2008-8#3)(2009-12#1)(2009-7#1)(2010-1#1)(2010-5#2)(2010-6#1)(2011-1#2)(2011-2#3)(2012-2#3)(2013-1#2)(2013-7#1)
was professor##2##2##(2007-12#1)(2013-8#1)
was programmed##3##2##(1992-3#1)(2008-10#2)
was progressively inhibited by##2##4##(1990-10#1)(1996-5#1)
was progressively reduced##3##3##(1991-6#1)(1992-4#1)(2008-1#1)
was progressively##15##2##(1990-10#1)(1990-11#1)(1991-12#1)(1991-6#1)(1992-4#1)(1992-9#2)(1993-3#1)(1996-5#1)(2008-1#1)(2008-9#1)(2009-2#1)(2010-1#1)(2010-11#1)(2013-1#1)
was prohibited##3##2##(1995-2#1)(2008-5#1)(2011-2#1)
was projected to##2##3##(2007-7#1)(2011-2#1)
was projected##4##2##(2007-7#1)(2008-10#1)(2011-2#2)
was prolonged by##2##3##(1995-12#1)(2005-8#1)
was prolonged for##2##3##(2010-5#1)(2012-2#1)
was prolonged in##3##3##(1994-6#1)(2007-11#1)(2009-2#1)
was prolonged##22##2##(1992-7#1)(1993-12#1)(1994-6#1)(1995-12#2)(1996-5#1)(1997-3#1)(2005-7#1)(2005-8#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-8#2)(2008-11#1)(2008-8#1)(2008-9#2)(2009-2#1)(2010-5#1)(2011-3#1)(2012-2#1)
was prominent##4##2##(1991-7#1)(1993-7#1)(1996-11#1)(2006-10#1)
was promoted by##3##3##(1992-6#1)(1995-6#1)(2009-8#1)
was promoted in##2##3##(1994-6#1)(2009-2#1)
was promoted##9##2##(1992-6#1)(1992-7#1)(1994-6#1)(1995-6#1)(2006-4#1)(2008-11#1)(2009-2#1)(2009-8#1)(2010-12#1)
was prompted by a##2##4##(2008-11#1)(2012-12#1)
was prompted by##4##3##(1994-4#1)(1996-12#1)(2008-11#1)(2012-12#1)
was promptly##2##2##(1997-6#1)(2008-5#1)
was prone to##2##3##(1994-11#1)(2011-1#1)
was pronounced in##2##3##(1993-3#1)(2010-6#1)
was pronounced##4##2##(1990-3#1)(1993-3#1)(1996-2#1)(2010-6#1)
was propagated##3##2##(1993-3#1)(2009-2#1)(2011-1#1)
was properly##3##2##(1993-6#1)(1996-10#1)(2008-11#1)
was proportional to the amount of##2##6##(1991-10#1)(1994-3#1)
was proportional to the concentration of##7##6##(1991-3#1)(2008-10#6)
was proportional to the square of the##2##7##(2008-3#2)
was proportional to the##35##4##(1990-10#1)(1990-2#1)(1990-5#1)(1991-10#1)(1991-3#1)(1991-9#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-9#1)(2005-11#1)(2007-8#2)(2008-10#12)(2008-11#1)(2008-3#3)(2008-7#1)(2012-2#1)
was proportional to viable cell number##2##6##(2008-11#2)
was proportional to##46##3##(1990-10#1)(1990-2#1)(1990-5#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-9#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-3#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-12#1)(2004-9#1)(2005-11#2)(2006-10#1)(2007-8#2)(2008-10#14)(2008-11#4)(2008-3#3)(2008-7#1)(2011-1#1)(2012-2#1)
was proposed and##9##3##(2007-12#2)(2007-6#1)(2008-10#5)(2008-2#1)
was proposed as a##5##4##(2008-10#1)(2011-2#1)(2012-1#2)(2012-2#1)
was proposed as an##4##4##(2008-2#2)(2011-2#1)(2011-3#1)
was proposed as the##2##4##(2008-5#1)(2008-8#1)
was proposed as##11##3##(2008-10#1)(2008-2#2)(2008-5#1)(2008-8#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-2#1)
was proposed based on##2##4##(2008-10#2)
was proposed by##7##3##(1990-11#1)(1991-1#1)(1995-6#1)(2005-11#1)(2007-11#1)(2008-10#2)
was proposed for the determination of trace##2##7##(2008-10#1)(2013-8#1)
was proposed for the determination of##7##6##(2008-10#6)(2013-8#1)
was proposed for the##15##4##(2006-2#1)(2007-8#1)(2008-10#10)(2012-2#1)(2013-1#1)(2013-8#1)
was proposed for##25##3##(1992-8#1)(2006-2#1)(2007-12#1)(2007-8#2)(2008-10#14)(2008-2#1)(2008-8#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
was proposed in the##3##4##(2008-10#1)(2008-7#1)(2013-8#1)
was proposed in##9##3##(1994-9#1)(2008-10#3)(2008-7#1)(2008-9#1)(2012-1#2)(2013-8#1)
was proposed on the##2##4##(1996-12#1)(2007-11#1)
was proposed that the##2##4##(2008-9#1)(2011-1#1)
was proposed that##8##3##(1992-8#1)(1995-12#1)(2005-11#1)(2008-9#1)(2009-4#1)(2010-4#1)(2011-1#1)(2012-3#1)
was proposed to be##4##4##(2008-10#2)(2012-1#2)
was proposed to explain the##2##5##(2008-10#2)
was proposed to predict the##2##5##(2005-11#1)(2008-7#1)
was proposed to##18##3##(1997-3#1)(2005-11#1)(2006-10#1)(2008-10#9)(2008-3#1)(2008-7#1)(2011-2#1)(2012-1#2)(2013-1#1)
was proposed using the##2##4##(2007-1#1)(2008-10#1)
was proposed using##3##3##(2007-1#1)(2008-10#2)
was proposed##148##2##(1990-11#1)(1990-5#1)(1991-1#1)(1991-2#1)(1992-6#1)(1992-8#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(2005-11#5)(2005-4#1)(2005-5#1)(2006-10#2)(2006-2#1)(2007-1#1)(2007-11#2)(2007-12#5)(2007-5#1)(2007-6#1)(2007-8#3)(2008-10#63)(2008-12#1)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-4#1)(2010-2#1)(2010-4#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#6)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#4)
was prospective##3##2##(2006-8#1)(2007-12#1)(2009-9#1)
was prospectively studied##2##3##(1994-12#1)(2008-1#1)
was prospectively##5##2##(1994-12#2)(1995-4#1)(2005-9#1)(2008-1#1)
was protected from##6##3##(1990-11#1)(1990-3#1)(1991-1#1)(1995-3#1)(1997-3#1)(2012-2#1)
was protected##9##2##(1990-11#1)(1990-3#1)(1991-1#1)(1991-9#1)(1992-4#1)(1994-8#1)(1995-3#1)(1997-3#1)(2012-2#1)
was protective##5##2##(1996-9#1)(2006-2#1)(2007-6#1)(2008-7#1)(2011-2#1)
was proteinase##2##2##(1992-4#1)(1994-12#1)
was proved by the##4##4##(2008-10#4)
was proved by##11##3##(1991-5#1)(1997-3#1)(2007-11#1)(2008-10#6)(2008-8#1)(2008-9#1)
was proved that the##4##4##(2008-10#1)(2008-5#1)(2008-9#1)(2013-8#1)
was proved that##12##3##(1995-3#1)(2004-9#1)(2007-10#1)(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#2)(2011-12#1)(2013-8#1)
was proved to be an##2##5##(1997-6#1)(2013-1#1)
was proved to be the##2##5##(2006-6#1)(2008-10#1)
was proved to be##17##4##(1996-2#1)(1997-1#1)(1997-6#1)(2004-9#1)(2005-4#1)(2006-4#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-5#1)(2008-8#1)(2013-1#1)
was proved with##2##3##(2007-5#1)(2008-2#1)
was proved##57##2##(1991-5#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-6#1)(2004-9#2)(2005-1#1)(2005-4#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#21)(2008-2#1)(2008-5#3)(2008-8#3)(2008-9#3)(2011-1#1)(2011-12#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
was proven by##7##3##(1991-5#1)(1997-6#1)(2006-1#1)(2007-10#1)(2007-11#1)(2008-10#1)(2010-7#1)
was proven in##2##3##(2007-11#1)(2008-1#1)
was proven to be the##3##5##(1996-12#1)(2006-6#1)(2008-5#1)
was proven to be##9##4##(1994-11#1)(1995-12#1)(1996-12#1)(2006-6#2)(2007-8#1)(2008-5#1)(2008-8#1)(2011-2#1)
was proven to##11##3##(1994-11#1)(1995-12#1)(1996-12#1)(2006-6#2)(2007-8#1)(2008-5#2)(2008-8#1)(2011-2#2)
was proven##28##2##(1991-5#1)(1994-11#1)(1995-12#1)(1995-4#1)(1996-12#1)(1997-6#1)(2006-1#1)(2006-6#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-5#3)(2008-8#1)(2010-7#1)(2011-2#2)
was provided by an##4##4##(1997-3#1)(2008-2#1)(2008-3#1)(2009-8#1)
was provided by the##8##4##(1996-12#1)(1997-2#1)(1997-7#1)(2006-12#1)(2008-1#1)(2008-8#1)(2013-8#2)
was provided by##19##3##(1993-8#1)(1996-12#2)(1997-2#1)(1997-3#1)(1997-7#1)(2006-12#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-8#1)(2012-12#1)(2013-1#1)(2013-8#2)
was provided following##2##3##(1997-8#1)(2012-2#1)
was provided for a##2##4##(1993-1#1)(2012-11#1)
was provided for##8##3##(1993-1#1)(2007-2#1)(2007-7#1)(2009-10#1)(2011-2#1)(2012-1#2)(2012-11#1)
was provided in##2##3##(2006-10#1)(2008-8#1)
was provided to##3##3##(2006-10#1)(2008-11#1)(2008-3#1)
was provided with##3##3##(2007-8#1)(2009-11#1)(2011-2#1)
was provided##43##2##(1991-12#1)(1993-1#1)(1993-8#1)(1996-12#2)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#2)(2006-10#2)(2006-12#2)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
was provisionally##2##2##(2007-4#1)(2007-7#1)
was published and##2##3##(1994-3#1)(2012-3#1)
was published in May 2002##2##5##(2006-8#2)
was published in the##3##4##(1993-12#1)(2004-2#1)(2005-7#1)
was published in##18##3##(1993-12#1)(2004-2#1)(2005-7#2)(2006-8#3)(2007-11#1)(2009-2#1)(2009-3#1)(2010-7#1)(2011-7#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#2)
was published##36##2##(1993-12#1)(1994-3#1)(2004-2#1)(2005-10#1)(2005-7#2)(2006-10#2)(2006-12#1)(2006-3#1)(2006-8#3)(2007-11#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-2#1)(2009-3#1)(2010-7#1)(2010-8#2)(2011-12#1)(2011-7#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#3)
was pulled##3##2##(2008-5#1)(2008-6#1)(2013-1#1)
was pumped at a##2##4##(1991-5#1)(2010-3#1)
was pumped at##5##3##(1991-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2010-3#1)
was pumped by a##3##4##(2007-11#1)(2007-12#2)
was pumped by##4##3##(2007-11#1)(2007-12#3)
was pumped through the##2##4##(2008-10#1)(2008-11#1)
was pumped with a##3##4##(2007-11#1)(2007-12#2)
was pumped with##5##3##(2007-11#1)(2007-12#4)
was pumped##18##2##(1991-5#1)(2007-11#3)(2007-12#7)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2010-3#1)
was purely##3##2##(2009-10#1)(2011-2#1)(2012-3#1)
was purified 500-fold from##2##4##(1990-12#1)(1994-8#1)
was purified after##2##3##(1991-11#1)(2005-11#1)
was purified and characterized from##3##5##(1992-12#1)(1994-3#1)(1995-6#1)
was purified and characterized##5##4##(1990-6#1)(1992-12#1)(1994-3#1)(1995-6#1)(2008-5#1)
was purified and identified##2##4##(1990-4#1)(1994-12#1)
was purified and separated##2##4##(1992-2#1)(2008-10#1)
was purified and used to##3##5##(1993-8#1)(1995-5#1)(2008-10#1)
was purified and used##5##4##(1993-8#1)(1994-2#1)(1995-5#1)(2008-10#1)(2008-8#1)
was purified and##26##3##(1990-4#1)(1990-6#1)(1992-12#2)(1992-2#1)(1992-7#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-5#1)(1995-6#1)(1996-7#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#1)(2011-1#1)
was purified approximately##2##3##(1990-3#1)(1992-6#1)
was purified as a##3##4##(1992-6#1)(1993-3#1)(2008-5#1)
was purified as##4##3##(1992-6#1)(1993-3#1)(1995-1#1)(2008-5#1)
was purified by a##4##4##(1994-3#1)(1996-11#1)(1997-8#1)(2008-11#1)
was purified by affinity chromatography##5##5##(1991-6#1)(1992-3#1)(1993-9#1)(1997-2#1)(2010-4#1)
was purified by sequential##2##4##(1994-11#2)
was purified by##34##3##(1990-4#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-11#1)(1997-2#2)(1997-8#1)(2005-11#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-6#1)(2008-8#1)(2010-4#1)(2011-2#1)
was purified from HeLa cell##2##5##(1991-1#1)(1994-3#1)
was purified from HeLa##3##4##(1991-1#1)(1991-10#1)(1994-3#1)
was purified from an extract of the##2##7##(1997-4#1)(1997-8#1)
was purified from bovine##2##4##(1990-4#1)(2008-8#1)
was purified from human##9##4##(1990-11#1)(1991-6#1)(1992-1#1)(1993-9#2)(1994-2#1)(1995-3#1)(1996-7#1)(1996-9#1)
was purified from rat liver##2##5##(1994-12#1)(1995-6#1)
was purified from serum-free conditioned##2##5##(1990-12#1)(1991-8#1)
was purified from serum-free##3##4##(1990-12#1)(1991-8#1)(1993-11#1)
was purified from soluble##2##4##(1990-5#1)(1994-3#1)
was purified from the venom of the##2##7##(1993-3#1)(1994-5#1)
was purified from the venom of##3##6##(1992-12#1)(1993-3#1)(1994-5#1)
was purified from the##20##4##(1990-8#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-3#2)(1994-5#1)(1995-1#1)(1996-10#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-2#1)
was purified from##71##3##(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-12#2)(1992-6#1)(1992-8#1)(1992-9#3)(1993-11#2)(1993-12#1)(1993-3#2)(1993-4#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-3#3)(1995-6#1)(1996-10#1)(1996-7#1)(1996-9#2)(1997-2#2)(1997-4#3)(1997-6#2)(1997-7#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2013-1#1)
was purified in##4##3##(1990-4#1)(1992-6#1)(1993-6#1)(2008-11#1)
was purified to an##2##4##(1990-11#1)(1994-5#1)
was purified to apparent homogeneity by##2##6##(1991-9#1)(1992-12#1)
was purified to apparent homogeneity##5##5##(1990-4#1)(1991-9#1)(1992-12#1)(1992-4#1)(1997-2#1)
was purified to electrophoretic homogeneity through a##2##7##(1990-7#1)(1995-2#1)
was purified to electrophoretic homogeneity##5##5##(1990-4#1)(1990-7#1)(1993-8#1)(1995-2#1)(2005-11#1)
was purified to homogeneity and found to##2##7##(1990-7#1)(1995-10#1)
was purified to homogeneity and##6##5##(1990-2#1)(1990-7#1)(1992-7#1)(1994-11#1)(1994-12#1)(1995-10#1)
was purified to homogeneity by a##3##6##(1990-8#1)(1991-2#1)(1991-8#1)
was purified to homogeneity by##10##5##(1990-8#1)(1991-2#1)(1991-8#2)(1993-12#1)(1995-3#1)(1995-8#1)(1997-4#1)(2009-3#1)(2010-4#1)
was purified to homogeneity from bovine##2##6##(1990-9#1)(1992-11#1)
was purified to homogeneity from the##4##6##(1990-1#1)(1990-11#1)(1990-5#1)(1991-12#1)
was purified to homogeneity from##13##5##(1990-1#1)(1990-11#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-8#1)(1992-11#1)(1992-8#1)(1996-3#1)(1997-2#1)(2006-3#1)(2008-10#1)(2008-8#1)
was purified to homogeneity##39##4##(1990-1#1)(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#3)(1992-11#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-12#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-3#1)(1997-2#1)(1997-4#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-3#1)(2010-4#1)
was purified to near homogeneity by##3##6##(1993-6#1)(1994-8#1)(1997-1#1)
was purified to near homogeneity from##2##6##(1990-8#1)(1993-11#1)
was purified to near homogeneity##6##5##(1990-7#1)(1990-8#1)(1993-11#1)(1993-6#1)(1994-8#1)(1997-1#1)
was purified to##58##3##(1990-1#1)(1990-10#1)(1990-11#2)(1990-2#1)(1990-4#2)(1990-5#1)(1990-7#3)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#3)(1991-9#1)(1992-11#1)(1992-12#2)(1992-4#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-4#1)(2005-11#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-8#2)(2009-3#1)(2010-4#1)
was purified using##2##3##(1993-12#1)(1994-6#1)
was purified with##3##3##(1990-10#1)(1995-12#1)(2008-10#1)
was purified##245##2##(1990-1#1)(1990-10#2)(1990-11#6)(1990-12#4)(1990-2#3)(1990-3#4)(1990-4#6)(1990-5#4)(1990-6#2)(1990-7#5)(1990-8#5)(1990-9#2)(1991-1#5)(1991-10#1)(1991-11#4)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#6)(1991-9#1)(1992-1#1)(1992-11#3)(1992-12#7)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#5)(1992-7#3)(1992-8#3)(1992-9#3)(1993-11#3)(1993-12#4)(1993-2#1)(1993-3#4)(1993-4#1)(1993-6#3)(1993-8#3)(1993-9#4)(1994-11#3)(1994-12#6)(1994-2#3)(1994-3#5)(1994-5#2)(1994-6#2)(1994-8#6)(1995-1#3)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#6)(1995-5#1)(1995-6#3)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#2)(1996-9#2)(1997-1#1)(1997-2#7)(1997-4#4)(1997-6#4)(1997-7#2)(1997-8#3)(2005-11#5)(2006-10#1)(2006-12#1)(2006-3#1)(2007-12#1)(2007-6#1)(2008-10#13)(2008-11#5)(2008-12#2)(2008-5#2)(2008-6#2)(2008-8#5)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-4#2)(2011-1#1)(2011-2#1)(2013-1#1)
was pursued##2##2##(1997-2#1)(2006-1#1)
was purulent##2##2##(2007-6#1)(2011-2#1)
was pushed##2##2##(2008-10#1)(2012-1#1)
was put forward##4##3##(2005-11#1)(2008-5#1)(2013-1#1)(2013-8#1)
was put in##2##3##(2007-11#1)(2011-3#1)
was put on a##2##4##(1993-12#1)(1997-3#1)
was put on the##2##4##(2005-8#1)(2011-2#1)
was put on##13##3##(1993-12#1)(1997-3#1)(2005-8#1)(2006-2#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-8#1)(2010-9#1)(2011-2#1)(2012-2#2)(2012-3#1)
was put##24##2##(1993-12#1)(1994-5#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-2#1)(2007-11#2)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-5#1)(2010-7#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
was pyrolysed##2##2##(1990-8#1)(2008-10#1)
was qualified as##3##3##(1991-6#1)(2011-2#1)(2012-3#1)
was qualified for##2##3##(2011-12#1)(2011-2#1)
was qualified to##2##3##(2007-1#1)(2013-8#1)
was qualified##8##2##(1991-6#1)(2007-1#1)(2008-9#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-8#1)
was qualitative##3##2##(2008-10#1)(2011-1#1)(2011-2#1)
was qualitatively similar##3##3##(1993-2#1)(1995-3#1)(1996-3#1)
was qualitatively##8##2##(1993-2#1)(1994-11#1)(1995-3#1)(1996-3#1)(2007-8#1)(2008-10#2)(2008-5#1)
was quantified and##5##3##(1996-3#1)(2007-8#1)(2008-10#1)(2012-11#2)
was quantified as a function of##2##6##(2005-11#1)(2010-4#1)
was quantified as a##3##4##(1995-9#1)(2005-11#1)(2010-4#1)
was quantified as##6##3##(1995-9#1)(2005-11#1)(2008-10#3)(2010-4#1)
was quantified by enzyme-linked immunosorbent assay##2##6##(2008-10#1)(2013-1#1)
was quantified by measuring the##2##5##(1995-1#1)(2008-7#1)
was quantified by measuring##3##4##(1995-1#1)(1996-4#1)(2008-7#1)
was quantified by the##5##4##(1995-2#1)(2006-6#1)(2007-10#1)(2008-10#1)(2008-11#1)
was quantified by##30##3##(1990-4#1)(1991-10#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-4#1)(1997-2#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-7#1)(2009-5#2)(2011-2#1)(2012-1#1)(2012-4#1)(2013-1#2)
was quantified in##7##3##(1990-3#1)(2008-10#2)(2008-7#1)(2009-4#1)(2010-8#1)(2013-1#1)
was quantified using##9##3##(1994-6#1)(1996-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-7#1)
was quantified with##2##3##(2006-10#1)(2008-10#1)
was quantified##77##2##(1990-3#1)(1990-4#1)(1991-10#1)(1992-7#1)(1993-2#1)(1993-9#1)(1994-6#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-7#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-4#1)(1997-2#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-6#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#16)(2008-11#1)(2008-5#4)(2008-7#3)(2009-4#1)(2009-5#2)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#2)(2012-4#1)(2013-1#3)(2013-7#1)(2013-8#2)
was quantitated by##3##3##(1991-12#1)(1992-6#1)(1996-6#1)
was quantitated in##3##3##(1994-5#1)(2008-4#1)(2008-6#1)
was quantitated##7##2##(1991-12#1)(1992-6#1)(1994-5#1)(1996-6#1)(2008-10#1)(2008-4#1)(2008-6#1)
was quantitative and##2##3##(2008-10#2)
was quantitative##6##2##(1991-12#2)(2008-10#4)
was quantitatively analyzed by##2##4##(2008-10#1)(2012-3#1)
was quantitatively analyzed##4##3##(1996-5#1)(2008-10#2)(2012-3#1)
was quantitatively determined##2##3##(2007-8#1)(2008-10#1)
was quantitatively eluted##2##3##(1990-12#1)(2008-10#1)
was quantitatively extracted with##3##4##(2008-10#3)
was quantitatively extracted##5##3##(2008-10#5)
was quantitatively retained##3##3##(2008-10#3)
was quantitatively##26##2##(1990-12#1)(1991-10#1)(1992-9#1)(1993-9#1)(1996-12#1)(1996-5#1)(2005-4#1)(2007-10#1)(2007-8#2)(2008-10#13)(2008-3#1)(2010-12#1)(2012-3#1)
was quenched##4##2##(1992-5#1)(1996-4#1)(2006-10#1)(2008-3#1)
was quickly##7##2##(1995-3#1)(2007-9#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
was quiescent##2##2##(1996-9#1)(2006-10#1)
was quite effective##2##3##(1992-12#1)(2007-11#1)
was quite similar##3##3##(2006-5#1)(2008-10#1)(2008-7#1)
was quite stable##2##3##(1996-5#1)(2005-4#1)
was quite##22##2##(1990-5#1)(1992-12#1)(1992-5#1)(1993-6#1)(1996-5#1)(2005-4#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-9#1)(2011-2#1)(2013-8#1)
was quoted##2##2##(2006-12#1)(2006-9#1)
was r=0##2##2##(2008-10#1)(2010-11#1)
was race##2##2##(2008-10#2)
was radical##2##2##(2008-7#1)(2011-1#1)
was radically##3##2##(1990-9#1)(2007-10#1)(2008-10#1)
was radiolabeled##3##2##(1991-12#1)(1997-6#1)(2012-2#1)
was raised against the##5##4##(1990-8#1)(1992-7#1)(1994-5#1)(1994-8#1)(2008-4#1)
was raised against##12##3##(1990-4#1)(1990-6#1)(1990-8#1)(1992-7#1)(1992-8#1)(1994-5#1)(1994-8#1)(1996-5#1)(1996-7#1)(2007-12#1)(2008-4#1)(2010-4#1)
was raised by##3##3##(1991-2#1)(1997-8#1)(2008-8#1)
was raised from##3##3##(1992-7#1)(1993-3#1)(2011-2#1)
was raised in rabbits##2##4##(1990-3#1)(1994-9#1)
was raised in the##3##4##(1991-12#1)(1992-9#1)(2008-10#1)
was raised in##13##3##(1990-3#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-3#1)(1992-9#1)(1994-9#1)(1995-12#1)(2006-8#1)(2007-7#1)(2008-10#2)(2008-6#1)
was raised to##3##3##(1990-11#1)(1990-2#1)(1990-9#1)
was raised##57##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-8#1)(2004-11#1)(2005-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#6)(2008-12#1)(2008-4#2)(2008-6#3)(2008-7#1)(2008-8#1)(2009-9#1)(2010-4#1)(2011-2#1)(2013-1#3)
was random##5##2##(1997-4#1)(2008-10#3)(2008-5#1)
was randomized##6##2##(1994-12#1)(1997-2#1)(1997-5#1)(2008-11#1)(2011-12#1)(2013-7#1)
was randomly divided into two##2##5##(2007-2#1)(2007-7#1)
was randomly mutagenized##2##3##(1995-2#1)(1997-1#1)
was randomly selected for each##2##5##(1993-12#1)(2012-2#1)
was randomly selected##3##3##(1993-12#1)(2012-2#1)(2013-1#1)
was randomly##14##2##(1993-11#1)(1993-12#1)(1995-12#1)(1995-2#1)(1995-9#1)(1997-1#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
was ranged from##2##3##(2007-8#1)(2011-2#1)
was ranked##2##2##(1990-4#1)(1994-6#1)
was rapid and occurred##2##4##(1991-2#1)(1994-12#1)
was rapid and##9##3##(1991-2#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-1#1)(2007-2#1)(2008-10#2)
was rapid during the##2##4##(2008-10#1)(2008-5#1)
was rapid##31##2##(1991-1#1)(1991-2#1)(1991-7#2)(1992-6#1)(1993-11#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-8#1)(1996-11#1)(1996-9#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-2#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#2)(2010-8#1)
was rapidly (within##2##3##(1990-3#1)(1993-6#1)
was rapidly cleared from##2##4##(1994-11#1)(1994-3#1)
was rapidly converted##2##3##(1990-12#1)(2008-10#1)
was rapidly diminished##2##3##(1995-7#2)
was rapidly followed by##2##4##(1994-11#1)(2006-12#1)
was rapidly increased##2##3##(1992-8#1)(1997-2#1)
was rapidly reduced to##2##4##(1992-2#1)(1995-6#1)
was rapidly reduced##3##3##(1990-3#1)(1992-2#1)(1995-6#1)
was rapidly##37##2##(1990-11#2)(1990-12#1)(1990-3#2)(1991-7#3)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-3#2)(1994-8#1)(1995-3#1)(1995-6#1)(1995-7#2)(1996-1#1)(1996-5#1)(1997-2#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-4#1)(2008-10#1)(2008-5#2)(2008-7#1)(2011-2#1)
was rare and##2##3##(2008-9#1)(2009-10#1)
was rare in##2##3##(2008-10#1)(2012-2#1)
was rare##10##2##(2006-8#1)(2008-1#1)(2008-10#4)(2008-9#1)(2009-10#1)(2011-3#1)(2012-2#1)
was rarely##5##2##(1994-2#1)(2009-2#1)(2010-2#1)(2012-12#2)
was rated as appropriate when there was##2##7##(2007-10#2)
was rated as being##2##4##(2009-9#1)(2011-2#1)
was rated as excellent##3##4##(1997-3#1)(2012-1#2)
was rated as the##2##4##(1995-9#1)(2007-11#1)
was rated as##13##3##(1993-2#1)(1995-9#1)(1997-3#1)(2006-8#1)(2007-10#2)(2007-11#1)(2009-9#1)(2010-2#1)(2011-2#2)(2012-1#2)
was rated by##2##3##(2010-4#1)(2012-2#1)
was rated highest##2##3##(1993-2#1)(2009-11#1)
was rated##24##2##(1992-2#1)(1993-2#3)(1995-9#1)(1997-3#1)(2004-10#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-4#1)(2009-11#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#1)
was rather low##2##3##(2008-9#1)(2012-2#1)
was rather slow##2##3##(1993-3#1)(2008-10#1)
was rather weak##2##3##(2004-12#1)(2008-8#1)
was rather##23##2##(1990-2#1)(1990-5#1)(1991-1#1)(1992-2#1)(1993-11#1)(1993-3#1)(1994-12#1)(1996-12#1)(2004-12#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
was rationalized##2##2##(1992-1#1)(1992-6#1)
was re-diagnosed##2##2##(2009-8#1)(2010-10#1)
was re-established in##2##3##(2007-8#1)(2008-6#1)
was re-evaluated##3##2##(2006-10#1)(2008-10#1)(2008-12#1)
was re-introduced into##2##3##(2010-10#1)(2011-1#1)
was re-introduced##3##2##(2010-10#1)(2011-1#1)(2012-1#1)
was reached after 60##2##4##(2008-10#2)
was reached after##6##3##(1991-10#1)(2007-5#1)(2008-10#2)(2011-1#1)(2013-1#1)
was reached and##2##3##(2011-2#1)(2013-1#1)
was reached at 10-15 min##2##5##(1993-4#1)(1996-11#1)
was reached at##8##3##(1990-5#1)(1991-9#1)(1993-4#2)(1996-11#1)(2006-8#1)(2007-5#1)(2008-5#1)
was reached by##3##3##(2006-5#1)(2007-8#1)(2008-10#1)
was reached for##3##3##(1992-9#1)(2008-10#2)
was reached in##7##3##(2005-8#1)(2008-10#2)(2011-1#2)(2011-2#1)(2013-8#1)
was reached with##2##3##(2008-10#1)(2008-2#1)
was reached within##3##3##(1991-12#1)(1995-11#1)(2010-5#1)
was reached##57##2##(1990-5#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-3#2)(1992-9#1)(1993-4#2)(1995-11#1)(1996-11#1)(1996-12#1)(1997-3#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-5#2)(2007-8#2)(2008-10#11)(2008-11#4)(2008-2#1)(2008-5#2)(2010-3#1)(2010-5#2)(2010-6#1)(2011-1#3)(2011-2#3)(2013-1#3)(2013-8#1)
was reacted with##13##3##(1991-5#1)(1992-3#1)(1995-10#1)(1996-5#1)(2007-11#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)
was reacted##14##2##(1991-5#1)(1992-3#1)(1995-10#1)(1996-5#1)(2007-11#3)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)
was reactivated##3##2##(1992-11#1)(1992-12#1)(2012-12#1)
was reactive in##3##3##(2007-8#1)(2008-12#1)(2011-11#1)
was reactive with##4##3##(1992-9#1)(1995-1#1)(1997-7#1)(2008-5#1)
was reactive##7##2##(1992-9#1)(1995-1#1)(1997-7#1)(2007-8#1)(2008-12#1)(2008-5#1)(2011-11#1)
was read by##2##3##(2008-10#2)
was readily detectable##4##3##(1994-3#1)(1996-11#1)(2007-8#1)(2011-2#1)
was readily detected in##2##4##(1995-2#1)(1995-8#1)
was readily detected##3##3##(1991-12#1)(1995-2#1)(1995-8#1)
was readily observed in the##2##5##(1991-2#1)(1995-9#1)
was readily observed in##3##4##(1991-2#1)(1995-9#1)(1996-5#1)
was readily observed##4##3##(1991-2#1)(1995-9#1)(1996-5#1)(2007-6#1)
was readily purified##4##3##(1993-9#1)(1994-11#1)(1995-2#1)(1997-4#1)
was readily##33##2##(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-2#2)(1995-3#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-5#3)(1997-1#2)(1997-4#1)(2006-3#1)(2007-6#1)(2007-8#1)(2008-10#6)(2008-3#1)(2010-5#1)(2011-2#1)
was readmitted##3##2##(2006-5#1)(2010-12#1)(2010-7#1)
was realised##2##2##(2008-5#1)(2009-1#1)
was realized after##2##3##(2007-8#1)(2008-10#1)
was realized and##2##3##(2008-2#1)(2010-3#1)
was realized between##2##3##(2008-10#1)(2008-12#1)
was realized by##7##3##(1994-9#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2012-3#1)
was realized in##3##3##(2007-11#1)(2009-9#1)(2010-12#1)
was realized that##3##3##(2005-12#1)(2010-2#1)(2013-1#1)
was realized under##2##3##(2007-12#1)(2007-8#1)
was realized with##3##3##(1993-9#1)(2008-9#1)(2013-1#1)
was realized##34##2##(1993-9#1)(1994-9#1)(2005-12#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#4)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#4)(2008-3#2)(2008-9#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2012-1#1)(2012-3#1)(2013-1#2)
was rearranged##2##2##(2007-12#1)(2008-5#1)
was reasonable##4##2##(1997-7#1)(2005-9#1)(2008-10#1)(2008-7#1)
was reasonably##2##2##(2008-11#1)(2009-7#1)
was reassessed##3##2##(2007-1#1)(2008-10#1)(2008-12#1)
was received by less than##2##5##(2008-1#2)
was received by##4##3##(2007-12#1)(2008-1#2)(2010-3#1)
was received##10##2##(1994-5#1)(1996-12#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-5#1)(2010-3#1)(2011-2#1)(2013-8#1)
was receiving##6##2##(1990-5#1)(1992-2#1)(2006-10#1)(2009-2#1)(2011-1#1)(2013-7#1)
was recently achieved by##2##4##(2005-7#1)(2007-12#1)
was recently approved in##2##4##(2006-10#1)(2009-11#1)
was recently approved##4##3##(2006-10#2)(2007-11#1)(2009-11#1)
was recently demonstrated##3##3##(1996-5#1)(2008-2#1)(2008-5#1)
was recently determined##2##3##(1997-3#1)(2012-2#1)
was recently developed##4##3##(1990-3#1)(2007-12#1)(2008-3#2)
was recently discovered that##2##4##(2009-6#1)(2010-7#1)
was recently discovered##3##3##(1991-12#1)(2009-6#1)(2010-7#1)
was recently found to be##2##5##(1992-3#1)(1994-11#1)
was recently found to##4##4##(1992-3#1)(1994-11#1)(1996-2#1)(2012-12#1)
was recently found##7##3##(1992-3#1)(1992-4#1)(1994-11#1)(1996-2#1)(1997-7#1)(2011-2#1)(2012-12#1)
was recently identified as a##4##5##(1997-4#1)(2006-10#1)(2008-10#1)(2008-9#1)
was recently identified as##5##4##(1994-11#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-9#1)
was recently identified##8##3##(1994-11#2)(1997-4#1)(2006-10#1)(2008-10#1)(2008-9#1)(2010-2#1)(2012-11#1)
was recently introduced##3##3##(1996-3#1)(2008-10#1)(2008-3#1)
was recently presented##2##3##(2008-3#2)
was recently proposed by##4##4##(1995-11#1)(2007-11#1)(2008-10#1)(2008-3#1)
was recently proposed##8##3##(1990-8#1)(1995-11#1)(2007-11#1)(2008-10#2)(2008-3#3)
was recently published##2##3##(2007-10#1)(2008-10#1)
was recently reported to be##3##5##(1992-1#1)(2007-12#1)(2008-4#1)
was recently reported##10##3##(1992-1#1)(1994-2#1)(1994-5#1)(1995-10#1)(2007-12#2)(2008-2#1)(2008-4#1)(2008-8#1)(2012-1#1)
was recently shown to##2##4##(2005-8#1)(2009-8#1)
was recently shown##3##3##(2005-8#1)(2009-8#1)(2011-2#1)
was recently suggested##3##3##(1995-8#1)(2008-10#1)(2008-8#1)
was recently##96##2##(1990-3#1)(1990-8#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-6#1)(1994-11#3)(1994-2#1)(1994-5#1)(1995-10#1)(1995-11#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(2005-7#1)(2005-8#1)(2006-10#7)(2007-10#1)(2007-11#2)(2007-12#4)(2008-10#9)(2008-12#2)(2008-2#2)(2008-3#9)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#1)(2009-6#2)(2009-8#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#3)
was receptor-specific##2##2##(1994-2#1)(1994-8#1)
was recessive##2##2##(1991-12#1)(2008-5#1)
was recognised##4##2##(1990-4#1)(1991-3#1)(2007-8#1)(2010-3#1)
was recognized and##2##3##(1997-7#1)(2003-11#1)
was recognized as a##2##4##(2008-3#1)(2012-2#1)
was recognized as##5##3##(2005-7#1)(2008-3#1)(2008-8#1)(2012-11#1)(2012-2#1)
was recognized by antibodies##2##4##(1990-11#1)(1994-11#1)
was recognized by the##3##4##(1991-7#2)(2008-10#1)
was recognized by##13##3##(1990-11#1)(1990-3#1)(1990-5#1)(1991-7#2)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-4#1)(2007-10#1)(2008-10#1)
was recognized in##7##3##(1996-9#1)(2006-8#1)(2007-11#1)(2008-12#1)(2008-7#1)(2011-2#2)
was recognized that##3##3##(2008-11#1)(2008-7#1)(2008-8#1)
was recognized##39##2##(1990-11#1)(1990-3#1)(1990-5#1)(1991-7#2)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-4#1)(1996-6#1)(1996-9#2)(1997-2#1)(1997-7#1)(1997-8#1)(2003-11#1)(2005-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-9#1)(2011-2#3)(2012-11#1)(2012-2#1)
was recommended for##2##3##(1990-12#1)(2008-7#1)
was recommended in##2##3##(2006-10#1)(2008-5#1)
was recommended that##3##3##(1997-1#1)(2008-10#1)(2010-8#1)
was recommended to##2##3##(2008-6#1)(2008-7#1)
was recommended##15##2##(1990-12#1)(1997-1#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-1#2)
was reconfirmed##2##2##(1993-12#1)(2011-2#1)
was reconstituted in vitro##3##4##(1992-12#1)(1993-8#1)(1994-8#1)
was reconstituted in##7##3##(1990-3#1)(1992-12#1)(1993-8#1)(1994-5#1)(1994-8#1)(1997-3#1)(2008-10#1)
was reconstituted into liposomes##2##4##(1990-2#1)(2008-8#1)
was reconstituted into##7##3##(1990-2#1)(1991-2#1)(1992-12#1)(1992-6#2)(1992-7#1)(2008-8#1)
was reconstituted with##4##3##(1996-5#1)(1997-8#2)(2011-2#1)
was reconstituted##20##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-2#1)(1992-12#2)(1992-6#2)(1992-7#1)(1993-8#1)(1994-5#1)(1994-8#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-8#2)(2008-10#1)(2008-8#1)(2011-2#1)
was reconstructed by##2##3##(2007-8#1)(2011-2#1)
was reconstructed from##2##3##(2006-12#1)(2008-2#1)
was reconstructed using##5##3##(2006-8#1)(2008-1#1)(2008-9#1)(2009-9#1)(2010-8#1)
was reconstructed with##4##3##(2007-11#1)(2011-2#2)(2013-1#1)
was reconstructed##21##2##(1992-3#1)(1994-12#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#1)
was recorded after##2##3##(2007-11#1)(2008-11#1)
was recorded and analyzed##3##4##(2008-3#1)(2009-11#1)(2012-1#1)
was recorded and the##2##4##(2004-9#1)(2013-8#1)
was recorded and##12##3##(1993-12#1)(1994-3#1)(1997-8#1)(2004-9#1)(2005-10#1)(2007-12#1)(2007-4#1)(2008-3#1)(2008-7#1)(2009-11#1)(2012-1#1)(2013-8#1)
was recorded as##5##3##(1994-2#1)(2008-10#1)(2008-9#1)(2010-2#1)(2013-8#1)
was recorded at##10##3##(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-6#2)
was recorded before##3##3##(1995-7#1)(2006-12#1)(2013-8#1)
was recorded between##3##3##(2008-12#1)(2010-8#1)(2013-8#1)
was recorded by a##2##4##(1993-9#1)(1996-8#1)
was recorded by the##2##4##(2007-7#1)(2008-12#1)
was recorded by##8##3##(1993-7#1)(1993-9#1)(1994-2#1)(1996-8#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-7#1)
was recorded during##7##3##(1993-6#2)(1996-2#1)(2006-5#1)(2007-5#1)(2011-12#1)(2013-1#1)
was recorded extracellularly##2##3##(1994-10#1)(2008-6#1)
was recorded for the first##2##5##(1991-5#1)(2012-12#1)
was recorded for the##5##4##(1991-5#2)(2008-10#1)(2012-12#1)(2013-8#1)
was recorded for##13##3##(1991-5#2)(1994-7#1)(2007-10#1)(2007-8#1)(2008-10#1)(2009-9#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#3)
was recorded from 64##2##4##(2008-11#1)(2013-8#1)
was recorded from the##6##4##(1991-3#2)(1992-9#1)(1995-12#1)(1996-1#1)(2010-9#1)
was recorded from##16##3##(1991-3#2)(1992-7#1)(1992-8#2)(1992-9#1)(1994-5#1)(1995-12#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-9#1)(2013-1#1)(2013-8#1)
was recorded in 11##2##4##(2006-6#1)(2007-7#1)
was recorded in 25##2##4##(2006-6#1)(2008-7#1)
was recorded in all##3##4##(2008-10#1)(2008-4#1)(2009-12#1)
was recorded in only##2##4##(1992-8#1)(1994-12#1)
was recorded in the##12##4##(1990-10#1)(1990-3#1)(1991-3#1)(1991-4#1)(1991-8#1)(1993-2#2)(1994-12#1)(2007-12#1)(2008-5#1)(2012-1#1)(2013-8#1)
was recorded in##65##3##(1990-10#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-3#3)(1991-4#1)(1991-8#1)(1992-1#1)(1992-8#1)(1993-2#2)(1993-7#1)(1994-12#2)(1994-6#1)(1996-12#1)(2004-10#1)(2006-5#1)(2006-6#4)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-3#3)(2007-7#1)(2008-1#1)(2008-10#7)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-6#1)(2010-4#1)(2010-9#1)(2011-2#4)(2012-1#2)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#3)
was recorded on##9##3##(1994-3#1)(2007-6#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2012-12#1)
was recorded using a##3##4##(2007-8#1)(2008-10#1)(2008-7#1)
was recorded using##4##3##(2007-8#1)(2008-10#2)(2008-7#1)
was recorded weekly##2##3##(1995-3#1)(2008-10#1)
was recorded with a##3##4##(1991-3#1)(1995-6#1)(1997-1#1)
was recorded with##8##3##(1991-3#1)(1995-6#1)(1995-7#1)(1997-1#1)(2005-8#1)(2008-3#2)(2011-2#1)
was recorded##237##2##(1990-10#3)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-3#6)(1991-4#2)(1991-5#2)(1991-8#1)(1992-1#4)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#4)(1992-9#1)(1993-12#1)(1993-2#2)(1993-6#2)(1993-7#2)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-7#2)(1996-1#3)(1996-12#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-8#1)(2004-10#1)(2004-9#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#3)(2006-6#7)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-3#4)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#4)(2008-1#3)(2008-10#29)(2008-11#3)(2008-12#7)(2008-2#3)(2008-3#6)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#1)(2009-6#3)(2009-9#1)(2010-2#1)(2010-4#2)(2010-8#2)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#3)(2012-12#4)(2013-1#6)(2013-7#1)(2013-8#14)
was recovered after##3##3##(1991-2#1)(2013-1#2)
was recovered and##4##3##(1990-3#1)(1994-9#1)(2005-9#1)(2011-2#1)
was recovered as##2##3##(1991-12#1)(2006-8#1)
was recovered by##3##3##(1993-12#1)(1997-4#1)(2008-7#1)
was recovered from a##3##4##(1995-8#1)(2008-10#1)(2012-3#1)
was recovered from the##5##4##(1991-11#1)(1994-9#1)(2008-10#2)(2008-7#1)
was recovered from##19##3##(1991-11#1)(1993-12#1)(1994-9#1)(1995-8#1)(1997-6#1)(2006-8#1)(2007-5#1)(2008-10#10)(2008-7#1)(2012-3#1)
was recovered in the##9##4##(1990-2#1)(1990-3#1)(1990-4#1)(1991-3#1)(1991-7#2)(1994-11#1)(1995-7#1)(1997-6#1)
was recovered in##12##3##(1990-2#1)(1990-3#1)(1990-4#1)(1991-3#1)(1991-7#2)(1992-4#1)(1994-11#1)(1995-7#1)(1996-6#1)(1997-6#1)(2011-2#1)
was recovered only from##2##4##(2007-6#1)(2008-10#1)
was recovered only##3##3##(2007-6#1)(2008-10#1)(2008-5#1)
was recovered with the dowex resin plus the##2##8##(2008-10#2)
was recovered##71##2##(1990-2#1)(1990-3#2)(1990-4#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#2)(1992-1#1)(1992-4#2)(1993-12#2)(1993-2#1)(1994-11#1)(1994-9#2)(1995-7#1)(1995-8#1)(1996-12#1)(1996-6#1)(1997-4#1)(1997-6#2)(2005-9#2)(2006-8#2)(2007-12#1)(2007-5#1)(2007-6#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#2)(2010-10#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#2)
was recruited during a period of##2##6##(1993-1#2)
was recruited from##2##3##(2012-1#1)(2012-2#1)
was recruited##8##2##(1993-1#2)(2008-11#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
was recurrence##2##2##(2011-12#1)(2011-2#1)
was redesigned##2##2##(2007-5#1)(2013-8#1)
was rediscovered in the##2##4##(2008-6#1)(2012-1#1)
was reduced (P &lt##2##4##(1992-12#1)(2011-3#1)
was reduced (P##3##3##(1990-2#1)(1992-12#1)(2011-3#1)
was reduced (P&lt##2##3##(2007-6#1)(2008-6#1)
was reduced after##6##3##(1990-12#1)(1995-12#1)(1996-9#1)(2008-10#1)(2009-4#1)(2013-1#1)
was reduced and the##2##4##(2008-7#1)(2010-12#1)
was reduced and##14##3##(1991-5#1)(1991-9#1)(1996-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#2)(2013-1#1)(2013-8#1)
was reduced as a##2##4##(1994-2#1)(2008-10#1)
was reduced as##5##3##(1992-6#1)(1994-2#1)(2008-10#1)(2009-7#1)(2010-5#1)
was reduced at 20##2##4##(1992-3#1)(2008-10#1)
was reduced at a##3##4##(1990-8#1)(2008-10#2)
was reduced at##12##3##(1990-8#1)(1992-3#1)(1993-9#1)(1995-8#1)(2007-11#1)(2007-6#1)(2008-10#6)
was reduced by &gt##2##4##(1995-5#1)(1995-8#1)
was reduced by 0##2##4##(2008-10#1)(2012-2#1)
was reduced by 10%##3##4##(1992-6#1)(1996-7#1)(2008-2#1)
was reduced by 25 and##2##5##(1991-5#1)(1994-8#1)
was reduced by 25##3##4##(1990-5#1)(1991-5#1)(1994-8#1)
was reduced by 40%##3##4##(1994-2#1)(1995-8#1)(2008-10#1)
was reduced by 5##2##4##(1997-8#1)(2007-3#1)
was reduced by 70%##2##4##(1993-3#1)(2006-9#1)
was reduced by a factor of 25##2##7##(1990-12#1)(2008-10#1)
was reduced by a factor of##3##6##(1990-12#1)(2008-10#1)(2008-7#1)
was reduced by a##5##4##(1990-12#1)(1994-2#1)(1996-2#1)(2008-10#1)(2008-7#1)
was reduced by about##4##4##(1995-5#1)(2008-10#2)(2008-6#1)
was reduced by more than##2##5##(1995-3#1)(2008-3#1)
was reduced by only##2##4##(1995-5#1)(2008-3#1)
was reduced by the##5##4##(1991-9#1)(1993-2#1)(1995-6#1)(2008-11#1)(2009-11#1)
was reduced by##112##3##(1990-12#1)(1990-3#1)(1990-5#2)(1990-9#1)(1991-2#2)(1991-5#2)(1991-9#1)(1992-1#1)(1992-2#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#4)(1995-6#1)(1995-8#3)(1996-1#1)(1996-12#1)(1996-2#3)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-8#1)(2004-11#1)(2006-3#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#22)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
was reduced compared to##2##4##(1990-2#1)(2010-12#1)
was reduced compared with##2##4##(1995-8#1)(2008-10#1)
was reduced compared##4##3##(1990-2#1)(1995-8#1)(2008-10#1)(2010-12#1)
was reduced considerably##2##3##(1990-11#1)(2008-1#1)
was reduced during the##3##4##(1997-7#1)(2008-1#1)(2012-2#1)
was reduced during##4##3##(1997-7#1)(2008-1#1)(2011-2#1)(2012-2#1)
was reduced for##5##3##(1991-2#1)(1992-7#1)(2008-10#1)(2008-5#1)(2011-2#1)
was reduced from 10##2##4##(2008-10#2)
was reduced from 46##2##4##(1990-8#1)(2008-4#1)
was reduced from 47##2##4##(1992-1#1)(2012-12#1)
was reduced from##25##3##(1990-8#1)(1992-1#1)(1992-2#1)(1993-5#1)(1993-7#3)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-4#1)(1997-8#2)(2007-12#1)(2008-10#4)(2008-3#1)(2008-4#4)(2012-12#1)
was reduced gradually##2##3##(1990-11#1)(2009-6#1)
was reduced if the##2##4##(2008-10#1)(2012-1#1)
was reduced in a dose-dependent manner##2##6##(2008-10#1)(2010-12#1)
was reduced in a##4##4##(1990-5#1)(2008-10#2)(2010-12#1)
was reduced in all##4##4##(1995-3#1)(1997-4#1)(2006-10#1)(2006-11#1)
was reduced in comparison##2##4##(1996-7#1)(2008-5#1)
was reduced in the absence of##2##6##(1993-6#1)(1997-6#1)
was reduced in the presence of##3##6##(1992-7#1)(1994-2#1)(1997-8#1)
was reduced in the##18##4##(1991-2#1)(1992-2#1)(1992-7#1)(1993-6#1)(1994-2#1)(1996-12#1)(1997-6#1)(1997-8#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-2#1)(2010-3#1)(2010-5#2)(2012-2#1)(2013-1#1)
was reduced in##57##3##(1990-10#1)(1990-11#1)(1990-5#1)(1991-10#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-2#2)(1995-3#2)(1995-7#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-3#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-8#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#1)(2011-2#1)(2012-2#4)(2013-1#2)
was reduced markedly##2##3##(1990-12#1)(1995-7#1)
was reduced on##2##3##(2004-2#1)(2008-10#1)
was reduced only##3##3##(1995-3#2)(2008-10#1)
was reduced sensitive to##2##4##(2007-6#2)
was reduced significantly after##2##4##(1996-5#1)(2008-10#1)
was reduced significantly by##2##4##(1995-3#1)(2004-11#1)
was reduced significantly in##2##4##(2008-7#1)(2011-2#1)
was reduced significantly##12##3##(1990-12#1)(1995-3#1)(1996-5#1)(2004-11#1)(2006-10#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-1#1)
was reduced to 0##3##4##(1994-3#1)(1994-5#1)(2007-12#1)
was reduced to 21##3##4##(2007-7#1)(2013-1#2)
was reduced to Cr(III)##2##4##(2008-10#2)
was reduced to about##3##4##(1994-6#1)(1995-12#1)(2006-8#1)
was reduced to approximately##3##4##(1992-5#1)(2007-12#1)(2008-11#1)
was reduced to less than##2##5##(1994-12#1)(2008-3#1)
was reduced to##56##3##(1990-5#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-5#1)(1992-4#1)(1992-5#1)(1993-1#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#1)(1995-10#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-5#2)(1997-2#1)(1997-6#1)(1997-8#1)(2006-12#2)(2006-8#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-7#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-5#1)(2013-1#2)
was reduced when##6##3##(1990-7#1)(1993-3#1)(2008-10#3)(2008-4#1)
was reduced with time##2##4##(1994-12#1)(2008-10#1)
was reduced with##9##3##(1993-9#1)(1994-12#1)(1994-2#1)(2006-5#1)(2007-11#2)(2007-7#1)(2008-10#1)(2012-2#1)
was reduced within##2##3##(1993-12#1)(2008-10#1)
was reduced##419##2##(1990-1#1)(1990-10#1)(1990-11#3)(1990-12#4)(1990-2#3)(1990-3#1)(1990-5#5)(1990-6#1)(1990-7#2)(1990-8#4)(1990-9#1)(1991-10#2)(1991-12#1)(1991-2#5)(1991-5#4)(1991-8#2)(1991-9#2)(1992-1#3)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#4)(1992-7#2)(1992-8#1)(1992-9#2)(1993-1#2)(1993-12#3)(1993-2#2)(1993-3#3)(1993-5#1)(1993-6#2)(1993-7#3)(1993-9#4)(1994-10#2)(1994-11#1)(1994-12#2)(1994-2#8)(1994-3#4)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#5)(1995-2#2)(1995-3#8)(1995-5#6)(1995-6#4)(1995-7#3)(1995-8#6)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#3)(1996-5#5)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#3)(1997-4#3)(1997-5#3)(1997-6#3)(1997-7#1)(1997-8#5)(2004-11#2)(2004-2#1)(2005-12#1)(2005-8#2)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#7)(2007-2#1)(2007-3#2)(2007-6#4)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#73)(2008-11#5)(2008-12#3)(2008-2#3)(2008-3#6)(2008-4#5)(2008-5#8)(2008-6#4)(2008-7#6)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#4)(2010-7#2)(2010-8#2)(2011-1#3)(2011-2#7)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#10)(2013-7#1)(2013-8#4)
was reexamined##3##2##(1991-3#1)(1991-8#1)(2011-2#1)
was referred because of##5##4##(1995-5#1)(2006-10#1)(2007-5#1)(2012-3#1)(2013-1#1)
was referred by the##2##4##(2010-3#1)(2011-1#1)
was referred by##3##3##(2007-3#1)(2010-3#1)(2011-1#1)
was referred for evaluation##2##4##(1997-3#1)(2013-8#1)
was referred for investigation of##2##5##(1992-11#1)(2007-3#1)
was referred for##16##3##(1992-11#1)(1997-3#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-12#1)(2008-8#1)(2009-3#2)(2010-12#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-8#1)
was referred from##2##3##(2009-7#1)(2012-2#1)
was referred to an##2##4##(1993-12#1)(2010-10#1)
was referred to our department##2##5##(2011-2#1)(2013-7#1)
was referred to our hospital for##5##6##(2010-12#1)(2011-2#2)(2013-8#2)
was referred to our hospital##6##5##(2008-1#1)(2010-12#1)(2011-2#2)(2013-8#2)
was referred to our##12##4##(2008-1#1)(2008-10#1)(2010-10#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#2)
was referred to the##7##4##(1994-12#1)(2007-5#1)(2008-6#1)(2009-8#2)(2011-1#1)(2012-3#1)
was referred to us##2##4##(2007-12#1)(2008-1#1)
was referred to##32##3##(1993-12#1)(1994-12#1)(1994-9#1)(1995-12#1)(2007-12#1)(2007-5#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-8#2)(2010-10#2)(2010-12#2)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#2)
was referred with##3##3##(2006-12#1)(2007-2#1)(2011-2#1)
was referred##65##2##(1991-11#1)(1992-11#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-5#1)(1997-3#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-5#3)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#2)(2009-7#1)(2009-8#2)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#5)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#3)
was refined at 2##2##4##(1992-4#1)(1993-8#1)
was refined to##3##3##(1995-6#1)(1996-2#1)(2008-5#1)
was refined using##2##3##(1995-10#1)(1995-3#1)
was refined##12##2##(1992-4#1)(1992-9#1)(1993-8#1)(1995-10#1)(1995-3#1)(1995-6#1)(1996-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-8#1)
was reflected by a##2##4##(1994-2#1)(2008-10#1)
was reflected by the##2##4##(1994-12#1)(2008-5#1)
was reflected by##6##3##(1992-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(2008-10#1)(2008-5#1)
was reflected in the level of##2##6##(1996-2#1)(1996-7#1)
was reflected in the##4##4##(1990-5#1)(1992-6#1)(1996-2#1)(1996-7#1)
was reflected in##16##3##(1990-5#1)(1991-3#1)(1992-6#2)(1996-2#1)(1996-7#1)(1997-5#1)(2005-11#1)(2005-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)(2010-8#1)(2011-2#2)
was reflected##24##2##(1990-5#1)(1991-3#1)(1992-3#1)(1992-6#2)(1992-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1996-2#1)(1996-7#1)(1997-5#1)(2005-11#1)(2005-9#1)(2008-10#2)(2008-11#1)(2008-5#2)(2009-8#1)(2010-5#1)(2010-8#1)(2011-2#2)
was refolded##3##2##(1992-5#1)(1995-3#1)(2011-2#1)
was refractory to treatment##2##4##(2007-7#1)(2012-12#1)
was refractory to##13##3##(1991-6#1)(1994-5#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-7#1)(2007-9#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
was refractory##14##2##(1991-6#1)(1992-9#1)(1994-5#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-7#1)(2007-9#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
was regained##2##2##(1994-8#1)(2007-8#1)
was regarded as a##5##4##(1990-11#1)(1990-3#1)(2008-1#1)(2008-3#1)(2010-4#1)
was regarded as the##3##4##(1992-6#1)(1996-2#1)(2005-11#1)
was regarded as##16##3##(1990-11#1)(1990-3#1)(1992-6#1)(1993-2#1)(1994-5#1)(1996-2#1)(2005-11#1)(2006-2#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-4#1)(2010-7#1)
was regarded##17##2##(1990-11#1)(1990-3#1)(1992-6#1)(1993-2#1)(1994-5#1)(1996-2#1)(2005-11#1)(2006-2#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-4#1)(2010-4#1)(2010-7#1)
was regenerated by##2##3##(2008-10#2)
was regenerated##3##2##(2008-10#3)
was registered for##2##3##(2011-2#2)
was registered in this##2##4##(1991-10#1)(2008-10#1)
was registered in##5##3##(1991-10#1)(1993-11#1)(1994-5#1)(1995-4#1)(2008-10#1)
was registered on##2##3##(2008-6#1)(2010-5#1)
was registered##21##2##(1990-4#1)(1991-10#1)(1991-2#1)(1993-11#1)(1994-5#1)(1995-4#1)(1996-5#1)(2006-6#1)(2007-3#1)(2007-9#1)(2008-10#3)(2008-5#1)(2008-6#1)(2009-2#1)(2010-5#1)(2010-8#1)(2011-2#2)(2013-7#1)
was regular##2##2##(1992-6#1)(1993-3#1)
was regularly##2##2##(1995-5#1)(2010-12#1)
was regulated by##11##3##(1990-10#1)(1991-9#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-5#1)(1997-6#1)(2008-10#1)(2009-10#1)(2009-3#1)
was regulated##12##2##(1990-10#1)(1991-5#1)(1991-9#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-5#1)(1997-6#1)(2008-10#1)(2009-10#1)(2009-3#1)
was reinforced with##2##3##(2009-7#1)(2013-8#1)
was reinforced##3##2##(2006-9#1)(2009-7#1)(2013-8#1)
was reinfused##2##2##(1996-9#1)(2012-12#1)
was reinserted with##2##3##(2007-11#1)(2007-7#1)
was reinstituted##3##2##(2007-7#1)(2012-12#1)(2013-8#1)
was reintroduced in##2##3##(2008-10#1)(2010-12#1)
was reintroduced##3##2##(1990-3#1)(2008-10#1)(2010-12#1)
was rejected by##2##3##(2008-10#1)(2009-3#1)
was rejected for##2##3##(1991-1#1)(2012-3#1)
was rejected##9##2##(1990-8#2)(1991-1#1)(1991-6#1)(1995-2#1)(2008-10#2)(2009-3#1)(2012-3#1)
was related directly to##2##4##(2007-8#1)(2012-2#1)
was related directly##3##3##(2007-8#1)(2012-2#1)(2012-3#1)
was related to a##5##4##(1993-4#1)(2006-6#1)(2008-11#1)(2008-9#1)(2013-1#1)
was related to an##2##4##(2012-1#1)(2012-2#1)
was related to both##2##4##(2008-10#1)(2008-5#1)
was related to changes##2##4##(1990-8#1)(2008-10#1)
was related to increased##2##4##(2008-10#1)(2013-7#1)
was related to its##2##4##(1992-11#1)(2008-10#1)
was related to reports of##2##5##(2006-7#1)(2012-12#1)
was related to the concentration of##3##6##(1990-1#1)(2008-10#2)
was related to the content of##2##6##(1991-10#1)(2008-10#1)
was related to the risk of##2##6##(1991-4#1)(2011-1#1)
was related to the##53##4##(1990-1#1)(1990-10#2)(1990-12#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-8#1)(1994-2#1)(1994-3#1)(1997-2#1)(1997-7#1)(2005-11#2)(2005-4#1)(2005-5#2)(2006-10#1)(2006-5#2)(2008-10#15)(2008-11#2)(2008-2#1)(2008-5#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-7#1)
was related to their##2##4##(2005-11#1)(2008-10#1)
was related to violent##2##4##(2009-7#2)
was related to##158##3##(1990-1#1)(1990-10#2)(1990-11#1)(1990-12#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#2)(1991-4#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#2)(1992-8#1)(1993-2#1)(1993-4#2)(1993-9#4)(1994-2#1)(1994-3#2)(1995-1#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-7#1)(2004-11#1)(2004-2#2)(2005-11#3)(2005-4#1)(2005-5#2)(2006-10#2)(2006-11#1)(2006-3#3)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#3)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#27)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-7#6)(2009-8#3)(2010-10#1)(2010-12#3)(2010-4#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
was related with the##2##4##(2005-11#1)(2008-11#1)
was related with##3##3##(2005-11#1)(2008-11#1)(2008-5#1)
was related##172##2##(1990-1#1)(1990-10#2)(1990-11#1)(1990-12#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#3)(1991-4#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#2)(1992-8#1)(1993-2#1)(1993-4#2)(1993-9#4)(1994-2#1)(1994-3#3)(1995-1#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-2#2)(2005-11#4)(2005-4#1)(2005-5#2)(2006-10#2)(2006-11#1)(2006-3#3)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#4)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#28)(2008-11#5)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-7#6)(2009-8#3)(2010-10#1)(2010-12#3)(2010-4#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#1)
was relative##4##2##(1995-3#1)(2007-7#1)(2007-9#1)(2008-10#1)
was relatively constant##4##3##(1990-11#1)(1995-8#1)(2007-3#1)(2008-5#1)
was relatively good##2##3##(1992-8#1)(2007-10#1)
was relatively high in##3##4##(1992-2#1)(2008-9#1)(2012-12#1)
was relatively high##12##3##(1992-2#1)(1992-8#1)(1996-2#1)(1997-6#1)(2005-4#1)(2008-10#4)(2008-8#1)(2008-9#1)(2012-12#1)
was relatively insensitive to##2##4##(1993-8#1)(1995-3#1)
was relatively low##6##3##(1990-3#1)(2005-4#1)(2006-2#1)(2007-8#1)(2011-1#1)(2013-7#1)
was relatively poor in activity##2##5##(2006-5#2)
was relatively rapid##3##3##(1992-3#1)(1992-6#1)(1994-5#1)
was relatively rare##2##3##(2011-2#1)(2013-1#1)
was relatively small##5##3##(2006-11#1)(2006-2#1)(2008-10#1)(2009-3#1)(2010-5#1)
was relatively stable##4##3##(1990-5#1)(1992-11#1)(1997-2#1)(2009-11#1)
was relatively unaffected##2##3##(1995-5#1)(2008-6#1)
was relatively well##2##3##(1994-12#1)(1997-2#1)
was relatively##74##2##(1990-11#1)(1990-3#1)(1990-5#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-2#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-4#3)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#2)(2006-5#2)(2006-8#1)(2007-10#1)(2007-3#1)(2007-8#2)(2008-10#7)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-3#1)(2009-7#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
was relaxed##2##2##(1997-7#1)(2012-3#1)
was released as##2##3##(1991-1#1)(2008-11#1)
was released by##6##3##(1992-6#1)(1994-11#1)(1997-4#1)(2008-10#1)(2013-8#2)
was released from the##4##4##(1991-5#1)(1992-5#1)(1994-3#1)(2011-2#1)
was released from##10##3##(1991-4#1)(1991-5#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-6#1)(1994-3#1)(2008-10#1)(2011-2#1)(2012-11#1)
was released in the##2##4##(2008-5#2)
was released in##4##3##(2008-4#1)(2008-5#2)(2010-6#1)
was released into the medium##2##5##(1990-2#1)(1996-7#1)
was released into the##5##4##(1990-2#1)(1995-2#1)(1996-7#2)(2011-2#1)
was released into##7##3##(1990-11#1)(1990-2#1)(1991-10#1)(1995-2#1)(1996-7#2)(2011-2#1)
was released with##2##3##(1996-8#1)(2008-10#1)
was released##43##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-4#1)(1991-5#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-7#4)(1996-8#1)(1997-4#1)(2004-12#1)(2007-2#1)(2007-4#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#2)(2010-6#1)(2011-2#2)(2012-11#1)(2013-8#2)
was relevant##2##2##(2008-2#1)(2008-7#1)
was reliable and##4##3##(1991-3#1)(2008-10#3)
was reliable for##3##3##(2008-10#3)
was reliable##12##2##(1991-3#1)(2007-10#1)(2007-7#2)(2008-10#7)(2011-1#1)
was reliably##3##2##(1996-12#1)(2008-10#1)(2008-5#1)
was relieved by##2##3##(1991-5#1)(2008-7#1)
was relieved with##2##3##(1994-9#1)(1996-10#1)
was relieved##10##2##(1991-12#1)(1991-5#1)(1994-9#1)(1996-10#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-8#1)
was relocated##2##2##(1992-7#1)(1995-5#1)
was remarkable for##2##3##(2008-11#1)(2008-7#1)
was remarkable##8##2##(1991-3#1)(1991-6#1)(1997-7#1)(2006-10#1)(2008-11#1)(2008-7#1)(2010-9#1)(2013-7#1)
was remarkably higher##2##3##(1996-2#1)(2008-9#1)
was remarkably inhibited##3##3##(1992-12#1)(2008-8#1)(2008-9#1)
was remarkably similar##2##3##(1990-4#1)(1991-10#1)
was remarkably##18##2##(1990-10#1)(1990-4#1)(1990-6#1)(1991-10#1)(1992-12#1)(1992-4#1)(1996-2#1)(1996-4#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#2)(2010-10#1)(2011-2#1)(2012-1#1)
was removed after##3##3##(2007-7#2)(2009-10#1)
was removed and replaced with##3##5##(2008-10#2)(2008-5#1)
was removed and replaced##4##4##(2008-10#2)(2008-5#1)(2008-9#1)
was removed and##13##3##(1997-2#1)(2005-10#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-9#1)(2011-2#1)(2012-11#1)(2012-12#1)
was removed at##2##3##(2010-3#1)(2011-1#1)
was removed by the##2##4##(2008-7#1)(2013-1#1)
was removed by##17##3##(1991-6#1)(1992-8#1)(1992-9#1)(1994-5#1)(1994-9#1)(1996-5#1)(2005-11#1)(2006-12#1)(2006-5#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
was removed completely##2##3##(2006-12#1)(2008-10#1)
was removed endoscopically##2##3##(2008-5#1)(2013-7#1)
was removed from embryonic##2##4##(1992-8#1)(2008-11#1)
was removed from the minicolumn with##2##6##(2008-10#2)
was removed from the##11##4##(1990-4#1)(1991-4#1)(1992-5#1)(2005-10#1)(2005-11#1)(2008-10#5)(2008-11#1)
was removed from##17##3##(1990-4#1)(1991-4#1)(1992-5#2)(1992-8#1)(2005-10#1)(2005-11#1)(2008-10#7)(2008-11#2)(2008-3#1)
was removed in##3##3##(1990-4#1)(1991-6#1)(1997-3#1)
was removed on##3##3##(2011-1#1)(2012-12#2)
was removed surgically##2##3##(2011-2#1)(2012-2#1)
was removed through an##2##4##(2006-12#1)(2008-7#1)
was removed under##3##3##(2007-8#2)(2010-5#1)
was removed via##2##3##(2006-12#1)(2012-2#1)
was removed with the##2##4##(1990-5#1)(2008-3#1)
was removed with##3##3##(1990-5#1)(2008-10#1)(2008-3#1)
was removed##111##2##(1990-4#2)(1990-5#1)(1991-4#1)(1991-5#1)(1991-6#2)(1992-4#1)(1992-5#2)(1992-7#1)(1992-8#3)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-10#2)(2005-11#2)(2006-12#7)(2006-4#1)(2006-5#2)(2006-7#1)(2007-12#2)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-3#3)(2008-5#6)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
was rendered##6##2##(1992-5#1)(1995-3#1)(2006-8#1)(2008-10#1)(2008-7#1)(2010-12#1)
was renewed##2##2##(2008-10#1)(2011-12#1)
was reoperated##7##2##(1992-10#1)(1992-8#1)(2007-8#3)(2008-10#1)(2008-6#1)
was repaired by##2##3##(2007-7#1)(2007-8#1)
was repaired in##2##3##(2009-6#1)(2011-2#1)
was repaired primarily##3##3##(2008-12#1)(2012-1#1)(2012-3#1)
was repaired with a##2##4##(2007-8#1)(2008-12#1)
was repaired with##7##3##(2005-5#1)(2007-8#4)(2008-10#1)(2008-12#1)
was repaired##19##2##(2005-5#1)(2006-10#1)(2007-7#1)(2007-8#5)(2008-10#1)(2008-12#3)(2008-4#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-3#2)
was repeatable##2##2##(2008-10#1)(2012-2#1)
was repeated at##3##3##(2006-8#1)(2008-10#1)(2012-1#1)
was repeated every##3##3##(2007-11#1)(2008-10#1)(2008-12#1)
was repeated for##2##3##(1992-7#1)(2008-5#1)
was repeated in##6##3##(1991-8#1)(1994-8#1)(2007-11#2)(2010-6#1)(2011-1#1)
was repeated on##3##3##(1990-2#1)(1994-6#1)(1994-7#1)
was repeated three times##4##4##(1990-8#1)(1994-2#1)(2005-1#1)(2008-10#1)
was repeated three##5##3##(1990-8#1)(1994-2#1)(2005-1#1)(2008-10#1)(2013-1#1)
was repeated twice##3##3##(1996-6#1)(2006-6#1)(2013-1#1)
was repeated until##2##3##(1997-6#1)(2008-1#1)
was repeated with##5##3##(1992-6#1)(1992-8#1)(2007-2#1)(2011-3#1)(2012-12#1)
was repeated##52##2##(1990-2#1)(1990-6#1)(1990-8#1)(1991-8#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-3#1)(1994-2#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-8#1)(1996-6#1)(1997-6#1)(1997-8#1)(2005-1#1)(2006-10#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-12#1)(2013-1#3)(2013-8#1)
was repeatedly##5##2##(1996-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2012-11#1)
was replaced by Ala##3##4##(1990-5#1)(1992-6#1)(1994-5#1)
was replaced by a single##2##5##(2008-10#2)
was replaced by a##5##4##(1990-2#1)(2006-10#1)(2008-10#3)
was replaced by the##9##4##(1990-2#1)(1994-2#1)(1994-9#1)(1995-8#1)(1997-3#1)(2006-10#1)(2006-11#1)(2008-8#1)(2013-8#1)
was replaced by valine##2##4##(1990-2#1)(1993-6#1)
was replaced by##60##3##(1990-10#1)(1990-2#4)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-10#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-6#4)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-9#2)(1995-10#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-3#2)(1997-6#1)(1997-7#1)(2004-12#1)(2004-9#1)(2006-10#2)(2006-11#1)(2006-6#2)(2007-11#1)(2008-10#5)(2008-8#1)(2008-9#3)(2011-12#1)(2012-11#1)(2013-1#2)(2013-8#1)
was replaced with a##3##4##(1990-12#1)(1994-3#1)(2011-1#1)
was replaced with valine##2##4##(1995-2#1)(1996-2#1)
was replaced with##27##3##(1990-12#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-1#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-2#2)(1997-6#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-2#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
was replaced##93##2##(1990-10#1)(1990-12#1)(1990-2#4)(1990-5#2)(1990-9#1)(1991-12#2)(1991-2#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-6#4)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-9#3)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#2)(1995-8#1)(1996-11#1)(1996-2#2)(1996-5#1)(1996-8#1)(1997-3#2)(1997-6#2)(1997-7#1)(2004-12#1)(2004-9#1)(2006-10#2)(2006-11#1)(2006-6#2)(2007-11#1)(2008-10#6)(2008-11#2)(2008-8#2)(2008-9#4)(2009-2#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-3#2)(2013-1#3)(2013-8#2)
was replicated in##2##3##(2006-6#1)(2008-11#1)
was replicated##5##2##(2006-6#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-8#1)
was reported and##4##3##(1990-12#1)(2008-11#2)(2011-2#1)
was reported as a##2##4##(1991-4#1)(2006-10#1)
was reported as##11##3##(1990-4#1)(1991-4#1)(1993-5#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2009-4#1)(2010-12#1)(2013-8#1)
was reported by##23##3##(1990-12#1)(1991-8#1)(1995-6#1)(1996-6#1)(1996-9#1)(1997-2#1)(2004-12#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-8#1)(2009-5#1)(2009-7#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
was reported for the##2##4##(1995-2#1)(2008-6#1)
was reported for##7##3##(1991-8#1)(1995-2#1)(2005-8#1)(2006-2#1)(2008-6#1)(2009-8#1)(2013-8#1)
was reported in the##5##4##(1994-6#1)(1994-9#1)(1996-5#1)(2008-12#1)(2008-3#1)
was reported in this paper##3##5##(2005-4#1)(2008-10#1)(2008-9#1)
was reported in this##5##4##(2005-11#1)(2005-4#1)(2008-10#1)(2008-9#1)(2011-2#1)
was reported in##41##3##(1990-6#2)(1991-3#1)(1992-11#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-3#2)(1996-5#1)(2005-11#1)(2005-4#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#2)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
was reported more than##2##4##(1991-2#1)(2013-1#1)
was reported more##3##3##(1991-2#1)(1991-5#1)(2013-1#1)
was reported on##2##3##(2008-10#2)
was reported only##2##3##(2007-8#1)(2012-3#1)
was reported previously for##2##4##(1994-3#1)(1995-10#1)
was reported previously##6##3##(1994-3#1)(1995-10#1)(1995-6#1)(1996-3#1)(2004-9#1)(2010-8#1)
was reported that the##2##4##(2008-11#1)(2010-7#1)
was reported that##6##3##(1990-9#1)(2006-8#1)(2008-11#2)(2010-7#1)(2012-12#1)
was reported to act as a##2##6##(1994-12#1)(2009-8#1)
was reported to be a##2##5##(1997-5#1)(2012-12#1)
was reported to be##19##4##(1995-12#1)(1996-12#1)(1996-8#1)(1997-5#1)(2005-7#1)(2005-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-12#1)(2012-1#1)(2012-11#1)(2012-12#2)(2013-8#1)
was reported to have##5##4##(1992-11#1)(2005-12#1)(2005-8#1)(2007-11#1)(2008-10#1)
was reported to increase##2##4##(1995-12#1)(2012-3#1)
was reported to##34##3##(1992-11#1)(1994-12#1)(1995-12#2)(1996-12#1)(1996-8#1)(1997-5#1)(2005-12#1)(2005-7#1)(2005-8#2)(2006-5#1)(2007-11#2)(2007-7#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-9#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-8#2)
was reported##181##2##(1990-12#2)(1990-4#1)(1990-6#2)(1990-9#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#2)(1992-11#2)(1992-6#1)(1993-5#2)(1993-6#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-12#3)(1995-2#2)(1995-6#2)(1996-1#1)(1996-12#2)(1996-3#3)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-5#1)(2004-12#1)(2004-9#1)(2005-11#1)(2005-12#1)(2005-4#1)(2005-7#1)(2005-8#3)(2006-10#4)(2006-2#2)(2006-5#1)(2006-6#1)(2006-8#3)(2007-10#3)(2007-11#8)(2007-12#1)(2007-2#2)(2007-7#2)(2007-8#6)(2008-1#3)(2008-10#15)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#8)(2012-2#7)(2012-3#2)(2013-1#3)(2013-8#5)
was reportedly##2##2##(2011-2#1)(2012-3#1)
was repositioned##2##2##(2006-8#2)
was representative of the##2##4##(1992-2#1)(2006-9#1)
was representative of##3##3##(1992-2#1)(2006-9#1)(2009-11#1)
was representative##4##2##(1992-2#1)(2004-11#1)(2006-9#1)(2009-11#1)
was represented by a##2##4##(2008-10#2)
was represented by the##2##4##(2008-7#1)(2009-2#1)
was represented by##6##3##(1994-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-2#1)
was represented in##3##3##(1992-12#1)(1992-3#1)(1995-11#1)
was represented##13##2##(1992-12#1)(1992-3#1)(1994-8#1)(1995-11#1)(2007-3#1)(2008-10#4)(2008-5#2)(2008-7#1)(2009-2#1)
was repressed by##5##3##(1990-1#1)(1992-11#1)(1994-2#1)(1994-8#1)(2008-3#1)
was repressed##7##2##(1990-1#1)(1992-11#1)(1994-2#1)(1994-8#1)(1997-4#1)(2008-11#1)(2008-3#1)
was reproduced by a second infusion##2##6##(1990-2#2)
was reproduced by a##3##4##(1990-2#2)(2009-4#1)
was reproduced by##4##3##(1990-2#2)(2007-8#1)(2009-4#1)
was reproduced##10##2##(1990-2#2)(1996-11#1)(1996-6#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-4#1)
was reproducible and##3##3##(1992-2#1)(2008-10#2)
was reproducible within##2##3##(2008-10#2)
was reproducible##6##2##(1990-11#1)(1992-2#1)(2008-10#4)
was reproducibly induced by##2##4##(2008-11#1)(2011-2#1)
was reproducibly##4##2##(1992-12#1)(2005-11#1)(2008-11#1)(2011-2#1)
was requested from##2##3##(2005-11#1)(2012-12#1)
was requested to##2##3##(1990-5#1)(2008-11#1)
was requested##5##2##(1990-5#1)(1996-3#1)(2005-11#1)(2008-11#1)(2012-12#1)
was required and##2##3##(1992-7#1)(2007-8#1)
was required as##2##3##(2008-10#1)(2008-11#1)
was required before##2##3##(1991-8#1)(1994-8#1)
was required due to##2##4##(2006-2#1)(2008-6#1)
was required for complete##2##4##(1994-12#1)(1996-2#1)
was required for growth##3##4##(1997-4#2)(2006-8#1)
was required for the##4##4##(1994-2#1)(1994-8#1)(1996-12#1)(2005-4#1)
was required for this##2##4##(1990-5#1)(1994-9#1)
was required for##36##3##(1990-5#2)(1991-4#1)(1992-12#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-4#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-4#2)(1997-6#1)(1997-7#1)(2005-4#1)(2006-10#1)(2006-8#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-6#2)(2009-10#1)(2011-2#1)(2012-3#1)
was required in the##4##4##(2008-1#1)(2008-10#1)(2009-11#1)(2010-10#1)
was required in this##2##4##(2007-8#1)(2008-10#1)
was required in##16##3##(1990-12#1)(1990-2#1)(1990-6#1)(1996-11#1)(1997-8#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#2)(2009-11#1)(2010-10#2)(2010-7#1)(2013-1#1)
was required to give##2##4##(1995-10#1)(2008-1#1)
was required to initiate##2##4##(1991-9#1)(1995-8#1)
was required to produce##2##4##(1990-12#1)(1991-7#1)
was required to reverse##2##4##(1990-2#1)(1996-8#1)
was required to##25##3##(1990-12#1)(1990-2#1)(1991-7#1)(1991-9#2)(1993-2#1)(1993-4#1)(1995-10#1)(1995-8#1)(1996-12#1)(1996-8#1)(1997-2#1)(2006-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-9#1)(2009-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
was required##119##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#2)(1990-6#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-7#1)(1993-2#1)(1993-4#1)(1994-12#2)(1994-2#2)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-10#1)(1995-11#1)(1995-2#2)(1995-4#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-8#4)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-4#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#4)(2008-1#2)(2008-10#19)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-10#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
was rescued by##3##3##(1995-2#1)(1996-3#1)(2008-3#1)
was rescued from##2##3##(1992-3#1)(1994-12#1)
was rescued##6##2##(1992-3#1)(1994-12#1)(1995-2#1)(1996-3#1)(2006-6#1)(2008-3#1)
was researched##3##2##(2012-3#1)(2013-8#2)
was resected and the##2##4##(2006-12#1)(2012-2#1)
was resected and##5##3##(2006-12#1)(2008-7#1)(2012-12#1)(2012-2#2)
was resected from##2##3##(1995-6#1)(2011-1#1)
was resected to##2##3##(2006-10#1)(2010-3#1)
was resected##34##2##(1991-9#3)(1992-9#1)(1995-3#1)(1995-6#1)(2005-5#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-8#8)(2008-6#2)(2008-7#3)(2010-12#3)(2010-3#1)(2010-5#1)(2011-1#2)(2012-12#2)(2012-2#2)
was resistant to all##6##4##(2007-6#1)(2008-10#2)(2008-5#1)(2009-3#1)(2009-5#1)
was resistant to cleavage##2##4##(1995-1#1)(1996-7#1)
was resistant to penicillin##2##4##(2007-8#1)(2008-12#1)
was resistant to the##4##4##(1992-6#1)(1993-12#1)(1994-12#1)(1995-2#1)
was resistant to##32##3##(1990-11#1)(1991-8#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#2)(1994-12#2)(1995-1#1)(1995-2#1)(1996-7#2)(1996-9#1)(2006-8#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2009-3#1)(2009-5#1)(2012-12#2)(2013-8#1)
was resistant##35##2##(1990-11#1)(1991-8#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#2)(1994-12#2)(1995-1#1)(1995-2#1)(1996-7#2)(1996-9#1)(2006-8#1)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2009-3#1)(2009-5#1)(2012-12#2)(2013-8#1)
was resolved by##6##3##(1991-12#1)(1992-7#1)(1993-3#1)(1997-4#1)(2007-8#1)(2008-10#1)
was resolved into##2##3##(1991-6#1)(2005-10#1)
was resolved##18##2##(1991-12#1)(1991-6#1)(1992-2#1)(1992-7#1)(1993-3#1)(1994-8#1)(1994-9#1)(1996-8#1)(1997-4#1)(2005-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
was respectively##6##2##(1991-8#1)(1995-6#1)(1996-10#1)(1997-6#1)(2008-10#1)(2011-2#1)
was responsible for generating##2##4##(2008-8#1)(2012-11#1)
was responsible for its##2##4##(1997-8#1)(2011-1#1)
was responsible for the##16##4##(1990-6#1)(1991-2#1)(1992-7#1)(1994-6#1)(2004-7#1)(2005-9#1)(2006-9#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-3#1)(2013-1#1)
was responsible for##44##3##(1990-6#1)(1991-2#2)(1991-4#1)(1992-7#1)(1993-5#1)(1994-11#1)(1994-6#1)(1996-2#1)(1997-5#1)(1997-6#1)(1997-8#2)(2004-7#1)(2005-9#1)(2006-10#1)(2006-3#1)(2006-9#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-5#3)(2008-7#1)(2008-8#2)(2009-5#1)(2011-1#1)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
was responsive to##2##3##(2008-8#1)(2011-9#1)
was responsive##3##2##(1990-8#1)(2008-8#1)(2011-9#1)
was restarted##2##2##(2009-6#1)(2012-2#1)
was restored and##2##3##(2007-11#1)(2007-8#1)
was restored by##11##3##(1991-5#2)(1992-3#1)(1993-12#1)(1996-4#1)(1997-2#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2011-3#1)
was restored in all##2##4##(2007-9#1)(2008-1#1)
was restored in the presence of##2##6##(1992-1#1)(1997-5#1)
was restored in the##3##4##(1992-1#1)(1997-3#1)(1997-5#1)
was restored in##8##3##(1992-1#1)(1997-3#1)(1997-5#1)(2007-9#1)(2008-1#1)(2008-11#1)(2012-3#2)
was restored to normal##2##4##(1997-4#1)(2011-2#1)
was restored to the##2##4##(1996-9#1)(2008-2#1)
was restored to##8##3##(1992-11#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-8#1)(2008-2#1)(2011-2#1)(2012-2#1)
was restored when##3##3##(2008-10#1)(2012-11#2)
was restored with a##3##4##(2013-1#3)
was restored with##10##3##(1994-2#1)(1997-8#1)(2007-11#1)(2012-12#1)(2012-3#1)(2013-1#5)
was restored##57##2##(1991-5#2)(1992-1#1)(1992-11#1)(1992-3#1)(1993-1#1)(1993-12#2)(1993-7#2)(1994-12#1)(1994-2#1)(1995-3#1)(1995-7#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#2)(2004-4#1)(2005-11#1)(2007-11#2)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#2)(2011-3#1)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#5)
was restricted by the##2##4##(2008-10#1)(2008-11#1)
was restricted by##4##3##(1991-12#1)(1995-1#1)(2008-10#1)(2008-11#1)
was restricted to a##3##4##(1997-1#1)(2007-7#1)(2013-8#1)
was restricted to the##16##4##(1990-11#1)(1991-12#1)(1991-9#1)(1992-8#1)(1994-2#1)(1995-6#1)(1995-8#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-8#1)(2012-3#1)(2013-7#1)
was restricted to##35##3##(1990-11#1)(1990-4#1)(1990-7#1)(1991-12#1)(1991-9#2)(1992-8#1)(1993-12#1)(1994-2#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-8#2)(2004-1#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-10#6)(2008-11#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
was restricted##50##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-7#1)(1991-12#2)(1991-9#2)(1992-7#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-7#1)(1995-1#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-6#1)(1997-8#2)(2004-1#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-10#11)(2008-11#3)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
was resumed##2##2##(1993-6#1)(1994-4#1)
was retained and##4##3##(1995-2#2)(2008-10#1)(2012-1#1)
was retained by the##3##4##(1992-6#1)(1994-3#1)(1997-4#1)
was retained by##5##3##(1992-6#1)(1993-1#1)(1994-3#1)(1997-4#1)(2008-10#1)
was retained in the##2##4##(2008-10#2)
was retained in##7##3##(1990-3#1)(1994-11#1)(1996-5#1)(2008-10#2)(2008-7#1)(2008-9#1)
was retained on##4##3##(1990-11#1)(1990-12#1)(1993-8#1)(1997-6#1)
was retained##35##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-3#1)(1995-2#2)(1995-3#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-1#1)
was retarded and##2##3##(1993-4#1)(2008-11#1)
was retarded by##2##3##(1994-3#1)(2008-10#1)
was retarded##9##2##(1990-5#1)(1990-8#1)(1991-4#1)(1993-4#1)(1994-3#1)(1995-12#1)(1996-10#1)(2008-10#1)(2008-11#1)
was retracted##2##2##(1990-7#1)(2008-10#1)
was retrieved by##2##3##(2007-7#1)(2008-3#1)
was retrieved from##3##3##(2006-10#1)(2008-10#1)(2008-3#1)
was retrieved##5##2##(2006-10#1)(2007-7#1)(2008-10#1)(2008-3#2)
was retrospective for##3##3##(2006-10#1)(2006-8#1)(2013-1#1)
was retrospective##6##2##(2006-10#1)(2006-8#1)(2007-11#1)(2009-9#1)(2012-3#1)(2013-1#1)
was retrospectively reviewed from##2##4##(2013-1#2)
was retrospectively reviewed##3##3##(2012-3#1)(2013-1#2)
was retrospectively##10##2##(1995-2#1)(2006-6#1)(2007-8#1)(2008-6#1)(2010-1#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
was returned to##3##3##(1993-12#1)(2007-8#1)(2008-10#1)
was revealed by##13##3##(1993-9#1)(1994-7#1)(1996-1#1)(2006-10#1)(2007-2#1)(2007-6#1)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-1#1)
was revealed in the##2##4##(2005-1#1)(2007-5#1)
was revealed in three##2##4##(2008-12#1)(2008-4#1)
was revealed in##13##3##(1990-7#1)(1992-8#1)(1993-9#1)(1994-2#1)(2005-1#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-9#1)(2008-12#1)(2008-4#1)(2008-7#1)
was revealed that the##9##4##(1997-8#1)(2005-11#3)(2007-10#1)(2008-10#1)(2008-12#1)(2009-12#1)(2009-3#1)
was revealed that##20##3##(1992-8#1)(1993-12#1)(1994-12#1)(1997-8#1)(2005-11#3)(2006-6#1)(2007-10#1)(2007-12#1)(2008-10#5)(2008-12#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)
was revealed to be##2##4##(1992-11#1)(1997-6#1)
was revealed to##4##3##(1992-11#1)(1992-7#1)(1997-4#1)(1997-6#1)
was revealed##83##2##(1990-5#1)(1990-7#1)(1990-8#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#2)(1993-12#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-7#1)(1995-5#1)(1996-1#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-1#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-4#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#11)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-12#2)(2012-2#2)(2013-7#1)
was reverse##2##2##(1991-11#1)(2013-1#1)
was reversed by the##7##4##(1991-8#1)(1991-9#1)(1992-7#1)(1996-12#1)(2007-10#1)(2008-10#1)(2008-7#1)
was reversed by##30##3##(1990-11#1)(1990-2#1)(1990-5#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-7#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-5#2)(1996-1#1)(1996-12#1)(1997-4#1)(2007-1#1)(2007-10#1)(2008-10#1)(2008-7#1)(2012-12#2)
was reversed in##4##3##(1993-2#1)(1996-10#1)(2012-3#2)
was reversed upon##3##3##(1991-12#1)(1992-4#1)(1997-7#1)
was reversed when##4##3##(1990-6#1)(1996-8#1)(2007-6#1)(2008-10#1)
was reversed##47##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#1)(1991-9#2)(1992-4#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-7#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-5#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-8#1)(1997-4#1)(1997-7#1)(2007-1#1)(2007-10#1)(2007-6#1)(2008-10#6)(2008-7#1)(2009-11#1)(2012-12#2)(2012-3#2)
was reversible after##2##3##(1995-7#1)(2006-10#1)
was reversible and the##2##4##(1990-4#1)(2008-10#1)
was reversible and##3##3##(1990-4#1)(1994-2#1)(2008-10#1)
was reversible by##2##3##(1991-2#1)(2009-3#1)
was reversible in##2##3##(1992-5#1)(2008-6#1)
was reversible upon##2##3##(1990-10#1)(1995-8#1)
was reversible##23##2##(1990-10#1)(1990-4#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-5#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-7#1)(1995-8#1)(2006-10#2)(2006-12#1)(2006-3#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-3#1)(2013-7#1)
was reversibly blocked by##2##4##(1990-7#1)(1995-3#1)
was reversibly inhibited by##2##4##(1991-12#1)(1992-1#1)
was reversibly##7##2##(1990-5#1)(1990-7#1)(1991-12#1)(1992-1#1)(1994-2#1)(1995-3#1)(2008-10#1)
was reviewed and##3##3##(1992-3#1)(2007-12#1)(2012-3#1)
was reviewed by##2##3##(2010-2#1)(2012-12#1)
was reviewed for##2##3##(2008-7#1)(2009-3#1)
was reviewed through##2##3##(2007-12#1)(2007-5#1)
was reviewed to##3##3##(2007-11#1)(2008-6#1)(2011-2#1)
was reviewed using##2##3##(2007-10#1)(2013-1#1)
was reviewed##25##2##(1991-12#1)(1992-3#1)(1994-2#1)(2004-10#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2008-12#1)(2008-6#2)(2008-7#2)(2009-3#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
was revised to##3##3##(2005-7#1)(2006-12#1)(2008-7#1)
was revised##8##2##(1993-6#1)(2005-3#1)(2005-7#1)(2006-12#1)(2007-10#1)(2008-7#1)(2009-8#1)(2011-12#1)
was rich in##4##3##(1990-4#1)(1995-6#1)(1997-8#1)(2007-1#1)
was rigidly##2##2##(2004-9#1)(2006-11#1)
was robust##6##2##(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
was robustly##2##2##(2012-12#1)(2013-7#1)
was rotated##4##2##(1993-6#1)(1997-5#1)(2008-11#1)(2012-12#1)
was rough##2##2##(2004-9#1)(2006-7#1)
was roughly##11##2##(1991-2#1)(1992-9#1)(1994-12#1)(1997-4#1)(1997-6#1)(2005-8#1)(2006-5#1)(2006-9#1)(2008-10#1)(2008-5#1)(2008-6#1)
was routine in##2##3##(1990-4#1)(1995-6#1)
was routinely##6##2##(1990-8#1)(1992-10#1)(2006-8#1)(2007-5#1)(2008-10#1)(2011-2#1)
was ruled out as##2##4##(1995-6#1)(2010-12#1)
was ruled out##10##3##(1995-2#1)(1995-6#1)(1995-8#1)(1996-6#1)(2005-1#1)(2005-11#1)(2009-3#1)(2010-12#2)(2013-1#1)
was run in##2##3##(1990-3#1)(2008-11#1)
was run on##2##3##(2011-2#1)(2013-1#1)
was run to##2##3##(2008-10#1)(2013-7#1)
was run##14##2##(1990-3#1)(1997-8#1)(2005-12#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
was sacrificed##2##2##(2008-7#1)(2008-9#1)
was safe and effective##3##4##(2008-12#1)(2010-8#1)(2012-12#1)
was safe and well tolerated##5##5##(2005-7#1)(2005-8#1)(2008-3#1)(2008-4#1)(2008-7#1)
was safe and##17##3##(2005-10#1)(2005-7#1)(2005-8#1)(2006-5#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2010-3#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
was safe##20##2##(2005-1#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-5#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2010-1#1)(2010-3#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
was safely##5##2##(2006-6#1)(2008-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
was said##2##2##(2012-12#1)(2012-3#1)
was same##2##2##(2011-2#1)(2012-12#1)
was sampled and##2##3##(2008-11#1)(2008-5#1)
was sampled by##2##3##(2007-10#1)(2008-5#1)
was sampled from##3##3##(1990-5#1)(2007-9#1)(2008-10#1)
was sampled##14##2##(1990-5#1)(1996-3#1)(1996-9#1)(2007-10#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-5#2)(2010-5#1)(2013-7#1)
was sandwiched between two##2##4##(2008-10#1)(2008-2#1)
was sandwiched between##3##3##(2008-10#1)(2008-2#1)(2009-2#1)
was sandwiched##4##2##(2008-10#1)(2008-2#2)(2009-2#1)
was satisfactorily applied to the determination of##6##7##(2008-10#6)
was satisfactorily applied to the##8##5##(1993-2#1)(2008-10#7)
was satisfactorily applied to##9##4##(1993-2#1)(2008-10#8)
was satisfactorily applied##10##3##(1993-2#1)(2008-10#9)
was satisfactorily##13##2##(1993-2#1)(2008-10#11)(2011-1#1)
was satisfactory and##2##3##(2006-6#1)(2013-1#1)
was satisfactory in both cases##3##5##(2008-10#1)(2011-2#2)
was satisfactory in##7##3##(1997-8#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-2#2)
was satisfactory##29##2##(1990-4#1)(1991-11#1)(1991-3#1)(1992-11#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-8#1)(2005-12#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-7#1)(2007-8#3)(2008-10#6)(2008-7#1)(2008-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
was satisfied##5##2##(2005-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-3#1)
was saturable and inhibited by##2##5##(1994-6#1)(1994-8#1)
was saturable and##7##3##(1990-2#1)(1990-5#1)(1992-12#3)(1994-6#1)(1994-8#1)
was saturable##12##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#1)(1992-12#3)(1992-9#1)(1993-8#1)(1994-6#1)(1994-8#1)
was saturated##3##2##(1990-5#2)(2008-2#1)
was saved##2##2##(2006-12#1)(2008-8#1)
was scaled to##2##3##(2006-11#1)(2008-7#1)
was scaled up and achieved##2##5##(2012-3#2)
was scaled up##4##3##(2005-8#1)(2008-11#1)(2012-3#2)
was scaled##6##2##(2005-8#1)(2006-11#1)(2008-11#1)(2008-7#1)(2012-3#2)
was scanned in##2##3##(2008-2#1)(2008-3#1)
was scanned over##2##3##(2008-2#1)(2008-3#1)
was scanned under##2##3##(2008-10#1)(2010-8#1)
was scanned##10##2##(2007-4#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-8#1)(2010-8#1)
was scanty##3##2##(1991-4#1)(2005-12#1)(2013-1#1)
was scarcely detected##2##3##(1994-12#1)(1995-11#1)
was scarcely observed##2##3##(1996-3#1)(2008-11#1)
was scarcely##6##2##(1993-12#1)(1994-12#1)(1995-11#1)(1996-3#1)(2008-11#1)(2008-5#1)
was scheduled for##2##3##(1996-9#1)(2013-7#1)
was scheduled to##2##3##(2007-8#1)(2008-5#1)
was scheduled##5##2##(1996-9#1)(2005-8#1)(2007-8#1)(2008-5#1)(2013-7#1)
was scored according to##4##4##(1994-3#1)(2006-6#1)(2008-10#1)(2008-6#1)
was scored by the##2##4##(2010-5#1)(2013-1#1)
was scored by##4##3##(1995-3#1)(2008-5#1)(2010-5#1)(2013-1#1)
was scored for the##2##4##(1996-9#1)(2011-2#1)
was scored on##2##3##(2006-10#1)(2008-10#1)
was scored##18##2##(1994-3#1)(1995-3#1)(1996-9#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#2)(2010-5#1)(2011-2#1)(2013-1#1)
was screened by##8##3##(1990-10#1)(1992-2#1)(1992-5#1)(1992-8#1)(1996-7#1)(2004-4#1)(2006-12#1)(2008-9#1)
was screened for##10##3##(1992-11#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(2006-1#1)(2008-10#3)
was screened in##2##3##(2008-8#1)(2008-9#1)
was screened out##2##3##(2008-8#2)
was screened to##3##3##(1996-11#1)(1996-7#1)(2008-7#1)
was screened using a##2##4##(1991-1#1)(1992-3#1)
was screened using##9##3##(1991-1#1)(1992-3#1)(1992-6#1)(1996-10#1)(2008-10#2)(2008-8#2)(2013-1#1)
was screened with a##6##4##(1990-8#1)(1991-12#1)(1991-9#1)(1993-7#1)(1994-9#1)(1997-1#1)
was screened with the##3##4##(1990-12#1)(1990-7#1)(1994-6#1)
was screened with##17##3##(1990-12#2)(1990-2#1)(1990-7#2)(1990-8#2)(1991-12#1)(1991-6#1)(1991-9#1)(1992-3#2)(1993-7#1)(1994-6#1)(1994-9#1)(1997-1#1)(2008-8#1)
was screened##58##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-6#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-7#2)(1997-1#1)(2004-4#1)(2006-1#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-7#1)(2008-8#6)(2008-9#2)(2013-1#1)(2013-8#2)
was scrutinized##3##2##(1996-12#1)(1996-2#1)(2011-1#1)
was searched for##6##3##(2005-5#1)(2008-1#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-1#1)
was searched##10##2##(2005-5#1)(2008-1#1)(2009-3#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
was secondary to##6##3##(1996-8#1)(2006-10#2)(2007-7#1)(2013-1#2)
was secondary##7##2##(1991-8#1)(1996-8#1)(2006-10#2)(2007-7#1)(2013-1#2)
was secreted and##3##3##(1990-11#1)(1991-5#1)(1992-10#1)
was secreted by##4##3##(1992-12#1)(1994-3#1)(2008-10#1)(2008-7#1)
was secreted in##3##3##(1995-1#1)(1995-8#1)(1997-2#1)
was secreted into the culture medium##6##6##(1993-3#1)(1993-9#1)(1996-11#1)(1996-3#1)(1997-4#2)
was secreted into the medium##4##5##(1990-3#1)(1991-9#2)(1996-9#1)
was secreted into the##11##4##(1990-3#1)(1991-9#2)(1993-3#1)(1993-9#2)(1996-11#1)(1996-3#1)(1996-9#1)(1997-4#2)
was secreted into##12##3##(1990-11#1)(1990-3#1)(1991-9#2)(1993-3#1)(1993-9#2)(1996-11#1)(1996-3#1)(1996-9#1)(1997-4#2)
was secreted to the##2##4##(1997-2#1)(2008-8#1)
was secreted via##2##3##(1996-4#1)(2008-10#1)
was secreted without##2##3##(1990-8#1)(2004-11#1)
was secreted##36##2##(1990-11#2)(1990-3#1)(1990-7#1)(1990-8#1)(1991-5#1)(1991-9#3)(1992-10#1)(1992-12#2)(1993-11#1)(1993-3#3)(1993-9#2)(1994-11#1)(1994-3#1)(1995-1#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-4#2)(2004-11#1)(2008-10#2)(2008-7#1)(2008-8#1)
was sectioned in##2##3##(2008-12#1)(2008-9#1)
was sectioned##4##2##(2008-12#1)(2008-9#1)(2009-4#1)(2013-1#1)
was secured in##2##3##(2005-5#1)(2010-4#1)
was secured##4##2##(2005-5#1)(2008-9#1)(2009-3#1)(2010-4#1)
was sedated##2##2##(2010-7#1)(2012-2#1)
was seedborne##2##2##(2008-10#2)
was seen 24##2##3##(1990-9#1)(1992-11#1)
was seen after the##2##4##(2007-10#1)(2007-12#1)
was seen after##13##3##(1990-2#1)(1991-5#1)(1991-8#1)(1994-5#1)(1996-2#1)(1997-2#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2010-11#1)(2013-7#1)
was seen among the##2##4##(1997-3#1)(2007-9#1)
was seen among those##2##4##(2006-8#1)(2007-8#1)
was seen among##7##3##(1997-3#1)(2006-8#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-5#1)
was seen and##2##3##(1997-6#1)(2007-8#1)
was seen as a##2##4##(2008-1#1)(2011-1#1)
was seen as an##3##4##(2007-8#1)(2008-10#1)(2012-12#1)
was seen as##12##3##(1991-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
was seen at concentrations of##2##5##(1991-3#1)(1996-5#1)
was seen at concentrations##3##4##(1991-3#1)(1996-5#1)(2008-5#1)
was seen at our##2##4##(1994-7#1)(1997-4#1)
was seen at the##4##4##(1996-5#1)(2006-10#1)(2008-10#1)(2010-3#1)
was seen at##25##3##(1990-10#1)(1990-12#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#1)(1992-12#2)(1994-5#1)(1994-7#1)(1995-2#1)(1996-5#2)(1997-4#1)(2005-7#1)(2006-10#2)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-6#1)(2010-3#1)(2010-8#1)
was seen between the two##2##5##(1993-7#1)(1993-9#1)
was seen between the##5##4##(1993-7#1)(1993-9#1)(2004-3#1)(2008-8#1)(2012-2#1)
was seen between##17##3##(1992-8#1)(1993-7#1)(1993-9#1)(1996-10#1)(1997-7#1)(2004-3#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-5#2)(2008-8#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
was seen both on##2##4##(2006-1#1)(2007-1#1)
was seen both##4##3##(1995-2#1)(2004-11#1)(2006-1#1)(2007-1#1)
was seen by##4##3##(1994-9#1)(2007-1#1)(2008-9#1)(2012-12#1)
was seen during##2##3##(1990-12#1)(2008-7#1)
was seen even in the##2##5##(1991-12#1)(1992-3#1)
was seen even##3##3##(1991-12#1)(1992-3#1)(1993-12#1)
was seen following##3##3##(1991-3#1)(1993-6#1)(1996-1#1)
was seen for##8##3##(1991-3#1)(1991-8#1)(1995-5#1)(1995-6#1)(1997-5#1)(2006-2#1)(2008-10#1)(2012-1#1)
was seen in 100%##2##4##(2012-3#1)(2013-1#1)
was seen in 12##2##4##(2006-2#1)(2008-3#1)
was seen in 2##2##4##(2007-7#1)(2007-8#1)
was seen in 28##2##4##(2007-8#1)(2011-2#1)
was seen in 3##2##4##(2007-7#1)(2007-8#1)
was seen in 34##2##4##(2008-1#2)
was seen in 4##3##4##(1996-2#1)(2007-8#1)(2008-8#1)
was seen in 6##8##4##(1991-3#1)(2006-4#1)(2007-7#3)(2012-2#2)(2013-8#1)
was seen in 64##2##4##(2007-12#1)(2011-2#1)
was seen in 8 patients##2##5##(1990-11#1)(2007-7#1)
was seen in 8##3##4##(1990-11#1)(2007-10#1)(2007-7#1)
was seen in a##3##4##(1995-6#1)(2007-7#1)(2010-10#1)
was seen in all##8##4##(1992-9#1)(1995-2#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-6#1)(2011-2#1)
was seen in both##2##4##(1996-12#1)(2007-7#1)
was seen in cells##2##4##(1994-8#1)(1995-8#1)
was seen in left##2##4##(1992-9#1)(2012-2#1)
was seen in one patient##2##5##(1994-12#1)(2008-7#1)
was seen in one##3##4##(1994-12#1)(2008-5#1)(2008-7#1)
was seen in only 2##2##5##(1994-7#1)(1997-8#1)
was seen in only##6##4##(1991-7#1)(1994-7#1)(1996-6#1)(1997-8#1)(2007-7#1)(2008-5#1)
was seen in patients with##4##5##(1991-3#1)(2007-10#1)(2007-9#1)(2008-7#1)
was seen in patients##6##4##(1991-3#1)(1992-4#1)(2006-10#1)(2007-10#1)(2007-9#1)(2008-7#1)
was seen in the surrounding##2##5##(1996-6#1)(2005-12#1)
was seen in the##32##4##(1990-12#1)(1992-11#1)(1992-9#1)(1993-6#1)(1994-12#1)(1996-12#4)(1996-6#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-12#2)(2006-11#1)(2006-9#2)(2007-7#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
was seen in three patients##3##5##(2004-1#1)(2007-1#1)(2013-8#1)
was seen in three##4##4##(1997-6#1)(2004-1#1)(2007-1#1)(2013-8#1)
was seen in##181##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-6#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#2)(1992-4#1)(1992-6#1)(1992-9#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-12#2)(1994-2#1)(1994-7#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-1#2)(1996-12#5)(1996-2#1)(1996-3#1)(1996-6#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#4)(2004-1#2)(2004-2#1)(2005-12#2)(2005-7#2)(2006-1#1)(2006-10#2)(2006-11#2)(2006-12#2)(2006-2#2)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#4)(2006-9#2)(2007-1#1)(2007-10#5)(2007-11#1)(2007-12#2)(2007-3#2)(2007-6#1)(2007-7#19)(2007-8#7)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2010-10#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#3)
was seen more##2##3##(2008-12#1)(2011-1#1)
was seen on the##2##4##(1990-2#1)(2008-6#1)
was seen on##8##3##(1990-11#1)(1990-2#1)(2006-10#1)(2006-12#1)(2007-4#1)(2007-9#1)(2008-6#1)(2013-8#1)
was seen that##8##3##(2006-4#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)
was seen throughout the##2##4##(2007-1#1)(2007-9#1)
was seen to be a##2##5##(2008-10#1)(2012-2#1)
was seen to be##6##4##(1996-4#1)(2006-1#1)(2008-10#1)(2008-8#1)(2011-1#1)(2012-2#1)
was seen to have##2##4##(2008-5#1)(2012-3#1)
was seen to##11##3##(1991-12#1)(1996-4#1)(2006-1#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-12#1)(2012-2#1)(2012-3#1)
was seen under##2##3##(1990-5#1)(1992-2#1)
was seen upon##2##3##(1994-12#1)(1995-12#1)
was seen when##2##3##(1994-11#1)(2008-10#1)
was seen with the##7##4##(1990-7#1)(1991-4#1)(1991-7#1)(1995-11#1)(1995-7#1)(2008-10#1)(2008-5#1)
was seen with##24##3##(1990-12#1)(1990-7#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1994-11#1)(1995-11#1)(1995-7#1)(1996-1#1)(1997-2#1)(2004-1#1)(2004-3#1)(2007-1#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#2)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
was seen##408##2##(1990-10#3)(1990-11#2)(1990-12#5)(1990-2#4)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#2)(1990-9#1)(1991-10#1)(1991-12#4)(1991-2#2)(1991-3#6)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#1)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#2)(1992-6#2)(1992-8#1)(1992-9#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#1)(1994-5#2)(1994-7#2)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#2)(1996-1#5)(1996-10#2)(1996-11#1)(1996-12#6)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#4)(1996-7#1)(1996-9#1)(1997-2#4)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#4)(2004-1#3)(2004-11#1)(2004-12#2)(2004-2#1)(2004-3#2)(2005-11#1)(2005-12#2)(2005-7#3)(2006-1#3)(2006-10#7)(2006-11#2)(2006-12#3)(2006-2#3)(2006-4#3)(2006-5#1)(2006-7#1)(2006-8#6)(2006-9#2)(2007-1#6)(2007-10#6)(2007-11#3)(2007-12#3)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#25)(2007-8#14)(2007-9#4)(2008-1#5)(2008-10#14)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#7)(2008-5#12)(2008-6#4)(2008-7#8)(2008-8#5)(2008-9#5)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-3#2)(2010-5#1)(2010-8#2)(2011-1#6)(2011-12#3)(2011-2#11)(2012-1#2)(2012-11#1)(2012-12#9)(2012-2#11)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#5)
was selected among##2##3##(2008-5#1)(2009-8#1)
was selected and further##2##4##(2006-11#1)(2009-10#1)
was selected and##7##3##(1994-12#1)(2005-11#1)(2006-11#1)(2006-4#1)(2008-10#1)(2009-10#1)(2011-2#1)
was selected as a potential##2##5##(1992-2#1)(1996-1#1)
was selected as a##9##4##(1992-2#1)(1992-5#1)(1996-1#1)(2008-10#2)(2008-5#1)(2013-1#2)(2013-8#1)
was selected as the##10##4##(1996-2#1)(2008-10#4)(2008-5#2)(2011-1#2)(2012-2#1)
was selected as##23##3##(1992-2#1)(1992-5#1)(1993-4#1)(1996-1#1)(1996-2#1)(2008-10#8)(2008-3#1)(2008-5#3)(2011-1#2)(2012-2#1)(2013-1#2)(2013-8#1)
was selected based on in vitro characteristics and used in vivo radiographic studies by incorporating barium sulphate##2##17##(2012-2#2)
was selected based on##4##4##(2009-3#1)(2012-2#2)(2013-1#1)
was selected because it##2##4##(2006-9#1)(2008-10#1)
was selected by##8##3##(1991-4#1)(1991-7#1)(1997-6#1)(2008-10#1)(2008-6#2)(2013-1#2)
was selected for a##2##4##(2007-7#1)(2008-5#1)
was selected for each##2##4##(1996-12#1)(2006-8#1)
was selected for further##5##4##(1992-5#1)(1992-7#1)(2008-9#1)(2009-6#1)(2012-2#1)
was selected for its##3##4##(1991-9#1)(2008-10#2)
was selected for study##2##4##(1990-11#1)(2008-9#1)
was selected for the determination of##3##6##(2008-10#3)
was selected for the##8##4##(2008-10#8)
was selected for##34##3##(1990-11#1)(1991-9#1)(1992-5#1)(1992-7#1)(1994-2#1)(1996-12#1)(2004-1#1)(2005-11#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-7#1)(2008-10#12)(2008-3#1)(2008-5#1)(2008-9#2)(2009-6#1)(2010-11#1)(2010-2#1)(2012-12#2)(2012-2#1)
was selected from a##3##4##(2006-11#1)(2008-10#1)(2013-8#1)
was selected from the##2##4##(2008-12#1)(2008-2#1)
was selected from##8##3##(1994-6#1)(2006-11#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2013-7#1)(2013-8#1)
was selected in##2##3##(2008-10#1)(2012-3#1)
was selected on the basis of its##2##7##(2008-10#1)(2008-3#1)
was selected on the basis of##5##6##(1996-11#1)(2005-8#1)(2008-10#1)(2008-3#1)(2010-3#1)
was selected that##2##3##(1997-7#1)(2008-10#1)
was selected to##9##3##(1991-2#1)(2004-8#1)(2007-4#1)(2007-9#1)(2008-3#1)(2008-5#2)(2008-6#1)(2012-12#1)
was selected##125##2##(1990-11#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-5#2)(1992-7#1)(1992-9#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-7#1)(2004-1#1)(2004-8#1)(2005-11#3)(2005-8#2)(2006-11#2)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#2)(2007-9#1)(2008-10#30)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#7)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-3#2)(2011-1#2)(2011-2#2)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#3)
was selective for##4##3##(1991-12#1)(1993-7#1)(1994-8#1)(2008-10#1)
was selective to##2##3##(1993-7#1)(2008-10#1)
was selective##13##2##(1991-12#1)(1992-9#1)(1993-7#2)(1994-8#1)(1996-4#1)(2008-1#1)(2008-10#4)(2011-3#2)
was selectively impaired##2##3##(1990-2#1)(1997-5#1)
was selectively inhibited by 5-HT3 receptor antagonists##2##7##(1993-11#2)
was selectively reduced##2##3##(1991-6#1)(1992-7#1)
was selectively##27##2##(1990-2#1)(1990-4#2)(1991-6#1)(1992-1#2)(1992-4#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-8#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-5#1)(1997-5#1)(2005-8#1)(2008-10#5)(2009-10#1)(2010-12#1)(2011-2#1)
was self-administered##2##2##(1994-12#1)(2008-10#1)
was sensed again##3##3##(2008-10#3)
was sensed by the##2##4##(2008-10#2)
was sensed by##3##3##(2008-10#3)
was sensed##7##2##(2008-10#7)
was sensitive and##4##3##(1993-12#1)(2007-11#1)(2008-10#1)(2008-5#1)
was sensitive enough to detect##2##5##(1997-1#1)(1997-4#1)
was sensitive enough to##4##4##(1997-1#1)(1997-2#1)(1997-4#1)(2013-7#1)
was sensitive to both##2##4##(1995-11#1)(2008-9#1)
was sensitive to the##5##4##(1994-3#1)(2007-11#1)(2008-10#1)(2009-6#2)
was sensitive to##41##3##(1990-11#2)(1990-2#2)(1991-2#1)(1991-4#1)(1991-9#2)(1992-4#1)(1993-3#3)(1993-9#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-11#1)(1996-2#1)(1996-6#1)(1997-5#1)(2007-10#1)(2007-11#2)(2008-10#6)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-6#2)(2010-2#1)(2010-3#1)
was sensitive##53##2##(1990-11#2)(1990-2#2)(1991-2#2)(1991-4#1)(1991-9#2)(1992-4#1)(1993-12#1)(1993-3#3)(1993-9#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-11#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(2007-10#1)(2007-11#4)(2008-10#9)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-6#2)(2010-2#1)(2010-3#1)(2013-7#1)
was sent to a##7##4##(1991-6#1)(1993-2#1)(1997-3#1)(2005-5#1)(2008-9#1)(2009-5#1)(2013-1#1)
was sent to all of the##2##6##(2005-8#1)(2006-8#1)
was sent to all##13##4##(1993-12#1)(1995-6#3)(1996-3#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-8#2)(2008-11#1)(2012-2#2)
was sent to general practitioners (GPs)##2##6##(2007-2#1)(2011-2#1)
was sent to the##6##4##(1994-1#1)(2005-10#1)(2006-12#1)(2007-12#1)(2007-7#1)(2013-1#1)
was sent to##52##3##(1990-2#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#2)(1994-1#1)(1994-4#1)(1995-6#3)(1996-1#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-10#1)(2005-5#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-8#2)(2007-12#1)(2007-2#4)(2007-7#2)(2007-9#2)(2008-1#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#2)
was sent##58##2##(1990-2#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#2)(1994-1#1)(1994-4#1)(1995-6#3)(1996-1#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-10#1)(2005-5#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-8#3)(2007-12#2)(2007-2#4)(2007-7#2)(2007-9#2)(2008-1#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#2)(2013-8#1)
was sentenced to##2##3##(1997-5#2)
was separated and##3##3##(2005-12#1)(2008-10#1)(2011-1#1)
was separated by a##2##4##(2005-12#1)(2007-2#1)
was separated by centrifugation and##2##5##(2008-10#1)(2008-5#1)
was separated by centrifugation##3##4##(1997-8#1)(2008-10#1)(2008-5#1)
was separated by the##2##4##(2005-4#1)(2011-1#1)
was separated by##16##3##(1993-4#1)(1993-9#1)(1996-5#2)(1996-9#1)(1997-8#1)(2005-12#1)(2005-4#1)(2007-2#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#1)(2011-1#1)
was separated from large##2##4##(2005-4#1)(2008-10#1)
was separated from sample##2##4##(2008-10#2)
was separated from the sample##2##5##(2008-10#1)(2008-5#1)
was separated from the##11##4##(1992-3#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-9#1)(2012-12#1)
was separated from##22##3##(1992-3#1)(1994-3#1)(1996-5#1)(1997-6#1)(2005-11#1)(2005-4#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#10)(2008-5#1)(2008-9#1)(2012-12#1)
was separated in##2##3##(2008-10#2)
was separated into##9##3##(1990-7#1)(1995-6#1)(1996-3#1)(1997-4#1)(2005-11#1)(2006-8#1)(2007-8#1)(2008-10#2)
was separated on a reversed-phase##2##5##(1993-2#1)(2008-10#1)
was separated on a##5##4##(1993-2#1)(2008-10#3)(2012-12#1)
was separated using##2##3##(1996-5#1)(2010-2#1)
was separated##67##2##(1990-7#1)(1992-3#1)(1993-2#1)(1993-4#1)(1993-9#1)(1994-3#1)(1995-6#1)(1996-3#1)(1996-5#5)(1996-9#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#2)(2005-12#2)(2005-4#3)(2006-8#1)(2007-12#1)(2007-2#2)(2007-8#3)(2008-10#25)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#2)(2010-2#1)(2011-1#2)(2012-12#2)
was separately##4##2##(1990-12#1)(2007-9#1)(2012-2#1)(2012-3#1)
was sequenced and analyzed##3##4##(1992-3#1)(1993-2#1)(2013-1#1)
was sequenced and found to##3##5##(1995-2#1)(1996-7#1)(2008-10#1)
was sequenced and identified as##2##5##(2008-10#2)
was sequenced and the amino acid sequence##2##7##(1991-9#1)(1994-9#1)
was sequenced and the##5##4##(1990-7#1)(1991-9#1)(1993-11#1)(1994-12#1)(1994-9#1)
was sequenced and##23##3##(1990-10#2)(1990-11#1)(1990-7#1)(1991-1#1)(1991-9#2)(1992-2#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-2#1)(1996-7#2)(2005-11#1)(2008-10#3)(2008-8#1)(2013-1#1)
was sequenced by##2##3##(1990-12#1)(1995-12#1)
was sequenced for##3##3##(2008-1#1)(2008-10#2)
was sequenced from##2##3##(2008-10#1)(2008-12#1)
was sequenced in##4##3##(1990-12#1)(1994-3#1)(2008-10#1)(2012-1#1)
was sequenced##53##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-7#2)(1991-1#1)(1991-2#1)(1991-7#1)(1991-9#3)(1992-2#1)(1992-3#1)(1993-11#2)(1993-2#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-5#1)(1996-7#2)(1997-2#1)(1997-9#1)(2005-11#1)(2008-1#1)(2008-10#11)(2008-12#1)(2008-5#1)(2008-8#1)(2012-1#1)(2012-11#1)(2013-1#1)
was sequestered##2##2##(2006-12#1)(2008-10#1)
was serially##3##2##(1990-9#1)(1997-8#1)(2011-2#1)
was serious##2##2##(1991-4#1)(1995-4#1)
was seriously##2##2##(1990-3#1)(2007-12#1)
was served##2##2##(2008-11#1)(2011-1#1)
was set at P &lt##2##5##(2008-10#1)(2010-1#1)
was set at p##2##4##(2005-10#1)(2013-1#1)
was set at##19##3##(1995-1#1)(1996-6#1)(2005-10#1)(2006-5#1)(2006-8#2)(2007-12#1)(2008-10#3)(2009-7#1)(2010-1#1)(2011-1#3)(2011-2#1)(2012-12#2)(2013-1#1)
was set in##2##3##(2008-3#1)(2008-5#1)
was set out##2##3##(2008-11#1)(2011-2#1)
was set to##7##3##(1990-9#1)(2007-12#1)(2008-8#1)(2010-6#1)(2010-9#1)(2012-3#1)(2013-1#1)
was set up and##2##4##(2008-10#1)(2008-3#1)
was set up based on the##2##6##(2008-10#1)(2013-1#1)
was set up for the##2##5##(2008-10#1)(2008-3#1)
was set up to investigate the##2##6##(1991-4#1)(2007-11#1)
was set up to##7##4##(1990-3#1)(1991-11#1)(1991-4#1)(1992-10#1)(2007-11#1)(2008-2#1)(2012-2#1)
was set up##22##3##(1990-3#1)(1991-11#1)(1991-4#1)(1992-10#1)(2007-11#2)(2008-10#4)(2008-2#1)(2008-3#3)(2008-7#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
was set##56##2##(1990-11#1)(1990-3#1)(1990-9#1)(1991-11#1)(1991-4#2)(1992-10#1)(1995-1#1)(1996-6#1)(2005-10#1)(2006-5#1)(2006-8#2)(2007-11#2)(2007-12#2)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#4)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
was setup##2##2##(2011-2#1)(2013-8#1)
was seven##3##2##(1993-10#1)(1995-3#1)(2008-3#1)
was several orders of magnitude##2##5##(1991-7#1)(2008-10#1)
was severe in##2##3##(1990-2#1)(2011-12#1)
was severe##12##2##(1990-2#1)(1993-5#1)(2004-12#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#2)(2009-10#1)(2010-12#1)(2011-12#1)(2012-12#1)
was severely compromised##2##3##(2011-2#1)(2012-2#1)
was severely damaged##2##3##(2008-10#1)(2011-12#1)
was severely impaired##4##3##(1996-3#1)(2008-10#2)(2009-4#1)
was severely inhibited##3##3##(1993-8#1)(1994-8#1)(2009-6#1)
was severely reduced##2##3##(1996-8#1)(2009-7#1)
was severely##21##2##(1992-9#1)(1993-8#1)(1994-8#1)(1996-3#1)(1996-8#1)(2004-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-6#1)(2009-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)
was shaped by##4##3##(2008-10#1)(2010-11#1)(2012-2#2)
was shaped##5##2##(2007-11#1)(2008-10#1)(2010-11#1)(2012-2#2)
was shared by##4##3##(1992-8#1)(2007-1#1)(2008-10#2)
was shared##5##2##(1992-8#1)(2007-1#1)(2008-10#2)(2012-12#1)
was shifted by##2##3##(1990-9#1)(1997-7#1)
was shifted from##2##3##(1994-3#1)(2008-11#1)
was shifted to a##3##4##(1991-9#1)(1995-6#1)(1995-8#1)
was shifted to the left##3##5##(1995-8#1)(2008-4#1)(2013-1#1)
was shifted to the right in the presence of##2##9##(1997-5#1)(2008-4#1)
was shifted to the right in##3##6##(1996-10#1)(1997-5#1)(2008-4#1)
was shifted to the right##5##5##(1990-12#1)(1990-5#1)(1996-10#1)(1997-5#1)(2008-4#1)
was shifted to the##9##4##(1990-12#1)(1990-5#1)(1995-8#1)(1996-10#1)(1997-5#1)(2008-4#2)(2010-5#1)(2013-1#1)
was shifted to##15##3##(1990-12#1)(1990-5#1)(1991-9#1)(1995-12#1)(1995-6#1)(1995-8#2)(1996-10#1)(1997-5#1)(2005-11#1)(2008-4#2)(2010-5#1)(2012-3#1)(2013-1#1)
was shifted##27##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-3#1)(1991-9#1)(1993-3#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-11#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
was short##5##2##(1996-12#1)(2007-12#1)(2008-10#1)(2009-4#1)(2011-2#1)
was shortened##9##2##(1990-5#1)(1991-2#1)(1991-4#1)(1992-3#1)(1992-5#1)(2006-9#1)(2008-1#1)(2008-2#1)(2013-8#1)
was shorter at##2##3##(1990-12#1)(2008-10#1)
was shorter for##2##3##(2004-11#1)(2007-6#1)
was shorter in##5##3##(1993-1#1)(1995-12#1)(2011-2#2)(2013-1#1)
was shorter than in##3##4##(1990-5#1)(1994-2#1)(2013-8#1)
was shorter than that of the##2##6##(1993-3#1)(2010-4#1)
was shorter than that of##4##5##(1993-3#1)(2006-12#1)(2010-4#1)(2010-8#1)
was shorter than##9##3##(1990-5#1)(1993-3#1)(1994-2#1)(2005-5#1)(2006-12#1)(2007-7#1)(2010-4#1)(2010-8#1)(2013-8#1)
was shorter##24##2##(1990-12#1)(1990-5#1)(1990-8#1)(1993-1#1)(1993-3#1)(1994-2#1)(1995-12#1)(2004-11#1)(2005-5#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-6#1)(2007-7#1)(2008-10#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#2)(2013-8#1)
was showed in##2##3##(2012-3#2)
was showed##9##2##(2005-11#1)(2005-4#1)(2008-10#2)(2012-2#1)(2012-3#3)(2013-8#1)
was shown after##3##3##(1994-6#1)(2008-11#1)(2008-7#1)
was shown as##2##3##(2008-7#1)(2008-8#1)
was shown at##3##3##(2005-11#1)(2008-10#2)
was shown between the##3##4##(2008-10#1)(2008-4#1)(2013-1#1)
was shown between##6##3##(1993-3#1)(1993-9#1)(2008-10#1)(2008-4#1)(2011-2#1)(2013-1#1)
was shown by X-ray##2##4##(2005-11#1)(2008-5#1)
was shown by gel##2##4##(1994-9#1)(1997-1#1)
was shown by nuclear##2##4##(1991-7#1)(1992-12#1)
was shown by the##7##4##(1990-12#1)(1991-7#1)(1992-5#1)(1996-4#1)(2007-1#1)(2008-10#2)
was shown by##55##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-7#1)(1991-3#2)(1991-7#3)(1992-1#1)(1992-10#1)(1992-12#1)(1992-5#2)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-5#3)(2008-9#2)(2009-7#1)(2010-12#1)(2013-1#2)
was shown for the first time##3##6##(1996-2#1)(2008-10#2)
was shown for##9##3##(1990-5#1)(1991-10#1)(1993-12#1)(1996-2#1)(2007-3#1)(2008-10#3)(2008-4#1)
was shown how the##2##4##(2008-10#1)(2008-3#1)
was shown in a##2##4##(1996-3#1)(2008-8#1)
was shown in all##2##4##(1992-9#1)(2006-8#1)
was shown in an##2##4##(2005-8#1)(2008-4#1)
was shown in the##4##4##(1990-12#1)(2006-10#1)(2010-4#1)(2013-1#1)
was shown in##24##3##(1990-10#1)(1990-12#1)(1991-1#1)(1991-7#1)(1991-9#1)(1992-9#1)(1996-3#1)(1996-5#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
was shown not only by##2##5##(1992-8#1)(2006-2#1)
was shown not only##3##4##(1992-8#1)(2006-2#1)(2011-2#1)
was shown not to be##2##5##(1990-11#1)(1991-2#1)
was shown not to##4##4##(1990-11#1)(1991-2#1)(2005-11#1)(2005-9#1)
was shown not##7##3##(1990-11#1)(1991-2#1)(1992-8#1)(2005-11#1)(2005-9#1)(2006-2#1)(2011-2#1)
was shown previously that##2##4##(1993-11#1)(1994-11#1)
was shown previously to be##2##5##(1991-2#1)(1996-12#1)
was shown previously to##6##4##(1991-2#1)(1993-8#1)(1994-10#1)(1995-5#1)(1996-12#1)(2007-6#1)
was shown previously##8##3##(1991-2#1)(1993-11#1)(1993-8#1)(1994-10#1)(1994-11#1)(1995-5#1)(1996-12#1)(2007-6#1)
was shown that a##4##4##(1990-3#1)(1996-1#1)(2008-8#1)(2012-2#1)
was shown that in##4##4##(1990-5#1)(2007-12#1)(2007-8#1)(2008-11#1)
was shown that only##3##4##(2008-10#1)(2008-11#1)(2013-7#1)
was shown that the##43##4##(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1997-7#1)(2005-11#1)(2006-8#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-2#1)(2009-3#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-7#1)
was shown that this##3##4##(2008-10#1)(2008-2#1)(2011-2#1)
was shown that##147##3##(1990-11#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-8#1)(1990-9#2)(1991-5#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-3#3)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-12#1)(2004-9#1)(2005-11#3)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#25)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#8)(2008-4#3)(2008-5#5)(2008-6#1)(2008-8#7)(2009-2#3)(2009-3#1)(2010-4#1)(2011-1#2)(2011-2#4)(2012-2#3)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#3)
was shown the##2##3##(2007-11#1)(2013-8#1)
was shown to act##2##4##(1993-12#1)(1994-12#1)
was shown to activate##3##4##(1995-2#1)(2008-7#1)(2010-8#1)
was shown to be 100%##2##5##(1996-12#1)(2006-8#1)
was shown to be a very##2##6##(1996-8#1)(2006-10#1)
was shown to be a##23##5##(1990-2#1)(1990-7#1)(1990-9#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-10#1)(1994-11#1)(1996-11#1)(1996-7#1)(1996-8#1)(2004-8#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#3)(2011-2#2)(2012-11#1)(2012-12#1)
was shown to be able to##3##6##(1990-3#1)(1994-9#1)(1996-8#1)
was shown to be an effective##2##6##(2005-11#1)(2005-8#1)
was shown to be an important##3##6##(1994-9#1)(2006-2#1)(2012-12#1)
was shown to be an##10##5##(1990-5#1)(1994-9#1)(1996-12#1)(2005-11#1)(2005-8#1)(2006-2#1)(2006-8#1)(2008-10#2)(2012-12#1)
was shown to be dependent on the##2##7##(1991-5#1)(2008-11#1)
was shown to be dependent on##3##6##(1990-11#1)(1991-5#1)(2008-11#1)
was shown to be dependent##4##5##(1990-11#1)(1991-5#1)(1992-6#1)(2008-11#1)
was shown to be different##2##5##(2008-10#1)(2009-12#1)
was shown to be due to##2##6##(2008-11#1)(2008-5#1)
was shown to be effective in##4##6##(2006-10#1)(2008-1#1)(2008-3#1)(2009-8#1)
was shown to be greater than##2##6##(1996-8#1)(2012-11#1)
was shown to be higher##2##5##(1996-1#1)(2008-11#1)
was shown to be highly##4##5##(1993-3#1)(1996-2#1)(1997-6#1)(2010-4#1)
was shown to be increased##2##5##(1992-8#1)(2008-5#1)
was shown to be lower##2##5##(2006-8#1)(2008-10#1)
was shown to be more##3##5##(2007-11#1)(2011-2#1)(2013-1#1)
was shown to be precise##2##5##(1990-11#1)(1996-11#1)
was shown to be present in##3##6##(1994-9#1)(1996-12#1)(2010-12#1)
was shown to be present##6##5##(1990-10#1)(1994-9#1)(1996-12#1)(1996-8#1)(2008-4#1)(2010-12#1)
was shown to be proportional to the##2##7##(1991-9#1)(2008-10#1)
was shown to be regulated by##2##6##(1993-8#1)(1997-2#1)
was shown to be responsible for##2##6##(1991-12#1)(2008-10#1)
was shown to be safe##2##5##(2008-5#1)(2009-4#1)
was shown to be significantly##3##5##(1996-7#1)(2006-8#1)(2009-1#1)
was shown to be similar to##2##6##(1994-11#1)(1997-8#1)
was shown to be stable##2##5##(2007-11#1)(2008-11#1)
was shown to be suitable for##2##6##(1990-12#1)(1997-8#1)
was shown to be superior to placebo##2##7##(2006-10#1)(2008-3#1)
was shown to be the major##2##6##(2008-11#1)(2008-7#1)
was shown to be the result of##2##7##(2008-10#1)(2008-3#1)
was shown to be the##8##5##(1990-4#1)(1990-9#1)(1996-12#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
was shown to be useful##2##5##(2008-10#1)(2008-2#1)
was shown to be##177##4##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#2)(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-12#1)(1992-3#1)(1992-6#2)(1992-7#1)(1992-8#4)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#4)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-11#3)(1996-12#5)(1996-2#3)(1996-5#1)(1996-7#2)(1996-8#5)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2004-8#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#4)(2007-1#2)(2007-11#2)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#23)(2008-11#5)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#6)(2008-7#1)(2008-8#1)(2009-1#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-12#3)(2010-4#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-11#2)(2012-12#3)(2013-1#1)
was shown to bind directly to##2##6##(1993-11#1)(1993-6#1)
was shown to bind to##2##5##(1995-12#1)(1997-1#1)
was shown to bind##10##4##(1990-10#1)(1991-1#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-11#1)(1995-12#2)(1997-1#1)
was shown to cause##3##4##(1990-11#1)(1997-6#1)(2008-5#1)
was shown to contain a##2##5##(1992-2#1)(1992-5#1)
was shown to contain an##2##5##(1992-3#1)(1994-11#1)
was shown to contain##8##4##(1991-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-12#1)(1994-11#1)(1995-8#1)
was shown to correlate with##2##5##(2011-1#1)(2013-1#1)
was shown to decrease##3##4##(2008-10#1)(2012-1#1)(2012-12#1)
was shown to depend on the##3##6##(1992-12#1)(1994-11#1)(2008-2#1)
was shown to eliminate the##2##5##(1997-7#1)(2008-10#1)
was shown to encode a##2##5##(1997-4#1)(2007-7#1)
was shown to enhance##2##4##(2007-11#1)(2007-8#1)
was shown to exist##2##4##(1995-8#1)(2008-9#1)
was shown to extend##2##4##(2008-1#1)(2008-10#1)
was shown to form##2##4##(1991-6#1)(2006-12#1)
was shown to function##2##4##(1993-3#1)(1994-12#1)
was shown to give##3##4##(2008-10#1)(2008-2#1)(2009-2#1)
was shown to have a##8##5##(1991-5#1)(1991-7#1)(1993-4#1)(1994-5#1)(2006-6#1)(2006-8#1)(2008-10#1)(2010-4#1)
was shown to have the##2##5##(1993-6#1)(2008-10#1)
was shown to have##20##4##(1990-12#2)(1990-5#1)(1991-5#1)(1991-7#1)(1993-4#1)(1993-6#1)(1994-5#1)(1994-6#1)(1995-7#1)(1996-7#1)(1997-8#1)(2006-6#1)(2006-7#2)(2006-8#1)(2008-10#3)(2010-4#1)
was shown to increase the##2##5##(2008-2#1)(2012-1#1)
was shown to increase with##2##5##(2007-1#1)(2008-7#1)
was shown to increase##8##4##(2005-8#1)(2007-1#1)(2008-2#2)(2008-7#1)(2010-12#1)(2012-1#1)(2012-12#1)
was shown to induce##3##4##(1996-5#1)(2008-3#1)(2008-8#1)
was shown to inhibit the##3##5##(1997-8#1)(2008-11#1)(2012-11#1)
was shown to inhibit##7##4##(1990-10#1)(1990-2#1)(1995-1#1)(1997-8#1)(2008-11#1)(2009-8#1)(2012-11#1)
was shown to occur##3##4##(1996-5#1)(2008-10#2)
was shown to possess##2##4##(2005-7#1)(2010-12#1)
was shown to potentiate##2##4##(1996-5#1)(2010-12#1)
was shown to prevent##2##4##(1994-11#1)(2010-8#1)
was shown to proceed by##2##5##(1990-12#2)
was shown to proceed##3##4##(1990-12#2)(1995-3#1)
was shown to produce##7##4##(1992-5#1)(1993-3#1)(1993-9#1)(1997-7#1)(2007-12#1)(2008-9#1)(2011-1#1)
was shown to provide##5##4##(2008-2#1)(2008-7#1)(2008-9#1)(2009-1#1)(2011-1#1)
was shown to recognize##2##4##(1992-8#1)(1994-12#1)
was shown to reduce the##2##5##(2008-5#1)(2010-12#1)
was shown to reduce##5##4##(1997-8#1)(2008-5#2)(2008-8#1)(2010-12#1)
was shown to significantly reduce##2##5##(2007-2#1)(2008-3#1)
was shown to stimulate##2##4##(1996-8#1)(1997-1#1)
was shown to##354##3##(1990-1#1)(1990-10#3)(1990-11#3)(1990-12#6)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#2)(1990-9#3)(1991-1#3)(1991-12#1)(1991-2#2)(1991-5#5)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#4)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#4)(1992-6#2)(1992-7#2)(1992-8#6)(1992-9#1)(1993-11#2)(1993-12#3)(1993-3#4)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#8)(1994-12#4)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#5)(1995-1#3)(1995-12#5)(1995-2#4)(1995-3#5)(1995-4#2)(1995-6#2)(1995-7#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#6)(1996-2#3)(1996-5#5)(1996-7#3)(1996-8#8)(1997-1#4)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#3)(1997-7#4)(1997-8#6)(2004-11#1)(2004-8#1)(2004-9#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#4)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#5)(2007-1#3)(2007-11#4)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#38)(2008-11#8)(2008-2#6)(2008-3#6)(2008-4#1)(2008-5#9)(2008-7#5)(2008-8#4)(2008-9#3)(2009-1#2)(2009-12#1)(2009-2#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-8#3)(2010-12#7)(2010-4#2)(2010-8#2)(2011-1#6)(2011-2#5)(2012-1#3)(2012-11#3)(2012-12#5)(2013-1#3)
was shown using##2##3##(1992-4#1)(1994-12#1)
was shown##670##2##(1990-1#1)(1990-10#7)(1990-11#7)(1990-12#10)(1990-2#4)(1990-3#2)(1990-4#2)(1990-5#7)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#5)(1991-1#4)(1991-10#1)(1991-12#1)(1991-2#4)(1991-3#2)(1991-5#7)(1991-6#2)(1991-7#7)(1991-8#2)(1991-9#7)(1992-1#1)(1992-10#1)(1992-12#5)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#6)(1992-6#3)(1992-7#3)(1992-8#8)(1992-9#3)(1993-11#4)(1993-12#4)(1993-2#1)(1993-3#6)(1993-4#2)(1993-6#2)(1993-8#3)(1993-9#4)(1994-10#2)(1994-11#11)(1994-12#6)(1994-2#3)(1994-3#6)(1994-5#2)(1994-6#4)(1994-8#3)(1994-9#8)(1995-1#3)(1995-12#8)(1995-2#5)(1995-3#7)(1995-4#2)(1995-5#4)(1995-6#3)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#2)(1996-11#3)(1996-12#9)(1996-2#5)(1996-3#2)(1996-4#1)(1996-5#8)(1996-7#3)(1996-8#8)(1997-1#6)(1997-2#3)(1997-3#4)(1997-4#2)(1997-6#4)(1997-7#5)(1997-8#8)(2004-11#1)(2004-12#1)(2004-8#1)(2004-9#2)(2005-11#7)(2005-7#2)(2005-8#3)(2005-9#2)(2006-1#1)(2006-10#7)(2006-12#4)(2006-2#3)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#8)(2007-1#5)(2007-11#7)(2007-12#7)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#3)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#6)(2008-10#77)(2008-11#18)(2008-12#2)(2008-2#8)(2008-3#16)(2008-4#7)(2008-5#18)(2008-6#1)(2008-7#9)(2008-8#17)(2008-9#8)(2009-1#2)(2009-12#1)(2009-2#6)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-12#9)(2010-4#4)(2010-8#2)(2011-1#10)(2011-2#12)(2012-1#3)(2012-11#3)(2012-12#7)(2012-2#4)(2012-3#3)(2013-1#13)(2013-7#3)(2013-8#5)
was significant (P &lt##3##4##(1997-8#1)(2008-10#2)
was significant (P = 0##2##5##(2008-10#1)(2008-6#1)
was significant (P##5##3##(1997-8#1)(2008-10#3)(2008-6#1)
was significant (P&lt##2##3##(2008-7#1)(2009-3#1)
was significant (p &lt##4##4##(2007-2#1)(2007-8#1)(2008-3#1)(2012-2#1)
was significant (p&lt##2##3##(2007-7#1)(2010-2#1)
was significant and##2##3##(2009-4#1)(2012-3#1)
was significant association between##3##4##(2009-7#1)(2011-1#2)
was significant at the##5##4##(1995-5#1)(1996-5#1)(2004-4#2)(2006-5#1)
was significant at##13##3##(1995-5#1)(1996-5#1)(1996-8#1)(2004-4#2)(2006-5#1)(2006-7#1)(2007-2#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
was significant correlation of##3##4##(2006-8#1)(2008-10#2)
was significant correlation##5##3##(2006-8#1)(2008-10#3)(2009-10#1)
was significant decrease in##2##4##(2007-7#1)(2007-9#1)
was significant decrease##3##3##(2007-7#1)(2007-9#1)(2011-2#1)
was significant for##8##3##(1995-12#1)(2007-3#1)(2008-4#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)
was significant improvement##2##3##(2008-9#2)
was significant in both##2##4##(2008-10#1)(2012-2#1)
was significant in the##3##4##(1992-4#1)(2008-3#1)(2012-3#1)
was significant in##14##3##(1990-11#1)(1992-4#1)(1993-12#1)(1993-4#1)(2008-10#3)(2008-3#2)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#2)
was significant only for##4##4##(2006-7#1)(2007-4#1)(2009-7#1)(2010-12#1)
was significant only##6##3##(1994-12#1)(2004-1#1)(2006-7#1)(2007-4#1)(2009-7#1)(2010-12#1)
was significant##131##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-6#1)(1991-3#1)(1991-8#1)(1992-4#1)(1992-6#2)(1993-1#1)(1993-12#1)(1993-4#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-5#2)(1996-8#1)(1997-7#1)(1997-8#1)(2004-1#1)(2004-4#2)(2005-10#1)(2006-12#1)(2006-5#1)(2006-7#2)(2006-8#1)(2007-10#1)(2007-2#4)(2007-3#2)(2007-4#1)(2007-7#5)(2007-8#1)(2007-9#1)(2008-10#16)(2008-11#1)(2008-12#3)(2008-3#6)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#6)(2009-10#1)(2009-3#2)(2009-4#2)(2009-7#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#6)(2011-12#1)(2011-2#6)(2011-3#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#2)(2013-8#1)
was significantly (P &lt##24##4##(1994-2#1)(1996-12#3)(1997-2#2)(1997-8#1)(2004-11#1)(2007-8#1)(2008-1#1)(2008-10#7)(2009-5#6)(2010-7#1)
was significantly (P = 0##4##5##(1996-8#2)(2005-10#1)(2008-10#1)
was significantly (P =##5##4##(1996-8#2)(2005-10#1)(2008-10#1)(2008-8#1)
was significantly (P##30##3##(1990-4#1)(1994-2#1)(1996-12#3)(1996-8#2)(1997-2#2)(1997-8#1)(2004-11#1)(2005-10#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-8#1)(2009-5#6)(2010-7#1)
was significantly (P&lt##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
was significantly (p &lt##7##4##(1993-3#1)(2007-8#2)(2008-11#1)(2008-3#1)(2009-5#2)
was significantly (p = 0##2##5##(1991-5#1)(2008-12#1)
was significantly (p##9##3##(1991-5#1)(1993-3#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-3#1)(2009-5#2)
was significantly (p&lt##4##3##(2008-12#1)(2010-4#1)(2013-1#1)(2013-8#1)
was significantly [P &lt##3##4##(2008-4#2)(2009-5#1)
was significantly accelerated by##3##4##(1993-4#1)(2006-5#1)(2008-4#1)
was significantly accelerated##4##3##(1993-4#1)(1996-5#1)(2006-5#1)(2008-4#1)
was significantly affected by the##2##5##(1995-8#1)(2011-1#1)
was significantly affected by##6##4##(1995-8#1)(2008-10#1)(2008-12#1)(2010-2#1)(2011-1#1)(2011-2#1)
was significantly affected##10##3##(1995-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#1)(2010-11#1)(2010-2#2)(2011-1#1)(2011-2#1)
was significantly altered##2##3##(1996-12#1)(2010-12#1)
was significantly amplified##2##3##(1991-12#1)(2011-12#1)
was significantly and##4##3##(2006-10#1)(2006-12#1)(2008-10#2)
was significantly antagonized by##2##4##(1991-3#1)(1996-12#1)
was significantly associated with a##5##5##(1997-4#1)(2007-8#2)(2011-11#1)(2013-8#1)
was significantly associated with an increased##2##6##(2007-2#1)(2012-1#1)
was significantly associated with an##3##5##(2007-2#1)(2008-12#1)(2012-1#1)
was significantly associated with chronic bronchitis##2##6##(2013-1#2)
was significantly associated with fewer##2##5##(2011-1#1)(2012-2#1)
was significantly associated with lower##2##5##(2008-4#1)(2013-1#1)
was significantly associated with reduced##2##5##(2008-10#2)
was significantly associated with the##5##5##(1990-4#1)(1996-11#1)(2011-1#1)(2011-2#1)(2012-12#1)
was significantly associated with##58##4##(1990-4#1)(1990-9#2)(1995-11#1)(1996-11#1)(1997-2#1)(1997-4#1)(2006-6#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-10#1)(2010-12#1)(2011-1#3)(2011-11#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#7)(2013-8#4)
was significantly associated##63##3##(1990-4#1)(1990-9#2)(1991-6#1)(1995-11#1)(1996-11#1)(1997-2#1)(1997-4#1)(2006-6#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#1)(2009-4#2)(2009-5#2)(2009-7#1)(2010-10#1)(2010-12#1)(2011-1#3)(2011-11#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#7)(2013-8#4)
was significantly attenuated by##4##4##(1990-9#1)(1991-5#1)(1993-3#1)(1994-9#1)
was significantly attenuated##6##3##(1990-9#1)(1991-5#1)(1993-3#1)(1994-9#1)(1996-12#1)(1997-7#1)
was significantly better for##2##4##(1994-2#1)(2007-9#1)
was significantly better in the##3##5##(1995-9#1)(2006-8#1)(2007-6#1)
was significantly better in##5##4##(1995-9#1)(2006-8#1)(2007-10#1)(2007-6#1)(2008-2#1)
was significantly better than the##2##5##(2008-10#1)(2010-3#1)
was significantly better than##4##4##(2007-12#1)(2008-10#1)(2008-4#1)(2010-3#1)
was significantly better##17##3##(1991-6#1)(1992-8#1)(1994-2#1)(1995-9#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2010-3#1)(2013-7#1)
was significantly blocked by##2##4##(1995-11#1)(1996-2#1)
was significantly correlated to##4##4##(1990-4#1)(1994-6#1)(2008-3#1)(2012-2#1)
was significantly correlated with the presence of##2##7##(2011-2#1)(2013-1#1)
was significantly correlated with the##13##5##(1992-1#1)(1996-5#1)(1997-2#1)(2005-8#1)(2008-10#2)(2008-5#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-5#1)(2013-1#1)(2013-8#1)
was significantly correlated with##34##4##(1990-10#1)(1990-8#1)(1991-8#1)(1992-1#1)(1993-12#1)(1995-3#1)(1995-4#1)(1996-5#1)(1997-2#1)(1997-8#1)(2005-8#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-5#2)(2008-6#1)(2008-7#1)(2010-3#1)(2010-7#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-5#1)(2012-7#1)(2013-1#1)(2013-8#1)
was significantly correlated##38##3##(1990-10#1)(1990-4#1)(1990-8#1)(1991-8#1)(1992-1#1)(1993-12#1)(1994-6#1)(1995-3#1)(1995-4#1)(1996-5#1)(1997-2#1)(1997-8#1)(2005-8#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-3#1)(2010-7#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-5#1)(2012-7#1)(2013-1#1)(2013-8#1)
was significantly decreased (P &lt##3##5##(1993-2#1)(2008-10#1)(2009-5#1)
was significantly decreased after##3##4##(1995-12#1)(1995-5#1)(2005-11#1)
was significantly decreased as compared to##2##6##(1992-9#1)(2009-5#1)
was significantly decreased as compared##3##5##(1992-9#1)(1995-12#1)(2009-5#1)
was significantly decreased as##4##4##(1992-9#1)(1993-2#1)(1995-12#1)(2009-5#1)
was significantly decreased at##2##4##(1994-11#1)(1995-12#1)
was significantly decreased by##5##4##(1993-3#2)(1995-12#1)(1996-2#1)(2008-5#1)
was significantly decreased compared to##2##5##(1993-1#1)(2004-9#1)
was significantly decreased from##3##4##(1996-2#1)(2008-6#1)(2013-1#1)
was significantly decreased in patients with##2##6##(2007-9#1)(2008-7#1)
was significantly decreased in the##4##5##(1996-9#1)(2008-4#1)(2008-7#2)
was significantly decreased in##13##4##(1995-4#1)(1996-9#1)(1997-2#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#3)(2010-4#1)(2011-2#1)(2013-7#1)
was significantly decreased on##2##4##(1994-2#1)(2013-1#1)
was significantly decreased only in the##2##6##(1994-2#1)(2011-2#1)
was significantly decreased##53##3##(1990-4#1)(1990-9#1)(1992-9#1)(1993-1#1)(1993-2#2)(1993-3#2)(1994-11#1)(1994-2#2)(1995-12#4)(1995-4#1)(1995-5#2)(1996-2#2)(1996-9#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-9#1)(2005-11#1)(2006-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-5#2)(2009-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#3)(2013-1#2)(2013-7#2)(2013-8#1)
was significantly delayed in##2##4##(1993-7#1)(2011-2#1)
was significantly delayed##4##3##(1993-7#1)(1997-3#2)(2011-2#1)
was significantly depressed##2##3##(1990-7#1)(1991-9#1)
was significantly different (P &lt##2##5##(2008-10#1)(2011-1#1)
was significantly different (P##3##4##(2008-10#1)(2011-1#1)(2012-2#1)
was significantly different (P&lt##2##4##(2008-10#1)(2012-12#1)
was significantly different (p &lt##2##5##(1994-3#1)(2008-3#1)
was significantly different between the##3##5##(2008-10#2)(2008-5#1)
was significantly different between treatments##2##5##(2011-12#2)
was significantly different between##6##4##(2008-10#3)(2008-5#1)(2011-12#2)
was significantly different from zero##2##5##(2008-10#2)
was significantly different from##7##4##(1994-8#1)(2008-10#3)(2011-2#1)(2012-2#1)(2013-7#1)
was significantly different in the##2##5##(2006-9#1)(2011-1#1)
was significantly different in##6##4##(1993-6#1)(2006-9#1)(2008-12#2)(2011-1#1)(2012-12#1)
was significantly different##37##3##(1993-6#1)(1994-3#1)(1994-8#1)(1996-12#1)(1997-8#1)(2006-9#1)(2007-12#1)(2007-4#1)(2008-10#8)(2008-12#3)(2008-3#1)(2008-5#3)(2008-7#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-12#2)(2011-2#1)(2012-12#2)(2012-2#2)(2013-7#1)
was significantly diminished##3##3##(1993-9#1)(1994-2#1)(1997-3#1)
was significantly down-regulated##3##3##(2008-11#1)(2008-7#1)(2013-8#1)
was significantly effective##2##3##(2005-8#1)(2012-2#1)
was significantly elevated in the##2##5##(1996-12#1)(2008-10#1)
was significantly elevated in##6##4##(1993-12#1)(1996-12#2)(2007-11#1)(2008-10#1)(2008-2#1)
was significantly elevated##15##3##(1992-9#1)(1993-12#2)(1994-3#1)(1996-12#2)(1997-2#1)(2005-7#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-6#1)
was significantly enhanced by the##4##5##(1995-12#1)(2007-12#1)(2008-10#1)(2008-11#1)
was significantly enhanced by##7##4##(1990-5#1)(1994-9#1)(1995-12#1)(2007-12#1)(2008-10#2)(2008-11#1)
was significantly enhanced in the##2##5##(1993-9#1)(2008-10#1)
was significantly enhanced in##3##4##(1993-9#1)(1996-7#1)(2008-10#1)
was significantly enhanced##17##3##(1990-5#1)(1993-3#1)(1993-9#2)(1994-9#1)(1995-12#1)(1996-7#1)(1996-9#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)
was significantly faster than##2##4##(2007-2#1)(2008-10#1)
was significantly faster##3##3##(2005-8#1)(2007-2#1)(2008-10#1)
was significantly greater (P &lt##2##5##(1997-8#1)(2008-10#1)
was significantly greater after##2##4##(2006-9#1)(2007-11#1)
was significantly greater for##5##4##(1993-9#1)(1995-2#1)(1997-4#1)(2009-7#1)(2013-1#1)
was significantly greater in the##15##5##(1992-8#1)(1992-9#1)(1994-7#1)(1996-10#1)(1996-5#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#3)(2011-2#2)(2012-12#1)
was significantly greater in##25##4##(1992-12#1)(1992-8#1)(1992-9#1)(1994-7#1)(1995-5#1)(1996-10#1)(1996-5#1)(2004-2#1)(2006-2#1)(2007-10#2)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2011-2#2)(2012-12#1)
was significantly greater than in##2##5##(1991-8#1)(2006-2#1)
was significantly greater than that in##3##6##(2008-5#1)(2008-9#2)
was significantly greater than that of##2##6##(1996-12#1)(2008-10#1)
was significantly greater than that##8##5##(1991-9#1)(1996-12#1)(2006-11#1)(2008-10#1)(2008-5#1)(2008-9#2)(2013-8#1)
was significantly greater than the##6##5##(1995-3#1)(1995-5#1)(1996-2#1)(2006-12#1)(2010-9#1)(2013-7#1)
was significantly greater than##26##4##(1991-8#1)(1991-9#1)(1992-10#2)(1992-5#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-2#1)(2006-11#1)(2006-12#1)(2006-2#1)(2007-6#1)(2008-10#3)(2008-5#2)(2008-9#2)(2010-9#1)(2011-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
was significantly greater with##2##4##(1994-6#1)(2007-4#1)
was significantly greater##70##3##(1991-5#1)(1991-8#1)(1991-9#2)(1992-10#2)(1992-12#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-5#1)(1993-9#1)(1994-6#1)(1994-7#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-2#1)(2006-11#1)(2006-12#1)(2006-2#2)(2006-9#1)(2007-10#2)(2007-11#1)(2007-4#2)(2007-6#1)(2007-8#1)(2008-10#8)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#3)(2008-9#3)(2009-7#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#1)
was significantly high (P &lt##3##5##(2007-6#2)(2012-2#1)
was significantly high##7##3##(1995-3#1)(2007-6#2)(2007-8#1)(2008-11#1)(2012-2#1)(2012-3#1)
was significantly higher (0##2##4##(1997-3#1)(2007-8#1)
was significantly higher (P &lt##11##5##(1992-12#1)(1996-1#1)(1996-12#1)(1997-6#1)(2006-5#1)(2007-1#1)(2007-6#1)(2007-7#1)(2008-10#3)
was significantly higher (p &lt##4##5##(1997-7#1)(2005-12#1)(2007-9#1)(2008-6#1)
was significantly higher (p##5##4##(1993-11#1)(1997-7#1)(2005-12#1)(2007-9#1)(2008-6#1)
was significantly higher (p&lt##2##4##(2006-6#1)(2013-8#1)
was significantly higher among patients##3##5##(1995-9#1)(2011-2#1)(2013-1#1)
was significantly higher among the##3##5##(1990-6#1)(2012-2#1)(2013-1#1)
was significantly higher among##19##4##(1990-6#1)(1991-8#1)(1993-10#1)(1994-5#1)(1995-9#1)(1996-2#1)(1996-5#1)(1997-1#2)(2006-2#2)(2007-3#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
was significantly higher and##3##4##(1992-1#1)(1994-4#1)(2009-10#1)
was significantly higher as compared##2##5##(1993-4#1)(2007-9#1)
was significantly higher at##5##4##(1995-12#1)(2006-10#1)(2006-2#1)(2008-10#2)
was significantly higher for those##2##5##(1997-8#1)(2008-7#1)
was significantly higher for##12##4##(1990-4#1)(1992-12#1)(1997-2#1)(1997-8#1)(2006-4#1)(2007-5#1)(2007-7#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)
was significantly higher in Group##2##5##(2011-1#1)(2013-7#1)
was significantly higher in cases##2##5##(1990-12#1)(1997-8#1)
was significantly higher in group A##2##6##(2007-2#1)(2007-8#1)
was significantly higher in group##4##5##(1993-4#1)(2007-2#2)(2007-8#1)
was significantly higher in males than in females##2##8##(2008-11#1)(2009-3#1)
was significantly higher in males##3##5##(2008-11#1)(2009-3#1)(2011-2#1)
was significantly higher in patients than in##2##7##(2007-2#1)(2008-6#1)
was significantly higher in patients who##2##6##(1991-8#1)(1993-12#1)
was significantly higher in patients with##6##6##(1992-12#1)(2007-7#1)(2008-5#1)(2009-2#1)(2010-4#1)(2013-1#1)
was significantly higher in patients##11##5##(1991-6#1)(1991-8#1)(1992-12#1)(1993-12#1)(2007-2#1)(2007-7#1)(2008-5#1)(2008-6#1)(2009-2#1)(2010-4#1)(2013-1#1)
was significantly higher in studies conducted using##2##7##(2008-10#2)
was significantly higher in the 0##2##6##(2007-8#1)(2012-2#1)
was significantly higher in the patients with##2##7##(1990-3#1)(2007-8#1)
was significantly higher in the second##2##6##(2007-11#1)(2008-6#1)
was significantly higher in the##42##5##(1990-3#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-8#1)(1992-2#1)(1992-3#1)(1993-1#1)(1995-10#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-2#2)(2006-2#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-3#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
was significantly higher in women##3##5##(1991-3#1)(2008-3#1)(2011-2#1)
was significantly higher in##127##4##(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-10#1)(1995-5#1)(1996-12#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-8#1)(2006-2#2)(2006-5#1)(2006-6#2)(2007-10#1)(2007-11#1)(2007-2#3)(2007-7#3)(2007-8#7)(2007-9#1)(2008-10#12)(2008-11#4)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-2#1)(2009-3#2)(2009-4#1)(2010-12#1)(2010-4#2)(2010-9#1)(2011-1#3)(2011-2#6)(2012-1#2)(2012-2#3)(2012-3#4)(2013-1#2)(2013-7#3)(2013-8#1)
was significantly higher on the##2##5##(2008-5#1)(2011-2#1)
was significantly higher on##5##4##(1992-5#1)(2008-10#1)(2008-5#2)(2011-2#1)
was significantly higher only in##2##5##(2006-11#1)(2011-2#1)
was significantly higher than in controls##2##6##(2009-2#1)(2012-1#1)
was significantly higher than in patients##2##6##(2006-6#1)(2012-1#1)
was significantly higher than in the##7##6##(1991-4#1)(1991-5#1)(1992-5#1)(1997-8#1)(2006-6#1)(2010-12#1)(2012-2#1)
was significantly higher than in##21##5##(1990-11#1)(1991-11#1)(1991-4#1)(1991-5#1)(1992-10#1)(1992-5#1)(1993-1#1)(1995-3#1)(1996-4#1)(1997-8#1)(2006-6#2)(2007-10#1)(2008-11#1)(2008-4#1)(2009-2#1)(2009-3#1)(2010-12#1)(2012-1#2)(2012-2#1)
was significantly higher than that found in##2##7##(1994-11#1)(2004-10#1)
was significantly higher than that in the control group##2##9##(1990-9#1)(2012-2#1)
was significantly higher than that in the control##4##8##(1990-9#1)(1995-3#1)(2012-2#1)(2013-8#1)
was significantly higher than that in the##6##7##(1990-9#1)(1995-3#1)(2007-10#1)(2010-10#1)(2012-2#1)(2013-8#1)
was significantly higher than that in##12##6##(1990-9#1)(1994-6#1)(1995-3#1)(2007-10#1)(2007-8#3)(2008-10#1)(2010-10#1)(2011-1#1)(2012-2#1)(2013-8#1)
was significantly higher than that of the control group##2##9##(1997-2#1)(2008-10#1)
was significantly higher than that of the##5##7##(1997-2#1)(2007-4#1)(2008-10#1)(2011-2#1)(2012-2#1)
was significantly higher than that of##15##6##(1992-3#1)(1993-4#1)(1997-2#1)(2006-12#1)(2006-6#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-5#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-7#2)
was significantly higher than that##34##5##(1990-9#1)(1992-3#1)(1993-4#1)(1994-11#1)(1994-6#1)(1995-3#1)(1997-2#1)(1997-7#1)(2004-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-10#3)(2008-2#1)(2008-5#1)(2010-10#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#2)(2013-7#2)(2013-8#1)
was significantly higher than the control##2##6##(2009-10#1)(2009-6#1)
was significantly higher than the##8##5##(1991-2#1)(1997-8#1)(2006-7#1)(2008-10#1)(2009-10#1)(2009-6#1)(2010-8#1)(2011-2#1)
was significantly higher than those in the##2##7##(1997-1#1)(2004-11#1)
was significantly higher than those##3##5##(1997-1#1)(2004-11#1)(2009-7#1)
was significantly higher than##85##4##(1990-11#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-10#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-4#2)(1994-11#1)(1994-6#1)(1995-3#2)(1996-4#1)(1997-1#1)(1997-2#2)(1997-7#1)(1997-8#3)(2004-10#1)(2004-11#1)(2006-12#1)(2006-2#1)(2006-6#3)(2006-7#1)(2007-10#2)(2007-4#1)(2007-7#2)(2007-8#5)(2008-1#3)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#3)(2012-12#2)(2012-2#3)(2013-7#2)(2013-8#2)
was significantly higher with##2##4##(2006-12#1)(2010-12#1)
was significantly higher##304##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-1#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#3)(1993-1#2)(1993-10#2)(1993-11#2)(1993-12#1)(1993-3#1)(1993-4#4)(1994-11#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#3)(1997-2#6)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#5)(2004-10#1)(2004-11#1)(2004-3#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#6)(2006-4#1)(2006-5#2)(2006-6#6)(2006-7#2)(2007-1#1)(2007-10#3)(2007-11#1)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#7)(2007-8#13)(2007-9#4)(2008-1#3)(2008-10#24)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#7)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#3)(2009-10#2)(2009-2#2)(2009-3#3)(2009-4#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#14)(2011-3#1)(2012-1#5)(2012-12#3)(2012-2#8)(2012-3#5)(2013-1#4)(2013-7#5)(2013-8#5)
was significantly impaired in##2##4##(1996-7#1)(2006-8#1)
was significantly impaired##4##3##(1991-2#1)(1992-12#1)(1996-7#1)(2006-8#1)
was significantly improved by##2##4##(2005-11#1)(2008-3#1)
was significantly improved##9##3##(2005-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-7#1)(2012-12#1)
was significantly increased (P &lt##2##5##(1992-12#1)(1996-1#1)
was significantly increased after##7##4##(1995-3#1)(2008-11#1)(2008-5#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
was significantly increased and##2##4##(2005-4#1)(2008-7#1)
was significantly increased at##4##4##(1995-12#1)(2008-10#1)(2008-4#1)(2013-8#1)
was significantly increased by##13##4##(1990-2#1)(1990-7#2)(1992-8#1)(1994-5#1)(1995-12#1)(1996-12#1)(2005-11#2)(2008-10#1)(2008-12#1)(2012-2#1)(2012-6#1)
was significantly increased in 200 mg/kg males##2##7##(2008-9#2)
was significantly increased in both##2##5##(1994-11#1)(1997-7#1)
was significantly increased in patients##2##5##(1997-8#1)(2007-8#1)
was significantly increased in the presence of##2##7##(1992-11#1)(2008-5#1)
was significantly increased in the##12##5##(1990-2#1)(1991-8#1)(1992-11#1)(1993-2#1)(1993-8#1)(1997-4#1)(2006-10#1)(2006-9#1)(2008-5#1)(2008-7#2)(2008-9#1)
was significantly increased in##40##4##(1990-12#2)(1990-2#2)(1991-8#2)(1992-11#1)(1993-2#1)(1993-8#1)(1994-11#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-12#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-8#2)(2008-10#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#6)(2011-2#1)(2013-1#1)
was significantly increased when the##2##5##(1992-12#1)(1993-3#1)
was significantly increased##99##3##(1990-12#2)(1990-2#3)(1990-7#2)(1991-1#1)(1991-2#1)(1991-8#2)(1992-11#1)(1992-12#2)(1992-7#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#2)(1997-8#1)(2005-11#2)(2005-12#1)(2005-4#1)(2006-10#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-8#3)(2007-9#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#7)(2009-10#1)(2009-4#2)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-6#1)(2013-1#2)(2013-8#1)
was significantly inferior to##2##4##(1993-1#1)(2010-3#1)
was significantly influenced by the##6##5##(1992-5#1)(2006-12#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-4#1)
was significantly influenced by##8##4##(1992-5#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-4#1)
was significantly influenced##9##3##(1992-5#1)(1995-12#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-4#1)
was significantly inhibited by##11##4##(1992-3#1)(1993-7#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-2#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-4#1)(2013-8#1)
was significantly inhibited in the presence of##2##7##(1996-5#1)(1997-1#1)
was significantly inhibited in the##3##5##(1994-3#1)(1996-5#1)(1997-1#1)
was significantly inhibited in##5##4##(1992-1#1)(1994-3#1)(1995-8#1)(1996-5#1)(1997-1#1)
was significantly inhibited##22##3##(1990-4#1)(1992-1#1)(1992-3#1)(1993-11#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-8#1)(2013-8#1)
was significantly larger in the ethanol-treated neurons##2##7##(1991-8#2)
was significantly larger in the group of##2##7##(1997-7#1)(2008-7#1)
was significantly larger in the##6##5##(1991-8#2)(1993-7#1)(1997-7#1)(2008-7#1)(2011-1#1)
was significantly larger in##10##4##(1991-8#2)(1993-7#1)(1997-7#2)(2007-10#1)(2008-7#1)(2011-1#1)(2012-3#1)(2013-8#1)
was significantly larger than the##2##5##(1995-3#1)(2005-11#1)
was significantly larger than##6##4##(1990-7#1)(1991-9#1)(1995-3#1)(2005-11#1)(2006-3#1)(2007-12#1)
was significantly larger##18##3##(1990-7#1)(1991-8#2)(1991-9#1)(1993-11#1)(1993-7#2)(1995-3#1)(1997-7#2)(2005-11#1)(2006-3#1)(2007-10#1)(2007-12#1)(2008-7#1)(2011-1#1)(2012-3#1)(2013-8#1)
was significantly less common##2##4##(1990-2#1)(1990-6#1)
was significantly less efficient##2##4##(1992-2#1)(2009-3#1)
was significantly less for##5##4##(2008-10#3)(2012-2#2)
was significantly less frequent##2##4##(2007-8#1)(2011-2#1)
was significantly less in group##2##5##(1996-3#1)(2012-2#1)
was significantly less in the##2##5##(1992-5#1)(2006-12#1)
was significantly less in##10##4##(1992-5#1)(1994-10#1)(1996-3#1)(2006-12#1)(2007-6#1)(2008-10#1)(2009-6#1)(2010-7#1)(2012-2#2)
was significantly less than in##3##5##(1995-12#1)(2008-10#2)
was significantly less than that of##2##6##(1997-4#1)(2004-11#1)
was significantly less than that##4##5##(1991-2#1)(1994-12#1)(1997-4#1)(2004-11#1)
was significantly less than##10##4##(1991-2#1)(1994-12#1)(1995-12#1)(1996-9#1)(1997-4#1)(2004-11#1)(2008-10#3)(2012-2#1)
was significantly less##42##3##(1990-2#1)(1990-6#1)(1991-2#2)(1992-2#1)(1992-5#1)(1994-10#1)(1994-12#1)(1994-8#1)(1995-12#2)(1996-3#1)(1996-9#1)(1997-3#1)(1997-4#1)(2004-11#1)(2005-11#1)(2006-12#1)(2006-6#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#9)(2009-3#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#5)
was significantly longer for##3##4##(2006-8#1)(2008-3#1)(2008-9#1)
was significantly longer in patients who##2##6##(2009-4#1)(2012-2#1)
was significantly longer in the##6##5##(2007-2#1)(2007-8#2)(2009-4#1)(2010-2#1)(2011-2#1)
was significantly longer in##12##4##(1990-6#1)(1994-2#1)(2007-2#1)(2007-8#2)(2008-5#1)(2009-4#2)(2010-2#1)(2010-4#1)(2011-2#1)(2012-2#1)
was significantly longer than that of##2##6##(2004-11#2)
was significantly longer than##3##4##(2004-11#2)(2006-8#1)
was significantly longer##24##3##(1990-6#1)(1993-1#1)(1994-2#1)(2004-11#2)(2006-4#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-8#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-4#2)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
was significantly low in##3##4##(2007-6#1)(2012-2#1)(2013-8#1)
was significantly low##4##3##(2007-6#1)(2012-2#2)(2013-8#1)
was significantly lower (P &lt##2##5##(1993-12#1)(1996-9#1)
was significantly lower (p &lt##3##5##(2005-11#1)(2013-1#2)
was significantly lower (p less than 0##2##7##(1991-8#1)(1992-3#1)
was significantly lower (p##6##4##(1991-8#1)(1992-3#1)(2005-11#1)(2008-1#1)(2013-1#2)
was significantly lower [P &lt##4##5##(2008-4#4)
was significantly lower among##2##4##(2006-10#1)(2012-12#1)
was significantly lower for the##2##5##(2008-7#1)(2009-9#1)
was significantly lower for##6##4##(1990-12#1)(1993-11#1)(2008-10#1)(2008-7#1)(2009-9#1)(2011-2#1)
was significantly lower in patients with##4##6##(2005-8#1)(2007-10#1)(2008-7#1)(2012-1#1)
was significantly lower in the##15##5##(1990-3#1)(1993-10#1)(1993-7#1)(1993-9#1)(1994-4#1)(1995-9#1)(1997-1#2)(2007-7#1)(2007-8#1)(2008-6#1)(2012-2#1)(2013-7#2)(2013-8#1)
was significantly lower in women##2##5##(1991-8#1)(1992-3#1)
was significantly lower in##43##4##(1990-3#1)(1991-8#1)(1992-3#1)(1993-10#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-4#1)(1995-11#1)(1995-5#1)(1995-7#1)(1995-9#2)(1997-1#2)(1997-6#2)(2005-8#2)(2007-10#1)(2007-7#1)(2007-8#3)(2008-10#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-1#1)(2011-1#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
was significantly lower on##2##4##(1990-9#1)(2008-10#1)
was significantly lower than in control##3##6##(1991-11#1)(2007-10#1)(2010-1#1)
was significantly lower than in the##9##6##(1995-11#1)(1995-8#1)(1996-2#1)(1997-2#2)(2006-9#1)(2007-5#1)(2008-7#1)(2011-2#1)
was significantly lower than in##19##5##(1990-11#1)(1991-11#1)(1995-11#1)(1995-8#1)(1996-2#1)(1997-2#2)(1997-3#1)(2006-9#1)(2007-10#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-7#2)(2010-1#1)(2010-2#1)(2011-2#1)(2012-2#1)
was significantly lower than that in the##4##7##(1995-4#1)(1995-8#1)(1996-11#1)(2012-2#1)
was significantly lower than that in##5##6##(1991-3#1)(1995-4#1)(1995-8#1)(1996-11#1)(2012-2#1)
was significantly lower than that of the##3##7##(2008-3#1)(2008-9#1)(2012-2#1)
was significantly lower than that of##5##6##(1994-8#1)(2004-8#1)(2008-3#1)(2008-9#1)(2012-2#1)
was significantly lower than that##13##5##(1991-3#1)(1994-6#1)(1994-8#1)(1995-4#1)(1995-8#1)(1996-11#1)(1996-2#1)(2004-8#1)(2007-1#1)(2008-3#1)(2008-9#1)(2012-2#2)
was significantly lower than the##5##5##(1994-7#1)(1996-12#1)(2008-5#1)(2008-7#1)(2010-12#1)
was significantly lower than those##2##5##(1997-1#1)(2008-8#1)
was significantly lower than##45##4##(1990-11#1)(1991-11#1)(1991-3#1)(1993-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-4#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#2)(1997-3#1)(2004-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#1)
was significantly lower when##2##4##(2008-10#1)(2008-7#1)
was significantly lower##124##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-3#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-4#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-11#2)(1995-4#1)(1995-5#1)(1995-7#1)(1995-8#2)(1995-9#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#1)(1997-6#2)(1997-8#1)(2004-8#1)(2005-11#1)(2005-8#2)(2006-10#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#9)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-1#2)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#4)(2013-1#4)(2013-7#2)(2013-8#2)
was significantly lowered compared##2##4##(2006-8#1)(2012-11#1)
was significantly more abundant##2##4##(2008-10#1)(2008-8#1)
was significantly more active##2##4##(1996-7#1)(2008-5#1)
was significantly more common in the##2##6##(2008-7#1)(2011-2#1)
was significantly more common in##4##5##(2008-7#2)(2010-4#1)(2011-2#1)
was significantly more common##5##4##(2008-7#2)(2010-4#1)(2011-2#1)(2012-3#1)
was significantly more effective than placebo in##2##7##(2007-11#1)(2008-3#1)
was significantly more effective than##5##5##(2006-5#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-12#1)
was significantly more effective##9##4##(1995-7#1)(2006-5#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-12#1)(2013-1#1)
was significantly more frequent in patients with##2##7##(1997-1#1)(2007-8#1)
was significantly more frequent in##4##5##(1990-4#1)(1997-1#1)(2007-8#2)
was significantly more frequent##5##4##(1990-4#1)(1990-6#1)(1997-1#1)(2007-8#2)
was significantly more in##5##4##(1992-12#1)(2007-6#1)(2008-1#1)(2011-12#1)(2012-2#1)
was significantly more likely##2##4##(2010-7#1)(2013-1#1)
was significantly more potent in##2##5##(1997-5#1)(2008-7#1)
was significantly more potent##3##4##(1994-10#1)(1997-5#1)(2008-7#1)
was significantly more prevalent##2##4##(2008-3#1)(2009-11#1)
was significantly more pronounced in##2##5##(2010-4#1)(2011-2#1)
was significantly more##58##3##(1990-3#1)(1990-4#1)(1990-6#1)(1992-11#1)(1992-12#1)(1992-5#1)(1994-10#1)(1995-7#1)(1996-10#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-4#2)(1997-5#1)(1997-7#1)(2004-2#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#2)(2009-11#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-7#1)(2011-12#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
was significantly negative##2##3##(2007-2#1)(2011-2#1)
was significantly negatively correlated with##2##5##(2013-8#2)
was significantly negatively##3##3##(2010-1#1)(2013-8#2)
was significantly observed##2##3##(2008-10#1)(2008-11#1)
was significantly prolonged##2##3##(1991-1#1)(2011-12#1)
was significantly raised##3##3##(1990-12#1)(2007-10#1)(2009-6#1)
was significantly reduced (p &lt##2##5##(2006-8#1)(2010-5#1)
was significantly reduced and##2##4##(1990-4#1)(2006-12#1)
was significantly reduced by P##2##5##(2008-10#2)
was significantly reduced by high (50 microg)##2##7##(1997-8#2)
was significantly reduced by the##2##5##(1992-10#1)(1996-3#1)
was significantly reduced by##27##4##(1990-11#1)(1990-5#1)(1991-2#1)(1991-8#1)(1992-10#1)(1992-3#1)(1993-11#1)(1993-12#1)(1995-11#2)(1995-3#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-8#3)(2008-10#4)(2008-11#1)(2008-4#1)(2010-10#1)(2012-12#1)(2012-3#1)
was significantly reduced compared with the##2##6##(1995-12#1)(2008-10#1)
was significantly reduced compared with##3##5##(1995-12#1)(2008-10#1)(2008-4#1)
was significantly reduced compared##4##4##(1992-10#1)(1995-12#1)(2008-10#1)(2008-4#1)
was significantly reduced for##3##4##(2005-10#1)(2007-1#1)(2008-10#1)
was significantly reduced in all##2##5##(1996-12#1)(2008-3#1)
was significantly reduced in both##2##5##(2009-5#1)(2012-2#1)
was significantly reduced in patients##2##5##(1991-7#1)(2013-1#1)
was significantly reduced in plants##2##5##(2008-10#2)
was significantly reduced in the##7##5##(1990-5#1)(1993-7#1)(1997-2#1)(1997-5#1)(2007-10#1)(2010-12#1)(2011-1#1)
was significantly reduced in##42##4##(1990-5#1)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-7#1)(1994-7#1)(1994-9#1)(1995-12#1)(1996-12#4)(1996-3#1)(1996-5#1)(1997-2#2)(1997-5#2)(2007-10#1)(2008-10#6)(2008-3#2)(2008-4#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
was significantly reduced to##2##4##(1990-11#1)(2008-5#1)
was significantly reduced when##3##4##(1997-7#1)(2009-9#1)(2011-2#1)
was significantly reduced with a##2##5##(1991-6#1)(2005-10#1)
was significantly reduced with##5##4##(1991-10#1)(1991-6#1)(2005-10#1)(2007-11#1)(2008-6#1)
was significantly reduced##116##3##(1990-11#2)(1990-4#1)(1990-5#2)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-10#2)(1992-3#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-7#1)(1993-8#1)(1994-7#1)(1994-9#1)(1995-11#2)(1995-12#3)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#8)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-2#2)(1997-5#2)(1997-7#1)(1997-8#3)(2005-10#2)(2006-1#1)(2006-12#2)(2006-3#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#14)(2008-11#2)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
was significantly related to##19##4##(1991-9#1)(1995-1#1)(1997-5#1)(1997-8#1)(2006-12#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-3#1)(2009-7#2)(2010-1#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
was significantly related##20##3##(1991-9#1)(1995-1#1)(1997-5#1)(1997-8#1)(2006-12#1)(2007-12#1)(2007-6#2)(2008-10#1)(2008-3#1)(2009-7#2)(2010-1#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
was significantly retarded (P##2##4##(2008-10#2)
was significantly shortened##3##3##(1990-11#1)(2007-5#1)(2008-5#1)
was significantly shorter for##2##4##(2006-6#1)(2009-9#1)
was significantly shorter in##6##4##(1996-12#1)(1997-1#1)(2007-9#1)(2008-5#1)(2011-2#1)(2013-8#1)
was significantly shorter than##3##4##(1991-2#1)(2008-8#2)
was significantly shorter##14##3##(1991-2#1)(1992-11#1)(1996-12#1)(1997-1#1)(2006-6#1)(2007-9#1)(2008-5#1)(2008-8#2)(2009-9#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
was significantly similar to##2##4##(1995-2#1)(2008-10#1)
was significantly slower than that##2##5##(2008-4#1)(2011-2#1)
was significantly slower##5##3##(2008-10#2)(2008-4#1)(2011-2#2)
was significantly smaller in the##2##5##(1994-2#1)(1996-7#1)
was significantly smaller in##5##4##(1994-2#1)(1995-12#2)(1996-7#1)(2011-2#1)
was significantly smaller than in##2##5##(1994-9#1)(1995-12#1)
was significantly smaller than that##5##5##(1990-3#1)(2008-10#2)(2012-12#2)
was significantly smaller than the##2##5##(2007-8#2)
was significantly smaller than##9##4##(1990-3#1)(1994-9#1)(1995-12#1)(2007-8#2)(2008-10#2)(2012-12#2)
was significantly smaller##17##3##(1990-3#1)(1994-2#1)(1994-9#1)(1995-12#3)(1996-7#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-3#1)(2011-2#1)(2012-12#2)
was significantly stimulated by##3##4##(1993-3#1)(1996-11#1)(2004-4#1)
was significantly superior to that of##2##6##(2006-4#1)(2010-3#1)
was significantly superior to##4##4##(2006-4#1)(2007-11#1)(2010-3#1)(2010-9#1)
was significantly superior##5##3##(2006-4#1)(2007-11#1)(2008-5#1)(2010-3#1)(2010-9#1)
was significantly suppressed by##3##4##(1991-12#1)(1994-8#1)(1997-1#1)
was significantly suppressed##6##3##(1991-12#1)(1992-8#1)(1994-8#2)(1997-1#1)(2012-3#1)
was significantly weaker##2##3##(1991-12#1)(1994-4#1)
was significantly##1391##2##(1990-10#1)(1990-11#5)(1990-12#5)(1990-2#4)(1990-3#4)(1990-4#8)(1990-5#4)(1990-6#4)(1990-7#6)(1990-8#2)(1990-9#7)(1991-1#4)(1991-10#1)(1991-11#3)(1991-12#4)(1991-2#7)(1991-3#4)(1991-4#2)(1991-5#7)(1991-6#8)(1991-7#2)(1991-8#14)(1991-9#7)(1992-1#4)(1992-10#5)(1992-11#3)(1992-12#8)(1992-2#2)(1992-3#7)(1992-5#7)(1992-7#1)(1992-8#4)(1992-9#3)(1993-1#5)(1993-10#3)(1993-11#7)(1993-12#6)(1993-2#4)(1993-3#10)(1993-4#5)(1993-5#1)(1993-6#1)(1993-7#6)(1993-8#2)(1993-9#6)(1994-10#2)(1994-11#4)(1994-12#2)(1994-2#8)(1994-3#8)(1994-4#3)(1994-5#2)(1994-6#5)(1994-7#3)(1994-8#5)(1994-9#5)(1995-1#3)(1995-10#1)(1995-11#8)(1995-12#19)(1995-2#6)(1995-3#9)(1995-4#3)(1995-5#7)(1995-7#3)(1995-8#4)(1995-9#5)(1996-1#3)(1996-10#2)(1996-11#4)(1996-12#27)(1996-2#9)(1996-3#7)(1996-4#1)(1996-5#8)(1996-6#2)(1996-7#5)(1996-8#2)(1996-9#5)(1997-1#12)(1997-2#19)(1997-3#7)(1997-4#7)(1997-5#7)(1997-6#4)(1997-7#11)(1997-8#16)(2004-10#1)(2004-11#5)(2004-12#2)(2004-2#2)(2004-3#1)(2004-4#2)(2004-8#1)(2004-9#1)(2005-1#1)(2005-10#3)(2005-11#7)(2005-12#2)(2005-4#1)(2005-7#1)(2005-8#5)(2006-1#1)(2006-10#4)(2006-11#2)(2006-12#9)(2006-2#8)(2006-3#2)(2006-4#3)(2006-5#5)(2006-6#11)(2006-7#3)(2006-8#10)(2006-9#4)(2007-1#3)(2007-10#15)(2007-11#12)(2007-12#6)(2007-2#9)(2007-3#3)(2007-4#4)(2007-5#3)(2007-6#11)(2007-7#12)(2007-8#39)(2007-9#12)(2008-1#6)(2008-10#135)(2008-11#18)(2008-12#15)(2008-2#3)(2008-3#21)(2008-4#24)(2008-5#33)(2008-6#11)(2008-7#30)(2008-8#12)(2008-9#17)(2009-10#3)(2009-11#1)(2009-2#2)(2009-3#6)(2009-4#8)(2009-5#15)(2009-6#4)(2009-7#5)(2009-8#5)(2009-9#4)(2010-1#4)(2010-10#3)(2010-11#2)(2010-12#14)(2010-2#6)(2010-3#5)(2010-4#14)(2010-5#2)(2010-7#10)(2010-8#4)(2010-9#3)(2011-1#20)(2011-11#1)(2011-12#7)(2011-2#52)(2011-3#1)(2012-1#11)(2012-11#1)(2012-12#15)(2012-2#36)(2012-3#14)(2012-5#1)(2012-6#1)(2012-7#1)(2013-1#33)(2013-7#13)(2013-8#27)
was significative##2##2##(2009-4#2)
was silenced##2##2##(2008-9#1)(2011-2#1)
was similar across##2##3##(2009-3#1)(2013-1#1)
was similar among the##2##4##(1994-11#1)(2007-10#1)
was similar among##6##3##(1994-11#1)(2007-10#1)(2008-11#1)(2008-5#1)(2011-11#1)(2013-8#1)
was similar and##3##3##(1996-3#1)(2008-10#1)(2011-12#1)
was similar between both groups##2##5##(2007-3#1)(2013-1#1)
was similar between men##2##4##(1991-9#1)(2007-7#1)
was similar between the##4##4##(2007-11#1)(2008-10#2)(2011-2#1)
was similar between##13##3##(1991-9#1)(1995-8#1)(1996-5#1)(2006-12#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-10#2)(2009-3#1)(2010-4#1)(2011-2#1)(2013-1#1)
was similar for all the##2##5##(2008-10#1)(2008-3#1)
was similar for all three##2##5##(1996-3#1)(2007-11#1)
was similar for all##6##4##(1996-3#1)(2007-11#1)(2008-10#2)(2008-3#1)(2011-2#1)
was similar for both groups##5##5##(1990-6#1)(1994-6#1)(2008-10#1)(2009-11#1)(2013-7#1)
was similar for both##9##4##(1990-10#1)(1990-6#1)(1994-6#1)(1995-8#1)(1996-1#1)(2008-10#2)(2009-11#1)(2013-7#1)
was similar for the three##2##5##(1995-6#1)(2008-8#1)
was similar for the##4##4##(1993-7#1)(1995-6#1)(2006-7#1)(2008-8#1)
was similar for##28##3##(1990-10#1)(1990-2#1)(1990-6#1)(1993-7#1)(1994-6#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-3#1)(1997-8#1)(2006-7#1)(2007-11#1)(2007-3#1)(2007-8#2)(2008-10#4)(2008-3#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-3#1)(2010-4#1)(2011-2#2)(2013-7#1)
was similar in all groups##3##5##(1993-4#1)(1996-8#1)(2006-5#1)
was similar in all##7##4##(1992-1#1)(1993-4#1)(1994-5#1)(1996-8#1)(2006-5#1)(2008-7#1)(2010-12#1)
was similar in both cell##2##5##(1991-1#1)(1997-7#1)
was similar in both groups##11##5##(1991-1#1)(1991-5#1)(1992-3#1)(2006-6#1)(2006-8#1)(2007-7#1)(2007-8#1)(2007-9#1)(2009-10#1)(2010-11#1)(2011-2#1)
was similar in both##27##4##(1990-10#1)(1990-3#1)(1990-4#1)(1991-1#2)(1991-10#1)(1991-5#1)(1992-3#1)(1995-11#1)(1996-6#1)(1997-7#1)(2006-6#2)(2006-8#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-9#1)(2009-10#1)(2010-11#1)(2011-2#1)(2013-7#1)
was similar in each##2##4##(2010-4#1)(2013-8#1)
was similar in patients##2##4##(1992-11#1)(2006-6#1)
was similar in the 2 groups##2##6##(1993-4#1)(2007-10#1)
was similar in the groups##2##5##(2006-7#2)
was similar in the two groups##7##6##(1991-4#1)(1992-2#1)(1992-3#1)(1993-1#1)(2007-8#3)
was similar in the two##9##5##(1991-12#1)(1991-4#1)(1992-2#1)(1992-3#1)(1993-1#1)(2007-8#3)(2012-3#1)
was similar in the##21##4##(1991-12#1)(1991-4#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-4#1)(1996-12#1)(2006-7#2)(2007-10#1)(2007-7#2)(2007-8#3)(2008-10#2)(2008-5#1)(2011-3#1)(2012-3#2)
was similar in##91##3##(1990-10#2)(1990-3#1)(1990-4#2)(1991-1#2)(1991-10#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-4#3)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-11#2)(1996-12#1)(1996-6#2)(1996-8#1)(1997-2#2)(1997-6#1)(1997-7#1)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#1)(2009-10#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#2)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
was similar irrespective of##2##4##(1990-12#1)(2007-7#1)
was similar on##3##3##(1997-8#1)(2008-10#2)
was similar to a##5##4##(1990-11#1)(1991-7#1)(1995-2#1)(2008-9#1)(2009-7#1)
was similar to other##5##4##(2007-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)
was similar to that by controls##2##6##(2008-9#2)
was similar to that by##6##5##(2008-8#2)(2008-9#4)
was similar to that for the##3##6##(1994-9#1)(1995-11#1)(2010-9#1)
was similar to that for##5##5##(1991-7#1)(1994-9#2)(1995-11#1)(2010-9#1)
was similar to that found in##3##6##(2007-3#1)(2008-7#1)(2010-10#1)
was similar to that from##3##5##(1996-2#1)(2004-12#1)(2008-6#1)
was similar to that in the control##2##7##(2008-9#1)(2009-10#1)
was similar to that in the##6##6##(1990-10#1)(1991-7#1)(1994-11#1)(1995-5#1)(2008-9#1)(2009-10#1)
was similar to that in##15##5##(1990-10#1)(1991-11#1)(1991-7#1)(1994-11#1)(1995-5#3)(1995-7#1)(1996-5#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)
was similar to that induced by##2##6##(1993-3#1)(1996-8#1)
was similar to that observed for##2##6##(2008-10#1)(2011-2#1)
was similar to that observed in the##2##7##(1991-8#1)(1996-6#1)
was similar to that observed in##8##6##(1990-7#1)(1991-12#1)(1991-2#1)(1991-8#1)(1993-8#1)(1995-11#1)(1996-6#1)(1997-2#1)
was similar to that observed with##2##6##(1994-8#1)(1996-6#1)
was similar to that observed##13##5##(1990-11#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-8#1)(1993-8#1)(1994-8#1)(1995-11#1)(1996-6#2)(1997-2#1)(2008-10#1)(2011-2#1)
was similar to that obtained##4##5##(1990-7#1)(1993-6#1)(1995-12#1)(2008-10#1)
was similar to that of control##4##6##(1992-3#1)(1993-8#1)(2008-9#2)
was similar to that of other##2##6##(2008-7#1)(2010-8#1)
was similar to that of the control groups##6##8##(2008-8#1)(2008-9#5)
was similar to that of the vehicle##5##7##(2008-9#5)
was similar to that of the##22##6##(1990-12#1)(1990-2#1)(1992-6#1)(1993-6#1)(1994-8#1)(1995-1#1)(2005-11#1)(2006-8#1)(2008-8#3)(2008-9#10)(2009-4#1)
was similar to that of##51##5##(1990-12#2)(1990-2#2)(1990-5#1)(1991-2#1)(1992-3#2)(1992-6#1)(1993-6#2)(1993-8#2)(1994-11#1)(1994-8#1)(1995-1#1)(1996-3#1)(1997-3#1)(1997-7#1)(2005-11#1)(2006-8#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#13)(2009-4#1)(2009-6#1)(2010-12#1)(2010-8#2)(2011-2#1)(2013-8#1)
was similar to that seen##2##5##(1995-1#1)(1996-4#1)
was similar to that##115##4##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#1)(1990-7#2)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-7#2)(1991-8#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-3#1)(1993-6#3)(1993-8#3)(1994-11#2)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#2)(1995-12#1)(1995-5#3)(1995-7#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#1)(2004-12#1)(2005-11#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#19)(2009-10#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
was similar to the one##2##5##(2010-7#1)(2011-2#1)
was similar to the value obtained##2##6##(1990-8#1)(1995-11#1)
was similar to the##33##4##(1990-4#1)(1990-8#1)(1993-2#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-11#1)(1996-12#1)(1997-6#1)(2005-4#1)(2007-1#1)(2007-10#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-7#2)(2009-10#3)(2009-8#1)(2010-4#2)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
was similar to those of##2##5##(1991-7#1)(2009-4#1)
was similar to those##5##4##(1991-7#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-12#1)
was similar to##193##3##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-7#4)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#4)(1994-11#2)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#3)(1995-1#2)(1995-11#3)(1995-12#1)(1995-2#1)(1995-5#3)(1995-7#1)(1995-8#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(2004-11#1)(2004-12#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#17)(2008-11#3)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#25)(2009-10#4)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
was similar with both##2##4##(1997-8#1)(2008-8#1)
was similar with##5##3##(1997-8#1)(2005-11#1)(2006-8#1)(2008-8#1)(2011-2#1)
was similar##400##2##(1990-10#4)(1990-11#3)(1990-12#3)(1990-2#3)(1990-3#1)(1990-4#3)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#5)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#5)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#4)(1992-12#1)(1992-2#1)(1992-3#4)(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-4#3)(1993-6#3)(1993-7#3)(1993-8#4)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#4)(1995-1#3)(1995-10#1)(1995-11#5)(1995-12#1)(1995-2#1)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#4)(1996-1#1)(1996-12#5)(1996-2#2)(1996-3#4)(1996-4#2)(1996-5#3)(1996-6#4)(1996-8#2)(1997-2#4)(1997-3#3)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#3)(2004-11#1)(2004-12#1)(2004-4#1)(2005-1#1)(2005-11#3)(2005-4#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#3)(2006-8#7)(2007-1#1)(2007-10#5)(2007-11#4)(2007-12#2)(2007-2#1)(2007-3#4)(2007-5#1)(2007-6#2)(2007-7#6)(2007-8#7)(2007-9#1)(2008-1#2)(2008-10#39)(2008-11#6)(2008-12#2)(2008-3#5)(2008-4#3)(2008-5#9)(2008-6#2)(2008-7#12)(2008-8#7)(2008-9#27)(2009-10#5)(2009-11#1)(2009-12#1)(2009-3#3)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#6)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-11#1)(2011-12#1)(2011-2#11)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#10)(2013-7#4)(2013-8#7)
was similarly inhibited##2##3##(1993-3#1)(1995-8#1)
was similarly##19##2##(1992-1#1)(1992-3#2)(1993-12#1)(1993-3#1)(1994-2#1)(1995-11#1)(1995-8#1)(1996-5#1)(1996-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2010-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
was simple and##9##3##(1991-2#1)(1996-3#1)(2005-4#1)(2008-10#4)(2008-11#1)(2008-7#1)
was simple##19##2##(1991-2#1)(1993-11#1)(1996-3#1)(1997-8#1)(2005-4#2)(2008-10#9)(2008-11#1)(2008-7#1)(2013-8#2)
was simplified##4##2##(1990-2#1)(1992-1#1)(1996-11#1)(2006-10#1)
was simply##9##2##(1996-3#1)(2005-8#1)(2006-7#1)(2008-10#4)(2008-4#1)(2009-12#1)
was simulated by a##4##4##(2007-9#2)(2008-3#1)(2013-1#1)
was simulated by##7##3##(1995-1#1)(2007-9#2)(2008-3#1)(2008-8#1)(2013-1#1)(2013-8#1)
was simulated for##2##3##(2008-2#1)(2010-9#1)
was simulated using a##4##4##(2008-10#3)(2013-7#1)
was simulated using##5##3##(2008-10#3)(2008-7#1)(2013-7#1)
was simulated with##4##3##(1991-2#1)(2008-2#1)(2008-3#1)(2011-1#1)
was simulated##28##2##(1991-2#1)(1995-1#1)(2005-11#1)(2007-12#1)(2007-9#2)(2008-10#4)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#1)(2013-1#1)(2013-7#1)(2013-8#2)
was simultaneous##2##2##(1992-8#1)(1995-1#1)
was simultaneously performed##2##3##(1994-3#1)(2010-12#1)
was simultaneously##15##2##(1990-8#1)(1991-11#1)(1992-11#1)(1993-6#1)(1994-3#1)(1994-7#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-11#1)(2010-12#1)(2010-2#1)
was single##3##2##(2007-11#1)(2007-12#1)(2007-8#1)
was singled out##2##3##(1996-12#1)(2008-11#1)
was situated in##3##3##(2007-11#1)(2009-3#1)(2011-2#1)
was situated##10##2##(1993-7#1)(1996-7#1)(2006-12#1)(2007-11#1)(2007-2#1)(2008-7#1)(2009-3#1)(2010-12#1)(2011-2#2)
was six months##2##3##(1990-2#1)(1991-11#1)
was six##4##2##(1990-2#1)(1991-11#1)(2006-6#1)(2012-1#1)
was skewed##3##2##(1993-1#1)(2008-10#1)(2008-7#1)
was sliced##2##2##(1991-1#1)(2008-11#1)
was slight##5##2##(1996-6#1)(2007-11#1)(2008-10#1)(2012-11#1)(2013-8#1)
was slightly but significantly higher##2##5##(1992-1#1)(2008-10#1)
was slightly but significantly##3##4##(1992-1#1)(2008-10#2)
was slightly but##4##3##(1990-7#1)(1992-1#1)(2008-10#2)
was slightly different from##2##4##(1996-6#1)(2008-11#1)
was slightly different##4##3##(1991-8#1)(1996-6#1)(2008-10#1)(2008-11#1)
was slightly elevated in##2##4##(1990-9#1)(2012-12#1)
was slightly elevated##4##3##(1990-9#1)(1995-3#1)(2006-4#1)(2012-12#1)
was slightly higher for records arriving via flat file##2##9##(2013-1#2)
was slightly higher in the##3##5##(2008-11#1)(2011-2#1)(2012-1#1)
was slightly higher in##10##4##(1994-4#1)(1995-1#1)(1997-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-3#1)
was slightly higher than that in##2##6##(1994-12#1)(2008-11#1)
was slightly higher than that##3##5##(1994-12#1)(2007-7#1)(2008-11#1)
was slightly higher than##8##4##(1994-12#1)(1994-9#1)(2006-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2010-3#1)
was slightly higher##27##3##(1992-12#2)(1994-12#1)(1994-4#1)(1994-9#1)(1995-1#1)(1997-6#1)(1997-8#1)(2004-2#1)(2006-2#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#2)
was slightly improved##3##3##(2008-11#1)(2008-7#1)(2011-1#1)
was slightly increased in the presence of##2##7##(1994-8#1)(2008-10#1)
was slightly increased in the##3##5##(1994-8#1)(2006-12#1)(2008-10#1)
was slightly increased in##5##4##(1990-11#1)(1994-8#1)(2006-12#1)(2008-10#1)(2011-1#1)
was slightly increased##9##3##(1990-11#2)(1992-9#1)(1994-8#1)(1996-7#1)(2006-12#1)(2008-10#1)(2010-10#1)(2011-1#1)
was slightly inhibited by##2##4##(1990-10#1)(2008-5#1)
was slightly less##2##3##(1997-8#1)(2008-10#1)
was slightly lower in##3##4##(1990-3#1)(1991-10#1)(2008-3#1)
was slightly lower than that of##5##6##(1991-5#1)(2007-12#1)(2008-11#1)(2010-8#1)(2013-1#1)
was slightly lower than that##6##5##(1991-5#1)(2006-10#1)(2007-12#1)(2008-11#1)(2010-8#1)(2013-1#1)
was slightly lower than##7##4##(1991-5#1)(2006-10#2)(2007-12#1)(2008-11#1)(2010-8#1)(2013-1#1)
was slightly lower##11##3##(1990-3#1)(1991-10#1)(1991-5#1)(1993-9#1)(2006-10#2)(2007-12#1)(2008-11#1)(2008-3#1)(2010-8#1)(2013-1#1)
was slightly more effective than##3##5##(1990-12#1)(2008-10#1)(2008-11#1)
was slightly more effective##4##4##(1990-12#1)(1994-3#1)(2008-10#1)(2008-11#1)
was slightly more potent##2##4##(1994-11#1)(1997-8#1)
was slightly more##12##3##(1990-12#1)(1990-7#1)(1991-6#1)(1992-1#1)(1992-5#1)(1994-11#1)(1994-3#1)(1997-8#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
was slightly reduced##2##3##(1991-7#1)(2007-11#1)
was slightly smaller than that##2##5##(1992-3#1)(2012-2#1)
was slightly smaller than##3##4##(1992-3#1)(2008-5#1)(2012-2#1)
was slightly smaller##4##3##(1992-3#1)(1994-8#1)(2008-5#1)(2012-2#1)
was slightly##114##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-3#2)(1990-7#2)(1990-9#1)(1991-10#1)(1991-3#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-12#3)(1992-3#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-4#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-5#1)(1997-6#1)(1997-8#3)(2004-2#1)(2005-11#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#12)(2008-11#9)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
was slow and##4##3##(1990-7#1)(2006-8#1)(2008-10#1)(2011-1#1)
was slow##11##2##(1990-7#1)(1990-9#1)(1992-3#1)(1993-9#1)(2005-11#1)(2006-8#1)(2008-10#3)(2008-3#1)(2011-1#1)
was slowed down##3##3##(1992-3#1)(1997-7#1)(2011-12#1)
was slowed##6##2##(1991-6#1)(1992-12#1)(1992-3#1)(1995-12#1)(1997-7#1)(2011-12#1)
was slower and##3##3##(1996-9#1)(2004-9#1)(2008-4#1)
was slower in##6##3##(1991-2#1)(1995-12#1)(1996-7#1)(2008-10#1)(2012-3#1)(2013-1#1)
was slower than that of##3##5##(1990-5#1)(1990-7#1)(2008-10#1)
was slower than that##4##4##(1990-5#1)(1990-7#1)(2008-10#2)
was slower than##6##3##(1990-5#1)(1990-7#1)(1992-9#1)(1994-2#1)(2008-10#2)
was slower##23##2##(1990-5#1)(1990-7#1)(1991-2#1)(1992-9#1)(1993-5#1)(1994-2#2)(1995-12#1)(1996-7#1)(1996-9#1)(2004-9#1)(2006-10#1)(2006-3#1)(2007-7#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-6#1)(2012-3#1)(2013-1#1)
was slowly##4##2##(1990-6#1)(1991-11#1)(1992-3#2)
was small and not##2##4##(1991-5#1)(2006-9#1)
was small and##4##3##(1991-5#1)(2005-11#1)(2006-9#1)(2007-2#1)
was small but significant##2##4##(1990-4#1)(1992-12#1)
was small but##4##3##(1990-4#1)(1992-12#1)(2008-10#1)(2008-5#1)
was small in##4##3##(1993-8#1)(1996-9#1)(2008-7#1)(2010-8#1)
was small##37##2##(1990-4#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-5#2)(1992-10#1)(1992-12#1)(1993-12#1)(1993-8#1)(1994-8#1)(1996-9#2)(1997-6#1)(2005-11#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-10#8)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-12#1)(2012-2#1)(2013-8#1)
was smaller (P &lt##2##4##(2007-8#2)
was smaller and##2##3##(1996-2#1)(2008-7#1)
was smaller in the##4##4##(1992-3#1)(2004-4#1)(2008-7#1)(2010-1#1)
was smaller in##8##3##(1992-3#1)(2004-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-1#1)(2012-3#1)
was smaller than in##2##4##(2008-5#1)(2008-7#1)
was smaller than that in##5##5##(1993-7#1)(1993-8#1)(2007-8#1)(2012-2#2)
was smaller than that of##2##5##(1992-3#1)(2004-11#1)
was smaller than that##10##4##(1992-12#1)(1992-3#1)(1993-7#1)(1993-8#1)(1995-11#1)(2004-11#1)(2007-8#1)(2011-1#1)(2012-2#2)
was smaller than the##3##4##(1994-8#1)(2004-4#1)(2011-1#1)
was smaller than##20##3##(1992-12#1)(1992-3#1)(1993-7#1)(1993-8#2)(1994-8#1)(1995-11#1)(1997-3#1)(2004-11#1)(2004-4#1)(2007-8#2)(2008-10#2)(2008-5#1)(2008-7#1)(2011-1#2)(2012-2#2)
was smaller##45##2##(1990-12#1)(1991-10#1)(1992-12#1)(1992-3#2)(1993-7#2)(1993-8#2)(1994-5#1)(1994-8#1)(1995-11#1)(1996-1#1)(1996-2#1)(1997-3#1)(2004-11#1)(2004-4#2)(2004-8#1)(2007-7#1)(2007-8#5)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#1)(2010-1#1)(2011-1#2)(2011-2#1)(2012-2#3)(2012-3#1)
was smooth and##2##3##(2008-7#1)(2011-2#1)
was smooth##4##2##(2006-7#1)(2008-7#1)(2011-2#1)(2013-8#1)
was so low that##2##4##(2007-12#1)(2008-3#1)
was so##11##2##(1992-4#1)(1995-8#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-12#1)(2013-1#2)
was sodium-dependent##3##2##(1990-3#2)(1991-3#1)
was solely##5##2##(1990-12#1)(1994-9#1)(1996-12#1)(2006-8#1)(2008-6#1)
was solid##2##2##(2008-10#1)(2008-5#1)
was solidified##2##2##(2006-3#1)(2010-2#1)
was solubilized and##3##3##(1990-8#1)(1994-11#1)(2008-10#1)
was solubilized by##2##3##(1990-7#1)(1996-4#1)
was solubilized from##3##3##(1990-5#1)(1994-12#2)
was solubilized in##4##3##(1990-2#1)(1992-6#1)(1995-11#1)(2010-1#1)
was solubilized##14##2##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1992-6#1)(1994-11#1)(1994-12#2)(1995-11#1)(1996-4#1)(1997-1#1)(2008-10#2)(2010-1#1)
was soluble and##3##3##(1992-12#1)(1992-7#1)(1993-6#1)
was soluble##7##2##(1992-12#1)(1992-7#2)(1993-6#1)(1994-11#1)(1996-8#1)(2011-2#1)
was solved and##2##3##(1995-3#1)(1997-2#1)
was solved by a combination of##2##6##(1994-8#1)(1997-5#1)
was solved by a##4##4##(1991-4#1)(1994-8#1)(1997-5#1)(2005-11#1)
was solved by multiple##2##4##(1990-7#1)(1993-6#1)
was solved by use of##2##5##(1991-9#1)(2008-8#1)
was solved by##12##3##(1990-7#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-12#1)(1993-6#1)(1994-8#1)(1996-2#1)(1997-5#1)(1997-7#1)(2005-11#1)(2008-8#1)
was solved using##2##3##(2008-7#1)(2009-11#1)
was solved with##2##3##(1996-3#1)(2011-3#1)
was solved##22##2##(1990-7#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-12#1)(1993-6#1)(1994-8#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-5#1)(1997-7#1)(2005-11#3)(2008-7#1)(2008-8#1)(2009-11#1)(2010-10#1)(2011-3#1)(2012-2#1)
was some evidence of##6##4##(1991-9#1)(2007-9#1)(2008-10#2)(2008-9#1)(2010-8#1)
was some evidence that the##2##5##(1992-1#1)(2008-10#1)
was some evidence that##3##4##(1990-12#1)(1992-1#1)(2008-10#1)
was some evidence##11##3##(1990-12#1)(1991-9#1)(1992-1#1)(1994-3#1)(2007-9#1)(2008-10#3)(2008-9#1)(2009-6#1)(2010-8#1)
was some variation##2##3##(2011-1#1)(2011-2#1)
was some##28##2##(1990-12#1)(1991-12#1)(1991-9#1)(1992-1#1)(1994-3#1)(1995-12#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-6#1)(2008-9#3)(2009-5#1)(2009-6#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#1)
was sometimes##6##2##(1990-3#1)(2008-10#2)(2013-1#3)
was somewhat greater##2##3##(1994-11#1)(2007-11#1)
was somewhat higher in the##2##5##(1994-11#1)(2006-8#1)
was somewhat higher##3##3##(1994-11#1)(2006-8#1)(2012-1#1)
was somewhat less##3##3##(1995-12#1)(2006-12#1)(2007-8#1)
was somewhat lower than##2##4##(1990-4#1)(2008-10#1)
was somewhat##23##2##(1990-4#1)(1990-5#1)(1990-6#1)(1991-6#1)(1991-8#1)(1992-10#1)(1993-7#1)(1994-11#2)(1994-9#1)(1995-1#1)(1995-12#1)(1997-8#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#4)(2012-1#1)(2013-8#1)
was soon##2##2##(2005-7#1)(2012-1#1)
was sorbed on the##2##4##(2007-8#1)(2008-10#1)
was sorbed on##3##3##(2007-8#1)(2008-10#2)
was sought for##2##3##(1996-5#1)(2011-12#1)
was sought from##2##3##(1992-2#1)(2006-6#1)
was sought in##3##3##(1992-6#1)(2007-2#1)(2008-5#1)
was sought##9##2##(1992-2#1)(1992-6#1)(1993-3#1)(1996-5#1)(2006-6#1)(2007-2#1)(2008-5#1)(2011-1#1)(2011-12#1)
was spared##2##2##(1992-10#1)(1995-8#1)
was speaking##2##2##(1992-5#1)(2007-8#1)
was specially##2##2##(1997-2#1)(2008-10#1)
was specific and##5##3##(1992-5#1)(1994-9#1)(1996-5#1)(2008-10#1)(2008-11#1)
was specific because##2##3##(1995-5#1)(2005-8#1)
was specific for the##4##4##(1995-1#2)(1995-4#1)(2013-8#1)
was specific for##22##3##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-6#1)(1992-6#1)(1992-7#1)(1993-11#1)(1994-10#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-5#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-11#1)(2013-8#1)
was specific to##9##3##(1990-8#1)(1991-9#1)(1992-8#1)(1996-9#1)(1997-6#1)(1997-8#1)(2008-10#2)(2009-2#1)
was specific##45##2##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-10#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#2)(1997-8#1)(2005-8#1)(2007-10#1)(2008-10#5)(2008-11#2)(2008-4#1)(2009-2#1)(2013-8#1)
was specifically bound to##3##4##(1991-9#1)(1993-3#1)(1996-3#1)
was specifically cleaved by##2##4##(1994-8#1)(1994-9#1)
was specifically designed for##2##4##(1992-1#1)(2008-2#1)
was specifically designed to##2##4##(2009-11#1)(2010-12#1)
was specifically designed##4##3##(1992-1#1)(2008-2#1)(2009-11#1)(2010-12#1)
was specifically expressed in##4##4##(1996-5#1)(2008-8#2)(2008-9#1)
was specifically labeled##2##3##(1992-12#1)(1994-2#1)
was specifically suppressed##2##3##(1991-12#1)(1994-6#1)
was specifically##42##2##(1990-5#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-3#2)(1993-8#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-12#1)(2011-1#1)(2013-8#1)
was specified##2##2##(2008-7#1)(2009-7#1)
was spectrally##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
was speculated##4##2##(1992-3#1)(2005-11#1)(2007-8#1)(2012-12#1)
was spent on##2##3##(1992-4#1)(1997-3#1)
was spent##7##2##(1992-4#1)(1997-2#1)(1997-3#2)(2006-8#1)(2010-8#1)(2011-1#1)
was spiked with##3##3##(1994-10#1)(1996-8#1)(2008-10#1)
was spiked##4##2##(1994-10#1)(1996-8#1)(2008-10#2)
was splenectomized##3##2##(1991-5#1)(1994-9#2)
was spliced##3##2##(1996-5#1)(2007-11#1)(2008-9#1)
was split by##2##3##(1995-11#1)(2008-10#1)
was split into two##2##4##(2008-10#1)(2013-8#1)
was split into##3##3##(2008-10#2)(2013-8#1)
was split##8##2##(1992-11#1)(1995-11#1)(1996-2#1)(1997-8#1)(2008-10#3)(2013-8#1)
was sponsored by##3##3##(1996-4#1)(2005-8#1)(2008-7#1)
was spontaneously##4##2##(1994-11#1)(2007-8#1)(2008-7#1)(2012-11#1)
was spotted##2##2##(1997-1#1)(2012-3#1)
was sprayed with##2##3##(2005-8#1)(2008-10#1)
was sprayed##3##2##(2005-8#1)(2008-10#2)
was spread##3##2##(1990-11#1)(1992-10#1)(2008-10#1)
was spreading##3##2##(1990-3#1)(2009-10#1)(2009-6#1)
was stabilized by##4##3##(1990-5#1)(1991-12#1)(1997-8#1)(2010-7#1)
was stabilized##15##2##(1990-5#1)(1991-12#1)(1992-7#1)(1997-8#1)(2006-3#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-2#1)(2010-7#1)(2012-12#2)
was stable and##5##3##(1990-9#1)(1992-7#1)(2008-10#3)
was stable at##4##3##(1991-12#1)(1992-7#1)(2008-11#1)(2008-5#1)
was stable during##4##3##(1994-11#1)(1995-4#1)(1997-8#1)(2008-11#1)
was stable for##11##3##(1990-11#1)(1996-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#2)(2009-10#1)
was stable in the##3##4##(2007-3#1)(2008-10#1)(2008-5#1)
was stable in##9##3##(1990-4#1)(1992-2#1)(1992-3#1)(1992-4#1)(1994-5#1)(2007-3#1)(2008-10#1)(2008-4#1)(2008-5#1)
was stable over##5##3##(1997-2#1)(2008-10#3)(2012-12#1)
was stable to heat##2##4##(1994-2#1)(2008-10#1)
was stable to##5##3##(1991-5#1)(1994-2#1)(2008-10#1)(2008-6#1)(2010-12#1)
was stable under##2##3##(1995-6#1)(2005-11#1)
was stable when##2##3##(1997-1#1)(2010-2#1)
was stable##65##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-9#1)(1991-12#1)(1991-5#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-7#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-5#1)(1994-9#1)(1995-4#1)(1995-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-11#1)(2006-12#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-10#12)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#2)(2009-1#1)(2009-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-3#2)
was stably expressed by##2##4##(2008-11#2)
was stably maintained in##2##4##(1994-3#1)(2012-12#1)
was stably maintained##3##3##(1994-3#1)(2008-7#1)(2012-12#1)
was stably transfected##2##3##(1992-9#1)(2008-8#1)
was stably##15##2##(1991-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-3#1)(2008-10#2)(2008-11#3)(2008-7#1)(2008-8#2)(2011-1#1)(2012-12#1)
was stage IV##3##3##(2008-10#1)(2008-5#1)(2013-7#1)
was stage##5##2##(1995-4#1)(2008-10#1)(2008-5#2)(2013-7#1)
was stained in##2##3##(1996-5#1)(2008-5#1)
was stained with##3##3##(1991-1#1)(1995-12#1)(2013-1#1)
was stained##6##2##(1991-1#1)(1991-12#1)(1995-12#1)(1996-5#1)(2008-5#1)(2013-1#1)
was standardised as##2##3##(2008-10#2)
was standardized for##2##3##(1995-1#1)(2012-12#1)
was standardized##6##2##(1995-1#1)(2008-3#1)(2008-5#1)(2010-2#1)(2010-3#1)(2012-12#1)
was started 24 h##2##4##(1995-5#1)(2006-8#1)
was started after##2##3##(1993-7#1)(2006-8#1)
was started and##4##3##(1991-11#1)(2007-2#1)(2011-1#1)(2012-3#1)
was started at the##4##4##(2007-11#1)(2008-4#1)(2008-7#1)(2011-2#1)
was started by##2##3##(2006-1#1)(2008-5#1)
was started for##2##3##(1990-10#1)(2013-8#1)
was started immediately##2##3##(2008-5#1)(2010-11#1)
was started in the##2##4##(2007-11#1)(2013-8#1)
was started in##8##3##(1991-12#1)(1992-11#1)(1996-6#1)(2007-11#1)(2007-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
was started on##13##3##(2005-11#1)(2006-11#1)(2006-7#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-12#1)(2009-11#1)(2011-1#1)(2012-2#1)(2013-8#2)
was started with a dose##2##5##(1991-6#1)(2013-8#1)
was started with##7##3##(1990-11#1)(1991-6#1)(2006-4#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
was started within##3##3##(1992-2#1)(2007-9#1)(2011-2#1)
was started##76##2##(1990-10#1)(1990-11#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#1)(1993-7#1)(1995-5#1)(1996-6#2)(1997-4#1)(1997-6#1)(2005-11#1)(2006-1#2)(2006-10#1)(2006-11#1)(2006-4#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-11#1)(2010-12#2)(2010-2#1)(2011-1#4)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#7)
was stated as##2##3##(1990-4#1)(2007-2#1)
was stated in##3##3##(1992-7#1)(2007-11#1)(2007-7#1)
was stated##11##2##(1990-4#1)(1992-7#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#4)(2008-7#1)
was statistically associated with##2##4##(1990-3#1)(2010-3#1)
was statistically different##4##3##(2007-2#1)(2007-8#1)(2008-5#1)(2010-3#1)
was statistically equivalent to##2##4##(1995-10#1)(2008-10#1)
was statistically evaluated##3##3##(2008-10#3)
was statistically higher in cases than controls##2##7##(2006-8#2)
was statistically higher in##3##4##(2006-8#2)(2008-4#1)
was statistically higher##5##3##(2006-8#2)(2008-4#1)(2010-8#2)
was statistically highly significant##3##4##(2007-7#1)(2008-8#2)
was statistically insignificant##3##3##(2007-2#1)(2008-2#1)(2010-4#1)
was statistically not##2##3##(2008-1#1)(2008-7#1)
was statistically significant (P &lt##6##5##(1996-12#1)(1996-6#2)(2008-5#1)(2008-8#2)
was statistically significant (P##8##4##(1990-3#1)(1996-12#1)(1996-6#2)(2008-10#1)(2008-5#1)(2008-8#2)
was statistically significant (p &lt##5##5##(2006-6#1)(2008-12#1)(2008-9#1)(2010-7#1)(2011-2#1)
was statistically significant (p = 0##2##6##(2012-2#1)(2013-1#1)
was statistically significant (p##7##4##(2006-6#1)(2008-12#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
was statistically significant (p&lt##3##4##(2013-8#3)
was statistically significant at##2##4##(1993-11#1)(2013-1#1)
was statistically significant between##2##4##(2006-9#1)(2011-2#1)
was statistically significant for##3##4##(2008-5#1)(2010-4#1)(2013-1#1)
was statistically significant in##4##4##(1991-10#1)(2008-6#1)(2012-2#1)(2013-8#1)
was statistically significant only in the##2##6##(1992-4#1)(2008-10#1)
was statistically significant##61##3##(1990-3#2)(1991-10#1)(1992-4#1)(1993-11#1)(1993-12#1)(1994-11#1)(1995-1#1)(1995-9#1)(1996-12#1)(1996-6#2)(2005-12#1)(2006-10#1)(2006-5#1)(2006-6#3)(2006-9#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#2)(2009-6#1)(2010-3#2)(2010-4#1)(2010-7#2)(2010-9#1)(2011-2#6)(2012-2#2)(2013-1#5)(2013-8#4)
was statistically significantly##2##3##(2004-2#1)(2009-10#1)
was statistically##98##2##(1990-3#3)(1991-10#1)(1992-4#1)(1993-11#1)(1993-12#1)(1994-11#1)(1995-1#1)(1995-10#1)(1995-9#1)(1996-12#1)(1996-6#2)(2004-2#1)(2005-12#1)(2006-10#1)(2006-5#1)(2006-6#3)(2006-8#2)(2006-9#1)(2007-2#4)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#8)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-3#2)(2009-6#1)(2010-2#1)(2010-3#4)(2010-4#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#4)
was steeper##3##2##(1995-12#1)(1995-8#1)(2008-10#1)
was sterile##3##2##(2006-10#1)(2007-7#1)(2011-2#1)
was sterilized##2##2##(2008-4#1)(2012-2#1)
was still able to induce##2##5##(1996-5#1)(2008-3#1)
was still able to##7##4##(1990-2#1)(1990-7#1)(1994-11#1)(1996-5#1)(2008-10#2)(2008-3#1)
was still active##2##3##(1990-11#1)(2006-4#1)
was still apparent##2##3##(1994-2#1)(2006-8#1)
was still continuing##2##3##(1995-9#1)(2008-2#1)
was still evident##3##3##(1990-5#1)(1996-9#1)(2008-10#1)
was still higher than##2##4##(2007-2#1)(2008-8#1)
was still higher##4##3##(1990-7#1)(1997-2#1)(2007-2#1)(2008-8#1)
was still low##3##3##(2007-11#1)(2007-9#1)(2011-2#1)
was still lower##2##3##(2006-10#1)(2007-8#1)
was still maintained##2##3##(2008-10#1)(2008-11#1)
was still observed##4##3##(1990-7#1)(1997-4#1)(2008-9#1)(2009-12#1)
was still persistent##2##3##(1993-11#1)(2007-1#1)
was still present##5##3##(1992-6#2)(1994-9#1)(1996-3#1)(2011-2#1)
was still retained##2##3##(1992-6#1)(1996-2#1)
was still significant##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
was still significantly greater##2##4##(1990-12#1)(2012-11#1)
was still##103##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#3)(1990-9#2)(1991-2#3)(1992-12#1)(1992-2#1)(1992-6#3)(1992-7#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-3#2)(1996-5#3)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-4#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-8#3)(2007-9#1)(2008-10#10)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2010-12#1)(2011-1#3)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
was stimulated at least##2##4##(1991-4#1)(1993-8#1)
was stimulated at##4##3##(1991-4#1)(1991-8#1)(1993-8#1)(1997-3#1)
was stimulated by all##2##4##(1995-12#1)(1996-8#1)
was stimulated by spermine##2##4##(1990-3#2)
was stimulated by the##2##4##(1991-9#1)(2008-11#1)
was stimulated by##32##3##(1990-10#2)(1990-3#3)(1990-5#1)(1990-7#1)(1991-3#1)(1991-7#1)(1991-9#2)(1992-3#1)(1992-6#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#2)(1995-7#1)(1996-11#1)(1996-8#2)(1997-6#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-9#1)(2009-3#1)
was stimulated electrically##2##3##(1993-12#1)(2008-9#1)
was stimulated in the presence of##2##6##(1990-12#1)(1991-2#1)
was stimulated in the##3##4##(1990-12#1)(1991-2#1)(2008-6#1)
was stimulated in##5##3##(1990-12#1)(1990-3#1)(1991-11#1)(1991-2#1)(2008-6#1)
was stimulated to##2##3##(1990-5#1)(2008-10#1)
was stimulated when##2##3##(1992-11#2)
was stimulated with##3##3##(1991-5#1)(2010-12#1)(2011-2#1)
was stimulated##65##2##(1990-10#2)(1990-12#1)(1990-3#4)(1990-5#2)(1990-7#3)(1991-11#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#2)(1992-3#1)(1992-6#4)(1993-12#1)(1993-6#1)(1993-8#2)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#2)(1995-7#1)(1996-1#1)(1996-11#1)(1996-5#1)(1996-8#2)(1997-3#1)(1997-6#1)(1997-7#1)(2006-8#1)(2007-1#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-6#1)(2008-9#2)(2009-3#1)(2010-12#1)(2011-2#1)
was stopped and##3##3##(1993-1#1)(2007-7#1)(2010-12#1)
was stopped at##2##3##(1990-8#1)(1994-5#1)
was stopped because##3##3##(2011-2#1)(2013-1#2)
was stopped by##2##3##(1991-6#1)(2007-10#1)
was stopped##26##2##(1990-10#1)(1990-8#1)(1990-9#1)(1991-6#1)(1993-1#1)(1994-5#1)(1996-3#1)(1997-1#2)(1997-6#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-7#1)(2010-1#2)(2010-12#1)(2011-2#1)(2013-1#2)
was stored at 4 degrees C##2##6##(1993-8#1)(1997-3#1)
was stored at##3##3##(1993-8#1)(1997-3#2)
was stored in##4##3##(2004-9#1)(2006-10#1)(2006-5#1)(2008-12#1)
was stored##9##2##(1993-8#1)(1997-3#2)(2004-9#1)(2006-10#1)(2006-5#1)(2008-11#1)(2008-12#1)(2013-1#1)
was straightforward##2##2##(1995-12#1)(2007-12#1)
was stratified by##4##3##(2006-12#2)(2010-3#1)(2013-1#1)
was stratified##6##2##(2006-12#2)(2006-8#1)(2008-10#1)(2010-3#1)(2013-1#1)
was strengthened by##2##3##(1990-8#1)(2012-12#1)
was strengthened##5##2##(1990-8#1)(1995-5#1)(2009-12#1)(2012-12#1)(2013-8#1)
was stressed##5##2##(1990-5#1)(1994-7#1)(2007-11#1)(2008-5#1)(2008-9#1)
was strictly controlled##2##3##(2008-8#1)(2008-9#1)
was strictly related to##2##4##(1990-7#1)(2006-6#1)
was strictly##10##2##(1990-7#1)(1991-7#1)(1994-8#1)(1997-3#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#1)
was striking##4##2##(1994-11#1)(2007-12#1)(2008-3#1)(2008-5#1)
was strikingly similar##2##3##(1996-4#1)(2008-8#1)
was strikingly##4##2##(1991-9#1)(1996-4#1)(2008-8#1)(2009-8#1)
was stripped from the##2##4##(2008-10#2)
was stripped from##3##3##(2008-10#3)
was stripped with##3##3##(2008-10#3)
was stripped##7##2##(2008-10#7)
was strong but that of##2##5##(2008-8#2)
was strong enough to##2##4##(1996-8#1)(2012-2#1)
was strong evidence that##3##4##(1994-9#1)(2011-1#1)(2012-12#1)
was strong evidence##4##3##(1994-9#1)(2006-8#1)(2011-1#1)(2012-12#1)
was strong##17##2##(1991-9#1)(1992-4#1)(1994-9#1)(1996-12#1)(1996-8#1)(1997-4#1)(2006-8#2)(2008-10#1)(2008-8#2)(2009-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-9#1)
was stronger for##7##3##(2007-12#1)(2007-2#1)(2007-9#1)(2010-1#1)(2012-2#2)(2013-1#1)
was stronger in##2##3##(2008-9#1)(2011-2#1)
was stronger than that of##3##5##(2008-10#1)(2008-8#1)(2009-8#1)
was stronger than that##4##4##(2008-10#1)(2008-8#2)(2009-8#1)
was stronger than the##2##4##(1992-5#1)(2012-12#1)
was stronger than##14##3##(1992-5#1)(1993-2#1)(1996-12#1)(1997-5#1)(1997-7#1)(2008-10#1)(2008-8#4)(2009-8#1)(2010-9#1)(2011-2#1)(2012-12#1)
was stronger when##2##3##(2008-1#1)(2009-10#1)
was stronger##28##2##(1992-5#1)(1993-2#1)(1996-12#1)(1997-5#1)(1997-7#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-8#1)(2010-1#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
was strongest in##3##3##(1991-7#1)(1996-9#2)
was strongest##4##2##(1991-7#1)(1996-9#2)(2008-8#1)
was strongly affected by##2##4##(2008-10#1)(2008-8#1)
was strongly and consistently##2##4##(1994-4#1)(2013-1#1)
was strongly and##5##3##(1994-11#1)(1994-2#1)(1994-4#1)(2008-10#1)(2013-1#1)
was strongly associated with the##3##5##(2008-3#1)(2010-12#1)(2011-2#1)
was strongly associated with##11##4##(2008-10#5)(2008-3#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
was strongly attenuated by##2##4##(1996-11#1)(1996-8#1)
was strongly correlated with the##2##5##(1990-5#1)(1995-3#1)
was strongly correlated with##7##4##(1990-5#1)(1991-8#1)(1995-3#1)(2008-10#2)(2009-10#1)(2012-1#1)
was strongly correlated##8##3##(1990-5#1)(1991-8#1)(1995-3#1)(2004-3#1)(2008-10#2)(2009-10#1)(2012-1#1)
was strongly decreased##4##3##(1990-12#1)(1994-12#1)(1995-5#2)
was strongly dependent on the presence of##2##7##(1995-6#1)(2008-10#1)
was strongly dependent on the##5##5##(1992-3#1)(1995-6#1)(2008-10#1)(2008-2#1)(2008-9#1)
was strongly dependent on##7##4##(1992-3#1)(1994-9#1)(1995-6#1)(2008-10#2)(2008-2#1)(2008-9#1)
was strongly dependent##9##3##(1992-3#1)(1994-9#1)(1995-6#1)(2008-10#4)(2008-2#1)(2008-9#1)
was strongly enhanced##3##3##(1991-2#1)(1997-7#1)(2011-2#1)
was strongly expressed##3##3##(1997-7#1)(2012-12#2)
was strongly induced##3##3##(1996-11#1)(2008-10#1)(2009-10#1)
was strongly influenced by the##4##5##(1990-9#1)(2007-5#1)(2008-8#1)(2011-1#1)
was strongly inhibited by##11##4##(1990-11#1)(1991-10#1)(1991-5#1)(1992-11#1)(1993-11#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-6#1)(2005-11#1)(2008-11#1)
was strongly inhibited##16##3##(1990-11#1)(1991-10#1)(1991-5#1)(1992-11#1)(1993-11#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-6#1)(1997-6#1)(2005-11#1)(2006-8#1)(2008-10#2)(2008-11#1)
was strongly positive##2##3##(1991-9#1)(1994-7#1)
was strongly reactive##2##3##(1994-9#1)(2008-11#1)
was strongly reduced in##3##4##(1993-9#1)(1995-5#1)(2008-10#1)
was strongly reduced##5##3##(1993-9#1)(1995-2#1)(1995-5#1)(2008-10#1)(2008-5#1)
was strongly related to##3##4##(2008-10#1)(2011-12#1)(2012-1#1)
was strongly suggested##2##3##(1990-5#1)(2008-10#1)
was strongly suspected##2##3##(2007-7#1)(2013-8#1)
was strongly##116##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-9#2)(1991-1#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-7#1)(1994-9#3)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#2)(1995-7#1)(1995-8#1)(1996-11#2)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-6#1)(1997-7#2)(2004-3#1)(2005-11#2)(2006-8#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#24)(2008-11#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#3)(2008-9#2)(2009-10#2)(2009-2#1)(2009-4#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#2)
was struck##2##2##(2008-2#1)(2008-6#1)
was structurally and##2##3##(1990-6#1)(2013-8#1)
was structurally##3##2##(1990-6#1)(2013-1#1)(2013-8#1)
was structured##6##2##(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#2)(2013-1#1)
was studied after##3##3##(1991-11#1)(1993-12#1)(2012-1#1)
was studied against##3##3##(1990-5#1)(1997-5#1)(2007-7#1)
was studied among##2##3##(2004-10#1)(2008-10#1)
was studied and compared with##3##5##(1990-7#1)(2008-10#2)
was studied and compared##4##4##(1990-7#1)(2008-10#3)
was studied and it was##2##5##(1995-2#1)(2008-10#1)
was studied and optimized##2##4##(2008-10#2)
was studied and the##9##4##(1990-11#1)(2005-4#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-12#1)(2010-5#1)(2013-1#1)
was studied and##26##3##(1990-11#1)(1990-12#1)(1990-7#1)(1995-2#1)(2004-11#1)(2005-4#1)(2007-10#1)(2007-7#1)(2008-10#11)(2008-12#1)(2008-3#1)(2008-5#2)(2010-5#2)(2013-1#1)
was studied as a function of the##3##7##(1996-1#1)(2007-11#1)(2008-10#1)
was studied as a function of##6##6##(1990-11#1)(1991-4#1)(1996-1#1)(2007-11#1)(2008-10#1)(2013-8#1)
was studied as a##13##4##(1990-11#1)(1991-4#1)(1991-8#1)(1996-1#1)(2007-11#1)(2008-10#5)(2008-3#1)(2010-2#1)(2013-8#1)
was studied as well##4##4##(1990-5#1)(2005-11#1)(2008-2#1)(2010-7#1)
was studied as##20##3##(1990-11#1)(1990-5#1)(1991-4#1)(1991-8#1)(1996-1#1)(2005-11#1)(2007-11#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-8#1)(2010-2#1)(2010-7#1)(2013-8#1)
was studied at 25 degrees C and in##2##8##(2008-10#2)
was studied at pH 3##2##5##(1991-2#1)(2008-10#1)
was studied at pH##3##4##(1990-6#1)(1991-2#1)(2008-10#1)
was studied at the##5##4##(1993-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2013-1#1)
was studied at two##2##4##(2007-6#1)(2008-7#1)
was studied at##26##3##(1990-6#1)(1991-2#1)(1992-6#1)(1993-2#1)(1995-12#1)(1996-1#1)(1997-2#1)(1997-4#1)(2005-11#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#8)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
was studied both in##2##4##(1996-7#1)(2008-11#1)
was studied both theoretically and experimentally##2##6##(1995-1#1)(2008-3#1)
was studied both##4##3##(1995-1#1)(1996-7#1)(2008-11#1)(2008-3#1)
was studied by X-ray##2##4##(1994-8#1)(2008-10#1)
was studied by a##5##4##(1993-12#1)(1997-4#1)(2005-11#1)(2007-12#1)(2008-10#1)
was studied by comparing the##2##5##(2010-12#1)(2010-4#1)
was studied by comparing##4##4##(1997-4#1)(2008-10#1)(2010-12#1)(2010-4#1)
was studied by cyclic voltammetry at a glassy carbon electrode##3##10##(2008-10#3)
was studied by cyclic voltammetry##6##5##(2005-11#1)(2008-10#5)
was studied by determination of##2##5##(1994-11#1)(2010-5#1)
was studied by determining the##2##5##(1990-2#1)(1990-5#1)
was studied by differential scanning calorimetry and##2##7##(1992-3#1)(2005-11#1)
was studied by differential scanning calorimetry##3##6##(1992-3#1)(1993-8#1)(2005-11#1)
was studied by employing##2##4##(1995-8#1)(2007-9#1)
was studied by immunohistochemical##2##4##(1994-2#1)(2011-2#1)
was studied by in situ##2##5##(2008-10#1)(2012-1#1)
was studied by in vitro##2##5##(2004-9#1)(2008-4#1)
was studied by in##5##4##(2004-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-1#1)
was studied by investigating the##2##5##(1997-2#1)(2008-10#1)
was studied by light microscopy and##2##6##(2007-12#1)(2010-12#1)
was studied by light##3##4##(2007-12#1)(2008-10#1)(2010-12#1)
was studied by means of##5##5##(1991-9#1)(1995-5#1)(2005-4#1)(2008-10#1)(2013-8#1)
was studied by measuring##8##4##(1990-1#1)(1990-12#1)(1991-1#1)(1995-5#1)(2005-11#1)(2008-8#1)(2008-9#1)(2009-5#1)
was studied by potentiometric##2##4##(2008-10#2)
was studied by quantitative##2##4##(2008-7#1)(2012-1#1)
was studied by stopped-flow##3##4##(1990-2#1)(1991-2#1)(1995-2#1)
was studied by the method of##2##6##(2012-1#1)(2013-1#1)
was studied by the##8##4##(1994-12#1)(1995-1#1)(2005-11#1)(2008-10#2)(2012-1#1)(2013-1#1)(2013-8#1)
was studied by using a##3##5##(1997-2#1)(2008-10#1)(2008-3#1)
was studied by using##15##4##(1990-10#1)(1990-12#1)(1991-1#1)(1991-11#1)(1992-11#1)(1992-7#1)(1997-2#1)(2005-4#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2010-5#1)(2013-1#1)
was studied by##176##3##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#4)(1990-5#2)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-3#1)(1992-5#2)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#4)(1995-1#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-5#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-7#2)(2004-9#1)(2005-11#9)(2005-12#1)(2005-4#6)(2006-10#1)(2006-12#2)(2007-12#4)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#37)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#6)(2008-7#1)(2008-8#5)(2008-9#2)(2009-11#1)(2009-5#2)(2010-1#2)(2010-12#2)(2010-4#3)(2010-5#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#3)(2012-2#1)(2013-1#3)(2013-8#4)
was studied during##8##3##(1992-6#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2012-1#3)
was studied employing##2##3##(2008-10#1)(2008-6#1)
was studied experimentally##2##3##(2005-11#1)(2008-10#1)
was studied for a##2##4##(1996-5#1)(2008-10#1)
was studied for the first time##4##6##(1992-8#1)(2007-3#1)(2008-10#1)(2010-4#1)
was studied for the##7##4##(1992-3#1)(1992-8#1)(2007-3#1)(2008-10#2)(2009-2#1)(2010-4#1)
was studied for##19##3##(1991-4#1)(1991-7#1)(1991-9#1)(1992-3#2)(1992-8#1)(1994-8#1)(1996-5#1)(2007-3#1)(2008-10#6)(2008-7#1)(2009-2#1)(2010-4#1)(2011-12#1)
was studied from September##2##4##(2007-3#1)(2008-5#1)
was studied from##8##3##(1994-6#1)(2007-3#2)(2008-10#3)(2008-5#2)
was studied in 1##3##4##(2007-11#1)(2007-9#1)(2008-9#1)
was studied in 115##2##4##(2004-2#1)(2008-7#1)
was studied in 41##2##4##(1991-12#1)(1996-10#1)
was studied in 56##2##4##(1993-12#1)(2008-5#1)
was studied in a group##2##5##(1992-7#1)(1996-7#1)
was studied in a mouse model##2##6##(1994-5#1)(2008-10#1)
was studied in a series of##2##6##(1997-4#1)(2005-8#1)
was studied in a##39##4##(1990-11#1)(1990-5#1)(1992-7#2)(1993-11#1)(1993-12#1)(1993-4#1)(1994-5#1)(1995-6#1)(1996-4#1)(1996-7#1)(1997-4#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2009-12#1)(2009-2#1)(2010-2#1)(2010-3#1)
was studied in adult##2##4##(1992-8#1)(2010-12#1)
was studied in an##5##4##(1993-12#1)(2006-3#1)(2006-8#1)(2008-7#1)(2008-9#1)
was studied in aqueous solution##2##5##(2008-10#1)(2008-3#1)
was studied in aqueous solutions##2##5##(2005-11#1)(2008-10#1)
was studied in aqueous##6##4##(2005-11#1)(2008-10#4)(2008-3#1)
was studied in batch##2##4##(2008-10#1)(2008-11#1)
was studied in cells##2##4##(1995-11#1)(1997-4#1)
was studied in crosses##2##4##(2008-10#2)
was studied in cultured##5##4##(1990-11#1)(1994-6#1)(1995-11#1)(1995-2#1)(1997-1#1)
was studied in detail and improved performance was observed at several instances##2##12##(2008-10#2)
was studied in detail##13##4##(1991-12#1)(2005-4#1)(2007-10#1)(2007-11#1)(2008-10#8)(2009-3#1)
was studied in experimental##2##4##(2010-12#1)(2013-7#1)
was studied in four##3##4##(2007-8#1)(2008-10#1)(2009-9#1)
was studied in freshly isolated rat##2##6##(1991-8#1)(1997-1#1)
was studied in insect##2##4##(1995-5#1)(2013-7#1)
was studied in isolated rat##2##5##(1995-8#2)
was studied in liquid##2##4##(2007-12#1)(2012-2#1)
was studied in male##2##4##(1990-3#1)(1995-12#1)
was studied in murine##2##4##(2008-9#1)(2010-8#1)
was studied in normal##6##4##(1991-3#1)(1992-2#1)(1994-4#1)(1996-5#1)(2008-5#1)(2009-5#1)
was studied in one##2##4##(2008-10#1)(2013-1#1)
was studied in order to determine the##2##7##(1994-11#1)(2007-2#1)
was studied in order to##7##5##(1990-8#1)(1994-11#1)(2007-2#1)(2008-10#2)(2008-5#1)(2010-8#1)
was studied in patients##2##4##(1990-12#1)(2008-1#1)
was studied in plasma##2##4##(1996-5#1)(1996-9#1)
was studied in rat##3##4##(1990-2#1)(1994-3#1)(1996-3#1)
was studied in rats##6##4##(1990-11#1)(1991-5#1)(1994-5#1)(1995-12#1)(2007-9#1)(2010-12#1)
was studied in relation to##2##5##(1997-7#1)(2008-10#1)
was studied in seven##3##4##(1990-6#1)(2007-8#1)(2008-10#1)
was studied in terms of##3##5##(1990-7#1)(1992-6#1)(2008-10#1)
was studied in the cerebellar cortex of##2##7##(1994-2#1)(1995-8#1)
was studied in the field##2##5##(2008-10#2)
was studied in the presence of##2##6##(2008-10#2)
was studied in the presence##3##5##(2008-10#3)
was studied in the range of##2##6##(1990-5#1)(2008-10#1)
was studied in the rat##3##5##(1996-12#2)(1997-2#1)
was studied in the##39##4##(1990-5#1)(1990-7#2)(1991-2#1)(1991-7#1)(1992-3#1)(1992-7#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-8#1)(1996-11#1)(1996-12#3)(1996-4#1)(1996-7#1)(1997-2#3)(1997-5#1)(2005-4#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#6)(2008-5#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-9#1)(2013-1#1)(2013-8#1)
was studied in this paper##3##5##(2008-10#3)
was studied in this work##3##5##(2007-11#1)(2008-3#1)(2011-1#1)
was studied in this##7##4##(1990-12#1)(2007-11#1)(2008-10#3)(2008-3#1)(2011-1#1)
was studied in two##5##4##(2008-10#1)(2008-12#1)(2008-9#1)(2009-8#1)(2010-4#1)
was studied in vitro##7##4##(1990-7#1)(1993-3#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2013-1#1)
was studied in vivo##3##4##(1992-7#1)(1993-12#1)(2008-5#1)
was studied in##352##3##(1990-10#1)(1990-11#5)(1990-12#2)(1990-2#3)(1990-3#5)(1990-4#3)(1990-5#4)(1990-6#2)(1990-7#4)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#4)(1991-3#2)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#6)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#3)(1993-12#4)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#2)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#4)(1994-3#2)(1994-4#2)(1994-5#3)(1994-6#4)(1994-8#2)(1994-9#2)(1995-11#5)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#3)(1995-9#1)(1996-1#3)(1996-10#2)(1996-11#3)(1996-12#3)(1996-2#3)(1996-3#2)(1996-4#2)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#6)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#2)(2004-2#1)(2004-9#1)(2005-11#3)(2005-4#2)(2005-8#1)(2006-1#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#3)(2007-3#3)(2007-6#1)(2007-7#4)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#54)(2008-11#3)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#14)(2008-6#7)(2008-7#8)(2008-8#2)(2008-9#4)(2009-12#1)(2009-2#2)(2009-3#2)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#3)(2013-8#1)
was studied of##2##3##(2006-6#2)
was studied on a##6##4##(2008-10#4)(2008-5#1)(2010-4#1)
was studied on human##2##4##(1990-8#1)(2010-12#1)
was studied on##20##3##(1990-8#1)(1991-2#1)(1991-4#1)(1991-9#1)(1993-9#1)(1994-6#1)(1995-12#1)(2007-3#1)(2008-10#7)(2008-5#2)(2009-8#1)(2010-12#1)(2010-4#1)
was studied over the##3##4##(1995-2#1)(1995-5#1)(1997-1#1)
was studied over##6##3##(1991-6#1)(1995-2#1)(1995-5#1)(1997-1#1)(2006-1#1)(2008-5#1)
was studied prospectively in##2##4##(1990-9#1)(1991-4#1)
was studied prospectively##3##3##(1990-9#1)(1991-4#1)(2008-10#1)
was studied spectrophotometrically##2##3##(2008-10#2)
was studied theoretically##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
was studied through##6##3##(2007-3#1)(2008-10#2)(2008-9#1)(2011-2#1)(2012-12#1)
was studied to assess##2##4##(1991-9#1)(1995-2#1)
was studied to determine the##2##5##(2008-7#1)(2012-3#1)
was studied to determine##4##4##(2005-4#1)(2008-5#1)(2008-7#1)(2012-3#1)
was studied to elucidate the role of the##2##8##(1992-3#1)(1996-1#1)
was studied to##15##3##(1990-4#1)(1991-9#1)(1992-2#1)(1992-3#1)(1995-2#1)(1996-1#1)(1997-2#1)(2005-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#1)(2012-3#1)
was studied under conditions of##2##5##(2010-12#1)(2012-1#1)
was studied under conditions##3##4##(1992-3#1)(2010-12#1)(2012-1#1)
was studied under##10##3##(1992-2#1)(1992-3#1)(1995-3#1)(1995-7#1)(1997-2#1)(2008-10#2)(2008-12#1)(2010-12#1)(2012-1#1)
was studied using a##11##4##(2004-1#1)(2005-11#1)(2007-8#1)(2008-10#4)(2008-5#2)(2008-9#1)(2010-10#1)
was studied using an in vitro##3##6##(1990-9#1)(1994-8#1)(1997-7#1)
was studied using an##7##4##(1990-9#1)(1994-8#1)(1996-2#1)(1997-7#1)(2008-10#3)
was studied using different##2##4##(2008-5#2)
was studied using flow##2##4##(2008-10#2)
was studied using fluorescence##2##4##(1995-5#1)(1997-6#1)
was studied using high-performance liquid chromatography##2##6##(1991-4#1)(2008-10#1)
was studied using human##3##4##(1990-11#1)(2008-5#1)(2011-1#1)
was studied using reverse##2##4##(1993-9#1)(1996-2#1)
was studied using the##6##4##(1991-9#1)(1992-12#1)(1995-10#1)(1995-5#1)(1996-8#1)(2006-8#1)
was studied using##93##3##(1990-11#1)(1990-4#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-7#1)(1993-10#1)(1993-2#1)(1993-9#1)(1994-4#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-5#3)(1995-7#1)(1996-1#1)(1996-12#2)(1996-2#3)(1996-6#1)(1996-8#1)(1997-6#1)(1997-7#3)(1997-8#2)(2004-1#1)(2005-11#3)(2006-10#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#23)(2008-12#1)(2008-5#6)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-8#1)
was studied while##2##3##(2008-11#1)(2008-2#1)
was studied with a##3##4##(1996-6#1)(2007-12#1)(2012-11#1)
was studied with regard to##3##5##(1996-2#1)(2006-8#1)(2008-10#1)
was studied with the use of##2##6##(2006-11#1)(2013-1#1)
was studied with the##6##4##(2006-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2013-1#1)
was studied with##29##3##(1990-5#1)(1991-3#1)(1992-6#1)(1993-12#1)(1994-6#1)(1995-6#1)(1996-2#1)(1996-6#1)(2006-11#1)(2006-8#1)(2007-12#2)(2008-10#5)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2012-11#1)(2013-1#1)(2013-8#1)
was studied within the##2##4##(1995-5#1)(2006-10#1)
was studied##1139##2##(1990-1#1)(1990-10#4)(1990-11#11)(1990-12#9)(1990-2#8)(1990-3#5)(1990-4#5)(1990-5#10)(1990-6#3)(1990-7#6)(1990-8#3)(1990-9#4)(1991-1#2)(1991-11#4)(1991-12#7)(1991-2#9)(1991-3#3)(1991-4#5)(1991-5#8)(1991-6#5)(1991-7#2)(1991-8#6)(1991-9#8)(1992-1#3)(1992-10#2)(1992-11#3)(1992-12#2)(1992-2#4)(1992-3#6)(1992-4#3)(1992-5#2)(1992-6#7)(1992-7#10)(1992-8#4)(1992-9#5)(1993-1#1)(1993-10#1)(1993-11#5)(1993-12#10)(1993-2#3)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#3)(1993-8#5)(1993-9#6)(1994-11#6)(1994-12#6)(1994-2#8)(1994-3#6)(1994-4#3)(1994-5#6)(1994-6#10)(1994-7#2)(1994-8#8)(1994-9#3)(1995-1#3)(1995-10#2)(1995-11#6)(1995-12#7)(1995-2#6)(1995-3#2)(1995-5#9)(1995-6#4)(1995-7#4)(1995-8#5)(1995-9#3)(1996-1#9)(1996-10#2)(1996-11#5)(1996-12#6)(1996-2#11)(1996-3#2)(1996-4#2)(1996-5#6)(1996-6#5)(1996-7#4)(1996-8#4)(1996-9#1)(1997-1#4)(1997-2#15)(1997-3#4)(1997-4#6)(1997-5#5)(1997-6#5)(1997-7#7)(1997-8#3)(2004-1#1)(2004-10#1)(2004-11#2)(2004-12#1)(2004-2#1)(2004-9#3)(2005-11#25)(2005-12#2)(2005-4#13)(2005-8#2)(2006-1#2)(2006-10#5)(2006-11#1)(2006-12#7)(2006-2#1)(2006-3#2)(2006-4#2)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#6)(2006-9#1)(2007-1#3)(2007-10#3)(2007-11#8)(2007-12#16)(2007-2#3)(2007-3#8)(2007-5#1)(2007-6#2)(2007-7#8)(2007-8#8)(2007-9#3)(2008-1#3)(2008-10#258)(2008-11#9)(2008-12#8)(2008-2#14)(2008-3#18)(2008-4#9)(2008-5#54)(2008-6#10)(2008-7#18)(2008-8#16)(2008-9#12)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#2)(2009-4#1)(2009-5#4)(2009-7#1)(2009-8#3)(2009-9#4)(2010-1#4)(2010-10#1)(2010-11#2)(2010-12#9)(2010-2#2)(2010-3#2)(2010-4#8)(2010-5#4)(2010-7#1)(2010-8#2)(2011-1#6)(2011-12#1)(2011-2#10)(2011-3#2)(2012-1#9)(2012-11#1)(2012-12#3)(2012-2#9)(2012-3#7)(2013-1#13)(2013-7#3)(2013-8#9)
was subcloned and##2##3##(1990-10#1)(1991-9#1)
was subcloned into an##2##4##(1994-8#1)(1995-3#1)
was subcloned into pcDNA3##2##4##(2005-10#1)(2008-11#1)
was subcloned into the##3##4##(1993-12#1)(1995-8#1)(2008-11#1)
was subcloned into##12##3##(1991-2#1)(1993-12#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-12#1)(1997-4#1)(2005-10#1)(2005-11#1)(2008-11#2)(2008-9#1)
was subcloned##20##2##(1990-10#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-9#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-5#1)(1994-12#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-12#1)(1997-4#1)(2005-10#1)(2005-11#1)(2008-11#2)(2008-9#1)
was subcultured##2##2##(2008-10#1)(2008-8#1)
was subdivided into##2##3##(2005-11#1)(2012-1#1)
was subdivided##5##2##(2005-1#1)(2005-11#1)(2008-10#1)(2009-2#1)(2012-1#1)
was subject to##11##3##(1997-8#1)(2008-10#1)(2008-12#2)(2008-5#2)(2009-3#1)(2011-12#1)(2012-12#2)(2013-1#1)
was subjected to a##5##4##(1990-6#1)(2004-11#1)(2005-11#1)(2007-7#1)(2012-12#1)
was subjected to acid and alkali hydrolysis##3##7##(2008-10#2)(2012-12#1)
was subjected to an electrochemical pretreatment in order to improve the##2##11##(2008-10#2)
was subjected to an##3##4##(2008-10#2)(2013-8#1)
was subjected to the##3##4##(2008-10#2)(2012-12#1)
was subjected to treatment with##2##5##(1997-2#1)(2012-2#1)
was subjected to##65##3##(1990-10#1)(1990-6#1)(1992-3#1)(1992-8#2)(1993-11#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-2#2)(1997-1#1)(1997-2#1)(1997-8#1)(2004-11#1)(2005-11#1)(2006-12#3)(2006-2#1)(2006-3#1)(2007-12#1)(2007-4#3)(2007-7#2)(2008-10#12)(2008-11#3)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#2)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#4)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
was subjectively##4##2##(2006-5#1)(2007-12#1)(2007-7#1)(2008-8#1)
was submitted for##2##3##(1992-3#1)(2010-9#1)
was submitted to a##2##4##(2007-1#1)(2009-4#1)
was submitted to the##3##4##(1992-7#1)(2005-9#1)(2007-2#1)
was submitted to##20##3##(1990-3#1)(1991-3#1)(1992-7#1)(1993-2#1)(1996-6#1)(1996-8#2)(2005-9#1)(2007-1#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-6#1)(2009-4#1)(2010-12#1)(2012-2#1)(2013-8#1)
was submitted##25##2##(1990-3#1)(1991-3#1)(1992-3#1)(1992-7#1)(1993-2#1)(1996-6#1)(1996-8#2)(2005-7#1)(2005-8#1)(2005-9#1)(2007-1#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-9#1)(2012-2#1)(2013-8#1)
was subnormal##2##2##(2008-8#1)(2009-5#1)
was suboptimal##4##2##(2007-2#1)(2007-7#1)(2007-9#1)(2012-2#1)
was subsequently assessed##2##3##(1994-3#1)(2007-6#1)
was subsequently confirmed by##3##4##(1993-11#1)(1994-7#1)(2008-7#1)
was subsequently confirmed##4##3##(1993-11#1)(1994-7#1)(2008-7#1)(2013-7#1)
was subsequently determined##2##3##(2007-8#1)(2008-10#1)
was subsequently diagnosed and##2##4##(2006-4#1)(2013-1#1)
was subsequently diagnosed##4##3##(1996-12#1)(2006-4#1)(2007-7#1)(2013-1#1)
was subsequently eluted with##2##4##(2006-12#1)(2008-10#1)
was subsequently evaluated in##2##4##(1996-2#1)(2011-2#1)
was subsequently found to have an##2##6##(2006-10#1)(2008-7#1)
was subsequently found to have##3##5##(2006-10#1)(2008-7#1)(2012-2#1)
was subsequently observed##2##3##(1992-3#1)(1996-12#1)
was subsequently performed##3##3##(1991-11#1)(2012-2#1)(2013-8#1)
was subsequently separated##2##3##(1996-5#2)
was subsequently shown to be##2##5##(1996-10#1)(2008-7#1)
was subsequently shown to##4##4##(1990-10#1)(1991-2#1)(1996-10#1)(2008-7#1)
was subsequently shown##5##3##(1990-10#1)(1991-2#1)(1992-6#1)(1996-10#1)(2008-7#1)
was subsequently tested##2##3##(1991-7#1)(2008-5#1)
was subsequently used as##2##4##(1993-3#1)(2010-6#1)
was subsequently used##4##3##(1993-3#1)(1996-5#1)(2008-10#1)(2010-6#1)
was subsequently##77##2##(1990-10#1)(1990-12#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-3#1)(1994-7#1)(1995-3#2)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-5#3)(1996-6#1)(1996-8#1)(1997-4#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#6)(2008-10#4)(2008-3#1)(2008-5#4)(2008-7#3)(2009-8#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#4)(2012-12#1)(2012-2#4)(2013-1#1)(2013-7#1)(2013-8#3)
was substantial##6##2##(1995-1#1)(1995-6#1)(2006-12#1)(2006-2#1)(2008-10#1)(2008-7#1)
was substantially higher##3##3##(1991-9#1)(1993-9#1)(1994-8#1)
was substantially increased##3##3##(1992-9#1)(1994-3#1)(2008-6#1)
was substantially##21##2##(1991-9#1)(1992-9#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-2#2)(1995-5#1)(1995-6#1)(1997-3#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-6#1)(2008-7#1)(2010-3#1)(2012-12#1)
was substantiated by the##3##4##(1994-2#1)(1994-3#1)(2008-10#1)
was substantiated by##7##3##(1994-2#1)(1994-3#1)(2007-1#1)(2008-10#4)
was substantiated##9##2##(1991-10#1)(1994-2#1)(1994-3#1)(2007-1#1)(2008-10#4)(2011-2#1)
was substituted by arginine##2##4##(1990-10#1)(1994-8#1)
was substituted by##8##3##(1990-10#1)(1990-7#1)(1991-6#1)(1994-8#1)(2008-10#2)(2008-11#1)(2008-8#1)
was substituted for the##4##4##(1990-12#1)(1992-9#1)(2008-10#1)(2013-8#1)
was substituted for##8##3##(1990-12#1)(1990-2#1)(1992-7#1)(1992-9#1)(1993-11#1)(2006-12#1)(2008-10#1)(2013-8#1)
was substituted with a##2##4##(1993-6#1)(1995-11#1)
was substituted with##6##3##(1993-6#1)(1994-10#1)(1995-11#1)(1995-5#1)(1997-3#1)(2008-10#1)
was substituted##28##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-7#1)(1991-6#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-10#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-6#1)(1997-3#1)(1997-8#1)(2006-12#1)(2008-10#5)(2008-11#1)(2008-8#2)(2013-8#1)
was subtotal in##2##3##(1991-8#1)(2005-5#1)
was subtracted from##2##3##(1996-1#1)(2008-2#1)
was subtracted##3##2##(1992-6#1)(1996-1#1)(2008-2#1)
was succeeded by a##2##4##(1990-11#1)(2006-8#1)
was succeeded##4##2##(1990-11#1)(2006-8#1)(2007-7#1)(2008-11#1)
was successful and the##2##4##(1993-7#1)(2007-2#1)
was successful and##7##3##(1990-9#1)(1993-7#1)(2006-4#1)(2007-2#1)(2007-8#1)(2008-10#1)(2013-8#1)
was successful at##2##3##(2007-7#1)(2012-2#1)
was successful for##2##3##(2008-10#1)(2013-7#1)
was successful in all##5##4##(2005-12#1)(2007-12#1)(2007-3#1)(2011-2#1)(2012-2#1)
was successful in##34##3##(1990-8#1)(1993-1#1)(1996-2#1)(1996-8#1)(2005-10#1)(2005-12#3)(2006-4#1)(2006-5#2)(2006-8#1)(2007-12#1)(2007-3#2)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-3#2)(2010-7#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#2)
was successful on##2##3##(2007-7#2)
was successful##65##2##(1990-8#1)(1990-9#1)(1991-1#1)(1993-1#1)(1993-7#1)(1996-2#1)(1996-8#1)(2005-10#1)(2005-12#3)(2006-12#1)(2006-4#2)(2006-5#3)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-3#3)(2007-5#2)(2007-7#5)(2007-8#3)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-3#2)(2010-7#1)(2011-2#3)(2012-11#1)(2012-12#4)(2012-2#3)(2013-7#1)(2013-8#1)
was successfully achieved##4##3##(1990-8#1)(2008-10#1)(2008-5#1)(2008-9#1)
was successfully applied for determination of##3##6##(2008-10#3)
was successfully applied for the analysis of##3##7##(2007-8#1)(2008-10#2)
was successfully applied for the assay of##2##7##(2008-10#2)
was successfully applied for the determination of##9##7##(2008-10#9)
was successfully applied for the##20##5##(2007-8#1)(2008-10#16)(2009-11#1)(2009-8#1)(2012-12#1)
was successfully applied for##28##4##(2007-8#1)(2008-10#24)(2009-11#1)(2009-8#1)(2012-12#1)
was successfully applied in the##5##5##(2008-10#3)(2013-8#2)
was successfully applied in##7##4##(2008-10#4)(2011-3#1)(2013-8#2)
was successfully applied to a##2##5##(1994-7#1)(2012-2#1)
was successfully applied to an##2##5##(1993-2#1)(1996-10#1)
was successfully applied to determination of##2##6##(2008-10#2)
was successfully applied to real##2##5##(2008-10#1)(2012-11#1)
was successfully applied to the analysis of##14##7##(2007-8#1)(2008-10#12)(2013-1#1)
was successfully applied to the determination of Cr(III) and##2##9##(2008-10#2)
was successfully applied to the determination of copper in##2##9##(2008-10#2)
was successfully applied to the determination of glucose in##2##9##(2008-10#1)(2010-5#1)
was successfully applied to the determination of trace##4##8##(2008-10#4)
was successfully applied to the determination of##62##7##(1994-9#1)(1996-5#1)(2007-8#1)(2008-10#57)(2010-5#2)
was successfully applied to the determination##63##6##(1994-9#1)(1996-5#1)(2007-8#1)(2008-10#58)(2010-5#2)
was successfully applied to the direct determination##2##7##(2008-10#2)
was successfully applied to the extraction and determination of##5##9##(2008-10#5)
was successfully applied to the extraction##6##6##(2008-10#5)(2012-1#1)
was successfully applied to the simultaneous determination of##9##8##(2008-10#9)
was successfully applied to the simultaneous##10##6##(2008-10#10)
was successfully applied to the speciation of##2##7##(2008-10#2)
was successfully applied to the speciation##3##6##(2008-10#3)
was successfully applied to the##110##5##(1994-9#1)(1996-5#1)(2007-1#1)(2007-8#3)(2008-10#97)(2008-12#1)(2010-1#1)(2010-5#2)(2011-2#1)(2012-1#1)(2013-1#1)
was successfully applied to##149##4##(1990-11#1)(1992-11#1)(1993-2#1)(1994-12#1)(1994-7#1)(1994-9#2)(1995-10#1)(1996-10#1)(1996-5#1)(1997-5#1)(2007-1#1)(2007-12#1)(2007-8#7)(2008-10#118)(2008-11#1)(2008-12#1)(2010-1#1)(2010-5#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
was successfully applied##188##3##(1990-11#1)(1992-11#1)(1993-2#1)(1994-12#1)(1994-7#1)(1994-9#2)(1995-10#1)(1996-10#1)(1996-5#1)(1997-5#1)(2007-1#1)(2007-12#1)(2007-8#8)(2008-10#149)(2008-11#1)(2008-12#1)(2008-3#1)(2009-11#1)(2009-8#1)(2010-1#1)(2010-5#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
was successfully cloned##3##3##(2005-11#1)(2008-8#1)(2010-6#1)
was successfully constructed##2##3##(2008-10#1)(2010-1#1)
was successfully controlled##2##3##(2006-10#1)(2011-1#1)
was successfully demonstrated##2##3##(2008-10#1)(2010-5#1)
was successfully developed##3##3##(2005-12#1)(2008-10#1)(2012-11#1)
was successfully done##2##3##(2008-1#1)(2008-6#1)
was successfully employed for the##2##5##(2008-10#2)
was successfully employed in the##2##5##(2008-10#2)
was successfully employed##7##3##(2008-10#5)(2011-1#1)(2013-7#1)
was successfully established##4##3##(2008-10#1)(2008-6#1)(2010-9#1)(2012-3#1)
was successfully evaluated##3##3##(2007-8#1)(2008-10#2)
was successfully excised##2##3##(2009-1#1)(2009-10#1)
was successfully expressed in##2##4##(2005-11#1)(2012-2#1)
was successfully expressed##4##3##(1991-7#1)(1996-11#1)(2005-11#1)(2012-2#1)
was successfully formed on##2##4##(2005-11#1)(2008-2#1)
was successfully identified##3##3##(1995-12#1)(2008-10#1)(2008-11#1)
was successfully implanted##3##3##(1992-10#1)(2007-7#1)(2007-8#1)
was successfully integrated##2##3##(1997-8#1)(2009-2#1)
was successfully managed with##6##4##(2005-10#1)(2006-12#1)(2007-8#1)(2010-10#1)(2011-12#2)
was successfully managed##7##3##(2005-10#1)(2006-12#1)(2007-8#2)(2010-10#1)(2011-12#2)
was successfully obtained##2##3##(2011-1#1)(2013-7#1)
was successfully performed in##4##4##(2007-7#1)(2007-8#2)(2012-3#1)
was successfully performed on##2##4##(2008-10#1)(2008-5#1)
was successfully performed##15##3##(2007-12#1)(2007-7#1)(2007-8#5)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
was successfully prepared##2##3##(2005-11#1)(2013-1#1)
was successfully reduced##2##3##(2007-11#1)(2008-3#1)
was successfully removed##5##3##(2008-7#2)(2011-2#1)(2012-12#1)(2013-8#1)
was successfully repaired##2##3##(2007-8#1)(2011-1#1)
was successfully resected##2##3##(2007-8#1)(2013-1#1)
was successfully separated##2##3##(2008-10#1)(2013-8#1)
was successfully synthesized##2##3##(2008-12#1)(2012-12#1)
was successfully tested##5##3##(2008-10#3)(2008-2#1)(2008-3#1)
was successfully transported to a community clinic##2##7##(2012-1#2)
was successfully treated by a##2##5##(1992-2#1)(2009-4#1)
was successfully treated by complete##2##5##(2012-2#2)
was successfully treated by##13##4##(1990-8#1)(1992-2#1)(2007-11#1)(2007-8#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2012-2#2)(2013-1#2)
was successfully treated conservatively##2##4##(2008-1#1)(2011-2#1)
was successfully treated using##3##4##(1993-10#1)(2010-12#1)(2013-8#1)
was successfully treated with a##4##5##(2007-8#1)(2010-12#1)(2013-1#2)
was successfully treated with coil embolization##3##6##(2008-1#1)(2012-12#2)
was successfully treated with surgical##2##5##(2008-10#1)(2013-8#1)
was successfully treated with topical##2##5##(2007-8#1)(2012-3#1)
was successfully treated with##33##4##(1994-6#1)(1996-4#1)(2007-12#1)(2007-8#3)(2008-1#2)(2008-10#2)(2008-4#1)(2008-7#1)(2009-5#1)(2010-12#2)(2010-5#1)(2010-6#4)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
was successfully treated##55##3##(1990-8#1)(1992-2#1)(1993-10#1)(1994-6#1)(1996-4#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-8#5)(2008-1#3)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2009-5#1)(2010-12#3)(2010-5#1)(2010-6#4)(2010-8#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#2)
was successfully used as a##2##5##(2008-10#1)(2012-2#1)
was successfully used as##5##4##(2008-10#3)(2008-2#1)(2012-2#1)
was successfully used for the determination of##6##7##(2008-10#6)
was successfully used for the##8##5##(2008-10#8)
was successfully used for##10##4##(2008-10#10)
was successfully used in the##2##5##(2007-8#1)(2008-10#1)
was successfully used in##4##4##(2006-6#1)(2007-8#1)(2008-10#1)(2011-3#1)
was successfully used to##15##4##(2005-10#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#1)(2010-12#1)(2010-5#1)(2011-1#1)(2013-1#2)
was successfully used##34##3##(2005-10#1)(2006-6#1)(2007-8#2)(2008-10#16)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-1#2)
was successfully validated##2##3##(2008-10#2)
was successfully weaned##2##3##(2007-8#1)(2012-2#1)
was successfully##426##2##(1990-11#1)(1990-8#2)(1991-3#1)(1991-7#1)(1991-8#3)(1992-10#1)(1992-11#1)(1992-2#1)(1993-10#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#2)(1995-10#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-5#2)(1997-8#1)(2005-10#2)(2005-11#4)(2005-12#1)(2005-9#2)(2006-10#2)(2006-12#1)(2006-6#1)(2007-1#1)(2007-11#3)(2007-12#7)(2007-7#3)(2007-8#32)(2008-1#4)(2008-10#195)(2008-11#6)(2008-12#3)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#6)(2008-6#5)(2008-7#4)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-12#5)(2010-4#1)(2010-5#6)(2010-6#5)(2010-8#1)(2010-9#1)(2011-1#7)(2011-12#2)(2011-2#7)(2011-3#2)(2012-1#6)(2012-11#2)(2012-12#7)(2012-2#9)(2012-3#3)(2013-1#12)(2013-7#4)(2013-8#8)
was successively##4##2##(1992-5#1)(1993-8#1)(1993-9#1)(2008-10#1)
was such that##4##3##(1992-7#1)(1997-2#1)(1997-3#1)(2012-2#1)
was such##6##2##(1992-7#1)(1997-2#1)(1997-3#2)(2006-8#1)(2012-2#1)
was suffering from##6##3##(1990-3#1)(1993-7#1)(2008-12#1)(2011-1#1)(2012-12#1)(2012-2#1)
was sufficient for the##3##4##(1995-3#1)(1996-6#1)(1997-2#1)
was sufficient for##13##3##(1991-2#1)(1995-2#2)(1995-3#1)(1996-6#1)(1997-2#1)(1997-7#1)(2008-10#4)(2009-6#1)(2011-2#1)
was sufficient to account for##2##5##(1996-8#1)(2009-11#1)
was sufficient to cause##3##4##(1995-2#1)(2008-8#1)(2010-10#1)
was sufficient to confer##2##4##(1994-9#1)(2013-8#1)
was sufficient to induce##2##4##(1997-4#1)(2008-10#1)
was sufficient to maintain##2##4##(1992-12#1)(2010-2#1)
was sufficient to##33##3##(1990-2#1)(1990-7#1)(1990-8#1)(1991-3#1)(1992-12#2)(1994-11#1)(1994-9#1)(1995-2#1)(1995-3#2)(1996-8#1)(1997-4#1)(2005-9#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-11#1)(2010-10#1)(2010-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
was sufficient##51##2##(1990-2#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#1)(1992-12#2)(1994-11#1)(1994-9#1)(1995-2#3)(1995-3#3)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-9#1)(2008-10#17)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-6#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
was sufficiently high##2##3##(2008-10#1)(2008-9#1)
was sufficiently low to##2##4##(2008-10#2)
was sufficiently##13##2##(1990-6#1)(1997-6#1)(2008-10#8)(2008-11#1)(2008-8#1)(2008-9#1)
was suggested and##4##3##(2008-10#1)(2012-11#1)(2012-12#2)
was suggested as a possible##2##5##(2007-8#1)(2012-12#1)
was suggested as a##3##4##(1990-3#1)(2007-8#1)(2012-12#1)
was suggested as##5##3##(1990-3#1)(1992-8#1)(2005-11#1)(2007-8#1)(2012-12#1)
was suggested by the##3##4##(1991-10#1)(1994-3#1)(2008-10#1)
was suggested by##12##3##(1990-7#1)(1991-10#1)(1994-2#1)(1994-3#1)(1996-5#1)(1997-8#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-3#1)(2012-2#1)
was suggested earlier##3##3##(1994-5#1)(2007-9#1)(2009-12#1)
was suggested for##3##3##(1991-10#1)(1997-3#1)(2012-3#1)
was suggested in##3##3##(2006-7#1)(2008-2#1)(2008-6#1)
was suggested that the##13##4##(1992-8#1)(1993-3#1)(1993-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-6#1)(1996-2#1)(2004-9#1)(2011-1#1)(2012-12#1)(2013-8#2)
was suggested that##47##3##(1990-2#1)(1990-4#1)(1991-1#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-7#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-12#2)(1996-2#1)(2003-11#1)(2004-9#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-4#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#11)
was suggested to be##6##4##(1993-11#1)(1994-9#1)(1996-8#1)(2008-7#1)(2008-9#1)(2009-8#1)
was suggested to##9##3##(1991-12#1)(1993-11#1)(1994-9#1)(1996-8#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-8#1)
was suggested##104##2##(1990-2#2)(1990-3#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-10#2)(1991-12#1)(1992-3#1)(1992-5#1)(1992-8#2)(1993-11#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#1)(2003-11#1)(2004-9#1)(2005-11#2)(2005-4#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#3)(2008-9#2)(2009-12#1)(2009-2#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-12#2)(2011-2#1)(2011-4#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#11)
was suggestive of##10##3##(1992-11#1)(2007-7#2)(2007-8#1)(2008-1#2)(2012-2#2)(2012-3#1)(2013-8#1)
was suggestive##11##2##(1992-11#1)(1996-7#1)(2007-7#2)(2007-8#1)(2008-1#2)(2012-2#2)(2012-3#1)(2013-8#1)
was suitable for the##4##4##(1991-10#1)(2007-5#1)(2008-10#1)(2010-2#1)
was suitable for use##2##4##(2008-10#1)(2008-9#1)
was suitable for##16##3##(1991-10#1)(2007-5#1)(2008-10#6)(2008-9#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#4)
was suitable##18##2##(1991-10#1)(2007-5#1)(2008-10#7)(2008-9#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#4)(2013-8#1)
was suitably##2##2##(2008-10#1)(2008-3#1)
was summarized##4##2##(2005-4#1)(2008-5#1)(2011-2#1)(2013-8#1)
was superficial##2##2##(2007-7#1)(2007-8#1)
was superimposed on##2##3##(1995-8#1)(2007-11#1)
was superimposed##4##2##(1995-8#1)(2007-1#1)(2007-11#1)(2008-10#1)
was superior for##2##3##(1993-1#1)(2012-3#1)
was superior in terms of##2##5##(2008-10#1)(2009-2#1)
was superior in##6##3##(2008-10#2)(2009-2#1)(2012-3#1)(2013-1#2)
was superior to a##3##4##(2008-3#1)(2010-3#1)(2012-1#1)
was superior to conventional##2##4##(2007-8#2)
was superior to that observed##2##5##(2008-10#2)
was superior to that of##2##5##(1996-2#1)(2008-10#1)
was superior to that##5##4##(1993-2#1)(1996-2#1)(2008-10#3)
was superior to the##8##4##(1992-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-7#1)(2011-2#1)(2012-1#1)
was superior to##34##3##(1992-5#1)(1992-7#1)(1993-12#1)(1993-2#1)(1996-2#1)(2004-1#1)(2005-12#1)(2006-8#1)(2007-11#1)(2007-5#1)(2007-8#4)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-1#2)(2012-12#1)
was superior##46##2##(1992-5#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#1)(1996-2#1)(2004-1#1)(2005-12#1)(2006-8#1)(2007-11#1)(2007-5#1)(2007-8#4)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-3#2)(2013-1#2)
was supplemented by##4##3##(1997-6#1)(2007-7#1)(2008-12#1)(2010-4#1)
was supplemented with 100 nmolml(-1)##2##5##(2013-1#2)
was supplemented with a##2##4##(2008-10#1)(2010-4#1)
was supplemented with peptone##2##4##(2008-5#2)
was supplemented with##17##3##(1991-2#1)(1996-11#1)(1996-2#1)(2006-5#1)(2006-8#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-5#3)(2010-12#1)(2010-4#1)(2013-1#2)(2013-8#1)
was supplemented##22##2##(1991-2#1)(1996-11#1)(1996-2#1)(1997-6#1)(2006-5#1)(2006-8#1)(2007-5#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#3)(2010-12#1)(2010-4#2)(2013-1#2)(2013-8#1)
was supplied by##2##3##(1996-9#1)(2006-11#1)
was supplied to the##3##4##(1995-3#1)(2008-10#1)(2013-8#1)
was supplied##7##2##(1995-3#1)(1996-9#1)(1997-2#1)(2006-11#1)(2007-5#1)(2008-10#1)(2013-8#1)
was supported by a##5##4##(2006-10#1)(2008-8#1)(2009-4#1)(2010-11#1)(2012-1#1)
was supported by an##3##4##(2008-10#1)(2008-3#1)(2012-1#1)
was supported by the finding that##2##6##(1997-5#1)(2008-10#1)
was supported by the##8##4##(1992-12#1)(1995-3#1)(1995-8#1)(1997-5#1)(2006-10#1)(2008-10#3)
was supported by##38##3##(1990-12#1)(1991-11#1)(1991-12#1)(1992-12#1)(1993-9#1)(1994-12#1)(1995-10#1)(1995-3#1)(1995-8#1)(1996-6#1)(1997-5#1)(1997-8#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-9#1)(2008-10#12)(2008-12#1)(2008-3#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-11#1)(2011-2#1)(2012-1#2)
was supported further by##2##4##(2008-10#2)
was supported in##5##3##(2006-11#1)(2008-1#1)(2008-6#1)(2010-7#1)(2010-9#1)
was supported##53##2##(1990-12#1)(1991-11#1)(1991-12#1)(1992-12#1)(1993-9#1)(1994-12#1)(1995-10#1)(1995-3#1)(1995-8#1)(1996-6#1)(1997-5#1)(1997-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#15)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-1#2)(2012-12#1)
was supposed to##3##3##(2006-10#1)(2012-2#1)(2013-7#1)
was supposed##4##2##(2006-10#1)(2008-8#1)(2012-2#1)(2013-7#1)
was suppressed after##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
was suppressed by the addition of##3##6##(1990-3#1)(1991-6#1)(1997-2#1)
was suppressed by the##11##4##(1990-3#1)(1991-6#1)(1994-8#1)(1996-11#1)(1997-1#1)(1997-2#1)(2005-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)
was suppressed by##27##3##(1990-2#1)(1990-3#1)(1991-6#1)(1991-7#1)(1992-8#3)(1994-3#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)(2013-7#1)
was suppressed in all##2##4##(2008-10#2)
was suppressed in the##2##4##(1994-2#1)(1997-5#1)
was suppressed in##6##3##(1994-2#1)(1994-9#1)(1997-5#1)(2008-10#2)(2011-2#1)
was suppressed only##2##3##(1995-10#1)(2008-10#1)
was suppressed under##2##3##(1992-4#1)(2010-11#1)
was suppressed when compared##2##4##(2008-10#1)(2008-12#1)
was suppressed when##5##3##(1992-3#1)(1994-8#1)(2008-10#1)(2008-12#1)(2008-9#1)
was suppressed##64##2##(1990-2#1)(1990-3#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#3)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#3)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-5#1)(2004-11#1)(2005-11#1)(2007-11#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-5#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
was suppressive##3##2##(2008-10#3)
was surgery##6##2##(2004-10#1)(2007-11#1)(2008-6#1)(2012-2#1)(2013-1#2)
was surgical##4##2##(1993-5#1)(1993-9#1)(2009-5#1)(2013-1#1)
was surgically corrected##2##3##(2007-12#1)(2007-8#1)
was surgically excised##3##3##(2011-1#1)(2012-2#1)(2013-1#1)
was surgically removed##2##3##(2007-12#1)(2007-7#1)
was surgically resected##4##3##(2007-12#1)(2007-8#1)(2008-5#1)(2010-7#1)
was surgically##17##2##(1993-2#1)(2007-12#3)(2007-7#1)(2007-8#3)(2008-5#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
was surprising##2##2##(2007-5#1)(2008-11#1)
was surprisingly##6##2##(1991-12#1)(1992-10#1)(1993-6#1)(1995-11#1)(2006-12#1)(2009-6#1)
was surrounded by a##4##4##(1990-9#1)(2008-10#2)(2012-2#1)
was surrounded by##7##3##(1990-9#1)(2008-10#3)(2008-5#1)(2012-1#1)(2012-2#1)
was surveyed by##3##3##(1995-1#1)(2007-12#1)(2007-5#1)
was surveyed in##5##3##(1992-3#1)(1997-3#1)(2008-10#1)(2008-5#1)(2011-1#1)
was surveyed##18##2##(1992-3#1)(1995-1#1)(1995-9#1)(1997-3#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#2)(2008-10#2)(2008-12#1)(2008-5#1)(2011-1#1)(2013-1#1)(2013-7#1)
was susceptible to both cyromazine and abamectin##2##7##(2011-2#2)
was susceptible to both##3##4##(2008-11#1)(2011-2#2)
was susceptible to infection##2##4##(2007-12#1)(2008-10#1)
was susceptible to##15##3##(1995-1#1)(2006-12#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-4#1)(2011-2#3)(2012-2#1)
was susceptible##16##2##(1995-1#1)(2006-12#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-4#1)(2011-2#3)(2012-2#1)
was suspected and##3##3##(2006-12#1)(2007-8#1)(2013-1#1)
was suspected as##2##3##(1990-2#1)(2006-4#1)
was suspected clinically##3##3##(2008-5#1)(2008-7#1)(2012-2#1)
was suspected from##3##3##(2008-7#2)(2010-2#1)
was suspected in##3##3##(1992-12#1)(1997-2#1)(2007-2#1)
was suspected of##2##3##(1996-9#1)(2009-3#1)
was suspected on the basis of##2##6##(1990-3#1)(2008-7#1)
was suspected on##5##3##(1990-3#1)(1991-3#1)(2008-7#1)(2012-2#1)(2013-1#1)
was suspected to be a##2##5##(2010-6#1)(2010-8#1)
was suspected to be the cause##2##6##(1995-9#1)(2008-10#1)
was suspected to be##4##4##(1995-9#1)(2008-10#1)(2010-6#1)(2010-8#1)
was suspected to##5##3##(1995-9#1)(2008-10#1)(2010-6#1)(2010-8#1)(2013-8#1)
was suspected##52##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-3#1)(1992-12#1)(1992-4#2)(1992-8#1)(1993-7#1)(1994-9#1)(1995-9#1)(1996-4#1)(1996-9#1)(1997-2#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-2#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-3#1)(2009-7#1)(2010-2#1)(2010-6#2)(2010-8#1)(2011-12#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-8#2)
was suspended for##2##3##(2011-2#1)(2012-2#1)
was suspended##6##2##(1991-5#1)(2004-1#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
was suspicious##2##2##(1995-5#1)(2011-1#1)
was sustained at##2##3##(1993-8#1)(2007-8#1)
was sustained even##2##3##(2008-6#1)(2009-9#1)
was sustained for 6 h##2##5##(1997-6#1)(2010-5#1)
was sustained for##5##3##(1990-10#1)(1997-6#1)(1997-7#1)(2008-7#1)(2010-5#1)
was sustained##20##2##(1990-10#1)(1991-10#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-3#1)(1997-6#2)(1997-7#1)(2006-1#1)(2006-5#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-5#2)(2012-1#1)(2012-12#1)
was sutured##3##2##(1994-8#1)(2007-8#2)
was swallowed##3##2##(1990-6#1)(2007-3#1)(2008-10#1)
was swept##2##2##(2008-10#1)(2008-3#1)
was switched off##2##3##(2008-10#1)(2008-4#1)
was switched on##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
was switched to##3##3##(1997-3#1)(2008-1#1)(2008-7#1)
was switched##9##2##(1997-3#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
was symmetric##2##2##(2008-8#2)
was sympathetic##2##2##(1995-5#1)(1996-12#1)
was symptom-free##2##2##(1991-6#1)(1992-2#1)
was symptomatic and##2##3##(2006-2#1)(2008-7#1)
was symptomatic##3##2##(2006-2#1)(2008-7#1)(2011-3#1)
was synergistic with##3##3##(1991-3#1)(1996-8#1)(2007-12#1)
was synergistic##5##2##(1991-3#1)(1996-8#1)(2007-12#1)(2008-10#1)(2010-2#1)
was synergistically increased by##2##4##(1997-1#2)
was synthesised by##2##3##(1991-5#1)(2008-10#1)
was synthesised##5##2##(1991-5#1)(1991-7#1)(2008-10#2)(2008-4#1)
was synthesized and characterized##8##4##(1993-8#1)(1995-3#1)(2007-8#1)(2008-10#2)(2008-5#1)(2009-3#1)(2010-2#1)
was synthesized and evaluated as##2##5##(1995-3#1)(1997-2#1)
was synthesized and evaluated##3##4##(1995-3#1)(1997-2#1)(2012-1#1)
was synthesized and found to##2##5##(1992-1#1)(1992-8#1)
was synthesized and its##5##4##(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#2)
was synthesized and tested##2##4##(1992-8#1)(2008-8#1)
was synthesized and the##2##4##(1992-7#1)(1992-8#1)
was synthesized and used##4##4##(1990-2#1)(1991-6#1)(2007-11#1)(2008-10#1)
was synthesized and##41##3##(1990-12#1)(1990-2#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-7#1)(1992-8#3)(1993-8#1)(1994-11#1)(1995-3#3)(1996-8#1)(1997-2#1)(2005-11#2)(2007-11#2)(2007-8#3)(2008-10#7)(2008-12#1)(2008-5#1)(2008-8#1)(2009-3#2)(2009-9#1)(2010-2#1)(2012-1#1)(2012-12#1)
was synthesized as a##2##4##(1990-8#1)(2008-10#1)
was synthesized at##2##3##(1993-6#1)(2008-10#1)
was synthesized by a##5##4##(1997-2#1)(2008-10#3)(2013-8#1)
was synthesized by coupling##2##4##(2009-11#1)(2011-2#1)
was synthesized by reacting##2##4##(1994-2#1)(1995-3#1)
was synthesized by the##5##4##(1990-7#1)(1991-2#1)(2005-7#1)(2008-10#1)(2009-3#1)
was synthesized by using##2##4##(2008-10#2)
was synthesized by##28##3##(1990-7#1)(1991-2#1)(1992-3#1)(1992-9#1)(1994-2#1)(1994-8#1)(1995-3#1)(1997-1#1)(1997-2#1)(2005-7#1)(2007-1#1)(2007-11#1)(2008-10#9)(2008-3#1)(2008-5#1)(2009-11#1)(2009-3#1)(2011-2#1)(2013-8#2)
was synthesized for##2##3##(1993-4#1)(2007-12#1)
was synthesized from the##2##4##(1996-10#1)(2008-6#1)
was synthesized from##7##3##(1996-10#1)(1996-11#1)(2008-10#2)(2008-6#1)(2009-3#1)(2011-1#1)
was synthesized in##12##3##(1990-11#1)(1990-9#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-5#1)(1994-9#1)(1996-9#1)(2007-11#1)(2008-12#1)(2008-8#1)
was synthesized on##2##3##(1997-3#1)(2005-11#1)
was synthesized using the##2##4##(2004-9#1)(2008-10#1)
was synthesized using##5##3##(2004-9#1)(2007-12#1)(2008-10#3)
was synthesized with a##4##4##(1990-5#1)(2010-10#1)(2013-1#2)
was synthesized with##5##3##(1990-5#1)(1994-5#1)(2010-10#1)(2013-1#2)
was synthesized##141##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#2)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-3#5)(1995-8#1)(1996-10#1)(1996-11#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#1)(2004-9#1)(2005-11#3)(2005-4#1)(2005-7#1)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-8#4)(2008-10#31)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#2)(2009-11#1)(2009-3#5)(2009-4#1)(2009-9#1)(2010-10#1)(2010-2#3)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
was synthetized##2##2##(1991-3#1)(2008-7#1)
was systematically examined by##2##4##(2008-10#1)(2011-12#1)
was systematically examined##5##3##(1992-6#1)(1994-11#1)(2008-10#1)(2009-4#1)(2011-12#1)
was systematically studied##2##3##(1991-12#1)(2008-10#1)
was systematically varied##2##3##(1991-11#1)(2013-8#1)
was systematically##16##2##(1991-11#1)(1991-12#1)(1992-6#2)(1993-3#1)(1994-11#1)(1995-5#1)(1997-5#1)(2007-8#1)(2008-10#2)(2009-4#1)(2009-5#1)(2011-12#1)(2012-2#1)(2013-8#1)
was tagged with##2##3##(2008-10#2)
was tailored##3##2##(1990-12#1)(2009-9#1)(2012-12#1)
was taken after##2##3##(2007-11#1)(2008-11#1)
was taken and##2##3##(1995-6#1)(2011-2#1)
was taken as a##3##4##(1990-7#1)(1992-6#1)(2008-2#1)
was taken as an##3##4##(1996-5#1)(2008-10#1)(2008-5#1)
was taken as evidence##2##4##(2008-10#1)(2008-8#1)
was taken as the##7##4##(1996-7#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-5#1)(2011-1#1)(2013-8#1)
was taken as##24##3##(1990-7#1)(1992-11#1)(1992-12#1)(1992-6#1)(1995-8#1)(1996-5#1)(1996-7#1)(2007-1#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-5#2)(2008-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
was taken at##3##3##(2007-10#1)(2008-3#1)(2008-7#1)
was taken by##2##3##(2011-2#1)(2012-3#1)
was taken for each##3##4##(2007-7#2)(2008-10#1)
was taken for##9##3##(2005-1#1)(2007-7#2)(2008-10#2)(2008-4#1)(2008-8#1)(2010-8#1)(2012-2#1)
was taken from a##3##4##(2007-6#1)(2010-8#1)(2012-12#1)
was taken from all##2##4##(2006-8#1)(2011-1#1)
was taken from the##3##4##(2004-10#1)(2008-5#2)
was taken from##14##3##(1996-9#1)(2004-10#1)(2006-10#1)(2006-8#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
was taken in##2##3##(2006-2#1)(2008-5#1)
was taken into account by##2##5##(1993-1#1)(2008-10#1)
was taken into account in##2##5##(2008-10#1)(2008-2#1)
was taken into account##11##4##(1993-1#1)(1994-9#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-2#1)(2009-4#1)(2010-4#1)(2010-8#1)(2013-1#1)
was taken into##12##3##(1992-6#1)(1993-1#1)(1994-9#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-2#1)(2009-4#1)(2010-4#1)(2010-8#1)(2013-1#1)
was taken off##2##3##(1995-12#1)(2008-10#1)
was taken on##2##3##(2004-2#1)(2006-4#1)
was taken to the operating room##2##6##(2010-12#1)(2011-12#1)
was taken to the##3##4##(2010-12#1)(2011-12#1)(2013-1#1)
was taken to##13##3##(2006-7#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-3#2)(2010-12#1)(2011-12#1)(2011-2#1)(2013-1#1)
was taken up by the##4##5##(1992-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
was taken up by##5##4##(1991-12#1)(1992-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
was taken up##11##3##(1991-12#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-4#1)(2008-10#1)(2008-11#2)(2008-5#1)(2012-2#1)
was taken##125##2##(1990-7#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-11#2)(1992-12#2)(1992-4#1)(1992-5#1)(1992-6#2)(1993-1#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-9#1)(2004-10#1)(2004-2#1)(2005-1#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-4#1)(2006-7#2)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#2)(2007-6#1)(2007-7#4)(2007-8#3)(2008-1#1)(2008-10#12)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#7)(2008-7#3)(2008-8#2)(2009-3#2)(2009-4#1)(2009-7#1)(2010-1#1)(2010-12#2)(2010-4#2)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#3)(2013-8#1)
was taking an##2##3##(1995-6#2)
was taking##8##2##(1992-11#1)(1994-12#1)(1995-6#3)(1996-11#1)(2007-12#1)(2010-4#1)
was tapered##2##2##(2007-7#1)(2011-12#1)
was targeted##6##2##(1995-11#1)(2007-12#1)(2008-5#2)(2010-2#1)(2011-2#1)
was taught##2##2##(2010-9#1)(2013-8#1)
was technically##2##2##(2008-12#1)(2012-12#1)
was temperature dependent##3##3##(1996-9#1)(2008-10#2)
was temperature##6##2##(1993-12#1)(1996-9#1)(2007-12#2)(2008-10#2)
was temporally##2##2##(1995-3#1)(2007-10#1)
was ten times higher than##3##5##(1990-12#1)(1991-5#1)(1992-5#1)
was ten times##5##3##(1990-12#1)(1991-5#1)(1992-5#1)(2008-2#1)(2008-9#1)
was ten##6##2##(1990-12#1)(1991-5#1)(1992-5#1)(1993-1#1)(2008-2#1)(2008-9#1)
was tentatively identified as##4##4##(1990-3#1)(1995-5#1)(2006-3#1)(2008-10#1)
was tentatively##9##2##(1990-3#1)(1993-3#1)(1995-5#1)(1997-2#1)(2006-3#1)(2008-10#3)(2009-2#1)
was termed##5##2##(1994-12#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#1)
was terminated by##2##3##(1995-12#1)(2008-12#1)
was terminated in##3##3##(1993-1#1)(1993-10#1)(2005-7#1)
was terminated##14##2##(1990-5#1)(1992-3#1)(1993-1#1)(1993-10#1)(1995-12#1)(2005-7#1)(2007-8#1)(2008-12#1)(2008-4#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-4#1)(2013-8#1)
was tested against##13##3##(1995-5#1)(1996-3#1)(2006-10#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-5#1)(2009-6#1)(2010-8#1)
was tested and##12##3##(1990-5#1)(1994-12#1)(1994-9#1)(2007-12#1)(2008-10#4)(2008-3#1)(2009-11#1)(2012-11#1)(2013-8#1)
was tested as a##4##4##(1994-9#1)(1997-6#1)(1997-8#1)(2012-1#1)
was tested as an##2##4##(2008-10#2)
was tested as##8##3##(1994-9#1)(1997-6#1)(1997-8#1)(2008-10#3)(2008-3#1)(2012-1#1)
was tested at 4##2##4##(1993-9#1)(1995-5#1)
was tested at##6##3##(1993-9#1)(1995-5#1)(2006-8#1)(2008-10#2)(2008-5#1)
was tested both in##2##4##(2006-8#1)(2008-3#1)
was tested by adding##2##4##(1990-11#1)(1995-3#1)
was tested by analysing a##3##5##(2008-10#3)
was tested by analysing##6##4##(1993-2#1)(2008-10#5)
was tested by analyzing##4##4##(2008-10#3)(2011-2#1)
was tested by applying##2##4##(1996-12#1)(2008-10#1)
was tested by comparing the##2##5##(1990-2#1)(2008-10#1)
was tested by comparing##3##4##(1990-2#1)(2008-10#1)(2012-11#1)
was tested by determining##3##4##(1995-8#1)(2008-10#2)
was tested by evaluating##2##4##(1993-3#1)(2008-10#1)
was tested by measurement of the##2##6##(2008-10#1)(2008-2#1)
was tested by measuring the##5##5##(1991-12#1)(1995-1#1)(1997-8#1)(2008-11#1)(2009-10#1)
was tested by measuring##7##4##(1991-12#1)(1994-11#1)(1995-1#1)(1997-8#1)(2008-11#1)(2008-8#1)(2009-10#1)
was tested by the##6##4##(2006-10#1)(2008-10#2)(2008-5#1)(2012-7#1)(2013-8#1)
was tested by using##4##4##(1995-8#1)(1996-5#1)(2008-7#1)(2008-8#1)
was tested by##76##3##(1990-11#2)(1990-2#1)(1991-12#1)(1991-9#1)(1992-7#2)(1992-8#1)(1993-2#2)(1993-3#1)(1993-4#1)(1994-11#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#2)(1996-12#1)(1996-5#2)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-1#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#24)(2008-11#1)(2008-2#3)(2008-5#3)(2008-7#1)(2008-8#2)(2009-10#1)(2009-3#1)(2010-4#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-11#1)(2012-7#1)(2013-1#1)(2013-8#1)
was tested experimentally by##2##4##(2008-10#1)(2008-7#1)
was tested experimentally##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
was tested for a##2##4##(1993-2#1)(2007-9#1)
was tested for its ability to prevent##2##7##(1991-8#1)(2008-10#1)
was tested for its ability to##5##6##(1991-8#1)(1992-2#1)(2006-8#1)(2008-10#2)
was tested for its##10##4##(1991-8#1)(1992-2#2)(1994-6#1)(1996-12#1)(2006-8#1)(2008-10#4)
was tested for potential toxicity and carcinogenicity in two relatively well-studied models##2##12##(2008-8#1)(2008-9#1)
was tested for potential##3##4##(2008-2#1)(2008-8#1)(2008-9#1)
was tested for the determination of##3##6##(2008-10#3)
was tested for the##6##4##(1990-12#1)(1993-7#1)(2008-10#4)
was tested for##54##3##(1990-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-2#2)(1993-2#1)(1993-7#1)(1994-6#1)(1994-8#2)(1996-12#1)(1996-8#1)(1997-1#1)(2006-12#1)(2006-8#1)(2007-9#2)(2008-10#22)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-3#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
was tested here##2##3##(2008-6#1)(2012-5#1)
was tested in a sample of##2##6##(2009-8#1)(2010-10#1)
was tested in a series of##2##6##(1995-6#1)(2007-12#1)
was tested in a##19##4##(1990-10#1)(1990-8#1)(1995-6#1)(2004-4#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-8#1)(2010-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
was tested in an##5##4##(1991-12#1)(1991-3#1)(2007-9#1)(2008-10#1)(2008-7#1)
was tested in several##2##4##(1990-12#1)(2008-1#1)
was tested in the analysis of##2##6##(2008-10#2)
was tested in the determination of##3##6##(2008-10#3)
was tested in the laboratory##2##5##(2008-10#2)
was tested in the presence##2##5##(2008-11#1)(2013-1#1)
was tested in the##17##4##(1990-5#1)(1995-8#1)(2005-4#1)(2008-10#10)(2008-11#1)(2008-7#1)(2013-1#1)(2013-8#1)
was tested in two##3##4##(1997-2#1)(2008-10#1)(2012-1#1)
was tested in vitro and in##2##6##(2008-10#1)(2011-2#1)
was tested in vitro##5##4##(2008-10#1)(2008-3#2)(2008-5#1)(2011-2#1)
was tested in##82##3##(1990-10#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-3#1)(1992-7#1)(1992-8#2)(1994-3#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-2#1)(2004-4#1)(2005-4#1)(2006-11#1)(2006-12#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#22)(2008-11#3)(2008-3#4)(2008-5#5)(2008-7#2)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#2)(2013-8#2)
was tested on a##3##4##(2008-10#1)(2008-2#1)(2012-1#1)
was tested on the##5##4##(1992-2#1)(1992-8#1)(1994-2#1)(1994-5#1)(2008-10#1)
was tested on three##2##4##(2008-12#1)(2012-2#1)
was tested on##32##3##(1990-2#1)(1991-3#1)(1992-2#1)(1992-8#1)(1993-6#1)(1994-2#1)(1994-5#2)(2006-8#2)(2007-8#2)(2008-10#10)(2008-12#3)(2008-2#2)(2008-3#2)(2008-8#1)(2012-1#1)(2012-2#1)
was tested that##3##3##(1994-8#1)(1995-10#1)(2012-12#1)
was tested through##3##3##(2010-10#1)(2011-2#1)(2013-8#1)
was tested to##4##3##(1995-2#1)(2008-10#2)(2008-2#1)
was tested under##4##3##(2008-10#1)(2008-6#1)(2012-2#1)(2012-3#1)
was tested using a##5##4##(1993-9#1)(2008-10#3)(2008-3#1)
was tested using the##4##4##(1990-5#1)(2007-10#1)(2008-12#1)(2010-4#1)
was tested using two##2##4##(1995-2#1)(2008-10#1)
was tested using##21##3##(1990-5#1)(1993-9#1)(1995-2#1)(2006-5#1)(2007-10#1)(2007-2#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-10#1)(2010-4#1)(2012-3#1)(2013-1#1)
was tested whether##2##3##(1991-6#1)(2010-6#1)
was tested with the##5##4##(1994-9#1)(2006-11#2)(2007-8#1)(2008-11#1)
was tested with two##3##4##(1990-6#1)(2007-12#1)(2008-4#1)
was tested with##23##3##(1990-6#1)(1994-9#1)(1995-2#1)(1997-8#1)(2006-11#2)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-1#1)
was tested##422##2##(1990-10#2)(1990-11#4)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-3#3)(1991-6#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#3)(1992-7#3)(1992-8#4)(1993-12#1)(1993-2#3)(1993-3#1)(1993-4#1)(1993-6#2)(1993-7#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#5)(1994-9#4)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#3)(1996-12#4)(1996-3#1)(1996-4#2)(1996-5#3)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-6#3)(1997-7#2)(1997-8#3)(2004-11#1)(2004-4#1)(2005-1#1)(2005-4#1)(2006-10#2)(2006-11#3)(2006-12#5)(2006-5#2)(2006-8#5)(2007-10#1)(2007-11#5)(2007-12#5)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#5)(2007-9#3)(2008-1#2)(2008-10#127)(2008-11#8)(2008-12#6)(2008-2#8)(2008-3#13)(2008-4#1)(2008-5#13)(2008-6#4)(2008-7#7)(2008-8#7)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#4)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-12#1)(2010-2#1)(2010-4#3)(2010-6#1)(2010-8#6)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#7)(2012-1#6)(2012-11#2)(2012-12#5)(2012-2#3)(2012-3#3)(2012-5#1)(2012-7#1)(2013-1#4)(2013-8#8)
was that a##3##3##(1995-6#1)(2006-4#1)(2007-10#1)
was that in##3##3##(2005-8#1)(2007-8#1)(2008-7#1)
was that of a##7##4##(1991-7#1)(1995-8#1)(2006-8#1)(2008-11#1)(2009-5#1)(2011-2#1)(2013-8#1)
was that of##21##3##(1991-7#1)(1992-12#1)(1992-6#1)(1994-9#1)(1995-8#1)(1997-2#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-3#1)(2009-5#1)(2010-10#1)(2011-2#2)(2012-12#1)(2013-8#1)
was that the##25##3##(1991-12#2)(1991-6#1)(1992-2#1)(1992-3#2)(1992-6#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-12#1)(2006-4#1)(2007-8#2)(2008-10#4)(2008-5#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-5#1)(2011-1#1)
was that there would be a difference##2##7##(1990-8#2)
was that there##3##3##(1990-8#2)(1996-3#1)
was that they were##3##4##(2007-10#1)(2008-11#1)(2010-12#1)
was that they##5##3##(1993-2#1)(2007-10#1)(2008-11#1)(2010-12#1)(2012-12#1)
was that writing to our Tobacco Treatment Specialists was negatively associated with quit outcomes##2##14##(2013-1#2)
was that##108##2##(1990-12#1)(1990-8#2)(1991-1#1)(1991-12#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#3)(1992-9#1)(1993-10#1)(1993-2#1)(1993-3#1)(1994-2#2)(1994-9#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-8#2)(2005-11#2)(2005-12#1)(2005-8#4)(2006-12#1)(2006-4#2)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#2)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#4)(2012-12#3)(2013-1#3)(2013-8#2)
was the &quot##2##3##(2010-8#1)(2012-2#1)
was the 1##2##3##(1990-10#1)(1991-10#1)
was the ability##2##3##(2005-7#1)(2007-2#1)
was the aim of the##2##5##(2008-7#1)(2009-10#1)
was the aim of this study##2##6##(1996-11#1)(2008-11#1)
was the aim of##4##4##(1996-11#1)(2008-11#1)(2008-7#1)(2009-10#1)
was the analysis of##5##4##(2007-11#1)(2007-12#1)(2008-7#1)(2010-9#1)(2011-2#1)
was the author of##2##4##(2008-12#1)(2009-4#1)
was the basis##2##3##(1992-3#1)(2012-3#1)
was the best choice for##2##5##(2008-10#2)
was the best one for##2##5##(2005-6#1)(2007-12#1)
was the best predictor of##4##5##(1993-2#1)(1996-7#1)(2006-11#1)(2013-1#1)
was the best##27##3##(1991-2#1)(1992-3#1)(1992-8#1)(1993-2#1)(1996-7#2)(1997-8#1)(2004-11#1)(2005-11#1)(2005-6#1)(2006-10#1)(2006-11#1)(2007-10#2)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-5#2)(2008-6#1)(2013-1#2)
was the case for##3##4##(1991-7#1)(1993-1#1)(2013-1#1)
was the case in##4##4##(1990-5#1)(1995-6#1)(2006-10#1)(2008-10#1)
was the case with the##2##5##(1990-7#1)(1997-2#1)
was the case with##3##4##(1990-7#1)(1997-2#1)(2006-8#1)
was the case##13##3##(1990-5#1)(1990-7#1)(1991-7#1)(1993-1#1)(1995-6#1)(1996-12#1)(1997-2#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-5#1)(2013-1#1)
was the cause of death##2##5##(1995-3#1)(2008-4#1)
was the cause of##12##4##(1990-4#1)(1990-5#1)(1992-5#1)(1995-3#1)(1996-9#1)(1997-1#1)(2006-2#1)(2007-1#1)(2007-3#1)(2007-8#1)(2008-4#2)
was the cause##13##3##(1990-4#1)(1990-5#1)(1992-5#1)(1995-3#1)(1996-9#1)(1997-1#1)(2006-2#1)(2007-1#1)(2007-3#1)(2007-8#1)(2008-4#2)(2013-1#1)
was the change in##2##4##(2008-4#1)(2010-5#1)
was the clinical##4##3##(2008-5#1)(2010-9#1)(2011-1#1)(2013-1#1)
was the common##2##3##(1990-12#1)(2010-8#1)
was the commonest STD##2##4##(2007-7#2)
was the commonest cause of secondary##2##6##(2007-7#1)(2008-1#1)
was the commonest cause of##4##5##(2007-7#2)(2008-1#1)(2008-4#1)
was the commonest cause##6##4##(2007-7#2)(2008-1#3)(2008-4#1)
was the commonest clinical##2##4##(2007-7#2)
was the commonest mode of presentation##3##6##(1997-8#1)(2007-7#1)(2008-1#1)
was the commonest mode of##4##5##(1997-8#1)(2007-7#2)(2008-1#1)
was the commonest offending##2##4##(2007-8#1)(2008-8#1)
was the commonest secondary##2##4##(2008-1#1)(2010-4#1)
was the commonest species##4##4##(2007-7#2)(2008-5#2)
was the commonest##37##3##(1997-8#1)(2006-2#1)(2006-8#1)(2007-7#16)(2007-8#1)(2008-1#5)(2008-3#1)(2008-4#3)(2008-5#3)(2008-8#1)(2010-4#1)(2011-12#2)(2011-2#1)
was the consequence of##2##4##(1991-12#1)(2013-8#1)
was the contact##2##3##(2007-6#1)(2011-1#1)
was the control group##2##4##(2006-10#1)(2011-1#1)
was the control##3##3##(2006-10#1)(2009-5#1)(2011-1#1)
was the core##2##3##(2008-10#1)(2013-8#1)
was the creation of##3##4##(2011-12#1)(2012-3#1)(2013-8#1)
was the criterion##2##3##(1991-11#1)(1991-4#1)
was the culmination of##2##4##(2006-10#1)(2006-7#1)
was the degree of##3##4##(1995-12#1)(2008-12#1)(2010-12#1)
was the demonstration of the##2##5##(2008-10#1)(2011-2#1)
was the determination of##5##4##(1992-8#1)(1994-7#1)(2007-8#1)(2010-5#1)(2011-2#1)
was the development and##3##4##(2008-5#1)(2012-12#1)(2013-1#1)
was the development of##4##4##(2008-10#3)(2008-3#1)
was the development##7##3##(2008-10#3)(2008-3#1)(2008-5#1)(2012-12#1)(2013-1#1)
was the discovery of##2##4##(1995-8#1)(2012-1#1)
was the discovery##3##3##(1995-8#1)(2012-1#1)(2012-12#1)
was the dissection of the##2##5##(2007-7#1)(2013-1#1)
was the dominant species##2##4##(2008-10#2)
was the dominant##7##3##(1993-8#1)(2008-10#4)(2008-12#1)(2011-2#1)
was the easiest##2##3##(2009-10#1)(2012-1#1)
was the evaluation of the##3##5##(2008-5#1)(2011-1#1)(2011-2#1)
was the evaluation of##7##4##(1996-10#1)(2006-6#1)(2007-2#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
was the evaluation##8##3##(1996-10#1)(2005-9#1)(2006-6#1)(2007-2#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
was the evidence of##2##4##(1992-10#1)(2013-1#1)
was the fact that##2##4##(1996-4#1)(2007-9#1)
was the finding of##2##4##(1996-12#1)(2011-2#1)
was the finding that both##2##5##(1995-1#1)(1996-5#1)
was the finding that##8##4##(1993-2#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-5#1)(2007-5#1)(2008-7#1)
was the finding##10##3##(1993-2#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-5#1)(2007-5#1)(2008-7#1)(2011-2#1)
was the first manifestation of the##2##6##(2007-2#1)(2011-2#1)
was the first of##3##4##(2008-5#1)(2010-12#1)(2012-2#1)
was the first time that##2##5##(2006-5#1)(2008-12#1)
was the first time##4##4##(1996-12#1)(2006-5#1)(2008-12#1)(2013-7#1)
was the first to##5##4##(2005-11#1)(2006-8#1)(2008-10#2)(2012-2#1)
was the first##49##3##(1990-12#1)(1992-5#1)(1992-9#1)(1993-5#1)(1994-11#1)(1996-1#1)(1996-12#1)(2005-10#1)(2005-11#1)(2005-7#2)(2006-5#2)(2006-8#3)(2007-11#1)(2007-12#2)(2007-2#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2009-5#1)(2010-12#4)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#5)(2013-7#2)(2013-8#1)
was the founder of the##2##5##(2007-5#1)(2008-10#1)
was the greatest##4##3##(2005-11#1)(2009-10#2)(2009-7#1)
was the high frequency of##3##5##(1992-5#1)(2013-1#2)
was the high frequency##4##4##(1992-5#1)(2007-4#1)(2013-1#2)
was the high##5##3##(1992-5#1)(1996-11#1)(2007-4#1)(2013-1#2)
was the highest among all##2##5##(2008-12#1)(2011-1#1)
was the highest among##4##4##(1996-3#1)(2008-12#1)(2011-1#1)(2013-1#1)
was the highest ever##2##4##(1992-5#1)(2008-10#1)
was the highest in the##3##5##(2005-6#1)(2008-10#2)
was the highest in##5##4##(2005-6#1)(2007-11#1)(2008-10#2)(2009-7#1)
was the highest##30##3##(1990-10#1)(1991-3#1)(1992-5#1)(1996-3#1)(1997-3#1)(2005-6#2)(2006-8#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#3)
was the impact##2##3##(2006-12#1)(2007-4#1)
was the implementation##3##3##(1994-1#1)(1996-1#1)(2008-10#1)
was the importance of##2##4##(2005-8#1)(2007-8#1)
was the increased##3##3##(1991-3#1)(2008-11#1)(2011-2#1)
was the index##2##3##(2008-7#1)(2010-11#1)
was the initial##3##3##(1990-9#1)(2004-4#1)(2007-8#1)
was the introduction of a##2##5##(1997-3#1)(2007-3#1)
was the introduction of the##2##5##(2008-12#1)(2013-1#1)
was the introduction of##4##4##(1997-3#1)(2007-3#1)(2008-12#1)(2013-1#1)
was the lack of##4##4##(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)
was the largest##4##3##(1992-5#1)(1993-12#1)(1995-4#1)(2013-8#1)
was the last##4##3##(1991-3#2)(1993-12#1)(2012-2#1)
was the leading cause of##3##5##(2007-7#1)(2008-1#1)(2008-2#1)
was the leading##5##3##(2007-11#1)(2007-7#1)(2008-1#2)(2008-2#1)
was the least affected##2##4##(2010-4#1)(2011-12#1)
was the least potent##2##4##(1992-11#1)(1996-3#1)
was the least sensitive##2##4##(2007-3#1)(2008-10#1)
was the least##18##3##(1992-11#1)(1992-12#1)(1996-3#1)(2006-10#1)(2007-3#1)(2008-10#6)(2008-3#2)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#1)(2013-8#1)
was the less##2##3##(2006-10#1)(2007-11#1)
was the limiting##2##3##(2008-10#1)(2011-2#1)
was the lowest among the##2##5##(2008-5#1)(2011-3#1)
was the lowest among##3##4##(2008-5#1)(2011-3#1)(2013-1#1)
was the lowest##8##3##(1991-2#1)(1994-6#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-3#1)(2013-1#1)
was the main causative##2##4##(1992-12#1)(2008-1#1)
was the main reason for##3##5##(2007-3#1)(2012-12#1)(2013-8#1)
was the main reason##4##4##(2007-3#1)(2011-1#1)(2012-12#1)(2013-8#1)
was the main source of##2##5##(2008-10#1)(2008-3#1)
was the main##28##3##(1991-10#1)(1991-12#1)(1991-6#1)(1992-12#1)(1996-6#1)(2007-1#1)(2007-10#1)(2007-3#1)(2008-1#2)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#3)(2013-1#1)(2013-8#2)
was the major component##2##4##(1992-3#1)(1995-3#1)
was the major compound##2##4##(2008-5#1)(2013-1#1)
was the major metabolic pathway##2##5##(1990-6#1)(1996-11#1)
was the major metabolite formed##2##5##(1991-7#1)(1991-8#1)
was the major metabolite##3##4##(1991-7#1)(1991-8#1)(2006-8#1)
was the major##33##3##(1990-10#1)(1990-6#2)(1991-7#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-4#1)(1993-7#1)(1995-10#1)(1995-3#1)(1996-11#1)(1997-6#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-3#1)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-5#1)(2008-8#1)(2010-11#1)(2013-1#1)
was the metabolic rate of the##2##6##(1996-11#2)
was the more##2##3##(2006-10#1)(2011-2#1)
was the most abundant species##4##5##(2011-2#3)(2013-1#1)
was the most abundant##12##4##(1990-7#1)(1992-12#1)(2007-1#1)(2007-3#2)(2010-5#1)(2011-2#4)(2013-1#1)(2013-7#1)
was the most active against##2##5##(2008-7#2)
was the most active compound##2##5##(1994-11#1)(2008-4#1)
was the most active##7##4##(1991-12#1)(1994-11#1)(2008-4#2)(2008-7#2)(2013-8#1)
was the most affected##3##4##(1992-5#1)(2004-4#1)(2011-2#1)
was the most aggressive in##2##5##(2008-10#1)(2011-2#1)
was the most appropriate one for##2##6##(2006-1#1)(2008-10#1)
was the most appropriate##3##4##(2006-1#1)(2008-10#2)
was the most common cause of death in##2##8##(2006-2#1)(2011-2#1)
was the most common cause of##3##6##(2006-2#1)(2007-7#1)(2011-2#1)
was the most common clinical##2##5##(2008-1#1)(2008-6#1)
was the most common diagnosis##3##5##(2006-8#1)(2007-2#1)(2011-2#1)
was the most common histological##3##5##(2008-1#1)(2011-11#1)(2011-2#1)
was the most common indication for biopsy##3##7##(2008-1#2)(2010-4#1)
was the most common malignancy##2##5##(2007-3#1)(2008-4#1)
was the most common mechanism of injury##2##7##(2007-7#1)(2010-1#1)
was the most common mechanism##3##5##(2007-7#1)(2010-1#1)(2013-8#1)
was the most common parasite##2##5##(2006-2#1)(2012-3#1)
was the most common pathology##2##5##(2005-9#1)(2008-1#1)
was the most common toxicity during##2##6##(2008-10#2)
was the most common type##2##5##(2007-10#1)(2008-1#1)
was the most common##65##4##(1990-6#1)(1997-1#1)(2005-9#1)(2006-10#2)(2006-2#2)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#3)(2007-12#1)(2007-2#1)(2007-3#3)(2007-7#8)(2007-8#2)(2007-9#1)(2008-1#9)(2008-10#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#2)(2009-2#1)(2010-1#1)(2010-4#1)(2011-1#3)(2011-11#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
was the most commonly isolated##3##5##(1996-3#1)(2006-10#1)(2008-10#1)
was the most commonly##8##4##(1996-3#1)(2006-10#1)(2006-2#1)(2006-8#2)(2007-6#1)(2008-10#1)(2011-2#1)
was the most consistent##2##4##(2006-12#1)(2008-10#1)
was the most diverse##3##4##(2008-10#1)(2008-5#1)(2013-7#1)
was the most effective agent##2##5##(2008-5#1)(2008-8#1)
was the most effective and##3##5##(1990-8#1)(2008-10#1)(2012-12#1)
was the most effective in##4##5##(2007-8#1)(2008-10#2)(2010-12#1)
was the most effective##25##4##(1990-5#1)(1990-8#2)(1991-4#1)(1992-7#1)(1993-12#1)(1995-2#1)(1996-6#1)(2007-8#1)(2008-10#9)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)(2012-12#1)(2012-2#1)
was the most efficient##5##4##(1993-6#1)(1994-6#1)(2006-2#1)(2007-6#1)(2008-10#1)
was the most famous##2##4##(2006-4#1)(2011-2#1)
was the most frequent species##3##5##(2006-10#2)(2008-6#1)
was the most frequent symptom##3##5##(1991-8#1)(1995-11#1)(2012-12#1)
was the most frequent type##2##5##(2007-3#1)(2010-8#1)
was the most frequent##28##4##(1990-10#1)(1991-8#2)(1993-5#1)(1995-11#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#5)(2008-6#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-12#4)(2012-3#2)(2013-1#1)
was the most frequently isolated##2##5##(1991-11#1)(2008-5#1)
was the most frequently##9##4##(1991-11#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-4#1)(2011-2#1)(2013-1#1)
was the most important factor##2##5##(1990-5#1)(2010-8#1)
was the most important risk factor for##2##7##(1994-7#1)(2008-5#1)
was the most important##15##4##(1990-5#1)(1991-2#1)(1994-7#1)(2006-11#1)(2007-10#1)(2007-3#2)(2007-8#1)(2008-12#1)(2008-3#2)(2008-5#1)(2010-8#1)(2012-12#1)(2013-7#1)
was the most likely##3##4##(2006-12#1)(2007-4#1)(2008-7#1)
was the most numerous##3##4##(2007-8#1)(2007-9#1)(2013-7#1)
was the most potent inhibitor of##2##6##(1992-11#1)(1994-3#1)
was the most potent##7##4##(1990-7#1)(1992-11#1)(1993-11#1)(1994-3#1)(1996-2#1)(1997-4#1)(2011-2#1)
was the most prevalent##14##4##(1992-3#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
was the most prominent##2##4##(1990-5#1)(2008-6#1)
was the most reliable##2##4##(1993-2#1)(2006-5#1)
was the most resistant##3##4##(2008-10#3)
was the most sensitive and##2##5##(1992-12#1)(2012-2#1)
was the most sensitive of the##2##6##(1995-12#1)(2008-10#1)
was the most sensitive to##2##5##(1995-1#1)(2008-8#1)
was the most sensitive##12##4##(1990-12#1)(1992-11#1)(1992-12#1)(1995-1#1)(1995-12#1)(2008-10#4)(2008-6#1)(2008-8#1)(2012-2#1)
was the most serious adverse event##2##6##(2007-11#1)(2012-2#1)
was the most serious##3##4##(1991-12#1)(2007-11#1)(2012-2#1)
was the most significant##4##4##(2008-10#1)(2008-6#1)(2008-8#1)(2012-2#1)
was the most suitable for##2##5##(1990-8#1)(2007-8#1)
was the most suitable##4##4##(1990-8#1)(2007-8#1)(2008-10#1)(2008-12#1)
was the most susceptible to##2##5##(2005-11#1)(2006-11#1)
was the most susceptible##4##4##(2004-4#1)(2005-11#1)(2006-11#1)(2008-12#1)
was the most toxic##2##4##(1992-1#1)(2007-11#1)
was the most variable##2##4##(2008-10#1)(2012-12#1)
was the most##292##3##(1990-10#1)(1990-12#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#3)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-8#2)(1992-1#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-7#1)(1996-2#1)(1996-3#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-8#1)(2004-4#3)(2005-11#2)(2005-9#1)(2006-1#1)(2006-10#6)(2006-11#2)(2006-12#2)(2006-2#4)(2006-4#1)(2006-5#1)(2006-8#5)(2006-9#2)(2007-1#3)(2007-10#6)(2007-11#3)(2007-12#1)(2007-2#2)(2007-3#8)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#16)(2007-8#7)(2007-9#2)(2008-1#11)(2008-10#37)(2008-12#8)(2008-3#4)(2008-4#3)(2008-5#5)(2008-6#7)(2008-7#3)(2008-8#3)(2009-2#1)(2009-4#2)(2010-1#1)(2010-12#2)(2010-4#3)(2010-5#1)(2010-8#2)(2011-1#4)(2011-11#1)(2011-2#19)(2012-1#1)(2012-12#9)(2012-2#6)(2012-3#4)(2013-1#8)(2013-7#6)(2013-8#4)
was the need##2##3##(2007-8#1)(2008-12#1)
was the observation##2##3##(1993-9#1)(1996-2#1)
was the occurrence of##2##4##(1992-10#1)(2007-8#1)
was the one that##3##4##(2006-2#1)(2008-1#1)(2008-10#1)
was the one##4##3##(1993-12#1)(2006-2#1)(2008-1#1)(2008-10#1)
was the only compound that##2##5##(2005-8#2)
was the only factor associated with##2##6##(2007-10#1)(2011-1#1)
was the only factor that was significantly##2##7##(2006-9#1)(2012-12#1)
was the only factor that##4##5##(1991-2#1)(2006-9#1)(2007-7#1)(2012-12#1)
was the only factor##8##4##(1991-2#1)(2006-9#1)(2007-10#1)(2007-7#1)(2008-4#1)(2011-1#1)(2012-12#1)(2012-2#1)
was the only independent predictor##2##5##(1997-1#1)(2013-1#1)
was the only major##2##4##(2008-7#1)(2011-12#1)
was the only one##6##4##(1990-12#1)(1991-5#1)(1994-2#1)(1997-5#1)(2006-12#1)(2008-7#1)
was the only product##2##4##(2004-9#1)(2008-5#1)
was the only race##2##4##(2008-10#2)
was the only side effect##2##5##(1990-9#1)(2005-7#1)
was the only significant predictor##3##5##(1993-1#1)(2007-10#1)(2008-9#1)
was the only significant risk factor for##2##7##(2011-2#1)(2012-2#1)
was the only significant##7##4##(1993-1#1)(1994-12#1)(2007-10#1)(2007-6#1)(2008-9#1)(2011-2#1)(2012-2#1)
was the only symptom##2##4##(1993-5#1)(1993-8#1)
was the only treatment##4##4##(2006-8#1)(2007-7#1)(2010-8#1)(2011-2#1)
was the only variable##2##4##(1990-8#1)(2013-1#1)
was the only##105##3##(1990-12#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-2#2)(1991-3#4)(1991-5#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#2)(2004-9#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-6#3)(2007-7#4)(2007-9#1)(2008-10#9)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#2)(2010-4#1)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#2)
was the opposite##2##3##(2007-8#1)(2012-12#1)
was the optimal##3##3##(1995-8#1)(2008-10#1)(2012-2#1)
was the optimized##2##3##(2008-10#1)(2012-12#1)
was the organic##2##3##(2008-10#1)(2011-12#1)
was the predominant compound##2##4##(1990-3#1)(2007-1#1)
was the predominant isolate##2##4##(2007-7#2)
was the predominant mode##3##4##(2008-10#3)
was the predominant species##5##4##(1990-3#1)(1994-11#1)(1996-12#1)(2007-8#1)(2008-10#1)
was the predominant##33##3##(1990-3#3)(1991-9#1)(1992-12#1)(1992-6#1)(1994-11#1)(1996-12#1)(2004-9#1)(2006-10#2)(2006-8#1)(2007-1#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#10)(2008-5#1)(2010-12#1)(2010-5#1)(2012-1#1)(2013-1#1)(2013-8#1)
was the preferred strategy##3##4##(2012-3#3)
was the preferred##6##3##(1993-10#1)(1996-6#1)(2006-10#1)(2012-3#3)
was the presence of a##3##5##(1991-9#1)(1992-3#1)(2012-12#1)
was the presence of##7##4##(1991-9#1)(1992-3#1)(1996-7#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-3#1)
was the presence##10##3##(1990-7#2)(1991-9#1)(1992-3#1)(1996-7#1)(2008-2#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-3#1)
was the presenting feature##2##4##(2007-7#1)(2008-1#1)
was the presenting##3##3##(2007-7#1)(2007-8#1)(2008-1#1)
was the primary diagnosis in##2##5##(1992-1#2)
was the primary##16##3##(1992-1#2)(1993-8#1)(1994-9#1)(2005-7#1)(2007-1#1)(2007-12#3)(2007-8#1)(2008-10#4)(2009-4#1)(2013-1#1)
was the principal##3##3##(1990-5#1)(2008-1#1)(2011-1#1)
was the principle##2##3##(1997-1#1)(2008-5#1)
was the production of##2##4##(1996-2#1)(2012-2#1)
was the proportion of patients achieving##2##6##(2010-8#1)(2013-1#1)
was the proportion of patients##3##5##(2007-10#1)(2010-8#1)(2013-1#1)
was the proportion of##4##4##(2007-10#1)(2010-8#1)(2012-2#1)(2013-1#1)
was the reason for##2##4##(1992-9#1)(2006-10#1)
was the result of a##3##5##(1990-12#1)(1990-7#1)(2009-1#1)
was the result of three##2##5##(1996-1#1)(2009-2#1)
was the result of##16##4##(1990-12#1)(1990-7#1)(1992-1#1)(1995-2#1)(1996-1#1)(1996-4#1)(1997-5#1)(1997-8#1)(2004-1#1)(2004-3#1)(2007-12#1)(2007-8#2)(2009-1#1)(2009-2#1)(2013-1#1)
was the rule##2##3##(1995-9#1)(2007-7#1)
was the same as at##2##5##(2007-10#1)(2010-8#1)
was the same as that observed for##2##7##(1992-7#1)(1995-3#1)
was the same as that of the##3##7##(1993-9#1)(2007-1#1)(2008-5#1)
was the same as that of##8##6##(1990-5#1)(1990-6#1)(1993-9#1)(1995-5#1)(2007-1#1)(2008-10#1)(2008-5#1)(2013-8#1)
was the same as that##13##5##(1990-5#1)(1990-6#1)(1992-7#1)(1993-9#1)(1995-3#1)(1995-5#1)(2004-12#1)(2007-1#1)(2007-7#1)(2008-10#2)(2008-5#1)(2013-8#1)
was the same as the##3##5##(1994-8#1)(2005-11#1)(2012-3#1)
was the same as##29##4##(1990-5#1)(1990-6#1)(1991-12#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-9#1)(1994-8#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-8#1)(2004-12#1)(2005-11#1)(2007-1#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-8#1)(2012-3#1)(2013-8#1)
was the same for both##4##5##(1990-2#1)(1995-11#1)(1996-2#1)(2008-5#1)
was the same for##7##4##(1990-2#1)(1995-11#1)(1996-2#1)(1996-9#1)(2004-9#1)(2008-10#1)(2008-5#1)
was the same in all##2##5##(1996-1#1)(2008-10#1)
was the same in both groups##3##6##(1993-9#1)(1994-3#1)(1996-7#1)
was the same in both##6##5##(1991-2#1)(1993-9#1)(1994-3#1)(1995-1#1)(1996-7#1)(2008-11#1)
was the same in the presence or absence of##2##9##(1993-11#1)(1997-1#1)
was the same in the two groups##3##7##(1992-11#1)(2007-7#1)(2009-9#1)
was the same in the##5##5##(1992-11#1)(1993-11#1)(1997-1#1)(2007-7#1)(2009-9#1)
was the same in##15##4##(1991-2#2)(1991-4#1)(1992-11#1)(1993-11#1)(1993-9#1)(1994-3#1)(1995-1#1)(1996-1#1)(1996-7#1)(1997-1#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-9#1)
was the same##59##3##(1990-2#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-2#2)(1991-4#1)(1992-11#1)(1992-5#1)(1992-6#2)(1992-7#1)(1993-11#1)(1993-2#1)(1993-9#2)(1994-3#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(2004-12#1)(2004-9#1)(2005-11#1)(2007-1#1)(2007-10#1)(2007-3#1)(2007-7#3)(2008-10#6)(2008-11#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-8#1)(2012-3#1)(2013-8#2)
was the second in##2##4##(2005-8#1)(2008-5#1)
was the second most common lesion##2##6##(2007-7#1)(2008-1#1)
was the second most common##3##5##(2007-2#1)(2007-7#1)(2008-1#1)
was the second most frequent##2##5##(2007-10#1)(2011-2#1)
was the second most##6##4##(2007-10#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-12#1)(2011-2#1)
was the second##9##3##(2005-8#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
was the selected##4##3##(2008-10#2)(2013-1#2)
was the single##2##3##(1997-2#1)(2006-8#1)
was the site of##2##4##(1991-10#1)(2008-9#1)
was the situation##2##3##(2005-11#1)(2007-12#1)
was the sole##13##3##(1990-12#1)(1992-11#1)(1992-2#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-6#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-3#1)
was the source of##3##4##(1997-1#1)(1997-5#1)(2008-5#1)
was the species##2##3##(2008-12#1)(2008-5#1)
was the specific##2##3##(1997-7#1)(2008-9#1)
was the standard##2##3##(1993-12#1)(2010-3#1)
was the strongest predictor of##9##5##(1995-5#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-3#1)
was the strongest predictor##10##4##(1995-5#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-3#2)
was the strongest##15##3##(1995-5#1)(2007-8#1)(2008-12#1)(2008-3#2)(2008-9#1)(2009-2#1)(2010-10#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-3#2)
was the subject of##3##4##(1991-9#1)(2005-8#2)
was the technique##2##3##(2008-10#1)(2010-6#1)
was the tendency##2##3##(1997-2#1)(2008-1#1)
was the third leading cause##2##5##(2008-4#1)(2013-1#1)
was the third##5##3##(1992-2#1)(2008-12#1)(2008-4#1)(2008-5#1)(2013-1#1)
was the treatment of choice##2##5##(1992-3#1)(2013-8#1)
was the treatment of##3##4##(1992-3#1)(2005-8#1)(2013-8#1)
was the type##2##3##(1994-2#1)(2013-1#1)
was the use of high##2##5##(2008-10#1)(2008-3#1)
was the use of##8##4##(1992-2#1)(1992-8#1)(2008-10#2)(2008-3#1)(2011-1#2)(2013-1#1)
was the variable##2##3##(1991-2#1)(1993-11#1)
was the work of##2##4##(1996-1#1)(2008-10#1)
was the##1430##2##(1990-1#1)(1990-10#6)(1990-11#3)(1990-12#7)(1990-2#2)(1990-3#5)(1990-4#2)(1990-5#8)(1990-6#6)(1990-7#8)(1990-8#7)(1990-9#4)(1991-1#1)(1991-10#5)(1991-11#2)(1991-12#10)(1991-2#13)(1991-3#9)(1991-4#4)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#8)(1991-9#4)(1992-1#6)(1992-10#3)(1992-11#8)(1992-12#5)(1992-2#4)(1992-3#7)(1992-4#3)(1992-5#10)(1992-6#3)(1992-7#4)(1992-8#3)(1992-9#4)(1993-1#4)(1993-10#2)(1993-11#3)(1993-12#10)(1993-2#6)(1993-4#1)(1993-5#5)(1993-6#2)(1993-7#2)(1993-8#4)(1993-9#6)(1994-1#1)(1994-11#4)(1994-12#2)(1994-2#5)(1994-3#3)(1994-6#3)(1994-7#2)(1994-8#6)(1994-9#3)(1995-1#5)(1995-10#1)(1995-11#4)(1995-12#5)(1995-2#4)(1995-3#3)(1995-4#1)(1995-5#3)(1995-6#5)(1995-7#1)(1995-8#4)(1995-9#1)(1996-1#6)(1996-10#1)(1996-11#7)(1996-12#5)(1996-2#4)(1996-3#7)(1996-4#2)(1996-5#3)(1996-6#5)(1996-7#6)(1996-8#2)(1996-9#5)(1997-1#7)(1997-2#5)(1997-3#7)(1997-4#2)(1997-5#3)(1997-6#3)(1997-7#4)(1997-8#6)(2004-1#1)(2004-10#2)(2004-11#3)(2004-12#2)(2004-3#2)(2004-4#4)(2004-9#5)(2005-10#2)(2005-11#8)(2005-6#3)(2005-7#7)(2005-8#14)(2005-9#4)(2006-1#1)(2006-10#21)(2006-11#4)(2006-12#6)(2006-2#11)(2006-4#3)(2006-5#4)(2006-6#2)(2006-7#1)(2006-8#17)(2006-9#3)(2007-1#11)(2007-10#17)(2007-11#14)(2007-12#13)(2007-2#11)(2007-3#15)(2007-4#7)(2007-5#7)(2007-6#7)(2007-7#57)(2007-8#30)(2007-9#7)(2008-1#35)(2008-10#151)(2008-11#14)(2008-12#28)(2008-2#6)(2008-3#21)(2008-4#14)(2008-5#49)(2008-6#15)(2008-7#19)(2008-8#13)(2008-9#12)(2009-1#1)(2009-10#6)(2009-11#2)(2009-2#3)(2009-4#6)(2009-5#6)(2009-7#3)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#3)(2010-12#16)(2010-2#2)(2010-3#4)(2010-4#12)(2010-5#7)(2010-6#1)(2010-8#10)(2010-9#3)(2011-1#23)(2011-11#1)(2011-12#10)(2011-2#48)(2011-3#2)(2012-1#4)(2012-11#2)(2012-12#27)(2012-2#27)(2012-3#15)(2013-1#47)(2013-7#16)(2013-8#28)
was their##6##2##(1991-12#1)(1992-3#1)(2007-10#1)(2007-3#1)(2009-4#1)(2009-9#1)
was then added##2##3##(1990-12#1)(2012-12#1)
was then administered##2##3##(1991-3#1)(2010-2#1)
was then adopted as a##2##5##(2006-10#1)(2008-11#1)
was then analyzed##2##3##(2007-12#1)(2010-12#1)
was then applied for##2##4##(2008-10#1)(2012-2#1)
was then applied in##2##4##(2008-10#1)(2013-7#1)
was then applied to the##3##5##(2008-10#2)(2011-1#1)
was then applied to##8##4##(1991-9#1)(2006-12#1)(2008-10#2)(2009-2#1)(2011-1#1)(2012-2#1)(2012-3#1)
was then applied##15##3##(1991-9#1)(2006-12#1)(2008-10#4)(2008-5#2)(2009-2#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)
was then assessed##3##3##(2006-7#1)(2008-10#1)(2013-1#1)
was then attached to the##2##5##(2008-11#1)(2008-4#1)
was then calculated for##2##4##(2008-10#1)(2010-2#1)
was then calculated##3##3##(2008-10#1)(2008-6#1)(2010-2#1)
was then carried##2##3##(1994-3#1)(2008-10#1)
was then chosen##2##3##(2006-12#1)(2008-7#1)
was then cloned into##2##4##(1991-6#1)(2005-11#1)
was then compared with the##2##5##(2004-10#1)(2008-2#1)
was then compared##4##3##(2004-10#1)(2008-10#1)(2008-2#1)(2008-5#1)
was then confirmed by##2##4##(2010-12#1)(2012-12#1)
was then confirmed##3##3##(2008-12#1)(2010-12#1)(2012-12#1)
was then constructed##2##3##(1992-7#1)(2013-8#1)
was then converted to##4##4##(1994-12#1)(1994-3#1)(2008-10#1)(2008-4#1)
was then coupled with##2##4##(2008-10#1)(2008-5#1)
was then demonstrated##2##3##(1990-12#1)(1990-8#1)
was then determined by##3##4##(2008-10#2)(2008-5#1)
was then determined##7##3##(1990-6#1)(2006-8#1)(2008-10#4)(2008-5#1)
was then developed for##2##4##(2008-10#1)(2008-7#1)
was then digested with##2##4##(1990-7#1)(2008-8#1)
was then eluted with##2##4##(2008-10#2)
was then evaluated in##2##4##(2007-8#1)(2008-11#1)
was then evaluated##5##3##(1992-1#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)
was then examined##3##3##(1995-3#1)(2008-7#1)(2009-10#1)
was then extracted with##2##4##(2007-8#1)(2008-10#1)
was then extracted##5##3##(2007-2#1)(2007-8#1)(2008-10#2)(2008-5#1)
was then followed##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
was then fractionated by##2##4##(1992-4#1)(1994-3#1)
was then identified##3##3##(2005-11#1)(2006-9#1)(2010-11#1)
was then implemented##2##3##(2006-10#1)(2008-11#1)
was then incorporated into##2##4##(1995-8#1)(2010-2#1)
was then induced##2##3##(2007-9#1)(2010-6#1)
was then injected##2##3##(1995-12#1)(2008-10#1)
was then investigated##2##3##(1993-8#1)(2006-3#1)
was then isolated##2##3##(1992-7#1)(1994-3#1)
was then made##4##3##(1991-7#1)(1994-2#1)(2010-3#1)(2011-2#1)
was then measured##3##3##(1996-9#1)(2007-8#1)(2008-5#1)
was then mixed with the reagent##2##6##(2008-10#2)
was then optimised##2##3##(2007-8#1)(2008-10#1)
was then performed by##4##4##(1993-3#1)(2008-10#2)(2013-7#1)
was then performed in##2##4##(2005-11#1)(2005-12#1)
was then performed to##4##4##(2006-7#1)(2008-11#1)(2013-1#2)
was then performed##13##3##(1993-3#1)(2005-11#1)(2005-12#1)(2006-7#1)(2007-11#1)(2008-10#3)(2008-11#1)(2011-2#1)(2013-1#2)(2013-7#1)
was then placed##2##3##(2008-10#1)(2012-2#1)
was then purified by##3##4##(1994-2#1)(1994-8#1)(1996-11#1)
was then purified##4##3##(1994-2#1)(1994-8#1)(1996-11#1)(2008-5#1)
was then removed##5##3##(1990-2#1)(1990-5#1)(2013-1#2)(2013-8#1)
was then repeated##3##3##(1993-2#1)(2008-10#2)
was then separated##3##3##(2007-4#1)(2008-10#2)
was then successfully treated with##2##5##(1990-8#1)(2012-2#1)
was then successfully##4##3##(1990-8#1)(2005-11#1)(2008-7#1)(2012-2#1)
was then taken##2##3##(2008-3#1)(2012-12#1)
was then tested in##2##4##(1990-10#1)(2008-5#1)
was then tested##4##3##(1990-10#1)(2008-10#1)(2008-3#1)(2008-5#1)
was then transferred##3##3##(1996-8#1)(2007-8#1)(2008-10#1)
was then treated with##9##4##(1994-3#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-9#2)(2008-10#1)(2009-3#1)(2012-2#1)
was then used as a##3##5##(1991-2#1)(2005-11#1)(2009-12#1)
was then used as##5##4##(1991-2#1)(2005-11#1)(2008-5#1)(2009-11#1)(2009-12#1)
was then used for a##2##5##(1995-2#1)(2008-10#1)
was then used for##4##4##(1995-2#1)(2008-10#2)(2013-8#1)
was then used in##2##4##(2007-12#1)(2008-10#1)
was then used to predict##3##5##(1995-8#1)(2008-3#1)(2008-7#1)
was then used to study##2##5##(2006-11#1)(2008-5#1)
was then used to##19##4##(1991-5#1)(1993-9#1)(1995-8#1)(2006-11#1)(2007-12#1)(2008-10#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#2)
was then used##30##3##(1991-2#1)(1991-5#1)(1993-9#1)(1995-2#1)(1995-8#1)(2005-11#1)(2006-11#1)(2007-12#2)(2008-10#5)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#2)(2009-12#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
was then utilized##2##3##(2006-11#1)(2011-2#1)
was then##295##2##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#2)(1994-3#5)(1994-8#1)(1995-12#3)(1995-2#3)(1995-3#2)(1995-8#2)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-10#1)(2005-11#8)(2005-12#1)(2005-4#1)(2006-10#3)(2006-11#4)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-4#2)(2007-7#2)(2007-8#7)(2007-9#3)(2008-10#60)(2008-11#8)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#14)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#3)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#8)(2012-12#7)(2012-2#8)(2012-3#1)(2013-1#9)(2013-7#3)(2013-8#6)
was theoretically and##2##3##(2007-12#2)
was theoretically##8##2##(2005-11#1)(2007-12#3)(2008-2#1)(2008-3#3)
was therapeutic##3##2##(2006-5#1)(2007-3#1)(2010-12#1)
was there a significant##3##4##(1992-4#1)(1996-8#1)(2008-10#1)
was there a##5##3##(1992-4#1)(1996-8#1)(2008-10#1)(2008-3#1)(2010-8#1)
was there any evidence##2##4##(1991-4#1)(1992-5#1)
was there any##4##3##(1991-4#1)(1992-5#1)(1992-9#1)(1996-9#1)
was there##15##2##(1990-4#1)(1991-4#1)(1992-4#1)(1992-5#1)(1992-9#1)(1996-5#1)(1996-8#1)(1996-9#1)(2005-11#1)(2007-2#1)(2008-10#1)(2008-3#1)(2010-11#1)(2010-8#1)(2013-8#1)
was thereafter##2##2##(2008-10#1)(2008-4#1)
was thereby##4##2##(1996-8#1)(1997-7#1)(2008-8#1)(2009-4#1)
was therefore assessed##2##3##(2006-7#1)(2011-2#1)
was therefore carried out##3##4##(2005-11#1)(2010-10#1)(2011-2#1)
was therefore concluded##6##3##(1991-7#1)(1996-2#1)(1996-7#1)(1997-3#1)(2007-1#1)(2008-10#1)
was therefore conducted##2##3##(2007-7#1)(2011-2#1)
was therefore considered##2##3##(2007-8#1)(2008-5#1)
was therefore designed##5##3##(1994-12#2)(2008-3#1)(2009-5#1)(2011-1#1)
was therefore not##3##3##(1991-11#1)(1996-1#1)(1997-7#1)
was therefore performed##2##3##(2007-12#1)(2008-5#1)
was therefore the##2##3##(1991-4#1)(2007-4#1)
was therefore undertaken##2##3##(2008-12#1)(2012-2#1)
was therefore##75##2##(1990-5#2)(1990-9#1)(1991-11#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-7#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-10#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-1#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#3)(2009-5#2)(2009-6#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
was thermally stable##2##3##(2008-5#1)(2010-4#1)
was thermally##5##2##(1995-3#1)(1996-11#1)(1997-5#1)(2008-5#1)(2010-4#1)
was thickened##4##2##(1991-8#1)(2005-7#1)(2007-11#1)(2008-10#1)
was thicker and##2##3##(2007-11#1)(2010-12#1)
was thinner##2##2##(1997-3#1)(2008-9#1)
was thirty times##2##3##(1991-10#1)(1992-12#1)
was this##2##2##(1995-12#1)(2008-12#1)
was thoroughly##5##2##(1990-5#1)(1993-2#1)(2004-9#1)(2005-8#1)(2008-10#1)
was thought to be a##7##5##(2005-11#1)(2005-5#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-8#1)
was thought to be an##2##5##(1991-7#1)(1993-3#1)
was thought to be due to##2##6##(1992-12#1)(2011-1#1)
was thought to be of##2##5##(2011-2#1)(2013-1#1)
was thought to be the##4##5##(1994-4#1)(2007-10#1)(2008-7#2)
was thought to be##27##4##(1990-10#1)(1991-7#1)(1992-12#1)(1993-1#1)(1993-3#1)(1994-4#1)(1996-11#1)(2005-11#1)(2005-5#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
was thought to have been##2##5##(1992-3#1)(1996-12#1)
was thought to have caused##2##5##(2012-2#2)
was thought to have##8##4##(1992-3#1)(1996-12#1)(2006-6#2)(2008-4#1)(2010-6#1)(2012-2#2)
was thought to occur##2##4##(2008-10#1)(2008-7#1)
was thought to##43##3##(1990-10#1)(1991-7#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-4#1)(1996-11#1)(1996-12#1)(2005-11#1)(2005-5#1)(2006-6#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2010-2#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#1)
was thought##53##2##(1990-10#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-4#1)(1996-11#1)(1996-12#1)(1996-3#1)(2004-12#1)(2005-11#1)(2005-5#1)(2006-6#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#2)(2010-2#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#1)
was three times greater##2##4##(2008-10#2)
was three times##4##3##(1994-8#1)(1995-1#1)(2008-10#2)
was three##5##2##(1994-8#1)(1995-1#1)(2006-6#1)(2008-10#2)
was three-fold##2##2##(1997-5#1)(2009-5#1)
was through binding##2##3##(2008-11#2)
was through##8##2##(1995-6#1)(2007-8#2)(2008-11#2)(2008-7#1)(2010-12#1)(2011-1#1)
was thus concluded##4##3##(1994-2#1)(1995-3#1)(2007-10#1)(2009-8#1)
was thus demonstrated##3##3##(1994-3#1)(2008-10#1)(2008-11#1)
was thus##31##2##(1990-2#1)(1990-6#1)(1990-8#1)(1991-11#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-10#1)(1996-4#1)(2006-4#1)(2006-8#1)(2007-10#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-6#1)(2009-8#1)(2011-2#1)(2012-12#1)
was tightly##5##2##(1992-12#1)(1992-6#1)(1995-2#1)(1997-6#1)(2008-7#1)
was time and##2##3##(1990-12#1)(1991-4#1)
was time##6##2##(1990-12#1)(1991-4#1)(2006-9#1)(2007-8#1)(2008-5#1)(2009-10#1)
was time- and dose-dependent##2##4##(1993-12#1)(1995-12#1)
was time- and##4##3##(1993-12#1)(1994-6#1)(1995-12#1)(1995-5#1)
was time-dependent and##3##3##(1992-3#1)(1994-10#1)(1996-6#1)
was time-dependent##6##2##(1990-8#1)(1992-3#1)(1994-10#1)(1994-12#1)(1994-2#1)(1996-6#1)
was titrated with##4##3##(1992-6#1)(1994-5#1)(1995-2#1)(2009-12#1)
was titrated##8##2##(1992-6#1)(1994-5#1)(1995-2#1)(1997-2#1)(2008-10#2)(2008-7#1)(2009-12#1)
was to address this##2##4##(2008-12#1)(2009-4#1)
was to address##4##3##(2007-7#1)(2008-12#1)(2009-4#2)
was to analyse the##14##4##(2004-10#1)(2007-10#1)(2007-8#2)(2008-4#1)(2008-5#1)(2008-6#2)(2009-2#1)(2010-3#1)(2011-1#1)(2011-12#1)(2013-1#1)(2013-8#1)
was to analyse##20##3##(2004-10#1)(2007-10#1)(2007-11#1)(2007-8#3)(2008-4#1)(2008-5#1)(2008-6#2)(2009-2#1)(2010-3#1)(2011-1#2)(2011-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
was to analyze the##29##4##(1995-8#1)(1997-8#1)(2006-11#1)(2006-5#1)(2007-3#1)(2007-6#1)(2007-7#4)(2007-8#4)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-9#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#2)
was to analyze##47##3##(1995-8#1)(1997-8#1)(2004-2#1)(2005-5#1)(2006-11#1)(2006-4#1)(2006-5#1)(2007-3#1)(2007-6#1)(2007-7#4)(2007-8#5)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#2)(2010-4#1)(2010-9#1)(2011-12#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#1)
was to answer the following##2##5##(1994-8#1)(2012-3#1)
was to answer the##3##4##(1994-8#1)(2007-8#1)(2012-3#1)
was to apply a##2##4##(2008-10#1)(2008-5#1)
was to apply##8##3##(2008-10#2)(2008-2#1)(2008-5#2)(2013-1#3)
was to ascertain the##6##4##(1991-12#1)(2007-7#1)(2007-8#1)(2008-9#1)(2010-3#1)(2011-1#1)
was to ascertain whether##3##4##(1997-4#1)(1997-8#1)(2010-7#1)
was to ascertain##11##3##(1991-12#1)(1992-3#1)(1997-4#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-9#1)(2010-3#1)(2010-7#1)(2011-1#1)
was to assess outcome in##2##5##(2007-7#2)
was to assess the accuracy##2##5##(1994-3#1)(2007-11#1)
was to assess the effectiveness of##8##6##(1993-9#1)(2006-10#1)(2007-7#2)(2011-2#2)(2012-12#1)(2012-3#1)
was to assess the effectiveness##10##5##(1993-9#1)(2006-10#1)(2006-6#1)(2007-7#2)(2008-3#1)(2011-2#2)(2012-12#1)(2012-3#1)
was to assess the efficiency of##2##6##(1993-5#1)(2007-7#1)
was to assess the extent##2##5##(2005-11#1)(2013-1#1)
was to assess the feasibility and##3##6##(2006-6#1)(2007-10#1)(2009-11#1)
was to assess the feasibility of##3##6##(1993-12#1)(1997-8#1)(2007-8#1)
was to assess the feasibility##6##5##(1993-12#1)(1997-8#1)(2006-6#1)(2007-10#1)(2007-8#1)(2009-11#1)
was to assess the impact of##3##6##(1992-1#1)(2007-8#1)(2008-3#1)
was to assess the impact##4##5##(1992-1#1)(2007-8#2)(2008-3#1)
was to assess the incidence##2##5##(1990-6#1)(2007-8#1)
was to assess the influence of##6##6##(2008-5#1)(2009-2#1)(2009-8#1)(2010-10#1)(2013-1#1)(2013-7#1)
was to assess the possible##3##5##(2007-9#1)(2012-3#1)(2012-8#1)
was to assess the potential efficacy and safety of##2##9##(2008-7#1)(2013-1#1)
was to assess the potential##5##5##(1996-9#1)(2008-5#2)(2008-7#1)(2013-1#1)
was to assess the validity of##2##6##(1991-12#1)(2008-4#1)
was to assess the##127##4##(1990-6#2)(1991-12#1)(1991-6#1)(1992-1#1)(1992-10#2)(1992-12#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-3#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-9#2)(1997-8#1)(2004-12#1)(2004-9#1)(2005-1#2)(2005-11#1)(2006-10#2)(2006-6#3)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-2#4)(2007-3#1)(2007-7#11)(2007-8#9)(2007-9#4)(2008-12#3)(2008-3#3)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#2)(2009-4#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-9#1)(2011-1#1)(2011-2#5)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#3)(2012-8#1)(2013-1#3)(2013-7#1)(2013-8#3)
was to assess whether##12##4##(1991-6#1)(1995-6#2)(2006-7#1)(2006-8#2)(2007-7#1)(2008-5#1)(2008-7#1)(2009-7#1)(2012-2#2)
was to assess##175##3##(1990-6#2)(1990-8#1)(1991-12#1)(1991-6#2)(1992-1#1)(1992-10#2)(1992-12#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-3#2)(1995-1#2)(1995-6#2)(1996-1#1)(1996-12#1)(1996-9#2)(1997-8#1)(2004-12#1)(2004-2#1)(2004-9#1)(2005-1#2)(2005-11#1)(2006-10#5)(2006-2#1)(2006-6#3)(2006-7#2)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-2#5)(2007-3#1)(2007-7#18)(2007-8#11)(2007-9#5)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#3)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#7)(2008-8#2)(2008-9#3)(2009-11#1)(2009-2#2)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#8)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#3)(2012-8#1)(2013-1#4)(2013-7#1)(2013-8#3)
was to be##11##3##(1994-3#1)(1996-9#1)(2005-10#1)(2007-5#1)(2007-8#1)(2008-8#1)(2009-3#1)(2010-1#1)(2010-4#1)(2012-12#2)
was to become##3##3##(2006-5#1)(2008-8#1)(2013-1#1)
was to bring the##2##4##(1992-1#1)(2008-3#1)
was to bring together##3##4##(2006-2#1)(2007-11#1)(2011-1#1)
was to bring##5##3##(1992-1#1)(2006-2#1)(2007-11#1)(2008-3#1)(2011-1#1)
was to build a##2##4##(2007-11#1)(2013-1#1)
was to build##3##3##(2007-11#1)(2008-7#1)(2013-1#1)
was to change the##2##4##(1991-1#1)(2013-7#1)
was to change##3##3##(1991-1#1)(1996-7#1)(2013-7#1)
was to characterize the##12##4##(2004-9#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-2#1)(2010-4#2)(2011-2#1)(2012-12#1)
was to characterize##23##3##(1993-1#1)(1994-8#1)(1996-11#1)(2004-9#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-5#3)(2009-11#1)(2010-2#1)(2010-4#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
was to clarify the##6##4##(2007-10#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
was to clarify##8##3##(2007-10#1)(2007-2#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-8#2)
was to classify##4##3##(2006-5#1)(2008-10#1)(2009-11#1)(2010-4#1)
was to collect##3##3##(1995-3#1)(2007-12#1)(2010-3#1)
was to compare differences in##2##5##(2008-12#1)(2011-2#1)
was to compare efficacy##2##4##(2004-1#1)(2008-3#1)
was to compare laparoscopically assisted vaginal hysterectomy##2##7##(1993-12#1)(1994-2#1)
was to compare the effectiveness##2##5##(2007-7#1)(2013-8#1)
was to compare the efficacy##4##5##(2006-10#1)(2007-9#1)(2011-12#1)(2013-1#1)
was to compare the functional##2##5##(1992-10#1)(2013-8#1)
was to compare the##75##4##(1990-10#1)(1992-10#1)(1993-9#1)(1994-3#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-5#1)(1997-8#2)(2004-1#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#5)(2007-8#6)(2007-9#4)(2008-10#1)(2008-12#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#5)(2012-12#1)(2013-1#7)(2013-8#5)
was to compare##127##3##(1990-10#1)(1990-2#1)(1992-10#1)(1993-12#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-5#1)(1997-8#3)(2004-1#3)(2004-9#1)(2005-8#1)(2006-10#4)(2006-11#2)(2006-12#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-2#3)(2007-4#1)(2007-7#7)(2007-8#11)(2007-9#4)(2008-10#1)(2008-11#1)(2008-12#6)(2008-2#1)(2008-3#4)(2008-5#4)(2008-6#2)(2008-7#1)(2008-9#5)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-3#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-12#3)(2013-1#10)(2013-7#1)(2013-8#7)
was to conduct a##3##4##(2006-2#1)(2007-8#1)(2008-10#1)
was to conduct##4##3##(2006-2#1)(2007-8#1)(2008-10#1)(2008-4#1)
was to confirm the##2##4##(2012-2#2)
was to confirm##5##3##(2006-4#1)(2007-8#1)(2008-10#1)(2012-2#2)
was to construct##2##3##(2012-2#1)(2013-8#1)
was to correlate##3##3##(1996-5#1)(2004-12#1)(2013-8#1)
was to create a##4##4##(2005-10#1)(2008-7#1)(2011-1#1)(2012-12#1)
was to create awareness##2##4##(1992-12#1)(2013-8#1)
was to create##7##3##(1992-12#1)(2005-10#2)(2008-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
was to critically##2##3##(2005-8#1)(2010-11#1)
was to decrease##2##3##(1990-12#1)(1992-1#1)
was to define factors##2##4##(2008-9#1)(2011-2#1)
was to define the##7##4##(1995-2#1)(1997-7#1)(2007-11#1)(2007-9#1)(2008-8#1)(2011-2#1)(2013-7#1)
was to define##14##3##(1991-5#1)(1995-2#1)(1997-7#1)(2006-11#1)(2007-11#1)(2007-9#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#2)(2013-1#2)(2013-7#1)
was to delineate the##6##4##(1990-2#1)(1996-1#1)(2010-12#1)(2012-12#1)(2013-1#2)
was to demonstrate that##2##4##(1995-1#1)(2011-1#1)
was to demonstrate the possibility##2##5##(2007-8#1)(2011-1#1)
was to demonstrate the##6##4##(2007-8#1)(2008-10#2)(2009-2#1)(2011-1#1)(2011-2#1)
was to demonstrate##8##3##(1995-1#1)(2007-8#1)(2008-10#2)(2009-2#1)(2011-1#2)(2011-2#1)
was to describe a##2##4##(2007-8#1)(2009-4#1)
was to describe the##25##4##(1992-3#1)(1992-8#1)(1993-12#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-2#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-3#1)(2009-7#1)(2010-10#1)(2010-3#1)(2010-5#1)(2011-1#2)(2012-12#2)(2013-1#3)(2013-7#1)
was to describe##44##3##(1992-3#1)(1992-8#1)(1993-12#1)(1995-12#1)(1996-12#1)(1996-9#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-3#1)(2010-5#2)(2011-1#2)(2011-2#2)(2011-7#1)(2012-12#3)(2012-2#2)(2013-1#4)(2013-7#1)
was to design##5##3##(1992-5#1)(2006-5#1)(2008-10#1)(2008-5#1)(2010-4#1)
was to detect the##3##4##(2009-2#1)(2013-1#2)
was to detect##10##3##(1994-8#1)(1997-8#1)(2008-7#1)(2009-2#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#3)
was to determine how##6##4##(1991-2#1)(1992-7#1)(1996-2#1)(2007-7#1)(2007-8#1)(2008-10#1)
was to determine if the##7##5##(1996-5#1)(2006-7#1)(2008-10#2)(2008-11#1)(2010-10#1)(2011-2#1)
was to determine if##34##4##(1993-2#1)(1993-7#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-5#2)(1997-3#1)(2005-9#1)(2006-1#1)(2006-2#1)(2006-7#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-8#1)
was to determine the effect of##9##6##(1991-8#1)(1994-2#1)(1995-7#1)(2007-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-4#1)(2011-2#1)
was to determine the effect##11##5##(1991-8#1)(1994-2#1)(1995-7#1)(2004-9#1)(2007-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-4#1)(2011-2#1)
was to determine the effects of##14##6##(1993-7#1)(2005-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-5#3)(2010-4#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#2)
was to determine the extent of##2##6##(1996-12#1)(2008-12#1)
was to determine the extent##4##5##(1996-12#1)(2006-8#1)(2007-7#1)(2008-12#1)
was to determine the feasibility of##2##6##(1991-9#1)(2006-8#1)
was to determine the frequency of##2##6##(2007-2#1)(2007-5#1)
was to determine the frequency##3##5##(2007-2#1)(2007-5#1)(2008-8#1)
was to determine the impact of##2##6##(2011-2#2)
was to determine the incidence of##3##6##(1991-11#1)(2010-10#1)(2013-8#1)
was to determine the incidence##4##5##(1991-11#1)(2005-12#1)(2010-10#1)(2013-8#1)
was to determine the possible##4##5##(1995-9#1)(2004-10#1)(2008-11#1)(2008-4#1)
was to determine the prevalence of##10##6##(1993-12#1)(2006-8#1)(2007-2#1)(2008-12#2)(2008-3#1)(2008-4#1)(2010-2#1)(2012-2#1)(2013-1#1)
was to determine the prevalence##12##5##(1993-12#1)(2006-8#2)(2007-2#1)(2008-12#2)(2008-3#1)(2008-4#1)(2010-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
was to determine the results of##2##6##(2006-8#1)(2008-9#1)
was to determine the##182##4##(1990-11#1)(1990-12#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-11#1)(1993-12#1)(1993-7#1)(1994-2#1)(1994-5#1)(1995-7#1)(1995-9#1)(1996-12#2)(1996-4#1)(1996-9#1)(1997-6#1)(2004-10#1)(2004-11#1)(2004-12#1)(2004-9#2)(2005-12#3)(2005-8#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-8#7)(2007-1#1)(2007-10#2)(2007-11#2)(2007-2#11)(2007-3#2)(2007-5#1)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#8)(2008-3#2)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-2#2)(2009-5#3)(2009-6#1)(2010-10#2)(2010-12#1)(2010-2#3)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#13)(2012-1#1)(2012-12#2)(2012-2#9)(2012-3#1)(2012-6#1)(2013-1#8)(2013-3#1)(2013-7#1)(2013-8#9)
was to determine whether a##4##5##(1996-6#1)(1997-7#1)(2006-7#1)(2008-8#1)
was to determine whether and how##2##6##(2007-11#1)(2011-2#1)
was to determine whether or not##3##6##(2006-8#1)(2007-7#1)(2012-3#1)
was to determine whether the##6##5##(1990-11#1)(1990-8#1)(1995-12#1)(2007-7#1)(2008-10#1)(2010-12#1)
was to determine whether##62##4##(1990-10#1)(1990-11#1)(1990-3#1)(1990-8#1)(1991-2#1)(1992-11#1)(1992-7#1)(1993-3#1)(1993-9#1)(1994-11#1)(1995-10#1)(1995-12#1)(1995-3#2)(1996-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-12#1)(2006-5#2)(2006-7#1)(2006-8#2)(2007-10#4)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)
was to determine which factors##2##5##(1991-6#1)(2007-8#1)
was to determine which##10##4##(1991-6#1)(1994-3#1)(1995-5#1)(2006-1#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-2#1)(2012-2#1)(2013-1#1)
was to determine##325##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-2#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-7#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-7#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-12#3)(1996-2#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-10#1)(2004-11#1)(2004-12#1)(2004-9#2)(2005-10#1)(2005-12#3)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#3)(2006-4#1)(2006-5#5)(2006-7#2)(2006-8#9)(2007-1#1)(2007-10#9)(2007-11#3)(2007-12#1)(2007-2#16)(2007-3#2)(2007-4#2)(2007-5#2)(2007-7#8)(2007-8#9)(2007-9#3)(2008-1#1)(2008-10#17)(2008-11#4)(2008-12#10)(2008-3#2)(2008-4#4)(2008-5#10)(2008-6#3)(2008-7#5)(2008-8#5)(2008-9#5)(2009-10#2)(2009-2#4)(2009-5#5)(2009-6#1)(2009-9#1)(2010-10#4)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#3)(2011-1#5)(2011-2#22)(2012-1#2)(2012-12#4)(2012-2#11)(2012-3#4)(2012-6#1)(2013-1#11)(2013-3#1)(2013-7#2)(2013-8#12)
was to develop a method of##2##6##(2008-6#1)(2010-9#1)
was to develop a method##3##5##(2008-6#1)(2010-9#1)(2012-4#1)
was to develop a simple##2##5##(2008-10#1)(2013-7#1)
was to develop a##46##4##(1993-11#1)(1993-12#1)(1995-11#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-10#1)(2006-11#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-4#3)(2007-7#2)(2007-9#2)(2008-10#4)(2008-4#1)(2008-5#3)(2008-6#1)(2010-2#1)(2010-7#1)(2010-9#2)(2011-1#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-4#1)(2013-1#2)(2013-7#3)
was to develop an##12##4##(1991-5#1)(1991-9#1)(2008-10#2)(2008-11#1)(2009-9#1)(2011-2#1)(2012-2#2)(2013-1#3)
was to develop and validate a##5##6##(2006-11#1)(2008-10#1)(2008-5#1)(2012-1#1)(2012-2#1)
was to develop and validate an##2##6##(2008-10#1)(2011-1#1)
was to develop and validate##8##5##(2006-11#1)(2008-10#2)(2008-5#1)(2011-1#1)(2012-1#2)(2012-2#1)
was to develop and##16##4##(2006-11#1)(2007-7#1)(2008-10#4)(2008-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#4)(2012-2#2)
was to develop novel##3##4##(2008-5#1)(2009-4#1)(2011-1#1)
was to develop##94##3##(1991-5#1)(1991-9#1)(1992-2#1)(1993-11#1)(1993-12#2)(1994-4#1)(1995-11#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-10#1)(2006-11#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-4#3)(2007-7#3)(2007-9#2)(2008-1#1)(2008-10#10)(2008-11#4)(2008-4#1)(2008-5#7)(2008-6#1)(2009-4#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-9#3)(2011-1#4)(2011-12#1)(2011-2#3)(2012-1#6)(2012-12#2)(2012-2#6)(2012-4#1)(2013-1#5)(2013-7#3)
was to discuss the##3##4##(2008-5#1)(2010-5#1)(2013-1#1)
was to discuss##5##3##(2008-4#1)(2008-5#1)(2009-4#1)(2010-5#1)(2013-1#1)
was to document the##3##4##(2008-10#1)(2008-8#1)(2009-2#1)
was to document##5##3##(2006-10#1)(2006-2#1)(2008-10#1)(2008-8#1)(2009-2#1)
was to elucidate the##9##4##(1994-3#1)(1995-6#1)(1997-8#1)(2005-10#1)(2006-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-8#1)
was to elucidate##14##3##(1992-12#1)(1994-3#1)(1995-6#1)(1997-8#1)(2005-10#1)(2006-11#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-9#1)(2013-1#1)(2013-8#1)
was to enhance the##2##4##(2010-1#1)(2010-12#1)
was to establish a##7##4##(1990-10#1)(1992-8#1)(1997-4#1)(2007-10#1)(2007-5#1)(2010-6#1)(2013-1#1)
was to establish the##11##4##(1992-2#1)(1994-2#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-3#1)(2008-4#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
was to establish whether or not##2##6##(2006-8#1)(2011-1#1)
was to establish whether##4##4##(2006-8#1)(2008-11#1)(2011-1#1)(2011-2#1)
was to establish##31##3##(1990-10#1)(1992-2#1)(1992-8#1)(1993-12#1)(1994-2#1)(1997-4#1)(1997-8#1)(2004-9#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-3#1)(2007-5#1)(2008-11#2)(2008-4#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
was to estimate the number of##2##6##(2008-10#1)(2008-7#1)
was to estimate the##21##4##(1996-1#1)(2006-8#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-7#1)(2013-8#2)
was to estimate##26##3##(1996-1#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
was to evaluate a possible##2##5##(2011-2#1)(2012-2#1)
was to evaluate a##12##4##(1996-9#1)(2006-10#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#2)(2009-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
was to evaluate clinical and##2##5##(1993-8#1)(2013-8#1)
was to evaluate clinical##4##4##(1993-8#1)(2007-8#2)(2013-8#1)
was to evaluate efficacy##2##4##(2007-2#1)(2012-2#1)
was to evaluate how##3##4##(2007-7#1)(2013-8#2)
was to evaluate if##3##4##(1996-3#1)(1996-9#1)(2013-1#1)
was to evaluate in##2##4##(2005-1#1)(2009-6#1)
was to evaluate the capacity of##2##6##(2013-1#2)
was to evaluate the effect of##16##6##(1992-8#1)(1996-2#2)(2004-1#1)(2006-5#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-5#2)(2010-10#1)(2012-2#3)(2013-1#1)
was to evaluate the effect##17##5##(1992-8#1)(1996-2#2)(2004-1#1)(2006-5#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-5#2)(2010-10#1)(2010-4#1)(2012-2#3)(2013-1#1)
was to evaluate the effectiveness of a##4##7##(2006-2#1)(2006-6#1)(2007-7#1)(2008-9#1)
was to evaluate the effectiveness of##14##6##(2006-2#1)(2006-6#1)(2006-8#1)(2007-7#5)(2007-8#3)(2008-9#1)(2011-12#1)(2013-1#1)
was to evaluate the effects of##8##6##(1993-12#1)(2007-7#1)(2007-8#1)(2008-12#1)(2009-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
was to evaluate the efficacy of##10##6##(2006-10#1)(2007-2#1)(2007-7#2)(2008-5#2)(2009-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
was to evaluate the impact of a##2##7##(1996-1#1)(2008-3#1)
was to evaluate the impact of##4##6##(1996-1#1)(2007-11#1)(2008-12#1)(2008-3#1)
was to evaluate the impact##5##5##(1996-1#1)(2006-8#1)(2007-11#1)(2008-12#1)(2008-3#1)
was to evaluate the importance of##2##6##(2006-5#1)(2007-12#1)
was to evaluate the incidence of##2##6##(2013-1#1)(2013-8#1)
was to evaluate the influence of##9##6##(2004-12#1)(2006-10#1)(2006-9#1)(2007-7#1)(2007-9#1)(2008-12#1)(2009-8#1)(2013-1#1)(2013-8#1)
was to evaluate the influence##10##5##(2004-12#1)(2006-10#1)(2006-9#1)(2007-7#1)(2007-9#1)(2008-12#1)(2008-7#1)(2009-8#1)(2013-1#1)(2013-8#1)
was to evaluate the long-term##3##5##(1990-6#1)(2010-3#1)(2013-1#1)
was to evaluate the performance of##3##6##(2007-8#1)(2008-11#1)(2012-12#1)
was to evaluate the relationship##2##5##(2011-12#1)(2012-2#1)
was to evaluate the reliability of##2##6##(2007-12#1)(2012-1#1)
was to evaluate the reliability##3##5##(2007-12#1)(2010-10#1)(2012-1#1)
was to evaluate the results of##6##6##(1997-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-9#1)(2011-2#1)
was to evaluate the role of##7##6##(2005-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
was to evaluate the stability##2##5##(2008-12#1)(2010-3#1)
was to evaluate the suitability##3##5##(2005-5#1)(2010-4#1)(2010-9#1)
was to evaluate the usefulness of##2##6##(2007-11#1)(2007-9#1)
was to evaluate the usefulness##3##5##(2006-8#1)(2007-11#1)(2007-9#1)
was to evaluate the##223##4##(1990-10#1)(1990-11#1)(1990-6#1)(1991-3#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-11#1)(1996-1#1)(1996-2#2)(1997-3#1)(1997-6#1)(1997-8#5)(2004-1#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-5#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#5)(2006-8#4)(2006-9#1)(2007-10#2)(2007-11#8)(2007-12#3)(2007-2#3)(2007-7#14)(2007-8#15)(2007-9#4)(2008-1#3)(2008-10#6)(2008-11#2)(2008-12#9)(2008-3#4)(2008-4#1)(2008-5#15)(2008-7#4)(2008-8#2)(2008-9#4)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#2)(2010-12#1)(2010-3#2)(2010-4#6)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#3)(2011-2#8)(2012-1#4)(2012-12#3)(2012-2#11)(2012-3#2)(2013-1#18)(2013-7#2)(2013-8#5)
was to evaluate whether the##3##5##(1995-12#1)(2006-8#1)(2013-8#1)
was to evaluate whether##13##4##(1992-2#1)(1995-12#1)(2006-10#1)(2006-8#2)(2007-11#1)(2008-11#1)(2008-7#1)(2010-11#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
was to evaluate##335##3##(1990-10#1)(1990-11#1)(1990-6#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#8)(2004-1#1)(2004-12#2)(2005-1#1)(2005-10#2)(2005-11#1)(2005-5#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#4)(2006-6#7)(2006-7#4)(2006-8#6)(2006-9#1)(2007-10#2)(2007-11#11)(2007-12#3)(2007-2#4)(2007-3#1)(2007-7#19)(2007-8#21)(2007-9#5)(2008-1#3)(2008-10#11)(2008-11#3)(2008-12#12)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#20)(2008-6#1)(2008-7#9)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#1)(2010-3#2)(2010-4#6)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#5)(2011-12#4)(2011-2#16)(2012-1#4)(2012-12#4)(2012-2#16)(2012-3#2)(2013-1#21)(2013-7#3)(2013-8#13)
was to examine differences in##2##5##(2007-10#1)(2011-2#1)
was to examine how##3##4##(2007-3#1)(2009-8#1)(2010-4#1)
was to examine possible##2##4##(2008-11#1)(2008-4#1)
was to examine the effects of a##4##7##(2007-12#2)(2009-3#1)(2013-8#1)
was to examine the effects of##13##6##(1991-12#1)(2005-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-5#1)(2008-6#1)(2009-3#1)(2009-7#1)(2013-1#1)(2013-8#2)
was to examine the extent to which##2##7##(2008-1#1)(2009-9#1)
was to examine the impact of##3##6##(2006-2#1)(2007-10#1)(2011-2#1)
was to examine the influence of##3##6##(1995-3#1)(2007-10#1)(2008-12#1)
was to examine the relationship between##6##6##(1990-4#1)(1997-7#1)(2007-1#1)(2007-12#1)(2010-2#1)(2011-2#1)
was to examine the relationship##7##5##(1990-4#1)(1997-7#1)(2007-1#1)(2007-12#1)(2010-2#1)(2011-2#2)
was to examine the reliability##2##5##(2007-12#1)(2011-1#1)
was to examine the##103##4##(1990-4#1)(1990-5#1)(1990-6#1)(1991-12#1)(1992-2#1)(1992-6#1)(1993-12#2)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-2#1)(1997-3#1)(1997-7#1)(2004-1#1)(2005-10#1)(2005-11#1)(2006-11#1)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#2)(2007-1#2)(2007-10#5)(2007-11#1)(2007-12#4)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-11#3)(2008-12#4)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#3)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-9#1)(2011-1#5)(2011-2#8)(2012-12#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#4)
was to examine whether##7##4##(1991-10#1)(1994-10#1)(1997-2#2)(2006-7#1)(2007-6#1)(2013-1#1)
was to examine##154##3##(1990-4#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-12#1)(1992-2#2)(1992-6#1)(1993-12#2)(1994-10#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#2)(1997-3#1)(1997-7#1)(2004-1#1)(2005-10#2)(2005-11#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-4#1)(2006-7#4)(2006-8#2)(2007-1#2)(2007-10#6)(2007-11#1)(2007-12#5)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-11#5)(2008-12#5)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#4)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#4)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#2)(2010-9#1)(2011-1#5)(2011-2#11)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#4)
was to explain##2##3##(2010-3#1)(2012-2#1)
was to explore how##2##4##(2006-9#1)(2008-11#1)
was to explore the##29##4##(1996-3#1)(2004-9#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-3#1)(2007-7#2)(2008-1#1)(2008-12#1)(2008-7#2)(2009-11#1)(2009-9#1)(2010-11#1)(2010-12#2)(2011-2#3)(2012-1#2)(2012-12#1)(2013-1#2)(2013-8#1)
was to explore##53##3##(1996-3#1)(1997-7#1)(2004-9#1)(2006-12#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#3)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#3)(2007-9#1)(2008-1#1)(2008-11#2)(2008-12#3)(2008-2#1)(2008-7#2)(2009-11#1)(2009-6#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
was to find a##4##4##(2008-10#1)(2008-6#1)(2009-10#1)(2012-1#1)
was to find out if##4##5##(1990-8#1)(1994-9#1)(2007-2#1)(2007-3#1)
was to find out the##2##5##(2006-8#1)(2011-1#1)
was to find out whether##2##5##(2007-1#1)(2011-1#1)
was to find out##12##4##(1990-2#1)(1990-8#1)(1994-9#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-5#1)(2011-1#2)
was to find the##2##4##(2012-12#1)(2013-8#1)
was to find##21##3##(1990-2#1)(1990-5#1)(1990-8#1)(1994-9#1)(1995-11#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-10#1)(2011-1#2)(2012-1#1)(2012-12#1)(2013-8#1)
was to follow a group of##2##6##(2008-2#1)(2013-1#1)
was to formulate and##2##4##(2010-2#1)(2011-1#1)
was to formulate##6##3##(2008-3#1)(2008-5#2)(2010-2#1)(2011-1#1)(2012-7#1)
was to further evaluate the##2##5##(1995-2#1)(2011-2#1)
was to further evaluate##3##4##(1995-2#1)(2011-2#2)
was to further##8##3##(1992-12#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-5#1)(2011-2#2)
was to gain##3##3##(2007-3#1)(2010-9#1)(2012-12#1)
was to gather##4##3##(2006-10#1)(2006-6#1)(2007-2#1)(2008-10#1)
was to get##3##3##(1997-3#1)(2007-8#1)(2010-2#1)
was to give a brief##2##5##(2007-5#1)(2011-2#1)
was to give a##3##4##(1992-3#1)(2007-5#1)(2011-2#1)
was to give##5##3##(1992-3#1)(2007-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
was to have##2##3##(1997-2#1)(2007-4#1)
was to highlight##2##3##(2008-5#1)(2013-1#1)
was to identify and describe##2##5##(2007-2#1)(2009-8#1)
was to identify and##3##4##(2007-2#1)(2009-8#1)(2010-3#1)
was to identify factors that##2##5##(2006-10#1)(2009-7#1)
was to identify genes##2##4##(2008-9#1)(2012-3#1)
was to identify morphological##2##4##(2007-12#1)(2010-12#1)
was to identify risk factors##3##5##(1996-12#1)(2004-10#1)(2013-1#1)
was to identify the##35##4##(1992-2#1)(1994-5#1)(1996-12#1)(1996-6#1)(2006-12#1)(2007-11#3)(2007-2#2)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-6#2)(2009-1#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-9#1)(2011-2#6)(2012-11#1)(2013-1#1)
was to identify##78##3##(1990-2#1)(1990-7#1)(1992-2#1)(1994-2#1)(1994-5#1)(1996-12#2)(1996-6#1)(1997-8#1)(2004-10#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#3)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#4)(2008-7#1)(2008-9#2)(2009-1#1)(2009-2#2)(2009-7#2)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-9#1)(2011-1#1)(2011-2#10)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#4)
was to improve the health##2##5##(2009-8#1)(2012-2#1)
was to improve the##6##4##(2007-11#1)(2008-11#1)(2009-8#1)(2010-8#1)(2012-2#1)(2012-3#1)
was to improve##10##3##(1994-2#1)(2007-11#1)(2008-10#1)(2008-11#2)(2009-4#1)(2009-8#1)(2010-8#1)(2012-2#1)(2012-3#1)
was to increase the sensitivity##2##5##(2008-10#1)(2008-5#1)
was to increase the##4##4##(2007-3#1)(2008-10#1)(2008-5#1)(2011-12#1)
was to increase##6##3##(1995-1#1)(1997-1#1)(2007-3#1)(2008-10#1)(2008-5#1)(2011-12#1)
was to initiate##2##3##(2005-7#1)(2013-7#1)
was to investigate and##2##4##(2006-2#1)(2011-2#1)
was to investigate if##2##4##(1990-12#1)(2005-10#1)
was to investigate possible##5##4##(1995-12#1)(2006-6#1)(2008-10#1)(2008-4#1)(2012-2#1)
was to investigate the association between##2##6##(2011-2#1)(2013-1#1)
was to investigate the association##3##5##(2007-10#1)(2011-2#1)(2013-1#1)
was to investigate the effect of##27##6##(1994-6#1)(1995-3#1)(1996-7#1)(2005-8#1)(2006-11#1)(2007-10#3)(2007-8#1)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-6#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#2)(2011-1#1)(2011-11#1)(2011-12#1)(2012-2#1)
was to investigate the effects of##13##6##(1990-8#1)(1990-9#1)(1997-3#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
was to investigate the effects##14##5##(1990-8#1)(1990-9#1)(1997-3#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
was to investigate the possibility of##4##6##(2005-11#1)(2006-8#1)(2012-3#1)(2013-7#1)
was to investigate the prevalence of##4##6##(2006-1#1)(2007-8#1)(2008-7#1)(2011-1#1)
was to investigate the prevalence##6##5##(2006-1#1)(2007-2#1)(2007-8#1)(2008-7#1)(2011-1#1)(2012-1#1)
was to investigate the relationship between##12##6##(1991-10#1)(2006-7#1)(2008-5#1)(2008-8#1)(2009-7#2)(2010-12#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#2)
was to investigate the relationships between##3##6##(2008-10#1)(2010-6#1)(2013-1#1)
was to investigate the relationships##4##5##(2007-12#1)(2008-10#1)(2010-6#1)(2013-1#1)
was to investigate the therapeutic##2##5##(2006-8#1)(2013-1#1)
was to investigate the utilization of##2##6##(2009-11#1)(2013-7#1)
was to investigate the##172##4##(1990-8#1)(1990-9#1)(1991-10#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-12#2)(1995-3#1)(1996-10#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-3#1)(2005-11#2)(2005-8#1)(2006-1#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-7#1)(2006-8#4)(2007-10#6)(2007-11#2)(2007-12#2)(2007-2#4)(2007-3#1)(2007-4#2)(2007-6#1)(2007-8#9)(2008-1#1)(2008-10#7)(2008-12#5)(2008-3#4)(2008-4#2)(2008-5#8)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-6#3)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#6)(2010-2#3)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-11#1)(2011-12#2)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#6)(2012-3#1)(2013-1#14)(2013-7#2)(2013-8#4)
was to investigate whether a##3##5##(2007-12#1)(2008-5#1)(2012-3#1)
was to investigate whether the effects of##2##7##(2010-7#1)(2013-1#1)
was to investigate whether the##7##5##(1995-4#1)(1997-7#1)(2007-10#1)(2008-5#1)(2010-7#1)(2012-12#1)(2013-1#1)
was to investigate whether there is##3##6##(1992-12#1)(2011-1#1)(2012-1#1)
was to investigate whether##31##4##(1992-12#1)(1994-2#1)(1995-4#1)(1995-9#1)(1997-7#1)(2006-5#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#1)(2010-10#1)(2010-3#1)(2010-7#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#2)
was to investigate##257##3##(1990-12#1)(1990-8#1)(1990-9#1)(1991-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#2)(2005-10#1)(2005-11#2)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#2)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#7)(2006-9#1)(2007-1#1)(2007-10#7)(2007-11#2)(2007-12#4)(2007-2#5)(2007-3#1)(2007-4#2)(2007-6#2)(2007-8#9)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-12#6)(2008-3#4)(2008-4#4)(2008-5#13)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#4)(2009-1#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-6#4)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#3)(2010-12#6)(2010-2#4)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#6)(2011-11#1)(2011-12#3)(2011-2#12)(2012-1#3)(2012-11#1)(2012-12#8)(2012-2#7)(2012-3#3)(2013-1#17)(2013-7#5)(2013-8#4)
was to know the##4##4##(2007-11#1)(2007-7#1)(2008-9#1)(2012-12#1)
was to learn##2##3##(1990-12#1)(2009-11#1)
was to look at##2##4##(1995-11#1)(2004-10#1)
was to look##4##3##(1995-11#1)(2004-10#1)(2006-8#1)(2007-2#1)
was to measure the##10##4##(1990-8#1)(1994-3#1)(2006-7#1)(2007-1#1)(2008-5#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
was to measure##16##3##(1990-8#1)(1992-3#1)(1994-3#1)(2006-7#1)(2007-1#1)(2008-11#1)(2008-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
was to model##2##3##(2006-11#1)(2010-4#1)
was to modify##2##3##(1997-8#1)(2008-11#1)
was to observe##4##3##(2008-10#2)(2011-2#1)(2013-1#1)
was to obtain a##2##4##(1993-1#1)(2013-8#1)
was to obtain an##2##4##(1997-3#1)(2007-5#1)
was to obtain data##2##4##(1994-5#1)(2006-10#1)
was to obtain information##2##4##(1996-4#1)(2006-6#1)
was to obtain##18##3##(1990-4#1)(1992-12#1)(1993-1#1)(1994-5#1)(1995-6#1)(1996-4#1)(1997-3#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-6#1)(2008-7#1)(2013-7#1)(2013-8#1)
was to optimize the##2##4##(2008-5#1)(2010-12#1)
was to optimize##4##3##(2008-5#1)(2009-2#1)(2010-12#1)(2013-1#1)
was to perform a pilot##2##5##(2005-10#1)(2012-12#1)
was to perform a##5##4##(2005-10#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-12#1)
was to perform##7##3##(2005-10#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-12#1)
was to predict##2##3##(2008-10#1)(2011-1#1)
was to prepare a##2##4##(2008-5#1)(2013-7#1)
was to prepare and characterize##3##5##(1993-11#1)(2010-12#1)(2012-12#1)
was to prepare##8##3##(1993-11#1)(2008-5#3)(2010-12#1)(2010-5#1)(2012-12#1)(2013-7#1)
was to present a##3##4##(2005-8#1)(2008-10#1)(2008-5#1)
was to present and##3##4##(2005-7#1)(2008-11#1)(2008-5#1)
was to present the##6##4##(2005-10#1)(2007-7#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
was to present##21##3##(1994-2#1)(2005-10#1)(2005-7#1)(2005-8#2)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-5#4)(2008-6#1)(2009-2#1)(2011-2#2)(2012-12#1)(2013-8#1)
was to produce a##2##4##(2009-11#1)(2012-3#1)
was to produce##7##3##(1996-12#1)(1997-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2012-2#1)(2012-3#1)
was to promote##2##3##(2007-1#1)(2008-1#1)
was to propose a##2##4##(2007-8#1)(2010-3#1)
was to prove##2##3##(2008-5#1)(2009-8#1)
was to provide a##7##4##(1995-2#1)(2007-5#1)(2007-8#1)(2009-5#1)(2010-6#1)(2012-1#1)(2012-2#1)
was to provide an##2##4##(2008-5#1)(2010-11#1)
was to provide##18##3##(1995-2#1)(2004-3#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-5#1)(2009-5#2)(2010-10#1)(2010-11#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
was to quantify the effects of##2##6##(2007-1#1)(2008-10#1)
was to quantify the##7##4##(2007-1#1)(2007-10#1)(2007-4#2)(2008-10#2)(2009-5#1)
was to quantify##9##3##(1996-6#1)(2007-1#1)(2007-10#1)(2007-4#2)(2008-10#2)(2009-5#1)(2010-9#1)
was to reduce the##3##4##(2006-2#1)(2008-10#1)(2010-8#1)
was to reduce##4##3##(2006-2#1)(2008-10#1)(2008-11#1)(2010-8#1)
was to relate the##2##4##(2007-9#1)(2008-5#1)
was to relate##3##3##(2007-12#1)(2007-9#1)(2008-5#1)
was to report a case##2##5##(2008-5#1)(2013-8#1)
was to report a##5##4##(2008-5#2)(2013-1#1)(2013-8#2)
was to report the##2##4##(2008-5#1)(2008-9#1)
was to report##9##3##(2008-5#3)(2008-9#2)(2012-1#1)(2013-1#1)(2013-8#2)
was to reveal##2##3##(2006-8#1)(2011-2#1)
was to review the##16##4##(1991-12#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-2#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-5#1)(2010-5#1)(2011-1#2)(2011-7#1)(2012-12#1)(2013-1#1)
was to review##30##3##(1991-12#1)(1993-6#1)(1996-2#1)(2005-4#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-2#1)(2007-2#2)(2007-3#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-5#1)(2011-1#2)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
was to search##6##3##(2006-10#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-7#1)(2013-1#1)
was to see if##3##4##(2007-10#1)(2007-12#1)(2010-12#1)
was to see whether##2##4##(2007-2#1)(2008-12#1)
was to see##7##3##(2007-10#1)(2007-12#1)(2007-2#1)(2008-12#1)(2010-12#1)(2011-2#1)(2012-2#1)
was to set up a##2##5##(1993-11#1)(2008-5#1)
was to show how##2##4##(2009-2#1)(2011-2#1)
was to show the##2##4##(2008-1#1)(2008-12#1)
was to show##7##3##(1995-7#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-12#1)(2009-2#1)(2011-2#1)
was to simulate##2##3##(2008-6#1)(2011-1#1)
was to study the behavior of##2##6##(1991-3#1)(2008-2#1)
was to study the effect of##4##6##(1996-5#1)(2006-11#1)(2012-2#1)(2013-1#1)
was to study the effect##5##5##(1996-5#1)(1996-9#1)(2006-11#1)(2012-2#1)(2013-1#1)
was to study the effects of##2##6##(1997-7#1)(2006-8#1)
was to study the influence of##3##6##(2006-10#1)(2008-10#1)(2010-4#1)
was to study the prevalence of##4##6##(1990-9#1)(2006-7#1)(2007-10#1)(2007-3#1)
was to study the relationship##3##5##(1991-11#1)(2008-7#1)(2013-8#1)
was to study the##47##4##(1990-9#1)(1991-11#1)(1991-3#1)(1992-3#1)(1993-5#1)(1995-6#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-7#2)(2005-11#1)(2006-10#1)(2006-11#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-2#3)(2007-3#2)(2008-10#1)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
was to study##66##3##(1990-9#1)(1991-11#1)(1991-3#1)(1992-3#1)(1993-5#1)(1993-6#1)(1995-6#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-11#1)(2006-10#2)(2006-11#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-2#3)(2007-3#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-2#2)(2010-1#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#3)(2013-8#2)
was to summarize##2##3##(2008-10#1)(2013-8#1)
was to systematically##3##3##(1993-2#1)(2007-10#1)(2013-1#1)
was to test if##2##4##(1994-12#1)(2007-10#1)
was to test the hypothesis that##7##6##(1990-8#1)(1993-12#1)(1996-9#1)(2006-9#1)(2007-10#1)(2008-7#1)(2009-6#1)
was to test the##18##4##(1990-12#1)(1990-8#1)(1991-11#1)(1991-9#1)(1993-12#1)(1996-9#1)(2006-9#1)(2007-10#1)(2007-8#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-6#1)(2010-12#1)(2010-3#1)(2012-1#1)(2012-2#1)
was to test whether##5##4##(1995-3#1)(1997-2#1)(2006-10#1)(2008-4#1)(2010-2#1)
was to test##33##3##(1990-12#1)(1990-8#1)(1991-11#2)(1991-9#1)(1993-12#2)(1994-12#1)(1995-11#1)(1995-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-9#1)(2007-10#2)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-2#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2012-1#1)(2012-2#1)(2012-3#1)
was to translate and validate##2##5##(2006-10#1)(2007-12#1)
was to translate##3##3##(2006-10#1)(2007-12#1)(2011-1#1)
was to understand the##6##4##(2008-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
was to understand##8##3##(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
was to use##15##3##(1993-12#1)(1993-9#1)(2006-3#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-2#1)(2013-1#2)
was to utilize##2##3##(2006-5#1)(2008-5#1)
was to validate the##5##4##(2007-8#1)(2008-12#1)(2008-9#1)(2009-12#1)(2013-1#1)
was to validate##7##3##(2007-8#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-12#1)(2013-1#2)
was to verify if##2##4##(2008-10#2)
was to verify the occurrence of##2##6##(1991-9#1)(2008-6#1)
was to verify the##10##4##(1991-9#1)(1992-3#1)(2007-2#1)(2008-10#2)(2008-6#2)(2008-7#2)(2011-1#1)
was to verify##18##3##(1991-9#1)(1992-3#1)(1996-3#1)(1997-1#1)(2007-2#1)(2007-3#1)(2008-10#4)(2008-5#2)(2008-6#2)(2008-7#2)(2010-9#1)(2011-1#1)
was to##2546##2##(1990-10#4)(1990-11#3)(1990-12#7)(1990-2#4)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#4)(1990-7#1)(1990-8#6)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#4)(1991-12#4)(1991-2#2)(1991-3#2)(1991-5#3)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#3)(1992-10#3)(1992-11#3)(1992-12#7)(1992-2#8)(1992-3#8)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#4)(1993-1#3)(1993-11#4)(1993-12#16)(1993-2#4)(1993-3#3)(1993-5#2)(1993-6#3)(1993-7#2)(1993-8#3)(1993-9#5)(1994-10#1)(1994-11#2)(1994-12#6)(1994-2#8)(1994-3#7)(1994-4#1)(1994-5#5)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#7)(1995-10#2)(1995-11#5)(1995-12#7)(1995-2#7)(1995-3#9)(1995-4#1)(1995-5#3)(1995-6#7)(1995-7#2)(1995-8#1)(1995-9#2)(1996-1#7)(1996-10#1)(1996-11#1)(1996-12#10)(1996-2#6)(1996-3#6)(1996-4#2)(1996-5#5)(1996-6#5)(1996-7#3)(1996-8#1)(1996-9#10)(1997-1#5)(1997-2#8)(1997-3#8)(1997-4#5)(1997-5#1)(1997-6#4)(1997-7#7)(1997-8#25)(2004-1#5)(2004-10#4)(2004-11#1)(2004-12#5)(2004-2#2)(2004-3#1)(2004-9#7)(2005-1#3)(2005-10#16)(2005-11#7)(2005-12#3)(2005-4#1)(2005-5#2)(2005-7#3)(2005-8#8)(2005-9#1)(2006-1#4)(2006-10#36)(2006-11#15)(2006-12#7)(2006-2#13)(2006-3#1)(2006-4#4)(2006-5#17)(2006-6#17)(2006-7#17)(2006-8#41)(2006-9#6)(2007-1#14)(2007-10#46)(2007-11#39)(2007-12#28)(2007-2#55)(2007-3#18)(2007-4#14)(2007-5#11)(2007-6#9)(2007-7#72)(2007-8#100)(2007-9#31)(2008-1#13)(2008-10#103)(2008-11#45)(2008-12#56)(2008-2#12)(2008-3#33)(2008-4#29)(2008-5#113)(2008-6#32)(2008-7#53)(2008-8#30)(2008-9#35)(2009-1#4)(2009-10#6)(2009-11#9)(2009-12#7)(2009-2#20)(2009-3#7)(2009-4#16)(2009-5#16)(2009-6#11)(2009-7#15)(2009-8#15)(2009-9#9)(2010-1#7)(2010-10#18)(2010-11#6)(2010-12#24)(2010-2#17)(2010-3#19)(2010-4#29)(2010-5#13)(2010-6#12)(2010-7#9)(2010-8#15)(2010-9#15)(2011-1#58)(2011-11#1)(2011-12#16)(2011-2#136)(2011-7#2)(2012-1#29)(2012-11#5)(2012-12#53)(2012-2#72)(2012-3#32)(2012-4#1)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#127)(2013-3#1)(2013-7#30)(2013-8#65)
was told##3##2##(2005-9#2)(2006-12#1)
was tolerant to##2##3##(2008-10#1)(2013-1#1)
was tolerated well##3##3##(1991-3#1)(1996-8#1)(2007-2#1)
was tolerated##4##2##(1991-3#1)(1996-8#1)(2007-2#1)(2008-1#1)
was too low to##2##4##(1992-3#1)(1995-1#1)
was too low##4##3##(1992-3#1)(1995-1#1)(2008-10#1)(2008-11#1)
was too small to##4##4##(1991-3#1)(1994-12#1)(2007-4#1)(2008-10#1)
was too##23##2##(1990-6#1)(1991-3#1)(1992-3#1)(1992-6#1)(1992-8#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-5#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)
was topically applied##2##3##(2008-5#1)(2011-1#1)
was topically##3##2##(2008-5#2)(2011-1#1)
was total##3##2##(1993-10#1)(2008-7#1)(2008-9#1)
was totally abolished##4##3##(1990-2#1)(1991-10#1)(1992-8#1)(1996-8#1)
was totally asymptomatic##2##3##(2006-2#1)(2011-1#1)
was totally dependent on##2##4##(1991-12#1)(2012-1#1)
was totally ineffective##2##3##(1990-11#1)(1994-6#1)
was totally inhibited##2##3##(1991-2#1)(2008-7#1)
was totally removed with##2##4##(2006-12#1)(2012-3#1)
was totally removed##4##3##(2006-12#1)(2008-7#2)(2012-3#1)
was totally suppressed##2##3##(1992-1#1)(1995-7#1)
was totally##30##2##(1990-11#1)(1990-2#2)(1991-10#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-6#2)(1992-8#1)(1994-11#1)(1994-6#1)(1995-7#1)(1996-8#1)(2004-11#1)(2006-12#1)(2006-2#1)(2008-10#1)(2008-12#1)(2008-7#4)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
was toxic to##2##3##(2008-10#1)(2008-11#1)
was toxic##6##2##(1992-12#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#1)
was traced to the##2##4##(2008-10#1)(2012-2#1)
was traced to##5##3##(1995-3#1)(2008-10#1)(2008-6#1)(2009-9#1)(2012-2#1)
was traced##8##2##(1995-3#1)(2008-10#3)(2008-3#1)(2008-6#1)(2009-9#1)(2012-2#1)
was tracked##2##2##(2007-1#1)(2008-10#1)
was traditionally##6##2##(1991-6#1)(1994-3#1)(2008-5#1)(2010-2#1)(2011-1#1)(2013-7#1)
was trained as a##2##4##(2010-7#2)
was trained by##4##3##(2008-10#3)(2012-2#1)
was trained with##2##3##(1996-6#1)(2008-2#1)
was trained##16##2##(1992-10#2)(1993-2#1)(1996-6#1)(2007-4#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-8#1)(2010-7#2)(2012-2#1)
was transcribed and##2##3##(1990-12#1)(1993-5#1)
was transcribed in brain##2##4##(1996-7#1)(2008-8#1)
was transcribed in##8##3##(1992-4#1)(1996-7#1)(1997-3#1)(1997-5#1)(2008-8#3)(2011-2#1)
was transcribed##14##2##(1990-12#1)(1991-8#1)(1992-4#1)(1993-12#1)(1993-5#1)(1996-7#1)(1997-3#2)(1997-5#1)(2006-4#1)(2008-8#3)(2011-2#1)
was transcriptionally##2##2##(1993-2#1)(1997-4#1)
was transduced##3##2##(2007-3#2)(2012-12#1)
was transected##2##2##(2005-9#1)(2006-9#1)
was transfected into Chinese hamster ovary cells##2##7##(1993-9#1)(1996-6#1)
was transfected into##10##3##(1990-5#2)(1990-8#1)(1991-9#1)(1993-9#1)(1994-12#1)(1995-1#1)(1996-6#1)(2008-3#1)(2011-2#1)
was transfected with pcDNA3##2##4##(2005-10#1)(2005-6#1)
was transfected with##4##3##(1992-9#1)(2005-10#1)(2005-6#1)(2008-9#1)
was transfected##18##2##(1990-5#2)(1990-8#1)(1990-9#1)(1991-9#1)(1992-9#1)(1993-9#1)(1994-12#1)(1995-1#1)(1996-6#1)(2005-10#1)(2005-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#2)(2011-2#1)
was transferable##2##2##(1996-3#1)(2008-10#1)
was transferred from the##4##4##(2006-12#1)(2007-11#1)(2008-4#1)(2013-1#1)
was transferred from##6##3##(1991-9#1)(1997-3#1)(2006-12#1)(2007-11#1)(2008-4#1)(2013-1#1)
was transferred into a##2##4##(2008-10#1)(2012-12#1)
was transferred into##10##3##(1994-9#1)(2008-10#3)(2008-11#1)(2008-8#4)(2012-12#1)
was transferred to a##2##4##(2012-12#1)(2013-8#1)
was transferred to our hospital##2##5##(2006-4#1)(2007-8#1)
was transferred to our##3##4##(2006-4#1)(2007-8#1)(2012-2#1)
was transferred to the##7##4##(2008-3#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#3)
was transferred to##19##3##(1992-3#1)(1997-7#1)(2006-4#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
was transferred##42##2##(1991-9#1)(1992-3#1)(1994-9#1)(1996-8#1)(1997-3#2)(1997-7#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-6#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
was transformed by##3##3##(1996-8#1)(2008-8#1)(2010-3#1)
was transformed in##3##3##(1993-11#1)(2006-8#1)(2007-10#1)
was transformed into a##4##4##(1996-7#1)(2007-12#1)(2008-2#1)(2012-1#1)
was transformed into the##2##4##(2005-11#1)(2008-10#1)
was transformed into##12##3##(1996-7#1)(1997-1#1)(2005-11#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-9#1)(2011-1#1)(2012-1#1)(2013-1#1)
was transformed to four##2##4##(2004-4#1)(2008-11#1)
was transformed to##4##3##(2004-4#1)(2008-11#2)(2010-11#1)
was transformed with a##3##4##(1990-12#1)(1995-11#1)(2008-10#1)
was transformed with the##3##4##(1995-2#1)(2006-12#1)(2008-10#1)
was transformed with##8##3##(1990-12#1)(1995-11#1)(1995-2#1)(2006-10#1)(2006-12#1)(2008-10#2)(2008-8#1)
was transformed##32##2##(1990-12#1)(1992-6#1)(1993-11#1)(1995-11#1)(1995-2#1)(1996-7#1)(1996-8#1)(1997-1#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-8#3)(2008-9#1)(2010-11#1)(2010-3#1)(2011-1#1)(2012-1#1)(2013-1#1)
was transfused in the##2##4##(2007-9#2)
was transfused with##6##3##(1993-9#1)(1994-12#2)(1994-6#2)(1994-9#1)
was transfused##12##2##(1992-3#1)(1993-9#1)(1994-12#3)(1994-6#2)(1994-9#1)(1996-3#1)(2007-12#1)(2007-9#2)
was transient##11##2##(1990-7#1)(1991-12#1)(1992-1#1)(1992-7#1)(1993-4#1)(1994-3#1)(1994-9#1)(1995-2#1)(2006-12#1)(2007-6#1)(2008-11#1)
was transiently elevated##2##3##(1996-5#1)(1997-2#1)
was transiently induced##2##3##(1993-8#1)(2009-8#1)
was transiently suppressed##2##3##(1997-1#1)(2008-11#1)
was transiently##11##2##(1993-8#1)(1995-12#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-2#1)(2007-6#1)(2008-11#2)(2009-8#1)(2012-12#1)
was translated from##2##3##(1996-2#1)(2006-10#1)
was translated in##2##3##(1994-8#1)(2008-10#1)
was translated into##4##3##(1992-8#1)(2006-7#1)(2007-5#1)(2008-10#1)
was translated##11##2##(1992-8#1)(1994-8#1)(1994-9#1)(1996-2#1)(2006-10#1)(2006-7#1)(2007-5#1)(2008-10#2)(2008-3#1)(2012-11#1)
was translocated from the cytosol to##3##6##(1992-6#1)(1996-2#1)(2011-2#1)
was translocated##5##2##(1992-6#1)(1993-2#1)(1996-2#1)(2008-10#1)(2011-2#1)
was transmissible##3##2##(2008-10#3)
was transmitted by##8##3##(2008-10#7)(2010-1#1)
was transmitted mechanically##2##3##(2008-10#2)
was transmitted through##2##3##(1996-5#1)(2012-2#1)
was transmitted to the##2##4##(1992-6#1)(2012-12#1)
was transmitted##21##2##(1991-8#1)(1992-6#1)(1996-5#1)(2007-12#1)(2008-10#13)(2008-12#1)(2010-1#1)(2012-12#1)(2012-2#1)
was transplanted into##5##3##(1995-3#1)(2006-10#1)(2008-10#1)(2010-11#1)(2013-8#1)
was transplanted##10##2##(1991-3#1)(1994-11#1)(1995-3#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-11#1)(2013-8#2)
was transported by##2##3##(1993-8#1)(2008-10#1)
was transported to the##4##4##(1996-8#1)(2008-10#3)
was transported to##5##3##(1996-8#1)(2008-10#4)
was transported##9##2##(1993-8#1)(1996-1#1)(1996-8#1)(2008-10#5)(2013-1#1)
was transposed##2##2##(1992-9#1)(2008-6#1)
was trapped##3##2##(1994-6#1)(2008-10#1)(2009-2#1)
was treated as##3##3##(1993-7#1)(2006-6#1)(2007-8#1)
was treated by a##2##4##(2008-9#1)(2009-3#1)
was treated by an##2##4##(2007-8#1)(2008-12#1)
was treated by radiotherapy##2##4##(2007-2#1)(2007-4#1)
was treated by surgery##2##4##(1994-4#1)(2007-2#1)
was treated by surgical excision##2##5##(2006-10#1)(2012-12#1)
was treated by surgical##4##4##(2006-10#1)(2007-8#1)(2011-2#1)(2012-12#1)
was treated by##38##3##(1990-8#1)(1992-1#1)(1993-10#1)(1994-4#1)(1994-5#1)(1994-7#1)(1996-9#1)(2004-1#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-8#1)(2007-2#2)(2007-4#1)(2007-8#4)(2008-10#1)(2008-12#3)(2008-2#1)(2008-4#1)(2008-9#1)(2009-3#1)(2009-5#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-8#1)
was treated conservatively and##3##4##(2007-7#1)(2013-1#2)
was treated conservatively with##3##4##(2007-8#1)(2010-5#1)(2010-7#1)
was treated conservatively##10##3##(2007-7#1)(2007-8#2)(2008-12#1)(2008-7#1)(2010-5#1)(2010-7#1)(2012-12#1)(2013-1#2)
was treated endoscopically##2##3##(2006-12#1)(2008-5#1)
was treated for##9##3##(2005-11#1)(2006-7#1)(2007-2#1)(2008-6#1)(2009-5#1)(2010-2#1)(2010-3#1)(2012-2#2)
was treated in##4##3##(1995-3#1)(2005-11#1)(2011-1#1)(2013-1#1)
was treated medically##5##3##(1997-1#1)(2007-9#1)(2008-10#1)(2008-12#1)(2011-2#1)
was treated successfully with##6##4##(2007-7#2)(2007-8#2)(2009-11#1)(2012-2#1)
was treated successfully##8##3##(1990-9#1)(2007-7#2)(2007-8#2)(2008-1#1)(2009-11#1)(2012-2#1)
was treated surgically using##2##4##(2008-9#1)(2011-2#1)
was treated surgically##8##3##(1990-10#1)(2008-12#1)(2008-9#1)(2009-1#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)
was treated using##4##3##(2010-3#1)(2010-4#1)(2011-2#1)(2013-1#1)
was treated with 0##3##4##(1996-12#1)(2008-10#1)(2010-7#1)
was treated with 2##2##4##(1994-12#1)(1996-12#1)
was treated with 2ml of##2##5##(2008-10#1)(2013-8#1)
was treated with a##9##4##(1991-9#1)(1994-5#1)(2004-10#1)(2008-11#1)(2008-4#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
was treated with an##3##4##(2008-6#1)(2013-1#1)(2013-7#1)
was treated with antibiotics and##2##5##(1996-11#1)(2011-2#1)
was treated with antibiotics##4##4##(1996-11#1)(2005-10#1)(2011-2#1)(2013-1#1)
was treated with both##2##4##(1992-2#1)(2010-7#1)
was treated with chemotherapy and##2##5##(2007-9#1)(2011-2#1)
was treated with chemotherapy##4##4##(2007-7#1)(2007-9#1)(2009-8#1)(2011-2#1)
was treated with ciprofloxacin and##2##5##(2007-7#1)(2011-2#1)
was treated with ciprofloxacin##3##4##(1997-6#1)(2007-7#1)(2011-2#1)
was treated with combination of##2##5##(1997-6#1)(2007-7#1)
was treated with intravenous antibiotics##3##5##(2006-10#1)(2008-1#1)(2013-1#1)
was treated with intravenous##7##4##(2006-10#1)(2007-9#1)(2008-1#1)(2009-8#1)(2010-10#1)(2011-2#1)(2013-1#1)
was treated with local radiotherapy and##2##6##(2006-4#1)(2012-2#1)
was treated with local##3##4##(2006-10#1)(2006-4#1)(2012-2#1)
was treated with oral##5##4##(1996-6#1)(2006-10#1)(2007-7#1)(2008-10#1)(2012-2#1)
was treated with palliative##2##4##(2007-2#1)(2012-2#1)
was treated with prednisone##4##4##(1993-9#1)(1994-12#1)(2011-2#1)(2013-8#1)
was treated with radiation therapy##3##5##(2006-12#1)(2010-12#1)(2012-2#1)
was treated with radical##2##4##(1991-4#1)(2007-11#1)
was treated with shortwave diathermy##2##5##(2008-5#2)
was treated with snake venom plus##3##6##(2008-5#3)
was treated with surgery followed by##2##6##(2005-11#1)(2013-8#1)
was treated with surgery##4##4##(2005-11#1)(2010-12#1)(2012-2#1)(2013-8#1)
was treated with the combination##2##5##(2007-7#1)(2008-12#1)
was treated with the##8##4##(1990-9#1)(2005-11#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)
was treated with##206##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#2)(1993-11#1)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#3)(1994-2#2)(1994-5#2)(1994-6#1)(1995-8#1)(1996-11#1)(1996-12#3)(1996-5#2)(1996-6#2)(1997-6#3)(1997-8#1)(2004-10#1)(2005-1#1)(2005-10#2)(2005-11#2)(2006-10#13)(2006-12#1)(2006-4#6)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#13)(2007-8#3)(2007-9#3)(2008-1#2)(2008-10#8)(2008-11#5)(2008-12#2)(2008-4#2)(2008-5#7)(2008-6#9)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-7#4)(2010-8#1)(2011-1#2)(2011-2#8)(2012-12#5)(2012-2#10)(2012-3#2)(2013-1#12)(2013-7#1)(2013-8#9)
was treated##320##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#2)(1993-10#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#3)(1994-2#2)(1994-4#1)(1994-5#3)(1994-6#2)(1994-7#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-12#3)(1996-5#4)(1996-6#2)(1996-9#1)(1997-1#1)(1997-6#3)(1997-8#1)(2004-1#1)(2004-10#1)(2005-1#1)(2005-10#3)(2005-11#4)(2005-12#1)(2006-10#15)(2006-11#1)(2006-12#3)(2006-4#6)(2006-6#2)(2006-7#1)(2006-8#3)(2007-10#2)(2007-11#5)(2007-12#3)(2007-2#4)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#16)(2007-8#13)(2007-9#4)(2008-1#3)(2008-10#12)(2008-11#5)(2008-12#8)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#8)(2008-6#10)(2008-7#2)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#2)(2009-5#5)(2009-6#2)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#5)(2010-8#1)(2011-1#6)(2011-12#1)(2011-2#14)(2012-12#8)(2012-2#16)(2012-3#3)(2013-1#17)(2013-7#1)(2013-8#10)
was tried in##2##3##(2007-3#2)
was tried##4##2##(1996-5#1)(2007-3#2)(2010-2#1)
was triggered by the##2##4##(1990-6#1)(1991-5#1)
was triggered by##5##3##(1990-6#1)(1991-5#1)(2004-12#1)(2008-10#1)(2008-8#1)
was triggered##9##2##(1990-11#1)(1990-6#1)(1991-5#1)(1992-11#1)(1996-8#1)(2004-12#1)(2008-10#2)(2008-8#1)
was tripled##2##2##(2008-3#1)(2010-6#1)
was true even##2##3##(2006-4#1)(2012-2#1)
was true for##6##3##(1992-9#1)(2008-11#1)(2009-9#1)(2010-11#1)(2010-8#1)(2012-2#1)
was true##12##2##(1990-8#1)(1992-9#1)(1996-5#1)(1997-8#1)(2006-4#2)(2008-11#1)(2009-9#1)(2010-11#1)(2010-8#1)(2012-2#2)
was truncated##4##2##(1990-6#1)(1992-8#1)(1993-8#1)(1995-1#1)
was tunable in##2##3##(2007-12#1)(2008-2#1)
was tunable##4##2##(2007-12#1)(2008-1#1)(2008-2#2)
was tuned from##4##3##(2007-11#2)(2007-12#2)
was tuned to##2##3##(2008-2#1)(2008-3#1)
was tuned##9##2##(2006-11#1)(2007-11#3)(2007-12#3)(2008-2#1)(2008-3#1)
was turned off##3##3##(1992-1#1)(1995-8#1)(2008-11#1)
was turned to##2##3##(1991-8#1)(1996-1#1)
was turned##6##2##(1991-8#1)(1992-1#1)(1995-8#1)(1996-1#1)(2008-11#1)(2008-7#1)
was twice as high as##2##5##(2008-10#1)(2008-11#1)
was twice as high##3##4##(1992-10#1)(2008-10#1)(2008-11#1)
was twice as toxic as##2##5##(2006-5#1)(2011-2#1)
was twice as##10##3##(1992-10#1)(1992-4#1)(1993-3#1)(1994-12#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)
was twice that in##2##4##(1991-5#1)(2008-10#1)
was twice that of##2##4##(2008-10#1)(2008-11#1)
was twice that##5##3##(1991-5#1)(1994-9#1)(2008-10#2)(2008-11#1)
was twice##16##2##(1991-5#1)(1992-10#1)(1992-4#1)(1993-3#1)(1994-12#1)(1994-9#1)(2006-5#1)(2008-10#4)(2008-11#2)(2008-6#1)(2008-7#1)(2011-2#1)
was two fold##2##3##(1993-6#1)(2006-9#1)
was two times##3##3##(1990-4#1)(1993-6#1)(2013-1#1)
was two to three##2##4##(1996-2#1)(2008-5#1)
was two to##3##3##(1991-6#1)(1996-2#1)(2008-5#1)
was two years##3##3##(1993-11#1)(1996-3#1)(2007-8#1)
was two##18##2##(1990-4#1)(1991-6#1)(1993-11#1)(1993-6#2)(1995-8#1)(1996-2#1)(1996-3#1)(1997-6#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-5#2)(2008-7#1)(2013-1#1)
was two-fold higher in##3##4##(1995-10#1)(2008-4#2)
was two-fold##4##2##(1995-10#1)(2007-6#1)(2008-4#2)
was twofold##4##2##(1992-8#1)(1994-1#1)(1995-2#1)(2010-8#1)
was type II##3##3##(1991-7#1)(2006-4#1)(2007-11#1)
was type##4##2##(1991-7#1)(1997-6#1)(2006-4#1)(2007-11#1)
was typical for##3##3##(2006-10#1)(2007-11#1)(2008-5#1)
was typical of##6##3##(1990-8#1)(2006-4#1)(2008-10#3)(2010-4#1)
was typical##12##2##(1990-8#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-5#1)(2010-4#1)
was typically a##2##3##(1990-7#1)(2007-12#1)
was typically##17##2##(1990-7#2)(1995-3#1)(1996-11#1)(1996-12#1)(2004-8#1)(2007-12#3)(2008-10#4)(2008-12#1)(2011-12#1)(2012-12#1)(2013-8#1)
was ubiquitously expressed in##2##4##(1996-2#1)(1997-8#1)
was ubiquitously expressed##3##3##(1996-2#1)(1997-4#1)(1997-8#1)
was ultimately##8##2##(1990-4#1)(1997-4#1)(2005-11#1)(2006-3#1)(2007-7#1)(2008-6#1)(2009-5#2)
was ultrastructurally investigated##2##3##(1995-11#1)(2008-10#1)
was unable to bind##2##4##(1994-9#2)
was unable to detect##2##4##(2007-9#1)(2008-5#1)
was unable to induce##2##4##(1994-12#1)(2008-10#1)
was unable to infect##5##4##(2008-10#5)
was unable to inhibit the##2##5##(1991-8#1)(2008-6#1)
was unable to inhibit##4##4##(1991-8#1)(1992-7#1)(1994-5#1)(2008-6#1)
was unable to prevent the##2##5##(1990-11#1)(1992-7#1)
was unable to prevent##4##4##(1990-11#1)(1992-7#1)(1996-10#1)(1997-7#1)
was unable to reach a##2##5##(2007-6#1)(2008-4#1)
was unable to show a##2##5##(2008-5#2)
was unable to take##3##4##(1993-3#1)(1995-6#1)(2008-1#1)
was unable to##59##3##(1990-10#1)(1990-11#1)(1990-9#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-7#3)(1992-9#1)(1993-11#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-4#1)(1995-6#1)(1996-10#1)(1996-12#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-9#1)(2010-10#1)(2011-1#1)(2012-2#3)(2013-1#2)
was unacceptable##2##2##(2008-10#1)(2008-8#1)
was unaffected by age##2##4##(1991-6#2)
was unaffected by dietary##2##4##(1993-12#1)(1997-5#1)
was unaffected by indomethacin##2##4##(1990-2#1)(1990-7#1)
was unaffected by the presence of##3##6##(1992-6#1)(1994-3#1)(2011-12#1)
was unaffected by the##12##4##(1990-7#1)(1991-1#1)(1991-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1994-3#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-8#1)(2011-12#1)
was unaffected by whether##2##4##(2006-3#1)(2011-2#1)
was unaffected by##54##3##(1990-10#2)(1990-2#2)(1990-7#2)(1991-1#2)(1991-12#1)(1991-2#1)(1991-6#2)(1992-3#2)(1992-4#1)(1992-6#1)(1993-12#1)(1993-3#2)(1993-6#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-5#3)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-6#1)(1996-7#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#2)(2006-3#1)(2008-10#2)(2010-7#1)(2011-12#1)(2011-2#2)(2012-12#1)
was unaffected in##2##3##(1994-12#1)(2008-7#1)
was unaffected or##2##3##(1991-5#1)(2008-10#1)
was unaffected##86##2##(1990-10#2)(1990-2#2)(1990-7#4)(1991-1#3)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-3#2)(1993-6#2)(1993-7#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#4)(1995-1#1)(1995-11#2)(1995-12#2)(1995-3#1)(1995-5#3)(1995-6#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-8#2)(2006-12#1)(2006-3#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-7#1)(2009-9#2)(2010-12#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
was unaltered by##4##3##(1991-12#1)(1991-6#1)(2008-11#1)(2010-12#1)
was unaltered in both##2##4##(1996-12#1)(2013-8#1)
was unaltered in##4##3##(1993-12#1)(1993-7#1)(1996-12#1)(2013-8#1)
was unaltered##14##2##(1991-12#1)(1991-6#1)(1993-12#1)(1993-2#1)(1993-7#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-11#1)(2010-12#1)(2013-8#1)
was unambiguously##2##2##(2008-10#2)
was uncertainty about##2##3##(2008-10#1)(2012-11#1)
was unchanged after##2##3##(1990-6#1)(1990-8#1)
was unchanged by the##2##4##(1993-12#1)(2008-10#1)
was unchanged by##6##3##(1993-12#1)(1993-3#1)(1994-12#1)(1995-5#1)(2008-10#1)(2008-8#1)
was unchanged during##3##3##(1991-1#1)(1992-6#1)(1993-10#1)
was unchanged from##2##3##(1995-5#1)(1996-6#1)
was unchanged in the##4##4##(1995-7#1)(2007-8#1)(2007-9#1)(2008-3#1)
was unchanged in##9##3##(1990-5#1)(1994-7#1)(1995-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)
was unchanged##50##2##(1990-10#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#1)(1992-6#1)(1993-10#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-7#1)(1995-3#1)(1995-5#2)(1995-7#2)(1995-9#1)(1996-10#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(2005-8#1)(2007-12#1)(2007-8#7)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-9#1)(2011-2#1)
was unclear##8##2##(1991-1#1)(2006-10#1)(2007-7#1)(2008-11#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
was uncommon in##2##3##(2005-11#1)(2007-7#1)
was uncommon##6##2##(1993-10#1)(1994-2#1)(2005-11#1)(2007-7#1)(2008-8#1)(2008-9#1)
was uncompetitive##2##2##(1990-3#1)(1997-7#1)
was uncomplicated and thus lymphedema##2##5##(2009-3#2)
was uncomplicated##5##2##(1993-9#1)(2009-3#2)(2011-2#1)(2012-12#1)
was uncovered in##2##3##(1991-7#1)(2009-10#1)
was uncovered##5##2##(1991-7#1)(2004-12#1)(2007-11#1)(2009-10#1)(2010-2#1)
was under the control of the##2##6##(1992-8#1)(2007-9#1)
was under the##4##3##(1992-8#1)(2007-9#1)(2008-10#1)(2012-12#1)
was under##14##2##(1990-5#1)(1992-4#1)(1992-8#1)(1993-3#1)(2006-2#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2010-12#2)(2012-12#1)
was undergoing##4##2##(1992-1#1)(2005-7#1)(2012-12#1)(2013-7#1)
was understood##2##2##(2007-12#1)(2008-10#1)
was undertaken as##2##3##(2007-5#1)(2008-5#1)
was undertaken at a##2##4##(1993-11#1)(2013-1#1)
was undertaken at##3##3##(1993-11#1)(2011-1#1)(2013-1#1)
was undertaken between##4##3##(1992-6#1)(1994-2#1)(2008-1#1)(2008-10#1)
was undertaken by the##2##4##(2008-10#1)(2010-3#1)
was undertaken by using##2##4##(2006-12#1)(2013-8#1)
was undertaken by##8##3##(1990-4#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-3#1)(2013-8#2)
was undertaken during##3##3##(2007-10#1)(2008-4#1)(2011-1#1)
was undertaken for articles published##5##5##(2012-12#5)
was undertaken for##7##3##(2007-10#1)(2012-12#5)(2012-2#1)
was undertaken from##2##3##(2007-7#1)(2008-1#1)
was undertaken in an attempt to##2##6##(1992-3#1)(2005-11#1)
was undertaken in order to##4##5##(1990-12#1)(1991-5#1)(2006-6#1)(2007-10#1)
was undertaken in the##7##4##(1991-5#1)(1996-5#1)(2008-5#2)(2009-6#1)(2011-2#1)(2012-1#1)
was undertaken in two##2##4##(2008-11#1)(2008-3#1)
was undertaken in##35##3##(1990-10#1)(1990-11#2)(1990-12#1)(1991-5#2)(1992-2#1)(1992-3#1)(1993-12#1)(1994-3#2)(1996-5#1)(2005-11#1)(2005-8#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-3#3)(2008-5#2)(2008-7#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
was undertaken of##9##3##(1990-12#1)(1991-9#1)(1994-3#1)(2004-10#1)(2005-8#1)(2005-9#1)(2008-6#1)(2010-1#1)(2013-1#1)
was undertaken on##6##3##(1990-12#1)(2006-10#1)(2009-8#1)(2011-1#1)(2012-2#1)(2012-3#1)
was undertaken over a##2##4##(1993-9#1)(2007-2#1)
was undertaken that##2##3##(2007-10#1)(2008-10#1)
was undertaken through##2##3##(1991-6#1)(2008-11#1)
was undertaken to analyze##4##4##(2005-10#1)(2007-11#1)(2010-8#1)(2012-2#1)
was undertaken to ascertain##2##4##(1995-5#1)(2008-3#1)
was undertaken to assess the##10##5##(1991-12#1)(1991-9#1)(1994-6#1)(1997-2#1)(2008-10#2)(2008-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
was undertaken to assess whether##2##5##(1993-12#1)(1995-11#1)
was undertaken to assess##13##4##(1991-12#1)(1991-9#1)(1993-12#1)(1994-6#1)(1995-11#1)(1997-2#1)(2007-10#1)(2008-10#2)(2008-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
was undertaken to characterize the##2##5##(2007-7#1)(2008-10#1)
was undertaken to compare the##4##5##(1995-2#1)(2006-12#1)(2008-5#1)(2011-2#1)
was undertaken to compare##6##4##(1992-3#1)(1995-2#1)(2006-12#1)(2008-5#2)(2011-2#1)
was undertaken to detect##2##4##(2005-12#1)(2009-2#1)
was undertaken to determine if##2##5##(1994-8#1)(2008-7#1)
was undertaken to determine the effect of##2##7##(2008-12#1)(2008-3#1)
was undertaken to determine the##22##5##(1993-4#1)(1994-2#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-4#1)(2006-10#2)(2006-8#1)(2007-8#2)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-4#1)(2010-4#1)(2012-12#1)
was undertaken to determine whether##7##5##(1993-2#1)(1993-6#1)(1996-1#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-6#1)
was undertaken to determine##35##4##(1993-2#1)(1993-4#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-4#1)(2006-10#2)(2006-8#1)(2007-1#1)(2007-12#1)(2007-8#3)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-3#1)(2009-4#1)(2010-4#1)(2010-6#1)(2012-12#1)(2013-8#1)
was undertaken to develop##2##4##(1992-11#1)(1993-9#1)
was undertaken to establish a##2##5##(1993-2#1)(2011-2#1)
was undertaken to establish the##2##5##(2008-7#1)(2012-2#1)
was undertaken to establish##7##4##(1990-11#1)(1993-2#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#2)
was undertaken to estimate##2##4##(2008-10#2)
was undertaken to evaluate and##2##5##(2006-8#2)
was undertaken to evaluate the effect of##4##7##(1991-4#1)(2006-1#1)(2006-8#1)(2011-2#1)
was undertaken to evaluate the safety and efficacy of the##2##10##(2006-8#1)(2008-11#1)
was undertaken to evaluate the##17##5##(1991-4#1)(1996-1#1)(1996-11#1)(2006-1#1)(2006-5#1)(2006-8#2)(2007-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#2)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
was undertaken to evaluate##23##4##(1991-4#1)(1996-1#1)(1996-11#1)(2006-1#1)(2006-5#1)(2006-8#6)(2007-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
was undertaken to examine the effect of##2##7##(1996-6#1)(2010-12#1)
was undertaken to examine the##4##5##(1991-8#1)(1996-6#1)(2009-12#1)(2010-12#1)
was undertaken to examine##10##4##(1991-8#1)(1996-6#1)(2007-3#1)(2007-8#1)(2008-5#1)(2009-12#1)(2010-12#1)(2010-8#1)(2011-2#2)
was undertaken to explore the##3##5##(1991-10#1)(2009-5#1)(2012-3#1)
was undertaken to identify##4##4##(1993-3#1)(2006-2#1)(2012-12#1)(2012-3#1)
was undertaken to investigate the##9##5##(1991-2#1)(1994-12#1)(2006-9#1)(2007-9#1)(2008-7#1)(2008-8#1)(2010-3#1)(2012-2#2)
was undertaken to investigate##12##4##(1991-2#1)(1994-12#1)(1997-2#1)(1997-8#1)(2006-9#1)(2007-9#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-3#1)(2012-2#2)
was undertaken to study the##8##5##(1994-12#1)(1997-8#1)(2006-1#2)(2007-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
was undertaken to understand##2##4##(1994-3#1)(2008-5#1)
was undertaken to##169##3##(1990-11#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-3#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-8#2)(2005-10#1)(2005-12#1)(2006-1#3)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#8)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#2)(2007-7#5)(2007-8#5)(2007-9#1)(2008-10#11)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#6)(2008-6#1)(2008-7#8)(2008-8#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#7)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
was undertaken using a##2##4##(2008-3#1)(2008-7#1)
was undertaken using the##3##4##(1997-5#1)(2006-12#1)(2009-7#1)
was undertaken using##9##3##(1997-5#2)(2006-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-7#1)(2011-2#1)(2013-1#1)
was undertaken where##2##3##(1990-9#1)(2011-12#1)
was undertaken with the##5##4##(1990-12#1)(2006-10#1)(2007-7#1)(2007-8#1)(2011-1#1)
was undertaken with##7##3##(1990-12#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-5#1)(2011-1#1)
was undertaken within##2##3##(2008-11#2)
was undertaken##322##2##(1990-10#1)(1990-11#3)(1990-12#5)(1990-4#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#2)(1992-11#2)(1992-2#1)(1992-3#3)(1992-6#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#3)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#4)(1994-6#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#3)(1996-10#1)(1996-11#1)(1996-2#1)(1996-5#2)(1996-6#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-8#2)(2004-10#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-8#2)(2005-9#1)(2006-1#3)(2006-10#4)(2006-12#3)(2006-2#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#11)(2006-9#1)(2007-1#1)(2007-10#6)(2007-11#2)(2007-12#1)(2007-2#3)(2007-3#3)(2007-5#1)(2007-6#1)(2007-7#10)(2007-8#6)(2007-9#1)(2008-1#3)(2008-10#20)(2008-11#15)(2008-12#3)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#13)(2008-6#2)(2008-7#10)(2008-8#3)(2008-9#4)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-12#3)(2011-2#12)(2012-1#1)(2012-11#1)(2012-12#12)(2012-2#11)(2012-3#4)(2013-1#6)(2013-7#2)(2013-8#6)
was underused##4##2##(2007-10#1)(2007-9#1)(2008-3#1)(2012-11#1)
was undetectable in the##3##4##(1991-3#1)(1994-11#1)(1996-12#1)
was undetectable in##9##3##(1990-5#1)(1991-3#1)(1991-5#1)(1994-11#1)(1996-12#1)(1996-8#1)(1996-9#1)(2006-12#1)(2009-10#1)
was undetectable##12##2##(1990-5#1)(1991-3#1)(1991-5#1)(1994-11#1)(1994-12#1)(1996-12#1)(1996-8#1)(1996-9#1)(2006-12#1)(2008-10#1)(2009-10#1)(2012-3#1)
was undetected in##2##3##(1997-6#2)
was undetected##3##2##(1997-6#2)(2008-10#1)
was uneven##3##2##(1992-5#1)(2008-8#1)(2008-9#1)
was unevenly distributed##3##3##(1992-1#1)(2008-10#2)
was uneventful and the##2##4##(2007-2#1)(2012-3#1)
was uneventful and##5##3##(2007-2#1)(2008-10#1)(2008-12#1)(2009-5#1)(2012-3#1)
was uneventful without##2##3##(2010-12#1)(2012-2#1)
was uneventful##41##2##(1991-11#1)(1996-8#1)(2005-12#1)(2006-12#1)(2006-4#1)(2007-2#1)(2007-7#1)(2007-8#6)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-12#2)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#4)
was unexpected##5##2##(1992-10#1)(1992-7#1)(1993-2#1)(2006-11#1)(2008-4#1)
was unexpectedly##4##2##(2008-11#1)(2008-5#1)(2012-1#1)(2013-1#1)
was unexplained##2##2##(1994-5#1)(1995-6#1)
was uniformly distributed##2##3##(2007-1#1)(2008-10#1)
was uniformly superior to##2##4##(1990-10#1)(1994-5#1)
was uniformly##9##2##(1990-10#1)(1991-3#1)(1991-8#1)(1994-5#1)(2007-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-7#1)
was unilaterally##3##2##(1995-12#1)(1997-7#1)(2007-1#1)
was unique for##2##3##(1997-4#1)(2008-10#1)
was unique in that it##2##5##(1997-4#1)(2009-8#1)
was unique in that##3##4##(1994-5#1)(1997-4#1)(2009-8#1)
was unique##8##2##(1991-11#1)(1991-9#1)(1994-5#1)(1997-4#2)(2008-10#1)(2009-8#1)(2011-2#1)
was uniquely##3##2##(2008-10#1)(2009-7#1)(2009-8#1)
was universally##2##2##(1996-1#1)(2012-2#1)
was unknown##6##2##(1993-8#1)(1994-11#1)(2008-10#2)(2010-12#1)(2012-2#1)
was unlikely to##3##3##(1990-8#1)(2009-3#2)
was unlikely##9##2##(1990-8#1)(1992-2#1)(1995-6#1)(1996-12#1)(2008-10#1)(2008-11#1)(2009-3#2)(2010-2#1)
was unrelated to the degree of##2##6##(2008-7#1)(2011-2#1)
was unrelated to the##4##4##(2005-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
was unrelated to##17##3##(1990-12#2)(1994-11#1)(1994-9#1)(1997-7#2)(2005-11#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-7#1)(2009-4#1)(2011-2#2)(2013-1#2)
was unrelated##18##2##(1990-12#2)(1994-11#1)(1994-9#2)(1997-7#2)(2005-11#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-7#1)(2009-4#1)(2011-2#2)(2013-1#2)
was unremarkable and##3##3##(1990-3#1)(2012-2#2)
was unremarkable##10##2##(1990-3#1)(1991-9#1)(1992-7#1)(2006-10#1)(2007-2#1)(2007-3#1)(2011-1#1)(2012-2#2)(2013-1#1)
was unresponsive to##7##3##(1994-2#1)(1996-11#1)(2007-8#1)(2008-4#1)(2010-2#1)(2011-2#2)
was unsatisfactory##2##2##(2008-7#1)(2012-2#1)
was unstable in##2##3##(2008-10#1)(2008-11#1)
was unstable##7##2##(1990-7#1)(1994-5#1)(2005-11#1)(2008-10#2)(2008-11#1)(2010-7#1)
was unsuccessful and##2##3##(2007-7#1)(2007-8#1)
was unsuccessful in##2##3##(2007-7#1)(2008-11#1)
was unsuccessful##16##2##(1992-11#1)(1995-11#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-3#1)(2012-3#2)(2013-1#3)(2013-7#1)
was unsuitable##4##2##(2007-7#1)(2008-10#1)(2008-11#1)(2013-8#1)
was unusual in##2##3##(1993-9#1)(2009-7#1)
was unusual##5##2##(1992-5#1)(1993-9#1)(1995-10#1)(2009-7#1)(2013-8#1)
was up to 25##2##4##(1991-5#1)(1993-4#1)
was up to##25##3##(1990-4#1)(1990-5#1)(1991-11#1)(1991-5#1)(1991-8#1)(1992-12#1)(1993-4#1)(1995-8#1)(1997-5#2)(2005-4#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-8#3)(2012-2#1)(2013-8#1)
was up-regulated after##2##3##(2010-4#1)(2013-1#1)
was up-regulated in##5##3##(1995-11#1)(1997-7#1)(2008-10#1)(2009-4#1)(2010-4#1)
was up-regulated##8##2##(1995-11#1)(1997-7#1)(2008-10#1)(2009-4#1)(2010-4#2)(2012-3#1)(2013-1#1)
was upregulated in##7##3##(1996-12#1)(2008-7#1)(2009-4#1)(2010-12#2)(2010-5#1)(2013-7#1)
was upregulated to##2##3##(1994-8#2)
was upregulated##13##2##(1993-6#1)(1994-8#2)(1996-12#1)(2008-1#1)(2008-7#1)(2009-4#1)(2010-12#3)(2010-5#1)(2013-1#1)(2013-7#1)
was urgently##3##2##(2008-12#1)(2010-1#1)(2011-3#1)
was used after##4##3##(1990-6#1)(2006-12#1)(2008-10#1)(2011-2#1)
was used alone##4##3##(1993-12#1)(1997-5#1)(2008-10#1)(2009-9#1)
was used and a##3##4##(1991-5#1)(2008-10#1)(2013-8#1)
was used and the##14##4##(1990-8#1)(1991-7#1)(2006-8#1)(2007-2#1)(2008-10#9)(2008-8#1)
was used and##26##3##(1990-8#1)(1991-5#1)(1991-7#1)(1996-7#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-2#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-3#1)(2013-7#1)(2013-8#1)
was used as a bioassay##3##5##(1993-12#1)(2008-10#2)
was used as a control##7##5##(1991-12#1)(1991-7#1)(1995-12#2)(2007-1#1)(2008-11#1)(2008-5#1)
was used as a fluorescent##2##5##(1991-5#1)(2008-10#1)
was used as a functional##2##5##(1997-7#1)(2010-4#1)
was used as a marker for##5##6##(1993-2#1)(1994-2#1)(2006-4#1)(2007-10#1)(2010-10#1)
was used as a measure of##6##6##(1990-2#1)(1990-4#1)(1991-4#1)(2006-6#1)(2009-2#1)(2011-2#1)
was used as a model system for##2##7##(1994-9#1)(1995-3#1)
was used as a model to##2##6##(1993-12#1)(1993-9#1)
was used as a model##10##5##(1990-12#1)(1991-10#1)(1993-12#1)(1993-9#1)(1994-9#1)(1995-3#1)(1996-12#1)(1996-8#1)(2008-10#1)(2011-1#1)
was used as a photoaffinity##2##5##(1990-8#1)(1992-6#1)
was used as a positive##2##5##(1992-12#1)(1996-12#1)
was used as a precursor of##2##6##(2005-11#1)(2008-5#1)
was used as a probe for##2##6##(2005-11#1)(2008-10#1)
was used as a probe to##2##6##(1990-6#1)(1997-1#1)
was used as a probe##11##5##(1990-10#2)(1990-6#1)(1991-2#1)(1992-6#1)(1997-1#1)(1997-4#1)(2005-11#1)(2008-10#1)(2008-5#1)(2008-8#1)
was used as a pump##2##5##(2007-11#1)(2007-12#1)
was used as a reference##7##5##(1993-8#1)(1994-3#1)(2008-10#1)(2008-5#2)(2012-2#1)(2013-7#1)
was used as a sample##3##5##(2008-10#2)(2010-5#1)
was used as a selective##3##5##(2005-11#1)(2008-10#1)(2012-12#1)
was used as a solid##2##5##(2008-10#2)
was used as a source of##2##6##(1996-5#1)(2011-1#1)
was used as a source##3##5##(1996-5#1)(2007-12#1)(2011-1#1)
was used as a starting material for##2##7##(2007-1#1)(2007-11#1)
was used as a starting##3##5##(1995-11#1)(2007-1#1)(2007-11#1)
was used as a substrate to##2##6##(1995-10#1)(2008-10#1)
was used as a substrate##3##5##(1993-6#1)(1995-10#1)(2008-10#1)
was used as a support material for##2##7##(2008-10#2)
was used as a target##2##5##(1997-7#1)(2008-10#1)
was used as a working electrode in##2##7##(2008-10#2)
was used as a working electrode##3##6##(2008-10#3)
was used as a##168##4##(1990-10#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-6#1)(1990-8#3)(1991-10#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#3)(1991-7#1)(1992-12#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-3#1)(1995-9#1)(1996-12#2)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(2005-11#3)(2005-4#2)(2005-8#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#7)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#46)(2008-11#3)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#6)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-5#3)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#2)
was used as amperometric##2##4##(2008-10#2)
was used as an additive##2##5##(2007-8#1)(2010-4#1)
was used as an affinity##2##5##(2008-7#1)(2010-5#1)
was used as an amperometric##3##5##(2008-10#3)
was used as an index of##7##6##(1990-9#1)(1992-2#1)(1993-2#1)(1993-9#1)(1996-12#1)(2006-9#1)(2008-11#1)
was used as an indicator electrode##4##6##(2008-10#4)
was used as an indicator of##2##6##(2008-10#1)(2008-5#1)
was used as an indicator##8##5##(2007-10#1)(2008-10#5)(2008-5#1)(2008-7#1)
was used as an internal standard and##2##7##(1992-2#1)(2008-10#1)
was used as an internal standard to##2##7##(1991-5#1)(2008-10#1)
was used as an internal standard##14##6##(1991-5#1)(1992-2#1)(1993-1#1)(1993-3#1)(1997-3#1)(2008-10#7)(2008-6#1)(2010-2#1)
was used as an internal##16##5##(1990-4#1)(1991-5#1)(1992-2#1)(1993-1#1)(1993-3#1)(1997-3#1)(2008-10#7)(2008-2#1)(2008-6#1)(2010-2#1)
was used as an ulcerogen##2##5##(2010-12#1)(2012-2#1)
was used as an##60##4##(1990-4#1)(1990-9#1)(1991-5#1)(1992-2#2)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-6#1)(1995-1#1)(1996-12#1)(1997-3#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-8#1)(2008-10#27)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2012-2#1)
was used as another control##2##5##(2008-10#1)(2008-5#1)
was used as antigen##2##4##(2008-10#1)(2008-5#1)
was used as attractant##2##4##(2004-11#2)
was used as both supporting electrolyte and##2##7##(2008-10#2)
was used as chemical modifier##4##5##(2008-10#4)
was used as control##9##4##(1991-8#1)(1993-11#1)(1994-9#1)(2006-6#1)(2007-6#1)(2008-12#1)(2008-5#1)(2009-2#1)(2013-7#1)
was used as detector##2##4##(2005-4#1)(2011-3#1)
was used as internal standard##9##5##(1990-10#1)(1990-11#1)(1996-8#1)(2007-8#1)(2008-10#5)
was used as internal##10##4##(1990-10#1)(1990-11#1)(1996-8#1)(2007-8#1)(2008-10#6)
was used as model##5##4##(1990-12#1)(1994-11#1)(2008-10#3)
was used as primary##2##4##(1990-11#1)(2012-3#1)
was used as reference##3##4##(2008-1#1)(2011-1#1)(2012-3#1)
was used as substrate##3##4##(1993-12#1)(1996-5#1)(2004-12#1)
was used as template##2##4##(2008-10#1)(2008-9#1)
was used as the analytical##2##5##(2008-10#2)
was used as the benchmark##2##5##(2005-12#1)(2008-5#1)
was used as the chemical modifier##3##6##(2008-10#3)
was used as the control##2##5##(2004-9#1)(2008-5#1)
was used as the detector##2##5##(2008-10#1)(2013-7#1)
was used as the indicator##2##5##(2008-10#2)
was used as the internal standard for the##2##8##(2007-8#1)(2008-10#1)
was used as the internal standard##7##6##(1993-2#1)(1996-8#1)(1997-3#1)(2007-8#1)(2008-10#2)(2008-6#1)
was used as the labelled signal antibody for the assay of##2##11##(1991-3#2)
was used as the light source##3##6##(2007-12#1)(2008-10#1)(2008-2#1)
was used as the mobile phase##6##6##(1990-8#2)(2007-8#1)(2008-10#1)(2011-1#2)
was used as the model##2##5##(2008-10#1)(2008-7#1)
was used as the pump##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
was used as the reference##2##5##(2008-11#1)(2011-1#1)
was used as the sole##3##5##(1995-6#1)(2008-6#1)(2008-7#1)
was used as the source##2##5##(1990-11#1)(2008-10#1)
was used as the substrate##2##5##(1990-12#1)(2008-6#1)
was used as the##105##4##(1990-11#1)(1990-12#1)(1990-8#4)(1991-3#2)(1992-3#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(2004-9#1)(2005-11#2)(2005-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2007-10#2)(2007-12#4)(2007-8#2)(2008-10#37)(2008-11#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#6)(2008-6#4)(2008-7#2)(2010-2#1)(2011-1#6)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
was used as working electrode##2##5##(2008-10#2)
was used as##445##3##(1990-10#3)(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#3)(1990-6#1)(1990-8#7)(1990-9#1)(1991-10#2)(1991-12#3)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#4)(1991-7#1)(1991-8#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-6#3)(1992-7#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#3)(1994-11#2)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-11#1)(1996-12#3)(1996-5#2)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-7#2)(2004-1#1)(2004-11#2)(2004-12#1)(2004-9#1)(2005-11#7)(2005-12#1)(2005-4#3)(2005-8#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#4)(2007-11#3)(2007-12#11)(2007-6#2)(2007-8#9)(2007-9#1)(2008-1#2)(2008-10#155)(2008-11#6)(2008-12#2)(2008-2#9)(2008-3#7)(2008-4#4)(2008-5#18)(2008-6#6)(2008-7#6)(2008-8#3)(2008-9#2)(2009-2#2)(2009-3#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#4)(2011-1#10)(2011-2#5)(2011-3#2)(2012-12#1)(2012-2#5)(2012-3#2)(2012-7#1)(2013-1#3)(2013-7#5)(2013-8#1)
was used at different##2##4##(1991-9#1)(2010-2#1)
was used at pH 7##2##5##(2008-10#2)
was used at##10##3##(1991-10#1)(1991-9#1)(1996-8#1)(2008-10#3)(2008-5#1)(2010-2#2)(2013-1#1)
was used before##3##3##(1992-8#1)(2008-5#1)(2008-7#1)
was used by##12##3##(1993-10#1)(2005-8#1)(2006-10#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-10#1)(2011-2#1)(2012-2#2)
was used containing##2##3##(2008-5#1)(2011-12#1)
was used due to the##2##5##(2005-4#1)(2006-11#1)
was used during##5##3##(1993-12#1)(1996-9#1)(2008-11#1)(2008-2#1)(2012-2#1)
was used for DNA##2##4##(1996-4#1)(2008-10#1)
was used for a##8##4##(2006-2#1)(2007-1#1)(2007-5#1)(2008-1#1)(2008-10#2)(2010-10#1)(2012-12#1)
was used for all##2##4##(1996-1#1)(2006-12#1)
was used for analysis of##2##5##(2008-10#1)(2013-1#1)
was used for analysis##6##4##(2007-10#1)(2008-10#2)(2013-1#3)
was used for both##2##4##(2007-11#1)(2007-12#1)
was used for comparison##4##4##(2008-10#1)(2010-4#1)(2011-1#1)(2012-2#1)
was used for data analysis##4##5##(2007-7#1)(2008-10#1)(2010-11#1)(2011-1#1)
was used for data collection and analysis##2##7##(2005-12#1)(2009-11#1)
was used for data collection##5##5##(2005-12#1)(2008-3#1)(2009-11#1)(2011-1#1)(2013-8#1)
was used for data##11##4##(2005-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-11#1)(2010-11#1)(2011-1#2)(2013-1#1)(2013-8#1)
was used for detection of##3##5##(2007-2#1)(2008-10#1)(2008-2#1)
was used for detection##6##4##(1997-3#1)(2005-3#1)(2007-2#1)(2008-10#2)(2008-2#1)
was used for determination of##6##5##(2008-10#6)
was used for determining##2##4##(1995-2#1)(2008-7#1)
was used for efficient##2##4##(1996-7#1)(2008-2#1)
was used for evaluating##3##4##(2004-11#1)(2008-10#2)
was used for evaluation of##3##5##(2007-7#1)(2008-7#2)
was used for fabrication of##2##5##(2008-10#1)(2008-3#1)
was used for filters with##2##5##(2008-2#2)
was used for further##2##4##(2007-8#1)(2009-3#1)
was used for genomic##2##4##(1995-12#1)(2008-10#1)
was used for identification of##2##5##(2004-9#1)(2008-10#1)
was used for identification##3##4##(2004-9#1)(2008-10#2)
was used for imaging##3##4##(2007-12#2)(2012-12#1)
was used for in situ##2##5##(2008-10#1)(2010-2#1)
was used for in##3##4##(1994-3#1)(2008-10#1)(2010-2#1)
was used for measuring the##3##5##(1994-11#1)(2008-8#1)(2013-1#1)
was used for numerical##2##4##(2008-10#1)(2008-2#1)
was used for preconcentration of##2##5##(2008-10#2)
was used for preparation##2##4##(1990-9#1)(2008-11#1)
was used for quantification##2##4##(2008-10#1)(2008-11#1)
was used for sample##2##4##(2008-10#1)(2011-1#1)
was used for screening the##2##5##(2007-11#1)(2010-8#1)
was used for selective##2##4##(2007-8#1)(2008-10#1)
was used for statistical analysis##6##5##(1994-9#1)(2006-7#2)(2007-11#1)(2012-2#1)(2012-3#1)
was used for statistical##7##4##(1994-9#1)(2006-7#2)(2007-11#1)(2008-10#1)(2012-2#1)(2012-3#1)
was used for testing##3##4##(2007-4#1)(2008-10#1)(2013-8#1)
was used for the analysis of##3##6##(2006-7#1)(2007-8#1)(2008-10#1)
was used for the analysis##5##5##(1997-3#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-9#1)
was used for the assay of##2##6##(2008-10#2)
was used for the detection of##6##6##(1992-8#1)(2006-8#1)(2008-10#2)(2008-4#1)(2011-1#1)
was used for the determination of trace##3##7##(2008-10#3)
was used for the determination of##25##6##(1991-5#1)(1996-5#1)(1997-8#1)(2005-4#1)(2007-12#1)(2008-10#19)(2008-2#1)
was used for the development of a##2##7##(2008-10#1)(2013-1#1)
was used for the electroanalytical determination of##2##7##(2008-10#2)
was used for the evaluation of##3##6##(2008-10#1)(2010-3#1)(2012-2#1)
was used for the first time to##3##7##(2008-10#2)(2013-8#1)
was used for the immobilization of##2##6##(2008-10#2)
was used for the preparation of##2##6##(1994-2#1)(2008-8#1)
was used for the quantitative determination of##3##7##(2008-10#3)
was used for the quantitative##5##5##(2008-10#4)(2013-8#1)
was used for the separation of##2##6##(2008-10#1)(2012-12#1)
was used for the separations and##2##6##(1991-3#1)(2008-4#1)
was used for the simultaneous##3##5##(2008-1#1)(2008-10#2)
was used for the##132##4##(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-8#1)(1993-2#1)(1994-11#1)(1994-2#2)(1996-2#1)(1996-4#1)(1996-5#4)(1996-8#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-4#1)(2006-12#2)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#4)(2008-1#1)(2008-10#70)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
was used for thermal##2##4##(2007-1#1)(2008-10#1)
was used for these studies##2##5##(1991-12#1)(2008-8#1)
was used for this purpose##3##5##(2008-10#3)
was used for this##5##4##(1990-7#1)(2008-10#3)(2008-2#1)
was used for transmission##2##4##(2007-12#1)(2009-7#1)
was used for two##2##4##(1995-8#1)(2008-3#1)
was used for##403##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-8#3)(1993-2#2)(1994-11#3)(1994-2#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#4)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#3)(1997-3#5)(1997-6#2)(1997-7#1)(1997-8#2)(2004-11#1)(2004-12#1)(2004-9#2)(2005-11#2)(2005-12#2)(2005-3#1)(2005-4#1)(2006-10#1)(2006-12#6)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#3)(2006-8#3)(2007-1#2)(2007-10#2)(2007-11#6)(2007-12#10)(2007-2#6)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#12)(2008-1#4)(2008-10#146)(2008-11#6)(2008-12#1)(2008-2#9)(2008-3#7)(2008-4#3)(2008-5#10)(2008-6#1)(2008-7#5)(2008-8#9)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#3)(2009-3#2)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#7)(2011-2#3)(2012-1#1)(2012-10#1)(2012-12#7)(2012-2#3)(2012-3#3)(2013-1#12)(2013-7#1)(2013-8#7)
was used here as a##3##5##(1990-2#1)(2008-10#1)(2008-7#1)
was used here##5##3##(1990-2#1)(1994-12#1)(2008-10#2)(2008-7#1)
was used in 14##2##4##(2005-5#1)(2013-1#1)
was used in 3##2##4##(2007-9#1)(2013-1#1)
was used in a##12##4##(1996-11#1)(1996-12#1)(2004-10#1)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#1)
was used in all cases##2##5##(1996-2#1)(2006-6#1)
was used in all patients##2##5##(2006-8#1)(2011-12#1)
was used in all##8##4##(1994-10#1)(1996-2#1)(2006-6#1)(2006-8#1)(2007-7#1)(2008-10#1)(2009-3#1)(2011-12#1)
was used in an##4##4##(1993-4#1)(1995-2#1)(2006-4#1)(2008-10#1)
was used in both##2##4##(1996-4#1)(2006-10#1)
was used in combination with a##2##6##(2007-12#2)
was used in combination with##5##5##(1991-7#1)(2007-12#2)(2008-10#1)(2013-8#1)
was used in conjunction with a##2##6##(2008-10#1)(2008-3#1)
was used in conjunction with##9##5##(1996-5#1)(1997-6#1)(2008-10#4)(2008-3#1)(2008-8#2)
was used in determination of##2##5##(2008-10#2)
was used in each##3##4##(2006-8#1)(2008-10#1)(2008-6#1)
was used in one##2##4##(2006-2#1)(2013-8#1)
was used in order to determine##3##6##(2007-10#1)(2008-10#2)
was used in order to##12##5##(1990-12#1)(2006-10#1)(2007-10#1)(2007-9#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-7#1)
was used in place of##2##5##(1994-12#1)(1994-9#1)
was used in the analysis##2##5##(1997-8#1)(2012-6#1)
was used in the data analysis##2##6##(2008-10#1)(2008-6#1)
was used in the determination of##2##6##(2007-8#1)(2008-10#1)
was used in the diagnosis of##2##6##(1994-2#1)(2010-12#1)
was used in the preparation of##2##6##(2007-11#1)(2010-12#1)
was used in the study##3##5##(1996-1#1)(2007-7#1)(2008-10#1)
was used in the treatment of##3##6##(2006-3#1)(2007-11#1)(2007-8#1)
was used in the##45##4##(1990-8#1)(1991-2#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-7#1)(1996-1#1)(1996-11#1)(1997-4#1)(1997-8#1)(2006-3#1)(2006-4#1)(2006-6#1)(2007-11#3)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#11)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2010-12#2)(2010-8#1)(2012-2#1)(2012-6#1)(2013-8#1)
was used in these##2##4##(2007-9#1)(2008-10#1)
was used in this study##9##5##(1992-10#1)(1994-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-12#1)(2011-2#1)(2013-7#1)
was used in this##12##4##(1991-10#1)(1992-10#1)(1994-3#1)(1996-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2009-12#1)(2011-2#1)(2013-7#1)
was used in##211##3##(1990-11#1)(1990-12#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-4#4)(1991-7#1)(1992-10#1)(1992-2#1)(1992-6#2)(1992-8#3)(1993-11#1)(1993-4#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-10#2)(2005-1#1)(2005-5#1)(2006-10#5)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#3)(2006-8#2)(2007-10#2)(2007-11#7)(2007-12#4)(2007-6#1)(2007-7#4)(2007-8#10)(2007-9#3)(2008-1#1)(2008-10#41)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#4)(2008-8#5)(2009-12#2)(2009-3#3)(2009-7#1)(2010-1#2)(2010-12#2)(2010-2#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#3)(2012-6#1)(2013-1#3)(2013-7#1)(2013-8#3)
was used instead of##4##4##(1990-11#1)(1997-7#1)(1997-8#1)(2008-10#1)
was used instead##7##3##(1990-11#1)(1994-9#1)(1996-11#1)(1997-7#1)(1997-8#1)(2008-10#1)(2012-2#1)
was used more##2##3##(2007-7#1)(2008-11#1)
was used not only##2##4##(1995-1#1)(2008-10#1)
was used on the##2##4##(2007-9#1)(2013-8#1)
was used on##8##3##(1990-3#1)(1991-3#1)(2007-9#1)(2008-10#1)(2009-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
was used previously##2##3##(2007-12#1)(2007-8#1)
was used primarily##2##3##(2004-1#1)(2008-3#1)
was used prior to##3##4##(1992-2#1)(2008-10#2)
was used successfully for the##2##5##(2008-10#2)
was used successfully for##3##4##(2008-10#2)(2008-2#1)
was used successfully in the##2##5##(2008-10#2)
was used successfully##5##3##(2008-10#4)(2008-2#1)
was used the##2##3##(2006-5#1)(2008-10#1)
was used through##2##3##(1992-1#1)(2013-1#1)
was used throughout##2##3##(1996-5#1)(2008-10#1)
was used to account for##2##5##(2008-3#1)(2013-1#1)
was used to achieve the##2##5##(2013-8#2)
was used to achieve##10##4##(1997-2#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2012-2#1)(2013-8#2)
was used to adjust for differences##2##6##(2008-3#1)(2012-2#1)
was used to adjust for##3##5##(2008-3#2)(2012-2#1)
was used to adjust##4##4##(2007-8#1)(2008-3#2)(2012-2#1)
was used to aid##3##4##(2008-11#1)(2008-7#1)(2013-1#1)
was used to amplify a##3##5##(1992-8#1)(1993-8#1)(2008-10#1)
was used to amplify##10##4##(1991-7#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-12#1)(1996-5#1)(1996-6#1)(2006-10#1)(2008-10#2)
was used to analyse the##4##5##(1991-12#1)(1991-7#1)(1997-4#1)(2008-12#1)
was used to analyse##5##4##(1991-12#1)(1991-7#1)(1997-4#1)(2008-12#1)(2010-3#1)
was used to analyze the##10##5##(1992-1#1)(1993-6#1)(2007-12#1)(2008-10#2)(2008-6#1)(2008-8#1)(2010-1#1)(2010-12#1)(2011-2#1)
was used to analyze##24##4##(1992-1#1)(1993-6#1)(2006-3#1)(2007-12#1)(2008-10#6)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
was used to ascertain##2##4##(2005-11#1)(2008-10#1)
was used to assay##2##4##(1996-12#1)(2008-11#1)
was used to assess body##2##5##(2006-9#1)(2007-12#1)
was used to assess changes in##2##6##(2007-7#1)(2010-5#1)
was used to assess the effect of##3##7##(2007-8#1)(2011-2#1)(2012-12#1)
was used to assess the##23##5##(1990-4#1)(1992-7#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2013-1#2)
was used to assess##56##4##(1990-4#1)(1992-7#1)(1993-1#1)(1993-4#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(2005-10#1)(2006-10#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-10#7)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-2#1)(2010-10#1)(2010-12#2)(2010-5#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#1)(2013-1#3)
was used to calculate the##9##5##(1992-4#1)(1996-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2011-1#1)(2011-2#1)
was used to calculate##14##4##(1992-4#1)(1995-5#1)(1996-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2011-1#1)(2011-2#1)(2013-8#1)
was used to calibrate the##2##5##(1990-12#1)(1992-4#1)
was used to calibrate##3##4##(1990-12#1)(1992-4#1)(2012-2#1)
was used to catalyze##2##4##(2008-7#1)(2009-6#1)
was used to categorize the##2##5##(1993-9#1)(2013-8#1)
was used to categorize##3##4##(1993-9#1)(2007-3#1)(2013-8#1)
was used to characterise##3##4##(1991-7#1)(2008-10#1)(2008-5#1)
was used to characterize and##2##5##(1991-1#1)(2012-3#1)
was used to characterize the interfacial##3##6##(2008-10#3)
was used to characterize the##12##5##(1990-3#1)(1991-12#1)(1995-3#1)(1997-4#2)(2007-12#1)(2007-2#1)(2008-10#5)
was used to characterize##22##4##(1990-3#1)(1991-1#1)(1991-12#1)(1991-9#1)(1993-11#1)(1995-1#1)(1995-3#1)(1997-4#2)(2006-12#1)(2007-12#2)(2007-2#1)(2008-10#7)(2012-2#1)(2012-3#1)
was used to classify##3##4##(2007-8#1)(2012-12#1)(2013-1#1)
was used to clone and##2##5##(1993-2#1)(1997-2#1)
was used to clone##4##4##(1990-11#1)(1993-2#1)(1994-9#1)(1997-2#1)
was used to collect data##3##5##(2008-3#1)(2012-12#1)(2013-1#1)
was used to collect the data##2##6##(2008-9#1)(2013-8#1)
was used to collect the##3##5##(2008-10#1)(2008-9#1)(2013-8#1)
was used to collect##11##4##(2008-10#1)(2008-11#1)(2008-3#3)(2008-9#1)(2009-10#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
was used to compare the##15##5##(1991-5#1)(1994-5#1)(1995-5#1)(1996-10#1)(1996-7#1)(2005-11#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-6#1)(2011-1#2)(2013-7#1)
was used to compare with##2##5##(2008-1#1)(2008-10#1)
was used to compare##28##4##(1991-5#1)(1994-5#2)(1995-5#1)(1996-10#1)(1996-7#1)(2005-11#1)(2006-8#1)(2007-11#1)(2008-1#3)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-6#2)(2010-9#2)(2011-1#2)(2012-1#1)(2012-12#1)(2013-7#1)
was used to compress the##3##5##(2007-12#2)(2011-1#1)
was used to compute##4##4##(2007-2#1)(2008-3#1)(2009-5#1)(2012-1#1)
was used to concentrate##3##4##(2008-10#3)
was used to conduct the##2##5##(2010-3#1)(2013-8#1)
was used to conduct##4##4##(2007-4#1)(2008-7#1)(2010-3#1)(2013-8#1)
was used to confirm the##5##5##(1990-6#1)(2008-10#2)(2008-6#1)(2013-1#1)
was used to confirm##9##4##(1990-6#1)(1997-3#1)(2008-10#3)(2008-2#1)(2008-6#1)(2010-11#1)(2013-1#1)
was used to construct a gene##2##6##(1994-9#1)(1996-6#1)
was used to construct a recombinant baculovirus which##2##8##(1992-3#1)(1994-5#1)
was used to construct a recombinant##3##6##(1992-3#1)(1994-5#1)(2008-8#1)
was used to construct a##13##5##(1990-7#1)(1992-3#1)(1994-5#1)(1994-9#1)(1996-6#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)
was used to construct the##2##5##(2008-3#1)(2008-8#1)
was used to construct##17##4##(1990-7#1)(1992-3#1)(1994-5#1)(1994-9#1)(1996-6#1)(1996-8#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#2)(2011-1#1)
was used to control for##2##5##(1996-10#1)(2012-2#1)
was used to control##5##4##(1996-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
was used to correct for##2##5##(2007-8#1)(2008-8#1)
was used to correct##3##4##(2007-8#1)(2008-4#1)(2008-8#1)
was used to correlate the##2##5##(2007-10#1)(2009-4#1)
was used to create the first##2##6##(1992-1#1)(2012-2#1)
was used to create the##3##5##(1992-1#1)(2009-7#1)(2012-2#1)
was used to create##7##4##(1992-1#1)(1995-5#1)(2009-11#1)(2009-7#1)(2010-4#1)(2012-2#1)(2013-7#1)
was used to cultivate##2##4##(1991-9#1)(2008-11#1)
was used to decrease##2##4##(1996-11#1)(2010-4#1)
was used to define##2##4##(1994-2#1)(2012-2#1)
was used to deliver##2##4##(1991-11#1)(2009-4#1)
was used to demonstrate that##7##5##(1991-2#1)(1993-9#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
was used to demonstrate the##6##5##(1994-11#1)(2008-10#4)(2008-11#1)
was used to demonstrate##17##4##(1991-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1996-1#1)(2007-1#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-7#1)
was used to derive a##2##5##(1995-8#1)(2008-3#1)
was used to derive##6##4##(1995-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)
was used to describe the##3##5##(1996-5#1)(2006-10#1)(2006-8#1)
was used to describe##5##4##(1996-5#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-8#1)
was used to design the##2##5##(2008-10#1)(2008-3#1)
was used to design##5##4##(2006-5#1)(2008-10#2)(2008-3#1)(2012-2#1)
was used to detect the##7##5##(1992-11#1)(1995-3#1)(2008-10#2)(2008-4#1)(2010-3#1)(2010-4#1)
was used to detect##33##4##(1990-12#1)(1990-9#1)(1992-11#2)(1994-8#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-6#1)(2007-12#1)(2007-8#2)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-3#1)(2010-4#1)(2012-12#1)(2013-8#1)
was used to determine the amount of##2##7##(2008-10#2)
was used to determine the concentration of##3##7##(1991-12#1)(2008-10#2)
was used to determine the effect of##2##7##(1990-11#1)(2008-10#1)
was used to determine the effects of the##2##8##(2008-2#1)(2011-2#1)
was used to determine the effects of##3##7##(1996-11#1)(2008-2#1)(2011-2#1)
was used to determine the extent of##2##7##(2005-11#1)(2008-7#1)
was used to determine the impact##2##6##(1996-7#1)(2012-1#1)
was used to determine the presence##3##6##(1995-5#1)(2004-11#1)(2008-7#1)
was used to determine the relative##2##6##(2005-11#1)(2008-11#1)
was used to determine the spatial distribution of##2##8##(2008-10#2)
was used to determine the stoichiometry of##2##7##(1993-8#1)(1995-11#1)
was used to determine the##61##5##(1990-10#1)(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-11#1)(1993-7#1)(1993-8#1)(1995-10#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-7#1)(1997-2#1)(2004-11#1)(2005-11#2)(2006-10#1)(2006-2#1)(2006-5#1)(2007-8#1)(2007-9#1)(2008-10#17)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)
was used to determine these##3##5##(1992-1#1)(2008-10#2)
was used to determine whether or not##2##7##(2008-5#1)(2008-6#1)
was used to determine whether##6##5##(1993-8#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-6#1)(2013-8#1)
was used to determine##115##4##(1990-10#1)(1990-11#2)(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-7#2)(1993-8#3)(1994-10#1)(1994-11#1)(1995-10#1)(1995-11#1)(1995-5#1)(1995-6#2)(1996-11#1)(1996-7#1)(1997-2#2)(1997-3#1)(1997-4#1)(2004-11#1)(2005-11#2)(2006-10#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-5#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#38)(2008-11#1)(2008-2#3)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-6#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#3)(2013-8#1)
was used to develop a##15##5##(1990-12#1)(1990-8#1)(1991-6#1)(1991-8#1)(1992-4#1)(1994-5#1)(1997-4#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-6#1)(2010-4#1)
was used to develop an##7##5##(1991-12#1)(1993-3#1)(2008-10#4)(2008-2#1)
was used to develop the##3##5##(2008-10#3)
was used to develop##29##4##(1990-12#1)(1990-8#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-4#1)(1993-3#1)(1994-5#1)(1997-4#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#12)(2008-2#1)(2008-4#1)(2008-6#1)(2010-4#1)(2012-1#1)
was used to devise##2##4##(2005-8#1)(2008-2#1)
was used to directly##2##4##(1995-3#1)(1996-8#1)
was used to discriminate##2##4##(2007-11#1)(2013-8#1)
was used to distinguish##2##4##(1997-1#1)(2006-2#1)
was used to drive the##3##5##(1995-8#1)(2006-12#1)(2008-10#1)
was used to drive##5##4##(1995-8#1)(2006-12#2)(2007-12#1)(2008-10#1)
was used to eliminate##2##4##(2008-10#1)(2008-2#1)
was used to elucidate##3##4##(1997-4#1)(2008-10#1)(2011-12#1)
was used to enhance the##6##5##(1990-11#1)(2008-10#3)(2008-2#1)(2008-6#1)
was used to enhance##7##4##(1990-11#1)(2008-10#3)(2008-2#1)(2008-6#1)(2012-2#1)
was used to establish the##2##5##(2008-10#1)(2013-1#1)
was used to establish##6##4##(1990-12#1)(1995-11#1)(1995-3#1)(2008-10#2)(2013-1#1)
was used to estimate the##17##5##(1991-11#1)(1991-5#1)(1994-3#1)(1995-1#1)(2006-12#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2009-10#1)(2009-8#1)(2011-2#1)
was used to estimate##28##4##(1991-11#1)(1991-5#1)(1993-6#1)(1994-3#1)(1995-1#1)(2005-12#1)(2006-11#1)(2006-12#2)(2006-6#1)(2007-1#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-8#1)(2011-2#2)
was used to evaluate a model##2##6##(2008-10#1)(2008-6#1)
was used to evaluate the effects of##4##7##(1996-2#1)(1997-2#1)(2008-11#1)(2009-11#1)
was used to evaluate the##37##5##(1996-2#1)(1996-9#1)(1997-2#1)(1997-6#1)(2004-12#2)(2004-3#1)(2006-10#1)(2006-11#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-8#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
was used to evaluate##62##4##(1990-12#1)(1991-12#2)(1991-3#1)(1994-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-6#1)(2004-12#2)(2004-3#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#4)(2008-6#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#1)(2009-8#2)(2010-5#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)
was used to examine a##2##5##(1996-12#1)(2008-5#1)
was used to examine the effect of##2##7##(1991-10#2)
was used to examine the effects of##2##7##(1994-2#1)(1995-11#1)
was used to examine the expression##2##6##(1991-5#1)(1992-12#1)
was used to examine the##25##5##(1991-10#2)(1991-12#1)(1991-5#1)(1992-12#1)(1994-2#2)(1994-5#1)(1995-11#1)(1995-3#1)(1996-11#1)(1997-4#1)(2006-3#1)(2008-10#4)(2008-8#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
was used to examine whether##2##5##(1996-7#1)(2008-10#1)
was used to examine##44##4##(1991-10#2)(1991-12#1)(1991-5#1)(1991-8#1)(1992-12#1)(1994-2#2)(1994-5#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-4#1)(1997-5#1)(2005-1#2)(2006-3#1)(2007-8#1)(2008-10#7)(2008-5#3)(2008-8#1)(2009-5#1)(2009-7#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)
was used to excite the##3##5##(1991-3#1)(2007-9#2)
was used to explain##2##4##(1997-1#1)(2008-10#1)
was used to explore the##2##5##(2008-1#1)(2008-6#1)
was used to explore##6##4##(1994-6#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-6#1)
was used to express##4##4##(1995-8#1)(1997-1#1)(2008-4#1)(2008-7#1)
was used to extend the##2##5##(2008-10#1)(2009-3#1)
was used to extract##13##4##(1997-2#1)(1997-3#1)(2006-4#1)(2008-10#9)(2008-6#1)
was used to fabricate##5##4##(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2013-1#1)
was used to fill##2##4##(2007-5#1)(2009-3#1)
was used to find the##5##5##(2008-10#3)(2008-6#1)(2012-12#1)
was used to find##11##4##(2006-8#1)(2008-10#7)(2008-5#1)(2008-6#1)(2012-12#1)
was used to fit##2##4##(1990-8#1)(2007-2#1)
was used to fix the##2##5##(1994-9#1)(1995-1#1)
was used to follow##4##4##(1990-11#1)(1996-12#1)(2005-11#1)(2008-10#1)
was used to form the##3##5##(1995-4#1)(2007-10#1)(2008-10#1)
was used to form##4##4##(1995-4#1)(2007-10#1)(2007-12#1)(2008-10#1)
was used to gather data##3##5##(2006-10#1)(2007-7#2)
was used to gather##4##4##(1996-2#1)(2006-10#1)(2007-7#2)
was used to generate a##3##5##(1990-8#1)(2009-8#1)(2010-12#1)
was used to generate an optical##2##6##(2008-10#1)(2008-2#1)
was used to generate##20##4##(1990-6#1)(1990-8#1)(1991-8#1)(1994-8#1)(1995-1#1)(1995-8#1)(1997-3#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2009-8#1)(2010-12#1)(2010-8#1)
was used to identify a##6##5##(1990-11#1)(1993-6#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-4#1)
was used to identify differences in##2##6##(2006-10#1)(2006-2#1)
was used to identify differences##3##5##(2006-10#1)(2006-2#1)(2009-5#1)
was used to identify genes##2##5##(1996-5#1)(2008-10#1)
was used to identify independent##2##5##(2007-8#1)(2008-7#1)
was used to identify the##15##5##(1990-11#1)(1990-12#1)(1991-2#1)(1992-7#1)(1993-3#1)(1996-5#1)(2007-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2009-10#1)(2010-6#1)(2010-8#1)(2013-7#1)
was used to identify##67##4##(1990-11#3)(1990-12#2)(1990-2#1)(1991-12#1)(1991-2#2)(1992-7#2)(1993-3#1)(1993-6#1)(1994-2#1)(1994-9#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-5#2)(2006-10#1)(2006-2#1)(2007-1#2)(2007-8#3)(2008-10#10)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
was used to image the##3##5##(2007-11#1)(2008-2#1)(2011-1#1)
was used to image##5##4##(1996-5#1)(2007-11#1)(2008-2#2)(2011-1#1)
was used to improve the##2##5##(2008-10#2)
was used to incorporate##2##4##(2006-12#1)(2008-10#1)
was used to increase the##2##5##(1997-3#1)(2013-7#1)
was used to increase##5##4##(1994-6#1)(1997-3#1)(2006-12#1)(2006-4#1)(2013-7#1)
was used to indicate the##3##5##(1992-8#1)(2008-12#1)(2012-3#1)
was used to indicate##4##4##(1991-6#1)(1992-8#1)(2008-12#1)(2012-3#1)
was used to induce##5##4##(1990-4#1)(1992-9#1)(2008-8#1)(2008-9#1)(2010-12#1)
was used to infect##4##4##(1991-1#1)(1995-1#1)(1996-11#1)(1997-1#1)
was used to infer the##2##5##(1992-12#1)(2006-12#1)
was used to infer##3##4##(1992-12#1)(2006-12#1)(2010-3#1)
was used to inhibit##4##4##(2006-8#3)(2008-8#1)
was used to initiate##2##4##(2008-10#2)
was used to introduce##3##4##(1994-5#1)(2008-10#1)(2008-6#1)
was used to investigate the effect of##3##7##(1994-3#1)(1996-3#1)(1996-4#1)
was used to investigate the effects of##2##7##(1995-12#1)(2007-9#1)
was used to investigate the role of##2##7##(1994-6#1)(2009-2#1)
was used to investigate the##33##5##(1990-11#1)(1990-2#1)(1991-2#1)(1991-7#1)(1992-9#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#2)(1996-4#1)(1997-3#1)(2005-11#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2010-6#1)(2013-8#1)
was used to investigate whether##3##5##(1991-9#1)(1994-11#1)(2010-8#1)
was used to investigate##46##4##(1990-11#1)(1990-2#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#2)(1996-4#1)(1997-3#1)(2005-11#1)(2006-8#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2012-2#1)(2013-8#1)
was used to isolate a##4##5##(1993-11#1)(1995-2#1)(1997-4#1)(2008-10#1)
was used to isolate genomic##2##5##(1990-11#1)(2008-10#1)
was used to isolate##14##4##(1990-11#1)(1991-12#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-2#1)(1997-4#2)(2008-10#2)(2008-4#1)(2009-10#1)(2010-5#1)
was used to label##4##4##(1991-9#1)(1992-1#2)(2008-10#1)
was used to lengthen##2##4##(2007-11#1)(2007-8#1)
was used to localize##4##4##(1990-4#1)(1993-5#1)(1995-12#1)(2011-1#1)
was used to locate##3##4##(2008-10#1)(2009-12#1)(2013-7#1)
was used to make##3##4##(2008-10#1)(2008-4#1)(2009-7#1)
was used to manage##2##4##(2010-3#1)(2013-1#1)
was used to map the##3##5##(1993-7#1)(1994-5#1)(2008-3#1)
was used to map##7##4##(1993-7#1)(1994-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
was used to measure a##2##5##(1997-6#1)(2008-3#1)
was used to measure both##2##5##(2008-10#1)(2008-3#1)
was used to measure the change of##2##7##(2011-3#1)(2012-3#1)
was used to measure the##34##5##(1990-2#1)(1991-4#1)(1992-12#1)(1992-6#1)(1993-11#1)(1994-9#1)(1995-12#1)(1996-5#1)(1996-7#1)(1997-8#1)(2005-11#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-2#4)(2008-3#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#3)(2012-3#1)
was used to measure##75##4##(1990-12#1)(1990-2#2)(1991-4#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-6#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-5#2)(1996-7#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#6)(2008-3#9)(2008-4#1)(2008-8#1)(2009-7#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#3)(2012-3#1)(2013-1#4)
was used to minimize the##3##5##(1992-12#1)(1995-2#1)(2008-2#1)
was used to minimize##4##4##(1992-12#1)(1994-9#1)(1995-2#1)(2008-2#1)
was used to model the##4##5##(1997-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
was used to model##7##4##(1997-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2010-6#1)
was used to modify##2##4##(1992-9#1)(2008-10#1)
was used to modulate the##2##5##(2007-12#1)(2008-11#1)
was used to monitor the##13##5##(1991-9#1)(1993-2#1)(1995-12#1)(1997-4#1)(2008-10#8)(2008-11#1)
was used to monitor##28##4##(1991-5#1)(1991-9#1)(1992-7#1)(1993-2#1)(1993-7#1)(1993-9#1)(1995-12#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-5#1)(2007-8#2)(2008-10#12)(2008-11#1)(2008-7#1)(2010-5#1)
was used to observe the##4##5##(2007-10#1)(2008-10#3)
was used to observe##7##4##(1991-9#1)(1993-3#1)(2007-10#1)(2008-10#3)(2008-5#1)
was used to obtain a##2##5##(1991-4#1)(1995-3#1)
was used to obtain an##3##5##(1994-5#1)(2007-12#1)(2008-2#1)
was used to obtain the##7##5##(1993-8#1)(2007-3#1)(2008-10#2)(2008-4#1)(2012-2#1)(2013-8#1)
was used to obtain##31##4##(1991-4#1)(1992-7#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-2#1)(2006-12#2)(2007-11#2)(2007-12#1)(2007-3#2)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2012-2#1)(2013-8#1)
was used to optimize the##4##5##(2008-10#3)(2011-12#1)
was used to optimize##6##4##(2008-10#3)(2008-5#2)(2011-12#1)
was used to perform##8##4##(1990-3#1)(2008-10#2)(2008-2#2)(2013-1#1)(2013-8#2)
was used to place##2##4##(2008-10#1)(2008-5#1)
was used to precipitate##3##4##(1996-6#1)(2008-10#1)(2008-5#1)
was used to predict the##8##5##(1993-9#1)(1997-7#1)(2005-11#1)(2007-10#1)(2008-1#1)(2008-3#2)(2008-5#1)
was used to predict##13##4##(1991-2#1)(1993-9#1)(1996-1#1)(1996-12#1)(1997-7#1)(2005-11#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#1)
was used to prepare a##4##5##(1990-11#1)(1993-7#1)(1995-2#1)(2008-10#1)
was used to prepare the##6##5##(2005-12#1)(2008-10#3)(2012-1#1)(2013-7#1)
was used to prepare##12##4##(1990-11#1)(1992-12#1)(1993-7#1)(1995-2#1)(2005-12#1)(2008-10#4)(2008-5#1)(2012-1#1)(2013-7#1)
was used to probe the##4##5##(1990-10#1)(1991-4#1)(1992-6#1)(2007-12#1)
was used to produce a##3##5##(2007-12#1)(2008-2#1)(2009-6#1)
was used to produce the##2##5##(1995-5#1)(2008-11#1)
was used to produce##10##4##(1995-5#1)(1997-2#1)(1997-4#1)(2005-8#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-5#1)(2009-6#1)
was used to promote##2##4##(2008-10#1)(2008-2#1)
was used to provide a##3##5##(1996-3#1)(1997-8#1)(2006-12#1)
was used to provide the##2##5##(2007-12#1)(2008-3#1)
was used to provide##10##4##(1996-3#1)(1997-8#1)(2006-12#2)(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-1#1)(2012-1#1)
was used to purify##3##4##(1997-7#1)(1997-8#1)(2012-12#1)
was used to quantify the##4##5##(1990-7#1)(1997-8#1)(2008-11#1)(2012-1#1)
was used to quantify##8##4##(1990-7#1)(1997-8#1)(2008-10#2)(2008-11#1)(2010-1#1)(2010-12#1)(2012-1#1)
was used to quantitate##2##4##(1992-12#1)(2008-1#1)
was used to quantitatively determine##2##5##(2007-5#1)(2008-10#1)
was used to quantitatively explain##2##5##(2005-11#1)(2008-9#1)
was used to quantitatively##6##4##(2005-11#1)(2007-5#1)(2008-10#1)(2008-9#1)(2009-7#1)(2009-9#1)
was used to rapidly##2##4##(1994-6#1)(2008-10#1)
was used to record the##3##5##(2007-1#1)(2007-10#1)(2009-8#1)
was used to record##8##4##(1991-6#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-2#1)(2009-11#1)(2009-8#1)(2012-2#1)
was used to recover##2##4##(2008-10#1)(2013-1#1)
was used to recruit##2##4##(2007-10#2)
was used to reduce the##2##5##(1995-12#1)(2008-10#1)
was used to reduce##3##4##(1995-12#1)(2007-11#1)(2008-10#1)
was used to reflect##2##4##(1996-12#1)(2011-1#1)
was used to relate##2##4##(2008-10#2)
was used to remove the##4##5##(2008-10#2)(2008-2#1)(2012-12#1)
was used to remove##7##4##(1990-12#1)(1995-2#1)(2008-10#3)(2008-2#1)(2012-12#1)
was used to replace##2##4##(1995-1#1)(2013-8#1)
was used to resect##2##4##(1993-10#1)(2006-8#1)
was used to resolve##2##4##(1994-12#1)(2013-7#1)
was used to reveal##2##4##(2007-10#1)(2008-10#1)
was used to sample##2##4##(2008-7#1)(2012-12#1)
was used to scan##3##4##(2008-2#2)(2008-9#1)
was used to screen a##5##5##(1990-2#1)(1990-4#1)(1993-5#1)(1993-7#1)(2007-2#1)
was used to screen##10##4##(1990-2#1)(1990-4#1)(1993-5#1)(1993-7#1)(1997-8#1)(2007-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2013-8#1)
was used to seal the##2##5##(2008-10#1)(2013-8#1)
was used to select the number of factors##4##8##(2008-10#4)
was used to select the##8##5##(2008-10#7)(2008-11#1)
was used to select##18##4##(1993-3#1)(1994-3#1)(2007-12#1)(2008-10#9)(2008-11#1)(2009-9#1)(2010-3#1)(2012-12#2)(2013-8#1)
was used to separate##4##4##(1992-12#1)(2004-8#1)(2008-10#2)
was used to show that the##2##6##(1990-8#1)(2008-10#1)
was used to show that##4##5##(1990-8#1)(1991-3#1)(2008-10#2)
was used to show##5##4##(1990-8#1)(1991-3#1)(2008-10#2)(2011-12#1)
was used to simulate##4##4##(2006-11#1)(2007-4#1)(2008-2#1)(2010-1#1)
was used to simultaneously##2##4##(2007-12#1)(2011-1#1)
was used to stimulate##3##4##(1990-2#1)(1991-9#1)(2012-11#1)
was used to study the effect of##3##7##(1990-2#1)(1993-8#1)(1997-1#1)
was used to study the effects of##2##7##(1993-6#1)(1997-7#1)
was used to study the interaction##2##6##(1990-4#1)(2009-6#1)
was used to study the##35##5##(1990-12#1)(1990-2#2)(1990-4#3)(1990-7#1)(1991-9#1)(1993-6#2)(1993-8#2)(1995-12#2)(1996-6#1)(1997-1#1)(1997-6#1)(1997-7#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-7#1)(2011-1#1)(2012-1#1)
was used to study##54##4##(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-6#1)(1993-4#1)(1993-6#2)(1993-8#2)(1994-11#1)(1995-12#2)(1996-6#1)(1997-1#1)(1997-6#2)(1997-7#1)(2005-11#1)(2007-1#1)(2007-12#2)(2007-8#1)(2008-10#10)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-6#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-1#1)
was used to successfully##2##4##(2008-10#1)(2009-12#1)
was used to support##2##4##(2008-10#1)(2011-9#1)
was used to test a##2##5##(2008-12#1)(2008-3#1)
was used to test for##4##5##(1992-7#1)(1995-3#1)(2008-5#1)(2010-2#1)
was used to test the##10##5##(1991-8#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2011-12#1)(2013-1#1)
was used to test##25##4##(1990-3#1)(1991-8#1)(1991-9#1)(1992-7#1)(1993-3#1)(1995-3#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#3)(2009-7#1)(2010-2#1)(2010-3#1)(2011-12#1)(2012-3#1)(2013-1#2)
was used to the determination of##2##6##(2008-10#2)
was used to the##4##4##(2008-10#4)
was used to track the##2##5##(1994-3#1)(2005-11#1)
was used to train##2##4##(2008-10#1)(2012-1#1)
was used to transduce##2##4##(1992-12#1)(2008-8#1)
was used to transfect##2##4##(1990-8#1)(2013-1#1)
was used to transform##4##4##(1990-5#1)(1995-2#1)(1997-7#1)(2008-10#1)
was used to treat##6##4##(1990-3#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-7#1)(2008-5#1)
was used to validate the##6##5##(2008-10#1)(2008-3#1)(2010-2#1)(2011-2#3)
was used to validate##7##4##(2008-10#1)(2008-3#1)(2010-2#1)(2011-2#3)(2013-8#1)
was used to verify the##3##5##(1997-4#1)(2008-10#1)(2010-5#1)
was used to visualize the##3##5##(1993-4#1)(2007-12#1)(2010-2#1)
was used to##1533##3##(1990-10#2)(1990-11#12)(1990-12#10)(1990-2#10)(1990-3#4)(1990-4#7)(1990-5#2)(1990-6#3)(1990-7#4)(1990-8#8)(1990-9#3)(1991-1#3)(1991-10#2)(1991-11#2)(1991-12#9)(1991-2#7)(1991-3#3)(1991-4#5)(1991-5#5)(1991-6#3)(1991-7#5)(1991-8#4)(1991-9#9)(1992-1#8)(1992-11#4)(1992-12#9)(1992-2#2)(1992-3#2)(1992-4#3)(1992-6#4)(1992-7#7)(1992-8#2)(1992-9#4)(1993-1#2)(1993-10#1)(1993-11#6)(1993-12#3)(1993-2#2)(1993-3#6)(1993-4#3)(1993-5#2)(1993-6#6)(1993-7#6)(1993-8#7)(1993-9#5)(1994-10#1)(1994-11#4)(1994-12#6)(1994-2#6)(1994-3#5)(1994-5#10)(1994-6#7)(1994-8#4)(1994-9#9)(1995-1#7)(1995-10#3)(1995-11#4)(1995-12#10)(1995-2#10)(1995-3#7)(1995-4#1)(1995-5#5)(1995-6#3)(1995-8#4)(1995-9#1)(1996-1#6)(1996-10#3)(1996-11#4)(1996-12#7)(1996-2#7)(1996-3#4)(1996-4#1)(1996-5#9)(1996-6#4)(1996-7#5)(1996-8#2)(1996-9#1)(1997-1#6)(1997-2#8)(1997-3#6)(1997-4#15)(1997-5#1)(1997-6#7)(1997-7#5)(1997-8#7)(2004-11#1)(2004-12#3)(2004-2#1)(2004-3#1)(2004-4#2)(2004-8#1)(2005-1#2)(2005-10#3)(2005-11#16)(2005-12#2)(2005-4#1)(2005-8#2)(2006-10#10)(2006-11#4)(2006-12#14)(2006-2#4)(2006-3#2)(2006-4#2)(2006-5#4)(2006-6#2)(2006-7#2)(2006-8#10)(2006-9#1)(2007-1#8)(2007-10#10)(2007-11#16)(2007-12#33)(2007-2#10)(2007-3#4)(2007-4#3)(2007-5#4)(2007-6#2)(2007-7#8)(2007-8#29)(2007-9#8)(2008-1#9)(2008-10#312)(2008-11#35)(2008-12#8)(2008-2#46)(2008-3#46)(2008-4#11)(2008-5#34)(2008-6#14)(2008-7#23)(2008-8#21)(2008-9#11)(2009-10#5)(2009-11#4)(2009-12#4)(2009-2#3)(2009-3#3)(2009-4#6)(2009-5#7)(2009-6#5)(2009-7#7)(2009-8#5)(2009-9#3)(2010-1#3)(2010-10#2)(2010-11#2)(2010-12#9)(2010-2#5)(2010-3#9)(2010-4#5)(2010-5#10)(2010-6#7)(2010-7#2)(2010-8#5)(2010-9#4)(2011-1#25)(2011-12#4)(2011-2#25)(2011-3#1)(2011-9#1)(2012-1#13)(2012-11#2)(2012-12#25)(2012-2#19)(2012-3#15)(2013-1#32)(2013-7#8)(2013-8#22)
was used when##3##3##(1994-3#1)(2008-7#1)(2010-12#1)
was used which##4##3##(1992-3#1)(1994-12#1)(1996-9#1)(2012-12#1)
was used while##2##3##(2007-8#1)(2011-2#1)
was used with a##8##4##(1992-2#1)(1993-6#1)(1994-12#1)(1996-6#1)(2005-12#1)(2007-1#1)(2008-11#1)(2011-1#1)
was used with information##2##4##(2007-11#1)(2013-1#1)
was used with the##4##4##(1997-8#1)(2008-10#1)(2008-5#1)(2009-8#1)
was used with##30##3##(1992-2#1)(1993-6#1)(1994-12#1)(1996-6#1)(1997-4#1)(1997-8#2)(2005-12#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#3)(2009-4#1)(2009-8#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
was used without##2##3##(2008-10#1)(2008-6#1)
was used##3092##2##(1990-10#8)(1990-11#19)(1990-12#21)(1990-2#13)(1990-3#7)(1990-4#11)(1990-5#4)(1990-6#7)(1990-7#5)(1990-8#18)(1990-9#5)(1991-1#3)(1991-10#6)(1991-11#4)(1991-12#13)(1991-2#10)(1991-3#7)(1991-4#11)(1991-5#11)(1991-6#4)(1991-7#8)(1991-8#6)(1991-9#10)(1992-1#11)(1992-10#1)(1992-11#5)(1992-12#14)(1992-2#8)(1992-3#5)(1992-4#3)(1992-6#9)(1992-7#9)(1992-8#11)(1992-9#6)(1993-1#4)(1993-10#2)(1993-11#9)(1993-12#9)(1993-2#7)(1993-3#9)(1993-4#5)(1993-5#3)(1993-6#10)(1993-7#7)(1993-8#8)(1993-9#8)(1994-10#3)(1994-11#10)(1994-12#11)(1994-2#13)(1994-3#12)(1994-5#17)(1994-6#8)(1994-7#1)(1994-8#5)(1994-9#14)(1995-1#10)(1995-10#4)(1995-11#7)(1995-12#16)(1995-2#13)(1995-3#8)(1995-4#2)(1995-5#7)(1995-6#4)(1995-7#1)(1995-8#7)(1995-9#4)(1996-1#9)(1996-10#3)(1996-11#9)(1996-12#13)(1996-2#10)(1996-3#6)(1996-4#7)(1996-5#19)(1996-6#11)(1996-7#7)(1996-8#9)(1996-9#4)(1997-1#9)(1997-2#15)(1997-3#16)(1997-4#18)(1997-5#2)(1997-6#11)(1997-7#9)(1997-8#18)(2004-1#2)(2004-10#2)(2004-11#4)(2004-12#5)(2004-2#2)(2004-3#1)(2004-4#2)(2004-8#3)(2004-9#3)(2005-1#3)(2005-10#3)(2005-11#27)(2005-12#8)(2005-3#2)(2005-4#7)(2005-5#1)(2005-6#1)(2005-8#4)(2006-1#1)(2006-10#20)(2006-11#5)(2006-12#25)(2006-2#8)(2006-3#5)(2006-4#10)(2006-5#8)(2006-6#10)(2006-7#8)(2006-8#25)(2006-9#2)(2007-1#15)(2007-10#20)(2007-11#46)(2007-12#70)(2007-2#17)(2007-3#5)(2007-4#4)(2007-5#6)(2007-6#6)(2007-7#24)(2007-8#75)(2007-9#14)(2008-1#19)(2008-10#743)(2008-11#58)(2008-12#18)(2008-2#80)(2008-3#84)(2008-4#22)(2008-5#80)(2008-6#26)(2008-7#48)(2008-8#42)(2008-9#25)(2009-10#6)(2009-11#6)(2009-12#6)(2009-2#9)(2009-3#11)(2009-4#8)(2009-5#8)(2009-6#5)(2009-7#10)(2009-8#8)(2009-9#7)(2010-1#5)(2010-10#5)(2010-11#3)(2010-12#18)(2010-2#12)(2010-3#15)(2010-4#11)(2010-5#20)(2010-6#7)(2010-7#5)(2010-8#9)(2010-9#8)(2011-1#49)(2011-12#6)(2011-2#56)(2011-3#5)(2011-9#1)(2012-1#17)(2012-10#1)(2012-11#6)(2012-12#42)(2012-2#41)(2012-3#27)(2012-6#1)(2012-7#1)(2013-1#70)(2013-7#16)(2013-8#41)
was used) was##2##3##(2008-10#1)(2008-3#1)
was used)##3##2##(1992-5#1)(2008-10#1)(2008-3#1)
was useful for##12##3##(2007-10#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-9#1)(2010-2#1)(2010-8#1)
was useful in the##3##4##(1994-12#1)(2008-10#2)
was useful in##9##3##(1990-2#1)(1994-12#1)(2008-10#5)(2008-9#1)(2009-4#1)
was useful to##8##3##(2007-7#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-5#1)(2011-2#1)(2012-3#1)
was useful##32##2##(1990-2#1)(1992-12#1)(1994-12#1)(2007-10#1)(2007-7#1)(2008-10#12)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-5#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
was using##3##2##(2007-10#1)(2011-2#2)
was usually##12##2##(1990-10#1)(1991-6#1)(1993-12#2)(1995-7#1)(1996-12#1)(2007-1#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-3#1)(2012-11#1)
was utilised for##3##3##(2006-8#1)(2008-10#2)
was utilised in##2##3##(2008-10#1)(2008-11#1)
was utilised to##3##3##(1997-3#1)(2008-11#2)
was utilised##11##2##(1997-2#1)(1997-3#1)(2006-8#1)(2007-9#1)(2008-10#4)(2008-11#3)
was utilized as a##5##4##(1991-4#1)(1992-3#1)(1994-9#1)(2008-10#1)(2008-11#1)
was utilized as##7##3##(1991-4#1)(1992-3#1)(1994-9#1)(2007-12#1)(2008-10#2)(2008-11#1)
was utilized by##2##3##(1995-1#1)(2011-1#1)
was utilized for sample##2##4##(2008-10#2)
was utilized for the##3##4##(2005-11#1)(2008-10#1)(2008-2#1)
was utilized for##18##3##(2005-11#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-2#1)(2011-1#1)(2012-2#1)
was utilized in the##3##4##(1992-8#1)(1997-4#1)(2010-10#1)
was utilized in##8##3##(1991-3#1)(1992-8#1)(1997-4#1)(2007-7#1)(2008-10#1)(2010-10#1)(2012-2#2)
was utilized to assess##4##4##(1990-12#1)(1992-10#1)(1996-1#1)(2013-8#1)
was utilized to detect##2##4##(2008-10#1)(2013-1#1)
was utilized to determine the##3##5##(2008-10#1)(2008-12#1)(2010-4#1)
was utilized to determine##4##4##(2007-2#1)(2008-10#1)(2008-12#1)(2010-4#1)
was utilized to estimate the##2##5##(2008-11#1)(2010-3#1)
was utilized to examine the relationship between##2##7##(2007-12#1)(2012-11#1)
was utilized to examine the##3##5##(2007-12#1)(2012-11#1)(2012-12#1)
was utilized to examine##4##4##(2007-12#1)(2008-11#1)(2012-11#1)(2012-12#1)
was utilized to identify##2##4##(1993-3#1)(2012-2#1)
was utilized to investigate the##2##5##(2004-11#1)(2008-10#1)
was utilized to isolate##2##4##(1992-6#1)(1995-1#1)
was utilized to map the##2##5##(1995-2#1)(2008-10#1)
was utilized to##42##3##(1990-12#1)(1990-2#1)(1990-6#1)(1992-10#1)(1992-12#1)(1992-6#1)(1993-3#1)(1995-1#1)(1995-2#2)(1996-1#1)(2004-11#1)(2007-1#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#1)(2009-11#1)(2010-3#1)(2010-4#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
was utilized##93##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-9#1)(1995-1#4)(1995-2#2)(1996-1#1)(1996-2#1)(1997-2#1)(1997-4#1)(2004-11#1)(2005-11#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#20)(2008-11#5)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#1)(2011-1#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2013-1#4)(2013-8#1)
was valgus##2##2##(2009-3#2)
was validated against##4##3##(2006-11#1)(2007-4#2)(2012-7#1)
was validated by analysis of the certified reference##2##8##(2008-10#2)
was validated by analysis##3##4##(2008-10#3)
was validated by comparing the##2##5##(2008-10#2)
was validated by determining##2##4##(1991-8#1)(2008-10#1)
was validated by standard addition##2##5##(2006-12#1)(2008-10#1)
was validated by the analysis of##2##6##(2008-10#2)
was validated by the##4##4##(2008-10#3)(2012-1#1)
was validated by using##2##4##(2008-10#1)(2010-2#1)
was validated by##32##3##(1991-8#1)(1993-4#1)(1996-3#1)(2006-12#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#18)(2008-3#1)(2008-7#1)(2009-9#1)(2010-2#1)(2012-1#1)(2013-8#2)
was validated for the##2##4##(2008-10#2)
was validated for##12##3##(2007-8#2)(2008-10#6)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
was validated in a##2##4##(2011-1#1)(2012-2#1)
was validated in##9##3##(2008-10#2)(2010-2#3)(2010-3#1)(2011-1#1)(2012-2#2)
was validated on a##3##4##(2007-4#1)(2008-8#1)(2012-1#1)
was validated using two##3##4##(2008-10#2)(2010-10#1)
was validated using##14##3##(1997-2#1)(2007-8#1)(2008-10#9)(2009-7#1)(2010-10#1)(2013-1#1)
was validated with a##4##4##(2007-12#1)(2008-10#3)
was validated with##12##3##(2007-12#1)(2008-10#8)(2008-11#1)(2011-1#1)(2013-1#1)
was validated##112##2##(1991-8#1)(1993-4#1)(1995-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#1)(2005-11#1)(2006-11#2)(2006-12#1)(2007-12#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-8#4)(2008-10#53)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#4)(2010-3#2)(2011-1#3)(2011-2#1)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#2)(2012-7#1)(2013-1#3)(2013-7#4)(2013-8#2)
was valuable##2##2##(2007-8#1)(2012-2#1)
was vaporized at##2##3##(1991-2#1)(2008-10#1)
was vaporized##4##2##(1991-2#1)(2008-10#2)(2008-5#1)
was variability in##2##3##(2012-2#1)(2013-1#1)
was variability##4##2##(1990-7#1)(2008-10#1)(2012-2#1)(2013-1#1)
was variable among##2##3##(1997-8#1)(2012-12#1)
was variable depending on##2##4##(1996-9#1)(2008-12#1)
was variable in##2##3##(2008-1#1)(2011-11#1)
was variable##25##2##(1993-2#2)(1993-7#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-9#1)(1997-8#1)(2004-2#1)(2007-11#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-5#1)(2008-6#1)(2010-2#2)(2011-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
was variably##3##2##(1990-5#1)(1996-11#1)(2009-8#1)
was varied across##2##3##(2007-1#1)(2008-5#1)
was varied between##4##3##(2007-8#1)(2008-12#3)
was varied by changing the##2##5##(1992-6#1)(2005-11#1)
was varied by the##3##4##(1990-11#1)(1994-11#1)(2010-4#1)
was varied by##7##3##(1990-11#1)(1992-6#1)(1994-11#1)(2005-11#1)(2009-11#2)(2010-4#1)
was varied from 0 to##2##5##(2008-7#1)(2011-2#1)
was varied from##6##3##(2005-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
was varied in response to##2##5##(2008-10#2)
was varied in##4##3##(2007-12#1)(2008-10#2)(2008-3#1)
was varied to##3##3##(2005-11#1)(2007-1#1)(2008-10#1)
was varied##35##2##(1990-11#1)(1991-4#1)(1992-6#1)(1993-3#1)(1994-11#1)(2005-11#3)(2007-1#2)(2007-12#3)(2007-4#1)(2007-8#1)(2008-10#6)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-11#2)(2010-4#1)(2011-2#1)
was verified and##2##3##(2008-10#1)(2011-12#1)
was verified at##2##3##(2007-8#1)(2008-6#1)
was verified by PCR##2##4##(2006-10#1)(2008-10#1)
was verified by the##8##4##(1990-5#1)(1995-3#1)(2008-10#5)(2010-4#1)
was verified by##41##3##(1990-5#1)(1990-6#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-9#1)(1994-12#1)(1995-3#1)(1997-2#1)(2004-2#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-7#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2009-3#1)(2010-4#2)
was verified for##2##3##(2008-3#1)(2010-2#1)
was verified in a##2##4##(2008-11#1)(2008-5#1)
was verified in the##4##4##(2008-10#3)(2012-1#1)
was verified in##7##3##(2008-10#4)(2008-11#1)(2008-5#1)(2012-1#1)
was verified that the##4##4##(2005-10#1)(2006-5#1)(2008-10#1)(2008-11#1)
was verified that##6##3##(2005-10#1)(2006-5#1)(2008-10#3)(2008-11#1)
was verified through##3##3##(2007-8#1)(2008-10#2)
was verified to be##2##4##(2008-10#1)(2008-5#1)
was verified to##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
was verified using##2##3##(2012-2#1)(2013-1#1)
was verified with##3##3##(2008-2#1)(2010-4#1)(2012-3#1)
was verified##88##2##(1990-5#1)(1990-6#1)(1990-8#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-9#1)(1994-12#1)(1995-3#1)(1996-2#1)(1997-2#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-3#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-7#1)(2007-8#2)(2008-10#30)(2008-11#3)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#1)(2009-3#1)(2009-8#1)(2010-2#1)(2010-4#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
was very accurate in##2##4##(2006-5#1)(2008-3#1)
was very active##3##3##(1990-2#1)(2006-5#1)(2008-5#1)
was very close to##5##4##(1997-1#1)(2008-5#1)(2012-12#1)(2012-2#2)
was very common##2##3##(1997-3#1)(2012-12#1)
was very different from##2##4##(2008-10#1)(2009-12#1)
was very effective for##2##4##(2008-10#1)(2013-1#1)
was very effective in##3##4##(1992-3#1)(1995-3#1)(2012-2#1)
was very effective##5##3##(1992-3#1)(1995-3#1)(2008-10#1)(2012-2#1)(2013-1#1)
was very encouraging##2##3##(1992-1#1)(2008-5#1)
was very fast##2##3##(2008-10#1)(2010-5#1)
was very good and the##2##5##(1994-8#1)(2007-8#1)
was very good for##2##4##(2011-1#1)(2013-8#1)
was very good or good##2##5##(2006-8#1)(2007-7#1)
was very good##16##3##(1993-2#1)(1994-8#1)(1994-9#1)(1995-4#1)(1995-6#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#3)(2009-11#1)(2011-1#1)(2013-8#1)
was very high in both##2##5##(2008-7#1)(2008-9#1)
was very high in##5##4##(1993-2#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#1)
was very high##16##3##(1991-12#1)(1993-2#2)(1995-5#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#1)
was very important in##2##4##(1997-1#1)(2007-3#1)
was very important##4##3##(1997-1#1)(2007-3#1)(2008-1#2)
was very labile##2##3##(1990-2#1)(1997-4#1)
was very limited##3##3##(2005-11#1)(2005-7#1)(2007-4#1)
was very little##2##3##(1994-8#1)(1995-9#1)
was very low (0##2##4##(1992-11#1)(2007-5#1)
was very low and##3##4##(1990-4#1)(2008-1#1)(2012-12#1)
was very low or##2##4##(2008-12#1)(2008-5#1)
was very low##32##3##(1990-4#1)(1990-8#1)(1992-11#1)(1992-9#1)(1995-10#1)(1995-9#1)(1996-11#1)(2005-12#1)(2007-12#1)(2007-5#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#1)(2009-8#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-7#1)
was very poorly##2##3##(1992-9#1)(2006-5#1)
was very satisfactory##2##3##(2007-8#1)(2008-9#1)
was very sensitive##2##3##(2005-9#1)(2008-9#1)
was very similar to that of the##4##7##(1990-3#1)(1991-7#1)(1994-2#1)(2008-5#1)
was very similar to that of##8##6##(1990-3#1)(1991-7#1)(1993-2#1)(1994-2#1)(1995-11#1)(2005-10#1)(2008-5#1)(2008-6#1)
was very similar to that##10##5##(1990-3#1)(1990-4#1)(1991-7#1)(1993-2#1)(1994-2#1)(1995-11#1)(2005-10#1)(2008-5#1)(2008-6#1)(2008-7#1)
was very similar to the##2##5##(2008-10#2)
was very similar to##14##4##(1990-3#1)(1990-4#2)(1991-7#1)(1993-2#1)(1994-2#1)(1995-11#1)(1997-8#1)(2005-10#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)
was very similar##19##3##(1990-3#1)(1990-4#2)(1991-7#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-2#1)(1995-11#2)(1997-8#1)(2005-10#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2013-1#1)
was very simple##3##3##(2008-10#3)
was very slow##3##3##(1992-9#1)(1993-8#1)(2008-10#1)
was very small##5##3##(1997-8#1)(2006-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
was very stable##3##3##(2006-10#1)(2008-10#2)
was very strong##2##3##(1990-10#1)(2004-9#1)
was very useful##2##3##(2004-11#1)(2008-5#1)
was very weak##2##3##(2013-8#2)
was very well tolerated##3##4##(1990-10#1)(1990-5#1)(2008-5#1)
was very well##4##3##(1990-10#1)(1990-5#1)(2008-5#1)(2010-7#1)
was very##198##2##(1990-10#2)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#3)(1990-5#3)(1990-8#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-9#4)(1993-11#1)(1993-2#4)(1993-6#1)(1993-8#2)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-9#2)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#2)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-4#2)(2006-5#3)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#3)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#3)(2008-1#5)(2008-10#30)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#11)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#5)(2012-2#5)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#3)
was via the##2##3##(1990-3#1)(2009-6#1)
was via##3##2##(1990-3#1)(2009-6#1)(2011-2#1)
was viable##3##2##(2008-10#1)(2010-3#1)(2012-12#1)
was videotaped and analysed##2##4##(1993-9#1)(2008-11#1)
was viewed as##3##3##(2007-11#1)(2007-8#1)(2009-9#1)
was viewed##5##2##(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#1)(2009-9#1)
was violated by##3##3##(1995-2#1)(1996-12#1)(2008-8#1)
was violated##4##2##(1995-12#1)(1995-2#1)(1996-12#1)(2008-8#1)
was virtually absent##2##3##(1990-4#1)(1995-2#1)
was virtually identical for##2##4##(1994-11#1)(1994-2#1)
was virtually identical to that of##2##6##(1996-7#1)(2008-10#1)
was virtually identical to##3##4##(1991-6#1)(1996-7#1)(2008-10#1)
was virtually identical##5##3##(1991-6#1)(1994-11#1)(1994-2#1)(1996-7#1)(2008-10#1)
was virtually##13##2##(1990-10#1)(1990-4#1)(1990-6#1)(1991-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-7#1)(1997-2#1)(2008-10#1)(2011-1#1)
was virulent##2##2##(2008-10#2)
was visible in the##2##4##(2008-5#1)(2009-8#1)
was visible in##3##3##(2007-11#1)(2008-5#1)(2009-8#1)
was visible on##2##3##(2007-10#1)(2011-12#1)
was visible##13##2##(1992-11#2)(2007-10#1)(2007-11#2)(2008-5#1)(2008-7#2)(2009-8#1)(2010-10#1)(2010-12#1)(2011-12#1)(2011-2#1)
was visibly##2##2##(2006-11#1)(2008-5#1)
was visualised##2##2##(1996-5#1)(2008-8#1)
was visualized as a##2##4##(1996-5#1)(2008-10#1)
was visualized by##4##3##(1992-8#1)(2007-9#1)(2010-8#1)(2011-2#1)
was visualized in##8##3##(1992-7#1)(1995-10#1)(1995-12#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-4#1)
was visualized using##4##3##(1992-1#1)(1996-6#1)(2007-7#1)(2011-12#1)
was visualized with##3##3##(1996-6#1)(2007-8#1)(2008-10#1)
was visualized##27##2##(1992-1#1)(1992-7#1)(1992-8#1)(1995-10#1)(1995-12#1)(1996-5#1)(1996-6#2)(1997-1#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-5#1)(2008-9#3)(2009-4#1)(2010-8#1)(2011-12#1)(2011-2#1)
was visually##2##2##(2008-10#1)(2012-2#1)
was vital##2##2##(2008-12#1)(2012-12#1)
was voluntarily##2##2##(1994-3#1)(2010-12#1)
was warmed##2##2##(1994-11#1)(2006-5#1)
was washed and##2##3##(1991-5#1)(1992-6#1)
was washed with##5##3##(1991-5#1)(1992-11#1)(1997-8#1)(2008-10#1)(2009-2#1)
was washed##9##2##(1991-5#2)(1992-11#1)(1992-6#1)(1997-8#1)(2008-10#1)(2009-2#1)(2010-3#1)(2010-8#1)
was water##2##2##(2004-9#1)(2007-8#1)
was weak##11##2##(1990-12#1)(1991-8#1)(1993-3#1)(1993-8#1)(1995-10#1)(2008-10#3)(2008-3#1)(2008-8#2)
was weaker than##2##3##(1997-4#1)(2013-1#1)
was weaker##3##2##(1997-4#1)(2012-1#1)(2013-1#1)
was weakly associated with##2##4##(2007-12#1)(2008-8#1)
was weakly expressed##2##3##(1994-8#1)(1997-7#1)
was weakly inhibited by##2##4##(1992-3#1)(2009-9#1)
was weakly##14##2##(1991-4#1)(1992-3#2)(1994-8#1)(1996-5#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-8#1)(2008-9#1)(2009-9#1)
was weaned from##4##3##(2007-9#1)(2012-2#3)
was weaned##5##2##(2007-9#1)(2009-6#1)(2012-2#3)
was weighted##2##2##(1992-7#1)(2010-4#1)
was well accepted by patients and##2##6##(2007-7#1)(2012-3#1)
was well accepted by##4##4##(1994-8#1)(2006-10#1)(2007-7#1)(2012-3#1)
was well below that##2##4##(2010-11#1)(2011-1#1)
was well below##4##3##(1992-12#1)(2010-11#1)(2011-1#1)(2012-12#1)
was well circumscribed and##2##4##(2007-8#1)(2009-7#1)
was well circumscribed##3##3##(1990-2#1)(2007-8#1)(2009-7#1)
was well described by a##4##5##(1995-8#1)(2008-10#3)
was well described by##6##4##(1995-8#1)(1996-3#1)(2008-10#4)
was well described##7##3##(1995-8#1)(1996-3#1)(2005-11#1)(2008-10#4)
was well tolerated and no##3##5##(1991-3#1)(1996-1#1)(2007-11#1)
was well tolerated and##11##4##(1991-3#1)(1996-1#1)(2005-8#2)(2007-11#1)(2007-6#1)(2007-7#1)(2008-3#1)(2008-7#2)(2011-2#1)
was well tolerated by all patients and##2##7##(2007-8#2)
was well tolerated by all patients##3##6##(2007-8#3)
was well tolerated by most patients##2##6##(1992-12#1)(2006-10#1)
was well tolerated by the skin and provided significant##2##9##(2008-5#2)
was well tolerated by##8##4##(1992-12#1)(1993-5#1)(2006-10#1)(2007-8#3)(2008-5#2)
was well tolerated in all##2##5##(2008-3#2)
was well tolerated in clinical trials and the##2##8##(2007-11#2)
was well tolerated in the##2##5##(1993-11#1)(2007-11#1)
was well tolerated in##9##4##(1993-11#1)(2005-7#1)(2007-11#4)(2008-3#3)
was well tolerated with no##2##5##(2004-2#1)(2007-11#1)
was well tolerated with##5##4##(2004-2#1)(2006-6#2)(2007-11#1)(2008-7#1)
was well tolerated##59##3##(1990-6#1)(1991-12#1)(1991-3#1)(1991-4#2)(1992-12#2)(1992-8#1)(1993-11#1)(1993-5#1)(1996-1#1)(1997-1#1)(2004-2#1)(2005-7#2)(2005-8#2)(2006-10#2)(2006-12#2)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#8)(2007-6#1)(2007-7#1)(2007-8#3)(2008-3#7)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
was well##105##2##(1990-2#1)(1990-6#1)(1991-12#1)(1991-3#1)(1991-4#2)(1991-6#1)(1992-12#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-5#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-7#1)(2004-2#1)(2005-11#1)(2005-4#1)(2005-7#3)(2005-8#2)(2006-10#4)(2006-12#2)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#9)(2007-6#1)(2007-7#2)(2007-8#5)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#7)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-11#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
was well-tolerated and##4##3##(2007-8#1)(2008-1#1)(2008-5#2)
was well-tolerated##9##2##(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#6)
was what##2##2##(1990-2#1)(2008-10#1)
was when the##2##3##(2007-9#1)(2012-1#1)
was when##3##2##(1994-4#1)(2007-9#1)(2012-1#1)
was whether or not##2##4##(1996-8#1)(2004-11#1)
was whether there##4##3##(1996-11#1)(2007-8#3)
was whether##58##2##(1992-8#1)(1996-11#1)(1996-8#1)(1997-3#1)(2004-11#1)(2007-8#52)(2011-2#1)
was white##2##2##(2007-12#1)(2008-11#1)
was widely distributed in##2##4##(2012-11#1)(2013-8#1)
was widely distributed##4##3##(2008-10#1)(2010-8#1)(2012-11#1)(2013-8#1)
was widely used in the##2##5##(2007-8#1)(2008-10#1)
was widely used##4##3##(2007-8#1)(2008-10#1)(2008-11#1)(2009-4#1)
was widely##16##2##(1992-2#1)(2005-8#1)(2007-8#1)(2008-10#2)(2008-11#2)(2009-4#1)(2009-5#1)(2010-8#2)(2010-9#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
was widespread##4##2##(2007-3#1)(2008-10#2)(2011-2#1)
was willing to##3##3##(1991-5#1)(2006-8#1)(2013-1#1)
was with the##6##3##(1996-4#1)(2004-2#1)(2008-10#2)(2008-5#1)(2011-2#1)
was with##14##2##(1996-4#1)(2004-2#1)(2006-7#1)(2006-8#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
was withdrawn from##2##3##(1992-8#1)(2009-5#1)
was withdrawn##11##2##(1990-7#3)(1992-11#1)(1992-8#1)(2004-11#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-5#1)(2012-2#1)
was within +/-20%##2##3##(2008-10#2)
was within 2##2##3##(1990-11#1)(2012-12#1)
was within a##3##3##(2005-11#1)(2008-10#1)(2012-1#1)
was within normal range in##3##5##(2007-7#3)
was within normal##4##3##(1993-2#1)(2007-7#3)
was within the range of##2##5##(2010-11#1)(2012-12#1)
was within the range##3##4##(2008-9#1)(2010-11#1)(2012-12#1)
was within the##8##3##(1990-10#1)(1990-3#1)(2008-3#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-12#2)
was within##32##2##(1990-10#1)(1990-11#1)(1990-3#1)(1993-2#1)(1996-5#1)(2005-11#1)(2006-4#1)(2007-7#3)(2008-10#10)(2008-3#3)(2008-9#1)(2009-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)
was without effect on the##2##5##(1990-5#1)(1995-12#1)
was without effect on##11##4##(1990-2#1)(1990-5#1)(1991-5#1)(1991-6#1)(1994-6#1)(1994-9#2)(1995-12#1)(1995-8#1)(1997-8#1)(2010-3#1)
was without effect##27##3##(1990-2#2)(1990-4#1)(1990-5#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-5#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-1#1)(1997-8#1)(2007-8#1)(2010-3#1)
was without significant##2##3##(1990-5#1)(1995-6#1)
was without##36##2##(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1991-3#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-8#1)(2006-8#1)(2007-8#1)(2007-9#1)(2010-3#1)
was witnessed in##2##3##(1993-8#1)(2010-4#1)
was worked out##3##3##(1990-2#1)(2005-4#1)(2008-11#1)
was working##2##2##(2008-8#1)(2010-12#1)
was worse in##2##3##(1992-7#1)(2007-8#1)
was worse##6##2##(1992-7#1)(2006-10#1)(2007-8#2)(2008-7#1)(2009-5#1)
was wrapped##3##2##(2008-7#1)(2010-3#1)(2011-2#1)
was written according to a structured protocol##61##7##(2007-8#61)
was written by##2##3##(2006-9#1)(2010-4#1)
was written in##5##3##(1994-3#2)(2008-10#2)(2008-5#1)
was written to##2##3##(2007-6#1)(2011-2#1)
was written with##2##3##(2008-10#1)(2013-8#1)
was written##83##2##(1993-3#1)(1994-3#2)(1996-5#1)(2006-9#1)(2007-12#1)(2007-6#4)(2007-8#61)(2008-10#4)(2008-2#1)(2008-5#2)(2009-4#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
was wrongly##2##2##(1993-4#1)(1995-11#1)
was young##2##2##(2006-7#1)(2011-2#1)
was zero##6##2##(1990-12#1)(1990-3#1)(1993-10#1)(1995-9#1)(2007-8#1)(2010-8#1)
was ~0##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
was ~1##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
was ~4##2##2##(2007-11#1)(2008-2#1)
was ≥##4##2##(2010-12#3)(2012-3#1)
was##93375##1##(1990-1#35)(1990-10#337)(1990-11#441)(1990-12#561)(1990-2#495)(1990-3#343)(1990-4#285)(1990-5#488)(1990-6#265)(1990-7#395)(1990-8#363)(1990-9#272)(1991-1#189)(1991-10#232)(1991-11#198)(1991-12#416)(1991-2#500)(1991-3#309)(1991-4#247)(1991-5#383)(1991-6#264)(1991-7#287)(1991-8#399)(1991-9#435)(1992-1#241)(1992-10#155)(1992-11#295)(1992-12#390)(1992-2#326)(1992-3#407)(1992-4#185)(1992-5#253)(1992-6#380)(1992-7#288)(1992-8#399)(1992-9#327)(1993-1#140)(1993-10#74)(1993-11#308)(1993-12#504)(1993-2#337)(1993-3#409)(1993-4#206)(1993-5#130)(1993-6#293)(1993-7#186)(1993-8#311)(1993-9#402)(1994-1#39)(1994-10#88)(1994-11#398)(1994-12#536)(1994-2#444)(1994-3#493)(1994-4#55)(1994-5#290)(1994-6#348)(1994-7#81)(1994-8#441)(1994-9#464)(1995-1#283)(1995-10#164)(1995-11#303)(1995-12#466)(1995-2#477)(1995-3#475)(1995-4#79)(1995-5#366)(1995-6#391)(1995-7#138)(1995-8#337)(1995-9#109)(1996-1#243)(1996-10#160)(1996-11#222)(1996-12#518)(1996-2#361)(1996-3#321)(1996-4#163)(1996-5#504)(1996-6#361)(1996-7#229)(1996-8#317)(1996-9#285)(1997-1#341)(1997-2#570)(1997-3#434)(1997-4#416)(1997-5#273)(1997-6#426)(1997-7#398)(1997-8#542)(1997-9#10)(2003-11#9)(2004-1#69)(2004-10#85)(2004-11#159)(2004-12#99)(2004-2#71)(2004-3#39)(2004-4#70)(2004-7#5)(2004-8#32)(2004-9#164)(2005-1#55)(2005-10#199)(2005-11#782)(2005-12#217)(2005-2#3)(2005-3#12)(2005-4#161)(2005-5#52)(2005-6#25)(2005-7#135)(2005-8#273)(2005-9#94)(2006-1#66)(2006-10#845)(2006-11#212)(2006-12#571)(2006-2#209)(2006-3#107)(2006-4#238)(2006-5#330)(2006-6#322)(2006-7#247)(2006-8#779)(2006-9#177)(2007-1#325)(2007-10#617)(2007-11#1187)(2007-12#1254)(2007-2#661)(2007-3#375)(2007-4#212)(2007-5#266)(2007-6#253)(2007-7#1290)(2007-8#2300)(2007-9#473)(2008-1#667)(2008-10#14441)(2008-11#1877)(2008-12#957)(2008-2#901)(2008-3#1467)(2008-4#778)(2008-5#2647)(2008-6#944)(2008-7#1519)(2008-8#1180)(2008-9#1006)(2009-1#49)(2009-10#265)(2009-11#147)(2009-12#144)(2009-2#292)(2009-3#319)(2009-4#297)(2009-5#277)(2009-6#221)(2009-7#244)(2009-8#249)(2009-9#189)(2010-1#133)(2010-10#172)(2010-11#147)(2010-12#744)(2010-2#384)(2010-3#272)(2010-4#486)(2010-5#327)(2010-6#141)(2010-7#217)(2010-8#412)(2010-9#184)(2011-1#1222)(2011-10#7)(2011-11#26)(2011-12#318)(2011-2#2495)(2011-3#102)(2011-4#5)(2011-7#12)(2011-9#6)(2012-1#538)(2012-10#3)(2012-11#171)(2012-12#1338)(2012-2#1556)(2012-3#883)(2012-4#4)(2012-5#16)(2012-6#15)(2012-7#21)(2012-8#9)(2012-9#4)(2013-1#2376)(2013-3#4)(2013-7#477)(2013-8#1501)
was)##2##1##(2008-10#1)(2008-7#1)
wasenhanced##2##1##(2008-11#2)
wasfound##2##1##(2008-11#1)(2008-2#1)
wash away##2##2##(2008-4#1)(2009-3#1)
wash samples##2##2##(2013-1#2)
wash##41##1##(1990-11#1)(1992-1#1)(1993-12#1)(1993-3#1)(1994-2#1)(1996-7#1)(1996-8#1)(1997-4#1)(2004-12#1)(2005-11#1)(2007-2#2)(2008-10#7)(2008-11#2)(2008-2#1)(2008-4#3)(2008-5#4)(2008-8#2)(2009-11#1)(2009-3#1)(2010-12#1)(2010-2#2)(2010-8#1)(2012-2#2)(2013-1#2)
wash-out of##2##2##(1995-5#1)(1997-5#1)
wash-out period##3##2##(1990-5#1)(1990-9#1)(1996-3#1)
wash-out##10##1##(1990-3#1)(1990-5#1)(1990-9#1)(1995-5#1)(1996-3#1)(1997-5#1)(2008-5#2)(2008-8#1)(2010-5#1)
washed and##9##2##(1991-5#1)(1991-9#1)(1992-6#1)(1994-8#1)(2008-10#3)(2008-4#2)
washed away##3##2##(2007-5#1)(2008-10#1)(2008-4#1)
washed free of##2##3##(2008-10#2)
washed free##3##2##(2006-5#1)(2008-10#2)
washed human platelets##2##3##(1990-10#1)(1995-3#1)
washed human##3##2##(1990-10#1)(1993-4#1)(1995-3#1)
washed in##2##2##(2006-2#1)(2008-8#1)
washed off##3##2##(2005-11#1)(2008-10#1)(2008-11#1)
washed out to##2##3##(1997-3#1)(1997-5#1)
washed out##4##2##(1990-6#1)(1997-3#1)(1997-5#1)(2008-4#1)
washed platelets##7##2##(1990-10#1)(1991-12#1)(1991-6#1)(1991-8#1)(1996-12#1)(2008-7#1)(2008-8#1)
washed rat##2##2##(1990-4#1)(1995-11#1)
washed roots##3##2##(2008-10#3)
washed the##2##2##(1992-6#1)(2011-2#1)
washed their hands before##2##4##(2012-1#1)(2012-12#1)
washed their hands##3##3##(2012-1#1)(2012-12#2)
washed turkey muscle##4##3##(2010-4#4)
washed turkey##5##2##(2010-4#5)
washed with deionized water and##2##5##(1997-8#1)(2013-7#1)
washed with water##3##3##(2006-2#1)(2008-10#2)
washed with##21##2##(1990-11#2)(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-2#1)(1993-12#1)(1997-8#1)(2006-2#2)(2008-10#3)(2008-11#1)(2008-8#1)(2009-2#1)(2010-4#1)(2013-7#1)
washed##109##1##(1990-10#3)(1990-11#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-6#2)(1991-8#3)(1991-9#2)(1992-11#1)(1992-2#2)(1992-3#1)(1992-6#2)(1993-12#1)(1993-4#1)(1994-12#2)(1994-8#2)(1994-9#2)(1995-11#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-3#1)(1997-5#1)(1997-8#1)(2004-11#1)(2005-11#1)(2006-2#3)(2006-5#1)(2007-5#1)(2007-8#2)(2008-10#19)(2008-11#2)(2008-2#2)(2008-4#5)(2008-7#1)(2008-8#6)(2009-2#1)(2009-3#1)(2010-3#1)(2010-4#7)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#4)(2013-7#1)
washer##2##1##(2007-8#2)
washes and##5##2##(1990-7#1)(2008-1#3)(2013-1#1)
washes##22##1##(1990-7#2)(1993-6#1)(1994-11#2)(2006-10#1)(2007-11#1)(2007-2#1)(2008-1#3)(2008-10#6)(2008-11#2)(2008-9#1)(2011-2#1)(2013-1#1)
washing and elution##2##3##(2008-10#1)(2008-11#1)
washing and##13##2##(1997-3#1)(2005-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2009-2#1)(2012-2#1)(2013-1#1)
washing before##2##2##(1990-3#1)(1997-4#1)
washing for##3##2##(1991-3#1)(2007-8#1)(2013-8#1)
washing hands##3##2##(1994-6#1)(2008-1#1)(2008-3#1)
washing in##4##2##(1994-8#1)(1997-8#1)(2005-11#1)(2009-2#1)
washing of free##2##3##(2008-10#1)(2008-4#1)
washing of the##5##3##(1992-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-1#1)
washing of##9##2##(1992-2#1)(1993-3#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-7#1)(2010-1#1)
washing powders##2##2##(2008-10#2)
washing practices##4##2##(2011-1#4)
washing procedure##2##2##(2007-3#1)(2008-4#1)
washing procedures##2##2##(1991-1#1)(2005-7#1)
washing step##4##2##(1997-2#1)(2008-10#2)(2008-11#1)
washing steps##4##2##(1992-7#1)(2007-12#1)(2008-10#1)(2012-2#1)
washing the##9##2##(1994-12#1)(1996-6#1)(2008-10#5)(2008-4#1)(2008-5#1)
washing with water##2##3##(2008-10#2)
washing with##10##2##(2006-2#1)(2008-10#6)(2008-4#1)(2008-6#1)(2011-1#1)
washing##132##1##(1990-11#1)(1990-3#1)(1991-1#1)(1991-3#1)(1991-9#1)(1992-2#2)(1992-3#1)(1992-7#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-6#1)(1994-8#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-8#1)(2005-11#3)(2005-7#1)(2005-8#1)(2006-2#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#5)(2008-1#2)(2008-10#37)(2008-11#5)(2008-3#1)(2008-4#6)(2008-5#10)(2008-6#1)(2008-7#3)(2009-2#4)(2009-3#1)(2009-6#1)(2010-1#1)(2011-1#12)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
washing)##4##1##(1994-2#1)(2008-10#1)(2008-3#1)(2009-2#1)
washings and##7##2##(1994-2#1)(1997-4#1)(2006-10#1)(2008-5#3)(2010-12#1)
washings are##2##2##(1991-11#1)(2008-5#1)
washings were##2##2##(2006-10#1)(2008-10#1)
washings##23##1##(1990-2#1)(1991-11#1)(1994-2#1)(1996-12#1)(1997-4#1)(2006-10#4)(2007-9#3)(2008-10#3)(2008-5#7)(2010-12#1)
washington state##4##2##(2008-10#2)(2013-1#2)
washington##5##1##(2008-10#3)(2013-1#2)
washout and##2##2##(2008-10#1)(2008-3#1)
washout of muscarine##2##3##(1996-3#2)
washout of##7##2##(1996-12#1)(1996-3#2)(2007-10#1)(2008-10#1)(2009-12#1)(2010-3#1)
washout period##5##2##(1990-11#1)(1992-4#1)(1994-2#1)(2008-1#1)(2011-1#1)
washout solution##2##2##(2008-11#2)
washout##38##1##(1990-11#1)(1992-2#1)(1992-4#2)(1993-12#1)(1993-6#2)(1994-11#1)(1994-2#2)(1995-11#1)(1996-12#1)(1996-3#2)(2004-11#1)(2006-8#2)(2007-10#4)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#1)(2009-12#2)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
wasn't##10##1##(1990-6#1)(1993-12#1)(1995-12#1)(1995-8#1)(1996-2#1)(1997-3#1)(2006-6#1)(2007-1#1)(2012-2#1)(2013-7#1)
wasnot##2##1##(2008-11#1)(2008-8#1)
wasobtained##2##1##(2008-11#2)
wasp Cotesia##2##2##(1990-11#1)(2008-8#1)
wasp size##2##2##(2008-9#2)
wasp stings##3##2##(2006-2#1)(2010-4#2)
wasp##33##1##(1990-11#1)(1990-7#1)(1991-2#3)(1992-6#1)(1993-5#1)(1995-1#1)(2006-2#1)(2007-12#6)(2008-10#3)(2008-6#1)(2008-8#2)(2008-9#5)(2010-4#4)(2011-12#2)(2013-8#1)
wasperformed##2##1##(2009-8#1)(2013-8#1)
wasps and##6##2##(2006-8#1)(2007-12#1)(2008-6#4)
wasps##38##1##(1990-11#1)(2006-8#1)(2007-12#15)(2007-9#1)(2008-10#4)(2008-6#4)(2008-8#2)(2008-9#5)(2009-8#2)(2010-2#2)(2011-12#1)
wasshown to be##2##3##(2008-11#2)
wasshown##3##1##(2008-11#3)
wastage of time and##2##4##(2008-10#1)(2008-11#1)
wastage of##6##2##(1996-9#1)(2007-7#1)(2008-10#1)(2008-11#1)(2010-3#1)(2012-3#1)
wastage##9##1##(1996-9#3)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-3#1)(2012-3#1)
waste and##8##2##(1990-12#1)(1990-9#1)(2005-7#1)(2007-7#1)(2008-10#2)(2008-5#1)(2011-2#1)
waste by##2##2##(2008-10#1)(2008-5#1)
waste compost##4##2##(1995-11#2)(2008-10#2)
waste containing##2##2##(2008-10#1)(2010-9#1)
waste cooking oils##2##3##(2008-5#2)
waste disposal##7##2##(1991-4#1)(2008-12#3)(2008-6#2)(2012-3#1)
waste during##2##2##(2008-5#1)(2008-7#1)
waste effluent##2##2##(2008-10#2)
waste from##7##2##(1995-3#1)(1997-2#1)(2005-11#1)(2008-2#1)(2008-6#1)(2012-12#1)(2013-1#1)
waste generation##13##2##(2008-10#13)
waste in##6##2##(1997-3#1)(2008-2#1)(2009-6#1)(2010-9#1)(2013-7#2)
waste incineration##2##2##(2008-10#1)(2008-2#1)
waste is##3##2##(2008-6#1)(2009-4#1)(2009-6#1)
waste management and##2##3##(2008-1#1)(2008-2#1)
waste management in##2##3##(2008-12#1)(2008-2#1)
waste management practises##2##3##(1996-1#2)
waste management system in Mashad##2##5##(2008-12#2)
waste management##16##2##(1996-1#4)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#4)(2008-2#4)(2009-12#1)
waste materials##3##2##(2008-10#2)(2009-6#1)
waste of##8##2##(1994-2#1)(1997-3#1)(2007-10#1)(2008-10#1)(2010-8#2)(2012-2#1)(2013-8#1)
waste plastics##4##2##(2005-11#1)(2008-10#3)
waste polymers##4##2##(2008-10#4)
waste polystyrene##2##2##(2013-1#2)
waste prior to##2##3##(1993-2#1)(2007-8#1)
waste product##2##2##(1995-12#1)(2008-9#1)
waste production##4##2##(2008-10#2)(2008-11#1)(2008-12#1)
waste products##6##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-2#1)(2011-1#1)
waste rules##2##2##(1994-2#1)(2007-7#1)
waste samples##3##2##(2008-10#3)
waste site##2##2##(2006-12#1)(2008-10#1)
waste solution##2##2##(2008-10#2)
waste stabilization##2##2##(2009-6#2)
waste stream##2##2##(2008-10#1)(2013-1#1)
waste streams and##2##3##(2008-10#1)(2008-11#1)
waste streams##6##2##(2006-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)
waste treatment##3##2##(2008-10#1)(2008-5#1)(2008-6#1)
waste using##3##2##(2008-10#1)(2008-5#1)(2008-6#1)
waste was##3##2##(2008-10#1)(2008-5#1)(2009-6#1)
waste water and industrial##2##4##(1993-9#1)(2008-10#1)
waste water and##8##3##(1993-9#1)(2008-10#5)(2008-5#1)(2012-2#1)
waste water by##3##3##(2008-10#2)(2012-12#1)
waste water from a wheat and rye straw paper pulp##2##10##(1992-6#2)
waste water from##3##3##(1992-6#2)(1993-9#1)
waste water in##2##3##(2012-2#2)
waste water samples##6##3##(2008-10#6)
waste water using##2##3##(2008-1#1)(2008-10#1)
waste water##47##2##(1992-6#3)(1993-9#2)(1994-5#1)(2008-1#1)(2008-10#30)(2008-5#1)(2008-6#1)(2011-1#1)(2012-12#2)(2012-2#4)(2013-1#1)
waste waters and##2##3##(2008-10#2)
waste waters with##2##3##(2007-8#1)(2008-10#1)
waste waters##16##2##(1993-9#1)(2007-8#1)(2008-10#14)
waste##326##1##(1990-12#1)(1990-3#1)(1990-4#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-4#3)(1992-1#1)(1992-2#1)(1992-6#3)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-9#3)(1994-2#2)(1994-5#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-7#1)(1996-1#6)(1996-11#2)(1996-12#2)(1996-3#2)(1997-2#2)(1997-3#4)(2004-4#1)(2005-11#6)(2005-7#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-4#2)(2007-7#3)(2007-8#4)(2008-1#2)(2008-10#130)(2008-11#5)(2008-12#13)(2008-2#10)(2008-4#1)(2008-5#21)(2008-6#14)(2008-7#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-6#9)(2010-8#3)(2010-9#7)(2011-1#2)(2011-12#4)(2011-2#3)(2012-12#4)(2012-2#9)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#1)
waste)##3##1##(1991-4#1)(2006-10#1)(2012-2#1)
waste-water##8##1##(2008-10#6)(2008-6#1)(2012-12#1)
waste]##2##1##(1991-8#1)(2012-12#1)
wasted and##3##2##(2007-7#1)(2008-10#1)(2008-4#1)
wasted##9##1##(2006-2#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-4#2)(2012-2#1)(2012-3#1)
wasteful##4##1##(1997-1#1)(1997-3#1)(2007-4#1)(2008-6#1)
wastes and the##2##3##(2008-10#2)
wastes and##8##2##(1991-7#1)(2008-10#5)(2008-7#1)(2010-5#1)
wastes are##2##2##(1991-4#1)(2007-10#1)
wastes as the C source##2##5##(2008-6#2)
wastes by##2##2##(2008-10#2)
wastes in the process of endovascular stent procurement in interventional radiology##2##11##(2012-2#2)
wastes in the##3##3##(2007-10#1)(2012-2#2)
wastes in##7##2##(1991-4#2)(2007-10#2)(2008-2#1)(2012-2#2)
wastes to##2##2##(2008-12#1)(2008-6#1)
wastes##75##1##(1990-3#1)(1991-4#6)(1991-7#1)(1992-3#1)(1994-11#2)(1997-4#1)(2006-5#1)(2007-10#9)(2007-5#1)(2008-10#28)(2008-12#2)(2008-2#1)(2008-5#4)(2008-6#7)(2008-7#2)(2009-11#1)(2009-6#1)(2010-5#1)(2011-2#1)(2012-2#3)(2013-1#1)
wastewater and##6##2##(2008-10#5)(2012-12#1)
wastewater as##2##2##(2008-10#1)(2008-6#1)
wastewater effluents##3##2##(1992-7#1)(2008-10#2)
wastewater from a##5##3##(2006-8#1)(2008-10#2)(2009-6#1)(2012-12#1)
wastewater from an electroplating plant##2##5##(2008-10#2)
wastewater from an##3##3##(2008-10#3)
wastewater from##10##2##(2006-8#1)(2008-10#6)(2009-6#2)(2012-12#1)
wastewater in##2##2##(2007-6#1)(2008-1#1)
wastewater is##2##2##(2008-10#1)(2013-1#1)
wastewater of##2##2##(2008-10#1)(2012-2#1)
wastewater or##2##2##(2005-11#1)(2008-7#1)
wastewater quality##4##2##(2008-10#4)
wastewater sample##2##2##(2007-8#1)(2008-10#1)
wastewater samples and##2##3##(2008-10#2)
wastewater samples from##2##3##(2008-10#2)
wastewater samples with##3##3##(2008-10#3)
wastewater samples##27##2##(2007-10#1)(2008-10#22)(2008-5#1)(2012-12#3)
wastewater toxicity assessment##3##3##(2008-10#3)
wastewater treatment plant (WWTP)##4##4##(2007-8#1)(2008-10#3)
wastewater treatment plant##10##3##(2005-11#2)(2006-8#1)(2007-8#2)(2008-10#3)(2008-12#2)
wastewater treatment plants (WWTP)##2##4##(2008-10#1)(2010-5#1)
wastewater treatment plants##9##3##(2008-10#5)(2008-7#1)(2009-6#1)(2010-5#2)
wastewater treatment sludge##2##3##(2005-11#1)(2008-6#1)
wastewater treatment system##4##3##(2005-11#2)(2012-12#1)(2013-1#1)
wastewater treatment##41##2##(1997-4#2)(2005-11#6)(2006-8#2)(2007-8#2)(2008-10#12)(2008-12#2)(2008-6#2)(2008-7#2)(2009-4#1)(2009-6#2)(2010-5#2)(2012-12#1)(2013-1#5)
wastewater was##3##2##(2008-10#2)(2012-2#1)
wastewater were##3##2##(2008-1#2)(2012-1#1)
wastewater##180##1##(1992-7#2)(1997-4#2)(2005-11#8)(2006-12#1)(2006-8#6)(2007-10#1)(2007-6#4)(2007-8#6)(2008-1#6)(2008-10#92)(2008-12#5)(2008-5#6)(2008-6#3)(2008-7#3)(2009-4#1)(2009-6#5)(2010-5#6)(2011-2#2)(2012-1#2)(2012-12#6)(2012-2#3)(2013-1#10)
wastewater)##3##1##(2008-10#3)
wastewaters and##2##2##(2007-6#1)(2008-5#1)
wastewaters were##2##2##(2008-1#1)(2008-10#1)
wastewaters##23##1##(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#14)(2008-5#2)(2008-6#1)(2008-7#1)(2012-2#1)
wasting and lipodystrophy##3##3##(2006-9#3)
wasting and##8##2##(1997-3#1)(2006-1#1)(2006-9#4)(2007-2#1)(2012-2#1)
wasting disorders##3##2##(2006-10#2)(2006-2#1)
wasting in##3##2##(1994-9#1)(2007-11#1)(2008-12#1)
wasting may##2##2##(2006-9#1)(2007-11#1)
wasting syndrome##6##2##(2005-10#1)(2006-4#3)(2006-9#1)(2012-3#1)
wasting was##2##2##(2007-12#1)(2013-1#1)
wasting##51##1##(1994-6#1)(1994-9#1)(1996-11#1)(1997-3#1)(1997-8#1)(2005-10#2)(2005-11#1)(2006-1#1)(2006-10#4)(2006-2#1)(2006-4#3)(2006-6#1)(2006-9#8)(2007-1#1)(2007-11#7)(2007-12#1)(2007-2#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-12#1)(2010-6#1)(2010-8#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
watch##22##1##(1992-10#1)(1993-1#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-2#1)(1996-7#1)(1997-2#2)(2005-12#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2011-2#2)(2012-11#1)(2012-12#1)
watchdog##2##1##(1991-6#1)(2005-11#1)
watched##9##1##(1996-8#1)(2004-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
watchful waiting##3##2##(2006-9#1)(2009-5#1)(2012-2#1)
watchful##4##1##(2006-9#1)(2009-5#1)(2010-10#1)(2012-2#1)
watching and##3##2##(2008-11#1)(2010-10#1)(2013-1#1)
watching television##2##2##(2009-7#1)(2010-6#1)
watching##15##1##(1996-1#1)(2007-3#1)(2008-11#2)(2008-3#1)(2009-7#1)(2010-10#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#2)(2013-1#1)
watchman's wife##2##2##(1992-6#2)
water (0##5##2##(2008-10#4)(2012-3#1)
water (10##2##2##(2008-5#2)
water (15##2##2##(1990-4#1)(2008-5#1)
water (4##2##2##(2009-6#1)(2012-2#1)
water (80##2##2##(2010-3#1)(2011-3#1)
water (EC =##3##3##(2008-10#3)
water (EC##4##2##(2008-10#3)(2008-12#1)
water (at##2##2##(1995-3#1)(2008-10#1)
water (containing##2##2##(2008-5#1)(2011-1#1)
water (n =##5##3##(1995-1#1)(1995-12#1)(2008-5#2)(2010-8#1)
water (or##2##2##(2008-10#1)(2009-12#1)
water (pH 6##2##3##(2008-10#1)(2010-12#1)
water (pH 7##2##3##(1992-8#1)(2008-10#1)
water (pH##6##2##(1992-8#1)(2008-10#4)(2010-12#1)
water (v/v)##3##2##(1990-10#1)(1996-5#1)(2007-9#1)
water + NaCl +##3##4##(2006-10#3)
water +##7##2##(1997-7#1)(2006-10#6)
water O-H##2##2##(1995-10#2)
water a##2##2##(2008-11#1)(2011-1#1)
water above##2##2##(2006-10#1)(2008-10#1)
water absorption capacity##2##3##(2008-5#2)
water absorption##10##2##(2006-12#1)(2008-2#1)(2008-3#3)(2008-5#4)(2010-2#1)
water activities##3##2##(2005-12#1)(2008-7#2)
water activity (a(w))##4##3##(1992-7#1)(2008-10#1)(2008-5#1)(2008-7#1)
water activity##15##2##(1992-7#2)(1994-3#1)(1994-9#2)(1996-2#1)(2005-12#1)(2008-10#2)(2008-5#1)(2008-7#5)
water ad libitum##3##3##(2005-10#1)(2007-1#2)
water added##2##2##(2008-5#1)(2013-1#1)
water addition##2##2##(2008-10#2)
water adsorption##2##2##(2005-11#2)
water affected the##2##3##(2008-10#1)(2008-12#1)
water after preconcentration of##2##4##(2008-10#2)
water after preconcentration##3##3##(2008-10#3)
water after the##2##3##(1995-5#1)(2005-11#1)
water after##13##2##(1995-5#3)(1997-6#1)(2005-11#1)(2008-10#7)(2008-5#1)
water agar##12##2##(2008-10#12)
water alone was##2##3##(2008-10#1)(2008-5#1)
water alone##7##2##(1997-2#2)(2008-10#2)(2008-5#3)
water among residents of##2##4##(2011-2#1)(2012-3#1)
water among##3##2##(2011-2#1)(2012-1#1)(2012-3#1)
water analysis and##2##3##(2008-10#2)
water analysis##17##2##(2008-1#1)(2008-10#15)(2008-2#1)
water and 0##3##3##(1993-2#1)(2005-11#1)(2008-10#1)
water and 19##2##3##(2007-10#1)(2008-5#1)
water and 2 M NaOH##2##5##(2005-11#2)
water and a phosphate buffer##2##5##(2008-10#2)
water and a##5##3##(2006-8#1)(2008-10#4)
water and acetonitrile##7##3##(1991-3#1)(1997-4#2)(2008-10#3)(2012-12#1)
water and acid extracts from coal##2##6##(2008-10#2)
water and alloy samples##2##4##(2008-10#2)
water and also in##2##4##(2007-8#1)(2008-10#1)
water and also##4##3##(2007-8#1)(2008-10#3)
water and biological##3##3##(2008-10#3)
water and by##2##3##(2008-10#1)(2013-1#1)
water and chlorophyll##2##3##(2008-3#2)
water and electrolyte homeostasis##2##4##(1994-12#1)(2012-12#1)
water and electrolyte##8##3##(1993-12#1)(1994-12#1)(2006-10#2)(2007-7#1)(2010-2#1)(2012-12#1)(2013-7#1)
water and estimated##2##3##(2008-10#2)
water and ethanol##3##3##(2005-11#1)(2007-12#1)(2007-9#1)
water and food##4##3##(1995-12#1)(2009-5#1)(2011-12#1)(2012-3#1)
water and from##3##3##(1993-11#1)(1996-2#1)(2008-10#1)
water and fruit juice##4##4##(2008-10#4)
water and fumonisin-producing fungus added##2##5##(2013-1#2)
water and heat##2##3##(1997-4#1)(2007-9#1)
water and human##2##3##(2008-10#1)(2012-1#1)
water and in the presence of##2##6##(2005-11#2)
water and in the##3##4##(2005-11#2)(2008-5#1)
water and in##15##3##(1990-9#1)(1991-3#1)(1992-12#1)(2005-11#3)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)
water and ion##3##3##(2006-8#1)(2008-5#2)
water and its##3##3##(2011-1#1)(2011-2#1)(2012-3#1)
water and methanol##2##3##(1997-8#1)(2006-12#1)
water and mineral water samples##2##5##(2008-10#2)
water and natural##3##3##(2008-10#2)(2008-11#1)
water and on##2##3##(1992-1#1)(2005-11#1)
water and organic solvents##2##4##(1996-2#1)(2008-10#1)
water and organic##3##3##(1996-2#1)(2008-10#1)(2010-4#1)
water and other##6##3##(2006-10#1)(2007-2#1)(2007-8#1)(2008-10#3)
water and removal of##2##4##(1996-10#1)(2008-10#1)
water and river water##4##4##(2008-10#4)
water and river##5##3##(2008-10#5)
water and salt##3##3##(1995-5#1)(2010-3#1)(2012-1#1)
water and sea##2##3##(2008-10#1)(2008-3#1)
water and seawater##3##3##(2007-8#1)(2008-2#2)
water and sediment samples##2##4##(2007-10#1)(2008-10#1)
water and sediment##4##3##(2007-10#1)(2008-10#3)
water and soil##6##3##(2005-11#1)(2007-10#2)(2008-10#2)(2008-5#1)
water and solute##2##3##(2006-5#1)(2011-2#1)
water and some##6##3##(2008-10#6)
water and stream sediment##2##4##(2008-10#2)
water and synthetic##2##3##(2008-10#2)
water and tap water##4##4##(2008-10#3)(2008-5#1)
water and the##19##3##(1990-8#1)(1995-1#1)(1997-5#1)(2004-4#1)(2005-11#3)(2007-2#1)(2007-7#1)(2008-10#8)(2010-8#1)(2013-8#1)
water and their##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
water and then##4##3##(1992-2#1)(1997-8#1)(2008-10#1)(2008-4#1)
water and therefore##3##3##(2007-9#2)(2008-8#1)
water and those##2##3##(2009-6#1)(2010-8#1)
water and to##2##3##(1990-7#1)(2006-10#1)
water and two##2##3##(2008-10#2)
water and urine##2##3##(2008-10#2)
water and vegetable samples##4##4##(2008-10#4)
water and very##2##3##(2008-10#1)(2012-12#1)
water and wastewater samples##4##4##(2008-10#4)
water and wastewater##6##3##(2008-10#6)
water and water##3##3##(2007-5#1)(2008-10#1)(2008-2#1)
water and well water##3##4##(2007-8#1)(2008-10#2)
water and with##2##3##(1991-3#1)(2008-5#1)
water and##404##2##(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-8#1)(1992-1#1)(1992-12#4)(1992-2#2)(1992-7#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#2)(1996-10#1)(1996-11#1)(1996-2#2)(1996-3#2)(1996-8#3)(1997-1#1)(1997-2#1)(1997-4#3)(1997-5#1)(1997-8#4)(2004-12#1)(2004-4#2)(2005-11#17)(2005-4#1)(2005-7#1)(2006-10#8)(2006-12#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-10#5)(2007-11#2)(2007-12#3)(2007-2#2)(2007-5#2)(2007-7#3)(2007-8#4)(2007-9#4)(2008-1#2)(2008-10#167)(2008-11#1)(2008-12#2)(2008-2#6)(2008-3#12)(2008-4#4)(2008-5#15)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-5#2)(2009-6#4)(2009-8#1)(2010-2#3)(2010-3#1)(2010-4#6)(2010-5#1)(2010-6#1)(2010-8#4)(2011-1#3)(2011-12#3)(2011-2#4)(2012-1#3)(2012-12#6)(2012-2#4)(2012-3#7)(2013-1#8)(2013-7#3)(2013-8#3)
water are the##2##3##(2005-11#1)(2007-11#1)
water are##20##2##(1996-9#1)(2005-11#3)(2005-4#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#6)(2008-2#2)(2008-3#1)(2010-4#1)(2011-2#1)
water as a##12##3##(1990-11#1)(1992-7#1)(2007-4#1)(2008-10#4)(2008-3#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)
water as an##4##3##(2008-10#2)(2008-7#1)(2010-12#1)
water as mobile phase##2##4##(1991-3#1)(2008-10#1)
water as solvent##4##3##(2008-10#1)(2011-1#1)(2012-2#2)
water as the##7##3##(1992-12#1)(1993-9#1)(1995-3#1)(2007-11#1)(2008-10#1)(2009-9#1)(2013-7#1)
water as well as##2##4##(2008-10#1)(2010-12#1)
water as##42##2##(1990-11#1)(1990-5#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-7#1)(1993-9#1)(1995-3#1)(2007-10#2)(2007-11#1)(2007-4#1)(2008-10#14)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-12#2)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#2)(2013-7#1)
water at 0##2##3##(2006-6#1)(2007-5#1)
water at 25 degrees C##3##5##(2005-11#1)(2008-10#1)(2013-8#1)
water at 37 degrees C##3##5##(2004-9#1)(2006-8#1)(2009-8#1)
water at a##3##3##(1990-7#1)(2008-10#1)(2008-2#1)
water at the end of##2##5##(2008-10#1)(2010-3#1)
water at the##7##3##(1993-12#1)(2006-4#1)(2008-10#3)(2010-3#1)(2010-4#1)
water at##52##2##(1990-7#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-12#1)(1995-2#1)(1996-6#1)(1997-2#1)(1997-6#1)(2004-9#2)(2005-11#2)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-12#2)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#12)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#2)(2009-8#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#2)
water availability##7##2##(2005-12#2)(2008-10#1)(2011-2#1)(2012-5#1)(2012-8#1)(2013-7#1)
water available##2##2##(1990-7#1)(2008-5#1)
water bands##2##2##(1995-5#1)(2008-2#1)
water barrier##6##2##(2008-5#5)(2010-4#1)
water bath at##2##3##(2008-10#1)(2008-3#1)
water bath of##2##3##(2007-8#1)(2008-10#1)
water bath##18##2##(1992-1#1)(2005-10#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#2)(2011-1#1)(2012-2#1)(2013-8#2)
water before##6##2##(2004-9#1)(2007-2#1)(2008-11#1)(2009-6#1)(2011-2#2)
water beginning##2##2##(1996-5#1)(2008-10#1)
water being##2##2##(2008-6#1)(2011-2#1)
water between##3##2##(2006-10#1)(2007-11#1)(2008-5#1)
water binding capacity##2##3##(2007-11#1)(2013-1#1)
water binding##7##2##(2006-10#1)(2006-3#1)(2007-11#1)(2007-7#1)(2010-4#2)(2013-1#1)
water bodies in##2##3##(2008-3#1)(2008-5#1)
water bodies##11##2##(2007-10#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-8#1)
water body##17##2##(2008-10#1)(2008-2#3)(2008-3#4)(2008-5#5)(2013-1#1)(2013-8#3)
water buffalo##6##2##(1991-6#1)(2008-12#4)(2008-5#1)
water bug species##2##3##(2008-5#2)
water bug##3##2##(2008-5#2)(2013-7#1)
water but with##2##3##(2005-11#1)(2008-5#1)
water but##8##2##(1995-5#1)(2005-11#1)(2008-10#3)(2008-2#1)(2008-5#1)(2010-4#1)
water by a##2##3##(2008-10#2)
water by capillary##2##3##(2008-10#1)(2012-12#1)
water by electrothermal atomic absorption spectrometry##2##6##(2008-10#2)
water by graphite furnace atomic absorption spectrometry##3##7##(2008-10#3)
water by graphite furnace atomic absorption##4##6##(2005-4#1)(2008-10#3)
water by inductively coupled##2##4##(2008-10#2)
water by means of##2##4##(1995-1#1)(2013-8#1)
water by solid-phase##2##3##(2008-10#2)
water by the##2##3##(2008-10#2)
water by use of##2##4##(2008-2#1)(2008-3#1)
water by using##4##3##(2008-1#1)(2008-10#2)(2011-2#1)
water by##77##2##(1990-4#1)(1995-1#1)(1995-3#1)(1995-7#1)(1995-8#1)(1997-5#1)(2005-4#4)(2007-12#2)(2008-1#1)(2008-10#52)(2008-2#1)(2008-3#3)(2008-5#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#2)
water can also##2##3##(2007-12#1)(2008-10#1)
water can be##6##3##(2008-10#4)(2008-2#1)(2010-5#1)
water can##11##2##(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#2)(2010-5#1)
water carrier##4##2##(2007-8#1)(2008-10#3)
water cavity##3##2##(1992-9#1)(1997-5#2)
water channel protein##2##3##(2012-3#1)(2013-1#1)
water channel##7##2##(1991-2#1)(1993-3#1)(1996-8#1)(2008-2#2)(2012-3#1)(2013-1#1)
water channels##7##2##(1991-2#1)(1996-8#1)(2006-10#3)(2007-12#1)(2008-7#1)
water chemistry##2##2##(2004-4#1)(2007-3#1)
water chlorination##2##2##(1994-3#1)(2008-10#1)
water circulation##3##2##(2007-5#1)(2008-5#1)(2010-5#1)
water clarity##3##2##(2009-5#3)
water clusters##3##2##(1990-8#1)(2006-8#2)
water coefficients##2##2##(2010-2#2)
water collected in summer##2##4##(2008-10#1)(2011-1#1)
water collected##3##2##(2008-10#1)(2011-1#1)(2012-3#1)
water color##2##2##(2008-3#1)(2013-8#1)
water column##23##2##(2006-3#2)(2006-7#1)(2007-5#6)(2007-9#1)(2008-2#6)(2008-3#3)(2008-5#1)(2008-8#2)(2012-2#1)
water compared##2##2##(2008-10#2)
water concentration##6##2##(1993-2#1)(1997-6#1)(2007-8#1)(2010-8#3)
water concentrations of##2##3##(2008-10#1)(2010-8#1)
water concentrations##6##2##(1991-2#1)(2005-11#2)(2008-10#1)(2010-8#1)(2013-1#1)
water conservation##6##2##(1997-1#1)(2008-1#1)(2008-9#3)(2013-8#1)
water consumption declined with increasing exposure concentration##2##7##(2008-9#2)
water consumption was##4##3##(1993-12#1)(2005-10#1)(2008-10#1)(2008-9#1)
water consumption##16##2##(1993-12#1)(2005-10#5)(2007-2#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-9#4)(2011-2#1)
water contact angle##4##3##(1990-2#1)(2010-4#3)
water contact angles##2##3##(2005-11#2)
water contact##6##2##(1990-2#1)(2005-11#2)(2010-4#3)
water contained in##2##3##(2007-12#1)(2008-5#1)
water containing 0##13##3##(2008-10#3)(2008-9#10)
water containing bromide##3##3##(2008-9#2)(2010-5#1)
water containing sodium acetate##2##4##(2008-10#1)(2008-5#1)
water containing sodium##3##3##(2006-2#1)(2008-10#1)(2008-5#1)
water containing##36##2##(1990-7#1)(1990-8#1)(1991-9#1)(1997-3#1)(2006-2#1)(2008-10#11)(2008-11#1)(2008-4#1)(2008-5#2)(2008-9#12)(2009-3#1)(2010-5#1)(2012-12#1)(2012-3#1)
water contaminated by##2##3##(1991-2#1)(2007-2#1)
water contaminated##3##2##(1991-2#1)(2007-2#1)(2008-10#1)
water contamination##6##2##(2007-10#1)(2008-10#1)(2011-1#1)(2011-12#3)
water content and the##4##4##(1992-5#1)(1995-2#1)(2007-10#1)(2008-3#1)
water content and##14##3##(1992-5#1)(1993-7#1)(1995-2#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-2#1)(2010-4#1)(2010-9#1)(2012-7#1)(2013-8#1)
water content as a##2##4##(1992-8#1)(2008-10#1)
water content as##3##3##(1992-8#1)(2008-10#1)(2011-1#1)
water content determination##3##3##(2008-10#3)
water content in the SC##2##5##(2008-5#2)
water content in the##5##4##(2004-8#1)(2008-10#2)(2008-5#2)
water content in##8##3##(2004-8#1)(2008-10#3)(2008-12#2)(2008-5#2)
water content is##3##3##(2008-10#3)
water content of acetonitrile##3##4##(2005-11#3)
water content of the stratum corneum##4##6##(2007-7#1)(2008-5#3)
water content of the##8##4##(2007-10#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#3)(2009-6#1)
water content of##17##3##(1996-9#1)(2004-9#1)(2005-11#3)(2007-10#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#4)(2009-6#1)(2012-8#1)(2013-1#1)
water content was##5##3##(1995-11#1)(2008-10#2)(2008-5#2)
water content##101##2##(1991-2#1)(1992-5#1)(1992-8#1)(1993-7#2)(1995-1#1)(1995-11#1)(1995-2#1)(1996-9#1)(1997-3#2)(2004-4#1)(2004-8#1)(2004-9#1)(2005-11#3)(2006-10#1)(2007-10#2)(2007-7#1)(2008-10#23)(2008-12#2)(2008-3#3)(2008-5#20)(2008-7#3)(2009-10#1)(2009-12#1)(2009-6#3)(2009-9#2)(2010-2#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#2)(2012-12#2)(2012-2#1)(2012-7#1)(2012-8#2)(2012-9#1)(2013-1#1)(2013-8#3)
water contents in##3##3##(2007-10#1)(2008-10#1)(2008-5#1)
water contents##9##2##(2004-8#1)(2006-10#2)(2007-10#1)(2008-10#2)(2008-2#1)(2008-5#1)(2010-4#1)
water control##5##2##(2008-10#2)(2008-12#3)
water conveyance##2##2##(2008-10#1)(2010-2#1)
water coolers##4##2##(1996-3#4)
water cooling##2##2##(2006-4#1)(2008-7#1)
water correlated strongly with##2##4##(1993-2#2)
water correlated##3##2##(1993-2#2)(2008-10#1)
water could be##2##3##(2008-7#1)(2012-2#1)
water could##3##2##(1996-5#1)(2008-7#1)(2012-2#1)
water current##2##2##(2007-3#1)(2008-10#1)
water currents and##2##3##(2007-5#1)(2008-8#1)
water cycle##2##2##(2013-8#2)
water deficit##7##2##(2007-3#1)(2009-8#5)(2012-5#1)
water density##3##2##(2006-10#1)(2010-8#2)
water deprivation in##2##3##(1994-10#1)(1995-7#1)
water deprivation##12##2##(1994-10#4)(1995-7#5)(1996-8#1)(2012-2#1)(2013-1#1)
water depth on##2##3##(2008-10#2)
water depth##6##2##(2008-10#2)(2008-2#1)(2008-6#1)(2009-11#2)
water determination##2##2##(1993-2#2)
water did not result in##2##5##(2008-10#1)(2009-2#1)
water did not##3##3##(1993-8#1)(2008-10#1)(2009-2#1)
water diffusion across the##2##4##(1991-5#2)
water diffusion##6##2##(1991-5#2)(2005-11#1)(2010-9#2)(2012-1#1)
water dipoles##2##2##(2005-11#1)(2008-10#1)
water discharges##2##2##(2007-5#1)(2013-1#1)
water disinfection##5##2##(1994-3#1)(2008-10#2)(2008-9#2)
water droplet##11##2##(2005-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2009-5#1)(2011-1#1)
water droplets or ice##2##4##(2008-2#2)
water droplets or##3##3##(2008-10#1)(2008-2#2)
water droplets##17##2##(2005-11#2)(2007-11#1)(2008-10#2)(2008-2#9)(2008-3#2)(2011-1#1)
water drops##3##2##(2008-10#1)(2008-2#2)
water during##6##2##(1992-8#1)(1996-6#1)(2005-11#1)(2008-10#2)(2008-12#1)
water eluent##4##2##(2008-10#4)
water emulsions##2##2##(2008-10#1)(2008-5#1)
water environment##10##2##(1995-1#1)(2007-7#2)(2008-10#2)(2008-9#1)(2013-8#4)
water exchange##2##2##(1991-5#1)(1996-9#1)
water excretion##2##2##(2008-2#2)
water exposure in##2##3##(2006-12#1)(2007-2#1)
water extract of##10##3##(2007-1#1)(2008-10#1)(2008-6#3)(2010-4#2)(2011-2#1)(2012-3#2)
water extract##21##2##(2007-1#1)(2008-10#9)(2008-5#1)(2008-6#3)(2009-6#1)(2010-4#2)(2011-2#1)(2012-3#2)(2013-8#1)
water extraction and##4##3##(2008-10#3)(2013-8#1)
water extraction##13##2##(2008-10#11)(2012-1#1)(2013-8#1)
water extracts of propolis##3##4##(2008-11#3)
water extracts of##9##3##(2005-11#1)(2008-10#2)(2008-11#3)(2009-5#1)(2010-4#2)
water extracts##13##2##(2005-11#1)(2007-1#1)(2008-10#5)(2008-11#3)(2009-5#1)(2010-4#2)
water film##2##2##(2005-11#1)(2008-10#1)
water flow and##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
water flow##10##2##(2005-11#3)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2013-1#1)
water fluoridation in##5##3##(2006-8#5)
water fluoridation##6##2##(2006-8#6)
water flux##4##2##(1990-2#1)(2006-8#1)(2008-5#1)(2008-6#1)
water followed by##4##3##(1996-2#1)(2008-5#1)(2008-9#1)(2011-1#1)
water footprints##2##2##(2011-2#2)
water for 10 min##2##4##(2006-11#1)(2008-10#1)
water for 10##3##3##(2006-11#1)(2008-10#1)(2008-12#1)
water for 4 h##2##4##(2008-5#2)
water for 4##3##3##(2008-10#1)(2008-5#2)
water for a period of##2##5##(2009-5#1)(2011-2#1)
water for human consumption##2##4##(2008-11#1)(2008-5#1)
water for irrigation##2##3##(2007-10#2)
water for patient care##2##4##(2011-12#2)
water for the##7##3##(1994-3#1)(2008-10#3)(2008-5#1)(2008-7#1)(2012-12#1)
water for##63##2##(1994-3#2)(1994-6#1)(1995-12#1)(2004-12#1)(2004-4#1)(2004-9#2)(2006-11#1)(2007-10#3)(2008-10#11)(2008-11#1)(2008-12#3)(2008-2#2)(2008-4#1)(2008-5#9)(2008-7#1)(2008-9#8)(2009-10#1)(2009-5#1)(2009-6#2)(2011-1#1)(2011-12#2)(2011-2#1)(2012-1#2)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
water fraction of##2##3##(2007-5#1)(2008-10#1)
water fraction##7##2##(2007-5#1)(2008-10#5)(2010-2#1)
water from a##8##3##(1992-6#2)(1993-4#1)(2008-10#2)(2008-5#2)(2012-3#1)
water from an##2##3##(2008-10#1)(2011-1#1)
water from the##13##3##(1992-5#1)(1997-2#1)(2006-8#1)(2007-5#1)(2008-10#5)(2008-3#1)(2008-4#1)(2011-2#1)(2012-2#1)
water from water##2##3##(1996-3#1)(2011-2#1)
water from##43##2##(1992-3#1)(1992-5#1)(1992-6#2)(1993-4#1)(1993-9#1)(1996-3#2)(1997-2#1)(2005-10#1)(2006-1#1)(2006-8#1)(2007-5#1)(2008-1#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#1)(2009-7#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
water group##6##2##(1997-2#1)(2008-5#5)
water hardness##2##2##(2007-8#1)(2008-10#1)
water has a##2##3##(2007-12#1)(2008-5#1)
water has been developed##5##4##(2008-10#5)
water has been##17##3##(1994-3#1)(2005-11#1)(2006-10#1)(2008-10#11)(2008-7#1)(2011-1#1)(2012-1#1)
water has##24##2##(1994-3#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#12)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#2)(2012-1#1)(2012-2#2)
water have been studied##2##4##(1995-4#1)(2008-10#1)
water have been##9##3##(1992-9#1)(1995-4#1)(2008-10#5)(2008-3#1)(2012-5#1)
water have##10##2##(1992-9#1)(1995-4#1)(2008-10#5)(2008-3#1)(2008-7#1)(2012-5#1)
water holding capacity##10##3##(2008-5#2)(2010-4#5)(2011-12#1)(2013-1#1)(2013-7#1)
water holding##11##2##(2008-5#2)(2010-4#6)(2011-12#1)(2013-1#1)(2013-7#1)
water hyacinth and##2##3##(2007-10#2)
water hyacinth##4##2##(2007-10#4)
water hydrogen bonding##2##3##(1991-2#1)(2009-10#1)
water ice##4##2##(2008-3#4)
water immersion and##2##3##(2008-5#2)
water immersion##9##2##(2005-8#1)(2007-3#1)(2008-3#1)(2008-5#5)(2009-4#1)
water in a##7##3##(1992-2#1)(1993-12#1)(1996-2#1)(2008-3#2)(2008-5#1)(2012-12#1)
water in fractures##2##3##(2005-11#2)
water in oil##2##3##(2008-10#1)(2008-5#1)
water in the Canada Basin##2##5##(1991-11#2)
water in the presence of##2##5##(2008-10#2)
water in the whole##2##4##(2007-11#1)(2008-10#1)
water in the##34##3##(1990-7#1)(1991-11#2)(1991-3#1)(1992-12#1)(1993-4#1)(1995-1#2)(1996-5#1)(2006-10#1)(2007-11#2)(2007-6#2)(2008-10#10)(2008-2#4)(2008-5#1)(2008-7#2)(2010-3#1)(2011-1#1)(2012-2#1)
water in##93##2##(1990-7#1)(1990-9#1)(1991-11#2)(1991-3#1)(1992-12#2)(1992-2#1)(1992-9#2)(1993-12#1)(1993-4#1)(1995-1#2)(1996-2#1)(1996-5#1)(2005-11#4)(2005-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-5#1)(2007-6#2)(2008-1#1)(2008-10#27)(2008-11#3)(2008-2#4)(2008-3#4)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#2)
water increased##4##2##(2008-4#1)(2008-5#1)(2008-7#1)(2012-3#1)
water injection injury##2##3##(2007-3#1)(2009-4#1)
water injection##4##2##(2007-3#2)(2008-10#1)(2009-4#1)
water inside##2##2##(2005-11#1)(2010-9#1)
water insoluble##4##2##(2008-10#1)(2008-5#1)(2010-12#1)(2013-1#1)
water intake##15##2##(1991-10#1)(1993-12#1)(1996-12#1)(2007-2#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-4#1)(2010-2#1)(2011-1#1)(2011-2#3)(2013-1#1)
water into the##5##3##(1994-8#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)
water into##12##2##(1991-2#1)(1994-8#2)(2006-10#1)(2008-10#4)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)
water is 0##2##3##(2008-10#1)(2008-2#1)
water is a##6##3##(1993-11#1)(1994-3#1)(1995-11#1)(2006-10#1)(2008-10#1)(2009-10#1)
water is an##2##3##(2008-10#1)(2008-5#1)
water is demonstrated##2##3##(2008-10#1)(2008-2#1)
water is described##5##3##(2005-4#1)(2008-10#3)(2008-2#1)
water is found##2##3##(1992-12#1)(2008-2#1)
water is not##3##3##(2008-7#1)(2009-2#1)(2011-1#1)
water is proposed##2##3##(2008-10#2)
water is reported##3##3##(2008-10#2)(2008-3#1)
water is the##2##3##(1995-5#1)(2008-5#1)
water is thought to##2##4##(2008-5#2)
water is used##3##3##(2005-11#1)(2008-10#1)(2010-3#1)
water is##82##2##(1990-10#2)(1991-8#1)(1992-12#2)(1992-5#1)(1993-11#1)(1994-3#1)(1995-11#1)(1995-5#2)(1997-1#2)(2005-11#6)(2005-4#1)(2006-10#5)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#27)(2008-11#2)(2008-2#5)(2008-3#5)(2008-5#6)(2008-7#1)(2009-10#1)(2009-2#1)(2010-3#1)(2011-1#2)(2013-1#1)(2013-7#1)
water level in##2##3##(2005-10#2)
water level on##2##3##(2007-3#1)(2012-3#1)
water level##7##2##(2005-10#3)(2007-3#1)(2008-5#1)(2012-3#1)(2013-7#1)
water levels##5##2##(1996-6#1)(2008-5#3)(2012-2#1)
water ligand##4##2##(1991-7#1)(1993-3#1)(2006-3#2)
water ligands of metal##2##4##(1990-7#2)
water limiting conditions in the study area##2##7##(2008-12#2)
water logging##2##2##(2007-7#1)(2013-8#1)
water loss (TEWL) and##3##4##(2008-5#3)
water loss (TEWL)##13##3##(2008-5#12)(2012-2#1)
water loss and##2##3##(2006-12#1)(2007-12#1)
water loss from##3##3##(2008-10#1)(2008-5#1)(2010-4#1)
water loss##30##2##(2006-12#1)(2007-12#1)(2008-10#2)(2008-5#21)(2009-8#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-7#1)
water management##4##2##(2008-1#1)(2008-10#1)(2008-5#1)(2011-2#1)
water mass##3##2##(1993-2#1)(2004-4#1)(2008-5#1)
water masses##4##2##(2007-5#1)(2008-2#1)(2010-8#1)(2012-2#1)
water matrices##2##2##(2008-10#2)
water matrix##3##2##(2008-10#3)
water may be performed##2##4##(2008-10#1)(2008-5#1)
water may be##3##3##(2008-10#1)(2008-5#2)
water may##6##2##(2008-10#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-6#1)
water maze and passive avoidance##4##5##(1993-11#1)(1996-12#3)
water maze and##8##3##(1993-11#1)(1994-2#1)(1996-12#4)(2008-12#1)(2008-9#1)
water maze task##11##3##(1993-2#2)(1994-3#3)(1997-2#1)(2005-8#1)(2008-10#1)(2008-4#2)(2013-1#1)
water maze test##4##3##(2008-10#1)(2008-12#1)(2011-2#1)(2012-3#1)
water maze##68##2##(1991-2#1)(1992-8#1)(1992-9#2)(1993-11#3)(1993-12#14)(1993-2#4)(1993-3#3)(1993-7#1)(1994-10#1)(1994-2#1)(1994-3#5)(1994-6#2)(1994-8#2)(1995-12#1)(1996-12#6)(1996-6#1)(1997-2#3)(2005-8#1)(2008-10#2)(2008-12#3)(2008-4#3)(2008-7#1)(2008-9#3)(2011-2#1)(2012-3#2)(2013-1#1)
water media##3##2##(1990-10#1)(1994-3#1)(2008-10#1)
water medium##5##2##(2005-11#1)(2008-10#3)(2008-3#1)
water membrane permeability##2##3##(2008-7#1)(2013-7#1)
water meniscus##2##2##(2008-2#1)(2010-4#1)
water miscible##3##2##(2008-10#3)
water mist##3##2##(1991-2#3)
water mixtures##2##2##(1990-10#1)(2008-6#1)
water mobile phase was##2##4##(2008-10#2)
water mobile phase##9##3##(2008-10#9)
water model##3##2##(1995-8#1)(2008-12#2)
water molds##3##2##(2007-7#3)
water molecule and##3##3##(1997-1#1)(1997-7#1)(2006-3#1)
water molecule from the##2##4##(1990-2#1)(2006-1#1)
water molecule in the##2##4##(1992-3#1)(1997-1#1)
water molecule in##3##3##(1992-3#1)(1995-5#1)(1997-1#1)
water molecule is##4##3##(1993-3#1)(1995-2#1)(1997-1#1)(2011-1#1)
water molecule##29##2##(1990-2#2)(1991-7#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-11#1)(1995-1#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-8#1)(1997-1#5)(1997-7#1)(2006-1#1)(2006-3#2)(2006-8#2)(2008-3#1)(2008-8#1)(2009-9#1)(2011-1#1)
water molecules and##6##3##(1996-7#1)(2008-10#2)(2009-11#1)(2009-6#1)(2012-12#1)
water molecules are located in the first solvation shell##2##9##(2006-1#2)
water molecules are##7##3##(1991-12#1)(1992-9#1)(2006-1#2)(2006-10#1)(2008-10#1)(2009-6#1)
water molecules around the##2##4##(2006-10#1)(2008-10#1)
water molecules around##4##3##(2006-10#3)(2008-10#1)
water molecules at##2##3##(1991-3#1)(2007-8#1)
water molecules in the##7##4##(1992-12#1)(1995-5#2)(2006-1#3)(2006-10#1)
water molecules in##11##3##(1992-12#1)(1995-10#1)(1995-5#2)(2006-1#3)(2006-10#3)(2008-10#1)
water molecules is##5##3##(1992-12#1)(2006-10#1)(2008-2#1)(2008-3#1)(2012-11#1)
water molecules near##2##3##(1992-9#1)(2008-2#1)
water molecules were found##2##4##(1995-6#1)(1996-7#1)
water molecules were##5##3##(1995-6#1)(1996-7#1)(1997-1#1)(2006-10#1)(2008-9#1)
water molecules which##2##3##(1991-12#1)(1997-2#1)
water molecules within a cavernous active center##2##7##(1990-7#2)
water molecules##107##2##(1990-2#1)(1990-7#2)(1991-12#2)(1991-3#1)(1992-12#3)(1992-4#1)(1992-6#1)(1992-9#3)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-10#2)(1995-11#3)(1995-3#1)(1995-5#2)(1995-6#1)(1996-11#1)(1996-2#1)(1996-7#3)(1997-1#7)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#2)(2005-11#5)(2005-4#1)(2006-1#5)(2006-10#19)(2006-12#1)(2007-3#1)(2007-8#1)(2008-10#15)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-6#2)(2010-12#1)(2011-1#1)(2012-11#1)(2012-12#1)
water movement during##2##3##(2007-12#1)(2008-10#1)
water movement##4##2##(2007-12#2)(2008-10#2)
water must be##2##3##(2008-10#1)(2011-12#1)
water near##2##2##(1992-9#1)(2008-3#1)
water obtained##2##2##(2005-11#1)(2008-10#1)
water of hydration##2##3##(1991-11#1)(2004-9#1)
water of the##4##3##(1990-2#1)(2007-5#1)(2008-10#1)(2008-5#1)
water of##28##2##(1990-2#1)(1991-11#2)(1994-5#1)(1995-11#1)(1996-11#1)(2004-9#1)(2007-10#1)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#8)(2008-2#1)(2008-3#1)(2008-5#1)(2010-9#1)(2012-12#2)(2013-7#1)(2013-8#1)
water on both sides##2##4##(1995-6#2)
water on the##5##3##(2005-11#1)(2006-10#1)(2007-1#1)(2008-10#1)(2009-6#1)
water on##23##2##(1995-5#1)(1995-6#2)(1996-5#1)(2005-11#1)(2006-10#2)(2007-1#1)(2007-9#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#1)(2009-1#1)(2009-6#1)(2010-1#1)(2010-4#1)(2010-9#1)(2012-2#2)
water onto##2##2##(1996-12#1)(2012-2#1)
water or 0##2##3##(2004-12#1)(2004-9#1)
water or food##2##3##(1992-7#1)(1994-3#1)
water or in##3##3##(1994-8#1)(2008-10#2)
water or saline##2##3##(2010-3#1)(2011-12#1)
water or##39##2##(1990-3#1)(1991-2#1)(1992-7#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#1)(1997-1#1)(2004-12#1)(2004-9#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-6#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-10#1)(2013-1#1)
water oxidation by photosystem II##2##5##(1997-6#2)
water oxidation##9##2##(1991-12#1)(1997-6#3)(2009-2#4)(2010-5#1)
water oxygen atoms##2##3##(1997-7#1)(2008-5#1)
water oxygen##5##2##(1994-8#1)(1997-7#1)(2008-5#3)
water per day##2##3##(2008-5#2)
water per##4##2##(1995-11#1)(2008-5#2)(2011-2#1)
water permeability##12##2##(1990-2#1)(1991-2#2)(1991-5#1)(1993-12#1)(1993-3#2)(1995-6#1)(2008-7#1)(2010-11#1)(2010-9#1)(2013-7#1)
water phantoms##2##2##(1996-12#1)(2012-1#1)
water phase was##2##3##(1991-5#1)(2013-8#1)
water phase##11##2##(1991-5#1)(1993-11#1)(1994-9#1)(2005-4#1)(2006-10#1)(2008-10#2)(2008-5#2)(2013-8#2)
water pollution##3##2##(2007-10#1)(2008-6#1)(2009-6#1)
water pores##2##2##(2006-10#1)(2008-10#1)
water potential of##2##3##(2008-10#1)(2013-8#1)
water potential##9##2##(2008-10#6)(2008-7#1)(2012-7#1)(2013-8#1)
water potentials##7##2##(2005-12#1)(2008-10#4)(2008-12#1)(2008-7#1)
water pretreatment##7##2##(2004-8#1)(2008-5#4)(2013-1#2)
water prior##2##2##(2005-11#1)(2008-10#1)
water properties##2##2##(2008-3#2)
water protection##2##2##(2008-5#2)
water purification##2##2##(2005-11#1)(2008-3#1)
water quality and##5##3##(2007-3#1)(2007-5#1)(2008-5#1)(2011-1#1)(2012-2#1)
water quality at##2##3##(2008-1#1)(2009-6#1)
water quality in Coimbatore##2##4##(2009-6#2)
water quality in##6##3##(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-6#2)
water quality management##3##3##(2007-10#1)(2008-1#1)(2008-5#1)
water quality of##10##3##(2008-1#2)(2008-10#2)(2008-5#1)(2013-8#5)
water quality parameters##4##3##(1996-8#1)(2007-10#1)(2011-12#1)(2013-1#1)
water quality##58##2##(1996-3#1)(1996-8#1)(2007-10#6)(2007-3#2)(2007-5#3)(2007-8#1)(2008-1#8)(2008-10#11)(2008-5#5)(2008-8#1)(2009-6#6)(2011-1#1)(2011-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#7)
water rather than##2##3##(1990-10#1)(2008-3#1)
water reference##5##2##(1993-2#1)(2007-8#1)(2008-10#3)
water regain##3##2##(2008-10#3)
water relations and##2##3##(2009-8#2)
water reorientation##2##2##(2011-1#2)
water required##2##2##(1993-4#1)(1995-3#1)
water residues##2##2##(2010-4#2)
water resistance of##4##3##(2008-5#3)(2012-12#1)
water resistance##9##2##(2008-5#5)(2012-12#4)
water resources##6##2##(2007-8#1)(2008-10#2)(2008-12#2)(2012-1#1)
water resulted in##3##3##(1991-5#1)(2005-11#1)(2013-1#1)
water retention and##2##3##(2006-10#1)(2008-2#1)
water retention##10##2##(1990-5#1)(1997-7#3)(2006-10#1)(2008-2#1)(2009-2#1)(2009-8#1)(2010-4#1)(2011-2#1)
water sac ducts are##2##4##(2007-12#2)
water sac##5##2##(2007-12#5)
water sacs##2##2##(2007-12#2)
water sample and the##2##4##(2008-10#1)(2008-2#1)
water sample and##4##3##(2008-10#3)(2008-2#1)
water sample by##2##3##(2008-10#2)
water sample containing##2##3##(2008-10#2)
water sample in##3##3##(2008-10#3)
water sample is##3##3##(2008-10#2)(2008-3#1)
water sample were##2##3##(2007-8#1)(2008-10#1)
water sample with##2##3##(2008-10#2)
water sample##49##2##(1993-9#1)(2007-8#3)(2008-10#42)(2008-2#1)(2008-3#1)(2012-2#1)
water sample)##2##2##(2008-10#2)
water samples (0##2##3##(2008-10#2)
water samples (relative standard deviation (R##2##6##(2008-10#2)
water samples (tap##3##3##(2008-10#3)
water samples after preconcentration of##2##5##(2008-10#2)
water samples after##6##3##(2008-10#6)
water samples and the##2##4##(2008-10#2)
water samples and##26##3##(2007-8#1)(2008-10#24)(2012-1#1)
water samples are described##2##4##(1990-9#1)(2008-10#1)
water samples are##6##3##(1990-9#1)(2007-8#1)(2008-10#4)
water samples as well as in##2##6##(2008-10#1)(2008-11#1)
water samples as##3##3##(2008-10#2)(2008-11#1)
water samples at##5##3##(2007-5#1)(2008-10#4)
water samples by electrothermal##2##4##(2008-10#2)
water samples by flame atomic absorption spectrometry##2##7##(2008-10#2)
water samples by flame##3##4##(2008-10#3)
water samples by flow##2##4##(2008-10#2)
water samples by inductively coupled plasma##2##6##(1996-3#1)(2008-10#1)
water samples by solid phase##2##5##(2008-10#2)
water samples by using##4##4##(2008-10#4)
water samples by##39##3##(1996-3#1)(2005-4#1)(2006-12#1)(2008-10#34)(2008-4#1)(2011-12#1)
water samples can be##2##4##(2008-10#2)
water samples collected from##4##4##(2008-10#2)(2009-6#1)(2011-12#1)
water samples collected##6##3##(2008-10#4)(2009-6#1)(2011-12#1)
water samples containing##5##3##(2008-10#5)
water samples for##3##3##(2007-10#1)(2008-10#2)
water samples from##9##3##(2008-10#8)(2010-5#1)
water samples has been developed##3##5##(2008-10#3)
water samples has been##6##4##(2008-10#6)
water samples have been##2##4##(2008-10#2)
water samples in##8##3##(2007-7#1)(2008-10#5)(2011-2#1)(2012-2#1)
water samples is described##4##4##(2008-10#4)
water samples is presented##2##4##(2008-10#2)
water samples is successful##2##4##(2008-10#2)
water samples is##15##3##(2008-10#15)
water samples obtained from##3##4##(2008-10#2)(2012-2#1)
water samples of different##2##4##(2008-10#1)(2011-1#1)
water samples of##6##3##(2007-10#1)(2008-10#3)(2011-1#1)(2011-2#1)
water samples on the##2##4##(2008-10#2)
water samples on##3##3##(2008-10#3)
water samples spiked with known##2##5##(2008-10#1)(2012-3#1)
water samples spiked with##6##4##(2008-10#4)(2011-1#1)(2012-3#1)
water samples using a##2##4##(2008-10#2)
water samples using##16##3##(1991-8#1)(2007-8#1)(2008-10#14)
water samples was also##3##4##(2008-10#3)
water samples was##19##3##(2007-8#2)(2008-10#16)(2008-5#1)
water samples were analyzed##4##4##(2005-4#1)(2008-10#3)
water samples were collected from##2##5##(2007-5#2)
water samples were collected##3##4##(2007-5#2)(2008-5#1)
water samples were demonstrated##2##4##(2008-10#2)
water samples were determined##2##4##(2007-10#1)(2008-10#1)
water samples were in##2##4##(2008-10#2)
water samples were subjected to##2##5##(2007-10#1)(2011-1#1)
water samples were##30##3##(2005-4#1)(2007-10#2)(2007-5#3)(2008-1#1)(2008-10#18)(2008-11#1)(2008-5#1)(2009-6#1)(2011-1#1)(2012-12#1)
water samples when##2##3##(2008-10#2)
water samples with a##5##4##(2008-10#5)
water samples with satisfactory results##8##5##(2007-8#1)(2008-10#7)
water samples with##23##3##(2007-8#2)(2008-10#19)(2008-3#1)(2011-1#1)
water samples##483##2##(1990-9#1)(1991-8#2)(1996-3#1)(2005-4#2)(2006-12#1)(2007-10#5)(2007-5#5)(2007-7#1)(2007-8#18)(2008-1#2)(2008-10#416)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#4)(2009-6#2)(2010-5#1)(2011-1#5)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-8#2)
water scarcity##3##2##(2009-8#1)(2012-1#1)(2012-2#1)
water seal drainage##2##3##(2007-8#2)
water seal##3##2##(2007-8#3)
water should##3##2##(1994-3#1)(2006-2#1)(2008-10#1)
water showed##7##2##(1990-2#1)(1994-2#1)(1996-3#1)(2006-2#2)(2007-10#1)(2007-9#1)
water significantly##2##2##(2008-10#1)(2010-6#1)
water sites##2##2##(1992-12#2)
water solubility and##2##3##(1995-3#1)(2008-5#1)
water solubility of##2##3##(1994-8#1)(2008-10#1)
water solubility##16##2##(1990-4#1)(1994-8#1)(1995-3#1)(2005-11#4)(2005-8#1)(2008-10#2)(2008-4#1)(2008-5#3)(2009-2#1)(2011-2#1)
water soluble PROG##2##3##(1996-9#2)
water soluble and##3##3##(2007-10#1)(2009-7#1)(2010-2#1)
water soluble contrast##2##3##(1990-11#1)(2008-3#1)
water soluble polymer##3##3##(2008-10#3)
water soluble##43##2##(1990-11#1)(1990-12#1)(1991-8#1)(1991-9#1)(1992-8#1)(1993-4#1)(1994-3#1)(1995-5#1)(1995-6#1)(1996-9#2)(1997-1#1)(2005-8#1)(2007-10#4)(2007-8#2)(2008-10#7)(2008-3#3)(2008-4#1)(2008-5#4)(2009-3#3)(2009-7#1)(2010-12#1)(2010-2#2)(2010-4#1)(2013-8#1)
water solution is##2##3##(2008-10#1)(2008-3#1)
water solution##18##2##(1990-6#1)(1991-5#1)(1993-6#3)(1995-2#1)(2005-11#1)(2008-10#6)(2008-12#2)(2008-3#2)(2013-8#1)
water solutions of##2##3##(2008-10#2)
water solutions##7##2##(1990-2#1)(2007-8#1)(2008-10#5)
water solvent##2##2##(1992-4#1)(2011-1#1)
water sorption and solubility##2##4##(2013-1#2)
water sorption and##3##3##(2008-5#1)(2013-1#2)
water sorption##8##2##(2008-5#2)(2008-8#1)(2010-3#1)(2013-1#2)(2013-8#2)
water source##5##2##(2007-7#1)(2008-10#2)(2011-12#1)(2012-3#1)
water sources and##4##3##(2007-8#1)(2012-2#3)
water sources##18##2##(2004-4#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-8#2)(2008-10#5)(2008-5#1)(2008-7#1)(2012-2#5)
water sources/sanitation##3##2##(2012-2#3)
water spiked with##4##3##(2008-10#4)
water spiked##5##2##(2008-10#5)
water splitting##3##2##(2009-2#1)(2010-7#2)
water standard##2##2##(1993-2#1)(2007-8#1)
water standards##2##2##(2008-10#1)(2009-6#1)
water storage##6##2##(2007-12#1)(2008-12#1)(2008-8#1)(2009-7#1)(2013-8#2)
water stream##6##2##(1994-6#1)(2008-10#4)(2008-5#1)
water stress in##2##3##(2008-8#1)(2012-7#1)
water stress than##2##3##(2008-5#1)(2012-7#1)
water stress##30##2##(2008-10#6)(2008-12#3)(2008-5#4)(2008-8#3)(2009-8#3)(2012-7#5)(2013-8#6)
water stress-induced ABA accumulation##4##4##(2008-8#4)
water stressed##2##2##(2004-2#1)(2007-1#1)
water structure around##2##3##(1995-8#1)(2006-10#1)
water structure is##2##3##(1995-10#1)(1995-8#1)
water structure##7##2##(1995-10#1)(1995-8#2)(2005-11#1)(2006-10#2)(2008-5#1)
water studies)##4##2##(2008-9#4)
water subjected to##2##3##(2010-5#2)
water supplemented with##2##3##(2008-11#1)(2010-12#1)
water supplies and##2##3##(1996-6#1)(2012-2#1)
water supplies in##2##3##(1992-5#1)(2007-6#1)
water supplies of##2##3##(1996-6#1)(2008-1#1)
water supplies##9##2##(1992-5#1)(1996-6#3)(2007-6#1)(2008-1#1)(2008-10#1)(2008-9#1)(2012-2#1)
water supply and##2##3##(2011-2#2)
water supply##13##2##(2006-10#2)(2006-7#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#5)
water surface##16##2##(1990-11#1)(2005-11#7)(2007-8#1)(2008-10#2)(2008-3#2)(2008-5#2)(2008-9#1)
water surfaces##2##2##(2008-2#1)(2008-3#1)
water suspensions##3##2##(2008-10#2)(2009-2#1)
water system##7##2##(1990-10#1)(2008-10#1)(2008-9#1)(2011-12#2)(2012-12#2)
water systems##12##2##(1990-10#1)(1992-5#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#3)(2010-4#1)(2011-12#2)(2012-2#1)
water tank##5##2##(1996-9#2)(2008-3#1)(2011-2#2)
water tanks##2##2##(2011-2#1)(2012-1#1)
water temperature and##2##3##(2007-2#1)(2013-8#1)
water temperature##19##2##(2007-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#3)(2010-8#4)(2011-2#1)(2012-11#1)(2013-7#3)(2013-8#2)
water temperatures##3##2##(2010-8#1)(2013-7#2)
water than##10##2##(1991-12#2)(1993-11#1)(1993-2#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)
water that is##4##3##(1994-3#1)(2006-8#1)(2008-11#1)(2010-9#1)
water that must be##2##4##(2008-5#2)
water that##9##2##(1992-12#1)(1994-3#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-9#1)(2011-2#1)
water the##2##2##(2008-2#2)
water through the##3##3##(2008-10#1)(2008-5#1)(2008-6#1)
water through##7##2##(2005-11#2)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-2#1)
water throughout##2##2##(1994-11#1)(2009-5#1)
water to 1##2##3##(1997-7#1)(2008-10#1)
water to a##2##3##(1991-6#1)(1992-1#1)
water to clusters containing##2##4##(2006-8#2)
water to form a##2##4##(1994-12#1)(2008-5#1)
water to form##3##3##(1994-12#1)(2006-3#1)(2008-5#1)
water to the##12##3##(1991-4#1)(1992-5#1)(1994-12#1)(2006-3#1)(2006-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2010-3#1)
water to##54##2##(1991-2#1)(1991-4#1)(1991-6#1)(1992-1#2)(1992-12#1)(1992-5#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-12#2)(1995-6#1)(1997-4#1)(1997-7#2)(2004-11#1)(2005-11#1)(2006-10#2)(2006-3#2)(2006-8#3)(2007-2#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-7#1)
water toxicity##4##2##(2008-10#4)
water transparency##2##2##(2008-5#1)(2011-2#1)
water transport and##3##3##(2009-8#2)(2013-1#1)
water transport properties##3##3##(2009-12#3)
water transport##13##2##(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#2)(2009-12#3)(2009-8#4)(2013-1#1)
water treatment facilities##2##3##(2008-10#1)(2013-1#1)
water treatment plant##2##3##(2008-10#1)(2013-1#1)
water treatment technologies##2##3##(2008-1#1)(2008-3#1)
water treatment##16##2##(1992-5#1)(2006-8#1)(2008-1#2)(2008-10#6)(2008-3#1)(2012-1#1)(2013-1#4)
water types##5##2##(2008-10#2)(2008-3#3)
water under##5##2##(1996-5#1)(2007-10#1)(2008-10#1)(2010-6#1)(2010-9#1)
water until##2##2##(1997-4#1)(2011-12#1)
water uptake and##2##3##(2009-8#1)(2010-8#1)
water uptake##8##2##(2005-11#2)(2007-12#1)(2008-5#3)(2009-8#1)(2010-8#1)
water use and##2##3##(2009-6#1)(2011-2#1)
water use efficiency##2##3##(2008-5#2)
water use##8##2##(2008-12#1)(2008-5#2)(2009-6#1)(2010-11#1)(2011-2#3)
water used for irrigation in##2##5##(2008-10#1)(2009-6#1)
water used for##3##3##(2008-10#1)(2008-5#1)(2009-6#1)
water used in##3##3##(1994-3#1)(2006-8#1)(2008-10#1)
water used to##2##3##(2008-10#1)(2012-3#1)
water used##10##2##(1994-3#1)(2006-8#1)(2008-10#4)(2008-5#1)(2008-6#1)(2009-6#1)(2012-3#1)
water using a##2##3##(2008-10#2)
water using##22##2##(2005-11#1)(2006-12#1)(2008-1#1)(2008-10#15)(2008-3#1)(2009-5#1)(2012-1#1)(2012-3#1)
water vapor and ammonia##2##4##(2008-3#2)
water vapor and##4##3##(2008-3#4)
water vapor are presented##2##4##(2008-3#2)
water vapor at##2##3##(2008-2#1)(2008-3#1)
water vapor in the##3##4##(2008-2#1)(2008-3#2)
water vapor in##9##3##(2008-2#3)(2008-3#6)
water vapor with##2##3##(2008-3#2)
water vapor##52##2##(1991-5#3)(1997-1#1)(2005-11#2)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#11)(2008-3#25)(2008-5#1)(2009-3#1)(2013-8#3)
water vapour##3##2##(1996-12#1)(2013-7#1)(2013-8#1)
water varies##2##2##(2008-3#1)(2013-1#1)
water velocities##2##2##(2008-10#1)(2010-8#1)
water volume##3##2##(1994-5#1)(2010-10#1)(2011-1#1)
water was added##2##3##(2008-5#2)
water was detected##2##3##(1990-5#1)(2013-8#1)
water was developed##2##3##(2008-10#2)
water was found to be##2##5##(1993-2#1)(2008-10#1)
water was found to##3##4##(1993-2#1)(2008-10#1)(2008-5#1)
water was measured by##2##4##(2008-10#1)(2010-9#1)
water was measured##4##3##(2008-10#1)(2008-2#1)(2010-8#1)(2010-9#1)
water was not##2##3##(1991-2#1)(2009-6#1)
water was studied##3##3##(2005-11#1)(2008-10#2)
water was used as the##2##5##(2008-5#1)(2008-6#1)
water was used as##4##4##(2008-1#1)(2008-12#1)(2008-5#1)(2008-6#1)
water was used##6##3##(2008-1#1)(2008-12#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-10#1)
water was##63##2##(1990-5#1)(1991-2#2)(1991-8#1)(1992-11#1)(1992-7#1)(1993-2#1)(1994-2#1)(1994-3#1)(2005-11#2)(2006-4#1)(2007-1#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#16)(2008-11#1)(2008-12#2)(2008-2#2)(2008-5#7)(2008-6#1)(2009-11#1)(2009-6#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-12#2)(2011-2#2)(2012-10#1)(2012-2#3)(2013-1#2)(2013-8#1)
water washing##2##2##(2005-11#1)(2009-3#1)
water were analyzed##2##3##(1995-6#1)(2008-10#1)
water were determined##3##3##(2006-10#1)(2008-10#1)(2008-2#1)
water were prepared##2##3##(2008-3#1)(2008-5#1)
water were##40##2##(1990-9#1)(1992-6#1)(1994-3#1)(1995-6#1)(1997-1#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#17)(2008-2#2)(2008-3#2)(2008-5#3)(2009-5#1)(2010-8#3)(2013-1#1)
water when##2##2##(1993-2#1)(2008-5#1)
water which##2##2##(2008-5#1)(2009-3#1)
water with a##6##3##(2005-11#1)(2008-10#4)(2008-3#1)
water with an##2##3##(1997-1#1)(2008-5#1)
water with high##2##3##(2008-10#1)(2012-2#1)
water with low##2##3##(2008-10#2)
water with satisfactory results##8##4##(2008-10#8)
water with the##4##3##(1996-6#2)(2006-10#1)(2008-10#1)
water with##61##2##(1990-9#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-6#2)(1997-1#1)(1997-3#1)(1997-8#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-1#2)(2008-10#28)(2008-2#2)(2008-3#2)(2008-5#4)(2009-7#1)(2011-1#1)(2012-1#1)(2012-2#2)
water within##3##2##(1995-11#1)(2008-2#1)(2008-5#1)
water without##4##2##(2008-10#2)(2010-2#1)(2012-2#1)
water would be##2##3##(1996-4#1)(2008-10#1)
water##5006##1##(1990-10#10)(1990-11#3)(1990-12#3)(1990-2#15)(1990-3#2)(1990-4#4)(1990-5#6)(1990-6#2)(1990-7#12)(1990-8#8)(1990-9#8)(1991-1#1)(1991-10#3)(1991-11#11)(1991-12#7)(1991-2#28)(1991-3#10)(1991-4#5)(1991-5#13)(1991-6#6)(1991-7#2)(1991-8#10)(1991-9#2)(1992-1#9)(1992-11#8)(1992-12#21)(1992-2#5)(1992-3#2)(1992-4#3)(1992-5#10)(1992-6#7)(1992-7#9)(1992-8#6)(1992-9#15)(1993-11#11)(1993-12#22)(1993-2#25)(1993-3#9)(1993-4#6)(1993-5#5)(1993-6#6)(1993-7#9)(1993-8#2)(1993-9#7)(1994-10#5)(1994-11#4)(1994-12#5)(1994-2#4)(1994-3#27)(1994-5#3)(1994-6#4)(1994-8#14)(1994-9#6)(1995-1#10)(1995-10#5)(1995-11#11)(1995-12#4)(1995-2#10)(1995-3#14)(1995-4#2)(1995-5#24)(1995-6#9)(1995-7#6)(1995-8#8)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#10)(1996-12#17)(1996-2#11)(1996-3#12)(1996-4#3)(1996-5#9)(1996-6#10)(1996-7#3)(1996-8#16)(1996-9#8)(1997-1#23)(1997-2#14)(1997-3#6)(1997-4#11)(1997-5#7)(1997-6#12)(1997-7#14)(1997-8#10)(2004-11#4)(2004-12#4)(2004-2#1)(2004-4#8)(2004-8#4)(2004-9#13)(2005-10#12)(2005-11#132)(2005-12#9)(2005-4#16)(2005-7#2)(2005-8#9)(2005-9#2)(2006-1#7)(2006-10#94)(2006-11#2)(2006-12#12)(2006-2#8)(2006-3#11)(2006-4#4)(2006-5#5)(2006-6#2)(2006-7#3)(2006-8#32)(2007-1#15)(2007-10#57)(2007-11#20)(2007-12#40)(2007-2#19)(2007-3#17)(2007-4#5)(2007-5#34)(2007-6#6)(2007-7#22)(2007-8#83)(2007-9#18)(2008-1#42)(2008-10#1693)(2008-11#49)(2008-12#51)(2008-2#140)(2008-3#175)(2008-4#28)(2008-5#332)(2008-6#21)(2008-7#45)(2008-8#30)(2008-9#70)(2009-1#1)(2009-10#8)(2009-11#7)(2009-12#6)(2009-2#14)(2009-3#10)(2009-4#4)(2009-5#17)(2009-6#34)(2009-7#9)(2009-8#26)(2009-9#5)(2010-1#4)(2010-10#2)(2010-11#3)(2010-12#15)(2010-2#34)(2010-3#16)(2010-4#47)(2010-5#16)(2010-6#4)(2010-7#8)(2010-8#40)(2010-9#13)(2011-1#57)(2011-12#40)(2011-2#65)(2011-3#1)(2012-1#22)(2012-10#2)(2012-11#4)(2012-12#38)(2012-2#58)(2012-3#32)(2012-5#7)(2012-6#1)(2012-7#9)(2012-8#3)(2012-9#2)(2013-1#63)(2013-7#29)(2013-8#78)
water&quot##6##1##(2005-6#1)(2008-10#3)(2008-5#1)(2009-4#1)
water) and##7##2##(1991-5#1)(1992-2#1)(2008-10#2)(2010-10#1)(2011-1#1)(2012-12#1)
water) by##2##2##(2008-10#1)(2008-5#1)
water) to##2##2##(1995-11#1)(2008-10#1)
water) was##2##2##(2008-10#2)
water) were##2##2##(1996-10#1)(2006-8#1)
water) with##2##2##(2008-10#1)(2008-2#1)
water)##57##1##(1990-7#1)(1990-8#1)(1991-5#1)(1991-9#1)(1992-2#1)(1993-12#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-10#1)(1996-12#1)(1996-2#1)(2005-12#1)(2006-8#2)(2007-7#1)(2008-10#22)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
water-##3##1##(2008-10#3)
water-accessible nonpolar surface area##3##4##(1991-4#3)
water-accessible nonpolar surface##4##3##(1991-4#4)
water-accessible surface##2##2##(1992-4#1)(1992-5#1)
water-accessible##7##1##(1991-11#1)(1991-4#4)(1992-4#1)(1992-5#1)
water-acetonitrile##2##1##(2008-10#1)(2013-1#1)
water-air interface##2##2##(2005-11#1)(2012-11#1)
water-alcohol##3##1##(2005-11#2)(2008-10#1)
water-assisted##2##1##(2008-7#2)
water-based##5##1##(2007-11#1)(2008-10#1)(2010-5#1)(2011-2#1)(2013-1#1)
water-bath and##2##2##(2008-10#1)(2008-12#1)
water-bath##4##1##(2008-10#2)(2008-12#2)
water-borne##6##1##(1994-3#1)(2008-10#1)(2008-8#1)(2011-1#2)(2012-12#1)
water-contact##3##1##(2008-8#3)
water-contacts##2##1##(2008-8#2)
water-containing##3##1##(2007-8#1)(2008-10#1)(2013-8#1)
water-cooled##7##1##(2006-4#2)(2008-10#1)(2008-2#2)(2008-3#2)
water-deprived##2##1##(1996-8#2)
water-drinking##2##1##(2004-11#2)
water-electrolyte imbalance##2##2##(2013-8#2)
water-electrolyte##4##1##(2008-8#2)(2013-8#2)
water-equivalent##3##1##(2008-3#2)(2009-10#1)
water-ethanol##5##1##(2008-10#2)(2008-3#1)(2008-4#2)
water-filled##6##1##(1995-1#1)(2006-10#1)(2007-4#1)(2008-10#2)(2012-1#1)
water-hammer##2##1##(1991-5#1)(2008-11#1)
water-holding capacity (WHC)##3##3##(2010-4#2)(2011-2#1)
water-holding##5##1##(2004-11#2)(2010-4#2)(2011-2#1)
water-ice films##3##2##(2008-2#3)
water-immersion lenses##2##2##(2008-3#2)
water-immersion objective##2##2##(2008-3#2)
water-immersion##6##1##(2008-3#5)(2008-5#1)
water-immiscible##3##1##(1994-3#1)(2006-12#1)(2008-10#1)
water-in-oil (W/O)##2##2##(2005-11#1)(2008-10#1)
water-in-oil emulsion of##2##3##(1992-8#1)(2008-11#1)
water-in-oil emulsion##6##2##(1992-8#1)(2004-12#1)(2008-10#2)(2008-11#1)(2012-2#1)
water-in-oil microemulsion##6##2##(2005-11#1)(2008-10#2)(2008-5#2)(2010-1#1)
water-in-oil##16##1##(1992-8#1)(2004-12#1)(2005-11#3)(2008-10#5)(2008-11#1)(2008-5#3)(2010-1#1)(2012-2#1)
water-insoluble Curdlan fraction##2##3##(2007-8#2)
water-insoluble Curdlan were##2##3##(2007-8#2)
water-insoluble Curdlan##6##2##(2007-8#6)
water-insoluble##25##1##(1992-9#1)(1994-3#1)(1995-12#2)(1996-5#1)(1997-8#1)(2006-11#1)(2007-8#7)(2008-10#5)(2008-5#3)(2008-6#1)(2010-6#1)(2011-2#1)
water-leaving radiance and##2##3##(2008-3#2)
water-leaving radiance in##3##3##(2008-3#3)
water-leaving radiance##14##2##(2008-2#3)(2008-3#11)
water-leaving radiances##11##2##(2008-2#2)(2008-3#9)
water-leaving reflectance##9##2##(2008-2#5)(2008-3#4)
water-leaving##35##1##(2008-2#11)(2008-3#24)
water-maze task##3##2##(1994-8#3)
water-maze##8##1##(1993-3#1)(1994-11#1)(1994-8#4)(1996-12#1)(2008-7#1)
water-mediated and polar##2##3##(1997-1#2)
water-mediated##4##1##(1994-3#1)(1996-7#1)(1997-1#2)
water-methanol##2##1##(2005-11#1)(2012-1#1)
water-microemulsion-oil systems##2##2##(2008-10#2)
water-miscible##3##1##(2008-10#2)(2010-12#1)
water-only##2##1##(2008-10#2)
water-organic##3##1##(2005-11#1)(2008-10#2)
water-oxidation complex##3##2##(1990-5#2)(2009-2#1)
water-oxidizing##4##1##(1990-5#2)(1994-8#1)(1997-7#1)
water-polymer&quot##2##1##(2013-1#2)
water-purification systems##2##2##(1994-3#2)
water-purification##3##1##(1994-3#3)
water-resistance of##2##2##(2008-5#2)
water-resistance##4##1##(2008-5#4)
water-resistant##4##1##(2008-5#1)(2008-9#1)(2012-11#2)
water-soaked lesions on##2##3##(2008-10#2)
water-soaked##5##1##(2008-10#5)
water-soaking##3##1##(2008-10#2)(2008-12#1)
water-solubility##2##1##(1994-12#1)(2009-12#1)
water-solubilized##2##1##(2010-4#1)(2010-7#1)
water-soluble [(MGD)2-Fe(2+)-NO] complex##2##3##(1993-9#1)(1994-5#1)
water-soluble and##3##2##(1992-4#1)(2005-11#1)(2008-10#1)
water-soluble antioxidant##5##2##(1992-9#1)(1993-2#1)(2006-12#1)(2008-10#1)(2010-8#1)
water-soluble antioxidants##2##2##(2005-8#1)(2007-8#1)
water-soluble calixarenes##2##2##(2008-10#2)
water-soluble carbodiimide##2##2##(1996-10#1)(1997-2#1)
water-soluble complex##2##2##(2008-10#1)(2008-3#1)
water-soluble conjugates of BaP 7##2##5##(1992-2#2)
water-soluble conjugates##4##2##(1992-2#3)(1992-3#1)
water-soluble contrast##2##2##(1993-10#1)(2006-8#1)
water-soluble fraction of##7##3##(1990-11#1)(2006-8#1)(2007-8#2)(2008-11#3)
water-soluble fraction##11##2##(1990-11#2)(1991-9#1)(2006-8#1)(2007-8#2)(2008-11#5)
water-soluble organic compounds##2##3##(2008-10#2)
water-soluble organic##5##2##(2008-10#5)
water-soluble polymer##6##2##(2008-10#3)(2008-7#2)(2012-2#1)
water-soluble polymers##6##2##(1991-11#1)(2005-11#1)(2008-10#3)(2009-3#1)
water-soluble porphyrin##4##2##(2007-11#1)(2008-10#3)
water-soluble protein##2##2##(1990-9#1)(1994-2#1)
water-soluble proteins##5##2##(1990-9#4)(1995-12#1)
water-soluble substrate##2##2##(1990-4#1)(1995-10#1)
water-soluble tertiary amines##2##3##(2008-10#2)
water-soluble trace metal fraction##2##4##(2007-8#2)
water-soluble trace metal##4##3##(2007-8#4)
water-soluble vitamin##3##2##(2006-10#1)(2008-12#1)(2009-9#1)
water-soluble vitamins excreted in human urine##2##6##(2008-10#2)
water-soluble vitamins excreted in##3##4##(2008-10#3)
water-soluble vitamins##10##2##(2006-10#1)(2008-10#9)
water-soluble##188##1##(1990-11#3)(1990-12#1)(1990-2#4)(1990-4#3)(1990-8#1)(1990-9#5)(1991-1#1)(1991-11#1)(1991-2#2)(1991-3#3)(1991-5#2)(1991-7#1)(1991-9#1)(1992-2#3)(1992-3#4)(1992-4#2)(1992-7#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#2)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#4)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-10#1)(1996-2#2)(1996-4#1)(1996-5#2)(1997-2#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#5)(2005-8#1)(2006-10#2)(2006-12#2)(2006-8#3)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#11)(2008-10#46)(2008-11#6)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#8)(2008-7#2)(2008-9#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#1)
water-specific##3##1##(2012-12#3)
water-temperature sensors##2##2##(2008-3#2)
water-transporting##2##1##(1993-3#2)
water-treated##3##1##(2008-10#3)
water-vapor absorption band##2##3##(2008-2#1)(2008-3#1)
water-vapor and temperature##3##3##(2008-2#3)
water-vapor and##4##2##(2008-2#4)
water-vapor concentration##2##2##(2008-3#2)
water-vapor differential absorption lidar##2##4##(2008-3#2)
water-vapor lidar##3##2##(2008-3#3)
water-vapor measurements by##4##3##(2008-2#1)(2008-3#3)
water-vapor measurements with##2##3##(2008-2#2)
water-vapor measurements##8##2##(2008-2#3)(2008-3#5)
water-vapor mixing ratio##6##3##(2008-3#6)
water-vapor mixing##7##2##(2008-3#7)
water-vapor profiles##4##2##(2008-2#1)(2008-3#3)
water-vapor retrievals##3##2##(2008-2#3)
water-vapor values##2##2##(2008-2#2)
water-vapor##62##1##(2007-12#1)(2008-2#23)(2008-3#38)
water-window##3##1##(2007-12#2)(2008-3#1)
water/acetonitrile##3##1##(2008-10#3)
water/ethanol mixtures##2##2##(2005-11#2)
water/ethanol##3##1##(2005-11#3)
water/methanol##3##1##(2008-10#2)(2008-4#1)
water/oil##2##1##(2008-5#1)(2010-4#1)
water/toluene-diluted##2##1##(2005-11#2)
water]##7##1##(1992-11#1)(1993-11#1)(1996-2#1)(1997-4#1)(2005-4#2)(2013-8#1)
waterbath##2##1##(1994-6#1)(1995-12#1)
waterbirth##3##1##(2007-2#3)
waterbodies##2##1##(2008-5#2)
waterborne##14##1##(1995-5#1)(1996-6#1)(2004-4#2)(2007-10#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-3#1)(2010-4#2)(2010-8#1)
watered##5##1##(2004-4#2)(2008-10#3)
waterfowl##3##1##(2005-9#1)(2008-5#2)
watergrass##2##1##(2008-10#2)
watering##9##1##(2004-4#4)(2006-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2012-2#1)
watermark is##2##2##(2008-2#2)
watermark##4##1##(2008-2#4)
watermarking method##2##2##(2008-2#2)
watermarking methods##2##2##(2008-2#2)
watermarking##13##1##(2008-2#11)(2010-8#2)
watermelon (Citrullus##2##2##(1993-12#1)(2008-10#1)
watermelon and##3##2##(2008-10#3)
watermelon blossoms##2##2##(2008-10#2)
watermelon cultivars##3##2##(2008-10#3)
watermelon fruit##2##2##(2008-10#2)
watermelon plants##2##2##(2008-10#2)
watermelon silver mottle virus##2##4##(2008-10#2)
watermelon##35##1##(1993-12#3)(2008-10#30)(2010-8#2)
waterpipe smoking##2##2##(2013-1#2)
waterpipe##5##1##(2010-2#1)(2013-1#4)
waterproofing##4##1##(2009-5#1)(2012-12#2)(2012-3#1)
waters after##3##2##(2008-10#2)(2009-6#1)
waters and a##2##3##(2008-2#2)
waters and the##3##3##(1994-6#1)(2008-10#2)
waters and##47##2##(1992-12#1)(1994-6#1)(2005-11#1)(2006-12#1)(2007-8#2)(2008-10#33)(2008-2#2)(2008-3#2)(2008-9#1)(2009-6#1)(2010-8#1)(2013-1#1)
waters are##7##2##(1992-12#2)(2007-5#1)(2007-8#1)(2008-10#2)(2008-9#1)
waters as well as in##2##5##(2008-10#1)(2008-12#1)
waters as well as##3##4##(2008-10#2)(2008-12#1)
waters based on##6##3##(2007-5#1)(2007-8#1)(2008-10#3)(2008-3#1)
waters by electrothermal atomic absorption spectrometry##2##6##(2008-10#2)
waters by electrothermal##3##3##(2008-10#3)
waters by flow##2##3##(2007-8#1)(2008-10#1)
waters by the##6##3##(2008-10#5)(2013-1#1)
waters by use of##2##4##(2008-10#1)(2008-3#1)
waters by##32##2##(2007-8#1)(2008-10#27)(2008-3#3)(2013-1#1)
waters can be##2##3##(2008-10#1)(2008-3#1)
waters can##3##2##(2008-10#2)(2008-3#1)
waters containing##3##2##(2008-10#3)
waters dominated by##2##3##(2008-3#2)
waters from the##2##3##(2008-10#1)(2008-3#1)
waters from##4##2##(2008-10#3)(2008-3#1)
waters has been determined##2##4##(2008-10#2)
waters has been developed##2##4##(2008-10#2)
waters has been##5##3##(1993-9#1)(2008-10#4)
waters have##2##2##(2005-4#1)(2013-8#1)
waters in the##4##3##(2007-5#1)(2008-10#1)(2008-4#1)(2011-12#1)
waters in##8##2##(2006-12#1)(2007-3#1)(2007-5#1)(2008-10#2)(2008-4#1)(2011-12#1)(2013-8#1)
waters is described##5##3##(2008-10#5)
waters is presented##2##3##(2007-8#1)(2008-10#1)
waters is proposed##3##3##(2008-10#2)(2008-3#1)
waters is##15##2##(2007-3#1)(2007-8#1)(2008-10#10)(2008-2#2)(2008-3#1)
waters of the##11##3##(1991-11#1)(2007-3#1)(2007-5#2)(2008-10#3)(2008-5#1)(2009-12#1)(2010-5#1)(2011-12#1)
waters of##23##2##(1990-11#1)(1991-11#1)(1997-1#1)(2007-3#1)(2007-5#5)(2007-7#1)(2008-10#5)(2008-5#2)(2009-12#1)(2010-5#1)(2011-12#1)(2012-11#2)(2012-2#1)
waters on##2##2##(1990-10#1)(2008-10#1)
waters samples##4##2##(2008-10#4)
waters that##3##2##(2007-3#1)(2008-5#1)(2009-6#1)
waters to##2##2##(2008-10#2)
waters using a##3##3##(2008-10#3)
waters using##15##2##(2008-10#14)(2010-4#1)
waters was also##2##3##(2008-10#2)
waters was##4##2##(2007-8#1)(2008-10#2)(2011-12#1)
waters were analyzed##2##3##(2006-3#1)(2008-10#1)
waters were determined##2##3##(2008-10#2)
waters were##11##2##(2006-3#1)(2007-10#1)(2007-8#1)(2008-10#6)(2008-3#1)(2009-6#1)
waters with an##2##3##(2008-10#1)(2008-2#1)
waters with arbitrary##2##3##(2008-2#2)
waters with the##2##3##(2008-10#2)
waters with##19##2##(2007-8#1)(2008-10#11)(2008-2#3)(2008-3#2)(2010-8#1)(2013-8#1)
waters without##2##2##(2008-10#2)
waters##462##1##(1990-10#1)(1990-11#1)(1991-11#3)(1992-12#4)(1993-9#2)(1994-11#1)(1994-6#1)(1994-8#1)(1995-1#1)(1996-11#1)(1996-8#1)(1997-1#2)(2004-4#3)(2005-11#2)(2005-4#1)(2006-10#1)(2006-12#2)(2006-3#2)(2006-5#1)(2006-8#1)(2007-10#3)(2007-3#9)(2007-5#12)(2007-7#3)(2007-8#15)(2007-9#1)(2008-1#1)(2008-10#268)(2008-11#1)(2008-12#4)(2008-2#28)(2008-3#34)(2008-4#1)(2008-5#9)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#2)(2009-4#1)(2009-6#6)(2010-4#1)(2010-5#1)(2010-8#6)(2011-12#4)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#6)
waters)##8##1##(2008-1#1)(2008-10#6)(2008-5#1)
watershed management##2##2##(2008-10#2)
watershed segmentation##2##2##(2008-2#2)
watershed transform is##3##3##(2008-2#3)
watershed transform##5##2##(2008-2#5)
watershed zones##2##2##(2010-12#1)(2013-1#1)
watershed##26##1##(2006-5#1)(2006-7#2)(2008-1#1)(2008-10#3)(2008-2#13)(2008-5#2)(2008-9#1)(2009-4#1)(2010-12#1)(2013-1#1)
watersheds##4##1##(2007-5#1)(2008-1#1)(2008-5#1)(2013-7#1)
watertight dural closure##2##3##(2012-3#1)(2013-8#1)
watertight##4##1##(2012-3#2)(2013-8#2)
waterways##2##1##(2008-10#1)(2013-1#1)
watery diarrhea##5##2##(1993-7#1)(1993-8#1)(1996-3#1)(2007-8#1)(2008-4#1)
watery diarrhoea##4##2##(1994-4#1)(2008-1#1)(2008-3#2)
watery##17##1##(1993-7#1)(1993-8#1)(1994-4#1)(1996-3#1)(1997-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#3)(2008-4#1)(2008-5#2)(2009-4#1)(2011-1#1)(2012-3#1)
watts##3##1##(2007-12#1)(2008-1#1)(2008-2#1)
wave UV-light##2##2##(1991-6#2)
wave aberration##5##2##(2007-12#3)(2008-2#2)
wave aberrations##2##2##(2007-12#1)(2008-3#1)
wave action##2##2##(2006-1#1)(2011-2#1)
wave activity##8##2##(1990-3#1)(1991-2#1)(1992-9#1)(1995-9#1)(1996-1#2)(2008-3#1)(2008-7#1)
wave adsorptive stripping voltammetric##2##4##(2008-10#2)
wave adsorptive stripping##9##3##(2008-10#9)
wave amplification##2##2##(2007-12#1)(2008-3#1)
wave amplitudes##2##2##(1991-9#1)(2008-3#1)
wave analysis##4##2##(2007-11#1)(2008-3#1)(2009-5#1)(2013-8#1)
wave and its##2##3##(2008-10#1)(2009-5#1)
wave and the##6##3##(2007-11#1)(2008-3#5)
wave and##30##2##(1990-8#1)(1992-10#1)(1996-1#1)(2006-6#1)(2007-11#3)(2007-12#3)(2008-10#4)(2008-2#3)(2008-3#8)(2009-5#1)(2010-1#2)(2011-1#2)
wave at -0##2##3##(2008-10#2)
wave at the##4##3##(2007-12#3)(2008-10#1)
wave at##9##2##(2007-12#4)(2008-1#1)(2008-10#4)
wave band##4##2##(2008-2#1)(2008-3#2)(2013-7#1)
wave bands##2##2##(2008-12#1)(2008-2#1)
wave behavior##2##2##(1995-9#1)(2007-12#1)
wave biosensors##3##2##(2008-1#1)(2009-3#2)
wave blocking##2##2##(2009-8#2)
wave by a##3##3##(2008-2#1)(2009-10#2)
wave by##6##2##(2007-12#2)(2008-10#1)(2008-2#1)(2009-10#2)
wave characteristics##2##2##(2008-10#1)(2008-2#1)
wave condition##2##2##(2008-3#2)
wave could##2##2##(2011-1#1)(2011-2#1)
wave coupling##2##2##(2007-12#1)(2008-3#1)
wave detection##5##2##(2008-1#1)(2008-10#2)(2009-5#2)
wave detector##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
wave equation and##2##3##(2007-12#1)(2008-2#1)
wave equation##9##2##(2007-12#2)(2008-2#3)(2008-3#3)(2013-7#1)
wave exposure##2##2##(2008-5#2)
wave field##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
wave fields##12##2##(2007-11#4)(2007-12#6)(2008-2#1)(2008-3#1)
wave for##5##2##(2006-5#3)(2007-12#2)
wave front and##2##3##(2008-3#2)
wave front are##3##3##(2008-2#2)(2008-3#1)
wave front at a##2##4##(2008-3#2)
wave front at##4##3##(2008-3#4)
wave front can be##5##4##(2007-12#1)(2008-2#3)(2008-3#1)
wave front from##4##3##(2007-12#2)(2008-3#2)
wave front in the##2##4##(2008-2#1)(2008-3#1)
wave front in##3##3##(2008-2#1)(2008-3#2)
wave front is reconstructed from##2##5##(2008-3#2)
wave front is reconstructed##3##4##(2007-12#1)(2008-3#2)
wave front is then reconstructed##2##5##(2008-3#2)
wave front is##10##3##(2007-12#1)(2008-2#3)(2008-3#6)
wave front of the##2##4##(2008-3#2)
wave front of##4##3##(1995-10#1)(2007-12#1)(2008-3#2)
wave front under study##2##4##(2008-3#2)
wave front under test##4##4##(2008-3#4)
wave front under##7##3##(2008-3#7)
wave front was##3##3##(2008-2#2)(2008-3#1)
wave front with a##2##4##(2007-12#1)(2008-3#1)
wave front with##3##3##(2007-12#1)(2008-3#2)
wave front##95##2##(1990-3#1)(1995-10#1)(2007-12#16)(2008-2#29)(2008-3#48)
wave fronts are##2##3##(2007-12#1)(2008-2#1)
wave fronts can be##3##4##(2008-2#1)(2008-3#2)
wave fronts of##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
wave fronts that##2##3##(2008-3#2)
wave fronts with##4##3##(2008-2#2)(2008-3#2)
wave fronts##46##2##(2007-11#5)(2007-12#9)(2008-2#11)(2008-3#21)
wave function##7##2##(1993-8#1)(1995-7#1)(2006-10#1)(2008-2#1)(2012-1#1)(2012-12#2)
wave functions##10##2##(1991-5#1)(1992-6#1)(1994-5#1)(1995-2#1)(1995-7#1)(2008-11#1)(2008-2#2)(2012-1#1)(2012-2#1)
wave generated by##3##3##(2007-12#1)(2008-3#1)(2009-1#1)
wave generated##4##2##(2007-12#1)(2008-3#1)(2009-1#1)(2009-5#1)
wave generation##4##2##(2005-11#1)(2007-11#2)(2007-12#1)
wave in a##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
wave in an##2##3##(2007-12#1)(2008-3#1)
wave in the##8##3##(1992-8#1)(1993-8#1)(1996-3#1)(2008-1#1)(2008-2#1)(2008-3#3)
wave in##20##2##(1992-8#1)(1993-8#1)(1996-3#1)(2006-5#2)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#6)(2008-5#1)
wave interference##2##2##(2008-3#1)(2008-5#1)
wave into##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
wave is calculated##2##3##(2008-2#1)(2008-3#1)
wave is##26##2##(1995-6#1)(2007-11#5)(2007-12#5)(2008-1#1)(2008-10#2)(2008-2#4)(2008-3#7)(2008-5#1)
wave laser##3##2##(2008-5#2)(2011-1#1)
wave lasted for##3##3##(2011-1#3)
wave lasted##4##2##(2011-1#4)
wave length##3##2##(1994-6#1)(1996-11#1)(2007-8#1)
wave light##2##2##(2005-11#1)(2008-2#1)
wave lithotripsy##18##2##(1990-11#1)(1990-8#1)(1991-12#1)(1993-2#1)(1996-12#2)(2006-9#2)(2007-10#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#1)(2009-5#2)(2011-2#1)(2012-12#1)(2013-1#1)
wave mixing in##4##3##(2007-11#1)(2007-12#2)(2008-1#1)
wave mixing##14##2##(2007-11#2)(2007-12#8)(2008-1#2)(2009-7#2)
wave mode##3##2##(1996-1#1)(2008-10#1)(2008-3#1)
wave modes##4##2##(2007-11#3)(2009-6#1)
wave nature##2##2##(2007-11#1)(2008-7#1)
wave near the##2##3##(2007-11#1)(2007-12#1)
wave number##5##2##(2007-12#3)(2008-2#2)
wave numbers##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
wave numbers)##2##2##(1995-3#1)(2008-2#1)
wave of a##5##3##(2006-4#1)(2007-12#2)(2008-7#1)(2010-5#1)
wave of the##11##3##(1991-5#2)(1992-3#1)(1995-6#1)(1996-12#1)(1997-3#1)(2007-12#1)(2007-3#1)(2008-10#2)(2010-11#1)
wave of##42##2##(1991-12#2)(1991-5#2)(1992-3#1)(1993-6#2)(1994-3#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-5#1)(1997-3#1)(2006-4#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-7#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#2)
wave on the##4##3##(2007-12#1)(2008-3#2)(2011-1#1)
wave on##6##2##(2007-12#1)(2008-2#1)(2008-3#2)(2011-1#2)
wave optics##2##2##(2008-2#1)(2008-3#1)
wave over the##2##3##(2007-11#1)(2008-10#1)
wave packets##5##2##(1995-11#1)(1995-7#1)(2007-12#2)(2008-11#1)
wave pattern##5##2##(1992-9#1)(2008-2#1)(2011-2#3)
wave patterns##5##2##(1995-10#1)(2007-12#1)(2008-2#2)(2011-2#1)
wave plate and##2##3##(2007-12#1)(2008-3#1)
wave plate##5##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
wave polarization##2##2##(2007-11#1)(2008-3#1)
wave power##3##2##(2007-11#2)(2008-3#1)
wave propagating through##2##3##(2007-11#1)(2007-12#1)
wave propagating##4##2##(2006-5#1)(2007-11#2)(2007-12#1)
wave propagation and the##2##4##(2007-9#1)(2008-7#1)
wave propagation in a##3##4##(1995-8#1)(2007-11#1)(2008-3#1)
wave propagation in the##3##4##(2006-2#1)(2008-3#1)(2009-7#1)
wave propagation in##11##3##(1995-8#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-7#1)(2009-8#1)
wave propagation through##3##3##(2007-12#2)(2008-2#1)
wave propagation##26##2##(1990-3#1)(1995-8#1)(1995-9#1)(2004-9#2)(2006-2#1)(2007-11#1)(2007-12#4)(2007-9#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-7#3)(2009-7#1)(2009-8#1)
wave reflection##2##2##(2009-1#1)(2010-7#1)
wave sleep##7##2##(1990-11#1)(1990-7#1)(1996-1#1)(1996-3#3)(2004-11#1)
wave solutions##2##2##(1990-3#1)(2007-9#1)
wave spectroscopy##2##2##(2008-10#1)(2008-3#1)
wave speed##3##2##(1990-3#1)(2008-2#1)(2008-8#1)
wave that is incident upon a##2##6##(2007-11#1)(2007-12#1)
wave that is##8##3##(2007-11#3)(2007-12#1)(2008-3#2)(2008-7#1)(2009-1#1)
wave that##12##2##(2005-8#1)(2007-11#4)(2007-12#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-1#1)
wave theory##7##2##(2007-12#1)(2008-2#1)(2008-3#5)
wave through a##3##3##(2007-11#1)(2008-3#1)(2009-10#1)
wave to##8##2##(2007-11#1)(2007-9#2)(2008-1#1)(2008-2#1)(2008-3#2)(2008-4#1)
wave transit time##2##3##(2008-3#2)
wave treatment##2##2##(2012-12#2)
wave upon##2##2##(2007-12#1)(2008-3#1)
wave variables##2##2##(1996-8#2)
wave vector##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
wave vectors##5##2##(2008-2#3)(2008-3#2)
wave velocity##5##2##(2007-10#2)(2010-12#1)(2013-3#1)(2013-7#1)
wave voltammetry##31##2##(2007-8#1)(2008-10#28)(2008-8#2)
wave was##9##2##(1995-11#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)
wave were##3##2##(2007-12#1)(2008-5#1)(2011-2#1)
wave with a##2##3##(2008-3#2)
wave with an##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
wave with##10##2##(2006-5#1)(2007-12#1)(2008-1#2)(2008-2#1)(2008-3#5)
wave##1000##1##(1990-11#2)(1990-3#6)(1990-5#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#2)(1991-12#5)(1991-2#1)(1991-3#5)(1991-5#3)(1991-6#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#3)(1993-8#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-10#2)(1995-11#3)(1995-2#1)(1995-3#2)(1995-6#4)(1995-7#3)(1995-8#3)(1995-9#4)(1996-1#8)(1996-11#1)(1996-12#3)(1996-3#5)(1996-5#2)(1996-6#4)(1996-8#3)(1997-3#2)(1997-6#2)(2004-11#1)(2004-9#2)(2005-11#3)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#4)(2006-2#1)(2006-4#2)(2006-5#8)(2006-6#1)(2006-8#5)(2006-9#4)(2007-1#1)(2007-10#3)(2007-11#70)(2007-12#133)(2007-2#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#6)(2007-9#10)(2008-1#20)(2008-10#131)(2008-11#11)(2008-12#1)(2008-2#114)(2008-3#196)(2008-4#2)(2008-5#13)(2008-7#14)(2008-8#7)(2008-9#3)(2009-1#5)(2009-10#4)(2009-2#2)(2009-3#5)(2009-5#7)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#3)(2010-1#2)(2010-11#1)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#4)(2011-1#17)(2011-12#2)(2011-2#16)(2012-1#2)(2012-12#9)(2012-2#4)(2012-3#4)(2013-1#1)(2013-3#1)(2013-7#3)(2013-8#6)
wave&quot##4##1##(1995-2#1)(2006-7#1)(2008-4#1)(2011-1#1)
wave's##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
wave) and##2##2##(2007-12#1)(2008-2#1)
wave)##3##1##(2007-12#1)(2007-7#1)(2008-2#1)
wave-aberration##2##1##(2007-12#1)(2008-3#1)
wave-front aberration##8##2##(2007-12#2)(2008-2#3)(2008-3#3)
wave-front aberrations of##3##3##(2008-2#3)
wave-front aberrations##13##2##(2007-11#1)(2008-2#8)(2008-3#4)
wave-front coding##4##2##(2008-2#2)(2008-3#2)
wave-front correction by##2##3##(2007-12#1)(2008-3#1)
wave-front correction##10##2##(2007-11#1)(2007-12#6)(2008-2#2)(2008-3#1)
wave-front corrector##5##2##(2007-11#1)(2007-12#3)(2008-2#1)
wave-front curvature of the##2##4##(2007-12#2)
wave-front curvature##5##2##(2007-12#3)(2008-3#2)
wave-front deformation##4##2##(2008-2#1)(2008-3#3)
wave-front dislocations##3##2##(2007-11#1)(2007-12#2)
wave-front distortion##6##2##(2007-11#2)(2007-12#1)(2008-2#3)
wave-front distortions##5##2##(2007-11#2)(2007-12#1)(2008-3#2)
wave-front error##4##2##(2008-2#4)
wave-front errors##3##2##(2008-2#1)(2008-3#2)
wave-front generation##7##2##(2007-12#4)(2008-3#3)
wave-front gradients##2##2##(2007-12#2)
wave-front measurement##2##2##(2008-2#1)(2008-3#1)
wave-front measurements##5##2##(2007-11#1)(2007-12#3)(2008-2#1)
wave-front phase distortion##2##3##(2007-11#1)(2008-2#1)
wave-front phase##6##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
wave-front quality##3##2##(2007-12#1)(2008-3#2)
wave-front reconstruction algorithm##2##3##(2008-2#1)(2008-3#1)
wave-front reconstruction##11##2##(2007-12#1)(2008-2#1)(2008-3#9)
wave-front scanner##3##2##(2007-12#1)(2008-3#2)
wave-front sensing with##2##3##(2008-3#2)
wave-front sensing##15##2##(2007-11#3)(2007-12#3)(2008-2#5)(2008-3#4)
wave-front sensor and a##2##4##(2007-12#1)(2008-3#1)
wave-front sensor is##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
wave-front sensor to##2##3##(2007-12#1)(2008-3#1)
wave-front sensor##34##2##(2007-11#1)(2007-12#16)(2008-2#5)(2008-3#12)
wave-front sensors##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
wave-front slopes##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
wave-front testing##2##2##(2008-3#2)
wave-front tilt##3##2##(2007-12#1)(2008-3#2)
wave-front transformer##2##2##(2008-1#2)
wave-front##212##1##(2007-11#19)(2007-12#57)(2008-1#2)(2008-2#56)(2008-3#78)
wave-front-correction element##2##2##(2008-2#2)
wave-front-sensing##2##1##(2008-3#2)
wave-fronts in a##2##3##(2006-10#2)
wave-fronts##4##1##(2006-10#4)
wave-guiding layer##2##2##(2008-10#2)
wave-mixing##2##1##(1993-6#1)(2007-11#1)
wave-number##4##1##(2007-12#1)(2008-2#1)(2008-3#2)
wave-vector mismatch##2##2##(2007-12#1)(2008-3#1)
wave-vector separations##2##2##(2008-3#2)
wave-vector##8##1##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#4)
waveband##4##1##(2008-10#1)(2013-8#3)
wavebands##2##1##(2008-10#2)
waved-2##2##1##(1995-2#2)
waveform analysis##2##2##(1992-1#1)(2012-1#1)
waveform and##5##2##(2008-10#2)(2008-3#1)(2010-1#1)(2011-2#1)
waveform can be##2##3##(2007-12#1)(2012-1#1)
waveform generation##3##2##(2007-11#2)(2008-2#1)
waveform is##2##2##(2008-2#1)(2009-1#1)
waveform of the##3##3##(1991-5#1)(1996-11#1)(2007-11#1)
waveform of##7##2##(1991-5#1)(1994-2#1)(1996-11#1)(2005-11#1)(2007-11#1)(2007-9#1)(2008-10#1)
waveform was##3##2##(2008-10#1)(2008-11#1)(2010-8#1)
waveform with a##3##3##(2007-11#1)(2007-12#2)
waveform##67##1##(1991-5#2)(1992-1#1)(1992-12#3)(1994-2#1)(1994-3#1)(1995-5#1)(1996-11#1)(1997-1#1)(1997-8#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-11#8)(2007-12#10)(2007-9#1)(2008-10#13)(2008-11#1)(2008-2#4)(2008-3#3)(2008-5#1)(2009-1#1)(2009-10#1)(2010-1#2)(2010-8#1)(2011-2#1)(2012-1#2)
waveforms and##3##2##(2006-10#1)(2008-2#1)(2010-2#1)
waveforms are##5##2##(2007-11#1)(2008-2#2)(2008-3#1)(2008-7#1)
waveforms from##3##2##(1990-6#1)(2008-2#1)(2012-1#1)
waveforms in##2##2##(1990-6#1)(2008-2#1)
waveforms of the pulse trains were##2##6##(2007-11#1)(2007-12#1)
waveforms of the##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2012-1#1)
waveforms of##8##2##(2005-11#1)(2007-11#1)(2007-12#2)(2008-3#1)(2011-1#1)(2012-1#2)
waveforms to##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
waveforms was##2##2##(1990-6#1)(2006-5#1)
waveforms were##4##2##(1992-2#1)(2007-12#1)(2009-2#1)(2012-1#1)
waveforms with##4##2##(2007-11#2)(2007-12#1)(2011-1#1)
waveforms##70##1##(1990-6#6)(1990-7#1)(1992-2#1)(1993-2#1)(1995-5#1)(2005-11#1)(2006-10#1)(2006-5#1)(2007-11#7)(2007-12#12)(2008-10#1)(2008-12#1)(2008-2#10)(2008-3#4)(2008-7#1)(2009-2#1)(2010-2#2)(2010-5#2)(2010-8#1)(2011-1#3)(2012-1#8)(2013-1#4)
wavefront reconstructor##2##2##(2010-5#2)
wavefront##5##1##(2008-3#1)(2010-5#3)(2010-8#1)
wavefunction##4##1##(2007-5#1)(2010-7#1)(2012-2#2)
waveguide (LCW)##5##2##(2008-10#4)(2008-2#1)
waveguide Bragg gratings##2##3##(2007-11#1)(2008-2#1)
waveguide and a##5##3##(2007-11#1)(2007-8#1)(2008-3#3)
waveguide and the photonic##2##4##(2007-12#1)(2008-3#1)
waveguide and the##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
waveguide and##16##2##(2007-11#3)(2007-12#4)(2007-8#1)(2008-2#1)(2008-3#6)(2008-7#1)
waveguide are##5##2##(2007-11#1)(2007-12#2)(2008-3#1)(2008-7#1)
waveguide arrays##6##2##(2007-11#2)(2007-12#2)(2008-2#1)(2012-2#1)
waveguide as a##3##3##(2007-11#2)(2008-3#1)
waveguide as##4##2##(2007-11#2)(2008-2#1)(2008-3#1)
waveguide at##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
waveguide autocorrelator##2##2##(2008-2#2)
waveguide based##2##2##(2008-10#1)(2008-2#1)
waveguide bends##4##2##(2007-11#2)(2008-2#1)(2008-3#1)
waveguide birefringence##3##2##(2008-2#3)
waveguide by the##2##3##(2008-2#2)
waveguide by##8##2##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#2)
waveguide can be##6##3##(2007-12#1)(2008-2#2)(2008-3#2)(2010-8#1)
waveguide can##7##2##(2007-12#2)(2008-2#2)(2008-3#2)(2010-8#1)
waveguide capillary##3##2##(2008-10#3)
waveguide cladding##2##2##(2007-12#1)(2008-2#1)
waveguide composed of##2##3##(2007-12#2)
waveguide configurations##2##2##(2008-3#2)
waveguide consisting of##2##3##(2007-11#1)(2007-12#1)
waveguide coupler##4##2##(2007-12#2)(2008-3#2)
waveguide couplers##2##2##(2008-2#1)(2008-3#1)
waveguide coupling loss##2##3##(2008-2#2)
waveguide coupling##3##2##(2008-2#3)
waveguide crystal##4##2##(2007-12#4)
waveguide delivery##2##2##(2008-3#1)(2008-7#1)
waveguide device##6##2##(2005-11#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-3#1)
waveguide devices##3##2##(2007-12#2)(2008-2#1)
waveguide diffractive doublets##3##3##(2008-2#3)
waveguide diffractive##4##2##(2008-2#4)
waveguide evolves##2##2##(2007-11#1)(2007-12#1)
waveguide filter##3##2##(2007-11#1)(2007-12#2)
waveguide for##6##2##(2007-11#1)(2007-12#3)(2007-9#1)(2008-2#1)
waveguide formation in##2##3##(2007-12#1)(2008-3#1)
waveguide formation##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
waveguide frequency##2##2##(2007-12#2)
waveguide geometry##2##2##(2008-1#1)(2008-2#1)
waveguide grating mirror##2##3##(2007-11#2)
waveguide grating##10##2##(2007-11#3)(2007-12#6)(2008-2#1)
waveguide gratings##10##2##(2007-12#1)(2008-2#2)(2008-3#7)
waveguide has a##2##3##(2007-11#1)(2008-10#1)
waveguide has##5##2##(2007-11#1)(2008-10#1)(2008-3#3)
waveguide hologram##5##2##(2007-12#1)(2008-3#4)
waveguide imperfections##2##2##(2007-12#1)(2012-11#1)
waveguide in a##2##3##(2007-11#2)
waveguide in##5##2##(2007-11#2)(2007-12#2)(2008-3#1)
waveguide induced by##3##3##(2007-11#2)(2008-1#1)
waveguide intersections with##2##3##(2007-11#2)
waveguide intersections##3##2##(2007-11#2)(2007-12#1)
waveguide is presented##2##3##(2008-3#1)(2010-5#1)
waveguide is reported##2##3##(2008-10#1)(2008-2#1)
waveguide is##15##2##(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#5)(2010-5#1)
waveguide laser is##2##3##(2007-12#1)(2008-2#1)
waveguide laser that##2##3##(2007-11#2)
waveguide laser##18##2##(2007-11#6)(2007-12#3)(2008-1#3)(2008-2#1)(2008-3#5)
waveguide lasers##6##2##(2007-11#1)(2007-12#1)(2008-3#4)
waveguide layer##4##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)
waveguide loss has##2##3##(2007-12#2)
waveguide made of##2##3##(2008-10#2)
waveguide mode##5##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)
waveguide model##3##2##(2008-2#3)
waveguide modes##5##2##(1992-8#1)(2007-11#2)(2008-3#2)
waveguide modulator##4##2##(2007-12#1)(2008-2#3)
waveguide of##3##2##(2007-12#1)(2008-3#2)
waveguide on##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
waveguide on-off intensity modulator##2##4##(2007-12#2)
waveguide or##2##2##(2008-2#1)(2008-3#1)
waveguide photodetectors##2##2##(2007-11#2)
waveguide properties##2##2##(2007-12#1)(2008-2#1)
waveguide sensor##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
waveguide sensors##2##2##(2008-2#2)
waveguide structure##7##2##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#1)
waveguide structures##5##2##(2007-12#2)(2008-1#1)(2008-3#2)
waveguide system##2##2##(2007-12#1)(2008-10#1)
waveguide temperature##2##2##(2007-12#1)(2008-2#1)
waveguide that consists of##2##4##(2007-12#2)
waveguide that is##2##3##(2007-12#1)(2010-8#1)
waveguide that##7##2##(2006-2#1)(2007-12#4)(2008-3#1)(2010-8#1)
waveguide thickness##3##2##(2008-2#2)(2008-3#1)
waveguide to##6##2##(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#1)
waveguide type##2##2##(2007-11#1)(2008-2#1)
waveguide using##2##2##(2007-12#1)(2008-10#1)
waveguide was formed##2##3##(2007-12#2)
waveguide was##16##2##(2007-11#5)(2007-12#7)(2008-1#1)(2008-10#2)(2008-2#1)
waveguide when##2##2##(2007-11#1)(2008-2#1)
waveguide width##3##2##(2007-12#2)(2008-3#1)
waveguide with a##7##3##(2007-12#4)(2008-2#2)(2012-11#1)
waveguide with##17##2##(2007-11#1)(2007-12#10)(2008-1#2)(2008-2#2)(2008-3#1)(2012-11#1)
waveguide##596##1##(1992-3#1)(1992-8#1)(2005-11#1)(2006-2#3)(2007-11#97)(2007-12#188)(2007-8#5)(2007-9#5)(2008-1#23)(2008-10#45)(2008-2#98)(2008-3#112)(2008-7#4)(2010-5#2)(2010-8#4)(2012-11#4)(2012-2#1)(2013-8#2)
waveguide's##2##1##(2008-2#2)
waveguide)##2##1##(2007-12#2)
waveguide-fabrication##2##1##(2007-12#1)(2008-3#1)
waveguide-grating filter##2##2##(2007-11#1)(2008-3#1)
waveguide-grating##4##1##(2007-11#2)(2008-3#2)
waveguide-type optical##2##2##(2007-12#1)(2008-2#1)
waveguide-type##4##1##(2007-12#3)(2008-2#1)
waveguides and also##2##3##(2007-12#1)(2008-2#1)
waveguides and circuits##2##3##(2007-11#2)
waveguides and fibers##2##3##(2008-2#2)
waveguides and microfluidic channels##2##4##(2006-2#1)(2011-1#1)
waveguides and the##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
waveguides and##27##2##(2006-2#1)(2007-11#4)(2007-12#9)(2008-2#9)(2008-3#3)(2011-1#1)
waveguides are also##2##3##(2007-12#2)
waveguides are##19##2##(2006-2#1)(2007-11#6)(2007-12#6)(2008-2#1)(2008-3#5)
waveguides as##3##2##(2008-3#2)(2013-8#1)
waveguides at 1##3##3##(2007-11#2)(2007-12#1)
waveguides at##8##2##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#2)
waveguides based on surface plasmons##2##5##(2007-12#2)
waveguides based on##3##3##(2007-11#1)(2007-12#2)
waveguides because of##2##3##(2008-2#2)
waveguides by a##2##3##(2007-11#1)(2007-12#1)
waveguides by use of##3##4##(2007-11#2)(2008-1#1)
waveguides by##15##2##(2007-11#3)(2007-12#5)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#3)
waveguides can be##7##3##(2007-12#3)(2008-2#2)(2008-3#2)
waveguides can##9##2##(2007-12#4)(2008-2#3)(2008-3#2)
waveguides fabricated##5##2##(2007-12#1)(2008-2#4)
waveguides for sensor applications##2##4##(2008-10#1)(2008-2#1)
waveguides for the##2##3##(2008-2#2)
waveguides for use##2##3##(2008-2#2)
waveguides for##21##2##(2006-2#1)(2007-12#5)(2008-1#1)(2008-10#1)(2008-2#10)(2008-3#2)(2009-2#1)
waveguides formed by##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
waveguides formed##5##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
waveguides had##3##2##(2008-2#3)
waveguides have been##5##3##(2007-12#1)(2008-2#3)(2008-3#1)
waveguides in sapphire##2##3##(2007-12#2)
waveguides in the##2##3##(2007-12#1)(2008-2#1)
waveguides in##20##2##(2007-11#4)(2007-12#8)(2008-1#1)(2008-2#4)(2008-3#3)
waveguides induced by photorefractive solitons##2##5##(2007-12#2)
waveguides induced by photorefractive##3##4##(2007-12#3)
waveguides induced by##8##3##(2007-12#6)(2008-1#1)(2008-2#1)
waveguides is presented##2##3##(2008-2#1)(2008-3#1)
waveguides is reported##2##3##(2007-12#1)(2008-3#1)
waveguides is##12##2##(2007-12#3)(2008-1#1)(2008-2#4)(2008-3#4)
waveguides made from silver##2##4##(2007-12#2)
waveguides made##5##2##(2007-12#3)(2008-2#1)(2008-3#1)
waveguides of##2##2##(2007-12#1)(2008-2#1)
waveguides on##5##2##(2006-2#2)(2007-11#1)(2008-2#2)
waveguides that are##2##3##(2007-12#2)
waveguides that##6##2##(2007-12#6)
waveguides was##2##2##(2008-3#2)
waveguides were fabricated from##3##4##(2007-11#1)(2008-2#2)
waveguides were fabricated##5##3##(2007-11#1)(2008-2#4)
waveguides were found to##2##4##(2007-12#1)(2008-2#1)
waveguides were##11##2##(2007-11#1)(2007-12#1)(2008-2#6)(2008-3#3)
waveguides with a##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
waveguides with an##2##3##(2007-11#1)(2008-2#1)
waveguides with discrete translational symmetry##2##5##(2007-12#2)
waveguides with integrated coupling structures##2##5##(2007-12#2)
waveguides with the##2##3##(2008-3#2)
waveguides with##22##2##(2007-11#3)(2007-12#8)(2008-2#5)(2008-3#6)
waveguides##390##1##(2006-2#8)(2007-11#49)(2007-12#133)(2007-8#1)(2008-1#10)(2008-10#4)(2008-2#105)(2008-3#73)(2008-7#1)(2009-2#2)(2010-8#1)(2011-1#1)(2013-8#2)
waveguiding in##3##2##(2007-12#2)(2008-2#1)
waveguiding layer##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
waveguiding plate##2##2##(2008-3#2)
waveguiding##25##1##(2006-2#1)(2007-11#4)(2007-12#3)(2008-1#1)(2008-2#11)(2008-3#4)(2008-7#1)
wavelength absorption##2##2##(2008-10#1)(2008-7#1)
wavelength accuracy of##3##3##(2008-2#3)
wavelength accuracy##4##2##(2008-2#4)
wavelength and a##3##3##(2007-11#1)(2008-2#1)(2008-5#1)
wavelength and is##2##3##(2008-1#1)(2008-3#1)
wavelength and on the##2##4##(1997-1#1)(2008-2#1)
wavelength and the optical##2##4##(2008-3#1)(2008-4#1)
wavelength and the wavelength##2##4##(2007-12#1)(2008-10#1)
wavelength and the##19##3##(1991-12#1)(2007-11#4)(2007-12#3)(2008-10#3)(2008-3#6)(2008-4#1)(2008-7#1)
wavelength and##57##2##(1991-12#1)(1997-1#1)(2005-4#1)(2007-11#9)(2007-12#9)(2008-1#2)(2008-10#4)(2008-2#7)(2008-3#14)(2008-4#1)(2008-5#1)(2008-7#2)(2009-5#1)(2009-9#1)(2010-2#1)(2013-1#2)
wavelength are presented##2##3##(2008-2#2)
wavelength are##7##2##(2007-11#1)(2008-2#5)(2008-3#1)
wavelength as##5##2##(2008-2#1)(2008-3#4)
wavelength at which##3##3##(2008-2#1)(2008-3#2)
wavelength at##17##2##(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-2#2)(2008-3#3)(2012-12#1)(2013-7#1)
wavelength band##4##2##(1993-3#1)(2008-2#1)(2008-3#2)
wavelength bandpass centered at 30 nm##2##6##(2008-3#2)
wavelength bands##4##2##(2007-12#1)(2008-1#1)(2008-3#2)
wavelength between##2##2##(2007-12#1)(2008-2#1)
wavelength by a##2##3##(2008-1#1)(2008-3#1)
wavelength by##5##2##(2007-11#1)(2008-1#1)(2008-3#3)
wavelength calibration##3##2##(2007-11#2)(2008-3#1)
wavelength can be obtained##2##4##(2007-12#1)(2008-1#1)
wavelength can be tuned##2##4##(2007-11#2)
wavelength can be##9##3##(2007-11#2)(2007-12#3)(2008-1#1)(2008-2#1)(2008-7#1)(2009-7#1)
wavelength can##10##2##(2007-11#2)(2007-12#3)(2008-1#2)(2008-2#1)(2008-7#1)(2009-7#1)
wavelength change##4##2##(2007-12#2)(2008-3#2)
wavelength channel##2##2##(2007-12#1)(2008-3#1)
wavelength channels##3##2##(2007-11#1)(2008-3#2)
wavelength combination##2##2##(2008-2#2)
wavelength combinations for##2##3##(2008-2#2)
wavelength combinations##3##2##(2008-2#3)
wavelength control##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
wavelength conversion are##2##3##(2007-12#2)
wavelength conversion based on##3##4##(2007-12#3)
wavelength conversion of##5##3##(2007-12#5)
wavelength conversion with##2##3##(2007-12#2)
wavelength conversion##20##2##(2007-11#3)(2007-12#16)(2008-3#1)
wavelength converter##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
wavelength converters##2##2##(2007-11#1)(2007-12#1)
wavelength could be tuned##2##4##(2007-11#1)(2007-12#1)
wavelength could be##3##3##(1996-5#1)(2007-11#1)(2007-12#1)
wavelength coverage##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
wavelength demultiplexing##2##2##(2007-12#1)(2008-3#1)
wavelength dependence in##2##3##(2008-2#1)(2008-3#1)
wavelength dependence of the##14##4##(1995-6#1)(1997-1#1)(2007-11#2)(2007-12#2)(2008-2#4)(2008-3#3)(2011-1#1)
wavelength dependence of##17##3##(1995-6#1)(1997-1#1)(2007-11#2)(2007-12#4)(2008-2#5)(2008-3#3)(2011-1#1)
wavelength dependence over the 633-1539-nm range##2##6##(2008-3#2)
wavelength dependence##22##2##(1995-6#1)(1997-1#1)(2007-11#2)(2007-12#4)(2008-2#6)(2008-3#7)(2011-1#1)
wavelength dependent##4##2##(1997-1#1)(2005-4#1)(2008-2#2)
wavelength determination##4##2##(2006-4#1)(2008-10#2)(2008-3#1)
wavelength discrimination##3##2##(1993-2#1)(2008-2#1)(2008-3#1)
wavelength dispersive X-ray fluorescence spectroscopy##2##5##(2008-10#2)
wavelength dispersive##3##2##(2008-10#3)
wavelength division multiplexer##2##3##(2008-2#2)
wavelength division multiplexing##6##3##(2008-1#2)(2008-2#1)(2008-3#3)
wavelength division##10##2##(2008-1#2)(2008-2#5)(2008-3#3)
wavelength emission##2##2##(2008-10#2)
wavelength for##10##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2010-1#1)(2011-7#1)(2013-1#1)
wavelength has been demonstrated##2##4##(2008-2#1)(2008-3#1)
wavelength has been developed##2##4##(2007-12#1)(2008-2#1)
wavelength has been##9##3##(2007-12#1)(2008-2#3)(2008-3#5)
wavelength has##10##2##(2007-12#1)(2008-2#3)(2008-3#6)
wavelength in a##2##3##(2007-12#2)
wavelength in the visible##2##4##(2008-2#1)(2008-3#1)
wavelength in the##7##3##(2007-12#1)(2008-2#2)(2008-3#3)(2013-1#1)
wavelength in three##2##3##(2007-12#1)(2008-3#1)
wavelength in##21##2##(2005-4#1)(2007-11#3)(2007-12#6)(2008-2#3)(2008-3#6)(2011-1#1)(2013-1#1)
wavelength independent and##2##3##(2007-12#2)
wavelength interchange##5##2##(2007-12#5)
wavelength interval##4##2##(2008-10#2)(2008-3#2)
wavelength is at##2##3##(2008-10#2)
wavelength is increased##2##3##(2007-11#1)(2008-3#1)
wavelength is known##2##3##(2008-2#2)
wavelength is##36##2##(2005-4#1)(2006-12#1)(2006-5#1)(2007-11#5)(2007-12#3)(2008-1#3)(2008-10#4)(2008-2#6)(2008-3#9)(2013-8#3)
wavelength lambda =##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
wavelength lambda##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
wavelength light##3##2##(2008-10#1)(2011-7#1)(2013-1#1)
wavelength mixing ratio##3##3##(2013-1#3)
wavelength mixing##4##2##(2013-1#4)
wavelength modulation SPR biosensor##4##4##(2008-10#4)
wavelength modulation of a distributed-feedback##2##5##(2008-3#2)
wavelength modulation of a##3##4##(2007-12#1)(2008-3#2)
wavelength modulation spectroscopy with##3##4##(2008-2#1)(2008-3#2)
wavelength modulation spectroscopy##7##3##(2007-12#1)(2008-2#3)(2008-3#3)
wavelength modulation##22##2##(2007-12#2)(2008-10#9)(2008-2#3)(2008-3#8)
wavelength multiplexing##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
wavelength near##6##2##(1995-2#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
wavelength of 0##3##3##(2007-12#1)(2008-3#2)
wavelength of 1##22##3##(2007-11#2)(2007-12#9)(2008-2#3)(2008-3#8)
wavelength of 10##8##3##(2007-11#5)(2007-12#2)(2008-3#1)
wavelength of 1064 nm##6##4##(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#1)
wavelength of 1540 nm##2##4##(2007-12#2)
wavelength of 2##7##3##(2007-12#2)(2008-2#4)(2008-3#1)
wavelength of 214 nm##2##4##(1990-12#1)(1997-8#1)
wavelength of 220 nm##2##4##(1996-8#1)(2007-1#1)
wavelength of 440 nm##2##4##(2008-10#1)(2012-12#1)
wavelength of 488 nm##2##4##(1996-5#1)(2008-2#1)
wavelength of 532 nm##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
wavelength of 632##5##3##(2007-11#1)(2007-12#4)
wavelength of 635 nm##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
wavelength of 800 nm##3##4##(2007-12#2)(2008-2#1)
wavelength of a##9##3##(2007-12#5)(2008-2#1)(2008-3#3)
wavelength of an##2##3##(2007-12#1)(2008-2#1)
wavelength of approximately##3##3##(2008-2#2)(2008-3#1)
wavelength of lambda = 633 nm##2##6##(2008-2#1)(2008-3#1)
wavelength of lambda##3##3##(2008-2#2)(2008-3#1)
wavelength of light##8##3##(2005-7#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)
wavelength of maximum##2##3##(1996-8#1)(2008-10#1)
wavelength of the fiber##2##4##(2007-11#2)
wavelength of the incident light##3##5##(2007-11#1)(2008-1#1)(2008-3#1)
wavelength of the incident##7##4##(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)
wavelength of the light##6##4##(1992-4#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
wavelength of the##59##3##(1992-4#1)(1995-5#1)(2006-4#2)(2007-11#9)(2007-12#15)(2008-1#1)(2008-10#2)(2008-2#14)(2008-3#14)
wavelength of ~1##2##3##(2007-11#1)(2007-12#1)
wavelength of##278##2##(1990-12#2)(1991-3#1)(1992-4#1)(1995-5#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-2#2)(1997-3#1)(1997-8#1)(2005-12#1)(2005-7#1)(2006-4#2)(2007-1#1)(2007-11#37)(2007-12#75)(2007-9#1)(2008-1#3)(2008-10#34)(2008-11#1)(2008-2#45)(2008-3#57)(2008-6#1)(2012-11#1)(2012-12#3)(2013-1#1)(2013-8#1)
wavelength on##2##2##(2007-12#1)(2008-3#1)
wavelength or##3##2##(2008-2#2)(2008-3#1)
wavelength pair##3##2##(2008-2#3)
wavelength pairs##6##2##(2008-10#3)(2008-2#1)(2008-3#2)
wavelength position##2##2##(1993-5#1)(2008-1#1)
wavelength precision##2##2##(2007-12#1)(2008-2#1)
wavelength programming##2##2##(2008-10#2)
wavelength purity##2##2##(2008-10#1)(2008-2#1)
wavelength range and##6##3##(2008-10#2)(2008-2#4)
wavelength range from 1##2##4##(2007-11#1)(2007-12#1)
wavelength range from##17##3##(2007-11#3)(2007-12#4)(2008-10#1)(2008-2#6)(2008-3#1)(2008-5#1)(2013-7#1)
wavelength range is##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
wavelength range of the##2##4##(2008-3#1)(2010-5#1)
wavelength range of##21##3##(2006-12#3)(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#5)(2008-3#6)(2010-5#1)
wavelength range was##2##3##(2007-11#1)(2008-10#1)
wavelength range with##2##3##(2008-2#1)(2008-3#1)
wavelength range##129##2##(2006-12#3)(2006-4#1)(2006-6#1)(2007-11#18)(2007-12#15)(2008-1#1)(2008-10#14)(2008-2#38)(2008-3#33)(2008-5#1)(2010-5#3)(2013-7#1)
wavelength ranges of##2##3##(2008-10#1)(2008-3#1)
wavelength ranges##5##2##(2007-12#1)(2008-10#2)(2008-3#1)(2008-6#1)
wavelength ratio##2##2##(2008-2#2)
wavelength region from##3##3##(2007-12#2)(2008-3#1)
wavelength region has been##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
wavelength region of##5##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
wavelength region with##2##3##(2006-10#1)(2007-11#1)
wavelength region##40##2##(1990-8#1)(1994-11#1)(2006-10#1)(2006-3#1)(2007-11#4)(2007-12#6)(2008-10#3)(2008-2#10)(2008-3#12)(2009-3#1)
wavelength regions##7##2##(2008-10#2)(2008-2#3)(2008-3#2)
wavelength response##2##2##(2008-2#1)(2008-3#1)
wavelength scanning##7##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#3)
wavelength selection in##3##3##(2008-10#2)(2008-9#1)
wavelength selection##10##2##(2008-10#7)(2008-3#1)(2008-9#2)
wavelength selectivity of##3##3##(2007-12#2)(2008-3#1)
wavelength selectivity##5##2##(2007-12#2)(2008-3#2)(2008-9#1)
wavelength separation##2##2##(2008-2#1)(2008-3#1)
wavelength separations of ~1##2##4##(2007-12#2)
wavelength separations##3##2##(2007-12#3)
wavelength shift##8##2##(2007-11#1)(2008-1#3)(2008-2#1)(2008-3#3)
wavelength shifts##7##2##(2007-12#4)(2008-2#1)(2008-3#2)
wavelength spacing##3##2##(2007-11#2)(2008-3#1)
wavelength span##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
wavelength switching##3##2##(2007-12#2)(2008-3#1)
wavelength than the##2##3##(2007-12#1)(2008-3#1)
wavelength than##5##2##(2007-12#2)(2008-2#2)(2008-3#1)
wavelength that is##2##3##(2008-3#2)
wavelength that##8##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#3)
wavelength the##5##2##(2007-11#1)(2008-2#1)(2008-3#2)(2008-5#1)
wavelength to a##2##3##(2007-12#1)(2011-1#1)
wavelength to the##3##3##(2007-12#3)
wavelength to##14##2##(2007-11#1)(2007-12#7)(2008-2#1)(2008-3#2)(2008-9#1)(2011-1#1)(2012-3#1)
wavelength tuning and##2##3##(2008-3#1)(2008-9#1)
wavelength tuning from##2##3##(2007-11#1)(2007-12#1)
wavelength tuning in##2##3##(2007-12#2)
wavelength tuning of a##2##4##(2007-12#1)(2008-1#1)
wavelength tuning of##4##3##(2007-11#1)(2007-12#2)(2008-1#1)
wavelength tuning over##2##3##(2007-12#1)(2008-1#1)
wavelength tuning##19##2##(2007-11#3)(2007-12#9)(2008-1#3)(2008-2#1)(2008-3#2)(2008-9#1)
wavelength uncertainty##3##2##(2008-2#3)
wavelength used##4##2##(2005-11#1)(2008-2#1)(2008-3#1)(2010-4#1)
wavelength value of##2##3##(2008-10#2)
wavelength was at##2##3##(2007-12#1)(2008-10#1)
wavelength was continuously##2##3##(2007-12#1)(2008-2#1)
wavelength was found to be##2##5##(2007-11#1)(2008-3#1)
wavelength was tuned##2##3##(2007-12#1)(2008-3#1)
wavelength was##26##2##(2005-12#1)(2006-4#1)(2007-11#4)(2007-12#4)(2008-10#6)(2008-2#3)(2008-3#3)(2011-1#2)(2011-2#1)(2012-3#1)
wavelength were##5##2##(2008-10#1)(2008-2#2)(2008-3#2)
wavelength will##2##2##(2008-2#1)(2008-3#1)
wavelength windows##3##2##(2008-3#3)
wavelength with a##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
wavelength with##7##2##(1990-8#1)(1995-3#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
wavelength within##2##2##(1992-8#1)(2007-12#1)
wavelength##1384##1##(1990-12#2)(1990-5#2)(1990-8#2)(1991-12#1)(1991-3#2)(1991-8#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-5#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-11#1)(1996-2#1)(1996-5#2)(1996-6#1)(1996-8#4)(1997-1#3)(1997-2#3)(1997-3#3)(1997-6#1)(1997-8#1)(2005-11#1)(2005-12#4)(2005-3#1)(2005-4#7)(2005-7#2)(2006-10#1)(2006-12#5)(2006-3#1)(2006-4#8)(2006-5#2)(2006-6#1)(2007-1#1)(2007-11#151)(2007-12#276)(2007-2#1)(2007-6#1)(2007-8#4)(2007-9#1)(2008-1#31)(2008-10#151)(2008-11#3)(2008-2#273)(2008-3#326)(2008-4#1)(2008-5#11)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#6)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-5#7)(2010-8#1)(2011-1#11)(2011-2#1)(2011-7#3)(2012-11#1)(2012-12#6)(2012-2#1)(2012-3#2)(2013-1#13)(2013-7#3)(2013-8#5)
wavelength) and##2##2##(1990-3#1)(2008-2#1)
wavelength)##10##1##(1990-3#1)(2007-11#1)(2008-2#2)(2008-3#6)
wavelength- and mode-selective coupler##2##4##(2007-11#2)
wavelength- and##3##2##(2007-11#2)(2007-12#1)
wavelength-conversion##6##1##(2007-11#2)(2007-12#3)(2008-3#1)
wavelength-dependent angular##2##2##(2008-2#2)
wavelength-dependent phase shift##2##3##(2007-12#1)(2008-3#1)
wavelength-dependent phase##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
wavelength-dependent signal of absorptive particles in surface plasmon##2##8##(2008-4#2)
wavelength-dependent transmission##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
wavelength-dependent##27##1##(1995-6#1)(2007-11#3)(2007-12#4)(2008-2#6)(2008-3#10)(2008-4#3)
wavelength-dispersive##3##1##(2008-10#1)(2008-3#2)
wavelength-division demultiplexer##2##2##(2008-1#1)(2008-3#1)
wavelength-division demultiplexing##4##2##(2007-12#1)(2008-3#3)
wavelength-division multiplexed (WDM)##2##3##(2007-11#1)(2008-3#1)
wavelength-division multiplexed soliton##3##3##(2007-12#3)
wavelength-division multiplexed system##2##3##(2007-11#1)(2007-12#1)
wavelength-division multiplexed systems##3##3##(2007-11#1)(2007-12#2)
wavelength-division multiplexed##15##2##(2007-11#3)(2007-12#9)(2008-2#2)(2008-3#1)
wavelength-division multiplexer is##2##3##(2007-11#1)(2008-1#1)
wavelength-division multiplexer##3##2##(2007-11#1)(2008-1#1)(2008-3#1)
wavelength-division multiplexing applications##3##3##(2007-11#2)(2008-3#1)
wavelength-division multiplexing system##2##3##(2007-12#2)
wavelength-division multiplexing systems##5##3##(2007-11#1)(2007-12#3)(2008-2#1)
wavelength-division multiplexing transmissions##2##3##(2007-11#2)
wavelength-division multiplexing##33##2##(2007-11#7)(2007-12#14)(2008-2#3)(2008-3#9)
wavelength-division multiplexing-passive optical net demultiplexer##2##5##(2008-3#2)
wavelength-division##65##1##(2007-11#11)(2007-12#25)(2008-1#2)(2008-2#6)(2008-3#21)
wavelength-division-multiplexed network system applications##2##4##(2007-12#2)
wavelength-division-multiplexed optical##5##2##(2007-11#3)(2007-12#2)
wavelength-division-multiplexed soliton transmission system##2##4##(2007-12#2)
wavelength-division-multiplexed soliton transmission##4##3##(2007-12#4)
wavelength-division-multiplexed soliton##5##2##(2007-11#1)(2007-12#4)
wavelength-division-multiplexed system##4##2##(2007-12#3)(2008-1#1)
wavelength-division-multiplexed systems##4##2##(2007-12#2)(2008-1#1)(2008-2#1)
wavelength-division-multiplexed##30##1##(2007-11#5)(2007-12#19)(2008-1#4)(2008-2#2)
wavelength-division-multiplexing (WDM)##2##2##(2007-12#1)(2008-2#1)
wavelength-division-multiplexing systems##2##2##(2007-12#1)(2008-2#1)
wavelength-division-multiplexing##7##1##(2007-12#3)(2008-2#3)(2008-3#1)
wavelength-drop##2##1##(2007-12#2)
wavelength-independent imaging##2##2##(2007-12#1)(2008-3#1)
wavelength-independent##4##1##(2007-11#1)(2007-12#2)(2008-3#1)
wavelength-modulated##5##1##(2007-12#1)(2008-3#4)
wavelength-modulation (WM)##2##2##(2008-3#2)
wavelength-modulation absorption spectroscopy##2##3##(2007-12#1)(2008-3#1)
wavelength-modulation spectrometry in terms of##2##5##(2008-3#2)
wavelength-modulation spectrometry##4##2##(2008-3#4)
wavelength-modulation spectroscopy##2##2##(2008-2#1)(2008-3#1)
wavelength-modulation##11##1##(2007-12#1)(2008-2#2)(2008-3#8)
wavelength-multiplexed optical##2##2##(2008-3#2)
wavelength-multiplexed##9##1##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#3)
wavelength-scanning interferometer with a##2##4##(2008-3#2)
wavelength-scanning interferometer with##3##3##(2008-3#3)
wavelength-scanning interferometry##2##2##(2008-3#2)
wavelength-scanning width##2##2##(2007-12#1)(2008-3#1)
wavelength-scanning##15##1##(2007-12#4)(2008-2#1)(2008-3#10)
wavelength-selective photodetector##2##2##(2008-3#2)
wavelength-selective##13##1##(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#6)
wavelength-time##3##1##(2008-10#1)(2011-1#2)
wavelength-to-depth encoding##2##2##(2007-12#2)
wavelength-to-depth##3##1##(2007-12#2)(2008-2#1)
wavelength-tunable##7##1##(2007-11#2)(2007-12#4)(2008-3#1)
wavelength-tuned##2##1##(2008-3#2)
wavelength-tuning range##2##2##(2007-12#1)(2008-2#1)
wavelength-tuning##4##1##(2007-12#2)(2008-2#2)
wavelengths (e##2##2##(2008-3#2)
wavelengths (i##2##2##(2008-11#2)
wavelengths and the##5##3##(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
wavelengths and was##2##3##(1995-6#1)(2009-11#1)
wavelengths and with##2##3##(2007-12#1)(2008-3#1)
wavelengths and##29##2##(1995-6#1)(2005-11#1)(2005-4#1)(2006-7#1)(2007-11#3)(2007-12#6)(2007-9#1)(2008-10#4)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#1)(2009-11#1)(2013-1#1)
wavelengths are near##2##3##(2007-12#2)
wavelengths are recorded##2##3##(2007-11#1)(2008-3#1)
wavelengths are##24##2##(1991-8#1)(2005-4#1)(2007-11#3)(2007-12#3)(2008-10#4)(2008-2#4)(2008-3#6)(2009-12#1)(2011-1#1)
wavelengths as short as##2##4##(2007-11#1)(2008-2#1)
wavelengths as##5##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)
wavelengths at the same time##2##5##(2008-3#2)
wavelengths at the##3##3##(2007-12#1)(2008-3#2)
wavelengths at which the##2##4##(2008-10#2)
wavelengths at which##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
wavelengths at##9##2##(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#3)
wavelengths between##6##2##(2006-12#1)(2008-1#1)(2008-2#3)(2008-3#1)
wavelengths but##2##2##(2007-12#2)
wavelengths by use of##2##4##(2007-12#1)(2008-2#1)
wavelengths by##4##2##(2007-12#1)(2008-2#3)
wavelengths can be##4##3##(2007-11#1)(2007-12#3)
wavelengths can##7##2##(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#1)
wavelengths centered at##2##3##(2007-12#1)(2008-2#1)
wavelengths could be##2##3##(2007-12#1)(2008-3#1)
wavelengths could##3##2##(2007-12#1)(2008-3#2)
wavelengths determined by the##2##4##(2007-11#1)(2007-12#1)
wavelengths employed##2##2##(1990-2#1)(2008-2#1)
wavelengths far##2##2##(2008-2#1)(2010-1#1)
wavelengths for the##3##3##(2005-4#1)(2010-4#2)
wavelengths for##10##2##(2005-4#1)(2008-10#1)(2008-2#3)(2008-3#2)(2009-4#1)(2010-4#2)
wavelengths from 0##2##3##(2007-12#1)(2008-2#1)
wavelengths from 1##4##3##(2006-5#2)(2007-12#1)(2008-3#1)
wavelengths from 650##2##3##(2007-11#1)(2008-4#1)
wavelengths from##23##2##(1996-5#1)(2006-5#2)(2007-11#3)(2007-12#6)(2008-1#1)(2008-2#4)(2008-3#5)(2008-4#1)
wavelengths has been##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
wavelengths have##3##2##(2007-11#1)(2008-2#2)
wavelengths in the near##2##4##(2007-11#1)(2007-12#1)
wavelengths in the visible##5##4##(2008-3#4)(2009-12#1)
wavelengths in the##19##3##(2007-11#3)(2007-12#2)(2007-8#1)(2008-2#5)(2008-3#7)(2009-12#1)
wavelengths in##24##2##(2006-4#1)(2007-11#4)(2007-12#2)(2007-8#1)(2008-10#1)(2008-2#5)(2008-3#8)(2009-12#1)(2011-2#1)
wavelengths is presented##3##3##(2007-12#2)(2008-3#1)
wavelengths is##15##2##(2007-11#1)(2007-12#5)(2008-2#2)(2008-3#5)(2011-1#1)(2013-8#1)
wavelengths longer than approximately##2##4##(2008-3#2)
wavelengths longer than##5##3##(1991-5#1)(2008-3#4)
wavelengths near the##4##3##(2006-4#3)(2008-1#1)
wavelengths near##11##2##(2006-4#3)(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#2)
wavelengths of 0##6##3##(2006-5#1)(2007-12#1)(2008-2#2)(2008-3#2)
wavelengths of 1##4##3##(2007-11#1)(2008-1#1)(2008-2#2)
wavelengths of 355 and 266 nm##2##6##(2008-1#1)(2012-2#1)
wavelengths of 420##2##3##(2008-3#2)
wavelengths of 460##2##3##(2007-12#1)(2008-10#1)
wavelengths of a##2##3##(2007-12#1)(2008-2#1)
wavelengths of excitation##5##3##(2008-10#4)(2010-5#1)
wavelengths of light##2##3##(2008-11#1)(2008-9#1)
wavelengths of the##19##3##(2006-12#1)(2007-11#1)(2007-12#8)(2007-8#1)(2008-10#1)(2008-3#4)(2008-7#3)
wavelengths of##81##2##(1990-8#1)(1993-2#1)(2006-12#1)(2006-5#1)(2007-11#6)(2007-12#15)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#1)(2008-2#13)(2008-3#20)(2008-7#3)(2008-9#1)(2010-5#1)(2011-2#2)(2012-2#1)
wavelengths over##2##2##(2007-11#1)(2008-3#1)
wavelengths ranging from##9##3##(1994-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#3)(2008-3#2)
wavelengths shorter than##2##3##(2007-12#1)(2008-3#1)
wavelengths than the##2##3##(1995-11#1)(2008-3#1)
wavelengths that##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
wavelengths the##4##2##(2008-2#1)(2008-3#3)
wavelengths through##2##2##(2008-2#1)(2008-3#1)
wavelengths to obtain##2##3##(2008-3#2)
wavelengths to##8##2##(1990-8#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#3)
wavelengths under##2##2##(2008-2#1)(2010-5#1)
wavelengths was obtained##2##3##(2007-11#1)(2008-3#1)
wavelengths was##8##2##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#3)
wavelengths were chosen##2##3##(2008-10#1)(2008-3#1)
wavelengths were##15##2##(1996-8#1)(2004-2#1)(2007-11#1)(2008-1#1)(2008-10#9)(2008-3#2)
wavelengths when##2##2##(2008-3#1)(2008-7#1)
wavelengths where##2##2##(2008-10#1)(2008-2#1)
wavelengths with a##2##3##(2007-11#1)(2008-3#1)
wavelengths with##7##2##(1990-3#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)
wavelengths##577##1##(1990-2#1)(1990-3#1)(1990-8#3)(1991-5#1)(1991-8#1)(1992-8#1)(1993-2#1)(1994-11#1)(1995-11#1)(1995-6#2)(1996-5#1)(1996-8#1)(1997-5#2)(1997-6#1)(2004-2#1)(2005-11#1)(2005-4#7)(2006-12#3)(2006-3#1)(2006-4#6)(2006-5#3)(2006-7#2)(2007-11#46)(2007-12#92)(2007-2#1)(2007-8#7)(2007-9#1)(2008-1#13)(2008-10#60)(2008-11#3)(2008-2#102)(2008-3#167)(2008-4#4)(2008-5#1)(2008-7#6)(2008-9#3)(2009-11#1)(2009-12#3)(2009-4#1)(2010-1#1)(2010-2#1)(2010-4#3)(2010-5#4)(2011-1#6)(2011-2#4)(2012-11#1)(2012-2#2)(2013-1#1)(2013-8#1)
wavelengths)##4##1##(1995-6#1)(2007-12#1)(2008-2#1)(2008-3#1)
wavelet MRA and##2##3##(2008-10#2)
wavelet MRA##4##2##(2008-10#4)
wavelet analysis and##2##3##(2008-10#1)(2008-3#1)
wavelet analysis##4##2##(2007-1#1)(2008-10#2)(2008-3#1)
wavelet blocks##2##2##(2008-2#2)
wavelet coefficients and##4##3##(2008-2#3)(2008-6#1)
wavelet coefficients of##3##3##(2007-11#1)(2008-2#2)
wavelet coefficients##18##2##(2007-11#1)(2008-2#14)(2008-3#1)(2008-6#2)
wavelet compression##2##2##(2008-2#1)(2011-1#1)
wavelet decomposition that##2##3##(2008-2#1)(2008-3#1)
wavelet decomposition##4##2##(2008-2#2)(2008-3#1)(2010-8#1)
wavelet filter was found to yield a##2##7##(2008-2#2)
wavelet filter##4##2##(2008-2#4)
wavelet filters##3##2##(2008-2#3)
wavelet functions##3##2##(2008-3#1)(2010-8#2)
wavelet graph model##3##3##(2008-2#3)
wavelet graph##5##2##(2008-2#5)
wavelet image coders##2##3##(2008-2#2)
wavelet multiresolution##2##2##(2008-10#1)(2008-3#1)
wavelet neural network##2##3##(2008-10#2)
wavelet packet basis##2##3##(2007-1#1)(2008-2#1)
wavelet packet##5##2##(2007-1#1)(2008-2#4)
wavelet packets and##2##3##(2008-2#2)
wavelet packets##4##2##(2008-2#4)
wavelet processor##2##2##(2008-2#2)
wavelet produced the best model##2##5##(2010-4#2)
wavelet shrinkage##2##2##(2008-2#2)
wavelet synthesis##3##2##(2008-2#2)(2008-3#1)
wavelet transform and##3##3##(2008-2#2)(2008-3#1)
wavelet transform coefficients on the finest##2##6##(2008-2#2)
wavelet transform coefficients##3##3##(2008-2#3)
wavelet transform to##4##3##(2007-12#1)(2008-10#1)(2008-2#2)
wavelet transform with##2##3##(2008-2#2)
wavelet transform##54##2##(2007-12#3)(2008-1#1)(2008-10#14)(2008-2#26)(2008-3#7)(2008-6#1)(2010-4#1)(2011-1#1)
wavelet transformation##5##2##(2008-10#1)(2008-2#3)(2011-1#1)
wavelet transformer##2##2##(2008-2#2)
wavelet transforms and##3##3##(2008-2#2)(2008-3#1)
wavelet transforms##10##2##(2008-10#3)(2008-2#4)(2008-3#2)(2010-4#1)
wavelet type##2##2##(2010-4#2)
wavelet##201##1##(2007-1#2)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#39)(2008-2#112)(2008-3#22)(2008-6#5)(2010-4#8)(2010-8#3)(2011-1#4)
wavelet-based image##2##2##(2008-2#2)
wavelet-based##15##1##(2008-10#1)(2008-2#11)(2008-3#2)(2009-3#1)
wavelet-matched filtering##2##2##(2008-2#2)
wavelet-packet noise-reduction##3##2##(2008-3#3)
wavelet-transform##2##1##(2007-11#1)(2008-3#1)
wavelet-transformed images##2##2##(2008-2#2)
wavelets and##2##2##(2008-2#2)
wavelets in##2##2##(2008-2#2)
wavelets proposed by##2##3##(2008-2#2)
wavelets##18##1##(2007-12#1)(2008-2#12)(2008-6#3)(2011-1#2)
wavemeter for##2##2##(2008-2#1)(2008-3#1)
wavemeter##13##1##(2007-12#2)(2008-2#4)(2008-3#7)
wavenumber range##2##2##(2007-12#1)(2008-10#1)
wavenumber##12##1##(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-8#1)(2009-5#2)(2010-5#1)
wavenumbers was##2##2##(2008-10#2)
wavenumbers##8##1##(1992-6#1)(2005-11#1)(2007-11#1)(2008-10#5)
waves 1##2##2##(2011-2#2)
waves and the##2##3##(2005-11#1)(2007-12#1)
waves and##22##2##(1991-9#1)(1994-5#1)(1995-8#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#3)(2008-3#4)(2010-2#1)(2011-1#1)
waves are considered to##2##4##(1991-3#1)(2007-11#1)
waves are##20##2##(1991-3#1)(2007-11#3)(2007-12#8)(2008-10#1)(2008-3#5)(2008-8#1)(2011-1#1)
waves as##6##2##(1991-3#1)(1994-8#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-2#1)
waves at##4##2##(2007-12#1)(2008-10#1)(2009-9#1)(2010-7#1)
waves between##3##2##(2007-12#1)(2008-3#2)
waves by means of##2##4##(2007-12#1)(2008-3#1)
waves by##10##2##(2007-12#4)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-5#1)
waves can be##2##3##(2007-12#2)
waves can##3##2##(2007-12#2)(2008-1#1)
waves during##4##2##(2007-11#1)(2011-1#1)(2012-2#2)
waves for##6##2##(1991-3#1)(2007-11#1)(2008-3#2)(2012-3#1)(2013-8#1)
waves from a film##2##4##(2008-3#2)
waves from a##3##3##(2007-11#1)(2008-3#2)
waves from an##2##3##(2008-2#1)(2008-3#1)
waves from the##3##3##(2008-3#2)(2009-12#1)
waves from##9##2##(2007-11#1)(2008-2#1)(2008-3#5)(2009-12#1)(2011-1#1)
waves generated by the##2##4##(1990-8#1)(1995-11#1)
waves generated by##4##3##(1990-8#1)(1995-11#1)(2007-12#1)(2010-6#1)
waves generated##9##2##(1990-8#1)(1994-2#1)(1994-5#1)(1995-11#1)(2007-11#1)(2007-12#2)(2008-3#1)(2010-6#1)
waves in a single##2##4##(2007-12#2)
waves in a##15##3##(1990-12#1)(1995-12#1)(2007-12#9)(2008-1#2)(2008-3#1)(2011-1#1)
waves in nonuniform periodic Bragg arrays##2##6##(2008-3#2)
waves in optical fibers##3##4##(2007-12#1)(2008-1#2)
waves in the treatment of##2##5##(1993-8#1)(2007-11#1)
waves in the##16##3##(1993-8#1)(1994-7#1)(1994-8#1)(1996-1#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#2)(2008-5#1)(2011-2#1)
waves in##70##2##(1990-12#1)(1991-3#1)(1992-3#1)(1993-1#1)(1993-8#1)(1994-7#1)(1994-8#1)(1995-12#1)(1996-1#1)(2006-5#1)(2007-1#1)(2007-11#4)(2007-12#24)(2007-5#1)(2008-1#5)(2008-10#1)(2008-2#8)(2008-3#11)(2008-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
waves increases##2##2##(2008-3#1)(2009-9#1)
waves inside##2##2##(2007-12#1)(2008-3#1)
waves is##10##2##(2007-11#2)(2007-12#3)(2008-1#2)(2008-2#2)(2008-3#1)
waves near##2##2##(1991-3#1)(2008-3#1)
waves observed in the##2##4##(2007-12#1)(2008-4#1)
waves obtained from##2##3##(2008-2#1)(2009-5#1)
waves of data from##2##4##(2010-4#1)(2013-8#1)
waves of data##3##3##(2010-4#1)(2013-1#1)(2013-8#1)
waves of interaction##2##3##(2007-12#2)
waves of the##5##3##(2007-12#1)(2008-10#1)(2008-3#1)(2010-10#1)(2011-2#1)
waves of##32##2##(1990-6#1)(1997-3#1)(2007-11#1)(2007-12#7)(2007-2#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#2)(2010-10#1)(2010-11#2)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
waves on the##3##3##(2007-9#1)(2011-1#1)(2013-7#1)
waves on##12##2##(1995-10#1)(2005-11#1)(2007-9#1)(2008-10#1)(2008-2#3)(2008-3#2)(2011-1#1)(2011-2#1)(2013-7#1)
waves passed##2##2##(2008-2#1)(2011-2#1)
waves propagating between an isotropic medium and an##2##8##(2007-11#2)
waves propagating through##2##3##(2007-12#1)(2008-3#1)
waves propagating##5##2##(2007-11#2)(2007-12#1)(2008-3#2)
waves scattered from##2##3##(2008-2#1)(2008-3#1)
waves supported by##2##3##(2007-12#1)(2008-3#1)
waves that are##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
waves that propagate##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
waves that##13##2##(2006-10#1)(2007-11#2)(2007-12#6)(2008-10#1)(2008-2#1)(2008-3#2)
waves through a##10##3##(2007-12#7)(2008-3#3)
waves through##13##2##(2007-12#9)(2008-1#1)(2008-3#3)
waves to be##2##3##(2007-12#1)(2008-2#1)
waves to the##2##3##(2007-12#1)(2008-3#1)
waves to##8##2##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#2)
waves using##2##2##(2007-9#1)(2012-2#1)
waves was##6##2##(1996-9#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-8#1)
waves were##5##2##(1990-5#1)(2007-11#1)(2008-10#2)(2008-3#1)
waves with##11##2##(2007-11#3)(2007-12#5)(2008-2#1)(2011-2#1)(2013-8#1)
waves##493##1##(1990-12#1)(1990-3#3)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#14)(1991-9#1)(1992-3#1)(1993-1#3)(1993-3#1)(1993-8#1)(1993-9#1)(1994-2#4)(1994-5#2)(1994-7#1)(1994-8#3)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#3)(1996-12#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#2)(2004-9#1)(2005-11#4)(2005-12#1)(2006-10#4)(2006-12#1)(2006-5#2)(2006-6#1)(2006-8#2)(2007-1#3)(2007-11#38)(2007-12#118)(2007-2#1)(2007-5#1)(2007-9#7)(2008-1#19)(2008-10#19)(2008-11#1)(2008-12#1)(2008-2#50)(2008-3#79)(2008-4#3)(2008-5#2)(2008-6#1)(2008-8#3)(2009-1#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#5)(2009-6#1)(2009-8#2)(2009-9#3)(2010-10#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#8)(2011-2#8)(2012-2#6)(2012-3#7)(2013-1#4)(2013-7#2)(2013-8#10)
waves)##5##1##(1991-12#1)(1994-2#1)(1995-6#1)(1997-8#1)(2008-1#1)
waviness and##4##2##(2008-3#4)
waviness scale##2##2##(2008-3#2)
waviness##11##1##(2008-2#1)(2008-3#10)
waving##2##1##(2006-12#2)
wavy##4##1##(2006-10#1)(2006-12#1)(2007-7#1)(2010-6#1)
wax and oil##5##3##(2008-5#5)
wax and##8##2##(2006-12#1)(2007-10#1)(2008-5#5)(2012-3#1)
wax at##2##2##(2006-1#1)(2008-5#1)
wax covering##4##2##(2007-12#4)
wax esters##4##2##(2010-3#2)(2011-1#1)(2012-2#1)
wax is##2##2##(1992-6#1)(2010-2#1)
wax matrix at the surface region##2##6##(2008-5#2)
wax matrix##13##2##(2006-1#1)(2008-5#12)
wax monomers##2##2##(2009-8#2)
wax tests of##2##3##(2007-12#2)
wax tests##3##2##(2007-12#3)
wax##83##1##(1991-2#1)(1992-6#4)(2006-1#6)(2006-12#1)(2007-10#1)(2007-12#7)(2007-3#1)(2007-8#4)(2007-9#1)(2008-10#14)(2008-11#1)(2008-5#19)(2008-7#1)(2009-3#1)(2009-8#3)(2010-2#6)(2010-3#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
wax-encased##5##1##(2008-10#5)
wax-lipid##2##1##(2006-1#2)
waxes were##3##2##(2008-10#2)(2008-5#1)
waxes##11##1##(2008-10#6)(2008-2#1)(2008-5#2)(2009-8#1)(2012-2#1)
waxing and waning##2##3##(2006-8#1)(2007-9#1)
waxy##11##1##(2007-11#3)(2007-12#3)(2007-7#2)(2008-5#1)(2012-2#1)(2012-3#1)
way ANOVA##3##2##(2007-3#1)(2010-3#1)(2013-8#1)
way a##8##2##(1990-9#1)(1992-6#1)(1996-6#1)(2008-10#1)(2008-2#2)(2008-8#1)(2012-11#1)
way across##2##2##(1995-8#1)(2006-2#1)
way an##3##2##(2008-10#1)(2008-2#1)(2009-3#1)
way and the##3##3##(2007-11#1)(2008-10#1)(2011-2#1)
way and##17##2##(1994-12#1)(2004-10#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#2)
way are##4##2##(1996-3#1)(2005-4#1)(2008-10#2)
way around##3##2##(1991-9#1)(1992-1#1)(2012-1#1)
way as it##2##3##(1995-8#1)(2009-4#1)
way as##27##2##(1990-8#1)(1990-9#1)(1991-9#2)(1993-3#2)(1994-8#1)(1995-2#1)(1995-8#1)(1995-9#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2009-4#1)(2012-11#2)
way between##2##2##(1997-6#1)(2006-7#1)
way but##2##2##(1995-11#1)(2006-10#1)
way by the##2##3##(2008-3#1)(2008-6#1)
way by##10##2##(1997-2#1)(2007-9#2)(2008-1#1)(2008-12#1)(2008-3#2)(2008-6#2)(2008-7#1)
way could be##3##3##(1997-6#1)(2009-6#1)(2013-8#1)
way could##4##2##(1997-6#1)(2008-7#1)(2009-6#1)(2013-8#1)
way encryption##2##2##(2006-10#2)
way for a##9##3##(1992-1#1)(1992-3#1)(1994-11#1)(1995-3#1)(1995-4#1)(2007-12#1)(2010-12#1)(2010-2#1)(2011-1#1)
way for gene##2##3##(1996-2#1)(2011-2#1)
way for the##18##3##(1994-2#1)(2005-8#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-8#1)(2009-8#1)(2010-8#1)(2011-1#1)(2012-2#2)(2013-8#1)
way for##82##2##(1992-1#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-7#1)(1995-3#1)(1995-4#1)(1996-2#1)(1996-7#1)(1997-4#1)(2005-10#1)(2005-11#1)(2005-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#4)(2012-10#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-8#4)
way forward for##2##3##(1996-8#1)(2009-10#1)
way forward in##2##3##(2008-10#1)(2008-11#1)
way forward##11##2##(1991-10#1)(1996-8#1)(2004-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#2)(2010-5#1)(2012-12#1)
way from##7##2##(1990-2#1)(1992-11#1)(1994-3#1)(1995-12#1)(2006-9#1)(2008-3#1)(2010-12#1)
way has##3##2##(1992-2#1)(2008-4#1)(2008-9#1)
way have##2##2##(2008-10#1)(2008-4#1)
way how##2##2##(1994-12#1)(2005-3#1)
way in the##7##3##(1990-11#1)(1995-3#1)(2005-11#1)(2007-1#1)(2007-5#1)(2008-10#1)(2008-5#1)
way in which it is##3##5##(1993-5#1)(2008-8#2)
way in which it##4##4##(1992-1#1)(1993-5#1)(2008-8#2)
way in which the##13##4##(1992-1#1)(1993-8#1)(1997-7#1)(2006-4#1)(2007-12#2)(2007-9#1)(2008-11#2)(2008-5#1)(2008-9#1)(2011-1#1)(2012-3#1)
way in which##60##3##(1992-1#2)(1993-2#1)(1993-5#1)(1993-8#1)(1994-9#1)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#2)(2005-10#1)(2005-5#1)(2006-10#2)(2006-3#1)(2006-4#1)(2006-5#3)(2006-9#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-5#2)(2009-7#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-2#2)(2012-3#2)(2013-1#1)
way in##94##2##(1990-11#1)(1991-11#1)(1991-4#1)(1992-1#2)(1993-2#1)(1993-5#1)(1993-8#1)(1994-9#1)(1995-12#2)(1995-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#2)(2005-10#1)(2005-11#1)(2005-5#1)(2005-7#1)(2006-10#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-12#4)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#4)(2008-9#2)(2009-3#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-5#2)(2010-7#3)(2011-1#2)(2011-2#5)(2012-1#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
way into clinical##2##3##(1996-3#1)(2007-7#1)
way into the##2##3##(1994-3#1)(2008-11#1)
way into##7##2##(1994-3#1)(1995-6#1)(1996-2#1)(1996-3#1)(2004-11#1)(2007-7#1)(2008-11#1)
way is##8##2##(1991-8#1)(1992-5#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
way it is possible to##2##5##(1991-12#1)(2008-3#1)
way it is##5##3##(1991-12#1)(1992-3#1)(2008-3#2)(2009-10#1)
way it was##2##3##(1994-12#1)(2007-7#1)
way it##8##2##(1991-12#1)(1992-12#1)(1992-3#1)(1994-12#1)(2007-7#1)(2008-3#2)(2009-10#1)
way of a##8##3##(2006-4#1)(2006-7#1)(2007-2#1)(2008-2#1)(2008-5#1)(2009-7#1)(2011-2#1)(2013-8#1)
way of achieving##3##3##(2008-2#1)(2008-5#1)(2010-10#1)
way of an##5##3##(2008-11#1)(2008-3#1)(2009-9#1)(2012-11#2)
way of assessing##4##3##(1991-3#1)(1991-8#1)(2008-7#1)(2010-8#1)
way of changing##2##3##(2008-2#1)(2008-7#1)
way of comparing##2##3##(1994-6#1)(2008-10#1)
way of determining the##2##4##(2008-10#1)(2009-4#1)
way of doing things##2##4##(1991-3#1)(1995-2#1)
way of doing##6##3##(1991-3#1)(1993-11#1)(1995-2#1)(1996-3#1)(2012-2#1)(2013-1#1)
way of expressing##2##3##(1992-3#1)(2006-2#1)
way of implementing##2##3##(1994-9#1)(2008-8#1)
way of improving##3##3##(2008-6#1)(2010-12#1)(2010-8#1)
way of its##2##3##(1991-6#1)(2008-12#1)
way of learning##2##3##(2009-11#1)(2013-8#1)
way of life##6##3##(1991-12#1)(1995-1#1)(2007-7#1)(2008-10#1)(2008-6#1)(2013-8#1)
way of obtaining##3##3##(1997-3#1)(1997-8#1)(2010-11#1)
way of recording##2##3##(1997-8#1)(2008-2#1)
way of studying##2##3##(1990-4#1)(2010-8#1)
way of the##10##3##(1993-3#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-7#1)(2010-5#1)(2011-1#1)
way of thinking about##2##4##(2006-5#1)(2008-2#1)
way of thinking##9##3##(1993-6#1)(1994-12#1)(1995-5#1)(2006-5#1)(2008-2#2)(2008-8#1)(2008-9#1)(2011-1#1)
way of treatment##2##3##(2008-1#1)(2010-4#1)
way of understanding##2##3##(2006-4#1)(2009-4#1)
way of using##3##3##(2008-10#1)(2008-2#1)(2012-1#1)
way of working##4##3##(1995-6#1)(2006-2#1)(2008-11#1)(2013-1#1)
way of##220##2##(1990-3#1)(1990-4#1)(1990-6#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#1)(1991-6#2)(1991-8#2)(1992-3#3)(1992-7#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-8#3)(2004-2#1)(2006-10#4)(2006-12#1)(2006-2#2)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#3)(2007-11#3)(2007-12#4)(2007-2#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#2)(2008-10#17)(2008-11#6)(2008-12#8)(2008-2#11)(2008-3#6)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#7)(2008-8#5)(2008-9#4)(2009-1#1)(2009-10#2)(2009-11#2)(2009-2#1)(2009-4#2)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#3)(2010-8#8)(2011-1#4)(2011-12#1)(2011-2#3)(2012-1#3)(2012-11#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#6)
way on the##2##3##(1993-5#1)(2008-5#1)
way on##8##2##(1993-5#1)(1995-5#1)(1996-6#1)(1996-9#1)(2006-4#1)(2006-8#1)(2008-10#1)(2008-5#1)
way one##2##2##(2006-8#1)(2008-9#1)
way or the##2##3##(1992-2#1)(2004-3#1)
way or##3##2##(1991-6#1)(1992-2#1)(2004-3#1)
way out##4##2##(1992-6#1)(1993-5#1)(1994-5#1)(1996-12#1)
way patients are##2##3##(2007-4#1)(2013-1#1)
way she##2##2##(1990-3#1)(2008-10#1)
way so that##2##3##(1992-5#1)(2008-3#1)
way some##2##2##(2004-9#1)(2007-4#1)
way than with##2##3##(2007-12#1)(2008-4#1)
way than##4##2##(1991-6#1)(2007-12#1)(2008-4#1)(2008-8#1)
way that a##4##3##(1996-2#1)(2008-2#1)(2008-3#1)(2009-5#1)
way that it##7##3##(1990-9#1)(2008-11#2)(2008-3#2)(2010-5#1)(2011-2#1)
way that the##16##3##(1991-2#1)(1994-1#1)(2006-4#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-6#1)(2009-7#1)(2010-5#1)(2012-1#1)
way that these##2##3##(2009-1#1)(2010-1#1)
way that they##8##3##(1997-4#1)(1997-5#2)(2006-10#1)(2008-4#1)(2008-5#1)(2009-4#1)(2013-8#1)
way that will##2##3##(1997-2#1)(2006-5#1)
way that##114##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-2#2)(1991-5#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-5#1)(1994-1#1)(1994-6#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#2)(1996-6#1)(1997-2#1)(1997-4#2)(1997-5#3)(1997-6#1)(1997-8#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-12#2)(2007-8#3)(2008-1#1)(2008-10#7)(2008-11#7)(2008-2#6)(2008-3#11)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-12#2)(2011-2#1)(2012-1#2)(2012-12#1)(2013-8#1)
way the course##2##3##(1990-6#1)(1995-1#1)
way the##39##2##(1990-6#1)(1990-8#1)(1992-9#1)(1995-1#1)(1997-2#1)(1997-4#1)(2006-10#2)(2006-6#1)(2006-8#2)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#5)(2008-2#3)(2008-3#2)(2008-6#1)(2008-8#1)(2010-11#1)(2010-4#1)(2010-6#1)(2011-1#2)(2012-2#1)(2013-1#3)
way they##19##2##(1994-2#1)(1997-2#1)(2005-8#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2012-3#1)(2013-8#1)
way this##3##2##(1994-6#1)(1995-1#1)(2010-2#1)
way through##2##2##(2007-8#1)(2008-11#1)
way to a more##2##4##(1991-1#1)(2006-10#1)
way to a##8##3##(1991-1#1)(1996-1#1)(2005-11#1)(2006-10#2)(2007-11#1)(2007-6#1)(2008-7#1)
way to address##3##3##(2008-12#1)(2009-11#1)(2012-1#1)
way to an##2##3##(1995-2#1)(2006-12#1)
way to analyze##2##3##(2012-2#1)(2012-3#1)
way to assess the##3##4##(2006-12#1)(2007-10#1)(2008-10#1)
way to assess##6##3##(2005-11#1)(2006-12#1)(2007-10#1)(2008-10#1)(2011-2#1)(2012-2#1)
way to avoid##3##3##(1995-1#1)(2006-10#1)(2011-2#1)
way to calculate##2##3##(1994-6#1)(2008-7#1)
way to classify##2##3##(1995-12#1)(2008-5#1)
way to combat##2##3##(2006-8#1)(2012-2#1)
way to control the##3##4##(2007-11#1)(2007-12#1)(2008-11#1)
way to control##7##3##(1997-2#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-11#1)(2010-5#1)
way to create##4##3##(1996-1#1)(2006-12#1)(2008-2#1)(2012-11#1)
way to deliver##2##3##(2007-12#1)(2009-8#1)
way to describe##3##3##(2007-12#1)(2008-2#2)
way to detect##2##3##(2007-12#1)(2008-6#1)
way to determine soil ingestion##2##5##(2008-7#2)
way to determine##6##3##(1996-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-12#1)
way to distinguish##3##3##(1991-4#1)(1992-12#1)(2012-2#1)
way to effectively##2##3##(1997-5#1)(2007-11#1)
way to elucidate the##2##4##(2009-6#1)(2012-3#1)
way to enhance##2##3##(2007-12#1)(2008-7#1)
way to estimate the##2##4##(2008-2#1)(2008-3#1)
way to estimate##3##3##(1991-11#1)(2008-2#1)(2008-3#1)
way to evaluate the##3##4##(1991-2#1)(1993-12#1)(2012-3#1)
way to evaluate##4##3##(1991-2#1)(1993-12#1)(1995-2#1)(2012-3#1)
way to examine the##3##4##(1995-2#1)(1996-12#1)(2008-2#1)
way to explain##2##3##(2008-12#1)(2012-3#1)
way to explore the##2##4##(2007-12#1)(2010-2#1)
way to extend##2##3##(2007-11#1)(2008-6#1)
way to fabricate##2##3##(2008-2#1)(2008-3#1)
way to feed##2##3##(2007-9#1)(2008-10#1)
way to go##6##3##(1992-12#1)(1995-11#1)(2007-9#1)(2008-11#1)(2010-8#1)(2012-3#1)
way to help##2##3##(1997-2#1)(2013-1#1)
way to identify##3##3##(1996-6#1)(2008-9#1)(2012-3#1)
way to implement##2##3##(1996-1#1)(2008-11#1)
way to improve the##4##4##(1993-3#1)(2006-1#1)(2008-11#1)(2008-6#1)
way to improve##10##3##(1992-11#1)(1993-3#1)(1997-3#1)(2006-1#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2010-2#1)
way to increase##3##3##(1994-2#1)(2006-4#1)(2008-3#1)
way to induce##2##3##(1991-2#1)(2008-11#1)
way to integrate##4##3##(1993-2#1)(1997-2#1)(2006-11#1)(2008-9#1)
way to investigate the##3##4##(2007-11#1)(2008-8#1)(2010-12#1)
way to isolate##2##3##(1997-2#1)(2008-9#1)
way to learn##2##3##(2013-1#1)(2013-8#1)
way to make##5##3##(2005-11#1)(2006-4#1)(2008-8#1)(2009-7#1)(2011-1#1)
way to manage this problem##3##5##(1994-3#2)(2013-8#1)
way to manage##5##3##(1994-3#2)(2006-9#1)(2007-10#1)(2013-8#1)
way to measure##4##3##(1997-1#1)(2008-10#1)(2008-4#1)(2008-5#1)
way to modify##2##3##(2006-5#1)(2007-11#1)
way to monitor the##2##4##(2007-12#1)(2008-10#1)
way to monitor##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
way to obtain##8##3##(2005-12#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#1)
way to predict##2##3##(2008-7#1)(2008-8#1)
way to prepare##2##3##(2005-10#1)(2008-10#1)
way to prevent or##2##4##(2008-10#1)(2010-7#1)
way to prevent##7##3##(1996-9#1)(2008-10#2)(2008-5#1)(2010-7#1)(2011-1#1)(2011-2#1)
way to produce##3##3##(2005-6#1)(2008-10#1)(2008-4#1)
way to protect##2##3##(2005-9#1)(2011-1#1)
way to provide##3##3##(1991-2#1)(2006-10#1)(2008-11#1)
way to raise##2##3##(2006-10#1)(2008-12#1)
way to reach##2##3##(1994-3#1)(1996-1#1)
way to reconstruct##2##3##(2007-11#1)(2008-7#1)
way to reduce##3##3##(2007-2#1)(2011-2#1)(2012-12#1)
way to solve##2##3##(2008-10#1)(2008-2#1)
way to store##2##3##(1993-3#1)(1996-11#1)
way to study the##3##4##(2008-10#1)(2008-9#1)(2013-8#1)
way to study##5##3##(2008-10#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-8#1)
way to tackle##2##3##(2007-7#1)(2012-1#1)
way to test##2##3##(2007-12#1)(2009-8#1)
way to that of##2##4##(2008-1#1)(2008-9#1)
way to the##10##3##(1991-1#1)(1991-7#1)(1996-4#1)(1997-1#1)(2008-5#1)(2010-7#1)(2011-1#2)(2013-1#1)(2013-8#1)
way to think##2##3##(2008-6#1)(2010-8#1)
way to treat the##3##4##(2008-12#1)(2013-1#2)
way to treat##5##3##(2008-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
way to understand##2##3##(2006-11#1)(2008-11#1)
way to use##2##3##(2005-7#1)(2013-7#1)
way to##403##2##(1990-11#1)(1990-12#1)(1990-6#2)(1991-1#2)(1991-11#3)(1991-12#1)(1991-2#4)(1991-3#1)(1991-4#3)(1991-5#2)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#1)(1993-7#1)(1994-12#1)(1994-2#2)(1994-3#5)(1994-4#1)(1994-6#2)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#2)(1995-2#4)(1996-1#4)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-1#3)(1997-2#6)(1997-3#2)(1997-5#1)(1997-6#3)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#5)(2005-12#1)(2005-5#1)(2005-6#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#6)(2006-11#2)(2006-12#4)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#3)(2007-11#15)(2007-12#13)(2007-2#4)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#4)(2007-9#4)(2008-1#2)(2008-10#25)(2008-11#13)(2008-12#5)(2008-2#15)(2008-3#7)(2008-4#4)(2008-5#5)(2008-6#8)(2008-7#12)(2008-8#12)(2008-9#10)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#5)(2010-11#1)(2010-12#5)(2010-2#3)(2010-3#5)(2010-4#3)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#3)(2011-1#10)(2011-2#10)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#9)(2012-3#8)(2013-1#11)(2013-7#3)(2013-8#5)
way toward##7##2##(1990-11#1)(1992-12#1)(1996-1#1)(2007-8#1)(2008-1#1)(2008-8#1)(2009-9#1)
way towards##6##2##(1993-11#1)(2007-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-11#1)
way using##4##2##(2007-11#1)(2008-10#1)(2010-1#1)(2013-1#1)
way we show that##2##4##(1993-2#1)(2008-3#1)
way we##22##2##(1991-2#1)(1993-2#1)(1994-2#1)(2005-7#1)(2006-2#1)(2007-12#1)(2007-8#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2009-8#1)(2010-7#1)(2011-2#2)(2012-2#2)(2013-7#1)
way were##2##2##(2007-11#1)(2008-10#1)
way will##2##2##(1997-8#1)(2007-11#1)
way with##4##2##(1992-5#1)(2005-1#1)(2008-3#1)(2008-5#1)
way##1634##1##(1990-10#2)(1990-11#4)(1990-12#6)(1990-2#1)(1990-3#3)(1990-4#3)(1990-5#4)(1990-6#4)(1990-8#3)(1990-9#4)(1991-1#5)(1991-10#2)(1991-11#6)(1991-12#4)(1991-2#8)(1991-3#5)(1991-4#9)(1991-5#5)(1991-6#5)(1991-7#2)(1991-8#5)(1991-9#5)(1992-1#5)(1992-10#2)(1992-11#4)(1992-12#7)(1992-2#2)(1992-3#9)(1992-5#6)(1992-6#3)(1992-7#4)(1992-8#2)(1992-9#5)(1993-1#2)(1993-10#1)(1993-11#6)(1993-12#7)(1993-2#4)(1993-3#8)(1993-5#4)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#3)(1994-10#2)(1994-11#1)(1994-12#7)(1994-2#6)(1994-3#9)(1994-4#1)(1994-5#4)(1994-6#10)(1994-7#1)(1994-8#2)(1994-9#5)(1995-1#11)(1995-11#4)(1995-12#9)(1995-2#10)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#6)(1995-9#1)(1996-1#12)(1996-11#3)(1996-12#7)(1996-2#7)(1996-3#7)(1996-4#1)(1996-5#2)(1996-6#5)(1996-7#6)(1996-8#1)(1996-9#4)(1997-1#4)(1997-2#14)(1997-3#4)(1997-4#5)(1997-5#5)(1997-6#6)(1997-7#3)(1997-8#11)(2004-10#3)(2004-11#1)(2004-12#2)(2004-2#1)(2004-3#3)(2004-4#2)(2004-9#3)(2005-1#1)(2005-10#5)(2005-11#10)(2005-12#1)(2005-3#1)(2005-4#2)(2005-5#3)(2005-6#1)(2005-7#5)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#26)(2006-11#5)(2006-12#11)(2006-2#9)(2006-3#3)(2006-4#8)(2006-5#10)(2006-6#4)(2006-7#6)(2006-8#9)(2006-9#8)(2007-1#2)(2007-10#6)(2007-11#35)(2007-12#46)(2007-2#11)(2007-3#2)(2007-4#9)(2007-5#5)(2007-6#4)(2007-7#7)(2007-8#27)(2007-9#17)(2008-1#20)(2008-10#114)(2008-11#53)(2008-12#25)(2008-2#63)(2008-3#52)(2008-4#19)(2008-5#28)(2008-6#21)(2008-7#46)(2008-8#41)(2008-9#25)(2009-1#2)(2009-10#17)(2009-11#4)(2009-12#3)(2009-2#5)(2009-3#7)(2009-4#7)(2009-5#5)(2009-6#6)(2009-7#9)(2009-8#14)(2009-9#5)(2010-1#3)(2010-10#3)(2010-11#5)(2010-12#13)(2010-2#10)(2010-3#7)(2010-4#11)(2010-5#13)(2010-6#3)(2010-7#7)(2010-8#14)(2010-9#7)(2011-1#26)(2011-12#5)(2011-2#39)(2012-1#18)(2012-10#2)(2012-11#8)(2012-12#16)(2012-2#24)(2012-3#27)(2013-1#36)(2013-7#6)(2013-8#29)
way&quot##3##1##(2008-12#2)(2012-2#1)
way?##5##1##(2006-7#1)(2007-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
wayfinding##4##1##(2012-12#2)(2012-2#2)
ways and thus##2##3##(1992-12#1)(2007-3#1)
ways and##13##2##(1990-2#1)(1991-3#1)(1992-12#1)(1995-5#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-5#1)(2010-9#1)(2013-1#1)
ways are##2##2##(2005-10#1)(2011-2#1)
ways by which##3##3##(1997-2#1)(2008-3#1)(2013-1#1)
ways by##5##2##(1991-11#1)(1997-2#1)(2007-4#1)(2008-3#1)(2013-1#1)
ways for controlling##2##3##(2006-12#1)(2008-10#1)
ways for##8##2##(1997-1#1)(2006-1#1)(2006-12#1)(2006-6#1)(2008-10#2)(2008-2#1)(2010-9#1)
ways forward##3##2##(2008-10#1)(2010-4#1)(2012-2#1)
ways from those##2##3##(1996-6#1)(2009-12#1)
ways have##2##2##(1994-3#1)(2006-6#1)
ways health care##3##3##(1992-3#1)(1994-3#1)(2006-2#1)
ways how##3##2##(1990-11#1)(2005-1#1)(2012-12#1)
ways in which a##2##4##(2008-4#1)(2009-12#1)
ways in which it##4##4##(2007-5#1)(2007-7#1)(2008-8#1)(2012-3#1)
ways in which public##2##4##(1996-3#1)(2008-9#1)
ways in which the##11##4##(1994-11#1)(1994-3#1)(1995-3#1)(2007-1#1)(2008-10#1)(2008-2#1)(2008-7#2)(2009-12#1)(2009-5#1)(2010-2#1)
ways in which these##4##4##(2006-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
ways in which to##3##4##(1996-3#1)(2008-3#2)
ways in which##81##3##(1991-3#2)(1992-12#1)(1992-2#2)(1994-11#1)(1994-3#1)(1995-3#1)(1996-1#1)(1996-3#2)(1997-7#1)(2005-11#1)(2005-5#1)(2005-7#1)(2006-10#4)(2006-11#1)(2006-7#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#4)(2008-9#1)(2009-12#2)(2009-4#2)(2009-5#2)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#1)
ways in##89##2##(1991-3#2)(1992-12#1)(1992-2#2)(1992-4#1)(1993-12#1)(1994-11#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-3#2)(1997-3#1)(1997-7#1)(2005-11#1)(2005-5#1)(2005-7#1)(2006-10#4)(2006-11#1)(2006-7#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#4)(2008-9#1)(2009-12#2)(2009-4#2)(2009-5#2)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-3#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#4)(2012-9#1)(2013-1#1)
ways is##2##2##(2008-7#1)(2010-2#1)
ways not##3##2##(1996-5#1)(2007-8#1)(2009-11#1)
ways of achieving##4##3##(1990-6#1)(2005-10#1)(2007-11#1)(2008-3#1)
ways of controlling##5##3##(1993-6#1)(1994-6#1)(1996-4#1)(1997-8#1)(2009-5#1)
ways of coping and##2##4##(1990-10#1)(2011-2#1)
ways of coping##4##3##(1990-10#2)(2011-2#2)
ways of delivering##2##3##(1995-1#1)(2006-2#1)
ways of doing business##2##4##(1993-2#1)(1994-3#1)
ways of doing##3##3##(1993-2#1)(1994-3#1)(2008-2#1)
ways of improving##2##3##(1992-11#1)(2008-2#1)
ways of preventing##3##3##(2006-3#1)(2007-11#1)(2007-8#1)
ways of providing##3##3##(1992-12#1)(1994-3#1)(2008-1#1)
ways of thinking about##3##4##(1992-1#1)(2008-2#1)(2010-5#1)
ways of thinking##5##3##(1992-1#1)(2008-2#1)(2008-7#1)(2010-5#1)(2013-1#1)
ways of understanding development as a teacher##2##7##(2012-1#2)
ways of understanding development##3##4##(2012-1#3)
ways of understanding##4##3##(2007-3#1)(2012-1#3)
ways of using##4##3##(1991-2#1)(2007-7#1)(2010-12#1)(2010-9#1)
ways of##116##2##(1990-10#2)(1990-12#1)(1990-3#2)(1990-6#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-9#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-4#1)(1997-8#2)(2005-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#5)(2007-2#2)(2007-3#1)(2007-6#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#3)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#4)(2009-3#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-11#3)(2010-12#3)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#3)(2012-11#4)(2012-2#2)(2013-1#4)(2013-8#3)
ways on##3##2##(1993-7#1)(1996-1#1)(2012-3#1)
ways ranging from##2##3##(2006-11#1)(2008-5#1)
ways than##2##2##(2008-10#1)(2011-12#1)
ways that have##2##3##(2006-10#1)(2006-4#1)
ways that this##2##3##(2008-12#1)(2010-2#1)
ways that##47##2##(1990-7#1)(1992-3#1)(1994-2#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-7#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-4#1)(2006-5#2)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#7)(2013-7#1)
ways the##5##2##(1996-2#1)(1996-3#1)(1997-4#1)(2007-4#1)(2007-7#1)
ways they##2##2##(2004-12#1)(2007-10#1)
ways through which##2##3##(2008-5#1)(2010-4#1)
ways to assess##3##3##(2008-5#1)(2011-2#1)(2013-1#1)
ways to avoid them##2##4##(2007-8#1)(2010-8#1)
ways to better##2##3##(2005-11#1)(2009-4#1)
ways to compensate##2##3##(1997-1#1)(2006-5#1)
ways to control##2##3##(2006-10#1)(2009-6#1)
ways to create##2##3##(2008-9#1)(2009-9#1)
ways to cure##2##3##(2008-11#1)(2010-12#1)
ways to cut##2##3##(1990-4#1)(2008-8#1)
ways to deal with##2##4##(2007-3#1)(2007-9#1)
ways to design##2##3##(2008-7#1)(2010-11#1)
ways to determine the##2##4##(1994-1#1)(2008-2#1)
ways to develop##3##3##(1992-2#1)(2005-8#1)(2013-1#1)
ways to eliminate##2##3##(2008-4#1)(2010-11#1)
ways to enhance##2##3##(2007-4#1)(2012-3#1)
ways to express##2##3##(1995-1#1)(2007-2#1)
ways to help##3##3##(1994-1#1)(1995-9#1)(2010-4#1)
ways to identify##2##3##(2004-4#1)(2006-10#1)
ways to implement##2##3##(2005-12#1)(2012-2#1)
ways to improve the##5##4##(1994-2#1)(2008-8#1)(2008-9#1)(2010-4#1)(2013-8#1)
ways to improve##16##3##(1994-2#1)(1996-12#1)(1996-3#1)(1997-3#1)(2007-10#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#1)(2012-12#1)(2013-8#2)
ways to incorporate##2##3##(1996-11#1)(2008-6#1)
ways to increase the##4##4##(1996-9#1)(2008-5#1)(2011-1#1)(2012-12#1)
ways to increase##6##3##(1996-9#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-12#1)(2012-3#1)
ways to measure the performance of fund development programs##2##9##(1995-1#1)(1995-3#1)
ways to measure the##3##4##(1995-1#1)(1995-3#1)(2008-4#1)
ways to measure##5##3##(1995-1#1)(1995-3#1)(2006-10#1)(2008-4#1)(2010-2#1)
ways to overcome the##2##4##(1991-2#1)(2008-10#1)
ways to overcome##3##3##(1991-2#1)(2007-11#1)(2008-10#1)
ways to prevent##6##3##(1996-5#1)(2006-2#1)(2007-9#1)(2008-11#2)(2009-9#1)
ways to promote##4##3##(2005-7#1)(2008-12#1)(2013-7#2)
ways to reduce the##2##4##(1996-12#1)(2010-1#1)
ways to reduce##6##3##(1993-2#1)(1996-12#1)(2007-11#2)(2007-9#1)(2010-1#1)
ways to support patients##2##4##(2008-1#1)(2011-1#1)
ways to support##4##3##(1992-3#1)(2008-1#1)(2011-1#1)(2013-7#1)
ways to take care in##2##5##(2011-2#2)
ways to tune the##2##4##(1992-3#1)(2010-2#1)
ways to use##2##3##(2006-10#1)(2008-11#1)
ways to work##2##3##(1996-12#1)(2008-12#1)
ways to##192##2##(1990-12#2)(1990-4#1)(1990-8#1)(1991-1#1)(1991-2#2)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#2)(1993-1#1)(1993-12#1)(1993-2#1)(1994-1#2)(1994-12#2)(1994-2#5)(1994-9#1)(1995-1#4)(1995-11#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#3)(1996-3#2)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#2)(2004-4#1)(2005-11#1)(2005-12#3)(2005-7#1)(2005-8#1)(2006-10#4)(2006-2#1)(2006-4#1)(2006-5#2)(2007-10#2)(2007-11#5)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#3)(2007-5#1)(2007-8#1)(2007-9#3)(2008-1#4)(2008-10#6)(2008-11#6)(2008-12#3)(2008-2#5)(2008-3#5)(2008-4#5)(2008-5#12)(2008-6#1)(2008-7#10)(2008-8#3)(2008-9#5)(2009-4#1)(2009-6#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#6)(2013-7#4)(2013-8#2)
ways when##2##2##(1993-1#1)(2008-7#1)
ways which##5##2##(1997-4#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
ways with##3##2##(1994-5#1)(2006-3#1)(2008-4#1)
ways##719##1##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#3)(1990-4#1)(1990-6#2)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#4)(1991-12#2)(1991-2#4)(1991-3#5)(1991-5#1)(1992-1#3)(1992-10#1)(1992-11#4)(1992-12#6)(1992-2#4)(1992-3#5)(1992-4#1)(1992-9#1)(1993-1#2)(1993-12#3)(1993-2#3)(1993-3#2)(1993-6#1)(1993-7#1)(1994-1#2)(1994-11#1)(1994-12#6)(1994-2#8)(1994-3#6)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#5)(1995-10#2)(1995-11#1)(1995-12#1)(1995-3#3)(1995-4#1)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#4)(1996-11#2)(1996-12#4)(1996-2#2)(1996-3#9)(1996-4#5)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#4)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#5)(1997-8#6)(2004-12#1)(2004-4#1)(2005-1#1)(2005-10#3)(2005-11#3)(2005-12#3)(2005-5#1)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#14)(2006-11#2)(2006-12#4)(2006-2#3)(2006-3#2)(2006-4#3)(2006-5#5)(2006-6#4)(2006-7#5)(2006-8#2)(2007-1#1)(2007-10#4)(2007-11#15)(2007-12#4)(2007-2#5)(2007-3#6)(2007-4#7)(2007-5#2)(2007-6#3)(2007-7#6)(2007-8#9)(2007-9#4)(2008-1#10)(2008-10#31)(2008-11#19)(2008-12#11)(2008-2#14)(2008-3#17)(2008-4#9)(2008-5#22)(2008-6#5)(2008-7#32)(2008-8#16)(2008-9#15)(2009-11#2)(2009-12#5)(2009-2#1)(2009-3#1)(2009-4#6)(2009-5#4)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#4)(2010-1#2)(2010-10#4)(2010-11#5)(2010-12#8)(2010-2#11)(2010-3#4)(2010-4#6)(2010-5#4)(2010-6#1)(2010-8#1)(2010-9#4)(2011-1#16)(2011-12#1)(2011-2#15)(2012-1#5)(2012-11#4)(2012-12#12)(2012-2#9)(2012-3#14)(2012-9#1)(2013-1#28)(2013-7#9)(2013-8#9)
wc-1##2##1##(1994-5#2)
wc-2##2##1##(1994-5#2)
wcmmVtg##4##1##(2010-5#4)
we (1)##2##2##(1992-3#1)(2012-3#1)
we a##2##2##(2008-4#1)(2012-2#1)
we accept the##2##3##(2006-10#1)(2008-10#1)
we accomplish##2##2##(1992-8#1)(2008-2#1)
we achieve high##3##3##(2007-12#1)(2013-1#2)
we achieve the##2##3##(2007-12#1)(2009-9#1)
we achieve##13##2##(1995-11#1)(2007-11#2)(2007-12#4)(2008-3#2)(2008-6#1)(2009-9#1)(2013-1#2)
we achieved a##6##3##(1997-4#1)(2007-12#1)(2008-10#1)(2008-3#3)
we achieved an##5##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)
we achieved##32##2##(1997-4#1)(2005-4#1)(2006-6#1)(2007-11#2)(2007-12#5)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#12)(2008-6#1)(2012-2#1)
we acknowledge##2##2##(2008-7#1)(2008-8#1)
we adapt the##3##3##(2007-12#1)(2008-8#2)
we adapt##4##2##(2007-12#1)(2008-8#2)(2012-3#1)
we adapted##2##2##(1995-5#1)(2007-12#1)
we add a##3##3##(2007-6#1)(2008-3#1)(2012-2#1)
we add##4##2##(2007-3#1)(2007-6#1)(2008-3#1)(2012-2#1)
we added##4##2##(1994-8#1)(2007-10#1)(2008-2#1)(2013-1#1)
we address key##2##3##(2008-11#2)
we address the question of##2##5##(1990-5#1)(2008-9#1)
we address the##13##3##(1990-5#1)(1990-9#1)(1994-5#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-7#1)(2008-2#1)(2008-9#1)(2010-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
we address these##2##3##(2008-5#1)(2009-2#1)
we address##26##2##(1990-5#1)(1990-9#1)(1994-5#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-9#1)(2011-1#2)(2012-1#2)(2012-12#1)(2013-1#2)(2013-8#1)
we addressed the question of the##2##6##(1997-8#1)(2011-2#1)
we addressed the question of##3##5##(1997-6#1)(1997-8#1)(2011-2#1)
we addressed the question##4##4##(1994-8#1)(1997-6#1)(1997-8#1)(2011-2#1)
we addressed the##5##3##(1994-8#1)(1997-6#1)(1997-8#1)(2011-2#1)(2012-3#1)
we addressed##9##2##(1994-8#1)(1997-6#1)(1997-8#1)(2006-12#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#1)
we administered a##3##3##(1990-5#1)(1994-2#1)(2006-10#1)
we administered##17##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-9#1)(1994-2#1)(2006-10#1)(2007-6#2)(2008-7#1)(2008-9#1)(2009-2#1)(2011-1#1)(2012-12#1)(2013-1#1)
we adopt a##3##3##(1995-4#1)(2006-10#1)(2008-3#1)
we adopted##2##2##(1996-5#1)(2008-9#1)
we advocate##4##2##(2007-8#1)(2008-10#1)(2011-2#1)(2012-2#1)
we aim at minimizing unnecessary invasive procedures (thus decreasing false positives) and concomitantly addressing overdiagnosis##2##15##(2013-1#2)
we aim for##2##3##(2006-4#2)
we aim to##17##3##(2005-7#2)(2006-10#1)(2006-4#1)(2007-10#1)(2008-7#3)(2010-12#1)(2010-7#2)(2011-2#1)(2012-1#1)(2013-1#3)(2013-8#1)
we aim##21##2##(2005-7#2)(2006-10#1)(2006-4#3)(2007-10#1)(2008-7#3)(2010-12#1)(2010-7#2)(2011-2#1)(2012-1#1)(2013-1#5)(2013-8#1)
we aimed at##2##3##(1994-5#1)(2008-11#1)
we aimed to evaluate##3##4##(2007-10#1)(2007-8#1)(2010-10#1)
we aimed to investigate the##3##5##(2011-1#1)(2013-7#1)(2013-8#1)
we aimed to##22##3##(2004-2#1)(2007-10#2)(2007-8#2)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-8#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-1#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
we aimed##24##2##(1994-5#1)(2004-2#1)(2007-10#2)(2007-8#2)(2008-1#1)(2008-11#2)(2008-5#1)(2008-7#2)(2009-8#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-1#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
we all##3##2##(1994-2#1)(1995-1#1)(2012-2#1)
we also conducted##2##3##(2007-7#1)(2012-3#1)
we also demonstrate that##2##4##(1991-12#1)(2010-12#1)
we also demonstrate the##2##4##(2008-3#1)(2012-2#1)
we also demonstrate##7##3##(1991-12#1)(1993-12#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-12#1)(2012-2#1)
we also demonstrated that##2##4##(1994-3#1)(2003-11#1)
we also demonstrated##3##3##(1994-3#1)(2003-11#1)(2008-5#1)
we also describe##2##3##(2008-2#1)(2009-6#1)
we also detected the presence of##2##6##(2007-11#1)(2008-5#1)
we also detected##4##3##(1995-5#1)(2007-11#1)(2007-12#1)(2008-5#1)
we also developed a##2##4##(1996-6#1)(2008-8#1)
we also developed##3##3##(1996-6#1)(2008-8#1)(2012-3#1)
we also discuss the##5##4##(1992-5#1)(2008-2#1)(2009-8#2)(2013-1#1)
we also discuss##7##3##(1992-5#1)(2007-5#1)(2008-11#1)(2008-2#1)(2009-8#2)(2013-1#1)
we also examined the##2##4##(1994-3#1)(1995-11#1)
we also examined##6##3##(1994-3#1)(1995-11#1)(2006-6#1)(2008-11#1)(2009-8#1)(2011-2#1)
we also found a significant##2##5##(1990-4#1)(1997-6#1)
we also found a##3##4##(1990-4#1)(1991-12#1)(1997-6#1)
we also found areas in which the QDM could be usefully extended##2##12##(2013-1#2)
we also found that the##2##5##(2007-7#1)(2009-8#1)
we also found that##5##4##(2007-11#1)(2007-2#1)(2007-7#1)(2008-9#1)(2009-8#1)
we also found##16##3##(1990-4#1)(1991-12#1)(1992-4#1)(1993-9#1)(1996-12#1)(1997-6#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2013-1#2)
we also have##2##3##(1996-2#1)(2009-2#1)
we also identified##3##3##(1994-12#1)(2008-10#1)(2012-3#1)
we also investigate##4##3##(1995-8#1)(2008-6#1)(2008-8#2)
we also investigated the##3##4##(1994-6#1)(2008-10#1)(2008-4#1)
we also investigated whether##2##4##(1993-6#1)(1996-9#1)
we also investigated##6##3##(1993-6#1)(1994-6#1)(1996-9#1)(2008-10#1)(2008-3#1)(2008-4#1)
we also isolated a##2##4##(1993-6#1)(1997-2#1)
we also measured##3##3##(1992-2#1)(1994-8#1)(2012-1#1)
we also observed a##2##4##(2007-10#1)(2008-3#1)
we also observed##4##3##(2005-11#1)(2007-10#1)(2008-10#1)(2008-3#1)
we also present##6##3##(1990-6#1)(2007-12#1)(2008-3#3)(2011-1#1)
we also report##3##3##(2007-5#1)(2008-2#1)(2011-2#1)
we also review the##2##4##(2010-6#1)(2013-1#1)
we also review##4##3##(2008-8#1)(2009-12#1)(2010-6#1)(2013-1#1)
we also show how the##2##5##(2008-2#1)(2008-7#1)
we also show that the##2##5##(2007-12#1)(2008-2#1)
we also show that##4##4##(1993-8#1)(2007-12#2)(2008-2#1)
we also show##6##3##(1993-8#1)(2007-12#2)(2008-2#2)(2008-7#1)
we also showed that##3##4##(1990-10#1)(1994-8#1)(1996-11#1)
we also used##3##3##(2008-9#2)(2009-10#1)
we also##138##2##(1990-10#1)(1990-4#1)(1990-6#1)(1991-12#2)(1992-11#1)(1992-2#1)(1992-4#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#2)(1995-11#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-6#1)(2003-11#1)(2004-2#1)(2005-11#1)(2005-4#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#7)(2007-2#1)(2007-5#2)(2007-7#2)(2008-10#5)(2008-11#3)(2008-2#11)(2008-3#6)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#7)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#5)(2013-8#1)
we amplified a##2##3##(1992-9#1)(1995-1#1)
we amplified and##2##3##(1991-10#1)(2008-5#1)
we amplified the##2##3##(1990-12#1)(2008-11#1)
we amplified##8##2##(1990-12#1)(1991-10#1)(1992-9#1)(1995-1#1)(1996-3#1)(2008-11#2)(2008-5#1)
we analyse the##6##3##(2008-11#1)(2008-7#3)(2009-5#1)(2012-5#1)
we analyse##12##2##(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#4)(2009-5#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-5#1)
we analysed the expression##2##4##(2006-11#1)(2009-4#1)
we analysed the##11##3##(1990-8#1)(1992-10#1)(1997-8#1)(2006-11#1)(2007-12#1)(2008-7#1)(2009-4#1)(2009-9#1)(2011-2#1)(2012-2#2)
we analysed##20##2##(1990-8#2)(1992-10#1)(1993-12#1)(1993-9#1)(1997-7#1)(1997-8#1)(2006-11#1)(2006-2#1)(2007-12#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-9#1)(2011-2#1)(2012-2#2)(2013-1#1)
we analytically##3##2##(2007-11#1)(2008-3#1)(2012-2#1)
we analyze how tokens and phrases in a large corpus distribute and how well the UMLS captures the semantics##2##19##(2013-1#2)
we analyze how##3##3##(2010-2#1)(2013-1#2)
we analyze in detail the##2##5##(2008-3#1)(2012-3#1)
we analyze the behavior of##2##5##(2007-12#1)(2008-3#1)
we analyze the results obtained in 20 patients treated with phrenic-musculocutaneous nerve transfer to restore elbow flexion after brachial plexus injuries##2##21##(2008-9#2)
we analyze the##22##3##(1990-8#1)(1994-1#1)(2007-12#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-4#1)(2009-7#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
we analyze these##2##3##(2008-6#1)(2008-8#1)
we analyze##43##2##(1990-8#1)(1993-6#1)(1994-1#1)(1994-9#1)(1995-1#1)(2004-10#1)(2005-10#1)(2007-12#2)(2007-6#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#2)(2009-4#1)(2009-7#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#3)
we analyzed a##2##3##(1991-3#1)(2008-11#1)
we analyzed and compared the therapeutic effects of oncolytic herpes simplex virus (oHSV) type 1 G47Δ (γ34##2##17##(2012-12#2)
we analyzed and compared the##3##5##(2012-12#2)(2012-2#1)
we analyzed data from##2##4##(1991-2#1)(2012-2#1)
we analyzed data##3##3##(1991-2#1)(2009-7#1)(2012-2#1)
we analyzed its##2##3##(2008-9#1)(2010-4#1)
we analyzed the clinical##3##4##(1991-3#1)(2006-10#1)(2011-2#1)
we analyzed the effect of##2##5##(1993-7#1)(2013-1#1)
we analyzed the effects of##2##5##(1995-1#1)(2010-7#1)
we analyzed the expression##2##4##(1995-2#1)(2013-1#1)
we analyzed the relationship between##2##5##(1994-9#1)(2007-9#1)
we analyzed the role of##2##5##(1995-2#1)(2013-1#1)
we analyzed the##59##3##(1990-11#1)(1990-9#1)(1991-12#2)(1991-3#1)(1992-11#1)(1993-7#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-4#2)(1997-6#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#4)(2008-4#1)(2009-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#7)(2013-7#1)
we analyzed whether the##2##4##(1995-12#1)(2008-10#1)
we analyzed whether##3##3##(1995-12#1)(2008-10#1)(2013-1#1)
we analyzed##124##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#2)(1992-11#1)(1993-5#1)(1993-7#1)(1994-12#3)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#2)(1995-2#2)(1995-6#1)(1996-12#2)(1996-4#1)(1996-6#2)(1996-8#1)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#2)(2004-11#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-4#1)(2007-7#3)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#8)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#4)(2009-10#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#12)(2013-7#1)(2013-8#2)
we and others have demonstrated that##2##6##(2007-11#1)(2012-12#1)
we and others have shown##2##5##(1996-5#1)(2008-11#1)
we and others have##6##4##(1996-5#1)(2007-11#1)(2008-1#1)(2008-11#1)(2009-8#1)(2012-12#1)
we and##11##2##(1990-6#1)(1996-5#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2009-3#1)(2009-5#1)(2009-8#1)(2012-12#1)(2013-1#1)
we anticipate##3##2##(2008-5#1)(2009-12#1)(2012-12#1)
we anticipated##2##2##(1991-9#1)(1995-5#1)
we applied a combination of##2##5##(2007-8#1)(2008-10#1)
we applied a##10##3##(1993-12#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-8#1)(2012-3#2)
we applied the##8##3##(1993-3#1)(1994-9#1)(1997-8#1)(2008-5#1)(2009-10#1)(2010-2#1)(2010-5#1)(2010-8#1)
we applied##44##2##(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-9#1)(1996-2#1)(1996-5#2)(1997-2#3)(1997-4#1)(1997-8#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#3)(2008-8#1)(2009-10#2)(2009-12#1)(2010-12#2)(2010-2#1)(2010-5#2)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#3)(2013-8#1)
we apply a##5##3##(1996-4#1)(2008-12#1)(2008-2#1)(2010-2#1)(2010-5#1)
we apply it to##2##4##(1997-8#1)(2008-2#1)
we apply it##3##3##(1997-8#1)(2008-2#1)(2011-1#1)
we apply only##2##3##(2008-3#2)
we apply our##2##3##(1997-6#1)(2008-2#1)
we apply the##6##3##(2007-12#1)(2008-2#1)(2008-5#1)(2010-2#1)(2010-8#1)(2012-3#1)
we apply##33##2##(1993-1#1)(1996-4#1)(1997-6#1)(1997-8#1)(2005-11#1)(2007-12#3)(2007-9#1)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-2#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2012-3#2)(2013-7#1)
we approach the##2##3##(2005-8#1)(2008-4#1)
we approach##4##2##(2005-8#1)(2008-10#1)(2008-4#1)(2013-7#1)
we are able to construct##2##5##(2006-12#1)(2007-12#1)
we are able to estimate the##2##6##(2008-10#1)(2009-11#1)
we are able to learn accurate models for this task##2##10##(2013-1#2)
we are able to predict the##2##6##(1990-7#1)(2007-12#1)
we are able to use##2##5##(1992-10#1)(2007-11#1)
we are able to##36##4##(1990-7#1)(1990-8#1)(1992-10#1)(1994-5#1)(2006-10#1)(2006-12#2)(2007-11#3)(2007-12#6)(2007-9#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-9#1)(2009-10#1)(2009-11#2)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
we are able##37##3##(1990-7#1)(1990-8#1)(1992-10#1)(1994-5#1)(2006-10#1)(2006-12#2)(2007-11#3)(2007-12#6)(2007-9#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-9#1)(2009-10#1)(2009-11#2)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
we are aware of the##3##5##(1992-12#1)(2007-10#1)(2008-3#1)
we are aware of##4##4##(1992-12#1)(2007-10#1)(2008-3#1)(2008-6#1)
we are aware##9##3##(1992-12#1)(1993-6#1)(1995-8#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-12#1)(2008-3#1)(2008-6#1)
we are beginning to understand##2##5##(2006-10#1)(2007-4#1)
we are beginning to##3##4##(2006-10#1)(2007-4#1)(2008-8#1)
we are concerned with##2##4##(2009-12#1)(2010-12#1)
we are currently##4##3##(1996-2#1)(2005-11#1)(2008-6#1)(2008-7#1)
we are developing a visual ontology for biomedical image retrieval##2##10##(2013-1#2)
we are developing a##4##4##(1995-2#1)(2007-6#1)(2013-1#2)
we are developing##6##3##(1995-2#1)(2007-6#1)(2008-11#1)(2011-1#1)(2013-1#2)
we are discussing the##2##4##(2009-10#1)(2011-2#1)
we are discussing##3##3##(2009-10#2)(2011-2#1)
we are expecting the##2##4##(2010-8#2)
we are expecting##3##3##(1997-8#1)(2010-8#2)
we are exploring##2##3##(1994-6#1)(2007-12#1)
we are faced with##4##4##(1995-12#1)(2010-11#1)(2010-12#1)(2011-1#1)
we are going to##4##4##(2006-6#1)(2012-3#1)(2013-1#2)
we are going##8##3##(1994-12#1)(2006-6#1)(2009-5#1)(2012-3#1)(2013-1#4)
we are in a##3##4##(1990-5#1)(2008-11#1)(2008-3#1)
we are in##5##3##(1990-5#1)(1991-4#1)(2007-12#1)(2008-11#1)(2008-3#1)
we are interested in##2##4##(2005-11#1)(2009-2#1)
we are not able to##2##5##(1990-10#1)(2011-2#1)
we are not going to##2##5##(2005-7#1)(2007-3#1)
we are not##7##3##(1990-10#1)(2005-7#1)(2007-3#1)(2007-8#1)(2008-12#1)(2008-4#1)(2011-2#1)
we are now##5##3##(1992-4#1)(2008-8#1)(2010-3#1)(2010-5#1)(2011-2#1)
we are obliged to##2##4##(1996-3#1)(2009-9#1)
we are presenting a##2##4##(1992-11#1)(2008-10#1)
we are presenting##6##3##(1992-11#1)(2008-10#1)(2010-7#1)(2012-12#1)(2013-1#2)
we are reporting a case of a##2##7##(2013-8#2)
we are reporting a case of##9##6##(2008-7#1)(2010-11#1)(2011-1#1)(2012-2#1)(2013-8#5)
we are reporting a##11##4##(2008-7#1)(2009-9#1)(2010-1#1)(2010-11#1)(2011-1#1)(2012-2#1)(2013-8#5)
we are reporting##14##3##(2006-12#1)(2008-7#1)(2009-9#1)(2010-1#1)(2010-11#1)(2011-1#1)(2012-2#1)(2013-8#7)
we are therefore##2##3##(1996-7#1)(2005-10#1)
we are to understand##3##4##(2007-6#1)(2008-11#1)(2008-2#1)
we are to##16##3##(1992-9#1)(1997-3#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-6#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-6#1)(2010-3#1)(2013-1#1)
we are unable to##2##4##(2006-8#1)(2012-1#1)
we are using##2##3##(2008-2#1)(2008-7#1)
we are witnessing a##2##4##(2010-8#1)(2011-1#1)
we are##198##2##(1990-10#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-4#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-3#2)(1993-6#2)(1994-1#1)(1994-12#2)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#7)(2006-12#3)(2006-2#1)(2006-5#1)(2006-6#3)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#9)(2007-3#1)(2007-4#3)(2007-6#4)(2007-8#3)(2007-9#3)(2008-1#3)(2008-10#3)(2008-11#5)(2008-12#6)(2008-2#7)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#3)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-9#2)(2010-1#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#13)(2013-8#8)
we argue that a##3##4##(2008-11#1)(2008-2#1)(2008-8#1)
we argue that the precise retrieval of such diagrams is of great value for answering specific and otherwise hard-to-meet information needs##2##21##(2013-1#2)
we argue that the##10##4##(1992-2#1)(1996-10#1)(2007-12#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-2#1)(2013-1#2)
we argue that##31##3##(1991-11#1)(1992-11#1)(1992-2#1)(1996-10#1)(2005-7#1)(2006-11#1)(2006-5#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-2#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)
we argue##37##2##(1991-11#1)(1992-11#1)(1992-2#1)(1996-10#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)
we as a##2##3##(2008-12#1)(2011-2#1)
we as##3##2##(2008-12#1)(2009-3#1)(2011-2#1)
we ask how##2##3##(2008-7#1)(2011-2#1)
we ask whether##3##3##(2008-7#1)(2009-2#1)(2011-12#1)
we ask##7##2##(1993-12#1)(2008-7#2)(2009-2#1)(2010-2#1)(2011-12#1)(2011-2#1)
we asked whether##7##3##(1995-2#1)(1996-5#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-7#1)(2013-8#1)
we asked##15##2##(1990-11#1)(1995-2#1)(1996-5#1)(2005-7#1)(2006-6#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-11#1)(2012-12#1)(2012-3#1)(2012-7#1)(2013-8#1)
we assayed##3##2##(1990-11#1)(2006-10#1)(2011-2#1)
we assess the##9##3##(1996-2#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
we assess whether##2##3##(2008-8#1)(2010-11#1)
we assess##14##2##(1996-2#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#2)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
we assessed the acceptability of the family-focused intervention and its effect on information-seeking behavior##2##14##(2013-1#2)
we assessed the effect of##4##5##(1994-3#1)(1996-12#1)(2008-8#1)(2012-2#1)
we assessed the effects of##6##5##(1994-6#1)(1995-5#1)(2006-3#1)(2009-10#1)(2012-3#2)
we assessed the##39##3##(1993-1#1)(1993-5#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-5#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-9#1)(2004-11#1)(2006-2#1)(2006-3#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-9#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-2#1)(2010-2#1)(2010-3#1)(2010-7#1)(2012-2#2)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#1)
we assessed##64##2##(1993-1#1)(1993-3#1)(1993-5#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-5#2)(1996-10#1)(1996-12#2)(1996-2#1)(1996-7#1)(1996-9#1)(2004-11#1)(2006-10#1)(2006-2#1)(2006-3#1)(2007-12#2)(2007-2#1)(2007-7#2)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-6#2)(2009-9#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#6)(2013-7#2)(2013-8#2)
we assigned a##2##3##(1995-3#1)(1996-6#1)
we associate with##2##3##(1991-7#1)(2008-10#1)
we assume that the##2##4##(1997-7#1)(2008-3#1)
we assume that##8##3##(1991-7#1)(1997-7#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-3#1)
we assume##12##2##(1991-7#1)(1995-12#1)(1996-4#1)(1997-1#1)(1997-7#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-3#2)
we assumed that the##2##4##(1995-6#1)(2013-1#1)
we assumed that##4##3##(1995-6#1)(2004-11#1)(2008-8#1)(2013-1#1)
we assumed##5##2##(1991-11#1)(1995-6#1)(2004-11#1)(2008-8#1)(2013-1#1)
we at##2##2##(1996-1#1)(2008-9#1)
we attempt to clarify##2##4##(2008-1#1)(2009-2#1)
we attempt to link##2##4##(2008-2#1)(2008-8#1)
we attempt to##21##3##(1993-12#1)(1996-10#1)(2005-10#1)(2007-11#1)(2008-1#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-2#1)(2009-4#1)(2010-2#1)(2012-2#1)(2012-3#1)
we attempted to define##2##4##(1993-12#1)(1994-6#1)
we attempted to detect the##2##5##(1994-3#1)(2008-10#1)
we attempted to establish the##2##5##(2010-12#1)(2012-3#1)
we attempted to evaluate the##2##5##(1996-6#1)(2008-10#1)
we attempted to evaluate##3##4##(1996-6#1)(2008-10#1)(2008-11#1)
we attempted to identify##5##4##(1994-8#1)(2007-3#1)(2008-10#1)(2009-10#1)(2012-12#1)
we attempted to replicate##2##4##(1994-2#1)(2009-4#1)
we attempted to##34##3##(1990-5#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-4#1)(1996-6#1)(1997-4#1)(2006-10#1)(2007-3#1)(2008-10#3)(2008-11#4)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#2)(2009-4#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
we attempted##37##2##(1990-5#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-4#1)(1996-6#1)(1997-4#1)(2006-10#1)(2007-3#1)(2008-10#3)(2008-11#4)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#2)(2009-4#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
we attribute to a##2##4##(2008-1#1)(2008-3#1)
we attribute to the##3##4##(1992-8#1)(2008-7#1)(2008-9#1)
we attribute to##7##3##(1992-8#1)(2008-1#2)(2008-3#1)(2008-7#2)(2008-9#1)
we attribute##8##2##(1992-8#1)(2008-1#2)(2008-3#1)(2008-7#2)(2008-9#1)(2010-2#1)
we attributed to##2##3##(2005-1#1)(2008-8#1)
we attributed##3##2##(1993-5#1)(2005-1#1)(2008-8#1)
we avoid##2##2##(2005-12#1)(2006-4#1)
we avoided##2##2##(2007-8#1)(2009-11#1)
we await##2##2##(2004-1#1)(2006-12#1)
we be##7##2##(1991-6#1)(1994-3#1)(2006-10#2)(2006-12#1)(2008-11#1)(2012-2#1)
we began by##2##3##(1996-10#1)(2012-12#1)
we began##3##2##(1996-10#1)(1996-11#1)(2012-12#1)
we begin by##2##3##(1993-1#1)(2008-11#1)
we begin to##4##3##(2008-11#1)(2009-12#1)(2010-11#1)(2013-8#1)
we begin##8##2##(1993-1#1)(2005-11#1)(2008-11#2)(2009-12#1)(2010-11#1)(2011-2#1)(2013-8#1)
we believe are##7##3##(2006-12#1)(2007-12#3)(2007-4#1)(2009-4#1)(2012-2#1)
we believe is##22##3##(2007-12#5)(2008-1#1)(2008-2#1)(2008-3#14)(2008-9#1)
we believe it is##2##4##(2008-7#1)(2009-5#1)
we believe it##3##3##(1997-2#1)(2008-7#1)(2009-5#1)
we believe that it##2##4##(2008-1#1)(2012-3#1)
we believe that our##2##4##(1991-5#1)(2008-7#1)
we believe that the ADSCs offer advantages because of lower morbidity during the harvesting procedure##2##15##(2012-12#2)
we believe that the##17##4##(1990-8#1)(1991-2#1)(1991-4#1)(1992-2#1)(1995-12#1)(1996-11#1)(1996-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-9#1)(2009-8#1)(2012-1#1)(2012-12#2)
we believe that these tools are essential to ensure that the safety of the &quot##2##15##(2013-1#2)
we believe that this##2##4##(2011-2#2)
we believe that##49##3##(1990-10#2)(1990-8#1)(1991-2#3)(1991-4#1)(1991-5#1)(1992-2#1)(1994-6#1)(1995-12#1)(1996-11#1)(1996-6#1)(1996-7#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#3)(2009-9#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#3)
we believe the##4##3##(1992-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
we believe to be a##8##5##(2007-11#1)(2007-12#1)(2008-3#6)
we believe to be the##19##5##(1994-3#1)(2007-11#1)(2007-12#8)(2007-4#1)(2008-1#3)(2008-2#1)(2008-3#4)
we believe to be##31##4##(1994-3#1)(2007-11#2)(2007-12#10)(2007-4#2)(2008-1#3)(2008-2#1)(2008-3#11)(2008-9#1)
we believe##133##2##(1990-10#2)(1990-8#1)(1991-2#3)(1991-4#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-9#1)(1996-11#1)(1996-6#1)(1996-7#1)(1997-2#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-6#1)(2006-7#1)(2007-11#4)(2007-12#19)(2007-4#4)(2007-7#1)(2008-1#7)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#27)(2008-5#3)(2008-7#6)(2008-9#5)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)
we best##2##2##(2006-10#1)(2009-3#1)
we blocked##2##2##(2007-11#1)(2009-3#1)
we briefly describe##2##3##(2008-7#1)(2012-2#1)
we briefly discuss the##3##4##(2008-3#1)(2010-5#1)(2011-1#1)
we briefly discuss##6##3##(2008-11#2)(2008-3#1)(2010-5#1)(2011-1#1)(2012-2#1)
we briefly highlight##2##3##(2007-12#1)(2010-7#1)
we briefly review the##2##4##(2008-5#1)(2008-7#1)
we briefly summarize##3##3##(2008-11#1)(2008-7#1)(2010-12#1)
we briefly##20##2##(1993-12#1)(2006-3#1)(2007-12#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#3)(2009-3#1)(2010-12#2)(2010-5#1)(2010-7#1)(2011-1#1)(2012-2#2)(2013-8#1)
we build a##4##3##(2008-9#1)(2009-11#2)(2011-1#1)
we build##6##2##(2005-10#1)(2008-9#1)(2009-11#2)(2011-1#1)(2012-2#1)
we built a differential##2##4##(2008-1#1)(2008-3#1)
we built a sequence of supervised classifiers##2##7##(2013-1#2)
we built a##7##3##(2007-3#1)(2007-5#1)(2008-1#1)(2008-3#1)(2009-8#1)(2013-1#2)
we built##9##2##(2007-3#1)(2007-5#1)(2008-1#1)(2008-3#2)(2008-8#1)(2009-8#1)(2013-1#2)
we calculate the##9##3##(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#3)
we calculate##15##2##(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#4)(2008-3#3)(2008-5#1)(2009-2#1)(2011-12#1)(2012-2#1)
we calculated a##2##3##(1992-9#1)(1995-2#1)
we calculated emergency department physician performance and subsequent outcomes on a measure used in the Centers for Medicare &amp##2##19##(2013-1#2)
we calculated the##9##3##(1996-1#1)(2006-2#1)(2007-8#1)(2008-2#1)(2008-3#2)(2011-1#1)(2012-2#1)(2012-5#1)
we calculated##24##2##(1992-6#1)(1992-9#1)(1995-2#1)(1996-1#1)(2006-2#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-2#2)(2008-3#3)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-5#1)(2013-1#3)
we call &quot##3##3##(2008-10#1)(2008-2#2)
we call a##2##3##(2007-11#1)(2008-4#1)
we call the##7##3##(2007-11#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-9#1)(2013-7#1)
we call these##2##3##(2006-12#1)(2011-1#1)
we call##28##2##(1990-12#1)(1990-3#2)(1990-5#1)(1990-6#1)(1994-9#1)(1997-3#1)(2006-12#1)(2007-11#4)(2007-9#1)(2008-10#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#2)(2011-1#1)(2013-7#1)
we called##5##2##(1992-3#1)(1993-4#1)(2008-5#1)(2010-8#1)(2012-2#1)
we can achieve##6##3##(2006-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#1)
we can calculate##2##3##(2008-3#1)(2008-7#1)
we can change the##2##4##(2008-2#1)(2008-3#1)
we can choose##2##3##(2008-5#1)(2010-8#1)
we can conclude that##7##4##(1996-4#1)(2005-9#1)(2006-8#1)(2008-3#1)(2011-2#1)(2011-7#1)(2013-1#1)
we can conclude##8##3##(1996-4#1)(2005-9#1)(2006-8#1)(2008-3#1)(2008-9#1)(2011-2#1)(2011-7#1)(2013-1#1)
we can control##2##3##(2007-12#1)(2011-2#1)
we can develop##2##3##(2008-10#1)(2009-9#1)
we can distinguish##2##3##(1991-7#1)(2008-6#1)
we can establish##2##3##(1995-6#1)(2013-8#1)
we can estimate##2##3##(1992-6#1)(1996-4#1)
we can expect##6##3##(2006-10#1)(2007-2#1)(2008-11#1)(2008-3#1)(2010-3#2)
we can find##2##3##(2007-11#1)(2011-2#1)
we can get##2##3##(2008-3#1)(2010-8#1)
we can have##2##3##(1997-6#1)(2008-12#1)
we can improve the##2##4##(2006-6#1)(2011-2#1)
we can learn from##2##4##(1996-2#1)(2006-7#1)
we can learn##4##3##(1993-12#2)(1996-2#1)(2006-7#1)
we can make##3##3##(1996-2#1)(2006-10#1)(2008-2#1)
we can now##6##3##(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-4#1)
we can observe##3##3##(2007-12#1)(2008-5#1)(2008-7#1)
we can obtain information##2##4##(2007-12#1)(2012-2#1)
we can obtain##6##3##(1997-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-2#1)(2012-2#1)
we can perform##2##3##(2008-2#1)(2012-12#1)
we can predict##3##3##(2008-4#1)(2010-3#1)(2011-2#1)
we can presume that##2##4##(2010-4#1)(2011-1#1)
we can provide##2##3##(2006-6#1)(2008-3#1)
we can realize##2##3##(2007-12#1)(2008-12#1)
we can reduce##2##3##(1990-3#1)(2008-2#1)
we can rely on##2##4##(2008-7#1)(2008-8#1)
we can safely##2##3##(2008-12#1)(2010-2#1)
we can say that##4##4##(2004-9#1)(2006-1#1)(2007-9#1)(2013-7#1)
we can see that##2##4##(2008-11#1)(2008-2#1)
we can see##3##3##(1993-10#1)(2008-11#1)(2008-2#1)
we can show that##2##4##(1994-2#1)(2008-5#1)
we can state that the##2##5##(2007-11#1)(2007-8#1)
we can suppress##2##3##(2006-10#1)(2007-12#1)
we can take##2##3##(1995-1#1)(2008-2#1)
we can then##2##3##(1991-11#1)(2009-6#1)
we can understand##2##3##(2006-3#1)(2008-5#1)
we can use the##2##4##(2007-11#1)(2007-12#1)
we can use##4##3##(2007-11#1)(2007-12#1)(2008-12#1)(2012-3#1)
we can't##2##2##(1990-10#1)(2007-9#1)
we cannot completely discount the##2##5##(2008-10#2)
we cannot exclude the possibility that##2##6##(1992-12#1)(1996-3#1)
we cannot exclude the##4##4##(1990-10#1)(1992-12#1)(1995-11#1)(1996-3#1)
we cannot exclude##5##3##(1990-10#1)(1991-2#1)(1992-12#1)(1995-11#1)(1996-3#1)
we cannot##21##2##(1990-10#1)(1990-8#1)(1991-2#1)(1992-10#1)(1992-12#1)(1992-6#1)(1995-11#1)(1995-6#1)(1996-3#1)(1997-8#1)(2005-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-8#2)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
we captured##2##2##(2009-4#2)
we care##2##2##(2007-2#1)(2008-6#1)
we carried out Northern blot analysis##3##6##(1990-11#1)(1993-8#1)(1997-8#1)
we carried out a study##2##5##(1991-6#1)(2006-6#1)
we carried out a##17##4##(1990-12#1)(1991-6#2)(1991-7#1)(1994-2#1)(1994-3#1)(1997-5#1)(2006-6#1)(2007-1#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-1#1)(2010-12#2)(2012-2#1)
we carried out##31##3##(1990-11#1)(1990-12#1)(1991-6#2)(1991-7#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2006-6#1)(2007-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2010-1#1)(2010-12#2)(2012-2#2)(2012-3#2)
we carry out##3##3##(1997-2#1)(2008-2#1)(2011-2#1)
we caution##2##2##(2006-10#1)(2009-9#1)
we characterised the biochemical composition of the ribonucleoprotein complexes that form around the gurken mRNA localisation signal in the oocyte##2##20##(2012-12#2)
we characterised##4##2##(1996-12#1)(2012-1#1)(2012-12#2)
we characterize the##6##3##(2008-3#1)(2009-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)
we characterize this##2##3##(2006-7#1)(2012-2#1)
we characterize##12##2##(2006-5#1)(2006-7#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
we characterized an##3##3##(1990-2#1)(2008-10#1)(2009-8#1)
we characterized the##16##3##(1990-3#1)(1991-5#1)(1992-12#1)(1993-9#1)(1995-11#1)(1995-2#1)(1996-3#1)(1996-9#1)(1997-6#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-12#1)(2010-2#1)(2012-2#1)(2012-3#1)
we characterized##31##2##(1990-2#1)(1990-3#1)(1991-5#1)(1992-12#1)(1993-7#1)(1993-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-2#1)(2008-10#4)(2008-11#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
we checked the##2##3##(1992-3#1)(2005-11#1)
we checked##4##2##(1992-3#1)(1994-6#1)(1997-7#1)(2005-11#1)
we choose##3##2##(2007-8#1)(2009-10#1)(2012-1#1)
we chose a disease where gene expression classifiers signatures alone had failed to significantly stratify a larger collection of samples and that exhibited poor or no genetic overlap##2##28##(2013-1#2)
we chose the##2##3##(2007-8#1)(2011-1#1)
we chose to##3##3##(1995-7#1)(2006-12#1)(2008-12#1)
we chose##9##2##(1995-7#1)(2006-12#1)(2007-8#1)(2008-12#1)(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#2)
we claim##2##2##(2006-11#1)(2008-5#1)
we clarify the##2##3##(2008-3#2)
we clarify##3##2##(2008-3#2)(2009-6#1)
we classified##3##2##(1991-12#1)(1997-1#1)(2010-4#1)
we cloned a cDNA encoding a##2##6##(1992-8#1)(1995-8#1)
we cloned a cDNA##3##4##(1992-8#1)(1995-8#1)(2008-8#1)
we cloned a##5##3##(1992-8#1)(1995-8#1)(1997-1#1)(1997-6#1)(2008-8#1)
we cloned and characterized a##2##5##(1993-3#1)(1997-4#1)
we cloned and determined the nucleotide sequence of##2##8##(1991-9#1)(1993-8#1)
we cloned and sequenced the##2##5##(1993-6#1)(1995-8#1)
we cloned and sequenced##4##4##(1993-6#2)(1994-12#1)(1995-8#1)
we cloned and##9##3##(1991-9#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-12#1)(1995-8#1)(1997-4#2)
we cloned the##5##3##(1992-6#1)(1994-8#1)(1996-4#1)(1997-7#1)(2008-5#1)
we cloned##28##2##(1991-9#2)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-8#2)(1996-4#1)(1996-8#1)(1997-1#1)(1997-4#2)(1997-6#1)(1997-7#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-4#1)(2013-1#1)
we collapse##2##2##(2012-3#2)
we collected data from##2##4##(1997-6#1)(2009-3#1)
we collected data##3##3##(1997-6#1)(2009-3#1)(2009-4#1)
we collected the##2##3##(2006-2#1)(2013-1#1)
we collected##16##2##(1997-6#1)(2006-2#1)(2006-9#1)(2008-4#1)(2008-5#3)(2009-2#1)(2009-3#1)(2009-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
we combine the##2##3##(2008-8#1)(2013-8#1)
we combine##6##2##(2008-8#1)(2009-5#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-8#1)
we combined##11##2##(1994-12#1)(1995-6#1)(2008-3#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
we come to##2##3##(2006-3#1)(2008-5#1)
we come##3##2##(2006-3#1)(2008-5#1)(2010-6#1)
we comment on##5##3##(1991-12#1)(2008-7#2)(2009-3#1)(2010-9#1)
we compare our##3##3##(2008-10#1)(2009-10#1)(2009-8#1)
we compare the effects of##4##5##(1993-11#1)(1995-3#1)(1996-9#1)(2012-5#1)
we compare the performance of a##2##6##(2008-2#1)(2008-3#1)
we compare the performance of##5##5##(2008-2#1)(2008-3#2)(2012-3#2)
we compare the results##2##4##(2008-10#1)(2008-2#1)
we compare the##34##3##(1993-11#1)(1993-2#1)(1995-3#1)(1996-9#1)(1997-2#1)(1997-6#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#5)(2009-6#1)(2010-11#1)(2010-2#1)(2010-9#1)(2012-11#1)(2012-2#1)(2012-3#6)(2012-5#1)
we compare these##2##3##(1997-7#1)(2010-4#1)
we compare##68##2##(1993-11#1)(1993-2#1)(1993-6#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-9#2)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#2)(2004-1#1)(2007-12#4)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#6)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#1)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#8)(2012-5#1)
we compared changes in##2##4##(2006-10#1)(2007-9#1)
we compared in##2##3##(1995-2#1)(2012-12#1)
we compared performance of three existing clinical NLP systems in handling abbreviations##2##12##(2013-1#2)
we compared performance under eight##2##5##(2008-6#2)
we compared performance##4##3##(2008-6#2)(2013-1#2)
we compared the effect of##5##5##(1993-11#1)(1994-12#1)(2004-11#1)(2006-7#1)(2011-12#1)
we compared the effectiveness of corpus-derived and UMLS-derived semantic lexicons in the concept extraction task of the 2010 i2b2 clinical NLP challenge##2##22##(2013-1#2)
we compared the effectiveness##3##4##(2008-10#1)(2013-1#2)
we compared the effects of##6##5##(1990-10#1)(1993-5#1)(1994-7#1)(1995-11#1)(1997-5#1)(2009-12#1)
we compared the effects##7##4##(1990-10#1)(1993-5#1)(1994-7#1)(1995-11#1)(1997-5#1)(2008-10#1)(2009-12#1)
we compared the results of##4##5##(2007-8#1)(2008-3#1)(2011-2#1)(2012-3#1)
we compared the##64##3##(1990-10#1)(1990-3#1)(1991-12#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-5#1)(1994-12#2)(1994-2#2)(1994-7#1)(1995-11#2)(1995-2#1)(1995-9#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-5#1)(2004-11#2)(2006-10#2)(2006-4#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#1)(2011-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
we compared their##3##3##(1995-6#1)(2008-11#1)(2013-8#1)
we compared trends in order set creation and usage at two academic medical centers over a three-year period##2##18##(2013-1#2)
we compared two##2##3##(2010-7#1)(2011-2#1)
we compared##112##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-4#1)(1991-12#1)(1991-9#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-5#1)(1994-12#2)(1994-2#2)(1994-7#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#1)(2004-11#2)(2006-10#3)(2006-11#1)(2006-4#1)(2006-6#2)(2006-7#1)(2007-10#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-8#2)(2007-9#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-7#1)(2011-12#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#10)(2013-8#5)
we compute the##6##3##(1996-8#1)(2008-2#1)(2008-7#1)(2009-3#1)(2010-2#1)(2012-2#1)
we compute##10##2##(1993-6#1)(1996-8#1)(1997-2#1)(2008-2#1)(2008-6#1)(2008-7#2)(2009-3#1)(2010-2#1)(2012-2#1)
we computed##2##2##(1996-8#1)(2012-2#1)
we concentrate on the##2##4##(1990-10#1)(2008-2#1)
we concentrate on##5##3##(1990-10#1)(2006-10#1)(2008-11#1)(2008-2#1)(2013-8#1)
we conclude that a##3##4##(1991-2#1)(1994-12#1)(2004-9#1)
we conclude that an##2##4##(1992-6#1)(1995-2#1)
we conclude that both##3##4##(1990-11#1)(1997-4#1)(2008-8#1)
we conclude that inositol##2##4##(1993-5#2)
we conclude that one##2##4##(1994-6#1)(2007-12#1)
we conclude that the##33##4##(1990-5#2)(1991-5#2)(1992-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-4#1)(1995-5#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-8#1)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#5)(2008-5#1)(2008-7#1)(2009-6#1)
we conclude that there has been##2##6##(1995-2#1)(2007-2#1)
we conclude that there is##3##5##(2008-3#2)(2012-12#1)
we conclude that there##6##4##(1995-2#1)(2007-2#1)(2008-3#2)(2008-8#1)(2012-12#1)
we conclude that these##3##4##(1990-2#1)(1991-2#1)(1992-12#1)
we conclude that this##6##4##(1993-2#1)(1994-3#1)(1996-12#1)(2008-10#1)(2013-1#1)(2013-8#1)
we conclude that##131##3##(1990-11#1)(1990-2#3)(1990-5#2)(1990-8#2)(1990-9#2)(1991-2#3)(1991-4#1)(1991-5#3)(1991-6#2)(1991-9#2)(1992-12#1)(1992-2#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-10#1)(1995-2#3)(1995-4#1)(1995-5#2)(1995-6#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#2)(1997-1#3)(1997-4#1)(1997-8#1)(2004-11#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#6)(2008-8#2)(2009-4#1)(2009-6#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#3)(2013-8#1)
we conclude##139##2##(1990-11#1)(1990-2#3)(1990-5#3)(1990-8#2)(1990-9#2)(1991-2#3)(1991-4#1)(1991-5#3)(1991-6#2)(1991-9#2)(1992-12#1)(1992-2#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-10#1)(1995-2#3)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#2)(1997-1#3)(1997-4#1)(1997-6#1)(1997-8#1)(2004-11#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#6)(2008-8#4)(2009-4#1)(2009-6#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#3)(2013-8#1)
we concluded that at least##2##5##(1991-7#1)(1995-12#1)
we concluded that the##15##4##(1990-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1995-12#1)(1997-8#1)(2005-10#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-12#1)(2010-2#1)(2012-12#1)
we concluded that##39##3##(1990-11#1)(1990-5#1)(1990-6#1)(1991-7#2)(1991-9#1)(1992-10#1)(1992-12#1)(1993-9#2)(1994-2#1)(1994-8#1)(1995-12#2)(1996-8#1)(1997-1#1)(1997-4#1)(1997-8#1)(2005-10#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#4)(2010-10#1)(2010-12#1)(2010-2#2)(2011-1#2)(2012-12#1)(2013-7#1)(2013-8#2)
we conduct a##3##3##(2007-8#2)(2008-8#1)
we conduct##5##2##(2007-8#2)(2008-8#1)(2008-9#1)(2009-7#1)
we conducted a cross-sectional##2##4##(2006-2#1)(2009-10#1)
we conducted a study of##2##5##(1993-4#1)(1994-6#1)
we conducted a study##4##4##(1993-4#1)(1994-6#1)(1996-3#1)(2013-1#1)
we conducted a##31##3##(1991-2#1)(1992-2#1)(1993-3#1)(1993-4#1)(1994-6#1)(1996-3#2)(2006-12#1)(2006-2#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#2)(2008-10#3)(2008-11#1)(2009-10#2)(2009-6#1)(2010-8#1)(2011-2#3)(2012-1#2)(2012-11#1)(2013-1#2)(2013-8#1)
we conducted an##2##3##(2007-2#1)(2012-11#1)
we conducted several##2##3##(2008-10#1)(2008-3#1)
we conducted the##3##3##(2006-12#1)(2007-2#1)(2013-7#1)
we conducted##59##2##(1991-2#1)(1992-2#1)(1993-3#1)(1993-4#1)(1994-6#1)(1996-3#2)(1997-4#1)(2006-10#1)(2006-12#2)(2006-2#1)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#2)(2008-10#4)(2008-11#3)(2008-3#1)(2008-5#3)(2008-8#1)(2009-10#2)(2009-4#2)(2009-6#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#3)(2012-1#3)(2012-11#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#1)
we configure##2##2##(2008-2#2)
we confirm that##7##3##(1991-10#1)(1994-2#1)(1994-8#1)(2008-3#2)(2012-12#2)
we confirm##12##2##(1991-10#1)(1993-4#1)(1994-2#1)(1994-6#1)(1994-8#1)(2005-11#1)(2008-3#3)(2009-7#1)(2012-12#2)
we confirmed that the##3##4##(2008-3#1)(2011-1#1)(2013-8#1)
we confirmed that##12##3##(1995-2#1)(1996-10#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#3)
we confirmed the##7##3##(1991-3#1)(1992-8#1)(2007-10#1)(2008-3#1)(2009-4#1)(2009-9#1)(2011-2#1)
we confirmed##24##2##(1991-2#1)(1991-3#1)(1992-8#2)(1995-2#1)(1996-10#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-3#2)(2008-6#1)(2009-4#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#3)
we consider a##7##3##(1990-8#1)(2008-10#1)(2009-10#1)(2010-2#1)(2010-6#1)(2012-3#1)(2013-8#1)
we consider all##2##3##(2008-5#1)(2012-3#1)
we consider how the##2##4##(2006-10#1)(2008-8#1)
we consider how##5##3##(1995-4#1)(2006-10#1)(2008-8#1)(2009-9#1)(2012-1#1)
we consider our##2##3##(2008-10#1)(2008-11#1)
we consider that the##3##4##(1991-10#1)(2005-11#1)(2007-9#1)
we consider that##6##3##(1991-10#1)(2005-11#1)(2007-9#1)(2008-5#1)(2010-7#1)(2011-2#1)
we consider the consequences##2##4##(2008-8#1)(2008-9#1)
we consider the problem of##2##5##(2011-3#1)(2012-3#1)
we consider the##33##3##(1995-5#1)(1996-1#1)(1996-11#1)(1997-2#1)(1997-6#1)(2006-3#1)(2006-7#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-2#3)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-9#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-8#2)
we consider three##3##3##(2007-5#1)(2012-3#2)
we consider to be##2##4##(2007-11#1)(2008-9#1)
we consider##100##2##(1990-8#1)(1990-9#1)(1991-10#1)(1991-3#1)(1992-9#1)(1994-1#1)(1994-2#1)(1994-4#1)(1995-10#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-4#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-3#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#5)(2009-10#2)(2009-11#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-2#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#4)(2012-12#1)(2012-2#1)(2012-3#8)(2013-1#1)(2013-7#1)(2013-8#3)
we considered the##4##3##(1997-8#1)(2005-11#1)(2006-5#1)(2008-3#1)
we considered##14##2##(1994-11#1)(1995-8#1)(1997-8#1)(2004-1#1)(2004-10#1)(2005-11#1)(2006-5#1)(2007-12#1)(2007-7#1)(2008-2#1)(2008-3#1)(2010-9#1)(2012-12#1)(2012-3#1)
we construct a model##2##4##(1994-3#1)(1997-4#1)
we construct a##7##3##(1994-3#1)(1997-4#1)(2008-2#1)(2008-6#1)(2008-8#1)(2012-3#1)(2013-8#1)
we construct an##2##3##(2008-2#1)(2008-3#1)
we construct##12##2##(1994-3#1)(1997-1#1)(1997-4#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-3#2)(2013-8#1)
we constructed a cDNA library##3##5##(1993-3#1)(2008-8#1)(2008-9#1)
we constructed a plasmid##2##4##(1992-12#1)(1997-6#1)
we constructed a recombinant##2##4##(2013-1#2)
we constructed a##19##3##(1991-6#1)(1991-9#1)(1992-12#1)(1993-3#1)(1995-12#1)(1996-2#1)(1997-2#2)(1997-6#1)(1997-8#1)(2008-11#2)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
we constructed by##2##3##(1994-6#1)(2008-2#1)
we constructed the##2##3##(1991-9#1)(2008-9#1)
we constructed two##2##3##(1994-9#1)(1995-5#1)
we constructed##41##2##(1991-1#1)(1991-12#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-6#2)(1997-8#1)(2008-11#3)(2008-2#1)(2008-8#1)(2008-9#3)(2009-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
we contacted##3##2##(2007-3#1)(2012-2#1)(2013-1#1)
we continually strive to compare our group's performance to accepted standards of cost and production##2##15##(1994-3#2)
we continually##5##2##(1990-12#1)(1994-3#2)(2006-4#1)(2008-10#1)
we continue to##5##3##(1995-9#1)(2007-9#1)(2010-12#1)(2013-1#2)
we continue##6##2##(1995-9#1)(2006-12#1)(2007-9#1)(2010-12#1)(2013-1#2)
we continued##2##2##(2009-2#1)(2012-3#1)
we contrasted##2##2##(2009-4#1)(2013-1#1)
we control the##2##3##(2007-11#1)(2008-3#1)
we control##3##2##(2007-11#1)(2008-3#1)(2010-2#1)
we correctly##2##2##(2011-2#1)(2012-2#1)
we corroborate##2##2##(1996-8#1)(2009-9#1)
we could demonstrate that##3##4##(1990-8#1)(1996-5#1)(2006-10#1)
we could demonstrate##4##3##(1990-8#1)(1996-5#1)(2006-10#1)(2007-8#1)
we could detect no##2##4##(1991-4#1)(1995-12#1)
we could detect##6##3##(1991-4#1)(1993-8#1)(1994-2#1)(1995-12#1)(1996-12#1)(1997-6#1)
we could determine##2##3##(2007-8#1)(2009-8#1)
we could easily##3##3##(1990-8#1)(1995-8#1)(2007-10#1)
we could examine the##2##4##(2007-12#1)(2008-3#1)
we could not detect##4##4##(1993-8#1)(1994-8#1)(2011-12#1)(2013-8#1)
we could not find##2##4##(2008-12#1)(2008-8#1)
we could not##13##3##(1993-8#1)(1994-6#1)(1994-8#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-8#1)(2010-7#1)(2011-1#1)(2011-12#1)(2013-8#1)
we could observe##2##3##(2008-11#1)(2013-1#1)
we could provide##2##3##(1991-11#1)(2008-7#1)
we could reduce##3##3##(2008-1#1)(2010-8#1)(2011-1#1)
we could show that the##2##5##(1997-7#1)(2008-11#1)
we could show that##6##4##(1994-2#1)(1997-7#1)(2008-11#1)(2009-6#1)(2011-1#1)(2012-12#1)
we could show##7##3##(1994-2#1)(1997-7#1)(2008-11#1)(2009-12#1)(2009-6#1)(2011-1#1)(2012-12#1)
we could##80##2##(1990-11#1)(1990-8#2)(1991-11#1)(1991-4#2)(1993-8#2)(1994-2#2)(1994-6#1)(1994-7#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-6#1)(1997-7#2)(2003-11#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#3)(2009-2#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-12#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
we create a##2##3##(2008-2#1)(2008-8#1)
we create an##2##3##(2007-8#1)(2011-1#1)
we create##5##2##(2007-8#1)(2008-2#1)(2008-6#1)(2008-8#1)(2011-1#1)
we created a##10##3##(1995-8#1)(2007-12#1)(2008-7#1)(2009-10#2)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
we created##14##2##(1995-8#1)(2006-3#1)(2007-12#1)(2008-7#2)(2009-10#2)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
we critically evaluate the role of##2##6##(2012-2#2)
we critically evaluate##3##3##(2012-2#3)
we critically review##2##3##(2008-10#1)(2012-12#1)
we critically##8##2##(2008-10#1)(2009-12#1)(2009-8#1)(2012-11#1)(2012-12#1)(2012-2#3)
we cultured the##2##3##(1993-6#1)(2010-11#1)
we currently have##2##3##(2010-1#1)(2010-11#1)
we currently use##2##3##(2010-7#1)(2011-2#1)
we currently##9##2##(1994-3#1)(1997-5#1)(2005-9#1)(2008-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#1)
we deal with##4##3##(2007-8#1)(2008-3#1)(2008-8#1)(2011-2#1)
we decided to analyze##2##4##(1996-12#1)(2007-8#1)
we decided to evaluate the##2##5##(2007-5#1)(2007-7#1)
we decided to investigate the##2##5##(1991-11#1)(1995-12#1)
we decided to study##2##4##(2007-9#1)(2013-7#1)
we decided to##15##3##(1991-11#1)(1994-11#1)(1995-12#1)(1996-12#1)(1997-8#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-5#1)(2013-1#1)(2013-7#1)
we deduce that##2##3##(1992-2#1)(2008-9#1)
we deduce the##2##3##(2007-11#1)(2013-1#1)
we deduce##7##2##(1990-7#1)(1992-2#1)(2007-11#1)(2007-3#1)(2008-2#1)(2008-9#1)(2013-1#1)
we define as##3##3##(1995-8#1)(2008-10#1)(2012-2#1)
we define the##5##3##(1991-8#1)(1994-2#1)(2008-4#1)(2008-7#1)(2009-6#1)
we define##13##2##(1991-8#1)(1994-2#1)(1995-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-6#1)(2012-2#1)(2013-1#1)
we defined four##2##3##(2008-10#1)(2011-2#1)
we defined the##2##3##(1995-2#1)(2008-8#1)
we defined##5##2##(1993-7#1)(1995-2#1)(2008-10#1)(2008-8#1)(2011-2#1)
we delineate##4##2##(1992-12#1)(2006-5#1)(2009-3#1)(2012-2#1)
we demonstrate a novel##4##4##(1993-9#1)(2008-11#1)(2012-2#2)
we demonstrate a simple##3##4##(2008-10#1)(2008-3#2)
we demonstrate a##20##3##(1993-9#1)(1994-2#1)(2007-12#4)(2007-8#2)(2008-10#2)(2008-11#3)(2008-3#4)(2012-2#3)
we demonstrate an##3##3##(1994-6#1)(2007-12#1)(2008-1#1)
we demonstrate binding of##2##4##(1994-8#2)
we demonstrate by##5##3##(1994-3#1)(1994-9#1)(1997-7#1)(2008-3#1)(2010-11#1)
we demonstrate efficient##2##3##(2007-12#1)(2008-11#1)
we demonstrate for the first time that##2##7##(2007-12#1)(2008-10#1)
we demonstrate for the first time##3##6##(2007-12#2)(2008-10#1)
we demonstrate for##4##3##(2007-12#2)(2008-10#1)(2008-8#1)
we demonstrate here that##2##4##(1992-8#1)(2012-12#1)
we demonstrate here##4##3##(1992-8#1)(1996-8#1)(2012-12#1)(2012-2#1)
we demonstrate how our lab##3##5##(2008-8#3)
we demonstrate how to##7##4##(2008-11#5)(2008-6#1)(2008-8#1)
we demonstrate how##17##3##(2006-12#1)(2008-10#1)(2008-11#5)(2008-6#1)(2008-8#5)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
we demonstrate in##2##3##(1997-4#1)(2009-9#1)
we demonstrate such##2##3##(2008-11#1)(2008-3#1)
we demonstrate that a##9##4##(1991-8#1)(1992-4#1)(1997-2#1)(2007-12#4)(2008-5#1)(2009-11#1)
we demonstrate that an##4##4##(1991-12#1)(1991-9#1)(1993-11#1)(2012-3#1)
we demonstrate that in##4##4##(1993-12#1)(1994-9#1)(2008-7#1)(2012-12#1)
we demonstrate that it is##2##5##(1994-8#1)(2008-11#1)
we demonstrate that successful##2##4##(2008-10#1)(2012-1#1)
we demonstrate that the intracerebral transplantation of human DPSCs 24 hours following focal cerebral ischemia in a rodent model resulted in significant improvement in forelimb sensorimotor function at 4 weeks post-treatment##2##31##(2012-12#2)
we demonstrate that the predominant##2##5##(2007-4#1)(2010-9#1)
we demonstrate that the##49##4##(1990-11#1)(1991-5#1)(1991-8#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-8#2)(1994-10#1)(1994-12#1)(1994-3#1)(1994-8#2)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-2#1)(1996-8#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#7)(2012-2#1)
we demonstrate that these##4##4##(1994-6#1)(1995-8#1)(1997-4#1)(2010-4#1)
we demonstrate that this##6##4##(1990-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-10#1)(2013-8#1)
we demonstrate that##182##3##(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#4)(1991-2#1)(1991-4#2)(1991-5#4)(1991-8#2)(1991-9#3)(1992-12#1)(1992-2#1)(1992-4#2)(1992-7#2)(1993-11#2)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#3)(1994-10#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#5)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#3)(1995-3#5)(1995-5#6)(1995-6#3)(1995-8#7)(1996-1#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-8#2)(1997-2#2)(1997-4#2)(1997-6#2)(1997-7#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#11)(2007-4#1)(2008-10#2)(2008-11#2)(2008-2#5)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#1)(2009-10#3)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#11)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
we demonstrate the feasibility of##2##5##(1992-9#1)(2007-11#1)
we demonstrate the feasibility##3##4##(1992-9#1)(2007-11#1)(2010-4#1)
we demonstrate the potential##3##4##(2008-10#1)(2008-2#2)
we demonstrate the preparation of##2##5##(2008-11#2)
we demonstrate the role of using Resource Description Framework (RDF) for representing EHR diagnoses and procedure data##2##17##(2013-1#2)
we demonstrate the role of##3##5##(2008-11#1)(2013-1#2)
we demonstrate the use of advanced image processing and classification for identifying bar and line charts by the shape and relative location of the different image elements that make up the charts##2##32##(2013-1#2)
we demonstrate the use of the##2##6##(2008-11#1)(2008-7#1)
we demonstrate the use of##7##5##(2006-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#1)(2013-1#2)
we demonstrate the##52##3##(1990-12#1)(1991-9#1)(1992-2#1)(1992-8#1)(1992-9#1)(1996-8#1)(2006-7#1)(2007-11#4)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#9)(2008-2#4)(2008-3#2)(2008-7#2)(2008-8#1)(2009-3#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)
we demonstrate through##3##3##(1994-6#1)(1994-9#1)(2007-11#1)
we demonstrate what we believe to be##2##7##(2007-12#2)
we demonstrate what##3##3##(2007-11#1)(2007-12#2)
we demonstrate##343##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#4)(1991-2#1)(1991-4#2)(1991-5#4)(1991-8#2)(1991-9#4)(1992-12#1)(1992-2#2)(1992-4#2)(1992-7#3)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-10#2)(1994-12#3)(1994-2#2)(1994-3#3)(1994-6#3)(1994-8#8)(1994-9#3)(1995-1#1)(1995-10#2)(1995-12#1)(1995-2#3)(1995-3#5)(1995-5#7)(1995-6#3)(1995-8#7)(1996-1#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-8#4)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#5)(1997-6#2)(1997-7#2)(2006-10#2)(2006-12#2)(2006-7#1)(2007-10#1)(2007-11#9)(2007-12#27)(2007-4#1)(2007-8#2)(2008-1#2)(2008-10#11)(2008-11#25)(2008-2#13)(2008-3#15)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#11)(2008-8#10)(2008-9#1)(2009-10#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#3)(2009-9#2)(2010-1#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#3)(2012-12#14)(2012-2#13)(2012-3#2)(2013-1#8)(2013-8#2)
we demonstrated a##7##3##(1992-12#1)(1994-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)
we demonstrated for the first time##2##6##(2009-5#1)(2013-8#1)
we demonstrated that a##7##4##(1992-5#1)(1993-8#1)(1996-12#1)(2008-10#1)(2009-2#1)(2009-8#1)(2011-1#1)
we demonstrated that both##2##4##(1991-12#1)(2008-10#1)
we demonstrated that intratumoral injection of G47ΔUs11fluc##2##7##(2012-12#2)
we demonstrated that the##19##4##(1990-11#1)(1991-5#1)(1992-11#1)(1992-12#1)(1994-6#1)(1994-9#1)(1995-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-9#2)(2009-8#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
we demonstrated that this##2##4##(1996-2#1)(2008-5#1)
we demonstrated that##78##3##(1990-11#1)(1990-4#1)(1991-12#2)(1991-5#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-3#2)(1996-10#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-6#1)(1996-8#2)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-5#1)(2008-9#2)(2009-2#1)(2009-5#1)(2009-8#4)(2010-11#2)(2010-12#3)(2010-3#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
we demonstrated the feasibility##2##4##(2013-1#2)
we demonstrated the##9##3##(1990-7#1)(1996-5#2)(2007-11#1)(2007-8#1)(2008-3#1)(2009-4#1)(2013-1#2)
we demonstrated this##2##3##(2007-12#1)(2008-5#1)
we demonstrated##112##2##(1990-11#1)(1990-4#1)(1990-7#1)(1991-12#2)(1991-5#1)(1991-7#1)(1992-11#1)(1992-12#2)(1992-5#2)(1992-6#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#3)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-3#2)(1996-10#1)(1996-12#2)(1996-2#1)(1996-5#4)(1996-6#1)(1996-8#2)(1997-2#1)(1997-6#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-9#2)(2009-2#1)(2009-4#1)(2009-5#3)(2009-8#4)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#3)
we derive a##12##3##(1995-8#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#2)(2009-5#1)(2010-8#1)(2011-1#1)
we derive an##2##3##(2007-12#1)(2008-2#1)
we derive explicit##2##3##(1995-5#1)(2008-3#1)
we derive the##3##3##(2007-11#1)(2007-12#1)(2013-8#1)
we derive##30##2##(1995-5#1)(1995-8#1)(2007-11#1)(2007-12#5)(2008-10#1)(2008-2#5)(2008-3#3)(2008-8#3)(2008-9#2)(2009-5#2)(2010-2#2)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
we derived a##2##3##(1997-2#1)(2008-3#1)
we derived the##2##3##(2008-3#1)(2012-2#1)
we derived##7##2##(1993-5#1)(1997-2#1)(2008-3#3)(2012-2#2)
we describe 2##2##3##(2007-10#1)(2013-8#1)
we describe a case of a##3##6##(1996-12#1)(2010-9#1)(2013-1#1)
we describe a case of##9##5##(1996-12#1)(2010-12#1)(2010-6#2)(2010-7#1)(2010-9#1)(2012-12#1)(2013-1#2)
we describe a case##11##4##(1993-4#1)(1996-12#1)(2007-8#1)(2010-12#1)(2010-6#2)(2010-7#1)(2010-9#1)(2012-12#1)(2013-1#2)
we describe a method##3##4##(1990-12#1)(2008-12#1)(2011-2#1)
we describe a new method for##2##6##(2007-12#1)(2008-7#1)
we describe a new method##4##5##(2007-12#1)(2008-11#1)(2008-7#1)(2012-2#1)
we describe a new##11##4##(1992-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-11#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-8#1)
we describe a novel##11##4##(1992-11#1)(1994-3#1)(1997-4#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-12#1)(2011-1#1)(2012-12#1)(2012-2#1)
we describe a patient who##2##5##(2007-8#1)(2008-4#1)
we describe a patient##5##4##(2007-2#1)(2007-8#1)(2008-4#1)(2010-11#1)(2011-1#1)
we describe a rapid##3##4##(1992-7#1)(1994-3#1)(1997-3#1)
we describe a set of##2##5##(2008-4#1)(2010-11#1)
we describe a simple and##2##5##(2008-11#1)(2010-5#1)
we describe a simple##7##4##(1990-11#1)(1990-12#1)(1990-8#1)(2008-11#1)(2010-5#1)(2012-2#2)
we describe a study##2##4##(1997-2#1)(2012-2#1)
we describe a unique##3##4##(1992-11#1)(2007-8#1)(2010-3#1)
we describe a##114##3##(1990-11#1)(1990-12#3)(1990-8#1)(1992-11#2)(1992-4#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-4#1)(1994-3#2)(1994-6#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-4#2)(2007-6#2)(2007-8#5)(2008-1#3)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#1)(2008-7#5)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-11#3)(2010-12#4)(2010-3#1)(2010-5#2)(2010-6#3)(2010-7#2)(2010-9#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#2)(2013-1#4)(2013-8#1)
we describe an alternative##2##4##(2007-8#1)(2008-3#1)
we describe an approach##4##4##(2008-4#1)(2008-7#1)(2009-5#1)(2010-5#1)
we describe an automated##3##4##(2008-10#1)(2009-9#1)(2013-1#1)
we describe an interactive visualization-based system for intervention analysis and apply it to patients at risk of developing congestive heart failure (CHF)##2##22##(2013-1#2)
we describe an##29##3##(1990-8#1)(1994-12#1)(1995-11#1)(1996-8#1)(1997-2#1)(2006-10#2)(2006-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-5#1)(2009-9#2)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#3)
we describe and compare the##2##5##(2008-7#1)(2011-2#1)
we describe and##5##3##(1996-12#1)(2007-8#1)(2008-7#1)(2011-2#1)(2012-2#1)
we describe both##2##3##(2008-8#1)(2010-5#1)
we describe current##2##3##(2007-7#1)(2012-2#1)
we describe for the first time a##2##7##(2008-10#1)(2008-6#1)
we describe for the first time##3##6##(2007-8#1)(2008-10#1)(2008-6#1)
we describe here a##2##4##(2007-12#1)(2008-7#1)
we describe here##3##3##(2007-12#1)(2008-11#1)(2008-7#1)
we describe how the GLARE system has been extended to deal with exceptions in CIGs##2##15##(2013-1#2)
we describe how the##5##4##(2008-10#1)(2008-9#1)(2010-2#1)(2013-1#2)
we describe how##13##3##(1992-9#1)(1993-5#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-9#2)(2009-5#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-1#2)
we describe important considerations in the design and execution of specific studies to monitor the efficacy##2##16##(2012-12#2)
we describe in##2##3##(2008-11#2)
we describe methods for##2##4##(1995-6#1)(2008-9#1)
we describe methods##3##3##(1993-6#1)(1995-6#1)(2008-9#1)
we describe one##2##3##(2008-8#1)(2010-8#1)
we describe our approach to##2##5##(2011-2#1)(2012-12#1)
we describe our experience with##2##5##(2007-8#1)(2011-2#1)
we describe our recent##2##4##(2006-3#1)(2006-4#1)
we describe our##13##3##(1994-11#1)(1997-9#1)(2006-3#1)(2006-4#1)(2006-7#1)(2007-8#1)(2008-2#1)(2008-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#1)
we describe rabbit monoclonal antibodies (RabMabs) against the extracellular domains of αv integrins that react with both native integrins and formalin fixed##2##22##(2012-12#2)
we describe recent advances in##2##5##(2012-1#1)(2012-11#1)
we describe recent advances##3##4##(2009-8#1)(2012-1#1)(2012-11#1)
we describe recent##7##3##(2007-8#1)(2008-7#1)(2009-8#1)(2012-1#2)(2012-11#1)(2013-1#1)
we describe several##2##3##(2010-7#1)(2011-2#1)
we describe six##3##3##(1997-3#1)(2006-7#1)(2007-7#1)
we describe some of the##3##5##(2009-9#1)(2010-2#1)(2010-7#1)
we describe some of##5##4##(1991-3#1)(2009-9#1)(2010-2#1)(2010-7#1)(2011-1#1)
we describe some##8##3##(1991-3#1)(2005-9#1)(2006-10#2)(2009-9#1)(2010-2#1)(2010-7#1)(2011-1#1)
we describe that##3##3##(1991-7#1)(2008-10#1)(2011-2#1)
we describe the application of the##3##6##(2008-2#1)(2013-1#2)
we describe the application of##5##5##(2008-10#1)(2008-2#1)(2008-7#1)(2013-1#2)
we describe the application##6##4##(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2013-1#2)
we describe the applications##2##4##(2005-4#1)(2008-10#1)
we describe the basic##4##4##(2009-5#1)(2011-2#2)(2012-2#1)
we describe the case of a##4##6##(2007-11#1)(2011-2#1)(2012-2#1)(2013-7#1)
we describe the case of##5##5##(1990-8#1)(2007-11#1)(2011-2#1)(2012-2#1)(2013-7#1)
we describe the construction of a##2##6##(1990-8#1)(2008-11#1)
we describe the construction of##5##5##(1990-8#1)(1996-7#1)(2008-11#1)(2008-7#1)(2011-1#1)
we describe the current##3##4##(2007-11#1)(2010-11#1)(2012-1#1)
we describe the design of##2##5##(2008-10#1)(2012-1#1)
we describe the design##3##4##(2008-10#1)(2009-9#1)(2012-1#1)
we describe the effects of##2##5##(1992-11#1)(1994-3#1)
we describe the experience##2##4##(2011-2#1)(2013-1#1)
we describe the features of this organism##17##7##(2011-2#17)
we describe the features of this##18##6##(2011-2#18)
we describe the features of##23##5##(2011-2#23)
we describe the first##3##4##(1997-6#1)(2008-9#1)(2012-12#1)
we describe the further##2##4##(1995-11#1)(1996-2#1)
we describe the identification and characterization of a##2##8##(1994-12#1)(1995-3#1)
we describe the identification and##3##5##(1994-12#2)(1995-3#1)
we describe the identification of the##2##6##(2009-8#1)(2013-1#1)
we describe the identification##5##4##(1994-12#2)(1995-3#1)(2009-8#1)(2013-1#1)
we describe the in vitro##2##5##(1995-8#1)(2008-11#1)
we describe the in##3##4##(1995-8#1)(2008-11#1)(2012-12#1)
we describe the isolation and characterization of##3##7##(1991-7#1)(1997-6#1)(2008-7#1)
we describe the molecular##3##4##(1992-8#1)(1993-3#1)(1994-12#1)
we describe the preparation of##2##5##(1991-2#1)(2010-12#1)
we describe the purification and characterization of##2##7##(1995-3#1)(1997-4#1)
we describe the purification##3##4##(1995-3#2)(1997-4#1)
we describe the results of##3##5##(2008-2#1)(2008-6#1)(2013-8#1)
we describe the role of##4##5##(2006-12#1)(2007-9#1)(2011-2#1)(2013-1#1)
we describe the role##5##4##(2006-12#1)(2007-9#1)(2008-6#1)(2011-2#1)(2013-1#1)
we describe the synthesis and##3##5##(1996-8#1)(2010-12#1)(2011-12#1)
we describe the synthesis##4##4##(1996-12#1)(1996-8#1)(2010-12#1)(2011-12#1)
we describe the use of##6##5##(1992-7#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)
we describe the##183##3##(1990-11#1)(1990-3#1)(1990-8#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-12#6)(1994-3#1)(1995-1#1)(1995-11#1)(1995-3#3)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#2)(2005-4#1)(2006-12#2)(2007-1#1)(2007-11#3)(2007-12#3)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#3)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-6#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#32)(2012-1#2)(2012-12#6)(2012-2#7)(2012-3#2)(2013-1#7)(2013-7#3)(2013-8#1)
we describe treatment of a maxillary central incisor affected by severe##2##11##(2013-1#2)
we describe two cases of##2##5##(1990-10#1)(2009-10#1)
we describe two##11##3##(1990-10#1)(1992-11#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-10#1)(2011-12#1)(2012-2#1)(2012-3#1)
we describe##482##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#5)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#3)(1991-9#1)(1992-1#1)(1992-11#4)(1992-4#1)(1992-7#2)(1992-8#2)(1992-9#2)(1993-1#1)(1993-12#1)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#3)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#7)(1994-3#4)(1994-6#1)(1994-8#1)(1995-1#2)(1995-11#2)(1995-2#2)(1995-3#3)(1995-5#2)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#5)(1997-3#4)(1997-4#5)(1997-5#1)(1997-6#4)(1997-7#2)(1997-9#1)(2004-9#1)(2005-4#1)(2005-9#1)(2006-10#6)(2006-12#3)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#10)(2007-2#2)(2007-3#1)(2007-4#3)(2007-6#5)(2007-7#2)(2007-8#11)(2007-9#1)(2008-1#4)(2008-10#19)(2008-11#13)(2008-12#2)(2008-2#12)(2008-3#10)(2008-4#7)(2008-5#4)(2008-6#4)(2008-7#16)(2008-8#7)(2008-9#9)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#6)(2009-6#4)(2009-7#2)(2009-8#3)(2009-9#6)(2010-10#2)(2010-11#4)(2010-12#10)(2010-2#4)(2010-3#4)(2010-5#4)(2010-6#4)(2010-7#5)(2010-8#2)(2010-9#3)(2011-1#10)(2011-12#2)(2011-2#43)(2012-1#7)(2012-11#1)(2012-12#16)(2012-2#20)(2012-3#7)(2013-1#20)(2013-7#3)(2013-8#5)
we described a##4##3##(1996-8#1)(2007-6#1)(2008-3#1)(2012-11#1)
we described the##7##3##(1994-2#1)(1994-6#1)(2005-10#1)(2008-11#1)(2009-8#1)(2012-12#1)(2013-7#1)
we described##17##2##(1991-2#1)(1994-2#1)(1994-6#1)(1995-8#1)(1996-12#1)(1996-8#1)(2005-10#1)(2005-6#1)(2005-7#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-3#1)(2009-8#1)(2012-11#1)(2012-12#1)(2013-7#1)
we design FaceReview based on information visualization techniques that are proven to be useful and therefore commonly used##2##18##(2013-1#2)
we design a##4##3##(2006-10#1)(2008-2#2)(2008-3#1)
we design##10##2##(1995-5#1)(2006-10#1)(2008-2#2)(2008-3#1)(2009-5#1)(2010-2#1)(2010-4#1)(2013-1#2)
we designate##4##2##(1990-8#1)(1993-6#1)(1994-11#1)(2006-8#1)
we designated##4##2##(1994-12#1)(1994-9#1)(1997-1#1)(2008-10#1)
we designed a##10##3##(1996-2#1)(1997-6#1)(2007-2#3)(2007-5#1)(2008-1#1)(2008-7#1)(2009-2#1)(2010-2#1)
we designed and##3##3##(1996-8#1)(2008-10#1)(2008-9#1)
we designed can##2##3##(2008-3#1)(2008-9#1)
we designed experiments##2##3##(1997-5#1)(2010-8#1)
we designed the SAFER project (Safety Assurance Factors for EHR Resilience) to proactively identify potential safety issues and best practices for addressing them##2##23##(2013-1#2)
we designed the##5##3##(2008-2#1)(2008-7#2)(2013-1#2)
we designed two##2##3##(1993-12#1)(2013-1#1)
we designed##29##2##(1993-12#1)(1996-2#2)(1996-8#1)(1997-2#1)(1997-5#1)(1997-6#1)(2007-2#3)(2007-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-2#1)(2010-2#1)(2010-8#1)(2012-11#1)(2013-1#3)
we detail the##2##3##(2007-9#1)(2008-11#1)
we detail##5##2##(2007-9#1)(2008-11#1)(2008-4#1)(2009-9#1)(2013-1#1)
we detect##5##2##(1992-6#1)(1994-10#1)(2010-4#1)(2012-2#1)(2013-7#1)
we detected a##7##3##(1992-6#1)(1993-3#1)(1994-10#1)(1994-12#1)(1994-2#1)(1996-12#1)(1997-4#1)
we detected the##2##3##(1990-7#1)(2008-11#1)
we detected##30##2##(1990-3#1)(1990-5#1)(1990-7#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-12#2)(1994-2#1)(1995-12#2)(1996-12#1)(1997-4#2)(1997-6#1)(1997-7#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
we determine that##2##3##(2008-8#1)(2012-3#1)
we determine the use and applicability of ODPs in a case study of biomedical ontologies##2##15##(2013-1#2)
we determine the##17##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#5)(2008-6#1)(2008-8#1)(2009-4#1)(2013-1#2)
we determine##25##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#5)(2008-3#7)(2008-6#1)(2008-8#2)(2009-10#1)(2009-4#1)(2012-2#1)(2012-3#1)(2013-1#2)
we determined also the##2##4##(2008-10#1)(2012-12#1)
we determined that 1) the state or regional cancer registry makes the most efficient starting point for determining inclusion of subjects##2##21##(2013-1#2)
we determined that the##4##4##(1992-12#1)(1994-9#1)(2008-2#1)(2008-3#1)
we determined that##14##3##(1992-12#1)(1993-12#1)(1994-9#1)(1995-2#1)(1996-10#1)(1996-6#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)(2013-1#2)
we determined the absolute##2##4##(1997-2#1)(2008-3#1)
we determined the effect of##2##5##(2008-10#1)(2010-12#1)
we determined the effects of##3##5##(1996-5#1)(2004-12#1)(2013-7#1)
we determined the expression of##2##5##(1994-8#1)(2013-7#1)
we determined the expression##4##4##(1994-8#1)(2010-12#1)(2013-7#1)(2013-8#1)
we determined the nucleotide sequences of##2##6##(1990-8#1)(1996-4#1)
we determined the##41##3##(1990-8#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-4#1)(1995-8#1)(1996-4#1)(1996-5#1)(1997-2#3)(1997-3#1)(2004-12#1)(2006-12#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#2)(2013-8#1)
we determined whether##5##3##(1992-9#1)(1995-8#1)(1995-9#1)(1996-11#1)(1997-3#1)
we determined##84##2##(1990-2#1)(1990-8#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-4#2)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#4)(1997-3#2)(1997-8#1)(2004-12#1)(2006-11#1)(2006-12#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#10)(2008-11#3)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#4)(2009-10#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
we develop a general##2##4##(1996-3#1)(2013-1#1)
we develop a new##3##4##(2008-3#1)(2008-7#1)(2009-9#1)
we develop a simple##2##4##(1997-8#1)(2008-11#1)
we develop a##32##3##(1993-1#1)(1993-9#1)(1996-3#1)(1997-8#1)(2006-4#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-2#4)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-6#1)(2011-1#1)(2012-3#1)(2013-1#3)(2013-8#3)
we develop an approach##2##4##(2008-2#2)
we develop an##8##3##(1997-3#1)(2008-2#3)(2008-3#1)(2008-8#2)(2010-2#1)
we develop and apply##2##4##(2008-3#1)(2012-3#1)
we develop and##6##3##(1991-11#1)(1992-2#1)(2008-3#1)(2008-9#1)(2012-3#2)
we develop the##2##3##(2007-8#1)(2010-11#1)
we develop##56##2##(1991-11#1)(1992-2#1)(1993-1#1)(1993-9#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#9)(2008-3#4)(2008-4#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#3)(2013-1#3)(2013-8#3)
we developed a Distributed Privacy Preserving Support Vector Machine (DPP-SVM)##2##10##(2013-1#2)
we developed a computer application that automatically converts text to pictures using natural language processing and computer graphics techniques##2##19##(2013-1#2)
we developed a computer-based##2##4##(2011-1#1)(2011-2#1)
we developed a method for building semantic lexicons from clinical corpus##2##11##(2013-1#2)
we developed a method for##3##5##(2012-2#1)(2013-1#2)
we developed a method to##2##5##(1997-4#1)(2008-8#1)
we developed a method##5##4##(1997-4#1)(2008-8#1)(2012-2#1)(2013-1#2)
we developed a model##4##4##(1996-5#1)(2008-3#1)(2008-8#1)(2013-1#1)
we developed a new##10##4##(1995-6#1)(1997-8#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-8#1)(2013-1#1)
we developed a novel method##2##5##(1993-11#1)(2010-12#1)
we developed a novel##8##4##(1993-11#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-9#1)
we developed a rapid##3##4##(2008-10#1)(2008-11#2)
we developed a search algorithm to identify urogynecologic surgeries with mesh implantation and associated inpatient adverse events##2##17##(2013-1#2)
we developed a sensitive##3##4##(1991-8#1)(1991-9#1)(1993-12#1)
we developed a simple##3##4##(2005-5#1)(2008-3#1)(2008-5#1)
we developed a strategy to combine sense frequency information estimated from a clustering analysis with the profile-based method##2##18##(2013-1#2)
we developed a system##3##4##(2008-5#1)(2013-1#2)
we developed a translator tool for converting QDM defined phenotyping algorithm criteria into executable Drools rules scripts##2##17##(2013-1#2)
we developed a##96##3##(1990-8#1)(1991-3#1)(1991-8#1)(1991-9#1)(1993-11#1)(1993-12#1)(1994-3#1)(1995-2#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-2#2)(2008-3#4)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-2#2)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#18)(2013-8#2)
we developed an Institutional Privacy-preserving Distributed binary Logistic Regression model (IPDLR) that considers both individual and institutional privacy for building a logistic regression model in a distributed manner##2##28##(2013-1#2)
we developed an improved##2##4##(1992-8#1)(2008-5#1)
we developed an in vivo system##2##6##(1990-6#1)(2009-3#1)
we developed an in vivo##3##5##(1990-6#1)(1990-8#1)(2009-3#1)
we developed an in##4##4##(1990-6#1)(1990-8#1)(2009-3#1)(2013-1#1)
we developed an innovative system##2##5##(2013-1#2)
we developed an##21##3##(1990-6#1)(1990-8#1)(1991-7#1)(1992-8#1)(1996-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-3#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#6)
we developed and optimized##2##4##(1997-2#1)(2008-10#1)
we developed and tested##2##4##(2008-3#1)(2008-8#1)
we developed and##7##3##(1997-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-6#1)(2013-8#1)
we developed for##2##3##(1994-11#1)(2006-10#1)
we developed novel##2##3##(2008-10#2)
we developed the##3##3##(2008-1#1)(2011-2#1)(2013-8#1)
we developed two in vitro##2##5##(2008-10#1)(2012-2#1)
we developed two##5##3##(2008-10#2)(2008-8#1)(2012-11#1)(2012-2#1)
we developed##160##2##(1990-6#1)(1990-8#2)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-5#2)(1997-2#2)(1997-4#1)(1997-8#1)(2005-5#1)(2006-10#2)(2006-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#21)(2008-11#6)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#1)(2009-2#2)(2009-3#2)(2009-4#3)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#25)(2013-8#4)
we devised a##2##3##(1997-4#1)(2008-10#1)
we devised an##3##3##(2008-10#1)(2008-5#1)(2010-8#1)
we devised##8##2##(1991-10#1)(1994-4#1)(1997-4#1)(2005-11#1)(2008-10#2)(2008-5#1)(2010-8#1)
we diagnose##3##2##(2006-12#1)(2011-1#1)(2012-2#1)
we diagnosed this##3##3##(2009-1#1)(2010-6#2)
we diagnosed##12##2##(1994-6#1)(1997-8#1)(2005-5#1)(2007-7#1)(2007-8#2)(2008-10#1)(2009-1#1)(2010-6#2)(2011-2#1)(2012-1#1)
we did a##4##3##(1992-10#2)(1992-2#1)(2009-4#1)
we did not detect##2##4##(1996-9#1)(2008-10#1)
we did not find a##2##5##(2012-3#1)(2013-1#1)
we did not find any##4##5##(2009-2#1)(2009-4#1)(2010-9#1)(2012-2#1)
we did not find##12##4##(1995-11#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-4#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
we did not observe a##2##5##(2006-8#1)(2012-12#1)
we did not observe any effect of##2##7##(1990-2#1)(1991-10#1)
we did not observe any##3##5##(1990-2#1)(1991-10#1)(2009-6#1)
we did not observe##6##4##(1990-2#1)(1991-10#1)(2006-8#1)(2009-6#1)(2012-12#2)
we did not##29##3##(1990-2#1)(1991-10#1)(1995-11#1)(1995-4#1)(1996-9#1)(2006-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
we did##39##2##(1990-2#1)(1991-10#1)(1992-10#2)(1992-2#1)(1994-3#1)(1995-11#1)(1995-4#1)(1996-2#1)(1996-9#2)(2006-8#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-4#2)(2009-6#1)(2009-7#2)(2010-9#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
we directly##6##2##(1995-6#1)(1995-8#1)(2007-12#1)(2008-3#1)(2008-8#1)(2013-8#1)
we discovered a##4##3##(2007-11#1)(2010-12#1)(2012-2#1)(2012-3#1)
we discovered that the##5##4##(1993-9#1)(1995-3#1)(2009-2#1)(2012-2#1)(2013-8#1)
we discovered that##12##3##(1993-9#1)(1995-3#1)(1997-4#1)(2009-2#1)(2009-8#2)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
we discovered the##2##3##(1990-5#1)(2005-11#1)
we discovered##22##2##(1990-5#1)(1993-9#1)(1995-3#1)(1997-4#2)(2005-11#1)(2007-11#1)(2007-7#1)(2007-8#1)(2009-2#1)(2009-8#2)(2010-12#2)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
we discuss a case##2##4##(2008-5#1)(2013-8#1)
we discuss a##8##3##(1995-2#1)(2006-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
we discuss an##3##3##(2010-10#1)(2010-2#1)(2010-4#1)
we discuss briefly the##2##4##(2008-7#1)(2012-2#1)
we discuss current##2##3##(2008-1#1)(2008-3#1)
we discuss different##3##3##(1992-2#1)(2008-11#1)(2010-9#1)
we discuss examples##2##3##(2006-4#1)(2008-11#1)
we discuss how the##3##4##(1995-4#1)(2007-8#1)(2008-3#1)
we discuss how these##2##4##(1995-4#1)(2010-12#1)
we discuss how to##3##4##(1997-6#1)(2007-11#1)(2011-2#1)
we discuss how##21##3##(1995-4#3)(1997-6#1)(2006-10#2)(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-5#1)(2009-8#3)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#1)
we discuss in##4##3##(2008-3#1)(2009-8#1)(2011-1#1)(2012-2#1)
we discuss its##2##3##(2007-12#1)(2008-10#1)
we discuss limitations##2##3##(2006-10#1)(2012-12#1)
we discuss not only##2##4##(2006-12#1)(2010-2#1)
we discuss our##4##3##(1990-10#1)(2008-10#1)(2012-12#1)(2012-3#1)
we discuss possible##3##3##(2009-8#3)
we discuss potential##2##3##(2009-6#1)(2011-2#1)
we discuss recent advancements in##2##5##(2009-3#1)(2012-1#1)
we discuss recent advances in##3##5##(1994-3#1)(2010-7#1)(2012-12#1)
we discuss recent advances##4##4##(1994-3#1)(2010-7#1)(2011-1#1)(2012-12#1)
we discuss recent results##2##4##(1997-6#1)(2010-12#1)
we discuss recent studies##3##4##(2007-5#1)(2011-2#1)(2012-12#1)
we discuss recent##17##3##(1994-3#1)(1997-6#1)(2006-10#3)(2007-5#1)(2009-3#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)
we discuss several##8##3##(1994-2#1)(1995-9#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-12#1)(2010-12#1)(2012-12#1)
we discuss some of the##3##5##(2008-11#1)(2009-2#1)(2009-3#1)
we discuss some##8##3##(1994-6#2)(2008-11#2)(2009-2#1)(2009-3#1)(2009-6#1)(2010-5#1)
we discuss studies##2##3##(2007-11#1)(2009-9#1)
we discuss the advantages and##2##5##(2008-3#1)(2011-2#1)
we discuss the application of##2##5##(2010-2#1)(2012-1#1)
we discuss the characteristics##2##4##(2006-10#1)(2008-11#1)
we discuss the clinical##2##4##(2007-5#1)(2010-12#1)
we discuss the current state of##2##6##(1997-8#1)(2007-8#1)
we discuss the current##6##4##(1997-8#1)(2007-8#1)(2008-11#1)(2011-1#1)(2013-1#2)
we discuss the evidence##2##4##(2007-1#1)(2010-2#1)
we discuss the evolution of##2##5##(2009-5#1)(2009-8#1)
we discuss the impact of##2##5##(2008-7#1)(2009-5#1)
we discuss the implications of##3##5##(2008-8#1)(2009-8#1)(2011-2#1)
we discuss the importance of##3##5##(2008-11#2)(2011-2#1)
we discuss the issues of##2##5##(2007-8#1)(2008-8#1)
we discuss the major##2##4##(1991-12#1)(2010-7#1)
we discuss the molecular##2##4##(2008-1#1)(2009-12#1)
we discuss the need##2##4##(2008-11#1)(2009-8#1)
we discuss the possibility##3##4##(2008-2#1)(2011-1#1)(2011-2#1)
we discuss the possible##8##4##(2008-1#1)(2009-6#1)(2009-8#3)(2011-12#1)(2011-2#2)
we discuss the potential##6##4##(2006-4#1)(2008-1#1)(2009-5#1)(2009-8#2)(2010-7#1)
we discuss the recent advances in##2##6##(2006-11#1)(2012-1#1)
we discuss the results##2##4##(2008-2#1)(2012-2#1)
we discuss the role of##8##5##(2005-12#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
we discuss the use of this technology in an existing biomedical image search engine##2##14##(2013-1#2)
we discuss the use of##3##5##(2008-11#1)(2013-1#2)
we discuss the##149##3##(1991-12#1)(1992-11#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#2)(2006-9#2)(2007-1#1)(2007-11#2)(2007-12#4)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#10)(2008-12#3)(2008-2#5)(2008-3#3)(2008-5#1)(2008-7#4)(2008-8#3)(2009-12#1)(2009-3#2)(2009-5#4)(2009-6#2)(2009-8#11)(2010-1#2)(2010-10#1)(2010-12#2)(2010-2#2)(2010-5#1)(2010-7#3)(2011-1#3)(2011-12#2)(2011-2#13)(2012-1#5)(2012-12#6)(2012-2#5)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#5)
we discuss their##3##3##(2006-5#1)(2009-5#1)(2010-12#1)
we discuss these processes and##2##5##(2010-12#1)(2011-2#1)
we discuss these##5##3##(2009-8#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)
we discuss three##5##3##(2008-11#1)(2008-3#1)(2010-12#1)(2011-11#1)(2012-2#1)
we discuss two##3##3##(2007-11#1)(2008-9#1)(2010-1#1)
we discuss various##2##3##(2008-11#1)(2010-8#1)
we discuss what##2##3##(1990-5#1)(2013-1#1)
we discuss which##2##3##(1995-3#1)(2008-2#1)
we discuss##320##2##(1990-10#1)(1990-5#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-2#2)(1994-2#1)(1994-3#1)(1994-6#3)(1995-2#1)(1995-3#1)(1995-4#3)(1995-9#1)(1997-4#1)(1997-6#3)(1997-8#3)(2004-10#1)(2005-10#1)(2005-12#1)(2005-6#1)(2005-8#1)(2006-10#8)(2006-11#2)(2006-12#2)(2006-4#2)(2006-5#3)(2006-7#1)(2006-9#4)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#7)(2007-3#1)(2007-5#3)(2007-6#2)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#5)(2008-10#9)(2008-11#17)(2008-12#4)(2008-2#11)(2008-3#10)(2008-4#1)(2008-5#2)(2008-7#10)(2008-8#5)(2008-9#2)(2009-10#1)(2009-12#4)(2009-2#1)(2009-3#4)(2009-5#7)(2009-6#5)(2009-8#21)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#9)(2010-2#4)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#7)(2011-11#1)(2011-12#2)(2011-2#21)(2012-1#7)(2012-11#1)(2012-12#12)(2012-2#11)(2012-3#6)(2013-1#10)(2013-7#1)(2013-8#6)
we discussed the##2##3##(2007-9#1)(2012-1#1)
we discussed##4##2##(2007-9#1)(2008-10#1)(2009-8#1)(2012-1#1)
we disrupted the##3##3##(1995-11#1)(1996-8#1)(2006-12#1)
we disrupted##4##2##(1995-11#1)(1996-8#1)(2006-12#1)(2008-10#1)
we distinguish##5##2##(2008-1#1)(2008-7#1)(2010-3#1)(2013-1#2)
we divided the##3##3##(2008-12#1)(2008-8#1)(2011-2#1)
we divided##5##2##(2008-12#1)(2008-4#1)(2008-8#1)(2011-2#1)(2013-7#1)
we do and##2##3##(2006-8#1)(2010-2#1)
we do in##3##3##(2010-12#1)(2012-12#2)
we do it##10##3##(2006-8#1)(2008-9#9)
we do know##2##3##(1990-9#1)(2005-10#1)
we do not have##3##4##(2006-2#1)(2008-5#1)(2010-8#1)
we do not know exactly##2##5##(2007-11#1)(2007-8#1)
we do not know how##2##5##(1991-3#1)(2012-3#1)
we do not know if##2##5##(2008-10#1)(2008-2#1)
we do not know##7##4##(1991-3#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2012-3#1)
we do not yet##3##4##(1997-8#1)(2006-9#1)(2008-8#1)
we do not##34##3##(1990-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-4#1)(1993-12#1)(1994-2#1)(1994-9#1)(1997-8#1)(2005-10#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-8#4)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-8#1)(2010-11#1)(2010-3#1)(2010-8#2)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#1)
we do with##3##3##(2008-8#1)(2010-10#2)
we do##67##2##(1990-10#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-4#1)(1993-12#1)(1994-1#1)(1994-2#2)(1994-9#1)(1996-9#1)(1997-1#1)(1997-8#2)(2005-10#2)(2006-2#1)(2006-8#2)(2006-9#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#4)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#9)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-8#2)(2011-2#1)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
we do?##3##2##(2009-5#1)(2010-2#1)(2010-9#1)
we document the##5##3##(1995-6#1)(2006-12#1)(2008-11#1)(2008-9#1)(2011-3#1)
we document##8##2##(1995-6#1)(1997-1#1)(2006-12#1)(2007-12#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-3#1)
we documented##5##2##(2007-10#1)(2008-10#1)(2008-9#1)(2010-9#1)(2013-7#1)
we doing enough?##2##3##(2007-8#1)(2008-11#1)
we doing##7##2##(1991-3#1)(2006-12#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-11#1)(2012-12#1)
we don't##2##2##(1995-1#1)(2011-2#1)
we draw##3##2##(2008-6#1)(2008-9#1)(2011-2#1)
we elected to##4##3##(1991-3#1)(2007-11#1)(2007-8#1)(2012-12#1)
we eliminated the##2##3##(2008-1#1)(2013-1#1)
we elongated the##2##3##(2008-10#1)(2008-2#1)
we embark##2##2##(2006-4#1)(2008-1#1)
we emphasize that##2##3##(1994-2#1)(2008-10#1)
we emphasize the importance of##2##5##(2006-10#1)(2011-2#1)
we emphasize the##7##3##(2006-10#1)(2007-10#1)(2008-2#1)(2008-5#1)(2009-8#1)(2009-9#1)(2011-2#1)
we emphasize##9##2##(1994-2#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-8#1)(2009-9#1)(2011-2#1)
we emphasized##2##2##(2007-9#1)(2008-11#1)
we employ a##2##3##(2007-12#1)(2008-11#1)
we employ causal Bayesian networks to define and analyze a novel framework that can be used to model a spectrum of aspects related to multimorbidity##2##25##(2013-1#2)
we employ##8##2##(1992-9#1)(1994-5#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-8#1)(2013-1#2)
we employed a##6##3##(1991-9#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-2#1)
we employed the##4##3##(1990-8#1)(1991-5#1)(2008-2#1)(2011-2#1)
we employed##22##2##(1990-8#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-3#1)(1995-3#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#2)(2012-2#1)
we encounter##2##2##(2008-7#1)(2012-2#1)
we encountered in##2##3##(2011-1#1)(2012-2#1)
we encourage##2##2##(2009-4#1)(2010-8#1)
we engineered##3##2##(1996-4#1)(2008-10#1)(2011-2#1)
we ensure##2##2##(1996-12#1)(2005-12#1)
we enter##4##2##(2004-1#1)(2006-10#1)(2007-2#1)(2008-12#1)
we eradicate the##2##3##(2006-8#1)(2007-5#1)
we essentially##2##2##(2008-10#1)(2012-2#1)
we establish a##3##3##(2008-10#1)(2008-9#1)(2010-8#1)
we establish the##4##3##(1995-2#1)(2010-2#1)(2012-12#2)
we establish##10##2##(1995-2#1)(1995-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-2#1)(2010-8#1)(2012-12#2)
we established a new##2##4##(1993-3#1)(2008-10#1)
we established a novel##3##4##(2007-8#1)(2008-10#1)(2013-1#1)
we established a##15##3##(1993-3#1)(1995-2#1)(1997-1#1)(2007-8#1)(2008-10#4)(2009-10#1)(2009-9#1)(2010-4#1)(2010-8#1)(2013-1#1)(2013-8#2)
we established an in vitro##2##5##(2007-2#2)
we established an##5##3##(1991-5#1)(1994-2#1)(1997-2#1)(2007-2#2)
we established rat astrocyte cell lines containing the plasmid for production of recombinant rat Epo##2##15##(2008-11#2)
we established that the##2##4##(1992-8#1)(2011-2#1)
we established that##4##3##(1991-5#1)(1992-8#1)(1996-10#1)(2011-2#1)
we established the##2##3##(2005-10#1)(2008-10#1)
we established to##2##3##(1997-4#1)(2012-12#1)
we established##39##2##(1990-5#1)(1991-5#2)(1992-8#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-2#1)(1996-10#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-10#1)(2007-2#2)(2007-8#1)(2008-10#5)(2008-11#4)(2008-5#2)(2009-10#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
we estimate a##2##3##(2005-11#1)(2012-3#1)
we estimate that the##3##4##(1990-9#1)(2007-12#1)(2008-11#1)
we estimate that##10##3##(1990-9#1)(1991-7#1)(1993-12#1)(1994-12#1)(1994-9#1)(1996-11#1)(2007-12#1)(2008-10#1)(2008-11#2)
we estimate the##5##3##(2004-1#1)(2008-3#2)(2013-1#2)
we estimate##27##2##(1990-9#1)(1991-7#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-5#1)(1996-11#1)(2004-1#1)(2005-11#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-11#3)(2008-3#3)(2008-8#1)(2009-8#1)(2010-11#1)(2010-3#1)(2012-3#1)(2013-1#3)
we estimated that at least##2##5##(2008-10#1)(2008-9#1)
we estimated that##7##3##(1992-9#1)(2007-7#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#2)
we estimated the##11##3##(1990-2#1)(1995-12#1)(2006-7#1)(2008-3#4)(2008-6#1)(2008-7#1)(2008-9#1)(2013-7#1)
we estimated##23##2##(1990-2#1)(1992-9#1)(1995-12#1)(1996-1#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-2#1)(2011-2#2)(2013-7#2)
we evaluate a##2##3##(2007-10#1)(2008-4#1)
we evaluate its##2##3##(1992-12#1)(2008-3#1)
we evaluate the performance of the##2##6##(1997-6#1)(2011-2#1)
we evaluate the performance of##3##5##(1997-6#1)(2007-5#1)(2011-2#1)
we evaluate the statistical properties of##2##6##(2012-3#2)
we evaluate the##18##3##(1994-8#1)(1995-6#1)(1997-6#1)(2007-5#1)(2007-7#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-2#2)(2010-5#1)(2011-2#2)(2012-3#4)
we evaluate##29##2##(1992-12#1)(1994-8#1)(1995-6#1)(1997-6#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-5#1)(2007-7#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#2)(2010-5#1)(2010-7#1)(2011-2#2)(2012-3#6)
we evaluated Test Procedure for §170##2##6##(2013-1#2)
we evaluated a##2##3##(2008-2#1)(2010-12#1)
we evaluated the ability of##2##5##(2006-11#1)(2009-3#1)
we evaluated the association between##3##5##(2010-7#1)(2011-2#1)(2012-2#1)
we evaluated the association##4##4##(2010-7#1)(2011-2#1)(2012-2#2)
we evaluated the effect of mirtazapine on##2##7##(2012-2#2)
we evaluated the effect of##10##5##(1990-5#1)(1993-12#1)(1994-6#1)(1995-6#1)(1996-3#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#2)
we evaluated the effects of##5##5##(1993-4#1)(2008-11#1)(2008-5#1)(2009-4#1)(2013-1#1)
we evaluated the efficacy of##2##5##(2005-12#1)(2011-2#1)
we evaluated the efficacy##3##4##(2005-12#1)(2010-4#1)(2011-2#1)
we evaluated the expression of##2##5##(2011-2#1)(2012-12#1)
we evaluated the mating performance of Schistocerca gregaria (Försk##2##9##(2012-12#2)
we evaluated the potential##2##4##(1992-12#1)(2008-10#1)
we evaluated the public's understanding and interpretation of graphical displays of risk information (2 bar graphs)##2##16##(2013-1#2)
we evaluated the use of##2##5##(2005-11#1)(2007-2#1)
we evaluated the##79##3##(1990-12#2)(1990-5#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-3#2)(1997-2#2)(1997-8#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-4#3)(2010-7#1)(2011-2#7)(2012-12#4)(2012-2#5)(2012-5#1)(2013-1#7)(2013-8#1)
we evaluated whether##4##3##(1997-3#1)(2010-4#1)(2013-1#2)
we evaluated##121##2##(1990-12#2)(1990-5#1)(1991-10#1)(1991-12#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-6#2)(1995-7#1)(1996-10#1)(1996-12#1)(1996-3#3)(1997-2#2)(1997-3#1)(1997-8#2)(2005-11#1)(2005-12#1)(2006-10#1)(2006-11#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#4)(2010-7#1)(2011-1#1)(2011-2#10)(2012-1#1)(2012-12#5)(2012-2#6)(2012-3#2)(2012-5#1)(2013-1#12)(2013-8#1)
we examine a##3##3##(2008-9#1)(2010-3#1)(2010-7#1)
we examine how the##2##4##(2010-10#1)(2010-7#1)
we examine how##5##3##(2008-2#1)(2008-8#1)(2009-12#1)(2010-10#1)(2010-7#1)
we examine the case of a##2##6##(2008-4#1)(2011-12#1)
we examine the development of##2##5##(2006-10#1)(2012-2#1)
we examine the effect of##2##5##(2009-3#1)(2009-4#1)
we examine the effects of##2##5##(1995-1#1)(2012-3#1)
we examine the hypothesis that##2##5##(2008-10#1)(2008-3#1)
we examine the impact of##3##5##(2008-3#1)(2009-12#1)(2010-8#1)
we examine the relative##3##4##(2008-6#1)(2008-9#1)(2011-1#1)
we examine the role of##3##5##(1991-2#1)(2007-12#1)(2010-3#1)
we examine the role##4##4##(1991-2#1)(2006-10#1)(2007-12#1)(2010-3#1)
we examine the##56##3##(1991-2#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-12#1)(1997-8#1)(2006-1#1)(2006-10#4)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)
we examine these##2##3##(2007-10#1)(2011-1#1)
we examine whether##7##3##(1990-8#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-2#1)(2011-1#1)
we examine##108##2##(1990-8#1)(1991-2#1)(1992-2#1)(1992-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-12#1)(1997-1#1)(1997-8#1)(2006-1#1)(2006-10#4)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#3)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#2)(2009-7#3)(2010-1#1)(2010-10#3)(2010-12#3)(2010-2#1)(2010-3#2)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#3)(2012-12#4)(2012-2#4)(2012-3#2)(2012-5#1)(2013-1#3)(2013-8#1)
we examined (1)##2##3##(2007-8#1)(2012-3#1)
we examined changes in##2##4##(1992-3#1)(2010-2#1)
we examined how postwar appraisals of service mediated the effects of objective aspects of service##2##15##(2013-1#2)
we examined how##7##3##(2007-9#1)(2008-11#1)(2008-9#1)(2009-12#1)(2010-7#1)(2013-1#2)
we examined in##3##3##(2008-11#1)(2009-8#1)(2011-2#1)
we examined its##2##3##(1991-6#1)(1993-5#1)
we examined relationships##2##3##(2008-12#1)(2010-7#1)
we examined the ability of##4##5##(1995-8#1)(2007-12#1)(2008-10#1)(2010-2#1)
we examined the activity of##2##5##(1995-12#1)(2008-10#1)
we examined the chemical##2##4##(1997-4#1)(2010-5#1)
we examined the correlation between the##2##6##(1993-11#1)(2010-9#1)
we examined the distribution of##2##5##(1994-10#1)(2008-5#1)
we examined the effect of PRL on##2##7##(1996-8#2)
we examined the effect of##35##5##(1990-10#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-4#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#3)(1997-4#1)(2007-10#2)(2008-10#1)(2008-11#3)(2008-8#1)(2010-2#1)(2011-2#1)(2012-2#1)
we examined the effects of two##2##6##(1994-8#1)(1996-3#1)
we examined the effects of##37##5##(1990-9#1)(1991-10#1)(1991-4#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-3#1)(1996-9#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#2)(2009-10#1)(2009-7#1)(2009-8#1)(2012-12#1)(2013-8#1)
we examined the expression of##10##5##(1993-3#1)(1994-5#1)(1996-12#2)(1996-5#1)(1997-5#1)(1997-6#1)(2008-7#1)(2008-8#1)(2013-1#1)
we examined the expression##13##4##(1993-3#1)(1994-5#1)(1995-8#1)(1996-12#2)(1996-5#1)(1997-5#1)(1997-6#1)(2004-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
we examined the feeding response to##2##6##(2011-2#1)(2012-11#1)
we examined the functional##4##4##(1991-8#1)(1995-8#1)(1997-6#1)(2008-8#1)
we examined the impact of##2##5##(2010-2#1)(2012-1#1)
we examined the in vitro##2##5##(1995-12#1)(2006-8#1)
we examined the influence of##2##5##(1990-2#1)(2008-10#1)
we examined the involvement of##2##5##(1994-9#1)(2008-11#1)
we examined the moderating effects of##2##6##(1996-1#1)(2011-2#1)
we examined the performance of##3##5##(1997-8#1)(2004-9#1)(2008-2#1)
we examined the possibility that##2##5##(1997-8#1)(2008-10#1)
we examined the potential of##2##5##(1992-5#1)(2012-7#1)
we examined the potential##3##4##(1992-5#1)(2008-5#1)(2012-7#1)
we examined the production of##3##5##(1993-4#1)(1994-12#1)(2012-2#1)
we examined the relationship between##8##5##(1994-7#1)(1996-1#1)(1997-4#1)(1997-6#1)(2008-3#1)(2012-2#1)(2013-1#2)
we examined the role of##5##5##(2008-11#1)(2008-4#1)(2009-4#1)(2009-9#1)(2010-7#1)
we examined the##207##3##(1990-10#2)(1990-2#1)(1990-5#1)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#3)(1993-4#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-12#3)(1994-2#4)(1994-3#2)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#5)(1995-3#2)(1995-6#1)(1995-8#4)(1995-9#1)(1996-1#3)(1996-12#4)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#2)(1997-1#1)(1997-4#4)(1997-5#3)(1997-6#4)(1997-7#1)(1997-8#5)(2004-11#1)(2004-9#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-12#4)(2008-10#10)(2008-11#12)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#6)(2008-7#2)(2008-8#6)(2009-10#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-2#3)(2010-5#1)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#3)(2012-7#1)(2013-1#7)(2013-7#1)(2013-8#4)
we examined their##2##3##(1996-11#1)(2008-11#1)
we examined whether the##5##4##(1994-2#1)(1995-11#1)(2006-8#1)(2008-10#1)(2008-6#1)
we examined whether this##2##4##(1996-11#1)(1996-2#1)
we examined whether##30##3##(1990-11#1)(1991-10#1)(1993-12#1)(1994-2#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#2)(1997-7#1)(2006-8#1)(2007-10#1)(2008-10#2)(2008-11#2)(2008-6#2)(2008-8#2)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#3)
we examined##329##2##(1990-10#3)(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#3)(1991-11#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#2)(1991-8#2)(1992-1#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#2)(1994-11#1)(1994-12#4)(1994-2#5)(1994-3#2)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#5)(1994-9#1)(1995-1#2)(1995-10#3)(1995-11#1)(1995-12#6)(1995-2#4)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#4)(1995-9#1)(1996-1#3)(1996-11#2)(1996-12#7)(1996-2#3)(1996-3#3)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#4)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#5)(1997-5#3)(1997-6#4)(1997-7#4)(1997-8#6)(2004-1#1)(2004-11#1)(2004-9#1)(2006-5#1)(2006-8#2)(2007-10#3)(2007-11#1)(2007-12#7)(2007-8#1)(2007-9#2)(2008-10#15)(2008-11#21)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#7)(2008-6#3)(2008-7#3)(2008-8#10)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#5)(2009-9#2)(2010-12#4)(2010-2#5)(2010-5#1)(2010-7#3)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#8)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#4)(2012-7#2)(2013-1#13)(2013-7#1)(2013-8#5)
we excluded##3##2##(1997-2#1)(2006-7#1)(2013-8#1)
we expanded the vascular Hoxc11 expression domain normally restricted to the lower limbs by utilizing an innovative integrated tetracycline regulatory system and Transgelin promoter elements to induce Hoxc11 expression universally in VSMCs of transgenic mice##2##35##(2012-12#2)
we expanded##4##2##(2010-8#1)(2012-12#2)(2013-1#1)
we expect that##3##3##(2007-12#1)(2008-3#1)(2011-2#1)
we expect to##3##3##(2008-7#1)(2008-8#1)(2013-7#1)
we expect##16##2##(1993-1#2)(1997-7#1)(2007-12#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-9#1)(2011-1#2)(2011-2#1)(2013-7#2)
we expected##2##2##(1991-1#1)(2004-2#1)
we experienced##2##2##(1996-6#1)(2007-8#1)
we experimentally##11##2##(2008-1#1)(2008-2#2)(2008-7#1)(2008-9#1)(2012-12#2)(2012-2#3)(2013-1#1)
we explain how##2##3##(2008-10#1)(2010-11#1)
we explain the##4##3##(2007-11#2)(2008-3#1)(2008-7#1)
we explain##11##2##(2007-10#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-11#1)
we explicitly##3##2##(2008-2#1)(2008-3#1)(2010-2#1)
we exploit the##2##3##(1996-9#1)(2008-6#1)
we exploit##3##2##(1996-9#1)(2007-11#1)(2008-6#1)
we exploited##4##2##(1991-5#1)(1993-2#1)(1994-5#1)(2013-1#1)
we explore both##2##3##(2005-11#1)(2012-2#1)
we explore here their use in the context of multi-drug prescription##2##11##(2013-1#2)
we explore some of the##2##5##(2008-7#1)(2010-8#1)
we explore the effects of##2##5##(1995-9#1)(2008-7#1)
we explore the evidence##2##4##(2006-10#1)(2008-1#1)
we explore the role of##2##5##(2008-8#1)(2009-5#1)
we explore the##38##3##(1993-12#1)(1995-9#1)(1996-5#1)(2005-11#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#7)(2009-5#1)(2009-8#2)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
we explore this idea##2##4##(2007-9#1)(2012-3#1)
we explore whether##2##3##(2007-12#1)(2007-5#1)
we explore##63##2##(1993-12#1)(1994-3#1)(1995-9#1)(1996-2#1)(1996-5#1)(2005-11#2)(2005-12#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-12#2)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#3)(2008-8#7)(2009-12#1)(2009-5#1)(2009-8#2)(2010-11#1)(2010-12#2)(2010-6#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#1)
we explored how##2##3##(2008-12#1)(2009-8#1)
we explored the possibility of##2##5##(2008-10#1)(2009-12#1)
we explored the role of##3##5##(2007-12#1)(2012-2#1)(2013-8#1)
we explored the##15##3##(1993-4#1)(1996-5#2)(1996-9#1)(1997-3#1)(2006-9#1)(2007-12#1)(2008-10#1)(2009-12#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
we explored whether##2##3##(2007-10#1)(2009-2#1)
we explored##23##2##(1993-4#1)(1996-5#2)(1996-9#1)(1997-3#1)(2006-9#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-8#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
we exposed##5##2##(1993-12#1)(1995-12#1)(2008-1#1)(2009-9#1)(2012-12#1)
we express##3##2##(1996-6#1)(2008-2#1)(2008-3#1)
we expressed a##2##3##(1996-11#1)(2006-12#1)
we expressed in##2##3##(1990-11#1)(1994-11#1)
we expressed the##2##3##(1991-8#1)(1992-3#1)
we expressed##11##2##(1990-11#1)(1991-8#1)(1992-3#1)(1994-11#1)(1996-1#1)(1996-11#1)(1997-6#1)(2006-12#1)(2007-12#1)(2008-7#1)(2011-1#1)
we extend our analysis##2##4##(1996-3#1)(1997-1#1)
we extend our##4##3##(1996-3#1)(1997-1#1)(2009-12#1)(2009-2#1)
we extend the##9##3##(2006-10#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-12#1)(2010-3#1)
we extend this##3##3##(2008-11#1)(2008-6#1)(2008-8#1)
we extend##23##2##(1996-12#1)(1996-3#1)(1997-1#1)(1997-4#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-6#3)(2008-8#3)(2009-12#1)(2009-2#1)(2009-7#1)(2010-12#1)(2010-3#1)
we extended the##6##3##(1990-5#1)(1997-4#1)(2006-8#1)(2009-5#1)(2011-2#1)(2012-3#1)
we extract the##3##3##(2007-11#1)(2007-12#1)(2008-9#1)
we extract##5##2##(1992-12#1)(2007-11#1)(2007-12#1)(2008-9#1)(2011-2#1)
we extracted##2##2##(1997-2#1)(1997-6#1)
we fabricate and##2##3##(2008-11#1)(2008-2#1)
we fabricate##3##2##(2008-11#1)(2008-2#2)
we fabricated a##3##3##(2007-12#1)(2008-2#1)(2012-2#1)
we fabricated and##2##3##(2007-11#1)(2008-3#1)
we fabricated##10##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#3)(2009-5#1)(2012-2#1)
we faced##3##2##(2008-10#1)(2012-2#1)(2012-3#1)
we failed to find any##2##5##(2007-12#1)(2007-7#1)
we failed to find##4##4##(1994-2#1)(2007-12#1)(2007-7#1)(2012-1#1)
we failed to##7##3##(1994-2#1)(2007-12#1)(2007-7#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-1#1)
we fed##3##2##(1990-6#1)(2008-11#1)(2008-5#1)
we feel that early BCC localized at any site perhaps constitutes a biological continuum that may ultimately manifest with metastasis in some individuals and should be evaluated as such##2##29##(2013-1#2)
we feel that##4##3##(2007-11#1)(2008-10#1)(2013-1#2)
we feel##7##2##(2006-6#1)(2007-11#1)(2008-10#1)(2012-11#1)(2012-12#1)(2013-1#2)
we filter##2##2##(2007-12#1)(2008-2#1)
we finally##3##2##(1995-6#1)(2008-7#1)(2009-9#1)
we find a##12##3##(1991-2#1)(1996-2#1)(1996-4#1)(1997-7#1)(2006-6#1)(2007-10#1)(2007-12#2)(2008-3#1)(2008-8#1)(2011-2#1)(2012-2#1)
we find an##8##3##(1996-12#1)(1997-2#1)(2008-11#1)(2008-3#2)(2012-2#2)(2012-3#1)
we find evidence for##2##4##(2008-2#1)(2008-8#1)
we find evidence##4##3##(1997-2#1)(2008-2#1)(2008-8#1)(2012-1#1)
we find it##2##3##(1995-5#1)(2007-7#1)
we find no evidence for a##2##6##(1993-3#1)(2009-10#1)
we find that an##2##4##(1991-9#1)(2008-5#1)
we find that both##2##4##(1992-3#1)(1995-8#1)
we find that the##25##4##(1990-11#1)(1990-7#1)(1992-2#1)(1992-3#2)(1994-9#1)(1996-8#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-12#3)(2008-1#2)(2008-11#2)(2008-2#2)(2008-3#2)(2008-7#1)(2009-2#1)(2009-3#1)(2012-12#1)
we find that there##2##4##(2008-9#1)(2009-4#1)
we find that this##2##4##(1990-8#1)(2009-2#1)
we find that##87##3##(1990-11#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-8#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-11#2)(1995-3#1)(1995-8#2)(1996-8#2)(1997-1#1)(2005-11#1)(2005-8#1)(2006-10#2)(2007-11#1)(2007-12#6)(2007-5#1)(2008-1#2)(2008-11#2)(2008-2#4)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#5)(2009-10#1)(2009-2#3)(2009-3#2)(2009-4#2)(2009-7#1)(2010-2#1)(2010-3#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#1)(2013-8#1)
we find the##9##3##(1994-8#2)(2007-12#1)(2008-1#1)(2008-2#2)(2008-7#1)(2009-2#1)(2013-8#1)
we find##151##2##(1990-11#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-8#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#2)(1995-3#1)(1995-5#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-7#2)(2005-11#1)(2005-8#1)(2006-10#2)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#13)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#4)(2008-11#3)(2008-12#1)(2008-2#10)(2008-3#10)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#7)(2009-10#2)(2009-12#1)(2009-2#4)(2009-3#2)(2009-4#3)(2009-7#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-3#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#6)(2013-1#2)(2013-8#2)
we first demonstrated##2##3##(2009-4#1)(2012-1#1)
we first describe##2##3##(2008-10#1)(2012-1#1)
we first developed##2##3##(2008-10#1)(2009-10#1)
we first discuss the##2##4##(2008-9#1)(2011-2#1)
we first established##2##3##(1994-8#1)(2013-8#1)
we first examined##3##3##(2008-11#1)(2008-7#1)(2009-4#1)
we first present a##2##4##(2006-11#1)(2009-12#1)
we first show that##2##4##(1991-12#1)(1996-5#1)
we first summarize##2##3##(2008-7#1)(2008-8#1)
we first##45##2##(1990-10#1)(1991-12#1)(1993-9#1)(1994-2#1)(1994-8#1)(1994-9#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-7#1)(2006-10#1)(2006-11#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#5)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-4#2)(2010-1#1)(2011-10#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
we fit##2##2##(2008-9#1)(2012-2#1)
we focus on a##4##4##(2008-9#1)(2010-10#1)(2011-1#1)(2013-8#1)
we focus on current##2##4##(2007-11#1)(2013-8#1)
we focus on how##6##4##(2008-5#1)(2009-5#1)(2009-6#1)(2011-1#1)(2012-1#1)(2012-12#1)
we focus on recent##2##4##(2007-8#1)(2008-1#1)
we focus on the effects of##2##6##(2008-11#2)
we focus on the##24##4##(1996-3#1)(2007-11#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#3)(2009-11#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)
we focus on two##4##4##(2008-4#1)(2010-6#1)(2010-7#1)(2013-8#1)
we focus on##66##3##(1996-3#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#3)
we focus our attention on##2##5##(2005-11#1)(2008-10#1)
we focus our discussion on##2##5##(2010-3#1)(2011-1#1)
we focus our##4##3##(2005-11#1)(2008-10#1)(2010-3#1)(2011-1#1)
we focus the##2##3##(2007-12#1)(2011-1#1)
we focus##77##2##(1996-3#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#6)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#3)
we focused on subjective aspects of military service##2##8##(2013-1#2)
we focused on the role of##2##6##(1997-4#1)(2008-10#1)
we focused on the##5##4##(1997-4#1)(2008-10#1)(2008-5#1)(2009-9#1)(2013-8#1)
we focused on two##3##4##(2006-12#1)(2012-12#2)
we focused on##18##3##(1991-4#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-5#3)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#1)
we focused our##2##3##(2009-9#1)(2013-1#1)
we focused##21##2##(1991-4#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#3)(2009-9#2)(2010-12#1)(2011-2#1)(2012-12#2)(2013-1#3)(2013-8#1)
we follow the##2##3##(2008-2#1)(2012-12#1)
we follow up##2##3##(2006-6#1)(2010-11#1)
we follow##5##2##(2006-6#1)(2008-2#1)(2010-11#1)(2010-2#1)(2012-12#1)
we followed a##2##3##(2008-7#1)(2009-8#1)
we followed the##3##3##(1997-4#1)(2008-10#2)
we followed##6##2##(1997-4#1)(2007-7#1)(2008-10#2)(2008-7#1)(2009-8#1)
we forget##2##2##(2010-4#1)(2011-1#1)
we formed##4##2##(2007-7#1)(2007-8#1)(2008-11#1)(2011-2#1)
we formulate a##2##3##(1994-2#1)(2010-1#1)
we formulate the optimal##2##4##(2007-12#1)(2008-2#1)
we formulate##5##2##(1994-2#1)(2007-12#1)(2008-2#1)(2010-1#1)(2012-2#1)
we found EMS personnel requested patient data on 14% of all transports##2##12##(2013-1#2)
we found a gene##2##4##(1990-6#1)(1995-6#1)
we found a high prevalence of##2##6##(2008-1#1)(2010-4#1)
we found a high##5##4##(1992-9#1)(1993-4#1)(2007-3#1)(2008-1#1)(2010-4#1)
we found a positive##3##4##(2009-2#1)(2009-8#1)(2012-2#1)
we found a significant association between the##2##7##(2011-2#1)(2013-8#1)
we found a significant correlation##2##5##(2007-12#1)(2013-8#1)
we found a significant##8##4##(1993-12#1)(2007-12#1)(2007-8#1)(2008-11#1)(2011-2#1)(2013-1#1)(2013-8#2)
we found a specific##2##4##(2009-10#2)
we found a##43##3##(1990-10#1)(1990-12#1)(1990-6#1)(1992-10#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-2#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#2)(2009-2#2)(2009-8#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#2)
we found an increased##2##4##(1994-2#1)(2006-6#1)
we found an inverse relationship between##2##6##(1995-12#1)(2009-7#1)
we found an##11##3##(1991-5#1)(1992-12#1)(1994-2#1)(1995-12#1)(2005-11#1)(2006-6#1)(2008-10#1)(2008-7#1)(2009-7#1)(2010-12#1)(2013-8#1)
we found enhanced##2##3##(2008-11#1)(2008-3#1)
we found evidence of##2##4##(2012-3#1)(2013-1#1)
we found evidence that##4##4##(2008-7#1)(2009-10#1)(2009-12#1)(2011-2#1)
we found evidence##7##3##(2008-11#1)(2008-7#1)(2009-10#1)(2009-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
we found high##2##3##(2011-2#2)
we found in the##4##4##(1994-8#1)(2008-10#1)(2008-11#2)
we found in##9##3##(1991-10#1)(1993-8#1)(1994-8#1)(1995-12#1)(1996-2#1)(1996-8#1)(2008-10#1)(2008-11#2)
we found large##3##3##(1990-11#1)(1995-12#1)(2013-8#1)
we found little##2##3##(1992-10#1)(2008-9#1)
we found lower##2##3##(1995-7#1)(2013-1#1)
we found many##2##3##(2007-7#1)(2012-3#1)
we found no differences##3##4##(1995-5#1)(2012-1#1)(2013-1#1)
we found no evidence for##2##5##(1995-12#1)(2009-8#1)
we found no evidence##4##4##(1995-12#1)(2008-6#1)(2009-8#1)(2013-1#1)
we found no significant##2##4##(1995-11#1)(1997-5#1)
we found no##23##3##(1994-11#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-11#1)(1997-5#1)(2006-3#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-6#2)(2009-4#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#2)(2013-7#1)
we found only##2##3##(1996-5#1)(2011-2#1)
we found out that##2##4##(1996-6#1)(2013-1#1)
we found out##3##3##(1990-7#1)(1996-6#1)(2013-1#1)
we found positive##2##3##(2006-6#1)(2008-10#1)
we found robust##2##3##(2008-1#1)(2011-1#1)
we found significant increases##2##4##(1992-3#1)(2008-7#1)
we found significant##4##3##(1992-3#1)(2008-7#1)(2008-8#1)(2013-1#1)
we found significantly##3##3##(2008-11#1)(2009-5#1)(2010-2#1)
we found that a single interaction with this tutorial led to significant changes in thinking toward a clearer articulation of the effects of mutational change##2##25##(2012-12#2)
we found that a##7##4##(1997-7#1)(2008-11#1)(2009-7#1)(2011-1#1)(2012-12#3)
we found that all##3##4##(2008-10#1)(2010-11#1)(2013-1#1)
we found that at least##2##5##(2007-10#1)(2008-10#1)
we found that in##2##4##(1994-8#1)(2008-10#1)
we found that individuals who##2##5##(2008-5#1)(2009-12#1)
we found that individuals##3##4##(2008-5#1)(2008-8#1)(2009-12#1)
we found that one of the downregulated genes##2##8##(2012-12#2)
we found that one##4##4##(1995-3#1)(1996-12#1)(2012-12#2)
we found that some##2##4##(1997-4#1)(2009-5#1)
we found that the BCMA acceptance rate was 6##2##9##(2013-1#2)
we found that the PKC##2##5##(1992-6#1)(1994-2#1)
we found that the expression##2##5##(1994-11#1)(1994-12#1)
we found that the majority##2##5##(2008-11#1)(2009-6#1)
we found that the relative##2##5##(2007-11#1)(2008-5#1)
we found that the same##2##5##(1990-11#1)(1997-4#1)
we found that the striatal FDOPA uptake rate constant##2##9##(1997-8#2)
we found that the##83##4##(1990-11#2)(1992-11#1)(1992-6#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-11#2)(1995-3#2)(1995-8#2)(1996-12#1)(1996-9#1)(1997-2#1)(1997-4#3)(1997-6#1)(1997-8#3)(2005-10#1)(2006-10#1)(2006-3#1)(2007-11#4)(2007-12#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-8#3)(2008-9#3)(2009-3#1)(2009-6#2)(2009-8#2)(2010-4#1)(2011-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
we found that there was a##2##6##(2008-10#1)(2012-2#1)
we found that there##4##4##(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
we found that this##2##4##(1990-5#1)(2012-2#1)
we found that virgin females##2##5##(1995-1#2)
we found that##279##3##(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#4)(1991-1#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#6)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#3)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#2)(1995-10#2)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#3)(1995-8#2)(1996-12#4)(1996-5#2)(1996-7#1)(1996-8#2)(1996-9#2)(1997-2#1)(1997-4#7)(1997-6#2)(1997-7#3)(1997-8#3)(2005-10#2)(2006-1#1)(2006-10#3)(2006-12#3)(2006-3#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#8)(2007-12#3)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#12)(2008-12#1)(2008-2#3)(2008-3#10)(2008-5#7)(2008-6#3)(2008-7#6)(2008-8#12)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2010-11#2)(2010-12#1)(2010-2#2)(2010-4#1)(2011-1#4)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#8)(2012-2#8)(2012-3#8)(2013-1#9)(2013-7#1)(2013-8#8)
we found the following##3##4##(2008-8#1)(2008-9#1)(2012-2#1)
we found the use of tailored emails to dramatically increase participation for a short period##2##15##(2013-1#2)
we found the##17##3##(1990-12#1)(1991-5#1)(1992-9#1)(1994-5#1)(1996-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
we found to##3##3##(2007-7#1)(2009-5#1)(2012-3#1)
we found two##6##3##(1995-2#1)(1996-11#1)(1996-5#1)(1996-7#1)(2008-3#1)(2009-2#1)
we found##519##2##(1990-10#3)(1990-11#5)(1990-12#5)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#5)(1990-7#1)(1991-1#2)(1991-10#1)(1991-12#1)(1991-4#1)(1991-5#3)(1991-7#1)(1991-9#1)(1992-10#3)(1992-11#6)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#3)(1993-11#1)(1993-12#2)(1993-3#1)(1993-4#4)(1993-5#1)(1993-6#1)(1993-8#4)(1993-9#2)(1994-10#1)(1994-11#5)(1994-12#2)(1994-2#4)(1994-3#3)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#8)(1994-9#5)(1995-1#2)(1995-10#2)(1995-11#3)(1995-12#10)(1995-2#5)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#4)(1995-7#1)(1995-8#2)(1996-1#1)(1996-11#2)(1996-12#7)(1996-2#4)(1996-5#7)(1996-6#2)(1996-7#2)(1996-8#3)(1996-9#3)(1997-2#2)(1997-4#8)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#3)(2005-10#2)(2005-11#1)(2006-1#1)(2006-10#5)(2006-12#3)(2006-3#3)(2006-6#2)(2006-7#2)(2006-9#1)(2007-10#1)(2007-11#9)(2007-12#6)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#24)(2008-11#19)(2008-12#3)(2008-2#5)(2008-3#17)(2008-4#3)(2008-5#13)(2008-6#5)(2008-7#10)(2008-8#17)(2008-9#7)(2009-10#5)(2009-11#2)(2009-12#2)(2009-2#5)(2009-3#3)(2009-4#3)(2009-5#3)(2009-6#2)(2009-7#3)(2009-8#5)(2009-9#1)(2010-11#2)(2010-12#3)(2010-2#3)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#6)(2011-12#2)(2011-2#22)(2012-1#3)(2012-11#2)(2012-12#12)(2012-2#14)(2012-3#14)(2013-1#21)(2013-7#3)(2013-8#16)
we functionally##2##2##(2006-6#1)(2010-2#1)
we further show that##2##4##(1996-8#1)(2006-10#1)
we further##17##2##(1991-9#1)(1994-3#1)(1995-11#2)(1995-3#1)(1996-8#2)(2006-10#1)(2007-8#1)(2008-11#1)(2008-3#1)(2009-6#1)(2009-8#2)(2009-9#1)(2012-1#1)(2012-3#1)
we gain##5##2##(1992-3#1)(2006-7#1)(2008-2#1)(2008-5#1)(2013-8#1)
we generalize##3##2##(2008-8#1)(2009-12#1)(2012-3#1)
we generate##4##2##(2008-3#2)(2012-12#2)
we generated a set of##2##5##(2008-3#2)
we generated a stable##2##4##(1997-4#1)(2008-11#1)
we generated a##7##3##(1992-11#1)(1996-5#1)(1997-4#1)(2007-12#1)(2008-11#1)(2008-3#2)
we generated recombinant##2##3##(1995-8#1)(2011-2#1)
we generated the##2##3##(2007-12#1)(2013-8#1)
we generated transgenic mice that##2##5##(1991-11#1)(1997-4#1)
we generated transgenic##6##3##(1991-11#1)(1997-4#1)(2006-12#1)(2008-11#1)(2010-2#1)(2012-12#1)
we generated##40##2##(1991-11#1)(1992-11#1)(1994-8#1)(1995-8#1)(1996-10#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-4#3)(1997-6#1)(2006-12#1)(2007-11#1)(2007-12#5)(2008-1#1)(2008-11#6)(2008-2#2)(2008-3#4)(2008-8#1)(2010-2#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#2)
we genotyped##3##2##(1996-1#1)(2012-1#1)(2013-1#1)
we get##6##2##(1991-2#1)(1991-6#1)(2005-11#1)(2007-8#1)(2008-2#1)(2012-12#1)
we give a brief overview of current methods used for patient care and discuss two types of possible treatments and the materials used for these therapies-(i) artificial pancreases##2##28##(2012-11#2)
we give a##9##3##(1991-2#1)(1992-9#1)(2006-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2012-11#2)
we give an overview of##2##5##(2006-10#1)(2013-1#1)
we give an##4##3##(1991-6#1)(2006-10#1)(2008-2#1)(2013-1#1)
we give evidence##3##3##(1992-7#1)(2009-10#1)(2013-1#1)
we give the##2##3##(1990-2#1)(2008-3#1)
we give##21##2##(1990-2#1)(1991-2#1)(1991-6#1)(1992-7#1)(1992-9#1)(2006-10#2)(2008-2#1)(2008-3#3)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#1)(2010-11#1)(2012-11#2)(2013-1#2)
we go##3##2##(1995-4#1)(2008-11#1)(2008-8#1)
we go?##4##2##(2006-4#1)(2006-8#1)(2007-10#1)(2008-10#1)
we got the##2##3##(2008-5#1)(2010-7#1)
we got##4##2##(2008-10#1)(2008-5#1)(2010-7#1)(2013-8#1)
we grouped##2##2##(2008-8#1)(2012-3#1)
we had found##2##3##(2006-9#1)(2008-10#1)
we had no##2##3##(2007-7#1)(2008-8#1)
we had observed##3##3##(2008-1#1)(2008-5#1)(2008-6#1)
we had previously isolated##2##4##(1992-11#2)
we had previously##9##3##(1991-8#1)(1992-11#2)(1994-12#1)(1994-2#1)(1994-6#1)(1996-10#1)(1996-3#1)(1997-2#1)
we had the##2##3##(1993-5#1)(2009-8#1)
we had to##4##3##(2008-2#1)(2008-3#2)(2011-2#1)
we had##34##2##(1991-8#1)(1992-11#2)(1993-5#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-12#1)(1996-10#1)(1996-11#1)(1996-3#1)(1997-2#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#2)
we harvested definitional phrases from the Web and contrasted them with the terms and their logical definitions as stated in SNOMED CT##2##22##(2013-1#2)
we have SMART-enabled the Informatics for Integrating Biology and the Bedside (i2b2) open source analytical platform##2##16##(2013-1#2)
we have a##11##3##(1991-6#1)(1995-4#1)(1997-1#2)(2004-3#1)(2006-10#1)(2006-4#1)(2007-7#1)(2009-3#1)(2009-4#1)(2012-3#1)
we have achieved##8##3##(2006-3#1)(2007-11#3)(2007-12#2)(2008-11#1)(2008-2#1)
we have addressed##2##3##(1994-11#1)(2008-8#1)
we have adopted is to##2##5##(2008-1#1)(2009-2#1)
we have advanced##3##3##(1995-12#1)(1996-8#1)(2010-4#1)
we have aimed to##2##4##(2007-11#1)(2013-1#1)
we have already reported##2##4##(2006-12#1)(2008-5#1)
we have already##3##3##(2006-12#1)(2008-5#1)(2013-1#1)
we have also shown that the##2##6##(1992-12#1)(1996-11#1)
we have also shown that##4##5##(1992-12#1)(1996-10#2)(1996-11#1)
we have also##11##3##(1992-12#1)(1996-10#2)(1996-11#1)(1996-2#1)(2008-1#1)(2008-12#1)(2008-3#2)(2008-5#1)(2009-6#1)
we have always##2##3##(2007-8#1)(2008-12#1)
we have an##2##3##(2008-3#1)(2013-1#1)
we have analysed the##2##4##(1996-3#1)(2008-7#1)
we have analysed##8##3##(1993-9#1)(1996-3#2)(2005-12#1)(2007-10#1)(2007-9#1)(2008-7#1)(2008-9#1)
we have analyzed the effects of##2##6##(2008-11#1)(2008-8#1)
we have analyzed the promoter##2##5##(1995-2#1)(1995-3#1)
we have analyzed the##15##4##(1991-1#1)(1992-9#1)(1994-2#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-5#1)(1997-8#1)(2006-12#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)
we have analyzed##20##3##(1990-5#1)(1991-1#1)(1992-9#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-5#1)(1997-8#1)(2006-12#1)(2007-2#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2009-8#1)
we have applied the##3##4##(2008-2#3)
we have applied this##2##4##(1996-7#1)(2010-7#1)
we have applied##14##3##(1990-9#1)(1994-10#1)(1996-7#1)(2006-12#2)(2007-11#2)(2008-1#1)(2008-11#1)(2008-2#3)(2010-7#1)(2011-2#1)
we have assayed##2##3##(1990-5#1)(1991-12#1)
we have assessed the##3##4##(1995-6#1)(2008-5#1)(2008-7#1)
we have assessed##4##3##(1995-6#1)(2008-5#1)(2008-7#1)(2008-8#1)
we have assigned##2##3##(1991-2#1)(1994-9#1)
we have attempted to##6##4##(1990-2#1)(1992-7#1)(2007-1#1)(2008-11#1)(2008-2#1)(2012-12#1)
we have been able to detect##2##6##(1990-5#1)(2008-7#1)
we have been able to identify##2##6##(1991-12#1)(1997-4#1)
we have been able to##17##5##(1990-2#1)(1990-5#1)(1991-12#1)(1993-6#1)(1996-5#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-5#2)(2008-7#2)(2010-8#1)
we have been developing##2##4##(2008-7#1)(2012-1#1)
we have been informed by the head of the Department of Chemistry at Sri Venkateswara University that the university authorities have taken disciplinary action against Professor Chiranjeevi##2##27##(2008-10#2)
we have been informed by the head of the Department of Chemistry at Sri Venkateswara University that the university authorities have taken disciplinary action against##3##25##(2008-10#3)
we have been##35##3##(1990-2#1)(1990-5#1)(1991-12#1)(1993-11#1)(1993-6#1)(1994-12#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-6#2)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2010-8#1)(2012-1#1)
we have begun to##4##4##(1994-11#1)(1994-2#1)(2008-8#1)(2009-6#1)
we have begun##5##3##(1994-11#1)(1994-2#1)(2008-7#1)(2008-8#1)(2009-6#1)
we have calculated##5##3##(1990-8#1)(1995-4#1)(1997-7#1)(2006-6#1)(2008-3#1)
we have carried out a##4##5##(1991-2#1)(1991-5#1)(2008-10#1)(2008-2#1)
we have carried out the##2##5##(1990-10#1)(2010-12#1)
we have carried out##10##4##(1990-10#1)(1990-7#1)(1991-2#1)(1991-5#1)(1993-11#1)(1997-4#1)(2008-10#1)(2008-2#1)(2010-12#1)(2012-2#1)
we have changed##3##3##(1990-3#1)(1997-2#1)(2008-9#1)
we have characterized the##10##4##(1990-11#1)(1990-2#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1997-2#1)(2008-10#1)(2009-8#1)
we have characterized their##2##4##(1994-11#1)(2009-2#1)
we have characterized##18##3##(1990-11#1)(1990-2#1)(1991-2#2)(1991-4#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1997-2#1)(1997-7#1)(2006-12#1)(2008-10#1)(2009-2#1)(2009-8#1)
we have chosen to##3##4##(1996-8#1)(2008-11#1)(2008-7#1)
we have chosen##6##3##(1993-12#1)(1996-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
we have cloned a cDNA##2##5##(1993-6#1)(1997-8#1)
we have cloned a##4##4##(1992-11#1)(1993-6#1)(1997-4#1)(1997-8#1)
we have cloned and characterized##2##5##(1994-9#1)(1996-2#1)
we have cloned and sequenced the##4##6##(1991-2#1)(1992-12#1)(1994-5#1)(1997-7#1)
we have cloned and sequenced##5##5##(1991-12#1)(1991-2#1)(1992-12#1)(1994-5#1)(1997-7#1)
we have cloned and##9##4##(1991-12#1)(1991-2#1)(1991-8#1)(1992-12#1)(1994-5#1)(1994-9#1)(1995-8#1)(1996-2#1)(1997-7#1)
we have cloned cDNAs encoding##2##5##(1990-12#1)(1996-11#1)
we have cloned cDNAs##3##4##(1990-12#1)(1991-5#1)(1996-11#1)
we have cloned the##3##4##(1993-12#1)(1996-4#1)(1996-7#1)
we have cloned##25##3##(1990-12#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-6#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-12#1)(2008-5#1)
we have combined##3##3##(2008-11#1)(2008-8#1)(2013-1#1)
we have come to understand that##2##6##(1991-1#1)(2006-10#1)
we have come to##4##4##(1991-1#1)(1993-3#1)(2006-10#1)(2008-3#1)
we have come##5##3##(1991-1#1)(1993-3#1)(2006-10#1)(2008-3#1)(2013-1#1)
we have compared the##11##4##(1993-11#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-11#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2012-3#1)
we have compared##20##3##(1993-11#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-8#1)(1996-4#1)(1996-6#1)(1997-4#1)(1997-7#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2012-3#1)
we have computed the##2##4##(1994-3#1)(2008-2#1)
we have concluded that the##2##5##(2008-3#1)(2011-2#1)
we have concluded that##4##4##(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
we have concluded##5##3##(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#2)
we have conducted a##2##4##(1991-12#1)(2011-2#1)
we have conducted##3##3##(1991-12#1)(1992-10#1)(2011-2#1)
we have confirmed that##2##4##(1995-11#1)(2008-7#1)
we have confirmed##4##3##(1995-11#1)(2008-7#2)(2010-12#1)
we have considered##2##3##(1994-9#1)(2010-7#1)
we have constructed a##10##4##(1990-9#1)(1993-4#1)(1994-3#1)(1995-10#1)(1997-2#2)(1997-4#1)(2008-11#3)
we have constructed an##3##4##(1990-9#1)(1991-5#1)(2008-3#1)
we have constructed##23##3##(1990-5#1)(1990-9#2)(1991-5#1)(1992-12#1)(1993-4#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-10#1)(1995-11#1)(1995-3#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-8#1)(2008-11#3)(2008-3#1)(2008-7#1)(2008-9#1)
we have created a##2##4##(1990-6#1)(2007-11#1)
we have created##4##3##(1990-6#1)(2007-11#1)(2010-9#1)(2012-12#1)
we have defined##4##3##(1990-6#1)(1991-11#1)(2007-11#1)(2008-7#1)
we have demonstrated a##6##4##(1994-10#1)(1994-2#1)(2007-12#2)(2008-2#1)(2013-1#1)
we have demonstrated that the##3##5##(1992-8#1)(1994-8#1)(2004-12#1)
we have demonstrated that two##2##5##(1994-2#1)(2006-12#1)
we have demonstrated that##19##4##(1990-6#1)(1990-9#1)(1992-1#1)(1992-6#1)(1992-8#1)(1994-11#1)(1994-2#1)(1994-8#1)(1996-5#1)(2004-12#1)(2006-12#1)(2006-8#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-8#1)(2012-3#1)
we have demonstrated the##3##4##(1994-8#1)(2007-11#1)(2013-8#1)
we have demonstrated##40##3##(1990-6#1)(1990-9#1)(1992-1#1)(1992-6#1)(1992-8#2)(1994-10#1)(1994-11#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#2)(1996-5#1)(1997-4#1)(2004-12#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-5#2)(2008-7#1)(2009-8#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
we have described a##2##4##(1992-12#1)(1997-3#1)
we have described the##4##4##(1995-12#1)(2008-10#1)(2008-7#1)(2009-6#1)
we have described##11##3##(1990-7#1)(1992-12#1)(1995-12#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-5#2)(2008-7#2)(2009-6#1)
we have designated##5##3##(1990-4#1)(1990-5#1)(1991-7#1)(1996-5#1)(2007-11#1)
we have designed a##2##4##(1990-12#1)(2008-2#1)
we have designed and##4##4##(1994-11#1)(2007-12#1)(2008-2#1)(2009-6#1)
we have designed##13##3##(1990-12#1)(1994-11#1)(1997-3#1)(2006-12#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#1)(2009-6#1)
we have detected##8##3##(1991-10#1)(1991-3#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-9#1)(2007-2#1)(2013-1#1)
we have determined a##3##4##(1997-4#1)(2008-10#1)(2008-8#1)
we have determined its##2##4##(1994-11#1)(1997-7#1)
we have determined that there##2##5##(1992-4#1)(2010-8#1)
we have determined that##4##4##(1992-4#1)(1994-3#1)(1995-3#1)(2010-8#1)
we have determined the complete nucleotide sequence of the gene encoding##2##11##(1993-11#1)(1994-12#1)
we have determined the complete##3##5##(1991-5#1)(1993-11#1)(1994-12#1)
we have determined the gene##2##5##(1990-7#1)(1993-6#1)
we have determined the nucleotide##2##5##(1992-2#1)(1997-2#1)
we have determined the##20##4##(1990-7#1)(1991-10#1)(1991-12#2)(1991-5#1)(1992-2#1)(1992-4#1)(1993-11#1)(1993-6#2)(1993-9#2)(1994-12#1)(1995-5#1)(1996-4#1)(1996-7#1)(1997-2#2)(1997-3#1)(2008-3#1)
we have determined##32##3##(1990-7#1)(1991-10#1)(1991-12#2)(1991-5#1)(1992-2#1)(1992-4#2)(1992-9#1)(1993-11#1)(1993-6#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-5#2)(1996-4#1)(1996-7#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-8#1)
we have developed a classification method that automatically labels image regions with appropriate concepts based solely on their appearance##2##19##(2013-1#2)
we have developed a method##3##5##(1992-2#1)(1993-8#1)(2009-12#1)
we have developed a new method of##2##7##(2006-6#1)(2007-8#1)
we have developed a new method##5##6##(1992-3#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-3#1)
we have developed a new##13##5##(1992-3#1)(1995-1#1)(1995-3#1)(2006-10#1)(2006-6#2)(2007-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-2#1)
we have developed a novel##4##5##(2007-11#1)(2008-7#2)(2011-1#1)
we have developed a series of##2##6##(2007-11#1)(2008-7#1)
we have developed a unique##2##5##(1996-3#1)(2008-3#1)
we have developed a##60##4##(1990-12#1)(1991-11#1)(1992-2#1)(1992-3#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-1#1)(1997-3#1)(2006-10#1)(2006-6#2)(2007-11#2)(2007-12#3)(2007-5#2)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#3)(2009-12#1)(2009-9#2)(2010-2#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)
we have developed an in vitro##2##6##(1994-12#1)(2008-11#1)
we have developed an integrated##2##5##(2007-5#1)(2008-7#1)
we have developed an##11##4##(1993-11#1)(1993-8#1)(1994-12#1)(2007-5#1)(2007-8#1)(2008-11#2)(2008-5#1)(2008-7#1)(2010-9#1)(2011-2#1)
we have developed and##2##4##(2011-1#1)(2013-1#1)
we have developed for##3##4##(2008-2#1)(2008-7#1)(2012-2#1)
we have developed four##2##4##(2008-3#1)(2010-2#1)
we have developed such methods as part of a collaborative multi-institutional CER study of patterns##2##15##(2013-1#2)
we have developed the Epilepsy Data Extraction and Annotation (EpiDEA) system for effective processing of discharge summaries##2##17##(2013-1#2)
we have developed the##5##4##(2008-2#2)(2008-7#1)(2013-1#2)
we have developed to##3##4##(1997-6#1)(2007-12#1)(2008-6#1)
we have developed##105##3##(1990-12#1)(1991-11#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-3#2)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-1#2)(1997-3#1)(1997-6#1)(2006-10#2)(2006-4#1)(2006-6#2)(2007-10#1)(2007-11#2)(2007-12#5)(2007-5#3)(2007-6#1)(2007-8#2)(2008-10#9)(2008-11#4)(2008-2#5)(2008-3#5)(2008-5#4)(2008-6#1)(2008-7#7)(2009-12#1)(2009-9#2)(2010-2#2)(2010-9#1)(2011-1#5)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#8)
we have devised a reproducible##2##5##(1994-3#1)(2008-7#1)
we have devised a##3##4##(1994-3#1)(2008-10#1)(2008-7#1)
we have devised##5##3##(1992-6#1)(1994-3#1)(1997-4#1)(2008-10#1)(2008-7#1)
we have directly measured##2##4##(1994-12#1)(2008-5#1)
we have directly##4##3##(1994-11#1)(1994-12#1)(1995-8#1)(2008-5#1)
we have discovered that##2##4##(1991-3#1)(2008-2#1)
we have discovered##4##3##(1991-3#1)(1994-5#1)(2008-2#1)(2008-8#1)
we have discussed a##2##4##(1996-4#1)(2004-2#1)
we have documented in##2##4##(1996-6#1)(2008-10#1)
we have employed##7##3##(1994-8#1)(1995-5#1)(1996-3#1)(1997-1#1)(1997-4#1)(2007-8#1)(2010-8#1)
we have enough##3##3##(2006-12#1)(2008-6#1)(2008-7#1)
we have established a##3##4##(1991-12#1)(1991-7#1)(1994-9#1)
we have established an##2##4##(2008-11#1)(2009-3#1)
we have established the##2##4##(2010-1#1)(2011-1#1)
we have established two##2##4##(2008-10#1)(2008-5#1)
we have established##13##3##(1990-2#1)(1991-12#1)(1991-7#1)(1994-3#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-3#1)(2010-1#1)(2010-3#1)(2011-1#1)(2013-8#1)
we have estimated##2##3##(2008-11#1)(2008-8#1)
we have evaluated the effect of##2##6##(1990-5#1)(1993-6#1)
we have evaluated the##6##4##(1990-5#1)(1993-6#1)(2008-11#1)(2008-6#2)(2010-3#1)
we have evaluated##13##3##(1990-12#1)(1990-5#1)(1991-10#1)(1992-12#1)(1993-6#1)(2006-10#1)(2008-11#1)(2008-5#1)(2008-6#2)(2010-3#1)(2011-2#1)(2012-3#1)
we have examined its##2##4##(1996-8#1)(2006-12#1)
we have examined the effect of mianserin in combination with the selective dopamine (DA) D(2/3) receptor antagonist raclopride on conditioned avoidance response (CAR)##2##23##(2008-6#2)
we have examined the effect of##6##6##(1992-8#1)(1994-3#1)(1995-5#1)(2008-11#1)(2008-6#2)
we have examined the expression and##2##6##(1994-3#1)(1996-2#1)
we have examined the expression##3##5##(1994-2#1)(1994-3#1)(1996-2#1)
we have examined the regulation of##3##6##(1991-10#1)(1993-12#1)(1995-6#1)
we have examined the##35##4##(1991-10#1)(1991-3#3)(1991-4#1)(1991-9#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-3#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-2#1)(1997-4#2)(1997-7#1)(2006-10#2)(2007-10#1)(2008-11#2)(2008-6#2)(2008-7#2)
we have examined whether similar##2##5##(1991-7#1)(1995-3#1)
we have examined whether##3##4##(1991-7#1)(1995-3#1)(1996-9#1)
we have examined##58##3##(1990-12#1)(1990-3#1)(1991-10#1)(1991-12#1)(1991-3#3)(1991-4#1)(1991-7#1)(1991-9#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#2)(1996-2#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-4#3)(1997-7#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-10#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2010-10#1)
we have expanded##2##3##(2006-3#1)(2009-2#1)
we have experimentally##4##3##(2006-6#2)(2008-2#2)
we have explored the##5##4##(1990-8#1)(1993-12#1)(2007-11#1)(2008-10#1)(2008-3#1)
we have explored##7##3##(1990-8#1)(1993-12#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)
we have expressed the##2##4##(1990-8#1)(1995-8#1)
we have expressed##9##3##(1990-7#1)(1990-8#1)(1994-11#3)(1994-8#1)(1995-6#1)(1995-8#1)(1997-7#1)
we have extended an##2##4##(1997-2#1)(2008-5#1)
we have extended these results to##2##6##(1990-5#1)(1991-12#1)
we have extended##4##3##(1990-5#1)(1991-12#1)(1997-2#1)(2008-5#1)
we have focused on##2##4##(1996-7#1)(2009-8#1)
we have focused##4##3##(1996-7#1)(1997-6#1)(2007-11#1)(2009-8#1)
we have followed##2##3##(2007-5#1)(2008-8#1)
we have for##2##3##(1997-3#1)(2007-9#1)
we have found a significant##2##5##(2006-12#1)(2012-1#1)
we have found a##4##4##(1997-1#1)(2006-12#1)(2011-1#1)(2012-1#1)
we have found that a##2##5##(1991-11#1)(1995-2#1)
we have found that the##9##5##(1992-12#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-2#1)(1997-6#1)(2006-10#1)(2008-11#1)(2010-11#1)
we have found that these##2##5##(1993-11#1)(2008-1#1)
we have found that##34##4##(1990-3#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1992-12#2)(1992-8#2)(1993-11#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-3#1)(1997-6#2)(1997-7#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-11#2)(2008-4#1)(2009-8#1)(2010-11#1)(2010-5#1)(2012-2#1)
we have found the##3##4##(1995-12#1)(2008-4#1)(2008-7#1)
we have found##59##3##(1990-3#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-9#1)(1992-12#2)(1992-8#2)(1993-11#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-9#1)(1996-8#1)(1997-1#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-4#1)(2008-1#1)(2008-11#2)(2008-4#2)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)
we have further characterized the##2##5##(1990-10#1)(1997-4#1)
we have further characterized##4##4##(1990-10#1)(1991-3#1)(1995-1#1)(1997-4#1)
we have further##5##3##(1990-10#1)(1991-3#1)(1995-1#1)(1997-4#1)(2012-12#1)
we have generated a##4##4##(2005-8#1)(2008-7#1)(2011-1#1)(2013-8#1)
we have generated mice that are##2##6##(1995-2#1)(1995-6#1)
we have generated mice that##3##5##(1993-12#1)(1995-2#1)(1995-6#1)
we have generated##15##3##(1990-12#1)(1993-12#1)(1995-2#1)(1995-6#1)(1996-6#1)(1997-2#1)(1997-4#1)(2005-8#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
we have highlighted##2##3##(2007-8#1)(2011-2#1)
we have identified a##13##4##(1991-1#1)(1991-5#1)(1993-8#2)(1994-12#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-5#1)(1997-6#1)(2010-3#1)(2013-8#1)
we have identified and characterized##2##5##(1991-4#1)(2008-10#1)
we have identified and##6##4##(1990-12#1)(1991-4#1)(1995-1#1)(1995-2#1)(2008-10#1)(2013-1#1)
we have identified that##2##4##(1990-3#1)(2010-11#1)
we have identified the##15##4##(1990-5#1)(1990-7#1)(1991-9#1)(1992-5#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-8#1)(1995-9#1)(2006-10#1)(2008-4#2)(2008-6#1)(2010-4#1)(2011-2#1)
we have identified three##2##4##(1990-11#1)(1991-5#1)
we have identified two##7##4##(1990-11#1)(1990-3#1)(1991-10#1)(1992-12#1)(1994-8#1)(2013-1#2)
we have identified##64##3##(1990-11#2)(1990-12#1)(1990-3#2)(1990-5#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-4#1)(1991-5#2)(1991-9#1)(1992-12#1)(1992-5#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-5#2)(1997-5#1)(1997-6#1)(2006-10#1)(2007-9#1)(2008-10#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#1)(2013-1#3)(2013-8#2)
we have implemented a##2##4##(2008-3#1)(2008-6#1)
we have implemented##5##3##(2007-12#1)(2008-2#1)(2008-3#2)(2008-6#1)
we have incorporated##2##3##(2007-5#1)(2009-8#1)
we have increased the##2##4##(2007-11#1)(2008-3#1)
we have initiated a##3##4##(1995-11#1)(2007-7#1)(2012-3#1)
we have initiated##7##3##(1990-6#1)(1995-11#2)(2007-6#1)(2007-7#1)(2008-10#1)(2012-3#1)
we have introduced a##4##4##(1993-11#1)(1995-1#1)(1995-8#1)(1997-4#1)
we have introduced##5##3##(1993-11#1)(1995-1#1)(1995-2#1)(1995-8#1)(1997-4#1)
we have investigated a possible##2##5##(1994-8#1)(2008-5#1)
we have investigated a##5##4##(1994-8#1)(1995-3#1)(2008-2#1)(2008-5#1)(2012-2#1)
we have investigated the ability of##2##6##(1994-12#1)(2010-11#1)
we have investigated the binding##2##5##(1997-4#1)(2008-10#1)
we have investigated the effect of##3##6##(1990-11#1)(2008-12#1)(2008-7#1)
we have investigated the expression##2##5##(1995-11#1)(2008-7#1)
we have investigated the involvement of the##2##7##(1993-7#1)(1996-12#1)
we have investigated the kinetics of##2##6##(1995-11#1)(1997-3#1)
we have investigated the possible##2##5##(1990-10#1)(1995-12#1)
we have investigated the potential##2##5##(1994-11#1)(1995-6#1)
we have investigated the role of##5##6##(1994-6#1)(1997-2#1)(2008-10#1)(2008-7#1)(2009-8#1)
we have investigated the use of##2##6##(1991-5#1)(2008-7#1)
we have investigated the##46##4##(1990-10#1)(1990-11#1)(1991-2#2)(1991-5#1)(1992-6#1)(1992-8#1)(1993-7#1)(1994-11#1)(1994-12#2)(1994-6#1)(1995-11#3)(1995-12#2)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#5)(2009-8#1)(2010-11#1)(2012-12#1)(2012-2#2)(2013-8#2)
we have investigated whether the##3##5##(1992-9#1)(1994-2#1)(1996-5#1)
we have investigated whether##6##4##(1992-9#1)(1994-2#1)(1994-9#1)(1996-5#1)(2006-12#1)(2012-2#1)
we have investigated##62##3##(1990-10#1)(1990-11#1)(1990-12#1)(1991-2#2)(1991-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-7#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#2)(1995-3#1)(1995-6#2)(1995-7#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-12#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#5)(2009-8#1)(2010-11#1)(2012-12#1)(2012-2#4)(2013-8#2)
we have isolated a novel##2##5##(2007-1#1)(2008-11#1)
we have isolated a##10##4##(1991-5#1)(1992-6#1)(1993-2#1)(1993-7#1)(1995-6#1)(1997-4#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-5#1)
we have isolated and characterized##2##5##(1991-6#1)(1992-4#1)
we have isolated and sequenced##2##5##(1990-4#1)(1991-2#1)
we have isolated and##6##4##(1990-4#1)(1991-2#1)(1991-6#1)(1992-4#1)(1993-2#1)(1994-12#1)
we have isolated cDNA clones encoding##2##6##(1995-2#1)(2008-5#1)
we have isolated from the##2##5##(1993-9#1)(1996-1#1)
we have isolated several##2##4##(1992-9#1)(1996-9#1)
we have isolated the gene##2##5##(1990-5#1)(1994-8#1)
we have isolated the##4##4##(1990-4#1)(1990-5#1)(1992-5#1)(1994-8#1)
we have isolated three novel##2##5##(1991-9#1)(1997-7#1)
we have isolated##36##3##(1990-4#2)(1990-5#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-2#2)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#2)(1995-6#1)(1996-1#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-7#1)(2006-12#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2010-12#1)
we have learned##8##3##(1996-9#1)(2004-2#1)(2008-2#1)(2008-3#1)(2009-1#1)(2009-8#1)(2010-12#2)
we have limited##2##3##(2005-7#1)(2012-2#1)
we have localized##4##3##(1990-11#1)(1993-6#1)(1994-9#1)(1995-2#1)
we have located##2##3##(1996-12#1)(2008-2#1)
we have lost##2##3##(1995-6#1)(2008-8#1)
we have made a##6##4##(1990-11#1)(1995-2#1)(1996-12#1)(2007-11#1)(2008-2#1)(2012-12#1)
we have made an##3##4##(1991-10#1)(2009-7#1)(2011-2#1)
we have made##17##3##(1990-11#1)(1991-10#1)(1995-2#1)(1996-12#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
we have mapped the##7##4##(1991-4#1)(1994-12#1)(1996-4#1)(1996-5#1)(2007-12#1)(2008-11#1)(2008-7#1)
we have measured the##10##4##(1991-12#1)(1991-5#1)(1991-8#1)(1993-9#1)(1995-8#1)(1996-11#1)(2007-11#1)(2007-12#1)(2008-4#1)(2010-11#1)
we have measured##14##3##(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1993-2#1)(1993-9#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-7#1)(2007-11#1)(2007-12#1)(2008-4#1)(2010-11#1)
we have modeled the##2##4##(2007-11#1)(2008-3#1)
we have modeled##3##3##(2007-11#1)(2008-3#1)(2010-4#1)
we have modified the##5##4##(1995-2#1)(2008-10#1)(2008-11#2)(2008-3#1)
we have modified##7##3##(1990-12#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2012-12#1)
we have monitored the effect of##2##6##(1997-1#1)(2008-9#1)
we have monitored the##3##4##(1995-3#1)(1997-1#1)(2008-9#1)
we have named the##2##4##(2008-10#1)(2008-3#1)
we have named##10##3##(1990-7#1)(1994-12#2)(1996-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#2)
we have no##2##3##(1990-7#1)(1996-4#1)
we have not##6##3##(1992-1#1)(1993-12#1)(1994-2#1)(1995-8#1)(2006-10#1)(2006-12#1)
we have now isolated##4##4##(1990-8#1)(1994-8#1)(1995-2#1)(1996-11#1)
we have now##18##3##(1990-12#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-7#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-11#2)(1997-4#1)(1997-7#1)(2006-12#1)(2009-6#1)(2010-11#1)
we have observed a##3##4##(1990-3#1)(1996-3#1)(2008-7#1)
we have observed an approximately##2##5##(2010-12#2)
we have observed an##3##4##(1992-6#1)(2010-12#2)
we have observed in##2##4##(1997-4#1)(2008-7#1)
we have observed that##5##4##(1991-10#1)(1992-3#1)(1994-8#1)(1996-9#1)(2007-1#1)
we have observed##22##3##(1990-3#1)(1991-10#1)(1992-3#1)(1992-6#1)(1994-8#3)(1995-12#1)(1995-5#1)(1996-3#1)(1996-9#1)(1997-4#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2010-12#2)
we have obtained a##4##4##(1994-11#1)(2007-11#1)(2008-11#1)(2008-12#1)
we have obtained evidence that##2##5##(1993-11#1)(2008-9#1)
we have obtained##21##3##(1990-10#1)(1990-9#1)(1992-9#2)(1993-11#1)(1994-11#1)(1995-3#1)(1996-6#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-11#3)(2008-12#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-11#1)
we have optimized the##3##4##(2008-11#1)(2011-2#1)(2012-1#1)
we have optimized##4##3##(2008-11#2)(2011-2#1)(2012-1#1)
we have performed a##4##4##(1992-6#1)(2008-7#1)(2009-8#1)(2010-2#1)
we have performed an##2##4##(1994-6#1)(1996-2#1)
we have performed in##2##4##(2008-8#1)(2012-12#1)
we have performed##11##3##(1992-6#1)(1994-6#1)(1996-2#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-2#1)(2012-12#1)
we have prepared##7##3##(1991-10#1)(1992-9#1)(1993-9#1)(1994-11#2)(2008-11#1)(2008-3#1)
we have presented##3##3##(1997-3#1)(1997-5#1)(2012-2#1)
we have previously described##2##4##(1992-8#1)(1996-12#1)
we have previously isolated from##2##5##(1995-2#1)(2008-5#1)
we have previously observed##2##4##(1994-2#1)(2008-3#1)
we have previously reported##2##4##(1996-12#1)(1997-8#1)
we have previously shown that##5##5##(1990-12#1)(1997-2#1)(2006-9#1)(2007-11#1)(2013-1#1)
we have previously shown to be##2##6##(2008-10#1)(2008-11#1)
we have previously shown##8##4##(1990-12#1)(1995-11#1)(1997-2#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2013-1#1)
we have previously##24##3##(1990-12#1)(1990-4#1)(1992-8#1)(1994-2#1)(1995-11#2)(1995-2#1)(1995-6#1)(1996-12#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-8#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2010-11#1)(2012-2#1)(2013-1#1)
we have produced a##4##4##(1994-3#1)(2007-11#1)(2007-7#1)(2010-11#1)
we have produced the##2##4##(1994-8#1)(2006-12#1)
we have produced##16##3##(1994-12#2)(1994-3#1)(1994-8#1)(1995-12#2)(1996-11#1)(2006-12#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#2)(2010-11#1)
we have proposed a model##2##5##(1995-3#1)(2010-9#1)
we have proposed a##6##4##(1995-3#1)(2007-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)
we have proposed that##2##4##(2008-11#1)(2009-8#1)
we have proposed##9##3##(1994-8#1)(1995-3#1)(2007-11#1)(2008-11#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)
we have provided##4##3##(1995-3#1)(2008-3#2)(2011-2#1)
we have purified the##2##4##(1994-3#1)(1997-4#1)
we have purified##5##3##(1991-10#1)(1992-2#1)(1994-3#1)(1996-7#1)(1997-4#1)
we have quantified##4##3##(1992-8#1)(1994-8#1)(2008-10#1)(2012-1#1)
we have recently cloned the##2##5##(1995-10#1)(2008-5#1)
we have recently demonstrated##2##4##(1995-10#1)(2008-11#1)
we have recently identified##4##4##(1996-10#1)(1997-7#1)(2008-5#1)(2009-8#1)
we have recently reported##2##4##(1997-3#1)(2006-12#1)
we have recently shown that##6##5##(1996-5#1)(2008-11#1)(2009-8#3)(2013-8#1)
we have recently##22##3##(1993-6#1)(1995-10#2)(1996-10#1)(1996-5#1)(1997-3#1)(1997-7#1)(2006-12#1)(2008-11#2)(2008-5#2)(2008-6#1)(2009-2#1)(2009-5#1)(2009-8#6)(2013-8#1)
we have reported that##3##4##(2008-11#1)(2009-8#1)(2011-2#1)
we have reported##8##3##(1991-5#1)(2008-10#2)(2008-11#1)(2009-8#2)(2011-2#1)(2012-12#1)
we have resolved##2##3##(2007-12#1)(2008-3#1)
we have reviewed our##2##4##(1994-12#1)(2007-7#1)
we have reviewed the literature##2##5##(1996-6#1)(2012-2#1)
we have reviewed the recent literature##2##6##(1997-7#1)(2011-1#1)
we have reviewed the recent##3##5##(1997-7#1)(2011-1#2)
we have reviewed the##7##4##(1996-6#1)(1997-7#1)(2006-2#1)(2008-10#1)(2011-1#2)(2012-2#1)
we have reviewed##15##3##(1994-12#1)(1994-2#1)(1996-6#1)(1997-7#1)(2006-12#2)(2006-2#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-8#1)(2011-1#2)(2012-2#1)
we have routinely used##2##4##(2007-8#1)(2010-9#1)
we have screened a##2##4##(1994-2#1)(1996-11#1)
we have screened##5##3##(1990-11#1)(1991-11#1)(1991-5#1)(1994-2#1)(1996-11#1)
we have searched the##2##4##(1997-2#1)(2005-11#1)
we have searched##3##3##(1991-5#1)(1997-2#1)(2005-11#1)
we have seen a##3##4##(1992-8#1)(2008-1#1)(2008-7#1)
we have seen##8##3##(1992-7#1)(1992-8#1)(1993-3#1)(2006-8#1)(2008-1#1)(2008-7#2)(2008-8#1)
we have selected##3##3##(1994-2#1)(2005-8#1)(2013-7#1)
we have sequenced the##3##4##(1990-8#1)(1997-4#1)(1997-5#1)
we have shown that a##3##5##(2008-11#1)(2008-7#1)(2011-2#1)
we have shown that dicyanogold inhibits the binding of##2##9##(2008-5#2)
we have shown that in the adult mouse##2##8##(2012-12#2)
we have shown that in the##3##6##(2009-9#1)(2012-12#2)
we have shown that the##19##5##(1990-8#1)(1990-9#1)(1992-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-10#1)(1995-12#1)(1996-12#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)(2009-8#1)(2013-8#1)
we have shown that##63##4##(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1992-6#1)(1992-8#2)(1993-3#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-6#1)(1994-8#2)(1994-9#5)(1995-10#1)(1995-12#2)(1996-12#1)(1996-4#1)(1997-1#1)(1997-4#1)(1997-6#2)(2006-8#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#2)(2009-10#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#6)(2009-9#1)(2010-2#1)(2011-2#2)(2012-12#2)(2013-1#2)(2013-8#2)
we have shown the##6##4##(1991-1#1)(1994-12#1)(2007-7#1)(2008-2#1)(2008-7#1)(2010-11#1)
we have shown##77##3##(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-6#1)(1992-8#2)(1993-3#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-6#1)(1994-8#2)(1994-9#5)(1995-10#1)(1995-12#2)(1996-12#1)(1996-4#1)(1997-1#1)(1997-4#1)(1997-6#2)(2005-7#1)(2006-8#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-5#3)(2008-7#3)(2009-10#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#6)(2009-9#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#2)
we have sought to identify##2##5##(1991-12#1)(1995-3#1)
we have sought to##4##4##(1991-12#1)(1995-3#1)(2007-11#1)(2008-11#1)
we have sought##5##3##(1991-12#1)(1992-2#1)(1995-3#1)(2007-11#1)(2008-11#1)
we have studied a##4##4##(1995-1#1)(1997-4#1)(2008-5#1)(2008-8#1)
we have studied by##2##4##(1993-11#1)(1997-2#1)
we have studied its##2##4##(1990-11#1)(2008-2#1)
we have studied the effect of##3##6##(1992-9#1)(1993-1#1)(2008-12#1)
we have studied the effects of##4##6##(1994-12#1)(1994-2#1)(1995-10#1)(2008-3#1)
we have studied the expression of##4##6##(1992-5#1)(1995-3#1)(2008-7#1)(2008-9#1)
we have studied the expression##5##5##(1992-5#1)(1995-3#1)(2008-10#1)(2008-7#1)(2008-9#1)
we have studied the functional##2##5##(1990-9#1)(1991-5#1)
we have studied the##38##4##(1990-9#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-9#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-9#1)(1994-12#1)(1994-2#1)(1995-10#1)(1995-3#1)(1995-4#1)(1996-8#1)(1997-5#1)(2005-4#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-7#2)
we have studied##62##3##(1990-11#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-9#1)(1992-5#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#3)(1993-9#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-4#1)(1995-9#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#2)(2005-4#2)(2006-10#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-11#1)(2010-7#2)(2012-2#1)
we have substituted##2##3##(1995-10#1)(1996-11#1)
we have succeeded in##2##4##(2008-11#1)(2008-3#1)
we have successfully##9##3##(1996-4#1)(1996-8#1)(1997-4#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-11#1)(2010-7#1)
we have suggested##2##3##(1991-7#1)(2010-2#1)
we have summarized the##2##4##(2008-1#1)(2012-2#1)
we have summarized##3##3##(2008-1#1)(2010-8#1)(2012-2#1)
we have synthesized a series of##3##6##(1993-6#1)(1994-9#1)(1995-10#1)
we have synthesized a##5##4##(1993-6#1)(1994-9#1)(1995-10#1)(2005-8#1)(2006-12#1)
we have synthesized##13##3##(1992-11#1)(1992-6#1)(1993-6#1)(1994-9#1)(1995-10#1)(1996-11#1)(1997-2#1)(1997-4#1)(1997-5#1)(2005-8#1)(2006-12#1)(2008-5#2)
we have systematically##2##3##(1994-9#1)(1995-6#1)
we have taken into account seven promising technologies that can improve rehabilitation of patients with stroke in the early future##2##20##(2013-1#2)
we have taken into account##3##5##(2008-2#1)(2013-1#2)
we have taken##6##3##(1991-3#1)(1997-3#1)(1997-6#1)(2008-2#1)(2013-1#2)
we have termed##4##3##(1995-6#1)(1995-8#1)(2008-10#1)(2008-7#1)
we have tested the##4##4##(2008-10#1)(2008-11#1)(2009-6#1)(2012-3#1)
we have tested##7##3##(1991-8#1)(1994-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2009-6#1)(2012-3#1)
we have the##6##3##(1995-4#1)(1995-8#1)(2005-10#1)(2008-10#1)(2008-3#1)(2009-11#1)
we have to##10##3##(1992-12#1)(1995-5#1)(2005-11#1)(2008-7#1)(2010-11#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)
we have transfected##3##3##(1990-5#1)(1991-12#1)(1994-8#1)
we have treated##4##3##(1991-5#1)(1992-8#1)(1997-4#1)(2009-2#1)
we have undertaken a##3##4##(1996-12#1)(2008-11#1)(2010-9#1)
we have undertaken the##2##4##(2006-4#1)(2007-8#1)
we have undertaken##9##3##(1996-12#1)(1996-6#1)(2006-10#1)(2006-4#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-5#1)(2010-9#1)
we have used 19F NMR to probe##2##7##(1991-4#2)
we have used a##14##4##(1991-11#1)(1991-7#1)(1992-12#1)(1992-8#1)(1995-8#1)(1996-7#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)
we have used an##3##4##(1992-2#1)(2011-2#1)(2012-12#1)
we have used the##9##4##(1991-9#1)(1993-12#1)(1994-2#1)(1995-2#1)(2005-10#1)(2008-10#1)(2008-11#1)(2009-4#1)(2010-4#1)
we have used these##2##4##(1990-7#1)(2005-10#1)
we have used this##4##4##(1991-12#1)(1996-5#1)(2009-12#1)(2012-2#1)
we have used three##2##4##(1992-12#1)(2008-10#1)
we have used##70##3##(1990-7#1)(1991-11#1)(1991-12#1)(1991-4#2)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-8#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-11#1)(1996-12#2)(1996-5#1)(1996-7#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(2005-10#2)(2006-12#1)(2007-11#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#3)(2009-12#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
we have utilized the##3##4##(1990-12#1)(1994-5#1)(2006-12#1)
we have utilized##9##3##(1990-12#1)(1992-3#1)(1994-5#1)(1995-2#1)(2006-12#1)(2008-10#1)(2009-2#1)(2009-9#1)(2012-12#1)
we have witnessed##3##3##(2008-5#1)(2010-10#1)(2013-8#1)
we have##1664##2##(1990-10#4)(1990-11#8)(1990-12#13)(1990-2#4)(1990-3#6)(1990-4#4)(1990-5#12)(1990-6#5)(1990-7#8)(1990-8#9)(1990-9#10)(1991-1#5)(1991-10#10)(1991-11#9)(1991-12#16)(1991-2#8)(1991-3#10)(1991-4#7)(1991-5#17)(1991-6#5)(1991-7#7)(1991-8#3)(1991-9#7)(1992-1#2)(1992-10#4)(1992-11#4)(1992-12#12)(1992-2#5)(1992-3#9)(1992-4#5)(1992-5#4)(1992-6#10)(1992-7#2)(1992-8#14)(1992-9#11)(1993-1#2)(1993-11#14)(1993-12#8)(1993-2#6)(1993-3#7)(1993-4#1)(1993-6#12)(1993-7#5)(1993-8#7)(1993-9#10)(1994-10#2)(1994-11#26)(1994-12#26)(1994-2#17)(1994-3#17)(1994-5#5)(1994-6#6)(1994-8#23)(1994-9#22)(1995-1#9)(1995-10#7)(1995-11#13)(1995-12#13)(1995-2#23)(1995-3#18)(1995-4#4)(1995-5#7)(1995-6#13)(1995-7#2)(1995-8#11)(1995-9#4)(1996-1#2)(1996-10#6)(1996-11#16)(1996-12#10)(1996-2#5)(1996-3#6)(1996-4#8)(1996-5#12)(1996-6#7)(1996-7#8)(1996-8#7)(1996-9#5)(1997-1#10)(1997-2#18)(1997-3#12)(1997-4#29)(1997-5#7)(1997-6#10)(1997-7#19)(1997-8#6)(2004-12#2)(2004-2#2)(2004-3#1)(2005-10#4)(2005-11#7)(2005-12#1)(2005-4#2)(2005-7#2)(2005-8#4)(2006-1#1)(2006-10#14)(2006-12#25)(2006-2#3)(2006-3#2)(2006-4#3)(2006-6#9)(2006-8#3)(2006-9#2)(2007-1#3)(2007-10#4)(2007-11#29)(2007-12#27)(2007-2#3)(2007-4#3)(2007-5#8)(2007-6#3)(2007-7#9)(2007-8#18)(2007-9#6)(2008-1#12)(2008-10#72)(2008-11#63)(2008-12#9)(2008-2#37)(2008-3#42)(2008-4#11)(2008-5#39)(2008-6#11)(2008-7#58)(2008-8#21)(2008-9#11)(2009-1#1)(2009-10#5)(2009-11#2)(2009-12#2)(2009-2#9)(2009-3#4)(2009-4#3)(2009-5#3)(2009-6#7)(2009-7#2)(2009-8#27)(2009-9#4)(2010-1#2)(2010-10#3)(2010-11#13)(2010-12#9)(2010-2#5)(2010-3#6)(2010-4#5)(2010-5#2)(2010-6#1)(2010-7#8)(2010-8#9)(2010-9#6)(2011-1#14)(2011-2#21)(2012-1#7)(2012-12#15)(2012-2#20)(2012-3#9)(2013-1#27)(2013-7#1)(2013-8#14)
we here report##2##3##(1996-10#1)(2007-8#1)
we here show that##2##4##(1994-5#1)(2012-2#1)
we here##9##2##(1994-5#1)(1996-10#1)(2007-8#1)(2010-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-8#1)
we herein##2##2##(2009-8#1)(2010-11#1)
we highlight a##2##3##(2008-7#1)(2012-2#1)
we highlight the##5##3##(2008-10#1)(2009-6#1)(2009-9#1)(2012-2#1)(2013-1#1)
we highlight##21##2##(2007-2#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#2)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#3)
we hope that the##2##4##(2008-4#1)(2008-7#1)
we hope that##5##3##(2007-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2013-8#1)
we hope to##4##3##(1993-12#1)(1996-4#1)(2008-1#1)(2013-8#1)
we hope##12##2##(1993-12#1)(1996-4#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-8#2)
we hypothesise that##2##3##(1997-5#1)(2008-11#1)
we hypothesised##2##2##(1997-8#1)(2006-3#1)
we hypothesize that the##6##4##(1991-2#1)(1992-8#1)(1994-9#1)(1995-12#1)(1996-3#1)(2009-8#1)
we hypothesize that##23##3##(1990-4#1)(1990-9#1)(1991-2#1)(1992-8#1)(1992-9#1)(1994-9#1)(1995-12#1)(1996-11#1)(1996-3#1)(1996-9#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-8#1)
we hypothesize##26##2##(1990-4#1)(1990-9#1)(1991-2#1)(1992-8#1)(1992-9#1)(1994-9#1)(1995-12#1)(1996-11#1)(1996-3#1)(1996-9#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-8#1)
we hypothesized that the##5##4##(1994-2#1)(2008-10#1)(2010-6#1)(2011-2#1)(2012-3#1)
we hypothesized that##31##3##(1993-12#1)(1994-2#1)(1994-3#2)(1995-2#1)(1995-3#2)(1996-3#1)(1996-9#1)(2004-1#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-8#1)(2010-1#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-7#1)
we hypothesized##32##2##(1993-12#1)(1994-2#1)(1994-3#2)(1995-2#1)(1995-3#2)(1996-3#1)(1996-9#1)(2004-1#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-8#1)(2010-1#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
we identified a gene##2##4##(2006-12#1)(2008-2#1)
we identified a new metric##2##5##(2013-1#2)
we identified a new##3##4##(1996-12#1)(2013-1#2)
we identified a novel frog gene named pirica that affects the waterproofing of the skin membrane in tadpoles##2##18##(2012-12#2)
we identified a novel##7##4##(1990-8#1)(2008-10#1)(2008-7#1)(2009-8#2)(2012-12#2)
we identified a single amino acid##2##6##(1994-12#1)(2008-10#1)
we identified a single##4##4##(1990-8#1)(1993-2#1)(1994-12#1)(2008-10#1)
we identified a##40##3##(1990-8#2)(1991-3#1)(1993-2#1)(1994-12#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-4#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#4)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#3)
we identified all##3##3##(1993-6#2)(2012-12#1)
we identified an##3##3##(1992-6#1)(1996-5#1)(1997-1#1)
we identified five##4##3##(1993-12#1)(2008-7#1)(2013-1#1)(2013-7#1)
we identified four##3##3##(1994-11#1)(2009-5#1)(2012-3#1)
we identified several##2##3##(1994-12#1)(2009-4#1)
we identified the hinge region as a potential regulator of localization of atypical PKCs##2##14##(2012-12#2)
we identified the##13##3##(1994-8#1)(1995-6#1)(1995-8#1)(2007-2#1)(2008-10#1)(2008-11#1)(2009-2#1)(2010-11#1)(2011-1#1)(2012-12#3)(2013-1#1)
we identified three##5##3##(1991-2#1)(1994-12#1)(1995-12#1)(1997-5#1)(2008-10#1)
we identified two##6##3##(1990-11#1)(1991-8#1)(1992-2#1)(2008-10#1)(2012-3#2)
we identified were##2##3##(2008-10#1)(2012-3#1)
we identified##143##2##(1990-11#2)(1990-12#1)(1990-8#2)(1991-2#1)(1991-3#1)(1991-8#1)(1992-2#1)(1992-4#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-6#3)(1994-11#1)(1994-12#6)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-4#1)(1996-5#2)(1997-1#1)(1997-2#2)(1997-5#3)(1997-6#1)(1997-7#2)(2005-11#1)(2006-10#2)(2006-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#4)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#1)(2009-10#6)(2009-11#1)(2009-2#2)(2009-4#3)(2009-5#3)(2009-6#1)(2009-8#6)(2010-11#1)(2010-12#2)(2010-6#1)(2011-1#3)(2011-2#7)(2011-3#1)(2012-12#7)(2012-2#1)(2012-3#8)(2013-1#8)(2013-7#1)(2013-8#1)
we identify a##6##3##(1992-4#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)
we identify and##2##3##(2010-3#1)(2012-2#1)
we identify several##2##3##(2011-3#1)(2012-3#1)
we identify some of the##2##5##(1991-1#1)(1995-4#1)
we identify the##4##3##(1994-6#1)(1995-1#1)(2008-2#1)(2008-8#1)
we identify three##3##3##(1995-1#1)(2006-5#1)(2012-3#1)
we identify##36##2##(1990-11#1)(1991-1#1)(1992-4#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-4#1)(1995-8#1)(1997-8#1)(2006-5#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-3#1)(2010-6#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
we illustrate how##4##3##(1995-6#1)(1996-3#1)(2011-1#1)(2013-1#1)
we illustrate the approach##2##4##(2008-7#1)(2009-9#1)
we illustrate the method with##2##5##(2009-5#1)(2012-1#1)
we illustrate the##11##3##(1994-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2009-5#1)(2009-9#1)(2011-1#1)(2012-1#1)(2012-2#1)
we illustrate this method##2##4##(2008-3#1)(2010-4#1)
we illustrate this##4##3##(2008-2#1)(2008-3#1)(2009-9#1)(2010-4#1)
we illustrate##28##2##(1994-2#1)(1995-6#1)(1996-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-7#2)(2008-9#1)(2009-5#1)(2009-9#2)(2010-4#1)(2011-1#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
we implanted##3##2##(2007-7#1)(2008-3#1)(2009-5#1)
we implement a##2##3##(2008-2#1)(2012-3#1)
we implement##5##2##(2007-12#1)(2008-2#2)(2008-6#1)(2012-3#1)
we implemented a synonym expansion strategy that used a few selected vocabularies##2##12##(2013-1#2)
we implemented a##6##3##(1992-10#1)(2007-12#1)(2013-1#4)
we implemented##9##2##(1992-10#1)(2007-12#1)(2008-2#1)(2010-2#1)(2010-8#1)(2013-1#4)
we improve the##2##3##(2008-2#1)(2013-1#1)
we improve##7##2##(1992-5#1)(2006-2#1)(2008-2#1)(2009-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
we improved##2##2##(2007-12#1)(2008-10#1)
we in##5##2##(1991-3#1)(1994-11#1)(2007-12#1)(2009-7#1)(2013-7#1)
we include##8##2##(1993-5#1)(2006-12#1)(2008-12#1)(2008-2#1)(2008-3#2)(2009-5#1)(2013-8#1)
we included##3##2##(2007-7#1)(2012-3#1)(2013-1#1)
we incorporate##2##2##(2008-2#1)(2008-8#1)
we incorporated##5##2##(1990-12#1)(1991-9#1)(2008-11#1)(2008-3#1)(2012-2#1)
we increase the##2##3##(1991-2#1)(2008-8#1)
we increase##4##2##(1991-2#1)(2008-5#1)(2008-8#1)(2012-2#1)
we induced##3##2##(1994-5#1)(2012-1#1)(2012-12#1)
we infected##2##2##(1992-7#1)(1994-5#1)
we infer that##3##3##(1990-2#1)(1995-3#1)(2008-5#1)
we infer##6##2##(1990-2#1)(1995-3#1)(1997-4#1)(2008-5#1)(2009-2#1)(2013-1#1)
we inferred that##2##3##(1993-12#1)(2013-1#1)
we inferred##4##2##(1993-12#1)(2010-6#1)(2013-1#2)
we initially##2##2##(2007-11#1)(2009-7#1)
we initiated a##2##3##(2008-10#1)(2013-8#1)
we injected##8##2##(1991-9#1)(1994-12#1)(1996-6#1)(1997-2#1)(2008-11#1)(2008-7#1)(2010-11#1)(2012-1#1)
we inserted a##2##3##(1996-2#1)(2008-5#1)
we inserted the##3##3##(1991-9#1)(1994-12#1)(2008-9#1)
we inserted##6##2##(1991-9#1)(1994-12#1)(1996-2#1)(2007-7#1)(2008-5#1)(2008-9#1)
we insist##2##2##(2009-5#1)(2012-3#1)
we installed##2##2##(2007-8#1)(2008-11#1)
we intend to provide##2##4##(2011-2#1)(2012-2#1)
we intend to use the##2##5##(1995-3#1)(2012-2#1)
we intend to##9##3##(1995-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#2)(2012-2#2)(2013-7#1)
we intended to##3##3##(2008-10#1)(2013-8#2)
we interpret the##3##3##(1997-8#1)(2007-12#1)(2008-11#1)
we interpret this##2##3##(1993-11#1)(1993-12#1)
we interpret##9##2##(1993-11#1)(1993-12#1)(1997-8#1)(2007-12#3)(2008-11#1)(2008-2#1)(2011-1#1)
we interpreted##2##2##(2008-2#1)(2009-11#1)
we interviewed##6##2##(2005-9#1)(2007-2#1)(2008-8#2)(2009-4#1)(2012-12#1)
we introduce a metadata driven web-based clinical data management system named ClinData Express##2##13##(2013-1#2)
we introduce a method for##2##5##(1995-8#1)(2007-5#1)
we introduce a new##5##4##(2008-2#2)(2008-7#1)(2012-1#1)(2013-8#1)
we introduce a##22##3##(1995-8#1)(2007-11#1)(2007-5#1)(2008-2#7)(2008-3#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
we introduce an##6##3##(2008-3#1)(2010-10#1)(2010-2#1)(2011-1#1)(2012-12#2)
we introduce here##2##3##(2008-5#1)(2009-12#1)
we introduce the##7##3##(1993-2#1)(1994-2#2)(2007-5#1)(2008-3#1)(2010-7#1)(2012-2#1)
we introduce three##2##3##(2006-10#1)(2009-4#1)
we introduce##52##2##(1993-2#1)(1994-2#2)(1995-8#1)(1996-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-5#2)(2007-6#1)(2007-8#1)(2008-10#1)(2008-2#9)(2008-3#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
we introduced a##10##3##(1992-11#1)(1997-1#1)(2006-12#1)(2008-10#1)(2008-2#2)(2010-2#1)(2011-1#1)(2013-1#2)
we introduced the##4##3##(1990-11#1)(1993-11#1)(2008-2#1)(2013-1#1)
we introduced##26##2##(1990-11#1)(1992-11#1)(1993-11#1)(1994-5#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-5#1)(2006-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#5)(2013-8#1)
we investigate a number of Bayesian techniques for predicting 1-year- survival and making treatment selection recommendations for lung cancer##2##19##(2013-1#2)
we investigate a##4##3##(2006-4#1)(2012-1#1)(2013-1#2)
we investigate how to facilitate detection of anomalies in an unsupervised manner##2##12##(2013-1#2)
we investigate how##6##3##(2006-4#1)(2008-3#1)(2008-8#1)(2010-8#1)(2013-1#2)
we investigate the applicability##2##4##(2008-2#1)(2010-8#1)
we investigate the behavior##2##4##(2007-12#1)(2008-3#1)
we investigate the effect of##2##5##(2008-2#1)(2008-3#1)
we investigate the feasibility of##2##5##(2008-2#1)(2012-3#1)
we investigate the##35##3##(1992-3#1)(1996-10#1)(1996-5#2)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#2)
we investigate whether##5##3##(1993-2#1)(2008-11#1)(2012-3#1)(2013-1#2)
we investigate##68##2##(1992-2#1)(1992-3#1)(1993-2#1)(1995-5#1)(1996-10#1)(1996-12#1)(1996-5#2)(1997-6#1)(2006-12#1)(2006-4#2)(2006-7#2)(2007-11#1)(2007-12#3)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#7)(2008-4#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#6)
we investigated a##3##3##(1995-7#1)(1996-12#1)(2006-10#1)
we investigated how##6##3##(1995-1#1)(2008-10#1)(2008-11#1)(2009-4#1)(2010-9#1)(2012-1#1)
we investigated if##3##3##(1996-12#1)(2008-10#1)(2008-4#1)
we investigated in the##2##4##(1995-12#1)(2008-6#1)
we investigated in##3##3##(1995-12#1)(2008-6#1)(2011-2#1)
we investigated possible##3##3##(1993-11#1)(1994-3#1)(2008-1#1)
we investigated the ability of##4##5##(1993-9#1)(2006-7#1)(2008-8#1)(2013-8#1)
we investigated the action of##2##5##(1995-5#1)(1995-7#1)
we investigated the association##2##4##(2007-10#1)(2008-6#1)
we investigated the binding##2##4##(1997-1#1)(2008-11#1)
we investigated the capacity of##2##5##(1995-12#1)(2011-1#1)
we investigated the changes in##3##5##(1993-2#1)(1996-10#1)(1997-1#1)
we investigated the direct involvement of Stx in the inflammatory responses of human astrocytes (HASTs) treated with Stx##2##18##(2013-1#2)
we investigated the direct##3##4##(2008-10#1)(2013-1#2)
we investigated the distribution of##2##5##(1995-5#1)(1997-2#1)
we investigated the distribution##3##4##(1995-5#1)(1997-2#1)(2007-10#1)
we investigated the dynamics of reproductive rate##2##7##(2012-12#2)
we investigated the effect of these##2##6##(1997-2#1)(2009-9#1)
we investigated the effect of##25##5##(1991-10#1)(1992-6#1)(1992-9#1)(1994-2#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#2)(2009-4#1)(2009-8#1)(2009-9#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#2)
we investigated the effect##26##4##(1991-10#1)(1992-6#1)(1992-9#1)(1994-2#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-4#1)(2009-8#1)(2009-9#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#2)
we investigated the effects of a##2##6##(1991-10#1)(2008-10#1)
we investigated the effects of the##6##6##(1995-2#1)(2008-11#2)(2008-9#1)(2009-9#1)(2010-12#1)
we investigated the effects of##26##5##(1991-10#1)(1991-9#1)(1992-1#1)(1993-11#1)(1994-10#1)(1994-2#2)(1995-11#1)(1995-2#1)(1997-3#1)(2003-11#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-12#2)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
we investigated the efficacy of##3##5##(2008-10#1)(2011-2#2)
we investigated the evolution of##2##5##(1996-1#1)(2008-10#1)
we investigated the expression and##2##5##(1995-6#1)(2012-3#1)
we investigated the expression of##3##5##(2008-4#1)(2009-5#1)(2013-1#1)
we investigated the expression##5##4##(1995-6#1)(2008-4#1)(2009-5#1)(2012-3#1)(2013-1#1)
we investigated the involvement of##2##5##(1991-2#1)(2009-8#1)
we investigated the possibility that##2##5##(1990-8#1)(2011-2#1)
we investigated the possibility##3##4##(1990-8#1)(2010-4#1)(2011-2#1)
we investigated the possible##3##4##(2007-2#1)(2012-2#1)(2013-7#1)
we investigated the potential##3##4##(2008-10#1)(2008-7#1)(2013-1#1)
we investigated the regulation of##2##5##(1996-12#1)(2010-11#1)
we investigated the relationship between##2##5##(1996-12#1)(2011-2#1)
we investigated the response to##2##5##(1995-2#1)(2009-8#1)
we investigated the role of the##2##6##(1994-5#1)(1995-12#1)
we investigated the role of##7##5##(1994-3#1)(1994-5#1)(1995-12#1)(1996-4#1)(2008-6#1)(2010-6#1)(2012-2#1)
we investigated the roles of##2##5##(1997-2#1)(2009-9#1)
we investigated the sublanguage used to describe actions within the operative report 'procedure description' section##2##15##(2013-1#2)
we investigated the##208##3##(1990-8#1)(1991-10#2)(1991-11#2)(1991-2#2)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-9#4)(1993-11#1)(1993-2#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#3)(1994-3#1)(1994-5#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#1)(1995-7#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#3)(1996-4#1)(1996-5#2)(1996-8#1)(1997-1#3)(1997-2#7)(1997-3#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2003-11#1)(2004-11#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#3)(2007-12#3)(2007-2#3)(2007-8#2)(2008-10#11)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#2)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#4)(2009-9#4)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#1)(2010-4#1)(2010-6#2)(2011-1#4)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#6)(2012-3#4)(2013-1#10)(2013-7#1)(2013-8#5)
we investigated their effects on the##2##6##(1991-5#1)(1993-8#1)
we investigated their##4##3##(1991-5#1)(1993-8#1)(1995-11#1)(2010-6#1)
we investigated these##2##3##(2008-11#1)(2009-2#1)
we investigated whether the##5##4##(1995-8#1)(1997-8#1)(2010-9#1)(2011-1#1)(2011-2#1)
we investigated whether##34##3##(1993-8#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-12#1)(2006-10#1)(2007-10#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-12#2)(2009-5#1)(2009-8#1)(2010-6#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)
we investigated##321##2##(1990-8#1)(1991-10#3)(1991-11#2)(1991-2#2)(1991-5#2)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-9#4)(1993-11#2)(1993-2#1)(1993-3#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#4)(1994-3#3)(1994-5#3)(1994-9#1)(1995-1#2)(1995-10#2)(1995-11#2)(1995-12#8)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#1)(1995-7#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#5)(1996-2#5)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#7)(1997-3#2)(1997-5#2)(1997-6#4)(1997-7#2)(1997-8#3)(2003-11#1)(2004-11#1)(2004-12#2)(2005-8#2)(2006-10#3)(2006-11#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#6)(2007-12#5)(2007-2#4)(2007-8#2)(2008-1#1)(2008-10#15)(2008-11#12)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#7)(2008-5#6)(2008-6#4)(2008-7#6)(2008-8#5)(2008-9#3)(2009-10#1)(2009-12#4)(2009-2#5)(2009-3#1)(2009-4#4)(2009-5#2)(2009-7#1)(2009-8#5)(2009-9#5)(2010-10#2)(2010-11#2)(2010-12#5)(2010-2#1)(2010-4#1)(2010-6#5)(2010-9#2)(2011-1#8)(2011-2#15)(2012-1#4)(2012-11#1)(2012-12#7)(2012-2#8)(2012-3#5)(2012-7#1)(2013-1#15)(2013-7#1)(2013-8#7)
we isolated a cDNA clone##2##5##(1993-12#1)(1997-4#1)
we isolated a cDNA##3##4##(1993-12#1)(1996-10#1)(1997-4#1)
we isolated a##13##3##(1992-3#1)(1993-12#1)(1993-6#1)(1994-12#1)(1995-10#1)(1996-10#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-3#1)(2008-5#1)(2010-1#1)
we isolated an##2##3##(1993-9#1)(2008-11#1)
we isolated and characterized the##2##5##(1991-6#1)(1995-3#1)
we isolated and characterized##6##4##(1991-2#1)(1991-6#1)(1994-12#1)(1995-3#1)(2009-8#1)(2010-5#1)
we isolated and sequenced the entire##2##6##(1993-6#1)(1994-12#1)
we isolated and sequenced the##4##5##(1991-1#1)(1993-6#1)(1994-12#1)(1995-11#1)
we isolated and##12##3##(1991-1#2)(1991-2#1)(1991-6#1)(1993-6#1)(1994-12#2)(1995-11#1)(1995-3#1)(1996-7#1)(2009-8#1)(2010-5#1)
we isolated the##4##3##(1990-9#1)(1996-10#1)(1996-7#1)(2008-10#1)
we isolated three##2##3##(1997-4#1)(2008-11#1)
we isolated##45##2##(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-6#3)(1993-9#1)(1994-12#3)(1994-8#1)(1995-10#1)(1995-11#1)(1995-3#1)(1996-10#2)(1996-4#1)(1996-6#1)(1996-7#3)(1997-2#1)(1997-4#3)(1997-6#1)(2006-3#1)(2007-1#1)(2008-10#2)(2008-11#2)(2008-5#2)(2009-8#1)(2010-1#1)(2010-5#1)
we knew##2##2##(1995-3#1)(2007-2#1)
we know about the##6##4##(1995-5#1)(1996-2#1)(2006-9#1)(2007-12#1)(2008-10#1)(2013-1#1)
we know about##10##3##(1994-1#1)(1995-5#1)(1996-2#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2013-1#2)
we know and what we##2##5##(1996-8#1)(2010-12#1)
we know and where##2##4##(2006-7#1)(2009-5#1)
we know and##5##3##(1996-8#1)(2006-6#1)(2006-7#1)(2009-5#1)(2010-12#1)
we know how to##2##4##(1994-3#1)(2011-1#1)
we know how##4##3##(1994-3#1)(2011-1#1)(2012-12#1)(2012-2#1)
we know little about the##2##5##(2005-10#1)(2008-2#1)
we know little about##6##4##(2005-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-7#1)(2009-9#1)
we know more##2##3##(1991-12#1)(2008-5#1)
we know that the##2##4##(2008-2#1)(2012-12#1)
we know that##7##3##(2006-7#1)(2006-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-8#1)(2012-12#1)
we know the##4##3##(2006-7#2)(2006-9#1)(2011-2#1)
we know today##2##3##(2007-11#1)(2008-10#1)
we know##66##2##(1991-12#1)(1992-3#1)(1994-1#1)(1994-3#2)(1995-3#1)(1995-5#1)(1996-2#1)(1996-8#1)(1997-4#1)(2005-10#1)(2006-10#1)(2006-12#2)(2006-6#2)(2006-7#4)(2006-9#3)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#3)
we lack a##2##3##(2008-8#1)(2009-2#1)
we lack##3##2##(2007-7#1)(2008-8#1)(2009-2#1)
we lay##3##2##(2008-1#1)(2008-7#1)(2010-10#1)
we learn about the##2##4##(2008-5#1)(2008-7#1)
we learn about##3##3##(2008-5#1)(2008-7#1)(2009-8#1)
we learn from##8##3##(1991-3#1)(1993-6#1)(2007-2#1)(2008-1#1)(2008-7#1)(2010-1#1)(2010-12#1)(2011-2#1)
we learn##16##2##(1991-3#1)(1993-12#1)(1993-6#1)(2005-7#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-2#2)
we learned from##4##3##(2008-7#1)(2009-4#1)(2012-2#1)(2013-7#1)
we learned in##3##3##(2006-10#1)(2013-1#2)
we learned that##2##3##(1997-3#1)(2008-4#1)
we learned##10##2##(1997-3#1)(2006-10#1)(2007-12#1)(2008-4#1)(2008-7#1)(2009-4#1)(2012-2#1)(2013-1#2)(2013-7#1)
we live##6##2##(1990-12#1)(1997-8#1)(2008-1#2)(2009-8#1)(2012-3#1)
we localized##3##2##(1994-8#1)(1996-9#1)(1997-4#1)
we look at the##3##4##(1992-3#1)(1997-3#1)(1997-6#1)
we look at##5##3##(1992-3#1)(1997-3#1)(1997-6#1)(2006-5#1)(2006-7#1)
we look##10##2##(1992-3#1)(1994-6#1)(1997-3#1)(1997-6#1)(2006-5#1)(2006-7#1)(2007-6#1)(2007-7#1)(2008-12#1)(2010-11#1)
we looked at the##7##4##(1990-7#1)(1996-8#1)(1997-7#1)(2006-6#1)(2006-8#1)(2012-1#2)
we looked at##8##3##(1990-7#1)(1996-8#1)(1997-7#1)(2004-3#1)(2006-6#1)(2006-8#1)(2012-1#2)
we looked for##2##3##(1990-5#1)(1995-8#1)
we looked##11##2##(1990-5#1)(1990-7#1)(1995-8#1)(1996-8#1)(1997-7#1)(2004-3#1)(2006-6#1)(2006-8#1)(2011-1#1)(2012-1#2)
we made a##6##3##(1991-2#1)(1994-2#1)(1996-6#1)(1997-7#1)(2008-5#1)(2012-12#1)
we made an##2##3##(1991-1#1)(2007-12#1)
we made the##2##3##(2007-7#1)(2012-2#1)
we made use of a##2##5##(1994-8#1)(2008-3#1)
we made##22##2##(1990-7#1)(1991-1#1)(1991-2#1)(1992-7#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-6#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
we mainly##2##2##(2006-10#1)(2009-5#1)
we make a##5##3##(2008-1#1)(2008-12#1)(2008-7#1)(2009-12#1)(2011-1#1)
we make it##2##3##(2012-3#2)
we make predictions##2##3##(2008-8#1)(2012-12#1)
we make recommendations##3##3##(1994-12#1)(2010-11#1)(2010-8#1)
we make the##3##3##(2005-10#1)(2008-10#1)(2008-11#1)
we make##22##2##(1994-1#1)(1994-12#1)(2005-10#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#2)(2010-11#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#2)
we making progress?##2##3##(2006-4#1)(2012-1#1)
we making##3##2##(2006-4#1)(2008-5#1)(2012-1#1)
we manage##2##2##(2009-9#1)(2010-3#1)
we managed##2##2##(2007-8#1)(2008-4#1)
we mapped the##3##3##(1996-8#1)(1997-7#1)(2007-3#1)
we mapped##7##2##(1996-8#1)(1997-4#1)(1997-7#1)(2005-8#1)(2007-3#1)(2008-10#2)
we may be##2##3##(1992-5#1)(1993-11#1)
we may conclude that##3##4##(1990-12#1)(2009-10#1)(2012-2#1)
we may find##2##3##(2010-9#1)(2012-3#1)
we may gain##2##3##(1994-10#1)(2012-3#1)
we may have a##2##4##(1997-2#1)(1997-7#1)
we may increase##2##3##(2007-9#1)(2013-1#1)
we may##27##2##(1990-12#1)(1992-5#1)(1993-11#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-2#2)(1994-8#1)(1995-9#1)(1997-2#1)(1997-7#1)(2006-7#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-9#1)(2011-1#1)(2012-2#2)(2012-3#2)(2013-1#2)
we measure a##3##3##(2007-12#2)(2008-2#1)
we measure the##9##3##(1997-5#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)(2009-4#1)
we measure##19##2##(1991-11#1)(1997-5#1)(2006-4#1)(2007-11#1)(2007-12#6)(2008-1#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#2)(2009-4#1)
we measured a##2##3##(1994-11#1)(2008-1#1)
we measured an##4##3##(2007-11#1)(2008-11#1)(2008-3#2)
we measured and##2##3##(2008-2#1)(2010-8#1)
we measured binding##2##3##(1992-8#1)(1993-3#1)
we measured habitat##2##3##(2013-7#2)
we measured in##2##3##(1996-4#1)(2007-1#1)
we measured plasma##2##3##(1997-2#1)(2008-7#1)
we measured serum##2##3##(1991-8#1)(1993-2#1)
we measured the effect of##2##5##(1991-12#1)(1991-2#1)
we measured the rate of##2##5##(1991-2#1)(2008-7#1)
we measured the time##2##4##(1997-4#1)(2007-11#1)
we measured the##36##3##(1990-4#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-8#1)(1992-4#1)(1993-7#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-5#1)(1997-4#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#4)(2008-3#2)(2008-7#2)(2009-5#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-8#2)
we measured##101##2##(1990-11#1)(1990-4#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-8#2)(1992-12#1)(1992-4#1)(1992-6#1)(1992-8#4)(1993-2#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-5#2)(1996-2#1)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(2004-11#1)(2007-1#1)(2007-11#3)(2007-12#3)(2007-6#1)(2007-7#1)(2008-1#3)(2008-10#2)(2008-11#3)(2008-2#7)(2008-3#7)(2008-5#2)(2008-7#3)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#3)(2013-8#2)
we might be able to##2##5##(2006-10#1)(2008-7#1)
we might##7##2##(1995-5#1)(1997-2#1)(2006-10#1)(2006-6#1)(2008-7#1)(2009-3#1)(2010-2#1)
we missing##2##2##(2007-8#1)(2010-10#1)
we model the##2##3##(2008-2#2)
we model##7##2##(2008-2#2)(2008-8#1)(2008-9#1)(2013-1#2)(2013-8#1)
we modeled the experiment into two groups of mice with benign and malignant primary lung tumors##2##16##(2013-1#2)
we modeled the##3##3##(2010-10#1)(2013-1#2)
we modeled##5##2##(1995-1#1)(2008-11#1)(2010-10#1)(2013-1#2)
we modified the##5##3##(1994-12#1)(1994-2#1)(2008-3#1)(2009-2#1)(2010-9#1)
we modified##8##2##(1994-12#1)(1994-2#1)(2005-11#1)(2007-12#1)(2008-3#1)(2009-2#1)(2010-9#1)(2012-12#1)
we modify the##4##3##(2008-2#2)(2008-3#2)
we molecularly##2##2##(1997-7#1)(2012-3#1)
we monitored the##3##3##(1997-7#1)(2007-12#1)(2008-10#1)
we monitored##9##2##(1992-10#1)(1996-2#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2010-4#1)
we move into the##3##4##(1995-2#1)(2005-11#1)(2007-6#1)
we move the##2##3##(1997-8#1)(2006-10#1)
we move##8##2##(1995-2#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-6#1)(2008-11#1)(2008-7#1)(2008-8#1)
we moving##2##2##(2006-10#1)(2010-12#1)
we must also##2##3##(1995-5#1)(2010-12#1)
we must be##3##3##(2008-10#1)(2013-1#2)
we must develop##3##3##(1992-5#1)(2006-6#1)(2010-3#1)
we must know##2##3##(2006-7#2)
we must take##2##3##(1993-2#1)(2012-1#1)
we must##38##2##(1991-12#1)(1992-5#1)(1993-2#1)(1994-1#2)(1995-5#1)(1996-10#1)(2006-6#1)(2006-7#2)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-2#1)(2009-6#1)(2010-10#2)(2010-12#4)(2010-3#4)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)
we mutated##4##2##(1994-12#1)(1995-2#1)(1996-4#1)(2008-4#1)
we named##9##2##(1995-4#1)(2005-10#2)(2007-6#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-10#1)(2011-1#1)
we need a new##2##4##(2005-4#1)(2008-5#1)
we need a##7##3##(1991-12#1)(2005-4#1)(2007-4#1)(2008-5#1)(2011-1#1)(2011-12#1)(2013-8#1)
we need more medical knowledge##2##5##(2008-12#2)
we need more##4##3##(1990-4#1)(2006-8#1)(2008-12#2)
we need to develop##2##4##(1991-12#1)(2013-1#1)
we need to identify##2##4##(1991-1#1)(1993-8#1)
we need to rethink##2##4##(2010-3#1)(2011-3#1)
we need to##24##3##(1991-1#1)(1991-12#1)(1992-4#1)(1993-12#1)(1993-8#1)(1994-1#1)(1995-9#2)(1996-8#2)(1997-1#1)(2006-2#1)(2008-2#1)(2008-4#1)(2009-11#1)(2010-12#1)(2010-3#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#4)
we need##54##2##(1990-4#1)(1991-1#1)(1991-12#2)(1992-4#1)(1993-12#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-9#1)(1995-9#2)(1996-8#2)(1997-1#2)(1997-3#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-4#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
we needed to##2##3##(1994-12#1)(2008-2#1)
we needed##3##2##(1994-12#1)(2008-2#2)
we newly determined the sequences of##2##6##(1996-10#1)(1996-2#1)
we newly determined the##3##4##(1996-10#1)(1996-2#1)(1997-4#1)
we newly##5##2##(1995-8#1)(1996-10#1)(1996-2#1)(1997-4#1)(2008-2#1)
we next determined whether##2##4##(2008-5#2)
we next##4##2##(2008-11#1)(2008-5#2)(2008-7#1)
we no longer##2##3##(1995-5#1)(2010-3#1)
we not only##2##3##(2008-10#1)(2008-9#1)
we not##5##2##(1993-2#2)(2008-10#1)(2008-9#1)(2010-3#1)
we note that##3##3##(1991-8#1)(2008-10#1)(2009-10#1)
we note##4##2##(1991-8#1)(2007-6#1)(2008-10#1)(2009-10#1)
we noted a##2##3##(1991-12#1)(2008-5#1)
we noted that##2##3##(1997-5#1)(2009-9#1)
we noted##8##2##(1991-12#1)(1997-5#1)(2007-11#3)(2008-5#1)(2009-9#1)(2012-2#1)
we noticed that the##2##4##(1995-6#1)(2011-1#1)
we noticed##6##2##(1995-6#1)(2007-10#1)(2007-11#2)(2008-5#1)(2011-1#1)
we now believe that##2##4##(2007-7#2)
we now demonstrate##2##3##(1990-10#1)(1994-12#1)
we now have a##2##4##(2008-2#1)(2013-1#1)
we now have##4##3##(1990-2#1)(1992-11#1)(2008-2#1)(2013-1#1)
we now know that##3##4##(1993-2#1)(2005-8#1)(2008-1#1)
we now know##5##3##(1993-2#1)(1996-9#1)(2005-8#1)(2008-1#1)(2013-7#1)
we now report the##2##4##(1993-2#1)(1997-5#1)
we now report##5##3##(1991-12#1)(1992-5#1)(1993-2#1)(1997-5#1)(2008-8#1)
we now show that the##2##5##(1993-8#1)(1995-8#1)
we now show that##3##4##(1992-6#1)(1993-8#1)(1995-8#1)
we now show##5##3##(1992-6#1)(1993-3#1)(1993-8#1)(1995-8#1)(2008-5#1)
we now use the##2##4##(2008-5#1)(2010-7#1)
we now use##3##3##(1992-10#1)(2008-5#1)(2010-7#1)
we now##40##2##(1990-10#1)(1990-2#1)(1991-12#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-2#2)(1993-3#1)(1993-8#1)(1994-12#2)(1995-3#1)(1995-8#1)(1996-5#1)(1996-9#2)(1997-2#1)(1997-5#1)(1997-7#1)(2005-8#1)(2007-7#2)(2008-1#2)(2008-2#1)(2008-5#2)(2008-8#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)
we numerically##5##2##(2007-12#1)(2008-2#1)(2008-3#2)(2012-2#1)
we observe a##3##3##(1992-12#1)(2006-10#1)(2008-3#1)
we observe in##2##3##(2007-9#1)(2012-2#1)
we observe that the##2##4##(2007-12#1)(2008-2#1)
we observe that##5##3##(1997-2#1)(2007-12#1)(2008-11#1)(2008-2#1)(2009-8#1)
we observe the##6##3##(2007-11#1)(2007-12#2)(2008-3#1)(2012-12#2)
we observe##34##2##(1992-12#1)(1992-5#1)(1993-12#1)(1994-4#1)(1995-3#1)(1997-1#1)(1997-2#1)(2006-10#2)(2007-11#3)(2007-12#4)(2007-9#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-7#1)(2009-7#1)(2009-8#1)(2012-12#2)(2012-2#2)(2013-1#1)
we observed 3##3##3##(2006-6#1)(2007-5#1)(2008-4#1)
we observed a decrease##2##4##(1997-6#1)(2008-11#1)
we observed a marked##2##4##(1995-6#1)(2006-7#1)
we observed a significant increase in the##2##7##(1996-8#1)(2008-5#1)
we observed a significant increase in##3##6##(1996-8#1)(2008-5#1)(2012-1#1)
we observed a significant increase##4##5##(1996-8#1)(2008-11#1)(2008-5#1)(2012-1#1)
we observed a significant##7##4##(1991-9#1)(1996-8#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-1#1)(2013-7#1)
we observed a##35##3##(1991-9#1)(1992-11#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-8#2)(1997-3#1)(1997-6#1)(1997-7#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#4)(2008-5#1)(2008-8#1)(2009-3#1)(2011-2#2)(2012-1#2)(2012-12#2)(2013-1#1)(2013-7#1)
we observed an increase in##2##5##(1994-6#1)(1995-12#1)
we observed an##6##3##(1990-3#1)(1991-12#1)(1994-6#1)(1995-12#1)(1996-11#1)(2012-12#1)
we observed higher##2##3##(1992-8#1)(2011-2#1)
we observed is##2##3##(1996-9#1)(2008-8#1)
we observed no##3##3##(1991-10#1)(2008-8#1)(2011-2#1)
we observed significant differences in##2##5##(2007-12#1)(2009-5#1)
we observed significant##3##3##(1992-4#1)(2007-12#1)(2009-5#1)
we observed that Msx2 is not expressed in the eye vascular tree in contrast to Msx1##2##16##(2012-12#2)
we observed that in##2##4##(2008-11#1)(2009-3#1)
we observed that rbFGF##2##4##(1994-12#2)
we observed that the##9##4##(1991-5#1)(1993-3#1)(1994-8#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-7#1)
we observed that##44##3##(1991-5#2)(1992-9#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-2#2)(1994-8#1)(1994-9#1)(1995-1#1)(1996-11#2)(1996-12#1)(1996-5#1)(2007-12#2)(2007-3#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#1)
we observed the behavior of##2##5##(2007-10#1)(2009-4#1)
we observed the##10##3##(1993-12#1)(2005-11#1)(2007-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-2#1)(2011-1#1)
we observed two##2##3##(2007-11#1)(2007-7#1)
we observed##165##2##(1990-3#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#4)(1995-6#1)(1996-11#3)(1996-12#1)(1996-2#2)(1996-5#1)(1996-8#2)(1996-9#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#2)(2005-11#1)(2005-8#1)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#5)(2007-12#8)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#4)(2008-1#1)(2008-10#7)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#9)(2008-4#2)(2008-5#5)(2008-7#2)(2008-8#5)(2008-9#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#7)(2011-7#1)(2012-1#2)(2012-12#6)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#3)(2013-8#2)
we obtain 2##2##3##(2007-11#1)(2007-12#1)
we obtain a##9##3##(1995-5#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#2)
we obtain an##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
we obtain the##6##3##(1996-2#1)(2007-12#2)(2008-3#1)(2010-2#1)(2012-2#1)
we obtain##36##2##(1990-2#1)(1993-1#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-2#1)(2006-10#1)(2006-4#1)(2007-11#4)(2007-12#7)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#4)(2008-7#2)(2009-10#1)(2010-2#1)(2012-2#1)
we obtained a broad##2##4##(2007-12#2)
we obtained a##16##3##(1991-7#1)(1992-8#1)(1994-6#1)(1997-7#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2009-6#1)
we obtained an overall precision of 86%##2##7##(2013-1#2)
we obtained an##7##3##(1991-1#1)(1992-1#1)(1994-11#1)(2008-3#2)(2013-1#2)
we obtained evidence##2##3##(1994-2#1)(1994-8#1)
we obtained good##2##3##(2007-11#1)(2007-8#1)
we obtained information##2##3##(2006-10#1)(2007-10#1)
we obtained related terms from a large predicate database derived from Medline abstracts for query expansion##2##16##(2013-1#2)
we obtained results comparable to the best obtained in previous studies##2##11##(2013-1#2)
we obtained the##9##3##(2005-11#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-9#1)(2010-7#1)(2012-1#1)(2012-12#1)
we obtained two##2##3##(1995-6#1)(2006-12#1)
we obtained with##2##3##(2008-10#1)(2008-2#1)
we obtained##106##2##(1991-1#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-3#1)(1992-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-3#1)(1995-5#3)(1995-6#1)(1996-11#1)(1996-2#1)(1997-7#1)(2005-10#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-11#10)(2007-12#10)(2007-7#2)(2007-8#5)(2008-1#2)(2008-10#10)(2008-11#1)(2008-2#11)(2008-3#6)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#7)
we offer a##7##3##(1996-11#1)(2007-11#1)(2008-6#1)(2008-9#1)(2009-1#1)(2010-2#1)(2011-2#1)
we offer##11##2##(1991-3#1)(1996-11#1)(2005-8#1)(2007-11#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-1#1)(2010-2#1)(2011-2#1)(2013-7#1)
we often##6##2##(1992-2#1)(1996-8#1)(2009-12#1)(2009-6#1)(2009-7#1)(2013-1#1)
we only##5##2##(1993-10#1)(2004-11#1)(2006-10#1)(2008-2#1)(2012-1#1)
we operate##2##2##(2008-3#1)(2009-5#1)
we operated##3##2##(2007-7#2)(2011-2#1)
we opted##2##2##(2010-12#1)(2013-8#1)
we originally##2##2##(2007-3#1)(2008-3#1)
we outline a method##2##4##(2006-7#1)(2008-10#1)
we outline a##6##3##(2005-8#1)(2006-7#1)(2008-10#1)(2008-11#2)(2011-2#1)
we outline important parameters to guide the design of preclinical studies for stem cell-based therapeutics##2##15##(2012-12#2)
we outline some of the##2##5##(2008-11#1)(2008-7#1)
we outline the experimental##3##4##(2008-11#2)(2008-7#1)
we outline the##11##3##(2006-10#1)(2006-5#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-5#1)(2011-2#1)(2012-3#1)
we outline##29##2##(1992-3#1)(2005-2#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-7#1)(2008-10#1)(2008-11#5)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-4#1)(2010-12#1)(2010-5#2)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)
we overcome##3##2##(2008-2#1)(2012-2#2)
we overexpressed##2##2##(1995-2#1)(1996-4#1)
we owe##3##2##(2006-9#1)(2009-5#1)(2012-2#1)
we perceive##2##2##(2008-11#1)(2012-2#1)
we perform a##4##3##(2007-11#1)(2008-1#1)(2008-7#1)(2012-2#1)
we perform an##2##3##(2008-10#1)(2008-7#1)
we perform##13##2##(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-10#1)(2012-2#1)(2013-1#2)
we performed a classical surgical closure of the PDA with simultaneous intraoperative miniinvasive catheter removal of the displaced implant from the left pulmonary artery using a muscle bioptome (Cook##2##29##(2012-12#2)
we performed a comparative analysis of atypical aPKCι/λ and ζ in MDCK cells##2##13##(2012-12#2)
we performed a detailed##2##4##(1994-12#1)(1997-4#1)
we performed a prospective##2##4##(2008-8#1)(2011-2#1)
we performed a retrospective##2##4##(2009-10#1)(2013-8#1)
we performed a second##2##4##(1997-8#1)(2007-8#1)
we performed a##43##3##(1990-11#1)(1990-9#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-9#1)(1994-12#1)(1994-4#1)(1995-8#1)(1997-4#1)(1997-8#1)(2003-11#1)(2005-8#1)(2006-2#1)(2006-3#1)(2007-5#1)(2007-8#3)(2008-1#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#2)
we performed an##8##3##(1995-7#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
we performed comparative microarray analysis of Drosophila muscles before and after innervation##2##12##(2012-12#2)
we performed direct##2##3##(1996-2#1)(1997-7#1)
we performed exhaustive analyses of a variety of labeled sub-graph motifs##2##11##(2013-1#2)
we performed immunolabeling studies in conjunction with co-transfection and chromatin immunoprecipitation (ChIP) assays using mouse vascular smooth muscle (MOVAS) cells##2##20##(2012-12#2)
we performed manual inspection of the resulting FMA fragments and tracked down sources of abnormal inferred conclusions (logical inconsistencies)##2##19##(2013-1#2)
we performed the##8##3##(1997-2#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-4#1)(2009-8#1)(2013-1#1)
we performed total##3##3##(2007-7#2)(2008-7#1)
we performed##122##2##(1990-11#1)(1990-9#1)(1991-2#1)(1991-6#2)(1992-1#1)(1992-12#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-2#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2003-11#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-7#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#7)(2007-9#1)(2008-1#3)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-2#6)(2012-11#1)(2012-12#10)(2012-2#3)(2012-3#6)(2013-1#7)(2013-7#1)(2013-8#6)
we place##2##2##(2005-8#1)(2006-10#1)
we placed##3##2##(1992-3#1)(2007-7#1)(2008-3#1)
we point out that##2##4##(2008-2#1)(2009-3#1)
we point out the##2##4##(1995-8#1)(2006-12#1)
we point out##5##3##(1995-8#1)(2006-12#1)(2008-2#1)(2009-3#1)(2010-4#1)
we point##7##2##(1991-6#1)(1995-8#1)(1996-4#1)(2006-12#1)(2008-2#1)(2009-3#1)(2010-4#1)
we postulate that the##5##4##(1990-12#1)(1990-2#1)(1994-8#1)(1996-12#1)(2006-8#1)
we postulate that##9##3##(1990-12#1)(1990-2#1)(1993-6#1)(1994-8#1)(1996-12#1)(1996-9#1)(2006-8#1)(2007-12#1)(2008-2#1)
we postulate##11##2##(1990-12#1)(1990-2#1)(1993-6#1)(1994-8#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-9#1)(2006-8#1)(2007-12#1)(2008-2#1)
we postulated that##3##3##(2007-12#1)(2008-5#1)(2008-7#1)
we postulated##4##2##(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)
we precisely##2##2##(2008-2#1)(2010-12#1)
we predict that##5##3##(1995-1#1)(1995-3#1)(2007-11#1)(2008-11#1)(2012-2#1)
we predict the##4##3##(1992-9#1)(2006-10#1)(2008-3#1)(2008-8#1)
we predict##12##2##(1992-9#1)(1995-1#1)(1995-3#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-5#1)(2012-2#1)
we predicted that##3##3##(1994-9#1)(2009-1#1)(2009-8#1)
we predicted##6##2##(1993-12#1)(1994-9#1)(2009-1#1)(2009-5#1)(2009-8#1)(2011-2#1)
we prepare##2##2##(1993-9#1)(2007-12#1)
we prepared a##7##3##(1993-6#2)(1994-8#1)(1995-11#1)(2007-6#1)(2008-9#1)(2010-2#1)
we prepared an antiserum##3##4##(1992-7#1)(1993-9#1)(1994-12#1)
we prepared an##5##3##(1991-2#1)(1992-7#1)(1993-9#1)(1994-12#1)(2008-11#1)
we prepared##26##2##(1991-2#1)(1992-3#2)(1992-7#1)(1993-6#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-5#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-6#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-9#1)(2011-1#1)(2012-1#1)
we present 2 cases of##2##5##(2009-1#1)(2011-2#1)
we present 3##2##3##(2008-7#1)(2009-2#1)
we present FaceReview##2##3##(2013-1#2)
we present a brief overview of the##2##7##(2010-11#1)(2011-1#1)
we present a brief overview of##3##6##(2010-11#1)(2010-9#1)(2011-1#1)
we present a brief##4##4##(2010-11#1)(2010-9#1)(2011-1#1)(2012-11#1)
we present a case of a 55-year-old woman affected by lupus profundus##2##12##(2013-1#2)
we present a case of a##6##6##(2007-8#1)(2008-4#1)(2013-1#4)
we present a case of an acquired form of angioedema of the oropharyngeal region secondary to the simultaneous occurrence of two causative factors##2##23##(2013-1#2)
we present a case of an##3##6##(2013-1#2)(2013-8#1)
we present a case of gastric##2##6##(2007-5#1)(2009-8#1)
we present a case of##24##5##(1997-7#1)(2007-5#1)(2007-8#1)(2008-12#1)(2008-4#1)(2009-8#1)(2010-11#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#9)(2013-8#1)
we present a case report of a##4##7##(2008-6#1)(2011-12#1)(2011-2#1)(2012-2#1)
we present a case report##5##5##(2008-6#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
we present a case study##2##5##(2010-8#1)(2012-12#1)
we present a case##37##4##(1997-7#1)(2007-5#1)(2007-8#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#1)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#9)(2013-8#1)
we present a comprehensive##2##4##(2008-3#1)(2012-1#1)
we present a computationally##2##4##(2008-2#1)(2012-2#1)
we present a conceptual framework of hypothesized risk factors for adult children of parents with chronic pain##2##17##(2013-1#2)
we present a conceptual##3##4##(2009-12#1)(2013-1#2)
we present a human##2##4##(1990-6#1)(2011-2#1)
we present a method and##2##5##(1993-1#1)(2008-1#1)
we present a method for##7##5##(1992-6#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-12#1)
we present a method of##2##5##(1992-8#1)(2009-11#1)
we present a method to##2##5##(2009-3#1)(2012-3#1)
we present a method##14##4##(1992-6#1)(1992-8#1)(1993-1#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
we present a methodology##2##4##(2008-10#1)(2008-12#1)
we present a mobile app developed on the iOS platform that monitors activity levels using accelerometry##2##16##(2013-1#2)
we present a model of##2##5##(1996-9#1)(2007-12#1)
we present a model##4##4##(1996-9#1)(2007-12#1)(2008-2#1)(2012-2#1)
we present a natural language processing system that can be used in hospital surveillance applications with the purpose of identifying patients with pneumonia##2##23##(2013-1#2)
we present a new method for##2##6##(2007-11#1)(2008-5#1)
we present a new method to classify the window setting types of brain CT images##2##15##(2013-1#2)
we present a new method##4##5##(2007-11#1)(2008-5#1)(2013-1#2)
we present a new##19##4##(1993-8#1)(1997-3#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-8#1)(2012-2#1)(2013-1#3)
we present a novel##5##4##(2008-2#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-2#1)
we present a patient who underwent successful surgical excision of a third arm attached to the back in the midline over the low-dorsal region##2##24##(2013-1#2)
we present a patient who##4##5##(1990-9#1)(2008-1#1)(2013-1#2)
we present a patient with##2##5##(2008-9#1)(2013-7#1)
we present a patient##6##4##(1990-9#1)(2008-1#1)(2008-9#1)(2013-1#2)(2013-7#1)
we present a point process##2##5##(2009-9#1)(2010-5#1)
we present a quantitative##2##4##(2008-8#1)(2012-2#1)
we present a rare case of##3##6##(2008-9#1)(2011-2#2)
we present a refined##2##4##(2008-11#1)(2008-3#1)
we present a review of the literature##2##7##(2008-2#1)(2008-4#1)
we present a review of##5##5##(2008-10#1)(2008-2#1)(2008-4#1)(2009-5#1)(2012-1#1)
we present a review##7##4##(2007-7#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-5#2)(2012-1#1)
we present a series of##2##5##(2008-11#1)(2008-3#1)
we present a set of##2##5##(2006-5#1)(2012-2#1)
we present a simple and##3##5##(2008-8#1)(2010-12#1)(2010-4#1)
we present a simple##7##4##(2007-11#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#1)(2010-9#1)
we present a step-by-step##2##4##(2008-11#2)
we present a study on##2##5##(2012-3#2)
we present a study##3##4##(1994-5#1)(2012-3#2)
we present a systematic##2##4##(2008-2#1)(2008-7#1)
we present a technique for##2##5##(2008-10#1)(2013-1#1)
we present a##202##3##(1990-6#1)(1990-9#1)(1992-6#2)(1992-8#2)(1993-1#2)(1993-8#1)(1994-5#1)(1995-11#1)(1995-12#1)(1996-11#2)(1996-9#1)(1997-3#1)(1997-7#1)(2005-11#1)(2006-1#1)(2006-10#4)(2006-4#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#6)(2008-1#3)(2008-10#6)(2008-11#6)(2008-12#2)(2008-2#11)(2008-3#12)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#4)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#3)(2009-7#1)(2009-8#2)(2009-9#4)(2010-1#1)(2010-11#2)(2010-12#2)(2010-2#5)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#3)(2011-1#7)(2011-12#2)(2011-2#5)(2012-1#3)(2012-11#1)(2012-12#7)(2012-2#8)(2012-3#5)(2013-1#23)(2013-7#3)(2013-8#1)
we present additional##2##3##(2009-8#1)(2011-2#1)
we present an algorithm for##2##5##(2008-3#1)(2013-1#1)
we present an analysis of the##2##6##(1995-8#1)(2008-7#1)
we present an analysis of##4##5##(1995-8#1)(2008-7#1)(2008-8#1)(2009-5#1)
we present an analysis##5##4##(1995-8#1)(2006-8#1)(2008-7#1)(2008-8#1)(2009-5#1)
we present an efficient##2##4##(2008-6#1)(2013-7#1)
we present an evaluation of the approaches we undertook and the lessons we learned in building and validating the Oncoshare data resource##2##22##(2013-1#2)
we present an evaluation of the hybrid best-of-breed automated VHA (Veteran's Health Administration) clinical text de-identification system##2##17##(2013-1#2)
we present an evaluation of the##4##6##(2013-1#4)
we present an experimental##2##4##(2009-8#1)(2012-2#1)
we present an interesting case of##2##6##(2011-1#1)(2012-2#1)
we present an investigation of##2##5##(2009-5#1)(2011-12#1)
we present an overview of the clinical knowledge management strategy at Intermountain Healthcare in support of our electronic medical record systems##2##21##(2013-1#2)
we present an overview of the##7##6##(2008-4#1)(2010-2#1)(2010-8#1)(2012-3#2)(2013-1#2)
we present an overview of##9##5##(2008-10#1)(2008-4#1)(2008-5#1)(2010-2#1)(2010-8#1)(2012-3#2)(2013-1#2)
we present an overview##10##4##(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-2#1)(2010-8#1)(2012-3#2)(2013-1#2)
we present an##56##3##(1992-8#1)(1992-9#1)(1995-8#1)(2005-11#1)(2006-8#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#8)(2013-7#1)
we present and##4##3##(2007-4#1)(2008-2#1)(2008-3#1)(2013-1#1)
we present data from##2##4##(2008-7#1)(2013-8#1)
we present data that##3##4##(2008-3#2)(2009-2#1)
we present data##10##3##(2007-8#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#1)(2013-8#2)
we present different##2##3##(2006-6#1)(2008-5#1)
we present evidence from##4##4##(1990-12#1)(1994-3#1)(2008-4#1)(2009-10#1)
we present evidence that the##2##5##(1994-11#1)(2006-11#1)
we present evidence that##11##4##(1994-11#1)(1994-3#1)(1994-6#1)(1996-5#1)(1997-6#1)(2006-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2011-1#1)
we present evidence##21##3##(1990-12#1)(1991-9#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-6#1)(1996-5#2)(1997-6#1)(2006-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#1)(2011-1#2)
we present experimental evidence that##2##5##(2005-11#1)(2008-9#1)
we present experimental results##2##4##(2008-2#1)(2008-3#1)
we present experimental##5##3##(2005-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-3#1)
we present findings##2##3##(2008-9#1)(2012-3#1)
we present four##2##3##(2008-2#1)(2012-2#1)
we present further##2##3##(1991-7#1)(2010-7#1)
we present here##4##3##(1990-11#1)(1995-12#1)(2008-11#1)(2008-7#1)
we present in##2##3##(2006-3#1)(2012-2#1)
we present methods for##4##4##(1997-3#1)(2008-11#1)(2010-1#1)(2010-2#1)
we present new data##2##4##(1994-11#1)(2008-11#1)
we present new##4##3##(1994-11#1)(2008-11#1)(2008-8#1)(2012-2#1)
we present numerical##2##3##(1992-2#1)(2011-1#1)
we present one##2##3##(2007-8#1)(2012-3#1)
we present our experience with##3##5##(2007-5#1)(2012-2#1)(2012-3#1)
we present our experience##6##4##(2007-5#1)(2007-7#1)(2012-2#2)(2012-3#1)(2013-1#1)
we present our results##2##4##(1992-8#1)(2012-1#1)
we present our##20##3##(1992-8#1)(1996-10#1)(2007-11#1)(2007-12#1)(2007-5#2)(2007-7#1)(2008-7#2)(2008-8#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
we present recent##2##3##(2008-10#1)(2009-1#1)
we present relevant predictions from theoretical models that identify the interpersonal effects of chronic illness and pain on family relationships##2##20##(2013-1#2)
we present results from a##3##5##(1995-6#1)(2006-12#1)(2008-8#1)
we present results from##5##4##(1990-11#1)(1995-5#1)(1995-6#1)(2006-12#1)(2008-8#1)
we present results of a##2##5##(2008-3#1)(2008-5#1)
we present results of the##2##5##(1995-5#1)(2008-10#1)
we present results of##7##4##(1995-5#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-4#1)
we present results##13##3##(1990-11#1)(1995-5#2)(1995-6#1)(2006-12#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-4#1)(2012-1#1)
we present some of the##2##5##(2008-7#1)(2012-1#1)
we present some##3##3##(2006-6#1)(2008-7#1)(2012-1#1)
we present the (1)H/(13)C/(15)N NMR assignments of the bases and sugars of the##2##13##(2009-7#2)
we present the analysis of##2##5##(2008-10#1)(2012-1#1)
we present the case of a##6##6##(2006-6#1)(2007-4#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-8#1)
we present the case##7##4##(2006-6#1)(2007-4#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
we present the complete nucleotide sequence##2##6##(1994-12#1)(1995-2#1)
we present the complete##4##4##(1991-12#1)(1994-12#1)(1995-2#1)(2008-10#1)
we present the design##2##4##(2007-6#1)(2012-1#1)
we present the development of a##2##6##(2008-11#1)(2013-8#1)
we present the first case of##2##6##(2010-12#1)(2012-2#1)
we present the first case##3##5##(2008-10#1)(2010-12#1)(2012-2#1)
we present the first##16##4##(1993-9#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-2#1)(2009-4#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
we present the most##3##4##(2008-10#1)(2008-9#1)(2010-9#1)
we present the results obtained##2##5##(1995-11#1)(2008-10#1)
we present the results of a study##2##7##(2007-12#1)(2009-6#1)
we present the results of a##3##6##(1993-5#1)(2007-12#1)(2009-6#1)
we present the results of studies##2##6##(2004-9#1)(2009-2#1)
we present the results of##8##5##(1993-5#1)(2004-9#1)(2007-12#2)(2009-2#1)(2009-6#1)(2010-12#1)(2010-9#1)
we present the results##10##4##(1993-5#1)(1995-11#1)(2004-9#1)(2007-12#2)(2008-10#1)(2009-2#1)(2009-6#1)(2010-12#1)(2010-9#1)
we present the technique of##2##5##(2008-3#1)(2012-2#1)
we present the use of##2##5##(2008-10#1)(2008-2#1)
we present the##87##3##(1991-12#1)(1991-8#1)(1993-1#1)(1993-5#2)(1993-6#1)(1993-9#1)(1994-12#2)(1994-3#1)(1995-10#1)(1995-11#1)(1995-2#1)(1996-2#1)(1997-3#1)(2004-9#1)(2005-11#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#3)(2008-7#3)(2008-9#1)(2009-10#1)(2009-2#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2010-10#1)(2010-12#4)(2010-4#1)(2010-7#1)(2010-9#2)(2011-1#5)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#4)
we present three##5##3##(1992-2#1)(2008-10#1)(2009-11#1)(2009-12#1)(2011-1#1)
we present two cases of##5##5##(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)
we present two cases##6##4##(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2012-11#1)
we present two methods##2##4##(2008-9#1)(2010-12#1)
we present two##15##3##(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-11#1)
we present what we believe to be##2##7##(2008-1#1)(2008-3#1)
we present what##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
we present##538##2##(1990-11#2)(1990-12#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-6#2)(1992-8#4)(1992-9#2)(1993-1#3)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-5#2)(1995-6#1)(1995-8#2)(1996-10#1)(1996-11#2)(1996-2#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-3#3)(1997-6#1)(1997-7#1)(2004-9#1)(2005-11#4)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#11)(2007-3#2)(2007-4#3)(2007-5#4)(2007-6#1)(2007-7#3)(2007-8#10)(2008-1#8)(2008-10#22)(2008-11#18)(2008-12#4)(2008-2#24)(2008-3#30)(2008-4#5)(2008-5#6)(2008-6#4)(2008-7#21)(2008-8#12)(2008-9#9)(2009-1#2)(2009-10#4)(2009-11#3)(2009-12#2)(2009-2#5)(2009-3#2)(2009-4#3)(2009-5#7)(2009-6#3)(2009-7#7)(2009-8#8)(2009-9#4)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#9)(2010-2#9)(2010-3#1)(2010-4#4)(2010-5#1)(2010-6#4)(2010-7#2)(2010-8#4)(2010-9#6)(2011-1#20)(2011-12#4)(2011-2#13)(2012-1#10)(2012-11#2)(2012-12#11)(2012-2#20)(2012-3#11)(2013-1#43)(2013-7#5)(2013-8#8)
we presented a##4##3##(1993-5#1)(2006-10#1)(2011-2#1)(2013-8#1)
we presented the##2##3##(2011-1#1)(2012-1#1)
we presented##12##2##(1993-5#1)(1997-5#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#1)
we prevent##5##2##(1992-1#1)(2007-6#1)(2007-8#1)(2008-10#1)(2010-3#1)
we previously demonstrated##4##3##(1994-3#1)(2008-11#1)(2008-8#1)(2012-1#1)
we previously found in##2##4##(1993-3#1)(2010-2#1)
we previously found##3##3##(1990-3#1)(1993-3#1)(2010-2#1)
we previously identified a##2##4##(1990-8#1)(1996-4#1)
we previously identified##3##3##(1990-8#1)(1995-2#1)(1996-4#1)
we previously introduced##2##3##(1996-2#1)(2008-2#1)
we previously reported##4##3##(1997-1#1)(2007-5#1)(2008-11#1)(2008-4#1)
we previously##26##2##(1990-10#1)(1990-3#1)(1990-8#1)(1991-4#1)(1991-8#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-2#2)(1995-5#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-4#1)(2007-10#1)(2007-5#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-2#1)(2012-1#1)
we probably##2##2##(1996-4#1)(2008-6#1)
we probe##2##2##(2010-7#1)(2012-2#1)
we probed the##2##3##(1996-11#1)(2008-9#1)
we probed##4##2##(1996-11#1)(2007-7#1)(2008-9#1)(2011-12#1)
we produced a##3##3##(1991-2#1)(2009-7#1)(2013-1#1)
we produced##13##2##(1991-2#1)(1994-5#1)(1995-12#1)(1996-12#1)(1996-4#1)(1997-4#1)(2007-12#2)(2008-3#3)(2009-7#1)(2013-1#1)
we propose a &quot##2##4##(2005-11#1)(2009-3#1)
we propose a Reinforcement Learning-based queue management and scheduling scheme##2##10##(2013-1#2)
we propose a common##2##4##(2008-11#1)(2011-2#1)
we propose a detailed##2##4##(2008-11#1)(2013-8#1)
we propose a global##2##4##(1993-6#1)(2008-2#1)
we propose a mechanism for##2##5##(1994-8#1)(1995-6#1)
we propose a mechanism##3##4##(1994-8#1)(1995-6#1)(2012-2#1)
we propose a method for##2##5##(2008-5#1)(2010-8#1)
we propose a method to##3##5##(1993-1#1)(2008-3#1)(2012-1#1)
we propose a method##7##4##(1993-1#1)(1994-9#1)(2007-12#1)(2008-3#1)(2008-5#1)(2010-8#1)(2012-1#1)
we propose a model for the##2##6##(2009-8#1)(2011-1#1)
we propose a model for##5##5##(1991-5#1)(2008-7#1)(2009-6#1)(2009-8#1)(2011-1#1)
we propose a model in which##2##6##(2005-8#1)(2006-10#1)
we propose a model##8##4##(1991-2#1)(1991-5#1)(2005-8#1)(2006-10#1)(2008-7#1)(2009-6#1)(2009-8#1)(2011-1#1)
we propose a modified##2##4##(2008-9#1)(2012-2#1)
we propose a new approach to##3##6##(1997-8#1)(2012-3#1)(2013-8#1)
we propose a new approach##5##5##(1997-8#1)(2009-10#1)(2012-2#1)(2012-3#1)(2013-8#1)
we propose a new##19##4##(1993-7#1)(1993-9#1)(1997-8#1)(2006-12#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-8#1)(2010-6#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
we propose a novel approach##2##5##(2012-3#1)(2013-1#1)
we propose a novel##10##4##(2008-2#2)(2008-3#1)(2008-6#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)
we propose a numerical##2##4##(2005-11#1)(2013-8#1)
we propose a simple##7##4##(2005-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-3#2)
we propose a##121##3##(1990-9#1)(1991-2#1)(1991-5#1)(1993-1#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-8#1)(1994-9#2)(1995-6#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-11#3)(2005-8#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-9#1)(2008-10#5)(2008-11#6)(2008-2#12)(2008-3#10)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-6#1)(2010-8#3)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#6)(2012-3#9)(2013-1#6)(2013-7#1)(2013-8#5)
we propose an alternative##6##4##(1995-4#1)(2008-11#1)(2008-2#1)(2009-2#1)(2012-2#1)(2012-3#1)
we propose an approach##3##4##(2007-11#1)(2009-4#1)(2011-2#1)
we propose an##28##3##(1991-10#1)(1995-4#1)(2005-8#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2010-2#2)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#1)
we propose and##2##3##(2007-12#1)(2009-8#1)
we propose here a##3##4##(1993-3#1)(1995-11#1)(2008-11#1)
we propose here##5##3##(1993-3#1)(1995-11#1)(2006-5#1)(2008-11#1)(2009-6#1)
we propose new##2##3##(2008-2#2)
we propose that P2X receptors are extracellular##2##7##(2008-4#2)
we propose that a##5##4##(1996-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)
we propose that elevated##2##4##(2008-4#1)(2010-2#1)
we propose that it##2##4##(2008-10#1)(2008-3#1)
we propose that lysosomal hydrolases degrade extracellular##2##7##(2012-12#2)
we propose that the##27##4##(1990-2#1)(1990-5#1)(1991-2#1)(1991-9#2)(1992-12#2)(1993-3#1)(1993-4#1)(1994-8#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-6#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2013-1#1)
we propose that these##5##4##(1997-4#1)(2008-10#1)(2008-6#1)(2012-2#1)(2012-3#1)
we propose that this##5##4##(1990-9#1)(1991-2#1)(1996-6#1)(2008-9#1)(2012-2#1)
we propose that##91##3##(1990-12#1)(1990-2#1)(1990-5#2)(1990-9#1)(1991-2#2)(1991-9#2)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-8#1)(1994-9#2)(1995-12#2)(1995-3#2)(1995-6#1)(1996-12#1)(1996-2#2)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#1)(2006-4#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#2)(2010-2#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)
we propose the following##2##4##(1991-12#1)(2008-7#1)
we propose the use of##3##5##(2008-2#1)(2008-7#1)(2012-12#1)
we propose the##20##3##(1991-12#1)(1996-5#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-5#1)(2009-8#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
we propose to designate##2##4##(2006-8#1)(2007-12#1)
we propose to name##2##4##(1994-12#1)(1994-8#1)
we propose to use two soft classifications##2##7##(2013-1#2)
we propose to use##5##4##(1992-5#1)(2008-2#1)(2008-7#1)(2013-1#2)
we propose to##25##3##(1992-5#1)(1994-12#1)(1994-8#1)(1996-3#1)(1996-7#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#3)(2013-7#1)
we propose two##4##3##(2007-12#1)(2008-2#2)(2010-12#1)
we propose using##2##3##(2007-11#1)(2008-2#1)
we propose##329##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-9#2)(1991-10#1)(1991-12#2)(1991-2#3)(1991-5#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-3#2)(1993-4#1)(1993-6#3)(1993-7#1)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-8#3)(1994-9#4)(1995-11#1)(1995-12#2)(1995-3#2)(1995-4#1)(1995-6#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#3)(2005-8#2)(2006-10#4)(2006-12#1)(2006-4#1)(2006-5#2)(2006-8#1)(2007-11#8)(2007-12#9)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#19)(2008-11#10)(2008-2#26)(2008-3#20)(2008-4#6)(2008-5#6)(2008-6#3)(2008-7#11)(2008-8#4)(2008-9#3)(2009-10#3)(2009-12#4)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#2)(2009-8#6)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#4)(2010-3#1)(2010-4#2)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#6)(2012-1#4)(2012-12#5)(2012-2#13)(2012-3#15)(2013-1#14)(2013-7#2)(2013-8#6)
we proposed a model of##2##5##(2008-5#1)(2011-1#1)
we proposed a profile-based method that used dictated discharge summaries as an external source to automatically build sense profiles and applied them to disambiguate abbreviations in hospital admission notes via the vector space model##2##34##(2013-1#2)
we proposed a##15##3##(1992-11#1)(2006-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
we proposed an##2##3##(2008-10#1)(2012-1#1)
we proposed that##7##3##(1991-4#1)(1993-8#1)(1995-3#1)(2008-10#1)(2008-11#1)(2009-4#1)(2010-4#1)
we proposed the##3##3##(2008-10#1)(2013-1#2)
we proposed##31##2##(1991-4#1)(1992-11#1)(1993-8#1)(1995-2#1)(1995-3#1)(1996-7#1)(2006-8#1)(2008-10#6)(2008-11#3)(2008-5#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#4)
we prospectively enrolled##2##3##(2007-7#1)(2008-4#1)
we prospectively##7##2##(1995-1#1)(2007-10#1)(2007-7#2)(2008-4#1)(2009-7#1)(2010-4#1)
we prove that the##2##4##(2008-2#1)(2008-7#1)
we prove that##6##3##(2008-2#1)(2008-3#1)(2008-7#2)(2009-4#1)(2013-8#1)
we proved that these##2##4##(1997-5#1)(2011-2#1)
we proved that##4##3##(1997-5#1)(2008-9#1)(2011-2#1)(2013-8#1)
we proved##6##2##(1992-2#1)(1997-5#1)(2005-11#1)(2008-9#1)(2011-2#1)(2013-8#1)
we provide a brief##2##4##(2005-8#1)(2008-9#1)
we provide a comprehensive overview of##2##6##(2008-11#1)(2011-2#1)
we provide a comprehensive##3##4##(2008-11#1)(2008-9#1)(2011-2#1)
we provide a concise##3##4##(2008-11#2)(2012-12#1)
we provide a detailed##2##4##(1992-6#1)(2012-12#1)
we provide a##35##3##(1991-12#1)(1992-6#1)(1996-11#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-10#2)(2009-4#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-3#1)
we provide an overview of the##9##6##(2008-5#1)(2008-7#1)(2009-3#1)(2010-10#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)
we provide an overview of##13##5##(2008-1#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-10#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)
we provide an overview##14##4##(2008-1#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-10#1)(2010-11#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)
we provide an##19##3##(1992-10#1)(2008-1#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-3#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)
we provide details of the technique to supplement the video##2##10##(2008-11#2)
we provide evidence that Gene Ontology-anchored signatures (GO-signatures) show reliable prognosis in lung cancer##2##14##(2013-1#2)
we provide evidence that the##5##5##(1992-9#1)(1995-8#1)(1997-7#1)(2007-5#1)(2008-7#1)
we provide evidence that##22##4##(1990-11#1)(1990-8#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-12#1)(1995-2#1)(1995-8#1)(1996-9#1)(1997-6#2)(1997-7#1)(2006-8#1)(2007-5#1)(2008-10#1)(2008-7#2)(2011-1#1)(2012-2#1)(2013-1#2)
we provide evidence##24##3##(1990-11#1)(1990-8#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-12#1)(1995-2#1)(1995-8#1)(1996-9#1)(1997-6#2)(1997-7#1)(2006-8#1)(2007-5#1)(2008-10#1)(2008-7#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
we provide insight into the##4##5##(2009-8#1)(2012-12#3)
we provide support##2##3##(2006-5#1)(2008-4#1)
we provide the first##4##4##(2008-10#1)(2008-5#1)(2008-9#2)
we provide the##7##3##(2008-10#1)(2008-5#2)(2008-8#1)(2008-9#2)(2013-1#1)
we provide##118##2##(1990-11#1)(1990-8#1)(1991-12#1)(1992-10#1)(1992-3#2)(1992-6#2)(1992-9#1)(1993-8#1)(1994-12#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-6#2)(1997-7#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-4#1)(2007-5#2)(2008-1#1)(2008-10#2)(2008-11#7)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#10)(2008-8#3)(2008-9#4)(2009-10#2)(2009-3#1)(2009-4#1)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#5)(2011-12#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#9)(2012-2#7)(2012-3#2)(2013-1#5)(2013-8#1)
we provided evidence that##4##4##(1992-3#1)(2008-9#1)(2009-8#2)
we provided evidence##5##3##(1992-3#1)(1995-12#1)(2008-9#1)(2009-8#2)
we provided##7##2##(1992-3#1)(1995-12#1)(2008-11#1)(2008-9#1)(2009-8#2)(2010-11#1)
we purified a##2##3##(1991-5#1)(1992-11#1)
we purified and##2##3##(1990-12#1)(1992-10#1)
we purified the##4##3##(1991-1#1)(1992-7#1)(1992-9#1)(1995-6#1)
we purified##13##2##(1990-12#1)(1991-1#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-7#1)(1992-9#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-1#1)(2007-2#1)
we put##2##2##(2010-7#1)(2012-2#1)
we quantified the levels of##2##5##(1993-12#1)(2008-9#1)
we quantified the use of uncertainty expressions##2##7##(2013-1#2)
we quantified the##6##3##(1993-12#1)(2006-9#1)(2008-9#1)(2012-2#1)(2013-1#2)
we quantified##13##2##(1990-2#1)(1993-12#1)(2006-9#1)(2008-10#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-3#1)(2012-2#2)(2013-1#2)
we quantify the##4##3##(2008-10#1)(2010-7#1)(2012-3#1)(2013-8#1)
we quantify##7##2##(2008-10#1)(2008-2#1)(2008-8#1)(2010-7#1)(2012-3#2)(2013-8#1)
we quantitatively##4##2##(1990-10#1)(2008-10#1)(2008-2#1)(2008-3#1)
we question the##2##3##(1997-8#1)(2008-2#1)
we question whether##2##3##(1994-9#1)(2007-6#1)
we question##4##2##(1994-9#1)(1997-8#1)(2007-6#1)(2008-2#1)
we raised an antibody against##2##5##(1991-9#1)(1993-7#1)
we raised##7##2##(1991-9#1)(1992-8#1)(1993-7#1)(1994-12#1)(1996-5#1)(2008-10#1)(2008-5#1)
we rapidly##2##2##(2005-11#1)(2009-12#1)
we rated##2##2##(2007-11#1)(2011-2#1)
we reach an##2##3##(2007-11#1)(2008-2#1)
we reached##2##2##(2008-1#1)(2008-8#1)
we ready for##4##3##(1992-2#1)(2008-12#2)(2009-4#1)
we realized a##2##3##(2007-11#1)(2007-12#1)
we realized##5##2##(2007-11#2)(2007-12#2)(2011-2#1)
we really need##3##3##(2007-6#1)(2008-3#1)(2012-12#1)
we really##8##2##(1992-3#1)(1994-6#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-3#1)(2010-12#1)(2012-12#1)
we reasoned that##3##3##(1996-1#1)(2009-6#1)(2012-12#1)
we recall##2##2##(2008-10#1)(2010-7#1)
we recently developed##4##3##(2008-3#1)(2011-2#1)(2013-1#2)
we recently identified##2##3##(1994-9#1)(1996-8#1)
we recently reported##3##3##(2008-5#1)(2009-8#1)(2011-2#1)
we recently##16##2##(1994-9#1)(1995-11#1)(1996-12#1)(1996-8#1)(2004-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-8#3)(2011-2#2)(2013-1#2)
we recognize the##2##3##(1995-1#1)(1997-8#1)
we recognize##3##2##(1995-1#1)(1997-8#1)(2009-1#1)
we recombinantly##2##2##(1995-6#1)(2013-1#1)
we recommend a##4##3##(1993-3#1)(2006-9#1)(2008-10#1)(2010-5#1)
we recommend adding##2##3##(1991-4#1)(2010-2#1)
we recommend that##9##3##(1990-3#1)(1994-2#1)(1995-3#1)(2006-10#1)(2007-2#1)(2007-5#1)(2010-8#1)(2011-12#1)(2011-2#1)
we recommend the use of##2##5##(2007-11#1)(2009-2#1)
we recommend the##7##3##(1990-8#1)(2006-10#1)(2007-11#1)(2008-8#1)(2009-2#1)(2011-2#1)(2013-7#1)
we recommend##40##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-4#1)(1991-5#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-3#1)(1996-8#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-9#1)(2007-11#2)(2007-2#2)(2007-5#2)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#2)(2013-1#1)(2013-7#2)
we reconstruct##2##2##(2008-2#1)(2010-11#1)
we reconstructed##3##2##(1994-4#1)(2007-11#1)(2008-3#1)
we recorded##11##2##(1991-12#1)(1993-12#1)(1995-11#1)(1997-7#1)(2007-5#1)(2008-3#1)(2008-8#1)(2009-2#1)(2009-4#1)(2013-1#1)(2013-7#1)
we recovered##2##2##(2008-9#1)(2012-3#1)
we recruited##2##2##(2007-12#1)(2013-1#1)
we reduce the##3##3##(1990-3#1)(2008-3#1)(2008-6#1)
we reduced##2##2##(2007-11#1)(2008-10#1)
we reexamine##2##2##(2008-8#2)
we refer the##2##3##(2008-2#2)
we refer to as the##3##5##(1990-6#1)(1995-6#1)(1996-4#1)
we refer to as##7##4##(1990-6#1)(1992-6#1)(1995-6#1)(1996-11#2)(1996-4#1)(2013-8#1)
we refer to##18##3##(1990-3#1)(1990-6#1)(1992-6#1)(1993-6#1)(1994-3#1)(1995-6#1)(1996-11#2)(1996-4#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2011-2#1)(2012-11#1)(2013-8#1)
we refer##22##2##(1990-3#1)(1990-6#1)(1992-6#1)(1993-6#1)(1994-3#1)(1995-6#1)(1996-11#2)(1996-4#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2011-2#1)(2012-11#1)(2013-8#1)
we reflect on##3##3##(2009-4#1)(2012-3#1)(2013-1#1)
we regard##2##2##(2012-2#2)
we registered##5##2##(1990-8#1)(1991-12#1)(1992-5#1)(1995-4#1)(2008-5#1)
we relate##5##2##(2007-9#1)(2008-11#1)(2008-3#1)(2012-12#2)
we relied on##2##3##(1993-6#1)(2008-11#1)
we rely on##2##3##(1995-8#1)(2007-8#1)
we rely##3##2##(1995-8#1)(2006-10#1)(2007-8#1)
we remove##2##2##(2008-5#1)(2008-8#1)
we removed the##2##3##(2009-4#1)(2011-1#1)
we removed##6##2##(1992-7#1)(2008-5#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-3#1)
we replace the##2##3##(2008-2#2)
we replace##3##2##(2008-2#2)(2010-5#1)
we replaced a##2##3##(2007-8#1)(2013-7#1)
we replaced the##2##3##(1994-12#1)(2008-11#1)
we replaced##6##2##(1993-6#1)(1994-12#1)(1996-9#1)(2007-8#1)(2008-11#1)(2013-7#1)
we report a 30-year-old##3##4##(2012-12#1)(2013-1#2)
we report a case of a patient with##2##8##(2007-8#1)(2010-4#1)
we report a case of a##12##6##(2007-8#2)(2008-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-12#1)(2012-2#3)(2012-3#2)
we report a case of an##2##6##(2007-8#1)(2008-6#1)
we report a case of high-grade lymphoma of both adrenal glands that was found in a young patient of 32 years of age##2##23##(2013-1#2)
we report a case of##37##5##(1991-11#1)(2006-1#1)(2007-12#1)(2007-8#5)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#3)(2010-6#3)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#5)(2012-3#3)(2013-1#2)(2013-8#2)
we report a case##40##4##(1991-11#1)(2006-1#1)(2007-12#1)(2007-8#5)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-4#4)(2010-6#3)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#5)(2012-3#3)(2013-1#2)(2013-8#2)
we report a female patient##2##5##(2012-12#2)
we report a new##7##4##(1990-8#1)(1997-6#1)(2008-12#1)(2008-7#2)(2008-9#1)(2012-2#1)
we report a novel##9##4##(1997-4#1)(2008-3#2)(2008-8#1)(2009-7#1)(2012-12#1)(2012-2#2)(2012-3#1)
we report a patient who had##2##6##(2006-10#1)(2011-1#1)
we report a patient who##4##5##(2006-10#1)(2007-8#1)(2008-7#1)(2011-1#1)
we report a patient##6##4##(2006-10#1)(2007-10#1)(2007-8#1)(2008-7#1)(2011-1#1)(2012-12#1)
we report a precision of 73##2##6##(2013-1#2)
we report a rare case of##4##6##(2007-11#1)(2008-6#1)(2012-2#1)(2013-1#1)
we report a series of##2##5##(2009-7#1)(2012-12#1)
we report a systematic investigation of the##2##7##(2010-5#1)(2012-2#1)
we report a systematic##4##4##(2010-5#1)(2010-6#1)(2012-2#1)(2013-8#1)
we report a##124##3##(1990-8#1)(1991-11#1)(1991-2#1)(1992-2#1)(1993-11#1)(1995-2#2)(1995-5#1)(1997-4#2)(1997-6#1)(2006-1#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#8)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#3)(2009-10#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#4)(2009-9#1)(2010-11#2)(2010-12#4)(2010-3#1)(2010-4#4)(2010-5#2)(2010-6#4)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#1)(2012-11#2)(2012-12#8)(2012-2#13)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#3)
we report about##3##3##(2007-7#1)(2009-3#1)(2013-1#1)
we report an unusual case of##2##6##(2006-8#1)(2010-10#1)
we report an##12##3##(1996-12#1)(1997-5#1)(2006-4#1)(2006-7#1)(2006-8#1)(2008-11#1)(2008-7#2)(2009-4#1)(2010-10#1)(2011-2#1)(2013-1#1)
we report for the first time that##2##7##(1990-3#1)(2008-10#1)
we report for the first time the##3##7##(1994-3#1)(1995-6#1)(2008-7#1)
we report for the first time##6##6##(1990-3#1)(1994-3#1)(1995-6#1)(2008-10#1)(2008-7#1)(2009-2#1)
we report here a##2##4##(1992-12#1)(2008-12#1)
we report here the synthesis and##2##6##(2008-5#1)(2010-12#1)
we report here##7##3##(1992-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-12#1)
we report measurements##2##3##(2008-2#1)(2008-7#1)
we report observations##2##3##(2006-7#1)(2008-11#1)
we report on a##15##4##(1990-1#1)(1991-11#1)(1993-3#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-6#1)(2012-2#1)(2012-3#1)
we report on an##4##4##(1996-12#1)(2008-11#1)(2008-3#1)(2009-3#1)
we report on the application of##2##6##(2008-5#1)(2008-7#1)
we report on the effect of##2##6##(1996-1#1)(2012-1#1)
we report on the identification of##2##6##(1990-7#1)(1991-5#1)
we report on the identification##3##5##(1990-7#1)(1991-5#1)(1994-3#1)
we report on the##29##4##(1990-2#1)(1990-7#1)(1991-5#2)(1991-9#1)(1994-3#1)(1994-8#1)(1995-11#1)(1996-1#1)(1996-9#1)(2007-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#3)(2009-4#1)(2010-12#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
we report on two##2##4##(2008-3#1)(2013-1#1)
we report on##60##3##(1990-1#1)(1990-2#1)(1990-7#1)(1991-11#1)(1991-5#2)(1991-9#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-9#1)(2007-1#2)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
we report one such case##2##5##(2009-9#1)(2010-2#1)
we report one##3##3##(2007-2#1)(2009-9#1)(2010-2#1)
we report our experience with##2##5##(2007-12#1)(2011-2#1)
we report our experience##3##4##(1991-9#1)(2007-12#1)(2011-2#1)
we report our##6##3##(1991-3#1)(1991-9#1)(2007-12#1)(2008-2#1)(2011-2#1)(2012-2#1)
we report results of##2##4##(2008-11#1)(2008-2#1)
we report results##4##3##(1992-9#1)(1997-7#1)(2008-11#1)(2008-2#1)
we report some of##2##4##(1994-8#1)(2012-3#1)
we report some##3##3##(1994-8#1)(1996-5#1)(2012-3#1)
we report such a case##2##5##(2012-2#1)(2012-3#1)
we report that a##8##4##(1990-5#1)(1992-12#1)(1992-2#1)(1992-9#1)(1994-2#1)(1995-3#1)(1997-7#1)(2009-7#1)
we report that both##2##4##(1990-11#1)(1993-6#1)
we report that human##2##4##(1990-6#1)(1993-6#1)
we report that mice##3##4##(2012-12#2)(2012-2#1)
we report that the##21##4##(1990-9#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-4#2)(1992-7#1)(1994-11#2)(1994-5#1)(1994-8#1)(1995-10#1)(1995-8#2)(1996-4#1)(1996-5#1)(1997-2#1)(2008-7#1)(2012-2#1)(2013-8#1)
we report that this##2##4##(1993-9#1)(2013-8#1)
we report that##110##3##(1990-11#3)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#3)(1993-7#1)(1993-9#2)(1994-11#3)(1994-12#2)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#5)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#2)(1995-3#3)(1995-5#1)(1995-8#3)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#2)(2007-10#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-11#6)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-1#3)(2012-12#4)(2012-2#6)(2013-8#2)
we report the NMR spectral##2##5##(2009-7#2)
we report the NMR##3##4##(2009-7#3)
we report the X-ray structure of the##2##7##(1994-8#1)(2007-11#1)
we report the case of a##3##6##(2008-6#1)(2008-9#1)(2013-8#1)
we report the case of##4##5##(2008-6#1)(2008-9#1)(2010-5#1)(2013-8#1)
we report the case##5##4##(2008-6#1)(2008-9#1)(2010-5#1)(2013-1#1)(2013-8#1)
we report the cloning and##5##5##(1992-3#1)(1993-3#1)(1994-12#1)(1995-3#1)(1997-4#1)
we report the cloning of a cDNA encoding##2##8##(1994-9#1)(1996-5#1)
we report the cloning of##5##5##(1994-12#1)(1994-9#1)(1995-11#1)(1996-5#1)(2008-7#1)
we report the cloning##12##4##(1992-3#2)(1993-3#1)(1994-12#2)(1994-9#1)(1995-11#1)(1995-3#1)(1996-5#1)(1997-4#1)(2008-7#1)(2013-1#1)
we report the construction of##5##5##(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2013-8#1)
we report the crystal structure of##3##6##(1993-9#1)(2011-1#2)
we report the crystal structures of##2##6##(2011-1#1)(2012-2#1)
we report the crystal##5##4##(1993-9#1)(2011-1#3)(2012-2#1)
we report the development of a##2##6##(2008-10#1)(2010-10#1)
we report the development of##4##5##(2008-10#1)(2010-10#1)(2012-2#1)(2013-8#1)
we report the development##5##4##(1994-10#1)(2008-10#1)(2010-10#1)(2012-2#1)(2013-8#1)
we report the effect of##2##5##(1997-7#1)(2008-1#1)
we report the expression##5##4##(1992-8#1)(1993-9#1)(1995-8#1)(2009-3#1)(2009-9#1)
we report the fabrication of##2##5##(2010-7#1)(2012-2#1)
we report the first case##2##5##(2006-9#1)(2011-1#1)
we report the first experimental##2##5##(2008-7#1)(2012-2#1)
we report the first observation of##2##6##(2007-12#1)(2008-2#1)
we report the first observation##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
we report the first##17##4##(1991-10#1)(1995-3#1)(2006-12#1)(2006-9#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-12#1)(2011-1#2)(2012-2#1)(2012-3#1)
we report the generation##2##4##(1994-12#1)(2012-2#1)
we report the identification of a##4##6##(1990-11#1)(2008-10#1)(2009-6#1)(2012-3#1)
we report the identification of##6##5##(1990-11#1)(1994-11#1)(2008-10#2)(2009-6#1)(2012-3#1)
we report the identification##7##4##(1990-11#1)(1994-11#1)(2008-10#2)(2009-6#1)(2012-3#1)(2013-8#1)
we report the isolation and##3##5##(1991-4#1)(1993-6#1)(2006-12#1)
we report the isolation of a##4##6##(1990-2#1)(1992-11#1)(1995-2#1)(1995-8#1)
we report the isolation of##11##5##(1990-2#1)(1992-11#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-11#1)(1997-3#1)(1997-7#1)(2008-10#1)(2012-12#1)
we report the isolation##16##4##(1990-2#1)(1991-4#1)(1992-11#1)(1993-6#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-11#1)(1997-3#1)(1997-7#1)(2006-12#1)(2008-10#1)(2010-8#1)(2012-12#1)
we report the molecular##2##4##(1993-12#1)(1996-9#1)
we report the nucleotide sequence##2##5##(1994-8#1)(2008-10#1)
we report the presence of##2##5##(2008-5#1)(2011-12#1)
we report the production of##2##5##(2009-2#1)(2012-2#1)
we report the resonance##3##4##(2009-7#3)
we report the results of a##3##6##(2008-11#1)(2008-9#1)(2013-1#1)
we report the results of##8##5##(1995-8#1)(2006-11#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-3#1)(2013-1#1)
we report the structure and##2##5##(1991-3#1)(1991-6#1)
we report the structure##3##4##(1991-3#1)(1991-6#1)(1994-6#1)
we report the study of##3##5##(2005-11#1)(2008-7#1)(2012-2#1)
we report the successful##3##4##(2007-8#1)(2010-6#1)(2012-2#1)
we report the synthesis of##6##5##(1995-11#1)(2007-11#1)(2008-10#1)(2009-6#1)(2010-4#1)(2012-2#1)
we report the synthesis##7##4##(1995-11#1)(2007-11#1)(2008-10#2)(2009-6#1)(2010-4#1)(2012-2#1)
we report the use of##5##5##(1991-1#1)(1991-6#1)(2007-11#1)(2008-10#1)(2008-11#1)
we report the##195##3##(1990-11#1)(1990-2#1)(1990-3#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#2)(1992-11#2)(1992-3#2)(1992-8#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-11#3)(1995-2#2)(1995-3#2)(1995-6#3)(1995-8#4)(1995-9#1)(1996-11#1)(1996-2#2)(1996-4#2)(1996-5#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-7#2)(1997-8#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-2#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#8)(2008-8#1)(2008-9#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#13)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#8)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#14)(2012-3#4)(2012-4#1)(2013-1#4)(2013-8#5)
we report three##2##3##(2006-10#1)(2009-9#1)
we report two patients##2##4##(2009-4#1)(2010-7#1)
we report two##10##3##(1994-2#1)(2007-7#2)(2008-7#1)(2009-4#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
we report##604##2##(1990-1#1)(1990-11#5)(1990-2#3)(1990-3#3)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#4)(1991-2#4)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#3)(1991-9#3)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#4)(1992-4#2)(1992-7#1)(1992-8#3)(1992-9#2)(1993-11#3)(1993-12#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#4)(1993-7#1)(1993-8#1)(1993-9#4)(1994-10#1)(1994-11#7)(1994-12#6)(1994-2#4)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#10)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#4)(1995-2#7)(1995-3#5)(1995-5#2)(1995-6#4)(1995-8#8)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#3)(1996-5#5)(1996-6#1)(1996-8#1)(1996-9#3)(1997-2#1)(1997-3#2)(1997-4#4)(1997-5#2)(1997-6#1)(1997-7#5)(1997-8#1)(2004-5#1)(2005-11#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#1)(2006-7#2)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#5)(2007-11#5)(2007-12#8)(2007-2#2)(2007-3#3)(2007-7#7)(2007-8#10)(2008-1#2)(2008-10#21)(2008-11#17)(2008-12#2)(2008-2#9)(2008-3#8)(2008-4#6)(2008-5#7)(2008-6#6)(2008-7#30)(2008-8#5)(2008-9#7)(2009-10#3)(2009-2#3)(2009-3#5)(2009-4#6)(2009-5#1)(2009-6#4)(2009-7#22)(2009-8#1)(2009-9#5)(2010-10#2)(2010-11#4)(2010-12#10)(2010-2#2)(2010-3#2)(2010-4#8)(2010-5#3)(2010-6#6)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#21)(2011-12#3)(2011-2#12)(2012-1#2)(2012-11#2)(2012-12#17)(2012-2#44)(2012-3#12)(2012-4#1)(2013-1#16)(2013-7#3)(2013-8#11)
we reported a##6##3##(2008-9#1)(2009-8#1)(2010-1#1)(2011-2#2)(2013-7#1)
we reported on the##2##4##(2006-5#1)(2013-1#1)
we reported on##3##3##(2006-5#1)(2009-8#1)(2013-1#1)
we reported previously##3##3##(1992-12#1)(1997-2#1)(2010-7#1)
we reported that the##5##4##(1991-4#1)(1997-4#1)(1997-6#1)(2011-2#1)(2013-8#1)
we reported that##24##3##(1990-2#1)(1991-4#1)(1991-8#1)(1993-4#1)(1994-6#1)(1994-8#1)(1995-12#1)(1996-9#1)(1997-4#2)(1997-6#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-6#1)(2009-8#3)(2009-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
we reported the development of##2##5##(1990-12#1)(1996-5#1)
we reported the isolation##2##4##(1994-12#1)(1996-2#1)
we reported the##11##3##(1990-12#1)(1991-5#1)(1994-12#1)(1996-2#1)(1996-5#2)(2009-8#1)(2010-1#1)(2010-3#1)(2010-4#1)(2013-8#1)
we reported##52##2##(1990-12#1)(1990-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-12#1)(1993-4#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1996-2#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-9#1)(2009-6#1)(2009-8#7)(2009-9#1)(2010-1#2)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-7#1)(2013-8#2)
we represent##3##2##(1994-6#1)(1996-8#1)(2013-1#1)
we resected the##2##3##(2007-10#1)(2013-1#1)
we resected##3##2##(2007-10#1)(2007-11#1)(2013-1#1)
we resolved##2##2##(2007-12#1)(2008-3#1)
we retrieved##2##2##(2004-10#1)(2013-8#1)
we retrospectively analyzed the##2##4##(2007-7#1)(2007-8#1)
we retrospectively analyzed##3##3##(2006-10#1)(2007-7#1)(2007-8#1)
we retrospectively compared ablation and disease outcomes in high-risk differentiated thyroid carcinoma (DTC) patients undergoing radioiodine thyroid remnant ablation aided by recombinant human thyrotropin (rhTSH) versus thyroid hormone withdrawal/withholding (THW)##2##30##(2013-1#2)
we retrospectively evaluated the##2##4##(2006-10#1)(2011-2#1)
we retrospectively reviewed the records of##2##6##(2007-3#1)(2008-1#1)
we retrospectively reviewed the##3##4##(2007-3#1)(2007-7#1)(2008-1#1)
we retrospectively reviewed##4##3##(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)
we retrospectively studied##3##3##(1993-11#1)(2008-4#1)(2009-8#1)
we retrospectively##18##2##(1993-11#1)(2006-10#2)(2006-12#1)(2007-3#1)(2007-7#2)(2007-8#4)(2008-1#1)(2008-4#1)(2009-8#1)(2011-2#2)(2013-1#2)
we reveal that##2##3##(2008-7#1)(2013-1#1)
we reveal##4##2##(2007-12#1)(2008-7#1)(2009-6#1)(2013-1#1)
we revealed a##2##3##(2008-11#1)(2010-12#1)
we revealed##3##2##(1996-7#1)(2008-11#1)(2010-12#1)
we review a##2##3##(2008-11#1)(2008-2#1)
we review and discuss##2##4##(2008-1#1)(2008-8#1)
we review and##6##3##(2007-4#1)(2008-1#1)(2008-8#1)(2010-3#1)(2011-1#1)(2012-12#1)
we review both##3##3##(1993-3#1)(2008-8#1)(2009-5#1)
we review briefly##2##3##(2009-1#1)(2011-1#1)
we review current knowledge of##3##5##(2003-11#1)(2005-8#1)(2008-7#1)
we review current##6##3##(2003-11#1)(2005-8#1)(2007-11#1)(2008-7#1)(2009-3#1)(2012-1#1)
we review data##2##3##(2008-3#1)(2010-3#1)
we review evidence for##2##4##(2008-11#1)(2013-8#1)
we review evidence##5##3##(1991-12#1)(2008-11#1)(2008-4#1)(2010-2#1)(2013-8#1)
we review how##5##3##(2008-8#1)(2010-12#1)(2010-4#1)(2012-1#1)(2012-3#1)
we review its##2##3##(1990-12#1)(1992-12#1)
we review major##2##3##(2009-6#1)(2013-8#1)
we review our recent##2##4##(2009-3#1)(2011-2#1)
we review our##7##3##(1997-4#1)(2007-9#1)(2008-8#1)(2009-3#1)(2010-5#1)(2010-8#1)(2011-2#1)
we review potential##2##3##(2008-1#1)(2011-1#1)
we review progress made in##2##5##(2012-12#1)(2012-2#1)
we review recent advances in##2##5##(2010-11#1)(2011-1#1)
we review recent progress in##2##5##(2008-1#1)(2008-11#1)
we review recent research##2##4##(2008-2#1)(2008-7#1)
we review recent studies##2##4##(2012-2#1)(2013-1#1)
we review recent##15##3##(1990-8#1)(2005-10#1)(2006-5#1)(2006-9#1)(2008-1#1)(2008-11#3)(2008-2#1)(2008-7#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
we review several##5##3##(1996-12#1)(2007-8#1)(2008-1#1)(2008-3#1)(2011-2#1)
we review some of the##4##5##(2006-10#1)(2008-5#1)(2009-5#1)(2011-1#1)
we review some of##5##4##(2006-10#2)(2008-5#1)(2009-5#1)(2011-1#1)
we review some##10##3##(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-1#1)
we review strategies to##2##4##(2009-10#1)(2012-2#1)
we review studies##2##3##(2008-7#1)(2012-2#1)
we review the application of##3##5##(2006-9#1)(2011-2#1)(2012-11#1)
we review the available##3##4##(2007-11#1)(2008-7#1)(2012-2#1)
we review the current knowledge of##3##6##(2006-12#1)(2008-1#1)(2013-1#1)
we review the current knowledge##4##5##(2006-12#1)(2008-1#1)(2008-11#1)(2013-1#1)
we review the current literature and##2##6##(2011-12#2)
we review the current literature##4##5##(2008-3#1)(2010-9#1)(2011-12#2)
we review the current status of##2##6##(2012-11#1)(2013-1#1)
we review the current##17##4##(1996-11#1)(2006-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-12#2)(2012-11#1)(2013-1#2)
we review the currently##2##4##(2008-10#1)(2011-2#1)
we review the development of##3##5##(2005-11#1)(2008-11#1)(2012-1#1)
we review the development##4##4##(2005-11#1)(2008-10#1)(2008-11#1)(2012-1#1)
we review the epidemiology##3##4##(2010-8#1)(2011-2#1)(2012-2#1)
we review the evidence for##2##5##(2007-10#1)(2007-11#1)
we review the evidence##5##4##(2007-10#1)(2007-11#1)(2008-8#1)(2009-11#1)(2010-2#1)
we review the evolution##2##4##(1996-2#1)(2011-2#1)
we review the genetic##2##4##(2008-6#1)(2012-2#1)
we review the latest##3##4##(2006-10#1)(2008-1#1)(2009-12#1)
we review the literature of##2##5##(2008-11#2)
we review the literature on the##2##6##(2011-2#1)(2012-2#1)
we review the literature on##3##5##(2011-2#2)(2012-2#1)
we review the literature##7##4##(1996-9#1)(2008-11#2)(2010-12#1)(2011-2#2)(2012-2#1)
we review the main##2##4##(2007-7#1)(2011-1#1)
we review the most recent##2##5##(2007-5#1)(2008-4#1)
we review the most##4##4##(2007-5#1)(2008-10#1)(2008-4#1)(2010-7#1)
we review the recent##6##4##(2006-6#1)(2008-1#1)(2008-8#1)(2010-12#1)(2011-1#2)
we review the relevant##3##4##(2009-7#1)(2010-6#2)
we review the results of##4##5##(2007-6#1)(2008-11#1)(2009-8#1)(2011-1#1)
we review the results##5##4##(2007-6#1)(2008-11#1)(2008-4#1)(2009-8#1)(2011-1#1)
we review the role of##2##5##(1996-5#1)(2008-1#1)
we review the roles of##3##5##(2007-7#1)(2009-8#2)
we review the types of preclinical studies that should be considered depending on the nature and specific use of the intended stem cell therapeutic product##2##25##(2012-12#2)
we review the##137##3##(1991-9#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#2)(2007-10#2)(2007-11#7)(2007-2#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-9#1)(2008-1#6)(2008-10#5)(2008-11#7)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#2)(2009-11#1)(2009-12#3)(2009-7#1)(2009-8#3)(2009-9#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#3)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#7)(2011-12#3)(2011-2#7)(2012-1#3)(2012-11#3)(2012-12#3)(2012-2#8)(2012-3#1)(2013-1#3)(2013-8#1)
we review these##6##3##(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-4#1)(2011-12#1)
we review this##4##3##(2008-10#1)(2008-7#1)(2013-1#2)
we review those##2##3##(2008-11#1)(2009-5#1)
we review what is known##2##5##(2007-12#1)(2008-3#1)
we review work##2##3##(1994-11#1)(2009-10#1)
we review##266##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-12#1)(1993-3#1)(1994-11#1)(1994-2#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-4#2)(1997-6#1)(1997-8#1)(2003-11#1)(2005-10#1)(2005-11#1)(2005-8#2)(2006-10#4)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#3)(2007-10#2)(2007-11#9)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#1)(2007-9#2)(2008-1#10)(2008-10#6)(2008-11#14)(2008-2#4)(2008-3#4)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#11)(2008-8#8)(2009-1#1)(2009-10#3)(2009-11#3)(2009-12#3)(2009-2#1)(2009-3#3)(2009-5#4)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#3)(2010-11#2)(2010-12#9)(2010-2#2)(2010-3#3)(2010-4#6)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#4)(2011-1#15)(2011-12#4)(2011-2#13)(2012-1#5)(2012-11#3)(2012-12#6)(2012-2#13)(2012-3#2)(2013-1#8)(2013-8#4)
we reviewed a##2##3##(1992-1#1)(2011-2#1)
we reviewed all##3##3##(1996-11#1)(2007-2#1)(2011-2#1)
we reviewed our##2##3##(1993-5#1)(2007-7#1)
we reviewed the medical records##2##5##(2008-1#1)(2010-4#1)
we reviewed the##13##3##(1996-6#1)(2005-8#1)(2007-5#1)(2008-1#2)(2008-9#1)(2009-1#1)(2010-4#1)(2011-2#2)(2012-2#2)(2013-8#1)
we reviewed##34##2##(1992-1#1)(1993-5#1)(1993-6#1)(1996-11#1)(1996-3#1)(1996-6#1)(2005-8#1)(2007-2#2)(2007-5#1)(2007-7#2)(2008-1#4)(2008-3#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-4#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
we revisit the##2##3##(2009-12#1)(2013-8#1)
we revisit##3##2##(2009-12#1)(2012-2#1)(2013-8#1)
we routinely##2##2##(1997-4#1)(2009-5#1)
we sampled##5##2##(2008-10#1)(2008-5#1)(2008-6#1)(2009-11#1)(2012-3#1)
we saw##5##2##(1994-6#1)(1996-4#1)(2008-10#2)(2009-10#1)
we scan##2##2##(2008-3#2)
we screened a human##3##4##(1994-12#1)(1995-3#1)(2008-8#1)
we screened a##5##3##(1993-8#1)(1994-12#1)(1995-3#1)(2008-8#1)(2013-1#1)
we screened the##3##3##(2008-1#1)(2008-8#1)(2011-2#1)
we screened##18##2##(1993-8#1)(1994-12#1)(1995-3#1)(1997-5#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-8#3)(2008-9#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
we searched for genes##2##4##(1994-11#1)(1997-7#1)
we searched for the##2##4##(1992-12#1)(1994-9#1)
we searched for##16##3##(1990-7#1)(1991-3#1)(1992-12#1)(1994-11#1)(1994-9#1)(1996-4#1)(1996-7#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-11#1)(2012-3#1)(2013-1#1)
we searched the##2##3##(2007-3#1)(2009-5#1)
we searched##22##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-3#1)(1992-12#1)(1994-11#1)(1994-9#2)(1996-4#1)(1996-7#1)(1997-4#1)(1997-7#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
we see in our##2##4##(1991-12#1)(2008-12#1)
we see that##2##3##(2008-2#1)(2009-4#1)
we see##12##2##(1991-12#1)(1991-6#1)(1993-2#1)(2006-2#1)(2006-7#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2009-4#1)(2010-10#1)
we seek a##2##3##(2008-3#1)(2009-8#1)
we seek to establish##2##4##(2010-4#1)(2013-1#1)
we seek to##7##3##(2005-7#1)(2006-4#1)(2007-7#1)(2010-4#1)(2013-1#2)(2013-8#1)
we seek##11##2##(2005-7#1)(2006-4#1)(2007-7#1)(2008-3#1)(2008-8#1)(2009-8#1)(2010-4#1)(2012-12#1)(2013-1#2)(2013-8#1)
we select##3##2##(2008-2#1)(2011-2#1)(2012-3#1)
we selected a##7##3##(1990-12#2)(1994-8#1)(1995-8#1)(1997-5#1)(2008-5#2)
we selected the##4##3##(2010-2#1)(2011-2#1)(2012-2#1)(2013-7#1)
we selected##26##2##(1990-12#2)(1994-8#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-6#1)(1997-2#1)(1997-5#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
we separate##4##2##(1996-5#1)(2007-12#1)(2008-2#1)(2008-8#1)
we separated##3##2##(1992-12#1)(1995-6#1)(2008-10#1)
we sequenced##6##2##(1995-1#1)(2005-8#1)(2008-8#1)(2012-3#2)(2013-8#1)
we set forth##2##3##(2010-9#1)(2012-1#1)
we set out to develop##2##5##(2009-9#1)(2011-1#1)
we set out to##6##4##(2007-12#1)(2008-1#1)(2009-4#1)(2009-9#1)(2010-11#1)(2011-1#1)
we set out##8##3##(2007-12#1)(2008-1#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-11#1)(2011-1#1)(2013-8#1)
we set up a##2##4##(2004-11#1)(2013-8#1)
we set##13##2##(2004-11#1)(2007-12#2)(2008-1#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-9#1)(2011-1#1)(2012-1#1)(2013-8#2)
we shall describe the##2##4##(2008-10#1)(2013-1#1)
we shall##14##2##(2006-10#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#1)(2009-11#1)(2009-4#2)(2010-12#1)(2013-1#1)
we share our experiences##2##4##(1995-12#1)(2008-12#1)
we share##3##2##(1993-5#1)(1995-12#1)(2008-12#1)
we should be able to##2##5##(2008-10#1)(2008-5#1)
we should be##5##3##(2005-8#1)(2008-10#2)(2008-5#1)(2008-9#1)
we should have##2##3##(2008-3#1)(2012-11#1)
we should not##4##3##(2008-8#1)(2009-6#1)(2010-12#1)(2012-3#1)
we should strengthen the##2##4##(2012-3#2)
we should take##2##3##(1993-7#1)(1995-10#1)
we should##30##2##(1992-11#1)(1993-7#2)(1995-10#1)(1996-6#1)(1997-7#1)(2005-11#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-8#2)(2012-11#1)(2012-3#3)(2013-1#1)(2013-7#1)
we show a new##2##4##(2008-12#1)(2008-7#1)
we show a novel##4##4##(1991-7#1)(1995-11#1)(2007-12#1)(2008-7#1)
we show a##11##3##(1991-7#1)(1995-11#1)(2007-12#1)(2008-12#1)(2008-3#2)(2008-7#3)(2009-10#1)(2010-12#1)
we show an##2##3##(1994-10#2)
we show by##6##3##(1990-12#1)(1991-2#1)(1991-3#1)(2008-7#1)(2012-12#2)
we show development of a DAPI-intense doughnut-like structure co-localizing with the acrosomal sac and sub acrosomal PNT##2##17##(2012-12#2)
we show direct evidence##2##4##(1994-9#1)(2008-7#1)
we show experimentally that##2##4##(2007-11#1)(2008-2#1)
we show for the first time##4##6##(2011-2#1)(2012-12#2)(2012-2#1)
we show for##6##3##(1992-10#1)(1996-11#1)(2011-2#1)(2012-12#2)(2012-2#1)
we show here that RNA##2##5##(1996-7#1)(2010-11#1)
we show here that##4##4##(1996-7#1)(1997-5#1)(1997-6#1)(2010-11#1)
we show here##5##3##(1996-7#1)(1996-9#1)(1997-5#1)(1997-6#1)(2010-11#1)
we show how a##2##4##(2008-9#1)(2010-12#1)
we show how the##4##4##(2008-10#1)(2008-5#1)(2009-12#1)(2010-11#1)
we show how they##2##4##(1991-3#1)(2008-2#1)
we show how this##2##4##(2008-11#1)(2008-9#1)
we show how to##11##4##(1995-12#1)(2005-11#1)(2006-7#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#1)(2009-12#1)
we show how##29##3##(1991-3#1)(1995-12#1)(2005-11#1)(2006-7#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-2#3)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#2)(2009-5#1)(2010-11#1)(2010-12#1)(2011-2#1)
we show in##7##3##(1995-12#1)(2007-11#1)(2008-8#1)(2009-4#1)(2011-12#1)(2012-12#2)
we show some##3##3##(1990-11#1)(2008-2#1)(2011-2#1)
we show that ARNT transcripts##2##5##(2008-7#2)
we show that a key##2##5##(1994-9#1)(2010-6#1)
we show that a logistic regression model trained exclusively on our learned layer outperforms a customized SAPS II score on the mortality prediction task##2##24##(2013-1#2)
we show that a##20##4##(1990-3#1)(1990-6#1)(1990-9#1)(1991-2#1)(1994-6#1)(1994-9#1)(2005-8#1)(2006-11#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#2)
we show that an##8##4##(1990-5#1)(1996-11#1)(1997-8#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)
we show that at##2##4##(2008-1#1)(2013-8#1)
we show that both the##2##5##(2007-12#1)(2012-12#1)
we show that both##8##4##(1992-8#1)(1993-8#1)(1996-4#1)(2006-12#1)(2007-12#1)(2011-12#1)(2012-12#2)
we show that by##2##4##(2007-11#1)(2007-12#1)
we show that expression of##3##5##(1994-9#1)(1996-9#1)(2011-2#1)
we show that for##2##4##(2008-2#1)(2008-3#1)
we show that if##2##4##(2007-12#1)(2013-1#1)
we show that in addition to the lysosomal exocytosis markers##2##10##(2012-12#2)
we show that in the##3##5##(2004-4#1)(2008-9#1)(2012-1#1)
we show that in vitro##2##5##(1994-8#1)(2012-12#1)
we show that in##16##4##(1990-8#1)(1991-11#1)(1994-8#1)(1995-10#1)(1995-6#1)(1997-1#1)(1997-7#1)(2004-4#1)(2005-11#1)(2008-9#2)(2010-2#1)(2012-1#1)(2012-12#3)
we show that insertion of##2##5##(1997-4#1)(2013-8#1)
we show that it is possible to##5##7##(1990-5#1)(2008-2#3)(2009-2#1)
we show that it is##7##5##(1990-5#1)(2007-9#1)(2008-2#4)(2009-2#1)
we show that loss of##2##5##(1990-11#1)(2012-2#1)
we show that modeling operations at a higher level of granularity (e##2##12##(2013-1#2)
we show that one##2##4##(1997-4#1)(2008-1#1)
we show that positive##3##4##(1994-12#1)(2008-9#1)(2011-12#1)
we show that protein##2##4##(2009-6#1)(2012-3#1)
we show that such a##3##5##(2008-11#1)(2008-2#1)(2012-2#1)
we show that such##6##4##(2007-11#1)(2008-11#1)(2008-2#2)(2008-5#1)(2012-2#1)
we show that suramin##2##4##(1994-9#2)
we show that the AS makes a greater (Ush-dependent) contribution to closure than the epidermis##2##15##(2012-12#2)
we show that the dynamic##2##5##(2008-1#1)(2012-2#1)
we show that the expression of##2##6##(2010-2#1)(2011-1#1)
we show that the first##2##5##(1996-7#1)(2008-3#1)
we show that the optimal##2##5##(2008-3#2)
we show that the presence of##2##6##(2011-12#1)(2011-2#1)
we show that the unique##2##5##(1996-5#1)(2008-6#1)
we show that the##128##4##(1990-5#2)(1990-7#1)(1991-11#1)(1991-8#2)(1992-12#2)(1992-4#1)(1992-5#1)(1992-6#1)(1993-12#2)(1993-3#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-2#2)(1996-5#2)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#2)(2006-12#2)(2006-7#2)(2007-11#3)(2007-12#3)(2007-7#1)(2008-1#3)(2008-10#2)(2008-11#5)(2008-2#11)(2008-3#11)(2008-6#2)(2008-7#3)(2008-8#3)(2009-4#1)(2009-8#2)(2009-9#1)(2010-2#2)(2010-3#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#8)(2012-2#2)(2012-3#4)(2013-1#4)
we show that there are##2##5##(2008-3#1)(2009-9#1)
we show that there is a##3##6##(1996-6#1)(1997-1#1)(2008-3#1)
we show that there is##5##5##(1993-2#1)(1996-6#1)(1997-1#1)(2008-3#2)
we show that there##9##4##(1993-2#1)(1996-6#1)(1997-1#1)(2008-12#1)(2008-3#3)(2009-8#1)(2009-9#1)
we show that these##8##4##(1990-8#1)(1994-8#1)(1995-1#1)(1995-8#1)(2006-12#1)(2007-12#1)(2008-3#1)(2008-5#1)
we show that this is##2##5##(1993-1#1)(2008-2#1)
we show that this##23##4##(1991-11#1)(1991-5#1)(1992-7#1)(1993-1#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-6#1)(2006-7#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2012-12#3)(2013-1#1)
we show that today their use in a case study of widely used biomedical ontologies is limited##2##17##(2013-1#2)
we show that when##3##4##(1994-6#1)(1995-8#1)(1996-4#1)
we show that##518##3##(1990-10#1)(1990-11#1)(1990-2#3)(1990-3#1)(1990-5#6)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#4)(1991-2#2)(1991-4#1)(1991-5#3)(1991-8#3)(1991-9#1)(1992-12#3)(1992-3#2)(1992-4#1)(1992-5#4)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#4)(1993-9#1)(1994-10#1)(1994-11#5)(1994-12#5)(1994-2#3)(1994-3#7)(1994-5#2)(1994-6#4)(1994-8#5)(1994-9#13)(1995-1#1)(1995-10#2)(1995-11#4)(1995-12#1)(1995-2#8)(1995-3#6)(1995-5#1)(1995-6#3)(1995-8#7)(1995-9#1)(1996-10#2)(1996-11#2)(1996-12#1)(1996-2#3)(1996-4#3)(1996-5#7)(1996-6#3)(1996-7#1)(1996-8#2)(1996-9#3)(1997-1#4)(1997-2#3)(1997-3#1)(1997-4#6)(1997-5#1)(1997-6#7)(1997-7#9)(1997-8#3)(2004-4#1)(2005-11#1)(2005-8#3)(2006-10#4)(2006-11#1)(2006-12#7)(2006-7#4)(2006-9#2)(2007-10#1)(2007-11#10)(2007-12#20)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#5)(2008-10#11)(2008-11#12)(2008-12#3)(2008-2#24)(2008-3#24)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#14)(2008-8#12)(2008-9#7)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#7)(2009-9#6)(2010-12#3)(2010-2#7)(2010-3#2)(2010-6#4)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#3)(2011-2#11)(2012-1#4)(2012-12#23)(2012-2#17)(2012-3#9)(2013-1#17)(2013-7#1)(2013-8#5)
we show the effects of##2##5##(1997-8#1)(2007-12#1)
we show the involvement of##2##5##(2006-12#1)(2009-8#1)
we show the##23##3##(1991-1#1)(1993-6#1)(1995-4#1)(1997-8#1)(2006-12#1)(2007-12#2)(2008-2#4)(2008-3#2)(2008-7#2)(2009-3#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-8#1)
we show these##2##3##(1996-11#1)(2008-8#1)
we show##659##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#7)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#4)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#3)(1991-7#1)(1991-8#3)(1991-9#1)(1992-10#1)(1992-12#3)(1992-3#2)(1992-4#1)(1992-5#4)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#4)(1993-9#1)(1994-10#3)(1994-11#5)(1994-12#5)(1994-2#3)(1994-3#7)(1994-5#2)(1994-6#4)(1994-8#5)(1994-9#14)(1995-1#1)(1995-10#2)(1995-11#5)(1995-12#3)(1995-2#8)(1995-3#6)(1995-4#1)(1995-5#1)(1995-6#4)(1995-8#7)(1995-9#1)(1996-10#2)(1996-11#4)(1996-12#1)(1996-2#3)(1996-4#5)(1996-5#8)(1996-6#3)(1996-7#2)(1996-8#2)(1996-9#4)(1997-1#4)(1997-2#3)(1997-3#1)(1997-4#6)(1997-5#2)(1997-6#8)(1997-7#9)(1997-8#4)(2004-4#1)(2005-11#2)(2005-8#3)(2006-10#4)(2006-11#1)(2006-12#8)(2006-7#5)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#14)(2007-12#28)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#6)(2008-10#12)(2008-11#17)(2008-12#4)(2008-2#37)(2008-3#31)(2008-4#1)(2008-5#7)(2008-6#5)(2008-7#25)(2008-8#18)(2008-9#10)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#5)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#10)(2009-9#7)(2010-11#3)(2010-12#5)(2010-2#8)(2010-3#2)(2010-4#1)(2010-6#4)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#4)(2011-2#16)(2012-1#4)(2012-12#31)(2012-2#23)(2012-3#9)(2012-8#1)(2013-1#18)(2013-7#1)(2013-8#6)
we showed a##2##3##(2008-10#1)(2013-1#1)
we showed here that##2##4##(1997-7#1)(2008-11#1)
we showed in an earlier paper that four step-to-step transition types occur##2##12##(2012-12#2)
we showed in##4##3##(2008-11#1)(2009-8#1)(2012-12#2)
we showed that a##4##4##(1991-1#1)(2008-10#1)(2008-4#1)(2012-3#1)
we showed that human##2##4##(2008-11#1)(2012-3#1)
we showed that some##2##4##(2010-11#1)(2013-8#1)
we showed that the##12##4##(1994-12#1)(1995-12#1)(1995-8#1)(1996-10#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-6#2)(2012-12#1)(2012-2#1)(2013-7#1)
we showed that##62##3##(1990-4#1)(1990-5#2)(1991-1#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-7#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-10#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#1)(1996-7#1)(1997-7#1)(1997-8#1)(2004-11#1)(2006-12#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#1)(2008-6#2)(2008-9#3)(2009-5#1)(2009-6#1)(2009-8#3)(2010-11#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-7#1)(2013-8#3)
we showed the##3##3##(1990-3#1)(1997-5#1)(2005-4#1)
we showed##80##2##(1990-3#1)(1990-4#1)(1990-5#2)(1991-1#1)(1991-10#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-7#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-10#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#1)(1996-7#1)(1997-5#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-4#1)(2006-12#1)(2007-8#1)(2008-10#5)(2008-11#5)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-9#3)(2009-5#1)(2009-6#1)(2009-8#4)(2010-11#2)(2010-12#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#1)(2013-7#2)(2013-8#3)
we simulate the##2##3##(1996-4#1)(2008-2#1)
we simulate##3##2##(1996-4#1)(2008-2#1)(2010-10#1)
we simulated the##3##3##(2008-11#1)(2008-2#1)(2008-9#1)
we simulated##5##2##(1997-5#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-9#1)
we simultaneously##3##2##(2008-2#1)(2008-8#1)(2012-1#1)
we solubilized the##2##3##(1990-2#1)(1997-6#1)
we solve the##2##3##(1992-9#1)(2008-3#1)
we solve##3##2##(1992-9#1)(2008-3#1)(2012-2#1)
we sought to clarify##2##4##(2008-8#1)(2013-8#1)
we sought to determine if the##2##6##(1994-2#1)(2012-2#1)
we sought to determine if##6##5##(1990-11#1)(1993-6#1)(1994-2#1)(1996-10#1)(2010-11#1)(2012-2#1)
we sought to determine the extent to which##2##8##(2008-5#1)(2010-2#1)
we sought to determine the methylation status of##2##8##(2007-10#2)
we sought to determine the##7##5##(1997-8#1)(2007-10#2)(2007-12#1)(2008-5#1)(2010-2#1)(2011-2#1)
we sought to determine whether the##2##6##(1993-11#1)(2012-3#1)
we sought to determine whether##4##5##(1991-2#1)(1993-11#1)(2008-10#1)(2012-3#1)
we sought to determine##18##4##(1990-11#1)(1991-2#1)(1993-11#1)(1993-6#1)(1994-2#1)(1995-2#1)(1996-10#1)(1997-8#1)(2007-10#2)(2007-12#1)(2008-10#1)(2008-5#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)
we sought to examine the##2##5##(1996-9#1)(2012-2#1)
we sought to identify##5##4##(1997-4#1)(2007-10#2)(2008-10#1)(2008-9#1)
we sought to##37##3##(1990-11#1)(1990-12#1)(1991-2#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-2#1)(1996-10#1)(1996-9#1)(1997-4#1)(1997-8#1)(2006-8#1)(2007-10#4)(2007-12#1)(2007-9#2)(2008-10#3)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
we sought##40##2##(1990-11#1)(1990-12#1)(1991-2#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-2#1)(1996-10#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-8#1)(2006-8#1)(2007-10#4)(2007-12#1)(2007-9#2)(2008-10#3)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
we spatially modulate the phase##2##5##(2008-3#2)
we speak##3##2##(2010-9#2)(2012-3#1)
we specifically##3##2##(2008-4#1)(2009-6#1)(2012-12#1)
we speculate on the##6##4##(1991-6#1)(1995-4#1)(1996-3#1)(2006-1#1)(2007-12#1)(2012-12#1)
we speculate on##8##3##(1991-6#1)(1995-4#1)(1996-3#1)(2006-1#1)(2007-12#1)(2008-11#1)(2008-3#1)(2012-12#1)
we speculate that the##2##4##(1994-5#1)(2008-4#1)
we speculate that these##2##4##(1992-5#1)(2008-10#1)
we speculate that this##2##4##(1994-12#1)(2012-3#1)
we speculate that##14##3##(1990-4#1)(1991-9#1)(1992-5#1)(1994-12#1)(1994-5#1)(1995-1#1)(1997-3#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2012-3#1)(2013-8#1)
we speculate##26##2##(1990-4#1)(1991-6#1)(1991-9#1)(1992-5#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-4#1)(1996-3#1)(1997-3#1)(2006-1#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
we speculated that##2##3##(2009-12#1)(2012-2#1)
we start##3##2##(1993-3#1)(2012-8#1)(2013-1#1)
we started##3##2##(1993-4#1)(2011-2#1)(2013-1#1)
we still have##4##3##(1991-12#1)(1994-9#1)(2007-8#1)(2009-3#1)
we still need to##3##4##(1994-1#1)(2008-1#1)(2008-7#1)
we still##20##2##(1991-12#1)(1994-1#1)(1994-9#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-5#1)(2012-10#1)(2012-12#1)(2012-3#1)
we stopped##2##2##(2007-7#1)(2007-8#1)
we stress that serum##2##4##(1990-11#1)(2008-4#1)
we stress the##2##3##(1990-12#1)(1992-12#1)
we stress##5##2##(1990-11#1)(1990-12#1)(1992-12#1)(1993-6#1)(2008-4#1)
we strongly##2##2##(1997-6#1)(2012-12#1)
we studied 17##2##3##(1991-9#1)(2007-7#1)
we studied a##3##3##(1997-7#1)(2008-3#1)(2012-2#1)
we studied how##2##3##(2008-10#2)
we studied in##5##3##(1993-12#1)(1995-12#1)(2005-11#1)(2008-11#1)(2012-12#1)
we studied its##2##3##(1991-6#1)(2008-10#1)
we studied patients##2##3##(2006-2#1)(2008-5#1)
we studied receptor##2##3##(1995-3#1)(1995-6#1)
we studied the binding##2##4##(1997-4#1)(1997-6#1)
we studied the effect of##5##5##(1992-6#1)(1995-7#1)(1996-9#1)(1997-4#1)(2004-12#1)
we studied the effects of two##2##6##(1994-10#1)(1997-8#1)
we studied the effects of##11##5##(1992-4#1)(1993-1#1)(1994-10#1)(1994-5#1)(1995-11#1)(1995-3#2)(1996-11#1)(1997-1#1)(1997-8#1)(2008-4#1)
we studied the effects##12##4##(1992-4#1)(1993-1#1)(1994-10#1)(1994-5#1)(1995-11#1)(1995-3#2)(1996-11#1)(1997-1#1)(1997-5#1)(1997-8#1)(2008-4#1)
we studied the impact of##3##5##(2007-8#1)(2008-7#1)(2013-1#1)
we studied the levels of##4##5##(2006-9#1)(2008-10#1)(2012-1#1)(2013-7#1)
we studied the localization##2##4##(1995-5#1)(2009-8#1)
we studied the role of##4##5##(1990-3#1)(1996-12#1)(1997-6#1)(2007-2#1)
we studied the tracking behaviors of 25 women with breast cancer##2##11##(2013-1#2)
we studied the##86##3##(1990-3#1)(1991-12#2)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-4#1)(1993-8#2)(1994-10#1)(1994-11#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#3)(1995-5#1)(1995-7#1)(1996-11#3)(1996-12#1)(1996-2#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#2)(2004-12#1)(2005-4#1)(2006-8#2)(2006-9#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2009-12#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-9#1)(2012-1#2)(2012-9#1)(2013-1#3)(2013-7#3)(2013-8#2)
we studied two##2##3##(1995-6#1)(2008-10#1)
we studied whether##2##3##(1996-10#1)(2011-12#1)
we studied##176##2##(1990-3#1)(1990-4#1)(1991-12#2)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-4#1)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#2)(1994-5#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#4)(1995-3#4)(1995-5#1)(1995-6#3)(1995-7#2)(1996-1#2)(1996-10#1)(1996-11#3)(1996-12#1)(1996-2#1)(1996-7#2)(1996-9#2)(1997-1#1)(1997-4#3)(1997-5#3)(1997-6#4)(1997-7#3)(1997-8#2)(2004-11#1)(2004-12#1)(2005-11#1)(2005-4#2)(2006-10#1)(2006-2#1)(2006-8#3)(2006-9#2)(2007-10#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-7#4)(2007-8#2)(2007-9#3)(2008-1#3)(2008-10#9)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#3)(2009-10#1)(2009-12#1)(2009-8#3)(2010-2#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-12#2)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-9#1)(2013-1#6)(2013-7#5)(2013-8#2)
we study a##5##3##(2008-5#1)(2009-5#1)(2010-1#1)(2010-7#1)(2013-8#1)
we study and develop a new probabilistic approach for learning classification models from labels provided by multiple experts##2##18##(2013-1#2)
we study how emerging Semantic Web technologies can be applied in conjunction with clinical and genotype data stored at the Mayo Clinic Biobank to mine the phenotype data for genetic associations##2##31##(2013-1#2)
we study how##3##3##(2008-10#1)(2013-1#2)
we study the effect of##2##5##(2008-2#1)(2013-1#1)
we study the possible##2##4##(2007-12#1)(2008-10#1)
we study the use of##2##5##(2008-10#1)(2010-2#1)
we study the##26##3##(1996-3#1)(1997-2#1)(2006-7#1)(2007-11#1)(2007-12#4)(2008-10#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-7#1)(2009-8#1)(2010-2#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
we study##49##2##(1991-6#1)(1995-5#1)(1996-3#1)(1997-2#1)(2006-7#1)(2007-11#1)(2007-12#6)(2007-8#1)(2008-10#4)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#2)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#4)
we subjected##2##2##(2008-10#1)(2010-2#1)
we submitted##2##2##(1994-6#1)(2008-10#1)
we subsequently investigated##2##3##(1996-9#1)(2010-4#1)
we subsequently##3##2##(1996-5#1)(1996-9#1)(2010-4#1)
we succeed##2##2##(1997-3#1)(2007-8#1)
we succeeded in recording##2##4##(1997-4#1)(2007-12#1)
we succeeded in##7##3##(1997-4#1)(1997-6#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2013-8#1)
we successfully demonstrated##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
we successfully treated##3##3##(2010-6#1)(2012-12#1)(2013-8#1)
we successfully##22##2##(1995-8#1)(2006-2#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2009-12#1)(2010-6#1)(2011-1#4)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-8#1)
we suggest a##5##3##(2008-12#2)(2009-8#1)(2009-9#1)(2011-2#1)
we suggest an##2##3##(2007-4#1)(2009-4#1)
we suggest that a##2##4##(1992-1#1)(2006-5#1)
we suggest that an##2##4##(1996-5#1)(2008-4#1)
we suggest that it is##3##5##(2006-4#1)(2007-9#1)(2011-2#1)
we suggest that it##5##4##(1991-8#1)(2006-4#1)(2007-9#1)(2011-12#1)(2011-2#1)
we suggest that the same##2##5##(1994-12#1)(2012-2#1)
we suggest that the##19##4##(1990-11#1)(1990-12#1)(1991-12#1)(1992-12#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1996-7#1)(1997-4#1)(2004-10#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2012-2#1)
we suggest that there is##2##5##(2007-2#1)(2009-12#1)
we suggest that these##4##4##(1991-1#1)(2008-10#1)(2008-7#1)(2009-4#1)
we suggest that this##4##4##(1992-8#1)(2009-1#1)(2012-11#1)(2013-1#1)
we suggest that##88##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-6#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-5#2)(1991-8#1)(1992-1#2)(1992-12#2)(1992-2#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-7#1)(1996-5#1)(1996-7#1)(1997-4#2)(1997-7#1)(2004-10#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-2#1)(2007-8#1)(2007-9#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#6)(2008-8#4)(2008-9#2)(2009-1#2)(2009-12#2)(2009-4#1)(2009-7#1)(2009-8#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
we suggest the use of##2##5##(2008-2#1)(2008-3#1)
we suggest the##5##3##(1990-6#1)(2008-10#1)(2008-2#1)(2008-3#2)
we suggest to##3##3##(2006-12#1)(2008-2#1)(2009-8#1)
we suggest using##4##3##(1996-2#1)(2005-10#1)(2007-7#1)(2009-8#1)
we suggest##135##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-6#4)(1991-1#1)(1991-10#1)(1991-12#1)(1991-5#2)(1991-8#1)(1992-1#2)(1992-12#2)(1992-2#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-4#2)(1997-7#1)(2004-10#1)(2005-10#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-10#3)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#7)(2008-8#4)(2008-9#2)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#2)(2009-7#1)(2009-8#7)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-5#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-2#5)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
we suggested that the##2##4##(1995-8#1)(1997-3#1)
we suggested##5##2##(1994-11#1)(1995-8#1)(1997-3#1)(2007-9#1)(2008-9#1)
we summarise the current##2##4##(2006-10#1)(2009-12#1)
we summarise the##4##3##(1996-8#1)(2006-10#1)(2007-11#1)(2009-12#1)
we summarise##8##2##(1996-8#1)(2006-10#1)(2007-11#2)(2007-4#1)(2008-4#2)(2009-12#1)
we summarize findings##2##3##(2008-11#2)
we summarize our##3##3##(2009-8#1)(2010-6#1)(2012-2#1)
we summarize recent##4##3##(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)
we summarize research findings##2##4##(2008-8#1)(2009-12#1)
we summarize the available##2##4##(2005-10#1)(2010-10#1)
we summarize the current##4##4##(2008-1#1)(2010-12#1)(2011-2#1)(2012-11#1)
we summarize the evidence##2##4##(1995-5#1)(2010-11#1)
we summarize the results##2##4##(2006-1#1)(2009-2#1)
we summarize the role of##2##5##(2008-4#2)
we summarize the##29##3##(1995-5#1)(2005-10#1)(2006-1#1)(2006-9#1)(2008-1#5)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#1)
we summarize these##2##3##(2008-11#1)(2011-1#1)
we summarize##53##2##(1995-5#1)(2005-10#1)(2006-1#1)(2006-9#1)(2007-12#1)(2008-1#6)(2008-10#2)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-11#1)(2012-2#2)
we summarized##3##2##(2008-1#1)(2008-11#1)(2009-12#1)
we suppose##2##2##(1994-2#1)(2004-9#1)
we supposed##2##2##(1996-3#1)(2010-8#1)
we surgically##2##2##(2007-8#1)(2007-9#1)
we survey##4##2##(2007-11#1)(2008-4#1)(2008-9#1)(2012-11#1)
we surveyed 99 physicians regarding usage of and satisfaction with push HIE and pull HIE available in their communities as well as effects of HIE on practice and overall HIE satisfaction##2##31##(2013-1#2)
we surveyed the##2##3##(2007-5#1)(2011-2#1)
we surveyed##9##2##(2007-3#1)(2007-5#1)(2008-1#1)(2008-11#1)(2011-10#1)(2011-2#1)(2012-3#1)(2013-1#2)
we suspect##3##2##(1996-1#1)(2010-10#1)(2010-4#1)
we suspected##3##2##(2012-2#1)(2013-7#1)(2013-8#1)
we synthesize##4##2##(1997-2#1)(2008-6#1)(2009-3#1)(2010-5#1)
we synthesized a##2##3##(1994-2#1)(2007-11#1)
we synthesized##12##2##(1990-3#1)(1991-4#1)(1994-2#1)(1994-9#2)(1996-11#1)(2006-12#2)(2007-11#1)(2008-12#1)(2009-2#1)(2012-3#1)
we systematically##7##2##(2008-11#1)(2008-3#1)(2008-7#1)(2012-1#1)(2012-2#1)(2013-8#2)
we take a##3##3##(1993-6#1)(1997-4#1)(2010-6#1)
we take into account the##3##5##(1992-12#1)(1994-2#1)(2012-1#1)
we take into account##4##4##(1992-12#1)(1994-2#1)(2008-2#1)(2012-1#1)
we take the##2##3##(1997-6#1)(2009-2#1)
we take##14##2##(1992-12#2)(1993-6#1)(1994-2#1)(1997-4#1)(1997-6#1)(2008-2#1)(2008-5#1)(2009-2#1)(2010-2#1)(2010-3#1)(2010-6#1)(2012-1#1)(2012-3#1)
we talk?##2##2##(2005-7#1)(2012-12#1)
we targeted##2##2##(2010-11#1)(2013-7#1)
we teach##2##2##(2008-3#1)(2012-2#1)
we tend to##2##3##(2008-11#1)(2011-1#1)
we tentatively identify##2##3##(1990-7#1)(2010-5#1)
we tentatively##6##2##(1990-7#1)(1993-8#1)(1994-9#1)(1996-10#1)(2008-7#1)(2010-5#1)
we term##7##2##(1991-12#1)(1991-5#1)(1995-3#2)(2008-8#1)(2009-9#1)(2010-4#1)
we termed##2##2##(1992-8#1)(1997-6#1)
we test an automatic approach for ADE detection from letters using off-the-shelf machine learning tools##2##15##(2013-1#2)
we test for##2##3##(1997-2#1)(2009-9#1)
we test the hypothesis that the##2##6##(1991-1#1)(1996-5#1)
we test the hypothesis that##3##5##(1991-1#1)(1996-5#1)(2012-2#1)
we test the##11##3##(1991-1#1)(1996-5#1)(2006-10#1)(2008-2#1)(2008-9#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)
we test this##3##3##(1994-6#1)(2008-9#1)(2011-2#1)
we test##24##2##(1991-1#1)(1994-6#1)(1996-5#1)(1997-2#1)(2006-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#2)
we tested 2##2##3##(1994-3#1)(1995-6#1)
we tested a##8##3##(1991-12#1)(1994-3#1)(1995-7#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-7#1)(2013-1#1)
we tested for##2##3##(1994-12#1)(2008-11#1)
we tested the ability of##4##5##(1993-4#1)(1995-12#1)(2008-2#1)(2012-1#1)
we tested the ability##5##4##(1993-4#1)(1995-12#1)(2008-2#1)(2009-3#1)(2012-1#1)
we tested the effect of##3##5##(1995-12#1)(1997-6#1)(2013-1#1)
we tested the effects of##2##5##(1994-8#1)(1997-1#1)
we tested the functions of the Decide2Quit##2##7##(2013-1#2)
we tested the hypothesis that the##2##6##(1992-8#1)(2008-1#1)
we tested the hypothesis that##6##5##(1990-4#1)(1992-5#1)(1992-8#1)(1995-2#1)(2008-1#1)(2010-2#1)
we tested the possibility that##2##5##(1996-4#1)(2009-8#1)
we tested the##42##3##(1990-4#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-4#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#2)(1995-2#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-6#1)(2006-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#4)
we tested this hypothesis by##2##5##(1996-4#1)(2009-4#1)
we tested this hypothesis##3##4##(1996-4#1)(2009-4#1)(2009-7#1)
we tested this##4##3##(1996-4#1)(2009-4#1)(2009-7#1)(2009-8#1)
we tested two##2##3##(2007-2#1)(2008-9#1)
we tested whether the##4##4##(1991-5#1)(1992-12#1)(1994-11#1)(2012-12#1)
we tested whether##19##3##(1991-5#2)(1992-10#1)(1992-12#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-12#1)(2008-11#1)(2008-4#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
we tested##101##2##(1990-12#1)(1990-4#1)(1991-11#1)(1991-12#1)(1991-5#2)(1992-10#1)(1992-12#1)(1992-5#1)(1992-8#2)(1993-12#4)(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#5)(1994-6#2)(1994-8#2)(1995-10#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-7#1)(1996-12#2)(1996-4#2)(1996-7#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#6)(2008-2#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#3)(2009-8#2)(2010-2#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#2)(2013-1#6)
we the##2##2##(2006-8#1)(2010-7#1)
we then designed a prototype that corrected or improved on perceived weaknesses in the functionality served by the test procedure##2##20##(2013-1#2)
we then##17##2##(1992-9#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-2#1)(2011-12#1)(2013-1#2)(2013-8#1)
we theoretically##3##2##(2007-11#1)(2008-1#1)(2008-8#1)
we therefore##4##2##(1995-6#1)(1995-8#1)(2006-10#1)(2008-1#1)
we think about##3##3##(2006-2#1)(2012-12#1)(2012-3#1)
we think that the##2##4##(1995-6#1)(2007-7#1)
we think that this##2##4##(2006-11#1)(2006-6#1)
we think that##7##3##(1995-6#1)(1997-3#1)(2006-11#1)(2006-6#1)(2007-7#1)(2008-8#1)(2012-2#1)
we think##16##2##(1990-5#1)(1995-6#1)(1997-3#1)(2006-11#1)(2006-2#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
we thought##2##2##(1994-2#1)(2011-2#1)
we thus##3##2##(1996-12#1)(1997-8#1)(2008-2#1)
we took advantage of the##3##5##(2008-12#1)(2008-7#2)
we took advantage of##5##4##(2008-12#1)(2008-7#2)(2009-9#1)(2012-3#1)
we trace the##2##3##(1995-4#1)(1997-2#1)
we tracked##4##2##(1994-3#1)(2008-3#1)(2013-1#2)
we trained a topic model on a large set of clinical documents##2##12##(2013-1#2)
we trained##3##2##(1995-8#1)(2013-1#2)
we transfected##4##2##(1990-5#1)(1997-7#1)(2008-11#1)(2008-3#1)
we transplanted##3##2##(1991-5#1)(1994-3#1)(2013-1#1)
we treat##3##2##(2007-8#1)(2008-10#1)(2008-2#1)
we treated 16 patients##2##4##(1990-4#1)(2007-7#1)
we treated with##2##3##(1996-9#1)(2008-8#1)
we treated##15##2##(1990-4#1)(1991-8#1)(1992-5#1)(1993-3#1)(1996-6#1)(1996-9#1)(1997-6#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
we tried to eliminate##2##4##(2013-8#2)
we tried to find##3##4##(1993-5#1)(2006-6#1)(2007-10#1)
we tried to##19##3##(1990-12#1)(1991-5#1)(1993-5#1)(1997-5#1)(1997-6#1)(2006-6#1)(2007-10#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-8#1)(2010-12#1)(2012-2#1)(2013-8#2)
we tried##20##2##(1990-12#1)(1991-5#1)(1993-5#1)(1997-5#1)(1997-6#1)(2005-11#1)(2006-6#1)(2007-10#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-8#1)(2010-12#1)(2012-2#1)(2013-8#2)
we try to##11##3##(1993-3#1)(2006-3#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-12#2)(2010-7#1)
we tuned the##2##3##(2007-11#1)(2007-12#1)
we turn##2##2##(2007-10#1)(2010-12#1)
we uncovered a##3##3##(1992-2#1)(2008-8#2)
we understand the##3##3##(2008-3#1)(2008-7#1)(2009-12#1)
we understand##9##2##(1995-12#1)(1996-3#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-12#1)
we undertook a##4##3##(1991-9#1)(1993-8#1)(1996-8#1)(2008-5#1)
we undertook this study##2##4##(2007-7#1)(2008-7#1)
we undertook to##3##3##(1994-11#1)(2007-8#1)(2013-8#1)
we undertook##14##2##(1990-5#1)(1991-9#1)(1993-8#1)(1994-11#1)(1996-8#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-5#2)(2008-7#1)(2013-1#2)(2013-8#1)
we unexpectedly##3##2##(1994-11#1)(1996-9#1)(1997-6#1)
we use a game-theoretical approach where patients compete for transmission resources by assigning different utility values to data packets##2##19##(2013-1#2)
we use a new##2##4##(1995-9#1)(2010-2#1)
we use a simple method##2##5##(2008-10#1)(2010-7#1)
we use a simple##4##4##(2008-10#3)(2010-7#1)
we use a##37##3##(1992-4#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-4#1)(2006-12#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-4#2)(2009-6#1)(2010-2#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-3#2)(2013-1#4)
we use an##3##3##(2008-2#1)(2010-2#1)(2011-1#1)
we use data from a##2##5##(1997-7#1)(2012-12#1)
we use data from##4##4##(1997-7#1)(2007-12#1)(2008-8#1)(2012-12#1)
we use data##5##3##(1997-7#1)(2007-12#1)(2008-8#1)(2011-2#1)(2012-12#1)
we use machine-learning methods to induce models for making these predictions##2##11##(2013-1#2)
we use our##2##3##(1994-2#1)(2008-3#1)
we use the##28##3##(1992-2#1)(1994-8#1)(1995-8#1)(1997-4#1)(2005-12#1)(2006-10#1)(2007-12#3)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-7#1)(2011-1#2)(2012-3#2)
we use these##2##3##(2008-8#1)(2013-7#1)
we use this method to##2##5##(2008-3#1)(2010-6#1)
we use this##8##3##(2007-11#1)(2007-6#1)(2008-3#1)(2009-11#1)(2009-2#1)(2010-10#1)(2010-6#1)(2011-12#1)
we use to##3##3##(2007-12#1)(2008-11#1)(2009-4#1)
we use two##3##3##(1990-8#1)(2005-11#1)(2012-3#1)
we use##158##2##(1990-8#2)(1992-2#1)(1992-4#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#3)(1995-9#1)(1996-1#1)(1996-2#1)(1996-4#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-12#2)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#2)(2007-12#6)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#13)(2008-11#10)(2008-2#7)(2008-3#9)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#2)(2009-11#1)(2009-12#3)(2009-2#1)(2009-4#3)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-2#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#9)(2013-1#9)(2013-7#2)(2013-8#3)
we used a combination of##4##5##(2008-11#1)(2008-5#1)(2008-8#1)(2009-8#1)
we used a large##2##4##(1992-9#1)(2011-2#1)
we used a transgenic approach##2##5##(1996-3#1)(2009-8#1)
we used a##63##3##(1991-1#1)(1991-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-10#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-5#1)(2006-7#1)(2007-10#1)(2008-10#3)(2008-11#2)(2008-2#6)(2008-3#7)(2008-5#3)(2008-6#1)(2008-8#3)(2008-9#3)(2009-1#1)(2009-11#1)(2009-7#1)(2009-8#2)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-8#1)
we used an in##2##4##(1994-12#1)(1995-3#1)
we used an##13##3##(1993-3#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-5#1)(1997-7#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-1#1)(2010-12#1)
we used as##2##3##(2008-3#1)(2009-10#1)
we used data from##2##4##(2007-2#1)(2010-10#1)
we used data##4##3##(2007-2#1)(2007-8#1)(2010-10#1)(2010-8#1)
we used fMRI to examine##2##5##(2010-2#1)(2012-2#1)
we used fMRI to##3##4##(2008-11#1)(2010-2#1)(2012-2#1)
we used functional magnetic resonance imaging (fMRI) to##2##8##(2008-11#2)
we used in our##3##4##(2005-10#1)(2008-3#1)(2011-1#1)
we used in##5##3##(1994-9#1)(2005-10#1)(2008-3#1)(2011-1#1)(2013-1#1)
we used microdialysis##2##3##(1993-12#1)(1994-2#1)
we used polymerase chain reaction##2##5##(1992-7#1)(1993-8#1)
we used quantitative##4##3##(1995-11#1)(1996-4#1)(2008-8#1)(2012-3#1)
we used real-time##2##3##(2008-4#1)(2008-8#1)
we used several##3##3##(1994-9#1)(1997-8#1)(2007-12#1)
we used the following##2##4##(2008-11#1)(2008-2#1)
we used the method of##2##5##(2011-2#1)(2012-3#1)
we used the model##2##4##(1991-7#1)(2010-6#1)
we used the same##2##4##(2008-10#1)(2008-3#1)
we used the##45##3##(1991-11#1)(1991-3#1)(1991-7#1)(1992-9#1)(1993-11#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-3#1)(2005-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-2#4)(2008-3#3)(2008-5#1)(2009-10#1)(2009-9#1)(2010-6#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-3#2)
we used this##4##3##(1990-12#1)(2007-12#1)(2008-3#1)(2012-2#1)
we used three-dimensional video and force analysis to describe and characterize these four step-to-step transition types##2##16##(2012-12#2)
we used to##4##3##(1990-2#1)(2008-8#1)(2013-1#2)
we used two different methods##2##5##(2008-11#1)(2008-2#1)
we used two##8##3##(1990-8#1)(1994-2#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2013-1#1)
we used##298##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-6#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-5#2)(1991-7#2)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-8#2)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#5)(1994-3#2)(1994-5#1)(1994-8#3)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#3)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#3)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-10#2)(2005-8#2)(2006-12#3)(2006-6#1)(2006-7#1)(2007-10#2)(2007-11#3)(2007-12#6)(2007-2#2)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#18)(2008-11#13)(2008-12#2)(2008-2#13)(2008-3#18)(2008-4#1)(2008-5#10)(2008-6#3)(2008-7#1)(2008-8#12)(2008-9#7)(2009-1#1)(2009-10#5)(2009-11#2)(2009-12#2)(2009-3#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#1)(2010-6#3)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#10)(2012-12#7)(2012-2#5)(2012-3#7)(2013-1#7)(2013-7#5)(2013-8#5)
we utilize a##2##3##(1995-3#1)(2007-12#1)
we utilize##5##2##(1995-3#1)(2007-12#1)(2011-1#1)(2012-1#1)(2012-3#1)
we utilized a##4##3##(1991-1#1)(1992-10#1)(1995-2#1)(2010-8#1)
we utilized population-based data analysis to construct surgical outcome predictive models for spinal fusion surgery using hospital##2##17##(2013-1#2)
we utilized the##3##3##(2008-2#1)(2010-12#2)
we utilized##16##2##(1990-5#1)(1991-1#1)(1992-10#1)(1993-9#1)(1994-9#1)(1995-2#1)(1995-5#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-11#1)(2010-12#2)(2010-8#1)(2013-1#2)
we varied##2##2##(1997-4#1)(2008-2#1)
we verified the##4##3##(2008-11#1)(2008-3#2)(2013-7#1)
we verify the##4##3##(1992-12#1)(2006-6#1)(2008-2#1)(2008-3#1)
we verify##5##2##(1992-12#1)(2006-6#1)(2008-2#1)(2008-3#1)(2009-4#1)
we view##3##2##(2008-2#1)(2008-9#1)(2009-10#1)
we visualized##2##2##(2008-5#1)(2012-2#1)
we want to make the analytic model results available to clinicians and researchers for pre-operative surgical risk assessment##2##18##(2013-1#2)
we want to##12##3##(1994-3#1)(2006-10#1)(2008-11#1)(2008-4#1)(2009-5#2)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
we want##14##2##(1994-3#1)(2006-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-5#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
we wanted to compare the##2##5##(2011-2#1)(2013-1#1)
we wanted to compare##3##4##(2011-2#2)(2013-1#1)
we wanted to##11##3##(1993-5#1)(1995-5#2)(2008-10#1)(2011-1#1)(2011-12#1)(2011-2#4)(2013-1#1)
we were able to characterize##2##5##(1992-7#1)(2010-1#1)
we were able to conclude##2##5##(2008-12#1)(2008-7#1)
we were able to decrease##2##5##(1996-2#1)(2007-10#1)
we were able to demonstrate##3##5##(1990-4#1)(2006-2#1)(2008-7#1)
we were able to detect##3##5##(1990-12#1)(2010-5#1)(2013-1#1)
we were able to determine##3##5##(1993-8#1)(2008-10#2)
we were able to differentiate between##2##6##(1992-12#1)(2011-1#1)
we were able to differentiate##3##5##(1992-12#1)(2008-5#1)(2011-1#1)
we were able to distinguish##2##5##(1991-11#1)(2008-3#1)
we were able to find publications 44% of the time (NPV=56%) by searching PubMed##2##14##(2013-1#2)
we were able to find##3##5##(1993-9#1)(2013-1#2)
we were able to generate##3##5##(2007-12#1)(2008-11#1)(2012-12#1)
we were able to identify a##2##6##(1997-1#1)(2011-2#1)
we were able to identify##7##5##(1990-7#1)(1997-1#1)(2006-8#1)(2008-8#1)(2011-2#1)(2012-11#1)(2012-3#1)
we were able to isolate##2##5##(1990-2#1)(2008-11#1)
we were able to obtain##2##5##(2008-10#1)(2008-5#1)
we were able to prove##2##5##(2008-10#1)(2008-3#1)
we were able to recognize differences in subcellular localization and nucleocytoplasmic shuttling of both isoforms##2##15##(2012-12#2)
we were able to show##4##5##(1992-7#1)(1997-4#1)(2007-7#1)(2008-5#1)
we were able to##79##4##(1990-12#2)(1990-2#1)(1990-4#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-7#2)(1992-8#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-2#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#4)(2012-3#2)(2013-1#3)(2013-8#1)
we were also able to##2##5##(1996-9#1)(2009-8#1)
we were interested in##4##4##(1994-10#1)(2008-5#1)(2010-2#1)(2013-1#1)
we were not able to##3##5##(2008-10#1)(2012-12#1)(2013-1#1)
we were not##4##3##(1996-12#1)(2008-10#1)(2012-12#1)(2013-1#1)
we were struck by the##2##5##(1997-4#1)(2010-7#1)
we were unable to demonstrate##2##5##(1995-12#1)(2009-9#1)
we were unable to detect any##2##6##(1996-2#1)(1996-3#1)
we were unable to detect##3##5##(1990-11#1)(1996-2#1)(1996-3#1)
we were unable to##11##4##(1990-11#1)(1993-9#1)(1995-12#1)(1996-2#1)(1996-3#1)(2006-12#1)(2008-2#1)(2009-6#1)(2009-9#1)(2012-2#1)(2013-8#1)
we were##115##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-7#2)(1992-8#1)(1992-9#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-6#1)(2006-12#2)(2006-2#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#5)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#6)(2008-7#3)(2008-8#1)(2008-9#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
we will also##3##3##(2008-1#1)(2009-11#1)(2011-2#1)
we will analyse##2##3##(2005-7#1)(2008-1#1)
we will be able to##6##5##(1997-8#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-7#2)
we will briefly##4##3##(1996-1#1)(2008-2#1)(2012-1#1)(2012-2#1)
we will concentrate on##2##4##(2005-8#1)(2010-12#1)
we will consider the##3##4##(2006-12#1)(2008-7#1)(2011-2#1)
we will consider##5##3##(2006-12#1)(2008-1#1)(2008-7#1)(2010-12#1)(2011-2#1)
we will describe the##3##4##(2006-9#1)(2008-1#1)(2010-7#1)
we will describe##6##3##(2006-7#1)(2006-9#1)(2008-1#1)(2008-10#1)(2010-7#1)(2013-8#1)
we will discuss how##2##4##(2009-5#1)(2012-2#1)
we will discuss the recent##2##5##(2011-1#1)(2012-1#1)
we will discuss the state of science around creating and maintaining structured problem lists that accommodate numerous external requirements##2##19##(2013-1#2)
we will discuss the##22##4##(2006-10#2)(2006-8#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#1)(2011-1#1)(2012-1#1)(2013-1#3)
we will discuss##42##3##(2005-10#1)(2005-11#1)(2006-10#2)(2006-3#1)(2006-8#1)(2007-12#1)(2007-6#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-7#3)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)
we will examine the##2##4##(2008-7#1)(2010-2#1)
we will examine##4##3##(2008-1#1)(2008-7#2)(2010-2#1)
we will explore##4##3##(1994-1#1)(1994-12#1)(2005-10#1)(2008-2#1)
we will focus on recent##2##5##(2008-1#1)(2013-1#1)
we will focus on the role of##2##7##(2009-9#1)(2011-1#1)
we will focus on the##8##5##(2008-10#1)(2008-11#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#1)
we will focus on##14##4##(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2011-1#2)(2011-2#1)(2013-1#2)
we will focus##16##3##(2008-1#3)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2011-1#2)(2011-2#1)(2013-1#2)(2013-8#1)
we will give an overview of##3##6##(2009-3#1)(2010-12#1)(2013-1#1)
we will have##4##3##(1995-2#1)(1997-3#1)(2012-2#1)(2013-8#1)
we will highlight the##2##4##(2012-12#1)(2013-1#1)
we will highlight##4##3##(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
we will know if##2##4##(1997-3#1)(2013-1#1)
we will point out##2##4##(2009-5#1)(2010-11#1)
we will present our##2##4##(2008-11#1)(2008-5#1)
we will present##5##3##(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
we will provide a##2##4##(2012-2#1)(2013-1#1)
we will provide an overview of##2##6##(2010-11#1)(2012-11#1)
we will provide an##5##4##(2006-10#1)(2010-11#1)(2010-6#1)(2012-1#1)(2012-11#1)
we will provide##9##3##(2006-10#1)(2008-7#1)(2009-9#1)(2010-11#1)(2010-6#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)
we will review recent##2##4##(2006-9#1)(2008-1#1)
we will review some##2##4##(1995-7#1)(2010-1#1)
we will review the current knowledge##2##6##(2008-1#1)(2012-2#1)
we will review the##11##4##(2006-6#1)(2007-8#1)(2008-1#2)(2008-7#1)(2008-9#1)(2009-1#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
we will review##18##3##(1995-7#1)(2006-6#1)(2006-9#1)(2007-8#1)(2008-1#5)(2008-7#1)(2008-9#1)(2009-1#1)(2009-12#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
we will see##2##3##(2006-4#1)(2009-4#1)
we will show##3##3##(2007-8#1)(2008-11#2)
we will soon##2##3##(2007-11#1)(2007-7#1)
we will summarize our##2##4##(2011-2#1)(2013-8#1)
we will summarize the##5##4##(2008-7#1)(2009-11#1)(2010-12#1)(2011-1#1)(2012-3#1)
we will summarize##9##3##(2008-1#1)(2008-7#1)(2009-11#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-8#1)
we will try to##3##4##(2008-10#1)(2011-1#1)(2013-1#1)
we will##201##2##(1992-12#1)(1992-4#1)(1992-5#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1995-2#1)(1995-7#1)(1996-1#1)(1997-3#2)(1997-8#1)(2005-10#2)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#5)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#18)(2008-10#11)(2008-11#8)(2008-12#3)(2008-2#5)(2008-3#1)(2008-4#6)(2008-5#1)(2008-7#12)(2008-9#5)(2009-1#1)(2009-11#2)(2009-12#1)(2009-3#3)(2009-4#2)(2009-5#6)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#5)(2010-12#5)(2010-2#2)(2010-3#1)(2010-6#2)(2010-7#1)(2011-1#9)(2011-2#6)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#4)
we wish to##6##3##(1994-1#1)(1995-5#1)(1997-8#1)(2008-8#1)(2009-8#1)(2013-8#1)
we wished to determine##3##4##(1992-7#1)(1995-12#1)(2008-9#1)
we wished to##5##3##(1992-7#1)(1995-12#1)(1995-5#1)(2008-11#1)(2008-9#1)
we witnessed##2##2##(1992-6#1)(1994-12#1)
we work##2##2##(2006-9#1)(2008-12#1)
we would like to present##2##5##(2012-12#1)(2012-3#1)
we would like to report a##2##6##(2007-8#1)(2012-2#1)
we would like to##12##4##(1997-6#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-2#1)(2009-6#1)(2010-12#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
we would not##2##3##(2008-10#1)(2009-6#1)
we would suggest##2##3##(1991-3#1)(2006-10#1)
we would##27##2##(1991-3#1)(1991-9#1)(1993-6#1)(1995-11#1)(1995-5#1)(1996-12#1)(1997-6#1)(2006-10#2)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-6#2)(2010-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
we wrote##2##2##(2005-10#1)(2011-2#1)
we##15891##1##(1990-1#2)(1990-10#26)(1990-11#51)(1990-12#57)(1990-2#33)(1990-3#29)(1990-4#19)(1990-5#56)(1990-6#29)(1990-7#25)(1990-8#54)(1990-9#27)(1991-1#28)(1991-10#30)(1991-11#34)(1991-12#67)(1991-2#55)(1991-3#36)(1991-4#28)(1991-5#60)(1991-6#27)(1991-7#32)(1991-8#29)(1991-9#51)(1992-1#13)(1992-10#23)(1992-11#39)(1992-12#57)(1992-2#36)(1992-3#52)(1992-4#26)(1992-5#29)(1992-6#37)(1992-7#25)(1992-8#57)(1992-9#51)(1993-1#20)(1993-10#3)(1993-11#38)(1993-12#67)(1993-2#28)(1993-3#50)(1993-4#22)(1993-5#22)(1993-6#61)(1993-7#18)(1993-8#47)(1993-9#47)(1994-1#19)(1994-10#19)(1994-11#78)(1994-12#124)(1994-2#96)(1994-3#91)(1994-4#6)(1994-5#40)(1994-6#67)(1994-7#5)(1994-8#108)(1994-9#89)(1995-1#47)(1995-10#30)(1995-11#57)(1995-12#96)(1995-2#103)(1995-3#86)(1995-4#27)(1995-5#67)(1995-6#73)(1995-7#15)(1995-8#89)(1995-9#20)(1996-1#27)(1996-10#36)(1996-11#58)(1996-12#77)(1996-2#70)(1996-3#47)(1996-4#56)(1996-5#93)(1996-6#40)(1996-7#41)(1996-8#61)(1996-9#50)(1997-1#54)(1997-2#96)(1997-3#52)(1997-4#132)(1997-5#43)(1997-6#90)(1997-7#99)(1997-8#75)(1997-9#1)(2003-11#5)(2004-1#7)(2004-10#6)(2004-11#13)(2004-12#6)(2004-2#5)(2004-3#2)(2004-4#1)(2004-5#1)(2004-9#7)(2005-1#2)(2005-10#32)(2005-11#57)(2005-12#8)(2005-2#1)(2005-4#10)(2005-5#2)(2005-6#2)(2005-7#12)(2005-8#39)(2005-9#5)(2006-1#9)(2006-10#172)(2006-11#20)(2006-12#108)(2006-2#22)(2006-3#22)(2006-4#34)(2006-5#28)(2006-6#53)(2006-7#50)(2006-8#34)(2006-9#41)(2007-1#14)(2007-10#78)(2007-11#272)(2007-12#445)(2007-2#49)(2007-3#32)(2007-4#36)(2007-5#50)(2007-6#41)(2007-7#121)(2007-8#186)(2007-9#67)(2008-1#195)(2008-10#636)(2008-11#554)(2008-12#101)(2008-2#534)(2008-3#584)(2008-4#131)(2008-5#287)(2008-6#114)(2008-7#449)(2008-8#345)(2008-9#220)(2009-1#13)(2009-10#106)(2009-11#40)(2009-12#75)(2009-2#81)(2009-3#63)(2009-4#107)(2009-5#93)(2009-6#77)(2009-7#86)(2009-8#216)(2009-9#97)(2010-1#30)(2010-10#52)(2010-11#88)(2010-12#176)(2010-2#135)(2010-3#61)(2010-4#72)(2010-5#52)(2010-6#61)(2010-7#71)(2010-8#81)(2010-9#58)(2011-1#264)(2011-10#2)(2011-11#1)(2011-12#48)(2011-2#457)(2011-3#8)(2011-7#2)(2012-1#131)(2012-10#1)(2012-11#45)(2012-12#336)(2012-2#449)(2012-3#317)(2012-4#1)(2012-5#6)(2012-7#5)(2012-8#2)(2012-9#1)(2013-1#610)(2013-7#92)(2013-8#262)
we'll##4##1##(2009-10#2)(2011-2#1)(2013-1#1)
we're##4##1##(1991-2#1)(1994-1#1)(1995-5#1)(2011-2#1)
we've##4##1##(1991-2#1)(2008-6#1)(2010-12#1)(2012-3#1)
we-ness##4##1##(2007-11#4)
weak ATPase activity##2##3##(1995-6#1)(1997-7#1)
weak CL##4##2##(2008-10#4)
weak CO(2)##2##2##(1991-5#1)(2007-11#1)
weak absorption of##2##3##(2008-2#1)(2008-3#1)
weak absorption##4##2##(1991-5#1)(2007-12#1)(2008-2#1)(2008-3#1)
weak acid##6##2##(2008-10#3)(2008-11#1)(2010-12#1)(2013-8#1)
weak acidic##4##2##(2008-10#3)(2012-11#1)
weak acids##7##2##(2008-10#6)(2008-9#1)
weak acoustic##2##2##(1996-1#1)(2010-8#1)
weak activity##5##2##(1990-6#1)(1993-11#1)(1993-4#1)(1994-2#1)(2008-5#1)
weak affinity for##4##3##(1992-12#1)(1994-9#1)(1996-7#1)(1997-1#1)
weak and strong##3##3##(1995-12#1)(2008-11#1)(2008-2#1)
weak and transient##3##3##(1997-7#1)(2008-7#1)(2008-8#1)
weak and##22##2##(1993-3#1)(1994-12#1)(1995-12#1)(1997-1#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-1#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#2)(2009-8#1)(2010-4#1)(2011-12#1)(2012-1#1)(2012-3#1)
weak as##3##2##(1996-10#1)(2007-11#1)(2007-12#1)
weak association equilibria##2##3##(2008-10#2)
weak association##5##2##(1994-2#1)(1997-8#1)(2007-5#1)(2008-10#2)
weak at##3##2##(2008-9#1)(2012-12#1)(2013-8#1)
weak base##2##2##(1993-9#1)(2008-10#1)
weak binding of##2##3##(1995-2#1)(2006-10#1)
weak binding##8##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1993-3#1)(1995-2#1)(2006-10#1)(2008-3#1)
weak but significant##3##3##(1990-11#1)(2008-10#1)(2012-3#1)
weak but statistically significant##2##4##(2007-10#1)(2007-12#1)
weak but##7##2##(1990-11#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#1)(2012-3#1)
weak cation exchange##2##3##(2008-10#1)(2012-12#1)
weak competitive##3##2##(1994-3#1)(1994-9#2)
weak competitors##2##2##(2008-8#2)
weak contribution of the##2##4##(2005-11#1)(2008-10#1)
weak correlation between the##2##4##(1990-7#1)(2009-5#1)
weak correlation between##3##3##(1990-7#1)(2009-5#1)(2013-8#1)
weak correlation was##2##3##(2007-8#1)(2008-10#1)
weak correlation with the##3##4##(1995-5#1)(1996-4#1)(2012-12#1)
weak correlation##10##2##(1990-7#1)(1995-5#1)(1996-4#1)(2007-8#1)(2008-10#2)(2009-5#1)(2010-2#1)(2012-12#1)(2013-8#1)
weak coupling between##2##3##(2007-12#1)(2008-3#1)
weak coupling##5##2##(2006-10#1)(2007-11#1)(2007-12#1)(2008-3#2)
weak dependence on##2##3##(2005-11#1)(2008-10#1)
weak dependence##3##2##(2005-11#1)(2007-11#1)(2008-10#1)
weak effect##5##2##(2008-10#1)(2008-3#1)(2008-6#1)(2012-2#1)(2012-3#1)
weak electric##3##2##(2008-10#1)(2010-4#1)(2012-12#1)
weak electrolyte and##2##3##(2007-8#2)
weak electrolyte##3##2##(2007-8#3)
weak emission##2##2##(2008-10#1)(2010-5#1)
weak evidence for linkage##2##4##(1996-5#1)(1997-5#1)
weak evidence##3##2##(1996-5#2)(1997-5#1)
weak expression of##3##3##(1995-5#1)(1996-10#2)
weak expression##4##2##(1995-5#1)(1996-10#2)(1996-12#1)
weak features##2##2##(1993-3#1)(2012-2#1)
weak ferromagnetic##2##2##(1997-7#1)(2007-11#1)
weak fluorescence was observed##2##4##(2006-5#1)(2008-11#1)
weak fluorescence##4##2##(1996-8#1)(2006-5#1)(2007-11#1)(2008-11#1)
weak fluorescent##2##2##(2008-10#1)(2008-4#1)
weak for##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
weak homology##4##2##(1990-10#1)(1991-12#1)(1992-3#1)(1995-6#1)
weak hydrogen##2##2##(2007-11#1)(2013-1#1)
weak hydrophobic##2##2##(1996-1#1)(2008-10#1)
weak hydrophobicity##2##2##(1991-11#1)(2008-10#1)
weak in##10##2##(1990-10#1)(1993-11#1)(1996-12#1)(1996-4#1)(1997-4#1)(1997-7#1)(2004-9#1)(2007-1#1)(2007-12#1)(2008-9#1)
weak increase##2##2##(1993-11#1)(2007-9#1)
weak inhibition##5##2##(1990-11#1)(1990-7#1)(1994-6#1)(1996-7#1)(2008-8#1)
weak inhibitors of##3##3##(1992-5#1)(1995-2#1)(1995-6#1)
weak inhibitors##4##2##(1992-5#1)(1993-4#1)(1995-2#1)(1995-6#1)
weak inhibitory effect##2##3##(1996-2#1)(2008-4#1)
weak inhibitory##4##2##(1991-8#1)(1996-2#1)(2008-4#1)(2010-4#1)
weak interaction##4##2##(1991-7#1)(1993-6#1)(2005-11#1)(2008-10#1)
weak interactions##2##2##(1997-7#1)(2009-2#1)
weak intermolecular##2##2##(1992-6#1)(2010-4#1)
weak inversion##2##2##(2008-2#2)
weak light##3##2##(2007-12#2)(2008-2#1)
weak link##4##2##(2008-10#1)(2008-12#1)(2008-7#1)(2013-1#1)
weak links##2##2##(1996-5#1)(2008-7#1)
weak mixing##2##2##(1994-5#1)(1996-5#1)
weak modes##2##2##(2010-10#2)
weak negative##2##2##(1994-12#1)(2008-9#1)
weak nonspecific binding##2##3##(1993-11#2)
weak opioids##3##2##(2006-10#3)
weak optical##3##2##(2007-12#2)(2008-2#1)
weak or absent in##2##4##(1993-11#1)(2007-12#1)
weak or absent##3##3##(1993-11#1)(2007-12#2)
weak or impalpable##2##3##(2007-8#2)
weak or no expression##2##4##(1991-12#1)(1995-5#1)
weak or no##6##3##(1991-12#1)(1991-7#1)(1992-5#1)(1995-12#1)(1995-5#1)(2008-11#1)
weak or strong##4##3##(2005-11#1)(2007-8#2)(2008-3#1)
weak or##20##2##(1991-12#1)(1991-7#1)(1992-3#1)(1992-5#1)(1993-11#1)(1995-12#1)(1995-5#1)(2005-11#1)(2007-10#1)(2007-12#3)(2007-8#4)(2008-11#1)(2008-3#1)(2011-1#1)(2012-2#1)
weak patterns##2##2##(1995-3#1)(2011-2#1)
weak phase##2##2##(2008-3#2)
weak photorefractive##2##2##(2008-3#2)
weak points of the##2##4##(1995-11#1)(2006-6#1)
weak points of##3##3##(1995-11#1)(2006-6#1)(2008-5#1)
weak points##4##2##(1992-6#1)(1995-11#1)(2006-6#1)(2008-5#1)
weak positive##3##2##(1994-2#1)(2007-10#1)(2009-8#1)
weak pulses##2##2##(1996-1#1)(2012-1#1)
weak reaction##3##2##(1996-6#1)(2008-8#1)(2013-8#1)
weak relationships were found##2##4##(1992-4#1)(2008-7#1)
weak scatterers##2##2##(2008-2#2)
weak signal##7##2##(2007-12#2)(2008-1#1)(2008-10#3)(2008-3#1)
weak signals##2##2##(1991-5#1)(2008-10#1)
weak spectral##2##2##(2008-3#2)
weak staining of##2##3##(1991-7#1)(1996-9#1)
weak statistical##2##2##(2012-1#1)(2012-3#1)
weak stimulus##2##2##(1995-12#1)(1997-1#1)
weak tetanus##2##2##(1995-12#2)
weak to##8##2##(1992-10#1)(1994-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2011-1#1)(2012-2#1)(2013-8#1)
weak training##3##2##(1993-11#1)(1996-9#2)
weak ultrashort##2##2##(2007-12#2)
weak##648##1##(1990-10#3)(1990-11#3)(1990-12#4)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#2)(1990-7#3)(1990-8#4)(1991-11#1)(1991-12#4)(1991-2#5)(1991-3#1)(1991-4#3)(1991-5#5)(1991-6#1)(1991-7#6)(1991-8#4)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#5)(1992-8#3)(1992-9#3)(1993-11#7)(1993-3#7)(1993-4#3)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#2)(1994-11#3)(1994-12#4)(1994-2#3)(1994-3#3)(1994-4#1)(1994-5#5)(1994-6#2)(1994-8#3)(1994-9#5)(1995-1#2)(1995-10#2)(1995-11#2)(1995-12#7)(1995-2#3)(1995-3#3)(1995-4#3)(1995-5#4)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#4)(1996-10#6)(1996-12#2)(1996-2#6)(1996-4#2)(1996-5#5)(1996-6#1)(1996-7#2)(1996-8#6)(1996-9#5)(1997-1#7)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#8)(1997-8#3)(2004-12#2)(2004-9#1)(2005-10#1)(2005-11#12)(2005-4#1)(2005-8#1)(2006-10#7)(2006-12#4)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#4)(2007-10#4)(2007-11#22)(2007-12#36)(2007-2#2)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#11)(2007-9#3)(2008-1#4)(2008-10#82)(2008-11#8)(2008-12#5)(2008-2#19)(2008-3#27)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#9)(2008-8#14)(2008-9#11)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#2)(2010-10#2)(2010-12#2)(2010-2#2)(2010-3#3)(2010-4#4)(2010-5#4)(2010-6#1)(2010-8#5)(2011-1#6)(2011-12#1)(2011-2#9)(2011-3#1)(2012-1#6)(2012-11#1)(2012-12#6)(2012-2#14)(2012-3#6)(2013-1#7)(2013-7#2)(2013-8#10)
weak)##3##1##(1996-2#1)(2008-8#1)(2012-2#1)
weaken the##9##2##(1995-1#1)(2003-11#1)(2005-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-5#1)
weaken##14##1##(1995-1#1)(1995-2#2)(2003-11#1)(2005-1#1)(2006-11#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-5#1)(2013-1#1)
weakened and##2##2##(2005-10#1)(2009-3#1)
weakened by##3##2##(1995-5#1)(2008-1#1)(2008-11#1)
weakened the##3##2##(2006-10#1)(2007-2#1)(2009-12#1)
weakened##29##1##(1991-2#1)(1993-12#1)(1994-11#1)(1995-1#1)(1995-5#1)(1995-9#1)(1996-1#1)(2005-10#1)(2006-10#2)(2007-11#1)(2007-2#1)(2007-7#4)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
weakening of the##7##3##(1996-6#1)(2006-12#1)(2007-7#1)(2008-5#2)(2010-12#1)(2013-1#1)
weakening of##13##2##(1992-8#1)(1996-4#2)(1996-6#1)(2006-10#1)(2006-12#1)(2007-7#1)(2008-5#3)(2008-8#1)(2010-12#1)(2013-1#1)
weakening or##2##2##(1995-12#1)(1996-4#1)
weakening##23##1##(1992-8#1)(1995-12#2)(1996-4#5)(1996-6#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-7#1)(2008-10#2)(2008-5#4)(2008-8#1)(2010-12#1)(2010-5#1)(2013-1#1)
weakens the##3##2##(2007-7#1)(2010-5#1)(2013-1#1)
weakens##7##1##(2007-7#1)(2008-11#1)(2008-4#1)(2010-5#1)(2012-12#1)(2013-1#2)
weaker acids##2##2##(1995-5#2)
weaker and the##2##3##(2005-11#1)(2006-7#1)
weaker and##4##2##(2005-11#1)(2006-7#1)(2008-10#2)
weaker as##3##2##(1995-11#1)(1997-2#1)(2010-2#1)
weaker association with##2##3##(2007-10#1)(2008-8#1)
weaker association##3##2##(1996-5#1)(2007-10#1)(2008-8#1)
weaker binding of##2##3##(1994-8#1)(1996-6#1)
weaker binding##5##2##(1994-8#1)(1995-2#1)(1995-8#1)(1996-4#1)(1996-6#1)
weaker but##3##2##(1993-6#1)(1997-2#1)(2012-2#1)
weaker effects##2##2##(1995-3#1)(1996-1#1)
weaker in##6##2##(1991-12#1)(1992-12#1)(1996-3#1)(2008-8#1)(2008-9#1)(2012-12#1)
weaker ligand##2##2##(1990-7#1)(1995-5#1)
weaker repulsive##2##2##(2005-11#1)(2008-11#1)
weaker than in the##3##4##(1994-9#1)(2008-3#1)(2011-2#1)
weaker than in##4##3##(1994-12#1)(1994-9#1)(2008-3#1)(2011-2#1)
weaker than that of##2##4##(2008-10#1)(2013-1#1)
weaker than that##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
weaker than the##4##3##(1994-2#1)(1995-10#1)(1995-3#1)(1995-8#1)
weaker than those##3##3##(1992-9#1)(1993-3#1)(2008-8#1)
weaker than##22##2##(1992-9#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-6#2)(1994-9#1)(1995-10#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-4#1)(2006-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#2)(2011-2#1)(2013-1#1)
weaker with age##2##3##(2008-7#1)(2009-7#1)
weaker with##3##2##(2008-7#1)(2009-7#1)(2012-2#1)
weaker##138##1##(1990-11#2)(1990-2#1)(1990-7#3)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-12#2)(1992-7#1)(1992-9#2)(1993-11#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-12#3)(1994-2#1)(1994-4#1)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#3)(1995-6#2)(1995-7#1)(1995-8#3)(1996-1#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-2#2)(1997-4#2)(1997-5#1)(1997-7#1)(2005-10#1)(2005-11#5)(2006-12#1)(2006-4#1)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-9#2)(2008-10#6)(2008-11#4)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#6)(2008-9#3)(2009-10#1)(2009-2#1)(2009-4#3)(2009-5#2)(2009-7#2)(2009-8#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#1)
weakest link in##2##3##(2007-12#1)(2009-11#1)
weakest##16##1##(1994-3#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-5#1)(2006-11#2)(2007-12#1)(2008-5#2)(2008-7#1)(2009-11#1)(2010-12#1)(2012-3#2)
weakfish Cynoscion##2##2##(2010-8#2)
weakfish##4##1##(2010-8#2)(2013-7#2)
weakly absorbing particles##2##3##(2008-2#2)
weakly absorbing thin##4##3##(2008-2#2)(2008-3#2)
weakly absorbing##16##2##(2007-11#2)(2007-12#1)(2008-2#8)(2008-3#5)
weakly acidic medium##3##3##(2008-10#3)
weakly acidic##13##2##(1990-8#1)(1997-1#1)(2008-10#10)(2008-3#1)
weakly activated##2##2##(2008-10#2)
weakly active##3##2##(1995-1#1)(1996-8#1)(1997-2#1)
weakly adherent##3##2##(2006-8#2)(2008-11#1)
weakly affected by##2##3##(2008-1#1)(2008-10#1)
weakly affected##3##2##(1996-9#1)(2008-1#1)(2008-10#1)
weakly and strongly absorbing aerosols##3##5##(2008-2#2)(2008-3#1)
weakly and##5##2##(1990-11#1)(2008-2#2)(2008-3#1)(2008-9#1)
weakly associated with##5##3##(1996-2#1)(2007-12#1)(2008-10#1)(2008-8#1)(2013-7#1)
weakly associated##6##2##(1993-6#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-8#1)(2013-7#1)
weakly basic##6##2##(1996-5#1)(2008-10#4)(2010-5#1)
weakly bound##8##2##(1991-5#1)(1994-8#1)(1997-2#1)(2006-10#1)(2007-8#1)(2010-12#1)(2010-7#1)(2011-1#1)
weakly by##2##2##(1994-12#1)(2008-3#1)
weakly charged##2##2##(1996-8#1)(2008-3#1)
weakly confined##2##2##(2007-12#2)
weakly coordinating##2##2##(2008-10#2)
weakly correlated with##2##3##(2008-12#1)(2008-9#1)
weakly correlated##3##2##(1995-2#1)(2008-12#1)(2008-9#1)
weakly dependent on##2##3##(2008-2#1)(2008-3#1)
weakly electric fish##3##3##(1996-5#1)(2010-8#2)
weakly electric gymnotiform##2##3##(1995-5#1)(1996-5#1)
weakly electric##6##2##(1995-5#2)(1996-5#2)(2010-8#2)
weakly expressed in##9##3##(1990-8#1)(1996-10#1)(1997-5#1)(2006-9#1)(2008-9#1)(2009-8#1)(2012-12#2)(2012-2#1)
weakly expressed##13##2##(1990-8#1)(1992-9#1)(1994-8#1)(1996-10#1)(1997-5#1)(1997-7#1)(2006-9#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-12#2)(2012-2#1)
weakly immobilized##2##2##(2008-11#2)
weakly in##5##2##(1990-2#1)(1992-2#1)(1994-11#1)(1997-2#1)(1997-8#1)
weakly inhibited##4##2##(1990-5#1)(1992-3#1)(1997-2#1)(2009-9#1)
weakly interacting##2##2##(1992-6#1)(1995-1#1)
weakly labeled##3##2##(1993-1#2)(1995-10#1)
weakly or not at all##5##5##(1991-9#1)(1992-10#1)(1992-6#1)(1996-8#1)(2008-11#1)
weakly or strongly absorbing##2##4##(2008-2#2)
weakly or##9##2##(1991-9#1)(1992-10#1)(1992-6#1)(1992-7#1)(1994-3#1)(1996-8#1)(2008-11#1)(2008-2#2)
weakly pathogenic to##3##3##(2008-10#3)
weakly pathogenic##5##2##(2008-10#5)
weakly positive##8##2##(1992-3#1)(1993-9#1)(1994-12#1)(1995-2#1)(1996-3#1)(2007-7#1)(2008-3#1)(2010-3#1)
weakly reactive##2##2##(1992-9#1)(1994-12#1)
weakly reinforced##2##2##(1994-2#2)
weakly related to##5##3##(2007-12#1)(2008-10#2)(2008-9#1)(2010-12#1)
weakly responding##3##2##(1993-7#3)
weakly scattering##3##2##(2007-12#2)(2010-4#1)
weakly soluble##3##2##(2008-10#1)(2008-4#2)
weakly stained##2##2##(1992-3#1)(1997-6#1)
weakly than##5##2##(1990-4#1)(1991-5#1)(1993-8#1)(1995-3#1)(1996-5#1)
weakly to vesicles##2##3##(1992-12#2)
weakly to##8##2##(1990-2#1)(1992-12#2)(1993-12#1)(1994-9#1)(1996-6#1)(1997-4#1)(1997-7#1)
weakly virulent isolates##2##3##(2008-10#2)
weakly virulent##4##2##(2008-10#4)
weakly with a##2##3##(1992-11#1)(1992-6#1)
weakly with##8##2##(1991-7#1)(1992-11#1)(1992-6#1)(1995-1#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-8#1)
weakly##263##1##(1990-11#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-4#1)(1991-5#3)(1991-7#2)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#4)(1992-6#3)(1992-7#2)(1992-9#3)(1993-1#2)(1993-11#1)(1993-12#1)(1993-6#1)(1993-7#3)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#3)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#3)(1995-10#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#2)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#7)(1996-6#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#4)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#2)(2005-11#1)(2006-10#3)(2006-4#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#15)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#40)(2008-11#9)(2008-12#1)(2008-2#19)(2008-3#16)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#7)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-7#1)
weakness and limited motion##3##4##(2008-6#3)
weakness and pain##2##3##(1994-5#1)(2008-6#1)
weakness and sensory loss##2##4##(2008-6#1)(2008-7#1)
weakness and sensory##3##3##(2008-12#1)(2008-6#1)(2008-7#1)
weakness and##36##2##(1992-3#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-5#1)(2004-11#1)(2005-12#1)(2005-7#1)(2006-4#2)(2007-10#2)(2007-11#1)(2007-2#1)(2007-7#1)(2008-12#2)(2008-6#5)(2008-7#1)(2009-3#1)(2010-12#1)(2010-8#1)(2011-12#1)(2012-2#7)(2012-3#1)(2013-8#1)
weakness as##3##2##(2008-7#1)(2009-3#1)(2012-2#1)
weakness in all##2##3##(2012-3#1)(2013-8#1)
weakness in both legs##2##4##(2008-12#2)
weakness in the##5##3##(2006-10#1)(2006-3#1)(2006-8#1)(2007-5#1)(2012-3#1)
weakness in##12##2##(2006-10#1)(2006-3#1)(2006-8#1)(2007-5#1)(2008-12#2)(2008-9#1)(2012-2#1)(2012-3#3)(2013-8#1)
weakness is##4##2##(1991-12#1)(1996-9#1)(2006-10#1)(2006-3#1)
weakness of her##2##3##(1991-12#1)(2009-3#1)
weakness of the current##2##4##(1993-6#1)(2007-11#1)
weakness of the left##3##4##(2007-10#1)(2007-12#1)(2009-3#1)
weakness of the right##2##4##(1992-11#1)(2008-12#1)
weakness of the##15##3##(1991-8#1)(1992-11#1)(1993-6#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-1#1)(2009-3#1)(2009-5#1)(2010-9#1)(2012-2#1)
weakness of##28##2##(1991-12#1)(1991-8#1)(1992-11#1)(1993-6#1)(2006-2#1)(2006-3#1)(2007-10#4)(2007-11#1)(2007-12#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-3#2)(2009-5#1)(2010-4#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-2#2)
weakness or##4##2##(1991-8#1)(2008-12#1)(2010-7#2)
weakness that##3##2##(2006-10#1)(2008-5#1)(2008-7#1)
weakness was##4##2##(2006-10#1)(2007-11#1)(2012-12#1)(2012-2#1)
weakness with##4##2##(1994-3#1)(2006-10#1)(2008-7#1)(2009-5#1)
weakness##192##1##(1990-9#1)(1991-12#3)(1991-8#2)(1992-11#1)(1992-3#1)(1992-5#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-9#2)(1997-3#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-10#2)(2005-11#1)(2005-12#2)(2005-7#1)(2006-10#12)(2006-12#1)(2006-2#2)(2006-3#5)(2006-4#5)(2006-8#4)(2007-10#9)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#4)(2008-1#1)(2008-10#1)(2008-12#8)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#9)(2008-7#8)(2008-8#3)(2008-9#1)(2009-1#1)(2009-2#1)(2009-3#7)(2009-5#3)(2009-9#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#4)(2012-12#2)(2012-2#19)(2012-3#8)(2013-7#3)(2013-8#2)
weaknesses and##5##2##(1991-12#1)(1996-2#1)(2007-8#1)(2008-9#1)(2010-2#1)
weaknesses in the##7##3##(1991-4#1)(1992-5#1)(1993-8#1)(2008-9#1)(2010-7#1)(2013-1#2)
weaknesses in##10##2##(1991-4#1)(1992-5#1)(1993-8#1)(2007-9#2)(2008-9#1)(2010-7#1)(2011-1#1)(2013-1#2)
weaknesses of each##3##3##(2011-12#1)(2011-2#1)(2012-2#1)
weaknesses of the##12##3##(1992-12#1)(1994-1#1)(2006-12#1)(2007-1#1)(2007-4#1)(2007-8#4)(2008-2#1)(2010-2#1)(2012-1#1)
weaknesses of these##31##3##(2007-4#1)(2007-8#30)
weaknesses of##63##2##(1991-2#1)(1992-12#2)(1993-5#1)(1994-1#1)(1994-6#1)(1996-3#1)(1997-2#1)(1997-3#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-4#2)(2007-8#34)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-9#1)(2010-2#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#1)
weaknesses were tabulated##26##3##(2007-8#26)
weaknesses##135##1##(1991-12#1)(1991-2#1)(1991-4#1)(1992-12#2)(1992-5#1)(1993-1#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-1#2)(1994-3#1)(1994-6#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-6#1)(2007-1#2)(2007-4#2)(2007-7#1)(2007-8#62)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-4#1)(2009-5#1)(2010-1#1)(2010-2#3)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#1)(2012-2#2)(2013-1#5)
wealth and##7##2##(1993-10#1)(2006-12#1)(2007-3#1)(2008-9#1)(2011-2#3)
wealth are##2##2##(1994-2#1)(2007-8#1)
wealth in##3##2##(2005-11#1)(2010-12#2)
wealth of data##2##3##(2012-12#2)
wealth of information on##2##4##(1996-3#1)(2008-8#1)
wealth of information to##2##4##(2010-11#1)(2011-10#1)
wealth of information##8##3##(1994-3#1)(1996-2#1)(1996-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-11#1)(2011-10#1)
wealth of sequences and annotation data brought about by genomics##2##10##(2009-5#1)(2011-2#1)
wealth of##42##2##(1993-1#1)(1994-3#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-7#2)(2006-10#1)(2007-12#1)(2007-6#1)(2007-8#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#2)(2009-4#1)(2009-5#2)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#1)(2012-12#3)(2012-3#1)
wealth##75##1##(1991-2#2)(1993-1#1)(1993-10#1)(1994-2#1)(1994-3#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-7#2)(2005-11#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#4)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#3)(2009-3#2)(2009-4#1)(2009-5#2)(2010-11#1)(2010-12#5)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#5)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#1)
wealthier nations##2##2##(2009-4#1)(2011-1#1)
wealthier##3##1##(1991-6#1)(2009-4#1)(2011-1#1)
wealthy countries##2##2##(2008-7#1)(2010-12#1)
wealthy families##2##2##(1992-4#1)(2006-7#1)
wealthy##9##1##(1992-4#1)(1994-1#1)(2006-7#1)(2008-11#1)(2008-7#1)(2010-11#1)(2010-12#2)(2012-3#1)
weaned at##3##2##(1993-6#1)(1997-6#1)(2010-4#1)
weaned from the ventilator##2##4##(2009-6#1)(2012-2#1)
weaned from the##3##3##(2007-9#1)(2009-6#1)(2012-2#1)
weaned from##9##2##(1996-9#1)(1997-3#1)(2007-8#1)(2007-9#1)(2009-6#2)(2012-2#3)
weaned lambs##3##2##(1996-12#1)(2008-9#2)
weaned off the ventilator##2##4##(2009-6#1)(2012-2#1)
weaned off the##3##3##(1990-3#1)(2009-6#1)(2012-2#1)
weaned off##5##2##(1990-3#1)(2007-8#2)(2009-6#1)(2012-2#1)
weaned on##3##2##(1991-2#2)(1996-4#1)
weaned pigs##2##2##(1996-12#1)(2006-8#1)
weaned their##2##2##(2008-2#1)(2009-7#1)
weaned##39##1##(1990-3#1)(1991-2#4)(1993-6#1)(1996-12#4)(1996-4#1)(1996-9#1)(1997-3#1)(1997-6#1)(2005-7#1)(2006-8#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-2#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-6#3)(2009-7#3)(2010-4#1)(2012-12#2)(2012-2#4)
weaning and##6##2##(1991-2#1)(2005-11#1)(2008-11#1)(2010-12#1)(2010-4#1)(2013-1#1)
weaning food##2##2##(1997-4#1)(2008-2#1)
weaning from ECMO##2##3##(1997-3#2)
weaning from cardiopulmonary bypass##3##4##(2006-10#2)(2007-8#1)
weaning from mechanical ventilation##2##4##(2007-6#2)
weaning from##10##2##(1997-3#2)(2006-10#3)(2007-6#2)(2007-8#1)(2012-2#2)
weaning of pups to##2##4##(1991-2#2)
weaning of pups##3##3##(1991-2#2)(2008-10#1)
weaning of##5##2##(1991-2#3)(1993-10#1)(2008-10#1)
weaning or##3##2##(1994-6#2)(2008-7#1)
weaning pap##3##2##(1997-4#3)
weaning piglets as##2##3##(2005-11#1)(2006-8#1)
weaning piglets##3##2##(2005-11#2)(2006-8#1)
weaning weight and average daily gain of##2##7##(2012-2#2)
weaning##107##1##(1990-4#1)(1990-5#6)(1991-11#1)(1991-12#1)(1991-2#5)(1992-11#3)(1992-3#1)(1992-9#1)(1993-10#1)(1994-2#2)(1994-6#2)(1994-7#2)(1995-12#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-3#2)(1997-4#10)(1997-6#1)(1997-7#1)(2004-8#1)(2005-11#5)(2005-7#1)(2006-10#5)(2006-2#1)(2006-8#2)(2006-9#1)(2007-5#1)(2007-6#2)(2007-8#6)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#4)(2008-9#1)(2009-7#2)(2010-12#1)(2010-4#4)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#6)(2013-1#7)(2013-8#5)
weaning&quot##2##1##(1994-8#2)
weanling and adult##2##3##(1992-10#2)
weanling and##5##2##(1992-1#1)(1992-10#2)(1994-5#1)(1997-4#1)
weanling rats fed##2##3##(1992-11#1)(1993-6#1)
weanling rats##8##2##(1991-2#1)(1992-10#1)(1992-11#1)(1992-5#1)(1993-6#1)(1995-3#1)(2004-11#1)(2012-1#1)
weanling##19##1##(1990-5#1)(1991-2#1)(1991-5#1)(1992-1#2)(1992-10#4)(1992-11#1)(1992-5#1)(1993-6#1)(1994-5#1)(1995-3#1)(1997-4#2)(2004-11#1)(2012-1#1)(2012-2#1)
weapon against##2##2##(1990-5#1)(1991-10#1)
weapon for##2##2##(1996-2#1)(2007-12#1)
weapon in the##4##3##(1995-2#1)(2008-10#1)(2008-11#1)(2013-8#1)
weapon in##5##2##(1995-2#1)(2007-4#1)(2008-10#1)(2008-11#1)(2013-8#1)
weapon to##2##2##(1995-2#1)(2013-1#1)
weapon##32##1##(1990-5#1)(1991-10#1)(1995-11#1)(1995-2#2)(1996-2#2)(1997-5#1)(2007-12#4)(2007-4#2)(2008-10#2)(2008-11#1)(2009-2#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#4)(2013-8#2)
weaponry##3##1##(2006-12#1)(2008-1#1)(2008-10#1)
weapons and##4##2##(1992-5#1)(2006-7#1)(2007-12#1)(2008-7#1)
weapons in the##2##3##(2011-12#1)(2013-1#1)
weapons is##2##2##(1990-2#1)(2008-10#1)
weapons of mass destruction##2##4##(2004-7#1)(2006-8#1)
weapons to##2##2##(1993-4#1)(2010-6#1)
weapons##40##1##(1990-2#3)(1992-12#4)(1992-4#1)(1992-5#2)(1993-4#1)(1995-1#1)(1996-6#1)(1997-2#1)(2004-7#3)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-8#2)(2007-9#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
wear a##4##2##(2008-12#1)(2008-9#1)(2012-12#1)(2013-8#1)
wear and tear##2##3##(2008-7#1)(2008-9#1)
wear and##13##2##(1993-8#1)(1993-9#1)(1996-6#1)(2004-9#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-7#1)
wear behaviour##2##2##(2009-7#1)(2011-2#1)
wear damage##2##2##(2008-8#2)
wear debris is##3##3##(2004-9#2)(2008-8#1)
wear debris##15##2##(2004-9#9)(2008-8#6)
wear in##5##2##(2005-11#1)(2008-8#2)(2011-2#1)(2012-12#1)
wear metals##5##2##(2008-10#5)
wear of &quot##2##3##(2004-9#2)
wear of the##2##3##(2004-9#1)(2011-1#1)
wear of##7##2##(2004-9#4)(2008-8#1)(2011-1#1)(2011-2#1)
wear on the##2##3##(2007-8#1)(2013-1#1)
wear on##6##2##(2005-11#3)(2007-8#2)(2013-1#1)
wear particles##5##2##(2004-9#2)(2008-11#2)(2008-8#1)
wear properties##2##2##(2008-5#1)(2008-8#1)
wear rate and##2##3##(2004-9#1)(2008-8#1)
wear rate of##4##3##(2004-9#2)(2008-5#1)(2009-3#1)
wear rate was calculated##2##4##(2008-8#2)
wear rate was##3##3##(2008-8#3)
wear rate##12##2##(2004-9#5)(2008-5#1)(2008-8#4)(2009-3#2)
wear regime##2##2##(2005-11#2)
wear resistance of##2##3##(2004-9#1)(2011-2#1)
wear resistance##7##2##(2004-9#3)(2008-12#1)(2008-3#1)(2011-2#2)
wear tests##2##2##(2004-9#1)(2009-4#1)
wear was detected##2##3##(2005-11#1)(2008-8#1)
wear was found for the##2##5##(2011-2#2)
wear was##5##2##(2005-11#1)(2008-8#2)(2011-2#2)
wear with##3##2##(2005-11#1)(2008-8#1)(2013-1#1)
wear zone##4##2##(2009-7#4)
wear##181##1##(1992-4#1)(1993-2#1)(1993-8#2)(1993-9#3)(1996-6#1)(1997-3#1)(1997-7#1)(2004-9#32)(2005-11#26)(2006-12#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#34)(2008-9#3)(2009-10#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#7)(2009-9#1)(2010-1#1)(2010-10#1)(2010-4#2)(2011-1#1)(2011-12#2)(2011-2#7)(2012-12#7)(2012-2#2)(2013-1#6)(2013-8#1)
wearable exoskeletons##2##2##(2012-1#2)
wearable##9##1##(2008-3#1)(2009-11#1)(2010-8#1)(2012-1#4)(2013-1#2)
wearer##4##1##(2005-11#2)(2011-2#2)
wearers of##2##2##(1993-11#1)(2007-4#1)
wearers##14##1##(1993-11#2)(2005-11#1)(2007-4#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-8#2)(2011-1#1)(2011-2#2)(2013-1#1)
wearing a##4##2##(1991-2#1)(2005-10#1)(2007-12#1)(2012-1#1)
wearing the PK##2##3##(2013-1#2)
wearing the##7##2##(2007-3#1)(2007-4#1)(2007-9#1)(2012-1#1)(2013-1#3)
wearing##40##1##(1990-12#1)(1991-2#2)(1992-10#2)(1994-4#1)(2005-10#1)(2005-11#4)(2006-12#2)(2007-1#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#3)(2007-9#3)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#2)(2010-6#1)(2011-1#1)(2011-7#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#5)
wears##4##1##(1995-6#1)(2008-5#1)(2008-6#2)
weasel M##4##2##(2008-6#4)
weasel##8##1##(1994-8#3)(2008-6#5)
weather and##5##2##(1990-8#1)(2008-10#3)(2008-2#1)
weather as a##2##3##(2008-10#2)
weather conditions and##4##3##(2008-10#2)(2010-12#1)(2011-12#1)
weather conditions in##2##3##(1996-3#1)(2008-10#1)
weather conditions to the incidence of##2##6##(1990-8#1)(2008-10#1)
weather conditions##31##2##(1990-8#1)(1995-5#1)(1996-3#1)(2008-1#1)(2008-10#15)(2008-2#1)(2008-3#2)(2008-5#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-12#1)(2011-12#1)(2013-1#2)(2013-8#1)
weather data##9##2##(2008-10#9)
weather forecasting##2##2##(1992-2#1)(2006-11#1)
weather patterns##4##2##(2008-10#3)(2012-3#1)
weather variable and##2##3##(2008-10#2)
weather variable##6##2##(2008-10#6)
weather variables and inoculum##2##4##(2008-10#2)
weather variables and##4##3##(2008-10#4)
weather variables at##2##3##(2008-10#2)
weather variables for##2##3##(2008-10#1)(2012-3#1)
weather variables only##3##3##(2008-10#3)
weather variables prior to the##2##5##(2012-3#2)
weather variables##25##2##(2008-10#21)(2012-3#4)
weather##132##1##(1990-8#2)(1991-1#1)(1992-2#1)(1992-3#2)(1995-5#1)(1996-2#1)(1996-3#1)(2006-11#1)(2006-12#1)(2007-9#1)(2008-1#1)(2008-10#88)(2008-2#3)(2008-3#4)(2008-5#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#7)(2013-1#2)(2013-8#2)
weather-based##3##1##(2008-10#3)
weathered oil in##2##3##(2008-11#2)
weathered oil##4##2##(2008-11#4)
weathered##7##1##(2008-10#3)(2008-11#4)
weathering of##2##2##(2008-10#1)(2008-5#1)
weathering##16##1##(2006-12#2)(2007-2#1)(2008-10#6)(2008-5#1)(2010-4#2)(2010-5#1)(2010-7#1)(2012-11#2)
weave##2##1##(2008-10#2)
weaver##3##1##(1991-6#1)(1996-12#2)
weaving##6##1##(1991-2#1)(1996-12#1)(2004-12#1)(2007-8#1)(2008-12#1)(2008-3#1)
web and##3##2##(2008-4#2)(2008-8#1)
web applications##3##2##(2008-10#1)(2013-1#2)
web based##4##2##(2007-6#1)(2008-11#1)(2013-1#2)
web databases##2##2##(2008-10#1)(2008-7#1)
web inspection##2##2##(2008-2#2)
web interface##4##2##(2007-6#1)(2008-7#1)(2013-1#2)
web is##3##2##(2008-11#1)(2008-9#2)
web of##14##2##(2005-10#1)(2006-10#1)(2006-12#3)(2008-10#2)(2008-11#3)(2008-5#1)(2009-10#1)(2009-8#1)(2013-1#1)
web page##3##2##(2007-5#1)(2009-10#1)(2012-3#1)
web server##5##2##(2007-6#2)(2008-7#1)(2012-2#2)
web service for##3##3##(2008-7#1)(2013-1#2)
web service##4##2##(2008-7#2)(2013-1#2)
web site##10##2##(2005-7#3)(2005-8#1)(2006-12#2)(2006-5#1)(2007-2#1)(2008-11#1)(2008-4#1)
web sites##9##2##(2004-10#4)(2006-3#1)(2007-2#1)(2008-4#1)(2008-7#1)(2011-2#1)
web space##7##2##(2006-3#1)(2008-9#5)(2012-3#1)
web stability##2##2##(2008-9#2)
web structure##2##2##(2008-9#1)(2013-1#1)
web survey##5##2##(2007-10#4)(2010-4#1)
web technologies##2##2##(2007-12#1)(2010-4#1)
web that##2##2##(2006-12#1)(2007-8#1)
web to##2##2##(2006-12#1)(2008-9#1)
web tools##2##2##(2011-2#2)
web##161##1##(1990-5#1)(1996-12#1)(2004-10#4)(2005-10#1)(2005-7#3)(2005-8#1)(2006-10#6)(2006-12#10)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#2)(2007-10#7)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#7)(2008-12#1)(2008-2#3)(2008-4#7)(2008-5#2)(2008-7#17)(2008-8#7)(2008-9#19)(2009-10#2)(2009-2#1)(2009-8#1)(2009-9#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#3)(2012-3#3)(2013-1#16)(2013-7#1)(2013-8#1)
web-accessible##4##1##(2008-7#2)(2013-1#2)
web-based assessment##3##2##(2008-8#3)
web-based clinical##4##2##(2008-10#1)(2013-1#3)
web-based course##2##2##(2010-10#2)
web-based distance learning##2##3##(2010-10#1)(2012-12#1)
web-based distance##3##2##(2010-10#2)(2012-12#1)
web-based learning##2##2##(2008-11#1)(2008-12#1)
web-based survey##2##2##(2012-1#1)(2012-3#1)
web-based training##4##2##(2010-12#2)(2013-1#2)
web-based##53##1##(2006-10#1)(2007-10#2)(2008-10#5)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-9#1)(2010-10#5)(2010-12#5)(2010-4#2)(2010-5#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#1)
webbing##2##1##(1996-6#1)(2007-3#1)
webs and##5##2##(2007-5#1)(2008-8#2)(2008-9#2)
webs##22##1##(1996-12#1)(2004-4#1)(2007-5#1)(2008-8#6)(2008-9#9)(2010-12#1)(2012-12#2)(2012-2#1)
website (http##2##2##(2008-7#1)(2011-2#1)
website approaches##2##2##(2013-1#2)
website for##2##2##(2006-2#1)(2008-9#1)
website messaging##2##2##(2013-1#2)
website was##2##2##(2008-12#1)(2012-2#1)
website##33##1##(1996-6#1)(2005-7#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-7#4)(2008-9#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#7)(2013-7#1)
websites maintained by##2##3##(2013-1#2)
websites of##2##2##(2008-12#1)(2011-2#1)
websites to engage##2##3##(2012-2#1)(2013-1#1)
websites to##3##2##(2012-2#1)(2013-1#2)
websites were##2##2##(2008-12#1)(2011-2#1)
websites##40##1##(2006-10#1)(2006-6#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#3)(2008-7#1)(2008-8#1)(2009-9#2)(2010-8#1)(2011-12#2)(2011-2#9)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#9)(2013-7#1)(2013-8#1)
wedge angle##3##2##(2008-2#3)
wedge angles##2##2##(2008-3#2)
wedge biopsy of##2##3##(1990-11#1)(2012-3#1)
wedge biopsy##3##2##(1990-11#1)(2007-2#1)(2012-3#1)
wedge filters##5##2##(2007-10#5)
wedge in##2##2##(2007-11#1)(2007-8#1)
wedge low tibial osteotomy##2##4##(2011-2#2)
wedge or##2##2##(1990-2#1)(2008-8#1)
wedge osteotomy##3##2##(2006-4#1)(2008-9#1)(2009-9#1)
wedge pressure##6##2##(1991-6#1)(1992-1#1)(2007-9#2)(2008-3#1)(2010-8#1)
wedge prisms##3##2##(2008-3#3)
wedge resection in##2##3##(2007-8#2)
wedge resection of##2##3##(1992-9#1)(2012-12#1)
wedge resection##7##2##(1992-9#1)(2006-10#1)(2007-8#3)(2011-12#1)(2012-12#1)
wedge resections of##3##3##(2011-2#3)
wedge resections##4##2##(2007-8#1)(2011-2#3)
wedge shaped##2##2##(2006-4#1)(2009-9#1)
wedge##84##1##(1990-11#1)(1990-2#1)(1991-6#1)(1992-1#1)(1992-9#1)(1997-6#2)(2006-10#2)(2006-4#3)(2007-1#1)(2007-10#5)(2007-11#3)(2007-12#1)(2007-2#1)(2007-5#2)(2007-8#6)(2007-9#2)(2008-2#8)(2008-3#13)(2008-5#3)(2008-7#2)(2008-8#5)(2008-9#1)(2009-9#2)(2010-2#1)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#6)(2012-12#3)(2012-3#3)(2013-1#1)
wedge-shaped##7##1##(2005-11#1)(2007-11#2)(2007-5#1)(2008-2#1)(2008-3#1)(2013-1#1)
wedged##9##1##(1992-3#1)(1993-10#1)(2007-10#1)(2007-12#4)(2008-2#1)(2008-3#1)
wedges and##2##2##(2007-12#1)(2008-4#1)
wedges##6##1##(2007-12#1)(2008-2#1)(2008-3#3)(2008-4#1)
wedging##9##1##(2006-9#1)(2007-11#1)(2007-8#6)(2008-7#1)
wee1+ gene product is##2##4##(1991-2#2)
wee1+##5##1##(1991-2#4)(1994-12#1)
weed control##6##2##(2008-10#1)(2011-2#5)
weed density##4##2##(2008-12#3)(2011-1#1)
weed habitats##3##2##(2008-10#3)
weed hosts##5##2##(2008-10#4)(2011-2#1)
weed in##3##2##(1993-2#1)(2008-10#2)
weed of##2##2##(2008-10#1)(2008-8#1)
weed species##4##2##(2008-10#3)(2008-12#1)
weed##52##1##(1993-2#1)(2005-11#1)(2006-12#1)(2007-11#1)(2008-10#25)(2008-12#9)(2008-5#1)(2008-7#1)(2008-8#2)(2010-12#2)(2011-1#2)(2011-2#6)
weeds and##3##2##(2008-10#2)(2008-12#1)
weeds in the##3##3##(2008-10#1)(2008-12#2)
weeds in##8##2##(2008-10#4)(2008-11#1)(2008-12#3)
weeds or##2##2##(2008-10#2)
weeds##39##1##(2007-11#1)(2007-2#4)(2007-3#1)(2008-10#18)(2008-11#1)(2008-12#9)(2011-2#1)(2013-8#4)
weeds)##2##1##(2008-10#1)(2008-12#1)
week (95% CI was##2##4##(2008-5#2)
week 1 and from##2##4##(2007-8#2)
week 1 and##3##3##(2007-8#2)(2010-2#1)
week 1##10##2##(2004-3#1)(2007-8#2)(2008-3#1)(2008-4#1)(2008-7#3)(2010-2#1)(2012-12#1)
week 10##4##2##(1993-9#1)(2013-1#3)
week 11##5##2##(2010-2#2)(2013-1#3)
week 12##18##2##(1991-3#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-7#1)(2004-9#1)(2007-11#1)(2008-5#3)(2008-7#1)(2010-5#1)(2013-1#4)(2013-8#2)
week 13##2##2##(1992-11#1)(2008-9#1)
week 16##4##2##(1992-12#1)(2008-4#2)(2012-12#1)
week 17 of##2##3##(2008-3#1)(2012-1#1)
week 17##4##2##(2008-3#1)(2008-7#1)(2008-9#1)(2012-1#1)
week 18##3##2##(1991-9#1)(1992-7#1)(2008-3#1)
week 2##6##2##(1992-3#1)(2004-3#1)(2007-8#2)(2013-1#2)
week 24##5##2##(2008-5#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#1)
week 26##2##2##(2004-3#1)(2008-3#1)
week 3##2##2##(1991-6#1)(2013-1#1)
week 4##7##2##(2008-4#1)(2008-5#2)(2008-7#1)(2011-1#1)(2012-1#1)(2013-1#1)
week 5 of##2##3##(2008-7#1)(2012-1#1)
week 5##9##2##(2006-8#1)(2008-5#1)(2008-7#5)(2011-2#1)(2012-1#1)
week 6 and week##2##4##(1993-9#1)(2010-2#1)
week 6##6##2##(1993-9#1)(2008-7#2)(2010-2#1)(2011-1#1)(2012-12#1)
week 7##2##2##(1992-8#1)(2011-2#1)
week 8##8##2##(1996-7#1)(2004-3#3)(2006-9#1)(2008-7#2)(2008-9#1)
week after birth##6##3##(1990-12#1)(1993-2#1)(1994-2#1)(1995-3#1)(1996-3#1)(1997-6#1)
week after discharge##2##3##(1990-12#1)(2007-10#1)
week after immunization##2##3##(1990-12#1)(2013-1#1)
week after the##17##3##(1992-2#1)(1992-4#1)(1992-7#2)(1993-1#1)(1995-10#1)(1995-3#1)(1996-3#1)(2007-11#2)(2008-11#1)(2008-4#1)(2008-6#1)(2011-1#1)(2011-2#1)(2013-1#2)
week after##69##2##(1990-12#3)(1990-2#1)(1991-2#2)(1991-3#1)(1992-2#2)(1992-4#1)(1992-7#2)(1993-1#1)(1993-2#1)(1993-8#1)(1994-12#2)(1994-2#2)(1995-10#1)(1995-3#2)(1996-10#1)(1996-12#2)(1996-3#2)(1996-5#1)(1996-9#1)(1997-5#2)(1997-6#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-8#1)(2007-10#3)(2007-11#2)(2007-3#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-3#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#4)(2013-8#2)
week and for##2##3##(1994-2#1)(2008-3#1)
week and the##3##3##(2005-11#1)(2007-2#1)(2012-2#1)
week and##36##2##(1990-11#1)(1991-9#2)(1992-4#1)(1992-8#1)(1993-12#1)(1993-7#1)(1994-2#1)(1996-5#1)(2005-11#2)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#1)(2013-8#1)
week at##8##2##(1990-3#1)(1995-6#1)(2007-9#1)(2008-11#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
week before the##2##3##(1991-2#1)(2008-11#1)
week before##12##2##(1991-2#1)(1996-3#1)(1996-9#1)(2007-3#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-12#2)(2010-8#1)(2011-2#1)
week by##4##2##(1997-4#1)(2007-9#1)(2008-5#1)(2011-2#1)
week course of##3##3##(2006-10#1)(2007-6#1)(2012-2#1)
week course##4##2##(2006-10#1)(2007-6#1)(2008-11#1)(2012-2#1)
week during the##3##3##(1992-6#2)(2007-7#1)
week during##8##2##(1990-8#1)(1992-6#2)(2006-10#1)(2007-7#2)(2008-1#1)(2012-12#1)
week following##7##2##(1990-12#1)(1991-2#1)(1995-5#1)(1996-8#1)(2005-12#1)(2008-7#1)(2010-3#1)
week for 13 weeks##3##4##(1990-3#1)(2008-9#2)
week for 14##6##3##(2008-11#1)(2008-9#4)(2009-8#1)
week for 2##3##3##(1997-5#1)(2008-10#2)
week for 27 weeks##3##4##(2008-9#3)
week for 3 weeks##4##4##(2008-5#1)(2008-8#1)(2008-9#2)
week for 3##6##3##(1992-1#1)(1996-9#1)(2008-5#1)(2008-8#1)(2008-9#2)
week for 6 weeks##4##4##(1991-3#1)(2008-10#2)(2009-1#1)
week for 6##6##3##(1991-3#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-1#1)
week for 8 weeks##2##4##(2010-1#1)(2013-1#1)
week for a period of##2##5##(2005-1#1)(2008-8#1)
week for a##4##3##(2005-1#1)(2007-11#1)(2008-8#1)(2010-4#1)
week for six##2##3##(1995-9#1)(2008-12#1)
week for##83##2##(1990-3#2)(1990-4#2)(1991-3#2)(1991-6#1)(1992-1#1)(1994-6#1)(1995-12#1)(1995-9#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-5#1)(2005-1#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-7#3)(2007-9#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#29)(2009-1#1)(2009-8#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
week from the##2##3##(1996-11#1)(2008-12#1)
week from##6##2##(1994-9#1)(1996-11#1)(2008-10#2)(2008-12#1)(2012-2#1)
week groups##2##2##(2010-12#2)
week history of##4##3##(1996-9#1)(2006-4#1)(2008-12#1)(2010-6#1)
week in culture##4##3##(1991-2#1)(2008-11#2)(2008-5#1)
week in##38##2##(1990-11#1)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-2#1)(1992-2#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-2#1)(1993-4#1)(1993-7#1)(1994-2#1)(1994-7#1)(1994-9#1)(1995-3#1)(1995-6#2)(1995-8#1)(1995-9#1)(2005-10#1)(2007-8#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-8#1)(2009-9#1)(2013-1#1)
week interval##5##2##(1994-6#1)(1994-9#1)(2007-12#1)(2008-1#1)(2008-3#1)
week intervals##2##2##(1992-1#1)(1997-3#1)
week later##16##2##(1992-2#1)(1993-3#1)(1993-5#1)(1994-6#1)(1997-8#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#2)(2009-3#1)(2010-12#1)(2012-12#2)(2013-1#1)
week of 12-h##2##3##(2011-2#2)
week of admission##2##3##(2005-12#2)
week of age##5##3##(1992-4#1)(1996-5#1)(2007-11#1)(2008-12#2)
week of each##4##3##(1991-11#1)(1991-2#1)(2005-10#1)(2008-5#1)
week of gestation##13##3##(1990-2#1)(1992-6#1)(1994-6#2)(1996-11#2)(1996-12#1)(2007-2#1)(2011-1#3)(2011-2#1)(2012-12#1)
week of illness##3##3##(1992-2#1)(2007-2#1)(2009-3#1)
week of life##7##3##(1992-7#1)(1996-3#1)(1997-5#1)(2007-11#1)(2007-2#1)(2008-4#1)(2011-2#1)
week of pregnancy and##2##4##(2007-11#1)(2009-6#1)
week of pregnancy##11##3##(1990-9#1)(1991-4#1)(1994-2#1)(1995-6#1)(2004-10#1)(2007-11#1)(2009-6#2)(2009-9#1)(2011-1#1)(2012-3#1)
week of rest##2##3##(2006-6#1)(2012-1#1)
week of storage##2##3##(2004-9#1)(2008-10#1)
week of the##6##3##(2006-6#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-9#1)(2011-1#1)
week of treatment##8##3##(1991-12#1)(1992-3#1)(1994-10#2)(2007-11#1)(2010-5#1)(2010-9#1)(2011-2#1)
week of##105##2##(1990-2#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-2#1)(1994-10#2)(1994-12#2)(1994-2#1)(1994-4#1)(1994-6#3)(1995-6#3)(1995-9#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#2)(1997-5#1)(1997-6#2)(1997-7#1)(2004-10#1)(2004-9#1)(2005-10#1)(2005-12#2)(2006-10#1)(2006-2#1)(2006-6#2)(2007-10#1)(2007-11#7)(2007-2#3)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#3)(2009-9#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-9#2)(2011-1#6)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
week old##14##2##(1991-12#2)(1992-7#1)(1994-6#1)(1995-12#1)(1996-5#2)(1996-9#2)(1997-6#1)(2007-11#1)(2008-7#1)(2011-2#2)
week or##8##2##(1991-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
week period in##2##3##(1996-12#1)(2011-1#1)
week period with##2##3##(1991-8#1)(2007-5#1)
week period##14##2##(1990-5#1)(1991-5#1)(1991-8#1)(1992-6#2)(1996-12#2)(2007-5#1)(2008-12#1)(2008-7#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-1#1)
week post##2##2##(1992-7#1)(2012-1#1)
week postinfection##2##2##(2009-8#2)
week postinoculation##2##2##(2008-10#2)
week prior to##5##3##(1997-2#1)(2007-2#1)(2008-8#1)(2009-2#1)(2010-8#1)
week study##5##2##(1995-12#2)(1996-1#1)(2008-5#2)
week the##5##2##(1991-4#1)(1993-9#1)(1995-4#1)(2004-11#1)(2007-9#1)
week to##6##2##(2007-7#1)(2007-9#1)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#1)
week until##2##2##(1991-12#1)(1996-10#1)
week up to##2##3##(2007-2#1)(2013-1#1)
week was significantly##2##3##(2008-5#1)(2012-12#1)
week was##12##2##(1991-7#1)(2007-6#1)(2007-7#1)(2008-5#2)(2008-6#1)(2011-1#1)(2011-11#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
week were##2##2##(2008-7#1)(2013-1#1)
week when##3##2##(1993-8#1)(1995-3#1)(2008-10#1)
week with the##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
week##949##1##(1990-11#4)(1990-12#4)(1990-2#3)(1990-3#4)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#2)(1991-11#1)(1991-12#6)(1991-2#7)(1991-3#6)(1991-4#3)(1991-5#4)(1991-6#3)(1991-7#2)(1991-8#3)(1991-9#6)(1992-1#6)(1992-10#3)(1992-11#2)(1992-12#3)(1992-2#10)(1992-3#5)(1992-4#4)(1992-5#3)(1992-6#6)(1992-7#10)(1992-8#5)(1992-9#2)(1993-1#2)(1993-10#1)(1993-12#3)(1993-2#5)(1993-3#1)(1993-4#1)(1993-5#3)(1993-6#1)(1993-7#3)(1993-8#2)(1993-9#3)(1994-10#2)(1994-11#1)(1994-12#6)(1994-2#7)(1994-4#2)(1994-6#7)(1994-7#1)(1994-8#1)(1994-9#3)(1995-10#2)(1995-12#6)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#6)(1995-8#1)(1995-9#5)(1996-1#4)(1996-10#5)(1996-11#5)(1996-12#7)(1996-2#1)(1996-3#8)(1996-5#7)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#7)(1997-2#10)(1997-3#3)(1997-4#1)(1997-5#6)(1997-6#7)(1997-7#1)(1997-8#3)(2004-10#1)(2004-11#2)(2004-2#1)(2004-3#6)(2004-9#6)(2005-1#2)(2005-10#4)(2005-11#7)(2005-12#3)(2005-3#1)(2005-6#2)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#9)(2006-11#1)(2006-12#2)(2006-2#3)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#4)(2006-7#5)(2006-8#10)(2006-9#3)(2007-1#1)(2007-10#13)(2007-11#20)(2007-12#4)(2007-2#11)(2007-3#4)(2007-5#4)(2007-6#3)(2007-7#20)(2007-8#22)(2007-9#26)(2008-1#4)(2008-10#38)(2008-11#23)(2008-12#9)(2008-2#1)(2008-3#11)(2008-4#8)(2008-5#35)(2008-6#7)(2008-7#29)(2008-8#11)(2008-9#35)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#4)(2009-6#7)(2009-7#1)(2009-8#4)(2009-9#5)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#14)(2010-2#6)(2010-3#2)(2010-4#7)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#3)(2011-1#21)(2011-11#2)(2011-12#1)(2011-2#29)(2012-1#10)(2012-11#1)(2012-12#21)(2012-2#16)(2012-3#5)(2013-1#45)(2013-7#5)(2013-8#14)
week's issue##2##2##(1991-11#1)(2007-9#1)
week's##6##1##(1991-11#1)(1995-11#1)(2007-9#2)(2010-2#1)(2013-1#1)
week) and##2##2##(1991-9#1)(1994-6#1)
week) for##2##2##(1996-6#1)(2008-7#1)
week)##16##1##(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1994-6#2)(1995-10#1)(1996-6#1)(2004-11#1)(2008-10#2)(2008-5#1)(2008-7#3)(2013-1#1)
week-long##3##1##(2008-11#2)(2011-12#1)
week-old male##2##2##(1990-7#1)(2013-1#1)
week-old rats##2##2##(1991-1#1)(1995-9#1)
week-old##5##1##(1990-7#1)(1991-1#1)(1995-9#2)(2013-1#1)
weekdays and##2##2##(2012-2#1)(2013-1#1)
weekdays##7##1##(2006-8#1)(2010-6#2)(2012-2#3)(2013-1#1)
weekend physical therapy##2##3##(1994-3#2)
weekend##12##1##(1991-12#1)(1993-10#1)(1994-3#6)(1996-5#1)(2010-5#1)(2013-1#1)(2013-7#1)
weekends##10##1##(1995-2#2)(2006-12#2)(2011-1#1)(2012-2#5)
weekly Kt/V urea##5##3##(2011-2#5)
weekly Kt/V##7##2##(2007-8#2)(2011-2#5)
weekly administration of##2##3##(1990-6#1)(2007-11#1)
weekly and##7##2##(1994-7#1)(1996-4#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-7#1)(2012-2#1)
weekly application##3##2##(1990-7#1)(2008-10#1)(2010-11#1)
weekly applications of##3##3##(1992-7#1)(2008-10#2)
weekly applications##4##2##(1992-7#1)(2008-10#3)
weekly at##2##2##(2008-3#1)(2009-9#1)
weekly basis##7##2##(1997-4#2)(2006-2#1)(2008-5#1)(2011-2#1)(2011-9#1)(2012-1#1)
weekly clinic visits##2##3##(2004-3#1)(2012-1#1)
weekly clinic##3##2##(2004-3#1)(2008-11#1)(2012-1#1)
weekly dose of##4##3##(1994-8#1)(2007-7#2)(2008-1#1)
weekly dose##6##2##(1991-6#1)(1994-8#1)(2007-7#3)(2008-1#1)
weekly doses of##3##3##(1994-2#1)(2006-10#1)(2008-10#1)
weekly doses##4##2##(1994-2#1)(2006-10#1)(2008-10#1)(2008-5#1)
weekly dosing##2##2##(2008-3#1)(2008-7#1)
weekly doxorubicin##2##2##(1992-10#2)
weekly during the##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
weekly during##8##2##(2004-4#1)(2006-10#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
weekly for 2 years##2##4##(2007-11#2)
weekly for 2##4##3##(1992-3#1)(1992-6#1)(2007-11#2)
weekly for 3##2##3##(2006-6#1)(2007-7#1)
weekly for 6##3##3##(1992-8#1)(2007-11#1)(2007-2#1)
weekly for 7 weeks##2##4##(2006-6#1)(2008-12#1)
weekly for##29##2##(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#1)(1997-2#1)(2006-10#1)(2006-2#1)(2006-6#2)(2007-11#4)(2007-12#1)(2007-2#2)(2007-7#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-6#1)(2010-12#1)(2011-2#4)(2012-1#1)(2012-3#1)
weekly from##4##2##(1997-3#1)(2008-10#1)(2008-12#1)(2012-6#1)
weekly in##2##2##(2008-5#1)(2008-7#1)
weekly infusions##3##2##(2008-7#1)(2009-1#2)
weekly injections of##2##3##(1992-4#1)(2006-10#1)
weekly intake##2##2##(1992-12#1)(2011-2#1)
weekly intervals##7##2##(1993-7#1)(1994-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)
weekly or##2##2##(2008-7#2)
weekly schedule##2##2##(1993-2#1)(1994-8#1)
weekly sessions##2##2##(1992-1#1)(2012-12#1)
weekly to##6##2##(1992-12#1)(1993-7#1)(1997-3#1)(2008-1#1)(2009-8#1)(2011-2#1)
weekly visits##2##2##(1992-6#2)
weekly with##2##2##(2006-6#1)(2008-5#1)
weekly##241##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#3)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#3)(1992-7#2)(1992-8#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-7#2)(1994-2#2)(1994-4#1)(1994-5#1)(1994-7#2)(1994-8#2)(1995-3#1)(1995-4#1)(1995-9#1)(1996-10#1)(1996-3#1)(1996-4#2)(1997-2#1)(1997-3#3)(1997-4#2)(2004-11#1)(2004-3#1)(2004-4#1)(2005-8#3)(2006-10#10)(2006-2#2)(2006-6#3)(2006-9#1)(2007-1#1)(2007-11#14)(2007-12#4)(2007-2#4)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#25)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#3)(2008-5#9)(2008-6#6)(2008-7#16)(2009-1#2)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-8#1)(2011-1#2)(2011-11#1)(2011-2#21)(2011-9#1)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2012-6#1)(2013-1#8)(2013-8#2)
weeks (0##2##2##(2008-3#2)
weeks (1##2##2##(2008-10#2)
weeks (P&lt##4##2##(2004-2#1)(2009-3#3)
weeks (Regimen##2##2##(1992-8#2)
weeks (equivalent to average daily doses of approximately##8##8##(2008-8#1)(2008-9#7)
weeks (equivalent to##9##3##(2008-8#1)(2008-9#8)
weeks (mean##4##2##(2007-11#2)(2009-8#1)(2012-2#1)
weeks (median##2##2##(1990-6#1)(1993-12#1)
weeks (n=5##2##2##(2007-8#2)
weeks (p =##2##3##(2010-7#1)(2011-2#1)
weeks (p##4##2##(1991-4#1)(2008-3#1)(2010-7#1)(2011-2#1)
weeks (range##10##2##(1991-2#1)(1991-3#1)(1996-12#1)(2007-2#1)(2007-7#1)(2008-4#1)(2008-8#1)(2011-2#2)(2012-2#1)
weeks (six##2##2##(2007-12#1)(2007-2#1)
weeks 2##3##2##(1991-9#1)(2009-12#2)
weeks 3 and 5##2##4##(2006-8#2)
weeks 4 and##2##3##(1994-5#1)(2008-5#1)
weeks 4##4##2##(1994-5#1)(2007-11#1)(2008-5#2)
weeks 6 and##2##3##(2007-7#1)(2011-2#1)
weeks a##2##2##(1992-12#1)(1992-2#1)
weeks after PTCA##2##3##(1992-4#1)(1993-12#1)
weeks after a##3##3##(2007-11#1)(2007-8#1)(2013-1#1)
weeks after admission##3##3##(1991-6#1)(2011-2#1)(2012-2#1)
weeks after application##3##3##(2008-10#2)(2013-7#1)
weeks after being##3##3##(1994-8#1)(2006-10#1)(2012-12#1)
weeks after birth##9##3##(1991-6#1)(1992-8#1)(1995-2#1)(1996-3#1)(1997-6#3)(2007-2#1)(2012-2#1)
weeks after commencement of##2##4##(1990-5#1)(2007-1#1)
weeks after delivery##4##3##(2006-4#1)(2010-8#2)(2013-8#1)
weeks after diagnosis##2##3##(1992-10#1)(2007-11#1)
weeks after discharge##4##3##(1993-12#1)(1994-3#1)(2007-12#1)(2008-1#1)
weeks after exposure to##2##4##(2008-7#1)(2008-8#1)
weeks after exposure##3##3##(1996-8#1)(2008-7#1)(2008-8#1)
weeks after fistula##2##3##(2008-7#1)(2010-4#1)
weeks after fruit set##2##4##(2008-10#2)
weeks after grafting##2##3##(1995-3#1)(2006-9#1)
weeks after harvest##3##3##(2008-10#3)
weeks after immunization with##2##4##(1995-12#1)(2006-8#1)
weeks after implantation##3##3##(2011-2#1)(2012-12#1)(2013-1#1)
weeks after infection##4##3##(1994-2#1)(1997-4#1)(2009-10#1)(2010-7#1)
weeks after initial##2##3##(2008-5#1)(2009-3#1)
weeks after initiation of##4##4##(1992-11#1)(2005-11#1)(2009-7#1)(2013-7#1)
weeks after initiation##6##3##(1990-6#1)(1992-11#1)(1994-6#1)(2005-11#1)(2009-7#1)(2013-7#1)
weeks after injection of##2##4##(1995-5#1)(2006-6#1)
weeks after injection##5##3##(1992-8#1)(1995-5#1)(2006-6#1)(2008-9#1)(2011-1#1)
weeks after injury##6##3##(2007-8#1)(2012-3#5)
weeks after inoculation##17##3##(1992-8#1)(1995-2#1)(2008-10#14)(2010-12#1)
weeks after surgery##23##3##(1990-3#1)(1992-3#2)(1997-2#1)(2007-11#5)(2007-7#4)(2007-8#3)(2009-3#1)(2009-5#1)(2010-12#2)(2010-2#1)(2010-7#1)(2012-1#1)
weeks after termination of##3##4##(1993-12#1)(1996-12#1)(2005-8#1)
weeks after the change##2##4##(1992-1#2)
weeks after the completion of##2##5##(2008-3#1)(2009-8#1)
weeks after the first injection of##2##6##(1997-2#2)
weeks after the first injection##3##5##(1997-2#3)
weeks after the first##6##4##(1992-4#1)(1992-5#1)(1997-2#3)(2008-10#1)
weeks after the initial##4##4##(2007-5#1)(2009-3#1)(2011-1#1)(2012-2#1)
weeks after the injection##3##4##(1996-3#1)(2008-7#1)(2008-9#1)
weeks after the last##3##4##(1996-10#2)(1997-6#1)
weeks after the onset of##3##5##(1994-12#1)(1995-11#1)(2007-10#1)
weeks after the operation##3##4##(1992-10#1)(1994-9#1)(2008-7#1)
weeks after the surgery##2##4##(2009-7#1)(2011-2#1)
weeks after the##60##3##(1990-12#2)(1990-2#1)(1990-5#1)(1991-5#1)(1992-1#2)(1992-10#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-2#1)(1993-5#1)(1993-7#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-2#4)(1997-6#1)(2004-2#1)(2006-8#1)(2007-10#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-7#5)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
weeks after therapy##2##3##(2007-9#1)(2008-7#1)
weeks after tracheal obstruction##2##4##(2013-1#2)
weeks after transplantation##5##3##(2006-4#1)(2010-12#1)(2010-2#2)(2012-12#1)
weeks after treatment##6##3##(1992-12#1)(2006-10#1)(2007-11#1)(2008-10#1)(2010-12#1)(2012-1#1)
weeks after##273##2##(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#4)(1992-10#2)(1992-11#1)(1992-12#1)(1992-3#3)(1992-4#3)(1992-5#1)(1992-7#1)(1992-8#3)(1993-12#3)(1993-2#1)(1993-5#1)(1993-6#1)(1993-7#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#2)(1996-1#1)(1996-10#2)(1996-12#4)(1996-2#1)(1996-3#4)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#6)(1997-3#1)(1997-4#1)(1997-6#4)(2004-2#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-4#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#12)(2007-12#2)(2007-2#2)(2007-5#1)(2007-7#5)(2007-8#7)(2007-9#2)(2008-1#1)(2008-10#38)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#9)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#3)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-12#5)(2010-2#4)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#4)(2012-12#4)(2012-2#4)(2012-3#5)(2013-1#9)(2013-7#3)(2013-8#6)
weeks afterwards##3##2##(1993-7#1)(2007-8#1)(2008-1#1)
weeks aimed at##2##3##(1993-5#1)(2007-9#1)
weeks and 1 year after the##2##6##(1994-3#1)(1996-1#1)
weeks and 1##3##3##(1994-3#1)(1996-1#1)(2004-9#1)
weeks and 20##2##3##(2007-7#1)(2008-10#1)
weeks and 4##2##3##(2006-9#1)(2007-7#1)
weeks and 5##3##3##(1990-3#1)(2013-1#2)
weeks and 6 months##2##4##(1996-5#1)(1997-7#1)
weeks and 6##5##3##(1996-5#1)(1997-7#1)(2012-2#1)(2013-1#2)
weeks and 8 weeks##2##4##(2008-10#1)(2010-12#1)
weeks and a##3##3##(1995-12#1)(2008-10#1)(2008-9#1)
weeks and by##2##3##(2007-8#1)(2008-9#1)
weeks and consisted of##3##4##(2008-5#1)(2008-7#1)(2012-12#1)
weeks and in##6##3##(1991-9#1)(2007-11#1)(2008-9#4)
weeks and months##3##3##(1991-2#1)(1992-4#1)(1993-10#1)
weeks and ten##2##3##(2008-5#1)(2011-1#1)
weeks and that##2##3##(1992-7#1)(1996-12#1)
weeks and the##4##3##(1991-11#1)(2007-2#1)(2008-10#1)(2011-2#1)
weeks and then##7##3##(1991-6#1)(2006-10#1)(2007-8#1)(2008-12#1)(2008-3#1)(2009-3#1)(2010-8#1)
weeks and was##2##3##(1991-8#1)(1995-9#1)
weeks and with##2##3##(2007-10#1)(2012-3#1)
weeks and##112##2##(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#2)(1991-11#3)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-4#1)(1992-5#1)(1992-7#2)(1993-10#1)(1994-3#1)(1995-12#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#2)(1997-7#1)(2004-12#1)(2004-9#1)(2005-8#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#6)(2008-7#2)(2008-9#7)(2009-10#1)(2009-3#1)(2009-5#1)(2010-12#3)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#2)
weeks apart##4##2##(2006-12#1)(2006-8#1)(2008-4#1)(2010-3#1)
weeks are##4##2##(1993-5#1)(1995-11#1)(2005-10#1)(2007-7#1)
weeks as##2##2##(2006-8#1)(2013-1#1)
weeks at 25 degrees C##2##5##(2008-10#1)(2008-8#1)
weeks at 4##2##3##(1995-2#1)(1995-3#1)
weeks at a daily dose of##2##6##(2008-5#1)(2008-6#1)
weeks at a##4##3##(2008-5#1)(2008-6#1)(2012-12#1)(2013-1#1)
weeks at the##3##3##(2008-10#1)(2013-1#2)
weeks at##18##2##(1992-11#1)(1992-6#1)(1995-2#1)(1995-3#1)(1997-3#1)(2006-8#2)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#3)
weeks backward (r = 0##2##5##(2010-12#2)
weeks before Ramadan##2##3##(2006-2#2)
weeks before commercial harvest##2##4##(2008-10#2)
weeks before harvest##2##3##(2008-10#2)
weeks before the##4##3##(1993-8#1)(2007-11#1)(2008-2#1)(2008-7#1)
weeks before##29##2##(1990-12#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-8#1)(1994-10#1)(1996-11#1)(1996-12#1)(2006-2#2)(2007-11#1)(2007-4#1)(2008-10#10)(2008-2#1)(2008-7#1)(2008-8#1)(2013-1#1)(2013-8#1)
weeks between##2##2##(2009-10#1)(2009-6#1)
weeks but##2##2##(1996-6#1)(2011-2#1)
weeks by##6##2##(1992-5#1)(2008-3#1)(2008-7#1)(2009-3#1)(2010-7#1)(2012-1#1)
weeks caused##2##2##(2004-12#1)(2008-8#1)
weeks compared to##2##3##(2006-8#1)(2013-1#1)
weeks compared with the##2##4##(2008-3#1)(2009-10#1)
weeks compared##4##2##(2006-8#1)(2008-3#1)(2009-10#1)(2013-1#1)
weeks did not##2##3##(2007-5#1)(2008-10#1)
weeks duration##2##2##(1993-3#1)(2010-11#1)
weeks during the first##2##4##(1990-6#1)(2007-9#1)
weeks during the##6##3##(1990-6#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-12#1)(2013-1#1)
weeks each##2##2##(1992-12#1)(2008-10#1)
weeks earlier in##2##3##(2008-10#2)
weeks earlier##3##2##(2008-10#2)(2012-12#1)
weeks ex ovo##4##3##(1990-3#4)
weeks exhibited##2##2##(1994-8#1)(2008-4#1)
weeks following surgery##2##3##(2006-9#1)(2011-1#1)
weeks following the##11##3##(1992-12#1)(1993-11#1)(1993-12#1)(2006-8#1)(2007-1#1)(2007-2#1)(2008-7#1)(2009-3#1)(2009-6#1)(2010-4#1)(2012-1#1)
weeks following treatment##3##3##(1995-11#1)(2007-7#1)(2009-6#1)
weeks following##37##2##(1991-11#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-2#3)(1995-11#1)(1995-12#1)(1995-7#1)(1996-8#1)(1997-5#1)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#1)(2007-2#2)(2007-7#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#2)(2009-6#2)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#1)
weeks for Group##2##3##(2006-8#2)
weeks for the##3##3##(2007-7#2)(2012-12#1)
weeks for##17##2##(1991-2#1)(1991-3#1)(1991-7#1)(1992-8#1)(1995-8#1)(1996-3#1)(2004-1#1)(2006-10#1)(2006-8#3)(2007-7#2)(2008-10#1)(2008-9#1)(2010-2#1)(2012-12#1)
weeks from the##3##3##(1991-11#1)(1992-2#1)(2007-1#1)
weeks from##6##2##(1991-11#1)(1992-2#1)(1995-5#1)(2007-1#1)(2009-10#1)(2013-1#1)
weeks full-time##2##2##(1995-12#2)
weeks gestation and was##2##4##(1996-12#1)(2008-7#1)
weeks gestation and##3##3##(1996-12#1)(2006-7#1)(2008-7#1)
weeks gestation were##2##3##(1993-4#1)(2012-2#1)
weeks gestation##15##2##(1991-2#1)(1993-4#1)(1994-12#1)(1996-12#1)(1996-6#2)(2006-7#2)(2007-10#1)(2008-12#1)(2008-7#2)(2009-4#1)(2011-1#1)(2012-2#1)
weeks gestation)##3##2##(1992-2#1)(2007-10#1)(2012-2#1)
weeks gestational age##7##3##(1992-7#2)(2008-1#1)(2008-11#2)(2010-11#1)(2012-12#1)
weeks gestational##8##2##(1992-7#2)(2008-1#1)(2008-11#2)(2010-11#1)(2011-2#1)(2012-12#1)
weeks had a##2##3##(1993-9#1)(2007-7#1)
weeks had##8##2##(1993-9#1)(1994-3#1)(1995-9#1)(2006-10#1)(2007-7#1)(2008-7#1)(2008-9#1)(2011-2#1)
weeks if##2##2##(2007-12#1)(2008-3#1)
weeks in a##5##3##(2005-11#1)(2005-7#1)(2007-11#1)(2008-10#1)(2013-1#1)
weeks in all groups##2##4##(2007-10#1)(2007-7#1)
weeks in culture##3##3##(1996-5#1)(2008-11#2)
weeks in patients with##3##4##(2007-12#1)(2008-10#1)(2008-7#1)
weeks in seven##2##3##(1993-12#1)(1997-6#1)
weeks in the grade III##3##5##(2013-8#3)
weeks in the grade##5##4##(2013-8#5)
weeks in the##18##3##(1990-7#1)(1991-2#1)(1991-9#1)(1992-4#1)(1993-12#1)(1995-1#2)(1995-3#1)(1995-8#1)(1996-3#2)(1997-8#1)(2008-10#1)(2013-8#5)
weeks in their##2##3##(1993-3#1)(2013-1#1)
weeks in treated animals than in controls##2##7##(2011-2#2)
weeks in##78##2##(1990-10#1)(1990-7#1)(1991-2#1)(1991-9#1)(1992-4#1)(1992-7#1)(1992-8#2)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#2)(1994-12#1)(1994-2#1)(1994-6#2)(1995-1#2)(1995-3#1)(1995-8#1)(1996-11#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-6#1)(1997-8#2)(2004-4#1)(2005-11#1)(2005-7#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#1)(2008-10#6)(2008-11#2)(2008-5#3)(2008-7#3)(2008-8#1)(2009-12#1)(2009-6#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#5)
weeks incubation##3##2##(1992-2#3)
weeks is##4##2##(1991-12#1)(2004-3#1)(2006-2#1)(2007-11#1)
weeks later after##3##3##(1993-12#1)(2010-12#1)(2012-2#1)
weeks later with##2##3##(1997-3#1)(2008-10#1)
weeks later##57##2##(1991-10#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-3#2)(1993-12#2)(1994-12#1)(1994-9#1)(1995-9#1)(1996-11#1)(1996-5#2)(1997-3#1)(2005-8#2)(2006-5#1)(2007-2#1)(2007-7#1)(2007-8#5)(2008-10#11)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-3#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2012-8#1)
weeks may have##2##3##(1990-12#1)(1995-6#1)
weeks may##3##2##(1990-12#1)(1995-6#1)(2007-7#1)
weeks of 10##2##3##(1996-1#1)(2013-1#1)
weeks of AMT treatment##2##4##(1993-2#2)
weeks of a##2##3##(1996-3#1)(2012-11#1)
weeks of abstinence##2##3##(1995-1#1)(1995-11#1)
weeks of age and a##2##5##(1996-10#1)(2008-5#1)
weeks of age and##5##4##(1990-4#1)(1996-10#1)(2008-10#1)(2008-5#1)(2009-4#1)
weeks of age compared to##2##5##(1992-7#1)(2008-10#1)
weeks of age the##2##4##(1991-6#1)(1997-5#1)
weeks of age were##4##4##(1995-8#1)(2007-9#1)(2009-8#1)(2012-1#1)
weeks of age##78##3##(1990-11#1)(1990-3#1)(1990-4#3)(1990-5#1)(1991-12#1)(1991-6#3)(1991-9#1)(1992-1#1)(1992-3#2)(1992-7#4)(1993-3#1)(1993-7#1)(1994-4#1)(1994-6#1)(1995-3#1)(1995-8#1)(1996-10#3)(1996-9#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#5)(2005-7#2)(2005-9#1)(2007-8#1)(2007-9#1)(2008-10#10)(2008-5#8)(2008-7#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#1)(2011-2#3)(2012-1#3)(2012-2#4)(2013-1#1)(2013-8#1)
weeks of combined##3##3##(1993-8#1)(2009-6#1)(2011-2#1)
weeks of culture in##2##4##(2008-5#1)(2009-7#1)
weeks of culture##4##3##(1992-8#1)(2008-5#1)(2009-7#1)(2013-1#1)
weeks of exposure to##3##4##(1994-2#2)(1997-3#1)
weeks of follow-up##4##3##(1991-8#1)(1995-2#1)(2009-11#2)
weeks of gestation with##5##4##(2007-7#1)(2012-2#2)(2013-1#2)
weeks of gestation##36##3##(1990-2#1)(1993-5#2)(1994-12#1)(1995-8#1)(1996-12#3)(1996-6#1)(1996-9#1)(1997-3#1)(2007-3#1)(2007-7#2)(2008-11#3)(2009-9#2)(2011-1#2)(2011-2#1)(2012-2#5)(2012-3#3)(2013-1#6)
weeks of gestational##2##3##(2008-11#1)(2008-7#1)
weeks of growth at low light##2##6##(2006-12#2)
weeks of incubation##3##3##(2008-10#2)(2009-3#1)
weeks of life and##2##4##(2008-5#2)
weeks of life with##2##4##(2008-10#1)(2011-1#1)
weeks of life##17##3##(1992-5#1)(1992-7#2)(1993-12#1)(1993-2#1)(1994-2#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#2)(2011-1#2)(2011-2#1)(2013-1#1)
weeks of open-label##2##3##(2004-3#1)(2010-4#1)
weeks of placebo##2##3##(2006-9#1)(2013-1#1)
weeks of pregnancy and##2##4##(1993-12#1)(1995-8#1)
weeks of pregnancy with##2##4##(1993-5#1)(2009-1#1)
weeks of pregnancy##9##3##(1993-12#1)(1993-5#1)(1994-3#2)(1995-6#1)(1995-8#1)(2006-8#1)(2008-7#1)(2009-1#1)
weeks of storage##2##3##(2008-10#2)
weeks of the experiment##2##4##(2004-11#1)(2008-7#1)
weeks of the onset of##2##5##(1993-7#1)(2008-7#1)
weeks of the study##3##4##(2004-3#1)(2008-9#2)
weeks of the##16##3##(1993-12#1)(1993-7#2)(1994-6#1)(1996-2#1)(1997-3#1)(2004-11#1)(2004-3#1)(2007-8#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-6#1)
weeks of their##4##3##(1991-10#1)(1994-12#1)(1995-1#1)(2010-3#1)
weeks of therapy in##3##4##(1991-4#1)(2007-9#1)(2008-10#1)
weeks of therapy with##2##4##(1997-2#1)(2013-1#1)
weeks of therapy##18##3##(1991-12#1)(1991-4#1)(1992-6#1)(1997-2#1)(2004-3#1)(2005-7#1)(2006-9#1)(2007-11#1)(2007-7#3)(2007-9#2)(2008-10#1)(2008-7#2)(2009-8#1)(2013-1#1)
weeks of treatment and##2##4##(1997-3#1)(2004-4#1)
weeks of treatment was##2##4##(2008-6#1)(2008-7#1)
weeks of treatment with a##2##5##(1990-11#1)(2013-1#1)
weeks of treatment with##13##4##(1990-10#1)(1990-11#1)(1991-7#2)(1992-11#1)(1996-4#1)(2004-3#1)(2006-10#1)(2007-7#1)(2010-5#2)(2010-9#1)(2013-1#1)
weeks of treatment##50##3##(1990-10#1)(1990-11#1)(1991-11#1)(1991-6#1)(1991-7#2)(1992-11#1)(1993-3#1)(1994-6#1)(1996-2#1)(1996-4#5)(1996-5#2)(1997-3#1)(1997-8#1)(2004-3#1)(2004-4#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#3)(2010-5#2)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#1)(2013-1#2)
weeks of##379##2##(1990-10#1)(1990-11#3)(1990-2#1)(1990-3#1)(1990-4#4)(1990-5#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-6#4)(1991-7#4)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#3)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#6)(1992-8#2)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#3)(1993-5#3)(1993-7#3)(1993-8#1)(1993-9#1)(1994-12#3)(1994-2#5)(1994-3#2)(1994-4#1)(1994-6#3)(1994-8#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#3)(1996-1#2)(1996-10#3)(1996-12#5)(1996-2#2)(1996-3#1)(1996-4#6)(1996-5#3)(1996-6#1)(1996-9#2)(1997-2#1)(1997-3#6)(1997-4#2)(1997-5#1)(1997-6#5)(1997-8#3)(2004-11#1)(2004-3#5)(2004-4#1)(2005-12#1)(2005-7#3)(2005-9#1)(2006-10#5)(2006-12#3)(2006-2#1)(2006-4#2)(2006-6#2)(2006-8#2)(2006-9#2)(2007-10#2)(2007-11#4)(2007-12#2)(2007-2#3)(2007-3#3)(2007-5#1)(2007-7#9)(2007-8#5)(2007-9#6)(2008-1#1)(2008-10#23)(2008-11#5)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#24)(2008-6#2)(2008-7#15)(2008-8#2)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#4)(2009-3#6)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#13)(2012-1#5)(2012-11#1)(2012-12#2)(2012-2#16)(2012-3#3)(2013-1#19)(2013-7#2)(2013-8#2)
weeks old male##2##3##(2011-2#1)(2013-1#1)
weeks old showed##2##3##(1992-7#1)(2008-5#1)
weeks old##15##2##(1992-7#2)(1992-9#1)(1996-12#1)(1997-5#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
weeks old)##3##2##(2008-10#2)(2008-6#1)
weeks on a##2##3##(1996-5#1)(2010-12#1)
weeks on##14##2##(1991-7#1)(1995-12#1)(1996-5#1)(1996-6#1)(1997-4#1)(2004-9#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-5#1)(2009-1#1)(2010-12#1)(2013-1#1)
weeks one##2##2##(1996-6#1)(2008-10#1)
weeks or by##2##3##(2008-9#2)
weeks or more after##2##4##(2006-2#1)(2007-12#1)
weeks or more##5##3##(2006-2#1)(2007-12#1)(2008-10#1)(2008-9#1)(2011-1#1)
weeks or##19##2##(1995-12#1)(1997-6#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#6)(2009-12#1)(2011-1#1)
weeks orally for##2##3##(2007-8#2)
weeks over##2##2##(1992-2#1)(2007-7#1)
weeks period##5##2##(1990-5#1)(2007-2#1)(2007-8#1)(2008-5#2)
weeks post discharge using##2##4##(2007-11#2)
weeks post discharge##3##3##(2007-11#3)
weeks post injection##3##3##(1992-7#1)(2007-11#2)
weeks post operatively##2##3##(2007-7#1)(2007-8#1)
weeks post partum##2##3##(1993-10#1)(2005-7#1)
weeks post##20##2##(1992-7#1)(1993-10#1)(1996-8#1)(2005-7#1)(2007-1#2)(2007-10#1)(2007-11#7)(2007-7#1)(2007-8#2)(2008-10#1)(2010-12#1)(2012-2#1)
weeks post-capture##3##2##(2008-5#3)
weeks post-crush##2##2##(1990-2#2)
weeks post-immunization were##2##3##(2009-5#2)
weeks post-immunization##4##2##(2009-5#4)
weeks post-implantation##3##2##(2008-5#2)(2013-1#1)
weeks post-infection##2##2##(2008-12#1)(2008-5#1)
weeks post-injury##3##2##(2011-2#2)(2012-12#1)
weeks post-treatment##3##2##(2007-11#1)(2012-12#2)
weeks postbloom##8##2##(2008-10#8)
weeks postinoculation##6##2##(2008-10#4)(2010-10#2)
weeks postoperatively and##2##3##(1991-12#1)(2009-3#1)
weeks postoperatively##12##2##(1991-12#1)(1992-2#1)(1994-3#1)(2006-11#1)(2007-11#1)(2008-10#1)(2009-3#1)(2009-5#1)(2010-4#1)(2012-12#2)(2012-3#1)
weeks postpartum##8##2##(2004-3#2)(2006-10#1)(2007-10#1)(2012-2#2)(2013-8#2)
weeks postsurgery##2##2##(1991-3#1)(1992-12#1)
weeks pregnant##2##2##(1992-1#2)
weeks prior to presentation##2##4##(2009-3#1)(2012-11#1)
weeks prior to testing produced##2##5##(1993-7#1)(1994-2#1)
weeks prior to the##2##4##(1994-8#1)(2008-10#1)
weeks prior to##8##3##(1993-7#1)(1994-2#1)(1994-8#1)(1996-7#1)(2008-10#2)(2009-3#1)(2012-11#1)
weeks provided##3##2##(1991-6#1)(2008-5#2)
weeks respectively##5##2##(2007-1#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-9#1)
weeks resulted in##2##3##(2008-10#2)
weeks revealed##2##2##(2007-7#1)(2008-5#1)
weeks shorter##3##2##(2008-10#3)
weeks showed a##2##3##(2006-2#1)(2008-10#1)
weeks showed##3##2##(1996-4#1)(2006-2#1)(2008-10#1)
weeks significantly reduced##2##3##(2008-4#1)(2009-5#1)
weeks storage##2##2##(2004-9#1)(2008-5#1)
weeks that##3##2##(2005-10#1)(2008-5#1)(2008-9#1)
weeks the results were##2##4##(2007-7#1)(2008-5#1)
weeks the##14##2##(1991-3#1)(1992-6#1)(1993-4#2)(1995-5#1)(1995-8#1)(1996-4#1)(1996-5#1)(2004-11#1)(2004-9#1)(2006-9#1)(2007-7#1)(2008-5#1)(2009-4#1)
weeks there##2##2##(1996-8#1)(2009-5#1)
weeks thereafter##3##2##(2008-1#1)(2010-7#1)(2011-2#1)
weeks through the##2##3##(2008-10#1)(2009-12#1)
weeks to 2##3##3##(1992-7#1)(2008-10#1)(2008-8#1)
weeks to 4##3##3##(2007-11#1)(2007-7#1)(2008-2#1)
weeks to a##2##3##(1994-5#1)(2008-7#1)
weeks to months##2##3##(1993-2#1)(2006-11#1)
weeks to several months##3##4##(1991-8#1)(1995-2#1)(2006-10#1)
weeks to several##4##3##(1990-3#1)(1991-8#1)(1995-2#1)(2006-10#1)
weeks to##43##2##(1990-3#1)(1990-5#1)(1991-3#1)(1991-8#1)(1992-7#2)(1993-2#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-9#1)(1996-11#1)(1996-4#1)(2004-10#1)(2005-12#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-5#4)(2008-7#3)(2008-8#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-2#1)(2011-12#1)(2011-2#3)(2012-2#2)
weeks treatment with##2##3##(1996-1#1)(2008-2#1)
weeks treatment##9##2##(1991-2#1)(1996-1#1)(2007-5#1)(2007-7#4)(2008-2#1)(2011-2#1)
weeks under##3##2##(2008-10#2)(2012-12#1)
weeks until##2##2##(1990-6#1)(1996-7#1)
weeks using Fast Optical##2##4##(2008-5#2)
weeks using##3##2##(2008-5#2)(2012-1#1)
weeks was##16##2##(1991-8#1)(1992-10#1)(1994-5#1)(2006-7#1)(2007-11#3)(2007-6#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2013-1#2)
weeks were considered##2##3##(2008-9#1)(2013-1#1)
weeks were examined##2##3##(1991-8#1)(1993-5#1)
weeks were studied##2##3##(1996-12#1)(2008-8#1)
weeks were used##2##3##(1996-2#1)(2007-10#1)
weeks were##21##2##(1991-12#1)(1991-8#1)(1993-5#1)(1994-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
weeks when##2##2##(2007-11#1)(2008-10#1)
weeks while##2##2##(1991-2#1)(2009-5#1)
weeks with the##2##3##(1990-9#1)(2006-8#1)
weeks with##20##2##(1990-9#1)(1991-2#1)(1991-6#1)(1993-9#1)(1994-2#1)(1995-12#1)(2006-8#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#3)(2010-3#1)(2013-1#1)(2013-8#1)
weeks without any##3##3##(1994-2#1)(2008-10#2)
weeks without##6##2##(1994-2#2)(1995-2#1)(2008-10#3)
weeks##2555##1##(1990-10#7)(1990-11#9)(1990-12#10)(1990-2#5)(1990-3#12)(1990-4#11)(1990-5#10)(1990-6#7)(1990-7#3)(1990-8#4)(1990-9#5)(1991-1#1)(1991-10#3)(1991-11#8)(1991-12#9)(1991-2#20)(1991-3#12)(1991-4#8)(1991-5#3)(1991-6#21)(1991-7#7)(1991-8#13)(1991-9#12)(1992-1#13)(1992-10#8)(1992-11#6)(1992-12#7)(1992-2#11)(1992-3#11)(1992-4#8)(1992-5#10)(1992-6#3)(1992-7#31)(1992-8#15)(1992-9#6)(1993-1#1)(1993-10#2)(1993-11#7)(1993-12#20)(1993-2#9)(1993-3#7)(1993-4#4)(1993-5#8)(1993-6#5)(1993-7#13)(1993-8#4)(1993-9#4)(1994-10#2)(1994-11#2)(1994-12#11)(1994-2#16)(1994-3#10)(1994-4#2)(1994-5#7)(1994-6#15)(1994-7#1)(1994-8#6)(1994-9#4)(1995-1#4)(1995-10#1)(1995-11#7)(1995-12#13)(1995-2#8)(1995-3#8)(1995-4#1)(1995-5#5)(1995-6#10)(1995-7#1)(1995-8#13)(1995-9#6)(1996-1#6)(1996-10#8)(1996-11#8)(1996-12#20)(1996-2#5)(1996-3#11)(1996-4#10)(1996-5#13)(1996-6#11)(1996-7#3)(1996-8#6)(1996-9#6)(1997-1#3)(1997-2#8)(1997-3#13)(1997-4#4)(1997-5#7)(1997-6#16)(1997-7#5)(1997-8#9)(2004-1#4)(2004-10#3)(2004-11#10)(2004-12#3)(2004-2#2)(2004-3#10)(2004-4#4)(2004-9#13)(2005-1#1)(2005-10#6)(2005-11#6)(2005-12#3)(2005-3#1)(2005-7#7)(2005-8#5)(2005-9#2)(2006-10#23)(2006-11#3)(2006-12#15)(2006-2#13)(2006-3#3)(2006-4#9)(2006-5#1)(2006-6#10)(2006-7#13)(2006-8#31)(2006-9#13)(2007-1#13)(2007-10#20)(2007-11#70)(2007-12#15)(2007-2#16)(2007-3#8)(2007-4#1)(2007-5#7)(2007-6#10)(2007-7#67)(2007-8#47)(2007-9#16)(2008-1#15)(2008-10#227)(2008-11#33)(2008-12#10)(2008-2#7)(2008-3#28)(2008-4#19)(2008-5#116)(2008-6#25)(2008-7#68)(2008-8#23)(2008-9#140)(2009-1#3)(2009-10#10)(2009-11#8)(2009-12#8)(2009-2#1)(2009-3#23)(2009-4#5)(2009-5#22)(2009-6#11)(2009-7#5)(2009-8#9)(2009-9#6)(2010-1#2)(2010-10#3)(2010-11#5)(2010-12#29)(2010-2#16)(2010-3#9)(2010-4#10)(2010-5#5)(2010-6#3)(2010-7#7)(2010-8#9)(2010-9#4)(2011-1#30)(2011-12#3)(2011-2#69)(2011-3#1)(2012-1#26)(2012-11#6)(2012-12#39)(2012-2#65)(2012-3#22)(2012-8#1)(2013-1#93)(2013-7#8)(2013-8#26)
weeks' duration##2##2##(2006-2#1)(2006-8#1)
weeks' gestation and##4##3##(1993-12#1)(1994-4#1)(2004-10#1)(2007-12#1)
weeks' gestation in##2##3##(1990-9#1)(1995-8#1)
weeks' gestation is##3##3##(1994-4#1)(1995-8#1)(2011-2#1)
weeks' gestation##39##2##(1990-6#1)(1990-9#4)(1992-1#1)(1992-2#1)(1993-12#2)(1993-3#1)(1994-4#8)(1995-8#3)(1996-12#1)(1996-5#1)(2004-10#4)(2006-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-11#2)(2008-7#1)(2011-2#2)(2012-8#1)
weeks' gestation)##3##2##(1990-6#1)(2008-11#2)
weeks'##54##1##(1990-6#2)(1990-8#1)(1990-9#4)(1991-9#1)(1992-1#1)(1992-2#2)(1993-11#1)(1993-12#2)(1993-3#1)(1994-4#9)(1995-8#3)(1996-12#1)(1996-5#1)(2004-10#4)(2006-1#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-11#4)(2008-7#1)(2011-12#1)(2011-2#2)(2012-8#1)(2013-1#4)
weeks) administration of##2##3##(1992-10#1)(2007-11#1)
weeks) and old##2##3##(1990-3#1)(2010-7#1)
weeks) and##14##2##(1990-3#2)(1990-7#1)(1990-9#1)(1991-4#1)(1994-3#1)(1994-6#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-4#1)(2009-8#1)(2010-7#1)(2011-2#1)
weeks) as well as##3##4##(1996-7#1)(2007-10#1)(2012-2#1)
weeks) for##2##2##(2007-3#1)(2011-2#1)
weeks) has been##2##3##(1994-6#1)(2011-2#1)
weeks) in the##2##3##(1994-4#1)(2008-8#1)
weeks) in##5##2##(1992-12#1)(1994-4#1)(2008-10#1)(2008-8#1)(2011-2#1)
weeks) male##2##2##(1990-3#1)(2010-7#1)
weeks) was##2##2##(2010-2#1)(2013-1#1)
weeks) were##2##2##(2004-10#1)(2009-10#1)
weeks) with##3##2##(2004-1#1)(2011-2#1)(2013-1#1)
weeks)##118##1##(1990-3#3)(1990-4#2)(1990-6#2)(1990-7#1)(1990-9#1)(1991-4#2)(1992-10#1)(1992-12#3)(1992-2#3)(1992-3#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-4#1)(1994-3#1)(1994-4#1)(1994-6#2)(1995-2#2)(1995-5#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(2004-1#1)(2004-10#1)(2005-10#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#8)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-3#2)(2008-4#2)(2008-5#6)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#3)(2009-8#3)(2010-2#1)(2010-4#1)(2010-7#2)(2011-2#13)(2012-11#1)(2012-2#6)(2012-3#1)(2013-1#2)
week 12##2##1##(2011-12#2)
week 2##2##1##(2011-12#2)
week 4##2##1##(2011-12#2)
weevil and##2##2##(2011-12#1)(2012-2#1)
weevil densities##3##2##(2011-12#3)
weevil##16##1##(2008-10#3)(2011-10#2)(2011-12#6)(2011-2#3)(2012-2#1)(2013-8#1)
weevils (Coleoptera##3##2##(2008-5#2)(2008-7#1)
weevils##8##1##(2008-5#3)(2008-7#1)(2011-2#4)
weft##2##1##(2008-12#1)(2011-12#1)
weigh less##2##2##(2007-2#1)(2013-1#1)
weigh the##3##2##(2008-10#1)(2009-2#1)(2012-2#1)
weigh##17##1##(1991-9#1)(1994-2#1)(1995-3#1)(2006-10#2)(2007-2#1)(2007-9#2)(2008-10#2)(2008-9#1)(2009-2#1)(2009-3#1)(2012-12#1)(2012-2#2)(2013-1#1)
weighed against the benefits of##3##5##(1992-8#1)(2010-8#1)(2013-1#1)
weighed against the benefits##4##4##(1992-8#1)(2006-10#1)(2010-8#1)(2013-1#1)
weighed against the##9##3##(1992-8#1)(1994-6#1)(1995-9#1)(2006-10#2)(2007-11#1)(2010-8#1)(2011-1#1)(2013-1#1)
weighed against this##2##3##(2008-11#1)(2009-5#1)
weighed against##14##2##(1992-8#1)(1994-6#1)(1995-9#1)(2006-10#2)(2006-9#2)(2007-11#1)(2008-11#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-1#1)(2013-1#1)
weighed and sacrificed##2##3##(2007-9#1)(2010-4#1)
weighed and##8##2##(1993-3#1)(2007-1#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-4#1)(2010-4#1)
weighed in the##2##3##(2008-10#2)
weighed in##5##2##(1991-3#1)(2007-3#1)(2008-10#3)
weighed less than##4##3##(1990-9#1)(1994-1#1)(2006-2#1)(2011-1#1)
weighed less##5##2##(1990-9#1)(1994-1#1)(2006-2#1)(2011-1#1)(2012-2#1)
weighed more##2##2##(2008-5#1)(2011-1#1)
weighed significantly less##2##3##(2006-6#1)(2006-9#1)
weighed up##2##2##(2008-4#2)
weighed##67##1##(1990-11#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-3#1)(1992-8#1)(1993-3#2)(1994-1#1)(1994-6#1)(1995-2#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-6#1)(1997-8#1)(2006-10#2)(2006-2#1)(2006-6#1)(2006-9#3)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-5#1)(2007-9#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#3)(2008-6#2)(2009-4#2)(2009-5#2)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
weighing &lt##2##2##(1993-7#1)(1994-3#1)
weighing 1##3##2##(2007-7#1)(2008-4#1)(2008-9#1)
weighing 200-250##2##2##(2008-10#1)(2011-12#1)
weighing and##3##2##(1991-10#1)(1995-1#1)(2008-10#1)
weighing less than 1500 g##3##5##(2008-11#2)(2008-12#1)
weighing less than##5##3##(2006-10#1)(2008-11#2)(2008-12#1)(2012-2#1)
weighing of##3##2##(2008-10#2)(2008-7#1)
weighing the##6##2##(1994-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-2#1)(2010-2#1)
weighing##70##1##(1991-10#2)(1991-6#2)(1991-7#1)(1993-12#1)(1993-7#2)(1994-3#2)(1995-1#1)(1997-2#1)(1997-4#1)(2004-9#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-7#1)(2008-10#9)(2008-11#3)(2008-12#4)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#4)(2009-6#1)(2010-2#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#4)(2013-1#4)(2013-8#1)
weighs in##2##2##(2008-6#1)(2008-7#1)
weighs the##2##2##(2011-2#1)(2013-1#1)
weighs##7##1##(1994-5#1)(1995-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
weight (&lt##4##2##(1993-5#1)(1993-8#1)(2007-11#1)(2010-2#1)
weight (0##3##2##(2008-10#2)(2011-1#1)
weight (1##2##2##(2008-12#1)(2008-3#1)
weight (BW)##7##2##(2008-10#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#3)
weight (MW)##6##2##(1992-8#1)(2005-11#1)(2006-8#1)(2008-10#2)(2008-3#1)
weight (P &lt##3##3##(2007-8#1)(2010-2#1)(2011-2#1)
weight (less than##3##3##(1991-3#1)(1993-6#1)(2008-11#1)
weight (r = 0##2##4##(2008-8#1)(2013-1#1)
weight (r=0##2##2##(2011-1#1)(2011-11#1)
weight (β = 0##2##4##(2011-2#2)
weight 10##2##2##(1993-3#1)(2009-4#1)
weight 4##2##2##(1993-7#1)(2008-10#1)
weight 53##2##2##(2006-11#1)(2008-12#1)
weight DNA##4##2##(1995-2#1)(1996-6#1)(2008-2#1)(2008-5#1)
weight after 48 h##2##4##(2008-7#1)(2009-4#1)
weight after the##2##3##(2010-4#1)(2012-1#1)
weight after##6##2##(2008-11#1)(2008-7#1)(2009-4#2)(2010-4#1)(2012-1#1)
weight among##2##2##(2008-11#1)(2013-1#1)
weight and BMI##6##3##(2007-8#2)(2011-2#2)(2012-1#1)(2012-3#1)
weight and age##3##3##(2008-3#1)(2008-5#1)(2009-5#1)
weight and at##3##3##(2007-3#1)(2009-4#1)(2011-2#1)
weight and average daily gain of suckling kids##2##8##(2012-2#2)
weight and average daily gain of##3##6##(2012-2#3)
weight and body composition##3##4##(2006-9#1)(2012-1#1)(2012-2#1)
weight and body mass index (BMI)##2##6##(2007-9#1)(2011-2#1)
weight and body mass index##5##5##(2007-9#1)(2008-6#1)(2008-7#1)(2009-5#1)(2011-2#1)
weight and body weight gain##3##5##(2008-7#1)(2008-9#2)
weight and body##14##3##(1996-8#1)(2006-9#1)(2007-12#2)(2007-9#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
weight and cellularity##2##3##(1992-12#1)(1996-10#1)
weight and composition##2##3##(1995-11#1)(2006-9#1)
weight and eating##3##3##(2007-12#2)(2013-7#1)
weight and feed conversion ratio##2##5##(2008-12#2)
weight and feed##4##3##(1997-3#1)(2008-12#2)(2008-5#1)
weight and height of##4##4##(2006-1#1)(2006-10#1)(2011-1#1)(2012-2#1)
weight and height##11##3##(1991-7#1)(2006-1#1)(2006-10#1)(2007-1#1)(2007-12#1)(2009-2#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#1)
weight and increase muscles##2##4##(2007-12#2)
weight and increasing##2##3##(2005-11#1)(2007-12#1)
weight and length##2##3##(1994-7#1)(2012-3#1)
weight and lower body##3##4##(2004-11#1)(2007-12#1)(2012-2#1)
weight and mandible weight##2##4##(2008-7#2)
weight and metabolism##2##3##(2008-3#2)
weight and protein##2##3##(1994-11#1)(2012-11#1)
weight and shape##3##3##(2007-12#2)(2007-7#1)
weight and the##11##3##(1990-12#1)(1993-4#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-5#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-8#1)
weight and volume of##2##4##(1990-11#1)(1996-5#1)
weight and volume##4##3##(1990-11#1)(1996-5#1)(2008-3#1)(2011-2#1)
weight and##236##2##(1990-11#2)(1990-12#1)(1990-6#1)(1990-9#3)(1991-10#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-7#2)(1992-10#2)(1992-11#1)(1992-12#2)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-10#2)(1996-2#1)(1996-5#1)(1996-8#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#1)(2004-11#1)(2004-12#1)(2005-10#1)(2005-11#1)(2006-1#2)(2006-10#2)(2006-2#1)(2006-3#1)(2006-7#1)(2006-8#3)(2006-9#4)(2007-1#2)(2007-11#3)(2007-12#19)(2007-3#2)(2007-7#1)(2007-8#5)(2007-9#2)(2008-10#8)(2008-11#4)(2008-12#9)(2008-2#1)(2008-3#8)(2008-4#3)(2008-5#11)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#4)(2009-9#1)(2010-12#2)(2010-2#3)(2010-4#7)(2011-1#2)(2011-12#2)(2011-2#16)(2011-3#1)(2012-1#8)(2012-11#1)(2012-2#13)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#4)
weight and/or##2##2##(2008-8#1)(2013-1#1)
weight approximately##3##2##(1993-3#1)(2005-8#1)(2007-1#1)
weight are##9##2##(1990-12#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-7#1)(2008-10#1)(2008-5#1)(2011-1#1)(2013-1#1)
weight as compared##2##3##(1990-5#1)(2008-12#1)
weight as well as##6##4##(1990-9#1)(1993-6#1)(1997-7#1)(2006-10#1)(2007-9#1)(2008-10#1)
weight as##16##2##(1990-5#1)(1990-9#1)(1992-3#1)(1992-6#1)(1993-6#1)(1994-9#1)(1997-7#1)(2006-10#1)(2006-3#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-5#1)(2013-8#1)
weight associated with##2##3##(2008-5#1)(2008-7#1)
weight at birth##6##3##(1994-2#1)(1996-12#1)(1997-5#1)(2006-10#1)(2007-11#2)
weight at the##3##3##(1995-11#1)(2006-8#1)(2011-2#1)
weight at##22##2##(1991-11#1)(1993-7#1)(1994-10#1)(1994-2#1)(1995-11#1)(1996-12#1)(1997-5#1)(2004-3#1)(2006-10#1)(2006-7#2)(2006-8#1)(2007-11#2)(2007-8#1)(2008-3#1)(2008-7#1)(2010-2#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-7#1)
weight basis##7##2##(1990-2#1)(1991-9#1)(1992-4#1)(2004-2#1)(2007-7#1)(2008-10#1)(2008-7#1)
weight bearing after##2##3##(2009-3#1)(2012-2#1)
weight bearing and##2##3##(2007-11#1)(2007-8#1)
weight bearing lift##4##3##(2012-1#4)
weight bearing on##2##3##(2007-7#1)(2007-8#1)
weight bearing was##2##3##(2008-6#1)(2011-2#1)
weight bearing##29##2##(2006-10#1)(2006-12#3)(2007-11#4)(2007-7#2)(2007-8#2)(2008-1#1)(2008-6#1)(2008-9#1)(2009-3#5)(2010-3#1)(2011-2#2)(2012-1#4)(2012-2#1)(2013-7#1)
weight before##2##2##(1993-9#1)(2010-12#1)
weight between##6##2##(1992-12#1)(1993-4#1)(1996-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
weight by##7##2##(1991-10#1)(1995-6#1)(2006-10#1)(2007-12#1)(2007-2#1)(2009-2#1)(2009-4#1)
weight can##3##2##(2009-2#1)(2010-12#1)(2010-8#1)
weight change from##2##3##(2009-9#1)(2013-1#1)
weight change of##3##3##(1990-4#1)(1991-2#1)(2012-2#1)
weight change##15##2##(1990-4#1)(1991-2#2)(2008-3#2)(2009-12#1)(2009-9#1)(2010-8#2)(2011-2#3)(2012-2#2)(2013-1#1)
weight changes in##2##3##(2011-2#1)(2013-8#1)
weight changes were##5##3##(1997-5#1)(2009-12#1)(2011-2#2)(2012-2#1)
weight changes##14##2##(1991-10#1)(1996-9#1)(1997-5#1)(2008-5#1)(2009-12#1)(2009-8#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-8#2)
weight children##2##2##(2008-12#1)(2011-2#1)
weight compared with##2##3##(2008-10#2)
weight compared##3##2##(2008-10#2)(2011-1#1)
weight concern##2##2##(2006-7#2)
weight concerns and##4##3##(2006-7#2)(2007-12#2)
weight concerns##8##2##(2006-7#2)(2007-12#6)
weight control behaviors##4##3##(2007-12#3)(2012-2#1)
weight control##19##2##(1994-2#1)(2006-7#2)(2007-12#3)(2007-2#1)(2007-9#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#1)
weight control/obesity counselling##2##3##(1993-2#2)
weight correlated with##2##3##(2007-8#1)(2013-8#1)
weight correlated##3##2##(2007-8#1)(2008-10#1)(2013-8#1)
weight cutoff##2##2##(1990-2#1)(2005-11#1)
weight data##6##2##(1991-8#1)(2008-7#1)(2009-12#2)(2010-2#1)(2012-12#1)
weight decreased##2##2##(2008-1#1)(2012-3#1)
weight development##3##2##(1992-12#1)(2006-8#1)(2007-5#1)
weight deviation##3##2##(1992-12#3)
weight did not##2##3##(1992-5#1)(2007-9#1)
weight dissatisfaction##2##2##(2006-7#1)(2007-12#1)
weight does not##3##3##(1994-12#1)(2004-10#1)(2009-6#1)
weight due to##2##3##(2008-5#1)(2011-2#1)
weight during pregnancy##3##3##(1992-12#1)(2012-12#1)(2013-1#1)
weight during the##4##3##(2007-3#1)(2008-7#1)(2008-9#2)
weight during##9##2##(1992-12#1)(2007-3#1)(2008-7#1)(2008-9#3)(2012-12#1)(2013-1#1)(2013-7#1)
weight estimated##2##2##(1992-7#1)(2008-12#1)
weight factor##2##2##(1990-2#1)(2006-11#1)
weight factors##4##2##(2008-10#1)(2008-3#3)
weight for age##5##3##(1991-12#1)(2006-2#2)(2008-4#2)
weight for each##2##3##(1995-2#1)(2011-1#1)
weight for height curves##2##4##(1996-3#2)
weight for height##6##3##(1991-12#1)(1993-2#1)(1996-3#3)(2008-12#1)
weight for the##4##3##(2008-10#2)(2010-4#1)(2012-2#1)
weight for##35##2##(1991-12#2)(1993-2#1)(1995-2#1)(1995-4#1)(1996-3#3)(2006-2#2)(2006-6#1)(2006-7#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#3)(2008-7#2)(2008-9#1)(2009-6#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
weight fraction##4##2##(1990-4#1)(1993-11#1)(1996-2#1)(2009-5#1)
weight fractions of##2##3##(2007-12#1)(2008-10#1)
weight fractions##4##2##(2007-12#1)(2008-10#3)
weight from the##2##3##(1995-5#1)(2008-10#1)
weight from##6##2##(1990-4#1)(1995-5#1)(2008-10#1)(2008-5#2)(2009-12#1)
weight gain (GWG)##2##3##(2011-1#1)(2013-1#1)
weight gain (WG) and##2##4##(2008-7#1)(2013-7#1)
weight gain after##5##3##(1996-1#1)(2007-12#1)(2010-7#2)(2013-1#1)
weight gain and##26##3##(1991-12#1)(1991-7#1)(1994-6#1)(1995-10#1)(1996-12#1)(1996-8#1)(2005-11#1)(2006-10#3)(2006-2#1)(2007-6#1)(2007-8#2)(2008-3#4)(2008-5#1)(2009-5#1)(2010-1#1)(2010-4#1)(2011-1#2)(2011-2#1)(2013-7#1)
weight gain during the##2##4##(2008-12#1)(2013-1#1)
weight gain during##6##3##(1992-7#1)(1997-7#1)(2007-12#1)(2008-12#1)(2013-1#1)(2013-7#1)
weight gain following##3##3##(1994-6#2)(2013-1#1)
weight gain in children##3##4##(1991-2#1)(2006-1#1)(2013-1#1)
weight gain in##17##3##(1991-2#1)(1992-12#1)(1996-1#1)(2006-1#1)(2006-6#1)(2007-2#1)(2008-10#1)(2008-3#3)(2008-5#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
weight gain is##7##3##(2008-3#3)(2011-1#1)(2013-1#3)
weight gain of##7##3##(2008-9#4)(2010-4#1)(2011-1#2)
weight gain on treatment##2##4##(2004-3#1)(2008-3#1)
weight gain or##4##3##(1993-2#1)(2007-8#1)(2008-12#1)(2008-3#1)
weight gain than those##2##4##(2007-12#1)(2013-1#1)
weight gain than##5##3##(1993-9#1)(2004-3#1)(2007-12#1)(2013-1#2)
weight gain was##10##3##(2004-3#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-4#1)(2011-12#1)(2011-2#3)(2013-1#1)
weight gain##182##2##(1991-12#1)(1991-2#2)(1991-7#3)(1992-12#1)(1992-7#1)(1993-2#1)(1993-9#2)(1994-6#4)(1995-10#1)(1995-12#1)(1996-1#4)(1996-12#1)(1996-3#1)(1996-8#3)(1997-7#2)(2004-3#9)(2005-11#1)(2005-7#1)(2006-1#3)(2006-10#5)(2006-2#1)(2006-6#2)(2006-7#1)(2006-8#6)(2006-9#1)(2007-12#7)(2007-2#2)(2007-6#1)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#6)(2008-12#7)(2008-3#19)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#5)(2009-4#1)(2009-5#3)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#5)(2010-7#2)(2011-1#9)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#22)(2013-7#5)(2013-8#1)
weight gain)##3##2##(1992-8#1)(1994-7#1)(2008-12#1)
weight gains were##4##3##(2004-11#1)(2007-7#1)(2008-5#2)
weight gains##13##2##(1991-12#1)(2004-11#2)(2007-12#1)(2007-7#2)(2008-5#5)(2008-9#1)(2011-2#1)
weight goals of##2##3##(2007-12#2)
weight growth##3##2##(1992-9#1)(1996-10#1)(2010-7#1)
weight has##3##2##(2006-10#1)(2008-3#1)(2011-1#1)
weight heparin##35##2##(1990-12#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-6#1)(1997-2#2)(1997-5#1)(2005-10#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-7#3)(2007-8#3)(2008-1#2)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#2)(2011-12#1)(2013-1#6)
weight in an##2##3##(2006-7#1)(2009-2#1)
weight in diabetes##2##3##(2008-12#2)
weight in the##7##3##(1993-8#1)(2006-6#2)(2009-2#1)(2009-6#1)(2010-3#1)(2011-2#1)
weight in##70##2##(1990-5#1)(1991-11#1)(1991-12#1)(1993-8#1)(1995-3#2)(1995-9#1)(1996-8#1)(1997-4#1)(2005-10#1)(2006-12#1)(2006-6#2)(2006-7#1)(2007-1#2)(2007-12#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#21)(2009-2#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-11#2)(2012-12#1)(2013-1#1)(2013-7#1)
weight increase and##2##3##(1996-12#1)(2009-12#1)
weight increase##4##2##(1995-3#1)(1996-12#1)(2004-1#1)(2009-12#1)
weight increased##3##2##(2008-10#1)(2010-4#1)(2010-8#1)
weight increases##2##2##(1997-1#1)(2008-10#1)
weight infants (&lt##2##3##(2004-10#1)(2007-2#1)
weight infants born##4##3##(2007-2#1)(2008-6#1)(2012-2#2)
weight infants##17##2##(1991-6#1)(1993-3#1)(1993-5#1)(1995-8#2)(2004-10#1)(2006-12#1)(2006-6#1)(2007-2#2)(2008-10#1)(2008-11#1)(2008-6#2)(2012-2#3)
weight information##3##2##(2007-1#1)(2007-8#2)
weight is##19##2##(1991-8#1)(1992-11#1)(1992-4#1)(1994-9#1)(1996-12#1)(1997-4#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)
weight less than##4##3##(1992-2#1)(2007-10#1)(2008-4#1)(2008-5#1)
weight loss &gt##2##3##(1992-12#1)(2010-9#1)
weight loss after##2##3##(2008-5#1)(2010-8#1)
weight loss and exercise##2##4##(2007-5#1)(2008-3#1)
weight loss and walking program##2##5##(2006-10#2)
weight loss and##31##3##(1991-12#1)(1993-1#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-10#1)(1995-9#1)(1996-9#1)(2006-10#2)(2006-2#2)(2006-4#1)(2006-8#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-3#4)(2008-4#1)(2008-7#1)(2009-10#1)(2009-2#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#2)
weight loss and/or##2##3##(2006-6#1)(2006-8#1)
weight loss associated with##3##4##(2008-5#2)(2013-8#1)
weight loss at##2##3##(2010-3#1)(2011-2#1)
weight loss between##2##3##(1992-8#1)(2013-1#1)
weight loss diets among low-income obese##2##6##(2008-9#2)
weight loss diets##6##3##(2008-3#3)(2008-9#3)
weight loss due to##3##4##(1993-2#1)(2005-12#1)(2008-3#1)
weight loss for##4##3##(2004-9#1)(2006-10#1)(2006-6#1)(2010-8#1)
weight loss in animals bearing##2##5##(1992-8#2)
weight loss in severely##2##4##(2006-2#1)(2008-3#1)
weight loss in the pre-treatment period (n =##2##8##(2008-3#2)
weight loss in the##3##4##(2006-10#1)(2008-3#2)
weight loss in##12##3##(1992-8#2)(1996-9#1)(2006-10#2)(2006-2#1)(2008-3#4)(2012-2#1)(2013-8#1)
weight loss interventions##2##3##(2006-8#1)(2009-12#1)
weight loss is##6##3##(1994-11#2)(2007-1#1)(2008-3#1)(2011-1#1)(2012-2#1)
weight loss of 5##2##4##(2006-10#1)(2013-8#1)
weight loss of##7##3##(1990-11#1)(1992-4#1)(1992-8#1)(2006-10#1)(2010-4#1)(2013-8#2)
weight loss over##2##3##(2005-7#1)(2008-6#1)
weight loss program##2##3##(2008-4#1)(2013-8#1)
weight loss results##2##3##(2006-2#1)(2013-1#1)
weight loss therapy##2##3##(2008-3#2)
weight loss was##4##3##(2006-6#1)(2007-12#1)(2007-8#2)
weight loss with##5##3##(1994-11#1)(2006-10#1)(2008-3#1)(2010-12#1)(2013-8#1)
weight loss##259##2##(1990-11#1)(1991-12#3)(1991-2#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-8#4)(1993-1#1)(1993-12#2)(1993-2#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#4)(1995-12#1)(1995-2#2)(1995-9#2)(1996-2#1)(1996-8#2)(1996-9#3)(1997-3#2)(1997-4#1)(1997-7#1)(2004-9#1)(2005-10#4)(2005-12#4)(2005-7#1)(2006-1#1)(2006-10#14)(2006-12#1)(2006-2#10)(2006-4#1)(2006-6#3)(2006-8#3)(2007-1#3)(2007-11#1)(2007-12#6)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#9)(2008-10#3)(2008-11#1)(2008-12#3)(2008-3#30)(2008-4#4)(2008-5#12)(2008-6#2)(2008-7#4)(2008-9#3)(2009-10#1)(2009-12#5)(2009-2#1)(2009-5#2)(2009-6#2)(2009-9#1)(2010-10#1)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#7)(2010-9#2)(2011-1#5)(2011-12#2)(2011-2#4)(2012-11#2)(2012-12#4)(2012-2#8)(2012-3#5)(2013-1#13)(2013-7#2)(2013-8#12)
weight lower than##2##3##(1992-2#1)(2008-10#1)
weight maintenance##5##2##(1997-3#1)(2006-10#1)(2010-8#1)(2012-2#1)(2013-8#1)
weight management##8##2##(2007-12#1)(2008-10#1)(2008-5#1)(2009-5#2)(2010-8#1)(2012-1#1)(2012-2#1)
weight markers##2##2##(2008-4#1)(2008-5#1)
weight mass##2##2##(1992-8#1)(2008-2#1)
weight matrix##4##2##(2008-3#3)(2008-9#1)
weight may be a##2##4##(2008-12#1)(2009-2#1)
weight measurements##3##2##(1997-8#1)(2006-7#1)(2008-4#1)
weight newborns##4##2##(1991-12#1)(2007-8#2)(2013-1#1)
weight observed##3##2##(1993-3#1)(2012-12#2)
weight of 0##2##3##(2007-3#1)(2008-7#1)
weight of 1##5##3##(2007-12#1)(2008-10#1)(2008-12#1)(2008-8#2)
weight of 10##2##3##(1993-4#1)(2009-10#1)
weight of 100##4##3##(2008-5#1)(2008-9#2)(2011-12#1)
weight of 1000##2##3##(2008-11#1)(2012-2#1)
weight of 13##3##3##(1993-11#1)(1995-6#1)(2007-3#1)
weight of 42##2##3##(1994-11#1)(2007-9#1)
weight of a##4##3##(1996-8#2)(2008-7#1)(2010-9#1)
weight of about##14##3##(1990-1#2)(1991-5#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-9#1)(1997-7#1)(2005-10#1)(2006-3#1)(2010-3#1)
weight of animals##2##3##(2008-12#1)(2008-6#1)
weight of control##2##3##(2008-7#1)(2009-5#1)
weight of different body organs (breast##2##6##(2008-12#2)
weight of different##3##3##(2008-12#2)(2012-3#1)
weight of each##3##3##(1992-7#1)(2008-5#1)(2008-8#1)
weight of evidence##3##3##(2005-8#1)(2007-11#1)(2010-9#1)
weight of less than##3##4##(2006-2#1)(2006-8#1)(2008-11#1)
weight of primary##2##3##(2006-8#1)(2008-10#1)
weight of the evidence##2##4##(2008-10#1)(2008-11#1)
weight of the mammary glands##4##5##(2012-12#4)
weight of the protein##3##4##(1996-2#1)(1996-8#1)(2010-3#1)
weight of the##84##3##(1990-11#1)(1990-2#1)(1990-4#1)(1991-12#5)(1991-2#1)(1991-4#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-8#1)(1993-11#1)(1993-7#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-3#2)(1995-4#1)(1996-2#2)(1996-6#1)(1996-8#1)(1997-6#2)(2005-11#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-1#2)(2007-3#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#8)(2008-8#3)(2008-9#1)(2009-1#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#8)(2013-1#3)(2013-7#1)
weight of##377##2##(1990-1#4)(1990-11#4)(1990-12#2)(1990-2#4)(1990-4#4)(1990-5#2)(1990-6#1)(1990-7#5)(1990-8#1)(1990-9#2)(1991-1#2)(1991-11#2)(1991-12#6)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#3)(1991-7#2)(1991-9#1)(1992-1#2)(1992-11#3)(1992-12#5)(1992-2#4)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#3)(1992-8#2)(1992-9#1)(1993-11#4)(1993-12#1)(1993-3#3)(1993-4#3)(1993-6#3)(1993-7#2)(1993-8#1)(1994-11#7)(1994-12#2)(1994-2#2)(1994-5#3)(1994-6#2)(1994-8#2)(1994-9#4)(1995-11#2)(1995-2#1)(1995-3#3)(1995-4#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-2#3)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#4)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(2004-9#3)(2005-10#1)(2005-11#4)(2005-8#1)(2006-10#1)(2006-2#2)(2006-3#1)(2006-5#1)(2006-8#5)(2006-9#3)(2007-1#4)(2007-11#2)(2007-12#1)(2007-3#5)(2007-9#1)(2008-1#1)(2008-10#28)(2008-11#7)(2008-12#11)(2008-3#1)(2008-4#21)(2008-5#16)(2008-6#2)(2008-7#4)(2008-8#11)(2008-9#7)(2009-1#1)(2009-10#1)(2009-12#1)(2009-5#3)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#3)(2010-2#3)(2010-3#2)(2010-4#4)(2010-5#1)(2010-9#2)(2011-1#7)(2011-12#4)(2011-2#6)(2012-1#7)(2012-11#1)(2012-12#8)(2012-2#8)(2012-3#9)(2013-1#6)(2013-7#2)(2013-8#1)
weight on the##3##3##(2007-2#1)(2008-6#1)(2010-4#1)
weight on##13##2##(1994-12#1)(1994-3#1)(1995-8#1)(2004-12#1)(2007-12#1)(2007-2#1)(2008-3#1)(2008-6#2)(2009-5#1)(2010-4#1)(2013-1#2)
weight or length##2##3##(1993-7#1)(2006-7#1)
weight or##23##2##(1992-12#1)(1993-7#1)(1993-9#1)(1994-12#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-3#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-6#1)(2010-2#1)(2010-4#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#1)
weight over##2##2##(1992-8#1)(2010-3#1)
weight patients##3##2##(2007-8#2)(2010-12#1)
weight per##8##2##(1991-2#2)(1996-12#2)(2006-8#1)(2008-12#1)(2009-6#1)(2010-9#1)
weight preoperatively##2##2##(2010-8#2)
weight proteins##13##2##(1990-4#1)(1991-12#1)(1991-4#1)(1994-10#1)(2007-12#1)(2007-6#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-8#1)
weight range##5##2##(1990-11#1)(1991-3#1)(1997-3#1)(2008-11#2)
weight ranged between##2##3##(2008-5#1)(2011-2#1)
weight ranged from 0##2##4##(1995-8#1)(2011-12#1)
weight ranged from##3##3##(1995-8#1)(2010-7#1)(2011-12#1)
weight ranged##5##2##(1995-8#1)(2008-5#1)(2010-7#1)(2011-12#1)(2011-2#1)
weight ratio and##4##3##(1994-6#1)(2008-5#2)(2011-2#1)
weight ratio of##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
weight ratio##21##2##(1992-11#1)(1993-3#1)(1993-7#1)(1994-3#1)(1994-6#1)(1995-3#1)(2005-9#1)(2007-3#2)(2007-8#1)(2008-10#1)(2008-5#3)(2010-1#1)(2010-12#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
weight ratios of##3##3##(2007-11#1)(2008-11#1)(2009-11#1)
weight ratios were significantly##2##4##(2008-10#1)(2008-5#1)
weight ratios##10##2##(1993-3#1)(1997-4#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#3)(2009-11#1)
weight reducing##2##2##(1991-2#1)(2008-1#1)
weight reduction in##2##3##(2004-11#1)(2013-8#1)
weight reduction##16##2##(1990-12#2)(1991-2#1)(1991-5#1)(1996-11#1)(2004-11#1)(2006-10#1)(2006-8#1)(2008-3#3)(2008-5#1)(2011-2#1)(2012-3#1)(2013-8#2)
weight remained##2##2##(1990-5#1)(1991-8#1)
weight retention##2##2##(2004-11#1)(2005-10#1)
weight satisfaction##4##2##(2006-7#3)(2007-12#1)
weight showed##2##2##(2008-7#1)(2009-2#1)
weight status was##2##3##(2008-9#1)(2013-1#1)
weight status##14##2##(2007-12#1)(2008-9#1)(2011-2#4)(2012-1#3)(2012-2#1)(2013-1#3)(2013-8#1)
weight still##2##2##(2007-12#1)(2012-1#1)
weight terms##4##2##(2007-12#3)(2008-2#1)
weight than the##3##3##(1991-12#1)(2006-8#1)(2008-10#1)
weight than urban##2##3##(2007-12#1)(2013-1#1)
weight than##15##2##(1991-12#1)(1995-4#1)(1995-5#1)(1996-7#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-12#2)(2008-10#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
weight that##4##2##(1991-2#1)(1996-12#1)(2005-11#1)(2007-2#1)
weight the##3##2##(1993-3#1)(1996-2#1)(2012-2#1)
weight thiol##3##2##(1992-11#1)(1995-5#1)(2009-8#1)
weight to the##8##3##(1992-6#1)(1993-1#1)(1995-5#1)(2006-2#1)(2007-9#1)(2008-4#1)(2010-10#1)(2012-12#1)
weight to##25##2##(1991-1#1)(1992-6#1)(1993-1#1)(1993-7#1)(1995-5#1)(1997-2#1)(2005-7#1)(2006-2#1)(2007-12#1)(2007-9#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-5#1)(2010-10#1)(2010-4#1)(2012-1#1)(2012-12#1)
weight training##3##2##(1995-8#1)(2006-9#1)(2009-1#1)
weight trimming##2##2##(2009-12#2)
weight value##2##2##(1996-6#1)(2011-1#1)
weight variation##6##2##(2010-12#1)(2010-2#1)(2012-2#1)(2013-1#3)
weight variations##3##2##(2005-10#3)
weight versus##2##2##(1993-2#1)(2008-5#1)
weight was 0##2##3##(1996-8#1)(2007-3#1)
weight was 30##2##3##(1992-9#1)(2013-1#1)
weight was determined##2##3##(1997-8#1)(2011-2#1)
weight was higher##3##3##(2006-12#1)(2010-2#1)(2013-1#1)
weight was measured##3##3##(2008-3#1)(2011-2#1)(2012-11#1)
weight was not affected by##2##5##(2010-2#1)(2013-1#1)
weight was recorded in##2##4##(2007-3#1)(2008-3#1)
weight was recorded##3##3##(1995-3#1)(2007-3#1)(2008-3#1)
weight was reduced##2##3##(1992-12#1)(2012-12#1)
weight was significantly##2##3##(2008-10#1)(2011-2#1)
weight was##65##2##(1990-11#1)(1990-8#2)(1991-2#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-3#3)(1993-4#1)(1995-3#1)(1996-8#2)(1997-7#1)(1997-8#1)(2004-12#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-12#5)(2007-2#1)(2007-3#2)(2007-7#1)(2008-10#2)(2008-12#2)(2008-3#5)(2008-5#2)(2008-6#1)(2009-5#1)(2010-12#1)(2010-2#2)(2010-4#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#5)
weight were also##3##3##(1996-4#1)(2008-12#1)(2008-4#1)
weight were examined##2##3##(1992-2#1)(2008-11#1)
weight were found##2##3##(2007-1#1)(2007-12#1)
weight were measured##3##3##(1995-5#1)(1997-1#1)(2008-10#1)
weight were observed##3##3##(1996-12#1)(1997-5#1)(2008-10#1)
weight were studied##2##3##(2008-12#1)(2012-1#1)
weight were##27##2##(1991-2#1)(1992-2#1)(1995-5#1)(1996-10#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-5#1)(2004-10#1)(2007-1#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2009-2#1)(2010-2#2)(2011-2#1)(2012-1#1)(2013-7#1)
weight when##3##2##(1992-9#1)(2007-12#1)(2007-3#1)
weight which##3##2##(1990-7#1)(1996-12#1)(2007-8#1)
weight with##4##2##(1993-1#1)(2006-8#1)(2008-3#1)(2013-1#1)
weight within##3##2##(2008-10#1)(2008-11#1)(2009-12#1)
weight##2998##1##(1990-1#4)(1990-10#1)(1990-11#18)(1990-12#28)(1990-2#13)(1990-3#6)(1990-4#10)(1990-5#13)(1990-6#5)(1990-7#14)(1990-8#3)(1990-9#12)(1991-1#5)(1991-10#12)(1991-11#8)(1991-12#30)(1991-2#23)(1991-3#6)(1991-4#8)(1991-5#8)(1991-6#9)(1991-7#12)(1991-8#6)(1991-9#11)(1992-1#3)(1992-10#4)(1992-11#13)(1992-12#21)(1992-2#17)(1992-3#10)(1992-4#10)(1992-5#5)(1992-6#4)(1992-7#10)(1992-8#21)(1992-9#7)(1993-1#7)(1993-10#1)(1993-11#5)(1993-12#8)(1993-2#9)(1993-3#23)(1993-4#8)(1993-5#4)(1993-6#5)(1993-7#12)(1993-8#4)(1993-9#9)(1994-10#3)(1994-11#18)(1994-12#14)(1994-2#10)(1994-3#15)(1994-4#1)(1994-5#12)(1994-6#10)(1994-7#3)(1994-8#8)(1994-9#9)(1995-1#2)(1995-10#1)(1995-11#6)(1995-12#7)(1995-2#8)(1995-3#17)(1995-4#6)(1995-5#7)(1995-6#7)(1995-8#14)(1995-9#4)(1996-1#8)(1996-10#5)(1996-11#4)(1996-12#12)(1996-2#16)(1996-3#7)(1996-4#2)(1996-5#4)(1996-6#8)(1996-7#5)(1996-8#15)(1996-9#11)(1997-1#8)(1997-2#12)(1997-3#10)(1997-4#8)(1997-5#7)(1997-6#3)(1997-7#11)(1997-8#10)(2004-1#1)(2004-10#4)(2004-11#6)(2004-12#6)(2004-2#1)(2004-3#10)(2004-4#3)(2004-8#1)(2004-9#14)(2005-10#13)(2005-11#19)(2005-12#5)(2005-7#8)(2005-8#2)(2005-9#2)(2006-1#9)(2006-10#46)(2006-11#2)(2006-12#15)(2006-2#24)(2006-3#4)(2006-4#2)(2006-5#5)(2006-6#14)(2006-7#29)(2006-8#34)(2006-9#24)(2007-1#22)(2007-10#4)(2007-11#21)(2007-12#96)(2007-2#20)(2007-3#25)(2007-5#6)(2007-6#3)(2007-7#26)(2007-8#41)(2007-9#12)(2008-1#24)(2008-10#159)(2008-11#42)(2008-12#71)(2008-2#12)(2008-3#113)(2008-4#58)(2008-5#116)(2008-6#29)(2008-7#63)(2008-8#28)(2008-9#55)(2009-1#3)(2009-10#6)(2009-11#4)(2009-12#19)(2009-2#17)(2009-3#7)(2009-4#15)(2009-5#23)(2009-6#10)(2009-7#3)(2009-8#9)(2009-9#9)(2010-1#4)(2010-10#4)(2010-11#8)(2010-12#24)(2010-2#27)(2010-3#9)(2010-4#40)(2010-5#2)(2010-6#3)(2010-7#9)(2010-8#21)(2010-9#6)(2011-1#51)(2011-11#3)(2011-12#13)(2011-2#94)(2011-3#2)(2012-1#51)(2012-11#9)(2012-12#31)(2012-2#65)(2012-3#31)(2012-5#1)(2013-1#119)(2013-7#27)(2013-8#37)
weight'##2##1##(2007-8#1)(2009-2#1)
weight's effects ranged from##2##4##(1993-10#2)
weight) and##5##2##(1997-3#1)(2005-11#1)(2008-4#1)(2010-4#1)(2012-12#1)
weight) for##2##2##(1996-12#1)(2008-11#1)
weight) had##2##2##(1993-4#1)(1996-6#1)
weight) in##6##2##(1996-7#1)(2006-4#2)(2007-1#1)(2008-5#1)(2009-8#1)
weight) of##3##2##(1990-9#1)(2008-5#1)(2011-2#1)
weight) significantly##2##2##(1994-8#1)(2013-1#1)
weight) than##2##2##(2008-11#1)(2011-12#1)
weight) were##5##2##(1995-5#1)(2007-1#1)(2007-11#1)(2008-4#1)(2010-4#1)
weight)##69##1##(1990-10#1)(1990-9#1)(1991-2#1)(1991-4#1)(1992-11#1)(1992-6#1)(1993-4#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-7#1)(1996-12#2)(1996-6#2)(1996-7#1)(1996-9#2)(1997-3#1)(1997-6#1)(2004-8#1)(2005-11#1)(2006-4#2)(2007-1#3)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#4)(2008-11#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-11#2)(2010-4#2)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#1)
weight-average##3##1##(2005-11#1)(2006-12#1)(2007-8#1)
weight-based##2##1##(2008-7#1)(2012-3#1)
weight-bearing exercise##2##2##(1993-11#1)(2008-3#1)
weight-bearing##22##1##(1990-4#1)(1993-11#1)(1993-8#1)(1995-6#1)(1997-5#1)(2005-7#4)(2006-7#1)(2007-10#1)(2007-11#2)(2007-9#1)(2008-12#1)(2008-3#2)(2008-4#1)(2010-5#1)(2011-2#3)
weight-for-age and##2##2##(1997-4#1)(2007-7#1)
weight-for-age##6##1##(1997-4#2)(2007-2#1)(2007-7#1)(2008-2#1)(2010-6#1)
weight-for-height##4##1##(1991-12#2)(2007-2#1)(2010-6#1)
weight-loss dynamics##4##2##(2013-8#4)
weight-loss##11##1##(1994-6#1)(2008-12#1)(2010-8#4)(2013-8#5)
weight-matched controls##3##2##(2008-6#3)
weight-matched##4##1##(2008-3#1)(2008-6#3)
weight-reducing##2##1##(2008-3#1)(2010-8#1)
weight-related beliefs and##3##3##(2011-2#3)
weight-related words and personal characteristics##2##5##(2007-12#2)
weight-related words##4##2##(2007-12#4)
weight-related##11##1##(2006-6#1)(2007-12#6)(2011-2#3)(2013-1#1)
weight/body weight##3##2##(1991-2#1)(1995-3#1)(2008-12#1)
weight]##4##1##(1991-6#1)(1996-1#1)(2012-2#1)(2012-3#1)
weightbearing##4##1##(2006-12#1)(2007-11#1)(2009-5#1)(2011-12#1)
weighted DH(w)##2##2##(2008-10#2)
weighted Krawtchouk polynomials##3##3##(2008-2#3)
weighted according to the##2##4##(2006-5#1)(2012-3#1)
weighted and##3##2##(1992-4#1)(2006-11#1)(2012-2#1)
weighted average of the##2##4##(2008-2#1)(2008-3#1)
weighted average of##3##3##(2008-2#1)(2008-3#1)(2008-8#1)
weighted average##12##2##(1992-12#1)(1995-1#1)(2008-2#3)(2008-3#1)(2008-8#2)(2009-3#1)(2010-2#1)(2011-2#1)(2013-8#1)
weighted by a##2##3##(2007-9#1)(2008-3#1)
weighted by the##3##3##(2008-3#2)(2010-2#1)
weighted by##10##2##(2007-9#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-8#1)(2010-2#1)(2010-4#1)(2011-2#1)
weighted cases##2##2##(1992-12#2)
weighted filtering##2##2##(2008-3#2)
weighted imaging##2##2##(2012-12#1)(2012-2#1)
weighted kappa##3##2##(1993-12#1)(2007-7#1)(2012-1#1)
weighted least squares (WLS)##2##4##(1994-6#1)(2008-2#1)
weighted least-squares##2##2##(2008-2#2)
weighted linear##2##2##(2008-3#1)(2010-4#1)
weighted mean of##4##3##(2007-4#1)(2008-10#3)
weighted mean##8##2##(2007-10#1)(2007-4#1)(2008-10#5)(2011-2#1)
weighted measure##2##2##(2007-8#2)
weighted median##2##2##(2008-2#2)
weighted nonlinear least-squares##2##3##(2008-3#2)
weighted numbers of items##2##4##(2006-5#2)
weighted probit regression analysis##2##4##(1992-8#2)
weighted regression##3##2##(2010-7#1)(2012-12#1)(2012-3#1)
weighted sum of the##2##4##(2008-3#1)(2009-10#1)
weighted sum##4##2##(2008-3#1)(2009-10#1)(2012-3#2)
weighted version of##2##3##(1996-7#1)(2012-3#1)
weighted##161##1##(1990-8#2)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#2)(1993-12#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-7#2)(1996-9#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-3#1)(2006-5#4)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-2#23)(2008-3#13)(2008-4#3)(2008-7#2)(2008-8#5)(2008-9#1)(2009-10#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#2)(2010-7#1)(2011-2#7)(2012-1#5)(2012-12#3)(2012-2#5)(2012-3#16)(2013-8#3)
weighted-order statistic##2##2##(2008-2#2)
weighted-sum##5##1##(2012-3#5)
weighting and##2##2##(2007-11#1)(2008-3#1)
weighting factors##3##2##(2008-7#1)(2011-1#2)
weighting formula##2##2##(2007-11#2)
weighting is##2##2##(1990-8#1)(2012-3#1)
weighting matrices##2##2##(2008-2#2)
weighting method##4##2##(2008-10#1)(2011-1#3)
weighting of##7##2##(1994-5#1)(1995-2#1)(2007-11#1)(2008-6#1)(2008-9#1)(2010-8#1)(2013-8#1)
weighting scheme##2##2##(1994-5#1)(2010-12#1)
weighting schemes##2##2##(2010-12#2)
weighting the##2##2##(2008-8#1)(2013-7#1)
weighting##46##1##(1990-8#3)(1994-5#2)(1995-2#1)(2007-11#4)(2008-10#1)(2008-12#1)(2008-2#6)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#3)(2010-8#1)(2011-1#11)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
weightings##2##1##(1992-2#1)(2008-11#1)
weights and heights##2##3##(1993-2#1)(2007-6#1)
weights and thresholds##2##3##(2008-2#2)
weights and volumes##2##3##(1994-3#1)(1995-12#1)
weights and##30##2##(1991-11#1)(1991-2#1)(1992-3#1)(1993-1#1)(1993-10#2)(1993-2#1)(1994-3#1)(1995-12#1)(1997-6#1)(2005-7#1)(2007-6#1)(2008-10#4)(2008-2#3)(2008-4#1)(2008-5#3)(2008-9#1)(2009-12#1)(2010-4#1)(2011-2#1)(2012-3#2)(2013-1#1)
weights are##14##2##(1990-12#2)(1993-1#3)(1996-2#1)(2006-2#1)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#1)(2011-3#1)(2012-3#1)
weights as##2##2##(1991-10#1)(2007-9#1)
weights at##4##2##(1991-12#1)(2009-12#1)(2012-2#1)(2013-8#1)
weights between##3##2##(1997-2#1)(2005-10#1)(2013-1#1)
weights calculated##2##2##(1992-12#2)
weights can##2##2##(2008-11#1)(2009-12#1)
weights for##10##2##(1991-2#1)(1993-10#1)(2007-11#2)(2008-10#3)(2009-2#1)(2010-3#1)(2013-8#1)
weights from##2##2##(1992-12#1)(2008-11#1)
weights have##2##2##(1994-12#1)(1996-2#1)
weights in 256 mg/kg##2##4##(2008-9#2)
weights in a##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
weights in the##4##3##(1990-12#1)(2007-3#1)(2008-2#1)(2008-5#1)
weights in##16##2##(1990-12#1)(2007-3#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-9#5)
weights is##2##2##(1992-12#1)(2008-5#1)
weights less than##2##3##(1992-4#1)(1993-5#1)
weights obtained from##2##3##(2010-2#1)(2010-8#1)
weights of 100##2##3##(2008-2#1)(2008-9#1)
weights of 12 mg/kg males were significantly##2##7##(2008-9#2)
weights of 12 mg/kg males##3##5##(2008-9#3)
weights of 12 mg/kg##4##4##(2008-9#4)
weights of 12##5##3##(1991-7#1)(2008-9#4)
weights of 3##2##3##(1996-2#1)(2008-8#1)
weights of 350 and 700 mg/L males were significantly less than those of the control group##2##16##(2008-9#2)
weights of 350 and 700 mg/L males were##4##8##(2008-9#4)
weights of 350##5##3##(2008-9#4)(2013-1#1)
weights of 6 and 12 mg/kg males and females were##2##10##(2008-9#2)
weights of 6 and 12 mg/kg males and##3##8##(2008-9#3)
weights of 6 and 12 mg/kg##4##6##(2008-9#4)
weights of 81##2##3##(2006-3#1)(2008-8#1)
weights of all dosed groups of males##2##7##(2008-9#2)
weights of all dosed groups of##3##6##(2008-9#3)
weights of all##4##3##(2008-12#1)(2008-9#3)
weights of connections between the core##2##6##(1994-8#2)
weights of exposed males##2##4##(2008-9#2)
weights of males administered 50 mg/kg or greater and 200 mg/kg females were significantly less than those of the vehicle controls##2##21##(2008-9#2)
weights of males administered 50 mg/kg or greater were##2##9##(2008-9#2)
weights of males administered 50 mg/kg or greater##4##8##(2008-9#4)
weights of males administered 50##5##5##(2008-9#5)
weights of males administered##6##4##(2008-9#6)
weights of males##9##3##(2008-9#9)
weights of the##19##3##(1992-11#1)(1992-3#1)(1993-6#1)(1996-2#1)(1997-3#1)(1997-7#1)(2007-12#2)(2007-4#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#2)(2010-2#1)(2011-2#1)
weights of thymus##2##3##(2008-5#2)
weights of##145##2##(1990-11#2)(1990-12#3)(1990-4#1)(1990-5#1)(1990-7#2)(1991-11#1)(1991-7#1)(1991-9#1)(1992-11#3)(1992-3#2)(1992-8#1)(1992-9#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#3)(1995-3#1)(1995-4#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-8#1)(1997-3#1)(1997-4#1)(1997-7#3)(2004-9#1)(2005-11#1)(2006-10#1)(2006-3#1)(2007-12#2)(2007-4#1)(2007-8#4)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#8)(2008-8#7)(2008-9#52)(2010-12#1)(2010-2#2)(2011-2#1)(2012-11#2)(2013-1#2)
weights on##2##2##(2007-11#1)(2008-5#1)
weights or##2##2##(1995-2#1)(2008-10#1)
weights result in higher payments to##2##6##(1990-12#2)
weights that##2##2##(1993-1#1)(1995-1#1)
weights to##8##2##(1993-1#1)(1995-8#1)(2007-12#1)(2008-2#1)(2008-9#1)(2009-12#1)(2012-3#1)(2013-1#1)
weights under##2##2##(2008-2#1)(2012-2#1)
weights was##3##2##(2008-5#1)(2009-12#1)(2012-12#1)
weights were increased##3##3##(1995-3#1)(2008-9#2)
weights were observed##3##3##(1995-11#1)(1997-2#1)(2005-7#1)
weights were significantly decreased in 800 mg/L##2##7##(2008-9#2)
weights were significantly decreased in##3##5##(2008-9#3)
weights were significantly##4##3##(2008-9#4)
weights were similar##4##3##(2008-3#1)(2008-9#3)
weights were##27##2##(1990-12#1)(1992-7#1)(1993-2#1)(1995-11#1)(1995-3#1)(1997-2#1)(2005-7#1)(2008-10#4)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#9)(2009-12#1)(2009-5#1)(2012-2#1)
weights with##5##2##(1990-6#1)(1993-1#1)(2008-3#1)(2009-10#1)(2009-12#1)
weights##431##1##(1990-10#1)(1990-11#2)(1990-12#11)(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#3)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#4)(1992-12#7)(1992-2#2)(1992-3#3)(1992-4#5)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#10)(1993-10#5)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#3)(1993-5#3)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-4#1)(1995-7#1)(1995-8#3)(1995-9#1)(1996-12#2)(1996-2#5)(1996-8#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#5)(2004-4#2)(2004-9#1)(2005-10#3)(2005-11#1)(2005-7#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#1)(2007-1#1)(2007-11#4)(2007-12#8)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#3)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#37)(2008-11#5)(2008-12#7)(2008-2#19)(2008-3#11)(2008-4#9)(2008-5#20)(2008-7#1)(2008-8#9)(2008-9#75)(2009-10#1)(2009-12#10)(2009-2#1)(2009-4#1)(2009-5#2)(2009-9#2)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#5)(2013-8#5)
weights&quot##3##1##(2007-12#2)(2010-2#1)
weihenstephanensis##5##1##(2011-2#5)
weird##3##1##(2007-9#2)(2013-8#1)
weirii##2##1##(2008-10#2)
welcome##19##1##(1991-1#1)(1991-12#1)(1995-2#1)(1996-11#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-9#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-6#3)(2010-3#1)(2011-2#1)(2013-1#1)
welcomed by##4##2##(1993-12#1)(1995-1#1)(1997-7#1)(2010-9#1)
welcomed the##3##2##(1993-11#1)(1993-3#1)(1993-6#1)
welcomed##16##1##(1992-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1995-1#1)(1996-11#1)(1997-7#1)(2005-8#2)(2007-11#1)(2008-11#1)(2008-8#2)(2010-9#1)(2011-1#1)
weld##3##1##(2008-10#1)(2008-3#2)
welded##6##1##(2008-3#1)(2011-2#2)(2012-2#1)(2013-8#2)
welders in Calabar##2##3##(2008-4#2)
welders than##2##2##(2008-4#2)
welders##12##1##(1994-6#1)(2008-10#1)(2008-4#10)
welding fume##3##2##(2008-10#3)
welding method##2##2##(2013-8#2)
welding of##2##2##(1990-10#1)(2008-3#1)
welding process##2##2##(1994-6#2)
welding##31##1##(1990-10#1)(1994-6#3)(1996-1#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#7)(2008-4#8)(2012-2#1)(2013-8#3)
welfare and##9##2##(2005-5#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#1)(2012-11#1)(2012-2#1)(2013-8#1)
welfare as##2##2##(1996-2#1)(2013-8#1)
welfare concerns##3##2##(2013-8#3)
welfare for##2##2##(2013-8#2)
welfare implications##2##2##(2011-1#2)
welfare in##3##2##(1990-11#1)(1994-3#1)(2007-12#1)
welfare loss##3##2##(1997-2#1)(2011-1#2)
welfare of animals##2##3##(2005-5#1)(2009-4#1)
welfare of children##3##3##(1991-10#2)(2013-1#1)
welfare of patients##2##3##(1992-3#1)(2008-4#1)
welfare of the##4##3##(1991-10#1)(1997-2#1)(2006-6#1)(2011-1#1)
welfare of##26##2##(1991-10#3)(1992-3#2)(1995-11#1)(1996-9#1)(1997-2#1)(2005-5#1)(2005-7#6)(2006-6#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-4#2)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
welfare policies##2##2##(2008-9#2)
welfare reform##3##2##(2007-12#1)(2008-2#1)(2011-12#1)
welfare services##5##2##(1990-5#1)(1996-2#2)(2008-6#1)(2008-9#1)
welfare spending##2##2##(2013-1#2)
welfare state in##2##3##(1996-8#1)(2008-9#1)
welfare state##4##2##(1996-8#2)(2006-2#1)(2008-9#1)
welfare states##2##2##(2013-1#2)
welfare system##4##2##(1994-1#1)(2008-4#2)(2008-9#1)
welfare to##2##2##(1992-5#1)(2008-10#1)
welfare would be##2##3##(2005-9#1)(2010-4#1)
welfare##137##1##(1990-11#1)(1990-4#1)(1990-5#1)(1991-10#3)(1992-1#1)(1992-2#2)(1992-3#3)(1992-5#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-3#5)(1994-4#2)(1994-7#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-11#2)(1996-2#4)(1996-3#2)(1996-8#4)(1996-9#2)(1997-2#3)(2005-11#1)(2005-5#2)(2005-7#6)(2005-9#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#7)(2007-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#1)(2008-4#5)(2008-6#1)(2008-9#10)(2009-4#2)(2010-1#1)(2010-10#1)(2010-4#3)(2010-6#1)(2011-1#6)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#7)(2013-8#13)
well ELISA##2##2##(2008-10#1)(2013-8#1)
well above the##8##3##(1991-12#1)(1992-2#1)(2005-11#1)(2008-8#1)(2009-10#1)(2009-7#1)(2010-8#1)(2013-1#1)
well above those##2##3##(1990-12#1)(2008-2#1)
well above##16##2##(1990-12#1)(1991-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1994-1#1)(1997-7#1)(2005-10#1)(2005-11#1)(2007-11#1)(2008-2#1)(2008-8#1)(2009-10#1)(2009-7#1)(2010-8#1)(2013-1#1)
well absorbed##2##2##(2008-12#1)(2008-7#1)
well accepted and##2##3##(2007-2#1)(2008-5#1)
well accepted by patients and##3##5##(1991-6#1)(2007-7#1)(2012-3#1)
well accepted by patients##4##4##(1991-6#1)(2007-7#1)(2009-1#1)(2012-3#1)
well accepted by##8##3##(1991-6#1)(1994-8#1)(2006-10#1)(2007-7#2)(2009-1#1)(2010-2#1)(2012-3#1)
well accepted that older##2##4##(1991-1#1)(2006-10#1)
well accepted that##5##3##(1991-1#1)(2006-10#1)(2006-3#1)(2008-10#1)(2008-3#1)
well accepted##24##2##(1991-1#1)(1991-6#1)(1993-11#1)(1994-2#1)(1994-8#1)(2004-12#1)(2006-10#2)(2006-3#1)(2007-2#1)(2007-7#2)(2008-10#4)(2008-3#2)(2008-5#1)(2009-1#1)(2009-10#1)(2010-2#1)(2012-3#1)(2013-8#1)
well accessible##2##2##(1997-2#1)(2010-5#1)
well achieved##2##2##(2008-3#1)(2008-5#1)
well adapted to the##4##4##(2006-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
well adapted to##12##3##(1991-11#1)(1992-9#1)(2006-5#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
well adapted##17##2##(1991-11#1)(1992-9#1)(1997-5#1)(1997-7#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-1#1)(2012-2#3)(2012-3#1)(2013-1#1)
well advanced in##3##3##(2006-10#1)(2008-3#1)(2010-12#1)
well advanced##6##2##(1993-6#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-3#1)(2010-12#1)
well advised to##4##3##(2006-8#1)(2008-11#1)(2011-2#1)(2012-12#1)
well after##15##2##(1990-8#2)(1992-2#1)(1996-4#1)(1997-5#1)(2006-10#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2012-2#1)(2013-1#2)
well against##2##2##(1995-9#1)(2007-4#1)
well agree with those obtained by the method of standard additions##2##11##(2008-10#2)
well aligned##3##2##(2008-8#1)(2008-9#1)(2010-3#1)
well and are##2##3##(1997-2#1)(2010-12#1)
well and no##2##3##(2007-8#1)(2012-1#1)
well and were##3##3##(1990-4#1)(2008-10#1)(2008-2#1)
well and##35##2##(1990-4#1)(1991-11#1)(1991-9#1)(1994-5#1)(1997-2#1)(1997-4#1)(2005-1#1)(2005-11#1)(2007-10#2)(2007-2#1)(2007-6#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#1)(2009-1#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)
well approximated by a##2##4##(2007-12#1)(2008-3#1)
well approximated by##5##3##(1992-9#1)(1996-11#1)(2007-12#1)(2008-3#2)
well approximated##8##2##(1992-9#1)(1996-11#1)(2007-12#1)(2008-2#1)(2008-3#3)(2009-9#1)
well are##3##2##(1996-2#1)(2006-12#1)(2008-11#1)
well as a large##3##4##(2008-10#1)(2012-12#1)(2013-1#1)
well as a low##3##4##(1997-5#1)(2009-11#1)(2012-3#1)
well as a##225##3##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#2)(1991-11#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-6#3)(1994-7#2)(1994-9#1)(1995-1#2)(1995-2#1)(1995-4#1)(1995-6#2)(1995-8#2)(1996-10#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#3)(1996-5#2)(1997-2#3)(1997-3#1)(1997-5#1)(2004-2#1)(2004-4#1)(2005-10#2)(2005-11#3)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-3#2)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#21)(2008-11#8)(2008-12#2)(2008-2#9)(2008-3#8)(2008-4#10)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#3)(2009-4#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#7)(2012-2#3)(2012-3#2)(2013-1#3)
well as all the##6##4##(1991-12#1)(1997-3#1)(2006-1#1)(2007-11#1)(2009-12#2)
well as all##15##3##(1991-12#1)(1997-3#1)(1997-6#1)(2006-1#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-9#2)(2009-12#2)(2010-12#1)
well as an##68##3##(1990-10#1)(1990-4#1)(1991-5#1)(1992-2#1)(1992-6#1)(1992-7#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-8#1)(1996-10#2)(1996-12#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-6#1)(2005-9#1)(2006-10#4)(2006-11#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#2)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#1)(2010-12#1)(2010-5#1)(2011-2#4)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#2)
well as being useful in##2##5##(1991-11#1)(1997-4#1)
well as being##12##3##(1991-11#1)(1992-7#1)(1993-3#1)(1997-4#1)(2005-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2009-10#1)(2009-6#1)
well as dry##2##3##(2008-8#1)(2011-1#1)
well as for the analysis of##2##6##(2006-5#1)(2008-3#1)
well as for the##38##4##(1992-7#1)(1996-7#1)(1996-8#1)(2006-10#1)(2006-2#1)(2006-5#2)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#2)(2008-8#2)(2008-9#1)(2009-8#1)(2010-2#1)(2010-7#1)(2012-12#2)(2013-1#2)(2013-7#1)
well as for##137##3##(1990-4#1)(1991-12#1)(1991-3#1)(1992-7#2)(1992-8#1)(1993-3#2)(1993-4#1)(1993-7#1)(1993-8#1)(1994-12#3)(1994-3#1)(1994-8#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-3#1)(1996-7#2)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-5#2)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#14)(2008-11#5)(2008-12#1)(2008-2#8)(2008-3#8)(2008-4#6)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#5)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
well as having a##2##4##(2008-8#1)(2011-2#1)
well as having##3##3##(2008-11#1)(2008-8#1)(2011-2#1)
well as in##372##3##(1990-11#3)(1990-12#1)(1990-3#2)(1990-4#2)(1990-6#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#1)(1992-12#5)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#3)(1992-6#2)(1992-7#2)(1992-9#2)(1993-11#2)(1993-12#3)(1993-3#3)(1993-4#2)(1993-5#2)(1993-6#1)(1993-8#2)(1994-12#5)(1994-3#3)(1994-5#1)(1994-6#6)(1994-8#2)(1994-9#2)(1995-11#2)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#2)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#4)(1996-2#1)(1996-4#2)(1996-5#1)(1996-6#2)(1996-7#4)(1996-8#3)(1996-9#1)(1997-1#1)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#4)(1997-8#2)(2004-11#1)(2004-12#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-6#1)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#2)(2006-6#3)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#6)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#8)(2008-10#34)(2008-11#13)(2008-12#5)(2008-2#7)(2008-3#4)(2008-4#3)(2008-5#15)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#7)(2009-10#2)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#2)(2009-8#4)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#3)(2010-3#1)(2010-4#2)(2010-6#2)(2010-8#1)(2011-1#4)(2011-12#2)(2011-2#10)(2012-1#3)(2012-11#2)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#12)(2013-7#2)(2013-8#2)
well as it##5##3##(2005-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2013-1#1)
well as other##80##3##(1991-2#1)(1991-3#2)(1991-8#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-4#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-12#2)(2007-3#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#2)(2009-3#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)
well as our##6##3##(2008-3#1)(2008-6#2)(2008-8#1)(2009-8#1)(2012-12#1)
well as providing##10##3##(1996-1#1)(1997-2#1)(2006-3#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-6#1)
well as smaller##2##3##(1997-8#1)(2008-4#1)
well as that of##28##4##(1990-3#1)(1990-5#2)(1992-10#1)(1992-3#1)(1993-11#1)(1994-6#1)(1996-7#1)(1997-3#1)(1997-5#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)
well as that##33##3##(1990-3#2)(1990-5#2)(1992-10#1)(1992-3#1)(1993-11#1)(1994-6#1)(1996-2#2)(1996-7#1)(1997-3#1)(1997-5#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#2)(2009-10#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#2)
well as the challenges##2##4##(2008-2#1)(2013-1#1)
well as the##1138##3##(1990-10#3)(1990-11#4)(1990-12#6)(1990-2#5)(1990-3#4)(1990-4#1)(1990-7#3)(1990-8#1)(1990-9#2)(1991-1#3)(1991-10#4)(1991-11#2)(1991-12#5)(1991-2#4)(1991-3#2)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#3)(1992-2#4)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#3)(1992-8#6)(1992-9#5)(1993-1#1)(1993-10#3)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#4)(1993-4#1)(1993-5#2)(1993-6#4)(1993-7#1)(1993-8#2)(1993-9#4)(1994-1#2)(1994-11#3)(1994-12#6)(1994-2#2)(1994-3#7)(1994-6#6)(1994-8#5)(1994-9#4)(1995-1#1)(1995-11#5)(1995-12#3)(1995-2#8)(1995-3#3)(1995-4#1)(1995-5#7)(1995-6#5)(1995-8#4)(1995-9#2)(1996-1#1)(1996-11#2)(1996-12#8)(1996-2#4)(1996-3#5)(1996-4#1)(1996-5#4)(1996-6#2)(1996-7#2)(1996-8#3)(1996-9#3)(1997-1#5)(1997-2#7)(1997-3#5)(1997-4#7)(1997-5#2)(1997-6#6)(1997-7#5)(1997-8#3)(2004-1#1)(2004-11#3)(2004-12#1)(2004-4#2)(2004-9#2)(2005-1#1)(2005-10#2)(2005-11#12)(2005-12#1)(2005-2#1)(2005-4#1)(2005-6#1)(2005-7#3)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#26)(2006-11#4)(2006-12#10)(2006-2#3)(2006-3#1)(2006-4#4)(2006-5#11)(2006-6#5)(2006-7#2)(2006-8#11)(2006-9#2)(2007-1#6)(2007-10#4)(2007-11#17)(2007-12#23)(2007-2#5)(2007-3#4)(2007-4#5)(2007-5#1)(2007-6#2)(2007-7#11)(2007-8#11)(2007-9#3)(2008-1#13)(2008-10#107)(2008-11#28)(2008-12#7)(2008-2#30)(2008-3#39)(2008-4#19)(2008-5#33)(2008-6#12)(2008-7#30)(2008-8#18)(2008-9#18)(2009-10#5)(2009-11#1)(2009-12#8)(2009-2#8)(2009-3#3)(2009-4#8)(2009-5#10)(2009-6#4)(2009-7#8)(2009-8#6)(2009-9#3)(2010-1#3)(2010-10#3)(2010-11#6)(2010-12#12)(2010-2#5)(2010-3#4)(2010-4#5)(2010-5#10)(2010-6#6)(2010-7#4)(2010-8#8)(2010-9#4)(2011-1#23)(2011-12#4)(2011-2#35)(2011-3#2)(2011-7#1)(2012-1#4)(2012-11#6)(2012-12#20)(2012-2#25)(2012-3#5)(2013-1#34)(2013-7#4)(2013-8#10)
well as their##103##3##(1990-11#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-5#2)(1991-6#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-10#1)(1997-2#1)(1997-6#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-2#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
well as theoretical##2##3##(2004-11#1)(2008-2#1)
well as those with##6##4##(1995-4#1)(2007-11#2)(2008-6#1)(2008-8#1)(2009-8#1)
well as those##29##3##(1991-5#1)(1992-1#1)(1992-8#1)(1993-2#1)(1994-11#1)(1995-4#1)(1997-2#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-11#2)(2007-2#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2011-2#1)
well as to assess the##4##5##(1994-3#1)(1994-8#1)(2010-6#1)(2011-1#1)
well as to assess##6##4##(1994-3#1)(1994-8#1)(2010-6#1)(2011-1#2)(2012-2#1)
well as to##176##3##(1990-12#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-6#2)(1992-1#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#4)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-7#3)(1997-8#1)(2005-7#2)(2006-10#7)(2006-11#2)(2006-12#3)(2006-2#1)(2006-6#3)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#15)(2008-11#4)(2008-2#8)(2008-3#3)(2008-4#4)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#4)(2009-11#1)(2009-3#1)(2009-4#2)(2010-10#4)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#8)(2011-2#7)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#3)
well as what is##2##4##(1994-3#1)(2007-4#1)
well as##6141##2##(1990-1#2)(1990-10#12)(1990-11#20)(1990-12#20)(1990-2#11)(1990-3#17)(1990-4#13)(1990-5#11)(1990-6#4)(1990-7#22)(1990-8#18)(1990-9#15)(1991-1#17)(1991-10#7)(1991-11#14)(1991-12#25)(1991-2#21)(1991-3#20)(1991-4#12)(1991-5#13)(1991-6#15)(1991-7#7)(1991-8#14)(1991-9#22)(1992-1#13)(1992-10#2)(1992-11#13)(1992-12#18)(1992-2#11)(1992-3#28)(1992-4#10)(1992-5#10)(1992-6#16)(1992-7#12)(1992-8#18)(1992-9#30)(1993-1#5)(1993-10#6)(1993-11#15)(1993-12#28)(1993-2#15)(1993-3#26)(1993-4#11)(1993-5#11)(1993-6#15)(1993-7#13)(1993-8#18)(1993-9#12)(1994-1#8)(1994-10#3)(1994-11#23)(1994-12#35)(1994-2#17)(1994-3#40)(1994-4#2)(1994-5#10)(1994-6#41)(1994-7#4)(1994-8#33)(1994-9#24)(1995-1#15)(1995-10#6)(1995-11#21)(1995-12#23)(1995-2#42)(1995-3#23)(1995-4#5)(1995-5#27)(1995-6#24)(1995-7#6)(1995-8#21)(1995-9#7)(1996-1#8)(1996-10#16)(1996-11#7)(1996-12#34)(1996-2#25)(1996-3#22)(1996-4#15)(1996-5#22)(1996-6#13)(1996-7#15)(1996-8#16)(1996-9#17)(1997-1#16)(1997-2#36)(1997-3#20)(1997-4#23)(1997-5#21)(1997-6#26)(1997-7#32)(1997-8#24)(1997-9#1)(2004-1#1)(2004-11#6)(2004-12#7)(2004-2#4)(2004-3#3)(2004-4#6)(2004-9#6)(2005-1#4)(2005-10#17)(2005-11#48)(2005-12#11)(2005-2#1)(2005-3#1)(2005-4#1)(2005-5#1)(2005-6#6)(2005-7#21)(2005-8#31)(2005-9#9)(2006-1#9)(2006-10#137)(2006-11#23)(2006-12#43)(2006-2#25)(2006-3#6)(2006-4#13)(2006-5#24)(2006-6#22)(2006-7#16)(2006-8#44)(2006-9#14)(2007-1#28)(2007-10#31)(2007-11#110)(2007-12#107)(2007-2#27)(2007-3#23)(2007-4#25)(2007-5#21)(2007-6#18)(2007-7#43)(2007-8#63)(2007-9#31)(2008-1#90)(2008-10#496)(2008-11#168)(2008-12#55)(2008-2#186)(2008-3#165)(2008-4#149)(2008-5#152)(2008-6#51)(2008-7#134)(2008-8#93)(2008-9#114)(2009-1#1)(2009-10#43)(2009-11#20)(2009-12#28)(2009-2#31)(2009-3#20)(2009-4#46)(2009-5#26)(2009-6#19)(2009-7#32)(2009-8#46)(2009-9#14)(2010-1#11)(2010-10#22)(2010-11#24)(2010-12#59)(2010-2#35)(2010-3#27)(2010-4#39)(2010-5#35)(2010-6#28)(2010-7#28)(2010-8#33)(2010-9#22)(2011-1#83)(2011-11#2)(2011-12#21)(2011-2#201)(2011-3#5)(2011-4#1)(2011-7#2)(2011-8#1)(2012-1#39)(2012-11#17)(2012-12#107)(2012-2#140)(2012-3#59)(2012-6#1)(2013-1#157)(2013-7#30)(2013-8#69)
well at the##3##3##(1992-7#1)(1994-9#1)(2008-12#1)
well at##15##2##(1991-2#1)(1992-3#1)(1992-7#1)(1994-9#1)(1995-3#1)(2004-12#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2009-4#1)
well attended##4##2##(2005-7#1)(2005-8#1)(2008-5#1)(2012-3#1)
well aware of the##3##4##(1995-6#1)(2008-5#2)
well balanced##4##2##(1994-7#1)(2005-11#1)(2007-8#1)(2008-6#1)
well be applied##2##3##(2008-10#1)(2010-8#1)
well be the##5##3##(1995-8#1)(2006-7#1)(2006-8#1)(2009-11#1)(2012-2#1)
well be##24##2##(1991-5#1)(1992-1#1)(1993-5#1)(1994-4#1)(1994-6#1)(1994-9#1)(1995-5#1)(1995-8#1)(1997-8#1)(2004-12#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-11#1)(2010-8#1)(2012-12#1)(2012-2#1)
well before the##3##3##(1996-3#1)(2006-10#1)(2012-2#1)
well before##6##2##(1996-3#1)(2006-10#1)(2007-2#1)(2008-10#1)(2009-11#1)(2012-2#1)
well behaved##4##2##(1991-3#2)(2008-2#1)(2012-2#1)
well being as##2##3##(2008-1#1)(2011-1#1)
well being in##3##3##(1990-1#1)(2006-2#1)(2008-11#1)
well being of the##2##4##(2010-8#1)(2012-11#1)
well being of##4##3##(2006-2#1)(2008-7#1)(2010-8#1)(2012-11#1)
well being##29##2##(1990-1#1)(1993-2#1)(1994-6#1)(1995-1#3)(1996-9#1)(2006-10#2)(2006-2#2)(2006-7#3)(2007-2#1)(2007-9#1)(2008-1#3)(2008-11#1)(2008-2#2)(2008-7#2)(2009-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)
well below that required##2##4##(2007-12#1)(2008-7#1)
well below that##5##3##(1997-5#1)(2007-12#1)(2008-7#1)(2010-11#1)(2011-1#1)
well below the diffraction##2##4##(2008-2#2)
well below the limits##2##4##(2008-3#1)(2008-5#1)
well below the##15##3##(1992-12#1)(1993-2#1)(1995-12#1)(1995-2#1)(1997-7#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#3)(2013-7#1)
well below##34##2##(1990-11#1)(1992-12#1)(1993-2#1)(1995-12#1)(1995-2#1)(1997-5#1)(1997-7#1)(2005-11#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2010-11#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
well beyond the##7##3##(1997-1#1)(2006-4#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-3#1)(2012-12#1)
well beyond##8##2##(1992-3#1)(1997-1#1)(2006-4#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-3#1)(2012-12#1)
well but##4##2##(1994-8#1)(2008-10#1)(2008-12#1)(2012-3#1)
well by a##2##3##(2008-10#1)(2008-2#1)
well by the##6##3##(1996-4#1)(2005-11#1)(2008-10#2)(2008-3#1)(2009-5#1)
well by##21##2##(1990-10#1)(1991-3#1)(1992-4#1)(1993-6#1)(1996-4#1)(1996-8#1)(2005-11#1)(2006-2#1)(2007-7#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-9#1)(2009-5#1)(2013-1#2)
well characterised##5##2##(1991-7#1)(2006-2#1)(2007-1#1)(2007-11#1)(2008-1#1)
well characterized and##4##3##(2008-10#1)(2009-5#1)(2011-1#1)(2012-12#1)
well characterized in the##2##4##(1991-7#1)(2007-2#1)
well characterized in##10##3##(1991-10#1)(1991-7#1)(1995-11#1)(2006-10#1)(2007-2#2)(2008-11#1)(2008-8#2)(2009-4#1)
well characterized##58##2##(1990-11#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-3#1)(1993-5#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-3#3)(1996-11#1)(1996-12#2)(1996-5#1)(1997-1#1)(1997-6#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-2#2)(2008-10#2)(2008-11#1)(2008-4#2)(2008-8#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-11#1)(2010-5#1)(2011-1#4)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
well children##3##2##(1996-1#1)(2012-2#1)(2013-1#1)
well circumscribed##4##2##(1990-2#1)(2007-8#1)(2009-7#2)
well clarified##3##2##(2006-10#1)(2008-11#1)(2008-8#1)
well conditioned##2##2##(2008-2#1)(2008-3#1)
well conducted##3##2##(2007-2#1)(2007-7#1)(2007-8#1)
well connected##3##2##(1996-4#1)(2008-8#1)(2009-7#1)
well conserved among the##3##4##(1991-3#1)(1996-5#1)(2012-2#1)
well conserved among##7##3##(1991-3#1)(1994-9#1)(1996-5#2)(1997-2#1)(2008-7#1)(2012-2#1)
well conserved and##2##3##(2008-7#1)(2009-10#1)
well conserved between##2##3##(1991-12#1)(1994-3#1)
well conserved##30##2##(1990-5#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-5#1)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-3#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-5#2)(1997-2#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#1)(2010-10#1)(2012-2#1)
well containing##2##2##(1991-9#1)(2008-11#1)
well controlled with##2##3##(1994-12#1)(2011-1#1)
well controlled##15##2##(1992-6#1)(1994-12#2)(1997-8#1)(2006-10#1)(2006-4#1)(2008-10#1)(2008-12#2)(2008-6#1)(2009-2#1)(2010-10#1)(2011-1#1)(2012-1#1)(2012-3#1)
well correlated to##2##3##(2004-12#1)(2006-12#1)
well correlated with##8##3##(1992-1#1)(1993-12#1)(1995-5#1)(1996-1#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-7#1)
well correlated##12##2##(1992-1#1)(1993-12#1)(1995-5#1)(1996-1#1)(2004-12#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-6#1)(2008-7#1)(2012-3#1)
well counter##2##2##(1992-10#1)(1994-12#1)
well defined and##7##3##(1990-2#1)(1996-2#1)(2005-5#1)(2009-8#1)(2009-9#1)(2011-1#1)(2012-11#1)
well defined at##2##3##(2008-7#1)(2010-6#1)
well defined but##2##3##(1992-2#1)(2008-11#1)
well defined flow conditions##2##4##(2008-10#1)(2008-11#1)
well defined in the##3##4##(2006-1#1)(2008-3#1)(2008-9#1)
well defined in##5##3##(2006-1#1)(2008-10#1)(2008-3#2)(2008-9#1)
well defined surface##2##3##(2007-8#1)(2008-10#1)
well defined##93##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-8#1)(1990-9#2)(1991-4#1)(1991-7#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-5#1)(1994-9#2)(1995-11#1)(1995-3#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-4#1)(2004-1#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-5#1)(2006-1#1)(2006-10#7)(2006-11#1)(2006-2#1)(2006-5#2)(2006-8#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#3)(2007-8#4)(2008-10#8)(2008-11#3)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#4)(2008-9#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-6#1)(2011-1#3)(2011-2#4)(2012-11#1)(2012-2#2)(2013-1#2)
well delineated##2##2##(1993-6#1)(2008-4#1)
well demarcated##3##2##(1993-9#1)(2007-8#1)(2012-12#1)
well demonstrated##3##2##(1996-9#2)(2007-11#1)
well depth##3##2##(1992-9#1)(2010-2#2)
well described and##3##3##(2005-11#1)(2007-7#1)(2009-1#1)
well described by a##10##4##(1990-7#1)(1992-11#1)(1995-8#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-3#1)
well described by the beta-binomial##2##5##(2008-10#2)
well described by the##7##4##(1992-2#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)
well described by##22##3##(1990-7#1)(1992-11#1)(1992-2#1)(1995-8#1)(1996-3#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#1)(2010-4#1)
well described complication##2##3##(2008-5#1)(2008-8#1)
well described for##3##3##(2005-10#1)(2009-11#1)(2009-12#1)
well described in the##3##4##(2007-1#1)(2007-12#1)(2008-1#1)
well described in##12##3##(1991-6#1)(1994-9#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-9#1)(2008-1#2)(2009-12#1)(2009-7#1)(2009-8#1)(2013-1#1)
well described##63##2##(1990-7#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-3#1)(2005-10#1)(2005-11#2)(2006-10#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#3)(2008-5#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-7#1)(2009-8#1)(2010-4#1)(2011-2#5)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
well designed clinical trials##3##4##(1997-3#1)(2006-6#1)(2008-7#1)
well designed clinical##4##3##(1997-3#1)(2006-6#1)(2007-11#1)(2008-7#1)
well designed trials of##2##4##(2007-11#2)
well designed##10##2##(1995-12#1)(1997-3#1)(2006-6#1)(2007-11#3)(2008-4#1)(2008-7#1)(2011-1#1)(2011-12#1)
well determined##4##2##(1992-3#1)(1994-11#1)(2008-3#1)(2011-1#1)
well developed in##2##3##(2006-5#1)(2012-3#1)
well developed on##2##3##(2008-7#1)(2013-7#1)
well developed##19##2##(1994-12#1)(1994-7#1)(2006-5#1)(2007-1#1)(2007-12#1)(2008-11#1)(2008-5#3)(2008-7#4)(2009-12#1)(2009-9#1)(2012-3#1)(2013-1#2)(2013-7#1)
well differentiated and##2##3##(1994-6#1)(2006-8#1)
well differentiated endocrine##2##3##(2011-2#2)
well differentiated##12##2##(1990-2#1)(1991-7#1)(1992-2#1)(1994-10#1)(1994-6#1)(1994-9#1)(2006-8#1)(2008-6#1)(2008-8#2)(2011-2#2)
well dispersed##2##2##(2005-11#1)(2013-1#1)
well distributed##3##2##(1995-4#1)(2008-8#1)(2009-7#1)
well do##3##2##(1997-3#1)(2008-10#1)(2008-8#1)
well documented and##9##3##(1994-12#1)(1996-9#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-12#1)(2009-6#1)(2011-2#1)
well documented for##4##3##(1996-2#1)(2006-11#1)(2008-7#1)(2012-1#1)
well documented in the##3##4##(1997-8#1)(2006-10#1)(2008-5#1)
well documented in##15##3##(1991-4#1)(1993-4#1)(1997-7#1)(1997-8#1)(2006-10#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-2#1)(2009-6#1)(2013-1#1)
well documented that##6##3##(1994-2#1)(1995-6#1)(2007-7#1)(2008-3#1)(2008-7#1)(2011-2#1)
well documented##104##2##(1990-6#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-12#1)(1992-4#1)(1993-11#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-4#1)(1995-6#2)(1995-9#1)(1996-12#2)(1996-2#1)(1996-8#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-3#1)(2005-10#1)(2006-10#7)(2006-11#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#3)(2009-10#2)(2009-12#2)(2009-2#2)(2009-6#2)(2009-7#1)(2010-11#1)(2010-3#2)(2011-1#2)(2011-2#2)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#2)
well educated and##2##3##(2006-1#1)(2007-10#1)
well educated##5##2##(1995-2#1)(2006-1#1)(2007-10#1)(2013-1#1)(2013-7#1)
well equipped##2##2##(1993-10#1)(2007-12#1)
well established and##6##3##(2007-6#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-9#1)(2013-1#1)
well established as##5##3##(2005-2#1)(2008-11#1)(2008-8#1)(2009-3#1)(2013-8#1)
well established case##2##3##(2008-2#1)(2010-12#1)
well established in the treatment of##2##6##(2007-11#1)(2008-1#1)
well established in the##8##4##(2007-11#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-5#2)(2009-10#1)(2013-1#1)
well established in##15##3##(1995-5#1)(1996-9#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-5#2)(2009-10#2)(2012-11#1)(2013-1#1)
well established since the##2##4##(2007-8#1)(2008-10#1)
well established that patients with##2##5##(1996-7#1)(2006-10#1)
well established that the##5##4##(1992-9#1)(1996-4#1)(2006-10#1)(2008-5#1)(2009-9#1)
well established that##29##3##(1992-9#1)(1994-11#1)(1996-4#1)(1996-7#1)(1997-1#1)(2005-10#1)(2006-10#3)(2006-3#1)(2007-10#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-11#1)(2011-2#1)(2013-8#1)
well established##157##2##(1990-11#1)(1990-4#1)(1991-11#2)(1991-12#1)(1991-5#1)(1992-3#2)(1992-6#1)(1992-9#1)(1994-1#1)(1994-10#1)(1994-11#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#1)(2004-12#1)(2005-10#1)(2005-11#2)(2005-2#1)(2005-8#1)(2006-10#10)(2006-12#1)(2006-2#2)(2006-3#2)(2006-8#1)(2007-10#3)(2007-11#3)(2007-12#1)(2007-2#3)(2007-3#2)(2007-6#2)(2007-7#4)(2007-8#4)(2007-9#2)(2008-1#5)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#4)
well evident##2##2##(1991-4#1)(1994-9#1)
well explained by##4##3##(1997-7#1)(2007-5#1)(2007-7#1)(2008-8#1)
well explained##6##2##(1997-7#1)(2007-5#1)(2007-7#1)(2008-8#1)(2009-3#1)(2013-8#1)
well extracted##2##2##(2008-10#1)(2008-7#1)
well fit by a##2##4##(1996-9#1)(2008-2#1)
well fit by##3##3##(1996-9#1)(2007-4#1)(2008-2#1)
well fit##4##2##(1996-9#1)(2007-4#1)(2007-8#1)(2008-2#1)
well fitted by##3##3##(1995-6#1)(2008-3#2)
well fitted to##2##3##(2007-12#1)(2008-10#1)
well fitted##6##2##(1995-6#1)(2007-12#1)(2008-10#1)(2008-3#2)(2011-2#1)
well for all the##2##4##(2007-12#1)(2008-12#1)
well for all##4##3##(1996-8#1)(2007-12#1)(2008-10#1)(2008-12#1)
well for almost##2##3##(2007-8#1)(2012-3#1)
well for the##9##3##(1993-2#1)(1993-3#1)(1995-9#1)(2006-8#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-12#1)(2012-2#1)
well for##44##2##(1993-2#1)(1993-3#1)(1995-9#1)(1996-8#1)(2006-7#1)(2006-8#1)(2007-12#4)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#4)(2008-4#4)(2008-5#1)(2008-8#1)(2010-5#1)(2010-6#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#1)
well formed##4##2##(1993-1#1)(1996-11#1)(2005-11#1)(2010-4#1)
well founded##2##2##(1993-5#1)(1996-12#1)
well from##2##2##(2008-1#1)(2012-12#1)
well have##6##2##(1992-2#1)(1993-5#1)(1995-1#1)(2007-9#1)(2008-10#1)(2012-3#1)
well illustrated in the##2##4##(1990-2#1)(2008-10#1)
well in a##2##3##(2011-1#1)(2013-1#1)
well in advance of##2##4##(1992-7#1)(1993-9#1)
well in all##2##3##(2008-10#1)(2008-3#1)
well in both##4##3##(1992-9#1)(1997-3#1)(2006-4#1)(2009-7#1)
well in numerical##2##3##(2008-3#1)(2008-6#1)
well in terms of##2##4##(2005-11#1)(2008-10#1)
well in the pH range##2##5##(2008-10#2)
well in the##15##3##(1995-2#1)(2004-12#1)(2007-12#1)(2007-6#1)(2008-10#5)(2008-11#2)(2008-2#1)(2010-10#1)(2010-12#1)(2013-8#1)
well in this##2##3##(2006-10#1)(2010-5#1)
well in two##2##3##(1990-2#1)(1997-8#1)
well in##68##2##(1990-2#1)(1992-7#1)(1992-9#1)(1993-9#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-8#2)(1997-3#1)(1997-8#1)(2004-12#1)(2005-11#3)(2006-10#1)(2006-12#1)(2006-4#2)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#11)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#5)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
well influence the##2##3##(2008-7#1)(2008-9#1)
well informed about the##6##4##(1996-3#1)(1997-6#1)(2007-9#1)(2008-10#1)(2008-9#1)(2009-9#1)
well informed##12##2##(1996-2#1)(1996-3#1)(1997-6#1)(2005-11#1)(2007-9#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-9#1)(2011-1#1)(2011-2#2)
well inside the##2##3##(1991-8#1)(2008-2#1)
well integrated##3##2##(1996-1#1)(2007-11#1)(2008-3#1)
well into the next##2##4##(2005-7#1)(2007-8#1)
well into the##12##3##(1992-9#1)(1996-2#1)(2005-11#1)(2005-7#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)
well into##18##2##(1991-12#1)(1991-7#1)(1992-9#1)(1996-2#1)(2005-11#1)(2005-7#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-5#2)(2008-6#1)(2009-5#1)(2012-11#1)(2012-12#1)
well investigated in##2##3##(1992-8#1)(1996-1#1)
well investigated##6##2##(1992-8#1)(1996-1#1)(2006-10#1)(2007-8#1)(2008-7#1)(2008-9#1)
well is##6##2##(1994-2#1)(1996-2#1)(2006-7#1)(2007-12#1)(2007-2#1)(2008-4#1)
well known and##4##3##(1990-2#1)(1996-3#1)(1997-5#1)(2008-3#1)
well known as a##4##4##(1991-6#1)(2005-7#1)(2008-5#1)(2012-2#1)
well known as##7##3##(1991-6#1)(1992-6#1)(2005-7#1)(2007-11#1)(2008-5#1)(2008-7#1)(2012-2#1)
well known but##4##3##(1995-11#1)(2007-8#1)(2011-12#1)(2012-2#1)
well known complications##2##3##(2007-7#1)(2012-3#1)
well known for their##2##4##(2008-1#1)(2008-5#1)
well known for##6##3##(2008-1#1)(2008-2#1)(2008-5#1)(2009-6#1)(2012-12#1)(2012-2#1)
well known in the##6##4##(1996-3#1)(2006-10#1)(2006-3#1)(2008-12#1)(2009-10#1)(2012-2#1)
well known in##8##3##(1995-2#1)(1996-3#1)(2006-10#2)(2006-3#1)(2008-12#1)(2009-10#1)(2012-2#1)
well known is##2##3##(2006-12#1)(2011-2#1)
well known that a##3##4##(1996-3#1)(2007-2#1)(2008-2#1)
well known that the##13##4##(1990-9#1)(1993-3#1)(1997-2#1)(1997-6#1)(2005-11#1)(2007-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2013-1#1)
well known that##52##3##(1990-9#1)(1991-6#1)(1991-8#1)(1992-6#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-4#1)(1996-3#1)(1997-2#1)(1997-5#1)(1997-6#1)(2005-11#1)(2006-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#7)(2008-5#1)(2008-8#1)(2009-12#1)(2009-2#1)(2010-12#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)
well known to be##9##4##(1994-11#1)(2007-1#1)(2007-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-3#1)(2010-4#1)(2013-8#1)
well known to the##3##4##(1997-3#1)(2010-12#1)(2011-2#1)
well known to##24##3##(1990-4#1)(1994-11#1)(1997-1#1)(1997-3#1)(2006-1#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-5#2)(2008-7#2)(2009-8#1)(2010-12#2)(2010-3#1)(2010-4#1)(2011-2#1)(2013-1#2)(2013-8#1)
well known trophic##2##3##(1995-12#1)(1997-4#1)
well known##232##2##(1990-2#1)(1990-4#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#2)(1991-6#2)(1991-8#1)(1992-11#3)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-11#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-4#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#4)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(2005-11#2)(2005-7#1)(2006-1#2)(2006-10#4)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#8)(2007-12#5)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#4)(2007-9#3)(2008-1#4)(2008-10#12)(2008-11#6)(2008-12#2)(2008-2#7)(2008-3#12)(2008-4#1)(2008-5#8)(2008-7#6)(2008-8#2)(2008-9#2)(2009-10#3)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#5)(2010-3#1)(2010-4#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-11#1)(2012-12#1)(2012-2#10)(2012-3#5)(2013-1#9)(2013-8#3)
well lead to##2##3##(1995-1#1)(1997-8#1)
well localized##2##2##(1993-12#1)(2008-10#1)
well logs##2##2##(1997-5#1)(2013-1#1)
well maintained##4##2##(2007-8#2)(2008-4#1)(2008-9#1)
well managed##3##2##(2005-11#1)(2008-7#1)(2011-3#1)
well matched to##2##3##(2008-11#1)(2008-2#1)
well matched##7##2##(1991-6#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2010-7#1)
well mixed##2##2##(2008-8#2)
well of a 96-well microtiter##2##5##(1994-3#1)(2008-9#1)
well of a##3##3##(1994-3#1)(2008-11#1)(2008-9#1)
well of##7##2##(1994-3#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)
well on both##2##3##(2006-10#1)(2009-4#1)
well on the##3##3##(1995-9#1)(2008-11#1)(2008-5#1)
well on their##2##3##(2008-5#1)(2009-4#1)
well on##19##2##(1991-8#1)(1993-12#1)(1995-9#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2009-4#2)(2010-12#1)(2013-1#2)(2013-8#1)
well one year##2##3##(2006-7#1)(2013-1#1)
well onto##2##2##(2006-12#1)(2008-3#1)
well or better##3##3##(1997-8#1)(2008-11#1)(2008-9#1)
well or##7##2##(1997-8#1)(2006-6#1)(2007-7#1)(2008-11#1)(2008-9#2)(2012-2#1)
well organized##8##2##(1992-9#1)(2005-8#2)(2006-10#1)(2008-10#1)(2012-2#1)(2013-1#2)
well outside##2##2##(2008-3#1)(2010-8#1)
well over 100##2##3##(1991-5#1)(2006-11#1)
well over a wide##3##4##(2007-11#1)(2008-10#2)
well over a##9##3##(1990-5#1)(2007-11#1)(2008-10#5)(2008-3#1)(2011-2#1)
well over the##2##3##(1997-1#1)(2006-7#1)
well over##17##2##(1990-5#1)(1991-5#1)(1997-1#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-11#1)(2008-10#6)(2008-3#1)(2011-2#1)(2012-12#2)
well placed to##4##3##(2010-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
well planned##4##2##(2008-7#1)(2011-1#1)(2011-2#2)
well plate##2##2##(2008-11#2)
well posed##2##2##(2006-12#1)(2008-3#1)
well positioned to##3##3##(2007-4#1)(2008-9#1)(2012-12#1)
well predicted##5##2##(1995-11#1)(1995-6#1)(2007-4#1)(2008-10#2)
well prepared##5##2##(1994-1#1)(1997-2#1)(2008-9#1)(2009-4#1)(2012-2#1)
well preserved after##2##3##(1994-3#1)(2012-3#1)
well preserved##12##2##(1990-11#1)(1994-3#2)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-12#1)(2010-7#1)(2012-2#1)(2012-3#1)
well protected##3##2##(2008-10#1)(2008-9#1)(2011-1#1)
well proven##3##2##(1997-3#1)(2008-1#1)(2010-7#1)
well qualified##2##2##(2007-7#1)(2009-4#1)
well received by the##4##4##(1997-8#1)(2007-9#1)(2008-11#1)(2008-12#1)
well received by##5##3##(1997-8#1)(2007-9#1)(2008-11#1)(2008-12#2)
well received##7##2##(1996-3#1)(1997-8#1)(2007-9#1)(2008-11#1)(2008-12#2)(2008-5#1)
well recognised##5##2##(1993-12#1)(2008-11#1)(2008-6#1)(2008-7#1)(2012-2#1)
well recognized and##3##3##(2008-10#1)(2009-9#1)(2012-12#1)
well recognized that##7##3##(1990-9#1)(1996-9#1)(2006-3#1)(2008-1#1)(2008-8#1)(2009-9#1)(2010-2#1)
well recognized##30##2##(1990-2#2)(1990-9#1)(1993-12#1)(1993-9#1)(1995-6#1)(1996-11#1)(1996-9#1)(2006-10#3)(2006-3#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#2)(2010-2#1)(2010-3#1)(2011-2#2)(2012-12#2)
well reported##2##2##(2007-8#1)(2008-5#1)
well represented by##2##3##(1992-9#1)(1996-5#1)
well represented in the##2##4##(1992-9#1)(2010-2#1)
well represented##6##2##(1992-9#2)(1996-5#1)(2008-1#1)(2008-8#1)(2010-2#1)
well reproduced by##2##3##(1995-1#1)(2005-11#1)
well reproduced##4##2##(1995-1#1)(2005-11#1)(2011-2#2)
well resolved from##4##3##(1991-5#1)(2008-10#1)(2010-2#1)(2011-1#1)
well resolved##13##2##(1991-2#1)(1991-5#1)(2007-12#1)(2007-5#1)(2008-10#4)(2008-4#1)(2009-9#2)(2010-2#1)(2011-1#1)
well separated from cytotoxicity##3##4##(1997-2#3)
well separated from the##2##4##(2008-10#1)(2010-12#1)
well separated from##7##3##(1996-8#1)(1997-2#3)(2007-8#1)(2008-10#1)(2010-12#1)
well separated in##3##3##(1996-8#1)(2008-10#2)
well separated within##6##3##(1994-9#1)(2008-10#5)
well separated##31##2##(1990-8#1)(1994-9#1)(1996-2#1)(1996-5#1)(1996-8#2)(1997-2#3)(1997-3#1)(1997-8#1)(2005-11#1)(2005-4#1)(2007-11#1)(2007-8#1)(2008-10#15)(2010-12#1)
well simulated with##2##3##(1996-2#1)(2008-7#1)
well simulated##3##2##(1996-2#1)(2005-11#1)(2008-7#1)
well since##2##2##(1995-4#1)(2013-7#1)
well soluble in##2##3##(1991-12#1)(2008-10#1)
well statistically##2##2##(2008-4#1)(2013-7#1)
well studied in##4##3##(2007-1#1)(2007-7#1)(2008-1#1)(2008-8#1)
well studied##26##2##(1990-8#1)(1991-12#2)(1994-9#1)(1995-11#1)(1997-3#2)(2005-8#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-1#3)(2008-5#2)(2008-8#2)(2008-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
well suitable for##2##3##(2008-10#2)
well suitable##3##2##(2006-10#1)(2008-10#2)
well suited as##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
well suited for a##2##4##(2008-2#2)
well suited for applications##2##4##(1993-11#1)(2008-1#1)
well suited for the##7##4##(1996-8#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-4#2)(2011-1#1)
well suited for use##3##4##(2004-11#1)(2007-12#2)
well suited for##47##3##(1993-11#1)(1995-2#1)(1996-8#1)(1997-3#1)(1997-6#1)(2004-11#1)(2007-11#2)(2007-12#6)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#8)(2010-8#1)(2010-9#1)(2011-1#3)
well suited to the##11##4##(1991-5#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-6#1)(2010-2#1)
well suited to##30##3##(1991-5#2)(1993-11#1)(1993-2#1)(1994-2#1)(1996-5#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-1#1)(2013-1#2)
well suited##81##2##(1991-5#2)(1993-11#2)(1993-2#1)(1994-2#1)(1995-2#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-11#1)(2006-12#1)(2007-11#3)(2007-12#8)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#8)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-1#1)(2013-1#2)
well supported by##4##3##(1995-11#1)(1996-3#1)(2008-11#1)(2009-4#1)
well supported##7##2##(1995-11#1)(1996-3#1)(2008-11#1)(2009-4#1)(2011-2#1)(2012-12#2)
well that##6##2##(1990-8#1)(2006-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
well the observed##2##3##(2007-12#1)(2008-9#1)
well the##38##2##(1990-11#1)(1990-12#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-4#1)(2004-2#1)(2006-10#1)(2006-11#2)(2007-12#3)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-2#1)(2010-3#1)(2011-4#1)(2013-1#4)
well to a##3##3##(1990-7#1)(2007-2#1)(2007-6#1)
well to all##2##3##(1997-8#1)(2009-9#1)
well to an##2##3##(1997-6#1)(2008-10#1)
well to provide##2##3##(2007-3#1)(2013-3#1)
well to the treatment##2##4##(2007-7#1)(2012-2#1)
well to the##16##3##(1991-11#1)(1992-12#1)(1993-12#1)(1994-6#1)(1994-9#1)(1996-6#1)(1997-2#1)(2004-4#1)(2007-12#1)(2007-7#3)(2008-10#1)(2008-6#1)(2012-2#1)(2013-8#1)
well to treatment##3##3##(2006-7#1)(2008-1#1)(2013-1#1)
well to##79##2##(1990-1#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-2#1)(1996-6#1)(1997-2#2)(1997-4#2)(1997-6#1)(1997-8#2)(2004-4#1)(2005-11#1)(2006-10#7)(2006-12#1)(2006-3#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#9)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#3)(2008-6#1)(2008-8#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-3#1)(2013-8#1)
well tolerated and effective in patients with##2##7##(2007-11#1)(2009-3#1)
well tolerated and effective in##4##5##(2006-2#1)(2007-11#2)(2009-3#1)
well tolerated and effective##5##4##(1993-5#1)(2006-2#1)(2007-11#2)(2009-3#1)
well tolerated and immunogenic##2##4##(2012-12#1)(2013-1#1)
well tolerated and it##2##4##(1990-10#1)(2011-2#1)
well tolerated and no##6##4##(1990-5#1)(1991-3#1)(1996-1#1)(2007-11#1)(2007-7#1)(2008-3#1)
well tolerated and the##2##4##(2007-7#1)(2011-2#1)
well tolerated and##40##3##(1990-10#1)(1990-5#1)(1991-3#1)(1992-10#1)(1993-5#1)(1995-10#1)(1996-1#1)(1996-9#1)(2005-10#1)(2005-8#2)(2006-2#1)(2006-6#1)(2007-11#6)(2007-6#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#3)(2009-3#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
well tolerated as##2##3##(1997-1#1)(2007-11#1)
well tolerated by most##3##4##(1992-12#1)(2006-10#2)
well tolerated by patients##6##4##(1990-12#1)(1993-5#1)(2007-11#1)(2007-7#1)(2008-2#1)(2010-6#1)
well tolerated by the patient##2##5##(1990-4#1)(2007-8#1)
well tolerated by the##7##4##(1990-12#1)(1990-4#1)(1992-8#1)(1994-9#1)(2007-8#1)(2008-5#2)
well tolerated by##23##3##(1990-12#2)(1990-4#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-5#1)(1994-9#1)(2006-10#2)(2007-11#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-2#1)(2008-5#3)(2009-4#1)(2010-6#1)
well tolerated for##2##3##(2008-7#1)(2012-12#1)
well tolerated in both the##2##5##(2008-3#2)
well tolerated in combination with##2##5##(2008-7#1)(2008-8#1)
well tolerated in healthy##2##4##(1996-1#1)(2011-2#1)
well tolerated in the treatment of##2##6##(2008-3#1)(2008-5#1)
well tolerated in the##7##4##(1993-11#1)(2007-11#1)(2008-11#2)(2008-3#1)(2008-5#1)(2011-2#1)
well tolerated in this##2##4##(2007-1#1)(2007-11#1)
well tolerated in##28##3##(1993-11#1)(1996-1#1)(1996-8#1)(2005-7#1)(2007-1#1)(2007-11#5)(2007-8#1)(2008-11#2)(2008-3#7)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#2)(2012-12#1)
well tolerated over##2##3##(2005-7#1)(2008-3#1)
well tolerated with no##3##4##(2004-2#1)(2007-11#1)(2011-2#1)
well tolerated with##9##3##(1997-3#1)(2004-2#1)(2005-8#1)(2006-6#2)(2007-11#1)(2008-6#1)(2008-7#1)(2011-2#1)
well tolerated##217##2##(1990-10#2)(1990-12#4)(1990-3#1)(1990-4#5)(1990-5#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-4#3)(1991-6#1)(1991-7#1)(1992-10#2)(1992-11#1)(1992-12#2)(1992-8#2)(1993-11#1)(1993-5#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-6#1)(1994-9#3)(1995-10#1)(1995-9#1)(1996-1#2)(1996-2#2)(1996-8#1)(1996-9#2)(1997-1#2)(1997-3#1)(1997-8#2)(2004-2#1)(2005-10#1)(2005-7#4)(2005-8#4)(2006-10#7)(2006-12#3)(2006-2#1)(2006-4#2)(2006-6#3)(2006-7#1)(2007-1#2)(2007-10#2)(2007-11#24)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#6)(2007-9#3)(2008-1#2)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#21)(2008-4#1)(2008-5#10)(2008-6#6)(2008-7#9)(2008-8#5)(2008-9#1)(2009-3#2)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#6)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
well trained young##2##3##(1994-4#1)(2007-6#1)
well trained##8##2##(1993-11#1)(1994-4#1)(1994-8#1)(1996-2#1)(2007-6#1)(2008-8#1)(2011-1#1)(2012-2#1)
well under way##2##3##(1993-6#1)(2008-2#1)
well under##7##2##(1993-6#1)(2007-11#1)(2008-2#3)(2008-8#1)(2013-7#1)
well understand the##2##3##(2008-10#2)
well understood by the##2##4##(1997-6#1)(2005-11#1)
well understood in##5##3##(2008-10#2)(2009-4#1)(2011-2#1)(2013-8#1)
well understood that##4##3##(2010-12#1)(2012-12#1)(2013-1#2)
well understood##94##2##(1990-4#1)(1991-9#1)(1992-5#1)(1993-3#1)(1993-9#2)(1994-2#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(2004-11#1)(2005-11#1)(2006-10#3)(2006-3#1)(2007-11#3)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#5)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#3)(2008-9#2)(2009-1#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#2)
well underway##2##2##(2006-7#1)(2009-10#1)
well until##2##2##(2006-10#1)(2007-12#1)
well using##2##2##(2008-10#1)(2009-6#1)
well validated##8##2##(2007-6#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
well vascularized##2##2##(2008-12#1)(2008-7#1)
well versed in##3##3##(2005-7#1)(2007-12#1)(2010-2#1)
well versed##4##2##(2005-7#1)(2007-12#1)(2010-2#1)(2012-2#1)
well visualized##3##2##(1997-8#1)(2009-10#1)(2010-8#1)
well water and##2##3##(2008-10#2)
well water##10##2##(2007-8#1)(2008-10#6)(2008-4#1)(2011-12#1)(2011-2#1)
well when the##3##3##(1996-8#1)(2008-10#1)(2008-2#1)
well when##10##2##(1996-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-6#1)(2012-3#1)
well which##2##2##(2008-10#1)(2008-5#1)
well with Monte Carlo##2##4##(2008-3#2)
well with a simple##2##4##(1995-8#1)(2007-11#1)
well with a sixth-order polynomial##2##5##(2008-2#2)
well with a##18##3##(1994-3#1)(1995-8#2)(2005-11#1)(2007-11#2)(2007-12#3)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-2#1)
well with an##2##3##(1992-9#1)(2007-12#1)
well with corresponding##2##3##(2008-10#1)(2008-3#1)
well with data obtained by##2##5##(1992-2#1)(2008-10#1)
well with data obtained##6##4##(1992-2#1)(2007-8#1)(2008-10#4)
well with data##7##3##(1992-2#1)(2007-8#1)(2008-10#4)(2008-3#1)
well with existing##2##3##(2008-3#1)(2010-10#1)
well with experimental values##2##4##(1995-8#1)(2008-11#1)
well with experimental##5##3##(1995-8#1)(2007-12#1)(2008-11#1)(2008-3#1)(2009-7#1)
well with literature values##2##4##(2008-10#1)(2008-7#1)
well with no evidence of##3##5##(2006-10#1)(2007-12#1)(2007-8#1)
well with no##4##3##(2006-10#1)(2007-12#1)(2007-8#1)(2010-10#1)
well with others##2##3##(2007-8#1)(2011-1#1)
well with our##3##3##(2007-12#2)(2008-3#1)
well with previous##4##3##(1996-5#1)(2005-11#1)(2008-10#1)(2008-3#1)
well with results##3##3##(2007-8#1)(2008-10#2)
well with simple##2##3##(2008-3#1)(2010-2#1)
well with that observed##2##4##(1996-5#1)(2008-10#1)
well with that##9##3##(1992-3#1)(1994-11#2)(1996-5#1)(2008-10#3)(2008-3#1)(2008-8#1)
well with the activity of the##2##6##(1997-7#1)(2008-6#1)
well with the certified values##2##5##(2008-10#2)
well with the certified##3##4##(2008-10#3)
well with the changes in##2##5##(1994-12#1)(2007-11#1)
well with the corresponding##2##4##(2008-10#1)(2008-11#1)
well with the exact##2##4##(2008-2#1)(2008-3#1)
well with the experimental data##3##5##(2008-2#1)(2008-3#1)(2008-7#1)
well with the experimental results##5##5##(2006-10#1)(2006-11#1)(2007-11#1)(2008-3#1)(2010-5#1)
well with the experimental##10##4##(2006-10#1)(2006-11#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2010-5#1)
well with the expression##2##4##(1994-7#1)(1996-3#1)
well with the high performance liquid chromatography (HPLC) method##2##9##(1995-7#1)(2008-10#1)
well with the known##2##4##(1991-4#1)(2008-11#1)
well with the literature##2##4##(2008-10#2)
well with the observed##2##4##(1995-2#1)(2010-12#1)
well with the results of##5##5##(1991-12#1)(1992-7#1)(1992-9#1)(1995-2#1)(1996-9#1)
well with the results##8##4##(1990-11#1)(1991-12#1)(1992-7#1)(1992-9#1)(1995-2#1)(1996-9#1)(2008-10#2)
well with the severity of##2##5##(1997-6#1)(2006-10#1)
well with the size of##2##5##(1995-2#1)(2010-2#1)
well with the standard##3##4##(2005-4#1)(2008-10#2)
well with the theoretical##5##4##(2007-11#1)(2007-12#1)(2008-2#2)(2008-5#1)
well with the##128##3##(1990-11#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-7#1)(1994-9#1)(1995-2#3)(1995-3#2)(1995-7#1)(1995-8#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-6#1)(1997-7#1)(2005-11#2)(2005-4#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-4#1)(2007-11#4)(2007-12#3)(2007-4#2)(2007-8#2)(2008-1#2)(2008-10#25)(2008-11#4)(2008-2#11)(2008-3#9)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
well with their##4##3##(1994-8#1)(2008-11#2)(2013-7#1)
well with theoretical##2##3##(2007-12#1)(2008-3#1)
well with those found##3##4##(2008-10#3)
well with those from##2##4##(1996-4#1)(2008-10#1)
well with those obtained by a##2##6##(2008-10#2)
well with those obtained by the##6##6##(2008-10#6)
well with those obtained by##12##5##(1991-8#1)(2008-10#11)
well with those obtained with##2##5##(2008-10#2)
well with those obtained##18##4##(1991-8#1)(1993-12#1)(2007-8#1)(2008-10#14)(2008-3#1)
well with those of##6##4##(1992-12#1)(1993-11#1)(1994-10#1)(1995-3#1)(2008-10#1)(2012-2#1)
well with those##36##3##(1991-8#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-10#1)(1995-12#1)(1995-3#1)(1996-4#1)(2007-12#1)(2007-8#2)(2008-10#19)(2008-3#2)(2008-7#1)(2010-5#1)(2012-2#1)
well with two##2##3##(1991-10#1)(1992-2#1)
well with##335##2##(1990-1#1)(1990-11#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#8)(1992-3#2)(1992-6#2)(1992-7#1)(1992-9#3)(1993-11#1)(1993-12#2)(1993-3#2)(1993-6#1)(1993-7#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#3)(1995-7#3)(1995-8#4)(1996-11#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#4)(2005-4#1)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#2)(2006-5#2)(2007-11#10)(2007-12#16)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#10)(2008-1#4)(2008-10#69)(2008-11#8)(2008-2#17)(2008-3#31)(2008-4#1)(2008-5#6)(2008-6#4)(2008-7#7)(2008-8#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#3)(2010-12#1)(2010-2#3)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#2)
well within safety##2##3##(2006-8#1)(2007-12#1)
well within the normal##2##4##(2009-4#1)(2010-7#1)
well within the##8##3##(1992-7#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-4#1)(2010-11#1)(2010-7#1)
well within##13##2##(1992-7#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2009-4#1)(2010-11#1)(2010-7#1)
well without any##3##3##(2007-8#1)(2008-1#1)(2008-5#1)
well without##7##2##(2007-8#3)(2008-1#1)(2008-5#1)(2008-7#1)(2013-1#1)
well worth##2##2##(1992-3#1)(2005-7#1)
well##9488##1##(1990-1#6)(1990-10#18)(1990-11#28)(1990-12#28)(1990-2#19)(1990-3#19)(1990-4#26)(1990-5#18)(1990-6#9)(1990-7#25)(1990-8#30)(1990-9#21)(1991-1#18)(1991-10#10)(1991-11#21)(1991-12#38)(1991-2#30)(1991-3#30)(1991-4#23)(1991-5#25)(1991-6#24)(1991-7#15)(1991-8#20)(1991-9#28)(1992-1#16)(1992-10#5)(1992-11#21)(1992-12#27)(1992-2#29)(1992-3#44)(1992-4#14)(1992-5#15)(1992-6#25)(1992-7#18)(1992-8#21)(1992-9#47)(1993-1#8)(1993-10#8)(1993-11#27)(1993-12#41)(1993-2#21)(1993-3#34)(1993-4#12)(1993-5#18)(1993-6#22)(1993-7#16)(1993-8#22)(1993-9#19)(1994-1#15)(1994-10#6)(1994-11#35)(1994-12#52)(1994-2#28)(1994-3#47)(1994-4#4)(1994-5#17)(1994-6#50)(1994-7#7)(1994-8#44)(1994-9#43)(1995-1#25)(1995-10#10)(1995-11#35)(1995-12#32)(1995-2#58)(1995-3#37)(1995-4#10)(1995-5#34)(1995-6#32)(1995-7#11)(1995-8#32)(1995-9#15)(1996-1#18)(1996-10#18)(1996-11#18)(1996-12#47)(1996-2#42)(1996-3#38)(1996-4#24)(1996-5#40)(1996-6#19)(1996-7#17)(1996-8#29)(1996-9#28)(1997-1#33)(1997-2#51)(1997-3#37)(1997-4#35)(1997-5#29)(1997-6#40)(1997-7#41)(1997-8#41)(1997-9#1)(2003-11#1)(2004-1#2)(2004-11#8)(2004-12#15)(2004-2#6)(2004-3#4)(2004-4#7)(2004-9#7)(2005-1#5)(2005-10#28)(2005-11#83)(2005-12#13)(2005-2#2)(2005-3#1)(2005-4#3)(2005-5#2)(2005-6#6)(2005-7#31)(2005-8#42)(2005-9#9)(2006-1#14)(2006-10#230)(2006-11#32)(2006-12#66)(2006-2#39)(2006-3#14)(2006-4#24)(2006-5#32)(2006-6#34)(2006-7#30)(2006-8#63)(2006-9#15)(2007-1#37)(2007-10#52)(2007-11#196)(2007-12#188)(2007-2#50)(2007-3#32)(2007-4#41)(2007-5#27)(2007-6#34)(2007-7#92)(2007-8#143)(2007-9#50)(2008-1#141)(2008-10#820)(2008-11#258)(2008-12#77)(2008-2#287)(2008-3#313)(2008-4#199)(2008-5#241)(2008-6#84)(2008-7#216)(2008-8#142)(2008-9#152)(2009-1#7)(2009-10#59)(2009-11#28)(2009-12#41)(2009-2#40)(2009-3#30)(2009-4#66)(2009-5#38)(2009-6#31)(2009-7#45)(2009-8#57)(2009-9#30)(2010-1#16)(2010-10#35)(2010-11#37)(2010-12#83)(2010-2#56)(2010-3#38)(2010-4#47)(2010-5#49)(2010-6#35)(2010-7#41)(2010-8#55)(2010-9#27)(2011-1#123)(2011-11#2)(2011-12#31)(2011-2#278)(2011-3#7)(2011-4#2)(2011-7#3)(2011-8#1)(2012-1#56)(2012-11#24)(2012-12#151)(2012-2#206)(2012-3#99)(2012-4#1)(2012-6#1)(2013-1#240)(2013-3#1)(2013-7#44)(2013-8#103)
well)##3##1##(1991-6#1)(1997-4#1)(2008-1#1)
well-##2##1##(2007-10#1)(2008-10#1)
well-accepted model##2##2##(2012-12#1)(2013-8#1)
well-accepted##4##1##(1995-2#1)(2007-11#1)(2012-12#1)(2013-8#1)
well-aged##2##1##(2008-10#1)(2013-7#1)
well-annotated##3##1##(2007-12#1)(2008-8#1)(2008-9#1)
well-attended##4##1##(1990-7#1)(2005-7#1)(2005-8#1)(2005-9#1)
well-balanced ecosystem##2##2##(1995-11#1)(2008-10#1)
well-balanced##9##1##(1993-12#2)(1994-2#1)(1995-11#1)(1996-6#1)(2008-10#2)(2008-5#1)(2010-9#1)
well-behaved##5##1##(2007-12#1)(2008-2#4)
well-being among people with greater depressive symptoms##2##7##(2010-4#2)
well-being among people with##3##4##(2005-9#1)(2010-4#2)
well-being among##8##2##(2005-9#1)(2006-7#1)(2006-8#1)(2008-7#1)(2009-7#1)(2010-4#2)(2013-8#1)
well-being and quality of life##6##5##(1997-8#2)(2006-10#1)(2006-2#1)(2008-1#1)(2008-9#1)
well-being and the##2##3##(2008-4#1)(2013-7#1)
well-being and##29##2##(1991-8#2)(1994-3#1)(1996-7#1)(1997-8#2)(2005-12#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-2#2)(2010-7#1)(2011-1#1)(2012-2#2)(2013-7#1)
well-being are##7##2##(1992-3#1)(1993-6#1)(2004-2#1)(2008-10#1)(2009-11#1)(2012-2#2)
well-being as##3##2##(2006-7#1)(2008-2#1)(2008-7#1)
well-being by##2##2##(2006-8#1)(2008-11#1)
well-being during##3##2##(1991-8#1)(2004-10#1)(2006-7#1)
well-being for the##2##3##(2007-12#1)(2010-3#1)
well-being from##2##2##(2007-9#1)(2010-2#1)
well-being in##8##2##(1996-7#1)(2009-7#1)(2010-9#1)(2011-2#4)(2012-2#1)
well-being index##2##2##(2008-11#1)(2008-5#1)
well-being is##2##2##(2008-1#1)(2011-2#1)
well-being of all##4##3##(2005-5#1)(2006-2#1)(2008-1#1)(2012-2#1)
well-being of children##2##3##(1995-12#1)(2011-12#1)
well-being of patients##2##3##(1995-12#1)(2008-12#1)
well-being of people##2##3##(1992-3#1)(2008-2#1)
well-being of the##6##3##(1991-9#1)(2008-11#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
well-being of youth##2##3##(2010-11#1)(2010-9#1)
well-being of##38##2##(1991-9#1)(1992-3#2)(1994-9#1)(1995-12#2)(2005-5#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-2#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-3#2)(2009-5#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-9#3)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
well-being than##2##2##(1995-1#1)(2006-7#1)
well-being was##2##2##(1991-8#1)(2012-2#1)
well-being which##3##2##(2008-12#1)(2011-2#2)
well-being##274##1##(1990-2#2)(1991-12#1)(1991-6#2)(1991-8#6)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#7)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#3)(1994-3#1)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#2)(1996-11#2)(1996-2#1)(1996-4#1)(1996-7#2)(1997-3#1)(1997-8#2)(2004-10#1)(2004-11#1)(2004-2#1)(2005-11#1)(2005-12#1)(2005-5#1)(2005-8#1)(2005-9#3)(2006-10#3)(2006-11#2)(2006-2#3)(2006-4#1)(2006-7#7)(2006-8#5)(2006-9#4)(2007-10#3)(2007-11#2)(2007-12#6)(2007-2#2)(2007-6#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#3)(2008-11#8)(2008-12#6)(2008-2#7)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#15)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#7)(2009-12#3)(2009-3#5)(2009-5#3)(2009-6#1)(2009-7#11)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#6)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#8)(2010-8#2)(2010-9#4)(2011-1#4)(2011-12#2)(2011-2#13)(2012-1#2)(2012-12#4)(2012-2#12)(2012-3#3)(2012-5#1)(2013-1#10)(2013-7#1)(2013-8#3)
well-calibrated##2##1##(1996-5#1)(2008-2#1)
well-characterised##2##1##(1994-6#1)(2007-6#1)
well-characterized and##2##2##(2008-1#1)(2009-8#1)
well-characterized patients with##2##3##(2012-3#1)(2013-1#1)
well-characterized patients##3##2##(2010-5#1)(2012-3#1)(2013-1#1)
well-characterized samples##2##2##(2005-11#1)(2008-7#1)
well-characterized system##2##2##(1991-3#1)(1991-6#1)
well-characterized##67##1##(1990-7#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-8#1)(1993-6#1)(1993-9#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-12#2)(1996-7#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#2)(2007-11#2)(2007-12#4)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-8#3)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-12#1)(2011-2#2)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
well-child visits##2##2##(1996-1#1)(2008-7#1)
well-child##5##1##(1996-1#2)(1996-2#1)(2008-7#1)(2010-8#1)
well-chosen##3##1##(2007-12#1)(2008-3#1)(2010-10#1)
well-circumscribed##8##1##(1991-8#1)(2004-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)
well-collimated##3##1##(2008-3#1)(2012-11#2)
well-conceived##4##1##(1991-2#1)(2008-8#1)(2009-1#1)(2010-12#1)
well-conducted##4##1##(1993-3#1)(2006-10#2)(2010-5#1)
well-conserved##7##1##(1992-2#1)(1995-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-12#1)(2012-2#1)
well-controlled clinical##2##2##(2009-7#1)(2013-8#1)
well-controlled studies##3##2##(2007-8#1)(2012-12#2)
well-controlled trials##2##2##(2007-9#1)(2008-5#1)
well-controlled with##2##2##(2010-5#1)(2012-12#1)
well-controlled##25##1##(1990-9#1)(1993-11#1)(1994-11#1)(1996-3#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-7#1)(2010-4#2)(2010-5#1)(2010-9#3)(2011-2#1)(2012-12#3)(2012-2#1)(2013-8#1)
well-defined and##9##2##(1994-5#1)(1994-9#1)(2006-6#1)(2008-10#3)(2008-2#1)(2010-10#1)(2010-4#1)
well-defined anodic##2##2##(2008-10#2)
well-defined cathodic wave##2##3##(2008-10#2)
well-defined cathodic##3##2##(2008-10#3)
well-defined cystic##2##2##(2006-1#1)(2013-8#1)
well-defined mutants##2##2##(1996-8#1)(2008-10#1)
well-defined oxidation peak##3##3##(2008-10#3)
well-defined oxidation##4##2##(2008-10#4)
well-defined peak##2##2##(2008-10#2)
well-defined redox peaks##3##3##(2008-10#3)
well-defined redox##5##2##(2008-10#5)
well-defined reduction peak##2##3##(2008-10#2)
well-defined solid##2##2##(2013-1#2)
well-defined stable##2##2##(2008-10#1)(2012-2#1)
well-defined structure##5##2##(1990-10#1)(1994-8#1)(1995-4#1)(2007-12#1)(2008-4#1)
well-defined structures##2##2##(1997-4#1)(2008-5#1)
well-defined##185##1##(1990-10#2)(1990-12#1)(1990-7#1)(1990-8#1)(1990-9#3)(1991-11#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#3)(1995-11#1)(1995-4#1)(1995-5#1)(1996-3#1)(1996-4#2)(1996-8#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-11#4)(2005-12#1)(2005-5#1)(2006-1#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-6#3)(2006-9#1)(2007-10#2)(2007-12#6)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#39)(2008-11#1)(2008-12#2)(2008-2#7)(2008-3#6)(2008-4#7)(2008-5#4)(2008-6#2)(2009-10#2)(2009-12#1)(2009-2#3)(2009-3#1)(2009-5#1)(2009-8#2)(2010-10#2)(2010-12#2)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#6)(2013-1#6)(2013-8#1)
well-demarcated##3##1##(2011-1#1)(2012-3#1)(2013-1#1)
well-described##10##1##(2006-5#1)(2007-8#1)(2008-10#1)(2008-4#1)(2010-11#1)(2010-12#1)(2011-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
well-designed clinical trials##2##3##(2008-5#1)(2013-8#1)
well-designed randomized##3##2##(2006-12#2)(2006-8#1)
well-designed studies are##2##3##(2007-7#1)(2012-3#1)
well-designed studies##5##2##(2007-11#1)(2007-7#1)(2008-1#1)(2012-3#1)(2013-1#1)
well-designed trials##4##2##(2006-8#1)(2008-10#1)(2012-1#1)(2013-8#1)
well-designed##25##1##(1991-9#1)(1995-1#1)(1996-3#1)(2006-10#1)(2006-12#2)(2006-8#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-12#1)(2009-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
well-developed##22##1##(1993-1#1)(2005-11#2)(2007-1#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-7#1)(2011-12#1)(2012-11#1)(2012-12#1)(2012-2#1)
well-differentiated adenocarcinoma##3##2##(1993-8#1)(2010-2#1)(2013-8#1)
well-differentiated liposarcoma##9##2##(2007-2#1)(2008-6#1)(2009-7#3)(2010-12#1)(2013-1#2)(2013-8#1)
well-differentiated specimens expressed the##2##4##(1991-9#2)
well-differentiated specimens##3##2##(1991-9#3)
well-differentiated squamous cell carcinoma##3##4##(2009-10#1)(2010-8#1)(2012-12#1)
well-differentiated##42##1##(1990-3#1)(1991-9#3)(1992-2#2)(1992-3#2)(1992-4#1)(1993-8#1)(1996-6#1)(2005-10#1)(2007-12#1)(2007-2#3)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-3#1)(2009-7#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-8#1)(2011-12#1)(2012-12#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
well-dispersed##2##1##(2007-12#1)(2010-5#1)
well-distributed##2##1##(2005-11#1)(2008-10#1)
well-documented case of##2##3##(1992-5#1)(1996-3#1)
well-documented case##3##2##(1992-5#1)(1996-3#1)(1996-4#1)
well-documented cases##2##2##(2006-12#1)(2008-11#1)
well-documented in Caucasian##2##3##(1997-3#1)(2010-3#1)
well-documented in##3##2##(1990-5#1)(1997-3#1)(2010-3#1)
well-documented##45##1##(1990-5#1)(1990-9#1)(1991-6#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-10#1)(1994-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#2)(1997-1#1)(1997-2#1)(1997-3#2)(2004-10#1)(2005-12#1)(2006-12#1)(2007-1#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-5#2)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-3#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
well-educated##3##1##(1991-8#1)(2008-10#1)(2008-7#1)
well-established and##3##2##(1993-6#1)(2011-12#1)(2013-8#1)
well-established association##2##2##(2008-3#1)(2012-11#1)
well-established method##4##2##(1990-12#1)(2008-10#1)(2008-3#1)(2013-7#1)
well-established model of##2##3##(2007-9#1)(2008-4#1)
well-established programs##2##2##(1991-1#1)(2007-2#1)
well-established risk##2##2##(2008-3#1)(2010-7#1)
well-established techniques##2##2##(2006-10#1)(2010-4#1)
well-established that##3##2##(2005-12#1)(2007-10#1)(2012-3#1)
well-established##95##1##(1990-12#1)(1990-7#1)(1991-1#1)(1991-3#1)(1991-5#1)(1992-10#1)(1992-4#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-6#1)(1996-11#1)(1996-2#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#2)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#7)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#3)(2010-11#1)(2010-12#2)(2010-4#2)(2010-7#2)(2011-1#2)(2011-12#1)(2012-1#3)(2012-11#2)(2012-12#1)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#2)
well-fed##2##1##(1994-8#1)(2007-8#1)
well-focused##2##1##(1991-10#1)(2011-1#1)
well-formed##4##1##(2007-12#1)(2008-5#1)(2009-6#1)(2012-2#1)
well-founded##4##1##(1994-9#1)(1996-6#1)(2007-12#1)(2013-1#1)
well-functioning##2##1##(1995-2#1)(2012-12#1)
well-healed##2##1##(2011-2#1)(2013-8#1)
well-illustrated##2##1##(1993-6#1)(2008-1#1)
well-informed about##2##2##(2007-1#1)(2007-11#1)
well-informed##6##1##(1994-7#1)(2007-1#1)(2007-11#1)(2010-11#1)(2011-2#1)(2012-3#1)
well-isolated##3##1##(1993-9#1)(2008-11#1)(2008-7#1)
well-known and##3##2##(2005-11#1)(2009-8#1)(2010-12#1)
well-known but##2##2##(1996-11#1)(2013-8#1)
well-known complications##2##2##(2005-10#1)(2007-7#1)
well-known corner##2##2##(2008-2#2)
well-known endemic areas in##2##4##(1996-11#2)
well-known endemic##3##2##(1996-11#3)
well-known example of##2##3##(1993-7#1)(2009-8#1)
well-known for its##2##3##(2008-2#1)(2010-11#1)
well-known for##4##2##(1993-12#1)(2008-2#1)(2010-11#1)(2012-2#1)
well-known in##2##2##(2007-8#1)(2008-1#1)
well-known model##2##2##(1996-3#1)(2013-1#1)
well-known risk factor##2##3##(2006-10#1)(2008-1#1)
well-known risk##3##2##(2006-10#1)(2008-1#1)(2012-12#1)
well-known risks of##2##3##(1994-6#1)(2013-1#1)
well-known technique for##4##3##(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#1)
well-known techniques for##2##3##(1991-12#1)(2007-12#1)
well-known##221##1##(1990-12#1)(1990-5#1)(1990-7#3)(1991-12#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-8#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-9#1)(1995-1#1)(1995-12#2)(1995-5#1)(1995-6#2)(1996-1#1)(1996-10#2)(1996-11#4)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-7#2)(2005-10#1)(2005-11#8)(2005-5#1)(2005-8#1)(2006-10#8)(2006-12#2)(2006-6#3)(2006-8#1)(2007-10#1)(2007-11#8)(2007-12#9)(2007-2#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#25)(2008-3#10)(2008-5#11)(2008-6#3)(2008-7#3)(2008-8#5)(2008-9#1)(2009-12#2)(2009-2#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#4)(2010-10#1)(2010-11#2)(2010-12#6)(2010-4#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-12#5)(2012-2#3)(2012-3#3)(2013-1#8)(2013-8#2)
well-matched##4##1##(1995-2#2)(2007-12#1)(2009-10#1)
well-mixed##5##1##(1990-11#1)(2008-11#1)(2008-2#2)(2008-8#1)
well-nourished##7##1##(2008-11#6)(2013-7#1)
well-ordered##8##1##(1993-8#1)(1994-11#2)(2007-12#2)(2008-10#1)(2008-4#1)(2008-7#1)
well-organized rehabilitation##2##2##(2007-8#2)
well-organized##9##1##(1992-6#1)(2005-11#1)(2007-8#2)(2007-9#1)(2008-5#1)(2008-7#1)(2009-7#1)(2012-1#1)
well-oxygenated##3##1##(1992-9#1)(1995-1#1)(2008-4#1)
well-perfused##2##1##(2008-3#1)(2013-8#1)
well-planned##2##1##(2007-11#1)(2011-1#1)
well-plate##2##1##(2008-11#2)
well-positioned##3##1##(2008-5#1)(2010-2#1)(2011-2#1)
well-preserved##8##1##(1991-6#2)(1992-3#1)(1996-9#1)(2006-10#1)(2007-12#1)(2010-8#1)(2012-2#1)
well-proven##3##1##(1990-10#1)(1990-2#1)(1997-6#1)
well-qualified##2##1##(1996-3#1)(2005-5#1)
well-recognised##2##1##(2007-8#1)(2010-12#1)
well-recognized##10##1##(1992-6#1)(1995-10#1)(2006-10#2)(2007-1#1)(2008-7#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-3#1)
well-reproducible##2##1##(2007-2#1)(2007-8#1)
well-researched##3##1##(1992-1#1)(2010-8#1)(2013-7#1)
well-resolved resonances in##2##3##(1990-4#1)(2008-2#1)
well-resolved##19##1##(1990-4#1)(1991-2#1)(1991-4#1)(1991-9#1)(1994-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2009-3#1)(2011-1#1)(2012-12#2)(2013-7#1)(2013-8#1)
well-rounded##2##1##(2007-8#1)(2008-12#1)
well-selected patients##4##2##(2006-10#1)(2006-6#1)(2008-7#1)(2008-9#1)
well-selected##5##1##(2006-10#1)(2006-6#1)(2008-7#1)(2008-9#1)(2012-11#1)
well-separated peaks##3##2##(1991-7#1)(1997-2#1)(2008-10#1)
well-separated##10##1##(1991-7#1)(1996-6#1)(1997-2#1)(2007-12#1)(2008-10#3)(2010-5#1)(2013-7#2)
well-shaped##2##1##(2008-10#1)(2008-3#1)
well-structured##6##1##(1991-9#1)(1996-11#1)(2005-10#1)(2005-5#1)(2008-1#1)(2012-2#1)
well-studied##24##1##(1993-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-5#1)(1997-7#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-4#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-1#3)(2012-2#1)
well-suited for the##3##3##(2008-11#1)(2008-7#1)(2008-8#1)
well-suited for##13##2##(1993-1#1)(1994-9#1)(2008-11#1)(2008-6#3)(2008-7#1)(2008-8#1)(2010-10#1)(2012-11#2)(2013-1#2)
well-suited to##3##2##(2008-7#1)(2009-11#1)(2011-2#1)
well-suited##17##1##(1993-1#1)(1994-9#1)(1996-7#1)(2008-11#1)(2008-6#3)(2008-7#2)(2008-8#1)(2009-11#1)(2010-10#1)(2011-2#1)(2012-11#2)(2013-1#2)
well-supported clades##2##2##(2010-3#1)(2010-6#1)
well-supported monophyletic##2##2##(1995-2#1)(2008-10#1)
well-supported##7##1##(1995-2#1)(2008-10#3)(2010-3#2)(2010-6#1)
well-tolerated and effective##5##3##(1995-4#1)(2004-12#1)(2007-11#1)(2008-1#1)(2012-1#1)
well-tolerated and efficacious##2##3##(2007-1#1)(2008-5#1)
well-tolerated and##15##2##(1990-2#1)(1995-4#1)(2004-12#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-5#4)(2012-1#1)(2013-1#1)
well-tolerated by patients##3##3##(2007-11#1)(2007-8#1)(2012-12#1)
well-tolerated##56##1##(1990-2#1)(1990-8#1)(1992-4#1)(1993-12#1)(1994-2#1)(1994-8#1)(1995-4#1)(1995-5#1)(1996-9#1)(2004-12#2)(2004-3#1)(2005-7#3)(2005-8#1)(2006-10#1)(2007-1#2)(2007-10#4)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-3#3)(2008-5#10)(2008-7#1)(2009-5#1)(2010-3#1)(2010-5#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#2)
well-trained##5##1##(1990-12#1)(1994-3#1)(2008-7#1)(2010-7#1)(2013-1#1)
well-tried##2##1##(2007-9#1)(2008-11#1)
well-type chamber##2##2##(2007-11#2)
well-type##3##1##(2007-11#3)
well-understood##5##1##(1992-9#1)(1994-12#1)(2007-12#1)(2009-12#1)(2009-8#1)
well-validated##3##1##(2008-3#1)(2011-1#1)(2012-2#1)
well-vascularized tissue##3##2##(2006-12#1)(2007-12#1)(2008-9#1)
well-vascularized##4##1##(2006-12#1)(2007-12#1)(2008-9#1)(2009-2#1)
well-water for drinking##3##3##(2013-1#3)
well-water##4##1##(2013-1#4)
wellbeing and##4##2##(2008-10#1)(2008-3#1)(2010-9#1)(2013-8#1)
wellbeing in##4##2##(1996-6#1)(2010-9#1)(2011-2#1)(2013-1#1)
wellbeing of the##2##3##(2011-1#1)(2012-12#1)
wellbeing of##8##2##(1991-3#1)(2008-5#1)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
wellbeing##47##1##(1990-9#1)(1991-3#1)(1991-8#1)(1996-6#1)(2006-10#2)(2006-7#1)(2007-11#1)(2008-10#5)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-9#5)(2011-1#2)(2011-2#3)(2012-12#2)(2013-1#9)(2013-8#1)
wellestablished##2##1##(2005-7#1)(2007-9#1)
wellknown##3##1##(1992-11#1)(1993-8#1)(2013-1#1)
wellness and##6##2##(2008-11#1)(2009-5#1)(2013-1#1)(2013-8#3)
wellness in##2##2##(1996-1#1)(2012-12#1)
wellness model##2##2##(2007-2#1)(2010-12#1)
wellness of##2##2##(2013-7#1)(2013-8#1)
wellness programs##2##2##(1992-12#2)
wellness##45##1##(1992-12#3)(1993-1#1)(1994-12#1)(1994-3#1)(1995-1#1)(1996-1#1)(1997-3#1)(2005-8#1)(2006-2#2)(2007-2#1)(2008-11#2)(2008-12#2)(2008-4#2)(2008-9#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#4)(2012-12#1)(2013-1#4)(2013-7#1)(2013-8#8)
wells and the##2##3##(2008-4#1)(2009-6#1)
wells and##9##2##(1992-7#1)(2007-10#1)(2008-1#1)(2008-11#2)(2008-4#2)(2009-6#1)(2011-1#1)
wells by##3##2##(1992-7#1)(2008-10#1)(2008-2#1)
wells coated with##2##3##(1991-3#1)(1994-9#1)
wells containing##2##2##(2013-1#1)(2013-8#1)
wells in a##2##3##(1990-2#1)(2008-4#1)
wells in##6##2##(1990-2#1)(1992-6#1)(1994-9#1)(2007-8#1)(2008-4#1)(2013-1#1)
wells of a 96-well##2##4##(1997-7#1)(2008-5#1)
wells of a##5##3##(1990-12#1)(1994-8#1)(1997-7#1)(2008-11#1)(2008-5#1)
wells of##9##2##(1990-12#2)(1991-11#1)(1992-6#1)(1994-8#1)(1997-7#1)(2008-11#2)(2008-5#1)
wells on##2##2##(2007-12#1)(2009-6#1)
wells to##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)
wells with##3##2##(2006-10#1)(2008-3#1)(2011-12#1)
wells##93##1##(1990-12#2)(1990-2#1)(1991-11#1)(1991-12#2)(1991-3#1)(1992-12#1)(1992-6#3)(1992-7#2)(1992-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#6)(1995-7#1)(1996-2#2)(1996-4#1)(1996-5#1)(1997-7#1)(2004-4#1)(2006-10#1)(2006-2#1)(2007-10#2)(2007-11#3)(2007-12#15)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#6)(2008-2#6)(2008-3#1)(2008-4#3)(2008-5#2)(2008-9#2)(2009-6#2)(2010-11#1)(2011-1#2)(2011-12#1)(2013-1#4)(2013-8#1)
wells)##2##1##(1991-11#1)(2008-9#1)
wenrichi##2##1##(2008-9#2)
went down##2##2##(1990-8#1)(1995-5#1)
went far beyond##2##3##(1992-12#1)(1995-6#1)
went for##2##2##(1991-6#1)(2013-1#1)
went from 0##2##3##(2007-8#1)(2008-10#1)
went from a median of##3##5##(2013-1#3)
went from flexion##2##3##(2007-4#2)
went from##14##2##(1990-6#1)(2006-9#1)(2007-11#1)(2007-4#2)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#3)
went home##6##2##(1992-2#2)(1992-3#1)(1995-3#2)(2007-9#1)
went in##2##2##(1992-4#1)(2008-2#1)
went into##6##2##(1991-11#1)(2005-12#1)(2007-7#1)(2008-5#1)(2011-1#1)(2011-2#1)
went on to develop##2##4##(2007-7#1)(2012-3#1)
went on to##7##3##(2004-3#1)(2006-5#1)(2007-7#1)(2008-10#2)(2008-12#1)(2012-3#1)
went on##10##2##(1992-1#1)(2004-10#1)(2004-3#1)(2006-5#1)(2007-7#1)(2008-10#2)(2008-12#1)(2009-7#1)(2012-3#1)
went online##2##2##(2005-7#1)(2007-12#1)
went out of##3##3##(1994-2#1)(2008-4#1)(2009-10#1)
went through a##2##3##(1997-5#1)(2008-10#1)
went through##4##2##(1997-5#1)(2008-10#1)(2008-5#1)(2012-1#1)
went to the##2##3##(1993-7#1)(2007-9#1)
went to##12##2##(1991-1#2)(1992-10#1)(1992-12#1)(1993-7#1)(1995-12#1)(2005-8#1)(2007-8#1)(2007-9#2)(2009-10#1)(2011-2#1)
went up by##2##3##(1990-8#1)(2008-7#1)
went up##5##2##(1990-8#1)(2007-10#1)(2007-7#1)(2008-7#2)
went##86##1##(1990-6#1)(1990-8#2)(1991-1#3)(1991-11#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1993-7#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1997-5#2)(2004-10#1)(2004-3#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#2)(2010-4#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-3#1)(2013-1#4)(2013-8#1)
were &gt##25##2##(1995-3#1)(1996-12#1)(1996-2#1)(1997-3#1)(2004-4#1)(2007-12#1)(2007-2#2)(2007-8#2)(2008-10#6)(2008-6#3)(2008-7#1)(2009-4#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-3#1)
were &lt##35##2##(1995-10#1)(1995-2#1)(1996-6#1)(2005-12#1)(2006-4#2)(2006-5#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#13)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#2)
were &quot##23##2##(1990-11#1)(1991-9#2)(1992-3#1)(1992-9#1)(1993-8#1)(1994-1#1)(1995-3#1)(2007-12#1)(2008-7#2)(2009-5#1)(2009-7#2)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
were (0##2##2##(2010-12#2)
were (1) to##3##3##(2009-1#1)(2010-4#1)(2013-1#1)
were (1)##6##2##(1995-10#1)(2007-8#1)(2009-1#1)(2010-4#1)(2013-1#2)
were (3##2##2##(2011-1#1)(2011-3#1)
were (5##2##2##(2008-10#1)(2011-1#1)
were (i) to##4##3##(1994-6#1)(2008-10#1)(2008-5#1)(2008-8#1)
were (i)##9##2##(1990-11#1)(1990-7#1)(1994-6#1)(1996-4#1)(2008-10#3)(2008-5#1)(2008-8#1)
were 0##298##2##(1990-10#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-6#2)(1990-8#4)(1991-12#1)(1991-2#2)(1991-4#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#2)(1993-3#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-2#3)(1996-3#2)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-11#1)(2004-12#1)(2004-8#1)(2004-9#1)(2005-11#4)(2005-12#6)(2005-4#2)(2005-7#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-5#4)(2007-6#2)(2007-8#7)(2008-10#112)(2008-11#4)(2008-12#6)(2008-3#5)(2008-4#1)(2008-5#8)(2008-7#2)(2008-8#5)(2008-9#2)(2009-11#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#2)(2010-8#2)(2010-9#2)(2011-1#7)(2011-12#2)(2011-2#5)(2012-1#3)(2012-11#2)(2012-12#11)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#4)
were 0%##2##2##(2008-10#1)(2013-1#1)
were 1 and##2##3##(2008-10#2)
were 1 to##2##3##(2008-10#1)(2008-5#1)
were 1##132##2##(1990-10#1)(1990-12#2)(1991-10#2)(1991-11#1)(1991-2#1)(1991-3#2)(1991-5#2)(1992-11#1)(1992-2#1)(1992-3#1)(1993-6#1)(1993-8#1)(1993-9#4)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-11#2)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#38)(2008-11#3)(2008-12#3)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#4)(2009-7#1)(2010-12#3)(2010-5#1)(2010-9#1)(2011-1#5)(2011-2#5)(2012-12#5)(2012-3#3)(2013-8#3)
were 1)##3##2##(1993-3#1)(2008-10#1)(2013-1#1)
were 10 and##2##3##(1992-3#1)(2008-10#1)
were 10 days##2##3##(1997-6#1)(2008-10#1)
were 10##32##2##(1991-11#1)(1992-3#1)(1992-8#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-7#1)(1996-6#2)(1997-3#1)(1997-6#1)(2004-12#1)(2004-9#1)(2006-6#1)(2006-8#1)(2007-8#2)(2007-9#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-9#1)(2010-2#1)(2011-11#1)(2011-2#1)(2012-3#1)
were 10%##2##2##(1996-5#1)(2008-2#1)
were 10(-3)##2##2##(2008-10#1)(2008-3#1)
were 100##15##2##(1990-10#1)(1991-6#1)(1993-9#1)(1994-7#1)(2006-8#1)(2007-12#2)(2008-1#2)(2008-10#2)(2009-6#1)(2011-3#1)(2012-3#1)(2013-7#1)
were 100% and##3##3##(2007-12#1)(2008-12#1)(2011-2#1)
were 100% for##2##3##(2008-10#1)(2011-11#1)
were 100%##14##2##(1995-8#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-8#1)(2009-2#1)(2011-11#1)(2011-2#2)(2012-3#1)
were 103##2##2##(2008-10#1)(2011-2#1)
were 107##2##2##(2007-10#1)(2008-3#1)
were 11 and##2##3##(1997-2#1)(2008-7#1)
were 11##20##2##(1990-8#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-5#1)(1994-12#1)(1997-2#1)(2005-10#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-7#1)(2009-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
were 114##3##2##(2008-4#1)(2011-2#1)(2013-7#1)
were 116##2##2##(2008-11#1)(2009-11#1)
were 12 and##3##3##(1992-6#1)(1995-1#1)(2008-10#1)
were 12##22##2##(1990-2#1)(1990-6#1)(1990-8#1)(1992-6#1)(1993-4#1)(1994-6#1)(1995-1#1)(2007-7#2)(2008-10#6)(2008-6#2)(2008-8#1)(2009-10#1)(2011-2#1)(2012-11#1)(2013-1#1)
were 12-##2##2##(1994-11#1)(2009-8#1)
were 120##3##2##(2006-5#1)(2007-8#1)(2008-11#1)
were 123##2##2##(2006-10#1)(2008-10#1)
were 124##2##2##(2005-10#1)(2012-3#1)
were 125##3##2##(1991-11#1)(2006-7#1)(2008-3#1)
were 128##3##2##(2006-10#1)(2008-10#1)(2011-2#1)
were 13 and##3##3##(1993-2#1)(2008-10#2)
were 13##17##2##(1993-2#1)(1993-8#1)(1994-9#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-10#6)(2008-12#1)(2008-5#1)(2011-1#1)(2011-2#1)
were 13%##3##2##(1997-3#1)(2008-10#1)(2010-3#1)
were 130##2##2##(2006-7#1)(2010-6#1)
were 133##2##2##(2008-10#1)(2011-12#1)
were 14##16##2##(1990-7#1)(1992-9#1)(1995-5#1)(1997-6#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-6#2)(2011-1#1)(2013-8#1)
were 1400##2##2##(2008-10#1)(2008-3#1)
were 15 and 7##2##4##(1990-6#1)(2008-10#1)
were 15##17##2##(1990-6#1)(1991-5#1)(1994-11#1)(1996-3#1)(1997-6#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-9#1)(2010-8#2)(2011-12#1)(2011-3#1)(2012-2#1)
were 150##2##2##(2006-7#1)(2008-10#1)
were 152##2##2##(2008-10#2)
were 153##2##2##(1993-6#1)(2009-6#1)
were 154##3##2##(1992-11#1)(2007-11#1)(2013-8#1)
were 156##2##2##(1991-2#1)(2007-8#1)
were 16##12##2##(1993-4#1)(1994-9#1)(1997-2#1)(1997-8#1)(2007-10#1)(2007-8#2)(2008-10#1)(2008-3#1)(2012-3#2)(2013-1#1)
were 16%##2##2##(2005-10#1)(2012-2#1)
were 161##3##2##(2006-10#1)(2010-12#1)(2011-1#1)
were 162##2##2##(2007-8#1)(2008-6#1)
were 169##2##2##(2004-1#2)
were 17##17##2##(1990-8#1)(1993-8#1)(1997-2#1)(1997-8#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-6#1)(2008-8#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-3#1)
were 18 and##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
were 18##16##2##(1993-10#1)(1995-7#1)(2004-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#2)(2008-5#3)(2009-10#1)(2012-12#1)(2013-1#1)
were 19##12##2##(1995-11#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-6#1)(2010-1#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
were 19%##2##2##(2007-10#2)
were 2 h##2##3##(2006-8#1)(2008-10#1)
were 2##120##2##(1990-1#1)(1990-12#1)(1990-4#1)(1990-7#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#1)(1993-1#2)(1993-2#1)(1993-3#1)(1993-6#1)(1995-11#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#1)(2005-12#1)(2005-4#1)(2006-4#1)(2006-8#2)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#33)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#5)(2008-6#2)(2008-7#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-4#2)(2011-1#4)(2011-12#1)(2011-2#6)(2011-3#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
were 2-fold##2##2##(1994-3#1)(2006-6#1)
were 20 and 10##2##4##(1993-2#1)(2008-10#1)
were 20 and##10##3##(1990-6#1)(1992-6#1)(1993-2#1)(1996-1#1)(1997-2#1)(2004-4#1)(2008-10#2)(2008-2#1)(2013-1#1)
were 20##29##2##(1990-6#1)(1991-12#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-2#1)(1996-1#1)(1997-2#1)(2004-4#1)(2005-11#1)(2005-12#1)(2006-10#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-4#1)(2013-1#1)(2013-7#1)(2013-8#1)
were 20% and##2##3##(2008-5#1)(2012-12#1)
were 20% more##2##3##(1993-8#1)(2010-2#1)
were 20%##6##2##(1991-12#1)(1993-8#1)(2008-5#1)(2009-5#1)(2010-2#1)(2012-12#1)
were 200##4##2##(1990-12#1)(2008-10#2)(2008-11#1)
were 205##2##2##(1996-3#1)(2008-4#1)
were 208##2##2##(1990-5#1)(2008-1#1)
were 21##9##2##(2006-10#1)(2008-10#1)(2010-2#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#3)
were 21%##2##2##(1996-12#1)(2011-1#1)
were 211##2##2##(2006-7#1)(2008-5#1)
were 215##3##2##(1996-7#1)(2012-1#1)(2012-12#1)
were 218##2##2##(1990-11#1)(2007-8#1)
were 22##8##2##(1990-4#1)(1991-7#1)(2006-2#1)(2007-10#1)(2008-10#3)(2013-8#1)
were 23##8##2##(1993-10#1)(1996-10#1)(1997-1#1)(2007-4#1)(2008-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
were 230##4##2##(1992-11#1)(1996-8#1)(2008-5#2)
were 238##3##2##(2010-1#1)(2013-1#2)
were 24##6##2##(1993-8#1)(2007-1#1)(2008-10#1)(2008-9#1)(2010-11#1)(2013-1#1)
were 24%##2##2##(1991-1#1)(1997-1#1)
were 25##8##2##(2005-8#1)(2008-10#2)(2008-4#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
were 250##3##2##(2007-7#2)(2013-1#1)
were 251##2##2##(2006-10#1)(2006-7#1)
were 256##3##2##(2005-11#1)(2006-5#1)(2012-11#1)
were 26##7##2##(1993-12#1)(1995-12#1)(1995-2#1)(1996-9#1)(2008-5#1)(2011-2#1)(2012-1#1)
were 26%##3##2##(2007-8#1)(2008-3#1)(2009-11#1)
were 27##10##2##(1994-3#1)(1994-8#1)(1995-7#1)(1996-6#1)(2006-5#1)(2007-8#1)(2008-5#1)(2010-12#1)(2011-2#2)
were 28##14##2##(1994-3#1)(1994-9#1)(2004-10#1)(2007-10#1)(2007-12#1)(2007-7#2)(2008-10#2)(2008-12#1)(2011-1#1)(2013-1#3)
were 28%##2##2##(2006-10#1)(2008-11#1)
were 280##2##2##(2007-10#1)(2008-10#1)
were 29##8##2##(1994-3#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-4#2)(2011-1#1)(2012-3#1)
were 3 and##3##3##(2007-8#1)(2008-10#2)
were 3 cases of##2##4##(2007-7#1)(2012-12#1)
were 3 times##2##3##(1995-8#1)(2013-1#1)
were 3##78##2##(1990-11#2)(1990-3#1)(1990-9#1)(1991-12#1)(1991-9#2)(1992-3#1)(1992-4#1)(1993-8#1)(1994-5#1)(1995-1#2)(1995-8#1)(1996-6#1)(1997-6#3)(2005-12#2)(2005-4#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-7#3)(2007-8#5)(2008-10#22)(2008-11#1)(2008-12#1)(2008-5#3)(2008-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#3)
were 30##19##2##(1990-12#1)(1991-8#1)(1993-12#1)(1993-4#1)(2005-11#1)(2006-9#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#2)(2010-2#1)(2011-1#1)(2011-11#1)(2013-1#1)
were 302##2##2##(2007-9#1)(2009-3#1)
were 31##8##2##(1993-10#1)(1997-2#1)(2005-11#1)(2011-2#1)(2012-12#1)(2013-8#3)
were 32##10##2##(1990-2#1)(1994-9#1)(1997-6#1)(1997-7#1)(2005-10#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-2#1)(2012-2#1)
were 32%##3##2##(2004-11#2)(2008-2#1)
were 33##7##2##(1991-5#1)(2006-10#1)(2006-5#1)(2007-3#1)(2008-10#1)(2008-12#1)(2012-2#1)
were 34 and##2##3##(2007-8#1)(2012-12#1)
were 34##13##2##(1992-4#1)(1992-8#1)(1996-3#1)(1997-6#1)(2004-10#1)(2005-9#1)(2006-12#1)(2007-8#1)(2012-12#2)(2013-1#3)
were 35 and##5##3##(1990-2#1)(2008-6#1)(2009-4#1)(2010-12#2)
were 35##11##2##(1990-2#1)(1994-9#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#2)
were 35%##2##2##(1997-6#1)(2008-8#1)
were 351##2##2##(2009-7#1)(2011-1#1)
were 36##7##2##(1992-2#1)(1997-6#1)(2006-6#1)(2007-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
were 361##2##2##(2004-11#1)(2006-10#1)
were 37##11##2##(2005-12#1)(2007-10#1)(2007-3#1)(2007-7#1)(2008-11#1)(2008-4#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)
were 38##9##2##(1990-5#1)(1996-12#1)(2006-4#1)(2008-10#1)(2008-6#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-2#1)
were 38%##2##2##(1994-8#1)(2012-3#1)
were 39 and##2##3##(1991-2#1)(2008-10#1)
were 39##13##2##(1991-12#1)(1991-2#1)(1993-9#1)(1995-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-12#2)(2013-1#2)
were 392##2##2##(2006-8#1)(2008-10#1)
were 4##54##2##(1990-10#1)(1990-4#1)(1990-9#1)(1991-4#1)(1991-9#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#1)(1996-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-2#3)(2007-7#2)(2007-8#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2011-1#3)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
were 4%##2##2##(1995-10#1)(2008-10#1)
were 40 and##2##3##(2007-8#1)(2008-10#1)
were 40 mm##2##3##(1992-5#1)(2008-3#1)
were 40##14##2##(1990-5#1)(1992-5#1)(1997-8#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-2#1)
were 40%##2##2##(2010-3#1)(2012-3#1)
were 400##4##2##(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)
were 41##5##2##(1993-9#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#1)
were 42##7##2##(2006-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2013-1#2)
were 43%##2##2##(1990-8#1)(1991-12#1)
were 44##9##2##(1991-9#1)(2006-5#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2013-7#1)(2013-8#1)
were 445##3##2##(2007-12#1)(2007-3#1)(2007-7#1)
were 45 to##2##3##(2008-10#1)(2008-11#1)
were 45##10##2##(1993-12#1)(1997-1#1)(1997-8#1)(2004-2#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-11#1)(2011-2#1)(2013-1#1)
were 45%##2##2##(2007-7#1)(2009-5#1)
were 46##7##2##(2007-11#1)(2008-1#1)(2008-10#2)(2008-7#1)(2012-2#1)(2013-1#1)
were 48##4##2##(2005-9#2)(2008-10#1)(2011-11#1)
were 49##4##2##(1991-4#1)(1995-10#1)(2008-10#1)(2008-12#1)
were 49% and##2##3##(2004-1#1)(2004-11#1)
were 5 and##4##3##(2008-10#3)(2012-2#1)
were 5 cases##2##3##(1993-6#1)(2013-8#1)
were 5##65##2##(1990-7#1)(1990-9#1)(1992-2#1)(1992-3#2)(1992-4#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-5#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-12#1)(2006-2#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#22)(2008-11#1)(2008-3#1)(2008-5#3)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#2)
were 5-fold##2##2##(1994-12#1)(2011-1#1)
were 50##14##2##(1990-11#1)(1991-1#1)(1991-11#1)(1991-2#1)(1992-2#1)(1992-7#1)(1993-8#1)(1993-9#1)(1996-1#1)(1997-8#1)(2006-6#1)(2008-3#1)(2011-2#2)
were 50%##4##2##(1990-10#1)(2008-9#1)(2010-2#1)(2013-1#1)
were 51##4##2##(1990-6#1)(1995-1#1)(2007-10#1)(2007-2#1)
were 512##2##2##(1991-2#1)(2010-1#1)
were 52##6##2##(1991-12#1)(1997-8#1)(2011-11#1)(2011-2#2)(2013-1#1)
were 53##4##2##(1991-2#1)(1993-1#1)(2008-1#1)(2008-2#1)
were 54##2##2##(2007-7#1)(2013-1#1)
were 54% and##4##3##(1996-10#1)(2006-6#2)(2008-3#1)
were 54%##5##2##(1996-10#1)(2006-6#2)(2007-8#1)(2008-3#1)
were 556##2##2##(1996-3#1)(2008-8#1)
were 56##5##2##(2007-8#1)(2008-10#1)(2008-4#1)(2008-6#1)(2013-8#1)
were 56% and##2##3##(1991-2#1)(2011-2#1)
were 57##6##2##(1996-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)
were 58##9##2##(2005-4#1)(2007-8#2)(2008-1#1)(2008-10#4)(2011-2#1)
were 58%##2##2##(1994-2#1)(2012-3#1)
were 59##3##2##(2007-8#1)(2008-10#1)(2013-8#1)
were 6 months##2##3##(1991-2#1)(1996-5#1)
were 6##51##2##(1990-11#1)(1990-2#1)(1991-11#1)(1991-2#1)(1992-4#1)(1993-10#1)(1993-2#1)(1994-11#1)(1995-12#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-8#1)(2006-11#2)(2006-4#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-2#1)(2011-2#4)(2012-2#1)(2012-3#1)
were 6%##2##2##(1990-8#1)(2007-10#1)
were 60##9##2##(1992-4#1)(1993-2#1)(1996-7#1)(2006-5#1)(2008-1#2)(2008-12#1)(2012-1#1)(2012-12#1)
were 60%##4##2##(2006-10#1)(2007-7#1)(2008-7#1)(2013-1#1)
were 61##3##2##(1991-8#1)(2005-10#1)(2008-8#1)
were 61% and##2##3##(1994-2#1)(2011-2#1)
were 61%##3##2##(1994-2#1)(2007-7#1)(2011-2#1)
were 62##7##2##(1995-9#1)(2006-7#1)(2008-1#1)(2008-7#2)(2011-1#1)(2012-12#1)
were 63##4##2##(1997-8#1)(2006-6#1)(2007-8#1)(2012-3#1)
were 64##4##2##(2006-12#1)(2008-4#1)(2008-6#1)(2010-3#1)
were 641##2##2##(2008-1#1)(2008-10#1)
were 65##3##2##(2005-11#1)(2007-2#2)
were 66##3##2##(1997-8#1)(2007-12#1)(2013-1#1)
were 66%##3##2##(2008-5#1)(2009-5#1)(2011-2#1)
were 67##3##2##(2006-6#1)(2008-5#1)(2009-2#1)
were 67% and##2##3##(1997-2#1)(2007-7#1)
were 67%##3##2##(1997-2#1)(2007-7#1)(2008-10#1)
were 68##6##2##(1990-2#1)(1997-2#1)(2008-10#1)(2011-1#1)(2012-12#1)(2012-2#1)
were 69##6##2##(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-4#1)(2012-2#1)
were 7 and##3##3##(2007-12#1)(2008-10#1)(2013-8#1)
were 7##30##2##(1991-12#1)(1992-6#1)(1993-6#1)(1994-12#1)(1994-6#1)(1996-11#1)(1996-2#1)(1996-4#1)(2005-10#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#10)(2008-3#1)(2008-6#1)(2009-11#1)(2010-12#1)(2011-1#1)(2013-8#2)
were 7%##2##2##(2008-7#1)(2013-1#1)
were 7-9##2##2##(1991-5#1)(2012-12#1)
were 70##7##2##(1991-12#1)(1997-3#1)(1997-8#1)(2005-9#1)(2008-10#1)(2011-12#1)(2011-2#1)
were 70%##2##2##(1990-10#1)(2008-7#1)
were 71##3##2##(2007-2#1)(2007-8#1)(2012-12#1)
were 72##4##2##(1992-6#1)(2008-12#1)(2008-9#1)(2011-2#1)
were 73##2##2##(2007-9#1)(2008-10#1)
were 73% and##2##3##(1992-9#1)(1994-2#1)
were 73%##3##2##(1992-9#1)(1994-2#1)(2011-2#1)
were 74##4##2##(2006-7#1)(2008-1#1)(2011-2#2)
were 75##8##2##(1993-8#1)(2007-3#1)(2009-4#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)
were 75%##2##2##(1991-4#1)(1994-11#1)
were 76##5##2##(2009-5#1)(2011-12#1)(2011-2#2)(2013-1#1)
were 76%##3##2##(2008-1#1)(2011-2#2)
were 77##4##2##(2010-7#1)(2011-1#1)(2013-1#2)
were 78##3##2##(2006-7#1)(2010-3#2)
were 78%##4##2##(1990-3#1)(2004-1#1)(2007-4#1)(2012-2#1)
were 79##3##2##(1991-5#1)(2007-7#1)(2012-3#1)
were 8##23##2##(1991-2#1)(1992-11#1)(1994-12#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(2008-10#6)(2009-3#1)(2010-10#1)(2010-7#1)(2011-1#3)(2011-2#1)
were 8% and##2##3##(1994-3#1)(2005-10#1)
were 8%##4##2##(1994-3#1)(1994-8#1)(2005-10#1)(2007-10#1)
were 80 and##2##3##(1995-2#1)(2007-8#1)
were 80##7##2##(1993-2#1)(1995-2#1)(2007-8#1)(2008-10#2)(2008-7#1)(2011-1#1)
were 80%##2##2##(2010-11#1)(2011-2#1)
were 81##2##2##(1991-2#1)(2006-10#1)
were 81%##2##2##(2010-2#1)(2012-12#1)
were 82##6##2##(1997-6#1)(2008-10#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
were 82%##2##2##(2008-10#1)(2008-3#1)
were 83##3##2##(2008-6#1)(2011-2#1)(2012-2#1)
were 83%##2##2##(1992-11#1)(1996-9#1)
were 84##5##2##(1992-4#1)(2007-9#1)(2008-10#2)(2008-12#1)
were 85##6##2##(2006-10#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
were 85%##3##2##(1992-12#1)(2007-10#1)(2007-12#1)
were 86##6##2##(1991-2#1)(1995-9#1)(2006-6#2)(2008-3#1)(2011-1#1)
were 87 and##2##3##(2005-9#1)(2008-10#1)
were 87##7##2##(1995-4#1)(1996-8#1)(2005-9#1)(2007-1#1)(2007-9#1)(2008-10#1)(2012-1#1)
were 88##5##2##(2005-12#1)(2008-5#1)(2010-8#1)(2011-1#2)
were 89##5##2##(1996-8#1)(2011-1#3)(2011-2#1)
were 9##15##2##(1991-9#1)(1994-12#1)(1996-1#1)(1997-8#1)(2004-9#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-10#1)(2011-1#1)(2013-1#1)
were 90##6##2##(2008-10#2)(2012-12#1)(2013-1#2)(2013-8#1)
were 90%##4##2##(1991-11#1)(2005-10#1)(2007-7#1)(2012-2#1)
were 91##6##2##(1990-9#1)(2008-10#1)(2008-12#1)(2008-6#1)(2011-1#1)(2013-8#1)
were 92##5##2##(1993-2#1)(2006-10#1)(2008-10#2)(2012-2#1)
were 92% and##4##3##(1991-8#1)(1993-1#1)(2006-10#1)(2007-7#1)
were 93##5##2##(1993-2#1)(2008-7#1)(2011-11#1)(2012-12#1)(2012-2#1)
were 93%##2##2##(1996-4#1)(2008-10#1)
were 94##8##2##(2005-12#1)(2007-8#1)(2008-10#4)(2008-7#1)(2012-12#1)
were 95##11##2##(1990-12#1)(2005-11#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-8#1)(2011-1#1)(2013-8#1)
were 95%##3##2##(1997-5#1)(2008-10#1)(2012-3#1)
were 96##9##2##(1990-9#1)(1996-8#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-1#1)(2013-8#1)
were 96% and##2##3##(1992-3#1)(2012-2#1)
were 96%##3##2##(1992-3#1)(2011-12#1)(2012-2#1)
were 97##11##2##(1994-12#1)(1996-8#1)(1997-3#2)(1997-8#1)(2005-12#1)(2005-4#1)(2007-2#1)(2008-1#1)(2008-5#1)(2013-1#1)
were 97%##3##2##(2008-2#1)(2011-2#2)
were 98##12##2##(2006-10#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-5#2)(2010-1#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
were 98% identical with##2##4##(2008-10#2)
were 99##9##2##(1993-10#1)(2005-12#1)(2007-1#1)(2008-10#4)(2011-1#1)(2012-2#1)
were 99%##2##2##(1991-7#1)(2008-3#1)
were A##3##2##(2007-7#1)(2007-8#1)(2008-12#1)
were American##2##2##(2011-2#1)(2013-8#1)
were An##2##2##(2008-2#1)(2012-12#1)
were Anopheles##2##2##(2008-2#1)(2011-1#1)
were Aseptic##3##2##(1991-2#3)
were Asian##2##2##(2009-4#1)(2012-2#1)
were B##2##2##(1993-6#1)(1997-8#1)
were C##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
were CD8+##2##2##(1991-5#1)(2008-2#1)
were CVA16##2##2##(2013-8#2)
were Caucasian##6##2##(1996-12#1)(2007-9#1)(2008-3#1)(2009-4#1)(2011-1#1)(2011-2#1)
were Caucasians##2##2##(2008-1#1)(2010-12#1)
were Chinese##3##2##(2005-12#1)(2008-7#1)(2008-8#1)
were Class 3 evidence##2##4##(2007-6#2)
were Class##4##2##(2007-6#4)
were Culex##2##2##(2008-2#1)(2011-1#1)
were E##5##2##(2007-7#1)(2007-8#1)(2011-1#2)(2012-2#1)
were Escherichia coli and##2##4##(1990-6#1)(2008-5#1)
were Escherichia coli##8##3##(1990-6#1)(1996-8#1)(2007-7#3)(2008-5#1)(2008-7#1)(2011-1#1)
were Fusarium##2##2##(2007-7#1)(2008-12#1)
were Gram negative##2##3##(2012-2#2)
were Gram positive and##2##4##(2012-2#2)
were Gram##4##2##(2012-2#4)
were Group A##2##3##(2007-6#1)(2008-10#1)
were Group##3##2##(2007-6#1)(2008-10#2)
were Gómez##2##2##(2012-12#2)
were HBsAg##3##2##(1990-8#1)(2007-7#1)(2011-2#1)
were HCV RNA positive##3##4##(2010-4#3)
were HCV##6##2##(2007-2#1)(2008-1#2)(2010-4#3)
were HER-2/neu positive##2##3##(2004-2#2)
were HEV71##2##2##(2013-8#2)
were HIV positive##6##3##(1993-11#2)(1997-6#1)(2007-12#1)(2011-2#1)(2012-2#1)
were HIV##8##2##(1993-11#2)(1997-6#1)(2007-12#2)(2007-7#1)(2011-2#1)(2012-2#1)
were HO-2 immunoreactive##2##3##(1995-12#2)
were Hudson##2##2##(2004-4#2)
were I##2##2##(2007-8#1)(2011-2#1)
were ILI flu##2##3##(2010-4#2)
were IgM##2##2##(2007-2#2)
were L##3##2##(2008-10#2)(2008-5#1)
were M1##2##2##(2013-8#2)
were Malays##2##2##(2008-8#1)(2011-1#1)
were N##2##2##(1992-3#1)(2006-8#1)
were NPD##5##2##(2008-12#5)
were Nostoc spp##2##3##(2006-3#2)
were P##4##2##(1997-4#1)(2008-10#2)(2013-1#1)
were R##2##2##(2008-10#2)
were S##6##2##(1990-6#1)(2007-5#2)(2008-11#1)(2008-5#1)(2013-8#1)
were S3/S2##2##2##(2008-4#2)
were SN0 V0##3##3##(2008-9#3)
were SN1##2##2##(2008-9#2)
were Salmonella##3##2##(2011-2#3)
were Saudis##5##2##(2006-2#1)(2007-2#1)(2008-1#2)(2011-1#1)
were Soxhlet extracted##3##3##(2006-3#1)(2008-10#1)(2008-11#1)
were Staphylococcus##2##2##(1990-6#1)(2007-8#1)
were Streptococcus##2##2##(1997-8#1)(2008-7#1)
were T cells##3##3##(1992-6#1)(2008-11#1)(2008-9#1)
were T##4##2##(1992-6#1)(2008-11#1)(2008-8#1)(2008-9#1)
were Type##3##2##(2007-8#3)
were ZIP code 55%##2##4##(2013-1#2)
were a few##3##3##(2008-12#1)(2008-9#2)
were a frequent cause of##2##5##(1991-12#1)(2008-7#1)
were a little##3##3##(1994-5#1)(2008-3#1)(2013-8#1)
were a major##6##3##(1991-11#1)(1995-1#1)(1995-11#1)(2007-6#2)(2011-1#1)
were a mean of##2##4##(2008-7#1)(2010-4#1)
were a mean##3##3##(2008-7#1)(2009-10#1)(2010-4#1)
were a number of##5##4##(2005-8#3)(2007-4#1)(2008-11#1)
were a positive##2##3##(1994-6#1)(2007-7#1)
were a preoperative##2##3##(1995-9#1)(2011-2#1)
were a random##2##3##(2008-10#1)(2012-3#1)
were a reduction##2##3##(1990-10#1)(2008-10#1)
were a result of##2##4##(1995-9#1)(2013-7#1)
were a subset of##2##4##(1996-11#1)(2008-10#1)
were a total of##5##4##(2007-10#1)(2007-7#2)(2012-12#1)(2013-7#1)
were a##103##2##(1990-10#1)(1990-4#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1993-12#1)(1993-6#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-4#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-11#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(2004-10#1)(2005-10#1)(2005-8#3)(2005-9#1)(2006-10#1)(2007-10#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#2)(2008-10#14)(2008-11#1)(2008-12#2)(2008-3#4)(2008-5#7)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#2)(2009-4#1)(2009-6#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#1)
were able to accurately##2##4##(1993-11#1)(2013-8#1)
were able to achieve##3##4##(2008-10#1)(2008-11#1)(2008-12#1)
were able to acquire##2##4##(1994-3#1)(1994-6#1)
were able to activate the##2##5##(1990-8#1)(1993-9#1)
were able to activate##3##4##(1990-8#1)(1991-8#1)(1993-9#1)
were able to adhere##2##4##(1996-12#1)(2011-2#1)
were able to amplify##3##4##(2006-10#1)(2006-8#1)(2008-10#1)
were able to bind to##3##5##(1994-9#1)(2007-1#1)(2008-10#1)
were able to bind##6##4##(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(2007-1#1)(2008-10#1)
were able to compensate##2##4##(2008-7#2)
were able to complement##2##4##(1990-5#1)(2008-10#1)
were able to correctly##3##4##(2011-2#2)(2013-1#1)
were able to define##2##4##(1990-12#1)(2008-12#1)
were able to demonstrate significant##2##5##(2006-2#1)(2012-2#1)
were able to demonstrate##6##4##(1990-4#1)(2006-2#1)(2007-7#1)(2008-7#1)(2009-9#1)(2012-2#1)
were able to detect and##2##5##(2008-10#1)(2010-5#1)
were able to detect as little as##2##7##(2008-10#2)
were able to detect##13##4##(1990-12#1)(1994-3#1)(1995-2#1)(2008-10#5)(2008-3#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
were able to determine##4##4##(1993-8#1)(1996-11#1)(2008-10#2)
were able to differentiate##4##4##(1992-12#1)(2008-5#1)(2011-1#1)(2012-12#1)
were able to discriminate##3##4##(2007-10#1)(2007-8#1)(2008-9#1)
were able to distinguish between##2##5##(1990-7#1)(2013-8#1)
were able to distinguish##6##4##(1990-7#1)(1991-11#1)(2008-10#1)(2008-3#2)(2013-8#1)
were able to establish##2##4##(2008-11#1)(2010-4#1)
were able to find the##2##5##(1993-7#1)(1993-9#1)
were able to find##5##4##(1993-7#1)(1993-9#1)(2010-8#1)(2013-1#2)
were able to follow##2##4##(2008-5#1)(2012-1#1)
were able to form##4##4##(1990-2#1)(1995-2#1)(2006-12#1)(2008-10#1)
were able to generate a##2##5##(1996-9#1)(2007-12#1)
were able to generate##4##4##(1996-9#1)(2007-12#1)(2008-11#1)(2012-12#1)
were able to grow in##2##5##(1991-3#1)(2006-5#1)
were able to grow##5##4##(1991-3#1)(1994-12#1)(2006-5#1)(2008-10#1)(2011-2#1)
were able to identify the##2##5##(1990-7#1)(2008-5#1)
were able to identify##12##4##(1990-7#1)(1991-10#1)(1997-1#1)(2006-8#1)(2007-4#1)(2007-5#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-11#1)(2012-3#1)(2012-7#1)
were able to increase the##3##5##(2009-6#1)(2009-7#1)(2011-1#1)
were able to induce##12##4##(1991-5#1)(1993-6#1)(1994-10#1)(1995-11#1)(1995-12#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#1)
were able to inhibit the##2##5##(1992-7#1)(1996-6#1)
were able to inhibit##7##4##(1992-7#1)(1994-6#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-4#1)(2010-4#1)
were able to maintain##3##4##(1993-12#1)(2008-7#1)(2010-8#1)
were able to obtain##4##4##(1992-2#1)(2007-8#1)(2008-10#1)(2008-5#1)
were able to offer##2##4##(2006-5#1)(2008-11#1)
were able to pass##2##4##(2006-12#1)(2013-1#1)
were able to perform##3##4##(2008-1#1)(2010-6#1)(2013-8#1)
were able to predict##2##4##(1997-2#1)(2008-10#1)
were able to produce##7##4##(1991-12#1)(1991-4#1)(1992-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#1)
were able to recognize##4##4##(1996-8#1)(2008-5#1)(2012-12#2)
were able to reconstitute##2##4##(1993-6#1)(2006-3#1)
were able to reduce the##2##5##(1992-11#1)(2007-8#1)
were able to reduce##4##4##(1992-11#1)(1996-6#1)(2007-8#1)(2008-10#1)
were able to reflect the##2##5##(2007-5#1)(2008-10#1)
were able to reproduce##3##4##(1992-9#1)(2008-10#1)(2008-11#1)
were able to return to their##2##6##(1990-8#1)(1992-5#1)
were able to return to##4##5##(1990-8#1)(1992-5#1)(2006-11#1)(2006-8#1)
were able to show that##4##5##(1992-7#1)(2008-5#1)(2008-7#1)(2011-1#1)
were able to show##7##4##(1992-7#1)(1997-4#1)(2007-7#1)(2008-5#2)(2008-7#1)(2011-1#1)
were able to significantly##2##4##(2008-10#1)(2008-11#1)
were able to stimulate##4##4##(1992-5#1)(1995-5#1)(2008-11#1)(2008-5#1)
were able to successfully##3##4##(2008-10#1)(2012-3#1)(2013-1#1)
were able to survive##2##4##(2008-11#1)(2008-5#1)
were able to synthesize##2##4##(1991-4#1)(1992-12#1)
were able to transform##2##4##(1990-1#1)(2008-2#1)
were able to transmit##3##4##(2008-10#3)
were able to use##3##4##(1992-3#1)(2008-7#1)(2011-2#1)
were able to walk##3##4##(1996-9#1)(2007-7#2)
were able to##321##3##(1990-1#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#3)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#2)(1992-7#3)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#3)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#3)(1994-9#3)(1995-11#3)(1995-12#3)(1995-2#3)(1995-5#2)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-6#2)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#2)(2005-10#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#3)(2006-3#1)(2006-5#3)(2006-8#6)(2007-1#1)(2007-10#4)(2007-11#2)(2007-12#5)(2007-4#1)(2007-5#3)(2007-7#4)(2007-8#3)(2008-1#2)(2008-10#45)(2008-11#12)(2008-12#6)(2008-2#2)(2008-3#5)(2008-5#12)(2008-6#1)(2008-7#11)(2008-8#3)(2008-9#3)(2009-11#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#7)(2012-1#3)(2012-11#2)(2012-12#7)(2012-2#4)(2012-3#4)(2012-6#1)(2012-7#1)(2013-1#7)(2013-8#4)
were able##322##2##(1990-1#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#3)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#2)(1992-7#3)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#3)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#3)(1994-9#3)(1995-11#3)(1995-12#3)(1995-2#3)(1995-5#2)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-6#2)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#2)(2005-10#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#3)(2006-3#1)(2006-5#3)(2006-8#6)(2007-1#1)(2007-10#4)(2007-11#2)(2007-12#5)(2007-4#1)(2007-5#3)(2007-7#4)(2007-8#3)(2008-1#2)(2008-10#45)(2008-11#13)(2008-12#6)(2008-2#2)(2008-3#5)(2008-5#12)(2008-6#1)(2008-7#11)(2008-8#3)(2008-9#3)(2009-11#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#7)(2012-1#3)(2012-11#2)(2012-12#7)(2012-2#4)(2012-3#4)(2012-6#1)(2012-7#1)(2013-1#7)(2013-8#4)
were abnormal in##3##3##(2007-11#1)(2007-9#1)(2010-11#1)
were abnormal##6##2##(1990-5#1)(1994-3#1)(2006-10#1)(2007-11#1)(2007-9#1)(2010-11#1)
were abolished by the##3##4##(1990-12#1)(1996-8#1)(1997-4#1)
were abolished by##9##3##(1990-12#1)(1990-2#1)(1991-8#1)(1993-11#1)(1993-7#1)(1995-5#1)(1996-8#1)(1997-4#1)(2008-8#1)
were abolished in the presence of##2##6##(2010-12#1)(2013-7#1)
were abolished in##3##3##(1997-4#1)(2010-12#1)(2013-7#1)
were abolished##18##2##(1990-12#1)(1990-2#1)(1990-5#2)(1991-8#1)(1993-11#1)(1993-3#1)(1993-7#1)(1995-5#1)(1995-6#1)(1996-8#1)(1997-4#3)(2008-1#1)(2008-8#1)(2010-12#1)(2013-7#1)
were about 0##3##3##(1996-8#1)(1997-3#1)(2008-10#1)
were about 1##4##3##(1992-5#1)(2008-10#1)(2008-11#1)(2009-4#1)
were about 2##3##3##(1990-11#1)(2008-10#2)
were about 3##2##3##(1997-4#1)(2008-10#1)
were about half##3##3##(1991-7#1)(1993-6#1)(1994-8#1)
were about##52##2##(1990-10#1)(1990-11#2)(1990-2#1)(1991-11#1)(1991-3#1)(1991-7#1)(1992-5#1)(1992-6#1)(1992-7#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-8#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-3#3)(1997-4#3)(1997-8#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-10#1)(2008-10#14)(2008-11#1)(2008-5#2)(2008-8#1)(2009-4#1)(2010-11#1)(2011-12#1)
were above the 20##2##4##(2013-8#2)
were above the##7##3##(1992-8#1)(1993-2#1)(2008-12#1)(2013-1#1)(2013-8#3)
were above unity##2##3##(1990-6#1)(1992-9#1)
were above##16##2##(1990-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-2#1)(2008-10#3)(2008-12#1)(2008-3#1)(2013-1#2)(2013-8#3)
were abrogated##2##2##(2008-3#1)(2011-1#1)
were abrupt##2##2##(1991-8#1)(2011-2#1)
were absent from##4##3##(1990-8#1)(1993-11#1)(1997-1#1)(2004-4#1)
were absent in the##5##4##(1993-12#1)(1994-12#1)(1997-8#1)(2008-10#1)(2009-8#1)
were absent in##15##3##(1991-3#1)(1991-4#1)(1993-12#1)(1994-12#1)(1995-10#1)(1996-7#1)(1997-3#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-4#2)(2009-8#1)(2012-3#1)
were absent or##3##3##(1994-5#1)(2007-2#1)(2008-10#1)
were absent##44##2##(1990-8#1)(1991-3#1)(1991-4#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-10#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-1#2)(1997-3#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-5#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#2)(2012-3#3)(2013-8#2)
were absorbed in##2##3##(2008-10#1)(2009-8#1)
were absorbed##3##2##(2008-10#2)(2009-8#1)
were abstinent##3##2##(1991-12#1)(2007-2#1)(2013-8#1)
were abstracted independently by 2 authors##2##6##(2009-9#2)
were abstracted##4##2##(2007-10#1)(2008-8#1)(2009-9#2)
were abundant in##4##3##(1990-7#1)(2008-10#1)(2008-7#1)(2011-2#1)
were abundant##7##2##(1990-7#1)(1997-4#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-2#1)
were accelerated##2##2##(1993-2#1)(2005-4#1)
were accentuated##3##2##(1990-4#1)(2008-5#1)(2008-7#1)
were acceptable in##2##3##(2010-4#1)(2012-12#1)
were acceptable##6##2##(1995-9#1)(2006-6#1)(2008-6#1)(2010-4#1)(2011-10#1)(2012-12#1)
were accepted as##4##3##(2006-8#1)(2007-10#1)(2008-11#1)(2011-1#1)
were accepted##11##2##(2006-8#1)(2007-10#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#1)
were accepting##2##2##(2008-4#1)(2011-2#1)
were accompanied by a##7##4##(1992-1#1)(1997-4#1)(2005-12#1)(2007-12#1)(2008-9#1)(2012-1#2)
were accompanied by an increase in the##2##7##(2010-12#1)(2010-4#1)
were accompanied by an##3##4##(1995-3#1)(2010-12#1)(2010-4#1)
were accompanied by##29##3##(1990-9#1)(1991-6#1)(1992-1#1)(1993-3#1)(1993-4#1)(1994-5#1)(1995-12#1)(1995-3#2)(1996-10#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-12#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-11#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-1#2)(2013-1#2)
were accompanied##30##2##(1990-9#1)(1991-6#1)(1992-1#1)(1993-3#1)(1993-4#1)(1994-5#1)(1995-12#1)(1995-3#2)(1996-10#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-12#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-11#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-12#1)(2010-4#1)(2011-1#2)(2012-1#2)(2013-1#2)
were accomplished by##5##3##(1990-9#1)(1994-12#1)(2008-10#1)(2008-2#2)
were accomplished via##2##3##(1997-2#1)(2008-10#1)
were accomplished##17##2##(1990-9#1)(1991-1#1)(1994-12#1)(1995-3#1)(1997-2#1)(2007-8#1)(2008-10#7)(2008-2#2)(2009-3#1)(2009-7#1)
were accounted for by##4##4##(1990-5#1)(1992-6#1)(1995-1#1)(2008-10#1)
were accounted for##8##3##(1990-5#1)(1992-6#1)(1995-1#1)(1997-5#1)(2007-2#1)(2008-10#3)
were accumulated in the##2##4##(1990-12#1)(1992-6#1)
were accumulated in##7##3##(1990-12#1)(1991-9#1)(1992-6#1)(1996-7#1)(1996-9#1)(1997-5#1)(2004-11#1)
were accumulated##10##2##(1990-12#1)(1991-9#1)(1992-6#1)(1995-2#1)(1996-7#1)(1996-9#1)(1997-5#1)(2004-11#1)(2007-8#1)(2010-7#1)
were accurate##4##2##(2006-7#1)(2008-10#1)(2011-2#1)(2012-1#1)
were accurately determined by##2##4##(1990-8#1)(2005-12#1)
were accurately##5##2##(1990-8#1)(2005-12#1)(2006-11#1)(2008-5#1)(2012-3#1)
were acetate##3##2##(2006-8#2)(2008-10#1)
were achieved after##4##3##(2008-11#1)(2008-5#1)(2009-10#1)(2011-1#1)
were achieved at a##2##4##(1990-9#1)(2008-3#1)
were achieved at##6##3##(1990-9#1)(1992-6#1)(1995-6#1)(2008-10#1)(2008-12#1)(2008-3#1)
were achieved by the##3##4##(1991-8#1)(2008-10#1)(2008-6#1)
were achieved by using##3##4##(2007-2#1)(2008-10#2)
were achieved by##19##3##(1990-5#1)(1991-6#1)(1991-8#1)(1995-7#1)(1996-5#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)
were achieved experimentally##2##3##(2007-12#1)(2008-3#1)
were achieved for the##2##4##(2008-10#2)
were achieved for##17##3##(1994-1#1)(2004-11#1)(2007-8#1)(2007-9#1)(2008-10#11)(2008-2#1)(2013-8#1)
were achieved in 27##2##4##(2007-11#1)(2008-6#1)
were achieved in the##2##4##(2006-12#1)(2008-10#1)
were achieved in##36##3##(1991-8#1)(1992-1#1)(1997-8#2)(2006-12#1)(2006-2#1)(2007-11#3)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#9)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-6#1)(2012-12#1)(2013-1#2)
were achieved through##3##3##(2007-12#2)(2008-2#1)
were achieved to##2##3##(2008-10#1)(2009-4#1)
were achieved using a##2##4##(2007-8#1)(2008-10#1)
were achieved using##7##3##(1990-5#1)(2007-8#1)(2008-10#3)(2008-7#1)(2008-9#1)
were achieved when the experiments were carried out##2##8##(2008-10#2)
were achieved when the##4##4##(1997-4#1)(2004-8#1)(2008-10#2)
were achieved when##7##3##(1997-4#1)(2004-8#1)(2007-11#1)(2008-10#3)(2008-6#1)
were achieved with a##5##4##(2007-11#1)(2007-12#1)(2008-10#2)(2010-12#1)
were achieved with the##2##4##(1997-8#1)(2008-10#1)
were achieved with##15##3##(1990-6#1)(1990-9#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-3#2)(2010-12#1)
were achieved within 1##2##4##(2008-10#2)
were achieved within##3##3##(2008-10#3)
were achieved without##4##3##(2008-10#1)(2008-2#2)(2011-1#1)
were achieved##193##2##(1990-2#1)(1990-5#2)(1990-6#2)(1990-9#2)(1991-6#1)(1991-8#3)(1992-1#1)(1992-6#1)(1994-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-8#4)(2004-11#1)(2004-8#1)(2005-11#2)(2006-12#2)(2006-2#1)(2007-11#6)(2007-12#10)(2007-2#1)(2007-7#6)(2007-8#7)(2007-9#1)(2008-1#2)(2008-10#68)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#12)(2008-5#4)(2008-6#3)(2008-7#3)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#8)(2013-8#2)
were acquired at##2##3##(1994-11#1)(2008-6#1)
were acquired by a##2##4##(2008-2#1)(2011-2#1)
were acquired by##6##3##(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#1)
were acquired during##2##3##(2007-6#1)(2011-2#1)
were acquired for##2##3##(2008-10#1)(2012-12#1)
were acquired from##6##3##(2007-11#1)(2008-2#2)(2009-12#1)(2011-1#1)(2013-7#1)
were acquired in the##2##4##(2008-10#1)(2008-2#1)
were acquired in##6##3##(1992-1#1)(1997-8#1)(2008-10#1)(2008-2#1)(2009-12#2)
were acquired on a 1##2##5##(2008-5#1)(2010-12#1)
were acquired using##3##3##(2008-10#1)(2012-1#1)(2012-3#1)
were acquired with a##2##4##(2006-12#1)(2010-9#1)
were acquired with##5##3##(2006-12#1)(2007-11#1)(2008-3#1)(2010-9#1)(2012-1#1)
were acquired##42##2##(1992-1#1)(1994-11#1)(1997-8#1)(2005-11#1)(2005-12#1)(2006-12#1)(2007-11#2)(2007-6#1)(2007-8#1)(2008-10#6)(2008-2#4)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-12#3)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#1)(2012-3#1)(2013-7#1)
were acting##2##2##(1995-12#1)(1996-8#1)
were activated and##2##3##(1990-5#1)(2007-12#1)
were activated by##13##3##(1990-8#1)(1991-4#1)(1992-5#1)(1994-2#1)(1995-11#2)(1997-5#1)(2008-11#2)(2008-4#2)(2008-7#1)(2008-9#1)
were activated from the##2##4##(1993-12#2)
were activated in HC##2##4##(2008-11#2)
were activated in the presence of##2##6##(1990-12#1)(1992-11#1)
were activated in##9##3##(1990-12#1)(1992-11#1)(1993-9#1)(2008-11#2)(2008-9#1)(2009-3#1)(2011-1#1)(2012-2#1)
were activated##33##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-8#1)(1991-12#1)(1991-4#1)(1992-11#1)(1992-5#1)(1993-12#2)(1993-9#1)(1994-2#1)(1994-3#1)(1995-11#2)(1997-5#1)(2007-12#1)(2008-10#1)(2008-11#4)(2008-4#2)(2008-7#1)(2008-9#2)(2009-3#1)(2010-2#2)(2011-1#1)(2012-2#1)
were active against HCMV (IC50's =##2##6##(1997-2#2)
were active against HCMV##3##4##(1996-8#1)(1997-2#2)
were active against the##2##4##(1992-3#1)(2007-11#1)
were active against##9##3##(1992-3#1)(1994-8#1)(1996-8#1)(1997-2#4)(2007-11#1)(2012-12#1)
were active in the field##2##5##(2005-9#1)(2006-12#1)
were active in the##5##4##(1992-8#1)(1996-5#1)(2005-9#1)(2006-12#1)(2010-3#1)
were active in##11##3##(1992-5#1)(1992-8#1)(1994-6#1)(1996-5#1)(1997-2#1)(2005-9#1)(2006-12#1)(2008-12#1)(2008-5#1)(2009-10#1)(2010-3#1)
were active on##3##3##(1990-6#1)(2009-3#1)(2011-3#1)
were active##36##2##(1990-6#1)(1991-5#1)(1991-6#1)(1992-3#2)(1992-5#1)(1992-8#1)(1994-6#1)(1994-8#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#5)(1997-3#1)(1997-6#1)(2005-9#1)(2006-12#2)(2006-8#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-3#1)(2010-3#1)(2011-1#1)(2011-3#1)(2012-12#2)
were actively accumulated##2##3##(2008-12#2)
were actively involved in##2##4##(1990-12#1)(1996-12#1)
were actively##10##2##(1990-12#1)(1993-9#2)(1995-8#1)(1996-1#1)(1996-12#1)(2008-12#2)(2008-4#1)(2008-8#1)
were actually##9##2##(1992-3#1)(1994-11#1)(1994-6#1)(2006-4#1)(2007-2#1)(2007-3#1)(2008-10#1)(2009-2#1)(2013-1#1)
were acute##8##2##(1990-10#1)(1990-12#1)(1990-5#1)(1993-5#1)(2008-1#2)(2010-6#1)(2011-1#1)
were acutely##5##2##(1991-5#1)(1992-2#1)(1993-5#2)(2008-5#1)
were acylated##2##2##(1996-10#1)(1996-5#1)
were adapted from##5##3##(2006-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
were adapted to the##2##4##(1995-8#1)(2008-10#1)
were adapted to##10##3##(1993-4#1)(1995-8#1)(1996-12#1)(2004-11#1)(2005-9#1)(2008-10#1)(2008-11#3)(2010-11#1)
were adapted##16##2##(1993-4#1)(1995-8#1)(1996-12#1)(2004-11#1)(2005-9#1)(2006-11#1)(2008-10#1)(2008-11#4)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
were added (g- 0##2##4##(2007-3#2)
were added as##2##3##(2008-10#1)(2008-11#1)
were added in the##4##4##(1997-8#1)(2004-11#1)(2007-11#1)(2013-1#1)
were added in##10##3##(1996-2#1)(1997-8#1)(2004-11#1)(2007-11#1)(2007-8#2)(2008-10#2)(2010-4#1)(2013-1#1)
were added into the##2##4##(2006-10#1)(2008-10#1)
were added into##4##3##(2004-9#1)(2006-10#1)(2008-10#1)(2008-12#1)
were added to a##3##4##(1991-5#1)(1997-8#1)(2008-10#1)
were added to an##2##4##(2007-2#1)(2008-10#1)
were added to different##2##4##(2009-4#1)(2012-2#1)
were added to each##2##4##(2007-2#1)(2008-10#1)
were added to pooled##2##4##(1990-11#1)(1990-12#1)
were added to soil lacking##2##5##(2008-10#2)
were added to soil##4##4##(2008-10#4)
were added to the medium##2##5##(2008-11#1)(2008-5#1)
were added to the soil##2##5##(2008-10#1)(2011-12#1)
were added to the##26##4##(1991-6#1)(1992-6#1)(1996-1#1)(1996-12#1)(1996-5#1)(2006-11#1)(2007-8#1)(2008-10#6)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-6#1)(2011-12#1)
were added to##67##3##(1990-11#1)(1990-12#2)(1990-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-6#1)(1992-9#1)(1994-3#1)(1994-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-8#1)(2006-11#2)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#21)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-3#1)(2010-4#2)(2011-12#1)(2012-2#1)(2012-3#1)
were added together##2##3##(1994-5#1)(2010-4#1)
were added##121##2##(1990-11#4)(1990-12#3)(1990-3#1)(1990-4#1)(1990-5#1)(1990-9#2)(1991-5#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-3#2)(1994-3#1)(1994-5#1)(1994-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-8#2)(2004-11#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-11#2)(2007-10#3)(2007-11#2)(2007-2#2)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#28)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#1)(2010-3#1)(2010-4#4)(2011-1#1)(2011-12#2)(2012-2#1)(2012-3#2)(2013-1#3)
were additional##3##2##(2007-11#1)(2011-2#1)(2012-12#1)
were additionally##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2009-7#1)
were additive##13##2##(1990-5#1)(1990-8#1)(1993-4#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-6#1)(1995-10#1)(1996-6#1)(2008-10#1)(2008-11#2)
were addressed and##2##3##(2007-4#1)(2008-9#1)
were addressed by##2##3##(2005-9#1)(2007-8#1)
were addressed using##2##3##(1994-9#1)(2008-10#1)
were addressed##10##2##(1994-6#1)(1994-9#1)(1997-1#1)(2005-9#2)(2007-4#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-11#1)
were adequate for##5##3##(1991-1#1)(1991-8#1)(2008-10#2)(2013-8#1)
were adequate##9##2##(1990-12#1)(1991-1#1)(1991-8#1)(2006-10#1)(2008-10#2)(2012-2#1)(2012-3#1)(2013-8#1)
were adequately controlled with##3##4##(2006-9#1)(2010-8#2)
were adequately##7##2##(1990-4#1)(2005-10#1)(2006-9#1)(2010-8#2)(2012-2#1)(2013-8#1)
were adjacent to##2##3##(2004-12#1)(2008-10#1)
were adjacent##4##2##(2004-12#1)(2008-10#1)(2013-1#2)
were adjusted by##3##3##(1993-12#1)(2008-10#1)(2012-2#1)
were adjusted for age##3##4##(1993-12#1)(2010-5#1)(2011-2#1)
were adjusted for##9##3##(1990-10#1)(1993-12#1)(1993-3#1)(1995-8#1)(2008-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#1)
were adjusted to##6##3##(1990-12#1)(1995-6#1)(2008-10#2)(2011-2#1)(2013-7#1)
were adjusted##24##2##(1990-10#1)(1990-12#1)(1993-12#2)(1993-3#1)(1995-6#1)(1995-8#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-7#2)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-2#1)(2013-7#2)
were administered 0##18##3##(1997-3#1)(2008-9#17)
were administered a second##2##4##(1993-12#1)(2007-2#1)
were administered a single##2##4##(1993-7#1)(1994-5#1)
were administered a##8##3##(1992-8#1)(1993-12#1)(1993-7#1)(1994-5#1)(2007-2#1)(2008-5#1)(2011-2#1)(2013-1#1)
were administered at##5##3##(1990-3#1)(2007-7#1)(2008-7#1)(2010-2#1)(2011-1#1)
were administered by##8##3##(1990-8#1)(1992-5#1)(1993-4#1)(1997-6#1)(2005-10#1)(2007-12#1)(2010-12#1)(2012-2#1)
were administered daily##3##3##(1991-10#1)(1992-1#1)(2008-10#1)
were administered during the##2##4##(1996-6#1)(2008-8#1)
were administered during##4##3##(1996-6#1)(2007-2#1)(2007-7#1)(2008-8#1)
were administered for##3##3##(1990-12#1)(2007-11#1)(2011-2#1)
were administered in##9##3##(1990-5#1)(1992-11#1)(1994-12#1)(1997-8#2)(2005-10#1)(2006-8#1)(2007-9#1)(2008-5#1)
were administered intraperitoneally##3##3##(1990-5#1)(1996-8#1)(2008-10#1)
were administered intravenously##2##3##(1992-5#1)(2013-1#1)
were administered measures of##2##4##(1993-1#1)(2004-12#1)
were administered orally to##3##4##(1992-7#1)(2008-10#1)(2013-1#1)
were administered orally##4##3##(1992-7#1)(1995-3#1)(2008-10#1)(2013-1#1)
were administered subcutaneously##2##3##(1992-1#1)(2008-5#1)
were administered the##9##3##(1997-2#1)(2007-9#1)(2008-11#1)(2008-9#1)(2009-11#1)(2010-3#1)(2011-1#2)(2011-12#1)
were administered to each##2##4##(1991-2#1)(1994-8#1)
were administered to mice##2##4##(1996-1#1)(2008-4#1)
were administered to subjects##2##4##(1996-2#1)(2008-4#1)
were administered to the##5##4##(1992-3#1)(2007-2#1)(2007-7#1)(2013-1#2)
were administered to##34##3##(1991-2#1)(1992-3#1)(1993-9#1)(1994-8#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(2004-12#1)(2004-8#1)(2005-10#1)(2006-4#1)(2006-7#1)(2007-1#2)(2007-10#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2011-1#2)(2012-2#1)(2013-1#2)
were administered together##2##3##(1991-12#1)(1993-6#1)
were administered with##3##3##(2008-10#2)(2008-7#1)
were administered##203##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-6#1)(1992-1#3)(1992-11#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#3)(1997-3#1)(1997-6#1)(1997-8#2)(2004-12#2)(2004-8#1)(2005-10#3)(2006-10#1)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#2)(2007-1#3)(2007-10#3)(2007-11#4)(2007-12#3)(2007-2#5)(2007-7#5)(2007-8#1)(2007-9#4)(2008-1#2)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#3)(2008-9#26)(2009-11#1)(2009-8#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#2)(2011-1#5)(2011-11#1)(2011-12#1)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#4)(2013-1#8)(2013-8#3)
were administrated with##3##3##(2011-3#1)(2012-3#2)
were administrated##10##2##(2007-8#1)(2010-2#1)(2011-3#1)(2012-3#5)(2013-1#1)(2013-7#1)
were admitted during##3##3##(2008-2#1)(2012-2#2)
were admitted for elective##2##4##(2008-7#1)(2011-2#1)
were admitted for##8##3##(1990-10#1)(1991-8#1)(2007-8#1)(2007-9#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)
were admitted from##3##3##(1991-8#1)(2007-2#1)(2008-3#1)
were admitted in our##3##4##(2007-7#1)(2011-2#1)(2013-1#1)
were admitted in the##2##4##(1991-9#1)(1994-6#1)
were admitted in##7##3##(1991-9#1)(1994-6#1)(2007-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
were admitted to hospital and##2##5##(1991-12#1)(2007-8#1)
were admitted to hospital##5##4##(1991-12#1)(1996-3#1)(1997-6#1)(2007-6#1)(2007-8#1)
were admitted to our department##4##5##(1991-8#1)(1997-8#1)(2007-8#1)(2009-6#1)
were admitted to our##9##4##(1991-8#1)(1997-8#1)(2007-8#3)(2009-6#1)(2010-9#1)(2011-1#1)(2012-12#1)
were admitted to the Department of##2##6##(1993-5#1)(1995-11#1)
were admitted to the ICU##3##5##(2004-1#1)(2006-10#1)(2009-6#1)
were admitted to the##20##4##(1990-10#1)(1992-1#1)(1992-10#1)(1993-1#1)(1993-10#1)(1993-5#2)(1995-11#1)(2004-1#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-8#2)(2007-2#2)(2008-3#1)(2009-6#1)(2012-2#1)(2013-1#1)
were admitted to##44##3##(1990-10#1)(1990-12#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-10#1)(1993-1#1)(1993-10#2)(1993-5#2)(1995-11#1)(1996-3#1)(1997-6#1)(1997-8#1)(2004-1#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-8#3)(2007-10#1)(2007-11#1)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#4)(2008-3#1)(2009-6#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
were admitted with a##2##4##(2007-10#1)(2010-12#1)
were admitted with##6##3##(1997-8#1)(2007-10#1)(2007-8#1)(2007-9#1)(2010-12#1)(2011-2#1)
were admitted within##2##3##(1996-9#2)
were admitted##86##2##(1990-10#2)(1990-12#1)(1991-12#1)(1991-8#3)(1991-9#2)(1992-1#1)(1992-10#1)(1992-9#1)(1993-1#1)(1993-10#2)(1993-5#2)(1994-6#1)(1995-11#1)(1996-3#1)(1996-9#3)(1997-6#1)(1997-8#3)(2004-1#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#3)(2007-10#2)(2007-11#1)(2007-2#3)(2007-6#1)(2007-7#4)(2007-8#6)(2007-9#3)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#2)(2009-6#2)(2010-12#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#2)
were admixed##2##2##(2012-1#1)(2012-3#1)
were adopted as##2##3##(2006-2#1)(2013-1#1)
were adopted for##2##3##(1995-5#1)(2013-8#1)
were adopted##10##2##(1993-10#1)(1995-5#1)(2005-11#2)(2006-2#1)(2008-1#1)(2008-10#1)(2013-1#2)(2013-8#1)
were adrenalectomized##2##2##(1994-2#1)(1995-12#1)
were adsorbed on##2##3##(1990-8#1)(2008-10#1)
were adsorbed##8##2##(1990-8#1)(2007-8#2)(2008-10#4)(2008-9#1)
were adult##7##2##(1996-11#1)(2005-8#1)(2006-2#1)(2007-2#1)(2008-3#1)(2009-4#1)(2012-3#1)
were adults##5##2##(1994-8#1)(2007-3#1)(2008-2#1)(2011-2#1)(2013-7#1)
were advanced##6##2##(1991-5#1)(2008-10#1)(2008-7#1)(2009-4#1)(2011-2#1)(2013-1#1)
were adversely affected in##2##4##(2008-7#1)(2011-2#1)
were advertised in the##2##4##(1990-6#1)(2008-5#1)
were advertised in##3##3##(1990-6#2)(2008-5#1)
were advised to##5##3##(1997-8#1)(2007-4#1)(2007-7#2)(2008-10#1)
were affected and##2##3##(2008-5#1)(2010-12#1)
were affected by LH##2##4##(2009-10#2)
were affected by the growth##2##5##(1990-12#1)(2008-11#1)
were affected by the##11##4##(1990-11#1)(1990-12#1)(2007-11#1)(2008-10#3)(2008-11#1)(2010-2#1)(2011-12#1)(2011-2#2)
were affected by##40##3##(1990-11#1)(1990-12#2)(1990-5#2)(1990-9#2)(1991-4#1)(1993-10#1)(1993-2#1)(1994-11#1)(1996-1#2)(1996-3#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2010-2#1)(2010-4#2)(2011-12#1)(2011-2#2)(2013-8#1)
were affected greatly##2##3##(1993-10#1)(2008-10#1)
were affected in##4##3##(2006-2#1)(2008-10#1)(2008-6#1)(2012-9#1)
were affected more than##2##4##(2008-10#1)(2008-11#1)
were affected more##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
were affected significantly##4##3##(2007-4#1)(2008-10#1)(2008-9#1)(2011-2#1)
were affected##78##2##(1990-11#1)(1990-12#2)(1990-5#2)(1990-9#2)(1991-1#1)(1991-10#1)(1991-4#1)(1992-1#1)(1993-10#2)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1995-3#2)(1996-1#2)(1996-3#1)(1997-3#1)(2005-11#1)(2006-10#3)(2006-2#2)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#2)(2009-2#1)(2010-12#1)(2010-2#1)(2010-4#3)(2011-12#1)(2011-2#10)(2012-9#1)(2013-8#1)
were affiliated to##2##3##(2011-2#1)(2012-12#1)
were affiliated##4##2##(2008-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
were affinity##2##2##(1990-11#1)(2010-3#1)
were afflicted##2##2##(2007-7#1)(2012-11#1)
were afraid##3##2##(2007-8#1)(2012-12#1)(2012-3#1)
were after##2##2##(1995-12#2)
were again##7##2##(1993-1#1)(1996-9#1)(1997-1#1)(2006-10#1)(2008-6#1)(2011-2#1)(2012-12#1)
were age matched##2##3##(1993-12#1)(2011-1#1)
were age##14##2##(1990-11#1)(1993-12#1)(1994-12#1)(1994-8#1)(1996-9#1)(2004-10#1)(2006-1#1)(2006-9#1)(2010-10#1)(2010-3#1)(2011-1#2)(2011-2#1)(2013-1#1)
were age- and sex-matched and were##2##6##(2007-10#1)(2007-9#1)
were aged between##4##3##(2007-2#1)(2008-3#1)(2010-8#1)(2012-3#1)
were aged##20##2##(1991-8#1)(2005-8#1)(2006-2#1)(2007-2#2)(2007-8#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#4)
were aggravated##2##2##(1990-3#1)(2009-8#1)
were aggregated with##2##3##(2006-5#2)
were aggregated##8##2##(1990-4#1)(1995-6#1)(2006-5#2)(2007-9#1)(2008-10#2)(2013-1#1)
were aggressive##6##2##(2008-10#1)(2010-1#1)(2010-4#4)
were agonists##3##2##(1990-2#1)(1995-3#1)(1997-2#1)
were agreed##3##2##(2008-10#1)(2008-6#1)(2009-2#1)
were agreeing##2##2##(2008-7#1)(2011-2#1)
were aimed at##4##3##(1992-5#1)(1995-2#1)(2009-2#1)(2012-1#1)
were alanine##2##2##(2008-5#1)(2010-8#1)
were aligned and##2##3##(1990-7#1)(1990-8#1)
were aligned with the##2##4##(2006-5#1)(2011-1#1)
were aligned with##4##3##(2006-5#1)(2008-10#1)(2011-1#1)(2013-7#1)
were aligned##13##2##(1990-7#1)(1990-8#1)(1991-5#1)(2006-4#1)(2006-5#1)(2008-10#2)(2008-6#1)(2009-10#1)(2009-4#2)(2011-1#1)(2013-7#1)
were alive and disease-free##2##4##(1992-4#1)(2008-6#1)
were alive and##6##3##(1991-8#2)(1992-4#1)(2008-6#2)(2012-12#1)
were alive at the time of##2##6##(2007-8#1)(2010-3#1)
were alive at the##3##4##(2007-8#1)(2010-3#1)(2011-2#1)
were alive at##5##3##(1991-8#1)(2007-7#1)(2007-8#1)(2010-3#1)(2011-2#1)
were alive for more than##2##5##(1990-7#1)(1991-2#1)
were alive of which##4##4##(2008-12#4)
were alive with##2##3##(2008-6#2)
were alive without##2##3##(1991-10#1)(2010-1#1)
were alive##28##2##(1990-5#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-8#3)(1992-4#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#5)(2008-6#4)(2010-1#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)
were all associated with##3##4##(2008-9#2)(2011-2#1)
were all below##3##3##(2008-10#3)
were all compared##2##3##(2004-1#1)(2008-2#1)
were all correctly##3##3##(1990-9#1)(2007-3#1)(2011-1#1)
were all elevated##2##3##(1992-6#1)(1993-6#1)
were all found to be##3##5##(1990-5#1)(2006-12#1)(2008-8#1)
were all found to##6##4##(1990-5#1)(1991-12#1)(1996-4#1)(2006-12#1)(2008-11#1)(2008-8#1)
were all found##7##3##(1990-5#1)(1991-12#1)(1996-4#1)(1996-6#1)(2006-12#1)(2008-11#1)(2008-8#1)
were all in the range##2##5##(1990-3#1)(1995-2#1)
were all increased in##2##4##(1992-7#1)(2010-10#1)
were all low##2##3##(2007-2#1)(2013-1#1)
were all lower than 1%##3##5##(2008-10#3)
were all male##2##3##(2007-8#1)(2008-4#1)
were all more than 0##2##5##(2013-8#2)
were all negative by##2##4##(2005-10#1)(2008-5#1)
were all negative##7##3##(1996-2#1)(2005-10#2)(2006-10#1)(2007-11#1)(2008-5#1)(2010-12#1)
were all normal##2##3##(2006-10#1)(2012-2#1)
were all sensitive to##2##4##(1994-11#1)(2008-10#1)
were all significantly decreased in##2##5##(1996-5#1)(2008-10#1)
were all significantly greater##2##4##(2010-11#1)(2011-1#1)
were all significantly higher than##2##5##(1991-8#1)(2013-8#1)
were all significantly##12##3##(1991-8#1)(1992-12#1)(1996-5#1)(2008-10#3)(2008-5#1)(2009-5#1)(2010-11#1)(2011-1#2)(2013-8#1)
were all statistically##2##3##(1992-2#1)(2008-10#1)
were all within the##2##4##(1990-12#1)(2008-11#1)
were all within##3##3##(1990-12#1)(2008-10#1)(2008-11#1)
were all##136##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-7#1)(1991-8#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-7#2)(1993-6#1)(1993-8#1)(1994-11#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#2)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#2)(1997-2#1)(1997-3#1)(1997-6#1)(2004-1#1)(2005-10#2)(2005-11#1)(2005-4#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#23)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#4)(2008-8#2)(2008-9#2)(2009-5#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#6)(2011-10#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#4)
were allergic##2##2##(1991-3#1)(2011-2#1)
were alleviated##2##2##(2008-4#1)(2008-7#1)
were allocated into##3##3##(2008-10#1)(2012-2#2)
were allocated to the##6##4##(1991-10#1)(1994-2#1)(1996-5#1)(2006-6#1)(2008-12#2)
were allocated to two##2##4##(2009-8#1)(2012-2#1)
were allocated to##14##3##(1990-4#1)(1991-10#1)(1991-8#1)(1993-7#1)(1994-2#1)(1996-5#1)(2006-6#1)(2007-2#1)(2008-12#3)(2009-8#1)(2011-2#1)(2012-2#1)
were allocated##22##2##(1990-4#1)(1991-10#1)(1991-8#1)(1993-7#1)(1993-8#1)(1994-2#1)(1996-5#1)(2006-6#2)(2007-2#1)(2007-9#1)(2008-10#1)(2008-12#3)(2009-8#1)(2010-12#1)(2011-2#2)(2012-2#3)
were allotted##2##2##(2008-5#1)(2008-9#1)
were allowed a##2##3##(2008-10#1)(2011-2#1)
were allowed to bind to##2##5##(1990-12#1)(1992-3#1)
were allowed to##20##3##(1990-10#1)(1990-12#1)(1990-7#1)(1990-8#1)(1992-3#1)(1993-4#1)(1994-2#1)(1994-3#1)(1995-4#1)(1996-5#1)(2005-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-8#2)
were allowed##31##2##(1990-10#1)(1990-12#1)(1990-7#1)(1990-8#1)(1992-3#1)(1993-4#1)(1994-2#1)(1994-3#1)(1995-4#1)(1996-5#1)(2005-7#1)(2007-1#1)(2007-10#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#2)(2009-5#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-2#1)
were almost completely##6##3##(1990-3#1)(1992-3#1)(1995-6#1)(1997-8#1)(2006-12#1)(2008-10#1)
were almost equally##2##3##(1990-2#1)(1994-2#1)
were almost equivalent in both##2##5##(1994-5#2)
were almost exclusively##2##3##(2004-2#1)(2005-8#1)
were almost identical##5##3##(1990-12#1)(1991-8#1)(1996-5#1)(1997-1#1)(2008-9#1)
were almost similar##2##3##(1992-4#1)(2008-10#1)
were almost the same as those in peripheral arterial blood##2##10##(1996-3#2)
were almost the same as those of##2##7##(1993-6#1)(1997-8#1)
were almost the same as those##5##6##(1993-6#1)(1996-3#2)(1997-8#1)(2008-3#1)
were almost the same as##6##5##(1993-6#1)(1996-3#2)(1997-8#1)(2008-10#1)(2008-3#1)
were almost the same##11##4##(1990-1#1)(1990-5#1)(1993-6#1)(1993-7#1)(1996-3#2)(1997-8#1)(2004-4#1)(2004-8#1)(2008-10#1)(2008-3#1)
were almost totally##2##3##(1992-11#1)(1996-5#1)
were almost twice as likely to##2##6##(2008-11#1)(2011-2#1)
were almost##60##2##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-8#1)(1992-11#2)(1992-3#1)(1992-4#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-2#1)(1994-5#2)(1994-7#1)(1994-9#2)(1995-10#1)(1995-2#1)(1995-6#1)(1996-3#2)(1996-5#2)(1997-1#1)(1997-8#2)(2004-11#1)(2004-2#2)(2004-4#1)(2004-8#1)(2004-9#1)(2005-8#1)(2006-12#2)(2007-1#1)(2007-10#1)(2007-12#2)(2007-3#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-3#2)
were alpha-pinene##2##2##(2008-10#1)(2008-12#1)
were already present##3##3##(2004-4#1)(2008-7#1)(2008-9#1)
were already##25##2##(1995-3#1)(1996-4#1)(1996-5#1)(1997-3#1)(2004-4#1)(2007-2#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-7#1)(2011-2#4)(2012-12#2)(2013-1#1)(2013-8#2)
were also a##2##3##(2007-5#1)(2009-6#1)
were also able to##7##4##(1990-12#1)(1992-7#1)(1996-9#1)(2008-12#1)(2008-3#1)(2009-8#1)(2010-3#1)
were also achieved##8##3##(2007-10#1)(2007-12#1)(2008-10#6)
were also activated##2##3##(1993-7#1)(1997-5#1)
were also addressed##2##3##(1996-7#1)(2007-2#1)
were also affected by the##2##5##(1990-6#1)(1995-11#1)
were also affected##7##3##(1990-6#1)(1991-8#1)(1992-5#1)(1995-11#1)(2008-7#1)(2009-12#1)(2010-10#1)
were also altered##2##3##(1992-4#1)(1995-5#1)
were also amplified##3##3##(1992-4#1)(1995-2#1)(1997-7#1)
were also analysed and##2##4##(2008-10#1)(2008-7#1)
were also analysed by##3##4##(1994-2#1)(2008-10#1)(2008-6#1)
were also analysed for##2##4##(1993-8#1)(2010-4#1)
were also analysed##11##3##(1993-8#1)(1994-2#1)(2004-4#1)(2007-5#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-4#2)
were also analyzed by##6##4##(1990-10#1)(1990-8#1)(1992-3#1)(2006-4#1)(2009-8#1)(2012-12#1)
were also analyzed for##2##4##(1994-6#1)(2011-1#1)
were also analyzed in##5##4##(1994-3#1)(1996-7#1)(1997-6#1)(2011-2#2)
were also analyzed##29##3##(1990-10#1)(1990-8#1)(1992-3#1)(1994-12#1)(1994-3#1)(1994-6#1)(1996-7#1)(1997-6#1)(2006-10#1)(2006-4#1)(2007-3#1)(2008-10#5)(2009-8#1)(2011-1#3)(2011-2#2)(2012-12#2)(2013-1#2)(2013-8#3)
were also apparent##2##3##(2008-5#1)(2008-9#1)
were also applied for##2##4##(2008-10#1)(2009-6#1)
were also applied##3##3##(2008-10#1)(2009-6#1)(2012-3#1)
were also asked to complete##2##5##(1995-2#1)(2012-12#1)
were also asked to rank##2##5##(2010-12#1)(2013-8#1)
were also asked to##6##4##(1995-2#1)(2008-11#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-8#1)
were also asked##7##3##(1995-2#1)(2006-9#1)(2008-11#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-8#1)
were also assayed##5##3##(1991-2#1)(2007-5#1)(2008-10#1)(2013-1#2)
were also assessed##15##3##(1991-5#1)(1991-8#1)(1992-8#1)(1994-11#1)(1995-2#1)(1996-12#1)(2006-10#1)(2006-8#1)(2007-11#2)(2008-11#1)(2008-5#1)(2010-10#1)(2011-2#1)(2013-1#1)
were also associated with increased##2##5##(2010-2#1)(2010-8#1)
were also associated with##10##4##(1997-4#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-6#1)(2009-5#1)(2010-2#1)(2010-8#2)(2012-12#1)
were also available##2##3##(1991-3#1)(2007-7#1)
were also avoided##2##3##(2012-12#2)
were also calculated and the##2##5##(1994-8#1)(2008-10#1)
were also calculated and##5##4##(1994-8#1)(2008-10#2)(2008-7#1)(2010-9#1)
were also calculated for##3##4##(1996-3#1)(2007-1#1)(2008-3#1)
were also calculated##15##3##(1994-8#1)(1996-12#1)(1996-3#1)(2004-4#1)(2007-1#1)(2008-10#5)(2008-3#1)(2008-7#1)(2010-6#1)(2010-9#1)(2011-2#1)
were also carried out for the##2##6##(2008-10#1)(2009-12#1)
were also carried out with##2##5##(1991-4#1)(2008-5#1)
were also carried out##11##4##(1991-4#1)(1992-9#1)(2006-5#1)(2008-10#4)(2008-12#1)(2008-5#1)(2009-12#1)(2012-1#1)
were also characterized by##7##4##(2007-11#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-11#1)
were also characterized using##2##4##(1997-8#1)(2013-8#1)
were also characterized##13##3##(1994-9#1)(1996-7#1)(1997-8#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-11#1)(2013-1#1)(2013-8#1)
were also collected in##2##4##(2007-3#1)(2007-7#1)
were also collected##9##3##(1994-6#1)(1997-4#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-5#2)(2011-1#1)(2012-12#1)
were also common##3##3##(1997-3#1)(2008-5#1)(2008-7#1)
were also comparable##3##3##(2007-1#1)(2011-1#1)(2011-2#1)
were also compared for##2##4##(1997-4#1)(2008-10#1)
were also compared with the##3##5##(2007-7#1)(2008-2#1)(2008-5#1)
were also compared with those obtained by##2##7##(1993-1#1)(2008-10#1)
were also compared with those##4##5##(1991-9#1)(1993-1#1)(2008-10#1)(2008-3#1)
were also compared with##12##4##(1991-9#1)(1993-1#1)(1995-7#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2010-5#1)(2011-1#1)(2011-10#1)
were also compared##22##3##(1991-9#1)(1992-9#1)(1993-1#1)(1995-2#1)(1995-4#1)(1995-7#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2010-5#1)(2011-1#1)(2011-10#1)(2012-12#1)
were also conducted with the##2##5##(2006-11#1)(2010-8#1)
were also conducted with##6##4##(2004-4#1)(2006-11#1)(2007-2#1)(2007-7#1)(2010-8#1)(2013-1#1)
were also conducted##12##3##(1996-6#1)(1997-2#1)(2004-4#1)(2006-11#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-10#1)(2010-8#1)(2013-1#2)
were also confirmed by the##2##5##(1995-6#1)(2008-10#1)
were also confirmed by##5##4##(1995-6#1)(1997-2#1)(2008-10#3)
were also confirmed##7##3##(1995-6#1)(1997-2#1)(2008-10#3)(2009-8#1)(2013-8#1)
were also considered##10##3##(1991-3#1)(1993-7#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-9#1)(2010-4#1)
were also consistent with##3##4##(1991-2#1)(1995-2#1)(2008-10#1)
were also constructed##3##3##(1994-9#1)(1995-8#1)(2007-12#1)
were also converted into##2##4##(1995-6#1)(2008-3#1)
were also converted##3##3##(1995-6#1)(1997-8#1)(2008-3#1)
were also correlated with##2##4##(2007-2#1)(2008-10#1)
were also correlated##3##3##(2007-2#1)(2008-10#2)
were also decreased by##2##4##(1995-1#1)(2008-10#1)
were also decreased in the##2##5##(2006-12#1)(2008-10#1)
were also decreased in##4##4##(2006-12#1)(2007-11#1)(2008-10#1)(2008-7#1)
were also decreased##10##3##(1995-1#1)(2005-8#1)(2006-12#2)(2007-11#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)
were also defined##4##3##(1993-11#1)(2008-10#1)(2009-10#1)(2009-8#1)
were also demonstrated in##2##4##(1990-7#1)(1991-10#1)
were also demonstrated##5##3##(1990-7#1)(1991-10#1)(1994-11#1)(2007-11#1)(2007-6#1)
were also derived from##2##4##(2007-10#1)(2007-11#1)
were also derived##3##3##(2007-10#1)(2007-11#1)(2008-2#1)
were also detectable in##2##4##(1994-3#1)(1995-11#1)
were also detected by##3##4##(1996-7#1)(1997-6#1)(2008-5#1)
were also detected in the##4##5##(2008-10#1)(2009-12#1)(2010-5#1)(2013-8#1)
were also detected in##14##4##(1993-2#1)(1994-12#1)(1996-12#2)(1997-2#2)(2006-8#1)(2008-10#1)(2009-12#1)(2010-5#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-8#1)
were also detected on##2##4##(2008-10#1)(2008-8#1)
were also detected##36##3##(1992-12#2)(1992-7#1)(1993-2#1)(1994-12#1)(1996-12#2)(1996-7#1)(1997-2#2)(1997-6#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#8)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-12#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-8#1)
were also determined and##2##4##(2008-10#1)(2008-7#1)
were also determined as##2##4##(2007-12#1)(2008-6#1)
were also determined by##3##4##(1993-7#1)(2007-3#1)(2008-3#1)
were also determined in##4##4##(1993-1#1)(1993-2#1)(1997-7#1)(2006-10#1)
were also determined##37##3##(1991-5#1)(1992-2#1)(1993-1#1)(1993-2#1)(1993-7#1)(1994-10#1)(1994-2#1)(1994-3#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-6#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2010-6#1)(2012-11#1)(2012-2#1)(2013-1#1)
were also developed and##2##4##(2007-8#1)(2012-1#1)
were also developed##5##3##(2006-4#1)(2007-8#1)(2008-10#2)(2012-1#1)
were also diagnosed##2##3##(1992-8#1)(1994-7#1)
were also different from##2##4##(2008-7#1)(2011-2#1)
were also discussed##17##3##(2005-6#1)(2005-7#1)(2005-8#2)(2006-5#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-10#1)(2010-12#1)(2011-7#1)(2012-1#1)(2013-8#2)
were also distributed##2##3##(1991-9#1)(1996-9#1)
were also divided##2##3##(2006-6#1)(2012-3#1)
were also done##7##3##(1993-11#1)(1993-9#1)(2006-10#1)(2007-8#1)(2008-5#2)(2013-8#1)
were also effective in##3##4##(1990-4#1)(1990-5#1)(1993-6#1)
were also effective##4##3##(1990-4#1)(1990-5#1)(1992-5#1)(1993-6#1)
were also efficient in##3##4##(1991-12#1)(2012-11#2)
were also elevated by##2##4##(1990-5#1)(1991-10#1)
were also elevated##3##3##(1990-5#1)(1991-10#1)(2006-9#1)
were also employed##3##3##(1993-9#1)(1997-3#1)(2009-4#1)
were also enhanced##2##3##(1994-8#1)(2011-12#1)
were also equally##2##3##(1990-7#1)(2007-7#1)
were also established##3##3##(2004-9#1)(2006-11#1)(2008-10#1)
were also estimated##4##3##(2005-11#1)(2007-12#1)(2011-12#1)(2011-2#1)
were also evaluated in##2##4##(2008-3#1)(2013-7#1)
were also evaluated on##2##4##(2007-11#1)(2010-8#1)
were also evaluated##32##3##(1993-12#1)(1993-3#1)(1994-2#1)(1994-9#1)(2004-3#1)(2004-9#1)(2005-11#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#2)(2009-12#1)(2009-8#1)(2010-8#1)(2011-1#2)(2011-12#1)(2012-12#1)(2013-7#1)(2013-8#1)
were also evident##5##3##(2007-12#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-1#1)
were also examined by##2##4##(2007-12#1)(2008-9#1)
were also examined for##7##4##(1991-3#1)(2004-11#1)(2005-11#1)(2007-10#1)(2008-10#1)(2008-8#1)(2009-12#1)
were also examined in##3##4##(1993-1#1)(1993-2#1)(2010-8#1)
were also examined to determine##2##5##(2006-8#1)(2009-7#1)
were also examined to##4##4##(1996-9#1)(2006-8#1)(2008-10#1)(2009-7#1)
were also examined using##2##4##(1996-12#1)(1996-6#1)
were also examined with##2##4##(2006-10#1)(2009-11#1)
were also examined##50##3##(1990-10#1)(1990-4#1)(1990-6#1)(1991-3#1)(1991-8#1)(1993-1#1)(1993-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-12#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-6#1)(2004-11#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-8#1)(2011-1#1)
were also explored##5##3##(1991-2#1)(2008-1#1)(2009-5#1)(2010-12#1)(2013-7#1)
were also exposed to##2##4##(2008-11#1)(2012-3#1)
were also expressed in##7##4##(1994-3#1)(1995-11#2)(1996-5#1)(1997-4#1)(2006-12#1)(2008-5#1)
were also extracted##2##3##(2008-10#2)
were also fabricated and##2##4##(2008-2#1)(2008-5#1)
were also fabricated##3##3##(2008-2#1)(2008-5#1)(2009-2#1)
were also fitted##2##3##(2008-3#1)(2011-2#1)
were also followed##2##3##(1992-9#1)(2008-10#1)
were also formed##2##3##(1991-8#1)(2008-10#1)
were also found between##3##4##(1995-2#1)(2009-3#1)(2010-1#1)
were also found for the##2##5##(1996-7#1)(2008-10#1)
were also found for##4##4##(1995-2#1)(1996-7#1)(2005-10#1)(2008-10#1)
were also found in the##2##5##(2008-10#1)(2008-8#1)
were also found in##13##4##(1992-12#1)(1992-8#1)(1992-9#1)(1994-5#1)(1995-4#1)(2007-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#1)(2010-8#1)(2013-1#2)
were also found to be more##2##6##(1995-3#1)(2012-2#1)
were also found to be##16##5##(1992-6#1)(1994-10#1)(1994-3#1)(1995-10#1)(1995-3#1)(2005-11#1)(2007-10#1)(2009-10#1)(2010-7#1)(2011-12#2)(2012-2#3)(2013-1#1)(2013-8#1)
were also found to inhibit##2##5##(2010-11#1)(2011-2#1)
were also found to##31##4##(1991-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-4#1)(1994-10#1)(1994-3#1)(1995-10#1)(1995-3#1)(1997-1#1)(2005-11#1)(2005-9#1)(2007-10#1)(2008-1#1)(2008-11#1)(2009-10#1)(2009-12#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-12#2)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#1)
were also found##75##3##(1990-12#1)(1990-4#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-6#1)(1992-8#2)(1992-9#3)(1993-4#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-10#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-7#1)(1996-1#1)(1996-7#1)(1997-1#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-9#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-12#2)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#1)
were also given##2##3##(2005-8#1)(2008-11#1)
were also higher in the##2##5##(1993-9#2)
were also higher in##5##4##(1993-9#2)(1994-2#1)(1996-4#1)(1996-8#1)
were also higher##7##3##(1993-9#2)(1994-2#1)(1996-4#1)(1996-8#1)(2006-10#1)(2009-9#1)
were also highly##4##3##(1991-2#1)(1992-11#1)(1992-4#1)(2008-5#1)
were also identified as##2##4##(2008-12#1)(2008-3#1)
were also identified by##4##4##(2007-1#1)(2009-12#2)(2011-1#1)
were also identified in the##2##5##(1994-12#1)(2009-6#1)
were also identified in##3##4##(1990-11#1)(1994-12#1)(2009-6#1)
were also identified##28##3##(1990-11#1)(1993-2#1)(1994-12#1)(1994-3#1)(2004-3#1)(2005-10#1)(2006-7#1)(2007-1#2)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-12#2)(2009-3#1)(2009-6#1)(2010-4#1)(2011-1#2)(2011-2#1)
were also in##2##3##(1995-11#1)(2008-7#1)
were also included in the##3##5##(1996-3#1)(2008-10#1)(2010-6#1)
were also included##10##3##(1996-3#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-6#1)(2013-8#1)
were also increased##7##3##(1993-11#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-9#2)(2013-1#1)
were also induced by##2##4##(1994-6#1)(2008-5#1)
were also induced during##2##4##(2008-7#1)(2009-8#1)
were also induced##4##3##(1994-6#1)(2008-5#1)(2008-7#1)(2009-8#1)
were also inhibited by##7##4##(1991-2#1)(1992-11#1)(1994-10#1)(1997-5#1)(2011-2#1)(2011-3#1)(2013-1#1)
were also inhibited##8##3##(1991-2#1)(1992-11#1)(1994-10#1)(1997-5#1)(2006-3#1)(2011-2#1)(2011-3#1)(2013-1#1)
were also integrated##2##3##(2008-10#2)
were also investigated and##2##4##(2008-10#2)
were also investigated as##3##4##(1995-1#1)(2006-8#1)(2008-10#1)
were also investigated in##3##4##(1994-12#1)(2008-10#1)(2008-7#1)
were also investigated##47##3##(1991-10#1)(1991-4#1)(1992-7#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1997-5#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-7#3)(2008-10#22)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)
were also involved in##2##4##(2007-7#1)(2007-8#1)
were also isolated from##3##4##(1997-4#1)(2005-9#1)(2006-12#1)
were also isolated##13##3##(1993-6#1)(1995-3#1)(1995-4#1)(1997-4#1)(2005-9#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-1#1)
were also labelled##4##3##(1992-3#1)(1996-5#1)(1997-5#2)
were also less likely to be##2##6##(2005-8#1)(2012-3#1)
were also less likely to##4##5##(2005-8#1)(2012-3#2)(2013-1#1)
were also less##5##3##(2005-8#1)(2009-9#1)(2012-3#2)(2013-1#1)
were also lower##3##3##(1995-7#1)(2009-7#1)(2013-8#1)
were also made in##2##4##(2006-7#1)(2008-10#1)
were also made to##2##4##(2008-5#1)(2011-2#1)
were also made##6##3##(2004-4#1)(2006-7#1)(2008-10#2)(2008-5#1)(2011-2#1)
were also measured at 25 degrees C##2##7##(2008-10#2)
were also measured at##3##4##(1991-6#1)(2008-10#2)
were also measured for##2##4##(2008-10#1)(2009-10#1)
were also measured in##3##4##(1990-11#1)(1990-3#1)(1990-7#1)
were also measured using##2##4##(1993-4#1)(2008-10#1)
were also measured##29##3##(1990-11#2)(1990-3#1)(1990-7#1)(1991-12#1)(1991-6#1)(1993-4#1)(1994-12#1)(1997-3#1)(2007-12#2)(2007-8#1)(2008-10#10)(2008-3#2)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#2)
were also modified by##2##4##(1992-7#1)(2008-5#1)
were also modified##3##3##(1992-7#1)(2008-5#1)(2008-9#1)
were also monitored##4##3##(1990-2#1)(1997-4#1)(2007-10#1)(2008-10#1)
were also more likely to report##2##6##(1997-8#1)(2013-1#1)
were also more likely to##4##5##(1997-8#1)(2008-8#1)(2013-1#2)
were also more likely##5##4##(1997-8#1)(2007-10#1)(2008-8#1)(2013-1#2)
were also more resistant to##2##5##(1995-10#1)(1997-4#1)
were also more responsive to##2##5##(1991-2#1)(2006-4#1)
were also more sensitive to##3##5##(1995-5#1)(1997-7#1)(2008-10#1)
were also more##20##3##(1991-2#1)(1995-10#1)(1995-5#2)(1997-4#1)(1997-7#1)(1997-8#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-11#1)(2010-12#1)(2011-1#1)(2013-1#2)
were also negative##3##3##(1992-6#1)(2005-10#1)(2008-5#1)
were also not##5##3##(1992-12#1)(1993-6#1)(1996-8#1)(2006-10#1)(2008-10#1)
were also noted##12##3##(1992-8#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-2#1)(2007-7#2)(2007-9#1)(2013-1#2)
were also noticed##2##3##(2008-12#1)(2013-1#1)
were also observed among##2##4##(2008-10#1)(2008-11#1)
were also observed between##4##4##(2006-11#1)(2008-11#1)(2008-2#1)(2010-4#1)
were also observed for##3##4##(1995-10#1)(1997-3#1)(2008-9#1)
were also observed in a##2##5##(1996-5#1)(2008-10#1)
were also observed in the##15##5##(1993-2#1)(1995-5#1)(1995-6#1)(1997-7#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
were also observed in##32##4##(1990-7#1)(1991-10#2)(1992-3#1)(1993-2#2)(1993-3#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-5#1)(1997-7#1)(2005-12#1)(2006-10#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-4#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
were also observed on##2##4##(2008-1#1)(2008-2#1)
were also observed with##2##4##(1992-3#1)(2007-8#1)
were also observed##78##3##(1990-6#1)(1990-7#1)(1991-10#2)(1991-6#1)(1992-12#1)(1992-3#2)(1993-2#2)(1993-3#3)(1993-6#1)(1994-3#1)(1995-10#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-12#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-2#2)(2008-4#2)(2008-5#2)(2008-7#5)(2008-9#2)(2009-4#2)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
were also obtained from this##2##5##(2006-12#1)(2007-1#1)
were also obtained from##8##4##(1992-12#1)(1994-12#1)(2006-12#1)(2007-1#1)(2008-10#1)(2008-5#2)(2010-5#1)
were also obtained in the##2##5##(1990-8#1)(2005-12#1)
were also obtained in##3##4##(1990-8#1)(2005-12#1)(2007-11#1)
were also obtained##32##3##(1990-8#1)(1992-12#1)(1994-12#1)(1996-12#1)(1996-2#1)(2005-12#1)(2006-12#2)(2006-2#1)(2007-1#3)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-5#2)(2008-7#1)(2008-8#3)(2010-3#1)(2010-5#1)(2012-2#1)(2013-8#1)
were also occasionally##2##3##(2007-12#1)(2010-9#1)
were also of##2##3##(2007-8#1)(2008-1#1)
were also operated on##2##4##(1991-2#1)(2010-8#1)
were also optimized##2##3##(2008-10#2)
were also performed and##2##4##(2007-2#1)(2013-7#1)
were also performed on the##2##5##(2007-5#1)(2008-2#1)
were also performed with##3##4##(1992-8#1)(1994-5#1)(1996-1#1)
were also performed##14##3##(1990-8#1)(1991-7#2)(1992-8#1)(1994-5#1)(1996-1#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-3#1)(2013-7#1)(2013-8#1)
were also positive for##6##4##(1991-9#1)(1992-6#1)(1995-11#1)(2007-2#1)(2008-10#1)(2010-7#1)
were also positive##10##3##(1991-9#2)(1992-6#1)(1995-11#1)(1996-5#1)(2004-11#1)(2007-11#1)(2007-2#1)(2008-10#1)(2010-7#1)
were also predicted by##2##4##(1997-8#1)(2011-1#1)
were also predicted##3##3##(1997-6#1)(1997-8#1)(2011-1#1)
were also prepared##9##3##(1992-9#1)(1994-5#1)(1995-7#1)(1997-3#1)(2006-12#1)(2008-10#2)(2009-11#1)(2010-4#1)
were also present in the##2##5##(1996-1#1)(2010-8#1)
were also present in##11##4##(1990-10#1)(1992-6#1)(1994-2#1)(1995-12#1)(1996-1#1)(1996-12#1)(2006-12#1)(2008-10#1)(2008-7#1)(2010-8#1)(2013-8#1)
were also present##19##3##(1990-10#1)(1992-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-7#1)(1997-3#1)(1997-7#1)(2006-12#1)(2008-10#2)(2008-7#2)(2010-8#1)(2012-12#1)(2013-8#1)
were also presented##3##3##(1992-10#1)(2005-8#1)(2008-3#1)
were also processed##2##3##(1993-12#1)(2007-7#1)
were also recorded for##2##4##(1996-7#1)(1997-4#1)
were also recorded##13##3##(1990-8#1)(1994-10#1)(1996-7#1)(1997-4#1)(2006-4#1)(2007-11#1)(2007-3#2)(2007-7#1)(2007-8#1)(2008-4#1)(2010-2#1)(2013-7#1)
were also reduced by##3##4##(1991-9#1)(2008-10#1)(2008-2#1)
were also reduced##6##3##(1991-9#1)(1993-12#1)(2008-10#2)(2008-2#1)(2008-8#1)
were also related to##3##4##(1992-4#1)(1996-3#1)(2011-1#1)
were also reported##5##3##(1993-1#1)(2007-11#1)(2011-2#1)(2012-1#1)(2012-11#1)
were also resistant to##5##4##(1992-8#1)(1993-10#1)(1994-7#1)(2008-5#2)
were also resistant##6##3##(1992-8#1)(1993-10#1)(1994-7#1)(2008-10#1)(2008-5#2)
were also revealed##3##3##(1991-1#1)(2011-1#1)(2011-2#1)
were also reviewed##7##3##(1993-1#1)(2007-9#1)(2008-2#1)(2008-6#1)(2010-12#1)(2013-1#1)(2013-8#1)
were also risk factors for##2##5##(2010-7#1)(2013-8#1)
were also screened for##3##4##(2007-7#1)(2007-9#1)(2008-3#1)
were also seen in the##5##5##(1991-10#1)(1997-3#1)(1997-6#1)(2008-7#2)
were also seen in##8##4##(1991-10#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#1)(2008-5#1)(2008-7#2)
were also seen##13##3##(1991-10#1)(1992-3#1)(1992-6#1)(1992-9#1)(1995-10#1)(1997-3#1)(1997-6#1)(2004-11#1)(2007-10#1)(2007-11#1)(2008-5#1)(2008-7#2)
were also selected##3##3##(2008-10#1)(2008-7#1)(2009-12#1)
were also shown to affect##2##5##(1990-12#1)(2012-2#1)
were also shown to be##6##5##(1992-3#1)(1992-6#1)(1994-2#1)(1996-10#1)(2008-3#1)(2010-7#1)
were also shown to##11##4##(1990-12#1)(1992-3#1)(1992-6#1)(1994-2#1)(1995-5#1)(1996-10#1)(2008-10#2)(2008-3#1)(2010-7#1)(2012-2#1)
were also shown##12##3##(1990-12#1)(1992-3#1)(1992-6#1)(1994-2#1)(1995-5#1)(1996-10#1)(1997-2#1)(2008-10#2)(2008-3#1)(2010-7#1)(2012-2#1)
were also significant##3##3##(2006-1#1)(2007-2#1)(2011-1#1)
were also significantly decreased##2##4##(1995-7#1)(2008-9#1)
were also significantly greater##2##4##(1994-10#1)(2012-11#1)
were also significantly higher in##2##5##(1993-4#1)(1997-7#1)
were also significantly higher##6##4##(1993-4#1)(1995-11#1)(1996-1#1)(1997-7#1)(2007-10#1)(2011-2#1)
were also significantly increased##2##4##(1995-12#1)(2005-8#1)
were also significantly more likely to##3##6##(2009-5#1)(2010-2#1)(2010-9#1)
were also significantly more##5##4##(1991-5#1)(1995-1#1)(2009-5#1)(2010-2#1)(2010-9#1)
were also significantly##26##3##(1991-5#1)(1993-4#1)(1994-10#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-7#1)(1996-1#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-7#1)(2004-12#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-11#1)
were also similar to##2##4##(2008-10#1)(2008-8#1)
were also similar##7##3##(2006-1#1)(2008-10#1)(2008-8#2)(2009-12#1)(2010-4#1)(2011-1#1)
were also some##2##3##(1994-10#1)(2008-7#1)
were also stained for NADPH-diaphorase##3##5##(1992-8#3)
were also stained for##4##4##(1992-8#3)(1993-12#1)
were also stained##10##3##(1992-7#1)(1992-8#3)(1993-12#1)(1995-12#2)(1996-12#1)(2008-5#1)(2009-2#1)
were also strongly positive for##2##5##(1991-9#1)(2008-5#1)
were also strongly##6##3##(1991-9#1)(1992-4#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)
were also studied as##2##4##(2009-5#1)(2011-1#1)
were also studied for##5##4##(1995-3#1)(2007-2#1)(2007-7#1)(2008-10#1)(2013-8#1)
were also studied in detail##3##5##(2008-10#2)(2008-3#1)
were also studied in##7##4##(1990-3#1)(1993-8#1)(1995-1#1)(2008-10#2)(2008-3#2)
were also studied##51##3##(1990-3#2)(1991-11#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-6#1)(1995-1#2)(1995-3#1)(1995-5#1)(1997-1#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#15)(2008-12#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#2)(2009-5#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
were also subject##2##3##(2010-6#1)(2012-2#1)
were also subjected to##2##4##(1996-2#1)(2013-7#1)
were also successfully##4##3##(2008-10#3)(2009-11#1)
were also supported by the##2##5##(2007-12#1)(2008-10#1)
were also suppressed by##2##4##(1997-5#1)(2008-5#1)
were also synthesised##2##3##(1990-2#1)(2008-5#1)
were also taken##4##3##(2006-10#1)(2006-3#1)(2006-7#1)(2007-7#1)
were also tested as##2##4##(2007-6#1)(2008-10#1)
were also tested by##2##4##(2008-10#1)(2013-8#1)
were also tested for##6##4##(1995-1#1)(1995-12#1)(1997-2#1)(2007-11#1)(2008-10#2)
were also tested in##4##4##(2008-10#1)(2008-11#1)(2008-5#1)(2010-3#1)
were also tested on a##2##5##(1993-3#1)(2008-5#1)
were also tested on##3##4##(1993-3#1)(2008-5#1)(2008-9#1)
were also tested using##2##4##(2007-12#1)(2009-12#1)
were also tested##31##3##(1993-12#1)(1993-3#1)(1993-4#1)(1994-3#1)(1995-1#1)(1995-12#1)(1997-2#1)(2005-11#2)(2006-12#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-12#1)(2010-3#1)(2013-1#1)(2013-8#1)
were also the most##2##4##(2008-10#1)(2009-7#1)
were also the##7##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-7#1)(2009-8#1)(2013-1#1)
were also those##2##3##(1992-10#1)(2006-6#1)
were also treated with##2##4##(1992-10#1)(1996-4#1)
were also treated##5##3##(1990-2#1)(1992-10#1)(1996-4#1)(2008-10#1)(2008-3#1)
were also unable to block##2##5##(1990-2#1)(1992-5#1)
were also unable to##3##4##(1990-2#1)(1992-5#1)(2008-12#1)
were also undertaken##3##3##(1994-10#2)(2008-10#1)
were also up-regulated in##3##4##(2008-10#1)(2008-11#1)(2009-4#1)
were also used in the##4##5##(1990-4#1)(1996-8#1)(2009-6#1)(2010-5#1)
were also used in##6##4##(1990-4#1)(1996-8#1)(2008-10#1)(2009-6#1)(2010-5#1)(2012-12#1)
were also used to calculate the##2##6##(2008-5#1)(2010-7#1)
were also used to##10##4##(2008-10#6)(2008-3#1)(2008-5#1)(2008-9#1)(2010-7#1)
were also used##23##3##(1990-4#1)(1996-8#1)(2005-11#1)(2005-9#1)(2007-8#1)(2008-10#11)(2008-3#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-5#1)(2010-7#1)(2012-12#1)
were also very##5##3##(1990-5#1)(2008-10#2)(2008-7#1)(2010-8#1)
were also##1494##2##(1990-1#1)(1990-10#4)(1990-11#4)(1990-12#5)(1990-2#4)(1990-3#4)(1990-4#5)(1990-5#5)(1990-6#3)(1990-7#5)(1990-8#4)(1990-9#1)(1991-1#2)(1991-10#8)(1991-11#1)(1991-12#4)(1991-2#9)(1991-3#5)(1991-4#3)(1991-5#4)(1991-6#2)(1991-7#3)(1991-8#5)(1991-9#8)(1992-10#3)(1992-11#3)(1992-12#6)(1992-2#1)(1992-3#6)(1992-4#5)(1992-5#3)(1992-6#7)(1992-7#5)(1992-8#13)(1992-9#10)(1993-1#5)(1993-10#1)(1993-11#3)(1993-12#7)(1993-2#8)(1993-3#7)(1993-4#5)(1993-5#1)(1993-6#4)(1993-7#4)(1993-8#2)(1993-9#7)(1994-10#9)(1994-11#2)(1994-12#12)(1994-2#8)(1994-3#12)(1994-5#6)(1994-6#6)(1994-7#2)(1994-8#2)(1994-9#7)(1995-1#7)(1995-10#4)(1995-11#9)(1995-12#8)(1995-2#8)(1995-3#5)(1995-4#3)(1995-5#9)(1995-6#4)(1995-7#7)(1995-8#2)(1996-1#7)(1996-10#2)(1996-12#13)(1996-2#3)(1996-3#5)(1996-4#4)(1996-5#9)(1996-6#2)(1996-7#9)(1996-8#4)(1996-9#4)(1997-1#4)(1997-2#9)(1997-3#8)(1997-4#10)(1997-5#7)(1997-6#6)(1997-7#8)(1997-8#9)(2004-11#4)(2004-12#1)(2004-3#2)(2004-4#4)(2004-9#2)(2005-10#3)(2005-11#7)(2005-12#2)(2005-6#2)(2005-7#1)(2005-8#9)(2005-9#3)(2006-1#3)(2006-10#15)(2006-11#4)(2006-12#15)(2006-2#3)(2006-3#2)(2006-4#4)(2006-5#4)(2006-6#4)(2006-7#3)(2006-8#11)(2006-9#2)(2007-1#8)(2007-10#14)(2007-11#18)(2007-12#19)(2007-2#14)(2007-3#8)(2007-4#2)(2007-5#6)(2007-6#6)(2007-7#20)(2007-8#20)(2007-9#9)(2008-1#10)(2008-10#223)(2008-11#20)(2008-12#16)(2008-2#14)(2008-3#25)(2008-4#8)(2008-5#53)(2008-6#14)(2008-7#34)(2008-8#24)(2008-9#19)(2009-10#7)(2009-11#4)(2009-12#11)(2009-2#2)(2009-3#5)(2009-4#5)(2009-5#6)(2009-6#5)(2009-7#3)(2009-8#9)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#4)(2010-12#6)(2010-2#4)(2010-3#4)(2010-4#10)(2010-5#6)(2010-6#6)(2010-7#6)(2010-8#13)(2010-9#5)(2011-1#26)(2011-10#1)(2011-12#7)(2011-2#30)(2011-3#2)(2011-7#1)(2012-1#8)(2012-11#7)(2012-12#17)(2012-2#18)(2012-3#7)(2013-1#31)(2013-7#5)(2013-8#23)
were altered by HG##2##4##(2012-12#2)
were altered by##8##3##(1991-8#1)(1993-2#1)(1995-12#1)(1996-12#2)(2012-12#3)
were altered in##4##3##(1991-2#1)(2006-11#1)(2009-6#1)(2010-7#1)
were altered##15##2##(1991-2#1)(1991-7#1)(1991-8#1)(1993-2#1)(1995-12#1)(1996-12#3)(2006-11#1)(2009-6#1)(2010-7#1)(2012-12#3)(2013-8#1)
were always below##2##3##(1997-3#1)(2008-10#1)
were always lower##2##3##(1990-3#1)(2008-10#1)
were always present in##2##4##(1997-3#1)(2008-10#1)
were always##27##2##(1990-3#1)(1990-5#1)(1991-11#1)(1993-3#1)(1994-2#1)(1996-11#1)(1997-3#2)(1997-5#1)(1997-6#1)(2005-11#1)(2006-7#1)(2007-11#3)(2008-10#4)(2008-11#2)(2008-5#1)(2008-8#2)(2009-2#1)(2010-12#1)(2012-1#1)
were amenable to##2##3##(1992-10#1)(2013-8#1)
were amended with##2##3##(2008-10#2)
were among persons##2##3##(1992-6#1)(1996-3#1)
were among the##12##3##(1990-9#1)(1996-1#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-9#1)(2009-10#1)(2010-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
were among##22##2##(1990-9#1)(1992-6#2)(1996-1#1)(1996-3#1)(1996-6#1)(1997-5#1)(2006-12#1)(2007-11#2)(2008-10#1)(2008-9#1)(2009-10#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
were amongst the##2##3##(2005-8#1)(2011-2#1)
were amplified and cloned##2##4##(2005-11#1)(2008-10#1)
were amplified and sequenced##6##4##(2007-6#1)(2008-10#2)(2008-12#1)(2012-2#1)(2013-8#1)
were amplified and##11##3##(1992-6#1)(2005-11#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2012-2#2)(2013-8#1)
were amplified by PCR and##3##5##(1997-4#1)(2008-10#1)(2008-8#1)
were amplified by PCR##5##4##(1997-4#1)(2005-11#1)(2006-8#1)(2008-10#1)(2008-8#1)
were amplified by polymerase chain reaction (PCR)##2##7##(2005-11#1)(2008-10#1)
were amplified by polymerase chain reaction##5##6##(1990-12#1)(1994-12#1)(2005-11#1)(2008-10#2)
were amplified by the##3##4##(1995-12#1)(1995-6#1)(2008-10#1)
were amplified by##18##3##(1990-12#1)(1994-12#1)(1995-12#1)(1995-6#1)(1996-12#1)(1997-4#1)(2005-11#3)(2006-8#1)(2008-10#4)(2008-11#1)(2008-8#1)(2010-10#1)(2010-5#1)
were amplified from the##4##4##(1990-11#1)(1997-7#1)(2008-10#1)(2010-4#1)
were amplified from##13##3##(1990-11#1)(1990-7#1)(1993-9#1)(1994-12#1)(1996-6#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-8#2)(2010-4#1)(2013-8#1)
were amplified in##2##3##(2005-11#1)(2008-9#1)
were amplified to##2##3##(1992-7#1)(1996-7#1)
were amplified using the polymerase chain reaction##2##7##(1994-11#1)(2008-11#1)
were amplified using the##3##4##(1994-11#1)(1997-6#1)(2008-11#1)
were amplified using##7##3##(1994-11#1)(1997-6#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
were amplified with##3##3##(1997-8#1)(2008-10#1)(2009-10#1)
were amplified##65##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1992-6#1)(1992-7#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-8#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#7)(2006-10#1)(2006-12#1)(2006-8#3)(2007-6#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-8#3)
were an exception##2##3##(1996-7#1)(2008-10#1)
were an##20##2##(1995-11#1)(1996-7#1)(1997-2#1)(2006-10#1)(2006-3#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-7#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
were anaemia##3##2##(1993-3#1)(2006-6#1)(2011-12#1)
were anaemic##3##2##(1990-3#1)(2007-3#1)(2013-7#1)
were anaesthetized and##2##3##(1993-7#1)(1995-9#1)
were anaesthetized with##4##3##(1997-6#1)(2006-8#1)(2011-2#2)
were anaesthetized##9##2##(1993-7#1)(1995-9#1)(1997-6#1)(2006-8#1)(2007-8#1)(2008-4#2)(2011-2#2)
were analysed according to the##2##5##(1994-3#1)(2008-7#1)
were analysed according to##6##4##(1991-9#1)(1994-3#1)(1997-6#1)(2006-2#1)(2008-7#1)(2008-9#1)
were analysed after##5##3##(2008-10#2)(2008-3#1)(2012-7#1)(2013-1#1)
were analysed and discussed##2##4##(2005-4#1)(2008-10#1)
were analysed and the##2##4##(2007-8#1)(2008-10#1)
were analysed and##11##3##(1990-2#1)(2005-4#1)(2007-8#1)(2008-10#5)(2008-7#1)(2008-9#1)(2011-12#1)
were analysed as##2##3##(2011-2#1)(2012-8#1)
were analysed before##2##3##(1996-5#1)(2007-8#1)
were analysed by a procedure##2##5##(1993-11#1)(1996-4#1)
were analysed by a##4##4##(1993-11#1)(1996-4#1)(2008-11#1)(2012-1#1)
were analysed by flame##2##4##(2007-5#1)(2008-10#1)
were analysed by gas chromatography##4##5##(2007-7#1)(2008-10#3)
were analysed by gas chromatography-mass spectrometry (GC-MS) and##2##8##(1990-5#1)(2007-1#1)
were analysed by gas##6##4##(1990-5#1)(2007-1#1)(2007-7#1)(2008-10#3)
were analysed by means of##5##5##(1991-8#2)(1992-3#1)(2008-5#1)(2009-6#1)
were analysed by the proposed##2##5##(2008-10#2)
were analysed by using##6##4##(2008-5#1)(2008-6#1)(2012-1#1)(2013-1#2)(2013-8#1)
were analysed by##69##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-8#2)(1992-2#1)(1992-3#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-4#1)(1997-8#1)(2004-4#2)(2005-11#1)(2006-10#1)(2007-1#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#15)(2008-11#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-6#1)(2011-2#3)(2012-1#2)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#1)
were analysed for the##4##4##(2008-10#1)(2008-11#2)(2012-2#1)
were analysed for their##4##4##(2006-12#1)(2008-12#2)(2013-1#1)
were analysed for total##2##4##(1993-9#1)(2010-5#1)
were analysed for##28##3##(1991-12#1)(1992-6#1)(1993-9#1)(1995-12#1)(1996-1#1)(1997-7#1)(2004-4#1)(2005-8#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-7#1)(2008-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-6#1)(2013-1#1)(2013-7#1)
were analysed in a##2##4##(2011-1#1)(2012-1#1)
were analysed in detail##2##4##(2006-12#1)(2007-1#1)
were analysed in terms of##2##5##(1990-8#1)(1992-1#1)
were analysed in the##3##4##(1996-2#1)(2007-2#1)(2009-6#1)
were analysed in urine##2##4##(1993-2#1)(2011-1#1)
were analysed in##30##3##(1990-2#1)(1990-6#1)(1990-8#1)(1991-2#1)(1992-1#1)(1992-12#1)(1993-2#1)(1995-12#1)(1996-2#1)(2004-4#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-7#2)(2008-10#3)(2008-5#1)(2008-7#1)(2009-6#1)(2011-1#3)(2011-12#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
were analysed on##3##3##(1991-2#1)(2005-12#1)(2009-8#1)
were analysed over##2##3##(1996-2#1)(2010-8#1)
were analysed retrospectively##4##3##(1990-11#1)(1990-8#1)(1992-11#1)(1997-2#1)
were analysed separately##3##3##(2007-1#1)(2007-8#1)(2009-2#1)
were analysed to determine##2##4##(2007-11#1)(2010-4#1)
were analysed to##11##3##(1991-6#1)(1994-9#1)(1996-5#1)(1996-8#1)(2006-4#1)(2007-11#1)(2007-3#1)(2008-10#1)(2010-4#1)(2011-2#1)(2012-3#1)
were analysed using SPSS##2##4##(2010-11#1)(2012-2#1)
were analysed using a##7##4##(1996-6#1)(2008-11#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
were analysed using an##2##4##(2010-10#1)(2012-1#1)
were analysed using the##5##4##(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
were analysed using##44##3##(1992-8#1)(1994-3#1)(1995-7#1)(1996-3#1)(1996-6#1)(1997-1#1)(2006-11#1)(2006-12#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2009-4#1)(2010-10#1)(2010-11#1)(2011-2#2)(2012-1#2)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#1)
were analysed with a##2##4##(2008-10#1)(2008-11#1)
were analysed with the##4##4##(2008-10#4)
were analysed with##11##3##(1993-5#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#1)
were analysed##321##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1990-8#3)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-6#1)(1991-8#3)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#3)(1995-2#1)(1995-7#1)(1995-8#1)(1996-1#3)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-4#4)(2005-11#1)(2005-12#1)(2005-4#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-2#4)(2006-4#1)(2006-8#2)(2007-1#5)(2007-10#2)(2007-11#6)(2007-12#1)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#10)(2007-9#1)(2008-1#1)(2008-10#47)(2008-11#8)(2008-12#6)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#9)(2008-8#3)(2008-9#4)(2009-2#3)(2009-4#1)(2009-6#3)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-4#3)(2010-5#1)(2010-8#3)(2011-1#4)(2011-12#4)(2011-2#11)(2012-1#6)(2012-12#6)(2012-2#11)(2012-3#4)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#13)(2013-7#6)(2013-8#8)
were analytically##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
were analyzed according to the type of##3##7##(1993-11#1)(1993-4#1)(2012-3#1)
were analyzed according to the##5##5##(1993-11#1)(1993-4#1)(1995-12#1)(2008-3#1)(2012-3#1)
were analyzed according to##9##4##(1993-11#1)(1993-4#1)(1994-3#1)(1995-12#1)(2008-3#1)(2008-7#2)(2011-2#1)(2012-3#1)
were analyzed according##10##3##(1993-11#1)(1993-4#1)(1994-3#1)(1995-12#1)(2008-3#1)(2008-7#2)(2011-2#2)(2012-3#1)
were analyzed after##4##3##(1990-7#1)(1994-12#1)(1996-6#1)(2010-6#1)
were analyzed along##3##3##(2008-10#3)
were analyzed and compared with those##2##6##(2008-1#1)(2013-1#1)
were analyzed and compared with##5##5##(2007-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2013-1#1)
were analyzed and compared##10##4##(1996-9#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2012-1#1)(2013-1#2)
were analyzed and quantified##2##4##(1991-12#1)(1991-5#1)
were analyzed and the results##3##5##(2007-10#1)(2008-10#2)
were analyzed and the##5##4##(2007-10#1)(2008-10#3)(2013-7#1)
were analyzed and##41##3##(1991-12#1)(1991-5#1)(1993-12#1)(1994-12#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-9#1)(2004-9#1)(2005-4#1)(2006-8#1)(2007-10#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-3#1)(2009-10#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#2)(2013-7#2)
were analyzed as##6##3##(1990-8#1)(2008-10#2)(2010-7#1)(2011-1#1)(2013-8#1)
were analyzed at the##3##4##(1990-12#1)(2011-2#1)(2012-12#1)
were analyzed at##5##3##(1990-12#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-12#1)
were analyzed based on##3##4##(2008-10#2)(2008-11#1)
were analyzed both##2##3##(2006-10#1)(2012-12#1)
were analyzed by GC and GC/MS##4##6##(2007-1#2)(2008-11#1)(2008-12#1)
were analyzed by GC and##5##5##(2007-1#2)(2008-11#1)(2008-12#1)(2012-2#1)
were analyzed by GC-MS##2##4##(1995-8#1)(2012-3#1)
were analyzed by HPLC and##2##5##(1995-11#1)(1996-8#1)
were analyzed by HPTLC##2##4##(1991-1#1)(2008-11#1)
were analyzed by a##11##4##(1993-11#1)(1996-11#1)(1997-7#1)(2004-12#1)(2008-10#2)(2008-3#2)(2008-9#1)(2010-9#1)(2013-1#1)
were analyzed by atomic absorption##2##5##(1994-6#1)(2008-10#1)
were analyzed by atomic##3##4##(1994-6#1)(2008-10#1)(2009-7#1)
were analyzed by both##3##4##(2006-3#1)(2008-10#1)(2009-6#1)
were analyzed by flow cytometry##2##5##(1997-7#1)(2013-1#1)
were analyzed by gas chromatography##2##5##(2008-10#1)(2008-9#1)
were analyzed by gas chromatography-mass spectrometry##3##6##(1993-2#1)(2008-10#1)(2013-8#1)
were analyzed by gas##7##4##(1993-2#1)(2007-1#1)(2008-10#3)(2008-9#1)(2013-8#1)
were analyzed by high-performance TLC##2##5##(1993-11#1)(1994-3#1)
were analyzed by high-performance liquid chromatography##3##6##(1990-3#1)(1992-2#1)(2008-5#1)
were analyzed by high-performance##5##4##(1990-3#1)(1992-2#1)(1993-11#1)(1994-3#1)(2008-5#1)
were analyzed by means of##6##5##(1990-12#1)(1997-8#1)(2006-12#1)(2008-10#1)(2008-5#1)(2008-7#1)
were analyzed by percentage##2##4##(1990-2#1)(1990-8#1)
were analyzed by real-time##2##4##(2008-10#1)(2012-3#1)
were analyzed by reverse##4##4##(1990-12#1)(1996-12#1)(2008-11#1)(2008-6#1)
were analyzed by scanning electron microscopy##2##6##(2009-7#1)(2012-2#1)
were analyzed by scanning##3##4##(2007-12#1)(2009-7#1)(2012-2#1)
were analyzed by the method##2##5##(1990-3#1)(2009-5#1)
were analyzed by the proposed method##2##6##(2008-10#2)
were analyzed by the proposed##3##5##(2008-10#3)
were analyzed by the##16##4##(1990-3#2)(2007-10#1)(2007-8#1)(2008-10#6)(2009-5#1)(2011-2#3)(2012-12#1)(2013-1#1)
were analyzed by this method##2##5##(2005-4#1)(2008-10#1)
were analyzed by this##4##4##(1993-12#1)(2005-4#1)(2008-10#2)
were analyzed by two##2##4##(1994-3#1)(1995-1#1)
were analyzed by use of##2##5##(1997-7#1)(2008-2#1)
were analyzed by using the##3##5##(1996-7#1)(2008-10#2)
were analyzed by using##11##4##(1996-7#1)(1997-7#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-6#1)(2013-8#2)
were analyzed by##206##3##(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#4)(1990-7#3)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#1)(1992-2#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#3)(1994-11#1)(1994-3#3)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-8#1)(1996-11#2)(1996-12#2)(1996-7#1)(1996-8#2)(1997-1#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#4)(1997-8#3)(2004-12#1)(2005-10#1)(2005-11#2)(2005-4#1)(2006-10#1)(2006-12#2)(2006-3#1)(2006-5#1)(2007-1#3)(2007-10#3)(2007-12#2)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#37)(2008-11#6)(2008-12#3)(2008-2#6)(2008-3#4)(2008-4#1)(2008-5#11)(2008-6#2)(2008-7#1)(2008-9#2)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#6)
were analyzed considering##2##3##(2007-3#2)
were analyzed during##3##3##(1993-9#1)(2008-10#1)(2008-11#1)
were analyzed following##3##3##(2008-10#2)(2010-5#1)
were analyzed for a##2##4##(2008-10#1)(2009-8#1)
were analyzed for copper##2##4##(2008-10#2)
were analyzed for mating type##2##5##(2008-10#2)
were analyzed for the presence of##4##6##(1990-6#1)(1992-9#1)(1994-8#1)(2008-10#1)
were analyzed for the##15##4##(1990-12#1)(1990-6#1)(1992-9#1)(1993-4#1)(1994-8#1)(1995-1#1)(1997-2#1)(2007-8#1)(2008-10#2)(2008-4#2)(2010-10#1)(2011-2#1)(2013-8#1)
were analyzed for their##7##4##(1991-5#1)(1992-2#1)(1993-2#1)(1996-8#1)(2008-10#1)(2008-7#1)(2012-11#1)
were analyzed for total##4##4##(2007-7#1)(2008-10#1)(2008-5#2)
were analyzed for virulence on##2##5##(2008-10#2)
were analyzed for virulence##3##4##(2008-10#3)
were analyzed for##105##3##(1990-12#1)(1990-5#1)(1990-6#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-7#1)(1992-9#1)(1993-2#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#2)(1997-2#2)(2004-4#1)(2006-10#2)(2006-5#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#28)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#2)(2012-5#1)(2013-1#2)(2013-7#1)(2013-8#2)
were analyzed from a##2##4##(2007-8#1)(2013-1#1)
were analyzed from##11##3##(1992-2#1)(1995-2#1)(1996-9#1)(2006-12#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#1)
were analyzed histologically##2##3##(2008-10#1)(2009-3#1)
were analyzed in a##11##4##(1994-1#1)(1995-6#1)(1997-2#1)(2005-10#1)(2007-11#1)(2008-12#1)(2008-5#2)(2008-9#1)(2010-2#1)(2012-2#1)
were analyzed in detail##4##4##(1995-12#1)(1995-6#1)(2006-11#1)(2012-3#1)
were analyzed in five##3##4##(1997-2#1)(2008-7#2)
were analyzed in order to##3##5##(1990-10#1)(1990-2#1)(2008-10#1)
were analyzed in relation to the##2##6##(1991-6#1)(2007-10#1)
were analyzed in relation to##3##5##(1991-6#1)(2007-10#1)(2011-2#1)
were analyzed in terms of##6##5##(1995-6#1)(1996-1#1)(1997-6#1)(2007-11#1)(2008-10#2)
were analyzed in the##8##4##(1992-2#1)(2005-4#1)(2006-8#1)(2008-10#3)(2008-7#1)(2012-11#1)
were analyzed in this##3##4##(2008-4#1)(2008-7#1)(2012-3#1)
were analyzed in##71##3##(1990-10#1)(1990-2#1)(1991-1#1)(1991-6#1)(1992-2#1)(1992-8#1)(1993-12#2)(1994-1#1)(1995-12#1)(1995-2#1)(1995-6#5)(1996-1#2)(1997-2#2)(1997-6#1)(1997-7#1)(2005-10#1)(2005-12#1)(2005-4#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-9#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-7#1)
were analyzed of##3##3##(2005-4#1)(2007-7#1)(2012-12#1)
were analyzed on the##2##4##(2005-11#1)(2011-2#1)
were analyzed on##7##3##(1991-9#1)(2005-11#1)(2008-5#1)(2011-1#1)(2011-2#2)(2012-1#1)
were analyzed over##2##3##(2006-12#1)(2007-9#1)
were analyzed prospectively##4##3##(2005-12#1)(2006-12#1)(2007-8#1)(2008-1#1)
were analyzed quantitatively##3##3##(1994-3#1)(1997-8#1)(2006-9#1)
were analyzed retrospectively##5##3##(1990-6#1)(1996-12#1)(1997-8#1)(2013-1#2)
were analyzed separately##3##3##(1993-2#1)(2006-7#1)(2008-2#1)
were analyzed statistically using##2##4##(2007-11#1)(2013-1#1)
were analyzed statistically##4##3##(2007-11#1)(2008-12#1)(2013-1#2)
were analyzed to determine the##6##5##(1995-1#1)(1995-3#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
were analyzed to determine their##2##5##(2008-10#1)(2013-1#1)
were analyzed to determine##11##4##(1994-2#1)(1995-1#1)(1995-12#1)(1995-3#1)(2006-12#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2013-1#1)
were analyzed to investigate##2##4##(2007-10#1)(2008-8#1)
were analyzed to##26##3##(1994-2#1)(1995-1#1)(1995-12#1)(1995-3#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-5#1)(2013-1#3)(2013-8#1)
were analyzed under##5##3##(2005-12#1)(2009-10#1)(2010-9#1)(2011-2#1)(2013-1#1)
were analyzed using Student's##2##4##(2010-12#1)(2013-7#1)
were analyzed using a combination of Linstone's Multiple Perspective approach and the ABC framework to determine lessons learned about novel system creation##2##22##(2013-1#2)
were analyzed using a complete relaxation matrix##2##7##(1993-11#1)(1994-11#1)
were analyzed using a mass##2##5##(1996-1#1)(2007-8#1)
were analyzed using a##18##4##(1993-11#1)(1994-11#1)(1996-1#1)(1997-8#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-6#1)(2009-2#1)(2009-4#1)(2010-2#2)(2011-1#1)(2011-2#1)(2013-1#4)
were analyzed using both##3##4##(2007-8#2)(2008-10#1)
were analyzed using data from the##2##6##(1994-6#1)(1995-5#1)
were analyzed using fluorescence##2##4##(1995-5#1)(2007-5#1)
were analyzed using modified grounded theory##2##6##(2012-11#1)(2013-1#1)
were analyzed using principal##2##4##(2008-10#1)(2008-6#1)
were analyzed using the##11##4##(1995-8#1)(2006-10#1)(2007-10#1)(2008-10#2)(2008-12#2)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
were analyzed using##91##3##(1990-12#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-11#3)(1994-3#1)(1994-4#1)(1994-6#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-3#1)(1996-7#1)(1997-8#1)(2004-3#1)(2005-10#1)(2005-11#3)(2006-10#2)(2007-1#1)(2007-10#2)(2007-12#1)(2007-5#2)(2007-7#1)(2007-8#3)(2008-10#11)(2008-12#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-2#2)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#9)(2013-7#2)(2013-8#1)
were analyzed via##2##3##(2008-10#1)(2009-7#1)
were analyzed with SPSS version##2##5##(2009-7#1)(2011-2#1)
were analyzed with a##6##4##(2005-4#1)(2007-3#1)(2008-11#1)(2008-12#1)(2013-1#2)
were analyzed with respect to##3##5##(1992-6#1)(2007-1#1)(2008-10#1)
were analyzed with the##5##4##(2008-10#4)(2011-1#1)
were analyzed with##35##3##(1992-6#1)(1994-11#1)(1995-11#1)(2005-4#2)(2006-12#1)(2007-1#1)(2007-3#1)(2008-10#11)(2008-11#1)(2008-12#2)(2009-4#1)(2009-7#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
were analyzed within##2##3##(1994-5#1)(2013-1#1)
were analyzed##902##2##(1990-10#3)(1990-11#2)(1990-12#11)(1990-2#2)(1990-3#4)(1990-5#1)(1990-6#3)(1990-7#4)(1990-8#2)(1991-1#3)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#5)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#5)(1993-12#5)(1993-2#5)(1993-3#2)(1993-4#2)(1993-8#3)(1993-9#5)(1994-1#1)(1994-11#8)(1994-12#4)(1994-2#1)(1994-3#9)(1994-4#1)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#5)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#6)(1995-3#4)(1995-5#4)(1995-6#7)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#3)(1996-12#3)(1996-2#1)(1996-3#4)(1996-4#2)(1996-5#2)(1996-6#2)(1996-7#3)(1996-8#4)(1996-9#3)(1997-1#2)(1997-2#5)(1997-3#3)(1997-4#1)(1997-6#2)(1997-7#5)(1997-8#6)(2004-12#2)(2004-3#1)(2004-4#2)(2004-9#2)(2005-10#4)(2005-11#7)(2005-12#3)(2005-4#6)(2005-5#1)(2005-8#1)(2006-10#8)(2006-11#1)(2006-12#7)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#6)(2007-10#12)(2007-11#6)(2007-12#5)(2007-2#6)(2007-3#8)(2007-4#4)(2007-5#5)(2007-7#9)(2007-8#19)(2007-9#3)(2008-1#5)(2008-10#152)(2008-11#17)(2008-12#15)(2008-2#13)(2008-3#11)(2008-4#10)(2008-5#28)(2008-6#7)(2008-7#12)(2008-8#3)(2008-9#9)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#5)(2009-3#4)(2009-4#4)(2009-5#2)(2009-6#2)(2009-7#7)(2009-8#3)(2009-9#4)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#5)(2010-2#4)(2010-3#2)(2010-4#6)(2010-5#3)(2010-6#2)(2010-7#4)(2010-8#5)(2010-9#3)(2011-1#14)(2011-12#3)(2011-2#29)(2012-1#5)(2012-11#4)(2012-12#9)(2012-2#18)(2012-3#19)(2012-5#1)(2013-1#45)(2013-7#16)(2013-8#27)
were and##5##2##(2007-5#1)(2008-5#2)(2009-5#1)(2010-12#1)
were anemic##2##2##(1991-4#1)(2008-7#1)
were anesthetized and##5##3##(1990-4#1)(1995-6#1)(1997-6#1)(2008-3#1)(2011-2#1)
were anesthetized with halothane and implanted with##2##7##(1995-7#2)
were anesthetized with halothane and##3##5##(1995-7#2)(2009-12#1)
were anesthetized with halothane##4##4##(1995-7#2)(2007-9#1)(2009-12#1)
were anesthetized with##5##3##(1993-4#1)(1995-7#2)(2007-9#1)(2009-12#1)
were anesthetized##17##2##(1990-12#1)(1990-4#1)(1992-3#2)(1993-4#1)(1994-6#1)(1995-12#1)(1995-6#1)(1995-7#2)(1997-6#1)(2007-9#2)(2008-3#1)(2009-12#1)(2011-2#2)
were annealed at##2##3##(2008-2#1)(2010-1#1)
were annealed##3##2##(1994-12#1)(2008-2#1)(2010-1#1)
were announced in##2##3##(2008-5#2)
were announced##4##2##(1996-11#1)(2008-5#3)
were annual##2##2##(2007-8#1)(2011-2#1)
were antagonised by##2##3##(1992-9#1)(1996-12#1)
were antagonized by naloxone##3##4##(1990-2#3)
were antagonized by##8##3##(1990-2#3)(1990-7#1)(1991-5#1)(1993-3#2)(1995-11#1)
were anti-HCV##2##2##(2006-6#1)(2007-2#1)
were anticoagulated##2##2##(2007-3#1)(2008-10#1)
were antigenically related##2##3##(2008-5#2)
were antigenically##5##2##(1992-6#2)(2008-5#2)(2013-8#1)
were anxiety##3##2##(1990-10#1)(1996-9#1)(2004-2#1)
were any##6##2##(1994-12#1)(1996-9#1)(2007-8#1)(2008-11#1)(2008-9#1)(2011-3#1)
were apparent between##2##3##(1991-9#1)(1993-12#1)
were apparent in##4##3##(1995-5#1)(2008-3#2)(2008-4#1)
were apparent##21##2##(1990-6#1)(1990-8#1)(1991-9#1)(1992-11#1)(1992-9#1)(1993-12#1)(1995-5#1)(2006-10#1)(2007-2#1)(2008-10#3)(2008-3#3)(2008-4#1)(2008-5#1)(2010-3#1)(2013-1#3)
were apparently healthy##2##3##(2007-2#1)(2013-1#1)
were apparently not##2##3##(1992-3#1)(2007-5#1)
were apparently##18##2##(1990-2#1)(1991-9#1)(1992-3#1)(1992-8#1)(1994-8#1)(1995-5#1)(2004-2#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-12#1)(2012-11#1)(2013-1#2)
were applied according to##2##4##(2008-12#1)(2012-2#1)
were applied alone##2##3##(2008-10#2)
were applied and##2##3##(1992-9#1)(2008-11#1)
were applied as##4##3##(2008-1#1)(2008-10#3)
were applied at the##2##4##(2008-10#1)(2008-6#1)
were applied at##5##3##(2008-10#4)(2008-6#1)
were applied daily for##2##4##(2008-5#1)(2012-12#1)
were applied for the simultaneous determination of##2##7##(2008-10#2)
were applied for the##6##4##(2008-10#5)(2012-12#1)
were applied for##19##3##(1996-1#1)(2007-12#1)(2007-8#1)(2008-10#10)(2008-11#1)(2011-2#4)(2012-12#1)
were applied in order to##4##5##(1993-3#1)(2005-11#1)(2008-5#1)(2010-5#1)
were applied in the##2##4##(2008-10#2)
were applied in this##2##4##(2007-8#1)(2008-10#1)
were applied in##18##3##(1990-7#1)(1993-3#1)(2005-11#1)(2007-8#1)(2008-10#7)(2008-5#2)(2009-10#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-8#1)
were applied into the##2##4##(1995-12#1)(2008-10#1)
were applied on##4##3##(1990-6#1)(2007-11#1)(2008-5#1)(2012-12#1)
were applied satisfactorily to the determination of##2##7##(2008-10#2)
were applied successfully for the##2##5##(2008-10#1)(2008-3#1)
were applied successfully##3##3##(2008-10#1)(2008-3#1)(2010-4#1)
were applied to a##4##4##(1992-5#1)(2005-11#1)(2008-2#1)(2008-5#1)
were applied to all##2##4##(2008-10#1)(2011-2#1)
were applied to an##3##4##(1991-6#1)(2006-5#1)(2008-10#1)
were applied to both##2##4##(2006-11#1)(2008-10#1)
were applied to determine##3##4##(2008-10#1)(2012-12#1)(2013-1#1)
were applied to estimate##2##4##(2006-10#1)(2012-2#1)
were applied to human##2##4##(1993-12#1)(1997-2#1)
were applied to investigate the##3##5##(1996-3#1)(2006-12#1)(2013-1#1)
were applied to measure the##3##5##(2007-4#1)(2011-2#1)(2013-8#1)
were applied to study the distribution of##2##7##(1992-8#1)(2008-10#1)
were applied to study the##3##5##(1992-8#1)(2008-10#1)(2011-1#1)
were applied to the analysis of##7##6##(2005-4#1)(2006-11#1)(2007-8#1)(2008-10#4)
were applied to the determination of##14##6##(1992-1#1)(2008-10#13)
were applied to the determination##15##5##(1992-1#1)(2008-10#14)
were applied to the same##2##5##(1991-8#1)(2008-10#1)
were applied to the##54##4##(1990-2#1)(1991-8#1)(1992-1#1)(1994-3#1)(1997-3#1)(2005-11#1)(2005-4#1)(2006-11#1)(2006-8#1)(2007-8#2)(2008-10#32)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#2)(2008-9#2)(2010-3#1)(2011-2#1)(2012-2#1)
were applied to##149##3##(1990-2#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-2#2)(1997-3#2)(2005-11#3)(2005-4#1)(2006-10#1)(2006-11#3)(2006-12#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-8#4)(2008-10#67)(2008-11#2)(2008-2#3)(2008-3#1)(2008-5#3)(2008-7#3)(2008-9#3)(2010-12#1)(2010-3#1)(2010-4#3)(2011-1#2)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#4)(2013-8#2)
were applied under##2##3##(2008-5#2)
were applied using##2##3##(2007-2#1)(2011-2#1)
were applied with##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
were applied##261##2##(1990-2#2)(1990-6#1)(1990-7#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#1)(1997-2#2)(1997-3#2)(2004-4#2)(2005-11#6)(2005-4#1)(2006-10#2)(2006-11#3)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#8)(2008-1#1)(2008-10#103)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#14)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-3#2)(2010-4#4)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#12)(2012-1#1)(2012-11#2)(2012-12#5)(2012-2#4)(2012-8#2)(2013-1#7)(2013-8#3)
were appreciably##4##2##(1990-2#1)(1990-7#1)(1991-2#1)(2007-1#1)
were approached for##2##3##(2007-12#1)(2007-2#1)
were approached##5##2##(2007-12#1)(2007-2#1)(2008-11#1)(2010-12#1)(2013-8#1)
were appropriate in##2##3##(2010-12#2)
were appropriate##7##2##(1991-10#1)(1996-3#1)(2008-8#1)(2010-12#2)(2011-1#1)(2012-12#1)
were appropriately##2##2##(1995-11#1)(2006-2#1)
were approved by##2##3##(2008-8#1)(2010-8#1)
were approved##4##2##(2008-4#1)(2008-5#1)(2008-8#1)(2010-8#1)
were approx##2##2##(1993-11#1)(2008-6#1)
were approximately 0##2##3##(1991-7#1)(1991-8#1)
were approximately 1##5##3##(1994-5#1)(2008-10#2)(2011-2#1)(2013-1#1)
were approximately 12##2##3##(1995-2#1)(2008-10#1)
were approximately 2##2##3##(2008-10#2)
were approximately 20##2##3##(2008-10#1)(2008-2#1)
were approximately 3##3##3##(1991-3#1)(2008-10#2)
were approximately equal##2##3##(1993-11#1)(2008-8#1)
were approximately ten##2##3##(1990-5#1)(2006-11#1)
were approximately the same##2##4##(1996-6#1)(2008-7#1)
were approximately twice##2##3##(2008-10#1)(2008-5#1)
were approximately##57##2##(1990-1#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-3#2)(1991-7#1)(1991-8#1)(1992-11#1)(1992-4#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-10#1)(1994-2#1)(1994-5#1)(1995-2#2)(1996-6#1)(1996-7#1)(2005-9#1)(2006-11#1)(2007-12#1)(2007-9#1)(2008-10#16)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-9#1)(2010-10#1)(2011-2#1)(2013-1#1)
were arbitrarily##2##2##(2008-10#1)(2008-5#1)
were around##6##2##(1990-10#1)(1997-6#1)(2008-10#2)(2011-1#2)
were arranged in a##8##4##(2007-5#1)(2008-1#1)(2008-10#4)(2008-2#2)
were arranged in the##2##4##(1993-9#1)(2008-10#1)
were arranged in##12##3##(1993-9#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#2)(2012-1#1)
were arranged##18##2##(1993-9#1)(1994-6#1)(1997-2#1)(1997-4#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#2)(2009-1#1)(2012-1#1)
were arrayed##2##2##(2008-10#1)(2008-9#1)
were arrested at the##2##4##(1993-3#1)(1996-11#1)
were arrested in##2##3##(1992-8#1)(1995-3#1)
were arrested##4##2##(1992-8#1)(1993-3#1)(1995-3#1)(1996-11#1)
were arrived at##4##3##(1994-5#1)(2008-10#3)
were artificially inoculated##4##3##(2008-10#4)
were artificially inseminated##2##3##(2006-5#1)(2013-1#1)
were artificially##8##2##(1991-9#1)(1992-8#1)(2006-5#1)(2008-10#4)(2013-1#1)
were as effective as##3##4##(1994-3#1)(2007-6#1)(2008-5#1)
were as fast##3##3##(1991-9#1)(2007-1#1)(2007-12#1)
were as follows##67##3##(1990-10#2)(1990-12#1)(1990-2#1)(1990-9#1)(1991-2#3)(1992-10#1)(1993-10#1)(1993-12#2)(1993-8#1)(1995-2#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-8#1)(1997-2#2)(1997-8#1)(2004-11#1)(2004-3#1)(2005-10#1)(2006-11#1)(2006-2#1)(2006-9#2)(2007-10#1)(2007-11#1)(2007-3#2)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#7)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
were as high as##5##4##(1992-8#1)(2007-12#1)(2010-8#1)(2012-11#1)(2013-1#1)
were as low as##3##4##(1991-2#1)(1991-8#1)(2008-10#1)
were as much as##2##4##(1994-6#1)(2008-1#1)
were as##102##2##(1990-10#2)(1990-12#1)(1990-2#1)(1990-9#1)(1991-2#4)(1991-8#1)(1991-9#1)(1992-10#2)(1992-8#1)(1993-10#1)(1993-12#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-3#2)(1994-6#1)(1995-2#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-8#1)(1997-2#2)(1997-8#2)(2004-11#1)(2004-3#1)(2005-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#2)(2007-6#2)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)
were ascertained by##3##3##(1992-2#1)(1996-6#1)(2008-5#1)
were ascertained clinically and cytogenetically##2##5##(2007-2#2)
were ascertained to be##2##4##(1997-5#1)(2006-6#1)
were ascertained##13##2##(1990-2#1)(1991-10#1)(1992-2#1)(1996-6#2)(1997-5#1)(2006-6#1)(2007-2#2)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#1)
were ascribed to##2##3##(1993-8#1)(2007-12#1)
were asked about their##2##4##(2007-2#1)(2008-9#1)
were asked about##8##3##(1992-6#1)(1996-1#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-9#1)(2012-2#1)(2013-8#1)
were asked for##2##3##(2008-10#1)(2008-11#1)
were asked how##3##3##(1994-2#1)(2005-10#1)(2007-10#1)
were asked of##2##3##(2008-2#1)(2008-9#1)
were asked to answer##2##4##(2007-7#1)(2008-10#1)
were asked to assess##3##4##(1992-6#2)(2009-4#1)
were asked to complete a questionnaire##3##6##(2004-3#1)(2010-12#1)(2012-2#1)
were asked to complete a##5##5##(1995-2#1)(2004-3#1)(2010-12#1)(2012-2#2)
were asked to complete the questionnaire##2##6##(2008-11#1)(2008-8#1)
were asked to complete##12##4##(1993-1#1)(1995-2#1)(2004-3#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2010-12#1)(2012-2#2)
were asked to describe##4##4##(2008-2#1)(2010-7#1)(2013-1#2)
were asked to evaluate the##2##5##(2008-11#1)(2012-12#1)
were asked to fill in##2##5##(2006-10#1)(2013-1#1)
were asked to fill out##2##5##(2011-2#1)(2013-8#1)
were asked to fill##5##4##(2006-10#1)(2007-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
were asked to give##2##4##(2008-11#1)(2012-1#1)
were asked to identify##3##4##(2006-8#1)(2008-11#1)(2013-8#1)
were asked to perform##2##4##(2006-6#1)(2013-8#1)
were asked to rate the##3##5##(1995-3#1)(1996-2#1)(2007-8#1)
were asked to rate their##5##5##(1993-1#1)(1993-2#1)(2007-8#1)(2008-12#1)(2008-7#1)
were asked to rate##13##4##(1991-6#1)(1993-1#1)(1993-2#1)(1995-3#1)(1996-2#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-12#1)(2008-7#1)(2013-8#1)
were asked to respond##2##4##(2006-8#1)(2007-12#1)
were asked to select##2##4##(2005-10#1)(2013-1#1)
were asked to view##2##4##(1996-2#1)(2008-5#1)
were asked to wear##2##4##(2005-11#1)(2012-12#1)
were asked to##94##3##(1991-6#1)(1991-9#1)(1992-6#2)(1993-1#2)(1993-12#1)(1993-2#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#3)(1996-3#1)(1997-1#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-12#4)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-10#2)(2008-11#11)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#2)(2009-4#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#5)
were asked what##2##3##(2006-6#1)(2007-2#1)
were asked whether they would##2##5##(1993-8#1)(2007-2#1)
were asked whether they##3##4##(1993-8#1)(2007-2#1)(2007-9#1)
were asked##124##2##(1991-6#1)(1991-9#1)(1992-6#3)(1993-1#2)(1993-12#2)(1993-2#1)(1993-8#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-2#3)(1996-3#1)(1997-1#1)(2004-12#1)(2004-3#1)(2005-10#2)(2005-11#1)(2005-4#1)(2006-10#4)(2006-6#2)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-12#4)(2007-2#5)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#3)(2008-10#4)(2008-11#12)(2008-12#2)(2008-2#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#2)(2009-4#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#8)(2013-8#6)
were aspirated##5##2##(1990-2#1)(1993-3#1)(2007-8#2)(2008-10#1)
were assayed after##3##3##(1990-11#1)(1993-1#1)(1993-11#1)
were assayed against##2##3##(2007-11#1)(2012-12#1)
were assayed as##2##3##(1994-3#1)(2008-10#1)
were assayed at##2##3##(1994-11#1)(2010-2#1)
were assayed by ELISA##2##4##(2008-10#1)(2008-5#1)
were assayed by##11##3##(1996-11#1)(1996-3#1)(1997-7#1)(2005-11#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#2)(2010-4#1)(2013-8#1)
were assayed for TGF-beta1##2##4##(2007-8#2)
were assayed for the##2##4##(1990-2#1)(2008-10#1)
were assayed for their##5##4##(1991-3#1)(1992-3#1)(1995-3#1)(2012-2#1)(2013-1#1)
were assayed for##34##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-3#1)(1992-3#1)(1992-8#2)(1993-2#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-4#1)(1997-4#1)(2006-12#1)(2007-8#2)(2008-10#9)(2012-1#1)(2012-2#2)(2013-1#2)
were assayed in vitro##2##4##(1991-10#1)(1994-9#1)
were assayed in##17##3##(1991-10#1)(1991-2#1)(1992-11#1)(1992-8#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-7#1)(1996-10#1)(1996-7#1)(1997-3#1)(1997-6#1)(2004-11#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-7#1)
were assayed over a##2##4##(1994-8#1)(2008-10#1)
were assayed using an##2##4##(1993-12#1)(2011-1#1)
were assayed using##5##3##(1993-12#1)(1994-3#1)(1996-7#1)(2011-1#1)(2011-2#1)
were assayed with##3##3##(2008-10#1)(2008-4#1)(2008-8#1)
were assayed##104##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1991-10#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#3)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#1)(1994-11#3)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-7#2)(1995-8#1)(1996-10#1)(1996-11#2)(1996-3#1)(1996-4#1)(1996-7#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-11#1)(2005-11#1)(2006-12#2)(2006-6#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#22)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
were assembled from##2##3##(1992-5#1)(2012-2#1)
were assembled in a##2##4##(1996-10#1)(2008-3#1)
were assembled in##4##3##(1996-10#1)(2008-10#1)(2008-3#1)(2008-7#1)
were assembled into a##2##4##(2009-2#1)(2011-1#1)
were assembled into##3##3##(2008-2#1)(2009-2#1)(2011-1#1)
were assembled on##2##3##(1997-3#1)(2010-4#1)
were assembled##13##2##(1992-5#1)(1995-3#1)(1996-10#1)(1997-3#1)(2005-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-4#1)(2011-1#1)(2012-2#1)
were assesed##4##2##(2007-11#4)
were assessed according to##2##4##(2007-8#1)(2013-8#1)
were assessed after##4##3##(1994-3#1)(2008-10#1)(2009-5#1)(2011-1#1)
were assessed and##2##3##(2006-9#1)(2011-2#1)
were assessed as##3##3##(2006-2#1)(2008-6#1)(2012-12#1)
were assessed at 3##2##4##(1993-7#1)(2007-9#1)
were assessed at a##2##4##(2008-12#1)(2008-3#1)
were assessed at baseline and after##2##6##(2012-3#1)(2013-7#1)
were assessed at baseline and endpoint##2##6##(2006-4#1)(2012-2#1)
were assessed at baseline and##5##5##(2006-4#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
were assessed at baseline##10##4##(2006-10#1)(2006-4#1)(2007-12#1)(2008-4#1)(2010-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
were assessed at entry##2##4##(1993-11#1)(2007-8#1)
were assessed at##27##3##(1993-11#1)(1993-7#1)(1995-8#1)(1997-3#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
were assessed before and after##2##5##(2004-10#1)(2010-12#1)
were assessed before##4##3##(2004-10#1)(2007-7#1)(2010-12#1)(2012-1#1)
were assessed both##2##3##(1995-12#1)(1996-6#1)
were assessed by a##4##4##(1996-7#1)(2007-3#1)(2007-7#1)(2010-4#1)
were assessed by applying##3##4##(1990-7#1)(2007-11#1)(2008-11#1)
were assessed by comparing##2##4##(2006-4#1)(2008-10#1)
were assessed by comparison##2##4##(1995-7#1)(2011-2#1)
were assessed by the##8##4##(1990-10#1)(1990-3#1)(1993-2#1)(2006-8#1)(2007-12#1)(2012-1#1)(2013-7#1)(2013-8#1)
were assessed by using##2##4##(2013-8#2)
were assessed by##69##3##(1990-10#1)(1990-12#1)(1990-3#1)(1990-7#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-7#1)(1996-5#1)(1996-7#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(2005-9#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#3)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-1#1)(2010-2#1)(2010-4#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-4#1)(2013-7#1)(2013-8#7)
were assessed during##2##3##(2009-7#1)(2011-2#1)
were assessed every##2##3##(2009-5#1)(2013-1#1)
were assessed following##5##3##(1992-10#1)(2008-10#1)(2009-6#1)(2010-6#1)(2013-8#1)
were assessed for the presence of##2##6##(2008-10#1)(2012-3#1)
were assessed for the##3##4##(2007-7#1)(2008-10#1)(2012-3#1)
were assessed for their ability to##5##6##(1990-11#1)(1991-10#1)(1995-11#1)(1997-2#1)(2011-2#1)
were assessed for their##10##4##(1990-11#1)(1991-10#1)(1995-11#1)(1997-2#1)(2008-10#1)(2008-5#1)(2010-7#1)(2011-2#2)(2012-2#1)
were assessed for##45##3##(1990-11#1)(1991-10#1)(1992-8#1)(1995-11#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#6)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#3)(2009-6#1)(2010-1#1)(2010-7#2)(2011-2#6)(2012-2#2)(2012-3#2)
were assessed from##3##3##(1996-5#1)(1997-3#1)(2008-10#1)
were assessed in a##7##4##(1990-3#1)(1995-11#1)(1995-4#1)(2009-6#1)(2010-11#1)(2010-12#1)(2012-12#1)
were assessed in terms of##2##5##(2008-3#1)(2010-2#1)
were assessed in the##7##4##(1994-6#1)(2008-10#1)(2010-3#1)(2010-4#1)(2012-12#2)(2012-2#1)
were assessed in two##2##4##(1992-8#1)(1993-11#1)
were assessed in##58##3##(1990-11#1)(1990-3#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-6#2)(1995-11#1)(1995-3#1)(1995-4#1)(1996-1#1)(1996-10#1)(1996-12#1)(1997-2#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-12#2)(2008-3#1)(2008-4#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#4)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#2)
were assessed on a variety of##2##6##(2007-9#1)(2013-8#1)
were assessed on a##3##4##(2007-9#1)(2008-2#1)(2013-8#1)
were assessed on the basis of##2##6##(2011-11#1)(2011-12#1)
were assessed on the##5##4##(1996-12#1)(1997-7#1)(2009-6#1)(2011-11#1)(2011-12#1)
were assessed on##19##3##(1990-12#1)(1996-12#1)(1997-7#2)(2007-9#1)(2008-10#1)(2008-2#1)(2009-11#2)(2009-6#1)(2010-2#1)(2011-11#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
were assessed over a##2##4##(2008-1#1)(2008-5#1)
were assessed over##3##3##(2008-1#1)(2008-5#1)(2011-2#1)
were assessed through##2##3##(2008-3#1)(2010-4#1)
were assessed to##6##3##(2008-11#1)(2009-12#1)(2009-2#1)(2010-4#1)(2010-6#1)(2011-2#1)
were assessed under##2##3##(2008-10#1)(2008-8#1)
were assessed using a##5##4##(1997-2#1)(2007-5#1)(2008-1#1)(2008-7#1)(2013-1#1)
were assessed using an##2##4##(1996-9#1)(2008-6#1)
were assessed using both##2##4##(2004-3#1)(2009-7#1)
were assessed using the Short##2##5##(1996-3#1)(2013-7#1)
were assessed using the##20##4##(1993-12#1)(1996-3#1)(2006-10#1)(2006-12#1)(2007-7#3)(2007-8#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#1)(2010-6#1)(2011-1#1)(2013-1#1)(2013-7#2)
were assessed using##45##3##(1992-7#1)(1993-12#1)(1996-3#1)(1996-9#1)(1997-2#1)(2004-3#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-6#2)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-7#1)(2010-6#1)(2011-1#2)(2012-1#2)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#1)
were assessed via##2##3##(2008-7#1)(2009-9#1)
were assessed with a##3##4##(2008-3#1)(2008-7#1)(2012-2#1)
were assessed with the##8##4##(1995-11#2)(2006-3#1)(2006-7#1)(2009-7#1)(2012-2#1)(2013-7#1)(2013-8#1)
were assessed with##17##3##(1995-11#2)(2006-3#1)(2006-7#1)(2007-11#2)(2008-3#1)(2008-7#1)(2009-7#1)(2009-9#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
were assessed##440##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-3#2)(1990-5#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#3)(1992-10#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-5#1)(1993-7#3)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#4)(1995-12#2)(1995-2#4)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#4)(1996-3#2)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#5)(1997-4#2)(1997-5#1)(1997-7#4)(1997-8#2)(2004-10#1)(2004-3#2)(2004-8#1)(2004-9#1)(2005-10#1)(2005-9#2)(2006-10#4)(2006-12#2)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#4)(2007-11#9)(2007-12#5)(2007-2#2)(2007-3#2)(2007-5#2)(2007-7#8)(2007-8#14)(2007-9#4)(2008-1#2)(2008-10#37)(2008-11#7)(2008-12#7)(2008-2#3)(2008-3#6)(2008-4#7)(2008-5#9)(2008-6#5)(2008-7#11)(2008-8#3)(2008-9#8)(2009-1#1)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#1)(2009-5#2)(2009-6#5)(2009-7#4)(2009-8#1)(2009-9#6)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#4)(2010-3#1)(2010-4#9)(2010-6#3)(2010-7#3)(2010-8#3)(2011-1#6)(2011-11#1)(2011-12#2)(2011-2#20)(2012-1#6)(2012-11#1)(2012-12#7)(2012-2#12)(2012-3#8)(2012-4#2)(2013-1#16)(2013-7#6)(2013-8#15)
were assigned and##2##3##(1992-12#1)(1997-7#1)
were assigned as##4##3##(1991-8#1)(1997-7#1)(2008-3#2)
were assigned by##5##3##(1991-2#1)(1991-4#1)(1992-3#1)(2007-11#1)(2012-2#1)
were assigned into##3##3##(2008-5#1)(2009-7#1)(2012-3#1)
were assigned numerical scores##2##4##(1991-2#1)(1996-8#1)
were assigned on the##2##4##(1996-6#1)(2010-6#1)
were assigned on##3##3##(1996-12#1)(1996-6#1)(2010-6#1)
were assigned randomly to one of##2##6##(1991-1#1)(1992-1#1)
were assigned randomly to receive##2##5##(2008-8#1)(2009-6#1)
were assigned randomly to##6##4##(1991-1#1)(1992-1#1)(1994-2#1)(2006-10#1)(2008-8#1)(2009-6#1)
were assigned randomly##8##3##(1991-1#1)(1992-1#1)(1994-2#1)(1995-3#1)(2006-10#1)(2008-8#1)(2009-6#1)(2012-2#1)
were assigned to a##2##4##(1996-3#1)(2011-2#1)
were assigned to chromosomes##2##4##(1996-12#1)(2008-10#1)
were assigned to concurrent##2##4##(2008-10#2)
were assigned to each##2##4##(1995-2#1)(2013-1#1)
were assigned to either##2##4##(1991-12#1)(1992-3#1)
were assigned to four groups##2##5##(2010-8#1)(2012-2#1)
were assigned to four##3##4##(2010-8#1)(2012-2#2)
were assigned to one of the##3##6##(2007-5#1)(2008-12#1)(2008-7#1)
were assigned to one of##4##5##(1994-3#1)(2007-5#1)(2008-12#1)(2008-7#1)
were assigned to receive##2##4##(2008-1#1)(2008-10#1)
were assigned to six##2##4##(2008-10#2)
were assigned to the##8##4##(1991-12#2)(1991-3#1)(1997-4#1)(2005-11#1)(2008-5#1)(2010-2#1)(2012-1#1)
were assigned to three##2##4##(2008-12#2)
were assigned to two##2##4##(2004-11#1)(2010-4#1)
were assigned to##57##3##(1990-7#1)(1991-12#3)(1991-2#1)(1991-3#1)(1992-3#1)(1992-5#1)(1993-11#1)(1994-3#1)(1995-2#1)(1996-12#2)(1996-3#1)(1997-4#1)(2004-11#1)(2005-11#1)(2006-12#1)(2007-1#1)(2007-2#1)(2007-5#2)(2008-1#1)(2008-10#9)(2008-12#4)(2008-5#3)(2008-7#1)(2010-2#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#1)
were assigned using##4##3##(1991-1#1)(1991-9#1)(2009-2#1)(2011-2#1)
were assigned##110##2##(1990-7#1)(1991-1#2)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-5#1)(1993-11#1)(1993-5#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-2#1)(1995-3#1)(1996-12#3)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-4#2)(1997-7#2)(2004-11#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-12#1)(2007-1#2)(2007-11#1)(2007-2#1)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#13)(2008-12#4)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-4#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-2#6)(2012-3#4)(2013-1#2)(2013-7#1)
were associated in##3##3##(2006-3#1)(2008-10#1)(2012-1#1)
were associated to##2##3##(1990-2#1)(1990-6#1)
were associated with a history of##2##6##(1992-10#1)(1996-8#1)
were associated with a more##3##5##(1997-5#1)(2006-10#1)(2008-8#1)
were associated with a reduction in##2##6##(1993-11#1)(1994-3#1)
were associated with a reduction##3##5##(1993-11#1)(1994-3#1)(2013-1#1)
were associated with a significant##2##5##(2008-5#1)(2013-8#1)
were associated with a##27##4##(1991-2#1)(1992-10#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-3#1)(1996-1#1)(1996-8#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-4#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#1)(2013-1#2)(2013-8#2)
were associated with activation of##2##5##(1996-1#1)(2008-5#1)
were associated with an increased risk of##2##7##(1995-9#1)(2010-9#1)
were associated with an increased##3##5##(1995-9#1)(2010-6#1)(2010-9#1)
were associated with an unfavorable##2##5##(1995-12#1)(2008-8#1)
were associated with an##12##4##(1990-6#1)(1991-8#1)(1995-12#1)(1995-9#1)(1996-1#1)(2007-10#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-6#1)(2010-9#1)
were associated with any of the##2##6##(2008-10#1)(2012-1#1)
were associated with better##3##4##(1993-1#1)(2007-7#1)(2008-9#1)
were associated with black compared with white men##2##8##(2013-7#2)
were associated with both##4##4##(1997-4#1)(2006-2#1)(2008-10#1)(2012-3#1)
were associated with declining##2##4##(2008-7#1)(2013-1#1)
were associated with decreased##3##4##(1996-5#1)(2011-2#2)
were associated with early##2##4##(2006-7#1)(2007-8#1)
were associated with greater##10##4##(2007-12#2)(2007-3#1)(2008-12#1)(2008-6#1)(2012-11#1)(2012-12#1)(2013-1#3)
were associated with high##4##4##(1991-5#1)(2007-2#1)(2008-10#1)(2008-2#1)
were associated with higher levels of##2##6##(1994-2#1)(2009-5#1)
were associated with higher odds of##2##6##(2011-12#2)
were associated with higher##10##4##(1990-4#1)(1994-2#1)(1995-12#1)(2008-8#1)(2009-5#1)(2010-5#1)(2011-12#2)(2012-12#1)(2012-2#1)
were associated with increased risk##2##5##(1993-3#1)(2012-3#1)
were associated with increased##11##4##(1993-3#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-5#1)(2011-1#3)(2012-3#1)(2013-8#1)
were associated with increases in##2##5##(1990-6#1)(1991-5#1)
were associated with less##4##4##(2007-12#1)(2008-10#1)(2009-9#1)(2011-2#1)
were associated with low##2##4##(1991-3#1)(2008-3#1)
were associated with lower levels of##2##6##(1995-3#1)(2009-5#1)
were associated with lower##8##4##(1995-3#1)(2007-12#2)(2008-7#1)(2009-5#1)(2010-7#1)(2011-1#1)(2012-1#1)
were associated with more severe##2##5##(2008-10#1)(2012-11#1)
were associated with more##10##4##(1995-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-2#1)(2009-5#1)(2010-1#1)(2012-11#1)
were associated with partial resistance##2##5##(2008-10#2)
were associated with reduced##2##4##(2008-7#1)(2011-11#1)
were associated with resistance##2##4##(2008-10#2)
were associated with scores on##2##5##(2007-12#1)(2012-1#1)
were associated with severe##2##4##(2006-10#1)(2008-5#1)
were associated with significant##4##4##(1990-5#1)(2007-11#1)(2008-10#1)(2010-8#1)
were associated with smoking##3##4##(1994-6#1)(2011-2#1)(2012-2#1)
were associated with stronger effects##2##5##(2012-2#2)
were associated with stronger##4##4##(2009-11#1)(2012-2#3)
were associated with the risk of##2##6##(2009-12#1)(2010-4#1)
were associated with the same##2##5##(2008-10#1)(2008-9#1)
were associated with the severity of##2##6##(1995-11#1)(2010-10#1)
were associated with the##39##4##(1990-5#1)(1991-2#1)(1993-2#1)(1993-6#1)(1994-3#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-10#1)(1995-11#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-4#2)(2007-10#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#4)(2009-12#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
were associated with their##3##4##(2005-8#1)(2009-5#1)(2010-3#1)
were associated with total##2##4##(1991-3#1)(2005-12#1)
were associated with##344##3##(1990-10#1)(1990-12#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#3)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#2)(1992-10#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#3)(1994-3#2)(1994-6#4)(1994-7#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-3#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-12#1)(1996-3#1)(1996-5#3)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-4#1)(2005-12#2)(2005-8#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-2#5)(2006-4#1)(2006-7#3)(2007-10#4)(2007-11#2)(2007-12#14)(2007-2#3)(2007-3#2)(2007-7#2)(2007-8#4)(2008-10#38)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#12)(2008-8#5)(2008-9#10)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#1)(2009-5#7)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-11#1)(2011-12#2)(2011-2#14)(2012-1#8)(2012-11#2)(2012-12#12)(2012-2#13)(2012-3#9)(2013-1#15)(2013-7#2)(2013-8#6)
were associated##362##2##(1990-10#2)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#4)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#2)(1992-10#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#3)(1994-3#2)(1994-6#4)(1994-7#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#3)(1995-3#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-12#1)(1996-3#1)(1996-5#3)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-4#1)(2005-12#2)(2005-8#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-2#5)(2006-3#1)(2006-4#1)(2006-7#3)(2007-10#4)(2007-11#2)(2007-12#14)(2007-2#3)(2007-3#3)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#41)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#3)(2008-7#12)(2008-8#5)(2008-9#10)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#1)(2009-5#7)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#5)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-11#1)(2011-12#2)(2011-2#14)(2012-1#10)(2012-11#2)(2012-12#13)(2012-2#14)(2012-3#9)(2013-1#16)(2013-7#2)(2013-8#6)
were assumed as##4##3##(1990-6#1)(1993-5#1)(2008-7#1)(2010-10#1)
were assumed to be##7##4##(1991-9#1)(2004-4#1)(2007-4#1)(2008-10#1)(2009-4#1)(2010-5#1)(2011-2#1)
were assumed to##12##3##(1990-5#1)(1991-9#1)(1997-8#1)(2004-4#1)(2005-11#1)(2007-4#1)(2008-10#2)(2009-4#1)(2010-5#1)(2011-2#1)(2012-12#1)
were assumed##19##2##(1990-5#1)(1990-6#1)(1990-8#1)(1991-9#1)(1993-5#1)(1997-8#1)(2004-4#1)(2005-11#1)(2007-4#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-4#1)(2010-10#1)(2010-5#1)(2011-2#2)(2012-12#1)
were asymptomatic and##3##3##(1993-5#1)(1994-6#1)(2007-10#1)
were asymptomatic in##4##3##(1997-3#1)(2007-2#1)(2013-1#2)
were asymptomatic##19##2##(1990-8#1)(1991-11#1)(1993-5#1)(1994-6#1)(1995-11#1)(1997-3#1)(2007-10#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#1)(2009-6#1)(2012-2#3)(2013-1#2)
were at a##6##3##(1997-7#1)(2004-10#1)(2008-10#1)(2008-12#2)(2008-7#1)
were at gametic equilibrium for##2##5##(2008-10#2)
were at gametic equilibrium##3##4##(2008-10#3)
were at high risk for##2##5##(2007-8#1)(2010-10#1)
were at high risk##4##4##(2007-10#1)(2007-8#1)(2010-10#2)
were at higher risk for##2##5##(2013-1#1)(2013-8#1)
were at highest risk##2##4##(2005-8#1)(2011-2#1)
were at increased risk for developing##2##6##(2007-11#1)(2011-1#1)
were at increased risk for##4##5##(2007-11#1)(2011-1#1)(2012-3#1)(2013-8#1)
were at increased risk of##2##5##(1991-9#1)(2012-12#1)
were at increased risk##7##4##(1991-9#1)(2007-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
were at increased##8##3##(1991-9#1)(2007-11#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
were at least two##2##4##(2004-9#1)(2008-10#1)
were at least##9##3##(1993-12#1)(1995-10#1)(2004-9#1)(2006-7#1)(2008-10#1)(2008-11#1)(2010-8#1)(2013-1#2)
were at low risk##2##4##(1991-11#1)(2007-3#1)
were at or##2##3##(1990-9#1)(1992-10#1)
were at risk for##4##4##(2006-10#1)(2007-3#1)(2008-12#1)(2008-5#1)
were at risk of overweight or overweight##2##7##(2007-12#2)
were at risk of##4##4##(2007-12#2)(2008-7#1)(2013-8#1)
were at risk##8##3##(2006-10#1)(2007-12#2)(2007-3#1)(2008-12#1)(2008-5#1)(2008-7#1)(2013-8#1)
were at significantly##2##3##(2009-8#1)(2011-2#1)
were at the level of##2##5##(1990-3#1)(1997-3#1)
were at the##14##3##(1990-3#1)(1991-10#1)(1991-12#1)(1993-9#1)(1996-4#1)(1997-3#1)(2005-10#1)(2007-1#1)(2007-2#1)(2008-12#1)(2008-5#1)(2010-9#1)(2011-2#1)(2012-3#1)
were at##87##2##(1990-3#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-10#1)(1993-12#1)(1993-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2004-10#1)(2004-9#1)(2005-10#2)(2005-8#1)(2006-10#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#2)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#6)(2008-2#1)(2008-5#2)(2008-7#2)(2009-8#2)(2010-10#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-11#1)(2012-12#1)(2012-3#3)(2013-1#3)(2013-8#3)
were attached to the##4##4##(1991-7#1)(2006-12#1)(2008-10#1)(2008-11#1)
were attached to##8##3##(1991-7#1)(1993-11#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-4#1)
were attached##13##2##(1991-7#1)(1993-11#1)(1995-5#1)(2006-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-5#1)(2013-1#1)
were attained by##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
were attained##13##2##(1990-12#1)(1990-2#1)(2008-10#4)(2008-11#1)(2008-5#4)(2008-6#1)(2013-8#1)
were attempted##2##2##(2008-7#1)(2011-2#1)
were attended##5##2##(1994-6#1)(2004-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
were attending##5##2##(2006-2#1)(2007-7#1)(2008-11#1)(2011-2#1)(2012-12#1)
were attenuated by the##2##4##(1997-8#1)(2009-6#1)
were attenuated by##8##3##(1990-2#1)(1991-3#1)(1992-8#1)(1995-12#1)(1996-12#1)(1997-8#1)(2009-6#1)(2010-5#1)
were attenuated in##2##3##(1996-1#1)(1997-8#1)
were attenuated##13##2##(1990-2#1)(1991-3#1)(1992-8#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-8#2)(2009-5#1)(2009-6#1)(2010-2#1)(2010-5#1)(2011-2#1)
were attracted by##2##3##(2008-5#1)(2013-7#1)
were attracted##5##2##(2008-10#1)(2008-5#2)(2009-8#1)(2013-7#1)
were attractive##2##2##(2007-11#1)(2013-8#1)
were attributable to the##2##4##(1990-12#1)(1995-6#1)
were attributable to##7##3##(1990-12#1)(1991-1#1)(1995-6#1)(2007-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
were attributable##8##2##(1990-12#1)(1990-9#1)(1991-1#1)(1995-6#1)(2007-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
were attributed to administration of##2##5##(2008-9#2)
were attributed to differences in##2##5##(2008-10#2)
were attributed to exposure to aspartame##2##6##(2008-8#2)
were attributed to exposure to##5##5##(2008-8#2)(2008-9#3)
were attributed to the##5##4##(2008-10#2)(2008-5#2)(2008-9#1)
were attributed to##28##3##(1990-11#1)(1990-5#1)(1995-6#1)(2006-11#1)(2008-10#6)(2008-12#1)(2008-5#5)(2008-8#2)(2008-9#6)(2012-2#1)(2013-1#2)(2013-8#1)
were attributed##32##2##(1990-11#1)(1990-5#1)(1995-6#1)(2006-11#1)(2008-10#9)(2008-12#1)(2008-5#5)(2008-8#2)(2008-9#6)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
were atypical##3##2##(1992-9#1)(2008-10#1)(2011-2#1)
were audio-recorded##2##2##(2012-12#2)
were audiotaped##2##2##(2008-11#1)(2013-1#1)
were audited##2##2##(1996-9#1)(2013-1#1)
were augmented in##2##3##(1992-8#1)(2009-6#1)
were augmented##5##2##(1992-8#1)(2004-10#1)(2007-12#1)(2009-6#1)(2011-2#1)
were automatically##7##2##(1992-2#1)(1994-6#2)(1997-4#1)(2008-10#2)(2013-1#1)
were available and##4##3##(2008-10#1)(2008-8#1)(2011-3#1)(2012-12#1)
were available as##2##3##(2006-5#1)(2007-8#1)
were available at the##2##4##(2009-2#1)(2010-8#1)
were available for 32##2##4##(1996-2#1)(2007-10#1)
were available for analysis##7##4##(1990-6#1)(1993-8#1)(1995-1#1)(2006-7#1)(2008-10#2)(2012-3#1)
were available for only##2##4##(2008-12#1)(2008-3#1)
were available for review##2##4##(2004-10#1)(2008-6#1)
were available for##32##3##(1990-6#1)(1991-2#1)(1993-8#1)(1995-1#1)(1995-5#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-5#1)(2004-10#1)(2006-10#2)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#3)(2008-10#3)(2008-12#2)(2008-3#2)(2008-5#1)(2008-6#1)(2009-3#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
were available from##8##3##(1995-2#1)(1995-3#1)(1996-7#1)(1997-7#1)(2004-10#1)(2008-5#1)(2010-7#1)(2012-3#1)
were available in##7##3##(1991-7#1)(1992-6#1)(2008-3#1)(2008-8#1)(2011-11#1)(2012-2#1)(2013-1#1)
were available on##3##3##(1993-2#1)(2006-8#1)(2013-8#1)
were available to##6##3##(1996-1#1)(2006-8#1)(2007-7#1)(2008-5#1)(2010-8#1)(2012-3#1)
were available##87##2##(1990-1#1)(1990-6#1)(1991-2#1)(1991-4#1)(1991-7#2)(1992-2#1)(1992-3#1)(1992-6#1)(1993-2#2)(1993-8#1)(1994-7#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-5#1)(1997-7#1)(2004-10#2)(2006-10#2)(2006-5#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#3)(2007-7#2)(2007-8#1)(2008-10#7)(2008-12#2)(2008-3#3)(2008-5#3)(2008-6#1)(2008-8#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-11#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
were averaged and compared##2##4##(2008-12#1)(2008-2#1)
were averaged and##3##3##(2007-10#1)(2008-12#1)(2008-2#1)
were averaged##4##2##(1992-8#1)(2007-10#1)(2008-12#1)(2008-2#1)
were avirulent on##3##3##(1990-11#1)(2008-10#2)
were avirulent##5##2##(1990-11#1)(2008-10#4)
were avoided##2##2##(2009-2#1)(2012-12#1)
were aware of HIV/AIDS##2##4##(2010-8#1)(2011-1#1)
were aware of the benefits of##2##6##(1997-1#1)(2007-2#1)
were aware of the condition##2##5##(2008-11#1)(2011-2#1)
were aware of the##13##4##(1996-8#1)(1997-1#1)(2007-2#1)(2007-6#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
were aware of##25##3##(1991-6#1)(1996-1#1)(1996-8#1)(1997-1#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-3#3)(2007-6#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
were aware that##6##3##(1995-6#1)(1996-8#1)(2004-10#2)(2008-1#1)(2010-9#1)
were aware##32##2##(1991-6#1)(1995-6#1)(1996-1#1)(1996-8#2)(1997-1#1)(2004-10#2)(2006-10#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-3#3)(2007-6#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
were back##2##2##(1992-8#1)(2008-10#1)
were back-extracted into##2##3##(2008-10#2)
were balanced with##2##3##(1991-12#1)(2011-2#1)
were balanced##5##2##(1991-12#1)(1995-3#1)(2008-11#1)(2011-2#1)(2012-11#1)
were barely detectable##5##3##(1992-3#1)(1993-4#1)(1994-12#1)(1994-3#1)(2011-2#1)
were barely##6##2##(1992-3#1)(1993-4#1)(1994-12#1)(1994-3#1)(2011-2#1)(2013-8#1)
were based on a##4##4##(2008-10#2)(2008-5#1)(2012-2#1)
were based on the results of##2##6##(1996-9#1)(2006-4#1)
were based on the##21##4##(1990-3#1)(1990-9#1)(1991-6#1)(1996-9#1)(1997-2#1)(1997-8#1)(2006-4#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-5#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)
were based on##68##3##(1990-12#2)(1990-3#1)(1990-9#1)(1991-6#2)(1992-2#1)(1993-3#1)(1993-6#1)(1995-2#2)(1995-6#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#9)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#4)(2009-3#1)(2009-9#1)(2010-3#1)(2011-1#4)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
were based upon##4##3##(1990-8#1)(1992-4#1)(1996-5#1)(2008-1#1)
were based##74##2##(1990-12#2)(1990-3#1)(1990-8#1)(1990-9#1)(1991-6#2)(1991-7#1)(1992-2#1)(1992-4#1)(1993-3#1)(1993-6#1)(1995-2#2)(1995-6#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#4)(2008-9#1)(2009-3#1)(2009-9#1)(2010-3#1)(2011-1#4)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
were baseline separated##2##3##(1996-11#1)(2013-8#1)
were baseline##3##2##(1996-11#1)(2012-5#1)(2013-8#1)
were basically##4##2##(2007-6#1)(2008-10#3)
were batch##2##2##(2008-7#1)(2009-4#1)
were being made##2##3##(2006-4#1)(2009-2#1)
were being##24##2##(1992-4#1)(1994-6#1)(1995-12#1)(1996-11#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-4#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2011-1#1)(2012-3#1)
were believed to be##4##4##(2009-2#1)(2009-4#2)(2013-1#1)
were believed to##6##3##(2008-11#1)(2008-5#1)(2009-2#1)(2009-4#2)(2013-1#1)
were belong to C##2##4##(2011-1#2)
were belong to##3##3##(2008-12#1)(2011-1#2)
were below 0##6##3##(2006-8#1)(2008-10#3)(2012-1#1)(2013-8#1)
were below 1##2##3##(1992-9#1)(2008-5#1)
were below 10##3##3##(1991-11#1)(2008-10#1)(2011-3#1)
were below 9##2##3##(1996-2#1)(1997-1#1)
were below 9%##3##3##(2008-10#3)
were below detection##2##3##(1993-4#1)(2011-2#1)
were below the permissible##2##4##(1992-6#1)(2005-11#1)
were below the##14##3##(1992-6#1)(1992-8#1)(1994-6#1)(1995-8#1)(2005-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-4#1)(2011-12#1)(2013-8#1)
were below##54##2##(1990-4#1)(1991-11#1)(1991-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-4#1)(1994-6#1)(1995-8#1)(1996-2#1)(1997-1#1)(2004-4#1)(2005-11#1)(2006-8#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#19)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-6#1)(2011-1#1)(2011-12#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#2)
were beneficial##4##2##(2008-1#1)(2008-5#1)(2012-2#1)(2013-1#1)
were benign##7##2##(1990-2#1)(1990-4#1)(1990-5#1)(1991-11#1)(2007-8#1)(2008-3#1)(2010-7#1)
were best described by##2##4##(1993-11#1)(1995-11#1)
were best fit##2##3##(1991-3#1)(1995-1#1)
were best##8##2##(1991-3#1)(1993-11#1)(1993-8#1)(1995-1#1)(1995-11#1)(1997-1#1)(2007-11#1)(2010-12#1)
were better able to##3##4##(1992-2#1)(1996-5#1)(2008-5#1)
were better fit##2##3##(1990-7#1)(2008-10#1)
were better in those##2##4##(1993-11#1)(2013-1#1)
were better in##4##3##(1993-11#2)(2008-5#1)(2013-1#1)
were better than 0##2##4##(2008-10#2)
were better than for##3##4##(2007-7#1)(2011-2#1)(2013-1#1)
were better than the other##2##5##(1990-8#1)(2011-1#1)
were better than the##4##4##(1990-8#1)(1996-6#1)(2008-2#1)(2011-1#1)
were better than those obtained by##2##6##(2008-10#2)
were better than those obtained##3##5##(2008-10#3)
were better than##15##3##(1990-8#1)(1996-6#1)(2007-11#1)(2007-7#1)(2008-10#7)(2008-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
were better##40##2##(1990-7#1)(1990-8#1)(1991-2#1)(1992-2#1)(1993-11#2)(1996-5#2)(1996-6#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-5#3)(2009-6#1)(2010-1#1)(2011-1#1)(2011-2#1)(2013-1#4)
were between 0##12##3##(1997-4#1)(2005-11#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#1)
were between 1 and##4##4##(1993-9#1)(2008-10#2)(2013-1#1)
were between 1##6##3##(1993-9#1)(2008-10#2)(2008-5#2)(2013-1#1)
were between 11##2##3##(1997-4#1)(2011-2#1)
were between 3##2##3##(1994-9#1)(2011-1#1)
were between 30 and##2##4##(1990-4#1)(2007-4#1)
were between 80% and##2##4##(2007-8#1)(2012-12#1)
were between 84##2##3##(2012-1#1)(2012-12#1)
were between 91##2##3##(2008-10#2)
were between 92 and##3##4##(2008-10#3)
were between 92##4##3##(2008-10#3)(2008-5#1)
were between 93 and##2##4##(2008-10#2)
were between the##2##3##(2007-3#1)(2010-12#1)
were between##83##2##(1990-4#1)(1992-6#1)(1993-5#1)(1993-9#1)(1994-3#1)(1994-9#2)(1995-1#1)(1997-4#2)(2004-10#1)(2004-9#1)(2005-11#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#3)(2008-10#34)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-3#1)(2013-1#2)(2013-8#1)
were biased##2##2##(1992-3#1)(2008-10#1)
were big##2##2##(1990-5#1)(2011-1#1)
were bigger than##3##3##(2007-9#1)(2008-10#1)(2011-12#1)
were bigger##5##2##(2007-11#1)(2007-9#1)(2008-10#1)(2011-12#1)(2011-2#1)
were bilateral##4##2##(2007-11#1)(2008-1#1)(2008-5#2)
were bilaterally##4##2##(1991-2#1)(1994-2#1)(2010-9#1)(2013-1#1)
were biochemically##3##2##(2008-5#1)(2009-8#1)(2013-8#1)
were biologically tested##2##3##(2008-11#1)(2008-12#1)
were biologically##4##2##(2008-10#2)(2008-11#1)(2008-12#1)
were biopsied##4##2##(1991-2#2)(2006-6#1)(2008-5#1)
were biphasic##2##2##(1990-10#1)(1991-2#1)
were black##2##2##(1995-6#1)(2007-3#1)
were bled##2##2##(1992-7#1)(1997-3#1)
were blended with##2##3##(1992-2#1)(2008-5#1)
were blended##5##2##(1992-2#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-5#1)
were blind##3##2##(2007-1#2)(2007-9#1)
were blinded to##4##3##(2008-12#1)(2011-2#1)(2012-1#2)
were blinded##5##2##(2008-12#1)(2008-2#1)(2011-2#1)(2012-1#2)
were blocked and##2##3##(1995-11#1)(2008-10#1)
were blocked by preincubation##2##4##(1991-8#1)(1995-3#1)
were blocked by pretreatment with##2##5##(1993-9#1)(1997-6#1)
were blocked by the##4##4##(1990-11#1)(1994-2#2)(1996-5#1)
were blocked by##33##3##(1990-11#1)(1990-2#1)(1990-4#1)(1990-7#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-2#2)(1994-3#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-6#1)(2005-8#1)(2008-8#2)(2010-4#1)
were blocked in##3##3##(1995-6#1)(2008-10#1)(2008-11#1)
were blocked##47##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-9#2)(1994-2#2)(1994-3#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-6#1)(2005-8#1)(2006-7#1)(2008-10#2)(2008-11#1)(2008-8#2)(2009-12#1)(2010-4#1)
were blood##2##2##(2008-12#1)(2009-10#1)
were bonded to the##2##4##(1992-2#1)(2008-2#1)
were bonded with##3##3##(2009-7#2)(2013-1#1)
were bonded##7##2##(1992-2#1)(2008-2#1)(2009-7#2)(2009-8#1)(2013-1#1)(2013-8#1)
were bone##2##2##(2007-7#1)(2011-2#1)
were boosted##3##2##(1992-8#1)(2006-10#1)(2008-10#1)
were borderline##2##2##(1990-2#1)(1991-6#1)
were born alive##2##3##(1990-9#1)(1993-12#1)
were born at the##4##4##(1990-2#1)(1991-11#1)(1995-2#1)(2008-12#1)
were born by##2##3##(2006-8#1)(2013-7#1)
were born in the##2##4##(1994-6#1)(2004-11#1)
were born in##12##3##(1990-12#1)(1994-6#1)(1996-11#1)(2004-10#1)(2004-11#1)(2006-10#2)(2007-3#1)(2009-4#2)(2012-12#1)(2013-1#1)
were born to mothers who##2##5##(1992-2#1)(2007-2#1)
were born to##5##3##(1990-12#1)(1992-2#1)(2007-2#2)(2011-1#1)
were born##37##2##(1990-12#2)(1990-2#2)(1990-9#1)(1991-11#1)(1992-1#1)(1992-2#1)(1993-12#1)(1994-1#1)(1994-6#2)(1994-7#1)(1995-2#1)(1996-11#1)(1997-8#1)(2004-10#1)(2004-11#1)(2005-7#1)(2006-10#3)(2006-8#1)(2007-2#2)(2007-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-4#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
were both associated with##2##4##(2011-1#1)(2013-1#1)
were both at##2##3##(2008-10#1)(2008-8#1)
were both found to be##3##5##(1996-2#1)(2008-5#1)(2008-7#1)
were both found##4##3##(1996-2#1)(2008-11#1)(2008-5#1)(2008-7#1)
were both greatly##2##3##(2005-11#1)(2008-11#1)
were both immobilized on an anion-exchange column##2##7##(2008-10#2)
were both more##2##3##(2008-6#1)(2013-8#1)
were both reduced##4##3##(1991-8#1)(1995-3#1)(1995-5#1)(2008-10#1)
were both significantly##2##3##(1991-5#1)(2011-12#1)
were both statistically significant##2##4##(1993-7#1)(1994-7#1)
were both tested##3##3##(1992-6#1)(2008-10#2)
were both the##2##3##(2008-10#1)(2009-4#1)
were both##86##2##(1990-6#1)(1990-8#1)(1991-10#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-6#1)(1993-1#2)(1993-7#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-7#1)(1997-8#1)(2003-11#1)(2004-2#1)(2005-11#2)(2005-4#1)(2007-2#1)(2007-8#2)(2008-10#15)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
were bound to the##3##4##(1991-5#1)(1995-8#1)(2008-10#1)
were bound to##8##3##(1990-2#1)(1990-4#1)(1991-5#1)(1991-8#1)(1995-8#1)(1997-4#1)(2008-10#2)
were bound##16##2##(1990-12#1)(1990-2#1)(1990-4#1)(1991-4#2)(1991-5#1)(1991-8#1)(1992-3#1)(1994-12#1)(1995-8#1)(1997-4#1)(2008-10#3)(2009-11#1)(2009-3#1)
were boys and##4##3##(1992-8#2)(2008-12#1)(2012-2#1)
were boys##7##2##(1992-8#2)(1996-5#1)(2008-12#1)(2011-2#1)(2012-2#2)
were breast##2##2##(1995-5#2)
were breast-fed##2##2##(1991-11#2)
were breathing normally##2##3##(1996-3#2)
were bred##3##2##(2006-5#1)(2008-10#1)(2012-1#1)
were breech##2##2##(2004-10#1)(2011-12#1)
were brief##2##2##(1991-6#1)(2012-2#1)
were briefly##3##2##(1997-5#1)(2005-4#1)(2012-2#1)
were brightly stained##2##3##(1992-11#1)(1994-9#1)
were broken##3##2##(2006-8#1)(2010-4#1)(2013-8#1)
were brought to the##4##4##(1991-11#2)(1995-9#1)(2008-3#1)
were brought##9##2##(1991-11#2)(1995-9#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-2#1)
were built and##2##3##(2008-10#1)(2008-3#1)
were built by##3##3##(2008-10#1)(2010-5#1)(2010-9#1)
were built with##2##3##(2008-10#2)
were built##17##2##(1990-12#1)(1992-12#1)(1993-11#1)(1996-3#1)(2006-12#1)(2008-10#5)(2008-3#2)(2010-4#2)(2010-5#1)(2010-9#1)(2013-8#1)
were buried in##2##3##(2008-10#2)
were buried##7##2##(2008-10#7)
were by far##2##3##(1994-11#1)(2008-11#1)
were by##6##2##(1991-7#1)(1994-11#1)(2008-10#1)(2008-11#2)(2008-9#1)
were ca##6##2##(1993-2#1)(2005-11#1)(2008-10#3)(2009-2#1)
were caged with##2##3##(2008-10#2)
were calcified##2##2##(2007-8#1)(2011-2#1)
were calculated according to the##2##5##(2007-6#1)(2008-5#1)
were calculated according to##3##4##(2007-6#1)(2008-5#1)(2012-2#1)
were calculated after##2##3##(1997-7#1)(2008-10#1)
were calculated and compared with##3##5##(2007-11#1)(2008-10#1)(2011-1#1)
were calculated and compared##5##4##(2006-11#1)(2007-11#1)(2008-10#1)(2011-1#1)(2013-1#1)
were calculated and the##2##4##(2008-10#1)(2013-8#1)
were calculated and##23##3##(1991-2#1)(2006-11#1)(2006-7#2)(2007-11#1)(2008-10#7)(2008-11#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
were calculated as the##2##4##(1991-6#1)(1997-8#1)
were calculated as##12##3##(1991-6#1)(1994-11#1)(1995-5#1)(1997-8#1)(2007-8#2)(2008-10#3)(2009-3#1)(2011-2#1)(2012-2#1)
were calculated at##2##3##(2008-10#2)
were calculated based on the##3##5##(1997-7#1)(2008-10#1)(2009-6#1)
were calculated based on##6##4##(1997-7#1)(2008-10#2)(2008-7#1)(2009-6#2)
were calculated based##7##3##(1997-7#1)(2008-10#3)(2008-7#1)(2009-6#2)
were calculated by comparing##2##4##(1990-6#1)(2008-7#1)
were calculated by the##4##4##(1993-3#1)(2006-10#1)(2008-11#1)(2008-3#1)
were calculated by using the##2##5##(2008-10#1)(2009-1#1)
were calculated by using##5##4##(2005-11#1)(2007-4#1)(2008-10#1)(2008-7#1)(2009-1#1)
were calculated by##26##3##(1990-11#2)(1990-6#1)(1993-3#1)(1995-11#1)(2005-11#4)(2005-4#1)(2006-10#1)(2007-4#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#2)(2009-1#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#2)
were calculated for all the##2##5##(2008-2#1)(2008-5#1)
were calculated for all##3##4##(2008-10#1)(2008-2#1)(2008-5#1)
were calculated for each##9##4##(1992-3#1)(2007-3#1)(2008-10#1)(2008-8#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
were calculated for the period##2##5##(2007-9#2)
were calculated for the##9##4##(1994-1#1)(1995-3#1)(1996-3#1)(2006-4#1)(2007-9#2)(2008-10#1)(2008-8#1)(2012-2#1)
were calculated for various##3##4##(2008-10#1)(2008-3#2)
were calculated for##47##3##(1992-3#1)(1994-1#1)(1995-3#1)(1995-5#1)(1996-3#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-3#1)(2007-9#2)(2008-10#13)(2008-2#2)(2008-3#4)(2008-5#1)(2008-8#3)(2010-12#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
were calculated from the measured##2##5##(2006-10#1)(2008-2#1)
were calculated from the##10##4##(1991-2#1)(1994-11#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-2#1)(2009-4#1)(2012-1#1)
were calculated from##25##3##(1991-2#1)(1994-11#1)(1995-1#1)(1996-11#1)(1996-3#1)(2005-4#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-1#1)
were calculated in MPa##2##4##(2008-12#1)(2009-8#1)
were calculated in##10##3##(1995-5#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-12#1)(2009-2#1)(2009-8#1)(2012-12#1)(2012-3#1)
were calculated of##2##3##(1996-7#1)(2011-2#1)
were calculated on the##2##4##(1992-3#1)(2005-4#1)
were calculated through##2##3##(2008-12#1)(2012-2#1)
were calculated to be##10##4##(1992-8#1)(1993-1#1)(1994-6#1)(2007-8#1)(2008-10#4)(2008-5#1)(2011-1#1)
were calculated to determine##4##4##(2007-7#2)(2008-10#1)(2011-2#1)
were calculated to examine the##2##5##(2011-1#1)(2012-1#1)
were calculated to##21##3##(1992-8#1)(1993-1#1)(1994-6#1)(2007-7#2)(2007-8#1)(2008-10#5)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)
were calculated using a##3##4##(2008-3#1)(2008-7#1)(2011-2#1)
were calculated using the equation##2##5##(2008-10#1)(2009-8#1)
were calculated using the method##2##5##(2008-10#2)
were calculated using the##19##4##(1990-12#1)(1997-1#1)(2007-11#1)(2007-6#1)(2008-10#5)(2008-11#1)(2009-8#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-3#1)(2013-8#1)
were calculated using##32##3##(1990-12#1)(1992-12#1)(1995-3#1)(1997-1#1)(2007-1#1)(2007-11#1)(2007-6#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#2)(2010-9#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
were calculated with the##3##4##(1990-8#1)(2008-2#1)(2010-12#1)
were calculated with##7##3##(1990-8#1)(2005-12#1)(2008-10#2)(2008-2#1)(2010-12#1)(2011-1#1)
were calculated##331##2##(1990-11#2)(1990-12#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-2#2)(1991-4#1)(1991-6#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-1#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#2)(1994-6#2)(1995-1#1)(1995-11#1)(1995-3#3)(1995-5#3)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-7#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-11#5)(2005-12#1)(2005-4#7)(2006-10#7)(2006-11#3)(2006-12#1)(2006-2#1)(2006-4#1)(2006-7#2)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-3#3)(2007-4#2)(2007-6#2)(2007-7#2)(2007-8#7)(2007-9#2)(2008-10#84)(2008-11#6)(2008-12#3)(2008-2#5)(2008-3#8)(2008-5#8)(2008-6#1)(2008-7#8)(2008-8#5)(2009-1#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#2)(2009-8#4)(2010-10#1)(2010-12#5)(2010-2#3)(2010-3#4)(2010-5#1)(2010-7#1)(2010-9#2)(2011-1#10)(2011-12#2)(2011-2#25)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#10)(2012-2#5)(2012-3#3)(2013-1#9)(2013-8#7)
were calibrated to##2##3##(2007-4#1)(2007-9#1)
were calibrated using the##2##4##(2007-11#1)(2008-3#1)
were calibrated##9##2##(1993-3#1)(2007-11#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#2)
were called upon to##3##4##(2008-10#3)
were called##9##2##(1991-2#1)(1996-2#1)(2004-11#1)(2006-11#1)(2008-1#1)(2008-10#3)(2008-5#1)
were cancers##3##2##(1990-10#1)(2006-10#2)
were candidate##2##2##(2007-7#1)(2010-4#1)
were cannulated##3##2##(2007-8#1)(2008-7#1)(2012-2#1)
were capable of binding##3##4##(1992-12#1)(1996-5#1)(2012-2#1)
were capable of inducing##2##4##(1994-12#1)(2008-10#1)
were capable of infecting##3##4##(2008-10#3)
were capable of##43##3##(1991-4#1)(1991-8#1)(1992-12#1)(1992-7#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-8#1)(2004-11#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-2#2)(2008-10#10)(2008-11#2)(2008-6#1)(2009-10#1)(2009-12#1)(2010-5#1)(2012-2#2)
were capable##44##2##(1991-4#1)(1991-8#1)(1992-12#1)(1992-7#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-8#1)(2004-11#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-2#2)(2007-9#1)(2008-10#10)(2008-11#2)(2008-6#1)(2009-10#1)(2009-12#1)(2010-5#1)(2012-2#2)
were captured as##2##3##(2007-2#1)(2009-10#1)
were captured by##5##3##(1995-2#1)(2007-5#2)(2011-2#2)
were captured during##2##3##(2007-3#1)(2008-10#1)
were captured in##4##3##(2008-10#2)(2008-5#1)(2010-8#1)
were captured##22##2##(1995-2#1)(1997-6#1)(2006-4#1)(2007-2#2)(2007-3#2)(2007-5#2)(2008-10#4)(2008-5#3)(2009-10#1)(2010-8#2)(2011-2#2)(2013-7#1)
were carefully studied##3##3##(2008-10#3)
were carefully##11##2##(2007-4#1)(2008-10#7)(2009-10#1)(2009-6#1)(2010-3#1)
were carried from##2##3##(2008-10#1)(2008-12#1)
were carried out according to the##2##6##(2006-4#1)(2010-9#1)
were carried out and showed that##2##6##(2008-10#1)(2010-5#1)
were carried out and##5##4##(2008-10#2)(2008-5#2)(2010-5#1)
were carried out as##4##4##(2005-11#1)(2008-10#1)(2010-8#1)(2012-3#1)
were carried out at the##4##5##(1996-5#2)(2008-3#2)
were carried out at##27##4##(1996-5#2)(1996-9#1)(1997-2#1)(2004-1#1)(2005-11#1)(2007-11#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-3#3)(2008-5#2)(2009-10#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-8#1)
were carried out between##4##4##(2007-2#1)(2011-2#1)(2012-3#1)(2013-7#1)
were carried out by a##2##5##(2008-10#1)(2013-1#1)
were carried out by means of##3##6##(1991-5#1)(2007-11#1)(2007-12#1)
were carried out by the##2##5##(2008-10#1)(2011-2#1)
were carried out by using##4##5##(2008-10#2)(2008-2#1)(2009-3#1)
were carried out by##31##4##(1990-4#1)(1990-5#1)(1990-8#1)(1991-5#2)(1996-12#1)(1996-3#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#11)(2008-2#1)(2008-3#1)(2008-5#1)(2009-2#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
were carried out during##3##4##(2008-5#2)(2008-8#1)
were carried out for the##2##5##(1996-11#1)(2012-2#1)
were carried out for##9##4##(1994-11#1)(1996-11#1)(2006-5#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-2#1)
were carried out in a##12##5##(1992-3#1)(2006-10#1)(2008-10#5)(2008-5#1)(2008-7#1)(2009-4#1)(2013-1#2)
were carried out in all##2##5##(1992-6#1)(2007-7#1)
were carried out in aqueous##3##5##(2006-12#1)(2008-10#1)(2008-6#1)
were carried out in order to examine##2##7##(2004-12#1)(2005-11#1)
were carried out in order to study##2##7##(1992-6#1)(1994-2#1)
were carried out in order to##7##6##(1992-6#1)(1994-2#1)(2004-12#1)(2005-11#1)(2007-8#1)(2008-10#2)
were carried out in phantoms##2##5##(2007-12#1)(2008-3#1)
were carried out in the presence of##3##7##(1992-3#1)(2008-4#1)(2011-2#1)
were carried out in the##11##5##(1992-3#1)(1995-12#1)(1997-1#1)(1997-5#1)(2006-8#1)(2008-10#3)(2008-2#1)(2008-4#1)(2011-2#1)
were carried out in##80##4##(1990-6#1)(1991-6#1)(1992-3#2)(1992-6#2)(1992-7#1)(1992-8#1)(1993-10#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1995-12#1)(1996-3#2)(1997-1#1)(1997-4#1)(1997-5#1)(2004-12#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#15)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#4)(2008-7#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#4)
were carried out on a##2##5##(2008-10#1)(2011-2#1)
were carried out on male##3##5##(1994-2#1)(1995-12#1)(2008-4#1)
were carried out on the spreading of##2##7##(2005-11#2)
were carried out on the##13##5##(1991-11#1)(1996-7#1)(2005-10#1)(2005-11#2)(2007-6#1)(2008-10#4)(2008-5#1)(2009-12#1)(2009-2#1)
were carried out on three##2##5##(2007-8#1)(2008-7#1)
were carried out on##39##4##(1990-2#1)(1991-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1996-6#1)(1996-7#1)(1996-9#1)(2005-10#1)(2005-11#2)(2006-5#1)(2006-9#1)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-10#5)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-2#1)(2010-2#2)(2011-2#3)(2012-1#1)
were carried out over the##2##5##(2008-10#2)
were carried out simultaneously##2##4##(2010-4#1)(2011-2#1)
were carried out through##2##4##(2007-10#1)(2008-9#1)
were carried out to assess##4##5##(2005-9#1)(2008-1#1)(2008-5#1)(2013-1#1)
were carried out to clarify the##2##6##(2008-6#1)(2010-5#1)
were carried out to determine the influence of##2##8##(2008-5#1)(2011-2#1)
were carried out to determine the##6##6##(2008-10#2)(2008-12#1)(2008-5#1)(2011-2#1)(2013-1#1)
were carried out to determine##7##5##(1991-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2011-2#1)(2013-1#1)
were carried out to establish##3##5##(1996-2#1)(2008-5#1)(2011-2#1)
were carried out to evaluate the##2##6##(2008-10#1)(2008-12#1)
were carried out to investigate the##4##6##(2008-2#1)(2008-5#1)(2009-6#1)(2010-8#1)
were carried out to produce##2##5##(1997-4#1)(2005-11#1)
were carried out to study##3##5##(2006-5#1)(2008-11#1)(2008-5#1)
were carried out to##52##4##(1991-11#1)(1991-8#1)(1996-2#1)(1996-7#1)(1997-4#1)(2005-11#2)(2005-9#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#4)(2008-5#5)(2008-6#2)(2009-6#1)(2009-7#1)(2010-2#3)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2013-1#2)
were carried out under##8##4##(1995-8#1)(1996-8#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-10#2)(2011-2#1)
were carried out using a##9##5##(1991-3#1)(1996-2#1)(2008-10#3)(2008-6#1)(2010-8#1)(2013-1#1)(2013-7#1)
were carried out using both##2##5##(2007-12#1)(2012-11#1)
were carried out using the##8##5##(1991-4#1)(1993-12#1)(1994-12#1)(1996-5#1)(2005-11#1)(2008-10#1)(2009-12#1)(2012-2#1)
were carried out using two##3##5##(2006-2#1)(2008-10#1)(2008-5#1)
were carried out using##34##4##(1991-3#1)(1991-4#1)(1993-12#1)(1993-4#1)(1994-12#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(2005-11#1)(2006-2#1)(2007-12#1)(2008-10#12)(2008-5#1)(2008-6#1)(2009-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
were carried out with an##2##5##(1991-6#1)(2008-5#1)
were carried out with both##2##5##(2005-11#1)(2008-10#1)
were carried out with the##2##5##(1990-12#1)(2008-10#1)
were carried out with this##2##5##(1990-8#1)(2008-10#1)
were carried out with##31##4##(1990-10#1)(1990-12#1)(1990-8#1)(1991-3#1)(1991-4#1)(1991-6#2)(1993-6#1)(1994-3#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-4#1)(2013-1#1)(2013-7#1)
were carried out##399##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#2)(1991-10#1)(1991-11#2)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#3)(1991-8#1)(1992-3#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#4)(1994-7#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#1)(1997-4#3)(1997-5#1)(1997-7#1)(2004-1#1)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#9)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#4)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#11)(2007-12#6)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#3)(2007-7#6)(2007-8#6)(2007-9#2)(2008-1#4)(2008-10#88)(2008-11#3)(2008-12#4)(2008-2#9)(2008-3#10)(2008-4#5)(2008-5#26)(2008-6#8)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#6)(2010-3#2)(2010-4#1)(2010-5#5)(2010-8#4)(2010-9#1)(2011-1#4)(2011-2#13)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#6)(2012-3#5)(2013-1#10)(2013-7#4)(2013-8#1)
were carried##407##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#2)(1991-10#1)(1991-11#2)(1991-3#3)(1991-4#2)(1991-5#2)(1991-6#3)(1991-8#1)(1992-3#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#4)(1994-7#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#1)(1997-4#3)(1997-5#1)(1997-7#1)(2004-1#1)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#9)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#4)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#11)(2007-12#6)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#3)(2007-7#6)(2007-8#6)(2007-9#2)(2008-1#4)(2008-10#90)(2008-11#3)(2008-12#5)(2008-2#9)(2008-3#10)(2008-4#5)(2008-5#27)(2008-6#8)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#6)(2010-3#2)(2010-4#1)(2010-5#5)(2010-8#4)(2010-9#1)(2011-1#4)(2011-2#13)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#6)(2012-3#5)(2013-1#10)(2013-7#4)(2013-8#1)
were carriers of##4##3##(1993-9#1)(2013-1#1)(2013-8#2)
were carriers##6##2##(1990-11#1)(1993-9#1)(2008-9#1)(2013-1#1)(2013-8#2)
were carrying##2##2##(2008-10#1)(2011-2#1)
were cases of##2##3##(2011-2#2)
were cast onto##2##3##(2008-10#2)
were cast##4##2##(2008-10#3)(2009-4#1)
were categorised as##4##3##(1994-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
were categorised##9##2##(1994-7#1)(1997-3#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2011-1#1)(2012-12#1)(2012-2#1)
were categorized according to##4##4##(2006-12#1)(2008-8#1)(2011-2#1)(2013-4#1)
were categorized as &quot##2##4##(2005-9#1)(2008-1#1)
were categorized as##11##3##(2005-9#1)(2007-10#2)(2007-8#1)(2008-1#1)(2009-6#1)(2012-2#1)(2013-1#4)
were categorized based on##2##4##(2011-2#1)(2013-1#1)
were categorized by##2##3##(2010-10#1)(2013-3#1)
were categorized into one of##2##5##(1997-4#1)(2008-3#1)
were categorized into three groups##3##5##(2008-10#1)(2012-2#1)(2013-8#1)
were categorized into three##4##4##(2008-10#1)(2011-1#1)(2012-2#1)(2013-8#1)
were categorized into two groups##3##5##(1995-12#1)(2008-10#1)(2010-2#1)
were categorized into two##5##4##(1995-12#1)(2008-10#1)(2008-5#1)(2010-2#1)(2013-8#1)
were categorized into##17##3##(1990-9#1)(1991-12#1)(1995-12#1)(1997-4#1)(2007-10#2)(2007-8#2)(2008-10#2)(2008-3#1)(2008-5#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-8#2)
were categorized##39##2##(1990-9#1)(1991-12#1)(1995-12#1)(1997-4#1)(2005-9#1)(2006-12#1)(2006-8#1)(2007-10#4)(2007-8#3)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#5)(2013-3#1)(2013-4#1)(2013-8#2)
were catheterized##2##2##(1994-3#1)(2007-8#1)
were caught by##2##3##(1995-3#1)(2013-7#1)
were caught##12##2##(1995-3#1)(2007-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-12#3)(2012-2#1)(2013-1#1)(2013-7#2)
were caused by##27##3##(1990-4#1)(1990-6#1)(1994-12#1)(1996-11#1)(1996-3#2)(2005-10#2)(2006-2#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2009-10#1)(2009-3#1)(2010-12#3)(2011-1#1)(2011-2#2)(2013-8#2)
were caused##29##2##(1990-4#1)(1990-6#1)(1991-5#1)(1994-12#1)(1996-11#1)(1996-3#2)(2005-10#2)(2006-2#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2009-10#1)(2009-3#1)(2010-12#3)(2011-1#2)(2011-2#2)(2013-8#2)
were causing##3##2##(2006-5#1)(2011-2#1)(2013-8#1)
were cells##2##2##(1992-7#1)(2005-12#1)
were cemented##2##2##(2009-8#1)(2013-8#1)
were censored##3##2##(2007-7#1)(2009-3#1)(2011-2#1)
were centrally##2##2##(1992-4#1)(2007-11#1)
were centrifuged##2##2##(1997-6#1)(2006-5#1)
were certified##5##2##(1990-4#1)(1991-9#1)(2005-12#1)(2009-4#1)(2012-12#1)
were challenged by##3##3##(1993-12#1)(1997-6#1)(2008-10#1)
were challenged with 10000 CFU of CD strain B1##2##9##(2006-8#2)
were challenged with a##2##4##(2008-5#1)(2008-9#1)
were challenged with the##3##4##(1991-8#1)(2008-10#1)(2013-8#1)
were challenged with##26##3##(1991-7#1)(1991-8#3)(1992-7#1)(1993-12#1)(1993-5#1)(1995-10#1)(1995-12#1)(1997-8#1)(2005-11#1)(2006-8#2)(2008-10#7)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#1)(2013-8#2)
were challenged##35##2##(1991-7#1)(1991-8#3)(1992-7#1)(1993-12#2)(1993-5#1)(1995-10#1)(1995-12#1)(1997-1#1)(1997-6#1)(1997-8#1)(2005-11#2)(2006-8#2)(2008-10#11)(2008-5#2)(2008-8#1)(2008-9#1)(2010-4#1)(2013-8#2)
were changed by##2##3##(1995-5#1)(2008-10#1)
were changed in the##2##4##(1995-1#1)(2010-1#1)
were changed into##2##3##(2005-11#1)(2010-12#1)
were changed to##5##3##(1991-5#1)(1992-1#1)(1993-8#1)(1996-2#1)(2011-2#1)
were changed##19##2##(1990-6#1)(1991-5#1)(1992-1#1)(1992-6#1)(1993-2#1)(1993-8#1)(1995-1#1)(1995-5#1)(1996-2#1)(1997-1#1)(2005-11#1)(2008-10#2)(2008-4#1)(2010-1#1)(2010-10#1)(2010-12#2)(2011-2#1)
were changes in body weight##3##5##(2008-3#1)(2012-12#2)
were changes in the##2##4##(1990-5#1)(2008-10#1)
were changes in##7##3##(1990-5#1)(1991-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-12#2)
were changes##8##2##(1990-5#1)(1991-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2012-12#2)
were characterised as##3##3##(1997-2#1)(2005-7#1)(2008-11#1)
were characterised by elemental##2##4##(2008-5#1)(2010-5#1)
were characterised by##7##3##(1992-3#1)(2008-10#1)(2008-5#2)(2010-5#2)(2010-7#1)
were characterised##18##2##(1992-3#1)(1996-12#1)(1997-2#1)(1997-6#1)(2005-7#1)(2008-10#5)(2008-11#1)(2008-5#2)(2010-5#2)(2010-7#1)(2012-12#1)(2013-7#1)
were characteristic for##2##3##(1997-3#1)(2011-2#1)
were characteristic of the##2##4##(1991-4#1)(1992-8#1)
were characteristic of##5##3##(1991-4#1)(1992-1#2)(1992-8#1)(2008-10#1)
were characteristic##9##2##(1991-4#2)(1992-1#2)(1992-8#1)(1997-3#1)(2008-10#1)(2008-5#1)(2011-2#1)
were characteristics of##2##3##(2008-10#1)(2009-8#1)
were characterized and compared##2##4##(2008-10#1)(2008-5#1)
were characterized and the##2##4##(2008-10#1)(2008-9#1)
were characterized and their##3##4##(2005-11#1)(2008-4#1)(2012-2#1)
were characterized and##17##3##(1995-12#1)(1996-10#1)(1996-8#1)(2005-11#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#1)(2012-2#2)(2013-7#1)(2013-8#1)
were characterized as##12##3##(1992-3#1)(1994-3#1)(1994-9#1)(1996-2#1)(1997-3#1)(2007-1#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-4#1)
were characterized at the##2##4##(1991-3#1)(2012-12#1)
were characterized based on##2##4##(2008-10#2)
were characterized by DNA##2##4##(2008-10#1)(2011-2#1)
were characterized by IR##3##4##(2007-10#1)(2008-5#1)(2012-3#1)
were characterized by NMR and##2##5##(1996-2#1)(2007-10#1)
were characterized by NMR##3##4##(1996-2#1)(2007-10#1)(2010-5#1)
were characterized by SEM##3##4##(2006-12#1)(2008-5#1)(2009-7#1)
were characterized by UV-vis##2##4##(1994-9#1)(2008-10#1)
were characterized by X-ray diffraction (XRD)##2##6##(2010-1#1)(2010-4#1)
were characterized by X-ray diffraction##5##5##(2004-9#1)(2008-5#1)(2010-1#1)(2010-4#1)(2010-7#1)
were characterized by X-ray##7##4##(2004-9#2)(2008-5#1)(2010-1#1)(2010-4#1)(2010-7#1)(2011-3#1)
were characterized by a##9##4##(1995-12#1)(1995-6#1)(2004-2#1)(2005-10#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-2#1)(2010-8#1)
were characterized by an##2##4##(2008-10#1)(2009-11#1)
were characterized by determining##2##4##(2008-10#1)(2008-8#1)
were characterized by elemental analyses##4##5##(2007-11#1)(2008-3#1)(2008-5#2)
were characterized by elemental analysis##4##5##(1996-2#1)(2007-10#1)(2008-5#2)
were characterized by elemental##9##4##(1996-2#1)(2007-10#1)(2007-11#2)(2008-3#1)(2008-5#4)
were characterized by high##3##4##(2008-10#1)(2008-4#1)(2013-7#1)
were characterized by mating type##2##5##(2008-10#2)
were characterized by means of##4##5##(2007-5#1)(2008-10#2)(2009-8#1)
were characterized by melting point##3##5##(2008-5#2)(2010-5#1)
were characterized by pathogenicity##3##4##(2008-10#3)
were characterized by relatively##2##4##(2008-12#1)(2010-4#1)
were characterized by restriction##2##4##(1992-3#1)(2008-10#1)
were characterized by the presence of##2##6##(1991-2#1)(2008-10#1)
were characterized by the##8##4##(1991-2#1)(1991-8#1)(1996-6#1)(2008-10#3)(2008-2#1)(2010-12#1)
were characterized by their##5##4##(1994-3#1)(1994-9#1)(2008-10#1)(2008-5#1)(2013-1#1)
were characterized by use of##3##5##(2007-11#1)(2007-12#1)(2013-1#1)
were characterized by using##3##4##(2007-11#1)(2008-5#1)(2009-9#1)
were characterized by various molecular methods and##3##7##(2008-10#3)
were characterized by various molecular methods##4##6##(2008-10#4)
were characterized by various##5##4##(2008-10#4)(2008-3#1)
were characterized by x-ray diffraction##2##5##(2008-2#1)(2008-5#1)
were characterized by##172##3##(1990-11#1)(1990-2#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-3#3)(1994-9#3)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#2)(1996-6#1)(1996-8#1)(1997-8#1)(2004-11#1)(2004-2#1)(2004-9#2)(2005-10#1)(2005-11#7)(2005-12#1)(2005-4#1)(2006-10#1)(2006-12#2)(2007-10#3)(2007-11#8)(2007-12#3)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#37)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#17)(2008-6#1)(2008-8#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-4#5)(2010-5#3)(2010-7#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2011-3#1)(2012-1#3)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#1)
were characterized first##2##3##(1990-9#1)(2008-5#1)
were characterized for their##7##4##(1990-4#1)(2008-10#1)(2008-5#1)(2010-1#1)(2010-12#1)(2012-12#1)(2013-8#1)
were characterized for##25##3##(1990-4#1)(1992-9#1)(1993-6#1)(1995-11#1)(2008-10#7)(2008-5#3)(2010-1#2)(2010-12#2)(2010-2#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-8#1)
were characterized further##2##3##(1992-11#1)(2010-10#1)
were characterized in a##2##4##(1997-3#1)(2012-12#1)
were characterized in detail##3##4##(2006-12#1)(2008-10#1)(2012-1#1)
were characterized in terms of##5##5##(2006-12#1)(2006-5#1)(2008-10#1)(2008-5#2)
were characterized in the##4##4##(1990-2#1)(1992-12#1)(1992-9#1)(1995-6#1)
were characterized in vitro##2##4##(1993-12#1)(2012-12#1)
were characterized in##28##3##(1990-12#1)(1990-2#1)(1992-12#1)(1992-9#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1997-3#1)(2005-8#1)(2006-12#2)(2006-5#1)(2007-11#1)(2008-10#5)(2008-5#2)(2010-4#1)(2012-1#1)(2012-12#2)(2013-8#1)
were characterized on the basis of##2##6##(2008-10#1)(2010-3#1)
were characterized to##2##3##(2011-2#1)(2013-1#1)
were characterized using X-ray diffraction##3##5##(2008-10#2)(2010-4#1)
were characterized using a##2##4##(2007-2#1)(2008-10#1)
were characterized using vegetative compatibility group (VCG)##2##7##(2008-10#2)
were characterized using##28##3##(2004-12#1)(2005-11#2)(2007-11#1)(2007-2#1)(2008-10#12)(2008-5#3)(2008-8#1)(2008-9#1)(2010-4#2)(2010-7#2)(2012-11#1)(2013-8#1)
were characterized via##2##3##(2009-2#1)(2010-4#1)
were characterized with regard to##2##5##(1990-8#1)(1995-12#1)
were characterized with respect to##2##5##(2010-2#1)(2010-8#1)
were characterized with##10##3##(1990-8#1)(1991-3#1)(1994-12#1)(1995-12#1)(1997-4#1)(2008-10#2)(2010-2#2)(2010-8#1)
were characterized##344##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#3)(1992-6#1)(1992-9#3)(1993-12#2)(1993-6#2)(1994-12#3)(1994-2#1)(1994-3#5)(1994-8#1)(1994-9#5)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#3)(1995-6#3)(1996-10#1)(1996-2#3)(1996-5#1)(1996-6#1)(1996-8#2)(1997-3#2)(1997-4#2)(1997-8#2)(2004-11#1)(2004-12#1)(2004-2#1)(2004-9#2)(2005-10#1)(2005-11#12)(2005-12#1)(2005-4#2)(2005-8#1)(2006-10#1)(2006-12#4)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#11)(2007-12#4)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#84)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#28)(2008-6#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#3)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#4)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#9)(2010-5#3)(2010-7#4)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#6)(2011-3#1)(2012-1#4)(2012-11#2)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#4)(2013-8#5)
were checked by##3##3##(2007-5#1)(2007-6#1)(2010-3#1)
were checked for##2##3##(2007-7#1)(2008-5#1)
were checked on##2##3##(2008-10#2)
were checked using##3##3##(2007-1#1)(2008-10#2)
were checked##21##2##(1994-4#1)(1994-7#1)(2006-8#1)(2007-1#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#5)(2008-3#1)(2008-5#1)(2010-3#2)(2011-12#1)(2012-12#2)(2012-2#1)(2012-3#1)
were chemically and##2##3##(2010-4#1)(2012-12#1)
were chemically synthesized and##2##4##(1996-5#1)(2005-7#1)
were chemically synthesized##4##3##(1995-3#1)(1996-5#1)(1997-1#1)(2005-7#1)
were chemically##12##2##(1995-10#1)(1995-3#1)(1996-5#1)(1997-1#1)(2005-7#1)(2007-11#1)(2008-10#2)(2008-2#1)(2010-4#1)(2012-12#1)(2012-2#1)
were children aged##2##3##(2005-9#1)(2006-2#1)
were children below##2##3##(2007-7#1)(2009-10#1)
were children##8##2##(1994-3#1)(2005-9#1)(2006-2#1)(2007-12#1)(2007-7#2)(2008-2#1)(2009-10#1)
were cholinergic##2##2##(1990-11#1)(1991-9#1)
were chosen and##4##3##(1997-8#1)(2005-4#1)(2008-10#1)(2011-2#1)
were chosen as a##3##4##(1991-11#1)(2007-12#1)(2008-10#1)
were chosen as model##2##4##(2008-10#2)
were chosen as the##3##4##(2004-9#1)(2008-10#1)(2008-4#1)
were chosen as##20##3##(1991-11#1)(1991-7#1)(1991-8#1)(1992-12#1)(1993-8#1)(1995-2#1)(1995-3#1)(2004-9#1)(2007-12#2)(2008-10#8)(2008-4#1)(2010-2#1)
were chosen at random##2##4##(2007-3#1)(2011-2#1)
were chosen at##3##3##(2007-3#1)(2008-3#1)(2011-2#1)
were chosen based on##2##4##(2008-10#1)(2010-6#1)
were chosen because they##2##4##(1993-12#1)(1996-2#1)
were chosen because##3##3##(1993-12#1)(1996-2#1)(2006-10#1)
were chosen by convenience##2##4##(2007-10#1)(2013-1#1)
were chosen by##4##3##(2007-10#1)(2008-10#2)(2013-1#1)
were chosen for each##2##4##(2008-10#1)(2009-2#1)
were chosen for##10##3##(1995-8#1)(1996-8#1)(2005-11#1)(2007-12#1)(2008-10#3)(2009-2#1)(2011-2#1)(2012-1#1)
were chosen from the##5##4##(1993-12#1)(1996-7#1)(2006-12#1)(2008-10#1)(2008-8#1)
were chosen from##11##3##(1993-12#2)(1996-7#1)(2006-10#1)(2006-12#1)(2007-5#1)(2008-10#2)(2008-8#1)(2012-12#1)(2012-3#1)
were chosen in##5##3##(1994-2#1)(1996-1#1)(2008-10#2)(2013-7#1)
were chosen so##2##3##(2006-11#1)(2008-10#1)
were chosen to be##2##4##(2008-10#2)
were chosen to##13##3##(1993-6#1)(1995-5#1)(2005-11#3)(2007-10#1)(2008-10#4)(2008-11#1)(2010-5#1)(2011-2#1)
were chosen##100##2##(1991-11#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#1)(1993-12#3)(1993-6#1)(1993-8#1)(1994-2#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-7#1)(1996-8#1)(1997-8#1)(2004-9#2)(2005-11#4)(2005-4#1)(2006-10#2)(2006-11#2)(2006-12#2)(2006-8#1)(2007-10#2)(2007-12#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-8#1)(2007-9#1)(2008-10#28)(2008-11#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-1#1)(2010-2#1)(2010-5#1)(2010-6#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
were chromatographed on a C18##2##5##(1990-8#1)(1993-2#1)
were chromatographed on a##6##4##(1990-12#1)(1990-8#1)(1992-2#1)(1993-2#1)(1996-8#1)(2012-12#1)
were chromatographed on##9##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-8#1)(1992-2#1)(1993-2#1)(1996-8#1)(2007-8#1)(2012-12#1)
were chromatographed##11##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-8#2)(1992-2#1)(1993-2#1)(1996-8#1)(2007-8#1)(2008-10#1)(2012-12#1)
were chromatographically##2##2##(1996-8#1)(2008-10#1)
were chronic##6##2##(1997-4#1)(1997-8#1)(2007-2#1)(2007-8#1)(2008-5#1)(2012-12#1)
were chronically treated with##3##4##(1992-10#1)(1992-2#1)(1992-5#1)
were chronically##6##2##(1991-12#1)(1992-10#1)(1992-2#1)(1992-5#1)(1993-6#1)(1996-10#1)
were cinnabar##2##2##(2008-10#1)(2008-5#1)
were clamped##2##2##(1996-10#1)(2008-5#1)
were clarified##2##2##(1994-5#1)(2008-8#1)
were classed as##2##3##(1991-8#1)(2006-2#1)
were classed##3##2##(1991-8#1)(2006-2#1)(2012-11#1)
were classical##3##2##(1992-10#1)(2007-7#1)(2009-12#1)
were classically##2##2##(1996-3#1)(2009-3#1)
were classified according to the##10##5##(1991-8#1)(1994-9#1)(1995-4#1)(2007-8#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-1#1)(2012-3#1)
were classified according to##20##4##(1991-8#1)(1993-8#1)(1994-9#1)(1995-4#1)(1996-3#1)(2007-3#1)(2007-7#2)(2007-8#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
were classified and##2##3##(2008-8#1)(2009-4#1)
were classified as &quot##2##4##(2008-1#1)(2008-12#1)
were classified as being##2##4##(1993-5#1)(2011-1#1)
were classified as cases##2##4##(2008-12#1)(2010-4#1)
were classified as having##5##4##(1993-7#1)(1995-11#1)(1996-12#1)(2011-1#1)(2011-2#1)
were classified as normal##2##4##(2011-1#1)(2012-3#1)
were classified as obese##3##4##(1993-2#1)(2006-10#2)
were classified as type##2##4##(2007-7#1)(2009-3#1)
were classified as##96##3##(1990-4#1)(1990-8#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-11#1)(1992-5#1)(1992-6#1)(1993-2#2)(1993-5#1)(1993-7#1)(1993-8#3)(1994-12#1)(1994-3#2)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-2#2)(2006-10#3)(2006-12#1)(2006-2#1)(2006-3#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-6#2)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#5)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#2)(2009-3#2)(2009-7#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#7)(2011-2#3)(2012-12#3)(2012-3#2)(2013-1#5)(2013-8#1)
were classified by##11##3##(1995-12#1)(1995-6#1)(2007-10#1)(2008-10#2)(2008-5#2)(2010-12#1)(2012-1#1)(2013-1#1)(2013-8#1)
were classified in four##2##4##(1992-6#1)(2013-7#1)
were classified in two##3##4##(2008-10#3)
were classified in##8##3##(1990-9#1)(1991-10#1)(1992-6#1)(2008-10#3)(2012-2#1)(2013-7#1)
were classified into 3##2##4##(2007-10#1)(2011-1#1)
were classified into five##2##4##(1997-6#1)(2008-5#1)
were classified into four##2##4##(2008-10#1)(2009-12#1)
were classified into one##2##4##(2008-10#1)(2009-5#1)
were classified into six##2##4##(2008-10#1)(2008-11#1)
were classified into three groups based on##2##7##(2008-10#1)(2010-4#1)
were classified into three groups##5##5##(1997-6#1)(2007-3#1)(2008-10#1)(2010-4#1)(2013-8#1)
were classified into three##10##4##(1990-12#1)(1997-6#1)(2007-3#1)(2007-9#1)(2008-10#3)(2008-3#1)(2010-4#1)(2013-8#1)
were classified into two##5##4##(1993-12#1)(1994-2#1)(2004-11#1)(2008-10#2)
were classified into various##2##4##(2008-5#1)(2011-2#1)
were classified into##48##3##(1990-12#1)(1990-7#1)(1993-12#1)(1994-2#1)(1997-6#2)(2004-11#1)(2006-6#2)(2007-10#3)(2007-3#2)(2007-8#1)(2007-9#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2009-10#2)(2009-12#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
were classified using##2##3##(2006-10#1)(2007-2#1)
were classified with##2##3##(2008-10#1)(2010-8#1)
were classified##200##2##(1990-12#1)(1990-4#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-5#1)(1992-6#2)(1993-12#1)(1993-2#3)(1993-5#1)(1993-7#1)(1993-8#4)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#1)(2004-2#2)(2006-10#4)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#2)(2006-7#1)(2007-1#1)(2007-10#6)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#3)(2007-6#2)(2007-7#5)(2007-8#6)(2007-9#3)(2008-1#2)(2008-10#22)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#11)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#3)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#9)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#4)
were clear##3##2##(2005-4#1)(2008-3#1)(2009-5#1)
were cleared##7##2##(1990-12#1)(1990-5#1)(1992-12#1)(2009-10#2)(2010-8#1)(2011-1#1)
were clearly different##2##3##(2008-10#1)(2008-5#1)
were clearly differentiated##3##3##(1991-7#1)(2008-10#2)
were clearly higher##2##3##(1995-12#1)(2008-7#1)
were clearly observed##4##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)
were clearly stained##2##3##(1995-3#1)(1996-2#1)
were clearly visible##2##3##(2008-11#1)(2009-3#1)
were clearly##41##2##(1990-11#1)(1991-7#1)(1992-12#1)(1992-6#1)(1992-9#1)(1995-11#1)(1995-12#1)(1995-3#2)(1996-1#2)(1996-2#1)(2004-2#1)(2005-12#1)(2006-10#2)(2007-10#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-5#4)(2008-7#1)(2009-3#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-3#1)
were cleaved by##2##3##(1990-11#1)(1991-8#1)
were cleaved##6##2##(1990-11#1)(1991-12#1)(1991-8#1)(1992-7#1)(1993-3#1)(1994-5#1)
were clinical##4##2##(1990-9#1)(2008-4#1)(2010-6#1)(2012-3#1)
were clinically and##2##3##(2006-10#1)(2007-11#1)
were clinically diagnosed##3##3##(1990-10#1)(2008-12#1)(2009-5#1)
were clinically improved##2##3##(2008-5#2)
were clinically significant##2##3##(1997-8#1)(2012-3#1)
were clinically suspected##2##3##(2007-2#1)(2012-12#1)
were clinically##25##2##(1990-10#1)(1990-9#1)(1992-2#1)(1992-7#1)(1993-5#1)(1995-9#1)(1996-9#1)(1997-8#1)(2004-2#1)(2006-10#1)(2007-11#1)(2007-2#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2009-5#1)(2009-7#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
were clinicians##2##2##(1995-2#1)(2008-5#1)
were cloned and expressed in Escherichia coli##2##7##(1997-3#1)(2008-10#1)
were cloned and found to##2##5##(1991-12#1)(1992-10#1)
were cloned and sequenced##17##4##(1992-6#1)(1993-12#1)(1994-12#1)(1995-6#1)(2005-11#2)(2008-10#8)(2008-5#1)(2008-8#1)(2009-5#1)
were cloned and the##2##4##(1997-7#1)(2009-5#1)
were cloned and##30##3##(1991-12#1)(1992-10#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-4#1)(1997-3#2)(1997-7#1)(2005-11#2)(2008-10#10)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#2)
were cloned by##2##3##(1995-3#1)(2008-10#1)
were cloned from a cDNA library prepared from##2##8##(1993-3#1)(1997-8#1)
were cloned from a##6##4##(1992-8#1)(1993-3#1)(1994-11#1)(1996-10#1)(1997-8#1)(2008-10#1)
were cloned from an##2##4##(1990-5#1)(1993-3#1)
were cloned from human##2##4##(1993-11#1)(1995-6#1)
were cloned from the##4##4##(1997-4#1)(2006-12#1)(2008-6#1)(2009-9#1)
were cloned from##22##3##(1990-5#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-11#1)(1994-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1997-4#1)(1997-8#1)(2006-12#1)(2008-10#4)(2008-6#1)(2009-9#1)(2010-5#1)
were cloned in##4##3##(1991-7#1)(1992-9#1)(2008-8#1)(2010-10#1)
were cloned into a##2##4##(1995-8#1)(1997-6#1)
were cloned into the mammalian expression vector##2##7##(1997-2#1)(2008-8#1)
were cloned into the##6##4##(1990-9#1)(1994-3#1)(1994-9#1)(1997-2#1)(2008-8#2)
were cloned into##18##3##(1990-1#1)(1990-9#1)(1994-3#1)(1994-9#2)(1995-8#1)(1997-2#1)(1997-6#1)(2005-11#4)(2008-10#2)(2008-11#1)(2008-8#2)(2010-6#1)
were cloned using##2##3##(1996-10#1)(2010-6#1)
were cloned##93##2##(1990-1#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-7#2)(1992-10#1)(1992-2#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-3#3)(1994-11#1)(1994-12#2)(1994-3#2)(1994-8#2)(1994-9#3)(1995-3#1)(1995-6#2)(1995-8#3)(1996-10#2)(1996-4#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#7)(2006-12#1)(2006-9#1)(2008-10#17)(2008-11#1)(2008-5#2)(2008-6#2)(2008-8#7)(2008-9#1)(2009-5#2)(2009-9#1)(2010-10#1)(2010-5#1)(2010-6#2)
were close to 100%##4##4##(2008-10#4)
were close to the##3##4##(2004-12#1)(2008-10#1)(2011-12#1)
were close to those obtained##2##5##(2008-10#2)
were close to those##3##4##(2008-10#2)(2008-8#1)
were close to##15##3##(1992-2#1)(1996-8#1)(2004-12#1)(2008-10#7)(2008-3#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-12#1)
were close##17##2##(1992-2#1)(1996-8#1)(2004-12#1)(2006-10#1)(2008-10#7)(2008-3#1)(2008-8#1)(2008-9#1)(2010-4#2)(2011-12#1)
were closed down##2##3##(1990-5#1)(1997-8#1)
were closed##4##2##(1990-5#1)(1997-8#1)(2009-6#1)(2013-8#1)
were closely associated with the##3##5##(1990-5#1)(2008-10#2)
were closely associated with##6##4##(1990-5#1)(1991-11#1)(2008-1#1)(2008-10#3)
were closely correlated with##3##4##(1990-5#1)(1992-12#1)(1993-7#1)
were closely correlated##4##3##(1990-5#1)(1992-12#1)(1992-5#1)(1993-7#1)
were closely linked to##2##4##(2008-10#2)
were closely linked with##2##4##(2007-1#1)(2008-8#1)
were closely linked##4##3##(2007-1#1)(2008-10#2)(2008-8#1)
were closely related to##8##4##(2006-8#1)(2007-10#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-12#1)(2009-8#1)
were closely related##13##3##(1994-9#1)(2005-9#1)(2006-8#1)(2007-10#1)(2007-6#1)(2007-9#1)(2008-10#4)(2008-12#1)(2009-8#1)(2010-12#1)
were closely##35##2##(1990-5#2)(1991-11#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-5#1)(1993-7#1)(1994-9#1)(2005-9#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-12#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-1#2)(2012-1#1)(2012-12#1)
were closer to the##2##4##(2009-5#1)(2011-1#1)
were closer to##3##3##(1994-8#1)(2009-5#1)(2011-1#1)
were clustered into##3##3##(2008-10#2)(2011-1#1)
were clustered within##2##3##(1996-6#1)(2013-1#1)
were clustered##14##2##(1996-6#1)(2008-10#7)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#2)(2013-1#1)
were co-cultured##3##2##(2006-5#1)(2008-5#1)(2012-4#1)
were co-expressed in##3##3##(1994-11#1)(2012-12#2)
were co-immobilized##2##2##(2008-10#1)(2008-6#1)
were co-inoculated##5##2##(2008-10#5)
were co-transfected with##2##3##(1992-5#1)(2008-11#1)
were co-transfected##4##2##(1992-5#1)(1993-12#1)(1994-9#1)(2008-11#1)
were coadministered##3##2##(1993-11#1)(1996-10#1)(1997-4#1)
were coated on##2##3##(1993-9#1)(2008-10#1)
were coated with nail varnish##2##5##(2012-2#2)
were coated with silica##3##4##(2009-7#2)(2010-3#1)
were coated with##12##3##(1990-12#1)(1994-3#1)(2004-9#1)(2006-5#1)(2008-10#2)(2009-7#2)(2010-3#1)(2012-2#2)(2013-8#1)
were coated##15##2##(1990-12#1)(1993-9#1)(1994-3#1)(2004-9#1)(2006-5#1)(2008-10#3)(2009-7#3)(2010-3#1)(2012-2#2)(2013-8#1)
were cochlear##2##2##(2006-12#1)(2008-9#1)
were cocultured##3##2##(1990-5#1)(2008-10#1)(2008-8#1)
were coded from##2##3##(2006-8#1)(2006-9#1)
were coded in##2##3##(1995-5#2)
were coded to##3##3##(1992-8#1)(1995-6#1)(2009-5#1)
were coded##16##2##(1991-6#1)(1992-8#1)(1994-3#1)(1995-5#2)(1995-6#1)(1996-1#1)(2006-8#1)(2006-9#1)(2008-11#1)(2008-12#1)(2009-5#1)(2010-2#1)(2012-12#2)(2012-3#1)
were coinoculated with##4##3##(2008-10#4)
were coinoculated##5##2##(2008-10#5)
were collapsed##4##2##(2008-10#1)(2012-3#3)
were collated and##2##3##(2007-2#1)(2013-8#1)
were collated##4##2##(2006-12#1)(2007-2#1)(2008-6#1)(2013-8#1)
were collected after##5##3##(1996-11#1)(2006-5#1)(2006-9#1)(2008-12#1)(2012-1#1)
were collected and analysed##2##4##(2007-10#1)(2010-4#1)
were collected and analyzed by the##2##6##(2008-10#1)(2013-8#1)
were collected and analyzed for the##2##6##(2012-2#1)(2012-3#1)
were collected and analyzed for##6##5##(2004-11#1)(2007-10#1)(2008-5#1)(2008-7#1)(2012-2#1)(2012-3#1)
were collected and analyzed##16##4##(1992-1#1)(2004-11#1)(2007-10#2)(2007-4#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
were collected and assayed for##2##5##(1997-2#1)(2010-9#1)
were collected and identified##3##4##(2011-2#1)(2012-12#1)(2013-1#1)
were collected and processed##2##4##(2008-6#1)(2013-1#1)
were collected and the##3##4##(2007-5#1)(2008-11#1)(2011-1#1)
were collected and their##3##4##(2008-5#2)(2009-5#1)
were collected and##52##3##(1990-12#1)(1992-1#1)(1997-2#1)(2004-11#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-10#3)(2007-3#1)(2007-4#1)(2007-5#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2010-4#2)(2010-9#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#3)
were collected around##2##3##(2007-1#1)(2008-10#1)
were collected as a##2##4##(2008-10#1)(2012-12#1)
were collected as##7##3##(1996-3#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-6#1)(2012-12#1)
were collected at 0##4##4##(2007-1#1)(2007-2#1)(2009-8#1)(2013-1#1)
were collected at a##2##4##(1996-3#1)(2007-4#1)
were collected at baseline and at##2##6##(2006-10#1)(2011-1#1)
were collected at baseline and during follow-up##2##7##(2012-12#2)
were collected at baseline and during##3##6##(2008-3#1)(2012-12#2)
were collected at baseline and##5##5##(2006-10#1)(2008-3#1)(2011-1#1)(2012-12#2)
were collected at different##4##4##(2007-10#1)(2008-10#1)(2008-7#1)(2012-1#1)
were collected at surface##2##4##(2006-12#1)(2012-2#1)
were collected at the##6##4##(1995-6#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-1#1)
were collected at two##2##4##(2010-1#1)(2013-8#1)
were collected at##44##3##(1991-6#1)(1993-4#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-3#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#3)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-1#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#1)
were collected before##15##3##(1991-12#1)(1993-3#1)(1993-7#1)(1995-4#1)(1995-5#1)(2006-5#1)(2007-5#1)(2007-8#1)(2007-9#2)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)
were collected between April and##2##5##(2008-5#1)(2010-10#1)
were collected between April##3##4##(2008-5#1)(2010-10#1)(2011-2#1)
were collected between June##2##4##(2007-2#1)(2007-5#1)
were collected between##8##3##(2007-2#1)(2007-5#1)(2008-5#2)(2010-10#1)(2011-2#2)(2012-2#1)
were collected by means of##3##5##(1992-5#1)(2009-12#1)(2010-3#1)
were collected by pyrethrum spray##2##5##(2006-4#1)(2008-2#1)
were collected by questionnaire##2##4##(2007-2#1)(2013-1#1)
were collected by the##3##4##(2007-8#1)(2011-2#2)
were collected by using a##2##5##(2008-10#1)(2011-2#1)
were collected by using##3##4##(2008-10#1)(2011-2#1)(2013-1#1)
were collected by##31##3##(1990-8#1)(1992-3#1)(1992-5#1)(1996-4#1)(1997-8#1)(2006-4#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#2)(2009-12#1)(2009-5#1)(2010-3#1)(2011-2#5)(2013-1#3)(2013-7#2)
were collected during 1994##2##4##(2008-10#2)
were collected during a##2##4##(1991-6#1)(1993-2#1)
were collected during the period##3##5##(1994-9#1)(2006-8#1)(2013-8#1)
were collected during the##8##4##(1994-9#1)(2004-11#1)(2006-8#1)(2007-12#1)(2007-3#1)(2010-8#1)(2011-2#1)(2013-8#1)
were collected during##30##3##(1990-2#1)(1990-4#1)(1991-6#1)(1993-2#1)(1993-5#1)(1994-9#1)(1995-12#1)(2004-11#2)(2006-8#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#2)(2008-10#2)(2008-5#3)(2008-7#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-7#1)(2013-8#2)
were collected each##2##3##(2008-1#1)(2008-10#1)
were collected every month##2##4##(2007-5#1)(2011-1#1)
were collected every##4##3##(2007-5#1)(2008-2#1)(2011-1#1)(2012-1#1)
were collected following##2##3##(1997-8#1)(2013-8#1)
were collected for a##4##4##(1994-3#1)(2008-10#1)(2008-2#1)(2011-2#1)
were collected for analysis##3##4##(1993-4#1)(2008-10#1)(2012-2#1)
were collected for each##3##4##(2008-10#1)(2008-11#1)(2012-12#1)
were collected for up to##2##5##(1997-8#1)(2008-10#1)
were collected for##38##3##(1991-2#1)(1993-4#1)(1994-3#1)(1995-3#1)(1995-5#1)(1997-8#1)(2004-1#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
were collected from 1##4##4##(2008-10#3)(2009-7#1)
were collected from 150##2##4##(2008-6#1)(2010-3#1)
were collected from 20##2##4##(1991-7#1)(2007-3#1)
were collected from 21##3##4##(1992-10#1)(2005-8#1)(2008-10#1)
were collected from 33##2##4##(2004-11#1)(2008-10#1)
were collected from 58##3##4##(2008-12#1)(2009-11#1)(2010-11#1)
were collected from 90##2##4##(2011-1#1)(2013-8#1)
were collected from February 2008 to January 2009##2##8##(2011-1#1)(2012-2#1)
were collected from February##3##4##(2004-11#1)(2011-1#1)(2012-2#1)
were collected from March##2##4##(2004-11#1)(2008-7#1)
were collected from a total of##2##6##(2007-7#1)(2013-8#1)
were collected from a##8##4##(2007-7#1)(2007-8#1)(2008-12#1)(2010-3#2)(2010-5#1)(2012-12#1)(2013-8#1)
were collected from both##4##4##(1990-5#1)(2008-12#1)(2013-1#2)
were collected from cattle##3##4##(2008-5#1)(2011-2#1)(2012-2#1)
were collected from children##2##4##(2007-6#1)(2013-8#1)
were collected from different##6##4##(2007-1#1)(2007-3#1)(2008-10#3)(2013-8#1)
were collected from each##7##4##(1995-2#1)(2006-8#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-5#1)(2013-8#1)
were collected from five##3##4##(2008-10#2)(2013-1#1)
were collected from four##2##4##(2008-10#1)(2011-2#1)
were collected from healthy##2##4##(2011-1#1)(2012-12#1)
were collected from patients who##2##5##(1991-7#1)(2008-2#1)
were collected from patients with##2##5##(2007-12#1)(2010-8#1)
were collected from patients##5##4##(1991-7#1)(2007-12#1)(2008-2#1)(2010-8#1)(2012-3#1)
were collected from pregnant women##2##5##(2005-10#1)(2007-7#1)
were collected from ten##3##4##(2010-4#1)(2012-2#1)(2013-7#1)
were collected from the field##2##5##(2008-10#2)
were collected from the##25##4##(1991-2#1)(1991-6#1)(1991-7#1)(2007-2#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-4#1)(2009-6#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
were collected from three##2##4##(2008-10#1)(2008-5#1)
were collected from two##3##4##(2008-2#1)(2008-5#2)
were collected from various##2##4##(2007-10#1)(2008-11#1)
were collected from##234##3##(1990-3#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-6#1)(1991-7#3)(1992-10#1)(1993-12#1)(1993-6#1)(1993-9#1)(1995-2#1)(1995-8#1)(1996-3#2)(1997-6#1)(2004-11#7)(2004-4#2)(2004-9#1)(2005-10#1)(2005-8#2)(2006-1#2)(2006-10#2)(2006-5#3)(2006-8#2)(2007-1#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#5)(2007-3#3)(2007-5#4)(2007-6#1)(2007-7#6)(2007-8#3)(2008-1#3)(2008-10#40)(2008-11#1)(2008-12#10)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#15)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#3)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#8)(2011-12#2)(2011-2#11)(2012-12#3)(2012-2#8)(2012-3#3)(2013-1#10)(2013-7#3)(2013-8#10)
were collected in a##3##4##(1990-12#1)(1990-6#1)(2007-3#1)
were collected in five##2##4##(2006-12#1)(2008-12#1)
were collected in four##2##4##(1994-6#1)(2008-10#1)
were collected in the##15##4##(1992-8#1)(1994-9#1)(1996-12#1)(1996-2#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#2)(2013-1#1)
were collected in two##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
were collected in##55##3##(1990-12#1)(1990-6#1)(1992-8#1)(1994-6#1)(1994-9#1)(1995-5#1)(1996-12#2)(1996-2#1)(2004-11#1)(2006-10#1)(2006-12#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#2)(2008-10#10)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-2#1)(2013-1#2)(2013-8#1)
were collected monthly##5##3##(2007-3#1)(2008-10#1)(2008-5#1)(2010-8#1)(2013-7#1)
were collected on a##2##4##(1997-2#1)(2012-1#1)
were collected on##23##3##(1993-6#1)(1996-3#1)(1997-2#1)(2004-1#1)(2004-10#1)(2004-11#1)(2006-4#1)(2006-8#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#2)(2009-4#1)(2009-9#2)(2010-7#2)(2012-1#1)(2012-2#1)(2012-3#1)
were collected over a##3##4##(2004-9#1)(2008-10#1)(2012-2#1)
were collected over two##2##4##(2008-4#1)(2010-8#1)
were collected over##7##3##(2004-9#1)(2007-6#1)(2008-10#2)(2008-4#1)(2010-8#1)(2012-2#1)
were collected prospectively in##2##4##(2007-10#1)(2008-7#1)
were collected prospectively##8##3##(1991-6#1)(1996-11#1)(2007-10#1)(2007-8#1)(2008-7#1)(2011-2#2)(2012-3#1)
were collected randomly from##2##4##(2008-10#1)(2008-12#1)
were collected randomly##3##3##(1997-6#1)(2008-10#1)(2008-12#1)
were collected through a questionnaire##2##5##(1996-1#1)(2008-9#1)
were collected through a##4##4##(1996-1#1)(2007-10#1)(2007-2#1)(2008-9#1)
were collected through semi-structured interviews##3##5##(2012-12#1)(2013-7#1)(2013-8#1)
were collected through##19##3##(1994-2#1)(1996-1#1)(2007-10#1)(2007-2#1)(2007-9#1)(2008-9#1)(2009-4#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-3#3)(2013-7#1)(2013-8#2)
were collected to determine##3##4##(2008-10#1)(2009-4#1)(2011-2#1)
were collected to##12##3##(2006-8#1)(2008-1#1)(2008-10#2)(2008-7#2)(2008-8#1)(2009-3#1)(2009-4#1)(2011-1#2)(2011-2#1)
were collected using a##7##4##(1990-10#1)(2007-8#1)(2008-10#1)(2010-6#1)(2011-1#1)(2013-1#2)
were collected using##17##3##(1990-10#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-6#1)(2011-1#1)(2012-12#1)(2013-1#3)
were collected via##4##3##(1991-8#2)(2011-2#1)(2012-11#1)
were collected while##2##3##(2008-10#1)(2008-11#1)
were collected with CDC##2##4##(2012-12#1)(2012-2#1)
were collected with the##3##4##(2010-8#1)(2012-12#1)(2013-8#1)
were collected with##11##3##(2007-12#1)(2007-6#1)(2008-2#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
were collected within##2##3##(2008-10#1)(2012-2#1)
were collected##777##2##(1990-10#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-12#1)(1991-2#2)(1991-6#4)(1991-7#3)(1991-8#2)(1992-1#1)(1992-10#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#1)(1995-8#1)(1996-1#3)(1996-11#2)(1996-12#4)(1996-2#1)(1996-3#5)(1996-4#1)(1997-2#4)(1997-6#4)(1997-7#1)(1997-8#3)(2004-1#2)(2004-10#1)(2004-11#18)(2004-4#2)(2004-9#2)(2005-10#2)(2005-11#1)(2005-8#2)(2006-1#3)(2006-10#6)(2006-12#4)(2006-4#5)(2006-5#7)(2006-7#1)(2006-8#7)(2006-9#1)(2007-1#6)(2007-10#9)(2007-11#4)(2007-12#5)(2007-2#20)(2007-3#14)(2007-4#3)(2007-5#12)(2007-6#3)(2007-7#13)(2007-8#15)(2007-9#4)(2008-1#7)(2008-10#95)(2008-11#11)(2008-12#22)(2008-2#9)(2008-3#9)(2008-4#3)(2008-5#45)(2008-6#7)(2008-7#10)(2008-8#4)(2008-9#5)(2009-11#1)(2009-12#2)(2009-3#3)(2009-4#8)(2009-5#7)(2009-6#4)(2009-7#3)(2009-8#1)(2009-9#5)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#3)(2010-2#4)(2010-3#4)(2010-4#8)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#9)(2010-9#1)(2011-1#23)(2011-12#3)(2011-2#41)(2011-3#1)(2012-1#7)(2012-11#2)(2012-12#23)(2012-2#20)(2012-3#14)(2013-1#41)(2013-7#15)(2013-8#25)
were colocalised in##2##3##(1997-3#2)
were colonized by the##2##4##(2008-10#2)
were colonized by##8##3##(1991-3#1)(2008-10#7)
were colonized with##2##3##(2010-4#1)(2013-1#1)
were colonized##11##2##(1991-3#1)(2008-10#8)(2010-4#1)(2013-1#1)
were combined and analyzed##3##4##(2008-10#1)(2008-7#1)(2012-3#1)
were combined and##6##3##(2008-10#3)(2008-5#1)(2008-7#1)(2012-3#1)
were combined for##2##3##(2008-10#2)
were combined in a##3##4##(1994-3#1)(2007-2#1)(2008-10#1)
were combined in the##2##4##(2008-10#2)
were combined in##7##3##(1994-3#1)(2006-11#1)(2007-2#1)(2008-10#4)
were combined to yield a##2##5##(2007-12#1)(2013-1#1)
were combined to##11##3##(1991-8#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2011-1#1)(2013-1#1)(2013-8#1)
were combined with a##2##4##(2008-5#1)(2009-9#1)
were combined with the##2##4##(2009-7#1)(2009-8#1)
were combined with##15##3##(1992-3#1)(1994-11#1)(1994-12#1)(2005-9#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#1)
were combined##61##2##(1990-7#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-3#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-7#2)(2005-9#1)(2006-11#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-9#1)(2008-1#1)(2008-10#15)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
were combusted##2##2##(1996-8#1)(2008-10#1)
were comfortable##3##2##(2007-9#1)(2008-11#1)(2009-5#1)
were commented##2##2##(2007-3#1)(2010-8#1)
were commissioned##2##2##(2010-12#1)(2012-3#1)
were common but##2##3##(2007-2#1)(2008-7#1)
were common findings##2##3##(2007-10#1)(2011-2#1)
were common in the##3##4##(1997-3#1)(2008-2#1)(2012-12#1)
were common in##13##3##(1995-6#1)(1997-3#1)(2007-7#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)(2012-12#1)(2012-3#1)(2013-8#1)
were common to all##2##4##(2006-8#1)(2012-2#1)
were common to both##2##4##(2008-10#1)(2008-5#1)
were common to##6##3##(2006-8#1)(2008-10#1)(2008-2#1)(2008-5#2)(2012-2#1)
were common##37##2##(1990-5#1)(1995-6#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-4#1)(2007-7#3)(2008-10#6)(2008-12#1)(2008-2#2)(2008-5#4)(2008-7#2)(2009-7#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#2)
were commonly found##2##3##(2008-10#1)(2009-4#1)
were commonly isolated from##2##4##(2008-10#2)
were commonly isolated##3##3##(2008-10#3)
were commonly##13##2##(1991-9#1)(1992-1#1)(2007-8#1)(2008-10#6)(2008-2#1)(2009-4#1)(2010-5#1)(2012-3#1)
were commonplace##2##2##(2008-10#1)(2010-7#1)
were communicated##2##2##(1992-9#1)(2012-12#1)
were community acquired##2##3##(2012-3#1)(2013-8#1)
were comparable across##2##3##(1996-12#1)(2013-1#1)
were comparable and##3##3##(1992-6#1)(1995-5#1)(2004-12#1)
were comparable between the two groups##2##6##(2007-9#1)(2010-3#1)
were comparable between the##3##4##(2007-1#1)(2007-9#1)(2010-3#1)
were comparable between##6##3##(1996-11#1)(2006-5#1)(2007-1#1)(2007-9#1)(2008-12#1)(2010-3#1)
were comparable for##2##3##(2004-1#1)(2008-7#1)
were comparable in both groups##3##5##(2006-6#2)(2013-1#1)
were comparable in both##6##4##(2006-6#2)(2008-10#2)(2011-11#1)(2013-1#1)
were comparable in terms of##4##5##(1995-6#1)(2007-2#1)(2008-5#1)(2011-2#1)
were comparable in##16##3##(1995-5#1)(1995-6#1)(1997-7#1)(2006-6#2)(2007-2#1)(2008-10#2)(2008-5#1)(2009-11#1)(2011-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
were comparable to currently##2##4##(2007-12#1)(2008-10#1)
were comparable to other##2##4##(2006-1#1)(2008-10#1)
were comparable to that of##3##5##(2008-10#2)(2013-8#1)
were comparable to the values obtained##2##6##(2006-1#1)(2008-10#1)
were comparable to the##7##4##(1995-8#1)(1996-11#1)(2004-4#1)(2006-1#1)(2006-10#1)(2008-10#1)(2010-5#1)
were comparable to those induced by##2##6##(1992-3#1)(1997-6#1)
were comparable to those observed in##2##6##(1990-5#1)(1994-12#1)
were comparable to those obtained by##3##6##(2008-10#2)(2008-5#1)
were comparable to those obtained##4##5##(2008-10#3)(2008-5#1)
were comparable to those of the##2##6##(1991-12#1)(2008-10#1)
were comparable to those of##6##5##(1991-12#1)(1994-7#1)(2007-11#1)(2008-10#2)(2008-5#1)
were comparable to those reported in##2##6##(1991-2#1)(2008-10#1)
were comparable to those##26##4##(1990-12#1)(1990-5#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-3#1)(1994-12#1)(1994-7#1)(1997-2#1)(1997-6#1)(2006-12#1)(2007-11#1)(2008-10#10)(2008-11#1)(2008-5#2)(2008-8#1)
were comparable to##51##3##(1990-12#2)(1990-5#1)(1991-12#2)(1991-2#1)(1992-1#1)(1992-3#1)(1993-12#2)(1994-12#1)(1994-7#1)(1995-8#1)(1996-11#1)(1997-2#1)(1997-6#1)(2004-4#1)(2006-1#2)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#16)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#2)(2010-5#1)(2013-1#1)(2013-8#1)
were comparable with respect to##2##5##(2008-10#1)(2011-2#1)
were comparable with respect##3##4##(1991-3#1)(2008-10#1)(2011-2#1)
were comparable with the##3##4##(1997-8#1)(2008-4#1)(2013-8#1)
were comparable with those obtained by##4##6##(1997-7#1)(2008-10#3)
were comparable with those obtained##6##5##(1997-7#1)(2008-10#5)
were comparable with those of##3##5##(2007-3#1)(2008-2#1)(2008-3#1)
were comparable with those##11##4##(1993-3#1)(1997-7#1)(2007-2#1)(2007-3#1)(2008-10#5)(2008-2#1)(2008-3#1)
were comparable with##26##3##(1991-3#1)(1993-12#1)(1993-3#1)(1994-10#1)(1995-3#1)(1995-6#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-2#1)(2007-3#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-11#1)(2010-8#1)(2011-2#1)(2013-8#1)
were comparable##135##2##(1990-12#2)(1990-5#2)(1990-7#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-1#1)(1992-3#2)(1992-5#2)(1992-6#1)(1993-12#3)(1993-3#1)(1993-5#1)(1994-10#1)(1994-12#1)(1994-7#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-1#1)(2004-12#1)(2004-4#1)(2005-11#2)(2006-1#2)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-10#28)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2009-11#2)(2010-3#1)(2010-5#1)(2010-8#1)(2011-11#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#2)
were comparably##2##2##(2006-9#1)(2008-5#1)
were comparatively analyzed##3##3##(2007-7#1)(2013-1#1)(2013-8#1)
were comparatively examined##2##3##(1991-8#1)(1996-12#1)
were comparatively##10##2##(1991-8#1)(1992-9#1)(1996-12#1)(2006-12#1)(2007-1#1)(2007-7#1)(2008-10#1)(2008-5#1)(2013-1#1)(2013-8#1)
were compared according to##4##4##(2008-7#1)(2010-5#1)(2011-1#1)(2013-1#1)
were compared across##3##3##(1991-3#1)(2010-7#1)(2011-2#1)
were compared against##6##3##(1993-9#1)(1994-5#1)(1996-6#1)(2009-12#1)(2013-1#2)
were compared among##8##3##(1995-6#1)(1996-5#1)(2007-5#1)(2008-10#2)(2010-8#1)(2012-11#1)(2012-2#1)
were compared and discussed##3##4##(2008-10#3)
were compared and it was##2##5##(2008-10#1)(2008-3#1)
were compared and the##3##4##(1993-7#1)(2008-10#1)(2008-11#1)
were compared and##18##3##(1992-11#1)(1993-7#1)(1994-12#1)(1996-5#1)(2005-11#1)(2008-10#8)(2008-11#3)(2008-3#1)(2013-8#1)
were compared as##4##3##(1990-11#1)(1993-9#1)(2008-10#1)(2008-3#1)
were compared at different##2##4##(2012-12#1)(2012-3#1)
were compared at##7##3##(1994-11#1)(1996-12#1)(2007-10#1)(2007-6#1)(2007-9#1)(2012-12#1)(2012-3#1)
were compared based on the##2##5##(2007-7#1)(2008-9#1)
were compared based on##3##4##(2007-7#1)(2008-9#1)(2011-2#1)
were compared between a##3##4##(2008-1#1)(2008-9#1)(2011-12#1)
were compared between groups##2##4##(2011-2#1)(2012-12#1)
were compared between patients##2##4##(2007-9#1)(2013-1#1)
were compared between the groups##3##5##(1995-4#1)(2006-10#1)(2011-2#1)
were compared between the two groups##2##6##(1996-2#1)(2011-2#1)
were compared between the two##4##5##(1991-6#1)(1996-2#1)(2007-8#1)(2011-2#1)
were compared between the##9##4##(1991-6#1)(1995-4#1)(1996-2#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-2#2)
were compared between two##2##4##(2006-8#1)(2008-7#1)
were compared between##36##3##(1991-6#1)(1992-3#1)(1995-4#1)(1996-2#1)(1996-5#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#3)(2012-5#1)(2013-1#2)
were compared by##23##3##(1990-12#1)(1991-12#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-4#1)(1997-6#1)(2004-11#1)(2004-12#1)(2005-11#1)(2006-12#1)(2006-3#1)(2007-9#1)(2008-10#4)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
were compared following##2##3##(1991-11#1)(1997-8#1)
were compared for each##3##4##(2008-3#1)(2009-2#1)(2011-2#1)
were compared for the##10##4##(1990-8#1)(1996-12#1)(2005-9#1)(2006-11#1)(2007-2#1)(2008-10#4)(2008-4#1)
were compared for their capacities to protect immunodeficient##2##8##(2008-5#2)
were compared for their##6##4##(1991-9#1)(2008-10#1)(2008-12#1)(2008-5#2)(2012-3#1)
were compared for##40##3##(1990-8#2)(1990-9#1)(1991-1#1)(1991-9#1)(1992-8#1)(1993-9#1)(1996-12#1)(1997-7#1)(2004-9#1)(2005-9#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-2#2)(2007-3#1)(2008-10#12)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2009-2#1)(2011-2#1)(2012-3#1)
were compared in a##4##4##(1991-7#1)(1993-11#1)(1993-4#1)(2007-7#1)
were compared in different##4##4##(2007-7#1)(2008-12#1)(2008-8#1)(2012-12#1)
were compared in each##2##4##(1992-10#1)(2008-7#1)
were compared in patients with##2##5##(1993-12#1)(1996-7#1)
were compared in rabbits##2##4##(1992-7#1)(1992-8#1)
were compared in terms of##4##5##(2005-4#1)(2008-10#2)(2010-9#1)
were compared in the##2##4##(1990-11#1)(2010-4#1)
were compared in their##2##4##(2008-10#1)(2008-5#1)
were compared in##58##3##(1990-11#1)(1991-11#1)(1991-7#3)(1992-1#1)(1992-10#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-12#1)(1994-2#1)(1996-1#2)(1996-12#1)(1996-7#2)(1996-8#1)(1997-3#1)(2005-4#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-3#1)
were compared on the##3##4##(1993-2#1)(2011-2#1)(2012-2#1)
were compared on##13##3##(1990-10#1)(1993-2#1)(1996-3#1)(1997-2#1)(2005-10#1)(2006-3#1)(2006-7#1)(2007-2#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#1)
were compared statistically##4##3##(1994-3#1)(2006-9#1)(2008-10#1)(2011-1#1)
were compared to a##7##4##(1994-2#1)(1995-11#1)(1996-12#1)(1996-9#1)(2007-8#1)(2008-11#1)(2008-9#1)
were compared to age-##2##4##(2004-12#1)(2009-4#1)
were compared to an##2##4##(2008-10#1)(2011-2#1)
were compared to assess the##3##5##(2006-11#1)(2007-6#1)(2012-1#1)
were compared to data##3##4##(1994-2#1)(2006-9#1)(2007-4#1)
were compared to determine the##2##5##(2010-1#1)(2010-8#1)
were compared to determine##4##4##(1997-2#1)(2010-1#1)(2010-8#1)(2011-2#1)
were compared to evaluate##2##4##(2013-1#1)(2013-8#1)
were compared to identify##2##4##(2008-9#1)(2011-2#1)
were compared to that of a##2##6##(2007-3#1)(2008-10#1)
were compared to that of##3##5##(2007-3#1)(2008-10#2)
were compared to the data published##2##6##(2008-7#1)(2013-1#1)
were compared to the findings##2##5##(2007-8#1)(2010-9#1)
were compared to the reference##2##5##(2008-10#2)
were compared to the##31##4##(1990-5#1)(1991-12#1)(1991-2#1)(1993-8#1)(1994-9#1)(1995-7#1)(1997-2#1)(1997-8#1)(2004-9#1)(2007-7#2)(2007-8#3)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-7#1)(2010-10#1)(2010-9#1)(2011-1#1)(2013-1#3)(2013-7#1)
were compared to those obtained by the##2##7##(2008-10#2)
were compared to those obtained by using##2##7##(2008-10#1)(2010-4#1)
were compared to those obtained by##5##6##(2008-10#4)(2010-4#1)
were compared to those obtained with##2##6##(1994-9#1)(2008-10#1)
were compared to those obtained##11##5##(1992-2#1)(1992-7#1)(1994-9#1)(2007-11#1)(2008-10#6)(2010-4#1)
were compared to those of an##2##6##(2007-1#1)(2008-10#1)
were compared to those of the##2##6##(1995-2#1)(2008-10#1)
were compared to those of##18##5##(1990-1#1)(1990-9#1)(1991-10#2)(1992-12#1)(1994-10#1)(1995-2#1)(1997-1#2)(1997-8#2)(2006-12#1)(2007-1#1)(2008-10#2)(2010-4#2)(2011-2#1)
were compared to those who##2##5##(1994-1#1)(2007-2#1)
were compared to those##37##4##(1990-1#1)(1990-9#1)(1991-10#2)(1991-4#1)(1992-12#1)(1992-2#1)(1992-7#1)(1994-1#1)(1994-10#1)(1994-8#1)(1994-9#1)(1995-2#1)(1997-1#2)(1997-3#1)(1997-8#2)(2006-12#1)(2007-1#1)(2007-11#1)(2007-2#1)(2008-10#9)(2008-12#1)(2008-8#1)(2010-4#3)(2011-2#1)
were compared to traditional##2##4##(2007-8#1)(2008-3#1)
were compared to##150##3##(1990-1#1)(1990-10#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-5#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-8#3)(2004-12#1)(2004-9#1)(2006-11#1)(2006-12#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-11#2)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#6)(2008-10#19)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#5)(2009-12#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-4#6)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-2#4)(2013-1#5)(2013-7#2)(2013-8#3)
were compared using a solid##2##5##(1991-1#1)(1995-1#1)
were compared using a##5##4##(1991-1#1)(1995-1#1)(1997-4#1)(2008-10#2)
were compared using the##4##4##(1995-10#1)(2004-12#1)(2007-6#1)(2012-12#1)
were compared using##27##3##(1991-1#1)(1992-8#1)(1995-1#1)(1995-10#1)(1995-12#1)(1996-9#1)(1997-4#1)(2004-12#1)(2005-10#1)(2006-10#3)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#8)(2009-3#1)(2010-12#1)(2012-12#1)
were compared when##2##3##(2008-8#1)(2008-9#1)
were compared with 200 hospital visitor controls##2##7##(1993-9#2)
were compared with 31 matched##2##5##(1997-8#2)
were compared with 31##3##4##(1997-8#2)(2008-5#1)
were compared with P##3##4##(2006-8#1)(2008-10#2)
were compared with a control group##3##6##(2005-10#1)(2007-7#1)(2008-10#1)
were compared with a previous##2##5##(2007-2#1)(2008-10#1)
were compared with a sample of##2##6##(2010-2#1)(2013-8#1)
were compared with a##21##4##(1991-8#1)(1997-1#1)(2005-10#1)(2005-12#1)(2006-3#1)(2007-2#1)(2007-7#1)(2008-10#6)(2008-3#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-12#1)(2012-2#1)(2013-8#1)
were compared with an##2##4##(1991-7#1)(2010-12#1)
were compared with available##3##4##(2006-11#1)(2008-5#1)(2010-8#1)
were compared with control##2##4##(1996-8#1)(2008-12#1)
were compared with conventional##2##4##(2008-10#2)
were compared with data from##3##5##(2004-4#1)(2008-8#1)(2010-6#1)
were compared with data##6##4##(2004-4#1)(2008-11#1)(2008-8#1)(2010-5#1)(2010-6#1)(2012-1#1)
were compared with each other and##3##6##(2008-10#2)(2011-2#1)
were compared with each other##5##5##(2008-10#2)(2008-11#1)(2008-2#1)(2011-2#1)
were compared with experimental##2##4##(2008-2#2)
were compared with findings in##2##5##(1990-12#1)(1990-6#1)
were compared with four control##2##5##(1993-12#1)(2004-10#1)
were compared with four##3##4##(1990-12#1)(1993-12#1)(2004-10#1)
were compared with healthy##2##4##(1995-11#1)(2007-6#1)
were compared with levels##2##4##(1994-2#1)(2009-2#1)
were compared with measured##2##4##(2008-3#1)(2011-1#1)
were compared with one another##3##5##(2007-10#1)(2008-10#1)(2013-1#1)
were compared with other##7##4##(1993-11#1)(2006-10#1)(2007-2#1)(2008-10#2)(2012-2#1)(2013-8#1)
were compared with previous##3##4##(2007-4#1)(2008-11#1)(2012-3#1)
were compared with previously##3##4##(1993-9#1)(2006-11#1)(2008-3#1)
were compared with profiles of##2##5##(1996-8#1)(2010-12#1)
were compared with reference strains of##2##6##(2008-10#2)
were compared with respect to the##2##6##(1994-12#1)(2012-12#1)
were compared with respect to##6##5##(1992-10#1)(1994-12#1)(1997-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
were compared with results from##2##5##(2008-3#1)(2011-2#1)
were compared with results obtained##2##5##(2006-6#1)(2008-10#1)
were compared with results##4##4##(2006-6#1)(2008-10#1)(2008-3#1)(2011-2#1)
were compared with that of the##2##6##(1997-2#1)(2012-2#1)
were compared with that of##6##5##(1990-3#1)(1997-2#1)(2005-10#1)(2007-9#1)(2008-10#1)(2012-2#1)
were compared with that##8##4##(1990-3#1)(1992-7#1)(1997-2#1)(2005-10#1)(2007-9#1)(2008-10#1)(2008-8#1)(2012-2#1)
were compared with the control group##3##6##(1994-3#1)(2006-10#1)(2007-11#1)
were compared with the control##4##5##(1994-3#1)(2006-10#1)(2006-12#1)(2007-11#1)
were compared with the corresponding##3##5##(1995-7#1)(2008-2#2)
were compared with the ones obtained by##2##7##(2008-10#1)(2008-6#1)
were compared with the results obtained using##2##7##(2008-10#2)
were compared with the results obtained##4##6##(2007-8#1)(2008-10#3)
were compared with the results of a finite##2##8##(2006-2#1)(2008-7#1)
were compared with the results##6##5##(2006-2#1)(2007-8#1)(2008-10#3)(2008-7#1)
were compared with the standard values##2##6##(2007-10#1)(2008-1#1)
were compared with the values##2##5##(2008-10#1)(2008-6#1)
were compared with the##85##4##(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1993-9#1)(1994-3#3)(1994-8#1)(1995-11#1)(1995-3#1)(1995-7#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-8#1)(2005-11#1)(2005-5#2)(2006-10#2)(2006-11#2)(2006-12#2)(2006-2#1)(2007-10#3)(2007-11#4)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#20)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#5)
were compared with those achieved##3##5##(2007-8#1)(2008-10#2)
were compared with those for##3##5##(2007-9#1)(2008-3#1)(2008-5#1)
were compared with those from similar##2##6##(1990-2#1)(2008-10#1)
were compared with those from##8##5##(1990-2#1)(1991-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-2#1)
were compared with those having##2##5##(2009-5#1)(2011-2#1)
were compared with those in##6##5##(1993-1#1)(2006-2#1)(2008-10#2)(2008-5#1)(2012-1#1)
were compared with those obtained by a##4##7##(2007-10#1)(2008-10#2)(2008-2#1)
were compared with those obtained by the##3##7##(2008-10#3)
were compared with those obtained by##13##6##(2007-10#1)(2008-10#10)(2008-2#1)(2008-3#1)
were compared with those obtained from##2##6##(2008-10#1)(2008-5#1)
were compared with those obtained in a##2##7##(1994-4#1)(2006-10#1)
were compared with those obtained in##4##6##(1991-2#1)(1994-4#1)(1996-5#1)(2006-10#1)
were compared with those obtained using##6##6##(1995-2#1)(2008-10#5)
were compared with those obtained with##5##6##(2008-10#4)(2008-6#1)
were compared with those obtained##32##5##(1991-2#1)(1994-4#1)(1995-2#1)(1996-5#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-10#20)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2012-12#1)
were compared with those of a##3##6##(1994-8#1)(1997-8#1)(2008-10#1)
were compared with those of control##2##6##(1991-6#1)(2008-10#1)
were compared with those of other##4##6##(2007-10#1)(2007-4#1)(2008-10#1)(2008-7#1)
were compared with those of the##6##6##(1993-9#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)
were compared with those of two##2##6##(2008-10#1)(2009-4#1)
were compared with those of##49##5##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1991-10#1)(1991-3#1)(1991-6#1)(1992-4#1)(1992-8#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-4#1)(2007-9#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#1)(2013-8#1)
were compared with those##117##4##(1990-10#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-9#1)(1994-4#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-5#2)(1996-7#1)(1997-1#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#3)(2007-11#1)(2007-4#1)(2007-8#2)(2007-9#3)(2008-10#42)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-5#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
were compared with traditional##2##4##(2008-3#1)(2008-5#1)
were compared with##448##3##(1990-10#2)(1990-12#3)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#2)(1992-4#1)(1992-7#2)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-9#5)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#5)(1994-4#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#3)(1995-7#1)(1996-2#2)(1996-3#1)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#2)(1997-1#2)(1997-2#2)(1997-5#1)(1997-7#3)(1997-8#5)(2004-1#1)(2004-10#1)(2004-11#1)(2004-12#1)(2004-4#1)(2005-10#4)(2005-11#4)(2005-12#1)(2005-4#2)(2005-5#2)(2006-10#8)(2006-11#5)(2006-12#5)(2006-2#2)(2006-3#1)(2006-6#1)(2006-8#4)(2007-10#7)(2007-11#7)(2007-12#3)(2007-2#3)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#9)(2007-9#5)(2008-1#3)(2008-10#105)(2008-11#11)(2008-12#3)(2008-2#10)(2008-3#16)(2008-4#1)(2008-5#12)(2008-6#4)(2008-7#9)(2008-8#5)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-12#6)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#11)(2012-1#4)(2012-12#5)(2012-2#9)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#10)
were compared within##2##3##(2007-8#1)(2012-2#1)
were compared##1058##2##(1990-1#1)(1990-10#4)(1990-11#2)(1990-12#5)(1990-2#5)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#3)(1990-8#5)(1990-9#4)(1991-1#2)(1991-10#3)(1991-11#4)(1991-12#4)(1991-2#3)(1991-3#2)(1991-4#3)(1991-5#2)(1991-6#4)(1991-7#5)(1991-8#4)(1991-9#3)(1992-1#2)(1992-10#3)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#2)(1992-4#1)(1992-7#4)(1992-8#10)(1992-9#2)(1993-1#4)(1993-11#4)(1993-12#5)(1993-2#4)(1993-3#2)(1993-4#2)(1993-7#1)(1993-8#1)(1993-9#11)(1994-1#2)(1994-10#1)(1994-11#3)(1994-12#4)(1994-2#4)(1994-3#7)(1994-4#2)(1994-5#2)(1994-8#3)(1994-9#6)(1995-1#3)(1995-10#3)(1995-11#4)(1995-12#4)(1995-2#3)(1995-3#3)(1995-4#3)(1995-5#1)(1995-6#5)(1995-7#2)(1996-1#3)(1996-11#1)(1996-12#7)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#10)(1996-6#3)(1996-7#4)(1996-8#3)(1996-9#3)(1997-1#4)(1997-2#7)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#2)(1997-7#5)(1997-8#9)(2004-1#1)(2004-10#1)(2004-11#2)(2004-12#4)(2004-2#1)(2004-4#1)(2004-9#3)(2005-10#7)(2005-11#8)(2005-12#2)(2005-4#4)(2005-5#2)(2005-9#1)(2006-1#1)(2006-10#13)(2006-11#8)(2006-12#11)(2006-2#3)(2006-3#3)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#9)(2006-9#3)(2007-1#2)(2007-10#11)(2007-11#11)(2007-12#6)(2007-2#10)(2007-3#3)(2007-4#5)(2007-5#4)(2007-6#4)(2007-7#10)(2007-8#23)(2007-9#8)(2008-1#5)(2008-10#219)(2008-11#22)(2008-12#6)(2008-2#14)(2008-3#26)(2008-4#5)(2008-5#27)(2008-6#10)(2008-7#19)(2008-8#11)(2008-9#12)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#3)(2009-3#3)(2009-4#3)(2009-5#1)(2009-6#3)(2009-7#4)(2009-8#2)(2010-1#2)(2010-10#2)(2010-12#9)(2010-2#4)(2010-3#2)(2010-4#12)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#7)(2010-9#3)(2011-1#10)(2011-12#2)(2011-2#31)(2012-1#6)(2012-11#1)(2012-12#14)(2012-2#22)(2012-3#10)(2012-4#1)(2012-5#1)(2013-1#20)(2013-7#5)(2013-8#19)
were compatible with the##4##4##(1990-8#1)(1995-1#1)(2007-12#1)(2008-7#1)
were compatible with those##2##4##(1997-6#1)(2006-2#1)
were compatible with##20##3##(1990-8#1)(1991-10#1)(1991-8#2)(1992-3#1)(1993-9#1)(1995-1#1)(1996-3#1)(1997-2#1)(1997-6#1)(2006-2#2)(2006-4#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-6#1)(2011-2#1)
were compatible##22##2##(1990-8#1)(1991-10#1)(1991-8#2)(1992-3#1)(1993-9#1)(1995-1#1)(1996-3#1)(1997-2#1)(1997-5#1)(1997-6#1)(2006-2#2)(2006-4#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-7#1)(2010-6#1)(2011-2#1)
were compensated for##3##3##(1991-1#1)(2007-8#1)(2008-3#1)
were compensated##4##2##(1991-1#1)(2007-8#1)(2008-3#1)(2012-1#1)
were competent##2##2##(1992-12#1)(2008-11#1)
were competitive inhibitors of##2##4##(1994-5#1)(1994-9#1)
were competitive inhibitors##3##3##(1991-5#1)(1994-5#1)(1994-9#1)
were competitive with##2##3##(1990-4#1)(1992-9#1)
were competitive##7##2##(1990-4#1)(1990-5#1)(1991-5#1)(1992-9#1)(1994-5#1)(1994-9#1)(2004-12#1)
were competitively##2##2##(1990-2#1)(1995-3#1)
were compiled from##2##3##(1997-4#1)(2008-5#1)
were compiled##4##2##(1993-8#1)(1997-4#1)(2006-8#1)(2008-5#1)
were complained##2##2##(1990-8#1)(1994-6#1)
were complementary to##2##3##(2008-10#2)
were complementary##3##2##(2005-11#1)(2008-10#2)
were complemented by the##2##4##(1991-12#1)(2005-9#1)
were complemented with##3##3##(2008-6#1)(2009-10#1)(2013-7#1)
were complemented##5##2##(1991-12#1)(2005-9#1)(2008-6#1)(2009-10#1)(2013-7#1)
were complete##4##2##(2006-10#1)(2006-6#1)(2008-6#1)(2008-9#1)
were completed as##3##3##(2006-5#1)(2013-1#2)
were completed by a##2##4##(2008-4#1)(2010-12#1)
were completed by the##2##4##(2006-10#1)(2008-10#1)
were completed by##14##3##(1997-5#1)(2004-2#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-4#2)(2010-12#1)(2010-7#1)(2011-2#3)(2013-1#1)
were completed for##2##3##(2007-12#1)(2012-1#1)
were completed in##9##3##(1991-11#2)(1991-2#1)(2005-7#1)(2008-5#3)(2008-8#1)(2011-2#1)
were completed without##2##3##(2008-9#1)(2012-1#1)
were completed##49##2##(1991-11#2)(1991-2#1)(1993-12#1)(1995-2#1)(1996-2#1)(1997-5#1)(2004-2#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-10#2)(2007-12#5)(2008-10#2)(2008-4#2)(2008-5#4)(2008-8#1)(2008-9#1)(2010-1#2)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#2)(2011-2#6)(2012-1#2)(2012-12#1)(2013-1#4)(2013-8#1)
were completely abolished by the##2##5##(1990-4#1)(1993-4#1)
were completely abolished by##4##4##(1990-4#1)(1993-4#1)(1997-6#1)(2005-8#1)
were completely abolished##5##3##(1990-4#1)(1990-5#1)(1993-4#1)(1997-6#1)(2005-8#1)
were completely blocked by the##2##5##(1990-7#1)(1994-9#1)
were completely blocked by##3##4##(1990-7#2)(1994-9#1)
were completely blocked##4##3##(1990-7#2)(1994-9#1)(1995-8#1)
were completely concordant##2##3##(1997-7#1)(2012-2#1)
were completely cured##2##3##(1990-7#1)(2007-7#1)
were completely depleted##2##3##(2008-5#1)(2013-8#1)
were completely different##2##3##(2008-10#1)(2009-8#1)
were completely eliminated##2##3##(2008-8#1)(2010-2#1)
were completely inhibited##2##3##(1994-12#1)(2008-12#1)
were completely or##2##3##(2008-10#1)(2008-9#1)
were completely relieved##3##3##(1992-3#1)(1995-11#1)(2008-7#1)
were completely resistant##2##3##(2008-10#2)
were completely separated##6##3##(1990-9#1)(1997-2#1)(2008-10#3)(2011-1#1)
were completely##80##2##(1990-12#1)(1990-4#1)(1990-5#2)(1990-7#3)(1990-9#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-4#1)(1993-6#1)(1993-9#2)(1994-12#1)(1994-9#2)(1995-11#1)(1995-2#2)(1995-8#1)(1996-1#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-6#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
were complex and##2##3##(1996-1#1)(2008-10#1)
were complex##5##2##(1996-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-4#1)
were complexed with##2##3##(1996-2#1)(2008-10#1)
were compliant##2##2##(2008-6#1)(2010-12#1)
were complicated by##4##3##(1991-4#1)(1996-12#1)(2007-7#1)(2013-1#1)
were complicated##7##2##(1991-4#1)(1993-8#1)(1996-12#1)(2005-11#1)(2007-7#1)(2008-10#1)(2013-1#1)
were complied##2##2##(2006-4#1)(2012-3#1)
were composed mainly of##2##4##(1991-3#1)(1997-6#1)
were composed of a##3##4##(1990-2#1)(2007-8#1)(2008-10#1)
were composed of##22##3##(1990-2#1)(1991-6#1)(1991-8#1)(1993-3#1)(1993-7#1)(1995-8#1)(1996-1#1)(1996-4#1)(2004-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#2)(2009-4#1)(2009-5#1)(2010-4#1)(2011-2#1)(2013-1#2)(2013-8#1)
were composed principally of##2##4##(1990-2#1)(2008-10#1)
were composed##28##2##(1990-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1993-3#1)(1993-7#1)(1995-8#1)(1996-1#1)(1996-4#1)(1997-6#1)(2004-2#1)(2005-8#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-9#2)(2009-4#1)(2009-5#1)(2010-4#1)(2011-2#1)(2013-1#2)(2013-8#1)
were compound##2##2##(1995-2#1)(2007-12#1)
were comprehensively assessed##2##3##(2007-8#1)(2008-6#1)
were comprehensively##3##2##(2007-8#1)(2008-6#1)(2013-8#1)
were compressed##7##2##(1990-11#1)(1992-7#1)(2007-11#1)(2007-9#1)(2008-2#1)(2010-5#1)(2013-8#1)
were comprised of##6##3##(1997-5#1)(2008-10#1)(2008-5#2)(2013-1#1)(2013-7#1)
were comprised##7##2##(1997-5#1)(2008-10#2)(2008-5#2)(2013-1#1)(2013-7#1)
were computed and##5##3##(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-2#1)
were computed by##2##3##(2008-10#1)(2011-2#1)
were computed for##3##3##(2006-11#1)(2008-10#1)(2010-12#1)
were computed from the##2##4##(2006-11#1)(2009-6#1)
were computed from##5##3##(2006-11#2)(2007-6#1)(2008-5#1)(2009-6#1)
were computed to##3##3##(2009-3#1)(2012-2#2)
were computed##27##2##(1994-8#1)(2006-11#3)(2006-8#1)(2007-11#1)(2007-12#1)(2007-6#2)(2008-10#5)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)
were computer##2##2##(2007-11#1)(2008-5#1)
were conceived##3##2##(2009-10#2)(2009-4#1)
were concentrated and##2##3##(2008-10#1)(2012-3#1)
were concentrated at##2##3##(1996-1#1)(1997-7#1)
were concentrated by ultrafiltration##2##4##(2008-5#1)(2008-7#1)
were concentrated by##6##3##(1996-12#1)(2008-10#3)(2008-5#1)(2008-7#1)
were concentrated in the##6##4##(1993-12#1)(1994-12#1)(1996-5#1)(2011-1#2)(2013-7#1)
were concentrated in##10##3##(1993-12#1)(1993-3#1)(1994-12#1)(1996-5#1)(2008-10#2)(2010-6#1)(2011-1#2)(2013-7#1)
were concentrated on##2##3##(2008-10#1)(2008-5#1)
were concentrated to##2##3##(1992-2#1)(1993-2#1)
were concentrated##30##2##(1992-2#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-7#1)(2006-12#1)(2006-8#1)(2008-10#8)(2008-11#1)(2008-5#2)(2008-7#1)(2010-6#1)(2011-1#3)(2012-3#1)(2013-7#1)
were concentration-dependent##3##2##(1991-8#1)(1996-3#1)(2008-8#1)
were concerned about becoming##2##4##(1995-6#1)(2007-7#1)
were concerned about their##2##4##(1995-6#1)(2013-8#1)
were concerned about##7##3##(1995-6#3)(2007-4#1)(2007-7#1)(2013-8#2)
were concerned that##2##3##(2007-5#1)(2011-1#1)
were concerned with##3##3##(1993-3#1)(2007-12#1)(2008-7#1)
were concerned##20##2##(1990-10#1)(1990-4#1)(1991-6#1)(1993-3#2)(1995-6#3)(2006-6#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#2)(2008-7#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
were concerns about##2##3##(2006-8#1)(2012-2#1)
were concerns##3##2##(2006-8#1)(2008-5#1)(2012-2#1)
were concluded##2##2##(1992-2#1)(2009-4#1)
were concomitantly##3##2##(1991-7#1)(2011-2#1)(2013-8#1)
were concordant with the##2##4##(2008-10#1)(2010-12#1)
were concordant##4##2##(2008-10#1)(2010-12#2)(2013-1#1)
were concordantly##2##2##(2008-8#2)
were condensed##2##2##(1994-9#1)(2008-7#1)
were conditioned at##2##3##(2008-10#1)(2009-3#1)
were conditioned to##3##3##(1993-2#1)(2007-2#1)(2009-5#1)
were conditioned with##2##3##(2007-9#1)(2013-8#1)
were conditioned##10##2##(1993-2#1)(2007-2#1)(2007-9#1)(2008-10#3)(2009-3#1)(2009-5#1)(2011-1#1)(2013-8#1)
were conducted after##2##3##(2008-10#1)(2008-8#1)
were conducted among##2##3##(2008-3#1)(2012-2#1)
were conducted and##5##3##(1991-12#1)(2008-11#1)(2010-3#1)(2012-3#1)(2013-8#1)
were conducted at 25 degrees C##2##6##(2008-10#2)
were conducted at the##2##4##(1993-7#1)(2008-10#1)
were conducted at##18##3##(1993-7#1)(2005-11#1)(2006-11#1)(2006-12#1)(2007-5#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)
were conducted by##12##3##(1993-9#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#2)(2009-4#1)(2013-1#1)(2013-8#1)
were conducted during the##2##4##(2007-5#1)(2010-7#1)
were conducted during##5##3##(1990-8#1)(2006-6#1)(2007-5#1)(2008-10#1)(2010-7#1)
were conducted for##12##3##(2004-11#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-9#1)(2010-8#1)(2012-3#1)(2013-1#1)
were conducted from##6##3##(2006-12#1)(2008-10#1)(2008-9#1)(2009-12#1)(2009-4#1)(2013-7#1)
were conducted in 1997##2##4##(2008-10#2)
were conducted in July##2##4##(1992-12#1)(2008-10#1)
were conducted in a##6##4##(2006-11#1)(2008-10#1)(2008-5#1)(2011-2#2)(2013-8#1)
were conducted in acute##2##4##(2008-11#1)(2013-7#1)
were conducted in four##2##4##(2008-10#1)(2012-2#1)
were conducted in order to##2##5##(2008-10#1)(2012-3#1)
were conducted in the##4##4##(1993-8#1)(2008-4#1)(2008-8#1)(2011-12#1)
were conducted in two##2##4##(1994-9#1)(2009-6#1)
were conducted in##65##3##(1991-9#1)(1992-12#1)(1993-8#1)(1993-9#1)(1994-9#1)(1995-3#1)(1996-6#1)(2004-11#1)(2005-10#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#8)(2009-1#1)(2009-6#1)(2010-2#1)(2010-6#1)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
were conducted into##2##3##(2007-4#2)
were conducted on a##3##4##(2007-12#1)(2007-3#1)(2009-8#1)
were conducted on both##2##4##(2006-11#1)(2008-5#1)
were conducted on eight##2##4##(2007-4#1)(2008-10#1)
were conducted on the##7##4##(1994-6#1)(1995-6#1)(2006-11#1)(2008-10#1)(2008-3#1)(2010-10#1)(2012-12#1)
were conducted on##29##3##(1994-6#1)(1995-6#1)(1996-1#1)(2004-9#1)(2005-11#1)(2005-7#1)(2006-11#3)(2007-1#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-10#5)(2008-3#1)(2008-5#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)
were conducted to assess the impact of##2##7##(2008-10#2)
were conducted to assess the##4##5##(2005-11#1)(2007-11#1)(2008-10#2)
were conducted to assess##5##4##(2005-11#1)(2007-11#1)(2008-10#2)(2010-8#1)
were conducted to compare the##2##5##(1991-5#1)(2008-3#1)
were conducted to determine if##2##5##(1992-3#1)(1997-8#1)
were conducted to determine the effect of##2##7##(1995-7#1)(2011-2#1)
were conducted to determine the##9##5##(1992-7#1)(1993-12#1)(1995-7#1)(1996-8#1)(2008-10#2)(2010-11#1)(2011-2#1)(2012-11#1)
were conducted to determine whether##4##5##(1995-2#1)(1995-5#1)(1995-9#1)(2008-10#1)
were conducted to determine##19##4##(1991-5#1)(1992-3#1)(1992-7#1)(1993-12#1)(1995-2#1)(1995-5#1)(1995-7#1)(1995-9#1)(1996-8#1)(1997-8#1)(2008-10#4)(2010-11#1)(2011-2#2)(2012-11#1)(2013-7#1)
were conducted to elicit##2##4##(2011-1#1)(2013-1#1)
were conducted to establish the##3##5##(1995-2#1)(1996-2#1)(2008-10#1)
were conducted to evaluate the##5##5##(2006-11#1)(2007-1#1)(2008-10#2)(2008-5#1)
were conducted to evaluate##6##4##(2006-11#1)(2007-1#1)(2008-10#2)(2008-5#1)(2012-12#1)
were conducted to examine the##4##5##(1996-1#1)(2008-11#1)(2008-8#1)(2013-1#1)
were conducted to examine##6##4##(1993-4#1)(1996-1#1)(2008-11#1)(2008-8#1)(2013-1#2)
were conducted to identify the##2##5##(2008-10#2)
were conducted to identify##4##4##(2008-10#2)(2008-7#1)(2012-12#1)
were conducted to investigate the##5##5##(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2010-12#1)
were conducted to investigate##6##4##(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-12#1)
were conducted to measure the##3##5##(2004-9#1)(2005-11#1)(2008-12#1)
were conducted to measure##4##4##(2004-9#1)(2005-11#1)(2008-10#1)(2008-12#1)
were conducted to obtain##2##4##(2007-10#1)(2011-2#1)
were conducted to study the effect of##2##7##(1994-10#1)(2008-10#1)
were conducted to study the##6##5##(1994-10#1)(2008-10#4)(2008-12#1)
were conducted to test if##2##5##(2008-11#1)(2008-8#1)
were conducted to test the##3##5##(2007-8#1)(2008-10#1)(2008-5#1)
were conducted to test##5##4##(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
were conducted to##85##3##(1991-4#1)(1991-5#2)(1992-3#1)(1992-7#1)(1993-12#1)(1993-4#1)(1994-10#1)(1995-2#2)(1995-5#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-8#1)(1997-8#1)(2004-9#1)(2005-11#2)(2006-11#3)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-4#3)(2007-8#1)(2008-10#20)(2008-11#2)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-7#1)
were conducted under##2##3##(2007-3#1)(2007-8#1)
were conducted using a##7##4##(1994-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-1#2)(2013-1#1)
were conducted using the##4##4##(1995-3#1)(2007-1#1)(2008-5#1)(2012-3#1)
were conducted using three##2##4##(2005-11#1)(2007-4#1)
were conducted using two##2##4##(2006-8#1)(2008-11#1)
were conducted using##24##3##(1991-12#1)(1994-8#1)(1995-3#1)(1996-2#1)(2005-11#1)(2006-8#1)(2007-1#1)(2007-4#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-2#1)(2011-11#1)(2012-1#2)(2012-3#1)(2013-1#2)(2013-8#1)
were conducted with a##4##4##(1997-3#1)(2008-12#1)(2008-5#1)(2010-4#1)
were conducted with each##2##4##(2006-11#1)(2011-1#1)
were conducted with four##2##4##(1993-9#1)(2012-3#1)
were conducted with the##2##4##(2006-11#1)(2008-10#1)
were conducted with##62##3##(1991-8#1)(1993-9#1)(1995-1#1)(1996-1#1)(1997-3#2)(2004-8#1)(2006-11#2)(2006-12#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#2)(2008-10#7)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#3)(2009-5#4)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#4)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
were conducted##392##2##(1990-8#1)(1991-12#2)(1991-4#1)(1991-5#3)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-7#1)(1993-8#2)(1993-9#3)(1994-10#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#3)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#2)(1997-6#1)(1997-8#1)(2004-11#2)(2004-8#2)(2004-9#2)(2005-10#2)(2005-11#5)(2005-7#2)(2006-10#1)(2006-11#14)(2006-12#3)(2006-2#3)(2006-5#2)(2006-6#1)(2006-8#1)(2007-1#4)(2007-10#4)(2007-11#3)(2007-12#7)(2007-2#4)(2007-3#4)(2007-4#9)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#3)(2008-1#2)(2008-10#69)(2008-11#10)(2008-12#7)(2008-2#3)(2008-3#8)(2008-4#4)(2008-5#11)(2008-6#4)(2008-7#6)(2008-8#7)(2008-9#12)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#3)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#9)(2011-11#1)(2011-12#1)(2011-2#10)(2012-1#2)(2012-11#5)(2012-12#7)(2012-2#7)(2012-3#10)(2012-5#1)(2013-1#17)(2013-7#3)(2013-8#8)
were confined to the##7##4##(1992-8#1)(1994-3#1)(1997-1#1)(2008-10#1)(2008-5#1)(2008-7#2)
were confined to##12##3##(1992-8#1)(1994-3#1)(1995-1#1)(1996-5#1)(1997-1#1)(1997-7#1)(2005-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#2)
were confined##15##2##(1991-4#1)(1992-8#1)(1994-3#1)(1995-1#1)(1996-5#1)(1997-1#1)(1997-7#1)(2005-10#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#2)(2011-2#1)
were confirmed after##2##3##(1991-7#1)(2008-9#1)
were confirmed and##2##3##(2008-10#1)(2011-2#1)
were confirmed as E##2##4##(2006-10#2)
were confirmed as##6##3##(1992-11#1)(2006-10#2)(2006-6#1)(2010-8#1)(2011-2#1)
were confirmed at##2##3##(2008-10#1)(2011-2#1)
were confirmed by PCR##2##4##(1991-9#1)(2007-7#1)
were confirmed by Western blot##2##5##(1995-10#1)(2007-7#1)
were confirmed by a##2##4##(1997-4#1)(2010-12#1)
were confirmed by amino acid##2##5##(1992-3#1)(1995-8#1)
were confirmed by elemental##4##4##(2007-11#4)
were confirmed by the conventional##2##5##(2006-8#1)(2008-6#1)
were confirmed by the##7##4##(1996-8#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)
were confirmed by##82##3##(1990-11#1)(1990-2#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-8#2)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2005-6#1)(2006-12#5)(2006-8#1)(2007-11#6)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#3)
were confirmed for##2##3##(1997-2#1)(2009-6#1)
were confirmed in a##3##4##(1992-11#1)(2004-4#1)(2008-11#1)
were confirmed in the##5##4##(2006-10#1)(2007-12#1)(2008-10#1)(2010-1#1)(2011-2#1)
were confirmed in vitro##2##4##(1994-12#1)(1997-7#1)
were confirmed in##15##3##(1992-11#1)(1994-12#1)(1997-7#1)(2004-4#1)(2005-10#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2010-1#1)(2011-2#1)(2012-1#1)
were confirmed on##5##3##(1991-2#1)(2005-7#1)(2007-11#1)(2007-3#1)(2008-11#1)
were confirmed to be##7##4##(1991-6#1)(2005-11#1)(2006-9#1)(2008-10#2)(2009-4#1)(2013-1#1)
were confirmed to contain##2##4##(1996-12#1)(2008-5#1)
were confirmed to have##4##4##(1991-9#1)(2011-2#1)(2013-1#2)
were confirmed to##17##3##(1991-6#1)(1991-9#1)(1996-12#1)(2005-11#1)(2006-9#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#3)
were confirmed using##8##3##(1990-6#1)(1992-3#1)(1995-1#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-5#2)
were confirmed with##11##3##(1996-1#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-8#1)(2010-12#1)(2011-2#1)(2011-3#2)(2012-12#1)
were confirmed##171##2##(1990-11#1)(1990-2#1)(1990-6#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#2)(1992-3#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#1)(1995-1#2)(1995-10#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-4#1)(2005-10#1)(2005-11#1)(2005-6#1)(2005-7#2)(2006-10#3)(2006-12#6)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#9)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#16)(2008-11#7)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#3)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#8)(2011-3#3)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#2)(2013-1#6)
were congruent with##3##3##(2008-10#1)(2009-11#1)(2009-4#1)
were conjugated to##3##3##(1990-5#1)(1992-9#1)(1995-2#1)
were conjugated with##2##3##(1992-7#1)(2008-5#1)
were conjugated##9##2##(1990-5#1)(1992-7#1)(1992-9#1)(1995-2#1)(1996-4#1)(2008-5#1)(2012-11#2)(2012-12#1)
were connected by a##2##4##(1991-2#1)(2008-10#1)
were connected in series##2##4##(2008-10#1)(2011-1#1)
were connected to a##2##4##(2006-10#1)(2008-4#1)
were connected to##5##3##(1990-2#1)(2006-10#1)(2006-8#1)(2008-4#1)(2012-2#1)
were connected with the##2##4##(2007-11#2)
were connected with##5##3##(1990-2#1)(2007-11#2)(2008-12#1)(2011-2#1)
were connected##18##2##(1990-2#2)(1991-2#1)(1991-6#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-7#1)(2008-10#3)(2008-12#1)(2008-4#2)(2011-1#1)(2011-2#1)(2012-2#1)
were consanguineous##2##2##(1996-6#1)(2007-2#1)
were consecutively##6##2##(1996-9#1)(2006-7#1)(2008-10#1)(2011-1#1)(2013-1#2)
were conservative##2##2##(1992-5#1)(2013-1#1)
were conservatively treated##2##3##(1993-9#1)(2006-6#1)
were conserved among##2##3##(1994-12#1)(2008-10#1)
were conserved in##2##3##(1990-8#1)(1995-8#1)
were conserved##10##2##(1990-8#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-8#1)(1996-10#1)(2008-10#2)(2008-5#1)
were considerable##5##2##(1990-9#1)(1994-9#1)(1995-12#1)(1996-1#1)(2012-1#1)
were considerably different##2##3##(2008-3#1)(2008-7#1)
were considerably higher##2##3##(1991-2#1)(1992-8#1)
were considerably less##4##3##(1990-4#1)(1995-3#1)(2008-5#2)
were considerably lower##3##3##(1993-5#1)(1994-9#1)(2008-10#1)
were considerably##18##2##(1990-3#1)(1990-4#1)(1991-2#1)(1992-8#2)(1992-9#1)(1993-5#1)(1994-9#1)(1995-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2011-2#1)
were considered and analyzed##2##4##(2012-3#1)(2013-1#1)
were considered and##4##3##(2008-10#1)(2008-5#1)(2012-3#1)(2013-1#1)
were considered appropriate##3##3##(2005-12#1)(2010-12#2)
were considered as chemical descriptors to##2##6##(2008-10#2)
were considered as chemical descriptors##3##5##(2008-10#3)
were considered as indications##2##4##(1996-12#1)(2009-2#1)
were considered as the##4##4##(2008-1#1)(2008-12#1)(2008-5#1)(2012-1#1)
were considered as##36##3##(1991-2#1)(1991-4#1)(1992-10#1)(1992-9#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-7#2)(2006-10#2)(2006-12#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-12#2)(2008-5#5)(2008-8#1)(2009-2#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#2)(2013-8#1)
were considered at risk for##2##5##(1990-5#1)(2007-9#1)
were considered at##3##3##(1990-5#1)(1996-1#1)(2007-9#1)
were considered for analysis##2##4##(2006-8#1)(2011-2#1)
were considered for inclusion##2##4##(2012-12#1)(2013-8#1)
were considered for##11##3##(2006-11#1)(2006-8#1)(2008-10#2)(2008-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
were considered good##2##3##(2007-8#1)(2011-2#1)
were considered in the##3##4##(2007-4#1)(2008-10#1)(2012-2#1)
were considered in##6##3##(1994-3#1)(2007-4#2)(2008-10#1)(2009-12#1)(2012-2#1)
were considered normal##2##3##(2008-7#1)(2012-2#1)
were considered poor##3##3##(1991-3#1)(2007-8#1)(2012-12#1)
were considered positive##3##3##(2005-9#2)(2006-10#1)
were considered potential##2##3##(1992-11#1)(2007-10#1)
were considered significant##5##3##(1995-1#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-1#1)
were considered the most reliable##2##5##(1993-12#2)
were considered the##5##3##(1993-12#2)(1996-9#1)(2008-10#1)(2008-7#1)
were considered to be related to##2##6##(1996-10#1)(2008-9#1)
were considered to be##28##4##(1990-10#2)(1991-10#1)(1991-6#1)(1992-3#1)(1994-6#1)(1996-10#1)(1996-9#1)(2006-12#2)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-11#2)(2008-5#1)(2008-9#1)(2009-7#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)
were considered to have##4##4##(1993-5#1)(1996-12#1)(2008-2#1)(2008-3#1)
were considered to represent##2##4##(1991-9#1)(2008-11#1)
were considered to##39##3##(1990-10#2)(1991-10#1)(1991-6#1)(1991-9#1)(1992-3#1)(1993-5#1)(1994-6#1)(1996-10#1)(1996-12#1)(1996-9#1)(2005-11#1)(2006-12#2)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)
were considered together##2##3##(1993-11#1)(2011-10#1)
were considered##230##2##(1990-10#5)(1990-11#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-3#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-5#2)(1994-3#2)(1994-6#1)(1995-1#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#2)(1996-9#3)(1997-2#1)(1997-7#2)(1997-8#1)(2004-3#1)(2005-11#2)(2005-12#1)(2005-9#3)(2006-10#7)(2006-11#1)(2006-12#3)(2006-2#1)(2006-8#1)(2007-10#4)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#2)(2007-7#3)(2007-8#7)(2007-9#3)(2008-1#3)(2008-10#26)(2008-11#4)(2008-12#3)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#10)(2008-7#7)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-4#3)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#3)(2011-10#1)(2011-12#2)(2011-2#12)(2012-1#4)(2012-12#5)(2012-2#5)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#7)
were considering##2##2##(2007-4#1)(2012-2#1)
were consistent across##4##3##(1993-9#1)(2008-10#1)(2009-7#1)(2011-1#1)
were consistent and##3##3##(1991-5#1)(2011-1#1)(2013-1#1)
were consistent between AxB(I) and##2##5##(2008-10#2)
were consistent in##3##3##(2008-10#2)(2010-8#1)
were consistent with a diagnosis of##6##6##(1991-8#1)(1997-8#1)(2007-2#2)(2008-1#1)(2008-11#1)
were consistent with a model##2##5##(1995-2#1)(1997-7#1)
were consistent with a##15##4##(1991-12#1)(1991-8#1)(1993-11#1)(1995-11#1)(1995-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
were consistent with an##4##4##(2006-12#1)(2008-10#1)(2012-3#1)(2013-1#1)
were consistent with previously reported##2##5##(2008-10#1)(2008-4#1)
were consistent with previously##3##4##(2008-10#1)(2008-4#1)(2008-7#1)
were consistent with that##2##4##(2008-10#2)
were consistent with the diagnosis of##3##6##(2007-12#1)(2013-1#2)
were consistent with the hypothesis that##2##6##(1992-2#1)(2009-8#1)
were consistent with the hypothesis##3##5##(1992-2#1)(2008-10#1)(2009-8#1)
were consistent with the##33##4##(1990-5#2)(1990-6#1)(1991-2#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-8#1)(1995-5#1)(1995-6#1)(1997-2#1)(2005-4#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#1)(2012-12#2)(2013-1#3)
were consistent with their##2##4##(1992-6#1)(2012-1#1)
were consistent with theoretical##2##4##(2007-12#1)(2008-9#1)
were consistent with these##2##4##(2008-10#1)(2012-2#1)
were consistent with this diagnosis##2##5##(1992-11#1)(2010-11#1)
were consistent with this##4##4##(1992-11#1)(1997-3#1)(2008-4#1)(2010-11#1)
were consistent with those of##2##5##(1995-7#1)(2008-8#1)
were consistent with those##11##4##(1995-7#1)(1996-9#1)(1997-2#1)(1997-7#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)(2012-3#1)
were consistent with##120##3##(1990-5#2)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#3)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-9#2)(1993-11#1)(1994-11#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-11#1)(2005-4#1)(2006-10#2)(2006-12#1)(2006-5#2)(2006-9#1)(2007-11#1)(2007-12#4)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#17)(2008-11#3)(2008-2#3)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-8#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
were consistent##138##2##(1990-5#2)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#3)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-9#2)(1993-11#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-11#1)(2005-4#1)(2006-10#2)(2006-12#1)(2006-5#2)(2006-9#1)(2007-11#1)(2007-12#4)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#23)(2008-11#3)(2008-2#3)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-8#2)(2011-1#4)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#1)
were consistently associated with##3##4##(2008-10#2)(2012-12#1)
were consistently detectable##2##3##(1995-12#1)(2013-8#1)
were consistently detected in##2##4##(2008-10#1)(2008-9#1)
were consistently detected##3##3##(2008-10#1)(2008-9#1)(2009-4#1)
were consistently greater than##3##4##(1990-8#1)(2008-10#1)(2012-3#1)
were consistently greater##5##3##(1990-8#1)(2006-8#1)(2008-10#2)(2012-3#1)
were consistently higher than##3##4##(1993-7#1)(2008-10#1)(2008-9#1)
were consistently higher##5##3##(1993-7#2)(1995-2#1)(2008-10#1)(2008-9#1)
were consistently less##2##3##(2007-3#1)(2008-10#1)
were consistently lower than##2##4##(1990-6#1)(1994-8#1)
were consistently more##3##3##(2008-12#1)(2008-6#1)(2009-9#1)
were consistently observed in##3##4##(1995-5#1)(2008-10#2)
were consistently observed##4##3##(1995-5#1)(2008-10#2)(2013-1#1)
were consistently##54##2##(1990-4#1)(1990-6#1)(1990-8#1)(1992-8#1)(1993-7#2)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#2)(2006-8#1)(2007-3#1)(2008-10#18)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-4#1)(2009-9#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
were consolidated##3##2##(1995-6#1)(2005-7#1)(2010-9#1)
were constant during##2##3##(1991-12#1)(1992-11#1)
were constant##4##2##(1991-12#1)(1992-11#1)(2010-1#1)(2011-2#1)
were constantly##2##2##(1994-8#1)(2012-12#1)
were constituted##2##2##(1990-3#1)(2012-3#1)
were constitutively expressed in##2##4##(1997-7#1)(2008-6#1)
were constitutively##4##2##(1993-7#1)(1994-9#1)(1997-7#1)(2008-6#1)
were constructed according to the##2##5##(1994-8#1)(1995-6#1)
were constructed and analyzed##2##4##(1997-3#1)(2008-6#1)
were constructed and characterized##2##4##(1993-11#1)(2008-10#1)
were constructed and expressed in##5##5##(1992-11#1)(1995-1#1)(1995-3#1)(1996-11#1)(1997-4#1)
were constructed and expressed##7##4##(1992-11#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-11#1)(1997-4#1)(2008-10#1)
were constructed and the##2##4##(2008-10#1)(2011-1#1)
were constructed and##31##3##(1990-4#2)(1991-8#1)(1992-11#1)(1993-11#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-4#1)(1996-10#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2005-10#1)(2008-10#6)(2008-11#1)(2008-6#1)(2008-8#3)(2011-1#1)(2013-1#1)(2013-8#1)
were constructed based on##3##4##(1995-6#1)(1997-2#1)(2008-12#1)
were constructed by site-directed mutagenesis##5##5##(1993-9#1)(1994-2#1)(1995-10#1)(1995-2#1)(1995-5#1)
were constructed by substituting##2##4##(1992-3#1)(1997-4#1)
were constructed by the##2##4##(2008-6#1)(2012-12#1)
were constructed by##23##3##(1991-2#1)(1992-3#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-10#1)(1995-2#2)(1995-5#1)(1995-8#1)(1997-2#2)(1997-4#1)(2007-12#1)(2008-10#2)(2008-6#1)(2008-7#2)(2008-8#1)(2010-4#1)(2012-12#1)
were constructed for the##4##4##(2004-11#1)(2007-4#1)(2008-10#2)
were constructed for##12##3##(1993-6#1)(1995-4#1)(2004-11#1)(2006-2#1)(2007-4#1)(2008-10#4)(2008-5#1)(2011-2#1)(2012-12#1)
were constructed from data##3##4##(1993-12#3)
were constructed from##12##3##(1990-5#1)(1993-12#3)(1993-3#1)(2006-12#1)(2008-10#4)(2008-9#1)(2011-2#1)
were constructed in a##2##4##(1995-11#1)(2007-3#1)
were constructed in which the##2##5##(1993-3#1)(1993-5#1)
were constructed in which##3##4##(1993-3#1)(1993-5#1)(1997-4#1)
were constructed in##10##3##(1990-9#1)(1993-3#1)(1993-5#1)(1995-11#2)(1996-10#1)(1997-4#1)(2007-3#1)(2007-8#1)(2008-11#1)
were constructed of##2##3##(2008-10#1)(2011-2#1)
were constructed on the basis of##2##6##(1990-7#1)(1994-5#1)
were constructed on##3##3##(1990-7#1)(1994-5#1)(2008-10#1)
were constructed that##2##3##(1990-5#1)(1995-5#1)
were constructed to determine##3##4##(1994-8#1)(1995-3#1)(2008-9#1)
were constructed to##13##3##(1991-10#1)(1993-12#2)(1993-3#1)(1994-8#1)(1995-3#1)(2007-10#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-5#1)(2010-8#1)(2013-1#1)
were constructed using a##2##4##(1990-5#1)(2011-2#1)
were constructed using##12##3##(1990-11#1)(1990-5#1)(1992-12#1)(1993-9#1)(2007-12#1)(2008-10#3)(2008-9#1)(2010-4#1)(2011-2#1)(2013-8#1)
were constructed which##4##3##(1993-11#1)(1994-6#1)(1994-8#1)(2011-1#1)
were constructed with##5##3##(2007-3#1)(2007-7#1)(2008-10#2)(2008-9#1)
were constructed##178##2##(1990-11#1)(1990-4#2)(1990-5#5)(1990-7#1)(1990-8#1)(1990-9#2)(1991-10#2)(1991-2#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-11#2)(1993-12#7)(1993-3#3)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#5)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-2#3)(1995-3#2)(1995-4#2)(1995-5#2)(1995-6#2)(1995-8#2)(1996-10#2)(1996-11#1)(1996-2#1)(1996-9#1)(1997-2#4)(1997-3#1)(1997-4#4)(1997-5#1)(2004-11#1)(2004-3#1)(2005-10#1)(2005-11#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#31)(2008-11#4)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#11)(2008-9#5)(2009-2#1)(2009-7#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-12#2)(2013-1#2)(2013-8#2)
were consulted##6##2##(2006-10#1)(2007-3#2)(2009-8#1)(2010-7#1)(2011-2#1)
were consumed##7##2##(1991-11#1)(2005-12#1)(2007-12#1)(2008-10#1)(2010-6#1)(2013-1#1)(2013-7#1)
were consuming##3##2##(2006-4#2)(2013-1#1)
were contacted and##2##3##(1995-1#1)(1996-1#1)
were contacted by phone and##2##5##(2006-10#1)(2006-9#1)
were contacted by##4##3##(1997-3#1)(2006-10#1)(2006-9#1)(2012-12#1)
were contacted##9##2##(1995-1#1)(1996-1#1)(1997-3#1)(2006-10#2)(2006-9#1)(2011-2#2)(2012-12#1)
were contained in##2##3##(1990-2#1)(2008-10#1)
were contained within the##2##4##(1997-2#1)(2008-2#1)
were contained##4##2##(1990-2#1)(1997-2#1)(2008-10#1)(2008-2#1)
were contaminated with##9##3##(1996-12#1)(2007-2#1)(2008-10#2)(2008-12#2)(2010-12#1)(2012-12#1)(2013-8#1)
were contaminated##14##2##(1996-12#1)(2007-2#1)(2008-10#3)(2008-11#2)(2008-12#3)(2010-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
were content with the vocational rehabilitation offered##2##7##(2006-8#2)
were content##3##2##(2006-8#2)(2012-3#1)
were continued for##2##3##(1997-2#1)(2007-11#1)
were continued on##3##3##(2004-9#1)(2006-8#2)
were continued##6##2##(1997-2#1)(2004-9#1)(2006-5#1)(2006-8#2)(2007-11#1)
were continuous with##2##3##(1997-6#1)(2011-2#1)
were continuous##4##2##(1997-6#1)(2008-10#2)(2011-2#1)
were continuously recorded##2##3##(1994-2#1)(1994-8#1)
were continuously##7##2##(1994-2#1)(1994-8#1)(1996-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-8#1)
were contradictory##2##2##(2008-9#1)(2011-1#1)
were contraindicated##2##2##(2012-2#2)
were contrasted with##2##3##(1992-10#1)(2013-7#1)
were contrasted##3##2##(1992-10#1)(2007-9#1)(2013-7#1)
were contributed by the##2##4##(2008-10#2)
were contributed by##3##3##(2008-10#2)(2011-2#1)
were contributed##4##2##(2008-10#2)(2011-1#1)(2011-2#1)
were control##3##2##(1995-12#1)(2013-7#1)(2013-8#1)
were controlled by a##4##4##(1994-12#1)(2008-10#3)
were controlled by means of##2##5##(2005-11#1)(2008-10#1)
were controlled by##14##3##(1991-8#1)(1993-3#1)(1994-12#1)(2005-11#1)(2007-1#1)(2008-10#5)(2008-9#1)(2011-2#1)(2012-11#1)(2012-12#1)
were controlled for##3##3##(1996-7#1)(2007-4#1)(2009-5#1)
were controlled##30##2##(1991-8#1)(1993-10#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-8#1)(1996-7#1)(1997-5#1)(2004-11#1)(2005-11#1)(2006-12#1)(2007-1#1)(2007-4#1)(2008-10#7)(2008-3#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-4#1)(2011-2#3)(2012-11#1)(2012-12#1)
were conventionally##4##2##(1996-5#1)(2008-10#2)(2011-2#1)
were converted into a##4##4##(1992-2#1)(1997-3#1)(2007-11#1)(2008-5#1)
were converted into the corresponding##2##5##(1996-4#1)(2007-11#1)
were converted into the##5##4##(1991-9#1)(1996-4#1)(2007-11#1)(2008-10#2)
were converted into their##2##4##(1993-1#1)(2007-11#1)
were converted into##18##3##(1990-4#1)(1991-9#1)(1992-2#1)(1993-1#1)(1995-6#1)(1996-4#1)(1997-3#1)(2005-11#1)(2007-11#4)(2007-12#1)(2008-10#3)(2008-2#1)(2008-5#1)
were converted to laparotomy##2##4##(1995-3#1)(1996-1#1)
were converted to the corresponding##2##5##(1996-10#1)(1996-6#1)
were converted to the##3##4##(1996-10#1)(1996-6#2)
were converted to##33##3##(1990-12#3)(1990-4#1)(1990-8#1)(1991-7#1)(1992-2#1)(1993-11#2)(1993-3#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-6#2)(1997-5#1)(2004-8#1)(2005-12#1)(2006-10#1)(2006-6#1)(2008-10#4)(2008-2#2)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
were converted##56##2##(1990-12#3)(1990-4#2)(1990-8#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-2#2)(1993-1#1)(1993-11#2)(1993-3#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-4#1)(1996-6#2)(1997-3#1)(1997-5#1)(2004-1#1)(2004-8#1)(2004-9#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-6#1)(2007-11#4)(2007-12#1)(2008-10#8)(2008-2#3)(2008-5#3)(2008-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
were cooked##3##2##(2010-2#1)(2010-4#2)
were cookies##2##2##(2012-2#2)
were coordinated##2##2##(2008-10#1)(2011-2#1)
were coordinately regulated##2##3##(1991-9#1)(1994-3#1)
were copolymerized##2##2##(2010-4#2)
were coronary##2##2##(2008-11#1)(2008-3#1)
were corrected for the##2##4##(1990-4#1)(1991-5#1)
were corrected for##4##3##(1990-4#1)(1991-5#1)(1991-8#1)(2008-9#1)
were corrected using the##2##4##(2007-3#1)(2013-1#1)
were corrected with a##2##4##(2007-11#1)(2008-2#1)
were corrected with##3##3##(2007-11#2)(2008-2#1)
were corrected##15##2##(1990-4#1)(1991-5#1)(1991-8#1)(1997-6#1)(2006-12#1)(2007-11#2)(2007-3#1)(2007-7#1)(2008-2#2)(2008-9#1)(2013-1#1)(2013-8#2)
were correctly classified as##2##4##(1993-8#2)
were correctly classified##6##3##(1993-8#2)(1995-6#1)(1996-6#1)(2008-10#1)(2008-7#1)
were correctly diagnosed by##2##4##(1994-7#1)(2008-6#1)
were correctly diagnosed##4##3##(1991-12#1)(1994-7#1)(2006-5#1)(2008-6#1)
were correctly identified##3##3##(1996-11#1)(1997-6#1)(2011-1#1)
were correctly processed##2##3##(1993-3#1)(1993-6#1)
were correctly##24##2##(1991-12#1)(1993-3#1)(1993-6#2)(1993-8#2)(1994-7#1)(1994-9#1)(1995-11#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-6#1)(1997-6#1)(2004-10#1)(2006-5#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-1#2)(2012-11#1)(2012-12#1)
were correlated to the##3##4##(1996-12#1)(2008-10#1)(2011-1#1)
were correlated to##10##3##(1990-4#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2009-7#1)(2011-1#1)(2011-2#1)
were correlated well with the##2##5##(2007-11#1)(2011-12#1)
were correlated with a##2##4##(1997-7#1)(2008-2#1)
were correlated with host##2##4##(2008-10#1)(2013-7#1)
were correlated with known##2##4##(2006-12#1)(2008-10#1)
were correlated with low##2##4##(2007-5#1)(2008-10#1)
were correlated with percentage##2##4##(2007-5#1)(2012-1#1)
were correlated with the##22##4##(1992-3#1)(1992-6#1)(1993-9#1)(1997-8#1)(2006-4#1)(2007-8#1)(2007-9#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#1)(2009-9#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
were correlated with##83##3##(1990-12#1)(1990-7#1)(1991-2#1)(1991-8#1)(1992-3#2)(1992-6#1)(1993-9#1)(1994-9#1)(1995-11#1)(1995-3#2)(1996-5#3)(1997-1#1)(1997-7#2)(1997-8#3)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-12#1)(2007-5#3)(2007-8#3)(2007-9#2)(2008-10#12)(2008-11#1)(2008-2#4)(2008-3#1)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#2)
were correlated##112##2##(1990-12#2)(1990-4#1)(1990-7#1)(1991-2#1)(1991-8#1)(1992-3#2)(1992-6#1)(1993-9#1)(1994-9#1)(1995-11#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#3)(1996-7#1)(1997-1#1)(1997-6#1)(1997-7#2)(1997-8#3)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#3)(2007-8#4)(2007-9#2)(2008-10#17)(2008-11#2)(2008-2#5)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#2)(2012-1#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#2)
were correspondingly##3##2##(1996-12#1)(1997-2#1)(2008-8#1)
were corroborated by##4##3##(1990-7#1)(1993-7#1)(1997-3#1)(2008-8#1)
were corroborated##6##2##(1990-7#1)(1993-7#1)(1994-9#1)(1997-3#1)(2008-8#1)(2008-9#1)
were cost##2##2##(1991-1#1)(2007-7#1)
were countable##2##2##(2008-10#2)
were counted after##2##3##(2006-8#1)(2008-10#1)
were counted and##5##3##(2006-5#1)(2007-5#1)(2008-10#1)(2012-12#1)(2013-1#1)
were counted in##6##3##(1992-10#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-8#1)(2011-1#1)
were counted##25##2##(1992-10#1)(1992-12#1)(1993-12#1)(1994-11#1)(1996-12#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-5#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-1#1)(2012-12#2)(2013-1#1)
were counterfeit##2##2##(2007-1#1)(2010-4#1)
were coupled to##5##3##(1995-10#1)(2007-10#1)(2008-10#1)(2010-2#1)(2010-7#1)
were coupled with##6##3##(1996-10#1)(2008-1#1)(2008-10#2)(2009-11#1)(2010-3#1)
were coupled##14##2##(1992-7#1)(1995-10#1)(1996-10#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#3)(2009-11#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-2#1)
were covalently attached to##3##4##(1994-11#1)(1997-4#2)
were covalently immobilized##2##3##(2007-8#1)(2008-10#1)
were covalently##12##2##(1990-7#1)(1992-12#1)(1994-11#1)(1996-7#1)(1997-4#2)(2006-12#1)(2007-8#1)(2008-10#2)(2010-3#1)(2010-9#1)
were covered in##4##3##(1994-9#1)(2005-8#1)(2008-10#1)(2013-8#1)
were covered with a##4##4##(2007-8#1)(2008-10#3)
were covered with##8##3##(1992-10#1)(1997-2#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#1)
were covered##17##2##(1992-10#1)(1994-9#1)(1997-2#1)(2005-8#2)(2007-8#1)(2008-10#4)(2008-3#1)(2008-5#3)(2010-8#1)(2013-1#1)(2013-8#1)
were created and assessed##2##4##(2008-10#1)(2008-11#1)
were created and##3##3##(2008-10#1)(2008-11#1)(2009-3#1)
were created at##2##3##(1990-4#1)(2008-8#1)
were created by the##2##4##(2007-6#1)(2008-3#1)
were created by##6##3##(2007-5#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-2#1)
were created for##4##3##(2007-5#1)(2008-10#1)(2008-7#1)(2013-7#1)
were created in a##2##4##(2007-8#2)
were created in##7##3##(1995-10#1)(1995-12#1)(2007-8#2)(2008-7#1)(2010-6#1)(2012-12#1)
were created on the##2##4##(1996-7#1)(2010-4#1)
were created on##4##3##(1996-7#1)(2010-4#1)(2012-11#2)
were created to##2##3##(1997-3#1)(2010-8#1)
were created using a##3##4##(1992-1#1)(2009-11#1)(2010-10#1)
were created using##6##3##(1992-1#1)(2007-7#1)(2008-3#1)(2009-11#1)(2010-10#1)(2010-12#1)
were created with##4##3##(2006-12#1)(2007-8#1)(2013-1#1)(2013-8#1)
were created within##2##3##(1993-1#1)(2010-9#1)
were created##56##2##(1990-4#1)(1991-12#1)(1992-1#1)(1993-1#1)(1993-4#1)(1995-10#1)(1995-12#1)(1996-7#1)(1996-8#1)(1997-3#1)(2006-12#1)(2006-7#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#4)(2008-11#3)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
were critical##4##2##(1995-5#1)(1996-5#1)(2007-8#1)(2008-7#1)
were critically evaluated##2##3##(2008-10#1)(2013-1#1)
were critically reviewed##2##3##(2006-2#1)(2008-10#1)
were critically##5##2##(2006-2#1)(2008-10#2)(2013-1#1)(2013-8#1)
were cross-linked##4##2##(1992-12#1)(1993-8#1)(2008-5#1)(2008-6#1)
were cross-resistant to##4##3##(1997-7#1)(2008-5#3)
were cross-validated##2##2##(2010-12#2)
were crossed and##2##3##(2006-9#1)(2008-10#1)
were crossed with the susceptible##2##5##(2008-10#1)(2012-11#1)
were crossed with the##3##4##(2008-10#2)(2012-11#1)
were crossed with##8##3##(2008-10#6)(2012-11#1)(2012-12#1)
were crossed##13##2##(1995-2#1)(2006-9#1)(2008-10#8)(2012-11#1)(2012-12#1)(2012-3#1)
were crosslinked##3##2##(1990-7#1)(1993-8#1)(2013-1#1)
were crucial to##2##3##(2008-7#1)(2009-12#1)
were crucial##5##2##(2007-7#1)(2007-8#1)(2008-7#1)(2009-12#1)(2011-12#1)
were crustaceans##2##2##(2007-3#2)
were cryopreserved##2##2##(2008-9#2)
were cultivated in the presence of##2##6##(1997-4#1)(2008-5#1)
were cultivated in the##4##4##(1997-4#1)(2007-1#1)(2008-11#1)(2008-5#1)
were cultivated in##10##3##(1997-4#1)(2007-1#1)(2008-11#6)(2008-5#1)(2012-11#1)
were cultivated with##2##3##(2008-10#1)(2008-5#1)
were cultivated##18##2##(1990-12#1)(1997-4#1)(2004-4#1)(2007-1#2)(2007-6#1)(2008-10#2)(2008-11#6)(2008-5#2)(2011-3#1)(2012-11#1)
were culture positive##4##3##(2006-2#1)(2007-7#2)(2012-3#1)
were cultured and used##3##4##(1991-2#1)(1994-9#1)(2008-9#1)
were cultured and##6##3##(1991-2#1)(1994-9#1)(1995-3#1)(1996-12#1)(2008-9#1)(2013-1#1)
were cultured at##3##3##(1990-12#1)(1991-12#1)(1994-12#1)
were cultured for 24 h##2##5##(1995-3#1)(2006-5#1)
were cultured for 24##3##4##(1995-3#1)(2006-5#1)(2006-9#1)
were cultured for##13##3##(1995-11#1)(1995-3#1)(1995-8#1)(1996-5#1)(1996-6#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-7#1)(2008-11#1)(2008-5#1)(2012-2#1)(2013-1#1)
were cultured in a medium containing##3##6##(1994-8#1)(2008-10#1)(2008-9#1)
were cultured in a medium##4##5##(1994-8#1)(2008-10#2)(2008-9#1)
were cultured in a##8##4##(1992-3#1)(1994-8#1)(2008-10#3)(2008-4#1)(2008-9#1)(2011-2#1)
were cultured in an##2##4##(2007-7#1)(2008-11#1)
were cultured in medium with##2##5##(2006-5#1)(2008-5#1)
were cultured in medium##4##4##(2006-5#1)(2008-11#1)(2008-5#1)(2011-12#1)
were cultured in the medium containing##2##6##(1996-11#1)(2008-11#1)
were cultured in the presence of##9##6##(1990-10#2)(1990-11#1)(1993-3#1)(1995-6#1)(1997-2#1)(2008-11#3)
were cultured in the presence##10##5##(1990-10#2)(1990-11#1)(1993-3#1)(1994-5#1)(1995-6#1)(1997-2#1)(2008-11#3)
were cultured in the##14##4##(1990-10#2)(1990-11#1)(1993-3#1)(1994-5#1)(1995-6#1)(1996-11#1)(1997-2#1)(2006-5#1)(2008-11#5)
were cultured in##54##3##(1990-10#2)(1990-11#1)(1991-5#1)(1992-12#2)(1992-3#1)(1993-12#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-2#1)(2004-11#1)(2006-5#4)(2006-6#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-11#11)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-9#1)(2010-7#1)(2011-12#1)(2011-2#3)(2012-4#1)(2013-1#1)
were cultured on a##2##4##(2008-5#1)(2011-2#1)
were cultured on these##3##4##(2006-5#1)(2008-5#2)
were cultured on##15##3##(2006-5#1)(2007-8#2)(2008-11#3)(2008-5#4)(2008-6#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-11#1)
were cultured under##5##3##(2008-11#3)(2008-5#1)(2012-2#1)
were cultured with the##3##4##(1995-6#1)(1997-2#1)(2011-3#1)
were cultured with##10##3##(1991-8#1)(1992-8#1)(1993-3#1)(1995-12#1)(1995-6#1)(1997-2#2)(2010-10#1)(2010-12#1)(2011-3#1)
were cultured##117##2##(1990-10#2)(1990-11#1)(1990-12#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#1)(2004-11#1)(2006-4#1)(2006-5#6)(2006-6#2)(2006-9#1)(2007-11#1)(2007-7#3)(2007-8#2)(2008-10#5)(2008-11#19)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#11)(2008-6#1)(2008-9#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#4)(2011-3#1)(2012-11#1)(2012-2#2)(2012-4#1)(2013-1#4)
were cured##13##2##(1990-3#1)(1995-11#1)(1997-1#1)(2004-10#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-5#2)(2008-7#1)(2011-12#1)(2013-1#1)
were current smokers##2##3##(2006-7#1)(2007-11#1)
were current##5##2##(1997-6#1)(2006-7#1)(2007-11#1)(2007-12#1)(2012-2#1)
were currently##5##2##(1995-12#1)(2007-12#1)(2009-7#1)(2011-2#1)(2012-3#1)
were cut and##3##3##(2007-8#1)(2008-4#1)(2012-3#1)
were cut from the##2##4##(2007-3#1)(2009-7#1)
were cut from##3##3##(2007-3#1)(2009-7#1)(2011-2#1)
were cut into##2##3##(2007-8#1)(2008-7#1)
were cut off##2##3##(2008-5#2)
were cut##17##2##(1995-3#1)(1995-6#1)(1997-2#1)(2007-3#1)(2007-8#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-7#2)(2010-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
were cytologically diagnosed as benign##2##5##(2007-6#2)
were cytotoxic for##3##3##(1990-5#1)(1994-2#1)(1995-3#1)
were cytotoxic to##3##3##(1993-9#1)(1994-9#1)(2012-3#1)
were cytotoxic##7##2##(1990-5#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-3#1)(2008-10#1)(2012-3#1)
were daily##5##2##(1990-2#1)(1993-2#1)(1996-10#1)(2012-12#2)
were damaged by##2##3##(1992-12#1)(2008-5#1)
were damaged##4##2##(1992-12#1)(2008-10#1)(2008-5#1)(2013-8#1)
were dated##2##2##(2008-10#1)(2011-1#1)
were dead##2##2##(2007-10#1)(2012-3#1)
were dealt with##2##3##(1995-5#1)(2012-2#1)
were decalcified##2##2##(1991-1#1)(2005-12#1)
were decapitated##5##2##(1995-6#1)(1996-10#1)(2008-7#1)(2009-2#1)(2013-8#1)
were decoded##2##2##(2007-8#1)(2009-5#1)
were decorated with##2##3##(2005-11#1)(2010-7#1)
were decorated##3##2##(1990-4#1)(2005-11#1)(2010-7#1)
were decreased after the##2##4##(1995-1#1)(1997-1#1)
were decreased after##4##3##(1995-1#1)(1997-1#1)(2010-2#1)(2012-3#1)
were decreased at the##2##4##(2006-7#1)(2008-10#1)
were decreased at##5##3##(1994-11#1)(2006-7#1)(2008-10#1)(2008-9#1)(2011-12#1)
were decreased by##16##3##(1990-4#1)(1991-8#1)(1992-5#1)(1993-1#1)(1993-6#1)(1994-5#1)(1995-5#1)(1996-8#1)(2006-10#1)(2008-10#1)(2008-5#2)(2008-7#2)(2010-2#1)(2012-3#1)
were decreased in the##6##4##(1993-2#1)(1995-11#1)(1996-5#1)(1996-9#1)(2006-6#1)(2011-2#1)
were decreased in these##2##4##(2004-11#1)(2008-10#1)
were decreased in##19##3##(1992-3#1)(1993-2#1)(1994-6#1)(1995-1#1)(1995-11#1)(1996-3#1)(1996-5#1)(1996-9#1)(2004-11#1)(2006-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#3)(2009-6#1)(2010-2#1)(2011-2#1)
were decreased significantly (P &lt##2##5##(1997-7#1)(2008-10#1)
were decreased significantly##4##3##(1997-7#1)(2008-10#2)(2008-12#1)
were decreased to##3##3##(1992-1#1)(1994-11#1)(1997-1#1)
were decreased##87##2##(1990-4#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-7#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#6)(2008-9#6)(2009-12#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#3)(2011-12#3)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#1)
were decreases in the##2##4##(1991-12#1)(2012-12#1)
were decreases in##3##3##(1991-12#1)(1992-1#1)(2012-12#1)
were decreases##4##2##(1991-12#1)(1992-1#1)(2010-7#1)(2012-12#1)
were decreasing##4##2##(2007-11#1)(2008-3#1)(2008-4#1)(2009-4#1)
were deduced by comparing##2##4##(1990-12#1)(1990-7#1)
were deduced from the##3##4##(1991-2#1)(1993-11#1)(2008-5#1)
were deduced from##6##3##(1991-2#1)(1992-7#1)(1993-11#1)(1994-3#1)(2008-3#1)(2008-5#1)
were deduced##12##2##(1990-12#1)(1990-7#1)(1991-2#1)(1991-5#1)(1992-7#1)(1993-11#1)(1994-3#1)(2005-11#1)(2007-1#1)(2008-3#2)(2008-5#1)
were deemed to be##3##4##(1993-3#1)(2007-8#1)(2008-9#1)
were deemed##14##2##(1990-8#1)(1993-3#1)(1995-12#1)(1997-2#1)(2006-11#1)(2007-6#1)(2007-8#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
were defective for##2##3##(1992-2#1)(1994-3#1)
were defective in##5##3##(1995-3#1)(1996-8#1)(2008-10#1)(2009-2#1)(2009-6#1)
were defective##7##2##(1992-2#1)(1994-3#1)(1995-3#1)(1996-8#1)(2008-10#1)(2009-2#1)(2009-6#1)
were deficient in##7##3##(1990-5#1)(1991-11#1)(2006-7#1)(2008-1#1)(2008-10#2)(2010-5#1)
were deficient##9##2##(1990-5#1)(1991-11#1)(2006-7#1)(2008-1#1)(2008-10#2)(2010-5#1)(2012-1#1)(2013-8#1)
were defined according to the##2##5##(2007-12#1)(2013-1#1)
were defined as patients who##2##5##(1997-1#1)(2007-10#1)
were defined as those##2##4##(1990-10#1)(2008-8#1)
were defined as##23##3##(1990-10#1)(1992-7#1)(1993-5#1)(1994-11#1)(1994-7#1)(1995-11#1)(1997-1#1)(2004-11#3)(2005-10#1)(2007-10#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-8#2)(2011-2#2)(2012-12#1)(2012-4#1)(2013-1#1)
were defined by the##2##4##(1995-6#1)(2011-2#1)
were defined by##10##3##(1992-6#1)(1995-6#1)(2007-1#1)(2008-10#3)(2009-3#1)(2010-1#1)(2011-2#1)(2012-1#1)
were defined for the##2##4##(2006-11#1)(2007-3#1)
were defined in##6##3##(1991-3#1)(1995-11#1)(2008-10#1)(2008-9#1)(2011-1#1)(2013-1#1)
were defined that##2##3##(1993-11#1)(2008-6#1)
were defined to##2##3##(1990-11#1)(1997-8#1)
were defined##70##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-3#1)(1992-3#2)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-11#1)(1994-7#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-6#1)(1997-1#1)(1997-8#1)(2004-11#3)(2005-10#1)(2005-11#1)(2005-7#1)(2006-11#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#7)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-10#2)(2009-3#1)(2010-1#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-4#1)(2013-1#5)
were definitely##3##2##(1993-4#1)(2004-2#1)(2007-2#1)
were degenerated##2##2##(1996-9#1)(2012-1#1)
were degraded in##2##3##(1992-12#1)(1994-9#1)
were degraded##10##2##(1990-10#1)(1992-12#3)(1994-9#1)(1995-10#1)(2004-11#1)(2007-11#1)(2008-11#1)(2008-8#1)
were delayed in##2##3##(1997-6#1)(2008-10#1)
were delayed##7##2##(1991-6#1)(1997-5#1)(1997-6#1)(2006-2#1)(2008-10#1)(2009-8#1)(2011-2#1)
were deleted from##2##3##(1995-2#1)(2013-8#1)
were deleted##11##2##(1990-11#1)(1992-12#1)(1995-2#2)(1996-10#1)(1996-5#1)(1996-8#1)(1997-5#1)(1997-6#2)(2013-8#1)
were delineated##4##2##(1993-11#1)(1997-4#1)(2008-10#1)(2009-11#1)
were delivered after##2##3##(2008-7#1)(2013-1#1)
were delivered at##3##3##(1991-6#1)(2008-10#2)
were delivered by vacuum##2##4##(1991-6#1)(1996-8#1)
were delivered by##5##3##(1991-6#1)(1996-8#1)(2004-10#1)(2004-12#1)(2011-3#1)
were delivered in##3##3##(1992-7#1)(2008-3#1)(2011-2#1)
were delivered into the##3##4##(2007-8#1)(2008-10#1)(2012-2#1)
were delivered into##4##3##(2007-8#1)(2008-10#2)(2012-2#1)
were delivered to##3##3##(2008-4#1)(2009-5#2)
were delivered via##2##3##(1996-6#1)(2011-1#1)
were delivered##35##2##(1991-6#2)(1992-1#1)(1992-7#2)(1992-8#2)(1994-7#1)(1996-1#1)(1996-6#1)(1996-8#1)(1996-9#1)(2004-10#1)(2004-12#1)(2005-7#1)(2006-6#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#2)(2009-5#2)(2009-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
were demarcated##2##2##(2004-11#1)(2008-10#1)
were demonstrable##4##2##(1990-12#1)(1992-9#1)(1997-2#1)(2006-10#1)
were demonstrated and##5##3##(1990-3#1)(1994-8#1)(2006-8#2)(2008-10#1)
were demonstrated as compared##2##4##(1991-9#1)(2006-5#1)
were demonstrated as##3##3##(1991-9#1)(2006-5#1)(2008-7#1)
were demonstrated between the##4##4##(1994-5#1)(2006-10#1)(2011-3#2)
were demonstrated by##10##3##(1991-9#1)(1993-12#1)(1995-5#1)(2007-12#1)(2008-10#2)(2008-6#1)(2008-8#1)(2008-9#1)(2013-1#1)
were demonstrated for##4##3##(2006-8#1)(2008-10#1)(2009-8#1)(2010-2#1)
were demonstrated in the##6##4##(1991-10#1)(1996-3#1)(1997-3#1)(1997-8#1)(2007-8#1)(2010-12#1)
were demonstrated in##21##3##(1990-12#1)(1990-6#1)(1991-10#1)(1991-3#1)(1993-8#1)(1995-5#1)(1996-3#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-8#1)(2006-12#1)(2007-8#2)(2008-10#2)(2008-5#2)(2010-12#1)(2012-1#1)(2013-8#1)
were demonstrated on##2##3##(2005-7#1)(2012-1#1)
were demonstrated to be##11##4##(1991-10#1)(1993-11#1)(1995-10#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-6#1)(2012-12#1)(2013-1#1)
were demonstrated to have##2##4##(2008-2#1)(2011-1#1)
were demonstrated to##16##3##(1991-10#2)(1993-11#1)(1994-3#1)(1995-10#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-6#1)(2011-1#1)(2012-12#2)(2013-1#1)
were demonstrated using##2##3##(1991-5#1)(1992-3#1)
were demonstrated when##2##3##(1997-3#1)(2008-6#1)
were demonstrated with##4##3##(2006-2#1)(2008-3#2)(2008-7#1)
were demonstrated##116##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-10#3)(1991-3#1)(1991-5#1)(1991-9#2)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-8#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-5#2)(1996-3#2)(1997-3#3)(1997-6#2)(1997-7#2)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-8#6)(2007-10#1)(2007-11#2)(2007-12#3)(2007-8#2)(2008-1#1)(2008-10#12)(2008-11#2)(2008-2#1)(2008-3#9)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#1)(2011-1#2)(2011-3#2)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#2)
were denatured##2##2##(1992-8#1)(1994-9#1)
were densely##7##2##(1994-10#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-7#1)(2009-7#1)
were dependent on the chemical##2##5##(2006-8#1)(2008-6#1)
were dependent on the##19##4##(1990-2#1)(1990-4#1)(1990-7#1)(1991-7#1)(1992-11#1)(1992-5#1)(1994-11#1)(1994-3#1)(1995-10#1)(1995-2#1)(1995-8#2)(2004-11#1)(2005-11#1)(2006-8#2)(2008-10#1)(2008-5#1)(2008-6#1)
were dependent on##30##3##(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-4#1)(1991-7#1)(1992-11#1)(1992-5#1)(1992-6#1)(1993-4#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-8#2)(2004-11#1)(2005-11#1)(2006-8#2)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-1#1)(2013-1#1)
were dependent upon the##2##4##(1994-3#1)(2008-10#1)
were dependent upon##4##3##(1992-5#1)(1993-12#1)(1994-3#1)(2008-10#1)
were dependent##35##2##(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-4#1)(1991-7#1)(1992-11#1)(1992-5#2)(1992-6#1)(1993-12#1)(1993-4#1)(1994-11#1)(1994-3#2)(1994-5#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-8#2)(2004-11#1)(2005-11#1)(2006-8#2)(2007-10#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-1#1)(2013-1#1)
were depicted##3##2##(2004-12#1)(2007-12#1)(2011-2#1)
were depleted of##5##3##(1992-7#1)(1994-12#1)(1996-8#1)(1996-9#1)(2008-12#1)
were depleted##7##2##(1992-7#1)(1993-11#1)(1994-12#1)(1996-8#1)(1996-9#1)(2008-12#1)(2008-5#1)
were deployed for##2##3##(2004-4#1)(2008-10#1)
were deployed##7##2##(2004-4#1)(2007-4#1)(2007-5#1)(2008-10#3)(2011-2#1)
were deposited by electron beam evaporation##2##6##(2008-10#2)
were deposited by##6##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-1#1)
were deposited in##2##3##(1990-3#1)(1992-12#1)
were deposited on##5##3##(2005-11#1)(2008-10#1)(2008-2#2)(2008-3#1)
were deposited onto##2##3##(2008-3#1)(2009-12#1)
were deposited##25##2##(1990-3#1)(1991-4#1)(1992-12#1)(1995-3#1)(1997-1#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#6)(2008-2#3)(2008-3#3)(2009-12#1)(2010-4#1)(2012-1#1)(2012-11#1)
were depressed by##5##3##(1992-1#1)(1992-8#1)(1993-3#1)(1995-12#2)
were depressed##14##2##(1990-3#1)(1991-10#1)(1991-5#1)(1992-1#1)(1992-8#1)(1993-3#1)(1995-12#3)(1996-3#1)(1997-3#1)(2007-10#1)(2008-12#1)(2012-2#1)
were depression##2##2##(2007-10#1)(2009-5#1)
were deprived of##2##3##(1996-4#1)(2010-4#1)
were deprotected##3##2##(1991-9#1)(2007-11#1)(2008-11#1)
were derivatized using##2##3##(1992-8#1)(2011-1#1)
were derivatized with a##2##4##(1990-6#1)(1997-8#1)
were derivatized with##10##3##(1990-6#2)(1990-8#3)(1995-2#1)(1996-1#1)(1996-5#1)(1997-8#1)(2005-12#1)
were derivatized##19##2##(1990-6#2)(1990-7#1)(1990-8#4)(1992-8#2)(1995-2#1)(1996-1#1)(1996-5#2)(1997-8#2)(2005-12#1)(2007-8#1)(2011-1#1)(2012-1#1)
were derived and##2##3##(2004-8#1)(2008-3#1)
were derived by##5##3##(1990-11#1)(2007-10#1)(2007-12#1)(2013-1#1)(2013-8#1)
were derived for##2##3##(2008-10#1)(2012-2#1)
were derived from a##9##4##(1997-1#1)(1997-3#1)(2005-11#1)(2008-10#3)(2013-1#2)(2013-8#1)
were derived from bacterial##2##4##(2006-12#1)(2008-10#1)
were derived from the##15##4##(1991-6#1)(1994-12#1)(1995-10#1)(1997-8#1)(2005-10#2)(2007-10#2)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-11#1)(2012-2#1)
were derived from##63##3##(1991-6#1)(1991-7#1)(1992-3#1)(1992-8#1)(1993-9#2)(1994-12#1)(1994-3#1)(1994-5#1)(1995-10#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-8#1)(2005-10#2)(2005-11#1)(2005-9#1)(2006-11#1)(2006-12#2)(2007-10#2)(2007-12#1)(2007-4#1)(2008-10#12)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-9#1)(2009-2#1)(2009-3#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
were derived to##2##3##(2008-10#2)
were derived using##5##3##(2006-10#1)(2008-10#2)(2012-2#2)
were derived with the##2##4##(2007-9#1)(2008-10#1)
were derived##98##2##(1990-11#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-5#1)(1993-9#2)(1994-12#1)(1994-3#1)(1994-5#1)(1995-10#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-8#1)(2004-8#1)(2005-10#2)(2005-11#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#3)(2007-10#3)(2007-12#2)(2007-4#1)(2007-9#2)(2008-10#19)(2008-11#2)(2008-2#5)(2008-3#4)(2008-4#3)(2008-5#4)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-11#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2013-1#3)(2013-8#3)
were dermally administered 0##7##4##(2008-9#7)
were dermally administered##9##3##(2008-9#9)
were described and##3##3##(1996-3#1)(2008-10#1)(2012-2#1)
were described as##5##3##(2008-10#2)(2011-1#1)(2013-1#1)(2013-8#1)
were described at##2##3##(2007-8#1)(2011-1#1)
were described by##4##3##(1996-10#1)(1997-3#1)(2007-8#1)(2008-10#1)
were described for##4##3##(2005-8#1)(2008-1#1)(2010-1#1)(2012-12#1)
were described in terms of##2##5##(2005-11#1)(2012-4#1)
were described in the##2##4##(1991-4#1)(2012-2#1)
were described in##14##3##(1991-4#1)(1991-6#1)(1997-3#1)(2005-11#1)(2005-4#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#2)(2012-3#1)(2012-4#1)
were described recently##2##3##(1992-6#1)(2008-7#1)
were described using##5##3##(2007-4#1)(2007-8#2)(2008-10#1)(2013-1#1)
were described##94##2##(1990-7#1)(1991-4#1)(1991-6#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-12#2)(1993-5#1)(1995-12#1)(1996-10#1)(1996-3#1)(1997-3#2)(1997-8#2)(2005-11#1)(2005-4#1)(2005-7#3)(2005-8#2)(2006-11#1)(2006-7#1)(2007-11#2)(2007-3#2)(2007-4#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#19)(2008-12#1)(2008-5#2)(2008-7#4)(2009-1#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2012-4#1)(2013-1#3)(2013-8#2)
were designated as &quot##2##4##(2008-1#2)
were designated as race 0##2##5##(2008-10#2)
were designated as race 2##3##5##(2008-10#3)
were designated as race##6##4##(2008-10#6)
were designated as##13##3##(1996-2#1)(1997-8#1)(2006-12#1)(2008-1#2)(2008-10#6)(2008-8#1)(2008-9#1)
were designated race##2##3##(2008-10#2)
were designated##24##2##(1995-2#1)(1996-2#1)(1996-6#1)(1997-8#1)(2006-12#1)(2007-8#1)(2008-1#2)(2008-10#12)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
were designed and fabricated##2##4##(2008-3#2)
were designed and prepared##2##4##(2007-11#1)(2012-1#1)
were designed and synthesized as##3##5##(1994-9#1)(2008-11#1)(2010-5#1)
were designed and synthesized##13##4##(1992-9#1)(1994-9#1)(1995-1#1)(2007-11#1)(2008-10#2)(2008-11#1)(2010-5#1)(2011-3#3)(2012-12#1)(2012-3#1)
were designed and##26##3##(1990-7#1)(1992-9#1)(1994-9#1)(1995-1#1)(2007-11#2)(2008-10#7)(2008-11#1)(2008-3#2)(2008-8#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-3#3)(2012-1#1)(2012-12#1)(2012-3#1)
were designed based on the##3##5##(2008-10#2)(2011-2#1)
were designed based on##5##4##(2008-10#2)(2011-2#1)(2012-11#1)(2012-12#1)
were designed for the##5##4##(1990-12#1)(2008-10#3)(2008-3#1)
were designed for##14##3##(1990-12#1)(1991-9#1)(2007-10#1)(2008-10#6)(2008-3#2)(2008-5#2)(2009-9#1)
were designed from conserved regions of##2##6##(2008-10#2)
were designed from##6##3##(1993-6#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)
were designed on##2##3##(2008-8#1)(2010-4#1)
were designed specifically for##3##4##(2007-12#1)(2008-10#2)
were designed such that##2##4##(1993-3#1)(2008-10#1)
were designed to amplify##3##4##(2008-10#3)
were designed to change the##2##5##(1993-11#1)(2008-10#1)
were designed to determine whether##2##5##(1990-11#1)(1996-6#1)
were designed to distinguish##2##4##(1997-4#1)(2008-12#1)
were designed to evaluate the##3##5##(2008-10#1)(2008-5#1)(2012-12#1)
were designed to explore the##2##5##(1991-9#1)(2009-11#1)
were designed to form##2##4##(1993-11#2)
were designed to further##3##4##(1993-3#1)(1993-5#1)(2013-7#1)
were designed to have##2##4##(2007-7#1)(2008-11#1)
were designed to identify##3##4##(1994-8#1)(1995-5#1)(2012-12#1)
were designed to maximize##3##4##(2007-4#1)(2008-3#1)(2008-4#1)
were designed to perform##2##4##(2008-10#2)
were designed to provide##2##4##(1994-1#1)(2008-3#1)
were designed to test##3##4##(2007-12#1)(2008-10#1)(2008-7#1)
were designed to##73##3##(1990-11#1)(1990-2#1)(1990-7#1)(1991-3#1)(1991-9#1)(1992-6#1)(1993-11#3)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-10#1)(1996-6#1)(1997-4#2)(2005-11#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#9)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-4#1)(2010-6#1)(2010-9#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
were designed using##4##3##(2008-10#3)(2013-1#1)
were designed with a##5##4##(2008-2#1)(2008-3#1)(2009-9#1)(2010-2#1)(2010-3#1)
were designed##170##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#2)(1991-3#1)(1991-9#2)(1992-1#1)(1992-6#1)(1992-9#1)(1993-11#3)(1993-12#2)(1993-3#2)(1993-5#1)(1993-6#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-10#1)(1996-6#1)(1997-2#1)(1997-4#2)(2005-11#2)(2006-12#1)(2006-3#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#39)(2008-11#7)(2008-12#2)(2008-2#6)(2008-3#15)(2008-4#2)(2008-5#5)(2008-7#2)(2008-8#4)(2009-11#1)(2009-2#1)(2009-8#1)(2009-9#2)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#1)(2011-3#3)(2012-1#2)(2012-11#1)(2012-12#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#4)
were desorbed into##2##3##(2008-10#1)(2011-2#1)
were desorbed##4##2##(1990-6#1)(2008-10#2)(2011-2#1)
were destroyed by##2##3##(1990-2#1)(2009-3#1)
were destroyed##3##2##(1990-2#1)(2009-3#1)(2009-4#1)
were destructively##2##2##(2004-4#1)(2008-10#1)
were detailed##3##2##(2007-8#1)(2008-10#1)(2011-2#1)
were detectable during the##2##4##(1995-8#1)(1996-12#1)
were detectable in##9##3##(1991-3#1)(1992-8#2)(1993-4#1)(1993-5#1)(1996-4#1)(2006-8#1)(2008-11#1)(2013-8#1)
were detectable on##2##3##(2008-10#1)(2008-4#1)
were detectable only##2##3##(1997-2#1)(2008-5#1)
were detectable##29##2##(1991-3#1)(1991-7#1)(1992-8#3)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-8#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-8#1)(2006-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-2#1)(2013-8#1)
were detected after##6##3##(1990-7#1)(1991-8#1)(1992-8#1)(2008-10#2)(2010-2#1)
were detected among isolates##2##4##(2008-10#2)
were detected among the##3##4##(2008-10#2)(2008-5#1)
were detected among##12##3##(2005-10#1)(2008-10#9)(2008-5#1)(2011-12#1)
were detected and identified##2##4##(1994-6#1)(2008-6#1)
were detected and quantified##2##4##(1997-3#1)(2008-10#1)
were detected and the##3##4##(1990-12#1)(2008-10#1)(2008-5#1)
were detected and##16##3##(1990-11#1)(1990-12#1)(1991-4#2)(1994-6#1)(1995-6#1)(1997-3#1)(2006-12#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-6#1)(2011-12#1)
were detected as early as##4##5##(1990-12#1)(2008-10#2)(2009-7#1)
were detected as##17##3##(1990-12#1)(1991-12#1)(1993-7#1)(2006-12#1)(2007-12#1)(2007-3#1)(2008-10#6)(2008-5#1)(2008-9#2)(2009-7#1)(2010-12#1)
were detected at the##3##4##(2007-10#1)(2007-3#1)(2008-10#1)
were detected at##22##3##(1990-9#1)(1991-8#1)(1992-2#1)(1993-6#1)(1994-8#1)(1995-11#1)(1996-9#1)(1997-2#1)(2007-10#1)(2007-3#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#2)(2010-8#1)(2012-12#1)
were detected between the##3##4##(2012-2#1)(2013-1#2)
were detected between##18##3##(1992-9#1)(1993-9#1)(1996-11#1)(2005-10#1)(2006-5#1)(2006-9#1)(2007-11#1)(2008-10#3)(2009-4#1)(2009-5#2)(2009-9#1)(2012-2#1)(2013-1#2)(2013-7#1)
were detected but##2##3##(2008-5#1)(2008-8#1)
were detected by Northern##2##4##(1993-9#1)(1995-8#1)
were detected by PCR##2##4##(1992-5#1)(1993-4#1)
were detected by Southern##2##4##(1992-4#1)(1997-2#1)
were detected by Western##2##4##(2012-2#1)(2012-3#1)
were detected by a combination of##2##6##(2006-4#1)(2008-10#1)
were detected by a##4##4##(1994-12#1)(1994-2#1)(2006-4#1)(2008-10#1)
were detected by both##3##4##(2005-12#1)(2007-7#1)(2008-10#1)
were detected by computed tomography (CT)##2##6##(2005-5#1)(2007-8#1)
were detected by physical examination##2##5##(1992-2#1)(1995-4#1)
were detected by reverse transcription-polymerase chain reaction (RT-PCR)##2##8##(2008-5#1)(2010-12#1)
were detected by the PCR##3##5##(2008-10#1)(2008-5#1)(2012-12#1)
were detected by the polymerase chain reaction##2##7##(1995-8#1)(1996-9#1)
were detected by the##13##4##(1990-5#1)(1995-8#1)(1996-9#1)(1997-4#1)(2007-1#1)(2007-5#1)(2008-10#1)(2008-5#2)(2008-8#1)(2012-12#2)(2012-3#1)
were detected by their##3##4##(1993-2#2)(2008-4#1)
were detected by using##3##4##(2008-10#1)(2008-12#1)(2013-8#1)
were detected by##94##3##(1990-11#1)(1990-12#1)(1990-5#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-2#1)(1992-4#1)(1992-5#1)(1993-2#2)(1993-3#1)(1993-4#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-4#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-12#1)(2005-5#1)(2006-3#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#15)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#5)(2008-8#1)(2008-9#1)(2009-2#1)(2010-11#1)(2010-12#2)(2011-1#3)(2011-2#2)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#2)(2013-8#2)
were detected compared to##2##4##(2007-8#1)(2013-8#1)
were detected consistently##2##3##(2008-10#2)
were detected during the##3##4##(2008-10#2)(2008-5#1)
were detected during##9##3##(1990-12#1)(1991-12#1)(1993-5#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2012-1#1)
were detected following##2##3##(1997-6#1)(2008-10#1)
were detected for a##2##4##(2008-10#1)(2012-12#1)
were detected for all##2##4##(1991-2#1)(1994-7#1)
were detected for each##2##4##(1993-11#1)(2007-8#1)
were detected for the first time in##2##7##(2010-10#1)(2012-1#1)
were detected for the##6##4##(1991-4#1)(2008-10#1)(2010-10#1)(2011-2#2)(2012-1#1)
were detected for##22##3##(1991-2#1)(1991-4#1)(1992-5#1)(1993-11#1)(1994-7#1)(2006-10#1)(2007-8#1)(2008-10#5)(2008-9#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#1)
were detected from the##4##4##(1993-12#1)(1997-4#1)(2008-10#1)(2011-12#1)
were detected from##11##3##(1993-12#1)(1997-4#1)(2005-9#1)(2008-10#5)(2008-11#1)(2008-8#1)(2011-12#1)
were detected in 1##2##4##(2008-9#1)(2012-3#1)
were detected in 10##2##4##(2007-8#1)(2008-5#1)
were detected in 15##2##4##(1997-1#1)(2007-7#1)
were detected in 2##3##4##(1994-4#1)(2005-11#1)(2012-3#1)
were detected in 3##2##4##(2011-2#1)(2012-3#1)
were detected in 33##2##4##(2011-1#1)(2012-2#1)
were detected in 6##2##4##(2008-8#1)(2012-2#1)
were detected in Abyssinian 14##2##5##(2008-10#2)
were detected in a##2##4##(1994-6#1)(2013-1#1)
were detected in adult##2##4##(1995-3#1)(1997-1#1)
were detected in all cases##2##5##(1992-8#1)(2011-1#1)
were detected in all the##4##5##(1997-6#1)(2004-4#1)(2008-5#1)(2009-2#1)
were detected in all##15##4##(1992-8#1)(1993-7#1)(1997-1#1)(1997-6#1)(2004-4#1)(2007-10#1)(2007-2#1)(2008-10#2)(2008-5#2)(2009-2#1)(2011-1#1)(2013-1#1)(2013-7#1)
were detected in almost##2##4##(1992-4#1)(1993-4#1)
were detected in both##8##4##(1991-1#1)(1994-2#1)(1994-8#1)(1995-12#1)(1997-4#1)(2006-8#1)(2008-10#1)(2008-4#1)
were detected in either##2##4##(1996-6#1)(2006-2#1)
were detected in human##3##4##(1990-2#1)(1992-8#1)(2008-4#1)
were detected in low##2##4##(1991-12#1)(2008-10#1)
were detected in mouse##2##4##(1990-11#1)(2008-10#1)
were detected in other##2##4##(2008-10#1)(2008-8#1)
were detected in patients##4##4##(1991-2#1)(1992-3#1)(2009-3#1)(2011-2#1)
were detected in plasma##2##4##(2007-11#1)(2008-11#1)
were detected in rat##2##4##(1995-5#1)(2008-10#1)
were detected in respiratory##2##4##(2008-5#1)(2013-1#1)
were detected in six##2##4##(1994-3#1)(1996-12#1)
were detected in some samples##2##5##(2008-10#1)(2008-5#1)
were detected in some##4##4##(1991-11#1)(2008-10#1)(2008-4#1)(2008-5#1)
were detected in the brain of the##2##7##(1994-2#1)(1996-12#1)
were detected in the human##2##5##(1993-4#1)(2008-10#1)
were detected in the majority of##2##6##(2009-9#1)(2011-2#1)
were detected in the purified fraction##2##6##(1991-10#1)(1996-7#1)
were detected in the purified##3##5##(1991-10#1)(1994-9#1)(1996-7#1)
were detected in the rectum##2##5##(2010-12#1)(2012-1#1)
were detected in the##81##4##(1990-12#2)(1991-10#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-5#1)(1995-6#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-2#1)(2004-8#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-5#1)(2007-1#2)(2007-7#2)(2007-8#1)(2008-10#12)(2008-12#2)(2008-3#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-12#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#1)
were detected in their##2##4##(2008-10#1)(2012-2#1)
were detected in these##4##4##(1996-11#1)(2008-10#2)(2012-12#1)
were detected in this##3##4##(1990-7#1)(1997-6#1)(2008-10#1)
were detected in three##2##4##(2008-10#1)(2008-7#1)
were detected in two of##2##5##(1992-2#1)(2008-4#1)
were detected in two##4##4##(1992-2#1)(2006-8#1)(2008-4#1)(2008-9#1)
were detected in urine##2##4##(1996-12#1)(2008-10#1)
were detected in##319##3##(1990-11#2)(1990-12#4)(1990-2#2)(1990-3#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-7#2)(1991-9#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#3)(1993-7#1)(1993-9#2)(1994-11#2)(1994-2#6)(1994-3#2)(1994-4#1)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#7)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#3)(1996-10#1)(1996-11#1)(1996-12#5)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#2)(1996-7#1)(1996-9#3)(1997-1#3)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#2)(2004-11#1)(2004-2#3)(2004-4#1)(2004-8#1)(2005-11#1)(2005-12#1)(2005-8#3)(2006-10#2)(2006-2#1)(2006-3#1)(2006-5#1)(2006-8#4)(2007-1#4)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#2)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#62)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#4)(2008-5#11)(2008-7#2)(2008-8#8)(2008-9#3)(2009-10#1)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#4)(2010-4#1)(2011-1#3)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#3)(2012-11#2)(2012-12#2)(2012-2#5)(2012-3#6)(2013-1#5)(2013-7#3)(2013-8#6)
were detected more##2##3##(2007-4#1)(2008-10#1)
were detected on chromosomes##2##4##(2008-10#2)
were detected on the basis of##2##6##(1993-11#1)(2006-10#1)
were detected on the##8##4##(1991-7#1)(1993-11#1)(1994-12#1)(1994-7#1)(2006-10#1)(2008-10#1)(2009-8#1)(2013-8#1)
were detected on##21##3##(1991-7#2)(1993-11#1)(1994-12#1)(1994-7#2)(2006-10#1)(2006-3#1)(2006-9#1)(2008-10#5)(2008-8#1)(2009-4#1)(2009-8#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
were detected only in the##3##5##(1994-9#1)(2007-8#1)(2012-1#1)
were detected only in##5##4##(1992-8#1)(1994-9#1)(1996-12#1)(2007-8#1)(2012-1#1)
were detected only##6##3##(1992-8#1)(1994-9#1)(1996-12#1)(2006-8#1)(2007-8#1)(2012-1#1)
were detected over##2##3##(1990-12#1)(2008-10#1)
were detected simultaneously##2##3##(2008-2#1)(2010-5#1)
were detected through##2##3##(2006-10#1)(2008-7#1)
were detected to##2##3##(1990-3#1)(1994-5#1)
were detected using a##4##4##(1997-8#1)(2008-10#3)
were detected using the##3##4##(2005-11#1)(2006-6#1)(2008-10#1)
were detected using##12##3##(1991-9#1)(1994-2#1)(1997-8#1)(2005-11#1)(2005-4#1)(2006-6#1)(2007-10#1)(2008-10#5)
were detected when##6##3##(1994-5#1)(1997-4#1)(2006-9#1)(2008-10#2)(2008-5#1)
were detected with a##2##4##(2005-12#1)(2012-12#1)
were detected with an##2##4##(1992-9#1)(2007-8#1)
were detected with the##4##4##(2008-10#3)(2011-2#1)
were detected with##26##3##(1990-11#1)(1990-8#1)(1992-4#1)(1992-7#1)(1992-9#2)(1993-1#1)(1997-3#1)(1997-8#1)(2005-12#1)(2007-8#2)(2008-10#6)(2008-3#1)(2008-5#1)(2009-7#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-7#1)
were detected within##6##3##(1993-3#1)(1994-9#1)(1996-11#1)(1997-4#1)(2008-10#1)(2009-8#1)
were detected##833##2##(1990-10#1)(1990-11#7)(1990-12#10)(1990-2#3)(1990-3#4)(1990-5#3)(1990-6#1)(1990-7#4)(1990-8#3)(1990-9#2)(1991-1#2)(1991-10#4)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#1)(1991-4#5)(1991-5#3)(1991-7#5)(1991-8#2)(1991-9#2)(1992-12#1)(1992-2#6)(1992-3#2)(1992-4#5)(1992-5#4)(1992-6#2)(1992-7#1)(1992-8#4)(1992-9#4)(1993-1#1)(1993-11#5)(1993-12#6)(1993-2#4)(1993-3#5)(1993-4#6)(1993-5#1)(1993-6#1)(1993-7#2)(1993-9#7)(1994-11#5)(1994-12#5)(1994-2#10)(1994-3#2)(1994-4#2)(1994-5#3)(1994-6#3)(1994-7#3)(1994-8#6)(1994-9#6)(1995-1#2)(1995-10#1)(1995-11#10)(1995-12#2)(1995-2#2)(1995-3#5)(1995-4#1)(1995-5#4)(1995-6#5)(1995-7#1)(1995-8#5)(1995-9#1)(1996-10#2)(1996-11#4)(1996-12#7)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#4)(1996-7#1)(1996-8#2)(1996-9#6)(1997-1#3)(1997-2#5)(1997-3#4)(1997-4#6)(1997-5#2)(1997-6#5)(1997-7#3)(1997-8#3)(2004-10#1)(2004-11#1)(2004-2#3)(2004-4#1)(2004-8#2)(2005-10#2)(2005-11#3)(2005-12#5)(2005-4#2)(2005-5#1)(2005-8#3)(2005-9#2)(2006-10#9)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#5)(2006-4#3)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#7)(2006-9#3)(2007-1#7)(2007-10#6)(2007-11#4)(2007-12#2)(2007-2#5)(2007-3#2)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#5)(2007-8#12)(2007-9#2)(2008-1#1)(2008-10#175)(2008-11#5)(2008-12#6)(2008-2#5)(2008-3#6)(2008-4#8)(2008-5#33)(2008-6#1)(2008-7#7)(2008-8#17)(2008-9#10)(2009-10#1)(2009-12#1)(2009-2#5)(2009-3#2)(2009-4#4)(2009-5#6)(2009-7#2)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#9)(2010-2#1)(2010-4#1)(2010-5#4)(2010-7#1)(2010-8#1)(2011-1#9)(2011-12#6)(2011-2#17)(2011-3#3)(2012-1#8)(2012-11#3)(2012-12#10)(2012-2#10)(2012-3#13)(2013-1#11)(2013-7#7)(2013-8#14)
were determinate##2##2##(2005-10#1)(2008-8#1)
were determinated##3##2##(2005-4#1)(2007-5#1)(2008-10#1)
were determined according to the##3##5##(1997-8#1)(2008-5#2)
were determined according to##6##4##(1997-6#1)(1997-8#1)(2007-2#1)(2007-9#1)(2008-5#2)
were determined after##5##3##(1990-5#1)(2004-9#1)(2007-9#1)(2009-9#1)(2013-8#1)
were determined against##2##3##(1990-5#1)(2005-7#1)
were determined along##2##3##(2008-2#1)(2010-10#1)
were determined also##2##3##(2008-10#1)(2010-12#1)
were determined and analyzed using##2##5##(2008-10#1)(2010-3#1)
were determined and analyzed##3##4##(1994-12#1)(2008-10#1)(2010-3#1)
were determined and compared in##2##5##(2008-11#1)(2008-12#1)
were determined and compared to##4##5##(1991-12#1)(1994-12#1)(2007-4#2)
were determined and compared with those of##2##7##(2008-10#1)(2011-2#1)
were determined and compared with those##4##6##(1990-9#1)(2008-10#2)(2011-2#1)
were determined and compared with##6##5##(1990-9#1)(1996-1#1)(2008-10#3)(2011-2#1)
were determined and compared##16##4##(1990-9#1)(1991-12#1)(1994-12#1)(1996-1#1)(1997-2#1)(2005-11#1)(2007-4#2)(2008-10#4)(2008-11#1)(2008-12#1)(2009-3#1)(2011-2#1)
were determined and related to##2##5##(1994-11#1)(1996-2#1)
were determined and the##8##4##(1990-7#1)(2005-11#1)(2005-4#1)(2008-10#2)(2010-8#1)(2011-1#1)(2012-12#1)
were determined and their##2##4##(2008-10#1)(2008-11#1)
were determined and##51##3##(1990-4#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#1)(1994-11#1)(1994-12#2)(1995-3#1)(1996-1#1)(1996-2#1)(1997-2#2)(1997-3#1)(2005-11#3)(2005-4#1)(2006-8#1)(2007-4#2)(2008-10#14)(2008-11#2)(2008-12#1)(2008-5#2)(2009-3#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)
were determined as a function of##3##6##(2005-11#1)(2006-4#1)(2013-7#1)
were determined as a##4##4##(1993-11#1)(2005-11#1)(2006-4#1)(2013-7#1)
were determined as markers of bone##2##6##(1996-9#2)
were determined as well as##2##5##(2008-10#2)
were determined as##26##3##(1990-5#1)(1993-11#1)(1996-5#1)(1996-7#1)(1996-9#2)(2005-11#2)(2006-4#1)(2007-1#2)(2008-10#6)(2008-12#3)(2008-5#2)(2010-12#1)(2010-4#1)(2012-3#1)(2013-7#1)
were determined at 25 degrees C##5##6##(2008-10#5)
were determined at different ionic strengths##2##6##(1995-1#1)(2008-10#1)
were determined at different##3##4##(1995-1#1)(2008-10#2)
were determined at the##2##4##(1994-2#1)(2012-11#1)
were determined at##27##3##(1990-3#1)(1990-6#1)(1992-9#1)(1994-2#1)(1995-1#1)(1995-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#11)(2008-4#2)(2008-5#1)(2010-4#1)(2012-11#1)(2012-12#1)(2013-8#1)
were determined based on the##2##5##(2008-10#2)
were determined based on##5##4##(2008-10#4)(2009-7#1)
were determined before and##2##4##(2008-10#1)(2008-12#1)
were determined before##3##3##(2008-10#1)(2008-12#1)(2008-7#1)
were determined between##4##3##(2004-3#1)(2008-10#2)(2008-5#1)
were determined by HPLC in##2##5##(1991-5#1)(1996-3#1)
were determined by HPLC##4##4##(1991-5#1)(1996-3#1)(2007-11#1)(2007-8#1)
were determined by NOESY spectra at##2##6##(1991-7#1)(1993-6#1)
were determined by UV##2##4##(1992-2#1)(2006-12#1)
were determined by X-ray##4##4##(1994-9#1)(1996-2#1)(2005-11#1)(2010-5#1)
were determined by a combination of##2##6##(1996-5#1)(2008-2#1)
were determined by a flame atomic absorption spectrometer##2##8##(2008-10#2)
were determined by a##12##4##(1990-5#1)(1990-8#1)(1996-5#1)(1997-4#1)(2005-11#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-2#1)(2011-2#1)
were determined by amino acid##2##5##(1991-2#1)(1992-6#1)
were determined by an enzyme-linked##2##5##(1993-9#1)(2012-12#1)
were determined by an##5##4##(1992-1#1)(1993-9#1)(1996-3#1)(2008-10#1)(2012-12#1)
were determined by analysis of##2##5##(1996-2#1)(2008-9#1)
were determined by analyzing##2##4##(1991-8#1)(1996-1#1)
were determined by atomic absorption##2##5##(2011-2#1)(2013-1#1)
were determined by atomic##3##4##(2005-4#1)(2011-2#1)(2013-1#1)
were determined by broth##2##4##(2006-8#1)(2011-2#1)
were determined by capillary electrophoresis##2##5##(2008-10#2)
were determined by capillary##3##4##(1994-9#1)(2008-10#2)
were determined by circular dichroism##3##5##(1992-6#1)(1993-3#1)(2006-12#1)
were determined by direct##3##4##(1994-2#1)(1996-12#1)(2008-10#1)
were determined by employing##2##4##(2008-10#1)(2011-2#1)
were determined by enzymatic##3##4##(2008-10#1)(2011-12#1)(2013-1#1)
were determined by flame atomic absorption##2##6##(2008-10#2)
were determined by flame##3##4##(2008-10#3)
were determined by flow##2##4##(2010-10#1)(2013-8#1)
were determined by gas chromatography with##3##6##(1997-6#1)(2007-8#1)(2008-10#1)
were determined by gas chromatography##8##5##(1990-9#1)(1997-6#1)(2007-3#1)(2007-8#1)(2008-10#1)(2009-8#1)(2010-4#1)(2012-2#1)
were determined by gas chromatography-mass spectrometry##3##6##(1990-8#1)(1992-2#1)(1992-5#1)
were determined by gas##11##4##(1990-8#1)(1990-9#1)(1992-2#1)(1992-5#1)(1997-6#1)(2007-3#1)(2007-8#1)(2008-10#1)(2009-8#1)(2010-4#1)(2012-2#1)
were determined by high performance liquid chromatography##2##7##(1997-5#1)(2008-10#1)
were determined by high##3##4##(1997-5#1)(2008-10#2)
were determined by high-performance liquid chromatography##2##6##(1997-2#1)(2007-1#1)
were determined by inductively coupled plasma mass spectrometry (ICP-MS)##4##9##(2008-10#2)(2013-8#2)
were determined by inductively coupled plasma mass spectrometry##5##8##(2008-10#3)(2013-8#2)
were determined by inductively coupled plasma##6##6##(2008-10#4)(2013-8#2)
were determined by inductively coupled##7##5##(2008-10#5)(2013-8#2)
were determined by inductively##8##4##(2008-10#6)(2013-8#2)
were determined by least-squares fitting of theoretical##2##7##(2008-2#1)(2008-3#1)
were determined by least-squares fitting of##3##6##(2008-2#2)(2008-3#1)
were determined by matrix-assisted laser desorption/ionization##2##6##(2008-11#2)
were determined by means of the##2##6##(2007-7#1)(2008-8#1)
were determined by means of##6##5##(1991-7#1)(1996-2#1)(2007-7#1)(2008-5#1)(2008-8#1)(2013-1#1)
were determined by measuring the##3##5##(2005-11#2)(2008-2#1)
were determined by measuring##4##4##(2005-11#2)(2008-2#1)(2009-4#1)
were determined by pH##2##4##(2005-11#1)(2008-10#1)
were determined by potentiometric pH##2##5##(2008-5#2)
were determined by potentiometric##3##4##(2008-10#1)(2008-5#2)
were determined by quantitative##3##4##(1990-7#1)(1994-2#1)(2008-3#1)
were determined by radioimmunoassay##4##4##(1992-3#1)(1996-2#1)(1997-3#1)(2011-12#1)
were determined by spectroscopic methods##4##5##(2007-1#4)
were determined by spectroscopic##6##4##(2007-1#4)(2008-3#1)(2010-6#1)
were determined by the proposed##2##5##(2008-10#2)
were determined by the##23##4##(1991-7#1)(1995-11#1)(1995-8#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)
were determined by using the##4##5##(2005-11#1)(2008-10#2)(2010-11#1)
were determined by using##13##4##(1991-8#1)(2005-11#1)(2005-4#1)(2006-4#1)(2008-10#7)(2010-11#1)(2010-2#1)
were determined by##274##3##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-7#3)(1991-8#3)(1992-1#1)(1992-2#3)(1992-3#4)(1992-5#1)(1992-6#2)(1992-7#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#2)(1995-11#2)(1995-2#1)(1995-6#1)(1995-7#1)(1995-8#3)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#4)(1996-3#2)(1996-5#2)(1996-7#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#9)(2005-4#2)(2005-7#1)(2006-10#2)(2006-12#6)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-1#6)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#3)(2008-10#61)(2008-11#2)(2008-12#2)(2008-2#6)(2008-3#6)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#4)(2009-4#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#2)(2011-1#4)(2011-12#2)(2011-2#6)(2011-3#1)(2012-12#7)(2012-2#5)(2012-3#2)(2013-1#6)(2013-8#4)
were determined crystallographically##2##3##(2008-5#2)
were determined directly##2##3##(1992-9#1)(2008-10#1)
were determined during a##3##4##(2008-5#2)(2011-2#1)
were determined during the##4##4##(1991-9#1)(2007-10#1)(2007-6#1)(2013-1#1)
were determined during##9##3##(1991-9#1)(1993-4#1)(2007-10#1)(2007-6#1)(2008-5#2)(2008-7#1)(2011-2#1)(2013-1#1)
were determined exclusively by##2##4##(2005-11#1)(2008-10#1)
were determined fluorimetrically##2##3##(1990-8#1)(2008-10#1)
were determined for 12##3##4##(1997-3#1)(2008-10#1)(2008-12#1)
were determined for a##4##4##(1992-7#1)(1993-9#1)(1994-2#1)(2004-4#1)
were determined for all##3##4##(2005-11#1)(2007-11#2)
were determined for each species##2##5##(2011-2#1)(2012-12#1)
were determined for each##12##4##(1990-2#1)(1990-6#1)(2007-8#2)(2008-10#4)(2008-4#1)(2008-5#1)(2011-2#1)(2012-12#1)
were determined for several##2##4##(1990-11#1)(1992-12#1)
were determined for the##12##4##(1990-5#1)(1993-7#1)(1994-12#1)(1994-8#1)(1995-8#1)(1996-7#1)(1997-8#1)(2004-11#1)(2005-11#1)(2008-10#1)(2008-5#1)(2008-6#1)
were determined for two##2##4##(1996-8#1)(2008-10#1)
were determined for##60##3##(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#1)(1992-12#1)(1992-7#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-6#2)(1995-8#3)(1996-12#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-8#2)(2004-11#1)(2004-4#1)(2005-11#3)(2006-8#1)(2007-11#3)(2007-12#1)(2007-8#3)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-2#1)(2010-11#1)(2011-2#1)(2012-12#1)
were determined from the temperature dependence of##3##7##(1990-7#1)(2006-4#1)(2008-10#1)
were determined from the##19##4##(1990-7#1)(1991-11#1)(1991-7#1)(1992-3#1)(1995-2#1)(1996-5#1)(1997-2#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#1)(2009-8#1)(2009-9#1)
were determined from##50##3##(1990-12#2)(1990-7#1)(1991-11#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-8#1)(1992-9#1)(1995-2#1)(1996-5#1)(1997-2#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-5#1)(2008-10#13)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-8#1)(2012-12#1)(2012-2#1)
were determined in 30##4##4##(1991-4#1)(1992-4#1)(2007-1#1)(2008-7#1)
were determined in a##5##4##(1994-9#1)(1996-12#1)(2008-10#3)
were determined in all the##2##5##(2008-10#1)(2013-8#1)
were determined in all##4##4##(1995-3#1)(2008-10#1)(2010-12#1)(2013-8#1)
were determined in aqueous##2##4##(2008-10#2)
were determined in different ionic##2##5##(2008-10#1)(2010-6#1)
were determined in different##4##4##(1995-12#1)(2007-3#1)(2008-10#1)(2010-6#1)
were determined in human##2##4##(1994-5#1)(2008-10#1)
were determined in liver##2##4##(2008-7#1)(2011-1#1)
were determined in rat##3##4##(1991-2#1)(1994-3#1)(2008-6#1)
were determined in serum##2##4##(1995-3#1)(2008-10#1)
were determined in solution##2##4##(1993-3#1)(1995-8#1)
were determined in the same##2##5##(1991-2#1)(1994-11#1)
were determined in the serum##2##5##(2008-10#2)
were determined in the##22##4##(1991-2#1)(1991-7#1)(1994-11#1)(1997-4#1)(1997-6#1)(2006-12#1)(2007-10#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-5#3)(2008-6#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-12#1)
were determined in two##2##4##(1991-1#1)(2013-7#1)
were determined in##138##3##(1990-12#1)(1990-3#1)(1990-9#1)(1991-1#2)(1991-10#2)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-9#3)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-7#1)(1994-9#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-4#1)(2006-12#2)(2006-8#2)(2007-1#2)(2007-10#3)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#37)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#6)(2008-6#2)(2008-7#4)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#3)(2013-1#1)(2013-7#1)(2013-8#1)
were determined independently##2##3##(1997-3#1)(2011-2#1)
were determined mainly##2##3##(2006-12#1)(2007-1#1)
were determined on the basis of##3##6##(2006-12#1)(2007-9#1)(2008-4#1)
were determined on the##5##4##(1997-8#1)(2006-12#1)(2007-9#1)(2008-10#1)(2008-4#1)
were determined on##13##3##(1991-9#1)(1995-3#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)
were determined over a##2##4##(1996-3#1)(2004-11#1)
were determined over##6##3##(1993-11#1)(1996-3#1)(2004-11#1)(2007-8#1)(2008-11#1)(2010-4#1)
were determined potentiometrically##4##3##(2006-12#1)(2008-10#3)
were determined previously##2##3##(1996-6#1)(2011-1#1)
were determined respectively##2##3##(1990-7#1)(2007-7#1)
were determined satisfactorily##3##3##(2008-10#3)
were determined simultaneously##4##3##(2006-10#1)(2008-10#2)(2008-3#1)
were determined spectrophotometrically##2##3##(2008-10#1)(2012-2#1)
were determined through##3##3##(2006-11#1)(2008-10#1)(2008-3#1)
were determined to assess the viability of the method##2##9##(2008-10#2)
were determined to assess##3##4##(1993-2#1)(2008-10#2)
were determined to be 0##4##5##(2007-12#1)(2008-10#2)(2008-8#1)
were determined to be 10##2##5##(2008-10#2)
were determined to be##36##4##(1990-5#1)(1990-7#1)(1990-8#1)(1991-7#1)(1993-4#1)(1994-11#1)(1994-8#1)(1995-10#1)(1995-2#1)(1996-2#1)(1997-2#2)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-12#1)(2009-8#1)(2012-12#2)(2013-1#1)
were determined to##51##3##(1990-5#1)(1990-7#1)(1990-8#1)(1991-7#1)(1992-8#1)(1993-2#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-2#2)(2005-11#1)(2007-11#2)(2007-12#1)(2008-10#18)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-8#1)(2012-12#2)(2013-1#1)
were determined under##4##3##(1992-3#1)(2005-11#1)(2008-10#1)(2008-3#1)
were determined using a##10##4##(1990-3#1)(1991-2#1)(1992-5#1)(2005-11#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-5#1)(2010-6#1)(2013-8#1)
were determined using an##3##4##(1993-12#1)(2008-2#1)(2008-5#1)
were determined using standard##2##4##(2009-5#1)(2010-12#1)
were determined using the##8##4##(2007-11#1)(2007-8#2)(2008-10#3)(2008-12#1)(2013-1#1)
were determined using##70##3##(1990-12#1)(1990-3#1)(1991-12#2)(1991-2#2)(1991-3#1)(1992-11#1)(1992-5#1)(1992-7#1)(1992-8#2)(1993-12#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1997-3#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-10#15)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#5)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-2#5)(2012-3#1)(2013-1#3)(2013-8#1)
were determined via##3##3##(2006-10#1)(2007-8#1)(2008-7#1)
were determined with a##2##4##(2007-11#1)(2008-10#1)
were determined with an accuracy of##2##6##(2008-3#2)
were determined with an##4##4##(1990-8#1)(2008-2#1)(2008-3#2)
were determined with satisfactory##3##4##(2008-10#3)
were determined with the##8##4##(2006-8#1)(2008-10#4)(2008-2#1)(2008-5#1)(2013-8#1)
were determined with##38##3##(1990-2#1)(1990-8#1)(1992-6#1)(1994-9#1)(1997-2#1)(2006-8#1)(2007-10#1)(2007-11#2)(2008-10#16)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-9#1)(2011-2#1)(2013-8#1)
were determined without##3##3##(2008-10#3)
were determined##1176##2##(1990-11#3)(1990-12#5)(1990-2#3)(1990-3#4)(1990-4#3)(1990-5#9)(1990-6#2)(1990-7#6)(1990-8#7)(1990-9#5)(1991-1#3)(1991-10#3)(1991-11#1)(1991-12#5)(1991-2#8)(1991-3#1)(1991-4#2)(1991-5#4)(1991-6#1)(1991-7#7)(1991-8#4)(1991-9#4)(1992-1#2)(1992-11#2)(1992-12#2)(1992-2#6)(1992-3#8)(1992-4#2)(1992-5#3)(1992-6#5)(1992-7#4)(1992-8#5)(1992-9#3)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#4)(1993-4#3)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#6)(1994-11#6)(1994-12#8)(1994-2#4)(1994-3#4)(1994-5#5)(1994-7#1)(1994-8#6)(1994-9#4)(1995-1#4)(1995-10#1)(1995-11#3)(1995-12#4)(1995-2#6)(1995-3#6)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#8)(1996-1#2)(1996-10#4)(1996-12#5)(1996-2#8)(1996-3#4)(1996-4#2)(1996-5#5)(1996-6#2)(1996-7#4)(1996-8#6)(1996-9#5)(1997-1#1)(1997-2#12)(1997-3#7)(1997-4#4)(1997-5#3)(1997-6#5)(1997-7#4)(1997-8#6)(2004-11#2)(2004-3#1)(2004-4#2)(2004-9#2)(2005-10#1)(2005-11#27)(2005-12#2)(2005-4#8)(2005-7#2)(2005-9#1)(2006-10#7)(2006-11#2)(2006-12#11)(2006-4#4)(2006-5#2)(2006-6#1)(2006-8#10)(2006-9#2)(2007-1#17)(2007-10#9)(2007-11#15)(2007-12#7)(2007-2#5)(2007-3#6)(2007-4#5)(2007-5#5)(2007-6#1)(2007-7#3)(2007-8#18)(2007-9#5)(2008-1#3)(2008-10#305)(2008-11#16)(2008-12#18)(2008-2#21)(2008-3#22)(2008-4#9)(2008-5#57)(2008-6#9)(2008-7#16)(2008-8#11)(2008-9#9)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#4)(2009-4#4)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#6)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#8)(2010-2#5)(2010-3#1)(2010-4#10)(2010-5#1)(2010-6#4)(2010-8#2)(2010-9#1)(2011-1#12)(2011-12#4)(2011-2#24)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#20)(2012-2#9)(2012-3#9)(2013-1#16)(2013-7#2)(2013-8#11)
were developed and analyzed##3##4##(2008-10#1)(2013-1#2)
were developed and implemented to##2##5##(2008-10#1)(2010-11#1)
were developed and implemented##3##4##(2008-10#1)(2008-2#1)(2010-11#1)
were developed and introduced##2##4##(2007-8#1)(2010-8#1)
were developed and tested##2##4##(2008-10#1)(2009-3#1)
were developed and validated##2##4##(1997-8#1)(2008-10#1)
were developed and##24##3##(1993-2#1)(1995-2#1)(1997-8#2)(2006-6#1)(2007-1#1)(2007-4#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-5#1)(2009-3#2)(2010-11#1)(2010-8#2)(2013-1#2)
were developed as##3##3##(2008-6#1)(2010-8#1)(2013-1#1)
were developed based on the##5##5##(1996-5#1)(2008-10#3)(2012-12#1)
were developed based on##8##4##(1993-3#1)(1996-5#1)(2007-12#1)(2008-10#4)(2012-12#1)
were developed by a##2##4##(2008-3#1)(2010-12#1)
were developed by the##4##4##(1990-12#1)(2008-10#1)(2008-2#1)(2011-2#1)
were developed by using##2##4##(2007-12#1)(2008-10#1)
were developed by##21##3##(1990-12#1)(1997-8#1)(2005-12#1)(2006-11#1)(2006-8#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-2#1)(2008-3#2)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
were developed employing##2##3##(2008-5#1)(2012-2#1)
were developed for a##2##4##(1996-12#1)(2009-6#1)
were developed for the analysis of##2##6##(2008-10#2)
were developed for the determination of##4##6##(2008-10#4)
were developed for the##16##4##(1990-12#1)(1990-8#1)(1997-8#1)(2007-11#1)(2008-10#9)(2009-7#1)(2011-2#2)
were developed for##35##3##(1990-12#1)(1990-5#1)(1990-8#1)(1995-8#1)(1996-12#1)(1996-8#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-3#1)(2008-7#2)(2009-10#1)(2009-6#1)(2009-7#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-3#1)
were developed from the##2##4##(1997-8#1)(2011-2#1)
were developed from##7##3##(1997-8#1)(2008-10#4)(2008-7#1)(2011-2#1)
were developed in a##2##4##(2008-5#1)(2008-9#1)
were developed in order to##2##5##(2008-10#1)(2008-12#1)
were developed in this##2##4##(2008-10#1)(2008-8#1)
were developed in##19##3##(1990-6#1)(1991-9#1)(1997-5#1)(2005-7#1)(2006-11#1)(2006-5#1)(2007-2#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2013-1#1)
were developed that were##2##4##(2008-10#2)
were developed that##8##3##(1996-5#1)(2008-10#5)(2008-8#1)(2010-9#1)
were developed through##3##3##(2007-8#1)(2008-1#1)(2008-10#1)
were developed to assess##2##4##(1991-2#1)(2006-7#1)
were developed to detect##2##4##(2008-10#2)
were developed to facilitate##3##4##(1991-12#1)(2007-12#1)(2008-8#1)
were developed to guide##2##4##(1994-3#1)(2008-10#1)
were developed to identify##2##4##(2008-10#1)(2012-1#1)
were developed to measure##2##4##(1991-3#1)(2006-10#1)
were developed to study the##2##5##(2008-10#2)
were developed to##48##3##(1990-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-1#1)(1992-5#2)(1994-3#1)(1994-9#1)(1997-7#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-7#1)(2007-1#3)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#10)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-1#2)(2012-3#1)(2013-8#1)
were developed under##2##3##(2008-10#1)(2011-12#1)
were developed using a##3##4##(1991-7#1)(2008-10#2)
were developed using##15##3##(1991-7#1)(1993-1#1)(2005-10#1)(2008-10#9)(2008-6#1)(2010-2#1)(2011-2#1)
were developed with##6##3##(2007-4#1)(2008-10#4)(2009-7#1)
were developed within a##2##4##(2006-10#1)(2008-8#1)
were developed##269##2##(1990-1#1)(1990-12#3)(1990-5#1)(1990-6#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-5#2)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#5)(2004-3#1)(2005-10#1)(2005-12#1)(2005-5#1)(2005-7#1)(2006-1#1)(2006-10#4)(2006-11#5)(2006-12#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#4)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-4#3)(2007-6#1)(2007-8#6)(2008-1#2)(2008-10#89)(2008-11#2)(2008-12#5)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#6)(2008-9#2)(2009-10#2)(2009-12#2)(2009-3#3)(2009-4#1)(2009-6#1)(2009-7#3)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#3)(2010-8#4)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#6)(2012-1#3)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#4)(2013-8#2)
were developing##2##2##(1993-6#1)(2013-1#1)
were devised##6##2##(1991-5#1)(1991-8#1)(2007-11#1)(2008-10#2)(2012-1#1)
were devoid of activity##2##4##(1991-4#1)(1996-5#1)
were devoid of the##2##4##(1992-11#1)(1996-9#1)
were devoid of##13##3##(1990-8#1)(1991-4#1)(1992-11#1)(1992-2#1)(1994-5#1)(1995-12#1)(1995-5#1)(1996-12#2)(1996-5#1)(1996-9#2)(2008-10#1)
were diabetic##3##2##(1991-2#1)(2007-7#1)(2008-11#1)
were diabetics##2##2##(2008-1#1)(2012-2#1)
were diagnosed according to##3##4##(2006-10#1)(2008-3#1)(2011-1#1)
were diagnosed after##3##3##(1990-2#1)(1992-10#1)(2007-12#1)
were diagnosed and##5##3##(2007-2#1)(2008-5#1)(2011-2#2)(2012-12#1)
were diagnosed as having##8##4##(1991-4#1)(1995-11#1)(1996-4#1)(1996-6#1)(2006-10#1)(2008-6#1)(2008-9#1)(2009-2#1)
were diagnosed as##26##3##(1991-11#1)(1991-4#1)(1993-5#1)(1994-6#1)(1995-11#1)(1996-4#1)(1996-6#1)(2005-8#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-2#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-8#3)
were diagnosed at##2##3##(1996-3#1)(2010-9#1)
were diagnosed by##4##3##(1997-3#1)(2007-10#1)(2011-2#1)(2013-8#1)
were diagnosed during##2##3##(1994-12#1)(2010-12#1)
were diagnosed either##2##3##(1992-5#1)(2006-8#1)
were diagnosed in a##2##4##(1995-11#1)(2007-8#1)
were diagnosed in the##3##4##(1993-5#1)(1995-12#1)(2004-10#1)
were diagnosed in##21##3##(1992-2#1)(1992-5#1)(1993-5#2)(1993-8#1)(1995-11#1)(1995-12#1)(1996-6#1)(2004-10#1)(2006-10#2)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#1)(2010-12#1)(2010-9#1)(2012-3#1)
were diagnosed on##3##3##(1990-11#1)(1996-12#1)(2007-8#1)
were diagnosed to have##7##4##(1991-2#1)(2006-3#1)(2006-8#1)(2007-2#1)(2007-7#1)(2009-10#1)(2013-1#1)
were diagnosed to##8##3##(1991-2#1)(2006-3#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2009-10#1)(2013-1#1)
were diagnosed with a##3##4##(2006-8#1)(2008-7#1)(2008-9#1)
were diagnosed with active##2##4##(2012-2#1)(2013-7#1)
were diagnosed with disseminated##2##4##(2006-10#1)(2007-7#1)
were diagnosed with old septal deviation##3##6##(2011-2#3)
were diagnosed with pre-eclampsia##2##4##(2011-2#2)
were diagnosed with##45##3##(1991-6#1)(1994-2#1)(1997-5#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#4)(2007-10#2)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-4#1)(2008-6#2)(2008-7#2)(2008-9#1)(2011-1#1)(2011-12#1)(2011-2#8)(2012-2#2)(2012-3#1)(2013-7#1)
were diagnosed##156##2##(1990-11#1)(1990-2#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-9#1)(1993-12#1)(1993-5#3)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-6#1)(1995-11#3)(1995-12#1)(1996-12#1)(1996-3#3)(1996-4#2)(1996-6#2)(1997-2#1)(1997-3#1)(1997-5#1)(2004-10#1)(2004-2#1)(2005-11#1)(2005-8#1)(2006-10#9)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#1)(2006-6#3)(2006-8#7)(2007-10#3)(2007-11#2)(2007-12#2)(2007-2#5)(2007-3#2)(2007-7#4)(2007-8#10)(2008-1#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#2)(2008-9#3)(2009-10#1)(2009-2#1)(2010-12#2)(2010-8#1)(2010-9#3)(2011-1#3)(2011-12#1)(2011-2#13)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#4)
were diagnostic of##3##3##(2006-10#1)(2007-7#1)(2011-12#1)
were diagnostic##4##2##(2006-10#1)(2007-7#1)(2007-9#1)(2011-12#1)
were dichotomized into##2##3##(2007-10#1)(2010-4#1)
were differences between##3##3##(2010-3#1)(2012-12#1)(2013-7#1)
were differences in the##5##4##(1990-2#1)(1991-7#1)(1996-2#1)(2008-10#2)
were differences in##15##3##(1990-2#1)(1991-7#1)(1996-2#1)(2007-3#1)(2007-9#1)(2008-10#3)(2008-5#1)(2008-7#1)(2012-8#1)(2013-1#3)(2013-7#1)
were differences##18##2##(1990-2#1)(1991-7#1)(1996-2#1)(2007-3#1)(2007-9#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-3#1)(2012-12#1)(2012-8#1)(2013-1#3)(2013-7#2)
were different among##2##3##(2009-5#1)(2012-2#1)
were different and##3##3##(1994-11#1)(2008-10#1)(2013-7#1)
were different as##2##3##(1993-3#1)(2006-3#1)
were different between##4##3##(1995-11#1)(2008-10#1)(2010-8#1)(2011-1#1)
were different for the two##2##5##(1992-12#1)(2008-7#1)
were different for##5##3##(1992-12#1)(2008-10#2)(2008-7#1)(2013-1#1)
were different from that seen after DEX##2##7##(1995-12#2)
were different from that##4##4##(1992-10#1)(1995-12#2)(2005-11#1)
were different from the##2##4##(2007-12#1)(2007-2#1)
were different from those of the##2##6##(1990-5#1)(2008-5#1)
were different from those of##6##5##(1990-12#1)(1990-5#1)(1997-2#1)(2006-3#1)(2008-2#1)(2008-5#1)
were different from those##10##4##(1990-12#1)(1990-5#1)(1992-8#1)(1997-2#1)(2006-3#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-2#1)
were different from##21##3##(1990-12#1)(1990-5#1)(1992-10#1)(1992-8#1)(1995-12#2)(1997-2#1)(1997-4#1)(2005-11#1)(2006-3#1)(2006-8#1)(2007-12#1)(2007-2#2)(2008-10#4)(2008-2#1)(2008-5#1)(2012-2#1)
were different in each##2##4##(2010-12#2)
were different in the##2##4##(2010-8#1)(2011-1#1)
were different in##13##3##(1996-10#1)(2007-2#1)(2007-7#1)(2008-10#1)(2010-12#2)(2010-8#1)(2011-1#3)(2011-3#1)(2012-1#1)(2013-7#1)
were different##75##2##(1990-12#1)(1990-5#1)(1991-3#1)(1992-10#1)(1992-12#1)(1992-8#2)(1993-1#1)(1993-3#1)(1994-11#1)(1995-11#1)(1995-12#3)(1996-10#1)(1996-3#1)(1997-2#1)(1997-4#1)(2004-1#1)(2005-11#2)(2005-8#1)(2006-3#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#5)(2007-7#1)(2008-10#12)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#3)(2009-5#1)(2010-12#2)(2010-8#2)(2011-1#4)(2011-3#1)(2012-1#2)(2012-2#3)(2013-1#2)(2013-7#2)
were differentiable##2##2##(2008-10#1)(2011-2#1)
were differentially associated with##2##4##(1994-12#1)(2012-11#1)
were differentially expressed between##4##4##(2009-12#1)(2013-8#3)
were differentially expressed##6##3##(2009-10#1)(2009-12#1)(2013-8#4)
were differentially##16##2##(1991-3#1)(1991-5#1)(1992-1#1)(1994-12#1)(1997-6#1)(2008-10#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-8#1)(2012-11#1)(2013-8#4)
were differentiated by##3##3##(2008-10#1)(2011-2#1)(2011-3#1)
were differentiated from##2##3##(2008-10#2)
were differentiated into##2##3##(2008-10#1)(2008-5#1)
were differentiated with respect to##2##5##(2008-2#1)(2012-2#1)
were differentiated##12##2##(2008-10#5)(2008-2#1)(2008-5#1)(2008-7#1)(2009-11#1)(2011-2#1)(2011-3#1)(2012-2#1)
were difficult to##6##3##(2004-10#1)(2004-9#1)(2008-10#2)(2008-7#1)(2011-1#1)
were difficult##7##2##(2004-10#1)(2004-9#1)(2008-10#2)(2008-7#1)(2011-1#1)(2012-3#1)
were diffusely positive##2##3##(2008-11#1)(2013-8#1)
were diffusely##5##2##(1991-9#1)(2007-3#1)(2008-11#1)(2008-7#1)(2013-8#1)
were digested by microwave digestion##2##5##(2013-8#2)
were digested by##5##3##(2008-10#2)(2009-3#1)(2013-8#2)
were digested in##2##3##(2008-10#2)
were digested with##8##3##(1991-3#1)(1991-6#1)(1994-9#1)(1997-2#2)(2006-8#2)(2008-10#1)
were digested##19##2##(1991-3#1)(1991-6#1)(1992-6#1)(1994-9#1)(1996-8#1)(1997-2#2)(2006-8#2)(2008-10#7)(2009-3#1)(2013-8#2)
were digitally recorded##2##3##(2008-2#1)(2012-12#1)
were digitally##3##2##(2007-8#1)(2008-2#1)(2012-12#1)
were digitized##5##2##(2007-1#1)(2008-12#2)(2008-3#1)(2013-1#1)
were dilated##3##2##(2005-10#1)(2007-8#1)(2008-7#1)
were diluted and##3##3##(1993-11#1)(2006-8#1)(2008-10#1)
were diluted in##2##3##(1992-6#1)(1994-3#1)
were diluted with##6##3##(2004-9#1)(2006-12#1)(2008-10#3)(2008-12#1)
were diluted##16##2##(1992-6#1)(1993-11#1)(1994-3#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-8#1)(2008-10#7)(2008-12#1)
were diminished by##3##3##(1992-3#1)(1992-4#1)(1994-9#1)
were diminished##10##2##(1990-12#1)(1992-3#1)(1992-4#1)(1992-8#1)(1994-9#1)(1995-2#1)(2006-3#1)(2006-5#1)(2008-3#1)(2013-1#1)
were diploid##2##2##(2010-7#2)
were dipped in a##2##4##(1990-6#1)(2008-10#1)
were dipped in##5##3##(1990-6#2)(1993-12#1)(2007-3#1)(2008-10#1)
were dipped##6##2##(1990-6#2)(1993-12#1)(2007-3#1)(2008-10#2)
were direct antiglobulin test##2##4##(1994-9#1)(1996-4#1)
were direct##7##2##(1992-3#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-4#1)(2008-1#1)(2009-6#1)
were directed against the##2##4##(1993-8#1)(2008-10#1)
were directed against##3##3##(1993-8#1)(2008-10#1)(2008-5#1)
were directed at##3##3##(1991-8#1)(1994-2#1)(2008-10#1)
were directed to##5##3##(1995-11#1)(1995-12#1)(2006-11#1)(2007-10#1)(2008-11#1)
were directed##14##2##(1991-8#1)(1993-8#1)(1994-2#3)(1995-11#1)(1995-12#1)(2006-11#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-5#2)
were directionally##2##2##(1990-2#1)(1992-7#1)
were directly correlated with##5##4##(1991-2#1)(1993-4#1)(1996-9#1)(2006-10#1)(2008-10#1)
were directly dependent##2##3##(1990-12#1)(2008-5#1)
were directly exposed to##3##4##(2008-10#1)(2009-6#2)
were directly immobilized##2##3##(1997-4#1)(2008-10#1)
were directly introduced##2##3##(1995-2#1)(2008-10#1)
were directly related to##4##4##(1993-11#1)(2006-8#1)(2008-10#1)(2013-8#1)
were directly##52##2##(1990-12#1)(1990-8#2)(1990-9#1)(1991-2#1)(1992-3#1)(1993-11#1)(1993-4#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-4#1)(2005-11#2)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#15)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#2)(2010-11#1)(2010-12#1)(2012-1#1)(2013-8#1)
were disappointed##2##2##(1995-12#1)(1996-11#1)
were discarded from##2##3##(2007-7#1)(2008-10#1)
were discarded##3##2##(2007-7#1)(2008-10#1)(2009-4#1)
were discerned##2##2##(1994-9#1)(1995-1#1)
were discernible##2##2##(2008-5#1)(2013-7#1)
were discharged directly##2##3##(1992-6#1)(2008-10#1)
were discharged from hospital##4##4##(2007-2#1)(2007-3#1)(2007-8#1)(2012-2#1)
were discharged from the##3##4##(2006-10#1)(2013-1#2)
were discharged from##9##3##(1991-9#1)(1992-11#1)(2006-10#1)(2007-2#1)(2007-3#1)(2007-8#1)(2012-2#1)(2013-1#2)
were discharged home##5##3##(2007-10#3)(2008-1#1)(2012-12#1)
were discharged in##3##3##(2007-8#2)(2011-1#1)
were discharged on##2##3##(2007-8#1)(2008-7#1)
were discharged to their homes##2##5##(1990-12#1)(1990-8#1)
were discharged to##5##3##(1990-12#2)(1990-8#1)(2007-8#1)(2011-2#1)
were discharged##37##2##(1990-12#2)(1990-8#1)(1991-9#1)(1992-11#1)(1992-6#1)(1993-3#1)(1996-9#1)(2006-1#1)(2006-10#1)(2007-10#4)(2007-2#1)(2007-3#1)(2007-8#8)(2008-1#1)(2008-10#1)(2008-7#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#1)
were disclosed##3##2##(2005-7#1)(2007-3#2)
were discontinued##7##2##(1990-12#1)(1992-9#1)(1994-3#1)(1995-6#1)(2006-6#1)(2007-1#1)(2008-1#1)
were discordant##3##2##(2008-11#1)(2013-1#2)
were discovered and##2##3##(2011-12#1)(2012-12#1)
were discovered in a##2##4##(2006-12#1)(2008-5#1)
were discovered in the##4##4##(1990-3#1)(1991-12#1)(2004-9#1)(2012-3#1)
were discovered in##8##3##(1990-3#1)(1991-12#1)(1996-3#1)(2004-9#1)(2006-12#1)(2007-11#1)(2008-5#1)(2012-3#1)
were discovered to have##2##4##(1997-5#1)(2008-3#1)
were discovered to##3##3##(1992-2#1)(1997-5#1)(2008-3#1)
were discovered##35##2##(1990-3#1)(1990-6#1)(1991-12#1)(1991-4#1)(1991-8#1)(1992-2#1)(1992-4#1)(1995-11#1)(1995-12#1)(1996-3#1)(1997-5#1)(2004-9#1)(2006-10#1)(2006-12#2)(2006-7#1)(2007-11#3)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2009-8#1)(2010-6#1)(2011-12#1)(2012-12#1)(2012-3#1)
were discriminated against##2##3##(2007-6#1)(2008-2#1)
were discriminated by##2##3##(1997-6#1)(2008-10#1)
were discriminated##6##2##(1997-6#1)(2007-6#1)(2008-10#2)(2008-2#1)(2012-2#1)
were discussed and##11##3##(1990-3#1)(1992-3#1)(1995-9#1)(2005-11#1)(2005-4#1)(2008-10#3)(2008-12#1)(2009-8#1)(2010-2#1)
were discussed at three##2##4##(1994-12#1)(1997-6#1)
were discussed at##4##3##(1994-12#1)(1997-6#1)(2008-5#1)(2012-12#1)
were discussed in depth##3##4##(2005-7#1)(2005-8#2)
were discussed in detail##4##4##(2005-8#1)(2008-10#3)
were discussed in terms of##2##5##(1994-3#1)(2005-11#1)
were discussed in the##2##4##(2005-8#1)(2008-12#1)
were discussed in view of their##2##6##(2005-8#1)(2008-5#1)
were discussed in##21##3##(1994-2#1)(1994-3#1)(2005-11#1)(2005-7#1)(2005-8#5)(2006-10#1)(2006-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-11#1)
were discussed with##3##3##(1993-11#1)(1997-2#1)(2008-12#1)
were discussed##100##2##(1990-3#1)(1990-6#1)(1992-10#1)(1992-3#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-9#1)(1996-2#1)(1997-2#1)(1997-6#1)(2004-3#1)(2005-11#4)(2005-4#4)(2005-6#1)(2005-7#3)(2005-8#7)(2006-1#1)(2006-10#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#21)(2008-11#3)(2008-12#4)(2008-5#7)(2008-6#1)(2008-8#4)(2008-9#3)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-2#1)(2011-1#1)(2011-2#2)(2011-3#1)(2011-7#1)(2012-11#1)(2012-12#4)(2013-7#1)(2013-8#1)
were discussions##2##2##(2005-8#2)
were disease##2##2##(2004-1#1)(2008-10#1)
were disease-free##3##2##(1991-2#1)(2008-5#1)(2013-8#1)
were dismissed##2##2##(1993-5#1)(1996-5#1)
were dispensed##4##2##(2007-5#1)(2008-10#2)(2008-11#1)
were dispersed on##2##3##(2008-10#1)(2008-3#1)
were dispersed##9##2##(1990-2#1)(1992-5#1)(1995-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2010-2#1)
were displaced##3##2##(1997-1#1)(2007-7#1)(2008-10#1)
were displayed by##2##3##(1997-4#1)(2008-5#1)
were displayed##5##2##(1997-4#2)(2008-12#1)(2008-5#2)
were disproportionately##2##2##(2007-10#1)(2007-8#1)
were disrupted##8##2##(1992-8#1)(1992-9#1)(2007-12#1)(2008-10#2)(2009-10#1)(2009-3#1)(2009-6#1)
were dissatisfied with##3##3##(1990-12#1)(1995-9#1)(2007-12#1)
were dissatisfied##5##2##(1990-12#1)(1995-9#1)(2007-12#1)(2008-7#1)(2008-8#1)
were dissected and##3##3##(2004-11#1)(2007-9#1)(2011-1#1)
were dissected free##2##3##(2008-8#1)(2013-1#1)
were dissected from the##2##4##(2006-11#1)(2008-10#1)
were dissected from##4##3##(2006-11#1)(2008-10#3)
were dissected in##2##3##(2005-5#1)(2009-1#1)
were dissected into##2##3##(1997-8#1)(2006-11#1)
were dissected##21##2##(1992-3#1)(1994-5#1)(1997-8#1)(2004-11#1)(2005-5#1)(2006-11#2)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-1#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-1#1)
were dissociated and##2##3##(1994-5#1)(1995-10#1)
were dissociated##3##2##(1994-5#1)(1995-10#1)(2008-5#1)
were dissolved in##9##3##(1990-11#1)(1990-8#2)(2008-10#3)(2008-5#2)(2012-12#1)
were dissolved with##2##3##(2008-10#2)
were dissolved##12##2##(1990-11#1)(1990-8#2)(2008-10#5)(2008-5#2)(2010-8#1)(2012-12#1)
were distinct from the##2##4##(2008-10#2)
were distinct from##8##3##(2007-5#1)(2008-10#6)(2013-1#1)
were distinct##15##2##(1991-12#1)(1995-1#1)(2007-5#1)(2008-10#10)(2008-11#1)(2013-1#1)
were distinctive##2##2##(1993-12#1)(2008-10#1)
were distinctly more##2##3##(1993-3#1)(2008-10#1)
were distinctly##6##2##(1992-6#1)(1993-12#1)(1993-3#1)(2008-10#2)(2011-1#1)
were distinguishable##2##2##(2008-10#1)(2008-6#1)
were distinguished among the##2##4##(2008-10#2)
were distinguished among##3##3##(2006-12#1)(2008-10#2)
were distinguished by their##3##4##(1991-11#1)(1995-8#1)(1996-9#1)
were distinguished from each other by##2##6##(2008-10#2)
were distinguished from##4##3##(1995-12#1)(2008-10#2)(2008-5#1)
were distinguished in##2##3##(2008-10#1)(2008-5#1)
were distinguished using##2##3##(2008-10#2)
were distinguished##22##2##(1991-11#1)(1995-12#1)(1995-8#1)(1996-9#1)(1997-6#1)(2006-12#1)(2008-10#10)(2008-3#1)(2008-5#2)(2008-9#1)(2009-7#1)(2012-3#1)
were distributed among the##2##4##(1996-7#1)(2008-5#1)
were distributed among##6##3##(1993-4#1)(1995-11#1)(1996-7#1)(1997-2#1)(2008-5#1)(2011-1#1)
were distributed between##2##3##(2008-11#1)(2009-7#1)
were distributed evenly in##2##4##(2004-11#1)(2009-2#1)
were distributed in a##2##4##(1992-8#1)(2008-10#1)
were distributed in the##3##4##(1996-12#1)(2011-1#1)(2013-8#1)
were distributed in two groups##2##5##(1996-7#1)(2013-8#1)
were distributed in##14##3##(1992-8#1)(1996-12#1)(1996-7#1)(2006-10#1)(2007-3#1)(2008-10#4)(2008-6#1)(2011-1#1)(2012-1#1)(2013-8#2)
were distributed into##3##3##(2007-5#1)(2007-6#1)(2010-10#1)
were distributed mainly in the##2##5##(1990-7#1)(2006-8#1)
were distributed mainly##3##3##(1990-7#1)(2006-8#1)(2007-11#1)
were distributed over a##2##4##(1993-12#1)(2012-12#1)
were distributed over all##2##4##(2008-10#2)
were distributed over##5##3##(1993-12#1)(2006-4#1)(2008-10#2)(2012-12#1)
were distributed throughout the##5##4##(1993-12#1)(1993-2#1)(2008-10#2)(2008-5#1)
were distributed to all##2##4##(2007-11#1)(2010-8#1)
were distributed to##7##3##(2006-8#1)(2007-11#1)(2010-12#2)(2010-8#1)(2012-3#1)(2013-1#1)
were distributed##69##2##(1990-12#1)(1990-7#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-7#2)(1997-2#2)(1997-3#1)(2004-11#1)(2006-10#1)(2006-4#1)(2006-7#1)(2006-8#2)(2007-11#2)(2007-3#1)(2007-5#1)(2007-6#1)(2008-10#13)(2008-11#1)(2008-5#3)(2008-6#1)(2008-8#4)(2008-9#1)(2009-2#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-8#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
were disturbed##3##2##(1991-1#1)(2004-11#1)(2008-10#1)
were divergent##2##2##(2008-10#2)
were diverse in##2##3##(2006-3#1)(2008-11#1)
were diverse##6##2##(1995-5#1)(2005-9#1)(2006-3#1)(2008-11#1)(2011-1#1)(2013-8#1)
were divided according to the##3##5##(1990-3#1)(2007-11#1)(2007-7#1)
were divided between##2##3##(1996-8#1)(2008-10#1)
were divided equally into##2##4##(2008-6#1)(2009-5#1)
were divided in 4 groups##2##5##(2007-11#1)(2011-2#1)
were divided in three groups according##2##6##(2007-6#1)(2013-1#1)
were divided in three groups##3##5##(2007-6#1)(2011-1#1)(2013-1#1)
were divided in three##4##4##(2007-6#1)(2008-7#1)(2011-1#1)(2013-1#1)
were divided in to##2##4##(2007-2#1)(2008-12#1)
were divided in two groups##2##5##(2005-10#1)(2012-2#1)
were divided in two##3##4##(2005-10#1)(2012-2#1)(2013-1#1)
were divided in##13##3##(1997-4#1)(2005-10#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
were divided into 2 groups##6##5##(1990-2#1)(2007-10#1)(2007-8#1)(2007-9#1)(2012-1#1)(2013-8#1)
were divided into 3 groups according to##2##7##(2008-4#1)(2008-5#1)
were divided into 3 groups##9##5##(1995-6#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#1)
were divided into 3##10##4##(1995-6#1)(2006-5#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#1)
were divided into 4 groups##11##5##(1990-5#1)(1992-9#1)(1993-7#1)(2007-10#1)(2007-6#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-2#1)(2012-12#1)(2013-8#1)
were divided into 4##13##4##(1990-5#1)(1992-7#1)(1992-9#1)(1993-7#1)(2007-10#1)(2007-6#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
were divided into 5 groups##2##5##(1997-2#1)(2009-6#1)
were divided into 5##3##4##(1997-2#1)(2007-1#1)(2009-6#1)
were divided into a group##2##5##(1992-5#1)(2007-8#1)
were divided into a##4##4##(1992-5#1)(1997-2#1)(2007-8#1)(2008-9#1)
were divided into an##2##4##(2008-7#1)(2010-6#1)
were divided into five groups##6##5##(1990-12#1)(2007-1#1)(2008-10#1)(2008-4#1)(2011-1#1)(2011-2#1)
were divided into five##9##4##(1990-12#1)(1995-12#1)(2007-1#1)(2008-10#3)(2008-4#1)(2011-1#1)(2011-2#1)
were divided into four groups and##3##6##(1995-5#1)(2006-8#1)(2011-1#1)
were divided into four groups by##2##6##(1997-2#1)(2009-9#1)
were divided into four groups##22##5##(1991-2#1)(1992-1#1)(1992-12#1)(1995-5#1)(1997-2#1)(2006-8#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-4#2)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#3)
were divided into four##24##4##(1991-2#1)(1992-1#1)(1992-12#1)(1995-5#1)(1997-2#1)(2005-5#1)(2006-8#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-4#2)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#3)
were divided into group A##2##5##(2007-7#1)(2013-8#1)
were divided into groups##7##4##(1993-2#1)(1997-8#1)(2007-12#1)(2008-3#1)(2008-4#1)(2010-12#1)(2012-2#1)
were divided into six##6##4##(2008-10#1)(2008-3#1)(2008-4#2)(2011-2#1)(2013-7#1)
were divided into ten groups##2##5##(1996-7#1)(2008-12#1)
were divided into the following##3##5##(1992-4#1)(2007-10#1)(2012-12#1)
were divided into the##4##4##(1992-4#1)(2007-10#1)(2007-8#1)(2012-12#1)
were divided into three age groups##2##6##(2010-12#2)
were divided into three categories##2##5##(1997-2#1)(2008-8#1)
were divided into three groups according to##5##7##(1991-4#1)(2007-8#1)(2010-10#1)(2011-1#1)(2011-12#1)
were divided into three groups of##2##6##(2009-5#1)(2011-12#1)
were divided into three groups##29##5##(1991-4#1)(1994-6#1)(1995-1#1)(2006-6#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-10#1)(2010-3#1)(2011-1#3)(2011-12#2)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#2)
were divided into three##42##4##(1991-4#1)(1994-6#1)(1995-1#1)(1995-7#1)(1997-2#1)(2006-11#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-5#1)(2010-10#1)(2010-12#2)(2010-3#1)(2011-1#3)(2011-12#2)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#3)
were divided into two different##2##5##(2008-6#1)(2012-1#1)
were divided into two distinct##2##5##(2008-10#2)
were divided into two groups according to the presence##2##9##(2006-5#1)(2007-7#1)
were divided into two groups according to the##3##8##(1997-7#1)(2006-5#1)(2007-7#1)
were divided into two groups according to##5##7##(1997-7#1)(2006-5#1)(2007-7#1)(2008-3#2)
were divided into two groups based on the##2##8##(1992-7#1)(2008-10#1)
were divided into two groups based on##4##7##(1992-7#1)(2008-10#2)(2013-8#1)
were divided into two groups of##5##6##(2006-6#1)(2008-3#1)(2008-7#2)(2011-2#1)
were divided into two groups##51##5##(1992-3#1)(1992-7#1)(1992-8#1)(1995-12#1)(1995-3#1)(1995-7#1)(1996-9#1)(1997-5#1)(1997-7#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-10#4)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#3)
were divided into two treatment##2##5##(1995-4#1)(2008-3#1)
were divided into two##71##4##(1991-3#1)(1992-3#1)(1992-7#1)(1992-8#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-7#1)(1996-11#1)(1996-8#1)(1996-9#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#7)(2008-12#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-4#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#3)
were divided into##245##3##(1990-12#2)(1990-2#1)(1990-5#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-7#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-7#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#2)(1996-11#1)(1996-12#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-2#4)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-5#1)(2005-8#1)(2006-10#2)(2006-11#2)(2006-5#2)(2006-6#2)(2006-8#3)(2007-1#4)(2007-10#4)(2007-11#4)(2007-12#3)(2007-2#2)(2007-6#2)(2007-7#7)(2007-8#8)(2007-9#4)(2008-1#1)(2008-10#17)(2008-11#4)(2008-12#3)(2008-3#9)(2008-4#8)(2008-5#8)(2008-6#1)(2008-7#8)(2008-8#5)(2008-9#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#4)(2010-6#1)(2010-7#1)(2011-1#9)(2011-12#2)(2011-2#13)(2012-1#3)(2012-12#5)(2012-2#5)(2013-1#11)(2013-7#2)(2013-8#10)
were divided to##2##3##(2008-12#1)(2011-2#1)
were divided##272##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-7#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-7#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#2)(1996-11#1)(1996-12#1)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#2)(1997-2#4)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-10#1)(2005-5#1)(2005-8#1)(2006-10#2)(2006-11#2)(2006-5#2)(2006-6#2)(2006-8#3)(2007-1#4)(2007-10#4)(2007-11#6)(2007-12#3)(2007-2#4)(2007-6#3)(2007-7#8)(2007-8#8)(2007-9#4)(2008-1#1)(2008-10#18)(2008-11#4)(2008-12#6)(2008-3#9)(2008-4#9)(2008-5#8)(2008-6#2)(2008-7#9)(2008-8#5)(2008-9#3)(2009-4#2)(2009-5#2)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#4)(2010-6#1)(2010-7#1)(2011-1#10)(2011-12#2)(2011-2#15)(2012-1#3)(2012-12#5)(2012-2#6)(2013-1#14)(2013-7#2)(2013-8#10)
were divorced##3##2##(1994-6#2)(2012-12#1)
were dizziness##2##2##(2007-10#1)(2008-3#1)
were docked into##2##3##(2010-12#1)(2012-2#1)
were docked##3##2##(2008-8#1)(2010-12#1)(2012-2#1)
were documented by##4##3##(1993-2#1)(2006-11#1)(2008-11#1)(2008-5#1)
were documented in the##2##4##(1994-8#1)(2008-12#1)
were documented in##8##3##(1993-8#1)(1994-8#1)(1996-11#1)(2007-10#1)(2007-7#1)(2008-12#1)(2013-1#2)
were documented##26##2##(1990-8#1)(1991-7#1)(1993-2#1)(1993-8#1)(1994-8#1)(1996-11#1)(2006-10#1)(2006-11#1)(2006-9#2)(2007-10#1)(2007-4#2)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
were doing##2##2##(2009-4#1)(2010-7#1)
were dominant and##2##3##(1994-9#1)(2011-2#1)
were dominant in##2##3##(2008-10#2)
were dominant##9##2##(1994-9#1)(2008-10#3)(2008-5#3)(2011-2#2)
were dominated by a##2##4##(2007-5#1)(2010-2#1)
were dominated by the##6##4##(2007-12#1)(2008-10#1)(2008-9#1)(2011-10#1)(2011-2#2)
were dominated by##18##3##(1995-10#1)(2005-11#1)(2007-12#1)(2007-5#2)(2008-1#1)(2008-10#4)(2008-9#1)(2010-2#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-12#2)
were dominated##19##2##(1995-10#1)(2005-11#1)(2007-12#1)(2007-5#2)(2008-1#1)(2008-10#5)(2008-9#1)(2010-2#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-12#2)
were done and##2##3##(2008-3#1)(2012-12#1)
were done as##3##3##(2007-12#1)(2008-6#1)(2008-8#1)
were done at##4##3##(1993-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
were done before##2##3##(2008-10#1)(2013-1#1)
were done by using the##2##5##(2013-8#2)
were done by##11##3##(1992-11#1)(2008-10#5)(2008-12#1)(2008-5#1)(2013-1#1)(2013-8#2)
were done for##2##3##(1995-1#1)(2008-5#1)
were done from##3##3##(1994-3#1)(1996-3#1)(2011-2#1)
were done in duplicate##2##4##(2006-10#1)(2008-5#1)
were done in##14##3##(1990-8#1)(1995-2#1)(1995-7#1)(1996-3#1)(2006-10#2)(2006-5#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-5#1)(2011-1#1)(2013-1#2)
were done of##2##3##(1996-7#1)(2008-5#1)
were done on##8##3##(1996-3#1)(1996-5#1)(1997-2#1)(2008-12#1)(2008-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
were done simultaneously##2##3##(2005-11#1)(2011-2#1)
were done to determine the##2##5##(1991-3#1)(2008-11#1)
were done to##7##3##(1990-5#1)(1991-3#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)
were done under##2##3##(2008-5#1)(2013-8#1)
were done using##7##3##(2007-1#1)(2007-8#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
were done with##7##3##(1990-9#1)(1996-12#1)(1997-4#1)(2006-8#1)(2007-7#1)(2008-12#1)(2013-1#1)
were done##109##2##(1990-5#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-5#1)(1992-11#1)(1993-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-7#1)(1996-12#1)(1996-3#3)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-10#3)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#7)(2007-8#3)(2008-1#1)(2008-10#14)(2008-11#1)(2008-12#3)(2008-3#2)(2008-5#8)(2008-6#2)(2008-7#1)(2008-8#3)(2009-6#1)(2010-12#1)(2011-1#5)(2011-2#5)(2012-12#3)(2012-2#3)(2013-1#6)(2013-7#1)(2013-8#6)
were dose dependent##3##3##(1996-9#1)(2009-5#1)(2012-12#1)
were dose##4##2##(1996-9#1)(2008-8#1)(2009-5#1)(2012-12#1)
were dose-dependent and##2##3##(1995-5#1)(2008-5#1)
were dose-dependent in##2##3##(1994-11#1)(1996-12#1)
were dose-dependent##9##2##(1991-10#1)(1994-11#1)(1994-9#1)(1995-5#1)(1996-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2012-2#1)
were dose-related##2##2##(1992-9#1)(2008-9#1)
were dosed with##3##3##(1997-3#1)(2008-10#1)(2008-5#1)
were dosed##6##2##(1995-12#1)(1997-3#2)(2008-10#1)(2008-5#2)
were double##2##2##(1995-5#1)(2013-7#1)
were double-labeled##3##2##(1993-11#1)(1997-1#1)(1997-6#1)
were down##3##2##(1995-2#1)(2008-10#1)(2012-2#1)
were down-regulated and##2##3##(2010-4#1)(2013-8#1)
were down-regulated in##2##3##(2006-11#1)(2008-10#1)
were down-regulated##6##2##(1997-5#1)(2006-11#1)(2008-10#2)(2010-4#1)(2013-8#1)
were downregulated##7##2##(2010-12#4)(2010-5#1)(2011-2#1)(2013-7#1)
were dramatic##2##2##(1990-11#1)(1993-5#1)
were dramatically increased##6##3##(1990-9#1)(1992-11#1)(1995-12#1)(1996-10#1)(1996-5#1)(2008-6#1)
were dramatically reduced in##2##4##(1991-12#1)(2012-12#1)
were dramatically##12##2##(1990-8#1)(1990-9#1)(1991-12#1)(1992-11#1)(1994-12#1)(1995-12#1)(1996-10#1)(1996-5#1)(2008-6#1)(2008-9#1)(2012-12#1)(2013-8#1)
were drastically reduced##2##3##(2008-5#2)
were drawn and##2##3##(1997-1#1)(2008-10#1)
were drawn before##3##3##(1990-11#1)(1991-6#1)(1992-12#1)
were drawn for##2##3##(2009-6#1)(2010-10#1)
were drawn from a##4##4##(1992-2#1)(2009-7#1)(2011-2#1)(2013-7#1)
were drawn from an##2##4##(2008-9#1)(2013-1#1)
were drawn from the##4##4##(2007-11#1)(2008-1#1)(2008-10#1)(2011-1#1)
were drawn from##15##3##(1992-2#1)(1993-12#1)(1993-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)
were drawn##35##2##(1990-11#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-11#1)(1997-1#1)(1997-3#1)(2004-7#1)(2005-12#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
were dried##5##2##(2008-10#3)(2010-12#1)(2013-7#1)
were driven by the##2##4##(2006-12#1)(2008-10#1)
were driven by##3##3##(2006-12#1)(2008-10#1)(2008-9#1)
were driven##6##2##(1992-6#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)
were dropped##3##2##(2007-1#1)(2008-10#1)(2008-12#1)
were dry##2##2##(2006-10#1)(2008-10#1)
were due mainly to##2##4##(1995-5#1)(2010-4#1)
were due to a##7##4##(1991-5#1)(1994-12#1)(1996-12#1)(1997-1#1)(1997-4#1)(2008-10#1)(2009-5#1)
were due to alterations##2##4##(1997-2#1)(2008-8#1)
were due to an##2##4##(1995-1#1)(2008-5#1)
were due to other##2##4##(2007-2#1)(2010-8#1)
were due to the use of##2##6##(2006-7#1)(2011-2#1)
were due to the##8##4##(2005-11#1)(2006-7#1)(2007-6#1)(2008-2#1)(2009-2#1)(2010-12#1)(2011-2#1)(2013-1#1)
were due to##51##3##(1990-1#1)(1990-3#1)(1991-5#1)(1994-12#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#4)(2013-8#2)
were due##55##2##(1990-1#1)(1990-3#1)(1991-5#1)(1993-10#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-4#1)(2004-9#1)(2005-11#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#4)(2013-8#2)
were duplicated##2##2##(2004-4#1)(2006-11#1)
were during##2##2##(1992-1#1)(2008-10#1)
were each independently associated with##2##5##(2007-12#1)(2012-3#1)
were each seen in##2##4##(2007-7#1)(2008-1#1)
were each substantially##2##3##(1995-11#1)(1997-7#1)
were each##27##2##(1990-10#1)(1992-8#1)(1995-11#2)(1997-5#1)(1997-7#1)(2004-10#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#4)(2008-9#1)(2009-2#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#2)
were earlier##2##2##(2007-7#1)(2008-12#1)
were early##5##2##(1990-6#1)(1993-9#1)(2009-8#1)(2010-3#1)(2012-2#1)
were easily controlled##2##3##(2006-8#1)(2008-2#1)
were easily detected##3##3##(1992-7#1)(2008-10#1)(2010-8#1)
were easily identified by##2##4##(1992-2#1)(1996-12#1)
were easily##22##2##(1991-10#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-7#1)(1996-11#1)(1996-12#1)(2005-8#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-2#1)(2008-7#1)(2010-8#1)(2012-1#1)
were easy to perform##2##4##(1993-2#1)(1996-4#1)
were easy to##4##3##(1993-2#1)(1996-4#1)(2006-8#1)(2008-10#1)
were easy##5##2##(1993-2#1)(1996-4#1)(2006-8#1)(2008-10#1)(2012-1#1)
were ecologically##2##2##(2008-10#1)(2008-8#1)
were ectopic##2##2##(1995-6#1)(2006-7#1)
were educated about##2##3##(2006-2#1)(2011-2#1)
were educated##4##2##(2006-2#1)(2008-8#1)(2010-9#1)(2011-2#1)
were education##2##2##(1992-3#1)(2006-4#1)
were effective against##2##3##(2008-10#1)(2010-4#1)
were effective and##2##3##(1992-4#1)(2009-8#1)
were effective for##9##3##(1997-3#1)(2005-3#1)(2007-2#1)(2007-7#1)(2008-10#2)(2009-11#1)(2012-2#1)(2013-7#1)
were effective in controlling##3##4##(2008-10#1)(2008-5#1)(2011-12#1)
were effective in reducing the##2##5##(2007-8#1)(2008-10#1)
were effective in reducing##4##4##(1993-7#1)(1997-8#1)(2007-8#1)(2008-10#1)
were effective in the##5##4##(1996-5#1)(1997-6#1)(2007-12#1)(2008-10#1)(2012-2#1)
were effective in##31##3##(1990-5#1)(1990-8#1)(1992-1#1)(1993-2#1)(1993-7#1)(1994-6#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-1#1)(2005-11#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#1)(2011-12#1)(2012-2#1)
were effective inhibitors of##2##4##(1992-6#1)(1996-5#1)
were effective inhibitors##4##3##(1992-6#1)(1994-12#1)(1996-5#1)(1997-1#1)
were effective##62##2##(1990-5#1)(1990-8#1)(1992-1#1)(1992-4#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1996-12#1)(1996-4#2)(1996-5#2)(1997-1#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-1#1)(2005-11#1)(2005-3#1)(2006-11#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-5#4)(2008-6#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-4#1)(2011-12#2)(2012-11#1)(2012-2#2)(2013-1#2)(2013-7#1)
were effectively controlled##2##3##(2007-2#1)(2008-8#1)
were effectively##18##2##(1990-11#1)(1990-6#1)(1992-12#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-12#2)(2009-3#1)(2009-7#1)(2012-2#2)(2013-1#1)
were efficient##11##2##(1990-12#1)(1994-9#1)(1997-3#1)(2008-10#4)(2008-3#1)(2010-11#1)(2011-1#1)(2011-2#1)
were efficiently cleaved##2##3##(1992-5#1)(2008-10#1)
were efficiently incorporated into##2##4##(1997-2#1)(2008-10#1)
were efficiently separated##2##3##(2007-8#1)(2008-5#1)
were efficiently transmitted##2##3##(2008-10#2)
were efficiently##22##2##(1991-6#2)(1992-4#1)(1992-5#2)(1992-6#1)(1993-12#1)(1995-1#1)(1997-2#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-8#1)(2009-10#1)
were eight##9##2##(1992-2#1)(1993-12#2)(1997-3#1)(1997-5#1)(2006-8#1)(2008-1#1)(2008-3#1)(2008-5#1)
were either absent or##2##4##(2008-10#1)(2008-8#1)
were either congruent or##2##4##(2012-1#1)(2013-8#1)
were either cultured fresh##2##4##(2006-5#2)
were either from##2##3##(1995-11#1)(2008-4#1)
were either given##2##3##(1993-6#1)(1994-2#1)
were either homozygous##2##3##(2008-10#1)(2009-2#1)
were either less##2##3##(1994-10#1)(2004-4#1)
were either not##3##3##(2008-10#1)(2008-7#1)(2013-7#1)
were either overweight or obese##2##5##(2007-3#1)(2012-3#1)
were either positive##3##3##(1994-1#1)(2007-8#1)(2013-7#1)
were either reduced##2##3##(1996-12#1)(2008-7#1)
were either treated##4##3##(1995-8#1)(2007-10#1)(2007-9#1)(2010-12#1)
were either##87##2##(1990-2#2)(1990-4#1)(1990-9#1)(1991-11#1)(1992-11#2)(1992-2#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-9#1)(1995-11#1)(1995-8#3)(1996-12#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-6#1)(2004-4#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-5#4)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#11)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#2)(2009-2#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#2)(2013-8#2)
were elaborated##7##2##(1990-3#1)(1991-4#1)(1993-3#1)(2008-10#1)(2008-2#1)(2011-2#2)
were electively##2##2##(2007-8#2)
were electrically stimulated##3##3##(1991-6#1)(1997-2#1)(2013-1#1)
were electrochemically##2##2##(2008-10#2)
were electrodeposited##2##2##(2008-10#2)
were electrophoresed##2##2##(1991-7#1)(1993-6#1)
were elegible for##2##3##(1992-12#1)(2013-1#1)
were elevated at##2##3##(2010-6#1)(2010-8#1)
were elevated by##2##3##(2004-11#1)(2013-1#1)
were elevated in the##3##4##(1996-2#1)(2006-8#1)(2007-12#1)
were elevated in##26##3##(1990-10#1)(1991-3#1)(1991-4#1)(1992-9#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-2#1)(2005-11#1)(2005-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#1)(2013-8#1)
were elevated on##2##3##(1994-10#1)(2011-1#1)
were elevated##57##2##(1990-10#1)(1990-11#3)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-10#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-2#1)(1996-3#1)(1996-6#1)(2004-11#2)(2005-11#2)(2005-12#1)(2005-7#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-10#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#3)(2009-6#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
were elicited by##5##3##(1992-6#1)(1993-4#1)(2004-11#1)(2005-11#1)(2009-3#1)
were elicited in##3##3##(1995-7#1)(1996-2#1)(1996-9#1)
were elicited##17##2##(1990-2#1)(1991-6#1)(1992-6#1)(1993-12#2)(1993-4#1)(1995-7#1)(1996-2#1)(1996-9#1)(1997-5#1)(2004-11#1)(2005-11#1)(2006-8#1)(2007-7#1)(2008-8#1)(2009-3#1)(2010-2#1)
were eligible for analysis##2##4##(2010-3#1)(2012-2#1)
were eligible for evaluation##4##4##(1997-7#2)(2011-2#2)
were eligible for inclusion##3##4##(2006-2#1)(2010-12#1)(2013-1#1)
were eligible for the##2##4##(1997-7#1)(2012-3#1)
were eligible for this##2##4##(2013-1#1)(2013-8#1)
were eligible for##17##3##(1997-7#3)(1997-8#1)(2006-2#1)(2007-10#1)(2007-12#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
were eligible to##3##3##(2006-4#1)(2008-7#1)(2012-3#1)
were eligible##25##2##(1990-6#1)(1997-7#3)(1997-8#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-12#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
were eliminated by the##3##4##(1991-8#1)(2008-10#2)
were eliminated by##7##3##(1991-12#1)(1991-8#1)(1993-1#1)(2008-10#3)(2013-8#1)
were eliminated from the##4##4##(2005-10#1)(2007-6#2)(2008-10#1)
were eliminated with##3##3##(2008-10#3)
were eliminated##29##2##(1991-12#1)(1991-8#1)(1993-1#1)(1994-9#1)(1996-6#1)(2005-10#1)(2005-4#1)(2006-11#1)(2007-2#1)(2007-6#3)(2007-8#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-8#2)(2011-3#1)(2012-2#1)(2013-7#1)(2013-8#1)
were elongated##2##2##(2006-10#1)(2006-12#1)
were elucidated as##2##3##(2007-1#2)
were elucidated by spectroscopic##5##4##(2007-1#5)
were elucidated by##19##3##(1990-7#1)(1995-11#2)(2006-12#3)(2007-1#9)(2007-3#1)(2007-8#1)(2009-2#1)(2011-3#1)
were elucidated in##2##3##(2010-5#1)(2012-11#1)
were elucidated on the basis of spectroscopic##2##7##(2008-10#1)(2013-1#1)
were elucidated on the basis of##5##6##(2007-1#1)(2007-11#1)(2008-10#1)(2008-8#1)(2013-1#1)
were elucidated to be##2##4##(1994-3#1)(2007-1#1)
were elucidated##43##2##(1990-7#1)(1994-3#1)(1995-11#2)(1997-2#1)(1997-4#1)(2006-12#6)(2007-1#15)(2007-11#1)(2007-3#2)(2007-8#1)(2008-10#5)(2008-8#1)(2009-2#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-11#1)(2013-1#1)
were eluted at the##2##4##(1990-5#1)(1990-7#1)
were eluted at##3##3##(1990-5#1)(1990-7#1)(2007-8#1)
were eluted by##2##3##(1992-2#1)(2008-10#1)
were eluted from a##2##4##(1990-6#1)(2008-10#1)
were eluted from the column##3##5##(2008-10#2)(2012-12#1)
were eluted from the##7##4##(1992-12#1)(1994-9#1)(2008-10#4)(2012-12#1)
were eluted from##9##3##(1990-6#1)(1992-12#1)(1994-9#1)(2008-10#5)(2012-12#1)
were eluted in the##2##4##(1991-11#1)(2008-10#1)
were eluted in##3##3##(1991-11#1)(2008-10#2)
were eluted using##3##3##(1993-2#1)(1996-3#1)(2008-10#1)
were eluted with water##2##4##(2007-8#1)(2008-10#1)
were eluted with##9##3##(1990-4#1)(1991-3#1)(1995-7#1)(2007-8#1)(2008-10#5)
were eluted##40##2##(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-2#1)(1994-9#1)(1995-7#1)(1996-3#1)(1996-8#1)(1997-2#1)(2007-8#3)(2008-10#19)(2012-12#1)
were embarrassed##2##2##(1992-10#1)(2008-4#1)
were embedded in##8##3##(1994-6#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2009-11#1)(2012-3#1)(2013-1#1)
were embedded##10##2##(1994-6#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-11#1)(2009-4#1)(2012-3#1)(2013-1#1)
were embolized##4##2##(1991-2#1)(2006-12#1)(2007-9#1)(2012-12#1)
were emitted##2##2##(2008-3#1)(2011-10#1)
were emphasised##3##2##(2007-11#1)(2008-10#1)(2010-2#1)
were emphasized##2##2##(1995-8#1)(2006-12#1)
were employed and##2##3##(1991-11#1)(2008-10#1)
were employed as##12##3##(1991-12#1)(1993-3#1)(1996-8#1)(1997-2#1)(1997-5#1)(2005-11#1)(2008-10#3)(2010-5#1)(2012-1#1)(2012-3#1)
were employed by##3##3##(1996-9#1)(2008-10#1)(2008-4#1)
were employed for the identification of##2##6##(2008-10#1)(2010-7#1)
were employed for the##10##4##(1995-1#1)(2008-10#6)(2008-5#1)(2008-7#1)(2010-7#1)
were employed for##19##3##(1995-1#1)(2006-6#2)(2008-10#10)(2008-5#1)(2008-7#2)(2009-3#1)(2010-7#1)(2011-2#1)
were employed in a##2##4##(1994-6#1)(1997-1#1)
were employed in order to##2##5##(1997-7#1)(2004-9#1)
were employed in the##9##4##(1992-9#1)(1996-8#1)(1997-8#1)(2006-2#1)(2007-12#2)(2007-8#1)(2008-12#1)(2013-1#1)
were employed in##18##3##(1990-5#1)(1992-9#1)(1994-6#1)(1996-8#1)(1997-1#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-2#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-12#1)(2010-11#1)(2011-2#1)(2013-1#1)
were employed more##2##3##(1990-4#1)(1994-2#1)
were employed to assess the##3##5##(1995-12#1)(1996-2#1)(2008-2#1)
were employed to assess##5##4##(1995-12#1)(1995-8#1)(1996-2#1)(2008-2#1)(2013-1#1)
were employed to confirm##2##4##(2008-7#1)(2013-8#1)
were employed to define##2##4##(1990-4#1)(1994-11#1)
were employed to estimate the##2##5##(2012-11#1)(2013-8#1)
were employed to estimate##3##4##(2008-9#1)(2012-11#1)(2013-8#1)
were employed to examine the##4##5##(1992-8#1)(1997-5#1)(2007-4#1)(2012-2#1)
were employed to examine##5##4##(1992-8#1)(1997-5#1)(2007-4#1)(2008-10#1)(2012-2#1)
were employed to explore##2##4##(2007-8#1)(2008-8#1)
were employed to investigate the##2##5##(2009-7#1)(2010-7#1)
were employed to study the##2##5##(1997-7#1)(2013-8#1)
were employed to##50##3##(1990-3#1)(1990-4#1)(1992-8#1)(1994-11#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-8#1)(1996-2#1)(1997-5#1)(1997-7#1)(2004-9#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-7#1)(2010-7#1)(2011-3#1)(2012-11#1)(2012-2#2)(2013-1#1)(2013-8#4)
were employed##154##2##(1990-10#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-8#2)(1991-11#2)(1991-12#1)(1991-5#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-3#2)(1993-9#2)(1994-11#3)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-5#5)(1997-7#2)(1997-8#1)(2004-9#2)(2005-11#2)(2006-2#1)(2006-6#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#29)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#4)(2008-8#3)(2008-9#3)(2009-11#1)(2009-3#1)(2009-7#2)(2010-11#1)(2010-5#1)(2010-7#4)(2011-2#2)(2011-3#1)(2012-1#1)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#4)
were employees##2##2##(2006-7#1)(2007-2#1)
were encapsulated within##2##3##(2008-5#1)(2010-4#1)
were encapsulated##3##2##(2008-10#1)(2008-5#1)(2010-4#1)
were enclosed##3##2##(2008-10#2)(2008-4#1)
were encountered during the##2##4##(2008-10#1)(2008-5#1)
were encountered during##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
were encountered in the##2##4##(2007-7#1)(2011-2#1)
were encountered in##12##3##(1991-3#1)(1995-3#1)(2005-9#1)(2006-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-4#1)(2011-2#2)
were encountered##31##2##(1990-3#1)(1991-2#1)(1991-3#2)(1995-3#1)(1996-9#1)(2004-10#1)(2005-12#1)(2005-9#1)(2006-11#1)(2006-7#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#4)(2008-3#1)(2008-5#2)(2008-9#1)(2009-4#1)(2011-2#2)(2012-2#2)
were encouraging##4##2##(1991-6#2)(2008-1#1)(2010-1#1)
were endometrial##2##2##(2007-3#2)
were endotoxin##2##2##(1996-1#2)
were energy##2##2##(1995-1#1)(2007-2#1)
were engaged in the##2##4##(2008-5#1)(2011-7#1)
were engaged in##6##3##(2007-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-7#1)(2013-7#1)
were engaged##8##2##(2007-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-7#1)(2013-7#1)
were engineered for##2##3##(1997-2#1)(2008-7#1)
were engineered to##2##3##(1994-8#1)(2010-2#1)
were engineered##8##2##(1991-4#1)(1994-8#1)(1995-1#1)(1997-2#1)(2008-7#1)(2010-2#1)(2012-11#2)
were enhanced after##2##3##(1995-3#1)(2008-10#1)
were enhanced by the presence of##2##6##(1997-7#1)(2005-11#1)
were enhanced by##11##3##(1992-8#1)(1997-7#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
were enhanced in the latently infected strain##2##7##(2008-10#2)
were enhanced in##5##3##(1997-2#1)(2008-10#2)(2008-7#1)(2009-8#1)
were enhanced##30##2##(1992-3#1)(1992-8#1)(1995-3#1)(1995-4#1)(1996-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-11#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#1)
were enlarged in##2##3##(1994-11#1)(2008-10#1)
were enlarged##7##2##(1994-11#1)(1995-11#1)(1995-2#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-7#1)
were enriched from##2##3##(1994-3#1)(2008-10#1)
were enriched in the##3##4##(1994-8#1)(2008-10#2)
were enriched in##8##3##(1990-12#1)(1993-6#1)(1994-8#1)(2008-10#3)(2009-8#1)(2013-8#1)
were enriched with##6##3##(1992-1#1)(1994-2#1)(2006-4#1)(2008-10#1)(2008-11#2)
were enriched##21##2##(1990-12#1)(1992-1#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-8#1)(1997-2#1)(2006-4#1)(2008-10#6)(2008-11#2)(2008-4#1)(2009-12#1)(2009-8#1)(2013-8#1)
were enrolled and##7##3##(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#4)
were enrolled as##2##3##(2007-2#1)(2012-2#1)
were enrolled at##2##3##(2010-6#1)(2013-8#1)
were enrolled during the##2##4##(1995-9#1)(2007-7#1)
were enrolled for the study##2##5##(2008-3#1)(2010-7#1)
were enrolled for the##3##4##(2008-3#1)(2010-7#1)(2012-3#1)
were enrolled for##6##3##(2008-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
were enrolled from##2##3##(2008-8#1)(2012-12#1)
were enrolled in a phase##2##5##(2006-6#1)(2008-6#1)
were enrolled in a prospective##5##5##(1996-3#1)(2006-10#1)(2006-7#1)(2007-7#1)(2008-9#1)
were enrolled in a##14##4##(1995-9#1)(1996-3#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-6#2)(2008-9#1)(2010-4#1)(2012-3#1)(2013-1#1)
were enrolled in an on-going crash surveillance system which links insurance claims data to##2##14##(2006-11#1)(2007-1#1)
were enrolled in an##4##4##(2006-11#1)(2007-1#1)(2009-11#1)(2012-12#1)
were enrolled in the study between##2##6##(2008-11#1)(2012-2#1)
were enrolled in the study##16##5##(1994-2#1)(2006-10#2)(2006-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
were enrolled in the##21##4##(1994-2#1)(2006-10#3)(2006-2#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#2)
were enrolled in this study##13##5##(1994-12#1)(2006-6#1)(2007-2#2)(2007-8#3)(2008-1#1)(2008-8#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
were enrolled in this##17##4##(1994-12#1)(2006-6#1)(2007-2#3)(2007-8#3)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#2)
were enrolled in##68##3##(1991-12#1)(1994-12#1)(1994-2#1)(1995-9#1)(1996-12#1)(1996-3#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-3#1)(2006-6#2)(2006-7#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#4)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#4)
were enrolled into##3##3##(2007-8#1)(2008-1#1)(2008-6#1)
were enrolled onto##3##3##(2006-6#2)(2008-6#1)
were enrolled to##4##3##(2004-11#1)(2006-8#1)(2008-6#1)(2010-7#1)
were enrolled##149##2##(1990-3#1)(1991-12#1)(1992-10#1)(1994-12#1)(1994-2#1)(1995-9#2)(1996-12#1)(1996-3#1)(1997-2#1)(2004-1#1)(2004-11#1)(2005-7#1)(2006-10#5)(2006-11#1)(2006-2#1)(2006-3#1)(2006-6#5)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#3)(2007-12#1)(2007-2#6)(2007-7#3)(2007-8#7)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#6)(2008-7#7)(2008-8#2)(2008-9#2)(2009-11#1)(2009-3#1)(2009-7#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#2)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#4)(2011-1#3)(2011-11#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#6)(2012-3#4)(2013-1#13)(2013-7#2)(2013-8#6)
were entered in the##3##4##(2007-8#1)(2008-4#1)(2008-7#1)
were entered in this study##2##5##(1990-2#1)(2007-2#1)
were entered in this##3##4##(1990-2#1)(1994-7#1)(2007-2#1)
were entered in##7##3##(1990-2#1)(1993-1#1)(1994-7#1)(2007-2#1)(2007-8#1)(2008-4#1)(2008-7#1)
were entered into a##3##4##(1996-8#1)(2008-1#1)(2008-6#1)
were entered into the study##2##5##(2008-1#1)(2011-1#1)
were entered into the##3##4##(2007-7#1)(2008-1#1)(2011-1#1)
were entered into##7##3##(1996-8#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-6#1)(2011-1#1)
were entered##18##2##(1990-2#1)(1993-1#1)(1994-7#1)(1996-8#1)(2004-2#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-11#1)(2011-1#1)(2013-1#2)
were entertained##2##2##(1993-7#1)(2009-7#1)
were entirely##6##2##(1990-11#1)(1997-4#1)(2008-10#3)(2008-6#1)
were entrapped in##2##3##(2004-8#1)(2008-10#1)
were entrapped##3##2##(2004-8#1)(2005-11#1)(2008-10#1)
were enucleated##3##2##(1994-8#1)(1995-9#1)(2008-9#1)
were enumerated##3##2##(2006-8#1)(2007-5#1)(2008-8#1)
were enzymatically##3##2##(1995-5#1)(1997-6#1)(2008-5#1)
were equal in their##2##4##(2006-10#1)(2012-3#1)
were equal in##4##3##(2006-10#1)(2008-10#1)(2008-5#1)(2012-3#1)
were equal to 0##2##4##(2005-11#1)(2008-2#1)
were equal to or##4##4##(1992-9#1)(1997-6#1)(2006-8#1)(2008-10#1)
were equal to##9##3##(1992-3#1)(1992-9#1)(1995-3#1)(1997-6#1)(2005-11#1)(2006-8#1)(2008-10#2)(2008-2#1)
were equal##21##2##(1992-3#1)(1992-9#1)(1995-3#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#2)(2012-3#1)
were equally able to##2##4##(1995-11#1)(2012-2#1)
were equally effective against##2##4##(2008-10#2)
were equally effective at##2##4##(2007-9#1)(2013-8#1)
were equally effective in##7##4##(1993-1#1)(1995-10#2)(1995-5#1)(2008-10#2)(2008-5#1)
were equally effective##13##3##(1993-1#1)(1994-8#1)(1995-10#2)(1995-5#1)(2007-9#1)(2008-10#4)(2008-4#1)(2008-5#1)(2013-8#1)
were equally likely to##3##4##(1995-3#1)(2006-6#1)(2007-10#1)
were equally potent in##2##4##(1992-3#1)(2008-4#1)
were equally potent##3##3##(1991-9#1)(1992-3#1)(2008-4#1)
were equally sensitive##3##3##(1992-10#1)(1992-3#1)(2007-3#1)
were equally specific##2##3##(2005-8#1)(2007-2#1)
were equally suitable for##2##4##(2007-8#1)(2008-6#1)
were equally susceptible to##2##4##(1995-11#1)(2008-10#1)
were equally susceptible##4##3##(1995-11#1)(1997-3#1)(2008-10#2)
were equally##53##2##(1991-9#1)(1992-10#1)(1992-3#3)(1992-8#1)(1993-1#1)(1994-2#1)(1994-8#1)(1995-10#2)(1995-11#2)(1995-3#1)(1995-5#1)(1996-3#1)(1997-3#1)(1997-6#1)(1997-9#1)(2005-8#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-2#2)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
were equipotent##3##2##(1995-12#1)(1995-3#1)(1997-5#1)
were equipped with##5##3##(1990-12#1)(2007-1#1)(2007-4#1)(2007-5#1)(2008-8#1)
were equivalent to##7##3##(1993-1#1)(1993-8#1)(1994-8#1)(1996-5#1)(2007-1#1)(2008-11#1)(2008-4#1)
were equivalent##14##2##(1993-1#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-5#1)(1996-2#1)(1996-5#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)
were especially##5##2##(1990-9#1)(1994-6#1)(2008-10#1)(2009-12#1)(2009-9#1)
were essential for##5##3##(1991-9#1)(2006-12#1)(2008-10#2)(2013-1#1)
were essential##6##2##(1991-9#1)(2006-12#1)(2008-10#3)(2013-1#1)
were essentially identical##3##3##(1996-6#1)(1997-4#1)(2008-8#1)
were essentially similar to##3##4##(1991-2#1)(1995-1#1)(2007-11#1)
were essentially the same in##2##5##(1995-5#1)(2008-10#1)
were essentially the same##4##4##(1990-7#1)(1993-4#1)(1995-5#1)(2008-10#1)
were essentially##26##2##(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-3#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-9#2)(1995-1#1)(1995-5#1)(1996-6#1)(1997-2#1)(1997-4#2)(2005-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-8#1)(2013-1#1)
were established after##2##3##(2008-10#1)(2012-11#1)
were established and the##2##4##(1990-11#1)(2008-12#1)
were established and##11##3##(1990-11#1)(1991-12#1)(1994-8#1)(2004-12#1)(2005-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#2)(2010-12#1)
were established as##9##3##(2007-1#2)(2007-11#1)(2008-10#4)(2008-11#1)(2012-3#1)
were established at##4##3##(1994-9#1)(2007-5#1)(2010-12#1)(2012-2#1)
were established between##2##3##(2008-10#1)(2008-5#1)
were established by means of##2##5##(2007-11#1)(2008-11#1)
were established by spectral##2##4##(2007-1#2)
were established by spectroscopic analysis##2##5##(2006-12#1)(2007-1#1)
were established by spectroscopic##4##4##(2006-12#1)(2007-1#3)
were established by the##2##4##(2006-11#1)(2010-12#1)
were established by##29##3##(1992-7#2)(1992-8#1)(1993-11#1)(1994-12#1)(2005-11#1)(2006-11#1)(2006-12#2)(2006-8#1)(2007-1#5)(2007-11#3)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#1)(2010-12#1)(2010-5#1)(2013-1#1)
were established for the##8##4##(2005-4#1)(2007-4#1)(2008-10#3)(2008-6#1)(2011-2#1)(2012-12#1)
were established for##16##3##(1992-10#1)(1994-9#1)(2005-4#1)(2006-8#1)(2007-4#1)(2008-10#6)(2008-4#1)(2008-6#1)(2011-12#1)(2011-2#1)(2012-12#1)
were established from a##2##4##(1992-11#1)(1996-11#1)
were established from##11##3##(1990-7#1)(1992-11#1)(1993-7#1)(1995-1#1)(1996-11#1)(1996-2#1)(1997-4#1)(2008-10#1)(2008-11#2)(2011-2#1)
were established in a##2##4##(1997-1#1)(2008-10#1)
were established in the##4##4##(1997-4#1)(2008-10#3)
were established in##10##3##(1997-1#1)(1997-4#1)(2008-10#6)(2008-5#1)(2013-8#1)
were established on the basis of##3##6##(2007-11#2)(2008-5#1)
were established on##6##3##(2006-10#1)(2007-1#1)(2007-11#2)(2007-8#1)(2008-5#1)
were established through##2##3##(2006-12#1)(2008-10#1)
were established to##11##3##(1990-4#1)(2007-11#1)(2008-10#7)(2013-1#2)
were established using##5##3##(1991-2#1)(1991-9#1)(1997-9#1)(2008-5#2)
were established with##6##3##(2007-10#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-3#1)(2013-1#1)
were established##186##2##(1990-11#1)(1990-4#2)(1990-5#1)(1990-7#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-7#1)(1994-12#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-9#1)(2004-12#1)(2005-11#1)(2005-12#1)(2005-4#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-8#2)(2007-1#8)(2007-10#1)(2007-11#7)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#56)(2008-11#9)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#11)(2008-6#1)(2008-8#2)(2008-9#5)(2009-2#1)(2009-3#1)(2010-12#3)(2010-5#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
were estimated and##4##3##(2008-10#2)(2012-12#1)(2013-8#1)
were estimated as 0##3##4##(2008-10#3)
were estimated as##15##3##(1996-11#1)(1997-8#1)(2007-8#1)(2008-10#11)(2010-4#1)
were estimated at each##2##4##(2008-10#2)
were estimated at##8##3##(1991-1#1)(2007-8#1)(2007-9#1)(2008-10#4)(2011-2#1)
were estimated by using##4##4##(1994-5#1)(2006-10#1)(2008-10#2)
were estimated by##25##3##(1991-9#1)(1993-9#1)(1994-5#1)(1996-1#1)(1996-7#1)(1997-7#1)(2006-10#1)(2007-8#1)(2008-10#12)(2008-2#1)(2008-3#1)(2008-5#1)(2009-8#1)(2011-2#1)
were estimated following##2##3##(1994-10#1)(2007-10#1)
were estimated for each##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
were estimated for the##3##4##(1995-11#1)(2006-11#1)(2013-4#1)
were estimated for##15##3##(1995-11#1)(2006-11#1)(2006-12#1)(2007-11#1)(2008-10#6)(2008-5#1)(2008-8#1)(2010-9#1)(2011-2#1)(2013-4#1)
were estimated from a##3##4##(1992-4#1)(2008-12#1)(2008-5#1)
were estimated from the analytical curves##2##6##(2008-10#2)
were estimated from the dependence of##2##6##(2005-11#2)
were estimated from the##12##4##(1997-4#1)(2005-11#2)(2007-12#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-5#1)(2010-2#1)
were estimated from##23##3##(1992-4#1)(1996-5#1)(1997-4#1)(2005-11#2)(2007-12#2)(2007-8#1)(2008-10#5)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-12#1)
were estimated in a##2##4##(2005-12#1)(2008-12#1)
were estimated in##14##3##(1990-2#1)(2004-11#1)(2005-12#1)(2006-10#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-6#1)(2009-7#1)(2012-12#1)
were estimated on##2##3##(2009-6#1)(2011-2#1)
were estimated to be 0##3##5##(1994-6#1)(1997-8#1)(2008-10#1)
were estimated to be approximately##2##5##(1996-7#1)(2008-5#1)
were estimated to be less than##2##6##(1990-11#1)(2008-10#1)
were estimated to be##24##4##(1990-11#1)(1992-3#1)(1992-7#1)(1994-6#1)(1995-1#1)(1996-2#1)(1996-7#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-12#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-5#1)(2010-4#2)(2010-8#1)(2012-12#1)
were estimated to##32##3##(1990-11#1)(1992-3#1)(1992-7#1)(1993-3#1)(1994-6#1)(1995-1#1)(1996-2#1)(1996-7#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-12#1)(2008-10#7)(2008-2#1)(2008-3#3)(2008-5#1)(2010-4#2)(2010-8#1)(2012-12#1)(2012-2#3)
were estimated using the##4##4##(1996-9#1)(2004-11#1)(2008-11#1)(2011-2#1)
were estimated using##14##3##(1996-9#1)(2004-11#1)(2006-10#1)(2007-1#1)(2007-7#1)(2007-9#1)(2008-11#1)(2009-11#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
were estimated with##6##3##(2007-11#1)(2008-5#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
were estimated##217##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-1#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-11#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-7#2)(1996-9#1)(1997-4#2)(1997-7#1)(1997-8#2)(2004-10#1)(2004-11#2)(2005-11#4)(2005-12#1)(2005-7#1)(2006-10#5)(2006-11#1)(2006-12#3)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-2#2)(2007-3#1)(2007-6#2)(2007-7#3)(2007-8#8)(2007-9#3)(2008-10#58)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#9)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-6#3)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#4)(2010-6#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#12)(2012-12#7)(2012-2#4)(2012-3#2)(2013-1#5)(2013-4#1)(2013-7#1)(2013-8#4)
were estrus synchronized with MGA##2##5##(2006-5#2)
were etched##5##2##(1990-7#1)(2005-4#1)(2006-2#1)(2006-8#1)(2008-2#1)
were euthanased##4##2##(1993-7#1)(1996-11#1)(1996-6#1)(1997-8#1)
were euthanised##2##2##(2005-7#1)(2009-4#1)
were euthanized##5##2##(1995-11#1)(2007-1#1)(2008-10#1)(2010-8#1)(2011-2#1)
were euthyroid##3##2##(1990-6#1)(2006-9#1)(2013-8#1)
were evacuated##3##2##(1992-6#1)(2009-4#1)(2012-2#1)
were evaluable for response##6##4##(1991-6#1)(1992-4#1)(2007-10#1)(2008-6#3)
were evaluable for##10##3##(1990-10#1)(1990-12#1)(1991-6#1)(1992-4#1)(2007-10#1)(2008-6#5)
were evaluable##21##2##(1990-10#2)(1990-12#1)(1990-2#3)(1991-3#1)(1991-4#1)(1991-6#1)(1992-4#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-6#5)(2008-7#2)
were evaluated according to the##4##5##(2007-8#2)(2008-10#1)(2011-1#1)
were evaluated according to##7##4##(2007-8#3)(2008-10#1)(2010-4#1)(2011-1#1)(2013-1#1)
were evaluated after##8##3##(1992-4#1)(1993-11#1)(1996-1#1)(2008-2#1)(2008-5#1)(2010-4#1)(2013-1#1)(2013-8#1)
were evaluated against##2##3##(2007-10#1)(2007-4#1)
were evaluated and a##2##4##(2008-11#1)(2013-1#1)
were evaluated and compared in##2##5##(1997-5#1)(2008-10#1)
were evaluated and compared with##3##5##(2008-10#3)
were evaluated and compared##6##4##(1997-5#1)(2008-10#4)(2008-5#1)
were evaluated and found to##2##5##(2005-11#2)
were evaluated and the results##2##5##(2008-10#2)
were evaluated and the##7##4##(1991-5#1)(2006-8#1)(2008-10#5)
were evaluated and##29##3##(1991-5#1)(1992-3#1)(1992-6#1)(1997-5#1)(2004-12#1)(2005-11#2)(2006-8#1)(2007-1#1)(2008-10#14)(2008-11#1)(2008-5#2)(2011-2#1)(2012-2#1)(2013-1#1)
were evaluated as to##2##4##(2004-11#1)(2011-2#1)
were evaluated as##23##3##(1991-9#1)(1996-11#1)(1996-9#1)(1997-5#1)(2004-11#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-2#1)(2007-7#1)(2008-10#4)(2008-6#1)(2009-2#1)(2009-9#1)(2010-4#2)(2011-1#2)(2011-2#1)(2012-2#1)
were evaluated at four##3##4##(2006-5#1)(2008-10#1)(2008-11#1)
were evaluated at the##3##4##(2008-10#2)(2008-4#1)
were evaluated at##17##3##(1991-2#1)(1992-10#1)(1992-12#1)(2006-5#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
were evaluated based on##4##4##(2008-3#1)(2008-7#1)(2012-2#2)
were evaluated before and after##3##5##(1990-3#1)(2010-12#1)(2012-1#1)
were evaluated before##6##3##(1990-3#1)(2008-4#1)(2010-12#1)(2010-4#1)(2012-1#1)(2013-1#1)
were evaluated by ELISA##2##4##(1991-5#1)(2007-10#1)
were evaluated by a##3##4##(2007-4#1)(2007-8#1)(2008-11#1)
were evaluated by comparing the##2##5##(2008-10#2)
were evaluated by comparing##3##4##(2008-10#2)(2008-5#1)
were evaluated by determining##2##4##(1992-8#1)(2008-10#1)
were evaluated by means of a##3##6##(1990-3#1)(1991-12#1)(2008-6#1)
were evaluated by means of the##4##6##(2006-12#1)(2008-10#1)(2008-11#1)(2011-1#1)
were evaluated by means of##10##5##(1990-3#1)(1991-12#1)(1997-6#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-1#2)(2011-2#1)
were evaluated by measuring##2##4##(2008-10#1)(2009-11#1)
were evaluated by the analysis of##2##6##(2008-10#2)
were evaluated by the##9##4##(2005-7#1)(2006-9#1)(2007-8#1)(2008-10#5)(2008-6#1)
were evaluated by use of##2##5##(2006-6#1)(2008-3#1)
were evaluated by using the##2##5##(2009-10#1)(2013-8#1)
were evaluated by using##10##4##(1990-2#1)(2005-11#1)(2006-4#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-10#1)(2011-1#1)(2013-1#1)(2013-8#1)
were evaluated by##105##3##(1990-2#1)(1990-3#1)(1991-1#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-1#1)(1994-3#1)(1994-4#1)(1995-11#1)(1995-3#1)(1995-9#1)(1996-11#1)(1996-3#1)(1997-6#1)(2005-1#1)(2005-11#2)(2005-4#1)(2005-7#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-10#2)(2007-4#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-10#25)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2010-4#2)(2011-1#4)(2011-2#3)(2012-11#1)(2012-12#3)(2013-1#5)(2013-8#3)
were evaluated clinically and##2##4##(2007-8#1)(2008-3#1)
were evaluated clinically using##3##4##(2007-11#1)(2007-7#2)
were evaluated clinically##8##3##(2007-11#2)(2007-7#2)(2007-8#2)(2008-3#2)
were evaluated during a##2##4##(1991-12#1)(1995-2#1)
were evaluated during the##3##4##(1992-2#1)(2008-7#1)(2013-8#1)
were evaluated during##8##3##(1991-12#1)(1992-2#1)(1995-2#1)(1995-4#1)(2007-10#1)(2008-7#1)(2012-2#1)(2013-8#1)
were evaluated every##3##3##(2007-7#1)(2013-8#2)
were evaluated following##3##3##(1993-1#1)(2008-3#1)(2010-12#1)
were evaluated for analgesic##2##4##(2011-1#2)
were evaluated for efficacy##4##4##(1994-7#1)(2007-2#1)(2008-10#1)(2008-3#1)
were evaluated for gray leaf spot##2##6##(2008-10#2)
were evaluated for growth##2##4##(2006-10#1)(2008-6#1)
were evaluated for in vitro##2##5##(2010-2#1)(2011-1#1)
were evaluated for resistance to##4##5##(2008-10#4)
were evaluated for the determination of##3##6##(2008-10#3)
were evaluated for the presence##2##5##(2008-11#1)(2013-8#1)
were evaluated for the##21##4##(1990-11#1)(1990-12#1)(1991-5#1)(1997-8#1)(2004-8#1)(2008-10#10)(2008-11#2)(2008-3#1)(2011-2#1)(2011-3#1)(2013-8#1)
were evaluated for their ability to##8##6##(1992-7#1)(1992-9#1)(1996-2#1)(1996-8#1)(1997-1#1)(2008-10#2)(2009-3#1)
were evaluated for their capacity to##2##6##(1991-11#1)(2011-1#1)
were evaluated for their effect on##2##6##(2008-12#1)(2008-5#1)
were evaluated for their effects on the##3##7##(2004-12#1)(2008-10#1)(2011-2#1)
were evaluated for their effects on##5##6##(2004-12#1)(2008-10#3)(2011-2#1)
were evaluated for their##41##4##(1991-11#1)(1992-7#1)(1992-9#1)(1994-9#2)(1996-2#1)(1996-8#2)(1997-1#2)(1997-6#1)(2004-12#2)(2006-12#1)(2006-5#1)(2007-11#1)(2008-10#9)(2008-12#1)(2008-5#4)(2008-8#1)(2009-3#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-7#1)
were evaluated for this##2##4##(1993-6#1)(2010-5#1)
were evaluated for trace enrichment of metal ions##2##8##(2008-10#2)
were evaluated for trace##3##4##(2007-8#1)(2008-10#2)
were evaluated for##155##3##(1990-11#1)(1990-12#1)(1990-3#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-3#2)(1992-7#1)(1992-9#1)(1993-6#1)(1994-7#1)(1994-9#2)(1996-2#1)(1996-8#2)(1997-1#5)(1997-2#1)(1997-6#1)(1997-8#1)(2004-12#2)(2004-8#1)(2005-11#1)(2006-10#1)(2006-12#3)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#49)(2008-11#2)(2008-12#3)(2008-3#2)(2008-5#8)(2008-6#3)(2008-7#2)(2008-8#1)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#1)(2010-12#3)(2010-2#4)(2010-3#2)(2010-4#2)(2010-5#2)(2010-7#1)(2011-1#5)(2011-2#5)(2011-3#1)(2012-11#2)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
were evaluated four times##2##4##(2008-10#2)
were evaluated from the##3##4##(2008-3#1)(2008-5#1)(2008-6#1)
were evaluated from##6##3##(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-4#1)(2012-2#1)
were evaluated immunohistochemically for the expression of##2##7##(2007-8#1)(2010-3#1)
were evaluated in 29##2##4##(1991-2#1)(2008-10#1)
were evaluated in a##10##4##(1992-8#1)(2004-2#1)(2006-4#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-12#1)
were evaluated in all cases##2##5##(2006-6#1)(2008-5#1)
were evaluated in all##3##4##(1992-6#1)(2006-6#1)(2008-5#1)
were evaluated in an##2##4##(2008-10#1)(2011-2#1)
were evaluated in both##2##4##(2007-4#1)(2008-6#1)
were evaluated in clinical trials##2##5##(2007-10#1)(2008-8#1)
were evaluated in comparison##2##4##(2006-12#1)(2012-2#1)
were evaluated in detail##2##4##(2008-10#1)(2013-1#1)
were evaluated in greenhouse##2##4##(2008-10#2)
were evaluated in inoculated and##2##5##(2008-10#2)
were evaluated in relation to##4##5##(1991-12#1)(1991-5#1)(2009-12#1)(2013-8#1)
were evaluated in terms of##3##5##(2008-10#1)(2008-6#1)(2008-9#1)
were evaluated in the greenhouse for##2##6##(2008-10#2)
were evaluated in the presence of##2##6##(2008-10#1)(2008-12#1)
were evaluated in the presence##3##5##(2008-10#1)(2008-11#1)(2008-12#1)
were evaluated in the study##2##5##(2011-1#1)(2011-2#1)
were evaluated in the##21##4##(1991-6#1)(1993-7#1)(2006-4#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-11#1)(2013-8#1)
were evaluated in this##2##4##(2008-7#1)(2013-8#1)
were evaluated in three##3##4##(2008-10#2)(2013-8#1)
were evaluated in vitro##2##4##(2008-10#1)(2010-12#1)
were evaluated in##126##3##(1990-12#1)(1990-3#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-3#2)(1996-5#1)(1996-9#1)(1997-5#1)(1997-7#2)(2004-2#1)(2006-12#1)(2006-4#3)(2006-6#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-4#2)(2007-7#1)(2007-9#2)(2008-10#29)(2008-11#3)(2008-12#4)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#2)(2009-12#1)(2009-7#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-11#2)(2012-12#3)(2012-2#3)(2013-1#1)(2013-7#2)(2013-8#5)
were evaluated on a##2##4##(2008-10#1)(2013-1#1)
were evaluated on the basis of##4##6##(1991-1#1)(2007-7#1)(2007-8#1)(2008-5#1)
were evaluated on the##7##4##(1990-7#1)(1991-1#1)(2006-11#1)(2007-7#1)(2007-8#1)(2008-5#1)(2013-8#1)
were evaluated on##15##3##(1990-7#1)(1991-1#1)(1991-10#1)(1993-12#1)(1996-5#1)(2006-11#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2013-1#1)(2013-8#1)
were evaluated over a##3##4##(1993-8#1)(2006-8#1)(2012-2#1)
were evaluated over##6##3##(1993-8#1)(2006-8#1)(2008-10#1)(2008-7#1)(2011-1#1)(2012-2#1)
were evaluated prospectively##3##3##(1992-2#1)(2007-3#1)(2007-8#1)
were evaluated regarding##3##3##(1990-3#1)(2011-2#1)(2012-12#1)
were evaluated retrospectively##2##3##(2008-5#1)(2008-6#1)
were evaluated through##3##3##(2007-1#1)(2007-8#1)(2011-2#1)
were evaluated to determine the##2##5##(2008-10#2)
were evaluated to determine their##3##5##(2006-2#1)(2008-10#2)
were evaluated to determine##6##4##(2006-2#1)(2008-10#4)(2008-6#1)
were evaluated to##19##3##(1994-5#1)(1996-12#1)(1997-3#1)(2005-11#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-8#1)(2008-10#9)(2008-6#1)(2010-2#1)
were evaluated under controlled##2##4##(2008-10#2)
were evaluated under##6##3##(1997-3#1)(2008-10#4)(2010-11#1)
were evaluated using HPLC##2##4##(1994-8#1)(2012-2#1)
were evaluated using a##7##4##(1991-7#1)(1995-4#1)(2007-11#1)(2008-10#1)(2008-4#1)(2011-2#1)(2013-1#1)
were evaluated using the##7##4##(2006-11#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)
were evaluated using##48##3##(1991-7#1)(1992-12#1)(1994-10#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-4#1)(1996-10#1)(1996-3#1)(1996-7#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#13)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
were evaluated via##2##3##(1997-2#1)(2008-10#1)
were evaluated with a##3##4##(2008-3#1)(2008-8#1)(2011-2#1)
were evaluated with respect to the##2##6##(2011-2#1)(2012-2#1)
were evaluated with respect to##5##5##(1993-8#1)(2006-8#1)(2008-10#1)(2011-2#1)(2012-2#1)
were evaluated with the##6##4##(1996-11#1)(1996-8#1)(2005-11#1)(2008-10#1)(2012-2#1)(2013-1#1)
were evaluated with transvaginal color Doppler##2##6##(1995-3#2)
were evaluated with##26##3##(1993-8#1)(1995-2#1)(1995-3#2)(1996-11#2)(1996-8#1)(2005-11#1)(2006-10#1)(2006-8#2)(2007-9#1)(2008-10#6)(2008-3#1)(2008-8#1)(2009-10#1)(2011-2#2)(2012-2#2)(2013-1#1)
were evaluated##916##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#7)(1990-4#1)(1990-6#2)(1990-7#2)(1990-8#1)(1990-9#2)(1991-1#2)(1991-10#3)(1991-11#1)(1991-12#5)(1991-2#3)(1991-5#6)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#4)(1992-2#2)(1992-3#4)(1992-4#3)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#1)(1993-1#4)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#4)(1994-10#2)(1994-11#1)(1994-12#2)(1994-3#2)(1994-4#1)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#4)(1994-9#2)(1995-11#3)(1995-2#3)(1995-3#6)(1995-4#2)(1995-9#2)(1996-1#2)(1996-10#1)(1996-11#4)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#3)(1996-7#1)(1996-8#4)(1996-9#2)(1997-1#6)(1997-2#2)(1997-3#3)(1997-5#5)(1997-6#3)(1997-7#2)(1997-8#1)(2004-11#2)(2004-12#3)(2004-2#1)(2004-8#1)(2005-1#1)(2005-11#12)(2005-4#2)(2005-7#1)(2005-8#1)(2006-10#6)(2006-11#4)(2006-12#10)(2006-2#2)(2006-3#1)(2006-4#4)(2006-5#5)(2006-6#4)(2006-7#1)(2006-8#6)(2006-9#1)(2007-1#3)(2007-10#10)(2007-11#12)(2007-12#3)(2007-2#2)(2007-3#2)(2007-4#6)(2007-6#2)(2007-7#17)(2007-8#26)(2007-9#6)(2008-1#3)(2008-10#228)(2008-11#14)(2008-12#12)(2008-2#2)(2008-3#17)(2008-4#10)(2008-5#31)(2008-6#19)(2008-7#16)(2008-8#7)(2008-9#3)(2009-10#6)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#4)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#2)(2010-11#3)(2010-12#11)(2010-2#6)(2010-3#5)(2010-4#13)(2010-5#3)(2010-7#1)(2010-8#4)(2011-1#19)(2011-12#3)(2011-2#31)(2011-3#2)(2012-1#2)(2012-11#5)(2012-12#19)(2012-2#20)(2012-3#4)(2012-5#1)(2012-7#1)(2013-1#30)(2013-7#6)(2013-8#22)
were evaporated and##2##3##(1990-12#1)(2008-3#1)
were evaporated to dryness##3##4##(2005-12#1)(2008-10#2)
were evaporated under##2##3##(1997-8#1)(2008-11#1)
were evaporated##7##2##(1990-12#1)(1997-8#1)(2005-12#1)(2008-10#2)(2008-11#1)(2008-3#1)
were even more pronounced##2##4##(1996-1#1)(2008-7#1)
were even##10##2##(1996-1#1)(2005-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#2)(2011-2#1)
were evenly distributed throughout the##3##5##(2010-8#1)(2012-11#2)
were evenly distributed##6##3##(1991-2#1)(1994-7#1)(2008-12#1)(2010-8#1)(2012-11#2)
were eventually##6##2##(1993-3#1)(1993-5#1)(2005-12#1)(2007-12#1)(2007-2#1)(2009-8#1)
were ever##4##2##(1995-1#1)(1997-3#1)(2007-3#1)(2009-4#1)
were evidence##2##2##(1994-12#1)(1995-11#1)
were evidenced after##2##3##(2006-12#1)(2008-5#1)
were evidenced by##2##3##(2008-10#1)(2008-5#1)
were evidenced in##3##3##(1994-3#1)(2008-10#1)(2009-10#1)
were evidenced to##2##3##(2008-5#1)(2012-3#1)
were evidenced##12##2##(1994-3#2)(2006-12#1)(2008-10#2)(2008-5#3)(2009-10#1)(2010-2#1)(2012-3#2)
were evident after##4##3##(1993-12#1)(1994-12#1)(2007-11#1)(2012-3#1)
were evident among##2##3##(1994-1#1)(2008-10#1)
were evident by 2##2##4##(1993-4#1)(1997-3#1)
were evident by##3##3##(1993-4#1)(1993-9#1)(1997-3#1)
were evident for##2##3##(1990-4#1)(1994-2#1)
were evident from##2##3##(2008-10#1)(2008-11#1)
were evident in the##2##4##(2008-3#1)(2010-8#1)
were evident in##10##3##(1991-5#1)(1996-3#1)(2006-4#1)(2007-10#1)(2007-12#1)(2008-3#1)(2010-1#1)(2010-8#2)(2012-3#1)
were evident on the##2##4##(1997-6#1)(2011-12#1)
were evident on##3##3##(1997-6#1)(2008-10#1)(2011-12#1)
were evident##46##2##(1990-4#1)(1991-5#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-5#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#8)(2008-11#2)(2008-3#1)(2009-10#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-8#2)(2011-12#1)(2012-3#2)(2013-1#2)(2013-7#1)
were evoked by##6##3##(1991-6#2)(1992-5#1)(1992-9#1)(1995-11#1)(1995-12#1)
were evoked##8##2##(1990-4#1)(1991-6#2)(1992-5#1)(1992-9#1)(1995-11#1)(1995-12#1)(2011-2#1)
were exacerbated when##2##3##(2007-5#1)(2012-7#1)
were exacerbated##5##2##(1995-8#1)(2007-5#1)(2012-7#1)(2013-1#2)
were examined after##7##3##(1993-8#2)(1995-2#1)(1997-5#1)(1997-7#1)(2004-9#1)(2008-10#1)
were examined among##2##3##(1992-2#1)(2009-5#1)
were examined and a##2##4##(1991-9#1)(2007-12#1)
were examined and compared with##3##5##(1992-5#1)(1994-6#1)(2008-5#1)
were examined and compared##6##4##(1992-5#1)(1994-6#1)(2008-10#2)(2008-5#1)(2008-7#1)
were examined and found##2##4##(1994-10#1)(2007-12#1)
were examined and interviewed##2##4##(2011-2#1)(2013-1#1)
were examined and operated##2##4##(1991-4#2)
were examined and the##2##4##(2008-10#2)
were examined and##32##3##(1991-2#1)(1991-4#2)(1991-9#1)(1992-5#1)(1994-1#1)(1994-10#1)(1994-6#1)(1994-8#1)(1996-6#1)(2005-8#1)(2007-10#1)(2007-12#2)(2007-2#1)(2008-10#8)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-5#1)(2011-2#3)(2013-1#1)
were examined as possible predictors of##2##6##(2006-5#1)(2010-4#1)
were examined as well##2##4##(2008-10#1)(2010-7#1)
were examined as##9##3##(2006-5#1)(2008-10#4)(2009-8#1)(2010-4#1)(2010-7#1)(2011-2#1)
were examined at different##2##4##(2008-8#1)(2011-2#1)
were examined at the##7##4##(1991-12#1)(1993-8#1)(1995-11#2)(1996-6#1)(2008-10#1)(2010-12#1)
were examined at##18##3##(1990-12#1)(1991-12#1)(1992-9#1)(1993-8#1)(1995-11#2)(1996-5#1)(1996-6#1)(2006-10#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)
were examined before##5##3##(1990-4#1)(1990-8#1)(1991-11#1)(1991-8#1)(2009-6#1)
were examined both##2##3##(1992-12#1)(1995-12#1)
were examined by Fourier transform infrared##2##6##(1992-1#1)(1994-3#1)
were examined by a##2##4##(1995-9#1)(2004-1#1)
were examined by an##2##4##(1997-4#1)(2010-12#1)
were examined by electron##2##4##(1993-11#1)(2008-7#1)
were examined by gel filtration##2##5##(1992-5#1)(1992-8#1)
were examined by immunohistochemistry##3##4##(1995-8#1)(2007-6#1)(2008-4#1)
were examined by light microscopy##2##5##(2008-11#1)(2008-7#1)
were examined by light##3##4##(2008-11#1)(2008-5#1)(2008-7#1)
were examined by means of##4##5##(1991-12#1)(1995-8#1)(2011-2#1)(2013-1#1)
were examined by measuring##2##4##(1993-11#1)(1994-5#1)
were examined by microarray analysis##2##5##(2007-11#1)(2008-10#1)
were examined by restriction##2##4##(2005-9#1)(2008-10#1)
were examined by scanning electron microscopy##2##6##(2008-10#1)(2013-1#1)
were examined by the##5##4##(1994-6#1)(2006-10#2)(2008-5#1)(2013-1#1)
were examined by transmission electron microscopy##2##6##(1997-6#1)(2008-10#1)
were examined by using##6##4##(1992-11#1)(1994-3#1)(1994-8#1)(2005-11#1)(2006-10#1)(2009-11#1)
were examined by##102##3##(1990-11#1)(1990-4#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-11#3)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#2)(1993-10#1)(1993-11#2)(1993-3#1)(1993-4#1)(1993-5#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#2)(1995-2#1)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2004-1#1)(2004-11#1)(2005-11#1)(2005-9#1)(2006-10#3)(2006-4#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#14)(2008-11#2)(2008-12#2)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#3)(2009-11#1)(2009-6#1)(2010-12#2)(2010-5#2)(2010-9#1)(2011-2#2)(2013-1#6)
were examined clinically and##4##4##(1991-12#1)(1993-5#1)(2006-6#1)(2011-1#1)
were examined clinically##5##3##(1991-12#1)(1992-3#1)(1993-5#1)(2006-6#1)(2011-1#1)
were examined following##3##3##(1997-2#1)(2007-5#1)(2008-6#1)
were examined for all##2##4##(1993-10#1)(2008-10#1)
were examined for antibodies to##2##5##(1995-1#1)(2013-8#1)
were examined for physical signs of puberty##2##7##(2006-10#2)
were examined for presence of##2##5##(2006-6#1)(2007-7#1)
were examined for reports of fatal and non-fatal incidents involving tourists##2##11##(2007-2#2)
were examined for the presence of##7##6##(2006-1#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-5#1)
were examined for the presence##8##5##(2006-1#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-5#2)
were examined for the##19##4##(1990-10#1)(1991-12#1)(1991-8#1)(1992-3#1)(1996-8#1)(2006-1#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-5#2)(2013-1#1)
were examined for their ability to bind to##2##8##(1994-6#1)(2010-7#1)
were examined for their ability to##7##6##(1994-6#1)(1995-7#1)(2008-10#2)(2008-5#1)(2009-4#1)(2010-7#1)
were examined for their effects on##3##6##(1993-12#1)(1993-4#1)(2008-10#1)
were examined for their##22##4##(1990-10#1)(1990-4#1)(1991-2#1)(1992-2#1)(1993-10#1)(1993-12#2)(1993-4#1)(1994-6#2)(1995-7#1)(2006-12#1)(2008-10#6)(2008-4#1)(2008-5#1)(2009-4#1)(2010-7#1)
were examined for virulence##3##4##(2005-9#1)(2008-10#2)
were examined for##115##3##(1990-10#2)(1990-4#2)(1991-12#1)(1991-2#2)(1991-6#1)(1991-8#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-4#2)(1993-10#2)(1993-12#2)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#2)(1995-7#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-9#1)(2006-1#1)(2006-10#3)(2006-12#2)(2006-6#1)(2007-2#4)(2007-7#5)(2007-8#3)(2008-10#23)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-8#2)(2009-3#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
were examined from##3##3##(2006-9#1)(2010-1#1)(2010-8#1)
were examined histochemically##2##3##(1991-9#2)
were examined histologically##6##3##(1990-6#1)(1993-9#1)(2006-10#1)(2008-7#1)(2012-3#1)(2013-1#1)
were examined histopathologically##2##3##(2008-5#1)(2012-1#1)
were examined immunohistochemically with##2##4##(1995-11#1)(1995-12#1)
were examined immunohistochemically##3##3##(1995-11#1)(1995-12#1)(2008-4#1)
were examined in a double-blind##2##5##(1996-2#1)(2008-5#1)
were examined in a##14##4##(1992-9#1)(1993-4#1)(1996-2#1)(1996-3#1)(2006-1#1)(2006-9#1)(2008-10#4)(2008-5#1)(2008-9#1)(2009-9#1)(2010-6#1)
were examined in both##3##4##(1992-8#1)(1996-7#1)(2007-8#1)
were examined in comparison with##2##5##(1991-9#1)(2008-6#1)
were examined in cultured##2##4##(1995-12#1)(2008-11#1)
were examined in detail##2##4##(2008-10#2)
were examined in isolated##2##4##(1993-3#1)(2005-8#1)
were examined in male mice##2##5##(1990-3#1)(1990-7#1)
were examined in male##3##4##(1990-3#1)(1990-7#1)(2007-8#1)
were examined in mice##2##4##(1994-11#1)(1997-2#1)
were examined in order to##4##5##(1996-12#2)(1996-8#1)(2008-10#1)
were examined in rat##2##4##(1994-8#1)(1995-10#1)
were examined in rats##4##4##(1991-6#1)(1993-11#1)(1995-5#1)(1997-7#1)
were examined in relation to##5##5##(1994-8#1)(2005-11#1)(2008-5#1)(2011-1#1)(2013-1#1)
were examined in terms of##2##5##(2008-11#1)(2008-12#1)
were examined in the adult##2##5##(1993-3#1)(1996-4#1)
were examined in the course of##2##6##(1991-10#1)(1991-11#1)
were examined in the rat##2##5##(1993-5#1)(1997-2#1)
were examined in the##25##4##(1990-11#1)(1991-10#1)(1991-11#1)(1991-7#1)(1992-10#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-10#1)(1994-2#1)(1994-5#1)(1996-4#1)(1997-2#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2013-8#1)
were examined in this study##7##5##(1991-4#1)(1992-9#1)(1995-6#1)(2007-3#1)(2008-10#2)(2011-12#1)
were examined in this##8##4##(1990-12#1)(1991-4#1)(1992-9#1)(1995-6#1)(2007-3#1)(2008-10#2)(2011-12#1)
were examined in two##2##4##(1993-12#1)(2008-1#1)
were examined in vitro##4##4##(1994-8#1)(2008-10#2)(2009-3#1)
were examined in vivo in##2##5##(1992-3#1)(1997-7#1)
were examined in##145##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-7#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-3#2)(1992-8#2)(1992-9#4)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-2#2)(1994-5#3)(1994-8#3)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-5#2)(1997-7#2)(2005-10#2)(2005-11#1)(2005-5#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-3#2)(2007-8#3)(2008-1#2)(2008-10#18)(2008-11#3)(2008-12#3)(2008-2#1)(2008-5#5)(2008-6#3)(2008-7#2)(2008-9#1)(2009-11#1)(2009-3#1)(2009-9#1)(2010-6#1)(2011-1#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
were examined on the##8##4##(1990-11#1)(1993-2#1)(1995-12#1)(1995-3#1)(1997-3#1)(2005-11#1)(2006-12#1)(2013-1#1)
were examined on##13##3##(1990-11#1)(1992-9#1)(1993-12#1)(1993-2#1)(1995-12#1)(1995-3#1)(1996-10#1)(1997-3#1)(2005-11#1)(2006-12#1)(2010-7#1)(2010-8#1)(2013-1#1)
were examined over##3##3##(1991-3#1)(2008-10#1)(2010-4#1)
were examined pathologically##2##3##(1997-3#1)(1997-6#1)
were examined three times##2##4##(1993-2#1)(2007-7#1)
were examined through##3##3##(2007-12#1)(2008-1#1)(2010-12#1)
were examined to determine whether##5##5##(1992-12#2)(1993-8#1)(1997-5#1)(2005-10#1)
were examined to determine which##2##5##(2008-10#2)
were examined to determine##10##4##(1992-12#2)(1993-8#1)(1997-5#1)(2005-10#1)(2008-10#4)(2009-7#1)
were examined to identify##2##4##(2008-10#1)(2008-6#1)
were examined to##20##3##(1992-12#2)(1993-3#1)(1993-5#1)(1993-8#1)(1994-12#1)(1995-1#1)(1997-5#1)(2005-10#1)(2008-10#6)(2008-11#1)(2008-6#1)(2009-2#1)(2009-7#1)(2013-8#1)
were examined twice##3##3##(2007-7#1)(2007-8#1)(2012-3#1)
were examined under##5##3##(1990-11#1)(1997-4#1)(2008-10#1)(2008-5#1)(2013-8#1)
were examined using a##6##4##(1994-5#1)(2007-7#1)(2008-10#2)(2008-6#1)(2013-8#1)
were examined using an##4##4##(1991-12#1)(1994-11#1)(2008-11#1)(2011-2#1)
were examined using light##2##4##(2008-10#1)(2008-7#1)
were examined using the##9##4##(1991-1#1)(1991-6#1)(1992-6#1)(1994-2#1)(2006-5#1)(2007-2#1)(2008-12#1)(2008-7#1)(2011-2#1)
were examined using##55##3##(1990-5#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-6#3)(1992-9#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-11#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-8#2)
were examined with different##2##4##(1996-10#1)(2012-2#1)
were examined with the##5##4##(1997-3#1)(2006-6#1)(2008-10#1)(2010-2#1)(2012-12#1)
were examined with##26##3##(1990-6#1)(1991-10#1)(1991-12#1)(1991-8#1)(1993-12#1)(1995-11#1)(1996-10#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(2004-9#1)(2006-6#1)(2007-7#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-2#1)(2012-12#1)(2012-2#1)
were examined within##2##3##(2006-7#1)(2008-7#1)
were examined##879##2##(1990-10#4)(1990-11#4)(1990-12#5)(1990-2#2)(1990-3#7)(1990-4#6)(1990-5#3)(1990-6#5)(1990-7#2)(1990-8#5)(1991-1#3)(1991-10#3)(1991-11#3)(1991-12#9)(1991-2#5)(1991-3#3)(1991-4#4)(1991-5#4)(1991-6#6)(1991-7#2)(1991-8#6)(1991-9#8)(1992-1#1)(1992-10#2)(1992-11#7)(1992-12#5)(1992-2#4)(1992-3#6)(1992-4#2)(1992-5#3)(1992-6#4)(1992-8#4)(1992-9#7)(1993-1#2)(1993-10#3)(1993-11#5)(1993-12#9)(1993-2#4)(1993-3#8)(1993-4#4)(1993-5#4)(1993-6#2)(1993-8#6)(1993-9#3)(1994-1#1)(1994-10#3)(1994-11#3)(1994-12#3)(1994-2#4)(1994-3#7)(1994-4#1)(1994-5#8)(1994-6#4)(1994-7#1)(1994-8#6)(1994-9#3)(1995-1#4)(1995-10#2)(1995-11#7)(1995-12#4)(1995-2#4)(1995-3#5)(1995-5#5)(1995-6#2)(1995-7#2)(1995-8#3)(1995-9#1)(1996-10#2)(1996-11#2)(1996-12#5)(1996-2#5)(1996-3#3)(1996-4#2)(1996-5#9)(1996-6#4)(1996-7#2)(1996-8#3)(1996-9#4)(1997-1#4)(1997-2#9)(1997-3#8)(1997-4#4)(1997-5#6)(1997-6#2)(1997-7#4)(1997-8#3)(2004-1#1)(2004-11#3)(2004-12#1)(2004-2#1)(2004-9#4)(2005-10#4)(2005-11#4)(2005-12#1)(2005-4#1)(2005-5#1)(2005-8#2)(2005-9#2)(2006-1#2)(2006-10#13)(2006-11#1)(2006-12#6)(2006-2#3)(2006-4#2)(2006-5#5)(2006-6#8)(2006-7#5)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#7)(2007-12#8)(2007-2#12)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#3)(2007-7#10)(2007-8#17)(2007-9#1)(2008-1#3)(2008-10#128)(2008-11#16)(2008-12#7)(2008-2#2)(2008-3#6)(2008-4#8)(2008-5#34)(2008-6#7)(2008-7#22)(2008-8#8)(2008-9#4)(2009-10#1)(2009-11#3)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#4)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#8)(2010-2#1)(2010-4#4)(2010-5#5)(2010-6#1)(2010-7#4)(2010-8#8)(2010-9#1)(2011-1#10)(2011-11#1)(2011-12#1)(2011-2#16)(2012-1#1)(2012-12#6)(2012-2#9)(2012-3#7)(2013-1#16)(2013-7#3)(2013-8#9)
were exceeded##2##2##(1994-6#1)(2008-9#1)
were excellent in##5##3##(1993-8#1)(1996-9#1)(2005-10#1)(2007-9#1)(2008-8#1)
were excellent##16##2##(1992-2#1)(1992-6#1)(1992-9#1)(1993-8#1)(1996-7#2)(1996-9#1)(2005-10#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-7#1)
were exchanged for##3##3##(1993-11#1)(2008-10#2)
were exchanged##8##2##(1993-11#1)(1995-12#1)(1997-4#1)(2005-11#1)(2007-7#1)(2008-10#2)(2009-5#1)
were excised and##4##3##(2007-1#1)(2008-10#2)(2011-2#1)
were excised##9##2##(1996-3#1)(2007-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2011-12#1)(2011-2#1)(2013-1#1)
were excitatory##2##2##(1991-3#1)(1997-3#1)
were excited by##8##3##(1991-2#1)(1992-2#2)(1992-8#1)(1992-9#1)(1993-12#1)(1997-3#1)(2008-3#1)
were excited with##2##3##(2008-3#2)
were excited##14##2##(1991-2#1)(1991-3#1)(1992-2#2)(1992-4#1)(1992-8#1)(1992-9#1)(1993-12#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-3#3)
were excluded because of##3##4##(2007-10#1)(2007-9#1)(2009-3#1)
were excluded because##4##3##(2007-10#1)(2007-9#1)(2008-10#1)(2009-3#1)
were excluded by##3##3##(1992-3#1)(2005-11#1)(2007-10#1)
were excluded for##3##3##(2005-10#1)(2006-8#1)(2013-1#1)
were excluded from analysis##3##4##(2005-10#1)(2011-1#1)(2013-8#1)
were excluded from study##2##4##(2008-3#1)(2010-9#1)
were excluded from the analysis##6##5##(1993-12#1)(1996-11#1)(2006-8#1)(2009-5#1)(2011-2#1)(2012-2#1)
were excluded from the final analysis##2##6##(2006-10#1)(2010-4#1)
were excluded from the study##13##5##(1991-12#1)(2006-10#1)(2006-12#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-7#1)(2011-1#1)(2011-2#2)(2013-1#2)
were excluded from the##25##4##(1991-12#1)(1993-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-7#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)
were excluded from##36##3##(1990-9#1)(1991-12#1)(1993-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-3#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
were excluded if they##3##4##(2012-12#2)(2013-1#1)
were excluded if##4##3##(1996-9#1)(2012-12#2)(2013-1#1)
were excluded##103##2##(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-10#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-8#1)(2004-10#1)(2005-10#3)(2005-11#1)(2006-10#5)(2006-12#2)(2006-3#1)(2006-8#5)(2007-10#3)(2007-11#2)(2007-2#2)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#3)(2008-10#6)(2008-3#2)(2008-5#1)(2008-7#3)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-4#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-1#2)(2012-12#5)(2012-2#3)(2013-1#6)(2013-7#1)(2013-8#6)
were exclusively breastfed##2##3##(2010-6#1)(2013-1#1)
were exclusively##7##2##(2005-9#1)(2008-10#4)(2010-6#1)(2013-1#1)
were excreted##2##2##(1991-12#1)(2008-10#1)
were executed##4##2##(1996-5#1)(1997-1#1)(2008-10#1)(2008-3#1)
were exercised##2##2##(1990-4#1)(1991-2#1)
were exhausted##7##2##(1993-12#1)(1994-4#1)(1997-6#1)(2006-12#1)(2008-10#1)(2010-8#1)(2011-3#1)
were exhibited by##2##3##(1995-11#1)(1996-2#1)
were exhibited##5##2##(1994-3#1)(1995-11#1)(1996-2#1)(2008-10#1)(2011-2#1)
were expanded by##2##3##(1990-2#1)(2005-7#1)
were expanded in##4##3##(1990-8#1)(1994-9#2)(2008-9#1)
were expanded##8##2##(1990-2#1)(1990-8#1)(1994-9#2)(2005-7#1)(2007-3#2)(2008-9#1)
were expected on the basis of##2##6##(1991-2#1)(1993-9#1)
were expected to be##3##4##(2008-10#1)(2011-12#1)(2012-1#1)
were expected to##9##3##(1994-5#1)(1995-1#1)(1996-5#1)(2005-6#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-12#1)(2012-1#1)
were expected##17##2##(1990-12#1)(1991-2#1)(1992-10#1)(1993-9#1)(1994-5#1)(1995-1#1)(1996-5#1)(2005-6#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-5#1)(2009-7#1)(2011-12#1)(2012-1#1)(2013-1#1)
were experienced in##2##3##(2006-12#1)(2009-7#1)
were experienced##7##2##(1993-1#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-9#1)(2009-7#1)(2013-7#1)
were experiencing##9##2##(1992-10#1)(1996-2#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#2)
were experimentally confirmed##3##3##(2008-2#1)(2008-3#1)(2009-6#1)
were experimentally observed##3##3##(2007-11#2)(2008-2#1)
were experimentally obtained##2##3##(2007-11#1)(2008-3#1)
were experimentally verified##2##3##(1990-2#1)(2007-12#1)
were experimentally##21##2##(1990-2#1)(1997-6#1)(2005-9#1)(2007-11#4)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2009-6#1)(2009-7#1)(2012-2#1)(2012-9#1)
were explained by a##2##4##(2007-8#1)(2008-8#1)
were explained by assuming the presence of##2##7##(2008-10#2)
were explained by assuming the##3##5##(2008-10#3)
were explained by the##2##4##(2008-10#1)(2008-12#1)
were explained by##11##3##(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-8#2)(2009-9#1)
were explained in##2##3##(2008-10#1)(2012-12#1)
were explained##17##2##(2005-11#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-8#2)(2009-9#1)(2012-12#1)(2013-7#1)
were explanted and##2##3##(2008-9#1)(2012-3#1)
were explanted##5##2##(2007-7#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-3#1)
were exploited to##2##3##(1995-1#1)(2010-4#1)
were exploited##6##2##(1995-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-4#1)(2010-5#1)
were explored among##2##3##(2008-10#1)(2012-1#1)
were explored and##2##3##(2006-10#1)(2013-8#1)
were explored as##2##3##(1995-1#1)(2012-1#1)
were explored by##3##3##(1993-12#1)(2007-6#1)(2009-2#1)
were explored in a##3##4##(1997-7#1)(2008-10#1)(2010-1#1)
were explored in##7##3##(1994-2#1)(1995-8#1)(1997-7#1)(2007-12#1)(2008-10#2)(2010-1#1)
were explored using##2##3##(1993-9#1)(2013-7#1)
were explored with##2##3##(1996-6#1)(2012-12#1)
were explored##37##2##(1990-12#1)(1993-12#1)(1993-9#1)(1994-2#1)(1995-1#1)(1995-8#1)(1996-6#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-6#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-12#1)(2011-1#1)(2012-1#2)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
were exponentially distributed with an overall median of##2##8##(2008-8#2)
were exposed for##4##3##(1995-7#1)(2005-10#1)(2007-8#1)(2008-9#1)
were exposed in##5##3##(1994-6#1)(1997-2#1)(2008-10#2)(2012-3#1)
were exposed only##2##3##(2008-9#2)
were exposed to 0##2##4##(2008-10#1)(2011-12#1)
were exposed to 1##2##4##(2004-4#1)(2007-9#1)
were exposed to 10##3##4##(1992-3#1)(1996-4#1)(2008-10#1)
were exposed to 100##2##4##(1990-5#1)(1996-4#1)
were exposed to 20##2##4##(2007-8#1)(2008-2#1)
were exposed to 25##3##4##(1991-9#1)(2008-10#2)
were exposed to 250##2##4##(1997-8#1)(2007-11#1)
were exposed to 3##4##4##(1992-7#1)(1996-1#1)(1996-9#1)(2008-12#1)
were exposed to a median of##2##6##(1990-2#2)
were exposed to a range of##2##6##(1997-4#1)(2010-5#1)
were exposed to a##24##4##(1990-2#2)(1992-6#1)(1992-7#1)(1994-6#1)(1995-12#1)(1996-5#1)(1997-4#1)(1997-6#1)(2005-9#1)(2006-5#1)(2007-6#1)(2008-10#2)(2008-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-7#1)
were exposed to an##3##4##(1990-5#1)(1994-5#1)(2006-8#1)
were exposed to cobalt##2##4##(1994-6#2)
were exposed to constant##2##4##(2008-10#1)(2012-4#1)
were exposed to different##5##4##(2007-8#1)(2008-10#2)(2009-2#1)(2013-1#1)
were exposed to inhalation##2##4##(2006-6#1)(2007-1#1)
were exposed to more##2##4##(1990-2#1)(2008-4#1)
were exposed to the##15##4##(1991-9#1)(1992-5#1)(1994-6#1)(1995-6#1)(1995-8#1)(2008-12#1)(2008-5#3)(2008-8#1)(2009-3#1)(2009-6#2)(2011-2#1)(2012-12#1)
were exposed to three##2##4##(2011-12#1)(2013-1#1)
were exposed to various concentrations##2##5##(1997-2#1)(2011-12#1)
were exposed to varying concentrations of##3##6##(1995-5#2)(2009-11#1)
were exposed to##203##3##(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#4)(1990-7#3)(1990-8#1)(1991-7#1)(1991-9#2)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#2)(1992-7#3)(1992-9#1)(1993-4#1)(1993-8#2)(1994-5#1)(1994-6#6)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-3#1)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-4#2)(1996-5#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-4#3)(1997-5#1)(1997-6#1)(1997-8#2)(2004-4#2)(2004-9#1)(2005-9#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#25)(2008-11#4)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#7)(2008-7#3)(2008-8#7)(2008-9#13)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#2)(2009-6#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#4)(2011-12#5)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#7)(2012-4#1)(2012-8#1)(2013-1#8)(2013-7#1)
were exposed##238##2##(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#4)(1990-7#3)(1990-8#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#5)(1992-5#2)(1992-6#2)(1992-7#3)(1992-9#1)(1993-12#1)(1993-4#1)(1993-8#2)(1994-5#2)(1994-6#7)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#4)(1995-3#1)(1995-5#2)(1995-6#2)(1995-7#2)(1995-8#1)(1996-1#1)(1996-11#3)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#1)(1996-9#2)(1997-1#2)(1997-2#3)(1997-4#3)(1997-5#1)(1997-6#1)(1997-8#2)(2004-4#2)(2004-9#1)(2005-10#1)(2005-9#2)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#29)(2008-11#4)(2008-12#5)(2008-2#1)(2008-4#1)(2008-5#8)(2008-7#4)(2008-8#7)(2008-9#16)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#4)(2011-1#4)(2011-12#5)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#7)(2012-3#1)(2012-4#1)(2012-8#1)(2013-1#8)(2013-7#1)
were expounded##2##2##(2005-8#1)(2008-8#1)
were expressed and purified##3##4##(1994-3#1)(1994-8#1)(1994-9#1)
were expressed and##4##3##(1992-3#1)(1994-3#1)(1994-8#1)(1994-9#1)
were expressed as a##3##4##(1992-11#1)(1992-7#1)(1996-9#1)
were expressed as the##2##4##(1995-2#1)(2008-10#1)
were expressed as##13##3##(1992-11#1)(1992-7#1)(1992-8#1)(1993-8#1)(1995-2#1)(1996-9#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2013-1#1)(2013-8#1)
were expressed at high levels##2##5##(1996-2#1)(2013-7#1)
were expressed at lower levels##2##5##(1992-9#1)(1997-6#1)
were expressed at##10##3##(1992-9#1)(1995-11#1)(1996-2#1)(1997-6#2)(2007-11#1)(2007-8#1)(2008-10#1)(2012-2#1)(2013-7#1)
were expressed by##5##3##(1990-12#1)(1991-9#1)(1994-3#1)(1994-5#1)(1996-5#1)
were expressed in E##3##4##(1993-6#1)(1995-8#1)(1997-7#1)
were expressed in Escherichia coli##7##5##(1990-10#1)(1990-12#1)(1990-7#1)(1994-11#1)(1994-12#1)(1996-5#1)(2008-10#1)
were expressed in Xenopus oocytes##4##5##(1993-6#1)(1994-9#1)(1995-5#1)(2008-4#1)
were expressed in a##5##4##(1993-8#1)(1995-8#1)(1997-7#1)(2008-11#1)(2010-12#1)
were expressed in all##5##4##(1996-10#1)(2008-5#1)(2011-2#1)(2012-3#2)
were expressed in baculovirus##2##4##(1997-6#1)(2013-8#1)
were expressed in cells##2##4##(1994-3#1)(1997-6#1)
were expressed in monkey kidney COS-1 cells##2##7##(1992-6#1)(1994-8#1)
were expressed in the##11##4##(1991-5#1)(1994-12#1)(1995-2#1)(2005-11#1)(2006-9#1)(2008-7#2)(2009-3#1)(2009-8#1)(2010-11#1)(2011-2#1)
were expressed in vitro and##2##5##(1990-6#1)(2008-10#1)
were expressed in vitro##3##4##(1990-6#1)(1995-8#1)(2008-10#1)
were expressed in##92##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-6#1)(1990-7#3)(1990-8#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-3#1)(1993-4#1)(1993-6#3)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#4)(1996-10#3)(1996-2#1)(1996-5#3)(1997-2#1)(1997-6#4)(1997-7#2)(2004-11#1)(2005-11#2)(2005-6#1)(2006-12#1)(2006-9#1)(2008-10#4)(2008-11#3)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-2#3)(2012-2#3)(2012-3#2)(2013-8#2)
were expressed on##3##3##(1991-9#1)(1994-3#1)(2010-4#1)
were expressed relative to##3##4##(2007-1#1)(2012-1#1)(2013-1#1)
were expressed throughout the##2##4##(2012-7#1)(2013-8#1)
were expressed transiently in##2##4##(1992-9#1)(1994-9#1)
were expressed ubiquitously##2##3##(1993-3#1)(1996-10#1)
were expressed##161##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-6#1)(1990-7#3)(1990-8#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#3)(1993-3#2)(1993-4#1)(1993-6#3)(1993-8#3)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#4)(1994-5#1)(1994-8#3)(1994-9#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-8#4)(1996-10#4)(1996-2#2)(1996-5#4)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#6)(1997-7#2)(1997-8#1)(2004-11#1)(2005-11#2)(2005-6#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#9)(2008-11#5)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#3)(2009-3#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#4)(2012-1#1)(2012-2#4)(2012-3#2)(2012-7#1)(2013-1#3)(2013-7#2)(2013-8#4)
were extended by##2##3##(2008-11#1)(2008-3#1)
were extended to##3##3##(1991-2#1)(1994-12#1)(2008-10#1)
were extended##7##2##(1991-2#1)(1994-12#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-3#1)
were extensive##2##2##(1991-3#1)(2010-3#1)
were extensively studied##2##3##(2007-8#1)(2010-2#1)
were extensively##12##2##(1990-10#1)(1995-3#2)(1997-4#2)(2005-9#1)(2006-8#1)(2007-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2013-1#1)
were extracted and analyzed##2##4##(2007-1#1)(2008-5#1)
were extracted and then##2##4##(1997-7#1)(2008-10#1)
were extracted and##13##3##(1990-12#1)(1997-7#1)(2007-1#1)(2008-10#1)(2008-5#2)(2008-9#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#2)
were extracted by liquid-liquid extraction using##2##6##(1997-8#1)(2011-2#1)
were extracted by the##2##4##(2005-11#1)(2008-11#1)
were extracted by using##2##4##(2007-8#1)(2008-10#1)
were extracted by##18##3##(1990-6#1)(1991-7#1)(1997-4#1)(1997-8#2)(2005-11#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
were extracted for##5##3##(1994-3#1)(2008-10#2)(2011-2#1)(2013-1#1)
were extracted from a##3##4##(2008-10#1)(2010-4#1)(2012-3#1)
were extracted from human plasma##2##5##(2008-10#1)(2012-12#1)
were extracted from plasma at basic pH with##2##8##(1993-2#1)(1996-8#1)
were extracted from plasma at##3##5##(1992-2#1)(1993-2#1)(1996-8#1)
were extracted from plasma##6##4##(1990-6#1)(1992-2#1)(1993-2#1)(1996-8#1)(1997-1#1)(1997-3#1)
were extracted from the##10##4##(1990-3#1)(1994-10#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-7#1)(2011-2#1)
were extracted from two##2##4##(2008-10#1)(2008-8#1)
were extracted from##51##3##(1990-11#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-8#1)(1992-2#1)(1993-2#2)(1994-10#1)(1995-1#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-12#1)(2007-11#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-4#1)(2010-4#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
were extracted in##2##3##(2008-10#2)
were extracted into chloroform##2##4##(2008-10#2)
were extracted into##5##3##(1997-8#1)(2008-10#4)
were extracted using a##2##4##(1990-8#1)(2007-11#1)
were extracted using##4##3##(1990-8#1)(2007-11#1)(2008-10#1)(2010-12#1)
were extracted with a##3##4##(2008-10#2)(2012-12#1)
were extracted with ethyl##2##4##(1997-3#1)(2005-12#1)
were extracted with water##2##4##(2008-10#1)(2010-2#1)
were extracted with##30##3##(1990-12#1)(1992-2#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-8#1)(2005-12#2)(2008-10#12)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-12#1)
were extracted##153##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-7#1)(1991-8#1)(1992-2#2)(1992-8#1)(1993-2#2)(1994-10#1)(1994-3#1)(1995-1#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#4)(2005-11#2)(2005-12#3)(2007-1#1)(2007-11#3)(2007-8#1)(2008-10#49)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#10)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-4#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-8#2)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#9)(2013-7#2)
were extrapolated to##2##3##(2008-10#1)(2012-2#1)
were extrapolated##3##2##(2008-10#1)(2008-2#1)(2012-2#1)
were extremely sensitive##2##3##(2008-10#1)(2008-9#1)
were extremely##15##2##(1991-2#1)(1991-7#1)(1993-9#1)(1995-11#1)(1996-2#1)(1997-7#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-7#1)(2012-12#1)(2012-2#1)
were extubated##2##2##(1990-2#1)(1997-4#1)
were fabricated and characterized##2##4##(2008-10#2)
were fabricated and##6##3##(2008-1#1)(2008-10#2)(2008-3#2)(2013-8#1)
were fabricated as##2##3##(2008-10#1)(2008-5#1)
were fabricated at the##2##4##(2008-10#1)(2008-2#1)
were fabricated by a##2##4##(2007-12#1)(2008-10#1)
were fabricated by means of##3##5##(2007-11#1)(2008-3#2)
were fabricated by##20##3##(2006-12#2)(2007-11#2)(2007-12#4)(2008-10#2)(2008-2#3)(2008-3#3)(2009-5#1)(2009-7#1)(2013-8#2)
were fabricated for##2##3##(2004-9#1)(2013-1#1)
were fabricated from##5##3##(2007-11#2)(2008-2#2)(2009-7#1)
were fabricated in photoresist##2##4##(2008-2#1)(2008-3#1)
were fabricated in the##2##4##(2006-12#1)(2008-2#1)
were fabricated in##6##3##(2006-12#1)(2007-11#1)(2008-2#2)(2008-3#2)
were fabricated on##5##3##(2007-12#2)(2008-2#1)(2008-3#1)(2013-8#1)
were fabricated to##2##3##(2008-2#1)(2009-12#1)
were fabricated using##3##3##(2009-11#2)(2010-7#1)
were fabricated with a##2##4##(2008-3#2)
were fabricated with##7##3##(2007-12#3)(2008-2#1)(2008-3#3)
were fabricated##74##2##(2004-9#1)(2006-12#3)(2007-11#7)(2007-12#11)(2008-1#1)(2008-10#8)(2008-12#1)(2008-2#13)(2008-3#15)(2008-5#2)(2009-11#2)(2009-12#1)(2009-5#1)(2009-7#2)(2010-7#1)(2013-1#1)(2013-8#4)
were faced##4##2##(2007-5#1)(2008-10#1)(2009-5#1)(2013-8#1)
were facing the##2##3##(1994-2#1)(2007-9#1)
were facing##3##2##(1994-2#1)(2007-9#1)(2008-2#1)
were factored##2##2##(2006-9#1)(2008-10#1)
were factors associated with##2##4##(1994-12#1)(2012-2#1)
were factors##4##2##(1994-12#1)(2006-2#1)(2010-8#1)(2012-2#1)
were fairly stable##2##3##(1997-1#1)(2008-10#1)
were fairly##9##2##(1996-12#1)(1997-1#1)(2008-10#4)(2009-9#1)(2010-1#1)(2012-1#1)
were familiar with the##3##4##(2006-12#1)(2008-3#1)(2012-1#1)
were familiar with##4##3##(2006-12#1)(2007-2#1)(2008-3#1)(2012-1#1)
were familiar##5##2##(1990-6#1)(2006-12#1)(2007-2#1)(2008-3#1)(2012-1#1)
were family##2##2##(2009-10#1)(2010-2#1)
were far less##2##3##(2007-8#1)(2008-11#1)
were far more##3##3##(2008-10#1)(2009-4#1)(2013-1#1)
were far##8##2##(2007-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2009-4#1)(2012-12#1)(2013-1#1)
were faster and more accurate at##2##6##(2007-12#1)(2009-4#1)
were faster to##2##3##(2008-9#1)(2010-5#1)
were faster##5##2##(1997-2#1)(2007-12#1)(2008-9#1)(2009-4#1)(2010-5#1)
were fasting##2##2##(1992-6#1)(2013-7#1)
were fatal##2##2##(1992-1#1)(1993-6#1)
were favorable##3##2##(2009-4#1)(2011-1#1)(2013-1#1)
were favored##2##2##(1995-3#1)(2008-10#1)
were favourable##2##2##(1993-2#1)(1996-1#1)
were fear of##2##3##(2006-10#1)(2011-2#1)
were fed 0##4##3##(2006-5#1)(2008-10#1)(2010-2#2)
were fed a##11##3##(1990-5#1)(1991-7#1)(1997-3#1)(2007-5#1)(2007-8#1)(2008-5#1)(2009-4#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-1#1)
were fed ad libitum##2##4##(2011-12#1)(2012-2#1)
were fed an##2##3##(2007-8#1)(2007-9#1)
were fed as##2##3##(2010-2#1)(2010-4#1)
were fed daily##3##3##(1994-2#1)(2008-10#1)(2008-6#1)
were fed diets containing##7##4##(2008-7#1)(2008-8#3)(2008-9#2)(2010-8#1)
were fed diets##10##3##(1992-9#1)(2006-8#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-4#1)(2010-8#1)
were fed either a##4##4##(2004-11#1)(2007-8#2)(2009-3#1)
were fed either##9##3##(1994-10#1)(2004-11#2)(2007-8#2)(2008-8#1)(2009-12#1)(2009-3#1)(2010-8#1)
were fed for##2##3##(1991-2#1)(2006-7#1)
were fed inhibitors of##2##4##(2008-8#2)
were fed into##2##3##(2005-4#1)(2007-8#1)
were fed on a##2##4##(1997-8#1)(2007-3#1)
were fed on##9##3##(1995-2#1)(1997-8#1)(2007-1#1)(2007-3#1)(2008-10#3)(2008-4#1)(2009-8#1)
were fed one of##2##4##(2009-9#1)(2010-4#1)
were fed pelleted##2##3##(2008-7#1)(2012-2#1)
were fed the##7##3##(1993-11#1)(2004-11#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-2#1)
were fed to##4##3##(2007-8#1)(2008-12#2)(2008-4#1)
were fed with##13##3##(1992-11#1)(1996-3#1)(2005-8#1)(2006-12#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
were fed##125##2##(1990-5#1)(1991-2#4)(1991-7#1)(1992-11#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-10#1)(1994-2#3)(1995-2#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-8#1)(2004-11#6)(2005-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-7#2)(2006-8#2)(2007-1#2)(2007-2#2)(2007-3#1)(2007-5#1)(2007-8#7)(2007-9#2)(2008-10#8)(2008-11#4)(2008-12#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#4)(2009-12#1)(2009-3#2)(2009-4#5)(2009-8#1)(2009-9#1)(2010-2#5)(2010-4#4)(2010-8#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#6)(2013-1#4)(2013-7#1)(2013-8#1)
were felt to be##2##4##(2006-10#2)
were felt to##3##3##(2006-10#2)(2006-8#1)
were felt##4##2##(2006-10#3)(2006-8#1)
were female and##7##3##(1993-5#1)(1997-8#1)(2008-8#1)(2010-5#1)(2011-2#2)(2013-1#1)
were female with##3##3##(2008-9#1)(2013-1#2)
were female##26##2##(1992-2#1)(1993-1#1)(1993-5#1)(1997-8#1)(2005-12#1)(2006-10#1)(2007-7#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#7)(2012-2#1)(2013-1#3)(2013-8#1)
were females and##7##3##(1991-8#1)(1992-5#1)(1995-10#1)(2007-10#1)(2008-8#1)(2010-7#1)(2013-1#1)
were females##28##2##(1991-8#1)(1992-5#1)(1995-10#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-7#2)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#2)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#3)(2013-1#3)(2013-8#2)
were fertile##3##2##(2008-5#1)(2012-12#2)
were fertilized##2##2##(1990-5#1)(2008-10#1)
were fever##4##2##(2006-10#1)(2007-2#1)(2008-1#1)(2012-3#1)
were few and##2##3##(1993-10#1)(2008-10#1)
were few##21##2##(1992-11#1)(1992-3#1)(1993-10#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-7#1)(2004-4#1)(2006-10#1)(2006-7#1)(2008-10#3)(2008-2#1)(2009-2#1)(2009-8#1)(2010-2#2)(2010-8#1)(2012-2#2)
were fewer hyphae##2##3##(2008-10#2)
were fewer##6##2##(1993-12#1)(2008-10#4)(2008-3#1)
were fibroid##2##2##(2007-3#2)
were filled with a##3##4##(2006-12#1)(2007-12#1)(2008-5#1)
were filled with##15##3##(1995-12#1)(1997-4#1)(2006-12#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)(2012-1#3)(2012-2#1)
were filled##18##2##(1993-8#1)(1995-12#1)(1997-4#1)(2006-12#2)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-4#1)(2012-1#3)(2012-2#1)
were filtered##2##2##(2004-2#1)(2008-1#1)
were finally compared##2##3##(1992-8#1)(2008-10#1)
were finally purified##2##3##(1993-11#1)(1996-5#1)
were finally##13##2##(1992-8#1)(1993-11#1)(1996-3#1)(1996-5#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-5#1)(2008-9#1)
were firmly##2##2##(1994-6#1)(2008-5#1)
were first applied to##2##4##(2008-8#1)(2011-2#1)
were first cousins##2##3##(2011-2#2)
were first described in##3##4##(2006-4#1)(2008-5#1)(2012-12#1)
were first described##6##3##(1994-4#1)(2006-4#1)(2008-5#2)(2011-2#1)(2012-12#1)
were first detected##5##3##(1993-3#1)(1993-7#1)(1995-1#1)(1995-11#1)(1997-6#1)
were first established in##2##4##(2008-11#1)(2012-2#1)
were first established##3##3##(1991-5#1)(2008-11#1)(2012-2#1)
were first evaluated##2##3##(1997-6#1)(2008-10#1)
were first introduced##3##3##(2005-7#1)(2010-8#1)(2011-2#1)
were first observed at##2##4##(1995-11#1)(2008-10#1)
were first observed in##3##4##(2008-10#1)(2008-7#1)(2012-1#1)
were first observed on##2##4##(2007-2#1)(2011-2#1)
were first observed##11##3##(1995-11#1)(2007-2#1)(2008-10#6)(2008-7#1)(2011-2#1)(2012-1#1)
were first prepared##2##3##(2008-10#1)(2008-7#1)
were first recorded##2##3##(1991-11#1)(2008-10#1)
were first seen##2##3##(1996-9#1)(2006-8#1)
were first tested for##3##4##(2007-5#1)(2008-10#1)(2010-5#1)
were first tested##4##3##(1994-3#1)(2007-5#1)(2008-10#1)(2010-5#1)
were first##88##2##(1991-11#1)(1991-5#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-1#2)(1995-11#2)(1996-12#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-6#2)(1997-7#1)(1997-8#2)(2005-7#1)(2005-9#1)(2006-4#1)(2006-8#2)(2006-9#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#16)(2008-11#4)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#2)(2009-2#1)(2009-6#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#2)
were firstly##3##2##(2008-10#2)(2009-12#1)
were fit to a##2##4##(2008-10#1)(2010-11#1)
were fit to the##4##4##(2008-10#4)
were fit to##11##3##(1992-2#1)(2008-10#7)(2010-11#1)(2010-9#1)(2013-1#1)
were fit##13##2##(1992-2#1)(1993-4#1)(2008-10#8)(2010-11#1)(2010-9#1)(2013-1#1)
were fitted by##4##3##(1991-6#1)(1994-8#1)(1996-1#1)(2008-10#1)
were fitted to a model##3##5##(2008-10#2)(2008-3#1)
were fitted to a##6##4##(2008-10#3)(2008-11#1)(2008-3#1)(2011-2#1)
were fitted to the##8##4##(1991-7#1)(2008-10#4)(2008-2#2)(2008-3#1)
were fitted to##24##3##(1991-7#1)(2007-3#1)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#2)(2008-8#1)(2010-5#1)(2011-2#3)(2013-1#1)
were fitted with a##2##4##(2008-2#1)(2008-9#1)
were fitted with##4##3##(2006-8#1)(2008-10#1)(2008-2#1)(2008-9#1)
were fitted##40##2##(1990-10#1)(1991-6#1)(1991-7#1)(1992-2#2)(1994-8#1)(1996-1#1)(1997-7#1)(2006-8#1)(2007-3#1)(2008-10#13)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#4)(2013-1#1)
were five times##2##3##(1990-4#1)(2011-2#1)
were five##8##2##(1990-4#1)(1994-12#1)(1996-3#1)(2007-7#1)(2008-10#1)(2011-1#1)(2011-2#2)
were fixated##2##2##(1991-9#1)(2007-11#1)
were fixed and##4##3##(2008-11#1)(2008-7#1)(2009-6#1)(2011-2#1)
were fixed at##3##3##(2008-10#2)(2010-2#1)
were fixed in##6##3##(2007-9#2)(2008-1#1)(2008-10#1)(2012-2#1)(2012-3#1)
were fixed to the##2##4##(2007-4#1)(2008-6#1)
were fixed to##3##3##(2007-4#1)(2008-6#1)(2009-3#1)
were fixed with##4##3##(1990-8#1)(2006-8#1)(2012-2#2)
were fixed##29##2##(1990-12#1)(1990-8#1)(2006-5#1)(2006-8#1)(2007-4#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-12#1)(2009-3#1)(2009-6#1)(2010-2#1)(2011-2#1)(2012-2#3)(2012-3#1)
were flanked by##2##3##(1995-11#1)(1996-11#1)
were flat##3##2##(2008-8#2)(2011-2#1)
were focal##4##2##(1991-4#1)(1993-5#1)(2007-9#1)(2013-8#1)
were focally##3##2##(1994-8#1)(1997-6#1)(2009-5#1)
were focused on##5##3##(2005-7#1)(2006-5#1)(2008-11#1)(2010-4#1)(2012-3#1)
were focused##10##2##(2005-7#1)(2006-5#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-4#1)(2012-3#1)
were follow-up with colour-Doppler##2##4##(2011-2#2)
were followed at##3##3##(1995-2#1)(2005-10#1)(2012-1#1)
were followed by##15##3##(1990-12#1)(1993-9#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-2#1)(2005-9#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2009-3#1)(2012-12#1)
were followed clinically##2##3##(2007-8#1)(2013-1#1)
were followed during the##2##4##(2008-11#1)(2013-1#1)
were followed for 24 months##2##5##(2007-10#1)(2007-7#1)
were followed for 4##3##4##(1991-11#1)(1991-4#1)(2013-1#1)
were followed for a period of##3##6##(2006-10#1)(2007-5#1)(2008-7#1)
were followed for a##5##4##(2006-10#1)(2006-7#1)(2007-5#1)(2007-8#1)(2008-7#1)
were followed for at least##4##5##(1990-10#1)(1996-1#1)(2006-10#1)(2006-7#1)
were followed for up to##4##5##(1991-2#1)(1993-2#1)(2008-5#1)(2011-1#1)
were followed for##31##3##(1990-10#1)(1990-2#1)(1991-11#1)(1991-2#1)(1991-4#1)(1992-11#1)(1993-2#2)(1995-12#1)(1996-1#1)(1997-2#1)(2006-10#3)(2006-5#1)(2006-7#2)(2006-8#1)(2007-10#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#2)(2009-10#1)(2010-7#1)(2011-1#1)(2013-1#2)
were followed in##2##3##(2012-3#1)(2013-1#1)
were followed over a##2##4##(2007-7#1)(2008-10#1)
were followed over##5##3##(2007-7#1)(2008-10#1)(2008-5#1)(2009-4#1)(2012-7#1)
were followed prospectively for##3##4##(1991-9#1)(2007-7#1)(2007-8#1)
were followed through##3##3##(2005-11#1)(2006-10#1)(2008-11#1)
were followed to##3##3##(1993-12#1)(2007-12#1)(2007-8#1)
were followed until##3##3##(2006-8#1)(2007-8#1)(2012-6#1)
were followed up after##2##4##(2006-10#1)(2007-11#1)
were followed up at##6##4##(1995-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-6#1)
were followed up by##4##4##(1991-11#1)(1992-2#1)(1993-5#1)(2007-3#1)
were followed up for 12 months##2##6##(2011-2#1)(2013-1#1)
were followed up for 12##3##5##(1995-12#1)(2011-2#1)(2013-1#1)
were followed up for 2##2##5##(2012-2#1)(2013-7#1)
were followed up for a##4##5##(1995-6#1)(2007-8#1)(2011-12#1)(2013-8#1)
were followed up for three years##2##6##(1995-5#1)(1996-9#1)
were followed up for##21##4##(1991-9#1)(1992-1#1)(1992-5#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-9#1)(2007-10#1)(2007-7#2)(2007-8#2)(2008-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
were followed up prospectively##3##4##(1991-3#1)(2007-8#1)(2011-2#1)
were followed up till##2##4##(2012-12#1)(2012-3#1)
were followed up to##2##4##(1991-12#1)(2007-10#1)
were followed up until##2##4##(2011-2#1)(2013-8#1)
were followed up with##2##4##(1997-3#1)(2006-1#1)
were followed up##54##3##(1991-11#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-5#1)(1993-5#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-9#1)(1997-3#1)(2006-1#1)(2006-10#1)(2006-2#1)(2007-10#2)(2007-11#2)(2007-3#1)(2007-7#4)(2007-8#4)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-9#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
were followed using##2##3##(2008-10#1)(2008-6#1)
were followed with##3##3##(2008-7#1)(2009-6#1)(2013-1#1)
were followed##150##2##(1990-10#1)(1990-12#1)(1990-2#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-5#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#2)(2006-8#2)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#7)(2007-8#10)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2012-6#1)(2012-7#2)(2013-1#11)(2013-7#1)(2013-8#2)
were followed-up at##2##3##(1991-6#1)(2011-2#1)
were followed-up for##3##3##(2005-8#1)(2007-7#1)(2008-1#1)
were followed-up##9##2##(1991-6#1)(2005-8#2)(2006-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2009-6#1)(2011-2#1)
were following##2##2##(2006-4#1)(2011-2#1)
were for the##2##3##(2005-11#1)(2008-5#1)
were for##24##2##(1991-4#1)(1992-2#1)(1994-2#1)(1995-1#1)(1995-6#1)(1995-9#1)(2005-11#1)(2005-12#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#3)(2013-8#1)
were forced to##6##3##(1993-9#1)(1996-6#1)(1997-5#1)(2006-4#1)(2009-2#1)(2013-1#1)
were forced##7##2##(1993-9#1)(1996-6#1)(1997-5#1)(2006-4#1)(2008-1#1)(2009-2#1)(2013-1#1)
were foreigners##2##2##(2007-2#2)
were formally##2##2##(2008-7#1)(2011-2#1)
were formed between##2##3##(1995-8#1)(2007-8#1)
were formed by the##3##4##(1990-9#1)(2006-12#1)(2013-8#1)
were formed by##16##3##(1990-9#1)(1991-5#1)(1993-6#1)(1996-7#1)(2006-12#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2012-2#1)(2013-8#1)
were formed during##3##3##(1997-8#1)(2005-11#1)(2008-10#1)
were formed from the##3##4##(2006-8#1)(2008-11#1)(2012-2#1)
were formed from##12##3##(1991-2#1)(1994-8#1)(1995-8#1)(2006-8#2)(2007-11#1)(2008-11#1)(2008-7#1)(2009-4#1)(2010-7#1)(2012-2#1)(2013-8#1)
were formed in the##4##4##(2008-10#2)(2008-5#1)(2012-12#1)
were formed in##14##3##(1991-5#1)(1993-3#1)(1995-6#1)(1996-5#1)(2005-11#1)(2005-8#1)(2008-10#4)(2008-5#1)(2008-7#1)(2009-2#1)(2012-12#1)
were formed on the##4##4##(1996-10#1)(2008-10#2)(2009-12#1)
were formed on##9##3##(1996-10#1)(2008-10#5)(2008-7#1)(2009-12#1)(2010-4#1)
were formed that##2##3##(2008-10#1)(2008-5#1)
were formed through##3##3##(2008-7#1)(2010-9#1)(2012-2#1)
were formed using##2##3##(1992-1#1)(2012-2#1)
were formed when the##2##4##(1994-9#1)(2007-9#1)
were formed when##6##3##(1994-9#1)(1995-4#1)(1995-6#1)(2007-9#1)(2008-6#1)(2009-11#1)
were formed with##4##3##(1996-11#1)(1997-3#2)(2008-10#1)
were formed##108##2##(1990-11#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-1#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-8#2)(1994-9#2)(1995-4#1)(1995-6#3)(1995-8#2)(1996-10#1)(1996-11#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-3#2)(1997-8#1)(2004-4#1)(2004-9#1)(2005-11#2)(2005-12#1)(2005-4#1)(2005-8#1)(2006-12#3)(2006-8#2)(2007-1#1)(2007-11#4)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#19)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#1)(2010-2#1)(2010-4#2)(2010-7#1)(2010-9#1)(2012-12#2)(2012-2#4)(2012-5#1)(2013-1#1)(2013-8#2)
were formerly##2##2##(2006-10#1)(2007-4#1)
were formulated and##2##3##(2007-8#1)(2008-5#1)
were formulated as##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
were formulated in##3##3##(1994-12#1)(2008-5#1)(2011-1#1)
were formulated using##4##3##(2007-2#1)(2009-4#1)(2010-12#1)(2011-2#1)
were formulated with##4##3##(1996-1#1)(2008-10#2)(2010-4#1)
were formulated##26##2##(1994-12#1)(1995-3#1)(1996-1#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#4)(2008-8#1)(2009-4#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
were fortified with##2##3##(1991-8#1)(2008-11#1)
were fortified##3##2##(1991-8#1)(2008-10#1)(2008-11#1)
were found (P &lt##2##4##(2008-8#1)(2013-8#1)
were found (p&lt##2##3##(2008-5#1)(2010-4#1)
were found 1##2##3##(1992-9#1)(2013-8#1)
were found across all##2##4##(2008-1#1)(2012-12#1)
were found across##4##3##(2008-1#1)(2008-10#1)(2010-12#1)(2012-12#1)
were found after injections##2##4##(1991-2#1)(1995-2#1)
were found after##11##3##(1991-2#2)(1991-3#1)(1991-8#1)(1994-8#1)(1995-2#1)(2007-11#1)(2008-10#2)(2008-8#1)(2011-2#1)
were found along the##2##4##(1996-4#1)(2011-2#1)
were found along##4##3##(1994-10#1)(1996-4#1)(2010-8#1)(2011-2#1)
were found also in##2##4##(1990-5#1)(2004-11#1)
were found among the three##2##5##(2008-10#1)(2012-5#1)
were found among the##13##4##(1993-11#1)(1993-2#1)(1997-3#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-5#2)(2009-8#1)(2012-2#1)(2012-5#1)
were found among##32##3##(1991-5#1)(1992-4#1)(1993-11#1)(1993-2#1)(1994-3#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#9)(2008-3#1)(2008-5#2)(2009-8#1)(2010-2#1)(2010-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)
were found and the##2##4##(2007-3#1)(2009-2#1)
were found and their##2##4##(2007-1#1)(2008-10#1)
were found and##11##3##(1997-9#1)(2007-1#1)(2007-3#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-2#1)(2009-8#1)(2011-1#1)(2013-1#1)
were found as the##2##4##(1994-3#1)(2008-11#1)
were found as##14##3##(1994-3#1)(1995-6#1)(1996-12#1)(2007-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2009-11#1)(2012-12#1)(2013-7#1)
were found associated with##2##4##(2012-2#1)(2013-8#1)
were found at the##10##4##(1991-8#1)(1997-5#1)(2007-7#1)(2008-10#3)(2008-12#2)(2008-7#1)(2010-12#1)
were found at##29##3##(1991-8#2)(1992-3#1)(1993-9#1)(1995-1#1)(1996-2#1)(1997-5#1)(2006-10#2)(2007-7#1)(2008-10#8)(2008-12#2)(2008-7#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-2#2)(2013-1#1)
were found based on##2##4##(2008-10#1)(2009-6#1)
were found between age##2##4##(2006-11#1)(2008-8#1)
were found between patients##2##4##(1993-3#1)(1997-8#1)
were found between the indoor and##2##6##(2010-5#2)
were found between the two groups##3##6##(1992-11#1)(2007-7#1)(2008-7#1)
were found between the two##5##5##(1992-11#1)(1992-12#1)(2007-7#1)(2008-10#1)(2008-7#1)
were found between the##39##4##(1990-7#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-2#1)(1995-12#1)(1995-5#1)(1997-3#1)(2004-4#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#1)(2010-4#2)(2010-5#2)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
were found between these##4##4##(1990-4#1)(1996-8#1)(2007-10#1)(2010-8#1)
were found between##113##3##(1990-4#1)(1990-7#2)(1990-8#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-9#1)(1995-1#1)(1995-12#2)(1995-5#1)(1996-1#1)(1996-10#1)(1996-5#1)(1996-8#1)(1997-3#2)(1997-4#1)(1997-8#1)(2004-11#1)(2004-3#1)(2004-4#1)(2006-11#1)(2006-6#1)(2006-7#2)(2006-8#2)(2007-1#3)(2007-10#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#2)(2007-9#2)(2008-10#13)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#2)(2012-5#1)(2013-1#2)(2013-7#2)(2013-8#1)
were found both##2##3##(1994-2#1)(1995-2#1)
were found by both##2##4##(2008-10#1)(2011-1#1)
were found by the##2##4##(1990-9#1)(2008-3#1)
were found by##16##3##(1990-9#1)(1993-4#1)(1994-5#1)(1995-5#1)(2007-10#2)(2007-8#1)(2008-10#3)(2008-3#2)(2008-5#1)(2010-4#1)(2011-1#1)(2012-12#1)
were found concerning##2##3##(2012-12#1)(2013-1#1)
were found differentially##2##3##(2008-12#1)(2013-1#1)
were found during the##5##4##(2008-5#1)(2008-6#1)(2012-1#1)(2012-2#1)(2013-1#1)
were found during##11##3##(1990-6#1)(1994-6#1)(1995-9#1)(2006-5#1)(2007-5#1)(2008-5#1)(2008-6#1)(2010-9#1)(2012-1#1)(2012-2#1)(2013-1#1)
were found for all three##2##5##(1990-12#1)(1997-1#1)
were found for both##4##4##(1991-2#1)(1995-10#1)(2007-12#1)(2008-10#1)
were found for each##3##4##(2008-10#1)(2008-5#1)(2011-1#1)
were found for maternal##2##4##(1992-4#1)(2008-10#1)
were found for some##2##4##(2008-10#2)
were found for spiked concentration levels from##2##7##(2008-10#2)
were found for the determination of##2##6##(2008-10#2)
were found for the neutral##2##5##(2006-10#1)(2009-11#1)
were found for the##18##4##(1991-11#1)(1996-6#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#6)(2008-2#1)(2008-7#1)(2009-11#1)(2011-1#1)(2012-11#1)(2013-7#1)
were found for##79##3##(1990-12#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-4#2)(1993-11#1)(1993-9#1)(1995-10#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-8#1)(2003-11#1)(2006-10#3)(2006-3#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-9#2)(2008-10#21)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#2)(2009-11#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#2)(2012-1#3)(2012-11#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
were found from##6##3##(2007-8#4)(2008-10#2)
were found highly##3##3##(2008-10#1)(2010-5#1)(2011-2#1)
were found in 1##2##4##(1992-6#1)(2008-10#1)
were found in 12%##2##4##(1992-9#1)(2008-8#1)
were found in 13 of##2##5##(1994-7#1)(2008-10#1)
were found in 13##3##4##(1994-7#1)(2007-8#1)(2008-10#1)
were found in 16##3##4##(2013-1#3)
were found in 20##3##4##(2007-7#1)(2013-1#1)(2013-7#1)
were found in 25##2##4##(1993-10#1)(1996-10#1)
were found in 28##2##4##(1992-12#1)(1994-12#1)
were found in 3##2##4##(1994-4#1)(2007-11#1)
were found in 30##2##4##(1990-6#1)(2007-7#1)
were found in 34##2##4##(2008-5#1)(2008-7#1)
were found in 4##2##4##(1991-12#1)(2007-7#1)
were found in 43##2##4##(1994-6#1)(2012-3#1)
were found in 5##2##4##(2007-11#2)
were found in 64##2##4##(2011-2#1)(2012-3#1)
were found in 7##3##4##(2007-11#1)(2008-10#1)(2011-1#1)
were found in 8##2##4##(2007-8#1)(2008-7#1)
were found in 8%##2##4##(2008-5#1)(2010-12#1)
were found in 90% of##2##5##(2007-8#1)(2008-10#1)
were found in B##2##4##(2006-5#2)
were found in M##2##4##(1996-5#1)(2011-10#1)
were found in a##8##4##(1992-3#1)(1993-9#1)(2008-10#3)(2008-5#1)(2011-2#1)(2012-12#1)
were found in all of the##2##6##(2006-8#1)(2008-5#1)
were found in all patients##2##5##(2006-6#1)(2010-1#1)
were found in all the##2##5##(2008-10#1)(2008-6#1)
were found in all##20##4##(1990-10#1)(1993-7#1)(1994-11#1)(1996-6#1)(2004-11#1)(2006-3#2)(2006-6#1)(2006-8#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-6#1)(2010-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
were found in an##3##4##(1992-5#1)(1993-1#1)(2008-10#1)
were found in areas##2##4##(2008-10#2)
were found in blood samples##2##5##(1990-8#1)(1993-9#1)
were found in blood##5##4##(1990-8#1)(1992-4#1)(1992-7#1)(1993-9#1)(1997-7#1)
were found in both the##2##5##(1996-10#1)(2008-10#1)
were found in both##17##4##(1992-8#1)(1993-9#1)(1994-2#1)(1995-6#1)(1996-10#3)(1996-5#2)(1997-5#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-6#1)(2008-7#1)(2012-12#1)
were found in concentrations##2##4##(2008-10#1)(2008-11#1)
were found in each of the##2##6##(2008-10#1)(2009-10#1)
were found in each##3##4##(2007-12#1)(2008-10#1)(2009-10#1)
were found in eight of the##2##6##(1992-3#1)(2008-7#1)
were found in either##2##4##(1997-5#1)(2007-3#1)
were found in every##2##4##(1991-4#1)(2008-10#1)
were found in five##2##4##(2008-10#1)(2012-12#1)
were found in normal human##2##5##(1990-7#1)(1991-8#1)
were found in patients with##4##5##(1990-12#1)(1991-5#1)(1995-12#1)(2006-6#1)
were found in patients##6##4##(1990-12#1)(1991-5#1)(1995-12#1)(2006-6#1)(2007-11#1)(2007-8#1)
were found in physical##2##4##(2007-12#1)(2011-2#1)
were found in relation to##2##5##(1997-8#1)(2006-11#1)
were found in samples##4##4##(2008-10#2)(2010-4#1)(2012-11#1)
were found in seven##3##4##(1991-9#1)(1997-3#1)(2008-10#1)
were found in similar##2##4##(2006-12#1)(2008-10#1)
were found in some##4##4##(2004-4#1)(2008-12#1)(2008-3#1)(2010-8#1)
were found in sympatry##2##4##(2005-8#2)
were found in terms of##2##5##(1990-2#1)(2008-7#1)
were found in the C-terminal##2##5##(1995-8#1)(1997-6#1)
were found in the areas of##2##6##(1996-2#1)(2007-8#1)
were found in the blood##2##5##(1995-2#1)(1996-1#1)
were found in the cytoplasm##2##5##(1994-12#1)(1996-3#1)
were found in the cytosolic##2##5##(1990-7#1)(1991-1#1)
were found in the faeces of##2##6##(1993-2#1)(2008-11#1)
were found in the group##2##5##(1993-8#1)(2013-1#1)
were found in the hippocampus##2##5##(1993-12#1)(1995-5#1)
were found in the ipsilateral##2##5##(1997-3#1)(2009-2#1)
were found in the latter##2##5##(1990-12#1)(1994-2#1)
were found in the levels of##2##6##(1993-12#1)(1995-4#1)
were found in the present##2##5##(1997-3#1)(2013-8#1)
were found in the range of##4##6##(2007-10#3)(2010-3#1)
were found in the same##3##5##(1991-12#1)(2006-10#1)(2010-12#1)
were found in the##168##4##(1990-10#1)(1990-11#3)(1990-12#2)(1990-3#2)(1990-5#2)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-7#1)(1993-12#4)(1993-2#2)(1993-5#2)(1993-6#2)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#3)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#4)(1995-7#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#1)(1997-6#1)(1997-8#2)(2004-11#1)(2006-10#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#4)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-10#14)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#2)(2010-1#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-11#3)(2012-12#2)(2013-1#3)(2013-7#2)(2013-8#5)
were found in these##2##4##(2008-10#1)(2008-5#1)
were found in this study##2##5##(2007-2#1)(2008-5#1)
were found in this##6##4##(1993-11#1)(1993-2#1)(1993-3#1)(2007-2#1)(2008-5#1)(2013-8#1)
were found in three##2##4##(1992-12#1)(1997-6#1)
were found in two##8##4##(1991-12#1)(1993-12#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-5#1)(2013-1#1)
were found in urine##2##4##(1992-8#1)(2008-7#1)
were found in##547##3##(1990-10#3)(1990-11#5)(1990-12#3)(1990-2#4)(1990-3#3)(1990-5#2)(1990-6#3)(1990-7#2)(1990-8#1)(1990-9#3)(1991-1#1)(1991-11#2)(1991-12#9)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#3)(1992-1#2)(1992-11#1)(1992-12#6)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#3)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#5)(1993-2#3)(1993-3#2)(1993-5#3)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#7)(1994-11#2)(1994-12#3)(1994-2#10)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#4)(1994-7#2)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#4)(1995-2#6)(1995-3#3)(1995-4#2)(1995-5#4)(1995-6#2)(1995-7#2)(1995-8#1)(1996-1#2)(1996-10#5)(1996-11#1)(1996-12#2)(1996-2#6)(1996-3#1)(1996-4#1)(1996-5#5)(1996-6#2)(1996-7#3)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#5)(1997-3#6)(1997-4#3)(1997-5#2)(1997-6#5)(1997-7#1)(1997-8#6)(2004-10#1)(2004-11#2)(2004-4#1)(2005-11#1)(2005-8#3)(2006-10#2)(2006-11#1)(2006-12#2)(2006-3#2)(2006-5#4)(2006-6#3)(2006-7#1)(2006-8#5)(2006-9#1)(2007-1#3)(2007-10#5)(2007-11#7)(2007-12#7)(2007-2#4)(2007-3#4)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#11)(2007-8#14)(2007-9#2)(2008-1#6)(2008-10#59)(2008-11#7)(2008-12#6)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#23)(2008-6#4)(2008-7#12)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#2)(2009-2#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#6)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#2)(2011-1#8)(2011-10#1)(2011-11#1)(2011-12#1)(2011-2#9)(2012-1#3)(2012-11#4)(2012-12#6)(2012-2#5)(2012-3#6)(2013-1#16)(2013-7#7)(2013-8#10)
were found infected##2##3##(2008-10#2)
were found inside##2##3##(1995-6#1)(1996-5#1)
were found mainly in the##2##5##(1990-9#1)(1994-11#1)
were found mainly in##3##4##(1990-9#1)(1994-11#1)(2008-10#1)
were found mainly##5##3##(1990-9#1)(1994-11#1)(1995-10#1)(2008-10#2)
were found more##7##3##(1992-9#1)(2007-10#2)(2008-10#1)(2008-7#1)(2010-7#1)(2012-11#1)
were found most frequently##2##4##(1991-10#1)(2008-5#1)
were found most##6##3##(1990-1#1)(1991-10#1)(1992-3#1)(2008-10#1)(2008-5#1)(2012-2#1)
were found near##2##3##(1994-8#1)(2013-1#1)
were found not to##4##4##(1993-6#1)(1995-5#1)(2008-10#1)(2008-8#1)
were found of##2##3##(2007-8#1)(2012-12#1)
were found on the surface of##2##6##(2009-12#1)(2010-12#1)
were found on the##5##4##(1991-2#1)(1996-11#1)(2009-12#1)(2009-4#1)(2010-12#1)
were found on##22##3##(1990-9#1)(1991-2#1)(1992-12#1)(1992-8#1)(1993-12#1)(1996-11#1)(1996-6#1)(2006-7#1)(2008-10#6)(2008-5#1)(2008-6#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-11#1)
were found only in one##2##5##(2008-10#1)(2008-5#1)
were found only in the##5##5##(1990-11#1)(1990-4#1)(2008-10#1)(2009-10#1)(2013-1#1)
were found only in##16##4##(1990-11#1)(1990-4#1)(1990-9#1)(1991-9#1)(1993-11#1)(1993-9#1)(1995-11#1)(2005-9#1)(2007-5#1)(2008-10#4)(2008-5#1)(2009-10#1)(2013-1#1)
were found only on##2##4##(2007-12#1)(2008-10#1)
were found only within##2##4##(2008-10#1)(2008-7#1)
were found only##23##3##(1990-11#1)(1990-4#1)(1990-9#1)(1991-9#1)(1992-6#1)(1993-11#1)(1993-5#1)(1993-9#1)(1995-11#1)(2005-9#1)(2007-12#1)(2007-5#1)(2008-10#6)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#1)(2013-1#1)
were found positive for##2##4##(2008-1#1)(2013-7#1)
were found positive##4##3##(1991-7#1)(1994-3#1)(2008-1#1)(2013-7#1)
were found relevant##2##3##(2008-5#1)(2011-2#1)
were found significantly##5##3##(1990-11#1)(1994-12#1)(1997-7#1)(2006-4#1)(2007-2#1)
were found statistically##2##3##(2011-2#2)
were found susceptible to##2##4##(2005-9#1)(2010-3#1)
were found that##4##3##(1991-12#1)(1994-8#1)(1997-7#1)(2008-10#1)
were found throughout the##3##4##(1990-4#1)(1993-7#1)(2008-10#1)
were found throughout##4##3##(1990-4#1)(1993-7#1)(1997-3#1)(2008-10#1)
were found to act as##2##5##(1993-4#1)(1996-10#1)
were found to affect the##2##5##(1992-7#1)(2007-1#1)
were found to affect##7##4##(1992-3#1)(1992-7#1)(2007-1#1)(2008-10#1)(2008-12#1)(2009-3#1)(2010-4#1)
were found to agree with##2##5##(2007-9#1)(2008-11#1)
were found to be &gt##3##5##(2008-10#3)
were found to be 0##16##5##(1997-3#1)(2005-4#1)(2008-10#10)(2008-2#1)(2009-6#1)(2012-12#2)
were found to be 1##13##5##(1992-2#1)(1993-2#1)(2008-10#8)(2012-1#1)(2013-1#2)
were found to be 100##2##5##(2008-10#1)(2010-2#1)
were found to be 16##2##5##(1997-6#1)(2008-10#1)
were found to be 2##11##5##(1995-2#1)(2008-10#8)(2008-5#2)
were found to be 250##2##5##(1994-3#1)(2010-12#1)
were found to be 3##5##5##(2008-10#2)(2010-2#1)(2011-1#1)(2012-2#1)
were found to be 4##5##5##(1994-5#1)(1996-12#1)(2008-10#3)
were found to be 5##3##5##(2008-10#3)
were found to be 7##2##5##(2008-10#1)(2008-5#1)
were found to be 8##3##5##(2006-12#1)(2008-10#1)(2008-2#1)
were found to be 9##2##5##(1991-4#1)(2008-10#1)
were found to be 99##3##5##(2008-10#3)
were found to be a##6##5##(1994-2#1)(2008-10#2)(2008-2#1)(2009-2#1)(2010-4#1)
were found to be able to##2##6##(2008-10#2)
were found to be active against##2##6##(2007-11#1)(2011-1#1)
were found to be active##5##5##(1995-3#1)(2007-11#1)(2008-5#1)(2011-1#2)
were found to be adequate##2##5##(2009-7#1)(2011-1#1)
were found to be approximately##3##5##(1996-4#1)(2007-12#1)(2008-10#1)
were found to be associated with##8##6##(2004-2#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-2#1)(2008-10#1)(2011-2#1)(2012-2#1)
were found to be associated##9##5##(2004-2#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-2#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
were found to be better than##2##6##(2008-10#1)(2008-5#1)
were found to be between##4##5##(2007-8#1)(2008-10#3)
were found to be capable of##2##6##(1991-10#1)(2006-6#1)
were found to be close to##2##6##(1992-5#1)(2008-3#1)
were found to be closely##2##5##(2011-2#1)(2012-2#1)
were found to be comparable to those##2##7##(2008-10#1)(2008-7#1)
were found to be comparable to##3##6##(2008-10#2)(2008-7#1)
were found to be comparable with##4##6##(2008-10#4)
were found to be comparable##7##5##(2008-10#6)(2008-7#1)
were found to be completely##4##5##(1990-7#1)(2006-4#1)(2007-11#1)(2008-7#1)
were found to be composed of##2##6##(1994-6#1)(2008-10#1)
were found to be consistent with those##2##7##(2007-12#1)(2008-3#1)
were found to be consistent with##6##6##(2007-12#1)(2008-10#1)(2008-3#2)(2008-7#1)(2012-11#1)
were found to be consistent##7##5##(2007-12#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-12#1)(2012-11#1)
were found to be correlated with##2##6##(2005-11#1)(2009-12#1)
were found to be dependent on the##2##7##(1991-9#1)(2008-10#1)
were found to be dependent on##3##6##(1991-9#1)(1995-3#1)(2008-10#1)
were found to be different##3##5##(1990-12#1)(1993-12#1)(1994-12#1)
were found to be differentially regulated##2##6##(2009-9#1)(2011-1#1)
were found to be directly##2##5##(1994-12#1)(2008-10#1)
were found to be effective in##3##6##(1990-3#1)(1994-3#1)(2010-7#1)
were found to be effective##5##5##(1990-3#1)(1994-3#1)(2005-11#1)(2006-4#1)(2010-7#1)
were found to be efficient##2##5##(1994-11#1)(2008-5#1)
were found to be elevated##2##5##(1992-8#1)(2004-10#1)
were found to be expressed##2##5##(1995-8#1)(1996-5#1)
were found to be good##2##5##(1996-3#1)(2008-10#1)
were found to be greater in##2##6##(1996-7#1)(2010-3#1)
were found to be greater##3##5##(1996-7#1)(2008-2#1)(2010-3#1)
were found to be higher in normal##2##7##(2008-4#1)(2009-12#1)
were found to be higher in##3##6##(2008-4#1)(2008-8#1)(2009-12#1)
were found to be higher##6##5##(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-2#1)
were found to be highly correlated##2##6##(1997-2#1)(2008-7#1)
were found to be highly resistant to##2##7##(2008-10#1)(2008-8#1)
were found to be highly significant##2##6##(2007-12#1)(2007-6#1)
were found to be highly##15##5##(1992-2#1)(1992-5#2)(1995-6#1)(1997-2#1)(2005-8#1)(2006-12#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-7#1)(2012-3#1)
were found to be identical to those of##2##8##(1991-3#1)(1992-3#1)
were found to be identical##5##5##(1990-8#1)(1991-3#1)(1992-3#1)(1997-6#1)(2008-2#1)
were found to be important##7##5##(1993-12#1)(2004-12#1)(2006-12#1)(2007-2#1)(2009-12#1)(2009-7#1)(2010-8#1)
were found to be in agreement with##3##7##(1996-8#1)(2008-10#2)
were found to be in good agreement##4##7##(2008-10#3)(2008-3#1)
were found to be in the range of##4##8##(1995-8#1)(2008-10#2)(2010-2#1)
were found to be in the##6##6##(1993-8#1)(1995-8#1)(1997-8#1)(2008-10#2)(2010-2#1)
were found to be in##18##5##(1993-8#1)(1995-8#1)(1996-8#1)(1997-8#1)(2008-10#9)(2008-3#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-12#1)
were found to be inactive when tested for##3##8##(1996-5#3)
were found to be inactive##6##5##(1992-5#1)(1994-8#1)(1996-5#3)(2008-5#1)
were found to be independent of the##2##7##(2008-10#1)(2009-8#1)
were found to be independent of##3##6##(1994-9#1)(2008-10#1)(2009-8#1)
were found to be independent##6##5##(1994-9#1)(1997-8#1)(2007-10#1)(2007-8#1)(2008-10#1)(2009-8#1)
were found to be induced##2##5##(1995-5#1)(2008-2#1)
were found to be ineffective##2##5##(1996-2#1)(2013-8#1)
were found to be infected by##2##6##(2008-10#2)
were found to be insignificant##2##5##(2007-7#1)(2011-2#1)
were found to be largely##2##5##(2004-2#1)(2007-11#1)
were found to be less than##2##6##(2008-11#1)(2008-2#1)
were found to be less##4##5##(2008-10#2)(2008-11#1)(2008-2#1)
were found to be linear##2##5##(1993-2#2)
were found to be linearly##2##5##(1995-3#1)(2008-10#1)
were found to be located in the##2##7##(1990-5#1)(2008-8#1)
were found to be located##3##5##(1990-5#1)(1997-6#1)(2008-8#1)
were found to be low##3##5##(2004-4#1)(2007-2#1)(2008-12#1)
were found to be lower##2##5##(2009-2#1)(2010-7#1)
were found to be malignant##2##5##(1997-2#1)(2007-8#1)
were found to be more effective##4##6##(1993-4#1)(2008-5#1)(2008-7#1)(2010-12#1)
were found to be more##16##5##(1993-4#1)(1995-4#1)(1995-5#1)(1997-1#1)(2006-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-7#2)(2010-12#1)(2010-3#1)(2010-9#1)(2012-2#1)
were found to be most##4##5##(1994-9#1)(2005-8#1)(2006-5#1)(2009-5#1)
were found to be mostly##2##5##(2012-2#1)(2012-3#1)
were found to be much##3##5##(1996-7#1)(2008-10#1)(2010-2#1)
were found to be nearly identical##2##6##(1991-12#1)(1995-11#1)
were found to be negative##3##5##(2004-10#1)(2013-1#2)
were found to be negatively##2##5##(1990-12#1)(1996-3#1)
were found to be normal##3##5##(1995-1#1)(2007-8#1)(2010-9#1)
were found to be not##2##5##(1996-7#1)(2008-3#1)
were found to be of##3##5##(1990-10#1)(1996-9#1)(2008-5#1)
were found to be pH##2##5##(1996-8#1)(2008-10#1)
were found to be phosphorylated in##2##6##(1995-6#1)(2009-6#1)
were found to be positive for##7##6##(1990-10#1)(1995-5#1)(2006-1#1)(2007-7#1)(2008-5#1)(2013-8#2)
were found to be positive##10##5##(1990-10#1)(1995-5#1)(1997-7#1)(2005-11#1)(2006-1#1)(2007-7#1)(2008-4#1)(2008-5#1)(2013-8#2)
were found to be potent inhibitors of##3##7##(1990-2#1)(2006-12#1)(2007-11#1)
were found to be potent##5##5##(1990-2#1)(1991-5#1)(1994-11#1)(2006-12#1)(2007-11#1)
were found to be present in##3##6##(1994-9#1)(1995-8#1)(2008-10#1)
were found to be present##4##5##(1992-11#1)(1994-9#1)(1995-8#1)(2008-10#1)
were found to be quite##2##5##(2008-10#1)(2008-3#1)
were found to be rapid and##2##6##(2008-10#1)(2010-4#1)
were found to be rather##2##5##(2008-10#2)
were found to be readily##2##5##(2004-10#1)(2008-5#1)
were found to be related to the##2##7##(1995-6#1)(2006-6#1)
were found to be related to##7##6##(1991-9#1)(1995-6#1)(2006-6#2)(2008-7#2)(2010-8#1)
were found to be relatively##5##5##(1994-5#1)(2008-10#2)(2008-2#1)(2010-7#1)
were found to be resistant to##3##6##(1992-9#1)(1993-5#1)(2008-5#1)
were found to be responsible for##2##6##(1994-12#1)(2010-10#1)
were found to be rich in##3##6##(1995-11#1)(2007-1#1)(2008-11#1)
were found to be sensitive to the##2##7##(2007-1#1)(2008-8#1)
were found to be sensitive to##5##6##(1997-4#1)(2007-1#1)(2008-5#1)(2008-8#1)(2010-8#1)
were found to be sensitive##7##5##(1997-4#1)(2007-1#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-8#1)
were found to be significant##3##5##(2007-4#1)(2008-10#1)(2008-5#1)
were found to be significantly associated with##5##7##(2005-10#1)(2007-10#1)(2011-1#1)(2012-1#1)(2012-2#1)
were found to be significantly correlated##2##6##(1992-12#1)(1995-4#1)
were found to be significantly different##3##6##(2007-12#1)(2008-2#1)(2008-3#1)
were found to be significantly higher in##3##7##(1990-11#1)(2011-1#1)(2012-1#1)
were found to be significantly higher##8##6##(1990-11#1)(1996-1#1)(2007-2#1)(2008-4#1)(2011-1#1)(2011-12#1)(2012-1#1)(2013-8#1)
were found to be significantly lower in##2##7##(2007-1#1)(2008-3#1)
were found to be significantly lower##3##6##(2007-1#1)(2007-2#1)(2008-3#1)
were found to be significantly reduced in##2##7##(1990-8#1)(1993-11#1)
were found to be significantly reduced##3##6##(1990-8#1)(1992-11#1)(1993-11#1)
were found to be significantly related to##3##7##(1996-3#1)(2008-12#1)(2008-7#1)
were found to be significantly##35##5##(1990-11#1)(1990-8#1)(1992-11#1)(1992-12#1)(1993-11#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-4#1)(2005-10#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2011-1#2)(2011-12#2)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
were found to be similar in##2##6##(1993-3#1)(2007-11#1)
were found to be similar to##4##6##(2008-10#2)(2008-4#1)(2008-7#1)
were found to be similar##8##5##(1993-3#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)
were found to be slightly##3##5##(1990-4#1)(1993-12#1)(2008-5#1)
were found to be stable##4##5##(1992-6#1)(2007-12#1)(2008-10#1)(2010-12#1)
were found to be statistically##3##5##(2008-10#1)(2010-8#1)(2012-12#1)
were found to be strongly dependent on##2##7##(2007-12#1)(2008-2#1)
were found to be strongly dependent##3##6##(2006-10#1)(2007-12#1)(2008-2#1)
were found to be strongly##6##5##(1991-12#1)(2005-12#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-8#1)
were found to be suffering from##2##6##(2008-10#1)(2011-1#1)
were found to be suitable for##2##6##(1991-12#1)(1995-2#1)
were found to be suitable##3##5##(1991-12#1)(1991-9#1)(1995-2#1)
were found to be susceptible to##2##6##(1994-9#1)(2008-10#1)
were found to be the best##2##6##(1990-9#1)(2008-5#1)
were found to be the main##4##6##(2007-7#1)(2008-10#1)(2008-11#1)(2012-2#1)
were found to be the most##9##6##(1991-6#1)(1996-8#1)(1997-8#1)(2007-2#1)(2008-6#1)(2013-1#2)(2013-7#2)
were found to be the same##3##6##(2008-7#1)(2008-8#1)(2012-1#1)
were found to be the##26##5##(1990-9#1)(1991-6#1)(1994-3#1)(1996-8#1)(1997-8#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#3)(2008-10#3)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#2)
were found to be tolerable##2##5##(2008-10#2)
were found to be unique##2##5##(2008-10#1)(2008-7#1)
were found to be upregulated in##2##6##(2009-8#2)
were found to be useful##4##5##(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)
were found to be very##3##5##(1991-9#1)(2007-7#1)(2008-10#1)
were found to be well##4##5##(1992-11#1)(1997-2#1)(2008-3#1)(2010-8#1)
were found to be within the##2##6##(1996-3#1)(1996-8#1)
were found to be without##2##5##(1997-7#1)(2010-12#1)
were found to be##685##4##(1990-10#3)(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#4)(1991-9#5)(1992-1#1)(1992-11#4)(1992-12#2)(1992-2#2)(1992-3#4)(1992-5#4)(1992-6#1)(1992-8#4)(1992-9#1)(1993-1#2)(1993-11#3)(1993-12#5)(1993-2#4)(1993-3#2)(1993-4#4)(1993-5#1)(1993-7#1)(1993-8#3)(1994-10#1)(1994-11#3)(1994-12#5)(1994-2#1)(1994-3#4)(1994-4#1)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#7)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#4)(1995-4#2)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#4)(1996-1#1)(1996-11#1)(1996-12#7)(1996-2#2)(1996-3#4)(1996-4#2)(1996-5#6)(1996-7#3)(1996-8#5)(1996-9#1)(1997-1#2)(1997-2#6)(1997-3#2)(1997-4#5)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#3)(2004-10#3)(2004-12#1)(2004-2#2)(2004-4#1)(2005-10#2)(2005-11#5)(2005-12#1)(2005-4#1)(2005-8#2)(2006-1#2)(2006-10#2)(2006-11#1)(2006-12#11)(2006-4#3)(2006-5#1)(2006-6#4)(2006-8#3)(2006-9#2)(2007-1#4)(2007-10#3)(2007-11#7)(2007-12#9)(2007-2#6)(2007-4#1)(2007-6#4)(2007-7#8)(2007-8#8)(2008-1#1)(2008-10#146)(2008-11#12)(2008-12#4)(2008-2#14)(2008-3#12)(2008-4#6)(2008-5#31)(2008-6#2)(2008-7#17)(2008-8#12)(2009-10#1)(2009-11#2)(2009-12#6)(2009-2#5)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#5)(2009-8#3)(2009-9#2)(2010-10#2)(2010-12#8)(2010-2#4)(2010-3#4)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#6)(2010-9#2)(2011-1#10)(2011-12#2)(2011-2#10)(2012-1#5)(2012-11#2)(2012-12#5)(2012-2#12)(2012-3#3)(2013-1#12)(2013-7#3)(2013-8#5)
were found to belong to##2##5##(1996-7#1)(2008-10#1)
were found to bind to##2##5##(1995-6#1)(2007-8#1)
were found to bind##7##4##(1990-11#1)(1992-11#1)(1992-9#1)(1995-5#1)(1995-6#1)(2007-8#1)(2011-1#1)
were found to carry##2##4##(1993-6#1)(1995-9#1)
were found to code for P450##2##6##(1993-6#2)
were found to code for##3##5##(1993-6#2)(2006-12#1)
were found to consist of##2##5##(1991-7#1)(2008-10#1)
were found to contain##21##4##(1990-11#1)(1990-3#1)(1991-8#1)(1992-10#1)(1994-12#2)(1995-10#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-7#1)(1997-2#1)(1997-3#1)(2007-8#1)(2008-10#4)(2008-12#1)(2011-1#1)(2012-12#1)
were found to contribute##3##4##(2008-1#1)(2010-12#1)(2012-2#1)
were found to correlate well with##2##6##(1992-2#1)(1997-7#1)
were found to correlate with##6##5##(1990-12#1)(2005-11#1)(2007-1#1)(2007-3#1)(2008-10#1)(2011-1#1)
were found to correlate##8##4##(1990-12#1)(1992-2#1)(1997-7#1)(2005-11#1)(2007-1#1)(2007-3#1)(2008-10#1)(2011-1#1)
were found to correspond to##2##5##(2008-10#2)
were found to decrease in##2##5##(1994-5#1)(2008-10#1)
were found to decrease##5##4##(1994-5#1)(2004-9#1)(2008-10#2)(2008-7#1)
were found to depend on the##2##6##(1991-1#1)(2008-7#1)
were found to depend on##4##5##(1991-1#1)(1995-3#1)(2006-10#1)(2008-7#1)
were found to depend##7##4##(1990-3#1)(1991-1#1)(1995-3#1)(1997-7#1)(2006-10#1)(2008-3#1)(2008-7#1)
were found to differ##3##4##(1990-7#1)(1991-11#1)(2007-12#1)
were found to display##4##4##(1990-12#1)(1996-9#1)(2006-12#1)(2008-10#1)
were found to either##2##4##(2008-10#1)(2010-11#1)
were found to elicit##2##4##(1992-7#1)(1995-5#1)
were found to enhance the##4##5##(1992-12#1)(2008-10#1)(2008-11#2)
were found to exert##3##4##(1995-3#1)(2007-10#1)(2008-10#1)
were found to exhibit##4##4##(2006-12#1)(2008-3#1)(2008-5#1)(2012-11#1)
were found to express##7##4##(1992-11#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-2#1)(2007-11#1)
were found to form##2##4##(2005-11#1)(2008-5#1)
were found to generate##2##4##(1990-12#1)(1994-3#1)
were found to give##5##4##(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)
were found to have a##16##5##(1991-10#1)(1991-11#1)(1991-12#1)(1991-9#1)(1993-3#1)(1995-1#1)(2005-10#1)(2006-12#1)(2007-10#1)(2008-1#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
were found to have an##2##5##(2008-10#1)(2008-2#1)
were found to have duodenal##2##5##(2007-3#2)
were found to have elevated##2##5##(1995-7#1)(1997-7#1)
were found to have had##2##5##(2008-1#1)(2012-11#1)
were found to have high##2##5##(1994-9#1)(2008-10#1)
were found to have increased##3##5##(1992-9#1)(2006-8#1)(2009-11#1)
were found to have lower##2##5##(1997-2#1)(2012-2#1)
were found to have multiple##2##5##(1991-9#1)(2012-3#1)
were found to have normal##2##5##(1997-1#1)(2008-9#1)
were found to have only##2##5##(1991-3#1)(2007-1#1)
were found to have reduced##2##5##(1994-11#1)(2008-7#1)
were found to have significant influence on extraction efficiency##2##9##(2008-10#2)
were found to have significant##6##5##(2007-9#1)(2008-10#4)(2012-11#1)
were found to have significantly##2##5##(1993-6#1)(1995-12#1)
were found to have the##5##5##(1995-4#2)(1996-12#1)(2008-1#1)(2012-3#1)
were found to have two##2##5##(1995-3#1)(2008-12#1)
were found to have##128##4##(1990-2#1)(1990-3#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-7#2)(1991-9#3)(1992-4#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-3#2)(1993-6#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#2)(1995-7#1)(1996-12#1)(1996-2#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-8#3)(2007-1#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-3#3)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#14)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#2)(2009-11#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-4#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-11#2)(2012-2#5)(2012-3#3)(2013-1#1)(2013-8#1)
were found to increase with age##2##6##(1994-10#1)(2009-2#1)
were found to increase with##3##5##(1994-10#1)(2005-11#1)(2009-2#1)
were found to increase##10##4##(1990-6#1)(1992-11#1)(1993-12#1)(1994-10#1)(1996-5#1)(2005-11#1)(2007-1#1)(2007-11#1)(2008-2#1)(2009-2#1)
were found to induce##3##4##(1993-6#1)(1995-12#1)(2008-10#1)
were found to influence##2##4##(2006-11#1)(2013-7#1)
were found to inhibit##12##4##(1990-9#1)(1991-7#1)(1994-8#1)(2005-11#1)(2005-8#1)(2007-11#1)(2007-6#1)(2008-10#2)(2008-8#1)(2010-2#1)(2011-3#1)
were found to interact with##2##5##(1993-5#1)(1994-12#1)
were found to mediate##2##4##(1996-3#1)(2010-2#1)
were found to possess##8##4##(2007-11#1)(2008-1#1)(2008-11#1)(2008-5#3)(2009-11#1)(2010-10#1)
were found to produce##3##4##(1991-10#1)(2007-1#1)(2012-2#1)
were found to range from##2##5##(2008-2#1)(2012-3#1)
were found to react with##2##5##(1991-7#1)(2008-10#1)
were found to release##2##4##(1991-9#1)(2008-5#1)
were found to respond##2##4##(1992-1#1)(2009-8#1)
were found to selectively##2##4##(1990-8#1)(2008-10#1)
were found to show##4##4##(1990-2#1)(1995-6#1)(2005-8#1)(2006-10#1)
were found to significantly##3##4##(1995-1#1)(2007-11#1)(2013-1#1)
were found to stimulate##3##4##(1990-10#1)(1994-9#1)(1995-2#1)
were found to strongly##3##4##(1993-12#1)(1994-11#1)(2008-10#1)
were found to suppress the##2##5##(2006-12#1)(2008-11#1)
were found to vary with##2##5##(1991-4#1)(1997-3#1)
were found to vary##10##4##(1991-4#1)(1995-3#1)(1997-3#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2012-3#1)
were found to##1116##3##(1990-10#4)(1990-11#4)(1990-12#9)(1990-2#4)(1990-3#6)(1990-4#2)(1990-5#3)(1990-6#3)(1990-7#4)(1990-8#3)(1990-9#2)(1991-1#1)(1991-10#3)(1991-11#5)(1991-12#6)(1991-3#2)(1991-4#4)(1991-5#1)(1991-6#2)(1991-7#6)(1991-8#5)(1991-9#10)(1992-1#2)(1992-10#1)(1992-11#7)(1992-12#3)(1992-2#4)(1992-3#5)(1992-4#1)(1992-5#4)(1992-6#1)(1992-7#2)(1992-8#6)(1992-9#6)(1993-1#3)(1993-11#4)(1993-12#9)(1993-2#4)(1993-3#5)(1993-4#6)(1993-5#4)(1993-6#6)(1993-7#1)(1993-8#3)(1994-10#2)(1994-11#5)(1994-12#9)(1994-2#1)(1994-3#7)(1994-4#1)(1994-5#6)(1994-6#4)(1994-7#1)(1994-8#4)(1994-9#10)(1995-1#3)(1995-10#2)(1995-11#6)(1995-12#3)(1995-2#8)(1995-3#9)(1995-4#4)(1995-5#6)(1995-6#6)(1995-7#3)(1995-8#6)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#8)(1996-2#4)(1996-3#5)(1996-4#2)(1996-5#8)(1996-6#2)(1996-7#5)(1996-8#6)(1996-9#5)(1997-1#3)(1997-2#10)(1997-3#6)(1997-4#7)(1997-5#2)(1997-6#3)(1997-7#6)(1997-8#3)(2004-10#3)(2004-11#1)(2004-12#2)(2004-2#2)(2004-3#1)(2004-4#1)(2004-9#1)(2005-10#4)(2005-11#12)(2005-12#1)(2005-4#1)(2005-8#4)(2006-1#2)(2006-10#6)(2006-11#2)(2006-12#16)(2006-4#3)(2006-5#2)(2006-6#5)(2006-8#7)(2006-9#2)(2007-1#9)(2007-10#6)(2007-11#16)(2007-12#13)(2007-2#8)(2007-3#5)(2007-4#1)(2007-6#6)(2007-7#13)(2007-8#12)(2007-9#2)(2008-1#7)(2008-10#201)(2008-11#26)(2008-12#9)(2008-2#17)(2008-3#18)(2008-4#12)(2008-5#43)(2008-6#2)(2008-7#22)(2008-8#15)(2008-9#6)(2009-10#3)(2009-11#5)(2009-12#6)(2009-2#9)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#6)(2009-8#4)(2009-9#3)(2010-10#3)(2010-11#1)(2010-12#10)(2010-2#8)(2010-3#6)(2010-4#6)(2010-5#3)(2010-6#1)(2010-7#4)(2010-8#6)(2010-9#2)(2011-1#18)(2011-12#4)(2011-2#12)(2011-3#1)(2012-1#5)(2012-11#5)(2012-12#6)(2012-2#20)(2012-3#8)(2013-1#15)(2013-7#6)(2013-8#6)
were found under##3##3##(1994-10#1)(1996-1#1)(2008-10#1)
were found upstream##2##3##(1993-5#1)(1997-3#1)
were found using the reported search##41##6##(2007-8#41)
were found using the##42##4##(2007-8#41)(2013-8#1)
were found using##45##3##(1992-8#1)(2007-8#41)(2009-8#1)(2013-1#1)(2013-8#1)
were found when a##2##4##(1997-8#1)(2008-10#1)
were found when##10##3##(1991-4#1)(1992-8#1)(1996-10#1)(1996-2#1)(1997-8#1)(2006-10#2)(2008-10#3)
were found which##2##3##(2011-2#1)(2012-12#1)
were found with the##2##4##(2007-4#1)(2008-10#1)
were found with##22##3##(1990-3#1)(1990-5#1)(1991-3#1)(1993-4#1)(1993-9#1)(1994-3#1)(1995-5#1)(1996-11#1)(1997-7#1)(2005-10#1)(2007-4#1)(2008-10#3)(2008-2#1)(2008-7#1)(2009-3#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
were found within the permissible limits##2##6##(2008-1#1)(2008-5#1)
were found within the##6##4##(1993-12#1)(1994-9#1)(1995-11#1)(2008-1#1)(2008-5#2)
were found within##14##3##(1993-12#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-7#1)(1997-7#1)(2006-6#1)(2008-1#1)(2008-10#2)(2008-5#3)(2008-7#1)
were found##2555##2##(1990-1#1)(1990-10#7)(1990-11#11)(1990-12#14)(1990-2#9)(1990-3#11)(1990-4#6)(1990-5#8)(1990-6#7)(1990-7#8)(1990-8#6)(1990-9#10)(1991-1#2)(1991-10#4)(1991-11#8)(1991-12#16)(1991-2#8)(1991-3#7)(1991-4#6)(1991-5#7)(1991-6#5)(1991-7#12)(1991-8#11)(1991-9#18)(1992-1#5)(1992-10#1)(1992-11#9)(1992-12#12)(1992-2#7)(1992-3#10)(1992-4#7)(1992-5#6)(1992-6#6)(1992-7#4)(1992-8#16)(1992-9#10)(1993-1#5)(1993-10#1)(1993-11#13)(1993-12#17)(1993-2#13)(1993-3#8)(1993-4#8)(1993-5#13)(1993-6#13)(1993-7#5)(1993-8#6)(1993-9#13)(1994-10#4)(1994-11#9)(1994-12#13)(1994-2#13)(1994-3#14)(1994-4#2)(1994-5#9)(1994-6#10)(1994-7#4)(1994-8#10)(1994-9#11)(1995-1#7)(1995-10#4)(1995-11#13)(1995-12#10)(1995-2#20)(1995-3#14)(1995-4#6)(1995-5#15)(1995-6#11)(1995-7#5)(1995-8#8)(1995-9#2)(1996-1#6)(1996-10#9)(1996-11#4)(1996-12#16)(1996-2#14)(1996-3#10)(1996-4#5)(1996-5#16)(1996-6#8)(1996-7#13)(1996-8#10)(1996-9#9)(1997-1#7)(1997-2#21)(1997-3#20)(1997-4#17)(1997-5#6)(1997-6#8)(1997-7#13)(1997-8#16)(1997-9#1)(2003-11#1)(2004-10#4)(2004-11#7)(2004-12#2)(2004-2#3)(2004-3#3)(2004-4#3)(2004-9#1)(2005-1#2)(2005-10#6)(2005-11#16)(2005-12#1)(2005-4#1)(2005-8#10)(2005-9#3)(2006-1#2)(2006-10#17)(2006-11#4)(2006-12#18)(2006-3#3)(2006-4#4)(2006-5#8)(2006-6#11)(2006-7#4)(2006-8#16)(2006-9#3)(2007-1#21)(2007-10#22)(2007-11#31)(2007-12#33)(2007-2#16)(2007-3#15)(2007-4#3)(2007-5#8)(2007-6#10)(2007-7#31)(2007-8#74)(2007-9#10)(2008-1#16)(2008-10#404)(2008-11#42)(2008-12#30)(2008-2#23)(2008-3#27)(2008-4#19)(2008-5#93)(2008-6#12)(2008-7#54)(2008-8#30)(2008-9#17)(2009-10#6)(2009-11#11)(2009-12#9)(2009-2#13)(2009-3#2)(2009-4#5)(2009-5#3)(2009-6#6)(2009-7#9)(2009-8#9)(2009-9#5)(2010-1#2)(2010-10#4)(2010-11#2)(2010-12#26)(2010-2#13)(2010-3#10)(2010-4#17)(2010-5#9)(2010-6#3)(2010-7#7)(2010-8#11)(2010-9#4)(2011-1#37)(2011-10#1)(2011-11#1)(2011-12#7)(2011-2#53)(2011-3#2)(2012-1#18)(2012-11#13)(2012-12#29)(2012-2#32)(2012-3#22)(2012-4#1)(2012-5#3)(2013-1#53)(2013-7#23)(2013-8#27)
were founded##4##2##(1997-5#1)(2009-2#1)(2010-10#1)(2011-1#1)
were four##26##2##(1990-11#1)(1992-6#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-7#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-3#2)(2007-8#4)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2013-1#1)
were fractionated and##2##3##(2008-10#1)(2008-6#1)
were fractionated by##8##3##(1991-1#1)(1993-11#1)(1996-11#1)(1997-7#1)(2004-4#1)(2008-10#1)(2008-11#1)(2008-5#1)
were fractionated on##2##3##(2007-8#1)(2013-8#1)
were fractionated##17##2##(1991-1#1)(1992-7#1)(1993-11#1)(1996-11#1)(1997-7#1)(2004-4#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-12#1)(2013-8#1)
were fractures##2##2##(2012-2#2)
were fragmented##6##2##(1991-9#1)(2008-11#1)(2009-12#1)(2009-9#1)(2013-1#2)
were free from##4##3##(1990-4#1)(2008-10#1)(2008-5#1)(2011-1#1)
were free of disease##3##4##(2008-6#1)(2009-5#1)(2013-7#1)
were free of pain##2##4##(1993-8#1)(1995-9#1)
were free of##22##3##(1990-12#1)(1991-3#1)(1992-5#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-9#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-6#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-2#2)(2013-7#1)
were free to##2##3##(2007-12#1)(2007-2#1)
were free##30##2##(1990-12#1)(1990-4#1)(1991-3#1)(1992-1#1)(1992-5#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-9#1)(1996-7#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-6#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-7#1)
were frequency##2##2##(2007-12#1)(2008-2#1)
were frequent##7##2##(1993-2#1)(2007-10#1)(2007-3#1)(2008-5#1)(2009-6#1)(2012-12#1)(2012-3#1)
were frequently accompanied by##2##4##(2008-5#1)(2013-8#1)
were frequently and##2##3##(1990-12#1)(2009-7#1)
were frequently associated with##2##4##(2007-8#1)(2008-10#1)
were frequently encountered##2##3##(1991-8#1)(2012-2#1)
were frequently found##2##3##(1997-6#1)(2008-10#1)
were frequently observed##5##3##(1991-3#1)(2008-10#1)(2008-3#1)(2009-7#1)(2013-1#1)
were frequently present##2##3##(1994-12#1)(2012-12#1)
were frequently##28##2##(1990-12#1)(1991-3#1)(1991-8#1)(1994-12#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-11#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-7#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
were freshly##2##2##(2008-10#1)(2010-10#1)
were from 0##4##3##(2008-10#2)(2011-1#1)(2012-12#1)
were from 1##2##3##(1997-8#1)(2007-8#1)
were from 5##2##3##(2008-10#1)(2008-6#1)
were from 88 to##2##4##(1997-3#1)(2008-10#1)
were from 96##2##3##(1997-3#1)(2005-12#1)
were from different##3##3##(1996-9#1)(2008-10#1)(2010-4#1)
were from the same##2##4##(2008-10#1)(2008-9#1)
were from the##13##3##(2008-10#2)(2008-9#2)(2010-9#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-8#3)
were from##81##2##(1991-12#1)(1991-8#1)(1992-5#1)(1994-5#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-3#2)(1997-8#3)(2004-2#1)(2005-10#1)(2005-12#1)(2006-2#1)(2006-5#1)(2007-12#2)(2007-3#1)(2007-7#4)(2007-8#2)(2008-10#21)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-6#1)(2010-4#2)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-7#1)(2013-8#3)
were frontal##2##2##(1994-10#1)(2008-7#1)
were frozen##3##2##(2007-8#1)(2008-1#1)(2008-10#1)
were fully active##2##3##(1995-2#1)(2008-10#1)
were fully characterized##4##3##(1990-3#1)(2006-12#2)(2008-8#1)
were fully reversible##3##3##(1990-3#1)(1991-3#1)(2008-10#1)
were fully##34##2##(1990-3#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-8#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-4#1)(2005-11#1)(2005-12#1)(2006-12#2)(2006-6#1)(2007-11#2)(2007-12#1)(2007-3#1)(2008-10#6)(2008-8#1)(2010-10#1)(2010-4#1)(2012-1#1)(2013-1#2)
were functional as##3##3##(1993-9#1)(1995-1#1)(2008-4#1)
were functional in##2##3##(1997-1#1)(2008-7#1)
were functional##10##2##(1991-2#1)(1992-9#1)(1993-9#1)(1994-3#1)(1995-1#1)(1997-1#1)(2007-10#1)(2008-4#1)(2008-7#1)(2012-11#1)
were functionalized with##5##3##(2007-8#2)(2009-11#1)(2009-4#1)(2011-1#1)
were functionalized##7##2##(2007-8#2)(2008-10#1)(2009-11#1)(2009-4#1)(2011-1#1)(2012-11#1)
were functionally##7##2##(1991-4#1)(1994-12#1)(2005-9#1)(2006-12#1)(2008-10#1)(2010-12#1)(2012-12#1)
were functioning##6##2##(1990-11#1)(1995-11#1)(2007-11#1)(2008-1#1)(2008-8#1)(2009-11#1)
were further analysed##2##3##(1994-2#1)(2012-2#1)
were further analyzed by##3##4##(1996-5#1)(2013-8#2)
were further analyzed using##2##4##(2008-10#1)(2010-6#1)
were further analyzed##9##3##(1996-5#1)(1997-4#1)(2005-8#1)(2008-10#1)(2010-6#1)(2010-7#1)(2011-1#1)(2013-8#2)
were further characterized by##4##4##(1990-12#1)(2006-3#1)(2008-10#2)
were further characterized##8##3##(1990-12#1)(2005-8#1)(2006-3#1)(2008-10#3)(2008-6#1)(2011-1#1)
were further classified according to##2##5##(2008-1#1)(2013-8#1)
were further classified##4##3##(1994-5#1)(2008-1#1)(2008-7#1)(2013-8#1)
were further confirmed by##4##4##(1996-2#1)(1997-1#1)(2009-4#1)(2011-2#1)
were further confirmed##6##3##(1991-4#1)(1996-2#1)(1997-1#1)(2008-10#1)(2009-4#1)(2011-2#1)
were further divided into##4##4##(2005-10#1)(2008-10#1)(2009-5#1)(2013-8#1)
were further elucidated##2##3##(1997-8#1)(2010-10#1)
were further enhanced##2##3##(1991-4#1)(2007-10#1)
were further evaluated for##2##4##(1992-8#1)(2008-6#1)
were further evaluated##5##3##(1990-3#1)(1992-8#1)(1992-9#1)(2008-10#1)(2008-6#1)
were further examined using##2##4##(1993-3#1)(2012-3#1)
were further fractionated##2##3##(1997-8#1)(2008-10#1)
were further identified by##3##4##(1990-4#1)(2006-8#1)(2008-10#1)
were further identified##5##3##(1990-4#1)(2006-8#1)(2008-10#1)(2008-8#1)(2009-8#1)
were further investigated by##2##4##(1992-6#1)(2008-10#1)
were further investigated##5##3##(1992-6#1)(2005-11#1)(2008-10#1)(2008-11#1)(2010-9#1)
were further processed##2##3##(2007-7#1)(2010-5#1)
were further purified by##2##4##(1990-9#1)(2008-5#1)
were further purified##4##3##(1990-9#1)(1992-2#1)(1995-3#1)(2008-5#1)
were further studied##3##3##(1992-5#1)(1993-2#1)(2008-10#1)
were further subjected to##2##4##(2008-8#1)(2013-8#1)
were further substantiated##2##3##(1994-11#1)(2010-5#1)
were further supported by##2##4##(1996-9#1)(2013-1#1)
were further tested##4##3##(2006-8#1)(2007-7#1)(2011-2#1)(2013-1#1)
were further##109##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-4#2)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-9#2)(1997-1#2)(1997-4#1)(1997-6#1)(1997-8#2)(2004-4#1)(2005-10#1)(2005-11#1)(2005-8#3)(2005-9#1)(2006-2#1)(2006-3#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-7#2)(2008-1#1)(2008-10#14)(2008-11#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#6)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-5#3)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#7)
were fused by##3##3##(1991-5#1)(2006-8#1)(2008-9#1)
were fused to form##2##4##(1993-8#1)(2005-11#1)
were fused to the##3##4##(1996-9#1)(1997-2#1)(2008-10#1)
were fused to##13##3##(1990-3#1)(1991-10#1)(1991-2#1)(1993-8#1)(1994-5#1)(1994-8#1)(1996-9#1)(1997-2#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
were fused with##4##3##(1995-1#1)(1996-9#1)(1997-4#1)(1997-7#1)
were fused##25##2##(1990-3#1)(1990-5#1)(1991-10#1)(1991-2#1)(1991-5#1)(1992-7#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-1#1)(1996-9#2)(1997-2#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-4#1)(2006-8#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#2)
were gained##3##2##(2007-11#2)(2008-10#1)
were gathered and analyzed##2##4##(1995-2#1)(2013-1#1)
were gathered from##7##3##(2006-11#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-9#1)(2013-1#2)
were gathered in##2##3##(2008-10#2)
were gathered on##2##3##(2008-12#1)(2008-2#1)
were gathered through##2##3##(1997-8#1)(2007-7#1)
were gathered##25##2##(1995-2#1)(1996-8#1)(1997-8#1)(2006-1#1)(2006-11#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-7#1)(2009-5#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#5)
were gavaged with##4##3##(1997-3#1)(2006-7#1)(2008-10#1)(2008-4#1)
were generalized##3##2##(2004-11#1)(2007-2#1)(2007-9#1)
were generally found to be##2##5##(2005-11#1)(2012-11#1)
were generally found##3##3##(2005-11#1)(2011-2#1)(2012-11#1)
were generally greater##2##3##(1995-7#1)(2008-9#1)
were generally high##2##3##(1991-11#1)(2007-10#1)
were generally higher than##2##4##(2008-10#1)(2013-8#1)
were generally higher##4##3##(1995-1#1)(2008-10#1)(2013-8#2)
were generally in##3##3##(2008-10#2)(2013-8#1)
were generally less than those of the##2##7##(2008-9#2)
were generally less##4##3##(1995-12#1)(2008-9#2)(2010-10#1)
were generally low##4##3##(1993-9#1)(1997-8#1)(2008-10#1)(2010-8#1)
were generally lower##2##3##(2008-10#1)(2010-8#1)
were generally mild and##3##4##(2007-11#1)(2011-2#1)(2012-2#1)
were generally mild##4##3##(1992-8#1)(2007-11#1)(2011-2#1)(2012-2#1)
were generally more##5##3##(1994-3#1)(1997-1#1)(1997-3#1)(2011-12#1)(2013-8#1)
were generally not##4##3##(1991-3#1)(1992-7#1)(1994-11#1)(2007-7#1)
were generally satisfied with the##2##5##(1995-9#1)(2006-10#1)
were generally satisfied with their clinical##2##6##(1990-12#1)(1996-2#1)
were generally satisfied with their##3##5##(1990-12#1)(1996-2#1)(2006-2#1)
were generally satisfied with##6##4##(1990-12#1)(1991-1#1)(1995-9#1)(1996-2#1)(2006-10#1)(2006-2#1)
were generally small##3##3##(2008-10#1)(2008-7#1)(2012-3#1)
were generally weaker##2##3##(1992-9#1)(1995-11#1)
were generally##103##2##(1990-12#1)(1991-1#1)(1991-11#1)(1991-3#1)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-10#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-7#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#3)(1997-1#2)(1997-3#2)(1997-4#2)(1997-8#1)(2004-11#1)(2004-2#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-8#1)(2007-10#2)(2007-11#4)(2007-12#2)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#5)(2009-4#1)(2009-7#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-8#3)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#4)
were generated and##16##3##(1991-8#1)(1994-11#1)(1995-12#1)(1996-7#1)(1997-9#1)(2008-1#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2009-12#1)(2009-4#1)(2011-2#2)(2012-1#1)
were generated at the##2##4##(1997-6#1)(2005-11#1)
were generated at##4##3##(1997-6#1)(2005-11#1)(2007-12#1)(2008-10#1)
were generated by PCR##2##4##(1990-11#1)(1993-9#1)
were generated by a##2##4##(1996-9#1)(2007-12#1)
were generated by insertional mutagenesis##2##5##(1996-9#1)(2008-10#1)
were generated by retroviral-mediated##2##4##(1995-8#2)
were generated by##31##3##(1990-10#1)(1990-11#1)(1990-3#1)(1991-2#1)(1991-7#2)(1993-9#1)(1994-12#1)(1994-3#1)(1995-6#1)(1995-8#2)(1996-7#1)(1996-9#2)(1997-7#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
were generated for each##2##4##(2006-11#1)(2008-10#1)
were generated for##7##3##(1996-7#1)(2006-11#1)(2008-10#3)(2008-2#1)(2008-3#1)
were generated from a##3##4##(2007-12#2)(2008-3#1)
were generated from an##2##4##(2008-1#1)(2008-10#1)
were generated from##19##3##(1990-2#1)(1992-6#1)(1995-6#1)(1997-6#1)(2007-12#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-12#1)(2010-8#1)
were generated in a##3##4##(2007-12#2)(2008-2#1)
were generated in rabbits##2##4##(1991-9#1)(2008-10#1)
were generated in the reaction##2##5##(1994-12#2)
were generated in the##10##4##(1991-12#1)(1993-8#1)(1994-12#2)(1997-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2013-8#1)
were generated in##20##3##(1991-12#1)(1991-9#1)(1993-8#1)(1994-12#2)(1996-12#1)(1996-2#1)(1997-2#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-2#2)(2012-12#1)(2013-8#1)
were generated to##3##3##(2009-10#1)(2011-2#1)(2012-1#1)
were generated using a##2##4##(2009-12#1)(2012-1#1)
were generated using an##2##4##(1992-8#1)(2006-12#1)
were generated using the##2##4##(1990-11#1)(2009-5#1)
were generated using##12##3##(1990-11#1)(1992-8#1)(1994-3#1)(2006-12#1)(2008-7#1)(2009-12#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-1#2)(2012-12#1)
were generated via##3##3##(2005-11#1)(2008-10#1)(2013-8#1)
were generated with a total##2##5##(2007-12#1)(2008-10#1)
were generated with a##5##4##(2007-12#2)(2008-10#1)(2008-2#2)
were generated with##9##3##(1993-6#1)(1996-12#1)(2007-12#2)(2008-10#2)(2008-2#2)(2012-2#1)
were generated##162##2##(1990-10#1)(1990-11#2)(1990-2#1)(1990-3#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-6#1)(1992-8#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-3#2)(1995-12#1)(1995-6#3)(1995-8#3)(1996-12#2)(1996-2#1)(1996-3#1)(1996-7#3)(1996-9#2)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-9#1)(2005-11#2)(2006-10#1)(2006-11#2)(2006-12#2)(2007-11#1)(2007-12#11)(2007-4#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#30)(2008-11#4)(2008-12#3)(2008-2#6)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#2)(2009-5#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-1#4)(2012-12#4)(2012-2#1)(2013-1#1)(2013-8#5)
were genetically distinct##2##3##(2008-10#2)
were genetically diverse##2##3##(2008-10#1)(2013-1#1)
were genetically similar to##4##4##(1991-11#1)(2008-10#3)
were genetically similar##5##3##(1991-11#1)(2008-10#4)
were genetically##21##2##(1990-11#1)(1991-11#2)(1991-12#1)(1991-5#1)(1994-12#1)(1995-3#1)(2008-10#13)(2013-1#1)
were genotype##4##2##(2007-2#2)(2011-10#1)(2013-1#1)
were genotyped at##2##3##(2008-10#2)
were genotyped by##4##3##(2007-2#2)(2008-10#1)(2013-8#1)
were genotyped for the##4##4##(2005-8#1)(2006-9#1)(2008-10#2)
were genotyped for##8##3##(2005-8#1)(2006-9#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-4#1)(2012-12#1)
were genotyped in##4##3##(2004-10#1)(2009-4#1)(2010-12#2)
were genotyped using##2##3##(2006-10#1)(2008-10#1)
were genotyped##25##2##(2004-10#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-2#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-8#1)(2009-4#2)(2010-12#3)(2012-12#1)(2013-8#3)
were genotypically distinct##3##3##(2008-10#3)
were genotypically##5##2##(2008-10#5)
were gently##2##2##(1992-9#1)(2008-11#1)
were girls and##3##3##(2008-12#2)(2011-2#1)
were girls##6##2##(2006-7#1)(2008-12#2)(2010-1#1)(2011-2#1)(2013-1#1)
were given 200##2##3##(1990-10#1)(2010-2#1)
were given 5##3##3##(1992-5#1)(1997-7#1)(2008-10#1)
were given a clinical##2##4##(2007-7#1)(2010-12#1)
were given a gluten-free diet##2##5##(1991-2#2)
were given a single intramuscular injection of##2##7##(1995-9#1)(2008-10#1)
were given a single##4##4##(1993-7#1)(1995-9#1)(2008-10#1)(2013-1#1)
were given a##28##3##(1991-12#1)(1991-2#2)(1991-4#1)(1991-6#1)(1992-3#1)(1992-4#1)(1993-7#1)(1995-9#1)(1996-11#1)(1996-5#1)(2006-10#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-2#1)(2009-4#1)(2010-12#2)(2011-2#1)(2012-1#2)(2013-1#2)
were given an##8##3##(1990-5#1)(1995-9#1)(1996-5#1)(2007-2#1)(2009-5#1)(2010-12#1)(2012-3#1)(2013-1#1)
were given as##2##3##(2013-1#1)(2013-8#1)
were given at different##2##4##(1993-3#1)(1994-8#1)
were given at##6##3##(1990-3#1)(1993-3#1)(1994-8#1)(2008-2#1)(2008-9#1)(2012-3#1)
were given drinking water containing NNM for 8 weeks##2##9##(1991-9#1)(2008-4#1)
were given drinking water containing##4##5##(1991-9#1)(2008-10#2)(2008-4#1)
were given either##6##3##(1990-11#1)(1992-11#1)(1993-4#1)(1993-7#1)(1997-7#1)(2012-2#1)
were given for##7##3##(1992-10#1)(1993-2#1)(1995-12#1)(2007-7#2)(2011-1#1)(2013-1#1)
were given on##3##3##(2005-7#1)(2007-1#1)(2010-5#1)
were given one##2##3##(1990-7#2)
were given oral##2##3##(1991-12#1)(2007-8#1)
were given placebo##3##3##(1991-11#1)(2007-7#1)(2007-8#1)
were given separately##2##3##(1995-5#1)(2008-4#1)
were given the opportunity to##3##5##(2005-8#1)(2006-7#1)(2008-11#1)
were given the option##2##4##(2012-3#2)
were given the same##2##4##(1997-8#1)(2009-11#1)
were given the##13##3##(1995-11#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-7#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-11#1)(2012-3#2)
were given this##2##3##(1993-6#1)(1997-8#1)
were given to##9##3##(1990-10#1)(1995-10#1)(2004-10#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-7#1)
were given together for##2##4##(2008-5#2)
were given two##3##3##(1993-11#1)(2009-12#1)(2010-2#1)
were given##218##2##(1990-10#2)(1990-11#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#3)(1991-11#1)(1991-12#3)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-10#2)(1992-11#2)(1992-3#3)(1992-4#1)(1992-5#2)(1993-1#1)(1993-11#2)(1993-12#4)(1993-2#3)(1993-3#3)(1993-4#1)(1993-6#2)(1993-7#3)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-9#4)(1996-1#1)(1996-11#1)(1996-5#3)(1997-4#2)(1997-7#2)(1997-8#2)(2004-1#1)(2004-10#2)(2004-3#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#11)(2007-8#7)(2008-1#5)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#5)(2008-6#6)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-9#1)(2010-12#3)(2010-2#3)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-2#3)(2012-3#5)(2013-1#8)(2013-8#5)
were glutamine##2##2##(2008-11#2)
were glycosylated##3##2##(1991-10#1)(1992-3#1)(1994-9#1)
were good amino##2##3##(1990-2#2)
were good and##2##3##(2008-5#1)(2012-12#1)
were good in##2##3##(1994-6#1)(2007-7#1)
were good##22##2##(1990-2#2)(1993-8#1)(1994-6#1)(2007-11#1)(2007-7#2)(2008-10#4)(2008-2#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-7#1)(2011-1#1)(2012-12#4)(2013-1#1)
were grade 1##2##3##(2007-11#1)(2008-6#1)
were grade II##2##3##(2006-10#1)(2007-2#1)
were grade##8##2##(2006-10#4)(2007-11#1)(2007-2#1)(2008-6#2)
were graded according to##4##4##(2007-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
were graded as##3##3##(1997-7#1)(2006-12#1)(2008-7#1)
were graded using##2##3##(2007-11#1)(2007-9#1)
were graded##14##2##(1996-9#1)(1997-7#2)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)
were gradually increased##3##3##(1992-8#1)(1997-8#1)(2013-1#1)
were gradually##9##2##(1992-8#1)(1994-11#1)(1995-6#1)(1996-12#1)(1997-8#1)(2006-2#1)(2008-5#1)(2008-9#1)(2013-1#1)
were graft inoculated##2##3##(2008-10#2)
were grafted onto##2##3##(2008-10#1)(2008-7#1)
were grafted with##2##3##(2008-8#1)(2009-7#1)
were grafted##6##2##(1995-3#1)(2006-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-7#1)
were gram##2##2##(2013-8#2)
were granted##2##2##(1996-12#1)(2008-12#1)
were grazed on##2##3##(2010-2#1)(2011-1#1)
were great##3##2##(2008-10#1)(2010-2#2)
were greater (P&lt##2##3##(2009-4#2)
were greater for the##2##4##(1995-3#1)(2008-5#1)
were greater for##3##3##(1995-3#1)(1996-11#1)(2008-5#1)
were greater in cv##2##4##(2008-10#2)
were greater in the##3##4##(1991-5#1)(1992-10#1)(2004-2#1)
were greater in##18##3##(1991-5#1)(1992-10#1)(1994-2#1)(1994-3#1)(1995-8#1)(1996-9#1)(2004-2#1)(2006-7#1)(2008-10#5)(2008-4#1)(2008-5#2)(2008-9#1)(2011-1#1)
were greater on the##3##4##(2007-10#2)(2011-2#1)
were greater on##4##3##(2007-10#2)(2008-10#1)(2011-2#1)
were greater than 0##3##4##(1997-3#1)(2008-10#1)(2011-1#1)
were greater than 90%##2##4##(1992-2#1)(1994-5#1)
were greater than in##2##4##(2008-11#1)(2010-4#1)
were greater than the##2##4##(1992-5#1)(1996-1#1)
were greater than those of##5##5##(1996-3#1)(2008-8#1)(2008-9#3)
were greater than those##7##4##(1996-3#1)(2007-4#1)(2008-8#1)(2008-9#3)(2011-2#1)
were greater than##29##3##(1990-12#1)(1991-8#1)(1992-2#1)(1992-5#1)(1993-2#1)(1994-5#1)(1995-2#1)(1996-1#1)(1996-3#1)(1997-3#1)(2004-4#1)(2007-4#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#3)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
were greater when##3##3##(1994-12#1)(2008-10#2)
were greater##67##2##(1990-12#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-3#1)(2004-2#1)(2004-4#1)(2006-11#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-4#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#4)(2009-4#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-8#1)
were greatest at##2##3##(2007-8#1)(2008-10#1)
were greatest in##3##3##(1994-3#1)(2008-10#2)
were greatest##7##2##(1994-3#1)(2007-8#1)(2008-10#4)(2010-4#1)
were greatly decreased##2##3##(1995-8#1)(1996-5#1)
were greatly enhanced by##2##4##(2008-10#2)
were greatly reduced in##2##4##(1995-6#1)(2008-7#1)
were greatly reduced##5##3##(1995-6#1)(2007-12#1)(2008-10#1)(2008-7#1)(2012-3#1)
were greatly##18##2##(1990-4#1)(1994-12#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-8#1)(2005-7#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-7#1)(2012-3#1)(2013-1#1)
were grossly##3##2##(1995-6#1)(1996-11#1)(2012-2#1)
were ground and##3##3##(2007-2#1)(2008-10#1)(2013-7#1)
were ground in##2##3##(1990-9#1)(2008-10#1)
were ground##6##2##(1990-9#1)(2006-8#1)(2007-2#1)(2008-10#2)(2013-7#1)
were grouped according to the##3##5##(2008-1#2)(2011-2#1)
were grouped according to##7##4##(1997-8#1)(2006-2#1)(2008-1#2)(2008-10#1)(2011-2#1)(2013-8#1)
were grouped as##2##3##(2008-10#1)(2008-3#1)
were grouped by##4##3##(2008-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
were grouped in two##3##4##(1992-11#1)(2008-10#2)
were grouped in##7##3##(1992-11#1)(1996-3#1)(2005-11#1)(2008-10#4)
were grouped into 15##2##4##(2008-10#1)(2008-5#1)
were grouped into four##2##4##(2008-10#1)(2008-7#1)
were grouped into the##3##4##(2004-11#1)(2008-10#1)(2013-1#1)
were grouped into three##4##4##(2007-1#1)(2008-4#1)(2011-1#1)(2012-2#1)
were grouped into##25##3##(1993-11#1)(1995-3#1)(2004-11#1)(2005-10#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
were grouped##57##2##(1992-11#1)(1993-11#1)(1993-2#1)(1995-3#1)(1996-3#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#2)(2006-2#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#17)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
were growing##4##2##(1994-8#1)(1995-3#1)(2008-10#1)(2011-2#1)
were grown at##5##3##(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)
were grown by##5##3##(2007-11#2)(2007-8#1)(2008-10#1)(2008-8#1)
were grown for##3##3##(1993-8#1)(2008-12#1)(2008-7#1)
were grown from##2##3##(1993-6#1)(2008-8#1)
were grown hydroponically in##3##4##(2008-10#2)(2008-5#1)
were grown hydroponically##4##3##(2008-10#2)(2008-5#1)(2008-9#1)
were grown in a##6##4##(1992-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2011-12#1)
were grown in culture and##2##5##(1994-2#1)(2010-3#1)
were grown in culture##3##4##(1994-2#1)(2008-10#1)(2010-3#1)
were grown in low##2##4##(2004-11#1)(2006-12#1)
were grown in soil##5##4##(2008-10#2)(2008-5#2)(2010-11#1)
were grown in the presence of##5##6##(1995-1#1)(1995-6#1)(2008-10#3)
were grown in the##7##4##(1995-1#1)(1995-6#1)(2008-10#5)
were grown in##42##3##(1990-9#1)(1992-11#1)(1993-9#1)(1994-2#1)(1995-1#1)(1995-6#1)(2004-11#2)(2004-4#1)(2006-12#1)(2006-8#1)(2008-10#16)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2010-11#1)(2010-3#2)(2011-12#1)(2011-2#1)(2012-9#1)(2013-7#1)
were grown on basal medium##2##5##(2008-6#2)
were grown on microcarriers##2##4##(2008-11#2)
were grown on the##2##4##(2008-10#1)(2008-6#1)
were grown on##16##3##(1995-5#1)(1995-9#1)(1996-7#1)(2006-3#1)(2006-8#1)(2008-10#2)(2008-11#3)(2008-5#2)(2008-6#3)(2013-1#1)
were grown under##4##3##(1997-2#1)(2008-10#2)(2010-5#1)
were grown with or without##2##5##(2005-8#1)(2008-10#1)
were grown with##4##3##(2005-8#1)(2008-10#1)(2008-9#1)(2011-2#1)
were grown##97##2##(1990-9#1)(1991-11#1)(1992-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-1#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-7#2)(1997-2#1)(2004-11#2)(2004-4#1)(2005-8#1)(2006-12#1)(2006-3#1)(2006-8#2)(2007-11#3)(2007-12#3)(2007-8#1)(2008-10#30)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#2)(2010-11#1)(2010-3#2)(2010-5#1)(2011-12#1)(2011-2#2)(2012-9#1)(2013-1#1)(2013-7#1)
were guided by##3##3##(2009-6#1)(2010-10#1)(2010-5#1)
were handled##4##2##(1992-9#1)(1993-7#1)(1996-11#1)(2010-8#1)
were hardened##3##2##(2004-8#1)(2010-2#1)(2013-1#1)
were hardly##3##2##(1992-8#1)(2008-10#2)
were harvested and##8##3##(2007-1#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)
were harvested at 1##2##4##(1995-2#1)(1996-7#1)
were harvested at##3##3##(1995-2#1)(1996-7#1)(2008-7#1)
were harvested for##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
were harvested from##4##3##(2008-12#1)(2008-5#1)(2008-9#1)(2009-3#1)
were harvested##30##2##(1995-2#1)(1996-7#1)(2006-7#1)(2007-1#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#2)(2008-12#3)(2008-5#3)(2008-7#1)(2008-9#3)(2009-3#1)(2010-10#1)(2011-2#2)(2012-2#1)
were having##5##2##(2006-2#1)(2006-4#2)(2010-4#1)(2012-3#1)
were headache##2##2##(1997-6#1)(2010-12#1)
were healed##3##2##(1992-2#1)(2007-7#1)(2011-2#1)
were health##4##2##(1992-1#1)(2008-12#1)(2011-2#1)(2013-1#1)
were healthy subjects##3##3##(1994-5#1)(2006-6#1)(2013-1#1)
were healthy##9##2##(1993-11#1)(1993-5#1)(1994-5#1)(1995-7#1)(1996-1#1)(2006-6#1)(2008-1#1)(2012-3#1)(2013-1#1)
were heard##2##2##(1996-5#1)(1997-8#1)
were hearing##2##2##(1995-6#1)(2009-10#1)
were heated at 45 degrees C##2##6##(1992-1#1)(1994-8#1)
were heated in##2##3##(2005-11#1)(2012-11#1)
were heated##6##2##(1990-3#1)(1992-1#1)(1992-7#1)(1994-8#1)(2005-11#1)(2012-11#1)
were heavier##3##2##(2008-5#1)(2010-4#1)(2013-7#1)
were heavily##6##2##(1995-12#1)(1997-5#1)(2006-4#1)(2008-2#1)(2010-8#1)(2013-7#1)
were held at##3##3##(1996-9#1)(2010-8#1)(2011-2#1)
were held in the##2##4##(1991-10#1)(2008-10#1)
were held in##7##3##(1991-10#1)(2005-8#2)(2008-10#1)(2009-5#1)(2010-8#1)(2011-2#1)
were held on the##2##4##(2006-9#1)(2013-1#1)
were held to##3##3##(2005-10#1)(2011-2#1)(2012-12#1)
were held with##4##3##(1996-1#1)(2008-7#1)(2010-8#1)(2011-2#1)
were held##28##2##(1991-10#1)(1996-1#1)(1996-9#1)(2005-10#1)(2005-7#1)(2005-8#3)(2006-10#1)(2006-9#1)(2008-10#1)(2008-7#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-8#3)(2011-2#5)(2012-12#1)(2012-3#1)(2012-7#1)(2013-1#1)
were helpful in monitoring therapeutic##2##5##(1991-8#1)(1993-9#1)
were helpful in the##2##4##(1990-3#1)(2007-2#1)
were helpful in##4##3##(1990-3#1)(1991-8#1)(1993-9#1)(2007-2#1)
were helpful##5##2##(1990-3#1)(1991-8#1)(1993-9#1)(2007-2#2)
were heterogeneous##4##2##(1990-11#1)(1994-11#1)(2008-10#1)(2013-1#1)
were heterogeneously##2##2##(1993-9#1)(2009-12#1)
were heterozygotes##2##2##(1990-4#1)(1997-4#1)
were heterozygous for a##2##4##(1993-12#1)(2008-3#1)
were heterozygous for the##3##4##(1995-2#1)(2012-12#1)(2013-1#1)
were heterozygous for this mutation##2##5##(1991-7#1)(1993-4#1)
were heterozygous for##8##3##(1991-7#1)(1993-12#2)(1993-4#1)(1995-2#1)(2008-3#1)(2012-12#1)(2013-1#1)
were heterozygous##13##2##(1991-12#1)(1991-7#1)(1993-12#2)(1993-4#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-12#1)(2013-1#1)
were high (0##2##3##(2008-10#2)
were high affinity (Kd = 0##2##6##(1994-8#2)
were high and##4##3##(1990-9#1)(2005-7#1)(2009-6#1)(2012-3#1)
were high in the##3##4##(1990-11#1)(2013-1#1)(2013-7#1)
were high in##7##3##(1990-11#1)(2007-3#1)(2008-10#2)(2008-8#1)(2013-1#1)(2013-7#1)
were high##53##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-5#1)(1992-12#1)(1992-2#1)(1993-5#1)(1994-11#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-12#1)(2005-7#1)(2005-9#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-3#2)(2008-10#6)(2008-4#2)(2008-5#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
were higher (P &lt##8##4##(2006-10#1)(2006-5#3)(2008-4#1)(2010-2#3)
were higher (p &lt##4##4##(2007-8#1)(2012-2#2)(2013-8#1)
were higher (p##5##3##(2007-8#1)(2012-2#2)(2013-8#2)
were higher among##5##3##(1991-1#1)(1996-3#1)(1997-1#1)(2006-10#1)(2011-2#1)
were higher and##7##3##(2006-9#1)(2007-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2013-7#2)
were higher at##6##3##(1993-3#1)(1995-11#1)(2008-10#1)(2008-5#1)(2009-3#1)(2013-7#1)
were higher before##2##3##(2006-8#1)(2007-10#1)
were higher by##2##3##(2008-10#2)
were higher compared with##2##4##(2006-5#1)(2008-10#1)
were higher compared##3##3##(2006-5#1)(2008-10#1)(2008-3#1)
were higher for the##4##4##(1992-7#1)(1995-8#1)(2007-8#1)(2009-2#1)
were higher for##14##3##(1992-7#1)(1995-8#1)(2004-9#1)(2007-6#1)(2007-8#1)(2008-10#3)(2009-2#1)(2009-4#1)(2011-1#1)(2011-2#2)(2013-8#1)
were higher in both##2##4##(2008-10#1)(2010-4#1)
were higher in children##2##4##(2004-12#1)(2006-1#1)
were higher in females##2##4##(1993-12#1)(2009-4#1)
were higher in group##2##4##(2007-7#1)(2008-12#1)
were higher in leaves##4##4##(1995-3#1)(2006-12#1)(2007-1#1)(2008-5#1)
were higher in left-pawed##2##4##(1997-2#2)
were higher in males than in females##2##7##(2007-12#1)(2012-12#1)
were higher in males than##3##5##(2007-12#2)(2012-12#1)
were higher in non reactional##2##5##(2011-2#2)
were higher in smokers##2##4##(2008-10#2)
were higher in the early##2##5##(1997-8#1)(2006-5#1)
were higher in the##32##4##(1991-12#1)(1992-6#1)(1993-1#1)(1993-7#1)(1994-6#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-4#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-5#4)(2007-8#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-1#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-7#2)(2013-8#1)
were higher in##107##3##(1990-10#1)(1990-11#1)(1990-4#1)(1990-9#1)(1991-12#2)(1991-7#1)(1992-1#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-7#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-3#2)(1996-12#1)(1996-3#1)(1996-9#1)(1997-2#3)(1997-7#1)(1997-8#1)(2004-12#1)(2004-4#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#2)(2007-1#2)(2007-12#2)(2007-5#5)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#9)(2012-11#1)(2012-12#4)(2012-2#3)(2013-1#1)(2013-7#2)(2013-8#1)
were higher on##2##3##(2008-5#1)(2011-12#1)
were higher than 95%##2##4##(2008-10#2)
were higher than control##2##4##(2007-11#1)(2008-8#1)
were higher than for##3##4##(1993-6#1)(2008-10#1)(2008-9#1)
were higher than in##8##4##(1995-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-2#1)(2011-2#1)(2013-1#1)
were higher than that in##2##5##(2008-9#1)(2011-1#1)
were higher than that of the##2##6##(2009-3#1)(2011-2#1)
were higher than that of##4##5##(1991-8#1)(2009-3#1)(2011-1#1)(2011-2#1)
were higher than that##7##4##(1991-8#1)(1996-12#1)(2008-9#1)(2009-3#1)(2011-1#2)(2011-2#1)
were higher than the controls##2##5##(2008-10#1)(2011-1#1)
were higher than the maximum##2##5##(1996-8#1)(2008-12#1)
were higher than the national##4##5##(2009-6#1)(2010-5#2)(2010-9#1)
were higher than the recommended##2##5##(2011-1#1)(2012-2#1)
were higher than the##19##4##(1990-2#1)(1993-2#1)(1996-4#1)(1996-8#1)(2006-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2009-6#1)(2010-5#2)(2010-9#3)(2011-1#2)(2012-2#1)(2013-8#1)
were higher than those for the##2##6##(2008-10#2)
were higher than those for##3##5##(2008-10#2)(2008-9#1)
were higher than those in the##2##6##(1993-4#1)(2006-3#1)
were higher than those in##5##5##(1993-4#1)(1995-8#1)(2006-3#1)(2008-7#1)(2013-8#1)
were higher than those of the##2##6##(2008-2#1)(2008-5#1)
were higher than those of##12##5##(1992-4#1)(1993-12#1)(2004-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
were higher than those##32##4##(1992-4#1)(1993-12#1)(1993-4#1)(1995-8#1)(2004-12#1)(2004-4#1)(2006-3#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
were higher than##91##3##(1990-2#1)(1991-8#1)(1992-1#1)(1992-4#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-8#1)(2004-12#1)(2004-4#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-5#2)(2010-7#1)(2010-9#3)(2011-1#4)(2011-2#3)(2012-1#3)(2012-2#2)(2012-6#1)(2013-1#4)(2013-8#2)
were higher then control group##2##5##(2008-12#2)
were higher under##2##3##(2013-8#2)
were higher when the##2##4##(2008-6#1)(2012-2#1)
were higher when##3##3##(1994-2#1)(2008-6#1)(2012-2#1)
were higher##291##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#1)(1990-9#1)(1991-1#1)(1991-12#3)(1991-7#1)(1991-8#1)(1992-1#3)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#3)(1993-6#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#2)(1995-8#2)(1996-12#2)(1996-3#2)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-7#1)(1997-8#1)(2004-11#1)(2004-12#2)(2004-4#2)(2004-9#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-3#2)(2006-4#1)(2006-5#6)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-5#6)(2007-6#2)(2007-7#3)(2007-8#4)(2008-1#1)(2008-10#35)(2008-11#6)(2008-12#8)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#12)(2008-6#4)(2008-7#5)(2008-8#2)(2008-9#4)(2009-10#1)(2009-2#2)(2009-3#2)(2009-4#3)(2009-6#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-4#4)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#7)(2011-12#1)(2011-2#17)(2012-1#4)(2012-11#2)(2012-12#4)(2012-2#10)(2012-6#1)(2013-1#6)(2013-7#5)(2013-8#10)
were highest at the##3##4##(2007-1#1)(2007-4#1)(2013-1#1)
were highest at##7##3##(2007-1#1)(2007-4#1)(2008-10#2)(2008-5#1)(2011-2#1)(2013-1#1)
were highest for##5##3##(1991-2#1)(1993-1#1)(1997-7#1)(2008-9#1)(2009-10#1)
were highest in the adult adrenal##2##6##(1996-12#2)
were highest in the##12##4##(1995-5#1)(1996-12#3)(1996-3#1)(1997-2#1)(2006-5#2)(2008-10#1)(2008-7#1)(2012-1#1)(2013-8#1)
were highest in##25##3##(1993-7#1)(1995-5#1)(1996-12#3)(1996-3#1)(1997-2#1)(1997-6#1)(2004-2#1)(2006-2#2)(2006-5#2)(2007-1#1)(2007-10#1)(2008-10#3)(2008-7#2)(2008-9#1)(2009-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
were highest##45##2##(1991-2#1)(1992-3#1)(1993-1#1)(1993-3#1)(1993-7#1)(1994-8#1)(1995-5#1)(1996-12#3)(1996-3#1)(1997-2#1)(1997-6#1)(1997-7#1)(2004-2#1)(2006-2#2)(2006-5#2)(2007-1#2)(2007-10#1)(2007-4#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
were highlighted by##2##3##(1992-12#1)(2007-9#1)
were highlighted##10##2##(1990-2#1)(1992-12#1)(2005-8#2)(2007-8#1)(2007-9#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
were highly active##3##3##(1991-9#1)(1994-8#1)(2008-7#1)
were highly conserved##2##3##(1995-6#1)(2008-10#1)
were highly correlated (r = 0##2##6##(1992-4#1)(1997-5#1)
were highly correlated with the##3##5##(1993-9#1)(2008-7#1)(2010-4#1)
were highly correlated with##15##4##(1993-6#1)(1993-9#1)(1995-1#1)(1995-11#1)(1995-4#1)(2006-6#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-9#1)
were highly correlated##28##3##(1990-4#1)(1990-8#1)(1992-4#1)(1993-6#1)(1993-9#1)(1995-1#1)(1995-11#1)(1995-4#1)(1997-5#1)(2006-6#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-9#1)(2012-1#1)
were highly dependent on##3##4##(1995-12#1)(2008-10#2)
were highly dependent##4##3##(1995-12#1)(2006-8#1)(2008-10#2)
were highly differentiated##2##3##(1990-9#1)(2008-10#1)
were highly effective in##4##4##(2007-12#1)(2008-10#2)(2008-5#1)
were highly effective##5##3##(1994-6#1)(2007-12#1)(2008-10#2)(2008-5#1)
were highly expressed during embryonic cardiac development##2##7##(1997-6#2)
were highly expressed in##6##4##(1994-12#1)(1997-6#1)(2008-11#1)(2008-8#1)(2010-12#1)(2012-3#1)
were highly expressed##9##3##(1994-12#1)(1997-6#3)(2005-11#1)(2008-11#1)(2008-8#1)(2010-12#1)(2012-3#1)
were highly homogeneous##2##3##(1995-1#1)(2008-10#1)
were highly homologous to##3##4##(1995-6#1)(1997-7#1)(2008-8#1)
were highly homologous##7##3##(1994-11#1)(1994-12#1)(1995-6#1)(1995-8#1)(1997-7#1)(2008-5#1)(2008-8#1)
were highly pathogenic on bean cultivars of both gene pools##2##10##(2008-10#2)
were highly pathogenic on##5##4##(2008-10#5)
were highly pathogenic##6##3##(2007-12#1)(2008-10#5)
were highly related to##2##4##(2010-8#1)(2011-1#1)
were highly reproducible##2##3##(1995-12#1)(2008-10#1)
were highly resistant to##3##4##(2008-10#1)(2008-8#2)
were highly satisfied with##2##4##(2013-1#2)
were highly sensitive to##3##4##(1990-8#1)(2008-8#1)(2010-5#1)
were highly sensitive##4##3##(1990-8#1)(1995-2#1)(2008-8#1)(2010-5#1)
were highly significant (P &lt##4##5##(2008-10#4)
were highly significant (P = 0##2##6##(2008-10#2)
were highly significant (P##7##4##(1992-8#1)(2008-10#6)
were highly significant##13##3##(1991-12#1)(1992-8#1)(2007-10#1)(2008-10#9)(2008-8#1)
were highly similar to##2##4##(1996-4#1)(2008-10#1)
were highly similar##4##3##(1996-4#1)(2008-10#2)(2012-2#1)
were highly specific and##2##4##(2008-10#2)
were highly specific##3##3##(2006-8#1)(2008-10#2)
were highly statistically significant##2##4##(1997-3#1)(2007-8#1)
were highly suggestive of##3##4##(2006-9#1)(2007-6#1)(2008-10#1)
were highly susceptible to##4##4##(2006-8#1)(2008-10#1)(2009-5#1)(2012-2#1)
were highly susceptible##5##3##(2006-8#1)(2008-10#2)(2009-5#1)(2012-2#1)
were highly variable##5##3##(2008-10#2)(2008-8#1)(2009-8#2)
were highly virulent##4##3##(2008-10#3)(2013-8#1)
were highly##165##2##(1990-4#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-8#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#3)(1995-11#2)(1995-12#2)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-4#1)(1996-9#1)(1997-3#2)(1997-5#1)(1997-6#3)(1997-7#1)(2005-11#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#3)(2007-6#2)(2007-8#2)(2008-1#1)(2008-10#48)(2008-11#1)(2008-12#2)(2008-2#2)(2008-5#5)(2008-7#4)(2008-8#7)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#3)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#2)(2011-9#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
were histologically##6##2##(1991-2#1)(1995-4#1)(2007-12#1)(2007-8#1)(2008-5#1)(2009-2#1)
were historically##2##2##(1992-2#1)(2007-9#1)
were homogeneous and##2##3##(1996-7#1)(2012-2#1)
were homogeneous##3##2##(1996-7#2)(2012-2#1)
were homogeneously##3##2##(1991-9#1)(1994-2#1)(2010-7#1)
were homogenized and##2##3##(1992-12#1)(2004-11#1)
were homogenized##4##2##(1992-12#1)(1994-8#1)(2004-11#1)(2010-2#1)
were homologous to other known genes##3##6##(1996-12#2)(1997-4#1)
were homologous to##7##3##(1994-9#1)(1995-4#1)(1996-12#2)(1997-4#2)(1997-8#1)
were homosexuals##2##2##(1990-9#1)(1993-5#1)
were homozygous and##2##3##(1991-7#1)(1993-4#1)
were homozygous for a##2##4##(1991-2#1)(1995-4#1)
were homozygous for the##2##4##(1995-12#1)(1995-2#1)
were homozygous for##4##3##(1991-2#1)(1995-12#1)(1995-2#1)(1995-4#1)
were homozygous##7##2##(1991-2#1)(1991-7#1)(1993-4#1)(1995-12#1)(1995-2#1)(1995-4#1)(2008-2#1)
were horizontally##2##2##(1997-1#1)(2008-10#1)
were hospitalized at##4##3##(2008-1#1)(2012-2#1)(2013-1#2)
were hospitalized for##4##3##(1996-12#1)(2006-7#1)(2009-12#1)(2011-12#1)
were hospitalized in the##3##4##(1993-5#1)(1995-1#1)(2011-2#1)
were hospitalized in##6##3##(1993-5#1)(1995-1#1)(2007-7#1)(2011-1#1)(2011-2#2)
were hospitalized with##2##3##(1991-6#1)(2006-8#1)
were hospitalized##31##2##(1990-12#1)(1991-4#2)(1991-6#1)(1992-5#2)(1993-10#1)(1993-5#1)(1995-1#1)(1995-6#1)(1995-9#1)(1996-12#2)(1996-2#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2009-12#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#3)
were host specific##2##3##(2008-10#2)
were hot##2##2##(1993-5#1)(2007-2#1)
were housed in individual##3##4##(1992-3#1)(2008-5#1)(2010-2#1)
were housed in##8##3##(1992-3#2)(1993-6#1)(1994-2#1)(2007-2#1)(2008-3#1)(2008-5#1)(2010-2#1)
were housed##15##2##(1991-2#1)(1992-3#2)(1993-6#1)(1993-9#1)(1994-2#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-2#3)(2012-2#1)(2013-8#1)
were housewives##2##2##(2007-7#1)(2013-1#1)
were however##10##2##(1991-8#1)(2006-8#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#1)(2010-8#1)(2013-7#1)
were human##2##2##(2007-8#1)(2010-7#1)
were hybridized to##2##3##(2008-10#2)
were hybridized with##3##3##(1997-8#1)(2008-10#1)(2008-7#1)
were hybridized##5##2##(1997-8#1)(2008-10#3)(2008-7#1)
were hydrated##3##2##(1993-7#1)(2007-1#1)(2009-10#1)
were hydrolysed by the enzyme##2##5##(1991-2#2)
were hydrolysed by##3##3##(1991-2#2)(1996-5#1)
were hydrolysed##4##2##(1991-2#2)(1993-2#1)(1996-5#1)
were hydrolyzed in##3##3##(1992-1#1)(1993-9#2)
were hydrolyzed with##3##3##(1991-9#1)(2008-10#1)(2011-1#1)
were hydrolyzed##11##2##(1991-9#1)(1992-1#1)(1993-9#2)(1994-5#1)(1995-6#1)(2006-12#1)(2006-6#1)(2008-10#1)(2008-5#1)(2011-1#1)
were hypercoagulable##2##2##(2007-7#2)
were hyperplastic##2##2##(1995-8#1)(2005-7#1)
were hypersensitive to##2##3##(1997-3#1)(2012-3#1)
were hypertension##2##2##(2008-8#1)(2009-6#1)
were hypertensive at the##2##4##(2007-7#1)(2010-12#1)
were hypertensive##10##2##(1995-2#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#2)(2010-12#2)(2013-8#1)
were hypoechoic and##2##3##(2008-10#1)(2008-5#1)
were hypomethylated##2##2##(1992-9#1)(2011-2#1)
were hypothesized to be##2##4##(1992-3#1)(2008-7#1)
were hypothesized to##5##3##(1992-3#1)(2008-12#1)(2008-7#1)(2009-8#2)
were identical for##5##3##(1993-7#1)(1994-11#1)(1995-6#1)(2008-10#2)
were identical in##8##3##(1992-11#1)(1992-8#1)(1995-11#1)(1996-8#1)(1996-9#1)(1997-8#1)(2004-11#1)(2008-11#1)
were identical or similar to hypothetical genes registered in databases##3##10##(1996-12#2)(1997-4#1)
were identical or##4##3##(1996-12#2)(1997-4#2)
were identical to fragments 31-40 (LVV-hemorphin-7) and 32-40 (VV-hemorphin 7) of the beta-chain of bovine hemoglobin##2##16##(1992-11#1)(1995-3#1)
were identical to that of the##2##6##(1992-8#1)(1993-11#1)
were identical to that of##4##5##(1990-10#1)(1992-8#1)(1993-11#1)(2007-12#1)
were identical to the##5##4##(1990-7#1)(2008-10#2)(2008-12#1)(2012-3#1)
were identical to those of##4##5##(1993-1#1)(1994-9#1)(1997-6#1)(2008-10#1)
were identical to those##17##4##(1990-8#2)(1991-9#1)(1992-12#1)(1993-1#1)(1994-7#1)(1994-9#1)(1997-6#1)(2008-10#6)(2008-2#1)(2008-5#1)(2009-2#1)
were identical to##36##3##(1990-10#1)(1990-7#1)(1990-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1994-12#1)(1994-7#1)(1994-9#1)(1995-3#1)(1996-6#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-2#1)(2012-3#1)
were identical with those of##3##5##(1991-9#1)(1992-12#1)(1994-11#1)
were identical with those##5##4##(1990-4#1)(1991-9#1)(1992-12#1)(1994-11#1)(2008-10#1)
were identical with##6##3##(1990-4#1)(1991-9#1)(1992-12#1)(1992-8#1)(1994-11#1)(2008-10#1)
were identical##80##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#1)(1990-8#2)(1991-9#2)(1992-11#2)(1992-12#2)(1992-2#1)(1992-7#1)(1992-8#3)(1993-1#1)(1993-11#1)(1993-7#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-12#2)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#2)(2004-11#1)(2007-12#1)(2008-10#21)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#2)(2009-2#2)(2011-2#1)(2012-3#2)
were identified (e##2##3##(1996-11#1)(2013-1#1)
were identified according to the##2##5##(2008-6#1)(2011-2#1)
were identified across##2##3##(2009-9#1)(2010-6#1)
were identified after##4##3##(1994-9#1)(2008-1#1)(2008-8#1)(2013-8#1)
were identified along##2##3##(1993-7#1)(1994-2#1)
were identified among the##8##4##(1994-3#1)(2008-10#6)(2013-8#1)
were identified among##19##3##(1991-8#1)(1994-3#1)(2006-12#1)(2008-1#1)(2008-10#11)(2009-12#1)(2012-2#1)(2013-8#2)
were identified and analyzed##3##4##(1997-1#1)(2006-10#1)(2010-8#1)
were identified and characterized##3##4##(1991-9#1)(1994-3#1)(1995-6#1)
were identified and classified##2##4##(1993-2#1)(2008-10#1)
were identified and confirmed##2##4##(1990-7#1)(2008-10#1)
were identified and matched##2##4##(2011-2#1)(2013-1#1)
were identified and measured##2##4##(2007-7#1)(2009-1#1)
were identified and the distribution across these reasons determined##2##9##(2013-1#2)
were identified and the##6##4##(1995-12#1)(2006-6#1)(2006-8#1)(2013-1#3)
were identified and their##4##4##(1991-4#1)(1997-2#1)(2008-10#1)(2010-11#1)
were identified and were##3##4##(1995-2#1)(2007-7#1)(2011-2#1)
were identified and##65##3##(1990-7#1)(1991-4#1)(1991-9#1)(1992-1#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-2#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-7#2)(2008-10#9)(2008-5#3)(2008-7#2)(2008-9#1)(2009-1#1)(2010-11#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-11#3)(2012-12#2)(2012-2#3)(2012-5#1)(2013-1#9)(2013-8#2)
were identified as &quot##2##4##(2007-10#1)(2008-8#1)
were identified as Class##3##4##(2007-6#3)
were identified as Mycobacterium##2##4##(2007-8#2)
were identified as P##5##4##(2006-8#1)(2008-10#3)(2008-8#1)
were identified as S##2##4##(2008-10#2)
were identified as T##3##4##(1996-12#1)(2008-10#2)
were identified as X##2##4##(2008-10#2)
were identified as a##6##4##(1993-9#1)(1995-6#1)(2006-10#1)(2007-1#1)(2008-11#1)(2008-5#1)
were identified as being##7##4##(1991-2#1)(2011-2#1)(2013-1#4)(2013-7#1)
were identified as having##5##4##(1990-12#1)(2008-12#1)(2008-3#1)(2008-9#1)(2013-8#1)
were identified as important##2##4##(2006-7#1)(2012-3#1)
were identified as independent##2##4##(2012-3#1)(2013-8#1)
were identified as key##2##4##(2010-4#1)(2013-8#1)
were identified as members of the##2##6##(1996-12#1)(2008-10#1)
were identified as members##3##4##(1996-12#1)(2005-11#1)(2008-10#1)
were identified as new##2##4##(1993-4#1)(2007-1#1)
were identified as optimal##2##4##(1996-12#1)(2012-3#1)
were identified as positive##3##4##(1993-8#1)(2008-10#1)(2008-5#1)
were identified as potential##3##4##(2008-10#1)(2009-6#1)(2010-4#1)
were identified as potentially##2##4##(2007-8#1)(2013-8#1)
were identified as salt tolerant##2##5##(2008-12#2)
were identified as the main##2##5##(2007-2#1)(2008-5#1)
were identified as the##16##4##(1990-8#1)(1992-5#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-4#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-5#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
were identified as those of##2##5##(1995-1#1)(2008-10#1)
were identified as##193##3##(1990-11#1)(1990-12#1)(1990-5#2)(1990-7#3)(1990-8#2)(1991-1#1)(1991-10#1)(1991-2#2)(1991-5#2)(1991-7#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#4)(1994-6#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-1#2)(1996-12#3)(1996-3#1)(1996-4#1)(1997-1#1)(1997-4#4)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-7#1)(2006-8#3)(2007-1#5)(2007-10#3)(2007-12#2)(2007-2#3)(2007-6#3)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#35)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#1)(2008-5#11)(2008-7#3)(2008-8#2)(2008-9#1)(2009-6#1)(2010-12#3)(2010-3#3)(2010-4#2)(2010-8#2)(2011-1#1)(2011-2#7)(2012-11#2)(2012-2#3)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#7)
were identified at the##3##4##(1997-1#1)(2008-5#1)(2008-9#1)
were identified at##10##3##(1993-6#1)(1997-1#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-9#2)(2011-2#1)(2012-12#2)
were identified based on##7##4##(1997-6#1)(2005-6#1)(2007-8#1)(2008-10#1)(2008-3#1)(2012-1#1)(2012-2#1)
were identified based upon##2##4##(2008-10#2)
were identified based##9##3##(1997-6#1)(2005-6#1)(2007-8#1)(2008-10#3)(2008-3#1)(2012-1#1)(2012-2#1)
were identified between##5##3##(2008-10#1)(2008-9#1)(2013-1#1)(2013-7#1)(2013-8#1)
were identified biochemically##2##3##(1996-12#1)(2013-1#1)
were identified by NH2-terminal##2##4##(1991-12#1)(1992-12#1)
were identified by PCR##2##4##(1994-3#1)(2005-11#1)
were identified by a##3##4##(1990-7#1)(1993-2#1)(1997-6#1)
were identified by comparison of their##2##6##(1995-8#1)(2008-10#1)
were identified by conventional##2##4##(2006-10#1)(2007-6#1)
were identified by electrospray ionization##2##5##(1995-2#1)(1996-8#1)
were identified by gas chromatography##2##5##(2004-2#1)(2008-7#1)
were identified by gas chromatography-mass spectrometry##2##6##(1990-10#1)(2008-10#1)
were identified by gas##5##4##(1990-10#1)(1993-9#1)(2004-2#1)(2008-10#1)(2008-7#1)
were identified by means of##2##5##(1990-7#1)(2013-8#1)
were identified by morphological##2##4##(1992-7#1)(2012-12#1)
were identified by morphology##2##4##(2008-10#1)(2010-2#1)
were identified by restriction##2##4##(1993-6#1)(2008-10#1)
were identified by sequencing of##2##5##(1993-12#1)(1995-1#1)
were identified by specific##2##4##(2009-4#1)(2009-7#1)
were identified by standard microbiological procedures##2##6##(2008-5#1)(2012-3#1)
were identified by standard##4##4##(2007-7#2)(2008-5#1)(2012-3#1)
were identified by the##7##4##(1993-2#1)(1993-7#1)(1997-2#1)(2008-10#1)(2008-5#1)(2012-3#1)(2013-8#1)
were identified by their##6##4##(1992-8#1)(1995-8#1)(2008-10#2)(2008-11#2)
were identified by using##5##4##(1992-3#1)(1994-12#1)(1997-6#1)(2013-1#1)(2013-8#1)
were identified by##135##3##(1990-10#2)(1990-5#1)(1990-7#4)(1990-8#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-5#2)(1992-12#3)(1992-2#1)(1992-3#2)(1992-7#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(2004-10#1)(2004-2#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-10#18)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#7)
were identified during##4##3##(2009-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
were identified for inclusion##2##4##(2012-3#1)(2013-1#1)
were identified for resistance to##2##5##(2008-10#2)
were identified for resistance##3##4##(2008-10#3)
were identified for the##7##4##(1994-12#1)(2008-12#1)(2008-8#1)(2012-12#2)(2013-8#2)
were identified for##26##3##(1990-11#1)(1991-12#1)(1991-9#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(2007-3#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-8#1)(2009-3#1)(2010-5#1)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#2)
were identified from a##5##4##(2006-9#1)(2007-10#1)(2007-3#1)(2008-10#1)(2008-6#1)
were identified from the##9##4##(2006-10#1)(2006-12#1)(2008-10#4)(2008-11#1)(2011-1#1)(2013-8#1)
were identified from##37##3##(1992-5#1)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-3#1)(2008-10#10)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-8#1)
were identified in a##6##4##(1990-6#1)(1991-4#1)(1992-6#1)(1994-12#1)(2006-2#1)(2008-10#1)
were identified in all##4##4##(2006-11#1)(2007-3#1)(2008-7#1)(2011-1#1)
were identified in the 5'##2##5##(1992-7#1)(1997-4#1)
were identified in the extract##2##5##(2006-12#1)(2009-6#1)
were identified in the##45##4##(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-7#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-8#1)(1994-9#1)(1996-4#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-5#2)(1997-7#1)(2006-12#1)(2006-8#2)(2007-3#1)(2007-8#2)(2008-10#6)(2008-4#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-12#4)
were identified in this study##3##5##(2008-10#1)(2009-5#1)(2010-11#1)
were identified in this##4##4##(1997-7#1)(2008-10#1)(2009-5#1)(2010-11#1)
were identified in three##2##4##(1997-4#1)(2007-9#1)
were identified in two##2##4##(1990-6#1)(1995-11#1)
were identified in which##2##4##(1997-2#1)(2012-1#1)
were identified in##130##3##(1990-6#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-12#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#3)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-8#3)(1996-9#1)(1997-2#3)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#2)(2004-2#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#2)(2006-8#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-8#4)(2007-9#2)(2008-10#20)(2008-11#2)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#7)(2012-2#2)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#1)
were identified including##3##3##(1994-12#1)(2008-12#1)(2011-2#1)
were identified of which##3##4##(1992-8#1)(2007-8#1)(2012-2#1)
were identified of##4##3##(1991-6#1)(1992-8#1)(2007-8#1)(2012-2#1)
were identified on chromosomes 1##2##5##(2008-10#1)(2008-9#1)
were identified on chromosomes##4##4##(2008-10#3)(2008-9#1)
were identified on the basis of##2##6##(2009-4#1)(2012-1#1)
were identified on the##5##4##(1996-9#1)(2007-12#1)(2008-5#1)(2009-4#1)(2012-1#1)
were identified on##18##3##(1994-7#1)(1995-8#1)(1996-5#1)(1996-9#1)(1997-2#1)(2007-12#1)(2007-8#2)(2008-10#4)(2008-12#1)(2008-5#1)(2008-9#1)(2009-4#1)(2012-1#1)(2012-11#1)
were identified retrospectively##2##3##(1996-8#1)(2005-5#1)
were identified that are##3##4##(1994-11#1)(2008-10#1)(2012-3#1)
were identified that could##2##4##(2008-10#1)(2008-9#1)
were identified that##12##3##(1992-5#1)(1994-11#1)(2005-10#1)(2008-10#5)(2008-5#1)(2008-9#1)(2012-3#1)(2013-8#1)
were identified through a##2##4##(1994-5#1)(1996-11#1)
were identified through the##4##4##(1995-12#1)(1997-5#1)(2008-5#1)(2012-12#1)
were identified through##11##3##(1992-10#1)(1994-5#1)(1995-12#1)(1996-11#1)(1997-5#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-12#1)
were identified throughout the##2##4##(2008-11#1)(2013-1#1)
were identified to be##3##4##(1990-12#1)(2008-11#1)(2012-3#1)
were identified to have##2##4##(2008-8#1)(2013-8#1)
were identified to species##2##4##(2008-10#1)(2008-5#1)
were identified to the##2##4##(2008-5#1)(2010-1#1)
were identified to##16##3##(1990-12#1)(2006-12#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-8#2)(2008-9#1)(2010-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
were identified using a##4##4##(1994-12#1)(1995-8#1)(2013-1#1)(2013-7#1)
were identified using bulked segregant analysis##2##6##(2008-10#1)(2008-5#1)
were identified using the##12##4##(1990-4#1)(2007-7#1)(2007-8#9)(2008-10#1)
were identified using##35##3##(1990-4#1)(1994-12#2)(1995-8#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-8#10)(2008-10#7)(2008-11#2)(2008-5#2)(2010-8#2)(2011-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
were identified which##7##3##(1991-2#1)(1994-11#1)(1996-4#1)(2005-10#1)(2007-1#1)(2008-11#1)(2008-7#1)
were identified with a##4##4##(2008-10#1)(2011-2#1)(2012-3#1)(2013-7#1)
were identified with the use of##2##6##(2006-11#1)(2013-8#1)
were identified with the##3##4##(1997-9#1)(2006-11#1)(2013-8#1)
were identified with##20##3##(1993-4#1)(1997-9#1)(2006-11#1)(2006-12#1)(2007-2#1)(2008-10#6)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
were identified within the##5##4##(1992-3#1)(1997-2#1)(2008-10#2)(2012-2#1)
were identified within##8##3##(1992-3#1)(1997-2#1)(2007-2#1)(2007-7#1)(2008-10#3)(2012-2#1)
were identified##1131##2##(1990-10#3)(1990-11#2)(1990-12#6)(1990-2#1)(1990-3#3)(1990-4#3)(1990-5#3)(1990-6#2)(1990-7#9)(1990-8#5)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#6)(1991-4#2)(1991-5#5)(1991-6#3)(1991-7#2)(1991-8#1)(1991-9#4)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#4)(1992-6#1)(1992-7#3)(1992-8#2)(1993-10#1)(1993-11#2)(1993-12#5)(1993-2#3)(1993-3#3)(1993-4#4)(1993-5#3)(1993-6#6)(1993-7#2)(1993-8#6)(1993-9#4)(1994-10#1)(1994-11#3)(1994-12#11)(1994-2#2)(1994-3#10)(1994-5#1)(1994-6#6)(1994-7#1)(1994-8#1)(1994-9#6)(1995-1#5)(1995-10#1)(1995-11#1)(1995-12#7)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#5)(1995-8#7)(1995-9#1)(1996-1#4)(1996-10#3)(1996-11#3)(1996-12#6)(1996-2#2)(1996-3#3)(1996-4#6)(1996-5#6)(1996-7#4)(1996-8#6)(1996-9#2)(1997-1#4)(1997-2#8)(1997-3#2)(1997-4#10)(1997-5#5)(1997-6#5)(1997-7#4)(1997-8#5)(1997-9#1)(2004-10#2)(2004-2#3)(2004-4#1)(2005-10#4)(2005-11#7)(2005-12#1)(2005-5#2)(2005-6#1)(2005-7#2)(2005-8#3)(2005-9#1)(2006-10#17)(2006-11#4)(2006-12#17)(2006-2#4)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#10)(2006-9#1)(2007-1#11)(2007-10#12)(2007-11#6)(2007-12#12)(2007-2#14)(2007-3#10)(2007-5#3)(2007-6#4)(2007-7#7)(2007-8#29)(2007-9#5)(2008-1#8)(2008-10#184)(2008-11#20)(2008-12#14)(2008-2#1)(2008-3#4)(2008-4#5)(2008-5#38)(2008-6#8)(2008-7#19)(2008-8#10)(2008-9#16)(2009-1#1)(2009-10#5)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#4)(2009-5#2)(2009-6#4)(2009-7#2)(2009-8#3)(2009-9#5)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#6)(2010-2#3)(2010-3#4)(2010-4#4)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#8)(2010-9#2)(2011-1#16)(2011-12#3)(2011-2#29)(2011-3#1)(2012-1#6)(2012-11#10)(2012-12#28)(2012-2#24)(2012-3#18)(2012-5#1)(2013-1#58)(2013-7#6)(2013-8#35)
were ignorant##2##2##(2006-2#1)(2006-4#1)
were illustrated##4##2##(1994-11#1)(2008-10#2)(2010-1#1)
were imaged at##2##3##(2008-2#1)(2012-12#1)
were imaged by##2##3##(1994-12#1)(2008-3#1)
were imaged to##2##3##(1992-1#1)(2009-5#1)
were imaged with##2##3##(2008-2#1)(2008-7#1)
were imaged##14##2##(1992-1#1)(1994-12#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-7#1)(2009-5#1)(2012-1#1)(2012-12#1)
were immediately##8##2##(1992-9#1)(1997-5#1)(2005-10#1)(2008-3#1)(2010-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
were immersed in##7##3##(2004-9#1)(2007-12#1)(2008-10#2)(2008-6#1)(2013-8#2)
were immobilized in a##2##4##(2008-10#1)(2008-11#1)
were immobilized in##6##3##(2005-11#1)(2008-10#3)(2008-11#2)
were immobilized on a##2##4##(2008-10#1)(2008-5#1)
were immobilized on the##3##4##(1996-2#1)(2008-10#2)
were immobilized on##13##3##(1991-3#1)(1991-5#1)(1993-6#1)(1994-12#1)(1996-2#1)(2007-8#1)(2008-10#6)(2008-5#1)
were immobilized onto##3##3##(2008-10#3)
were immobilized with##2##3##(2008-10#1)(2010-5#1)
were immobilized##35##2##(1991-3#1)(1991-5#1)(1992-8#1)(1993-6#1)(1994-12#1)(1996-2#1)(1996-5#2)(2005-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#15)(2008-11#3)(2008-5#2)(2008-7#1)(2010-5#1)
were immune to the##2##4##(2008-10#2)
were immune to##3##3##(2008-10#3)
were immunised##2##2##(1995-12#1)(1997-6#1)
were immunized with a##2##4##(1990-12#1)(1992-8#1)
were immunized with##12##3##(1990-12#1)(1990-8#1)(1991-9#1)(1992-8#4)(1994-9#1)(2007-10#1)(2007-2#1)(2008-7#1)(2012-2#1)
were immunized##19##2##(1990-12#1)(1990-8#1)(1991-9#1)(1992-8#4)(1994-9#1)(1995-11#1)(1997-4#1)(2007-10#1)(2007-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2012-2#1)
were immunocytochemically##2##2##(1991-6#1)(2008-5#1)
were immunohistochemically positive for##2##4##(2009-7#1)(2011-2#1)
were immunohistochemically positive##3##3##(1996-6#1)(2009-7#1)(2011-2#1)
were immunohistochemically stained for the##2##5##(1992-6#1)(2008-6#1)
were immunohistochemically stained with##2##4##(2005-12#1)(2008-7#1)
were immunohistochemically stained##4##3##(1992-6#1)(2005-12#1)(2008-6#1)(2008-7#1)
were immunohistochemically##10##2##(1992-6#1)(1996-6#1)(2005-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-2#1)
were immunoprecipitated by##3##3##(1992-9#1)(1993-2#1)(1997-8#1)
were immunoprecipitated with##4##3##(1990-5#1)(1991-10#1)(1992-12#1)(1996-2#1)
were immunoprecipitated##8##2##(1990-5#1)(1990-9#1)(1991-10#1)(1992-12#1)(1992-9#1)(1993-2#1)(1996-2#1)(1997-8#1)
were immunoreactive for##11##3##(1995-5#1)(1995-7#1)(1996-11#1)(1997-2#3)(1997-8#1)(2008-4#1)(2008-5#1)(2010-12#1)(2013-1#1)
were immunoreactive##13##2##(1994-2#1)(1995-5#1)(1995-7#1)(1996-11#1)(1997-2#3)(1997-6#1)(1997-8#1)(2008-4#1)(2008-5#1)(2010-12#1)(2013-1#1)
were immunostained for##3##3##(1994-2#1)(1997-8#1)(2010-3#1)
were immunostained##5##2##(1994-2#1)(1995-6#1)(1996-4#1)(1997-8#1)(2010-3#1)
were impacted by a##2##4##(2007-4#1)(2008-3#1)
were impacted by##3##3##(2007-2#1)(2007-4#1)(2008-3#1)
were impacted##6##2##(2006-11#2)(2007-2#1)(2007-4#2)(2008-3#1)
were impaired at##2##3##(1992-9#1)(2008-4#1)
were impaired in their##2##4##(1990-10#1)(1997-4#1)
were impaired in##10##3##(1990-10#1)(1991-2#1)(1993-7#1)(1993-9#1)(1995-12#1)(1997-4#1)(2004-4#1)(2008-10#1)(2008-4#1)(2008-7#1)
were impaired on##3##3##(1991-1#1)(1992-9#1)(2011-1#1)
were impaired##20##2##(1990-10#2)(1991-1#1)(1991-2#1)(1992-9#2)(1993-7#1)(1993-9#1)(1995-12#1)(1997-4#1)(2004-4#1)(2005-12#1)(2006-11#1)(2008-10#2)(2008-4#2)(2008-7#1)(2009-2#1)(2011-1#1)
were implant##3##2##(2013-1#3)
were implanted and##3##3##(2008-3#1)(2008-9#1)(2013-1#1)
were implanted in the##9##4##(1995-7#1)(1997-7#1)(2004-9#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-8#1)(2010-12#1)
were implanted in##15##3##(1990-8#1)(1995-7#1)(1997-7#1)(2004-9#1)(2007-4#1)(2007-7#3)(2007-8#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)
were implanted into the##4##4##(1996-12#1)(1997-3#1)(2007-8#1)(2012-1#1)
were implanted into##9##3##(1993-1#1)(1996-12#1)(1997-3#1)(2007-8#1)(2008-3#1)(2008-5#2)(2012-1#1)(2012-2#1)
were implanted subcutaneously##3##3##(2004-11#1)(2004-9#1)(2008-5#1)
were implanted through the##2##4##(2007-7#1)(2013-1#1)
were implanted through##3##3##(2007-7#1)(2008-8#1)(2013-1#1)
were implanted with chronic guide cannulae##2##6##(1991-3#1)(1993-2#1)
were implanted with##7##3##(1991-3#1)(1993-12#1)(1993-2#1)(1995-5#1)(1996-8#1)(2007-7#1)(2012-12#1)
were implanted##51##2##(1990-7#1)(1990-8#1)(1991-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1995-5#1)(1995-7#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-7#1)(2004-11#1)(2004-9#2)(2005-10#2)(2006-9#1)(2007-11#3)(2007-4#1)(2007-7#6)(2007-8#4)(2008-3#2)(2008-5#4)(2008-8#3)(2008-9#2)(2009-3#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
were implemented and##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
were implemented by##2##3##(2008-11#1)(2012-2#1)
were implemented in the Health##2##5##(1994-1#1)(1997-2#1)
were implemented in the##4##4##(1994-1#1)(1997-2#1)(2007-8#1)(2008-10#1)
were implemented in##7##3##(1994-1#2)(1997-2#1)(2006-4#1)(2007-8#1)(2008-10#2)
were implemented to##2##3##(2007-10#2)
were implemented##22##2##(1994-1#2)(1994-3#1)(1997-2#1)(2004-4#1)(2006-4#1)(2007-10#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-9#2)(2012-2#2)
were implicated##5##2##(1993-9#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-1#1)
were implied##2##2##(2006-12#1)(2010-11#1)
were important differences between the##2##5##(1992-7#1)(1993-6#1)
were important factors##3##3##(2007-3#1)(2007-8#1)(2011-2#1)
were important for##7##3##(1991-9#1)(1993-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2011-12#1)(2013-8#1)
were important in the##2##4##(1991-10#1)(2008-10#1)
were important in##5##3##(1991-10#1)(1991-5#1)(2008-10#3)
were important##26##2##(1990-8#1)(1991-10#1)(1991-5#1)(1991-9#1)(1992-7#1)(1993-6#2)(1996-1#1)(1996-11#1)(1997-8#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-11#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
were imported into the##2##4##(2008-10#1)(2011-1#1)
were imported##5##2##(2007-2#1)(2007-6#1)(2008-10#1)(2011-1#2)
were imposed##2##2##(2007-8#1)(2008-3#1)
were impregnated into##2##3##(2008-2#1)(2010-4#1)
were impregnated##3##2##(2008-10#1)(2008-2#1)(2010-4#1)
were improved after the##2##4##(1997-1#1)(2008-9#1)
were improved after##5##3##(1996-6#1)(1997-1#1)(2006-7#1)(2008-7#1)(2008-9#1)
were improved by the addition of##2##6##(2008-6#1)(2010-2#1)
were improved by##7##3##(2004-9#1)(2006-4#1)(2008-11#1)(2008-12#1)(2008-6#1)(2010-2#1)(2012-11#1)
were improved in##5##3##(1991-6#1)(2008-10#1)(2010-12#1)(2010-2#1)(2011-2#1)
were improved significantly##2##3##(2008-10#1)(2012-2#1)
were improved##32##2##(1990-6#1)(1991-6#1)(1993-11#1)(1996-6#1)(1997-1#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-2#2)(2011-2#1)(2012-11#1)(2012-2#2)
were improving##2##2##(2012-3#2)
were in Child's grade C##2##5##(2012-3#2)
were in New York Heart Association class##2##7##(1997-1#1)(2007-8#1)
were in VCG##3##3##(2008-10#3)
were in VCG1A##2##3##(2008-10#2)
were in a good agreement with the##2##7##(2008-10#2)
were in a good##4##4##(2008-10#2)(2008-7#2)
were in a##19##3##(1993-8#1)(1995-1#1)(1996-7#1)(2004-9#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#5)(2008-12#1)(2008-5#2)(2008-7#3)(2011-1#1)
were in accord with##2##4##(1991-9#1)(2007-9#1)
were in accordance with the##4##5##(1992-4#1)(2008-10#1)(2009-8#1)(2012-12#1)
were in accordance with those##2##5##(1993-4#1)(2008-3#1)
were in accordance with##7##4##(1992-4#1)(1993-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-8#1)(2012-12#1)
were in agreement with certified values##2##6##(2008-10#2)
were in agreement with the certified##3##6##(2008-10#3)
were in agreement with the known##2##6##(1997-8#1)(2005-11#1)
were in agreement with the##8##5##(1997-8#1)(2005-11#1)(2007-9#1)(2008-10#4)(2012-2#1)
were in agreement with those obtained by a##2##8##(2008-10#2)
were in agreement with those obtained by the##2##8##(2008-10#2)
were in agreement with those obtained by##6##7##(2008-10#6)
were in agreement with those obtained with##2##7##(2008-10#2)
were in agreement with those obtained##9##6##(2008-10#8)(2008-5#1)
were in agreement with those of the##2##7##(1992-1#1)(2005-4#1)
were in agreement with those of##4##6##(1992-1#1)(2005-4#3)
were in agreement with those##15##5##(1992-1#1)(2005-4#3)(2008-10#10)(2008-5#1)
were in agreement with##32##4##(1990-12#1)(1992-1#1)(1992-12#1)(1993-10#1)(1993-2#1)(1997-8#1)(2005-11#1)(2005-4#3)(2007-11#1)(2007-9#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-5#1)(2012-2#1)
were in agreement##37##3##(1990-12#1)(1992-1#1)(1992-12#1)(1993-10#1)(1993-2#1)(1994-6#1)(1997-8#1)(2005-11#1)(2005-4#3)(2007-11#1)(2007-9#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-5#2)(2010-11#1)(2012-2#1)
were in all cases##5##4##(1991-2#1)(2007-9#1)(2008-10#2)(2008-5#1)
were in all##7##3##(1991-2#1)(2007-9#1)(2008-10#4)(2008-5#1)
were in an##4##3##(2005-11#1)(2007-11#1)(2009-11#1)(2012-1#1)
were in asymmetric synaptic contact with dendritic##2##7##(1997-2#2)
were in attendance##2##3##(2005-8#2)
were in close proximity to##2##5##(1994-9#1)(1997-8#1)
were in close##4##3##(1994-9#1)(1995-3#1)(1997-8#1)(2008-10#1)
were in complete##3##3##(1997-4#1)(2008-10#1)(2008-6#1)
were in different##2##3##(2008-10#1)(2013-8#1)
were in each##2##3##(2008-4#1)(2013-1#1)
were in excellent agreement##2##4##(2008-10#2)
were in excellent##3##3##(2008-10#2)(2008-3#1)
were in favour of##3##4##(1996-1#1)(2007-7#1)(2008-7#1)
were in general agreement with##3##5##(2008-2#2)(2008-3#1)
were in general##9##3##(2004-4#1)(2006-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2012-12#1)(2012-2#1)
were in genotype##2##3##(2008-10#2)
were in good agreement with certified values##4##7##(2007-8#1)(2008-10#3)
were in good agreement with literature##2##6##(2008-10#1)(2009-4#1)
were in good agreement with previously reported##2##7##(1991-7#1)(2008-10#1)
were in good agreement with the certified values and##2##9##(2008-10#2)
were in good agreement with the certified values##5##8##(2008-10#5)
were in good agreement with the certified##6##7##(2008-10#6)
were in good agreement with the##16##6##(1991-7#1)(1992-9#1)(2008-10#12)(2008-3#2)
were in good agreement with those obtained by an##2##9##(2008-10#2)
were in good agreement with those obtained by##9##8##(2008-10#9)
were in good agreement with those obtained##11##7##(2008-10#11)
were in good agreement with those of##2##7##(2005-4#1)(2008-10#1)
were in good agreement with those reported by the##2##9##(2008-10#2)
were in good agreement with those reported##3##7##(2008-10#3)
were in good agreement with those##20##6##(2005-4#1)(2006-4#1)(2007-8#1)(2008-10#17)
were in good agreement with##58##5##(1991-7#2)(1992-9#1)(2005-4#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#2)(2008-10#38)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#1)(2009-4#1)
were in good agreement##68##4##(1991-7#2)(1992-9#1)(1995-10#1)(2005-4#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#2)(2008-10#43)(2008-2#4)(2008-3#6)(2008-5#1)(2008-7#1)(2009-4#1)
were in good##71##3##(1991-7#2)(1992-9#1)(1995-10#1)(2005-4#1)(2005-7#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#2)(2008-10#43)(2008-12#1)(2008-2#4)(2008-3#6)(2008-5#1)(2008-7#1)(2009-4#1)
were in group##2##3##(2013-8#2)
were in lamina##2##3##(1996-9#2)
were in line with##2##4##(2007-11#1)(2008-11#1)
were in part##3##3##(1995-2#1)(2008-5#1)(2013-8#1)
were in reality##2##3##(2008-10#1)(2010-3#1)
were in reasonable agreement with the##2##6##(2008-5#2)
were in satisfactory agreement with##2##5##(2008-10#1)(2008-2#1)
were in satisfactory##3##3##(2008-10#2)(2008-2#1)
were in sinus rhythm##3##4##(1995-12#1)(2007-8#1)(2011-2#1)
were in stage I##2##4##(1990-9#1)(2011-2#1)
were in stage##4##3##(1990-9#1)(2006-8#1)(2009-3#1)(2011-2#1)
were in the 5'-direction from the##2##6##(1995-10#2)
were in the age group of##5##6##(2006-4#1)(2008-11#1)(2010-5#1)(2013-8#2)
were in the age group##9##5##(1991-9#1)(2006-4#1)(2007-7#1)(2008-11#1)(2008-3#1)(2010-5#1)(2011-1#1)(2013-8#2)
were in the age range of##2##6##(2008-4#1)(2013-8#1)
were in the age##11##4##(1991-9#1)(2006-4#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-5#1)(2011-1#1)(2013-8#3)
were in the concentration range of##2##6##(2008-10#1)(2011-1#1)
were in the early##2##4##(1995-4#1)(2008-9#1)
were in the immediate vicinity of##2##6##(2008-10#2)
were in the low##2##4##(1996-8#1)(2010-11#1)
were in the normal range##3##5##(1991-10#1)(1994-3#1)(2008-9#1)
were in the order of method##2##6##(1990-8#2)
were in the order of##3##5##(1990-8#2)(2008-10#1)
were in the order##5##4##(1990-5#1)(1990-8#2)(1995-3#1)(2008-10#1)
were in the posterior##2##4##(1996-6#1)(2007-10#1)
were in the range 0##3##5##(2008-10#2)(2008-3#1)
were in the range 1##5##5##(2007-8#1)(2008-10#3)(2008-5#1)
were in the range from##2##5##(1990-8#1)(2005-11#1)
were in the range of 0##6##6##(2008-10#4)(2008-2#1)(2011-2#1)
were in the range of##28##5##(1993-7#1)(1995-12#1)(1996-9#1)(1997-3#1)(2005-4#1)(2006-12#1)(2007-11#1)(2008-10#15)(2008-2#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
were in the range##47##4##(1990-8#1)(1991-8#1)(1992-4#1)(1993-7#1)(1995-12#2)(1996-6#1)(1996-9#1)(1997-3#1)(2005-11#1)(2005-4#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#24)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
were in the ranges of 1##4##6##(1991-3#1)(2008-10#2)(2013-8#1)
were in the ranges of##7##5##(1991-3#1)(2005-4#1)(2008-10#4)(2013-8#1)
were in the ranges##10##4##(1991-3#1)(2005-4#1)(2008-10#6)(2013-8#2)
were in the renal##2##4##(2008-4#2)
were in the same clade##2##5##(2008-10#2)
were in the same order of magnitude##2##7##(1991-5#1)(2008-11#1)
were in the same range as those##2##7##(1992-2#1)(1993-11#1)
were in the same##7##4##(1991-5#2)(1992-2#1)(1993-11#1)(2008-10#2)(2008-11#1)
were in the size range##3##5##(1995-3#1)(2008-7#2)
were in the##163##3##(1990-5#2)(1990-8#3)(1991-10#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-4#1)(1992-5#1)(1993-11#1)(1993-7#2)(1993-8#2)(1994-12#1)(1994-3#2)(1994-4#1)(1995-10#2)(1995-12#2)(1995-3#2)(1995-4#1)(1996-2#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-3#3)(2004-2#1)(2005-11#1)(2005-4#2)(2006-10#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-10#3)(2007-11#3)(2007-12#1)(2007-3#1)(2007-4#2)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#46)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-2#1)(2009-4#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#5)(2013-1#1)(2013-8#7)
were in their first##2##4##(2008-9#1)(2010-3#1)
were in their##6##3##(2007-2#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-3#1)(2010-9#1)
were in turn##2##3##(2004-9#1)(2007-10#1)
were in vitro sensitive to##2##5##(1991-2#2)
were in##507##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#4)(1990-8#3)(1990-9#1)(1991-10#2)(1991-12#4)(1991-2#6)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#3)(1991-8#2)(1991-9#2)(1992-1#2)(1992-12#2)(1992-2#1)(1992-4#2)(1992-5#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#2)(1993-8#3)(1994-1#1)(1994-11#2)(1994-12#2)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#2)(1995-10#3)(1995-12#3)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#5)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#2)(1997-8#3)(1997-9#1)(2004-2#1)(2004-4#1)(2004-9#2)(2005-10#1)(2005-11#4)(2005-4#6)(2005-7#1)(2005-8#2)(2006-10#4)(2006-12#2)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#7)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#9)(2007-12#3)(2007-2#3)(2007-3#2)(2007-4#3)(2007-6#1)(2007-7#7)(2007-8#11)(2007-9#4)(2008-1#1)(2008-10#145)(2008-11#8)(2008-12#7)(2008-2#9)(2008-3#11)(2008-4#6)(2008-5#15)(2008-6#2)(2008-7#12)(2008-8#4)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#3)(2009-6#1)(2009-8#1)(2010-11#2)(2010-3#2)(2010-5#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#9)(2012-1#2)(2012-12#5)(2012-2#2)(2012-3#11)(2013-1#5)(2013-7#1)(2013-8#11)
were inactivated by##5##3##(1991-5#1)(1992-9#1)(1995-2#1)(2008-11#1)(2011-12#1)
were inactivated##6##2##(1991-5#1)(1992-9#2)(1995-2#1)(2008-11#1)(2011-12#1)
were inactive against both viruses##2##5##(1997-2#2)
were inactive against##5##3##(1992-8#1)(1996-8#1)(1997-2#2)(2007-11#1)
were inactive and##2##3##(1994-5#1)(2008-5#1)
were inactive as##3##3##(1991-12#1)(1994-9#1)(1996-6#1)
were inactive in##2##3##(1994-12#1)(1997-2#1)
were inactive##31##2##(1991-10#2)(1991-12#1)(1991-5#2)(1991-9#1)(1992-3#1)(1992-5#2)(1992-8#1)(1992-9#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-6#1)(2007-11#1)(2008-12#1)(2008-5#1)
were inadequate for##2##3##(1992-12#1)(2007-6#1)
were inadequate##5##2##(1992-12#1)(2007-6#1)(2008-10#2)(2013-1#1)
were inadvertently##2##2##(1997-8#1)(2008-5#1)
were incised##2##2##(2008-12#1)(2009-2#1)
were included about##2##3##(1991-8#1)(2004-10#1)
were included after##3##3##(1995-5#1)(2011-1#1)(2011-2#1)
were included and##3##3##(2008-10#2)(2011-2#1)
were included as controls##4##4##(1997-2#1)(2008-10#1)(2008-8#1)(2011-2#1)
were included as##8##3##(1996-1#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#2)
were included for the##2##4##(2007-7#1)(2010-4#1)
were included for##10##3##(1994-12#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-6#1)(2010-4#1)(2011-2#1)(2013-1#1)
were included if they##2##4##(2013-1#2)
were included if##3##3##(1990-12#1)(2013-1#2)
were included in a study##2##5##(1991-8#1)(1995-9#1)
were included in a##10##4##(1990-1#1)(1991-8#1)(1993-11#1)(1995-9#1)(1997-7#2)(2007-7#1)(2007-8#2)(2008-10#1)
were included in each##2##4##(2006-10#1)(2011-2#1)
were included in our##3##4##(1995-5#1)(2008-10#1)(2008-5#1)
were included in the analyses##3##5##(2008-7#1)(2013-1#1)(2013-8#1)
were included in the analysis##8##5##(2006-1#1)(2006-8#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-8#1)(2012-2#1)(2013-1#1)
were included in the control group##2##6##(2007-8#1)(2008-3#1)
were included in the experiments##2##5##(2008-11#2)
were included in the final##3##5##(1997-3#1)(1997-6#1)(2009-7#1)
were included in the meta-analysis##2##5##(2009-9#1)(2013-1#1)
were included in the model##2##5##(2006-11#1)(2008-7#1)
were included in the statistical analysis##2##6##(2008-8#1)(2013-8#1)
were included in the studies##2##5##(2008-11#1)(2013-8#1)
were included in the study and were##2##7##(1992-10#1)(2008-11#1)
were included in the study and##5##6##(1990-10#1)(1992-10#1)(2007-9#1)(2008-11#1)(2008-6#1)
were included in the study##74##5##(1990-10#1)(1990-11#1)(1991-2#1)(1992-10#1)(1992-12#1)(1992-9#1)(1993-10#1)(1993-12#1)(1994-3#1)(1997-8#1)(2004-2#1)(2006-10#3)(2006-7#1)(2006-8#5)(2007-10#1)(2007-3#2)(2007-7#5)(2007-9#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#7)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
were included in the survey##2##5##(2007-2#1)(2008-3#1)
were included in the##128##4##(1990-10#2)(1990-11#1)(1990-8#1)(1991-2#1)(1992-10#1)(1992-12#1)(1992-9#1)(1993-10#1)(1993-12#1)(1994-12#1)(1994-3#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-2#1)(2005-4#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-7#1)(2006-8#8)(2007-10#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#5)(2007-8#2)(2007-9#2)(2008-10#5)(2008-11#5)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#8)(2008-8#3)(2009-11#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#7)(2011-2#9)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#4)(2013-1#9)(2013-7#1)(2013-8#5)
were included in this prospective study##2##6##(2007-6#1)(2007-9#1)
were included in this prospective##3##5##(2007-6#1)(2007-9#1)(2012-12#1)
were included in this retrospective study##2##6##(2008-6#1)(2011-1#1)
were included in this retrospective##3##5##(2008-6#1)(2011-1#2)
were included in this review##2##5##(2009-2#1)(2013-8#1)
were included in this study##26##5##(1994-3#1)(2005-5#1)(2007-10#1)(2007-2#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-3#3)(2013-1#2)(2013-8#2)
were included in this##43##4##(1994-3#1)(2005-5#1)(2007-10#1)(2007-2#1)(2007-6#2)(2007-7#4)(2007-9#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-7#2)(2011-1#4)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#3)(2013-8#3)
were included in##203##3##(1990-1#1)(1990-10#2)(1990-11#1)(1990-8#1)(1991-2#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-12#1)(1994-3#2)(1995-5#1)(1995-9#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-2#1)(2005-4#1)(2005-5#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-7#1)(2006-8#8)(2007-10#2)(2007-2#2)(2007-3#2)(2007-4#1)(2007-6#2)(2007-7#10)(2007-8#4)(2007-9#4)(2008-1#1)(2008-10#13)(2008-11#5)(2008-12#1)(2008-3#4)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#9)(2008-8#3)(2008-9#2)(2009-11#1)(2009-2#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-4#3)(2010-7#3)(2010-8#1)(2011-1#11)(2011-12#1)(2011-2#13)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#5)(2013-1#13)(2013-7#1)(2013-8#8)
were included into the##4##4##(2008-10#1)(2008-11#2)(2011-2#1)
were included into##5##3##(1997-1#1)(2008-10#1)(2008-11#2)(2011-2#1)
were included to##7##3##(2007-11#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#2)(2013-7#1)
were included who##3##3##(2007-7#1)(2011-2#1)(2013-8#1)
were included with##4##3##(2006-8#1)(2009-9#1)(2010-12#1)(2011-2#1)
were included##362##2##(1990-1#1)(1990-10#3)(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-8#2)(1992-10#1)(1992-12#1)(1992-7#1)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-9#1)(1995-5#3)(1995-9#1)(1996-1#1)(1996-10#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-10#1)(2004-2#1)(2004-4#1)(2005-4#2)(2005-5#1)(2006-1#1)(2006-10#6)(2006-11#2)(2006-12#1)(2006-4#1)(2006-6#1)(2006-7#2)(2006-8#12)(2007-10#4)(2007-11#2)(2007-2#2)(2007-3#3)(2007-4#1)(2007-6#2)(2007-7#14)(2007-8#8)(2007-9#6)(2008-1#1)(2008-10#23)(2008-11#8)(2008-12#5)(2008-3#7)(2008-4#6)(2008-5#5)(2008-6#5)(2008-7#11)(2008-8#7)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#3)(2010-10#1)(2010-12#4)(2010-3#2)(2010-4#4)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#15)(2011-12#2)(2011-2#34)(2012-1#3)(2012-11#1)(2012-12#7)(2012-2#9)(2012-3#11)(2013-1#34)(2013-7#2)(2013-8#17)
were incompatible with##2##3##(2008-10#1)(2008-9#1)
were incomplete##3##2##(1990-12#1)(2007-3#1)(2007-7#1)
were inconclusive##8##2##(1993-8#1)(1994-12#1)(1996-6#1)(2006-2#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-8#1)
were inconsistent##10##2##(1994-4#1)(1996-12#1)(2004-4#1)(2005-3#1)(2007-11#1)(2008-10#1)(2010-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
were incorporated in the##2##4##(1990-2#1)(2012-2#1)
were incorporated in##5##3##(1990-2#1)(2008-10#1)(2010-2#1)(2010-5#1)(2012-2#1)
were incorporated into a##2##4##(2004-9#1)(2008-10#1)
were incorporated into an##3##4##(1995-6#1)(1996-6#1)(2008-5#1)
were incorporated into the##6##4##(1995-1#1)(1996-2#1)(2007-11#1)(2007-2#1)(2008-5#1)(2008-8#1)
were incorporated into##23##3##(1990-2#1)(1992-7#1)(1993-9#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-6#1)(1996-2#1)(1996-4#1)(1996-6#1)(2004-9#1)(2006-5#1)(2007-11#1)(2007-2#2)(2008-10#2)(2008-2#1)(2008-5#2)(2008-8#1)(2009-7#1)(2010-2#1)
were incorporated to##2##3##(2013-1#2)
were incorporated##37##2##(1990-2#2)(1990-4#1)(1992-7#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-7#1)(2004-9#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-2#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2009-3#1)(2009-7#1)(2010-2#2)(2010-5#1)(2012-2#1)(2013-1#2)
were incorrectly##2##2##(1990-11#1)(2007-9#1)
were increased 3##2##3##(1991-2#1)(2011-3#1)
were increased after##5##3##(1991-10#1)(1996-9#1)(2007-11#1)(2011-2#1)(2013-1#1)
were increased and the##2##4##(2007-8#1)(2008-7#1)
were increased and##6##3##(1994-6#2)(2007-8#2)(2008-7#2)
were increased at##4##3##(1990-3#1)(1993-12#1)(1997-7#1)(2013-1#1)
were increased by 10##2##4##(1994-6#1)(1996-12#1)
were increased by the##3##4##(1992-10#1)(2004-4#1)(2009-12#1)
were increased by##31##3##(1990-3#1)(1990-4#1)(1991-3#1)(1992-10#1)(1992-9#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-7#1)(2004-4#1)(2006-12#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-5#1)(2013-1#1)
were increased compared to##2##4##(1993-4#1)(1995-2#1)
were increased during##2##3##(1991-5#1)(2010-11#1)
were increased from##5##3##(2007-10#1)(2008-10#3)(2008-11#1)
were increased in 400##2##4##(2008-9#2)
were increased in a##2##4##(1993-3#1)(2008-9#1)
were increased in all##2##4##(2009-3#1)(2011-12#1)
were increased in males and females##2##6##(2008-9#2)
were increased in males##3##4##(2008-9#3)
were increased in the##12##4##(1991-8#1)(1992-12#1)(1995-11#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-7#1)(2012-2#1)
were increased in##41##3##(1990-10#1)(1990-11#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-4#1)(1993-3#1)(1993-7#1)(1994-8#1)(1995-11#1)(1996-10#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#10)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-12#1)(2012-2#1)(2013-1#2)
were increased incidences##3##3##(2008-9#3)
were increased markedly##2##3##(1995-3#1)(2008-8#1)
were increased more##2##3##(1995-7#1)(2007-10#1)
were increased on##2##3##(1990-3#1)(1992-1#1)
were increased only##2##3##(1990-7#1)(2006-10#1)
were increased severalfold##2##3##(1995-8#1)(2008-11#1)
were increased to##9##3##(1990-6#1)(1992-1#1)(1993-8#1)(1995-12#1)(1996-2#1)(1996-5#1)(2010-4#1)(2011-2#1)(2013-1#1)
were increased up to##4##4##(1991-1#1)(2007-6#1)(2008-10#2)
were increased with##2##3##(1994-3#1)(2013-8#1)
were increased##180##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-3#3)(1990-4#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#2)(1991-10#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-1#2)(1992-10#1)(1992-12#1)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-3#2)(1993-4#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-6#4)(1994-7#1)(1994-8#2)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#2)(1995-3#3)(1995-7#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#3)(1996-7#2)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#2)(1997-8#2)(2004-11#1)(2004-4#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-6#1)(2007-8#3)(2007-9#1)(2008-10#12)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#16)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-7#1)(2011-12#1)(2011-2#5)(2011-3#4)(2012-1#2)(2012-2#3)(2013-1#6)(2013-8#2)
were increasingly##6##2##(1990-12#1)(1991-3#1)(2006-7#1)(2007-12#1)(2008-9#1)(2012-1#1)
were incubated at##12##3##(1990-2#1)(1992-3#1)(1997-5#1)(2007-9#1)(2008-10#6)(2009-3#1)(2009-6#1)
were incubated for 1##2##4##(1992-7#1)(1994-6#1)
were incubated for 24 h##2##5##(2008-12#1)(2009-6#1)
were incubated for##13##3##(1991-2#1)(1991-4#1)(1992-7#1)(1993-6#1)(1994-6#1)(1995-11#1)(1995-7#1)(1995-8#1)(1996-4#1)(2008-12#1)(2009-6#1)(2010-8#1)(2012-3#1)
were incubated in a##2##4##(2008-10#1)(2008-8#1)
were incubated in the presence of##9##6##(1990-10#1)(1991-3#1)(1991-5#1)(1992-7#1)(1994-12#1)(1995-9#1)(2005-12#1)(2008-5#1)(2011-2#1)
were incubated in the##11##4##(1990-10#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-7#1)(1994-12#1)(1995-9#1)(2005-12#1)(2008-10#1)(2008-5#1)(2011-2#1)
were incubated in##31##3##(1990-10#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-7#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-9#1)(1996-1#1)(1996-3#1)(2004-11#1)(2005-12#1)(2006-5#1)(2008-10#5)(2008-11#4)(2008-5#1)(2008-8#1)(2009-3#1)(2010-8#1)(2011-2#1)(2012-12#1)
were incubated on##2##3##(2008-10#1)(2010-3#1)
were incubated with antibodies to##2##5##(1990-11#1)(1997-2#1)
were incubated with the##5##4##(1990-12#2)(1990-8#1)(1991-2#1)(1992-1#1)
were incubated with##71##3##(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#2)(1992-1#1)(1992-12#4)(1992-3#2)(1992-4#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-11#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-8#1)(2004-11#1)(2006-10#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-7#2)(2010-11#1)(2010-4#1)(2011-2#1)(2013-7#1)(2013-8#1)
were incubated##140##2##(1990-10#3)(1990-11#3)(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#2)(1990-8#1)(1991-10#1)(1991-12#3)(1991-2#4)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#2)(1991-8#1)(1992-1#1)(1992-12#4)(1992-3#3)(1992-4#1)(1992-6#1)(1992-7#3)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#2)(1993-9#1)(1994-11#2)(1994-12#2)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#2)(1995-11#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-5#1)(1997-8#1)(2004-11#2)(2005-12#1)(2006-10#1)(2006-5#2)(2006-8#1)(2007-5#1)(2007-9#1)(2008-10#15)(2008-11#6)(2008-12#1)(2008-5#2)(2008-7#4)(2008-8#1)(2009-3#2)(2009-6#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
were indeed##7##2##(1997-8#1)(2006-12#1)(2008-5#2)(2009-9#1)(2010-8#1)(2011-2#1)
were independent in ADL##3##4##(1990-8#1)(2006-7#1)(2008-7#1)
were independent in##5##3##(1990-8#1)(1994-8#1)(2006-7#2)(2008-7#1)
were independent of the body##2##5##(1993-11#1)(2008-5#1)
were independent of the##12##4##(1990-10#2)(1991-7#1)(1991-8#1)(1993-11#1)(1993-5#1)(1993-6#1)(1996-8#1)(2008-10#2)(2008-5#1)(2008-8#1)
were independent of##22##3##(1990-10#2)(1990-2#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-8#1)(1993-11#1)(1993-5#1)(1993-6#1)(1994-10#1)(1996-8#1)(1997-5#1)(1997-8#1)(2008-10#4)(2008-5#2)(2008-8#1)(2012-3#1)
were independent predictors for##2##4##(2004-2#1)(2013-1#1)
were independent predictors of##2##4##(1997-8#1)(2007-8#1)
were independent predictors##4##3##(1997-8#1)(2004-2#1)(2007-8#1)(2013-1#1)
were independent risk factors##2##4##(2011-2#1)(2013-1#1)
were independent##39##2##(1990-10#2)(1990-2#1)(1990-8#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-8#1)(1993-11#2)(1993-5#1)(1993-6#1)(1994-10#1)(1994-8#1)(1996-8#1)(1997-5#1)(1997-8#2)(2004-2#1)(2006-7#2)(2007-8#2)(2007-9#1)(2008-10#4)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#2)
were independently associated with##10##4##(1992-4#1)(1995-8#1)(1996-9#1)(1997-2#1)(2008-3#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
were independently reviewed by two##2##5##(1992-8#1)(2011-2#1)
were independently##25##2##(1990-3#1)(1991-2#1)(1992-4#1)(1992-8#1)(1993-1#1)(1995-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(2004-1#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
were indeterminate##2##2##(1991-9#2)
were indicated##7##2##(1995-9#1)(2005-1#1)(2008-12#1)(2008-6#1)(2010-12#1)(2010-8#1)(2011-1#1)
were indication for RT##2##4##(2010-3#2)
were indications##4##2##(1994-11#1)(2005-11#1)(2006-8#1)(2011-10#1)
were indicative of a##3##4##(2008-10#1)(2013-1#2)
were indicative of the##2##4##(2007-5#1)(2008-10#1)
were indicative of##13##3##(1993-1#1)(1994-9#1)(2006-4#1)(2007-5#1)(2008-10#2)(2008-5#1)(2010-10#1)(2012-12#1)(2013-1#4)
were indifferent##2##2##(1997-3#1)(2007-12#1)
were indirectly related to grades through##2##6##(2009-7#2)
were indirectly##3##2##(2009-7#2)(2011-12#1)
were indistinguishable from each other##2##5##(1997-3#1)(2008-10#1)
were indistinguishable from the##2##4##(1994-8#1)(1995-2#1)
were indistinguishable from those of##3##5##(1991-2#1)(1992-8#1)(1994-12#1)
were indistinguishable from those##4##4##(1991-2#1)(1992-6#1)(1992-8#1)(1994-12#1)
were indistinguishable from##13##3##(1990-4#1)(1991-2#1)(1992-6#1)(1992-8#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-8#1)(1997-3#1)(2008-10#3)(2008-12#1)
were indistinguishable##25##2##(1990-12#1)(1990-4#1)(1991-2#1)(1991-6#1)(1992-6#1)(1992-8#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-8#1)(1997-2#1)(1997-3#1)(2004-9#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#2)
were individually housed##2##3##(2007-2#1)(2009-4#1)
were individually##21##2##(1994-6#2)(1995-5#1)(1996-12#1)(1997-8#1)(2004-2#1)(2005-10#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-1#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-2#2)
were induced by the##6##4##(1990-12#1)(1993-7#1)(1994-12#1)(2007-10#1)(2007-12#1)(2008-11#1)
were induced by##26##3##(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-1#1)(1992-12#1)(1993-5#1)(1993-7#1)(1994-12#1)(1996-3#1)(1996-8#1)(1997-8#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2011-10#1)(2013-1#1)
were induced following##2##3##(2007-1#1)(2009-8#1)
were induced from##2##3##(2008-12#1)(2013-1#1)
were induced in experimental##2##4##(2008-10#1)(2009-8#1)
were induced in mice##2##4##(2008-10#1)(2010-12#1)
were induced in the##3##4##(2007-1#1)(2007-12#1)(2009-7#1)
were induced in##15##3##(1990-4#1)(1993-3#1)(1994-5#1)(1995-3#1)(2007-1#1)(2007-12#2)(2008-10#2)(2008-8#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-8#1)
were induced to##6##3##(1991-8#1)(1993-3#1)(1993-4#1)(2006-5#1)(2008-5#1)(2008-9#1)
were induced when##2##3##(1994-3#1)(2006-8#1)
were induced with##3##3##(1995-12#1)(2008-10#1)(2010-7#1)
were induced##74##2##(1990-12#1)(1990-3#1)(1990-4#2)(1990-7#1)(1991-1#1)(1991-8#1)(1992-12#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#4)(2008-10#13)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-12#2)(2010-7#2)(2011-10#1)(2011-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
were inducible by##2##3##(1992-6#1)(1997-4#1)
were ineffective at##2##3##(1990-3#1)(1991-4#1)
were ineffective in##5##3##(1991-4#1)(1992-8#1)(2008-10#2)(2008-5#1)
were ineffective##32##2##(1990-11#1)(1990-12#1)(1990-3#1)(1991-4#2)(1991-8#2)(1992-5#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-6#2)(1994-8#2)(1996-1#1)(2005-10#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#2)(2009-10#1)(2009-7#1)(2010-2#1)
were inefficient##2##2##(2006-12#1)(2012-3#1)
were ineligible##2##2##(2007-10#1)(2008-5#1)
were infant##2##2##(2007-8#2)
were infected and##3##3##(2008-10#2)(2008-4#1)
were infected by HIV##2##4##(1993-6#1)(2008-12#1)
were infected by##12##3##(1993-6#1)(1995-9#1)(1997-6#1)(2007-3#1)(2008-10#6)(2008-12#1)(2012-3#1)
were infected in##4##3##(1993-8#1)(1996-11#1)(2009-7#1)(2012-3#1)
were infected when##2##3##(1991-8#1)(2008-5#1)
were infected with P##3##4##(2007-1#1)(2007-7#2)
were infected with the##5##4##(1994-5#1)(1995-8#1)(1997-6#2)(2008-10#1)
were infected with##42##3##(1990-11#1)(1991-8#1)(1992-5#1)(1993-9#1)(1994-5#1)(1995-1#1)(1995-8#1)(1997-3#2)(1997-4#1)(1997-6#3)(2006-10#1)(2006-8#1)(2007-1#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#10)(2008-5#6)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)
were infected##80##2##(1990-11#1)(1991-8#2)(1992-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-5#1)(1995-1#1)(1995-8#1)(1995-9#1)(1996-11#1)(1997-3#2)(1997-4#2)(1997-6#4)(2006-10#1)(2006-2#1)(2006-8#2)(2007-1#1)(2007-3#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#24)(2008-12#1)(2008-4#1)(2008-5#9)(2008-9#1)(2009-7#1)(2009-8#1)(2010-12#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#3)
were infections in##3##3##(2007-7#1)(2008-1#1)(2011-1#1)
were infectious by biolistic inoculation to##3##6##(2008-10#3)
were infectious in##2##3##(1997-3#1)(2008-10#1)
were infectious on##2##3##(2008-10#1)(2008-9#1)
were infectious##10##2##(1996-3#1)(1997-3#1)(2008-10#7)(2008-9#1)
were inferior to the##2##4##(2004-1#1)(2008-11#1)
were inferior##5##2##(2004-1#1)(2008-11#1)(2008-8#1)(2009-5#1)(2011-2#1)
were inferred from the##2##4##(2008-3#1)(2008-6#1)
were inferred from##6##3##(1995-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-5#1)
were inferred##11##2##(1995-3#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-6#2)(2008-8#1)(2009-5#1)(2010-8#1)
were infertile##2##2##(1994-9#1)(2004-10#1)
were infested with##9##3##(1996-12#2)(2007-11#1)(2008-10#6)
were infested##11##2##(1996-12#2)(2007-11#1)(2008-10#7)(2011-2#1)
were infiltrated with##2##3##(2008-10#2)
were infiltrated##4##2##(1990-2#1)(2008-10#2)(2010-4#1)
were infiltrating##2##2##(1990-12#1)(2004-2#1)
were influenced by the##6##4##(1992-12#1)(1993-8#1)(1995-11#1)(2008-10#1)(2008-3#1)(2008-5#1)
were influenced by##16##3##(1992-12#1)(1992-4#1)(1993-6#1)(1993-8#1)(1994-1#1)(1995-11#1)(1996-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2012-2#1)
were influenced more by##2##4##(2008-4#1)(2013-8#1)
were influenced significantly by the pattern of siblings (P&lt##2##9##(2004-11#2)
were influenced##26##2##(1990-2#1)(1991-6#1)(1992-12#1)(1992-4#1)(1993-6#1)(1993-8#1)(1994-1#1)(1995-11#1)(1996-1#1)(1997-3#1)(1997-7#1)(2004-11#2)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
were influential##2##2##(2010-10#1)(2011-2#1)
were influenza A##2##3##(1992-6#1)(2011-2#1)
were influenza##3##2##(1992-6#2)(2011-2#1)
were informed##3##2##(2007-5#2)(2007-8#1)
were infrequent and##3##3##(2008-1#1)(2008-10#1)(2008-7#1)
were infrequent##8##2##(2006-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-2#1)
were infrequently##2##2##(1992-5#1)(2010-9#1)
were infused into the##2##4##(1993-12#1)(1997-5#1)
were infused with##2##3##(1993-12#1)(1997-2#1)
were infused##9##2##(1991-5#1)(1993-12#2)(1994-12#1)(1997-2#1)(1997-5#1)(2006-12#2)(2006-5#1)
were inherited##2##2##(1992-6#1)(2008-10#1)
were inhibited by electrical stimulation of the hepatic branch of the vagus##3##12##(1993-12#3)
were inhibited by the##9##4##(1992-12#1)(1993-3#1)(1993-4#1)(1995-12#1)(1996-11#1)(1997-6#1)(2006-8#1)(2008-11#1)(2008-4#1)
were inhibited by##47##3##(1990-11#1)(1990-12#1)(1990-2#1)(1991-1#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-12#3)(1993-3#2)(1993-4#1)(1993-9#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-5#2)(1997-6#1)(2004-4#1)(2006-8#2)(2008-10#1)(2008-11#3)(2008-4#2)(2008-8#1)(2011-12#1)
were inhibited with##2##3##(2008-10#1)(2009-10#1)
were inhibited##66##2##(1990-11#2)(1990-12#1)(1990-2#1)(1991-1#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-12#3)(1993-3#2)(1993-4#1)(1993-9#1)(1994-11#1)(1994-3#2)(1994-5#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-5#2)(1997-6#1)(2004-11#1)(2004-4#1)(2006-8#3)(2008-10#5)(2008-11#3)(2008-4#2)(2008-8#1)(2009-10#1)(2010-8#1)(2011-12#1)(2011-2#1)
were inhibitors of##2##3##(1995-3#1)(1997-7#1)
were inhibitors##3##2##(1994-5#1)(1995-3#1)(1997-7#1)
were inhibitory to##3##3##(2008-10#3)
were inhibitory##8##2##(1991-5#1)(1992-3#1)(1994-3#1)(1996-5#1)(1997-4#1)(2008-10#3)
were initially developed##2##3##(2009-2#1)(2012-2#1)
were initially diagnosed##2##3##(1992-4#1)(2006-2#1)
were initially identified##4##3##(1994-3#1)(2007-2#1)(2008-4#1)(2011-2#1)
were initially not##2##3##(1997-3#1)(2007-12#1)
were initially tested for##3##4##(1991-6#1)(1992-8#1)(1995-3#1)
were initially treated with##2##4##(1991-3#1)(2008-4#1)
were initially treated##3##3##(1991-3#1)(1996-11#1)(2008-4#1)
were initially##54##2##(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-2#1)(1994-2#2)(1994-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#2)(1996-12#1)(1997-1#1)(1997-3#1)(1997-8#2)(2006-2#1)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-12#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#1)(2011-2#2)(2012-1#1)(2012-2#4)(2013-1#1)(2013-7#2)
were initiated for##2##3##(2005-6#1)(2007-6#1)
were initiated from##2##3##(1990-11#1)(2008-5#1)
were initiated in##5##3##(1991-2#1)(1996-11#1)(2005-8#1)(2008-7#1)(2011-2#1)
were initiated on##3##3##(2006-12#1)(2007-7#1)(2012-2#1)
were initiated with##2##3##(1990-4#1)(1994-6#1)
were initiated##34##2##(1990-11#1)(1990-4#1)(1991-2#1)(1993-1#1)(1994-6#1)(1996-11#1)(1996-9#2)(1997-5#1)(2005-12#1)(2005-6#2)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-10#1)(2011-2#2)(2012-2#1)(2013-1#3)
were injected at##4##3##(1995-12#2)(2008-10#1)(2008-6#1)
were injected by##2##3##(2007-8#1)(2008-10#1)
were injected directly into##3##4##(2008-10#3)
were injected every other day with##2##6##(2008-8#1)(2011-2#1)
were injected i##3##3##(1997-4#1)(2010-1#2)
were injected in a##2##4##(1992-11#1)(2008-10#1)
were injected in##4##3##(1992-11#1)(2006-12#1)(2008-10#1)(2011-1#1)
were injected into a##3##4##(1990-8#1)(2008-10#2)
were injected into the flow line by an open sandwich method##2##11##(2008-10#2)
were injected into the graphite tube##2##6##(2008-10#2)
were injected into the##18##4##(1991-3#1)(1995-7#1)(1996-12#2)(1997-5#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-5#1)(2011-11#1)(2012-3#1)
were injected into##31##3##(1990-2#1)(1990-8#2)(1991-3#1)(1994-3#1)(1995-7#1)(1996-12#2)(1996-8#1)(1997-5#1)(1997-7#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-5#1)(2011-11#1)(2012-3#1)(2013-1#2)(2013-8#1)
were injected intraperitoneally with##6##4##(1991-2#1)(1992-11#1)(1995-3#1)(1996-11#1)(2008-11#1)(2008-5#1)
were injected intraperitoneally##7##3##(1991-2#1)(1992-11#1)(1995-3#1)(1996-11#1)(2008-11#1)(2008-5#1)(2010-5#1)
were injected intravenously with##3##4##(1994-9#1)(1995-2#1)(2008-8#1)
were injected intravenously##5##3##(1994-9#1)(1995-2#1)(2008-8#1)(2009-10#1)(2010-12#1)
were injected onto a##3##4##(1990-6#1)(2008-10#2)
were injected onto the##2##4##(1993-2#1)(2008-11#1)
were injected onto##5##3##(1990-6#1)(1993-2#1)(2008-10#2)(2008-11#1)
were injected via the tail vein##2##6##(2009-10#1)(2010-12#1)
were injected with 0##2##4##(1991-3#1)(2008-9#1)
were injected with either##3##4##(1990-7#1)(1991-8#2)
were injected with saline##2##4##(1995-12#1)(2004-10#1)
were injected with the##3##4##(2008-8#1)(2009-12#1)(2012-3#1)
were injected with##28##3##(1990-7#1)(1991-2#1)(1991-3#1)(1991-8#2)(1994-2#1)(1995-11#2)(1995-12#1)(1996-10#1)(1997-1#1)(1997-3#1)(2004-10#2)(2006-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-9#1)(2011-2#2)(2012-11#1)(2012-3#3)(2013-1#1)(2013-7#1)
were injected##120##2##(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-2#2)(1991-3#2)(1991-5#1)(1991-8#4)(1992-1#1)(1992-11#2)(1993-11#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#3)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-10#1)(1996-11#2)(1996-12#2)(1996-8#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#2)(2004-10#2)(2005-11#1)(2006-12#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#24)(2008-11#3)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#2)(2009-12#1)(2010-1#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-11#1)(2011-2#4)(2012-11#1)(2012-2#1)(2012-3#5)(2013-1#3)(2013-7#1)(2013-8#1)
were injured by##2##3##(2008-8#1)(2011-2#1)
were injured in##2##3##(1990-9#1)(2012-3#1)
were injured##10##2##(1990-2#1)(1990-9#1)(2006-8#1)(2007-9#1)(2008-8#1)(2009-4#2)(2011-2#1)(2012-3#1)(2013-1#1)
were innervated##2##2##(1996-5#1)(2010-12#1)
were inoculated and incubated in##2##5##(2008-10#2)
were inoculated and incubated##3##4##(2008-10#3)
were inoculated and##4##3##(2008-10#4)
were inoculated at the time of##2##6##(2006-3#1)(2006-9#1)
were inoculated at the##7##4##(2006-3#1)(2006-9#1)(2008-10#5)
were inoculated at##13##3##(2006-3#1)(2006-9#1)(2008-10#11)
were inoculated by##3##3##(1997-6#1)(2008-10#2)
were inoculated for##2##3##(2007-9#1)(2010-8#1)
were inoculated in the greenhouse with##2##6##(2008-10#2)
were inoculated in the##3##4##(2008-10#3)
were inoculated in##8##3##(2008-10#6)(2008-5#2)
were inoculated into the##2##4##(1991-3#1)(2008-5#1)
were inoculated into##6##3##(1991-12#1)(1991-3#1)(2008-10#2)(2008-5#2)
were inoculated on##4##3##(1994-9#1)(2007-1#1)(2008-10#2)
were inoculated onto a##2##4##(2008-10#2)
were inoculated onto##5##3##(2008-10#3)(2011-2#1)(2012-2#1)
were inoculated together##2##3##(2008-10#2)
were inoculated with P##3##4##(2008-10#3)
were inoculated with a##7##4##(2008-10#5)(2009-9#1)(2011-2#1)
were inoculated with an##2##4##(2008-10#2)
were inoculated with conidia of##2##5##(2008-10#2)
were inoculated with conidial suspensions of##2##6##(2008-10#2)
were inoculated with one of two##2##6##(1997-3#1)(2008-10#1)
were inoculated with the##2##4##(2008-10#2)
were inoculated with##59##3##(1991-3#1)(1992-7#1)(1997-3#1)(1997-6#2)(2005-9#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#40)(2008-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#3)
were inoculated##132##2##(1991-12#1)(1991-3#2)(1992-2#1)(1992-7#1)(1994-9#1)(1996-6#1)(1997-3#1)(1997-6#5)(2005-9#2)(2006-10#1)(2006-3#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#89)(2008-12#1)(2008-5#6)(2009-8#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-10#1)(2011-2#2)(2012-2#2)(2012-3#3)
were input##3##2##(2007-10#1)(2012-3#1)(2013-8#1)
were inscribed##2##2##(2006-6#1)(2007-11#1)
were inseminated in##2##3##(2006-5#2)
were inseminated with##4##3##(2006-5#3)(2012-2#1)
were inseminated##9##2##(2006-5#8)(2012-2#1)
were insensitive to the toxin##2##5##(2008-10#2)
were insensitive to##16##3##(1990-11#2)(1991-2#1)(1991-6#2)(1992-7#1)(1993-9#1)(1994-11#1)(2008-10#5)(2008-11#3)
were inserted between the##2##4##(1996-7#1)(2008-6#1)
were inserted between##4##3##(1994-9#1)(1996-7#1)(2008-5#1)(2008-6#1)
were inserted in a##2##4##(1990-11#1)(2013-8#1)
were inserted in the##2##4##(2007-8#1)(2008-10#1)
were inserted in##10##3##(1990-11#1)(1990-12#1)(1991-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-12#1)(2013-1#1)(2013-8#1)
were inserted into a##4##4##(1993-11#1)(1995-2#1)(2008-12#1)(2013-1#1)
were inserted into the##10##4##(1991-5#1)(1996-1#1)(2004-9#1)(2005-4#1)(2007-4#1)(2007-7#1)(2007-8#1)(2010-6#2)(2011-2#1)
were inserted into##19##3##(1991-12#1)(1991-5#1)(1993-11#1)(1993-12#1)(1995-2#1)(1996-1#1)(1997-6#1)(2004-9#1)(2005-4#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-8#1)(2010-6#2)(2011-2#1)(2013-1#2)
were inserted##40##2##(1990-11#1)(1990-12#2)(1991-12#1)(1991-2#1)(1991-5#1)(1993-11#1)(1993-12#1)(1993-4#1)(1994-9#1)(1995-2#1)(1996-1#1)(1996-7#1)(1997-6#1)(2004-9#1)(2005-4#1)(2006-12#1)(2006-5#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-3#1)(2010-6#2)(2011-12#1)(2011-2#1)(2013-1#3)(2013-8#1)
were insignificant##3##2##(1994-2#1)(2008-1#1)(2012-12#1)
were inspected for##2##3##(1997-3#1)(2011-2#1)
were inspected##4##2##(1997-3#1)(2007-1#1)(2011-2#2)
were installed##6##2##(2008-2#1)(2009-3#1)(2011-1#1)(2013-8#3)
were instead##2##2##(1992-9#1)(1997-1#1)
were instilled##2##2##(2006-9#1)(2010-3#1)
were instituted##5##2##(2005-11#1)(2006-4#1)(2007-2#1)(2007-6#1)(2009-4#1)
were instructed to perform##2##4##(2010-9#1)(2011-2#1)
were instructed to##15##3##(1990-4#1)(1991-2#1)(1994-2#1)(1997-1#1)(1997-7#1)(2006-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-9#1)(2011-2#1)(2012-2#1)
were instructed##21##2##(1990-4#1)(1991-2#1)(1994-2#1)(1995-5#1)(1997-1#1)(1997-7#1)(2006-10#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-8#1)
were instrumented with tri-axial##2##4##(2006-11#1)(2007-4#1)
were instrumented with##5##3##(1993-12#1)(2006-11#2)(2007-10#1)(2007-4#1)
were instrumented##6##2##(1993-12#1)(2006-11#2)(2007-10#1)(2007-4#1)(2008-11#1)
were insufficient data to##2##4##(1995-10#1)(2013-8#1)
were insufficient to##2##3##(2008-10#1)(2008-8#1)
were insufficient##6##2##(1992-8#1)(1995-10#1)(2008-10#1)(2008-8#1)(2011-12#1)(2013-8#1)
were intact##9##2##(1992-8#1)(1994-10#1)(1995-8#2)(1996-6#1)(2007-1#1)(2008-11#1)(2008-6#1)(2010-12#1)
were integrated in the wild phenotype##2##6##(2008-4#2)
were integrated in the##3##4##(2008-4#3)
were integrated in##4##3##(1995-5#1)(2008-4#3)
were integrated into the##5##4##(1991-6#1)(1994-3#1)(1997-7#1)(2007-8#1)(2008-9#1)
were integrated into##10##3##(1991-6#1)(1994-12#1)(1994-3#1)(1996-12#1)(1997-7#1)(2006-3#1)(2007-8#1)(2008-12#1)(2008-9#1)(2010-3#1)
were integrated to##2##3##(2006-2#1)(2010-12#1)
were integrated##21##2##(1991-6#1)(1994-12#1)(1994-3#1)(1995-5#1)(1996-12#1)(1997-7#1)(2006-2#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#3)(2008-8#1)(2008-9#1)(2010-12#1)(2010-3#1)
were intended for##2##3##(2008-5#1)(2013-1#1)
were intended to##3##3##(2007-8#1)(2008-6#1)(2012-1#1)
were intended##5##2##(2007-8#1)(2008-5#1)(2008-6#1)(2012-1#1)(2013-1#1)
were intensely##4##2##(1994-2#1)(1995-12#2)(2008-7#1)
were intensified##2##2##(2007-11#1)(2008-5#1)
were intensively studied for##2##4##(2008-10#1)(2009-5#1)
were intensively##4##2##(2008-10#1)(2008-5#1)(2008-7#1)(2009-5#1)
were interested in##10##3##(1991-10#1)(1994-10#1)(1997-3#1)(1997-7#1)(2006-10#1)(2008-5#1)(2010-2#1)(2011-9#1)(2013-1#1)(2013-7#1)
were interested##13##2##(1991-10#1)(1994-10#1)(1997-3#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-5#1)(2010-2#1)(2011-9#1)(2012-2#1)(2013-1#1)(2013-7#1)
were interesting##2##2##(2007-8#1)(2008-11#1)
were intermediate between##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
were intermediate in##4##3##(1992-7#1)(1995-3#1)(2008-10#2)
were intermediate##10##2##(1992-7#1)(1995-3#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-8#1)
were internally##3##2##(2008-10#1)(2013-8#2)
were interpersonal##2##2##(2008-9#1)(2009-3#1)
were interpretable##2##2##(2008-7#1)(2009-8#1)
were interpreted according to##2##4##(1991-9#1)(2006-8#1)
were interpreted as being##3##4##(2005-10#1)(2005-11#1)(2008-10#1)
were interpreted as##12##3##(1993-1#1)(1993-6#3)(2005-10#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-5#2)(2008-9#1)(2013-8#1)
were interpreted by##3##3##(1993-8#1)(2004-1#1)(2006-11#1)
were interpreted in terms of a##2##6##(1990-11#1)(1993-11#1)
were interpreted in terms of complex##2##6##(2008-10#2)
were interpreted in terms of##6##5##(1990-11#1)(1990-7#1)(1993-11#1)(2007-11#1)(2008-10#2)
were interpreted in##9##3##(1990-11#1)(1990-12#1)(1990-7#1)(1993-11#1)(2006-7#1)(2007-11#1)(2008-10#2)(2012-3#1)
were interpreted on the basis of##2##6##(1994-5#1)(2008-10#1)
were interpreted on the basis##3##5##(1990-4#1)(1994-5#1)(2008-10#1)
were interpreted to be##2##4##(1996-2#1)(2008-10#1)
were interpreted to##4##3##(1996-2#1)(2008-10#3)
were interpreted using##3##3##(2007-1#1)(2007-8#1)(2012-12#1)
were interpreted##40##2##(1990-11#2)(1990-12#1)(1990-4#1)(1990-7#1)(1991-9#1)(1993-1#1)(1993-11#1)(1993-6#3)(1993-8#1)(1994-5#1)(1996-2#1)(2004-1#1)(2005-10#2)(2005-11#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-5#2)(2008-9#1)(2009-6#1)(2009-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
were interrupted##3##2##(1990-8#1)(1995-10#1)(1997-4#1)
were interspersed##2##2##(2008-10#1)(2012-12#1)
were interviewed 1##3##3##(1996-12#2)(2007-10#1)
were interviewed about their experiences##3##5##(2009-9#1)(2013-1#2)
were interviewed about their##10##4##(1994-3#1)(1996-6#1)(1997-6#1)(2009-9#1)(2010-11#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#2)
were interviewed about##13##3##(1994-3#1)(1996-6#1)(1997-6#1)(2007-2#1)(2008-11#1)(2009-9#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
were interviewed and asked to##2##5##(1990-12#1)(2005-7#1)
were interviewed and##7##3##(1990-12#1)(1995-1#1)(1995-9#1)(2005-7#1)(2007-2#1)(2008-12#1)(2011-2#1)
were interviewed by phone##2##4##(2008-5#1)(2011-1#1)
were interviewed by questionnaire##2##4##(1996-1#1)(2006-2#1)
were interviewed by trained##2##4##(2009-5#1)(2011-2#1)
were interviewed by##9##3##(1996-1#1)(2006-2#1)(2007-10#1)(2008-5#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
were interviewed during##4##3##(2007-7#1)(2009-6#1)(2012-3#1)(2013-1#1)
were interviewed for##4##3##(1991-6#1)(2005-10#1)(2008-7#1)(2011-2#1)
were interviewed in depth##2##4##(1992-3#1)(2012-12#1)
were interviewed in##7##3##(1990-12#2)(1992-3#1)(2008-1#1)(2011-1#1)(2012-12#1)(2012-2#1)
were interviewed in-depth##2##3##(2013-1#1)(2013-8#1)
were interviewed individually##2##3##(2008-12#1)(2012-12#1)
were interviewed on##2##3##(2008-4#1)(2011-1#1)
were interviewed the##2##3##(1996-3#1)(2008-3#1)
were interviewed to##5##3##(1990-8#1)(1994-1#1)(2007-7#1)(2009-12#1)(2010-10#1)
were interviewed using a semistructured##3##5##(2004-12#1)(2010-9#1)(2011-1#1)
were interviewed using a structured questionnaire##3##6##(2007-10#1)(2008-8#1)(2011-1#1)
were interviewed using a##10##4##(2004-12#1)(2007-10#1)(2008-8#1)(2009-5#1)(2010-9#1)(2011-1#3)(2012-12#1)(2013-1#1)
were interviewed using the##5##4##(1992-2#1)(2006-4#1)(2007-7#1)(2008-7#1)(2011-1#1)
were interviewed using##16##3##(1992-2#1)(1995-12#1)(2004-12#1)(2006-4#1)(2007-10#1)(2007-7#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-9#1)(2011-1#4)(2012-12#1)(2013-1#1)
were interviewed with a##4##4##(1992-8#1)(1993-6#1)(2008-7#1)(2010-8#1)
were interviewed with##5##3##(1992-8#1)(1993-6#1)(2008-7#1)(2010-8#1)(2013-1#1)
were interviewed##131##2##(1990-12#4)(1990-8#2)(1991-3#1)(1991-6#2)(1992-2#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#2)(1994-1#1)(1994-3#2)(1995-1#2)(1995-12#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-6#1)(1997-6#1)(2004-12#1)(2005-10#1)(2005-4#1)(2005-7#1)(2006-2#1)(2006-4#1)(2007-10#4)(2007-11#1)(2007-12#1)(2007-2#3)(2007-3#2)(2007-6#1)(2007-7#5)(2008-1#2)(2008-10#2)(2008-11#5)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#2)(2009-5#4)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#10)(2011-2#5)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#9)(2013-8#3)
were interwoven##3##2##(2007-12#1)(2009-9#1)(2010-1#1)
were intoxicated##2##2##(1990-9#1)(1995-7#1)
were intramuscularly##2##2##(2008-4#1)(2009-5#1)
were intraperitoneally injected with##2##4##(1994-5#1)(2009-5#1)
were intravenous drug##2##3##(2007-7#1)(2013-1#1)
were intravenously injected##2##3##(1996-9#1)(2010-12#1)
were intravenously##3##2##(1996-9#1)(2006-8#1)(2010-12#1)
were introduced and##4##3##(1990-3#1)(1990-8#1)(2007-12#1)(2013-1#1)
were introduced as##3##3##(1997-8#1)(2008-10#2)
were introduced at##2##3##(1990-12#1)(1991-8#1)
were introduced by##4##3##(2007-8#1)(2008-10#1)(2008-3#1)(2008-8#1)
were introduced during##2##3##(1992-7#1)(2008-11#1)
were introduced early##2##3##(2011-1#2)
were introduced in the##6##4##(1993-11#1)(1996-2#1)(1996-7#1)(1997-8#1)(2008-10#2)
were introduced in##13##3##(1990-2#1)(1993-11#1)(1996-2#1)(1996-7#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-3#1)(2010-9#1)
were introduced into a##2##4##(2008-10#1)(2008-3#1)
were introduced into each of##2##5##(1997-5#1)(2008-5#1)
were introduced into the##16##4##(1991-12#1)(1991-4#1)(1991-5#1)(1992-3#1)(1993-8#1)(1996-4#1)(1997-1#1)(1997-2#1)(2006-12#1)(2006-5#1)(2006-6#1)(2008-10#5)
were introduced into##41##3##(1991-12#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-3#1)(1993-11#1)(1993-8#2)(1995-2#1)(1995-6#2)(1996-2#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#1)(2010-8#1)(2011-1#1)
were introduced on the##2##4##(2004-4#1)(2008-6#1)
were introduced to describe##2##4##(2006-10#1)(2008-2#1)
were introduced to the##3##4##(1994-1#1)(2006-2#1)(2008-10#1)
were introduced to##13##3##(1994-1#1)(2006-10#1)(2006-2#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2010-4#1)(2012-1#1)(2013-8#1)
were introduced using efficient##2##4##(1996-8#2)
were introduced using##3##3##(1996-8#2)(2007-11#1)
were introduced via##2##3##(1995-8#1)(2008-6#1)
were introduced##116##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-7#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-8#2)(1994-1#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-2#2)(1996-4#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-4#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-5#1)(2006-6#2)(2006-7#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#3)(2008-10#25)(2008-11#3)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#2)(2008-8#8)(2008-9#1)(2009-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
were intubated##2##2##(2008-11#1)(2010-12#1)
were invariably##2##2##(1993-4#1)(2007-11#1)
were invasive##2##2##(1994-12#1)(2007-2#1)
were inversely correlated with##4##4##(1997-4#1)(2008-11#1)(2008-9#1)(2011-1#1)
were inversely correlated##5##3##(1997-4#1)(1997-8#1)(2008-11#1)(2008-9#1)(2011-1#1)
were inversely related to the##3##5##(1995-12#2)(2009-8#1)
were inversely related to##9##4##(1990-2#1)(1991-5#1)(1995-12#2)(2007-3#1)(2007-6#1)(2008-9#1)(2009-8#1)(2011-2#1)
were inversely related##10##3##(1990-2#1)(1991-5#1)(1995-12#2)(2007-3#1)(2007-6#1)(2008-12#1)(2008-9#1)(2009-8#1)(2011-2#1)
were inversely##18##2##(1990-2#1)(1991-1#1)(1991-5#1)(1995-12#2)(1997-4#1)(1997-8#1)(2006-4#1)(2007-3#1)(2007-6#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#2)(2009-8#1)(2011-1#1)(2011-2#1)
were inverted##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
were invested in##3##3##(2004-7#1)(2011-2#2)
were invested##4##2##(2004-7#1)(2011-2#2)(2013-1#1)
were investigated according to##2##4##(1997-3#1)(2011-2#1)
were investigated against##2##3##(2007-3#1)(2009-5#1)
were investigated among##2##3##(2012-1#1)(2013-1#1)
were investigated and a##3##4##(2004-11#1)(2007-11#1)(2009-3#1)
were investigated and compared with the##4##6##(2008-10#1)(2008-3#1)(2012-3#1)(2013-1#1)
were investigated and optimized##5##4##(2008-10#3)(2010-4#1)(2012-1#1)
were investigated and the##6##4##(1992-2#1)(2008-10#4)(2011-1#1)
were investigated and##28##3##(1992-2#1)(1993-2#1)(1995-11#1)(2004-11#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#11)(2008-12#1)(2008-3#1)(2009-3#1)(2010-4#2)(2011-1#1)(2012-1#2)(2012-3#1)(2013-1#1)
were investigated as a##2##4##(1997-7#1)(2008-7#1)
were investigated as well as##3##5##(1997-8#1)(2008-10#2)
were investigated as##19##3##(1992-8#1)(1993-4#1)(1997-7#1)(1997-8#1)(2005-12#1)(2007-11#1)(2008-10#6)(2008-3#1)(2008-6#1)(2008-7#1)(2012-1#1)(2012-5#1)(2013-1#1)(2013-8#1)
were investigated at the##2##4##(1993-12#1)(2008-3#1)
were investigated at##7##3##(1993-12#1)(1993-9#1)(2007-10#1)(2008-10#3)(2008-3#1)
were investigated by Northern blot##2##5##(1992-6#1)(1994-8#1)
were investigated by Western blot##2##5##(1992-1#1)(2006-8#1)
were investigated by X-ray##2##4##(1992-8#1)(2004-9#1)
were investigated by a##2##4##(2007-12#1)(2007-8#1)
were investigated by comparing the##2##5##(1993-9#1)(2008-9#1)
were investigated by comparing##3##4##(1993-9#1)(1994-3#1)(2008-9#1)
were investigated by electron##2##4##(1993-3#1)(2008-10#1)
were investigated by evaluating##2##4##(1994-8#1)(2008-5#1)
were investigated by in vivo##2##5##(1994-2#1)(1996-10#1)
were investigated by means of a##2##6##(1990-8#1)(2008-3#1)
were investigated by means of the##2##6##(1990-3#1)(2008-6#1)
were investigated by means of##10##5##(1990-3#1)(1990-8#1)(1992-9#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-6#1)
were investigated by measuring##5##4##(1991-9#1)(1995-5#1)(1997-5#1)(2008-5#1)(2012-11#1)
were investigated by site-directed mutagenesis##2##5##(1993-6#1)(1994-11#1)
were investigated by the##3##4##(1992-11#1)(2005-4#1)(2008-11#1)
were investigated by transmission electron microscopy##3##6##(2008-10#2)(2008-7#1)
were investigated by univariate method##2##5##(2008-10#2)
were investigated by use of##2##5##(2007-12#1)(2008-3#1)
were investigated by using the##2##5##(2005-11#1)(2008-10#1)
were investigated by using##6##4##(1996-5#1)(2005-11#1)(2005-12#1)(2007-12#1)(2008-10#1)(2009-7#1)
were investigated by##108##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#2)(1991-2#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-5#1)(1997-1#1)(1997-5#1)(1997-6#1)(2004-9#1)(2005-11#4)(2005-12#1)(2005-4#3)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#2)(2007-1#2)(2007-11#2)(2007-12#5)(2007-8#1)(2008-10#22)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#2)(2009-7#1)(2010-12#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2013-1#2)
were investigated during the##3##4##(1993-2#1)(2008-10#1)(2013-1#1)
were investigated during##7##3##(1993-2#1)(1996-7#1)(2004-12#1)(2007-3#1)(2008-10#1)(2008-12#1)(2013-1#1)
were investigated experimentally and theoretically##2##5##(2008-10#1)(2008-2#1)
were investigated experimentally##5##3##(1997-2#1)(2008-10#2)(2008-2#1)(2008-9#1)
were investigated for a##3##4##(1994-9#1)(1996-3#1)(2008-10#1)
were investigated for different##2##4##(2008-10#1)(2012-12#1)
were investigated for the presence of##3##6##(1992-4#1)(2007-7#1)(2008-3#1)
were investigated for the##13##4##(1992-4#1)(1993-8#1)(1996-7#1)(2007-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#1)(2011-1#1)(2011-2#1)
were investigated for their##9##4##(1992-8#1)(1992-9#1)(1997-4#1)(2007-1#1)(2008-8#1)(2009-12#1)(2009-5#1)(2012-2#1)(2013-1#1)
were investigated for##46##3##(1990-12#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-9#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-4#1)(2005-11#1)(2006-12#1)(2006-6#1)(2007-1#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
were investigated from##4##3##(2004-12#1)(2006-8#1)(2008-10#1)(2008-5#1)
were investigated in 16##2##4##(1996-2#1)(2006-8#1)
were investigated in a group of##2##6##(1995-11#1)(2008-9#1)
were investigated in a##13##4##(1992-4#1)(1995-11#1)(1997-4#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-8#2)(2013-7#1)
were investigated in an##2##4##(1997-1#1)(2008-10#1)
were investigated in aqueous solutions##2##5##(1990-10#1)(2008-3#1)
were investigated in batch##2##4##(2005-11#1)(2006-8#1)
were investigated in cultured##2##4##(1990-4#1)(1993-2#1)
were investigated in detail and optimized##3##6##(2008-10#3)
were investigated in detail and##4##5##(2008-10#4)
were investigated in detail##20##4##(2007-12#1)(2007-8#1)(2008-10#16)(2008-6#1)(2011-1#1)
were investigated in four##2##4##(2011-1#1)(2012-12#1)
were investigated in human##3##4##(1990-12#1)(1992-6#1)(2011-3#1)
were investigated in isolated##2##4##(1991-5#1)(1996-5#1)
were investigated in male Sprague-Dawley rats##3##6##(1991-9#1)(1996-2#1)(2008-4#1)
were investigated in order to##5##5##(1992-2#1)(2006-2#1)(2008-10#3)
were investigated in rat##3##4##(1990-11#1)(1990-4#1)(1997-1#1)
were investigated in rats##10##4##(1992-7#1)(1994-10#1)(1994-11#1)(1994-3#2)(1994-6#1)(1995-2#1)(1996-2#1)(1997-7#2)
were investigated in relation to##2##5##(2006-8#1)(2008-3#1)
were investigated in several##2##4##(2009-3#1)(2011-2#1)
were investigated in the feline##2##5##(1991-2#1)(1993-3#1)
were investigated in the isolated##2##5##(1990-12#1)(1996-10#1)
were investigated in the rat##4##5##(1991-11#1)(1991-4#1)(1993-11#1)(1993-12#1)
were investigated in the##21##4##(1990-12#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-4#1)(1993-11#1)(1993-12#1)(1993-3#1)(1996-10#2)(1996-12#1)(2004-11#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-4#1)
were investigated in this study##6##5##(1995-1#1)(1997-4#1)(2007-2#2)(2008-12#1)(2011-12#1)
were investigated in this##10##4##(1991-10#1)(1995-1#1)(1997-4#1)(2007-2#2)(2008-10#2)(2008-12#2)(2011-12#1)
were investigated in three##2##4##(1995-7#1)(2007-12#1)
were investigated in two##2##4##(2010-4#1)(2010-8#1)
were investigated in vitro##6##4##(1990-11#1)(1992-11#1)(1992-5#1)(1996-12#1)(1996-3#1)(2006-6#1)
were investigated in vivo and in vitro##2##7##(1990-11#1)(2008-10#1)
were investigated in vivo##5##4##(1990-11#1)(1990-5#1)(1993-11#1)(1996-12#1)(2008-10#1)
were investigated in##198##3##(1990-10#1)(1990-11#3)(1990-12#2)(1990-3#1)(1990-4#2)(1990-5#2)(1990-7#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1994-10#1)(1994-11#2)(1994-2#1)(1994-3#3)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-11#3)(1995-2#3)(1995-3#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#2)(1996-12#4)(1996-2#4)(1996-3#1)(1996-5#1)(1997-1#4)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2004-11#1)(2004-9#3)(2005-11#2)(2006-2#1)(2006-6#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-8#3)(2008-10#35)(2008-11#1)(2008-12#3)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-4#5)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#2)(2012-4#1)(2013-7#1)
were investigated on fly ash samples that##2##7##(2008-10#2)
were investigated on the##2##4##(1992-3#1)(2008-10#1)
were investigated on##8##3##(1992-3#1)(1993-11#1)(1995-12#1)(2008-10#3)(2008-9#1)(2010-7#1)
were investigated over##2##3##(1993-5#1)(2008-10#1)
were investigated successfully##2##3##(2008-10#1)(2008-3#1)
were investigated through##7##3##(2008-10#1)(2008-2#1)(2008-3#2)(2009-7#1)(2013-7#1)(2013-8#1)
were investigated to acquire the optimum##2##6##(2008-10#2)
were investigated to assess##2##4##(2007-3#1)(2008-3#1)
were investigated to determine the##2##5##(2008-10#1)(2013-1#1)
were investigated to determine##3##4##(2008-10#1)(2008-2#1)(2013-1#1)
were investigated to evaluate##2##4##(2006-12#1)(2010-3#1)
were investigated to improve the##2##5##(2008-10#1)(2008-2#1)
were investigated to##33##3##(1991-12#1)(1991-2#1)(1992-4#1)(1992-6#1)(2005-11#1)(2006-12#1)(2007-3#1)(2007-8#2)(2008-10#16)(2008-2#3)(2008-3#1)(2010-3#1)(2011-12#1)(2012-12#1)(2013-1#1)
were investigated under the##2##4##(1990-8#1)(1996-6#1)
were investigated under##4##3##(1990-8#1)(1994-5#1)(1996-6#1)(2008-10#1)
were investigated using a##7##4##(1993-12#1)(1993-9#1)(1994-2#1)(2005-11#1)(2006-4#1)(2011-2#1)(2012-1#1)
were investigated using confocal##2##4##(2007-12#1)(2009-6#1)
were investigated using in vitro##2##5##(2008-11#1)(2008-5#1)
were investigated using qualitative##2##4##(2008-1#1)(2012-11#1)
were investigated using the dynamic##2##5##(2007-10#1)(2008-5#1)
were investigated using the##8##4##(1992-3#1)(1993-3#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-5#1)(2010-8#1)
were investigated using##69##3##(1991-5#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-11#2)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#12)(2008-11#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-5#1)(2010-8#2)(2011-2#4)(2012-1#1)(2012-11#1)(2013-1#1)
were investigated with a##2##4##(2007-11#1)(2008-4#1)
were investigated with regard to##4##5##(1995-5#1)(2008-10#2)(2013-1#1)
were investigated with respect to their##3##6##(2008-5#1)(2008-7#1)(2010-4#1)
were investigated with the##5##4##(2008-10#3)(2008-2#1)(2013-8#1)
were investigated with##33##3##(1991-12#1)(1993-12#1)(1995-11#1)(1995-5#1)(2005-11#1)(2006-12#2)(2006-8#1)(2007-1#1)(2007-11#1)(2008-10#12)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-4#1)(2012-3#1)(2013-1#2)(2013-8#1)
were investigated##975##2##(1990-10#1)(1990-11#5)(1990-12#6)(1990-2#2)(1990-3#4)(1990-4#3)(1990-5#3)(1990-7#2)(1990-8#9)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#3)(1991-3#3)(1991-4#2)(1991-5#5)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#5)(1992-1#1)(1992-11#3)(1992-12#3)(1992-2#2)(1992-3#2)(1992-4#4)(1992-5#3)(1992-6#6)(1992-7#3)(1992-8#9)(1992-9#4)(1993-1#1)(1993-10#1)(1993-11#10)(1993-12#7)(1993-2#6)(1993-3#9)(1993-4#2)(1993-5#3)(1993-6#2)(1993-8#5)(1993-9#6)(1994-10#1)(1994-11#5)(1994-12#2)(1994-2#4)(1994-3#6)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#4)(1994-9#3)(1995-1#6)(1995-11#7)(1995-12#4)(1995-2#4)(1995-3#4)(1995-4#2)(1995-5#2)(1995-6#4)(1995-7#2)(1995-8#3)(1995-9#1)(1996-1#4)(1996-10#3)(1996-12#5)(1996-2#7)(1996-3#2)(1996-4#1)(1996-5#8)(1996-6#2)(1996-7#3)(1996-8#1)(1997-1#6)(1997-2#5)(1997-3#2)(1997-4#6)(1997-5#3)(1997-6#3)(1997-7#4)(1997-8#4)(2004-11#3)(2004-12#2)(2004-4#1)(2004-9#6)(2005-10#1)(2005-11#14)(2005-12#5)(2005-4#6)(2006-10#4)(2006-11#2)(2006-12#8)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#11)(2007-1#8)(2007-10#3)(2007-11#9)(2007-12#17)(2007-2#3)(2007-3#6)(2007-7#1)(2007-8#12)(2007-9#1)(2008-1#4)(2008-10#260)(2008-11#18)(2008-12#9)(2008-2#12)(2008-3#23)(2008-4#10)(2008-5#33)(2008-6#8)(2008-7#12)(2008-8#10)(2008-9#9)(2009-10#3)(2009-12#3)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#7)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#4)(2010-3#1)(2010-4#12)(2010-5#2)(2010-7#1)(2010-8#8)(2011-1#8)(2011-10#1)(2011-12#3)(2011-2#13)(2011-3#1)(2012-1#6)(2012-11#2)(2012-12#8)(2012-2#3)(2012-3#7)(2012-4#1)(2012-5#1)(2012-6#1)(2013-1#14)(2013-7#4)(2013-8#6)
were invited to answer##2##4##(2008-11#1)(2013-1#1)
were invited to attend##3##4##(1992-5#1)(2008-10#1)(2012-2#1)
were invited to participate in a##2##6##(1995-5#1)(2012-12#1)
were invited to participate##8##4##(1995-5#1)(2007-10#1)(2008-11#1)(2011-1#2)(2012-12#2)(2013-7#1)
were invited to take part in##2##6##(2008-10#1)(2011-1#1)
were invited to undergo##2##4##(1992-7#1)(2011-1#1)
were invited to##22##3##(1991-6#1)(1992-5#1)(1992-7#1)(1995-5#1)(1997-6#1)(2007-10#1)(2008-10#2)(2008-11#2)(2010-8#1)(2010-9#1)(2011-1#4)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#1)
were invited##27##2##(1991-6#2)(1992-5#1)(1992-7#1)(1995-5#1)(1996-11#1)(1997-6#1)(1997-8#1)(2006-7#1)(2007-10#1)(2008-10#2)(2008-11#2)(2010-8#1)(2010-9#1)(2011-1#5)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#1)
were involved in a##4##4##(2006-10#1)(2007-2#1)(2008-11#1)(2010-11#1)
were involved in the production of##2##6##(1995-9#1)(1997-8#1)
were involved in the study##8##5##(1991-4#1)(2004-11#1)(2007-3#1)(2007-7#1)(2008-2#2)(2012-2#2)
were involved in the##22##4##(1991-1#1)(1991-4#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-5#1)(1997-8#1)(2004-11#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-9#1)(2009-3#1)(2012-12#1)(2012-2#2)
were involved in this study##2##5##(2009-5#1)(2013-8#1)
were involved in this##5##4##(1993-6#1)(2008-1#1)(2009-5#1)(2012-12#1)(2013-8#1)
were involved in##50##3##(1991-1#1)(1991-4#1)(1992-9#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-5#2)(1997-8#1)(2004-11#1)(2006-10#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-7#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-8#2)
were involved##62##2##(1990-10#2)(1991-1#1)(1991-4#1)(1992-1#2)(1992-3#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-5#2)(1997-8#1)(2004-11#1)(2006-10#2)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-2#2)(2008-7#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-8#2)
were ionized##2##2##(2011-1#1)(2012-12#1)
were irradiated at##3##3##(1991-2#1)(2007-3#1)(2008-10#1)
were irradiated by##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
were irradiated with a##2##4##(2011-2#1)(2012-3#1)
were irradiated with##9##3##(1990-5#1)(1990-7#1)(1996-6#1)(2005-11#1)(2006-2#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)
were irradiated##19##2##(1990-5#1)(1990-7#1)(1991-2#1)(1996-6#1)(2005-11#1)(2006-2#1)(2007-3#1)(2008-10#3)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#1)(2011-2#2)(2012-3#1)
were irregular##4##2##(1994-3#1)(2008-1#2)(2008-4#1)
were irrelevant##2##2##(1990-12#1)(2010-5#1)
were irreversibly##3##2##(1991-5#1)(2006-10#1)(2007-9#1)
were isolated after##3##3##(1991-9#1)(1995-2#1)(2008-10#1)
were isolated along with##2##4##(2007-1#1)(2008-4#1)
were isolated and characterised##2##4##(2006-12#1)(2008-11#1)
were isolated and characterized##10##4##(1990-8#1)(1991-7#1)(1992-12#1)(1992-6#1)(1993-6#1)(2008-10#2)(2008-5#1)(2009-4#1)(2013-8#1)
were isolated and cloned##2##4##(2008-8#2)
were isolated and cultured##2##4##(1995-8#1)(1997-3#1)
were isolated and further##2##4##(1996-8#1)(2007-8#1)
were isolated and identified as##2##5##(2007-1#1)(2007-2#1)
were isolated and identified##5##4##(1990-5#1)(2007-1#1)(2007-2#1)(2008-10#1)(2008-11#1)
were isolated and partially##2##4##(1993-2#1)(1996-10#1)
were isolated and purified by##3##5##(1992-12#1)(1995-11#1)(2008-9#1)
were isolated and purified from##4##5##(1994-6#1)(2006-8#1)(2008-10#1)(2008-12#1)
were isolated and purified##9##4##(1992-12#1)(1994-6#1)(1995-11#1)(2005-11#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-4#1)
were isolated and sequenced##5##4##(1991-6#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-8#1)
were isolated and the##2##4##(1992-3#1)(2008-1#1)
were isolated and##64##3##(1990-5#1)(1990-8#1)(1991-12#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-8#2)(1996-10#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-7#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-5#1)(2008-8#4)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
were isolated as a##2##4##(1990-2#1)(1997-2#1)
were isolated as##7##3##(1990-2#1)(1994-3#1)(1997-2#1)(2006-12#1)(2007-1#1)(2007-7#1)(2008-11#1)
were isolated at##5##3##(2008-10#4)(2008-12#1)
were isolated by a##3##4##(1991-2#1)(1993-3#1)(2008-10#1)
were isolated by reverse-phase##2##4##(1991-8#1)(1995-2#1)
were isolated by screening a human genomic library with##2##9##(1991-6#1)(1993-7#1)
were isolated by screening##3##4##(1990-5#1)(1991-6#1)(1993-7#1)
were isolated by the##2##4##(1996-10#1)(1997-5#1)
were isolated by##44##3##(1990-12#2)(1990-2#1)(1990-4#2)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-7#1)(1994-8#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-5#1)(2007-1#1)(2007-11#1)(2008-10#4)(2008-11#3)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-1#1)
were isolated for the first time##2##6##(2007-1#1)(2008-5#1)
were isolated for the##4##4##(2007-1#1)(2008-5#1)(2012-12#2)
were isolated for##7##3##(1992-1#1)(2007-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#2)
were isolated from 18 patients with##2##6##(1990-10#1)(2008-2#1)
were isolated from 18##3##4##(1990-10#1)(2008-2#1)(2008-5#1)
were isolated from 2##2##4##(1994-12#1)(2008-10#1)
were isolated from 48##2##4##(1993-8#1)(2007-7#1)
were isolated from Brazilian##2##4##(2008-6#2)
were isolated from Egyptian soil##2##5##(2008-4#1)(2008-6#1)
were isolated from a P1 library of the Arabidopsis thaliana##2##10##(1997-6#1)(1997-8#1)
were isolated from a bovine##2##5##(1992-11#1)(1997-2#1)
were isolated from a human##5##5##(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(2008-11#1)
were isolated from a lambda##2##5##(1991-8#1)(1992-12#1)
were isolated from a##30##4##(1991-8#2)(1992-11#1)(1992-12#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#2)(2006-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2010-6#1)(2011-2#1)(2013-7#1)
were isolated from all##2##4##(2008-10#1)(2008-5#1)
were isolated from an##2##4##(1990-11#1)(1991-1#1)
were isolated from blood##2##4##(1990-10#1)(1992-12#1)
were isolated from both##2##4##(1995-10#1)(2006-9#1)
were isolated from cDNA libraries##2##5##(1990-4#1)(1994-2#1)
were isolated from cDNA##3##4##(1990-4#1)(1991-10#1)(1994-2#1)
were isolated from chickens##2##4##(2005-9#2)
were isolated from diseased##3##4##(2008-10#3)
were isolated from human##10##4##(1991-2#1)(1991-5#1)(1992-1#1)(1992-12#1)(1996-12#1)(2008-11#2)(2008-8#1)(2010-12#1)(2013-8#1)
were isolated from marine##2##4##(2005-11#1)(2011-2#1)
were isolated from pooled##2##4##(1990-2#1)(1991-12#1)
were isolated from rice##2##4##(2008-8#1)(2009-8#1)
were isolated from six##2##4##(1995-4#1)(2008-10#1)
were isolated from soil##2##4##(2005-11#1)(2005-12#1)
were isolated from the aerial parts of##3##7##(2007-1#3)
were isolated from the bark##2##5##(2006-12#1)(2007-1#1)
were isolated from the fruits of##2##6##(2007-1#2)
were isolated from the fruits##3##5##(2007-1#2)(2008-11#1)
were isolated from the leaves of##3##6##(2007-1#1)(2008-8#1)(2011-3#1)
were isolated from the plasma of##2##6##(1991-2#2)
were isolated from the rhizomes of##2##6##(2007-1#1)(2008-11#1)
were isolated from the roots of##3##6##(2006-12#2)(2007-11#1)
were isolated from the same##2##5##(1990-2#1)(1990-5#1)
were isolated from the seeds of##2##6##(2007-1#2)
were isolated from the skin of##2##6##(1992-11#1)(1994-11#1)
were isolated from the whole plants##2##6##(2007-1#2)
were isolated from the whole##3##5##(2007-1#3)
were isolated from the##78##4##(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#2)(1991-9#1)(1992-11#2)(1992-2#1)(1994-11#1)(1994-12#3)(1995-3#1)(1997-6#1)(1997-8#1)(2004-2#1)(2006-12#6)(2006-2#1)(2006-3#2)(2006-5#1)(2006-8#2)(2007-1#22)(2007-10#1)(2007-11#2)(2007-6#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-5#6)(2008-8#2)(2010-12#1)(2010-2#1)(2011-12#1)(2011-3#1)(2012-2#2)(2013-1#1)
were isolated from this##2##4##(2008-10#1)(2011-3#1)
were isolated from three##2##4##(2004-11#1)(2013-8#1)
were isolated from tobacco##3##4##(2008-10#3)
were isolated from two different##2##5##(1994-12#1)(2007-1#1)
were isolated from two##5##4##(1990-8#1)(1992-11#1)(1994-12#1)(2007-1#1)(2008-8#1)
were isolated from##284##3##(1990-10#2)(1990-11#3)(1990-12#1)(1990-2#3)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#2)(1991-2#4)(1991-5#3)(1991-8#3)(1991-9#1)(1992-1#1)(1992-11#5)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#1)(1992-8#2)(1992-9#2)(1993-4#1)(1993-6#3)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#7)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-10#1)(1995-3#2)(1995-4#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#5)(2004-11#1)(2004-2#1)(2005-11#3)(2005-12#1)(2005-9#3)(2006-12#12)(2006-2#1)(2006-3#2)(2006-5#2)(2006-8#3)(2006-9#2)(2007-1#28)(2007-10#1)(2007-11#2)(2007-2#1)(2007-6#1)(2007-7#6)(2007-8#1)(2008-10#43)(2008-11#8)(2008-12#4)(2008-2#1)(2008-4#2)(2008-5#18)(2008-6#5)(2008-7#1)(2008-8#8)(2009-10#1)(2009-3#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#5)(2013-1#5)(2013-7#1)(2013-8#3)
were isolated in a##2##4##(1996-4#1)(2008-10#1)
were isolated in the##2##4##(2007-12#1)(2008-8#1)
were isolated in yields up to##2##6##(2008-5#2)
were isolated in##26##3##(1990-8#2)(1991-7#1)(1992-12#1)(1993-5#1)(1996-4#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-7#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#3)(2008-8#1)(2010-12#1)(2010-2#1)
were isolated into##2##3##(2008-10#1)(2009-12#1)
were isolated on##5##3##(1990-3#1)(1996-5#1)(2006-8#1)(2008-7#1)(2011-2#1)
were isolated that##3##3##(1990-8#1)(1994-11#1)(2008-10#1)
were isolated using##7##3##(1990-7#1)(1992-11#1)(1993-8#1)(1995-3#1)(1997-7#1)(1997-8#1)(2011-2#1)
were isolated with##2##3##(2008-10#1)(2011-1#1)
were isolated##549##2##(1990-10#2)(1990-11#3)(1990-12#3)(1990-2#6)(1990-3#1)(1990-4#4)(1990-5#5)(1990-7#1)(1990-8#6)(1990-9#3)(1991-1#3)(1991-10#3)(1991-12#4)(1991-2#5)(1991-4#1)(1991-5#3)(1991-6#3)(1991-7#2)(1991-8#4)(1991-9#3)(1992-1#4)(1992-10#1)(1992-11#6)(1992-12#6)(1992-2#3)(1992-3#5)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#4)(1992-9#3)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-4#2)(1993-5#2)(1993-6#5)(1993-7#1)(1993-8#3)(1993-9#3)(1994-11#3)(1994-12#9)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#4)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#3)(1995-4#2)(1995-5#2)(1995-8#4)(1996-10#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#4)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#6)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#3)(1997-8#8)(2004-11#1)(2004-2#1)(2005-11#4)(2005-12#1)(2005-9#3)(2006-10#1)(2006-12#16)(2006-2#1)(2006-3#2)(2006-5#2)(2006-8#9)(2006-9#2)(2007-1#37)(2007-10#3)(2007-11#3)(2007-12#1)(2007-2#4)(2007-6#2)(2007-7#11)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#75)(2008-11#16)(2008-12#11)(2008-2#2)(2008-4#4)(2008-5#27)(2008-6#5)(2008-7#5)(2008-8#17)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#2)(2010-1#1)(2010-12#5)(2010-2#2)(2010-4#2)(2010-6#2)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#8)(2011-3#2)(2012-12#4)(2012-2#6)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#6)
were isolates from##2##3##(2008-10#2)
were isolates##3##2##(2008-10#3)
were issued to##2##3##(1992-6#1)(1996-9#1)
were issued##7##2##(1992-6#1)(1993-3#1)(1996-9#1)(2004-9#1)(2007-7#1)(2010-7#1)(2011-2#1)
were joined by a##2##4##(1994-12#1)(2008-7#1)
were joined in##2##3##(1992-9#1)(2007-3#1)
were joined##5##2##(1992-9#1)(1994-12#1)(2007-3#1)(2008-7#1)(2010-8#1)
were judged to be##9##4##(1990-11#1)(1992-12#1)(1996-8#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2013-7#1)
were judged to have##2##4##(2007-7#1)(2009-4#1)
were judged to##11##3##(1990-11#1)(1992-12#1)(1996-8#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-4#1)(2013-7#1)
were judged##20##2##(1990-10#1)(1990-11#1)(1990-6#1)(1990-8#1)(1992-12#1)(1995-2#1)(1996-8#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2011-10#1)(2012-12#1)(2013-7#1)
were just as likely to##2##5##(1990-2#1)(2013-1#1)
were just##4##2##(1990-2#1)(2006-12#1)(2012-12#1)(2013-1#1)
were kept alive##2##3##(2011-2#2)
were kept as##2##3##(1996-12#1)(2013-1#1)
were kept at##4##3##(1995-3#1)(2008-10#1)(2008-11#1)(2008-5#1)
were kept constant##2##3##(1996-6#1)(2004-9#1)
were kept for##3##3##(1996-9#1)(2008-10#1)(2008-3#1)
were kept in a##3##4##(2007-7#1)(2008-12#1)(2008-5#1)
were kept in##14##3##(1997-6#1)(2006-8#1)(2007-1#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-7#1)(2010-3#1)(2011-1#2)(2011-12#1)
were kept##39##2##(1990-9#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-6#1)(2004-9#1)(2006-8#1)(2007-1#1)(2007-7#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#1)(2010-3#1)(2011-1#3)(2011-12#1)(2011-2#2)(2011-3#1)(2013-1#1)
were key factors##2##3##(2007-5#1)(2008-2#1)
were key in##2##3##(1996-3#1)(2008-10#1)
were key##7##2##(1990-12#1)(1996-3#1)(2007-5#1)(2008-10#2)(2008-2#1)(2010-1#1)
were killed 1##2##3##(1993-7#1)(1995-5#1)
were killed 24##2##3##(2007-10#1)(2013-1#1)
were killed 7 days##2##4##(1996-9#1)(2007-10#1)
were killed after##2##3##(1991-2#1)(2008-10#1)
were killed and examined##2##4##(1997-3#1)(2008-5#1)
were killed and##4##3##(1997-3#1)(2008-5#2)(2009-12#1)
were killed at##7##3##(1990-3#1)(1990-4#1)(1994-6#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)
were killed by##9##3##(1990-2#1)(1992-5#1)(1995-12#1)(1995-3#1)(2007-6#2)(2008-10#1)(2008-4#1)(2008-8#1)
were killed for##3##3##(1991-12#1)(2007-1#1)(2008-5#1)
were killed on##2##3##(2006-9#1)(2007-8#1)
were killed with##2##3##(1992-5#1)(1994-12#1)
were killed##49##2##(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-12#1)(1991-2#2)(1992-4#1)(1992-5#2)(1993-7#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-9#1)(1997-3#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-6#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2010-12#1)(2013-1#2)(2013-8#1)
were knowledgeable about##3##3##(2007-3#1)(2008-2#1)(2013-1#1)
were knowledgeable##4##2##(2007-3#1)(2008-2#1)(2013-1#2)
were known to have##2##4##(1992-12#1)(2008-5#1)
were known to##4##3##(1992-12#1)(1993-12#1)(2006-7#1)(2008-5#1)
were known##7##2##(1990-9#1)(1992-12#1)(1993-12#1)(2006-7#1)(2007-1#1)(2008-5#1)(2013-7#1)
were labeled as##2##3##(1993-7#1)(2013-8#1)
were labeled by##6##3##(1991-9#1)(1993-12#2)(1995-6#1)(2008-10#1)(2010-12#1)
were labeled with##16##3##(1990-2#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-8#1)(1993-9#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-12#1)(1997-2#1)(2006-12#1)(2008-4#1)(2009-8#1)
were labeled##43##2##(1990-11#2)(1990-2#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#3)(1992-8#1)(1993-12#2)(1993-7#1)(1993-9#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-6#1)(1996-12#2)(1996-5#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-8#1)(2005-12#1)(2006-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
were labelled in##3##3##(1995-11#1)(1995-12#1)(1997-4#1)
were labelled with##5##3##(1993-2#1)(1993-4#1)(1995-12#1)(1996-11#1)(2013-8#1)
were labelled##13##2##(1991-1#1)(1991-9#1)(1993-2#1)(1993-4#1)(1993-6#1)(1995-11#1)(1995-12#2)(1996-11#1)(1996-5#1)(1997-4#1)(1997-8#1)(2013-8#1)
were lack of##8##3##(2007-1#1)(2007-10#1)(2007-9#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
were lack##9##2##(2007-1#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
were lacking##5##2##(1990-6#1)(1993-12#1)(1995-12#1)(2008-10#2)
were laid##4##2##(2007-1#1)(2007-3#2)(2008-12#1)
were large amounts of##2##4##(1990-11#1)(2008-5#1)
were large and##2##3##(1992-8#1)(2012-11#1)
were large in size##2##4##(2007-9#2)
were large##15##2##(1990-11#1)(1991-7#1)(1992-8#1)(2007-9#2)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#1)(2010-12#1)(2012-11#1)
were largely absent##2##3##(2005-8#1)(2009-7#1)
were largely consistent with##2##4##(1994-10#1)(2008-5#1)
were largely due to##2##4##(1993-7#1)(2008-10#1)
were largely unaffected by##2##4##(1995-8#1)(1996-8#1)
were largely##31##2##(1990-4#2)(1992-8#1)(1993-6#1)(1993-7#1)(1994-10#1)(1994-2#1)(1994-9#2)(1995-3#1)(1995-8#1)(1996-1#1)(1996-8#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-10#1)(2009-7#1)(2010-10#1)(2011-1#1)(2011-2#2)
were larger for##2##3##(2007-8#1)(2012-2#1)
were larger in size##2##4##(1996-2#1)(2008-7#1)
were larger in##8##3##(1990-4#1)(1996-2#1)(2007-4#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-8#1)(2011-12#1)
were larger than the##3##4##(2007-10#1)(2007-3#1)(2010-9#1)
were larger than those in##2##5##(1996-6#1)(2009-7#1)
were larger than those produced in##2##6##(2008-10#2)
were larger than those##7##4##(1991-5#1)(1994-8#1)(1996-6#1)(2006-9#1)(2008-10#2)(2009-7#1)
were larger than##16##3##(1991-5#1)(1993-7#1)(1994-8#1)(1996-6#1)(2006-9#1)(2007-10#1)(2007-3#1)(2007-4#2)(2008-10#2)(2009-7#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#1)
were larger##35##2##(1990-4#1)(1991-5#1)(1992-7#1)(1993-7#1)(1994-8#2)(1996-2#1)(1996-6#1)(1996-9#1)(2006-9#1)(2007-10#1)(2007-3#1)(2007-4#3)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-7#2)(2009-7#1)(2010-12#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#2)
were largest##4##2##(1990-12#1)(1991-11#1)(1992-1#1)(1995-12#1)
were later##7##2##(1992-1#1)(2008-11#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2013-1#1)
were launched##3##2##(2007-11#1)(2008-3#1)(2013-1#1)
were lavaged##2##2##(2008-10#1)(2013-1#1)
were learned##6##2##(1991-2#1)(1996-2#1)(2007-7#1)(2008-12#1)(2010-6#1)(2011-2#1)
were least frequent##2##3##(2008-10#1)(2008-3#1)
were least satisfied##3##3##(1991-4#1)(1993-6#1)(2007-12#1)
were least##13##2##(1991-4#1)(1992-2#1)(1993-6#1)(1995-7#1)(2006-7#1)(2007-10#1)(2007-12#1)(2008-10#5)(2008-3#1)
were led to##2##3##(1992-11#1)(2006-8#1)
were left for##2##3##(2011-2#1)(2013-1#1)
were left in the##2##4##(2007-8#1)(2008-5#1)
were left in##4##3##(2007-8#1)(2008-5#2)(2013-1#1)
were left open##2##3##(2008-11#1)(2008-9#1)
were left to##2##3##(2006-8#1)(2008-2#1)
were left untreated##2##3##(1992-2#1)(1994-6#1)
were left##15##2##(1992-2#1)(1992-9#1)(1994-6#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#2)
were lengthened##3##2##(1993-7#1)(2007-8#2)
were lesioned##3##2##(1990-4#1)(2008-7#1)(2009-2#1)
were less able##2##3##(1990-2#1)(2012-2#1)
were less abundant##2##3##(1994-2#1)(2008-6#1)
were less accurate##2##3##(2008-1#1)(2009-7#1)
were less active than##3##4##(1992-3#1)(1993-3#1)(1994-12#1)
were less active##6##3##(1992-3#1)(1993-3#1)(1994-12#1)(1995-11#1)(1995-5#1)(1997-2#1)
were less affected by##2##4##(2006-4#1)(2008-8#1)
were less affected than##2##4##(1993-12#1)(2008-11#1)
were less affected##6##3##(1993-12#1)(1993-6#1)(2004-4#1)(2006-4#1)(2008-11#1)(2008-8#1)
were less after##2##3##(2008-9#2)
were less common##2##3##(1995-4#1)(2011-2#1)
were less diverse##2##3##(1992-2#1)(2007-5#1)
were less effective against##2##4##(1993-3#1)(2008-10#1)
were less effective in##2##4##(1992-2#1)(1996-2#1)
were less effective than##4##4##(1995-11#1)(1996-5#1)(2007-6#1)(2012-12#1)
were less effective##12##3##(1991-12#1)(1991-8#1)(1992-2#1)(1993-3#1)(1995-11#1)(1995-6#1)(1996-2#1)(1996-5#1)(2007-6#1)(2008-10#2)(2012-12#1)
were less efficient##4##3##(1995-4#1)(2008-10#2)(2009-12#1)
were less frequent in##2##4##(2010-10#1)(2013-1#1)
were less frequent##5##3##(2006-8#1)(2007-3#1)(2008-8#1)(2010-10#1)(2013-1#1)
were less frequently##2##3##(1991-2#1)(2010-5#1)
were less likely than##6##4##(1995-2#1)(1995-6#1)(2005-10#1)(2006-8#1)(2007-9#1)(2010-2#1)
were less likely to be##10##5##(1996-12#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-3#1)(2008-4#1)(2009-5#1)(2009-7#1)(2010-2#1)(2013-8#1)
were less likely to die in acute care##2##8##(2011-2#2)
were less likely to die##3##5##(2007-10#1)(2011-2#2)
were less likely to engage in##2##6##(2009-7#1)(2010-12#1)
were less likely to have a##2##6##(1995-11#1)(1995-12#1)
were less likely to have##6##5##(1994-8#1)(1995-11#1)(1995-12#1)(2006-7#1)(2007-8#1)(2007-9#1)
were less likely to provide##2##5##(1995-12#1)(2011-2#1)
were less likely to receive##2##5##(2011-2#1)(2012-3#1)
were less likely to report##2##5##(1997-2#1)(2012-3#1)
were less likely to##41##4##(1990-12#1)(1993-10#1)(1994-8#1)(1995-11#1)(1995-12#3)(1996-12#1)(1997-2#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#2)(2010-12#1)(2010-2#1)(2011-2#7)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
were less likely##47##3##(1990-12#1)(1993-10#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-6#1)(1996-12#1)(1997-2#1)(2005-10#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#2)(2010-12#1)(2010-2#2)(2011-2#7)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
were less often##3##3##(2007-1#1)(2013-1#1)(2013-7#1)
were less or##2##3##(1994-11#1)(2008-5#1)
were less potent than##3##4##(1994-8#1)(1996-12#1)(1997-7#1)
were less potent##5##3##(1994-6#1)(1994-8#1)(1995-12#1)(1996-12#1)(1997-7#1)
were less prominent##2##3##(1991-5#1)(2009-7#1)
were less pronounced in##2##4##(1996-5#1)(2011-1#1)
were less pronounced than those##2##5##(1996-10#1)(1996-9#1)
were less pronounced##8##3##(1990-2#1)(1992-9#1)(1996-10#1)(1996-5#1)(1996-9#1)(2009-12#1)(2009-9#1)(2011-1#1)
were less sensitive and##2##4##(2010-10#1)(2010-12#1)
were less sensitive to the##3##5##(1995-5#1)(2007-10#1)(2008-10#1)
were less sensitive to##6##4##(1994-6#1)(1995-5#2)(2007-10#1)(2008-10#2)
were less sensitive##8##3##(1994-6#1)(1995-5#2)(2007-10#1)(2008-10#2)(2010-10#1)(2010-12#1)
were less stable##2##3##(1991-8#1)(2008-5#1)
were less strongly##2##3##(1991-9#1)(2010-7#1)
were less susceptible to##2##4##(1996-12#1)(2008-10#1)
were less than 0##7##4##(1992-6#1)(2006-12#1)(2008-10#1)(2008-3#2)(2011-1#1)(2012-3#1)
were less than 1##6##4##(1991-8#1)(2008-10#3)(2010-7#1)(2012-2#1)
were less than 1%##2##4##(1996-5#1)(2008-10#1)
were less than 10%##3##4##(1993-2#1)(1997-3#1)(1997-8#1)
were less than 2##3##4##(1993-2#1)(2008-3#1)(2012-12#1)
were less than 2%##2##4##(2008-10#2)
were less than 20%##3##4##(1996-3#2)(1996-5#1)
were less than 3##7##4##(2004-4#1)(2005-12#1)(2005-4#1)(2008-10#1)(2012-12#1)(2012-3#1)(2013-7#1)
were less than 5%##3##4##(1991-12#1)(1996-8#1)(2005-10#1)
were less than 6##2##4##(2007-8#2)
were less than 6%##3##4##(1990-12#2)(1997-8#1)
were less than the mean of the components##2##8##(2008-10#2)
were less than the##4##4##(1996-12#1)(2008-10#3)
were less than those in##2##5##(1995-12#1)(2007-11#1)
were less than those of the controls##6##7##(2008-8#1)(2008-9#5)
were less than those of the vehicle controls during##2##9##(2008-9#2)
were less than those of the vehicle controls##6##8##(2008-9#6)
were less than those of the vehicle##7##7##(2008-9#7)
were less than those of the##16##6##(1990-5#1)(2008-8#1)(2008-9#14)
were less than those of##19##5##(1990-5#1)(1991-3#1)(1992-6#1)(2008-5#1)(2008-8#1)(2008-9#14)
were less than those##22##4##(1990-5#1)(1991-3#1)(1992-6#1)(1993-8#1)(1995-12#1)(2007-11#1)(2008-5#1)(2008-8#1)(2008-9#14)
were less than##92##3##(1990-12#3)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-6#2)(1992-8#1)(1993-12#1)(1993-2#2)(1993-8#1)(1995-12#1)(1996-12#2)(1996-3#2)(1996-5#2)(1996-8#1)(1997-3#1)(1997-8#2)(2004-4#1)(2005-10#1)(2005-12#1)(2005-4#1)(2005-7#1)(2006-12#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-8#3)(2008-10#17)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#15)(2010-5#1)(2010-7#1)(2011-1#2)(2012-12#4)(2012-2#1)(2012-3#3)(2013-7#1)(2013-8#1)
were less tolerant to##2##4##(2008-10#1)(2009-8#1)
were less tolerant##3##3##(2008-10#1)(2008-11#1)(2009-8#1)
were less toxic to##2##4##(2008-10#1)(2008-5#1)
were less toxic##3##3##(2008-10#1)(2008-5#1)(2010-12#1)
were less virulent##2##3##(2008-10#2)
were less well##2##3##(2008-11#1)(2012-2#1)
were less##290##2##(1990-12#4)(1990-2#3)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#3)(1991-9#2)(1992-1#1)(1992-2#2)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-10#1)(1993-12#2)(1993-2#3)(1993-3#2)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-8#2)(1995-11#3)(1995-12#6)(1995-2#2)(1995-4#2)(1995-5#4)(1995-6#4)(1996-10#1)(1996-12#5)(1996-2#1)(1996-3#2)(1996-5#4)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-7#1)(1997-8#2)(2004-4#2)(2005-10#3)(2005-11#1)(2005-12#1)(2005-4#1)(2005-7#1)(2006-12#1)(2006-4#1)(2006-7#2)(2006-8#4)(2007-1#2)(2007-10#3)(2007-11#3)(2007-2#2)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#44)(2008-11#4)(2008-3#4)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#6)(2008-9#20)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-7#4)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#4)(2010-2#2)(2010-4#1)(2010-5#3)(2010-7#2)(2011-1#5)(2011-2#10)(2012-12#7)(2012-2#4)(2012-3#5)(2013-1#5)(2013-7#2)(2013-8#3)
were liberated by##3##3##(1991-2#2)(2009-8#1)
were liberated##5##2##(1990-2#1)(1991-2#2)(2008-10#1)(2009-8#1)
were licensed##3##2##(1992-1#1)(2005-8#1)(2007-12#1)
were life##2##2##(2008-3#1)(2010-4#1)
were ligated##2##2##(1996-4#1)(2008-4#1)
were light##2##2##(2008-10#2)
were lightly##2##2##(1993-9#1)(2010-4#1)
were like##2##2##(1992-12#1)(2010-6#1)
were likely due to##3##4##(1995-12#1)(2007-7#1)(2008-11#1)
were likely to be##3##4##(2007-12#1)(2008-10#1)(2012-2#1)
were likely to have##2##4##(2006-10#1)(2006-7#1)
were likely to##16##3##(1997-1#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#2)(2008-2#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#1)
were likely##27##2##(1994-7#1)(1995-12#1)(1997-1#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-2#3)(2012-2#2)(2012-3#1)
were likewise##6##2##(1991-7#1)(1994-10#1)(1994-9#1)(2006-5#1)(2008-10#1)(2008-9#1)
were limited by##2##3##(2007-11#1)(2008-9#1)
were limited to the##8##4##(1991-5#1)(1992-7#1)(2008-10#2)(2008-5#2)(2010-2#1)(2012-12#1)
were limited to##15##3##(1990-8#1)(1991-5#1)(1992-7#1)(1996-9#1)(1997-4#1)(1997-8#1)(2007-11#1)(2008-10#4)(2008-5#2)(2010-2#1)(2012-12#1)
were limited##26##2##(1990-8#1)(1991-5#1)(1992-7#1)(1994-2#1)(1996-9#1)(1997-4#1)(1997-8#1)(2004-4#2)(2007-11#2)(2008-10#6)(2008-5#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-2#1)(2011-1#1)(2012-12#2)
were linear (r&gt##2##3##(2008-10#2)
were linear and##2##3##(1993-1#1)(1995-11#1)
were linear between##4##3##(1997-8#1)(2008-10#3)
were linear for##3##3##(1996-6#1)(2008-10#2)
were linear from##3##3##(2008-10#3)
were linear functions of##2##4##(1990-11#1)(2008-10#1)
were linear in the concentration range##3##6##(2007-8#1)(2008-10#2)
were linear in the concentration##5##5##(2007-8#1)(2008-10#4)
were linear in the range from##3##6##(1990-8#2)(2008-10#1)
were linear in the range of##8##6##(2007-8#1)(2008-10#7)
were linear in the range##12##5##(1990-8#2)(2007-8#1)(2008-10#9)
were linear in the ranges##2##5##(2005-12#1)(2008-10#1)
were linear in the##21##4##(1990-8#2)(2005-12#1)(2007-8#2)(2008-10#16)
were linear in##23##3##(1990-8#2)(1992-3#1)(2005-12#1)(2007-8#2)(2008-10#17)
were linear over a wide concentration range from##2##8##(2008-10#2)
were linear over a wide##3##5##(1993-2#1)(2008-10#2)
were linear over the concentration range of 0##2##8##(2008-10#2)
were linear over the concentration range of##3##7##(2008-10#3)
were linear over the range 1-30##2##6##(1996-5#1)(2008-10#1)
were linear over the range of 0##2##7##(2008-10#2)
were linear over the range of##3##6##(1996-8#1)(2008-10#2)
were linear over the range##9##5##(1996-5#1)(1996-8#1)(2008-10#7)
were linear over the##14##4##(1996-5#1)(1996-8#1)(1997-3#1)(2008-10#11)
were linear over##19##3##(1993-2#1)(1996-5#1)(1996-8#1)(1997-3#1)(2008-10#15)
were linear up to##2##4##(2008-10#2)
were linear with time##2##4##(1996-9#1)(2008-3#1)
were linear with##3##3##(1990-12#1)(1996-9#1)(2008-3#1)
were linear within##2##3##(1996-6#1)(2005-12#1)
were linear##72##2##(1990-11#1)(1990-12#2)(1990-8#2)(1992-2#1)(1992-3#1)(1993-1#1)(1993-2#2)(1995-11#1)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-3#1)(1997-8#1)(2005-12#2)(2007-8#3)(2008-10#48)(2008-3#1)
were linearly proportional to the##2##5##(1997-8#1)(2008-10#1)
were linearly related to the##2##5##(1994-11#1)(2008-10#1)
were linearly related to##4##4##(1991-6#1)(1993-12#1)(1994-11#1)(2008-10#1)
were linearly related##5##3##(1991-6#1)(1993-12#1)(1994-11#1)(2008-10#1)(2008-6#1)
were linearly##9##2##(1991-6#1)(1993-12#1)(1994-11#1)(1997-8#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)
were lined by##4##3##(1990-6#2)(1996-6#1)(2008-11#1)
were lined##5##2##(1990-6#2)(1996-6#1)(2006-8#1)(2008-11#1)
were linked by##3##3##(1997-1#1)(2008-9#1)(2010-8#1)
were linked to the chloramphenicol acetyltransferase##2##6##(1992-5#1)(1995-3#1)
were linked to the##8##4##(1992-5#1)(1995-3#1)(1996-12#1)(2008-10#3)(2009-12#1)(2011-2#1)
were linked to##26##3##(1992-10#1)(1992-5#1)(1993-3#1)(1995-3#1)(1996-12#1)(1996-7#1)(2007-2#1)(2007-5#1)(2008-10#7)(2008-11#1)(2008-12#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-2#2)
were linked##33##2##(1990-9#1)(1992-10#1)(1992-5#1)(1993-3#1)(1995-3#1)(1996-12#1)(1996-7#1)(1997-1#1)(2007-2#1)(2007-5#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#2)(2009-12#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-8#3)(2011-1#1)(2011-2#2)
were listed##6##2##(1995-8#1)(2006-12#1)(2008-10#1)(2011-2#1)(2011-3#1)(2013-8#1)
were little affected by##2##4##(1991-10#1)(1993-6#1)
were little##6##2##(1991-10#1)(1993-6#1)(1994-11#1)(1995-7#1)(1997-7#1)(2008-10#1)
were liver##4##2##(1992-8#1)(2011-2#2)(2013-8#1)
were living in##4##3##(1990-12#1)(2006-10#1)(2011-1#1)(2011-2#1)
were living with HIV##2##4##(1992-9#1)(2007-1#1)
were living with a##2##4##(1990-2#1)(2012-12#1)
were living with##6##3##(1990-2#1)(1992-9#1)(2007-1#1)(2008-6#1)(2008-7#1)(2012-12#1)
were living##12##2##(1990-12#1)(1990-2#1)(1992-9#1)(1995-6#1)(2006-10#1)(2007-1#1)(2008-1#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
were loaded in##4##3##(2007-8#1)(2008-12#1)(2009-7#1)(2013-7#1)
were loaded with##11##3##(1990-11#1)(1991-2#1)(1992-5#1)(1994-11#1)(1994-2#1)(1995-6#1)(1996-1#1)(1996-5#1)(1997-2#1)(2006-9#1)(2011-2#1)
were loaded##23##2##(1990-11#1)(1991-2#1)(1992-5#2)(1994-11#1)(1994-2#1)(1995-6#1)(1996-1#1)(1996-5#1)(1997-2#1)(2006-9#2)(2007-8#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-7#1)(2010-7#1)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
were local##6##2##(1994-9#1)(1996-8#1)(2007-11#1)(2007-2#1)(2008-4#1)(2008-6#1)
were localised in the##2##4##(1990-7#1)(2006-8#1)
were localised in##3##3##(1990-7#1)(1996-8#1)(2006-8#1)
were localised##5##2##(1990-7#1)(1992-5#1)(1996-8#1)(2006-8#1)(2007-11#1)
were localized at##3##3##(1996-7#1)(2006-8#1)(2008-10#1)
were localized by##2##3##(1991-6#1)(2008-8#1)
were localized in the##13##4##(1991-12#1)(1992-8#1)(1992-9#2)(1994-12#1)(1995-2#1)(1996-7#1)(2004-11#3)(2008-10#2)(2008-5#1)
were localized in##26##3##(1991-12#1)(1991-7#1)(1991-8#1)(1992-8#1)(1992-9#2)(1993-11#1)(1994-12#2)(1995-2#1)(1995-3#1)(1996-5#1)(1996-7#1)(2004-11#3)(2008-10#7)(2008-5#1)(2008-8#1)(2012-2#1)
were localized to the##3##4##(1994-3#1)(1996-10#1)(2011-11#1)
were localized to##11##3##(1991-5#1)(1991-7#1)(1994-3#1)(1995-3#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-11#1)(2011-11#1)
were localized##55##2##(1990-1#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1992-8#1)(1992-9#2)(1993-10#1)(1993-11#1)(1994-12#2)(1994-3#1)(1995-2#1)(1995-3#2)(1996-10#1)(1996-12#1)(1996-5#1)(1996-7#2)(1997-2#1)(1997-3#1)(1997-4#1)(2004-11#3)(2006-2#1)(2006-8#2)(2007-10#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#4)(2011-11#1)(2012-12#1)(2012-2#1)
were locally##2##2##(2008-6#1)(2012-2#1)
were located at the##8##4##(1990-4#1)(1996-5#1)(1997-3#1)(2005-12#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-7#1)
were located at##10##3##(1990-4#1)(1994-9#1)(1996-5#1)(1997-3#1)(2005-12#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-7#1)(2010-5#1)
were located in the cervical##2##5##(1995-11#1)(2013-8#1)
were located in the same##2##5##(1995-10#1)(2008-5#1)
were located in the##39##4##(1990-11#1)(1990-7#2)(1991-2#1)(1991-8#1)(1992-5#1)(1993-12#1)(1993-9#1)(1994-2#1)(1995-10#1)(1995-11#2)(1996-1#1)(1996-2#1)(1996-9#1)(2005-4#1)(2006-8#2)(2007-11#1)(2007-3#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-4#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
were located in their##2##4##(1996-10#1)(1996-5#1)
were located in##54##3##(1990-11#1)(1990-7#2)(1991-2#1)(1991-8#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-2#1)(1995-10#1)(1995-11#3)(1995-12#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#2)(2005-4#1)(2006-10#1)(2006-8#2)(2007-11#1)(2007-3#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-4#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
were located mainly##2##3##(1990-5#1)(2008-5#1)
were located more##2##3##(1993-2#2)
were located near the##2##4##(2008-10#1)(2010-2#1)
were located near##5##3##(2008-10#2)(2010-2#1)(2012-11#1)(2013-8#1)
were located on chromosome##3##4##(1997-2#1)(2008-8#1)(2010-2#1)
were located on chromosomes 3##2##5##(1997-4#1)(2008-8#1)
were located on chromosomes##3##4##(1996-12#1)(1997-4#1)(2008-8#1)
were located on the##6##4##(1990-4#1)(1991-6#1)(1995-12#1)(1996-12#1)(2009-4#1)(2011-2#1)
were located on##17##3##(1990-4#1)(1991-12#1)(1991-6#1)(1995-12#1)(1996-12#2)(1997-2#1)(1997-4#1)(2006-4#1)(2008-10#3)(2008-8#2)(2009-4#1)(2010-2#1)(2011-2#1)
were located within##2##3##(1996-4#1)(2012-12#1)
were located##121##2##(1990-11#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#2)(1991-12#1)(1991-2#2)(1991-6#1)(1991-8#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-2#3)(1994-9#1)(1995-10#2)(1995-11#3)(1995-12#2)(1996-1#2)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-8#1)(1996-9#2)(1997-2#3)(1997-3#1)(1997-4#1)(2005-12#1)(2005-4#1)(2006-10#1)(2006-4#2)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#2)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#1)(2009-2#1)(2009-4#2)(2009-7#1)(2010-2#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#5)
were log##2##2##(2008-10#1)(2011-2#1)
were long##3##2##(1991-5#1)(2008-10#1)(2010-8#1)
were longer than in##2##4##(2004-1#1)(2011-1#1)
were longer than those##2##4##(2008-10#1)(2011-2#1)
were longer than##5##3##(2004-1#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
were longer##6##2##(2004-1#1)(2008-10#2)(2011-1#1)(2011-2#1)(2012-2#1)
were loss of weight##2##4##(1990-9#1)(2008-3#1)
were loss of##3##3##(1990-9#1)(2006-4#1)(2008-3#1)
were lost to follow up##4##5##(1993-12#1)(1996-3#1)(2006-8#1)(2011-2#1)
were lost to follow-up##10##4##(1991-12#2)(1992-4#1)(1993-12#1)(2007-11#1)(2008-11#1)(2009-3#1)(2010-7#1)(2013-1#2)
were lost to##15##3##(1991-12#2)(1992-4#1)(1993-12#2)(1996-3#1)(2006-8#1)(2007-11#1)(2008-11#2)(2009-3#1)(2010-7#1)(2011-2#1)(2013-1#2)
were lost##27##2##(1990-3#3)(1991-12#2)(1991-9#1)(1992-4#1)(1993-12#2)(1994-5#1)(1994-8#1)(1995-2#1)(1996-3#1)(1996-8#1)(2005-4#1)(2006-8#1)(2007-11#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-2#1)(2009-3#1)(2010-7#1)(2011-2#1)(2013-1#2)
were low (&lt##2##3##(2007-2#1)(2008-10#1)
were low affinity (Kd = 0##2##6##(1994-8#2)
were low affinity##3##3##(1992-12#1)(1994-8#2)
were low and not##3##4##(1995-10#1)(1995-11#1)(2007-5#1)
were low and##6##3##(1995-10#1)(1995-11#1)(2007-10#1)(2007-5#1)(2009-5#1)(2011-2#1)
were low at##2##3##(2007-10#1)(2008-7#1)
were low compared to##2##4##(2010-8#1)(2011-1#1)
were low compared##3##3##(2008-10#1)(2010-8#1)(2011-1#1)
were low during##2##3##(1995-12#1)(1996-2#1)
were low enough##2##3##(1995-3#1)(1995-8#1)
were low in all##3##4##(2007-10#1)(2007-5#1)(2008-10#1)
were low in##7##3##(1992-6#1)(1995-3#1)(2007-10#1)(2007-3#1)(2007-5#1)(2008-10#2)
were low to moderate##2##4##(2008-10#1)(2010-4#1)
were low to##3##3##(2008-10#2)(2010-4#1)
were low whereas##2##3##(1990-4#1)(2008-5#1)
were low##64##2##(1990-2#1)(1990-4#2)(1990-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#2)(1994-8#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-2#1)(1997-8#1)(2004-4#1)(2004-9#1)(2006-9#1)(2007-10#3)(2007-2#1)(2007-3#2)(2007-5#3)(2008-10#10)(2008-5#2)(2008-7#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
were lower (P &lt##3##4##(1995-7#1)(2006-5#1)(2010-2#1)
were lower (P##4##3##(1991-8#1)(1995-7#1)(2006-5#1)(2010-2#1)
were lower after##4##3##(1996-5#1)(2008-4#2)(2009-9#1)
were lower age and good mobility##2##6##(2006-7#2)
were lower age##3##3##(2006-7#3)
were lower and##3##3##(2008-12#1)(2008-4#1)(2010-8#1)
were lower at##4##3##(1994-2#1)(2008-10#1)(2013-1#1)(2013-8#1)
were lower by##3##3##(2006-10#1)(2007-6#1)(2007-7#1)
were lower for movements into##2##5##(1996-9#2)
were lower for##11##3##(1993-2#1)(1995-1#1)(1996-9#2)(1997-2#1)(2005-10#1)(2006-10#1)(2008-12#1)(2008-5#1)(2009-4#1)(2011-2#1)
were lower in all##3##4##(1991-6#1)(1997-5#1)(2008-4#1)
were lower in men than in women##2##7##(2006-12#1)(2011-1#1)
were lower in patients##2##4##(1993-1#1)(2007-8#1)
were lower in the##13##4##(1990-3#1)(2006-10#1)(2006-5#1)(2007-10#2)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-12#1)
were lower in##41##3##(1990-3#1)(1991-12#1)(1991-6#2)(1993-1#1)(1994-12#1)(1994-6#1)(1995-12#2)(1997-2#1)(1997-5#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-10#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#2)(2013-8#2)
were lower than 0##2##4##(2008-10#2)
were lower than 2%##2##4##(2008-10#2)
were lower than 3##3##4##(2008-10#3)
were lower than Control##2##4##(1994-2#1)(2011-1#1)
were lower than for##4##4##(2006-5#1)(2007-8#1)(2008-10#1)(2008-4#1)
were lower than in controls##2##5##(1992-11#1)(2008-7#1)
were lower than in the##5##5##(1992-8#1)(1994-3#1)(1996-10#1)(2008-12#1)(2013-1#1)
were lower than in those##2##5##(2011-2#2)
were lower than in##15##4##(1990-11#1)(1992-11#1)(1992-4#1)(1992-8#1)(1994-3#1)(1996-10#1)(1996-8#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-2#1)(2011-2#2)(2013-1#1)
were lower than that in##2##5##(1990-5#1)(2008-10#1)
were lower than that##3##4##(1990-5#1)(2005-10#1)(2008-10#1)
were lower than the##7##4##(1995-10#1)(1996-9#2)(1997-3#1)(2007-7#1)(2010-8#1)(2011-1#1)
were lower than those for##3##5##(1990-10#1)(1993-9#1)(2006-12#1)
were lower than those in the##2##6##(1992-12#1)(2010-12#1)
were lower than those in##5##5##(1992-12#1)(1994-5#2)(2008-12#1)(2010-12#1)
were lower than those of##7##5##(1993-9#1)(1995-8#1)(1996-1#1)(2005-10#1)(2006-12#1)(2008-10#1)(2012-1#1)
were lower than those##17##4##(1990-10#1)(1990-8#1)(1992-12#1)(1993-9#2)(1994-5#2)(1995-8#1)(1996-1#1)(2005-10#1)(2006-12#2)(2008-10#1)(2008-12#1)(2010-12#1)(2012-1#1)(2013-1#1)
were lower than##74##3##(1990-10#1)(1990-11#1)(1990-5#1)(1990-8#1)(1990-9#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-3#1)(1993-9#2)(1994-2#1)(1994-3#1)(1994-5#2)(1995-1#1)(1995-10#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#1)(2005-10#2)(2006-12#2)(2006-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#22)(2008-12#2)(2008-4#1)(2008-7#1)(2009-2#1)(2010-12#2)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#2)(2013-1#3)
were lower using##2##3##(1991-8#1)(2013-7#1)
were lower##175##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-6#2)(1991-8#2)(1992-11#1)(1992-12#2)(1992-4#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-9#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#1)(1995-1#2)(1995-10#1)(1995-12#2)(1995-3#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-5#1)(1996-8#1)(1996-9#4)(1997-2#3)(1997-3#1)(1997-5#1)(2005-10#3)(2005-4#1)(2006-10#3)(2006-12#3)(2006-5#3)(2006-6#1)(2006-7#3)(2007-10#2)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-10#29)(2008-11#1)(2008-12#5)(2008-3#1)(2008-4#7)(2008-5#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-8#2)(2009-9#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-8#4)(2011-1#5)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#1)(2013-1#6)(2013-7#1)(2013-8#4)
were lowered##7##2##(1990-12#1)(1991-2#1)(1993-8#1)(2007-10#1)(2008-10#1)(2008-11#1)(2012-2#1)
were lowest at##2##3##(2007-5#1)(2008-10#1)
were lowest for##3##3##(2005-10#1)(2008-9#1)(2009-10#1)
were lowest##7##2##(2005-10#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-9#1)(2009-10#1)
were lung##2##2##(2008-7#1)(2011-2#1)
were luted##2##2##(2004-9#1)(2013-8#1)
were lyophilized##2##2##(2008-10#2)
were lysed##3##2##(1993-9#1)(1994-6#1)(1995-3#1)
were macroscopically##2##2##(2007-10#1)(2013-1#1)
were made according to the##2##5##(2005-4#1)(2012-3#1)
were made according##3##3##(2005-4#1)(2010-8#1)(2012-3#1)
were made across##2##3##(2010-3#1)(2012-12#1)
were made after##2##3##(2006-8#1)(2007-8#1)
were made and##6##3##(2007-2#1)(2007-3#1)(2008-10#1)(2008-12#1)(2011-1#1)(2011-2#1)
were made as##2##3##(2006-10#1)(2011-12#1)
were made at##10##3##(1990-7#1)(1991-10#1)(1995-7#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)
were made based on##3##4##(1990-11#1)(2008-5#1)(2010-10#1)
were made before##2##3##(1992-5#1)(1994-6#1)
were made between the##3##4##(1992-2#1)(1994-11#1)(2004-10#1)
were made between these##2##4##(2006-8#1)(2008-10#1)
were made between##12##3##(1991-7#1)(1992-2#1)(1992-9#1)(1994-11#1)(2004-10#1)(2006-8#1)(2008-10#4)(2009-12#1)(2012-1#1)
were made by means of##2##5##(2007-11#1)(2008-2#1)
were made by using##3##4##(2008-10#3)
were made by##28##3##(1991-3#1)(1992-10#1)(1992-2#1)(1992-9#1)(1994-12#1)(1994-3#1)(1995-11#1)(2007-11#3)(2007-8#1)(2008-10#10)(2008-2#1)(2008-5#1)(2008-7#2)(2008-9#1)(2012-12#1)(2012-2#1)
were made directly##2##3##(2008-11#1)(2008-9#1)
were made during##5##3##(1990-2#1)(1996-1#1)(2006-12#1)(2008-10#1)(2008-4#1)
were made for each##3##4##(2008-10#2)(2010-2#1)
were made for the##3##4##(1996-3#1)(2008-3#1)(2012-12#1)
were made for##25##3##(1993-4#1)(1994-3#1)(1996-3#1)(1996-5#1)(1997-4#2)(2006-8#1)(2007-1#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#2)(2010-2#1)(2010-5#1)(2012-11#1)(2012-12#1)(2013-1#2)
were made from a##2##4##(1993-12#1)(2009-7#1)
were made from the##3##4##(1995-12#2)(1997-3#1)
were made from##31##3##(1991-6#1)(1991-8#2)(1992-1#1)(1992-8#2)(1993-12#1)(1995-12#3)(1995-2#1)(1995-7#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-6#1)(2008-10#7)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-8#1)(2011-2#1)(2013-7#1)
were made in a##3##4##(1997-4#1)(2008-10#1)(2008-3#1)
were made in different##2##4##(2008-10#1)(2012-12#1)
were made in order to##3##5##(2006-11#1)(2008-11#1)(2012-7#1)
were made in real time##2##5##(1995-11#1)(2008-10#1)
were made in the##13##4##(1991-9#1)(1992-3#1)(1994-10#1)(1995-8#1)(1996-3#1)(1997-1#1)(2006-8#1)(2006-9#1)(2008-3#2)(2008-7#1)(2009-5#1)(2009-7#1)
were made in##42##3##(1990-4#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-6#1)(1994-10#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-9#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-3#5)(2008-5#2)(2008-7#1)(2009-5#1)(2009-7#1)(2012-12#1)(2012-7#1)
were made into the##2##4##(1992-10#1)(1996-5#1)
were made into##3##3##(1992-10#1)(1996-5#1)(2008-9#1)
were made of the##6##4##(1990-5#1)(1991-11#1)(1991-3#1)(1997-8#1)(2008-10#1)(2012-2#1)
were made of##17##3##(1990-5#1)(1991-11#1)(1991-3#1)(1991-7#1)(1993-12#1)(1994-7#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-8#1)(2004-9#1)(2007-8#1)(2008-10#1)(2008-3#2)(2012-2#1)(2012-3#1)
were made on the##4##4##(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)
were made on##13##3##(1992-6#1)(1993-12#1)(1994-11#1)(2007-9#2)(2008-10#3)(2008-3#2)(2008-5#2)(2013-7#1)
were made over a period of##2##6##(2008-10#1)(2009-5#1)
were made over a##3##4##(2008-10#1)(2008-5#1)(2009-5#1)
were made over##5##3##(2008-10#2)(2008-5#1)(2009-5#1)(2010-8#1)
were made regarding##2##3##(2008-3#1)(2011-2#1)
were made that##2##3##(1994-2#1)(2008-11#1)
were made to identify##2##4##(2007-11#1)(2012-1#1)
were made to reduce the##2##5##(1993-3#1)(2008-2#1)
were made to the##5##4##(1993-6#1)(1995-8#1)(2006-2#1)(2008-12#1)(2009-7#1)
were made to##37##3##(1990-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-7#1)(1995-8#1)(1996-3#1)(1997-5#1)(2005-7#1)(2005-8#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-2#3)(2008-10#5)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2009-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
were made under##3##3##(1990-10#1)(2007-11#1)(2008-3#1)
were made up of##2##4##(1992-8#1)(2009-5#1)
were made up##3##3##(1992-8#1)(2008-5#1)(2009-5#1)
were made using a##5##4##(1994-11#1)(1995-11#1)(2008-10#2)(2008-5#1)
were made using both##2##4##(2008-10#2)
were made using##20##3##(1991-5#1)(1993-8#1)(1994-11#1)(1995-1#1)(1995-11#1)(2004-1#1)(2004-3#1)(2007-5#2)(2008-10#8)(2008-11#1)(2008-5#1)(2008-7#1)
were made with a##2##4##(1991-3#1)(1995-5#1)
were made with the##4##4##(1996-9#1)(2005-11#1)(2007-5#1)(2008-7#1)
were made with##18##3##(1991-3#1)(1991-4#1)(1992-8#1)(1995-5#1)(1995-7#1)(1996-9#1)(1997-1#1)(2005-11#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-7#1)
were made within##2##3##(2006-8#1)(2008-10#1)
were made##379##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#2)(1991-3#4)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#4)(1992-9#2)(1993-12#4)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#5)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#5)(1995-2#1)(1995-5#2)(1995-7#4)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#4)(1996-5#3)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#1)(1997-8#2)(1997-9#1)(2004-1#2)(2004-10#1)(2004-3#1)(2004-4#1)(2004-9#2)(2005-11#1)(2005-4#2)(2005-7#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#5)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#7)(2007-12#2)(2007-2#5)(2007-3#2)(2007-4#1)(2007-5#5)(2007-6#1)(2007-7#1)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#67)(2008-11#8)(2008-12#5)(2008-2#11)(2008-3#18)(2008-4#1)(2008-5#18)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#6)(2009-10#1)(2009-12#2)(2009-5#4)(2009-7#3)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#3)(2012-3#3)(2012-7#1)(2013-1#6)(2013-7#3)(2013-8#5)
were mailed to##3##3##(2005-12#1)(2006-10#1)(2007-10#1)
were mailed##8##2##(1991-8#1)(1993-12#1)(1993-3#1)(2005-12#1)(2006-10#1)(2007-10#1)(2008-1#1)(2010-11#1)
were mainly associated with##2##4##(2008-10#1)(2011-3#1)
were mainly available in the##2##5##(2005-11#2)
were mainly distributed##3##3##(1991-9#1)(1993-12#1)(1996-9#1)
were mainly due to##3##4##(1997-8#1)(2007-3#1)(2008-5#1)
were mainly found##3##3##(1995-7#1)(2007-3#1)(2013-7#1)
were mainly in the##2##4##(2008-5#1)(2008-8#1)
were mainly located##2##3##(2008-9#1)(2011-2#1)
were mainly observed in##3##4##(2007-9#1)(2008-10#1)(2009-5#1)
were mainly##60##2##(1990-10#1)(1990-5#2)(1991-12#1)(1991-5#1)(1991-9#2)(1992-9#1)(1993-12#1)(1994-12#2)(1995-7#2)(1996-6#1)(1996-9#1)(1997-8#2)(2004-1#1)(2005-11#2)(2005-12#1)(2006-10#1)(2006-12#1)(2007-2#2)(2007-3#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-11#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#3)
were maintained at 37 degrees C##3##6##(1992-6#2)(1996-5#1)
were maintained at the##2##4##(2008-7#1)(2010-4#1)
were maintained at##12##3##(1992-6#3)(1994-5#1)(1996-5#1)(2008-10#3)(2008-7#1)(2009-3#1)(2009-4#1)(2010-4#1)
were maintained by##2##3##(1992-11#1)(2011-2#1)
were maintained during##3##3##(2011-2#1)(2012-12#2)
were maintained for 6##2##4##(1996-5#1)(2008-10#1)
were maintained for at least##3##5##(1993-4#1)(2007-2#1)(2013-1#1)
were maintained for##16##3##(1990-6#1)(1993-4#1)(1994-2#1)(1996-5#1)(2006-5#1)(2006-6#1)(2007-2#1)(2008-10#1)(2008-11#3)(2008-12#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
were maintained in a##2##4##(1991-9#1)(2008-10#1)
were maintained in the laboratory##2##5##(2008-9#1)(2012-12#1)
were maintained in the##5##4##(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2012-12#1)
were maintained in##15##3##(1991-9#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-12#1)(2012-12#1)(2013-1#2)
were maintained on##9##3##(1994-8#1)(1995-2#1)(1997-4#1)(2006-11#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-8#1)
were maintained under##3##3##(2008-11#2)(2012-12#1)
were maintained with##3##3##(1990-4#1)(2008-10#1)(2010-4#1)
were maintained##88##2##(1990-4#1)(1990-6#1)(1991-9#1)(1992-11#1)(1992-6#3)(1993-4#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-4#1)(1996-5#2)(1997-4#7)(2006-10#1)(2006-11#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-2#3)(2007-8#1)(2007-9#1)(2008-10#12)(2008-11#7)(2008-12#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#5)(2013-1#4)(2013-7#1)(2013-8#1)
were major components##2##3##(2005-12#2)
were major##15##2##(1992-5#1)(1992-8#1)(1994-11#1)(2004-11#1)(2005-12#2)(2007-3#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
were malaria##2##2##(1991-12#1)(2008-1#1)
were male and##4##3##(1991-3#1)(2010-5#1)(2013-1#2)
were male with mean age of##2##6##(2007-6#2)
were male with##3##3##(2007-6#2)(2013-1#1)
were male##40##2##(1990-9#1)(1991-3#1)(1994-3#1)(1997-8#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-2#1)(2007-6#2)(2007-8#4)(2007-9#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2010-1#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#1)
were males and six##2##4##(1990-2#1)(2007-7#1)
were males and##23##3##(1990-2#1)(1991-2#1)(1991-6#1)(1992-4#1)(1993-10#1)(2006-12#1)(2006-6#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-5#2)(2008-8#1)(2010-4#1)(2011-1#2)(2011-12#1)(2012-2#1)(2013-8#2)
were males##49##2##(1990-10#1)(1990-2#1)(1991-2#1)(1991-6#1)(1992-4#1)(1993-10#1)(1993-12#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-7#3)(2007-8#2)(2008-1#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-12#2)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
were malignant##8##2##(1991-10#1)(1992-5#1)(1993-8#1)(1994-3#1)(2007-3#1)(2007-6#1)(2008-6#1)(2013-8#1)
were manageable##2##2##(2008-10#1)(2010-12#1)
were managed according to##2##4##(2007-8#1)(2008-10#1)
were managed as outpatients##2##4##(1994-2#1)(2007-2#1)
were managed as##3##3##(1992-1#1)(1994-2#1)(2007-2#1)
were managed by##7##3##(1992-8#1)(2007-7#3)(2007-8#1)(2008-10#1)(2013-1#1)
were managed conservatively##3##3##(2007-3#1)(2008-11#1)(2013-1#1)
were managed in##2##3##(2007-8#1)(2009-10#1)
were managed using the##2##4##(2006-8#1)(2008-3#1)
were managed using##5##3##(2006-8#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#1)
were managed with the##2##4##(2007-11#1)(2007-9#1)
were managed with##7##3##(2007-11#1)(2007-9#1)(2008-7#2)(2011-2#1)(2013-1#2)
were managed##33##2##(1992-1#1)(1992-8#1)(1994-2#1)(1994-9#1)(1997-3#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#3)(2009-10#1)(2011-2#3)(2013-1#4)(2013-7#1)
were manifest in##2##3##(1991-3#1)(1995-5#1)
were manifested by the##2##4##(2008-5#1)(2009-4#1)
were manifested by##3##3##(2008-5#1)(2009-4#1)(2012-1#1)
were manifested##4##2##(2008-5#1)(2009-4#1)(2012-1#2)
were manipulated in##2##3##(2008-10#1)(2012-3#1)
were manipulated##6##2##(1994-6#1)(2008-10#2)(2010-10#1)(2012-12#1)(2012-3#1)
were manually##2##2##(2008-10#1)(2008-6#1)
were manufactured and##2##3##(2006-6#1)(2008-2#1)
were manufactured by##2##3##(2008-10#1)(2008-2#1)
were manufactured in##2##3##(2007-7#2)
were manufactured##10##2##(2006-6#1)(2007-7#2)(2008-10#1)(2008-2#2)(2008-5#1)(2009-11#1)(2010-12#1)(2010-4#1)
were many##12##2##(1992-7#1)(1996-10#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-8#1)(2012-3#2)
were mapped at##2##3##(2008-10#2)
were mapped by##2##3##(1996-5#1)(2008-10#1)
were mapped in the##2##4##(1994-12#1)(2008-5#1)
were mapped in##5##3##(1994-12#2)(2008-10#2)(2008-5#1)
were mapped on the##5##4##(1996-4#1)(1996-8#1)(1997-8#1)(2008-8#1)(2013-8#1)
were mapped on##6##3##(1996-10#1)(1996-4#1)(1996-8#1)(1997-8#1)(2008-8#1)(2013-8#1)
were mapped to a##2##4##(1993-12#1)(2006-12#1)
were mapped to##9##3##(1992-3#1)(1993-12#1)(1993-3#1)(1996-3#1)(2006-12#3)(2008-10#1)(2013-1#1)
were mapped using##2##3##(1996-10#1)(2008-5#1)
were mapped##34##2##(1992-3#1)(1993-12#1)(1993-3#1)(1994-12#2)(1995-2#1)(1996-10#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-12#3)(2007-11#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-8#2)(2011-1#1)(2013-1#1)(2013-8#1)
were marginally##2##2##(2007-2#1)(2008-10#1)
were marked and##2##3##(2008-5#1)(2008-8#1)
were marked##9##2##(1991-8#1)(1992-9#1)(1994-11#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-11#1)(2013-1#1)
were markedly altered##2##3##(2008-10#2)
were markedly decreased in##2##4##(1991-4#1)(2008-10#1)
were markedly decreased##7##3##(1990-2#1)(1991-4#1)(1995-11#1)(2005-7#1)(2008-10#2)(2008-8#1)
were markedly different##2##3##(2008-4#1)(2008-5#1)
were markedly diminished##2##3##(1995-2#1)(2010-5#1)
were markedly elevated in##3##4##(1993-5#1)(2009-9#1)(2012-12#1)
were markedly elevated##4##3##(1990-4#1)(1993-5#1)(2009-9#1)(2012-12#1)
were markedly improved##2##3##(1992-6#1)(2010-4#1)
were markedly increased##6##3##(1990-5#1)(1991-3#1)(1991-9#1)(1994-11#1)(1994-6#1)(2011-11#1)
were markedly inhibited##4##3##(1990-11#1)(1990-5#2)(2008-10#1)
were markedly lower than##2##4##(2008-10#1)(2013-7#1)
were markedly lower##3##3##(2008-10#1)(2010-4#1)(2013-7#1)
were markedly more##2##3##(1995-5#1)(1997-3#1)
were markedly reduced in##2##4##(2007-2#1)(2007-8#1)
were markedly reduced##4##3##(1994-12#1)(1996-2#1)(2007-2#1)(2007-8#1)
were markedly##53##2##(1990-11#1)(1990-2#2)(1990-4#1)(1990-5#3)(1991-12#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-6#2)(1993-5#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-3#1)(2005-7#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-4#1)(2008-5#3)(2008-8#1)(2009-9#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-11#1)(2012-12#2)(2013-1#1)(2013-7#2)(2013-8#1)
were married and##2##3##(2007-2#1)(2011-2#1)
were married or##3##3##(1991-12#1)(1994-6#1)(2007-12#1)
were married to men##2##4##(1994-6#2)
were married##17##2##(1991-12#1)(1994-6#3)(1996-5#1)(2007-12#4)(2007-2#1)(2007-6#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
were masked##3##2##(2008-10#1)(2010-8#1)(2013-1#1)
were mass scaled##2##3##(2006-11#2)
were matched according to##4##4##(1993-12#1)(2005-8#1)(2008-5#2)
were matched by##3##3##(1992-10#1)(2013-1#2)
were matched for age and##3##5##(1995-6#1)(2007-9#1)(2011-2#1)
were matched for age##6##4##(1995-6#1)(1996-3#1)(2007-3#1)(2007-9#1)(2008-8#1)(2011-2#1)
were matched for sex##2##4##(2006-9#1)(2008-3#1)
were matched for##13##3##(1991-12#1)(1993-4#1)(1995-6#1)(1996-3#1)(2006-3#1)(2006-9#1)(2007-3#1)(2007-9#1)(2008-3#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#1)
were matched to the##2##4##(2006-12#1)(2012-12#1)
were matched to##7##3##(1991-7#1)(2006-12#1)(2007-10#1)(2008-11#1)(2008-9#1)(2009-2#1)(2012-12#1)
were matched with##8##3##(1993-1#1)(1995-2#1)(1995-9#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-7#1)(2011-2#1)
were matched##38##2##(1991-12#1)(1991-7#1)(1992-10#1)(1993-1#1)(1993-12#1)(1993-4#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-3#1)(2005-8#1)(2006-12#1)(2006-3#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-3#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-7#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2013-1#2)
were mated##4##2##(1992-3#2)(2008-10#2)
were mature at 8 weeks##3##5##(2007-7#3)
were mature at##4##3##(2007-7#4)
were mature##8##2##(2007-7#4)(2008-10#1)(2008-5#3)
were matured##2##2##(2006-5#2)
were maximal at##4##3##(1990-10#1)(1992-6#1)(1995-3#1)(2007-10#1)
were maximally##2##2##(1993-3#1)(1994-12#1)
were maximum##2##2##(2008-12#1)(2010-7#1)
were measured after the##4##4##(2007-2#1)(2008-11#1)(2009-5#1)(2012-12#1)
were measured after##17##3##(1992-12#1)(1993-3#1)(1993-7#1)(1995-1#1)(1997-1#1)(1997-8#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-8#1)
were measured along##4##3##(2005-11#1)(2007-12#1)(2007-6#1)(2013-7#1)
were measured and analyzed##4##4##(2006-9#1)(2008-12#1)(2009-10#1)(2013-8#1)
were measured and compared between##2##5##(1995-12#1)(2011-2#1)
were measured and compared to##3##5##(2007-12#1)(2007-8#1)(2008-3#1)
were measured and compared with values##2##6##(1997-2#1)(2008-3#1)
were measured and compared with##5##5##(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-9#1)
were measured and compared##11##4##(1995-12#1)(1997-2#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-9#1)(2011-2#1)
were measured and evaluated##2##4##(2006-11#1)(2008-10#1)
were measured and found to be##2##6##(2005-11#1)(2012-3#1)
were measured and found to##3##5##(2005-11#1)(2007-11#1)(2012-3#1)
were measured and the##3##4##(2006-7#1)(2008-10#1)(2010-10#1)
were measured and their##2##4##(2007-12#1)(2008-10#1)
were measured and used to##2##5##(1996-2#1)(2008-10#1)
were measured and##42##3##(1991-3#1)(1992-8#1)(1993-12#1)(1994-3#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-8#1)(2005-11#1)(2006-11#2)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
were measured as a function of##5##6##(1996-5#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-3#1)
were measured as the##3##4##(1990-4#1)(2007-8#1)(2008-10#1)
were measured as##18##3##(1990-4#1)(1992-3#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-5#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-3#1)(2013-1#1)
were measured at a##2##4##(2008-10#1)(2008-3#1)
were measured at baseline and after##2##6##(2007-9#1)(2013-7#1)
were measured at baseline and at the##2##7##(2008-3#2)
were measured at baseline and##5##5##(2007-8#1)(2007-9#1)(2008-3#2)(2013-7#1)
were measured at different##2##4##(1996-12#1)(2012-12#1)
were measured at four##4##4##(2008-11#1)(2008-3#1)(2010-5#1)(2013-3#1)
were measured at specific##2##4##(2007-9#1)(2008-7#1)
were measured at the##9##4##(1991-10#1)(2006-11#1)(2007-10#2)(2008-10#2)(2008-3#1)(2010-7#1)(2012-4#1)
were measured at##56##3##(1990-2#2)(1990-8#1)(1991-10#1)(1993-11#1)(1994-9#1)(1995-11#1)(1996-12#1)(1996-5#1)(1996-9#1)(2005-11#1)(2005-8#1)(2006-11#1)(2006-2#1)(2007-10#2)(2007-12#2)(2007-8#1)(2007-9#2)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#7)(2008-7#1)(2009-2#1)(2010-2#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-4#1)(2013-1#1)(2013-3#1)(2013-7#1)(2013-8#2)
were measured before and after 4##2##6##(1996-4#1)(2008-3#1)
were measured before and after##6##5##(1996-4#1)(1996-8#1)(2008-3#1)(2009-5#1)(2011-1#1)(2012-2#1)
were measured before and at 1##2##6##(2007-8#2)
were measured before and at##3##5##(2007-8#2)(2008-3#1)
were measured before and##11##4##(1992-6#1)(1992-7#1)(1996-4#1)(1996-8#1)(2007-8#2)(2008-3#2)(2009-5#1)(2011-1#1)(2012-2#1)
were measured before##21##3##(1992-6#1)(1992-7#1)(1996-4#1)(1996-8#1)(2006-10#2)(2007-11#1)(2007-8#3)(2008-3#2)(2009-3#1)(2009-5#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#2)
were measured between##3##3##(1992-10#1)(1995-10#1)(2012-3#1)
were measured by ELISA##5##4##(2007-2#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)
were measured by RIA##4##4##(1991-12#1)(1991-6#1)(2006-5#1)(2006-6#1)
were measured by a fluorescence##2##5##(1997-2#1)(2007-8#1)
were measured by a##12##4##(1990-4#1)(1991-4#1)(1997-2#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#2)(2011-3#1)(2012-1#1)
were measured by an##7##4##(1992-2#1)(1993-12#2)(1993-2#1)(1996-11#1)(2006-10#1)(2007-2#1)
were measured by direct##2##4##(1990-5#1)(2008-10#1)
were measured by enzyme##2##4##(1996-9#1)(2006-2#1)
were measured by enzyme-linked##2##4##(2005-8#1)(2011-2#1)
were measured by gas##3##4##(1990-9#1)(1994-3#1)(2008-7#1)
were measured by high performance liquid chromatography##3##7##(1994-6#1)(1995-10#1)(2004-11#1)
were measured by in vivo##2##5##(1995-3#1)(1996-6#1)
were measured by in##4##4##(1995-3#1)(1996-12#1)(1996-6#1)(2008-10#1)
were measured by means of##3##5##(1996-2#1)(1996-9#1)(2008-10#1)
were measured by spectrophotometry##2##4##(2008-7#1)(2012-1#1)
were measured by the##7##4##(1992-3#1)(2007-12#1)(2008-10#3)(2011-1#1)(2012-12#1)
were measured by use of##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
were measured by using##7##4##(2008-10#1)(2008-2#1)(2008-5#1)(2010-7#1)(2013-8#3)
were measured by##120##3##(1990-11#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-12#2)(1993-2#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-6#1)(1996-9#2)(1997-2#2)(1997-4#1)(2004-11#1)(2005-11#1)(2005-4#1)(2005-8#1)(2006-10#2)(2006-2#3)(2006-5#1)(2006-6#1)(2007-12#3)(2007-2#2)(2007-7#1)(2007-8#4)(2008-10#16)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-9#2)(2010-12#2)(2010-4#1)(2010-7#2)(2011-1#4)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#6)
were measured directly##3##3##(1996-4#1)(2008-10#2)
were measured during the##2##4##(1991-2#1)(1992-2#1)
were measured during##9##3##(1990-10#1)(1990-4#1)(1991-2#1)(1992-2#1)(2007-10#1)(2007-5#1)(2010-8#1)(2012-1#1)(2013-1#1)
were measured every##5##3##(2006-10#1)(2007-2#1)(2008-7#1)(2012-3#1)(2013-1#1)
were measured following##2##3##(1995-5#1)(2008-10#1)
were measured for a##3##4##(1990-3#1)(2007-12#1)(2007-5#1)
were measured for each##5##4##(1995-11#1)(2004-11#1)(2005-11#1)(2012-12#1)(2013-7#1)
were measured for patients##2##4##(2006-10#1)(2008-8#1)
were measured for several##2##4##(1991-3#1)(2007-11#1)
were measured for the##6##4##(1996-12#1)(1996-5#1)(2005-11#1)(2007-12#1)(2008-3#1)(2008-5#1)
were measured for two##2##4##(1996-5#1)(2005-9#1)
were measured for##37##3##(1990-3#1)(1991-3#1)(1991-5#1)(1992-6#1)(1994-5#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#2)(2004-11#1)(2005-11#3)(2005-9#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-6#1)(2012-12#1)(2013-7#1)(2013-8#1)
were measured from the##3##4##(1991-5#1)(2008-12#1)(2008-3#1)
were measured from##11##3##(1991-5#1)(1992-3#1)(1992-5#1)(1993-9#1)(1996-5#1)(1997-8#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-3#1)
were measured in 12##3##4##(1995-1#1)(2008-7#1)(2008-8#1)
were measured in 14##2##4##(2007-8#1)(2011-2#1)
were measured in 21##2##4##(2006-11#1)(2010-9#1)
were measured in 58##2##4##(1996-3#1)(2012-12#1)
were measured in a sample of##2##6##(1997-2#1)(2010-8#1)
were measured in a series of##2##6##(2008-7#1)(2008-8#1)
were measured in a##10##4##(1993-11#1)(1994-9#1)(1996-2#1)(1996-3#1)(1997-2#1)(2004-1#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-8#1)
were measured in all##2##4##(2011-2#1)(2012-2#1)
were measured in aqueous##2##4##(1995-11#1)(2008-10#1)
were measured in blood##2##4##(1990-8#1)(2010-12#1)
were measured in both##3##4##(1994-3#1)(1996-8#1)(2013-7#1)
were measured in comparison with##2##5##(1992-11#1)(2008-4#1)
were measured in human##2##4##(1990-3#1)(1996-3#1)
were measured in plasma##2##4##(1990-2#1)(1993-2#1)
were measured in rat##2##4##(1993-8#1)(2008-11#1)
were measured in samples##2##4##(2010-5#1)(2013-1#1)
were measured in sera from##2##5##(1991-2#1)(1996-12#1)
were measured in sera##3##4##(1991-2#1)(1996-12#1)(2009-9#1)
were measured in serum##2##4##(2006-10#1)(2011-12#1)
were measured in seven##2##4##(1996-2#1)(2007-5#1)
were measured in the same##2##5##(2008-3#1)(2008-7#1)
were measured in the##30##4##(1990-12#1)(1990-4#1)(1991-5#1)(1991-9#1)(1993-2#1)(1994-10#1)(1994-2#1)(1994-7#1)(1995-1#1)(1995-12#1)(2004-4#1)(2006-10#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2012-1#1)
were measured in vitro##2##4##(1990-6#1)(2008-10#1)
were measured in##167##3##(1990-12#2)(1990-2#4)(1990-3#3)(1990-4#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-10#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-2#2)(1993-5#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#3)(1995-10#2)(1995-11#2)(1995-12#3)(1995-3#1)(1995-5#1)(1995-9#1)(1996-12#2)(1996-2#2)(1996-3#4)(1996-4#2)(1996-7#1)(1996-8#1)(1997-2#2)(1997-5#2)(2004-1#1)(2004-4#2)(2006-10#2)(2006-11#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#16)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#3)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#2)
were measured including##3##3##(2008-12#2)(2013-8#1)
were measured on a##2##4##(1996-3#1)(2008-10#1)
were measured on the##2##4##(1990-12#1)(2007-5#1)
were measured on##13##3##(1990-12#1)(1995-3#1)(1995-5#1)(1996-3#1)(2006-12#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#2)(2009-7#1)(2011-2#1)(2012-3#1)
were measured over a broad temperature range##2##7##(2008-2#2)
were measured over a##5##4##(1991-9#1)(2008-2#2)(2008-7#1)(2011-2#1)
were measured over the##2##4##(1996-5#1)(2008-3#1)
were measured over time##2##4##(2005-11#1)(2013-8#1)
were measured over##10##3##(1991-9#1)(1996-5#1)(2005-11#1)(2006-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2011-2#1)(2013-8#1)
were measured pre- and##2##4##(2006-6#1)(2012-12#1)
were measured preoperatively and at 6-month follow-up##2##7##(2008-9#2)
were measured preoperatively and##3##4##(2008-9#2)(2013-7#1)
were measured prior to##3##4##(2007-2#1)(2008-5#2)
were measured quantitatively##3##3##(1991-7#1)(1996-6#1)(2011-2#1)
were measured repeatedly##2##3##(1990-10#1)(2005-11#1)
were measured simultaneously in##2##4##(2008-10#1)(2008-5#1)
were measured simultaneously##6##3##(1992-3#1)(1996-5#1)(2008-10#2)(2008-2#1)(2008-5#1)
were measured spectrophotometrically##2##3##(1996-9#1)(2011-2#1)
were measured three##3##3##(1995-11#1)(2007-12#1)(2009-9#1)
were measured through##3##3##(1994-7#1)(2013-8#2)
were measured to assess the##2##5##(2008-1#1)(2010-4#1)
were measured to be##2##4##(2008-3#2)
were measured to characterize the##2##5##(1993-3#1)(1996-8#1)
were measured to determine##4##4##(1992-12#1)(2004-11#1)(2008-10#1)(2010-4#1)
were measured to evaluate##2##4##(1997-2#1)(2011-2#1)
were measured to##19##3##(1992-12#1)(1992-5#1)(1993-3#1)(1996-8#1)(1997-2#1)(2004-11#1)(2008-1#1)(2008-10#2)(2008-3#4)(2008-6#1)(2010-4#2)(2011-2#1)(2012-2#1)(2013-8#1)
were measured under##4##3##(2007-8#1)(2008-10#1)(2008-8#1)(2010-8#1)
were measured using a##13##4##(1997-3#1)(2006-5#1)(2007-2#1)(2008-10#1)(2008-7#1)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
were measured using an enzyme##2##5##(1995-4#1)(2004-10#1)
were measured using an##5##4##(1995-10#1)(1995-4#1)(1997-8#1)(2004-10#1)(2013-8#1)
were measured using surface##2##4##(1996-7#1)(2007-1#1)
were measured using the##13##4##(1993-2#2)(1994-11#1)(1996-4#1)(2005-11#1)(2006-7#1)(2008-7#2)(2010-3#1)(2011-11#1)(2012-11#1)(2012-2#1)(2013-1#1)
were measured using##70##3##(1990-5#1)(1990-8#1)(1991-10#1)(1993-2#2)(1994-11#2)(1994-2#1)(1995-10#1)(1995-4#1)(1995-5#1)(1996-2#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-10#1)(2005-11#3)(2006-11#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-1#2)(2007-2#1)(2007-4#2)(2007-7#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#3)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-11#3)(2011-2#2)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
were measured versus##2##3##(2007-12#1)(2008-3#1)
were measured with a new##2##5##(2008-10#1)(2008-3#1)
were measured with a##19##4##(1990-3#1)(2006-10#1)(2007-11#2)(2007-4#1)(2008-10#2)(2008-2#3)(2008-3#8)(2011-1#1)
were measured with an##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
were measured with and without##2##5##(2008-3#1)(2011-1#1)
were measured with the##7##4##(1991-8#1)(1993-5#1)(2004-12#1)(2007-12#1)(2007-7#1)(2008-2#2)
were measured with this##2##4##(2008-1#1)(2008-3#1)
were measured with##56##3##(1990-3#1)(1990-5#1)(1991-8#1)(1992-8#1)(1993-5#1)(1994-6#2)(1995-3#1)(1996-5#2)(1997-1#1)(2004-12#1)(2006-10#1)(2006-5#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#11)(2008-5#1)(2009-12#1)(2011-1#2)(2011-2#1)
were measured within the##2##4##(2008-10#1)(2008-11#1)
were measured within##5##3##(1993-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)
were measured##924##2##(1990-10#2)(1990-11#1)(1990-12#3)(1990-2#6)(1990-3#5)(1990-4#5)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#5)(1991-4#2)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#4)(1992-4#1)(1992-5#3)(1992-6#3)(1992-7#3)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#4)(1993-2#7)(1993-3#2)(1993-5#4)(1993-7#3)(1993-8#1)(1993-9#2)(1994-1#1)(1994-10#2)(1994-11#5)(1994-12#3)(1994-2#3)(1994-3#6)(1994-5#3)(1994-6#4)(1994-7#2)(1994-8#2)(1994-9#2)(1995-1#6)(1995-10#5)(1995-11#8)(1995-12#5)(1995-2#3)(1995-3#4)(1995-4#1)(1995-5#5)(1995-6#1)(1995-8#3)(1995-9#1)(1996-11#1)(1996-12#7)(1996-2#6)(1996-3#7)(1996-4#6)(1996-5#9)(1996-6#2)(1996-7#3)(1996-8#3)(1996-9#6)(1997-1#2)(1997-2#8)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#6)(2004-1#1)(2004-10#2)(2004-11#3)(2004-12#1)(2004-4#2)(2005-10#1)(2005-11#16)(2005-12#1)(2005-4#2)(2005-8#2)(2005-9#1)(2006-10#12)(2006-11#7)(2006-12#1)(2006-2#4)(2006-4#2)(2006-5#3)(2006-6#3)(2006-7#3)(2006-9#2)(2007-1#6)(2007-10#5)(2007-11#13)(2007-12#23)(2007-2#10)(2007-3#2)(2007-4#3)(2007-5#6)(2007-6#2)(2007-7#6)(2007-8#19)(2007-9#5)(2008-1#5)(2008-10#91)(2008-11#14)(2008-12#11)(2008-2#23)(2008-3#58)(2008-4#5)(2008-5#18)(2008-6#4)(2008-7#20)(2008-8#8)(2008-9#4)(2009-1#1)(2009-10#3)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#7)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#7)(2010-10#3)(2010-11#1)(2010-12#7)(2010-2#3)(2010-3#1)(2010-4#12)(2010-5#5)(2010-7#4)(2010-8#7)(2010-9#5)(2011-1#15)(2011-11#3)(2011-12#1)(2011-2#22)(2011-3#2)(2012-1#9)(2012-11#1)(2012-12#13)(2012-2#13)(2012-3#7)(2012-4#1)(2012-5#1)(2013-1#18)(2013-3#1)(2013-7#8)(2013-8#30)
were mechanically##6##2##(2006-11#1)(2007-3#1)(2008-10#2)(2009-2#1)(2013-8#1)
were mediated by a##2##4##(1990-7#1)(1991-8#1)
were mediated by the##3##4##(2006-3#1)(2007-10#1)(2008-11#1)
were mediated by##15##3##(1990-7#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-4#1)(1994-11#1)(1996-11#1)(2006-3#1)(2007-10#1)(2008-11#1)(2008-4#2)(2010-2#1)(2010-7#1)
were mediated via##2##3##(1994-12#1)(1995-12#1)
were mediated##19##2##(1990-7#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-4#1)(1992-9#1)(1994-11#1)(1994-12#1)(1995-12#1)(1996-11#1)(1997-5#1)(2006-3#1)(2007-10#1)(2008-11#1)(2008-4#2)(2010-2#1)(2010-7#1)
were medical##3##2##(2005-12#1)(2011-2#1)(2013-1#1)
were medically##2##2##(1995-4#1)(2008-1#1)
were meeting##2##2##(2007-12#1)(2012-12#1)
were members of a##4##4##(1991-7#1)(2008-10#2)(2009-2#1)
were members of the##6##4##(1993-1#1)(1997-1#1)(2008-10#3)(2009-10#1)
were members of##12##3##(1991-7#1)(1993-1#1)(1996-6#1)(1997-1#1)(2008-10#6)(2009-10#1)(2009-2#1)
were men (mean age##2##4##(1994-4#1)(2008-9#1)
were men and##11##3##(1991-9#1)(2006-11#1)(2006-3#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-10#1)(2009-8#1)(2010-4#1)(2010-9#2)
were men##25##2##(1990-5#1)(1990-6#1)(1991-9#1)(1994-4#1)(2006-11#1)(2006-3#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-9#2)(2009-6#1)(2009-8#1)(2010-4#1)(2010-9#3)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
were mentally retarded##2##3##(1991-6#1)(1997-8#1)
were mentally##4##2##(1991-6#1)(1997-8#1)(2006-1#1)(2007-8#1)
were mentioned as##2##3##(2008-9#1)(2010-5#1)
were mentioned##3##2##(2008-9#1)(2010-5#1)(2011-1#1)
were merged with##4##3##(1993-3#1)(2007-5#1)(2008-10#2)
were merged##6##2##(1993-3#1)(2007-5#1)(2008-10#2)(2008-3#1)(2011-2#1)
were met by##3##3##(1991-8#1)(1995-2#1)(2011-2#1)
were met in##3##3##(2008-9#1)(2009-10#1)(2009-9#1)
were met##10##2##(1991-8#1)(1995-2#1)(2005-7#1)(2007-5#1)(2008-9#1)(2009-10#1)(2009-9#2)(2011-2#1)(2012-1#1)
were metabolically##3##2##(1994-11#1)(2007-9#1)(2012-11#1)
were metabolised##3##2##(1992-11#1)(1994-8#2)
were metabolized by##2##3##(1990-10#2)
were metabolized##4##2##(1990-10#2)(1996-3#1)(2006-8#1)
were metastases from the##3##4##(1993-11#1)(2007-8#1)(2008-7#1)
were metastases##4##2##(1993-11#1)(2007-8#1)(2008-4#1)(2008-7#1)
were metastatic##2##2##(1991-9#1)(2010-12#1)
were methicillin-resistant##2##2##(2008-7#1)(2009-2#1)
were methionine##2##2##(2008-10#2)
were methods##2##2##(2008-10#1)(2008-6#1)
were methylated by##2##3##(1994-11#1)(2010-11#1)
were methylated##4##2##(1994-11#1)(2008-7#1)(2009-10#1)(2010-11#1)
were microdissected##2##2##(2004-1#1)(2008-9#1)
were microinjected into##2##3##(1990-5#1)(1996-1#1)
were microinjected with##2##3##(1993-12#1)(2008-11#1)
were microinjected##4##2##(1990-5#1)(1993-12#1)(1996-1#1)(2008-11#1)
were migrants and##2##3##(2010-8#1)(2011-2#1)
were migrants##5##2##(2007-8#1)(2008-5#1)(2010-8#1)(2011-2#2)
were mild and transient##2##4##(1992-8#1)(2007-11#1)
were mild and##3##3##(1992-8#1)(2007-11#1)(2012-1#1)
were mild in##2##3##(2007-6#1)(2007-7#1)
were mild or moderate in severity and##2##7##(2012-12#2)
were mild##14##2##(1992-8#1)(2004-10#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-2#1)(2008-6#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)
were milder##2##2##(2004-11#1)(2008-10#1)
were mimicked by##4##3##(1993-6#1)(1994-2#1)(1997-1#1)(2008-4#1)
were mimicked##6##2##(1991-11#1)(1993-6#1)(1994-2#1)(1997-1#1)(2007-12#1)(2008-4#1)
were minimal##20##2##(1990-6#1)(1991-8#1)(1992-2#1)(1992-7#1)(1993-2#1)(1996-12#1)(1997-3#1)(1997-7#1)(2005-7#1)(2006-5#1)(2006-8#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-7#1)(2010-12#1)(2012-12#1)(2013-1#1)
were minimally##2##2##(1994-8#1)(2010-8#1)
were minimized by##5##3##(1993-12#1)(1997-2#1)(2008-10#2)(2008-2#1)
were minimized##10##2##(1991-7#1)(1993-12#1)(1993-3#1)(1996-12#1)(1997-2#1)(2008-10#3)(2008-2#1)(2008-3#1)
were minor and##4##3##(1992-8#1)(2007-9#1)(2008-10#1)(2011-2#1)
were minor differences in##2##4##(2007-2#1)(2008-10#1)
were minor##12##2##(1992-8#1)(2006-11#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-10#3)(2008-5#1)(2008-7#1)(2011-2#1)
were miscible##2##2##(1993-8#1)(2005-11#1)
were misclassified as##3##3##(1993-8#2)(1995-6#1)
were missed by##4##3##(2008-11#1)(2008-4#1)(2012-2#1)(2013-7#1)
were missed or##2##3##(2008-9#1)(2012-12#1)
were missed##9##2##(2007-2#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-11#1)(2012-12#1)(2012-2#1)(2013-7#1)
were missing from the##2##4##(1996-2#1)(2008-10#1)
were missing##9##2##(1990-3#1)(1992-11#1)(1996-2#2)(2008-10#1)(2008-12#1)(2009-12#1)(2009-3#1)(2011-2#1)
were misused in the context of##2##6##(2013-8#2)
were mixed and##5##3##(2008-10#2)(2009-9#1)(2012-2#1)(2013-1#1)
were mixed in different##2##4##(2008-10#1)(2013-8#1)
were mixed in##4##3##(1990-12#1)(2008-10#1)(2008-2#1)(2013-8#1)
were mixed together##3##3##(1992-8#1)(2008-4#1)(2008-9#1)
were mixed with##9##3##(1991-1#1)(1992-2#2)(1996-3#1)(1997-6#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-12#1)
were mixed##33##2##(1990-12#1)(1990-2#1)(1991-1#1)(1992-2#2)(1992-8#1)(1993-11#1)(1996-3#1)(1997-6#1)(2007-11#1)(2007-5#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-7#2)(2009-9#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
were mobile##2##2##(1996-8#1)(2008-5#1)
were mobilized##2##2##(1996-2#1)(2007-7#1)
were modeled and##2##3##(2010-9#1)(2011-1#1)
were modeled in##3##3##(2007-9#1)(2008-8#1)(2009-9#1)
were modeled to##2##3##(1995-11#1)(2005-11#1)
were modeled using##2##3##(2006-11#1)(2007-10#1)
were modeled##16##2##(1994-11#1)(1995-11#1)(2005-11#1)(2006-11#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-8#1)(2009-9#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
were modelled using##2##3##(2010-4#1)(2011-2#1)
were moderate##9##2##(1991-2#1)(1993-4#1)(1994-7#1)(1996-3#2)(2007-10#1)(2009-12#1)(2012-2#1)(2012-5#1)
were moderated by##3##3##(2006-4#1)(2010-1#1)(2010-2#1)
were moderately active##2##3##(1991-9#1)(2007-11#1)
were moderately disabled##3##3##(2006-11#1)(2013-8#2)
were moderately##21##2##(1990-3#1)(1991-9#1)(1992-5#1)(1993-9#1)(1995-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-7#2)(2008-10#3)(2009-2#1)(2010-4#1)(2011-1#1)(2013-8#2)
were modest##5##2##(1992-1#1)(1997-3#1)(2007-8#1)(2008-3#1)(2009-7#1)
were modified at the##2##4##(1990-9#1)(1995-1#1)
were modified by##9##3##(1995-12#1)(1995-8#1)(2008-10#3)(2008-6#1)(2009-2#1)(2010-4#1)(2013-7#1)
were modified in##2##3##(1990-2#1)(2007-12#1)
were modified to##2##3##(2008-8#1)(2009-4#1)
were modified with##4##3##(1992-3#1)(1993-11#1)(2008-11#1)(2010-4#1)
were modified##34##2##(1990-2#1)(1990-5#2)(1990-9#1)(1991-8#1)(1992-3#1)(1993-11#1)(1995-1#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-7#1)(2006-11#1)(2006-6#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-4#2)(2011-2#1)(2013-1#1)(2013-7#1)
were modulated by##5##3##(1990-11#1)(2008-11#2)(2010-12#1)(2013-1#1)
were modulated##8##2##(1990-11#1)(1995-11#1)(1997-8#1)(2008-11#2)(2010-12#1)(2010-4#1)(2013-1#1)
were molecular##2##2##(2008-12#1)(2008-4#1)
were molecularly##3##2##(2008-10#3)
were monitored after##3##3##(1991-8#1)(2008-10#1)(2012-12#1)
were monitored and##3##3##(2008-6#1)(2010-4#1)(2010-5#1)
were monitored at##8##3##(1990-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-3#1)(2012-12#1)(2013-7#1)
were monitored before and##2##4##(1993-2#1)(1997-2#1)
were monitored by ELISA##2##4##(1992-1#2)
were monitored by measuring the##2##5##(1994-3#1)(2008-10#1)
were monitored by the##2##4##(1995-7#1)(1997-7#1)
were monitored by##24##3##(1990-8#1)(1991-3#1)(1991-9#1)(1992-1#2)(1992-5#1)(1994-10#1)(1994-3#1)(1995-1#1)(1995-7#1)(1995-8#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-7#1)(2005-11#1)(2005-4#1)(2006-8#1)(2008-10#5)(2008-11#1)
were monitored continuously##2##3##(1997-3#1)(1997-5#1)
were monitored during and##2##4##(2007-8#1)(2013-8#1)
were monitored during the##2##4##(1993-4#1)(1996-11#1)
were monitored during##8##3##(1993-4#1)(1994-4#1)(1995-7#1)(1996-11#1)(2005-11#1)(2007-8#1)(2008-10#1)(2013-8#1)
were monitored for##17##3##(1995-7#1)(2007-2#1)(2007-7#2)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#1)(2010-12#1)(2010-4#3)
were monitored in a##2##4##(1994-9#1)(2008-5#1)
were monitored in real time using##2##6##(1995-12#1)(2008-10#1)
were monitored in real time##3##5##(1995-12#1)(2008-10#2)
were monitored in the##3##4##(1990-7#1)(2007-8#1)(2009-4#1)
were monitored in##20##3##(1990-7#1)(1992-1#2)(1993-4#1)(1994-9#1)(1995-12#1)(1996-5#1)(2005-11#1)(2006-5#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-5#1)(2008-7#2)(2009-4#1)
were monitored on##2##3##(2004-4#1)(2008-10#1)
were monitored on-line##2##3##(2008-11#1)(2008-7#1)
were monitored over a##4##4##(1997-4#1)(2008-10#3)
were monitored over##6##3##(1997-4#1)(2008-10#5)
were monitored throughout the cultivation##2##5##(2008-6#2)
were monitored throughout the##3##4##(2008-6#2)(2013-7#1)
were monitored using##10##3##(1993-12#1)(1993-4#1)(2006-7#1)(2008-10#3)(2009-4#1)(2009-6#1)(2010-8#1)(2012-1#1)
were monitored via##2##3##(1993-2#1)(1996-5#1)
were monitored with##4##3##(1990-9#1)(2006-8#1)(2007-9#1)(2012-11#1)
were monitored##150##2##(1990-12#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#4)(1992-5#1)(1992-7#1)(1993-10#1)(1993-12#1)(1993-2#2)(1993-4#3)(1994-10#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-6#1)(1995-7#3)(1995-8#1)(1996-11#1)(1996-3#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-4#1)(2005-10#1)(2005-11#3)(2005-4#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-10#32)(2008-11#4)(2008-3#3)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#1)(2009-4#3)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#1)(2010-8#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
were more abundant in the##3##5##(1992-8#1)(2008-10#1)(2009-10#1)
were more abundant in##7##4##(1992-8#1)(2008-10#3)(2009-10#1)(2010-4#1)(2013-7#1)
were more abundant##8##3##(1992-8#1)(2008-10#4)(2009-10#1)(2010-4#1)(2013-7#1)
were more accurate##2##3##(2013-7#1)(2013-8#1)
were more activated in the script event##2##7##(1996-2#2)
were more active in##3##4##(1994-5#1)(1994-9#1)(2011-2#1)
were more active than the##4##5##(1995-1#1)(1997-2#2)(2006-12#1)
were more active than##10##4##(1995-1#1)(1997-2#2)(1997-7#1)(2006-12#1)(2007-1#1)(2008-5#3)(2011-2#1)
were more active##15##3##(1994-5#1)(1994-9#1)(1995-1#2)(1997-2#2)(1997-7#1)(2006-12#1)(2007-1#1)(2008-5#4)(2011-2#2)
were more affected by##3##4##(2008-1#2)(2010-2#1)
were more aware of##2##4##(2008-8#1)(2013-1#1)
were more aware##3##3##(2008-8#1)(2011-1#1)(2013-1#1)
were more closely related to each other##2##7##(2008-10#2)
were more closely related to##4##5##(2008-10#4)
were more closely related##5##4##(2008-10#5)
were more common among##2##4##(1997-4#1)(2013-8#1)
were more common in children##2##5##(2012-2#1)(2013-1#1)
were more common in patients with##2##6##(2010-10#1)(2013-1#1)
were more common in patients##3##5##(2006-12#1)(2010-10#1)(2013-1#1)
were more common in the elderly##2##6##(2008-1#1)(2010-4#1)
were more common in the##6##5##(2006-7#1)(2006-8#1)(2007-9#1)(2008-1#1)(2008-9#1)(2010-4#1)
were more common in##22##4##(1993-10#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-6#1)(2007-9#3)(2008-1#1)(2008-3#1)(2008-9#1)(2010-10#1)(2010-4#1)(2012-2#2)(2013-1#4)
were more common with##2##4##(2008-9#1)(2010-12#1)
were more common##31##3##(1993-10#1)(1997-4#1)(2004-4#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-4#1)(2007-6#1)(2007-9#3)(2008-1#1)(2008-3#1)(2008-9#2)(2010-10#1)(2010-12#2)(2010-4#1)(2011-1#1)(2012-2#2)(2013-1#4)(2013-8#1)
were more commonly##2##3##(2007-7#1)(2013-8#1)
were more complex##4##3##(1990-8#1)(1995-11#1)(1997-4#1)(2008-10#1)
were more concerned with##2##4##(2009-5#1)(2010-8#1)
were more consistent##3##3##(1996-5#1)(2013-1#2)
were more cytotoxic than##2##4##(1996-12#1)(2006-12#1)
were more dependent##2##3##(2007-10#1)(2007-7#1)
were more dissatisfied##2##3##(2007-12#2)
were more easily##4##3##(1994-6#1)(2009-4#1)(2010-2#1)(2011-1#1)
were more effective at##3##4##(1997-6#1)(2008-10#1)(2013-1#1)
were more effective in##5##4##(1995-8#1)(2006-5#1)(2008-10#2)(2008-5#1)
were more effective than##8##4##(1995-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2012-1#1)(2013-1#1)
were more effective##18##3##(1991-7#1)(1993-4#1)(1995-12#1)(1995-8#1)(1997-6#1)(2006-5#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2012-1#1)(2013-1#2)
were more efficient##2##3##(2008-10#1)(2008-5#1)
were more evident at##2##4##(2008-12#1)(2008-5#1)
were more evident in the##2##5##(1996-9#1)(2005-9#1)
were more evident##6##3##(1996-9#1)(2005-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-3#1)
were more extensive##2##3##(1993-8#1)(1996-6#1)
were more extensively##2##3##(1997-5#1)(2008-1#1)
were more favorable##2##3##(2009-4#1)(2010-4#1)
were more favourable in##2##4##(2011-1#1)(2012-2#1)
were more favourable##3##3##(1990-9#1)(2011-1#1)(2012-2#1)
were more frequent among##2##4##(2006-5#1)(2009-5#1)
were more frequent in the##2##5##(1996-8#1)(2011-2#1)
were more frequent in##8##4##(1990-8#1)(1996-8#1)(2007-8#2)(2011-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
were more frequent than in##2##5##(1990-6#1)(1992-6#1)
were more frequent than##3##4##(1990-6#1)(1992-6#1)(2008-10#1)
were more frequent##16##3##(1990-6#1)(1990-8#1)(1992-6#1)(1996-8#1)(2006-5#1)(2006-7#1)(2007-5#1)(2007-8#2)(2008-10#1)(2009-5#1)(2009-9#1)(2011-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
were more frequently males##2##4##(2008-3#2)
were more frequently mechanically ventilated##2##5##(1990-12#1)(2011-2#1)
were more frequently observed##3##4##(2008-5#2)(2012-2#1)
were more frequently##22##3##(1990-12#2)(1993-8#1)(1994-7#1)(2007-2#2)(2007-3#1)(2007-7#2)(2008-10#2)(2008-3#2)(2008-5#2)(2008-7#1)(2010-4#1)(2011-2#3)(2012-2#1)(2013-1#1)
were more highly##4##3##(2008-10#1)(2008-12#1)(2011-1#1)(2013-1#1)
were more impaired in##2##4##(2008-12#2)
were more impaired than##3##4##(1996-7#1)(1997-8#1)(2008-12#1)
were more impaired##5##3##(1996-7#1)(1997-8#1)(2008-12#3)
were more important in##2##4##(2005-11#1)(2008-5#1)
were more important##5##3##(2005-11#1)(2006-10#1)(2008-5#1)(2008-7#1)(2008-9#1)
were more in##2##3##(2008-4#1)(2012-2#1)
were more infected##2##3##(2006-2#1)(2012-2#1)
were more intense##2##3##(1993-9#1)(1996-12#1)
were more likely than men to##2##6##(2008-12#2)
were more likely than##16##4##(1991-8#1)(1993-1#1)(2006-3#1)(2006-8#2)(2008-12#5)(2009-4#1)(2009-7#1)(2010-10#1)(2012-3#2)(2013-7#1)
were more likely to achieve##2##5##(2007-2#1)(2013-1#1)
were more likely to be in##2##6##(2006-10#1)(2008-4#1)
were more likely to be overweight##2##6##(2010-11#2)
were more likely to be positive##2##6##(1995-2#1)(2005-10#1)
were more likely to be treated as outpatients##2##8##(2007-8#2)
were more likely to be vaccinated than##2##7##(2007-2#1)(2009-5#1)
were more likely to be##38##5##(1993-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-3#2)(2005-10#2)(2006-10#1)(2006-8#1)(2007-12#2)(2007-2#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-9#1)(2009-5#2)(2010-10#1)(2010-11#2)(2011-2#4)(2012-3#1)(2013-1#4)
were more likely to continue##2##5##(2012-12#1)(2012-2#1)
were more likely to die##3##5##(2007-9#1)(2008-8#1)(2012-12#1)
were more likely to engage in##4##6##(2006-5#1)(2008-1#1)(2009-7#1)(2012-3#1)
were more likely to experience##4##5##(1997-8#1)(2008-12#1)(2013-1#2)
were more likely to have a##5##6##(1996-8#1)(2006-7#1)(2008-3#1)(2008-6#1)(2012-2#1)
were more likely to have visited##2##6##(2007-2#1)(2007-3#1)
were more likely to have##30##5##(1995-12#1)(1995-2#1)(1996-8#1)(1996-9#1)(1997-8#1)(2004-3#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-2#1)(2007-3#2)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-12#1)(2009-5#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
were more likely to make##2##5##(2007-2#1)(2012-3#1)
were more likely to present with##2##6##(2009-11#1)(2012-2#1)
were more likely to remain visually impaired even##2##8##(2005-10#2)
were more likely to remain visually impaired##4##7##(2005-10#4)
were more likely to report a##2##6##(2006-10#1)(2009-5#1)
were more likely to report speaking and reading English##2##9##(2010-7#2)
were more likely to report that##4##6##(1997-8#1)(2007-9#1)(2013-1#2)
were more likely to report##19##5##(1995-12#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-6#1)(2009-5#2)(2009-7#1)(2010-3#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#4)
were more likely to show relatively high mental status scores (i##2##11##(2010-12#2)
were more likely to show relatively##3##6##(2010-12#3)
were more likely to survive##2##5##(1995-2#1)(2008-8#1)
were more likely to use##2##5##(2012-3#2)
were more likely to##156##4##(1991-12#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-12#3)(1995-2#3)(1995-3#1)(1996-3#2)(1996-8#1)(1996-9#1)(1997-8#4)(2004-3#1)(2005-10#7)(2006-10#3)(2006-5#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-11#1)(2007-12#3)(2007-2#6)(2007-3#4)(2007-7#3)(2007-8#3)(2007-9#4)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#6)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#5)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#5)(2009-7#2)(2010-10#1)(2010-11#4)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#9)(2013-1#19)(2013-8#2)
were more likely##172##3##(1991-12#1)(1991-8#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-12#3)(1995-2#3)(1995-3#1)(1996-3#2)(1996-8#1)(1996-9#1)(1997-8#4)(2004-3#1)(2005-10#7)(2006-10#3)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#5)(2007-1#1)(2007-11#1)(2007-12#3)(2007-2#6)(2007-3#4)(2007-7#3)(2007-8#3)(2007-9#4)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#11)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#5)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#5)(2009-7#3)(2010-10#2)(2010-11#4)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#11)(2013-1#19)(2013-7#1)(2013-8#2)
were more marked in##2##4##(1991-1#1)(2008-10#1)
were more marked##4##3##(1991-1#1)(1992-11#1)(2008-10#1)(2012-1#1)
were more numerous in the##2##5##(1993-12#1)(2008-5#1)
were more numerous##5##3##(1992-8#1)(1993-12#1)(1994-2#1)(2008-5#1)(2013-8#1)
were more often##11##3##(1992-8#1)(1996-6#1)(1997-6#1)(2006-11#1)(2007-9#1)(2008-6#1)(2008-7#2)(2010-7#1)(2010-8#1)(2011-12#1)
were more persistent##2##3##(2008-12#1)(2008-8#1)
were more positive##2##3##(2006-8#1)(2007-7#1)
were more potent in##3##4##(1991-5#1)(1995-3#1)(1996-12#1)
were more potent than##4##4##(1992-5#1)(1994-8#1)(1995-11#1)(1996-8#1)
were more potent##9##3##(1990-5#1)(1991-5#1)(1992-11#1)(1992-5#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-8#1)
were more predominant in##2##4##(2006-4#1)(2007-6#1)
were more prevalent in##5##4##(1993-6#1)(1996-12#2)(2013-1#1)(2013-7#1)
were more prevalent##8##3##(1993-6#1)(1996-12#2)(2008-10#1)(2009-4#1)(2013-1#1)(2013-7#1)(2013-8#1)
were more profound in##2##4##(2008-10#1)(2013-1#1)
were more prominent##2##3##(2007-11#1)(2008-7#1)
were more prone to##2##4##(2007-12#1)(2008-5#1)
were more pronounced in##8##4##(1997-6#1)(2006-8#1)(2008-4#1)(2008-8#1)(2010-12#1)(2010-2#1)(2011-12#1)(2012-12#1)
were more pronounced than##2##4##(2008-10#1)(2013-1#1)
were more pronounced##11##3##(1997-6#1)(2006-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-12#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
were more reliable##2##3##(2008-10#1)(2008-12#1)
were more resistant than the##2##5##(2008-11#1)(2008-5#1)
were more resistant than##7##4##(1994-9#1)(2008-10#3)(2008-11#1)(2008-5#1)(2011-2#1)
were more resistant to the##2##5##(1991-4#1)(2008-10#1)
were more resistant to##6##4##(1991-4#1)(2005-12#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
were more resistant##13##3##(1991-4#1)(1994-9#1)(2005-12#1)(2008-10#4)(2008-11#1)(2008-5#2)(2011-2#2)(2013-1#1)
were more responsive to##3##4##(1994-11#1)(2008-10#1)(2008-2#1)
were more satisfied than##2##4##(2007-12#1)(2012-2#1)
were more satisfied with##2##4##(1992-2#1)(1992-5#1)
were more satisfied##5##3##(1992-2#1)(1992-5#1)(2007-12#1)(2012-2#1)(2012-3#1)
were more sensitive than##5##4##(1990-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
were more sensitive to the##3##5##(1992-7#1)(2008-9#1)(2011-2#1)
were more sensitive to##14##4##(1992-6#1)(1992-7#1)(1994-3#1)(1994-5#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
were more sensitive##22##3##(1990-5#1)(1992-6#1)(1992-7#1)(1994-3#1)(1994-5#1)(1995-2#1)(2006-5#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-5#1)(2008-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
were more severe##4##3##(2004-11#1)(2007-9#1)(2008-5#1)(2011-2#1)
were more severely##3##3##(1994-1#1)(2008-10#2)
were more significant in##2##4##(2006-1#1)(2011-11#1)
were more significant##3##3##(2006-1#1)(2008-9#1)(2011-11#1)
were more similar to##2##4##(2006-5#1)(2010-4#1)
were more similar##3##3##(2006-5#1)(2008-10#1)(2010-4#1)
were more stable than##2##4##(1991-2#1)(1997-6#1)
were more stable##4##3##(1990-12#1)(1991-2#1)(1997-6#1)(2012-3#1)
were more strongly##4##3##(1997-2#1)(2007-12#1)(2009-8#1)(2012-3#1)
were more suitable for##2##4##(2008-10#1)(2008-5#1)
were more susceptible than##3##4##(1991-10#1)(2007-6#1)(2008-10#1)
were more susceptible to the##3##5##(1991-10#1)(2004-11#1)(2008-10#1)
were more susceptible to##14##4##(1990-7#1)(1991-10#1)(1991-12#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-2#1)(2004-11#1)(2008-10#5)(2012-12#1)
were more susceptible##17##3##(1990-7#1)(1991-10#2)(1991-12#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-2#1)(2004-11#1)(2007-6#1)(2008-10#6)(2012-12#1)
were more than 10##2##4##(1990-8#1)(2008-10#1)
were more than doubled##2##4##(1990-8#1)(1992-3#1)
were more than in the control group##2##7##(2011-1#2)
were more than in##3##4##(2008-12#1)(2011-1#2)
were more than twice as likely to##2##7##(2010-11#1)(2013-1#1)
were more than twice as##3##5##(2010-11#1)(2013-1#2)
were more than##28##3##(1990-7#1)(1990-8#2)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-2#1)(2004-4#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#3)(2008-12#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-1#3)(2011-2#1)(2012-12#1)(2013-1#2)
were more tolerant to##3##4##(2006-12#1)(2008-5#1)(2012-9#1)
were more tolerant##5##3##(2004-4#1)(2006-12#1)(2008-12#1)(2008-5#1)(2012-9#1)
were more toxic##4##3##(1993-3#1)(1996-4#1)(2008-10#1)(2012-2#1)
were more translucent than##2##4##(2012-2#2)
were more typical for##2##4##(2011-1#2)
were more uniform and##2##4##(2008-10#2)
were more useful##2##3##(2012-3#2)
were more variable##2##3##(2008-10#2)
were more virulent than##3##4##(2008-10#2)(2013-8#1)
were more virulent##6##3##(2008-10#5)(2013-8#1)
were more vulnerable to##2##4##(2006-3#1)(2008-10#1)
were more vulnerable##3##3##(2006-3#1)(2008-10#1)(2011-2#1)
were more##679##2##(1990-10#1)(1990-12#5)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#2)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#3)(1993-1#1)(1993-10#1)(1993-12#3)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#3)(1995-12#4)(1995-2#5)(1995-3#4)(1995-5#1)(1995-8#2)(1996-12#5)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#3)(1996-9#2)(1997-2#4)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#5)(1997-7#1)(1997-8#5)(2004-1#1)(2004-11#5)(2004-2#1)(2004-3#1)(2004-4#3)(2005-10#8)(2005-11#2)(2005-12#1)(2005-9#1)(2006-1#1)(2006-10#8)(2006-11#1)(2006-12#6)(2006-2#1)(2006-3#4)(2006-4#3)(2006-5#6)(2006-6#1)(2006-7#4)(2006-8#9)(2006-9#1)(2007-1#3)(2007-10#3)(2007-11#3)(2007-12#17)(2007-2#9)(2007-3#5)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#10)(2007-8#6)(2007-9#10)(2008-1#6)(2008-10#79)(2008-11#9)(2008-12#23)(2008-2#1)(2008-3#6)(2008-4#6)(2008-5#20)(2008-6#5)(2008-7#5)(2008-8#10)(2008-9#7)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#3)(2009-4#5)(2009-5#7)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#6)(2010-12#6)(2010-2#5)(2010-3#1)(2010-4#7)(2010-5#3)(2010-6#2)(2010-7#4)(2010-8#5)(2011-1#14)(2011-11#2)(2011-12#2)(2011-2#24)(2012-1#3)(2012-12#8)(2012-2#18)(2012-3#16)(2012-9#1)(2013-1#41)(2013-7#5)(2013-8#11)
were morphologically indistinguishable from##3##4##(1997-6#1)(2008-10#2)
were morphologically##10##2##(1997-6#1)(1997-8#1)(2008-10#5)(2008-12#1)(2008-5#2)
were most abundant in##3##4##(1992-6#1)(1995-3#1)(2008-10#1)
were most abundant##4##3##(1992-6#1)(1995-3#1)(2008-10#1)(2012-2#1)
were most affected by##2##4##(2008-10#1)(2011-2#1)
were most affected##5##3##(2008-10#1)(2008-12#1)(2010-3#1)(2011-2#2)
were most common in the##2##5##(1994-12#1)(2010-11#1)
were most common in##3##4##(1994-12#1)(2010-11#1)(2013-8#1)
were most common##8##3##(1994-12#1)(2006-10#1)(2006-12#1)(2008-12#1)(2010-11#1)(2012-3#2)(2013-8#1)
were most commonly affected##3##4##(2007-2#1)(2007-7#2)
were most commonly##9##3##(2007-2#1)(2007-7#3)(2007-8#1)(2008-9#1)(2011-2#1)(2013-1#2)
were most correlated with##2##4##(2008-10#1)(2009-3#1)
were most effectively##2##3##(1996-1#1)(1996-11#1)
were most evident##3##3##(1990-4#1)(1996-12#1)(2008-11#1)
were most frequent in##2##4##(2012-12#1)(2013-8#1)
were most frequent##4##3##(1990-6#1)(1994-3#1)(2012-12#1)(2013-8#1)
were most frequently affected##2##4##(2007-7#1)(2011-2#1)
were most frequently##10##3##(1990-4#1)(1993-12#1)(2005-8#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
were most likely to##5##4##(1995-3#1)(2007-12#1)(2008-12#1)(2010-2#1)(2013-1#1)
were most likely##9##3##(1995-3#1)(1997-1#1)(2007-12#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-2#1)(2013-1#2)
were most numerous##2##3##(1991-4#1)(1997-3#1)
were most often##5##3##(2008-6#1)(2010-4#1)(2011-1#1)(2013-1#2)
were most prominent at##2##4##(1995-12#1)(2008-7#1)
were most prominent##4##3##(1995-12#1)(1995-5#1)(2008-5#1)(2008-7#1)
were most pronounced##3##3##(1997-2#1)(2007-3#1)(2008-7#1)
were most susceptible##2##3##(2008-10#2)
were most##104##2##(1990-4#2)(1990-6#1)(1991-4#1)(1992-6#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#5)(2007-8#3)(2008-10#13)(2008-11#1)(2008-12#3)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#6)(2013-8#4)
were mostly detected##2##3##(2008-4#1)(2008-7#1)
were mostly in##3##3##(1991-2#1)(1993-2#2)
were mostly reported##2##3##(2008-4#1)(2013-1#1)
were mostly small##2##3##(1995-12#1)(2011-2#1)
were mostly##51##2##(1991-2#1)(1991-4#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-2#2)(1994-9#1)(1995-12#1)(1995-3#1)(1995-7#1)(1997-2#1)(1997-8#2)(2005-12#1)(2007-12#3)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-4#2)(2008-5#2)(2008-7#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
were mothers##2##2##(2007-12#1)(2009-6#1)
were motile##4##2##(1992-7#1)(1995-2#1)(2008-12#2)
were motivated to##2##3##(2009-6#1)(2012-3#1)
were mounted in a##3##4##(2006-8#1)(2008-10#1)(2013-1#1)
were mounted in##4##3##(1993-8#1)(2006-8#1)(2008-10#1)(2013-1#1)
were mounted##7##2##(1993-8#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-3#1)(2013-1#1)
were moved##2##2##(2007-8#1)(2008-10#1)
were much better than those obtained##2##6##(2008-10#1)(2012-3#1)
were much better##3##3##(1992-2#1)(2008-10#1)(2012-3#1)
were much greater than##2##4##(2008-10#1)(2008-8#1)
were much higher in##2##4##(1997-2#1)(2011-2#1)
were much higher than the##2##5##(2008-3#1)(2008-9#1)
were much higher than those of##2##6##(2008-5#1)(2008-8#1)
were much higher than those##4##5##(1991-12#1)(2008-10#1)(2008-5#1)(2008-8#1)
were much higher than##6##4##(1991-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)
were much higher##12##3##(1991-12#1)(1997-2#2)(2006-6#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
were much less affected##2##4##(1991-5#1)(1996-2#1)
were much less effective##3##4##(1994-2#1)(1994-8#1)(1995-3#1)
were much less likely to##2##5##(1994-4#1)(2010-11#1)
were much less potent##2##4##(1992-1#1)(1994-9#1)
were much less##11##3##(1991-5#1)(1992-1#1)(1994-2#1)(1994-4#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-2#1)(2007-11#1)(2008-11#1)(2010-11#1)
were much lower and##3##4##(1991-5#1)(1997-2#1)(2004-4#1)
were much lower compared##2##4##(2008-5#1)(2011-1#1)
were much lower in##2##4##(2012-12#1)(2012-2#1)
were much lower than those##3##5##(2006-3#1)(2008-6#1)(2010-5#1)
were much lower than##4##4##(1993-3#1)(2006-3#1)(2008-6#1)(2010-5#1)
were much lower##14##3##(1991-5#1)(1993-3#1)(1994-2#1)(1997-2#1)(2004-4#1)(2006-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
were much more dissatisfied with their bodies than##2##8##(2008-9#2)
were much more likely to##3##5##(2007-6#1)(2008-8#1)(2012-3#1)
were much more sensitive to##2##5##(1993-8#1)(1995-2#1)
were much more##15##3##(1990-6#1)(1992-12#1)(1993-8#1)(1995-2#1)(1997-2#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-8#1)(2008-9#2)(2012-12#1)(2012-3#1)(2012-8#1)(2013-1#1)
were much smaller than##3##4##(1990-1#1)(2006-12#1)(2008-10#1)
were much smaller##5##3##(1990-1#1)(1996-3#1)(1997-8#1)(2006-12#1)(2008-10#1)
were much##72##2##(1990-1#1)(1990-11#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-5#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-2#4)(1997-8#1)(2004-4#1)(2006-12#1)(2006-3#1)(2006-6#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-8#3)(2008-9#3)(2009-10#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2012-8#1)(2013-1#2)
were multidrug resistant##2##3##(2007-8#2)
were multiple##7##2##(1991-2#1)(1995-5#1)(1996-5#1)(2005-7#1)(2008-4#1)(2008-9#1)(2011-1#1)
were multiplied##2##2##(2005-11#1)(2008-11#1)
were mutagenized##2##2##(1993-11#1)(1994-9#1)
were mutated in##2##3##(1997-4#1)(1997-5#1)
were mutated to##2##3##(1993-3#1)(1994-8#1)
were mutated##11##2##(1991-4#1)(1993-3#1)(1994-8#1)(1994-9#1)(1996-10#1)(1996-4#1)(1996-7#1)(1997-4#1)(1997-5#1)(2008-4#2)
were mutually##2##2##(1990-7#1)(1991-12#1)
were named##6##2##(1997-8#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#1)
were narrow and##2##3##(2008-10#1)(2008-7#1)
were narrow##3##2##(2008-10#1)(2008-12#1)(2008-7#1)
were narrowed##2##2##(2008-7#1)(2010-12#1)
were national##2##2##(1992-2#1)(2007-9#1)
were natural##2##2##(2007-10#1)(2011-1#1)
were nausea##3##2##(1990-5#1)(2011-2#1)(2013-8#1)
were near##7##2##(1997-3#1)(2008-10#3)(2008-5#2)(2011-12#1)
were nearly identical##7##3##(1991-9#1)(1992-1#1)(1992-11#1)(1994-3#1)(1996-3#1)(2006-5#1)(2008-10#1)
were nearly normal##2##3##(1994-9#2)
were nearly the same as##2##5##(2007-11#1)(2008-8#1)
were nearly twice as##2##4##(1990-10#1)(2008-10#1)
were nearly##27##2##(1990-10#1)(1990-7#2)(1991-12#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1994-3#1)(1994-9#2)(1996-3#1)(1997-2#1)(1997-3#1)(2006-11#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-5#1)(2008-8#1)(2012-3#2)
were nebulized and##2##3##(1991-1#1)(2008-10#1)
were necessary for the##4##4##(1994-9#1)(2008-10#2)(2008-8#1)
were necessary for##9##3##(1990-2#1)(1991-8#1)(1994-9#1)(1997-3#1)(2007-9#1)(2008-10#3)(2008-8#1)
were necessary to achieve##2##4##(1995-6#1)(1997-5#1)
were necessary to obtain##2##4##(1990-5#1)(2006-11#1)
were necessary to##13##3##(1990-5#2)(1992-7#1)(1992-9#1)(1995-6#1)(1997-5#1)(2006-11#1)(2007-8#1)(2008-10#3)(2013-1#2)
were necessary##33##2##(1990-2#1)(1990-5#2)(1990-9#1)(1991-8#1)(1992-7#1)(1992-9#1)(1994-9#1)(1995-6#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-11#1)(2007-8#2)(2007-9#1)(2008-10#7)(2008-8#2)(2009-2#1)(2010-11#1)(2010-7#1)(2012-12#1)(2013-1#3)
were necropsied##2##2##(2007-6#1)(2008-5#1)
were necrotic##2##2##(2008-10#1)(2008-5#1)
were needed to obtain a##2##5##(2004-11#1)(2008-5#1)
were needed to##11##3##(1991-9#1)(1996-2#1)(1997-2#1)(1997-5#1)(2004-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-11#2)(2011-2#1)
were needed##18##2##(1990-9#1)(1991-10#1)(1991-9#1)(1994-8#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-5#1)(2004-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2009-11#2)(2011-2#1)(2013-8#1)
were negative and##4##3##(2006-11#1)(2007-6#1)(2008-10#1)(2010-7#1)
were negative by both##2##4##(2008-5#2)
were negative by##9##3##(2006-10#1)(2006-8#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-5#3)
were negative for all three tests##2##6##(1996-9#2)
were negative for all three##3##5##(1996-9#2)(2011-2#1)
were negative for all##5##4##(1993-9#1)(1996-9#2)(2004-2#1)(2011-2#1)
were negative for both##2##4##(1991-9#1)(1997-5#1)
were negative for the presence of##3##6##(2006-8#1)(2008-12#1)(2008-5#1)
were negative for the##5##4##(2006-8#1)(2008-12#1)(2008-5#1)(2011-2#2)
were negative for##35##3##(1990-2#1)(1991-3#2)(1991-9#1)(1992-2#1)(1992-6#1)(1993-7#1)(1993-9#2)(1994-7#1)(1996-9#2)(1997-5#2)(1997-7#1)(2004-2#1)(2005-8#1)(2006-2#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-5#1)(2008-12#1)(2008-4#1)(2008-5#2)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-8#1)
were negative in all the##2##5##(2008-5#1)(2011-2#1)
were negative in##7##3##(1997-8#1)(2004-2#1)(2008-10#1)(2008-5#1)(2011-10#1)(2011-2#2)
were negative on##2##3##(1991-9#1)(1993-2#1)
were negative when##2##3##(1993-2#1)(2008-5#1)
were negative##108##2##(1990-12#1)(1990-2#1)(1991-3#2)(1991-7#1)(1991-9#4)(1992-2#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-2#2)(1993-6#1)(1993-7#1)(1993-9#2)(1994-7#1)(1995-8#1)(1996-11#1)(1996-9#2)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-2#2)(2005-11#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-2#2)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#1)(2007-12#3)(2007-2#4)(2007-3#1)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#9)(2008-6#1)(2009-10#1)(2009-8#2)(2010-12#2)(2010-7#2)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-3#4)(2013-7#1)(2013-8#2)
were negatively associated with##5##4##(2007-4#1)(2011-1#1)(2011-2#2)(2013-1#1)
were negatively associated##7##3##(2007-4#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)
were negatively correlated with the##2##5##(1990-12#1)(2007-3#1)
were negatively correlated with##12##4##(1990-12#1)(1992-5#1)(2005-12#1)(2007-10#1)(2007-3#1)(2008-10#4)(2010-12#1)(2011-1#2)
were negatively correlated##18##3##(1990-12#1)(1992-5#1)(2005-12#1)(2007-10#1)(2007-3#2)(2008-10#5)(2008-5#1)(2008-9#1)(2010-12#1)(2011-1#2)(2011-2#1)(2013-8#1)
were negatively related to##2##4##(1992-2#1)(2008-10#1)
were negatively related##3##3##(1992-2#1)(2007-12#1)(2008-10#1)
were negatively##33##2##(1990-12#1)(1992-2#1)(1992-5#1)(1996-6#1)(2005-10#1)(2005-12#1)(2007-10#1)(2007-12#1)(2007-3#2)(2007-4#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
were neglected##2##2##(2011-2#1)(2012-3#1)
were negligent##2##2##(1996-6#1)(2011-2#1)
were negligible##7##2##(1991-1#1)(1991-8#1)(2007-1#1)(2008-10#3)(2008-6#1)
were neither##12##2##(1993-12#1)(1993-7#1)(1996-5#1)(1996-7#1)(1996-9#1)(2006-12#1)(2006-8#1)(2007-5#1)(2008-1#1)(2008-7#1)(2009-4#1)(2012-12#1)
were nephrotic syndrome##2##3##(2007-7#1)(2008-1#1)
were neutral##2##2##(1996-11#1)(2012-11#1)
were neutralized by antibodies##2##4##(1996-12#1)(2008-5#1)
were never detected in##2##4##(1995-12#1)(2008-10#1)
were never observed##2##3##(1992-1#1)(1995-12#1)
were never##11##2##(1992-1#2)(1993-10#1)(1995-12#2)(2006-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-12#1)(2012-3#1)
were new##5##2##(1997-8#1)(2005-4#1)(2006-8#1)(2007-2#1)(2008-7#1)
were newly diagnosed##2##3##(2008-3#1)(2013-1#1)
were newly identified as##3##4##(1995-12#1)(1995-2#1)(2006-12#1)
were newly synthesized##2##3##(1997-8#1)(2008-12#1)
were newly##8##2##(1995-12#1)(1995-2#1)(1997-8#1)(2006-10#1)(2006-12#1)(2008-12#1)(2008-3#1)(2013-1#1)
were nine##3##2##(1993-3#1)(2010-12#1)(2011-2#1)
were nitrated##2##2##(1990-5#2)
were no abnormal##2##3##(2008-1#1)(2012-2#1)
were no abnormalities##2##3##(2005-12#1)(2005-7#1)
were no accompanying##2##3##(2007-9#1)(2008-12#1)
were no adverse##5##3##(1997-1#1)(2007-8#1)(2007-9#1)(2012-1#1)(2012-12#1)
were no alterations in##2##4##(1996-9#1)(2007-8#1)
were no cases of##13##4##(1991-2#1)(2006-5#1)(2006-8#3)(2006-9#1)(2007-11#1)(2007-8#2)(2011-2#3)(2013-1#1)
were no cases##14##3##(1991-2#1)(1994-6#1)(2006-5#1)(2006-8#3)(2006-9#1)(2007-11#1)(2007-8#2)(2011-2#3)(2013-1#1)
were no changes in the##2##5##(2008-5#1)(2013-8#1)
were no changes in##4##4##(2006-2#1)(2008-11#1)(2008-5#1)(2013-8#1)
were no changes##6##3##(1995-10#1)(2006-2#1)(2008-11#1)(2008-5#1)(2009-3#1)(2013-8#1)
were no clear##2##3##(1994-12#1)(2007-9#1)
were no clinical##3##3##(1991-9#1)(2007-2#1)(2008-7#1)
were no clinically significant changes in##2##6##(1996-1#1)(2007-11#1)
were no clinically significant##3##4##(1996-1#1)(2007-11#1)(2012-2#1)
were no clinically##4##3##(1996-1#1)(2007-11#1)(2012-2#2)
were no complications in##3##4##(2006-8#1)(2008-1#1)(2012-12#1)
were no complications##10##3##(1990-12#1)(2006-10#1)(2006-8#4)(2008-1#1)(2008-7#1)(2011-2#1)(2012-12#1)
were no correlations between##2##4##(1996-3#1)(2011-2#1)
were no deaths in##3##4##(2007-9#1)(2008-4#1)(2008-8#1)
were no deaths##11##3##(1991-6#1)(1993-9#1)(2004-1#1)(2005-12#1)(2006-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-4#1)(2008-8#1)(2008-9#1)
were no detectable differences in##2##5##(2008-10#1)(2008-11#1)
were no differences between the##7##5##(1997-2#1)(2006-10#1)(2007-9#1)(2008-4#1)(2008-6#1)(2010-4#1)(2013-1#1)
were no differences between##14##4##(1997-2#1)(2006-10#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-4#2)(2008-6#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
were no differences in the##13##5##(1991-6#1)(1992-10#1)(1993-4#1)(1996-3#1)(1996-9#1)(2006-5#2)(2008-11#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
were no differences in##44##4##(1990-11#1)(1991-6#2)(1992-10#1)(1993-1#1)(1993-4#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-9#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-5#2)(2006-8#1)(2006-9#1)(2007-8#4)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#3)(2008-8#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
were no differences##65##3##(1990-11#1)(1990-3#1)(1991-6#2)(1992-10#1)(1993-1#1)(1993-4#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-9#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-5#2)(2006-8#1)(2006-9#2)(2007-8#5)(2007-9#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-10#1)(2010-2#1)(2010-4#2)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
were no false positives##2##4##(1994-7#1)(2004-11#1)
were no false##3##3##(1994-7#1)(2004-11#1)(2007-9#1)
were no interferences##2##3##(2008-10#2)
were no local recurrences##2##4##(2008-6#1)(2013-7#1)
were no local##3##3##(2008-6#1)(2011-12#1)(2013-7#1)
were no longer detectable##2##4##(1994-12#1)(1996-12#1)
were no longer observed##3##4##(1992-8#1)(1996-12#1)(2008-10#1)
were no longer responsive to##2##5##(1990-4#1)(1993-2#1)
were no longer significant after##2##5##(2007-12#1)(2012-5#1)
were no longer significant##3##4##(2007-12#1)(2010-8#1)(2012-5#1)
were no longer##25##3##(1990-4#1)(1991-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-12#2)(1997-4#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-5#1)(2009-4#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-5#1)
were no major complications##4##4##(1994-2#1)(1996-12#1)(2007-7#1)(2008-5#1)
were no major##6##3##(1994-2#1)(1996-12#1)(2005-8#1)(2007-7#1)(2008-5#1)(2010-10#1)
were no more##5##3##(2007-10#1)(2007-7#1)(2008-10#1)(2009-6#1)(2011-12#1)
were no other##7##3##(2006-10#1)(2006-12#1)(2007-8#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
were no recurrences##5##3##(1991-6#1)(1995-2#1)(1995-5#1)(2010-3#1)(2012-2#1)
were no relationships between##2##4##(1995-3#1)(2013-1#1)
were no risk##2##3##(1990-3#1)(2008-1#1)
were no serious complications##6##4##(1990-2#1)(1990-8#1)(1992-3#1)(2007-8#1)(2008-5#1)(2012-2#1)
were no serious##14##3##(1990-2#1)(1990-8#1)(1992-3#1)(1995-9#1)(2005-1#1)(2005-8#1)(2007-11#1)(2007-8#1)(2008-4#2)(2008-5#2)(2012-2#1)(2013-1#1)
were no sex differences in##2##5##(1993-12#1)(1996-1#1)
were no sex differences##3##4##(1993-12#1)(1996-1#1)(2012-11#1)
were no significant (P##2##4##(2008-10#2)
were no significant changes in resting heart rate##2##8##(2005-8#1)(2008-3#1)
were no significant changes in the##4##6##(1994-11#1)(1996-2#1)(1997-7#1)(2008-7#1)
were no significant changes in##15##5##(1993-12#1)(1994-11#1)(1996-2#1)(1997-3#1)(1997-7#1)(2005-8#1)(2006-12#1)(2006-9#1)(2007-8#2)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)
were no significant changes##17##4##(1993-12#1)(1994-11#1)(1996-2#1)(1997-3#1)(1997-7#1)(2005-8#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-8#2)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
were no significant complications##3##4##(1993-1#1)(2007-8#1)(2008-9#1)
were no significant difference between##2##5##(2007-2#1)(2011-2#1)
were no significant differences among##5##5##(1994-2#1)(2008-10#1)(2010-4#1)(2011-2#1)(2012-2#1)
were no significant differences between groups in##2##7##(2011-2#1)(2013-1#1)
were no significant differences between groups##6##6##(1993-4#1)(1994-5#1)(2006-7#1)(2011-2#1)(2013-1#2)
were no significant differences between the 2 groups##2##8##(1990-7#1)(2007-9#1)
were no significant differences between the two groups in##2##9##(1995-4#1)(2013-1#1)
were no significant differences between the two groups##4##8##(1995-10#1)(1995-4#1)(1996-12#1)(2013-1#1)
were no significant differences between the##13##6##(1990-7#1)(1995-10#1)(1995-4#1)(1995-7#1)(1996-12#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-12#1)(2009-5#2)(2013-1#1)
were no significant differences between##33##5##(1990-12#1)(1990-7#1)(1992-1#1)(1993-4#1)(1994-5#1)(1995-10#1)(1995-4#1)(1995-7#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-2#2)(2007-8#2)(2007-9#1)(2008-12#1)(2008-5#1)(2009-11#1)(2009-3#1)(2009-5#2)(2010-8#2)(2011-2#1)(2013-1#3)
were no significant differences in patient##2##6##(2006-8#1)(2007-8#1)
were no significant differences in serum##2##6##(1997-2#1)(2011-12#1)
were no significant differences in the##24##6##(1991-8#1)(1994-10#1)(1994-12#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-11#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-7#1)(2010-12#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
were no significant differences in##64##5##(1991-2#1)(1991-8#1)(1993-1#1)(1994-10#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-7#1)(1997-8#1)(2004-4#1)(2005-11#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-2#2)(2007-7#1)(2007-8#5)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-4#2)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#2)
were no significant differences##118##4##(1990-12#1)(1990-7#1)(1991-2#1)(1991-8#1)(1992-1#1)(1993-1#1)(1993-4#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-4#1)(1995-6#1)(1995-7#2)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#2)(1997-2#3)(1997-7#2)(1997-8#2)(2004-11#1)(2004-4#1)(2005-11#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-2#4)(2007-6#1)(2007-7#1)(2007-8#7)(2007-9#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#3)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#2)(2009-5#3)(2010-12#1)(2010-3#1)(2010-4#3)(2010-8#2)(2011-12#1)(2011-2#6)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#4)
were no significant effects of##2##5##(2011-2#1)(2013-1#1)
were no significant effects##3##4##(2008-11#1)(2011-2#1)(2013-1#1)
were no significant##168##3##(1990-12#1)(1990-6#1)(1990-7#1)(1991-2#1)(1991-8#1)(1992-1#1)(1993-1#2)(1993-12#1)(1993-4#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-4#1)(1995-6#1)(1995-7#2)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-7#4)(1997-8#2)(2004-11#1)(2004-12#1)(2004-4#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#2)(2006-9#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#6)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#12)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#4)(2008-3#4)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#4)(2009-11#1)(2009-3#2)(2009-5#3)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#3)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#11)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#4)
were no signs of##8##4##(1990-5#1)(1993-1#1)(1993-6#1)(2005-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2011-2#1)
were no signs##10##3##(1990-5#1)(1993-1#1)(1993-6#1)(2005-7#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2011-2#1)
were no statistical differences##3##4##(2005-10#1)(2008-12#1)(2012-2#1)
were no statistically significant differences between##7##6##(2008-5#1)(2009-10#1)(2010-12#2)(2012-3#1)(2013-1#2)
were no statistically significant differences in the##3##7##(1991-3#1)(2006-10#1)(2007-3#1)
were no statistically significant differences in##9##6##(1991-3#1)(1996-1#1)(1996-7#1)(2006-10#1)(2007-3#1)(2007-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
were no statistically significant differences##19##5##(1991-3#1)(1996-1#1)(1996-7#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
were no statistically significant##22##4##(1991-3#1)(1996-1#1)(1996-7#1)(2004-11#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
were no statistically##23##3##(1991-3#1)(1996-1#1)(1996-7#1)(2004-11#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
were no systemic##2##3##(1993-5#1)(2006-10#1)
were no tears##2##3##(2006-11#1)(2008-11#1)
were no treatment-related##4##3##(2005-10#1)(2008-9#3)
were no##575##2##(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#4)(1991-3#1)(1991-5#1)(1991-6#5)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-1#5)(1993-10#1)(1993-12#5)(1993-2#1)(1993-4#3)(1993-5#1)(1993-6#2)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-10#3)(1995-12#2)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#2)(1995-9#1)(1996-1#5)(1996-11#2)(1996-12#6)(1996-2#3)(1996-3#5)(1996-5#2)(1996-7#1)(1996-9#4)(1997-1#3)(1997-2#7)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#5)(1997-8#3)(2004-1#1)(2004-11#3)(2004-12#1)(2004-4#1)(2005-1#1)(2005-10#2)(2005-11#1)(2005-12#2)(2005-2#1)(2005-7#3)(2005-8#5)(2005-9#2)(2006-1#1)(2006-10#7)(2006-11#2)(2006-12#6)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#8)(2006-6#4)(2006-7#1)(2006-8#14)(2006-9#5)(2007-10#2)(2007-11#7)(2007-12#5)(2007-2#8)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#13)(2007-8#35)(2007-9#9)(2008-1#6)(2008-10#27)(2008-11#6)(2008-12#8)(2008-2#3)(2008-3#7)(2008-4#8)(2008-5#16)(2008-6#4)(2008-7#12)(2008-8#6)(2008-9#19)(2009-10#1)(2009-11#1)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#2)(2010-12#5)(2010-2#1)(2010-3#3)(2010-4#7)(2010-6#1)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#6)(2011-12#3)(2011-2#24)(2012-1#2)(2012-11#4)(2012-12#9)(2012-2#17)(2012-3#11)(2012-5#1)(2013-1#20)(2013-7#5)(2013-8#7)
were non-linear##3##2##(1995-8#1)(1997-1#1)(2008-10#1)
were non-metastatic##2##2##(1993-7#1)(2008-4#1)
were non-smokers##2##2##(1993-2#1)(2011-2#1)
were non/limited users##2##3##(2008-9#2)
were nonambulatory##2##2##(2007-7#2)
were nonpathogenic on##4##3##(2008-10#4)
were nonpathogenic##10##2##(2008-10#10)
were nonreactive with##3##3##(1994-12#1)(1994-6#1)(1994-9#1)
were nonreactive##4##2##(1994-12#1)(1994-6#1)(1994-9#1)(1995-8#1)
were nonsignificant##2##2##(2007-8#1)(2008-10#1)
were nonspecific##3##2##(1990-6#1)(2006-10#1)(2007-8#1)
were normal and##3##3##(1991-3#1)(2006-2#1)(2011-2#1)
were normal but##2##3##(2012-2#1)(2013-1#1)
were normal except for##3##4##(1991-10#1)(2007-8#1)(2008-7#1)
were normal in all##3##4##(1993-2#1)(1994-12#1)(2012-12#1)
were normal in appearance##2##4##(2005-7#1)(2006-10#1)
were normal in the##2##4##(1994-12#1)(1995-11#1)
were normal in##11##3##(1990-9#1)(1992-8#1)(1993-2#1)(1994-12#2)(1995-11#1)(2005-7#1)(2006-10#1)(2008-6#1)(2009-10#1)(2012-12#1)
were normal on##2##3##(2006-10#1)(2012-12#1)
were normal##82##2##(1990-4#1)(1990-6#1)(1990-9#2)(1991-10#2)(1991-3#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-7#1)(1992-8#1)(1993-2#1)(1993-6#2)(1993-7#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-3#1)(1997-3#1)(1997-4#1)(2005-11#1)(2005-7#2)(2006-10#6)(2006-12#1)(2006-2#2)(2006-9#1)(2007-12#2)(2007-2#2)(2007-3#2)(2007-7#2)(2007-8#3)(2007-9#2)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#4)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
were normalized after##3##3##(1995-1#1)(1996-3#1)(2009-10#1)
were normalized by##2##3##(1991-5#1)(1993-2#1)
were normalized to##2##3##(1991-12#1)(2008-11#1)
were normalized with respect to##3##5##(2006-11#3)
were normalized##21##2##(1990-9#1)(1991-12#1)(1991-5#1)(1993-2#1)(1994-8#1)(1995-1#1)(1996-3#1)(2006-11#3)(2007-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#1)(2012-3#1)(2013-1#1)(2013-8#2)
were normally##5##2##(1990-12#1)(1995-6#1)(2004-10#1)(2010-12#2)
were not a##4##3##(1990-12#1)(1991-2#1)(1995-8#1)(2007-7#1)
were not able to be##2##5##(2007-3#1)(2010-10#1)
were not able to find##2##5##(2007-9#1)(2012-12#1)
were not able to##16##4##(1991-9#1)(1994-12#1)(1994-6#1)(2006-12#1)(2007-3#1)(2007-9#1)(2008-10#3)(2008-11#1)(2010-10#1)(2011-2#2)(2012-12#1)(2013-1#2)
were not accepted##2##3##(2008-5#1)(2012-12#1)
were not accompanied by##3##4##(1991-8#1)(2008-10#1)(2010-7#1)
were not active##2##3##(1995-5#1)(2011-3#1)
were not adsorbed##2##3##(1990-6#1)(1996-8#1)
were not adversely affected##2##4##(1992-2#1)(1996-9#1)
were not affected by the##13##5##(1990-11#1)(1994-12#3)(1996-2#1)(1996-9#1)(2007-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2010-4#1)
were not affected by##42##4##(1990-11#1)(1991-5#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-2#1)(1994-12#3)(1994-2#1)(1994-8#1)(1995-2#1)(1995-3#2)(1996-10#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-7#1)(2006-5#1)(2007-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#1)
were not affected in##5##4##(1995-3#1)(2012-12#3)(2012-2#1)
were not affected significantly by##2##5##(1997-7#1)(2008-12#1)
were not affected significantly##4##4##(1991-1#1)(1997-7#1)(2008-12#1)(2013-8#1)
were not affected when##2##4##(1990-7#1)(2008-10#1)
were not affected##75##3##(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-2#1)(1994-12#3)(1994-2#1)(1994-8#2)(1995-2#1)(1995-3#3)(1996-10#1)(1996-2#3)(1996-4#1)(1996-9#1)(1997-2#1)(1997-5#2)(1997-7#2)(2005-1#1)(2005-11#1)(2005-7#1)(2006-5#1)(2007-1#1)(2008-10#9)(2008-11#2)(2008-12#4)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
were not all##4##3##(2006-5#1)(2008-10#2)(2009-4#1)
were not allowed##2##3##(2007-2#1)(2010-12#1)
were not altered by the##2##5##(1994-9#1)(2008-11#1)
were not altered by##11##4##(1990-5#1)(1992-5#1)(1993-8#1)(1994-10#1)(1994-6#1)(1994-9#1)(1995-12#1)(2007-10#1)(2008-10#1)(2008-11#1)(2011-2#1)
were not altered##19##3##(1990-5#2)(1992-3#1)(1992-5#1)(1993-8#1)(1994-10#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-9#1)(1996-12#1)(1996-8#1)(1997-7#1)(2007-10#1)(2008-10#2)(2008-11#2)(2011-2#1)
were not always##4##3##(2008-10#1)(2009-4#1)(2010-3#1)(2010-8#1)
were not amplified from##2##4##(2008-10#2)
were not amplified##3##3##(1993-7#1)(2008-10#2)
were not any##2##3##(1995-1#1)(2007-2#1)
were not apparent in##2##4##(2007-12#1)(2007-4#1)
were not apparent##4##3##(2007-12#1)(2007-4#1)(2008-10#1)(2013-1#1)
were not as##11##3##(2005-12#1)(2007-11#1)(2007-4#1)(2008-10#3)(2008-5#1)(2008-9#1)(2009-7#2)(2012-2#1)
were not associated with the##5##5##(1996-12#1)(2006-8#1)(2007-8#1)(2008-10#1)(2009-4#1)
were not associated with##25##4##(1990-3#1)(1990-4#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-9#1)(1996-12#1)(1997-6#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-1#1)(2013-8#1)
were not associated##27##3##(1990-3#1)(1990-4#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-9#1)(1996-12#1)(1997-6#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2013-8#1)
were not at##2##3##(1990-3#1)(2012-2#1)
were not available for##2##4##(1990-9#1)(2008-10#1)
were not available in##2##4##(2007-6#1)(2008-6#1)
were not available##7##3##(1990-9#1)(2006-11#1)(2006-8#1)(2007-6#1)(2008-10#1)(2008-6#1)(2013-8#1)
were not aware of##3##4##(2006-6#1)(2011-2#1)(2012-12#1)
were not being##2##3##(2011-2#1)(2013-1#1)
were not better##2##3##(2005-4#1)(2006-3#1)
were not called##2##3##(1991-1#1)(2007-8#1)
were not changed by##4##4##(1994-9#1)(1995-3#1)(2008-8#1)(2010-12#1)
were not changed##10##3##(1990-4#1)(1991-12#1)(1992-3#1)(1993-12#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-10#1)(2008-8#1)(2010-12#1)
were not clearly##2##3##(1990-7#1)(2010-8#1)
were not collected##2##3##(2008-5#2)
were not compatible with##2##4##(1996-3#1)(2007-7#1)
were not completely##4##3##(1992-1#1)(1994-3#1)(2009-3#1)(2013-1#1)
were not conclusive##3##3##(1997-4#1)(2013-1#1)(2013-8#1)
were not conducive##2##3##(2008-10#2)
were not conducted##2##3##(1991-12#1)(2008-10#1)
were not confined to the##2##5##(1996-10#1)(2011-2#1)
were not confirmed##2##3##(1997-5#1)(2012-2#1)
were not considered to be##2##5##(1990-5#1)(1992-2#1)
were not considered##8##3##(1990-5#1)(1992-2#1)(1992-4#1)(2008-10#4)(2011-2#1)
were not consistent with##4##4##(1997-7#1)(2006-12#1)(2008-10#1)(2008-11#1)
were not consistent##7##3##(1997-7#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2013-1#1)(2013-8#1)
were not consistently##2##3##(1996-8#1)(2012-12#1)
were not contained in the##2##5##(1991-7#1)(2012-12#1)
were not correlated with either##2##5##(1990-10#1)(1993-6#1)
were not correlated with the##2##5##(1994-6#1)(2007-3#1)
were not correlated with##11##4##(1990-10#1)(1993-6#1)(1994-6#1)(1996-11#1)(2006-10#1)(2007-3#1)(2008-10#4)(2013-1#1)
were not correlated##15##3##(1990-10#1)(1993-6#1)(1994-6#1)(1996-11#1)(2006-10#1)(2007-2#1)(2007-3#1)(2008-10#6)(2008-5#1)(2013-1#1)
were not cytotoxic##2##3##(1993-9#1)(1994-3#1)
were not decreased##2##3##(1993-12#1)(1993-3#1)
were not dependent on##2##4##(1994-9#1)(2008-12#1)
were not described##2##3##(1991-3#1)(2008-1#1)
were not designed##3##3##(1992-11#1)(2008-1#1)(2009-10#1)
were not detectable in##2##4##(1992-9#1)(1993-7#1)
were not detectable##4##3##(1992-9#1)(1993-7#1)(2010-12#1)(2012-3#1)
were not detected at##3##4##(1994-12#1)(2008-10#1)(2008-5#1)
were not detected by##3##4##(1990-9#1)(1994-8#1)(2008-12#1)
were not detected in any of##2##6##(1996-12#1)(2007-7#1)
were not detected in any##3##5##(1996-12#1)(1997-6#1)(2007-7#1)
were not detected in the##5##5##(1994-12#1)(1997-3#1)(2007-1#1)(2008-10#1)(2013-1#1)
were not detected in this##2##5##(1991-12#1)(1997-4#1)
were not detected in##27##4##(1990-12#1)(1991-12#1)(1991-4#1)(1992-10#1)(1994-12#2)(1994-9#1)(1995-11#1)(1995-4#1)(1995-8#1)(1996-12#1)(1997-3#2)(1997-4#1)(1997-6#2)(2007-1#1)(2007-6#1)(2007-7#1)(2008-10#5)(2013-1#2)(2013-8#1)
were not detected within the confines of the plot sizes tested##2##11##(2008-10#2)
were not detected##59##3##(1990-12#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-10#1)(1992-3#1)(1992-5#1)(1993-9#1)(1994-12#3)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-3#2)(1997-4#1)(1997-6#3)(2006-10#1)(2006-3#1)(2007-1#1)(2007-6#1)(2007-7#1)(2008-10#8)(2008-12#2)(2008-5#5)(2009-6#1)(2010-8#1)(2011-2#2)(2013-1#2)(2013-8#2)
were not diagnosed by##2##4##(2008-7#1)(2010-12#1)
were not diagnosed##3##3##(2008-7#1)(2010-12#1)(2013-8#1)
were not different between patients##2##5##(2006-11#1)(2007-8#1)
were not different between the two groups##3##7##(2007-12#1)(2008-4#1)(2013-8#1)
were not different between the two##4##6##(2007-12#2)(2008-4#1)(2013-8#1)
were not different between the##6##5##(1995-2#1)(2007-12#2)(2008-4#1)(2008-7#1)(2013-8#1)
were not different between##10##4##(1995-2#1)(2006-11#1)(2006-5#1)(2007-12#2)(2007-8#2)(2008-4#1)(2008-7#1)(2013-8#1)
were not different from control##2##5##(1996-7#1)(1997-7#1)
were not different from those of##3##6##(1991-9#1)(2010-12#1)(2010-6#1)
were not different from##9##4##(1991-9#1)(1992-3#1)(1996-7#1)(1997-7#1)(2007-12#1)(2008-10#1)(2010-12#1)(2010-6#1)(2010-7#1)
were not different in##2##4##(1990-12#1)(2006-11#1)
were not different##29##3##(1990-12#1)(1991-9#1)(1992-3#1)(1993-4#1)(1995-2#1)(1996-7#1)(1997-7#1)(2006-11#3)(2006-5#1)(2007-10#1)(2007-12#3)(2007-5#1)(2007-8#3)(2008-10#2)(2008-4#1)(2008-7#1)(2010-12#1)(2010-6#1)(2010-7#1)(2012-12#1)(2013-8#2)
were not diminished##2##3##(1992-3#1)(2009-12#1)
were not due to a##2##5##(1994-3#1)(1995-10#1)
were not due to the##3##5##(1992-7#1)(2008-7#1)(2011-1#1)
were not due to##11##4##(1992-7#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-8#1)(1996-6#2)(1997-1#1)(2007-10#1)(2008-7#1)(2011-1#1)
were not effected##2##3##(2004-11#1)(2007-6#1)
were not effective at##2##4##(1994-11#1)(2011-2#1)
were not effective##10##3##(1992-8#1)(1994-11#1)(1994-3#1)(2005-12#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-12#1)
were not efficient##2##3##(2008-10#1)(2009-11#1)
were not elevated in##4##4##(1990-11#1)(1992-8#1)(1993-6#1)(1995-2#1)
were not elevated##5##3##(1990-11#1)(1992-8#1)(1993-6#1)(1995-2#1)(1997-1#1)
were not employed##2##3##(2006-8#1)(2008-12#1)
were not encountered in##2##4##(1994-8#1)(2008-7#1)
were not encountered##4##3##(1990-3#1)(1994-8#1)(2008-7#1)(2011-1#1)
were not enough##2##3##(1996-11#1)(2008-10#1)
were not essential for##2##4##(1996-7#1)(1997-4#1)
were not essential##3##3##(1996-7#1)(1997-4#1)(2005-11#1)
were not evaluable##2##3##(1991-6#1)(2008-7#1)
were not evaluated in##2##4##(2011-12#1)(2012-2#1)
were not evaluated##3##3##(2011-12#1)(2011-2#1)(2012-2#1)
were not evident in##2##4##(2008-10#2)
were not evident##5##3##(2007-12#1)(2008-10#3)(2011-1#1)
were not expected##2##3##(2006-6#1)(2008-8#1)
were not exposed to the##3##5##(2008-10#1)(2008-12#1)(2008-7#1)
were not exposed to##7##4##(1995-6#1)(2007-1#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-1#1)
were not formed##5##3##(1991-2#1)(2007-1#1)(2008-10#3)
were not found in any##2##5##(1992-5#1)(2007-10#1)
were not found in the##4##5##(1990-4#1)(1993-12#1)(1995-6#1)(2013-8#1)
were not found in##14##4##(1990-3#1)(1990-4#1)(1992-5#1)(1993-12#1)(1995-6#1)(1996-5#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-8#2)(2010-12#1)(2011-2#1)(2013-8#1)
were not found to be significantly##2##6##(1997-3#1)(2004-4#1)
were not found to be##7##5##(1995-6#1)(1997-3#1)(1997-4#1)(2004-4#1)(2006-4#1)(2009-7#1)(2011-2#1)
were not found to correlate##2##5##(2004-10#1)(2007-9#1)
were not found to##12##4##(1995-6#1)(1996-3#1)(1996-4#1)(1997-3#1)(1997-4#1)(2004-10#1)(2004-4#1)(2006-4#1)(2007-9#1)(2008-5#1)(2009-7#1)(2011-2#1)
were not found##44##3##(1990-3#1)(1990-4#1)(1990-6#1)(1992-11#1)(1992-2#2)(1992-5#1)(1992-6#1)(1993-12#1)(1993-8#1)(1995-6#2)(1996-3#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#2)(2004-10#1)(2004-4#1)(2005-11#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-5#3)(2008-8#3)(2009-10#1)(2009-7#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
were not fully##4##3##(1993-7#1)(1996-3#1)(2008-3#1)(2011-2#1)
were not genotoxic##2##3##(1997-4#1)(2013-1#1)
were not given information##2##4##(1997-5#1)(2007-3#1)
were not greatly affected by##2##5##(2008-10#1)(2008-7#1)
were not high##3##3##(2004-9#1)(2008-9#1)(2011-2#1)
were not higher than##4##4##(1990-5#1)(1994-4#1)(2008-10#2)
were not higher##5##3##(1990-5#1)(1994-4#1)(2008-10#2)(2008-11#1)
were not identical##3##3##(1990-4#1)(1990-7#1)(2009-5#1)
were not identified##10##3##(1990-11#1)(1991-4#1)(1995-4#1)(2006-8#1)(2007-7#1)(2008-10#1)(2009-3#1)(2011-1#1)(2012-3#1)(2013-1#1)
were not impaired##3##3##(1993-12#1)(1993-9#1)(1994-3#1)
were not in##5##3##(1992-12#1)(2005-10#1)(2007-6#1)(2008-7#2)
were not included in the##5##5##(1993-5#1)(2007-6#1)(2007-7#1)(2010-1#1)(2010-5#1)
were not included in##7##4##(1993-5#1)(2007-6#1)(2007-7#1)(2008-11#1)(2010-1#1)(2010-5#1)(2012-3#1)
were not included##11##3##(1990-9#1)(1993-5#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-11#1)(2008-4#2)(2010-1#1)(2010-5#1)(2012-3#1)
were not increased in##2##4##(1997-7#1)(2004-12#1)
were not increased##4##3##(1997-7#1)(2004-12#1)(2008-6#1)(2012-2#1)
were not infected##4##3##(2008-10#2)(2008-5#1)(2010-12#1)
were not influenced by##5##4##(1991-7#1)(2008-7#1)(2010-2#1)(2011-12#1)(2012-12#1)
were not influenced##9##3##(1990-11#1)(1990-3#1)(1991-7#1)(2008-11#1)(2008-7#1)(2010-2#1)(2011-12#1)(2012-12#1)(2012-2#1)
were not inhibited by##4##4##(1990-9#1)(1992-12#1)(1995-3#1)(2008-4#1)
were not inhibited##7##3##(1990-9#1)(1991-12#1)(1991-9#1)(1992-12#1)(1995-3#1)(2006-3#1)(2008-4#1)
were not inhibitors##2##3##(1993-4#1)(1995-3#1)
were not injected with##2##4##(2009-10#1)(2012-3#1)
were not interested in##2##4##(1992-3#1)(2012-2#1)
were not involved in##5##4##(1993-6#1)(1996-9#1)(2008-5#1)(2008-6#1)(2008-9#1)
were not involved##8##3##(1993-6#1)(1996-9#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
were not isolated##3##3##(2006-8#1)(2007-2#1)(2012-12#1)
were not likely to##2##4##(1992-2#1)(2008-12#1)
were not linked to##2##4##(2008-10#2)
were not mediated by##3##4##(1995-10#1)(2007-10#1)(2008-11#1)
were not methylated in the##2##5##(1995-2#1)(2008-7#1)
were not modified by the##2##5##(1996-1#1)(2008-3#1)
were not modified by##6##4##(1991-4#1)(1993-3#1)(1994-3#1)(1996-1#1)(2008-3#1)(2008-4#1)
were not modified##9##3##(1991-4#1)(1993-3#1)(1994-12#1)(1994-3#1)(1996-1#1)(1996-7#1)(2008-3#2)(2008-4#1)
were not more impaired than##2##5##(1996-8#1)(2008-12#1)
were not more than##3##4##(1996-6#1)(2011-1#1)(2013-8#1)
were not more##10##3##(1991-3#1)(1992-11#1)(1995-1#1)(1996-6#1)(1996-8#1)(2008-12#2)(2011-1#1)(2012-3#1)(2013-8#1)
were not much##2##3##(2008-5#1)(2013-8#1)
were not necessarily##5##3##(1991-5#1)(2007-12#1)(2007-4#1)(2008-5#1)(2010-8#1)
were not observed between##2##4##(1995-3#1)(1997-7#1)
were not observed for##2##4##(1991-9#1)(2008-10#1)
were not observed in the##3##5##(2008-10#2)(2010-12#1)
were not observed in##17##4##(1990-2#1)(1990-4#1)(1992-5#1)(1993-12#1)(1994-8#1)(1995-12#1)(2006-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-1#1)
were not observed to##2##4##(1991-7#1)(2008-10#1)
were not observed with##2##4##(1990-10#1)(1993-8#1)
were not observed##48##3##(1990-10#2)(1990-11#1)(1990-2#1)(1990-4#1)(1991-2#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-7#1)(2005-12#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#9)(2008-11#1)(2008-12#1)(2010-12#1)(2010-7#2)(2011-2#1)(2012-1#1)
were not obtained##3##3##(1994-9#1)(2006-7#1)(2007-5#1)
were not obvious##2##3##(2007-11#1)(2008-7#1)
were not on##6##3##(2007-7#1)(2008-5#3)(2010-12#1)(2012-1#1)
were not only##8##3##(1990-5#1)(1995-1#1)(1996-9#1)(1997-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-7#1)
were not or##3##3##(1996-9#1)(2008-10#2)
were not paralleled##2##3##(1992-11#1)(1997-5#1)
were not performed##3##3##(1992-9#1)(1994-12#1)(1995-11#1)
were not positively##2##3##(2006-5#1)(2007-12#1)
were not possible in the##2##5##(1995-10#1)(2008-8#1)
were not possible##4##3##(1995-10#1)(2006-11#1)(2008-2#1)(2008-8#1)
were not predictive of##3##4##(2008-10#1)(2008-11#1)(2010-11#1)
were not predictive##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2010-11#1)
were not present in the##4##5##(2008-10#1)(2008-12#1)(2013-1#2)
were not present in##5##4##(1990-4#1)(2008-10#1)(2008-12#1)(2013-1#2)
were not present##12##3##(1990-4#1)(1992-2#1)(1994-12#1)(2008-10#2)(2008-12#1)(2009-6#1)(2010-6#1)(2011-12#1)(2012-12#1)(2013-1#2)
were not previously##6##3##(1991-5#1)(2008-10#1)(2010-4#1)(2012-12#1)(2013-1#2)
were not produced##2##3##(1993-9#1)(2008-8#1)
were not receiving##3##3##(2005-8#1)(2008-5#1)(2008-7#1)
were not recognized by##2##4##(1991-6#1)(1992-12#1)
were not recognized##3##3##(1991-6#1)(1992-12#1)(1995-3#1)
were not recorded##2##3##(1994-2#1)(2008-5#1)
were not recovered from##2##4##(2005-9#1)(2008-10#1)
were not recovered##3##3##(2005-9#1)(2008-10#2)
were not reduced in number##2##5##(1993-12#1)(1994-2#1)
were not reduced in##3##4##(1993-12#1)(1993-3#1)(1994-2#1)
were not related to the##6##5##(1992-11#1)(1992-5#1)(1993-2#1)(2004-2#1)(2009-5#1)(2010-8#1)
were not related to##20##4##(1992-11#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-12#1)(1996-12#1)(2004-2#1)(2007-12#2)(2008-10#1)(2008-12#1)(2009-12#1)(2009-5#1)(2010-8#2)(2011-1#1)
were not reliable##2##3##(1993-1#1)(1996-5#1)
were not reported##2##3##(1993-3#1)(2008-9#1)
were not required for##6##4##(1991-8#1)(1993-9#1)(1995-3#1)(1995-5#1)(1996-5#1)(1997-3#1)
were not required##10##3##(1991-8#1)(1993-9#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-5#1)(1997-3#1)(2013-1#1)
were not restricted to##3##4##(1996-9#1)(2007-10#1)(2008-4#1)
were not ruled out##2##4##(1997-5#1)(2008-10#1)
were not satisfied with their##2##5##(2007-10#1)(2012-2#1)
were not satisfied with##3##4##(2007-10#2)(2012-2#1)
were not seen in##2##4##(1995-11#1)(2007-12#1)
were not seen within the##2##5##(1997-3#1)(2013-1#1)
were not seen##7##3##(1991-11#1)(1995-11#1)(1997-3#1)(2007-12#1)(2010-12#1)(2010-9#1)(2013-1#1)
were not sensitive to##3##4##(1995-8#1)(1997-5#1)(2010-3#1)
were not severe##3##3##(2008-1#1)(2008-5#1)(2011-2#1)
were not shown##2##3##(2008-8#1)(2011-2#1)
were not significant (p &lt##2##5##(2008-5#2)
were not significant (p##3##4##(2007-6#1)(2008-5#2)
were not significant and##2##4##(1997-4#1)(2008-10#1)
were not significant for##3##4##(2008-10#1)(2008-12#1)(2008-4#1)
were not significant##55##3##(1990-12#1)(1992-2#2)(1994-12#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-6#1)(1996-10#1)(1997-4#1)(1997-5#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-6#3)(2007-7#1)(2008-10#5)(2008-12#4)(2008-3#1)(2008-4#3)(2008-5#5)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#2)(2009-5#1)(2010-12#1)(2010-8#3)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#4)
were not significantly (P &gt##2##5##(2008-10#1)(2012-2#1)
were not significantly (p &gt##2##5##(2007-8#2)
were not significantly affected by##7##5##(1993-12#1)(1994-3#1)(2004-9#1)(2005-8#1)(2008-10#2)(2010-2#1)
were not significantly affected##10##4##(1993-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1997-1#1)(2004-9#1)(2005-8#1)(2008-10#2)(2010-2#1)
were not significantly altered##5##4##(1990-5#1)(1995-3#1)(1996-11#1)(2009-6#1)(2012-12#1)
were not significantly associated with##2##5##(2008-10#1)(2012-2#1)
were not significantly changed##3##4##(1993-3#1)(1994-2#1)(1995-6#1)
were not significantly correlated with the##2##6##(2006-4#1)(2008-7#1)
were not significantly correlated with##6##5##(2006-4#1)(2008-10#1)(2008-7#2)(2011-2#2)
were not significantly correlated##7##4##(1990-8#1)(2006-4#1)(2008-10#1)(2008-7#2)(2011-2#2)
were not significantly different (p&gt##3##5##(2007-2#1)(2008-5#1)(2012-12#1)
were not significantly different after##2##5##(2004-11#1)(2011-2#1)
were not significantly different among the##2##6##(2008-12#1)(2008-7#1)
were not significantly different among##4##5##(2008-10#2)(2008-12#1)(2008-7#1)
were not significantly different between normal and##2##7##(1995-11#1)(1995-5#1)
were not significantly different between the two groups##2##8##(1992-10#1)(2008-5#1)
were not significantly different between the##5##6##(1992-10#1)(2007-1#1)(2008-5#1)(2012-11#1)(2012-12#1)
were not significantly different between##19##5##(1991-3#1)(1992-10#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-7#1)(1997-2#1)(2007-1#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-11#1)(2011-12#1)(2012-11#1)(2012-12#1)
were not significantly different for##3##5##(1994-2#1)(1995-9#1)(2008-10#1)
were not significantly different from controls##2##6##(1991-12#1)(2008-7#1)
were not significantly different from each other##2##7##(1995-2#1)(2008-5#1)
were not significantly different from that##2##6##(2008-8#1)(2012-12#1)
were not significantly different from the##6##6##(1994-3#1)(2008-10#2)(2009-3#1)(2011-2#1)(2012-3#1)
were not significantly different from those of##2##7##(1995-3#1)(2010-8#1)
were not significantly different from those##8##6##(1991-12#1)(1992-3#1)(1994-2#1)(1995-3#1)(1996-9#1)(2008-8#1)(2010-8#1)(2012-3#1)
were not significantly different from##30##5##(1991-12#2)(1992-3#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-9#2)(2006-6#1)(2008-10#8)(2008-5#1)(2008-7#1)(2008-8#2)(2009-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
were not significantly different in the two groups##2##8##(1992-3#1)(2007-1#1)
were not significantly different in the##6##6##(1992-3#1)(1995-6#1)(1997-7#1)(1997-8#1)(2007-1#1)(2008-11#1)
were not significantly different in##9##5##(1992-3#1)(1995-6#1)(1997-7#1)(1997-8#1)(2007-1#1)(2008-11#1)(2008-12#2)(2011-2#1)
were not significantly different when##2##5##(1996-3#1)(2011-12#1)
were not significantly different##94##4##(1990-9#1)(1991-12#3)(1991-3#1)(1992-10#1)(1992-3#2)(1992-7#1)(1994-2#3)(1994-3#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#3)(1997-2#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-1#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#13)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#3)(2009-11#1)(2009-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#4)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)
were not significantly increased in##2##5##(2007-11#1)(2009-3#1)
were not significantly increased##3##4##(2007-11#1)(2009-3#1)(2010-12#1)
were not significantly modified##2##4##(1997-7#1)(2008-5#1)
were not significantly related to##4##5##(1991-8#1)(1993-4#1)(2007-7#1)(2007-9#1)
were not significantly##147##3##(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#3)(1991-3#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-7#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-2#5)(1994-3#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#3)(1997-1#1)(1997-2#1)(1997-7#2)(1997-8#2)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-1#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#23)(2008-11#1)(2008-12#4)(2008-4#1)(2008-5#5)(2008-7#5)(2008-8#3)(2009-11#1)(2009-3#2)(2009-6#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#7)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#2)
were not so##3##3##(1992-2#1)(2008-10#1)(2008-11#1)
were not spatially##2##3##(2008-10#2)
were not stable##2##3##(2008-10#1)(2009-9#1)
were not stained by##2##4##(1990-3#1)(1990-6#1)
were not stained with##3##4##(1992-7#1)(1996-6#1)(1997-5#1)
were not stained##7##3##(1990-3#1)(1990-6#1)(1990-7#1)(1992-7#1)(1996-4#1)(1996-6#1)(1997-5#1)
were not statistically different between the##2##6##(2008-7#1)(2012-3#1)
were not statistically different between##3##5##(2008-7#1)(2012-3#2)
were not statistically different from those##2##6##(2008-10#1)(2011-1#1)
were not statistically different##11##4##(1994-2#1)(1997-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-1#1)(2011-1#1)(2011-2#1)(2012-3#2)
were not statistically significant (p##2##5##(2008-1#1)(2008-12#1)
were not statistically significant##31##4##(1991-11#2)(1991-6#1)(1992-2#1)(1996-3#1)(2004-10#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-12#1)(2008-8#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
were not statistically##44##3##(1991-11#2)(1991-6#1)(1992-2#1)(1994-2#1)(1996-3#1)(1997-8#1)(2004-10#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
were not strongly##2##3##(2006-12#1)(2008-10#1)
were not successful in##3##4##(1992-2#1)(2007-8#1)(2008-10#1)
were not successful##11##3##(1990-5#1)(1991-2#1)(1992-2#2)(1996-4#1)(2006-12#1)(2007-8#1)(2008-10#3)(2012-2#1)
were not sufficient to##2##4##(2005-12#1)(2010-8#1)
were not supported##3##3##(1996-3#1)(2006-10#1)(2007-12#1)
were not sure##2##3##(2008-10#1)(2012-2#1)
were not surprising##2##3##(1997-2#1)(2006-2#1)
were not taking their##2##4##(2010-1#2)
were not taking##9##3##(2006-7#1)(2007-8#1)(2007-9#1)(2008-7#1)(2008-9#1)(2010-1#4)
were not the same##2##4##(1994-3#1)(2008-10#1)
were not the##4##3##(1994-3#1)(2008-10#1)(2009-3#1)(2011-1#1)
were not told##2##3##(2007-2#1)(2008-10#1)
were not treated with##3##4##(1997-3#1)(2007-8#1)(2013-1#1)
were not treated##6##3##(1990-10#1)(1996-6#1)(1997-3#1)(2007-8#1)(2008-11#1)(2013-1#1)
were not uniform##2##3##(1991-1#1)(2008-10#1)
were not up-regulated in##2##4##(1993-2#1)(2008-10#1)
were not used##2##3##(2011-2#1)(2012-2#1)
were not useful##3##3##(2006-10#1)(2008-10#1)(2011-2#1)
were not usually available##2##4##(1992-10#1)(1995-2#1)
were not usually##3##3##(1992-10#1)(1995-2#1)(2008-10#1)
were not utilized##2##3##(1994-11#1)(2008-10#1)
were not validated##2##3##(2008-10#1)(2011-2#1)
were not very##4##3##(1990-12#1)(1991-2#1)(1991-3#1)(2013-8#1)
were not visible##4##3##(1993-10#1)(1993-2#1)(2007-11#1)(2008-10#1)
were not well understood##2##4##(2009-4#1)(2012-12#1)
were not well##7##3##(1996-1#1)(1996-8#1)(2007-4#1)(2009-4#1)(2010-8#1)(2012-12#1)(2012-2#1)
were not willing to##2##4##(2006-8#1)(2009-5#1)
were not##1447##2##(1990-10#5)(1990-11#6)(1990-12#6)(1990-2#1)(1990-3#9)(1990-4#8)(1990-5#8)(1990-6#3)(1990-7#6)(1990-8#5)(1990-9#6)(1991-1#3)(1991-10#2)(1991-11#4)(1991-12#11)(1991-2#6)(1991-3#8)(1991-4#4)(1991-5#4)(1991-6#6)(1991-7#4)(1991-8#6)(1991-9#7)(1992-1#3)(1992-10#4)(1992-11#5)(1992-12#6)(1992-2#13)(1992-3#9)(1992-4#2)(1992-5#5)(1992-6#4)(1992-7#4)(1992-8#6)(1992-9#4)(1993-1#4)(1993-10#1)(1993-11#3)(1993-12#13)(1993-2#5)(1993-3#6)(1993-4#3)(1993-5#2)(1993-6#5)(1993-7#3)(1993-8#6)(1993-9#11)(1994-10#2)(1994-11#4)(1994-12#14)(1994-2#13)(1994-3#14)(1994-4#1)(1994-5#1)(1994-6#5)(1994-8#10)(1994-9#8)(1995-1#5)(1995-10#5)(1995-11#5)(1995-12#11)(1995-2#10)(1995-3#13)(1995-4#2)(1995-5#4)(1995-6#7)(1995-8#4)(1995-9#2)(1996-1#3)(1996-10#5)(1996-11#3)(1996-12#11)(1996-2#6)(1996-3#6)(1996-4#4)(1996-5#6)(1996-6#7)(1996-7#4)(1996-8#6)(1996-9#10)(1997-1#5)(1997-2#7)(1997-3#8)(1997-4#7)(1997-5#12)(1997-6#7)(1997-7#10)(1997-8#5)(2004-10#2)(2004-11#4)(2004-12#1)(2004-2#1)(2004-4#2)(2004-9#2)(2005-1#2)(2005-10#2)(2005-11#4)(2005-12#4)(2005-4#1)(2005-7#1)(2005-8#4)(2005-9#1)(2006-10#8)(2006-11#5)(2006-12#11)(2006-2#3)(2006-3#4)(2006-4#2)(2006-5#7)(2006-6#3)(2006-7#5)(2006-8#10)(2006-9#2)(2007-1#9)(2007-10#12)(2007-11#9)(2007-12#23)(2007-2#14)(2007-3#6)(2007-4#4)(2007-5#6)(2007-6#8)(2007-7#14)(2007-8#18)(2007-9#6)(2008-1#7)(2008-10#193)(2008-11#20)(2008-12#27)(2008-2#4)(2008-3#8)(2008-4#14)(2008-5#47)(2008-6#5)(2008-7#28)(2008-8#17)(2008-9#9)(2009-1#1)(2009-10#3)(2009-11#3)(2009-12#4)(2009-2#3)(2009-3#5)(2009-4#5)(2009-5#7)(2009-6#3)(2009-7#4)(2009-8#2)(2009-9#2)(2010-1#5)(2010-10#3)(2010-11#1)(2010-12#15)(2010-2#7)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#4)(2010-7#7)(2010-8#16)(2010-9#4)(2011-1#17)(2011-12#7)(2011-2#46)(2011-3#1)(2012-1#7)(2012-11#1)(2012-12#26)(2012-2#22)(2012-3#12)(2013-1#47)(2013-7#1)(2013-8#23)
were notable for##4##3##(2004-3#1)(2007-10#1)(2008-5#1)(2012-3#1)
were notable##5##2##(2004-3#1)(2007-10#1)(2008-5#1)(2012-3#2)
were notably##4##2##(2007-5#1)(2007-7#1)(2008-5#1)(2013-8#1)
were noted after##4##3##(1996-10#1)(2006-10#1)(2008-5#1)(2008-7#1)
were noted among##5##3##(1993-2#1)(1994-1#1)(2008-10#1)(2008-7#1)(2012-3#1)
were noted and##5##3##(1995-9#1)(2006-1#1)(2009-4#1)(2010-4#1)(2013-8#1)
were noted at##4##3##(2006-10#1)(2007-2#1)(2010-8#1)(2013-1#1)
were noted between##7##3##(1995-2#1)(2007-2#1)(2007-7#1)(2007-8#1)(2009-2#1)(2010-3#1)(2012-12#1)
were noted down##2##3##(2007-11#1)(2010-7#1)
were noted during the##2##4##(1993-1#1)(1995-2#1)
were noted during##5##3##(1990-8#1)(1993-1#1)(1995-2#1)(1997-7#1)(2012-2#1)
were noted for the##3##4##(1991-3#1)(2006-12#1)(2007-2#1)
were noted for##13##3##(1990-6#1)(1991-3#1)(1993-9#1)(2006-12#1)(2007-2#2)(2007-6#1)(2008-10#2)(2009-11#1)(2011-12#1)(2011-2#2)
were noted in 12##2##4##(2007-7#1)(2013-1#1)
were noted in all##3##4##(2005-7#1)(2006-6#1)(2007-9#1)
were noted in patients with##3##5##(1993-12#1)(1997-8#1)(2005-8#1)
were noted in the group with##2##6##(2007-11#1)(2013-8#1)
were noted in the##20##4##(1995-4#1)(1996-2#1)(1996-9#1)(1997-7#1)(2004-11#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-2#2)(2007-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-2#1)(2010-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
were noted in##62##3##(1990-12#1)(1991-4#1)(1992-1#1)(1993-12#1)(1993-9#1)(1994-9#1)(1995-4#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-11#4)(2007-2#2)(2007-6#1)(2007-7#2)(2007-9#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#3)(2009-10#1)(2009-3#1)(2010-2#2)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#2)
were noted on##5##3##(1992-3#1)(1994-12#1)(2006-6#1)(2007-9#1)(2008-4#1)
were noted only in the##2##5##(1997-7#1)(2007-8#1)
were noted that##2##3##(2006-12#1)(2008-10#1)
were noted to be##3##4##(2006-6#1)(2008-7#1)(2009-7#1)
were noted to have##4##4##(2007-3#1)(2008-5#1)(2008-6#1)(2012-2#1)
were noted to##10##3##(1990-12#1)(1992-3#1)(2006-6#1)(2007-3#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2012-2#1)
were noted with##4##3##(1991-2#1)(1993-9#1)(2006-10#1)(2007-2#1)
were noted within##2##3##(2007-7#1)(2008-10#1)
were noted##192##2##(1990-12#2)(1990-2#1)(1990-6#3)(1990-8#1)(1991-2#2)(1991-3#3)(1991-4#1)(1992-1#1)(1992-3#2)(1993-1#2)(1993-12#2)(1993-2#2)(1993-3#2)(1993-7#1)(1993-9#4)(1994-1#1)(1994-12#2)(1994-2#1)(1994-9#2)(1995-11#1)(1995-2#2)(1995-4#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-7#3)(1997-8#1)(2004-11#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-11#2)(2006-12#3)(2006-4#2)(2006-6#3)(2006-7#1)(2006-8#3)(2007-11#7)(2007-2#10)(2007-3#1)(2007-5#2)(2007-6#2)(2007-7#5)(2007-8#4)(2007-9#3)(2008-1#2)(2008-10#7)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#5)(2008-9#4)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#8)(2013-8#6)
were noticeable##3##2##(1994-6#1)(2007-8#1)(2013-7#1)
were noticeably##2##2##(1995-11#1)(2008-9#1)
were noticed in the##2##4##(1996-1#1)(2013-8#1)
were noticed in##6##3##(1993-5#1)(1996-1#1)(2007-8#1)(2008-10#1)(2008-8#1)(2013-8#1)
were noticed##14##2##(1993-11#1)(1993-5#1)(1994-2#1)(1996-1#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-6#1)(2008-8#1)(2010-6#1)(2013-7#1)(2013-8#1)
were notified##3##2##(2010-10#1)(2012-1#1)(2012-12#1)
were novel##3##2##(1997-5#1)(2007-12#1)(2008-5#1)
were now##5##2##(1991-2#1)(1995-8#1)(1997-3#1)(2008-1#1)(2008-7#1)
were number of##3##3##(2007-1#1)(2011-1#1)(2011-2#1)
were numerous##6##2##(1992-1#1)(1995-7#1)(2007-8#1)(2008-10#1)(2011-1#1)(2013-8#1)
were nurses##4##2##(1993-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
were obese##12##2##(1997-2#1)(2006-8#1)(2008-3#2)(2008-7#1)(2009-2#1)(2009-9#1)(2012-2#1)(2013-1#2)(2013-8#2)
were obliged to##2##3##(2009-7#1)(2011-2#1)
were obscured##5##2##(2006-7#1)(2007-8#1)(2008-8#1)(2013-1#2)
were observable##2##2##(2007-12#1)(2012-2#1)
were observed (P &lt##2##4##(2008-5#1)(2011-1#1)
were observed (P##4##3##(1994-12#1)(2008-5#1)(2011-1#1)(2013-1#1)
were observed 6##2##3##(2008-10#1)(2011-2#1)
were observed according to the##2##5##(2004-12#1)(2008-10#1)
were observed across##2##3##(2007-5#1)(2008-11#1)
were observed after 12##2##4##(2004-9#1)(2008-12#1)
were observed after administration of##2##5##(1993-11#1)(2008-10#1)
were observed after the##2##4##(1993-11#1)(2007-2#1)
were observed after##26##3##(1990-2#1)(1991-2#1)(1991-4#1)(1992-1#1)(1992-11#1)(1993-11#2)(1995-3#1)(1996-3#1)(2004-9#1)(2006-10#2)(2007-12#1)(2007-2#1)(2008-10#3)(2008-12#2)(2008-5#1)(2008-7#1)(2009-10#1)(2012-1#1)(2012-3#2)(2013-1#1)
were observed among different##2##4##(2008-10#1)(2013-1#1)
were observed among isolates in##2##5##(2008-10#2)
were observed among isolates##4##4##(2008-10#4)
were observed among the##8##4##(1997-2#1)(2006-9#2)(2008-10#1)(2008-5#1)(2008-6#1)(2010-8#1)(2013-1#1)
were observed among these three##2##5##(1997-2#1)(2008-10#1)
were observed among##28##3##(1991-9#1)(1994-3#1)(1997-2#2)(2006-9#2)(2008-10#11)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-8#2)(2011-1#1)(2013-1#3)
were observed and no##2##4##(1997-3#1)(2008-10#1)
were observed and the##6##4##(2008-12#1)(2008-5#1)(2008-8#1)(2009-8#1)(2013-1#1)(2013-7#1)
were observed and##26##3##(1990-2#1)(1991-3#1)(1992-6#1)(1993-1#1)(1995-6#1)(1997-3#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-8#1)(2013-1#5)(2013-7#1)
were observed as a function of##2##6##(1993-6#1)(2007-4#1)
were observed as well##2##4##(1993-7#1)(2008-10#1)
were observed as##12##3##(1990-4#1)(1993-6#1)(1993-7#1)(1994-2#1)(1995-1#1)(1996-12#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-5#1)
were observed associated##2##3##(1995-2#1)(2013-1#1)
were observed at a##2##4##(1994-2#1)(2008-5#1)
were observed at both##2##4##(2005-7#1)(2008-10#1)
were observed at doses##2##4##(1993-11#1)(2008-10#1)
were observed at low##2##4##(1991-8#1)(1997-6#1)
were observed at the end of the##3##7##(2006-2#1)(2008-8#1)(2013-1#1)
were observed at the end of##5##6##(2006-2#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
were observed at the##20##4##(1993-3#1)(1993-8#1)(1996-8#1)(1997-6#2)(2006-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#3)(2008-8#1)(2010-10#1)(2011-2#2)(2012-2#1)(2013-1#2)
were observed at##66##3##(1990-2#1)(1990-4#1)(1990-9#1)(1991-11#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-2#3)(1995-12#1)(1996-3#1)(1996-8#1)(1997-5#1)(1997-6#5)(1997-7#1)(2005-10#1)(2005-7#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#6)(2008-8#1)(2008-9#3)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#2)
were observed before##2##3##(2008-10#1)(2012-3#1)
were observed between both##2##4##(1994-2#1)(1997-2#1)
were observed between control and##2##5##(1991-5#1)(2008-10#1)
were observed between control##3##4##(1991-5#1)(1992-1#1)(2008-10#1)
were observed between groups##2##4##(2008-5#2)
were observed between the two groups##3##6##(2008-10#1)(2008-3#1)(2011-2#1)
were observed between the two##6##5##(1994-6#1)(1995-5#1)(2008-10#2)(2008-3#1)(2011-2#1)
were observed between the##28##4##(1990-10#1)(1990-12#1)(1990-4#1)(1992-3#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-3#1)(1995-5#1)(2006-5#1)(2007-1#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-4#1)(2011-1#1)(2011-2#2)(2013-1#1)
were observed between two##2##4##(1996-11#1)(1997-8#1)
were observed between##76##3##(1990-10#1)(1990-12#2)(1990-4#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#2)(1994-9#1)(1995-10#1)(1995-3#1)(1995-5#1)(1996-11#2)(1996-2#1)(1997-2#1)(1997-8#1)(2005-11#1)(2006-5#1)(2007-1#1)(2007-10#2)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2009-4#2)(2010-5#1)(2011-1#3)(2011-2#4)(2012-11#1)(2013-1#2)
were observed bilaterally in the ventral##2##6##(1996-11#1)(2009-2#1)
were observed by 1 h##2##5##(1994-9#1)(2010-8#1)
were observed by scanning electron##2##5##(2004-9#1)(2008-10#1)
were observed by##16##3##(1992-2#1)(1992-5#1)(1994-9#1)(1996-7#1)(2004-9#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-11#1)(2012-12#1)
were observed during the early##2##5##(1995-12#1)(2008-6#1)
were observed during the period##2##5##(2007-8#1)(2012-12#1)
were observed during the study##2##5##(2005-12#1)(2008-4#1)
were observed during the##18##4##(1993-2#1)(1995-12#1)(2005-12#1)(2007-5#1)(2007-8#4)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#2)(2010-12#1)(2012-12#1)
were observed during##37##3##(1993-2#1)(1993-8#1)(1993-9#1)(1995-12#2)(1997-6#1)(2005-12#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-8#4)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#6)(2008-6#2)(2008-9#1)(2009-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-7#1)
were observed either in##2##4##(1991-5#1)(1994-6#1)
were observed even after##2##4##(1993-7#1)(2008-10#1)
were observed except##2##3##(1990-12#1)(2013-1#1)
were observed feeding##2##3##(2008-5#1)(2008-6#1)
were observed first##3##3##(2007-7#1)(2007-8#1)(2008-10#1)
were observed following##8##3##(1991-1#1)(1993-4#1)(1993-6#1)(1994-2#1)(1995-11#1)(2008-10#1)(2008-4#1)(2012-12#1)
were observed for a##4##4##(1993-6#1)(1996-5#1)(2008-5#1)(2013-8#1)
were observed for all the##2##5##(2008-10#2)
were observed for all##7##4##(1991-7#1)(2008-10#4)(2010-10#1)(2012-1#1)
were observed for both##5##4##(1993-11#1)(1996-11#1)(1996-2#1)(1996-8#1)(2008-10#1)
were observed for most of the##2##6##(2007-11#1)(2008-10#1)
were observed for mouth and pharynx##2##6##(1990-8#2)
were observed for the presence##2##5##(1991-8#1)(1995-10#1)
were observed for the##24##4##(1991-1#1)(1991-8#1)(1992-12#1)(1992-6#1)(1994-2#1)(1995-10#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(2005-11#1)(2007-11#3)(2007-5#1)(2008-10#6)(2008-5#1)(2008-6#1)(2011-2#1)
were observed for##98##3##(1990-12#1)(1990-7#1)(1990-8#4)(1991-1#1)(1991-2#1)(1991-5#3)(1991-7#2)(1991-8#1)(1992-10#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-10#2)(1995-5#1)(1996-11#4)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#2)(1996-8#1)(1997-4#1)(2005-11#2)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#24)(2008-2#2)(2008-5#3)(2008-6#1)(2008-7#1)(2009-11#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#4)(2013-8#2)
were observed from the##2##4##(2010-3#1)(2011-2#1)
were observed from##14##3##(1996-2#1)(2007-12#2)(2008-1#1)(2008-10#6)(2008-3#1)(2010-3#1)(2010-8#1)(2011-2#1)
were observed in 14##2##4##(2006-6#1)(2007-10#1)
were observed in 2##3##4##(1995-10#1)(2006-8#1)(2007-7#1)
were observed in 32##2##4##(1996-1#1)(2008-12#1)
were observed in 37##2##4##(1992-8#1)(2007-2#1)
were observed in 38##3##4##(2007-7#1)(2013-1#1)(2013-8#1)
were observed in 4##3##4##(2008-1#1)(2013-8#2)
were observed in Group##3##4##(2006-5#1)(2007-8#1)(2010-7#1)
were observed in a##18##4##(1990-10#1)(1990-5#1)(1991-2#1)(1991-9#1)(1997-4#1)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
were observed in all 3##2##5##(1997-7#1)(2011-2#1)
were observed in all cases##2##5##(2007-10#1)(2009-12#1)
were observed in all##13##4##(1990-2#1)(1993-8#1)(1996-11#1)(1997-6#1)(1997-7#1)(2007-10#2)(2008-10#1)(2008-5#1)(2009-12#1)(2011-1#1)(2011-2#2)
were observed in animals treated with##2##6##(1994-2#1)(1995-3#1)
were observed in animals##3##4##(1994-2#1)(1995-3#1)(2007-2#1)
were observed in any##2##4##(1996-12#1)(2008-10#1)
were observed in both##6##4##(1995-11#1)(1996-4#1)(2008-12#1)(2008-5#1)(2012-1#1)(2012-2#1)
were observed in brain##2##4##(1990-4#1)(1995-12#1)
were observed in cells##3##4##(1992-8#1)(1995-8#1)(1996-1#1)
were observed in comparison##2##4##(2008-10#1)(2013-7#1)
were observed in different##2##4##(2008-10#1)(2013-7#1)
were observed in either##3##4##(1990-6#1)(1996-9#1)(2013-1#1)
were observed in four patients##2##5##(2006-8#1)(2007-8#1)
were observed in four##3##4##(2006-8#1)(2007-8#2)
were observed in male and female##2##6##(1995-11#1)(2008-9#1)
were observed in male##4##4##(1995-11#1)(1996-11#1)(2008-9#1)(2011-2#1)
were observed in males##2##4##(1997-3#1)(2011-2#1)
were observed in many##2##4##(1994-12#1)(2009-12#1)
were observed in mice##2##4##(1997-8#1)(2010-12#1)
were observed in more##2##4##(2006-11#1)(2008-9#1)
were observed in most##3##4##(1995-12#1)(2008-10#1)(2008-5#1)
were observed in nuclear##2##4##(1993-12#1)(2013-1#1)
were observed in one of the##2##6##(1997-6#1)(1997-8#1)
were observed in only one##2##5##(1993-12#1)(2008-4#1)
were observed in only##5##4##(1990-2#1)(1990-9#1)(1991-4#1)(1993-12#1)(2008-4#1)
were observed in other##3##4##(1995-6#1)(2004-11#1)(2011-1#1)
were observed in patients receiving##2##5##(1992-2#1)(2011-2#1)
were observed in patients with##3##5##(2006-6#1)(2008-6#1)(2010-2#1)
were observed in patients##11##4##(1992-2#1)(1995-3#1)(2006-6#2)(2007-11#1)(2007-7#1)(2008-6#1)(2008-7#1)(2010-2#1)(2011-2#1)(2013-1#1)
were observed in poults fed##2##5##(2008-5#2)
were observed in relation to##2##5##(2008-5#1)(2008-6#1)
were observed in response to##3##5##(2005-12#1)(2008-10#1)(2009-4#1)
were observed in some##2##4##(1994-5#1)(2008-10#1)
were observed in subjects##2##4##(1992-2#1)(2008-7#1)
were observed in the absence##3##5##(1992-10#1)(1994-12#1)(2008-9#1)
were observed in the cerebral##2##5##(1993-7#1)(2012-12#1)
were observed in the control##2##5##(1994-5#1)(2008-10#1)
were observed in the fatty acid##2##6##(1996-4#1)(2010-4#1)
were observed in the first##2##5##(1992-7#1)(1992-8#1)
were observed in the groups##2##5##(2008-6#1)(2013-7#1)
were observed in the hippocampus##2##5##(1992-12#1)(1995-12#1)
were observed in the kidneys of##2##6##(1994-5#1)(1996-11#1)
were observed in the liver##2##5##(2007-9#1)(2008-7#1)
were observed in the majority of##2##6##(2007-11#1)(2008-6#1)
were observed in the olfactory bulb##2##6##(2008-6#1)(2008-7#1)
were observed in the presence of##2##6##(1995-11#1)(2008-10#1)
were observed in the ranges of##3##6##(2008-10#2)(2011-1#1)
were observed in the transgenic##2##5##(2006-12#1)(2010-5#1)
were observed in the ultraendurance runners##2##6##(2013-8#2)
were observed in the##171##4##(1990-4#1)(1990-5#2)(1990-6#2)(1991-10#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-7#1)(1993-9#1)(1994-12#2)(1994-2#3)(1994-5#3)(1994-8#1)(1995-1#3)(1995-11#4)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-8#1)(1997-9#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-12#1)(2007-10#3)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-9#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#7)(2008-6#6)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#5)
were observed in these##3##4##(1994-11#1)(2007-11#1)(2012-2#1)
were observed in this##5##4##(1992-3#1)(2005-8#1)(2006-8#1)(2008-10#1)(2010-5#1)
were observed in three##2##4##(1996-11#1)(2008-7#1)
were observed in two##3##4##(1990-12#1)(2007-7#2)
were observed in vitro##4##4##(1996-5#1)(2008-12#1)(2010-9#1)(2012-12#1)
were observed in##508##3##(1990-10#3)(1990-12#3)(1990-2#2)(1990-4#4)(1990-5#3)(1990-6#3)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#3)(1992-2#6)(1992-3#3)(1992-6#1)(1992-7#2)(1992-8#5)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#5)(1993-2#1)(1993-3#3)(1993-4#1)(1993-7#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#4)(1994-2#5)(1994-3#2)(1994-5#4)(1994-8#3)(1994-9#1)(1995-1#3)(1995-10#2)(1995-11#7)(1995-12#3)(1995-2#1)(1995-3#5)(1995-5#5)(1995-6#2)(1995-7#1)(1995-8#2)(1996-1#3)(1996-11#5)(1996-12#5)(1996-2#1)(1996-3#2)(1996-4#3)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#4)(1997-3#3)(1997-4#4)(1997-6#3)(1997-7#2)(1997-8#5)(1997-9#1)(2004-11#1)(2004-4#1)(2005-12#2)(2005-6#1)(2005-7#1)(2005-8#3)(2006-1#1)(2006-11#2)(2006-12#2)(2006-4#1)(2006-5#2)(2006-6#3)(2006-8#5)(2007-10#7)(2007-11#11)(2007-12#7)(2007-2#7)(2007-3#1)(2007-4#1)(2007-5#3)(2007-7#9)(2007-8#7)(2007-9#4)(2008-1#3)(2008-10#54)(2008-11#3)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#24)(2008-6#11)(2008-7#11)(2008-8#6)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#4)(2009-2#1)(2009-4#3)(2009-5#3)(2009-6#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#5)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#7)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#9)(2012-2#11)(2012-3#4)(2013-1#18)(2013-7#3)(2013-8#13)
were observed inside the##2##4##(2004-9#1)(2012-3#1)
were observed more frequently in##2##5##(2005-10#1)(2011-2#1)
were observed more frequently##3##4##(2005-10#1)(2008-5#1)(2011-2#1)
were observed more##4##3##(1995-6#1)(2005-10#1)(2008-5#1)(2011-2#1)
were observed on V/K##2##4##(1992-3#2)
were observed on the##12##4##(1990-5#1)(1990-7#1)(1991-6#1)(1994-10#1)(1996-9#1)(2005-11#1)(2005-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)
were observed on##39##3##(1990-11#1)(1990-5#1)(1990-7#1)(1991-6#1)(1992-10#1)(1992-3#2)(1992-8#1)(1994-10#1)(1996-10#1)(1996-8#1)(1996-9#1)(2004-11#1)(2005-11#1)(2005-7#1)(2006-8#1)(2007-1#1)(2007-5#2)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-2#1)(2011-2#1)(2013-8#1)
were observed once##2##3##(2011-2#1)(2012-6#1)
were observed only at##2##4##(1994-3#1)(2013-1#1)
were observed only in the##6##5##(1996-12#1)(2008-10#2)(2008-11#1)(2008-5#2)
were observed only in##11##4##(1990-3#1)(1991-8#1)(1992-6#1)(1996-12#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-5#2)
were observed only##13##3##(1990-3#1)(1991-8#1)(1992-6#1)(1994-3#1)(1996-12#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-5#2)(2013-1#1)
were observed over a##2##4##(2004-9#1)(2008-10#1)
were observed over##7##3##(2004-9#1)(2008-10#4)(2008-5#1)(2013-8#1)
were observed regardless of##2##4##(2008-11#1)(2008-9#1)
were observed that were##2##4##(1993-2#1)(1997-4#1)
were observed that##5##3##(1990-2#1)(1991-7#1)(1992-7#1)(1993-2#1)(1997-4#1)
were observed to be sensitive to the sequence of the first two monomers added to the initiator during polymer growth##2##20##(2012-12#2)
were observed to be##9##4##(1990-4#1)(1994-11#1)(2006-8#1)(2008-10#2)(2008-11#1)(2012-12#3)
were observed to have##2##4##(2006-12#1)(2008-5#1)
were observed to##33##3##(1990-4#1)(1991-4#1)(1991-7#1)(1993-6#1)(1994-11#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-3#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#4)(2008-8#1)(2008-9#1)(2010-3#1)(2012-12#3)(2012-2#1)(2012-3#1)
were observed under##7##3##(2005-11#2)(2008-10#1)(2008-9#1)(2009-4#1)(2010-2#1)(2013-7#1)
were observed up to the##2##5##(2007-12#1)(2008-5#1)
were observed up to##3##4##(1992-10#1)(2007-12#1)(2008-5#1)
were observed upon##4##3##(1993-6#1)(2005-11#1)(2012-12#2)
were observed using##4##3##(1996-2#1)(1996-5#1)(1997-4#1)(2008-5#1)
were observed when the two##2##5##(1991-8#1)(2008-10#1)
were observed when the##10##4##(1991-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2010-4#1)(2013-8#1)
were observed when##32##3##(1990-12#1)(1990-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-6#1)(1993-11#1)(1994-3#1)(1995-8#1)(1996-6#1)(1997-1#1)(2004-11#1)(2006-12#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#2)(2010-4#1)(2011-12#1)(2013-1#1)(2013-8#1)
were observed which##2##3##(1994-3#1)(1997-8#1)
were observed while##2##3##(2008-10#1)(2011-1#1)
were observed with increasing##2##4##(2007-8#1)(2008-10#1)
were observed with the##7##4##(1992-8#1)(1995-11#1)(1997-4#1)(2008-10#1)(2008-5#1)(2009-10#1)(2013-1#1)
were observed with##38##3##(1990-10#1)(1991-1#1)(1991-2#1)(1991-5#1)(1992-8#1)(1993-3#1)(1993-4#1)(1995-11#1)(1995-5#1)(1996-8#1)(1997-4#2)(1997-7#1)(2005-11#1)(2006-11#2)(2007-12#1)(2007-8#2)(2008-10#8)(2008-11#1)(2008-5#3)(2009-10#1)(2009-12#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-1#2)
were observed within##6##3##(1991-6#1)(1996-12#1)(2004-9#1)(2007-12#1)(2008-10#2)
were observed without##2##3##(1990-11#1)(1997-3#1)
were observed##1585##2##(1990-10#7)(1990-11#4)(1990-12#11)(1990-2#9)(1990-3#5)(1990-4#10)(1990-5#8)(1990-6#5)(1990-7#5)(1990-8#7)(1990-9#4)(1991-1#3)(1991-10#2)(1991-11#1)(1991-12#5)(1991-2#7)(1991-3#3)(1991-4#7)(1991-5#9)(1991-6#3)(1991-7#7)(1991-8#8)(1991-9#9)(1992-1#6)(1992-10#7)(1992-11#4)(1992-12#4)(1992-2#10)(1992-3#10)(1992-4#1)(1992-5#3)(1992-6#7)(1992-7#3)(1992-8#7)(1992-9#7)(1993-1#3)(1993-10#2)(1993-11#7)(1993-12#8)(1993-2#7)(1993-3#8)(1993-4#5)(1993-5#1)(1993-6#5)(1993-7#5)(1993-8#3)(1993-9#6)(1994-1#1)(1994-10#2)(1994-11#4)(1994-12#8)(1994-2#17)(1994-3#9)(1994-5#5)(1994-6#5)(1994-7#1)(1994-8#3)(1994-9#5)(1995-1#6)(1995-10#5)(1995-11#10)(1995-12#7)(1995-2#2)(1995-3#11)(1995-5#9)(1995-6#7)(1995-7#2)(1995-8#5)(1996-1#7)(1996-10#1)(1996-11#13)(1996-12#10)(1996-2#7)(1996-3#11)(1996-4#5)(1996-5#5)(1996-6#4)(1996-7#4)(1996-8#7)(1996-9#4)(1997-1#4)(1997-2#12)(1997-3#9)(1997-4#13)(1997-5#2)(1997-6#12)(1997-7#7)(1997-8#9)(1997-9#1)(2004-11#4)(2004-12#2)(2004-4#1)(2004-9#6)(2005-10#2)(2005-11#14)(2005-12#4)(2005-6#1)(2005-7#4)(2005-8#6)(2006-1#1)(2006-10#7)(2006-11#5)(2006-12#8)(2006-2#2)(2006-4#5)(2006-5#9)(2006-6#5)(2006-7#2)(2006-8#9)(2006-9#2)(2007-1#5)(2007-10#13)(2007-11#27)(2007-12#20)(2007-2#12)(2007-3#7)(2007-4#3)(2007-5#11)(2007-6#2)(2007-7#20)(2007-8#21)(2007-9#8)(2008-1#6)(2008-10#234)(2008-11#27)(2008-12#16)(2008-2#13)(2008-3#11)(2008-4#9)(2008-5#87)(2008-6#22)(2008-7#26)(2008-8#18)(2008-9#16)(2009-10#5)(2009-11#3)(2009-12#6)(2009-2#2)(2009-3#1)(2009-4#11)(2009-5#4)(2009-6#1)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#3)(2010-12#11)(2010-2#3)(2010-3#4)(2010-4#10)(2010-5#5)(2010-6#3)(2010-7#5)(2010-8#13)(2010-9#3)(2011-1#18)(2011-12#3)(2011-2#30)(2011-3#4)(2012-1#12)(2012-11#3)(2012-12#21)(2012-2#25)(2012-3#13)(2012-6#1)(2013-1#53)(2013-7#6)(2013-8#23)
were obstructive uropathy##2##3##(2006-8#1)(2007-8#1)
were obtained (mean##2##3##(1993-11#1)(1994-4#1)
were obtained after the##2##4##(2008-9#2)
were obtained after##14##3##(1990-2#1)(1994-11#1)(1997-8#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#2)(2012-1#1)(2012-3#1)
were obtained and analyzed##2##4##(2008-10#1)(2008-3#1)
were obtained and compared##2##4##(2007-9#1)(2008-10#1)
were obtained and one of##2##5##(2008-8#1)(2008-9#1)
were obtained and the##5##4##(2008-10#4)(2011-2#1)
were obtained and##30##3##(1991-8#1)(1992-3#1)(1993-4#2)(1997-1#1)(1997-3#1)(1997-8#1)(2005-11#1)(2007-9#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2010-4#1)(2011-2#2)(2012-3#1)
were obtained as a##3##4##(2008-10#1)(2008-6#1)(2012-1#1)
were obtained as the##3##4##(2005-8#1)(2008-10#2)
were obtained as##10##3##(2005-8#1)(2006-12#1)(2008-10#4)(2008-3#1)(2008-6#1)(2011-1#1)(2012-1#1)
were obtained at 0##2##4##(2008-5#2)
were obtained at 3##2##4##(2007-1#1)(2008-5#1)
were obtained at a repetition rate of##4##7##(2007-12#4)
were obtained at a##6##4##(2007-12#4)(2008-10#1)(2008-3#1)
were obtained at autopsy from##2##5##(2011-12#1)(2012-12#1)
were obtained at the following##2##5##(2007-9#1)(2008-10#1)
were obtained at the##11##4##(2006-10#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#5)(2008-3#1)(2008-6#1)
were obtained at various##2##4##(1997-8#1)(2008-6#1)
were obtained at##48##3##(1990-7#2)(1992-8#1)(1993-2#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-1#1)(2007-12#6)(2007-2#2)(2007-5#1)(2007-9#1)(2008-10#10)(2008-11#2)(2008-2#2)(2008-3#5)(2008-5#3)(2008-6#3)(2010-2#1)(2010-5#1)(2010-8#1)(2011-12#1)(2012-12#1)
were obtained before and after a##2##6##(2006-3#1)(2013-1#1)
were obtained before and after##5##5##(1991-10#1)(2006-3#1)(2007-8#1)(2007-9#1)(2013-1#1)
were obtained before##7##3##(1991-10#1)(1995-2#1)(2006-3#1)(2007-8#1)(2007-9#2)(2013-1#1)
were obtained between the##2##4##(2005-4#1)(2007-10#1)
were obtained between##6##3##(1995-10#1)(2005-4#1)(2007-10#1)(2008-10#1)(2012-1#1)(2012-12#1)
were obtained both before and##2##5##(2008-7#1)(2013-1#1)
were obtained both before##3##4##(2008-5#1)(2008-7#1)(2013-1#1)
were obtained both##5##3##(1991-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
were obtained by Southern blot##2##5##(2008-10#1)(2008-9#1)
were obtained by a##5##4##(1993-12#1)(1996-7#1)(1996-8#1)(2005-11#1)(2008-10#1)
were obtained by comparison##2##4##(2007-11#1)(2008-2#1)
were obtained by fitting##2##4##(2008-8#1)(2012-12#1)
were obtained by manual##2##4##(2004-11#1)(2007-3#1)
were obtained by measuring##2##4##(2008-10#2)
were obtained by single##2##4##(2008-10#1)(2013-1#1)
were obtained by subtracting the##2##5##(2008-8#1)(2012-1#1)
were obtained by taking a##2##5##(1990-10#1)(2008-10#1)
were obtained by the proposed##2##5##(2006-12#1)(2008-10#1)
were obtained by the use of##2##6##(1997-3#1)(2008-2#1)
were obtained by the##13##4##(1993-4#1)(1997-3#1)(2004-12#1)(2004-9#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-2#1)
were obtained by use of##4##5##(2007-11#1)(2008-3#3)
were obtained by using a##2##5##(2008-10#1)(2011-1#1)
were obtained by using electrodes##2##5##(2008-10#2)
were obtained by using##10##4##(1992-8#1)(2008-10#7)(2008-8#1)(2011-1#1)
were obtained by##142##3##(1990-10#2)(1990-2#1)(1991-12#1)(1991-6#1)(1991-9#2)(1992-8#2)(1993-12#2)(1993-3#1)(1993-4#1)(1993-9#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-2#1)(1995-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-2#2)(1997-3#1)(1997-4#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-10#2)(2005-11#7)(2005-4#1)(2006-11#1)(2006-12#4)(2007-11#6)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#35)(2008-2#6)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-4#1)(2010-12#2)(2010-4#3)(2011-1#1)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#2)
were obtained compared with##2##4##(2008-10#2)
were obtained depending##2##3##(1991-3#1)(1994-8#1)
were obtained due to##2##4##(1993-9#1)(2008-10#1)
were obtained during the##2##4##(1993-8#1)(2008-10#1)
were obtained during##9##3##(1993-8#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-5#1)(2011-2#1)(2013-1#1)
were obtained either##2##3##(1993-3#1)(2008-4#1)
were obtained following##5##3##(2006-12#1)(2006-5#1)(2007-12#1)(2013-1#1)(2013-7#1)
were obtained for 0##4##4##(2008-10#4)
were obtained for 2##2##4##(1995-3#1)(2008-10#1)
were obtained for E##2##4##(2007-1#1)(2012-2#1)
were obtained for a##2##4##(1994-11#1)(2007-11#1)
were obtained for all elements##2##5##(2011-2#2)
were obtained for all the##4##5##(2008-10#4)
were obtained for all##10##4##(2007-11#1)(2008-10#7)(2011-2#2)
were obtained for both the##2##5##(1994-11#1)(2008-10#1)
were obtained for both##5##4##(1994-11#1)(2008-10#3)(2008-2#1)
were obtained for different##3##4##(2008-10#2)(2008-3#1)
were obtained for each compound##2##5##(2008-10#2)
were obtained for each patient##2##5##(2007-12#1)(2013-1#1)
were obtained for each##12##4##(1995-8#1)(1996-6#1)(2007-12#1)(2008-10#5)(2010-5#1)(2012-12#1)(2013-1#2)
were obtained for evaluation##2##4##(1996-2#1)(2006-5#1)
were obtained for most##2##4##(2008-10#2)
were obtained for the determination of##4##6##(2008-10#4)
were obtained for the three##3##5##(2008-10#2)(2010-12#1)
were obtained for the##31##4##(1991-12#1)(1991-2#1)(1994-11#1)(1995-1#1)(1996-8#1)(2004-4#1)(2004-9#1)(2005-11#1)(2006-8#1)(2007-12#1)(2008-10#19)(2008-11#1)(2010-12#1)
were obtained for this##3##4##(1997-2#1)(2007-8#1)(2008-10#1)
were obtained for untreated and NEM-treated cells##2##7##(1995-8#2)
were obtained for##165##3##(1990-10#1)(1990-4#1)(1990-8#2)(1991-1#1)(1991-12#1)(1991-2#1)(1992-9#1)(1993-6#2)(1994-11#3)(1995-1#1)(1995-2#2)(1995-3#2)(1995-8#3)(1996-12#1)(1996-2#2)(1996-6#1)(1996-8#4)(1997-2#1)(1997-8#2)(2004-4#1)(2004-9#1)(2005-11#3)(2006-4#1)(2006-5#1)(2006-8#1)(2007-1#2)(2007-11#3)(2007-12#3)(2007-2#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#82)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#3)
were obtained from 0##2##4##(2008-10#2)
were obtained from 10##2##4##(2006-12#1)(2008-10#1)
were obtained from 11##2##4##(1994-4#1)(2008-11#1)
were obtained from 15##3##4##(2008-6#1)(2008-7#1)(2011-2#1)
were obtained from 20##2##4##(2008-10#1)(2008-11#1)
were obtained from 5##2##4##(1993-2#1)(1995-8#1)
were obtained from 72##2##4##(2008-7#1)(2011-1#1)
were obtained from a sample of##2##6##(2008-12#2)
were obtained from a##19##4##(1992-8#1)(1997-7#1)(2004-12#1)(2004-4#1)(2005-11#1)(2007-1#1)(2007-3#2)(2008-1#1)(2008-10#3)(2008-12#2)(2009-3#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
were obtained from all##2##4##(1996-10#1)(2012-12#1)
were obtained from commercial##2##4##(2007-3#1)(2008-10#1)
were obtained from diseased##2##4##(2008-10#2)
were obtained from each##4##4##(1993-12#1)(2007-2#1)(2011-2#1)(2013-8#1)
were obtained from four##3##4##(1994-12#1)(2010-10#1)(2013-7#1)
were obtained from patients##3##4##(1992-5#1)(2008-4#1)(2013-1#1)
were obtained from plant##2##4##(2006-10#1)(2008-10#1)
were obtained from rice##2##4##(2008-10#2)
were obtained from subjects##2##4##(1995-12#1)(2008-7#1)
were obtained from the results##2##5##(2008-10#1)(2010-2#1)
were obtained from the##48##4##(1991-12#1)(1991-2#1)(1991-6#1)(1992-8#1)(1995-10#1)(1995-3#1)(1997-5#1)(2005-11#1)(2006-12#2)(2006-8#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-6#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#4)
were obtained from these##3##4##(1993-3#1)(2005-11#1)(2013-8#1)
were obtained from three##2##4##(1990-12#1)(2012-2#1)
were obtained from two##3##4##(1992-10#1)(1996-9#1)(2007-2#1)
were obtained from##238##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1994-12#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#2)(1995-12#4)(1995-3#2)(1995-4#1)(1995-6#1)(1995-8#2)(1996-10#2)(1996-2#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-5#3)(1997-7#1)(2004-12#1)(2004-4#2)(2005-11#4)(2005-12#1)(2005-9#1)(2006-10#2)(2006-12#3)(2006-2#2)(2006-8#3)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#2)(2007-3#6)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#37)(2008-11#6)(2008-12#5)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#4)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#1)(2010-10#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#5)(2011-2#7)(2012-1#3)(2012-12#3)(2012-2#5)(2013-1#7)(2013-7#1)(2013-8#8)
were obtained in a##5##4##(1990-11#1)(1996-2#1)(2007-10#1)(2008-1#1)(2008-5#1)
were obtained in all cases##3##5##(1991-8#1)(2006-8#1)(2007-8#1)
were obtained in all##6##4##(1991-8#1)(1993-8#1)(2006-8#1)(2007-8#2)(2008-10#1)
were obtained in both cases##3##5##(2008-10#3)
were obtained in both##5##4##(1996-12#1)(2008-10#4)
were obtained in excellent yields##2##5##(2008-2#1)(2008-5#1)
were obtained in good yields##4##5##(2007-10#1)(2008-5#1)(2009-2#1)(2010-12#1)
were obtained in methanol##2##4##(2007-8#1)(2008-10#1)
were obtained in the absence of a##2##7##(2005-11#1)(2007-10#1)
were obtained in the concentration range##2##6##(2008-10#2)
were obtained in the presence of##2##6##(1994-12#1)(2005-11#1)
were obtained in the##24##4##(1993-2#1)(1994-12#1)(1997-3#1)(2005-11#2)(2007-10#1)(2007-3#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-8#1)
were obtained in##116##3##(1990-10#1)(1990-11#3)(1990-2#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-7#1)(1993-2#1)(1993-8#1)(1994-12#2)(1994-3#2)(1994-8#2)(1995-11#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-3#2)(1997-7#2)(2005-11#2)(2006-8#2)(2007-1#1)(2007-10#4)(2007-11#3)(2007-12#2)(2007-3#4)(2007-5#2)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#29)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#8)(2008-7#4)(2008-8#2)(2009-2#1)(2009-3#1)(2009-8#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-8#1)
were obtained on all##2##4##(2007-10#1)(2008-9#1)
were obtained on the##4##4##(1995-3#1)(1996-8#1)(2004-9#1)(2006-12#1)
were obtained on##14##3##(1991-7#1)(1995-12#1)(1995-3#1)(1996-8#1)(1997-2#1)(2004-9#1)(2006-12#1)(2007-10#3)(2007-12#1)(2008-9#1)(2012-11#1)(2012-2#1)
were obtained over the##4##4##(2008-10#3)(2008-3#1)
were obtained over##6##3##(2008-10#3)(2008-2#1)(2008-3#1)(2012-4#1)
were obtained prior to##2##4##(2006-8#1)(2011-2#1)
were obtained respectively##3##3##(1993-8#1)(1997-3#1)(2012-1#1)
were obtained showing##2##3##(1991-3#1)(2008-10#1)
were obtained simultaneously##2##3##(1991-12#1)(2008-2#1)
were obtained that were##2##4##(2004-2#1)(2008-10#1)
were obtained that##5##3##(1990-11#1)(1992-11#1)(1995-2#1)(2004-2#1)(2008-10#1)
were obtained through a##3##4##(1990-9#1)(1997-2#1)(2007-12#1)
were obtained through interviews with##2##5##(2008-9#1)(2011-2#1)
were obtained through interviews##3##4##(2006-12#1)(2008-9#1)(2011-2#1)
were obtained through the##3##4##(2008-10#1)(2013-1#2)
were obtained through##16##3##(1990-9#1)(1991-10#1)(1997-2#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#3)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
were obtained to assess the##2##5##(2008-7#1)(2011-2#1)
were obtained to determine##2##4##(1994-3#1)(2008-10#1)
were obtained to##13##3##(1992-11#1)(1994-3#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#2)(2013-8#1)
were obtained under the##3##4##(2008-10#2)(2008-3#1)
were obtained under##4##3##(1991-7#1)(2008-10#2)(2008-3#1)
were obtained upon##2##3##(2008-10#1)(2009-6#1)
were obtained using a##13##4##(1994-5#1)(1997-7#1)(2004-8#1)(2006-5#1)(2007-4#1)(2008-10#6)(2008-5#1)(2009-10#1)
were obtained using the##10##4##(1996-12#2)(1996-2#1)(2006-7#1)(2008-10#4)(2008-3#1)(2013-1#1)
were obtained using##50##3##(1992-5#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-7#1)(2004-8#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#15)(2008-3#1)(2008-5#2)(2008-7#3)(2009-10#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#1)(2013-1#1)
were obtained via##6##3##(1995-12#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-10#1)
were obtained when cells were##3##5##(1990-11#1)(1990-9#1)(2008-10#1)
were obtained when the##6##4##(1995-5#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2013-7#1)
were obtained when##36##3##(1990-11#1)(1990-5#1)(1990-9#1)(1991-3#1)(1992-6#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-5#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#2)(2011-12#1)(2012-2#1)(2013-7#1)
were obtained which##2##3##(1993-3#1)(2008-10#1)
were obtained with a##19##4##(1995-5#1)(1997-8#1)(2007-12#2)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-9#1)(2010-9#1)
were obtained with an##3##4##(2007-11#1)(2007-8#1)(2008-3#1)
were obtained with both##6##4##(1990-8#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#1)(2009-2#1)
were obtained with different##3##4##(1990-10#1)(1992-12#1)(1995-12#1)
were obtained with the##18##4##(1992-12#1)(1992-5#1)(1994-2#1)(1995-8#1)(1997-3#1)(2006-12#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-8#1)(2011-2#1)(2013-7#1)
were obtained with this##2##4##(2008-1#1)(2008-10#1)
were obtained with three##2##4##(1994-12#1)(2008-10#1)
were obtained with##91##3##(1990-10#1)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-5#1)(1992-11#1)(1992-12#2)(1992-5#1)(1992-6#2)(1992-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-5#1)(1995-8#1)(1997-3#1)(1997-8#2)(2003-11#1)(2006-10#2)(2006-12#3)(2007-11#2)(2007-12#4)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#27)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-8#2)(2009-2#1)(2009-9#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)
were obtained within the##2##4##(2007-8#1)(2008-6#1)
were obtained within##5##3##(1994-9#1)(1996-3#1)(2007-2#1)(2007-8#1)(2008-6#1)
were obtained without##2##3##(2007-12#1)(2010-3#1)
were obtained##1382##2##(1990-10#6)(1990-11#6)(1990-12#1)(1990-2#7)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#3)(1990-8#5)(1990-9#5)(1991-1#2)(1991-10#4)(1991-12#6)(1991-2#4)(1991-3#4)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#4)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#5)(1992-12#4)(1992-2#1)(1992-3#3)(1992-5#3)(1992-6#3)(1992-7#3)(1992-8#8)(1992-9#1)(1993-11#4)(1993-12#3)(1993-2#5)(1993-3#6)(1993-4#4)(1993-6#3)(1993-7#1)(1993-8#3)(1993-9#3)(1994-11#6)(1994-12#4)(1994-2#3)(1994-3#8)(1994-4#2)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#9)(1994-9#8)(1995-1#4)(1995-10#4)(1995-11#3)(1995-12#10)(1995-2#7)(1995-3#6)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#7)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#4)(1996-2#6)(1996-3#1)(1996-4#2)(1996-5#4)(1996-6#3)(1996-7#2)(1996-8#7)(1996-9#2)(1997-1#1)(1997-2#6)(1997-3#7)(1997-4#3)(1997-5#4)(1997-6#1)(1997-7#5)(1997-8#12)(2003-11#1)(2004-11#2)(2004-12#3)(2004-2#1)(2004-4#3)(2004-8#1)(2004-9#4)(2005-10#2)(2005-11#21)(2005-12#1)(2005-4#8)(2005-8#1)(2005-9#1)(2006-10#6)(2006-11#1)(2006-12#15)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#5)(2006-7#2)(2006-8#7)(2007-1#9)(2007-10#16)(2007-11#21)(2007-12#43)(2007-2#10)(2007-3#12)(2007-4#3)(2007-5#9)(2007-6#2)(2007-7#9)(2007-8#27)(2007-9#6)(2008-1#11)(2008-10#373)(2008-11#26)(2008-12#11)(2008-2#26)(2008-3#35)(2008-4#5)(2008-5#53)(2008-6#17)(2008-7#21)(2008-8#20)(2008-9#16)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#7)(2009-4#4)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#3)(2010-12#10)(2010-2#5)(2010-3#3)(2010-4#9)(2010-5#5)(2010-8#3)(2010-9#2)(2011-1#15)(2011-12#3)(2011-2#30)(2011-3#2)(2012-1#9)(2012-11#1)(2012-12#11)(2012-2#16)(2012-3#7)(2012-4#1)(2012-5#1)(2013-1#22)(2013-7#6)(2013-8#15)
were obvious##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
were obviously##5##2##(1992-6#1)(2005-4#1)(2008-10#1)(2008-3#1)(2008-9#1)
were occasional##2##2##(2007-3#1)(2008-10#1)
were occasionally observed##2##3##(1996-5#1)(2008-10#1)
were occasionally##6##2##(1996-5#1)(1996-9#1)(1997-3#1)(2008-10#3)
were occluded with##2##3##(2007-8#1)(2008-10#1)
were occluded##3##2##(2007-8#2)(2008-10#1)
were occupationally##2##2##(1995-5#1)(2010-9#1)
were occupied by##2##3##(1994-8#1)(2008-2#1)
were occupied##3##2##(1994-8#1)(1995-10#1)(2008-2#1)
were oesophageal##2##2##(1990-6#1)(2007-7#1)
were of 0##2##3##(2008-10#2)
were of a##7##3##(1992-10#1)(1994-6#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-8#1)
were of an##2##3##(2007-2#1)(2007-9#1)
were of different##2##3##(2008-1#1)(2008-4#1)
were of grade##5##3##(2013-8#5)
were of high##3##3##(2007-8#1)(2012-12#1)(2013-8#1)
were of less##2##3##(2006-1#1)(2007-10#1)
were of low##3##3##(1990-12#1)(2006-2#1)(2007-2#1)
were of mesenchymal##2##3##(1994-5#1)(1997-7#1)
were of no##3##3##(1990-12#1)(2010-1#1)(2011-1#1)
were of normal weight##2##4##(2006-8#1)(2011-2#1)
were of normal##3##3##(2006-10#1)(2006-8#1)(2011-2#1)
were of particular interest##2##4##(1991-12#1)(1996-12#1)
were of similar##2##3##(1994-2#1)(2008-12#1)
were of the order of##7##5##(1990-12#1)(2007-12#1)(2008-10#4)(2008-2#1)
were of the pure##2##4##(1995-4#1)(2006-10#1)
were of the same##5##4##(1995-10#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-3#1)
were of the##27##3##(1990-10#1)(1990-12#1)(1992-8#1)(1993-8#1)(1995-10#1)(1995-4#2)(2004-10#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-5#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
were of type##2##3##(1994-2#2)
were of##131##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-6#1)(1991-12#1)(1991-2#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-8#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-2#5)(1994-3#2)(1994-5#1)(1994-6#1)(1995-10#1)(1995-4#2)(1995-6#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-9#2)(1997-3#1)(1997-4#1)(1997-7#1)(2004-1#1)(2004-10#2)(2005-10#1)(2005-11#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-8#2)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-5#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#19)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-9#2)(2009-11#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#7)
were off##2##2##(1992-3#1)(2007-7#1)
were offered a##2##3##(2005-10#1)(2013-8#1)
were offered##24##2##(1991-1#1)(1991-9#1)(1992-12#1)(1992-8#2)(1993-8#1)(1994-8#1)(1997-5#1)(2004-2#1)(2005-10#1)(2006-4#1)(2006-6#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-8#1)(2012-2#1)(2013-8#2)
were offering##2##2##(2009-4#1)(2010-8#1)
were offset by##3##3##(1993-12#1)(1996-5#1)(2013-8#1)
were often associated with##2##4##(1990-5#1)(1996-7#1)
were often found##4##3##(1993-12#1)(2006-3#1)(2008-10#2)
were often not##2##3##(1990-3#1)(2010-10#1)
were often observed##3##3##(1990-2#1)(1993-12#1)(2008-7#1)
were often##45##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-8#1)(1991-9#1)(1992-4#1)(1993-12#2)(1995-6#1)(1996-2#2)(1996-7#1)(1997-7#1)(2006-10#2)(2006-3#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#4)(2010-10#1)(2010-12#1)(2010-7#1)(2011-2#3)(2012-2#1)(2013-1#1)
were old##2##2##(1991-4#1)(1994-8#1)
were older and##3##3##(2007-3#1)(2008-3#1)(2010-12#1)
were older than 65 years##2##5##(2006-8#1)(2013-1#1)
were older than the other##2##5##(1994-6#1)(2008-12#1)
were older than##10##3##(1992-6#1)(1994-6#1)(2006-8#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-7#1)(2010-5#1)(2013-1#1)
were older##19##2##(1991-10#1)(1992-6#1)(1994-6#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-2#1)(2013-1#1)
were oligo-anuric##2##2##(2008-4#2)
were on a##2##3##(1995-3#1)(2008-11#1)
were on average##7##3##(1991-12#1)(1991-6#1)(1996-11#1)(2007-10#1)(2008-10#2)(2008-11#1)
were on regular##2##3##(2008-8#1)(2013-1#1)
were on the average##2##4##(1995-1#1)(2006-10#1)
were on the right side##2##5##(2011-2#1)(2012-2#1)
were on the##8##3##(1991-9#1)(1995-1#1)(2005-6#1)(2006-10#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
were on their##2##3##(1990-6#2)
were on treatment##2##3##(2008-11#1)(2008-5#1)
were on##62##2##(1990-6#2)(1991-12#1)(1991-6#1)(1991-9#2)(1993-3#1)(1995-1#1)(1995-10#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-8#1)(2005-6#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#8)(2008-10#4)(2008-11#3)(2008-4#1)(2008-5#1)(2008-8#2)(2009-5#1)(2010-12#1)(2010-2#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#2)(2013-8#4)
were on-line##3##2##(2008-10#3)
were once##6##2##(1990-8#1)(2005-7#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-11#1)
were one##8##2##(1996-12#1)(2007-1#1)(2007-7#1)(2008-10#1)(2010-12#2)(2010-3#1)(2012-12#1)
were only 2##2##3##(1994-9#1)(2007-8#1)
were only 3##2##3##(2006-10#1)(2008-7#1)
were only a few##5##4##(1997-7#1)(1997-8#1)(2004-10#1)(2009-2#1)(2010-8#1)
were only a##7##3##(1997-3#1)(1997-7#1)(1997-8#1)(2004-10#1)(2006-2#1)(2009-2#1)(2010-8#1)
were only detected in##3##4##(1991-5#1)(2008-10#1)(2008-11#1)
were only detected##4##3##(1991-5#1)(2008-10#2)(2008-11#1)
were only evident##2##3##(1995-11#1)(2011-2#1)
were only found in the##2##5##(2006-8#1)(2007-5#1)
were only found in##4##4##(1995-12#1)(2006-8#1)(2007-5#1)(2012-3#1)
were only found##6##3##(1991-7#1)(1995-12#1)(2006-8#1)(2007-5#1)(2009-7#1)(2012-3#1)
were only in##2##3##(1994-11#1)(2004-4#1)
were only marginally##2##3##(1995-5#1)(2008-3#1)
were only mild##2##3##(1991-1#1)(2008-7#1)
were only observed in##4##4##(1994-6#1)(1996-6#1)(2007-3#1)(2011-2#1)
were only observed##8##3##(1993-7#1)(1994-6#2)(1996-6#1)(2007-3#1)(2008-7#1)(2009-7#1)(2011-2#1)
were only one##2##3##(1990-2#1)(2006-2#1)
were only partially##4##3##(1991-6#1)(1992-7#1)(1995-10#1)(2010-7#1)
were only rarely##2##3##(1991-12#1)(1991-6#1)
were only significantly##2##3##(1996-1#1)(2008-10#1)
were only slightly##5##3##(1990-12#1)(1991-11#1)(1995-11#1)(1995-5#1)(2008-5#1)
were only weak##2##3##(1992-5#1)(2010-4#1)
were only weakly pathogenic to##2##5##(2008-10#2)
were only weakly##5##3##(1992-12#1)(1995-10#1)(2008-10#2)(2008-12#1)
were only##125##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-10#2)(1995-11#2)(1995-12#1)(1995-5#2)(1996-1#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-10#1)(2004-4#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-2#2)(2006-8#1)(2007-11#2)(2007-12#4)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#12)(2008-11#4)(2008-12#2)(2008-3#2)(2008-5#2)(2008-7#4)(2008-8#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#3)(2012-1#2)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
were open##6##2##(1992-9#1)(1994-11#2)(2008-10#2)(2012-2#1)
were opened##3##2##(1993-2#1)(1997-6#1)(2008-7#1)
were operated by##4##3##(1992-2#1)(1993-8#1)(2007-11#1)(2012-2#1)
were operated for primary##2##4##(2007-7#1)(2013-8#1)
were operated for##7##3##(1990-5#1)(1992-5#1)(2007-7#1)(2007-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
were operated in the##2##4##(2007-7#2)
were operated in##4##3##(2007-7#3)(2007-8#1)
were operated on between##2##4##(1991-6#1)(2006-7#1)
were operated on for##5##4##(1990-8#1)(1991-8#1)(1992-8#1)(2007-8#1)(2008-10#1)
were operated on in##2##4##(1993-8#1)(2008-6#1)
were operated on using##2##4##(1992-1#1)(2007-8#1)
were operated on##29##3##(1990-8#1)(1991-12#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-8#2)(1993-2#1)(1993-3#1)(1993-5#2)(1993-8#2)(1996-2#1)(2006-12#1)(2006-7#2)(2006-8#1)(2007-11#1)(2007-8#5)(2008-10#1)(2008-6#1)(2008-7#1)
were operated upon##6##3##(1991-3#1)(1991-6#1)(1992-6#1)(1997-3#1)(2009-2#1)(2012-2#1)
were operated using the##2##4##(1993-11#1)(2007-7#1)
were operated using##4##3##(1993-11#1)(2007-11#1)(2007-7#1)(2013-1#1)
were operated with a##2##4##(1995-3#1)(2007-7#1)
were operated with##3##3##(1995-3#1)(2007-7#1)(2011-1#1)
were operated##75##2##(1990-5#1)(1990-8#1)(1991-12#2)(1991-3#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-11#2)(1993-2#1)(1993-3#1)(1993-5#2)(1993-8#3)(1995-3#1)(1996-2#1)(1996-9#1)(1997-3#1)(2006-12#1)(2006-3#1)(2006-7#3)(2006-8#2)(2007-11#5)(2007-7#8)(2007-8#9)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
were operating in##2##3##(1991-3#1)(2008-5#1)
were operative##2##2##(2008-10#2)
were optimal at##2##3##(1994-3#1)(2008-3#1)
were optimal##5##2##(1992-2#1)(1994-3#1)(2008-3#1)(2008-7#1)(2012-3#1)
were optimally##5##2##(1992-6#1)(2006-6#2)(2008-10#1)(2008-3#1)
were optimised by experimental##2##4##(2008-10#2)
were optimised by##5##3##(2008-10#5)
were optimised for the##2##4##(2008-10#2)
were optimised in order to##3##5##(2008-10#3)
were optimised to##2##3##(2008-10#2)
were optimised using##3##3##(2008-10#3)
were optimised##32##2##(2008-10#32)
were optimized and a##2##4##(2008-10#2)
were optimized and evaluated for##2##5##(2008-10#1)(2012-2#1)
were optimized and the##3##4##(1992-2#1)(2008-10#2)
were optimized and##11##3##(1992-2#1)(2008-10#8)(2010-5#1)(2012-2#1)
were optimized by a##2##4##(2008-10#2)
were optimized by both static and dynamic methods##2##8##(2008-10#2)
were optimized by the##3##4##(2008-10#1)(2008-3#1)(2011-1#1)
were optimized by##14##3##(1995-5#1)(2008-10#11)(2008-3#1)(2011-1#1)
were optimized for the##7##4##(2008-10#7)
were optimized for##15##3##(2008-10#12)(2008-2#1)(2010-5#1)(2011-1#1)
were optimized in terms of##2##5##(2008-10#1)(2011-3#1)
were optimized in##4##3##(2008-10#3)(2011-3#1)
were optimized so that##2##4##(1991-8#1)(2008-10#1)
were optimized to obtain##2##4##(2008-10#2)
were optimized to##7##3##(1991-5#1)(2004-11#1)(2008-10#4)(2008-3#1)
were optimized under##2##3##(2009-2#1)(2010-5#1)
were optimized using a##4##4##(2007-8#2)(2008-10#2)
were optimized using##7##3##(2007-8#2)(2008-10#5)
were optimized with##2##3##(1997-3#1)(2008-3#1)
were optimized##131##2##(1990-7#1)(1990-8#1)(1991-5#1)(1991-8#1)(1992-2#1)(1995-1#1)(1995-5#1)(1996-11#1)(1997-1#1)(1997-3#1)(2004-11#1)(2005-11#2)(2007-8#6)(2008-10#89)(2008-2#1)(2008-3#3)(2008-4#1)(2009-2#2)(2010-12#1)(2010-5#4)(2011-1#3)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#4)
were or were not##3##4##(1991-10#1)(1994-2#1)(1994-3#1)
were or##5##2##(1991-10#1)(1994-2#1)(1994-3#1)(1995-4#1)(2008-10#1)
were orally administered##2##3##(1996-12#2)
were orally infected with##2##4##(1992-8#1)(2008-12#1)
were orally##6##2##(1992-8#1)(1996-12#2)(2007-6#1)(2008-10#1)(2008-12#1)
were ordered for##4##3##(1994-9#1)(1997-4#1)(2005-10#1)(2007-8#1)
were ordered to##2##3##(1990-12#1)(1996-5#1)
were ordered##9##2##(1990-12#1)(1994-9#1)(1996-5#1)(1997-4#1)(2005-10#1)(2007-8#1)(2008-12#2)(2009-11#1)
were organized in##2##3##(1990-4#1)(2011-2#1)
were organized into##5##3##(1993-12#1)(1996-3#1)(2005-8#1)(2008-7#1)(2008-8#1)
were organized##9##2##(1990-4#1)(1992-12#1)(1993-12#1)(1996-3#1)(2005-8#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)
were oriented##2##2##(2008-6#2)
were originally described##2##3##(2010-12#1)(2011-1#1)
were originally developed as##2##4##(2008-10#1)(2008-11#1)
were originally developed for##2##4##(2008-10#1)(2012-3#1)
were originally developed##6##3##(2007-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-3#1)
were originally isolated from##4##4##(2005-8#1)(2005-9#1)(2011-2#1)(2012-2#1)
were originally isolated##5##3##(2005-8#1)(2005-9#1)(2008-10#1)(2011-2#1)(2012-2#1)
were originally##27##2##(1990-12#1)(1990-5#1)(1992-10#1)(1992-12#1)(1996-3#1)(1997-1#1)(2005-8#2)(2005-9#1)(2007-4#1)(2008-10#5)(2008-11#3)(2008-3#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)
were orphaned##2##2##(1997-6#1)(2011-1#1)
were other##4##2##(2006-10#1)(2006-7#1)(2011-2#1)(2013-8#1)
were otherwise##4##2##(1992-5#1)(1995-2#1)(2008-7#1)(2008-9#1)
were out of##2##3##(1994-6#1)(1997-9#1)
were outlined##4##2##(1990-8#1)(1995-9#1)(2005-8#1)(2012-12#1)
were over 70 years##2##4##(1990-10#1)(1991-10#1)
were over one##2##3##(2008-10#2)
were over seven times more likely to##2##7##(2009-5#1)(2012-12#1)
were over##26##2##(1990-10#1)(1990-8#1)(1991-10#1)(1994-7#1)(1995-12#1)(1997-2#1)(1997-3#1)(2005-12#1)(2005-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-5#1)(2010-11#1)(2012-12#2)(2013-8#1)
were overall##2##2##(2011-2#1)(2012-1#1)
were overexpressed in##3##3##(1994-8#1)(1997-7#1)(2008-7#1)
were overexpressed##6##2##(1994-8#1)(1995-2#1)(1997-7#1)(2008-11#1)(2008-7#1)(2010-12#1)
were overlapped##2##2##(1997-6#1)(2009-6#1)
were overproduced##2##2##(1994-8#1)(1995-2#1)
were overrepresented in the##2##4##(2006-3#1)(2009-7#1)
were overrepresented in##3##3##(2006-10#1)(2006-3#1)(2009-7#1)
were overrepresented##5##2##(1990-6#1)(2006-10#2)(2006-3#1)(2009-7#1)
were overweight (&gt##2##3##(2008-10#1)(2010-11#1)
were overweight and##5##3##(2008-10#1)(2009-2#1)(2011-1#1)(2013-8#2)
were overweight or obese##4##4##(2008-3#1)(2010-7#1)(2013-8#2)
were overweight##16##2##(1995-12#1)(2008-1#1)(2008-10#2)(2008-3#2)(2009-2#1)(2010-11#2)(2010-7#1)(2011-1#1)(2013-8#5)
were overwhelmingly positive##2##3##(2011-2#2)
were oxidized by##4##3##(2005-11#1)(2006-3#1)(2008-10#2)
were oxidized##12##2##(1990-4#1)(2005-11#2)(2006-3#1)(2007-11#1)(2008-10#4)(2008-11#1)(2011-2#2)
were pH 7##2##3##(2008-10#1)(2008-6#1)
were pH##13##2##(1990-1#1)(1991-9#1)(2006-8#1)(2007-10#1)(2008-10#5)(2008-6#2)(2012-12#1)(2013-7#1)
were packaged into##2##3##(1995-8#1)(2008-8#1)
were packaged##3##2##(1995-8#1)(2008-8#2)
were packed into a##2##4##(2008-10#2)
were packed into##3##3##(2008-10#2)(2013-8#1)
were packed##5##2##(2008-10#2)(2008-5#1)(2008-9#1)(2013-8#1)
were paid##3##2##(1995-3#1)(2008-10#1)(2013-1#1)
were pain-free##2##2##(2004-12#1)(2008-9#1)
were paired in##2##3##(2008-10#1)(2009-9#1)
were paired##4##2##(2008-10#1)(2008-5#1)(2009-9#1)(2012-2#1)
were palmitic##2##2##(2008-12#1)(2008-7#1)
were parallel to##3##3##(1991-2#1)(1992-12#1)(1995-8#1)
were parallel##7##2##(1991-2#2)(1992-12#1)(1995-2#1)(1995-8#1)(1997-8#1)(2008-10#1)
were paralleled by a##2##4##(1990-3#1)(1994-12#1)
were paralleled by##3##3##(1990-10#1)(1990-3#1)(1994-12#1)
were paralyzed and artificially ventilated##2##5##(1993-12#1)(1994-10#1)
were paralyzed##3##2##(1993-12#1)(1994-10#1)(2008-8#1)
were parasitized by##4##3##(2008-5#1)(2008-6#3)
were parents##6##2##(1994-3#1)(2006-12#1)(2007-9#1)(2012-12#3)
were part of a##7##4##(1990-2#1)(1991-10#1)(1991-6#1)(1996-1#1)(2007-5#1)(2008-11#1)(2008-7#1)
were part of the##7##4##(1991-9#1)(1997-3#1)(2008-10#1)(2009-10#1)(2013-1#2)(2013-8#1)
were part of##17##3##(1990-2#1)(1991-10#1)(1991-6#1)(1991-7#1)(1991-9#1)(1995-12#1)(1996-1#1)(1997-3#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)(2013-1#2)(2013-8#1)
were partial##2##2##(1992-3#1)(1994-5#1)
were partially blocked by##2##4##(1993-3#1)(1994-10#1)
were partially purified from##2##4##(1990-7#1)(2008-10#1)
were partially##31##2##(1990-7#1)(1991-3#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-3#1)(1994-8#1)(1994-9#1)(1997-4#1)(1997-6#1)(2005-12#1)(2006-5#1)(2006-9#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#1)
were participants in##3##3##(1995-1#1)(2006-8#1)(2011-2#1)
were participating in the##2##4##(2007-12#1)(2009-6#1)
were particularly important##2##3##(2007-12#1)(2008-10#1)
were particularly##14##2##(1996-12#1)(1996-4#1)(1997-6#1)(2006-10#1)(2006-3#1)(2006-7#1)(2007-12#2)(2008-10#1)(2009-1#1)(2009-3#1)(2009-8#1)(2012-12#2)
were partitioned##4##2##(1990-3#1)(1992-11#1)(2008-10#1)(2008-2#1)
were partly protected##2##3##(1995-12#1)(2005-11#1)
were partly##5##2##(1995-12#1)(2005-11#2)(2010-12#1)(2012-5#1)
were patch tested with##3##4##(1992-6#1)(2007-7#2)
were patent##3##2##(2007-8#1)(2008-6#1)(2008-8#1)
were pathogenic on##14##3##(2008-10#14)
were pathogenic to##11##3##(1996-7#1)(2008-10#10)
were pathogenic##29##2##(1996-7#1)(2008-10#26)(2008-5#2)
were pathological##2##2##(1994-8#1)(2008-7#1)
were pathologically##4##2##(1992-2#1)(2008-5#1)(2011-2#1)(2012-2#1)
were patients in whom##2##4##(2012-12#2)
were patients in##3##3##(1995-12#1)(2012-12#2)
were patients with##2##3##(2008-3#1)(2008-9#1)
were patients##9##2##(1995-12#1)(1995-7#1)(2007-10#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-12#2)(2013-1#1)
were patterned##2##2##(2008-3#1)(2010-4#1)
were penetrated by the##2##4##(2008-10#2)
were penetrated##3##2##(2006-5#1)(2008-10#2)
were penetrating##2##2##(1992-6#1)(1997-6#1)
were perceived as##4##3##(2008-10#1)(2010-2#1)(2010-4#1)(2012-11#1)
were perceived by##2##3##(1992-2#1)(2008-11#1)
were perceived to be##2##4##(2007-2#1)(2008-1#1)
were perceived to##3##3##(2007-2#1)(2008-1#1)(2012-3#1)
were perceived##10##2##(1992-2#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-2#1)(2010-4#1)(2012-11#1)(2012-3#1)
were performed after##3##3##(1993-6#1)(2005-5#1)(2008-10#1)
were performed and the##4##4##(2008-12#1)(2009-8#1)(2011-2#1)(2013-8#1)
were performed and##14##3##(1992-5#1)(1992-6#1)(2006-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
were performed approximately##2##3##(1990-12#1)(2009-4#1)
were performed as##4##3##(1995-2#1)(2006-6#1)(2007-1#1)(2009-4#1)
were performed at 10##2##4##(2008-10#1)(2012-3#1)
were performed at 6##2##4##(2006-11#1)(2006-12#1)
were performed at a##2##4##(1996-9#1)(2008-12#1)
were performed at diagnosis##2##4##(2006-11#1)(2013-1#1)
were performed at different##4##4##(2005-11#1)(2008-10#1)(2008-2#1)(2008-5#1)
were performed at pH##2##4##(2005-11#1)(2008-10#1)
were performed at the end of##2##6##(1995-2#1)(2005-10#1)
were performed at the##10##4##(1995-1#1)(1995-2#1)(2004-10#1)(2005-10#1)(2006-8#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-7#1)
were performed at three##2##4##(1995-5#1)(2008-12#1)
were performed at##56##3##(1991-1#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-7#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-9#2)(2004-10#1)(2005-10#1)(2005-11#2)(2006-10#1)(2006-11#3)(2006-12#1)(2006-8#3)(2007-11#1)(2007-4#2)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2010-1#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
were performed automatically and concomitantly using##2##6##(1992-2#1)(1997-3#1)
were performed automatically##3##3##(1992-2#1)(1997-3#1)(2008-10#1)
were performed because of##2##4##(1997-8#1)(2012-11#1)
were performed before and##2##4##(1990-11#1)(2007-8#1)
were performed before the##2##4##(2008-4#1)(2012-12#1)
were performed before treatment##2##4##(2007-7#1)(2007-8#1)
were performed before##6##3##(1990-11#1)(2007-7#1)(2007-8#2)(2008-4#1)(2012-12#1)
were performed between##2##3##(2008-10#2)
were performed by HPLC##2##4##(1990-5#1)(2008-10#1)
were performed by a##2##4##(2004-10#1)(2012-12#1)
were performed by an##2##4##(2006-8#1)(2013-1#1)
were performed by means of##3##5##(2007-9#1)(2008-10#1)(2008-2#1)
were performed by the##5##4##(1995-1#1)(2006-12#1)(2008-3#1)(2008-4#1)(2011-1#1)
were performed by two##2##4##(2008-10#1)(2013-1#1)
were performed by using##5##4##(2007-1#1)(2007-9#1)(2008-5#1)(2010-12#1)(2012-1#1)
were performed by##59##3##(1990-3#1)(1990-5#1)(1991-6#1)(1993-3#1)(1993-9#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-8#1)(1997-4#1)(1997-8#1)(2004-10#1)(2006-12#2)(2006-8#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-6#1)(2010-12#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
were performed daily##2##3##(1996-1#1)(2006-5#1)
were performed during the##7##4##(1990-8#1)(1996-6#1)(1996-9#1)(1997-8#1)(2006-10#1)(2007-2#1)(2008-3#1)
were performed during##11##3##(1990-8#1)(1996-6#1)(1996-9#1)(1997-8#1)(2006-10#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-3#1)(2011-12#1)(2012-2#1)
were performed every##2##3##(1991-7#1)(2007-7#1)
were performed for a##5##4##(1997-1#1)(2007-4#1)(2008-3#2)(2008-5#1)
were performed for each##3##4##(2008-10#1)(2008-8#1)(2009-3#1)
were performed for the##8##4##(1995-5#1)(1996-8#1)(2008-10#4)(2008-5#1)(2011-2#1)
were performed for##40##3##(1995-5#1)(1995-9#1)(1996-8#1)(1997-1#1)(1997-5#1)(2005-5#1)(2006-10#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#6)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#1)(2009-3#1)(2011-2#1)(2011-3#1)(2012-12#2)(2013-1#2)(2013-8#1)
were performed from##7##3##(1990-5#1)(1995-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2010-12#1)(2013-7#1)
were performed immediately##2##3##(2007-8#1)(2009-4#1)
were performed in 10##2##4##(1992-9#1)(2006-5#1)
were performed in 20##2##4##(1990-12#1)(2012-12#1)
were performed in 23##2##4##(2007-2#1)(2009-5#1)
were performed in 40##2##4##(1990-8#1)(2009-2#1)
were performed in 42 patients##2##5##(2007-11#1)(2013-1#1)
were performed in 6##2##4##(1997-6#1)(2006-10#1)
were performed in 95##2##4##(2008-11#1)(2008-5#1)
were performed in a##13##4##(2004-11#1)(2007-1#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#1)(2009-3#1)(2012-1#1)(2013-1#2)
were performed in all patients##4##5##(1994-5#1)(2006-6#1)(2006-8#1)(2007-9#1)
were performed in all##9##4##(1994-5#1)(1996-7#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-9#1)(2008-5#1)(2011-2#1)
were performed in an##3##4##(1996-7#1)(2006-10#1)(2008-10#1)
were performed in both##3##4##(2006-12#1)(2007-1#1)(2007-8#1)
were performed in non-hospital##2##4##(1996-1#2)
were performed in order to##7##5##(1990-8#1)(1994-12#1)(1995-12#1)(1995-5#1)(2008-10#2)(2008-7#1)
were performed in our##3##4##(2007-11#1)(2007-7#1)(2008-9#1)
were performed in the##16##4##(1992-7#1)(1995-11#1)(1996-5#1)(2007-8#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-11#1)(2010-9#1)(2012-11#1)(2012-12#1)(2013-1#2)
were performed in two##3##4##(1993-3#1)(2007-8#1)(2008-11#1)
were performed in##151##3##(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#3)(1991-1#1)(1991-4#2)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-11#3)(1995-12#1)(1995-5#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-5#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-6#2)(1997-7#1)(1997-8#3)(2004-11#1)(2005-10#1)(2006-10#3)(2006-12#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#4)(2007-1#2)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#4)(2007-8#10)(2007-9#1)(2008-10#10)(2008-11#4)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#12)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2013-1#6)(2013-8#1)
were performed of##2##3##(1997-7#1)(2008-1#1)
were performed on a##7##4##(1992-2#1)(1992-9#1)(1997-5#1)(2007-12#1)(2008-11#1)(2010-6#1)(2011-1#1)
were performed on all##2##4##(2007-11#1)(2013-1#1)
were performed on an##5##4##(2006-5#1)(2006-8#1)(2007-8#1)(2008-10#2)
were performed on both##2##4##(2008-10#1)(2012-2#1)
were performed on day##2##4##(1993-12#1)(1997-3#1)
were performed on different##3##4##(1996-5#1)(2008-5#1)(2010-3#1)
were performed on each##2##4##(2007-4#1)(2012-2#1)
were performed on human##2##4##(2007-1#1)(2007-7#1)
were performed on the##19##4##(1992-9#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#4)(2008-7#1)(2009-5#1)(2009-8#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
were performed on two##4##4##(1994-3#1)(2008-5#1)(2010-8#1)(2011-2#1)
were performed on##121##3##(1990-3#1)(1990-5#1)(1990-8#1)(1991-3#1)(1992-2#2)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-4#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2005-11#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-5#2)(2006-6#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#3)(2007-8#4)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#9)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
were performed once##2##3##(1990-11#1)(2008-10#1)
were performed over##2##3##(1993-8#1)(2007-2#1)
were performed prior to##2##4##(1993-5#1)(2007-11#1)
were performed regarding##2##3##(1997-8#1)(2009-10#1)
were performed simultaneously##2##3##(2008-7#1)(2013-7#1)
were performed successfully##2##3##(2006-6#1)(2007-2#1)
were performed through##3##3##(2006-6#1)(2008-3#1)(2009-3#1)
were performed to achieve##2##4##(2006-8#1)(2008-3#1)
were performed to assess the##3##5##(1995-11#1)(1997-2#1)(2013-1#1)
were performed to assess##5##4##(1995-11#1)(1997-2#1)(2008-5#1)(2013-1#1)(2013-8#1)
were performed to better##2##4##(2008-10#2)
were performed to characterize the##4##5##(1990-7#1)(1996-11#1)(2007-11#1)(2008-10#1)
were performed to characterize##6##4##(1990-3#1)(1990-7#1)(1996-11#1)(2007-11#1)(2008-10#1)(2013-7#1)
were performed to compare the##2##5##(2008-10#1)(2008-2#1)
were performed to compare##3##4##(2008-10#2)(2008-2#1)
were performed to confirm##3##4##(2007-10#1)(2009-12#1)(2013-8#1)
were performed to determine if##4##5##(1990-12#1)(1997-3#1)(2008-10#1)(2012-12#1)
were performed to determine the##10##5##(1990-9#1)(1993-11#1)(1996-2#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-2#1)(2012-1#1)
were performed to determine whether##4##5##(1997-1#1)(2006-5#1)(2007-10#1)(2012-12#1)
were performed to determine##23##4##(1990-12#1)(1990-9#1)(1993-11#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-6#1)(2004-11#1)(2006-5#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-4#1)(2010-2#1)(2012-1#1)(2012-12#2)(2012-2#1)
were performed to elucidate the structural##2##6##(1990-5#1)(1997-1#1)
were performed to elucidate the##4##5##(1990-5#1)(1997-1#1)(2005-11#1)(2008-10#1)
were performed to elucidate##6##4##(1990-5#1)(1996-10#1)(1997-1#1)(2005-11#1)(2008-10#2)
were performed to estimate the##3##5##(2010-11#1)(2013-1#2)
were performed to estimate##4##4##(2007-10#1)(2010-11#1)(2013-1#2)
were performed to evaluate the##7##5##(1994-9#1)(1995-3#1)(1996-7#1)(2007-8#1)(2008-3#2)(2008-5#1)
were performed to evaluate##8##4##(1994-9#1)(1995-3#1)(1996-7#1)(2007-8#1)(2008-3#2)(2008-5#1)(2011-12#1)
were performed to examine the##3##5##(1993-9#1)(1995-12#1)(2009-7#1)
were performed to examine##4##4##(1993-9#1)(1995-12#1)(1997-5#1)(2009-7#1)
were performed to identify##4##4##(1991-12#1)(2007-4#1)(2009-4#1)(2012-3#1)
were performed to investigate the##4##5##(1995-5#1)(1997-2#1)(2008-3#1)(2008-8#1)
were performed to investigate##6##4##(1995-5#1)(1997-2#1)(2005-11#1)(2006-10#1)(2008-3#1)(2008-8#1)
were performed to probe the##2##5##(1990-7#1)(1993-7#1)
were performed to select##2##4##(2008-10#1)(2011-3#1)
were performed to study the##3##5##(2008-10#1)(2008-5#1)(2011-2#1)
were performed to validate the##2##5##(2008-3#2)
were performed to##108##3##(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#3)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#1)(1993-11#1)(1993-7#1)(1993-9#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(2004-11#1)(2005-11#2)(2006-10#2)(2006-11#1)(2006-5#1)(2006-8#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-4#2)(2007-8#2)(2008-10#15)(2008-11#1)(2008-2#3)(2008-3#7)(2008-5#3)(2008-7#1)(2008-8#2)(2009-12#1)(2009-4#3)(2009-7#2)(2010-11#1)(2010-12#2)(2010-2#1)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
were performed twice##2##3##(2007-8#1)(2008-5#1)
were performed under fluoroscopic##2##4##(2006-8#1)(2011-1#1)
were performed under general##2##4##(1994-12#1)(2007-8#1)
were performed under##13##3##(1991-8#1)(1992-11#1)(1992-3#1)(1992-7#1)(1994-12#1)(2006-8#1)(2007-8#1)(2008-2#1)(2008-5#2)(2008-7#1)(2011-1#1)(2011-3#1)
were performed using a##9##4##(2004-9#1)(2007-3#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-7#1)
were performed using the##11##4##(1992-3#1)(2006-11#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-6#1)(2010-2#1)(2012-2#1)
were performed using##50##3##(1991-5#1)(1992-3#1)(1993-1#1)(1993-11#1)(1995-12#1)(1996-3#1)(1997-5#2)(2004-9#1)(2006-11#2)(2006-8#2)(2007-1#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#8)(2008-5#3)(2008-6#2)(2008-7#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
were performed via##2##3##(2007-8#1)(2011-2#1)
were performed with a##19##4##(1990-10#1)(1990-12#2)(1991-2#1)(1995-2#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-11#1)(2008-10#3)(2008-2#4)(2008-3#2)(2008-7#1)
were performed with an##2##4##(2007-8#1)(2008-10#1)
were performed with and without##2##5##(1996-8#1)(2008-10#1)
were performed with several##3##4##(2007-12#1)(2008-10#2)
were performed with the##11##4##(1995-10#1)(1995-7#1)(1996-4#1)(1997-7#1)(2006-11#1)(2007-12#1)(2008-11#2)(2008-5#1)(2009-3#1)(2012-3#1)
were performed with##65##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-7#1)(1991-2#1)(1992-11#1)(1992-12#1)(1994-3#2)(1994-5#1)(1995-10#1)(1995-2#1)(1995-7#1)(1996-4#1)(1996-8#1)(1997-7#2)(1997-8#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#5)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#7)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2009-3#1)(2009-7#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
were performed within##4##3##(2005-10#1)(2007-10#1)(2008-10#1)(2011-2#1)
were performed without##3##3##(1993-12#1)(2007-9#1)(2012-3#1)
were performed##963##2##(1990-10#2)(1990-11#3)(1990-12#5)(1990-2#2)(1990-3#4)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#4)(1990-8#5)(1990-9#2)(1991-1#3)(1991-10#1)(1991-12#4)(1991-2#2)(1991-3#3)(1991-4#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#4)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#1)(1992-9#4)(1993-1#1)(1993-11#4)(1993-12#4)(1993-3#4)(1993-5#3)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#3)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#6)(1994-4#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#3)(1995-10#1)(1995-11#4)(1995-12#5)(1995-2#5)(1995-3#1)(1995-4#1)(1995-5#5)(1995-6#2)(1995-7#3)(1995-8#1)(1995-9#1)(1996-1#6)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#3)(1996-7#3)(1996-8#5)(1996-9#5)(1997-1#4)(1997-2#3)(1997-3#4)(1997-4#2)(1997-5#5)(1997-6#4)(1997-7#6)(1997-8#9)(2004-10#2)(2004-11#2)(2004-12#2)(2004-9#1)(2005-10#3)(2005-11#8)(2005-5#2)(2005-9#1)(2006-10#16)(2006-11#10)(2006-12#5)(2006-4#2)(2006-5#10)(2006-6#9)(2006-7#4)(2006-8#16)(2006-9#1)(2007-1#6)(2007-10#11)(2007-11#13)(2007-12#15)(2007-2#5)(2007-3#7)(2007-4#10)(2007-5#3)(2007-7#20)(2007-8#48)(2007-9#7)(2008-1#7)(2008-10#105)(2008-11#12)(2008-12#8)(2008-2#24)(2008-3#37)(2008-4#6)(2008-5#44)(2008-6#8)(2008-7#19)(2008-8#11)(2008-9#7)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#6)(2009-4#8)(2009-5#2)(2009-6#5)(2009-7#4)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#10)(2010-2#3)(2010-3#2)(2010-4#3)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#11)(2011-12#3)(2011-2#22)(2011-3#5)(2012-1#5)(2012-11#3)(2012-12#20)(2012-2#13)(2012-3#10)(2012-7#1)(2013-1#28)(2013-7#6)(2013-8#9)
were performing##3##2##(1994-3#1)(2008-10#1)(2008-11#1)
were perfused with##5##3##(1994-12#1)(2007-8#1)(2007-9#1)(2008-9#2)
were perfused##11##2##(1992-2#1)(1993-2#1)(1993-4#1)(1994-12#1)(1995-7#1)(1996-12#1)(1997-3#1)(2007-8#1)(2007-9#1)(2008-9#2)
were periodic##2##2##(2007-7#1)(2010-8#1)
were periodically##5##2##(1992-7#1)(2007-11#1)(2008-10#3)
were permeabilized##5##2##(1992-5#1)(1992-6#1)(1992-7#1)(1993-8#1)(2012-11#1)
were persistent##5##2##(1991-2#1)(1997-1#1)(1997-8#1)(2008-9#1)(2012-2#1)
were persons##2##2##(1993-6#1)(2006-10#1)
were phenotypically##4##2##(1996-4#1)(1997-8#1)(2008-10#1)(2008-5#1)
were phosphorylated by##4##3##(1990-3#1)(1991-2#1)(1992-7#1)(2010-11#1)
were phosphorylated with##2##3##(1996-2#1)(2007-11#1)
were phosphorylated##10##2##(1990-3#1)(1991-2#1)(1992-7#1)(1993-7#1)(1994-3#1)(1995-6#1)(1996-2#1)(1996-9#1)(2007-11#1)(2010-11#1)
were photoaffinity labeled with##2##4##(1990-7#1)(1992-11#1)
were photographed##3##2##(2007-8#1)(2008-3#1)(2012-12#1)
were physical##2##2##(2008-7#1)(2012-12#1)
were physically separated##3##3##(1995-8#1)(2008-7#1)(2008-9#1)
were physically##11##2##(1990-12#1)(1991-11#2)(1992-12#1)(1995-8#1)(2005-11#1)(2007-8#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-10#1)
were physiologically##2##2##(1991-5#1)(1997-3#1)
were phytotoxic to##2##3##(2008-10#2)
were picked up##2##3##(2005-11#1)(2009-2#1)
were placed at##2##3##(2006-8#1)(2009-6#1)
were placed between##3##3##(1994-4#1)(2007-7#1)(2012-1#1)
were placed for##4##3##(2009-8#1)(2010-3#1)(2011-2#1)(2012-2#1)
were placed in a##9##4##(1992-7#1)(2008-10#2)(2008-6#1)(2008-7#2)(2011-2#1)(2012-12#1)(2013-8#1)
were placed in contact with##2##5##(2008-10#2)
were placed in patients##2##4##(2007-7#2)
were placed in the##10##4##(2007-4#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-10#1)
were placed in three##2##4##(2007-5#1)(2008-10#1)
were placed in##56##3##(1992-6#1)(1992-7#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-11#1)(2004-11#1)(2004-9#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#4)(2008-10#15)(2008-11#1)(2008-2#1)(2008-5#3)(2008-6#3)(2008-7#4)(2008-9#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
were placed into##6##3##(1993-9#1)(1996-4#1)(2008-10#2)(2008-7#1)(2008-8#1)
were placed on a##5##4##(2006-8#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-7#1)
were placed on the##5##4##(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#2)
were placed on##16##3##(1994-6#1)(2006-8#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-7#1)(2010-4#1)(2013-1#1)
were placed to##2##3##(2008-9#1)(2011-1#1)
were placed under##4##3##(1995-2#1)(2008-1#1)(2008-10#1)(2011-2#1)
were placed##121##2##(1992-6#1)(1992-7#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-4#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-11#1)(1996-4#1)(1997-3#1)(2004-11#1)(2004-9#1)(2006-11#2)(2006-12#1)(2006-6#4)(2006-8#5)(2007-11#1)(2007-3#2)(2007-4#2)(2007-5#2)(2007-7#10)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#27)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#1)(2008-9#3)(2009-2#1)(2009-3#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
were plain##2##2##(2007-7#2)
were planned##4##2##(1991-6#1)(2005-8#1)(2008-5#1)(2012-12#1)
were planted in a randomized##2##5##(2008-10#2)
were planted in a##3##4##(2008-10#3)
were planted in##14##3##(2004-4#1)(2008-10#9)(2008-12#1)(2008-5#1)(2008-9#1)(2012-2#1)
were planted with three##2##4##(2008-10#2)
were planted with##3##3##(2008-10#3)
were planted##20##2##(2004-4#1)(2008-10#15)(2008-12#1)(2008-5#1)(2008-9#1)(2012-2#1)
were plated in##4##3##(1997-4#1)(2008-12#1)(2013-1#2)
were plated on a##2##4##(2008-10#1)(2012-4#1)
were plated on the##2##4##(1992-6#1)(2012-4#1)
were plated on##6##3##(1992-6#1)(2008-10#2)(2008-5#1)(2012-4#2)
were plated##10##2##(1992-6#1)(1997-4#1)(2008-10#2)(2008-12#1)(2008-5#1)(2012-4#2)(2013-1#2)
were played##4##2##(1991-12#1)(1993-1#3)
were pleased with the##3##4##(2006-4#1)(2006-8#1)(2011-2#1)
were plotted against the##2##4##(1996-11#1)(1996-3#1)
were plotted against those##2##4##(2008-10#1)(2008-5#1)
were plotted against##6##3##(1996-11#1)(1996-3#1)(2008-10#3)(2008-5#1)
were plotted and##2##3##(2007-10#1)(2012-2#1)
were plotted##16##2##(1996-11#1)(1996-3#1)(2005-11#1)(2007-10#2)(2008-10#4)(2008-4#1)(2008-5#2)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
were polymerase chain reaction amplified##2##5##(2008-10#1)(2009-5#1)
were polymerase chain reaction##3##4##(2008-10#2)(2009-5#1)
were polymerase chain##4##3##(2008-10#3)(2009-5#1)
were polymerized##3##2##(2007-8#1)(2008-3#1)(2009-7#1)
were polymicrobial##2##2##(2007-7#2)
were polymorphic and##2##3##(2008-10#2)
were polymorphic for##2##3##(2008-10#2)
were polymorphic##13##2##(1994-8#1)(2006-2#1)(2008-10#8)(2008-4#1)(2011-12#1)(2013-7#1)
were pooled to evaluate the##2##5##(1992-4#1)(2009-12#1)
were pooled##8##2##(1992-4#1)(2006-11#1)(2008-10#2)(2008-7#2)(2009-12#1)(2011-1#1)
were poor substrates for##2##4##(1994-9#1)(1995-8#1)
were poor substrates##4##3##(1990-11#1)(1994-9#1)(1995-8#1)(1996-5#1)
were poor##15##2##(1990-11#1)(1994-3#1)(1994-9#1)(1995-8#1)(1996-11#1)(1996-5#1)(2006-6#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-7#1)(2008-8#1)(2011-2#1)
were poorly##14##2##(1992-6#1)(1994-12#1)(1994-3#1)(1995-1#1)(1997-3#1)(2005-7#1)(2006-8#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-6#1)(2013-8#1)
were portrayed##2##2##(2008-11#1)(2011-2#1)
were positioned##11##2##(1992-9#1)(1996-6#1)(2006-11#1)(2006-6#1)(2007-1#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-1#1)
were positive and##8##3##(1991-9#1)(1994-6#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-7#1)(2010-12#1)(2012-12#1)
were positive at##2##3##(1993-10#1)(2006-10#1)
were positive by PCR##3##4##(1991-9#1)(2006-6#1)(2008-5#1)
were positive by RT-PCR##2##4##(2006-3#1)(2008-1#1)
were positive by the##3##4##(1992-6#1)(2005-8#2)
were positive by##17##3##(1991-9#1)(1992-6#1)(1995-2#1)(1995-4#1)(2005-8#2)(2006-3#2)(2006-6#1)(2007-2#1)(2007-7#4)(2008-1#1)(2008-5#1)(2013-8#1)
were positive correlations between##3##4##(1990-10#1)(2007-1#1)(2008-5#1)
were positive for H##2##4##(2006-8#1)(2008-5#1)
were positive for HIV##2##4##(2007-7#2)
were positive for HPV##2##4##(1991-2#1)(2011-2#1)
were positive for N##2##4##(2008-3#2)
were positive for NADPH-d activity##2##5##(1995-5#2)
were positive for P##2##4##(2007-7#2)
were positive for S scabiei##2##5##(1990-3#2)
were positive for anti-HCV##2##4##(1991-9#1)(2008-1#1)
were positive for both ACA and ANA##2##7##(2011-2#2)
were positive for both##3##4##(1993-12#1)(2011-2#2)
were positive for helminths##2##4##(2012-12#2)
were positive for one##2##4##(2007-7#1)(2011-2#1)
were positive for the##8##4##(1991-8#1)(1992-11#1)(1992-2#1)(2007-7#1)(2011-2#2)(2012-12#1)(2013-8#1)
were positive for two tests##2##5##(1996-9#2)
were positive for vimentin and##2##5##(2008-6#1)(2009-7#1)
were positive for vimentin##3##4##(2008-6#1)(2008-9#1)(2009-7#1)
were positive for##124##3##(1990-3#2)(1990-6#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-11#1)(1992-2#2)(1992-5#1)(1993-10#1)(1993-12#1)(1993-5#1)(1994-2#1)(1995-11#1)(1995-5#2)(1996-6#1)(1996-9#4)(2004-11#3)(2004-2#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-7#1)(2006-8#3)(2007-12#1)(2007-2#6)(2007-3#1)(2007-5#2)(2007-7#13)(2007-8#3)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-6#3)(2010-7#3)(2011-1#1)(2011-2#8)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#7)
were positive in both##2##4##(1992-8#1)(2012-1#1)
were positive in the##2##4##(1993-1#1)(2011-1#1)
were positive in##29##3##(1990-3#1)(1992-8#1)(1993-1#1)(1995-10#1)(1995-12#1)(1997-2#1)(2005-1#1)(2005-11#1)(2006-10#1)(2006-8#2)(2007-7#3)(2007-8#1)(2008-4#1)(2008-5#1)(2008-8#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
were positive of##3##3##(2005-10#2)(2007-7#1)
were positive on##2##3##(1991-9#1)(2007-7#1)
were positive to the##3##4##(1996-6#1)(2006-10#1)(2007-6#1)
were positive to##6##3##(1990-2#1)(1996-6#1)(2006-10#1)(2007-6#1)(2013-1#1)(2013-8#1)
were positive using##2##3##(1993-10#1)(1996-12#1)
were positive with##2##3##(1997-7#1)(2006-4#1)
were positive##248##2##(1990-10#1)(1990-2#2)(1990-3#4)(1990-5#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-8#2)(1991-9#6)(1992-11#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#4)(1993-12#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-7#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-4#2)(1995-5#2)(1996-12#3)(1996-6#2)(1996-9#4)(1997-2#1)(1997-7#1)(2004-1#1)(2004-11#3)(2004-2#1)(2005-1#1)(2005-10#2)(2005-11#3)(2005-8#3)(2005-9#1)(2006-10#5)(2006-11#1)(2006-3#2)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#6)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#10)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#26)(2007-8#5)(2008-1#4)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#9)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-11#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-12#3)(2010-6#3)(2010-7#3)(2010-8#1)(2011-1#2)(2011-2#15)(2012-1#3)(2012-12#7)(2012-2#5)(2012-3#2)(2013-1#14)(2013-8#10)
were positively associated with the##2##5##(2008-11#1)(2009-9#1)
were positively associated with##9##4##(2008-11#1)(2009-7#1)(2009-9#1)(2011-1#1)(2011-2#3)(2013-1#2)
were positively associated##11##3##(2008-11#1)(2008-8#1)(2009-7#1)(2009-9#1)(2011-1#1)(2011-2#4)(2013-1#2)
were positively correlated to##3##4##(2008-10#1)(2008-7#1)(2013-7#1)
were positively correlated with infection##2##5##(2008-10#1)(2010-12#1)
were positively correlated with the##2##5##(2004-11#1)(2008-10#1)
were positively correlated with##20##4##(1993-12#1)(1994-3#1)(2004-11#1)(2007-10#1)(2008-10#5)(2008-3#1)(2010-11#1)(2010-12#1)(2011-10#2)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#2)(2013-7#1)
were positively correlated##32##3##(1990-4#1)(1993-12#1)(1993-6#1)(1994-3#1)(1995-3#1)(2004-11#1)(2007-10#1)(2007-3#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#2)(2010-11#1)(2010-12#1)(2011-10#2)(2011-2#2)(2012-1#1)(2012-11#1)(2013-1#2)(2013-7#2)(2013-8#1)
were positively identified in##2##4##(1994-9#1)(2008-10#1)
were positively identified##4##3##(1991-2#1)(1994-9#1)(2008-10#2)
were positively related to##9##4##(1992-2#1)(2006-10#1)(2006-3#1)(2007-12#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-12#1)(2011-2#1)
were positively selected##3##3##(2008-4#1)(2010-8#2)
were positively stained##2##3##(1992-3#1)(1995-3#1)
were positively##64##2##(1990-4#1)(1991-2#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-3#2)(2004-11#1)(2006-10#1)(2006-3#1)(2007-10#2)(2007-12#1)(2007-3#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-8#2)(2011-1#1)(2011-10#2)(2011-2#7)(2012-1#1)(2012-11#1)(2013-1#4)(2013-7#2)(2013-8#1)
were possible to##2##3##(2007-11#1)(2013-1#1)
were possible##15##2##(1992-5#1)(2007-11#1)(2008-1#1)(2008-10#8)(2008-3#1)(2009-2#1)(2009-4#1)(2013-1#1)
were possibly##3##2##(1994-9#1)(2009-4#1)(2011-2#1)
were posted##2##2##(2006-2#1)(2009-5#1)
were postmenopausal##3##2##(1992-1#1)(1996-3#1)(2008-7#1)
were postoperative##2##2##(1994-3#1)(2010-7#1)
were postulated to be##3##4##(2008-1#1)(2008-10#2)
were postulated##5##2##(2008-1#1)(2008-10#2)(2008-7#1)(2013-1#1)
were potent competitive##2##3##(1994-11#1)(1994-3#1)
were potent inhibitors of##7##4##(1990-9#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-3#1)(1997-6#1)(1997-7#1)
were potent##13##2##(1990-11#1)(1990-9#1)(1994-11#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-3#1)(1997-1#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-4#1)
were potentially##4##2##(2008-11#1)(2012-3#1)(2013-1#2)
were potentiated by the##3##4##(1993-6#2)(2007-10#1)
were potentiated by##6##3##(1990-7#1)(1993-6#2)(1996-12#1)(2007-10#2)
were potentiated##9##2##(1990-5#1)(1990-7#1)(1991-3#1)(1993-6#2)(1996-12#1)(2004-12#1)(2007-10#2)
were poured##2##2##(2007-11#1)(2008-10#1)
were powerful##3##2##(1995-1#2)(2011-2#1)
were practically identical##2##3##(1995-2#1)(1997-2#1)
were practically inactive##2##3##(1990-9#1)(2007-11#1)
were practically##9##2##(1990-12#1)(1990-9#1)(1995-2#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-12#1)(2011-1#1)
were pre-incubated##4##2##(1993-7#1)(2008-4#1)(2008-5#2)
were pre-trained by##2##3##(2008-6#2)
were pre-treated with a##2##4##(1992-9#1)(2008-7#1)
were pre-treated with##8##3##(1992-9#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-12#1)(2009-4#1)
were pre-treated##9##2##(1992-9#1)(1996-5#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-12#1)(2009-4#1)
were preceded by a##3##4##(1994-12#1)(1996-1#2)
were preceded by an##2##4##(2006-8#1)(2013-1#1)
were preceded by##12##3##(1991-3#1)(1992-9#1)(1994-12#1)(1996-1#3)(2006-8#1)(2007-7#1)(2008-6#1)(2012-1#1)(2013-1#1)(2013-8#1)
were preceded##13##2##(1991-3#1)(1992-9#1)(1994-12#1)(1996-1#3)(2006-8#1)(2007-7#1)(2008-6#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
were precipitated with##2##3##(1990-11#1)(2007-9#1)
were precipitated##6##2##(1990-11#1)(1995-11#1)(1996-5#1)(2007-9#1)(2008-6#1)(2013-1#1)
were precisely##4##2##(1997-2#1)(2008-11#1)(2012-2#1)(2012-3#1)
were preconcentrated in a membrane cell##2##6##(2008-10#2)
were preconcentrated in##3##3##(2008-10#3)
were preconcentrated on the##2##4##(2008-10#2)
were preconcentrated on##3##3##(2008-10#3)
were preconcentrated onto the##2##4##(2008-10#2)
were preconcentrated##11##2##(2008-10#11)
were preconditioned##2##2##(1996-9#1)(2007-1#1)
were predicted and##2##3##(2008-8#1)(2013-8#1)
were predicted as##2##3##(1990-7#1)(2013-8#1)
were predicted by the##4##4##(2008-10#1)(2008-4#1)(2012-1#1)(2012-3#1)
were predicted for##3##3##(1997-4#1)(2007-11#1)(2008-7#1)
were predicted in the##2##4##(1997-6#1)(2008-8#1)
were predicted in##3##3##(1997-6#1)(2008-8#1)(2011-2#1)
were predicted to be involved in##2##6##(1997-5#1)(2012-1#1)
were predicted to##6##3##(1995-12#1)(1997-5#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-1#1)
were predicted using##5##3##(2007-4#1)(2008-12#1)(2009-12#1)(2011-2#1)(2012-2#1)
were predicted##39##2##(1990-7#1)(1995-12#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-12#1)(2009-9#1)(2011-2#3)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#4)
were predictive of##11##3##(2005-5#1)(2007-10#1)(2008-12#1)(2009-5#2)(2009-7#2)(2010-11#1)(2010-8#1)(2012-2#1)(2012-3#1)
were predictive##12##2##(2005-5#1)(2007-10#1)(2007-8#1)(2008-12#1)(2009-5#2)(2009-7#2)(2010-11#1)(2010-8#1)(2012-2#1)(2012-3#1)
were predictors of##4##3##(2007-2#1)(2009-10#1)(2010-11#1)(2013-8#1)
were predominant in the##2##4##(2009-12#1)(2012-2#1)
were predominant in##5##3##(1994-2#1)(2008-10#1)(2009-12#1)(2011-2#1)(2012-2#1)
were predominant##20##2##(1992-9#1)(1993-12#1)(1993-2#1)(1994-2#2)(2006-10#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2009-12#1)(2009-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
were predominantly male##2##3##(2009-10#1)(2012-12#1)
were predominantly positive##3##3##(2011-1#1)(2013-1#2)
were predominantly related to##3##4##(1996-3#1)(2013-1#2)
were predominantly##37##2##(1991-3#1)(1991-6#1)(1992-12#1)(1993-12#2)(1993-9#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-5#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-5#1)(2009-10#1)(2009-11#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#5)(2013-7#1)
were predominately##3##2##(1995-3#1)(2008-10#1)(2009-10#1)
were preferably##2##2##(2008-10#1)(2008-11#1)
were preferentially##3##2##(1993-6#1)(2005-11#1)(2008-6#1)
were preferred by##2##3##(2008-10#1)(2011-2#1)
were preferred to##3##3##(1996-1#1)(2006-12#1)(2008-10#1)
were preferred##8##2##(1996-1#1)(2005-11#1)(2006-12#1)(2008-10#2)(2008-5#1)(2008-6#1)(2011-2#1)
were preformed##2##2##(2011-2#2)
were pregnant##5##2##(2006-7#1)(2007-6#1)(2007-7#1)(2008-3#1)(2013-7#1)
were preincubated for##2##3##(1990-3#1)(1994-3#1)
were preincubated in##3##3##(1991-10#1)(1994-2#1)(2008-8#1)
were preincubated with##3##3##(1990-2#1)(1990-8#1)(1994-12#1)
were preincubated##8##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(2008-8#1)
were prelabeled with##2##3##(1994-12#1)(2008-7#1)
were premature##4##2##(1995-2#1)(2006-10#1)(2008-9#1)(2011-1#1)
were premedicated with acepromazine and##2##5##(2012-2#1)(2012-3#1)
were premedicated with##3##3##(1996-6#1)(2012-2#1)(2012-3#1)
were prepared and analysed##3##4##(1995-8#1)(2008-10#1)(2008-5#1)
were prepared and characterised##4##4##(2007-10#1)(2007-11#1)(2008-5#2)
were prepared and evaluated for their ability to inhibit##2##9##(1992-5#1)(1994-9#1)
were prepared and evaluated for##3##5##(1992-5#1)(1994-9#1)(2007-10#1)
were prepared and evaluated in##2##5##(1992-12#1)(1994-9#1)
were prepared and evaluated##8##4##(1992-12#1)(1992-5#1)(1994-9#2)(2007-10#1)(2008-10#1)(2008-5#2)
were prepared and examined##2##4##(2008-1#1)(2008-8#1)
were prepared and investigated as##3##5##(2008-10#3)
were prepared and investigated##4##4##(2007-12#1)(2008-10#3)
were prepared and subjected to##2##5##(1992-4#1)(2005-10#1)
were prepared and tested for their##4##6##(1993-11#1)(2007-10#1)(2007-11#1)(2010-8#1)
were prepared and tested for##6##5##(1992-5#1)(1993-11#1)(1996-8#1)(2007-10#1)(2007-11#1)(2010-8#1)
were prepared and tested##8##4##(1992-5#1)(1993-11#1)(1993-4#1)(1996-8#1)(2007-10#1)(2007-11#2)(2010-8#1)
were prepared and their##3##4##(2007-11#1)(2008-10#1)(2009-12#1)
were prepared and##53##3##(1990-10#1)(1992-12#1)(1992-4#1)(1992-5#2)(1993-11#1)(1993-4#1)(1994-9#2)(1995-1#1)(1995-8#1)(1996-8#1)(2005-10#1)(2007-10#3)(2007-11#5)(2007-12#1)(2008-1#1)(2008-10#10)(2008-12#1)(2008-3#1)(2008-5#8)(2008-8#2)(2008-9#1)(2009-12#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-8#1)(2013-7#1)
were prepared as##9##3##(1991-12#1)(1991-8#1)(1995-3#1)(2004-9#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2012-2#1)
were prepared by a##5##4##(2007-11#2)(2008-10#2)(2010-1#1)
were prepared by adding##2##4##(2009-3#1)(2013-1#1)
were prepared by alkylation of##2##5##(1992-3#1)(1997-1#1)
were prepared by catalytic##2##4##(1992-8#1)(2008-10#1)
were prepared by centrifugation##2##4##(1995-1#1)(2010-2#1)
were prepared by chemical##2##4##(1995-3#1)(2007-11#1)
were prepared by coupling the##2##5##(1997-2#1)(2008-10#1)
were prepared by direct compression##2##5##(2008-5#2)
were prepared by dissolving##3##4##(2005-11#1)(2008-5#1)(2010-4#1)
were prepared by emulsion##2##4##(2005-11#1)(2010-12#1)
were prepared by first##2##4##(2008-10#1)(2010-4#1)
were prepared by incorporating##2##4##(2008-10#2)
were prepared by mixing 0##2##5##(2004-9#1)(2008-10#1)
were prepared by mixing##4##4##(2004-9#1)(2005-11#1)(2008-10#2)
were prepared by reacting##2##4##(2005-11#1)(2008-8#1)
were prepared by reverse##2##4##(2008-5#1)(2010-1#1)
were prepared by site-directed mutagenesis##2##5##(1996-7#1)(1997-6#1)
were prepared by solid-phase##2##4##(1992-5#1)(1993-11#1)
were prepared by the condensation of##3##6##(2007-11#1)(2010-5#1)(2011-1#1)
were prepared by the##19##4##(1991-7#1)(2005-11#1)(2007-11#2)(2008-10#2)(2008-12#2)(2008-2#1)(2008-5#4)(2008-6#1)(2010-5#2)(2011-1#1)(2011-2#1)(2013-8#1)
were prepared by two##2##4##(2005-11#1)(2010-2#1)
were prepared by using the##2##5##(2008-10#1)(2013-7#1)
were prepared by using##3##4##(2008-10#2)(2013-7#1)
were prepared by##128##3##(1990-10#2)(1991-5#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-5#2)(1992-6#2)(1992-8#1)(1993-11#1)(1994-9#2)(1995-1#1)(1995-3#2)(1996-7#2)(1997-1#1)(1997-2#1)(1997-6#2)(1997-9#1)(2004-9#1)(2005-11#10)(2006-12#4)(2007-11#8)(2007-12#2)(2008-1#1)(2008-10#23)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#15)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-1#4)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#2)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#2)
were prepared containing##2##3##(1997-7#1)(2008-10#1)
were prepared for each##2##4##(2009-7#1)(2010-2#1)
were prepared for##16##3##(1992-2#1)(1993-4#1)(1993-7#1)(1996-10#1)(1997-3#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-7#1)(2010-2#1)(2011-7#1)
were prepared from a##4##4##(1991-5#1)(2008-10#1)(2008-5#2)
were prepared from embryonic day 15##2##6##(1994-2#1)(1995-12#1)
were prepared from rat##2##4##(1996-11#1)(2008-7#1)
were prepared from the corresponding##2##5##(2007-11#2)
were prepared from the##10##4##(1994-10#1)(1994-12#1)(1995-12#1)(2006-6#1)(2007-11#4)(2008-11#1)(2010-8#1)
were prepared from##55##3##(1990-12#1)(1990-5#1)(1991-5#2)(1991-9#3)(1994-10#1)(1994-12#2)(1994-2#1)(1995-12#2)(1995-3#2)(1995-6#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-6#1)(2004-9#1)(2005-11#2)(2006-12#2)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#7)(2007-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2010-12#2)(2010-8#1)(2011-2#1)
were prepared in a##2##4##(2008-10#1)(2010-4#1)
were prepared in an##2##4##(1997-2#1)(2004-9#1)
were prepared in good yields by##2##6##(1996-5#1)(2007-10#1)
were prepared in order to##2##5##(1996-2#1)(2007-11#1)
were prepared in the##2##4##(2006-2#1)(2008-10#1)
were prepared in which the##3##5##(1992-1#1)(1995-3#1)(1996-7#1)
were prepared in which##4##4##(1992-1#1)(1995-3#1)(1996-7#1)(2006-10#1)
were prepared in##28##3##(1992-1#1)(1995-3#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#1)(2004-9#1)(2006-10#1)(2006-2#1)(2007-10#2)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#1)(2009-7#1)(2010-1#1)(2010-4#1)(2010-5#1)(2013-1#1)
were prepared of##2##3##(2008-5#1)(2011-1#1)
were prepared on the##2##4##(2005-4#1)(2010-12#1)
were prepared on##6##3##(1993-1#1)(2005-11#1)(2005-4#1)(2008-10#1)(2010-12#1)(2010-4#1)
were prepared spiking##2##3##(2008-10#2)
were prepared through##3##3##(2007-11#1)(2012-11#2)
were prepared to##9##3##(1993-3#1)(1995-8#1)(1996-8#2)(2005-11#1)(2008-10#2)(2008-6#1)(2010-3#1)
were prepared using a##4##4##(2008-12#1)(2008-5#1)(2008-9#1)(2012-12#1)
were prepared using the##2##4##(2008-5#1)(2011-2#1)
were prepared using##28##3##(1990-11#1)(1990-2#1)(1992-8#1)(1994-9#1)(2004-9#1)(2005-11#1)(2006-1#1)(2007-4#1)(2008-10#3)(2008-12#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)
were prepared via a##2##4##(2008-10#1)(2009-2#1)
were prepared via free radical polymerization##2##6##(2013-7#1)(2013-8#1)
were prepared via##11##3##(1997-2#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-2#2)(2013-7#1)(2013-8#1)
were prepared with a##4##4##(2006-5#1)(2008-10#2)(2008-3#1)
were prepared with##13##3##(1993-9#1)(1994-2#1)(2005-11#1)(2006-5#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-9#1)(2010-4#1)(2012-12#1)(2013-8#1)
were prepared##434##2##(1990-10#3)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#4)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#4)(1992-6#2)(1992-8#2)(1993-1#1)(1993-11#2)(1993-3#1)(1993-4#2)(1993-7#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#2)(1994-9#6)(1995-1#2)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#7)(1995-6#2)(1995-8#3)(1995-9#1)(1996-10#2)(1996-11#1)(1996-2#1)(1996-5#1)(1996-7#4)(1996-8#5)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#1)(1997-9#1)(2004-9#6)(2005-10#1)(2005-11#21)(2005-4#1)(2006-1#1)(2006-10#1)(2006-12#8)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#8)(2007-11#26)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#68)(2008-11#4)(2008-12#6)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#40)(2008-6#2)(2008-7#5)(2008-8#9)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#4)(2009-4#3)(2009-5#1)(2009-7#3)(2009-9#3)(2010-1#5)(2010-12#8)(2010-2#6)(2010-3#4)(2010-4#6)(2010-5#3)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#4)(2011-7#1)(2012-11#2)(2012-12#3)(2012-2#4)(2012-3#2)(2012-8#1)(2013-1#4)(2013-7#5)(2013-8#5)
were prescribed at##2##3##(1996-9#1)(2008-11#1)
were prescribed for##2##3##(2007-2#1)(2012-2#1)
were prescribed in##3##3##(1990-9#1)(2010-12#1)(2011-1#1)
were prescribed to##3##3##(1990-4#1)(2006-2#1)(2008-11#1)
were prescribed##30##2##(1990-4#1)(1990-9#1)(1992-7#1)(1996-9#1)(1997-6#1)(2006-2#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-2#1)(2008-11#4)(2008-4#2)(2009-9#1)(2010-1#1)(2010-12#2)(2010-6#1)(2011-1#1)(2012-2#2)(2013-7#1)(2013-8#2)
were present among##2##3##(2008-10#2)
were present as a##2##4##(1992-9#1)(2008-8#1)
were present as##7##3##(1990-12#1)(1992-9#1)(1996-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-8#1)
were present at a##3##4##(1994-3#1)(2006-12#1)(2011-2#1)
were present at low##2##4##(1993-9#1)(1994-8#1)
were present at the##3##4##(1995-9#1)(1996-6#1)(2008-5#1)
were present at##20##3##(1990-4#1)(1992-3#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-9#1)(1996-11#1)(1996-4#1)(1996-6#1)(2006-12#1)(2008-10#6)(2008-5#1)(2011-2#1)(2011-3#1)(2012-12#1)
were present but##2##3##(1994-8#1)(2011-1#1)
were present during##2##3##(2008-10#1)(2011-1#1)
were present each##2##3##(1995-6#1)(2008-10#1)
were present for##2##3##(2005-10#1)(2008-8#1)
were present in 12 patients##2##5##(1997-8#1)(2006-10#1)
were present in 15%##2##4##(2004-1#1)(2012-2#1)
were present in 17##2##4##(1994-7#1)(2006-9#1)
were present in 19##2##4##(2007-7#1)(2012-2#1)
were present in 3##3##4##(1991-3#1)(1997-4#1)(2006-8#1)
were present in 9##3##4##(2007-7#1)(2008-7#1)(2013-1#1)
were present in a variety of##2##6##(1991-2#1)(1992-6#1)
were present in a##5##4##(1991-12#1)(1991-2#1)(1992-3#1)(1992-6#1)(1995-5#1)
were present in about##2##4##(2008-6#1)(2008-8#1)
were present in all the##2##5##(1990-11#1)(2008-10#1)
were present in all##10##4##(1990-11#1)(2005-10#1)(2007-8#1)(2008-10#2)(2009-3#1)(2011-2#3)(2013-1#1)
were present in collections from##2##5##(2008-10#2)
were present in equal##3##4##(1990-11#1)(2008-10#1)(2013-1#1)
were present in low##2##4##(1994-2#1)(2007-12#1)
were present in more than##2##5##(1994-7#1)(2008-3#1)
were present in most##2##4##(1991-3#1)(1995-11#1)
were present in only##2##4##(1990-12#1)(2010-4#1)
were present in the central##3##5##(1992-12#1)(1995-12#1)(2008-10#1)
were present in the lateral##2##5##(1992-8#1)(1995-5#1)
were present in the liver##2##5##(1992-12#1)(2005-7#1)
were present in the##46##4##(1990-11#1)(1990-12#2)(1991-7#1)(1992-12#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-7#1)(1996-9#1)(1997-3#1)(2005-11#1)(2005-7#3)(2006-8#1)(2007-12#1)(2007-2#1)(2008-10#8)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-12#1)(2012-3#1)
were present in these##3##4##(1994-12#1)(2008-10#1)(2008-3#1)
were present in two##2##4##(2006-8#1)(2011-2#1)
were present in##161##3##(1990-10#1)(1990-11#3)(1990-12#4)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#3)(1991-3#3)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-12#3)(1992-2#1)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-12#3)(1994-2#4)(1994-3#1)(1994-6#2)(1994-7#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-4#2)(1995-5#4)(1996-7#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-8#1)(2004-1#1)(2005-10#1)(2005-11#1)(2005-7#4)(2005-8#1)(2006-10#2)(2006-8#3)(2006-9#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#4)(2008-10#23)(2008-11#1)(2008-3#3)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-3#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#1)
were present on the##3##4##(1991-6#1)(1996-5#1)(2012-3#1)
were present on##7##3##(1991-6#1)(1996-5#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-3#1)
were present only##2##3##(1994-3#1)(1997-6#1)
were present or##2##3##(1991-11#1)(1992-8#1)
were present throughout the year##2##5##(1993-9#1)(2008-10#1)
were present throughout the##3##4##(1993-9#1)(2008-10#1)(2008-7#1)
were present throughout##4##3##(1993-9#1)(1997-2#1)(2008-10#1)(2008-7#1)
were present together##2##3##(2008-10#1)(2012-7#1)
were present when the##2##4##(1992-10#1)(1995-4#1)
were present when##3##3##(1992-10#1)(1995-4#1)(2008-10#1)
were present within the##2##4##(2007-2#1)(2008-10#1)
were present within##3##3##(1994-12#1)(2007-2#1)(2008-10#1)
were present##300##2##(1990-10#1)(1990-11#4)(1990-12#6)(1990-4#2)(1990-5#1)(1990-7#3)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#4)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#3)(1992-10#1)(1992-12#3)(1992-2#2)(1992-3#3)(1992-4#2)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-12#7)(1994-2#4)(1994-3#3)(1994-5#2)(1994-6#2)(1994-7#3)(1994-8#4)(1994-9#1)(1995-1#3)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#3)(1995-4#3)(1995-5#5)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(1997-8#1)(2004-1#1)(2005-10#2)(2005-11#3)(2005-7#5)(2005-8#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-3#1)(2006-8#6)(2006-9#2)(2007-12#4)(2007-2#2)(2007-3#1)(2007-7#6)(2007-8#6)(2008-10#46)(2008-11#2)(2008-3#4)(2008-4#4)(2008-5#7)(2008-6#3)(2008-7#6)(2008-8#3)(2008-9#3)(2009-3#1)(2009-4#2)(2009-9#1)(2010-12#3)(2010-4#1)(2010-8#2)(2011-1#3)(2011-10#1)(2011-12#1)(2011-2#8)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#2)(2012-7#1)(2013-1#6)(2013-7#1)(2013-8#2)
were presented and##3##3##(1992-11#1)(2007-12#1)(2012-12#1)
were presented as##2##3##(1991-12#1)(2008-10#1)
were presented at an OSA Topical Meeting that was held##2##10##(2008-2#1)(2008-3#1)
were presented at the symposium##2##5##(2005-8#1)(2008-5#1)
were presented at the##11##4##(2005-8#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2013-8#1)
were presented at##16##3##(1994-6#1)(2005-8#2)(2005-9#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2013-8#1)
were presented by##2##3##(1997-4#1)(2005-9#1)
were presented during##4##3##(1994-9#1)(2005-9#1)(2007-2#1)(2007-3#1)
were presented for##7##3##(2005-7#1)(2005-9#1)(2008-11#1)(2009-10#1)(2009-3#3)
were presented in the##3##4##(2007-3#1)(2008-5#1)(2008-9#1)
were presented in##10##3##(1996-12#1)(2005-8#2)(2005-9#1)(2007-3#1)(2008-5#3)(2008-9#1)(2013-8#1)
were presented that##2##3##(1992-4#2)
were presented to the##3##4##(1993-12#1)(1993-3#1)(2010-2#1)
were presented to##12##3##(1993-12#1)(1993-3#1)(1996-2#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#2)(2009-10#1)(2010-2#1)(2012-12#1)(2012-3#1)
were presented with a##3##4##(2005-10#1)(2006-5#1)(2013-8#1)
were presented with##20##3##(1994-2#1)(1995-11#1)(1997-1#1)(1997-5#1)(2005-10#1)(2006-5#1)(2007-2#1)(2007-9#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-5#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-8#1)
were presented without##2##3##(1994-3#1)(1996-1#1)
were presented##134##2##(1991-12#1)(1992-11#2)(1992-4#2)(1993-12#2)(1993-2#3)(1993-3#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-11#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-5#1)(2004-12#2)(2005-10#2)(2005-6#1)(2005-7#1)(2005-8#8)(2005-9#5)(2006-10#1)(2006-11#1)(2006-5#3)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#16)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#3)(2009-4#2)(2009-5#1)(2009-9#1)(2010-10#1)(2010-2#5)(2010-3#1)(2010-9#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#4)
were preserved in the##3##4##(1992-7#1)(2008-11#1)(2008-4#1)
were preserved in##6##3##(1992-7#1)(1996-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2012-12#1)
were preserved with##2##3##(2008-10#2)
were preserved##15##2##(1992-7#2)(1996-12#1)(2005-11#1)(2006-12#1)(2007-1#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2012-12#1)
were presumably##5##2##(1992-3#1)(2007-10#1)(2007-4#1)(2008-10#2)
were presumed to be##2##4##(1991-8#1)(2012-2#1)
were presumed to##3##3##(1991-8#1)(2005-7#1)(2012-2#1)
were preterm##2##2##(1993-4#1)(2011-2#1)
were pretreated using##2##3##(2008-5#1)(2008-6#1)
were pretreated with a##2##4##(1997-3#1)(2008-5#1)
were pretreated with an##2##4##(2013-1#2)
were pretreated with the##3##4##(1992-3#1)(1996-12#1)(2010-7#1)
were pretreated with##29##3##(1990-10#1)(1991-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#3)(1993-8#1)(1994-8#1)(1995-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-3#1)(2005-4#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-3#1)(2010-7#2)(2011-1#1)(2011-2#1)(2013-1#2)
were pretreated##37##2##(1990-10#1)(1990-11#1)(1991-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#3)(1993-8#1)(1994-3#1)(1994-8#1)(1995-1#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-3#1)(2005-12#1)(2005-4#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2010-3#1)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#2)
were prevalent in##4##3##(2007-8#1)(2008-10#1)(2009-2#1)(2011-2#1)
were prevalent##8##2##(2007-8#1)(2008-10#3)(2009-2#1)(2009-9#1)(2011-2#1)(2012-3#1)
were prevented by the##2##4##(1996-8#1)(2008-11#1)
were prevented by##7##3##(1993-3#1)(1994-3#1)(1996-8#1)(1996-9#1)(2008-11#1)(2008-8#1)(2012-3#1)
were prevented from##2##3##(2007-5#1)(2008-9#1)
were prevented##12##2##(1993-3#1)(1994-3#1)(1994-5#1)(1996-8#1)(1996-9#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#1)
were previously considered to##2##4##(2008-10#1)(2008-4#1)
were previously evaluated##2##3##(1991-2#1)(2007-7#1)
were previously extracted from##2##4##(2008-10#2)
were previously identified##4##3##(1991-8#1)(1994-8#1)(1994-9#1)(2008-10#1)
were previously known##2##3##(1997-7#1)(2011-1#1)
were previously measured##2##3##(2007-1#1)(2010-6#1)
were previously reported##6##3##(1996-12#2)(1997-4#1)(2008-5#1)(2009-12#1)(2011-2#1)
were previously shown to be##2##5##(1991-5#1)(2009-4#1)
were previously shown to##7##4##(1991-4#1)(1991-5#1)(1993-3#1)(1996-8#1)(2008-10#1)(2008-11#1)(2009-4#1)
were previously unrecognized##2##3##(1996-2#1)(2008-8#1)
were previously used##2##3##(2006-12#1)(2008-3#1)
were previously##62##2##(1990-4#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#2)(1992-1#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-6#2)(1996-12#2)(1996-2#1)(1996-8#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-1#2)(2007-7#1)(2007-8#1)(2008-10#13)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-10#1)(2010-6#2)(2011-1#1)(2011-2#1)(2013-8#1)
were primarily caused by##2##4##(2007-9#2)
were primarily##19##2##(1991-1#1)(1991-6#1)(1995-5#1)(1996-10#1)(1997-8#1)(2005-10#1)(2007-7#1)(2007-9#3)(2008-10#1)(2008-9#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
were primary##6##2##(1990-12#1)(2007-7#1)(2008-1#1)(2008-12#1)(2010-8#1)(2011-1#1)
were primed with##3##3##(1994-5#1)(2008-10#1)(2010-8#1)
were primed##8##2##(1990-3#1)(1994-5#1)(2007-12#1)(2008-10#1)(2009-3#1)(2010-8#1)(2013-1#2)
were primiparas##2##2##(2004-10#1)(2008-4#1)
were principally##2##2##(1996-12#1)(2008-7#1)
were printed##4##2##(2005-11#1)(2008-2#1)(2008-7#1)(2010-9#1)
were prior##2##2##(1995-5#1)(2011-2#1)
were probably associated with##2##4##(1994-12#1)(2008-8#1)
were probably due to##4##4##(1994-6#1)(1996-1#1)(2006-6#1)(2007-2#1)
were probably related to##3##4##(1992-11#1)(1992-8#1)(1994-3#1)
were probably##24##2##(1991-12#1)(1992-11#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-3#1)(1996-1#1)(1996-4#1)(1997-3#1)(2005-12#1)(2006-6#1)(2007-11#1)(2007-2#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2012-11#1)
were probed by##3##3##(1990-7#1)(2006-12#2)
were probed with##5##3##(1991-10#1)(1991-5#1)(1997-1#1)(1997-3#1)(2008-10#1)
were probed##10##2##(1990-7#1)(1991-10#1)(1991-5#1)(1997-1#1)(1997-3#1)(2006-12#2)(2008-10#2)(2008-3#1)
were problems##3##2##(2006-6#1)(2007-8#1)(2008-12#1)
were processed and##3##3##(2007-11#1)(2007-7#1)(2013-8#1)
were processed by the##3##4##(2008-10#1)(2011-1#1)(2013-8#1)
were processed by##7##3##(2008-10#4)(2008-3#1)(2011-1#1)(2013-8#1)
were processed for##18##3##(1993-7#1)(1994-12#1)(1995-9#1)(1996-5#1)(2007-5#1)(2007-7#2)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
were processed in##2##3##(1991-9#1)(2008-10#1)
were processed to##3##3##(1990-5#1)(2007-8#1)(2012-2#1)
were processed using##8##3##(1992-8#1)(1996-4#1)(1997-8#1)(2007-2#1)(2008-10#1)(2009-3#1)(2011-2#1)(2012-12#1)
were processed with a##2##4##(2006-5#1)(2008-7#1)
were processed with##5##3##(2006-5#1)(2008-5#2)(2008-7#1)(2012-3#1)
were processed##54##2##(1990-5#1)(1990-6#1)(1991-9#1)(1992-8#1)(1993-2#1)(1993-7#1)(1994-12#1)(1995-9#1)(1996-4#1)(1996-5#1)(1997-8#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#2)(2009-3#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#3)(2013-8#3)
were procured##3##2##(2006-10#1)(2008-6#1)(2008-7#1)
were produced against##5##3##(1992-1#1)(1996-12#1)(2007-6#1)(2008-10#1)(2008-11#1)
were produced and characterized##2##4##(1992-1#1)(1996-12#1)
were produced and##11##3##(1992-1#1)(1992-8#1)(1996-12#1)(2007-1#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-11#1)
were produced at the##2##4##(2007-11#1)(2008-10#1)
were produced at##4##3##(1993-12#1)(2007-11#1)(2008-10#1)(2011-2#1)
were produced by a##2##4##(1995-3#1)(2008-10#1)
were produced by fusing##2##4##(2008-11#2)
were produced by subsequent##2##4##(2005-11#1)(2013-1#1)
were produced by the##4##4##(1991-7#1)(2008-2#1)(2008-4#1)(2010-4#1)
were produced by##45##3##(1990-3#1)(1991-12#1)(1991-7#1)(1992-6#1)(1992-9#1)(1993-10#3)(1993-12#1)(1993-7#1)(1994-3#2)(1994-6#1)(1995-3#1)(1996-1#2)(1996-8#1)(1997-2#1)(1997-4#1)(2004-9#1)(2005-11#2)(2005-8#1)(2006-11#1)(2006-12#2)(2008-10#3)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-4#1)(2012-3#1)(2013-1#1)
were produced for##2##3##(2004-9#1)(2008-2#1)
were produced from the##3##4##(1994-11#1)(2008-5#1)(2011-1#1)
were produced from##7##3##(1990-2#1)(1994-11#1)(2008-10#3)(2008-5#1)(2011-1#1)
were produced in E##2##4##(1990-5#1)(1993-5#1)
were produced in Escherichia coli##2##5##(1992-8#1)(1993-6#1)
were produced in a##2##4##(1994-2#1)(2007-12#1)
were produced in an##2##4##(1994-5#1)(2008-11#1)
were produced in less##2##4##(2008-11#1)(2008-9#1)
were produced in mice##2##4##(2008-10#1)(2012-3#1)
were produced in the##4##4##(1993-1#1)(2006-11#1)(2008-10#1)(2008-2#1)
were produced in this##2##4##(1991-2#1)(2008-10#1)
were produced in##31##3##(1990-5#1)(1991-2#1)(1991-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-10#1)(2005-4#1)(2006-11#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)(2012-3#2)
were produced on the##3##4##(2008-10#3)
were produced on##9##3##(2008-10#8)(2008-2#1)
were produced that##2##3##(1991-8#1)(2008-10#1)
were produced through##2##3##(1992-8#1)(2008-8#1)
were produced using##2##3##(1991-3#1)(1993-3#1)
were produced via##3##3##(1995-12#1)(2008-10#1)(2008-5#1)
were produced when##2##3##(2006-5#1)(2008-10#1)
were produced with##6##3##(2004-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)
were produced##165##2##(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-3#1)(1992-6#1)(1992-8#4)(1992-9#3)(1993-1#1)(1993-10#3)(1993-12#3)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-3#1)(1996-1#2)(1996-12#4)(1996-8#1)(1997-2#2)(1997-4#1)(2004-9#3)(2005-11#2)(2005-12#1)(2005-4#1)(2005-8#1)(2006-11#3)(2006-12#2)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-6#2)(2008-10#39)(2008-11#12)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#4)(2009-11#1)(2009-12#2)(2010-4#2)(2011-1#1)(2011-2#1)(2012-3#3)(2013-1#1)
were profiled##2##2##(2008-10#1)(2008-5#1)
were progressively##4##2##(1995-3#1)(1997-2#1)(2008-11#1)(2008-4#1)
were projected more##2##3##(2010-3#2)
were projected##3##2##(2010-3#2)(2011-7#1)
were prolonged##6##2##(1990-12#1)(1992-6#1)(1996-3#2)(2007-8#1)(2008-7#1)
were prominent in##3##3##(2005-8#1)(2008-3#1)(2013-1#1)
were prominent##6##2##(2005-8#1)(2008-3#1)(2008-9#1)(2009-2#1)(2011-12#1)(2013-1#1)
were promising but##2##3##(2007-11#1)(2011-2#1)
were promising##7##2##(2007-11#2)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#2)
were promoted##3##2##(2008-10#1)(2008-12#1)(2012-3#1)
were promptly##4##2##(1994-3#1)(2007-11#1)(2009-10#1)(2011-2#1)
were pronounced##4##2##(2004-11#1)(2008-10#1)(2010-2#1)(2012-1#1)
were propagated in##2##3##(1995-2#1)(2008-11#1)
were propagated##6##2##(1995-2#2)(1997-3#1)(2008-10#1)(2008-11#1)(2010-2#1)
were properly##3##2##(2004-7#1)(2005-10#1)(2012-2#1)
were prophylactic##2##2##(2011-2#1)(2013-1#1)
were proportional to the concentration of##3##6##(1990-8#1)(2007-8#1)(2008-10#1)
were proportional to the##9##4##(1990-8#1)(1992-1#1)(2005-11#1)(2007-8#2)(2008-10#3)(2012-2#1)
were proportional to##12##3##(1990-8#1)(1992-1#1)(2005-11#1)(2007-8#3)(2008-10#4)(2008-5#1)(2012-2#1)
were proposed and##2##3##(2008-10#2)
were proposed for the assay of##3##6##(2008-10#3)
were proposed for the##4##4##(2008-10#4)
were proposed for##7##3##(2008-10#5)(2012-1#1)(2013-1#1)
were proposed in##3##3##(2007-11#1)(2008-10#1)(2010-12#1)
were proposed to be##2##4##(1990-9#1)(1993-4#1)
were proposed to##5##3##(1990-9#1)(1993-4#1)(2007-8#1)(2008-11#1)(2012-2#1)
were proposed##35##2##(1990-9#1)(1993-4#1)(1996-12#1)(1996-6#1)(2005-11#2)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-2#2)(2008-8#1)(2009-4#2)(2010-12#1)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
were prospected##2##2##(2013-8#2)
were prospectively analyzed##2##3##(2004-2#1)(2006-5#1)
were prospectively collected in##2##4##(2007-8#2)
were prospectively collected##4##3##(2006-8#1)(2007-8#3)
were prospectively enrolled##2##3##(2007-8#1)(2013-1#1)
were prospectively evaluated##6##3##(1996-2#1)(2006-4#1)(2006-8#1)(2007-7#1)(2013-1#1)(2013-8#1)
were prospectively followed##2##3##(2007-10#1)(2011-2#1)
were prospectively included##2##3##(2011-2#1)(2013-1#1)
were prospectively randomized##2##3##(2007-7#1)(2007-8#1)
were prospectively recruited for##2##4##(2007-3#1)(2008-3#1)
were prospectively studied##2##3##(1995-6#1)(2007-9#1)
were prospectively##31##2##(1995-6#1)(1996-2#1)(1997-1#1)(2004-2#1)(2006-4#1)(2006-5#2)(2006-8#2)(2007-10#1)(2007-3#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-3#1)(2008-8#1)(2011-2#2)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#1)
were protected against the##3##4##(1996-10#1)(2008-9#1)(2012-2#1)
were protected against##6##3##(1995-12#1)(1995-2#1)(1996-10#1)(2008-8#1)(2008-9#1)(2012-2#1)
were protected from##11##3##(1990-5#1)(1993-9#1)(1995-12#1)(1995-2#1)(1997-2#1)(1997-3#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-8#1)
were protected##25##2##(1990-5#1)(1992-8#1)(1993-9#1)(1995-12#2)(1995-2#2)(1995-5#4)(1996-10#1)(1996-8#1)(1997-2#1)(1997-3#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)
were protective factors##3##3##(2008-1#1)(2011-1#1)(2011-2#1)
were protective##5##2##(1996-9#1)(2008-1#1)(2008-5#1)(2011-1#1)(2011-2#1)
were proved by##2##3##(1993-10#1)(1997-2#1)
were proved to be##3##4##(1993-2#1)(2007-6#1)(2008-12#1)
were proved to##5##3##(1993-2#1)(1996-6#1)(2007-6#1)(2008-10#1)(2008-12#1)
were proved##8##2##(1992-8#1)(1993-10#1)(1993-2#1)(1996-6#1)(1997-2#1)(2007-6#1)(2008-10#1)(2008-12#1)
were proven to be##3##4##(1996-8#1)(2008-9#1)(2013-1#1)
were proven##5##2##(1996-8#1)(2008-4#1)(2008-9#1)(2010-12#1)(2013-1#1)
were provided as##2##3##(1991-12#1)(1996-11#1)
were provided by##4##3##(2008-6#1)(2009-9#1)(2010-4#1)(2011-2#1)
were provided for##4##3##(1996-3#1)(2006-10#1)(2008-10#2)
were provided free##2##3##(1996-1#1)(2007-7#1)
were provided to##5##3##(1994-7#1)(1995-3#1)(1996-1#1)(2008-5#1)(2010-12#1)
were provided with a##2##4##(1993-8#1)(2013-7#1)
were provided with an##2##4##(1992-1#1)(2008-11#1)
were provided with##11##3##(1992-1#1)(1993-8#1)(1994-9#1)(2008-11#2)(2008-5#1)(2011-2#1)(2012-12#2)(2013-7#1)(2013-8#1)
were provided##44##2##(1991-12#1)(1992-1#1)(1992-6#1)(1993-8#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-1#2)(1996-11#1)(1996-3#1)(2006-10#1)(2007-7#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-5#3)(2008-6#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-4#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
were provoked##2##2##(1991-2#1)(2004-12#1)
were psychological##3##2##(2007-9#1)(2008-10#1)(2011-2#1)
were psychotic##2##2##(1990-5#1)(1991-9#1)
were published between##2##3##(2006-2#1)(2012-2#1)
were published in the##4##4##(2005-8#1)(2006-10#1)(2007-3#1)(2008-5#1)
were published in##11##3##(1997-8#1)(2005-8#2)(2006-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-5#1)(2010-4#1)(2011-1#1)(2011-2#1)
were published on##2##3##(2006-10#2)
were published recently##2##3##(1994-3#1)(2012-2#1)
were published##36##2##(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1993-11#1)(1994-3#1)(1994-4#1)(1997-8#1)(2005-7#1)(2005-8#2)(2006-10#5)(2006-2#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-2#2)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)
were pulmonary##3##2##(2007-8#1)(2008-1#1)(2011-2#1)
were pumped##2##2##(2007-12#1)(2008-11#1)
were purchased from##2##3##(1997-4#1)(2007-6#1)
were purified and##10##3##(1990-4#1)(1991-10#1)(1994-12#1)(1994-5#1)(1997-2#1)(1997-6#1)(2005-11#1)(2008-10#2)(2012-12#1)
were purified by HPLC##2##4##(1990-10#1)(1994-9#1)
were purified by a##3##4##(1991-5#1)(1994-9#1)(2007-7#1)
were purified by affinity chromatography##3##5##(1995-2#1)(2008-6#1)(2008-9#1)
were purified by using##2##4##(2008-8#1)(2010-12#1)
were purified by##25##3##(1990-10#2)(1990-11#1)(1990-12#1)(1990-9#1)(1991-5#1)(1991-9#2)(1993-3#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-8#2)(1994-9#2)(1995-12#1)(1995-2#1)(1997-4#1)(2007-7#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)
were purified from rat##2##4##(1993-8#1)(1994-9#1)
were purified from the##4##4##(1990-11#1)(1994-12#1)(1996-5#1)(2008-7#1)
were purified from##26##3##(1990-11#1)(1991-9#1)(1992-2#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-3#1)(1996-5#2)(1997-3#1)(1997-8#1)(2005-11#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)
were purified to apparent homogeneity##2##5##(1995-3#1)(1996-5#1)
were purified to homogeneity and##3##5##(1992-8#1)(1995-11#1)(1997-4#1)
were purified to homogeneity##8##4##(1990-7#1)(1992-5#1)(1992-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1997-4#1)
were purified to near homogeneity##3##5##(1991-2#1)(2008-4#1)(2012-2#1)
were purified to##14##3##(1990-7#1)(1991-2#1)(1992-5#1)(1992-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#2)(1996-5#1)(1997-4#1)(2008-4#1)(2008-8#1)(2012-2#1)
were purified with a##2##4##(1992-8#1)(1994-3#1)
were purified with an##2##4##(1992-1#1)(2008-10#1)
were purified with##4##3##(1992-1#1)(1992-8#1)(1994-3#1)(2008-10#1)
were purified##89##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-4#3)(1990-7#1)(1990-9#1)(1991-10#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-9#3)(1992-1#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-8#3)(1993-3#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#3)(1994-9#4)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#3)(1996-3#1)(1996-5#4)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-8#1)(2005-11#2)(2006-8#1)(2007-7#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-5#1)(2010-12#1)(2010-4#1)(2012-12#1)(2012-2#1)
were purposively selected##2##3##(2007-8#1)(2010-3#1)
were purposively##3##2##(2007-8#1)(2010-11#1)(2010-3#1)
were put forward##3##3##(2008-8#1)(2013-8#2)
were put in##5##3##(2007-7#1)(2008-12#1)(2008-6#1)(2010-1#2)
were put into practice##2##4##(2007-1#1)(2011-1#1)
were put into##6##3##(1990-7#1)(1995-3#1)(2004-12#1)(2004-9#1)(2007-1#1)(2011-1#1)
were put on##2##3##(2007-7#1)(2007-9#1)
were put to the##2##4##(2006-10#1)(2008-10#1)
were put to##3##3##(2006-10#1)(2008-10#1)(2008-5#1)
were put##19##2##(1990-7#1)(1995-3#1)(2004-12#1)(2004-9#1)(2006-10#1)(2007-1#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-1#2)(2011-1#1)(2013-8#2)
were qualified for##2##3##(2007-8#1)(2012-3#1)
were qualified to##2##3##(2007-11#1)(2007-7#1)
were qualified##6##2##(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2012-3#2)
were qualitatively similar to##2##4##(1994-3#1)(1996-5#1)
were qualitatively##6##2##(1994-3#1)(1995-6#1)(1996-5#1)(2006-10#1)(2008-10#1)(2008-11#1)
were quality##2##2##(2013-1#1)(2013-8#1)
were quantified and##3##3##(2009-9#1)(2012-2#1)(2013-1#1)
were quantified by the##3##4##(1990-12#1)(1993-2#1)(2007-6#1)
were quantified by##19##3##(1990-12#2)(1993-2#1)(1994-3#1)(1996-8#1)(1997-1#1)(1997-3#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-10#3)(2008-7#1)(2010-11#1)(2010-2#1)(2012-1#1)
were quantified for##2##3##(2004-11#1)(2008-10#1)
were quantified in terms of##2##5##(2005-11#1)(2008-3#1)
were quantified in the##2##4##(2007-12#1)(2008-10#1)
were quantified in##13##3##(1990-3#1)(1995-2#1)(1995-5#1)(2005-11#1)(2007-12#1)(2008-10#6)(2008-3#1)(2009-2#1)
were quantified using a##4##4##(2006-11#1)(2009-10#1)(2009-7#1)(2011-2#1)
were quantified using the##3##4##(1997-4#1)(2008-10#1)(2009-3#1)
were quantified using##13##3##(1997-4#1)(2006-11#1)(2008-10#3)(2008-5#1)(2008-7#2)(2009-10#1)(2009-3#1)(2009-7#1)(2010-4#1)(2011-2#1)
were quantified##64##2##(1990-12#2)(1990-3#1)(1993-2#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(2004-11#1)(2004-9#1)(2005-11#1)(2006-11#1)(2006-6#1)(2007-11#2)(2007-12#3)(2007-6#1)(2007-8#1)(2008-10#16)(2008-3#2)(2008-5#2)(2008-7#4)(2009-10#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-8#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
were quantitated by##3##3##(1990-7#1)(1994-12#1)(1996-11#1)
were quantitated in##3##3##(2008-12#1)(2010-12#1)(2011-2#1)
were quantitated using##2##3##(1992-6#1)(1994-2#1)
were quantitated##14##2##(1990-12#1)(1990-4#1)(1990-7#1)(1992-6#2)(1994-12#1)(1994-2#2)(1995-12#1)(1996-11#1)(2004-12#1)(2008-12#1)(2010-12#1)(2011-2#1)
were quantitative##7##2##(1992-11#1)(2008-10#6)
were quantitatively assessed by##2##4##(1990-4#1)(2008-11#1)
were quantitatively determined in##2##4##(1996-12#1)(2011-2#1)
were quantitatively determined using##2##4##(1997-3#1)(2008-10#1)
were quantitatively determined##4##3##(1996-12#1)(1997-3#1)(2008-10#1)(2011-2#1)
were quantitatively eluted##2##3##(2008-10#1)(2008-3#1)
were quantitatively evaluated##4##3##(1995-8#1)(1996-11#1)(2010-5#1)(2012-2#1)
were quantitatively recovered##5##3##(1990-7#1)(1997-2#1)(2008-10#3)
were quantitatively##32##2##(1990-2#1)(1990-4#1)(1990-7#1)(1992-11#1)(1993-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-3#2)(2008-10#12)(2008-11#1)(2008-3#2)(2008-8#1)(2010-5#1)(2011-2#1)(2012-2#1)
were quenched##3##2##(1992-7#1)(1996-6#1)(2008-8#1)
were questioned about their##3##4##(1993-10#1)(1996-2#1)(2012-12#1)
were questioned about##5##3##(1991-11#1)(1993-10#1)(1996-2#1)(2012-12#1)(2012-2#1)
were questioned##10##2##(1991-11#1)(1993-10#1)(1993-3#1)(1996-2#1)(1996-8#1)(2006-8#1)(2008-11#1)(2008-8#1)(2012-12#1)(2012-2#1)
were quickly##2##2##(2008-10#1)(2008-11#1)
were quite different from those of##2##6##(1992-12#1)(1992-7#1)
were quite different from##5##4##(1992-12#1)(1992-7#1)(1997-8#1)(2005-12#1)(2009-8#1)
were quite different##8##3##(1992-12#1)(1992-7#1)(1997-4#2)(1997-8#1)(2005-11#1)(2005-12#1)(2009-8#1)
were quite similar to those##2##5##(1993-6#1)(2008-11#1)
were quite similar##4##3##(1993-6#1)(2005-10#1)(2008-11#1)(2008-5#1)
were quite variable##2##3##(1994-3#1)(2012-3#1)
were quite##27##2##(1992-12#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-6#2)(1994-3#1)(1996-8#1)(1997-4#2)(1997-8#1)(2005-10#1)(2005-11#1)(2005-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-2#1)(2012-3#1)
were race 2##3##3##(2008-10#3)
were race##4##2##(2008-10#4)
were radiographed##3##2##(2007-1#1)(2009-4#1)(2011-2#1)
were radiolabeled with##3##3##(1991-2#1)(1992-2#1)(2013-7#1)
were radiolabeled##5##2##(1991-2#1)(1992-2#1)(1992-3#1)(1995-8#1)(2013-7#1)
were raised against the##2##4##(1994-5#1)(2008-11#1)
were raised against##7##3##(1990-3#1)(1990-7#1)(1994-5#1)(1995-3#1)(1996-10#1)(1997-4#1)(2008-11#1)
were raised from##2##3##(2004-4#1)(2008-3#1)
were raised in rabbits against synthetic##2##6##(1995-10#1)(2008-5#1)
were raised in rabbits against##3##5##(1991-7#1)(1995-10#1)(2008-5#1)
were raised in rabbits##4##4##(1990-8#1)(1991-7#1)(1995-10#1)(2008-5#1)
were raised in##11##3##(1990-11#1)(1990-8#1)(1991-6#1)(1991-7#1)(1992-8#1)(1992-9#1)(1995-10#1)(2008-10#1)(2008-5#2)(2012-3#1)
were raised to##6##3##(1990-7#1)(1992-1#1)(1995-10#1)(2008-9#1)(2010-7#1)(2011-2#1)
were raised##44##2##(1990-11#1)(1990-3#1)(1990-7#2)(1990-8#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-5#1)(1992-8#1)(1992-9#1)(1994-5#1)(1995-10#2)(1995-11#1)(1995-3#1)(1996-10#1)(1997-4#1)(2004-4#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
were random##2##2##(2008-10#2)
were randomised into##2##3##(1995-9#1)(2012-2#1)
were randomised to receive##2##4##(1992-10#1)(1993-7#1)
were randomised to##6##3##(1992-10#1)(1993-2#1)(1993-7#1)(2005-12#1)(2008-3#1)(2010-4#1)
were randomised##9##2##(1992-10#1)(1993-12#1)(1993-2#1)(1993-7#1)(1995-9#1)(2005-12#1)(2008-3#1)(2010-4#1)(2012-2#1)
were randomized in two groups##2##5##(2011-2#2)
were randomized in##4##3##(1993-8#1)(2008-7#1)(2011-2#2)
were randomized into four groups##2##5##(1992-4#1)(2013-1#1)
were randomized into three groups##2##5##(2007-2#1)(2011-1#1)
were randomized into two groups##5##5##(1991-2#1)(2005-1#1)(2008-5#1)(2008-8#1)(2012-2#1)
were randomized into##14##3##(1991-2#1)(1992-4#1)(2005-1#1)(2007-2#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-4#1)(2011-1#1)(2012-2#2)(2013-1#2)
were randomized to an##2##4##(2006-10#1)(2008-3#1)
were randomized to either##6##4##(2004-1#1)(2008-8#1)(2009-9#1)(2010-4#1)(2012-3#1)(2013-1#1)
were randomized to four groups##2##5##(2006-12#1)(2013-8#1)
were randomized to receive either##6##5##(1992-4#1)(2006-10#1)(2007-3#1)(2008-6#1)(2013-1#2)
were randomized to receive placebo##2##5##(2008-7#1)(2011-2#1)
were randomized to receive##17##4##(1992-4#1)(2004-2#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-3#1)(2008-6#1)(2008-7#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
were randomized to the##4##4##(2008-4#1)(2012-12#1)(2012-3#1)(2013-8#1)
were randomized to two##2##4##(2004-1#1)(2008-3#1)
were randomized to##56##3##(1991-10#1)(1992-4#1)(1992-8#1)(1993-4#1)(1997-6#1)(2004-1#3)(2004-2#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#1)(2007-3#1)(2007-8#1)(2008-3#2)(2008-4#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-4#3)(2010-8#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#7)(2013-8#3)
were randomized##82##2##(1990-4#1)(1991-10#1)(1991-2#1)(1992-4#2)(1992-8#1)(1993-4#1)(1993-8#1)(1996-5#1)(1997-6#1)(2004-1#4)(2004-2#1)(2005-1#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2009-3#1)(2009-6#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-4#4)(2010-8#2)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#9)(2013-8#4)
were randomly allocated into one of##3##6##(2008-10#2)(2011-12#1)
were randomly allocated into two groups##2##6##(2007-8#1)(2010-12#1)
were randomly allocated into##9##4##(2006-12#2)(2007-8#1)(2008-10#2)(2010-12#1)(2011-12#2)(2012-3#1)
were randomly allocated to receive either##4##6##(1993-4#1)(2009-10#1)(2010-7#1)(2013-7#1)
were randomly allocated to receive##10##5##(1991-6#1)(1991-8#1)(1993-4#1)(2004-1#1)(2008-4#1)(2009-10#1)(2010-12#1)(2010-7#1)(2013-1#1)(2013-7#1)
were randomly allocated to treatment with##3##6##(1990-9#1)(1995-5#1)(2008-1#1)
were randomly allocated to##24##4##(1990-11#1)(1990-6#1)(1990-9#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-5#1)(1993-4#1)(1995-5#1)(1997-1#1)(1997-8#1)(2004-1#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-7#2)
were randomly allocated##37##3##(1990-11#1)(1990-6#1)(1990-9#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-5#1)(1993-4#1)(1995-5#1)(1997-1#1)(1997-8#1)(2004-1#1)(2006-12#2)(2006-6#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2009-10#1)(2010-12#2)(2010-7#2)(2011-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#2)
were randomly assigned either to##2##5##(1990-5#1)(2011-1#1)
were randomly assigned in##2##4##(1994-2#1)(2013-7#1)
were randomly assigned into two groups##3##6##(2005-10#1)(2010-7#1)(2013-8#1)
were randomly assigned into##8##4##(2005-10#1)(2005-8#1)(2007-11#1)(2008-5#1)(2010-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
were randomly assigned to 1 of 2##2##7##(2006-10#1)(2011-1#1)
were randomly assigned to 1 of##3##6##(2006-10#1)(2011-1#1)(2013-8#1)
were randomly assigned to 1##4##5##(2006-10#1)(2008-12#1)(2011-1#1)(2013-8#1)
were randomly assigned to 4 groups##2##6##(1996-9#1)(2012-2#1)
were randomly assigned to 48 weeks of treatment with diet and placebo or##2##13##(1991-7#2)
were randomly assigned to a##10##5##(2004-10#1)(2007-11#1)(2007-12#1)(2008-12#2)(2008-6#1)(2010-2#1)(2012-2#2)(2013-1#1)
were randomly assigned to be##3##5##(1991-5#1)(2006-5#1)(2013-7#1)
were randomly assigned to either a##5##6##(2008-12#1)(2008-4#1)(2010-2#1)(2010-3#1)(2013-1#1)
were randomly assigned to either the##2##6##(2008-11#1)(2009-11#1)
were randomly assigned to either##11##5##(2007-2#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2013-1#1)(2013-7#1)
were randomly assigned to four##4##5##(2007-12#1)(2007-8#1)(2008-7#1)(2010-2#1)
were randomly assigned to one of four groups##2##8##(2011-2#2)
were randomly assigned to one of four##3##7##(2011-2#2)(2012-2#1)
were randomly assigned to one of the##2##7##(2010-4#1)(2013-8#1)
were randomly assigned to one of three groups##3##8##(2006-9#1)(2008-4#1)(2009-5#1)
were randomly assigned to one of three##4##7##(2006-9#1)(2008-4#2)(2009-5#1)
were randomly assigned to one of two groups##2##8##(1996-8#1)(2010-4#1)
were randomly assigned to one of##12##6##(1994-7#1)(1996-8#1)(2006-9#1)(2008-4#2)(2009-5#1)(2010-4#2)(2011-2#2)(2012-2#1)(2013-8#1)
were randomly assigned to receive either##4##6##(1990-9#1)(1996-2#1)(2007-2#1)(2007-8#1)
were randomly assigned to receive##18##5##(1990-12#1)(1990-9#1)(1993-1#1)(1994-2#1)(1996-2#1)(2006-6#1)(2007-2#1)(2007-8#4)(2008-8#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-7#1)
were randomly assigned to the treatment##2##6##(2006-4#1)(2007-8#1)
were randomly assigned to the##4##5##(2006-4#1)(2007-3#1)(2007-8#1)(2008-12#1)
were randomly assigned to three groups##2##6##(2009-3#1)(2011-2#1)
were randomly assigned to three##3##5##(2009-3#1)(2010-10#1)(2011-2#1)
were randomly assigned to treatment##2##5##(2006-10#1)(2008-2#1)
were randomly assigned to two groups##4##6##(2007-9#1)(2008-11#1)(2008-5#1)(2013-8#1)
were randomly assigned to two##5##5##(1993-1#1)(2007-9#1)(2008-11#1)(2008-5#1)(2013-8#1)
were randomly assigned to##103##4##(1990-12#1)(1990-9#1)(1991-11#1)(1991-5#1)(1991-7#2)(1992-12#1)(1992-8#1)(1993-1#2)(1994-2#1)(1994-7#1)(1996-1#1)(1996-2#1)(1996-8#1)(1996-9#1)(2004-10#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#1)(2007-8#6)(2007-9#2)(2008-11#2)(2008-12#7)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#3)(2010-6#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#6)(2013-1#4)(2013-7#3)(2013-8#3)
were randomly assigned##118##3##(1990-12#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-5#1)(1991-7#2)(1992-12#1)(1992-8#1)(1993-1#2)(1994-2#2)(1994-7#1)(1996-1#1)(1996-2#1)(1996-8#1)(1996-9#1)(2004-10#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-8#2)(2006-9#1)(2007-11#4)(2007-12#2)(2007-2#2)(2007-3#1)(2007-8#6)(2007-9#2)(2008-11#2)(2008-12#7)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#3)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#5)(2012-12#3)(2012-2#6)(2013-1#5)(2013-7#4)(2013-8#4)
were randomly chosen from the##2##5##(2007-9#1)(2009-5#1)
were randomly chosen from##3##4##(2007-9#1)(2008-10#1)(2009-5#1)
were randomly chosen##5##3##(2006-10#1)(2007-9#1)(2008-10#2)(2009-5#1)
were randomly collected from##3##4##(2008-12#1)(2008-4#1)(2011-1#1)
were randomly distributed into##2##4##(2008-5#1)(2009-4#1)
were randomly distributed##4##3##(1996-3#1)(2006-5#1)(2008-5#1)(2009-4#1)
were randomly divided into 2 groups##2##6##(2007-10#1)(2009-7#1)
were randomly divided into five groups##4##6##(2010-1#1)(2010-7#1)(2011-1#1)(2011-3#1)
were randomly divided into five##5##5##(2010-1#1)(2010-7#1)(2011-1#1)(2011-3#1)(2013-8#1)
were randomly divided into four groups##7##6##(2006-8#1)(2008-10#1)(2008-4#2)(2010-12#1)(2010-7#1)(2013-1#1)
were randomly divided into four##8##5##(2006-8#1)(2008-10#1)(2008-4#2)(2009-8#1)(2010-12#1)(2010-7#1)(2013-1#1)
were randomly divided into one##2##5##(2011-2#1)(2013-7#1)
were randomly divided into three groups##3##6##(2008-4#1)(2009-8#1)(2012-3#1)
were randomly divided into two groups of##2##7##(2008-10#1)(2008-5#1)
were randomly divided into two groups##10##6##(1993-2#1)(1994-7#1)(2006-4#1)(2007-8#2)(2008-10#1)(2008-5#1)(2012-12#1)(2013-1#2)
were randomly divided into two##11##5##(1993-2#1)(1994-7#1)(2006-4#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-5#1)(2012-12#1)(2013-1#2)
were randomly divided into##37##4##(1993-12#1)(1993-2#1)(1994-7#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-4#3)(2008-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-7#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
were randomly divided##39##3##(1993-12#1)(1993-2#1)(1994-7#1)(1997-3#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-4#3)(2008-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-7#3)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
were randomly evaluated##2##3##(1995-2#1)(2011-2#1)
were randomly grouped##2##3##(2008-12#1)(2008-6#1)
were randomly presented##2##3##(1997-7#1)(2011-1#1)
were randomly recruited##3##3##(2007-2#1)(2011-2#1)(2012-2#1)
were randomly sampled and##2##4##(2006-8#1)(2008-10#1)
were randomly sampled from##3##4##(1997-2#1)(2008-10#2)
were randomly sampled##5##3##(1997-2#1)(2006-8#1)(2008-10#3)
were randomly selected and##3##4##(2007-10#1)(2008-12#1)(2008-8#1)
were randomly selected for##5##4##(1996-12#1)(2006-8#1)(2008-3#1)(2008-5#1)(2013-1#1)
were randomly selected from the register of the##2##8##(2007-2#2)
were randomly selected from the##5##5##(2007-2#2)(2008-1#1)(2008-3#1)(2008-5#1)
were randomly selected from##11##4##(1992-11#1)(1996-12#1)(2006-7#1)(2006-8#1)(2007-2#2)(2008-1#1)(2008-3#1)(2008-5#1)(2010-2#1)(2010-3#1)
were randomly selected to participate in##2##6##(2009-7#1)(2011-2#1)
were randomly selected to##4##4##(1995-6#1)(2007-2#1)(2009-7#1)(2011-2#1)
were randomly selected##35##3##(1992-11#1)(1995-6#1)(1996-12#2)(2004-10#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#3)(2007-10#1)(2007-2#3)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#2)(2008-5#2)(2008-8#2)(2009-7#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#2)(2013-8#1)
were randomly treated with##2##4##(1997-6#1)(2008-3#1)
were randomly##270##2##(1990-11#2)(1990-12#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-1#2)(1993-12#1)(1993-2#2)(1993-4#1)(1994-10#1)(1994-2#2)(1994-7#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-1#1)(2004-10#2)(2005-10#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-4#3)(2006-5#5)(2006-6#2)(2006-7#1)(2006-8#7)(2006-9#1)(2007-10#2)(2007-11#4)(2007-12#2)(2007-2#6)(2007-3#1)(2007-7#1)(2007-8#11)(2007-9#3)(2008-1#2)(2008-10#13)(2008-11#2)(2008-12#11)(2008-2#1)(2008-3#5)(2008-4#8)(2008-5#8)(2008-6#2)(2008-7#2)(2008-8#3)(2009-10#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#2)(2009-8#3)(2010-1#3)(2010-10#1)(2010-12#5)(2010-2#5)(2010-3#2)(2010-4#4)(2010-6#1)(2010-7#7)(2011-1#7)(2011-12#2)(2011-2#10)(2011-3#1)(2012-12#5)(2012-2#9)(2012-3#3)(2013-1#15)(2013-7#8)(2013-8#6)
were ranged from##5##3##(2007-8#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-12#1)
were ranging from##2##3##(2008-10#1)(2009-7#1)
were ranked according to their##2##5##(1993-12#1)(2007-8#1)
were ranked according to##3##4##(1993-12#1)(2007-8#1)(2012-3#1)
were ranked as the##2##4##(1991-3#1)(2011-2#1)
were ranked by##2##3##(2007-6#1)(2008-5#1)
were ranked##14##2##(1991-3#1)(1991-6#1)(1993-12#1)(1995-1#1)(1995-3#1)(2007-6#2)(2007-8#1)(2008-5#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)
were rapid and##4##3##(1994-9#1)(1995-8#1)(2008-10#1)(2008-5#1)
were rapid##5##2##(1994-9#1)(1995-8#1)(2008-10#1)(2008-12#1)(2008-5#1)
were rapidly and##3##3##(1993-12#1)(2008-5#1)(2008-8#1)
were rapidly lost##3##3##(1994-12#1)(2008-11#1)(2010-7#1)
were rapidly reversible inhibitors with##2##5##(1990-5#2)
were rapidly##20##2##(1990-5#2)(1991-4#1)(1991-8#1)(1992-7#1)(1993-12#2)(1993-9#1)(1994-12#1)(1997-2#1)(2006-8#1)(2007-10#1)(2007-6#1)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#1)(2010-7#1)
were rare##16##2##(2006-2#2)(2006-7#1)(2008-10#7)(2008-9#1)(2009-9#1)(2010-6#1)(2011-2#2)(2012-3#1)
were rarely found##3##3##(1990-9#1)(1991-12#1)(1991-3#1)
were rarely observed##4##3##(1990-3#1)(1997-3#1)(2007-5#1)(2008-10#1)
were rarely##14##2##(1990-3#1)(1990-9#1)(1991-12#1)(1991-3#1)(1996-3#1)(1997-3#1)(2007-11#1)(2007-5#1)(2008-10#1)(2009-3#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
were rated as Class##2##4##(2007-6#2)
were rated as class##6##4##(2007-6#6)
were rated as##19##3##(2006-10#1)(2006-7#1)(2007-12#1)(2007-6#8)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#1)(2010-12#1)
were rated by##3##3##(1991-2#1)(2008-10#1)(2008-12#1)
were rated higher##2##3##(1993-12#2)
were rated on a##2##4##(2008-7#1)(2010-12#1)
were rated##37##2##(1990-12#1)(1991-2#1)(1993-12#2)(1993-2#1)(1994-11#1)(2006-10#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-6#8)(2008-10#3)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#1)(2010-12#3)(2011-2#2)(2012-12#1)
were rather##6##2##(1990-5#1)(2005-11#1)(2006-8#1)(2008-5#1)(2009-2#1)(2011-2#1)
were re-analyzed##2##2##(2009-4#1)(2012-2#1)
were re-established##2##2##(1991-9#1)(2012-2#1)
were re-evaluated##4##2##(2006-10#1)(2006-8#1)(2009-4#1)(2012-2#1)
were re-examined at##2##3##(1996-12#1)(2006-7#1)
were re-examined##8##2##(1991-8#1)(1992-2#1)(1992-5#1)(1995-12#1)(1996-12#1)(1996-7#1)(2006-7#1)(2008-5#1)
were re-tested##5##2##(1991-10#1)(1991-9#1)(1994-8#1)(2007-5#1)(2011-2#1)
were reached by##2##3##(1991-8#1)(2008-10#1)
were reached for##2##3##(2008-10#1)(2013-1#1)
were reached in##4##3##(2008-11#1)(2008-2#1)(2011-2#1)(2013-1#1)
were reached with##2##3##(1990-12#1)(2008-10#1)
were reached##18##2##(1990-12#1)(1991-8#1)(1993-12#1)(1994-11#1)(1994-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#2)
were reacted with##5##3##(1990-3#1)(1991-4#1)(2006-6#1)(2007-11#1)(2008-11#1)
were reacted##7##2##(1990-3#1)(1991-4#1)(2006-6#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#1)
were reactive by##2##3##(2007-12#1)(2008-1#1)
were reactive for##3##3##(1994-8#1)(1995-6#1)(2007-7#1)
were reactive in##2##3##(2006-10#1)(2008-3#1)
were reactive with the##2##4##(1990-7#1)(1995-12#1)
were reactive with##3##3##(1990-7#1)(1995-12#1)(1996-12#1)
were reactive##13##2##(1990-10#1)(1990-7#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)
were read##4##2##(2006-10#1)(2008-10#1)(2008-12#1)(2008-3#1)
were readily detected##2##3##(1996-5#1)(2008-10#1)
were readily##26##2##(1990-1#1)(1991-12#1)(1992-6#2)(1993-3#1)(1994-11#1)(1995-1#1)(1995-2#1)(1996-5#1)(1996-8#1)(1997-2#1)(2005-11#1)(2006-12#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#2)(2008-9#1)(2010-8#1)(2013-1#1)(2013-8#1)
were readmitted##2##2##(2006-1#1)(2012-12#1)
were ready for##2##3##(2006-6#1)(2008-12#1)
were ready##3##2##(2006-6#1)(2008-11#1)(2008-12#1)
were realized by##2##3##(2008-10#1)(2010-4#1)
were realized##9##2##(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#1)(2010-4#1)
were reanalysed##2##2##(2008-10#2)
were reared in##4##3##(2007-6#1)(2008-12#3)
were reared on##4##3##(1995-9#1)(2008-6#1)(2008-9#1)(2013-1#1)
were reared##15##2##(1995-9#1)(1997-7#1)(2007-6#1)(2007-7#1)(2008-12#3)(2008-5#1)(2008-6#1)(2008-9#1)(2010-4#1)(2010-8#3)(2013-1#1)
were reasonably similar##2##3##(1990-10#1)(1993-9#1)
were reasonably##9##2##(1990-10#1)(1993-9#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2010-4#1)
were reassessed##5##2##(1995-2#1)(2006-7#1)(2007-1#1)(2007-2#1)(2011-1#1)
were recalculated##2##2##(1994-1#1)(2008-10#1)
were recaptured##2##2##(2004-11#1)(2008-5#1)
were received from##8##3##(1990-10#1)(1992-11#1)(1993-9#1)(1994-2#1)(2007-12#1)(2008-1#1)(2012-3#2)
were received##19##2##(1990-10#1)(1992-11#1)(1992-12#1)(1993-9#1)(1994-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-12#1)(2010-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
were receiving##25##2##(1993-10#1)(1995-12#1)(1995-5#1)(2005-10#2)(2006-10#1)(2006-7#2)(2007-11#1)(2007-2#1)(2007-8#5)(2008-1#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
were recently identified##2##3##(2006-10#1)(2011-1#1)
were recently introduced##2##3##(1990-6#1)(2011-2#1)
were recently proposed##3##3##(1997-8#1)(2008-2#1)(2012-2#1)
were recently shown to have##3##5##(2008-7#1)(2009-10#2)
were recently shown to##7##4##(1993-12#1)(1993-3#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-10#2)
were recently used for##2##4##(1995-12#1)(2008-10#1)
were recently##30##2##(1990-6#1)(1991-6#1)(1991-7#1)(1991-9#1)(1993-12#1)(1993-3#1)(1995-12#1)(1995-6#1)(1997-8#1)(2006-10#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#2)(2008-7#1)(2009-10#2)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
were reciprocally##2##2##(1994-9#1)(2007-3#1)
were reclassified##2##2##(2009-8#1)(2013-8#1)
were recognised in##2##3##(2007-11#1)(2008-10#1)
were recognized as##6##3##(1996-11#1)(1996-8#1)(2007-12#1)(2007-7#1)(2008-5#1)(2011-1#1)
were recognized by the##3##4##(1995-2#1)(1995-8#1)(2008-10#1)
were recognized by##7##3##(1994-11#1)(1995-2#1)(1995-8#1)(2005-12#1)(2008-10#1)(2008-12#1)(2008-8#1)
were recognized in##2##3##(1996-9#1)(2007-8#1)
were recognized on##3##3##(1991-2#1)(1995-12#1)(2008-9#1)
were recognized##32##2##(1991-10#1)(1991-2#1)(1992-5#1)(1994-11#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-8#1)(1996-9#1)(1997-2#1)(2005-12#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
were recommended for the##2##4##(2007-8#1)(2008-10#1)
were recommended for##4##3##(2007-8#1)(2008-10#1)(2008-3#1)(2011-1#1)
were recommended##11##2##(1994-11#2)(2006-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-2#1)(2009-4#1)(2011-1#1)(2013-1#1)
were reconstituted in##3##3##(1990-12#1)(1992-5#1)(2008-4#1)
were reconstituted with##2##3##(1995-5#1)(1997-4#1)
were reconstituted##7##2##(1990-12#1)(1992-1#1)(1992-11#1)(1992-5#1)(1995-5#1)(1997-4#1)(2008-4#1)
were reconstructed by##3##3##(2007-12#1)(2008-3#1)(2008-9#1)
were reconstructed using##2##3##(2006-8#1)(2008-8#1)
were reconstructed with##4##3##(1996-2#1)(2007-12#1)(2008-3#1)(2008-7#1)
were reconstructed##21##2##(1990-12#1)(1990-5#1)(1990-7#1)(1995-8#1)(1996-2#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#3)(2008-7#2)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#2)
were recordable##2##2##(1995-6#1)(2006-6#1)
were recorded after the##2##4##(1993-9#1)(1997-8#1)
were recorded after##3##3##(1990-10#1)(1993-9#1)(1997-8#1)
were recorded among##2##3##(2006-2#1)(2008-10#1)
were recorded and analysed##3##4##(1996-12#1)(2008-10#1)(2009-6#1)
were recorded and analyzed##2##4##(2007-10#1)(2008-6#1)
were recorded and compared with##2##5##(1990-3#1)(2008-2#1)
were recorded and the##3##4##(1993-5#1)(1996-3#1)(2008-8#1)
were recorded and##27##3##(1990-3#1)(1992-9#1)(1993-5#1)(1996-12#1)(1996-3#1)(1997-7#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#1)(2009-7#1)(2010-4#1)(2010-6#1)(2011-1#1)(2013-1#2)(2013-7#1)
were recorded as##9##3##(1990-6#1)(1995-10#1)(2006-12#1)(2007-3#1)(2008-10#2)(2010-11#1)(2010-3#1)(2011-2#1)
were recorded at the beginning of##2##6##(2008-5#1)(2013-7#1)
were recorded at the##7##4##(1997-5#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-7#2)
were recorded at various##3##4##(2005-11#1)(2008-10#2)
were recorded at##25##3##(1990-7#1)(1997-5#1)(2005-11#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-4#1)(2009-5#1)(2009-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-7#2)
were recorded before and after the##2##6##(1995-11#1)(2012-12#1)
were recorded before and after##4##5##(1995-11#1)(2007-2#1)(2008-5#1)(2012-12#1)
were recorded before and##6##4##(1993-1#1)(1995-11#1)(2007-2#2)(2008-5#1)(2012-12#1)
were recorded before##9##3##(1992-12#1)(1993-1#1)(1995-11#1)(1995-12#1)(2007-2#3)(2008-5#1)(2012-12#1)
were recorded between##4##3##(2007-5#1)(2008-10#2)(2008-12#1)
were recorded by a##2##4##(2008-2#1)(2008-5#1)
were recorded by use of a##3##6##(1996-5#1)(2007-12#2)
were recorded by##15##3##(1996-5#1)(1997-3#1)(2007-1#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-5#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-2#3)(2012-3#1)
were recorded continuously during##2##4##(1991-10#1)(2007-9#1)
were recorded continuously##3##3##(1991-10#1)(2007-9#1)(2008-7#1)
were recorded during##10##3##(1991-4#1)(1994-6#1)(1996-3#1)(2007-7#1)(2008-3#1)(2008-7#1)(2011-12#1)(2013-7#1)(2013-8#2)
were recorded every 5 min##2##5##(1993-6#1)(2012-3#1)
were recorded every##4##3##(1993-6#1)(2008-12#1)(2008-7#1)(2012-3#1)
were recorded for each##3##4##(1993-9#1)(2007-2#1)(2008-3#1)
were recorded for the##2##4##(2010-12#1)(2013-1#1)
were recorded for##18##3##(1991-9#1)(1993-11#1)(1993-9#1)(2006-2#1)(2006-5#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-12#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-1#1)(2013-1#2)
were recorded from 11##2##4##(1996-5#1)(2008-11#1)
were recorded from the##11##4##(1990-4#1)(1992-8#1)(1993-2#1)(1994-5#1)(1996-6#1)(1996-9#1)(2006-12#1)(2009-4#1)(2011-1#1)(2012-7#1)(2013-7#1)
were recorded from##27##3##(1990-2#1)(1990-4#1)(1992-8#1)(1993-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(2006-12#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-10#1)(2011-1#1)(2012-7#1)(2013-1#1)(2013-7#1)
were recorded in 15##2##4##(2009-6#1)(2012-2#1)
were recorded in a##6##4##(1993-6#1)(1994-6#1)(1996-1#1)(2007-12#1)(2007-8#1)(2008-10#1)
were recorded in all three##2##5##(1991-11#1)(2007-10#1)
were recorded in all##4##4##(1991-11#1)(2006-12#1)(2007-10#1)(2013-1#1)
were recorded in four patients with##2##6##(1996-1#1)(1997-8#1)
were recorded in situ##2##4##(2005-11#1)(2008-2#1)
were recorded in the##16##4##(1993-12#1)(1994-12#1)(1995-12#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-8#1)(2010-9#1)(2012-12#1)(2013-1#1)
were recorded in##71##3##(1990-4#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-1#2)(1992-2#1)(1993-12#3)(1993-2#3)(1993-5#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#4)(1996-1#3)(1997-6#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-12#3)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-9#1)(2009-4#1)(2009-6#2)(2009-8#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
were recorded on a##2##4##(2008-5#1)(2008-7#1)
were recorded on an##2##4##(1995-6#1)(2007-6#1)
were recorded on##9##3##(1992-7#1)(1995-6#1)(2006-5#1)(2007-11#1)(2007-2#2)(2007-6#1)(2008-5#1)(2008-7#1)
were recorded over the left##2##5##(1993-9#2)
were recorded over the##4##4##(1993-9#2)(2008-10#1)(2008-7#1)
were recorded over##5##3##(1993-9#2)(2008-10#1)(2008-3#1)(2008-7#1)
were recorded prospectively##2##3##(1990-10#1)(2013-1#1)
were recorded simultaneously##5##3##(1991-3#1)(1997-5#1)(2005-11#1)(2007-8#1)(2008-3#1)
were recorded through##2##3##(2010-8#1)(2013-1#1)
were recorded to##3##3##(1997-3#1)(2007-8#1)(2008-3#1)
were recorded until##2##3##(2008-3#1)(2010-12#1)
were recorded using an##3##4##(2004-11#1)(2008-7#1)(2011-2#1)
were recorded using the##3##4##(1991-1#1)(2005-10#1)(2008-11#1)
were recorded using##12##3##(1991-1#1)(1992-6#1)(2004-11#1)(2005-10#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
were recorded while##2##3##(1994-3#1)(2006-3#1)
were recorded with a##5##4##(1995-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)
were recorded with an##4##4##(2008-3#2)(2008-5#1)(2008-7#1)
were recorded with the##3##4##(2007-10#2)(2008-8#1)
were recorded with##18##3##(1993-9#1)(1995-8#1)(2007-10#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)
were recorded##436##2##(1990-10#2)(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#3)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#4)(1992-10#2)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#4)(1993-2#4)(1993-3#1)(1993-5#2)(1993-6#2)(1993-9#5)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-10#1)(1995-11#5)(1995-12#7)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#3)(1996-12#4)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#1)(1996-9#1)(1997-3#2)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2004-2#1)(2005-10#3)(2005-11#3)(2005-12#1)(2005-5#1)(2005-8#1)(2006-10#4)(2006-11#3)(2006-12#5)(2006-2#2)(2006-3#1)(2006-5#2)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#7)(2007-11#4)(2007-12#9)(2007-2#6)(2007-3#2)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#6)(2007-8#10)(2007-9#5)(2008-1#3)(2008-10#33)(2008-11#6)(2008-12#7)(2008-2#7)(2008-3#21)(2008-4#4)(2008-5#25)(2008-6#1)(2008-7#14)(2008-8#4)(2008-9#4)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#4)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#11)(2011-12#3)(2011-2#13)(2012-1#2)(2012-12#5)(2012-2#13)(2012-3#3)(2012-7#1)(2013-1#18)(2013-7#6)(2013-8#6)
were recovered and##4##3##(1996-11#1)(2008-10#2)(2011-1#1)
were recovered by##3##3##(2008-10#1)(2008-6#1)(2013-8#1)
were recovered from a##4##4##(2008-10#3)(2008-7#1)
were recovered from diseased##3##4##(2008-10#3)
were recovered from noncultivated hosts##2##5##(2008-10#2)
were recovered from the##10##4##(2006-3#1)(2008-10#4)(2008-4#1)(2008-5#2)(2011-2#1)(2013-1#1)
were recovered from these##2##4##(2008-10#1)(2013-8#1)
were recovered from##48##3##(1991-1#1)(1993-9#1)(2004-11#1)(2006-3#1)(2007-7#1)(2007-8#2)(2008-10#29)(2008-12#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
were recovered in a##2##4##(2008-10#1)(2008-5#1)
were recovered in the##8##4##(1992-2#1)(1993-8#1)(1995-7#1)(1995-8#2)(1996-8#1)(1997-4#1)(2008-2#1)
were recovered in##14##3##(1992-2#1)(1993-8#1)(1995-1#1)(1995-7#1)(1995-8#2)(1996-8#2)(1997-4#1)(1997-5#1)(2008-10#2)(2008-2#1)(2008-5#1)
were recovered on##3##3##(2007-8#1)(2008-10#2)
were recovered with##2##3##(1996-7#1)(2008-10#1)
were recovered##102##2##(1990-11#1)(1990-3#1)(1990-4#1)(1991-1#1)(1992-2#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-1#1)(1995-7#2)(1995-8#2)(1996-11#1)(1996-7#1)(1996-8#2)(1997-4#1)(1997-5#1)(2004-11#1)(2006-12#1)(2006-3#1)(2007-3#1)(2007-7#3)(2007-8#3)(2008-10#50)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
were recruited and##7##3##(2007-8#1)(2008-10#1)(2008-4#1)(2012-2#1)(2013-1#3)
were recruited at two##2##4##(2007-9#1)(2010-8#1)
were recruited at##4##3##(2007-10#1)(2007-9#1)(2010-8#1)(2011-2#1)
were recruited by##3##3##(2008-12#1)(2009-5#1)(2012-1#1)
were recruited during the##2##4##(2007-2#1)(2013-1#1)
were recruited for the study##4##5##(2007-1#1)(2010-8#1)(2011-2#1)(2012-12#1)
were recruited for the##6##4##(2007-1#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)
were recruited for this study##5##5##(1995-3#1)(2008-1#1)(2008-12#1)(2008-8#1)(2013-1#1)
were recruited for this##7##4##(1995-3#1)(2008-1#1)(2008-12#1)(2008-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
were recruited for##15##3##(1995-3#1)(2007-1#1)(2008-1#1)(2008-12#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
were recruited from a##3##4##(2007-8#1)(2011-2#1)(2013-1#1)
were recruited from community##2##4##(2008-12#1)(2009-5#1)
were recruited from the##6##4##(1995-4#1)(2007-5#1)(2008-3#1)(2009-10#1)(2011-11#1)(2011-2#1)
were recruited from two##2##4##(2008-9#1)(2013-1#1)
were recruited from##31##3##(1995-4#1)(2004-3#1)(2006-7#4)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2011-1#1)(2011-11#1)(2011-2#3)(2013-1#6)
were recruited in the study##2##5##(2008-7#1)(2012-2#1)
were recruited in the##3##4##(2008-6#1)(2008-7#1)(2012-2#1)
were recruited in##8##3##(2006-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-2#1)(2012-2#2)(2013-8#1)
were recruited into the study##2##5##(2008-4#1)(2011-1#1)
were recruited into the##3##4##(2008-1#1)(2008-4#1)(2011-1#1)
were recruited into this##2##4##(2010-8#1)(2013-1#1)
were recruited into##8##3##(1994-3#1)(2006-4#1)(2008-1#1)(2008-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
were recruited over##2##3##(2009-10#1)(2011-1#1)
were recruited through##3##3##(1995-1#1)(2007-12#1)(2013-8#1)
were recruited to participate in##3##5##(2007-10#1)(2008-6#1)(2011-1#1)
were recruited to the study##2##5##(2006-10#1)(2011-12#1)
were recruited to the##3##4##(2006-10#1)(2008-2#1)(2011-12#1)
were recruited to##8##3##(2006-10#1)(2007-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-9#1)(2011-1#1)(2011-12#1)
were recruited##116##2##(1994-3#1)(1995-1#1)(1995-3#1)(1995-4#1)(2004-3#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-7#5)(2007-1#1)(2007-10#2)(2007-12#2)(2007-2#2)(2007-3#1)(2007-5#1)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#4)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#4)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-5#2)(2009-6#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#5)(2011-11#1)(2011-12#2)(2011-2#10)(2012-1#2)(2012-12#2)(2012-2#5)(2013-1#19)(2013-8#5)
were rectilinear over the##4##4##(2008-10#4)
were rectilinear##5##2##(2008-10#5)
were recurrent##5##2##(1994-6#1)(1996-9#1)(2006-12#1)(2006-6#1)(2007-3#1)
were redder##2##2##(2010-4#2)
were reduced (P &lt##2##4##(1992-12#1)(2010-2#1)
were reduced after##3##3##(1996-11#1)(2013-1#2)
were reduced and##2##3##(1991-5#1)(2007-10#1)
were reduced as##5##3##(1995-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-8#1)
were reduced at##2##3##(2006-3#1)(2008-8#1)
were reduced by 1-3 logs in 30##2##7##(1997-4#2)
were reduced by 2##2##4##(1990-10#1)(1991-6#1)
were reduced by a factor of##2##6##(1995-3#1)(2008-2#1)
were reduced by a##4##4##(1995-3#1)(1996-12#1)(2008-2#1)(2008-5#1)
were reduced by the##3##4##(1994-11#1)(2008-10#2)
were reduced by##43##3##(1990-10#1)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-3#2)(1996-12#1)(1997-1#1)(1997-4#2)(1997-6#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#1)(2009-8#2)(2010-8#1)
were reduced compared##2##3##(1993-5#1)(2008-10#1)
were reduced for##2##3##(2008-10#2)
were reduced from##4##3##(1995-12#2)(2004-9#1)(2008-5#1)
were reduced in a dose-dependent fashion##2##6##(1992-12#1)(2008-5#1)
were reduced in patients with##3##5##(1995-3#1)(2007-8#1)(2009-9#1)
were reduced in patients##4##4##(1995-3#1)(2007-8#1)(2008-5#1)(2009-9#1)
were reduced in the##5##4##(1996-12#1)(1996-5#1)(1997-1#1)(2008-4#1)(2010-7#1)
were reduced in##25##3##(1991-10#1)(1992-12#1)(1992-2#1)(1995-3#1)(1995-7#1)(1996-12#2)(1996-5#1)(1997-1#1)(2007-6#2)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#3)(2008-7#4)(2009-9#1)(2010-7#1)
were reduced more##3##3##(1997-7#1)(1997-8#1)(2008-10#1)
were reduced significantly##6##3##(2004-11#1)(2008-10#1)(2010-12#1)(2010-2#2)(2012-2#1)
were reduced to the##3##4##(2005-8#1)(2007-10#1)(2012-2#1)
were reduced to##15##3##(1993-3#1)(1993-8#1)(1994-5#1)(1996-11#1)(2005-8#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-2#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
were reduced under##3##3##(2012-1#1)(2012-6#1)(2013-1#1)
were reduced when##2##3##(1990-11#1)(1996-3#1)
were reduced##163##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#5)(1995-3#4)(1995-7#1)(1996-11#2)(1996-12#3)(1996-3#1)(1996-5#2)(1997-1#2)(1997-2#1)(1997-4#4)(1997-6#1)(1997-7#2)(1997-8#2)(2004-11#1)(2004-9#1)(2005-12#1)(2005-8#1)(2006-3#1)(2007-10#4)(2007-12#3)(2007-2#1)(2007-6#2)(2007-8#5)(2008-10#23)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#1)(2009-2#1)(2009-4#2)(2009-8#2)(2009-9#2)(2010-12#2)(2010-2#3)(2010-4#1)(2010-7#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2012-6#1)(2013-1#3)
were reductions in##3##3##(2008-10#1)(2011-11#1)(2012-12#1)
were reevaluated##3##2##(2006-10#1)(2007-7#1)(2008-10#1)
were reexamined##4##2##(1996-5#2)(2008-10#1)(2008-9#1)
were referred by##6##3##(1990-12#2)(1991-8#1)(2006-8#1)(2007-3#1)(2013-1#1)
were referred for##7##3##(1990-2#1)(1992-9#1)(2006-9#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-6#1)
were referred from the##3##4##(2008-9#3)
were referred from##5##3##(2007-3#1)(2008-6#1)(2008-9#3)
were referred to a##5##4##(1994-11#1)(2006-10#1)(2006-8#2)(2010-10#1)
were referred to our center##3##5##(2007-2#1)(2007-7#1)(2008-4#1)
were referred to our##6##4##(1997-1#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-4#1)
were referred to the Department of##2##6##(1995-6#1)(2008-6#1)
were referred to the Department##3##5##(1995-6#1)(2007-11#1)(2008-6#1)
were referred to the department##2##5##(1990-12#1)(2012-2#1)
were referred to the##13##4##(1990-12#1)(1990-8#1)(1993-3#1)(1993-9#1)(1995-6#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-6#1)(2008-7#1)(2012-2#1)
were referred to us##4##4##(1995-11#1)(2007-7#1)(2010-8#1)(2011-2#1)
were referred to##35##3##(1990-12#1)(1990-8#1)(1993-3#1)(1993-9#1)(1994-11#1)(1995-11#1)(1995-6#1)(1997-1#1)(2006-10#2)(2006-12#1)(2006-8#5)(2007-11#2)(2007-2#3)(2007-3#2)(2007-7#2)(2007-8#2)(2008-4#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
were referred##55##2##(1990-12#3)(1990-2#1)(1990-8#1)(1991-8#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-11#1)(1995-11#1)(1995-6#1)(1997-1#1)(2006-10#2)(2006-12#1)(2006-8#6)(2006-9#1)(2007-11#2)(2007-2#3)(2007-3#5)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#1)(2008-4#1)(2008-6#3)(2008-7#1)(2008-9#3)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
were refined##3##2##(1995-10#1)(2008-9#1)(2010-12#1)
were reflected by##2##3##(1996-8#1)(2005-11#1)
were reflected in the##4##4##(1995-3#1)(2008-5#1)(2008-6#1)(2008-8#1)
were reflected in##10##3##(1991-8#1)(1994-6#1)(1995-3#1)(2004-9#2)(2006-5#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-8#1)
were reflected##13##2##(1991-8#1)(1994-6#1)(1995-3#1)(1996-8#1)(2004-9#2)(2005-11#1)(2006-5#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-8#1)
were refractive##2##2##(2007-1#1)(2011-1#1)
were refractory to##2##3##(1992-9#1)(1994-5#1)
were refractory##3##2##(1992-9#2)(1994-5#1)
were refused##3##2##(1995-12#1)(1995-4#1)(1995-6#1)
were regarded as a##2##4##(1990-4#1)(1993-12#1)
were regarded as factors in the optimization##3##7##(2008-10#3)
were regarded as factors in the##4##6##(2008-10#4)
were regarded as##12##3##(1990-4#1)(1993-12#1)(1993-8#1)(2005-11#1)(2005-9#1)(2006-2#1)(2008-10#4)(2008-11#1)(2012-3#1)
were regenerated##5##2##(2006-12#1)(2008-9#2)(2013-1#2)
were registered and##2##3##(1991-9#1)(2007-8#1)
were registered as##3##3##(1993-5#2)(2008-10#1)
were registered at##3##3##(2005-10#1)(2006-10#1)(2006-4#1)
were registered between##2##3##(1995-9#1)(2008-11#1)
were registered during##3##3##(1990-5#1)(2008-5#2)
were registered in a##2##4##(1996-6#1)(2008-7#1)
were registered in males##2##4##(1991-6#1)(1995-5#1)
were registered in the##6##4##(1993-8#2)(1995-6#1)(2006-8#1)(2007-10#1)(2013-1#1)
were registered in##25##3##(1990-2#1)(1991-6#1)(1992-11#1)(1993-3#2)(1993-8#3)(1993-9#1)(1994-5#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#2)(1996-6#1)(1996-8#1)(1997-8#1)(2006-8#1)(2007-10#2)(2007-11#1)(2008-7#1)(2013-1#1)
were registered with##3##3##(1990-10#1)(2008-5#1)(2010-1#1)
were registered##66##2##(1990-10#1)(1990-2#1)(1990-4#1)(1990-5#1)(1991-11#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-11#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-5#3)(1993-8#3)(1993-9#3)(1994-5#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#4)(1996-2#1)(1996-6#1)(1996-8#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#2)
were regressed against##3##3##(2006-12#1)(2008-10#1)(2013-1#1)
were regressed onto##2##3##(2007-12#1)(2013-7#1)
were regressed##6##2##(2006-12#1)(2007-12#1)(2008-10#2)(2013-1#1)(2013-7#1)
were regular##5##2##(1992-2#1)(1993-3#1)(2008-10#1)(2012-3#1)(2013-1#1)
were regularly##2##2##(2008-12#1)(2011-2#1)
were regulated at the##2##4##(2009-8#2)
were regulated by##2##3##(1992-5#1)(2008-9#1)
were regulated##8##2##(1992-2#1)(1992-5#1)(1997-6#1)(2008-5#1)(2008-9#1)(2009-8#2)(2010-12#1)
were rehabilitated##2##2##(2007-2#1)(2010-10#1)
were rejected##3##2##(2008-9#2)(2010-12#1)
were related closely##2##3##(1992-7#1)(2008-10#1)
were related to a##3##4##(1991-12#1)(1991-8#1)(2010-11#1)
were related to high##2##4##(1995-1#1)(2008-10#1)
were related to more##2##4##(2007-12#1)(2008-7#1)
were related to patients##2##4##(1992-10#1)(2011-1#1)
were related to positive##2##4##(2004-2#1)(2007-12#1)
were related to the number of##2##6##(1992-1#1)(2009-9#1)
were related to the##31##4##(1990-5#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-6#1)(1993-5#1)(1994-3#1)(1996-6#1)(1997-6#1)(2005-5#1)(2006-3#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-9#2)(2010-5#1)(2011-1#1)(2013-1#1)
were related to their##4##4##(1991-1#1)(1991-2#1)(2008-10#1)(2010-8#1)
were related to##118##3##(1990-2#1)(1990-5#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#2)(1992-12#1)(1992-6#2)(1993-12#2)(1993-5#1)(1994-3#1)(1995-1#3)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#2)(1997-6#1)(2004-11#1)(2004-2#1)(2005-10#2)(2005-11#1)(2005-5#1)(2006-10#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-10#1)(2007-12#5)(2007-2#2)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#15)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#2)(2009-7#7)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#2)(2012-5#1)(2013-1#3)(2013-8#1)
were related with##3##3##(1993-12#1)(2007-8#1)(2012-3#1)
were related##133##2##(1990-2#1)(1990-5#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#2)(1992-12#1)(1992-6#2)(1992-7#1)(1993-12#3)(1993-5#1)(1994-3#1)(1995-1#3)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#2)(1997-6#1)(2004-11#1)(2004-2#1)(2005-10#2)(2005-11#1)(2005-5#1)(2006-10#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-10#1)(2007-12#7)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#17)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#2)(2009-4#2)(2009-7#8)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-8#2)(2011-1#4)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#3)(2013-8#1)
were relatively constant##3##3##(1997-4#1)(1997-7#1)(2007-8#1)
were relatively high##2##3##(2008-10#1)(2012-2#1)
were relatively insensitive to##2##4##(1991-4#1)(1993-12#1)
were relatively less##2##3##(2007-9#1)(2009-10#1)
were relatively low compared##3##4##(2008-5#1)(2010-8#1)(2011-2#1)
were relatively low##7##3##(1994-9#1)(2006-5#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#1)
were relatively more##2##3##(1992-12#1)(1993-12#1)
were relatively robust##2##3##(2008-10#1)(2010-4#1)
were relatively small##3##3##(1992-8#1)(1996-3#1)(2009-7#1)
were relatively unimportant##2##3##(2004-11#1)(2012-3#1)
were relatively weak##3##3##(1994-3#1)(1997-1#1)(2004-9#1)
were relatively##59##2##(1990-11#2)(1991-1#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-8#1)(1993-12#2)(1994-10#1)(1994-12#1)(1994-3#3)(1994-6#1)(1994-9#1)(1995-12#1)(1996-3#1)(1997-1#2)(1997-4#1)(1997-7#1)(2004-11#1)(2004-9#1)(2006-5#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-7#1)(2010-12#3)(2010-4#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-8#1)
were relatives and friends##2##4##(2007-7#1)(2008-2#1)
were relatives##3##2##(1997-8#1)(2007-7#1)(2008-2#1)
were released after##2##3##(1992-12#1)(2008-4#1)
were released and##2##3##(2011-12#2)
were released as##2##3##(1993-11#1)(2008-6#1)
were released by##3##3##(1990-12#1)(1991-12#1)(1992-9#1)
were released during##2##3##(2005-11#1)(2008-10#1)
were released from the enzyme##2##5##(1992-6#1)(1997-4#1)
were released from the##5##4##(1992-6#1)(1994-5#1)(1997-4#1)(2008-10#1)(2008-5#1)
were released from##10##3##(1992-6#1)(1992-8#1)(1994-5#1)(1997-4#1)(2008-10#2)(2008-5#1)(2012-12#2)(2013-1#1)
were released in##4##3##(1990-2#1)(2008-9#1)(2010-12#1)(2010-6#1)
were released to##2##3##(1991-1#1)(2006-12#1)
were released with##3##3##(1992-8#1)(1994-11#1)(2008-10#1)
were released##44##2##(1990-12#1)(1990-2#1)(1991-1#1)(1991-12#1)(1992-12#2)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#1)(1994-11#1)(1994-5#1)(1994-9#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-8#1)(2008-10#8)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-12#1)(2010-6#1)(2010-8#2)(2011-12#3)(2011-2#2)(2012-12#2)(2013-1#1)
were reliable##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
were reliably##2##2##(1992-1#1)(2009-7#1)
were relieved by##2##3##(1997-8#1)(2007-12#1)
were relieved##8##2##(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#3)(2010-7#1)(2011-2#1)
were reluctant to##3##3##(1991-5#1)(2008-1#1)(2009-2#1)
were remarkable##4##2##(1993-11#1)(1993-2#1)(1996-11#1)(2011-2#1)
were remarkably similar for##2##4##(1991-1#1)(2008-8#1)
were remarkably similar in##2##4##(2007-11#1)(2010-2#1)
were remarkably similar##6##3##(1991-1#1)(1991-5#1)(1995-6#1)(2007-11#1)(2008-8#1)(2010-2#1)
were remarkably##17##2##(1991-1#1)(1991-5#1)(1991-7#2)(1992-1#1)(1994-3#1)(1995-11#1)(1995-6#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#2)(2010-2#1)(2012-1#1)
were removed after##2##3##(2007-8#1)(2013-8#1)
were removed along with##2##4##(2006-12#1)(2009-8#1)
were removed and the##2##4##(1993-8#1)(1995-12#1)
were removed and##11##3##(1993-2#1)(1993-8#1)(1994-9#1)(1995-12#1)(1997-3#1)(2007-7#1)(2008-12#2)(2008-7#1)(2013-1#2)
were removed as##2##3##(2011-12#1)(2011-2#1)
were removed at##6##3##(1990-8#1)(1993-7#1)(1994-3#1)(2006-6#1)(2008-7#1)(2013-1#1)
were removed by a##3##4##(1995-3#1)(2007-8#1)(2008-11#1)
were removed by##14##3##(1993-6#1)(1995-10#1)(1995-3#1)(1996-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2009-2#1)(2010-4#1)(2011-2#1)(2012-2#1)
were removed for##3##3##(2006-6#1)(2008-10#1)(2013-1#1)
were removed from the##12##4##(1990-7#1)(1992-2#1)(1994-5#1)(1996-12#1)(1997-1#1)(2005-11#1)(2008-10#4)(2008-5#1)(2008-7#1)
were removed from##23##3##(1990-7#1)(1991-3#1)(1992-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-12#1)(1997-1#1)(2004-11#1)(2005-11#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-7#1)(2012-12#1)(2013-1#1)
were removed in##4##3##(1997-3#1)(2007-7#1)(2008-4#1)(2011-2#1)
were removed surgically and##2##4##(2010-7#1)(2011-2#1)
were removed surgically##3##3##(2008-8#1)(2010-7#1)(2011-2#1)
were removed to##3##3##(1993-4#1)(2006-8#1)(2012-2#1)
were removed using##3##3##(2006-2#1)(2008-10#1)(2008-5#1)
were removed with##3##3##(1991-8#1)(1997-2#1)(2010-11#1)
were removed within##3##3##(2008-10#2)(2011-2#1)
were removed without##2##3##(1991-3#1)(2006-12#1)
were removed##117##2##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-3#2)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#2)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-3#2)(2004-11#1)(2005-11#1)(2005-9#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#2)(2006-8#2)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#3)(2007-8#4)(2008-10#16)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#4)(2009-10#1)(2009-2#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-12#1)(2011-2#8)(2012-12#2)(2012-2#2)(2013-1#5)(2013-8#2)
were removed)##2##2##(1992-2#2)
were renal##2##2##(1997-3#1)(2008-1#1)
were rendered##8##2##(1991-1#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-12#1)(2010-3#1)(2010-4#1)(2011-7#1)
were repaired by##3##3##(2008-11#2)(2012-2#1)
were repaired##6##2##(2006-12#2)(2008-11#2)(2009-4#1)(2012-2#1)
were repeat##3##2##(2011-1#3)
were repeated after##6##3##(1990-10#1)(1995-12#1)(1995-7#1)(2006-3#1)(2008-7#1)(2013-1#1)
were repeated and compared##2##4##(1997-7#1)(2004-10#1)
were repeated every 28 days##2##5##(1990-2#1)(1992-2#1)
were repeated every##4##3##(1990-2#1)(1992-2#1)(2007-10#1)(2008-6#1)
were repeated in##2##3##(2008-10#1)(2008-5#1)
were repeated##26##2##(1990-10#1)(1990-2#1)(1990-5#1)(1992-2#1)(1994-2#1)(1995-12#2)(1995-7#1)(1997-7#1)(2004-10#1)(2005-1#1)(2006-11#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-1#2)
were repeatedly exposed to##3##4##(1993-12#2)(2004-9#1)
were repeatedly observed##2##3##(1992-5#1)(2008-7#1)
were repeatedly##11##2##(1991-1#1)(1992-5#1)(1993-12#2)(2004-9#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-7#1)(2009-8#1)(2012-2#1)
were replaced by the##2##4##(1991-4#1)(2013-8#1)
were replaced by##12##3##(1990-5#1)(1990-7#1)(1991-4#1)(1991-9#2)(1993-3#1)(1994-5#1)(1995-11#1)(1995-3#1)(2008-9#1)(2013-8#2)
were replaced with##8##3##(1992-6#1)(1993-3#2)(1994-6#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-2#1)
were replaced##25##2##(1990-5#1)(1990-7#1)(1991-4#1)(1991-9#2)(1992-6#1)(1993-3#3)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-3#1)(2007-7#1)(2008-9#1)(2011-2#1)(2013-8#2)
were replanted##3##2##(2008-10#2)(2008-9#1)
were replicated in##3##3##(1997-4#1)(2009-4#1)(2011-12#1)
were replicated##9##2##(1990-12#1)(1994-8#1)(1997-4#1)(2007-4#1)(2008-10#1)(2009-4#1)(2011-12#1)(2012-2#1)(2012-3#1)
were reported after##3##3##(1990-5#1)(2004-12#1)(2006-10#1)
were reported and##5##3##(2007-2#1)(2008-11#1)(2009-8#1)(2012-12#1)(2013-1#1)
were reported as positive##2##4##(2004-1#1)(2010-8#1)
were reported as##8##3##(1990-12#1)(2004-1#1)(2006-10#1)(2008-10#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)
were reported at##2##3##(2005-8#1)(2006-8#1)
were reported by##15##3##(1991-11#1)(1991-8#1)(1992-9#1)(1994-5#1)(1996-11#1)(2004-8#1)(2006-10#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-2#1)(2008-5#1)(2009-10#1)(2010-7#1)(2013-1#1)
were reported for the first time##5##6##(2008-10#1)(2008-11#1)(2010-9#1)(2012-3#1)(2013-8#1)
were reported for the first##6##5##(1991-12#1)(2008-10#1)(2008-11#1)(2010-9#1)(2012-3#1)(2013-8#1)
were reported for the##7##4##(1991-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2010-9#1)(2012-3#1)(2013-8#1)
were reported for##14##3##(1991-12#1)(1995-1#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-9#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
were reported from the##3##4##(2005-12#1)(2012-12#1)(2013-8#1)
were reported from##6##3##(1993-6#1)(2005-12#1)(2006-2#1)(2012-11#1)(2012-12#1)(2013-8#1)
were reported in the##5##4##(1990-11#1)(1991-12#1)(2008-10#1)(2008-2#1)(2012-12#1)
were reported in this##2##4##(2011-12#1)(2011-2#1)
were reported in##25##3##(1990-11#2)(1991-10#1)(1991-11#2)(1991-12#1)(1993-9#1)(1996-12#1)(1996-8#1)(1997-3#2)(2006-10#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)(2011-12#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
were reported previously##3##3##(1992-3#1)(2007-8#1)(2008-5#1)
were reported to be##11##4##(1993-12#1)(1994-2#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-8#1)(2011-2#1)(2013-1#1)
were reported to have##4##4##(1992-5#1)(2007-7#1)(2008-10#1)(2011-2#1)
were reported to the Norwegian##2##5##(1994-9#1)(1997-8#1)
were reported to the##4##4##(1993-3#1)(1993-6#1)(1994-9#1)(1997-8#1)
were reported to##26##3##(1991-11#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-9#1)(1997-8#1)(2005-7#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)
were reported with the##2##4##(2007-9#1)(2008-10#1)
were reported with##5##3##(1991-7#1)(2007-9#1)(2008-10#1)(2010-7#1)(2012-12#1)
were reported##197##2##(1990-11#2)(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#4)(1991-12#3)(1991-2#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-8#2)(1997-3#2)(1997-8#1)(2004-1#1)(2004-12#1)(2004-8#1)(2004-9#1)(2005-10#1)(2005-12#1)(2005-7#2)(2005-8#1)(2006-10#5)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-10#3)(2007-11#2)(2007-12#2)(2007-2#5)(2007-3#2)(2007-4#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#3)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#12)(2011-3#1)(2011-9#1)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#6)(2012-3#5)(2013-1#10)(2013-8#4)
were reportedly##5##2##(2007-2#1)(2007-9#1)(2010-3#1)(2012-2#1)(2013-1#1)
were representative of the##3##4##(1991-7#1)(2008-10#1)(2010-11#1)
were represented at##2##3##(2005-6#1)(2008-10#1)
were represented by the##3##4##(2008-10#1)(2009-2#1)(2013-7#1)
were represented by##13##3##(2007-1#1)(2007-10#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#1)(2009-2#1)(2011-1#2)(2011-2#1)(2013-7#1)
were represented in the##3##4##(1993-3#1)(1994-9#1)(2005-8#1)
were represented in##4##3##(1993-3#1)(1994-9#1)(2005-8#1)(2013-7#1)
were represented##24##2##(1993-3#1)(1994-9#1)(1995-7#1)(2004-11#1)(2005-6#1)(2005-8#1)(2006-2#1)(2007-1#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-2#1)(2011-1#2)(2011-2#1)(2013-7#2)
were repressed##2##2##(1991-9#1)(2007-12#1)
were reproduced by##2##3##(2006-8#1)(2007-12#1)
were reproduced##5##2##(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#2)
were reproducible to##2##3##(2008-3#2)
were reproducible##6##2##(2007-8#3)(2008-10#1)(2008-3#2)
were requested to##6##3##(1996-8#1)(2007-3#1)(2008-1#1)(2008-11#1)(2009-8#1)(2010-1#1)
were requested##7##2##(1996-8#1)(2007-3#1)(2008-1#1)(2008-11#2)(2009-8#1)(2010-1#1)
were required for its##2##4##(1992-5#1)(2008-10#1)
were required for the##5##4##(1992-2#1)(2006-2#1)(2007-2#1)(2008-10#2)
were required for##19##3##(1990-8#1)(1992-2#1)(1992-5#1)(1993-11#1)(1994-3#1)(1994-5#1)(1995-3#1)(1995-6#1)(2006-2#1)(2007-2#1)(2008-10#6)(2008-11#2)(2013-8#1)
were required in##4##3##(1990-2#1)(1995-12#1)(2006-8#1)(2008-5#1)
were required of##3##3##(2007-10#1)(2013-1#2)
were required to achieve##3##4##(1993-8#1)(2007-11#1)(2007-8#1)
were required to be##2##4##(2006-8#1)(2008-10#1)
were required to complete##2##4##(2008-12#1)(2013-7#1)
were required to have##3##4##(1993-12#1)(2008-7#1)(2010-4#1)
were required to make a##2##5##(1991-1#1)(2008-11#1)
were required to perform##2##4##(1993-2#1)(2008-4#1)
were required to provide##2##4##(1996-12#1)(2008-2#1)
were required to##42##3##(1990-12#1)(1990-7#1)(1991-1#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-3#3)(1994-8#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(2004-11#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-2#1)(2010-4#1)(2012-12#1)(2013-1#2)(2013-7#1)
were required##85##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-1#1)(1992-12#1)(1992-2#1)(1992-5#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-3#4)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(2004-10#1)(2004-11#1)(2005-2#1)(2006-2#1)(2006-5#1)(2006-8#4)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#3)(2007-8#1)(2008-10#9)(2008-11#6)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#4)(2013-7#1)(2013-8#1)
were research##2##2##(2005-7#1)(2008-10#1)
were researched##3##2##(2007-9#1)(2008-12#1)(2013-1#1)
were resected and##2##3##(2007-5#1)(2008-12#1)
were resected##7##2##(2006-7#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)
were resident##5##2##(2005-7#1)(2008-1#1)(2008-5#1)(2010-8#1)(2013-1#1)
were residents of##4##3##(1991-11#1)(2006-2#1)(2008-6#1)(2011-2#1)
were residents##7##2##(1991-11#1)(2004-3#1)(2006-2#1)(2008-6#1)(2011-2#1)(2012-12#2)
were residing in##2##3##(1990-5#1)(2011-1#1)
were resistant and##2##3##(2007-7#2)
were resistant to a##2##4##(1993-9#1)(1997-2#1)
were resistant to ampicillin##2##4##(1993-1#1)(2007-7#1)
were resistant to both##5##4##(1991-2#1)(2008-10#4)
were resistant to ofloxacin##2##4##(2007-7#1)(2011-2#1)
were resistant to penicillin##4##4##(2007-7#1)(2007-8#1)(2009-5#1)(2013-8#1)
were resistant to the action of##2##6##(1994-11#1)(1995-2#1)
were resistant to the##5##4##(1993-4#1)(1994-11#1)(1995-2#1)(2008-10#1)(2010-4#1)
were resistant to treatment##2##4##(1992-6#1)(2004-11#1)
were resistant to vancomycin##2##4##(2007-7#2)
were resistant to##80##3##(1990-9#1)(1991-2#1)(1991-4#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-4#1)(1993-5#2)(1993-9#1)(1994-11#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-7#1)(2004-11#1)(2005-11#1)(2006-12#1)(2006-8#2)(2007-4#1)(2007-7#8)(2007-8#2)(2008-10#19)(2008-11#1)(2008-12#1)(2008-5#5)(2009-3#1)(2009-5#1)(2010-12#1)(2010-4#2)(2010-6#1)(2010-9#1)(2011-10#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#4)
were resistant##93##2##(1990-9#1)(1991-2#1)(1991-4#1)(1992-1#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-4#1)(1993-5#2)(1993-9#1)(1994-11#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-7#1)(2004-11#1)(2005-11#1)(2006-12#1)(2006-4#1)(2006-8#2)(2007-4#1)(2007-7#10)(2007-8#2)(2008-10#24)(2008-11#1)(2008-12#1)(2008-5#6)(2008-7#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-10#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#4)
were resisted to##2##3##(2011-2#2)
were resolved and##2##3##(2008-10#2)
were resolved by consensus##5##4##(2009-9#1)(2010-2#1)(2012-12#3)
were resolved by electrophoresis##2##4##(1994-11#1)(1995-2#1)
were resolved by##23##3##(1990-12#1)(1990-5#1)(1990-7#1)(1993-2#1)(1993-6#1)(1994-11#2)(1995-2#1)(1995-6#1)(1996-5#1)(1996-8#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-7#1)(2009-9#1)(2010-2#1)(2012-12#3)(2013-7#1)
were resolved for##2##3##(1995-1#1)(2013-1#1)
were resolved from the##2##4##(1995-1#1)(2008-10#1)
were resolved with##4##3##(1990-8#1)(2007-7#1)(2008-10#1)(2008-2#1)
were resolved##47##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-8#1)(1992-10#1)(1992-7#1)(1993-2#1)(1993-6#1)(1994-11#2)(1995-1#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-5#2)(1996-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-2#1)(2012-12#3)(2013-1#1)(2013-7#1)
were respectively##24##2##(1990-11#1)(1990-3#1)(1991-2#1)(1992-4#1)(1992-8#1)(1994-6#1)(2005-11#1)(2005-4#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
were respiratory distress##2##3##(1990-3#1)(1995-5#1)
were respiratory##4##2##(1990-3#1)(1995-5#1)(1997-6#1)(2007-10#1)
were responsible for the##13##4##(1991-2#1)(1991-5#1)(1995-6#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-9#1)(2011-12#1)(2013-1#1)(2013-8#2)
were responsible for this##2##4##(1991-11#1)(2008-10#1)
were responsible for##40##3##(1990-12#1)(1990-3#1)(1991-11#1)(1991-2#1)(1991-5#1)(1993-3#1)(1993-4#1)(1993-5#2)(1995-6#1)(1997-7#1)(2006-12#1)(2007-12#1)(2007-3#2)(2007-8#2)(2008-1#1)(2008-10#10)(2008-8#1)(2009-5#1)(2009-9#1)(2010-1#2)(2010-5#1)(2011-12#1)(2012-12#1)(2013-1#1)(2013-8#3)
were responsive to##6##3##(1992-2#1)(1993-12#1)(1997-7#1)(2007-10#1)(2009-8#1)(2011-2#1)
were restored with##2##3##(2008-5#1)(2013-1#1)
were restored##14##2##(1990-11#1)(1990-12#1)(1990-5#1)(1993-4#1)(1995-5#1)(2006-9#1)(2007-10#1)(2008-5#2)(2008-8#1)(2009-8#2)(2010-6#1)(2013-1#1)
were restrained##5##2##(1996-2#1)(2007-4#1)(2008-4#1)(2008-7#2)
were restricted to a##2##4##(1990-4#1)(1995-6#1)
were restricted to the##6##4##(1990-11#1)(1996-3#1)(2008-10#2)(2008-2#1)(2008-5#1)
were restricted to##17##3##(1990-11#1)(1990-4#1)(1995-6#1)(1996-3#1)(1996-7#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-5#2)(2010-6#1)(2012-12#1)
were restricted##20##2##(1990-11#1)(1990-4#1)(1995-6#1)(1996-3#1)(1996-7#1)(2006-10#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2010-6#1)(2012-12#1)
were resulted##2##2##(2008-11#1)(2008-12#1)
were resuscitated##3##2##(1991-9#1)(1993-8#1)(1996-6#1)
were resuspended in##3##3##(1994-8#1)(1996-1#1)(2008-11#1)
were resuspended##5##2##(1994-8#1)(1995-1#1)(1996-1#1)(2008-11#2)
were retained by##2##3##(2004-8#1)(2008-10#1)
were retained in the##3##4##(1991-3#1)(2007-8#1)(2008-10#1)
were retained within the##2##4##(1990-3#1)(1997-4#1)
were retained##21##2##(1990-3#1)(1991-3#1)(1992-1#1)(1993-11#1)(1993-9#1)(1995-3#2)(1996-12#1)(1997-4#1)(2004-10#1)(2004-8#1)(2007-8#1)(2008-10#5)(2008-5#1)(2010-4#1)(2012-1#1)(2012-12#1)
were retested##7##2##(1992-7#1)(1994-3#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-8#1)(2013-1#1)
were retrieved and##3##3##(2006-8#1)(2012-12#1)(2013-1#1)
were retrieved for##2##3##(2011-11#1)(2013-1#1)
were retrieved from the##5##4##(2004-2#1)(2006-10#2)(2008-3#1)(2011-12#1)
were retrieved from##8##3##(2004-2#1)(2006-10#2)(2008-3#2)(2011-12#1)(2011-2#1)(2013-1#1)
were retrieved in##2##3##(2008-10#1)(2013-8#1)
were retrieved##23##2##(1993-11#1)(2004-2#1)(2006-10#3)(2006-8#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2011-11#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#2)
were retrogradely labeled##5##3##(1990-7#1)(1991-12#1)(1992-1#2)(1994-2#1)
were retrogradely##7##2##(1990-7#1)(1991-12#1)(1991-9#1)(1992-1#2)(1994-2#1)(1996-12#1)
were retrospective##2##2##(2006-2#1)(2012-3#1)
were retrospectively analysed##4##3##(1995-5#1)(1996-5#1)(2006-8#1)(2011-2#1)
were retrospectively analyzed from##2##4##(1993-5#1)(2006-10#1)
were retrospectively analyzed##12##3##(1993-5#1)(2004-3#1)(2006-10#1)(2006-12#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-3#1)
were retrospectively assessed##2##3##(2006-7#1)(2006-8#1)
were retrospectively evaluated by##2##4##(1995-2#1)(2007-8#1)
were retrospectively evaluated##4##3##(1992-10#1)(1995-2#1)(2007-8#1)(2011-2#1)
were retrospectively reviewed to##5##4##(1992-9#1)(2006-1#1)(2007-7#1)(2008-6#1)(2012-2#1)
were retrospectively reviewed##24##3##(1992-9#1)(1997-8#1)(2004-3#1)(2005-12#1)(2006-1#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#2)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-8#1)
were retrospectively studied##6##3##(1991-12#1)(1995-10#1)(2006-4#1)(2007-7#1)(2008-1#1)(2011-2#1)
were retrospectively##58##2##(1990-12#1)(1991-12#1)(1991-2#1)(1992-10#1)(1992-9#1)(1993-3#1)(1993-5#1)(1995-10#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-8#1)(2004-3#2)(2005-12#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#2)(2007-2#3)(2007-7#3)(2007-8#5)(2008-1#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2011-1#2)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
were returned (response##2##3##(2009-2#1)(2012-11#1)
were returned by##3##3##(1993-3#1)(1996-1#1)(1997-3#1)
were returned to the##2##4##(1990-7#1)(2010-10#1)
were returned to##3##3##(1990-7#1)(1992-2#1)(2010-10#1)
were returned##27##2##(1990-7#1)(1992-2#1)(1993-3#2)(1996-1#1)(1996-2#1)(1996-3#1)(1997-3#1)(2005-12#1)(2005-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-2#3)(2007-9#1)(2008-4#1)(2008-8#1)(2009-2#1)(2010-10#1)(2010-11#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
were revealed AluI(-) PstI(-) SmaI(+) BssHII(+)##2##6##(2011-1#2)
were revealed at##2##3##(1995-11#1)(2008-12#1)
were revealed between##2##3##(2011-1#1)(2013-8#1)
were revealed by##9##3##(1993-7#1)(1995-8#1)(1996-7#1)(1996-9#1)(2007-12#1)(2008-10#1)(2010-12#1)(2012-2#1)(2013-7#1)
were revealed for##2##3##(1992-6#1)(1995-11#1)
were revealed in the##3##4##(2013-1#3)
were revealed in##7##3##(1995-11#1)(2007-8#1)(2010-12#1)(2011-2#1)(2013-1#3)
were revealed to have##2##4##(2008-11#1)(2008-5#1)
were revealed to##5##3##(1990-5#1)(1991-2#1)(2008-11#1)(2008-5#1)(2008-8#1)
were revealed##47##2##(1990-5#1)(1991-2#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-7#1)(1995-11#3)(1995-8#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-5#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#2)(2009-2#1)(2010-12#2)(2011-1#5)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#1)
were reversed by##5##3##(1991-1#1)(1995-3#1)(1996-6#1)(2007-11#1)(2009-9#1)
were reversed##11##2##(1991-1#1)(1993-2#1)(1993-4#1)(1995-3#1)(1996-12#1)(1996-6#1)(2004-4#1)(2006-4#1)(2007-11#1)(2008-12#1)(2009-9#1)
were reversible after##2##3##(1993-12#1)(2007-2#1)
were reversible##5##2##(1993-12#1)(1994-2#1)(1995-2#1)(1996-5#1)(2007-2#1)
were reviewed and discussed##2##4##(2007-8#1)(2008-7#1)
were reviewed and##11##3##(1996-3#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-1#1)(2013-1#1)
were reviewed at##4##3##(1996-1#1)(2007-8#1)(2008-8#1)(2010-10#1)
were reviewed by##4##3##(1996-1#1)(2008-5#1)(2011-2#1)(2013-8#1)
were reviewed for all##2##4##(2008-7#1)(2012-1#1)
were reviewed for signalment##2##4##(2012-1#1)(2013-1#1)
were reviewed for##12##3##(1995-12#1)(2005-8#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-7#1)(2008-9#1)(2012-1#2)(2012-2#1)(2013-1#2)
were reviewed from##3##3##(1991-8#1)(2006-10#1)(2011-1#1)
were reviewed in##7##3##(2005-4#1)(2005-7#1)(2006-10#1)(2007-8#1)(2008-1#1)(2010-8#1)(2011-2#1)
were reviewed retrospectively##9##3##(1993-5#2)(1993-8#1)(2006-10#2)(2007-8#2)(2011-1#1)(2011-2#1)
were reviewed to determine the##2##5##(2005-9#1)(2010-6#1)
were reviewed to##3##3##(2005-9#1)(2010-6#2)
were reviewed with a##2##4##(1990-3#1)(2007-3#1)
were reviewed with special emphasis on##2##6##(1996-12#1)(2006-7#1)
were reviewed with##6##3##(1990-3#1)(1996-12#1)(1996-6#1)(2006-7#1)(2006-8#1)(2007-3#1)
were reviewed##157##2##(1990-3#1)(1991-4#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-5#3)(1993-8#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-6#1)(1997-8#1)(2004-1#1)(2004-10#1)(2004-2#1)(2005-4#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#4)(2007-1#1)(2007-10#5)(2007-12#1)(2007-2#7)(2007-3#4)(2007-7#2)(2007-8#13)(2008-1#5)(2008-10#3)(2008-3#2)(2008-5#2)(2008-6#4)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#2)(2009-12#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-10#1)(2010-11#2)(2010-3#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#7)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#10)(2013-8#3)
were revised##8##2##(1993-2#1)(2007-1#2)(2007-8#1)(2008-3#1)(2008-8#1)(2010-5#1)(2012-2#1)
were rewarded with##2##3##(1993-6#1)(2011-1#1)
were rewarded##4##2##(1993-6#1)(1993-9#1)(2010-2#1)(2011-1#1)
were rewarmed##2##2##(1990-9#1)(1992-1#1)
were rich in##5##3##(1991-12#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#1)
were risk factors for##2##4##(2008-1#1)(2008-7#1)
were risk factors##5##3##(2008-1#1)(2008-7#1)(2011-1#2)(2013-8#1)
were robust to##2##3##(2008-7#1)(2009-12#1)
were robust##5##2##(1996-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2012-3#1)
were roughly##3##2##(1990-3#1)(1994-12#1)(2009-2#1)
were routinely obtained##2##3##(2006-12#1)(2008-5#1)
were routinely##11##2##(1990-3#1)(1990-9#1)(1991-11#1)(1992-11#1)(1993-8#1)(1994-2#1)(2006-12#1)(2008-3#1)(2008-5#2)(2013-8#1)
were ruled out as##3##4##(1992-12#1)(2008-3#1)(2012-2#1)
were ruled out##7##3##(1990-3#1)(1992-12#1)(2007-2#1)(2008-3#1)(2010-2#1)(2012-12#1)(2012-2#1)
were run in##2##3##(1990-12#1)(2008-5#1)
were run##11##2##(1990-12#1)(1990-5#1)(1991-12#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-2#1)(2012-2#1)
were rurality##2##2##(2011-2#2)
were sacrificed 4##2##3##(1992-12#1)(2006-7#1)
were sacrificed after##3##3##(1992-2#1)(1993-9#2)
were sacrificed and##6##3##(1996-5#1)(1996-7#1)(2007-1#1)(2008-10#1)(2008-7#2)
were sacrificed at the end of the##2##7##(1994-2#1)(2007-1#1)
were sacrificed at the end of##5##6##(1994-2#1)(1997-4#3)(2007-1#1)
were sacrificed at##19##3##(1992-7#1)(1994-2#2)(1994-6#1)(1995-11#1)(1997-4#3)(2006-10#1)(2006-8#2)(2007-1#1)(2008-10#1)(2008-7#1)(2010-1#1)(2013-1#3)(2013-8#1)
were sacrificed for##2##3##(2008-11#1)(2013-8#1)
were sacrificed on##2##3##(1996-12#1)(2006-6#1)
were sacrificed##48##2##(1992-12#1)(1992-2#1)(1992-7#1)(1993-4#1)(1993-9#2)(1994-2#2)(1994-6#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-4#3)(2006-10#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#2)(2007-6#1)(2008-10#2)(2008-11#1)(2008-7#3)(2008-9#3)(2010-1#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#5)(2013-8#3)
were safe and well tolerated##2##5##(1996-1#1)(2008-8#1)
were safe and##3##3##(1996-1#1)(2008-7#1)(2008-8#1)
were safe to##2##3##(1997-4#1)(2012-3#1)
were safe##5##2##(1996-1#1)(1997-4#1)(2008-7#1)(2008-8#1)(2012-3#1)
were salient##2##2##(2007-12#1)(2007-8#1)
were same##2##2##(1991-12#1)(2012-3#1)
were sampled and analyzed##2##4##(2008-10#1)(2013-1#1)
were sampled and##7##3##(2004-4#1)(2007-8#1)(2008-10#3)(2008-12#1)(2013-1#1)
were sampled at##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
were sampled by##5##3##(1994-6#1)(2008-3#1)(2011-2#1)(2013-1#1)(2013-7#1)
were sampled during the##3##4##(1996-8#1)(2006-4#1)(2008-5#1)
were sampled during##4##3##(1996-8#1)(2006-4#1)(2008-10#1)(2008-5#1)
were sampled for##3##3##(2007-2#1)(2008-10#1)(2009-12#1)
were sampled from brown spot lesions##2##6##(2008-10#2)
were sampled from##18##3##(1996-3#1)(2005-10#1)(2007-5#1)(2008-10#11)(2008-8#1)(2009-2#1)(2009-7#1)(2010-8#1)
were sampled in##11##3##(2007-3#2)(2007-5#1)(2008-10#5)(2008-5#2)(2009-4#1)
were sampled three times##3##4##(2008-10#3)
were sampled three##4##3##(2008-10#3)(2013-8#1)
were sampled to##2##3##(2008-10#2)
were sampled with a##2##4##(2008-5#2)
were sampled with##3##3##(2008-5#2)(2008-6#1)
were sampled##75##2##(1994-6#1)(1996-3#1)(1996-4#1)(1996-8#1)(2004-11#1)(2004-4#1)(2005-10#1)(2006-4#1)(2007-2#1)(2007-3#3)(2007-5#3)(2007-8#1)(2008-10#32)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#2)(2013-7#2)(2013-8#1)
were saponified##2##2##(1997-1#2)
were satisfactorily##4##2##(2008-10#4)
were satisfactory and##2##3##(2008-10#2)
were satisfactory for##3##3##(2007-8#1)(2008-10#2)
were satisfactory with##3##3##(2006-9#1)(2008-10#2)
were satisfactory##32##2##(1990-9#1)(1991-4#1)(1991-5#1)(1992-12#1)(1993-2#1)(1997-1#1)(2006-9#1)(2007-8#2)(2008-1#1)(2008-10#17)(2008-4#1)(2008-7#1)(2008-9#1)(2010-11#1)(2012-2#1)
were satisfied with its##2##4##(2007-10#1)(2007-7#1)
were satisfied with the##16##4##(1990-4#1)(1991-1#1)(1991-2#1)(1997-2#1)(2007-7#2)(2008-11#1)(2008-12#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)
were satisfied with their##6##4##(2008-3#1)(2008-9#1)(2009-5#2)(2009-9#1)(2010-3#1)
were satisfied with##28##3##(1990-2#1)(1990-4#1)(1991-1#1)(1991-2#1)(1997-2#1)(2007-10#2)(2007-2#1)(2007-7#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#2)(2009-5#2)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#1)
were satisfied##35##2##(1990-2#1)(1990-4#1)(1990-9#1)(1991-1#1)(1991-2#1)(1992-5#1)(1993-3#1)(1997-2#1)(1997-3#1)(2007-10#2)(2007-2#1)(2007-7#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-5#2)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#1)
were saturable with##2##3##(1991-1#1)(1992-6#1)
were saturable##3##2##(1991-1#1)(1992-6#1)(1994-11#1)
were saturated with##3##3##(1990-2#2)(1990-4#1)
were saved##2##2##(2007-7#1)(2008-12#1)
were scaled##2##2##(2006-11#1)(2007-1#1)
were scanned at##2##3##(2010-4#1)(2012-2#1)
were scanned using##2##3##(2009-2#1)(2010-8#1)
were scanned with##2##3##(2007-10#1)(2010-5#1)
were scanned##11##2##(2007-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-2#1)
were scarce##3##2##(2007-2#1)(2008-7#1)(2009-2#1)
were scarcely##3##2##(2005-11#1)(2008-10#1)(2008-9#1)
were scattered throughout the##4##4##(1990-2#1)(1995-11#1)(2008-7#1)(2011-2#1)
were scattered throughout##6##3##(1990-2#1)(1995-10#1)(1995-11#1)(2008-7#1)(2011-2#1)(2012-2#1)
were scattered##9##2##(1990-2#1)(1991-3#1)(1995-10#1)(1995-11#1)(2008-7#2)(2010-12#1)(2011-2#1)(2012-2#1)
were scheduled for elective##2##4##(1993-10#1)(1996-3#1)
were scheduled for##9##3##(1990-12#1)(1991-4#1)(1993-1#1)(1993-10#1)(1996-3#1)(2006-12#1)(2006-6#1)(2008-5#1)(2011-2#1)
were scheduled##10##2##(1990-12#1)(1991-4#1)(1993-1#1)(1993-10#1)(1996-3#1)(2006-12#1)(2006-6#1)(2008-5#1)(2011-2#1)(2012-12#1)
were scored as##2##3##(1994-12#1)(2007-8#1)
were scored by##4##3##(2007-2#1)(2008-9#1)(2010-12#1)(2010-4#1)
were scored for variation at##2##5##(2008-10#2)
were scored for##5##3##(1997-8#1)(2008-10#3)(2008-7#1)
were scored in the##2##4##(1994-6#1)(2008-10#1)
were scored in##5##3##(1990-11#1)(1994-6#1)(1994-8#1)(2006-5#1)(2008-10#1)
were scored using a##2##4##(2008-10#1)(2013-1#1)
were scored##32##2##(1990-11#1)(1994-12#1)(1994-6#1)(1994-8#2)(1997-8#2)(2005-9#1)(2006-5#1)(2007-10#1)(2007-2#1)(2007-8#2)(2008-10#7)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#3)(2010-4#1)(2010-8#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)
were screened against the##2##4##(2008-10#2)
were screened and##5##3##(2007-2#1)(2008-10#2)(2011-3#1)(2012-3#1)
were screened by using##2##4##(1994-12#1)(2008-10#1)
were screened by##11##3##(1993-2#1)(1994-12#1)(1994-2#1)(2006-12#1)(2007-7#1)(2008-10#1)(2008-9#1)(2009-11#1)(2010-1#1)(2011-1#1)(2013-8#1)
were screened during the##2##4##(2008-1#1)(2008-11#1)
were screened for resistance to##3##5##(2008-10#3)
were screened for the presence of##4##6##(1990-6#1)(1994-11#1)(2006-12#1)(2008-10#1)
were screened for the##7##4##(1990-6#1)(1991-6#1)(1994-11#1)(2006-12#1)(2008-10#2)(2011-12#1)
were screened for their ability to inhibit the##2##8##(1997-1#1)(2008-5#1)
were screened for their ability to##5##6##(1990-5#1)(1997-1#1)(1997-4#1)(2006-5#1)(2008-5#1)
were screened for their##14##4##(1990-5#1)(1997-1#1)(1997-4#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
were screened for##71##3##(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1991-6#1)(1992-10#1)(1992-2#1)(1994-11#1)(1994-12#1)(1996-11#1)(1996-6#1)(1997-1#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-2#2)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#16)(2008-12#2)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-1#3)(2011-12#2)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#2)
were screened from##3##3##(1996-12#1)(1997-4#1)(2008-8#1)
were screened in##4##3##(1990-6#1)(2008-10#1)(2008-5#1)(2010-5#1)
were screened on the basis of their##2##7##(2006-9#1)(2010-4#1)
were screened on the basis of##3##6##(1997-4#1)(2006-9#1)(2010-4#1)
were screened out##2##3##(2006-9#1)(2012-2#1)
were screened to##7##3##(2007-1#1)(2008-10#2)(2008-5#1)(2011-2#1)(2011-3#1)(2012-2#1)
were screened with a##2##4##(2008-10#1)(2011-2#1)
were screened with##4##3##(1995-11#1)(2006-9#1)(2008-10#1)(2011-2#1)
were screened##134##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#2)(1991-6#1)(1992-10#1)(1992-2#1)(1992-8#1)(1993-2#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-6#1)(1995-11#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-4#3)(2005-11#2)(2006-10#2)(2006-12#2)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#4)(2007-1#3)(2007-11#2)(2007-2#3)(2007-6#1)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#26)(2008-11#1)(2008-12#3)(2008-3#2)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-6#2)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#6)(2011-12#2)(2011-2#5)(2011-3#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
were scrutinized##2##2##(1991-5#1)(1994-8#1)
were sealed with Embrace##2##4##(2008-5#1)(2012-12#1)
were sealed with##4##3##(2008-5#1)(2008-6#1)(2012-12#2)
were sealed##6##2##(2008-10#1)(2008-5#1)(2008-6#1)(2012-12#3)
were searched for##16##3##(1994-3#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2009-10#1)(2009-7#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#1)
were searched from##2##3##(2009-9#1)(2012-2#1)
were searched in##2##3##(2011-1#1)(2013-1#1)
were searched to identify relevant##2##5##(2007-11#1)(2010-12#1)
were searched to identify##5##4##(2007-11#1)(2010-12#1)(2012-12#3)
were searched using the##2##4##(2011-2#2)
were searched using##4##3##(2011-2#2)(2013-1#1)(2013-8#1)
were searched##43##2##(1994-3#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-6#1)(2009-10#1)(2009-11#1)(2009-7#2)(2009-9#1)(2010-12#3)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#1)
were seated on a##2##4##(2006-11#1)(2007-4#1)
were secondary to the##2##4##(2006-6#1)(2008-5#1)
were secondary to##3##3##(2006-10#1)(2006-6#1)(2008-5#1)
were secondary##4##2##(2006-10#1)(2006-6#2)(2008-5#1)
were secreted into the##3##4##(1993-11#1)(1993-3#1)(1993-6#1)
were secreted##12##2##(1990-7#1)(1990-9#1)(1991-9#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1995-3#1)(1996-4#1)(2007-11#1)(2008-11#1)(2008-6#1)
were sectioned##3##2##(1997-2#1)(2007-3#1)(2008-10#1)
were seeded at##3##3##(2008-11#2)(2008-5#1)
were seeded in##3##3##(2008-2#1)(2008-5#1)(2012-3#1)
were seeded on the##2##4##(2008-10#1)(2010-8#1)
were seeded on##4##3##(1990-8#1)(2008-10#1)(2008-5#1)(2010-8#1)
were seeded onto##7##3##(1992-12#1)(2008-11#1)(2008-5#2)(2010-11#1)(2012-4#1)(2012-8#1)
were seeded with##2##3##(2008-10#1)(2012-2#1)
were seeded##19##2##(1990-8#1)(1992-12#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-5#5)(2010-11#1)(2010-8#1)(2012-2#1)(2012-3#1)(2012-4#1)(2012-8#1)
were seeking##4##2##(1996-1#1)(1997-2#1)(2011-2#1)(2012-12#1)
were seen after injection of##2##5##(1993-4#1)(2012-1#1)
were seen after##7##3##(1992-2#1)(1993-4#1)(1995-12#1)(1996-5#1)(2010-3#1)(2012-1#1)(2012-12#1)
were seen and##2##3##(2005-7#1)(2008-8#1)
were seen as the##3##4##(1996-2#1)(2004-10#1)(2008-11#1)
were seen as##7##3##(1995-1#1)(1996-2#1)(2004-10#1)(2006-11#1)(2007-2#1)(2007-8#1)(2008-11#1)
were seen at the##4##4##(1991-10#1)(2006-8#1)(2007-3#2)
were seen at##11##3##(1991-10#1)(1991-11#1)(1995-3#1)(2005-7#1)(2006-3#1)(2006-8#1)(2007-3#3)(2008-6#1)(2008-9#1)
were seen between the##3##4##(1997-1#1)(1997-6#1)(2006-8#1)
were seen between##7##3##(1993-2#1)(1995-10#1)(1997-1#1)(1997-6#1)(2006-8#1)(2008-12#1)(2010-11#1)
were seen by##3##3##(1992-9#1)(1994-2#1)(2006-8#1)
were seen comparing##2##3##(1993-9#1)(2013-1#1)
were seen during a three week period##2##7##(1992-6#2)
were seen during a##3##4##(1992-6#2)(2008-4#1)
were seen during the##3##4##(1994-2#1)(2012-3#1)(2013-1#1)
were seen during##9##3##(1992-6#2)(1994-2#1)(1997-4#1)(2007-7#1)(2008-1#1)(2008-4#1)(2012-3#1)(2013-1#1)
were seen for both##2##4##(1997-4#1)(2011-1#1)
were seen for##8##3##(1992-10#1)(1994-9#1)(1995-2#1)(1996-1#1)(1997-1#1)(1997-4#1)(2006-6#1)(2011-1#1)
were seen in 2##2##4##(2006-10#1)(2008-7#1)
were seen in a##4##4##(2006-8#2)(2009-8#1)(2012-3#1)
were seen in all patients##3##5##(1997-1#1)(2008-5#1)(2008-6#1)
were seen in all##8##4##(1992-9#1)(1997-1#1)(2007-8#1)(2008-5#2)(2008-6#1)(2009-8#1)(2010-1#1)
were seen in any of the##2##6##(2008-5#2)
were seen in any##3##4##(2007-3#1)(2008-5#2)
were seen in both##4##4##(1996-12#1)(1997-6#1)(2008-10#1)(2008-9#1)
were seen in groups##3##4##(1992-9#1)(2007-8#1)(2011-2#1)
were seen in male##3##4##(2008-9#2)(2012-2#1)
were seen in nervous tissue##2##5##(2011-1#2)
were seen in one##2##4##(2008-5#1)(2008-9#1)
were seen in patients##4##4##(1992-11#1)(1995-12#1)(2007-8#1)(2011-11#1)
were seen in the brain##2##5##(1994-2#1)(2008-5#1)
were seen in the first##2##5##(2007-7#1)(2012-2#1)
were seen in the##48##4##(1990-12#1)(1990-2#1)(1990-3#1)(1991-12#2)(1993-7#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-5#1)(1996-9#1)(1997-6#1)(2005-12#1)(2006-3#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#6)(2008-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-2#2)(2012-3#1)(2013-8#2)
were seen in##151##3##(1990-12#1)(1990-2#1)(1990-3#1)(1991-11#1)(1991-12#5)(1991-2#2)(1991-4#1)(1992-11#1)(1992-9#2)(1993-7#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-3#1)(1996-5#4)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#2)(2005-12#3)(2006-10#1)(2006-3#1)(2006-8#4)(2007-10#1)(2007-11#2)(2007-3#4)(2007-7#7)(2007-8#5)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-5#16)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#6)(2009-8#3)(2010-1#1)(2010-11#2)(2010-12#1)(2010-8#2)(2011-1#2)(2011-11#2)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#4)(2013-8#2)
were seen more##3##3##(2007-2#1)(2012-2#1)(2012-3#1)
were seen on the##2##4##(2007-7#1)(2011-2#1)
were seen on##11##3##(1994-7#1)(1995-12#1)(1997-3#1)(2007-2#1)(2007-7#3)(2008-2#1)(2008-7#1)(2010-12#1)(2011-2#1)
were seen only in##2##4##(1995-2#1)(2008-5#1)
were seen only##4##3##(1990-2#1)(1995-11#1)(1995-2#1)(2008-5#1)
were seen to be##5##4##(1992-2#1)(1997-2#1)(2005-11#1)(2008-11#1)(2013-1#1)
were seen to have##2##4##(2008-11#1)(2008-12#1)
were seen to##15##3##(1990-11#1)(1992-2#1)(1997-2#1)(2005-11#1)(2006-5#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
were seen up to##2##4##(1996-3#1)(2008-1#1)
were seen when##5##3##(1992-3#1)(1994-2#1)(2006-10#1)(2008-11#1)(2008-12#1)
were seen with the##3##4##(1991-5#1)(1996-7#1)(2008-7#1)
were seen with##17##3##(1990-6#1)(1991-5#2)(1991-6#1)(1993-3#1)(1994-5#1)(1995-12#1)(1996-7#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
were seen within the##2##4##(2005-12#1)(2006-1#1)
were seen##331##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-6#1)(1991-10#2)(1991-11#2)(1991-12#5)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#3)(1993-11#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#2)(1993-9#3)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-5#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#2)(1996-1#2)(1996-10#1)(1996-11#3)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#6)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#4)(1997-2#2)(1997-3#7)(1997-4#2)(1997-5#1)(1997-6#5)(2004-10#1)(2005-11#1)(2005-12#5)(2005-7#4)(2006-1#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#8)(2007-10#2)(2007-11#2)(2007-2#4)(2007-3#8)(2007-7#15)(2007-8#9)(2008-1#4)(2008-10#15)(2008-11#7)(2008-12#5)(2008-2#1)(2008-4#2)(2008-5#22)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#7)(2009-8#3)(2010-1#1)(2010-11#3)(2010-12#3)(2010-3#1)(2010-8#2)(2011-1#6)(2011-11#2)(2011-2#9)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#10)(2012-3#5)(2013-1#9)(2013-8#3)
were segmented into##2##3##(2008-2#1)(2008-5#1)
were segregated##2##2##(1995-2#1)(2005-9#1)
were selected according to the##2##5##(1996-12#1)(2013-1#1)
were selected according to##6##4##(1996-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2013-1#1)
were selected after##3##3##(2008-10#1)(2009-4#1)(2012-12#1)
were selected and studied##2##4##(2007-2#1)(2011-2#1)
were selected and the##2##4##(2010-7#1)(2011-12#1)
were selected and##20##3##(1992-10#1)(1994-6#1)(1996-10#1)(2004-4#1)(2006-5#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
were selected as a##2##4##(1995-10#1)(2010-4#1)
were selected as analytical wavelengths##2##5##(2008-10#2)
were selected as representative##2##4##(2007-5#1)(2008-10#1)
were selected as the best##2##5##(2007-8#1)(2011-1#1)
were selected as the##8##4##(2004-10#1)(2007-8#1)(2008-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
were selected as##27##3##(1991-9#1)(1995-10#1)(1997-3#1)(2004-10#1)(2005-10#1)(2007-10#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#6)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
were selected at random from##2##5##(1996-12#1)(2005-8#1)
were selected at random##5##4##(1992-5#1)(1996-12#1)(2005-8#1)(2007-3#1)(2008-5#1)
were selected at##7##3##(1992-5#1)(1996-10#1)(1996-12#1)(2005-8#1)(2007-3#1)(2008-12#1)(2008-5#1)
were selected based on their##4##5##(2008-12#1)(2009-12#1)(2011-1#1)(2013-1#1)
were selected based on##7##4##(2006-11#1)(2007-12#1)(2008-12#1)(2009-12#1)(2009-2#1)(2011-1#1)(2013-1#1)
were selected based##8##3##(2006-11#1)(2007-12#1)(2007-6#1)(2008-12#1)(2009-12#1)(2009-2#1)(2011-1#1)(2013-1#1)
were selected because they##2##4##(1995-5#1)(2009-3#1)
were selected because##3##3##(1995-5#1)(2007-7#1)(2009-3#1)
were selected by the##2##4##(1995-6#1)(2008-8#1)
were selected by##15##3##(1991-2#1)(1993-2#1)(1994-8#1)(1995-6#1)(1996-10#1)(2005-8#1)(2007-10#1)(2007-3#1)(2007-8#2)(2008-10#2)(2008-8#1)(2011-2#1)(2012-12#1)
were selected during##3##3##(2012-1#1)(2013-1#2)
were selected for a##3##4##(1990-2#1)(2008-5#1)(2012-12#1)
were selected for assessment##3##4##(2006-8#1)(2008-10#1)(2012-12#1)
were selected for evaluation##3##4##(2005-7#2)(2008-10#1)
were selected for further study##2##5##(1995-3#1)(2008-10#1)
were selected for further##5##4##(1992-3#1)(1995-3#1)(2006-12#1)(2008-10#2)
were selected for increased sensitivity to##2##6##(2008-8#2)
were selected for investigation##3##4##(1992-12#1)(2008-5#2)
were selected for resistance##2##4##(2008-10#2)
were selected for sampling##2##4##(2007-5#1)(2008-10#1)
were selected for the investigation##2##5##(2007-2#1)(2009-4#1)
were selected for the study##3##5##(2007-8#1)(2011-2#1)(2013-8#1)
were selected for the##13##4##(1992-12#1)(2005-10#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-9#1)(2009-12#1)(2009-4#1)(2011-2#2)(2013-8#1)
were selected for their##2##4##(2008-10#2)
were selected for this study at random##2##7##(2007-7#2)
were selected for this study##5##5##(2007-7#2)(2008-12#1)(2013-1#2)
were selected for this##7##4##(2007-7#2)(2008-12#1)(2010-7#1)(2013-1#3)
were selected for##74##3##(1990-2#1)(1992-12#2)(1992-3#1)(1995-1#1)(1995-3#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-12#2)(2006-6#2)(2006-8#1)(2007-1#1)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-7#1)(2011-2#2)(2012-12#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
were selected from a large##3##5##(1993-9#1)(1997-8#1)(2008-5#1)
were selected from a##12##4##(1993-8#1)(1993-9#1)(1994-8#1)(1995-2#1)(1997-8#1)(2005-11#1)(2006-5#1)(2006-8#1)(2008-5#3)(2013-1#1)
were selected from each##5##4##(2008-10#1)(2008-5#1)(2011-1#1)(2013-1#2)
were selected from the##9##4##(1997-8#2)(2006-5#1)(2008-10#2)(2012-12#1)(2013-1#1)(2013-8#2)
were selected from##48##3##(1991-1#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-2#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-8#3)(2005-11#1)(2006-5#2)(2006-8#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2011-1#4)(2011-2#1)(2012-12#1)(2013-1#4)(2013-8#3)
were selected in the##2##4##(2008-10#1)(2008-11#1)
were selected in##6##3##(2007-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2013-1#1)
were selected on the basis of##3##6##(1995-8#1)(1996-9#1)(2008-1#1)
were selected on##8##3##(1990-5#1)(1995-4#1)(1995-8#1)(1996-9#1)(2007-2#1)(2008-1#1)(2008-9#1)(2011-12#1)
were selected randomly from##2##4##(1994-3#1)(2008-10#1)
were selected randomly##5##3##(1994-3#1)(2008-10#1)(2008-3#1)(2010-2#1)(2010-9#1)
were selected that##6##3##(1991-11#1)(1997-4#1)(2008-6#1)(2008-7#1)(2009-4#1)(2012-2#1)
were selected to evaluate the##2##5##(2007-6#1)(2008-10#1)
were selected to represent##3##4##(1991-12#1)(2006-4#1)(2008-10#1)
were selected to##26##3##(1991-12#1)(1997-2#1)(1997-8#1)(2006-4#1)(2007-6#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-5#1)(2008-9#1)(2009-10#1)(2010-2#1)(2010-4#1)(2012-11#2)(2012-2#2)(2013-8#1)
were selected using a##2##4##(2007-1#1)(2008-5#1)
were selected##321##2##(1990-2#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-10#3)(1996-12#3)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-7#2)(1997-8#5)(2004-10#1)(2004-4#1)(2005-10#2)(2005-11#2)(2005-7#2)(2005-8#3)(2006-10#1)(2006-11#1)(2006-12#2)(2006-4#1)(2006-5#3)(2006-6#3)(2006-8#3)(2007-1#4)(2007-10#4)(2007-12#1)(2007-2#5)(2007-3#2)(2007-5#3)(2007-6#2)(2007-7#5)(2007-8#8)(2007-9#1)(2008-1#1)(2008-10#53)(2008-11#5)(2008-12#5)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#19)(2008-6#4)(2008-7#4)(2008-8#6)(2008-9#4)(2009-10#1)(2009-12#3)(2009-2#3)(2009-3#2)(2009-4#4)(2009-6#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#10)(2011-12#2)(2011-2#15)(2012-1#1)(2012-11#2)(2012-12#7)(2012-2#7)(2012-3#2)(2013-1#17)(2013-7#5)(2013-8#7)
were selective to##2##3##(1991-5#1)(2008-10#1)
were selective##5##2##(1991-5#1)(1996-8#1)(2008-10#3)
were selectively generated##2##3##(1997-4#1)(2009-10#1)
were selectively##19##2##(1990-7#1)(1991-5#1)(1992-5#1)(1992-7#1)(1995-8#1)(1996-8#2)(1997-4#1)(2005-10#1)(2008-10#5)(2008-7#1)(2008-8#1)(2009-10#2)(2012-2#1)
were self-administered##2##2##(2009-5#1)(2010-9#1)
were selfed to##2##3##(2008-10#2)
were sensitive and##2##3##(2008-10#1)(2008-5#1)
were sensitive by both methods##2##5##(2007-7#2)
were sensitive to a##2##4##(2008-10#1)(2012-2#1)
were sensitive to all##2##4##(2008-10#1)(2011-2#1)
were sensitive to ampicillin##2##4##(2012-2#2)
were sensitive to metalaxyl##3##4##(2008-10#3)
were sensitive to tetracyclines##2##4##(1990-6#1)(2010-4#1)
were sensitive to the##6##4##(1990-12#1)(1996-3#1)(2007-7#1)(2008-10#1)(2008-9#1)(2013-1#1)
were sensitive to##59##3##(1990-12#2)(1990-6#1)(1991-2#2)(1991-6#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#2)(1994-9#1)(1995-3#1)(1995-8#2)(1996-12#1)(1996-3#1)(1997-5#1)(1997-6#1)(2006-8#1)(2007-10#1)(2007-7#4)(2007-8#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-9#1)(2009-2#1)(2009-5#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#1)
were sensitive##72##2##(1990-12#3)(1990-6#1)(1991-2#2)(1991-6#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#2)(1994-9#1)(1995-3#1)(1995-8#2)(1996-12#1)(1996-3#1)(1996-5#1)(1997-5#1)(1997-6#1)(2006-8#1)(2007-10#1)(2007-7#6)(2007-8#1)(2008-10#19)(2008-11#1)(2008-12#2)(2008-5#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#1)
were sensitized by##2##3##(2005-10#1)(2008-10#1)
were sensitized to##4##3##(1991-1#1)(1995-5#1)(2005-10#1)(2007-2#1)
were sensitized with##2##3##(1992-12#2)
were sensitized##8##2##(1991-1#1)(1992-12#2)(1995-5#1)(2005-10#2)(2007-2#1)(2008-10#1)
were sent a questionnaire##3##4##(1991-4#1)(1993-12#1)(1996-9#1)
were sent a##4##3##(1991-4#1)(1993-12#1)(1996-9#1)(1997-2#1)
were sent by##2##3##(2010-9#1)(2012-12#1)
were sent for##4##3##(1995-4#1)(2008-5#2)(2013-1#1)
were sent to a##3##4##(1993-8#1)(1994-2#1)(1995-11#1)
were sent to the##4##4##(1993-9#1)(2008-3#1)(2008-5#1)(2010-10#1)
were sent to##21##3##(1990-11#1)(1990-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-11#1)(1996-6#1)(1997-8#1)(2006-10#1)(2007-10#3)(2007-11#1)(2007-7#1)(2008-12#1)(2008-3#3)(2008-5#1)(2010-10#1)(2011-1#1)
were sent##36##2##(1990-11#1)(1990-6#1)(1991-4#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-7#1)(1995-11#1)(1995-4#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-8#1)(2006-10#1)(2007-10#3)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-3#3)(2008-5#5)(2010-10#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
were separate##4##2##(2007-11#1)(2008-11#1)(2012-12#1)(2012-3#1)
were separated and purified##2##4##(1993-4#1)(1993-8#1)
were separated and quantified##3##4##(1990-6#1)(1997-2#1)(2008-10#1)
were separated and##11##3##(1990-6#1)(1991-5#1)(1991-7#1)(1992-2#1)(1993-4#1)(1993-8#1)(1994-9#1)(1997-2#1)(2007-2#1)(2008-10#1)(2008-12#1)
were separated by 15 degrees##2##5##(2007-11#1)(2009-5#1)
were separated by HPLC and##2##5##(1995-8#1)(2008-10#1)
were separated by HPLC##3##4##(1995-3#1)(1995-8#1)(2008-10#1)
were separated by SDS-PAGE##3##4##(1993-8#1)(1996-12#1)(2008-5#1)
were separated by a##5##4##(1992-2#1)(1996-10#1)(2007-8#1)(2008-10#1)(2013-1#1)
were separated by an##2##4##(2008-10#1)(2013-8#1)
were separated by capillary zone electrophoresis##2##6##(1997-8#1)(2008-10#1)
were separated by capillary##3##4##(1997-8#1)(2008-10#2)
were separated by cation exchange chromatography##2##6##(2008-10#1)(2009-3#1)
were separated by column##2##4##(1992-1#1)(2007-11#1)
were separated by high-performance liquid chromatography (HPLC)##3##7##(1990-8#2)(2008-10#1)
were separated by ion-exchange chromatography##2##5##(1990-8#1)(1997-1#1)
were separated by native gel electrophoresis##2##6##(2008-11#2)
were separated by polyacrylamide gel electrophoresis##2##6##(1990-7#1)(2008-7#1)
were separated by reversed-phase HPLC##2##5##(1996-2#1)(1996-5#1)
were separated by reversed-phase##4##4##(1992-1#1)(1995-6#1)(1996-2#1)(1996-5#1)
were separated by two-dimensional##2##4##(2007-5#1)(2010-12#1)
were separated by##68##3##(1990-10#1)(1990-11#1)(1990-5#1)(1990-7#2)(1990-8#5)(1991-12#1)(1992-1#4)(1992-2#2)(1992-6#1)(1993-3#1)(1993-8#2)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#3)(1997-1#1)(1997-5#1)(1997-8#1)(2005-11#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
were separated from one another##2##5##(1993-9#1)(2008-2#1)
were separated from the##5##4##(1992-3#1)(2008-10#2)(2008-11#1)(2012-2#1)
were separated from##22##3##(1991-2#2)(1992-3#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-12#1)(1997-4#1)(1997-8#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-6#1)(2009-8#1)(2011-3#1)(2012-2#1)
were separated in a##6##4##(1994-9#2)(1997-8#1)(2008-10#3)
were separated in##15##3##(1994-9#2)(1997-8#1)(2006-6#1)(2008-10#10)(2012-12#1)
were separated into four##2##4##(2008-10#1)(2012-2#1)
were separated into three##3##4##(1991-3#1)(2008-1#1)(2008-12#1)
were separated into two groups##2##5##(2008-10#1)(2008-7#1)
were separated into##17##3##(1991-3#1)(1994-9#1)(1996-12#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-7#1)(2009-7#1)(2010-4#1)(2012-2#1)
were separated on a C18 column##2##6##(2008-10#1)(2011-1#1)
were separated on a##15##4##(1990-8#1)(1992-2#3)(1997-2#1)(1997-3#1)(2007-1#1)(2008-10#4)(2008-5#1)(2011-1#3)
were separated on an##2##4##(2007-7#1)(2011-2#1)
were separated on the stationary phase##2##6##(2008-10#2)
were separated on the##4##4##(2008-10#4)
were separated on##24##3##(1990-8#1)(1992-2#3)(1995-6#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-1#1)(2007-3#1)(2007-7#1)(2008-10#8)(2008-5#1)(2011-1#3)(2011-2#1)
were separated quantitatively##2##3##(2008-10#2)
were separated using an##2##4##(1990-8#1)(1996-3#1)
were separated using##8##3##(1990-8#1)(1990-9#2)(1991-3#1)(1992-8#1)(1996-3#1)(1996-6#1)(2012-12#1)
were separated well##2##3##(2005-11#1)(2008-10#1)
were separated with a##2##4##(2008-10#2)
were separated with##6##3##(1990-8#1)(1992-2#1)(1995-6#1)(2008-10#3)
were separated within##2##3##(2005-12#1)(2008-10#1)
were separated without##2##3##(2008-10#2)
were separated##201##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#9)(1990-9#2)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-7#1)(1992-1#4)(1992-2#7)(1992-3#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-8#3)(1993-9#1)(1994-12#1)(1994-3#1)(1994-9#5)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#3)(1995-8#1)(1996-10#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#6)(1996-6#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#3)(2005-11#2)(2005-12#2)(2006-6#1)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#53)(2008-11#4)(2008-12#4)(2008-2#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-11#1)(2012-12#3)(2012-2#2)(2013-1#3)(2013-8#1)
were separately analyzed##2##3##(1992-6#1)(1995-3#1)
were separately##11##2##(1990-7#1)(1992-4#1)(1992-6#1)(1994-12#1)(1995-3#1)(1997-4#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-1#1)
were sequenced and compared##2##4##(2008-10#1)(2009-10#1)
were sequenced and##11##3##(1996-2#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-8#1)(2009-10#1)(2013-8#1)
were sequenced by##2##3##(1991-8#1)(1992-1#1)
were sequenced from a##2##4##(2008-10#1)(2008-5#1)
were sequenced from##4##3##(1993-6#2)(2008-10#1)(2008-5#1)
were sequenced in##2##3##(2006-8#1)(2008-10#1)
were sequenced to##2##3##(2010-4#1)(2012-12#1)
were sequenced##55##2##(1990-12#1)(1991-12#2)(1991-8#1)(1992-1#1)(1992-3#1)(1992-4#2)(1993-11#1)(1993-2#2)(1993-3#1)(1993-6#2)(1994-12#3)(1994-5#1)(1995-1#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-9#1)(2006-8#2)(2008-10#11)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#3)(2009-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-3#2)(2013-7#1)(2013-8#2)
were sequentially aspirated##2##3##(2008-10#2)
were sequentially introduced into##3##4##(1994-3#1)(2008-10#2)
were sequentially treated with##2##4##(2008-10#1)(2012-1#1)
were sequentially##13##2##(1993-7#1)(1994-3#1)(1994-6#1)(2007-8#1)(2008-10#7)(2008-11#1)(2012-1#1)
were serious##2##2##(2007-7#1)(2008-8#1)
were seriously##2##2##(1994-12#1)(2013-8#1)
were serologically distinct from##2##4##(1992-10#1)(2008-10#1)
were serologically positive for##2##4##(1993-1#1)(2004-11#1)
were serologically##7##2##(1992-10#1)(1993-1#1)(1996-12#1)(2004-11#1)(2007-2#1)(2008-10#1)(2012-2#1)
were seronegative for##2##3##(2007-2#1)(2009-5#1)
were seronegative##5##2##(1991-8#1)(2007-2#1)(2009-10#1)(2009-5#1)(2011-2#1)
were seropositive for feline##2##4##(2007-2#2)
were seropositive for##4##3##(2006-10#1)(2007-2#2)(2008-5#1)
were seropositive##6##2##(1991-8#1)(1992-4#1)(2006-10#1)(2007-2#2)(2008-5#1)
were serotype##2##2##(2007-12#1)(2011-2#1)
were serotyped by##2##3##(1993-2#1)(2011-1#1)
were serotyped##4##2##(1993-2#1)(2007-8#1)(2008-5#1)(2011-1#1)
were serum##4##2##(1991-10#1)(2006-10#1)(2008-5#1)(2011-1#1)
were served##4##2##(1995-11#1)(1997-2#1)(1997-7#1)(2008-6#1)
were sessile##2##2##(2005-5#1)(2007-3#1)
were set and##2##3##(1996-7#1)(2012-12#1)
were set at##3##3##(2006-7#1)(2008-10#1)(2008-3#1)
were set up##5##3##(2006-7#1)(2007-3#1)(2008-10#1)(2008-5#1)(2013-7#1)
were set##17##2##(1995-3#1)(1996-7#1)(2004-9#1)(2006-7#2)(2007-3#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2012-12#2)(2013-1#1)(2013-7#1)
were seven##9##2##(1995-12#1)(1995-6#1)(2004-2#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-5#1)(2011-2#1)
were several##9##2##(1990-11#1)(1991-8#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-3#1)
were severe##3##2##(1992-9#1)(1997-8#1)(2007-2#1)
were severely impaired##3##3##(1993-5#1)(1994-12#1)(1995-12#1)
were severely##15##2##(1990-5#1)(1993-5#1)(1994-12#2)(1995-12#1)(2005-7#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-8#1)(2011-2#1)
were sexed##2##2##(1996-12#1)(2008-10#1)
were sexual##2##2##(1993-2#1)(2008-10#1)
were sexually active##8##3##(2007-7#2)(2010-8#2)(2011-2#1)(2012-12#1)(2013-1#2)
were sexually##13##2##(1990-5#1)(1996-11#1)(2004-2#1)(2007-3#1)(2007-7#2)(2008-10#1)(2010-8#2)(2011-2#1)(2012-12#1)(2013-1#2)
were sham##3##2##(1992-7#1)(1993-5#1)(2008-10#1)
were shared among##2##3##(2008-10#1)(2012-3#1)
were shared by##4##3##(1992-9#1)(2008-10#2)(2012-2#1)
were shared##13##2##(1992-9#1)(1994-3#1)(1997-9#1)(2007-4#1)(2008-10#4)(2008-2#1)(2010-10#1)(2012-12#1)(2012-2#1)(2012-3#1)
were shifted to a##2##4##(1992-7#1)(1993-12#1)
were shifted to##7##3##(1990-12#1)(1992-7#1)(1992-9#1)(1993-12#1)(1997-6#1)(2007-7#1)(2013-1#1)
were shifted##11##2##(1990-12#1)(1991-10#1)(1992-7#1)(1992-9#1)(1993-12#1)(1995-11#1)(1996-8#1)(1997-6#1)(2007-7#1)(2013-1#1)(2013-8#1)
were short##4##2##(1994-9#1)(1997-1#1)(2004-9#1)(2008-10#1)
were shortened##3##2##(1996-12#1)(2008-1#1)(2013-8#1)
were shorter and##2##3##(2010-6#1)(2011-1#1)
were shorter in##2##3##(1997-4#1)(2012-2#1)
were shorter than##2##3##(1996-6#1)(2011-1#1)
were shorter##8##2##(1994-11#1)(1996-6#1)(1997-2#1)(1997-4#1)(2010-6#1)(2011-1#2)(2012-2#1)
were showed##3##2##(2007-8#1)(2008-10#1)(2011-2#1)
were showing##2##2##(2008-11#2)
were shown by the##2##4##(1995-7#1)(2006-4#1)
were shown by##13##3##(1990-7#1)(1992-10#1)(1993-12#1)(1995-7#1)(1996-8#1)(1997-2#1)(2006-12#1)(2006-4#1)(2006-8#1)(2008-10#2)(2008-5#1)(2010-12#1)
were shown for##4##3##(1990-3#1)(2009-3#1)(2013-1#1)(2013-8#1)
were shown in##6##3##(1992-8#1)(2005-4#1)(2008-10#2)(2010-9#1)(2013-8#1)
were shown to accumulate##2##4##(1990-1#1)(2012-3#1)
were shown to affect the##2##5##(1992-5#1)(2009-9#1)
were shown to alter##2##4##(1994-9#1)(2008-11#1)
were shown to be covalently##2##5##(1993-6#1)(2008-5#1)
were shown to be dependent on##2##6##(1995-1#1)(2008-10#1)
were shown to be functional##2##5##(1993-3#1)(1994-2#1)
were shown to be highly##2##5##(2005-8#1)(2007-7#1)
were shown to be in##2##5##(1996-1#1)(2008-2#1)
were shown to be involved in##2##6##(1995-4#1)(2008-3#1)
were shown to be less##2##5##(2007-3#1)(2008-9#1)
were shown to be more##2##5##(2008-11#1)(2012-1#1)
were shown to be negligible##2##5##(2007-12#1)(2008-10#1)
were shown to be potent hypolipidemic agents in##2##8##(2008-5#2)
were shown to be potent##3##5##(1997-1#1)(2008-5#2)
were shown to be significantly##3##5##(1994-7#1)(2005-11#1)(2008-3#1)
were shown to be the##4##5##(2006-8#1)(2008-11#1)(2008-4#1)(2009-5#1)
were shown to be very##2##5##(1990-7#1)(1991-12#1)
were shown to be##91##4##(1990-10#1)(1990-11#1)(1990-3#1)(1990-7#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-3#2)(1992-6#2)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-1#2)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-7#1)(1997-8#1)(2005-11#2)(2005-8#2)(2006-12#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#7)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#2)(2010-4#2)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
were shown to bind to##2##5##(1994-8#1)(2008-6#1)
were shown to consist of##2##5##(1994-9#1)(2008-10#1)
were shown to contain##5##4##(1990-9#1)(1991-6#1)(1991-9#1)(1994-2#1)(2008-10#1)
were shown to decrease##2##4##(1995-1#1)(2004-9#1)
were shown to display##2##4##(1990-12#1)(2008-6#1)
were shown to have less##2##5##(1997-6#1)(2010-8#1)
were shown to have##16##4##(1992-11#1)(1992-8#1)(1995-10#1)(1996-4#1)(1997-6#1)(2005-7#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-10#1)(2009-7#2)(2010-8#1)(2011-1#1)
were shown to improve##2##4##(1991-2#1)(2005-7#1)
were shown to increase##2##4##(1996-5#1)(2006-9#1)
were shown to induce##4##4##(1994-2#2)(1997-1#1)(1997-5#1)
were shown to interact with##2##5##(1995-4#1)(2008-10#1)
were shown to make##2##4##(2008-2#1)(2011-2#1)
were shown to play##2##4##(2009-4#1)(2009-8#1)
were shown to possess##3##4##(1994-12#1)(1994-5#1)(2008-10#1)
were shown to produce##2##4##(1993-9#1)(1994-8#1)
were shown to provide##2##4##(2008-11#1)(2012-12#1)
were shown to##195##3##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#1)(1990-9#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-11#2)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-9#2)(1994-12#3)(1994-2#5)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#3)(1995-1#4)(1995-10#1)(1995-12#1)(1995-3#1)(1995-4#2)(1995-5#1)(1995-6#2)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#2)(2005-7#2)(2005-8#2)(2006-12#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#21)(2008-11#9)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#10)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#2)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
were shown##246##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#2)(1990-7#2)(1990-9#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#2)(1991-9#2)(1992-10#1)(1992-11#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#2)(1993-9#2)(1994-12#3)(1994-2#5)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#3)(1995-1#4)(1995-10#1)(1995-12#1)(1995-3#2)(1995-4#2)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#4)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#3)(2005-4#1)(2005-7#2)(2005-8#2)(2006-12#2)(2006-4#1)(2006-5#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-11#2)(2007-12#4)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#27)(2008-11#9)(2008-12#3)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#13)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#5)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#6)
were sicker##2##2##(1995-9#1)(2009-6#1)
were significant (P &lt##2##4##(2008-10#1)(2010-3#1)
were significant (P##3##3##(1992-8#1)(2008-10#1)(2010-3#1)
were significant and comparable with some others previously described##2##9##(1992-11#1)(1995-3#1)
were significant and##5##3##(1992-11#1)(1993-8#1)(1995-3#1)(1995-7#1)(2007-5#1)
were significant associations between##3##4##(2008-3#1)(2010-1#1)(2011-2#1)
were significant at##2##3##(2007-9#1)(2011-2#1)
were significant changes##3##3##(1991-3#1)(1993-1#1)(2009-7#1)
were significant correlations between##8##4##(1992-2#1)(1994-11#1)(1995-3#1)(2004-11#1)(2007-11#1)(2007-2#1)(2008-7#1)(2012-11#1)
were significant differences among the##2##5##(2006-12#1)(2013-8#1)
were significant differences among##7##4##(1993-2#1)(2006-12#1)(2007-3#1)(2008-10#2)(2012-3#1)(2013-8#1)
were significant differences between the groups##2##6##(1990-9#1)(2009-12#1)
were significant differences between the two##2##6##(2008-3#1)(2012-12#1)
were significant differences between the##7##5##(1990-9#1)(1991-9#1)(1994-9#1)(2008-10#1)(2008-3#1)(2009-12#1)(2012-12#1)
were significant differences between##16##4##(1990-9#1)(1991-9#1)(1993-2#1)(1994-9#1)(1995-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-12#1)(2010-4#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
were significant differences found##2##4##(2007-2#2)
were significant differences in the##8##5##(1990-6#1)(1994-2#1)(1995-12#1)(1996-7#1)(2006-12#1)(2008-12#1)(2008-7#1)(2011-2#1)
were significant differences in##19##4##(1990-6#1)(1994-2#1)(1995-12#1)(1995-8#1)(1996-7#1)(2006-12#1)(2007-12#1)(2007-7#2)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
were significant differences##47##3##(1990-6#1)(1990-9#1)(1991-9#1)(1993-2#2)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-7#1)(2006-12#2)(2007-12#1)(2007-2#3)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#7)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2009-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
were significant effects##2##3##(2006-5#1)(2008-10#1)
were significant factors##2##3##(2007-10#1)(2011-2#1)
were significant for##5##3##(1996-5#1)(1997-8#1)(2008-10#1)(2009-5#1)(2011-1#1)
were significant improvements in##5##4##(2006-10#1)(2007-2#1)(2008-3#1)(2008-5#1)(2013-1#1)
were significant in##6##3##(1991-2#1)(2007-12#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-7#1)
were significant increases in serum##2##5##(1992-10#1)(2007-1#1)
were significant increases in##5##4##(1992-10#1)(1992-7#1)(2006-9#1)(2007-1#1)(2013-1#1)
were significant increases##6##3##(1992-10#1)(1992-7#1)(2006-9#1)(2007-1#1)(2011-1#1)(2013-1#1)
were significant independent predictors of##2##5##(1993-12#1)(2011-2#1)
were significant only in##2##4##(2005-4#1)(2013-1#1)
were significant only##3##3##(2005-4#1)(2007-3#1)(2013-1#1)
were significant positive##3##3##(2007-5#1)(2008-9#1)(2010-8#1)
were significant predictors of##15##4##(1994-2#1)(1995-6#1)(1996-1#1)(1996-8#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#2)(2013-1#2)
were significant predictors##20##3##(1994-2#1)(1995-6#1)(1996-1#1)(1996-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-4#1)(2011-2#2)(2013-1#3)
were significant##174##2##(1990-6#2)(1990-9#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-8#1)(2004-11#1)(2005-4#1)(2005-7#1)(2006-10#3)(2006-12#2)(2006-5#1)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#3)(2007-12#5)(2007-2#6)(2007-3#2)(2007-5#3)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#15)(2008-11#1)(2008-12#6)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#3)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#2)(2010-8#2)(2011-1#6)(2011-2#9)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#11)(2013-7#1)(2013-8#2)
were significantly (P &lt##21##4##(1993-1#1)(1996-3#1)(1997-2#1)(2006-10#1)(2008-10#6)(2008-5#2)(2008-7#1)(2009-5#2)(2010-1#1)(2010-2#3)(2012-2#1)(2013-1#1)
were significantly (P less than 0##2##6##(1990-12#1)(1991-3#1)
were significantly (P##24##3##(1990-12#1)(1991-3#1)(1993-1#1)(1996-3#1)(1997-2#1)(2006-10#1)(2008-10#6)(2008-5#3)(2008-7#1)(2009-5#2)(2010-1#1)(2010-2#3)(2012-2#1)(2013-1#1)
were significantly (P&lt##2##3##(2008-10#2)
were significantly (p &lt##8##4##(1997-4#1)(1997-8#1)(2004-3#1)(2008-12#2)(2008-9#1)(2010-4#1)(2010-8#1)
were significantly affected by both##2##5##(2008-10#2)
were significantly affected by wheat type##2##6##(2008-10#2)
were significantly affected by##7##4##(1995-12#1)(2008-10#5)(2008-5#1)
were significantly and positively related to##2##6##(1995-7#1)(2009-7#1)
were significantly and positively##3##4##(1995-7#1)(2008-10#1)(2009-7#1)
were significantly and##7##3##(1995-10#1)(1995-7#1)(1996-3#1)(1996-5#1)(2008-10#1)(2009-7#1)(2011-2#1)
were significantly associated with knowledge##2##5##(2006-2#1)(2007-9#1)
were significantly associated with the##4##5##(2010-10#1)(2011-1#2)(2013-1#1)
were significantly associated with##40##4##(1997-2#1)(1997-4#1)(1997-7#1)(2005-10#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#2)(2009-4#1)(2010-10#1)(2011-1#4)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
were significantly associated##45##3##(1997-2#1)(1997-4#1)(1997-7#1)(2005-10#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-8#2)(2007-9#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#2)(2009-4#1)(2010-10#1)(2011-1#4)(2011-12#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
were significantly attenuated by##2##4##(1993-11#1)(2008-7#1)
were significantly attenuated##5##3##(1993-11#1)(1994-11#1)(1997-7#1)(1997-8#1)(2008-7#1)
were significantly attracted to##2##4##(2007-11#1)(2007-6#1)
were significantly better at##2##4##(2009-10#1)(2012-2#1)
were significantly better in##4##4##(1997-1#1)(2007-2#1)(2007-7#2)
were significantly better than##2##4##(2007-7#1)(2010-3#1)
were significantly better##10##3##(1997-1#1)(2007-11#1)(2007-2#1)(2007-7#3)(2009-10#1)(2010-3#1)(2011-12#1)(2012-2#1)
were significantly changed by##2##4##(1990-12#1)(1992-7#1)
were significantly changed##5##3##(1990-12#1)(1992-7#1)(1993-12#1)(1995-3#1)(2010-11#1)
were significantly correlated (r = 0##2##6##(1992-8#1)(2006-5#1)
were significantly correlated in##2##4##(2011-2#2)
were significantly correlated with a##2##5##(2007-12#1)(2013-8#1)
were significantly correlated with changes##2##5##(2010-6#1)(2012-1#1)
were significantly correlated with the##5##5##(1990-8#1)(1995-5#1)(2007-11#1)(2008-7#1)(2009-7#1)
were significantly correlated with those##2##5##(1995-7#1)(2007-5#1)
were significantly correlated with##23##4##(1990-8#1)(1992-8#1)(1995-5#1)(1995-7#1)(1996-11#1)(1997-8#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-7#1)(2009-7#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#2)
were significantly correlated##31##3##(1990-8#1)(1992-8#2)(1995-5#1)(1995-7#1)(1996-11#1)(1997-8#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-7#2)(2009-7#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#2)
were significantly decreased after##3##4##(2010-2#1)(2011-2#1)(2012-2#1)
were significantly decreased compared with##2##5##(1995-6#1)(2004-11#1)
were significantly decreased in the##7##5##(1993-12#1)(1995-12#1)(1995-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2013-8#1)
were significantly decreased in##17##4##(1990-7#1)(1993-12#1)(1995-12#1)(1995-5#1)(1996-7#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#3)(2011-1#1)(2011-2#1)(2013-8#1)
were significantly decreased##41##3##(1990-7#1)(1991-1#1)(1991-12#1)(1992-8#1)(1993-12#1)(1994-2#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-3#1)(1996-7#1)(1996-9#1)(2004-11#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#7)(2010-2#1)(2011-1#3)(2011-2#2)(2012-2#1)(2013-8#2)
were significantly depressed in##2##4##(1992-8#1)(2011-1#1)
were significantly depressed##3##3##(1992-8#1)(2004-11#1)(2011-1#1)
were significantly different (p &lt##2##5##(2007-10#1)(2008-7#1)
were significantly different among##3##4##(2008-10#1)(2008-9#1)(2010-7#1)
were significantly different between the##4##5##(1990-7#1)(1995-4#1)(2008-8#1)(2012-12#1)
were significantly different between##8##4##(1990-7#1)(1993-7#1)(1995-4#1)(2008-8#2)(2011-2#1)(2012-12#1)(2013-1#1)
were significantly different from each other##2##6##(2005-11#1)(2008-10#1)
were significantly different from the##7##5##(1992-11#1)(1994-5#1)(2008-10#1)(2009-10#1)(2012-2#1)(2013-1#2)
were significantly different from those of##3##6##(1993-8#1)(1995-1#1)(1995-11#1)
were significantly different from zero (P &lt##2##7##(2008-10#2)
were significantly different from zero##3##5##(1991-12#1)(2008-10#2)
were significantly different from##19##4##(1991-12#1)(1992-11#1)(1992-2#1)(1993-8#1)(1994-5#1)(1995-1#1)(1995-11#1)(2005-11#1)(2008-10#6)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#2)
were significantly different in the##2##5##(1993-11#1)(2008-5#1)
were significantly different in##6##4##(1993-11#1)(1996-5#1)(1996-8#1)(2008-10#2)(2008-5#1)
were significantly different only in##2##5##(2010-8#1)(2013-1#1)
were significantly different than##2##4##(2010-8#1)(2013-1#1)
were significantly different##56##3##(1990-7#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-7#1)(1993-8#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-4#1)(1996-5#1)(1996-8#1)(2005-11#1)(2006-10#1)(2007-10#1)(2008-10#12)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#1)
were significantly differentiated from##2##4##(2008-10#2)
were significantly differentiated##5##3##(2008-10#4)(2012-5#1)
were significantly diminished##4##3##(1991-2#1)(1996-5#1)(2008-10#1)(2013-1#1)
were significantly elevated and##2##4##(1991-2#1)(2010-4#1)
were significantly elevated in the##4##5##(1995-12#1)(1997-2#1)(2008-10#1)(2008-4#1)
were significantly elevated in##8##4##(1992-7#1)(1993-8#1)(1995-12#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)
were significantly elevated##22##3##(1990-11#1)(1991-10#1)(1991-2#1)(1992-7#1)(1992-8#1)(1993-8#1)(1994-12#1)(1995-12#1)(1997-2#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#2)
were significantly enhanced by##2##4##(2008-10#1)(2008-11#1)
were significantly enhanced##7##3##(1994-2#1)(1994-8#1)(1995-1#1)(1996-12#1)(1996-5#1)(2008-10#1)(2008-11#1)
were significantly greater (P##2##4##(1996-9#1)(2008-10#1)
were significantly greater in##7##4##(1991-8#1)(1993-9#1)(2006-6#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-7#1)
were significantly greater than the##3##5##(2008-1#1)(2008-10#1)(2012-3#1)
were significantly greater than those from##2##6##(1996-11#1)(2008-5#1)
were significantly greater than those in the##5##7##(2008-9#5)
were significantly greater than those in##6##6##(1990-12#1)(2008-9#5)
were significantly greater than those of the vehicle controls##3##9##(2008-9#3)
were significantly greater than those of the##4##7##(2008-5#1)(2008-9#3)
were significantly greater than those of##7##6##(1990-4#1)(1991-2#1)(2008-5#2)(2008-9#3)
were significantly greater than those##15##5##(1990-12#1)(1990-4#1)(1991-2#1)(1996-11#1)(2008-5#3)(2008-9#8)
were significantly greater than##23##4##(1990-12#1)(1990-4#1)(1991-2#1)(1996-11#1)(2008-1#1)(2008-10#2)(2008-5#3)(2008-8#1)(2008-9#11)(2012-3#1)
were significantly greater with##2##4##(2005-11#1)(2010-4#1)
were significantly greater##37##3##(1990-12#1)(1990-4#1)(1991-2#1)(1991-8#1)(1993-9#1)(1994-3#1)(1996-11#1)(1996-9#1)(2005-11#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#11)(2010-4#1)(2012-3#1)
were significantly heavier##3##3##(2004-11#1)(2008-3#1)(2011-2#1)
were significantly high##3##3##(2008-5#1)(2013-1#1)(2013-8#1)
were significantly higher (P &lt##4##5##(1995-3#1)(1996-12#1)(2006-5#2)
were significantly higher (P less than 0##2##7##(1991-2#1)(1991-8#1)
were significantly higher (P##6##4##(1991-2#1)(1991-8#1)(1995-3#1)(1996-12#1)(2006-5#2)
were significantly higher (P&lt##2##4##(2007-2#1)(2007-3#1)
were significantly higher (p##2##4##(1991-6#1)(2011-2#1)
were significantly higher after##3##4##(2007-10#1)(2008-6#1)(2013-7#1)
were significantly higher among##7##4##(1990-10#1)(1997-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2012-11#1)(2013-1#1)
were significantly higher for both##2##5##(2008-10#1)(2009-1#1)
were significantly higher for the##3##5##(2007-6#1)(2007-7#1)(2007-8#1)
were significantly higher for##12##4##(1990-4#1)(1996-11#1)(2004-10#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2009-1#1)(2011-1#1)(2011-2#2)
were significantly higher in breast##2##5##(1991-4#1)(1996-3#1)
were significantly higher in old##2##5##(1995-12#1)(1995-9#1)
were significantly higher in patients with severe##2##7##(2011-1#1)(2013-1#1)
were significantly higher in patients with##8##6##(1990-7#1)(1993-11#2)(1996-12#1)(2008-7#2)(2011-1#1)(2013-1#1)
were significantly higher in patients##9##5##(1990-7#1)(1993-11#2)(1996-11#1)(1996-12#1)(2008-7#2)(2011-1#1)(2013-1#1)
were significantly higher in the##32##5##(1990-2#1)(1992-12#1)(1995-11#1)(1995-6#1)(1996-6#1)(1997-6#1)(1997-7#1)(2004-11#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-6#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
were significantly higher in those##2##5##(2009-6#1)(2012-3#1)
were significantly higher in##88##4##(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#1)(1991-4#1)(1992-12#2)(1992-5#1)(1992-7#1)(1993-11#2)(1993-12#1)(1993-2#1)(1995-11#1)(1995-12#2)(1995-6#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-11#1)(2004-4#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#7)(2009-6#3)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#3)(2011-11#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#3)(2012-5#1)(2013-1#5)(2013-8#2)
were significantly higher on##2##4##(2008-10#1)(2012-9#1)
were significantly higher than control##2##5##(2008-11#1)(2009-11#1)
were significantly higher than in the##3##6##(1992-11#1)(2009-5#1)(2011-2#1)
were significantly higher than in##11##5##(1992-11#1)(1994-10#1)(2007-2#1)(2008-10#1)(2009-5#1)(2011-1#3)(2011-2#1)(2012-1#1)(2013-1#1)
were significantly higher than that in##2##6##(2011-1#1)(2011-2#1)
were significantly higher than that##3##5##(1993-11#1)(2011-1#1)(2011-2#1)
were significantly higher than the##5##5##(1996-1#1)(1996-10#1)(2006-12#1)(2006-9#1)(2012-2#1)
were significantly higher than those in the##5##7##(1994-3#1)(1996-7#2)(2007-2#1)(2011-2#1)
were significantly higher than those in##12##6##(1993-3#1)(1994-3#1)(1995-2#1)(1996-7#2)(1997-1#1)(2005-10#1)(2007-2#3)(2011-2#1)(2013-1#1)
were significantly higher than those of the##3##7##(1993-9#1)(2008-10#1)(2011-1#1)
were significantly higher than those of##14##6##(1992-12#1)(1992-3#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-4#1)(2008-10#2)(2008-5#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2013-1#1)
were significantly higher than those##32##5##(1990-8#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-4#1)(1996-7#2)(1997-1#1)(2005-10#1)(2007-2#3)(2008-10#3)(2008-5#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
were significantly higher than##64##4##(1990-8#1)(1991-12#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-4#1)(1996-1#1)(1996-10#1)(1996-7#4)(1997-1#1)(2005-10#1)(2006-12#1)(2006-9#1)(2007-2#4)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
were significantly higher with##3##4##(2007-11#1)(2008-9#1)(2009-4#1)
were significantly higher##208##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#2)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#2)(1992-11#1)(1992-12#3)(1992-3#1)(1992-5#1)(1992-7#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-7#1)(1995-11#3)(1995-12#3)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#3)(1996-3#1)(1996-6#1)(1996-7#4)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-10#1)(2004-11#1)(2004-2#1)(2004-4#2)(2005-10#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-5#2)(2006-6#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#6)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#9)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#3)(2009-5#1)(2009-6#3)(2009-8#1)(2009-9#1)(2010-12#1)(2010-8#2)(2011-1#9)(2011-11#1)(2011-12#2)(2011-2#11)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#4)(2012-5#1)(2012-9#1)(2013-1#9)(2013-7#1)(2013-8#3)
were significantly impaired in the##2##5##(1994-3#1)(1997-2#1)
were significantly impaired in##4##4##(1993-11#1)(1994-3#1)(1997-2#1)(2009-4#1)
were significantly impaired##6##3##(1993-11#1)(1993-3#1)(1994-3#2)(1997-2#1)(2009-4#1)
were significantly improved by##2##4##(2008-5#1)(2011-3#1)
were significantly improved in the##2##5##(2008-7#1)(2012-12#1)
were significantly improved in##3##4##(2008-7#1)(2012-11#1)(2012-12#1)
were significantly improved##11##3##(1991-8#1)(1995-2#1)(2004-3#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-11#1)(2012-12#2)
were significantly increased by the##2##5##(2008-4#1)(2013-1#1)
were significantly increased by##9##4##(1995-12#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2013-1#1)
were significantly increased for##2##4##(1993-2#1)(2010-5#1)
were significantly increased from##4##4##(1994-3#1)(2011-2#2)(2013-1#1)
were significantly increased in 400 and 800 mg/L females##2##9##(2008-9#2)
were significantly increased in all exposed groups of males##2##9##(2008-9#2)
were significantly increased in all##4##5##(2008-9#3)(2010-12#1)
were significantly increased in both##3##5##(2007-7#1)(2008-10#1)(2008-9#1)
were significantly increased in mice##2##5##(1992-7#1)(2008-9#1)
were significantly increased in the##9##5##(1995-12#1)(1996-9#1)(1997-2#1)(1997-8#1)(2006-6#1)(2008-10#1)(2008-12#1)(2010-10#1)(2013-8#1)
were significantly increased in##41##4##(1991-12#1)(1991-2#1)(1992-7#1)(1993-2#1)(1995-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-8#1)(2006-6#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-12#2)(2008-8#1)(2008-9#15)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-11#2)(2013-8#1)
were significantly increased on day##2##5##(1994-5#1)(2004-11#1)
were significantly increased##81##3##(1991-12#1)(1991-2#2)(1991-5#1)(1992-7#1)(1992-8#1)(1993-2#2)(1994-3#2)(1994-5#2)(1995-12#3)(1995-3#2)(1996-2#2)(1996-3#3)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-8#1)(2004-11#1)(2006-6#1)(2007-10#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#21)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2011-2#4)(2012-11#2)(2013-1#2)(2013-8#1)
were significantly induced##2##3##(2008-9#1)(2011-12#1)
were significantly inhibited##2##3##(1992-3#1)(2005-11#1)
were significantly larger for the##2##5##(2005-10#1)(2007-12#1)
were significantly larger than##2##4##(1997-1#1)(2011-2#1)
were significantly larger##7##3##(1997-1#1)(2005-10#1)(2007-12#2)(2008-10#1)(2008-7#1)(2011-2#1)
were significantly less in##2##4##(1994-8#1)(2010-7#1)
were significantly less likely to##3##5##(2007-11#1)(2013-1#2)
were significantly less likely##4##4##(2004-12#1)(2007-11#1)(2013-1#2)
were significantly less than that##2##5##(1990-4#1)(1997-6#1)
were significantly less than those of the vehicle controls##8##9##(2008-9#8)
were significantly less than those of the##13##7##(1991-11#1)(2008-9#12)
were significantly less than those##14##5##(1991-11#1)(2007-9#1)(2008-9#12)
were significantly less than##18##4##(1990-4#1)(1991-11#1)(1997-6#1)(2007-9#1)(2008-10#1)(2008-9#12)(2011-2#1)
were significantly less##32##3##(1990-4#1)(1991-1#1)(1991-11#1)(1994-8#1)(1996-11#1)(1997-6#1)(2004-12#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-9#12)(2009-10#1)(2009-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
were significantly longer in##3##4##(1996-5#1)(2006-6#1)(2007-11#1)
were significantly longer than##2##4##(2009-10#1)(2013-8#1)
were significantly longer##8##3##(1996-2#1)(1996-5#1)(1997-8#1)(2006-4#1)(2006-6#1)(2007-11#1)(2009-10#1)(2013-8#1)
were significantly low##2##3##(1994-8#1)(2013-8#1)
were significantly lower (P##2##4##(2008-10#1)(2009-5#1)
were significantly lower among##2##4##(2004-12#1)(2011-2#1)
were significantly lower and the##2##5##(2009-5#1)(2010-12#1)
were significantly lower and##4##4##(1995-11#1)(2008-9#1)(2009-5#1)(2010-12#1)
were significantly lower at##6##4##(2007-8#3)(2008-11#1)(2008-12#1)(2008-5#1)
were significantly lower compared with##2##5##(2007-10#1)(2011-2#1)
were significantly lower compared##3##4##(1995-10#1)(2007-10#1)(2011-2#1)
were significantly lower for##6##4##(1990-12#1)(2006-10#1)(2006-7#1)(2008-10#3)
were significantly lower in patients with##4##6##(1990-2#1)(1997-7#1)(2011-1#1)(2012-3#1)
were significantly lower in patients##6##5##(1990-2#1)(1995-11#1)(1997-7#1)(2009-6#1)(2011-1#1)(2012-3#1)
were significantly lower in the##13##5##(1995-7#1)(1996-1#1)(1996-3#1)(1997-2#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-6#1)(2009-8#1)
were significantly lower in##43##4##(1990-2#3)(1990-9#1)(1991-12#2)(1992-2#1)(1995-10#1)(1995-11#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-7#1)(2005-8#1)(2007-10#1)(2007-2#1)(2007-8#1)(2007-9#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-6#2)(2009-8#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
were significantly lower than in patients with##2##7##(1993-2#1)(2006-11#1)
were significantly lower than in##7##5##(1992-7#1)(1993-2#1)(1995-3#1)(1996-7#1)(2006-11#1)(2010-12#1)(2012-12#1)
were significantly lower than that of##2##6##(2011-1#1)(2012-3#1)
were significantly lower than that##4##5##(1993-11#1)(2011-1#1)(2012-3#1)(2013-1#1)
were significantly lower than the##6##5##(2005-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-2#1)
were significantly lower than those in the control##3##8##(2007-8#1)(2011-2#1)(2013-8#1)
were significantly lower than those in the##4##7##(2007-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
were significantly lower than those in##8##6##(1990-12#1)(1990-3#1)(2005-4#1)(2007-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
were significantly lower than those of the##3##7##(2004-9#1)(2008-10#2)
were significantly lower than those of##8##6##(1990-3#1)(1997-3#1)(2004-9#1)(2007-2#1)(2007-3#1)(2008-10#2)(2011-2#1)
were significantly lower than those##17##5##(1990-12#1)(1990-3#2)(1997-3#1)(2004-9#1)(2005-4#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#2)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
were significantly lower than##41##4##(1990-12#1)(1990-3#2)(1992-7#1)(1993-11#1)(1993-2#1)(1995-3#1)(1996-7#1)(1997-2#1)(1997-3#1)(2004-9#1)(2005-4#1)(2005-8#1)(2006-11#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#2)
were significantly lower##113##3##(1990-12#2)(1990-2#3)(1990-3#2)(1990-9#1)(1991-12#2)(1992-2#1)(1992-7#1)(1993-11#1)(1993-2#1)(1994-2#1)(1995-10#2)(1995-11#2)(1995-3#2)(1995-7#1)(1995-9#1)(1996-1#1)(1996-3#1)(1996-7#2)(1997-2#2)(1997-3#1)(1997-7#1)(2004-12#1)(2004-9#1)(2005-4#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-10#3)(2007-2#2)(2007-3#1)(2007-8#6)(2007-9#2)(2008-10#11)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#1)(2010-12#4)(2010-8#1)(2011-1#3)(2011-2#6)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#4)(2013-8#2)
were significantly lowered##7##3##(1994-6#1)(1994-8#1)(2007-11#1)(2007-8#1)(2008-11#1)(2009-6#1)(2010-5#1)
were significantly more accurate##2##4##(2013-1#2)
were significantly more aggressive than##2##5##(2008-10#2)
were significantly more common##2##4##(2006-10#1)(2007-9#1)
were significantly more frequent##4##4##(1997-1#1)(2004-1#1)(2008-1#1)(2011-1#1)
were significantly more impaired##2##4##(1995-11#1)(2008-7#1)
were significantly more in##3##4##(2007-2#1)(2007-6#1)(2011-12#1)
were significantly more knowledgeable than##2##5##(2006-2#1)(2007-3#1)
were significantly more likely than##5##5##(2004-12#1)(2010-3#1)(2011-1#2)(2013-1#1)
were significantly more likely to have##5##6##(2006-7#1)(2007-11#1)(2008-7#1)(2010-12#1)(2012-3#1)
were significantly more likely to##17##5##(1997-8#2)(2006-7#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-7#1)(2011-1#2)(2012-3#3)
were significantly more likely##22##4##(1997-8#2)(2004-12#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#4)(2012-3#3)(2013-1#1)
were significantly more pronounced among##2##5##(2006-7#2)
were significantly more resistant to##2##5##(1995-6#1)(2008-10#1)
were significantly more resistant##3##4##(1995-6#1)(2008-10#1)(2008-5#1)
were significantly more satisfied with their##3##6##(1993-3#1)(2007-1#1)(2007-2#1)
were significantly more variable##2##4##(2008-3#1)(2008-9#1)
were significantly more virulent than##2##5##(2008-10#2)
were significantly more##74##3##(1990-7#1)(1991-5#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-4#1)(1995-11#2)(1995-12#1)(1995-6#2)(1996-3#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-8#2)(2004-1#2)(2004-12#1)(2006-10#1)(2006-2#1)(2006-7#3)(2007-1#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-6#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-2#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-7#1)(2011-1#5)(2011-12#1)(2012-3#3)(2013-1#4)
were significantly older##3##3##(2007-3#1)(2007-8#1)(2010-11#1)
were significantly predicted by##2##4##(2008-11#2)
were significantly reduced at the##2##5##(2008-10#1)(2008-7#1)
were significantly reduced at##4##4##(1996-5#1)(2008-10#2)(2008-7#1)
were significantly reduced by##11##4##(1991-8#1)(1995-12#2)(1996-5#1)(1996-8#1)(1997-3#1)(1997-7#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#1)
were significantly reduced compared with the##2##6##(2006-5#1)(2011-2#1)
were significantly reduced compared##3##4##(2006-5#1)(2008-4#1)(2011-2#1)
were significantly reduced in aged##2##5##(1991-6#1)(1995-8#1)
were significantly reduced in the presence of##2##7##(1995-11#1)(2012-11#1)
were significantly reduced in the##4##5##(1995-11#1)(2012-11#1)(2013-1#2)
were significantly reduced in##19##4##(1991-12#1)(1991-6#1)(1994-4#1)(1995-11#2)(1995-8#1)(1996-12#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-5#1)(2012-11#1)(2012-12#1)(2013-1#2)(2013-7#1)
were significantly reduced with##3##4##(1995-12#1)(2008-3#1)(2010-4#1)
were significantly reduced##56##3##(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1994-4#1)(1995-11#2)(1995-12#3)(1995-8#1)(1996-12#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-5#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#8)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-3#1)(2010-12#2)(2010-4#2)(2010-8#1)(2011-10#1)(2011-11#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
were significantly related to the##4##5##(1993-9#1)(2004-11#1)(2011-1#1)(2012-2#1)
were significantly related to##12##4##(1992-4#1)(1993-12#1)(1993-9#1)(1996-3#1)(2004-11#1)(2008-8#2)(2011-1#2)(2012-2#1)(2013-1#2)
were significantly relieved in the 'benifuuki'##2##6##(2008-11#2)
were significantly shorter than##2##4##(1996-12#1)(2008-10#1)
were significantly shorter##3##3##(1996-12#1)(2008-10#1)(2008-11#1)
were significantly slower in##2##4##(2009-1#1)(2012-12#1)
were significantly slower##4##3##(2006-4#1)(2009-1#2)(2012-12#1)
were significantly smaller in##4##4##(1991-11#1)(1991-12#1)(1994-10#1)(2008-5#1)
were significantly smaller than those in##2##6##(2008-7#1)(2013-1#1)
were significantly smaller than those##4##5##(2007-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
were significantly smaller than##5##4##(2007-3#1)(2008-7#2)(2011-2#1)(2013-1#1)
were significantly smaller##13##3##(1991-11#1)(1991-12#1)(1994-10#1)(1995-6#1)(2007-3#1)(2008-5#1)(2008-7#2)(2009-3#1)(2011-2#1)(2012-3#2)(2013-1#1)
were significantly stronger than##2##4##(2004-9#1)(2006-9#1)
were significantly suppressed in##2##4##(1996-11#1)(2011-2#1)
were significantly suppressed##4##3##(1996-11#1)(2008-11#1)(2009-10#1)(2011-2#1)
were significantly younger than those##2##5##(2004-12#1)(2007-10#1)
were significantly younger than##3##4##(2004-12#1)(2007-10#2)
were significantly younger##6##3##(2004-12#1)(2007-10#2)(2007-8#1)(2008-12#1)(2011-2#1)
were significantly##1052##2##(1990-10#1)(1990-11#2)(1990-12#6)(1990-2#4)(1990-3#2)(1990-4#4)(1990-7#4)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#9)(1991-2#8)(1991-3#1)(1991-4#1)(1991-5#5)(1991-6#4)(1991-7#1)(1991-8#5)(1991-9#1)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#3)(1992-4#2)(1992-5#1)(1992-7#6)(1992-8#7)(1993-1#1)(1993-11#7)(1993-12#4)(1993-2#4)(1993-3#4)(1993-5#3)(1993-7#1)(1993-8#3)(1993-9#5)(1994-10#2)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#7)(1994-4#2)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#4)(1995-1#2)(1995-10#3)(1995-11#10)(1995-12#14)(1995-2#3)(1995-3#6)(1995-4#2)(1995-5#2)(1995-6#6)(1995-7#3)(1995-8#1)(1995-9#2)(1996-1#2)(1996-10#1)(1996-11#6)(1996-12#6)(1996-2#3)(1996-3#10)(1996-4#1)(1996-5#8)(1996-6#2)(1996-7#7)(1996-8#3)(1996-9#5)(1997-1#5)(1997-2#7)(1997-3#3)(1997-4#4)(1997-5#2)(1997-6#3)(1997-7#5)(1997-8#7)(2004-1#2)(2004-10#1)(2004-11#7)(2004-12#4)(2004-2#1)(2004-3#2)(2004-4#2)(2004-9#2)(2005-10#3)(2005-11#3)(2005-4#1)(2005-8#2)(2006-10#8)(2006-11#2)(2006-12#3)(2006-2#2)(2006-4#3)(2006-5#4)(2006-6#4)(2006-7#5)(2006-8#3)(2006-9#4)(2007-1#5)(2007-10#15)(2007-11#9)(2007-12#8)(2007-2#13)(2007-3#7)(2007-4#1)(2007-5#2)(2007-6#7)(2007-7#10)(2007-8#21)(2007-9#6)(2008-1#3)(2008-10#98)(2008-11#13)(2008-12#17)(2008-2#1)(2008-3#11)(2008-4#9)(2008-5#27)(2008-6#5)(2008-7#27)(2008-8#14)(2008-9#61)(2009-1#3)(2009-10#7)(2009-11#3)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#7)(2009-5#5)(2009-6#6)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#13)(2010-2#7)(2010-3#2)(2010-4#6)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#8)(2011-1#30)(2011-10#1)(2011-11#2)(2011-12#6)(2011-2#46)(2011-3#1)(2012-1#2)(2012-11#5)(2012-12#9)(2012-2#17)(2012-3#16)(2012-5#3)(2012-9#1)(2013-1#46)(2013-7#3)(2013-8#16)
were silent##5##2##(1993-2#1)(1993-8#1)(1996-10#1)(2008-2#1)(2008-4#1)
were similar (P&gt##2##3##(2010-4#1)(2012-12#1)
were similar across##6##3##(1991-3#1)(1994-3#1)(2008-3#1)(2009-4#1)(2010-11#1)(2012-3#1)
were similar among the##2##4##(2006-10#1)(2006-5#1)
were similar among##7##3##(1995-11#1)(1995-12#2)(2006-10#1)(2006-5#1)(2008-5#1)(2012-11#1)
were similar and##4##3##(1994-8#1)(2008-10#1)(2008-11#1)(2008-4#1)
were similar at##4##3##(1990-5#1)(1993-7#1)(2007-8#1)(2010-12#1)
were similar between the##4##4##(1996-7#1)(2006-10#1)(2007-8#1)(2013-1#1)
were similar between treatment##2##4##(2012-12#1)(2012-3#1)
were similar between##19##3##(1992-12#1)(1993-5#1)(1994-11#1)(1994-5#1)(1995-8#1)(1996-7#1)(2006-10#1)(2007-2#2)(2007-8#1)(2008-10#1)(2010-8#1)(2012-12#2)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#1)
were similar for all##3##4##(1990-12#1)(2008-10#1)(2011-2#1)
were similar for both##3##4##(1992-7#1)(2008-10#1)(2008-11#1)
were similar for each##2##4##(2008-10#2)
were similar for the two##4##5##(1992-3#1)(1994-3#1)(2008-10#1)(2008-3#1)
were similar for the##8##4##(1992-1#1)(1992-3#1)(1994-3#1)(1994-9#1)(2007-7#1)(2008-10#1)(2008-3#1)(2010-3#1)
were similar for##37##3##(1990-10#1)(1990-12#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-2#1)(1994-11#1)(1994-3#1)(1994-4#1)(1994-6#1)(1994-9#1)(2004-11#1)(2006-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-3#1)(2011-10#1)(2011-2#1)(2012-12#1)(2013-7#2)(2013-8#1)
were similar in age##2##4##(1993-4#1)(2007-8#1)
were similar in all groups##2##5##(2008-10#1)(2010-4#1)
were similar in all the##2##5##(1993-4#1)(2008-5#1)
were similar in all##6##4##(1993-4#1)(1993-7#1)(1994-8#1)(2008-10#1)(2008-5#1)(2010-4#1)
were similar in both groups##20##5##(1990-12#1)(1990-8#1)(1991-10#1)(1991-12#1)(1992-10#1)(1994-12#1)(1997-2#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-9#2)(2008-5#2)(2009-3#1)(2010-11#2)(2013-1#1)
were similar in both the##2##5##(2011-2#1)(2012-3#1)
were similar in both##33##4##(1990-12#1)(1990-8#1)(1991-10#1)(1991-12#1)(1992-10#1)(1993-2#1)(1993-8#1)(1994-12#1)(1995-7#1)(1996-1#1)(1996-6#1)(1997-2#3)(2006-1#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-5#2)(2009-3#1)(2010-11#2)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
were similar in cases##2##4##(1991-7#1)(2011-2#1)
were similar in control and##2##5##(1993-12#1)(1995-11#1)
were similar in patients with and without##2##7##(1996-12#1)(2007-11#1)
were similar in patients with##3##5##(1996-12#1)(2007-11#1)(2013-8#1)
were similar in patients##4##4##(1994-12#1)(1996-12#1)(2007-11#1)(2013-8#1)
were similar in size##2##4##(1997-6#1)(2008-10#1)
were similar in terms of##3##5##(2005-10#1)(2007-8#1)(2012-12#1)
were similar in the rats and DBA mice##2##8##(1997-2#2)
were similar in the rats and##3##6##(1997-2#3)
were similar in the two groups##6##6##(1990-12#1)(1992-11#1)(1995-9#1)(2007-8#2)(2012-2#1)
were similar in the##23##4##(1990-12#1)(1992-11#1)(1992-7#1)(1995-12#1)(1995-9#1)(1997-2#3)(2006-10#1)(2007-8#2)(2008-10#3)(2008-12#1)(2008-8#1)(2009-4#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
were similar in##121##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-3#1)(1991-7#1)(1992-10#2)(1992-11#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#2)(1993-7#2)(1993-8#3)(1994-12#2)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-7#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-4#1)(1996-6#1)(1997-2#6)(1997-3#1)(1997-4#1)(1997-6#1)(2005-10#1)(2006-1#1)(2006-10#2)(2006-2#1)(2007-10#2)(2007-11#2)(2007-2#2)(2007-7#1)(2007-8#4)(2007-9#3)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#2)(2009-8#1)(2010-11#2)(2010-2#1)(2010-4#1)(2011-12#1)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
were similar or##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
were similar regarding##2##3##(2006-8#1)(2011-2#1)
were similar to each other##3##5##(1997-8#1)(2008-10#2)
were similar to or##3##4##(1995-12#1)(1995-3#1)(2008-11#1)
were similar to previously reported##2##5##(1993-1#1)(2009-4#1)
were similar to results##2##4##(2008-10#1)(2010-4#1)
were similar to that of##4##5##(1994-8#1)(1996-12#1)(1997-2#1)(2008-10#1)
were similar to that##6##4##(1994-8#1)(1996-12#1)(1997-2#1)(2007-2#1)(2008-10#1)(2009-12#1)
were similar to the values##2##5##(1991-2#1)(1992-2#1)
were similar to the##23##4##(1990-11#1)(1991-2#1)(1992-2#1)(1995-12#1)(1996-10#1)(1996-12#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#2)(2009-4#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
were similar to those described in##2##6##(2008-6#1)(2011-2#1)
were similar to those for##5##5##(1991-8#1)(1991-9#1)(1993-12#1)(1996-7#1)(2005-7#1)
were similar to those found in other##2##7##(2006-8#1)(2007-12#1)
were similar to those found in##5##6##(1993-12#1)(1996-2#1)(2006-8#1)(2007-12#1)(2010-4#1)
were similar to those found##6##5##(1993-12#1)(1996-2#1)(2006-8#1)(2007-12#1)(2010-4#1)(2011-12#1)
were similar to those in the##2##6##(1991-2#1)(1993-12#1)
were similar to those in##4##5##(1991-2#1)(1993-12#1)(1994-12#1)(2013-1#1)
were similar to those observed in other##3##7##(1990-2#1)(1994-5#1)(2008-5#1)
were similar to those observed in the##2##7##(1997-8#1)(2008-10#1)
were similar to those observed in##8##6##(1990-2#1)(1993-11#1)(1994-5#1)(1996-10#1)(1997-8#1)(2007-9#1)(2008-10#1)(2008-5#1)
were similar to those observed##9##5##(1990-2#1)(1993-11#1)(1994-5#1)(1996-10#1)(1997-8#1)(2007-1#1)(2007-9#1)(2008-10#1)(2008-5#1)
were similar to those obtained in##3##6##(1990-4#1)(2007-5#1)(2008-10#1)
were similar to those obtained with##3##6##(1992-6#1)(1994-3#1)(2008-10#1)
were similar to those obtained##8##5##(1990-4#1)(1992-6#1)(1994-3#1)(2006-12#1)(2007-5#1)(2008-10#3)
were similar to those of the human##2##7##(1993-9#1)(2008-3#1)
were similar to those of the vehicle control groups##3##9##(2008-9#3)
were similar to those of the vehicle controls##8##8##(2008-9#8)
were similar to those of the vehicle##11##7##(2008-9#11)
were similar to those of the##21##6##(1993-8#1)(1993-9#1)(1995-3#1)(1995-5#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#11)(2011-1#1)(2011-2#1)
were similar to those of wild-type##2##6##(1993-11#1)(1994-11#1)
were similar to those of##41##5##(1990-3#1)(1990-4#1)(1992-4#1)(1993-11#1)(1993-2#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-7#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#2)(2008-9#13)(2011-1#1)(2011-2#1)
were similar to those reported for##2##6##(1990-2#1)(1994-2#1)
were similar to those reported##3##5##(1990-2#1)(1994-2#1)(1996-2#1)
were similar to those seen in##2##6##(1992-9#1)(2012-3#1)
were similar to those seen##3##5##(1992-9#1)(1995-11#1)(2012-3#1)
were similar to those with##2##5##(1996-9#1)(2007-3#1)
were similar to those##90##4##(1990-2#2)(1990-3#1)(1990-4#2)(1991-2#1)(1991-8#1)(1991-9#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#3)(1996-7#2)(1996-9#1)(1997-8#1)(2005-7#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-9#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#13)(2009-4#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-3#2)(2013-1#1)
were similar to##149##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#2)(1991-2#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-3#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-10#2)(1996-12#3)(1996-2#3)(1996-7#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#2)(2005-7#1)(2006-12#1)(2006-7#1)(2006-8#2)(2007-1#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-10#20)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#5)(2008-9#13)(2009-12#1)(2009-4#3)(2009-9#1)(2010-12#2)(2010-4#3)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
were similar under##2##3##(2008-10#2)
were similar when##2##3##(1995-1#1)(2006-10#1)
were similar with respect to##3##5##(1991-2#1)(2006-9#1)(2007-8#1)
were similar with the##2##4##(1990-2#1)(2008-3#1)
were similar with##6##3##(1990-2#1)(1991-2#1)(2006-9#1)(2007-8#1)(2008-3#1)(2008-6#1)
were similar##452##2##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#5)(1990-3#1)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#4)(1991-3#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#2)(1992-6#2)(1992-7#3)(1992-8#1)(1992-9#1)(1993-1#3)(1993-11#3)(1993-12#4)(1993-2#3)(1993-4#3)(1993-5#1)(1993-7#3)(1993-8#4)(1993-9#2)(1994-11#4)(1994-12#4)(1994-2#3)(1994-3#3)(1994-4#1)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#5)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#8)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#2)(1995-9#1)(1996-1#3)(1996-10#2)(1996-11#1)(1996-12#6)(1996-2#3)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#3)(1996-9#2)(1997-2#8)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#4)(2004-11#3)(2005-10#1)(2005-7#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-5#4)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#3)(2007-2#5)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#10)(2007-9#5)(2008-1#1)(2008-10#53)(2008-11#6)(2008-12#5)(2008-2#1)(2008-3#9)(2008-4#4)(2008-5#17)(2008-6#5)(2008-7#3)(2008-8#7)(2008-9#16)(2009-12#1)(2009-3#1)(2009-4#6)(2009-8#2)(2009-9#1)(2010-11#3)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#5)(2010-8#2)(2011-1#2)(2011-10#1)(2011-12#2)(2011-2#12)(2012-1#3)(2012-11#1)(2012-12#8)(2012-2#2)(2012-3#6)(2012-5#1)(2013-1#12)(2013-7#2)(2013-8#8)
were similarly affected by##2##4##(1994-12#1)(1996-8#1)
were similarly effective in##2##4##(2007-11#1)(2012-3#1)
were similarly efficacious##2##3##(2010-8#1)(2011-2#1)
were similarly##16##2##(1990-11#1)(1991-9#1)(1993-11#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-8#1)(1997-3#1)(2007-11#1)(2007-9#2)(2008-10#1)(2010-8#1)(2011-2#1)(2012-3#1)
were simplified to measure##4##4##(2013-1#4)
were simplified to##5##3##(2007-9#1)(2013-1#4)
were simplified##6##2##(1993-3#1)(2007-9#1)(2013-1#4)
were simply##5##2##(1994-12#1)(1995-1#1)(2006-8#1)(2008-11#1)(2012-3#1)
were simulated using a##2##4##(2006-11#1)(2013-1#1)
were simulated using##4##3##(1994-11#1)(2006-11#1)(2013-1#2)
were simulated with##2##3##(1996-11#1)(2012-3#1)
were simulated##15##2##(1993-12#1)(1993-9#1)(1994-11#1)(1996-11#1)(1997-2#1)(2006-11#1)(2006-2#1)(2007-5#1)(2007-7#1)(2008-3#1)(2009-3#1)(2011-2#1)(2012-3#1)(2013-1#2)
were simultaneously added##2##3##(1993-6#1)(2008-10#1)
were simultaneously amplified##2##3##(2008-10#2)
were simultaneously detected in##2##4##(2008-10#1)(2008-4#1)
were simultaneously detected##3##3##(2007-7#1)(2008-10#1)(2008-4#1)
were simultaneously determined by##2##4##(2008-10#2)
were simultaneously determined in##3##4##(2008-10#3)
were simultaneously determined##5##3##(2008-10#5)
were simultaneously fed##2##3##(2004-11#1)(2009-2#1)
were simultaneously recorded##5##3##(1992-1#1)(1995-11#1)(1997-6#1)(2006-8#1)(2007-12#1)
were simultaneously separated##2##3##(1990-8#1)(2008-10#1)
were simultaneously studied by applying a Plackett-Burman design (PBD)##2##9##(2008-10#2)
were simultaneously studied##3##3##(2008-10#2)(2008-5#1)
were simultaneously treated##2##3##(2006-6#1)(2008-6#1)
were simultaneously##48##2##(1990-8#1)(1991-7#1)(1992-1#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-6#1)(1997-6#1)(2004-11#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#18)(2008-4#1)(2008-5#1)(2008-6#1)(2009-2#1)(2009-9#1)(2012-12#1)(2013-1#1)
were single and##2##3##(2007-12#1)(2012-12#1)
were single##6##2##(1990-5#1)(1993-12#1)(1995-11#1)(2007-12#1)(2008-4#1)(2012-12#1)
were singly##2##2##(2008-10#1)(2008-3#1)
were site-specifically##2##2##(1995-5#1)(2008-4#1)
were situated##2##2##(1991-5#1)(2008-10#1)
were six patients##2##3##(2007-7#1)(2008-1#1)
were six##9##2##(1993-1#1)(2006-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-9#1)
were skin##2##2##(1996-3#1)(2006-10#1)
were slaughtered and##3##3##(1997-5#1)(2008-12#1)(2010-4#1)
were slaughtered at the##3##4##(1996-12#1)(2011-1#1)(2012-2#1)
were slaughtered at##7##3##(1996-12#1)(2010-4#3)(2011-1#1)(2012-2#1)(2013-1#1)
were slaughtered##16##2##(1994-7#1)(1996-12#1)(1997-5#1)(2006-5#2)(2008-12#1)(2008-9#1)(2010-2#1)(2010-4#5)(2011-1#1)(2012-2#1)(2013-1#1)
were sliced##2##2##(2007-8#1)(2008-3#1)
were slightly better##2##3##(2008-10#2)
were slightly higher than those of##2##6##(1995-5#1)(2008-10#1)
were slightly higher than those predicted solely from the##2##9##(1991-8#1)(1994-8#1)
were slightly higher than those##5##5##(1991-8#1)(1994-8#1)(1995-5#1)(2008-10#1)(2008-6#1)
were slightly higher than##6##4##(1991-8#1)(1994-8#1)(1995-5#1)(2008-10#1)(2008-6#1)(2012-1#1)
were slightly higher##10##3##(1991-8#1)(1992-1#1)(1992-9#1)(1994-8#1)(1995-5#1)(1997-6#1)(2005-11#1)(2008-10#1)(2008-6#1)(2012-1#1)
were slightly increased##2##3##(1991-10#1)(1993-12#1)
were slightly larger than##2##4##(2006-8#1)(2008-10#1)
were slightly larger##3##3##(2006-11#1)(2006-8#1)(2008-10#1)
were slightly less##3##3##(1992-1#1)(2008-10#1)(2009-2#1)
were slightly lower##4##3##(1994-2#1)(2005-10#1)(2007-8#1)(2008-11#1)
were slightly more potent than##2##5##(1993-4#1)(2007-10#1)
were slightly more##9##3##(1990-4#1)(1992-5#1)(1993-4#1)(2007-10#1)(2007-7#2)(2008-9#1)(2010-10#1)(2012-5#1)
were slightly##49##2##(1990-4#1)(1991-10#1)(1991-11#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-5#1)(1992-9#1)(1993-12#2)(1993-4#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-5#1)(1995-6#1)(1997-6#2)(2005-10#1)(2005-11#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-7#2)(2007-8#2)(2008-10#8)(2008-11#2)(2008-6#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-10#1)(2012-1#2)(2012-3#1)(2012-5#1)(2013-8#1)
were slow to##2##3##(2008-11#1)(2009-4#1)
were slow##5##2##(1994-3#1)(1995-10#1)(2008-10#1)(2008-11#1)(2009-4#1)
were slower and less accurate##3##5##(2007-12#1)(2009-4#1)(2010-2#1)
were slower and##4##3##(2007-12#1)(2008-10#1)(2009-4#1)(2010-2#1)
were slower than the##2##4##(2006-9#1)(2008-7#1)
were slower than##3##3##(2006-9#1)(2008-7#2)
were slower to##2##3##(1993-6#1)(2012-2#1)
were slower##12##2##(1993-6#1)(1994-11#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-7#2)(2009-4#1)(2010-2#1)(2010-3#1)(2012-12#1)(2012-2#1)
were slowly##4##2##(1992-3#1)(1992-6#1)(1996-9#1)(2006-8#1)
were small and##7##3##(1991-12#1)(1992-8#1)(1994-2#1)(1997-8#1)(2007-9#1)(2008-10#1)(2012-1#1)
were small##28##2##(1991-12#1)(1991-6#2)(1992-8#1)(1992-9#1)(1994-2#2)(1994-7#1)(1994-9#1)(1995-8#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-9#1)(2007-1#1)(2007-9#3)(2008-10#4)(2009-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
were smaller and produced##2##4##(2008-10#2)
were smaller and##5##3##(1990-7#1)(1991-2#1)(2008-10#2)(2008-6#1)
were smaller in the##2##4##(1994-11#1)(2004-11#1)
were smaller in##3##3##(1994-11#1)(2004-11#1)(2008-10#1)
were smaller than the##2##4##(2007-12#1)(2008-10#1)
were smaller than those##7##4##(1992-9#1)(1994-9#1)(2005-11#2)(2008-10#1)(2008-5#1)(2012-2#1)
were smaller than##20##3##(1992-5#1)(1992-7#1)(1992-9#1)(1994-9#1)(1995-1#1)(2005-11#2)(2007-12#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-6#1)(2009-10#1)(2009-6#1)(2011-12#1)(2012-2#1)
were smaller when##2##3##(2008-11#1)(2013-8#1)
were smaller##37##2##(1990-5#1)(1990-7#1)(1991-2#1)(1992-5#1)(1992-7#1)(1992-9#1)(1994-11#1)(1994-9#1)(1995-1#1)(2004-11#1)(2005-11#2)(2006-11#2)(2006-12#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#2)(2009-10#1)(2009-6#1)(2011-12#1)(2012-2#1)(2013-8#1)
were smokers or##2##3##(1991-3#1)(2008-4#1)
were smokers##15##2##(1990-10#1)(1991-3#1)(1993-6#1)(1996-8#1)(2004-1#1)(2007-7#1)(2008-10#2)(2008-4#1)(2009-2#1)(2009-5#1)(2011-2#3)(2013-8#1)
were smooth##2##2##(1997-2#1)(2013-8#1)
were so##5##2##(1993-10#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-11#1)
were soaked in a##2##4##(2008-10#2)
were soaked in##3##3##(2008-10#2)(2010-2#1)
were soaked##5##2##(2008-10#4)(2010-2#1)
were soft##2##2##(2006-7#1)(2012-2#1)
were solely##3##2##(1997-9#1)(2007-8#1)(2010-4#1)
were solicited##2##2##(2006-10#1)(2006-5#1)
were solitary##2##2##(2008-10#1)(2009-3#1)
were solubilized by##3##3##(1990-2#1)(1990-8#1)(1992-1#1)
were solubilized from##3##3##(1990-2#1)(1994-11#1)(2008-5#1)
were solubilized with##2##3##(1990-2#1)(1994-12#1)
were solubilized##12##2##(1990-11#1)(1990-2#4)(1990-8#1)(1991-3#1)(1991-4#1)(1992-1#1)(1994-11#1)(1994-12#1)(2008-5#1)
were solved by##2##3##(1992-8#1)(2013-1#1)
were solved##5##2##(1992-8#1)(2006-5#1)(2007-9#1)(2008-10#1)(2013-1#1)
were some differences in##3##4##(1991-6#1)(2007-6#1)(2008-5#1)
were some differences##5##3##(1991-6#1)(2006-7#1)(2007-6#1)(2008-5#1)(2012-12#1)
were some exceptions##2##3##(2010-8#1)(2011-2#1)
were some limitations to##2##4##(1994-12#1)(2008-11#1)
were some of the##2##4##(1994-1#1)(2006-10#1)
were some##19##2##(1991-6#1)(1993-5#1)(1994-1#1)(1994-12#1)(2006-10#2)(2006-7#1)(2007-6#1)(2007-7#2)(2008-11#1)(2008-5#2)(2010-1#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
were sometimes##7##2##(1991-3#1)(1991-5#1)(2008-10#1)(2008-5#1)(2010-8#1)(2013-1#2)
were somewhat larger##2##3##(2005-11#1)(2008-10#1)
were somewhat less##2##3##(1997-5#1)(2007-10#1)
were somewhat reduced##2##3##(1993-6#1)(1995-10#1)
were somewhat##11##2##(1991-1#1)(1993-6#1)(1995-10#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-5#1)(2005-11#1)(2006-7#1)(2007-10#1)(2008-10#1)
were soon##3##2##(1997-1#1)(2005-8#1)(2006-5#1)
were sorbed##4##2##(2008-10#4)
were sorted by##3##3##(1996-12#1)(2006-8#1)(2008-7#1)
were sorted into 3##2##4##(2007-10#1)(2012-3#1)
were sorted##8##2##(1994-2#1)(1995-8#1)(1996-12#2)(2006-8#1)(2007-10#1)(2008-7#1)(2012-3#1)
were sought between##2##3##(1990-10#1)(1992-6#1)
were sought from##3##3##(2007-12#1)(2007-8#1)(2012-12#1)
were sought using##3##3##(2008-11#2)(2008-12#1)
were sought##15##2##(1990-10#1)(1992-6#1)(1993-2#1)(1994-8#1)(1996-4#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)
were sources of##2##3##(2007-1#1)(2007-2#1)
were spared##7##2##(1991-4#1)(1994-5#1)(2005-2#1)(2006-10#1)(2006-5#1)(2006-7#1)(2010-6#1)
were sparse##2##2##(1993-12#1)(1996-5#1)
were spatially correlated in##2##4##(2008-10#2)
were spatially##11##2##(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#4)(2009-5#1)(2012-2#1)(2013-1#2)
were specially##2##2##(2008-10#2)
were specific for##8##3##(1992-8#1)(1996-8#1)(1997-6#1)(2008-10#5)
were specific since##2##3##(2008-4#1)(2013-1#1)
were specific to the##2##4##(1991-3#1)(1995-7#1)
were specific to##8##3##(1991-3#1)(1995-7#1)(2007-1#1)(2008-10#4)(2011-2#1)
were specific##22##2##(1991-3#1)(1991-9#1)(1992-8#1)(1995-7#1)(1995-8#1)(1996-8#1)(1997-1#1)(1997-6#1)(2007-1#1)(2008-10#9)(2008-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
were specifically designed##2##3##(1995-4#1)(2008-3#1)
were specifically detected##2##3##(2008-10#1)(2008-4#1)
were specifically recognized##2##3##(2006-12#1)(2008-5#1)
were specifically targeted##2##3##(1990-4#1)(2006-8#1)
were specifically##20##2##(1990-4#1)(1990-8#1)(1992-8#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-3#1)(1996-6#1)(1996-8#1)(2006-12#1)(2006-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-12#1)
were spiked with##11##3##(1990-12#1)(1992-8#1)(2007-8#1)(2008-10#8)
were spiked##12##2##(1990-12#1)(1992-8#1)(2007-8#1)(2008-10#9)
were spliced##2##2##(1993-12#1)(1994-12#1)
were split into##3##3##(1995-6#1)(2010-4#1)(2013-8#1)
were split##4##2##(1995-6#1)(1997-5#1)(2010-4#1)(2013-8#1)
were spondylolisthesis##2##2##(2007-11#1)(2007-7#1)
were spontaneously##2##2##(1996-11#1)(2008-11#1)
were sporadic##3##2##(1994-4#1)(2006-10#1)(2012-3#1)
were spray inoculated##2##3##(2006-3#1)(2008-10#1)
were sprayed on##2##3##(2008-10#2)
were sprayed with a##2##4##(2008-10#2)
were sprayed with the##2##4##(2008-10#2)
were sprayed with##8##3##(2008-10#6)(2008-8#1)(2011-2#1)
were sprayed##14##2##(2008-10#11)(2008-8#1)(2011-2#2)
were spread over##3##3##(2005-7#1)(2008-10#2)
were spread##8##2##(1996-8#1)(2004-11#1)(2005-7#1)(2005-8#1)(2007-3#1)(2008-10#2)(2008-9#1)
were sputter deposited on##2##4##(2008-2#1)(2008-3#1)
were stabilized by##2##3##(1994-11#1)(2005-11#1)
were stabilized with##2##3##(1995-2#1)(2007-8#1)
were stabilized##8##2##(1993-2#1)(1994-11#1)(1995-2#1)(2005-11#1)(2007-8#2)(2008-10#2)
were stable and##2##3##(2007-10#1)(2007-11#1)
were stable at##3##3##(1997-3#2)(2011-1#1)
were stable for a##2##4##(1996-5#1)(2008-10#1)
were stable for at least one##2##6##(1993-8#1)(2007-8#1)
were stable for at least##4##5##(1993-8#1)(2007-8#1)(2008-10#2)
were stable for##8##3##(1993-8#1)(1996-5#1)(1996-8#1)(2007-8#1)(2008-10#4)
were stable in all##2##4##(2006-12#1)(2007-7#1)
were stable in##6##3##(1991-2#1)(1994-9#1)(2006-12#1)(2007-7#1)(2008-10#1)(2010-4#1)
were stable over##6##3##(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#1)
were stable throughout the##2##4##(1994-6#1)(2012-1#1)
were stable to droplet growth##2##5##(2005-11#2)
were stable to##4##3##(1996-8#1)(2005-11#3)
were stable under##2##3##(1995-1#1)(2008-10#1)
were stable##52##2##(1990-12#1)(1991-2#1)(1993-8#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-12#1)(1996-5#1)(1996-8#2)(1997-3#2)(2005-11#3)(2006-12#3)(2007-10#2)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#3)
were stably expressed in Chinese hamster ovary cells##2##8##(1990-12#1)(1996-5#1)
were stably transfected with##4##4##(1995-2#1)(1996-11#1)(1997-1#1)(2008-11#1)
were stably transfected##6##3##(1995-2#2)(1996-11#1)(1997-1#1)(1997-2#1)(2008-11#1)
were stably##11##2##(1990-12#1)(1993-2#1)(1995-2#2)(1996-11#1)(1996-5#1)(1997-1#1)(1997-2#1)(2006-12#1)(2008-10#1)(2008-11#1)
were stage I##2##3##(1996-2#1)(2008-10#1)
were stage##6##2##(1991-2#1)(1996-2#1)(2004-1#2)(2008-10#1)(2011-12#1)
were staged according to the##2##5##(1990-8#1)(2008-6#1)
were staged##7##2##(1990-10#1)(1990-8#1)(1992-6#1)(2007-6#1)(2008-10#1)(2008-6#1)(2008-7#1)
were stained and##2##3##(1990-4#1)(2008-5#1)
were stained by the##2##4##(1997-2#1)(2008-10#1)
were stained by##9##3##(1995-2#1)(1996-12#1)(1997-2#1)(2006-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2010-2#1)(2011-2#1)
were stained for the##2##4##(2007-11#1)(2007-8#1)
were stained for##6##3##(1996-9#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-8#1)
were stained in##3##3##(2008-12#2)(2008-5#1)
were stained positively##3##3##(1996-11#1)(1996-12#1)(2012-1#1)
were stained with the##4##4##(1991-5#1)(1994-2#1)(2008-10#1)(2008-11#1)
were stained with##24##3##(1991-5#1)(1992-8#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-11#1)(2004-1#1)(2006-5#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-2#1)(2009-5#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-8#1)
were stained##56##2##(1990-4#1)(1991-12#1)(1991-5#1)(1992-8#1)(1993-12#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-5#2)(1995-11#1)(1995-2#1)(1996-11#1)(1996-12#2)(1996-5#1)(1996-9#1)(1997-2#1)(1997-8#1)(2004-1#1)(2004-2#1)(2006-5#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#3)(2007-9#2)(2008-10#3)(2008-11#1)(2008-12#3)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-2#2)(2011-2#1)(2012-1#2)(2012-2#1)(2013-8#1)
were standardized to##2##3##(2008-6#1)(2011-2#1)
were standardized##10##2##(1990-3#1)(1993-8#1)(1996-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-7#1)
were started at##2##3##(2007-3#1)(2013-8#1)
were started on##6##3##(2006-10#2)(2006-7#1)(2007-7#1)(2008-1#1)(2008-7#1)
were started##16##2##(1992-9#1)(1993-7#1)(1995-5#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-8#1)(2013-1#1)(2013-8#1)
were statistical##3##2##(1995-1#1)(2008-5#1)(2013-1#1)
were statistically analysed##2##3##(2006-8#1)(2008-9#1)
were statistically analyzed using##4##4##(2004-9#1)(2012-12#1)(2012-3#1)(2013-8#1)
were statistically analyzed##8##3##(1994-8#1)(2004-9#1)(2008-10#1)(2008-11#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-8#1)
were statistically comparable with those obtained by##2##7##(2008-10#2)
were statistically compared with##5##4##(2008-10#5)
were statistically compared##7##3##(2007-8#1)(2008-10#6)
were statistically different##4##3##(1996-7#1)(2007-2#1)(2008-5#1)(2011-2#1)
were statistically evaluated##3##3##(1990-8#1)(2008-10#1)(2008-12#1)
were statistically higher in the##2##5##(1995-4#1)(2010-1#1)
were statistically higher##5##3##(1995-4#1)(2007-10#1)(2009-8#1)(2010-1#1)(2010-12#1)
were statistically indistinguishable from##2##4##(1995-10#1)(2008-10#1)
were statistically indistinguishable##3##3##(1993-3#1)(1995-10#1)(2008-10#1)
were statistically non-significant##2##3##(2008-10#2)
were statistically processed##2##3##(1995-6#1)(2008-8#1)
were statistically significant (P &lt##2##5##(1994-12#1)(2008-7#1)
were statistically significant (p &lt##3##5##(2006-9#1)(2008-12#1)(2008-9#1)
were statistically significant (p=0##2##4##(2004-9#1)(2006-1#1)
were statistically significant associations between##2##5##(2008-8#2)
were statistically significant benefits of##2##5##(2013-8#2)
were statistically significant differences between##3##5##(2005-1#1)(2007-7#1)(2013-8#1)
were statistically significant differences##4##4##(2005-1#1)(2007-7#1)(2010-7#1)(2013-8#1)
were statistically significant for##2##4##(2011-2#1)(2013-8#1)
were statistically significant in the##2##5##(2008-7#1)(2010-1#1)
were statistically significant in##3##4##(2008-11#1)(2008-7#1)(2010-1#1)
were statistically significant predictors of##3##5##(2008-11#1)(2011-2#1)(2012-2#1)
were statistically significant predictors##4##4##(2008-11#1)(2011-2#1)(2012-2#2)
were statistically significant##54##3##(1990-4#1)(1990-8#1)(1991-10#1)(1992-11#1)(1992-4#2)(1992-7#1)(1994-1#1)(1994-12#1)(1994-2#1)(1996-2#1)(2004-9#1)(2005-1#1)(2006-1#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-7#2)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#5)(2008-8#4)(2008-9#1)(2010-1#1)(2010-7#1)(2011-2#4)(2012-2#2)(2013-1#1)(2013-8#5)
were statistically significantly more##2##4##(2009-6#1)(2013-8#1)
were statistically significantly##8##3##(2007-8#1)(2008-5#1)(2008-8#1)(2009-6#1)(2011-1#1)(2012-1#2)(2013-8#1)
were statistically similar in##2##4##(2006-8#1)(2013-1#1)
were statistically similar##5##3##(2006-8#1)(2007-3#1)(2008-10#1)(2013-1#2)
were statistically##123##2##(1990-4#1)(1990-8#2)(1991-10#1)(1992-11#1)(1992-2#1)(1992-4#2)(1992-7#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-10#1)(1995-4#1)(1995-6#1)(1996-2#1)(1996-7#1)(2004-9#2)(2005-1#1)(2006-1#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-10#22)(2008-11#3)(2008-12#3)(2008-3#1)(2008-5#3)(2008-7#5)(2008-8#6)(2008-9#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#6)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#7)
were steeper than those of##2##5##(2008-8#1)(2012-1#1)
were steeper##4##2##(1993-11#1)(1993-12#1)(2008-8#1)(2012-1#1)
were stepwise##2##2##(1994-12#1)(1997-3#1)
were stereospecific##2##2##(1991-11#1)(1993-12#1)
were sterile##3##2##(2008-10#1)(2012-12#2)
were sterilized##2##2##(1991-3#1)(2009-7#1)
were still able to##2##4##(2006-12#1)(2011-2#1)
were still alive##5##3##(1993-7#1)(1997-2#1)(2006-7#2)(2011-2#1)
were still being##2##3##(1991-8#1)(2008-11#1)
were still below##2##3##(1992-9#1)(2006-4#1)
were still detectable##2##3##(1996-12#1)(2009-10#1)
were still higher than##2##4##(1997-5#1)(2008-6#1)
were still in the##2##4##(1991-12#1)(2012-1#1)
were still in##7##3##(1991-12#1)(2006-10#1)(2007-1#1)(2008-1#1)(2009-7#1)(2012-1#2)
were still not##2##3##(1995-11#1)(2008-10#1)
were still on##2##3##(1995-5#1)(2007-7#1)
were still over##2##3##(2008-10#1)(2009-5#1)
were still positive##2##3##(2008-2#1)(2008-5#1)
were still present##7##3##(1992-7#1)(1992-8#1)(1994-2#1)(1997-4#1)(2005-11#1)(2006-12#1)(2009-12#1)
were still protected##2##3##(1991-9#1)(1997-4#1)
were still significantly##4##3##(1990-10#1)(1991-2#1)(1994-5#1)(2007-10#1)
were still working##2##3##(1994-6#1)(2006-10#1)
were still##95##2##(1990-10#2)(1990-12#2)(1991-1#1)(1991-12#1)(1991-2#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-7#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#3)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-12#3)(1996-4#1)(1997-2#1)(1997-4#2)(1997-5#2)(1997-6#1)(2004-10#1)(2005-11#1)(2006-10#3)(2006-12#3)(2006-4#1)(2006-7#3)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-3#3)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#3)(2012-3#1)(2013-1#2)
were stimulated by##12##3##(1990-11#2)(1990-12#1)(1991-2#1)(1991-8#1)(1992-1#1)(1994-10#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-1#1)
were stimulated for##2##3##(1994-6#1)(1997-3#1)
were stimulated in vitro with##3##5##(1992-11#1)(1995-8#1)(2008-5#1)
were stimulated in##4##3##(1992-11#1)(1993-11#1)(1995-8#1)(2008-5#1)
were stimulated or##2##3##(1991-5#1)(2008-9#1)
were stimulated to##3##3##(1991-12#1)(1993-3#1)(1996-8#1)
were stimulated with##18##3##(1990-2#2)(1991-3#1)(1991-6#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-10#1)(1995-1#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)
were stimulated##47##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-10#2)(1994-2#1)(1994-6#1)(1995-1#1)(1995-8#2)(1996-8#1)(1997-1#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-9#1)(2012-1#1)
were stirred at##2##3##(2007-8#1)(2008-10#1)
were stored at##3##3##(1993-2#1)(2008-10#2)
were stored for##3##3##(2006-5#1)(2006-8#1)(2010-2#1)
were stored in water or##2##5##(2008-12#1)(2008-3#1)
were stored in water##3##4##(2008-12#1)(2008-3#1)(2013-8#1)
were stored in##8##3##(1994-3#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-3#1)(2009-8#1)(2013-8#1)
were stored##17##2##(1993-2#1)(1994-3#1)(2005-11#1)(2006-5#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-2#1)(2013-8#1)
were strain specific##2##3##(1994-8#1)(2008-10#1)
were strain##3##2##(1994-8#2)(2008-10#1)
were strategies for##2##3##(2005-8#2)
were strategies##3##2##(2005-8#2)(2011-2#1)
were stratified according to##3##4##(1990-5#1)(1994-12#1)(2011-2#1)
were stratified by##8##3##(1991-2#1)(2006-5#1)(2007-2#1)(2007-7#1)(2008-7#1)(2011-2#2)(2012-12#1)
were stratified into a##2##4##(2011-2#2)
were stratified into three categories##2##5##(2010-12#2)
were stratified into three##3##4##(2008-5#1)(2010-12#2)
were stratified into##8##3##(2006-12#1)(2006-2#1)(2008-5#1)(2009-10#1)(2010-12#2)(2011-2#2)
were stratified##21##2##(1990-5#1)(1991-2#1)(1994-12#1)(1995-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-2#1)(2007-7#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-12#2)(2011-2#5)(2012-12#1)(2012-5#1)
were stressed##2##2##(1995-12#1)(2005-8#1)
were strictly conserved##2##3##(1995-5#1)(2008-10#1)
were strictly limited##2##3##(2006-7#1)(2008-11#1)
were strictly##8##2##(1992-7#1)(1994-9#1)(1995-5#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
were strikingly##4##2##(1992-3#1)(2006-10#1)(2008-7#1)(2009-4#1)
were strong predictors of##2##4##(2007-7#1)(2007-9#1)
were strong predictors##3##3##(1991-8#1)(2007-7#1)(2007-9#1)
were strong##14##2##(1991-2#1)(1991-8#1)(2004-11#1)(2006-5#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-2#1)(2011-2#1)
were stronger in##3##3##(1993-2#1)(1993-9#1)(2008-9#1)
were stronger##9##2##(1993-2#2)(1993-9#1)(1995-6#1)(2006-12#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-7#1)
were strongly associated with##6##4##(1991-3#1)(2004-10#1)(2008-1#1)(2009-7#2)(2011-1#1)
were strongly associated##8##3##(1991-3#1)(1991-6#1)(2004-10#1)(2008-1#1)(2009-7#2)(2011-1#2)
were strongly correlated with the##3##5##(2008-1#1)(2008-7#1)(2010-4#1)
were strongly correlated with##5##4##(1991-8#1)(2008-1#1)(2008-7#1)(2010-4#1)(2012-3#1)
were strongly correlated##6##3##(1991-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-4#1)(2012-3#1)
were strongly dependent on the##2##5##(1990-6#1)(2005-11#1)
were strongly dependent on##4##4##(1990-6#1)(1995-1#1)(2005-11#1)(2011-2#1)
were strongly differentiated##2##3##(2008-10#1)(2010-5#1)
were strongly influenced by##3##4##(1995-3#1)(2005-11#1)(2013-1#1)
were strongly inhibited by##3##4##(1991-7#1)(1993-9#1)(1994-9#1)
were strongly inhibited##4##3##(1991-7#1)(1993-9#1)(1994-9#1)(1996-4#1)
were strongly positive for##2##4##(1993-8#1)(2007-5#1)
were strongly positive##4##3##(1993-8#1)(2007-5#1)(2008-10#1)(2008-4#1)
were strongly reduced##3##3##(1995-1#1)(2008-10#2)
were strongly related to##3##4##(1991-9#1)(2008-10#1)(2012-1#1)
were strongly related##4##3##(1991-9#1)(2008-10#1)(2012-1#1)(2012-11#1)
were strongly##67##2##(1990-6#1)(1990-7#1)(1991-3#1)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#1)(1992-12#1)(1993-8#2)(1993-9#1)(1994-9#2)(1995-1#2)(1995-3#1)(1996-4#1)(1997-2#1)(1997-4#1)(2004-10#1)(2005-11#3)(2006-2#1)(2006-9#1)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-10#1)(2009-5#2)(2009-7#2)(2010-10#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#2)
were structurally##2##2##(1993-12#1)(1995-2#1)
were structured##3##2##(2008-11#1)(2008-8#1)(2011-2#1)
were students and##2##3##(2006-8#1)(2008-10#1)
were students##7##2##(1992-2#1)(2006-8#1)(2007-3#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
were studied after##10##3##(1995-12#1)(1996-5#1)(2004-9#1)(2007-11#1)(2007-7#1)(2008-3#1)(2008-5#1)(2010-12#1)(2012-1#2)
were studied and compared to##2##5##(1992-2#1)(2011-2#1)
were studied and compared with##3##5##(2008-3#1)(2008-5#1)(2008-7#1)
were studied and compared##8##4##(1992-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2011-3#1)
were studied and optimized##13##4##(2005-12#1)(2007-10#1)(2008-10#10)(2013-8#1)
were studied and the##6##4##(2007-8#1)(2008-10#5)
were studied and were##2##4##(2008-10#2)
were studied and##51##3##(1990-7#1)(1992-2#1)(2004-11#1)(2005-11#1)(2005-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#3)(2007-9#1)(2008-10#27)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-8#2)
were studied as a function of##2##6##(2007-11#1)(2009-10#1)
were studied as a##3##4##(1994-6#1)(2007-11#1)(2009-10#1)
were studied as well as##3##5##(2006-2#1)(2008-10#2)
were studied as well##4##4##(2006-2#1)(2008-10#3)
were studied as##15##3##(1994-6#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-2#1)(2009-10#1)(2010-2#1)
were studied at a##2##4##(1994-4#1)(2008-10#1)
were studied at four##4##4##(2007-3#1)(2007-5#1)(2008-10#1)(2011-2#1)
were studied at the##9##4##(1991-10#1)(1992-3#1)(1996-1#1)(2007-1#1)(2007-10#1)(2007-3#1)(2008-10#1)(2008-8#1)(2013-1#1)
were studied at##27##3##(1990-6#1)(1991-10#1)(1992-3#1)(1994-4#1)(1995-10#1)(1995-11#1)(1996-1#2)(1996-5#1)(1997-5#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-3#2)(2007-5#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
were studied by UV melting##2##5##(1991-8#1)(1993-3#1)
were studied by X-ray##2##4##(2006-12#1)(2013-8#1)
were studied by a##3##4##(1990-4#1)(2005-4#1)(2008-10#1)
were studied by comparing the##3##5##(1990-7#1)(1991-1#1)(1994-5#1)
were studied by confocal##2##4##(2005-11#1)(2008-10#1)
were studied by conventional##2##4##(2005-4#1)(2008-10#1)
were studied by cyclic voltammetry##4##5##(2007-11#1)(2007-8#1)(2008-10#2)
were studied by differential scanning calorimetry##2##6##(1993-8#1)(2011-2#1)
were studied by flow##3##4##(1994-5#1)(2008-10#1)(2012-1#1)
were studied by glass electrode##2##5##(2008-10#1)(2008-5#1)
were studied by in##2##4##(1991-5#1)(2010-11#1)
were studied by light##2##4##(2007-7#1)(2012-1#1)
were studied by means of##9##5##(1992-11#1)(1995-12#1)(1996-2#1)(1996-4#1)(2006-12#2)(2006-4#1)(2007-12#1)(2010-5#1)
were studied by measuring##2##4##(2008-10#1)(2012-2#1)
were studied by monitoring the##2##5##(1996-1#1)(2006-2#1)
were studied by principal component analysis (PCA)##2##7##(2008-10#2)
were studied by pulse radiolysis##2##5##(2005-4#1)(2010-5#1)
were studied by scanning electron microscopy##2##6##(2005-11#1)(2012-2#1)
were studied by the standard##2##5##(2007-8#1)(2008-1#1)
were studied by the##3##4##(1996-11#1)(2007-8#1)(2008-1#1)
were studied by using##10##4##(1991-7#1)(1997-4#1)(2005-4#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-9#1)
were studied by##119##3##(1990-4#1)(1990-7#1)(1990-8#3)(1991-1#1)(1991-11#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#3)(1992-2#1)(1992-3#1)(1992-8#2)(1993-3#1)(1993-8#1)(1994-5#2)(1994-9#1)(1995-11#1)(1995-12#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-4#1)(2005-11#5)(2005-4#5)(2006-10#1)(2006-12#3)(2006-2#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#24)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#5)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2010-11#1)(2010-5#2)(2011-2#2)(2012-1#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
were studied daily for##2##4##(2006-8#1)(2008-5#1)
were studied during a##4##4##(2007-2#3)(2008-10#1)
were studied during the##4##4##(1994-4#1)(2008-5#1)(2010-12#1)(2011-1#1)
were studied during##14##3##(1990-4#1)(1992-2#1)(1994-4#1)(2007-2#3)(2008-10#2)(2008-5#1)(2008-6#1)(2010-12#1)(2011-1#1)(2013-7#2)
were studied electrophysiologically using##2##4##(1990-7#1)(1996-2#1)
were studied electrophysiologically##3##3##(1990-7#1)(1992-8#1)(1996-2#1)
were studied for the first time##3##6##(2008-10#1)(2008-12#1)(2010-3#1)
were studied for the presence of##3##6##(1991-2#1)(2007-7#1)(2013-8#1)
were studied for the##12##4##(1990-12#1)(1990-8#1)(1991-2#1)(1992-9#1)(2006-6#1)(2007-7#1)(2008-10#2)(2008-12#1)(2010-3#1)(2013-8#2)
were studied for their ability to##2##6##(1992-2#1)(1995-12#1)
were studied for their effects on##2##6##(1992-5#1)(2012-2#1)
were studied for their##7##4##(1992-2#1)(1992-5#1)(1995-12#1)(2008-11#1)(2010-4#1)(2012-2#1)(2013-8#1)
were studied for##43##3##(1990-12#2)(1990-8#1)(1991-10#1)(1991-2#1)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#1)(1994-8#1)(1995-12#2)(1995-2#1)(1996-8#1)(1996-9#1)(2006-6#1)(2006-9#1)(2007-7#3)(2007-8#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-12#1)(2010-3#1)(2010-4#1)(2012-2#1)(2013-8#5)
were studied from April##2##4##(2006-10#1)(2007-7#1)
were studied from a##2##4##(2005-4#1)(2008-10#1)
were studied from##10##3##(1991-2#1)(1991-5#1)(2005-11#1)(2005-4#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#2)
were studied in 14##2##4##(1991-8#1)(2008-5#1)
were studied in 15##2##4##(1990-9#1)(2010-6#1)
were studied in ICR mice##2##5##(1997-8#1)(2008-11#1)
were studied in a model##2##5##(1993-11#1)(2008-10#1)
were studied in a##24##4##(1990-10#1)(1991-1#1)(1991-8#1)(1992-10#1)(1993-11#1)(1993-7#2)(1995-1#2)(1995-6#1)(2004-10#1)(2006-7#1)(2006-8#2)(2007-9#1)(2008-10#3)(2008-3#1)(2008-7#4)(2011-2#1)
were studied in an##4##4##(2004-4#1)(2008-10#1)(2008-11#1)(2011-2#1)
were studied in both##2##4##(1991-5#1)(2012-2#1)
were studied in cells##3##4##(1992-7#1)(2007-11#1)(2007-12#1)
were studied in detail by##3##5##(1990-12#1)(2008-10#1)(2010-4#1)
were studied in detail##9##4##(1990-12#1)(1993-2#1)(2007-8#1)(2008-10#5)(2010-4#1)
were studied in different##2##4##(1992-6#1)(2007-1#1)
were studied in ethanol##2##4##(1996-10#1)(2008-5#1)
were studied in freshly##2##4##(1990-10#1)(1997-1#1)
were studied in human##4##4##(1994-3#1)(1996-5#1)(2008-11#2)
were studied in laboratory##2##4##(2004-11#1)(2008-10#1)
were studied in male Fischer 344 rats##2##7##(1992-12#1)(2008-7#1)
were studied in male##3##4##(1992-12#1)(2008-5#1)(2008-7#1)
were studied in mouse liver##2##5##(1994-11#1)(2013-1#1)
were studied in nine##2##4##(1996-2#1)(2008-5#1)
were studied in order to##5##5##(1995-6#1)(2008-10#4)
were studied in patients with##2##5##(1995-4#1)(1996-3#1)
were studied in primary##2##4##(1991-9#1)(1994-2#1)
were studied in rat##7##4##(1991-9#1)(1992-11#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-5#1)(1997-2#1)
were studied in rats with##2##5##(2010-12#1)(2012-1#1)
were studied in rats##11##4##(1991-2#1)(1992-11#1)(1995-5#1)(2007-8#1)(2009-2#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-1#2)
were studied in relation to the##2##6##(1995-6#1)(2008-10#1)
were studied in relation to##3##5##(1995-6#1)(2008-10#1)(2008-5#1)
were studied in terms of##3##5##(1996-11#1)(2005-11#1)(2010-2#1)
were studied in the rat##3##5##(1994-2#1)(1995-12#1)(1996-2#1)
were studied in the##30##4##(1990-11#1)(1990-3#1)(1990-5#2)(1990-7#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-2#2)(1995-12#1)(1995-7#1)(1996-11#1)(1996-2#2)(1997-3#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)
were studied in this##3##4##(2005-4#1)(2007-7#1)(2010-1#1)
were studied in two##7##4##(1991-12#1)(1992-8#1)(1993-5#1)(2007-3#1)(2008-10#1)(2010-12#1)(2011-2#1)
were studied in vitro and##2##5##(2012-1#1)(2013-8#1)
were studied in vitro##7##4##(1991-2#1)(1993-9#1)(1994-2#1)(2008-5#2)(2012-1#1)(2013-8#1)
were studied in young##2##4##(1996-10#1)(2012-1#1)
were studied in##250##3##(1990-10#2)(1990-11#2)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#3)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#2)(1991-9#3)(1992-10#1)(1992-11#4)(1992-12#1)(1992-3#1)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-11#3)(1993-12#4)(1993-2#2)(1993-3#2)(1993-4#3)(1993-5#1)(1993-7#3)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#4)(1994-3#3)(1994-5#1)(1994-6#1)(1994-7#1)(1995-1#2)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#2)(1995-5#1)(1995-6#4)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#3)(1996-11#2)(1996-2#5)(1996-3#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#2)(1997-7#1)(1997-8#1)(2004-10#1)(2004-11#1)(2004-4#3)(2005-11#2)(2005-4#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-10#28)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#15)(2008-7#7)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#4)(2012-1#6)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
were studied morphologically and##2##4##(1993-7#1)(2008-5#1)
were studied morphologically##3##3##(1993-7#1)(2007-2#1)(2008-5#1)
were studied on the##4##4##(2007-12#1)(2008-10#1)(2008-11#1)(2012-1#1)
were studied on##20##3##(1990-11#1)(1990-12#1)(1991-2#1)(1991-3#1)(1994-8#1)(1995-6#1)(1996-12#1)(2005-11#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-10#1)(2012-1#3)
were studied over a period of##2##6##(1997-7#1)(2007-8#1)
were studied over a##4##4##(1994-7#1)(1997-2#1)(1997-7#1)(2007-8#1)
were studied potentiometrically (H(+)-glass electrode)##2##5##(2008-10#2)
were studied potentiometrically in aqueous solution##2##6##(2008-10#2)
were studied potentiometrically##4##3##(2008-10#4)
were studied prospectively##5##3##(2007-8#2)(2007-9#1)(2008-11#1)(2013-8#1)
were studied retrospectively##12##3##(1990-9#1)(1997-1#1)(1997-8#1)(2004-10#1)(2005-10#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-4#1)(2011-1#1)(2011-11#1)(2011-2#1)
were studied systematically##2##3##(2008-1#1)(2008-10#1)
were studied through##2##3##(2008-3#1)(2008-9#1)
were studied to assess##2##4##(1995-2#1)(2008-10#1)
were studied to determine the##2##5##(2008-10#1)(2011-2#1)
were studied to determine their##3##5##(2005-10#1)(2008-11#1)(2008-12#1)
were studied to determine##8##4##(1993-11#1)(2005-10#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)
were studied to evaluate their##2##5##(2008-10#1)(2012-2#1)
were studied to evaluate##4##4##(1991-8#1)(2008-10#1)(2008-5#1)(2012-2#1)
were studied to see whether##2##5##(1997-1#1)(2011-1#1)
were studied to##30##3##(1991-4#1)(1991-8#1)(1993-11#1)(1995-2#1)(1997-1#1)(2005-10#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-2#1)
were studied under different##2##4##(2008-10#2)
were studied under laboratory conditions##2##5##(2007-6#1)(2011-2#1)
were studied under the##2##4##(2008-10#1)(2009-5#1)
were studied under##15##3##(1991-2#2)(1992-8#1)(2006-1#1)(2007-6#1)(2008-10#5)(2008-12#1)(2008-7#1)(2009-5#1)(2010-11#1)(2011-2#1)
were studied using a##4##4##(1997-7#1)(2007-7#1)(2008-10#2)
were studied using an##2##4##(1997-6#1)(2006-7#1)
were studied using pulse radiolysis##2##5##(2006-10#1)(2008-9#1)
were studied using scanning electron microscopy##2##6##(1995-6#1)(2009-12#1)
were studied using scanning##3##4##(1995-6#1)(2009-12#1)(2010-8#1)
were studied using the whole-cell##2##5##(1993-3#1)(1996-10#1)
were studied using the##13##4##(1990-3#1)(1993-3#2)(1996-10#1)(1996-5#1)(1996-8#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2010-12#1)
were studied using various##2##4##(1990-4#1)(2012-11#1)
were studied using##77##3##(1990-3#2)(1990-4#2)(1990-5#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-4#1)(1992-8#2)(1993-3#3)(1994-9#2)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-8#3)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#4)(2006-10#2)(2006-7#1)(2007-5#1)(2007-7#1)(2008-10#15)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-8#1)(2010-12#2)(2010-8#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
were studied with an##2##4##(2005-11#1)(2007-8#1)
were studied with respect to##3##5##(1990-11#1)(1993-10#1)(2008-10#1)
were studied with the##3##4##(2007-12#1)(2008-7#1)(2012-3#1)
were studied with various##3##4##(1995-10#1)(1996-2#1)(2005-11#1)
were studied with##26##3##(1990-11#1)(1990-5#1)(1991-11#1)(1991-2#1)(1993-10#1)(1995-1#1)(1995-10#1)(1996-2#1)(1996-7#1)(2005-11#2)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-7#1)(2012-12#1)(2012-2#1)(2012-3#1)
were studied##1213##2##(1990-10#2)(1990-11#7)(1990-12#6)(1990-2#1)(1990-3#4)(1990-4#7)(1990-5#5)(1990-6#1)(1990-7#13)(1990-8#5)(1990-9#4)(1991-1#3)(1991-10#5)(1991-11#3)(1991-12#4)(1991-2#12)(1991-3#3)(1991-4#3)(1991-5#5)(1991-6#1)(1991-7#1)(1991-8#5)(1991-9#4)(1992-10#2)(1992-11#8)(1992-12#3)(1992-2#5)(1992-3#3)(1992-4#2)(1992-5#2)(1992-6#4)(1992-7#1)(1992-8#9)(1992-9#3)(1993-1#2)(1993-10#2)(1993-11#6)(1993-12#6)(1993-2#2)(1993-3#7)(1993-4#5)(1993-5#2)(1993-7#5)(1993-8#2)(1993-9#3)(1994-11#6)(1994-12#2)(1994-2#6)(1994-3#6)(1994-4#2)(1994-5#6)(1994-6#3)(1994-7#2)(1994-8#3)(1994-9#3)(1995-1#3)(1995-10#2)(1995-11#6)(1995-12#12)(1995-2#3)(1995-3#6)(1995-4#2)(1995-5#2)(1995-6#6)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#8)(1996-10#4)(1996-11#3)(1996-12#3)(1996-2#9)(1996-3#1)(1996-4#1)(1996-5#7)(1996-7#5)(1996-8#4)(1996-9#2)(1997-1#4)(1997-2#10)(1997-3#3)(1997-4#1)(1997-5#4)(1997-6#1)(1997-7#3)(1997-8#6)(2004-10#3)(2004-11#3)(2004-12#2)(2004-4#3)(2004-8#1)(2004-9#2)(2005-10#3)(2005-11#24)(2005-12#1)(2005-4#13)(2005-8#2)(2005-9#1)(2006-1#3)(2006-10#12)(2006-11#3)(2006-12#5)(2006-2#4)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#4)(2006-7#3)(2006-8#13)(2006-9#2)(2007-1#5)(2007-10#11)(2007-11#13)(2007-12#10)(2007-2#10)(2007-3#6)(2007-4#3)(2007-5#2)(2007-6#2)(2007-7#17)(2007-8#32)(2007-9#6)(2008-1#6)(2008-10#262)(2008-11#16)(2008-12#13)(2008-2#6)(2008-3#20)(2008-4#12)(2008-5#45)(2008-6#6)(2008-7#16)(2008-8#13)(2008-9#8)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#16)(2010-2#3)(2010-3#2)(2010-4#6)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#13)(2011-10#1)(2011-11#1)(2011-2#21)(2011-3#1)(2012-1#20)(2012-11#2)(2012-12#8)(2012-2#26)(2012-3#9)(2013-1#18)(2013-7#7)(2013-8#24)
were studies and##2##3##(1991-2#1)(2008-10#1)
were studies##7##2##(1991-2#1)(2005-4#1)(2006-9#1)(2008-10#2)(2008-12#1)(2008-4#1)
were stunted##3##2##(2008-4#2)(2013-7#1)
were subcloned and sequenced##2##4##(1991-11#1)(1993-11#1)
were subcloned into the##2##4##(1994-5#1)(2008-10#1)
were subcloned into##3##3##(1994-12#1)(1994-5#1)(2008-10#1)
were subcloned##7##2##(1991-11#1)(1992-3#1)(1993-11#1)(1994-12#1)(1994-5#1)(1995-8#1)(2008-10#1)
were subcultured in the##2##4##(2008-10#2)
were subcultured##7##2##(2006-10#2)(2008-10#4)(2012-12#1)
were subdivided according to the##2##5##(1990-8#1)(1992-6#1)
were subdivided according to##3##4##(1990-8#1)(1992-6#1)(2008-8#1)
were subdivided into three groups##2##5##(1990-4#1)(2006-10#1)
were subdivided into two groups##2##5##(1992-10#1)(1992-8#1)
were subdivided into##11##3##(1990-4#1)(1992-10#1)(1992-8#1)(1997-1#1)(1997-5#1)(2006-10#3)(2007-1#1)(2008-6#1)(2012-3#1)
were subdivided##15##2##(1990-4#1)(1990-8#1)(1992-10#1)(1992-6#2)(1992-8#1)(1997-1#1)(1997-5#1)(2006-10#3)(2007-1#1)(2008-6#1)(2008-8#1)(2012-3#1)
were subgrouped##2##2##(1992-8#1)(2012-12#1)
were subject to##7##3##(2004-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
were subjected for##3##3##(2007-7#1)(2011-1#1)(2013-8#1)
were subjected to 30 min of##3##6##(1996-5#1)(2007-8#1)(2013-1#1)
were subjected to SDS-PAGE##2##4##(2006-8#1)(2008-10#1)
were subjected to a##20##4##(1995-10#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-3#1)(2010-1#1)(2012-12#2)(2013-1#1)(2013-8#2)
were subjected to amino acid##2##5##(1992-12#1)(1997-4#1)
were subjected to an##2##4##(2007-6#1)(2008-11#1)
were subjected to analysis##3##4##(1992-7#1)(2007-11#1)(2012-2#1)
were subjected to clinical##2##4##(2005-1#1)(2011-2#1)
were subjected to complete##2##4##(1994-3#1)(2011-12#1)
were subjected to continuous##2##4##(2011-1#1)(2013-1#1)
were subjected to detailed clinical##2##5##(2007-7#1)(2007-8#1)
were subjected to different##2##4##(2008-10#1)(2008-11#1)
were subjected to four##2##4##(2007-8#1)(2008-12#1)
were subjected to full##2##4##(2009-8#1)(2011-1#1)
were subjected to longitudinal Gompertzian analysis##3##6##(1991-6#1)(1993-12#1)(1996-9#1)
were subjected to one##2##4##(2008-5#1)(2009-7#1)
were subjected to restriction##2##4##(2008-10#1)(2009-5#1)
were subjected to tensile##2##4##(2004-9#1)(2007-4#1)
were subjected to the##11##4##(1996-4#1)(1997-4#3)(2006-5#1)(2008-10#2)(2008-12#1)(2011-1#1)(2012-1#1)(2013-1#1)
were subjected to this##2##4##(1992-1#1)(2008-12#1)
were subjected to three##2##4##(2007-11#1)(2008-10#1)
were subjected to##219##3##(1990-10#1)(1990-11#2)(1990-3#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-6#1)(1992-7#2)(1993-10#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#1)(2004-9#2)(2005-1#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#3)(2007-2#1)(2007-3#2)(2007-4#4)(2007-6#1)(2007-7#11)(2007-8#11)(2007-9#1)(2008-1#1)(2008-10#22)(2008-11#5)(2008-12#7)(2008-3#1)(2008-4#1)(2008-5#9)(2008-7#2)(2008-9#3)(2009-3#2)(2009-5#1)(2009-7#2)(2009-8#1)(2010-1#2)(2010-12#1)(2010-2#3)(2010-3#2)(2010-4#1)(2011-1#8)(2011-12#2)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#2)(2012-7#1)(2013-1#10)(2013-7#3)(2013-8#4)
were subjected##227##2##(1990-10#1)(1990-11#2)(1990-3#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-6#1)(1992-7#2)(1993-10#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#1)(2004-9#3)(2005-1#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#3)(2007-2#1)(2007-3#2)(2007-4#4)(2007-6#1)(2007-7#12)(2007-8#11)(2007-9#1)(2008-1#1)(2008-10#23)(2008-11#5)(2008-12#8)(2008-3#1)(2008-4#1)(2008-5#10)(2008-7#2)(2008-9#3)(2009-3#2)(2009-5#1)(2009-7#2)(2009-8#1)(2010-1#2)(2010-12#1)(2010-2#3)(2010-3#2)(2010-4#1)(2011-1#9)(2011-12#2)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#2)(2012-7#1)(2013-1#10)(2013-7#3)(2013-8#5)
were subjectively##2##2##(1995-5#1)(2012-1#1)
were submitted for##3##3##(1993-3#1)(2008-5#1)(2011-2#1)
were submitted in##2##3##(1993-3#1)(2011-1#1)
were submitted to a##11##4##(1991-12#1)(1994-2#1)(2007-10#1)(2007-2#1)(2008-5#1)(2008-7#1)(2009-7#1)(2011-2#2)(2013-1#2)
were submitted to an##3##4##(2008-10#1)(2008-5#1)(2010-2#1)
were submitted to clinical examination and##2##6##(1991-2#1)(2008-3#1)
were submitted to diagnostic##2##4##(2011-1#1)(2011-2#1)
were submitted to the##7##4##(1990-7#1)(1993-3#1)(2007-7#1)(2008-11#1)(2008-6#1)(2010-1#1)(2010-6#1)
were submitted to three##2##4##(2007-1#1)(2008-10#1)
were submitted to two##2##4##(2007-10#1)(2009-4#1)
were submitted to##55##3##(1990-6#1)(1990-7#1)(1991-12#1)(1991-2#2)(1991-3#2)(1992-10#1)(1992-11#1)(1992-5#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-6#1)(1995-4#1)(1997-8#1)(2007-1#1)(2007-10#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-4#2)(2009-5#1)(2009-7#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#4)(2013-1#7)
were submitted##65##2##(1990-6#1)(1990-7#1)(1991-12#1)(1991-2#2)(1991-3#2)(1992-10#1)(1992-11#1)(1992-5#1)(1993-12#1)(1993-3#3)(1994-2#1)(1994-3#1)(1994-6#1)(1995-4#1)(1997-8#1)(2005-9#2)(2007-1#1)(2007-10#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-4#2)(2009-5#1)(2009-7#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-2#1)(2013-1#7)
were subsequently analyzed##3##3##(1996-12#1)(2008-10#1)(2011-1#1)
were subsequently compared##2##3##(2008-5#1)(2012-1#1)
were subsequently determined##2##3##(2008-10#2)
were subsequently found to##2##4##(2005-12#1)(2005-9#1)
were subsequently genotyped##2##3##(2010-12#1)(2012-1#1)
were subsequently identified##2##3##(1991-3#1)(2008-6#1)
were subsequently introduced##2##3##(1990-5#1)(2012-1#1)
were subsequently isolated and##2##4##(1993-11#1)(2004-12#1)
were subsequently tested for##4##4##(1991-2#1)(1994-2#1)(2008-10#1)(2010-4#1)
were subsequently tested##5##3##(1991-2#1)(1994-2#1)(2008-10#1)(2010-4#2)
were subsequently treated with##4##4##(1993-6#1)(1993-8#1)(1994-2#1)(1995-1#1)
were subsequently used##3##3##(1997-7#1)(2008-10#1)(2008-8#1)
were subsequently##71##2##(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1993-11#1)(1993-6#2)(1993-8#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-1#2)(1995-12#1)(1996-11#1)(1996-12#1)(1996-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2004-12#1)(2004-2#1)(2005-11#1)(2005-12#1)(2005-9#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#16)(2008-11#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-1#4)(2013-1#2)(2013-8#1)
were substantial##3##2##(1991-6#1)(2007-5#1)(2008-10#1)
were substantially higher##2##3##(1995-8#1)(1996-12#1)
were substantially larger##2##3##(2005-11#1)(2012-1#1)
were substantially less##2##3##(1993-2#1)(1994-5#1)
were substantially lower in##2##4##(1997-2#1)(2007-10#1)
were substantially lower than##2##4##(1993-12#1)(2008-10#1)
were substantially lower##5##3##(1993-12#1)(1997-2#2)(2007-10#1)(2008-10#1)
were substantially reduced##6##3##(1992-1#1)(1992-6#1)(2007-1#1)(2008-5#1)(2010-5#1)(2012-2#1)
were substantially##25##2##(1991-5#1)(1992-1#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-5#1)(1995-8#2)(1996-12#1)(1996-5#1)(1997-2#2)(2004-4#1)(2005-11#1)(2007-1#1)(2007-10#1)(2008-10#3)(2008-5#2)(2010-5#1)(2012-1#1)(2012-2#1)(2012-3#1)
were substituted by##4##3##(1991-2#1)(1995-6#1)(1997-4#1)(2005-4#1)
were substituted for##2##3##(1990-7#1)(2006-12#1)
were substituted with##3##3##(1992-11#1)(1995-5#1)(1996-5#1)
were substituted##12##2##(1990-7#1)(1991-2#1)(1992-11#1)(1994-11#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-4#1)(2005-4#1)(2006-12#1)(2008-7#1)
were substrates for##2##3##(1994-11#1)(1994-8#1)
were substrates##5##2##(1991-8#1)(1992-6#1)(1994-11#1)(1994-8#1)(2012-3#1)
were subtle##2##2##(1992-11#1)(1994-10#1)
were subtyped##2##2##(1990-12#1)(2007-10#1)
were successful and##2##3##(1992-2#1)(2006-10#1)
were successful in##10##3##(1990-12#1)(1997-8#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-6#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#1)
were successful##27##2##(1990-12#1)(1990-8#1)(1992-12#2)(1992-2#1)(1993-9#1)(1995-1#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#1)
were successfully analyzed using the proposed method##3##7##(2007-8#1)(2008-10#2)
were successfully analyzed##5##3##(2007-8#1)(2008-10#4)
were successfully applied for the determination of##2##7##(2008-10#2)
were successfully applied for the##7##5##(2008-10#6)(2013-8#1)
were successfully applied to the determination of##3##7##(2008-10#3)
were successfully applied to the##4##5##(2008-10#4)
were successfully applied to##7##4##(2008-10#5)(2008-5#1)(2011-2#1)
were successfully applied##14##3##(2008-10#11)(2008-5#1)(2011-2#1)(2013-8#1)
were successfully assigned##2##3##(1996-8#1)(2010-3#1)
were successfully detected##3##3##(2008-10#2)(2009-3#1)
were successfully determined by##2##4##(2008-10#2)
were successfully determined with##2##4##(1990-8#1)(2008-10#1)
were successfully determined##6##3##(1990-8#1)(2008-10#5)
were successfully established##2##3##(2008-11#1)(2012-12#1)
were successfully generated##3##3##(2007-12#1)(2007-6#1)(2008-11#1)
were successfully implanted##2##3##(1992-5#1)(2008-11#1)
were successfully incorporated into##2##4##(2006-12#1)(2008-10#1)
were successfully isolated##3##3##(1997-3#1)(2008-8#1)(2011-1#1)
were successfully managed with##2##4##(2006-10#1)(2012-2#1)
were successfully managed##3##3##(2006-10#1)(2012-2#1)(2013-1#1)
were successfully obtained experimentally##2##4##(2007-12#1)(2008-3#1)
were successfully obtained##7##3##(2007-12#2)(2008-2#1)(2008-3#2)(2008-8#1)(2010-4#1)
were successfully performed##3##3##(2007-8#2)(2008-7#1)
were successfully prepared##3##3##(1996-2#1)(2005-11#1)(2010-12#1)
were successfully produced##2##3##(2008-5#1)(2012-6#1)
were successfully removed##2##3##(1993-7#1)(2008-5#1)
were successfully separated by##2##4##(2005-12#1)(2008-10#1)
were successfully separated##8##3##(1997-2#1)(1997-8#1)(2005-12#1)(2007-1#1)(2007-8#1)(2008-10#3)
were successfully synthesized##3##3##(2006-12#1)(2008-5#1)(2013-8#1)
were successfully treated by embolization##2##5##(1992-9#1)(2007-8#1)
were successfully treated by##7##4##(1991-8#1)(1992-9#1)(1997-1#1)(2007-8#2)(2008-7#1)(2012-1#1)
were successfully treated with##5##4##(1995-3#1)(2006-10#1)(2006-4#1)(2007-8#1)(2012-12#1)
were successfully treated##16##3##(1991-8#1)(1992-9#1)(1995-3#1)(1997-1#1)(2006-10#1)(2006-4#1)(2007-3#1)(2007-8#3)(2008-1#1)(2008-4#1)(2008-7#1)(2009-3#1)(2012-1#1)(2012-12#1)
were successfully used for##2##4##(2008-10#2)
were successfully used in##3##4##(2008-10#2)(2008-5#1)
were successfully used to separate##2##5##(2008-10#2)
were successfully used to##6##4##(1997-6#1)(2007-12#1)(2007-8#1)(2008-10#2)(2013-8#1)
were successfully used##11##3##(1997-6#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-5#1)(2013-8#1)
were successfully##153##2##(1990-8#1)(1991-8#1)(1992-5#1)(1992-9#1)(1993-7#1)(1994-3#1)(1994-5#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#2)(1997-8#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-12#2)(2006-4#1)(2006-6#1)(2006-9#1)(2007-1#2)(2007-11#1)(2007-12#6)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#10)(2008-1#1)(2008-10#42)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#7)(2008-7#4)(2008-8#6)(2009-10#1)(2009-3#2)(2010-12#2)(2010-3#1)(2010-4#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)(2012-6#1)(2013-1#4)(2013-8#3)
were successively##3##2##(1990-11#1)(1992-8#1)(2008-10#1)
were sudden##2##2##(1997-1#1)(2008-3#1)
were suffering from##8##3##(1991-11#1)(1992-9#1)(2007-7#1)(2007-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
were sufficient for the##2##4##(2008-10#1)(2011-2#1)
were sufficient for##5##3##(2007-8#1)(2008-10#2)(2009-5#1)(2011-2#1)
were sufficient to allow##2##4##(2008-10#1)(2008-3#1)
were sufficient to confer##2##4##(1995-3#1)(1996-5#1)
were sufficient to##15##3##(1991-10#1)(1991-9#1)(1992-5#1)(1992-7#1)(1993-8#1)(1994-3#1)(1995-3#1)(1996-5#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-5#2)(2010-4#1)(2012-1#1)
were sufficient##20##2##(1991-10#1)(1991-9#1)(1992-5#1)(1992-7#1)(1993-8#1)(1994-3#1)(1995-3#1)(1996-5#1)(2006-12#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#2)(2009-5#1)(2010-4#1)(2011-2#1)(2012-1#1)
were sufficiently##8##2##(1990-10#2)(1990-5#1)(2006-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2009-2#1)
were suggested by##3##3##(1997-5#1)(2010-9#1)(2013-1#1)
were suggested to##5##3##(1994-6#1)(1997-8#1)(2007-10#1)(2010-8#1)(2011-1#1)
were suggested##17##2##(1993-8#1)(1994-2#1)(1994-6#1)(1994-8#1)(1997-5#1)(1997-8#1)(2005-11#1)(2007-10#3)(2008-10#2)(2010-8#1)(2010-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
were suggestive of a##6##4##(2007-2#1)(2008-1#1)(2009-1#1)(2010-9#1)(2013-8#2)
were suggestive of##18##3##(1992-11#1)(1997-1#1)(2005-12#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-7#1)(2009-1#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-8#4)
were suitable for the##6##4##(1990-11#1)(1996-6#1)(2005-11#1)(2008-10#3)
were suitable for##11##3##(1990-11#1)(1996-6#1)(1997-1#1)(2005-11#1)(2008-10#5)(2008-11#1)(2011-1#1)
were suitable##14##2##(1990-11#1)(1990-8#1)(1996-6#1)(1997-1#1)(2005-11#1)(2008-10#6)(2008-11#1)(2008-9#1)(2011-1#1)
were summarized as##3##3##(1990-8#1)(2007-8#1)(2008-11#1)
were summarized##7##2##(1990-8#1)(2007-8#1)(2008-11#1)(2008-5#1)(2010-12#1)(2010-5#1)(2012-12#1)
were summed up##2##3##(1997-6#1)(2013-7#1)
were summed##3##2##(1997-6#1)(2011-1#1)(2013-7#1)
were superimposed onto##2##3##(2006-10#1)(2006-8#1)
were superimposed##3##2##(2006-10#1)(2006-8#1)(2013-1#1)
were superinfected with##2##3##(2004-11#2)
were superinfected##3##2##(2004-11#2)(2007-2#1)
were superior in##2##3##(1990-8#1)(2008-10#1)
were superior to those obtained##2##5##(2007-11#1)(2008-5#1)
were superior to those##3##4##(2007-11#1)(2008-5#1)(2009-4#1)
were superior to##9##3##(1992-8#1)(1996-8#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-4#1)(2013-1#1)
were superior with##2##3##(2005-11#1)(2007-2#1)
were superior##15##2##(1990-8#1)(1991-12#1)(1992-8#1)(1996-8#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-4#1)(2013-1#1)
were supershifted by##2##3##(1996-5#1)(1997-2#1)
were supplemented by##2##3##(2006-7#1)(2008-10#1)
were supplemented with 1##2##4##(2004-11#1)(2007-8#1)
were supplemented with##8##3##(1993-8#2)(2004-11#1)(2007-5#1)(2007-8#1)(2011-2#1)(2012-3#2)
were supplemented##11##2##(1993-8#2)(1997-2#1)(2004-11#1)(2006-7#1)(2007-5#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-3#2)
were supplied by##3##3##(2006-11#3)
were supplied with##3##3##(1990-12#1)(2008-11#1)(2012-12#1)
were supplied##9##2##(1990-12#1)(2006-11#3)(2007-9#1)(2008-10#1)(2008-11#1)(2012-12#1)(2012-2#1)
were supported by in situ##2##5##(2008-3#1)(2008-5#1)
were supported by the##3##4##(1996-10#1)(2010-6#1)(2012-12#1)
were supported by##13##3##(1992-5#1)(1995-12#1)(1996-10#1)(2008-10#1)(2008-3#2)(2008-5#2)(2008-8#1)(2009-12#1)(2010-6#1)(2012-12#1)(2013-1#1)
were supported##20##2##(1992-5#1)(1993-12#1)(1995-12#1)(1995-8#1)(1996-10#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#1)(2009-12#1)(2010-6#4)(2012-12#1)(2013-1#1)
were supportive##3##2##(2007-12#1)(2010-11#1)(2012-12#1)
were suppressed by##11##3##(1990-11#1)(1990-7#1)(1990-9#1)(1991-4#1)(1992-11#1)(1992-4#1)(1995-11#1)(1995-12#1)(2008-11#1)(2013-1#1)(2013-8#1)
were suppressed in##4##3##(1993-9#1)(1996-6#1)(2006-8#1)(2008-11#1)
were suppressed##24##2##(1990-11#1)(1990-7#1)(1990-9#1)(1991-4#1)(1992-11#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-6#1)(1996-9#1)(2006-8#1)(2007-12#1)(2008-11#2)(2008-4#1)(2008-5#2)(2011-2#1)(2013-1#1)(2013-8#1)
were surgically removed##2##3##(2011-1#1)(2011-2#1)
were surgically treated for##2##4##(2005-9#1)(2007-11#1)
were surgically treated using the##2##5##(2006-12#1)(2011-2#1)
were surgically treated##9##3##(1992-9#1)(2005-9#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-8#2)(2011-2#1)(2013-1#1)
were surgically##11##2##(1992-9#1)(2005-9#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-8#2)(2011-1#1)(2011-2#2)(2013-1#1)
were surprisingly##5##2##(2005-8#1)(2007-10#1)(2008-8#1)(2012-2#1)(2013-1#1)
were surrounded by##2##3##(1994-6#1)(2008-10#1)
were surrounded##3##2##(1991-3#1)(1994-6#1)(2008-10#1)
were surveyed about##3##3##(2008-12#1)(2008-4#1)(2009-9#1)
were surveyed at##2##3##(2007-2#1)(2008-1#1)
were surveyed by##4##3##(1990-12#1)(2008-5#1)(2010-2#1)(2013-1#1)
were surveyed for##4##3##(2007-5#1)(2008-10#1)(2012-2#1)(2012-3#1)
were surveyed in the##2##4##(2008-10#1)(2008-11#1)
were surveyed in##8##3##(1996-2#1)(2006-7#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-11#1)(2012-12#2)
were surveyed regarding their##2##4##(1995-1#1)(2007-10#1)
were surveyed regarding##6##3##(1991-5#2)(1993-1#1)(1995-1#1)(2007-10#1)(2008-9#1)
were surveyed to determine how##2##5##(1996-1#1)(2007-12#1)
were surveyed to determine##3##4##(1996-1#1)(2007-12#1)(2008-10#1)
were surveyed to##8##3##(1990-12#1)(1995-1#1)(1996-1#1)(2004-4#1)(2005-7#1)(2007-12#1)(2008-10#1)(2011-2#1)
were surveyed with##2##3##(1995-12#1)(2010-2#1)
were surveyed##64##2##(1990-12#2)(1991-5#2)(1993-1#1)(1993-2#1)(1994-2#1)(1995-1#2)(1995-12#1)(1996-1#2)(1996-2#2)(1996-6#1)(1997-3#1)(2004-4#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-5#2)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-2#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
were susceptible and##2##3##(2006-8#1)(2008-10#1)
were susceptible in##2##3##(2008-5#1)(2011-2#1)
were susceptible to both##3##4##(1991-8#1)(1993-6#1)(2008-11#1)
were susceptible to infection##3##4##(2008-10#2)(2013-1#1)
were susceptible to penicillin##4##4##(2006-8#1)(2010-4#1)(2011-2#2)
were susceptible to race##2##4##(2008-10#2)
were susceptible to the##2##4##(2008-10#1)(2008-5#1)
were susceptible to##43##3##(1991-8#2)(1993-1#1)(1993-5#1)(1993-6#1)(1994-2#1)(1995-2#1)(2006-10#1)(2006-4#1)(2006-8#2)(2007-2#1)(2007-4#1)(2008-10#13)(2008-11#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-2#1)(2009-6#1)(2010-4#1)(2011-1#2)(2011-10#1)(2011-2#2)(2012-2#2)(2013-1#1)
were susceptible##51##2##(1991-8#2)(1993-1#1)(1993-5#1)(1993-6#1)(1994-2#1)(1995-2#1)(2006-10#1)(2006-4#1)(2006-8#3)(2007-2#1)(2007-4#1)(2008-10#15)(2008-11#2)(2008-5#3)(2008-6#1)(2008-8#1)(2009-2#2)(2009-6#1)(2010-4#1)(2011-1#2)(2011-10#2)(2011-2#4)(2012-2#2)(2013-1#1)
were suspected in##2##3##(1990-3#1)(2007-2#1)
were suspected of having##2##4##(1992-3#1)(1992-8#1)
were suspected of##4##3##(1992-3#1)(1992-8#1)(1997-2#2)
were suspected to have Down's syndrome after##2##7##(1990-2#2)
were suspected to have##3##4##(1990-2#2)(2006-10#1)
were suspected##13##2##(1990-2#2)(1990-3#1)(1992-3#1)(1992-8#1)(1997-2#2)(2006-10#1)(2007-2#2)(2007-5#1)(2007-8#1)(2008-1#1)
were suspended in##10##3##(1994-6#1)(1994-9#1)(1996-1#1)(2008-1#1)(2008-10#3)(2008-5#1)(2009-5#1)(2012-2#1)
were suspended##11##2##(1994-6#1)(1994-9#1)(1996-1#1)(2008-1#1)(2008-10#4)(2008-5#1)(2009-5#1)(2012-2#1)
were sustained until the##2##4##(2008-3#1)(2008-9#1)
were sustained##8##2##(1991-12#1)(1993-11#1)(1995-2#1)(2007-11#2)(2008-3#1)(2008-8#1)(2008-9#1)
were swimming##2##2##(2008-10#1)(2008-6#1)
were switched from##2##3##(1993-12#1)(2009-9#1)
were switched to##3##3##(1994-12#1)(1995-9#1)(2009-9#1)
were switched##5##2##(1993-12#1)(1994-12#1)(1995-9#1)(2009-9#2)
were swollen##2##2##(2008-5#1)(2012-2#1)
were symptom free##2##3##(2006-10#2)
were symptom-free##4##2##(1994-5#1)(2007-7#1)(2010-7#1)(2012-3#1)
were symptomatic and##2##3##(1996-8#1)(2010-8#1)
were symptomatic##11##2##(1991-3#2)(1991-4#1)(1996-8#1)(2007-8#1)(2008-1#1)(2008-4#1)(2010-8#1)(2012-2#2)(2012-3#1)
were symptoms##3##2##(1991-9#1)(2006-10#1)(2007-7#1)
were synchronized##4##2##(2006-5#2)(2010-4#1)(2013-1#1)
were synthesised and##2##3##(2007-11#1)(2011-2#1)
were synthesised from##3##3##(2006-12#1)(2008-10#1)(2012-12#1)
were synthesised##11##2##(1995-1#1)(2005-7#1)(2006-12#1)(2007-11#2)(2008-10#1)(2008-5#2)(2011-2#1)(2012-12#1)(2013-7#1)
were synthesized according to the##2##5##(1991-5#1)(1995-3#1)
were synthesized and characterized by##10##5##(2005-11#1)(2007-11#1)(2008-5#6)(2010-5#1)(2011-1#1)
were synthesized and characterized##12##4##(1994-8#1)(2005-11#1)(2007-11#1)(2008-5#7)(2010-5#1)(2011-1#1)
were synthesized and coated##2##4##(2008-10#1)(2013-1#1)
were synthesized and evaluated as##5##5##(1992-3#1)(1993-1#1)(1993-4#1)(1994-9#1)(2010-6#1)
were synthesized and evaluated for##4##5##(1992-12#1)(1997-1#1)(2007-11#1)(2007-2#1)
were synthesized and evaluated in vitro##2##6##(2006-12#1)(2007-11#1)
were synthesized and evaluated in##3##5##(2006-12#2)(2007-11#1)
were synthesized and evaluated##14##4##(1992-12#1)(1992-3#1)(1993-1#1)(1993-4#1)(1994-9#1)(1997-1#1)(2006-12#2)(2007-11#3)(2007-2#1)(2009-3#1)(2010-6#1)
were synthesized and examined for##3##5##(1994-8#1)(1996-8#1)(2009-7#1)
were synthesized and examined##4##4##(1994-8#1)(1996-8#1)(2008-10#1)(2009-7#1)
were synthesized and investigated##2##4##(1993-4#1)(2008-10#1)
were synthesized and screened against##2##5##(1992-6#1)(2012-11#1)
were synthesized and secreted##2##4##(1993-12#1)(2009-3#1)
were synthesized and studied##3##4##(1992-8#1)(1997-6#1)(2013-7#1)
were synthesized and tested as##2##5##(1990-7#1)(2008-11#1)
were synthesized and tested for##4##5##(1992-5#1)(1993-3#1)(1995-1#1)(2010-2#1)
were synthesized and tested##6##4##(1990-7#1)(1992-5#1)(1993-3#1)(1995-1#1)(2008-11#1)(2010-2#1)
were synthesized and the##2##4##(2008-10#1)(2012-2#1)
were synthesized and their##9##4##(1990-2#1)(1990-6#1)(1991-7#1)(1993-11#1)(1993-6#1)(1994-9#1)(2007-11#1)(2008-10#1)(2008-11#1)
were synthesized and used as##3##5##(2007-8#1)(2008-10#2)
were synthesized and used##4##4##(1996-7#1)(2007-8#1)(2008-10#2)
were synthesized and utilized##2##4##(1991-12#1)(1993-9#1)
were synthesized and##81##3##(1990-2#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#2)(1993-6#1)(1993-9#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-8#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-6#1)(2005-11#3)(2006-12#3)(2007-11#6)(2007-2#1)(2007-8#2)(2008-10#10)(2008-11#3)(2008-5#7)(2008-8#2)(2009-3#2)(2009-7#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
were synthesized as##5##3##(1994-9#1)(1995-8#1)(2007-11#1)(2008-5#1)(2011-1#1)
were synthesized by a##4##4##(2005-11#1)(2010-3#1)(2010-4#1)(2013-8#1)
were synthesized by condensation##2##4##(1996-4#1)(2007-10#1)
were synthesized by reaction of##2##5##(2004-9#1)(2008-6#1)
were synthesized by reaction##3##4##(2004-9#1)(2008-6#1)(2012-11#1)
were synthesized by ring-opening##2##4##(2009-11#1)(2010-12#1)
were synthesized by sol-gel method##3##5##(2008-10#3)
were synthesized by solid-phase##3##4##(1990-12#1)(2005-8#1)(2008-9#1)
were synthesized by the reaction of##2##6##(2005-4#1)(2012-11#1)
were synthesized by the##5##4##(1991-5#1)(1992-6#1)(2005-4#1)(2009-12#1)(2012-11#1)
were synthesized by using##2##4##(1991-3#1)(2008-10#1)
were synthesized by##46##3##(1990-12#1)(1990-2#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-6#1)(1993-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-4#1)(1997-1#1)(2004-9#1)(2005-11#3)(2005-4#1)(2005-8#1)(2007-10#1)(2007-11#3)(2007-8#1)(2008-10#6)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-11#2)(2013-8#1)
were synthesized chemically##2##3##(1994-8#1)(2008-8#1)
were synthesized for##3##3##(2005-11#1)(2008-10#2)
were synthesized from the##3##4##(1997-2#2)(2012-11#1)
were synthesized from##20##3##(1990-12#1)(1990-8#1)(1991-12#1)(1991-6#1)(1993-8#1)(1997-2#2)(1997-8#1)(2005-11#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-11#1)(2009-12#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-11#1)
were synthesized in a##4##4##(1996-2#1)(1997-2#1)(1997-3#1)(2005-4#1)
were synthesized in water##2##4##(2008-10#1)(2013-8#1)
were synthesized in##19##3##(1992-12#1)(1994-3#1)(1994-6#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-3#1)(2005-11#1)(2005-4#1)(2006-9#1)(2007-11#2)(2008-10#2)(2008-6#1)(2010-6#1)(2011-1#1)(2013-7#1)(2013-8#1)
were synthesized on##5##3##(1992-6#1)(1997-3#1)(2006-12#1)(2008-10#1)(2012-11#1)
were synthesized to##2##3##(1996-4#1)(2005-11#1)
were synthesized using a##3##4##(2008-10#2)(2008-8#1)
were synthesized using##8##3##(1995-1#1)(1995-3#1)(2008-10#3)(2008-5#1)(2008-8#1)(2012-3#1)
were synthesized via a##3##4##(1996-5#1)(1997-8#1)(2009-2#1)
were synthesized via##9##3##(1996-5#1)(1997-1#1)(1997-8#1)(2006-12#1)(2007-11#2)(2008-11#1)(2009-2#1)(2013-8#1)
were synthesized with##6##3##(2005-4#1)(2008-10#1)(2008-2#1)(2008-5#2)(2009-4#1)
were synthesized##269##2##(1990-12#2)(1990-2#4)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#2)(1991-12#2)(1991-2#1)(1991-3#3)(1991-5#3)(1991-6#1)(1991-7#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#2)(1993-6#3)(1993-8#2)(1993-9#1)(1994-12#3)(1994-3#3)(1994-6#1)(1994-8#4)(1994-9#8)(1995-1#3)(1995-11#2)(1995-2#1)(1995-3#4)(1995-5#1)(1995-8#3)(1996-2#3)(1996-4#2)(1996-5#1)(1996-7#1)(1996-8#2)(1997-1#4)(1997-2#4)(1997-3#2)(1997-6#2)(1997-8#2)(2004-9#1)(2005-11#15)(2005-4#3)(2005-8#1)(2006-12#7)(2006-9#1)(2007-10#2)(2007-11#18)(2007-12#1)(2007-2#1)(2007-8#3)(2008-10#31)(2008-11#7)(2008-2#1)(2008-4#1)(2008-5#18)(2008-6#3)(2008-8#6)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#2)(2011-1#5)(2011-2#2)(2012-11#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#3)
were systematically investigated##5##3##(2008-10#5)
were systematically replaced with##2##4##(1994-11#1)(1995-10#1)
were systematically replaced##3##3##(1990-3#1)(1994-11#1)(1995-10#1)
were systematically reviewed using##2##4##(2012-12#2)
were systematically reviewed##3##3##(2010-5#1)(2012-12#2)
were systematically studied by##2##4##(2006-12#1)(2013-8#1)
were systematically studied##5##3##(2006-12#1)(2008-10#3)(2013-8#1)
were systematically##36##2##(1990-3#1)(1991-5#1)(1992-8#1)(1994-11#1)(1994-2#1)(1995-10#1)(1995-2#1)(1996-2#1)(2005-11#1)(2006-12#2)(2008-10#10)(2008-5#3)(2010-5#1)(2011-2#2)(2012-12#3)(2013-1#1)(2013-7#1)(2013-8#4)
were tabulated##31##2##(1994-6#1)(2007-8#28)(2010-8#1)(2013-8#1)
were tagged##4##2##(2006-12#1)(2008-10#1)(2008-8#1)(2010-8#1)
were tailored##3##2##(2011-2#2)(2012-1#1)
were taken and##6##3##(1997-6#1)(2007-7#1)(2008-10#2)(2008-3#1)(2013-1#1)
were taken as control##2##4##(2006-4#1)(2008-5#1)
were taken as controls##2##4##(2007-7#1)(2012-12#1)
were taken as inputs for##2##5##(2008-10#2)
were taken as the##3##4##(2006-4#1)(2008-11#1)(2008-5#1)
were taken as##13##3##(2005-11#1)(2006-4#2)(2006-7#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#2)(2010-5#1)(2012-12#1)
were taken at 1##2##4##(2013-1#2)
were taken at baseline##2##4##(2006-6#1)(2008-5#1)
were taken at the##2##4##(1994-3#1)(2008-10#1)
were taken at##19##3##(1994-2#1)(1994-3#1)(2005-11#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-5#3)(2008-7#1)(2011-2#1)(2013-1#2)(2013-8#1)
were taken before and after##5##5##(1990-12#1)(2007-7#1)(2007-8#1)(2012-1#1)(2013-8#1)
were taken before and##8##4##(1990-12#1)(1995-1#1)(2007-7#1)(2007-8#2)(2008-10#1)(2012-1#1)(2013-8#1)
were taken before the##2##4##(1992-1#1)(2008-5#1)
were taken before##14##3##(1990-12#1)(1990-3#1)(1992-1#1)(1995-1#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-5#1)(2009-7#1)(2010-8#1)(2012-1#1)(2013-1#1)(2013-8#1)
were taken by##5##3##(1996-7#1)(2007-4#1)(2008-10#1)(2008-5#1)(2010-7#1)
were taken during##4##3##(1993-12#1)(1993-4#1)(2004-11#1)(2012-12#1)
were taken every 2##2##4##(1991-3#1)(2010-12#1)
were taken every##3##3##(1991-3#1)(2007-3#1)(2010-12#1)
were taken for##9##3##(2006-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-1#1)(2010-12#1)(2012-1#1)(2012-3#1)
were taken from a##2##4##(2004-4#1)(2008-10#1)
were taken from each patient##2##5##(2006-12#1)(2012-12#1)
were taken from each##3##4##(2006-12#1)(2008-5#1)(2012-12#1)
were taken from the literature##2##5##(2007-4#1)(2008-10#1)
were taken from the##22##4##(1995-12#1)(1996-12#2)(1996-6#1)(1997-2#1)(1997-5#1)(2006-5#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
were taken from##66##3##(1994-1#1)(1995-12#1)(1995-6#1)(1995-7#1)(1996-11#3)(1996-12#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(2004-11#1)(2004-4#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-7#2)(2007-12#2)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#7)(2008-7#1)(2008-9#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#1)
were taken in the##4##4##(2008-5#2)(2013-7#2)
were taken in##12##3##(1991-4#1)(2008-10#1)(2008-3#1)(2008-5#3)(2010-4#1)(2012-12#1)(2013-1#1)(2013-7#3)
were taken into account in##3##5##(2008-2#2)(2009-5#1)
were taken into account##12##4##(1990-2#1)(1990-9#1)(1991-9#1)(1992-7#1)(2008-10#1)(2008-2#2)(2008-8#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-6#1)
were taken into consideration##3##4##(2006-10#1)(2008-10#1)(2013-1#1)
were taken into##15##3##(1990-2#1)(1990-9#1)(1991-9#1)(1992-7#1)(2006-10#1)(2008-10#2)(2008-2#2)(2008-8#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-6#1)(2013-1#1)
were taken of##4##3##(1995-6#1)(1996-7#1)(2011-2#1)(2012-3#1)
were taken on##7##3##(1993-1#1)(1996-3#1)(2007-10#1)(2008-3#1)(2008-9#1)(2010-12#1)(2010-6#1)
were taken out##2##3##(2005-11#1)(2007-8#1)
were taken to determine##2##4##(2007-3#1)(2013-1#1)
were taken to##12##3##(1990-6#1)(1991-2#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-4#1)(2012-12#2)(2013-1#1)
were taken under##2##3##(2008-8#1)(2012-2#1)
were taken up for##2##4##(2007-7#1)(2007-9#1)
were taken up##3##3##(1994-6#1)(2007-7#1)(2007-9#1)
were taken using a##3##4##(1991-4#1)(1993-11#1)(2013-8#1)
were taken with##3##3##(2007-1#1)(2010-5#1)(2011-2#1)
were taken##251##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-6#2)(1995-1#1)(1995-12#1)(1995-6#2)(1995-7#1)(1996-11#3)(1996-12#2)(1996-3#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(2004-11#2)(2004-4#1)(2005-11#3)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-4#3)(2006-5#1)(2006-6#2)(2006-7#4)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#2)(2007-4#4)(2007-5#5)(2007-6#1)(2007-7#6)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#24)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#5)(2008-5#24)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2010-1#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#8)(2012-1#2)(2012-12#11)(2012-2#4)(2012-3#2)(2013-1#11)(2013-7#4)(2013-8#6)
were taking medications##2##3##(2005-6#1)(2006-7#1)
were taking place##2##3##(1994-1#1)(1997-4#1)
were taking warfarin##2##3##(2006-8#2)
were taking##25##2##(1993-9#2)(1994-1#1)(1997-4#1)(2005-6#1)(2006-10#1)(2006-12#1)(2006-7#2)(2006-8#4)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-2#1)(2012-4#1)(2013-1#1)
were tape recorded##2##3##(2007-10#1)(2008-12#1)
were taped##3##2##(1996-3#1)(2008-4#1)(2012-12#1)
were tapered##2##2##(2006-10#1)(2008-7#1)
were targeted for##5##3##(1991-5#1)(1995-7#1)(1996-2#1)(2004-11#1)(2011-1#1)
were targeted##9##2##(1991-5#1)(1995-7#1)(1996-2#1)(2004-11#1)(2007-10#1)(2008-10#1)(2010-10#1)(2010-7#1)(2011-1#1)
were targets of##2##3##(2010-4#1)(2013-1#1)
were taught##5##2##(1993-12#2)(1993-5#1)(2008-10#1)(2010-2#1)
were temporary##2##2##(1990-8#1)(2007-11#1)
were ten times##2##3##(1990-6#1)(2012-3#1)
were ten##3##2##(1990-6#1)(2012-12#1)(2012-3#1)
were tentatively identified##3##3##(1990-3#1)(1992-2#1)(1996-2#1)
were tentatively##7##2##(1990-3#1)(1992-2#1)(1993-3#1)(1996-2#1)(2007-12#2)(2008-10#1)
were terminated##4##2##(1991-4#1)(2008-10#1)(2008-3#1)(2008-6#1)
were tested against a##3##4##(2008-10#1)(2008-8#1)(2012-12#1)
were tested against five##2##4##(2006-8#1)(2007-11#1)
were tested against the##2##4##(2008-5#1)(2011-2#1)
were tested against##27##3##(1993-10#1)(1995-12#1)(1996-12#1)(2006-4#1)(2006-8#2)(2007-11#2)(2007-6#1)(2008-10#5)(2008-11#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
were tested and compared##2##4##(2008-10#1)(2008-2#1)
were tested and the##6##4##(1991-3#1)(1996-12#1)(2007-12#1)(2007-8#2)(2008-11#1)
were tested and##21##3##(1991-3#1)(1996-12#1)(1997-2#1)(2006-10#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-7#1)(2010-4#1)
were tested as a##2##4##(1993-12#1)(1995-5#1)
were tested as solid##2##4##(2008-10#2)
were tested as##19##3##(1990-11#3)(1990-8#1)(1993-12#1)(1994-11#1)(1995-3#1)(1995-5#1)(1996-7#1)(2007-10#1)(2008-10#5)(2008-11#2)(2008-5#1)(2013-1#1)
were tested at 6##2##4##(1992-7#1)(2007-4#1)
were tested at the##4##4##(1992-2#1)(1993-12#1)(2008-11#1)(2008-4#1)
were tested at##22##3##(1992-2#1)(1992-7#1)(1993-12#1)(2004-11#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-4#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2010-3#1)(2010-8#1)(2011-2#2)(2013-1#1)
were tested between##2##3##(2012-12#1)(2013-1#1)
were tested by ELISA and##2##5##(1991-9#1)(2007-7#1)
were tested by ELISA##3##4##(1991-9#1)(2006-10#1)(2007-7#1)
were tested by a##3##4##(1995-2#1)(2004-9#1)(2011-2#1)
were tested by the##3##4##(1994-12#1)(2008-5#1)(2013-1#1)
were tested by##33##3##(1991-9#1)(1992-7#1)(1994-12#2)(1995-2#1)(1995-8#1)(1996-5#1)(1997-4#1)(1997-6#1)(2004-12#1)(2004-9#1)(2006-10#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#3)
were tested during##5##3##(1992-10#1)(1993-5#1)(2007-6#1)(2008-5#1)(2010-8#1)
were tested for HCV RNA by##3##6##(2007-7#1)(2010-12#1)(2010-4#1)
were tested for HCV RNA##4##5##(2007-7#1)(2010-12#1)(2010-4#2)
were tested for HIV##3##4##(2007-12#1)(2007-7#1)(2010-8#1)
were tested for PCV2##2##4##(2013-1#2)
were tested for antibodies to##2##5##(2007-2#1)(2008-5#1)
were tested for differences in##3##5##(1997-5#1)(2008-10#2)
were tested for effects on##2##5##(1991-6#1)(2008-10#1)
were tested for in vitro##3##5##(1994-8#1)(2010-3#2)
were tested for its##2##4##(2006-12#1)(2008-10#1)
were tested for pathogenicity on##3##5##(2008-10#3)
were tested for resistance to##2##5##(2008-10#2)
were tested for specific##3##4##(1992-4#1)(1994-11#1)(2007-2#1)
were tested for susceptibility to##3##5##(2008-10#2)(2012-2#1)
were tested for the ability to##2##6##(1991-11#1)(2008-10#1)
were tested for the presence of##8##6##(1992-9#1)(2006-10#2)(2007-12#1)(2008-10#2)(2012-3#1)(2013-1#1)
were tested for the##18##4##(1991-11#1)(1992-9#1)(1993-2#1)(1994-2#1)(2006-10#2)(2007-12#1)(2008-10#5)(2008-7#1)(2010-2#1)(2010-5#1)(2012-11#1)(2012-3#1)(2013-1#1)
were tested for their abilities to##3##6##(1990-12#1)(1995-1#1)(2008-10#1)
were tested for their ability to infect##2##7##(1990-4#1)(2008-10#1)
were tested for their ability to inhibit##3##7##(1994-5#1)(1994-8#1)(2008-10#1)
were tested for their ability to transmit##2##7##(2008-10#2)
were tested for their ability to##19##6##(1990-10#1)(1990-4#1)(1991-4#2)(1992-6#1)(1994-5#1)(1994-6#1)(1994-8#1)(1996-7#1)(1997-6#1)(2007-12#1)(2007-6#1)(2008-10#6)(2008-5#1)
were tested for their capacity to##2##6##(1995-3#1)(2007-7#1)
were tested for their effect on##3##6##(1997-8#1)(2008-10#1)(2008-5#1)
were tested for their influence on##2##6##(1994-8#1)(2007-8#1)
were tested for their##50##4##(1990-10#1)(1990-12#1)(1990-4#1)(1990-9#2)(1991-4#2)(1992-6#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-3#1)(1996-7#1)(1997-6#1)(1997-8#1)(2005-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-4#1)(2008-5#5)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#2)
were tested for virulence to##2##5##(2008-10#2)
were tested for virulence##6##4##(2008-10#4)(2009-2#1)(2009-3#1)
were tested for##188##3##(1990-10#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-9#2)(1991-10#1)(1991-11#2)(1991-12#1)(1991-3#2)(1991-4#2)(1991-6#2)(1991-8#1)(1992-4#2)(1992-6#1)(1992-9#2)(1993-12#2)(1993-2#2)(1993-4#2)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#4)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-7#1)(1996-8#2)(1997-5#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-12#2)(2006-6#1)(2006-8#2)(2007-12#3)(2007-2#3)(2007-4#1)(2007-6#1)(2007-7#6)(2007-8#3)(2008-1#3)(2008-10#41)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#14)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#4)(2011-3#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#7)
were tested in a##12##4##(1991-3#1)(1991-6#1)(1997-7#1)(2006-11#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#2)(2010-5#1)(2012-2#1)
were tested in an##5##4##(1990-11#1)(2007-6#1)(2008-10#2)(2008-11#1)
were tested in multiple##2##4##(1993-9#1)(2008-10#1)
were tested in order to##3##5##(2005-11#1)(2008-10#2)
were tested in terms of##2##5##(2007-10#1)(2008-3#1)
were tested in the Morris##2##5##(1993-3#1)(1994-2#1)
were tested in the greenhouse##2##5##(2008-10#2)
were tested in the laboratory##2##5##(2004-2#1)(2011-1#1)
were tested in the##16##4##(1990-6#1)(1993-3#1)(1994-2#1)(2004-2#1)(2006-8#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)(2010-2#1)(2011-1#2)(2012-11#1)
were tested in this study##2##5##(2008-5#1)(2013-1#1)
were tested in this##4##4##(2008-5#1)(2008-9#1)(2010-8#1)(2013-1#1)
were tested in two##3##4##(2006-11#1)(2008-3#1)(2013-8#1)
were tested in vitro with##2##5##(1995-2#1)(2008-10#1)
were tested in vitro##4##4##(1995-2#1)(2007-1#1)(2008-10#1)(2013-8#1)
were tested in vivo for##2##5##(1994-9#1)(1997-3#1)
were tested in##86##3##(1990-11#1)(1990-6#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-3#1)(1997-7#2)(2004-2#1)(2004-4#2)(2004-8#1)(2005-1#1)(2005-11#1)(2006-11#2)(2006-12#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#16)(2008-11#1)(2008-12#3)(2008-3#4)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#3)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#3)
were tested on a set of##5##6##(2008-10#1)(2013-1#4)
were tested on a##12##4##(1994-3#1)(1995-3#1)(1997-8#2)(2008-10#1)(2009-9#1)(2012-1#1)(2012-2#1)(2013-1#4)
were tested on isolated##2##4##(2007-1#1)(2010-3#1)
were tested on the##5##4##(1991-5#1)(1992-5#1)(1997-5#1)(2004-2#1)(2008-10#1)
were tested on##33##3##(1991-5#1)(1992-11#1)(1992-3#1)(1992-5#1)(1994-3#1)(1994-9#1)(1995-3#1)(1997-5#1)(1997-8#2)(2004-2#1)(2007-1#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-9#2)(2009-1#1)(2009-9#1)(2010-3#1)(2012-1#1)(2012-2#1)(2013-1#4)(2013-7#2)
were tested ranging from##2##4##(1995-5#1)(2012-2#1)
were tested separately and together for suppression of Botrytis cinerea on strawberry leaves##2##13##(2008-10#2)
were tested singly and in##2##5##(2004-2#1)(2008-10#1)
were tested through##2##3##(2008-5#2)
were tested to determine their##2##5##(1990-5#1)(1991-5#1)
were tested to determine##4##4##(1990-5#1)(1991-5#1)(1991-9#1)(2008-5#1)
were tested to evaluate the##2##5##(1992-2#1)(2008-10#1)
were tested to failure in##2##5##(2006-11#1)(2008-9#1)
were tested to##16##3##(1990-5#1)(1991-5#1)(1991-9#1)(1992-2#1)(1997-5#1)(2006-11#1)(2008-10#6)(2008-12#1)(2008-5#2)(2008-9#1)
were tested under field conditions##2##5##(2008-10#2)
were tested under##5##3##(2008-10#2)(2008-11#1)(2009-3#2)
were tested using a##3##4##(2007-1#1)(2008-12#1)(2011-2#1)
were tested using the##5##4##(1996-2#1)(2008-10#1)(2008-3#1)(2009-2#1)(2011-2#1)
were tested using##19##3##(1990-2#1)(1995-2#1)(1996-2#1)(2006-8#1)(2007-1#1)(2007-4#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-2#1)(2011-2#2)(2012-1#1)(2013-1#1)
were tested with a##2##4##(2007-7#1)(2011-2#1)
were tested with human##2##4##(1993-6#1)(1994-3#1)
were tested with the##7##4##(1992-8#1)(1994-2#1)(2008-10#3)(2008-7#1)(2012-1#1)
were tested with##37##3##(1992-8#1)(1993-6#1)(1994-2#1)(1994-3#1)(1996-2#2)(1996-8#1)(2007-7#1)(2007-9#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-1#1)(2013-1#2)
were tested##640##2##(1990-10#2)(1990-11#4)(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-10#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#4)(1991-4#2)(1991-5#3)(1991-6#4)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#2)(1992-2#2)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#5)(1992-8#2)(1992-9#2)(1993-10#1)(1993-11#2)(1993-12#6)(1993-2#3)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#5)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#3)(1994-2#4)(1994-3#4)(1994-5#1)(1994-6#2)(1994-8#6)(1994-9#2)(1995-1#2)(1995-12#3)(1995-2#4)(1995-3#4)(1995-5#2)(1995-8#2)(1996-11#1)(1996-12#5)(1996-2#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#4)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#4)(1997-6#2)(1997-7#2)(1997-8#3)(2004-11#1)(2004-12#1)(2004-2#3)(2004-4#3)(2004-8#1)(2004-9#2)(2005-1#1)(2005-11#3)(2005-8#1)(2006-10#4)(2006-11#6)(2006-12#3)(2006-4#1)(2006-6#1)(2006-8#10)(2007-1#6)(2007-10#3)(2007-11#4)(2007-12#4)(2007-2#4)(2007-3#1)(2007-4#6)(2007-5#1)(2007-6#6)(2007-7#9)(2007-8#8)(2007-9#2)(2008-1#5)(2008-10#148)(2008-11#15)(2008-12#8)(2008-2#4)(2008-3#8)(2008-4#4)(2008-5#39)(2008-6#3)(2008-7#11)(2008-8#8)(2008-9#9)(2009-1#1)(2009-10#1)(2009-2#2)(2009-3#6)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-9#1)(2010-12#3)(2010-2#3)(2010-3#7)(2010-4#5)(2010-5#2)(2010-8#4)(2011-1#9)(2011-12#1)(2011-2#15)(2011-3#1)(2012-1#4)(2012-11#2)(2012-12#6)(2012-2#9)(2012-3#5)(2013-1#22)(2013-7#4)(2013-8#3)
were thalassaemia##2##2##(2011-12#2)
were that the##4##3##(1997-6#1)(2006-2#1)(2008-11#1)(2008-4#1)
were that##16##2##(1994-3#1)(1997-6#2)(2006-2#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-5#1)(2010-12#1)(2012-1#1)(2013-7#1)
were the absence of##2##4##(1992-7#1)(2008-5#1)
were the absence##3##3##(1992-7#1)(2005-5#1)(2008-5#1)
were the best predictors of##3##5##(2006-11#1)(2007-12#1)(2007-9#1)
were the best##9##3##(1992-8#1)(1993-3#1)(1995-6#1)(2006-11#1)(2007-12#1)(2007-9#1)(2008-5#2)(2011-2#1)
were the cause of##2##4##(2007-2#1)(2007-7#1)
were the common##3##3##(2007-7#1)(2013-1#1)(2013-8#1)
were the commonest findings in children below the age of##2##10##(2008-1#1)(2010-4#1)
were the commonest findings##3##4##(2008-1#2)(2010-4#1)
were the commonest##4##3##(2008-1#2)(2008-7#1)(2010-4#1)
were the development of##2##4##(2008-3#1)(2008-7#1)
were the dominant##3##3##(2008-5#2)(2012-2#1)
were the exception to this##2##5##(1992-1#1)(2007-10#1)
were the first##9##3##(1992-2#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-2#1)(2008-3#1)(2009-5#1)(2012-12#1)
were the following##9##3##(1990-12#1)(1992-7#1)(1994-11#1)(1995-1#1)(2006-10#1)(2006-7#1)(2008-10#1)(2008-5#1)(2013-1#1)
were the highest in##6##4##(2008-10#1)(2008-12#1)(2008-9#1)(2010-12#1)(2013-8#2)
were the highest##10##3##(1995-8#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-12#1)(2012-2#1)(2013-8#3)
were the important##2##3##(2008-11#1)(2008-9#1)
were the largest##4##3##(2008-6#1)(2008-8#1)(2009-7#1)(2010-8#1)
were the leading##4##3##(2007-7#1)(2008-7#1)(2013-7#1)(2013-8#1)
were the least##10##3##(2005-11#1)(2007-5#2)(2008-10#2)(2009-12#1)(2010-7#1)(2011-2#2)(2012-12#1)
were the loss##2##3##(1990-4#1)(2008-10#1)
were the lower values than##2##5##(2011-2#2)
were the lowest in##2##4##(2007-8#1)(2008-10#1)
were the lowest##5##3##(2007-8#1)(2008-10#2)(2008-2#1)(2011-2#1)
were the main factors##3##4##(2008-5#1)(2013-8#2)
were the main indications to surgery##2##6##(1991-5#1)(1993-3#1)
were the main reasons for##2##5##(1993-5#1)(2008-2#1)
were the main reasons##3##4##(1993-5#1)(2008-2#1)(2008-9#1)
were the main##30##3##(1991-11#1)(1991-4#1)(1991-5#1)(1992-2#1)(1993-2#1)(1993-3#1)(1993-5#1)(1997-2#1)(2005-12#1)(2005-6#1)(2005-8#1)(2007-3#1)(2007-7#2)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#3)
were the major component##2##4##(2006-12#2)
were the major##16##3##(1990-12#1)(1991-1#1)(1992-7#1)(1995-9#1)(1997-2#1)(2006-12#2)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#2)(2010-11#1)(2012-3#1)
were the most abundant and##2##5##(2007-12#1)(2012-2#1)
were the most abundant group with##2##6##(2007-5#2)
were the most abundant group##3##5##(2007-3#1)(2007-5#2)
were the most abundant##13##4##(2007-12#1)(2007-3#1)(2007-5#2)(2008-3#1)(2008-8#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-2#2)(2013-7#1)
were the most active##4##4##(1994-5#1)(2008-5#1)(2009-3#1)(2010-12#1)
were the most affected##2##4##(1996-3#1)(2008-2#1)
were the most common cause of##2##6##(2006-8#1)(2007-2#1)
were the most common histological##3##5##(2008-1#1)(2011-1#1)(2012-2#1)
were the most common injury##2##5##(2006-11#1)(2009-6#1)
were the most common malignancy##2##5##(2007-3#2)
were the most common reasons for not##2##7##(2007-10#1)(2007-3#1)
were the most common risk factors##2##6##(2006-10#1)(2007-10#1)
were the most common##40##4##(1990-6#1)(1992-2#1)(1992-8#1)(1997-3#1)(2005-12#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-8#3)(2007-1#1)(2007-10#3)(2007-2#2)(2007-3#3)(2007-7#2)(2008-1#3)(2008-3#1)(2008-5#1)(2008-6#1)(2009-6#1)(2011-1#3)(2011-11#1)(2011-2#3)(2012-2#1)(2013-7#1)
were the most commonly##8##4##(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-8#1)
were the most diverse##3##4##(2007-5#1)(2008-5#2)
were the most effective and##2##5##(1993-6#1)(2008-5#1)
were the most effective in##2##5##(1990-8#1)(1995-12#1)
were the most effective##10##4##(1990-8#1)(1993-6#1)(1994-12#1)(1995-12#1)(1996-5#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-5#1)(2013-7#1)
were the most efficient##3##4##(1990-7#1)(2007-3#1)(2013-8#1)
were the most frequent##18##4##(1991-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
were the most frequently detected and occurred in##2##8##(2008-10#2)
were the most frequently detected##4##5##(1996-12#1)(2008-10#2)(2011-2#1)
were the most frequently prescribed##2##5##(2008-11#1)(2010-5#1)
were the most frequently used##3##5##(1995-12#1)(2007-10#1)(2008-11#1)
were the most frequently##13##4##(1995-12#1)(1996-12#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-11#2)(2010-1#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)
were the most important factors##3##5##(1990-12#1)(2007-2#1)(2008-6#1)
were the most important##13##4##(1990-12#1)(1994-6#1)(2004-11#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-5#3)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
were the most likely to##3##5##(2007-8#1)(2009-5#1)(2012-3#1)
were the most likely##5##4##(2004-11#1)(2005-10#1)(2007-8#1)(2009-5#1)(2012-3#1)
were the most often found ones from the##2##8##(2008-10#2)
were the most often##4##4##(2006-2#1)(2008-10#2)(2008-11#1)
were the most potent##3##4##(1993-1#1)(1994-8#1)(2008-8#1)
were the most prevalent##8##4##(2006-12#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-5#1)(2011-1#1)
were the most prominent##2##4##(2008-10#2)
were the most pronounced##2##4##(1991-5#1)(2008-10#1)
were the most sensitive to##2##5##(1992-1#1)(2006-5#1)
were the most sensitive##5##4##(1992-1#1)(2006-5#1)(2008-10#1)(2008-5#2)
were the most severe##3##4##(2008-10#2)(2010-12#1)
were the most significant##3##4##(1991-2#1)(2007-7#1)(2013-8#1)
were the most suitable##3##4##(1990-10#1)(2008-8#1)(2011-2#1)
were the most widely##2##4##(2010-2#1)(2013-7#1)
were the most##202##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#2)(1992-1#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#2)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#2)(1997-3#1)(2004-11#2)(2005-10#1)(2005-12#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#2)(2006-5#1)(2006-8#3)(2007-1#1)(2007-10#4)(2007-11#1)(2007-12#1)(2007-2#5)(2007-3#6)(2007-5#3)(2007-7#8)(2007-8#4)(2007-9#1)(2008-1#6)(2008-10#22)(2008-11#4)(2008-2#2)(2008-3#2)(2008-5#14)(2008-6#3)(2008-7#2)(2008-8#4)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#8)(2011-11#1)(2011-2#13)(2012-1#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#4)(2013-8#4)
were the mothers##2##3##(1993-6#1)(2010-2#1)
were the need for##2##4##(2008-7#1)(2012-2#1)
were the only ones##3##4##(2008-10#1)(2010-12#1)(2013-1#1)
were the only##20##3##(1994-3#1)(1995-2#1)(1995-9#1)(1996-8#1)(2006-8#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
were the optimum##2##3##(2008-10#1)(2012-12#1)
were the other##4##3##(2006-5#1)(2007-5#1)(2007-8#1)(2008-3#1)
were the pH##2##3##(2008-10#1)(2013-1#1)
were the predominant clinical##2##4##(2007-8#1)(2009-6#1)
were the predominant##15##3##(1991-11#1)(1997-4#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-6#1)(2011-2#1)(2013-1#1)
were the presence of##2##4##(2007-10#1)(2008-7#1)
were the primary##6##3##(1993-8#1)(1995-5#1)(2007-7#1)(2008-12#1)(2011-2#1)(2013-1#1)
were the principal##2##3##(1993-11#1)(2006-8#1)
were the products##2##3##(1990-3#1)(1991-9#1)
were the reasons##2##3##(1991-6#1)(2007-11#1)
were the result of the##4##5##(1997-1#1)(2008-10#1)(2012-12#2)
were the result of##7##4##(1997-1#1)(2008-10#3)(2010-11#1)(2012-12#2)
were the results of##3##4##(1990-3#1)(2009-8#1)(2012-3#1)
were the same and##2##4##(1993-8#1)(2012-1#1)
were the same as that##2##5##(2008-11#1)(2008-9#1)
were the same as those of##2##6##(1996-12#1)(2007-5#1)
were the same as those##5##5##(1990-2#1)(1991-8#1)(1996-12#1)(2006-6#1)(2007-5#1)
were the same as##9##4##(1990-2#1)(1991-8#1)(1994-3#1)(1996-12#1)(1997-6#1)(2006-6#1)(2007-5#1)(2008-11#1)(2008-9#1)
were the same for all##4##5##(1994-2#1)(2008-10#2)(2009-9#1)
were the same for##5##4##(1994-2#1)(2008-10#2)(2008-8#1)(2009-9#1)
were the same in##3##4##(1994-12#1)(2008-5#1)(2013-8#1)
were the same or##2##4##(1991-2#1)(1996-2#1)
were the same##38##3##(1990-2#1)(1990-7#1)(1991-2#1)(1991-8#1)(1992-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-12#1)(1996-2#1)(1997-6#1)(2005-10#1)(2005-12#1)(2006-3#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-5#1)(2007-9#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-9#1)(2012-1#1)(2012-2#1)(2013-8#1)
were the second##2##3##(2007-2#1)(2008-10#1)
were the sole##2##3##(1992-3#1)(2007-7#1)
were the stomach and##2##4##(2011-2#2)
were the strongest##2##3##(2007-12#2)
were the subject of##2##4##(2005-8#1)(2011-2#1)
were the surgical##2##3##(2011-2#1)(2013-1#1)
were the third##2##3##(2008-12#1)(2008-5#1)
were the three##2##3##(1990-4#1)(2011-2#1)
were the transition##2##3##(2008-10#1)(2012-12#1)
were the two main##2##4##(1992-3#1)(2008-4#1)
were the two##7##3##(1990-2#1)(1991-12#1)(1992-3#1)(2008-10#1)(2008-4#1)(2010-4#1)(2013-1#1)
were the use of##2##4##(2008-10#1)(2011-2#1)
were the variables##3##3##(2004-12#1)(2008-10#1)(2012-12#1)
were the##701##2##(1990-10#2)(1990-12#4)(1990-2#3)(1990-3#3)(1990-4#2)(1990-6#4)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#5)(1991-4#2)(1991-5#2)(1991-6#4)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#1)(1992-2#5)(1992-3#2)(1992-6#1)(1992-7#3)(1992-8#3)(1993-1#1)(1993-10#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#5)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#4)(1994-1#1)(1994-10#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#3)(1994-8#1)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#7)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#2)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#3)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-6#2)(2004-11#2)(2004-12#1)(2004-3#1)(2005-10#2)(2005-11#3)(2005-12#7)(2005-5#1)(2005-6#1)(2005-8#3)(2006-10#9)(2006-11#4)(2006-12#7)(2006-2#4)(2006-3#2)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#12)(2006-9#1)(2007-1#4)(2007-10#10)(2007-11#4)(2007-12#4)(2007-2#9)(2007-3#12)(2007-5#8)(2007-7#23)(2007-8#13)(2007-9#4)(2008-1#11)(2008-10#82)(2008-11#10)(2008-12#8)(2008-2#7)(2008-3#9)(2008-4#3)(2008-5#33)(2008-6#5)(2008-7#18)(2008-8#11)(2008-9#5)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#7)(2010-2#4)(2010-3#1)(2010-4#5)(2010-5#4)(2010-7#2)(2010-8#11)(2011-1#11)(2011-11#1)(2011-12#4)(2011-2#37)(2012-1#5)(2012-11#1)(2012-12#18)(2012-2#12)(2012-3#6)(2013-1#22)(2013-7#7)(2013-8#17)
were their own##2##3##(2005-5#1)(2011-2#1)
were their##4##2##(2005-5#1)(2008-10#1)(2008-9#1)(2011-2#1)
were themselves##2##2##(2005-11#1)(2010-4#1)
were then able to##4##4##(1996-4#1)(2004-12#1)(2008-10#1)(2011-2#1)
were then analysed##3##3##(2007-8#1)(2007-9#1)(2008-10#1)
were then analyzed by##2##4##(1994-3#1)(2008-10#1)
were then analyzed##5##3##(1991-2#1)(1994-3#1)(2007-11#1)(2008-10#2)
were then applied to the##2##5##(1990-10#1)(2006-11#1)
were then applied to##5##4##(1990-10#1)(2006-11#1)(2007-8#1)(2008-10#1)(2008-11#1)
were then applied##7##3##(1990-10#1)(2006-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)
were then asked to rate the##2##6##(1997-8#1)(2008-10#1)
were then asked to##4##4##(1995-12#1)(1997-8#1)(2008-10#1)(2008-9#1)
were then characterized by##4##4##(1992-6#1)(1994-9#1)(2008-10#2)
were then characterized##5##3##(1992-11#1)(1992-6#1)(1994-9#1)(2008-10#2)
were then classified into##2##4##(2006-12#1)(2010-2#1)
were then classified##4##3##(2006-12#1)(2006-8#1)(2008-10#1)(2010-2#1)
were then combined with##2##4##(1996-5#1)(2008-3#1)
were then combined##4##3##(1996-5#1)(2008-3#1)(2010-9#1)(2012-1#1)
were then compared to##5##4##(1992-10#1)(1993-11#1)(2007-10#1)(2008-10#1)(2008-7#1)
were then compared with the##4##5##(1995-6#1)(2008-5#1)(2008-8#1)(2012-2#1)
were then compared with##9##4##(1995-6#1)(1997-4#1)(2006-6#1)(2008-3#1)(2008-5#2)(2008-8#1)(2012-2#2)
were then compared##21##3##(1992-10#1)(1993-11#1)(1995-6#1)(1997-4#1)(2004-4#1)(2006-6#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2010-3#1)(2010-7#1)(2012-2#2)
were then conducted##2##3##(1996-4#1)(2007-12#1)
were then converted into##2##4##(2007-11#2)
were then converted##3##3##(1996-10#1)(2007-11#2)
were then correlated with##2##4##(1996-3#1)(2008-12#1)
were then determined by##2##4##(1993-12#1)(2008-10#1)
were then determined##3##3##(1993-12#1)(2008-10#1)(2008-4#1)
were then divided into##2##4##(2012-12#1)(2013-1#1)
were then eluted##4##3##(1990-12#1)(2008-10#3)
were then evaluated in##3##4##(2008-11#1)(2008-3#1)(2008-5#1)
were then evaluated##6##3##(2005-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-12#1)
were then examined by##3##4##(1992-2#1)(1996-8#1)(2008-4#1)
were then examined##6##3##(1992-2#1)(1996-8#1)(1997-5#1)(2008-10#1)(2008-4#1)(2012-11#1)
were then further##3##3##(2007-12#1)(2011-1#1)(2013-8#1)
were then identified##2##3##(2009-6#1)(2011-2#1)
were then incorporated##2##3##(2010-2#1)(2013-7#1)
were then incubated##2##3##(1994-8#1)(2008-4#1)
were then integrated into##2##4##(2007-10#1)(2011-2#1)
were then investigated##3##3##(2008-10#1)(2009-11#1)(2012-12#1)
were then irradiated##2##3##(2008-3#1)(2013-1#1)
were then linked##3##3##(1991-9#1)(2011-1#1)(2012-12#1)
were then measured##5##3##(1990-12#1)(1991-3#1)(1994-5#1)(2008-10#2)
were then obtained##2##3##(2007-8#1)(2008-5#1)
were then performed##2##3##(2006-11#1)(2011-2#1)
were then placed##2##3##(1990-10#1)(2008-11#1)
were then prepared##2##3##(1996-7#1)(2007-11#1)
were then returned to##2##4##(1994-5#1)(1996-4#1)
were then sacrificed and##2##4##(1997-7#1)(2006-8#1)
were then separated by##3##4##(1991-1#1)(1993-11#1)(1997-2#1)
were then separated##4##3##(1991-1#1)(1993-11#1)(1995-2#1)(1997-2#1)
were then sequentially##3##3##(1997-2#1)(2008-10#2)
were then subjected to##6##4##(1992-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-7#1)(2012-3#1)
were then tested on a##2##5##(1994-6#1)(2012-1#1)
were then tested on##3##4##(1994-6#1)(2012-1#2)
were then tested##7##3##(1991-9#1)(1993-12#1)(1994-6#1)(2008-10#1)(2008-9#1)(2012-1#2)
were then transferred to##3##4##(1994-5#1)(1997-2#1)(2008-10#1)
were then transferred##4##3##(1994-5#1)(1997-2#1)(2008-10#1)(2008-11#1)
were then transformed##2##3##(1996-10#1)(2013-1#1)
were then transplanted into the##2##5##(1995-11#1)(2010-2#1)
were then treated with##4##4##(1992-3#1)(1995-11#1)(2007-7#1)(2008-6#1)
were then treated##5##3##(1992-3#1)(1995-11#1)(2007-11#1)(2007-7#1)(2008-6#1)
were then used as##3##4##(1993-11#1)(1997-5#1)(2011-2#1)
were then used for##2##4##(1992-6#1)(2011-1#1)
were then used in##3##4##(1994-1#1)(2005-11#1)(2008-10#1)
were then used to calculate##2##5##(1997-7#1)(2010-2#1)
were then used to estimate the##2##6##(1995-8#1)(2007-8#1)
were then used to evaluate##2##5##(1991-12#1)(2013-1#1)
were then used to##21##4##(1990-10#1)(1990-12#1)(1990-5#1)(1991-12#1)(1995-5#1)(1995-8#1)(1997-4#1)(1997-7#1)(2006-7#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-7#2)(2009-6#1)(2010-2#1)(2011-2#1)(2013-1#1)
were then used##29##3##(1990-10#1)(1990-12#1)(1990-5#1)(1991-12#1)(1992-6#1)(1993-11#1)(1994-1#1)(1995-5#1)(1995-8#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-7#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-7#2)(2009-6#1)(2010-2#1)(2011-1#1)(2011-2#2)(2013-1#1)
were then validated##3##3##(2007-8#1)(2008-10#1)(2012-2#1)
were then##284##2##(1990-10#5)(1990-12#4)(1990-5#1)(1990-8#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#2)(1992-10#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#4)(1993-12#2)(1993-5#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#2)(1996-3#3)(1996-4#3)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#4)(1997-4#3)(1997-5#2)(1997-7#3)(1997-8#1)(2004-11#1)(2004-12#1)(2004-4#1)(2005-11#3)(2005-5#1)(2005-7#1)(2006-11#2)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#5)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#8)(2007-9#2)(2008-1#1)(2008-10#45)(2008-11#8)(2008-12#4)(2008-3#6)(2008-4#5)(2008-5#8)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#4)(2009-11#2)(2009-12#2)(2009-6#2)(2009-7#1)(2009-9#1)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#11)(2012-1#5)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
were theoretically studied##2##3##(1996-8#1)(2008-10#1)
were theoretically##4##2##(1996-8#1)(2007-12#1)(2007-9#1)(2008-10#1)
were therapeutically##2##2##(1990-9#1)(2009-4#1)
were there any##2##3##(1992-2#1)(1995-9#1)
were there##6##2##(1992-2#1)(1995-9#1)(1997-8#1)(2007-6#1)(2008-10#1)(2013-8#1)
were thereafter##3##2##(1993-5#1)(2008-10#1)(2012-1#1)
were therefore##20##2##(1990-9#1)(1991-11#1)(1991-4#1)(1991-7#1)(1992-11#1)(1992-5#1)(1993-9#1)(1994-11#1)(1994-3#1)(1996-1#1)(1996-7#1)(2004-9#1)(2005-7#1)(2006-12#1)(2006-2#1)(2007-6#1)(2008-10#1)(2009-4#1)(2009-5#1)(2012-3#1)
were they##3##2##(2006-8#1)(2008-6#1)(2008-7#1)
were thicker##2##2##(2005-7#1)(2008-10#1)
were thin##2##2##(1995-6#1)(2008-5#1)
were thinner##3##2##(1991-12#1)(1992-4#1)(2007-12#1)
were thoroughly characterized##4##3##(1996-7#1)(2006-12#1)(2007-8#1)(2013-1#1)
were thoroughly investigated##4##3##(2008-10#3)(2010-4#1)
were thoroughly optimized##2##3##(2008-10#2)
were thoroughly##13##2##(1996-7#1)(2006-12#1)(2007-8#1)(2008-10#5)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
were those from##2##3##(2008-10#1)(2008-12#1)
were those in which##2##4##(1991-10#1)(2009-3#1)
were those of the##3##4##(1994-11#1)(1995-3#1)(2008-7#1)
were those of##8##3##(1994-11#1)(1995-3#1)(2005-8#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-3#1)
were those that##3##3##(2005-8#1)(2009-2#1)(2012-3#1)
were those who had##2##4##(1993-3#1)(2011-2#1)
were those who##6##3##(1993-3#1)(2007-8#2)(2008-11#1)(2008-7#1)(2011-2#1)
were those with an##2##4##(2006-4#1)(2010-12#1)
were those with the##2##4##(2007-5#1)(2008-10#1)
were those with##7##3##(2006-4#2)(2007-5#1)(2008-10#1)(2009-2#1)(2010-12#2)
were those##42##2##(1991-10#1)(1992-7#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-11#1)(1995-3#1)(1996-3#1)(2005-8#2)(2006-4#2)(2007-10#2)(2007-5#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-2#2)(2009-3#2)(2009-4#1)(2010-12#2)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#1)
were thought to be due to##2##6##(1990-6#1)(2006-10#1)
were thought to be##6##4##(1990-6#1)(1996-8#1)(2006-10#1)(2006-11#1)(2006-9#1)(2008-7#1)
were thought to##10##3##(1990-6#1)(1996-8#1)(1996-9#1)(2004-10#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-6#1)(2008-10#1)(2008-7#1)
were thought##13##2##(1990-6#1)(1996-8#1)(1996-9#1)(2004-10#1)(2006-10#2)(2006-11#1)(2006-9#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
were three deaths in##2##4##(2004-11#1)(2005-7#1)
were three deaths##3##3##(2004-11#1)(2005-7#1)(2012-12#1)
were three times higher##2##4##(1993-7#1)(1996-1#1)
were three##27##2##(1992-1#1)(1992-12#1)(1993-7#1)(1994-2#1)(1995-8#1)(1996-1#1)(2004-11#1)(2004-2#2)(2005-10#1)(2005-7#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-9#1)(2010-11#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
were thus determined in the ranges##2##6##(2008-10#2)
were thus determined##3##3##(2008-10#3)
were thus identified##3##3##(1995-4#1)(2008-10#1)(2008-7#1)
were thus not##3##3##(1991-11#1)(2008-10#1)(2008-8#1)
were thus obtained##2##3##(2007-10#1)(2007-12#1)
were thus##24##2##(1991-11#2)(1991-12#1)(1994-12#1)(1995-2#1)(1995-4#1)(1996-12#1)(2007-10#1)(2007-12#2)(2008-10#8)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)
were thymol##3##2##(2007-1#1)(2008-12#1)(2012-2#1)
were tied##2##2##(2007-7#1)(2011-2#1)
were tightly associated##2##3##(1994-8#1)(2008-10#1)
were tightly##5##2##(1994-8#1)(1995-6#1)(1996-11#1)(2008-10#1)(2013-8#1)
were time- and##2##3##(1991-9#1)(1993-2#1)
were time-##3##2##(1991-9#1)(1993-2#1)(1997-1#1)
were titrated potentiometrically with tetrabutylammonium hydroxide in four non-aqueous solvents (isopropyl alcohol##2##12##(2007-11#2)
were titrated##7##2##(1990-7#1)(1994-5#1)(1996-7#1)(2006-8#1)(2007-11#2)(2008-10#1)
were to (1)##3##3##(2009-7#1)(2013-1#2)
were to (i) determine##2##4##(2008-10#2)
were to (i)##5##3##(2008-10#3)(2010-12#1)(2013-1#1)
were to analyze##2##3##(2008-10#1)(2012-3#1)
were to assess the##8##4##(1991-5#1)(2007-2#1)(2008-10#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
were to assess##10##3##(1991-5#1)(1994-6#1)(2007-2#1)(2007-7#1)(2008-10#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
were to be used##3##4##(1992-2#1)(2013-1#2)
were to be##11##3##(1992-2#1)(1994-8#1)(1996-4#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-2#1)(2011-1#1)(2012-10#1)(2013-1#2)
were to compare the##2##4##(2010-8#1)(2011-1#1)
were to compare##4##3##(2006-8#1)(2010-8#1)(2011-1#1)(2013-1#1)
were to demonstrate the##2##4##(1997-6#1)(2008-2#1)
were to determine the effect of##2##6##(2008-10#1)(2008-8#1)
were to determine the prevalence of##5##6##(2008-12#1)(2008-3#1)(2008-8#2)(2009-10#1)
were to determine the##19##4##(1996-1#1)(2005-10#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#3)(2009-10#1)(2011-12#1)(2011-2#2)(2012-11#1)
were to determine##27##3##(1996-1#1)(2005-10#1)(2007-10#1)(2007-2#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#3)(2009-10#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
were to develop##3##3##(2008-10#1)(2010-2#1)(2013-1#1)
were to establish the##2##4##(2007-3#1)(2008-10#1)
were to establish##3##3##(2007-3#1)(2008-10#1)(2013-1#1)
were to evaluate the##9##4##(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2012-2#1)(2012-3#3)
were to evaluate##14##3##(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-3#1)(2012-2#2)(2012-3#3)
were to examine the##6##4##(2007-10#1)(2008-11#1)(2008-5#1)(2010-11#1)(2012-2#1)(2013-8#1)
were to examine##8##3##(2007-10#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-11#1)(2012-2#1)(2013-8#1)
were to identify the##3##4##(1995-5#1)(2007-4#1)(2009-9#1)
were to identify##9##3##(1995-5#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-9#1)(2013-1#1)
were to increase##2##3##(1995-3#1)(2006-10#1)
were to investigate the##6##4##(1995-10#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#1)
were to investigate##10##3##(1992-4#1)(1995-10#1)(2006-8#1)(2007-10#1)(2008-12#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#1)
were to provide##3##3##(2008-10#1)(2008-7#1)(2012-12#1)
were to study the##4##4##(2008-10#2)(2013-1#2)
were to undergo##2##3##(2007-10#1)(2007-12#1)
were to##201##2##(1990-10#1)(1991-5#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-8#1)(1993-1#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-3#3)(1996-4#2)(1997-6#1)(1997-8#1)(2004-12#1)(2005-10#3)(2005-12#1)(2005-7#1)(2006-10#3)(2006-2#1)(2006-5#2)(2006-8#3)(2007-1#1)(2007-10#4)(2007-12#3)(2007-2#4)(2007-3#1)(2007-4#4)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#29)(2008-11#5)(2008-12#5)(2008-2#2)(2008-3#1)(2008-5#6)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#2)(2009-2#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#3)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#8)(2012-1#1)(2012-10#1)(2012-11#3)(2012-12#3)(2012-2#6)(2012-3#6)(2013-1#17)(2013-7#1)(2013-8#3)
were together##3##2##(2006-10#1)(2008-12#1)(2008-4#1)
were told##3##2##(1995-6#1)(2008-3#1)(2013-1#1)
were tolerant##3##2##(2008-10#2)(2011-10#1)
were tolerated at##3##3##(1997-3#1)(2008-10#2)
were tolerated##6##2##(1997-2#1)(1997-3#1)(2008-10#4)
were too low to be##2##5##(2008-10#1)(2011-1#1)
were too low to##5##4##(1994-9#1)(1997-5#1)(2008-10#1)(2011-1#1)(2013-1#1)
were too low##6##3##(1994-9#1)(1997-5#1)(2007-6#1)(2008-10#1)(2011-1#1)(2013-1#1)
were too short##2##3##(2007-12#1)(2008-10#1)
were too small##3##3##(1992-10#1)(1994-9#1)(2007-2#1)
were too##20##2##(1990-12#1)(1992-10#1)(1994-9#2)(1996-3#1)(1996-9#1)(1997-5#1)(2005-7#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#2)(2008-2#1)(2009-5#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
were total##4##2##(2007-2#1)(2008-3#1)(2011-1#1)(2012-2#1)
were totally absent from##2##4##(1992-1#1)(2007-5#1)
were totally dependent##2##3##(1990-7#1)(2009-10#1)
were totally removed##2##3##(2008-7#2)
were totally##18##2##(1990-7#1)(1991-9#1)(1992-1#1)(1993-5#1)(1993-6#1)(1993-7#1)(1996-9#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-10#2)(2010-3#1)(2011-2#1)(2013-1#1)
were toxic to##4##3##(1990-3#1)(1997-2#1)(2008-10#1)(2008-7#1)
were toxic##6##2##(1990-3#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-7#1)
were traced##6##2##(1993-12#1)(1995-10#1)(2008-10#2)(2010-8#1)(2011-1#1)
were tracked##4##2##(1992-11#1)(2007-1#1)(2010-8#1)(2013-7#1)
were trained and tested on##2##5##(1993-2#1)(1994-3#1)
were trained and tested##4##4##(1992-10#1)(1993-2#1)(1994-3#1)(2010-8#1)
were trained in a##3##4##(1991-2#1)(1993-2#1)(1993-9#1)
were trained in##9##3##(1990-7#1)(1991-2#1)(1993-2#1)(1993-5#1)(1993-9#1)(1996-8#1)(1997-4#1)(2007-7#1)(2008-1#1)
were trained on a delayed match-to-sample (DMS) task##2##8##(1991-3#1)(1993-2#1)
were trained on a##9##4##(1991-3#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-5#1)(1994-5#1)(2011-2#1)
were trained on the##2##4##(1993-12#1)(1997-2#1)
were trained on##15##3##(1991-1#1)(1991-3#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-5#1)(1994-3#1)(1994-5#1)(1997-2#1)(2009-3#1)(2011-2#1)
were trained to detect##2##4##(1992-11#1)(1994-2#1)
were trained to discriminate##5##4##(1991-12#1)(1992-10#1)(1993-12#1)(1994-6#1)(1997-5#1)
were trained to##14##3##(1991-12#1)(1992-10#1)(1992-11#2)(1993-12#1)(1993-5#1)(1993-6#1)(1994-2#1)(1994-6#1)(1997-5#1)(2007-7#1)(2008-10#1)(2012-2#1)(2012-3#1)
were trained using##2##3##(2010-2#1)(2012-1#1)
were trained##49##2##(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-10#2)(1992-11#2)(1992-12#1)(1993-12#4)(1993-2#4)(1993-3#2)(1993-5#3)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-9#1)(2009-3#1)(2010-2#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
were transcribed and analyzed##2##4##(1995-1#1)(2008-4#1)
were transcribed and##4##3##(1993-2#1)(1995-1#1)(2008-4#1)(2010-3#1)
were transcribed in vitro##2##4##(1993-8#1)(1994-9#1)
were transcribed in##3##3##(1993-8#1)(1994-9#1)(1997-2#1)
were transcribed##15##2##(1992-3#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-9#1)(1995-1#1)(1997-2#1)(2007-11#1)(2008-11#1)(2008-4#1)(2010-3#1)(2010-7#1)(2011-1#1)(2013-1#1)
were transcriptionally active##2##3##(1995-3#1)(1995-6#1)
were transcriptionally##3##2##(1994-3#1)(1995-3#1)(1995-6#1)
were transduced by##2##3##(1990-3#1)(2006-12#1)
were transduced##6##2##(1990-3#1)(1996-10#1)(1996-5#1)(2006-12#1)(2007-3#1)(2010-12#1)
were transfected into COS cells##3##5##(1994-12#1)(1995-1#1)(1995-3#1)
were transfected into human##2##4##(2008-8#1)(2011-2#1)
were transfected into##14##3##(1991-12#1)(1991-2#1)(1993-3#2)(1994-12#1)(1994-6#1)(1995-1#1)(1995-3#1)(2008-11#2)(2008-8#2)(2011-2#1)(2012-2#1)
were transfected to##2##3##(1996-2#1)(1997-7#1)
were transfected with a plasmid##3##5##(1990-12#1)(2008-11#1)(2010-11#1)
were transfected with a##4##4##(1990-12#1)(2008-11#1)(2008-8#1)(2010-11#1)
were transfected with the##5##4##(1994-2#1)(1994-5#1)(1994-8#1)(1995-3#1)(2008-11#1)
were transfected with##19##3##(1990-12#1)(1993-12#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-3#1)(2008-10#2)(2008-11#4)(2008-8#1)(2008-9#1)(2010-11#2)(2011-2#1)(2012-3#1)
were transfected##38##2##(1990-12#1)(1991-12#1)(1991-2#2)(1992-2#1)(1993-12#1)(1993-3#2)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-3#2)(1996-2#1)(1997-7#1)(2008-10#2)(2008-11#7)(2008-8#3)(2008-9#1)(2010-11#2)(2011-2#2)(2012-2#1)(2012-3#1)
were transferred by##2##3##(2005-11#1)(2008-10#1)
were transferred from the Department of Oncology##2##7##(1993-3#2)
were transferred from##4##3##(1993-3#2)(2008-10#1)(2008-7#1)
were transferred in##2##3##(2007-11#1)(2008-12#1)
were transferred into##11##3##(1991-12#1)(2004-4#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-8#1)(2009-5#1)(2010-6#1)
were transferred to a##6##4##(2007-9#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-12#1)
were transferred to an esplenectomized calf##2##6##(2008-5#2)
were transferred to##23##3##(1990-9#1)(1996-11#1)(1997-2#1)(2007-3#2)(2007-9#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2010-8#1)(2011-1#1)(2011-12#1)
were transferred##52##2##(1990-6#1)(1990-9#1)(1991-12#1)(1993-3#3)(1993-5#1)(1996-11#1)(1996-5#1)(1997-2#1)(2004-4#2)(2005-11#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#2)(2007-9#1)(2008-10#9)(2008-11#4)(2008-12#3)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#3)(2009-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#2)
were transformed into##8##3##(1996-5#1)(1996-6#1)(2005-11#1)(2008-10#1)(2008-5#2)(2008-8#1)(2013-1#1)
were transformed to##3##3##(2008-10#2)(2008-11#1)
were transformed with a##3##4##(2007-9#1)(2008-10#2)
were transformed with the##3##4##(2008-10#3)
were transformed with##8##3##(2007-9#1)(2008-10#7)
were transformed##22##2##(1996-4#1)(1996-5#1)(1996-6#1)(2005-11#1)(2007-9#1)(2008-10#11)(2008-11#2)(2008-5#2)(2008-8#1)(2013-1#1)
were transfused##5##2##(1994-9#3)(2012-2#2)
were transient##4##2##(2005-8#1)(2007-8#1)(2008-1#1)(2008-10#1)
were transiently expressed in##3##4##(1995-3#1)(2008-8#2)
were transiently##9##2##(1991-1#1)(1991-12#1)(1992-11#1)(1995-3#1)(1996-11#2)(2008-5#1)(2008-8#2)
were translated in vitro##3##4##(1995-3#1)(1995-8#1)(2008-5#1)
were translated in##5##3##(1990-11#1)(1995-3#1)(1995-8#1)(1997-2#1)(2008-5#1)
were translated##8##2##(1990-11#1)(1995-3#1)(1995-8#1)(1997-2#2)(2007-5#1)(2008-12#1)(2008-5#1)
were translocated to the##2##4##(1993-3#1)(2008-10#1)
were translocated##5##2##(1993-3#1)(1996-2#1)(1996-5#1)(2008-10#1)(2009-8#1)
were transmitted by##2##3##(1994-3#1)(2008-10#1)
were transmitted from##3##3##(2007-9#1)(2008-10#1)(2008-7#1)
were transmitted##12##2##(1994-3#1)(1997-4#1)(1997-8#1)(2007-9#1)(2008-10#5)(2008-2#1)(2008-7#1)(2013-1#1)
were transplanted at##2##3##(1996-4#1)(2007-10#1)
were transplanted between##3##3##(2007-7#1)(2008-1#1)(2008-4#1)
were transplanted in##2##3##(1996-8#1)(2008-1#1)
were transplanted into##9##3##(2006-10#1)(2006-6#1)(2008-10#3)(2008-3#1)(2009-12#1)(2009-3#1)(2011-2#1)
were transplanted##23##2##(1996-4#1)(1996-8#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-7#1)(2008-1#4)(2008-10#4)(2008-3#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-7#1)
were transported by##3##3##(1991-11#1)(2007-9#1)(2013-1#1)
were transported to the##2##4##(1996-3#1)(2007-8#1)
were transported##8##2##(1991-11#2)(1996-3#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2013-1#1)
were trapped by##4##3##(1997-4#1)(2006-2#1)(2007-12#1)(2008-10#1)
were trapped in##3##3##(2008-10#3)
were trapped##14##2##(1991-8#1)(1992-12#1)(1994-11#1)(1997-4#1)(2006-2#1)(2006-3#1)(2007-12#1)(2007-6#1)(2008-10#5)(2011-1#1)
were trauma##3##2##(2007-11#1)(2007-2#1)(2013-1#1)
were treated according to##2##4##(1992-8#1)(2006-10#1)
were treated and followed##2##4##(2006-12#1)(2007-7#1)
were treated and##4##3##(2006-12#1)(2007-7#1)(2008-11#1)(2008-7#1)
were treated as##9##3##(1991-9#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#1)(2011-1#1)
were treated at a##3##4##(1990-12#1)(1995-7#1)(2008-6#1)
were treated at our department##3##5##(1990-9#1)(1997-3#1)(2007-8#1)
were treated at our##7##4##(1990-6#1)(1990-9#1)(1997-3#1)(2007-8#1)(2010-3#1)(2011-2#1)(2012-2#1)
were treated at the##10##4##(1991-6#2)(1993-6#1)(1993-9#1)(2006-6#1)(2007-7#1)(2008-10#1)(2010-12#1)(2011-12#1)(2012-2#1)
were treated at##25##3##(1990-12#1)(1990-6#1)(1990-9#1)(1991-6#2)(1993-6#1)(1993-9#1)(1995-7#1)(1997-3#1)(2006-6#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-6#1)(2008-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#2)
were treated between 1987 and##2##5##(1991-6#1)(1992-6#1)
were treated between##7##3##(1991-6#1)(1992-6#1)(2006-10#1)(2008-10#1)(2008-6#1)(2010-4#1)(2012-3#1)
were treated by a combination of##2##6##(1990-12#1)(2007-2#1)
were treated by a##6##4##(1990-12#1)(1996-11#1)(1997-3#1)(2007-2#1)(2008-10#1)(2012-2#1)
were treated by definitive##2##4##(1991-4#1)(1994-12#1)
were treated by gavage with##2##5##(2005-7#1)(2013-8#1)
were treated by intraperitoneal injection##3##5##(1997-2#1)(2008-7#1)(2009-4#1)
were treated by intraperitoneal##4##4##(1997-2#1)(2008-10#1)(2008-7#1)(2009-4#1)
were treated by radiotherapy##3##4##(1990-12#1)(1992-10#1)(2007-11#1)
were treated by subtotal parathyroidectomy##2##5##(1991-5#1)(1993-3#1)
were treated by surgery##3##4##(1993-10#1)(2007-2#1)(2008-7#1)
were treated by surgical##2##4##(2008-7#1)(2012-2#1)
were treated by the##4##4##(1995-11#1)(2007-11#1)(2007-8#1)(2012-2#1)
were treated by##91##3##(1990-12#2)(1990-3#2)(1990-6#1)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#2)(1992-10#1)(1992-11#1)(1992-5#1)(1992-9#1)(1993-10#1)(1993-3#1)(1993-4#1)(1994-12#2)(1994-7#1)(1994-8#1)(1995-10#1)(1995-11#1)(1996-11#1)(1996-3#2)(1997-2#1)(1997-3#1)(1997-4#1)(2004-2#1)(2005-7#2)(2006-5#1)(2007-11#3)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#7)(2008-11#1)(2008-3#4)(2008-4#2)(2008-6#2)(2008-7#8)(2008-9#1)(2009-2#1)(2009-4#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#1)
were treated chronically with##2##4##(1990-5#1)(2007-11#1)
were treated conservatively and##3##4##(2008-1#1)(2013-1#2)
were treated conservatively##10##3##(1997-8#1)(2006-6#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-7#2)(2012-12#1)(2013-1#2)
were treated during a##2##4##(1991-9#1)(2012-2#1)
were treated either with##3##4##(1990-12#1)(1994-12#1)(2007-11#1)
were treated either##4##3##(1990-12#1)(1994-12#1)(2006-11#1)(2007-11#1)
were treated for a period of##3##6##(1995-9#1)(2008-4#2)
were treated for a##4##4##(1995-9#1)(2008-4#3)
were treated for adenocarcinoma of the##2##6##(1990-9#1)(1994-2#1)
were treated for the first##2##5##(1990-6#1)(1995-2#1)
were treated for##46##3##(1990-10#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-4#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#4)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#4)(2008-5#1)(2009-3#1)(2011-2#1)(2013-7#1)
were treated from##3##3##(2005-10#1)(2007-11#1)(2007-7#1)
were treated in a##3##4##(2006-7#1)(2007-7#1)(2011-2#1)
were treated in hospital##3##4##(1996-5#1)(2006-2#1)(2011-12#1)
were treated in our department##3##5##(1993-6#1)(2008-1#1)(2012-2#1)
were treated in our##5##4##(1991-2#1)(1993-6#1)(2007-7#1)(2008-1#1)(2012-2#1)
were treated in the Department of##2##6##(1995-11#1)(2005-1#1)
were treated in the Department##3##5##(1991-12#1)(1995-11#1)(2005-1#1)
were treated in the##8##4##(1991-12#1)(1992-9#1)(1995-11#1)(2005-1#1)(2006-10#1)(2007-7#2)(2012-2#1)
were treated in##38##3##(1990-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-9#1)(1993-6#1)(1995-11#1)(1995-7#1)(1996-5#1)(1997-3#1)(1997-4#1)(2005-1#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-1#1)(2011-12#1)(2011-2#4)(2012-2#2)(2012-3#1)
were treated initially with##2##4##(1992-12#1)(2013-1#1)
were treated initially##3##3##(1992-12#1)(1996-11#1)(2013-1#1)
were treated on an##2##4##(2007-8#2)
were treated on##4##3##(1991-12#1)(2007-8#2)(2013-1#1)
were treated once daily##2##4##(2008-10#1)(2013-1#1)
were treated once##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
were treated over a##2##4##(1990-10#1)(2012-2#1)
were treated over##3##3##(1990-10#1)(2008-7#1)(2012-2#1)
were treated similarly##2##3##(1993-4#1)(2008-6#1)
were treated subcutaneously##2##3##(1991-6#1)(2008-5#1)
were treated successfully by##2##4##(2008-7#1)(2011-2#1)
were treated successfully with antibiotics##2##5##(1995-11#1)(1996-4#1)
were treated successfully with##8##4##(1995-11#1)(1996-4#1)(2007-8#2)(2008-2#1)(2012-2#1)(2013-1#2)
were treated successfully##12##3##(1995-11#1)(1996-4#1)(2007-8#2)(2008-12#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-2#2)(2013-1#2)
were treated surgically in our##2##5##(1993-10#1)(1993-8#1)
were treated surgically in##3##4##(1993-10#1)(1993-8#1)(2009-3#1)
were treated surgically using##2##4##(2007-7#2)
were treated surgically with either##2##5##(2006-7#1)(2007-8#1)
were treated surgically##20##3##(1993-10#1)(1993-8#1)(1997-2#1)(2005-10#1)(2006-7#1)(2007-7#3)(2007-8#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
were treated to##2##3##(2005-8#1)(2008-6#1)
were treated twice##5##3##(1992-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
were treated up to##2##4##(1996-6#1)(2008-3#1)
were treated using the##2##4##(2007-8#1)(2008-6#1)
were treated using this##2##4##(1990-3#1)(2005-6#1)
were treated using##8##3##(1990-3#1)(2005-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-6#1)(2009-8#1)(2013-7#1)
were treated with 0##7##4##(1994-11#1)(1995-2#1)(2007-9#1)(2008-1#1)(2008-4#1)(2010-8#1)(2011-2#1)
were treated with 1##4##4##(1990-12#1)(2008-10#3)
were treated with 10##2##4##(1992-11#1)(1992-7#1)
were treated with 100##2##4##(1991-12#1)(2009-3#1)
were treated with 2##3##4##(1996-11#1)(1997-5#1)(2008-10#1)
were treated with 3##4##4##(1990-12#1)(1991-10#1)(1993-2#1)(1996-6#1)
were treated with 300##2##4##(1995-11#1)(2011-1#1)
were treated with CO2 laser##2##5##(1995-2#1)(1996-1#1)
were treated with MPTP##2##4##(1995-7#1)(2008-7#1)
were treated with a chemotherapy regimen##2##6##(1991-12#1)(2010-3#1)
were treated with a combination of##7##6##(1990-10#1)(1991-2#1)(1991-3#1)(2005-7#1)(2008-3#1)(2008-6#1)(2011-2#1)
were treated with a combination##8##5##(1990-10#1)(1990-2#1)(1991-2#1)(1991-3#1)(2005-7#1)(2008-3#1)(2008-6#1)(2011-2#1)
were treated with a food supplement based on##2##8##(2008-5#2)
were treated with a single dose of##2##7##(2006-2#1)(2007-8#1)
were treated with a total of##2##6##(2006-12#1)(2008-12#1)
were treated with a##31##4##(1990-10#1)(1990-2#2)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-10#1)(1992-3#1)(1992-5#1)(1995-5#1)(1997-8#1)(2005-7#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-8#1)(2008-12#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#2)(2010-3#1)(2011-2#2)(2013-1#1)
were treated with additional##2##4##(2006-6#1)(2008-6#1)
were treated with an##4##4##(1990-8#1)(1994-6#1)(1997-8#1)(2008-10#1)
were treated with antioxidants##2##4##(1994-3#1)(2008-5#1)
were treated with azathioprine 50 mg twice daily##2##8##(2007-8#2)
were treated with azathioprine##3##4##(2007-8#3)
were treated with both##2##4##(1990-12#1)(1997-6#1)
were treated with chemotherapy##2##4##(2008-6#1)(2011-2#1)
were treated with cisplatin##2##4##(1992-12#1)(2008-5#1)
were treated with conventional##2##4##(2008-12#1)(2011-1#1)
were treated with cyclophosphamide##2##4##(2007-7#1)(2008-1#1)
were treated with dexamethasone##3##4##(1994-11#1)(1997-6#2)
were treated with different##2##4##(1992-8#1)(2013-1#1)
were treated with either saline##2##5##(1990-11#1)(1991-8#1)
were treated with either##8##4##(1990-11#1)(1991-7#1)(1991-8#1)(1992-8#1)(1994-11#1)(1994-2#1)(2007-7#1)(2008-3#1)
were treated with epirubicin##2##4##(1991-2#1)(2008-6#1)
were treated with external##2##4##(1993-2#1)(2006-12#1)
were treated with fat grafting##2##5##(2012-12#2)
were treated with intravenous##2##4##(2011-1#1)(2012-12#1)
were treated with laser##2##4##(1990-12#1)(1995-2#1)
were treated with lithium##2##4##(1995-11#1)(2009-8#1)
were treated with low##2##4##(1997-7#1)(2005-10#1)
were treated with micro-marsupialization##2##4##(2012-12#2)
were treated with oral##3##4##(1991-4#1)(2007-8#1)(2013-8#1)
were treated with ozone##2##4##(1995-7#1)(2007-8#1)
were treated with palliative##2##4##(2007-4#1)(2008-5#1)
were treated with percutaneous##3##4##(2006-10#1)(2006-8#2)
were treated with peritoneal##2##4##(2011-2#1)(2012-2#1)
were treated with pesticides##2##4##(1991-6#1)(2007-10#1)
were treated with photochemotherapy##2##4##(2007-7#2)
were treated with pulse##2##4##(2007-7#2)
were treated with radiation##2##4##(2008-6#1)(2012-2#1)
were treated with radical##2##4##(1993-8#1)(2004-1#1)
were treated with radiotherapy##2##4##(2006-12#1)(2013-1#1)
were treated with standard##3##4##(1992-4#1)(1996-11#1)(2004-9#1)
were treated with systemic##2##4##(2008-6#1)(2013-8#1)
were treated with the combination of##2##6##(1997-7#1)(2008-4#1)
were treated with the##24##4##(1990-10#1)(1990-5#1)(1991-4#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-6#1)(1994-4#1)(1994-9#1)(1995-5#1)(1996-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2012-3#1)(2013-1#2)
were treated with this##3##4##(1993-11#1)(2007-8#1)(2008-7#1)
were treated with three different##2##5##(2007-7#1)(2008-5#1)
were treated with two##4##4##(1990-12#1)(1997-7#2)(2008-8#1)
were treated with various##4##4##(1992-6#1)(1992-8#1)(1993-6#1)(1997-8#1)
were treated with##431##3##(1990-10#3)(1990-11#2)(1990-12#7)(1990-2#4)(1990-3#2)(1990-4#3)(1990-5#2)(1990-6#2)(1990-8#2)(1990-9#1)(1991-10#3)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#3)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#3)(1991-9#5)(1992-1#3)(1992-10#2)(1992-11#1)(1992-12#2)(1992-3#4)(1992-4#1)(1992-5#3)(1992-6#5)(1992-7#1)(1992-8#4)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#4)(1994-2#1)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#5)(1995-2#4)(1995-3#1)(1995-5#4)(1995-7#3)(1996-1#3)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#4)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#2)(1997-6#6)(1997-7#4)(1997-8#7)(2004-1#1)(2004-10#1)(2004-3#1)(2004-9#2)(2005-1#1)(2005-10#2)(2005-12#1)(2005-7#2)(2006-10#5)(2006-11#1)(2006-12#5)(2006-2#2)(2006-4#2)(2006-5#2)(2006-6#5)(2006-7#1)(2006-8#5)(2006-9#1)(2007-10#6)(2007-11#7)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#14)(2007-8#17)(2007-9#2)(2008-1#5)(2008-10#25)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#8)(2008-4#4)(2008-5#12)(2008-6#13)(2008-7#10)(2008-8#4)(2008-9#5)(2009-10#1)(2009-2#1)(2009-3#3)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#3)(2011-2#15)(2012-1#1)(2012-12#8)(2012-2#6)(2012-3#3)(2013-1#13)(2013-7#2)(2013-8#9)
were treated##811##2##(1990-10#8)(1990-11#2)(1990-12#11)(1990-2#4)(1990-3#6)(1990-4#5)(1990-5#4)(1990-6#5)(1990-8#2)(1990-9#4)(1991-10#3)(1991-11#1)(1991-12#5)(1991-2#7)(1991-3#3)(1991-4#7)(1991-5#4)(1991-6#7)(1991-7#3)(1991-8#9)(1991-9#7)(1992-1#4)(1992-10#5)(1992-11#3)(1992-12#3)(1992-3#6)(1992-4#1)(1992-5#4)(1992-6#6)(1992-7#1)(1992-8#6)(1992-9#4)(1993-10#2)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#4)(1993-7#1)(1993-8#3)(1993-9#3)(1994-1#1)(1994-11#5)(1994-12#3)(1994-2#2)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#9)(1995-12#1)(1995-2#5)(1995-3#1)(1995-5#4)(1995-7#5)(1995-9#1)(1996-1#5)(1996-10#1)(1996-11#4)(1996-12#1)(1996-2#5)(1996-3#4)(1996-4#1)(1996-5#2)(1996-6#4)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#5)(1997-4#4)(1997-5#2)(1997-6#6)(1997-7#4)(1997-8#10)(2004-1#1)(2004-10#1)(2004-2#1)(2004-3#1)(2004-9#2)(2005-1#2)(2005-10#4)(2005-12#1)(2005-6#1)(2005-7#4)(2005-8#2)(2006-10#11)(2006-11#3)(2006-12#8)(2006-2#3)(2006-4#2)(2006-5#5)(2006-6#7)(2006-7#3)(2006-8#8)(2006-9#1)(2007-10#6)(2007-11#20)(2007-2#6)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#29)(2007-8#40)(2007-9#3)(2008-1#8)(2008-10#48)(2008-11#9)(2008-12#3)(2008-2#5)(2008-3#17)(2008-4#11)(2008-5#21)(2008-6#23)(2008-7#26)(2008-8#8)(2008-9#7)(2009-1#1)(2009-10#1)(2009-2#2)(2009-3#5)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#3)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#2)(2011-1#7)(2011-12#2)(2011-2#28)(2012-1#2)(2012-12#11)(2012-2#20)(2012-3#8)(2013-1#29)(2013-7#4)(2013-8#11)
were treatment failures##2##3##(1996-11#1)(2007-10#1)
were tried to be##2##4##(2008-8#1)(2013-1#1)
were tried##5##2##(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#1)
were triggered by##2##3##(2008-7#1)(2012-2#1)
were triggered##5##2##(1992-9#1)(1997-4#1)(2008-7#1)(2010-8#1)(2012-2#1)
were trimmed##2##2##(1993-11#1)(1995-5#1)
were true##5##2##(1991-6#1)(2008-7#1)(2013-1#3)
were truncated##2##2##(1994-8#1)(1997-6#1)
were tumor-free##2##2##(1990-10#1)(1993-9#1)
were tuned##3##2##(1993-2#1)(2008-3#1)(2010-4#1)
were twice as likely to##3##5##(1996-9#1)(2011-12#1)(2011-2#1)
were twice as many##2##4##(2009-11#1)(2013-1#1)
were twice as##7##3##(1992-7#1)(1993-3#1)(1996-9#1)(2009-11#1)(2011-12#1)(2011-2#1)(2013-1#1)
were twice##11##2##(1992-7#1)(1993-3#1)(1995-12#1)(1995-9#1)(1996-5#1)(1996-9#1)(2008-11#1)(2009-11#1)(2011-12#1)(2011-2#1)(2013-1#1)
were twins##3##2##(1993-2#1)(2008-10#1)(2008-12#1)
were two cases##4##3##(1997-3#1)(2004-10#1)(2006-10#1)(2008-1#1)
were two different##3##3##(2006-1#1)(2007-12#1)(2010-2#1)
were two dominant##2##3##(2004-4#1)(2005-11#1)
were two types##2##3##(2008-10#1)(2008-8#1)
were two##53##2##(1990-2#1)(1991-10#1)(1991-4#1)(1992-1#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-2#2)(1995-2#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-7#1)(2004-1#1)(2004-10#3)(2004-4#1)(2004-9#1)(2005-11#1)(2005-8#2)(2006-1#1)(2006-10#2)(2006-8#1)(2007-12#1)(2007-8#5)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-11#2)(2012-3#1)(2013-1#2)
were two-##2##2##(2008-10#1)(2008-2#1)
were type II##2##3##(2007-2#1)(2009-3#1)
were type III##2##3##(2009-3#2)
were type##11##2##(2006-5#1)(2006-6#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-3#5)
were typed for##2##3##(1994-12#1)(2007-2#1)
were typed##8##2##(1994-12#1)(1994-8#1)(1996-5#1)(1996-7#2)(2007-2#1)(2008-5#1)(2011-2#1)
were typical findings##2##3##(1993-1#1)(2009-9#1)
were typical of the##2##4##(1994-11#1)(2008-10#1)
were typical of##7##3##(1991-7#1)(1994-11#1)(1997-7#1)(2007-1#1)(2008-10#2)(2012-1#1)
were typical##11##2##(1991-7#1)(1993-1#1)(1994-11#1)(1997-7#1)(2007-1#1)(2008-10#3)(2009-9#1)(2012-1#1)(2012-12#1)
were typically##8##2##(1996-7#1)(2008-10#3)(2008-2#1)(2008-7#1)(2010-2#1)(2012-12#1)
were tyrosine phosphorylated##2##3##(1996-10#1)(2008-6#1)
were ultrasound##2##2##(1996-3#1)(2008-10#1)
were unable to achieve##3##4##(2008-10#1)(2008-12#1)(2010-12#1)
were unable to demonstrate##7##4##(1990-6#1)(1991-2#1)(1995-12#1)(1997-3#1)(2006-10#1)(2008-8#1)(2009-9#1)
were unable to detect##4##4##(1990-11#1)(1996-2#1)(1996-3#2)
were unable to grow##3##4##(1991-12#1)(1996-7#1)(2008-11#1)
were unable to perform##2##4##(2008-1#1)(2008-7#1)
were unable to transmit##2##4##(2008-10#2)
were unable to use##2##4##(2012-1#1)(2012-2#1)
were unable to##64##3##(1990-11#2)(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#2)(1991-9#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-5#1)(1995-12#2)(1995-5#1)(1996-2#1)(1996-3#3)(1996-7#1)(1997-3#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-2#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#1)(2009-6#2)(2009-9#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
were unaccounted for##2##3##(1992-2#1)(1997-3#1)
were unaffected by age##2##4##(1991-12#1)(1993-12#1)
were unaffected by the presence of##2##6##(2008-10#2)
were unaffected by the presence or absence of##2##8##(2008-10#2)
were unaffected by the presence##4##5##(2008-10#4)
were unaffected by the##10##4##(1991-8#1)(1992-3#1)(1993-3#1)(1994-6#1)(1996-12#1)(1997-6#1)(2008-10#4)
were unaffected by##29##3##(1990-11#1)(1990-12#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-6#1)(1994-8#1)(1996-12#2)(1997-6#1)(2004-11#1)(2007-8#1)(2008-10#6)(2008-5#1)(2008-8#1)(2010-5#1)(2013-1#1)
were unaffected in##5##3##(1995-3#1)(1995-5#1)(1996-3#1)(1996-5#1)(2008-7#1)
were unaffected##51##2##(1990-11#1)(1990-12#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-3#2)(1992-6#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-6#2)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-6#1)(2004-11#1)(2007-2#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2010-5#1)(2013-1#2)
were unaltered by##2##3##(1990-4#1)(1997-7#1)
were unaltered in##3##3##(1991-7#1)(1996-12#2)
were unaltered when##2##3##(1990-7#1)(1993-8#1)
were unaltered##18##2##(1990-4#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-7#1)(1992-3#1)(1993-8#1)(1994-12#1)(1994-9#1)(1996-12#2)(1997-7#1)(2006-12#1)(2008-8#3)(2011-1#1)(2012-2#1)
were unanimous##2##2##(2007-2#1)(2011-2#1)
were unaware of the##2##4##(2010-5#1)(2013-8#1)
were unaware of##3##3##(2010-5#1)(2012-2#1)(2013-8#1)
were unaware##4##2##(1996-9#1)(2010-5#1)(2012-2#1)(2013-8#1)
were uncertain##2##2##(1991-2#1)(2009-5#1)
were unchanged after##2##3##(1995-12#1)(1996-9#1)
were unchanged and##2##3##(1996-3#1)(2007-11#1)
were unchanged at##2##3##(1995-5#1)(2010-2#1)
were unchanged by##2##3##(1991-2#1)(2013-1#1)
were unchanged compared with##2##4##(1991-8#1)(2012-12#1)
were unchanged in##4##3##(1995-12#1)(2005-5#1)(2010-5#1)(2012-12#1)
were unchanged or##2##3##(1993-12#1)(2008-10#1)
were unchanged##44##2##(1990-3#1)(1991-2#2)(1991-8#1)(1991-9#1)(1992-2#2)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#2)(1996-9#1)(2005-5#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
were uncommon##5##2##(2005-7#1)(2005-8#1)(2006-10#1)(2007-10#1)(2012-12#1)
were uncorrelated##2##2##(2008-10#1)(2010-2#1)
were uncovered##2##2##(2006-1#1)(2007-9#1)
were under control##2##3##(2008-1#1)(2011-2#1)
were under the age of##2##5##(2008-9#1)(2011-2#1)
were under the influence of##2##5##(1995-8#1)(2013-8#1)
were under the##6##3##(1995-8#1)(2007-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
were under##24##2##(1991-3#1)(1993-5#2)(1993-7#1)(1995-5#1)(1995-8#1)(2006-1#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-1#2)(2011-2#2)(2013-7#1)(2013-8#1)
were underestimated##4##2##(1993-12#1)(1997-7#1)(2006-8#1)(2008-7#1)
were undergoing hemodialysis##2##3##(1994-12#1)(2010-12#1)
were undergoing##10##2##(1990-12#1)(1994-12#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2010-12#1)(2011-1#1)(2013-8#1)
were undertaken in##4##3##(2005-12#1)(2007-3#1)(2008-9#1)(2011-1#1)
were undertaken to determine the##2##5##(1990-4#1)(1991-4#1)
were undertaken to determine##4##4##(1990-4#1)(1991-4#1)(1993-11#1)(2004-11#1)
were undertaken to investigate the##2##5##(1995-6#1)(2006-10#1)
were undertaken to##19##3##(1990-4#1)(1991-4#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2006-10#1)(2006-8#1)(2007-10#1)(2008-10#1)(2008-8#1)(2010-5#2)(2012-12#1)
were undertaken using the##2##4##(2008-10#1)(2013-1#1)
were undertaken using##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
were undertaken##46##2##(1990-4#2)(1991-4#1)(1992-10#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-5#1)(1995-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-10#1)(2007-3#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#2)(2010-10#1)(2010-5#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
were underway##2##2##(2005-7#1)(2005-8#1)
were underweight##2##2##(1996-9#1)(2013-7#1)
were undetectable in the##2##4##(1991-12#1)(1991-5#1)
were undetectable in##8##3##(1990-11#2)(1991-12#1)(1991-5#1)(1992-3#1)(1995-6#1)(1996-11#1)(2012-12#1)
were undetectable##12##2##(1990-11#2)(1991-12#1)(1991-5#1)(1992-3#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-5#1)(2008-12#1)(2012-12#1)
were unemployed##3##2##(1993-5#1)(2008-10#2)
were uneventful##3##2##(1993-2#1)(2011-1#1)(2012-12#1)
were unexpectedly##2##2##(1996-12#1)(2008-8#1)
were unfamiliar##2##2##(2007-9#1)(2008-4#1)
were uniform##3##2##(2008-10#2)(2013-1#1)
were uniformly susceptible to##2##4##(2008-10#2)
were uniformly susceptible##3##3##(2008-10#3)
were uniformly##13##2##(1994-11#1)(1995-1#1)(1995-8#1)(2007-12#1)(2007-9#1)(2008-10#6)(2010-3#1)(2013-7#1)
were unilaterally##3##2##(1990-4#1)(1990-6#1)(2009-7#1)
were unimodal##2##2##(1991-9#1)(2010-2#1)
were unique in##2##3##(1990-4#1)(2008-11#1)
were unique to CLP##2##4##(2012-3#2)
were unique to the##3##4##(1996-8#1)(1997-4#1)(2011-12#1)
were unique to##11##3##(1991-12#1)(1996-8#1)(1997-4#1)(2006-9#1)(2008-10#4)(2011-12#1)(2012-3#2)
were unique##20##2##(1990-4#1)(1991-12#1)(1992-6#1)(1996-8#1)(1997-4#1)(2006-9#1)(2008-10#5)(2008-11#1)(2008-12#2)(2011-12#1)(2012-11#1)(2012-2#1)(2012-3#2)(2013-8#1)
were uniquely##4##2##(2005-11#1)(2008-10#1)(2010-4#2)
were united##3##2##(2007-8#1)(2009-4#1)(2012-2#1)
were univariately##3##2##(2007-10#2)(2012-1#1)
were universally##2##2##(1992-2#1)(2012-2#1)
were unknown##4##2##(1994-12#1)(1997-8#1)(2008-7#1)(2012-12#1)
were unlike##3##2##(1991-9#1)(1993-12#1)(2008-10#1)
were unlikely to be##3##4##(2008-10#1)(2008-5#1)(2010-1#1)
were unlikely to##6##3##(1991-11#1)(1993-6#1)(2008-10#1)(2008-5#1)(2010-1#1)(2011-2#1)
were unlikely##8##2##(1991-11#1)(1993-6#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-1#1)(2011-2#1)
were unlinked##2##2##(1994-9#1)(2008-10#1)
were unmarried##3##2##(1993-5#1)(2007-2#1)(2007-3#1)
were unrelated to the##3##4##(2008-10#1)(2009-1#1)(2010-2#1)
were unrelated to##9##3##(1995-8#1)(1996-10#1)(1996-2#1)(2008-10#2)(2008-12#1)(2008-4#1)(2009-1#1)(2010-2#1)
were unrelated##12##2##(1992-1#1)(1995-8#1)(1996-10#1)(1996-2#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-4#1)(2009-1#1)(2010-2#1)
were unreliable##2##2##(2007-8#1)(2008-10#1)
were unremarkable##7##2##(1992-2#1)(1995-11#1)(2005-7#1)(2006-12#1)(2009-2#1)(2012-3#1)(2013-8#1)
were unresolved##2##2##(1990-12#1)(2006-8#1)
were unresponsive to##4##3##(1992-8#1)(1993-2#1)(2006-10#1)(2008-11#1)
were unresponsive##6##2##(1991-3#1)(1992-8#1)(1993-2#1)(2006-10#1)(2008-11#1)(2011-2#1)
were unsatisfactory##3##2##(1990-10#1)(2008-10#1)(2010-4#1)
were unstable in##2##3##(1990-3#1)(2011-1#1)
were unstable##7##2##(1990-3#1)(1991-3#1)(2007-7#1)(2007-8#1)(2008-11#1)(2011-1#1)(2012-2#1)
were unsuccessful in##2##3##(1991-12#1)(2007-12#1)
were unsuccessful##13##2##(1991-12#1)(1993-11#1)(1995-5#1)(1996-4#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-5#1)(2012-3#1)
were unsuitable##2##2##(1994-9#1)(2007-8#1)
were unsure or would object##2##5##(1993-8#2)
were unsure##3##2##(1993-8#2)(2006-10#1)
were untreated##5##2##(1990-6#1)(1991-2#1)(1995-2#1)(2006-4#1)(2008-5#1)
were unwilling to##3##3##(1993-3#1)(2006-12#1)(2012-3#1)
were up to 1##2##4##(2008-10#2)
were up to##15##3##(1991-10#1)(1996-12#1)(2006-10#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-8#1)(2012-12#1)(2013-8#1)
were up-regulated in##3##3##(1995-11#1)(2009-4#1)(2011-3#1)
were up-regulated##13##2##(1995-11#1)(1997-4#1)(2006-12#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-4#1)(2011-3#1)(2013-8#1)
were upper##3##2##(1994-3#1)(2007-8#1)(2010-1#1)
were upregulated and##2##3##(1996-8#1)(2010-5#1)
were upregulated in the##2##4##(2012-1#1)(2013-1#1)
were upregulated in##4##3##(2008-7#1)(2010-12#1)(2012-1#1)(2013-1#1)
were upregulated##13##2##(1996-8#1)(2008-10#2)(2008-7#1)(2009-8#1)(2010-12#1)(2010-5#2)(2011-2#1)(2012-1#1)(2013-1#2)(2013-7#1)
were urinary##2##2##(2007-8#1)(2013-8#1)
were use of##2##3##(1997-3#1)(2011-2#1)
were used -##3##3##(2012-2#1)(2013-1#2)
were used according to the##3##5##(1994-1#1)(2007-11#1)(2011-2#1)
were used after##2##3##(1995-9#1)(2004-11#1)
were used alone##2##3##(1991-1#1)(2008-10#1)
were used and compared as##2##5##(2008-10#1)(2008-2#1)
were used and compared##4##4##(2008-10#2)(2008-2#1)(2010-4#1)
were used and##17##3##(1990-3#1)(1992-9#1)(1993-4#1)(1995-2#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2010-3#1)(2010-4#2)(2012-3#1)(2013-1#1)
were used as a control##4##5##(2007-3#1)(2007-7#1)(2008-5#1)(2008-8#1)
were used as a model##5##5##(1991-5#1)(2006-5#1)(2008-10#1)(2008-6#1)(2010-8#1)
were used as a##20##4##(1991-5#1)(1996-9#1)(2005-8#1)(2006-5#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-1#1)(2010-4#1)(2010-8#1)(2012-6#1)
were used as age-matched controls##2##5##(2008-7#2)
were used as an##5##4##(1992-2#1)(1992-7#1)(2007-5#1)(2008-10#2)
were used as antigens##2##4##(1990-12#1)(2012-12#1)
were used as bait##2##4##(2007-7#1)(2008-6#1)
were used as chemical##2##4##(2008-10#2)
were used as control##3##4##(2008-8#1)(2009-8#1)(2012-12#1)
were used as controls for##2##5##(1992-2#1)(1995-7#1)
were used as controls##23##4##(1990-12#1)(1992-2#1)(1993-10#1)(1993-11#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-5#1)(2004-11#1)(2006-10#1)(2006-4#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-4#2)(2008-5#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
were used as criteria##3##4##(2008-10#1)(2008-12#1)(2013-7#1)
were used as female##2##4##(2008-5#1)(2013-8#1)
were used as host##3##4##(2004-2#1)(2008-10#1)(2008-3#1)
were used as input for##2##5##(2008-10#1)(2012-12#1)
were used as input##3##4##(2008-10#2)(2012-12#1)
were used as internal standards##2##5##(2008-10#2)
were used as markers for##2##5##(2008-10#1)(2011-1#1)
were used as markers##5##4##(2008-10#3)(2008-7#1)(2011-1#1)
were used as measures##2##4##(2004-9#1)(2008-3#1)
were used as model##3##4##(1996-7#1)(2008-10#1)(2010-9#1)
were used as parameters##2##4##(2008-11#1)(2008-7#1)
were used as positive##2##4##(1993-9#1)(2013-1#1)
were used as primary##2##4##(2007-12#1)(2008-1#1)
were used as primers##2##4##(1991-6#2)
were used as probes to##3##5##(1990-7#1)(1993-11#1)(2008-10#1)
were used as reference##2##4##(2009-5#1)(2010-10#1)
were used as sources of##2##5##(1993-12#1)(1997-4#1)
were used as starting##2##4##(1991-7#1)(2008-10#1)
were used as substrates##10##4##(1991-10#1)(1991-2#1)(1994-5#2)(1994-8#1)(1994-9#1)(2005-11#1)(2006-12#1)(2007-11#1)(2008-6#1)
were used as templates##3##4##(2007-12#1)(2008-10#1)(2008-5#1)
were used as test##4##4##(1995-8#1)(1996-8#1)(2008-10#2)
were used as the basis for##2##6##(2008-10#1)(2010-3#1)
were used as the internal standards for##2##7##(1992-2#1)(2012-12#1)
were used as the##29##4##(1991-12#1)(1992-2#1)(1994-6#1)(1996-5#1)(2005-11#1)(2005-8#1)(2007-11#2)(2007-8#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-3#1)(2012-12#4)(2012-9#1)
were used as##241##3##(1990-12#2)(1990-2#2)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-2#3)(1992-7#2)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-2#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-5#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(2004-11#2)(2004-2#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-8#2)(2006-10#1)(2006-12#2)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#5)(2008-1#1)(2008-10#56)(2008-11#5)(2008-12#5)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#7)(2008-6#5)(2008-7#5)(2008-8#5)(2008-9#3)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#8)(2012-2#2)(2012-3#1)(2012-6#2)(2012-9#1)(2013-1#4)(2013-7#1)(2013-8#5)
were used at all##2##4##(2006-8#1)(2008-10#1)
were used at different##2##4##(2004-9#1)(2006-5#1)
were used at##9##3##(2004-9#1)(2006-5#1)(2006-8#1)(2008-10#3)(2008-11#1)(2009-11#1)(2011-2#1)
were used by the##2##4##(2010-3#1)(2012-11#1)
were used by##10##3##(1991-2#2)(1997-9#1)(2008-10#1)(2008-3#1)(2010-3#2)(2012-11#1)(2012-2#1)(2013-1#1)
were used directly##2##3##(1993-6#1)(2007-1#1)
were used for a##7##4##(1990-2#1)(1994-1#1)(1996-8#1)(2008-10#2)(2010-12#1)(2013-1#1)
were used for analysis of##2##5##(2007-2#1)(2008-10#1)
were used for analysis##5##4##(2007-2#2)(2008-10#1)(2010-6#1)(2012-12#1)
were used for calibration##4##4##(1992-4#1)(2008-10#3)
were used for characterization of##3##5##(2008-10#1)(2009-3#2)
were used for comparison of##2##5##(2006-5#1)(2008-10#1)
were used for comparison##8##4##(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#2)(2009-8#1)(2013-1#1)(2013-7#1)
were used for constructing##3##4##(2008-10#2)(2009-10#1)
were used for data analysis##2##5##(2006-10#1)(2010-12#1)
were used for data##5##4##(1993-2#1)(2006-10#1)(2007-10#2)(2010-12#1)
were used for determination of##4##5##(2006-8#1)(2008-10#1)(2008-7#1)(2008-8#1)
were used for each##2##4##(2008-10#2)
were used for evaluation##2##4##(1996-3#1)(2011-2#1)
were used for fitting##2##4##(2007-12#1)(2008-10#1)
were used for histopathological examination##2##5##(2010-4#1)(2011-1#1)
were used for in##2##4##(1995-11#1)(2010-5#1)
were used for investigation of##2##5##(1990-5#1)(2009-8#1)
were used for preparation of##2##5##(2005-10#1)(2008-10#1)
were used for quantitative##2##4##(2008-10#1)(2008-5#1)
were used for selection of##2##5##(2008-10#1)(2009-2#1)
were used for sequential injection chromatographic separations in our study##2##10##(2008-10#2)
were used for statistical##3##4##(1996-12#1)(2008-6#1)(2008-9#1)
were used for studying the##2##5##(2006-5#1)(2008-10#1)
were used for studying##3##4##(2005-11#1)(2006-5#1)(2008-10#1)
were used for the assay##2##5##(1991-9#1)(2008-10#1)
were used for the determination of##4##6##(2008-10#4)
were used for the diagnosis##2##5##(2005-9#1)(2006-8#1)
were used for the estimation of the##2##7##(2005-11#1)(2008-10#1)
were used for the evaluation of the##2##7##(1997-3#1)(2012-1#1)
were used for the evaluation of##3##6##(1997-3#1)(2008-10#1)(2012-1#1)
were used for the evaluation##4##5##(1997-3#1)(2008-10#1)(2012-1#1)(2013-8#1)
were used for the study##4##5##(2008-1#1)(2009-5#2)(2011-2#1)
were used for the##68##4##(1990-2#1)(1991-9#1)(1993-6#1)(1993-9#2)(1994-3#1)(1997-3#1)(2005-11#1)(2005-9#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#28)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-4#1)(2009-5#3)(2010-4#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#3)(2013-1#1)(2013-8#1)
were used for this purpose##4##5##(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#1)
were used for this study##6##5##(1993-12#1)(1993-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2012-2#1)
were used for this##13##4##(1993-12#1)(1993-3#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#2)(2012-2#2)(2013-1#2)
were used for transfection of##2##5##(1993-4#1)(1997-5#1)
were used for treatment##2##4##(2007-11#1)(2013-8#1)
were used for##263##3##(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-9#1)(1992-1#1)(1992-4#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-9#3)(1994-1#1)(1994-3#1)(1995-11#1)(1995-7#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(2004-9#1)(2005-10#1)(2005-11#4)(2005-4#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-4#2)(2006-5#2)(2006-7#1)(2006-8#3)(2007-10#5)(2007-11#4)(2007-12#6)(2007-2#2)(2007-4#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#73)(2008-11#6)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#8)(2008-6#5)(2008-7#4)(2008-8#8)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#3)(2009-7#1)(2009-8#2)(2010-12#3)(2010-4#3)(2010-5#1)(2010-6#1)(2011-1#4)(2011-12#2)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#7)(2012-2#4)(2013-1#8)(2013-7#4)(2013-8#3)
were used from##2##3##(2009-7#1)(2013-8#1)
were used in a model##3##5##(1996-3#1)(1996-4#1)(2007-10#1)
were used in a##16##4##(1995-2#1)(1996-3#1)(1996-4#1)(2005-12#1)(2007-10#1)(2007-12#1)(2008-10#5)(2008-12#1)(2009-4#1)(2009-9#1)(2012-11#1)(2013-8#1)
were used in all##3##4##(2008-10#1)(2011-2#2)
were used in an##2##4##(1994-5#1)(2008-3#1)
were used in combination with##6##5##(1991-4#1)(2007-12#1)(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
were used in combination##9##4##(1991-4#1)(1993-12#2)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
were used in conjunction with##6##5##(1992-9#1)(1996-2#1)(1996-9#1)(1997-8#1)(2007-7#1)(2009-12#1)
were used in order to##10##5##(1994-6#2)(2007-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)
were used in the analyses##2##5##(2008-10#1)(2010-4#1)
were used in the analysis##2##5##(1995-5#1)(2008-10#1)
were used in the study##3##5##(2007-11#1)(2009-3#1)(2010-8#1)
were used in the validation##2##5##(2010-8#1)(2012-3#1)
were used in the##34##4##(1991-9#1)(1993-9#1)(1994-3#1)(1995-5#1)(1997-3#1)(2007-1#1)(2007-11#3)(2007-6#1)(2008-10#11)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-4#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-3#2)
were used in these experiments##2##5##(1995-9#1)(2008-10#1)
were used in these##3##4##(1995-9#1)(2008-10#1)(2008-7#1)
were used in this study to##2##6##(1996-12#1)(2011-2#1)
were used in this study##24##5##(1996-12#1)(1997-8#1)(2005-11#1)(2006-5#1)(2007-1#2)(2007-6#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-2#2)(2011-2#1)(2012-11#2)(2013-1#1)
were used in this##26##4##(1994-12#1)(1996-12#1)(1997-8#1)(2005-11#1)(2006-5#1)(2007-1#2)(2007-6#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-2#2)(2011-2#1)(2012-11#2)(2013-1#1)
were used in two##2##4##(2008-5#1)(2010-8#1)
were used in vitro##2##4##(1997-5#1)(2011-3#1)
were used in##165##3##(1991-4#1)(1991-7#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#2)(1995-12#2)(1995-2#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-8#3)(2005-11#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-1#3)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#2)(2007-6#2)(2007-7#5)(2007-8#2)(2008-1#2)(2008-10#42)(2008-11#5)(2008-12#6)(2008-2#2)(2008-3#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-2#2)(2010-4#1)(2010-8#3)(2011-1#1)(2011-2#8)(2011-3#1)(2012-11#3)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#2)
were used individually##2##3##(2009-3#1)(2009-4#1)
were used more##3##3##(2006-2#1)(2007-8#1)(2011-2#1)
were used on##5##3##(2007-7#1)(2008-10#2)(2008-5#1)(2011-1#1)
were used over##3##3##(2008-10#2)(2008-12#1)
were used to account for the##2##6##(1990-8#1)(2012-3#1)
were used to achieve##2##4##(2007-11#1)(2008-10#1)
were used to address##2##4##(2008-10#1)(2011-2#1)
were used to administer##2##4##(1991-3#2)
were used to amplify the##2##5##(2008-10#1)(2012-12#1)
were used to amplify##7##4##(1996-10#1)(2006-5#1)(2007-6#1)(2008-10#2)(2008-8#1)(2012-12#1)
were used to analyse the##4##5##(1995-11#1)(1997-1#1)(2010-2#1)(2012-3#1)
were used to analyse##7##4##(1995-11#1)(1997-1#1)(2007-9#1)(2008-10#2)(2010-2#1)(2012-3#1)
were used to analyze the data##5##6##(2007-10#1)(2008-10#1)(2010-12#1)(2011-12#1)(2013-1#1)
were used to analyze the##15##5##(1991-8#1)(1994-12#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-8#3)(2010-12#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
were used to analyze##22##4##(1991-8#1)(1994-12#1)(2006-4#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-8#3)(2009-9#1)(2010-12#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
were used to ascertain the##2##5##(2008-10#1)(2010-2#1)
were used to assess differences in##2##6##(1995-1#1)(2013-1#1)
were used to assess the effects of##2##7##(2005-11#1)(2008-5#1)
were used to assess the impact of##3##7##(1990-5#1)(2008-10#1)(2008-11#1)
were used to assess the outcome##2##6##(2007-11#1)(2007-7#1)
were used to assess the quality of##2##7##(2008-10#1)(2008-6#1)
were used to assess the##23##5##(1990-5#1)(1994-11#1)(1995-8#1)(2005-11#2)(2005-12#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2009-9#1)(2010-1#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)
were used to assess##51##4##(1990-3#1)(1990-5#1)(1990-7#1)(1991-6#1)(1994-11#1)(1995-1#1)(1995-8#1)(1996-12#1)(1997-2#1)(2005-11#2)(2005-12#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-1#1)(2010-12#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#2)
were used to assign##3##4##(1991-4#1)(1996-5#1)(2010-4#1)
were used to avoid##2##4##(1991-9#1)(1995-7#1)
were used to build##3##4##(2008-10#2)(2010-5#1)
were used to calculate a##3##5##(1993-11#1)(2004-11#1)(2009-8#1)
were used to calculate the##9##5##(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-7#1)(2011-12#1)(2013-8#1)
were used to calculate##21##4##(1990-4#1)(1990-5#1)(1992-5#1)(1993-11#1)(2004-11#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)(2009-7#1)(2009-8#2)(2011-12#1)(2013-8#1)
were used to characterize the##12##5##(1993-12#1)(2005-11#1)(2007-12#1)(2008-10#4)(2008-5#1)(2010-8#1)(2011-2#1)(2013-8#2)
were used to characterize##22##4##(1991-9#1)(1993-12#1)(1993-2#1)(2004-9#1)(2005-11#1)(2007-1#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-5#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-8#2)
were used to check the prediction ability of the##2##9##(2008-10#2)
were used to check the##5##5##(2005-11#1)(2008-10#2)(2008-12#1)(2008-5#1)
were used to check##8##4##(2005-11#1)(2008-10#4)(2008-12#1)(2008-5#1)(2009-4#1)
were used to classify##4##4##(1993-12#1)(1995-2#1)(2006-5#1)(2008-8#1)
were used to collect data##7##5##(2007-10#1)(2007-2#1)(2008-11#2)(2010-10#1)(2012-3#2)
were used to collect the##2##5##(2008-11#1)(2012-12#1)
were used to collect##14##4##(2007-10#1)(2007-2#1)(2008-10#2)(2008-11#3)(2010-10#1)(2010-5#1)(2012-12#2)(2012-3#2)(2013-1#1)
were used to compare the##6##5##(2008-1#1)(2008-10#1)(2008-5#1)(2011-1#2)(2013-7#1)
were used to compare##16##4##(1993-2#1)(1994-5#1)(1997-2#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-5#1)(2011-1#2)(2012-2#1)(2013-7#1)
were used to confirm the##2##5##(2006-3#1)(2011-2#1)
were used to confirm##3##4##(2006-3#1)(2008-10#1)(2011-2#1)
were used to construct a partial##2##6##(2006-10#1)(2008-10#1)
were used to construct a phylogenetic tree##2##7##(1995-3#1)(2012-2#1)
were used to construct a##6##5##(1991-4#1)(1995-3#1)(2006-10#1)(2008-10#2)(2012-2#1)
were used to construct##12##4##(1991-4#1)(1993-8#1)(1995-3#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-10#4)(2008-2#1)(2012-2#1)
were used to control##2##4##(2007-12#1)(2008-3#1)
were used to create##4##4##(1995-6#1)(2008-4#1)(2008-8#1)(2010-4#1)
were used to define the##3##5##(1996-7#1)(1997-3#1)(2010-10#1)
were used to define##6##4##(1990-11#1)(1996-7#1)(1997-3#1)(2005-8#1)(2010-10#1)(2011-2#1)
were used to demonstrate that##4##5##(1992-7#1)(1995-1#1)(2008-10#1)(2011-1#1)
were used to demonstrate the feasibility of##2##7##(2008-10#2)
were used to demonstrate the##7##5##(2007-7#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)
were used to demonstrate##11##4##(1992-7#1)(1995-1#1)(2007-7#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)
were used to derive a##2##5##(2007-8#1)(2011-2#1)
were used to derive##3##4##(2007-8#1)(2008-11#1)(2011-2#1)
were used to describe the##5##5##(1994-2#1)(2008-10#3)(2011-2#1)
were used to describe##7##4##(1993-3#1)(1994-2#1)(2008-10#3)(2010-3#1)(2011-2#1)
were used to design##7##4##(1995-3#1)(2008-10#4)(2008-5#1)(2009-5#1)
were used to detect the##6##5##(1996-5#1)(1996-8#1)(2007-2#1)(2008-10#2)(2011-2#1)
were used to detect##13##4##(1990-8#1)(1991-8#1)(1996-5#1)(1996-8#1)(2005-12#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-5#1)(2011-1#1)(2011-2#1)
were used to determine associations between##2##6##(2009-9#1)(2011-1#1)
were used to determine both##2##5##(2005-11#1)(2008-10#1)
were used to determine genetic relationships##2##6##(2008-10#2)
were used to determine significant##2##5##(2008-10#1)(2012-2#1)
were used to determine the conformations##2##6##(1990-5#1)(1995-11#1)
were used to determine the##48##5##(1990-5#1)(1990-7#1)(1991-1#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-3#1)(1994-12#1)(1994-7#1)(1995-11#3)(1995-2#1)(1995-7#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-5#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-8#1)(2010-12#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
were used to determine whether##6##5##(2007-12#1)(2008-10#2)(2011-2#1)(2012-12#1)(2013-1#1)
were used to determine##91##4##(1990-5#1)(1990-7#1)(1991-1#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-7#1)(1994-12#1)(1994-7#1)(1995-11#3)(1995-2#1)(1995-7#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-8#1)(2005-11#2)(2005-12#1)(2006-10#2)(2006-11#1)(2006-5#2)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-9#2)(2008-10#21)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-9#1)(2010-12#1)(2010-5#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
were used to develop a##4##5##(1996-3#1)(2007-4#1)(2007-9#1)(2012-12#1)
were used to develop the##4##5##(2008-10#1)(2013-1#2)(2013-8#1)
were used to develop##19##4##(1993-3#1)(1995-1#1)(1996-3#1)(2007-1#1)(2007-4#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2012-12#2)(2013-1#3)(2013-8#1)
were used to differentiate##2##4##(2008-5#1)(2008-7#1)
were used to drive the##2##5##(2008-8#1)(2009-8#1)
were used to elicit##2##4##(2007-3#1)(2008-11#1)
were used to elucidate the##2##5##(1990-3#1)(2008-10#1)
were used to elucidate##3##4##(1990-3#1)(2008-10#2)
were used to enhance##3##4##(2007-8#1)(2008-10#2)
were used to establish a##2##5##(1991-6#1)(2007-4#1)
were used to establish##9##4##(1991-1#1)(1991-6#1)(2007-4#1)(2009-2#1)(2011-1#1)(2012-2#2)(2013-1#2)
were used to estimate SA treatment expenditures##2##7##(2005-9#2)
were used to estimate the number of##2##7##(1996-9#1)(2007-1#1)
were used to estimate the##13##5##(1996-9#1)(1997-2#1)(2005-11#1)(2007-1#2)(2007-8#1)(2008-10#4)(2008-3#2)(2011-1#1)
were used to estimate##26##4##(1990-10#1)(1990-9#1)(1995-8#1)(1996-9#1)(1997-2#1)(2005-11#1)(2005-9#2)(2007-1#2)(2007-8#1)(2008-10#7)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-12#1)(2013-1#1)
were used to evaluate the effects of##2##7##(2012-2#1)(2012-3#1)
were used to evaluate the##25##5##(1993-1#1)(1993-3#1)(1996-11#1)(2005-11#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#6)(2008-5#1)(2008-6#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
were used to evaluate##39##4##(1990-10#1)(1993-1#1)(1993-3#1)(1994-3#1)(1996-11#1)(2005-11#1)(2006-12#1)(2006-3#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-10#7)(2008-12#2)(2008-5#2)(2008-6#1)(2009-10#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
were used to examine the effect of##2##7##(1996-12#1)(2007-5#1)
were used to examine the##16##5##(1990-2#1)(1993-12#1)(1994-11#1)(1995-4#1)(1996-12#1)(1996-5#1)(2005-10#1)(2006-11#1)(2007-5#1)(2008-10#2)(2009-4#1)(2010-9#1)(2012-1#1)(2012-2#1)(2012-3#1)
were used to examine whether##2##5##(1991-3#1)(2008-12#1)
were used to examine##28##4##(1990-2#1)(1991-3#1)(1992-3#1)(1993-12#1)(1994-11#1)(1995-4#1)(1996-12#1)(1996-5#1)(2005-10#1)(2006-11#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2009-11#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-9#1)(2012-1#1)(2012-2#1)(2012-3#1)
were used to exclude##2##4##(1994-6#1)(2008-3#1)
were used to explore the##7##5##(1990-12#1)(2007-8#1)(2009-12#1)(2009-5#1)(2010-2#1)(2012-2#1)(2012-3#1)
were used to explore##11##4##(1990-12#1)(1997-3#1)(2005-12#1)(2007-8#1)(2008-10#2)(2009-12#1)(2009-5#1)(2010-2#1)(2012-2#1)(2012-3#1)
were used to express##3##4##(2008-11#1)(2008-9#1)(2010-12#1)
were used to extract##2##4##(2012-12#1)(2012-3#1)
were used to fabricate##4##4##(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)
were used to find##3##4##(2006-9#1)(2008-3#1)(2008-8#1)
were used to fit the##3##5##(2004-12#1)(2008-10#1)(2008-9#1)
were used to fit##7##4##(2004-12#1)(2005-11#1)(2006-4#1)(2008-10#2)(2008-11#1)(2008-9#1)
were used to follow the##3##5##(1991-12#1)(2008-10#1)(2008-2#1)
were used to follow##4##4##(1991-12#1)(2006-8#1)(2008-10#1)(2008-2#1)
were used to further clarify the nature of##2##8##(2008-10#2)
were used to further##3##4##(1996-12#1)(2008-10#2)
were used to generate a##2##5##(2008-10#1)(2010-9#1)
were used to generate##11##4##(1991-9#1)(1994-3#1)(1995-1#1)(1997-3#1)(2007-11#1)(2008-10#5)(2010-9#1)
were used to guide the##2##5##(1995-3#1)(2007-4#1)
were used to identify a##2##5##(1992-2#1)(1997-2#1)
were used to identify and##2##5##(1994-8#1)(2011-2#1)
were used to identify markers linked to##2##7##(2008-10#2)
were used to identify predictors of##2##6##(2007-10#1)(2009-5#1)
were used to identify the##13##5##(1993-4#1)(1994-12#1)(2005-10#1)(2007-3#1)(2007-8#1)(2008-10#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
were used to identify##46##4##(1992-2#1)(1992-8#1)(1993-4#1)(1994-12#1)(1994-8#1)(1997-2#1)(2005-10#1)(2005-11#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-2#3)(2012-3#2)(2013-1#7)(2013-8#2)
were used to illustrate that##2##5##(2005-8#1)(2009-2#1)
were used to illustrate##3##4##(1994-9#1)(2005-8#1)(2009-2#1)
were used to improve the##3##5##(2008-10#1)(2008-3#2)
were used to improve##4##4##(2008-10#1)(2008-3#2)(2009-2#1)
were used to increase the##2##5##(2008-10#1)(2011-2#1)
were used to increase##3##4##(2008-10#1)(2010-11#1)(2011-2#1)
were used to infect##4##4##(1991-6#1)(1992-3#1)(1995-5#1)(2007-6#1)
were used to infer the##3##5##(1992-1#1)(1994-3#1)(2010-8#1)
were used to inoculate##4##4##(2008-10#4)
were used to investigate the effect of##4##7##(1993-3#1)(1994-9#1)(2008-10#1)(2013-1#1)
were used to investigate the effects of##3##7##(2008-8#1)(2009-8#1)(2010-4#1)
were used to investigate the genetic diversity##2##7##(2008-10#1)(2013-8#1)
were used to investigate the response##2##6##(1993-11#1)(2008-9#1)
were used to investigate the role of##2##7##(2008-6#1)(2011-2#1)
were used to investigate the##33##5##(1991-5#1)(1992-12#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-9#1)(1995-7#1)(1996-5#1)(1996-6#1)(2005-11#2)(2007-12#1)(2008-10#6)(2008-6#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
were used to investigate their##2##5##(1997-8#1)(2008-10#1)
were used to investigate##47##4##(1991-5#1)(1991-6#1)(1992-12#1)(1993-11#2)(1993-12#2)(1993-3#1)(1994-12#1)(1994-9#1)(1995-7#1)(1996-5#2)(1996-6#1)(1997-8#1)(2005-11#2)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
were used to isolate a##2##5##(1991-2#1)(1994-6#1)
were used to isolate##6##4##(1991-2#1)(1991-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-2#1)
were used to localize##3##4##(1994-10#1)(1994-2#1)(1997-6#1)
were used to make##4##4##(2007-11#1)(2008-3#1)(2008-9#1)(2010-10#1)
were used to map##2##4##(1993-12#1)(2008-10#1)
were used to measure changes in##3##6##(1991-5#1)(2008-7#1)(2012-3#1)
were used to measure the##7##5##(1990-12#1)(1994-5#1)(1995-6#1)(1997-1#1)(2008-7#1)(2012-12#1)(2012-3#1)
were used to measure##21##4##(1990-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-9#1)(1994-4#1)(1994-5#1)(1994-6#1)(1995-6#1)(1996-9#1)(1997-1#1)(2004-11#1)(2008-5#2)(2008-7#2)(2008-8#1)(2012-12#2)(2012-3#2)
were used to model the##5##5##(1992-12#1)(1994-8#1)(2008-10#2)(2009-7#1)
were used to model##7##4##(1992-12#1)(1994-8#1)(2008-10#2)(2009-7#1)(2011-2#1)(2013-7#1)
were used to modify the##2##5##(2004-9#1)(2008-10#1)
were used to modify##3##4##(2004-9#1)(2008-10#2)
were used to monitor the##5##5##(1994-9#1)(1995-4#1)(1997-5#1)(2005-11#1)(2008-10#1)
were used to monitor##11##4##(1991-2#1)(1994-9#1)(1995-11#1)(1995-4#1)(1995-5#1)(1997-5#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-7#1)
were used to observe##4##4##(2007-3#1)(2008-4#1)(2011-1#1)(2013-1#1)
were used to obtain a##2##5##(2004-12#1)(2005-11#1)
were used to obtain##15##4##(1991-11#1)(1993-6#1)(1994-3#1)(1995-2#1)(2004-12#1)(2005-11#2)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2012-12#1)
were used to predict the##5##5##(1992-4#1)(1997-2#1)(2009-3#1)(2009-6#1)(2009-9#1)
were used to predict##13##4##(1992-4#1)(1995-6#1)(1997-2#1)(2007-10#1)(2008-10#4)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#1)(2013-1#1)
were used to prepare##7##4##(1993-3#1)(2006-12#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-12#1)(2012-2#1)
were used to probe the##2##5##(1995-3#1)(2013-8#1)
were used to probe##8##4##(1991-12#1)(1991-9#1)(1994-3#1)(1995-3#1)(1995-9#1)(2008-8#1)(2009-12#1)(2013-8#1)
were used to produce the##2##5##(2008-3#1)(2011-3#1)
were used to produce##7##4##(1990-6#1)(1992-9#1)(2008-10#3)(2008-3#1)(2011-3#1)
were used to provide##2##4##(2006-12#1)(2008-11#1)
were used to quantify##4##4##(2006-11#1)(2008-10#2)(2010-10#1)
were used to rapidly detect microbial contamination##2##7##(2012-2#2)
were used to record##4##4##(1994-2#1)(1996-5#1)(1996-9#1)(2008-2#1)
were used to reduce##2##4##(1997-4#1)(2008-2#1)
were used to remove##3##4##(2007-6#1)(2008-10#1)(2008-5#1)
were used to represent the##2##5##(2008-10#1)(2008-12#1)
were used to represent##4##4##(2008-10#2)(2008-12#1)(2008-2#1)
were used to resolve##2##4##(2007-12#1)(2008-10#1)
were used to reveal##3##4##(1997-2#1)(1997-3#1)(2008-10#1)
were used to review##3##4##(1990-12#1)(1996-2#1)(1996-3#1)
were used to screen##3##4##(1992-8#1)(2008-8#1)(2008-9#1)
were used to secure the##2##5##(2008-10#1)(2013-1#1)
were used to select the##2##5##(1993-12#1)(2012-3#1)
were used to select##3##4##(1993-12#1)(2012-1#1)(2012-3#1)
were used to separate##3##4##(2008-10#3)
were used to show that the##2##6##(1993-6#1)(2008-11#1)
were used to show that##3##5##(1993-6#1)(1994-9#1)(2008-11#1)
were used to show the##6##5##(1995-10#1)(1997-7#1)(2008-10#1)(2008-3#1)(2012-2#1)(2012-3#1)
were used to show##9##4##(1993-6#1)(1994-9#1)(1995-10#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)(2012-3#1)
were used to simulate the##2##5##(2007-11#1)(2008-3#1)
were used to simulate##4##4##(2007-11#1)(2008-3#2)(2008-8#1)
were used to study the blood##2##6##(1996-3#1)(2006-5#1)
were used to study the effect of the radiation on##2##10##(2013-7#2)
were used to study the effect of##7##7##(1991-7#1)(1992-3#1)(2008-7#1)(2008-8#1)(2010-6#1)(2013-7#2)
were used to study the effects of##3##7##(1997-5#1)(2010-4#1)(2013-7#1)
were used to study the population##2##6##(2008-10#2)
were used to study the relationship between##2##7##(2008-10#2)
were used to study the##45##5##(1990-4#1)(1991-12#1)(1991-7#1)(1992-3#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-10#1)(1995-5#1)(1996-1#1)(1996-3#1)(1997-5#2)(2005-11#2)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-2#1)(2010-4#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-7#3)
were used to study their##2##5##(1991-5#1)(1995-12#1)
were used to study##62##4##(1990-2#1)(1990-4#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-3#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-3#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-5#2)(2005-11#2)(2006-12#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#3)(2009-2#1)(2009-5#1)(2010-4#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-7#3)
were used to synthesize##2##4##(2008-10#1)(2008-9#1)
were used to test the##5##5##(2006-11#1)(2008-10#2)(2008-11#1)(2013-7#1)
were used to test whether##2##5##(1992-8#1)(2008-10#1)
were used to test##13##4##(1992-8#1)(2006-11#1)(2008-10#4)(2008-11#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-7#1)
were used to track##2##4##(2008-10#1)(2008-6#1)
were used to treat##3##4##(2008-4#1)(2008-5#1)(2008-8#1)
were used to understand##2##4##(2010-4#1)(2012-3#1)
were used to validate the model##2##6##(2007-4#1)(2008-10#1)
were used to validate the##9##5##(1996-3#1)(2007-4#1)(2008-10#5)(2010-12#1)(2011-1#1)
were used to validate##11##4##(1995-3#1)(1996-3#1)(2007-12#1)(2007-4#1)(2008-10#5)(2010-12#1)(2011-1#1)
were used to visualize##2##4##(1997-5#1)(2009-7#1)
were used to##1030##3##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#3)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#2)(1991-1#2)(1991-11#3)(1991-12#3)(1991-2#5)(1991-3#3)(1991-4#2)(1991-5#3)(1991-6#4)(1991-7#1)(1991-8#3)(1991-9#5)(1992-1#2)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#4)(1992-9#1)(1993-1#2)(1993-11#3)(1993-12#10)(1993-2#2)(1993-3#8)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#3)(1993-9#3)(1994-10#2)(1994-11#3)(1994-12#6)(1994-2#3)(1994-3#6)(1994-4#1)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#3)(1994-9#4)(1995-1#6)(1995-10#3)(1995-11#5)(1995-12#1)(1995-2#5)(1995-3#6)(1995-4#2)(1995-5#3)(1995-6#3)(1995-7#3)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#4)(1996-5#8)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#4)(1997-2#7)(1997-3#5)(1997-4#2)(1997-5#6)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#2)(2004-12#2)(2004-9#2)(2005-10#2)(2005-11#19)(2005-12#4)(2005-8#3)(2005-9#2)(2006-10#6)(2006-11#5)(2006-12#6)(2006-3#5)(2006-4#2)(2006-5#6)(2006-7#1)(2006-8#5)(2006-9#1)(2007-1#4)(2007-10#11)(2007-11#13)(2007-12#15)(2007-2#4)(2007-3#4)(2007-4#9)(2007-5#2)(2007-6#3)(2007-7#10)(2007-8#17)(2007-9#6)(2008-1#3)(2008-10#210)(2008-11#21)(2008-12#11)(2008-2#13)(2008-3#22)(2008-4#6)(2008-5#25)(2008-6#9)(2008-7#13)(2008-8#23)(2008-9#9)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#4)(2009-3#1)(2009-4#4)(2009-5#6)(2009-6#2)(2009-7#6)(2009-8#7)(2009-9#4)(2010-1#1)(2010-10#5)(2010-11#3)(2010-12#5)(2010-2#5)(2010-3#4)(2010-4#9)(2010-5#9)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#11)(2011-12#5)(2011-2#29)(2011-3#2)(2012-1#3)(2012-11#2)(2012-12#13)(2012-2#19)(2012-3#21)(2013-1#34)(2013-7#9)(2013-8#12)
were used together##2##3##(2008-10#1)(2008-3#1)
were used under##2##3##(1990-2#1)(2008-10#1)
were used were##2##3##(2007-12#1)(2008-10#1)
were used with a##2##4##(1995-12#1)(2005-11#1)
were used with an##2##4##(2006-5#1)(2008-10#1)
were used with##14##3##(1990-2#1)(1995-12#1)(1997-6#1)(2005-11#1)(2006-12#1)(2006-5#2)(2008-1#2)(2008-10#3)(2008-7#1)(2013-1#1)
were used##2071##2##(1990-10#3)(1990-11#3)(1990-12#6)(1990-2#8)(1990-3#4)(1990-4#2)(1990-5#5)(1990-6#1)(1990-7#4)(1990-8#5)(1990-9#2)(1991-1#3)(1991-10#1)(1991-11#4)(1991-12#4)(1991-2#8)(1991-3#4)(1991-4#4)(1991-5#5)(1991-6#7)(1991-7#3)(1991-8#4)(1991-9#9)(1992-1#5)(1992-11#2)(1992-12#4)(1992-2#4)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#4)(1992-8#11)(1992-9#4)(1993-1#2)(1993-10#2)(1993-11#7)(1993-12#17)(1993-2#5)(1993-3#11)(1993-4#4)(1993-5#1)(1993-6#4)(1993-7#1)(1993-8#4)(1993-9#11)(1994-1#2)(1994-10#2)(1994-11#4)(1994-12#9)(1994-2#5)(1994-3#8)(1994-4#1)(1994-5#7)(1994-6#7)(1994-7#1)(1994-8#6)(1994-9#6)(1995-1#9)(1995-10#4)(1995-11#8)(1995-12#4)(1995-2#12)(1995-3#6)(1995-4#2)(1995-5#4)(1995-6#6)(1995-7#5)(1995-8#4)(1995-9#3)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#11)(1996-2#4)(1996-3#6)(1996-4#1)(1996-5#13)(1996-6#3)(1996-7#2)(1996-8#5)(1996-9#7)(1997-1#5)(1997-2#9)(1997-3#8)(1997-4#6)(1997-5#10)(1997-6#8)(1997-7#3)(1997-8#7)(1997-9#1)(2004-11#6)(2004-12#2)(2004-2#1)(2004-4#1)(2004-9#7)(2005-10#5)(2005-11#29)(2005-12#6)(2005-4#1)(2005-8#5)(2005-9#3)(2006-10#10)(2006-11#8)(2006-12#12)(2006-2#1)(2006-3#6)(2006-4#5)(2006-5#13)(2006-6#2)(2006-7#5)(2006-8#14)(2006-9#1)(2007-1#11)(2007-10#21)(2007-11#36)(2007-12#29)(2007-2#11)(2007-3#10)(2007-4#16)(2007-5#3)(2007-6#7)(2007-7#27)(2007-8#35)(2007-9#10)(2008-1#17)(2008-10#435)(2008-11#41)(2008-12#35)(2008-2#22)(2008-3#41)(2008-4#11)(2008-5#56)(2008-6#27)(2008-7#26)(2008-8#43)(2008-9#19)(2009-10#2)(2009-11#5)(2009-12#3)(2009-2#10)(2009-3#6)(2009-4#11)(2009-5#11)(2009-6#2)(2009-7#10)(2009-8#10)(2009-9#5)(2010-1#2)(2010-10#7)(2010-11#4)(2010-12#11)(2010-2#9)(2010-3#9)(2010-4#18)(2010-5#12)(2010-6#4)(2010-7#2)(2010-8#10)(2010-9#4)(2011-1#25)(2011-12#8)(2011-2#58)(2011-3#4)(2012-1#6)(2012-11#7)(2012-12#36)(2012-2#33)(2012-3#29)(2012-6#2)(2012-9#1)(2013-1#66)(2013-7#18)(2013-8#30)
were useful for the##4##4##(1991-9#1)(1992-11#1)(2011-2#1)(2013-1#1)
were useful for##8##3##(1991-9#1)(1992-11#1)(1994-7#1)(1997-2#1)(2008-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
were useful in##3##3##(2008-7#1)(2011-2#1)(2013-8#1)
were useful to##2##3##(1996-1#1)(2008-10#1)
were useful##16##2##(1991-9#1)(1992-11#1)(1992-2#1)(1994-7#1)(1996-1#1)(1997-2#1)(2006-12#1)(2008-10#2)(2008-7#1)(2010-8#2)(2011-2#2)(2013-1#1)(2013-8#1)
were using a##2##3##(1993-2#1)(2013-1#1)
were using an##2##3##(2013-1#2)
were using the##2##3##(1991-6#1)(2008-11#1)
were using##25##2##(1991-6#1)(1992-10#1)(1993-2#1)(2006-10#2)(2006-7#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-9#1)(2009-4#1)(2011-1#1)(2012-2#1)(2013-1#6)(2013-8#1)
were usually##18##2##(1991-11#1)(1993-6#1)(1994-2#1)(1995-12#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-8#1)(2012-12#1)(2013-8#1)
were uterine##2##2##(1995-12#1)(2004-10#1)
were utilised to##5##3##(2006-8#1)(2007-10#1)(2008-10#3)
were utilised##8##2##(2004-10#1)(2005-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-10#3)
were utilized as the##2##4##(1996-5#1)(2008-6#1)
were utilized as##9##3##(1990-10#1)(1993-3#1)(1996-5#1)(2005-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-4#1)
were utilized for the##4##4##(2008-10#3)(2013-1#1)
were utilized for##9##3##(2007-8#1)(2008-10#5)(2008-6#1)(2012-2#1)(2013-1#1)
were utilized in a##2##4##(2008-10#1)(2012-2#1)
were utilized in##11##3##(1990-7#1)(1992-9#1)(1994-9#1)(1995-3#1)(1996-2#1)(2006-11#1)(2007-6#1)(2008-10#1)(2008-5#1)(2012-2#1)(2012-3#1)
were utilized to identify##2##4##(2007-12#1)(2013-8#1)
were utilized to##19##3##(1990-2#2)(1990-4#1)(1995-1#1)(1996-4#1)(1997-3#1)(1997-5#1)(2006-8#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-8#1)(2010-5#1)(2011-2#2)(2013-8#2)
were utilized##58##2##(1990-10#1)(1990-2#2)(1990-4#1)(1990-7#1)(1991-9#1)(1992-7#1)(1992-9#1)(1993-3#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-3#1)(1997-5#1)(2005-12#1)(2006-11#1)(2006-8#2)(2007-12#2)(2007-6#1)(2007-8#2)(2008-10#10)(2008-5#2)(2008-6#2)(2008-8#2)(2009-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
were vaccinated with##8##3##(1991-3#1)(1997-3#1)(1997-6#1)(2005-11#1)(2005-9#1)(2006-10#1)(2008-5#1)(2013-8#1)
were vaccinated##17##2##(1991-3#1)(1995-9#1)(1996-1#1)(1997-3#1)(1997-6#2)(2005-11#1)(2005-9#1)(2006-10#1)(2008-5#3)(2010-4#1)(2011-2#1)(2013-8#3)
were valid##3##2##(2008-10#1)(2010-9#1)(2013-7#1)
were validated against##3##3##(1996-3#1)(2007-4#1)(2008-3#1)
were validated as##2##3##(2008-10#1)(2010-8#1)
were validated by comparing##3##4##(2005-11#1)(2008-10#1)(2013-8#1)
were validated by using##3##4##(2008-10#3)
were validated by##15##3##(1990-9#1)(1992-2#1)(2005-11#1)(2005-8#1)(2008-10#9)(2010-12#1)(2013-8#1)
were validated in##3##3##(1997-3#1)(2007-10#1)(2008-10#1)
were validated over##2##3##(2008-10#2)
were validated statistically and by recovery studies##4##7##(2010-2#2)(2010-5#2)
were validated with##2##3##(2008-10#1)(2008-2#1)
were validated##37##2##(1990-9#1)(1992-2#1)(1992-8#1)(1996-3#1)(1997-3#1)(2005-11#1)(2005-8#1)(2007-10#1)(2007-4#1)(2008-10#16)(2008-2#1)(2008-3#1)(2010-12#1)(2010-2#2)(2010-5#2)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
were valued##2##2##(1990-5#1)(2007-8#1)
were vaporized##3##2##(2007-8#1)(2008-10#2)
were variable##9##2##(1994-2#1)(1996-11#1)(1996-3#1)(2008-10#3)(2008-5#1)(2011-12#1)(2012-12#1)
were variably##2##2##(1992-6#1)(1996-11#1)
were varied between 0##2##4##(2008-10#2)
were varied from##4##3##(1994-3#1)(2008-7#1)(2011-1#1)(2011-2#1)
were varied in##6##3##(1994-2#1)(2007-10#1)(2008-10#2)(2008-2#1)(2013-1#1)
were varied over##2##3##(2008-1#1)(2008-11#1)
were varied to##3##3##(1994-9#1)(2007-12#1)(2010-8#1)
were varied within##2##3##(2006-12#1)(2008-10#1)
were varied##23##2##(1994-2#1)(1994-3#1)(1994-9#1)(1995-5#1)(1996-1#1)(1996-7#1)(2004-9#1)(2006-12#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
were variously##3##2##(1991-8#1)(1993-11#1)(2005-8#1)
were vegetatively compatible##3##3##(2008-10#3)
were vegetatively incompatible##2##3##(2008-10#2)
were vegetatively##7##2##(2008-10#7)
were ventilated##4##2##(1994-6#1)(2007-9#2)(2010-7#1)
were verified by the##2##4##(2008-3#1)(2010-12#1)
were verified by##10##3##(1991-5#1)(1992-8#1)(1993-11#1)(1993-8#1)(1996-8#1)(2007-10#1)(2008-3#1)(2010-10#1)(2010-12#1)(2012-4#1)
were verified to be##2##4##(2008-10#1)(2008-2#1)
were verified with##2##3##(2005-11#1)(2008-10#1)
were verified##18##2##(1990-12#1)(1991-5#1)(1992-8#1)(1993-11#1)(1993-8#1)(1996-8#1)(2005-11#1)(2007-10#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-6#1)(2012-4#1)
were very active in##2##4##(2006-8#1)(2008-12#1)
were very different from##2##4##(1995-2#1)(2012-3#1)
were very different##3##3##(1995-2#1)(2008-10#1)(2012-3#1)
were very effective##2##3##(1994-8#1)(2007-7#1)
were very high##4##3##(2008-10#1)(2008-5#1)(2011-1#1)(2013-1#1)
were very likely to##2##4##(1996-9#1)(2008-7#1)
were very low compared with##2##5##(2007-2#1)(2013-1#1)
were very low##16##3##(1995-1#1)(1995-11#1)(1995-4#1)(1996-4#1)(1996-7#1)(2004-10#1)(2007-2#1)(2007-7#1)(2008-10#4)(2009-11#1)(2012-2#1)(2012-8#1)(2013-1#1)
were very poor##2##3##(1990-4#1)(1991-4#1)
were very positive##4##3##(1993-1#1)(2008-11#1)(2008-12#1)(2011-2#1)
were very rare##4##3##(1991-3#2)(2009-11#1)(2010-7#1)
were very satisfied with push HIE##2##6##(2013-1#2)
were very satisfied with##3##4##(1994-1#1)(2013-1#2)
were very sensitive to##3##4##(2007-3#1)(2008-10#1)(2010-2#1)
were very similar for##2##4##(1997-1#1)(2008-10#1)
were very similar in the##2##5##(1992-8#1)(1995-2#1)
were very similar in##4##4##(1992-8#1)(1995-2#1)(2005-7#1)(2007-9#1)
were very similar to predicted##2##5##(1992-3#1)(1996-10#1)
were very similar to that##2##5##(1995-1#1)(1996-12#1)
were very similar to the##3##5##(2007-12#1)(2008-10#2)
were very similar to those##4##5##(1992-11#2)(1997-4#1)(2006-10#1)
were very similar to##12##4##(1992-11#2)(1992-3#1)(1994-6#1)(1995-1#1)(1996-10#1)(1996-12#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-10#2)
were very similar##29##3##(1992-11#2)(1992-3#1)(1992-8#1)(1993-12#1)(1994-6#1)(1995-1#2)(1995-2#1)(1996-10#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-8#1)(2005-7#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-5#1)(2009-8#1)(2011-1#1)
were very small##2##3##(1992-11#1)(2013-7#1)
were very specific##2##3##(2008-10#1)(2010-8#1)
were very stable##2##3##(1993-12#1)(1994-12#1)
were very successful##2##3##(2006-4#1)(2012-2#1)
were very weak##2##3##(1990-10#1)(1995-2#1)
were very weakly labeled##2##4##(1993-1#2)
were very##122##2##(1990-10#2)(1990-4#1)(1991-3#2)(1991-4#1)(1991-8#2)(1992-1#1)(1992-11#3)(1992-3#1)(1992-8#1)(1993-1#3)(1993-12#2)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#4)(1995-11#1)(1995-2#3)(1995-4#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2004-10#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#21)(2008-11#4)(2008-12#2)(2008-5#4)(2008-7#2)(2009-11#2)(2009-8#1)(2010-2#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#3)(2012-2#3)(2012-3#1)(2012-8#1)(2013-1#6)(2013-7#2)
were viable and##3##3##(1992-7#1)(1995-8#1)(2006-5#1)
were viable at 60 days##2##5##(2008-9#2)
were viable##13##2##(1992-7#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#1)(2006-5#1)(2008-10#2)(2008-5#1)(2008-9#2)(2013-1#1)
were video-recorded##2##2##(2012-1#1)(2012-3#1)
were videotaped##3##2##(2006-10#1)(2007-2#1)(2012-2#1)
were viewed as##4##3##(2008-10#1)(2008-8#1)(2009-10#1)(2010-2#1)
were viewed by##3##3##(1991-2#1)(2006-12#1)(2012-3#1)
were viewed in a confocal##2##5##(2006-8#1)(2007-12#1)
were viewed##11##2##(1991-2#1)(1991-9#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-8#1)(2009-10#1)(2010-2#1)(2012-3#1)
were virtually absent from##2##4##(1991-12#1)(2009-11#1)
were virtually absent in##2##4##(1991-8#1)(2008-5#1)
were virtually absent##6##3##(1991-12#1)(1991-8#1)(2006-2#1)(2008-5#1)(2008-8#1)(2009-11#1)
were virtually identical##4##3##(1990-1#1)(1994-9#1)(1996-2#1)(2009-4#1)
were virtually##15##2##(1990-1#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-8#1)(1994-9#1)(1995-8#1)(1996-2#1)(2006-12#1)(2006-2#1)(2008-5#1)(2008-8#2)(2009-11#1)(2009-4#1)
were virulent on##5##3##(2008-10#5)
were virulent to##2##3##(2008-10#2)
were virulent##9##2##(2008-10#8)(2008-5#1)
were visible in##3##3##(1993-12#1)(2007-2#1)(2013-8#1)
were visible##15##2##(1992-9#1)(1993-12#1)(1994-5#1)(1995-4#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#6)(2012-1#1)(2013-8#1)
were visited by##2##3##(2011-1#1)(2011-2#1)
were visited##6##2##(1994-7#1)(1995-9#1)(2007-2#1)(2010-12#1)(2011-1#1)(2011-2#1)
were visualised##3##2##(1996-11#1)(1996-3#1)(1997-3#1)
were visualized and##2##3##(1993-11#1)(2008-5#1)
were visualized by##11##3##(1990-7#1)(1991-9#1)(1992-3#1)(2008-10#4)(2008-11#1)(2010-3#1)(2012-1#1)(2013-1#1)
were visualized in the##2##4##(1991-9#1)(2011-12#1)
were visualized in##4##3##(1991-9#1)(1995-12#1)(1996-2#1)(2011-12#1)
were visualized using##2##3##(1995-11#1)(2008-5#1)
were visualized##24##2##(1990-7#1)(1991-9#3)(1992-3#1)(1993-11#1)(1995-11#1)(1995-12#1)(1996-2#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-5#2)(2010-3#1)(2011-12#1)(2012-1#1)(2013-1#1)(2013-8#1)
were visually inspected for##2##4##(2008-10#2)
were visually##7##2##(1993-2#2)(2007-1#1)(2007-8#1)(2008-10#2)(2013-7#1)
were vulnerable##2##2##(2007-2#1)(2013-1#1)
were walked##2##2##(1992-5#1)(2013-1#1)
were warranted##2##2##(1996-3#1)(2011-3#1)
were washed and##2##3##(1991-9#1)(2008-10#1)
were washed from##2##3##(2008-10#2)
were washed out##2##3##(1990-6#1)(1997-3#1)
were washed with##2##3##(1990-11#1)(1990-8#1)
were washed##13##2##(1990-11#1)(1990-6#1)(1990-8#1)(1991-9#1)(1997-3#1)(2006-5#1)(2007-5#1)(2008-10#5)(2008-8#1)
were watered with##2##3##(2004-4#2)
were watered##3##2##(2004-4#2)(2008-10#1)
were weak##10##2##(1994-8#1)(1996-4#1)(1996-9#1)(2008-10#1)(2008-12#2)(2009-6#1)(2012-12#1)(2012-2#2)
were weaker but##2##3##(1993-6#1)(1997-2#1)
were weaker##5##2##(1993-3#1)(1993-6#1)(1994-7#1)(1997-2#1)(2008-3#1)
were weakly active against HCMV##2##5##(1996-8#1)(1997-2#1)
were weakly##8##2##(1992-3#1)(1996-8#1)(1997-2#1)(1997-8#1)(2008-10#4)
were weaned at##2##3##(1993-6#1)(2010-4#1)
were weaned##5##2##(1990-3#1)(1993-6#1)(2007-7#1)(2009-5#1)(2010-4#1)
were weighed and##6##3##(1993-3#1)(2007-1#1)(2008-10#1)(2008-12#1)(2009-4#1)(2010-4#1)
were weighed##11##2##(1993-3#2)(2007-1#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-12#1)(2009-4#1)(2009-5#1)(2010-4#1)(2010-8#1)
were well below##2##3##(2007-2#1)(2007-5#1)
were well controlled##2##3##(2008-12#1)(2011-1#1)
were well correlated with##2##4##(1996-1#1)(2008-7#1)
were well correlated##3##3##(1996-1#1)(2004-12#1)(2008-7#1)
were well fitted##2##3##(1995-6#1)(2011-2#1)
were well matched##2##3##(1991-6#1)(2008-3#1)
were well predicted by a##2##5##(1995-11#1)(1995-6#1)
were well preserved##3##3##(1994-3#1)(2008-10#1)(2008-11#1)
were well received##3##3##(1996-3#1)(1997-8#1)(2008-5#1)
were well reproduced##2##3##(2005-11#1)(2011-2#1)
were well resolved from the pure drug with##2##8##(2008-10#1)(2010-2#1)
were well resolved from##3##4##(1991-5#1)(2008-10#1)(2010-2#1)
were well resolved##4##3##(1991-5#1)(2008-10#2)(2010-2#1)
were well separated and##5##4##(1990-8#1)(1997-8#1)(2008-10#3)
were well separated from##2##4##(1996-8#1)(2008-10#1)
were well separated in##2##4##(2008-10#2)
were well separated within##2##4##(1994-9#1)(2008-10#1)
were well separated##11##3##(1990-8#1)(1994-9#1)(1996-8#1)(1997-8#1)(2008-10#7)
were well simulated##2##3##(2005-11#1)(2008-7#1)
were well tolerated and##3##4##(2007-11#1)(2007-7#1)(2012-2#1)
were well tolerated##14##3##(1990-4#1)(1994-11#1)(1994-9#2)(1997-1#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-4#1)(2012-2#1)
were well##88##2##(1990-4#1)(1990-7#1)(1990-8#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-7#1)(1994-11#1)(1994-3#1)(1994-7#2)(1994-9#3)(1995-11#1)(1995-4#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-3#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-7#1)(1997-8#4)(2004-12#1)(2005-11#3)(2005-5#1)(2006-10#1)(2006-7#1)(2006-8#2)(2007-11#2)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#4)(2008-7#4)(2008-8#3)(2008-9#1)(2009-4#1)(2009-7#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)
were well-resolved from##3##3##(2012-12#2)(2013-7#1)
were well-tolerated##3##2##(2008-5#1)(2008-7#1)(2013-1#1)
were white##4##2##(1995-6#1)(2007-3#1)(2007-8#1)(2007-9#1)
were wide##2##2##(1997-8#1)(2013-8#1)
were widely distributed in##2##4##(2008-10#1)(2013-1#1)
were widely distributed##6##3##(1997-4#1)(2008-10#2)(2012-12#2)(2013-1#1)
were widely##14##2##(1990-6#1)(1996-7#1)(1997-4#1)(2006-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2012-12#2)(2013-1#1)(2013-8#1)
were widespread##5##2##(2004-11#1)(2008-10#3)(2008-8#1)
were willing and##2##3##(2006-10#1)(2010-8#1)
were willing to participate in a national health campaign to screen blood pressure of dental##2##15##(2008-1#2)
were willing to participate in the##2##6##(1994-12#1)(2013-8#1)
were willing to participate in##5##5##(1994-12#1)(2008-1#2)(2012-1#1)(2013-8#1)
were willing to participate##6##4##(1994-12#1)(2008-1#2)(2012-1#1)(2013-1#1)(2013-8#1)
were willing to pay##2##4##(2006-12#1)(2007-7#1)
were willing to undergo##2##4##(2013-1#2)
were willing to##17##3##(1992-12#1)(1994-12#1)(1997-6#1)(2006-12#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-8#1)(2009-5#1)(2012-1#1)(2013-1#3)(2013-8#2)
were willing##20##2##(1992-12#1)(1994-12#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-12#1)(2008-8#1)(2009-5#1)(2010-8#1)(2012-1#1)(2013-1#3)(2013-8#2)
were with##16##2##(1991-2#1)(1992-1#1)(1992-8#1)(1993-2#1)(1996-5#1)(1997-3#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-1#1)
were withdrawn and##2##3##(2009-5#1)(2013-8#1)
were withdrawn because of##2##4##(1992-11#1)(2008-12#1)
were withdrawn from the market##2##5##(2006-10#1)(2008-11#1)
were withdrawn from the##4##4##(1992-11#1)(2006-10#1)(2007-2#1)(2008-11#1)
were withdrawn##20##2##(1992-11#2)(1993-3#1)(1995-1#1)(1996-12#1)(2005-12#1)(2006-10#1)(2007-2#2)(2007-7#1)(2008-11#3)(2008-12#1)(2008-7#2)(2009-5#1)(2010-3#1)(2011-1#1)(2013-8#1)
were within 1##2##3##(2006-10#1)(2010-12#1)
were within 10%##3##3##(2005-11#1)(2008-10#2)
were within 3##2##3##(1996-6#1)(2010-12#1)
were within a##2##3##(2008-10#1)(2010-12#1)
were within acceptable limits##2##4##(2008-6#1)(2013-1#1)
were within acceptable##4##3##(2004-12#1)(2008-6#1)(2010-3#1)(2013-1#1)
were within normal limits##2##4##(1990-8#1)(2008-9#1)
were within normal range##6##4##(2006-9#1)(2007-9#1)(2008-7#4)
were within normal##10##3##(1990-8#1)(2006-4#1)(2006-9#1)(2007-9#1)(2008-7#4)(2008-9#1)(2012-2#1)
were within the normal range for##2##6##(2008-2#1)(2010-3#1)
were within the normal range in##3##6##(1994-10#1)(2006-8#1)(2007-7#1)
were within the normal range##10##5##(1994-10#1)(1997-5#2)(2005-12#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-12#1)(2008-2#1)(2010-3#1)
were within the range of##2##5##(2008-5#1)(2011-2#1)
were within the range##5##4##(1996-11#1)(1996-6#1)(2008-5#1)(2011-2#2)
were within the##25##3##(1994-10#1)(1996-11#1)(1996-6#1)(1997-5#3)(2005-12#1)(2006-10#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2010-3#1)(2011-12#1)(2011-2#2)(2012-12#1)
were within##70##2##(1990-8#1)(1992-1#1)(1994-10#1)(1996-11#1)(1996-6#2)(1997-3#2)(1997-5#4)(2004-12#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#4)(2008-9#2)(2009-8#1)(2010-12#3)(2010-3#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
were without any##4##3##(1995-3#1)(2007-7#1)(2008-3#1)(2008-5#1)
were without effect on the##2##5##(1993-6#1)(2008-10#1)
were without effect##10##3##(1990-4#1)(1991-6#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-6#1)(1994-6#1)(1996-1#1)(2005-8#1)(2008-10#1)
were without effects##2##3##(1993-11#1)(2008-10#1)
were without##23##2##(1990-4#1)(1991-6#1)(1992-5#1)(1992-6#2)(1992-7#1)(1993-1#1)(1993-11#1)(1993-6#1)(1994-6#2)(1995-10#1)(1995-3#1)(1996-1#1)(1996-2#1)(2005-10#1)(2005-8#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-5#1)
were women and##3##3##(2008-1#1)(2010-11#1)(2013-1#1)
were women with##3##3##(1994-12#1)(2008-9#1)(2012-12#1)
were women##23##2##(1993-9#1)(1994-12#1)(1996-8#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-9#1)(2009-1#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-12#1)(2013-1#2)
were worked out##6##3##(2008-10#6)
were working##4##2##(1991-12#1)(1995-2#1)(2007-10#2)
were worse in the##2##4##(1995-1#1)(1996-7#1)
were worse in##3##3##(1990-12#1)(1995-1#1)(1996-7#1)
were worse than##2##3##(2009-4#1)(2011-2#1)
were worse##7##2##(1990-12#1)(1995-1#1)(1996-7#1)(2006-8#1)(2008-6#1)(2009-4#1)(2011-2#1)
were wrapped##3##2##(1995-3#1)(2005-11#1)(2007-12#1)
were written at a level##2##5##(2013-7#2)
were written at a##3##4##(2008-2#1)(2013-7#2)
were written at##4##3##(2008-12#1)(2008-2#1)(2013-7#2)
were written by##2##3##(1992-6#1)(2007-12#1)
were written using##2##3##(2006-12#1)(2013-7#1)
were written##14##2##(1992-6#2)(2006-12#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-12#1)(2008-2#1)(2012-1#1)(2012-2#1)(2013-7#3)
were wrong##3##2##(1993-5#1)(1997-1#1)(1997-5#1)
were x-rayed##2##2##(2007-11#1)(2012-2#1)
were young##7##2##(1994-4#1)(2007-7#1)(2008-10#1)(2009-2#1)(2012-3#2)(2013-7#1)
were younger and##3##3##(1995-3#1)(2007-3#1)(2008-7#1)
were younger than##13##3##(1990-4#1)(1990-6#1)(1991-2#1)(1993-8#1)(1996-4#1)(1997-3#2)(2007-1#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-12#1)(2013-7#1)
were younger##27##2##(1990-4#1)(1990-6#1)(1991-10#1)(1991-2#1)(1991-4#1)(1993-8#1)(1995-3#1)(1996-4#1)(1997-3#2)(2007-1#1)(2007-10#2)(2007-3#2)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
were zero##2##2##(2008-10#1)(2008-2#1)
were ~0##2##2##(2007-12#1)(2008-2#1)
were##73818##1##(1990-1#20)(1990-10#200)(1990-11#254)(1990-12#384)(1990-2#267)(1990-3#211)(1990-4#217)(1990-5#250)(1990-6#175)(1990-7#231)(1990-8#268)(1990-9#175)(1991-1#114)(1991-10#141)(1991-11#132)(1991-12#302)(1991-2#354)(1991-3#220)(1991-4#167)(1991-5#231)(1991-6#214)(1991-7#159)(1991-8#268)(1991-9#281)(1992-1#174)(1992-10#112)(1992-11#181)(1992-12#217)(1992-2#248)(1992-3#266)(1992-4#124)(1992-5#173)(1992-6#238)(1992-7#185)(1992-8#335)(1992-9#228)(1993-1#128)(1993-10#71)(1993-11#226)(1993-12#415)(1993-2#274)(1993-3#302)(1993-4#154)(1993-5#147)(1993-6#193)(1993-7#120)(1993-8#227)(1993-9#289)(1994-1#39)(1994-10#70)(1994-11#236)(1994-12#348)(1994-2#305)(1994-3#366)(1994-4#34)(1994-5#196)(1994-6#250)(1994-7#78)(1994-8#265)(1994-9#317)(1995-1#249)(1995-10#125)(1995-11#318)(1995-12#386)(1995-2#317)(1995-3#341)(1995-4#78)(1995-5#245)(1995-6#248)(1995-7#109)(1995-8#233)(1995-9#86)(1996-1#218)(1996-10#120)(1996-11#180)(1996-12#389)(1996-2#269)(1996-3#276)(1996-4#129)(1996-5#362)(1996-6#189)(1996-7#191)(1996-8#252)(1996-9#249)(1997-1#216)(1997-2#430)(1997-3#352)(1997-4#339)(1997-5#197)(1997-6#287)(1997-7#252)(1997-8#413)(1997-9#14)(2003-11#3)(2004-1#50)(2004-10#81)(2004-11#201)(2004-12#69)(2004-2#74)(2004-3#28)(2004-4#104)(2004-7#3)(2004-8#21)(2004-9#134)(2005-1#16)(2005-10#193)(2005-11#580)(2005-12#159)(2005-2#3)(2005-3#2)(2005-4#129)(2005-5#23)(2005-6#17)(2005-7#124)(2005-8#196)(2005-9#87)(2006-1#44)(2006-10#698)(2006-11#236)(2006-12#509)(2006-2#186)(2006-3#96)(2006-4#162)(2006-5#291)(2006-6#213)(2006-7#208)(2006-8#645)(2006-9#124)(2007-1#409)(2007-10#631)(2007-11#836)(2007-12#847)(2007-2#696)(2007-3#424)(2007-4#202)(2007-5#268)(2007-6#234)(2007-7#1021)(2007-8#1518)(2007-9#390)(2008-1#511)(2008-10#11607)(2008-11#1331)(2008-12#921)(2008-2#612)(2008-3#1095)(2008-4#607)(2008-5#2528)(2008-6#627)(2008-7#1259)(2008-8#950)(2008-9#923)(2009-1#27)(2009-10#214)(2009-11#128)(2009-12#151)(2009-2#238)(2009-3#218)(2009-4#298)(2009-5#250)(2009-6#181)(2009-7#246)(2009-8#231)(2009-9#160)(2010-1#122)(2010-10#139)(2010-11#141)(2010-12#560)(2010-2#331)(2010-3#211)(2010-4#530)(2010-5#227)(2010-6#123)(2010-7#190)(2010-8#442)(2010-9#136)(2011-1#1109)(2011-10#24)(2011-11#35)(2011-12#258)(2011-2#2153)(2011-3#88)(2011-7#8)(2011-9#3)(2012-1#445)(2012-10#1)(2012-11#194)(2012-12#1092)(2012-2#1210)(2012-3#807)(2012-4#18)(2012-5#24)(2012-6#10)(2012-7#14)(2012-8#10)(2012-9#6)(2013-1#2108)(2013-3#2)(2013-4#3)(2013-7#444)(2013-8#1277)
weren't##4##1##(1995-8#1)(2008-11#1)(2012-3#2)
west Africa##3##2##(1991-6#1)(1997-3#1)(2008-10#1)
west and##2##2##(2008-10#2)
west central##2##2##(1992-6#1)(2010-3#1)
west coast of##6##3##(2007-7#1)(2009-12#1)(2010-10#1)(2010-8#2)(2011-12#1)
west coast##10##2##(1992-5#1)(2007-5#2)(2007-7#1)(2009-12#1)(2010-10#1)(2010-8#2)(2011-12#1)(2011-2#1)
west end##3##2##(2007-5#1)(2008-2#2)
west of Iran##4##3##(2008-12#2)(2010-4#1)(2012-12#1)
west of Scotland##2##3##(1992-10#1)(1997-8#1)
west of the##3##3##(1996-4#1)(2008-10#2)
west of##14##2##(1992-10#1)(1996-11#1)(1996-4#1)(1997-8#1)(2008-10#4)(2008-12#2)(2009-6#1)(2010-4#1)(2012-12#1)(2013-8#1)
west##68##1##(1991-4#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-5#1)(1992-6#1)(1995-10#1)(1995-9#1)(1996-11#1)(1996-4#1)(1997-3#2)(1997-8#1)(2006-10#1)(2006-12#4)(2006-9#6)(2007-12#1)(2007-3#1)(2007-5#5)(2007-7#1)(2008-10#12)(2008-12#4)(2008-2#2)(2008-6#1)(2009-12#1)(2009-6#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-8#5)(2011-12#1)(2011-2#1)(2012-12#2)(2013-7#1)(2013-8#2)
westermani##3##1##(1996-6#1)(1997-6#2)
western Atlantic and##2##3##(2008-5#1)(2011-2#1)
western Atlantic##4##2##(1992-8#1)(2008-5#2)(2011-2#1)
western Canada##12##2##(1994-3#1)(2008-10#8)(2012-2#1)(2013-1#1)(2013-8#1)
western Canadian##3##2##(2006-12#1)(2008-10#1)(2013-1#1)
western China##2##2##(2008-5#1)(2012-2#1)
western Colombia##2##2##(2008-12#1)(2008-5#1)
western Europe##3##2##(2006-10#1)(2008-10#1)(2010-8#1)
western European countries##3##3##(2006-10#1)(2006-2#1)(2012-1#1)
western European##4##2##(2006-10#1)(2006-2#1)(2011-2#1)(2012-1#1)
western France##2##2##(2008-10#1)(2008-7#1)
western Germany##6##2##(1992-1#1)(2008-11#1)(2009-10#3)(2013-1#1)
western Indian##2##2##(1995-10#1)(2006-7#1)
western Minnesota##2##2##(2008-10#2)
western Nepal##6##2##(2006-4#1)(2008-7#3)(2011-1#1)(2012-2#1)
western Nigeria##4##2##(2007-3#1)(2010-3#1)(2010-8#1)(2013-1#1)
western North America##12##3##(2008-10#8)(2008-2#1)(2008-8#1)(2010-8#2)
western North##14##2##(2008-10#8)(2008-2#2)(2008-3#1)(2008-8#1)(2010-8#2)
western Pacific##4##2##(1995-7#1)(1996-6#1)(1997-1#1)(2008-1#1)
western Sydney and##2##3##(2007-2#2)
western Sydney##3##2##(2006-9#1)(2007-2#2)
western United States##7##3##(2006-7#1)(2007-9#1)(2008-10#3)(2011-12#1)(2013-1#1)
western Washington##2##2##(2008-10#2)
western analysis##4##2##(2006-10#1)(2008-10#2)(2008-4#1)
western and central##3##3##(2008-10#3)
western and other oriental series##2##5##(2006-10#2)
western and##8##2##(2006-10#2)(2008-1#1)(2008-10#3)(2010-8#1)(2011-2#1)
western barred bandicoots##2##3##(2007-2#2)
western barred##3##2##(2007-2#3)
western blot analyses##2##3##(2008-10#1)(2013-8#1)
western blot analysis##13##3##(1993-6#1)(1994-3#1)(1994-8#1)(1996-10#1)(1997-3#1)(2008-10#4)(2008-11#1)(2010-12#1)(2010-4#1)(2012-12#1)
western blot##26##2##(1991-6#1)(1993-6#1)(1994-3#1)(1994-8#1)(1996-10#1)(1997-3#1)(2007-10#2)(2007-3#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-4#2)(2010-12#1)(2010-4#1)(2012-12#1)(2013-8#1)
western blots can be used to identify specific interacting proteins in a complex mixture of proteins##2##16##(2008-2#1)(2008-4#1)
western blots##7##2##(1990-3#1)(1991-9#1)(1997-7#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-9#1)
western blotting and##4##3##(1995-7#1)(2012-12#3)
western blotting of##2##3##(1991-5#1)(2008-10#1)
western blotting using##3##3##(1996-12#1)(1997-7#1)(2008-11#1)
western blotting##30##2##(1991-11#1)(1991-5#1)(1991-7#1)(1992-7#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-7#1)(1996-12#1)(1997-7#1)(2008-10#2)(2008-11#6)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#4)(2013-1#1)
western blotting)##2##2##(2008-2#1)(2008-4#1)
western corn rootworm (Diabrotica virgifera virgifera##2##6##(2010-12#1)(2011-12#1)
western corn rootworm larvae##3##4##(2011-2#3)
western corn rootworm##9##3##(2010-12#1)(2011-12#2)(2011-2#6)
western corn##10##2##(2010-12#1)(2011-12#3)(2011-2#6)
western countries##19##2##(1990-3#1)(1990-4#1)(1991-5#1)(1992-9#1)(1993-10#1)(2005-11#1)(2005-3#1)(2007-10#2)(2007-12#1)(2008-10#1)(2008-4#1)(2009-2#3)(2010-11#1)(2011-12#1)(2011-2#2)
western flower thrips##6##3##(2008-10#3)(2009-8#1)(2011-2#2)
western gray squirrels##3##3##(2010-6#3)
western gray##4##2##(2010-6#4)
western immunoblot##2##2##(2008-10#2)
western immunoblotting##2##2##(2008-10#2)
western isolates##2##2##(2008-10#2)
western lowland gorillas##2##3##(2007-2#2)
western medical injections were##2##4##(2011-2#2)
western medical injections##5##3##(2011-2#5)
western medical##7##2##(1991-12#1)(2011-2#5)(2013-8#1)
western medicine##4##2##(1991-12#1)(2008-10#1)(2012-2#1)(2012-3#1)
western music##2##2##(1993-1#2)
western part of Denmark##2##4##(1993-5#2)
western part of the##2##4##(2007-5#1)(2008-10#1)
western part of##4##3##(1993-5#2)(2007-5#1)(2008-10#1)
western part##6##2##(1993-5#3)(2006-4#1)(2007-5#1)(2008-10#1)
western population##2##2##(2011-12#1)(2011-2#1)
western populations##11##2##(2006-8#1)(2008-10#7)(2008-12#1)(2009-2#2)
western redbud##2##2##(2008-10#2)
western societies##5##2##(1995-11#1)(1996-11#1)(2006-8#1)(2013-1#2)
western society##3##2##(1991-12#2)(1993-11#1)
western white pine##10##3##(2008-10#10)
western world to##2##3##(1997-7#1)(2007-1#1)
western world##15##2##(1990-2#1)(1990-7#1)(1991-11#1)(1996-2#1)(1997-7#1)(2007-1#1)(2008-1#3)(2008-11#1)(2008-2#3)(2011-12#2)
western yellows##4##2##(2008-10#4)
western##361##1##(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-6#3)(1990-7#1)(1991-11#2)(1991-12#4)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#2)(1993-5#3)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#3)(1994-8#2)(1995-10#1)(1995-11#1)(1995-7#2)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#5)(2004-4#1)(2005-11#1)(2005-3#1)(2005-9#3)(2006-1#1)(2006-10#8)(2006-12#2)(2006-2#1)(2006-4#2)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#8)(2007-12#2)(2007-2#7)(2007-3#3)(2007-5#5)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#90)(2008-11#9)(2008-12#4)(2008-2#10)(2008-3#2)(2008-4#7)(2008-5#7)(2008-7#5)(2008-8#2)(2008-9#3)(2009-10#4)(2009-2#5)(2009-4#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#5)(2010-8#7)(2011-1#2)(2011-12#9)(2011-2#24)(2012-1#1)(2012-12#6)(2012-2#7)(2012-3#2)(2013-1#10)(2013-7#2)(2013-8#4)
western-blot##3##1##(2007-10#2)(2008-11#1)
western-blotting##2##1##(2008-11#2)
westernized##2##1##(2006-8#1)(2010-12#1)
westward##3##1##(1993-2#1)(1993-4#1)(2007-5#1)
wet and dry seasons##2##4##(2006-4#1)(2008-4#1)
wet and dry##6##3##(1997-1#1)(2006-4#1)(2008-10#2)(2008-4#1)(2010-8#1)
wet and##11##2##(1994-6#1)(1997-1#1)(1997-5#1)(2005-11#1)(2006-4#1)(2008-10#2)(2008-4#1)(2009-12#1)(2010-8#1)(2010-9#1)
wet ashing with H(2)SO(4)##2##4##(2008-10#2)
wet ashing##7##2##(2008-10#7)
wet cell##2##2##(1992-2#2)
wet chemical cleaning process##2##4##(2005-11#2)
wet chemical procedures##2##3##(2008-10#2)
wet chemical##7##2##(2004-9#1)(2005-11#2)(2007-12#1)(2008-10#3)
wet chemistry##5##2##(1992-12#3)(2005-11#2)
wet conditions##4##2##(2008-10#4)
wet cupping##4##2##(2013-1#4)
wet digestion methods##5##3##(2008-10#5)
wet digestion procedure##2##3##(2008-10#2)
wet digestion##9##2##(2008-10#9)
wet dog shakes were##2##4##(1991-11#1)(1993-12#1)
wet dog shakes##4##3##(1991-11#1)(1993-12#2)(1993-2#1)
wet etched##2##2##(2008-2#2)
wet etching##4##2##(2006-5#1)(2008-10#1)(2008-11#1)(2008-3#1)
wet grinding of hard metal tools##2##6##(1994-6#2)
wet heat##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
wet mass of##2##3##(2010-8#2)
wet mass##3##2##(2010-8#3)
wet mopping##3##2##(1997-2#3)
wet mount##8##2##(2006-4#1)(2007-7#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#2)
wet period of##2##3##(2008-10#2)
wet period##12##2##(2008-10#11)(2008-5#1)
wet periods##4##2##(2008-10#3)(2011-12#1)
wet preparation of SF##2##4##(2006-10#2)
wet preparation of##3##3##(2006-10#3)
wet season##18##2##(2007-3#3)(2007-5#9)(2008-10#1)(2008-3#2)(2008-5#3)
wet shave##2##2##(2008-4#1)(2008-5#1)
wet tissue##6##2##(1990-7#1)(1992-8#1)(1995-5#1)(1997-8#1)(2008-10#1)(2010-12#1)
wet to dry##2##3##(2005-12#1)(2008-8#1)
wet washing##2##2##(1997-2#2)
wet weight and##3##3##(1991-10#1)(1993-4#1)(2007-8#1)
wet weight basis##3##3##(1990-2#1)(1991-9#1)(2008-10#1)
wet weight##23##2##(1990-2#2)(1990-3#1)(1990-4#1)(1990-9#1)(1991-10#2)(1991-9#2)(1993-4#1)(1993-7#2)(1993-9#1)(1994-5#1)(1995-1#1)(1995-3#2)(2007-8#1)(2008-10#1)(2008-7#2)(2009-4#1)(2011-12#1)
wet weight)##5##2##(1990-10#1)(1992-11#1)(1993-4#1)(1995-5#1)(2008-10#1)
wet wipes##3##2##(2008-5#3)
wet wt##9##2##(1991-3#3)(2004-4#1)(2007-5#1)(2007-8#1)(2008-11#2)(2011-12#1)
wet wt)##4##2##(1991-3#1)(2007-5#1)(2008-11#2)
wet##240##1##(1990-10#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-11#1)(1991-3#4)(1991-9#2)(1992-11#1)(1992-12#3)(1992-2#2)(1992-8#2)(1993-12#2)(1993-2#1)(1993-4#2)(1993-7#2)(1993-9#1)(1994-5#1)(1994-6#4)(1995-1#1)(1995-3#2)(1995-5#2)(1996-11#1)(1996-12#3)(1997-1#1)(1997-2#6)(1997-4#3)(1997-5#1)(1997-8#1)(2004-4#1)(2004-9#2)(2005-11#7)(2005-12#2)(2005-4#1)(2006-10#3)(2006-2#1)(2006-4#3)(2006-5#1)(2006-8#1)(2007-12#1)(2007-3#3)(2007-5#11)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#63)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#16)(2008-6#1)(2008-7#3)(2008-8#3)(2009-12#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#4)(2010-9#1)(2011-1#3)(2011-12#3)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#3)
wet&quot##2##1##(2011-2#2)
wet-chemical synthesis##2##2##(2010-4#2)
wet-chemical##5##1##(2004-9#1)(2006-12#1)(2009-5#1)(2010-4#2)
wet-dog shakes##8##2##(1991-5#2)(1993-2#2)(1995-12#3)(1996-10#1)
wet-lab experiments##2##2##(2008-8#1)(2012-3#1)
wet-lab##3##1##(2008-8#2)(2012-3#1)
wet/dry weight ratio##2##3##(2013-1#2)
wether##4##1##(1990-12#1)(2009-2#1)(2010-4#1)(2011-2#1)
wetland and##2##2##(2007-5#1)(2013-8#1)
wetland ecosystem##2##2##(1997-4#2)
wetland landscape pattern##6##3##(2013-8#6)
wetland landscape##7##2##(2013-8#7)
wetland##35##1##(1997-4#3)(2004-2#1)(2005-12#1)(2007-3#1)(2007-5#7)(2008-10#2)(2009-6#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#14)
wetlands in Northeast Thailand##2##4##(2008-12#2)
wetlands##7##1##(2007-12#1)(2007-9#1)(2008-12#2)(2008-5#2)(2013-7#1)
wetness and##7##2##(2008-10#7)
wetness duration (WD)##2##3##(2008-10#2)
wetness duration and##3##3##(2008-10#3)
wetness duration at##3##3##(2008-10#3)
wetness duration on##3##3##(2008-10#3)
wetness duration requirement##3##3##(2008-10#3)
wetness duration##33##2##(2008-10#33)
wetness durations##5##2##(2008-10#5)
wetness for##3##2##(2008-10#3)
wetness of##2##2##(2008-10#2)
wetness period##6##2##(2008-10#6)
wetness periods##3##2##(2008-10#3)
wetness regimes##2##2##(2008-10#2)
wetness was required##2##3##(2008-10#2)
wetness was##8##2##(2008-10#8)
wetness were##2##2##(2008-10#2)
wetness##117##1##(2008-10#115)(2008-5#1)(2008-8#1)
wetness)##2##1##(2008-10#2)
wettability and##3##2##(2005-11#1)(2009-7#1)(2010-4#1)
wettability of the##2##3##(2008-10#1)(2008-5#1)
wettability of##4##2##(2008-10#1)(2008-5#3)
wettability##12##1##(2005-11#3)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#4)(2009-7#1)(2010-4#1)
wettable sulfur##3##2##(2011-2#3)
wettable##5##1##(2008-10#2)(2011-2#3)
wetted and##5##2##(2005-11#2)(2005-12#1)(2008-10#1)(2008-3#1)
wetted area inside the porous substrate##3##6##(2005-11#3)
wetted area##4##2##(2005-11#4)
wetted##16##1##(1994-5#1)(2005-11#11)(2005-12#1)(2008-10#2)(2008-3#1)
wetter##4##1##(2007-4#2)(2008-10#2)
wetting and drying##4##3##(2008-10#4)
wetting behavior##2##2##(2005-11#2)
wetting film extraction system##2##4##(2008-10#2)
wetting film extraction##3##3##(2008-10#3)
wetting film##9##2##(2008-10#8)(2011-1#1)
wetting liquid##2##2##(2005-11#1)(2008-5#1)
wetting of##2##2##(2005-11#1)(2010-4#1)
wetting properties##2##2##(2008-7#1)(2010-4#1)
wetting time##3##2##(2005-11#1)(2008-10#1)(2010-2#1)
wetting transition##2##2##(1992-9#1)(2008-3#1)
wetting##57##1##(1990-12#1)(1990-7#1)(1992-12#1)(1992-9#1)(1993-2#1)(1995-11#1)(2005-11#13)(2008-10#20)(2008-3#2)(2008-5#3)(2008-7#1)(2009-11#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#2)(2011-1#2)(2012-1#1)(2012-2#2)(2013-8#1)
wg##2##1##(1990-8#1)(2007-12#1)
whale##18##1##(1991-4#1)(1992-11#1)(1993-11#1)(1993-3#2)(1993-6#3)(1994-5#2)(1995-2#1)(1995-3#1)(2007-3#1)(2012-2#1)(2012-3#4)
whales##2##1##(1993-7#1)(2012-2#1)
what I call##2##3##(2007-12#1)(2008-12#1)
what I##4##2##(2006-7#1)(2007-12#1)(2008-12#1)(2009-10#1)
what a particular##2##3##(1996-12#1)(2008-3#1)
what a##6##2##(1991-2#2)(1993-11#1)(1996-12#1)(2007-9#1)(2008-3#1)
what about##6##2##(1993-12#1)(1995-2#1)(2005-8#1)(2006-7#1)(2007-2#1)(2013-1#1)
what allows##2##2##(2007-11#1)(2011-2#1)
what and##4##2##(2007-4#1)(2009-8#1)(2013-1#2)
what appears to be a##2##5##(2007-9#1)(2008-7#1)
what appears to be##3##4##(2007-9#1)(2008-7#1)(2009-3#1)
what appears to##4##3##(2007-9#2)(2008-7#1)(2009-3#1)
what are believed to be the first measurements of##2##9##(2007-12#1)(2008-2#1)
what are believed to be the first##3##7##(2007-11#1)(2007-12#1)(2008-2#1)
what are believed to be the##4##6##(2007-11#1)(2007-12#2)(2008-2#1)
what are the effects on the##2##6##(2006-2#2)
what are the##22##3##(1990-10#2)(1991-6#1)(1994-2#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-8#1)(2006-10#1)(2006-2#2)(2006-4#1)(2006-7#1)(2007-4#1)(2008-10#1)(2008-4#2)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#1)(2012-3#1)
what are they and##2##4##(1994-3#1)(1997-3#1)
what are to our knowledge the first##3##7##(2007-11#1)(2007-12#2)
what are to##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
what are we##4##3##(1991-3#1)(1992-2#1)(2006-10#1)(2012-12#1)
what are##40##2##(1990-10#2)(1991-3#1)(1991-6#1)(1992-2#1)(1992-6#1)(1994-10#1)(1994-2#1)(1994-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-3#1)(2006-10#2)(2006-2#2)(2006-4#1)(2006-7#1)(2007-11#2)(2007-12#4)(2007-4#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-4#2)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-3#1)
what aspects##2##2##(1991-3#1)(2011-2#1)
what business##2##2##(1993-3#1)(2007-4#1)
what can be done to improve##2##6##(1992-11#1)(2007-4#1)
what can be done to##3##5##(1992-11#1)(1996-1#1)(2007-4#1)
what can be done##6##4##(1992-11#1)(1996-1#1)(1997-1#1)(2007-4#2)(2008-11#1)
what can be learned##2##4##(2008-12#1)(2008-7#1)
what can be##14##3##(1992-11#1)(1996-1#1)(1997-1#1)(2007-4#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
what can it##2##3##(1997-4#1)(2012-12#1)
what can lead to##2##4##(2006-6#1)(2008-11#1)
what can we##5##3##(1991-3#1)(1993-2#1)(2009-10#1)(2010-2#1)(2010-9#1)
what can##31##2##(1991-3#1)(1992-11#1)(1993-2#1)(1994-5#1)(1996-1#1)(1997-1#1)(1997-4#1)(2004-12#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-4#2)(2008-11#3)(2008-12#1)(2008-2#2)(2008-7#1)(2009-10#1)(2009-6#1)(2010-2#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-8#1)
what causes the##2##3##(1996-6#1)(2013-1#1)
what causes##5##2##(1996-6#1)(2007-8#1)(2008-11#1)(2013-1#2)
what changes##5##2##(1996-2#1)(2006-5#1)(2006-6#1)(2008-10#1)(2011-2#1)
what circumstances##3##2##(2007-2#2)(2008-7#1)
what conditions##6##2##(1994-12#1)(2007-12#1)(2007-4#1)(2008-8#1)(2008-9#1)(2012-3#1)
what confidence##2##2##(1991-12#1)(2008-12#1)
what constitute##3##2##(1996-2#1)(2009-4#1)(2011-2#1)
what constitutes a good##2##4##(2010-10#1)(2012-2#1)
what constitutes a##4##3##(1992-9#1)(1995-2#1)(2010-10#1)(2012-2#1)
what constitutes an adequate##2##4##(2010-12#1)(2013-1#1)
what constitutes an##6##3##(2008-12#1)(2010-12#1)(2011-1#1)(2013-1#3)
what constitutes##20##2##(1992-9#1)(1994-12#1)(1995-2#2)(1995-3#2)(2007-4#1)(2008-12#1)(2008-7#1)(2009-5#1)(2010-10#2)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#5)
what consumers##2##2##(1991-2#1)(2008-12#1)
what could be##7##3##(2004-9#1)(2007-9#1)(2008-11#1)(2008-8#1)(2009-4#2)(2011-1#1)
what could##8##2##(2004-9#1)(2007-9#1)(2008-11#1)(2008-8#1)(2009-4#2)(2011-1#1)(2011-2#1)
what did##2##2##(2007-9#1)(2011-2#1)
what do I##2##3##(1994-12#1)(2012-3#1)
what do we know##3##4##(2006-7#1)(2008-12#1)(2009-5#1)
what do we##5##3##(1993-8#1)(2006-7#1)(2008-1#1)(2008-12#1)(2009-5#1)
what do##17##2##(1993-8#1)(1994-12#2)(1994-3#1)(2005-10#1)(2006-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-10#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
what does it##6##3##(2006-10#1)(2008-7#1)(2009-4#1)(2012-12#2)(2013-8#1)
what does the##2##3##(2008-11#1)(2012-3#1)
what does this##3##3##(2007-8#1)(2008-9#1)(2010-12#1)
what does##17##2##(1992-12#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-12#1)(2012-12#2)(2012-3#1)(2013-8#2)
what drug##2##2##(2007-3#1)(2008-6#1)
what each##2##2##(1996-2#1)(2011-2#1)
what effect##2##2##(2009-11#1)(2012-12#1)
what employers##2##2##(1996-2#1)(2008-6#1)
what equipment##2##2##(1994-6#1)(1997-2#1)
what evidence there is##2##4##(1997-5#1)(2008-8#1)
what exactly is##2##3##(1997-3#1)(2009-9#1)
what exactly##3##2##(1997-3#1)(2008-5#1)(2009-9#1)
what extent can##2##3##(1992-5#1)(1993-5#1)
what extent is##2##3##(2009-8#1)(2011-2#1)
what extent the##21##3##(1991-2#1)(1995-6#2)(1995-8#1)(1996-4#1)(1997-8#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)
what extent##52##2##(1991-2#1)(1992-1#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-5#1)(1994-3#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-8#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-2#3)(2013-1#3)(2013-7#1)
what factors are important##2##4##(2011-2#1)(2012-11#1)
what factors are##5##3##(1994-12#1)(2007-10#1)(2011-2#1)(2012-11#1)(2012-2#1)
what factors influence##2##3##(1996-1#1)(2013-8#1)
what factors##19##2##(1994-12#1)(1995-1#1)(1996-1#1)(2005-12#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#3)(2013-8#1)
what fraction of##3##3##(1990-8#1)(1992-9#1)(2013-1#1)
what future##2##2##(1997-1#1)(2012-3#1)
what had been observed##2##4##(2008-5#1)(2009-9#1)
what had been##4##3##(2008-5#1)(2008-6#1)(2008-9#1)(2009-9#1)
what had##5##2##(2005-8#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-9#1)
what happened to##2##3##(2008-10#1)(2008-7#1)
what happens to##3##3##(1996-8#1)(1997-8#1)(2008-12#1)
what happens when##2##3##(2010-2#1)(2012-3#1)
what happens##8##2##(1996-8#1)(1997-8#1)(2007-3#1)(2008-12#1)(2008-6#1)(2008-7#1)(2010-2#1)(2012-3#1)
what has been found in##2##5##(2008-10#1)(2008-5#1)
what has been learned##2##4##(2008-2#1)(2008-4#1)
what has been observed in##2##5##(1993-7#1)(2008-3#1)
what has been previously##2##4##(2008-3#1)(2008-9#1)
what has been reported for##2##5##(1990-8#1)(1994-9#1)
what has been reported##8##4##(1990-8#1)(1994-9#1)(1995-1#1)(2006-10#2)(2007-12#1)(2007-2#1)(2010-4#1)
what has been##35##3##(1990-12#1)(1990-8#1)(1993-3#1)(1993-7#1)(1994-9#1)(1995-1#1)(1997-1#1)(2006-10#3)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2010-4#1)(2013-1#1)
what has worked##2##3##(1992-3#1)(2009-4#1)
what has##44##2##(1990-12#1)(1990-8#1)(1991-5#1)(1992-3#1)(1993-3#1)(1993-7#1)(1994-9#1)(1995-1#1)(1997-1#1)(2006-10#3)(2006-3#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-4#1)(2009-5#1)(2010-4#1)(2010-9#1)(2013-1#1)
what have we learned##2##4##(2006-10#1)(2009-4#1)
what have we##6##3##(1995-9#1)(2006-10#1)(2008-8#1)(2009-10#1)(2009-4#1)(2012-3#1)
what he##2##2##(1990-5#1)(2007-8#1)
what helps##2##2##(2007-2#1)(2010-8#1)
what his##2##2##(2008-7#1)(2009-7#1)
what impact##2##2##(2006-2#1)(2012-1#1)
what information##6##2##(1996-1#1)(1997-8#2)(2007-2#1)(2010-12#1)(2011-1#1)
what is a##2##3##(2007-7#1)(2008-7#1)
what is already##2##3##(1994-1#1)(1997-4#1)
what is an##2##3##(1996-3#1)(2008-6#1)
what is being##4##3##(2006-5#1)(2008-11#1)(2010-1#1)(2011-12#1)
what is believed to be a novel##2##7##(2008-3#2)
what is believed to be a##4##6##(1992-12#1)(2007-11#1)(2008-3#2)
what is believed to be the first demonstration of##7##9##(2007-12#6)(2008-1#1)
what is believed to be the first demonstration##8##8##(2007-12#7)(2008-1#1)
what is believed to be the first experimental demonstration of##4##10##(2007-12#3)(2008-1#1)
what is believed to be the first experimental observation of##2##10##(2007-11#1)(2007-12#1)
what is believed to be the first experimental##7##8##(2007-11#1)(2007-12#5)(2008-1#1)
what is believed to be the first observation of##4##9##(2007-11#1)(2007-12#3)
what is believed to be the first time in##2##9##(2007-11#1)(2007-12#1)
what is believed to be the first time##32##8##(2007-11#13)(2007-12#18)(2008-1#1)
what is believed to be the first##59##7##(2007-11#18)(2007-12#38)(2008-1#3)
what is believed to be the##60##6##(2007-11#19)(2007-12#38)(2008-1#3)
what is believed to be##66##5##(1992-12#1)(2007-11#21)(2007-12#39)(2008-1#3)(2008-3#2)
what is called##2##3##(1993-12#1)(2008-7#1)
what is considered##2##3##(2008-7#1)(2008-9#1)
what is currently known about the##2##6##(2007-11#1)(2013-1#1)
what is currently known about##6##5##(2007-11#2)(2009-8#1)(2011-1#1)(2012-11#1)(2013-1#1)
what is currently##13##3##(1996-6#1)(2007-11#2)(2007-3#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-11#1)(2012-12#1)(2013-1#1)
what is expected##4##3##(1992-12#1)(1992-6#1)(2008-8#1)(2008-9#1)
what is generally##3##3##(1990-2#1)(1993-3#1)(2008-5#1)
what is going on in##2##5##(2010-8#1)(2012-3#1)
what is happening##6##3##(1997-2#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-4#1)(2012-3#1)
what is it##2##3##(1996-1#1)(2012-12#1)
what is its##2##3##(2006-10#1)(2006-12#1)
what is known about the role of##3##7##(2008-1#2)(2010-4#1)
what is known about the##17##5##(1994-9#1)(2005-7#1)(2006-2#1)(2007-11#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-4#1)(2013-1#1)
what is known about their##2##5##(1992-1#1)(2007-5#1)
what is known about##28##4##(1992-1#1)(1994-9#1)(2005-7#2)(2006-2#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#3)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-8#1)(2010-4#1)(2012-1#1)(2012-3#1)(2013-1#1)
what is known of##2##4##(1991-10#1)(2012-12#1)
what is known##36##3##(1991-10#1)(1991-4#1)(1992-1#1)(1993-9#1)(1994-9#1)(1995-1#1)(2005-11#1)(2005-7#2)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#3)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-8#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
what is meant by &quot##2##5##(1995-6#1)(2012-1#1)
what is meant by##4##4##(1995-6#1)(2008-12#1)(2008-8#1)(2012-1#1)
what is needed##2##3##(2006-10#1)(2010-12#1)
what is not##3##3##(1992-1#1)(2008-11#1)(2009-6#1)
what is now known##2##4##(2008-6#1)(2012-3#1)
what is now##5##3##(2004-1#1)(2006-4#1)(2008-4#1)(2008-6#1)(2012-3#1)
what is observed in##4##4##(1990-7#1)(1995-12#1)(1995-3#1)(2012-2#1)
what is observed##5##3##(1990-7#1)(1995-12#1)(1995-3#1)(2012-2#1)(2012-3#1)
what is possible##3##3##(2007-11#1)(2008-3#1)(2008-6#1)
what is reported##2##3##(2008-10#1)(2009-6#1)
what is required to##4##4##(1996-5#1)(2008-10#1)(2008-11#1)(2008-7#1)
what is seen##5##3##(1990-10#1)(1993-11#1)(2008-11#1)(2008-12#2)
what is so##2##3##(2007-8#1)(2013-1#1)
what is the best##2##4##(2007-11#1)(2007-8#1)
what is the evidence##2##4##(2006-10#1)(2013-1#1)
what is the evidence?##2##4##(2008-11#1)(2008-2#1)
what is the impact##2##4##(1994-3#1)(2008-7#1)
what is the mechanism?##2##4##(2009-11#1)(2009-12#1)
what is the value of##2##5##(1997-7#1)(2012-12#1)
what is the##33##3##(1990-10#1)(1991-12#1)(1993-11#1)(1994-3#1)(1994-8#1)(1995-11#1)(1997-7#1)(2006-10#3)(2006-12#1)(2006-9#1)(2007-11#3)(2007-12#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-12#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
what is to be##2##4##(2006-7#1)(2012-3#1)
what is to our knowledge a record##2##7##(2007-12#2)
what is to our knowledge a##3##6##(2007-12#3)
what is to our knowledge the first demonstration of a##2##10##(2007-12#2)
what is to our knowledge the first demonstration of##3##9##(2007-11#1)(2007-12#2)
what is to our knowledge the first detailed##2##8##(2007-12#2)
what is to our knowledge the first experimental observation##2##9##(2008-1#1)(2008-3#1)
what is to our knowledge the first experimental##6##8##(2007-11#1)(2007-12#3)(2008-1#1)(2008-3#1)
what is to our knowledge the first observation of##3##9##(2007-11#2)(2007-12#1)
what is to our knowledge the first time##8##8##(2007-12#7)(2008-3#1)
what is to our knowledge the first##45##7##(2007-11#11)(2007-12#24)(2008-1#4)(2008-2#3)(2008-3#3)
what is to our knowledge the##47##6##(2007-11#12)(2007-12#25)(2008-1#4)(2008-2#3)(2008-3#3)
what is to our knowledge##50##5##(2007-11#12)(2007-12#28)(2008-1#4)(2008-2#3)(2008-3#3)
what is to the##2##4##(2007-12#1)(2008-2#1)
what is to##55##3##(2006-7#1)(2007-11#12)(2007-12#29)(2008-1#4)(2008-2#5)(2008-3#3)(2012-3#1)
what is usually##2##3##(2005-11#1)(2006-10#1)
what is##350##2##(1990-10#2)(1990-2#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#2)(1991-4#1)(1992-1#3)(1992-12#2)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-3#9)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-1#1)(2004-11#2)(2005-10#2)(2005-11#2)(2005-7#2)(2006-10#7)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-11#44)(2007-12#72)(2007-3#1)(2007-4#4)(2007-5#2)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#12)(2008-10#4)(2008-11#12)(2008-12#3)(2008-2#9)(2008-3#8)(2008-4#4)(2008-5#4)(2008-6#4)(2008-7#8)(2008-8#3)(2008-9#7)(2009-1#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#4)(2009-8#3)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#2)(2011-1#2)(2011-12#2)(2011-2#2)(2012-1#4)(2012-11#2)(2012-12#6)(2012-2#2)(2012-3#8)(2013-1#9)(2013-8#1)
what it has##2##3##(2008-11#1)(2010-12#1)
what it is##6##3##(2008-1#2)(2008-5#1)(2008-7#1)(2009-10#1)(2012-2#1)
what it means to the##2##5##(1991-1#1)(2008-5#1)
what it means to##7##4##(1991-1#1)(1996-12#1)(1996-2#1)(2008-11#1)(2008-5#1)(2012-1#1)(2013-1#1)
what it means##8##3##(1991-1#1)(1996-12#1)(1996-2#1)(2008-11#1)(2008-5#1)(2012-1#1)(2013-1#2)
what it takes to##2##4##(1993-12#1)(2008-7#1)
what it was##2##3##(2010-5#1)(2010-7#1)
what it##32##2##(1990-11#1)(1990-7#1)(1991-1#1)(1993-12#1)(1995-1#1)(1996-12#1)(1996-2#1)(1997-8#1)(2008-1#5)(2008-11#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)
what kind of Model is suitable for##2##7##(2010-8#2)
what kind of##11##3##(1994-6#1)(1995-6#1)(2005-12#1)(2006-8#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-8#2)(2012-1#1)(2012-2#1)
what kinds of##2##3##(1992-11#1)(2012-1#1)
what lessons can##2##3##(2005-8#1)(2010-12#1)
what lessons##3##2##(2005-8#1)(2010-11#1)(2010-12#1)
what level of##3##3##(1993-1#1)(2006-9#1)(2008-1#1)
what level##4##2##(1993-1#1)(2005-10#1)(2006-9#1)(2008-1#1)
what lies##2##2##(2007-4#1)(2010-12#1)
what makes it##2##3##(2008-10#1)(2013-7#1)
what makes them##2##3##(2008-10#1)(2011-2#1)
what makes##9##2##(1996-6#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-7#1)
what many refer to as##2##5##(2011-2#1)(2012-12#1)
what many##5##2##(1991-10#1)(2007-9#1)(2011-2#1)(2012-12#2)
what may be considered##2##4##(2006-5#1)(2008-1#1)
what may be the##3##4##(1993-8#1)(2006-7#1)(2007-8#1)
what may be##8##3##(1993-8#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-6#1)(2009-8#1)
what may##18##2##(1992-8#2)(1993-8#1)(1995-11#1)(1995-6#1)(1995-8#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-6#1)(2009-3#1)(2009-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
what measures##2##2##(2008-9#1)(2012-2#1)
what might be done##2##4##(2009-4#1)(2012-1#1)
what might be expected##2##4##(1991-12#1)(2006-10#1)
what might be##8##3##(1991-12#1)(2006-10#2)(2008-7#1)(2009-4#2)(2009-7#1)(2012-1#1)
what might##12##2##(1991-12#1)(2006-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-4#2)(2009-7#1)(2010-7#1)(2012-1#1)
what must##2##2##(1991-4#1)(1994-1#1)
what needs to be done##2##5##(2006-7#1)(2008-10#1)
what nurse educators##2##3##(2012-3#2)
what occurs##2##2##(1996-2#1)(2008-1#1)
what one##6##2##(1995-1#1)(1995-11#1)(1997-1#1)(2008-12#1)(2008-4#1)(2009-11#1)
what part##2##2##(2007-8#1)(2011-2#1)
what percentage of##2##3##(2007-12#1)(2011-2#1)
what problems##2##2##(1997-6#1)(2007-1#1)
what proportion of##2##3##(2007-2#1)(2011-2#1)
what radiologists need to know##3##5##(2007-4#2)(2008-2#1)
what role does##2##3##(1995-1#1)(2009-10#1)
what role##9##2##(1993-12#1)(1995-1#1)(1997-8#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-4#1)(2009-10#1)(2009-7#1)
what seems##3##2##(1991-3#1)(2008-2#1)(2009-5#1)
what sense##2##2##(1992-1#1)(2008-2#1)
what shapes##2##2##(2006-10#1)(2009-5#1)
what she##2##2##(2009-4#1)(2011-2#1)
what should be done to##2##5##(1991-7#1)(2010-5#1)
what should be done##4##4##(1991-7#1)(2007-1#2)(2010-5#1)
what should be##8##3##(1991-7#1)(2005-8#1)(2007-1#2)(2007-8#1)(2008-11#1)(2010-5#1)(2011-12#1)
what should we do?##2##4##(2009-5#1)(2010-2#1)
what should we##3##3##(2007-7#1)(2009-5#1)(2010-2#1)
what should##15##2##(1991-3#1)(1991-7#1)(2005-8#1)(2007-1#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-8#2)(2009-5#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-12#1)
what some##2##2##(1993-2#1)(2009-9#1)
what specific##5##2##(2007-4#1)(2007-6#1)(2008-3#1)(2011-2#1)(2012-3#1)
what steps##2##2##(2006-6#1)(2011-2#1)
what the facility should##2##4##(1994-12#2)
what the health services##2##4##(1990-8#2)
what the public##2##3##(2008-10#1)(2013-1#1)
what the researchers need to do is to define the metadata and data model in the m-designer##2##17##(2013-1#2)
what the students##2##3##(1992-6#1)(2006-10#1)
what the##52##2##(1990-2#2)(1990-8#4)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-6#1)(1993-2#1)(1994-12#3)(1996-1#1)(1997-3#2)(2006-10#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-12#1)(2013-1#4)(2013-8#1)
what their##9##2##(1994-12#1)(1995-1#1)(1996-6#1)(2004-11#1)(2007-2#1)(2008-3#2)(2010-1#1)(2012-12#1)
what these##3##2##(2008-5#1)(2009-5#1)(2010-10#1)
what they believe is##2##4##(1995-1#1)(2012-3#1)
what they can##2##3##(2008-12#1)(2009-9#1)
what they do##4##3##(1992-12#1)(1995-1#1)(1995-2#1)(2005-7#1)
what they had##2##3##(2004-10#1)(2007-7#1)
what they have##2##3##(1994-12#1)(1996-11#1)
what they see##3##3##(1992-11#1)(2006-10#1)(2010-4#1)
what they think##2##3##(2007-12#1)(2013-1#1)
what they want##2##3##(1994-12#1)(1996-8#1)
what they wanted##2##3##(2009-5#1)(2011-2#1)
what they##52##2##(1990-4#1)(1992-11#1)(1992-12#3)(1993-6#1)(1994-12#4)(1995-1#2)(1995-2#1)(1995-5#1)(1995-7#1)(1996-11#1)(1996-3#1)(1996-8#1)(2004-10#1)(2005-7#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-4#2)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
what this##5##2##(2005-12#1)(2007-12#1)(2008-8#1)(2010-2#1)(2012-3#1)
what to expect##5##3##(1992-6#1)(1996-2#1)(2007-2#2)(2007-9#1)
what to look for##2##4##(1996-3#1)(1997-8#1)
what to measure##2##3##(2007-9#1)(2009-4#1)
what to our knowledge is a new##4##7##(2008-2#1)(2008-3#3)
what to our knowledge is a novel optical##2##8##(2008-3#2)
what to our knowledge is a novel##4##7##(2008-2#1)(2008-3#3)
what to our knowledge is a##8##6##(2008-2#2)(2008-3#6)
what to our knowledge##9##4##(2008-2#3)(2008-3#6)
what to watch out##2##4##(1995-12#1)(1997-2#1)
what to##27##2##(1992-6#1)(1994-1#1)(1995-12#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-2#2)(2007-4#1)(2007-9#2)(2008-1#1)(2008-2#3)(2008-3#7)(2009-4#1)(2010-5#1)
what tobacco##2##2##(1990-2#1)(2009-7#1)
what type of##4##3##(1990-10#1)(2008-12#1)(2009-4#1)(2010-5#1)
what types of##4##3##(1992-9#1)(2007-12#1)(2008-4#1)(2008-7#1)
what variables are##2##3##(2006-7#1)(2010-2#1)
what was considered a##2##4##(2008-3#1)(2009-7#1)
what was expected##2##3##(1993-3#1)(2008-8#1)
what was found in##2##4##(2008-5#2)
what was happening##2##3##(2008-3#1)(2009-4#1)
what was observed in##2##4##(2007-2#1)(2008-11#1)
what was observed##5##3##(1990-10#1)(1993-12#1)(2007-2#1)(2008-11#1)(2012-3#1)
what was the##4##3##(1991-2#1)(2005-8#1)(2009-5#1)(2010-10#1)
what was##32##2##(1990-10#1)(1991-2#1)(1993-12#1)(1993-3#1)(1996-6#1)(2005-11#1)(2005-8#1)(2006-5#1)(2006-6#1)(2007-2#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
what we believe are the first##3##6##(2007-12#3)
what we believe are##4##4##(2007-12#3)(2009-4#1)
what we believe is a new##8##6##(2008-3#8)
what we believe is a novel##3##6##(2008-3#3)
what we believe is a##11##5##(2008-3#11)
what we believe is the first##10##6##(2007-12#5)(2008-1#1)(2008-2#1)(2008-3#3)
what we believe is##21##4##(2007-12#5)(2008-1#1)(2008-2#1)(2008-3#14)
what we believe to be a novel method##2##8##(2008-3#2)
what we believe to be a novel##6##7##(2007-11#1)(2008-3#5)
what we believe to be a##7##6##(2007-11#1)(2008-3#6)
what we believe to be the first application of##2##9##(2007-12#1)(2008-3#1)
what we believe to be the first experimental##2##8##(2007-12#1)(2008-1#1)
what we believe to be the first use of##2##9##(2007-12#1)(2008-3#1)
what we believe to be the first##17##7##(2007-11#1)(2007-12#8)(2008-1#3)(2008-2#1)(2008-3#4)
what we believe to be the##18##6##(2007-11#1)(2007-12#8)(2007-4#1)(2008-1#3)(2008-2#1)(2008-3#4)
what we believe to be##28##5##(2007-11#2)(2007-12#9)(2007-4#1)(2008-1#3)(2008-2#1)(2008-3#11)(2008-9#1)
what we believe##53##3##(2007-11#2)(2007-12#17)(2007-4#1)(2008-1#4)(2008-2#2)(2008-3#25)(2008-9#1)(2009-4#1)
what we call &quot##2##4##(2008-10#1)(2008-2#1)
what we call##4##3##(2008-10#1)(2008-2#1)(2009-10#1)(2009-9#1)
what we can do##3##4##(1992-3#1)(2008-11#1)(2012-12#1)
what we do with what we know##2##7##(2010-10#2)
what we do##6##3##(1994-2#1)(2006-8#1)(2007-7#1)(2010-10#2)(2010-12#1)
what we have learned in##2##5##(2004-2#1)(2010-12#1)
what we have learned##3##4##(2004-2#1)(2010-12#2)
what we have##5##3##(2004-2#1)(2008-9#1)(2010-11#1)(2010-12#2)
what we know about the##2##5##(1996-2#1)(2006-9#1)
what we know about##4##4##(1994-1#1)(1996-2#1)(2006-9#1)(2013-1#1)
what we know and##2##4##(2009-5#1)(2010-12#1)
what we know##11##3##(1992-3#1)(1994-1#1)(1995-3#1)(1996-2#1)(2006-9#1)(2008-1#1)(2009-5#1)(2010-10#2)(2010-12#1)(2013-1#1)
what we need to do##2##5##(2008-4#1)(2012-12#1)
what we need to know about##2##6##(1996-8#1)(2006-2#1)
what we need to know##3##5##(1996-8#1)(2006-2#1)(2013-1#1)
what we need to##5##4##(1996-8#1)(2006-2#1)(2008-4#1)(2012-12#1)(2013-1#1)
what we previously##2##3##(1991-8#1)(2010-2#1)
what we term the##2##4##(2008-8#1)(2009-9#1)
what we##108##2##(1990-5#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-3#2)(1994-1#2)(1994-2#2)(1995-3#1)(1996-12#1)(1996-2#1)(1996-8#1)(2004-2#1)(2005-9#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#17)(2007-4#1)(2007-7#1)(2008-1#5)(2008-10#2)(2008-11#3)(2008-2#3)(2008-3#25)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-9#2)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#4)(2010-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
what were the##3##3##(1993-3#1)(2009-2#1)(2011-2#1)
what will be a##2##4##(2012-12#2)
what will be the##3##4##(1991-12#1)(2006-10#1)(2006-5#1)
what will be##6##3##(1991-12#1)(2006-10#1)(2006-5#1)(2009-4#1)(2012-12#2)
what will the##2##3##(2006-6#1)(2009-4#1)
what will##13##2##(1991-12#1)(1993-3#1)(1997-1#1)(2006-10#1)(2006-5#1)(2006-6#1)(2008-1#1)(2008-12#2)(2009-4#2)(2012-12#2)
what women##2##2##(1992-4#1)(2007-12#1)
what works and what does not##2##6##(1992-12#1)(2007-7#1)
what works##5##2##(1992-12#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-4#1)
what would be considered##2##4##(2007-12#1)(2012-1#1)
what would be expected from the##4##6##(1991-4#1)(2008-6#1)(2008-7#1)(2011-1#1)
what would be expected from##5##5##(1991-4#1)(1993-6#1)(2008-6#1)(2008-7#1)(2011-1#1)
what would be expected##7##4##(1991-4#1)(1992-6#1)(1993-6#1)(2008-6#1)(2008-7#2)(2011-1#1)
what would be##13##3##(1991-4#1)(1992-6#1)(1993-12#1)(1993-6#1)(2007-12#2)(2008-6#1)(2008-7#2)(2009-7#1)(2011-1#2)(2012-1#1)
what would##16##2##(1991-4#1)(1992-6#1)(1993-12#1)(1993-6#1)(2007-12#2)(2007-8#1)(2008-3#1)(2008-6#2)(2008-7#2)(2009-7#1)(2011-1#2)(2012-1#1)
what you do##3##3##(1994-2#1)(2007-4#2)
what you don't know##2##4##(1994-2#1)(2006-5#1)
what you don't##3##3##(1994-2#1)(2006-5#1)(2009-5#1)
what you need to know##3##5##(2007-4#1)(2008-9#1)(2010-8#1)
what you##16##2##(1991-11#1)(1994-2#2)(1994-3#1)(2006-5#1)(2007-4#3)(2007-7#2)(2008-4#1)(2008-9#1)(2009-5#2)(2010-8#1)(2012-1#1)
what your##2##2##(1995-2#1)(2008-12#1)
what##1538##1##(1990-10#6)(1990-11#1)(1990-12#3)(1990-2#5)(1990-4#1)(1990-5#3)(1990-7#2)(1990-8#7)(1991-1#4)(1991-10#2)(1991-11#1)(1991-12#7)(1991-2#9)(1991-3#12)(1991-4#4)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#7)(1992-10#1)(1992-11#3)(1992-12#11)(1992-2#2)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#7)(1992-8#4)(1992-9#5)(1993-1#2)(1993-11#4)(1993-12#9)(1993-2#3)(1993-3#7)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#3)(1993-9#1)(1994-1#10)(1994-10#1)(1994-12#16)(1994-2#5)(1994-3#10)(1994-5#2)(1994-6#5)(1994-8#2)(1994-9#4)(1995-1#11)(1995-11#3)(1995-12#3)(1995-2#6)(1995-3#5)(1995-5#1)(1995-6#8)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#7)(1996-11#5)(1996-12#6)(1996-2#11)(1996-3#13)(1996-4#1)(1996-5#1)(1996-6#6)(1996-8#7)(1997-1#8)(1997-2#4)(1997-3#6)(1997-4#5)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#8)(2004-1#2)(2004-10#1)(2004-11#3)(2004-12#1)(2004-2#1)(2004-7#1)(2004-9#3)(2005-10#6)(2005-11#3)(2005-12#5)(2005-7#5)(2005-8#5)(2005-9#1)(2006-10#29)(2006-11#1)(2006-12#6)(2006-2#7)(2006-3#2)(2006-4#5)(2006-5#8)(2006-6#7)(2006-7#11)(2006-8#6)(2006-9#5)(2007-1#4)(2007-10#5)(2007-11#58)(2007-12#114)(2007-2#20)(2007-3#5)(2007-4#23)(2007-5#5)(2007-6#1)(2007-7#13)(2007-8#21)(2007-9#16)(2008-1#31)(2008-10#35)(2008-11#47)(2008-12#27)(2008-2#30)(2008-3#51)(2008-4#21)(2008-5#19)(2008-6#16)(2008-7#37)(2008-8#25)(2008-9#24)(2009-1#1)(2009-10#10)(2009-11#4)(2009-12#1)(2009-2#3)(2009-3#4)(2009-4#24)(2009-5#14)(2009-6#8)(2009-7#9)(2009-8#9)(2009-9#10)(2010-1#3)(2010-10#14)(2010-11#4)(2010-12#20)(2010-2#9)(2010-3#4)(2010-4#5)(2010-5#7)(2010-6#1)(2010-7#5)(2010-8#14)(2010-9#7)(2011-1#17)(2011-12#7)(2011-2#41)(2012-1#16)(2012-11#5)(2012-12#31)(2012-2#19)(2012-3#31)(2012-7#1)(2013-1#42)(2013-7#6)(2013-8#15)
what&quot##5##1##(1993-7#1)(1994-2#1)(2008-5#1)(2009-2#1)(2013-8#1)
what's new##2##2##(2008-1#1)(2008-12#1)
what's not##3##2##(2007-12#1)(2007-9#1)(2008-4#1)
what's right##2##2##(1996-11#1)(2007-8#1)
what's the##3##2##(1997-1#1)(2013-1#2)
what's##24##1##(1991-1#1)(1991-4#1)(1994-12#1)(1996-11#1)(1997-1#1)(2004-5#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-12#2)(2008-4#1)(2008-5#1)(2009-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
what-functions##2##1##(1993-7#2)
what?##6##1##(1993-12#1)(1993-7#2)(2006-8#1)(2007-2#1)(2007-3#1)
what?]##3##1##(1990-2#1)(1991-4#1)(1993-5#1)
whatever his##3##2##(1992-3#1)(2008-2#1)(2008-4#1)
whatever the time period##2##4##(2009-2#2)
whatever the##20##2##(1993-3#1)(1993-4#1)(1994-12#2)(1995-1#1)(1997-5#1)(2004-12#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#2)(2009-9#1)(2013-1#1)
whatever their##3##2##(1993-12#1)(2006-12#1)(2008-7#1)
whatever##44##1##(1991-12#1)(1991-3#1)(1992-3#2)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-12#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-4#1)(1996-12#1)(1997-5#1)(2004-12#1)(2006-1#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#2)(2009-9#1)(2010-5#1)(2013-1#1)(2013-8#1)
whatsoever##4##1##(1992-1#1)(1995-1#1)(1996-6#1)(2008-7#1)
whcih##2##1##(2007-11#1)(2007-8#1)
wheal and##2##2##(2007-3#1)(2008-5#1)
wheal##4##1##(1990-7#1)(2007-3#1)(2007-7#1)(2008-5#1)
wheals##5##1##(2006-8#2)(2010-6#3)
wheat (T##3##2##(2008-10#2)(2012-3#1)
wheat (Triticum aestivum L##9##4##(1990-11#1)(2006-12#1)(2006-3#1)(2008-11#1)(2008-12#2)(2008-5#2)(2009-8#1)
wheat (Triticum aestivum##10##3##(1990-11#1)(2006-12#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#2)(2009-8#1)
wheat (Triticum aestivum) and##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
wheat (Triticum aestivum) worldwide##2##4##(2008-10#2)
wheat (Triticum aestivum)##12##3##(2008-10#9)(2008-11#1)(2008-12#1)(2008-9#1)
wheat (Triticum and Aegilops spp##2##5##(2008-10#2)
wheat (Triticum##27##2##(1990-11#1)(2006-12#1)(2006-3#1)(2008-10#14)(2008-11#2)(2008-12#3)(2008-5#2)(2008-9#1)(2009-8#1)(2012-3#1)
wheat CDPK genes##4##3##(2009-8#4)
wheat DH##3##2##(2008-8#3)
wheat DHs##2##2##(2008-8#2)
wheat NUE##2##2##(2013-8#2)
wheat and barley##10##3##(1992-8#1)(2008-10#8)(2008-8#1)
wheat and corn##2##3##(2008-10#2)
wheat and human##2##3##(1990-4#2)
wheat and maize##3##3##(2008-8#1)(2011-1#1)(2012-11#1)
wheat and rye##3##3##(1992-6#2)(2008-5#1)
wheat and to##2##3##(1990-3#1)(2008-10#1)
wheat and wild##3##3##(2008-10#3)
wheat and##37##2##(1990-3#1)(1990-4#2)(1992-6#2)(1992-8#1)(2008-10#24)(2008-11#1)(2008-5#1)(2008-8#2)(2011-1#1)(2012-11#1)(2013-8#1)
wheat are##3##2##(2008-10#3)
wheat bran and##2##3##(1993-11#1)(1997-2#1)
wheat bran##11##2##(1993-11#3)(1997-2#1)(1997-8#1)(2007-7#1)(2008-10#3)(2008-5#1)(2009-3#1)
wheat breeding programs##3##3##(2008-10#3)
wheat breeding##4##2##(2008-10#4)
wheat bugs##5##2##(2013-8#5)
wheat by##4##2##(2008-10#3)(2008-5#1)
wheat canopies##3##2##(2008-10#3)
wheat chromosome 1B##2##3##(2008-10#2)
wheat chromosome##10##2##(2008-10#7)(2008-5#2)(2008-9#1)
wheat chromosomes##8##2##(2008-5#5)(2008-8#2)(2008-9#1)
wheat crop##6##2##(2008-10#3)(2008-12#1)(2008-5#2)
wheat cropping##2##2##(2008-10#1)(2013-8#1)
wheat cultivar that has been##2##5##(2008-10#2)
wheat cultivar##10##2##(2008-10#10)
wheat cultivar-specific##3##2##(2008-10#3)
wheat cultivars and##3##3##(2008-10#3)
wheat cultivars differing in##2##4##(2008-10#1)(2008-12#1)
wheat cultivars in the##2##4##(2008-10#2)
wheat cultivars in##3##3##(2008-10#3)
wheat cultivars than in##2##4##(2008-10#2)
wheat cultivars were##2##3##(2008-10#2)
wheat cultivars with##3##3##(2008-10#2)(2011-10#1)
wheat cultivars##36##2##(2008-10#30)(2008-12#5)(2011-10#1)
wheat cultivation##2##2##(2008-10#2)
wheat cv##9##2##(2008-10#9)
wheat cvs##3##2##(2008-10#3)
wheat debris##2##2##(2008-10#2)
wheat differential##2##2##(2008-10#2)
wheat farming with##2##3##(2008-12#2)
wheat farming##3##2##(2008-12#3)
wheat fields in eastern##2##4##(2008-10#2)
wheat fields in##5##3##(2008-10#3)(2008-5#1)(2013-8#1)
wheat fields##12##2##(1995-1#1)(2008-10#9)(2008-5#1)(2013-8#1)
wheat flour was##2##3##(2006-4#1)(2008-10#1)
wheat flour with##2##3##(2008-10#2)
wheat flour##22##2##(2004-8#2)(2005-12#2)(2006-4#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
wheat for##2##2##(2008-10#2)
wheat from Hessian##2##3##(2011-2#2)
wheat from the##2##3##(2008-10#1)(2013-7#1)
wheat from##13##2##(2008-10#10)(2011-2#2)(2013-7#1)
wheat genotypes was##2##3##(2008-10#2)
wheat genotypes##19##2##(2008-10#17)(2008-12#1)(2012-3#1)
wheat germ agglutinin (WGA)##6##4##(1991-12#1)(1994-11#1)(1996-3#1)(1996-9#1)(1997-8#1)(2008-7#1)
wheat germ agglutinin##15##3##(1990-8#1)(1991-12#2)(1992-6#3)(1993-6#1)(1994-11#1)(1996-3#1)(1996-9#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#2)
wheat germ agglutinin-conjugated horseradish peroxidase (WGA-HRP)##2##6##(1993-12#1)(1996-11#1)
wheat germ agglutinin/ovomucoid-gold complex##3##4##(2008-10#3)
wheat germ extract##3##3##(1995-6#1)(2008-9#2)
wheat germ lectin##4##3##(1990-11#1)(1992-6#1)(1993-8#1)(1995-3#1)
wheat germ plasm##2##3##(2008-10#2)
wheat germ valyl-tRNA synthetase##4##4##(1992-9#4)
wheat germ##47##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#3)(1992-6#4)(1992-9#6)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#2)(2012-12#1)
wheat germplasm##2##2##(2006-4#1)(2008-10#1)
wheat gluten##3##2##(2008-10#1)(2008-11#1)(2012-1#1)
wheat glutenin##3##2##(1992-7#3)
wheat grain##9##2##(2006-12#3)(2008-10#5)(2008-12#1)
wheat grains##2##2##(2008-10#2)
wheat grown in a##2##4##(2008-10#2)
wheat grown in##3##3##(2008-10#3)
wheat grown##4##2##(2008-10#3)(2008-12#1)
wheat have been##3##3##(2006-4#1)(2008-10#1)(2011-2#1)
wheat heads##2##2##(2008-10#2)
wheat in Europe##2##3##(2012-2#2)
wheat in France##2##3##(2008-10#1)(2008-8#1)
wheat in North America##2##4##(2008-10#2)
wheat in the##4##3##(2008-10#3)(2011-2#1)
wheat in##23##2##(2008-10#14)(2008-8#3)(2011-2#2)(2012-2#2)(2013-8#2)
wheat induced##3##2##(2007-7#1)(2008-10#1)(2013-8#1)
wheat infected##2##2##(2008-10#2)
wheat is##8##2##(2008-10#8)
wheat kernels##2##2##(2008-10#1)(2008-12#1)
wheat leaf and##2##3##(2008-10#2)
wheat leaf rust severity##2##4##(2008-10#2)
wheat leaf rust##14##3##(2008-10#14)
wheat leaf##17##2##(2008-10#17)
wheat leaves##8##2##(1995-1#1)(2008-10#7)
wheat line##6##2##(2008-10#5)(2008-8#1)
wheat lines and##2##3##(2008-10#2)
wheat lines with##2##3##(2008-10#1)(2008-8#1)
wheat lines##18##2##(2008-10#17)(2008-8#1)
wheat may be##2##3##(2008-10#1)(2011-10#1)
wheat microsatellite##2##2##(2008-5#2)
wheat mosaic virus (SBWMV)##3##4##(2008-10#2)(2008-8#1)
wheat mosaic virus##7##3##(2008-10#3)(2008-8#4)
wheat mosaic##8##2##(2008-10#4)(2008-8#4)
wheat on##2##2##(2006-4#1)(2008-10#1)
wheat or##3##2##(2008-10#2)(2010-1#1)
wheat over##2##2##(2008-10#2)
wheat particles##2##2##(2008-8#2)
wheat pathogen##2##2##(2008-10#2)
wheat planting##3##2##(2008-10#2)(2013-8#1)
wheat plants was##2##3##(2008-10#1)(2008-12#1)
wheat plants were##2##3##(2008-10#2)
wheat plants##15##2##(2006-12#1)(2008-10#8)(2008-12#5)(2011-10#1)
wheat powdery mildew##5##3##(2008-10#5)
wheat production with##2##3##(2008-12#2)
wheat production##7##2##(2008-10#2)(2008-12#5)
wheat protein fractions##2##3##(1991-12#2)
wheat protein##5##2##(1991-12#2)(1994-3#1)(2008-11#1)(2008-5#1)
wheat resistance to##2##3##(2008-10#2)
wheat roots##2##2##(2008-10#2)
wheat rust##3##2##(2008-10#2)(2012-2#1)
wheat samples were##2##3##(2008-10#2)
wheat samples##5##2##(2008-10#5)
wheat seed##5##2##(2008-10#2)(2008-12#3)
wheat seedlings##4##2##(2008-10#4)
wheat seeds##3##2##(1993-8#1)(2008-10#1)(2008-12#1)
wheat sown##3##2##(2013-8#3)
wheat species##2##2##(2008-12#2)
wheat spikes##6##2##(2008-10#6)
wheat spindle streak mosaic##2##4##(2008-10#1)(2008-8#1)
wheat starch##6##2##(1991-12#2)(2008-7#3)(2010-8#1)
wheat stem##2##2##(2008-10#2)
wheat stillage##2##2##(2011-2#2)
wheat straw##3##2##(2006-8#1)(2008-10#1)(2011-1#1)
wheat streak mosaic virus##3##4##(2008-10#3)
wheat streak mosaic##4##3##(2008-10#4)
wheat stripe rust##9##3##(2008-10#9)
wheat stubble##2##2##(2008-10#2)
wheat than##3##2##(2008-10#3)
wheat that##6##2##(1994-3#1)(2008-10#5)
wheat tissues##2##2##(2008-10#2)
wheat to P##2##3##(2008-10#2)
wheat to##7##2##(2008-10#4)(2010-6#1)(2011-2#2)
wheat treated with##2##3##(2008-10#1)(2008-12#1)
wheat type (spring versus winter wheat)##2##6##(2008-10#2)
wheat type##3##2##(2008-10#3)
wheat under##2##2##(2008-10#1)(2008-12#1)
wheat using##2##2##(2008-10#2)
wheat varieties in##4##3##(2008-12#2)(2013-8#2)
wheat varieties##10##2##(2006-12#1)(2006-4#2)(2008-12#2)(2013-8#5)
wheat was##9##2##(2008-10#6)(2008-12#1)(2008-5#1)(2008-8#1)
wheat were##6##2##(2008-10#5)(2011-2#1)
wheat with##5##2##(2008-10#3)(2008-12#1)(2013-8#1)
wheat worldwide##5##2##(2008-10#4)(2011-10#1)
wheat yield##5##2##(2008-10#2)(2008-12#2)(2008-8#1)
wheat##920##1##(1990-11#3)(1990-12#1)(1990-3#1)(1990-4#5)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#10)(1991-5#1)(1992-12#1)(1992-3#6)(1992-6#6)(1992-7#5)(1992-8#1)(1992-9#6)(1993-11#3)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#4)(1994-11#1)(1994-12#1)(1994-3#2)(1995-1#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#3)(2004-8#2)(2005-12#2)(2006-12#18)(2006-3#1)(2006-4#11)(2006-8#1)(2007-7#7)(2007-8#1)(2008-1#2)(2008-10#569)(2008-11#9)(2008-12#47)(2008-4#1)(2008-5#31)(2008-7#5)(2008-8#33)(2008-9#10)(2009-12#3)(2009-3#1)(2009-8#6)(2010-1#1)(2010-2#2)(2010-6#1)(2010-8#2)(2011-1#2)(2011-10#6)(2011-2#15)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#6)(2012-3#5)(2013-1#1)(2013-7#1)(2013-8#33)
wheat) and##2##2##(2008-10#2)
wheat)##7##1##(2008-10#7)
wheat-cultivated##2##1##(2008-10#2)
wheat-dependent##2##1##(2010-6#2)
wheat-germ agglutinin and##2##3##(1995-11#2)
wheat-germ agglutinin##6##2##(1994-12#2)(1995-11#4)
wheat-germ lectin##3##2##(1991-1#2)(1991-5#1)
wheat-germ##10##1##(1991-1#2)(1991-5#1)(1994-12#3)(1995-11#4)
wheat-growing region##2##2##(2008-10#2)
wheat-growing regions##4##2##(2008-10#4)
wheat-growing##9##1##(2008-10#9)
wheat-producing##2##1##(2008-10#2)
wheatgrass##7##1##(2008-10#3)(2008-5#1)(2008-8#3)
wheats##4##1##(2008-10#4)
wheel and##2##2##(1994-6#2)
wheel##18##1##(1994-6#4)(2006-11#2)(2006-6#1)(2007-10#1)(2008-3#1)(2008-7#1)(2009-11#1)(2012-1#2)(2012-12#4)(2012-3#1)
wheel&quot##2##1##(2008-3#2)
wheelchair and wheelchair passenger##2##4##(2013-1#2)
wheelchair and##3##2##(2013-1#3)
wheelchair passenger##4##2##(2013-1#4)
wheelchair propulsion##2##2##(2007-10#2)
wheelchair use##4##2##(2007-7#4)
wheelchair users exercised##2##3##(2007-10#2)
wheelchair users##8##2##(2007-10#6)(2007-7#2)
wheelchair##42##1##(1993-9#1)(2007-10#13)(2007-7#9)(2007-8#1)(2008-1#1)(2009-3#1)(2012-1#5)(2013-1#11)
wheelchair-bound##2##1##(2012-1#2)
wheelchairs##8##1##(2007-10#1)(2007-7#4)(2012-1#2)(2013-1#1)
wheeled##5##1##(2008-10#1)(2010-10#2)(2012-1#2)
wheels and##2##2##(1994-6#1)(2012-11#1)
wheels##7##1##(1994-6#3)(2003-11#1)(2011-12#1)(2012-11#1)(2012-12#1)
wheeze and##3##2##(2007-2#1)(2010-4#1)(2012-3#1)
wheeze ever##2##2##(2007-2#2)
wheeze in##2##2##(1991-11#1)(2008-1#1)
wheeze was##4##2##(2007-2#2)(2008-12#1)(2012-12#1)
wheeze with##2##2##(2005-11#1)(2007-2#1)
wheeze##22##1##(1991-11#1)(2005-11#2)(2005-8#1)(2007-2#10)(2008-1#1)(2008-12#1)(2010-4#1)(2012-12#2)(2012-3#2)(2013-8#1)
wheezing illness##2##2##(2008-10#1)(2010-5#1)
wheezing or##3##2##(1996-3#1)(2007-2#1)(2012-2#1)
wheezing##29##1##(1992-5#2)(1993-12#1)(1996-3#1)(2005-8#1)(2006-8#2)(2007-11#1)(2007-2#4)(2007-8#1)(2008-1#3)(2008-10#1)(2008-3#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-5#2)(2010-6#2)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
wheezing/asthma##2##1##(2013-1#2)
when &lt##2##2##(1995-8#1)(2008-8#1)
when &quot##4##2##(1993-1#2)(1997-7#1)(2013-7#1)
when 0##7##2##(1994-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-4#1)(2010-5#1)
when 1##6##2##(1990-6#1)(2008-10#3)(2009-10#1)(2012-12#1)
when 100##2##2##(2007-1#1)(2008-3#1)
when 11##3##2##(1991-8#1)(2008-10#1)(2012-12#1)
when 2 or more##2##4##(2007-11#1)(2009-6#1)
when 2##4##2##(1997-6#1)(2007-11#1)(2008-10#1)(2009-6#1)
when 20##2##2##(1990-11#1)(2008-10#1)
when 3##2##2##(2009-9#1)(2011-2#1)
when 30 microM##2##3##(1990-11#1)(2008-4#1)
when 30##3##2##(1990-11#1)(2005-11#1)(2008-4#1)
when 50##2##2##(2008-10#1)(2008-11#1)
when 60##2##2##(2008-10#1)(2008-5#1)
when A##2##2##(2008-10#1)(2008-6#1)
when ATP##5##2##(1990-10#1)(1990-9#1)(1993-11#1)(1994-5#1)(2008-6#1)
when AmB##2##2##(1997-2#2)
when Aspergillus##2##2##(2008-10#1)(2008-6#1)
when B##2##2##(2004-11#1)(2008-6#1)
when BRJ##2##2##(1994-6#2)
when C##3##2##(1990-8#1)(2008-10#1)(2011-1#1)
when Ca2+ is##2##3##(1990-5#1)(1997-1#1)
when Ca2+##4##2##(1990-5#1)(1992-11#1)(1995-6#1)(1997-1#1)
when Chl##2##2##(2008-3#2)
when Cu##2##2##(1995-3#2)
when Cx43##2##2##(2008-6#2)
when DL-propranolol was##2##3##(2008-9#2)
when DM##2##2##(2006-6#1)(2007-12#1)
when DNA was##2##3##(2008-10#1)(2009-6#1)
when DNA##8##2##(1997-6#2)(2007-12#1)(2008-10#2)(2008-2#1)(2009-6#1)(2010-12#1)
when ER##2##2##(1995-2#1)(2008-7#1)
when ET was##2##3##(1994-9#2)
when EcoRI##2##2##(1994-8#1)(1997-3#1)
when GnRH was administered##2##4##(2006-5#2)
when Group##2##2##(2006-11#1)(2007-2#1)
when HCl and##2##3##(2004-9#1)(2008-10#1)
when HF##2##2##(2008-10#1)(2011-2#1)
when HGF was added##3##4##(2008-11#3)
when HSF##2##2##(1990-11#1)(2008-5#1)
when Hb &lt##2##3##(1996-12#2)
when I was##4##3##(2008-10#1)(2008-2#1)(2010-8#1)(2013-7#1)
when I##8##2##(1992-3#1)(2008-10#1)(2008-2#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-11#1)(2013-7#1)
when K562 cells##2##3##(1994-6#1)(1996-9#1)
when L-NAME was##2##3##(1996-5#1)(1997-7#1)
when Mg2+##2##2##(1990-3#1)(1993-4#1)
when Na+##2##2##(1990-3#1)(1990-7#1)
when NaCl is##2##3##(1993-12#1)(2008-10#1)
when P##6##2##(1993-2#1)(2008-10#3)(2008-5#1)(2012-3#1)
when PC12##2##2##(1995-3#1)(2008-11#1)
when PCR products##2##3##(1995-10#1)(2008-10#1)
when PCR##5##2##(1995-10#1)(2007-8#1)(2008-10#2)(2008-2#1)
when PKC was##2##3##(1992-9#1)(1996-8#1)
when PKC##3##2##(1992-9#1)(1994-8#1)(1996-8#1)
when R##2##2##(2008-10#2)
when RIW credit##2##3##(1991-12#2)
when RNA##2##2##(1990-5#1)(1991-12#1)
when S##2##2##(2008-6#1)(2012-2#1)
when SOD##2##2##(2006-5#2)
when T##2##2##(2008-10#1)(2008-5#1)
when TR##2##2##(1994-9#2)
when UV##2##2##(1991-1#1)(2004-2#1)
when UVB##2##2##(2010-7#1)(2011-2#1)
when X was##3##3##(1993-3#3)
when [L]/[M(+)]##2##2##(2008-10#2)
when a 0##2##3##(1997-8#1)(2008-10#1)
when a change##2##3##(2008-9#1)(2009-10#1)
when a child is##2##4##(1990-12#1)(2013-1#1)
when a child##5##3##(1990-12#1)(1991-8#1)(2008-10#1)(2008-11#1)(2013-1#1)
when a combination of##2##4##(1990-6#1)(1997-8#1)
when a commercial##2##3##(1995-8#1)(2012-12#1)
when a complex##2##3##(1994-5#1)(1997-3#1)
when a conventional##2##3##(2007-11#1)(2008-7#1)
when a doctor##2##3##(1993-5#1)(1996-6#1)
when a free##2##3##(1990-9#1)(2012-12#1)
when a functional##2##3##(2010-10#1)(2012-2#1)
when a general satisfaction question appears##2##6##(1993-12#2)
when a grating is##2##4##(2008-3#2)
when a group##3##3##(1990-5#1)(1993-2#1)(1997-3#1)
when a high##2##3##(2008-10#1)(2008-8#1)
when a higher##2##3##(2008-10#1)(2008-7#1)
when a laboring##2##3##(2007-2#2)
when a large number of##2##5##(2008-10#1)(2008-2#1)
when a large volume##2##4##(1995-3#1)(2008-10#1)
when a large##5##3##(1995-3#1)(2008-10#2)(2008-2#1)(2008-3#1)
when a lower##2##3##(1996-12#1)(2013-8#1)
when a mixture of##3##4##(1992-6#1)(2008-2#1)(2013-1#1)
when a more##2##3##(2009-10#1)(2013-1#1)
when a new##2##3##(2004-8#1)(2010-12#1)
when a patient has##2##4##(1996-7#1)(2008-5#1)
when a patient##6##3##(1996-7#1)(2005-8#1)(2008-5#1)(2009-3#1)(2010-12#1)(2010-2#1)
when a patient's##2##3##(2006-12#1)(2012-3#1)
when a person##2##3##(2004-12#1)(2006-7#1)
when a plane##2##3##(2008-3#2)
when a positive##2##3##(2005-11#1)(2013-8#1)
when a power##2##3##(2008-10#1)(2008-2#1)
when a prolonged##2##3##(2008-10#1)(2011-2#1)
when a protein##4##3##(1990-11#1)(2006-5#1)(2008-4#2)
when a sample##2##3##(2008-10#2)
when a second##2##3##(1996-6#1)(1997-4#1)
when a significant##2##3##(1996-6#1)(1996-7#1)
when a similar##2##3##(2006-10#1)(2008-10#1)
when a single##5##3##(2007-9#1)(2008-2#1)(2008-3#1)(2012-12#2)
when a small number of##2##5##(2008-11#1)(2008-3#1)
when a small##4##3##(2007-12#2)(2008-11#1)(2008-3#1)
when a specific##2##3##(2005-8#1)(2012-12#1)
when a subject##2##3##(1992-9#1)(2009-2#1)
when a##300##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#3)(1993-11#1)(1993-12#3)(1993-2#2)(1993-5#1)(1994-1#1)(1994-5#5)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#3)(1996-6#5)(1996-7#3)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#3)(1997-6#1)(1997-8#5)(2004-12#1)(2004-8#1)(2005-11#3)(2005-12#1)(2005-8#2)(2006-10#1)(2006-12#3)(2006-5#3)(2006-7#2)(2006-8#1)(2007-1#1)(2007-11#5)(2007-12#11)(2007-2#6)(2007-7#4)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#34)(2008-11#7)(2008-12#1)(2008-2#13)(2008-3#23)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#5)(2009-10#3)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-12#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#7)(2013-8#4)
when about##2##2##(1991-1#1)(2008-10#1)
when absolutely##2##2##(2008-3#1)(2012-12#1)
when absorption##2##2##(2008-3#2)
when access to##2##3##(1992-2#1)(1993-6#1)
when accompanied by##3##3##(2005-10#2)(2008-11#1)
when accompanied##4##2##(2005-10#2)(2008-11#1)(2011-2#1)
when accounting for##2##3##(2007-4#1)(2012-2#1)
when accurate##2##2##(1991-10#1)(2008-3#1)
when actin##2##2##(1991-5#1)(2012-2#1)
when activated##7##2##(1995-11#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-4#1)(2009-6#1)(2012-12#1)
when active##6##2##(1992-12#1)(1994-2#1)(1996-4#1)(2007-2#1)(2008-10#1)(2011-10#1)
when activity##3##2##(1990-2#1)(1993-2#1)(1995-4#1)
when acute##5##2##(2006-4#2)(2007-9#1)(2008-1#1)(2008-3#1)
when added directly to##2##4##(1990-9#1)(1994-9#1)
when added to the##7##4##(1991-2#1)(1991-5#1)(1995-10#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-9#1)
when added to##16##3##(1991-2#1)(1991-5#1)(1993-12#1)(1994-2#1)(1994-9#1)(1995-10#1)(1996-12#1)(1996-4#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-7#1)
when added together##2##3##(2008-11#1)(2008-2#1)
when added##29##2##(1990-4#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#1)(1996-12#1)(1996-4#1)(1997-5#1)(1997-6#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-7#1)
when additional##4##2##(2008-10#2)(2008-8#1)(2013-1#1)
when addressing##6##2##(2006-10#1)(2006-12#1)(2008-12#2)(2008-7#1)(2011-2#1)
when adequate##2##2##(1996-9#1)(2008-10#1)
when adjustments##2##2##(1996-1#1)(2010-5#1)
when administered 30 min before##2##5##(1994-5#2)
when administered acutely##2##3##(1990-2#1)(1996-12#1)
when administered alone##3##3##(1997-3#1)(1997-4#1)(2011-2#1)
when administered as a##3##4##(2007-11#1)(2008-5#1)(2012-12#1)
when administered at##3##3##(1992-3#1)(1994-9#1)(1997-2#1)
when administered chronically##2##3##(1996-6#1)(2005-8#1)
when administered for##6##3##(1990-11#1)(1992-3#2)(1994-6#1)(2007-11#1)(2008-5#1)
when administered in adequate amounts confer##2##6##(2008-4#1)(2013-8#1)
when administered in adequate amounts##3##5##(2008-4#1)(2011-2#1)(2013-8#1)
when administered in an##2##4##(2008-5#2)
when administered in drinking water##3##5##(1992-7#1)(2008-5#2)
when administered in the##2##4##(1997-4#1)(2013-7#1)
when administered in##15##3##(1992-7#1)(1997-4#1)(2007-11#2)(2008-4#1)(2008-5#4)(2009-8#1)(2011-2#1)(2012-2#1)(2013-7#2)(2013-8#1)
when administered intraperitoneally##3##3##(1995-2#1)(1997-4#1)(2007-1#1)
when administered orally##3##3##(1995-2#1)(1997-3#1)(2005-9#1)
when administered systemically##2##3##(1997-5#1)(2005-7#1)
when administered to animals##2##4##(2005-7#1)(2012-12#1)
when administered to##9##3##(1994-2#1)(1997-5#1)(2005-7#1)(2007-8#1)(2009-4#1)(2011-1#1)(2012-12#2)(2013-1#1)
when administered with##5##3##(1991-6#1)(2007-11#3)(2008-11#1)
when administered##76##2##(1990-11#1)(1990-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-3#3)(1992-7#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-2#2)(1996-12#2)(1996-2#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#2)(2005-7#2)(2005-8#1)(2005-9#1)(2007-1#1)(2007-11#9)(2007-8#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#6)(2009-10#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#4)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#1)
when administering##4##2##(1991-11#1)(2007-10#1)(2008-6#1)(2012-12#1)
when adolescents##3##2##(2009-3#1)(2009-7#1)(2012-1#1)
when adopting##4##2##(1992-2#1)(2012-12#1)(2013-1#2)
when adsorbed on##3##3##(2006-5#1)(2008-10#2)
when adsorbed##5##2##(1991-2#1)(2006-5#1)(2008-10#3)
when adult##3##2##(1996-9#1)(2008-6#1)(2011-12#1)
when age was included##2##4##(2010-12#1)(2011-1#1)
when age was##5##3##(1997-8#1)(2007-7#1)(2010-12#1)(2011-1#2)
when air##3##2##(2004-11#1)(2008-10#2)
when all of##2##3##(2008-4#1)(2013-8#1)
when all the##3##3##(2008-10#1)(2008-3#1)(2010-10#1)
when all three##2##3##(1993-9#1)(2008-6#1)
when all##26##2##(1992-3#1)(1993-12#1)(1993-9#3)(1994-4#1)(1996-5#1)(2006-10#1)(2006-11#1)(2006-4#1)(2007-7#1)(2008-10#4)(2008-3#2)(2008-4#1)(2008-6#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
when almost half##2##3##(2007-4#1)(2008-2#1)
when ambient##2##2##(2008-9#1)(2013-7#1)
when an appropriate##3##3##(2008-10#2)(2009-7#1)
when an individual##2##3##(2008-11#1)(2009-6#1)
when an object is located inside a scattering medium##2##9##(2008-3#2)
when an object##3##3##(2008-3#3)
when an##51##2##(1990-12#1)(1992-7#1)(1993-12#2)(1993-9#1)(1994-11#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-4#1)(2005-11#1)(2006-4#1)(2006-6#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-7#1)(2012-3#3)
when analysing a##2##3##(1997-4#1)(2008-10#1)
when analysing##5##2##(1991-1#1)(1994-2#1)(1997-4#1)(2008-10#1)(2008-7#1)
when analyzed by##5##3##(1991-12#1)(1992-12#1)(1997-1#1)(2010-5#1)(2011-1#1)
when analyzed with##2##3##(1993-11#1)(2006-12#1)
when analyzed##12##2##(1991-12#1)(1991-9#1)(1992-12#1)(1993-11#1)(1995-2#1)(1997-1#1)(2006-1#1)(2006-12#1)(2009-8#1)(2010-5#1)(2011-1#1)(2013-1#1)
when analyzing##7##2##(1993-3#1)(2007-4#1)(2008-10#3)(2008-4#1)(2008-8#1)
when and how M&amp##2##4##(2013-7#2)
when and how the##2##4##(2006-10#1)(2011-1#1)
when and how they##2##4##(2009-4#1)(2011-2#1)
when and how to##5##4##(1991-6#1)(2007-8#2)(2008-9#1)(2009-8#1)
when and how##21##3##(1991-6#1)(1994-3#1)(1997-3#1)(1997-5#1)(2006-10#2)(2007-7#1)(2007-8#2)(2008-4#1)(2008-6#1)(2008-9#2)(2009-4#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-7#2)
when and where to##2##4##(1992-3#1)(2010-12#1)
when and where##7##3##(1992-3#1)(1994-2#1)(2010-12#1)(2010-9#1)(2012-11#1)(2012-2#2)
when and##31##2##(1991-6#1)(1992-3#1)(1994-2#1)(1994-3#1)(1997-3#1)(1997-5#1)(2006-10#2)(2006-4#1)(2007-7#1)(2007-8#2)(2008-4#1)(2008-6#1)(2008-9#2)(2009-11#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-2#3)(2013-7#2)
when animals were##3##3##(1991-3#1)(1993-6#1)(1997-1#1)
when animals##4##2##(1991-3#1)(1993-6#1)(1997-1#1)(2008-11#1)
when antibodies##2##2##(1991-6#1)(1994-2#1)
when antigen##2##2##(1990-12#1)(1992-8#1)
when any##2##2##(2007-5#1)(2011-1#1)
when aphids were fed on source plants containing##2##8##(2008-10#2)
when applicable##3##2##(2013-1#3)
when applied as##2##3##(2008-10#1)(2008-3#1)
when applied at a##2##4##(2008-10#1)(2008-4#1)
when applied at##5##3##(1996-6#1)(2008-10#1)(2008-4#2)(2012-8#1)
when applied by##3##3##(2004-9#1)(2008-10#2)
when applied in combination with##2##5##(2008-10#2)
when applied in the##3##4##(1991-12#1)(2008-10#1)(2011-2#1)
when applied in##8##3##(1991-12#1)(1995-12#1)(2008-10#4)(2008-5#1)(2011-2#1)
when applied to a##3##4##(2008-3#1)(2010-2#1)(2012-1#1)
when applied to human##2##4##(1994-3#1)(2010-2#1)
when applied to normal##2##4##(2008-11#1)(2008-5#1)
when applied to patients with##2##5##(2008-1#1)(2008-12#1)
when applied to real data##2##5##(1991-12#1)(2013-8#1)
when applied to the##5##4##(1991-5#1)(1992-10#1)(1993-3#1)(2008-10#2)
when applied to whole##2##4##(2006-2#1)(2008-10#1)
when applied to##43##3##(1990-6#1)(1990-7#1)(1991-12#1)(1991-5#1)(1992-10#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-3#2)(2006-2#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2010-2#2)(2010-4#2)(2012-1#1)(2013-8#2)
when applied topically to##2##4##(2006-10#1)(2008-5#1)
when applied##81##2##(1990-2#1)(1990-6#1)(1990-7#1)(1991-12#2)(1991-5#1)(1992-10#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-3#2)(1995-12#2)(1995-3#1)(1996-6#1)(1997-7#2)(2004-9#1)(2006-10#2)(2006-2#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#21)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#3)(2008-7#3)(2008-8#1)(2009-10#1)(2010-12#1)(2010-2#2)(2010-4#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2012-8#1)(2013-7#1)(2013-8#2)
when applying a##2##3##(2008-5#2)
when applying the##2##3##(2008-2#1)(2008-4#1)
when applying##10##2##(2006-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-4#1)(2012-2#1)
when approaching##2##2##(2006-5#1)(2012-12#1)
when appropriate##13##2##(1990-11#1)(1993-12#1)(1993-3#1)(1995-1#1)(1995-12#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)
when are##3##2##(1996-8#1)(2007-8#1)(2013-1#1)
when arterial##2##2##(2006-5#1)(2008-9#1)
when artificial##2##2##(2012-2#2)
when as##2##2##(1993-8#1)(2007-6#1)
when ascorbate##3##2##(1992-11#1)(1994-8#1)(2012-2#1)
when asked##4##2##(2007-2#1)(2008-11#1)(2010-4#1)(2012-2#1)
when assayed against##2##3##(1990-12#1)(2008-11#1)
when assayed at##3##3##(1990-10#1)(1994-8#1)(1996-4#1)
when assayed in the presence of##4##6##(1990-10#1)(1992-11#1)(1992-3#1)(1995-8#1)
when assayed in##9##3##(1990-10#1)(1991-7#1)(1992-11#1)(1992-3#1)(1995-11#1)(1995-2#2)(1995-8#1)(2012-12#1)
when assayed with##2##3##(1990-12#1)(1991-8#1)
when assayed##17##2##(1990-10#2)(1990-12#2)(1991-7#1)(1991-8#1)(1992-11#1)(1992-3#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-8#1)(1996-4#1)(2008-10#1)(2008-11#1)(2012-12#1)
when assembled##2##2##(2008-10#1)(2009-2#1)
when assessed by##4##3##(1990-6#1)(2010-2#1)(2012-11#2)
when assessed##9##2##(1990-6#1)(1995-12#1)(2008-10#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-11#2)(2012-3#1)
when assessing a child with##2##5##(2008-10#1)(2010-7#1)
when assessing patients##3##3##(2007-8#1)(2008-1#1)(2012-2#1)
when assessing the##10##3##(1992-3#1)(1993-3#1)(1996-9#1)(2005-5#1)(2007-8#1)(2008-3#1)(2008-8#1)(2009-6#1)(2013-1#2)
when assessing##22##2##(1992-3#1)(1993-3#1)(1996-8#1)(1996-9#1)(2005-10#1)(2005-5#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-6#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
when associated with##10##3##(1994-6#1)(2006-10#1)(2006-3#1)(2007-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2011-2#1)
when associated##11##2##(1994-6#1)(2006-10#1)(2006-3#1)(2007-5#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2011-2#1)
when at least##2##3##(2008-5#1)(2012-2#1)
when at##3##2##(2008-5#1)(2010-7#1)(2012-2#1)
when attempting to##14##3##(1995-3#1)(1997-3#1)(2006-2#1)(2007-7#1)(2007-9#1)(2008-3#1)(2008-4#3)(2008-7#2)(2009-1#1)(2010-2#1)(2011-2#1)
when attempting##15##2##(1995-3#1)(1997-3#1)(2006-2#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-3#1)(2008-4#3)(2008-7#2)(2009-1#1)(2010-2#1)(2011-2#1)
when attitude objects are temporally distant vs##2##7##(2009-11#2)
when auditory##2##2##(1992-9#1)(2012-1#1)
when available and##2##3##(2008-5#1)(2008-9#1)
when available##12##2##(1995-12#1)(2004-3#1)(2006-10#1)(2007-4#1)(2008-2#2)(2008-5#2)(2008-9#1)(2009-7#1)(2010-8#1)(2011-1#1)
when averaged##2##2##(2008-3#1)(2011-2#1)
when avirulent strains##2##3##(2008-10#2)
when bacteria##3##2##(1995-11#1)(1996-12#1)(2008-5#1)
when based on a##2##4##(2007-10#1)(2007-3#1)
when basic##2##2##(1991-12#1)(2007-8#1)
when beginning##2##2##(2013-1#1)(2013-8#1)
when beneficial##2##2##(2008-8#1)(2013-1#1)
when binding to##2##3##(2006-12#1)(2008-10#1)
when binding##3##2##(1996-7#1)(2006-12#1)(2008-10#1)
when blocked with##2##3##(2012-3#2)
when blood##3##2##(2005-7#3)
when body rotation is applied##2##5##(1991-1#2)
when both the##6##3##(1990-12#1)(1993-6#1)(1995-12#1)(2007-9#1)(2008-11#1)(2008-3#1)
when both were##2##3##(1996-6#1)(2009-3#1)
when both##56##2##(1990-11#2)(1990-12#1)(1991-2#1)(1991-6#1)(1992-9#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-8#2)(1995-1#2)(1995-12#1)(1995-2#1)(1996-12#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-2#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-3#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-3#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-10#1)(2012-12#1)(2012-3#1)(2012-7#1)
when bound to DNA##2##4##(1991-4#1)(1997-4#1)
when bound to the##2##4##(1991-10#1)(1992-6#1)
when bound to##11##3##(1991-10#1)(1991-4#1)(1991-5#1)(1992-6#2)(1993-3#1)(1995-4#1)(1996-11#1)(1997-4#2)(2006-10#1)
when bound##13##2##(1990-2#1)(1991-10#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-6#2)(1993-3#1)(1995-4#1)(1996-11#1)(1997-4#2)(2006-10#1)
when brain##2##2##(1990-5#1)(2006-2#1)
when building##5##2##(2007-11#1)(2008-2#1)(2011-2#1)(2013-1#2)
when buying##2##2##(2005-5#1)(2008-12#1)
when caged##2##2##(2008-10#1)(2011-12#1)
when calcium ions were##2##4##(2005-11#2)
when calcium##4##2##(1994-6#1)(1995-11#1)(2005-11#2)
when calculated on##2##3##(2006-11#1)(2008-3#1)
when calculated##4##2##(2006-11#1)(2008-10#1)(2008-3#1)(2010-4#1)
when calculating the##2##3##(2008-10#1)(2008-3#1)
when calculating##5##2##(1992-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
when calves##2##2##(2008-7#2)
when cancer##2##2##(2011-2#1)(2012-3#1)
when careful##2##2##(2005-7#1)(2007-1#1)
when carefully##2##2##(2005-7#1)(2008-12#1)
when caring for##3##3##(2010-3#1)(2011-1#1)(2013-1#1)
when carried out in##2##4##(2008-2#1)(2008-7#1)
when carried out##3##3##(1990-9#1)(2008-2#1)(2008-7#1)
when carried##5##2##(1990-10#2)(1990-9#1)(2008-2#1)(2008-7#1)
when cases are given##2##4##(1992-2#1)(1992-9#1)
when cases##3##2##(1992-2#1)(1992-6#1)(1992-9#1)
when cell##4##2##(1992-2#1)(1995-8#1)(2008-10#1)(2008-7#1)
when cells are stimulated##2##4##(1990-12#1)(2008-4#1)
when cells are##7##3##(1990-12#1)(1995-6#1)(1996-9#1)(2006-10#1)(2008-4#1)(2009-12#1)(2010-7#1)
when cells were exposed to##4##5##(1992-5#1)(1994-6#1)(1996-4#1)(2008-10#1)
when cells were grown##2##4##(1990-9#1)(1995-9#1)
when cells were incubated##2##4##(1990-10#1)(1993-6#1)
when cells were treated with##6##5##(1990-11#1)(1990-12#1)(1990-9#1)(1993-6#1)(1996-8#1)(2008-10#1)
when cells were##24##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#2)(1991-8#1)(1992-11#1)(1992-5#1)(1993-6#2)(1994-2#1)(1994-6#1)(1995-9#1)(1996-10#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-7#1)(2008-10#3)(2008-11#1)(2011-2#1)
when cells##37##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-9#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-6#2)(1994-2#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-4#1)(1996-8#1)(1996-9#2)(1997-7#2)(2006-10#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-9#1)(2009-12#1)(2010-7#1)(2011-2#1)
when certain##4##2##(1990-10#1)(2006-10#1)(2008-10#1)(2008-9#1)
when challenged by##2##3##(2008-10#1)(2008-7#1)
when challenged with##7##3##(1991-8#1)(1991-9#1)(2006-8#1)(2008-10#2)(2008-12#1)(2012-2#1)
when challenged##14##2##(1991-12#1)(1991-8#1)(1991-9#1)(2005-9#1)(2006-8#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#2)(2012-2#1)
when changes in##3##3##(1996-7#1)(2006-8#1)(2008-5#1)
when changes##5##2##(1996-7#1)(2006-8#1)(2008-5#1)(2010-7#1)(2013-8#1)
when changing##2##2##(1993-2#1)(2008-2#1)
when chicks were##2##3##(1997-6#2)
when children begin##2##3##(2012-1#1)(2012-12#1)
when children were##2##3##(2009-10#2)
when children##5##2##(2009-10#2)(2012-1#1)(2012-12#1)(2013-8#1)
when cholesterol is##2##3##(1992-6#1)(1993-9#1)
when choosing a##5##3##(2005-11#1)(2008-8#1)(2009-5#1)(2009-8#1)(2012-12#1)
when choosing##14##2##(1993-12#1)(2005-11#1)(2005-4#1)(2006-5#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2011-1#1)(2012-12#1)
when chronically##2##2##(1992-7#1)(1994-5#1)
when clearly##2##2##(2007-11#1)(2008-10#1)
when clinical##6##2##(1992-11#1)(1997-8#1)(2006-1#1)(2007-10#2)(2007-11#1)
when cloacal##2##2##(1996-12#2)
when cloned into##2##3##(1993-9#1)(1995-2#1)
when cloned##3##2##(1991-7#1)(1993-9#1)(1995-2#1)
when co-administered with##4##3##(1990-5#1)(1994-11#1)(2008-3#1)(2008-4#1)
when co-cultured with##2##3##(1995-5#1)(2006-8#1)
when co-cultured##3##2##(1995-5#1)(2006-8#1)(2012-4#1)
when co-transfected##2##2##(1991-1#1)(2013-8#1)
when coated##3##2##(1990-6#1)(1997-3#1)(2009-5#1)
when cocultured with##2##3##(1995-2#1)(2008-7#1)
when coexpressed with##2##3##(1994-8#2)
when coinoculated with##2##3##(2008-10#2)
when coinoculated##4##2##(2008-10#4)
when collecting##3##2##(2008-10#1)(2008-2#1)(2011-1#1)
when combined with a##2##4##(1996-12#1)(2008-7#1)
when combined with the##4##4##(1996-2#1)(2008-2#1)(2010-2#2)
when combined with##41##3##(1991-7#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#2)(1996-7#1)(2006-9#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-2#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-8#1)
when combined##45##2##(1991-7#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#2)(1996-7#1)(2006-9#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-2#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
when combining##6##2##(1994-8#1)(2006-10#1)(2008-8#1)(2010-5#1)(2010-8#1)(2011-1#1)
when communicating##2##2##(2010-4#1)(2012-1#1)
when compared to CD##2##4##(2013-8#2)
when compared to EHR evaluations relatively few biomedical informatics researchers have published on evaluating EHR implementations##2##16##(2013-1#2)
when compared to POR##2##4##(1994-3#2)
when compared to a##6##4##(1996-10#1)(2006-11#1)(2007-7#1)(2007-8#1)(2008-10#2)
when compared to bare metal stents##2##6##(2008-11#1)(2008-12#1)
when compared to cells##3##4##(1992-8#1)(1997-2#1)(2008-11#1)
when compared to control##13##4##(1990-11#1)(1991-8#1)(1993-6#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-10#1)(2013-1#1)
when compared to controls##9##4##(1994-3#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-12#2)(2009-3#1)(2011-1#1)(2011-2#1)
when compared to conventional##2##4##(2007-10#1)(2008-10#1)
when compared to group 1##2##5##(2007-1#2)
when compared to infection with##2##5##(2008-7#2)
when compared to its##2##4##(1993-3#1)(2011-2#1)
when compared to known##2##4##(2006-6#1)(2008-5#1)
when compared to normal##5##4##(1991-9#1)(1992-8#1)(1993-11#1)(2004-9#1)(2008-7#1)
when compared to other##9##4##(1995-7#1)(2007-11#1)(2007-3#1)(2007-5#1)(2008-10#1)(2009-3#1)(2010-8#1)(2011-12#1)(2013-7#1)
when compared to patients##3##4##(2005-8#1)(2007-7#1)(2008-8#1)
when compared to placebo##2##4##(2007-7#2)
when compared to previous##2##4##(1992-6#1)(2012-1#1)
when compared to solvent extraction##2##5##(2008-10#2)
when compared to that of the##2##6##(1997-7#1)(2011-12#1)
when compared to that of##6##5##(1996-10#1)(1997-7#1)(2008-10#1)(2010-4#1)(2011-12#1)(2013-1#1)
when compared to that##10##4##(1994-3#1)(1994-5#1)(1996-10#1)(1997-7#1)(2007-8#1)(2008-10#1)(2010-10#1)(2010-4#1)(2011-12#1)(2013-1#1)
when compared to the control group##6##6##(2008-4#1)(2009-5#2)(2010-7#1)(2011-2#1)(2012-2#1)
when compared to the control##12##5##(2008-12#1)(2008-4#4)(2009-5#2)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-7#1)
when compared to the other##4##5##(1996-12#1)(1997-5#1)(2007-8#1)(2010-8#1)
when compared to the reference##3##5##(2006-7#1)(2008-10#1)(2008-12#1)
when compared to the standard##2##5##(2007-8#1)(2008-7#1)
when compared to the wild-type enzyme##2##6##(1993-6#1)(1996-2#1)
when compared to the##89##4##(1990-10#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-5#2)(1992-7#1)(1993-1#1)(1993-6#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-5#2)(1996-8#1)(1997-5#1)(1997-7#1)(2005-10#1)(2006-11#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-2#2)(2007-6#2)(2007-7#2)(2007-8#2)(2008-10#5)(2008-11#3)(2008-12#3)(2008-4#4)(2008-6#1)(2008-7#5)(2009-10#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-12#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
when compared to their##6##4##(1993-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-12#1)
when compared to those of##3##5##(1997-8#1)(2007-12#1)(2008-4#1)
when compared to those##10##4##(1991-8#1)(1993-11#1)(1995-12#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)
when compared to untreated##2##4##(1995-3#1)(2008-10#1)
when compared to wild-type##2##4##(1994-11#1)(2011-2#1)
when compared to##307##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-8#2)(1991-9#2)(1992-10#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#3)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#2)(1994-11#2)(1994-12#3)(1994-3#7)(1994-4#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#2)(1995-7#2)(1995-9#1)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-5#2)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2004-9#2)(2005-10#1)(2005-8#1)(2006-1#1)(2006-11#2)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#2)(2007-1#2)(2007-10#2)(2007-11#6)(2007-12#1)(2007-2#3)(2007-3#2)(2007-5#3)(2007-6#2)(2007-7#6)(2007-8#9)(2008-1#3)(2008-10#21)(2008-11#17)(2008-12#10)(2008-3#1)(2008-4#7)(2008-5#8)(2008-6#3)(2008-7#11)(2008-8#2)(2009-10#3)(2009-11#1)(2009-3#2)(2009-5#3)(2009-6#3)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#4)(2011-12#5)(2011-2#6)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#14)(2013-7#5)(2013-8#6)
when compared with a##10##4##(1996-9#1)(2008-10#4)(2008-2#1)(2008-7#1)(2011-2#1)(2013-1#2)
when compared with both##2##4##(1990-5#1)(2013-8#1)
when compared with control group##2##5##(2008-4#1)(2012-2#1)
when compared with control##11##4##(1990-7#1)(1996-8#1)(2007-3#3)(2008-11#1)(2008-4#1)(2009-5#3)(2012-2#1)
when compared with controls##11##4##(1990-11#1)(1995-12#1)(1996-8#1)(1997-8#1)(2006-10#1)(2007-8#2)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)
when compared with conventional##3##4##(1991-5#1)(2008-10#2)
when compared with data##2##4##(2008-1#1)(2008-10#1)
when compared with healthy##4##4##(1991-7#1)(2005-10#1)(2010-10#1)(2012-1#1)
when compared with human##2##4##(1991-3#1)(2007-11#1)
when compared with normal##2##4##(1991-8#1)(2011-2#1)
when compared with other##10##4##(1991-12#1)(1995-6#1)(2006-12#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-9#1)(2013-1#2)
when compared with patients with##2##5##(2011-2#1)(2012-3#1)
when compared with patients##3##4##(2010-2#1)(2011-2#1)(2012-3#1)
when compared with single##2##4##(2007-12#1)(2008-10#1)
when compared with that##3##4##(1996-9#1)(2006-10#1)(2008-11#1)
when compared with the control##10##5##(1992-4#1)(1993-11#1)(1993-12#1)(1994-2#1)(1997-6#1)(2007-1#1)(2008-10#2)(2008-5#1)(2010-12#1)
when compared with the group##2##5##(2008-5#1)(2011-2#1)
when compared with the other##2##5##(2008-10#1)(2013-8#1)
when compared with the standard##3##5##(2007-7#1)(2008-10#2)
when compared with the##65##4##(1990-12#1)(1991-8#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-7#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-6#1)(2004-10#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-11#2)(2006-8#1)(2006-9#1)(2007-1#2)(2007-7#2)(2008-10#14)(2008-2#2)(2008-5#4)(2008-7#1)(2009-10#1)(2010-1#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
when compared with their##5##4##(1997-4#1)(2007-7#1)(2008-3#1)(2010-5#1)(2013-8#1)
when compared with those of##3##5##(1990-11#1)(1994-8#1)(2010-12#1)
when compared with those who##2##5##(2007-3#1)(2012-12#1)
when compared with those##12##4##(1990-11#1)(1990-6#1)(1993-12#1)(1994-8#1)(1995-6#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-3#1)(2010-12#1)(2010-4#1)(2012-12#1)
when compared with traditional##2##4##(2006-10#1)(2007-1#1)
when compared with untreated##2##4##(1991-6#1)(2008-12#1)
when compared with young adult##2##5##(1995-7#1)(1996-2#1)
when compared with##275##3##(1990-11#2)(1990-12#2)(1990-5#1)(1990-6#1)(1990-7#2)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-11#1)(1992-4#1)(1992-5#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#5)(1995-5#1)(1995-6#3)(1995-7#2)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#2)(1996-8#2)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-1#1)(2004-10#1)(2004-2#1)(2005-10#3)(2005-8#1)(2006-10#8)(2006-11#2)(2006-12#2)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#5)(2007-11#2)(2007-12#3)(2007-2#3)(2007-3#5)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#42)(2008-11#7)(2008-12#4)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#10)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#1)(2009-4#2)(2009-5#4)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#16)(2012-1#1)(2012-11#2)(2012-12#5)(2012-2#5)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#4)
when compared##588##2##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#2)(1990-7#4)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#3)(1991-7#1)(1991-8#4)(1991-9#2)(1992-10#2)(1992-11#1)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#3)(1993-1#2)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#4)(1993-5#1)(1993-6#3)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#7)(1994-4#1)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#6)(1995-3#3)(1995-5#3)(1995-6#3)(1995-7#4)(1995-9#2)(1996-10#3)(1996-11#2)(1996-12#4)(1996-2#4)(1996-3#2)(1996-5#4)(1996-7#1)(1996-8#4)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#2)(2004-1#1)(2004-10#1)(2004-2#1)(2004-9#2)(2005-10#4)(2005-8#2)(2006-1#1)(2006-10#8)(2006-11#4)(2006-12#2)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#4)(2006-9#2)(2007-1#7)(2007-10#2)(2007-11#8)(2007-12#4)(2007-2#6)(2007-3#7)(2007-5#3)(2007-6#3)(2007-7#9)(2007-8#13)(2007-9#1)(2008-1#6)(2008-10#63)(2008-11#25)(2008-12#15)(2008-2#4)(2008-3#6)(2008-4#8)(2008-5#18)(2008-6#4)(2008-7#19)(2008-8#3)(2008-9#1)(2009-10#5)(2009-11#1)(2009-3#3)(2009-4#2)(2009-5#7)(2009-6#3)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#6)(2010-2#2)(2010-3#2)(2010-4#6)(2010-5#2)(2010-7#1)(2010-8#5)(2010-9#3)(2011-1#6)(2011-12#5)(2011-2#22)(2011-7#1)(2012-1#2)(2012-11#2)(2012-12#6)(2012-2#10)(2012-3#6)(2013-1#23)(2013-7#6)(2013-8#10)
when comparing all##2##3##(1996-2#1)(2009-2#1)
when comparing between##2##3##(2008-9#2)
when comparing groups##2##3##(2007-12#1)(2012-1#1)
when comparing the results##2##4##(1996-3#1)(2009-5#1)
when comparing the two##2##4##(2005-7#1)(2008-12#1)
when comparing the##11##3##(1996-3#1)(2005-7#1)(2006-8#1)(2008-10#3)(2008-12#1)(2008-8#2)(2009-5#1)(2012-3#1)
when comparing##36##2##(1991-6#1)(1994-6#1)(1996-2#1)(1996-3#1)(1997-7#1)(2005-7#1)(2006-8#2)(2007-12#1)(2008-10#8)(2008-12#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-4#1)(2009-5#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#2)
when competing##2##2##(1990-7#1)(2012-3#1)
when competition between##2##3##(2008-8#1)(2009-10#1)
when competition was##2##3##(2008-8#2)
when competition##5##2##(2008-8#4)(2009-10#1)
when complexed to##3##3##(1990-2#1)(2008-10#1)(2010-9#1)
when complexed with##3##3##(1992-3#1)(1994-3#1)(2008-10#1)
when complexed##6##2##(1990-2#1)(1992-3#1)(1994-3#1)(2008-10#2)(2010-9#1)
when complexity of disease was considered##2##6##(1995-3#2)
when compressed##2##2##(1992-7#1)(2010-4#1)
when compromised##2##2##(2008-3#1)(2008-5#1)
when computed tomography##2##3##(2007-7#1)(2008-7#1)
when concentrated H(2)SO(4)##2##3##(2008-10#2)
when concentration of##2##3##(2008-11#1)(2011-2#1)
when concentration##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
when concentrations of##4##3##(2008-10#1)(2008-6#1)(2010-5#1)(2012-2#1)
when concentrations##5##2##(1990-7#1)(2008-10#1)(2008-6#1)(2010-5#1)(2012-2#1)
when conditioned##2##2##(2008-11#2)
when conditions##3##2##(1997-8#1)(2008-10#2)
when conducting##3##2##(2008-9#1)(2009-10#1)(2012-2#1)
when confronted by##2##3##(1994-3#1)(2008-10#1)
when confronted with##7##3##(1992-2#1)(2005-8#1)(2008-7#1)(2011-1#1)(2012-12#2)(2013-8#1)
when confronted##9##2##(1992-2#1)(1994-3#1)(2005-8#1)(2008-10#1)(2008-7#1)(2011-1#1)(2012-12#2)(2013-8#1)
when conjugated to##3##3##(1994-11#1)(2005-7#1)(2008-10#1)
when conservative aa##2##3##(1991-6#1)(1993-2#1)
when conservative##4##2##(1991-6#1)(1993-2#1)(1997-8#1)(2008-10#1)
when considered in the context of##2##6##(1997-6#1)(2007-11#1)
when considered in##5##3##(1997-6#1)(2006-9#2)(2007-11#1)(2008-12#1)
when considered##8##2##(1991-5#1)(1997-6#1)(2006-9#2)(2007-11#1)(2008-12#1)(2008-7#1)(2011-2#1)
when considering a##2##3##(1995-12#1)(2010-6#1)
when considering the##7##3##(1994-2#1)(2006-11#1)(2008-6#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-8#1)
when considering##24##2##(1993-5#1)(1994-10#1)(1994-2#1)(1995-10#1)(1995-12#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-8#1)(2013-8#2)
when consumed##2##2##(2006-10#1)(2007-8#1)
when contact##2##2##(2008-3#1)(2010-9#1)
when controlling for##5##3##(2005-10#1)(2009-12#1)(2010-8#1)(2012-2#1)(2013-8#1)
when conventional##6##2##(1994-6#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-4#1)(2009-8#1)
when cooperation##2##2##(2008-8#2)
when copper##4##2##(1992-12#1)(2008-5#3)
when corrected for##6##3##(1990-11#1)(1995-3#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-12#1)
when corrected##7##2##(1990-11#1)(1992-1#1)(1995-3#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-12#1)
when correlated with##3##3##(1995-1#1)(1995-12#1)(2013-1#1)
when coupled with a##2##4##(2008-11#1)(2008-3#1)
when coupled with##5##3##(1995-8#1)(2008-11#1)(2008-3#1)(2009-9#1)(2013-1#1)
when coupled##6##2##(1995-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-9#1)(2013-1#1)
when cows##2##2##(2006-5#1)(2012-2#1)
when crossed with##2##3##(2008-10#2)
when cultivated##3##2##(2008-11#3)
when culture##2##2##(1991-6#1)(2008-10#1)
when cultured in the presence of##5##6##(1993-12#1)(1993-4#1)(2008-11#1)(2008-4#1)(2008-6#1)
when cultured in the##6##4##(1993-12#1)(1993-4#1)(2008-11#2)(2008-4#1)(2008-6#1)
when cultured in##13##3##(1993-12#1)(1993-4#1)(1995-10#1)(2008-11#4)(2008-4#1)(2008-6#1)(2008-7#2)(2010-6#1)(2012-4#1)
when cultured on##2##3##(2008-11#1)(2008-5#1)
when cultured with##3##3##(1993-8#1)(1995-9#1)(2008-11#1)
when cultured##20##2##(1991-7#1)(1993-12#1)(1993-4#1)(1993-8#1)(1995-10#1)(1995-9#1)(2008-11#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-6#1)(2012-4#1)(2013-7#1)
when cultures were##3##3##(1990-12#1)(1995-1#1)(2011-2#1)
when cultures##5##2##(1990-12#1)(1991-10#1)(1995-1#1)(2010-3#1)(2011-2#1)
when cycloheximide was added##2##4##(1991-10#1)(1994-12#1)
when daily##3##2##(1992-9#1)(2007-8#1)(2008-10#1)
when data are##5##3##(2008-10#1)(2009-9#1)(2011-2#1)(2013-1#2)
when data were##3##3##(1991-12#1)(1995-12#1)(2011-1#1)
when data##10##2##(1991-12#1)(1995-12#1)(2006-10#1)(2008-10#1)(2009-11#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
when day shifts were supported##2##5##(2010-6#2)
when dealing with##14##3##(1996-1#1)(1996-3#1)(1996-6#1)(1996-9#1)(2006-10#3)(2007-9#1)(2008-10#2)(2008-2#1)(2010-4#1)(2011-1#1)(2011-2#1)
when death##2##2##(1997-5#1)(2010-1#1)
when deciding to##2##3##(2008-10#1)(2008-7#1)
when deciding whether to##3##4##(2007-3#1)(2012-11#1)(2012-2#1)
when deciding##10##2##(1995-4#1)(2005-8#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-11#1)(2012-2#2)
when delivered alone##2##3##(1994-2#1)(2009-5#1)
when delivered by##3##3##(1994-12#1)(1996-2#1)(2008-5#1)
when delivered##7##2##(1994-12#1)(1994-2#1)(1996-2#1)(1997-2#1)(2005-7#1)(2008-5#1)(2009-5#1)
when describing their##2##3##(2012-12#1)(2012-2#1)
when describing##6##2##(2008-1#2)(2008-11#1)(2012-12#1)(2012-2#1)(2013-7#1)
when designing a##8##3##(1993-5#1)(1997-3#1)(2006-8#1)(2010-2#1)(2010-8#2)(2011-2#1)(2012-1#1)
when designing an##2##3##(2008-4#1)(2008-9#1)
when designing and comparing studies##2##5##(2011-1#2)
when designing##18##2##(1992-7#1)(1993-5#1)(1996-3#1)(1997-3#1)(2005-9#1)(2006-8#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-2#1)(2010-8#2)(2011-1#4)(2011-2#1)(2012-1#1)
when desired##2##2##(2008-5#1)(2012-12#1)
when detected##2##2##(2008-5#1)(2013-7#1)
when detergent##2##2##(1990-3#1)(2011-2#1)
when determined at##3##3##(1996-9#1)(2008-11#1)(2010-2#1)
when determined##6##2##(1990-12#1)(1996-9#1)(1997-8#1)(2008-10#1)(2008-11#1)(2010-2#1)
when determining 0##2##3##(2008-10#2)
when determining the##7##3##(1993-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2010-1#1)(2011-2#1)
when determining##17##2##(1993-12#1)(1993-2#1)(1993-3#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-4#1)(2010-1#1)(2010-4#1)(2011-2#2)
when developed##3##2##(1993-1#1)(2008-10#2)
when developing a##2##3##(2008-10#1)(2012-2#1)
when developing##13##2##(2008-10#3)(2008-11#1)(2010-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#2)
when diagnosed##3##2##(1995-4#1)(2006-10#1)(2011-2#1)
when diagnosing##2##2##(1992-9#1)(2012-3#1)
when did##2##2##(2007-7#1)(2008-8#1)
when dietary##2##2##(2006-10#1)(2010-2#1)
when dietitians##2##2##(1993-12#1)(1994-2#1)
when differences##2##2##(1993-11#1)(1994-4#1)
when different##7##2##(1992-5#1)(2008-10#4)(2008-3#1)(2009-11#1)
when differential##2##2##(2005-4#1)(2008-10#1)
when diffusion##2##2##(2006-10#1)(2008-2#1)
when directly##3##2##(1990-11#1)(1997-4#1)(2008-11#1)
when disaster strikes##2##3##(2008-2#1)(2010-8#1)
when discussing the possible##2##4##(2006-11#1)(2008-10#1)
when discussing the##3##3##(2006-11#1)(2008-10#1)(2010-3#1)
when discussing##6##2##(2006-11#1)(2008-10#1)(2008-3#1)(2010-3#2)(2011-2#1)
when disease##9##2##(2006-9#1)(2008-10#5)(2008-11#1)(2010-7#1)(2012-1#1)
when doing##2##2##(2012-12#1)(2012-2#1)
when drawing##2##2##(2008-11#1)(2008-5#1)
when drawn##2##2##(2007-11#2)
when drug##3##2##(1991-2#1)(2007-7#1)(2011-2#1)
when drugs##3##2##(1991-2#1)(1997-4#1)(2008-1#1)
when each neurone##2##3##(1995-11#2)
when each should be##2##4##(1992-12#1)(2008-4#1)
when each volunteer received a single dose of 5 mg zolpidem and##2##11##(2011-2#2)
when each##14##2##(1992-12#1)(1995-11#2)(1996-2#2)(2006-10#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#2)(2012-3#1)
when early##4##2##(2007-12#1)(2007-8#1)(2008-5#2)
when either sufficient or no##2##5##(2008-2#1)(2008-3#1)
when either the##5##3##(1991-8#1)(2007-10#1)(2008-2#1)(2008-4#1)(2010-2#1)
when either##19##2##(1990-7#1)(1991-12#1)(1991-8#1)(1992-10#1)(1992-12#1)(1993-12#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-2#3)(2008-3#2)(2008-4#1)(2010-2#1)
when electrophoresis was performed##2##4##(2008-5#2)
when elevated##3##2##(1990-12#1)(2011-2#1)(2012-7#1)
when employing##3##2##(1991-8#1)(1995-1#1)(1996-5#1)
when encountering##4##2##(2009-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
when endonuclease III was##2##4##(1995-2#2)
when endoscopic##2##2##(1997-8#1)(2008-5#1)
when energized with##2##3##(1990-11#2)
when energy##2##2##(2011-1#1)(2013-1#1)
when enhanced##2##2##(2006-10#1)(2008-7#1)
when entering##3##2##(1993-3#1)(2008-3#1)(2012-3#1)
when environmental conditions are##2##4##(2008-10#1)(2008-4#1)
when environmental##3##2##(2008-10#1)(2008-4#1)(2008-8#1)
when establishing##4##2##(2008-4#1)(2010-1#1)(2011-2#2)
when estimating##3##2##(1996-7#1)(1997-7#1)(2010-8#1)
when ethanol##2##2##(2007-7#1)(2010-12#1)
when evaluated by##2##3##(1997-2#1)(2010-3#1)
when evaluated for##2##3##(2007-7#1)(2008-5#1)
when evaluated##9##2##(1993-9#1)(1994-9#1)(1995-3#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-3#1)
when evaluating and##2##3##(1995-1#1)(2013-7#1)
when evaluating the##2##3##(2008-7#1)(2012-2#1)
when evaluating##16##2##(1990-8#1)(1993-2#1)(1994-5#1)(1995-1#1)(2006-12#1)(2006-5#1)(2007-7#1)(2008-4#1)(2008-7#2)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
when evidence is##2##3##(1993-12#2)
when examined at##2##3##(1990-3#1)(2008-10#1)
when examined by##7##3##(1995-3#1)(1996-4#1)(1997-4#1)(2008-10#3)(2008-7#1)
when examined##15##2##(1990-3#1)(1994-5#1)(1995-1#1)(1995-3#1)(1996-4#1)(1997-3#1)(1997-4#1)(2008-10#5)(2008-7#1)(2009-9#2)
when examining and##2##3##(2006-12#1)(2008-1#1)
when examining individual##2##3##(2006-8#1)(2013-1#1)
when examining the##2##3##(2007-7#1)(2013-8#1)
when examining##14##2##(1996-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-7#1)(2008-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
when excess##3##2##(2005-11#1)(2008-10#1)(2008-9#1)
when excised##2##2##(1993-10#1)(2011-1#1)
when excited at##7##3##(1991-2#1)(1996-12#1)(2007-11#4)(2008-10#1)
when excited by##3##3##(1997-4#1)(2008-3#1)(2008-5#1)
when excited##12##2##(1991-2#1)(1996-12#1)(1997-4#1)(2007-11#4)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-11#1)
when excluding##2##2##(1997-3#1)(2008-10#1)
when exogenous##2##2##(1992-6#1)(2008-10#1)
when experiencing##2##2##(2009-10#1)(2009-3#1)
when experiments are##2##3##(1997-5#1)(2008-10#1)
when experiments##3##2##(1997-5#1)(2008-10#2)
when exposed to a##5##4##(2007-4#2)(2008-11#1)(2008-2#1)(2009-4#1)
when exposed to air##2##4##(1992-1#2)
when exposed to the##2##4##(1990-2#1)(2009-6#1)
when exposed to##38##3##(1990-11#1)(1990-2#1)(1991-7#1)(1991-9#1)(1992-1#4)(1992-2#1)(1992-3#1)(1992-7#1)(1993-7#1)(1994-12#1)(2004-4#1)(2005-9#1)(2006-12#1)(2007-4#2)(2008-10#6)(2008-11#1)(2008-2#2)(2008-5#2)(2008-7#3)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-4#1)(2013-8#1)
when exposed##43##2##(1990-11#1)(1990-2#1)(1991-7#1)(1991-9#1)(1992-1#4)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#1)(1993-7#1)(1994-12#1)(1997-2#1)(2004-4#1)(2005-9#1)(2006-12#1)(2007-4#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#3)(2008-7#3)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-4#1)(2013-8#1)
when exposure to##3##3##(1994-6#1)(1997-1#1)(2010-6#1)
when exposure##6##2##(1994-6#1)(1997-1#1)(2008-10#1)(2008-7#1)(2010-6#1)(2011-2#1)
when expressed alone in##3##4##(1995-2#2)(1996-10#1)
when expressed as a function of##2##6##(1994-3#2)
when expressed as a##4##4##(1994-3#2)(2007-12#1)(2009-6#1)
when expressed as##5##3##(1994-3#2)(2007-12#2)(2009-6#1)
when expressed in CHO cells##2##5##(1993-11#1)(1996-10#1)
when expressed in the##3##4##(2006-12#1)(2008-11#1)(2010-9#1)
when expressed in##19##3##(1990-11#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-3#1)(1993-11#1)(1994-12#1)(1994-9#1)(1996-10#1)(1996-2#1)(1997-4#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-8#1)(2010-2#1)(2010-9#1)
when expressed##36##2##(1990-11#1)(1991-2#2)(1991-9#1)(1992-10#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-9#1)(1995-2#2)(1996-10#2)(1996-2#1)(1997-4#2)(2006-10#1)(2006-12#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-6#1)(2008-9#2)(2009-6#1)(2009-8#1)(2010-2#1)(2010-9#1)
when expressing##2##2##(1995-6#1)(1997-3#1)
when extracellular##3##2##(1991-9#1)(1995-12#1)(2010-2#1)
when extracts are##2##3##(1992-3#1)(1995-3#1)
when extrapolating##3##2##(1992-1#1)(2008-2#1)(2009-9#1)
when faced with a##5##4##(2008-10#1)(2008-3#1)(2010-8#1)(2011-2#1)(2012-11#1)
when faced with the##2##4##(2008-1#1)(2010-5#1)
when faced with##13##3##(1993-4#1)(1994-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-11#2)
when facing health##2##3##(1990-12#1)(2008-7#1)
when facing##6##2##(1990-12#1)(2008-7#2)(2009-5#1)(2012-12#1)(2013-8#1)
when factor##3##2##(1990-11#1)(1995-1#1)(2008-10#1)
when feasible##3##2##(2006-11#1)(2006-8#1)(2008-7#1)
when fed on##2##3##(2007-5#2)
when fed##4##2##(2007-3#1)(2007-5#2)(2008-6#1)
when feeding on##2##3##(2008-6#1)(2011-12#1)
when feeding##4##2##(2008-6#1)(2008-9#1)(2009-4#1)(2011-12#1)
when females##4##2##(2008-3#1)(2008-6#1)(2008-9#2)
when few or no##2##4##(1991-7#1)(2008-9#1)
when few##4##2##(1991-7#1)(2008-10#2)(2008-9#1)
when figures##3##2##(2008-9#3)
when first##4##2##(1997-8#1)(2006-2#1)(2007-3#1)(2013-1#1)
when five##2##2##(2008-3#1)(2010-8#1)
when fixed##2##2##(1990-2#1)(2010-2#1)
when flow##2##2##(1991-10#1)(2007-9#1)
when fluorescein##2##2##(1995-5#1)(2009-8#1)
when focusing on##2##3##(2007-12#2)
when followed by##2##3##(2010-6#1)(2011-1#1)
when followed##3##2##(1996-1#1)(2010-6#1)(2011-1#1)
when food##2##2##(2007-3#1)(2009-10#1)
when forskolin was##2##3##(1990-3#1)(1993-3#1)
when free BH4##2##3##(1995-1#2)
when free in aqueous solution##2##5##(1991-7#1)(2008-10#1)
when free in##3##3##(1991-7#1)(2005-7#1)(2008-10#1)
when free##9##2##(1990-11#1)(1991-5#1)(1991-7#2)(1995-1#2)(2005-7#1)(2007-11#1)(2008-10#1)
when frequency##2##2##(2006-10#1)(2008-8#1)
when frequency-doubled##2##2##(2008-3#2)
when fructose##2##2##(1990-7#1)(1992-1#1)
when fruit##2##2##(2008-10#2)
when fused to a##2##4##(1995-3#1)(2008-6#1)
when fused to the##2##4##(1994-9#1)(1996-10#1)
when fused to##7##3##(1991-10#1)(1994-9#1)(1995-3#1)(1996-10#1)(2008-6#1)(2009-10#1)(2010-10#1)
when fused##8##2##(1991-10#1)(1994-9#1)(1995-3#1)(1996-10#1)(2008-10#1)(2008-6#1)(2009-10#1)(2010-10#1)
when genetic##3##2##(2009-2#1)(2010-4#1)(2013-8#1)
when ghee was##3##3##(2004-11#3)
when given 180 min##2##4##(1996-1#2)
when given 6 or##2##4##(1994-5#1)(1995-3#1)
when given after##2##3##(1992-5#1)(1996-1#1)
when given alone##5##3##(1991-12#1)(1992-8#1)(1995-12#1)(1996-1#1)(2007-1#1)
when given as a single##2##5##(1992-12#1)(2007-11#1)
when given as a##4##4##(1991-6#1)(1992-12#1)(2007-11#1)(2008-7#1)
when given as##5##3##(1991-6#1)(1992-12#1)(2007-11#2)(2008-7#1)
when given at##3##3##(1995-5#1)(1996-4#1)(2008-10#1)
when given in##4##3##(1992-10#1)(1993-9#1)(1996-1#1)(2007-3#1)
when given orally or##2##4##(1992-12#1)(2008-5#1)
when given orally##3##3##(1992-12#1)(2006-10#1)(2008-5#1)
when given to##2##3##(1995-9#1)(2007-11#1)
when given with##3##3##(2007-2#1)(2008-5#1)(2008-6#1)
when given##44##2##(1991-12#1)(1991-6#1)(1992-10#1)(1992-12#2)(1992-5#1)(1992-8#1)(1993-9#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#7)(1996-4#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#3)(2007-2#2)(2007-3#1)(2007-6#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-7#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
when giving##2##2##(1997-3#1)(2011-2#1)
when glucokinase was##2##3##(1990-7#1)(2008-11#1)
when glucose was##3##3##(1994-11#1)(2005-12#1)(2008-6#1)
when glucose##6##2##(1994-11#1)(1995-9#1)(2005-12#1)(2008-6#2)(2011-2#1)
when glutamine was##2##3##(1994-11#1)(1994-5#1)
when glutathione was present##2##4##(1992-11#2)
when glutathione##3##2##(1992-11#2)(2008-2#1)
when glycerol is##2##3##(1997-1#1)(2006-5#1)
when glycerol##3##2##(1997-1#1)(2006-5#1)(2011-2#1)
when going##2##2##(2008-10#1)(2011-1#1)
when greater than 50%##2##4##(2006-8#1)(2009-10#1)
when greater than##3##3##(1990-2#1)(2006-8#1)(2009-10#1)
when greater##5##2##(1990-2#1)(1992-11#1)(2006-8#1)(2008-5#1)(2009-10#1)
when grown at 33##2##4##(2008-10#2)
when grown at##3##3##(2008-10#3)
when grown in MS medium##2##5##(2008-10#2)
when grown in the presence of##4##6##(1992-9#1)(1994-3#1)(2008-5#1)(2011-1#1)
when grown in the##5##4##(1992-9#1)(1994-3#1)(1995-8#1)(2008-5#1)(2011-1#1)
when grown in##16##3##(1990-11#1)(1992-9#1)(1994-3#1)(1995-2#1)(1995-8#1)(1997-4#2)(2008-10#5)(2008-11#1)(2008-5#2)(2011-1#1)
when grown on##8##3##(1990-5#1)(1991-9#1)(2006-8#1)(2008-10#2)(2008-5#2)(2008-6#1)
when grown##31##2##(1990-11#1)(1990-5#1)(1991-9#1)(1992-9#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-3#1)(1997-4#2)(2006-8#1)(2008-10#11)(2008-11#2)(2008-5#4)(2008-6#1)(2011-1#1)(2011-2#1)
when growth took place under vacuum##2##6##(2011-2#2)
when growth##3##2##(2011-2#3)
when he had##2##3##(2006-12#1)(2010-12#1)
when he is##2##3##(1991-2#1)(1993-11#1)
when he returned from the##2##5##(2009-4#1)(2009-7#1)
when he was##5##3##(1991-6#1)(1994-12#1)(2007-12#1)(2007-9#1)(2010-7#1)
when he##26##2##(1990-8#1)(1991-2#1)(1991-6#1)(1993-11#1)(1994-12#1)(1996-11#1)(2005-8#1)(2006-12#1)(2007-1#1)(2007-12#2)(2007-6#1)(2007-9#1)(2008-1#1)(2008-12#2)(2009-4#2)(2009-7#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-7#1)(2012-2#1)(2013-1#2)
when healthy##2##2##(2008-10#1)(2008-9#1)
when heart##3##2##(1994-5#1)(1995-12#1)(1995-2#1)
when heated to##2##3##(2010-2#2)
when heated##3##2##(2006-12#1)(2010-2#2)
when hepatocytes are##2##3##(1994-8#1)(2009-11#1)
when hepatocytes were##2##3##(1990-3#1)(1995-6#1)
when hepatocytes##4##2##(1990-3#1)(1994-8#1)(1995-6#1)(2009-11#1)
when her##2##2##(1993-9#1)(1996-11#1)
when high##8##2##(2004-12#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-3#1)
when higher##2##2##(2011-1#1)(2013-7#1)
when his##2##2##(1995-6#1)(2008-6#1)
when honey was added to the diets##2##7##(2008-6#2)
when hospitals##2##2##(1995-2#1)(1996-2#1)
when human milk##2##3##(2006-8#1)(2012-2#1)
when human##4##2##(1991-8#1)(2006-8#1)(2008-10#1)(2012-2#1)
when hydrogen peroxide##2##3##(1994-2#1)(1997-1#1)
when hydrogen##3##2##(1994-2#1)(1997-1#1)(2008-10#1)
when hydrolyzed##2##2##(2008-10#1)(2010-3#1)
when identical##2##2##(2007-8#1)(2008-11#1)
when identified##2##2##(2006-10#1)(2012-2#1)
when identifying the##3##3##(2008-4#1)(2010-9#1)(2012-3#1)
when identifying##7##2##(1997-2#1)(2008-11#1)(2008-4#1)(2010-2#1)(2010-9#1)(2012-12#1)(2012-3#1)
when illuminated with##3##3##(2008-2#1)(2008-3#1)(2010-4#1)
when immersed in##2##3##(2008-10#1)(2008-5#1)
when immobilized on##2##3##(2008-10#1)(2008-11#1)
when immobilized##3##2##(1990-5#1)(2008-10#1)(2008-11#1)
when implanted into##2##3##(2006-11#1)(2008-5#1)
when implanted subcutaneously in##2##4##(2006-9#1)(2013-8#1)
when implanted##6##2##(1996-5#1)(2006-11#1)(2006-9#1)(2008-1#1)(2008-5#1)(2013-8#1)
when implementing##6##2##(2008-10#1)(2008-11#1)(2009-9#1)(2012-11#2)(2013-1#1)
when in a##3##3##(2008-11#1)(2008-8#1)(2009-8#1)
when in contact with##3##4##(2008-7#2)(2010-4#1)
when in doubt##3##3##(2005-12#1)(2011-12#1)(2011-2#1)
when in the##5##3##(2006-6#1)(2008-8#1)(2009-10#1)(2009-8#1)(2013-1#1)
when in##27##2##(1990-4#1)(1992-12#1)(1994-11#1)(1994-5#1)(2005-12#1)(2006-1#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-5#1)(2009-8#2)(2010-4#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#1)
when included in##2##3##(2008-5#1)(2010-4#1)
when incorporated into##3##3##(1992-12#1)(2006-8#1)(2007-6#1)
when incorporated##5##2##(1990-2#1)(1992-12#1)(2006-8#1)(2007-6#1)(2008-5#1)
when increasing amounts of##4##4##(1991-5#2)(1992-3#1)(2004-9#1)
when increasing concentrations of##2##4##(1990-11#1)(1992-12#1)
when increasing the##3##3##(1995-6#1)(2006-10#1)(2013-1#1)
when increasing##11##2##(1990-11#1)(1991-5#2)(1992-12#1)(1992-3#1)(1995-6#1)(2004-9#1)(2006-10#1)(2008-10#1)(2008-8#1)(2013-1#1)
when incubated at 50 degrees C##2##6##(2008-10#1)(2008-6#1)
when incubated at##7##3##(1997-1#1)(2006-9#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-9#1)
when incubated on##2##3##(2007-6#1)(2008-10#1)
when incubated with##10##3##(1990-9#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-5#1)(1996-5#1)(1997-7#1)(2006-8#1)(2008-7#1)(2011-2#1)
when incubated##24##2##(1990-9#1)(1991-3#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-9#1)(1996-5#1)(1997-1#1)(1997-7#1)(2006-8#2)(2006-9#1)(2007-6#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2011-2#1)
when indicated##10##2##(1994-2#1)(2004-12#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-4#1)(2011-2#1)
when individually##2##2##(1993-12#1)(2012-3#1)
when individuals##6##2##(1991-12#1)(2008-5#1)(2008-9#2)(2009-9#1)(2012-12#1)
when induced by##2##3##(1997-1#1)(1997-6#1)
when induced##3##2##(1990-5#1)(1997-1#1)(1997-6#1)
when infants##2##2##(1992-2#1)(2012-1#1)
when infected by##2##3##(2008-10#2)
when infected with##5##3##(1990-11#1)(2006-10#1)(2008-10#2)(2011-10#1)
when infected##10##2##(1990-11#1)(1995-1#1)(1997-4#1)(2006-10#1)(2008-10#5)(2011-10#1)
when inferring##2##2##(2008-8#1)(2012-11#1)
when infiltrated into##2##3##(2006-3#1)(2008-10#1)
when influenza A outbreaks occur##2##5##(1991-8#1)(2007-12#1)
when information##3##2##(2008-4#1)(2008-6#1)(2008-7#1)
when infused into##2##3##(1996-4#1)(2008-9#1)
when infused##3##2##(1991-10#1)(1996-4#1)(2008-9#1)
when initiated##3##2##(1993-3#1)(1994-10#1)(2007-11#1)
when injected i##3##3##(1993-7#1)(1994-11#1)(1997-4#1)
when injected into the##5##4##(1990-2#1)(1991-3#1)(1993-12#1)(1993-2#1)(1997-3#1)
when injected into##11##3##(1990-2#1)(1991-3#1)(1992-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1997-3#1)(2008-1#1)(2008-6#1)(2010-8#1)(2011-12#1)
when injected subcutaneously##2##3##(1994-6#1)(2008-8#1)
when injected##30##2##(1990-2#1)(1991-3#1)(1992-11#1)(1992-5#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-6#1)(1996-10#1)(1996-12#1)(1997-3#1)(1997-4#2)(2006-12#1)(2006-5#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-6#2)(2008-8#1)(2010-8#1)(2011-12#1)(2012-12#1)
when injury##3##2##(1993-4#1)(1996-3#1)(2006-11#1)
when inoculated at anthesis##2##4##(2008-10#2)
when inoculated at##3##3##(2008-10#3)
when inoculated in##2##3##(1997-4#1)(2008-10#1)
when inoculated onto##2##3##(2008-10#2)
when inoculated with a##2##4##(2008-10#1)(2008-12#1)
when inoculated with##5##3##(1993-5#1)(2008-10#3)(2008-12#1)
when inoculated##24##2##(1993-5#1)(1997-4#1)(2006-3#1)(2008-10#17)(2008-12#1)(2008-4#2)(2008-5#1)
when inserted in the##2##4##(1995-2#1)(2008-5#1)
when inserted in##4##3##(1990-3#1)(1991-6#1)(1995-2#1)(2008-5#1)
when inserted##9##2##(1990-3#1)(1991-3#1)(1991-6#1)(1991-8#1)(1995-2#1)(2007-8#2)(2008-5#1)(2012-2#1)
when insulin binds to its receptor##2##6##(2008-1#1)(2008-9#1)
when insulin##3##2##(2008-1#1)(2008-9#1)(2011-1#1)
when intact##3##2##(1990-12#1)(1991-5#1)(1994-12#1)
when integrated and##3##3##(1990-9#1)(2013-1#2)
when integrated with##2##3##(2008-3#1)(2012-3#1)
when integrated##6##2##(1990-9#2)(2008-3#1)(2012-3#1)(2013-1#2)
when integrating##2##2##(2008-3#1)(2008-6#1)
when interacting with lipid##2##4##(2006-10#1)(2010-5#1)
when interests##2##2##(1991-6#1)(2013-8#1)
when interferograms##2##2##(2008-2#1)(2008-3#1)
when interpreting the##2##3##(1991-8#1)(1992-3#1)
when interpreting##11##2##(1991-8#1)(1992-1#1)(1992-3#1)(1997-6#1)(2007-9#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
when introduced into##3##3##(1992-10#1)(1994-12#1)(1995-2#1)
when introduced##6##2##(1992-10#1)(1994-12#1)(1995-2#1)(2008-10#2)(2009-6#1)
when investigated##2##2##(2012-12#1)(2013-1#1)
when investigating the##3##3##(2008-3#1)(2011-1#1)(2013-1#1)
when investigating##12##2##(1990-5#1)(1991-2#1)(1995-11#1)(2005-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2011-1#1)(2012-3#1)(2013-1#2)
when irradiated with##2##3##(2008-11#1)(2008-3#1)
when irradiated##3##2##(2008-11#1)(2008-3#1)(2010-1#1)
when is it##3##3##(1991-12#1)(1995-3#1)(2006-9#1)
when is##7##2##(1991-12#2)(1995-3#1)(2006-2#1)(2006-6#1)(2006-9#1)(2011-2#1)
when isolated and##2##3##(1993-6#1)(2006-8#1)
when isolated from the##2##4##(1992-9#1)(2008-10#1)
when isolated##8##2##(1992-9#1)(1993-6#1)(2006-8#1)(2007-5#1)(2007-8#1)(2008-10#2)(2009-3#1)
when it became##3##3##(1994-6#1)(2006-2#1)(2007-2#1)
when it comes to the##2##5##(2007-9#1)(2009-11#1)
when it comes to##9##4##(1991-3#1)(1996-9#1)(2006-8#1)(2007-8#1)(2007-9#1)(2009-11#2)(2010-12#1)(2011-2#1)
when it comes##10##3##(1991-3#1)(1995-12#1)(1996-9#1)(2006-8#1)(2007-8#1)(2007-9#1)(2009-11#2)(2010-12#1)(2011-2#1)
when it did##2##3##(1993-2#1)(2009-3#1)
when it has##2##3##(1991-9#1)(2006-10#1)
when it is applied##3##4##(1991-12#1)(1995-6#1)(2007-12#1)
when it is appropriate to transfer a patient##2##8##(1993-1#1)(1993-2#1)
when it is appropriate to##3##5##(1993-1#1)(1993-2#1)(2006-8#1)
when it is associated with##2##5##(2011-1#1)(2011-2#1)
when it is in##3##4##(1990-2#1)(2008-10#1)(2008-4#1)
when it is loaded##2##4##(2006-11#2)
when it is most##2##4##(2006-10#1)(2007-11#1)
when it is necessary to##2##5##(1991-1#1)(2006-5#1)
when it is necessary##3##4##(1991-1#1)(2006-5#1)(2007-7#1)
when it is needed##2##4##(2008-9#1)(2012-2#1)
when it is not##4##4##(2007-12#1)(2008-2#1)(2008-3#1)(2010-5#1)
when it is used##4##4##(2007-12#1)(2008-3#1)(2008-9#1)(2013-8#1)
when it is##89##3##(1990-11#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-7#2)(1992-6#1)(1993-1#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-6#1)(1997-4#2)(2005-10#1)(2005-11#1)(2006-10#2)(2006-11#2)(2006-2#1)(2006-5#2)(2006-8#1)(2007-11#3)(2007-12#12)(2007-7#1)(2008-1#1)(2008-10#6)(2008-2#2)(2008-3#7)(2008-4#3)(2008-5#2)(2008-7#1)(2008-9#3)(2009-11#2)(2009-2#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2013-8#1)
when it occurs in##3##4##(2006-1#1)(2006-9#1)(2010-11#1)
when it occurs##6##3##(2006-1#1)(2006-9#1)(2008-7#1)(2009-10#1)(2010-11#1)(2013-8#1)
when it presents##2##3##(2006-10#1)(2009-1#1)
when it was added to##2##5##(1995-1#1)(2008-11#1)
when it was applied during##2##5##(1995-6#2)
when it was applied to the##3##6##(2008-10#2)(2010-4#1)
when it was applied##6##4##(1995-6#2)(2008-10#2)(2008-5#1)(2010-4#1)
when it was assumed that the##3##6##(2008-2#1)(2008-6#2)
when it was calculated by use of the##2##8##(2008-3#2)
when it was combined with##2##5##(2008-10#1)(2008-3#1)
when it was compared##2##4##(1991-12#1)(2008-10#1)
when it was exposed to##2##5##(2007-12#1)(2010-4#1)
when it was incubated##3##4##(1990-4#1)(2008-7#2)
when it was inoculated##2##4##(2006-3#1)(2008-10#1)
when it was used##3##4##(1990-6#1)(2008-8#2)
when it was##62##3##(1990-12#1)(1990-4#2)(1990-6#1)(1991-12#1)(1991-3#1)(1992-2#1)(1992-7#1)(1993-7#1)(1995-1#1)(1995-3#2)(1995-5#1)(1995-6#2)(1996-1#1)(1996-2#1)(1997-1#1)(1997-3#1)(2004-12#1)(2006-3#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2009-4#1)(2010-10#1)(2010-2#1)(2010-4#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)
when it##220##2##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#3)(1991-5#1)(1991-6#1)(1991-7#3)(1991-9#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-7#1)(1993-9#2)(1994-1#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#4)(1996-1#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#2)(2004-12#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#6)(2006-11#2)(2006-2#2)(2006-3#1)(2006-5#2)(2006-7#1)(2006-8#2)(2006-9#2)(2007-11#4)(2007-12#18)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#15)(2008-11#3)(2008-2#5)(2008-3#10)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#7)(2008-8#4)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#4)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-11#1)(2012-12#3)(2012-2#6)(2013-1#2)(2013-8#4)
when its##17##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-2#1)(1993-8#1)(1995-12#1)(1997-5#2)(2004-4#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-8#1)(2012-1#1)
when just##3##2##(1992-12#1)(1994-8#1)(2008-10#1)
when k approximately##2##3##(2008-3#2)
when known##4##2##(1995-3#2)(1997-2#1)(2006-10#1)
when lactofen was applied at the##2##6##(2008-10#2)
when large amounts##2##3##(1996-8#1)(2008-4#1)
when large##7##2##(1996-8#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-4#1)(2013-1#1)
when larger##3##2##(2008-10#1)(2012-11#1)(2012-2#1)
when larvae##2##2##(2008-9#1)(2011-12#1)
when lasR is controlled by##2##5##(1995-2#2)
when learning##3##2##(2008-11#1)(2012-12#2)
when leaves were soaked##2##4##(2008-10#2)
when leaves were##4##3##(2008-10#4)
when leaves##5##2##(2008-10#4)(2008-9#1)
when left##3##2##(1992-9#1)(2006-9#1)(2008-7#1)
when lesions##2##2##(2008-5#1)(2012-12#1)
when life##2##2##(2005-7#1)(2012-2#1)
when light##3##2##(2007-11#1)(2008-3#1)(2008-9#1)
when limited##2##2##(1991-4#1)(1992-5#1)
when linked to the##3##4##(1994-2#1)(1995-3#1)(1997-4#1)
when linked to##4##3##(1992-5#1)(1994-2#1)(1995-3#1)(1997-4#1)
when linked##5##2##(1992-5#1)(1994-2#1)(1995-3#1)(1997-4#1)(2008-10#1)
when lipid##2##2##(1991-11#1)(2007-12#1)
when living in##2##3##(1996-11#1)(2010-9#1)
when living with##3##3##(2010-10#1)(2012-12#1)(2013-1#1)
when living##6##2##(1996-11#1)(2009-6#1)(2010-10#1)(2010-9#1)(2012-12#1)(2013-1#1)
when loaded##3##2##(2006-11#2)(2011-1#1)
when loading##2##2##(2013-1#1)(2013-8#1)
when local##6##2##(2006-7#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-12#1)
when lophophores are tightly packed and excurrents are vented through chimneys##2##11##(2008-9#2)
when low concentrations of##2##4##(1990-7#1)(1992-9#1)
when low##4##2##(1990-7#1)(1991-12#1)(1992-9#1)(2007-7#1)
when maintained##3##2##(1997-1#1)(2008-10#1)(2010-8#1)
when making decisions##2##3##(1996-3#1)(2007-10#1)
when making##14##2##(1990-10#1)(1994-1#2)(1996-3#1)(1997-3#1)(2007-10#1)(2007-8#1)(2008-11#2)(2008-8#1)(2009-5#1)(2010-2#1)(2013-7#1)(2013-8#1)
when male##3##2##(1990-8#1)(2008-8#1)(2008-9#1)
when managed by##2##3##(2007-11#1)(2007-2#1)
when managed##3##2##(2006-10#1)(2007-11#1)(2007-2#1)
when managing patients##2##3##(2007-8#1)(2010-9#1)
when manganese##2##2##(1990-7#1)(1995-8#1)
when many##3##2##(1994-1#1)(2007-11#1)(2008-10#1)
when mares were##2##3##(2006-5#2)
when mathematical##2##2##(2005-10#1)(2013-8#1)
when maximal##2##2##(1994-8#1)(2008-5#1)
when mean##3##2##(2005-7#1)(2008-10#1)(2008-7#1)
when measured at##2##3##(1994-2#1)(1995-5#1)
when measured by##2##3##(1996-7#1)(2006-8#1)
when measured in the presence of##2##6##(1991-12#1)(1995-10#1)
when measured in the##3##4##(1991-12#1)(1994-2#1)(1995-10#1)
when measured in##4##3##(1991-12#1)(1993-11#1)(1994-2#1)(1995-10#1)
when measured with##4##3##(1993-12#1)(2006-8#1)(2008-1#1)(2008-2#1)
when measured##18##2##(1991-12#1)(1993-11#1)(1993-12#1)(1994-2#2)(1995-10#1)(1995-5#1)(1996-7#1)(1997-6#1)(2006-5#1)(2006-8#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-6#1)(2011-2#1)
when measurements##2##2##(2007-12#1)(2008-3#1)
when measuring##7##2##(1991-9#2)(1993-12#1)(1995-1#1)(1997-8#1)(2008-10#1)(2008-12#1)
when medical##4##2##(1990-11#1)(2007-2#1)(2008-7#1)(2009-4#1)
when medication##3##2##(2008-2#1)(2009-9#1)(2011-2#1)
when medications are##2##3##(2008-9#1)(2010-7#1)
when meiosis##2##2##(1990-8#1)(2008-9#1)
when membrane##2##2##(1993-12#1)(2008-10#1)
when methamphetamine was administered 3 h##2##6##(1995-3#2)
when methamphetamine##3##2##(1995-3#3)
when methotrexate##2##2##(1993-12#2)
when mice were##2##3##(1993-3#1)(1996-4#1)
when microinjected into##3##3##(1990-2#1)(1991-12#2)
when migration##2##2##(2007-9#1)(2011-2#1)
when mitochondria are##2##3##(1994-10#1)(1995-3#1)
when mitochondria##3##2##(1990-2#1)(1994-10#1)(1995-3#1)
when mixed in a##2##4##(2008-10#1)(2008-11#1)
when mixed with##3##3##(1994-8#1)(2008-10#1)(2011-3#1)
when mixed##6##2##(1994-8#1)(2008-10#3)(2008-11#1)(2011-3#1)
when model##2##2##(2008-7#1)(2011-2#1)
when monitoring##2##2##(2007-12#1)(2011-1#1)
when more than 50 % of the population were##2##9##(2012-12#2)
when more than one##2##4##(1996-8#1)(2006-5#1)
when more than##7##3##(1996-8#1)(2006-5#1)(2008-3#1)(2008-5#1)(2012-12#2)(2013-8#1)
when more##14##2##(1994-2#1)(1996-8#1)(2004-2#1)(2006-5#1)(2007-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-12#2)(2013-8#1)
when morphine and##2##3##(1992-3#1)(1996-10#1)
when most##7##2##(1992-9#1)(1996-11#1)(2004-11#1)(2008-2#1)(2008-8#1)(2010-12#1)(2012-2#1)
when mothers##6##2##(1990-2#1)(1991-11#1)(2009-9#1)(2010-3#2)(2012-2#1)
when moving##3##2##(2006-6#1)(2008-10#1)(2010-4#1)
when mu was##2##3##(1991-4#1)(2008-10#1)
when multiple sequences##2##3##(2008-11#1)(2008-2#1)
when multiple##13##2##(1997-8#4)(2007-9#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2012-2#1)(2012-3#1)
when muscle##2##2##(1996-9#1)(2006-10#1)
when mutated##5##2##(1997-4#1)(2007-12#1)(2008-10#1)(2009-6#1)(2011-1#1)
when mutations##2##2##(1994-3#1)(2008-8#1)
when myogenic autoregulation is##2##4##(2009-1#2)
when myosin##3##2##(1991-5#2)(1995-1#1)
when n##4##2##(1991-7#1)(2005-11#1)(2007-11#2)
when natural##2##2##(2008-10#1)(2013-1#1)
when nearly##2##2##(1995-4#1)(2012-12#1)
when necessary##13##2##(1991-8#1)(1992-9#1)(1995-10#1)(1995-12#1)(1996-12#1)(1996-9#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-5#1)(2010-2#1)(2011-2#1)(2012-11#1)
when needed##8##2##(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-7#1)(2010-8#1)(2011-2#1)
when negative##2##2##(1994-4#1)(2013-1#1)
when neither##3##2##(1992-8#1)(2008-9#1)(2010-1#1)
when new##4##2##(1991-2#1)(2007-11#1)(2007-8#1)(2008-9#1)
when nitric oxide was##2##4##(2007-1#2)
when no##23##2##(1991-8#1)(1992-12#1)(1992-8#1)(1994-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
when non-steroidal anti-inflammatory drugs##2##4##(2006-10#1)(2008-10#1)
when normalized##2##2##(2008-10#1)(2008-2#1)
when not##7##2##(1993-9#1)(1996-5#2)(2006-10#1)(2006-4#1)(2006-6#1)(2008-7#1)
when nuclear##2##2##(1993-12#1)(2009-4#1)
when nutrients##2##2##(2008-8#1)(2011-1#1)
when object B was##2##4##(2012-1#2)
when observations##2##2##(1995-11#1)(1996-4#1)
when observed##2##2##(1991-3#1)(2008-7#1)
when obtaining##2##2##(1991-9#1)(1996-12#1)
when offspring##2##2##(2008-8#2)
when on##3##2##(2007-1#1)(2008-1#1)(2008-11#1)
when one can##2##3##(1992-6#1)(1994-2#1)
when one considers##2##3##(2005-5#1)(2008-2#1)
when one control measure##2##4##(2008-10#2)
when one has##3##3##(1995-3#1)(1995-9#1)(2013-8#1)
when one is dealing with##3##5##(2007-11#1)(2008-3#2)
when one is##7##3##(2007-11#1)(2007-12#1)(2007-2#1)(2008-3#3)(2012-2#1)
when one of the parents##2##5##(2008-5#1)(2013-1#1)
when one of the##5##4##(1994-8#1)(2006-12#1)(2008-3#1)(2008-5#1)(2013-1#1)
when one or more##3##4##(1992-3#1)(2008-2#1)(2013-8#1)
when one or##4##3##(1992-3#1)(2008-2#1)(2008-9#1)(2013-8#1)
when one uses##4##3##(2008-2#3)(2008-3#1)
when one##47##2##(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1994-2#1)(1994-8#2)(1995-3#1)(1995-9#1)(1996-9#1)(2005-5#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#4)(2008-2#6)(2008-3#7)(2008-5#1)(2008-8#1)(2008-9#3)(2009-3#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#3)
when only a small##2##4##(1995-12#1)(2008-4#1)
when only a##5##3##(1995-12#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-12#1)
when only one##3##3##(1994-6#1)(2008-10#1)(2012-3#1)
when only small##2##3##(1993-7#1)(2011-2#1)
when only the##2##3##(2008-5#1)(2008-7#1)
when only##38##2##(1990-4#1)(1990-6#1)(1990-8#1)(1992-4#1)(1993-3#1)(1993-7#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-3#2)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-12#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-4#3)(2011-2#3)(2012-2#1)(2012-3#2)
when open##3##2##(1991-12#1)(1994-3#1)(2007-12#1)
when operated##3##2##(2008-2#1)(2008-3#2)
when operating##3##2##(2007-5#1)(2008-10#1)(2008-2#1)
when opportunities to##2##3##(2011-1#1)(2013-1#1)
when optimized##2##2##(2008-10#1)(2008-2#1)
when oral##3##2##(1994-3#1)(1994-4#1)(1995-6#1)
when other group members were##2##5##(2008-9#2)
when other##20##2##(1994-3#1)(1994-7#1)(1997-7#1)(2005-7#1)(2006-12#2)(2006-8#1)(2007-11#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2011-2#2)(2013-1#1)
when our##2##2##(2008-2#1)(2008-3#1)
when overexpressed in##3##3##(1995-3#1)(1995-8#1)(1997-4#1)
when overexpressed##5##2##(1995-3#1)(1995-8#1)(1997-4#1)(1997-6#1)(2007-8#1)
when overproduced##2##2##(1995-6#1)(1997-1#1)
when oxidized##5##2##(1991-1#1)(1991-7#1)(1992-3#1)(1994-8#1)(1996-5#1)
when p was 0##2##4##(2008-10#2)
when p was##3##3##(2008-10#2)(2013-1#1)
when p##5##2##(2008-10#4)(2013-1#1)
when pH##2##2##(2008-10#1)(2008-3#1)
when pain is first evident##2##5##(2007-7#2)
when pain##3##2##(1995-5#1)(2007-7#2)
when parental##2##2##(2008-9#1)(2010-1#1)
when parents##2##2##(2008-9#1)(2010-1#1)
when partial##2##2##(2008-10#1)(2009-5#1)
when participants had##2##3##(2008-11#1)(2009-11#1)
when participants##6##2##(2007-6#1)(2008-11#1)(2008-7#1)(2009-11#1)(2010-5#1)(2012-12#1)
when pathogen##3##2##(2008-10#3)
when patient presents with##3##4##(2011-1#1)(2013-1#2)
when patient##7##2##(1993-12#1)(2011-1#1)(2013-1#5)
when patients are##3##3##(1993-9#1)(2010-12#1)(2011-2#1)
when patients present with##3##4##(2006-3#1)(2007-11#1)(2012-3#1)
when patients present##5##3##(2006-3#1)(2007-11#1)(2007-5#1)(2007-6#1)(2012-3#1)
when patients were##3##3##(2006-10#1)(2011-2#1)(2012-2#1)
when patients with##5##3##(2008-7#1)(2011-2#1)(2013-1#2)(2013-8#1)
when patients##27##2##(1993-4#1)(1993-9#1)(1994-2#1)(1996-2#1)(1997-1#1)(2006-10#1)(2006-3#2)(2007-11#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-7#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
when people##2##2##(2008-4#1)(2008-6#1)
when performed by##2##3##(2009-10#2)
when performed in##3##3##(2008-10#1)(2008-4#1)(2012-2#1)
when performed##10##2##(1996-11#1)(2006-8#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-10#2)(2012-12#1)(2012-2#1)
when performing a##3##3##(1991-5#1)(1995-2#1)(2007-8#1)
when performing##12##2##(1991-5#1)(1995-2#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
when perfusion##2##2##(1997-1#1)(2006-10#1)
when peripheral##2##2##(2008-4#2)
when phase##3##2##(2006-6#1)(2008-2#1)(2008-3#1)
when phorbol##2##2##(1991-3#1)(1996-5#1)
when phosphorylated##2##2##(1996-10#1)(1996-11#1)
when photoreceptors are embedded in RPE and choroid with blood circulation immediately after the surgery##2##15##(2012-12#2)
when physical##3##2##(1994-3#1)(2008-7#1)(2009-12#1)
when physicians##4##2##(1991-2#1)(1993-12#1)(1994-11#1)(2007-4#1)
when physiological##2##2##(1995-3#1)(2011-1#1)
when placed in##6##3##(1994-6#1)(1995-1#1)(2004-9#2)(2008-10#1)(2008-3#1)
when placed##11##2##(1993-12#1)(1993-3#1)(1994-6#1)(1995-1#1)(2004-9#2)(2005-10#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-7#1)
when planning a##2##3##(2007-7#1)(2008-3#1)
when planning for the##2##4##(2006-5#1)(2006-6#1)
when planning the##2##3##(1995-2#1)(2008-6#1)
when planning##14##2##(1992-11#1)(1992-8#1)(1995-2#1)(2006-5#1)(2006-6#2)(2007-7#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
when plant##2##2##(2008-10#1)(2008-9#1)
when plants were##8##3##(2004-4#1)(2006-12#1)(2008-10#3)(2008-12#1)(2008-8#1)(2009-3#1)
when plants##9##2##(2004-4#1)(2006-10#1)(2006-12#1)(2008-10#3)(2008-12#1)(2008-8#1)(2009-3#1)
when plasma membrane##2##3##(1994-11#1)(1996-8#1)
when plasma##4##2##(1994-11#1)(1994-7#1)(1996-8#1)(2005-8#1)
when platelets##2##2##(1992-11#1)(2006-6#1)
when playing on##2##3##(1990-6#1)(2013-1#1)
when plotted##2##2##(1990-12#1)(2005-11#1)
when populations##3##2##(2008-10#1)(2008-9#1)(2012-1#1)
when possible##18##2##(1991-11#1)(1991-2#1)(1992-4#1)(1994-5#1)(1995-3#1)(1997-2#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-4#1)(2007-5#2)(2007-8#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#1)
when practiced##2##2##(2008-3#1)(2009-9#1)
when predation is present##2##4##(2008-9#2)
when predation##3##2##(2008-8#1)(2008-9#2)
when predator##2##2##(2008-9#1)(2012-3#1)
when predicting##6##2##(1997-2#1)(2004-4#1)(2008-2#1)(2012-12#2)(2012-3#1)
when preincubated with##2##3##(1991-7#1)(2009-9#1)
when prepared##4##2##(1994-9#1)(1996-2#1)(2010-4#1)(2013-8#1)
when preparing##3##2##(1992-2#1)(2004-12#1)(2008-9#1)
when prescribed##3##2##(2009-6#1)(2010-7#1)(2013-1#1)
when prescribing##5##2##(1993-8#1)(2007-11#1)(2007-7#1)(2008-8#2)
when present at##5##3##(1991-9#1)(1993-8#1)(1997-4#1)(2008-10#1)(2008-5#1)
when present during##2##3##(1994-2#1)(2013-8#1)
when present in the##3##4##(1990-9#1)(2008-10#2)
when present in##9##3##(1990-9#1)(1991-7#1)(1994-3#1)(1994-8#1)(1994-9#1)(2006-9#1)(2008-10#3)
when present##29##2##(1990-9#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-9#1)(2007-4#1)(2007-7#1)(2008-10#5)(2008-5#1)(2009-4#1)(2010-5#1)(2012-2#2)(2013-8#1)
when presented in##2##3##(2009-8#1)(2010-7#1)
when presented to##2##3##(1991-8#1)(2008-4#1)
when presented with##2##3##(2009-6#2)
when presented##8##2##(1991-8#1)(1995-2#2)(2008-4#1)(2009-6#2)(2009-8#1)(2010-7#1)
when primary##3##2##(1992-4#1)(2008-10#1)(2008-6#1)
when processing##3##2##(1996-12#1)(2007-1#1)(2012-12#1)
when produced in##2##3##(1995-8#1)(2008-9#1)
when produced##5##2##(1994-2#1)(1994-9#1)(1995-8#1)(2008-10#1)(2008-9#1)
when professional##2##2##(1994-2#1)(2010-12#1)
when programming##2##2##(2006-9#1)(2008-9#1)
when proliferation##3##2##(2008-11#2)(2008-4#1)
when properly##4##2##(2005-9#1)(2008-2#2)(2012-3#1)
when proportion of differentially expressed genes is##2##7##(2012-2#2)
when protein##3##2##(1990-12#1)(2008-5#1)(2011-2#1)
when proteins##2##2##(2008-2#1)(2008-4#1)
when provided with##2##3##(2012-1#2)
when provided##3##2##(2008-3#1)(2012-1#2)
when providing care to##2##4##(2008-7#1)(2011-1#1)
when providing care##3##3##(2005-11#1)(2008-7#1)(2011-1#1)
when providing##6##2##(1995-9#1)(2005-10#1)(2005-11#2)(2008-7#1)(2011-1#1)
when pulmonary##2##2##(2007-7#1)(2007-8#1)
when pulse##2##2##(1994-2#1)(2008-5#1)
when pumped at##2##3##(2007-11#1)(2008-3#1)
when pumped by a##2##4##(2008-2#1)(2008-3#1)
when pumped by##4##3##(2008-2#1)(2008-3#3)
when pumped##6##2##(2007-11#1)(2008-2#1)(2008-3#4)
when purified##2##2##(1990-8#1)(1995-5#1)
when quantified##2##2##(1993-2#1)(1997-5#1)
when radiation is##2##3##(2008-2#1)(2008-7#1)
when rain begins at night##2##5##(2008-10#2)
when rat##2##2##(1992-3#1)(2012-12#1)
when rats were administered##2##4##(1991-12#1)(2012-2#1)
when rats were treated with##2##5##(1996-10#1)(2008-5#1)
when rats were##4##3##(1991-12#1)(1996-10#1)(2008-5#1)(2012-2#1)
when reading text##2##3##(2010-7#1)(2013-1#1)
when reading##4##2##(2005-9#1)(2008-2#1)(2010-7#1)(2013-1#1)
when real##2##2##(2008-10#1)(2011-1#1)
when receptor##2##2##(2008-10#1)(2008-4#1)
when recognized##2##2##(1992-3#1)(1992-5#1)
when recombinant##3##2##(1991-3#1)(1994-8#1)(2011-2#1)
when reconstituted in##2##3##(1990-12#1)(1995-8#1)
when recorded in##3##3##(1997-8#1)(2006-8#2)
when recording##2##2##(2008-2#1)(2012-2#1)
when recovering##3##2##(2007-11#1)(2009-8#1)(2013-1#1)
when referenced to nerve##3##4##(1993-7#3)
when referring##2##2##(1995-3#1)(2010-12#1)
when related to##2##3##(1996-9#1)(2008-4#1)
when related##3##2##(1996-9#1)(2008-4#1)(2011-2#1)
when relatively small##2##3##(2005-11#1)(2008-4#1)
when removing##2##2##(2012-3#1)(2013-1#1)
when repeated##5##2##(1993-12#1)(1994-8#1)(1996-3#2)(2006-8#1)
when replacing##3##2##(1994-12#1)(2008-10#1)(2012-12#1)
when reporting##3##2##(2007-11#1)(2010-9#2)
when represented##2##2##(1992-6#1)(2007-1#1)
when reproducing##2##2##(2012-2#1)(2013-8#1)
when required##6##2##(1994-5#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2012-12#1)
when resistant##2##2##(1990-10#1)(2008-10#1)
when resources are##3##3##(2008-9#2)(2009-10#1)
when responses##2##2##(1996-12#2)
when reviewing##6##2##(1995-3#1)(2006-12#1)(2009-4#3)(2010-4#1)
when root##2##2##(2008-9#1)(2013-1#1)
when sample sizes##2##3##(1993-1#1)(1993-4#1)
when sample##3##2##(1993-1#1)(1993-4#1)(2008-10#1)
when samples are##2##3##(2008-10#1)(2013-1#1)
when samples##3##2##(1992-2#1)(2008-10#1)(2013-1#1)
when sampling##5##2##(2007-6#1)(2008-10#1)(2008-5#1)(2009-5#1)(2011-1#1)
when sated##4##2##(1993-6#4)
when saturated##2##2##(2008-3#1)(2008-6#1)
when scaling up##2##3##(2006-12#1)(2010-8#1)
when scaling##3##2##(2006-12#1)(2008-3#1)(2010-8#1)
when scientific evidence is##3##4##(1993-12#1)(2013-1#2)
when scientific##4##2##(1993-12#1)(2012-3#1)(2013-1#2)
when screening##3##2##(2006-10#1)(2008-3#1)(2008-9#1)
when searching for##4##3##(1990-11#1)(2008-5#1)(2008-8#2)
when searching##6##2##(1990-11#1)(1993-3#1)(1994-3#1)(2008-5#1)(2008-8#2)
when secreted##3##2##(1990-6#1)(1992-5#1)(2012-2#1)
when seeded onto##2##3##(1991-1#1)(1993-4#1)
when seeded##5##2##(1991-1#1)(1993-4#1)(1993-9#1)(2007-12#1)(2008-11#1)
when seeing##2##2##(2012-1#2)
when seeking##4##2##(1993-3#1)(1995-3#1)(2011-2#1)(2013-1#1)
when seen by##2##3##(1993-12#1)(2010-2#1)
when seen##3##2##(1993-12#1)(2006-8#1)(2010-2#1)
when selecting patients for##2##4##(2008-7#1)(2011-2#1)
when selecting##11##2##(1991-12#1)(1992-4#1)(1996-4#1)(2007-11#1)(2007-4#2)(2008-4#1)(2008-7#1)(2009-8#1)(2010-3#1)(2011-2#1)
when separated from##2##3##(1997-5#1)(2006-3#1)
when serologic tests##2##3##(1997-2#1)(2012-3#1)
when serum##7##2##(1991-8#1)(1992-3#1)(1995-1#1)(1995-5#1)(2006-9#1)(2008-11#1)(2012-2#1)
when setting##2##2##(1993-2#1)(2007-6#1)
when several##5##2##(1991-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-2#1)
when severe##2##2##(2011-10#1)(2012-12#1)
when sexual##2##2##(2009-9#1)(2012-3#1)
when sharing##3##2##(2008-9#1)(2013-1#2)
when she presented with##3##4##(2007-9#1)(2013-1#2)
when she was##3##3##(2006-10#1)(2009-3#1)(2012-2#1)
when she##11##2##(1994-4#1)(1995-6#1)(2006-10#1)(2006-4#1)(2007-9#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#3)
when shorter##2##2##(2008-10#2)
when should##2##2##(2006-4#1)(2011-1#1)
when significant##4##2##(1993-11#1)(1994-12#1)(2008-2#1)(2012-2#1)
when simultaneously##2##2##(1994-5#1)(2009-6#1)
when small amounts of##2##4##(2008-10#2)
when small##5##2##(1993-5#1)(2005-11#1)(2008-10#2)(2008-2#1)
when sodium##2##2##(1990-3#1)(2008-10#1)
when soil was##2##3##(2008-10#2)
when soil##3##2##(2008-10#3)
when soils were##2##3##(2008-10#2)
when somatropin##2##2##(2007-11#2)
when some##3##2##(1990-2#1)(2008-3#1)(2010-2#1)
when spatial##4##2##(2007-12#1)(2008-8#1)(2012-12#1)(2013-8#1)
when species##5##2##(2008-8#3)(2008-9#1)(2010-6#1)
when sperm are##2##3##(1994-8#1)(2008-8#1)
when sperm##3##2##(1994-8#1)(2006-5#1)(2008-8#1)
when spermatozoa were##2##3##(2008-8#2)
when spermatozoa##3##2##(2008-8#3)
when stacked##2##2##(2008-3#1)(2008-4#1)
when standing##5##2##(2007-12#1)(2007-9#2)(2013-1#2)
when starting up with research##2##5##(2008-7#2)
when starting##5##2##(1992-12#1)(1992-6#1)(2008-7#2)(2011-2#1)
when stimulated by##5##3##(1994-3#1)(1994-6#1)(1997-2#1)(1997-7#1)(2008-4#1)
when stimulated with the aedeagi of##2##6##(2008-8#2)
when stimulated with the##3##4##(1994-6#1)(2008-8#2)
when stimulated with##7##3##(1990-11#1)(1990-3#1)(1991-2#1)(1994-6#1)(2008-8#3)
when stimulated##12##2##(1990-11#1)(1990-3#1)(1991-2#1)(1994-3#1)(1994-6#2)(1997-2#1)(1997-7#1)(2008-4#1)(2008-8#3)
when stored at 20##2##4##(2008-10#1)(2008-5#1)
when stored at 4 degrees C##2##6##(2008-10#2)
when stored at##8##3##(2007-8#1)(2008-10#4)(2008-5#2)(2008-6#1)
when stored for##2##3##(1992-2#1)(2008-10#1)
when stored##13##2##(1992-2#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-5#2)(2008-6#1)
when strains##2##2##(2008-10#1)(2011-1#1)
when stratified by##2##3##(2008-3#1)(2008-5#1)
when stratifying##2##2##(2010-4#1)(2011-2#1)
when stretched##3##2##(1992-7#1)(2007-9#2)
when students##3##2##(2008-11#2)(2008-8#1)
when studied##2##2##(1994-2#1)(2008-5#1)
when studying the##4##3##(2008-10#1)(2008-4#1)(2012-12#1)(2012-3#1)
when studying##13##2##(1992-7#1)(2006-7#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
when subjected to strong##2##4##(1997-5#1)(2008-9#1)
when subjected to the##2##4##(2008-1#1)(2008-11#1)
when subjected to##11##3##(1997-5#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2013-1#1)
when subjects fixated##2##3##(1993-7#1)(1995-8#1)
when subjects lifted##2##3##(2012-12#2)
when subjects were##2##3##(2007-5#1)(2008-11#1)
when subjects##12##2##(1993-7#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-5#1)(2007-5#1)(2008-11#3)(2012-12#3)
when submitted to##5##3##(1992-1#1)(1994-6#1)(2007-6#1)(2008-10#1)(2008-5#1)
when subsequently##3##2##(1990-12#1)(1991-7#1)(2010-4#1)
when such an##3##3##(1992-12#1)(2008-11#1)(2009-11#1)
when such##11##2##(1992-1#1)(1992-12#1)(1994-9#1)(2006-9#1)(2008-11#2)(2008-4#1)(2009-11#2)(2013-1#2)
when supplemented with##5##3##(1993-9#1)(1997-2#1)(2005-8#1)(2008-10#1)(2011-1#1)
when supported##2##2##(1990-12#1)(2007-2#1)
when surfactant##2##2##(1997-3#1)(2005-11#1)
when surgery is##3##3##(1991-12#1)(2008-1#1)(2009-7#1)
when surgery##4##2##(1991-12#1)(2008-1#1)(2008-3#1)(2009-7#1)
when surgical treatment##2##3##(2010-12#1)(2011-2#1)
when surgical##6##2##(1997-3#1)(2006-11#1)(2006-9#1)(2010-12#1)(2011-2#1)(2012-2#1)
when survival##2##2##(1990-8#1)(1994-2#1)
when symptoms##3##2##(1991-4#1)(2007-8#1)(2011-2#1)
when synaptic##2##2##(1993-8#1)(1997-3#1)
when taken early##2##3##(2006-8#1)(2007-9#1)
when taken in large##2##4##(2006-4#2)
when taken in##4##3##(2006-4#3)(2006-9#1)
when taken together##2##3##(1997-8#1)(2007-1#1)
when taken##11##2##(1997-8#1)(2005-8#1)(2006-4#4)(2006-8#1)(2006-9#1)(2007-1#1)(2007-9#1)(2009-6#1)
when taking into account##3##4##(2008-10#1)(2008-11#1)(2013-7#1)
when taking##7##2##(1996-1#1)(2005-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2013-7#1)
when target##2##2##(1997-1#1)(2008-1#1)
when targeted against##2##3##(2008-10#2)
when targeted##5##2##(2006-10#1)(2008-10#2)(2008-11#1)(2008-9#1)
when teaching##3##2##(2007-7#1)(2010-10#1)(2011-2#1)
when temperature##5##2##(1990-8#1)(1994-3#1)(2005-12#1)(2008-10#2)
when temperatures from##2##3##(2008-10#1)(2008-5#1)
when temperatures##5##2##(2008-10#1)(2008-11#1)(2008-5#3)
when tested 24 h##2##4##(1994-5#1)(2012-2#1)
when tested against a##2##4##(1992-3#1)(1994-6#1)
when tested against##5##3##(1992-3#1)(1994-6#1)(2008-5#1)(2011-2#2)
when tested at##2##3##(1996-9#1)(2008-10#1)
when tested by Western blot and##2##6##(1994-5#1)(1997-4#1)
when tested by##4##3##(1994-5#1)(1995-12#1)(1997-4#1)(2008-6#1)
when tested for##4##3##(1992-2#1)(1996-5#3)
when tested in an##2##4##(1990-12#1)(1993-2#1)
when tested in vitro##2##4##(2007-1#1)(2007-11#1)
when tested in##12##3##(1990-12#1)(1990-4#2)(1992-6#1)(1993-2#1)(1995-3#1)(1997-2#1)(1997-6#1)(2006-10#1)(2007-1#1)(2007-11#1)(2013-1#1)
when tested on##2##3##(2008-8#1)(2008-9#1)
when tested under##2##3##(1992-2#1)(2009-7#1)
when tested with a##2##4##(2008-10#1)(2012-1#1)
when tested with##7##3##(1990-12#1)(2005-10#1)(2008-10#2)(2008-5#1)(2012-1#2)
when tested##46##2##(1990-12#2)(1990-4#2)(1992-2#2)(1992-3#1)(1992-6#1)(1993-2#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-4#1)(1996-5#3)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#1)(2008-10#4)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#1)(2013-7#1)
when testing for##2##3##(2008-10#1)(2012-3#1)
when testing##5##2##(1992-1#1)(1994-8#1)(2008-10#1)(2012-3#1)(2013-1#1)
when tests were conducted at##2##5##(2008-10#2)
when thalamocortical##2##2##(1997-6#1)(2008-1#1)
when that##3##2##(1992-2#1)(1994-11#1)(2007-12#1)
when the ATL was increased from 0 kN##2##8##(2007-1#2)
when the CS##3##3##(2008-5#3)
when the DFM interaction is phase matched##2##7##(2007-12#2)
when the I##2##3##(2008-4#2)
when the KPS was &gt##3##5##(2008-5#3)
when the N-acyl group contains##2##5##(2005-11#2)
when the NaCl concentration is decreased##2##6##(1992-9#2)
when the RNA is extracted##2##5##(1990-4#2)
when the RNA##4##3##(1990-4#3)(2009-11#1)
when the UV light was extinguished at 35 %##2##9##(2008-3#2)
when the UV light was extinguished at##3##7##(2008-3#3)
when the VB is##2##4##(2005-11#2)
when the absorption##4##3##(2005-10#1)(2008-1#2)(2008-3#1)
when the activity of##2##4##(1996-7#1)(2008-10#1)
when the actual##2##3##(1996-7#1)(2008-1#1)
when the acute phase##2##4##(1993-5#1)(1995-2#1)
when the age of##2##4##(2008-10#1)(2013-8#1)
when the air temperature##2##4##(2008-10#1)(2008-6#1)
when the air##3##3##(1995-6#1)(2008-10#1)(2008-6#1)
when the amount of##2##4##(1995-2#1)(2008-10#1)
when the amounts of##2##4##(1993-2#1)(2006-10#1)
when the amplitude of##3##4##(1991-12#1)(1997-1#1)(2007-11#1)
when the analyte##3##3##(1995-2#1)(2006-12#1)(2008-10#1)
when the angle##2##3##(2008-3#2)
when the animal##3##3##(2007-3#1)(2008-4#2)
when the animals were##2##4##(1991-5#1)(1992-12#1)
when the animals##6##3##(1990-5#1)(1991-5#1)(1992-12#1)(1994-8#1)(2007-5#1)(2013-8#1)
when the anterior arch##2##4##(2006-9#2)
when the anterior##3##3##(2006-9#2)(2008-3#1)
when the aortic##2##3##(2007-7#1)(2007-8#1)
when the application##2##3##(2008-2#1)(2008-5#1)
when the appropriate##3##3##(1997-3#1)(2007-12#1)(2008-11#1)
when the atmospheric##2##3##(2008-2#1)(2008-3#1)
when the average length is##2##5##(1992-2#2)
when the background##2##3##(1990-9#1)(2008-3#1)
when the bacteria were applied##2##5##(2008-10#2)
when the basic##2##3##(2007-8#1)(2008-4#1)
when the beam is##2##4##(2007-11#1)(2008-3#1)
when the beam##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
when the bladder was##2##4##(1997-7#2)
when the bleaching protocol was applied##2##6##(2013-1#2)
when the body##2##3##(1991-8#1)(2007-6#1)
when the box approached##2##4##(2012-1#2)
when the box##3##3##(2012-1#3)
when the brain##3##3##(1991-2#1)(1994-3#1)(2006-1#1)
when the bulk flow velocity was##2##6##(2008-7#2)
when the calibration##3##3##(1995-9#1)(2007-11#1)(2008-10#1)
when the catalytic##2##3##(1996-8#1)(2008-8#1)
when the cause##2##3##(2006-10#1)(2006-2#1)
when the cavity##3##3##(2007-12#2)(2008-3#1)
when the cell density was##2##5##(2008-11#2)
when the cell density##3##4##(2008-11#3)
when the cell growth##2##4##(2008-11#2)
when the cell##11##3##(2005-8#1)(2007-11#1)(2008-11#7)(2008-2#1)(2008-8#1)
when the cells are##4##4##(1991-5#1)(1992-6#1)(1993-12#1)(2007-9#1)
when the cells were enriched with##2##6##(2008-11#2)
when the cells were##13##4##(1990-12#1)(1991-8#1)(1992-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-8#1)(1996-7#1)(1997-6#1)(2008-11#4)
when the cells##19##3##(1990-12#1)(1990-3#1)(1991-5#2)(1991-8#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-8#1)(1996-7#1)(1997-6#1)(2007-9#1)(2008-11#4)
when the central##2##3##(2007-12#1)(2008-3#1)
when the charging voltage##2##4##(2007-11#2)
when the child is##3##4##(2008-4#1)(2012-1#1)(2013-1#1)
when the child##8##3##(1990-12#1)(2005-10#1)(2008-4#1)(2010-2#1)(2010-6#1)(2012-1#1)(2012-12#1)(2013-1#1)
when the chlorine concentration##2##4##(1992-11#2)
when the circular##2##3##(1994-9#1)(1995-1#1)
when the clinical##2##3##(1996-11#1)(2009-5#1)
when the cognitive##2##3##(1991-6#1)(1993-11#1)
when the complex is##2##4##(1992-3#1)(1996-2#1)
when the concentration of IAA##2##5##(2008-9#2)
when the concentration of the##2##5##(1990-2#1)(2009-8#1)
when the concentration of##9##4##(1990-2#1)(1993-12#1)(1994-8#1)(2008-10#2)(2008-9#2)(2009-8#1)(2013-8#1)
when the concentration ratio##2##4##(2008-10#2)
when the concentration##13##3##(1990-2#1)(1993-12#1)(1994-8#1)(2005-11#1)(2008-10#5)(2008-9#2)(2009-8#1)(2013-8#1)
when the concentrations of##2##4##(1995-3#1)(1997-4#1)
when the contact##2##3##(2005-11#1)(2008-10#1)
when the cornea##2##3##(2010-12#2)
when the corresponding##2##3##(1991-1#1)(2011-2#1)
when the coupling##2##3##(2007-11#1)(2013-8#1)
when the crystal##2##3##(2006-4#1)(2007-12#1)
when the culture##4##3##(1990-12#1)(2006-8#1)(2008-10#1)(2008-11#1)
when the damage##2##3##(2013-1#2)
when the data are##3##4##(1995-12#1)(2009-3#1)(2013-8#1)
when the data##8##3##(1990-7#1)(1993-9#1)(1995-12#1)(2008-10#1)(2008-3#1)(2009-3#1)(2010-8#1)(2013-8#1)
when the device was pumped##2##5##(2007-12#1)(2008-1#1)
when the diagnosis is made##3##5##(2008-7#1)(2013-1#2)
when the diagnosis is##5##4##(1996-12#1)(2008-7#1)(2012-2#1)(2013-1#2)
when the diagnosis of##2##4##(2006-10#1)(2011-1#1)
when the diagnosis was##2##4##(1993-3#1)(2012-3#1)
when the diagnosis##9##3##(1993-3#1)(1996-12#1)(2006-10#1)(2008-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
when the dialysis##2##3##(1990-12#1)(2004-8#1)
when the dietary##2##3##(1990-2#1)(2012-2#1)
when the difference of female fecundity is##2##7##(2008-9#2)
when the difference##3##3##(2007-11#1)(2008-9#2)
when the different carrier assays were compared##2##7##(1992-8#2)
when the disease is##3##4##(1996-12#1)(2007-8#1)(2010-3#1)
when the disease##7##3##(1996-12#1)(2006-6#1)(2007-8#2)(2008-10#1)(2010-3#1)(2011-1#1)
when the distance from##2##4##(1997-7#1)(2008-2#1)
when the distance##4##3##(1997-7#1)(2008-2#1)(2011-2#1)(2013-8#1)
when the donor##2##3##(1991-3#1)(2011-2#1)
when the dose is##3##4##(1993-12#1)(1995-3#1)(2011-1#1)
when the dose of##2##4##(2007-11#1)(2013-8#1)
when the dose was##2##4##(1990-5#1)(1991-2#1)
when the dose##8##3##(1990-5#1)(1991-2#1)(1993-12#1)(1993-2#1)(1995-3#1)(2007-11#1)(2011-1#1)(2013-8#1)
when the drug is##4##4##(1992-3#1)(1992-7#1)(1994-6#1)(2010-3#1)
when the drug was##3##4##(1992-9#1)(1993-12#1)(1994-5#1)
when the drug##7##3##(1992-3#1)(1992-7#1)(1992-9#1)(1993-12#1)(1994-5#1)(1994-6#1)(2010-3#1)
when the drugs were##2##4##(1992-9#1)(2007-7#1)
when the drugs##3##3##(1992-9#1)(2006-9#1)(2007-7#1)
when the duration of##2##4##(1993-9#1)(2008-9#1)
when the dye##3##3##(1992-11#1)(1994-12#1)(2008-3#1)
when the dynamic##2##3##(2008-10#1)(2013-7#1)
when the effect of##2##4##(1991-2#1)(2006-10#1)
when the effects of##4##4##(1991-12#1)(1997-5#1)(2008-3#1)(2008-7#1)
when the electrodes##2##3##(2008-10#1)(2013-1#1)
when the enzyme is##4##4##(1991-3#1)(1994-11#1)(1996-2#1)(2007-6#1)
when the enzyme##6##3##(1991-3#1)(1991-9#1)(1994-11#1)(1996-2#1)(1996-5#1)(2007-6#1)
when the epithelium##2##3##(1995-8#1)(2009-10#1)
when the exercise was conducted) and arrive at a consensus for optimal treatment options##2##14##(2012-12#2)
when the experiments were##3##4##(1996-9#1)(2008-10#2)
when the expression of##2##4##(1993-8#1)(2008-5#1)
when the extracellular##2##3##(1997-3#2)
when the extracts##2##3##(1994-9#1)(2008-10#1)
when the faces were##2##4##(2009-4#2)
when the faces##3##3##(2009-4#2)(2009-9#1)
when the fiber##3##3##(1991-6#1)(2007-11#1)(2007-12#1)
when the fill##2##3##(2008-3#2)
when the first##4##3##(1990-7#1)(1994-5#1)(2008-1#1)(2011-2#1)
when the fish fingerlings##2##4##(2009-6#2)
when the fish##3##3##(2008-12#1)(2009-6#2)
when the flow rate##3##4##(2008-10#3)
when the flow##4##3##(1996-9#1)(2008-10#3)
when the form##2##3##(2007-12#1)(2008-3#1)
when the frequencies##2##3##(1993-3#1)(2008-3#1)
when the frequency of the##2##5##(2008-1#1)(2008-10#1)
when the frequency of##3##4##(2008-1#1)(2008-10#1)(2011-1#1)
when the frequency##4##3##(2008-1#1)(2008-10#2)(2011-1#1)
when the fringe##2##3##(2007-12#1)(2008-3#1)
when the functional##2##3##(2007-5#1)(2008-2#1)
when the fundamental##2##3##(2007-11#1)(2008-3#1)
when the gas concentration was relatively##2##6##(2005-4#2)
when the goal is##2##4##(2008-4#1)(2009-5#1)
when the grating##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
when the growth##3##3##(1992-8#1)(2006-8#1)(2008-10#1)
when the hapten was##2##4##(1992-8#1)(1994-8#1)
when the horse was##2##4##(2012-12#2)
when the human##3##3##(1990-12#1)(1990-9#1)(2008-11#1)
when the hydrolysis##2##3##(2005-11#1)(2008-6#1)
when the illumination##2##3##(2006-12#1)(2008-2#1)
when the images are##4##4##(2008-3#2)(2012-2#2)
when the incidence of##2##4##(2004-10#1)(2008-10#1)
when the incident beams##2##4##(2007-11#1)(2007-12#1)
when the incident light is##2##5##(2007-12#2)
when the incident##6##3##(2007-11#1)(2007-12#3)(2007-5#1)(2008-3#1)
when the individual##2##3##(2007-11#1)(2007-2#1)
when the infant##2##3##(1991-11#2)
when the information##2##3##(2007-4#1)(2008-9#1)
when the initial##13##3##(1993-5#1)(2004-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#3)(2008-8#1)(2011-12#1)(2011-2#1)(2012-12#2)
when the intensity of the##2##5##(2007-12#1)(2008-3#1)
when the intensity##3##3##(2007-12#1)(2008-3#2)
when the interval##2##3##(2008-10#1)(2008-5#1)
when the ischemic period##2##4##(1994-10#2)
when the knee is extended##2##5##(1997-8#2)
when the knee is flexed##2##5##(1997-8#2)
when the knee is##4##4##(1997-8#4)
when the knee was extended and##2##6##(1997-8#2)
when the knee was extended##3##5##(1997-8#3)
when the knee was flexed##3##5##(1997-8#3)
when the knee was##6##4##(1997-8#6)
when the knee##10##3##(1997-8#10)
when the laser was##2##4##(2007-12#1)(2008-3#1)
when the laser##7##3##(2007-12#1)(2008-2#3)(2008-3#2)(2013-8#1)
when the latter is##3##4##(1995-8#1)(2005-11#1)(2008-10#1)
when the latter##8##3##(1991-11#1)(1995-8#1)(1995-9#1)(2005-11#1)(2006-3#1)(2008-10#1)(2010-2#1)(2013-7#1)
when the layer is##2##4##(2008-3#2)
when the lens##2##3##(1994-6#1)(2008-2#1)
when the lesion is##2##4##(1990-10#1)(2011-2#1)
when the lesion##3##3##(1990-10#1)(1995-1#1)(2011-2#1)
when the lesions##2##3##(1995-1#1)(2007-8#1)
when the ligand is sensitive to chemical conditions required for oligonucleotide deprotection##2##12##(2008-4#2)
when the ligand is##6##4##(1994-11#1)(2008-10#1)(2008-4#4)
when the ligand##7##3##(1994-11#2)(2008-10#1)(2008-4#4)
when the liquid is##2##4##(1997-6#1)(2011-2#1)
when the liquid##4##3##(1997-6#1)(2004-9#1)(2005-11#1)(2011-2#1)
when the local elements were##2##5##(2008-4#2)
when the local##3##3##(2008-4#2)(2008-9#1)
when the low##2##3##(1996-12#1)(2008-7#1)
when the main vector species is##4##6##(2008-10#4)
when the main##5##3##(2008-10#4)(2008-4#1)
when the mean##2##3##(2008-2#1)(2013-1#1)
when the measurement error##2##4##(1993-6#1)(2008-7#1)
when the measurement was performed##2##5##(2005-10#2)
when the measurement##4##3##(1993-6#1)(2005-10#2)(2008-7#1)
when the measurements were##2##4##(2007-8#1)(2008-3#1)
when the measurements##3##3##(2007-8#1)(2008-3#2)
when the median##2##3##(2008-10#2)
when the medical##2##3##(2009-10#1)(2009-3#1)
when the medium was##2##4##(1991-2#1)(1993-11#1)
when the medium##3##3##(1991-2#1)(1993-11#1)(2008-11#1)
when the membrane was##2##4##(1993-4#1)(1996-5#1)
when the membrane##4##3##(1990-3#1)(1992-12#1)(1993-4#1)(1996-5#1)
when the membranes were##2##4##(1993-8#1)(2008-10#1)
when the metal##2##3##(1995-3#1)(2008-10#1)
when the mice were fed##2##5##(1995-8#1)(2013-1#1)
when the mice were##4##4##(1995-8#1)(2006-8#1)(2008-7#1)(2013-1#1)
when the missing##2##3##(2009-12#1)(2009-5#1)
when the mission of caring is##2##6##(2012-3#2)
when the mixture of the##2##5##(1990-7#1)(2008-10#1)
when the model##2##3##(1995-8#1)(1997-2#1)
when the modulation frequency is##2##5##(2007-12#2)
when the modulation##3##3##(2007-12#2)(2008-3#1)
when the mother##5##3##(1991-11#1)(2008-3#2)(2012-1#1)(2013-1#1)
when the mutant##2##3##(2008-10#1)(2009-8#1)
when the natural day length was##2##6##(2009-4#2)
when the need##2##3##(1991-4#1)(1996-11#1)
when the new##3##3##(2008-11#1)(2008-9#1)(2011-2#1)
when the normal##2##3##(1993-3#1)(2007-8#1)
when the number of independent clusters##2##6##(1996-8#2)
when the number of##21##4##(1992-9#1)(1993-6#1)(1995-8#2)(1996-8#2)(1997-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-8#1)
when the number##22##3##(1992-9#1)(1993-6#1)(1995-8#3)(1996-8#2)(1997-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-8#1)
when the numerical aperture##2##4##(2008-3#2)
when the nutrient was released by##2##6##(2013-8#2)
when the object is##3##4##(2008-3#2)(2011-1#1)
when the object was##2##4##(1994-6#1)(2008-2#1)
when the object##5##3##(1994-6#1)(2008-2#1)(2008-3#2)(2011-1#1)
when the old##2##3##(1992-3#1)(2009-7#1)
when the only##2##3##(2007-7#1)(2008-10#1)
when the operation was conducted##2##5##(2012-12#2)
when the optical##6##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
when the organic##2##3##(2008-10#1)(2013-7#1)
when the original##2##3##(2008-3#1)(2013-1#1)
when the other##2##3##(2007-7#1)(2008-8#1)
when the pH of the##2##5##(1994-6#1)(2008-10#1)
when the pH of##3##4##(1994-6#1)(2008-10#1)(2008-11#1)
when the pH was##3##4##(1991-4#1)(1995-5#1)(2013-8#1)
when the pH##7##3##(1991-4#1)(1994-6#1)(1995-5#1)(2008-10#2)(2008-11#1)(2013-8#1)
when the pain is##3##4##(1990-6#1)(2007-7#1)(2008-9#1)
when the parasite##2##3##(1991-10#1)(2007-9#1)
when the particle size##2##4##(2008-10#1)(2013-8#1)
when the particle was##2##4##(2008-10#1)(2010-4#1)
when the particle##4##3##(2008-10#2)(2010-4#1)(2013-8#1)
when the particles were##2##4##(1990-8#1)(2010-2#1)
when the patient developed##2##4##(1992-11#1)(2007-7#1)
when the patient has##2##4##(1992-3#1)(2012-2#1)
when the patient is##4##4##(1995-5#1)(2006-10#2)(2011-3#1)
when the patient suffered##2##4##(1993-2#1)(2008-12#1)
when the patient was##4##4##(1991-11#1)(2006-8#1)(2009-11#1)(2011-2#1)
when the patient##24##3##(1991-11#1)(1992-11#1)(1992-3#1)(1993-2#1)(1994-5#1)(1995-5#1)(1997-6#1)(2006-10#3)(2006-12#1)(2006-8#1)(2007-7#1)(2008-12#1)(2009-11#1)(2010-12#1)(2010-3#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#2)
when the patient's##3##3##(1991-12#1)(2007-7#1)(2010-11#1)
when the patients were##2##4##(1990-8#1)(1993-11#1)
when the patients##5##3##(1990-8#1)(1992-6#1)(1993-1#1)(1993-11#1)(1995-2#1)
when the pattern of##2##4##(1995-10#1)(2008-8#1)
when the pattern##3##3##(1995-10#1)(2006-10#1)(2008-8#1)
when the peptide##3##3##(1997-4#1)(2005-11#1)(2008-4#1)
when the phase##3##3##(2007-11#1)(2008-2#1)(2012-2#1)
when the photolysis was##2##4##(1992-1#1)(2010-5#1)
when the plane##2##3##(2008-2#1)(2008-3#1)
when the plants were##3##4##(1997-6#1)(2007-1#1)(2008-10#1)
when the platelet##2##3##(1997-7#1)(2007-6#1)
when the polarization##2##3##(2007-12#1)(2008-3#1)
when the polymer##3##3##(2005-11#1)(2012-11#2)
when the population##3##3##(1993-4#1)(2006-10#1)(2008-10#1)
when the pregnant##2##3##(1991-4#1)(1993-10#1)
when the presence of##4##4##(1991-5#1)(1992-12#1)(2008-1#1)(2008-12#1)
when the pressure##3##3##(1991-6#2)(2009-6#1)
when the primary##2##3##(1995-12#1)(1995-8#1)
when the prisoner##2##3##(1990-2#1)(1996-11#1)
when the probability##2##3##(2008-3#1)(2012-3#1)
when the probe##3##3##(2005-11#1)(2007-12#1)(2008-2#1)
when the proper##2##3##(2008-10#1)(2008-3#1)
when the proportion of##2##4##(1990-10#1)(2008-10#1)
when the protective time was##2##5##(2008-10#2)
when the protein is##2##4##(1990-12#1)(1992-9#1)
when the protein##8##3##(1990-12#1)(1992-9#1)(1993-12#1)(1993-3#2)(1996-5#1)(2008-4#1)(2013-1#1)
when the pulse width falls below##2##6##(2008-3#2)
when the pulse width##4##4##(2008-3#4)
when the pulse##7##3##(1993-2#1)(2007-12#2)(2008-3#4)
when the pump##2##3##(2008-3#2)
when the range of##3##4##(1997-3#1)(2006-9#1)(2007-11#1)
when the rate is##2##4##(1997-6#2)
when the rate of##2##4##(1994-3#1)(1994-6#1)
when the rate##4##3##(1994-3#1)(1994-6#1)(1997-6#2)
when the rates##2##3##(1995-5#1)(2008-7#1)
when the ratio of##3##4##(2006-8#1)(2008-10#2)
when the ratio##5##3##(2006-8#1)(2008-10#2)(2011-2#1)(2012-11#1)
when the rats were##2##4##(1997-2#1)(2013-1#1)
when the rats##3##3##(1994-2#1)(1997-2#1)(2013-1#1)
when the raw##2##3##(1996-7#1)(2008-4#1)
when the reciprocal##2##3##(1996-3#1)(2008-3#1)
when the redox component is##2##5##(1995-8#2)
when the reference##2##3##(1995-4#1)(2008-10#1)
when the refractive indices##2##4##(2008-2#1)(2008-3#1)
when the refractive##3##3##(2008-2#1)(2008-3#2)
when the repair##2##3##(2012-12#1)(2012-2#1)
when the required##2##3##(1990-8#1)(2006-1#1)
when the resolution of the##2##5##(2008-2#1)(2008-3#1)
when the response##2##3##(1994-6#1)(2008-2#1)
when the results of##3##4##(2006-10#1)(2007-12#1)(2007-6#1)
when the results were##3##4##(1990-12#2)(2007-10#1)
when the results##9##3##(1990-12#2)(2006-10#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-5#1)
when the same##10##3##(1992-12#1)(1992-6#1)(1993-12#1)(1994-9#1)(1996-7#1)(2005-3#1)(2007-6#1)(2007-9#1)(2008-10#1)(2009-11#1)
when the sample is##2##4##(2008-3#1)(2011-2#1)
when the sample size is##2##5##(2012-2#2)
when the sample size##4##4##(1996-12#1)(2011-2#1)(2012-2#2)
when the sample##11##3##(1994-11#1)(1996-12#1)(2008-10#2)(2008-3#2)(2008-6#1)(2011-2#2)(2012-2#2)
when the samples were##6##4##(1995-6#1)(2008-3#1)(2008-5#1)(2010-6#1)(2012-3#2)
when the scattering##2##3##(2007-12#1)(2008-2#1)
when the second##2##3##(1997-2#1)(2008-3#1)
when the secondary##2##3##(2008-10#1)(2008-7#1)
when the separation##2##3##(2008-10#1)(2008-2#1)
when the sequence##2##3##(1992-11#1)(1994-6#1)
when the signal is##2##4##(2008-3#2)
when the signal##3##3##(2008-2#1)(2008-3#2)
when the small##2##3##(1990-12#1)(2008-3#1)
when the solution pH##2##4##(2006-12#1)(2008-10#1)
when the solution##5##3##(2006-12#1)(2008-10#2)(2008-6#1)(2008-8#1)
when the solutions of##2##4##(2008-10#1)(2008-5#1)
when the solutions##3##3##(2005-11#1)(2008-10#1)(2008-5#1)
when the solvent##2##3##(2009-5#1)(2009-9#1)
when the specific##4##3##(1994-5#1)(2006-8#1)(2013-1#1)(2013-8#1)
when the spectrum is measured##2##5##(2007-12#1)(2008-10#1)
when the stimuli##2##3##(1992-11#2)
when the subjects##4##3##(1996-1#1)(2007-2#1)(2007-5#2)
when the substrate##4##3##(1993-11#1)(1994-3#1)(2008-3#2)
when the surface##3##3##(2006-7#1)(2008-3#1)(2008-6#1)
when the surfactant##2##3##(2005-11#1)(2008-10#1)
when the surgical##4##3##(1991-12#1)(2006-11#2)(2007-10#1)
when the symptoms are##2##4##(1994-5#1)(2006-2#1)
when the system##2##3##(2008-10#1)(2008-3#1)
when the tag##2##3##(2008-11#1)(2012-3#1)
when the target is##2##4##(1997-1#1)(2008-3#1)
when the target was##2##4##(1994-2#1)(1997-1#1)
when the target##9##3##(1994-2#1)(1996-1#1)(1997-1#2)(2008-10#1)(2008-3#3)(2010-5#1)
when the temperature increases##2##4##(2007-12#1)(2013-8#1)
when the temperature is decreased##2##5##(1995-2#2)
when the temperature is increased##2##5##(2005-11#1)(2008-10#1)
when the temperature is raised from##2##6##(1990-3#1)(2008-11#1)
when the temperature is##6##4##(1990-3#1)(1995-2#2)(2005-11#1)(2008-10#1)(2008-11#1)
when the temperature##13##3##(1990-3#1)(1992-2#1)(1995-2#2)(2005-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-12#1)(2012-12#1)(2013-8#1)
when the tests##2##3##(1990-10#1)(2008-4#1)
when the three##2##3##(2008-10#1)(2008-12#1)
when the threshold##3##3##(2008-9#1)(2009-8#1)(2013-8#1)
when the tide is##2##4##(2007-5#2)
when the time##2##3##(2008-11#1)(2012-11#1)
when the tip is above the##2##6##(2007-11#2)
when the tip##3##3##(1996-5#1)(2007-11#2)
when the total##2##3##(1996-9#1)(2008-8#1)
when the transfer of##2##4##(1997-4#1)(2008-5#1)
when the transformed cells were##2##5##(1990-12#1)(1991-2#1)
when the transmission##2##3##(2006-10#1)(2008-2#1)
when the treatment##2##3##(1993-9#1)(2010-1#1)
when the true##2##3##(1995-5#1)(2012-1#1)
when the tumor is##2##4##(2011-2#1)(2012-11#1)
when the tumor##4##3##(1996-6#1)(2011-2#2)(2012-11#1)
when the tumors##2##3##(1993-11#1)(2006-6#1)
when the two##17##3##(1990-11#1)(1990-6#1)(1991-11#1)(1991-8#1)(1992-7#1)(2006-8#1)(2007-12#2)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2013-1#1)
when the unattended stimulus was##2##5##(2010-5#2)
when the unattended stimulus##3##4##(2010-5#3)
when the underlying genetic model##2##5##(2008-4#1)(2012-11#1)
when the underlying##4##3##(1992-2#1)(1995-9#1)(2008-4#1)(2012-11#1)
when the value of##3##4##(1996-3#1)(2008-3#1)(2008-8#1)
when the values for##2##4##(2008-5#1)(2013-8#1)
when the valve body is positioned##2##6##(2006-8#2)
when the visual##2##3##(2007-9#1)(2012-2#1)
when the volume of##4##4##(1992-12#1)(1997-8#1)(2008-10#2)
when the water content##2##4##(2008-10#2)
when the water##4##3##(2007-3#1)(2008-10#2)(2009-6#1)
when the waveguide##3##3##(2007-11#1)(2007-12#1)(2008-1#1)
when the wavelength##2##3##(2007-12#1)(2008-3#1)
when the##1781##2##(1990-1#1)(1990-10#6)(1990-11#3)(1990-12#13)(1990-2#6)(1990-3#4)(1990-4#4)(1990-5#9)(1990-6#3)(1990-7#7)(1990-8#7)(1990-9#5)(1991-1#1)(1991-10#1)(1991-11#7)(1991-12#8)(1991-2#13)(1991-3#11)(1991-4#4)(1991-5#7)(1991-6#8)(1991-8#6)(1991-9#5)(1992-1#1)(1992-10#4)(1992-11#10)(1992-12#10)(1992-2#7)(1992-3#10)(1992-4#1)(1992-5#3)(1992-6#10)(1992-7#4)(1992-8#6)(1992-9#12)(1993-1#3)(1993-10#1)(1993-11#6)(1993-12#14)(1993-2#7)(1993-3#13)(1993-4#3)(1993-5#3)(1993-6#8)(1993-7#2)(1993-8#8)(1993-9#6)(1994-10#2)(1994-11#7)(1994-12#7)(1994-2#5)(1994-3#14)(1994-4#1)(1994-5#9)(1994-6#11)(1994-7#1)(1994-8#8)(1994-9#7)(1995-1#4)(1995-10#3)(1995-11#5)(1995-12#5)(1995-2#11)(1995-3#4)(1995-4#4)(1995-5#8)(1995-6#7)(1995-7#1)(1995-8#13)(1995-9#4)(1996-1#2)(1996-10#1)(1996-11#6)(1996-12#9)(1996-2#4)(1996-3#3)(1996-4#2)(1996-5#8)(1996-6#3)(1996-7#7)(1996-8#5)(1996-9#6)(1997-1#10)(1997-2#9)(1997-3#5)(1997-4#5)(1997-5#12)(1997-6#13)(1997-7#7)(1997-8#17)(2004-1#1)(2004-10#1)(2004-11#1)(2004-12#2)(2004-4#1)(2004-8#3)(2004-9#4)(2005-10#6)(2005-11#30)(2005-12#1)(2005-3#1)(2005-4#2)(2005-8#2)(2005-9#1)(2006-1#4)(2006-10#20)(2006-11#4)(2006-12#7)(2006-2#5)(2006-3#5)(2006-4#5)(2006-5#4)(2006-6#4)(2006-7#3)(2006-8#16)(2006-9#4)(2007-1#5)(2007-10#4)(2007-11#36)(2007-12#56)(2007-2#4)(2007-3#4)(2007-4#4)(2007-5#11)(2007-6#8)(2007-7#12)(2007-8#19)(2007-9#10)(2008-1#13)(2008-10#161)(2008-11#49)(2008-12#5)(2008-2#77)(2008-3#122)(2008-4#35)(2008-5#36)(2008-6#19)(2008-7#22)(2008-8#21)(2008-9#29)(2009-10#6)(2009-11#4)(2009-12#2)(2009-2#5)(2009-3#5)(2009-4#8)(2009-5#8)(2009-6#7)(2009-7#4)(2009-8#9)(2009-9#8)(2010-1#3)(2010-10#1)(2010-11#5)(2010-12#8)(2010-2#11)(2010-3#3)(2010-4#5)(2010-5#7)(2010-6#4)(2010-7#4)(2010-8#7)(2010-9#1)(2011-1#10)(2011-12#5)(2011-2#33)(2011-3#1)(2011-7#1)(2012-1#14)(2012-11#8)(2012-12#19)(2012-2#21)(2012-3#12)(2013-1#32)(2013-7#8)(2013-8#27)
when their UPDRS-III##2##3##(2008-7#2)
when their children##2##3##(1990-12#1)(2013-1#1)
when their concentration is##3##4##(2008-10#2)(2008-11#1)
when their concentrations were##2##4##(1992-6#1)(2013-1#1)
when their parents##2##3##(2007-7#1)(2013-1#1)
when their##46##2##(1990-12#1)(1990-2#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-9#1)(1992-6#1)(1995-3#1)(1996-5#1)(2005-11#1)(2006-4#2)(2006-8#1)(2007-1#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-6#2)(2010-6#1)(2011-1#2)(2011-2#1)(2012-11#1)(2013-1#5)(2013-8#2)
when theophylline##2##2##(1991-12#1)(2008-1#1)
when therapy was##2##3##(1997-2#1)(2013-8#1)
when therapy##3##2##(1997-2#1)(2010-12#1)(2013-8#1)
when there are changes in##3##5##(2008-10#1)(2008-5#2)
when there are no##2##4##(2008-9#2)
when there are##15##3##(1996-3#1)(1997-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#3)(2011-2#2)(2012-3#2)
when there is a change##2##5##(2006-10#1)(2012-2#1)
when there is a##19##4##(1991-1#1)(1991-6#1)(1992-6#1)(1993-8#1)(1997-4#1)(2006-10#1)(2006-12#1)(2008-10#2)(2008-3#2)(2008-4#2)(2008-9#1)(2009-8#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
when there is an##4##4##(1991-3#1)(1992-6#1)(1996-11#1)(2005-7#1)
when there is no evidence of##2##6##(2007-4#1)(2008-3#1)
when there is no##7##4##(2007-4#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-6#1)(2010-12#1)
when there is noise##2##4##(2007-12#1)(2012-3#1)
when there is pain##2##4##(2006-3#1)(2007-7#1)
when there is risk##2##4##(2006-10#2)
when there is##56##3##(1991-1#1)(1991-3#1)(1991-6#1)(1992-6#2)(1993-8#1)(1995-7#1)(1996-11#1)(1997-4#1)(1997-8#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-3#1)(2006-9#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-7#3)(2008-10#5)(2008-2#1)(2008-3#3)(2008-4#3)(2008-9#3)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
when there was a low##2##5##(1990-2#1)(2007-10#1)
when there was a##3##4##(1990-2#1)(1995-6#1)(2007-10#1)
when there was an##3##4##(2006-8#1)(2010-6#1)(2010-7#1)
when there was no##5##4##(2007-8#1)(2008-10#1)(2009-4#1)(2009-9#2)
when there was##15##3##(1990-2#1)(1995-11#1)(1995-6#1)(2006-10#1)(2006-8#1)(2007-10#2)(2007-8#1)(2008-10#2)(2009-4#1)(2009-9#2)(2010-6#1)(2010-7#1)
when there were##6##3##(1990-11#1)(2008-7#1)(2010-12#1)(2012-12#3)
when there##95##2##(1990-11#1)(1990-2#1)(1991-1#1)(1991-3#1)(1991-6#1)(1992-6#2)(1993-8#1)(1995-11#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-7#1)(2006-10#5)(2006-12#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-4#1)(2007-7#3)(2007-8#1)(2008-10#8)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#2)(2008-7#1)(2008-9#6)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#1)(2013-7#1)(2013-8#1)
when thermal##2##2##(2008-2#1)(2012-2#1)
when these are##4##3##(1997-4#2)(2008-10#1)(2011-1#1)
when these cells were##2##4##(1992-1#1)(1992-12#1)
when these cells##4##3##(1992-1#1)(1992-12#1)(1995-2#1)(2012-12#1)
when these drugs##2##3##(1993-11#1)(2008-3#1)
when these parameters##2##3##(1995-12#1)(1996-9#1)
when these sequences are##2##4##(2008-7#1)(2008-9#1)
when these two##4##3##(1991-12#1)(1991-2#1)(1992-11#1)(2008-3#1)
when these were##2##3##(1996-9#1)(2008-10#1)
when these##57##2##(1990-6#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-7#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-9#2)(1997-4#2)(1997-6#1)(2006-10#1)(2006-12#1)(2006-5#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-9#1)(2010-12#2)(2011-1#2)(2012-12#1)(2013-1#2)
when they act##3##3##(2008-8#1)(2009-6#1)(2011-1#1)
when they are used in combination with##2##7##(2008-7#1)(2013-8#1)
when they are used in##3##5##(2008-3#1)(2008-7#1)(2013-8#1)
when they are used##4##4##(2008-3#1)(2008-7#1)(2008-8#1)(2013-8#1)
when they are young##2##4##(1994-4#1)(2008-11#1)
when they are##61##3##(1990-12#1)(1991-10#1)(1991-6#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-5#1)(1994-4#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-8#1)(2005-11#2)(2006-12#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-3#1)(2009-4#2)(2009-5#1)(2010-2#1)(2010-8#1)(2012-12#1)(2013-1#5)(2013-8#1)
when they can##2##3##(2007-8#1)(2008-5#1)
when they develop##2##3##(2006-12#1)(2012-2#1)
when they did not##2##4##(2009-10#2)
when they did##3##3##(1995-6#1)(2009-10#2)
when they do##2##3##(1992-7#1)(2008-2#1)
when they encounter the##2##4##(2008-2#1)(2009-6#1)
when they encounter##3##3##(2008-2#1)(2009-6#1)(2010-8#1)
when they feel##2##3##(2008-3#1)(2009-12#1)
when they first##2##3##(1993-7#1)(2010-3#1)
when they had##3##3##(1991-4#1)(1997-5#1)(2009-11#1)
when they have##8##3##(2006-7#1)(2007-6#1)(2008-2#1)(2008-5#1)(2009-2#1)(2010-4#1)(2011-2#1)(2012-1#1)
when they interact with##2##4##(2008-4#1)(2011-2#1)
when they may##2##3##(2007-8#1)(2008-1#1)
when they need##2##3##(2011-2#2)
when they reach adulthood##2##4##(1996-6#1)(2011-2#1)
when they start##2##3##(2007-7#1)(2011-12#1)
when they undergo##2##3##(1991-3#1)(2008-11#1)
when they use##2##3##(2004-10#1)(2008-4#1)
when they were added##2##4##(2007-11#1)(2007-2#1)
when they were exposed to the scent mark of a##2##10##(2009-6#2)
when they were exposed to##4##5##(1990-5#1)(2009-6#2)(2011-12#1)
when they were grown##2##4##(2004-11#1)(2008-10#1)
when they were in##2##4##(2011-1#1)(2012-12#1)
when they were##44##3##(1990-10#1)(1990-5#2)(1991-3#2)(1993-12#1)(1993-6#1)(1995-1#1)(1997-5#1)(1997-8#1)(2004-11#1)(2004-2#1)(2005-12#1)(2005-4#1)(2005-9#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#2)(2010-5#1)(2010-6#1)(2011-1#2)(2011-12#1)(2012-12#1)(2013-8#1)
when they##217##2##(1990-10#1)(1990-12#1)(1990-5#2)(1991-10#3)(1991-12#1)(1991-3#4)(1991-4#1)(1991-6#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-4#1)(1994-5#2)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#4)(1995-8#3)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#2)(1996-9#1)(1997-2#2)(1997-3#1)(1997-5#3)(1997-6#1)(1997-8#2)(2004-10#1)(2004-11#1)(2004-2#1)(2005-11#2)(2005-12#1)(2005-4#1)(2005-7#1)(2005-9#2)(2006-10#1)(2006-12#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#4)(2007-12#2)(2007-2#2)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#8)(2008-11#6)(2008-12#3)(2008-2#5)(2008-3#4)(2008-4#6)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#8)(2008-9#1)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#4)(2009-8#1)(2010-2#4)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#4)(2011-1#4)(2011-11#1)(2011-12#2)(2011-2#7)(2012-1#3)(2012-12#3)(2012-2#2)(2013-1#7)(2013-8#2)
when thin##2##2##(1993-4#1)(2008-3#1)
when this assumption is violated##2##5##(1994-11#1)(2012-3#1)
when this assumption##3##3##(1994-11#1)(1997-8#1)(2012-3#1)
when this enzyme is##2##4##(1994-11#1)(1994-9#1)
when this is##2##3##(2008-11#1)(2009-4#1)
when this method##2##3##(2008-10#1)(2008-3#1)
when this substrate##2##3##(1991-12#1)(2004-4#1)
when this was##4##3##(1992-7#1)(2006-10#1)(2006-12#1)(2010-4#1)
when this##50##2##(1990-10#1)(1990-5#1)(1991-12#1)(1991-5#1)(1992-6#2)(1992-7#1)(1993-12#1)(1993-8#1)(1994-11#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-6#1)(1997-8#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#2)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
when those##5##2##(1992-2#1)(2008-11#1)(2008-8#1)(2010-2#1)(2013-8#1)
when three##3##2##(1995-3#1)(1997-6#1)(2011-2#1)
when tissue##2##2##(2008-1#1)(2008-4#1)
when to initiate##2##3##(2007-8#2)
when to intervene##2##3##(2008-12#1)(2009-4#1)
when to refer##2##3##(2006-8#1)(2008-9#1)
when to start##4##3##(1996-1#1)(2010-4#1)(2011-2#2)
when to use##3##3##(2004-12#1)(2007-9#1)(2008-4#1)
when to##34##2##(1992-9#1)(1993-10#1)(1993-12#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(2003-11#1)(2004-12#1)(2006-1#1)(2006-10#4)(2006-8#2)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-4#1)(2011-2#3)
when topically applied##2##3##(2008-5#2)
when total##4##2##(1994-3#1)(1997-8#1)(2008-5#1)(2011-12#1)
when traditional##4##2##(1990-4#1)(2006-6#1)(2007-7#1)(2008-10#1)
when training##3##2##(1995-9#2)(2008-2#1)
when transfected into##4##3##(1991-6#1)(1993-5#2)(2008-9#1)
when transfected##6##2##(1991-6#1)(1992-12#1)(1993-5#2)(1996-2#1)(2008-9#1)
when transiently##2##2##(1993-3#1)(1995-12#1)
when transition##2##2##(1996-4#1)(2011-2#1)
when transitioning from##2##3##(2008-10#1)(2009-8#1)
when transitioning##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
when translated##2##2##(1990-11#1)(1995-8#1)
when transplanted to##2##3##(1992-9#1)(2008-11#1)
when transplanted##4##2##(1992-9#1)(2006-6#1)(2008-11#1)(2011-2#1)
when transplants##2##2##(1991-5#1)(2008-10#1)
when treated with##15##3##(1991-5#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-9#1)(1994-11#1)(1995-3#1)(1997-2#1)(2005-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-2#1)(2012-2#1)
when treated##19##2##(1991-5#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-9#1)(1994-11#1)(1995-3#1)(1997-2#1)(1997-6#1)(2005-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-1#1)(2010-2#1)(2012-2#1)(2013-1#1)
when treating a##3##3##(2007-5#1)(2013-1#2)
when treating patients with##5##4##(1992-4#1)(1992-9#1)(1993-2#1)(2010-12#1)(2012-3#1)
when treating patients##6##3##(1992-4#1)(1992-9#1)(1993-2#1)(1996-12#1)(2010-12#1)(2012-3#1)
when treating the##2##3##(2008-7#1)(2013-1#1)
when treating##21##2##(1991-2#1)(1992-4#1)(1992-9#1)(1993-2#1)(1996-12#1)(2005-7#1)(2007-1#1)(2007-12#1)(2007-5#1)(2008-7#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#5)
when treatment is##8##3##(1990-2#1)(2005-2#1)(2007-11#1)(2007-2#1)(2009-10#1)(2010-12#3)
when treatment was##2##3##(1994-3#1)(2004-1#1)
when treatment##13##2##(1990-2#1)(1994-3#1)(1996-3#1)(2004-1#1)(2005-2#1)(2007-11#1)(2007-2#1)(2007-8#1)(2009-10#1)(2010-12#3)(2011-10#1)
when trees were##2##3##(2008-10#2)
when trees##3##2##(2008-10#3)
when trying to##6##3##(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)
when tumor##3##2##(1991-6#1)(1993-9#1)(2008-5#1)
when two gratings are used is simplified##2##7##(2008-3#2)
when two or more##3##4##(1995-6#1)(1997-2#1)(2006-4#1)
when two##22##2##(1990-4#1)(1991-11#1)(1992-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-3#1)(1997-2#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-2#1)(2013-1#1)
when under##2##2##(1992-2#1)(1993-12#1)
when used alone##8##3##(1990-2#1)(1995-5#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)
when used appropriately##2##3##(2007-11#1)(2010-11#1)
when used as a##2##4##(2009-12#1)(2010-7#1)
when used as an adjunct to##2##6##(1991-7#1)(2007-11#1)
when used as an##3##4##(1991-7#1)(2007-11#1)(2008-10#1)
when used as##18##3##(1991-7#1)(1995-4#1)(2005-12#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#1)(2009-12#2)(2010-7#1)(2011-1#1)(2012-3#1)
when used at high doses##2##5##(1996-9#1)(2007-5#1)
when used at##5##3##(1996-9#2)(2007-5#1)(2008-2#1)(2012-12#1)
when used by##3##3##(1994-2#1)(1996-7#1)(2006-10#1)
when used for appropriate##2##4##(2005-12#1)(2008-3#1)
when used for##9##3##(2005-10#1)(2005-12#1)(2005-8#1)(2007-12#1)(2008-11#1)(2008-3#1)(2009-5#1)(2010-3#1)(2012-1#1)
when used in a##2##4##(2008-10#2)
when used in combination with other##2##6##(2005-7#1)(2011-2#1)
when used in combination with the##2##6##(1992-1#1)(1996-10#1)
when used in combination with##10##5##(1992-1#1)(1996-10#1)(1996-9#1)(2005-7#1)(2007-11#2)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#1)
when used in combination##11##4##(1992-1#1)(1996-10#1)(1996-9#1)(2005-7#1)(2007-11#2)(2008-10#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#1)
when used in conjunction with##8##5##(1990-12#1)(1997-7#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-2#1)
when used in the##2##4##(1990-3#1)(2008-11#1)
when used in##36##3##(1990-12#1)(1990-3#1)(1992-1#1)(1996-10#1)(1996-6#1)(1996-9#1)(1997-7#1)(2005-7#1)(2006-10#1)(2007-11#2)(2007-8#2)(2008-10#4)(2008-11#4)(2008-5#4)(2008-6#1)(2008-7#2)(2009-8#1)(2010-2#1)(2010-4#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
when used to treat##4##4##(1994-11#1)(2007-11#1)(2008-5#1)(2011-2#1)
when used to##14##3##(1991-12#1)(1993-3#1)(1994-11#1)(1994-5#1)(1996-12#1)(2006-2#1)(2007-11#1)(2008-10#3)(2008-5#1)(2009-10#1)(2009-8#1)(2011-2#1)
when used with the##2##4##(2006-10#1)(2006-4#1)
when used with##8##3##(1991-2#1)(1997-1#1)(2006-10#1)(2006-4#1)(2007-8#1)(2008-3#1)(2008-7#1)(2010-7#1)
when used##115##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-1#1)(1992-2#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-5#1)(1995-4#1)(1995-5#1)(1996-10#1)(1996-12#1)(1996-6#1)(1996-7#1)(1996-9#3)(1997-1#1)(1997-7#1)(2005-10#1)(2005-12#2)(2005-7#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-4#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#4)(2008-1#1)(2008-10#17)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-12#2)(2009-5#1)(2009-8#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-7#1)
when using a##9##3##(1995-2#1)(2008-10#2)(2008-2#1)(2009-2#1)(2011-1#2)(2012-12#1)(2013-7#1)
when using different##3##3##(1992-12#1)(1993-4#1)(2013-8#1)
when using high##2##3##(2009-2#1)(2011-2#1)
when using standard##2##3##(1990-11#1)(1996-5#1)
when using the##24##3##(1992-11#1)(1993-2#1)(1995-1#1)(1995-6#1)(1996-3#1)(2005-9#1)(2006-12#1)(2006-4#1)(2007-4#1)(2008-10#7)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2010-7#1)(2012-12#1)(2013-8#1)
when using these drugs##2##4##(2006-10#1)(2013-1#1)
when using these##3##3##(1997-8#1)(2006-10#1)(2013-1#1)
when using this##3##3##(1992-2#1)(2008-10#1)(2008-12#1)
when using##108##2##(1990-11#1)(1990-12#1)(1990-3#1)(1991-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-7#1)(1992-8#2)(1993-11#2)(1993-2#1)(1993-4#1)(1993-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-8#1)(2005-4#1)(2005-9#1)(2006-10#2)(2006-12#2)(2006-4#1)(2006-9#1)(2007-11#1)(2007-4#1)(2007-8#4)(2007-9#1)(2008-10#22)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#2)(2009-10#1)(2009-2#4)(2009-3#1)(2010-5#1)(2010-7#1)(2011-1#4)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#5)(2013-7#2)(2013-8#4)
when variance##2##2##(2009-12#1)(2010-12#1)
when various##4##2##(1993-12#1)(1995-5#1)(1996-12#1)(2008-10#1)
when varying##2##2##(1994-8#1)(2008-7#1)
when verbs##2##2##(2010-2#2)
when viewed from the##4##4##(2006-12#1)(2008-3#1)(2008-4#1)(2010-12#1)
when viewed from##6##3##(2006-12#2)(2008-10#1)(2008-3#1)(2008-4#1)(2010-12#1)
when viewed##10##2##(2006-12#2)(2008-10#2)(2008-2#3)(2008-3#1)(2008-4#1)(2010-12#1)
when viewing##3##2##(2008-10#1)(2008-11#2)
when viral##2##2##(1997-5#1)(2007-11#1)
when virus##3##2##(1996-4#1)(1997-1#1)(2012-3#1)
when visiting##2##2##(1992-12#1)(2008-11#1)
when visual##5##2##(1993-12#1)(1995-9#1)(2007-9#1)(2008-12#1)(2010-9#1)
when visualized##2##2##(2008-1#1)(2008-10#1)
when vitamin##3##2##(2012-2#1)(2013-1#2)
when walking##2##2##(2006-10#1)(2007-10#1)
when water##5##2##(1993-2#1)(1995-8#1)(2006-10#1)(2007-5#1)(2008-10#1)
when we apply##2##3##(2008-2#1)(2008-3#1)
when we consider the##3##4##(2006-3#1)(2007-6#1)(2007-7#1)
when we consider##5##3##(1995-10#1)(2006-3#1)(2007-6#1)(2007-7#1)(2008-11#1)
when we have##2##3##(2008-2#1)(2011-1#1)
when we take into account##2##5##(1994-2#1)(2008-2#1)
when we use##2##3##(2008-11#1)(2010-8#1)
when we used##5##3##(1996-11#1)(2006-12#2)(2008-2#2)
when we were##3##3##(2007-12#2)(2013-7#1)
when we##48##2##(1993-12#1)(1993-2#1)(1993-7#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-10#1)(1996-11#1)(1996-4#1)(1996-8#1)(1997-2#1)(2005-10#1)(2006-12#2)(2006-3#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-11#3)(2008-2#6)(2008-3#7)(2008-5#1)(2010-12#2)(2010-8#2)(2011-1#1)(2012-2#2)(2013-7#1)(2013-8#1)
when weather supported mild epidemics##3##5##(2008-10#3)
when weather supported severe epidemics##4##5##(2008-10#4)
when weather supported##7##3##(2008-10#7)
when weight##2##2##(1992-11#1)(2007-12#1)
when wild-type cells are##2##4##(1995-8#2)
when wild-type##3##2##(1995-8#2)(1997-3#1)
when will##2##2##(2008-7#1)(2010-10#1)
when women##2##2##(2006-12#1)(2012-3#1)
when word n + 1##2##5##(2009-5#2)
when words##2##2##(1996-2#1)(2010-7#1)
when working in the##2##4##(1992-6#1)(2008-3#1)
when working with##12##3##(1991-8#1)(2004-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#3)(2008-9#1)(2010-8#1)(2013-1#1)
when working##16##2##(1991-8#1)(1992-6#1)(2004-12#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-9#1)(2009-4#1)(2010-8#1)(2013-1#1)
when writing##3##2##(2007-11#1)(2008-4#1)(2012-3#1)
when you##6##2##(1994-3#1)(1996-3#1)(2004-12#1)(2006-10#1)(2007-12#1)(2008-10#1)
when young patients##2##3##(2007-8#1)(2011-11#1)
when young##3##2##(1992-5#1)(2007-8#1)(2011-11#1)
when younger than 45 years##3##5##(2010-3#3)
when##9155##1##(1990-1#2)(1990-10#20)(1990-11#38)(1990-12#50)(1990-2#32)(1990-3#20)(1990-4#18)(1990-5#33)(1990-6#17)(1990-7#27)(1990-8#28)(1990-9#23)(1991-1#17)(1991-10#15)(1991-11#20)(1991-12#49)(1991-2#45)(1991-3#39)(1991-4#18)(1991-5#34)(1991-6#34)(1991-7#31)(1991-8#32)(1991-9#27)(1992-1#18)(1992-10#14)(1992-11#27)(1992-12#36)(1992-2#34)(1992-3#45)(1992-4#11)(1992-5#23)(1992-6#38)(1992-7#22)(1992-8#26)(1992-9#39)(1993-1#16)(1993-10#7)(1993-11#28)(1993-12#72)(1993-2#38)(1993-3#48)(1993-4#18)(1993-5#14)(1993-6#32)(1993-7#20)(1993-8#27)(1993-9#30)(1994-1#8)(1994-10#7)(1994-11#29)(1994-12#31)(1994-2#44)(1994-3#54)(1994-4#9)(1994-5#47)(1994-6#41)(1994-7#5)(1994-8#58)(1994-9#41)(1995-1#38)(1995-10#15)(1995-11#26)(1995-12#39)(1995-2#57)(1995-3#52)(1995-4#15)(1995-5#32)(1995-6#45)(1995-7#11)(1995-8#41)(1995-9#18)(1996-1#22)(1996-10#17)(1996-11#26)(1996-12#51)(1996-2#38)(1996-3#31)(1996-4#21)(1996-5#34)(1996-6#23)(1996-7#19)(1996-8#29)(1996-9#36)(1997-1#38)(1997-2#46)(1997-3#35)(1997-4#49)(1997-5#33)(1997-6#42)(1997-7#31)(1997-8#58)(2003-11#1)(2004-1#3)(2004-10#3)(2004-11#8)(2004-12#12)(2004-2#5)(2004-3#1)(2004-4#8)(2004-5#1)(2004-8#5)(2004-9#12)(2005-1#2)(2005-10#25)(2005-11#70)(2005-12#10)(2005-2#1)(2005-3#1)(2005-4#8)(2005-5#6)(2005-7#24)(2005-8#18)(2005-9#12)(2006-1#11)(2006-10#132)(2006-11#24)(2006-12#60)(2006-2#19)(2006-3#15)(2006-4#27)(2006-5#39)(2006-6#23)(2006-7#19)(2006-8#65)(2006-9#30)(2007-1#33)(2007-10#28)(2007-11#146)(2007-12#171)(2007-2#40)(2007-3#23)(2007-4#25)(2007-5#38)(2007-6#32)(2007-7#76)(2007-8#105)(2007-9#46)(2008-1#78)(2008-10#948)(2008-11#252)(2008-12#76)(2008-2#238)(2008-3#334)(2008-4#151)(2008-5#209)(2008-6#99)(2008-7#181)(2008-8#166)(2008-9#164)(2009-1#4)(2009-10#49)(2009-11#26)(2009-12#16)(2009-2#29)(2009-3#34)(2009-4#45)(2009-5#38)(2009-6#44)(2009-7#20)(2009-8#42)(2009-9#33)(2010-1#19)(2010-10#16)(2010-11#16)(2010-12#70)(2010-2#58)(2010-3#29)(2010-4#66)(2010-5#30)(2010-6#19)(2010-7#28)(2010-8#54)(2010-9#22)(2011-1#105)(2011-10#8)(2011-11#2)(2011-12#32)(2011-2#214)(2011-3#5)(2011-7#4)(2012-1#57)(2012-11#30)(2012-12#134)(2012-2#138)(2012-3#92)(2012-4#2)(2012-7#3)(2012-8#2)(2013-1#211)(2013-7#43)(2013-8#113)
when?##6##1##(1993-7#1)(2006-10#2)(2006-8#1)(2007-12#1)(2008-6#1)
whenever a##5##2##(1993-11#1)(1996-3#1)(2008-10#2)(2008-7#1)
whenever feasible##2##2##(2008-6#1)(2011-2#1)
whenever it##3##2##(1990-8#1)(2008-4#1)(2010-5#1)
whenever possible##15##2##(1995-1#1)(1996-3#1)(1996-9#1)(2004-9#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
whenever the true##2##3##(1993-9#1)(2008-7#1)
whenever the##15##2##(1993-9#1)(1997-2#1)(2005-11#1)(2007-12#3)(2007-7#3)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)
whenever there is##4##3##(1996-1#1)(2008-3#1)(2008-7#1)(2011-1#1)
whenever##79##1##(1990-10#2)(1990-8#3)(1991-12#1)(1992-3#1)(1993-11#2)(1993-5#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#3)(1996-8#1)(1996-9#2)(1997-2#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-12#3)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#8)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-2#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#2)
whenthe##3##1##(2008-11#3)
wheras the##2##2##(2006-6#1)(2006-8#1)
wheras##3##1##(2006-10#1)(2006-6#1)(2006-8#1)
where &quot##6##2##(1997-7#2)(2007-1#1)(2007-11#1)(2011-1#1)(2012-3#1)
where 0 = not at all appropriate/useful and 10 = very appropriate/useful)##2##12##(2013-1#2)
where 0##3##2##(2008-2#1)(2013-1#2)
where 1##2##2##(2008-10#1)(2008-4#1)
where 13##2##2##(2007-5#1)(2007-9#1)
where A is##2##3##(2008-10#1)(2008-2#1)
where A##6##2##(1997-8#2)(2008-10#2)(2008-2#1)(2008-6#1)
where AGTs##2##2##(2010-6#2)
where ALP##2##2##(1990-12#1)(2007-8#1)
where C is##2##3##(1991-2#1)(1993-3#1)
where CQ##2##2##(2005-8#2)
where Cr(III) is##2##3##(2008-10#2)
where DC-conversion was##2##3##(1993-8#2)
where E##2##2##(1994-12#1)(2007-11#1)
where GABA##2##2##(1992-8#1)(2007-12#1)
where H##2##2##(2008-3#2)
where HBV is endemic##2##4##(2006-2#1)(2009-11#1)
where HIC15 was##2##3##(2006-11#2)
where HIV##3##2##(1991-6#1)(1995-1#1)(2010-2#1)
where I(0) and I(100) represent the detected##2##7##(2008-10#2)
where K is##3##3##(1990-8#1)(2007-9#1)(2008-7#1)
where K##5##2##(1990-8#1)(1996-2#1)(2007-9#1)(2008-7#2)
where L is##2##3##(2007-11#1)(2013-1#1)
where L##6##2##(1997-7#1)(2005-4#1)(2007-11#1)(2008-10#2)(2013-1#1)
where M =##4##3##(1997-7#1)(2008-5#3)
where M is##2##3##(2007-11#1)(2009-12#1)
where M##7##2##(1997-7#1)(2007-11#1)(2008-5#3)(2009-12#1)(2010-7#1)
where N is a##2##4##(2008-7#2)
where N is the number of##2##6##(2007-11#1)(2008-8#1)
where N is the##5##4##(2006-10#1)(2007-11#1)(2007-3#1)(2008-3#1)(2008-8#1)
where N is##7##3##(2006-10#1)(2007-11#1)(2007-3#1)(2008-3#1)(2008-7#2)(2008-8#1)
where N##10##2##(1992-9#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-3#2)(2008-7#2)(2008-8#1)(2009-2#1)
where NO##3##2##(1994-2#1)(1996-2#1)(2011-2#1)
where O##3##2##(1991-12#1)(2008-10#1)(2008-3#1)
where P##5##2##(2006-2#1)(2007-12#1)(2008-10#2)(2009-6#1)
where Phytophthora##2##2##(2008-10#2)
where R##3##2##(2008-3#2)(2012-2#1)
where RZR##2##2##(1995-3#2)
where S##2##2##(2007-8#1)(2008-10#1)
where T##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
where T3##2##2##(1996-5#1)(2008-12#1)
where TotD is the sum of the##2##7##(1996-11#1)(1997-1#1)
where X =##6##3##(1992-6#1)(1994-9#1)(1995-5#1)(2008-5#3)
where X is##3##3##(1992-8#1)(2006-10#1)(2011-2#1)
where X##10##2##(1992-4#1)(1992-6#1)(1992-8#1)(1994-9#1)(1995-5#1)(2006-10#1)(2008-5#3)(2011-2#1)
where Y##2##2##(1993-3#1)(1996-8#1)
where [M = Cu(II)##2##4##(2008-5#2)
where [M =##3##3##(2008-5#3)
where a change in##2##4##(1993-12#1)(2008-10#1)
where a group##3##3##(1997-8#1)(2008-8#1)(2010-6#1)
where a large number of##2##5##(1993-11#1)(2009-12#1)
where a large##4##3##(1993-11#1)(2009-12#1)(2010-11#1)(2012-12#1)
where a more##2##3##(1992-3#1)(2009-10#1)
where a number of##2##4##(1993-2#1)(2008-1#1)
where a patient##2##3##(2006-4#1)(2007-8#1)
where a significant fraction of##2##5##(1991-5#1)(2008-9#1)
where a##117##2##(1990-10#1)(1990-12#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-4#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-4#1)(1995-7#1)(1996-3#1)(1997-2#2)(1997-7#1)(1997-8#1)(2005-11#5)(2005-9#1)(2006-10#2)(2006-11#1)(2006-4#3)(2006-5#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#2)(2009-2#1)(2009-4#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#2)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#5)(2012-3#1)(2013-1#6)(2013-8#2)
where absorption##2##2##(2007-11#1)(2008-10#1)
where access##2##2##(2009-8#1)(2012-12#1)
where additional##3##2##(2005-5#1)(2007-5#1)(2007-7#1)
where adhesion##2##2##(2004-9#1)(2005-11#1)
where agonist onset##2##3##(2008-7#2)
where all##10##2##(1990-2#1)(1990-5#1)(1992-1#1)(1994-2#1)(1997-1#1)(2007-2#1)(2008-9#1)(2013-1#1)(2013-7#1)(2013-8#1)
where an increase of##2##4##(1992-6#1)(2007-1#1)
where an increase##3##3##(1992-6#1)(2007-1#1)(2011-2#1)
where an##26##2##(1991-5#1)(1991-6#2)(1991-8#1)(1992-6#1)(1993-7#1)(1994-11#3)(1994-12#1)(1995-3#1)(1996-12#1)(1997-8#1)(2004-11#1)(2005-11#1)(2006-7#1)(2007-1#1)(2008-10#2)(2008-7#1)(2009-9#2)(2010-12#1)(2011-2#2)(2013-1#1)
where and how the##2##4##(2008-10#1)(2008-5#1)
where and how##4##3##(1994-1#1)(2008-10#1)(2008-5#1)(2010-8#1)
where and when they##2##4##(2008-7#1)(2010-2#1)
where and when##3##3##(1994-3#1)(2008-7#1)(2010-2#1)
where and##9##2##(1994-1#1)(1994-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-6#1)(2010-8#1)(2013-1#1)
where antibiotics are##2##3##(1992-6#2)
where appropriate##9##2##(1991-6#1)(1995-2#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)
where approximately##3##2##(2004-11#1)(2011-1#1)(2013-1#1)
where are the##3##3##(1995-12#1)(2005-8#1)(2006-10#1)
where are we and where are we##2##7##(2009-5#1)(2013-1#1)
where are we going?##2##4##(2008-10#1)(2009-5#1)
where are we now?##2##4##(2007-11#2)
where are we##11##3##(1990-6#1)(2006-10#2)(2006-7#1)(2007-11#2)(2008-10#1)(2009-5#2)(2013-1#2)
where are we?##3##3##(2007-2#1)(2008-3#1)(2008-7#1)
where are##19##2##(1990-6#1)(1994-4#1)(1995-12#1)(2005-8#1)(2006-10#3)(2006-7#1)(2007-11#2)(2007-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-5#2)(2010-7#1)(2013-1#2)
where as the##2##3##(2004-11#1)(2008-12#1)
where as##8##2##(2004-11#1)(2004-9#1)(2008-10#1)(2008-12#1)(2009-6#1)(2010-5#1)(2012-2#1)(2013-1#1)
where at least one hand is always in contact with the substrate##2##12##(2012-12#2)
where at least##4##3##(1996-6#1)(2008-9#1)(2012-12#2)
where available##6##2##(1997-5#1)(2006-10#1)(2008-1#1)(2009-11#1)(2009-6#1)(2010-12#1)
where bare##2##2##(2008-11#1)(2009-11#1)
where beta##2##2##(1991-7#1)(2008-10#1)
where biospecimens linked to personal health information##2##7##(2013-1#2)
where blacks live##2##3##(2009-9#2)
where blood##5##2##(1991-9#1)(1993-12#2)(2008-10#1)(2010-4#1)
where both the##5##3##(1994-8#1)(2008-2#1)(2010-2#1)(2012-2#1)(2013-8#1)
where both##30##2##(1994-8#2)(1995-8#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#2)(2010-2#2)(2010-5#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
where cell##7##2##(1997-8#1)(2008-1#1)(2008-11#3)(2008-5#2)
where cells are##3##3##(1995-8#1)(2008-11#2)
where cells##6##2##(1991-5#1)(1995-8#1)(1996-5#1)(2008-11#2)(2008-7#1)
where changes in##2##3##(2008-7#1)(2012-12#1)
where changes##3##2##(2008-5#1)(2008-7#1)(2012-12#1)
where common##2##2##(1990-5#1)(2008-10#1)
where community##2##2##(1996-2#1)(2010-10#1)
where control##2##2##(1997-7#1)(2006-2#1)
where conventional##4##2##(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)
where cortical##2##2##(1997-2#1)(2010-2#1)
where cost##2##2##(2008-10#1)(2008-11#1)
where cross##2##2##(2008-10#1)(2010-4#1)
where data##4##2##(1995-3#1)(2008-10#1)(2008-7#1)(2009-11#1)
where did##2##2##(2007-12#1)(2008-8#1)
where different##5##2##(1991-11#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-8#1)
where direct##2##2##(2008-11#1)(2008-12#1)
where disease pressure was##3##4##(2008-10#3)
where do we stand?##5##4##(2005-8#1)(2006-10#1)(2007-3#1)(2008-10#1)(2008-7#1)
where do we##6##3##(2005-8#1)(2006-10#1)(2007-3#1)(2008-10#1)(2008-7#1)(2008-8#1)
where do##9##2##(2005-8#1)(2006-10#1)(2007-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-9#1)(2013-1#1)
where doctors are##2##3##(1996-8#1)(2010-11#1)
where doctors##3##2##(1993-3#1)(1996-8#1)(2010-11#1)
where drug##2##2##(1994-11#1)(2010-2#1)
where each cluster##2##3##(1996-2#1)(2008-3#1)
where each##19##2##(1990-7#1)(1995-2#1)(1996-2#1)(1997-2#1)(2006-10#1)(2007-12#1)(2007-5#2)(2008-1#1)(2008-2#4)(2008-3#2)(2008-7#1)(2010-4#2)(2013-7#1)
where early##2##2##(1997-3#1)(2013-1#1)
where either##4##2##(1991-4#1)(1995-6#1)(2008-4#1)(2008-8#1)
where electrostatic##2##2##(2005-11#2)
where enhanced##2##2##(2006-10#2)
where environmental##2##2##(2008-8#1)(2012-2#1)
where epidemics occur##2##3##(2008-10#2)
where excess##4##2##(1991-12#1)(1997-6#1)(2007-11#1)(2008-3#1)
where exposure##2##2##(1996-10#2)
where expression##2##2##(1994-10#1)(1995-2#1)
where extensive##5##2##(1994-12#1)(1994-8#1)(1995-2#1)(2008-10#1)(2008-7#1)
where external##2##2##(1991-2#1)(2007-2#1)
where failure##2##2##(2009-7#1)(2013-1#1)
where families##2##2##(2009-4#1)(2012-1#1)
where fearful##2##2##(2009-3#2)
where feasible##2##2##(2007-10#1)(2007-8#1)
where females##2##2##(2008-8#2)
where first##2##2##(2008-3#1)(2011-1#1)
where five of the six echinoderm classes are represented##2##9##(2007-5#2)
where five##3##2##(1997-8#1)(2007-5#2)
where full##2##2##(1992-6#1)(2007-11#1)
where further##2##2##(2007-8#1)(2008-11#1)
where future##2##2##(2008-11#1)(2010-10#1)
where gene##3##2##(2008-11#1)(2013-1#2)
where genes##3##2##(2006-12#1)(2008-10#1)(2009-4#1)
where genetic##2##2##(1990-3#1)(2008-8#1)
where global##2##2##(1993-10#1)(2010-1#1)
where good##2##2##(1994-6#1)(2008-8#1)
where growth was##2##3##(2008-8#2)
where growth##4##2##(2006-7#1)(2008-10#1)(2008-8#2)
where h is the scattering depth##2##6##(2008-3#2)
where he was##3##3##(1995-3#1)(2010-7#1)(2011-1#1)
where he##17##2##(1990-12#1)(1990-5#1)(1994-3#1)(1995-3#1)(2005-8#1)(2007-10#1)(2007-4#1)(2007-5#1)(2008-10#1)(2010-1#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
where he/she##3##2##(2008-7#1)(2012-2#2)
where health care##2##3##(1991-12#1)(2008-7#1)
where health##7##2##(1991-12#1)(2008-1#1)(2008-7#2)(2009-5#1)(2012-12#1)(2013-8#1)
where healthcare##3##2##(2012-2#1)(2013-1#2)
where heating##2##2##(2008-10#1)(2011-12#1)
where high##9##2##(1993-8#1)(2007-5#1)(2008-1#1)(2008-8#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-1#1)(2013-1#1)
where honey##2##2##(1991-2#1)(2008-7#1)
where host##3##2##(2008-10#1)(2008-8#1)(2011-12#1)
where human##4##2##(1991-1#1)(2008-8#1)(2010-7#1)(2012-2#1)
where imaging##2##2##(1994-5#1)(2007-6#1)
where in most cases##2##4##(2006-4#1)(2008-12#1)
where in the trial##2##4##(2009-11#2)
where in the##5##3##(1993-3#1)(2007-9#1)(2008-10#1)(2009-11#2)
where in##13##2##(1993-3#1)(2005-11#1)(2006-4#1)(2007-9#1)(2008-10#2)(2008-12#1)(2009-11#2)(2011-2#2)(2012-3#2)
where increased##2##2##(1994-3#1)(2008-11#1)
where increasing##4##2##(1996-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
where individual##2##2##(2008-6#1)(2011-9#1)
where infected##3##2##(2006-10#1)(2008-10#2)
where infection##4##2##(2008-10#2)(2009-11#1)(2011-2#1)
where infections##3##2##(2007-11#1)(2008-5#1)(2012-12#1)
where information from##2##3##(2010-9#1)(2012-11#1)
where information##3##2##(2010-4#1)(2010-9#1)(2012-11#1)
where inhibition of##2##3##(2008-11#1)(2011-1#1)
where initial##3##2##(2006-12#1)(2008-10#1)(2008-3#1)
where instead##2##2##(2005-8#1)(2008-2#1)
where is the##6##3##(1990-12#1)(1994-12#1)(1996-2#1)(1996-3#1)(2006-10#1)(2010-3#1)
where is##10##2##(1990-12#1)(1994-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-11#1)(2010-3#1)
where it acts non-redundantly with DNA methylation to enforce transcriptional silencing##2##11##(2012-12#2)
where it acts##3##3##(2008-7#1)(2012-12#2)
where it becomes##3##3##(1993-2#1)(1994-9#1)(2007-12#1)
where it binds##2##3##(1996-8#1)(2012-12#1)
where it can be##3##4##(1992-1#1)(2008-7#1)(2013-8#1)
where it can cause##3##4##(2008-10#1)(2008-9#1)(2011-1#1)
where it can##9##3##(1992-1#1)(1992-4#1)(2008-10#2)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
where it caused##2##3##(2008-5#1)(2008-7#1)
where it causes##4##3##(1993-3#1)(1994-12#1)(2008-10#1)(2011-2#1)
where it could##2##3##(1991-8#1)(1994-8#1)
where it exhibits##2##3##(1996-1#1)(1996-4#1)
where it forms a##2##4##(1993-11#1)(1995-10#1)
where it forms##3##3##(1993-11#1)(1994-8#1)(1995-10#1)
where it had##3##3##(1990-11#1)(2006-2#1)(2007-7#1)
where it has been shown to##2##6##(2006-10#1)(2008-11#1)
where it has been##5##4##(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)
where it has##8##3##(1990-3#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-6#1)
where it hydrolyses##2##3##(2008-4#1)(2008-5#1)
where it is a##2##4##(2004-4#1)(2010-11#1)
where it is associated with##2##5##(1990-5#1)(2010-10#1)
where it is assumed that##2##5##(1997-1#1)(2008-7#1)
where it is converted##2##4##(1997-6#1)(2008-10#1)
where it is needed##2##4##(2007-8#1)(2008-12#1)
where it is shown##2##4##(2008-3#1)(2010-4#1)
where it is##43##3##(1990-2#1)(1990-4#1)(1990-5#1)(1992-6#1)(1992-7#1)(1993-10#1)(1994-11#1)(1994-5#1)(1995-2#2)(1997-1#1)(1997-4#1)(1997-6#1)(2004-4#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#1)(2007-12#3)(2007-4#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2013-1#1)(2013-8#1)
where it may##2##3##(1997-2#1)(2007-12#1)
where it mediates##3##3##(1993-3#1)(1997-2#1)(2012-2#1)
where it might##2##3##(1991-12#1)(2008-10#1)
where it promotes##2##3##(1991-6#1)(2012-12#1)
where it should be##2##4##(2008-11#1)(2008-2#1)
where it should##3##3##(2008-11#1)(2008-2#1)(2008-4#1)
where it was found##2##4##(2007-10#1)(2007-3#1)
where it was##19##3##(1992-1#1)(1992-2#1)(1992-9#1)(1994-8#1)(1994-9#1)(1996-8#1)(2004-9#1)(2006-8#2)(2007-10#1)(2007-3#1)(2008-10#4)(2008-7#1)(2011-2#1)(2012-2#1)(2013-7#1)
where it##158##2##(1990-11#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#2)(1992-2#1)(1992-4#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-11#1)(1994-12#1)(1994-4#1)(1994-5#1)(1994-8#5)(1994-9#2)(1995-10#1)(1995-2#3)(1995-3#1)(1996-1#1)(1996-3#1)(1996-4#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#4)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-4#1)(2004-9#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#4)(2006-12#3)(2006-2#2)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#5)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#18)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-12#5)(2012-2#5)(2013-1#1)(2013-7#1)(2013-8#2)
where its##13##2##(1990-2#1)(1994-10#1)(1996-4#1)(1997-6#1)(2008-10#3)(2008-2#1)(2008-4#2)(2009-8#1)(2011-2#1)(2013-8#1)
where k is##2##3##(1992-12#1)(2005-11#1)
where lambda is the##3##4##(2008-2#1)(2008-3#1)(2008-8#1)
where large##4##2##(2008-3#1)(2010-12#1)(2013-1#2)
where light is##2##3##(2008-9#1)(2012-2#1)
where little##5##2##(1995-1#1)(2006-10#1)(2007-1#1)(2008-1#1)(2008-12#1)
where local##2##2##(2008-8#1)(2009-5#1)
where low##4##2##(1995-2#1)(2008-5#1)(2008-7#1)(2010-5#1)
where lysine##2##2##(1994-8#1)(2008-10#1)
where m is the##2##4##(2007-12#1)(2008-10#1)
where m##5##2##(1991-8#1)(2007-12#1)(2008-10#3)
where mRNAs##2##2##(1994-11#1)(2008-2#1)
where major##2##2##(1990-11#1)(1996-9#1)
where males##3##2##(2008-5#1)(2009-9#1)(2011-1#1)
where many##7##2##(1994-12#1)(1995-5#1)(1997-6#1)(2005-7#1)(2008-10#1)(2008-4#1)(2008-8#1)
where measurements##2##2##(1993-9#1)(1994-8#1)
where medical##4##2##(1993-3#1)(1994-12#1)(1997-8#1)(2006-2#1)
where members of##2##3##(1990-2#1)(2010-6#1)
where members##3##2##(1990-2#1)(2007-8#1)(2010-6#1)
where models that map patient's clinical characteristics to the utilization level are built in order to quantify the deviation between the expected and actual utilization levels and identify anomalies##2##29##(2013-1#2)
where molecular##2##2##(2008-10#2)
where more than##4##3##(1992-5#1)(2008-6#1)(2008-8#1)(2011-2#1)
where more##9##2##(1990-6#1)(1992-5#1)(1995-7#1)(2007-10#1)(2008-6#1)(2008-8#1)(2009-9#1)(2011-2#1)(2013-1#1)
where mortality##2##2##(1991-6#1)(2008-8#1)
where most of the##2##4##(1991-2#1)(2012-2#1)
where most##7##2##(1991-2#1)(1993-3#1)(1997-6#1)(2006-9#1)(2008-12#1)(2009-7#1)(2012-2#1)
where mostly##2##2##(1996-12#2)
where multiple##13##2##(1992-6#1)(1997-4#1)(2007-5#1)(2008-10#2)(2008-5#1)(2009-12#1)(2010-4#1)(2010-8#1)(2012-12#1)(2013-1#3)
where mutations##2##2##(2008-4#1)(2013-8#1)
where n is the number of conjugated pi-electron double bonds##2##10##(2010-2#2)
where n is the number of##3##6##(2008-8#1)(2010-2#2)
where n is the##5##4##(2007-12#1)(2008-2#1)(2008-8#1)(2010-2#2)
where n##6##2##(1997-2#1)(2007-12#1)(2008-2#1)(2008-8#1)(2010-2#2)
where natural##4##2##(2008-10#2)(2012-11#2)
where necessary##5##2##(2008-4#2)(2008-6#1)(2009-2#1)(2012-2#1)
where neither##3##2##(2006-8#1)(2008-10#1)(2012-2#1)
where net##2##2##(2006-8#1)(2008-10#1)
where neuronal##3##2##(2008-6#1)(2008-7#1)(2009-3#1)
where new##5##2##(1990-12#1)(1994-3#1)(2008-3#1)(2008-7#1)(2009-8#1)
where next?##2##2##(1997-2#1)(2008-1#1)
where no##32##2##(1990-11#1)(1990-12#1)(1990-6#1)(1992-12#1)(1992-3#1)(1994-10#1)(1995-11#2)(1995-2#1)(1996-11#1)(1996-6#1)(1997-6#1)(2005-7#1)(2005-8#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-8#1)(2009-2#1)(2009-6#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)
where none##2##2##(2007-2#1)(2008-8#1)
where not only the##2##4##(2008-8#1)(2013-1#1)
where not only##3##3##(1990-2#1)(2008-8#1)(2013-1#1)
where numerous##2##2##(2007-8#1)(2010-1#1)
where nurses##3##2##(2008-1#1)(2008-11#1)(2009-4#1)
where on the##2##3##(1990-6#1)(1994-8#1)
where on##3##2##(1990-6#1)(1994-8#1)(2009-6#1)
where one of the##2##4##(1990-9#1)(1992-3#1)
where one of##3##3##(1990-9#1)(1992-3#1)(1993-7#1)
where one##19##2##(1990-9#1)(1992-3#1)(1992-6#1)(1993-7#1)(1996-7#1)(1997-2#1)(2004-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-8#1)(2011-1#1)(2011-12#1)(2011-2#2)
where only a##3##3##(2007-12#1)(2007-8#1)(2008-8#1)
where only one##2##3##(2008-7#1)(2008-8#1)
where only the##6##3##(1994-5#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-12#1)
where only three##2##3##(2008-10#1)(2011-1#1)
where only##30##2##(1990-5#1)(1991-10#1)(1993-3#1)(1993-5#1)(1994-4#1)(1994-5#1)(1995-9#1)(1996-7#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-10#7)(2008-12#2)(2008-7#1)(2008-8#2)(2009-3#1)(2010-4#1)(2011-1#1)(2012-1#1)(2013-1#2)
where optical phases are detected by##2##6##(2007-12#1)(2008-3#1)
where optimal##2##2##(1994-12#1)(2009-4#1)
where organic##2##2##(2004-4#1)(2006-12#1)
where other##7##2##(1991-12#2)(1994-3#1)(1995-3#1)(1996-3#1)(2008-10#1)(2008-2#1)
where our##2##2##(1997-2#1)(2006-10#1)
where p##2##2##(2008-2#2)
where parents##2##2##(1993-3#1)(1994-3#1)
where participants##3##2##(2008-11#2)(2013-1#1)
where particularly favorable##2##3##(2008-4#2)
where patient##3##2##(2007-4#1)(2013-1#2)
where patients are##3##3##(2007-1#1)(2008-12#1)(2010-6#1)
where patients##7##2##(2005-9#1)(2006-2#1)(2007-1#1)(2008-12#1)(2010-6#1)(2013-1#2)
where people are##2##3##(1996-5#1)(2012-1#1)
where people##6##2##(1991-3#1)(1996-5#1)(2010-4#1)(2011-2#1)(2012-1#2)
where phonological##2##2##(2007-10#1)(2008-9#1)
where physical##2##2##(2006-6#1)(2011-1#1)
where plant##2##2##(2011-1#1)(2012-2#1)
where possible##20##2##(1992-12#1)(1992-9#1)(1995-4#1)(1995-5#1)(2005-11#1)(2006-12#1)(2006-4#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-2#1)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
where premiums##2##2##(1997-1#1)(1997-8#1)
where real##2##2##(2008-2#1)(2012-3#1)
where recovery##2##2##(1995-5#1)(2008-2#1)
where reduction of##2##3##(1992-9#1)(2008-10#1)
where relief##2##2##(2013-7#2)
where renal##2##2##(1996-11#1)(2007-7#1)
where research##6##2##(2007-12#1)(2008-5#2)(2009-4#1)(2013-1#1)(2013-8#1)
where resources are##2##3##(2012-2#2)
where sample##3##2##(2008-10#3)
where samples##3##2##(1996-8#1)(2004-4#1)(2008-10#1)
where selected##2##2##(1991-9#1)(2008-10#1)
where selective##2##2##(1990-11#1)(1993-12#1)
where services are##2##3##(1996-12#1)(2007-3#1)
where several##2##2##(2007-8#1)(2010-12#1)
where sex##2##2##(2008-8#1)(2010-8#1)
where she had been admitted##2##5##(2006-4#1)(2012-12#1)
where she had##3##3##(2006-4#1)(2007-4#1)(2012-12#1)
where she was##2##3##(2009-3#1)(2011-2#1)
where she##8##2##(1994-1#1)(1997-3#1)(2006-12#1)(2006-4#1)(2007-4#1)(2009-3#1)(2011-2#1)(2012-12#1)
where signal##2##2##(1994-9#1)(2013-8#1)
where signals##2##2##(2007-12#1)(2009-9#1)
where similar##2##2##(2006-11#1)(2013-8#1)
where simple##2##2##(1993-3#1)(2008-8#1)
where skin##2##2##(2007-8#2)
where small##4##2##(2008-3#1)(2008-4#2)(2010-7#1)
where software design patterns have become a critical aspect of software development##2##12##(2013-1#2)
where soil##2##2##(2008-10#1)(2008-12#1)
where some of the##2##4##(2008-3#1)(2009-12#1)
where some of##3##3##(2008-2#1)(2008-3#1)(2009-12#1)
where some##10##2##(1992-10#1)(1995-3#1)(2008-2#2)(2008-3#2)(2008-8#1)(2009-12#1)(2011-12#1)(2011-2#1)
where soybean##2##2##(2012-11#1)(2012-2#1)
where species##2##2##(1992-8#1)(1997-4#1)
where specific##2##2##(2010-12#1)(2012-2#1)
where standard##2##2##(2007-11#1)(2008-4#1)
where strain 70T01##2##3##(2008-10#2)
where students##5##2##(1997-3#1)(2008-11#2)(2008-12#1)(2010-2#1)
where substantial##3##2##(1993-12#1)(2006-10#1)(2008-10#1)
where such a##2##3##(2006-10#1)(2008-4#1)
where such##7##2##(1993-12#1)(2006-10#1)(2007-3#1)(2008-4#1)(2009-3#1)(2009-6#1)(2012-12#1)
where surgery##2##2##(2007-12#1)(2007-8#1)
where surgical##4##2##(1992-6#1)(2007-8#2)(2008-6#1)
where technology can##2##3##(2012-3#1)(2013-1#1)
where technology##3##2##(2007-4#1)(2012-3#1)(2013-1#1)
where temperature##2##2##(2008-10#2)
where testing##2##2##(2005-1#1)(2009-7#1)
where that##2##2##(2005-11#1)(2008-8#1)
where the %##2##3##(1994-3#1)(1997-4#1)
where the &quot##2##3##(1994-9#1)(1996-4#1)
where the abdominal wall has been##2##6##(2011-2#2)
where the analyte##4##3##(2007-10#1)(2008-10#2)(2008-7#1)
where the analytes are##2##4##(2008-10#2)
where the analytical signal##2##4##(2008-10#2)
where the antigen is##2##4##(1994-11#1)(2007-11#1)
where the antigen##3##3##(1994-11#1)(2007-11#1)(2008-4#1)
where the assembly of##2##4##(2008-11#1)(2009-11#1)
where the baby##3##3##(1992-7#1)(2007-9#1)(2009-10#1)
where the binding##2##3##(1990-2#1)(1994-12#1)
where the clinical picture##2##4##(1990-2#1)(1990-8#1)
where the coating##2##3##(2008-3#2)
where the combination of##2##4##(2008-6#1)(2012-12#1)
where the conserved##2##3##(1990-4#1)(1994-9#1)
where the correlation##2##3##(2006-10#1)(2006-7#1)
where the corresponding FTIR##2##4##(2008-10#2)
where the corresponding##4##3##(2007-8#1)(2008-10#3)
where the data##2##3##(1994-2#1)(2013-8#1)
where the dataset corresponding to each classifier consists of a restricted set of time-ordered narrative reports##2##16##(2013-1#2)
where the development of##2##4##(1990-2#1)(2012-2#1)
where the diagnosis was##4##4##(2005-11#1)(2007-7#1)(2010-3#1)(2012-12#1)
where the diagnosis##5##3##(2005-11#1)(2007-7#2)(2010-3#1)(2012-12#1)
where the different##2##3##(2008-10#1)(2008-2#1)
where the disease has##2##4##(2008-10#1)(2012-2#1)
where the disease is endemic##2##5##(2008-5#1)(2012-12#1)
where the disease is##4##4##(1995-3#1)(2008-10#1)(2008-5#1)(2012-12#1)
where the disease was first##2##5##(2008-10#2)
where the disease was##3##4##(1993-1#1)(2008-10#2)
where the disease##9##3##(1993-1#1)(1995-3#1)(2008-10#4)(2008-5#1)(2012-12#1)(2012-2#1)
where the effect of##2##4##(1996-3#1)(2005-11#1)
where the effect##4##3##(1992-1#1)(1996-3#1)(2005-11#1)(2006-9#1)
where the electrode##4##3##(2008-10#4)
where the enzyme is##2##4##(1994-12#1)(1995-3#1)
where the enzyme##4##3##(1991-8#1)(1993-11#1)(1994-12#1)(1995-3#1)
where the film##2##3##(2005-11#1)(2008-5#1)
where the first##4##3##(2008-10#2)(2008-5#1)(2012-12#1)
where the fish##2##3##(2010-8#1)(2012-2#1)
where the fixation##2##3##(1995-8#1)(2008-6#1)
where the flux averaged##2##4##(2008-5#2)
where the formation of##2##4##(2008-10#2)
where the former##2##3##(2008-10#1)(2008-4#1)
where the frequency of##2##4##(1990-12#1)(2008-1#1)
where the fungus##2##3##(2008-10#2)
where the gain##2##3##(2008-3#1)(2008-9#1)
where the gene is##2##4##(1990-8#1)(1991-5#1)
where the gene##4##3##(1990-8#1)(1991-5#1)(1995-5#1)(2008-8#1)
where the general##2##3##(1993-8#1)(2012-2#1)
where the histology was of a##2##6##(2006-6#2)
where the human##3##3##(1995-8#1)(1997-4#1)(2008-1#1)
where the hydrocarbon##2##3##(2005-11#1)(2007-12#1)
where the in##2##3##(1993-11#1)(1996-3#1)
where the incidence of##2##4##(2006-12#1)(2009-6#1)
where the incidence##4##3##(1994-11#1)(2006-12#1)(2009-6#1)(2011-1#1)
where the increase##2##3##(1992-4#1)(1997-7#1)
where the index##2##3##(2007-12#1)(2008-2#1)
where the individual##2##3##(1990-5#1)(2013-8#1)
where the level of##2##4##(1991-5#1)(2007-8#1)
where the level##3##3##(1991-5#1)(2006-6#1)(2007-8#1)
where the main##2##3##(2005-8#1)(2008-5#1)
where the major##2##3##(1997-7#1)(2009-10#1)
where the majority of the##2##5##(2006-10#1)(2008-8#1)
where the majority of##3##4##(2006-10#1)(2008-8#2)
where the maximum##3##3##(2005-11#1)(2008-10#2)
where the mean concentration of##2##5##(2007-9#1)(2013-8#1)
where the mean time to co-invasion##2##6##(2008-8#2)
where the mean##5##3##(1991-10#1)(2007-9#1)(2008-8#2)(2013-8#1)
where the median##2##3##(2006-8#1)(2008-9#1)
where the mode##2##3##(1997-6#1)(2008-3#1)
where the most##4##3##(2006-10#1)(2007-3#1)(2008-11#1)(2010-6#1)
where the number of##5##4##(1990-12#1)(1996-8#1)(2008-1#1)(2008-4#1)(2008-7#1)
where the only##3##3##(1997-8#1)(2008-10#1)(2013-1#1)
where the organism##2##3##(1995-8#1)(2008-4#1)
where the original##2##3##(2009-12#1)(2011-2#1)
where the outcome##2##3##(2006-5#1)(2008-5#1)
where the palm##2##3##(2008-10#2)
where the particle##2##3##(2005-11#1)(2007-11#1)
where the patient was##3##4##(1990-5#1)(1995-7#1)(1997-6#1)
where the patient##7##3##(1990-5#1)(1995-7#1)(1995-8#1)(1997-6#1)(2005-10#1)(2010-4#1)(2013-8#1)
where the patients##6##3##(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#2)(2013-8#1)
where the peptide##2##3##(2008-8#1)(2009-12#1)
where the phase##2##3##(2008-2#1)(2008-3#1)
where the photosensitivity is due to##2##6##(1990-1#1)(1991-10#1)
where the population is##2##4##(1991-12#1)(2008-8#1)
where the population##3##3##(1991-12#1)(2006-2#1)(2008-8#1)
where the potential##2##3##(1996-1#1)(2008-8#1)
where the presence of##3##4##(1993-8#1)(2006-10#1)(2008-10#1)
where the previous##2##3##(2007-10#1)(2010-12#1)
where the primary tumor##2##4##(2007-8#1)(2008-4#1)
where the primary##5##3##(2006-10#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-7#1)
where the probability of##2##4##(2006-5#1)(2009-12#1)
where the protein is native##2##5##(1997-2#2)
where the protein is##5##4##(1994-8#1)(1995-1#1)(1996-5#1)(1997-2#2)
where the protein##8##3##(1991-1#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-5#1)(1997-2#2)(2010-10#1)
where the pulse##2##3##(1992-11#1)(2007-12#1)
where the rate##2##3##(1997-3#1)(2006-4#1)
where the receptor##2##3##(1994-5#1)(1997-7#1)
where the recorded##3##3##(2005-11#1)(2013-1#2)
where the reduced##2##3##(2005-11#1)(2008-10#1)
where the risk of##2##4##(1990-9#1)(2008-3#1)
where the same##2##3##(2005-7#1)(2013-1#1)
where the sample##2##3##(2008-10#1)(2008-7#1)
where the sexual state##2##4##(2008-10#2)
where the sexual##3##3##(2008-10#2)(2013-7#1)
where the signal##2##3##(2008-2#1)(2008-3#1)
where the size##2##3##(2008-3#1)(2012-12#1)
where the sorption##2##3##(2008-10#2)
where the sources##3##3##(1992-9#1)(2008-4#1)(2011-1#1)
where the terms##2##3##(2008-11#1)(2008-7#1)
where the traditional##2##3##(2008-10#1)(2012-12#1)
where the treatment was##2##4##(1995-11#1)(1995-12#1)
where the treatment##3##3##(1994-4#1)(1995-11#1)(1995-12#1)
where the tumor was##2##4##(2006-2#1)(2010-3#1)
where the tumor##3##3##(2006-2#1)(2008-1#1)(2010-3#1)
where the two##5##3##(1990-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)
where the underlying##3##3##(2008-2#1)(2010-2#2)
where the use of##3##4##(1994-5#1)(2008-4#1)(2013-7#1)
where the user##2##3##(2008-4#1)(2010-8#1)
where the vaccine##2##3##(1993-3#1)(2008-5#1)
where the virus##2##3##(2007-12#1)(2007-2#1)
where the whole##2##3##(2008-11#1)(2008-2#1)
where the##772##2##(1990-1#1)(1990-11#3)(1990-12#4)(1990-2#7)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#2)(1991-1#1)(1991-10#2)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#4)(1991-6#1)(1991-7#1)(1991-8#4)(1992-1#2)(1992-11#4)(1992-12#1)(1992-3#3)(1992-4#5)(1992-5#2)(1992-6#2)(1992-7#4)(1992-9#2)(1993-1#3)(1993-10#1)(1993-11#4)(1993-12#1)(1993-2#1)(1993-3#3)(1993-5#2)(1993-6#3)(1993-8#3)(1994-1#1)(1994-11#6)(1994-12#3)(1994-2#6)(1994-3#4)(1994-4#2)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#4)(1995-1#3)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#5)(1995-4#4)(1995-5#1)(1995-6#3)(1995-7#3)(1995-8#7)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#4)(1996-4#1)(1996-5#1)(1996-8#2)(1997-2#5)(1997-3#4)(1997-4#4)(1997-5#3)(1997-6#5)(1997-7#5)(1997-8#5)(2004-9#1)(2005-1#2)(2005-10#2)(2005-11#21)(2005-12#1)(2005-7#3)(2005-8#1)(2006-10#14)(2006-11#1)(2006-12#3)(2006-2#6)(2006-4#7)(2006-5#3)(2006-6#6)(2006-7#3)(2006-8#4)(2006-9#4)(2007-1#1)(2007-10#8)(2007-11#7)(2007-12#15)(2007-2#3)(2007-3#2)(2007-4#5)(2007-5#1)(2007-7#11)(2007-8#7)(2007-9#5)(2008-1#8)(2008-10#93)(2008-11#13)(2008-12#4)(2008-2#35)(2008-3#31)(2008-4#16)(2008-5#18)(2008-6#6)(2008-7#20)(2008-8#16)(2008-9#7)(2009-10#8)(2009-11#1)(2009-12#5)(2009-2#1)(2009-3#3)(2009-4#3)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-10#2)(2010-11#4)(2010-12#3)(2010-2#4)(2010-3#3)(2010-4#6)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#6)(2010-9#1)(2011-1#10)(2011-12#2)(2011-2#7)(2012-1#5)(2012-12#15)(2012-2#14)(2012-3#4)(2013-1#17)(2013-7#7)(2013-8#8)
where their##10##2##(1991-8#1)(1995-2#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-11#1)(2012-12#1)
where there are no##4##4##(1992-10#1)(2007-2#1)(2008-10#1)(2012-2#1)
where there are##12##3##(1992-10#1)(1997-5#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-12#2)(2012-2#1)(2012-3#1)
where there is a high##2##5##(1995-8#1)(2008-6#1)
where there is a##11##4##(1995-8#1)(1995-9#1)(1997-3#1)(2005-11#1)(2006-2#1)(2007-2#1)(2008-6#1)(2008-8#1)(2010-2#1)(2012-11#1)(2013-1#1)
where there is an##3##4##(2005-7#1)(2007-8#1)(2008-4#1)
where there is no##7##4##(1993-5#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-6#1)
where there is##33##3##(1991-11#1)(1993-5#1)(1994-12#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-3#1)(2005-11#2)(2005-7#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-6#3)(2008-8#3)(2010-2#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#1)
where there was evidence of##2##5##(1993-12#1)(1994-3#1)
where there was##9##3##(1991-12#1)(1993-12#1)(1994-3#1)(2007-8#1)(2008-10#4)(2008-5#1)
where there were##4##3##(1990-12#1)(2008-10#1)(2008-12#1)(2010-2#1)
where there##63##2##(1990-12#1)(1991-11#1)(1991-12#1)(1992-10#1)(1993-12#1)(1993-5#1)(1994-12#1)(1994-3#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-5#1)(2005-11#2)(2005-7#1)(2006-2#1)(2006-8#1)(2007-12#2)(2007-2#2)(2007-8#3)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#3)(2008-8#3)(2008-9#1)(2010-2#2)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
where these##22##2##(1994-8#1)(1996-11#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
where they are introduced than##2##5##(2008-8#2)
where they are used##3##4##(2007-1#1)(2007-5#1)(2009-12#1)
where they are##33##3##(1991-8#2)(1994-10#1)(1995-1#1)(1995-6#1)(1996-1#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-4#4)(2008-5#2)(2008-8#3)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
where they can be##2##4##(2008-9#1)(2010-3#1)
where they can##9##3##(1995-2#1)(2004-12#1)(2006-12#1)(2008-10#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-3#1)(2013-8#1)
where they could hamper their proper use##2##7##(2013-1#2)
where they could##5##3##(1992-10#1)(2012-12#1)(2013-1#2)(2013-8#1)
where they form##3##3##(1995-8#1)(1997-1#1)(2009-3#1)
where they home to##2##4##(2006-10#1)(2008-11#1)
where they interact with##2##4##(2010-9#1)(2011-2#1)
where they may##7##3##(1991-5#1)(1994-1#1)(1994-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2012-12#1)
where they remain##2##3##(2008-1#1)(2008-5#1)
where they were##20##3##(1993-4#1)(1995-2#1)(1995-5#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-2#2)(2010-7#1)(2010-8#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#4)
where they##143##2##(1991-5#1)(1991-8#2)(1992-10#2)(1992-8#1)(1993-4#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-3#1)(1997-1#1)(2004-12#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-5#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-5#3)(2007-7#2)(2007-8#3)(2008-1#3)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#8)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#2)(2009-10#1)(2009-12#3)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#10)(2013-7#1)(2013-8#2)
where this drug##2##3##(2007-10#1)(2012-3#1)
where this is##4##3##(1995-3#1)(2007-4#1)(2011-2#2)
where this##33##2##(1991-12#1)(1991-6#1)(1992-11#1)(1993-5#1)(1994-9#1)(1995-12#1)(1995-3#1)(1997-5#1)(2004-11#1)(2005-8#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-10#4)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#3)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#2)
where three##5##2##(1995-10#1)(2008-10#1)(2008-5#1)(2009-2#1)(2013-7#1)
where time##2##2##(2008-11#1)(2008-9#1)
where to look##2##3##(1997-8#1)(2008-12#1)
where to obtain##2##3##(2008-4#1)(2012-12#1)
where to##12##2##(1992-3#1)(1992-9#1)(1996-12#1)(1997-8#1)(2004-12#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-2#1)(2010-12#1)(2012-12#1)(2013-7#1)
where total##2##2##(2004-4#1)(2006-1#1)
where traditional##3##2##(2006-4#1)(2006-6#1)(2008-11#1)
where transmission##4##2##(2006-4#1)(2008-8#1)(2010-12#1)(2011-2#1)
where treatment##4##2##(2007-11#1)(2008-4#1)(2013-1#2)
where tuberculosis is##2##3##(1993-7#1)(1997-8#1)
where tuberculosis##4##2##(1993-7#1)(1995-3#1)(1997-8#1)(2008-7#1)
where two##14##2##(1994-10#1)(1995-2#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#2)(2009-4#1)(2010-7#1)(2012-2#1)
where use##3##2##(1994-12#1)(1996-9#1)(2011-1#1)
where various##3##2##(2008-1#1)(2008-11#1)(2008-9#1)
where very##3##2##(1991-12#1)(2007-12#1)(2008-9#1)
where water is##2##3##(2005-11#1)(2006-10#1)
where water##3##2##(1992-9#1)(2005-11#1)(2006-10#1)
where we are going##3##4##(1994-12#1)(2009-5#1)(2013-1#1)
where we are##5##3##(1990-10#1)(1994-12#1)(2009-5#1)(2013-1#2)
where we can##3##3##(1991-12#1)(2008-2#1)(2009-10#1)
where we had previously##2##4##(1994-6#1)(1997-2#1)
where we have##4##3##(1994-12#1)(1995-4#1)(2008-6#1)(2011-1#1)
where we use a vector space model to represent patient utilization profiles##2##12##(2013-1#2)
where we used##2##3##(2007-11#1)(2013-8#1)
where we##33##2##(1990-10#1)(1991-12#1)(1993-6#1)(1994-12#2)(1994-6#2)(1995-4#2)(1997-2#1)(1997-6#1)(2005-11#1)(2006-4#1)(2007-11#2)(2007-8#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
where weather##2##2##(2008-10#2)
where women are##2##3##(1996-11#1)(2009-4#1)
where x is##3##3##(1992-9#1)(1997-2#1)(2008-2#1)
where x##5##2##(1992-9#1)(1996-2#1)(1997-2#1)(2008-2#1)(2008-5#1)
where you##3##2##(1996-1#2)(2008-7#1)
where z is the##2##4##(2007-12#1)(2008-3#1)
where z##3##2##(2005-11#1)(2007-12#1)(2008-3#1)
where##3450##1##(1990-1#1)(1990-10#2)(1990-11#13)(1990-12#11)(1990-2#16)(1990-3#4)(1990-4#9)(1990-5#14)(1990-6#9)(1990-7#5)(1990-8#8)(1990-9#6)(1991-1#7)(1991-10#4)(1991-11#7)(1991-12#17)(1991-2#15)(1991-3#3)(1991-4#4)(1991-5#14)(1991-6#11)(1991-7#6)(1991-8#11)(1991-9#5)(1992-1#6)(1992-10#5)(1992-11#9)(1992-12#8)(1992-2#4)(1992-3#9)(1992-4#9)(1992-5#6)(1992-6#15)(1992-7#6)(1992-8#8)(1992-9#14)(1993-1#4)(1993-10#3)(1993-11#10)(1993-12#12)(1993-2#5)(1993-3#17)(1993-4#3)(1993-5#6)(1993-6#6)(1993-7#4)(1993-8#11)(1993-9#7)(1994-1#4)(1994-10#7)(1994-11#18)(1994-12#19)(1994-2#22)(1994-3#18)(1994-4#5)(1994-5#7)(1994-6#12)(1994-8#25)(1994-9#16)(1995-1#8)(1995-10#5)(1995-11#11)(1995-12#8)(1995-2#25)(1995-3#17)(1995-4#9)(1995-5#9)(1995-6#9)(1995-7#5)(1995-8#13)(1995-9#4)(1996-1#16)(1996-10#6)(1996-11#8)(1996-12#11)(1996-2#17)(1996-3#13)(1996-4#8)(1996-5#9)(1996-6#4)(1996-7#5)(1996-8#9)(1996-9#6)(1997-1#7)(1997-2#30)(1997-3#14)(1997-4#16)(1997-5#13)(1997-6#17)(1997-7#16)(1997-8#24)(2004-11#7)(2004-12#4)(2004-4#6)(2004-9#5)(2005-1#4)(2005-10#9)(2005-11#54)(2005-12#5)(2005-4#1)(2005-5#1)(2005-7#9)(2005-8#16)(2005-9#3)(2006-1#2)(2006-10#59)(2006-11#8)(2006-12#20)(2006-2#16)(2006-3#2)(2006-4#24)(2006-5#7)(2006-6#15)(2006-7#8)(2006-8#19)(2006-9#7)(2007-1#10)(2007-10#19)(2007-11#44)(2007-12#56)(2007-2#15)(2007-3#17)(2007-4#13)(2007-5#21)(2007-6#4)(2007-7#26)(2007-8#42)(2007-9#17)(2008-1#39)(2008-10#376)(2008-11#71)(2008-12#34)(2008-2#97)(2008-3#97)(2008-4#65)(2008-5#93)(2008-6#31)(2008-7#82)(2008-8#88)(2008-9#41)(2009-10#20)(2009-11#12)(2009-12#19)(2009-2#8)(2009-3#14)(2009-4#17)(2009-5#12)(2009-6#17)(2009-7#7)(2009-8#11)(2009-9#15)(2010-1#6)(2010-10#9)(2010-11#14)(2010-12#27)(2010-2#21)(2010-3#11)(2010-4#23)(2010-5#13)(2010-6#12)(2010-7#16)(2010-8#21)(2010-9#4)(2011-1#44)(2011-12#15)(2011-2#73)(2011-9#3)(2012-1#21)(2012-11#12)(2012-12#57)(2012-2#64)(2012-3#34)(2012-5#1)(2013-1#109)(2013-7#22)(2013-8#43)
where?##2##1##(2006-8#1)(2007-5#1)
whereafter the##2##2##(1992-4#1)(2011-2#1)
whereafter##3##1##(1992-4#1)(2006-10#1)(2011-2#1)
whereas &quot##3##2##(2006-5#1)(2009-6#1)(2010-3#1)
whereas 'easier' ones are passed over to the automatic classifier whose models already incorporate and gradually improve with previous annotation experience##2##21##(2013-1#2)
whereas 1##3##2##(1997-4#1)(2007-11#1)(2011-12#1)
whereas 10##2##2##(2008-10#1)(2008-4#1)
whereas 11##3##2##(2006-8#1)(2008-11#1)(2010-3#1)
whereas 16##3##2##(1991-8#1)(2008-8#1)(2013-8#1)
whereas 17##2##2##(2006-10#1)(2007-12#1)
whereas 2##3##2##(1991-4#1)(1994-11#1)(2007-7#1)
whereas 24##2##2##(1991-10#1)(2007-7#1)
whereas 3##6##2##(1991-2#1)(1997-3#1)(1997-6#1)(2007-9#1)(2008-5#1)(2013-8#1)
whereas 3- and 4-year-old children##2##5##(2008-2#2)
whereas 30##2##2##(1991-2#1)(2007-9#1)
whereas 41##3##2##(1994-6#1)(2008-10#1)(2008-8#1)
whereas 45##2##2##(1992-9#1)(2013-8#1)
whereas 5##3##2##(1991-10#1)(1996-6#1)(2008-10#1)
whereas 60%##2##2##(2008-4#1)(2008-9#1)
whereas 9##2##2##(1992-9#1)(2007-10#1)
whereas BMI-1##2##2##(2008-7#2)
whereas C##2##2##(2007-7#1)(2008-10#1)
whereas CTP##2##2##(1990-11#1)(1990-9#1)
whereas Cr(VI)##2##2##(2008-10#2)
whereas D2##2##2##(1990-5#1)(1993-9#1)
whereas G##2##2##(2008-4#1)(2009-4#1)
whereas GMGN showed global##2##4##(2007-8#2)
whereas HDL-cholesterol##2##2##(1996-9#1)(2012-2#1)
whereas HVA transients##2##3##(1997-7#2)
whereas M##4##2##(2008-10#1)(2008-4#1)(2010-2#1)(2011-12#1)
whereas MHC Class II expression##2##5##(2008-10#2)
whereas MICs##2##2##(2008-5#1)(2008-7#1)
whereas N##2##2##(1990-2#1)(2006-12#1)
whereas P##5##2##(2008-10#4)(2008-5#1)
whereas PKC beta##2##3##(1992-11#1)(1994-2#1)
whereas PKC##3##2##(1992-11#1)(1994-2#1)(1995-5#1)
whereas Rufous-breasted Hermit##2##3##(2008-9#2)
whereas S##3##2##(2008-10#2)(2011-2#1)
whereas SF##2##2##(2012-1#2)
whereas U87MG glioma lacked αvβ8 expression##2##6##(2012-12#2)
whereas WSS generated from the computational model ranged from 0##2##10##(2011-2#2)
whereas [Ca2+]i##2##2##(1990-12#1)(1994-12#1)
whereas a decrease in##2##4##(1994-3#1)(2012-3#1)
whereas a higher##2##3##(2007-8#1)(2009-5#1)
whereas a large##2##3##(1992-1#1)(1995-1#1)
whereas a phase##2##3##(1997-6#1)(2008-3#1)
whereas a receptor of the##2##5##(1997-5#2)
whereas a second##2##3##(1997-3#1)(2008-8#1)
whereas a shorter##2##3##(1991-8#1)(2007-12#1)
whereas a significant association##2##4##(1990-8#1)(1992-2#1)
whereas a significant##4##3##(1990-8#1)(1992-2#1)(1995-8#1)(1997-2#1)
whereas a strong##2##3##(1992-9#1)(1995-2#1)
whereas a##79##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#2)(1995-8#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(2004-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-4#1)(2009-5#1)(2010-2#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
whereas abnormal##2##2##(1997-8#1)(2013-8#1)
whereas actually##2##2##(1997-6#1)(2007-12#1)
whereas addition of##4##3##(1992-11#1)(1993-3#1)(2008-10#1)(2008-4#1)
whereas after##6##2##(1996-10#1)(1996-6#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-9#1)
whereas all other##2##3##(2008-10#1)(2008-3#1)
whereas all the##5##3##(1992-2#1)(1996-11#1)(1996-4#1)(2006-8#1)(2008-10#1)
whereas all##15##2##(1991-6#1)(1992-2#1)(1996-11#1)(1996-4#1)(1997-6#1)(2006-8#1)(2007-10#1)(2008-10#6)(2008-3#1)(2012-3#1)
whereas alpha##5##2##(1990-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(2005-11#1)
whereas among##4##2##(1991-9#1)(2006-10#1)(2008-3#1)(2010-12#1)
whereas an increase##2##3##(1990-12#1)(2008-10#1)
whereas an##23##2##(1990-12#1)(1990-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1994-12#1)(1995-3#1)(1996-11#1)(1997-4#1)(2005-11#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#3)(2013-8#1)
whereas another##6##2##(1992-12#1)(2008-4#1)(2008-6#1)(2010-8#1)(2010-9#1)(2012-12#1)
whereas apo A-II/DMPC complexes##2##4##(1990-12#2)
whereas apo##3##2##(1990-12#2)(1996-9#1)
whereas application of##2##3##(1994-3#1)(2008-10#1)
whereas at higher##2##3##(1995-10#1)(2010-12#1)
whereas at the##2##3##(1993-12#1)(1995-10#1)
whereas at##23##2##(1990-12#1)(1990-3#1)(1990-9#1)(1992-6#1)(1993-12#1)(1993-3#2)(1993-9#1)(1995-10#2)(1995-3#1)(1997-7#1)(2004-9#1)(2006-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#2)
whereas average##2##2##(1993-11#1)(2012-12#1)
whereas baclofen##2##2##(1990-2#1)(2006-12#1)
whereas beta##2##2##(1991-9#1)(1993-12#1)
whereas binding of##2##3##(1996-7#1)(1997-4#1)
whereas binding to##2##3##(1991-9#1)(1994-8#1)
whereas binding##4##2##(1991-9#1)(1994-8#1)(1996-7#1)(1997-4#1)
whereas both##10##2##(1992-2#1)(1994-9#1)(1996-2#1)(2005-11#1)(2008-10#3)(2008-5#1)(2008-7#1)(2012-1#1)
whereas bovine##2##2##(1991-3#1)(2008-7#1)
whereas brain##3##2##(1994-8#1)(1995-5#1)(2011-12#1)
whereas cells##2##2##(1994-8#1)(2012-2#1)
whereas changes in##4##3##(1991-1#1)(1996-7#1)(2006-10#1)(2006-8#1)
whereas chasmogamous cultivars##2##3##(2008-10#2)
whereas children##2##2##(2006-11#1)(2007-8#1)
whereas chronic infection##2##3##(2006-10#2)
whereas classical##2##2##(1993-6#1)(1994-6#1)
whereas clinical##2##2##(2006-10#1)(2010-12#1)
whereas complex pathotypes##2##3##(2008-10#2)
whereas complex##3##2##(1995-3#1)(2008-10#2)
whereas compound##2##2##(1990-7#1)(2012-2#1)
whereas considerable##2##2##(1990-9#1)(2007-7#1)
whereas control##5##2##(1993-4#1)(1995-6#1)(1996-1#1)(2007-12#1)(2009-5#1)
whereas conventional##2##2##(1995-6#1)(2008-10#1)
whereas deletion##2##2##(1991-8#1)(1995-1#1)
whereas dry##2##2##(2008-5#1)(2013-1#1)
whereas ethanol##3##2##(1995-3#1)(1997-8#1)(2006-8#1)
whereas evidence##2##2##(2004-3#1)(2008-3#1)
whereas expression of##3##3##(1993-9#1)(1995-8#1)(2006-8#1)
whereas expression##4##2##(1993-9#1)(1995-8#1)(2006-8#1)(2007-3#1)
whereas extracts from##2##3##(1991-11#1)(1996-8#1)
whereas extracts##3##2##(1990-7#1)(1991-11#1)(1996-8#1)
whereas female##6##2##(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
whereas five##4##2##(1992-11#1)(2008-10#3)
whereas for a##2##3##(2008-3#1)(2013-1#1)
whereas for the##8##3##(2005-11#1)(2006-7#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-9#1)
whereas for##37##2##(1991-12#1)(1991-7#1)(1991-8#1)(1992-4#1)(1994-10#1)(1994-12#1)(1995-5#1)(1997-8#1)(2004-9#2)(2005-11#1)(2005-12#1)(2006-10#1)(2006-7#1)(2007-12#2)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-6#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
whereas four##2##2##(2008-5#1)(2008-9#1)
whereas genes##3##2##(2008-10#2)(2012-3#1)
whereas glucose and##2##3##(1994-3#1)(2006-10#1)
whereas glucose##4##2##(1990-8#2)(1994-3#1)(2006-10#1)
whereas glutathione##2##2##(1990-4#1)(1992-11#1)
whereas glycogen##2##2##(2007-12#1)(2013-1#1)
whereas gram-negative organisms decolorize following such treatment and appear pink##2##10##(2008-4#1)(2008-9#1)
whereas group II##2##3##(2008-10#2)
whereas group##3##2##(2008-10#2)(2008-5#1)
whereas hexokinase##2##2##(1990-11#1)(1994-12#1)
whereas high##6##2##(1990-7#1)(2008-10#3)(2008-6#1)(2012-12#1)
whereas high-dose##2##2##(1992-10#1)(2006-10#1)
whereas higher concentrations##2##3##(1990-10#1)(2009-6#1)
whereas higher##5##2##(1990-10#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-1#1)
whereas hippocampal##2##2##(1991-10#1)(2011-2#1)
whereas human##5##2##(1992-2#1)(1992-5#1)(1995-3#1)(1997-7#2)
whereas if the##2##3##(1995-8#1)(2008-3#1)
whereas immunoreactivity for glycine##2##4##(1995-11#2)
whereas immunoreactivity##3##2##(1991-3#1)(1995-11#2)
whereas in BT##2##3##(2007-7#2)
whereas in Lb##2##3##(1997-2#2)
whereas in a lossless system the##2##6##(2007-11#1)(2007-12#1)
whereas in any given situation a patient may have more than one condition##2##13##(2013-1#2)
whereas in contrast##2##3##(1996-5#2)
whereas in females it##2##4##(1993-9#1)(2008-3#1)
whereas in females##5##3##(1991-1#1)(1993-9#1)(2008-3#1)(2008-7#1)(2011-2#1)
whereas in males##2##3##(2008-5#1)(2011-2#1)
whereas in other##3##3##(1997-2#1)(1997-8#1)(2011-2#1)
whereas in others the##2##4##(1991-3#1)(2007-9#1)
whereas in others##4##3##(1991-3#1)(2007-9#1)(2008-10#1)(2009-12#1)
whereas in patients with##3##4##(2006-6#1)(2007-8#1)(2008-7#1)
whereas in patients##4##3##(2006-6#1)(2006-8#1)(2007-8#1)(2008-7#1)
whereas in the absence of##2##5##(1995-8#2)
whereas in the other##2##4##(1996-8#1)(2006-12#1)
whereas in the presence of##4##5##(1990-8#1)(1993-11#1)(1994-3#1)(2004-12#1)
whereas in the second##2##4##(2008-10#1)(2010-7#1)
whereas in the##54##3##(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#2)(1991-10#2)(1991-2#1)(1991-4#1)(1991-5#1)(1992-10#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-8#2)(1996-5#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-4#1)(1997-8#1)(2004-12#1)(2005-12#1)(2006-10#1)(2006-12#2)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-5#2)(2008-6#1)(2009-8#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
whereas in three other##2##4##(1995-12#1)(2008-7#1)
whereas in##171##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#3)(1992-12#1)(1992-2#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#3)(1993-5#1)(1993-8#1)(1993-9#2)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#2)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#3)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#4)(1997-4#1)(1997-7#1)(1997-8#2)(2004-12#1)(2005-12#1)(2005-5#1)(2005-8#2)(2006-10#2)(2006-12#2)(2006-2#1)(2006-6#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-6#1)(2007-7#5)(2007-8#4)(2007-9#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-4#3)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#5)(2013-8#1)
whereas increase##2##2##(2008-10#1)(2012-12#1)
whereas increased##2##2##(1995-11#1)(1996-12#1)
whereas inhibition##3##2##(1994-11#1)(1995-7#1)(2012-2#1)
whereas insulin and phorbol esters##2##5##(1995-6#1)(1996-2#1)
whereas insulin##3##2##(1995-10#1)(1995-6#1)(1996-2#1)
whereas isolates from##3##3##(2008-10#3)
whereas isolates in##2##3##(2008-10#2)
whereas isolates of##4##3##(2006-8#1)(2008-10#3)
whereas isolates##10##2##(2006-8#1)(2008-10#9)
whereas it did not##4##4##(1994-6#1)(1997-2#1)(2008-11#1)(2008-4#1)
whereas it did##5##3##(1994-10#1)(1994-6#1)(1997-2#1)(2008-11#1)(2008-4#1)
whereas it enhanced the##2##4##(1990-2#1)(1995-3#1)
whereas it had no effect on##2##6##(1996-9#1)(2008-4#1)
whereas it had no effect##3##5##(1993-12#1)(1996-9#1)(2008-4#1)
whereas it had##5##3##(1993-12#1)(1996-2#1)(1996-9#1)(2008-4#1)(2010-4#1)
whereas it increased##4##3##(1992-8#1)(1994-2#1)(1994-8#1)(1996-9#1)
whereas it inhibited##2##3##(1994-11#1)(2008-11#1)
whereas it is a##3##4##(2008-10#1)(2011-2#1)(2012-11#1)
whereas it is##12##3##(1990-6#1)(1992-12#1)(1995-6#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-7#1)(2011-2#2)(2012-11#1)
whereas it only##2##3##(1994-9#1)(1997-7#1)
whereas it remains##2##3##(2008-3#1)(2012-3#1)
whereas it showed no##2##4##(1997-7#1)(2009-4#1)
whereas it was much##2##4##(1992-6#1)(1997-6#1)
whereas it was not##2##4##(1993-6#1)(2013-8#1)
whereas it was##24##3##(1990-5#1)(1990-8#1)(1991-9#1)(1992-6#1)(1993-11#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1996-5#1)(1997-6#1)(2006-8#2)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2012-2#1)(2013-8#2)
whereas it##79##2##(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-2#2)(1991-9#1)(1992-12#1)(1992-6#2)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-9#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(2006-8#2)(2007-11#2)(2007-8#1)(2008-10#8)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-11#1)(2010-4#1)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#2)
whereas its##25##2##(1990-12#1)(1990-4#1)(1990-7#1)(1992-6#1)(1992-7#1)(1993-9#1)(1994-3#1)(1995-11#1)(1995-3#1)(1997-2#1)(2005-11#2)(2006-10#1)(2006-7#1)(2007-10#1)(2007-12#1)(2008-3#1)(2008-4#3)(2008-6#1)(2009-11#1)(2010-8#1)(2012-12#1)(2013-1#1)
whereas laminin##2##2##(1991-3#1)(1995-3#1)
whereas large##3##2##(1990-8#1)(1997-6#1)(2011-1#1)
whereas larger##2##2##(1991-9#1)(2005-11#1)
whereas later##2##2##(2006-8#1)(2007-3#1)
whereas leaf##2##2##(1991-11#1)(2008-10#1)
whereas leaves##2##2##(2007-1#1)(2008-10#1)
whereas less##5##2##(2006-6#1)(2008-10#1)(2008-4#1)(2009-5#1)(2010-11#1)
whereas levels of##2##3##(1995-9#1)(1996-11#1)
whereas levels##4##2##(1995-9#1)(1996-11#1)(2006-10#1)(2013-1#1)
whereas little##2##2##(1997-6#1)(2008-10#1)
whereas low##4##2##(2006-7#1)(2008-10#1)(2008-12#1)(2011-12#1)
whereas lower##4##2##(2008-11#1)(2009-10#1)(2012-2#1)(2012-3#1)
whereas maximum##2##2##(1993-12#1)(2012-2#1)
whereas men##4##2##(2006-5#1)(2010-12#1)(2010-6#1)(2013-8#1)
whereas mice##2##2##(1990-8#1)(2008-4#1)
whereas mild##2##2##(1994-9#2)
whereas more than##2##3##(2007-8#1)(2008-6#1)
whereas more##7##2##(1993-4#1)(2007-8#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)
whereas mortality in##2##3##(1990-9#1)(2010-12#1)
whereas most of the##6##4##(1990-11#1)(1990-5#1)(2006-5#1)(2008-10#1)(2008-5#2)
whereas most##14##2##(1990-11#1)(1990-5#1)(1991-3#1)(1993-9#1)(1995-7#1)(2006-5#2)(2007-12#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-5#2)
whereas mouse##2##2##(1990-7#1)(2006-9#1)
whereas mutants##2##2##(1994-9#1)(1995-1#1)
whereas mutation of##2##3##(1992-9#1)(1995-10#1)
whereas mutations in##2##3##(2011-1#1)(2013-8#1)
whereas neither##4##2##(1990-10#1)(1994-6#1)(1995-10#1)(1997-7#1)
whereas nifedipine##2##2##(1994-3#2)
whereas no activity was##2##4##(1994-5#1)(2008-10#1)
whereas no age##2##3##(1991-12#1)(2008-7#1)
whereas no difference was seen in##2##6##(1991-6#1)(2006-9#1)
whereas no effect##2##3##(1992-9#1)(2010-2#1)
whereas no significant##5##3##(1991-6#1)(1995-3#1)(2008-5#2)(2008-7#1)
whereas no such##5##3##(1992-6#1)(1995-3#1)(1997-4#1)(2008-9#1)(2013-8#1)
whereas no transmission##2##3##(2008-10#2)
whereas no##46##2##(1990-2#2)(1991-12#1)(1991-2#2)(1991-6#2)(1992-11#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-3#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-4#2)(2006-9#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#3)(2008-9#1)(2010-11#1)(2010-2#1)(2011-2#2)(2013-8#1)
whereas none of the##3##4##(1995-12#1)(1995-2#1)(2008-10#1)
whereas none of them could##2##5##(2012-11#1)(2013-1#1)
whereas none of##5##3##(1995-12#1)(1995-2#1)(2008-10#1)(2012-11#1)(2013-1#1)
whereas none##9##2##(1994-12#1)(1995-12#1)(1995-2#1)(2008-10#1)(2012-11#1)(2012-2#2)(2013-1#2)
whereas nuclei##2##2##(2008-11#1)(2008-2#1)
whereas of the##2##3##(1995-6#2)
whereas on##4##2##(1997-8#1)(2004-9#1)(2007-11#1)(2008-10#1)
whereas one##4##2##(1994-9#1)(2008-5#1)(2008-7#1)(2011-2#1)
whereas only 4##2##3##(1992-3#1)(2012-2#1)
whereas only a few##3##4##(1996-5#1)(1997-1#1)(2008-12#1)
whereas only a##11##3##(1990-11#1)(1994-2#1)(1994-9#1)(1995-1#1)(1996-5#1)(1997-1#1)(2008-10#2)(2008-12#1)(2010-4#1)(2010-6#1)
whereas only##38##2##(1990-11#1)(1990-8#1)(1992-12#1)(1992-3#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-5#2)(1997-1#1)(2006-4#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-3#2)(2008-7#1)(2009-3#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
whereas other authors##2##3##(1994-3#1)(2009-3#1)
whereas other types of##2##4##(1990-2#1)(2007-8#1)
whereas other##29##2##(1990-2#1)(1990-7#1)(1990-8#1)(1991-2#1)(1993-11#1)(1993-7#1)(1994-3#1)(1994-6#1)(1995-8#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-7#1)(2006-10#1)(2006-12#3)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2012-1#1)(2012-3#1)
whereas others are##5##3##(2006-10#2)(2008-10#1)(2008-5#1)(2008-6#1)
whereas others do##2##3##(2006-10#1)(2008-9#1)
whereas others had##3##3##(1995-2#1)(2008-10#1)(2009-3#1)
whereas others have shown##2##4##(2006-10#2)
whereas others have##8##3##(2006-10#3)(2007-11#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-1#1)
whereas others may##2##3##(2008-10#1)(2008-7#1)
whereas others were##5##3##(1991-4#1)(1992-6#1)(2006-10#1)(2008-3#1)(2008-5#1)
whereas others##47##2##(1991-4#1)(1992-6#1)(1993-11#1)(1994-8#1)(1995-2#1)(1995-8#1)(2006-10#8)(2006-3#1)(2006-4#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
whereas overexpression of##2##3##(1990-6#1)(1997-4#1)
whereas pain##2##2##(2007-2#1)(2008-7#1)
whereas participants##2##2##(2010-12#1)(2010-4#1)
whereas patients##3##2##(1990-8#1)(2005-7#1)(2008-5#1)
whereas people##2##2##(2008-11#1)(2013-8#1)
whereas perceived##2##2##(2006-10#1)(2013-1#1)
whereas performance on##2##3##(2007-8#1)(2008-1#1)
whereas plasma##9##2##(1991-2#1)(1995-11#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#3)
whereas platelet##2##2##(1994-10#1)(2011-2#1)
whereas populations##2##2##(2008-10#2)
whereas posterior##2##2##(2006-7#1)(2008-6#1)
whereas pretreatment##2##2##(1990-12#1)(2011-2#1)
whereas previous##2##2##(1992-9#1)(2008-2#1)
whereas protein##2##2##(1991-6#1)(2008-9#1)
whereas psychological##2##2##(1993-7#1)(2008-12#1)
whereas ratio##2##2##(1996-2#1)(2012-2#1)
whereas rats##2##2##(1994-10#1)(1994-6#1)
whereas removal of##2##3##(1995-11#1)(1995-6#1)
whereas repeated##2##2##(2012-1#1)(2012-2#1)
whereas responses to##2##3##(1994-5#1)(1996-12#1)
whereas secondary##3##2##(1992-9#1)(1997-7#1)(2006-12#1)
whereas sensitivity##2##2##(2008-10#2)
whereas sequences##2##2##(1991-7#1)(1996-10#1)
whereas serum##7##2##(1990-10#1)(1992-6#1)(1997-6#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-4#1)
whereas significant##6##2##(2004-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-2#1)
whereas similar##2##2##(1993-5#1)(2006-12#1)
whereas single##2##2##(2007-10#1)(2007-8#1)
whereas six##3##2##(1993-7#1)(2006-11#1)(2007-1#1)
whereas some##6##2##(2007-6#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-2#1)
whereas specific##2##2##(1996-2#1)(2005-8#1)
whereas spontaneous##2##2##(2007-11#1)(2007-8#1)
whereas staurosporine##2##2##(1990-8#1)(1993-9#1)
whereas strain##2##2##(2008-10#1)(2008-6#1)
whereas strains##2##2##(2008-5#1)(2012-12#1)
whereas stroke##2##2##(1990-3#1)(2007-7#1)
whereas substitution of##3##3##(1995-1#1)(1995-4#1)(1996-5#1)
whereas substitution##4##2##(1995-1#1)(1995-4#1)(1996-5#1)(1997-2#1)
whereas such##2##2##(2006-10#1)(2007-3#1)
whereas surgery##2##2##(1991-4#1)(1992-12#1)
whereas that for##4##3##(1991-12#1)(1992-8#1)(1994-12#1)(1994-9#1)
whereas that of##23##3##(1990-3#1)(1990-6#1)(1990-8#2)(1992-8#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-11#1)(1996-4#1)(1997-2#2)(1997-4#1)(1997-8#1)(2005-11#1)(2008-10#3)(2008-2#1)(2008-8#1)
whereas that##34##2##(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-12#1)(1992-8#2)(1993-7#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-11#1)(1996-4#1)(1997-2#3)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#1)(2008-10#4)(2008-2#2)(2008-8#1)(2012-2#1)
whereas the &quot##3##3##(1991-10#1)(1994-9#1)(2007-12#1)
whereas the 0##2##3##(2007-8#1)(2013-1#1)
whereas the A##2##3##(1993-11#1)(2011-2#1)
whereas the C-terminal domain##2##4##(1997-6#1)(2008-4#1)
whereas the C-terminal##3##3##(1995-1#1)(1997-6#1)(2008-4#1)
whereas the PKC##2##3##(1994-12#1)(2011-12#1)
whereas the PM of##2##4##(2008-7#2)
whereas the R##2##3##(1996-2#1)(2008-10#1)
whereas the Rippey and##2##4##(2008-3#2)
whereas the abundance of##2##4##(2008-10#1)(2013-1#1)
whereas the activity of the##2##5##(1990-7#1)(2009-8#1)
whereas the activity of##7##4##(1990-11#1)(1990-7#1)(1995-7#1)(1995-9#1)(2007-8#1)(2009-3#1)(2009-8#1)
whereas the activity##8##3##(1990-11#1)(1990-7#1)(1994-6#1)(1995-7#1)(1995-9#1)(2007-8#1)(2009-3#1)(2009-8#1)
whereas the addition of##5##4##(1992-5#1)(1992-8#1)(1997-4#1)(1997-8#1)(2006-10#1)
whereas the alpha##2##3##(1991-5#1)(1995-5#1)
whereas the amino-terminal##2##3##(1991-10#1)(1991-9#1)
whereas the amount of##2##4##(1991-10#1)(2006-6#1)
whereas the amounts of##2##4##(1992-9#1)(2007-6#1)
whereas the amplitude##3##3##(2008-3#2)(2008-6#1)
whereas the average##4##3##(2007-1#1)(2007-7#1)(2008-3#1)(2010-6#1)
whereas the basal##2##3##(1995-12#1)(2008-7#1)
whereas the best##2##3##(2008-10#1)(2008-5#1)
whereas the beta##2##3##(1990-11#1)(1995-8#1)
whereas the binding of##2##4##(1993-9#1)(1996-2#1)
whereas the bovine and##2##4##(1992-6#1)(1992-7#1)
whereas the choroid has been much less investigated##2##8##(2012-12#2)
whereas the combination##2##3##(2008-10#1)(2008-6#1)
whereas the concentration of##2##4##(2007-12#1)(2008-10#1)
whereas the control group##2##4##(2008-12#1)(2013-1#1)
whereas the control##3##3##(2006-5#1)(2008-12#1)(2013-1#1)
whereas the corresponding##6##3##(1990-9#1)(1992-12#1)(1997-2#1)(2004-1#1)(2008-10#1)(2008-3#1)
whereas the decrease##2##3##(1992-4#1)(1994-3#1)
whereas the deduced##2##3##(1996-7#1)(2008-9#1)
whereas the disease##2##3##(1997-6#1)(2007-11#1)
whereas the distal##2##3##(1997-4#1)(2008-5#1)
whereas the distribution of##2##4##(1993-8#1)(2009-12#1)
whereas the effect of##6##4##(1990-11#1)(1993-12#1)(1996-5#1)(2008-10#1)(2008-8#1)(2013-1#1)
whereas the effects of##3##4##(2008-3#1)(2009-11#1)(2009-9#1)
whereas the elongation##2##3##(1991-1#1)(2008-2#1)
whereas the enzyme##2##3##(1990-5#1)(1992-6#1)
whereas the experimental##2##3##(2008-9#1)(2012-2#1)
whereas the exponential##2##3##(2008-10#2)
whereas the former##3##3##(1995-5#1)(2005-12#1)(2007-11#1)
whereas the highest##4##3##(1997-1#1)(2007-8#1)(2008-5#1)(2008-7#1)
whereas the hybrid##2##3##(1994-11#2)
whereas the identification of##2##4##(1994-3#1)(2010-4#1)
whereas the incidence of##2##4##(2006-10#1)(2008-6#1)
whereas the increase in##2##4##(1993-12#1)(2013-1#1)
whereas the increase##3##3##(1993-12#1)(2008-5#1)(2013-1#1)
whereas the instantaneous mean is##2##5##(2009-9#1)(2010-5#1)
whereas the intensity model##2##4##(2008-3#2)
whereas the isolated##2##3##(1992-6#1)(1994-3#1)
whereas the late phase##2##4##(1993-6#1)(1994-12#1)
whereas the late##3##3##(1993-6#1)(1994-12#1)(2012-2#1)
whereas the latter is##3##4##(1990-8#1)(2008-10#1)(2008-5#1)
whereas the latter##9##3##(1990-4#1)(1990-8#1)(1997-3#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-5#3)
whereas the level of tryptophan##2##5##(2009-8#2)
whereas the level of##5##4##(1994-9#1)(1995-7#1)(2007-12#1)(2009-8#2)
whereas the levels##2##3##(1992-11#1)(1994-6#1)
whereas the ligand##3##3##(1995-5#1)(2008-3#1)(2010-5#1)
whereas the limit##2##3##(2008-10#1)(2013-1#1)
whereas the mRNA levels##2##4##(1992-11#1)(1997-5#1)
whereas the magnitude of##2##4##(2007-1#1)(2008-10#1)
whereas the maximum##2##3##(1990-7#1)(2006-12#1)
whereas the mean##3##3##(1992-8#1)(2010-10#1)(2011-1#1)
whereas the mixed##2##3##(1990-2#1)(2012-3#1)
whereas the most##2##3##(2007-1#1)(2008-10#1)
whereas the number of##3##4##(1990-7#1)(2006-12#1)(2008-8#1)
whereas the opposite was true for##2##6##(2010-8#1)(2012-2#1)
whereas the opposite##7##3##(1991-10#1)(2008-11#1)(2008-2#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#1)
whereas the other group##2##4##(2008-10#1)(2012-11#1)
whereas the other is##2##4##(2008-5#1)(2009-3#1)
whereas the other three##2##4##(1994-12#1)(2008-6#1)
whereas the other two##4##4##(1990-11#1)(2008-10#2)(2008-2#1)
whereas the other was##3##4##(1996-11#1)(2006-7#1)(2008-10#1)
whereas the other##36##3##(1990-11#1)(1990-2#1)(1990-4#1)(1991-3#1)(1991-9#1)(1992-6#1)(1993-10#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-11#1)(1997-4#1)(2006-7#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-2#1)(2012-11#2)(2013-8#1)
whereas the others##3##3##(1994-12#1)(2008-10#1)(2010-7#1)
whereas the pair##2##3##(2008-10#1)(2008-12#1)
whereas the patients##2##3##(1990-2#1)(1993-8#1)
whereas the performance of the##2##5##(1993-3#1)(2010-7#1)
whereas the phase##2##3##(2007-12#1)(2008-3#1)
whereas the phosphatase##2##3##(1994-9#1)(2008-10#1)
whereas the plasma##2##3##(1991-3#1)(2007-8#1)
whereas the presence of##2##4##(1991-12#1)(2011-2#1)
whereas the production of##3##4##(1990-10#1)(1991-9#1)(1995-1#1)
whereas the proportion of##2##4##(1991-12#1)(2012-2#1)
whereas the proportion##3##3##(1990-4#1)(1991-12#1)(2012-2#1)
whereas the protein##2##3##(2008-12#1)(2008-6#1)
whereas the relative##2##3##(1993-2#1)(1994-12#1)
whereas the release of##2##4##(1990-12#1)(1997-6#1)
whereas the remaining species##2##4##(2008-10#1)(2013-8#1)
whereas the remaining##7##3##(1993-1#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2013-8#1)
whereas the response##2##3##(1996-8#1)(2009-9#1)
whereas the responses to##2##4##(1990-12#1)(1991-12#1)
whereas the reverse trend was##2##5##(2009-4#2)
whereas the reverse##4##3##(1991-9#1)(1996-6#1)(2009-4#2)
whereas the role of##3##4##(1992-8#1)(1994-8#1)(2012-11#1)
whereas the same##7##3##(1990-11#1)(1991-9#1)(1994-8#1)(1995-12#1)(1995-2#1)(2007-12#1)(2010-10#1)
whereas the second and##2##4##(1990-3#1)(2008-5#1)
whereas the second one##2##4##(2008-10#1)(2008-5#1)
whereas the second##14##3##(1990-3#1)(1991-9#1)(1992-5#1)(2008-10#5)(2008-5#3)(2008-8#1)(2012-3#1)(2013-7#1)
whereas the smaller##4##3##(1990-11#1)(1991-10#1)(1994-2#1)(2010-11#1)
whereas the stability##2##3##(1995-8#1)(2008-5#1)
whereas the temperature##2##3##(2005-11#1)(2008-3#1)
whereas the third##6##3##(1997-7#1)(2007-11#1)(2008-10#1)(2009-4#1)(2009-7#1)(2011-12#1)
whereas the three##2##3##(1990-8#1)(2008-1#1)
whereas the time course of##2##5##(1991-5#1)(1993-9#1)
whereas the transport##2##3##(1990-11#1)(1994-12#1)
whereas the two##5##3##(1990-1#1)(1991-2#1)(1992-11#1)(1996-4#1)(2008-5#1)
whereas the type##2##3##(1990-6#1)(2007-12#1)
whereas the unique##2##3##(1996-7#1)(2012-5#1)
whereas the virus##2##3##(2008-10#2)
whereas the visual##2##3##(2009-6#1)(2011-2#1)
whereas the##820##2##(1990-1#1)(1990-10#3)(1990-11#12)(1990-12#3)(1990-2#6)(1990-3#2)(1990-4#4)(1990-5#4)(1990-6#3)(1990-7#5)(1990-8#5)(1990-9#2)(1991-1#2)(1991-10#7)(1991-12#10)(1991-2#6)(1991-3#2)(1991-4#2)(1991-5#5)(1991-7#1)(1991-8#1)(1991-9#7)(1992-1#3)(1992-10#1)(1992-11#7)(1992-12#4)(1992-3#3)(1992-4#1)(1992-5#3)(1992-6#5)(1992-7#4)(1992-8#5)(1992-9#6)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#5)(1993-4#2)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#3)(1994-10#2)(1994-11#6)(1994-12#10)(1994-2#5)(1994-3#7)(1994-5#5)(1994-6#5)(1994-8#5)(1994-9#8)(1995-1#5)(1995-11#4)(1995-12#7)(1995-2#8)(1995-3#4)(1995-5#7)(1995-6#2)(1995-7#3)(1995-8#5)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#2)(1996-2#12)(1996-3#3)(1996-4#2)(1996-5#7)(1996-6#3)(1996-7#4)(1996-8#5)(1996-9#3)(1997-1#3)(1997-2#4)(1997-3#2)(1997-4#7)(1997-5#3)(1997-6#4)(1997-7#9)(1997-8#5)(2004-1#1)(2004-4#1)(2004-9#1)(2005-11#8)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#2)(2006-10#8)(2006-12#6)(2006-2#2)(2006-3#2)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#2)(2006-9#2)(2007-1#5)(2007-10#1)(2007-11#11)(2007-12#20)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#4)(2007-8#11)(2007-9#2)(2008-1#4)(2008-10#87)(2008-11#10)(2008-12#7)(2008-2#19)(2008-3#37)(2008-4#9)(2008-5#23)(2008-6#7)(2008-7#10)(2008-8#10)(2008-9#8)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#5)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#5)(2009-9#5)(2010-10#3)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#8)(2010-6#1)(2010-7#3)(2010-8#4)(2011-1#2)(2011-12#5)(2011-2#17)(2012-1#3)(2012-11#4)(2012-12#6)(2012-2#9)(2012-3#9)(2012-5#1)(2013-1#12)(2013-7#6)(2013-8#14)
whereas their##6##2##(1991-5#1)(1996-12#1)(2007-11#1)(2008-9#1)(2009-7#1)(2010-7#1)
whereas there is##2##3##(1994-3#1)(2005-11#1)
whereas there was a##2##4##(1996-12#1)(2006-3#1)
whereas there was no difference##2##5##(1992-12#1)(2011-2#1)
whereas there was no significant difference between##2##7##(1991-8#1)(1992-12#1)
whereas there was no significant##3##5##(1991-8#1)(1992-12#1)(2011-1#1)
whereas there was no statistical difference##2##6##(1991-5#1)(1996-6#1)
whereas there was no##8##4##(1991-5#1)(1991-8#1)(1992-12#2)(1996-6#1)(2007-10#1)(2011-1#1)(2011-2#1)
whereas there was##13##3##(1991-5#1)(1991-8#1)(1992-12#2)(1994-10#1)(1996-12#1)(1996-6#1)(2006-3#1)(2007-10#1)(2008-10#2)(2011-1#1)(2011-2#1)
whereas there were##4##3##(1994-9#1)(1995-5#1)(2006-9#1)(2012-12#1)
whereas there##22##2##(1991-5#1)(1991-8#1)(1992-12#2)(1994-10#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-6#1)(2005-11#1)(2006-3#1)(2006-9#1)(2007-10#1)(2008-10#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
whereas these##2##2##(1996-9#1)(2008-12#1)
whereas they are##5##3##(1997-1#1)(2003-11#1)(2008-10#1)(2008-2#1)(2008-4#1)
whereas they showed##2##3##(1990-11#1)(1995-8#1)
whereas they were##6##3##(1990-10#1)(1990-3#1)(1991-4#1)(1992-3#1)(1995-3#1)(1996-11#1)
whereas they##26##2##(1990-10#1)(1990-11#1)(1990-3#1)(1991-4#1)(1991-6#1)(1992-3#1)(1992-8#1)(1993-11#1)(1994-11#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-11#1)(1997-1#1)(1997-7#1)(2003-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2010-3#1)(2011-1#1)(2012-2#1)
whereas this effect##2##3##(1992-9#1)(1995-5#1)
whereas this same##2##3##(1995-2#1)(2008-5#1)
whereas this was##3##3##(1993-12#1)(2013-1#1)(2013-7#1)
whereas this##21##2##(1990-3#1)(1992-9#1)(1993-12#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-9#1)(1997-8#1)(2005-11#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2013-1#1)(2013-7#1)
whereas those collected##2##3##(2008-10#1)(2008-3#1)
whereas those for##4##3##(1994-9#1)(2006-7#1)(2010-4#2)
whereas those from##3##3##(1996-7#1)(2008-11#1)(2013-1#1)
whereas those in the##2##4##(1996-2#1)(2007-1#1)
whereas those in##7##3##(1991-3#1)(1995-10#1)(1996-2#1)(1996-3#1)(2007-1#1)(2008-10#2)
whereas those infected by##2##4##(2008-10#2)
whereas those of the##4##4##(1991-2#1)(1994-8#1)(2007-12#1)(2008-5#1)
whereas those of##16##3##(1990-3#1)(1991-2#2)(1992-6#1)(1992-8#1)(1994-8#1)(1994-9#1)(1995-9#1)(1996-9#1)(1997-1#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-5#1)(2013-8#1)
whereas those with a##2##4##(1992-9#1)(2005-10#1)
whereas those with##7##3##(1991-2#1)(1992-9#1)(1993-5#1)(1994-12#1)(2005-10#1)(2006-10#1)(2008-3#1)
whereas those##58##2##(1990-3#1)(1991-2#3)(1991-3#1)(1991-9#2)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-9#1)(1996-2#1)(1996-3#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-6#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-12#1)(2008-10#8)(2008-11#3)(2008-3#2)(2008-5#2)(2008-8#1)(2009-10#1)(2009-9#1)(2010-4#3)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
whereas three##2##2##(2008-10#1)(2008-5#1)
whereas total##2##2##(2008-10#2)
whereas treatment with##3##3##(1994-11#1)(1996-3#1)(1996-6#1)
whereas treatment##6##2##(1994-11#1)(1996-3#1)(1996-6#1)(2007-8#1)(2008-10#1)(2008-11#1)
whereas two others##2##3##(1995-8#1)(2008-10#1)
whereas two##8##2##(1993-3#1)(1995-7#1)(1995-8#1)(1997-4#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-12#1)
whereas type II##2##3##(1991-4#1)(2011-12#1)
whereas type##4##2##(1991-4#1)(1994-12#1)(2007-12#1)(2011-12#1)
whereas under##5##2##(1994-5#1)(1996-5#1)(2004-12#1)(2008-10#1)(2008-2#1)
whereas use of##2##3##(1993-3#1)(1993-9#1)
whereas using##2##2##(1992-8#1)(1993-2#1)
whereas values##2##2##(1996-9#1)(2007-8#1)
whereas vascular##2##2##(1992-3#1)(2008-10#1)
whereas virus##2##2##(2008-10#1)(2013-8#1)
whereas we##3##2##(1994-9#1)(1996-12#1)(2011-2#1)
whereas weak##2##2##(1995-5#1)(2008-11#1)
whereas weight##2##2##(1993-2#1)(2008-7#1)
whereas when##4##2##(1992-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
whereas wild-type##2##2##(2008-10#1)(2012-2#1)
whereas with the##3##3##(1990-9#1)(1997-5#1)(2009-10#1)
whereas with##11##2##(1990-2#1)(1990-9#1)(1993-8#1)(1994-5#1)(1995-11#1)(1997-5#1)(2007-8#1)(2008-3#1)(2008-6#1)(2009-10#1)(2012-2#1)
whereas workers##2##2##(2008-8#1)(2009-5#1)
whereas xanthine##2##2##(1990-4#1)(1993-12#1)
whereas younger adults##2##3##(2008-11#1)(2012-11#1)
whereas younger##3##2##(2007-8#1)(2008-11#1)(2012-11#1)
whereas##3302##1##(1990-1#2)(1990-10#12)(1990-11#27)(1990-12#16)(1990-2#24)(1990-3#15)(1990-4#10)(1990-5#21)(1990-6#9)(1990-7#21)(1990-8#26)(1990-9#11)(1991-1#10)(1991-10#15)(1991-11#6)(1991-12#21)(1991-2#23)(1991-3#12)(1991-4#10)(1991-5#10)(1991-6#15)(1991-7#5)(1991-8#15)(1991-9#22)(1992-1#6)(1992-10#8)(1992-11#15)(1992-12#18)(1992-2#12)(1992-3#10)(1992-4#6)(1992-5#7)(1992-6#18)(1992-7#10)(1992-8#19)(1992-9#18)(1993-1#3)(1993-10#1)(1993-11#21)(1993-12#20)(1993-2#10)(1993-3#16)(1993-4#7)(1993-5#5)(1993-6#9)(1993-7#6)(1993-8#10)(1993-9#18)(1994-10#10)(1994-11#16)(1994-12#36)(1994-2#25)(1994-3#22)(1994-4#1)(1994-5#14)(1994-6#18)(1994-7#3)(1994-8#29)(1994-9#31)(1995-1#17)(1995-10#9)(1995-11#20)(1995-12#26)(1995-2#24)(1995-3#25)(1995-4#4)(1995-5#19)(1995-6#13)(1995-7#8)(1995-8#23)(1995-9#5)(1996-1#5)(1996-10#3)(1996-11#11)(1996-12#17)(1996-2#25)(1996-3#11)(1996-4#7)(1996-5#30)(1996-6#12)(1996-7#14)(1996-8#13)(1996-9#23)(1997-1#11)(1997-2#20)(1997-3#7)(1997-4#24)(1997-5#9)(1997-6#19)(1997-7#31)(1997-8#19)(2003-11#2)(2004-1#1)(2004-10#1)(2004-11#6)(2004-12#2)(2004-3#1)(2004-4#5)(2004-8#1)(2004-9#5)(2005-10#5)(2005-11#24)(2005-12#3)(2005-2#1)(2005-5#2)(2005-7#4)(2005-8#9)(2005-9#1)(2006-10#51)(2006-11#2)(2006-12#27)(2006-2#5)(2006-3#4)(2006-4#4)(2006-5#5)(2006-6#10)(2006-7#13)(2006-8#24)(2006-9#10)(2007-1#13)(2007-10#12)(2007-11#41)(2007-12#48)(2007-2#11)(2007-3#5)(2007-4#3)(2007-5#1)(2007-6#6)(2007-7#23)(2007-8#45)(2007-9#16)(2008-1#13)(2008-10#393)(2008-11#54)(2008-12#20)(2008-2#54)(2008-3#94)(2008-4#55)(2008-5#90)(2008-6#25)(2008-7#56)(2008-8#38)(2008-9#33)(2009-1#1)(2009-10#10)(2009-11#9)(2009-12#4)(2009-2#7)(2009-3#11)(2009-4#16)(2009-5#7)(2009-6#7)(2009-7#6)(2009-8#14)(2009-9#11)(2010-1#1)(2010-10#5)(2010-11#7)(2010-12#15)(2010-2#8)(2010-3#11)(2010-4#23)(2010-5#14)(2010-6#6)(2010-7#8)(2010-8#16)(2010-9#2)(2011-1#24)(2011-10#1)(2011-12#17)(2011-2#71)(2011-3#1)(2012-1#15)(2012-11#10)(2012-12#35)(2012-2#44)(2012-3#28)(2012-5#2)(2012-7#1)(2012-9#1)(2013-1#54)(2013-7#15)(2013-8#47)
whereby a patient##2##3##(2007-12#1)(2007-9#1)
whereby a well-defined cathodic##2##4##(2008-10#2)
whereby a##15##2##(1990-9#1)(1992-6#1)(1993-9#1)(1994-8#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-8#1)(2012-12#2)(2012-3#1)(2013-1#1)
whereby an##2##2##(2007-12#1)(2008-1#1)
whereby biologists from a wide range of ecological disciplines are increasingly interested in assessing immunocompetence in their study organisms##2##19##(2012-12#2)
whereby bringing in rule-based flavor to the approach as well##2##10##(2013-1#2)
whereby it##2##2##(2005-9#1)(2008-3#1)
whereby new##2##2##(2006-10#1)(2006-12#1)
whereby stress##2##2##(1990-5#1)(1996-4#1)
whereby the cells##2##3##(2005-7#1)(2008-11#1)
whereby the##38##2##(1991-11#1)(1991-2#2)(1991-7#1)(1991-8#1)(1992-7#1)(1992-9#2)(1993-3#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-2#1)(2005-7#1)(2006-6#3)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
whereby their##2##2##(1996-5#1)(2012-11#1)
whereby these##3##2##(1990-2#1)(2006-10#1)(2012-3#1)
whereby they##4##2##(1994-3#1)(2008-1#1)(2008-12#1)(2009-5#1)
whereby##162##1##(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#2)(1991-7#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#5)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-2#1)(1996-4#1)(1996-5#3)(1997-1#1)(1997-4#2)(1997-6#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#5)(2006-12#2)(2006-4#1)(2006-6#4)(2007-11#3)(2007-12#6)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#6)(2008-10#12)(2008-11#3)(2008-12#2)(2008-2#6)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#4)(2009-5#1)(2009-9#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#7)(2013-8#2)
wherein a##5##2##(2006-7#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-7#1)
wherein both##4##2##(1993-11#1)(2007-12#1)(2008-3#1)(2008-4#1)
wherein it##3##2##(1990-10#1)(1993-9#1)(2008-2#1)
wherein only the##2##3##(2008-5#1)(2010-2#1)
wherein the##25##2##(1990-8#1)(1991-2#1)(1991-5#1)(1992-3#1)(1993-9#1)(1995-3#1)(1996-5#1)(1996-8#3)(1997-7#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-11#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#2)(2012-12#1)(2012-3#1)
wherein##74##1##(1990-10#1)(1990-8#1)(1991-2#1)(1991-5#2)(1992-3#2)(1993-11#2)(1993-9#2)(1994-9#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-8#3)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-7#1)(2007-12#2)(2007-2#1)(2007-4#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#2)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#3)(2010-4#2)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-7#1)
whereupon the##2##2##(2008-10#1)(2009-2#1)
whereupon##5##1##(2006-4#1)(2008-10#2)(2009-2#2)
wherever possible##9##2##(1993-12#1)(1996-10#1)(2005-7#1)(2006-10#1)(2008-3#1)(2008-4#1)(2012-11#1)(2013-1#2)
wherever they are##2##3##(1997-1#1)(2007-2#1)
wherever##19##1##(1991-11#1)(1991-9#1)(1993-12#1)(1994-3#1)(1996-10#1)(1997-1#1)(2005-7#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-11#1)(2013-1#2)(2013-8#1)
whether &quot##2##2##(2007-2#1)(2013-1#1)
whether (1)##2##2##(1997-4#1)(2013-7#1)
whether ATP##2##2##(1995-11#1)(2006-12#1)
whether Al##2##2##(1996-8#2)
whether C##2##2##(2008-10#1)(2012-1#1)
whether CD34##2##2##(2009-4#1)(2011-2#1)
whether CRP levels are##2##4##(2007-10#2)
whether DHEA##2##2##(1994-6#1)(1995-12#1)
whether G-Rg1 induces the##2##4##(1994-12#2)
whether HPV##2##2##(2011-1#1)(2013-7#1)
whether Mptx##2##2##(2008-10#2)
whether NO##2##2##(1992-6#1)(2013-8#1)
whether OCT##2##2##(2011-2#1)(2013-1#1)
whether PD##2##2##(2007-5#1)(2009-10#1)
whether T##2##2##(2008-8#1)(2013-8#1)
whether a clade constitutes##2##4##(2008-8#2)
whether a new drug##2##4##(2012-2#2)
whether a new##4##3##(1996-12#1)(2012-2#2)(2013-7#1)
whether a particular##4##3##(2008-1#1)(2012-2#1)(2013-1#2)
whether a patient##2##3##(1992-9#1)(2010-8#1)
whether a protein##3##3##(2008-4#3)
whether a relationship exists between##2##5##(1994-3#1)(2009-7#1)
whether a similar##4##3##(1996-5#1)(2007-10#1)(2008-7#1)(2012-12#1)
whether a simple##2##3##(2008-10#1)(2011-1#1)
whether a single##5##3##(2007-11#1)(2008-3#1)(2009-8#1)(2010-4#1)(2011-2#1)
whether a small##2##3##(1993-2#1)(1995-5#1)
whether a##115##2##(1990-11#1)(1991-2#1)(1991-3#1)(1992-10#2)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#2)(1994-3#1)(1994-8#1)(1995-11#1)(1995-5#1)(1996-12#3)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-12#2)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#2)(2007-8#3)(2007-9#3)(2008-1#3)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#4)(2008-5#4)(2008-7#2)(2008-8#4)(2008-9#3)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#3)(2013-8#1)
whether acetylcholine##2##2##(1995-7#1)(2011-2#1)
whether active##2##2##(2007-7#1)(2013-7#1)
whether acupuncture##2##2##(1995-9#1)(2006-10#1)
whether acute##2##2##(1994-12#1)(1996-10#1)
whether addition of##2##3##(1997-3#1)(2007-8#1)
whether additional##2##2##(2007-8#1)(2009-8#1)
whether age##5##2##(2010-3#3)(2013-8#2)
whether all these##2##3##(1991-4#1)(2013-8#1)
whether all##4##2##(1991-4#1)(1992-2#1)(2007-8#1)(2013-8#1)
whether alveolar bone is##2##4##(2011-2#2)
whether amino##2##2##(1994-11#1)(2010-1#1)
whether an individual##2##3##(1992-9#1)(2007-12#1)
whether an##31##2##(1990-6#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-9#1)(1993-7#1)(1993-9#1)(1995-11#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-4#1)(1997-6#1)(2004-2#1)(2005-9#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-5#1)(2008-8#2)(2008-9#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
whether and how these##2##4##(2009-5#1)(2011-2#1)
whether and how##14##3##(1992-10#1)(1997-3#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#2)(2009-5#1)(2011-2#4)(2013-1#1)
whether and to what extent##3##5##(1996-12#1)(2010-8#1)(2011-2#1)
whether and##20##2##(1992-10#1)(1996-12#1)(1997-3#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-2#2)(2009-5#1)(2010-8#1)(2011-2#5)(2013-1#1)
whether any##15##2##(1990-11#1)(1991-8#1)(1992-12#1)(1993-11#1)(1994-2#1)(1995-11#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-5#1)(2010-3#1)
whether as##2##2##(2007-8#1)(2008-11#1)
whether aspirin##2##2##(1997-1#1)(2007-8#1)
whether asymptomatic intracerebral hemorrhage##2##4##(2007-10#2)
whether asymptomatic##3##2##(2007-10#2)(2007-8#1)
whether attached to##2##3##(1994-9#1)(2006-9#1)
whether axillary##2##2##(1994-12#1)(1994-7#1)
whether behavioural##2##2##(2008-11#1)(2010-8#1)
whether both##2##2##(1994-8#1)(2008-10#1)
whether carotid##2##2##(2007-8#1)(2007-9#1)
whether cells##7##2##(1996-2#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-4#2)(2009-4#1)
whether cerebral##2##2##(1996-3#1)(2008-11#1)
whether certain##2##2##(1992-3#1)(2012-12#1)
whether changes in the##2##4##(1994-8#1)(1995-9#1)
whether changes in##10##3##(1994-3#1)(1994-8#1)(1995-9#1)(1996-8#1)(1996-9#1)(2006-6#1)(2008-11#1)(2008-9#1)(2010-2#1)(2011-12#1)
whether chemotherapy##2##2##(2006-8#2)
whether children with##4##3##(1994-2#1)(2004-12#1)(2012-2#1)(2013-7#1)
whether children##6##2##(1994-2#1)(2004-12#1)(2008-12#1)(2009-2#1)(2012-2#1)(2013-7#1)
whether chronic##3##2##(1990-11#1)(2007-11#1)(2008-10#1)
whether cigarette##2##2##(2009-7#1)(2013-1#1)
whether clinical##4##2##(1991-9#1)(2008-8#1)(2011-2#1)(2012-3#1)
whether common##2##2##(1994-11#1)(2006-10#1)
whether congruent##2##2##(2012-1#2)
whether constitutive nitric oxide (NO) synthase from rat cerebellum##2##9##(1992-11#1)(1992-6#1)
whether cosmetics##2##2##(2008-5#2)
whether cultured##3##2##(1993-9#1)(2008-11#2)
whether current##2##2##(1993-12#1)(1996-8#1)
whether deficits in communication skills##2##5##(2012-2#2)
whether dietary fish-oil has##2##4##(2006-8#2)
whether dietary##4##2##(1996-7#1)(2006-8#2)(2008-4#1)
whether differences in##5##3##(1996-4#1)(1997-5#1)(2006-5#1)(2008-10#1)(2011-1#1)
whether differences##8##2##(1996-4#1)(1997-5#1)(2006-5#1)(2007-9#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-1#1)
whether different##8##2##(1991-9#1)(2006-8#1)(2007-7#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
whether dopamine##2##2##(1992-9#1)(1995-10#1)
whether dystrophin##2##2##(1993-3#1)(2012-3#1)
whether each##3##2##(1994-12#1)(1997-2#1)(2012-3#1)
whether early##2##2##(2007-7#1)(2012-3#1)
whether efficiency of##2##3##(1993-2#1)(2012-2#1)
whether either##5##2##(1992-12#1)(1992-8#1)(2004-11#1)(2006-11#1)(2007-8#1)
whether endogenous##2##2##(1991-3#1)(1994-2#1)
whether enhanced##3##2##(1994-3#1)(1997-2#1)(2008-5#1)
whether enhancing##2##2##(2010-8#1)(2012-2#1)
whether epigenetic##3##2##(1994-11#1)(2010-12#1)(2011-2#1)
whether expressed per mg protein or per total kidney cortex##2##10##(1994-8#2)
whether expressed##4##2##(1994-8#2)(1997-8#1)(2009-8#1)
whether expression of##4##3##(1994-7#1)(1994-8#1)(1996-1#1)(2010-11#1)
whether forced##2##2##(2007-2#1)(2010-11#1)
whether genes##2##2##(2010-7#1)(2013-1#1)
whether genetically##3##2##(1994-5#1)(2008-9#1)(2009-4#1)
whether haloperidol##2##2##(1992-9#1)(2007-8#1)
whether he had##3##3##(1991-6#1)(2013-1#2)
whether he##4##2##(1990-9#1)(1991-6#1)(2013-1#2)
whether health##3##2##(1994-3#1)(2012-2#1)(2012-3#1)
whether high doses of##2##4##(1991-3#1)(2007-8#1)
whether high##6##2##(1991-3#1)(1997-7#1)(2004-11#1)(2007-8#1)(2009-9#1)(2012-6#1)
whether human##5##2##(1997-1#1)(2008-4#1)(2009-12#1)(2011-1#1)(2012-12#1)
whether immediate##2##2##(2007-8#1)(2009-3#1)
whether in a##2##3##(1991-3#1)(1993-5#1)
whether in the##5##3##(2006-10#1)(2006-6#1)(2008-12#1)(2008-5#1)(2013-8#1)
whether in##16##2##(1990-4#1)(1991-3#1)(1991-9#1)(1993-5#1)(1993-9#1)(1995-12#1)(1996-2#1)(1997-7#1)(2004-7#1)(2006-10#1)(2006-6#1)(2008-12#1)(2008-5#1)(2009-12#1)(2011-2#1)(2013-8#1)
whether increased##6##2##(1990-10#1)(1992-2#2)(1993-8#1)(1997-5#1)(2012-3#1)
whether individual##2##2##(1994-5#1)(2008-7#1)
whether individuals with##3##3##(1997-2#1)(2009-4#1)(2011-12#1)
whether individuals##6##2##(1997-2#1)(2006-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2011-12#1)
whether infants##3##2##(1990-5#1)(1992-7#1)(2010-2#1)
whether infants'##2##2##(2010-2#2)
whether information is##2##3##(2008-8#2)
whether information##3##2##(1990-5#1)(2008-8#2)
whether inhibition of##2##3##(2007-8#1)(2013-7#1)
whether injections of##2##3##(1993-12#1)(1993-4#1)
whether interactions between##2##3##(1995-12#1)(2010-2#1)
whether intracellular##2##2##(1991-10#1)(2005-12#1)
whether invasive##2##2##(2007-7#1)(2008-10#1)
whether it attenuates the##2##4##(2008-1#1)(2008-10#1)
whether it can##3##3##(2007-11#2)(2008-3#1)
whether it has##6##3##(1993-11#1)(2007-10#1)(2008-1#1)(2008-8#1)(2008-9#1)(2009-1#1)
whether it is a##7##4##(1994-5#1)(1995-11#1)(2005-10#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
whether it is an##2##4##(2010-8#1)(2011-2#1)
whether it is isolated or##2##5##(1996-12#1)(2007-12#1)
whether it is possible to##5##5##(2006-10#1)(2008-10#1)(2008-11#1)(2009-7#1)(2010-2#1)
whether it is possible##6##4##(2006-10#1)(2006-6#1)(2008-10#1)(2008-11#1)(2009-7#1)(2010-2#1)
whether it is specific##2##4##(1990-7#1)(2008-5#1)
whether it is##44##3##(1990-7#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-9#1)(1996-12#1)(2004-2#1)(2005-10#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#1)
whether it leads to##2##4##(1994-6#1)(2007-1#1)
whether it was possible##2##4##(1993-7#1)(2008-9#1)
whether it was##14##3##(1993-7#1)(1994-3#1)(1995-12#1)(1995-2#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
whether it would##2##3##(1990-5#1)(1994-12#1)
whether it##88##2##(1990-5#1)(1990-7#1)(1992-3#1)(1993-11#1)(1993-7#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-9#1)(1996-12#1)(1997-2#1)(1997-7#1)(2004-2#1)(2005-10#1)(2006-10#2)(2006-4#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-1#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#2)
whether its##6##2##(1992-5#1)(1994-6#1)(1995-11#1)(1996-11#1)(2010-9#1)(2012-1#1)
whether laminin##2##2##(1991-3#1)(2013-8#1)
whether light##2##2##(1993-9#1)(1994-8#1)
whether low##8##2##(1995-11#1)(2007-8#2)(2008-4#1)(2010-12#1)(2012-2#1)(2012-6#1)(2013-1#1)
whether male rats##2##3##(1994-6#1)(2008-5#1)
whether male##3##2##(1994-6#1)(2008-5#1)(2009-9#1)
whether males##2##2##(1997-2#1)(2013-1#1)
whether maternal##3##2##(2008-2#1)(2009-5#1)(2010-7#1)
whether medical##4##2##(1990-12#1)(1991-2#1)(2009-4#1)(2011-2#1)
whether moderate##2##2##(2007-12#1)(2008-9#1)
whether more##2##2##(2007-2#1)(2009-5#1)
whether multiple##3##2##(1993-10#1)(2007-11#1)(2010-7#1)
whether naturally occurring or##2##4##(2008-1#1)(2008-4#1)
whether normal##2##2##(1992-5#1)(2006-8#1)
whether nursing home##2##3##(1990-12#1)(2008-11#1)
whether obesity##4##2##(2006-9#1)(2008-1#1)(2012-2#1)(2013-1#1)
whether observed##2##2##(2006-3#1)(2010-8#1)
whether older##2##2##(2008-11#1)(2010-8#1)
whether one is dealing with##2##5##(1994-3#1)(2007-12#1)
whether one of##2##3##(1996-1#1)(2008-5#1)
whether one or##2##3##(1995-2#1)(2012-3#1)
whether one##9##2##(1991-12#1)(1993-9#1)(1994-3#1)(1995-2#1)(1996-1#1)(2007-12#1)(2008-2#1)(2008-5#1)(2012-3#1)
whether or how##2##3##(2007-12#1)(2008-11#1)
whether or not a##8##4##(1991-1#1)(1992-9#1)(1996-5#1)(2007-11#1)(2007-2#1)(2008-11#2)(2008-5#1)
whether or not associated with##2##5##(2010-11#1)(2013-8#1)
whether or not it is##3##5##(1992-9#1)(2008-5#1)(2011-2#1)
whether or not it##4##4##(1992-9#1)(2008-5#1)(2011-2#1)(2012-12#1)
whether or not such##3##4##(1995-5#1)(1997-8#1)(2008-6#1)
whether or not the##32##4##(1990-1#1)(1990-7#1)(1991-7#2)(1991-9#1)(1992-11#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-8#1)(1996-4#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-2#2)(2007-7#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-7#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
whether or not their##2##4##(1990-11#1)(2008-11#1)
whether or not there##4##4##(2006-10#1)(2006-8#1)(2008-1#1)(2012-1#1)
whether or not these##5##4##(1991-6#1)(2005-10#1)(2007-10#1)(2007-11#1)(2007-8#1)
whether or not they are##3##5##(1990-11#1)(1997-3#1)(2007-10#1)
whether or not they should##2##5##(2007-2#2)
whether or not they##11##4##(1990-11#1)(1991-3#1)(1996-10#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#2)(2012-2#1)(2013-1#1)
whether or not this##6##4##(1994-11#1)(1994-9#1)(1995-5#1)(1996-8#1)(2006-12#1)(2008-9#1)
whether or not to##7##4##(1991-3#1)(1995-4#1)(1995-6#1)(2007-6#1)(2007-8#1)(2012-2#1)(2013-1#1)
whether or not##142##3##(1990-1#1)(1990-11#2)(1990-3#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-3#2)(1991-6#2)(1991-7#2)(1991-9#1)(1992-11#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-8#1)(2005-9#2)(2006-10#2)(2006-12#3)(2006-8#3)(2007-10#3)(2007-11#3)(2007-2#5)(2007-6#2)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#3)(2008-11#8)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#6)(2008-6#4)(2008-7#4)(2008-9#4)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
whether or##144##2##(1990-1#1)(1990-11#2)(1990-3#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-3#2)(1991-6#2)(1991-7#2)(1991-9#1)(1992-11#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-8#1)(2005-9#2)(2006-10#2)(2006-12#3)(2006-8#3)(2007-10#3)(2007-11#3)(2007-12#1)(2007-2#5)(2007-6#2)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#3)(2008-11#9)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#6)(2008-6#4)(2008-7#4)(2008-9#4)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
whether oral##2##2##(2008-5#1)(2010-8#1)
whether other##8##2##(1990-8#1)(1991-3#1)(1992-6#1)(1994-12#1)(1997-4#1)(1997-7#1)(2007-11#1)(2012-3#1)
whether parents##2##2##(1994-2#1)(2008-9#1)
whether patients with##3##3##(2008-7#2)(2013-1#1)
whether patients##8##2##(1994-8#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-7#2)(2011-2#1)(2013-1#1)
whether patients' perception of early##2##5##(2013-1#2)
whether patients'##3##2##(1994-2#1)(2013-1#2)
whether people##2##2##(2009-12#1)(2013-1#1)
whether physical##2##2##(1991-7#1)(2009-6#1)
whether physicians##2##2##(1993-6#1)(2007-4#1)
whether preemptive analgesia##2##3##(2006-10#2)
whether prenatal##2##2##(1995-6#1)(2008-10#1)
whether prophylactic##9##2##(2006-11#1)(2007-8#8)
whether protein##3##2##(1994-2#2)(1994-5#1)
whether providing information##2##3##(1996-2#1)(1997-3#1)
whether providing##3##2##(1996-2#1)(1997-3#1)(2013-1#1)
whether psychological factors##2##3##(2006-10#2)
whether psychological##4##2##(1995-12#1)(2006-10#2)(2008-3#1)
whether rTMS##2##2##(2010-7#1)(2013-1#1)
whether rats were##2##3##(1992-7#1)(1997-2#1)
whether rats##3##2##(1992-7#1)(1997-2#1)(1997-8#1)
whether renal##2##2##(2007-8#1)(2010-12#1)
whether risk factors##2##3##(2006-2#1)(2012-2#1)
whether risk##3##2##(2006-2#1)(2008-8#1)(2012-2#1)
whether selected##2##2##(1994-12#1)(2007-7#1)
whether serum##3##2##(2007-10#1)(2007-8#1)(2012-5#1)
whether sexually##2##2##(1995-12#1)(1995-5#1)
whether similar##9##2##(1991-7#1)(1992-8#1)(1995-3#1)(2008-10#3)(2008-6#1)(2008-8#1)(2010-6#1)
whether single##2##2##(1996-12#1)(2010-6#1)
whether skin##2##2##(2008-11#1)(2013-1#1)
whether smoking##2##2##(2008-8#1)(2010-4#1)
whether social##5##2##(2004-3#1)(2009-10#1)(2009-12#1)(2010-4#1)(2012-3#1)
whether some##3##2##(1997-2#1)(2006-7#1)(2010-6#1)
whether specific##8##2##(1991-5#1)(1993-9#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-4#1)(2011-12#1)(2011-2#1)
whether stimulation of##2##3##(1996-1#1)(2008-4#1)
whether students##2##2##(2007-8#1)(2012-3#1)
whether such differences##2##3##(1992-8#1)(2013-1#1)
whether such##24##2##(1990-5#1)(1992-11#1)(1992-8#1)(1993-7#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-4#2)(2004-2#1)(2006-10#1)(2006-7#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#2)(2009-8#1)(2010-2#1)(2011-12#1)(2012-2#1)(2013-1#2)
whether systematic##2##2##(1996-12#1)(2012-2#1)
whether tamoxifen##2##2##(1993-12#1)(2009-2#1)
whether that##4##2##(1996-9#1)(2006-12#1)(2006-8#1)(2007-12#1)
whether the &quot##2##3##(2005-11#1)(2006-10#1)
whether the AVP binding sites##2##5##(1992-9#2)
whether the TCR##2##3##(1997-7#1)(2008-11#1)
whether the addition of##2##4##(1994-9#1)(2006-11#1)
whether the adjective described##2##4##(2008-11#2)
whether the adjective##3##3##(2008-11#3)
whether the age-related##2##3##(1994-5#1)(2013-1#1)
whether the analysis##2##3##(2007-8#1)(2008-10#1)
whether the animals are being used as experimental subjects##2##9##(2008-4#2)
whether the brain##2##3##(1994-2#1)(1997-8#1)
whether the calcium##2##3##(1992-12#1)(1995-4#1)
whether the child##3##3##(1993-12#1)(2005-11#1)(2010-2#1)
whether the client##2##3##(2006-4#1)(2007-6#1)
whether the clinical##2##3##(2010-3#1)(2011-2#1)
whether the current##2##3##(1992-9#1)(1994-3#1)
whether the data##2##3##(1992-11#1)(2004-9#1)
whether the decrease in##2##4##(1995-3#1)(2011-12#1)
whether the demands##2##3##(1992-9#1)(2010-12#1)
whether the difference##2##3##(2008-8#1)(2012-12#1)
whether the different##3##3##(1994-6#1)(2008-10#1)(2013-8#1)
whether the drug##2##3##(2008-5#1)(2008-8#1)
whether the early##2##3##(2008-12#1)(2010-3#1)
whether the effect of##2##4##(1994-8#1)(2010-8#1)
whether the effect##4##3##(1991-12#1)(1994-8#1)(1996-8#1)(2010-8#1)
whether the effects of##7##4##(1991-5#1)(1994-6#1)(1997-1#1)(2008-10#1)(2009-2#1)(2010-7#1)(2013-1#1)
whether the effects##9##3##(1991-5#1)(1994-6#1)(1997-1#1)(2008-10#1)(2009-11#1)(2009-2#1)(2010-7#1)(2012-1#1)(2013-1#1)
whether the exposure to##2##4##(1991-6#1)(2013-1#1)
whether the expression of##4##4##(1991-2#1)(1996-1#1)(1996-3#1)(1996-4#1)
whether the expression##5##3##(1991-2#1)(1996-1#1)(1996-3#1)(1996-4#1)(2013-8#1)
whether the hypothesis##2##3##(1992-12#1)(2009-4#1)
whether the implementation of##2##4##(1995-12#1)(2007-9#1)
whether the in vivo##2##4##(1993-12#1)(1996-10#1)
whether the inflammatory##3##3##(2006-6#1)(2008-5#1)(2010-12#1)
whether the instrument##2##3##(2008-3#1)(2010-10#1)
whether the interventions##2##3##(2009-6#2)
whether the level of##3##4##(2007-10#1)(2008-10#1)(2010-9#1)
whether the limbal##2##3##(2012-12#2)
whether the location##2##3##(1994-8#1)(2008-10#1)
whether the model##2##3##(1997-6#1)(2011-1#1)
whether the nature of the##2##5##(2008-12#1)(2009-12#1)
whether the observed##3##3##(1995-3#1)(2009-8#1)(2013-8#1)
whether the onset of##2##4##(2009-3#1)(2012-12#1)
whether the patient has##3##4##(1997-2#1)(2006-2#1)(2008-7#1)
whether the patient##10##3##(1996-11#1)(1996-6#1)(1997-2#1)(2006-2#2)(2006-7#1)(2008-7#1)(2010-2#1)(2013-1#2)
whether the patients##3##3##(2009-11#1)(2010-8#1)(2012-12#1)
whether the predicted##2##3##(1995-8#1)(2010-11#1)
whether the presence of##5##4##(1991-9#1)(1997-4#1)(1997-5#1)(2007-3#1)(2011-2#1)
whether the primary##2##3##(2007-9#1)(2010-5#1)
whether the protein is##2##4##(1994-12#1)(2011-12#1)
whether the protein##3##3##(1994-12#1)(2009-5#1)(2011-12#1)
whether the quality##2##3##(1997-8#1)(2006-8#1)
whether the reduced##2##3##(2008-1#1)(2008-7#1)
whether the relationship between##2##4##(2009-4#1)(2010-2#1)
whether the relationship##5##3##(1994-2#1)(2009-4#1)(2010-2#2)(2012-12#1)
whether the representations underlying##2##4##(2009-10#2)
whether the results of this##2##5##(2007-10#1)(2007-5#1)
whether the results of##3##4##(1994-3#1)(2007-10#1)(2007-5#1)
whether the same##3##3##(2006-8#1)(2009-10#1)(2010-12#1)
whether the sensitivity of##2##4##(1994-4#1)(2004-2#1)
whether the sensitivity##3##3##(1994-4#1)(1997-3#1)(2004-2#1)
whether the stimulus##3##3##(1991-1#1)(2008-11#1)(2008-4#1)
whether the susceptibility##2##3##(2004-12#1)(2009-2#1)
whether the target##4##3##(2006-12#1)(2007-8#1)(2008-3#1)(2012-2#1)
whether the technique can##2##4##(1993-2#1)(2011-1#1)
whether the technique##3##3##(1993-2#1)(2007-11#1)(2011-1#1)
whether the type of##2##4##(1993-12#1)(2008-8#1)
whether the use of##14##4##(1993-8#1)(1994-2#1)(2006-8#1)(2007-8#8)(2008-10#1)(2008-2#1)(2008-7#1)
whether the wound##2##3##(1992-2#1)(2006-9#1)
whether the##575##2##(1990-11#4)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#2)(1990-8#3)(1990-9#2)(1991-1#1)(1991-10#3)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#5)(1992-2#3)(1992-3#1)(1992-4#2)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#4)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#2)(1993-3#1)(1993-5#3)(1993-6#2)(1993-7#3)(1993-8#4)(1993-9#5)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#5)(1994-3#6)(1994-4#2)(1994-5#5)(1994-6#6)(1994-8#4)(1994-9#3)(1995-1#3)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#5)(1995-4#2)(1995-5#3)(1995-6#4)(1995-7#1)(1995-8#3)(1996-1#2)(1996-10#4)(1996-11#1)(1996-2#4)(1996-3#2)(1996-4#5)(1996-5#4)(1996-6#2)(1996-7#2)(1996-8#5)(1996-9#3)(1997-1#3)(1997-2#5)(1997-3#3)(1997-4#5)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#4)(2004-1#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-9#1)(2005-10#2)(2005-11#4)(2005-8#1)(2006-10#6)(2006-11#1)(2006-12#3)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#4)(2006-9#2)(2007-1#1)(2007-10#5)(2007-11#9)(2007-12#5)(2007-2#1)(2007-3#2)(2007-4#4)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#16)(2007-9#4)(2008-1#6)(2008-10#22)(2008-11#15)(2008-12#6)(2008-2#8)(2008-3#9)(2008-4#14)(2008-5#13)(2008-6#6)(2008-7#7)(2008-8#13)(2008-9#5)(2009-10#5)(2009-11#3)(2009-12#2)(2009-2#5)(2009-3#3)(2009-4#5)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#9)(2010-2#9)(2010-3#3)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#6)(2010-9#3)(2011-1#8)(2011-12#2)(2011-2#8)(2012-1#6)(2012-11#1)(2012-12#11)(2012-2#10)(2012-3#6)(2013-1#12)(2013-7#1)(2013-8#10)
whether their##15##2##(1993-1#1)(1994-10#1)(1995-2#1)(2006-4#1)(2006-7#1)(2006-9#1)(2007-12#2)(2008-3#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2012-1#1)(2013-1#1)
whether there are any##3##4##(1994-7#1)(1995-4#1)(2012-2#1)
whether there are differences in##2##5##(2009-3#1)(2013-1#1)
whether there are differences##3##4##(2009-3#1)(2010-7#1)(2013-1#1)
whether there are other##2##4##(1991-12#1)(1996-11#1)
whether there are##18##3##(1991-11#1)(1991-12#1)(1991-4#1)(1994-7#1)(1995-4#1)(1996-11#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(2007-6#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-7#1)(2012-2#1)(2013-1#1)
whether there has been##4##4##(1992-2#1)(1993-1#1)(1995-12#1)(2006-10#1)
whether there is a correlation between##2##6##(2006-2#1)(2011-2#1)
whether there is a correlation##3##5##(2006-2#1)(2011-2#2)
whether there is a difference in##2##6##(1997-2#1)(2010-10#1)
whether there is a need for##2##6##(1995-2#1)(2006-10#1)
whether there is a##19##4##(1995-2#1)(1997-2#1)(1997-6#1)(2004-11#1)(2006-10#2)(2006-2#1)(2007-2#1)(2007-8#2)(2008-11#1)(2008-8#1)(2009-11#1)(2010-10#1)(2010-6#1)(2010-9#1)(2011-2#2)(2013-1#1)
whether there is an##3##4##(1992-12#1)(2009-12#1)(2012-3#1)
whether there is any##7##4##(1995-7#1)(1996-12#1)(1997-5#1)(2007-8#2)(2007-9#1)(2008-3#1)
whether there is evidence##2##4##(2008-6#1)(2012-1#1)
whether there is##41##3##(1990-8#1)(1992-12#1)(1993-10#1)(1995-2#1)(1995-7#1)(1996-12#1)(1997-2#1)(1997-5#1)(1997-6#1)(2004-11#1)(2006-10#3)(2006-2#2)(2006-7#1)(2007-2#1)(2007-8#4)(2007-9#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
whether there might be##2##4##(1995-6#1)(2008-8#1)
whether there was a##5##4##(2004-1#1)(2007-12#1)(2008-1#1)(2008-7#1)(2008-8#1)
whether there was an##2##4##(2007-10#1)(2008-10#1)
whether there was any##3##4##(1995-3#1)(2008-4#1)(2011-2#1)
whether there was##15##3##(1995-12#1)(1995-3#1)(2004-1#1)(2005-11#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
whether there were##4##3##(2007-10#1)(2008-11#1)(2012-11#1)(2013-7#1)
whether there##90##2##(1990-12#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-4#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-10#1)(1994-7#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-5#2)(1997-6#1)(2004-1#1)(2004-11#1)(2005-11#1)(2006-10#4)(2006-2#2)(2006-7#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)
whether these alterations##4##3##(1996-1#1)(1996-5#1)(2011-1#1)(2012-1#1)
whether these are##3##3##(1995-12#1)(1997-4#1)(2008-6#1)
whether these associations are##2##4##(2008-1#1)(2009-10#1)
whether these benefits##2##3##(1997-8#1)(2007-11#1)
whether these changes have##2##4##(1996-10#1)(2006-10#1)
whether these effects are##2##4##(2009-11#1)(2012-2#1)
whether these effects##5##3##(2007-5#1)(2008-1#1)(2009-11#1)(2012-12#1)(2012-2#1)
whether these techniques can##2##4##(2008-10#1)(2008-7#1)
whether these two##2##3##(1993-12#1)(1996-5#1)
whether these##78##2##(1991-10#1)(1991-11#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-8#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#2)(2004-9#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
whether they are##22##3##(1991-6#1)(1994-9#1)(1995-11#2)(1996-2#1)(2006-10#1)(2006-2#2)(2007-12#1)(2007-2#1)(2007-5#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-4#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#1)
whether they be##2##3##(2009-8#1)(2010-11#1)
whether they can##2##3##(2012-1#1)(2012-2#1)
whether they contain##3##3##(1996-4#1)(2007-12#1)(2008-5#1)
whether they had##6##3##(1991-11#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-6#1)
whether they have been##2##4##(2006-8#1)(2008-4#1)
whether they have##3##3##(2006-8#1)(2008-4#1)(2008-8#1)
whether they may be##2##4##(2007-10#1)(2008-6#1)
whether they might##2##3##(1990-6#1)(1993-12#1)
whether they represented##2##3##(2011-1#1)(2013-7#1)
whether they should be##3##4##(1995-2#1)(1997-1#1)(2011-2#1)
whether they were##13##3##(1990-4#1)(1994-1#1)(1995-1#1)(1996-2#1)(1997-3#1)(2004-7#1)(2006-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-3#1)(2012-1#1)
whether they would##5##3##(1993-8#1)(1994-1#1)(2005-4#1)(2007-2#1)(2007-9#1)
whether they##93##2##(1990-3#1)(1990-4#1)(1990-6#1)(1991-11#1)(1991-6#1)(1992-12#1)(1993-12#1)(1993-8#2)(1994-1#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1996-2#2)(1996-4#2)(1997-1#2)(1997-3#1)(2004-7#1)(2005-4#1)(2006-10#1)(2006-2#2)(2006-3#1)(2006-7#1)(2006-8#4)(2007-10#3)(2007-12#3)(2007-2#2)(2007-5#1)(2007-6#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#3)(2009-10#1)(2009-11#1)(2009-4#2)(2009-8#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
whether this also##2##3##(1996-2#1)(2008-6#1)
whether this approach can be##2##5##(2012-1#1)(2012-3#1)
whether this compound##2##3##(1996-2#1)(2008-3#1)
whether this effect##4##3##(1991-11#1)(1995-7#1)(1997-8#1)(2013-8#1)
whether this has##2##3##(1995-2#1)(2008-8#1)
whether this increase is##2##4##(2005-7#1)(2008-11#1)
whether this increase##3##3##(1997-2#1)(2005-7#1)(2008-11#1)
whether this is a##3##4##(2008-5#1)(2008-7#1)(2011-2#1)
whether this is also true##2##5##(1991-5#1)(2006-10#1)
whether this is of clinical##2##5##(1994-11#1)(2004-10#1)
whether this is related to##2##5##(1990-1#1)(1994-6#1)
whether this is the case##2##5##(1992-7#1)(1995-9#1)
whether this is the##4##4##(1992-7#1)(1995-9#1)(2008-10#1)(2011-2#1)
whether this is##21##3##(1990-1#1)(1991-5#1)(1991-8#1)(1992-7#1)(1994-11#1)(1994-6#1)(1995-9#1)(1996-4#1)(1996-8#1)(2004-10#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
whether this loss of##2##4##(1990-5#1)(2007-5#1)
whether this mechanism##2##3##(1996-1#1)(2008-8#1)
whether this method##3##3##(1991-2#1)(1996-9#1)(2007-2#1)
whether this new##4##3##(2006-10#1)(2008-10#1)(2008-11#1)(2008-8#1)
whether this##130##2##(1990-1#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#3)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-4#3)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-5#2)(1997-8#2)(2004-1#1)(2004-10#1)(2004-2#1)(2005-10#2)(2005-7#1)(2005-8#1)(2006-10#6)(2006-4#2)(2007-12#1)(2007-2#1)(2007-5#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-12#2)(2011-2#6)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
whether those##5##2##(2009-5#1)(2010-2#1)(2011-12#1)(2012-2#1)(2013-1#1)
whether time##3##2##(1997-8#1)(2008-7#1)(2008-8#1)
whether to apply or##2##4##(2008-10#2)
whether to apply##3##3##(2008-10#3)
whether to continue##3##3##(1993-10#1)(1997-1#1)(2008-12#1)
whether to give##2##3##(2009-3#1)(2010-12#1)
whether to have##3##3##(1990-8#1)(2007-7#1)(2008-2#1)
whether to include##2##3##(1990-12#1)(2008-1#1)
whether to leave the##2##4##(2008-8#1)(2008-9#1)
whether to screen##2##3##(1994-7#1)(2006-10#1)
whether to use##4##3##(1996-1#1)(2008-12#1)(2008-7#1)(2012-2#1)
whether to##50##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-1#1)(1992-10#1)(1993-10#1)(1993-4#1)(1994-7#1)(1996-1#1)(1996-2#2)(1997-1#1)(2004-10#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-6#2)(2006-9#1)(2007-3#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-11#2)(2012-2#2)(2013-1#2)
whether topical applications of apigenin##2##5##(2013-1#2)
whether topical##3##2##(2007-8#1)(2013-1#2)
whether transcription##2##2##(1993-2#1)(2010-10#1)
whether transient##2##2##(2007-8#2)
whether treatment with##5##3##(2004-11#1)(2007-5#1)(2007-8#1)(2012-12#1)(2013-8#1)
whether treatment##9##2##(1990-11#1)(1993-9#1)(2004-11#1)(2007-5#1)(2007-8#1)(2010-11#1)(2011-1#1)(2012-12#1)(2013-8#1)
whether two##5##2##(1994-2#1)(1995-2#1)(2008-11#1)(2009-4#1)(2011-1#1)
whether tyrosine phosphorylation##2##3##(1992-3#1)(1994-3#1)
whether use of##5##3##(2007-8#2)(2008-11#1)(2008-5#1)(2012-12#1)
whether used##2##2##(2009-5#1)(2009-6#1)
whether variation in##3##3##(2010-3#1)(2012-3#1)(2013-1#1)
whether variation##4##2##(1990-6#1)(2010-3#1)(2012-3#1)(2013-1#1)
whether vitamin##2##2##(2010-12#1)(2013-1#1)
whether we could##2##3##(1991-11#1)(1996-12#1)
whether we have##2##3##(2008-11#1)(2009-11#1)
whether we need##2##3##(2008-7#1)(2011-12#1)
whether we##9##2##(1991-11#1)(1994-1#1)(1996-12#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-11#1)(2009-7#1)(2011-12#1)
whether women##6##2##(1992-4#1)(2004-2#1)(2004-3#1)(2007-12#1)(2008-6#1)(2013-1#1)
whether##2873##1##(1990-1#2)(1990-10#4)(1990-11#13)(1990-12#8)(1990-2#3)(1990-3#5)(1990-4#4)(1990-5#11)(1990-6#9)(1990-7#3)(1990-8#7)(1990-9#5)(1991-1#5)(1991-10#7)(1991-11#7)(1991-12#10)(1991-2#7)(1991-3#13)(1991-4#6)(1991-5#9)(1991-6#7)(1991-7#5)(1991-8#6)(1991-9#11)(1992-1#3)(1992-10#5)(1992-11#7)(1992-12#17)(1992-2#11)(1992-3#9)(1992-4#7)(1992-5#8)(1992-6#7)(1992-7#6)(1992-8#9)(1992-9#16)(1993-1#5)(1993-10#4)(1993-11#4)(1993-12#21)(1993-2#13)(1993-3#11)(1993-4#6)(1993-5#5)(1993-6#7)(1993-7#10)(1993-8#10)(1993-9#19)(1994-1#5)(1994-10#6)(1994-11#7)(1994-12#22)(1994-2#26)(1994-3#20)(1994-4#3)(1994-5#12)(1994-6#14)(1994-7#4)(1994-8#23)(1994-9#9)(1995-1#6)(1995-10#3)(1995-11#17)(1995-12#22)(1995-2#16)(1995-3#14)(1995-4#4)(1995-5#14)(1995-6#10)(1995-7#5)(1995-8#11)(1995-9#7)(1996-1#16)(1996-10#12)(1996-11#10)(1996-12#19)(1996-2#20)(1996-3#7)(1996-4#14)(1996-5#16)(1996-6#8)(1996-7#5)(1996-8#14)(1996-9#16)(1997-1#13)(1997-2#22)(1997-3#15)(1997-4#16)(1997-5#10)(1997-6#13)(1997-7#15)(1997-8#17)(2004-1#3)(2004-10#2)(2004-11#8)(2004-12#4)(2004-2#7)(2004-3#2)(2004-7#2)(2004-9#2)(2005-10#11)(2005-11#6)(2005-12#3)(2005-4#1)(2005-6#1)(2005-7#5)(2005-8#3)(2005-9#4)(2006-1#1)(2006-10#49)(2006-11#6)(2006-12#16)(2006-2#10)(2006-3#9)(2006-4#7)(2006-5#8)(2006-6#13)(2006-7#14)(2006-8#26)(2006-9#12)(2007-1#7)(2007-10#33)(2007-11#36)(2007-12#34)(2007-2#17)(2007-3#7)(2007-4#13)(2007-5#9)(2007-6#8)(2007-7#16)(2007-8#98)(2007-9#24)(2008-1#26)(2008-10#102)(2008-11#80)(2008-12#28)(2008-2#21)(2008-3#38)(2008-4#49)(2008-5#64)(2008-6#32)(2008-7#53)(2008-8#70)(2008-9#38)(2009-1#5)(2009-10#16)(2009-11#10)(2009-12#17)(2009-2#8)(2009-3#10)(2009-4#20)(2009-5#14)(2009-6#9)(2009-7#13)(2009-8#12)(2009-9#8)(2010-1#2)(2010-10#10)(2010-11#11)(2010-12#28)(2010-2#25)(2010-3#12)(2010-4#10)(2010-5#8)(2010-6#8)(2010-7#16)(2010-8#22)(2010-9#7)(2011-1#33)(2011-12#17)(2011-2#87)(2011-3#1)(2012-1#33)(2012-11#10)(2012-12#39)(2012-2#60)(2012-3#42)(2012-5#2)(2012-6#2)(2012-7#1)(2013-1#99)(2013-7#19)(2013-8#44)
whey by##3##2##(2008-10#1)(2008-6#2)
whey components##3##2##(2008-10#3)
whey lactose##2##2##(2008-6#2)
whey protein isolate##5##3##(2005-11#2)(2008-5#1)(2013-1#2)
whey protein##11##2##(1995-5#2)(1996-10#1)(2005-11#3)(2008-10#1)(2008-5#1)(2010-4#1)(2013-1#2)
whey protein-based biofilms##2##3##(2008-5#2)
whey##46##1##(1990-11#1)(1993-2#1)(1995-5#2)(1996-10#1)(1997-8#1)(2005-11#3)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#8)(2008-6#7)(2008-7#6)(2010-4#1)(2013-1#2)
whi2##5##1##(1997-6#5)
whiB##2##1##(2005-11#2)
whiH##2##1##(2008-8#2)
which &quot##6##2##(1994-8#1)(1996-11#1)(2006-3#1)(2008-1#1)(2011-1#1)(2013-8#1)
which (a)##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
which (i)##2##2##(1990-8#1)(1993-3#1)
which 1##6##2##(1995-5#1)(1996-2#1)(1997-1#1)(2007-7#1)(2011-3#1)(2013-8#1)
which 10##6##2##(2006-5#1)(2007-8#3)(2008-10#2)
which 100##3##2##(1996-4#1)(2012-2#1)(2013-1#1)
which 11##7##2##(1993-9#1)(2005-10#1)(2007-12#1)(2007-2#1)(2007-8#2)(2010-9#1)
which 12##7##2##(1994-5#1)(2004-9#1)(2007-8#5)
which 13##7##2##(2005-10#1)(2007-8#4)(2008-7#1)(2011-2#1)
which 14##7##2##(1991-12#1)(2007-8#4)(2008-12#1)(2012-1#1)
which 15##6##2##(1991-9#1)(1994-2#1)(2006-10#1)(2007-7#1)(2007-8#2)
which 18 were##2##3##(2005-8#1)(2012-2#1)
which 18##5##2##(2005-8#1)(2007-8#2)(2008-10#1)(2012-2#1)
which 26 were##2##3##(1995-12#1)(1997-8#1)
which 26##3##2##(1995-12#1)(1997-8#1)(2008-8#1)
which 3##4##2##(1993-5#1)(2007-8#1)(2011-2#1)(2013-8#1)
which 4##7##2##(2006-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-9#2)
which 44##2##2##(1991-8#1)(2012-3#1)
which 5##5##2##(1994-8#1)(2006-10#1)(2007-8#1)(2008-11#1)(2011-1#1)
which 53##2##2##(1996-1#1)(2011-12#1)
which 55##3##2##(2004-11#1)(2008-10#1)(2012-12#1)
which 6%##3##2##(1994-8#1)(2007-6#1)(2012-2#1)
which 60##3##2##(2006-10#1)(2008-5#1)(2013-1#1)
which 69%##2##2##(2008-4#1)(2011-1#1)
which 7##2##2##(1992-2#1)(2012-12#1)
which 8##8##2##(1991-11#1)(2007-2#1)(2007-8#5)(2013-8#1)
which A##3##2##(1995-8#1)(2008-10#1)(2012-3#1)
which ATP##5##2##(1994-9#1)(1995-2#1)(1996-8#1)(1997-7#1)(2006-12#1)
which B cells##2##3##(2008-4#2)
which B##3##2##(2008-10#1)(2008-4#2)
which Buffon##2##2##(2008-12#2)
which C##4##2##(2007-12#4)
which CO(2)##2##2##(2008-10#1)(2011-2#1)
which CR##2##2##(1994-5#1)(2008-7#1)
which CTB##2##2##(1997-7#2)
which Canadian##2##2##(2007-12#1)(2011-2#1)
which DA##2##2##(1996-8#1)(2008-5#1)
which DNA is##2##3##(2008-10#2)
which DNA##10##2##(1990-3#1)(1994-10#1)(1995-3#1)(1997-4#1)(2008-10#5)(2009-4#1)
which DSIP was injected##3##4##(1995-12#3)
which Gd(3+) has the greatest enhancement##2##6##(2008-10#2)
which HIV##5##2##(1991-6#1)(1996-5#1)(2008-10#1)(2008-5#1)(2012-3#1)
which I have##2##3##(2006-12#1)(2007-5#1)
which I##8##2##(1995-2#1)(1995-8#1)(2006-12#1)(2007-5#1)(2008-11#1)(2008-9#1)(2012-2#1)(2013-8#1)
which Medicare##3##2##(1997-3#1)(2008-7#1)(2012-3#1)
which NGF##2##2##(1996-3#2)
which NO##3##2##(2008-10#1)(2010-12#1)(2011-2#1)
which P##3##2##(2008-10#3)
which P1##2##2##(1992-9#1)(1994-5#1)
which RNA##4##2##(1993-8#1)(1994-8#1)(1995-8#1)(1996-11#1)
which S##2##2##(2008-10#1)(2012-7#1)
which T cell##2##3##(1990-12#1)(1994-2#1)
which T cells##3##3##(1995-2#1)(1996-4#1)(2008-8#1)
which T##6##2##(1990-12#1)(1994-2#1)(1995-2#1)(1996-4#1)(2008-10#1)(2008-8#1)
which UV##2##2##(2008-10#1)(2011-2#1)
which Wolbachia##3##2##(2008-8#1)(2008-9#1)(2012-12#1)
which a 3##2##3##(1992-7#1)(1995-8#1)
which a cell##2##3##(1993-9#1)(2008-7#1)
which a different##3##3##(2007-11#1)(2008-10#2)
which a direct##2##3##(1992-2#1)(2007-11#1)
which a fixed##3##3##(2008-3#1)(2010-2#2)
which a gene##3##3##(1992-8#1)(1996-3#1)(2008-9#1)
which a given##3##3##(1993-9#1)(2008-1#1)(2008-10#1)
which a high##4##3##(2007-8#1)(2008-7#1)(2010-10#1)(2011-2#1)
which a large##4##3##(1994-11#1)(1997-4#1)(2008-3#1)(2012-3#1)
which a microscope##2##3##(2008-2#1)(2008-9#1)
which a normal##2##3##(1997-1#1)(2005-12#1)
which a patient's##4##3##(2007-6#1)(2013-1#2)(2013-8#1)
which a portion of the##2##5##(2007-12#1)(2012-1#1)
which a sample##2##3##(2007-11#1)(2008-10#1)
which a series of##2##4##(1992-12#1)(1996-5#1)
which a signal##2##3##(1993-6#1)(2007-11#1)
which a significant##2##3##(1990-4#1)(1993-8#1)
which a simple##2##3##(2008-2#1)(2008-4#1)
which a single##8##3##(1990-6#1)(1997-4#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-6#1)
which a small number of##2##5##(1992-9#1)(2010-4#1)
which a small##6##3##(1992-9#1)(1995-11#1)(2007-12#1)(2008-4#1)(2010-3#1)(2010-4#1)
which a specific##5##3##(1991-10#1)(1995-8#1)(2008-4#1)(2009-5#1)(2012-2#1)
which a steady state##2##4##(2004-9#1)(2008-10#1)
which a strong##2##3##(2008-11#1)(2008-2#1)
which a subject##4##3##(2008-11#1)(2008-4#1)(2010-8#1)(2012-3#1)
which a test##2##3##(2007-11#1)(2008-4#1)
which a user##2##3##(2008-4#2)
which a variety of##2##4##(1993-6#1)(2009-12#1)
which a##330##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#2)(1991-10#1)(1991-2#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#3)(1994-10#1)(1994-11#2)(1994-2#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#3)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#5)(1997-7#2)(1997-8#1)(2004-9#2)(2005-10#2)(2005-11#3)(2005-12#1)(2005-5#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-5#4)(2006-6#2)(2006-8#2)(2007-11#12)(2007-12#19)(2007-2#3)(2007-3#1)(2007-6#3)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#5)(2008-10#19)(2008-11#6)(2008-12#1)(2008-2#18)(2008-3#19)(2008-4#11)(2008-5#10)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#4)(2009-10#2)(2009-12#3)(2009-3#1)(2009-5#1)(2009-6#4)(2009-7#1)(2009-9#1)(2010-10#3)(2010-12#1)(2010-2#2)(2010-3#4)(2010-4#2)(2010-5#2)(2010-7#4)(2010-8#1)(2010-9#1)(2011-2#7)(2012-1#6)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#9)(2013-8#6)
which abolished##2##2##(1992-3#1)(1997-2#1)
which about##3##2##(1990-3#1)(1997-4#1)(2008-10#1)
which accelerates the##3##3##(1992-12#1)(2011-12#1)(2013-8#1)
which accelerates##5##2##(1992-12#1)(1995-11#1)(1997-4#1)(2011-12#1)(2013-8#1)
which access##2##2##(2008-3#1)(2008-5#1)
which accommodates for relative prevalence##2##5##(2013-1#2)
which accommodates##4##2##(1994-3#1)(1996-5#1)(2013-1#2)
which accompanies##5##2##(1990-5#1)(1990-6#1)(1991-5#1)(2007-12#2)
which accompany the##2##3##(1997-2#1)(2008-9#1)
which accompany##4##2##(1997-1#1)(1997-2#1)(2006-10#1)(2008-9#1)
which according to##2##3##(1992-2#1)(1993-3#1)
which account for the##2##4##(1993-4#1)(2010-12#1)
which account for##7##3##(1993-4#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
which accounted for##10##3##(1992-6#1)(1994-12#1)(1996-8#1)(2005-11#1)(2008-10#5)(2010-5#1)
which accounts for about##2##4##(2008-10#1)(2011-1#1)
which accounts for the##8##4##(1990-8#1)(1994-6#1)(2007-11#1)(2008-2#1)(2008-3#1)(2009-5#1)(2009-9#1)(2012-2#1)
which accounts for##14##3##(1990-8#1)(1994-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
which accumulate in the##2##4##(1991-12#1)(2008-9#1)
which accumulate##4##2##(1991-12#1)(1994-2#1)(1997-4#1)(2008-9#1)
which accumulates in##2##3##(1992-7#1)(2008-5#1)
which accumulates##4##2##(1990-3#1)(1992-7#1)(1995-3#1)(2008-5#1)
which acetate##2##2##(1993-6#1)(2006-3#1)
which achieved##5##2##(2005-10#1)(2008-7#1)(2012-12#1)(2012-2#2)
which act as##12##3##(1990-12#1)(1991-1#1)(1991-5#1)(1992-9#1)(1994-5#1)(1994-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)
which act in##2##3##(1990-11#1)(2008-1#1)
which act##20##2##(1990-11#1)(1990-12#1)(1991-1#2)(1991-5#1)(1992-9#1)(1994-5#1)(1994-8#1)(2005-9#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#1)
which acted as##3##3##(1994-9#1)(2007-8#1)(2008-3#1)
which acted##4##2##(1994-9#1)(2007-8#1)(2008-3#1)(2008-8#1)
which activate the##2##3##(1990-3#1)(1996-8#1)
which activate##13##2##(1990-3#1)(1992-8#2)(1994-11#1)(1996-8#1)(2005-3#1)(2005-7#1)(2006-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-6#1)(2010-12#1)
which activated##3##2##(1996-1#1)(1997-8#1)(2008-8#1)
which activates the##6##3##(1990-4#1)(1993-3#1)(1993-9#1)(1996-5#1)(2008-3#1)(2011-2#1)
which activates##17##2##(1990-11#1)(1990-3#1)(1990-4#1)(1991-11#1)(1992-7#1)(1993-3#1)(1993-9#1)(1994-8#1)(1996-5#1)(1997-2#1)(1997-4#1)(2003-11#1)(2008-3#1)(2008-7#1)(2008-9#2)(2011-2#1)
which activation##3##2##(1997-4#1)(2008-4#2)
which active##2##2##(2010-12#1)(2011-12#1)
which actively##2##2##(2008-12#1)(2013-1#1)
which acts as a tethered ligand##2##6##(1991-9#1)(1992-4#1)
which acts as a##14##4##(1991-9#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-12#1)(1994-12#1)(1994-6#1)(1995-1#1)(1996-3#1)(2004-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-4#1)
which acts as an##6##4##(1993-3#1)(1994-5#1)(2005-7#1)(2008-4#1)(2008-6#1)(2013-1#1)
which acts as the##3##4##(1994-5#1)(2008-10#1)(2008-2#1)
which acts as##26##3##(1991-9#1)(1992-1#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-5#2)(1994-6#1)(1995-1#1)(1996-3#1)(1997-5#1)(2004-9#1)(2005-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-4#1)(2013-1#1)
which acts at##2##3##(2006-6#1)(2007-9#1)
which acts to##2##3##(2008-1#1)(2008-7#1)
which acts##38##2##(1991-2#1)(1991-9#1)(1992-1#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-5#2)(1994-6#1)(1995-1#1)(1996-3#1)(1997-2#1)(1997-5#1)(2004-9#1)(2005-7#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-4#1)(2012-1#1)(2013-1#1)
which actually##2##2##(1996-7#1)(2008-2#1)
which adapts##2##2##(1994-11#1)(2012-12#1)
which additional##3##2##(2007-6#1)(2008-1#1)(2008-4#1)
which address the##2##3##(1992-3#1)(2004-12#1)
which address##4##2##(1992-3#1)(2004-12#1)(2007-10#1)(2012-2#1)
which addresses the##3##3##(1994-1#1)(2008-7#1)(2011-1#1)
which addresses##5##2##(1994-1#1)(2006-10#1)(2008-7#1)(2011-1#1)(2013-7#1)
which administration of##2##3##(2006-8#1)(2007-7#1)
which adolescents##2##2##(2007-3#1)(2012-12#1)
which adopted##2##2##(1990-2#1)(2007-12#1)
which advanced##2##2##(2008-3#1)(2012-2#1)
which affect the##10##3##(1991-12#1)(1993-9#1)(1996-12#1)(1997-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-5#1)(2010-8#1)
which affect##21##2##(1991-12#1)(1993-9#1)(1994-3#1)(1996-12#1)(1996-8#1)(1997-2#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-5#1)(2010-8#2)(2012-1#1)(2013-1#1)
which affected the##3##3##(2007-12#1)(2010-8#1)(2012-12#1)
which affected##5##2##(1995-11#1)(2007-12#1)(2008-8#1)(2010-8#1)(2012-12#1)
which affects a##3##3##(2006-1#1)(2008-10#1)(2008-3#1)
which affects about 2% of the population##2##7##(1990-5#1)(1997-8#1)
which affects the##5##3##(2007-8#1)(2008-12#1)(2008-8#1)(2012-12#1)(2013-8#1)
which affects##30##2##(1990-5#1)(1990-9#1)(1991-12#1)(1994-4#1)(1995-6#1)(1997-8#1)(2005-7#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-9#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#3)
which afforded##2##2##(2008-10#1)(2009-10#1)
which affords the##2##3##(2008-9#1)(2012-2#1)
which after##5##2##(1995-3#1)(2007-8#2)(2008-11#1)(2009-2#1)
which again##2##2##(1990-5#1)(1995-6#1)
which aggregates##2##2##(1994-2#1)(2008-5#1)
which aging##3##2##(2007-12#1)(2008-7#1)(2013-1#1)
which agreed with##2##3##(2010-9#1)(2011-1#1)
which agreed##3##2##(2008-3#1)(2010-9#1)(2011-1#1)
which agrees with the##6##4##(1990-9#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-8#1)(2009-4#1)
which agrees with##7##3##(1990-10#1)(1990-9#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-8#1)(2009-4#1)
which agrees##8##2##(1990-10#1)(1990-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-8#1)(2009-4#1)
which aids in##2##3##(1991-8#1)(1993-12#1)
which aim at##3##3##(2006-6#1)(2011-2#1)(2013-8#1)
which aim to##3##3##(2008-10#1)(2010-9#1)(2011-2#1)
which aim##6##2##(2006-6#1)(2008-10#1)(2010-9#1)(2011-2#2)(2013-8#1)
which aimed at##3##3##(2008-10#1)(2012-12#1)(2012-2#1)
which aimed to##9##3##(2005-8#1)(2007-12#1)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#1)
which aimed##12##2##(2005-8#1)(2007-12#1)(2008-10#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)
which aims at the##2##4##(2004-8#1)(2013-8#1)
which aims at##6##3##(1996-7#1)(2004-8#1)(2006-8#1)(2008-7#1)(2010-1#1)(2013-8#1)
which aims to##4##3##(2008-11#1)(2008-6#1)(2009-12#1)(2010-8#1)
which aims##10##2##(1996-7#1)(2004-8#1)(2006-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-1#1)(2010-8#1)(2013-8#1)
which alcohol abusers can manage##2##5##(1994-2#2)
which alcohol##3##2##(1994-2#2)(2008-10#1)
which aligned##2##2##(1992-7#1)(2008-5#1)
which all minimize collision fraction and enhance energy recovery##2##9##(2012-12#2)
which all the##7##3##(2006-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)
which all were##2##3##(2008-11#1)(2010-1#1)
which all##51##2##(1990-2#1)(1990-4#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#1)(1992-3#1)(1993-12#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-5#1)(1996-7#1)(1997-4#1)(2004-10#1)(2005-10#1)(2006-1#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-1#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)
which allow a##4##3##(1990-7#1)(2006-10#1)(2008-5#1)(2008-6#1)
which allow for##3##3##(1992-6#1)(2008-1#1)(2009-5#1)
which allow the determination of##2##5##(2005-11#1)(2008-10#1)
which allow the##9##3##(1990-12#1)(1993-2#1)(1993-6#1)(2005-11#1)(2008-10#2)(2008-4#1)(2008-8#1)(2011-1#1)
which allow to##2##3##(2005-11#1)(2007-11#1)
which allow us to obtain##2##5##(2007-11#1)(2008-2#1)
which allow us to##5##4##(1990-11#1)(1996-5#1)(2007-11#1)(2008-2#1)(2013-8#1)
which allow##42##2##(1990-11#1)(1990-12#1)(1990-7#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-7#1)(1996-5#1)(1996-6#1)(1997-6#1)(2005-11#2)(2006-10#1)(2006-5#1)(2007-11#3)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-5#1)(2009-9#1)(2010-11#1)(2011-1#1)(2013-8#1)
which allowed a##3##3##(1995-6#1)(2006-10#1)(2010-10#1)
which allowed for##5##3##(1991-2#1)(1994-8#1)(2007-7#1)(2008-3#1)(2009-9#1)
which allowed the determination of##3##5##(2008-10#3)
which allowed the study of##2##5##(1994-6#1)(2008-11#1)
which allowed the##14##3##(1990-9#1)(1993-1#1)(1994-6#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-10#6)(2008-11#1)(2009-7#1)
which allowed to##2##3##(1990-11#1)(2008-10#1)
which allowed us to##3##4##(1991-6#1)(2011-2#2)
which allowed##49##2##(1990-11#1)(1990-9#2)(1991-2#1)(1991-6#1)(1993-1#1)(1993-6#1)(1994-12#1)(1994-6#2)(1994-8#1)(1995-3#1)(1995-6#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-1#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-5#1)(2011-2#3)(2013-1#2)
which allows a complete##2##4##(2006-12#1)(2008-3#1)
which allows a##12##3##(1993-2#1)(1993-5#1)(1997-6#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)
which allows an##4##3##(1994-3#1)(2008-12#1)(2008-3#1)(2009-4#1)
which allows both##2##3##(1992-3#1)(2009-6#1)
which allows cells to##2##4##(2007-10#1)(2010-1#1)
which allows for a##3##4##(2008-10#1)(2008-2#1)(2008-6#1)
which allows for the##5##4##(1990-5#1)(2007-12#1)(2008-3#2)(2008-4#1)
which allows for##21##3##(1990-5#1)(1993-3#1)(1997-2#1)(2005-7#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-2#1)(2013-1#1)
which allows one to##4##4##(2007-12#2)(2008-10#1)(2008-4#1)
which allows rapid##2##3##(1991-10#1)(1994-6#1)
which allows simultaneous##3##3##(1995-8#1)(1996-1#1)(2007-12#1)
which allows small##2##3##(2007-8#1)(2008-10#1)
which allows the determination of##2##5##(2007-8#1)(2008-10#1)
which allows the use of##2##5##(2008-5#1)(2011-1#1)
which allows the##36##3##(1990-3#1)(1990-4#1)(1990-9#1)(1991-11#2)(1991-5#1)(1992-12#1)(1992-9#1)(1996-5#1)(1997-6#1)(2006-2#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-12#1)(2010-7#1)(2011-1#2)
which allows to##8##3##(1991-2#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#2)(2009-10#1)(2012-3#1)
which allows us to##5##4##(1990-2#1)(1994-6#1)(1994-8#1)(2008-3#1)(2012-3#1)
which allows users to##3##4##(2008-4#1)(2008-7#1)(2011-3#1)
which allows##158##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-3#1)(1994-4#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-8#1)(2005-12#1)(2005-5#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#6)(2007-12#6)(2007-3#1)(2007-4#1)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#18)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#8)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#2)(2010-1#1)(2010-12#3)(2010-2#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#3)(2012-10#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
which almost##3##2##(1997-4#1)(2007-8#1)(2008-10#1)
which alone##4##2##(1993-12#1)(1993-6#1)(1997-1#1)(2009-6#1)
which already##2##2##(1991-9#1)(1996-3#1)
which also activates##2##3##(1995-11#1)(2007-12#1)
which also acts as an##2##5##(1993-6#2)
which also affects the##2##4##(2008-8#1)(2011-1#1)
which also affects##3##3##(2008-8#1)(2011-1#1)(2012-2#1)
which also binds##2##3##(1995-2#1)(2008-7#1)
which also cause##2##3##(1994-10#1)(2007-7#1)
which also contains the##2##4##(2005-10#1)(2008-3#1)
which also contains##4##3##(1991-12#1)(1992-1#1)(2005-10#1)(2008-3#1)
which also correlated##2##3##(2006-9#1)(2008-3#1)
which also exhibited##2##3##(1992-11#1)(1994-5#1)
which also had##2##3##(1996-4#1)(2008-10#1)
which also has##3##3##(1990-7#1)(1996-7#1)(2007-8#1)
which also included##3##3##(2005-8#1)(2008-10#1)(2012-3#1)
which also includes##5##3##(1993-9#1)(1994-12#1)(1997-8#1)(2006-10#1)(2008-10#1)
which also influence##2##3##(2008-11#1)(2012-2#1)
which also provides a##2##4##(1997-1#1)(2008-10#1)
which also provides##3##3##(1996-8#1)(1997-1#1)(2008-10#1)
which also showed##5##3##(1990-11#1)(1991-5#1)(1991-8#1)(1993-12#1)(2006-12#1)
which also was##3##3##(1991-3#1)(1996-12#1)(2013-1#1)
which also##125##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-3#1)(1992-9#2)(1993-12#1)(1993-3#2)(1993-6#2)(1993-9#1)(1994-10#1)(1994-12#3)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#2)(1996-7#2)(1996-8#2)(1997-1#1)(1997-4#1)(1997-5#1)(1997-8#2)(2004-11#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-5#2)(2006-7#1)(2006-9#2)(2007-11#1)(2007-12#4)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-3#2)(2009-8#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-11#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
which alter the##3##3##(1995-6#1)(2006-10#1)(2008-1#1)
which alter##7##2##(1990-6#1)(1991-2#1)(1995-12#1)(1995-6#1)(2006-10#1)(2008-1#1)(2009-3#1)
which alternative##2##2##(1997-3#1)(2007-5#1)
which alters the##4##3##(1991-12#1)(1994-9#1)(2008-3#1)(2009-12#1)
which alters##8##2##(1991-10#1)(1991-12#1)(1994-9#1)(1995-8#1)(1996-7#1)(2008-3#1)(2008-7#1)(2009-12#1)
which aluminum##2##2##(1996-8#2)
which always##4##2##(1990-7#1)(2005-11#1)(2007-9#1)(2008-10#1)
which amino##2##2##(1992-6#1)(1995-12#1)
which ammonia##2##2##(1990-8#1)(2008-10#1)
which amplifies##2##2##(2008-10#1)(2008-5#1)
which an accurate##2##3##(1992-2#1)(2008-3#1)
which an association##2##3##(2008-4#1)(2012-12#1)
which an autoimmune##2##3##(1996-11#1)(1997-4#1)
which an individual##3##3##(2008-2#1)(2008-4#1)(2008-5#1)
which an intense##2##3##(2008-10#2)
which an optical##3##3##(2007-3#1)(2008-2#1)(2008-3#1)
which an##73##2##(1990-11#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-2#1)(1992-2#2)(1992-6#1)(1993-12#1)(1994-6#1)(1995-3#1)(1996-11#3)(1997-4#1)(1997-7#1)(1997-8#2)(2006-12#1)(2007-11#3)(2007-12#4)(2007-3#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#2)(2008-3#7)(2008-4#6)(2008-5#2)(2008-6#1)(2009-12#1)(2009-9#1)(2010-11#1)(2010-2#1)(2011-12#1)(2011-2#2)(2011-8#1)(2012-12#2)(2013-1#4)
which analytical##3##2##(2008-10#1)(2008-2#2)
which analyzes the##2##3##(2008-2#2)
which animal##4##2##(1991-11#1)(2004-8#1)(2006-10#1)(2008-8#1)
which animals##7##2##(1992-8#1)(1996-4#1)(2007-9#1)(2008-12#1)(2008-4#1)(2009-8#1)(2012-2#1)
which anomalies are##3##3##(2007-8#1)(2013-1#2)
which antagonize the##2##3##(1992-2#1)(2005-8#1)
which antibodies##4##2##(2008-2#1)(2008-4#2)(2008-9#1)
which antibody##3##2##(1993-8#1)(1995-2#1)(2008-4#1)
which any##4##2##(1991-6#1)(2006-12#1)(2008-10#1)(2012-12#1)
which apoptosis##2##2##(2005-7#1)(2012-2#1)
which apoptotic##2##2##(2008-7#1)(2008-9#1)
which apothecia##2##2##(2008-10#2)
which apparently##5##2##(1991-7#1)(1997-8#1)(2006-4#1)(2008-10#1)(2013-1#1)
which appear as##2##3##(1990-12#1)(2010-6#1)
which appear to be##8##4##(1990-5#1)(1995-12#1)(1995-6#1)(2007-5#1)(2008-10#1)(2008-9#1)(2009-8#1)(2010-3#1)
which appear to have##2##4##(1997-7#1)(2007-12#1)
which appear to represent a##2##5##(2006-8#1)(2008-7#1)
which appear to##23##3##(1990-5#1)(1994-5#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-7#1)(2005-11#1)(2006-8#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-3#1)
which appear##35##2##(1990-12#1)(1990-5#1)(1992-6#1)(1994-5#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)
which appeared in the##4##4##(1991-5#1)(1995-3#1)(2005-7#1)(2006-10#1)
which appeared in##8##3##(1990-12#1)(1991-5#1)(1992-2#1)(1994-8#1)(1995-3#1)(2005-7#1)(2006-10#1)(2008-5#1)
which appeared to be##11##4##(1990-10#1)(1990-2#1)(1994-11#1)(2005-10#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)
which appeared to##21##3##(1990-10#1)(1990-2#1)(1990-5#1)(1990-6#1)(1993-12#1)(1994-11#1)(1995-12#1)(1995-6#1)(2005-10#1)(2007-1#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)
which appeared##38##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-12#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(2005-10#1)(2005-7#1)(2006-10#1)(2007-1#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#2)(2010-8#1)(2011-2#1)(2012-2#1)
which appears in##2##3##(2008-9#1)(2010-5#1)
which appears on##2##3##(1994-12#1)(2013-1#1)
which appears to be a##4##5##(1990-12#1)(1994-11#1)(1995-12#1)(1995-5#1)
which appears to be the most##2##6##(1995-7#1)(2007-11#1)
which appears to be the##4##5##(1995-7#1)(2007-11#1)(2008-1#1)(2011-2#1)
which appears to be##26##4##(1990-12#1)(1990-7#1)(1990-9#1)(1991-4#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-8#1)(2005-7#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
which appears to encode##2##4##(1994-12#1)(1997-1#1)
which appears to##33##3##(1990-12#1)(1990-7#1)(1990-9#1)(1991-4#1)(1993-11#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-8#1)(1997-1#1)(2004-1#1)(2005-7#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#2)
which appears##43##2##(1990-12#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-4#1)(1993-11#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-7#1)(1996-8#1)(1997-1#1)(2004-1#1)(2005-7#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#2)
which applies the##2##3##(1997-8#1)(2008-10#1)
which applies##3##2##(1997-8#1)(2008-10#1)(2008-2#1)
which apply##3##2##(2007-12#1)(2008-4#1)(2013-8#1)
which approach the##2##3##(2005-11#1)(2008-5#1)
which approach##5##2##(1993-6#1)(2004-12#1)(2005-11#1)(2008-10#1)(2008-5#1)
which approximate##2##2##(1996-1#1)(2008-10#1)
which approximately##5##2##(1992-11#1)(1992-3#1)(1994-11#1)(1995-8#1)(2011-12#1)
which approximates the##2##3##(1997-8#1)(2008-8#1)
which are DNA##2##3##(1995-5#1)(2008-10#1)
which are a very effective way of summarizing and communicating multi-faceted data sets##2##13##(2013-1#2)
which are a##8##3##(1994-12#1)(1995-3#1)(1997-8#1)(2008-12#1)(2010-8#1)(2012-2#1)(2013-1#2)
which are able to##7##4##(1994-6#1)(2006-2#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-7#1)(2011-1#1)
which are absent in##2##4##(1994-12#1)(2008-8#1)
which are absent##3##3##(1994-12#1)(1994-3#1)(2008-8#1)
which are abundant in the##2##5##(2008-10#1)(2009-5#1)
which are abundant in##3##4##(2008-10#1)(2008-5#1)(2009-5#1)
which are acceptable##2##3##(1994-3#1)(2012-2#1)
which are activated by##4##4##(2006-10#2)(2006-2#1)(2008-8#1)
which are active against##2##4##(1990-7#1)(2011-2#1)
which are active##3##3##(1990-7#1)(2010-5#1)(2011-2#1)
which are added##2##3##(2007-12#1)(2008-10#1)
which are aggregated##2##3##(2008-6#1)(2013-7#1)
which are all##4##3##(1995-2#1)(1997-4#1)(2008-10#1)(2009-11#1)
which are already##2##3##(1992-10#1)(2009-5#1)
which are also##15##3##(1991-5#1)(2004-9#1)(2006-10#1)(2007-7#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-12#1)(2011-3#1)(2012-2#1)
which are amendable for programmatic revision of the FMA##2##9##(2013-1#2)
which are among the##2##4##(2008-3#1)(2008-8#1)
which are applied##4##3##(2007-8#1)(2008-2#1)(2011-2#2)
which are approved##2##3##(2005-6#1)(2007-3#1)
which are arranged##2##3##(1995-1#1)(2008-6#1)
which are associated with a##4##5##(1992-2#1)(1996-8#1)(2008-4#1)(2011-2#1)
which are associated with the##5##5##(1995-5#1)(2008-10#1)(2008-4#1)(2013-8#2)
which are associated with##16##4##(1992-2#1)(1995-5#1)(1996-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2009-8#1)(2010-1#1)(2011-2#2)(2013-8#2)
which are associated##17##3##(1991-12#1)(1992-2#1)(1995-5#1)(1996-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2009-8#1)(2010-1#1)(2011-2#2)(2013-8#2)
which are assumed to be##2##5##(1990-7#1)(1991-2#1)
which are assumed to##4##4##(1990-7#1)(1991-2#1)(1994-12#1)(1996-2#1)
which are at the##2##4##(2007-4#1)(2010-7#1)
which are at##4##3##(2005-8#1)(2007-12#1)(2007-4#1)(2010-7#1)
which are attached##2##3##(2008-10#1)(2009-1#1)
which are attributed to##2##4##(1992-8#1)(2005-11#1)
which are available##5##3##(2007-8#2)(2008-11#1)(2008-4#1)(2013-8#1)
which are based on##11##4##(1992-5#1)(1992-9#1)(1993-7#1)(1994-9#1)(1995-9#1)(2007-9#1)(2008-10#3)(2008-2#1)(2010-5#1)
which are based##13##3##(1991-12#1)(1992-5#1)(1992-9#1)(1993-7#1)(1994-9#1)(1995-9#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-9#1)(2010-5#1)
which are being increasingly##2##4##(2008-4#1)(2008-9#1)
which are being##4##3##(2006-9#1)(2008-4#1)(2008-9#1)(2012-11#1)
which are believed to be##3##5##(1996-3#1)(2007-11#1)(2007-12#1)
which are believed to play a##2##6##(1991-9#1)(2007-7#1)
which are believed to##9##4##(1991-9#1)(1994-11#1)(1996-3#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2009-3#1)(2010-7#1)
which are biologically active##2##4##(1992-12#1)(2008-5#1)
which are biologically different from##2##5##(2008-10#1)(2010-3#1)
which are biologically##4##3##(1992-12#1)(2008-10#1)(2008-5#1)(2010-3#1)
which are both##7##3##(1990-10#1)(1992-9#1)(1995-1#1)(2005-5#1)(2007-11#1)(2008-10#1)(2011-2#1)
which are called##2##3##(1994-12#1)(2005-11#1)
which are capable of##7##4##(1990-2#1)(1994-12#1)(2006-10#1)(2008-1#1)(2008-10#1)(2010-11#1)(2011-12#1)
which are carried out##2##4##(1990-12#1)(2007-11#1)
which are carried##5##3##(1990-12#1)(2005-7#1)(2007-11#1)(2008-7#1)(2012-1#1)
which are caused by##2##4##(2012-2#1)(2013-8#1)
which are cellular##2##3##(2006-10#1)(2011-2#1)
which are characteristic for a given molecule (fluorophore)##2##8##(2008-1#1)(2008-4#1)
which are characteristic for##4##4##(2008-1#1)(2008-4#1)(2010-5#1)(2011-1#1)
which are characteristic of the##2##5##(1994-11#1)(1996-3#1)
which are characteristic of##4##4##(1994-11#1)(1996-3#1)(2005-12#1)(2008-5#1)
which are characteristic##9##3##(1994-11#1)(1996-3#1)(2005-12#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-5#1)(2010-5#1)(2011-1#1)
which are characteristics of a##2##5##(1991-12#1)(1992-9#1)
which are characterized by##12##4##(1990-10#1)(1992-12#1)(1994-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
which are characterized##13##3##(1990-10#1)(1992-12#1)(1994-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-2#1)(2008-7#1)(2008-8#2)(2011-2#1)(2013-1#1)
which are classified##4##3##(1993-3#1)(1994-3#1)(1997-2#1)(2012-1#1)
which are clearly##2##3##(1991-9#1)(2005-9#1)
which are cleaved in##2##4##(2008-4#1)(2008-9#1)
which are clinically##2##3##(2007-11#1)(2009-5#1)
which are close to##2##4##(1996-12#1)(2008-11#1)
which are close##3##3##(1996-12#1)(2006-4#1)(2008-11#1)
which are closed##2##3##(1993-11#1)(2007-4#1)
which are closely related to##3##5##(1995-3#1)(1995-8#1)(2008-10#1)
which are closely##6##3##(1995-3#2)(1995-8#1)(1997-7#1)(2006-10#1)(2008-10#1)
which are common in##3##4##(2006-2#1)(2008-3#1)(2010-2#1)
which are common to##2##4##(2006-10#1)(2008-3#1)
which are common##8##3##(1997-5#1)(2006-10#1)(2006-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2010-2#1)
which are commonly referred to as##2##6##(2008-10#1)(2008-3#1)
which are commonly used##3##4##(1995-12#1)(2008-10#1)(2008-2#1)
which are commonly##9##3##(1993-9#1)(1995-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2011-2#1)(2013-1#1)
which are comparable to##2##4##(2008-10#1)(2013-8#1)
which are comparable##3##3##(2008-10#1)(2012-1#1)(2013-8#1)
which are compared##2##3##(1994-5#1)(2008-3#1)
which are compatible with##2##4##(1990-8#1)(2008-5#1)
which are components of##2##4##(1991-1#1)(1996-5#1)
which are composed of##4##4##(1997-4#1)(2008-10#1)(2012-1#2)
which are conserved among##2##4##(1993-3#1)(1996-8#1)
which are conserved in##3##4##(1994-12#1)(1996-7#1)(1996-9#1)
which are conserved##5##3##(1993-3#1)(1994-12#1)(1996-7#1)(1996-8#1)(1996-9#1)
which are considered the##2##4##(2007-3#1)(2008-10#1)
which are considered to be##4##5##(1993-6#1)(2007-11#1)(2010-3#1)(2013-8#1)
which are considered##9##3##(1993-6#1)(2004-11#1)(2004-12#1)(2006-5#1)(2007-11#1)(2007-3#1)(2008-10#1)(2010-3#1)(2013-8#1)
which are consistent with##4##4##(1996-2#1)(2008-10#1)(2008-8#1)(2009-12#1)
which are constructed by##2##4##(2007-11#1)(2013-1#1)
which are conventionally##2##3##(2007-7#1)(2013-1#1)
which are critical for the##2##5##(1993-12#1)(2007-11#1)
which are critical for##4##4##(1993-12#1)(1993-8#1)(2007-11#1)(2008-11#1)
which are critical##5##3##(1993-12#1)(1993-8#1)(2007-11#1)(2008-11#1)(2008-9#1)
which are cumulative##2##3##(2007-11#1)(2008-4#1)
which are currently being##2##4##(2008-11#1)(2008-12#1)
which are currently the##2##4##(2007-11#1)(2008-5#1)
which are currently##10##3##(2006-11#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2011-2#1)
which are defective in##2##4##(1995-3#1)(1995-8#1)
which are dependent on the##2##5##(1994-8#1)(2013-1#1)
which are derived from the##2##5##(2009-2#1)(2013-8#1)
which are derived from##3##4##(2006-8#1)(2009-2#1)(2013-8#1)
which are derived##4##3##(2006-8#1)(2009-2#1)(2012-2#1)(2013-8#1)
which are described in##3##4##(1996-2#1)(2008-4#2)
which are described##7##3##(1996-2#1)(2008-4#3)(2008-5#1)(2008-9#1)(2011-1#1)
which are designed to##5##4##(1997-4#1)(2005-5#1)(2008-11#1)(2008-7#1)(2010-2#1)
which are designed##6##3##(1997-4#1)(2005-5#1)(2007-12#1)(2008-11#1)(2008-7#1)(2010-2#1)
which are detectable##2##3##(1992-10#1)(2008-11#1)
which are detected##3##3##(2006-10#1)(2008-3#2)
which are different from those##2##5##(1993-11#1)(2010-3#1)
which are different from##3##4##(1993-11#1)(2008-9#1)(2010-3#1)
which are different##4##3##(1993-11#1)(2007-9#1)(2008-9#1)(2010-3#1)
which are differentially expressed in##3##5##(1994-9#1)(2008-10#1)(2012-12#1)
which are differentially expressed##4##4##(1992-6#1)(1994-9#1)(2008-10#1)(2012-12#1)
which are differentially##5##3##(1991-9#1)(1992-6#1)(1994-9#1)(2008-10#1)(2012-12#1)
which are differently##2##3##(1995-2#1)(2007-11#1)
which are difficult to access##2##5##(1995-8#1)(2008-3#1)
which are difficult to separate##2##5##(1992-1#1)(2008-7#1)
which are difficult to##14##4##(1992-1#1)(1993-10#2)(1995-8#1)(1997-6#1)(2006-11#1)(2006-5#1)(2007-8#2)(2008-3#1)(2008-7#1)(2009-5#1)(2010-3#1)(2012-2#1)
which are directly##4##3##(1996-8#1)(1997-2#1)(2008-10#2)
which are discussed in this##4##5##(2005-11#1)(2008-5#1)(2009-6#1)(2013-1#1)
which are discussed in##5##4##(2005-11#1)(2006-10#1)(2008-5#1)(2009-6#1)(2013-1#1)
which are discussed##10##3##(1990-8#1)(1990-9#1)(1991-3#1)(1997-4#1)(2005-11#1)(2005-7#1)(2006-10#1)(2008-5#1)(2009-6#1)(2013-1#1)
which are distributed##3##3##(1995-10#1)(2008-10#2)
which are due to##4##4##(1990-5#1)(2008-11#1)(2008-2#1)(2010-8#1)
which are each##2##3##(1995-1#1)(1996-8#1)
which are easily##3##3##(2005-11#1)(2007-11#1)(2009-12#1)
which are effective in##2##4##(2007-11#1)(2008-12#1)
which are effective##5##3##(1995-11#1)(2005-10#1)(2007-11#1)(2008-12#1)(2013-8#1)
which are encoded by##2##4##(1992-4#1)(2008-4#1)
which are encoded##4##3##(1990-4#1)(1992-4#1)(2008-4#1)(2013-1#1)
which are endemic in##3##4##(2007-12#1)(2012-12#1)(2013-1#1)
which are enzymatically##3##3##(1992-4#1)(1993-3#1)(2009-8#1)
which are equipped##2##3##(2005-10#1)(2008-5#1)
which are essential constituents of the blood-brain barrier##2##8##(2013-1#2)
which are essential for##7##4##(1994-12#1)(1994-8#1)(2007-12#1)(2008-4#1)(2008-5#1)(2010-9#1)(2012-2#1)
which are essential to the##2##5##(1995-5#2)
which are essential to##6##4##(1995-5#2)(2007-8#1)(2008-11#1)(2011-2#1)(2012-2#1)
which are essential##17##3##(1994-12#1)(1994-8#1)(1995-5#2)(1996-2#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-1#3)
which are evaluated in a series of 12 test procedures##2##10##(2013-1#2)
which are evaluated##3##3##(2008-2#1)(2013-1#2)
which are expected##3##3##(2005-7#1)(2008-7#1)(2010-12#1)
which are expressed by##2##4##(2006-12#1)(2007-11#1)
which are expressed in the##2##5##(1992-9#1)(1996-11#1)
which are expressed in##6##4##(1991-9#1)(1992-6#1)(1992-9#1)(1996-11#1)(2005-8#1)(2008-11#1)
which are expressed on##2##4##(2008-4#1)(2008-7#1)
which are expressed##13##3##(1990-8#1)(1991-9#1)(1992-6#1)(1992-9#1)(1996-11#1)(2005-8#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)
which are extremely##2##3##(1995-5#1)(2008-10#1)
which are far more##2##4##(1992-11#1)(2008-9#1)
which are features of##2##4##(2008-10#1)(2012-2#1)
which are focused on##2##4##(2006-10#1)(2012-2#1)
which are formed in##2##4##(1991-3#1)(1996-5#1)
which are formed##7##3##(1991-3#1)(1994-2#1)(1996-5#1)(2006-3#1)(2007-12#1)(2008-10#2)
which are found in##2##4##(1992-8#1)(1994-8#1)
which are found to##3##4##(1991-2#1)(2008-7#1)(2008-8#1)
which are found##8##3##(1991-2#1)(1992-8#1)(1994-8#1)(2008-4#1)(2008-7#2)(2008-8#1)(2013-1#1)
which are frequent##2##3##(1991-12#1)(2010-11#1)
which are frequently found##2##4##(1995-1#1)(2008-7#1)
which are frequently##5##3##(1990-9#1)(1995-1#1)(2008-7#1)(2010-3#1)(2011-2#1)
which are generally associated##2##4##(1997-1#1)(2010-12#1)
which are generally considered##2##4##(1997-8#1)(2008-10#1)
which are generally present in##2##5##(1992-9#1)(1996-12#1)
which are generally referred to as the &quot##2##8##(1996-12#1)(1997-4#1)
which are generally##18##3##(1990-12#1)(1990-8#1)(1992-6#1)(1992-9#1)(1995-2#1)(1996-12#2)(1997-1#1)(1997-4#1)(1997-8#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)
which are generated##3##3##(2007-11#1)(2007-9#1)(2008-1#1)
which are greater##2##3##(1997-8#1)(2012-12#1)
which are growth##2##3##(2008-11#1)(2008-5#1)
which are highly conserved##3##4##(1996-10#1)(1996-8#1)(2011-1#1)
which are highly selective##2##4##(1996-1#1)(2008-10#1)
which are highly##15##3##(1991-7#1)(1994-6#1)(1996-1#1)(1996-10#1)(1996-5#1)(1996-7#1)(1996-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-1#1)
which are hydrolyzed##2##3##(1990-12#1)(2010-8#1)
which are identical to##2##4##(1993-11#1)(1994-2#1)
which are identical with##2##4##(1990-7#1)(1997-7#1)
which are identical##4##3##(1990-7#1)(1993-11#1)(1994-2#1)(1997-7#1)
which are important for the##6##5##(1993-9#1)(1994-8#1)(1995-8#1)(1997-2#1)(1997-4#1)(2008-10#1)
which are important for##11##4##(1993-9#1)(1994-8#1)(1995-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
which are important in##2##4##(1994-6#1)(2008-10#1)
which are important##20##3##(1993-9#1)(1994-6#1)(1994-8#1)(1995-8#1)(1996-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-8#1)
which are in a##2##4##(1997-6#1)(2012-12#1)
which are in addition to##2##5##(2006-10#1)(2012-3#1)
which are in the##3##4##(1990-4#1)(2008-10#1)(2008-11#1)
which are in##17##3##(1990-12#1)(1990-3#1)(1990-4#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-5#3)(2010-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
which are independent of##6##4##(1990-8#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-7#1)(2010-4#1)
which are indicative of the##2##5##(2007-12#1)(2011-1#1)
which are indicative of##4##4##(2007-12#1)(2008-3#1)(2010-12#1)(2011-1#1)
which are induced by##2##4##(1990-8#1)(2008-4#1)
which are influenced##2##3##(2005-11#1)(2008-2#1)
which are insensitive to##2##4##(1990-12#1)(2006-10#1)
which are inserted##3##3##(1991-3#1)(1993-6#1)(2007-12#1)
which are instrumental##2##3##(2006-10#1)(2010-4#1)
which are involved in the pathogenesis of##2##7##(2006-6#1)(2008-7#1)
which are involved in the##9##5##(1992-10#1)(1992-2#1)(1992-6#1)(1995-12#1)(1996-9#1)(2006-2#1)(2006-6#1)(2008-10#1)(2008-7#1)
which are involved in##21##4##(1992-10#1)(1992-2#1)(1992-4#1)(1992-6#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-7#1)(2006-2#1)(2006-5#1)(2006-6#1)(2008-10#2)(2008-11#2)(2008-7#1)(2009-8#1)
which are isolated from##2##4##(1991-5#1)(2010-5#1)
which are isolated##4##3##(1990-2#1)(1991-5#2)(2010-5#1)
which are known as##4##4##(1992-11#1)(1993-3#1)(2007-11#1)(2008-3#1)
which are known to be involved in##3##7##(1991-8#1)(2008-11#1)(2008-4#1)
which are known to be##14##5##(1991-8#1)(1994-3#1)(1995-3#1)(1996-3#1)(1997-8#1)(2005-10#1)(2008-1#1)(2008-11#3)(2008-4#1)(2008-7#1)(2010-4#1)(2013-8#1)
which are known to have##2##5##(2012-12#1)(2013-1#1)
which are known to induce##5##5##(1990-10#1)(1994-10#1)(1994-12#1)(1995-9#1)(2009-8#1)
which are known to interfere with other previously suggested sensors##2##10##(2008-10#2)
which are known to interfere with##3##6##(2008-10#3)
which are known to interfere##4##5##(2008-10#4)
which are known to regulate##3##5##(1991-9#1)(1994-12#1)(1995-11#1)
which are known to##47##4##(1990-10#2)(1991-8#1)(1991-9#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-3#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-9#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-8#1)(2005-10#1)(2008-1#2)(2008-10#4)(2008-11#5)(2008-4#1)(2008-7#3)(2008-9#1)(2009-2#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
which are known##56##3##(1990-10#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-5#1)(1992-8#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-3#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-9#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-8#1)(2005-10#1)(2007-11#1)(2008-1#2)(2008-10#4)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-2#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
which are largely##2##3##(2008-12#1)(2010-12#1)
which are less##4##3##(2003-11#1)(2008-5#1)(2010-10#1)(2011-2#1)
which are likely to be involved in##2##7##(1990-6#1)(1993-4#1)
which are likely to be##4##5##(1990-6#1)(1993-4#1)(2005-10#1)(2007-7#1)
which are likely to##8##4##(1990-6#1)(1993-4#1)(1997-3#1)(2005-10#1)(2006-9#1)(2007-7#1)(2009-7#1)(2013-8#1)
which are likely##10##3##(1990-6#1)(1992-9#1)(1993-4#1)(1997-3#1)(2005-10#1)(2005-8#1)(2006-9#1)(2007-7#1)(2009-7#1)(2013-8#1)
which are linked to the##2##5##(1995-8#1)(2008-5#1)
which are linked to##4##4##(1995-8#1)(2008-5#1)(2010-10#1)(2013-8#1)
which are localized in##2##4##(1994-12#1)(1997-2#1)
which are located in the##4##5##(1991-2#1)(1994-2#1)(1997-6#1)(2008-7#1)
which are located in##6##4##(1991-2#1)(1994-2#1)(1996-7#1)(1997-6#1)(2008-4#1)(2008-7#1)
which are located on##2##4##(1992-1#1)(2008-8#1)
which are located within the##3##5##(1991-3#1)(1994-12#1)(1995-8#1)
which are located##16##3##(1990-7#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-8#1)(1996-7#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-4#1)(2008-7#1)(2008-8#1)
which are made of##2##4##(1993-2#1)(1994-12#1)
which are mainly##5##3##(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)
which are major##2##3##(2008-10#1)(2010-11#1)
which are markers of the##2##5##(2008-10#2)
which are measured by##2##4##(2007-11#1)(2008-4#1)
which are measured##5##3##(1994-2#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-4#1)
which are mediated by##4##4##(1993-11#1)(1993-6#1)(2006-10#1)(2008-4#1)
which are mediated##5##3##(1991-2#1)(1993-11#1)(1993-6#1)(2006-10#1)(2008-4#1)
which are members of the nuclear##2##6##(1995-8#1)(2009-4#1)
which are members of the##8##5##(1992-11#1)(1993-9#1)(1995-8#1)(2006-10#1)(2006-8#1)(2008-10#2)(2009-4#1)
which are members of##9##4##(1990-5#1)(1992-11#1)(1993-9#1)(1995-8#1)(2006-10#1)(2006-8#1)(2008-10#2)(2009-4#1)
which are more effective##2##4##(1991-3#1)(2010-12#1)
which are more or less##2##5##(2007-12#1)(2008-10#1)
which are more##22##3##(1990-12#1)(1990-2#1)(1991-3#1)(1991-7#2)(1995-1#1)(2005-9#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-2#2)(2013-1#1)
which are most effective##2##4##(2006-9#1)(2008-3#1)
which are most likely##2##4##(1990-3#1)(1996-3#1)
which are most##5##3##(1990-3#1)(1996-3#1)(2006-9#1)(2008-10#1)(2008-3#1)
which are much smaller than the##2##6##(2007-12#1)(2008-10#1)
which are much##4##3##(1992-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
which are nearly##2##3##(1994-5#1)(2005-4#1)
which are necessary for##2##4##(1997-4#1)(2008-4#1)
which are necessary##6##3##(1993-9#1)(1997-4#1)(2006-10#1)(2008-4#1)(2011-1#1)(2011-2#1)
which are needed##3##3##(1997-5#1)(2008-2#1)(2008-5#1)
which are negatively coupled to adenylate cyclase##2##7##(1995-7#1)(2008-4#1)
which are normally##2##3##(1996-3#1)(2008-8#1)
which are not always##2##4##(2008-11#1)(2008-9#1)
which are not expressed##2##4##(1993-12#1)(2012-2#1)
which are not only##2##4##(1992-8#1)(2006-2#1)
which are not present in the##2##6##(1990-7#1)(1994-9#1)
which are not present in##3##5##(1990-7#1)(1994-9#1)(2010-4#1)
which are not readily##2##4##(1993-2#1)(1996-12#1)
which are not significantly##2##4##(1990-12#2)
which are not substrates for##3##5##(1991-5#1)(1993-3#1)(1994-5#1)
which are not##50##3##(1990-10#1)(1990-12#2)(1990-7#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#2)(1992-12#2)(1992-4#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-9#1)(1996-12#1)(2006-10#1)(2006-2#1)(2006-7#1)(2008-10#5)(2008-11#3)(2008-5#2)(2008-7#1)(2008-9#2)(2010-10#1)(2010-4#2)(2011-2#1)(2012-1#1)(2012-2#2)(2013-7#1)
which are now##3##3##(2005-8#1)(2008-4#1)(2009-8#1)
which are observed##2##3##(2007-12#1)(2012-11#1)
which are of both##2##4##(2008-10#1)(2010-3#1)
which are of##10##3##(1992-8#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-3#1)(2010-8#1)(2012-2#1)
which are often not useful for identifying errors##2##8##(2013-1#2)
which are often used in##2##5##(2005-7#1)(2008-3#1)
which are often##23##3##(1992-12#1)(1993-10#1)(1993-11#1)(1996-2#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
which are only##3##3##(1991-10#1)(1993-2#1)(1997-8#1)
which are part of the##2##5##(1992-2#1)(2013-8#1)
which are part of##3##4##(1992-2#1)(1993-6#1)(2013-8#1)
which are particularly##3##3##(1995-12#1)(1996-1#1)(2008-9#1)
which are performed by##2##4##(1996-8#1)(2013-1#1)
which are phosphorylated by protein kinase##2##6##(1991-2#1)(1995-10#1)
which are phosphorylated##3##3##(1991-2#1)(1992-11#1)(1995-10#1)
which are postulated to be##2##5##(2007-1#1)(2012-12#1)
which are potent inhibitors of the##2##6##(1991-3#1)(1992-5#1)
which are potent##4##3##(1991-3#1)(1992-5#1)(1995-3#1)(2008-4#1)
which are potentially##4##3##(1991-11#1)(1991-2#1)(1994-3#1)(1995-10#1)
which are predominantly##2##3##(1990-7#1)(2012-2#1)
which are prepared##2##3##(1991-6#1)(1997-8#1)
which are present at##3##4##(1996-8#1)(2008-4#1)(2008-7#1)
which are present in the##3##5##(1993-11#1)(1993-3#1)(2008-11#1)
which are present in##11##4##(1991-12#1)(1993-11#1)(1993-3#1)(2005-10#1)(2007-11#2)(2008-10#1)(2008-11#1)(2009-5#1)(2011-2#1)(2013-7#1)
which are present##14##3##(1991-12#1)(1993-11#1)(1993-3#1)(1996-8#1)(2005-10#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-7#1)
which are presented in##2##4##(2004-7#1)(2006-2#1)
which are presented##4##3##(2004-7#1)(2006-2#1)(2006-9#1)(2007-11#1)
which are prevalent in##2##4##(2007-8#1)(2013-8#1)
which are probably##4##3##(1991-10#1)(1997-5#1)(2008-11#1)(2008-5#1)
which are produced by##3##4##(2008-10#1)(2008-8#1)(2012-3#1)
which are produced##7##3##(1994-5#1)(1995-2#1)(2007-11#1)(2008-10#2)(2008-8#1)(2012-3#1)
which are promising##2##3##(2009-2#1)(2010-12#1)
which are prone to##2##4##(1997-8#1)(2008-4#1)
which are quite##6##3##(1996-3#1)(2006-12#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
which are rare##2##3##(1997-2#1)(2008-5#1)
which are rarely##2##3##(1993-6#1)(2007-7#1)
which are rather##2##3##(1997-2#1)(2012-11#1)
which are readily##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)
which are recognized by##2##4##(1992-6#1)(2007-8#1)
which are referred to as &quot##2##6##(2008-2#1)(2009-12#1)
which are reflected in##3##4##(1992-3#1)(1995-8#1)(2010-5#1)
which are reflected##4##3##(1992-3#1)(1993-12#1)(1995-8#1)(2010-5#1)
which are regulated by##6##4##(1992-2#1)(1993-6#1)(1994-3#1)(1995-5#1)(2011-1#1)(2013-1#1)
which are regulated##8##3##(1991-3#1)(1992-2#1)(1993-6#1)(1994-3#1)(1995-2#1)(1995-5#1)(2011-1#1)(2013-1#1)
which are related to the##8##5##(1992-8#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-4#1)(2011-1#1)(2011-2#1)
which are related to##12##4##(1992-8#1)(1995-7#1)(2005-8#1)(2006-3#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-4#1)(2011-1#1)(2011-2#2)
which are related##13##3##(1992-8#1)(1995-7#1)(2005-8#1)(2006-3#1)(2006-9#1)(2007-12#1)(2008-10#2)(2008-3#1)(2010-4#1)(2011-1#1)(2011-2#2)
which are relatively##5##3##(1994-3#1)(1994-6#1)(1996-8#1)(2006-4#1)(2008-10#1)
which are released##3##3##(2006-5#1)(2008-4#1)(2010-9#1)
which are relevant for##4##4##(1994-5#1)(1995-5#1)(2008-12#1)(2009-10#1)
which are relevant##6##3##(1994-5#1)(1994-8#1)(1995-5#1)(2006-10#1)(2008-12#1)(2009-10#1)
which are reminiscent of##2##4##(1993-4#1)(2009-2#1)
which are reported to##2##4##(1995-5#1)(2008-1#1)
which are required for##8##4##(1994-8#1)(1995-3#1)(1997-7#1)(2004-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)
which are required##9##3##(1994-8#1)(1995-3#1)(1997-7#1)(2004-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2012-3#1)
which are resistant to##4##4##(2006-11#1)(2008-10#2)(2010-11#1)
which are resistant##5##3##(2006-11#1)(2008-10#3)(2010-11#1)
which are responsible for the##6##5##(1991-2#1)(1996-3#1)(1997-7#1)(2008-10#1)(2008-5#1)(2011-2#1)
which are responsible for##12##4##(1991-2#1)(1996-3#1)(1997-7#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#3)(2011-2#1)(2013-8#1)
which are restricted##2##3##(1997-2#1)(2006-10#1)
which are selective##3##3##(1993-6#1)(1997-2#1)(2005-11#1)
which are selectively##3##3##(1995-6#1)(2006-8#1)(2008-7#1)
which are sensitive to##2##4##(2008-8#1)(2011-2#1)
which are separated by an##2##5##(1997-2#1)(2008-3#1)
which are separated by##4##4##(1990-11#1)(1997-2#2)(2008-3#1)
which are separated from##2##4##(1990-2#1)(2007-12#1)
which are separated##7##3##(1990-11#1)(1990-2#1)(1994-9#1)(1997-2#2)(2007-12#1)(2008-3#1)
which are similar to the##3##5##(1990-8#1)(1996-12#1)(2013-1#1)
which are similar to##6##4##(1990-8#1)(1993-12#1)(1996-12#1)(2007-12#1)(2008-10#1)(2013-1#1)
which are similar##7##3##(1990-8#1)(1993-12#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2013-1#1)
which are simple##2##3##(2008-5#1)(2010-12#1)
which are simultaneously##2##3##(2008-3#1)(2010-8#1)
which are so##2##3##(1997-6#1)(2007-6#1)
which are specialized##3##3##(2008-5#1)(2009-8#1)(2011-2#1)
which are specific for##2##4##(2007-2#1)(2008-7#1)
which are specific to##3##4##(1992-6#1)(2007-11#1)(2008-7#1)
which are specific##6##3##(1992-6#1)(1994-5#1)(2007-11#1)(2007-2#1)(2008-7#2)
which are still a##2##4##(2006-8#1)(2009-5#1)
which are still the##2##4##(2005-9#1)(2007-11#1)
which are still##7##3##(1990-3#1)(2005-8#1)(2005-9#1)(2006-8#1)(2007-11#1)(2009-5#1)(2012-2#1)
which are strongly##3##3##(2009-3#1)(2009-6#1)(2011-2#1)
which are structurally##4##3##(1992-7#1)(1993-8#1)(1994-11#1)(2007-11#1)
which are subject to##2##4##(2008-11#1)(2012-2#1)
which are subsequently##4##3##(1997-3#1)(2007-11#1)(2008-11#1)(2010-3#1)
which are sufficient##2##3##(1993-4#1)(1994-8#1)
which are sufficiently##2##3##(2008-10#1)(2008-3#1)
which are suggested##2##3##(1995-6#1)(2012-12#1)
which are suitable##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
which are susceptible to dust##2##5##(2012-11#2)
which are susceptible to##4##4##(1996-9#1)(2008-10#1)(2012-11#2)
which are susceptible##5##3##(1996-9#1)(2005-7#1)(2008-10#1)(2012-11#2)
which are termed##2##3##(2008-2#1)(2013-8#1)
which are the main##5##4##(1997-4#1)(1997-8#1)(2007-8#2)(2013-8#1)
which are the major##2##4##(2007-2#1)(2008-5#1)
which are the most common##2##5##(2008-10#1)(2010-11#1)
which are the most##3##4##(2008-1#1)(2008-10#1)(2010-11#1)
which are the neurons##2##4##(1992-8#1)(2012-12#1)
which are the same as those##2##6##(1992-8#1)(2006-12#1)
which are the two##3##4##(1997-1#1)(2012-12#1)(2012-2#1)
which are the##43##3##(1991-11#1)(1992-8#2)(1993-4#1)(1993-8#1)(1995-5#1)(1997-1#1)(1997-4#1)(1997-8#1)(2005-11#3)(2006-10#2)(2006-12#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#2)(2010-11#1)(2010-5#1)(2011-1#1)(2012-12#2)(2012-2#2)(2013-8#1)
which are then used##2##4##(2008-2#1)(2008-5#1)
which are then##10##3##(1997-3#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#1)(2011-1#2)(2013-1#1)
which are thought to be##4##5##(1991-3#1)(1991-5#1)(1994-12#1)(1994-2#1)
which are thought to##9##4##(1991-3#1)(1991-5#1)(1994-12#1)(1994-2#1)(1995-12#1)(1997-3#1)(2008-12#1)(2008-7#1)(2008-8#1)
which are thought##10##3##(1991-3#1)(1991-5#1)(1991-7#1)(1994-12#1)(1994-2#1)(1995-12#1)(1997-3#1)(2008-12#1)(2008-7#1)(2008-8#1)
which are tightly##2##3##(2012-2#1)(2013-7#1)
which are time##2##3##(2005-8#1)(2010-10#1)
which are to##2##3##(1996-8#1)(2008-11#1)
which are traced##2##3##(2007-9#1)(2012-2#1)
which are traditionally##2##3##(2008-10#1)(2008-5#1)
which are transferred##2##3##(2008-11#1)(2008-7#1)
which are transformed##3##3##(1996-8#1)(2007-11#1)(2013-1#1)
which are typical of##3##4##(2007-1#1)(2008-3#1)(2011-2#1)
which are typical##4##3##(2007-1#1)(2008-3#1)(2008-7#1)(2011-2#1)
which are typically##3##3##(1994-8#1)(1995-1#1)(2007-9#1)
which are unable to##5##4##(1991-5#1)(1993-11#1)(1994-3#1)(2005-11#1)(2008-10#1)
which are unique##2##3##(1991-12#1)(1991-6#1)
which are unknown##2##3##(2008-11#1)(2009-4#1)
which are up to##4##4##(1990-12#1)(2006-12#1)(2007-12#1)(2008-11#1)
which are used as##2##4##(2008-10#1)(2010-7#1)
which are used for##2##4##(2008-3#1)(2011-1#1)
which are used in the##2##5##(2008-11#1)(2010-8#1)
which are used in##11##4##(1991-11#1)(1996-2#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-8#1)
which are used to##11##4##(1992-6#1)(1993-5#1)(2006-6#1)(2006-7#1)(2007-12#2)(2008-2#1)(2008-3#1)(2010-7#1)(2010-8#2)
which are used##34##3##(1991-11#1)(1991-6#1)(1992-6#1)(1993-5#1)(1996-12#1)(1996-2#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-12#3)(2007-2#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-6#1)(2010-7#2)(2010-8#3)(2011-1#2)(2011-2#1)(2013-8#1)
which are useful for##3##4##(1997-8#1)(2008-2#1)(2008-4#1)
which are useful##5##3##(1996-5#1)(1997-8#1)(2008-2#2)(2008-4#1)
which are usually##7##3##(1993-10#1)(2008-10#2)(2008-3#1)(2011-2#1)(2013-1#2)
which are valuable##3##3##(1993-2#1)(2008-10#1)(2008-8#1)
which are vectors##2##3##(2007-11#1)(2008-11#1)
which are very##6##3##(1997-2#1)(2005-8#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-7#1)
which are viewed as##2##4##(2011-1#1)(2012-2#1)
which are vulnerable to##3##4##(2007-11#1)(2013-1#2)
which are well##6##3##(1990-12#1)(1992-11#1)(1994-2#1)(2007-11#1)(2008-2#1)(2012-2#1)
which are widely used in##2##5##(2009-10#1)(2012-12#1)
which are widely used##3##4##(2008-7#1)(2009-10#1)(2012-12#1)
which are widely##5##3##(2006-10#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-12#1)
which are without##2##3##(2006-8#1)(2008-11#1)
which are yet##2##3##(2008-11#1)(2009-3#1)
which are##1689##2##(1990-10#5)(1990-11#6)(1990-12#12)(1990-2#7)(1990-3#7)(1990-4#4)(1990-5#3)(1990-6#2)(1990-7#8)(1990-8#7)(1990-9#5)(1991-1#1)(1991-10#4)(1991-11#6)(1991-12#9)(1991-2#8)(1991-3#10)(1991-4#1)(1991-5#12)(1991-6#6)(1991-7#5)(1991-8#3)(1991-9#8)(1992-1#3)(1992-10#3)(1992-11#9)(1992-12#6)(1992-2#5)(1992-3#2)(1992-4#4)(1992-5#3)(1992-6#8)(1992-7#2)(1992-8#12)(1992-9#7)(1993-1#1)(1993-10#5)(1993-11#8)(1993-12#9)(1993-2#4)(1993-3#7)(1993-4#4)(1993-5#2)(1993-6#10)(1993-7#2)(1993-8#4)(1993-9#5)(1994-10#1)(1994-11#8)(1994-12#17)(1994-2#10)(1994-3#14)(1994-5#8)(1994-6#6)(1994-8#9)(1994-9#10)(1995-1#11)(1995-10#4)(1995-11#3)(1995-12#7)(1995-2#9)(1995-3#11)(1995-4#1)(1995-5#12)(1995-6#6)(1995-7#4)(1995-8#10)(1995-9#3)(1996-1#5)(1996-10#2)(1996-11#3)(1996-12#7)(1996-2#10)(1996-3#12)(1996-5#9)(1996-7#5)(1996-8#15)(1996-9#6)(1997-1#8)(1997-2#15)(1997-3#5)(1997-4#14)(1997-5#4)(1997-6#5)(1997-7#9)(1997-8#11)(2003-11#1)(2004-11#2)(2004-12#3)(2004-7#1)(2004-9#1)(2005-10#7)(2005-11#16)(2005-12#2)(2005-4#2)(2005-5#3)(2005-6#1)(2005-7#8)(2005-8#12)(2005-9#5)(2006-1#1)(2006-10#31)(2006-11#5)(2006-12#9)(2006-2#7)(2006-3#2)(2006-4#2)(2006-5#4)(2006-6#5)(2006-7#2)(2006-8#12)(2006-9#6)(2007-1#4)(2007-10#3)(2007-11#37)(2007-12#45)(2007-2#10)(2007-3#3)(2007-4#5)(2007-5#1)(2007-6#2)(2007-7#14)(2007-8#19)(2007-9#12)(2008-1#20)(2008-10#112)(2008-11#53)(2008-12#9)(2008-2#32)(2008-3#43)(2008-4#46)(2008-5#55)(2008-6#7)(2008-7#40)(2008-8#27)(2008-9#15)(2009-1#1)(2009-10#4)(2009-11#4)(2009-12#5)(2009-2#7)(2009-3#4)(2009-4#4)(2009-5#10)(2009-6#5)(2009-7#2)(2009-8#10)(2009-9#1)(2010-1#1)(2010-10#6)(2010-11#6)(2010-12#15)(2010-2#8)(2010-3#11)(2010-4#10)(2010-5#8)(2010-6#1)(2010-7#7)(2010-8#12)(2010-9#4)(2011-1#20)(2011-12#4)(2011-2#38)(2011-3#2)(2012-1#8)(2012-11#6)(2012-12#19)(2012-2#29)(2012-3#6)(2013-1#41)(2013-7#7)(2013-8#26)
which area##2##2##(1994-3#1)(2008-2#1)
which areas##4##2##(1990-2#1)(1996-3#1)(2010-5#1)(2013-1#1)
which arise during##2##3##(1992-10#1)(2008-5#1)
which arise from##4##3##(1991-2#1)(1995-9#1)(2005-8#1)(2007-12#1)
which arise in the##2##4##(2008-2#1)(2011-1#1)
which arise in##6##3##(1995-8#1)(2006-1#1)(2006-10#1)(2008-11#1)(2008-2#1)(2011-1#1)
which arise when##2##3##(1993-11#1)(2008-7#1)
which arise##19##2##(1990-7#1)(1991-10#1)(1991-2#1)(1992-10#1)(1993-11#1)(1995-8#1)(1995-9#1)(1997-2#1)(1997-4#1)(2005-8#1)(2006-1#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)
which arises from an##2##4##(2007-12#1)(2008-2#1)
which arises from the##4##4##(2005-11#1)(2007-12#1)(2011-2#1)(2013-8#1)
which arises from##8##3##(1993-10#1)(2005-11#1)(2007-12#2)(2008-2#1)(2008-7#1)(2011-2#1)(2013-8#1)
which arises##10##2##(1993-10#1)(1994-12#1)(2005-11#1)(2007-12#2)(2008-2#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
which arose from##2##3##(2008-10#1)(2008-7#1)
which arose##3##2##(1992-10#1)(2008-10#1)(2008-7#1)
which arrest##2##2##(2008-11#2)
which as##4##2##(1994-11#1)(2005-1#1)(2011-1#1)(2012-2#1)
which asked##2##2##(2012-1#1)(2012-12#1)
which aspects of##3##3##(2008-11#1)(2012-2#1)(2012-3#1)
which assess the##2##3##(1996-1#1)(2012-3#1)
which assess##3##2##(1996-1#1)(2008-10#1)(2012-3#1)
which assesses the##3##3##(1992-4#1)(1995-2#1)(2012-3#1)
which assesses##6##2##(1992-4#1)(1995-2#1)(1997-7#1)(2008-11#1)(2008-6#1)(2012-3#1)
which assists##2##2##(2008-10#1)(2013-1#1)
which associated with##2##3##(1996-4#1)(2011-1#1)
which associates##3##2##(1991-1#1)(2013-1#2)
which assumed##2##2##(2008-10#1)(2009-3#1)
which assumes a##2##3##(2008-8#1)(2012-3#1)
which assumes that the##4##4##(1992-12#1)(1992-2#1)(2008-10#1)(2008-5#1)
which assumes that##6##3##(1992-12#1)(1992-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)
which assumes##10##2##(1992-12#1)(1992-2#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#2)(2012-3#1)
which assures##2##2##(2010-8#1)(2011-1#1)
which at least##7##3##(1992-12#2)(1993-9#1)(1997-6#1)(2007-4#1)(2008-7#1)(2013-1#1)
which at present##3##3##(1994-11#1)(2008-10#1)(2010-6#1)
which at the same time##2##5##(1990-11#1)(2008-5#1)
which at the##3##3##(1990-11#1)(1992-8#1)(2008-5#1)
which at##18##2##(1990-11#1)(1990-7#1)(1992-12#2)(1992-8#1)(1993-9#1)(1994-11#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-7#1)(2007-4#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-6#1)(2013-1#1)
which attempt to##3##3##(1990-5#1)(1992-2#1)(2009-12#1)
which attempt##4##2##(1990-5#1)(1992-2#1)(2008-7#1)(2009-12#1)
which attempts to##4##3##(1991-12#1)(2006-3#1)(2008-1#1)(2010-2#1)
which authors##3##2##(1994-3#1)(2007-4#2)
which avoid the##2##3##(2007-12#1)(2007-8#1)
which avoid##3##2##(1994-9#1)(2007-12#1)(2007-8#1)
which avoided##2##2##(1993-11#1)(2005-8#1)
which avoids the##3##3##(1991-5#1)(1993-5#1)(2006-6#1)
which avoids##7##2##(1990-12#1)(1991-5#1)(1993-5#1)(2006-6#1)(2008-3#1)(2009-12#1)(2009-9#1)
which bacteria##6##2##(1995-10#1)(2006-10#1)(2006-11#1)(2006-2#1)(2008-10#2)
which bacterial##5##2##(2006-8#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-2#1)
which balances the##2##3##(2008-8#1)(2009-10#1)
which balances##3##2##(1995-10#1)(2008-8#1)(2009-10#1)
which based on the##2##4##(2008-10#2)
which basically consists of##2##4##(2007-7#1)(2011-1#1)
which basically##3##2##(2007-7#1)(2008-11#1)(2011-1#1)
which bear##4##2##(1990-5#1)(2006-12#1)(2007-12#1)(2010-9#1)
which bears a##2##3##(1995-1#1)(2006-12#1)
which bears##5##2##(1995-1#1)(1997-1#1)(2006-12#1)(2008-11#1)(2008-9#1)
which became the##3##3##(1992-2#1)(2008-4#1)(2009-7#1)
which became##11##2##(1992-2#1)(1994-11#1)(1994-12#1)(1994-2#1)(2005-7#1)(2006-5#1)(2008-10#1)(2008-4#1)(2009-7#1)(2010-12#1)(2011-2#1)
which become##6##2##(1992-9#1)(1995-11#1)(1995-6#1)(2008-10#1)(2010-5#1)(2010-7#1)
which becomes##12##2##(1994-9#1)(1995-12#1)(2005-11#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#1)
which began in##3##3##(1995-12#1)(2006-2#1)(2009-7#1)
which began with##2##3##(1997-8#1)(2008-3#1)
which began##5##2##(1995-12#1)(1997-8#1)(2006-2#1)(2008-3#1)(2009-7#1)
which begins with##2##3##(2008-3#1)(2011-2#1)
which begins##7##2##(1995-6#2)(2008-3#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-1#1)
which behave##2##2##(2008-10#1)(2009-8#1)
which behaves##4##2##(1994-9#1)(1995-8#1)(2012-2#1)(2013-7#1)
which behavioral##5##2##(2008-5#1)(2008-9#1)(2010-10#1)(2010-12#1)(2011-1#1)
which belong to the##4##4##(1992-9#1)(2007-11#1)(2008-12#1)(2008-5#1)
which belong to##6##3##(1992-9#1)(1996-9#1)(2007-11#1)(2008-12#1)(2008-5#2)
which belongs to a family of##2##6##(2005-7#1)(2009-10#1)
which belongs to the actinobacterial family##2##6##(2011-2#2)
which belongs to the class of##2##6##(2008-3#2)
which belongs to the family of##2##6##(1994-8#1)(1996-5#1)
which belongs to the family##5##5##(1994-8#1)(1996-5#1)(2011-2#3)
which belongs to the##17##4##(1994-8#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-2#1)(2008-10#2)(2008-3#2)(2008-9#1)(2011-1#1)(2011-2#5)(2012-2#1)
which belongs to##20##3##(1994-8#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-2#1)(2005-7#1)(2008-10#2)(2008-3#2)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#1)
which belongs##21##2##(1994-8#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-2#1)(2005-7#1)(2008-10#3)(2008-3#2)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#1)
which benefited##2##2##(2007-11#1)(2013-8#1)
which best##4##2##(1991-3#1)(1994-11#1)(2008-10#1)(2012-2#1)
which bind and##2##3##(1993-11#1)(1993-6#1)
which bind the##3##3##(1990-1#1)(1991-2#1)(1993-6#1)
which bind to specific##2##4##(1992-9#1)(1997-7#1)
which bind to the same##2##5##(1990-12#1)(1990-3#1)
which bind to the##7##4##(1990-12#1)(1990-3#1)(1991-12#1)(1993-5#1)(1994-2#1)(1995-6#1)(1997-5#1)
which bind to##18##3##(1990-12#1)(1990-3#1)(1991-10#1)(1991-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-5#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-6#1)(1997-2#1)(1997-5#1)(1997-7#1)(2006-10#1)(2007-7#1)(2013-8#1)
which bind##40##2##(1990-1#1)(1990-12#1)(1990-3#1)(1990-5#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-5#1)(1993-6#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-7#1)(1996-9#1)(1997-2#3)(1997-5#1)(1997-7#1)(2005-7#1)(2005-9#1)(2006-10#1)(2007-7#1)(2008-4#1)(2008-7#1)(2013-8#1)
which binding##2##2##(1990-4#1)(1992-6#1)
which binds and##2##3##(1991-8#1)(1995-2#1)
which binds preferentially to the##2##5##(1993-9#1)(1994-5#1)
which binds specifically to##2##4##(1991-8#1)(2008-9#1)
which binds specifically##3##3##(1991-8#1)(1992-12#1)(2008-9#1)
which binds the##6##3##(1990-12#1)(1991-7#1)(1993-8#1)(1995-5#1)(2008-11#1)(2009-7#1)
which binds to a specific##2##5##(1996-2#1)(2008-2#1)
which binds to a##3##4##(1990-11#1)(1996-2#1)(2008-2#1)
which binds to and##3##4##(1994-5#1)(2007-11#1)(2008-4#1)
which binds to the##9##4##(1990-3#1)(1990-7#1)(1990-8#1)(1993-3#2)(1994-11#1)(1994-3#1)(1996-4#1)(2008-9#1)
which binds to##28##3##(1990-11#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-4#1)(1992-9#1)(1993-3#2)(1993-6#1)(1994-11#2)(1994-3#2)(1994-5#1)(1994-8#1)(1995-2#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-6#1)(2007-11#1)(2008-2#1)(2008-4#1)(2008-9#2)
which binds with high affinity to##3##6##(1995-3#1)(2007-11#1)(2008-3#1)
which binds##64##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#2)(1992-12#1)(1992-4#1)(1992-9#2)(1993-3#2)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#3)(1994-12#2)(1994-3#2)(1994-5#2)(1994-8#1)(1995-2#2)(1995-3#2)(1995-5#1)(1996-10#1)(1996-2#1)(1996-4#2)(1996-5#3)(1997-1#1)(1997-4#1)(1997-6#2)(2006-3#1)(2007-11#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#3)(2009-10#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-3#1)
which biological##7##2##(1994-6#1)(1997-4#2)(2008-10#1)(2008-7#2)(2012-12#1)
which blends##2##2##(2006-10#1)(2013-7#1)
which block##4##2##(1991-2#1)(2006-12#2)(2011-3#1)
which blocked##4##2##(1990-4#1)(1994-9#1)(1995-12#1)(2008-11#1)
which blocks the##2##3##(1992-11#1)(1995-2#1)
which blocks##8##2##(1991-6#1)(1992-11#1)(1992-7#1)(1994-2#1)(1995-2#1)(1996-5#1)(1997-6#1)(2010-3#1)
which blood##3##2##(1994-3#1)(2006-11#1)(2007-8#1)
which bore##2##2##(1996-7#1)(1997-4#1)
which both the##8##3##(1994-8#1)(1995-6#1)(1996-8#1)(2007-12#2)(2008-10#2)(2011-2#1)
which both##49##2##(1990-11#1)(1991-12#1)(1991-4#1)(1992-1#1)(1993-2#1)(1994-10#1)(1994-3#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-5#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-4#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-1#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-2#2)(2013-8#1)
which bound to a##2##4##(1990-10#1)(2008-10#1)
which bound to the##3##4##(1990-12#1)(1990-7#1)(1993-8#1)
which bound to##10##3##(1990-10#1)(1990-12#2)(1990-7#1)(1993-8#1)(1994-2#1)(1994-5#1)(1996-4#1)(2008-10#1)(2008-8#1)
which bound##12##2##(1990-10#1)(1990-12#2)(1990-7#1)(1990-8#1)(1991-5#1)(1993-8#1)(1994-2#1)(1994-5#1)(1996-4#1)(2008-10#1)(2008-8#1)
which brain##3##2##(1996-5#1)(2006-4#1)(2013-1#1)
which bridge the##2##3##(1995-12#1)(1996-2#1)
which brings about a##2##4##(1992-4#1)(2008-10#1)
which brings about##3##3##(1991-11#1)(1992-4#1)(2008-10#1)
which brings the##2##3##(1995-10#1)(2012-2#1)
which brings##6##2##(1991-11#1)(1992-4#1)(1995-10#1)(2008-10#1)(2012-1#1)(2012-2#1)
which broke##2##2##(2008-5#2)
which builds##3##2##(1997-1#1)(2008-1#1)(2008-10#1)
which by definition##2##3##(1997-8#1)(2008-5#1)
which by its##2##3##(1990-3#1)(2006-6#1)
which by##11##2##(1990-1#1)(1990-3#1)(1991-8#1)(1992-10#1)(1994-8#2)(1997-8#1)(2006-6#2)(2008-4#1)(2008-5#1)
which calcium##4##2##(1990-2#1)(1991-11#1)(2013-1#1)(2013-8#1)
which calls into question##2##4##(2008-11#1)(2008-7#1)
which came##3##2##(2006-10#1)(2007-5#1)(2007-8#1)
which can accommodate##3##3##(1994-12#1)(2006-5#1)(2008-3#1)
which can achieve##2##3##(2008-2#1)(2011-1#1)
which can acquire##2##3##(2007-12#1)(2009-5#1)
which can act as##3##4##(1994-10#1)(2008-5#1)(2013-8#1)
which can affect the##3##4##(2008-3#2)(2010-10#1)
which can affect##6##3##(1995-11#1)(2008-3#2)(2009-7#1)(2010-10#1)(2012-1#1)
which can also be applied##2##5##(2008-3#1)(2012-2#1)
which can also be##6##4##(1990-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-7#1)(2012-2#1)
which can also##10##3##(1990-12#1)(1991-6#1)(1997-4#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-7#1)
which can arise##3##3##(2007-9#1)(2012-2#1)(2013-7#1)
which can assist in##2##4##(2006-7#1)(2008-3#1)
which can be a##2##4##(2005-11#1)(2008-2#1)
which can be accomplished##2##4##(2008-4#1)(2009-9#1)
which can be accounted for##2##5##(2005-11#1)(2006-12#1)
which can be achieved by##3##5##(2008-8#1)(2009-6#1)(2010-12#1)
which can be achieved##5##4##(1994-5#1)(2008-8#1)(2009-6#1)(2009-7#1)(2010-12#1)
which can be adjusted##2##4##(2008-2#2)
which can be aided by deriving abstraction networks from a large terminology##2##12##(2013-1#2)
which can be alternatively##2##4##(1993-12#1)(2008-10#1)
which can be applied to##4##5##(2006-10#1)(2008-10#1)(2008-4#1)(2008-9#1)
which can be applied##8##4##(1995-5#1)(2006-10#1)(2008-10#4)(2008-4#1)(2008-9#1)
which can be associated with the##2##6##(2007-3#1)(2009-9#1)
which can be associated with##3##5##(2007-12#1)(2007-3#1)(2009-9#1)
which can be at##2##4##(1997-7#1)(2007-7#1)
which can be attributed to the##2##6##(2007-12#1)(2008-11#1)
which can be attributed to##4##5##(1994-11#1)(2007-12#1)(2008-10#1)(2008-11#1)
which can be attributed##5##4##(1994-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
which can be beneficial##2##4##(1994-3#1)(2012-12#1)
which can be blocked##2##4##(1991-10#1)(2007-11#1)
which can be compared with##2##5##(1992-2#1)(1993-9#1)
which can be considered as##3##5##(2008-10#1)(2010-3#1)(2013-1#1)
which can be considered##5##4##(2008-10#1)(2008-5#1)(2010-3#1)(2011-1#1)(2013-1#1)
which can be controlled##2##4##(2008-10#1)(2008-7#1)
which can be converted into##3##5##(1996-5#1)(2009-9#1)(2010-5#1)
which can be converted##5##4##(1994-11#1)(1996-5#1)(1997-4#1)(2009-9#1)(2010-5#1)
which can be detected##4##4##(1993-12#1)(2007-11#1)(2008-5#1)(2009-7#1)
which can be determined by##3##5##(1990-8#1)(1992-3#1)(2008-10#1)
which can be determined##7##4##(1990-3#1)(1990-8#1)(1992-3#1)(1992-4#2)(2005-11#1)(2008-10#1)
which can be differentiated##2##4##(1991-11#1)(2007-12#1)
which can be difficult to##2##5##(2005-11#1)(2010-12#1)
which can be difficult##3##4##(2005-11#1)(2008-6#1)(2010-12#1)
which can be directly##3##4##(2006-3#1)(2007-11#1)(2012-3#1)
which can be divided into two##2##6##(2008-11#1)(2008-8#1)
which can be divided into##4##5##(2008-1#1)(2008-11#1)(2008-8#1)(2012-1#1)
which can be easily##5##4##(2007-8#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-7#1)
which can be enhanced##2##4##(2008-10#1)(2009-11#1)
which can be expected##2##4##(2006-1#1)(2013-8#1)
which can be explained by##2##5##(1990-5#1)(2010-12#1)
which can be explained##3##4##(1990-5#1)(2008-10#1)(2010-12#1)
which can be extracted##2##4##(1994-9#1)(2008-10#1)
which can be facilitated by##2##5##(1992-12#1)(2013-8#1)
which can be formed##2##4##(2008-2#1)(2008-4#1)
which can be found##3##4##(1990-12#1)(2008-10#1)(2009-4#1)
which can be further##3##4##(1996-5#1)(2007-11#1)(2008-10#1)
which can be helpful##3##4##(2008-3#1)(2008-8#1)(2012-2#1)
which can be identified##2##4##(1993-3#1)(1993-6#1)
which can be implemented with##2##5##(2008-2#1)(2008-3#1)
which can be implemented##3##4##(1993-9#1)(2008-2#1)(2008-3#1)
which can be induced by##4##5##(1994-8#1)(1997-8#1)(2007-12#1)(2008-11#1)
which can be induced##5##4##(1994-8#1)(1997-8#1)(2007-12#1)(2008-11#2)
which can be interpreted##2##4##(1995-3#1)(1996-5#1)
which can be mainly##2##4##(2008-11#1)(2012-2#1)
which can be measured##2##4##(1997-8#1)(2009-10#1)
which can be modulated##2##4##(1992-12#1)(2008-3#1)
which can be observed in##2##5##(1994-6#1)(1996-2#1)
which can be obtained##2##4##(2008-1#1)(2008-3#1)
which can be partially explained by the##2##7##(2008-4#1)(2011-2#1)
which can be partially##3##4##(2008-4#1)(2009-9#1)(2011-2#1)
which can be performed in the##2##6##(1996-12#1)(2010-5#1)
which can be performed##4##4##(1993-10#1)(1996-12#1)(2010-5#1)(2011-1#1)
which can be potentially##2##4##(2012-12#1)(2013-1#1)
which can be regarded as##4##5##(1994-2#1)(2007-12#1)(2013-1#2)
which can be restored by LIF replacement##2##7##(2008-4#2)
which can be restored by##3##5##(1990-11#1)(2008-4#2)
which can be seen as a##2##6##(2007-1#1)(2009-9#1)
which can be seen in##3##5##(2006-10#1)(2008-12#1)(2008-7#1)
which can be seen##6##4##(2006-10#1)(2007-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-9#1)
which can be solved##2##4##(2008-7#2)
which can be treated##2##4##(1990-12#1)(1996-11#1)
which can be tuned to##2##5##(2007-8#1)(2011-1#1)
which can be tuned##4##4##(2007-8#1)(2008-2#1)(2010-12#1)(2011-1#1)
which can be used as a##3##6##(1996-3#1)(2007-11#1)(2008-10#1)
which can be used as##5##5##(1992-6#1)(1994-9#1)(1996-3#1)(2007-11#1)(2008-10#1)
which can be used by##3##5##(1995-6#1)(2008-12#1)(2012-12#1)
which can be used for both##2##6##(1997-4#1)(2008-4#1)
which can be used for the##7##6##(1990-8#1)(1991-7#1)(2008-10#3)(2012-1#1)(2012-12#1)
which can be used for##21##5##(1990-8#1)(1991-7#1)(1994-5#1)(1994-6#1)(1996-2#1)(1997-4#2)(1997-7#1)(2005-4#1)(2006-9#1)(2008-10#5)(2008-11#1)(2008-4#2)(2011-1#1)(2012-1#1)(2012-12#1)
which can be used in##3##5##(1992-8#1)(2007-6#1)(2013-1#1)
which can be used to assess the##2##7##(2007-12#1)(2013-8#1)
which can be used to detect##2##6##(2008-4#1)(2012-3#1)
which can be used to determine the##2##7##(2004-9#1)(2008-10#1)
which can be used to evaluate the##2##7##(1991-1#1)(2004-12#1)
which can be used to evaluate##3##6##(1991-1#1)(2004-12#1)(2012-1#1)
which can be used to##26##5##(1990-12#1)(1991-1#1)(1991-5#1)(2004-12#2)(2004-9#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#3)(2009-10#1)(2010-1#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
which can be used##62##4##(1990-12#1)(1990-8#1)(1991-1#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-6#1)(1992-8#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-4#2)(1997-7#1)(2004-12#2)(2004-9#1)(2005-10#1)(2005-4#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#5)(2008-7#1)(2009-10#1)(2010-1#1)(2010-3#1)(2011-1#2)(2012-1#2)(2012-12#2)(2012-3#2)(2013-1#3)(2013-8#1)
which can be useful in##2##5##(2006-1#1)(2008-2#1)
which can be useful##3##4##(2006-1#1)(2008-2#1)(2008-3#1)
which can be utilized##2##4##(2008-2#1)(2010-6#1)
which can be very##2##4##(2007-1#1)(2007-7#1)
which can be##381##3##(1990-10#1)(1990-11#2)(1990-12#4)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#3)(1991-7#1)(1992-12#3)(1992-2#4)(1992-3#2)(1992-4#2)(1992-6#1)(1992-8#2)(1992-9#2)(1993-10#1)(1993-12#2)(1993-3#2)(1993-6#1)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#5)(1996-6#1)(1996-7#1)(1997-4#4)(1997-6#1)(1997-7#3)(1997-8#2)(2004-12#2)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#8)(2005-4#1)(2005-7#1)(2006-1#3)(2006-10#2)(2006-12#1)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#2)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#8)(2007-12#10)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#6)(2007-9#1)(2008-1#4)(2008-10#37)(2008-11#13)(2008-12#3)(2008-2#14)(2008-3#10)(2008-4#16)(2008-5#4)(2008-6#1)(2008-7#10)(2008-8#3)(2008-9#2)(2009-10#2)(2009-11#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#2)(2009-9#5)(2010-1#1)(2010-11#1)(2010-12#7)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#4)(2010-7#2)(2010-9#1)(2011-1#5)(2011-2#9)(2011-7#1)(2012-1#4)(2012-11#2)(2012-12#5)(2012-2#2)(2012-3#4)(2013-1#16)(2013-7#2)(2013-8#5)
which can bind to##2##4##(1991-9#1)(2008-5#1)
which can bind##5##3##(1991-9#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)
which can carry##2##3##(2005-7#1)(2008-5#1)
which can cause##20##3##(1990-12#1)(1997-1#1)(1997-3#1)(2005-10#1)(2006-12#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
which can commonly associate with##2##5##(2008-10#2)
which can contribute to##3##4##(2009-9#1)(2010-1#1)(2012-2#1)
which can convert##3##3##(1993-12#1)(1993-5#1)(2013-1#1)
which can detect##2##3##(1995-3#1)(2011-2#1)
which can determine##2##3##(2008-2#1)(2008-5#1)
which can differentiate##2##3##(2008-10#1)(2008-7#1)
which can directly##2##3##(1992-1#1)(2009-7#1)
which can discriminate##3##3##(1991-5#1)(2004-1#1)(2005-11#1)
which can either##3##3##(1992-6#1)(2008-11#1)(2010-6#1)
which can exhibit##2##3##(2008-10#1)(2012-1#1)
which can explain the different##2##5##(1994-11#1)(2006-2#1)
which can explain the##3##4##(1994-11#1)(2006-2#1)(2008-5#1)
which can explain##4##3##(1994-11#1)(2006-2#1)(2008-5#1)(2011-2#1)
which can facilitate the##2##4##(2012-12#1)(2012-3#1)
which can facilitate##4##3##(2008-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
which can form##2##3##(2008-10#1)(2008-7#1)
which can further##2##3##(2008-4#1)(2013-1#1)
which can give rise to##2##5##(2007-7#1)(2010-6#1)
which can give##5##3##(2007-7#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-6#1)
which can have a##3##4##(2008-5#1)(2012-2#1)(2013-1#1)
which can have##9##3##(1993-1#1)(1996-7#1)(2007-12#1)(2008-5#1)(2008-6#1)(2010-11#1)(2011-1#1)(2012-2#1)(2013-1#1)
which can help##4##3##(1995-1#1)(2008-5#1)(2009-4#1)(2011-3#1)
which can improve##4##3##(1995-5#1)(2007-11#1)(2008-5#1)(2013-1#1)
which can in turn##2##4##(1996-12#1)(2008-5#1)
which can include##2##3##(2005-7#1)(2008-6#1)
which can incorporate##2##3##(1997-7#1)(2008-10#1)
which can increase the sensitivity of the reaction by an order of magnitude##2##13##(2008-4#1)(2008-9#1)
which can increase the##3##4##(2008-4#1)(2008-9#1)(2013-8#1)
which can increase##4##3##(2008-10#1)(2008-4#1)(2008-9#1)(2013-8#1)
which can induce##4##3##(1994-6#1)(1997-6#1)(2006-8#1)(2008-6#1)
which can influence##3##3##(1994-2#1)(2008-10#1)(2013-1#1)
which can inhibit##5##3##(2005-11#1)(2008-1#1)(2008-5#1)(2011-3#1)(2012-12#1)
which can integrate into early postnatal retina##2##7##(2012-12#2)
which can interact with##3##4##(1995-6#1)(2007-12#1)(2010-5#1)
which can interact##4##3##(1992-9#1)(1995-6#1)(2007-12#1)(2010-5#1)
which can interfere with the##2##5##(2008-10#1)(2008-2#1)
which can interfere##3##3##(2008-10#2)(2008-2#1)
which can lead to significant##2##5##(1994-8#1)(2008-12#1)
which can lead to the##2##5##(2008-2#1)(2009-11#1)
which can lead to##19##4##(1990-6#1)(1994-8#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-7#1)(2012-2#1)(2013-1#3)
which can make##2##3##(2007-5#1)(2008-9#1)
which can measure##2##3##(1997-6#1)(2009-9#1)
which can modulate##2##3##(2006-12#1)(2008-10#1)
which can not be reduced on the Hg electrode##2##9##(2008-10#2)
which can not##3##3##(2008-10#2)(2008-7#1)
which can occur##7##3##(1996-12#1)(2004-9#1)(2007-11#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-7#1)
which can often be##2##4##(1996-3#1)(2011-2#1)
which can often##4##3##(1996-3#1)(2008-8#1)(2010-6#1)(2011-2#1)
which can only be##3##4##(1996-8#1)(2007-11#1)(2008-11#1)
which can only##5##3##(1996-8#1)(2007-11#1)(2007-12#1)(2008-11#1)(2010-12#1)
which can otherwise be##2##4##(2007-12#1)(2008-2#1)
which can play a##2##4##(2008-10#1)(2008-8#1)
which can potentially##2##3##(2008-12#1)(2011-2#1)
which can produce##4##3##(1994-6#1)(1996-1#1)(2008-2#1)(2008-8#1)
which can promote##2##3##(2008-5#1)(2009-9#1)
which can provide##3##3##(2010-4#1)(2012-2#1)(2013-8#1)
which can quantify##2##3##(2012-1#2)
which can range from##2##4##(2011-2#1)(2012-2#1)
which can range##3##3##(2008-2#1)(2011-2#1)(2012-2#1)
which can reach##2##3##(2007-12#1)(2007-9#1)
which can reduce##2##3##(2007-7#1)(2008-7#1)
which can result in a##3##5##(2008-9#1)(2013-1#1)(2013-8#1)
which can result in##7##4##(2008-1#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
which can seriously##2##3##(2007-11#1)(2008-2#1)
which can serve as a##3##5##(1990-3#1)(2008-11#2)
which can serve as##4##4##(1990-3#1)(2008-11#2)(2008-3#1)
which can significantly##5##3##(2007-9#1)(2008-11#1)(2008-2#1)(2008-8#1)(2012-10#1)
which can then be used##3##5##(2007-8#1)(2008-4#2)
which can then be##8##4##(2007-12#1)(2007-8#1)(2008-11#1)(2008-4#3)(2008-7#1)(2009-8#1)
which can then##9##3##(1996-5#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-4#3)(2008-7#1)(2009-8#1)
which can thus##2##3##(2007-12#1)(2008-3#1)
which can trigger##2##3##(1994-5#1)(2011-2#1)
which can undergo##2##3##(1991-7#1)(2007-9#1)
which can##743##2##(1990-10#1)(1990-11#2)(1990-12#6)(1990-3#4)(1990-4#1)(1990-5#1)(1990-6#3)(1990-8#3)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#2)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#5)(1991-6#1)(1991-7#2)(1991-9#1)(1992-1#1)(1992-12#4)(1992-2#5)(1992-3#3)(1992-4#2)(1992-6#3)(1992-8#2)(1992-9#3)(1993-1#1)(1993-10#1)(1993-12#3)(1993-3#4)(1993-5#1)(1993-6#1)(1993-9#3)(1994-10#2)(1994-11#5)(1994-12#3)(1994-2#4)(1994-3#2)(1994-5#3)(1994-6#4)(1994-8#2)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#2)(1995-8#2)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#2)(1996-5#7)(1996-6#1)(1996-7#3)(1996-8#2)(1997-1#1)(1997-3#1)(1997-4#8)(1997-6#3)(1997-7#4)(1997-8#3)(2004-1#1)(2004-12#2)(2004-9#3)(2005-1#1)(2005-10#2)(2005-11#12)(2005-12#1)(2005-4#1)(2005-7#4)(2006-1#3)(2006-10#3)(2006-12#3)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#3)(2006-6#5)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#4)(2007-10#2)(2007-11#17)(2007-12#20)(2007-2#2)(2007-3#2)(2007-5#3)(2007-6#1)(2007-7#9)(2007-8#8)(2007-9#5)(2008-1#9)(2008-10#58)(2008-11#26)(2008-12#8)(2008-2#30)(2008-3#23)(2008-4#25)(2008-5#19)(2008-6#4)(2008-7#20)(2008-8#12)(2008-9#11)(2009-10#2)(2009-11#3)(2009-12#1)(2009-4#3)(2009-5#6)(2009-6#3)(2009-7#5)(2009-8#4)(2009-9#10)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#9)(2010-2#2)(2010-3#3)(2010-4#3)(2010-5#3)(2010-6#7)(2010-7#6)(2010-8#1)(2010-9#1)(2011-1#10)(2011-2#18)(2011-3#2)(2011-7#1)(2012-1#10)(2012-10#1)(2012-11#4)(2012-12#15)(2012-2#13)(2012-3#7)(2013-1#32)(2013-7#4)(2013-8#12)
which cannabis##2##2##(2005-10#2)
which cannot be accounted for by##2##6##(1990-4#1)(2007-12#1)
which cannot be##22##3##(1990-4#1)(1991-12#1)(1991-5#1)(1992-5#1)(1992-6#1)(1994-11#1)(1995-12#1)(1996-6#1)(2005-11#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-11#2)(2008-5#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-5#1)(2013-7#1)
which cannot easily be##3##4##(1994-2#1)(2006-6#1)(2008-7#1)
which cannot##31##2##(1990-4#1)(1991-12#1)(1991-5#2)(1992-5#1)(1992-6#1)(1994-11#1)(1994-2#1)(1995-12#1)(1996-6#1)(1997-2#1)(2005-11#1)(2006-2#1)(2006-6#1)(2007-12#2)(2007-2#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-7#2)(2009-12#1)(2009-4#1)(2010-12#1)(2010-5#1)(2013-7#1)
which capabilities##2##2##(2008-11#1)(2011-2#1)
which captures##2##2##(1992-11#1)(2008-9#1)
which cardiac##2##2##(2004-11#1)(2007-9#1)
which carried the##3##3##(2008-7#1)(2008-8#1)(2008-9#1)
which carried##7##2##(1990-11#1)(1993-4#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)
which carries a##3##3##(1996-12#1)(2013-1#1)(2013-8#1)
which carries the##4##3##(1990-11#1)(1992-6#1)(1995-8#1)(1997-2#1)
which carries##13##2##(1990-11#1)(1991-12#1)(1992-6#1)(1994-9#1)(1995-8#1)(1996-12#1)(1997-2#2)(2008-10#2)(2011-12#1)(2013-1#1)(2013-8#1)
which carry a##2##3##(1990-7#1)(2013-1#1)
which carry the##2##3##(1995-4#1)(2008-10#1)
which carry##6##2##(1990-4#1)(1990-7#1)(1995-4#1)(2008-10#1)(2011-1#1)(2013-1#1)
which case##17##2##(1990-1#1)(1990-3#1)(1991-6#1)(1994-8#1)(1997-3#1)(2005-11#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-6#1)(2012-12#1)(2013-7#1)
which cases##2##2##(2008-10#1)(2011-2#1)
which catalyses the##2##3##(2007-9#1)(2008-6#1)
which catalyses##4##2##(1995-12#1)(2007-9#1)(2008-6#1)(2010-5#1)
which catalyzed the##2##3##(1992-7#1)(1994-5#1)
which catalyzes the conversion of##2##5##(2008-10#1)(2008-11#1)
which catalyzes the reversible##3##4##(1990-11#1)(1992-3#1)(1993-8#1)
which catalyzes the##22##3##(1990-10#1)(1990-11#1)(1990-3#1)(1990-7#1)(1991-1#1)(1991-11#1)(1992-3#2)(1992-8#1)(1993-8#1)(1995-9#1)(1996-6#1)(1996-7#3)(2006-10#1)(2006-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
which catalyzes##28##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-3#2)(1992-3#2)(1992-8#1)(1993-8#1)(1994-11#1)(1995-9#1)(1996-6#1)(1996-7#3)(2006-10#1)(2006-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-7#1)(2009-8#1)
which category##2##2##(2008-4#1)(2008-9#1)
which cause a##2##3##(2008-9#1)(2011-1#1)
which cause an##2##3##(1996-11#1)(2011-3#1)
which cause major##2##3##(2008-1#1)(2013-8#1)
which cause the##5##3##(1990-12#1)(1992-7#1)(1996-12#1)(2008-10#1)(2012-3#1)
which cause##32##2##(1990-12#1)(1991-11#1)(1992-7#1)(1995-12#1)(1995-4#1)(1996-11#1)(1996-12#2)(1997-6#1)(2005-11#1)(2007-10#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-6#1)(2008-7#1)(2008-9#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#2)
which caused symptoms##2##3##(2008-10#2)
which caused the##7##3##(1990-4#1)(1992-8#1)(1995-3#1)(2006-3#1)(2008-10#1)(2008-5#1)(2008-7#1)
which caused##30##2##(1990-4#2)(1991-7#1)(1992-11#1)(1992-2#1)(1992-8#1)(1994-3#1)(1995-3#1)(2006-11#1)(2006-12#1)(2006-3#1)(2007-12#1)(2007-5#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2011-2#2)(2012-2#1)(2013-7#1)(2013-8#1)
which causes a modulation of##2##5##(2007-12#2)
which causes a##7##3##(1992-7#1)(2007-12#2)(2007-5#1)(2008-10#2)(2013-7#1)
which causes an##4##3##(1994-8#1)(2008-7#1)(2010-12#1)(2012-2#1)
which causes serious##2##3##(2008-10#1)(2010-9#1)
which causes severe##2##3##(2008-10#1)(2010-11#1)
which causes the##11##3##(1990-4#1)(1993-3#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
which causes##68##2##(1990-4#1)(1991-5#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-3#1)(1994-6#1)(1994-8#1)(1996-3#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-1#1)(2005-11#1)(2005-7#2)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#13)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#3)(2009-8#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-7#2)
which ceased##3##2##(2005-9#1)(2008-11#1)(2009-12#1)
which cell proliferation##3##3##(1991-2#1)(2008-7#1)(2009-5#1)
which cell##7##2##(1991-2#1)(1996-5#1)(2006-3#1)(2008-11#2)(2008-7#1)(2009-5#1)
which cells and##2##3##(2006-6#1)(2011-1#1)
which cells##14##2##(1990-2#1)(1996-7#1)(2006-6#2)(2007-12#1)(2007-9#2)(2008-1#1)(2008-4#2)(2010-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
which cellular##3##2##(1993-9#1)(2005-8#1)(2008-12#1)
which central##2##2##(1996-7#1)(2006-4#1)
which cerebral##2##2##(1995-12#1)(2006-10#1)
which challenges the concept##2##4##(2005-10#1)(2008-7#1)
which challenges##3##2##(2005-10#1)(2008-7#1)(2012-3#1)
which change##4##2##(1991-2#1)(1991-6#1)(2008-4#1)(2008-5#1)
which changed##4##2##(1990-4#1)(1991-12#1)(2010-8#1)(2013-1#1)
which changes in##3##3##(1993-6#1)(2005-12#1)(2006-5#1)
which changes the##2##3##(1990-11#1)(2007-11#1)
which changes##15##2##(1990-11#2)(1992-9#2)(1993-6#1)(1994-3#1)(1997-4#1)(1997-7#1)(2005-12#1)(2006-5#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-8#1)
which characteristically##2##2##(1994-8#1)(2008-10#1)
which characterize the##3##3##(1992-10#1)(1995-12#1)(2008-10#1)
which characterize##6##2##(1992-10#1)(1995-12#1)(2007-2#1)(2008-10#1)(2011-2#2)
which characterizes the##4##3##(1991-8#1)(2005-11#1)(2008-5#1)(2012-1#1)
which characterizes##6##2##(1991-8#1)(1992-8#1)(2005-11#1)(2006-10#1)(2008-5#1)(2012-1#1)
which children##4##2##(2006-10#1)(2009-9#1)(2010-2#1)(2010-9#1)
which claim##3##2##(1995-8#1)(2008-1#1)(2009-10#1)
which claims##2##2##(2006-10#1)(2007-8#1)
which clearly showed##2##3##(1995-2#1)(2008-10#1)
which clearly##9##2##(1990-12#1)(1991-5#1)(1994-1#1)(1995-2#1)(2008-10#2)(2010-1#1)(2011-3#1)(2012-3#1)
which cleaves at##2##3##(1995-8#1)(1996-4#1)
which cleaves##9##2##(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-1#1)(1995-8#1)(1996-4#1)(1996-8#1)
which clinical##6##2##(1990-10#1)(1992-2#1)(2005-7#1)(2008-4#1)(2009-10#1)(2012-2#1)
which clinicians##3##2##(2005-7#1)(2005-8#1)(2009-7#1)
which closely apposed retrogradely labeled##2##5##(1992-1#2)
which closely resembles##2##3##(1991-8#1)(2012-3#1)
which closely##10##2##(1991-8#1)(1992-1#2)(1992-7#1)(1995-2#1)(1995-3#1)(2008-1#1)(2008-9#1)(2010-1#1)(2012-3#1)
which closes##2##2##(1990-7#1)(1992-11#1)
which clustered##2##2##(1993-2#1)(2008-10#1)
which co-exist##2##2##(2008-10#1)(2009-5#1)
which code for##5##3##(1990-5#1)(1993-4#1)(1993-9#1)(1996-3#1)(2010-2#1)
which code##7##2##(1990-5#1)(1993-4#1)(1993-9#1)(1996-3#1)(1996-8#1)(2005-11#1)(2010-2#1)
which coded for a##2##4##(1990-12#1)(1990-5#1)
which coded for##3##3##(1990-12#1)(1990-5#2)
which codes for a##3##4##(1990-11#1)(1994-12#1)(1996-2#1)
which codes for the##6##4##(1991-9#1)(1993-12#1)(2008-10#2)(2008-7#1)(2012-2#1)
which codes for##13##3##(1990-11#1)(1991-10#1)(1991-9#1)(1993-12#1)(1993-6#1)(1994-12#2)(1995-8#1)(1996-2#1)(2008-10#2)(2008-7#1)(2012-2#1)
which cognitive##3##2##(1994-7#1)(2004-10#1)(2005-10#1)
which coincided with a##2##4##(1994-7#1)(2008-11#1)
which coincided with the##7##4##(1990-5#1)(1993-8#1)(2005-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-3#1)
which coincided with##12##3##(1990-5#1)(1993-8#1)(1994-7#1)(2005-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2009-2#1)(2012-3#1)
which coincides with the##3##4##(1995-8#1)(2008-10#2)
which coincides with##4##3##(1995-8#1)(2008-10#2)(2008-2#1)
which coincides##5##2##(1995-8#1)(2008-10#2)(2008-2#1)(2008-5#1)
which collect##2##2##(2006-12#1)(2009-12#1)
which collectively##2##2##(2008-10#1)(2009-5#1)
which colloidal##2##2##(2007-12#1)(2007-9#1)
which combinations of these##2##4##(2007-10#1)(2007-5#1)
which combinations of##3##3##(2007-10#1)(2007-5#1)(2009-5#1)
which combine the##2##3##(1992-8#1)(2009-11#1)
which combine##6##2##(1990-2#1)(1992-8#1)(2007-8#1)(2008-10#1)(2009-11#1)(2013-8#1)
which combined the##3##3##(2008-10#2)(2008-8#1)
which combined##4##2##(2007-11#1)(2008-10#2)(2008-8#1)
which combines a##5##3##(1996-3#1)(2007-11#1)(2007-12#1)(2010-6#1)(2012-11#1)
which combines an##2##3##(2008-10#2)
which combines the##4##3##(2008-10#1)(2010-9#1)(2011-1#1)(2012-2#1)
which combines##25##2##(1993-2#1)(1996-3#1)(1997-7#1)(2007-11#3)(2007-12#2)(2008-10#4)(2008-3#1)(2008-5#1)(2009-10#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#1)(2012-1#2)(2012-11#1)(2012-2#1)(2013-1#1)
which comes##3##2##(1992-10#1)(2007-12#1)(2007-8#1)
which commonly##7##2##(1990-7#1)(2005-11#1)(2006-10#1)(2006-9#1)(2008-10#2)(2011-2#1)
which communicated with the##2##4##(2013-1#1)(2013-7#1)
which communicated##3##2##(1997-1#1)(2013-1#1)(2013-7#1)
which community##3##2##(1995-3#1)(2007-7#1)(2013-1#1)
which compare##4##2##(1993-12#1)(1996-12#1)(2008-10#1)(2011-1#1)
which compared##4##2##(2008-7#1)(2012-12#2)(2013-7#1)
which compares favourably with##2##4##(1991-9#1)(2008-7#1)
which compares##9##2##(1991-9#1)(1992-2#1)(2008-10#4)(2008-6#1)(2008-7#1)(2011-2#1)
which compensates##2##2##(2008-3#1)(2010-12#1)
which competes for the##2##4##(1993-11#1)(1995-1#1)
which competition##3##2##(2008-8#1)(2008-9#1)(2009-10#1)
which complement##2##2##(2010-12#1)(2010-5#1)
which complements##2##2##(1990-11#1)(1997-2#1)
which complete##3##2##(2006-12#1)(2008-6#1)(2013-7#1)
which completely##5##2##(1990-2#1)(1991-8#1)(1994-8#1)(1995-2#1)(2007-10#1)
which complicates high-volume albumin transfusion##2##5##(2013-1#2)
which complicates##3##2##(2008-4#1)(2013-1#2)
which component of the##2##4##(1995-5#1)(2008-10#1)
which components of##2##3##(1996-3#1)(1996-9#1)
which components##3##2##(1996-3#1)(1996-9#1)(2008-11#1)
which compounds##2##2##(2010-11#1)(2013-1#1)
which comprise##7##2##(1992-8#1)(1994-12#1)(1996-12#1)(2005-8#1)(2008-2#1)(2009-9#1)(2012-12#1)
which comprised##5##2##(1992-6#1)(2008-10#1)(2009-2#1)(2012-12#1)(2012-2#1)
which comprises the##5##3##(1990-3#1)(1990-7#1)(1995-5#1)(2006-12#1)(2008-3#1)
which comprises##11##2##(1990-3#1)(1990-7#1)(1995-5#1)(2006-12#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#2)
which compromise##4##2##(1990-9#1)(2008-3#1)(2010-4#2)
which concern##3##2##(2004-12#1)(2008-8#2)
which concerns##2##2##(2008-1#1)(2008-7#1)
which condition##4##2##(2008-10#2)(2011-1#1)(2012-11#1)
which conditions##7##2##(2005-11#1)(2008-10#3)(2008-3#1)(2008-7#1)(2010-9#1)
which condom##2##2##(2008-10#1)(2012-3#1)
which conducted phase##2##3##(2005-7#1)(2005-8#1)
which confer##6##2##(1996-9#1)(1997-4#1)(2005-8#1)(2008-5#1)(2009-10#1)(2013-1#1)
which conferred##3##2##(1994-11#1)(2008-10#1)(2008-11#1)
which confers##10##2##(1990-8#1)(1994-9#1)(1995-2#2)(1996-5#1)(1997-4#1)(1997-5#1)(2006-12#1)(2008-10#1)(2009-3#1)
which confirm the##3##3##(1992-6#1)(2007-9#1)(2009-6#1)
which confirm##4##2##(1992-6#1)(2007-9#1)(2009-6#1)(2013-7#1)
which confirmed the##5##3##(1992-6#1)(1995-11#1)(2005-11#1)(2006-10#1)(2012-1#1)
which confirmed##10##2##(1992-6#1)(1994-5#1)(1995-11#1)(2005-11#1)(2006-10#1)(2008-8#1)(2010-12#1)(2010-5#1)(2012-1#1)(2012-12#1)
which confirms the##4##3##(1991-6#1)(1992-5#1)(2007-12#1)(2012-12#1)
which confirms##5##2##(1991-6#1)(1992-5#1)(2007-12#1)(2011-1#1)(2012-12#1)
which conflict##2##2##(2009-7#1)(2009-9#1)
which conflicts with##2##3##(1990-8#1)(1996-11#1)
which conforms to##5##3##(1990-10#1)(1994-9#1)(2006-11#1)(2008-9#1)(2009-2#1)
which connects the##4##3##(1997-2#1)(2006-10#1)(2012-1#1)(2012-12#1)
which connects##5##2##(1997-2#1)(2006-10#1)(2007-8#1)(2012-1#1)(2012-12#1)
which consensus##2##2##(1991-11#1)(1991-7#1)
which consequently##5##2##(1995-10#1)(1996-5#1)(2008-3#1)(2009-9#1)(2013-1#1)
which consider the##3##3##(1992-3#1)(2008-11#1)(2008-12#1)
which considerably##2##2##(2008-5#1)(2011-2#1)
which considers the##2##3##(1990-12#1)(2008-4#1)
which considers##5##2##(1990-12#1)(2008-4#1)(2008-7#1)(2013-1#1)(2013-8#1)
which consist of##5##3##(1992-1#1)(1992-3#1)(1995-5#1)(2008-2#1)(2012-12#1)
which consisted of a##5##4##(1993-12#2)(1995-2#1)(2008-10#1)(2008-9#1)
which consisted of the##2##4##(2008-10#1)(2008-11#1)
which consisted of##22##3##(1990-2#1)(1991-12#1)(1993-12#2)(1993-5#1)(1995-10#1)(1995-12#1)(1995-2#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#2)(2009-3#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
which consisted##24##2##(1990-2#1)(1991-12#1)(1993-12#2)(1993-5#1)(1995-10#1)(1995-12#1)(1995-2#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#2)(2009-3#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
which consistently##4##2##(1994-3#1)(2008-10#1)(2008-12#1)(2008-7#1)
which consists in determining the##2##5##(2008-2#2)
which consists in##6##3##(1997-7#1)(2008-2#2)(2008-5#1)(2012-2#2)
which consists of a##13##4##(1991-4#1)(1994-8#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-3#3)(2010-5#1)(2011-2#1)(2012-2#1)
which consists of the##8##4##(1991-9#1)(1995-6#2)(1997-2#1)(1997-7#1)(1997-8#1)(2008-2#1)(2008-7#1)
which consists of three##2##4##(2007-12#1)(2008-11#1)
which consists of two##5##4##(1994-5#1)(1996-4#1)(2008-11#1)(2008-2#1)(2008-9#1)
which consists of##48##3##(1991-4#1)(1991-7#1)(1991-9#1)(1992-7#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-6#2)(1996-4#1)(1997-2#2)(1997-7#2)(1997-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-5#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-8#1)
which consists##56##2##(1991-4#1)(1991-7#1)(1991-9#1)(1992-5#1)(1992-7#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-6#2)(1996-4#1)(1997-2#2)(1997-7#3)(1997-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-5#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#4)(2013-8#1)
which constitute the##4##3##(1991-5#1)(2008-10#2)(2009-2#1)
which constitute##10##2##(1991-5#1)(1995-2#1)(2007-1#1)(2008-10#3)(2008-11#1)(2009-2#1)(2009-8#1)(2010-8#1)
which constitutes a##2##3##(1992-11#1)(2008-11#1)
which constitutes the##7##3##(1990-11#1)(2007-5#1)(2008-10#1)(2009-10#1)(2009-8#2)(2012-12#1)
which constitutes##12##2##(1990-11#1)(1992-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)(2009-7#1)(2009-8#2)(2011-2#1)(2012-12#1)
which consumes##2##2##(2006-6#1)(2008-5#1)
which contain DOM##2##3##(2008-10#2)
which contain a##8##3##(1994-9#1)(1995-1#2)(1997-6#1)(2006-5#1)(2006-9#1)(2007-10#1)(2011-1#1)
which contain high##2##3##(1994-6#1)(1994-9#1)
which contain leader region of##2##5##(2008-9#2)
which contain no##3##3##(1990-11#1)(1991-11#1)(2007-11#1)
which contain the##9##3##(1990-11#1)(1990-3#1)(1990-9#1)(1991-5#1)(1991-9#1)(1993-11#1)(1995-11#1)(2008-8#1)(2012-2#1)
which contain##65##2##(1990-11#2)(1990-3#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-7#2)(1993-11#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#3)(1995-11#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-2#1)(1996-4#1)(1997-2#2)(1997-4#1)(1997-6#1)(2005-11#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-10#7)(2008-4#1)(2008-8#1)(2008-9#2)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)
which contained a##7##3##(1991-9#1)(2004-4#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-10#1)
which contained all##2##3##(1990-9#1)(2010-2#1)
which contained an##4##3##(1990-9#1)(1991-8#1)(1995-2#1)(2008-10#1)
which contained either##2##3##(1995-12#1)(1995-6#1)
which contained several##2##3##(1990-11#1)(1997-7#1)
which contained the##6##3##(1994-6#1)(1994-8#1)(1995-11#1)(1996-5#1)(2008-10#1)(2008-11#1)
which contained two##2##3##(1992-2#1)(1996-5#1)
which contained##61##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-9#2)(1991-8#1)(1991-9#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-4#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(2004-4#1)(2005-11#2)(2005-12#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#2)(2010-10#1)(2010-2#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
which contains a polylinker for subcloning double-stranded cDNA##2##8##(2008-2#1)(2008-4#1)
which contains a potential##2##4##(1992-3#1)(1997-7#1)
which contains a##27##3##(1990-5#1)(1991-12#1)(1991-3#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-4#1)(1994-8#1)(1994-9#2)(1995-4#1)(1995-8#1)(1996-4#1)(1997-2#1)(1997-7#1)(2005-11#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-5#1)(2012-1#1)
which contains an##8##3##(1990-11#1)(1990-4#1)(1994-12#1)(1994-8#1)(1997-7#1)(2006-10#1)(2008-9#1)(2009-3#1)
which contains both##2##3##(1991-12#1)(1994-12#1)
which contains four##4##3##(1991-3#1)(1991-6#1)(1995-6#2)
which contains mainly##2##3##(2008-10#1)(2009-3#1)
which contains one##2##3##(1990-8#1)(1994-2#1)
which contains the active site of##2##6##(1993-4#1)(1994-8#1)
which contains the##24##3##(1991-2#1)(1991-5#1)(1991-7#1)(1992-1#2)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-8#2)(1994-9#1)(1995-7#1)(1996-9#1)(2007-10#1)(2008-10#1)(2008-4#1)(2009-5#1)(2009-9#1)(2010-5#1)
which contains two##2##3##(1992-3#1)(2008-10#1)
which contains##129##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#2)(1991-7#1)(1992-1#4)(1992-2#1)(1992-3#2)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#5)(1993-3#2)(1993-4#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#1)(1994-8#5)(1994-9#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-4#1)(1996-7#1)(1996-9#2)(1997-2#2)(1997-4#1)(1997-7#2)(2005-11#2)(2006-10#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#3)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#2)(2009-5#1)(2009-9#1)(2010-12#1)(2010-5#2)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
which continue to##4##3##(2004-3#1)(2006-10#1)(2007-11#1)(2008-1#1)
which continued##5##2##(1990-10#1)(2004-7#1)(2007-8#1)(2008-5#2)
which continuously##2##2##(2008-11#2)
which contrasted##2##2##(1990-12#1)(2010-4#1)
which contrasts to##2##3##(1992-3#1)(2010-5#1)
which contrasts with the##2##4##(2008-3#1)(2011-1#1)
which contrasts with##6##3##(1990-5#1)(1996-7#1)(2007-11#1)(2008-3#1)(2008-8#1)(2011-1#1)
which contrasts##11##2##(1990-5#1)(1992-3#1)(1996-7#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#2)(2009-10#1)(2010-5#1)(2011-1#1)
which contribute to the development of##4##6##(1992-12#1)(1996-9#1)(1997-6#1)(2007-1#1)
which contribute to the##9##4##(1992-12#1)(1996-9#1)(1997-6#1)(2007-1#1)(2008-7#2)(2010-2#1)(2011-1#1)(2012-3#1)
which contribute to##16##3##(1990-6#1)(1991-1#1)(1992-12#1)(1996-9#1)(1997-6#1)(2005-10#1)(2006-11#1)(2007-1#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-2#1)(2011-1#1)(2012-3#1)(2013-8#1)
which contribute##19##2##(1990-6#1)(1991-1#1)(1992-12#1)(1996-9#1)(1997-6#1)(2005-10#1)(2006-11#1)(2007-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
which contributed to the##5##4##(2005-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-11#1)
which contributed to##6##3##(1995-3#1)(2005-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-11#1)
which contributed##7##2##(1995-3#1)(2005-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-8#1)(2012-11#1)
which contributes to a##2##4##(2008-10#1)(2008-7#1)
which contributes to the##5##4##(1991-9#1)(1996-9#1)(2008-2#1)(2012-12#1)(2012-2#1)
which contributes to##16##3##(1991-9#1)(1995-8#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-7#2)(2009-12#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
which contributes##18##2##(1991-9#1)(1995-8#1)(1996-9#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-7#2)(2009-12#1)(2009-4#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
which control the##2##3##(2008-1#1)(2008-11#1)
which control##14##2##(1990-9#1)(1994-6#1)(1997-4#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-3#1)(2009-6#1)(2011-2#1)(2012-11#1)
which controls the production of##2##5##(2012-11#2)
which controls the##7##3##(1993-3#1)(1997-2#1)(2008-9#1)(2012-11#3)(2012-2#1)
which controls transcription##2##3##(1991-4#1)(2008-10#1)
which controls##15##2##(1991-4#1)(1993-3#1)(1997-2#1)(2003-11#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-11#3)(2012-2#1)
which conventional##4##2##(2006-10#1)(2007-8#1)(2011-1#1)(2013-1#1)
which converts the##3##3##(1993-6#1)(1997-1#1)(2008-9#1)
which converts##14##2##(1990-3#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-8#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-11#1)(1995-8#2)(1997-1#1)(2008-4#1)(2008-9#1)
which coordinates the##2##3##(2009-3#1)(2012-12#1)
which corrected the##2##3##(1992-2#1)(2012-2#1)
which correlate well with##2##4##(1990-9#1)(1994-8#1)
which correlate with##2##3##(1997-2#1)(2013-8#1)
which correlate##5##2##(1990-9#1)(1994-8#1)(1997-2#1)(2010-12#1)(2013-8#1)
which correlated well with##2##4##(2008-10#1)(2012-12#1)
which correlated with a##2##4##(2006-10#1)(2009-8#1)
which correlated with##10##3##(1990-2#1)(1993-8#1)(1996-12#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-2#1)(2008-10#1)(2009-8#1)(2009-9#1)
which correlated##18##2##(1990-2#1)(1993-8#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-5#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-8#1)(2009-9#2)(2012-12#1)
which correlates with the##9##4##(1992-9#1)(1993-5#1)(1994-2#1)(1995-2#1)(1995-9#1)(1996-8#1)(1997-9#1)(2007-12#1)(2008-9#1)
which correlates with##10##3##(1992-9#1)(1993-5#1)(1994-2#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-8#1)(1997-9#1)(2007-12#1)(2008-9#1)
which correlates##14##2##(1992-9#1)(1993-5#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-9#1)(2007-12#1)(2007-7#1)(2008-9#1)
which correspond to relatively long and nearly full-length transcripts##2##9##(1996-10#1)(1996-2#1)
which correspond to relatively long##3##5##(1996-10#1)(1996-2#1)(1997-4#1)
which correspond to the##6##4##(1996-3#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-9#1)(2010-8#1)
which correspond to##20##3##(1992-9#1)(1994-8#1)(1995-9#3)(1996-10#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-2#2)(1997-4#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-8#1)
which correspond with##2##3##(2008-10#1)(2012-3#1)
which correspond##23##2##(1992-9#1)(1994-8#1)(1995-9#3)(1996-10#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-2#2)(1997-4#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-3#1)
which corresponded to the##7##4##(1990-10#1)(1990-5#1)(1991-3#1)(2005-11#1)(2005-9#1)(2008-11#1)(2013-8#1)
which corresponded to##22##3##(1990-10#1)(1990-3#1)(1990-5#1)(1991-3#1)(1994-9#2)(1995-4#1)(2005-11#1)(2005-9#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
which corresponded##24##2##(1990-10#1)(1990-3#2)(1990-5#1)(1991-3#1)(1994-9#2)(1995-4#1)(2005-11#1)(2005-9#1)(2006-12#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
which corresponds to a##15##4##(1992-10#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-9#1)(2007-11#2)(2007-12#4)(2008-10#2)(2008-2#1)(2008-3#1)
which corresponds to an##6##4##(1993-2#1)(2007-12#1)(2008-2#2)(2011-2#1)(2012-12#1)
which corresponds to the human##2##5##(2008-8#1)(2009-2#1)
which corresponds to the size of##2##6##(1997-1#1)(2008-3#1)
which corresponds to the##19##4##(1990-8#1)(1991-1#1)(1991-5#2)(1992-6#1)(1993-12#1)(1994-11#1)(1994-5#1)(1994-8#1)(1997-1#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-8#1)(2009-2#1)
which corresponds to##58##3##(1990-8#1)(1991-1#2)(1991-5#2)(1992-10#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-2#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-9#1)(1997-1#1)(2006-11#1)(2007-11#3)(2007-12#5)(2008-1#2)(2008-10#7)(2008-11#2)(2008-2#6)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
which could account for the##3##5##(1992-5#1)(1996-4#1)(2008-10#1)
which could account for##6##4##(1990-2#1)(1992-5#1)(1996-4#1)(2008-1#1)(2008-10#1)(2012-2#1)
which could act##3##3##(1991-10#1)(1993-3#1)(2010-9#1)
which could affect the##3##4##(2007-8#1)(2008-10#2)
which could affect treatment outcome##2##5##(2013-1#2)
which could affect##9##3##(1994-11#1)(2006-12#1)(2007-8#1)(2008-10#2)(2009-5#1)(2012-12#1)(2013-1#2)
which could also be##3##4##(1996-8#1)(2008-10#1)(2010-5#1)
which could also##4##3##(1996-8#1)(2008-10#1)(2010-5#1)(2010-7#1)
which could alter the##2##4##(1990-10#1)(2008-9#1)
which could be a##6##4##(1990-11#1)(1994-6#1)(2007-10#1)(2008-12#1)(2011-2#1)(2012-3#1)
which could be applied##2##4##(1995-2#1)(2008-5#1)
which could be attributed to##4##5##(1995-12#1)(2008-3#1)(2011-12#1)(2011-2#1)
which could be blocked by##5##5##(1990-4#1)(1991-3#1)(1994-9#1)(1997-7#1)(2011-1#1)
which could be correlated with##2##5##(1990-7#1)(2008-5#1)
which could be correlated##3##4##(1990-7#1)(1994-9#1)(2008-5#1)
which could be detected##5##4##(1993-9#1)(1994-9#1)(2007-8#1)(2008-10#1)(2008-8#1)
which could be due to the##2##6##(1991-5#1)(1996-12#1)
which could be due to##3##5##(1991-5#1)(1996-12#1)(1997-3#1)
which could be enhanced##2##4##(1991-3#1)(1992-7#1)
which could be explained##2##4##(1992-8#1)(2008-10#1)
which could be further improved by increasing the##2##8##(2007-8#1)(2008-10#1)
which could be further##4##4##(1992-9#1)(2007-8#1)(2008-10#1)(2008-5#1)
which could be incorporated##2##4##(1996-12#1)(2008-10#1)
which could be inhibited by##2##5##(1990-2#1)(1995-8#1)
which could be interpreted##2##4##(2006-10#1)(2008-5#1)
which could be more##2##4##(2010-12#1)(2010-8#1)
which could be of##5##4##(1991-6#1)(2005-1#1)(2005-8#1)(2008-4#1)(2011-2#1)
which could be present##2##4##(1996-5#1)(2008-11#1)
which could be reduced##2##4##(1996-7#1)(2005-4#1)
which could be related to the##2##6##(1993-8#1)(2011-2#1)
which could be related to##5##5##(1992-12#1)(1993-8#1)(2007-9#1)(2011-2#2)
which could be relevant##2##4##(2006-11#1)(2012-2#1)
which could be restored by##3##5##(1990-6#1)(1991-1#1)(1994-2#1)
which could be the##2##4##(2005-9#1)(2008-1#1)
which could be used in the##4##6##(1990-2#1)(1994-6#1)(2006-8#1)(2007-7#1)
which could be used in##6##5##(1990-2#1)(1994-6#1)(1997-7#1)(2006-8#1)(2007-12#1)(2007-7#1)
which could be used to##4##5##(2008-10#2)(2011-2#1)(2012-12#1)
which could be used##11##4##(1990-2#1)(1990-7#1)(1994-6#1)(1997-7#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#2)(2011-2#1)(2012-12#1)
which could be##142##3##(1990-11#1)(1990-2#2)(1990-4#1)(1990-6#2)(1990-7#2)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#1)(1992-12#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-8#2)(1993-9#2)(1994-2#1)(1994-6#2)(1994-9#4)(1995-12#1)(1995-2#2)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-5#3)(1996-7#1)(1997-1#1)(1997-3#1)(1997-7#3)(2004-12#1)(2005-1#1)(2005-4#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-8#2)(2011-1#4)(2011-12#2)(2011-2#9)(2012-12#2)(2012-2#7)(2012-3#2)(2012-5#1)(2013-1#2)(2013-8#2)
which could bind##2##3##(1994-6#1)(1995-6#1)
which could broaden their application as cell markers in living systems and in micelle encapsulated drug delivery systems##2##18##(2012-11#2)
which could cause the##2##4##(2011-2#1)(2013-8#1)
which could cause##4##3##(2008-10#1)(2008-3#1)(2011-2#1)(2013-8#1)
which could contribute to##2##4##(1995-7#1)(2005-10#1)
which could easily be##2##4##(1993-3#1)(2012-3#1)
which could easily##4##3##(1993-3#1)(2005-11#1)(2010-1#1)(2012-3#1)
which could encode a##2##4##(1990-11#1)(1991-9#1)
which could explain the##4##4##(1991-4#1)(1996-11#1)(2006-8#1)(2009-5#1)
which could explain##8##3##(1991-4#1)(1992-5#1)(1996-11#1)(1996-5#1)(2006-8#1)(2008-10#1)(2009-5#1)(2011-10#1)
which could have been##2##4##(2010-5#1)(2010-9#1)
which could have##5##3##(1997-5#1)(2007-10#1)(2007-9#1)(2010-5#1)(2010-9#1)
which could help##3##3##(2007-2#1)(2007-8#1)(2008-10#1)
which could in turn##2##4##(2007-7#1)(2008-7#1)
which could increase the##4##4##(2008-10#1)(2008-6#1)(2010-10#1)(2010-8#1)
which could indicate##3##3##(2007-12#1)(2008-10#1)(2013-8#1)
which could involve##5##3##(1991-12#1)(2008-11#1)(2008-9#1)(2013-1#1)(2013-7#1)
which could lead to##10##4##(1990-9#1)(1995-10#1)(2007-7#1)(2009-2#1)(2010-10#1)(2011-2#2)(2012-12#2)(2013-1#1)
which could mask##2##3##(1991-9#1)(2010-4#1)
which could mediate##2##3##(1997-7#1)(2007-11#1)
which could not be achieved##2##5##(1996-5#1)(2007-8#1)
which could not be explained by##2##6##(1996-6#1)(2012-2#1)
which could not be explained##4##5##(1990-8#1)(1996-6#1)(2005-1#1)(2012-2#1)
which could not be managed endoscopically because of the compression due to hypopharingeal edema##2##14##(2008-8#1)(2008-9#1)
which could not be##19##4##(1990-8#1)(1991-9#1)(1995-6#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#1)(2005-1#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-12#1)(2010-8#1)(2012-2#1)
which could not##22##3##(1990-8#1)(1991-9#1)(1992-11#1)(1993-2#1)(1995-6#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#2)(2005-1#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-12#1)(2010-8#1)(2012-2#1)
which could occur at##2##4##(1996-6#1)(2007-2#1)
which could occur##3##3##(1996-6#1)(2007-2#1)(2013-1#1)
which could only##2##3##(1991-11#1)(2008-10#1)
which could play a role in##3##6##(1994-11#1)(1994-6#1)(1996-3#1)
which could play a##4##4##(1994-11#1)(1994-6#1)(1996-3#1)(2009-11#1)
which could possibly be##2##4##(1992-1#1)(2006-6#1)
which could potentially##5##3##(1990-5#1)(2007-2#1)(2008-10#2)(2009-12#1)
which could prevent##3##3##(1993-2#1)(2008-7#1)(2008-9#1)
which could produce##3##3##(1996-4#1)(2008-8#1)(2010-4#1)
which could prove##2##3##(2006-5#1)(2009-12#1)
which could provide##3##3##(2005-12#1)(2011-2#1)(2013-8#1)
which could reflect##2##3##(1995-2#1)(2006-8#1)
which could represent a##2##4##(1993-12#1)(1996-11#1)
which could result##2##3##(2008-10#1)(2011-2#1)
which could satisfy the sample examination request and provide scientific rationale for determining##2##13##(2013-8#2)
which could serve as##2##4##(1992-3#1)(2006-6#1)
which could serve##3##3##(1992-3#1)(2006-6#1)(2010-8#1)
which could then be##3##4##(1991-10#1)(1991-12#1)(1997-4#1)
which could then##4##3##(1991-10#1)(1991-12#1)(1997-4#1)(2008-12#1)
which could##351##2##(1990-10#2)(1990-11#3)(1990-2#5)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#3)(1992-7#1)(1992-8#2)(1992-9#2)(1993-12#2)(1993-2#2)(1993-3#2)(1993-7#1)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-6#4)(1994-9#5)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#2)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#5)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#4)(2004-10#1)(2004-12#1)(2005-1#2)(2005-10#2)(2005-11#1)(2005-12#1)(2005-4#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-3#1)(2006-5#2)(2006-6#2)(2006-8#3)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#4)(2007-8#8)(2007-9#4)(2008-1#2)(2008-10#32)(2008-11#8)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#9)(2008-6#3)(2008-7#4)(2008-8#5)(2008-9#8)(2009-11#2)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-4#2)(2010-5#4)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#4)(2011-10#1)(2011-12#2)(2011-2#16)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#7)(2012-2#10)(2012-3#6)(2012-5#1)(2013-1#7)(2013-7#1)(2013-8#7)
which couples the dynamics of##2##5##(2007-12#1)(2013-8#1)
which couples##4##2##(1993-11#1)(1993-8#1)(2007-12#1)(2013-8#1)
which covalently##2##2##(1990-2#1)(1992-4#1)
which cover##5##2##(1994-12#1)(1995-9#1)(2007-11#1)(2009-5#1)(2011-2#1)
which covered a##3##3##(1990-12#1)(1997-2#2)
which covered the##2##3##(1993-2#1)(2008-9#1)
which covered##7##2##(1990-12#1)(1993-2#1)(1997-2#2)(2008-7#1)(2008-9#1)(2010-12#1)
which covers the##4##3##(1995-12#1)(2007-12#1)(2008-10#1)(2008-2#1)
which covers##6##2##(1995-12#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#2)
which create##3##2##(1990-11#1)(1990-5#1)(2011-2#1)
which created##5##2##(1990-6#1)(2007-2#1)(2008-10#1)(2011-2#1)(2013-1#1)
which creates a##5##3##(2007-12#2)(2008-3#1)(2010-12#1)(2010-8#1)
which criteria##2##2##(1993-2#1)(2013-7#1)
which cross-reacted##2##2##(1993-9#1)(2010-8#1)
which cross-reacts with##2##3##(1991-3#1)(1992-12#1)
which culminates in##2##3##(1994-2#1)(1996-6#1)
which current##4##2##(2007-1#1)(2008-11#1)(2008-8#2)
which currently##10##2##(1990-12#1)(1996-12#1)(2005-5#1)(2006-10#1)(2006-7#1)(2008-10#1)(2008-8#2)(2008-9#1)(2010-12#1)
which cytoplasmic##2##2##(2007-12#1)(2009-6#1)
which damage##6##2##(1997-4#1)(2004-4#1)(2006-6#1)(2008-10#1)(2008-5#1)(2009-8#1)
which damaged##2##2##(2006-4#1)(2008-7#1)
which data from##2##3##(1997-3#1)(2009-11#1)
which data were##2##3##(2009-9#1)(2011-2#1)
which data##9##2##(1992-7#1)(1997-3#1)(2008-3#1)(2009-11#1)(2009-9#1)(2011-2#2)(2012-12#2)
which decisions are##2##3##(2008-5#1)(2012-12#1)
which declined##4##2##(1995-9#1)(1996-1#1)(2010-8#1)(2012-12#1)
which decrease with##2##3##(2008-5#1)(2013-7#1)
which decrease##5##2##(1993-9#1)(2007-7#1)(2008-2#1)(2008-5#1)(2013-7#1)
which decreased as##2##3##(1995-8#1)(2007-2#1)
which decreased to##3##3##(2006-8#1)(2008-1#1)(2008-3#1)
which decreased with##2##3##(1997-1#1)(2008-10#1)
which decreased##13##2##(1991-5#1)(1991-6#1)(1995-8#1)(1996-9#1)(1997-1#1)(2006-8#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-6#1)(2011-1#1)
which decreases##4##2##(1990-2#1)(2005-11#1)(2008-5#1)(2010-11#1)
which deep##2##2##(1996-1#1)(2013-1#1)
which defeats##2##2##(2008-10#2)
which define##3##2##(1993-7#1)(1994-12#1)(2008-1#1)
which defines a##3##3##(1991-4#2)(1991-7#1)
which defines the##3##3##(1990-11#1)(2008-10#1)(2012-2#1)
which defines##10##2##(1990-11#1)(1991-4#2)(1991-7#1)(1995-12#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#2)
which degrade the##2##3##(1996-3#1)(2008-10#1)
which degrade##3##2##(1996-3#1)(2007-12#1)(2008-10#1)
which degrades the##4##3##(1991-12#1)(2007-11#1)(2008-3#1)(2009-6#1)
which degrades##6##2##(1991-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-6#1)
which deliver##3##2##(1994-3#1)(2007-11#1)(2012-12#1)
which delivers##5##2##(2007-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)
which delta##2##2##(1991-4#1)(2008-2#1)
which demonstrate that the##2##4##(1992-6#1)(1996-5#1)
which demonstrate that##8##3##(1990-8#1)(1992-6#1)(1995-10#1)(1995-5#1)(1996-5#1)(2009-3#1)(2010-4#1)(2012-12#1)
which demonstrate##13##2##(1990-8#1)(1992-6#1)(1995-10#1)(1995-5#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-3#1)(2009-4#1)(2010-4#1)(2012-12#1)(2012-3#1)
which demonstrated a##8##3##(2004-9#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-12#1)
which demonstrated that the##5##4##(1992-5#1)(1996-9#1)(1997-4#1)(2009-8#1)(2010-8#1)
which demonstrated that##9##3##(1991-2#1)(1991-4#1)(1992-5#1)(1995-7#1)(1996-9#1)(1997-4#1)(2008-5#1)(2009-8#1)(2010-8#1)
which demonstrated##30##2##(1991-2#1)(1991-4#1)(1991-8#1)(1992-12#1)(1992-5#1)(1994-2#1)(1995-3#1)(1995-7#1)(1996-9#1)(1997-4#1)(2004-9#1)(2006-12#1)(2007-12#2)(2007-8#2)(2007-9#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-12#2)
which demonstrates that a##2##4##(1990-4#1)(1995-7#1)
which demonstrates that even##2##4##(2008-7#1)(2008-8#1)
which demonstrates that the##2##4##(1995-8#1)(2006-10#1)
which demonstrates that##10##3##(1990-4#1)(1990-7#1)(1995-7#1)(1995-8#1)(2006-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#1)
which demonstrates the##6##3##(1996-1#1)(2008-10#3)(2010-5#1)(2010-9#1)
which demonstrates##23##2##(1990-4#1)(1990-7#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-2#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-5#1)(2010-9#1)(2012-1#1)(2012-2#1)(2013-1#2)
which denotes##2##2##(1992-6#1)(2007-6#1)
which dental##2##2##(2006-2#2)
which depend on the##8##4##(1996-4#1)(1996-5#1)(1997-1#1)(2008-2#1)(2008-8#1)(2009-8#1)(2010-4#1)(2012-2#1)
which depend on##14##3##(1996-1#1)(1996-4#1)(1996-5#1)(1997-1#1)(2004-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)
which depend##15##2##(1994-2#1)(1996-1#1)(1996-4#1)(1996-5#1)(1997-1#1)(2004-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)
which depended on the##5##4##(1992-8#1)(1996-12#1)(2008-4#1)(2008-6#1)(2011-1#1)
which depends mainly on the##2##5##(2006-9#1)(2008-3#1)
which depends on the presence of##2##6##(1994-6#1)(2008-3#1)
which depends on the##15##4##(1990-9#1)(1991-9#1)(1994-6#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#1)(2011-2#1)(2012-1#1)(2013-7#1)(2013-8#1)
which depends on##20##3##(1990-9#1)(1991-11#1)(1991-9#1)(1994-6#1)(1997-6#1)(2005-10#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#3)(2008-8#1)(2011-2#1)(2012-1#1)(2013-7#1)(2013-8#1)
which depends only on##2##4##(2008-5#1)(2009-12#1)
which depends##29##2##(1990-9#1)(1991-11#1)(1991-9#1)(1994-6#1)(1997-6#1)(2005-10#1)(2006-9#1)(2007-12#4)(2008-10#3)(2008-2#1)(2008-3#4)(2008-5#2)(2008-8#1)(2009-12#1)(2011-2#1)(2012-1#2)(2013-1#1)(2013-7#1)(2013-8#1)
which describe the##4##3##(1997-7#1)(2006-4#1)(2007-8#1)(2008-10#1)
which describe##10##2##(1994-2#1)(1997-7#1)(1997-8#1)(2006-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-2#1)
which described##2##2##(2012-12#1)(2012-3#1)
which describes the dependence##2##4##(2008-10#2)
which describes the##12##3##(1990-8#1)(1993-2#1)(2005-11#1)(2007-8#1)(2008-10#3)(2008-3#2)(2010-7#1)(2010-9#1)(2013-8#1)
which describes##18##2##(1990-8#1)(1993-2#1)(1994-12#1)(1997-2#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#3)(2010-7#1)(2010-9#1)(2013-8#1)
which deserves##3##2##(1996-11#1)(2007-2#1)(2009-10#1)
which destroy##3##2##(1993-8#1)(1996-1#1)(1997-7#1)
which destroyed##2##2##(1991-8#1)(1996-6#1)
which detailed##3##2##(1990-8#1)(1995-5#1)(1995-6#1)
which details##2##2##(2008-8#1)(2012-1#1)
which detected##2##2##(2011-2#1)(2013-7#1)
which detects##5##2##(1992-5#1)(1993-2#1)(1995-2#1)(1997-2#1)(2007-10#1)
which deteriorates##3##2##(2007-11#1)(2008-2#1)(2013-1#1)
which determine the##9##3##(1991-12#1)(1991-3#1)(1992-6#1)(1995-12#1)(1997-2#1)(2008-10#2)(2010-2#1)(2012-2#1)
which determine their##2##3##(1990-7#1)(2013-1#1)
which determine##14##2##(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-6#1)(1992-8#1)(1995-12#1)(1997-2#1)(2005-11#1)(2008-10#2)(2010-2#1)(2012-2#1)(2013-1#1)
which determines the choice of##2##5##(2007-7#1)(2008-7#1)
which determines the##13##3##(1990-8#1)(1994-7#1)(1995-6#1)(1996-6#1)(2005-5#1)(2006-10#1)(2007-7#1)(2008-2#2)(2008-7#2)(2010-12#1)(2012-1#1)
which determines##18##2##(1990-8#1)(1994-7#1)(1995-6#1)(1996-6#1)(1996-8#1)(2005-5#1)(2006-10#1)(2007-7#1)(2008-2#2)(2008-7#2)(2009-6#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)
which develop##4##2##(1990-5#1)(2005-1#1)(2008-4#1)(2008-5#1)
which developed a##2##3##(2012-12#1)(2013-1#1)
which developed in a patient##2##5##(2005-12#1)(2007-9#1)
which developed in##5##3##(1991-9#1)(2005-12#1)(2007-9#1)(2008-4#1)(2008-6#1)
which developed within##2##3##(2006-11#1)(2012-2#1)
which developed##21##2##(1991-10#1)(1991-9#1)(1992-1#1)(2005-12#1)(2006-11#1)(2006-9#1)(2007-8#1)(2007-9#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
which development##2##2##(1991-3#1)(2011-12#1)
which develops in##2##3##(1991-9#1)(2006-6#1)
which develops##4##2##(1990-1#1)(1991-9#1)(2006-6#1)(2012-12#1)
which device##2##2##(1991-6#1)(2008-11#1)
which dictates##2##2##(1997-8#1)(2009-4#1)
which did not affect##3##4##(1991-8#1)(1995-3#1)(2012-5#1)
which did not appear in##2##5##(1997-8#1)(2008-5#1)
which did not demonstrate any##2##5##(1990-10#1)(2009-4#1)
which did not differ##2##4##(1993-2#1)(2012-1#1)
which did not have##3##4##(1993-11#1)(1993-9#1)(2008-5#1)
which did not include##3##4##(1997-5#1)(2005-10#1)(2013-8#1)
which did not inhibit##2##4##(1991-9#1)(2008-10#1)
which did not react with##2##5##(1997-7#1)(2008-5#1)
which did not respond to##3##5##(1990-8#1)(2005-11#1)(2010-12#1)
which did not respond##4##4##(1990-8#1)(1991-3#1)(2005-11#1)(2010-12#1)
which did not##53##3##(1990-10#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1993-11#2)(1993-2#1)(1993-5#1)(1993-9#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-11#1)(2006-12#1)(2006-5#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-5#4)(2009-12#1)(2009-2#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-8#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-5#1)(2013-8#2)
which died during an epornithic of##2##6##(2008-5#2)
which died##7##2##(1991-8#1)(1995-9#1)(2007-11#1)(2008-5#4)
which diet##2##2##(2008-12#1)(2008-9#1)
which differ by##3##3##(1991-12#1)(1995-2#1)(1997-9#1)
which differ from##4##3##(1997-7#1)(2005-8#1)(2006-12#1)(2008-8#1)
which differ in the##6##4##(1990-7#1)(1992-9#1)(1995-5#1)(1996-5#1)(2008-10#1)(2010-5#1)
which differ in their##9##4##(1992-11#1)(1992-4#1)(1994-6#1)(1994-8#1)(1996-2#1)(1996-9#1)(1997-2#1)(2007-11#1)(2012-11#1)
which differ in##21##3##(1990-5#1)(1990-7#1)(1992-11#1)(1992-4#1)(1992-9#1)(1993-2#1)(1993-5#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#1)(2007-11#1)(2008-10#1)(2009-4#1)(2010-5#1)(2012-11#1)
which differ significantly in##3##4##(1990-10#1)(1993-11#1)(2008-12#1)
which differ##35##2##(1990-10#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-3#1)(1992-11#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-5#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-5#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-7#1)(1997-9#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-4#1)(2010-5#1)(2012-11#1)
which differed from##4##3##(1992-12#1)(2006-8#1)(2008-11#1)(2013-7#1)
which differed in the##2##4##(2008-10#1)(2010-4#1)
which differed in##7##3##(1992-3#1)(2008-1#1)(2008-10#2)(2008-8#1)(2010-1#1)(2010-4#1)
which differed significantly##2##3##(2008-10#1)(2009-10#1)
which differed##17##2##(1991-7#1)(1992-12#1)(1992-3#1)(1995-12#1)(2006-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-8#1)(2009-10#1)(2010-1#1)(2010-4#1)(2011-2#1)(2013-7#1)
which different##15##2##(1992-3#1)(1996-4#1)(1997-7#1)(2006-10#2)(2008-10#1)(2008-2#2)(2008-8#4)(2010-4#1)(2011-2#1)(2012-3#1)
which differentially##2##2##(1990-7#1)(1996-2#1)
which differentiate into##2##3##(2007-12#1)(2008-11#1)
which differentiate##3##2##(2007-12#1)(2008-11#1)(2008-5#1)
which differentiated into##2##3##(2006-7#1)(2008-10#1)
which differentiated##3##2##(2006-7#1)(2008-1#1)(2008-10#1)
which differentiates##2##2##(2008-2#1)(2008-8#1)
which differs from that of the##2##6##(1991-10#1)(2008-2#1)
which differs from that of##4##5##(1990-5#1)(1991-10#1)(2007-12#1)(2008-2#1)
which differs from that##5##4##(1990-5#1)(1991-10#1)(1996-5#1)(2007-12#1)(2008-2#1)
which differs from the##7##4##(1991-9#1)(1994-12#1)(1995-3#1)(2006-10#1)(2007-11#1)(2008-10#1)(2010-5#1)
which differs from##16##3##(1990-5#1)(1991-10#1)(1991-12#1)(1991-9#1)(1994-12#1)(1995-3#1)(1996-4#1)(1996-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-5#1)(2011-2#2)
which differs in##2##3##(1991-2#1)(1997-7#1)
which differs##21##2##(1990-5#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-9#1)(1994-12#1)(1995-3#1)(1996-4#1)(1996-5#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2009-3#1)(2010-5#1)(2011-2#2)(2013-1#1)
which diminishes##2##2##(1991-5#1)(2007-11#1)
which direct the##2##3##(1990-3#1)(1991-5#1)
which direct##8##2##(1990-3#1)(1991-5#1)(1994-2#1)(1994-5#1)(2006-8#1)(2007-12#1)(2007-5#1)(2008-10#1)
which directed the##2##3##(1990-3#1)(1996-5#1)
which directed##3##2##(1990-3#1)(1996-5#1)(2008-10#1)
which directly##14##2##(1990-3#1)(1994-5#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-7#1)(2005-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2010-5#1)(2011-1#2)(2013-8#1)
which directs##2##2##(1995-1#1)(1996-5#1)
which disappeared after##2##3##(1997-7#1)(2008-11#1)
which disappeared##4##2##(1997-7#1)(2008-11#2)(2010-12#1)
which disappears##2##2##(1992-8#1)(2009-9#1)
which disease##6##2##(1997-3#1)(2008-10#3)(2008-9#1)(2010-5#1)
which dispersal##2##2##(2008-10#1)(2008-8#1)
which display similar results##2##4##(2012-12#2)
which display##20##2##(1991-2#1)(1992-12#1)(1992-9#1)(1994-12#1)(1995-6#2)(1996-5#2)(2005-11#1)(2006-10#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-8#1)
which displayed##8##2##(1990-10#1)(1991-3#1)(1995-12#1)(1996-8#1)(2007-7#1)(2008-10#1)(2011-2#1)(2013-1#1)
which displays a##4##3##(1990-10#1)(1992-3#1)(1996-11#1)(2007-11#1)
which displays##12##2##(1990-10#1)(1990-12#1)(1991-3#1)(1992-3#1)(1994-11#1)(1994-9#1)(1996-11#1)(1997-2#1)(2007-11#1)(2010-12#1)(2011-1#1)(2012-2#1)
which disrupt##2##2##(1990-8#1)(2006-12#1)
which disrupts the##3##3##(1993-3#1)(2009-7#1)(2012-2#1)
which disrupts##4##2##(1990-5#1)(1993-3#1)(2009-7#1)(2012-2#1)
which dissociates##2##2##(1995-8#1)(2007-8#1)
which distinguish##3##2##(1991-6#1)(1993-9#1)(2008-11#1)
which distinguishes##4##2##(1992-6#1)(1994-12#1)(2007-12#1)(2011-1#1)
which diverged##2##2##(2009-8#1)(2012-3#1)
which do not change##2##4##(1993-3#1)(1994-11#1)
which do not contain##2##4##(1992-6#1)(1992-9#1)
which do not exhibit##4##4##(1997-6#1)(1997-8#1)(2008-10#1)(2009-5#1)
which do not exist in##2##5##(2006-10#1)(2007-12#1)
which do not express the##2##5##(1996-8#1)(1997-7#1)
which do not express##4##4##(1995-3#1)(1996-2#1)(1996-8#1)(1997-7#1)
which do not have##3##4##(1993-11#1)(2008-10#1)(2009-10#1)
which do not include##2##4##(1994-6#1)(2005-11#1)
which do not require##2##4##(2008-3#1)(2013-1#1)
which do not##52##3##(1990-4#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-7#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
which do##55##2##(1990-4#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-7#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
which does not activate protein kinase C##2##7##(1991-7#1)(1992-5#1)
which does not affect##2##4##(2008-10#1)(2009-10#1)
which does not allow##2##4##(2008-10#2)
which does not assume##2##4##(1996-8#1)(2008-10#1)
which does not bind##4##4##(1990-10#1)(1995-2#1)(1996-11#1)(1997-6#1)
which does not block##2##4##(1994-2#1)(1996-10#1)
which does not contain the##2##5##(1996-12#1)(2008-10#1)
which does not contain##3##4##(1991-9#1)(1996-12#1)(2008-10#1)
which does not express##2##4##(1992-12#1)(1994-11#1)
which does not have##2##4##(1990-6#1)(2008-1#1)
which does not need##2##4##(2005-10#1)(2007-11#1)
which does not penetrate##2##4##(2005-8#1)(2008-5#1)
which does not permit##2##4##(1991-9#1)(2008-10#1)
which does not possess##2##4##(1994-8#1)(2010-3#1)
which does not produce##5##4##(1996-9#1)(2008-10#3)(2010-8#1)
which does not require a##3##5##(2007-12#1)(2008-10#1)(2011-2#1)
which does not require any##2##5##(2008-10#1)(2012-2#1)
which does not require the##2##5##(1995-4#1)(2008-7#1)
which does not require##12##4##(1990-4#1)(1990-5#1)(1993-1#1)(1995-4#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
which does not use##2##4##(2010-8#1)(2011-2#1)
which does not##70##3##(1990-10#1)(1990-4#1)(1990-5#1)(1990-6#2)(1991-7#1)(1991-9#3)(1992-12#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-6#1)(2005-10#1)(2005-8#1)(2006-11#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#15)(2008-11#2)(2008-3#1)(2008-5#3)(2008-7#1)(2009-10#2)(2010-3#1)(2010-8#2)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
which does##72##2##(1990-10#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#1)(1991-7#1)(1991-9#3)(1992-12#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-6#1)(2005-10#1)(2005-8#1)(2006-11#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#15)(2008-11#2)(2008-3#1)(2008-5#3)(2008-7#1)(2009-10#2)(2010-3#1)(2010-8#2)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
which domains of##2##3##(1996-5#1)(1997-4#1)
which domains##3##2##(1996-5#1)(1997-4#1)(2005-10#1)
which dominated##2##2##(2008-10#1)(2010-8#1)
which dominates##2##2##(2008-9#1)(2009-5#1)
which dorsal##2##2##(2006-7#1)(2008-4#1)
which dramatically##2##2##(1994-2#2)
which drive##2##2##(1992-7#1)(2012-2#1)
which drives the##2##3##(1992-9#1)(1997-4#1)
which drives##3##2##(1992-9#1)(1997-4#1)(2012-3#1)
which dropped##2##2##(1992-2#1)(2006-3#1)
which drugs##3##2##(2006-10#1)(2007-11#1)(2008-1#1)
which dummy##2##2##(2006-11#2)
which dynamic##2##2##(2005-11#1)(2006-9#1)
which each chip consists of a one-dimensional array of 12 devices##2##11##(2008-3#2)
which each chip##3##3##(2008-3#3)
which each is##2##3##(2005-6#1)(2007-7#1)
which each of these##2##4##(1994-9#1)(2009-2#1)
which each of##8##3##(1991-10#1)(1992-7#1)(1994-9#1)(1995-3#1)(2007-12#1)(2008-2#1)(2008-7#1)(2009-2#1)
which each##38##2##(1991-10#1)(1992-7#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-2#1)(1997-8#1)(2005-6#1)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#4)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-5#1)(2010-8#1)(2012-2#1)
which effect##3##2##(1997-7#1)(2006-10#1)(2011-1#1)
which effective##2##2##(2008-10#1)(2008-8#1)
which effectively##8##2##(1993-12#1)(1993-3#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-5#1)
which efficiently##5##2##(2008-3#1)(2008-7#1)(2011-2#1)(2012-11#1)(2013-8#1)
which either a##2##3##(2006-8#1)(2007-8#1)
which either##17##2##(1992-2#1)(1993-9#1)(1994-6#1)(1995-1#1)(1996-4#1)(2003-11#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-8#2)(2010-3#1)(2011-2#1)
which electrochemical##2##2##(2008-10#2)
which elements##3##2##(1995-4#1)(1996-11#1)(1997-8#1)
which elicit the##2##3##(1990-11#1)(2007-6#1)
which elicit##5##2##(1990-11#1)(1994-11#1)(1996-9#1)(2007-6#1)(2009-12#1)
which elicited##2##2##(1990-4#1)(2008-10#1)
which elicits##4##2##(1990-3#1)(2008-1#1)(2008-10#1)(2009-12#1)
which eliminates the need##3##4##(2008-10#1)(2008-2#1)(2008-4#1)
which eliminates##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)
which eluted##2##2##(1991-8#1)(2008-10#1)
which emerged from a##2##4##(1991-12#1)(2008-11#1)
which emerged from##4##3##(1991-12#1)(2008-11#1)(2008-5#1)(2010-12#1)
which emerged##12##2##(1991-12#1)(1992-4#1)(2005-7#1)(2005-8#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2010-12#1)(2013-1#1)
which emergency##3##2##(2004-10#1)(2007-8#1)(2009-6#1)
which emphasises the##2##3##(2007-12#1)(2012-12#1)
which emphasize the##3##3##(1991-12#1)(1992-7#1)(2008-2#1)
which emphasized the##2##3##(2008-4#2)
which emphasizes##4##2##(1994-2#1)(2008-2#1)(2011-1#1)(2012-3#1)
which employed##3##2##(2008-10#1)(2008-12#1)(2010-9#1)
which employees##3##2##(1993-1#1)(2008-12#2)
which employs a##3##3##(1997-6#1)(2007-12#1)(2008-2#1)
which employs the##3##3##(2007-9#1)(2008-3#1)(2008-5#1)
which employs two##2##3##(2008-10#1)(2008-3#1)
which employs##16##2##(1990-10#1)(1990-8#1)(1995-5#1)(1996-12#1)(1997-6#1)(2006-11#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#1)(2012-2#1)
which enable them to##3##4##(2004-4#1)(2008-9#1)(2009-12#1)
which enable to##2##3##(2008-2#1)(2012-12#1)
which enable##15##2##(1990-8#1)(1992-9#1)(1993-1#1)(1997-1#1)(2004-4#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-2#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-12#2)
which enabled the##5##3##(1991-6#1)(1994-11#1)(2004-9#1)(2008-4#1)(2013-7#1)
which enabled us to##3##4##(1992-11#1)(2010-4#1)(2013-1#1)
which enabled##12##2##(1991-6#1)(1992-11#1)(1994-11#1)(1997-2#1)(1997-3#1)(2004-9#1)(2008-11#1)(2008-4#1)(2010-4#1)(2012-11#1)(2013-1#1)(2013-7#1)
which enables a##2##3##(1991-5#1)(2008-7#1)
which enables the##16##3##(1991-2#1)(1996-11#1)(1996-9#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#1)(2010-3#1)
which enables us to##4##4##(1996-3#1)(2008-2#1)(2009-10#1)(2013-8#1)
which enables##47##2##(1990-3#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-3#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-4#1)(2007-11#2)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2009-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#1)(2013-1#3)(2013-8#1)
which encode a##2##3##(1990-8#1)(2007-12#1)
which encode for##2##3##(1994-6#1)(2008-10#1)
which encode meanings of words based on the different contexts in which they occur##2##14##(2013-1#2)
which encode the##4##3##(1990-11#1)(1990-4#1)(1990-9#1)(1994-12#1)
which encode two##2##3##(1992-4#1)(1993-9#1)
which encode##28##2##(1990-11#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-5#1)(1992-4#1)(1993-12#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#2)(2009-8#1)(2012-12#1)(2013-1#2)
which encoded a protein of##2##5##(1991-9#1)(1992-3#1)
which encoded a##3##3##(1991-4#1)(1991-9#1)(1992-3#1)
which encoded##7##2##(1990-7#1)(1991-11#1)(1991-4#1)(1991-9#1)(1992-3#1)(2008-10#1)(2008-9#1)
which encodes a BTB-Zn-finger transcription factor##2##6##(2012-12#2)
which encodes a novel##5##4##(1992-11#1)(1992-7#1)(1992-9#1)(1993-8#1)(1995-3#1)
which encodes a protein of##6##5##(1990-11#1)(1992-9#1)(1994-11#1)(1994-12#2)(1997-1#1)
which encodes a protein with##4##5##(1994-12#1)(1996-7#1)(2008-8#2)
which encodes a protein##11##4##(1990-11#1)(1992-9#1)(1994-11#1)(1994-12#3)(1996-7#1)(1997-1#1)(1997-3#1)(2008-8#2)
which encodes a small##2##4##(1993-8#1)(1996-8#1)
which encodes a##50##3##(1990-11#3)(1990-5#1)(1990-6#1)(1990-9#1)(1991-6#1)(1991-9#1)(1992-11#2)(1992-2#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#2)(1994-11#2)(1994-12#3)(1995-1#1)(1995-3#1)(1995-4#1)(1996-7#2)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-7#2)(2006-12#1)(2007-11#1)(2008-10#1)(2008-8#2)(2008-9#1)(2009-8#1)(2012-12#2)(2012-3#1)
which encodes an##4##3##(1994-12#1)(1994-8#1)(2008-10#2)
which encodes for a##2##4##(1995-4#1)(1996-12#1)
which encodes for##3##3##(1995-4#1)(1996-12#1)(1997-3#1)
which encodes the##20##3##(1990-3#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-3#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-7#1)(1996-8#1)(2008-11#1)(2010-12#1)(2012-12#1)(2013-8#1)
which encodes##93##2##(1990-11#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#3)(1991-6#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#2)(1994-11#2)(1994-12#7)(1994-3#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#2)(1995-6#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-7#3)(1996-8#2)(1997-1#2)(1997-2#1)(1997-3#3)(1997-7#2)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-12#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-8#1)
which encompasses the##2##3##(1995-10#1)(2009-5#1)
which encompasses##10##2##(1990-7#1)(1992-11#1)(1994-12#1)(1995-10#1)(1995-5#1)(1997-1#1)(2007-12#1)(2008-10#1)(2009-5#1)(2010-11#1)
which ends##2##2##(2007-12#1)(2008-3#1)
which enforces##2##2##(2008-11#1)(2012-12#1)
which enhance the##4##3##(1992-10#1)(2008-10#1)(2008-4#1)(2013-8#1)
which enhance##7##2##(1992-10#1)(1992-7#1)(1996-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2013-8#1)
which enhanced##4##2##(1991-10#1)(1993-3#1)(1996-9#1)(2008-6#1)
which enhances the sensitivity##2##4##(2008-10#1)(2008-3#1)
which enhances the##7##3##(1992-6#1)(1993-3#1)(1994-12#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-7#1)
which enhances##15##2##(1992-3#1)(1992-6#1)(1993-3#1)(1993-9#1)(1994-12#2)(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-11#1)
which ensures a##3##3##(1991-11#1)(2008-7#1)(2013-8#1)
which ensures##9##2##(1991-11#1)(1994-3#1)(2005-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2013-8#1)
which enters the##3##3##(2006-10#1)(2007-12#1)(2008-10#1)
which enters##4##2##(1994-6#1)(2006-10#1)(2007-12#1)(2008-10#1)
which environmental##4##2##(2008-1#1)(2008-11#1)(2008-7#1)(2011-2#1)
which enzyme activity##2##3##(1994-12#1)(2008-7#1)
which epithelial##2##2##(1995-5#1)(2011-2#1)
which equaled##2##2##(2006-12#1)(2008-10#1)
which equals##2##2##(2008-7#1)(2008-8#1)
which eradication##2##2##(2005-5#1)(2011-1#1)
which essentially##2##2##(1993-6#1)(2008-4#1)
which establish##2##2##(1996-12#1)(2010-4#1)
which established the##2##3##(1992-6#1)(2008-10#1)
which established##5##2##(1992-6#1)(1994-9#1)(2007-12#1)(2008-10#2)
which establishes a##3##3##(1992-4#1)(2007-12#1)(2008-6#1)
which establishes##6##2##(1992-4#1)(1994-6#1)(2007-12#1)(2008-2#1)(2008-6#1)(2011-2#1)
which estimates##4##2##(1996-2#1)(2007-11#1)(2010-8#1)(2012-1#1)
which evaluated the##4##3##(2006-6#1)(2007-12#1)(2010-2#1)(2013-1#1)
which evaluated##5##2##(2006-6#1)(2007-12#1)(2010-2#1)(2011-2#1)(2013-1#1)
which evaluates##3##2##(1992-1#1)(2009-3#1)(2013-8#1)
which eventually leads to##3##4##(2007-8#1)(2012-1#1)(2013-8#1)
which eventually led to##2##4##(2007-7#1)(2008-10#1)
which eventually##12##2##(1992-6#1)(1993-3#1)(1995-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-1#1)(2013-8#1)
which every##2##2##(1993-3#1)(2013-8#1)
which evidenced##2##2##(2007-3#1)(2010-2#1)
which evolve##3##2##(1991-6#1)(1992-11#1)(2012-2#1)
which evolved##2##2##(2007-12#1)(2008-11#1)
which exacerbates##2##2##(2010-11#1)(2011-2#1)
which examine the##2##3##(1993-1#1)(2006-10#1)
which examine##4##2##(1993-1#1)(1993-2#1)(2006-10#1)(2008-11#1)
which examined the##2##3##(1997-3#1)(2008-5#1)
which examined##3##2##(1997-3#1)(2008-5#1)(2010-11#1)
which examines##2##2##(1997-7#1)(2008-9#1)
which exceeded##6##2##(1992-3#1)(1992-9#1)(1997-7#1)(2007-7#1)(2008-10#2)
which exceeds##3##2##(1990-11#1)(1990-4#1)(2008-3#1)
which excludes the##2##3##(1991-9#1)(1997-1#1)
which excludes##4##2##(1991-2#1)(1991-9#1)(1995-6#1)(1997-1#1)
which exert##3##2##(1994-11#1)(2008-10#1)(2012-12#1)
which exerts a much##2##4##(1995-12#1)(2008-5#1)
which exerts a##4##3##(1993-6#1)(1995-12#1)(2006-10#1)(2008-5#1)
which exerts##5##2##(1993-6#1)(1995-12#1)(2005-7#1)(2006-10#1)(2008-5#1)
which exhibit a high##3##4##(1990-6#1)(1994-2#1)(2008-10#1)
which exhibit a##6##3##(1990-6#1)(1994-2#1)(2007-12#1)(2008-10#2)(2008-6#1)
which exhibit an##3##3##(1991-3#1)(1996-4#1)(2005-11#1)
which exhibit both##2##3##(1991-9#1)(2010-4#1)
which exhibit##33##2##(1990-12#1)(1990-6#1)(1991-3#1)(1991-9#1)(1992-9#1)(1994-11#1)(1994-2#1)(1995-10#1)(1995-2#1)(1996-2#2)(1996-4#1)(2005-11#1)(2006-10#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-2#1)
which exhibited a##4##3##(1993-2#1)(1994-8#1)(2008-11#1)(2010-4#1)
which exhibited##18##2##(1993-2#2)(1993-8#1)(1994-2#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-8#1)(1996-9#1)(1997-2#1)(2008-10#4)(2008-11#1)(2010-4#1)(2011-2#1)(2013-8#1)
which exhibits a##4##3##(1991-7#1)(1994-9#1)(1995-11#1)(2009-8#1)
which exhibits an##3##3##(2006-4#1)(2008-10#1)(2013-7#1)
which exhibits high##2##3##(1992-3#1)(2008-10#1)
which exhibits the##2##3##(1994-8#1)(2008-10#1)
which exhibits##27##2##(1990-12#1)(1990-9#1)(1991-7#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-12#2)(1994-8#1)(1994-9#2)(1995-11#1)(1995-3#1)(2005-8#1)(2006-4#1)(2008-10#7)(2008-2#1)(2008-7#1)(2009-8#1)(2013-7#1)
which exist in a##3##4##(1991-1#1)(1993-11#1)(1995-3#1)
which exist in##9##3##(1991-1#1)(1993-11#1)(1993-6#1)(1994-11#1)(1995-3#1)(1996-7#1)(2008-9#1)(2009-7#1)(2011-2#1)
which exist##11##2##(1991-1#1)(1991-12#1)(1993-11#1)(1993-6#1)(1994-11#1)(1995-3#1)(1996-7#1)(2005-11#1)(2008-9#1)(2009-7#1)(2011-2#1)
which existing##5##2##(2008-1#1)(2008-11#1)(2010-11#1)(2012-12#1)(2012-3#1)
which exists between##2##3##(1990-4#1)(2006-3#1)
which exists in a##2##4##(1994-6#1)(2009-9#1)
which exists in##7##3##(1990-11#1)(1993-3#1)(1994-2#1)(1994-6#1)(1997-5#1)(2008-8#1)(2009-9#1)
which exists##12##2##(1990-11#1)(1990-4#1)(1992-4#1)(1992-6#1)(1993-3#1)(1994-2#1)(1994-6#1)(1997-5#1)(2006-3#1)(2008-10#1)(2008-8#1)(2009-9#1)
which exogenous##2##2##(2007-11#1)(2008-7#1)
which experience##3##2##(1992-1#1)(1996-6#1)(2008-8#1)
which experiences##2##2##(2007-12#1)(2009-4#1)
which experimental##5##2##(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)
which explain##2##2##(2007-11#1)(2009-10#1)
which explained##3##2##(1993-8#1)(2009-12#1)(2013-1#1)
which explains the##9##3##(1991-3#1)(2005-11#1)(2006-7#1)(2006-8#1)(2007-12#1)(2008-2#1)(2009-7#1)(2012-12#1)(2013-1#1)
which explains why##2##3##(1992-5#1)(2012-2#1)
which explains##12##2##(1991-3#1)(1992-5#1)(2005-11#1)(2006-7#1)(2006-8#1)(2007-12#1)(2008-2#1)(2009-7#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
which explicitly##2##2##(2007-9#1)(2013-8#1)
which exploits##2##2##(1996-12#1)(2008-2#1)
which exposure to##2##3##(2005-8#1)(2008-9#1)
which exposure##3##2##(2005-8#1)(2008-4#1)(2008-9#1)
which express a##4##3##(1995-7#1)(1996-11#1)(2006-12#1)(2011-2#1)
which express the##3##3##(1990-6#1)(1992-1#1)(1993-8#1)
which express##23##2##(1990-6#1)(1991-12#1)(1992-1#1)(1992-7#1)(1993-4#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-11#1)(2006-12#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-4#1)(2011-2#2)
which expressed PCNA##2##3##(2008-4#2)
which expressed at##2##3##(1994-3#2)
which expressed##14##2##(1991-9#1)(1992-8#1)(1993-12#1)(1994-3#2)(1995-3#1)(1996-12#1)(1997-1#1)(2007-10#1)(2008-10#1)(2008-4#2)(2008-8#1)(2008-9#1)
which expresses a##2##3##(1993-3#1)(2012-2#1)
which expresses the##3##3##(1995-12#1)(2004-9#1)(2008-10#1)
which expresses##12##2##(1990-9#1)(1993-12#1)(1993-3#1)(1994-6#1)(1995-12#1)(1995-3#1)(1997-1#1)(2004-9#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-2#1)
which expression is##2##3##(1995-11#1)(2011-3#1)
which expression##5##2##(1995-11#2)(1995-7#1)(2011-1#1)(2011-3#1)
which extend##6##2##(1994-3#1)(1995-12#1)(1996-4#1)(1997-1#1)(2008-10#1)(2009-9#1)
which extended##5##2##(2007-8#1)(2008-5#1)(2009-5#1)(2009-7#1)(2012-2#1)
which extends##5##2##(1996-5#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-12#1)
which external##3##2##(1994-12#1)(1996-12#1)(2007-12#1)
which extracellular##3##2##(1995-5#1)(2007-8#1)(2008-1#1)
which facilitate the##4##3##(1993-6#1)(2007-11#2)(2009-8#1)
which facilitate##10##2##(1991-4#1)(1992-5#1)(1993-6#1)(2005-8#1)(2007-11#2)(2008-10#1)(2009-4#1)(2009-8#1)(2013-8#1)
which facilitated the##3##3##(1990-12#1)(2011-2#1)(2013-1#1)
which facilitated##6##2##(1990-12#1)(1990-6#1)(2009-3#1)(2009-7#1)(2011-2#1)(2013-1#1)
which facilitates the##7##3##(1992-7#1)(1996-12#1)(2005-1#1)(2007-9#1)(2008-3#2)(2012-2#1)
which facilitates##16##2##(1992-7#1)(1996-12#1)(1997-3#1)(2005-1#1)(2006-11#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-3#3)(2008-7#2)(2011-2#1)(2012-2#1)(2013-1#1)
which facilities##2##2##(1993-3#1)(2006-5#1)
which fact##3##2##(2006-6#3)
which factors are##2##3##(2007-8#1)(2008-9#1)
which factors influence##3##3##(2007-8#1)(2008-1#1)(2012-2#1)
which factors##11##2##(1991-6#1)(2007-10#1)(2007-8#2)(2008-1#1)(2008-9#2)(2010-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
which fail to##4##3##(1995-1#1)(1997-7#1)(2008-10#1)(2008-5#1)
which failed to##5##3##(1994-11#1)(1994-12#1)(2005-7#1)(2005-9#1)(2006-8#1)
which failed##6##2##(1994-11#1)(1994-12#1)(2005-7#1)(2005-9#1)(2006-8#1)(2008-10#1)
which fails to##2##3##(1995-12#1)(1996-6#1)
which fails##3##2##(1995-12#1)(1996-6#1)(2008-2#1)
which fall within##2##3##(1995-8#1)(2005-5#1)
which fall##3##2##(1995-8#1)(2005-5#1)(2008-10#1)
which fatty acids##2##3##(1994-8#1)(2012-2#1)
which favor##4##2##(1991-1#1)(2007-12#1)(2008-12#1)(2011-2#1)
which favors genotypes##2##3##(2008-8#2)
which favors##6##2##(1991-4#1)(2008-10#1)(2008-8#3)(2012-2#1)
which favours##2##2##(2006-2#1)(2008-10#1)
which fear##2##2##(2010-9#1)(2012-2#1)
which features##2##2##(1997-7#1)(2008-10#1)
which feed on##2##3##(2008-2#1)(2011-12#1)
which feed##3##2##(1992-3#1)(2008-2#1)(2011-12#1)
which females##4##2##(2008-8#2)(2008-9#2)
which few##2##2##(2010-8#1)(2013-8#1)
which finally##4##2##(2008-1#1)(2008-10#1)(2011-2#2)
which first##7##2##(1994-5#1)(1995-8#1)(1996-9#1)(1997-8#1)(2007-12#1)(2008-1#1)(2010-2#1)
which fish##2##2##(2008-1#1)(2010-8#1)
which fit the##2##3##(2008-10#1)(2012-1#1)
which fit##5##2##(1994-12#1)(2008-10#1)(2008-3#1)(2012-1#1)(2013-8#1)
which five##6##2##(1994-3#1)(2006-9#1)(2007-8#2)(2008-10#1)(2012-3#1)
which fixed##3##2##(1990-10#1)(1991-12#1)(2006-6#1)
which flank##2##2##(1993-9#1)(1994-9#1)
which fluorescent##2##2##(1991-2#1)(2008-9#1)
which focus on##4##3##(1990-9#1)(1996-2#1)(2008-12#1)(2010-8#1)
which focus##5##2##(1990-9#1)(1996-2#1)(2006-5#1)(2008-12#1)(2010-8#1)
which focused on##4##3##(2005-8#1)(2007-9#1)(2008-10#1)(2009-4#1)
which focuses on the##2##4##(2007-12#1)(2010-2#1)
which focuses on##8##3##(1996-2#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-5#1)(2010-2#1)(2010-8#1)(2011-2#1)
which focuses##9##2##(1996-2#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-2#1)(2010-8#1)(2011-2#1)
which followed a##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
which followed##6##2##(1993-9#1)(1996-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)
which follows the upfront##2##4##(2010-2#2)
which follows the##3##3##(1994-2#1)(2010-2#2)
which follows##7##2##(1990-7#1)(1990-8#1)(1994-2#1)(2008-3#1)(2009-2#1)(2010-2#2)
which food##3##2##(1997-1#1)(2008-10#1)(2008-11#1)
which foods##3##2##(1994-3#1)(2008-1#1)(2008-4#1)
which for the first time##2##5##(2005-8#1)(2012-10#1)
which for the##3##3##(2005-8#1)(2011-2#1)(2012-10#1)
which for##6##2##(1994-2#1)(2005-8#1)(2008-1#1)(2008-6#1)(2011-2#1)(2012-10#1)
which form a##4##3##(1992-12#1)(1995-2#1)(1997-4#1)(2010-3#1)
which form an##3##3##(1996-5#1)(2008-3#1)(2008-4#1)
which form meiotic##3##3##(2008-12#3)
which form the basis of##2##5##(2006-11#1)(2007-9#1)
which form the##5##3##(1990-12#1)(1990-5#1)(1992-2#1)(2006-11#1)(2007-9#1)
which form##31##2##(1990-12#1)(1990-5#1)(1991-11#1)(1992-12#1)(1992-2#1)(1993-4#1)(1993-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-5#3)(1997-4#2)(1997-6#1)(2006-11#1)(2006-6#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-3#2)(2008-4#1)(2008-9#1)(2010-3#1)(2013-1#1)
which formed a##3##3##(2005-7#1)(2008-10#1)(2008-8#1)
which formed##9##2##(1991-7#1)(1992-12#1)(2005-7#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-9#1)(2012-2#1)
which forms a##7##3##(1991-7#1)(1993-9#1)(1994-9#1)(1995-8#1)(2008-10#3)
which forms an##2##3##(1994-8#1)(1996-6#1)
which forms one##2##3##(2007-12#1)(2010-7#1)
which forms part of a##2##5##(2007-10#1)(2008-11#1)
which forms part of##3##4##(1992-6#1)(2007-10#1)(2008-11#1)
which forms the basis##2##4##(2007-5#1)(2008-10#1)
which forms the##6##3##(1992-6#1)(1995-11#1)(1997-9#1)(2007-12#1)(2007-5#1)(2008-10#1)
which forms##29##2##(1990-2#1)(1990-9#1)(1991-7#1)(1992-6#2)(1993-10#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-6#1)(1997-4#1)(1997-9#1)(2007-10#1)(2007-12#2)(2007-5#1)(2008-10#7)(2008-11#1)(2010-7#2)(2013-7#1)
which fosters##2##2##(2005-7#1)(2008-12#1)
which found##4##2##(1992-1#1)(1997-2#1)(2007-12#1)(2008-12#1)
which four##10##2##(1991-2#1)(1991-7#1)(1992-9#1)(1993-12#1)(2006-8#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-7#1)
which fragments##2##2##(1993-2#1)(1993-8#1)
which free##3##2##(1995-12#1)(1996-1#1)(2008-10#1)
which frequency##2##2##(2007-11#1)(2007-12#1)
which frequently accompanies##2##3##(1996-2#1)(2006-10#1)
which frequently##7##2##(1996-2#1)(2005-1#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-3#1)(2010-8#1)
which from the##2##3##(1996-5#1)(2012-3#1)
which from##3##2##(1996-3#1)(1996-5#1)(2012-3#1)
which fulfill##2##2##(2006-10#1)(2006-12#1)
which fully##2##2##(1997-7#1)(2007-11#1)
which function in##4##3##(1990-2#1)(1993-3#1)(1993-5#1)(2008-11#1)
which function##7##2##(1990-2#1)(1990-9#1)(1993-3#1)(1993-5#1)(1995-8#1)(2008-11#1)(2011-1#1)
which functional##5##2##(2006-10#1)(2006-3#1)(2009-10#2)(2012-2#1)
which functionally##2##2##(1995-3#1)(1996-3#1)
which functions as a##5##4##(1992-8#1)(1994-12#1)(1995-9#1)(2012-1#1)(2012-12#1)
which functions as##6##3##(1992-8#1)(1994-12#1)(1995-9#1)(2011-1#1)(2012-1#1)(2012-12#1)
which functions to##2##3##(1992-6#1)(1994-12#1)
which functions##12##2##(1992-6#1)(1992-8#1)(1994-12#2)(1994-5#1)(1995-9#1)(1996-10#1)(1996-5#1)(2007-12#1)(2011-1#1)(2012-1#1)(2012-12#1)
which further increase##2##3##(2008-10#1)(2012-12#1)
which further##15##2##(1994-3#1)(1994-9#1)(2005-11#1)(2006-8#1)(2007-7#1)(2008-10#3)(2008-5#2)(2008-7#1)(2009-11#1)(2009-8#1)(2010-3#1)(2012-12#1)
which future##5##2##(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-12#1)
which gains##2##2##(1993-6#1)(1997-8#1)
which gastric##2##2##(1993-12#1)(2008-5#1)
which gave rise to the##2##5##(2008-8#1)(2009-8#1)
which gave rise to##3##4##(1994-12#1)(2008-8#1)(2009-8#1)
which gave the##3##3##(2005-4#1)(2005-7#1)(2012-2#1)
which gave##19##2##(1990-6#1)(1991-3#1)(1994-12#1)(1995-7#1)(1996-5#1)(1997-5#1)(2005-4#1)(2005-7#1)(2006-12#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-8#2)(2009-8#1)(2012-1#1)(2012-2#1)
which gene##2##2##(2008-10#1)(2010-10#1)
which gene(s)##2##2##(2008-4#1)(2008-7#1)
which generally was found to be sustained in the 2-year survey##2##11##(2013-1#2)
which generally##9##2##(1992-6#1)(1993-3#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-2#1)(2013-1#2)(2013-8#1)
which generate##5##2##(1991-3#1)(1994-5#1)(1994-9#1)(2005-7#1)(2008-10#1)
which generated a##2##3##(1991-9#1)(2006-12#1)
which generated##5##2##(1991-9#1)(2006-12#1)(2008-10#1)(2008-3#2)
which generates a##2##3##(1993-2#1)(2007-12#1)
which generates an##2##3##(1990-10#1)(1997-3#1)
which generates the##3##3##(1992-12#1)(1992-5#1)(1994-12#1)
which generates##20##2##(1990-10#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-12#1)(1995-12#1)(1995-3#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-9#1)(2006-9#1)(2007-12#2)(2008-1#1)(2010-3#1)
which genes are##5##3##(2007-11#1)(2008-6#1)(2008-9#1)(2009-6#1)(2012-3#1)
which genes##10##2##(1990-10#1)(2007-11#1)(2008-11#2)(2008-6#1)(2008-9#1)(2009-5#1)(2009-6#1)(2012-2#1)(2012-3#1)
which genetic##3##2##(2008-11#1)(2010-12#1)(2011-2#1)
which genetically##2##2##(1995-5#1)(2006-5#1)
which give rise to the DLMZ##2##6##(2012-12#2)
which give rise to the##4##5##(1994-12#1)(2007-11#1)(2012-12#2)
which give rise to##17##4##(1991-11#1)(1991-9#1)(1994-11#1)(1994-12#2)(1996-11#1)(1997-5#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-4#1)(2009-7#1)(2009-8#1)(2011-1#1)(2012-12#2)
which give##21##2##(1990-11#1)(1991-11#1)(1991-9#1)(1994-11#1)(1994-12#2)(1996-11#1)(1997-5#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-7#1)(2009-8#1)(2011-1#1)(2012-12#2)
which gives a##9##3##(1990-10#1)(1991-2#1)(1992-8#1)(1994-11#1)(2004-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)
which gives information on the##2##5##(1991-5#1)(2007-12#1)
which gives rise to the##3##5##(1997-2#1)(2008-3#1)(2009-8#1)
which gives rise to##8##4##(1993-3#1)(1993-9#1)(1997-2#1)(2005-10#1)(2008-11#1)(2008-3#1)(2009-5#1)(2009-8#1)
which gives the##4##3##(1994-5#1)(1994-9#1)(1996-5#1)(2008-10#1)
which gives##31##2##(1990-10#1)(1991-2#1)(1991-5#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-9#1)(1996-5#1)(1997-2#1)(2004-1#1)(2005-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2009-2#1)(2009-5#2)(2009-8#1)(2010-7#1)(2011-2#1)
which glucose##3##2##(1994-8#1)(2007-8#1)(2009-3#1)
which glycosylation##2##2##(1991-5#1)(2008-4#1)
which go##2##2##(2010-7#1)(2011-2#1)
which goes beyond the##2##4##(2008-3#1)(2011-2#1)
which goes##4##2##(2007-8#1)(2008-10#1)(2008-3#1)(2011-2#1)
which good##3##2##(2008-4#1)(2009-2#1)(2012-2#1)
which govern the##3##3##(1994-8#2)(1996-3#1)
which govern##5##2##(1994-8#2)(1996-3#1)(1996-7#1)(2008-10#1)
which governs##2##2##(1996-3#1)(2012-12#1)
which gradually##4##2##(1993-7#1)(1994-8#1)(1997-7#1)(2010-12#1)
which greatly facilitates##2##3##(2007-12#1)(2010-2#1)
which greatly increases the selectivity##3##5##(2008-10#3)
which greatly increases the##4##4##(2007-7#1)(2008-10#3)
which greatly reduces##2##3##(2007-11#1)(2012-3#1)
which greatly simplifies the##2##4##(2008-10#1)(2008-3#1)
which greatly##18##2##(1991-5#1)(1994-2#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-3#1)(2010-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
which grew out##2##3##(1997-2#2)
which grew##7##2##(1990-9#1)(1996-5#1)(1997-2#2)(2006-3#1)(2006-5#1)(2006-7#1)
which group##2##2##(2008-2#1)(2008-8#1)
which groups large collections of personal comments into a series of topics##2##12##(2013-1#2)
which groups##3##2##(2007-11#1)(2013-1#2)
which grow##2##2##(1990-12#1)(2007-12#1)
which grown at##2##3##(2008-12#2)
which guarantee##3##2##(2006-10#1)(2008-7#1)(2012-12#1)
which guarantees##3##2##(1996-12#1)(2008-7#1)(2011-2#1)
which guides##2##2##(2006-6#1)(2008-8#1)
which had a good##2##4##(2013-8#2)
which had a##20##3##(1990-9#1)(1991-11#1)(1993-6#1)(1994-10#1)(1994-8#1)(1995-12#1)(1996-9#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-8#3)
which had acquired##2##3##(1993-9#1)(2008-10#1)
which had an##5##3##(1991-12#1)(1994-9#1)(2007-11#1)(2009-9#1)(2012-2#1)
which had been generated##2##4##(1994-11#1)(2008-11#1)
which had been identified by##2##5##(2007-1#1)(2008-11#1)
which had been incubated with##2##5##(1991-2#1)(1995-3#1)
which had been present##2##4##(2006-10#1)(2010-6#1)
which had been previously##7##4##(1990-10#1)(1991-12#1)(1992-9#1)(1993-6#1)(1994-10#1)(2005-9#1)(2008-10#1)
which had been shown to##2##5##(1992-2#1)(2008-10#1)
which had been shown##3##4##(1992-2#1)(1996-8#1)(2008-10#1)
which had been treated##2##4##(1991-3#1)(2011-1#1)
which had been used##2##4##(2008-10#1)(2008-3#1)
which had been##84##3##(1990-10#1)(1990-3#2)(1990-4#1)(1990-7#2)(1991-12#2)(1991-2#2)(1991-3#2)(1991-6#1)(1991-7#2)(1991-8#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#2)(1992-9#3)(1993-6#1)(1993-7#1)(1994-10#1)(1994-11#2)(1994-8#1)(1995-3#1)(1995-9#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-1#2)(2007-7#2)(2008-10#10)(2008-11#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2010-4#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2013-1#1)
which had begun##2##3##(1996-4#1)(2005-12#1)
which had developed##2##3##(2008-11#1)(2012-2#1)
which had experienced##2##3##(1993-5#1)(1997-5#1)
which had high##2##3##(1992-9#1)(2010-8#1)
which had led to##2##4##(1997-8#1)(2012-2#1)
which had little##2##3##(1991-10#1)(2008-11#1)
which had no effect##2##4##(1994-5#1)(2011-12#1)
which had no##9##3##(1993-1#1)(1994-5#1)(1995-12#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-12#1)
which had not been##4##4##(1993-7#1)(1995-6#1)(2008-10#1)(2008-6#1)
which had not##9##3##(1991-12#1)(1992-7#1)(1993-7#2)(1995-6#1)(1996-1#1)(2007-12#1)(2008-10#1)(2008-6#1)
which had previously been##5##4##(1990-4#1)(1990-5#2)(1996-12#1)(2008-2#1)
which had received##2##3##(1995-10#1)(1996-9#1)
which had ruptured into the##2##5##(1991-11#1)(2008-12#1)
which had shown##2##3##(1992-8#1)(1994-2#1)
which had significant effects on the##2##6##(2010-12#1)(2013-8#1)
which had the same##4##4##(1997-8#1)(2005-12#1)(2008-10#1)(2008-5#1)
which had the##8##3##(1991-6#1)(1997-8#1)(2005-12#1)(2008-10#3)(2008-5#1)(2008-9#1)
which had to be##2##4##(1996-6#1)(2006-8#1)
which had##233##2##(1990-10#1)(1990-3#2)(1990-4#2)(1990-5#2)(1990-7#3)(1990-9#2)(1991-10#2)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#2)(1991-6#2)(1991-7#3)(1991-8#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-7#2)(1992-8#3)(1992-9#5)(1993-1#1)(1993-10#2)(1993-12#1)(1993-5#1)(1993-6#2)(1993-7#4)(1993-8#1)(1993-9#2)(1994-10#2)(1994-11#2)(1994-12#3)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-4#2)(1995-6#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#1)(1996-4#2)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#2)(1997-7#1)(1997-8#3)(2005-11#1)(2005-12#2)(2005-9#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#4)(2007-8#2)(2008-10#24)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#6)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-12#3)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#5)(2013-1#1)(2013-8#8)
which half of the##2##4##(1991-2#1)(2008-3#1)
which half##3##2##(1991-2#1)(2008-3#1)(2010-4#1)
which happens to be an##2##5##(2008-5#2)
which harbor the##2##3##(2008-11#2)
which harbor##3##2##(2008-10#1)(2008-11#2)
which harbours##2##2##(1990-3#1)(1997-6#1)
which has a distinct##2##4##(1991-10#1)(2005-6#1)
which has a great##2##4##(2008-6#1)(2013-1#1)
which has a high##7##4##(1992-12#1)(1992-4#1)(2008-10#3)(2008-5#1)(2013-8#1)
which has a maximum absorption peak at##2##7##(2008-10#2)
which has a more##2##4##(1996-2#1)(2008-10#1)
which has a very##2##4##(2007-12#1)(2007-7#1)
which has a##74##3##(1990-2#1)(1990-4#2)(1991-10#1)(1991-6#1)(1992-12#1)(1992-4#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-4#3)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-6#1)(2005-7#1)(2007-12#2)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#2)(2009-3#2)(2009-7#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
which has allowed##3##3##(2007-10#1)(2008-10#1)(2012-2#1)
which has already been##3##4##(2008-5#1)(2010-8#1)(2012-2#1)
which has also been##2##4##(2006-12#1)(2008-8#1)
which has also##3##3##(2006-12#1)(2008-8#1)(2009-2#1)
which has an absorption maximum at##3##6##(2008-10#3)
which has an effect on##2##5##(1990-3#1)(2008-7#1)
which has an##23##3##(1990-2#1)(1990-3#1)(1990-5#1)(1994-12#1)(1995-3#1)(1996-2#2)(1996-7#1)(1997-5#1)(1997-7#1)(2005-8#1)(2006-10#1)(2008-10#7)(2008-3#1)(2008-7#1)(2010-2#1)(2012-12#1)
which has antibacterial and hemolytic activities##2##6##(1993-3#2)
which has as##2##3##(1994-2#1)(2008-10#1)
which has become##3##3##(1990-9#1)(2008-6#1)(2012-12#1)
which has been associated with##3##5##(1992-1#1)(1997-4#1)(2006-2#1)
which has been attributed to##4##5##(2007-7#1)(2008-4#1)(2008-5#1)(2010-2#1)
which has been characterized##3##4##(1996-5#1)(1997-2#1)(2008-3#1)
which has been considered##2##4##(2007-10#1)(2008-7#1)
which has been demonstrated to##3##5##(1995-10#1)(1995-3#1)(2010-2#1)
which has been demonstrated##5##4##(1995-10#1)(1995-3#1)(1996-9#1)(2008-4#1)(2010-2#1)
which has been described in##2##5##(1996-12#1)(2006-10#1)
which has been described##6##4##(1991-7#1)(1996-11#1)(1996-12#1)(2006-10#1)(2012-12#1)(2012-2#1)
which has been designed##3##4##(1993-6#1)(2007-10#1)(2010-5#1)
which has been developed based on the International League Against Epilepsy (ILAE) classification system##2##14##(2013-1#2)
which has been done##2##4##(2006-10#1)(2008-10#1)
which has been extensively##3##4##(1992-11#1)(2012-11#2)
which has been found to be##3##6##(1994-3#1)(1996-1#1)(1996-4#1)
which has been found to##5##5##(1994-3#1)(1996-1#1)(1996-4#1)(1997-2#1)(2008-4#1)
which has been identified as the##2##6##(1991-11#1)(1994-12#1)
which has been identified as##3##5##(1991-11#1)(1994-12#1)(2006-8#1)
which has been implicated in the##2##6##(1992-3#1)(2006-12#1)
which has been implicated in##7##5##(1992-10#1)(1992-3#1)(1992-4#1)(1993-8#1)(1997-2#1)(2006-12#1)(2008-5#1)
which has been implicated##8##4##(1990-9#1)(1992-10#1)(1992-3#1)(1992-4#1)(1993-8#1)(1997-2#1)(2006-12#1)(2008-5#1)
which has been in##2##4##(1993-3#1)(2005-5#1)
which has been known##2##4##(1997-8#1)(2008-10#1)
which has been linked to##3##5##(1994-5#1)(2006-12#1)(2009-5#1)
which has been postulated##2##4##(1996-2#1)(2012-2#1)
which has been previously##3##4##(2007-12#1)(2008-2#1)(2008-5#1)
which has been proposed to##2##5##(1992-3#1)(2008-6#1)
which has been proposed##3##4##(1990-5#1)(1992-3#1)(2008-6#1)
which has been proven##2##4##(2008-8#1)(2010-6#1)
which has been recently##3##4##(1991-8#1)(2008-5#1)(2009-3#1)
which has been reported previously##2##5##(2006-9#1)(2011-1#1)
which has been reported to##3##5##(1993-6#1)(1995-3#1)(2008-10#1)
which has been reported##6##4##(1993-6#1)(1995-3#1)(2006-9#1)(2008-10#1)(2011-1#1)(2012-11#1)
which has been shown in##2##5##(1994-11#1)(2010-5#1)
which has been shown to be a##3##7##(1994-2#1)(1994-9#1)(1995-1#1)
which has been shown to be regulated##2##7##(1991-2#1)(2011-2#1)
which has been shown to be##15##6##(1990-7#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-5#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-1#1)(2007-11#1)(2007-6#1)(2008-7#1)(2011-2#1)(2012-3#1)
which has been shown to bind##2##6##(1991-6#1)(1994-8#1)
which has been shown to have##2##6##(2007-11#1)(2008-11#1)
which has been shown to inhibit##2##6##(1995-1#1)(2013-1#1)
which has been shown to##37##5##(1990-7#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#2)(1997-4#1)(1997-6#1)(1997-8#1)(2004-11#1)(2007-11#2)(2007-6#1)(2007-7#1)(2008-11#3)(2008-5#1)(2008-7#2)(2008-9#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
which has been shown##41##4##(1990-2#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#2)(1997-4#1)(1997-6#1)(1997-8#1)(2004-11#1)(2007-11#2)(2007-6#1)(2007-7#1)(2008-11#3)(2008-5#1)(2008-7#2)(2008-9#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
which has been successfully##2##4##(2009-2#1)(2010-9#1)
which has been suggested to##2##5##(1997-3#1)(2008-5#1)
which has been suggested##3##4##(1997-3#1)(2006-2#1)(2008-5#1)
which has been the most##2##5##(2005-10#1)(2008-10#1)
which has been the##5##4##(1995-12#1)(2005-10#1)(2006-11#1)(2008-10#1)(2010-5#1)
which has been used as##2##5##(1991-2#1)(2008-10#1)
which has been used extensively##2##5##(2008-7#1)(2009-4#1)
which has been used for more than##2##7##(1995-12#1)(2011-2#1)
which has been used for##6##5##(1994-6#1)(1995-12#1)(2008-10#1)(2009-5#1)(2010-10#1)(2011-2#1)
which has been used in##4##5##(2005-10#1)(2007-9#1)(2008-10#1)(2013-8#1)
which has been used successfully##2##5##(1996-12#1)(2010-8#1)
which has been used to##2##5##(2006-10#1)(2013-1#1)
which has been used##19##4##(1991-2#1)(1994-6#1)(1995-12#1)(1996-12#1)(1997-7#1)(2005-10#1)(2006-10#1)(2007-9#1)(2008-10#3)(2008-7#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
which has been useful in##2##5##(2007-11#1)(2008-2#1)
which has been well##2##4##(1996-2#1)(2010-7#1)
which has been widely##3##4##(1990-8#1)(1996-8#1)(2010-4#1)
which has been##229##3##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-3#1)(1993-5#1)(1993-6#3)(1993-8#4)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#3)(1995-3#2)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2005-10#2)(2005-11#1)(2005-5#1)(2005-7#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#2)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#4)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-10#18)(2008-11#3)(2008-2#5)(2008-3#8)(2008-4#4)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#3)(2011-3#1)(2012-11#3)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#3)
which has both##4##3##(1995-3#1)(2010-7#1)(2012-11#2)
which has characteristics##2##3##(1994-11#1)(1994-12#1)
which has claimed##2##3##(2007-8#1)(2013-7#1)
which has demonstrated##2##3##(2008-11#1)(2008-3#1)
which has emerged as a##2##5##(2008-11#1)(2008-4#1)
which has emerged##3##3##(2007-2#1)(2008-11#1)(2008-4#1)
which has excellent##2##3##(1990-6#1)(2013-8#1)
which has had an##2##4##(2006-4#1)(2007-10#1)
which has high affinity for##2##5##(1994-8#1)(2011-2#1)
which has high##8##3##(1994-8#1)(2005-12#1)(2008-8#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
which has important##2##3##(2006-10#1)(2012-12#1)
which has increased##3##3##(1994-1#1)(2007-2#1)(2008-10#1)
which has its##5##3##(1993-2#1)(1994-3#1)(2007-4#1)(2009-2#1)(2012-2#1)
which has led to the##2##5##(2006-2#1)(2012-12#1)
which has led to##8##4##(1990-11#1)(2005-7#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-12#1)
which has long been##3##4##(1997-6#1)(2005-9#1)(2008-11#1)
which has made##2##3##(1997-4#1)(2010-3#1)
which has more##3##3##(1997-6#1)(2007-9#1)(2010-4#1)
which has much##2##3##(1990-8#1)(1994-11#1)
which has never been described in##2##6##(1993-9#1)(2012-12#1)
which has never been##4##4##(1991-5#1)(1993-9#1)(2008-8#1)(2012-12#1)
which has no##6##3##(1992-12#1)(1994-9#1)(1996-5#1)(1996-6#1)(2008-10#2)
which has not been described##3##5##(1990-4#1)(1991-6#1)(2006-10#1)
which has not been previously reported##3##6##(1996-12#1)(2006-10#1)(2008-10#1)
which has not been previously##5##5##(1992-5#1)(1996-12#1)(2006-10#1)(2008-10#1)(2008-7#1)
which has not been##14##4##(1990-4#1)(1991-6#1)(1992-5#1)(1996-12#1)(2006-10#2)(2006-2#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-7#1)(2011-12#1)(2011-2#1)
which has not previously been reported##2##6##(1996-5#1)(2008-10#1)
which has not previously been##3##5##(1996-5#1)(2008-10#1)(2010-4#1)
which has not yet been##3##5##(1990-11#1)(1992-12#1)(2010-4#1)
which has not##21##3##(1990-11#1)(1990-4#1)(1991-6#1)(1992-12#1)(1992-5#1)(1995-12#1)(1996-12#1)(1996-5#1)(2006-10#2)(2006-2#1)(2008-10#3)(2008-2#1)(2008-7#1)(2010-4#2)(2010-7#1)(2011-12#1)(2011-2#1)
which has now##3##3##(2005-8#1)(2007-7#1)(2007-9#1)
which has occurred##2##3##(1990-2#1)(2009-5#1)
which has only been##2##4##(2007-8#1)(2012-1#1)
which has only##4##3##(1990-12#1)(2005-12#1)(2007-8#1)(2012-1#1)
which has potential##3##3##(1994-9#1)(2007-9#1)(2008-10#1)
which has previously been##8##4##(1990-8#1)(1991-9#1)(1996-5#1)(2007-12#1)(2008-10#1)(2009-3#1)(2009-4#1)(2010-7#1)
which has provided##5##3##(2006-5#1)(2007-8#1)(2008-10#1)(2009-11#1)(2012-2#1)
which has rarely been##2##4##(1990-2#1)(2010-6#1)
which has received little attention##2##5##(2008-9#1)(2012-1#1)
which has received##6##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)(2012-1#1)
which has recently been##4##4##(1991-6#1)(1991-7#1)(2007-8#1)(2008-5#1)
which has recently##8##3##(1990-9#1)(1991-6#1)(1991-7#1)(1991-9#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-5#1)
which has resulted in##4##4##(2006-10#1)(2006-12#1)(2008-10#1)(2013-7#1)
which has so far not##2##5##(2010-3#1)(2011-2#1)
which has so far##3##4##(1997-7#1)(2010-3#1)(2011-2#1)
which has the ability of##2##5##(2011-1#1)(2012-12#1)
which has the ability to##2##5##(2008-11#1)(2008-5#1)
which has the ability##4##4##(2008-11#1)(2008-5#1)(2011-1#1)(2012-12#1)
which has the advantage to##2##5##(2009-11#1)(2009-3#1)
which has the advantages of both##2##6##(2008-2#2)
which has the advantages of##3##5##(2008-2#2)(2010-6#1)
which has the advantages##4##4##(2008-2#2)(2008-4#1)(2010-6#1)
which has the highest##3##4##(2008-10#1)(2008-6#1)(2013-1#1)
which has the potential to##5##5##(1994-11#1)(2008-1#1)(2009-10#1)(2011-12#1)(2013-1#1)
which has the same##2##4##(1994-6#1)(2008-3#1)
which has the##29##3##(1992-9#1)(1994-11#1)(1994-6#1)(1995-9#1)(2005-11#1)(2006-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-3#1)(2010-6#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#2)
which has three##2##3##(2007-11#1)(2013-8#1)
which has to be##3##4##(1990-10#1)(2008-3#1)(2008-7#1)
which has two##4##3##(1995-3#1)(2008-5#1)(2008-7#1)(2012-1#1)
which has until now##2##4##(2008-10#1)(2012-2#1)
which has yet to be##2##5##(1990-11#1)(1996-6#1)
which has yet to##3##4##(1990-11#1)(1996-6#1)(2009-2#1)
which has##645##2##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#6)(1990-3#1)(1990-4#5)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#3)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#4)(1991-5#2)(1991-6#4)(1991-7#4)(1991-8#1)(1991-9#2)(1992-1#2)(1992-10#2)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#2)(1992-4#3)(1992-5#2)(1992-7#2)(1992-8#1)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#4)(1993-4#3)(1993-5#1)(1993-6#3)(1993-8#5)(1993-9#2)(1994-1#1)(1994-11#7)(1994-12#5)(1994-2#5)(1994-3#5)(1994-5#3)(1994-6#4)(1994-8#5)(1994-9#5)(1995-1#2)(1995-10#1)(1995-12#6)(1995-2#1)(1995-3#6)(1995-5#2)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#6)(1996-3#1)(1996-4#1)(1996-5#5)(1996-6#4)(1996-7#4)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#5)(1997-3#2)(1997-4#5)(1997-5#2)(1997-6#4)(1997-7#5)(1997-8#2)(2004-11#1)(2005-10#2)(2005-11#3)(2005-12#2)(2005-5#1)(2005-6#1)(2005-7#3)(2005-8#3)(2005-9#1)(2006-10#11)(2006-11#2)(2006-12#4)(2006-2#4)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#8)(2007-12#7)(2007-2#3)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#8)(2007-9#8)(2008-1#4)(2008-10#67)(2008-11#13)(2008-12#1)(2008-2#12)(2008-3#17)(2008-4#8)(2008-5#17)(2008-6#5)(2008-7#12)(2008-8#8)(2008-9#4)(2009-10#4)(2009-11#2)(2009-12#2)(2009-2#5)(2009-3#6)(2009-4#2)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#4)(2010-3#4)(2010-4#7)(2010-5#4)(2010-6#5)(2010-7#5)(2010-8#5)(2010-9#2)(2011-1#6)(2011-12#4)(2011-2#12)(2011-3#1)(2012-1#4)(2012-11#6)(2012-12#11)(2012-2#13)(2012-3#5)(2013-1#12)(2013-7#2)(2013-8#9)
which have a high##2##4##(1997-5#1)(2013-8#1)
which have a##31##3##(1990-11#1)(1991-8#1)(1992-11#1)(1992-6#1)(1993-3#1)(1994-2#2)(1994-9#2)(1995-10#1)(1997-5#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#4)(2008-4#1)(2008-5#3)(2008-7#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
which have already been##2##4##(1996-2#1)(2008-11#1)
which have an important##2##4##(1990-8#1)(2008-12#1)
which have an##7##3##(1990-8#1)(2008-12#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
which have become available##2##4##(2006-10#1)(2009-5#1)
which have become##3##3##(2006-10#1)(2008-7#1)(2009-5#1)
which have been applied to##2##5##(1996-3#1)(2008-10#1)
which have been approved##3##4##(2007-11#1)(2007-8#1)(2008-1#1)
which have been assigned to##2##5##(1990-7#1)(1996-6#1)
which have been associated with##2##5##(1992-9#1)(2012-2#1)
which have been attributed##2##4##(2007-2#1)(2012-11#1)
which have been characterized##3##4##(1992-3#1)(2006-10#1)(2008-10#1)
which have been completely explained##2##5##(2013-1#2)
which have been confirmed by##2##5##(1992-3#1)(2007-11#1)
which have been confirmed##3##4##(1992-3#1)(2007-11#1)(2008-10#1)
which have been considered to be##2##6##(2007-10#1)(2010-8#1)
which have been correlated##2##4##(1997-5#1)(2010-2#1)
which have been demonstrated in##2##5##(1992-5#1)(1992-9#1)
which have been described##2##4##(1996-9#1)(2008-4#1)
which have been developed##5##4##(1991-12#1)(1993-2#1)(1994-3#1)(2009-12#1)(2010-11#1)
which have been employed##2##4##(2007-11#1)(2010-2#1)
which have been exposed to##2##5##(2008-11#1)(2008-9#1)
which have been found to be##2##6##(2008-6#1)(2009-9#1)
which have been identified##2##4##(1993-11#1)(2008-4#1)
which have been implemented##3##4##(2008-11#1)(2008-3#1)(2008-5#1)
which have been implicated in the##2##6##(2005-7#1)(2007-11#1)
which have been implicated in##6##5##(1992-6#1)(1994-2#1)(2005-7#1)(2006-9#1)(2007-11#1)(2013-7#1)
which have been made##3##4##(1993-7#1)(1997-2#1)(2013-1#1)
which have been proposed to##4##5##(1991-5#1)(2005-8#1)(2010-2#1)(2010-5#1)
which have been proposed##6##4##(1990-8#1)(1991-5#1)(2005-8#1)(2010-2#1)(2010-5#1)(2013-8#1)
which have been reported in##2##5##(1990-8#1)(1997-2#1)
which have been reported to##4##5##(1992-12#1)(1994-12#1)(2008-10#1)(2011-1#1)
which have been reported##6##4##(1990-8#1)(1992-12#1)(1994-12#1)(1997-2#1)(2008-10#1)(2011-1#1)
which have been shown to be associated with##2##8##(2008-4#1)(2011-1#1)
which have been shown to be##7##6##(1994-6#1)(1996-3#1)(1997-3#1)(2008-4#1)(2008-8#1)(2010-6#1)(2011-1#1)
which have been shown to decrease##2##6##(2008-3#1)(2008-8#1)
which have been shown to have##2##6##(2008-7#1)(2009-3#1)
which have been shown to##18##5##(1991-9#1)(1992-5#1)(1994-6#1)(1995-1#1)(1995-5#1)(1996-3#1)(1997-3#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-3#1)(2010-6#1)(2011-1#1)(2012-12#1)
which have been shown##20##4##(1991-9#1)(1992-5#1)(1992-7#1)(1994-6#1)(1995-1#1)(1995-5#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-3#1)(2010-6#1)(2011-1#1)(2012-12#1)
which have been treated##2##4##(1993-3#1)(2006-9#1)
which have been used to##2##5##(1996-12#1)(2008-2#1)
which have been used##6##4##(1993-2#1)(1996-12#1)(1997-4#1)(2008-2#1)(2008-4#1)(2012-12#1)
which have been##154##3##(1990-10#1)(1990-12#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#3)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-7#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-6#2)(1996-10#1)(1996-12#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(2005-10#2)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
which have compared##2##3##(2007-12#1)(2013-8#1)
which have different##3##3##(1990-11#1)(1994-10#1)(1997-4#1)
which have direct##3##3##(2007-5#1)(2010-7#1)(2011-1#1)
which have evaluated the##3##4##(2005-8#1)(2007-12#1)(2009-6#1)
which have great##2##3##(2006-10#1)(2008-12#1)
which have had##2##3##(1995-6#1)(1996-1#1)
which have high##3##3##(1994-11#1)(1995-2#1)(2011-1#1)
which have important##2##3##(2005-8#1)(2006-10#1)
which have incorporated##2##3##(2008-9#2)
which have limited##3##3##(1992-2#1)(2008-8#1)(2012-2#1)
which have more##2##3##(1992-7#1)(2009-4#1)
which have never been##2##4##(1992-5#1)(2008-3#1)
which have no##6##3##(1991-5#1)(1992-4#1)(1997-7#1)(2007-1#1)(2008-7#1)(2010-5#1)
which have not been##6##4##(1991-7#1)(1993-2#1)(2006-7#1)(2007-11#1)(2008-1#1)(2010-4#1)
which have not yet been##2##5##(1990-4#1)(2006-8#1)
which have not##13##3##(1990-4#1)(1990-7#1)(1991-7#1)(1992-3#1)(1993-2#1)(2006-7#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-4#2)(2008-7#1)(2010-4#1)
which have occurred in the##2##5##(2006-8#1)(2008-10#1)
which have occurred##3##3##(2006-8#1)(2008-10#1)(2011-2#1)
which have only been##2##4##(1992-9#1)(1995-8#1)
which have only##5##3##(1992-9#1)(1993-9#1)(1994-11#1)(1995-8#1)(2008-5#1)
which have potential for improving access by assisting in operations planning support##2##12##(2013-1#2)
which have potential value##2##4##(2009-1#1)(2012-2#1)
which have potential##5##3##(1993-4#1)(2009-1#1)(2012-2#1)(2013-1#2)
which have previously been shown to##3##6##(1992-5#1)(2010-8#1)(2011-1#1)
which have previously been##7##4##(1992-5#1)(1996-3#1)(1997-2#1)(2006-2#1)(2008-8#1)(2010-8#1)(2011-1#1)
which have proved effective in##2##5##(1994-7#1)(2008-6#1)
which have proved##4##3##(1992-1#1)(1994-7#1)(2007-11#1)(2008-6#1)
which have received##2##3##(1995-1#1)(2009-8#1)
which have recently been##2##4##(2008-11#1)(2010-2#1)
which have revealed##2##3##(2006-9#1)(2013-1#1)
which have shown##8##3##(1997-1#1)(2006-9#1)(2007-2#1)(2008-5#1)(2008-7#1)(2012-2#2)(2013-8#1)
which have similar##3##3##(1996-8#1)(2008-7#1)(2012-12#1)
which have so far##2##4##(1992-8#1)(2006-6#1)
which have sometimes been##2##4##(2008-7#1)(2008-8#1)
which have the potential to##5##5##(1996-4#1)(2004-9#1)(2007-9#1)(2008-7#1)(2011-2#1)
which have the potential##6##4##(1996-4#1)(2004-9#1)(2007-7#1)(2007-9#1)(2008-7#1)(2011-2#1)
which have the##9##3##(1990-2#1)(1996-1#1)(1996-4#1)(1996-5#1)(2004-9#1)(2007-7#1)(2007-9#1)(2008-7#1)(2011-2#1)
which have to be##4##4##(1994-1#1)(2006-6#1)(2008-11#1)(2012-3#1)
which have to##5##3##(1992-2#1)(1994-1#1)(2006-6#1)(2008-11#1)(2012-3#1)
which have unique##2##3##(1990-8#1)(2008-11#1)
which have yet to##2##4##(2005-7#1)(2008-5#1)
which have##434##2##(1990-10#1)(1990-11#4)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#2)(1990-7#3)(1990-8#7)(1991-10#2)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#4)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#3)(1992-4#2)(1992-5#4)(1992-6#2)(1992-7#3)(1992-8#2)(1992-9#3)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#4)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#5)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#3)(1996-10#2)(1996-12#2)(1996-2#2)(1996-3#5)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#3)(1997-5#4)(1997-7#1)(1997-8#1)(2004-12#1)(2004-7#1)(2004-9#2)(2005-10#4)(2005-11#1)(2005-6#2)(2005-7#3)(2005-8#5)(2006-10#9)(2006-11#1)(2006-2#1)(2006-6#3)(2006-7#3)(2006-8#5)(2006-9#4)(2007-1#2)(2007-10#1)(2007-11#10)(2007-12#8)(2007-2#3)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#6)(2008-10#25)(2008-11#13)(2008-12#5)(2008-2#1)(2008-3#5)(2008-4#12)(2008-5#18)(2008-6#3)(2008-7#20)(2008-8#7)(2008-9#4)(2009-1#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#2)(2009-6#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-2#4)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#8)(2011-10#1)(2011-2#8)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#10)(2012-3#5)(2013-1#11)(2013-7#1)(2013-8#5)
which he had##2##3##(1996-2#1)(2008-11#1)
which he was##4##3##(2007-7#1)(2007-8#1)(2008-4#1)(2008-6#1)
which he##27##2##(1994-3#3)(1996-2#1)(1996-9#1)(1997-4#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-6#3)(2008-7#1)(2009-10#1)(2009-2#2)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
which heals##2##2##(2012-12#2)
which health care is##2##4##(1992-2#1)(1997-3#1)
which health care##4##3##(1992-2#1)(1994-3#1)(1997-3#1)(2007-4#1)
which health##11##2##(1990-12#1)(1991-10#1)(1992-2#1)(1994-3#1)(1995-9#1)(1997-2#1)(1997-3#1)(2007-4#1)(2008-11#1)(2011-1#1)(2011-2#1)
which heat##2##2##(2006-12#1)(2008-5#1)
which held##3##2##(1996-11#1)(1997-5#1)(2005-8#1)
which help to##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
which help##6##2##(1994-2#1)(2005-8#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-8#1)
which helped to##2##3##(2008-7#1)(2011-2#1)
which helped##4##2##(2007-7#1)(2008-7#1)(2009-7#1)(2011-2#1)
which helps to produce##2##4##(2008-2#1)(2008-7#1)
which helps to reduce the##3##5##(2007-5#1)(2008-10#1)(2008-3#1)
which helps to##9##3##(2007-11#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#2)
which helps##15##2##(1997-2#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-12#3)
which high##6##2##(1990-3#1)(1991-3#1)(1996-9#1)(2005-11#1)(2008-3#1)(2012-12#1)
which highlight the##3##3##(2007-8#1)(2009-12#1)(2013-8#1)
which highlight##5##2##(2007-8#1)(2009-12#1)(2012-11#2)(2013-8#1)
which highlights the##4##3##(1991-2#1)(1992-9#1)(2010-5#1)(2011-2#1)
which highlights##5##2##(1991-2#1)(1992-9#1)(2010-2#1)(2010-5#1)(2011-2#1)
which highly##2##2##(2008-11#1)(2009-10#1)
which hinders##3##2##(1997-5#1)(2007-7#1)(2009-2#1)
which historically##2##2##(2006-9#1)(2008-12#1)
which hitherto##3##2##(1996-2#1)(2007-7#1)(2011-1#1)
which holds that the##2##4##(2012-11#1)(2013-8#1)
which holds that##3##3##(1997-1#1)(2012-11#1)(2013-8#1)
which holds##5##2##(1997-1#1)(2007-8#1)(2012-11#1)(2012-3#1)(2013-8#1)
which home##2##2##(1995-3#1)(2008-11#1)
which hormones##2##2##(1990-11#1)(1994-11#1)
which hospitals##2##2##(1994-1#1)(1996-2#1)
which host##2##2##(1995-12#1)(2008-9#1)
which however##4##2##(2008-11#1)(2008-8#1)(2012-12#1)(2013-8#1)
which human T##2##3##(2008-4#1)(2011-1#1)
which human##5##2##(1995-8#1)(2006-10#1)(2008-4#1)(2008-5#1)(2011-1#1)
which hybridized##2##2##(1991-10#1)(1992-4#1)
which hydrogen##2##2##(1991-8#1)(2009-7#1)
which hydrolyses##3##2##(1991-3#1)(1997-3#2)
which hydrolyzes##3##2##(1990-4#1)(1990-5#1)(1993-9#1)
which hypothesized##2##2##(1994-11#1)(1994-12#1)
which identified##6##2##(1993-2#1)(2007-12#1)(2008-11#1)(2009-8#1)(2011-1#1)(2012-3#1)
which identifies##5##2##(1993-2#1)(1995-9#1)(2005-11#1)(2008-11#1)(2008-9#1)
which identify##2##2##(1995-6#1)(2009-7#1)
which if##3##2##(2004-1#1)(2008-5#1)(2008-7#1)
which ignore##2##2##(1995-12#1)(2009-7#1)
which illustrate that##2##3##(2006-9#1)(2012-2#1)
which illustrate the##3##3##(2007-9#1)(2008-10#1)(2008-4#1)
which illustrate##6##2##(2006-9#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-2#1)
which illustrates that##2##3##(2008-2#1)(2010-2#1)
which illustrates##4##2##(1995-5#1)(2007-12#1)(2008-2#1)(2010-2#1)
which imaging can##2##3##(2007-4#1)(2011-2#1)
which imaging##3##2##(2007-4#1)(2011-2#2)
which immobilized##2##2##(1993-8#1)(1996-8#1)
which immunological##2##2##(2006-5#1)(2006-6#1)
which immunologically##2##2##(1990-4#1)(1993-6#1)
which impact on##2##3##(2008-11#1)(2011-12#1)
which impact##3##2##(2008-11#1)(2011-12#1)(2013-1#1)
which impairs##2##2##(2007-9#1)(2010-8#1)
which impeded##2##2##(2008-12#1)(2008-5#1)
which implicated##3##2##(1996-3#1)(1997-1#1)(2007-12#1)
which implicates##3##2##(1994-2#1)(1997-4#1)(2007-6#1)
which implied that##2##3##(2005-11#1)(2013-8#1)
which implies a##2##3##(1992-3#1)(1996-4#1)
which implies that the##3##4##(2008-2#1)(2008-5#1)(2009-8#1)
which implies that##9##3##(2007-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-8#1)(2012-3#1)(2013-8#1)
which implies the##2##3##(2004-2#1)(2005-11#1)
which implies##20##2##(1992-3#1)(1995-11#1)(1995-6#1)(1996-4#1)(2004-2#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
which imply that##2##3##(1993-7#1)(2007-2#1)
which imply##3##2##(1993-7#1)(2006-10#1)(2007-2#1)
which improve the##3##3##(2007-11#1)(2008-10#1)(2010-2#1)
which improve##8##2##(1991-6#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-2#1)(2012-3#1)
which improved the##4##3##(2007-7#1)(2008-10#2)(2012-12#1)
which improved##9##2##(1992-1#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2009-10#1)(2012-12#1)(2012-2#1)
which improves the##4##3##(2007-8#2)(2008-10#1)(2008-9#1)
which improves##8##2##(1990-11#1)(1995-6#1)(2007-3#1)(2007-8#2)(2008-10#1)(2008-9#1)(2011-1#1)
which in a##2##3##(2008-10#1)(2010-9#1)
which in effect##2##3##(1992-4#1)(2008-11#1)
which in general##2##3##(1990-4#1)(1997-6#1)
which in many##2##3##(1990-3#1)(2007-11#1)
which in some cases##3##4##(1994-12#1)(1997-7#1)(2007-2#1)
which in the presence of##2##5##(2008-10#1)(2010-11#1)
which in the##12##3##(1992-1#1)(1996-12#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-8#1)(2010-1#1)(2010-11#1)
which in turn activates##3##4##(1995-2#1)(1995-6#1)(1995-8#1)
which in turn affects the##2##5##(2008-8#1)(2009-11#1)
which in turn affects##4##4##(1996-5#1)(2008-8#1)(2009-11#1)(2010-11#1)
which in turn are##5##4##(1996-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-8#1)
which in turn can##4##4##(1990-4#1)(2005-8#1)(2006-2#1)(2010-5#1)
which in turn causes##2##4##(1994-9#1)(2010-12#1)
which in turn depends on##2##5##(2007-4#1)(2008-8#1)
which in turn has##4##4##(1996-6#1)(2007-11#1)(2008-11#1)(2008-9#1)
which in turn is related to##2##6##(2010-10#1)(2013-1#1)
which in turn is the##2##5##(2006-7#1)(2011-2#1)
which in turn is##12##4##(1990-12#1)(1990-6#1)(1994-12#1)(1996-4#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-4#2)(2010-10#1)(2011-2#1)(2013-1#1)
which in turn leads to##5##5##(2007-11#1)(2007-9#1)(2008-5#1)(2008-8#1)(2010-12#1)
which in turn leads##6##4##(1996-6#1)(2007-11#1)(2007-9#1)(2008-5#1)(2008-8#1)(2010-12#1)
which in turn may allow##2##5##(1993-7#1)(2009-8#1)
which in turn may##8##4##(1992-8#1)(1993-11#1)(1993-7#1)(1995-12#1)(1996-12#1)(2009-8#1)(2011-1#1)(2012-12#1)
which in turn promotes##2##4##(2007-11#1)(2008-6#1)
which in turn provides##2##4##(1994-12#1)(2007-12#1)
which in turn reduces##3##4##(1995-12#2)(2009-5#1)
which in turn results in##2##5##(2008-5#1)(2010-3#1)
which in turn should##2##4##(2008-11#1)(2012-3#1)
which in turn suggests that##2##5##(1995-12#1)(2008-3#1)
which in turn were##2##4##(1995-3#1)(2008-12#1)
which in turn would##4##4##(1996-4#1)(1997-2#1)(2005-7#1)(2009-4#1)
which in turn##129##3##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-4#1)(1991-9#1)(1992-11#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-9#2)(1995-12#4)(1995-2#2)(1995-3#3)(1995-6#1)(1995-8#1)(1996-12#2)(1996-4#2)(1996-5#1)(1996-6#2)(1997-2#2)(1997-4#1)(1997-6#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-2#2)(2006-7#1)(2007-11#5)(2007-12#3)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#3)(2009-11#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-5#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
which in##189##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1991-10#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-4#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-7#1)(1993-8#1)(1994-12#5)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#3)(1995-10#1)(1995-12#4)(1995-2#2)(1995-3#3)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#3)(1996-4#3)(1996-5#1)(1996-6#2)(1996-9#1)(1997-2#2)(1997-4#1)(1997-6#3)(1997-7#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-2#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#7)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#11)(2008-11#7)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#4)(2009-11#1)(2009-4#3)(2009-5#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#2)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
which inactivate##3##2##(1993-9#1)(2006-8#1)(2012-2#1)
which inactivated##2##2##(1996-7#1)(2006-3#1)
which inactivates##2##2##(1991-9#1)(2005-7#1)
which include a##6##3##(1995-9#1)(1996-8#1)(2006-8#1)(2007-12#1)(2008-10#1)(2012-12#1)
which include both##2##3##(2008-5#1)(2008-8#1)
which include not only##2##4##(1996-5#1)(2009-9#1)
which include only##2##3##(1992-9#1)(2010-5#1)
which include stricter technical specifications and a more efficient approach to patient identification (ID) matching and consent management##2##18##(2013-1#2)
which include the##7##3##(1994-8#1)(1997-4#1)(2006-10#1)(2008-4#1)(2008-9#1)(2010-11#1)(2013-1#1)
which include##91##2##(1990-8#1)(1991-2#1)(1991-5#1)(1992-9#1)(1993-5#1)(1993-9#1)(1994-12#2)(1994-8#1)(1995-10#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-8#2)(1997-4#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-4#1)(2006-5#1)(2006-8#5)(2006-9#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#2)(2008-10#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-5#3)(2009-8#1)(2009-9#1)(2010-11#1)(2010-5#2)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#2)
which included a##11##3##(1994-9#1)(2007-1#1)(2007-12#1)(2007-4#1)(2008-11#1)(2009-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
which included an##3##3##(1991-1#1)(1991-12#1)(2012-2#1)
which included four##2##3##(2008-10#1)(2011-2#1)
which included the##10##3##(1993-12#1)(1993-6#1)(1994-5#2)(1995-11#1)(1997-4#1)(2007-5#1)(2008-10#1)(2008-7#1)(2011-3#1)
which included two##2##3##(2010-11#1)(2012-3#1)
which included##84##2##(1990-12#1)(1991-1#1)(1991-12#1)(1991-6#1)(1992-10#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-5#3)(1994-9#1)(1995-11#1)(1995-12#1)(1996-3#1)(1997-4#1)(2005-10#1)(2005-11#1)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2009-11#1)(2009-2#2)(2009-4#1)(2009-8#3)(2010-11#1)(2010-5#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-1#3)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)
which includes a##7##3##(1990-12#1)(1991-8#1)(1996-7#1)(1997-4#1)(2007-5#1)(2008-11#1)(2012-2#1)
which includes all##2##3##(2007-12#1)(2007-4#1)
which includes an##3##3##(1992-1#1)(1993-2#1)(2008-3#1)
which includes deep##2##3##(2010-2#1)(2012-3#1)
which includes four##2##3##(1994-8#1)(2006-12#1)
which includes several##3##3##(1992-9#1)(1994-10#1)(2012-8#1)
which includes the##28##3##(1990-7#1)(1990-8#1)(1991-5#1)(1991-9#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-2#2)(2005-9#1)(2006-12#1)(2006-8#1)(2007-12#2)(2008-10#2)(2008-12#2)(2008-2#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-2#2)
which includes##115##2##(1990-11#2)(1990-12#1)(1990-7#2)(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-5#1)(1992-9#2)(1993-12#2)(1993-2#1)(1993-3#3)(1993-5#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#2)(1995-7#1)(1996-12#2)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(2005-7#2)(2005-9#1)(2006-10#2)(2006-12#3)(2006-8#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#1)(2012-8#1)(2013-1#1)(2013-8#2)
which incorporate##2##2##(1995-12#1)(2008-11#1)
which incorporated##2##2##(1994-11#1)(2007-8#1)
which incorporates a##2##3##(1996-3#1)(2008-2#1)
which incorporates the##4##3##(1991-2#1)(1996-12#1)(2006-10#1)(2012-2#1)
which incorporates##16##2##(1990-5#1)(1991-12#1)(1991-2#1)(1993-9#1)(1996-11#1)(1996-12#1)(1996-3#1)(2006-10#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2010-12#1)(2012-2#1)(2013-1#2)
which increase the risk of##2##5##(2008-7#1)(2013-1#1)
which increase the##8##3##(1990-4#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-12#1)(2013-1#1)
which increase##14##2##(1990-4#1)(1993-8#1)(1994-8#1)(1995-8#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-12#1)(2010-2#1)(2013-1#1)
which increased at##2##3##(2008-11#1)(2010-2#1)
which increased by##2##3##(1991-2#1)(2008-5#1)
which increased during the##2##4##(2007-7#1)(2010-8#1)
which increased during##3##3##(2007-7#1)(2008-3#1)(2010-8#1)
which increased the signal##2##4##(2007-8#1)(2008-10#1)
which increased the##8##3##(1991-3#1)(1995-1#1)(2007-8#1)(2008-10#3)(2008-6#1)(2010-4#1)
which increased to##3##3##(2004-9#2)(2006-7#1)
which increased with##4##3##(1991-9#1)(1992-1#1)(1992-4#1)(1996-2#1)
which increased##31##2##(1990-11#1)(1991-2#2)(1991-3#1)(1991-9#1)(1992-1#1)(1992-4#1)(1992-6#1)(1994-3#1)(1995-1#1)(1996-1#1)(1996-2#1)(2004-9#2)(2006-7#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-2#1)(2010-4#1)(2010-8#1)(2012-2#1)(2012-3#1)
which increases the kinoform size##2##5##(2008-2#2)
which increases the number of##3##5##(1997-7#1)(2008-10#1)(2008-3#1)
which increases the##10##3##(1997-7#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2009-8#1)(2010-5#1)
which increases with age##3##4##(1996-2#1)(2008-4#1)(2013-7#1)
which increases with##6##3##(1996-2#1)(2006-7#1)(2007-11#1)(2008-4#1)(2008-9#1)(2013-7#1)
which increases##32##2##(1990-2#1)(1990-6#1)(1990-7#1)(1992-3#1)(1995-2#1)(1996-2#1)(1996-4#1)(1997-7#2)(2005-8#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-5#1)(2011-2#1)(2013-1#2)(2013-7#1)
which indicate that the##7##4##(1990-10#1)(1992-7#1)(1995-3#1)(2005-11#1)(2008-2#1)(2009-4#1)(2010-2#1)
which indicate that##19##3##(1990-10#1)(1992-7#1)(1994-11#1)(1995-3#1)(1996-10#1)(1996-11#1)(1996-8#1)(1997-2#1)(2005-11#1)(2008-10#3)(2008-11#2)(2008-2#1)(2009-4#1)(2010-2#1)(2012-1#1)(2013-8#1)
which indicate##24##2##(1990-10#1)(1990-5#1)(1991-10#1)(1992-7#1)(1993-3#1)(1994-11#1)(1995-3#1)(1996-10#1)(1996-11#1)(1996-8#1)(1997-2#1)(2005-11#1)(2006-9#1)(2008-10#3)(2008-11#2)(2008-2#2)(2009-4#1)(2010-2#1)(2012-1#1)(2013-8#1)
which indicated a##2##3##(1990-6#1)(2013-8#1)
which indicated that the##8##4##(1991-10#1)(1995-5#1)(2005-11#1)(2008-10#1)(2008-5#1)(2010-8#1)(2012-1#1)(2013-1#1)
which indicated that##17##3##(1991-10#1)(1995-5#1)(1996-11#1)(2005-11#2)(2007-8#3)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
which indicated the occurrence of##2##5##(2008-11#1)(2008-3#1)
which indicated the##9##3##(2008-10#2)(2008-11#1)(2008-3#2)(2010-10#1)(2012-2#2)(2013-1#1)
which indicated##34##2##(1990-6#1)(1991-10#1)(1995-5#1)(1995-6#1)(1996-11#1)(1997-7#1)(2005-11#2)(2007-11#1)(2007-8#3)(2008-10#4)(2008-11#2)(2008-3#2)(2008-5#1)(2008-8#2)(2008-9#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
which indicates a##8##3##(1993-12#1)(1994-6#1)(2008-10#2)(2008-5#1)(2010-8#1)(2011-1#1)(2013-8#1)
which indicates that the##20##4##(1992-6#1)(1993-11#1)(1994-9#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-1#1)(2013-8#1)
which indicates that these##2##4##(1995-3#1)(2009-9#1)
which indicates that##56##3##(1990-7#1)(1991-7#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-6#1)(1997-7#2)(2005-11#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#3)(2008-8#3)(2008-9#2)(2009-3#1)(2009-6#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-8#2)
which indicates the presence of##2##5##(1991-12#1)(2004-4#1)
which indicates the presence##3##4##(1991-12#1)(1992-1#1)(2004-4#1)
which indicates the##13##3##(1990-12#1)(1991-12#1)(1992-1#1)(1995-3#1)(1997-7#1)(2004-4#1)(2006-8#1)(2007-12#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-8#1)
which indicates##89##2##(1990-12#1)(1990-7#1)(1991-12#1)(1991-7#1)(1992-1#1)(1992-3#1)(1992-6#2)(1993-11#1)(1993-12#2)(1994-12#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-3#2)(1995-6#1)(1996-5#1)(1997-6#1)(1997-7#3)(2004-4#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#6)(2008-7#5)(2008-8#4)(2008-9#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#2)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-1#2)(2012-2#1)(2013-8#4)
which individual##13##2##(1990-2#1)(1993-11#1)(1995-10#1)(1995-8#1)(2004-9#1)(2006-12#1)(2006-5#1)(2008-2#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-12#1)
which individuals##11##2##(1993-12#1)(1994-4#1)(1995-2#1)(2007-12#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-2#1)(2013-8#1)
which induce the##2##3##(1994-11#1)(2007-11#1)
which induce##9##2##(1990-4#1)(1992-12#1)(1994-11#1)(2007-11#1)(2008-1#1)(2008-5#1)(2008-8#1)(2012-12#1)(2012-2#1)
which induced a##5##3##(1990-12#1)(1993-8#1)(1994-2#1)(1996-8#1)(2008-10#1)
which induced##14##2##(1990-12#1)(1991-1#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-9#1)(1996-8#1)(2008-10#1)(2008-11#2)
which induces a##4##3##(1992-12#1)(1995-5#1)(2006-11#1)(2008-3#1)
which induces the##5##3##(1991-6#1)(1994-6#1)(1996-3#1)(2008-11#1)(2012-3#1)
which induces##24##2##(1991-1#1)(1991-6#1)(1992-12#1)(1992-5#1)(1993-6#1)(1994-6#1)(1995-5#1)(1996-3#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#1)
which infants##2##2##(1990-5#1)(1991-12#1)
which infect both##2##3##(2008-9#1)(2013-7#1)
which infect##3##2##(1997-1#1)(2008-9#1)(2013-7#1)
which infectious##4##2##(2004-11#1)(2008-10#2)(2008-9#1)
which influence the##7##3##(1993-6#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-8#1)(2013-1#1)(2013-8#1)
which influence their##2##3##(2010-9#1)(2013-8#1)
which influence##20##2##(1991-6#1)(1993-11#1)(1993-6#1)(1995-1#1)(1995-4#1)(1997-7#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-9#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
which influenced their##2##3##(2008-7#1)(2013-1#1)
which influenced##4##2##(2006-2#1)(2008-7#1)(2010-8#1)(2013-1#1)
which influences##3##2##(2006-8#1)(2008-8#1)(2010-12#1)
which informal##2##2##(2009-5#1)(2011-12#1)
which information is##6##3##(1995-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-10#1)(2012-3#1)
which information##7##2##(1995-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-10#1)(2012-3#1)
which inhaled##2##2##(1996-3#1)(1996-7#1)
which inhibit the activity of##2##5##(2005-7#1)(2005-8#1)
which inhibit the##6##3##(1991-3#1)(1996-2#1)(2005-7#2)(2005-8#1)(2008-10#1)
which inhibit##20##2##(1990-7#1)(1991-3#2)(1996-10#2)(1996-2#1)(1997-1#1)(1997-2#1)(2005-7#2)(2005-8#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-10#1)(2012-2#1)
which inhibited the##3##3##(1992-9#1)(1993-6#1)(1997-6#1)
which inhibited##13##2##(1991-12#2)(1991-7#1)(1991-8#3)(1991-9#1)(1992-9#1)(1993-6#1)(1993-8#1)(1997-6#1)(2006-12#1)(2007-1#1)
which inhibits protein kinases##2##4##(1991-9#1)(1992-4#1)
which inhibits protein##3##3##(1991-5#1)(1991-9#1)(1992-4#1)
which inhibits the proliferation of##2##5##(1996-2#1)(2007-11#1)
which inhibits the##12##3##(1990-9#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-7#1)(1996-12#1)(1996-2#1)(1997-6#1)(2007-11#2)(2008-10#1)(2013-1#1)
which inhibits##45##2##(1990-11#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-4#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-11#3)(1994-2#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-6#3)(1995-7#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-6#1)(1997-7#1)(2003-11#1)(2007-11#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-7#2)(2012-1#1)(2012-2#1)(2013-1#1)
which initially##4##2##(2005-10#1)(2008-10#1)(2008-7#1)(2009-4#1)
which initiates##2##2##(1997-8#1)(2008-4#1)
which innervate##3##2##(1994-2#1)(1995-7#1)(2010-2#1)
which insertion##2##2##(2006-5#1)(2009-11#1)
which inspired##2##2##(2008-7#1)(2009-7#1)
which instead##3##2##(1997-8#1)(2008-3#1)(2010-8#1)
which insulin##4##2##(1991-5#1)(2008-1#1)(2008-3#2)
which insurers##3##2##(1993-9#1)(1994-12#1)(1995-6#1)
which integrate the##2##3##(1991-8#1)(2008-11#1)
which integrate##5##2##(1991-8#1)(1995-5#1)(1996-1#1)(2008-11#1)(2012-1#1)
which integrated##2##2##(2006-3#1)(2008-10#1)
which integrates the##2##3##(2007-12#1)(2007-8#1)
which integrates##9##2##(1996-1#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
which interact with a##2##4##(1993-8#1)(2005-11#1)
which interact with the##4##4##(1990-10#1)(1992-11#1)(1993-3#1)(1994-2#1)
which interact with##13##3##(1990-10#2)(1991-12#1)(1992-11#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(2005-10#1)(2005-11#1)
which interact##15##2##(1990-10#2)(1991-12#1)(1992-11#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(2005-10#1)(2005-11#1)
which interacted with##2##3##(1992-12#1)(1995-3#1)
which interaction with##2##3##(1996-4#1)(2008-10#1)
which interactions##3##2##(2007-10#1)(2008-5#1)(2012-2#1)
which interacts with the##3##4##(1994-10#1)(2012-3#2)
which interacts with##10##3##(1992-9#1)(1993-8#1)(1994-10#1)(1994-9#1)(1997-4#1)(2007-11#1)(2008-7#1)(2012-1#1)(2012-3#2)
which interfere in##2##3##(2008-10#1)(2008-2#1)
which interfere with the##6##4##(1991-5#1)(1996-5#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)
which interfere with##9##3##(1991-5#1)(1996-5#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-1#1)
which interfere##12##2##(1991-5#1)(1996-5#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#2)(2013-1#1)
which interfered with the##2##4##(1993-9#1)(2007-9#1)
which interventions are##2##3##(2012-1#1)(2012-12#1)
which interventions##3##2##(2007-1#1)(2012-1#1)(2012-12#1)
which introduces a##2##3##(2008-2#1)(2008-9#1)
which introduces additional##2##3##(1995-3#1)(2008-3#1)
which introduces##8##2##(1995-3#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2010-12#1)(2013-7#1)
which invariably##3##2##(2009-12#1)(2009-5#1)(2011-1#1)
which investigated the##2##3##(1993-12#1)(1997-2#1)
which investigated##3##2##(1993-12#1)(1997-2#1)(1997-3#1)
which involve##12##2##(1991-1#1)(1991-6#1)(1993-3#1)(1993-4#1)(2006-2#1)(2007-8#1)(2008-5#2)(2009-10#1)(2011-1#1)(2011-2#1)(2013-7#1)
which involved the##8##3##(1990-2#1)(1992-5#1)(2005-11#1)(2006-5#1)(2008-10#1)(2010-8#1)(2013-1#1)(2013-8#1)
which involved##21##2##(1990-2#1)(1991-2#3)(1991-3#1)(1992-2#1)(1992-5#1)(1993-2#1)(2005-11#1)(2006-5#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-8#1)(2012-1#1)(2013-1#1)(2013-8#3)
which involves a##6##3##(1995-3#1)(1996-5#1)(2007-10#1)(2008-10#1)(2008-9#1)(2011-3#1)
which involves gamma phosphate cleavage from ATP##2##7##(2013-1#2)
which involves multiple##3##3##(1992-6#1)(2006-3#1)(2007-12#1)
which involves the use of##2##5##(1992-8#1)(2008-10#1)
which involves the##8##3##(1992-8#1)(1997-8#1)(2008-1#2)(2008-10#1)(2012-12#2)(2012-3#1)
which involves various##2##3##(2007-10#1)(2007-7#1)
which involves##50##2##(1990-6#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-9#1)(1994-12#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-2#1)(2006-3#1)(2007-10#2)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#4)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
which irreversibly##2##2##(1993-5#1)(1997-3#1)
which is 10##2##3##(2008-10#1)(2008-3#1)
which is 100% conserved##2##4##(1997-7#2)
which is 2##3##3##(1993-3#1)(2007-11#1)(2011-2#1)
which is 39% identical##2##4##(1993-11#1)(1997-6#1)
which is 4##2##3##(2008-7#1)(2008-9#1)
which is a characteristic##2##4##(2007-1#1)(2008-10#1)
which is a common##5##4##(1993-12#1)(1995-10#1)(1995-2#1)(2008-4#1)(2008-7#1)
which is a competitive antagonist##2##5##(2008-11#1)(2008-3#1)
which is a component of##4##5##(1994-2#1)(1994-8#1)(2007-12#1)(2008-11#1)
which is a component##5##4##(1994-2#1)(1994-8#1)(2007-12#1)(2008-11#1)(2013-1#1)
which is a direct##3##4##(2008-10#2)(2011-12#1)
which is a function of the##2##6##(2007-1#1)(2007-11#1)
which is a key##5##4##(1991-2#1)(1991-4#1)(2008-10#1)(2008-8#1)(2009-3#1)
which is a leading cause for hospital admissions nationally (particularly for the elderly)##2##13##(2013-1#2)
which is a learning-based but knowledge-rich system that compresses medical texts in a SMS style##2##15##(2013-1#2)
which is a liquid at##2##5##(1996-1#1)(1996-2#1)
which is a major##11##4##(1992-1#1)(1992-12#1)(1993-4#1)(2004-4#1)(2005-5#1)(2006-12#1)(2007-12#2)(2008-5#1)(2010-11#1)(2011-9#1)
which is a mandatory##2##4##(2007-11#1)(2008-10#1)
which is a measure of the##2##6##(1990-11#1)(2008-4#1)
which is a mediator of##3##5##(2008-11#1)(2010-5#1)(2011-12#1)
which is a member of the##2##6##(1994-9#1)(2012-12#1)
which is a member of##3##5##(1994-9#1)(1996-5#1)(2012-12#1)
which is a more##3##4##(2008-10#2)(2009-5#1)
which is a most##2##4##(1991-5#1)(2006-6#1)
which is a narrow##2##4##(2007-3#2)
which is a new##3##4##(1997-6#1)(2008-1#1)(2008-7#1)
which is a novel##2##4##(1997-1#1)(2013-1#1)
which is a part of the##2##6##(2012-1#1)(2013-8#1)
which is a potent##6##4##(1991-1#1)(1993-12#1)(1994-9#1)(1997-2#1)(2008-5#1)(2008-7#1)
which is a potential##2##4##(2008-5#1)(2010-1#1)
which is a prerequisite for##4##5##(2008-11#1)(2008-3#1)(2008-4#1)(2009-8#1)
which is a promising##2##4##(2008-1#1)(2008-10#1)
which is a rare##2##4##(2006-5#1)(2007-7#1)
which is a region##2##4##(1992-8#1)(2007-9#1)
which is a significant##2##4##(1997-3#1)(2008-7#1)
which is a special##2##4##(2006-10#1)(2008-4#1)
which is a specific##3##4##(1992-12#1)(2008-11#2)
which is a substrate for##3##5##(1992-7#2)(1994-8#1)
which is a substrate##4##4##(1992-7#2)(1994-8#1)(2009-8#1)
which is a type##2##4##(2008-10#2)
which is a very##4##4##(1992-2#1)(2008-10#1)(2008-5#1)(2013-1#1)
which is a##219##3##(1990-11#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#2)(1992-1#1)(1992-12#3)(1992-2#1)(1992-4#2)(1992-7#2)(1992-8#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-2#1)(1994-3#2)(1994-8#3)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#2)(1997-7#1)(1997-8#1)(2004-4#1)(2004-9#1)(2005-11#2)(2005-5#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-5#1)(2006-6#2)(2006-8#1)(2007-1#2)(2007-11#2)(2007-12#9)(2007-3#3)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#3)(2008-1#3)(2008-10#24)(2008-11#10)(2008-2#4)(2008-3#5)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#3)(2009-8#7)(2009-9#1)(2010-1#1)(2010-11#1)(2010-2#2)(2010-3#3)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#5)(2011-9#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#9)(2013-8#2)
which is able to be##2##5##(2007-9#1)(2008-9#1)
which is able to improve##2##5##(2008-8#2)
which is able to##10##4##(1991-6#1)(1994-9#1)(1997-8#1)(2006-3#1)(2007-9#1)(2008-10#1)(2008-8#2)(2008-9#1)(2010-5#1)
which is able##11##3##(1991-6#1)(1991-8#1)(1994-9#1)(1997-8#1)(2006-3#1)(2007-9#1)(2008-10#1)(2008-8#2)(2008-9#1)(2010-5#1)
which is about an order of magnitude##2##7##(1995-12#1)(2010-9#1)
which is about##10##3##(1994-2#1)(1995-10#1)(1995-12#1)(1995-3#1)(2008-10#3)(2009-5#1)(2010-9#1)(2012-12#1)
which is absent in##5##4##(1993-11#1)(1993-6#1)(1997-1#1)(2008-10#1)(2012-2#1)
which is absent##6##3##(1990-12#1)(1993-11#1)(1993-6#1)(1997-1#1)(2008-10#1)(2012-2#1)
which is accelerated by##2##4##(1991-9#1)(1997-4#1)
which is accelerated##4##3##(1991-9#2)(1995-8#1)(1997-4#1)
which is accepted##2##3##(2008-10#1)(2008-11#1)
which is accompanied by a##2##5##(1991-5#1)(1997-6#1)
which is accompanied by##4##4##(1991-5#1)(1996-2#1)(1997-6#1)(2012-12#1)
which is accomplished by##2##4##(1996-12#1)(2007-8#1)
which is accurate##3##3##(1992-9#1)(1996-5#1)(2008-3#1)
which is achieved##2##3##(2008-10#1)(2008-2#1)
which is activated in##2##4##(1996-5#1)(2010-11#1)
which is activated##3##3##(1996-5#1)(2008-11#1)(2010-11#1)
which is active in##3##4##(1990-11#1)(1994-8#1)(1995-10#1)
which is active##5##3##(1990-11#1)(1994-10#1)(1994-5#1)(1994-8#1)(1995-10#1)
which is added##2##3##(1990-9#1)(2008-10#1)
which is adjacent to##2##4##(1996-7#1)(2008-10#1)
which is affected by##3##4##(1991-5#1)(2007-11#1)(2008-3#1)
which is affected##4##3##(1991-5#1)(1995-6#1)(2007-11#1)(2008-3#1)
which is almost constant over a pH range of##2##9##(2008-10#2)
which is almost##6##3##(1993-4#1)(1993-9#1)(1995-12#1)(2008-10#3)
which is already##2##3##(1990-12#1)(2011-2#1)
which is also a##6##4##(1993-2#1)(1995-8#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-8#1)
which is also present in##2##5##(1990-4#1)(1991-2#1)
which is also supported by##4##5##(2006-1#1)(2007-8#1)(2008-4#1)(2011-1#1)
which is also the##3##4##(1992-1#1)(1994-9#1)(2008-9#1)
which is also##48##3##(1990-12#1)(1990-4#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-1#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-5#1)(1994-9#1)(1995-4#1)(1995-6#1)(1995-8#2)(1997-1#1)(1997-4#1)(1997-6#1)(2006-1#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#5)(2008-9#1)(2009-1#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#2)(2013-1#1)
which is always##2##3##(2008-9#1)(2009-5#1)
which is an autosomal##2##4##(2008-7#1)(2013-8#1)
which is an element##2##4##(2007-7#1)(2008-6#1)
which is an essential##2##4##(2008-11#1)(2009-6#1)
which is an extension of##2##5##(2008-3#1)(2013-8#1)
which is an important determinant of mortality in such patients##2##10##(2013-1#2)
which is an important factor##2##5##(2010-9#1)(2013-1#1)
which is an important first step##2##6##(2007-12#1)(2013-8#1)
which is an important##17##4##(1991-1#1)(1995-2#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-7#1)(2010-4#1)(2010-9#1)(2011-1#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
which is an indicator##2##4##(2008-10#1)(2008-12#1)
which is an##72##3##(1990-7#1)(1991-1#1)(1992-8#1)(1994-3#1)(1994-9#1)(1995-2#2)(1996-5#1)(1997-5#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#3)(2009-11#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#4)
which is apparently##3##3##(1994-9#1)(1995-1#1)(1995-2#1)
which is applicable for##2##4##(2007-11#1)(2008-2#1)
which is applicable to many##2##5##(1994-3#1)(2008-8#1)
which is applicable to##3##4##(1992-7#1)(1994-3#1)(2008-8#1)
which is applicable##5##3##(1992-7#1)(1994-3#1)(2007-11#1)(2008-2#1)(2008-8#1)
which is appropriate for##2##4##(1993-1#1)(2007-12#1)
which is approximately##10##3##(1994-2#1)(1997-7#1)(2006-7#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)
which is as low as##2##5##(2007-11#1)(2008-10#1)
which is as##5##3##(1995-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
which is assembled into##2##4##(1993-4#1)(2008-8#1)
which is assembled##4##3##(1993-4#1)(1994-8#1)(1996-10#1)(2008-8#1)
which is associated with Alzheimer's disease##2##6##(1994-5#1)(1997-2#1)
which is associated with a##4##5##(1990-8#1)(1994-12#1)(1995-3#1)(2008-10#1)
which is associated with an##3##5##(2007-12#1)(2010-4#1)(2011-2#1)
which is associated with high##2##5##(2006-12#1)(2009-8#1)
which is associated with higher##2##5##(1995-12#1)(2010-2#1)
which is associated with the##6##5##(1991-2#1)(1993-8#1)(1994-9#1)(1997-5#1)(2006-6#1)(2011-2#1)
which is associated with##28##4##(1990-8#1)(1991-2#1)(1992-1#1)(1992-2#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-3#1)(1996-6#1)(1997-2#1)(1997-5#1)(2006-12#1)(2006-6#1)(2007-12#2)(2007-4#1)(2008-10#2)(2008-11#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-2#2)
which is associated##29##3##(1990-8#1)(1991-2#1)(1992-1#1)(1992-2#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-3#1)(1996-6#1)(1997-2#1)(1997-5#1)(2006-12#1)(2006-6#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-2#2)
which is assumed to be##3##5##(1990-7#1)(1992-1#1)(2008-6#1)
which is assumed to##5##4##(1990-7#2)(1992-1#1)(2006-4#1)(2008-6#1)
which is assumed##6##3##(1990-7#2)(1992-1#1)(2006-4#1)(2008-10#1)(2008-6#1)
which is at least##3##4##(1995-3#1)(1996-10#1)(2008-10#1)
which is at##5##3##(1995-3#1)(1996-10#1)(2008-1#1)(2008-10#1)(2008-3#1)
which is attributed to the##5##5##(1996-4#1)(2005-11#2)(2009-6#1)(2012-2#1)
which is attributed to##12##4##(1996-4#1)(2005-11#2)(2006-12#1)(2008-3#2)(2008-8#1)(2009-2#1)(2009-6#3)(2012-2#1)
which is available to authorized users##27##6##(2010-1#2)(2010-12#6)(2011-1#3)(2011-2#2)(2012-1#3)(2012-11#2)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#1)
which is available##31##3##(1992-3#1)(2006-12#1)(2008-10#1)(2008-9#1)(2010-1#2)(2010-12#6)(2011-1#3)(2011-2#2)(2012-1#3)(2012-11#2)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#1)
which is based on a##5##5##(1997-6#1)(2007-11#1)(2007-8#1)(2008-3#1)(2012-2#1)
which is based on the ability of##2##7##(1996-3#1)(2007-11#1)
which is based on the##25##5##(1992-2#1)(1992-9#1)(1994-2#1)(1994-3#1)(1996-3#1)(2006-6#1)(2007-11#2)(2007-8#1)(2008-10#6)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#1)(2011-12#1)
which is based on##59##4##(1992-2#1)(1992-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1996-2#1)(1996-3#1)(1997-6#1)(2005-11#1)(2005-4#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-11#3)(2007-8#3)(2008-10#13)(2008-11#1)(2008-2#2)(2008-3#10)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2010-7#1)(2011-10#1)(2011-12#1)(2012-1#1)(2012-2#3)(2013-1#1)
which is based only on##2##5##(2007-6#1)(2007-8#1)
which is based##62##3##(1992-2#1)(1992-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1996-2#1)(1996-3#1)(1997-6#1)(2005-11#1)(2005-4#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-11#3)(2007-6#1)(2007-8#4)(2008-10#13)(2008-11#1)(2008-2#2)(2008-3#10)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2010-7#1)(2011-1#1)(2011-10#1)(2011-12#1)(2012-1#1)(2012-2#3)(2013-1#1)
which is becoming more##2##4##(1992-9#1)(2010-4#1)
which is becoming##3##3##(1992-9#1)(2008-11#1)(2010-4#1)
which is being developed##3##4##(1997-8#1)(2005-7#1)(2005-8#1)
which is being##8##3##(1997-8#1)(2005-7#1)(2005-8#3)(2007-8#1)(2011-1#1)(2013-7#1)
which is believed to be##7##5##(1994-11#2)(1994-5#1)(1996-8#1)(1997-2#1)(2007-12#1)(2008-4#1)
which is believed to##14##4##(1990-7#1)(1993-5#1)(1994-11#2)(1994-5#1)(1996-1#1)(1996-12#1)(1996-8#1)(1997-2#1)(2007-12#2)(2008-11#1)(2008-4#1)(2010-2#1)
which is below the##2##4##(1996-5#1)(2007-11#1)
which is beneficial##2##3##(2008-5#1)(2013-1#1)
which is best##2##3##(2006-10#1)(2008-4#1)
which is better than##2##4##(1994-6#1)(2010-8#1)
which is better##4##3##(1990-9#1)(1994-6#1)(2008-3#1)(2010-8#1)
which is both##3##3##(1992-5#1)(1995-1#1)(2011-2#1)
which is bound to##4##4##(1991-2#1)(1994-9#1)(1995-1#1)(1997-1#1)
which is bound##5##3##(1991-2#1)(1991-5#1)(1994-9#1)(1995-1#1)(1997-1#1)
which is calculated##2##3##(2008-3#1)(2008-9#1)
which is called##3##3##(2008-11#1)(2012-2#1)(2012-3#1)
which is capable of causing a persistent infection in vivo was compared to two tissue culture adapted CDV strains (passaged A75/17-CDV and Rockborn-CDV)##2##23##(1997-6#2)
which is capable of causing##4##5##(1997-6#2)(2011-1#1)(2013-8#1)
which is capable of##15##4##(1990-2#1)(1991-1#1)(1992-6#1)(1997-6#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-9#1)(2011-1#1)(2013-8#1)
which is capable##16##3##(1990-2#1)(1991-1#1)(1992-6#1)(1997-6#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-8#1)
which is caused by mutations in##2##6##(2007-2#1)(2007-7#1)
which is caused by mutations##3##5##(2007-2#1)(2007-7#2)
which is caused by the##4##5##(2008-10#1)(2008-2#1)(2013-7#1)(2013-8#1)
which is caused by##10##4##(1996-3#1)(2006-10#1)(2007-2#1)(2007-7#2)(2008-10#1)(2008-2#1)(2008-8#1)(2013-7#1)(2013-8#1)
which is caused##14##3##(1994-2#1)(1996-3#1)(2006-10#1)(2007-2#1)(2007-7#2)(2008-10#3)(2008-2#1)(2008-8#1)(2013-7#1)(2013-8#2)
which is central##2##3##(2006-8#1)(2011-1#1)
which is characterised##2##3##(2005-11#2)
which is characteristic of##8##4##(1990-2#1)(1990-7#1)(1991-5#1)(1992-6#1)(1992-9#1)(1995-6#1)(2007-11#1)(2008-5#1)
which is characteristic##9##3##(1990-2#1)(1990-7#1)(1991-5#1)(1992-6#1)(1992-9#1)(1995-6#1)(2005-1#1)(2007-11#1)(2008-5#1)
which is characterized by a high##2##6##(2010-3#1)(2012-3#1)
which is characterized by a##4##5##(1990-2#1)(2008-5#1)(2010-3#1)(2012-3#1)
which is characterized by its##2##5##(2006-12#1)(2007-12#1)
which is characterized by the##2##5##(1995-8#1)(2007-5#1)
which is characterized by##24##4##(1990-2#1)(1992-1#1)(1994-4#1)(1995-12#1)(1995-8#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#2)(2010-3#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-3#1)
which is cleaved##4##3##(1990-10#1)(1995-10#1)(2007-11#1)(2013-8#1)
which is clinically##3##3##(1993-3#1)(2007-9#1)(2008-7#1)
which is close to the##4##5##(2008-2#1)(2008-3#2)(2008-5#1)
which is close to##5##4##(2007-11#1)(2008-2#1)(2008-3#2)(2008-5#1)
which is closely associated with##2##5##(1995-1#1)(2008-8#1)
which is closely related to##2##5##(2008-10#1)(2008-4#1)
which is closely related##3##4##(1997-2#1)(2008-10#1)(2008-4#1)
which is closely##5##3##(1995-1#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-8#1)
which is commercially available##3##4##(2008-10#1)(2008-2#1)(2012-3#1)
which is commercially##4##3##(2008-10#1)(2008-2#1)(2010-4#1)(2012-3#1)
which is common in##5##4##(1993-12#1)(2007-2#1)(2010-2#1)(2012-12#1)(2013-8#1)
which is common to##4##4##(1991-5#1)(1991-9#1)(1997-4#1)(2013-7#1)
which is common##9##3##(1991-5#1)(1991-9#1)(1993-12#1)(1997-4#1)(2007-2#1)(2010-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
which is commonly used for##2##5##(1996-4#1)(2008-10#1)
which is commonly used##4##4##(1992-11#1)(1996-4#1)(2007-11#1)(2008-10#1)
which is commonly##9##3##(1992-11#1)(1996-4#1)(2006-6#1)(2007-11#1)(2008-10#2)(2012-3#2)(2013-8#1)
which is comparable to that##2##5##(1991-8#1)(2008-10#1)
which is comparable to##6##4##(1990-10#1)(1991-8#1)(2008-10#2)(2008-7#1)(2011-2#1)
which is comparable with the##3##5##(2008-2#1)(2008-5#1)(2010-3#1)
which is comparable##10##3##(1990-10#1)(1991-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#1)
which is compared##2##3##(2008-10#1)(2008-3#1)
which is compatible with a##2##5##(2006-7#1)(2008-2#1)
which is compatible with the##3##5##(1990-12#1)(1993-11#1)(2011-2#1)
which is compatible with##9##4##(1990-12#1)(1991-9#1)(1993-11#1)(1993-8#1)(2006-4#1)(2006-7#1)(2008-2#1)(2008-9#1)(2011-2#1)
which is complete##2##3##(1990-2#1)(2008-10#1)
which is completely##5##3##(1990-9#1)(1996-8#1)(1997-6#1)(2008-10#1)(2012-2#1)
which is composed of##6##4##(1990-8#1)(1991-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
which is confirmed by the##2##5##(1992-1#1)(2008-11#1)
which is confirmed by##3##4##(1992-1#1)(1995-7#1)(2008-11#1)
which is connected##2##3##(1992-11#1)(2007-11#1)
which is conserved among##2##4##(1991-4#1)(2008-10#1)
which is conserved in many##2##5##(1992-6#1)(2008-8#1)
which is conserved in##6##4##(1992-3#1)(1992-6#1)(1994-12#1)(1995-2#1)(1996-7#1)(2008-8#1)
which is conserved##12##3##(1990-11#1)(1991-4#1)(1992-3#2)(1992-6#2)(1994-12#1)(1995-11#1)(1995-2#1)(1996-7#1)(2008-10#1)(2008-8#1)
which is considerably##3##3##(1990-12#1)(2007-12#1)(2009-6#1)
which is considered a##3##4##(1992-12#1)(2010-5#1)(2012-1#1)
which is considered as a##2##5##(1995-1#1)(2010-1#1)
which is considered as##5##4##(1995-1#1)(1996-8#1)(2007-7#1)(2008-12#1)(2010-1#1)
which is considered to be##6##5##(1994-11#1)(1994-9#1)(2008-11#1)(2009-11#1)(2011-2#1)(2013-8#1)
which is considered to##8##4##(1994-11#1)(1994-9#1)(2008-11#1)(2009-11#1)(2011-2#2)(2012-2#1)(2013-8#1)
which is considered##18##3##(1992-12#1)(1994-11#1)(1994-9#1)(1995-1#1)(1996-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-11#1)(2010-1#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#1)
which is consistent with a##6##5##(1991-11#1)(1996-4#1)(2006-4#1)(2008-10#1)(2008-2#1)(2011-1#1)
which is consistent with some results of recent large clinical studies##2##11##(2013-1#2)
which is consistent with the observation that##2##7##(1994-8#1)(2008-10#1)
which is consistent with the##20##5##(1990-6#1)(1991-10#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-6#1)(1995-8#2)(1996-7#1)(1997-6#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#2)
which is consistent with##45##4##(1990-6#1)(1991-10#1)(1991-11#1)(1992-9#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-6#1)(1995-8#2)(1996-4#1)(1996-7#2)(1997-6#1)(2005-10#1)(2005-8#1)(2006-4#1)(2007-12#2)(2007-4#1)(2007-7#2)(2007-8#2)(2008-10#4)(2008-2#5)(2008-5#1)(2008-8#1)(2008-9#3)(2010-10#1)(2010-9#1)(2011-1#1)(2012-11#1)(2013-1#3)
which is consistent##47##3##(1990-6#1)(1991-10#1)(1991-11#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-6#1)(1995-8#2)(1996-4#1)(1996-7#2)(1997-6#1)(2005-10#1)(2005-8#1)(2006-4#1)(2007-12#2)(2007-4#1)(2007-7#2)(2007-8#2)(2008-10#4)(2008-2#5)(2008-5#1)(2008-8#1)(2008-9#3)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#3)
which is consumed##2##3##(1994-6#1)(2008-7#1)
which is continuous with the##2##5##(2008-10#1)(2008-5#1)
which is continuous##4##3##(2005-10#1)(2006-8#1)(2008-10#1)(2008-5#1)
which is controlled by##4##4##(2005-10#1)(2007-11#2)(2008-1#1)
which is converted##3##3##(1992-8#1)(2005-8#1)(2007-11#1)
which is correlated to the##2##5##(1992-12#1)(2008-7#1)
which is correlated with##2##4##(1992-9#1)(1994-6#1)
which is correlated##4##3##(1992-12#1)(1992-9#1)(1994-6#1)(2008-7#1)
which is coupled##4##3##(1990-8#1)(2005-11#1)(2008-11#1)(2008-2#1)
which is covalently##2##3##(1994-11#1)(2007-12#1)
which is critical for##11##4##(1992-12#1)(1995-5#1)(1995-6#1)(1996-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
which is critical##13##3##(1992-12#1)(1995-5#1)(1995-6#1)(1996-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-7#1)(2010-6#1)(2011-2#1)(2012-2#1)
which is crucial for##6##4##(2007-5#1)(2008-5#1)(2008-7#1)(2009-8#1)(2009-9#1)(2012-3#1)
which is crucial##7##3##(2007-5#1)(2007-7#1)(2008-5#1)(2008-7#1)(2009-8#1)(2009-9#1)(2012-3#1)
which is currently in##3##4##(2005-8#1)(2007-5#1)(2008-4#1)
which is currently the##3##4##(2008-10#1)(2011-2#2)
which is currently##17##3##(1991-12#1)(1996-1#1)(2005-8#1)(2006-12#1)(2006-2#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-2#4)(2012-12#1)
which is dangerous##2##3##(2007-11#1)(2008-11#1)
which is decreased linearly by addition of##2##7##(2008-10#2)
which is dedicated to billing purposes##2##6##(2013-1#2)
which is dedicated##3##3##(2008-1#1)(2013-1#2)
which is deficient in##3##4##(1994-9#1)(2005-8#1)(2012-3#1)
which is defined as the##6##5##(2007-12#1)(2008-10#2)(2008-3#2)(2008-9#1)
which is defined as##7##4##(1992-2#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-9#1)
which is defined##11##3##(1992-2#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-9#1)(2010-2#1)(2010-3#1)(2012-3#1)
which is delayed##2##3##(2006-10#1)(2008-4#1)
which is demonstrated##3##3##(2008-10#1)(2008-2#2)
which is dependent on the##3##5##(2005-11#1)(2008-8#1)(2010-5#1)
which is dependent on##6##4##(1990-11#1)(1995-7#1)(2005-11#1)(2008-10#1)(2008-8#1)(2010-5#1)
which is dependent##7##3##(1990-11#1)(1995-7#1)(2005-11#1)(2008-10#1)(2008-8#1)(2009-10#1)(2010-5#1)
which is derived from the##4##5##(1991-1#1)(1991-7#1)(2008-5#1)(2011-2#1)
which is derived from##5##4##(1991-1#1)(1991-7#1)(1994-3#1)(2008-5#1)(2011-2#1)
which is derived##7##3##(1991-1#1)(1991-7#1)(1994-3#1)(1997-5#1)(2008-5#1)(2011-2#1)(2013-1#1)
which is described by##2##4##(2007-11#1)(2007-12#1)
which is described in##3##4##(1997-6#1)(2008-4#1)(2013-1#1)
which is described##5##3##(1997-6#1)(2007-11#1)(2007-12#1)(2008-4#1)(2013-1#1)
which is designed to##5##4##(1995-1#1)(2008-7#2)(2010-2#1)(2013-1#1)
which is detected by##2##4##(2008-10#1)(2012-2#1)
which is detected in##2##4##(1990-11#1)(2008-9#1)
which is detected spectrophotometrically at##2##5##(2008-10#2)
which is detected##7##3##(1990-11#1)(2008-10#4)(2008-9#1)(2012-2#1)
which is determined##5##3##(2008-10#1)(2008-2#1)(2010-2#1)(2010-9#1)(2013-1#1)
which is developed##3##3##(2011-1#1)(2012-1#1)(2013-8#1)
which is developmentally regulated##2##4##(1994-11#1)(2006-10#1)
which is devoid of##2##4##(1992-6#1)(1996-9#1)
which is diagnosed##2##3##(2005-11#1)(2013-8#1)
which is diagnostic for##2##4##(1996-2#1)(2011-1#1)
which is different from the##5##5##(1991-1#1)(1992-6#1)(1994-8#1)(2008-8#2)
which is different from##9##4##(1991-1#1)(1992-6#1)(1993-8#1)(1994-8#1)(2006-10#1)(2008-10#1)(2008-7#1)(2008-8#2)
which is different##11##3##(1991-1#1)(1992-6#1)(1993-8#1)(1994-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2012-1#1)
which is difficult to##5##4##(1993-12#1)(1994-5#1)(2007-1#1)(2007-12#1)(2011-2#1)
which is difficult##6##3##(1993-12#1)(1994-5#1)(2007-1#1)(2007-12#1)(2008-6#1)(2011-2#1)
which is directed to##2##4##(1992-5#1)(2006-6#1)
which is directed##4##3##(1992-5#1)(1994-5#1)(2006-6#1)(2007-7#1)
which is directly related to the##3##6##(2005-11#1)(2007-11#1)(2009-10#1)
which is directly related to##5##5##(2005-11#1)(2007-11#1)(2007-4#1)(2009-10#1)(2009-5#1)
which is directly##8##3##(1993-3#1)(2005-11#1)(2007-11#1)(2007-4#1)(2008-10#1)(2009-10#1)(2009-5#1)(2009-8#1)
which is discussed in terms of##2##6##(1990-3#1)(2008-3#1)
which is discussed in##5##4##(1990-3#1)(2008-3#3)(2010-2#1)
which is discussed##7##3##(1990-3#1)(2006-12#1)(2008-3#3)(2009-8#1)(2010-2#1)
which is dissociated##2##3##(2009-3#1)(2010-7#1)
which is distinct from##6##4##(1990-2#1)(1990-3#1)(1992-3#1)(1994-3#1)(1996-5#1)(2008-8#1)
which is distributed##2##3##(2009-8#1)(2010-6#1)
which is dominated by##2##4##(2008-3#1)(2008-5#1)
which is dramatically different##2##4##(1995-11#1)(1997-2#1)
which is dramatically##4##3##(1995-11#1)(1997-2#1)(2008-10#1)(2010-10#1)
which is driven##3##3##(1991-1#1)(2008-10#1)(2008-5#1)
which is due to the##2##5##(2007-12#1)(2008-3#1)
which is due to##5##4##(2004-4#1)(2007-12#2)(2008-10#1)(2008-3#1)
which is easily##3##3##(1994-7#1)(1995-11#1)(2007-12#1)
which is easy##2##3##(2006-10#1)(2008-5#1)
which is effective but##2##4##(2011-1#2)
which is effective##6##3##(1994-10#1)(2006-2#1)(2006-9#1)(2008-3#1)(2011-1#2)
which is encoded by the##2##5##(2009-7#1)(2011-1#1)
which is encoded by##4##4##(1993-2#1)(1995-3#1)(2009-7#1)(2011-1#1)
which is encoded##5##3##(1993-2#1)(1995-3#1)(2009-7#1)(2011-1#2)
which is enhanced##2##3##(1997-1#1)(2008-10#1)
which is equal##2##3##(2005-4#1)(2008-10#1)
which is equivalent to##8##4##(1997-4#1)(1997-5#1)(2006-10#1)(2008-10#3)(2012-3#1)(2013-7#1)
which is equivalent##9##3##(1997-4#1)(1997-5#1)(2006-10#1)(2008-10#3)(2008-11#1)(2012-3#1)(2013-7#1)
which is especially##6##3##(2005-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-2#1)
which is essential for the function##2##6##(2008-11#1)(2009-9#1)
which is essential for the##6##5##(1996-4#1)(2007-7#1)(2008-11#2)(2009-4#1)(2009-9#1)
which is essential for##24##4##(1990-8#1)(1991-5#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-4#1)(1997-6#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-9#1)(2009-10#2)(2009-4#1)(2009-9#1)(2010-12#1)(2012-2#1)(2012-3#1)
which is essential in##2##4##(2006-6#1)(2008-11#1)
which is essential to##3##4##(2008-2#1)(2008-5#1)(2013-1#1)
which is essential##30##3##(1990-8#1)(1991-5#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-4#1)(1997-6#1)(2006-6#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#2)(2009-4#1)(2009-9#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
which is essentially##4##3##(1991-5#1)(1993-5#1)(1994-12#1)(2009-10#1)
which is estimated##2##3##(2007-12#1)(2012-1#1)
which is even more##2##4##(1995-11#1)(2006-6#1)
which is evidence of##3##4##(2008-10#1)(2012-12#1)(2012-3#1)
which is evident##2##3##(1996-9#1)(2010-11#1)
which is evolutionarily##3##3##(1995-6#1)(2007-12#1)(2012-3#1)
which is expected to be##2##5##(2006-4#1)(2010-6#1)
which is expected to##4##4##(2006-4#1)(2007-5#1)(2008-10#1)(2010-6#1)
which is expected##5##3##(2006-4#1)(2007-12#1)(2007-5#1)(2008-10#1)(2010-6#1)
which is explored in this##2##5##(2007-8#1)(2008-12#1)
which is exposed##2##3##(1997-6#1)(1997-8#1)
which is expressed at##2##4##(1992-2#1)(1995-3#1)
which is expressed in##7##4##(1991-5#1)(1994-8#1)(1995-2#1)(2008-1#1)(2008-8#1)(2009-3#1)(2010-11#1)
which is expressed##14##3##(1991-5#1)(1991-7#1)(1992-2#1)(1993-12#1)(1994-8#1)(1995-2#1)(1995-3#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-11#1)
which is extremely##3##3##(2007-12#1)(2008-12#1)(2010-5#1)
which is facilitated by##2##4##(1990-2#1)(2008-11#1)
which is far##6##3##(1991-2#1)(2007-10#1)(2007-11#1)(2008-2#1)(2010-8#1)(2012-11#1)
which is fatal##2##3##(2008-9#1)(2013-1#1)
which is followed by a##2##5##(1996-11#1)(2011-1#1)
which is followed by##5##4##(1990-6#1)(1996-11#1)(2006-4#1)(2011-1#1)(2012-3#1)
which is formed by rotation of the beam-splitter grating around##2##10##(2008-3#2)
which is formed by##5##4##(1994-2#1)(2007-12#1)(2008-3#3)
which is formed##7##3##(1990-7#1)(1994-2#1)(2007-12#1)(2007-8#1)(2008-3#3)
which is found in a##2##5##(1993-9#1)(1994-8#1)
which is found in many##2##5##(2006-10#1)(2011-1#1)
which is found in the##5##5##(1990-7#1)(1990-8#1)(1995-2#1)(1995-3#1)(2010-8#1)
which is found in##13##4##(1990-11#1)(1990-7#2)(1990-8#1)(1992-6#1)(1993-9#1)(1994-8#1)(1995-2#1)(1995-3#1)(2006-10#1)(2008-7#1)(2010-8#1)(2011-1#1)
which is found to be##3##5##(2007-12#2)(2009-2#1)
which is found##19##3##(1990-11#1)(1990-7#2)(1990-8#1)(1992-6#1)(1993-6#1)(1993-9#1)(1994-8#1)(1995-2#1)(1995-3#1)(2006-10#1)(2007-12#2)(2008-7#1)(2009-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-2#1)
which is frequently##3##3##(2008-10#2)(2011-1#1)
which is fully##3##3##(1991-9#1)(1993-4#1)(2008-11#1)
which is functional##2##3##(1991-8#1)(1993-3#1)
which is further##4##3##(1993-12#1)(2008-10#1)(2012-1#2)
which is generally##5##3##(2006-3#1)(2008-10#1)(2008-7#1)(2011-1#1)(2013-1#1)
which is generated by##3##4##(2007-11#1)(2007-12#1)(2008-8#1)
which is generated through##2##4##(2008-11#1)(2012-12#1)
which is generated##6##3##(2007-11#1)(2007-12#1)(2008-11#1)(2008-8#1)(2011-1#1)(2012-12#1)
which is given##4##3##(1997-8#1)(2006-5#1)(2007-11#1)(2012-2#1)
which is governed by the##2##5##(1991-2#1)(2008-10#1)
which is greater than##2##4##(2007-10#1)(2011-1#1)
which is hardly##3##3##(1993-11#1)(1996-4#1)(2006-10#1)
which is here##2##3##(2007-10#1)(2008-10#1)
which is high##3##3##(1991-12#1)(2007-12#1)(2013-7#1)
which is higher for##2##4##(2005-11#1)(2007-8#1)
which is higher than##4##4##(2007-7#1)(2008-10#1)(2009-4#1)(2013-8#1)
which is higher##7##3##(1993-11#1)(2005-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2009-4#1)(2013-8#1)
which is highly conserved among##2##5##(1990-8#1)(1993-11#1)
which is highly conserved in##3##5##(1992-3#1)(1994-12#1)(1997-4#1)
which is highly conserved##8##4##(1990-8#1)(1992-3#1)(1993-11#1)(1994-12#3)(1997-4#1)(2008-9#1)
which is highly expressed##2##4##(1995-8#1)(2007-11#1)
which is highly selective##2##4##(2008-10#2)
which is highly sensitive##2##4##(2008-11#1)(2008-7#1)
which is highly##25##3##(1990-10#1)(1990-8#1)(1992-3#1)(1993-11#1)(1993-6#1)(1994-12#3)(1995-8#2)(1997-3#1)(1997-4#1)(2005-11#1)(2007-11#2)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#2)
which is homologous to the##2##5##(1991-8#1)(2006-8#1)
which is homologous to##5##4##(1991-8#1)(1993-4#1)(1997-1#1)(2006-8#1)(2008-11#1)
which is homologous##6##3##(1991-5#1)(1991-8#1)(1993-4#1)(1997-1#1)(2006-8#1)(2008-11#1)
which is however##2##3##(2008-12#2)
which is identical to that of##2##6##(1990-12#1)(2009-9#1)
which is identical to that##3##5##(1990-12#1)(1996-5#1)(2009-9#1)
which is identical to##7##4##(1990-12#1)(1991-5#1)(1991-8#1)(1992-4#1)(1995-12#1)(1996-5#1)(2009-9#1)
which is identical with##2##4##(1993-6#1)(2008-8#1)
which is identical##11##3##(1990-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-4#1)(1993-6#1)(1995-12#1)(1996-5#1)(2007-11#1)(2008-8#1)(2009-9#1)
which is identified##2##3##(1996-5#1)(2010-7#1)
which is immunologically##2##3##(1990-12#1)(1992-11#1)
which is implemented##2##3##(2008-10#1)(2008-3#1)
which is implicated in##2##4##(1994-12#2)
which is important for##11##4##(1992-12#1)(1994-9#1)(2006-11#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-9#1)(2013-1#1)(2013-7#1)
which is important in##2##4##(2005-10#1)(2007-9#1)
which is important to##2##4##(2008-2#1)(2008-5#1)
which is important##15##3##(1992-12#1)(1994-9#1)(2005-10#1)(2006-11#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-9#1)(2009-9#1)(2013-1#1)(2013-7#1)
which is improved##2##3##(2008-5#1)(2012-2#1)
which is in accordance with the##2##6##(1992-2#1)(1997-4#1)
which is in agreement with that##2##6##(2008-10#2)
which is in agreement with the##5##6##(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)
which is in agreement with##11##5##(1990-12#1)(1994-6#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-1#1)
which is in contrast to the##5##6##(1997-7#1)(2006-10#1)(2008-10#1)(2008-11#1)(2010-12#1)
which is in contrast to##9##5##(1994-3#1)(1997-7#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-4#1)(2010-12#1)
which is in contrast with the##2##6##(1993-3#1)(2008-10#1)
which is in contrast with##3##5##(1993-3#1)(1996-8#1)(2008-10#1)
which is in contrast##12##4##(1993-3#1)(1994-3#1)(1996-8#1)(1997-7#1)(2006-10#1)(2008-10#4)(2008-11#1)(2008-4#1)(2010-12#1)
which is in development##2##4##(2008-1#1)(2008-7#1)
which is in good agreement with the value##2##8##(2008-10#1)(2009-12#1)
which is in good agreement with the##6##7##(1993-9#1)(2007-12#1)(2008-10#2)(2009-12#1)(2013-8#1)
which is in good agreement with##7##6##(1993-9#1)(2007-12#1)(2008-10#2)(2008-3#1)(2009-12#1)(2013-8#1)
which is in phase III clinical trials for the treatment of##2##11##(2005-8#1)(2005-9#1)
which is in phase##3##4##(2005-8#2)(2005-9#1)
which is in the##5##4##(1990-12#1)(1996-5#1)(2006-5#1)(2009-6#1)(2013-1#1)
which is in turn##4##4##(1990-8#1)(1992-11#1)(2006-10#1)(2008-10#1)
which is in##64##3##(1990-12#2)(1990-8#1)(1992-11#1)(1992-2#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-4#2)(1997-7#1)(2005-8#2)(2005-9#1)(2006-10#2)(2006-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
which is included in a##2##5##(2008-11#1)(2008-5#1)
which is inconsistent with the##2##5##(2008-12#1)(2010-8#1)
which is inconsistent with##3##4##(2008-12#1)(2008-3#1)(2010-8#1)
which is increased##2##3##(1990-5#1)(1991-9#1)
which is increasing##3##3##(1993-11#1)(1995-12#1)(2007-8#1)
which is increasingly##2##3##(1991-3#1)(2010-7#1)
which is independent of protein##2##5##(1993-3#1)(1993-6#1)
which is independent of##6##4##(1990-11#1)(1992-9#1)(1993-3#1)(1993-6#1)(1995-3#1)(1995-7#1)
which is independent##8##3##(1990-11#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-7#1)(1995-3#1)(1995-7#1)(2007-1#1)
which is indicative of an##3##5##(1991-5#1)(2005-11#1)(2009-9#1)
which is indicative of##6##4##(1991-5#1)(2005-11#1)(2005-7#1)(2007-12#1)(2008-5#1)(2009-9#1)
which is indispensable for##3##4##(1997-3#1)(2008-11#1)(2008-8#1)
which is indispensable##4##3##(1997-3#1)(2008-11#1)(2008-4#1)(2008-8#1)
which is indistinguishable##2##3##(1997-4#1)(2007-11#1)
which is induced by##7##4##(1993-4#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-12#1)(2011-2#1)
which is induced##9##3##(1991-7#1)(1993-4#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-8#1)(2010-12#1)(2011-2#1)
which is inevitable##2##3##(2008-2#1)(2011-2#1)
which is influenced by the##3##5##(1995-4#1)(2007-8#1)(2008-5#1)
which is influenced by##5##4##(1991-2#1)(1995-4#1)(2007-8#1)(2008-5#1)(2009-8#1)
which is influenced##6##3##(1991-2#1)(1995-4#1)(2007-8#1)(2008-2#1)(2008-5#1)(2009-8#1)
which is inhibited by##5##4##(1990-9#1)(1991-12#1)(1991-2#1)(1994-8#1)(1997-1#1)
which is inhibited##6##3##(1990-9#1)(1991-12#1)(1991-2#1)(1994-8#1)(1995-10#1)(1997-1#1)
which is innervated by##2##4##(1996-9#1)(2007-12#1)
which is insensitive to##2##4##(2008-10#1)(2008-3#1)
which is inserted##2##3##(1994-8#1)(2010-11#1)
which is intermediate between##2##4##(1991-7#1)(1993-3#1)
which is intrinsically##2##3##(1993-2#1)(2008-3#1)
which is introduced##5##3##(2007-10#1)(2008-10#3)(2008-3#1)
which is investigated##2##3##(2005-10#1)(2006-6#1)
which is involved in the regulation of##2##7##(1991-5#1)(2008-8#1)
which is involved in the##10##5##(1990-8#1)(1991-5#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-3#1)(2007-11#1)(2008-5#1)(2008-8#1)(2010-11#1)
which is involved in##29##4##(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-5#1)(1991-7#1)(1993-3#1)(1994-12#1)(1994-8#2)(1995-2#2)(1995-3#1)(1995-8#1)(1996-3#1)(1996-4#1)(1997-1#1)(2006-11#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2013-8#1)
which is just##2##3##(1991-4#1)(1995-8#1)
which is known as##5##4##(1991-3#1)(1991-8#1)(1997-1#1)(2007-12#1)(2010-8#1)
which is known to be a##2##6##(1994-11#1)(2008-11#1)
which is known to be involved in##2##7##(1996-9#1)(2008-4#1)
which is known to be present##2##6##(1990-8#1)(2005-5#1)
which is known to be##16##5##(1990-8#1)(1992-3#1)(1994-10#1)(1994-11#2)(1994-9#1)(1995-8#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-7#2)(2005-5#1)(2008-11#1)(2008-3#1)(2008-4#1)
which is known to enhance##2##5##(1992-3#1)(2008-11#1)
which is known to have been##2##6##(2011-2#1)(2012-2#1)
which is known to induce##3##5##(1990-2#1)(2006-5#1)(2008-10#1)
which is known to inhibit##2##5##(1992-6#1)(1994-3#1)
which is known to##42##4##(1990-2#1)(1990-8#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-6#1)(1993-12#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-3#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(2005-5#1)(2006-12#1)(2006-5#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-2#1)(2010-3#1)(2011-2#1)(2012-2#2)(2013-1#2)
which is known##51##3##(1990-2#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-6#1)(1993-12#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-3#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(2005-5#1)(2006-12#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2009-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)
which is largely##5##3##(2008-11#1)(2008-4#1)(2008-8#1)(2010-8#1)(2013-1#1)
which is larger than##2##4##(2008-2#1)(2008-3#1)
which is less##2##3##(1992-10#1)(2008-2#1)
which is likely to be##7##5##(1990-10#1)(1991-7#1)(1992-12#1)(2005-10#1)(2006-8#1)(2007-12#1)(2008-7#1)
which is likely to##14##4##(1990-10#1)(1991-2#1)(1991-7#1)(1992-12#1)(1997-6#1)(2005-10#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-7#1)(2009-3#1)(2009-6#1)(2010-12#1)
which is likely##15##3##(1990-10#1)(1990-12#1)(1991-2#1)(1991-7#1)(1992-12#1)(1997-6#1)(2005-10#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-7#1)(2009-3#1)(2009-6#1)(2010-12#1)
which is limited##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
which is linear##2##3##(2005-10#1)(2007-11#1)
which is linked to the##2##5##(1994-12#1)(2008-5#1)
which is linked to##6##4##(1992-9#1)(1993-10#1)(1994-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
which is linked##7##3##(1992-9#1)(1993-10#1)(1994-12#1)(2005-8#1)(2008-10#1)(2008-3#1)(2008-5#1)
which is located at##2##4##(1995-12#1)(1995-6#1)
which is located in the##7##5##(1992-11#1)(1993-5#1)(1996-2#1)(1997-6#1)(2007-12#1)(2008-9#1)(2013-8#1)
which is located in##9##4##(1992-11#1)(1993-5#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-6#1)(2007-12#1)(2008-9#1)(2013-8#1)
which is located on chromosome##2##5##(2008-1#1)(2008-8#1)
which is located on##3##4##(1991-6#1)(2008-1#1)(2008-8#1)
which is located##20##3##(1991-6#1)(1992-11#1)(1993-5#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-6#1)(2007-12#2)(2008-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#2)(2013-8#1)
which is low##2##3##(1990-1#1)(2012-3#1)
which is lower than the##2##5##(1991-9#2)
which is lower than##5##4##(1991-9#2)(2006-10#1)(2007-2#1)(2007-7#1)
which is made##2##3##(2008-1#1)(2008-11#1)
which is mainly due to the##2##6##(2009-10#1)(2009-7#1)
which is mainly due to##3##5##(2007-8#1)(2009-10#1)(2009-7#1)
which is mainly expressed##2##4##(1997-2#1)(2006-10#1)
which is mainly##10##3##(1991-2#1)(1997-2#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-8#1)(2008-11#1)(2009-10#1)(2009-7#1)
which is manifested##2##3##(2005-1#1)(2011-2#1)
which is many times a critical concern of data custodians##2##10##(2013-1#2)
which is meant##3##3##(1995-11#1)(2008-2#1)(2009-6#1)
which is measured at##2##4##(2008-10#2)
which is measured##8##3##(1990-2#1)(2008-10#6)(2011-1#1)
which is mediated by an increase in##2##7##(1993-3#1)(2009-8#1)
which is mediated by the##2##5##(2005-7#1)(2007-12#1)
which is mediated by##15##4##(1993-11#1)(1993-3#1)(1995-7#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(2005-7#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-8#1)(2012-12#1)(2012-3#1)
which is mediated##16##3##(1993-11#1)(1993-3#1)(1994-12#1)(1995-7#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(2005-7#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-8#1)(2012-12#1)(2012-3#1)
which is modified##2##3##(1990-7#1)(1995-6#1)
which is monitored at##2##4##(2008-10#2)
which is monitored##3##3##(2008-10#3)
which is more in keeping with the##2##7##(1997-8#1)(2009-8#1)
which is more likely##2##4##(1990-3#1)(2005-11#1)
which is more sensitive than##2##5##(1991-8#1)(1996-5#1)
which is more sensitive##3##4##(1991-8#1)(1992-8#1)(1996-5#1)
which is more than##4##4##(2007-12#2)(2007-8#1)(2007-9#1)
which is more##22##3##(1990-3#1)(1990-7#1)(1991-2#1)(1991-8#1)(1992-6#1)(1992-8#1)(1993-7#1)(1995-5#1)(1996-5#1)(1997-8#1)(2005-11#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2009-6#1)(2009-8#1)(2010-7#1)(2013-1#1)
which is most widely used##2##5##(2008-1#1)(2008-11#1)
which is most##10##3##(1991-5#1)(1992-11#1)(1992-2#1)(1994-12#1)(1995-5#1)(2007-10#1)(2008-1#1)(2008-11#1)(2009-10#1)(2012-2#1)
which is mostly##2##3##(2008-10#1)(2012-12#1)
which is much cheaper##2##4##(2007-2#1)(2008-4#1)
which is much higher than the##2##6##(2007-9#1)(2008-3#1)
which is much higher than##3##5##(2007-9#1)(2008-3#1)(2012-12#1)
which is much less##4##4##(1990-9#1)(2006-2#1)(2008-7#1)(2011-2#1)
which is much lower than##2##5##(2008-10#1)(2012-1#1)
which is much lower##3##4##(2005-3#1)(2008-10#1)(2012-1#1)
which is much##17##3##(1990-9#1)(2005-3#1)(2006-2#1)(2007-2#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
which is mutated in##2##4##(1992-4#1)(2010-7#1)
which is necessary for##7##4##(1990-11#1)(1997-7#1)(2007-11#1)(2008-3#2)(2008-4#1)(2010-7#1)
which is necessary to initiate##2##5##(1990-3#1)(2008-2#1)
which is necessary to##3##4##(1990-3#1)(1995-2#1)(2008-2#1)
which is necessary##13##3##(1990-11#1)(1990-3#1)(1995-2#1)(1997-7#1)(2007-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-7#1)(2010-7#1)
which is needed to##3##4##(1997-1#1)(2004-9#1)(2008-3#1)
which is needed##4##3##(1997-1#1)(2004-9#1)(2008-2#1)(2008-3#1)
which is negatively##2##3##(1990-11#1)(2009-8#1)
which is neither##2##3##(1993-3#1)(1997-4#1)
which is no longer##2##4##(1990-5#1)(1992-9#1)
which is normally##6##3##(1993-12#1)(1994-11#1)(1996-4#1)(2008-10#1)(2008-5#2)
which is not a##3##4##(1995-2#1)(2011-1#1)(2013-1#1)
which is not affected##2##4##(1990-2#1)(1997-1#1)
which is not always##3##4##(1992-3#1)(2008-11#1)(2009-5#1)
which is not amenable to##2##5##(2008-10#1)(2010-12#1)
which is not an##3##4##(1992-3#1)(2008-3#2)
which is not easily##2##4##(2008-10#1)(2008-6#1)
which is not found in##4##5##(1994-12#1)(1997-1#1)(2008-7#1)(2008-8#1)
which is not identical##2##4##(1990-5#1)(1995-5#1)
which is not only##3##4##(1990-11#1)(2008-1#1)(2013-7#1)
which is not phosphorylated##2##4##(1991-10#1)(1992-4#1)
which is not possible##4##4##(2007-12#1)(2008-10#1)(2008-2#1)(2011-2#1)
which is not sensitive to##2##5##(1991-6#1)(2007-11#1)
which is not the case##2##5##(1995-3#1)(2008-11#1)
which is not the##3##4##(1995-3#1)(2008-11#1)(2008-3#1)
which is not##85##3##(1990-11#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-2#1)(1992-3#2)(1992-4#3)(1992-9#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-2#2)(1995-3#1)(1995-5#2)(1996-11#1)(1996-6#1)(1997-1#2)(1997-6#1)(1997-8#1)(2003-11#1)(2004-2#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#5)(2008-6#1)(2008-7#3)(2008-8#2)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
which is notoriously##2##3##(2012-2#1)(2013-1#1)
which is now available##2##4##(1991-3#1)(2007-11#1)
which is now##11##3##(1991-3#1)(1992-1#1)(1994-4#1)(1994-5#1)(1997-8#1)(2005-7#1)(2007-11#2)(2008-12#1)(2008-5#1)(2008-7#1)
which is obtained by##2##4##(2006-10#1)(2007-11#1)
which is obtained##4##3##(2006-10#1)(2007-11#1)(2007-9#1)(2008-3#1)
which is obviously##2##3##(2008-10#1)(2013-1#1)
which is occupied by##2##4##(1996-2#1)(2010-12#1)
which is of great##2##4##(2008-2#1)(2012-2#1)
which is of utmost importance##2##5##(2008-2#1)(2012-2#1)
which is of##15##3##(1994-8#1)(1996-8#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-2#2)
which is often a##2##4##(2008-11#1)(2013-8#1)
which is often associated with serious complications##2##7##(2013-1#2)
which is often associated with##3##5##(2004-12#1)(2013-1#2)
which is often more##2##4##(1995-11#1)(2008-9#1)
which is often##28##3##(1991-12#1)(1994-3#1)(1994-7#1)(1995-11#1)(2004-12#1)(2005-10#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-3#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
which is on the##3##4##(2007-10#1)(2013-1#2)
which is one of the main##2##6##(1992-12#1)(2003-11#1)
which is one of the most common##3##7##(2008-4#1)(2012-12#1)(2013-1#1)
which is one of the most##8##6##(2008-10#3)(2008-4#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
which is one of the##25##5##(1990-7#1)(1992-12#1)(1994-2#1)(1996-6#2)(2003-11#1)(2006-12#1)(2007-3#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
which is one of##27##4##(1990-7#1)(1992-12#1)(1994-2#1)(1996-6#2)(2003-11#1)(2006-12#1)(2007-3#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#2)
which is one##31##3##(1990-7#1)(1992-12#1)(1994-2#1)(1994-3#2)(1996-6#2)(2003-11#1)(2006-12#1)(2007-3#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#2)
which is only partially##2##4##(1996-10#1)(2008-4#1)
which is only##8##3##(1996-10#1)(1996-12#1)(1996-2#1)(1996-6#1)(2006-4#1)(2008-2#1)(2008-4#1)(2009-2#1)
which is part of the##4##5##(1990-12#1)(1991-12#1)(2008-11#1)(2011-2#1)
which is part of##6##4##(1990-12#1)(1991-12#1)(1997-7#1)(2007-2#1)(2008-11#1)(2011-2#1)
which is partially##2##3##(1994-9#1)(1997-1#1)
which is particularly useful for##2##5##(1994-6#1)(2012-11#1)
which is particularly useful##3##4##(1994-6#1)(2008-4#1)(2012-11#1)
which is particularly##9##3##(1992-12#1)(1994-6#1)(1995-9#1)(1996-2#1)(2005-9#1)(2008-2#1)(2008-4#1)(2008-7#1)(2012-11#1)
which is partly##2##3##(2007-11#1)(2008-11#1)
which is performed##2##3##(1993-10#1)(2006-6#1)
which is phenotypically##2##3##(1990-10#1)(1996-6#1)
which is phosphorylated##3##3##(1992-3#1)(1994-12#1)(2008-8#1)
which is pivotal in##2##4##(2008-1#1)(2009-2#1)
which is pivotal##3##3##(2008-1#2)(2009-2#1)
which is placed in##2##4##(1996-2#1)(2007-12#1)
which is placed##4##3##(1996-2#1)(2007-12#1)(2008-10#1)(2008-2#1)
which is poorly##2##3##(2008-10#1)(2010-12#1)
which is possible##3##3##(2007-11#1)(2007-12#1)(2008-11#1)
which is postulated##2##3##(2006-11#1)(2008-5#1)
which is predicted to result in##2##6##(1997-4#1)(2006-12#1)
which is predicted to##5##4##(1994-12#1)(1995-6#1)(1997-4#1)(2006-12#1)(2013-1#1)
which is preferentially##3##3##(1994-6#1)(1997-2#1)(2006-8#1)
which is present in all##3##5##(1991-10#1)(1991-2#1)(1995-2#1)
which is present in human##2##5##(1993-11#1)(2007-11#1)
which is present in the##3##5##(1993-6#1)(2008-10#1)(2008-6#1)
which is present in##18##4##(1990-2#1)(1991-10#1)(1991-2#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-9#1)(1995-2#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-10#3)(2008-6#1)(2013-1#1)
which is present##20##3##(1990-11#1)(1990-2#1)(1991-10#1)(1991-2#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-9#1)(1995-2#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-10#3)(2008-6#1)(2009-6#1)(2013-1#1)
which is presumably the##3##4##(1992-11#1)(1992-12#1)(1995-12#1)
which is presumably##5##3##(1992-11#1)(1992-12#1)(1994-3#1)(1995-12#1)(2012-3#1)
which is presumed to be##2##5##(1991-3#1)(1991-8#1)
which is presumed to##4##4##(1991-12#1)(1991-3#1)(1991-8#1)(1992-12#1)
which is prevented by##2##4##(1990-11#1)(1994-5#1)
which is primarily##3##3##(1994-8#1)(2008-3#1)(2008-4#1)
which is probably related to##4##5##(1996-2#1)(2007-12#1)(2010-2#1)(2011-1#1)
which is probably the##2##4##(2008-5#1)(2012-3#1)
which is probably##9##3##(1993-3#1)(1996-2#1)(2006-10#1)(2007-12#1)(2008-5#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-3#1)
which is processed##2##3##(1991-9#1)(1992-12#1)
which is produced by the##2##5##(2008-2#1)(2009-12#1)
which is produced by##5##4##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-12#1)
which is produced##10##3##(1995-11#1)(1995-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-12#1)
which is proportional to the##2##5##(2007-12#1)(2008-3#1)
which is proportional to##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
which is proportional##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
which is proposed to be##2##5##(2008-5#1)(2011-2#1)
which is quite##3##3##(2007-12#1)(2008-3#1)(2008-8#1)
which is rapid##2##3##(1996-5#1)(1997-8#1)
which is rapidly degraded##2##4##(2006-6#1)(2008-1#1)
which is rapidly##8##3##(1992-5#1)(1993-3#1)(1994-11#1)(2006-6#1)(2008-1#1)(2008-5#1)(2008-8#1)(2013-8#1)
which is rarely##2##3##(1990-6#1)(1991-4#1)
which is readily##3##3##(1991-5#1)(1995-2#2)
which is recognized as##2##4##(2008-6#1)(2009-3#1)
which is recommended##2##3##(1991-9#1)(2009-6#1)
which is reduced by##3##4##(1996-11#1)(1997-2#1)(2013-8#1)
which is reduced##4##3##(1996-11#1)(1997-2#1)(2008-10#1)(2013-8#1)
which is referred to as##2##5##(2007-12#1)(2012-12#1)
which is reflected from the##2##5##(2008-3#2)
which is reflected in##4##4##(1995-12#1)(1996-12#1)(2009-11#1)(2012-11#1)
which is reflected##7##3##(1990-5#1)(1995-12#1)(1996-12#1)(2008-3#2)(2009-11#1)(2012-11#1)
which is refractory to##2##4##(2009-2#1)(2012-3#1)
which is regulated by the##2##5##(1990-12#1)(2006-1#1)
which is regulated by##6##4##(1990-12#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-12#1)(2006-1#1)
which is regulated##8##3##(1990-12#1)(1990-5#1)(1992-9#1)(1993-12#1)(1993-3#2)(1994-12#1)(2006-1#1)
which is related to the##10##5##(2005-11#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-6#2)(2008-8#1)
which is related to##12##4##(1990-12#1)(1995-11#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-6#2)(2008-8#1)
which is related##13##3##(1990-12#1)(1994-2#1)(1995-11#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-6#2)(2008-8#1)
which is relatively##9##3##(1992-4#1)(1994-2#1)(1996-5#1)(1997-2#1)(2004-9#1)(2005-11#1)(2007-8#2)(2008-10#1)
which is relevant for##3##4##(2006-12#1)(2008-3#1)(2010-12#1)
which is relevant##4##3##(2006-12#1)(2008-3#1)(2010-12#1)(2011-2#1)
which is remarkably##2##3##(1990-10#1)(2008-9#1)
which is reported##3##3##(1991-8#1)(1995-6#1)(2008-11#1)
which is represented by##4##4##(1990-12#1)(1997-6#1)(1997-8#1)(2005-11#1)
which is required for its##2##5##(1991-10#1)(2013-8#1)
which is required for the##5##5##(1996-8#1)(2005-8#1)(2008-10#1)(2008-2#1)(2009-10#1)
which is required for##14##4##(1991-10#1)(1992-1#1)(1992-3#1)(1994-3#1)(1996-2#1)(1996-8#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-2#1)(2009-10#1)(2009-3#1)(2009-6#1)(2013-8#1)
which is required##15##3##(1991-10#1)(1992-1#1)(1992-3#1)(1994-3#1)(1996-2#1)(1996-8#1)(2005-3#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-2#1)(2009-10#1)(2009-3#1)(2009-6#1)(2013-8#1)
which is resistant to##2##4##(2008-10#1)(2011-2#1)
which is responsible for a##2##5##(1996-2#1)(1997-1#1)
which is responsible for the##10##5##(1990-4#1)(1990-9#1)(1993-9#1)(1996-2#1)(1996-4#1)(2007-12#1)(2007-8#1)(2008-10#1)(2009-8#1)(2010-5#1)
which is responsible for##18##4##(1990-4#1)(1990-9#1)(1993-9#1)(1994-2#1)(1994-8#1)(1996-2#2)(1996-4#1)(1997-1#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-5#2)
which is responsible##19##3##(1990-4#1)(1990-9#1)(1993-9#1)(1994-2#1)(1994-8#1)(1996-2#2)(1996-4#1)(1997-1#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-5#2)
which is restricted##3##3##(1990-3#1)(2008-5#1)(2011-1#1)
which is reversible##2##3##(1994-8#1)(1996-9#1)
which is rich in##2##4##(1991-5#1)(2008-3#1)
which is safe##2##3##(2007-12#1)(2012-3#1)
which is scaled##2##3##(2008-10#1)(2008-8#1)
which is secondary to##2##4##(2007-10#1)(2008-7#1)
which is secreted by##2##4##(1997-4#1)(2007-1#1)
which is secreted##7##3##(1991-2#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-1#1)(2007-8#1)(2008-8#1)
which is seen in##2##4##(2009-5#1)(2013-8#1)
which is seen##4##3##(1991-5#1)(2009-5#1)(2009-9#1)(2013-8#1)
which is sensitive to both##2##5##(1990-4#1)(1992-1#1)
which is sensitive to##8##4##(1990-4#1)(1992-1#2)(1995-10#1)(1996-8#1)(2007-7#1)(2008-10#1)(2008-12#1)
which is sensitive##10##3##(1990-4#1)(1992-1#2)(1995-10#1)(1996-8#1)(2007-7#1)(2008-10#3)(2008-12#1)
which is shifted##2##3##(1990-3#1)(2008-10#1)
which is shown to be##6##5##(1990-6#1)(1994-3#1)(2006-7#1)(2008-2#1)(2010-2#1)(2011-2#1)
which is shown to##9##4##(1990-6#1)(1994-3#1)(1997-7#1)(2006-7#1)(2008-10#1)(2008-2#2)(2010-2#1)(2011-2#1)
which is shown##10##3##(1990-6#1)(1994-3#1)(1997-2#1)(1997-7#1)(2006-7#1)(2008-10#1)(2008-2#2)(2010-2#1)(2011-2#1)
which is significantly different##2##4##(1993-8#1)(2008-3#1)
which is significantly lower##2##4##(1991-3#1)(2009-4#1)
which is significantly##10##3##(1991-3#1)(1993-8#1)(1995-2#1)(1996-9#1)(2006-11#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-4#1)
which is similar to a##2##5##(2008-10#1)(2008-5#1)
which is similar to that found##2##6##(1995-8#1)(2008-5#1)
which is similar to that of the##2##7##(1991-9#1)(1997-2#1)
which is similar to that of##4##6##(1991-9#1)(1992-11#1)(1995-3#1)(1997-2#1)
which is similar to that##8##5##(1991-2#1)(1991-9#1)(1992-11#1)(1995-3#1)(1995-8#1)(1997-2#1)(1997-4#1)(2008-5#1)
which is similar to the##8##5##(1992-3#1)(1995-11#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-5#1)(2012-3#1)
which is similar to##21##4##(1991-2#1)(1991-9#1)(1992-11#1)(1992-3#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#2)(2008-5#3)(2012-3#1)
which is simple and##2##4##(2007-12#1)(2011-2#1)
which is simple##3##3##(2007-12#1)(2008-2#1)(2011-2#1)
which is situated##2##3##(1996-7#1)(2012-3#1)
which is slightly##3##3##(1993-6#1)(1996-9#1)(2007-12#1)
which is small enough##2##4##(2007-11#1)(2008-10#1)
which is small##3##3##(2007-11#2)(2008-10#1)
which is smaller than##2##4##(1990-3#1)(1995-6#1)
which is specific for##3##4##(1990-5#1)(2009-2#1)(2013-8#1)
which is specifically##3##3##(1993-12#1)(1995-3#1)(2009-9#1)
which is stabilized by##2##4##(2005-11#1)(2011-2#1)
which is stable in##2##4##(1991-5#1)(2007-12#1)
which is stable##3##3##(1991-5#1)(2007-12#1)(2008-10#1)
which is still##5##3##(1994-5#1)(2006-10#1)(2008-10#1)(2008-2#1)(2009-3#1)
which is strongly associated with##3##5##(1997-8#1)(2011-2#1)(2011-7#1)
which is strongly##9##3##(1991-8#1)(1995-4#1)(1997-8#1)(2004-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)(2011-7#1)
which is structurally related to##2##5##(1990-11#1)(2008-11#1)
which is structured##2##3##(2008-2#1)(2012-3#1)
which is subsequently##11##3##(1990-2#1)(1991-2#1)(1992-11#1)(1993-9#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-8#2)
which is substituted##2##3##(1994-9#1)(1995-11#1)
which is sufficient to##2##4##(1990-6#1)(1995-1#1)
which is sufficient##3##3##(1990-6#1)(1995-1#1)(1995-2#1)
which is suggested to##3##4##(1994-9#1)(2008-10#1)(2013-1#1)
which is suggestive of a##2##5##(1995-12#1)(2012-12#1)
which is suggestive of##4##4##(1995-12#1)(1995-2#1)(2010-10#1)(2012-12#1)
which is suitable for the##2##5##(1996-2#1)(2008-10#1)
which is suitable for##6##4##(1996-2#1)(2007-11#1)(2008-10#2)(2008-4#1)(2010-12#1)
which is supported by##3##4##(1992-3#1)(1997-2#1)(1997-5#1)
which is susceptible to##3##4##(2008-10#3)
which is susceptible##4##3##(2008-10#4)
which is synthesised##2##3##(1992-8#1)(2013-7#1)
which is synthesized in the##2##5##(1993-7#1)(2008-10#1)
which is ten times higher than##2##6##(1992-2#1)(2007-12#1)
which is ten times##3##4##(1992-2#1)(2007-12#1)(2008-10#1)
which is the active##2##4##(1994-12#1)(2013-8#1)
which is the actual##2##4##(1995-8#1)(2007-12#1)
which is the basis for the##2##6##(1997-6#1)(2008-7#1)
which is the basis for##3##5##(1997-6#1)(2008-7#1)(2009-3#1)
which is the basis of##2##5##(2008-10#1)(2008-6#1)
which is the basis##5##4##(1997-6#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-3#1)
which is the best##3##4##(2007-8#1)(2008-10#1)(2012-2#1)
which is the comparison of the##2##6##(1993-6#2)
which is the first##6##4##(1995-8#1)(2005-11#1)(2008-10#2)(2010-7#1)(2013-8#1)
which is the focus of this review##2##7##(2008-5#1)(2011-12#1)
which is the functional##2##4##(1990-3#1)(2009-10#1)
which is the highest##2##4##(2007-11#1)(2008-12#1)
which is the key##3##4##(2007-11#2)(2008-1#1)
which is the largest##3##4##(1991-5#1)(2011-2#1)(2012-12#1)
which is the leading cause of##3##6##(2007-8#1)(2010-4#1)(2012-12#1)
which is the leading##4##4##(2007-8#1)(2008-7#1)(2010-4#1)(2012-12#1)
which is the main##4##4##(1994-11#1)(2005-3#1)(2007-12#1)(2013-8#1)
which is the major##5##4##(1996-3#1)(1996-4#1)(2007-11#1)(2008-10#1)(2008-11#1)
which is the most common##2##5##(2010-5#1)(2011-12#1)
which is the most severe##2##5##(2008-10#1)(2013-8#1)
which is the most widely##2##5##(2008-3#1)(2008-8#1)
which is the most##21##4##(1993-4#1)(1994-8#1)(1995-1#1)(2006-10#1)(2006-8#1)(2007-5#1)(2008-10#2)(2008-3#2)(2008-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
which is the natural##2##4##(2006-2#1)(2007-12#1)
which is the only##6##4##(1990-10#1)(1991-5#1)(1993-6#1)(2006-10#2)(2010-5#1)
which is the predominant##2##4##(2007-6#1)(2008-4#1)
which is the primary##4##4##(1991-4#1)(2008-1#1)(2008-7#1)(2010-8#1)
which is the prime##2##4##(2006-1#1)(2010-8#1)
which is the principal##2##4##(1993-11#1)(2004-11#1)
which is the rate-limiting##2##4##(1991-9#1)(2008-5#1)
which is the ratio between the transverse and longitudinal##2##9##(2007-12#2)
which is the result of a##2##6##(2007-10#1)(2013-7#1)
which is the result of##4##5##(2007-10#1)(2007-12#1)(2010-2#1)(2013-7#1)
which is the same as that of##3##7##(1990-12#1)(1990-7#1)(1991-9#1)
which is the same as that##6##6##(1990-12#1)(1990-7#1)(1991-9#1)(1993-8#1)(2008-10#1)(2008-8#1)
which is the same as##7##5##(1990-12#1)(1990-7#1)(1991-9#1)(1993-8#1)(2008-10#2)(2008-8#1)
which is the same##12##4##(1990-12#1)(1990-7#1)(1991-9#1)(1993-8#1)(1994-6#1)(1995-11#1)(1997-7#1)(2006-10#1)(2008-10#2)(2008-8#1)(2012-2#1)
which is the species most frequently maintained in the laboratory##2##10##(2008-4#2)
which is the type##2##4##(2011-2#2)
which is the typical##2##4##(1997-8#1)(2013-1#1)
which is the##183##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-4#2)(1991-5#2)(1991-7#1)(1991-9#3)(1992-11#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-11#3)(1993-2#1)(1993-4#1)(1993-6#3)(1993-8#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-6#2)(1995-8#3)(1996-10#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#2)(2005-3#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#4)(2006-2#1)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#5)(2007-12#7)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#3)(2008-10#16)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#4)(2011-1#1)(2011-12#4)(2011-2#8)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#5)
which is then converted to a##2##6##(1990-3#1)(1992-12#1)
which is then oxidized##2##4##(2008-10#1)(2008-11#1)
which is then##22##3##(1990-3#1)(1992-12#2)(1993-3#1)(1994-11#1)(1994-8#1)(2007-12#2)(2008-10#6)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2009-8#1)
which is thought to be a##2##6##(1992-11#1)(2007-9#1)
which is thought to be an##2##6##(1994-12#1)(2005-10#1)
which is thought to be involved in##3##7##(1995-5#1)(1995-8#1)(2008-7#1)
which is thought to be##13##5##(1990-11#1)(1992-11#1)(1994-12#1)(1994-9#1)(1995-5#1)(1995-8#1)(1997-1#1)(2005-10#1)(2007-4#1)(2007-9#1)(2008-3#1)(2008-7#1)(2008-9#1)
which is thought to##22##4##(1990-11#1)(1991-12#2)(1992-11#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-9#2)(1995-5#1)(1995-8#1)(1996-1#1)(1997-1#1)(2005-10#1)(2006-4#1)(2007-4#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-1#1)
which is thought##23##3##(1990-11#1)(1991-12#2)(1992-11#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-9#2)(1995-5#1)(1995-8#1)(1996-1#1)(1997-1#1)(2005-10#1)(2006-4#1)(2007-4#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-1#1)
which is three times higher than##2##6##(1991-9#1)(2008-2#1)
which is three##3##3##(1991-9#1)(1996-5#1)(2008-2#1)
which is tightly##2##3##(2008-10#1)(2012-2#1)
which is to our knowledge the highest##3##7##(2007-11#1)(2007-12#2)
which is to##9##3##(1993-6#1)(1994-12#1)(2007-11#1)(2007-12#3)(2007-4#1)(2012-3#1)(2013-1#1)
which is too##2##3##(1996-9#1)(2006-2#1)
which is toxic##2##3##(1992-12#1)(1995-8#1)
which is transcribed##2##3##(1995-5#1)(1997-2#1)
which is transmitted##2##3##(2005-11#1)(2009-10#1)
which is typical for##2##4##(1994-2#1)(2007-11#1)
which is typical of##4##4##(2005-12#1)(2008-12#1)(2008-2#1)(2010-10#1)
which is typical##7##3##(1994-2#1)(2005-12#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#1)(2010-10#1)
which is typically##3##3##(2007-11#1)(2007-3#1)(2008-10#1)
which is ubiquitous##2##3##(1995-8#1)(2013-1#1)
which is unable to##4##4##(1994-3#1)(2008-4#1)(2008-6#1)(2010-10#1)
which is unable##5##3##(1994-3#1)(2008-4#2)(2008-6#1)(2010-10#1)
which is under development by##3##5##(2005-7#1)(2005-8#1)(2008-5#1)
which is under##5##3##(1996-5#1)(2005-7#1)(2005-8#1)(2008-5#2)
which is unique to the##2##5##(2009-10#1)(2011-2#1)
which is unique to##4##4##(1993-2#1)(2008-10#1)(2009-10#1)(2011-2#1)
which is unique##5##3##(1990-5#1)(1993-2#1)(2008-10#1)(2009-10#1)(2011-2#1)
which is unprecedented for##2##4##(2007-11#1)(2010-2#1)
which is unstable##2##3##(2007-12#1)(2008-5#1)
which is unusual##2##3##(1991-4#1)(2006-10#1)
which is upregulated##2##3##(2008-6#1)(2009-8#1)
which is used as a##4##5##(1992-6#1)(2008-10#1)(2008-4#1)(2011-1#1)
which is used as an##3##5##(2008-11#1)(2011-2#1)(2012-12#1)
which is used as##8##4##(1992-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
which is used for##5##4##(2008-4#1)(2008-5#1)(2013-1#1)(2013-7#1)(2013-8#1)
which is used in the##6##5##(1990-11#1)(1993-7#1)(1996-3#1)(1996-9#1)(2007-4#1)(2010-8#1)
which is used in##12##4##(1990-11#1)(1992-12#2)(1993-7#1)(1996-3#1)(1996-9#1)(2004-12#1)(2005-7#1)(2007-4#1)(2008-5#1)(2010-8#1)(2011-2#1)
which is used to produce##2##5##(2010-8#1)(2012-2#1)
which is used to##10##4##(1997-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2010-8#1)(2011-1#1)(2012-2#1)
which is used##37##3##(1990-11#1)(1992-12#2)(1992-6#1)(1993-7#1)(1996-3#1)(1996-9#1)(1997-3#1)(2004-12#1)(2005-7#1)(2007-4#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2010-8#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
which is useful for##8##4##(1996-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#2)(2010-8#1)(2011-1#1)
which is useful##9##3##(1996-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#3)(2010-8#1)(2011-1#1)
which is usually##16##3##(1992-10#1)(1995-6#1)(2005-12#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-6#1)(2013-7#1)
which is utilized##2##3##(2008-2#1)(2008-6#1)
which is valid for##2##4##(1995-3#1)(2008-2#1)
which is very close to the##2##6##(2008-10#1)(2012-3#1)
which is very similar to##2##5##(1995-8#1)(2008-10#1)
which is very similar##3##4##(1994-11#1)(1995-8#1)(2008-10#1)
which is very##18##3##(1994-11#1)(1995-8#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-5#2)(2010-12#1)(2010-9#1)(2012-12#1)(2012-3#1)
which is well within the##2##5##(2008-2#1)(2010-11#1)
which is well##6##3##(1995-12#1)(2007-10#1)(2008-10#1)(2008-2#2)(2010-11#1)
which is why the##2##4##(2008-7#1)(2011-2#1)
which is why##4##3##(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
which is widely used for##2##5##(2008-11#1)(2011-1#1)
which is widely used in##3##5##(1990-10#1)(2008-10#1)(2010-12#1)
which is widely used##7##4##(1990-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-12#1)(2011-1#1)
which is widely##10##3##(1990-10#1)(2006-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-8#2)(2010-12#1)(2011-1#1)
which is within the##3##4##(1993-8#1)(1995-2#1)(2008-3#1)
which is within##4##3##(1992-10#1)(1993-8#1)(1995-2#1)(2008-3#1)
which is##3232##2##(1990-1#1)(1990-10#9)(1990-11#21)(1990-12#16)(1990-2#16)(1990-3#13)(1990-4#7)(1990-5#12)(1990-6#6)(1990-7#17)(1990-8#15)(1990-9#9)(1991-1#7)(1991-10#5)(1991-11#5)(1991-12#15)(1991-2#23)(1991-3#10)(1991-4#10)(1991-5#25)(1991-6#8)(1991-7#12)(1991-8#11)(1991-9#21)(1992-1#11)(1992-10#4)(1992-11#14)(1992-12#21)(1992-2#10)(1992-3#15)(1992-4#12)(1992-5#5)(1992-6#13)(1992-7#4)(1992-8#10)(1992-9#14)(1993-1#2)(1993-10#2)(1993-11#15)(1993-12#13)(1993-2#7)(1993-3#20)(1993-4#8)(1993-5#5)(1993-6#14)(1993-7#4)(1993-8#14)(1993-9#10)(1994-10#5)(1994-11#15)(1994-12#23)(1994-2#16)(1994-3#25)(1994-4#2)(1994-5#13)(1994-6#8)(1994-7#3)(1994-8#24)(1994-9#24)(1995-1#12)(1995-10#8)(1995-11#15)(1995-12#13)(1995-2#26)(1995-3#22)(1995-4#4)(1995-5#11)(1995-6#17)(1995-7#5)(1995-8#27)(1995-9#2)(1996-1#5)(1996-10#4)(1996-11#7)(1996-12#7)(1996-2#26)(1996-3#11)(1996-4#11)(1996-5#23)(1996-6#8)(1996-7#10)(1996-8#9)(1996-9#13)(1997-1#20)(1997-2#22)(1997-3#9)(1997-4#17)(1997-5#7)(1997-6#27)(1997-7#14)(1997-8#14)(2003-11#2)(2004-11#1)(2004-12#2)(2004-2#1)(2004-4#2)(2004-9#6)(2005-1#2)(2005-10#11)(2005-11#26)(2005-12#3)(2005-3#3)(2005-4#3)(2005-5#3)(2005-6#1)(2005-7#11)(2005-8#20)(2005-9#2)(2006-1#3)(2006-10#37)(2006-11#4)(2006-12#18)(2006-2#9)(2006-3#3)(2006-4#12)(2006-5#5)(2006-6#14)(2006-7#4)(2006-8#10)(2006-9#3)(2007-1#10)(2007-10#12)(2007-11#71)(2007-12#101)(2007-2#8)(2007-3#6)(2007-4#8)(2007-5#6)(2007-6#5)(2007-7#24)(2007-8#39)(2007-9#17)(2008-1#38)(2008-10#297)(2008-11#81)(2008-12#22)(2008-2#94)(2008-3#106)(2008-4#50)(2008-5#80)(2008-6#18)(2008-7#58)(2008-8#49)(2008-9#31)(2009-1#1)(2009-10#15)(2009-11#4)(2009-12#5)(2009-2#9)(2009-3#9)(2009-4#5)(2009-5#15)(2009-6#13)(2009-7#8)(2009-8#26)(2009-9#11)(2010-1#4)(2010-10#7)(2010-11#10)(2010-12#25)(2010-2#18)(2010-3#9)(2010-4#8)(2010-5#14)(2010-6#9)(2010-7#13)(2010-8#21)(2010-9#7)(2011-1#44)(2011-10#1)(2011-12#11)(2011-2#65)(2011-3#2)(2011-7#1)(2011-9#1)(2012-1#19)(2012-11#9)(2012-12#23)(2012-2#45)(2012-3#43)(2013-1#67)(2013-7#18)(2013-8#40)
which isolates##2##2##(2008-10#1)(2008-7#1)
which it appeared##2##3##(1990-4#1)(2009-2#1)
which it binds##3##3##(1996-7#1)(2008-3#1)(2010-10#1)
which it can be##3##4##(1990-11#1)(2008-8#1)(2012-3#1)
which it can##6##3##(1990-11#1)(1994-3#1)(2005-7#1)(2008-11#1)(2008-8#1)(2012-3#1)
which it does##2##3##(2008-4#1)(2011-1#1)
which it had##2##3##(1993-2#1)(2006-10#1)
which it has an##2##4##(1992-3#1)(2007-6#1)
which it has been##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
which it has##10##3##(1992-3#1)(2006-6#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-3#1)(2009-2#1)(2009-3#1)(2011-12#1)
which it interacts##3##3##(1991-9#1)(1994-12#1)(2005-7#1)
which it is concluded that##2##5##(1996-8#1)(2008-5#1)
which it is not possible to##4##6##(2005-11#1)(2006-2#1)(2010-12#2)
which it is not##5##4##(2005-11#1)(2006-2#1)(2006-9#1)(2010-12#2)
which it is possible to##3##5##(1992-3#1)(2006-12#1)(2008-9#1)
which it is##64##3##(1990-5#2)(1991-3#1)(1992-3#1)(1992-6#1)(1993-10#2)(1993-5#1)(1994-11#1)(1994-12#1)(1995-10#1)(1995-2#1)(1995-4#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-2#2)(1997-8#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-12#3)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-8#2)(2008-9#2)(2009-12#1)(2009-6#1)(2010-12#2)(2011-1#4)(2012-12#2)(2012-2#1)(2013-8#2)
which it may##2##3##(1995-9#1)(2007-11#1)
which it was isolated##3##4##(1994-12#1)(1995-3#1)(2012-3#1)
which it was##17##3##(1991-4#1)(1991-5#1)(1994-12#1)(1995-3#1)(1995-6#1)(1996-4#1)(1997-2#1)(2004-10#1)(2006-5#1)(2007-6#1)(2008-1#1)(2008-10#1)(2009-11#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-7#1)
which it##154##2##(1990-11#1)(1990-4#1)(1990-5#2)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-3#2)(1992-5#1)(1992-6#2)(1993-10#2)(1993-2#1)(1993-5#1)(1994-11#1)(1994-12#4)(1994-3#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#2)(1995-9#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-8#1)(2004-10#1)(2005-10#1)(2005-11#2)(2005-7#2)(2005-9#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-5#1)(2007-6#2)(2007-7#1)(2007-9#2)(2008-1#4)(2008-10#11)(2008-11#5)(2008-2#3)(2008-3#6)(2008-4#5)(2008-5#3)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#1)(2009-6#2)(2010-10#1)(2010-12#3)(2010-3#1)(2010-8#2)(2011-1#5)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#4)
which its##10##2##(1992-1#1)(1994-5#3)(1995-2#1)(1997-1#1)(2008-10#1)(2011-12#1)(2011-2#1)(2013-1#1)
which itself is##2##3##(2005-1#1)(2007-8#1)
which itself##5##2##(1995-5#1)(1995-6#1)(2005-1#1)(2007-8#1)(2009-3#1)
which joint##3##2##(1991-12#1)(1992-12#1)(2007-8#1)
which kills##2##2##(1994-5#1)(1996-9#1)
which lack the core PCP constituent Vang-like protein 2 (Vangl2)##2##10##(2012-12#2)
which lack the##4##3##(1991-3#1)(2005-8#1)(2012-12#2)
which lack##12##2##(1990-3#1)(1991-3#1)(1994-11#1)(1994-2#1)(1994-8#1)(1997-6#1)(2005-8#1)(2008-3#1)(2008-4#2)(2012-12#2)
which lacked the##3##3##(1992-2#1)(1997-7#1)(2008-10#1)
which lacked##10##2##(1991-2#1)(1991-9#2)(1992-2#1)(1994-2#1)(1994-3#1)(1997-4#1)(1997-7#1)(2006-8#1)(2008-10#1)
which lacks a##3##3##(1994-8#1)(1996-5#1)(2009-8#1)
which lacks the##10##3##(1990-8#1)(1991-5#1)(1991-8#1)(1994-9#1)(1995-12#1)(1997-6#1)(2008-7#2)(2011-2#1)(2012-3#1)
which lacks##23##2##(1990-8#1)(1990-9#1)(1991-5#1)(1991-8#1)(1993-6#2)(1993-8#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-4#1)(1996-12#1)(1996-5#1)(1997-6#2)(2008-7#3)(2008-9#1)(2009-8#1)(2011-2#1)(2012-3#1)
which large##4##2##(2008-10#1)(2008-11#2)(2008-2#1)
which largely##3##2##(1990-3#1)(1992-6#1)(2012-12#1)
which lasing##2##2##(2007-12#1)(2008-3#1)
which lasted for##4##3##(1991-6#1)(1994-12#1)(2008-12#1)(2011-2#1)
which lasted##9##2##(1990-6#1)(1991-6#1)(1993-2#1)(1994-12#1)(2006-8#1)(2008-11#1)(2008-12#1)(2009-7#1)(2011-2#1)
which later##4##2##(1990-3#1)(1994-5#1)(1996-3#1)(2012-3#1)
which lead to a##2##4##(2007-11#1)(2008-3#1)
which lead to the##4##4##(1990-4#1)(1990-6#1)(1996-11#1)(2009-8#1)
which lead to##27##3##(1990-4#1)(1990-6#1)(1991-10#1)(1992-6#2)(1993-9#1)(1994-3#1)(1996-11#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-6#1)(2007-11#2)(2007-7#1)(2008-11#2)(2008-3#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-9#2)(2011-1#1)(2012-1#1)(2012-12#1)(2013-8#1)
which lead##28##2##(1990-4#1)(1990-6#1)(1991-10#1)(1992-6#2)(1993-9#1)(1994-3#1)(1996-11#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-6#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-9#2)(2011-1#1)(2012-1#1)(2012-12#1)(2013-8#1)
which leads to a higher##2##5##(1991-11#1)(2013-1#1)
which leads to a##8##4##(1991-11#1)(1992-8#1)(1996-5#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-9#1)(2013-1#1)
which leads to an##5##4##(1991-2#1)(1992-1#1)(2008-10#1)(2008-3#1)(2008-6#1)
which leads to increased##2##4##(2008-3#1)(2008-8#1)
which leads to metabolic##2##4##(2007-10#1)(2012-3#1)
which leads to the##11##4##(1993-12#1)(1995-3#1)(1996-10#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-7#1)(2010-2#1)(2012-3#1)(2013-1#1)
which leads to##79##3##(1991-11#1)(1991-2#2)(1992-1#2)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-9#1)(1994-2#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-3#1)(1997-4#1)(2006-10#1)(2006-6#2)(2006-9#1)(2007-10#1)(2007-12#4)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-1#1)(2009-6#1)(2009-7#2)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#2)
which leads##81##2##(1991-11#1)(1991-2#2)(1992-1#2)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-9#1)(1994-2#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-3#1)(1997-4#1)(2006-10#1)(2006-6#2)(2006-9#1)(2007-10#1)(2007-12#4)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-1#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#2)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#2)
which learning##2##2##(1997-2#1)(2010-5#1)
which leaves##2##2##(2007-3#1)(2008-10#1)
which led to a diagnosis of##2##6##(2010-3#1)(2011-2#1)
which led to a##5##4##(2008-10#1)(2008-7#1)(2010-3#1)(2011-2#2)
which led to death##2##4##(2009-4#1)(2010-12#1)
which led to the formation of##2##6##(2009-11#1)(2013-8#1)
which led to the##11##4##(1990-11#1)(1992-5#1)(1996-5#1)(1997-1#1)(2005-10#1)(2006-12#1)(2007-9#1)(2009-11#1)(2009-5#1)(2012-12#1)(2013-8#1)
which led to##37##3##(1990-11#1)(1990-12#1)(1991-12#1)(1992-5#1)(1995-3#1)(1996-5#1)(1997-1#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-11#1)(2009-4#2)(2009-5#1)(2009-7#3)(2010-12#2)(2010-3#1)(2011-2#3)(2012-12#1)(2012-2#3)(2013-8#1)
which led us to develop##2##5##(2007-5#1)(2012-3#1)
which led##40##2##(1990-11#1)(1990-12#1)(1991-12#1)(1992-5#1)(1995-3#1)(1996-5#1)(1997-1#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-11#1)(2009-4#2)(2009-5#1)(2009-7#3)(2010-12#3)(2010-3#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#1)
which lesion##2##2##(2008-10#1)(2010-11#1)
which lesions##5##2##(1992-10#1)(1993-4#2)(2006-5#1)(2008-10#1)
which level##2##2##(2006-8#1)(2008-7#1)
which liability##2##2##(1991-3#1)(1992-3#1)
which lie##3##2##(1991-8#1)(1995-6#1)(2008-10#1)
which lies between the##2##4##(1992-12#1)(2007-12#1)
which lies in the##2##4##(1991-7#1)(1994-3#1)
which lies in##3##3##(1991-7#1)(1994-3#1)(1995-2#1)
which lies outside the##2##4##(1995-2#1)(2008-4#1)
which lies outside##3##3##(1995-2#1)(1997-4#1)(2008-4#1)
which lies within the##2##4##(1990-11#1)(2007-12#1)
which lies##15##2##(1990-11#1)(1991-7#1)(1992-12#1)(1992-9#1)(1993-6#1)(1994-3#1)(1995-2#2)(1997-3#1)(1997-4#1)(2007-12#2)(2008-2#1)(2008-4#2)
which life##2##2##(2010-1#1)(2011-2#1)
which ligand##3##2##(1994-11#1)(1995-3#1)(1996-4#1)
which likely##7##2##(1993-3#1)(1994-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2009-10#1)(2012-3#1)
which limit the##2##3##(2008-9#1)(2009-7#1)
which limit##4##2##(2007-7#1)(2008-10#1)(2008-9#1)(2009-7#1)
which limited##2##2##(2007-11#1)(2013-1#1)
which limits the##7##3##(2006-2#1)(2006-5#1)(2007-4#1)(2008-2#3)(2010-1#1)
which limits their##5##3##(1994-10#1)(1997-4#1)(2007-11#1)(2007-7#1)(2008-2#1)
which limits##16##2##(1991-6#1)(1994-10#1)(1994-4#1)(1997-4#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-2#4)(2010-1#1)(2011-2#1)(2012-1#1)
which link with##2##3##(2011-1#1)(2013-1#1)
which link##3##2##(2008-11#1)(2011-1#1)(2013-1#1)
which links the##2##3##(2008-2#1)(2008-6#1)
which links##6##2##(1991-3#1)(2006-11#1)(2007-1#1)(2008-10#1)(2008-2#1)(2008-6#1)
which liquid##2##2##(2008-10#1)(2008-3#1)
which live##3##2##(2004-11#1)(2008-5#2)
which lives##2##2##(2006-10#1)(2007-12#1)
which localized##2##2##(1994-12#1)(2008-7#1)
which long-term##3##2##(1996-2#1)(2010-11#1)(2012-3#1)
which looks##2##2##(1994-2#1)(2008-5#1)
which loss of##4##3##(2007-2#1)(2008-10#1)(2008-3#1)(2009-5#1)
which low levels##2##3##(2008-10#1)(2008-7#1)
which low##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
which lower the##2##3##(1990-4#1)(1991-2#1)
which lower##4##2##(1990-3#1)(1990-4#1)(1991-2#1)(2008-5#1)
which made it possible to identify##2##6##(2008-10#1)(2013-8#1)
which made it##3##3##(2008-10#1)(2013-8#2)
which made##8##2##(1994-12#1)(2006-11#1)(2008-10#2)(2008-3#1)(2013-8#3)
which main##2##2##(2008-10#1)(2009-2#1)
which mainly affects##5##3##(1992-2#1)(2005-11#1)(2012-2#1)(2013-1#2)
which mainly involves the##2##4##(1991-9#1)(2005-4#1)
which mainly##12##2##(1991-8#1)(1991-9#1)(1992-2#1)(2005-11#1)(2005-4#1)(2008-10#2)(2008-7#1)(2012-2#1)(2013-1#2)(2013-8#1)
which maintained##3##2##(2007-8#1)(2008-7#1)(2009-3#1)
which maintains the##4##3##(2008-10#1)(2008-3#1)(2012-1#1)(2013-1#1)
which maintains##7##2##(1995-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-1#1)(2013-1#1)
which major##4##2##(1994-2#1)(2008-1#1)(2008-7#1)(2010-9#1)
which make it possible##2##4##(1990-5#1)(2010-3#1)
which make it##7##3##(1990-5#1)(1995-3#1)(2006-10#1)(2009-8#1)(2010-3#1)(2012-11#1)(2013-8#1)
which make the##4##3##(1993-2#1)(2008-10#1)(2012-3#1)(2013-8#1)
which make them##4##3##(2008-10#2)(2012-1#1)(2012-2#1)
which make this##2##3##(1996-3#1)(2007-12#1)
which make up the##5##4##(1993-3#1)(2008-5#2)(2011-1#2)
which make##31##2##(1990-5#1)(1991-3#1)(1993-2#1)(1993-3#1)(1995-3#1)(1996-3#1)(1997-2#2)(1997-4#1)(2006-10#2)(2007-12#1)(2008-10#3)(2008-5#2)(2009-11#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-9#1)(2011-1#2)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#3)
which makes it a powerful##2##5##(2008-7#1)(2012-3#1)
which makes it a##4##4##(2008-12#1)(2008-7#1)(2012-11#1)(2012-3#1)
which makes it difficult to predict which care providers need access to what and when##2##15##(2013-1#2)
which makes it difficult to##4##5##(2011-1#1)(2012-3#1)(2013-1#2)
which makes it possible to##5##5##(1997-8#1)(2005-4#1)(2007-11#1)(2008-10#1)(2008-4#1)
which makes it possible##7##4##(1997-8#1)(2005-4#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-6#1)
which makes it##29##3##(1990-7#1)(1993-9#1)(1997-8#2)(2005-4#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2010-4#1)(2011-1#1)(2012-11#1)(2012-3#3)(2013-1#2)(2013-8#1)
which makes possible a##3##4##(2007-11#1)(2008-10#1)(2008-11#1)
which makes possible##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
which makes the system##2##4##(2008-10#1)(2008-11#1)
which makes the##13##3##(1992-3#1)(1993-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-4#1)(2012-1#1)(2013-8#1)
which makes them less##2##4##(2007-11#1)(2008-3#1)
which makes them##9##3##(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)
which makes this##2##3##(2008-10#1)(2012-2#1)
which makes use of##3##4##(1994-12#1)(2007-12#1)(2008-10#1)
which makes##79##2##(1990-5#1)(1990-7#1)(1992-3#2)(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1996-1#1)(1996-6#1)(1997-8#2)(2005-4#1)(2006-10#1)(2006-2#1)(2007-11#4)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-3#1)(2010-12#2)(2010-4#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#2)
which males##2##2##(1995-1#1)(2013-1#1)
which malignant##2##2##(1995-1#1)(2008-6#1)
which manifest##2##2##(1995-3#1)(2012-1#1)
which manifested as##2##3##(2010-11#1)(2012-12#1)
which manifested in##3##3##(2012-1#3)
which manifested with##2##3##(2006-2#1)(2009-5#1)
which manifested##7##2##(2006-2#1)(2009-5#1)(2010-11#1)(2012-1#3)(2012-12#1)
which manifests as increased##2##4##(2008-10#2)
which manifests as##3##3##(2007-7#1)(2008-10#2)
which manifests in##3##3##(2008-11#1)(2009-4#1)(2010-12#1)
which manifests itself##2##3##(2008-5#1)(2010-8#1)
which manifests##10##2##(1997-1#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-4#1)(2010-12#1)(2010-8#1)
which many##9##2##(1996-8#1)(1997-1#1)(2006-5#1)(2007-12#2)(2008-10#1)(2008-4#1)(2010-12#1)(2011-1#1)
which map##3##2##(1990-5#1)(1993-11#1)(1996-4#1)
which maps to the##2##4##(1990-11#1)(1997-1#1)
which maps to##6##3##(1990-11#1)(1993-9#1)(1997-1#1)(1997-7#1)(2007-4#1)(2008-6#1)
which maps##7##2##(1990-11#1)(1993-3#1)(1993-9#1)(1997-1#1)(1997-7#1)(2007-4#1)(2008-6#1)
which marked the post-apartheid##2##4##(2006-7#2)
which markedly##3##2##(1993-8#1)(2007-8#1)(2012-2#1)
which matched the##2##3##(1995-2#1)(2008-11#1)
which matched##4##2##(1995-2#1)(2005-10#1)(2007-12#1)(2008-11#1)
which matter##2##2##(1992-5#1)(2013-8#1)
which maximises##2##2##(1997-4#1)(2012-1#1)
which maximizes##2##2##(2008-2#1)(2008-9#1)
which maximum##2##2##(2008-5#2)
which may account for the##2##5##(1995-3#1)(2010-3#1)
which may account for##4##4##(1995-3#1)(2008-10#1)(2010-3#1)(2012-3#1)
which may act as##3##4##(1996-2#1)(2008-10#1)(2012-2#1)
which may act##6##3##(1996-2#1)(1996-3#1)(2006-10#1)(2008-10#1)(2008-11#1)(2012-2#1)
which may affect the##6##4##(1995-1#1)(2007-11#1)(2008-1#1)(2008-12#1)(2011-1#1)(2012-3#1)
which may affect##14##3##(1991-11#1)(1991-7#1)(1994-9#1)(1995-1#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
which may aid in the##2##5##(2007-9#1)(2012-2#1)
which may aid in##3##4##(2007-8#1)(2007-9#1)(2012-2#1)
which may aid##4##3##(2007-8#1)(2007-9#1)(2011-2#1)(2012-2#1)
which may allow##2##3##(2008-10#1)(2008-3#1)
which may also be##5##4##(1990-2#1)(1992-8#1)(2005-7#1)(2008-3#1)(2008-5#1)
which may also##10##3##(1990-2#1)(1992-8#1)(1994-9#1)(2005-7#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-5#1)(2009-12#1)(2012-3#1)
which may alter##2##3##(2006-12#1)(2010-5#1)
which may appear##5##3##(1990-8#1)(1993-1#1)(1994-8#1)(2008-8#1)(2012-1#1)
which may arise from##2##4##(1995-8#1)(2007-4#1)
which may arise##4##3##(1994-7#1)(1995-8#1)(2007-4#1)(2012-3#1)
which may be a##6##4##(1991-10#1)(1994-4#1)(2006-10#1)(2006-2#1)(2011-1#1)(2012-12#1)
which may be an important##2##5##(2005-9#1)(2006-8#1)
which may be an##3##4##(2005-9#1)(2006-8#1)(2008-4#1)
which may be associated with the##3##6##(1992-12#1)(1993-3#1)(1996-3#1)
which may be associated with##6##5##(1992-12#1)(1993-3#1)(1994-4#1)(1996-3#1)(2006-6#1)(2011-2#1)
which may be attributable to##3##5##(1997-8#1)(2008-11#1)(2008-2#1)
which may be attributed to the##3##6##(1992-11#1)(1995-3#1)(2008-10#1)
which may be attributed to##6##5##(1992-11#1)(1995-3#1)(1996-8#1)(2008-10#1)(2008-8#1)(2012-3#1)
which may be caused##2##4##(2007-1#1)(2009-6#1)
which may be considered as##2##5##(2006-9#1)(2010-8#1)
which may be considered##4##4##(1994-2#1)(2006-9#1)(2008-12#1)(2010-8#1)
which may be derived from##2##5##(1994-6#1)(1997-3#1)
which may be different##2##4##(1996-12#1)(2007-11#1)
which may be difficult to##3##5##(1991-2#1)(2006-10#1)(2011-1#1)
which may be due to the##3##6##(2008-9#1)(2010-7#1)(2012-3#1)
which may be due to##13##5##(1990-10#1)(1995-1#1)(1996-10#1)(2006-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-3#2)
which may be due##14##4##(1990-10#1)(1995-1#1)(1996-10#1)(2006-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#2)(2010-7#1)(2011-2#1)(2012-11#1)(2012-3#2)
which may be either##3##4##(1990-8#1)(2006-10#1)(2007-11#1)
which may be essential for##2##5##(1990-11#1)(1994-8#1)
which may be explained by##2##5##(2006-6#1)(2007-12#1)
which may be important to##2##5##(2012-1#1)(2013-1#1)
which may be important##4##4##(1992-4#1)(2009-5#1)(2012-1#1)(2013-1#1)
which may be influenced by##2##5##(2007-8#1)(2008-11#1)
which may be involved in the##3##6##(1990-9#1)(1996-8#1)(2008-10#1)
which may be involved in##9##5##(1990-9#1)(1991-6#1)(1992-12#1)(1994-8#1)(1996-10#1)(1996-8#1)(1997-4#1)(2006-12#1)(2008-10#1)
which may be mediated by##2##5##(1997-1#1)(2008-12#1)
which may be more##7##4##(1990-10#1)(1991-2#1)(2008-1#1)(2008-8#1)(2009-5#1)(2010-2#1)(2011-2#1)
which may be necessary for##2##5##(1992-3#1)(2008-7#1)
which may be of importance in##2##6##(1990-12#1)(1995-8#1)
which may be of importance##3##5##(1990-12#1)(1995-4#1)(1995-8#1)
which may be of##12##4##(1990-12#1)(1990-8#1)(1992-3#1)(1994-8#1)(1995-4#1)(1995-8#1)(1997-3#1)(2008-10#1)(2008-11#1)(2009-3#1)(2010-4#1)(2012-12#1)
which may be partly##2##4##(2010-8#1)(2013-8#1)
which may be present in##2##5##(1994-3#1)(2008-10#1)
which may be present##3##4##(1994-3#1)(2008-10#2)
which may be related to differences in##2##7##(2008-10#1)(2010-4#1)
which may be related to its##2##6##(2007-1#1)(2007-12#1)
which may be related to the##2##6##(1997-2#1)(2006-5#1)
which may be related to##12##5##(1990-6#1)(1991-6#1)(1995-4#1)(1997-2#1)(2006-5#1)(2007-1#1)(2007-12#1)(2008-10#1)(2009-12#1)(2010-2#1)(2010-4#1)(2011-2#1)
which may be relevant##2##4##(1996-2#1)(1996-5#1)
which may be responsible for the##3##6##(1993-12#1)(1994-3#1)(1994-5#1)
which may be responsible for##9##5##(1990-8#1)(1993-12#2)(1994-3#1)(1994-5#1)(1996-12#1)(2006-10#1)(2008-10#2)
which may be the##2##4##(1997-3#1)(2008-12#1)
which may be triggered by##2##5##(1994-8#1)(1997-6#1)
which may be used as##2##5##(2010-5#1)(2013-1#1)
which may be used for##2##5##(1991-10#1)(2008-5#1)
which may be used in##4##5##(1995-1#1)(1996-2#1)(1997-8#1)(2008-3#1)
which may be used##11##4##(1991-10#1)(1995-1#1)(1996-2#1)(1996-9#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-5#1)(2013-1#1)
which may be useful for##5##5##(1991-2#1)(1995-1#1)(2005-12#1)(2007-8#1)(2013-8#1)
which may be useful in##2##5##(2007-11#1)(2009-5#1)
which may be useful##8##4##(1991-2#1)(1994-6#1)(1995-1#1)(2005-12#1)(2007-11#1)(2007-8#1)(2009-5#1)(2013-8#1)
which may be##246##3##(1990-10#2)(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#4)(1990-9#1)(1991-10#2)(1991-2#3)(1991-6#2)(1992-11#1)(1992-12#2)(1992-3#2)(1992-4#2)(1992-7#1)(1992-9#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#3)(1994-4#2)(1994-5#1)(1994-6#2)(1994-8#4)(1994-9#1)(1995-1#4)(1995-11#1)(1995-12#1)(1995-3#2)(1995-4#3)(1995-5#1)(1995-8#1)(1996-10#3)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2005-1#2)(2005-10#1)(2005-11#1)(2005-12#2)(2005-9#1)(2006-10#6)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#3)(2007-10#2)(2007-11#3)(2007-12#3)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#17)(2008-11#6)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#4)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#8)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#4)(2013-8#3)
which may benefit##2##3##(1997-4#1)(2006-10#1)
which may better define tumor targets than available intraoperative imaging##2##10##(2013-1#2)
which may bring##2##3##(2006-12#1)(2010-8#1)
which may cause##15##3##(1991-8#1)(2006-2#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-9#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
which may constitute a##2##4##(1990-8#1)(1991-7#1)
which may contain##7##3##(1990-5#1)(1991-2#1)(1992-3#1)(1994-8#1)(2007-12#1)(2008-5#1)(2008-8#1)
which may contribute to the pathophysiology of##2##7##(1992-7#1)(2005-7#1)
which may contribute to the##14##5##(1990-12#1)(1990-3#1)(1991-1#1)(1992-6#1)(1992-7#1)(1994-3#1)(1995-6#1)(1996-1#1)(1996-10#1)(2005-7#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
which may contribute to##24##4##(1990-12#1)(1990-3#1)(1991-1#1)(1992-6#1)(1992-7#1)(1994-3#1)(1994-5#1)(1995-6#1)(1996-1#1)(1996-10#1)(2005-7#1)(2007-12#1)(2008-4#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-7#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#1)(2013-7#1)
which may control##3##3##(2005-11#1)(2006-8#1)(2012-11#1)
which may correspond to##4##4##(1990-5#1)(1993-11#1)(1995-5#1)(1997-3#1)
which may develop in##2##4##(2006-8#1)(2011-2#1)
which may develop##4##3##(2006-8#1)(2007-8#1)(2011-2#1)(2012-2#1)
which may enable more effective auditing strategies##2##7##(2013-1#2)
which may enable the##2##4##(2008-10#1)(2011-2#1)
which may enable##4##3##(2008-10#1)(2011-2#1)(2013-1#2)
which may enhance##2##3##(2006-10#1)(2011-7#1)
which may explain the##6##4##(1990-12#1)(1991-1#1)(1995-6#1)(1996-5#1)(1996-9#1)(2008-5#1)
which may explain why##2##4##(1991-8#1)(2010-7#1)
which may explain##10##3##(1990-12#1)(1991-1#1)(1991-8#1)(1993-9#1)(1995-6#1)(1996-5#1)(1996-9#1)(2006-9#1)(2008-5#1)(2010-7#1)
which may facilitate the##2##4##(2009-12#1)(2013-7#1)
which may function as##2##4##(1992-9#1)(2008-5#1)
which may function in##2##4##(1992-4#1)(1995-3#1)
which may function##4##3##(1992-4#1)(1992-9#1)(1995-3#1)(2008-5#1)
which may give rise to##2##5##(1991-3#1)(1996-12#1)
which may have a##5##4##(1995-3#1)(2010-12#1)(2012-2#1)(2013-1#2)
which may have been due to##2##6##(2007-3#1)(2009-5#1)
which may have been##7##4##(1991-11#1)(1994-8#1)(2007-3#1)(2008-10#1)(2008-7#1)(2009-5#1)(2013-7#1)
which may have contributed to the##2##6##(2008-10#1)(2010-4#1)
which may have contributed to##3##5##(2008-10#1)(2010-4#1)(2010-9#1)
which may have important implications for##2##6##(1993-11#1)(2009-7#1)
which may have important implications##3##5##(1991-3#1)(1993-11#1)(2009-7#1)
which may have important##5##4##(1991-1#1)(1991-3#1)(1993-11#1)(2007-12#1)(2009-7#1)
which may have##35##3##(1991-1#1)(1991-11#1)(1991-3#1)(1992-11#1)(1993-11#1)(1993-3#1)(1994-8#1)(1995-3#1)(2004-7#1)(2007-12#3)(2007-3#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#2)
which may help in##2##4##(2007-10#1)(2008-10#1)
which may help to explain##2##5##(2009-12#1)(2012-2#1)
which may help to reduce##2##5##(2008-6#1)(2011-2#1)
which may help to##7##4##(2008-5#1)(2008-6#1)(2009-12#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-9#1)
which may help##10##3##(2007-10#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-12#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-9#1)
which may imply##2##3##(2006-6#1)(2008-2#1)
which may improve named entity recognition tasks and may aid in augmenting synonymy within existing terminologies##2##16##(2013-1#2)
which may improve##5##3##(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)
which may in turn##2##4##(1994-2#1)(2013-1#1)
which may in##3##3##(1994-2#1)(2008-8#1)(2013-1#1)
which may include##8##3##(1995-3#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-2#1)(2013-8#1)
which may increase the##2##4##(2008-7#1)(2012-2#1)
which may increase##4##3##(1994-2#1)(2008-3#1)(2008-7#1)(2012-2#1)
which may indeed##2##3##(1991-9#1)(2010-6#1)
which may indicate a##2##4##(1997-8#1)(2008-10#1)
which may indicate that##2##4##(1993-7#1)(1996-7#1)
which may indicate##7##3##(1990-5#1)(1993-7#1)(1996-7#1)(1997-8#1)(2008-10#1)(2008-9#1)(2012-2#1)
which may influence the##3##4##(1990-12#1)(2007-7#1)(2008-12#1)
which may influence their##2##4##(1994-3#1)(2010-3#1)
which may influence##10##3##(1990-12#1)(1992-3#1)(1994-3#1)(1994-9#1)(1995-6#1)(1996-1#1)(2007-7#1)(2008-12#1)(2008-5#1)(2010-3#1)
which may interact with##3##4##(1996-10#1)(2008-1#2)
which may interact##4##3##(1996-10#1)(2008-1#2)(2008-8#1)
which may interfere with the##2##5##(1992-10#1)(2009-4#1)
which may interfere with##3##4##(1992-10#1)(2009-4#1)(2010-2#1)
which may involve##5##3##(1990-5#1)(1992-9#1)(1993-8#1)(2007-11#1)(2009-3#1)
which may justify a##2##4##(1990-12#1)(1997-8#1)
which may justify##3##3##(1990-12#1)(1997-8#1)(2008-5#1)
which may lead to a##3##5##(1996-3#1)(2004-12#1)(2012-2#1)
which may lead to the##3##5##(1995-7#1)(2007-7#1)(2011-2#1)
which may lead to##24##4##(1995-6#1)(1995-7#1)(1996-3#1)(2004-12#1)(2006-10#2)(2007-12#1)(2007-7#3)(2008-1#2)(2008-11#1)(2008-4#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
which may mask##2##3##(1991-10#1)(2007-7#1)
which may mediate##2##3##(1993-11#1)(1995-1#1)
which may mimic##3##3##(2007-5#1)(2010-3#1)(2012-2#1)
which may modulate##2##3##(1992-12#1)(1994-6#1)
which may not be##5##4##(1990-12#1)(1993-9#1)(2006-10#1)(2007-1#1)(2008-11#1)
which may not go on to##3##6##(1995-8#1)(2013-1#2)
which may not##13##3##(1990-12#1)(1993-9#1)(1994-2#1)(1995-8#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-11#2)(2013-1#2)
which may obscure##2##3##(2008-10#1)(2010-3#1)
which may occur in##6##4##(1990-8#1)(1993-2#1)(2006-12#1)(2010-4#1)(2013-1#1)(2013-8#1)
which may occur##12##3##(1990-10#1)(1990-8#1)(1993-2#1)(2006-12#1)(2008-10#1)(2008-8#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
which may offer##4##3##(2005-7#1)(2006-10#1)(2007-10#1)(2010-11#1)
which may or may not be##3##6##(1994-3#1)(2007-10#1)(2008-7#1)
which may or may not##5##5##(1994-3#1)(2006-2#1)(2007-10#1)(2008-7#2)
which may otherwise##3##3##(1996-2#1)(2008-9#1)(2010-2#1)
which may play a crucial role in##2##7##(1997-7#1)(2007-10#1)
which may play a role in##2##6##(1991-11#1)(2008-7#1)
which may play a##7##4##(1991-11#1)(1995-1#1)(1997-7#1)(2006-8#1)(2007-10#1)(2008-7#1)(2009-8#1)
which may play an important role in##3##7##(1990-3#1)(1992-11#1)(1994-3#1)
which may play##12##3##(1990-3#1)(1991-11#1)(1992-10#1)(1992-11#1)(1994-3#1)(1995-1#1)(1997-7#1)(2006-8#1)(2007-10#1)(2008-4#1)(2008-7#1)(2009-8#1)
which may possibly##2##3##(1992-3#1)(1997-4#1)
which may potentially##2##3##(2007-10#1)(2009-8#1)
which may predispose##2##3##(1997-8#1)(2009-12#1)
which may present in##2##4##(1992-9#1)(2005-11#1)
which may produce##2##3##(1990-9#1)(1996-12#1)
which may progress##2##3##(2007-11#1)(2010-12#1)
which may promote the##2##4##(1991-12#1)(2008-10#1)
which may prove##2##3##(1996-6#1)(2006-6#1)
which may provide a##4##4##(1992-9#1)(2007-11#2)(2013-8#1)
which may provide an##3##4##(1992-7#1)(2008-10#1)(2013-1#1)
which may provide##10##3##(1992-7#1)(1992-9#1)(1994-2#1)(2007-11#2)(2008-10#1)(2008-4#1)(2010-5#1)(2013-1#1)(2013-8#1)
which may reduce##3##3##(2008-10#1)(2010-12#1)(2012-1#1)
which may reflect some##2##4##(1993-2#1)(2004-9#1)
which may reflect the##3##4##(1994-11#1)(1994-9#1)(2008-8#1)
which may reflect##10##3##(1993-2#1)(1994-11#1)(1994-9#1)(1996-4#1)(1997-7#1)(2004-9#1)(2007-10#1)(2008-8#1)(2009-10#1)(2011-2#1)
which may relate to##2##4##(1993-5#1)(2008-8#1)
which may render##2##3##(2009-6#1)(2012-2#1)
which may represent a##3##4##(1996-5#1)(2008-10#1)(2013-8#1)
which may represent##6##3##(1996-5#1)(2006-9#1)(2008-10#1)(2008-9#1)(2010-12#1)(2013-8#1)
which may require##5##3##(1992-3#1)(2008-11#1)(2009-5#1)(2013-1#2)
which may result from a##2##5##(1996-3#1)(2007-11#1)
which may result from the##2##5##(1990-12#1)(2010-12#1)
which may result from##9##4##(1990-12#1)(1994-9#1)(1996-3#1)(2007-11#1)(2008-8#1)(2009-8#1)(2010-12#1)(2012-1#1)(2012-2#1)
which may result in##16##4##(1995-12#1)(1995-8#1)(1995-9#1)(2004-11#1)(2005-8#1)(2006-12#1)(2007-8#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-2#1)
which may result##25##3##(1990-12#1)(1994-9#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-3#1)(2004-11#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-2#1)
which may reveal novel therapeutic strategies for atherosclerosis and restenosis after angioplasty##2##12##(2008-4#2)
which may reveal novel##3##4##(2008-4#2)(2012-2#1)
which may serve as##5##4##(1993-2#1)(1994-12#1)(1995-7#1)(2006-12#1)(2009-4#1)
which may significantly##2##3##(2008-1#1)(2008-8#1)
which may stimulate##2##3##(1993-9#1)(2008-8#1)
which may suggest##3##3##(1990-10#1)(2008-10#1)(2008-4#1)
which may take##3##3##(1993-6#1)(1997-2#1)(2007-7#1)
which may therefore##2##3##(2008-11#1)(2012-12#1)
which may underlie##2##3##(2007-12#1)(2012-12#1)
which may vary##2##3##(2009-12#1)(2013-1#1)
which may##767##2##(1990-10#4)(1990-11#1)(1990-12#7)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#4)(1990-6#2)(1990-8#7)(1990-9#2)(1991-1#4)(1991-10#3)(1991-11#3)(1991-12#1)(1991-2#5)(1991-3#2)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#1)(1992-10#2)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#8)(1992-4#3)(1992-6#1)(1992-7#3)(1992-8#1)(1992-9#5)(1993-1#1)(1993-11#3)(1993-12#5)(1993-2#4)(1993-3#2)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#2)(1993-9#4)(1994-10#2)(1994-11#4)(1994-12#2)(1994-2#7)(1994-3#7)(1994-4#2)(1994-5#2)(1994-6#4)(1994-7#1)(1994-8#9)(1994-9#6)(1995-1#7)(1995-11#1)(1995-12#2)(1995-3#7)(1995-4#3)(1995-5#2)(1995-6#5)(1995-7#2)(1995-8#4)(1995-9#1)(1996-1#2)(1996-10#5)(1996-12#6)(1996-2#4)(1996-3#6)(1996-4#1)(1996-5#4)(1996-6#3)(1996-7#2)(1996-8#3)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#4)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#7)(2004-11#1)(2004-12#3)(2004-4#1)(2004-7#1)(2004-9#1)(2005-1#2)(2005-10#1)(2005-11#5)(2005-12#3)(2005-7#4)(2005-8#1)(2005-9#1)(2006-10#16)(2006-12#7)(2006-2#4)(2006-4#1)(2006-5#1)(2006-6#5)(2006-7#1)(2006-8#4)(2006-9#4)(2007-1#4)(2007-10#10)(2007-11#12)(2007-12#13)(2007-2#3)(2007-3#4)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#8)(2007-8#8)(2007-9#5)(2008-1#9)(2008-10#39)(2008-11#18)(2008-12#7)(2008-2#5)(2008-3#11)(2008-4#13)(2008-5#11)(2008-6#3)(2008-7#11)(2008-8#16)(2008-9#8)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#7)(2009-2#2)(2009-3#7)(2009-4#4)(2009-5#7)(2009-6#3)(2009-7#2)(2009-8#7)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#10)(2010-2#7)(2010-3#5)(2010-4#7)(2010-5#4)(2010-6#1)(2010-7#5)(2010-8#4)(2010-9#2)(2011-1#7)(2011-2#22)(2011-3#1)(2011-7#2)(2012-1#5)(2012-11#3)(2012-12#9)(2012-2#21)(2012-3#9)(2012-9#1)(2013-1#29)(2013-7#6)(2013-8#10)
which means that a##2##4##(1991-12#1)(2008-10#1)
which means that the##3##4##(2008-3#1)(2008-5#1)(2008-8#1)
which means that##16##3##(1990-2#1)(1990-9#1)(1991-12#1)(1991-8#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-4#1)(2013-1#1)(2013-8#1)
which means##20##2##(1990-2#1)(1990-9#1)(1991-12#1)(1991-8#1)(1997-6#2)(2005-11#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)(2010-4#1)(2013-1#1)(2013-8#1)
which meant that the##2##4##(2005-11#1)(2011-3#1)
which meant that##3##3##(2005-11#1)(2008-10#1)(2011-3#1)
which meant##4##2##(1990-8#1)(2005-11#1)(2008-10#1)(2011-3#1)
which measure the##2##3##(2005-5#1)(2008-2#1)
which measure##5##2##(1995-2#1)(2005-5#1)(2008-2#1)(2008-4#1)(2012-12#1)
which measured exposure during##2##4##(1993-1#2)
which measured##8##2##(1993-1#2)(1996-6#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-2#1)(2013-1#1)
which measurement##2##2##(1994-8#1)(2009-4#1)
which measurements##4##2##(1990-2#1)(1995-4#1)(2007-11#1)(2008-3#1)
which measures colorimetric reaction of tyrosyl residues in##2##8##(2008-1#1)(2008-2#1)
which measures of##2##3##(1997-2#1)(2008-3#1)
which measures the average##2##4##(1997-7#1)(2007-12#1)
which measures the diffusion##2##4##(2005-11#1)(2007-5#1)
which measures the##14##3##(1990-8#1)(1994-3#1)(1996-5#2)(1997-2#1)(1997-7#1)(2005-11#2)(2007-12#1)(2007-5#1)(2008-2#1)(2008-3#2)(2012-12#1)
which measures##26##2##(1990-2#1)(1990-8#1)(1991-6#1)(1992-1#1)(1994-3#1)(1996-3#1)(1996-5#2)(1997-2#2)(1997-7#1)(2005-11#2)(2007-12#1)(2007-5#1)(2008-1#1)(2008-2#2)(2008-3#4)(2008-9#1)(2009-4#1)(2012-12#1)(2013-8#1)
which mechanical##3##2##(2005-8#1)(2006-6#1)(2008-2#1)
which mechanism##2##2##(1997-1#1)(2010-11#1)
which mediate the##3##3##(1991-5#1)(1997-7#1)(2008-8#1)
which mediate##16##2##(1990-2#1)(1991-10#1)(1991-5#1)(1991-6#1)(1994-11#1)(1994-8#1)(1995-6#1)(1996-12#2)(1997-7#1)(2005-9#1)(2008-8#3)(2009-9#1)(2012-2#1)
which mediated##2##2##(1993-3#1)(2008-8#1)
which mediates DNA##2##3##(1995-8#1)(2012-1#1)
which mediates the##8##3##(1991-11#1)(1991-7#1)(1993-2#1)(1996-12#1)(1996-8#1)(2009-7#1)(2009-9#1)(2012-12#1)
which mediates transcriptional##2##3##(1992-12#1)(1997-2#1)
which mediates##20##2##(1991-11#1)(1991-7#1)(1992-12#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-9#1)(1995-8#2)(1996-12#1)(1996-5#1)(1996-8#1)(1997-2#1)(2007-8#1)(2009-7#1)(2009-9#1)(2012-1#1)(2012-12#1)
which medical##4##2##(1995-2#1)(1997-1#1)(2007-8#1)(2011-1#1)
which medicine was##2##3##(2007-5#1)(2008-12#1)
which medicine##4##2##(2007-5#1)(2008-12#1)(2008-7#1)(2013-8#1)
which meet##2##2##(2005-5#1)(2007-2#1)
which meets the##2##3##(2008-10#1)(2013-1#1)
which meets##3##2##(2007-9#1)(2008-10#1)(2013-1#1)
which membrane##2##2##(2008-6#1)(2009-5#1)
which men##2##2##(2009-5#2)
which merge##2##2##(1997-4#1)(2011-2#1)
which met the##3##3##(2007-9#1)(2008-2#1)(2009-7#1)
which met##7##2##(1991-2#1)(2005-10#1)(2007-9#1)(2008-2#1)(2009-7#1)(2010-1#1)(2011-2#1)
which metastases##2##2##(1993-10#1)(2007-8#1)
which might act as a##2##5##(1992-11#1)(2008-2#1)
which might also##2##3##(2010-10#1)(2012-2#1)
which might be a##2##4##(1996-1#1)(2008-10#1)
which might be due to##3##5##(1993-8#1)(2008-10#1)(2008-9#1)
which might be explained by##2##5##(1997-5#1)(2008-10#1)
which might be involved in##3##5##(1993-11#1)(1994-2#1)(1997-8#1)
which might be related to##2##5##(1995-8#1)(2008-5#1)
which might be##29##3##(1990-8#1)(1992-12#1)(1993-11#1)(1993-8#1)(1994-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-8#1)(1997-5#1)(1997-8#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-5#4)(2008-8#3)(2008-9#1)(2010-4#1)(2011-2#1)
which might contribute to the##2##5##(2008-8#1)(2010-12#1)
which might contribute to##3##4##(1993-8#1)(2008-8#1)(2010-12#1)
which might explain the##6##4##(1990-2#1)(1991-11#1)(1995-3#1)(2007-9#1)(2008-5#1)(2012-12#1)
which might explain##7##3##(1990-2#1)(1991-11#1)(1995-3#1)(2007-9#1)(2008-5#1)(2009-6#1)(2012-12#1)
which might have a protective effect##2##6##(2008-7#1)(2011-2#1)
which might have a##3##4##(1996-3#1)(2008-7#1)(2011-2#1)
which might have resulted##2##4##(2007-2#1)(2008-7#1)
which might have##12##3##(1996-3#1)(1997-2#1)(2006-6#1)(2006-9#1)(2007-2#1)(2007-3#1)(2008-5#1)(2008-7#2)(2009-1#1)(2011-2#1)(2012-2#1)
which might help to##2##4##(1992-3#1)(2008-8#1)
which might induce the##2##4##(2006-8#1)(2008-11#1)
which might induce##3##3##(2006-8#1)(2008-11#1)(2011-2#1)
which might influence##2##3##(1990-12#1)(2008-10#1)
which might involve##2##3##(1990-2#1)(2013-7#1)
which might lead to##2##4##(1995-11#1)(2008-3#1)
which might lead##3##3##(1995-11#1)(2008-3#1)(2012-1#1)
which might not##2##3##(1994-5#1)(2007-8#1)
which might represent##2##3##(2007-12#1)(2011-2#1)
which might##99##2##(1990-12#1)(1990-2#2)(1990-8#2)(1991-11#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#1)(1993-11#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-4#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-2#1)(2008-3#1)(2008-5#6)(2008-7#3)(2008-8#5)(2008-9#3)(2009-1#1)(2009-6#2)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2013-7#1)(2013-8#1)
which migrate at##3##3##(1994-2#2)(1994-9#1)
which migrate to##2##3##(2007-11#1)(2009-5#1)
which migrate##7##2##(1992-10#1)(1994-2#2)(1994-9#1)(1996-4#1)(2007-11#1)(2009-5#1)
which migrates##2##2##(1991-4#1)(1996-5#1)
which mimic the##3##3##(1990-8#1)(1997-4#1)(2008-8#1)
which mimic##6##2##(1990-8#1)(1991-5#1)(1993-6#1)(1997-4#1)(2007-10#1)(2008-8#1)
which mimicked a##2##3##(2009-5#1)(2010-5#1)
which mimicked##4##2##(2007-7#1)(2009-5#1)(2010-5#1)(2013-8#1)
which mimics##10##2##(1990-11#2)(1990-7#1)(1993-12#1)(1995-12#1)(1995-3#1)(1997-7#1)(2007-11#1)(2008-10#1)(2012-1#1)
which minimized##2##2##(1993-1#1)(1993-2#1)
which minimizes interference##2##3##(1996-12#1)(2013-7#1)
which minimizes the##2##3##(2007-8#1)(2008-3#1)
which minimizes##7##2##(1996-12#1)(2007-8#1)(2008-2#2)(2008-3#1)(2008-9#1)(2013-7#1)
which mixtures##2##2##(1992-10#1)(1996-7#1)
which model##5##2##(1994-11#1)(2006-10#1)(2008-5#1)(2008-9#1)(2012-3#1)
which models##4##2##(1995-10#1)(2005-10#1)(2007-12#1)(2008-8#1)
which modified##2##2##(2007-11#1)(2011-2#1)
which modifies the##3##3##(1997-6#1)(2007-8#1)(2013-1#1)
which modifies##4##2##(1997-6#1)(2007-8#1)(2008-12#1)(2013-1#1)
which modify##3##2##(2008-10#1)(2011-1#1)(2013-7#1)
which modulate their##2##3##(1996-4#1)(1997-7#1)
which modulate##12##2##(1990-6#1)(1991-10#1)(1993-3#1)(1995-5#1)(1996-1#1)(1996-4#1)(1997-7#1)(2006-2#1)(2008-4#1)(2009-3#3)
which modulates##6##2##(1990-1#2)(1994-9#1)(1995-2#1)(2008-11#1)(2008-4#1)
which molecular analysis##2##3##(2012-3#2)
which molecular##8##2##(1994-5#1)(1994-6#1)(2008-10#1)(2008-3#1)(2009-5#1)(2012-12#1)(2012-3#2)
which monitors the##2##3##(1995-3#1)(2008-10#1)
which monitors##5##2##(1990-2#1)(1995-3#1)(2007-4#1)(2008-10#1)(2008-7#1)
which more than 80%##2##4##(2007-12#1)(2009-2#1)
which more than##6##3##(2007-12#1)(2008-10#1)(2009-2#1)(2011-2#2)(2011-3#1)
which more##11##2##(2006-5#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-2#1)(2010-12#1)(2011-2#2)(2011-3#1)(2012-12#1)
which most likely##4##3##(1994-2#1)(1995-3#1)(2006-10#1)(2008-7#1)
which most of the##3##4##(2008-11#1)(2008-5#1)(2011-1#1)
which most##17##2##(1992-7#1)(1994-2#1)(1995-3#1)(1996-7#1)(2006-10#2)(2007-12#1)(2007-9#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
which mostly concerns##2##3##(2007-11#1)(2007-8#1)
which mostly##3##2##(1997-2#1)(2007-11#1)(2007-8#1)
which mothers##3##2##(2009-5#2)(2009-6#1)
which motivated the##3##3##(1990-6#1)(1996-6#1)(2009-4#1)
which motivated##4##2##(1990-6#1)(1996-6#1)(2009-4#1)(2012-2#1)
which motor vehicles##2##3##(2005-8#1)(2012-1#1)
which multiple##11##2##(1991-4#1)(1992-12#1)(1995-3#1)(2005-10#1)(2008-1#1)(2008-10#1)(2008-8#2)(2009-12#1)(2009-5#1)(2013-1#1)
which must be considered##2##4##(1993-11#1)(1994-9#1)
which must be taken into account##2##6##(1995-3#1)(2005-1#1)
which must be taken into consideration##2##6##(1991-11#1)(2007-11#1)
which must be taken into##4##5##(1991-11#1)(1995-3#1)(2005-1#1)(2007-11#1)
which must be unprotonated for##2##5##(1994-11#2)
which must be##23##3##(1990-11#1)(1991-11#1)(1993-10#1)(1993-11#1)(1993-3#1)(1994-11#2)(1994-8#1)(1994-9#1)(1995-3#1)(1995-9#1)(1996-3#1)(1997-3#1)(2005-1#2)(2006-10#1)(2007-11#1)(2008-2#2)(2008-9#1)(2009-10#1)(2010-3#1)(2011-2#1)
which must##27##2##(1990-11#1)(1991-11#1)(1993-10#1)(1993-11#1)(1993-3#1)(1994-11#2)(1994-8#1)(1994-9#1)(1995-3#1)(1995-9#1)(1996-11#1)(1996-3#1)(1997-3#1)(2005-1#2)(2006-10#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-10#1)(2010-3#1)(2011-2#1)
which mutations##3##2##(1992-1#1)(2008-10#1)(2011-1#1)
which natural##2##2##(1995-2#1)(2005-7#1)
which naturally##4##2##(1991-3#1)(1994-8#1)(2005-10#1)(2012-12#1)
which nearly all##2##3##(1996-8#1)(2008-9#1)
which nearly##4##2##(1996-8#1)(2008-10#1)(2008-9#1)(2009-8#1)
which necessitated##3##2##(2006-12#1)(2008-3#1)(2012-2#1)
which need a##2##3##(2007-12#1)(2011-2#1)
which need to be considered##2##5##(2007-8#1)(2008-1#1)
which need to be##8##4##(1997-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2011-1#1)(2011-2#1)
which need to##9##3##(1997-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2011-1#1)(2011-2#1)
which need##12##2##(1997-8#1)(2006-3#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2011-1#1)(2011-2#2)
which needs further investigation##4##4##(2007-2#1)(2012-12#1)(2013-1#2)
which needs further##5##3##(2007-2#1)(2008-1#1)(2012-12#1)(2013-1#2)
which needs to be addressed##2##5##(2009-3#1)(2010-10#1)
which needs to be##9##4##(1994-4#1)(2006-8#1)(2007-2#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-10#1)(2012-1#1)(2013-7#1)
which needs##18##2##(1994-4#1)(2006-6#1)(2006-8#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-12#1)(2008-5#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-10#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
which neither##2##2##(1992-1#1)(2006-6#1)
which neural##2##2##(1996-2#1)(2008-11#1)
which neurons##3##2##(1996-9#1)(1997-3#1)(2009-5#1)
which neutralizes the##2##3##(1990-11#1)(2008-5#1)
which nevertheless##3##2##(2008-7#1)(2009-5#1)(2011-1#1)
which new##9##2##(1990-12#1)(1997-3#1)(1997-5#1)(1997-7#1)(2005-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2009-6#1)
which nine##4##2##(1993-7#1)(2007-8#2)(2012-1#1)
which no longer##3##3##(1995-3#1)(1996-6#1)(2008-11#1)
which no##36##2##(1990-10#1)(1990-11#1)(1991-5#1)(1992-5#2)(1992-9#1)(1993-2#1)(1994-2#1)(1995-1#1)(1995-3#1)(1996-6#1)(1997-2#1)(2005-12#1)(2005-7#3)(2005-8#1)(2006-8#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-7#1)(2012-2#1)(2013-1#1)
which nonlinear##2##2##(2008-3#2)
which normally##10##2##(1994-2#1)(1994-9#1)(1995-3#1)(2005-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-10#1)(2010-7#1)
which not only provides##2##4##(2005-11#1)(2008-8#1)
which not only##13##3##(1995-12#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-8#1)(2012-12#1)(2012-2#1)
which now##8##2##(1991-11#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-5#3)(2012-1#1)
which nurse##2##2##(2007-12#1)(2010-6#1)
which nursing##4##2##(2005-12#1)(2008-11#1)(2008-12#1)(2011-1#1)
which obesity##2##2##(2006-2#1)(2011-2#1)
which obeys##2##2##(2008-10#2)
which observed##2##2##(2008-8#2)
which occupies a##2##3##(1990-11#1)(2008-8#1)
which occupy the##2##3##(1995-11#1)(2005-4#1)
which occupy##5##2##(1991-12#1)(1991-8#1)(1995-11#1)(2005-4#1)(2009-5#1)
which occur at##5##3##(1991-2#1)(1994-12#1)(1994-5#1)(2005-8#1)(2010-12#1)
which occur during the##3##4##(1991-2#1)(1995-4#1)(2007-12#1)
which occur during##8##3##(1990-9#1)(1991-2#1)(1995-4#1)(1996-10#1)(1997-8#1)(2007-12#1)(2007-4#1)(2008-1#1)
which occur frequently in##2##4##(1997-2#1)(2009-3#1)
which occur in a##2##4##(1994-6#1)(2013-8#1)
which occur in the##2##4##(1990-7#1)(2008-10#1)
which occur in these##2##4##(1994-5#1)(2008-7#1)
which occur in##14##3##(1990-11#1)(1990-7#1)(1993-2#1)(1994-5#2)(1994-6#2)(2006-12#1)(2008-10#1)(2008-7#1)(2009-6#1)(2010-1#1)(2010-11#1)(2013-8#1)
which occur when##2##3##(1993-4#1)(1996-11#1)
which occur within the##2##4##(1990-6#1)(1997-6#1)
which occur##43##2##(1990-11#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-2#2)(1991-9#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-4#1)(1994-12#1)(1994-5#3)(1994-6#2)(1995-4#1)(1996-10#1)(1996-11#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-8#1)(2006-12#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-12#1)(2013-8#1)
which occurred as a##2##4##(2010-11#1)(2012-12#1)
which occurred as##4##3##(1992-12#1)(2009-2#1)(2010-11#1)(2012-12#1)
which occurred at a##2##4##(2006-12#1)(2008-11#1)
which occurred at the##3##4##(1995-8#1)(2007-8#1)(2008-10#1)
which occurred at##7##3##(1993-2#1)(1995-8#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2012-11#1)
which occurred during##3##3##(1993-10#1)(1995-6#1)(2011-1#1)
which occurred in a##5##4##(1991-11#1)(1991-9#1)(2005-8#1)(2008-11#1)(2013-1#1)
which occurred in the##3##4##(1995-8#1)(2005-4#1)(2011-2#1)
which occurred in##20##3##(1990-10#1)(1990-9#1)(1991-11#2)(1991-9#1)(1995-2#1)(1995-8#1)(1997-5#1)(2005-4#1)(2005-8#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
which occurred when##2##3##(1991-3#1)(2004-1#1)
which occurred within##2##3##(2007-7#1)(2007-8#1)
which occurred##54##2##(1990-10#1)(1990-9#1)(1991-11#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-10#1)(1993-2#1)(1995-2#1)(1995-6#2)(1995-8#2)(1997-1#1)(1997-5#1)(2004-1#1)(2005-4#1)(2005-8#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#4)(2013-1#3)(2013-8#3)
which occurs after##2##3##(1996-5#1)(2008-10#1)
which occurs at##8##3##(1990-11#1)(1990-7#1)(1997-7#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-3#1)(2010-1#1)
which occurs during the##3##4##(1990-8#1)(2007-5#1)(2009-12#1)
which occurs during##5##3##(1990-12#1)(1990-8#1)(2005-7#1)(2007-5#1)(2009-12#1)
which occurs in a##2##4##(1994-3#1)(2007-5#1)
which occurs in most##2##4##(1996-10#1)(2008-6#1)
which occurs in the##7##4##(1994-11#1)(1995-6#1)(1996-3#1)(2007-10#1)(2007-11#1)(2008-5#1)(2010-9#1)
which occurs in##24##3##(1990-12#1)(1992-1#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-6#2)(1996-10#1)(1996-2#1)(1996-3#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2010-9#1)(2011-2#1)
which occurs mainly in##2##4##(2008-10#2)
which occurs through the##2##4##(1995-6#1)(2012-1#1)
which occurs within the##2##4##(1993-2#1)(2013-8#1)
which occurs##68##2##(1990-11#1)(1990-12#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#1)(1992-1#1)(1992-2#1)(1993-2#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-7#1)(1994-8#2)(1995-3#1)(1995-6#3)(1996-10#2)(1996-2#2)(1996-3#1)(1996-5#2)(1996-7#1)(1997-7#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-10#2)(2007-11#2)(2007-5#2)(2008-1#2)(2008-10#6)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-1#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-7#1)(2013-8#1)
which of its##2##3##(1991-5#1)(2008-9#1)
which of several##3##3##(1996-1#1)(2006-10#1)(2008-2#1)
which of the two##4##4##(1993-11#1)(2008-2#1)(2008-4#1)(2012-1#1)
which of the##19##3##(1990-6#1)(1993-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-5#1)(1996-5#1)(1996-6#1)(1997-1#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-8#1)(2011-12#1)(2012-1#1)(2012-2#1)
which of these three##2##4##(2006-4#1)(2008-8#1)
which of these two##4##4##(2007-11#1)(2007-12#1)(2008-4#1)(2009-8#1)
which of these##12##3##(1991-9#1)(1996-5#1)(2006-10#1)(2006-4#1)(2007-11#2)(2007-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)
which of##40##2##(1990-6#1)(1991-5#1)(1991-9#1)(1993-11#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-5#1)(1996-1#1)(1996-5#2)(1996-6#1)(1997-1#1)(2006-10#2)(2006-4#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#2)(2011-1#1)(2011-12#1)(2012-1#1)(2012-2#1)
which offer##2##2##(1992-1#1)(2008-2#1)
which offers a##3##3##(2007-7#1)(2008-2#1)(2012-1#1)
which offers an##3##3##(2005-4#1)(2008-11#1)(2013-1#1)
which offers new##2##3##(1997-8#1)(2010-12#1)
which offers the##2##3##(2004-2#1)(2008-10#1)
which offers##15##2##(1997-8#1)(2004-2#1)(2005-4#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-8#1)(2010-12#1)(2012-1#1)(2012-3#1)(2013-1#1)
which often are##2##3##(1996-12#1)(2008-9#1)
which often can##2##3##(1994-9#1)(2008-3#1)
which often have##2##3##(1994-5#1)(2008-10#1)
which often lead to##2##4##(1997-4#1)(2010-2#1)
which often leads to##2##4##(2006-11#1)(2006-6#1)
which often requires cataloguing of concomitant conditions (&quot##2##8##(2013-1#2)
which often requires##3##3##(2013-1#2)(2013-8#1)
which often##29##2##(1992-9#1)(1993-10#1)(1993-11#1)(1994-11#1)(1994-4#1)(1994-5#2)(1994-9#1)(1996-12#1)(1997-4#1)(2005-11#2)(2006-11#1)(2006-6#1)(2006-9#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-6#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
which on histopathology##2##3##(2007-8#1)(2012-3#1)
which on the one hand##2##5##(1991-3#1)(2007-11#1)
which on the##3##3##(1991-3#1)(2007-11#1)(2008-3#1)
which on##19##2##(1990-2#1)(1990-5#1)(1991-3#1)(1991-9#1)(1995-5#1)(2006-10#1)(2007-11#2)(2007-3#1)(2007-8#3)(2008-3#1)(2008-8#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
which one can##7##3##(1992-6#1)(1993-1#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-4#1)
which one is##4##3##(2008-10#2)(2008-6#1)(2009-10#1)
which one isolate##2##3##(2005-11#1)(2008-10#1)
which one may##2##3##(2007-12#1)(2009-8#1)
which one might##3##3##(1996-9#1)(2006-12#1)(2012-2#1)
which one or more##2##4##(1994-3#1)(2012-3#1)
which one or##5##3##(1993-3#2)(1994-3#1)(1994-6#1)(2012-3#1)
which one##54##2##(1990-6#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-3#3)(1993-5#1)(1994-3#1)(1994-6#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-8#1)(2005-11#1)(2006-12#1)(2007-12#5)(2007-9#1)(2008-10#7)(2008-2#3)(2008-3#2)(2008-4#4)(2008-6#1)(2008-7#2)(2009-10#1)(2009-8#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#2)
which ones##4##2##(1997-4#1)(2007-11#1)(2007-8#1)(2011-2#1)
which only a##6##3##(1993-3#1)(1994-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-11#1)
which only one##6##3##(1990-11#1)(1996-11#1)(2006-12#1)(2007-11#1)(2007-8#1)(2009-6#1)
which only two##2##3##(2007-1#1)(2012-12#1)
which only##53##2##(1990-11#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-4#1)(1992-3#1)(1993-3#2)(1994-10#1)(1994-8#1)(1995-10#1)(1996-11#1)(1996-6#1)(1997-2#3)(2005-9#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
which opens##4##2##(2007-12#1)(2009-5#1)(2010-2#1)(2012-11#1)
which operate##2##2##(1995-3#1)(1996-9#1)
which operates at##2##3##(2007-11#1)(2008-3#1)
which operates in the##2##4##(2007-11#1)(2008-3#1)
which operates in##3##3##(2007-11#1)(2008-3#2)
which operates##10##2##(1994-8#1)(1995-8#1)(2007-11#2)(2007-12#1)(2008-12#1)(2008-3#3)(2008-7#1)
which optical##4##2##(1995-8#1)(2007-11#1)(2007-12#1)(2013-1#1)
which optimal##2##2##(2007-12#1)(2008-9#1)
which optimizes##2##2##(2008-10#1)(2008-4#1)
which originate from the##2##4##(1995-3#1)(2009-1#1)
which originated##3##2##(1993-11#1)(1993-12#1)(2008-10#1)
which originates from the##2##4##(2008-3#1)(2009-6#1)
which originates from##4##3##(2008-10#2)(2008-3#1)(2009-6#1)
which oscillates##2##2##(1991-7#1)(2007-9#1)
which other##7##2##(1995-2#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2009-9#1)
which otherwise##4##2##(1991-5#1)(1993-2#1)(1995-3#1)(2012-2#1)
which our knowledge is still incomplete##2##6##(1990-8#1)(1992-11#1)
which our##7##2##(1990-8#1)(1992-11#1)(2006-10#1)(2009-4#1)(2010-4#1)(2011-2#1)(2012-3#1)
which outlines##2##2##(1993-3#1)(2007-3#1)
which ovarian##2##2##(2006-1#1)(2010-8#1)
which over##2##2##(1992-9#1)(2008-10#1)
which overcomes the##4##3##(2005-9#1)(2007-12#1)(2008-10#2)
which overcomes##5##2##(2005-9#1)(2007-12#1)(2008-10#2)(2012-3#1)
which overexpress##3##2##(1990-5#1)(2008-11#1)(2011-1#1)
which overlapped##2##2##(2008-10#2)
which overlaps the##2##3##(1996-5#1)(2008-8#1)
which overlaps##4##2##(1990-1#1)(1995-10#1)(1996-5#1)(2008-8#1)
which oxidative stress##2##3##(1994-5#1)(2008-5#1)
which oxidized##2##2##(1992-2#1)(2008-10#1)
which oxidizes the##2##3##(1991-7#1)(2008-10#1)
which oxidizes##3##2##(1990-7#1)(1991-7#1)(2008-10#1)
which pairs of##2##3##(1995-5#1)(2011-2#1)
which parallel the##2##3##(1993-8#1)(1997-2#1)
which paralleled the##2##3##(1990-4#1)(2009-9#1)
which parallels the##2##3##(1991-3#1)(1992-7#1)
which parameter##3##2##(1994-5#1)(2008-10#1)(2009-10#1)
which parental##3##2##(2009-10#1)(2009-7#1)(2010-12#1)
which parents are##3##3##(1992-11#1)(1992-2#1)(1995-12#1)
which parents##7##2##(1992-11#1)(1992-2#1)(1994-2#1)(1995-12#1)(2005-7#1)(2010-10#1)(2012-12#1)
which part of the##2##4##(2006-2#1)(2007-12#1)
which part of##3##3##(2006-2#1)(2007-12#1)(2011-2#1)
which partially##5##2##(1990-11#1)(1992-6#1)(2006-10#1)(2008-10#2)
which participants##12##2##(1994-7#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#2)(2009-10#1)(2009-5#1)(2009-9#1)(2012-12#2)
which participate in the##3##4##(1991-11#1)(1992-5#1)(1994-8#1)
which participate in##5##3##(1990-11#1)(1991-11#1)(1992-5#1)(1994-8#1)(2013-1#1)
which participated##2##2##(2010-3#1)(2010-6#1)
which participates in the##2##4##(2008-10#2)
which participates##3##2##(2008-10#2)(2011-1#1)
which particular##5##2##(1993-9#1)(2006-9#1)(2007-12#1)(2009-8#1)(2011-1#1)
which particularly##3##2##(1993-6#1)(2006-2#1)(2007-7#1)
which parts of the##2##4##(2008-7#1)(2012-2#1)
which party##2##2##(2006-5#1)(2008-8#1)
which pass through the##2##4##(1996-11#1)(2008-7#1)
which passes##2##2##(1994-8#1)(2008-10#1)
which patient##3##2##(2006-2#1)(2010-12#1)(2012-11#1)
which patients are at highest risk for##2##7##(2008-7#1)(2010-12#1)
which patients are most##3##4##(2010-12#1)(2013-1#2)
which patients are##7##3##(2008-7#1)(2010-12#2)(2010-9#1)(2011-2#1)(2013-1#2)
which patients benefit the most##2##5##(2008-8#1)(2013-1#1)
which patients may##2##3##(2008-10#1)(2008-6#1)
which patients need##2##3##(1996-8#1)(2008-11#1)
which patients should receive##2##4##(1993-12#1)(1995-10#1)
which patients should##4##3##(1993-12#1)(1994-2#1)(1995-10#1)(2008-6#1)
which patients were##3##3##(1993-2#1)(2012-2#1)(2012-3#1)
which patients will##5##3##(2006-10#2)(2007-5#1)(2008-5#1)(2008-6#1)
which patients with##5##3##(1994-2#1)(2008-1#1)(2008-11#1)(2012-2#2)
which patients##43##2##(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#3)(1995-10#1)(1996-12#1)(1996-8#1)(2006-10#4)(2006-8#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2010-10#1)(2010-12#3)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#4)(2012-3#2)(2013-1#3)
which patterns##2##2##(2008-3#1)(2009-8#1)
which peaked approximately##2##3##(1991-12#1)(2008-10#1)
which peaked at##3##3##(1990-2#1)(1990-4#1)(2012-12#1)
which peaked##6##2##(1990-2#1)(1990-4#1)(1991-12#1)(2008-10#1)(2008-11#1)(2012-12#1)
which peaks##2##2##(2008-8#1)(2010-11#1)
which pelvic##2##2##(2006-11#1)(2006-9#1)
which penetrated##2##2##(1990-5#1)(2006-7#1)
which people##3##2##(2009-5#1)(2010-4#1)(2011-1#1)
which peptide##2##2##(2006-12#1)(2008-4#1)
which percutaneous##2##2##(1990-12#1)(2006-11#1)
which performs a##2##3##(2008-2#1)(2008-4#1)
which performs##5##2##(2005-5#1)(2008-10#1)(2008-2#1)(2008-4#1)(2012-3#1)
which period##2##2##(2006-9#1)(2013-1#1)
which peripheral blood##2##3##(1991-12#1)(2008-4#1)
which peripheral##4##2##(1991-12#1)(1991-3#1)(2006-12#1)(2008-4#1)
which permit the##3##3##(2008-2#1)(2008-5#1)(2009-12#1)
which permit##8##2##(1993-12#1)(1997-3#1)(2007-11#1)(2008-2#3)(2008-5#1)(2009-12#1)
which permits a##3##3##(2007-5#1)(2008-2#2)
which permits an##3##3##(1994-12#1)(2008-10#1)(2008-4#1)
which permits the determination of##3##5##(2008-10#2)(2008-2#1)
which permits the use of##2##5##(2007-12#1)(2008-3#1)
which permits the##9##3##(1990-12#1)(1995-3#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)
which permits to classify the present method as green##2##9##(2008-10#2)
which permits##33##2##(1990-12#2)(1991-2#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-5#1)(2005-11#1)(2007-12#4)(2007-5#1)(2008-10#5)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2009-5#1)(2010-11#1)
which permitted the##2##3##(1994-12#1)(1995-2#1)
which permitted##8##2##(1992-6#1)(1994-12#1)(1995-2#1)(2008-10#2)(2008-6#1)(2010-2#1)(2012-2#1)
which persist##2##2##(1997-8#1)(2008-10#1)
which persisted at##2##3##(1991-12#1)(1991-7#1)
which persisted for##4##3##(1990-12#1)(2009-12#1)(2009-2#1)(2012-2#1)
which persisted##13##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-7#1)(1992-9#1)(1993-5#1)(1997-7#1)(2007-12#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-2#1)(2012-2#1)
which persists for##2##3##(2005-11#1)(2008-4#1)
which personality##2##2##(2008-5#1)(2011-1#1)
which pesticides##2##2##(2008-10#2)
which phase##4##2##(2008-2#1)(2008-3#1)(2008-5#1)(2012-3#1)
which phosphorus##2##2##(2007-9#1)(2008-10#1)
which phosphorylate##4##2##(1996-4#1)(2008-4#2)(2011-2#1)
which phosphorylates##2##2##(1993-12#1)(1993-3#1)
which physicians##5##2##(1991-12#1)(1993-2#1)(2006-10#2)(2006-12#1)
which physiologic##2##2##(1994-3#1)(2010-7#1)
which places the##3##3##(1992-12#1)(1994-9#1)(2005-11#1)
which places##6##2##(1992-12#1)(1994-3#1)(1994-9#1)(2005-11#1)(2007-11#1)(2012-2#1)
which plant##2##2##(2008-9#1)(2009-3#1)
which plants##2##2##(2008-10#2)
which play a key role in the##2##7##(1996-4#1)(2008-10#1)
which play a key role in##3##6##(1996-4#1)(2007-2#1)(2008-10#1)
which play a role in##5##5##(1995-2#1)(2005-7#1)(2008-3#1)(2008-5#1)(2010-7#1)
which play a##11##3##(1990-5#1)(1995-2#1)(1996-4#1)(2005-7#1)(2007-2#1)(2008-10#2)(2008-3#2)(2008-5#1)(2010-7#1)
which play an important role in the##2##7##(2010-2#1)(2012-2#1)
which play an important role in##3##6##(2008-10#1)(2010-2#1)(2012-2#1)
which play an important##4##4##(1995-6#1)(2008-10#1)(2010-2#1)(2012-2#1)
which play crucial roles in##2##5##(2009-8#1)(2012-12#1)
which play important roles in##2##5##(2007-11#1)(2010-9#1)
which play##22##2##(1990-5#1)(1992-12#1)(1995-2#1)(1995-6#1)(1996-4#1)(2005-7#1)(2007-1#1)(2007-11#1)(2007-2#1)(2008-10#4)(2008-3#2)(2008-5#1)(2009-8#1)(2010-2#1)(2010-7#1)(2010-9#1)(2012-12#1)(2012-2#1)
which plays a central role in##2##6##(2009-9#1)(2010-2#1)
which plays a critical role in##2##6##(2008-11#1)(2012-2#1)
which plays a crucial role in##2##6##(2008-11#1)(2009-12#1)
which plays a key role in the##3##7##(1991-5#1)(2007-11#1)(2011-1#1)
which plays a key role in##4##6##(1991-5#1)(2007-11#1)(2009-3#1)(2011-1#1)
which plays a##13##3##(1991-5#1)(2007-11#1)(2008-11#2)(2009-12#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-2#1)(2011-1#1)(2012-2#1)
which plays an essential role in##2##6##(1997-3#1)(2006-2#1)
which plays an important role in##4##6##(1991-4#1)(1993-11#1)(1996-1#1)(2008-10#1)
which plays an important role##5##5##(1991-4#1)(1993-11#1)(1996-1#1)(2008-10#1)(2013-7#1)
which plays an##7##3##(1991-4#1)(1993-11#1)(1996-1#1)(1997-3#1)(2006-2#1)(2008-10#1)(2013-7#1)
which plays##22##2##(1991-4#1)(1991-5#1)(1993-11#1)(1996-1#1)(1996-11#1)(1997-3#1)(2006-2#1)(2007-11#1)(2008-10#2)(2008-11#2)(2009-12#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-2#1)(2011-1#1)(2012-2#1)(2013-7#1)
which point to a##2##4##(1995-10#1)(2011-1#1)
which point##7##2##(1991-3#1)(1995-10#1)(1996-2#1)(2008-3#1)(2011-1#1)(2012-12#1)(2013-8#1)
which points to the##4##4##(1990-5#1)(2006-10#1)(2007-7#1)(2010-8#1)
which points to##5##3##(1990-5#2)(2006-10#1)(2007-7#1)(2010-8#1)
which points towards##2##3##(1995-12#1)(2006-4#1)
which points##8##2##(1990-5#2)(1993-8#1)(1995-12#1)(2006-10#1)(2006-4#1)(2007-7#1)(2010-8#1)
which policy##2##2##(1993-12#1)(1994-1#1)
which polyclonal##2##2##(1994-2#1)(2008-4#1)
which populations of##2##3##(2008-10#2)
which poses a##3##3##(2007-8#1)(2008-3#1)(2008-9#1)
which poses##6##2##(1997-2#1)(2007-8#1)(2008-3#1)(2008-9#1)(2009-2#1)(2012-2#1)
which positions##2##2##(1995-11#1)(2010-6#1)
which positive##2##2##(1990-8#1)(1997-6#1)
which posses##2##2##(2008-11#1)(2010-8#1)
which possess a##2##3##(2005-8#1)(2009-12#1)
which possess intrinsic tyrosine kinase activity##2##6##(1992-7#1)(1995-8#1)
which possess##9##2##(1990-5#1)(1992-7#1)(1995-8#1)(2005-8#1)(2006-12#1)(2008-11#1)(2008-3#1)(2009-12#1)(2010-5#1)
which possessed the##2##3##(1992-5#1)(2008-10#1)
which possessed##7##2##(1991-4#1)(1991-9#1)(1992-5#1)(1997-4#1)(2007-12#1)(2008-10#2)
which possesses a##2##3##(1990-7#1)(2008-10#1)
which possesses##9##2##(1990-10#1)(1990-7#1)(1992-1#1)(2005-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)
which possibly##3##2##(1996-11#1)(2011-2#2)
which potentially##2##2##(2007-8#1)(2008-3#1)
which potentiates##2##2##(1990-7#1)(1994-2#1)
which precede##2##2##(1990-9#1)(1994-5#1)
which precedes##2##2##(1990-11#1)(1992-11#1)
which predict##2##2##(2008-11#1)(2013-8#1)
which predicted##2##2##(2006-5#1)(2008-9#1)
which predicts that##4##3##(1995-6#1)(1996-5#1)(1997-6#1)(2008-3#1)
which predicts the##2##3##(1997-6#1)(2008-2#1)
which predicts##9##2##(1995-6#1)(1996-5#1)(1997-6#2)(2008-2#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)
which predispose patients to##2##4##(2007-11#1)(2007-9#1)
which predispose##3##2##(2007-11#1)(2007-9#1)(2008-11#1)
which predominantly##3##2##(2009-2#1)(2010-3#1)(2012-2#1)
which predominates in##2##3##(1992-6#1)(2008-5#1)
which preferentially binds##2##3##(1995-11#1)(2008-11#1)
which preferentially##4##2##(1992-3#1)(1995-11#1)(1995-6#1)(2008-11#1)
which present##10##2##(2006-1#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
which presented to##2##3##(2013-1#2)
which presented with##4##3##(2008-7#2)(2012-2#1)(2013-1#1)
which presented##13##2##(1991-10#1)(2006-10#1)(2008-12#1)(2008-7#3)(2008-8#1)(2011-2#1)(2012-2#2)(2013-1#3)
which presents a##6##3##(1990-3#1)(2006-12#1)(2007-8#1)(2008-10#1)(2012-12#1)(2012-3#1)
which presents the same##2##4##(2007-12#1)(2008-5#1)
which presents##12##2##(1990-3#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-7#1)(2012-12#1)(2012-2#1)(2012-3#1)
which preserves the##2##3##(2008-9#1)(2013-1#1)
which preserves##5##2##(1996-3#1)(2008-2#1)(2008-9#1)(2012-1#1)(2013-1#1)
which presumably##3##2##(1991-10#1)(1995-6#1)(1996-1#1)
which prevent the##3##3##(2005-10#1)(2006-6#1)(2011-2#1)
which prevent##4##2##(1990-11#1)(2005-10#1)(2006-6#1)(2011-2#1)
which prevented the##2##3##(1991-3#1)(2013-1#1)
which prevented##5##2##(1991-10#1)(1991-3#1)(1995-7#1)(2008-11#1)(2013-1#1)
which prevents the##4##3##(1995-2#1)(1995-3#1)(2008-4#1)(2009-12#1)
which prevents##15##2##(1990-8#1)(1991-3#2)(1992-3#1)(1993-7#1)(1995-2#1)(1995-3#1)(1996-9#1)(1997-6#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-12#1)
which previously##6##2##(1995-8#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-12#1)(2010-12#1)
which primarily affects##2##3##(2006-8#1)(2012-2#1)
which primarily##8##2##(1990-6#2)(1992-8#1)(1996-2#1)(2006-8#1)(2007-7#1)(2008-8#1)(2012-2#1)
which primary care##2##3##(2004-3#1)(2006-9#1)
which primary##3##2##(1995-8#1)(2004-3#1)(2006-9#1)
which prior##2##2##(2009-10#1)(2013-1#1)
which probably##16##2##(1991-8#1)(1992-6#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-4#1)(1997-7#2)(1997-8#1)(2006-8#1)(2007-12#2)(2008-10#1)(2012-1#1)(2013-8#1)
which procedures were##2##3##(1997-7#1)(2013-7#1)
which procedures##3##2##(1997-7#1)(2006-10#1)(2013-7#1)
which proceeds##3##2##(1990-3#1)(1990-5#1)(1991-3#1)
which produce a##4##3##(1991-12#1)(2008-11#1)(2008-7#1)(2008-9#1)
which produce the##3##3##(1991-4#1)(2007-8#1)(2010-4#1)
which produce##20##2##(1991-12#1)(1991-4#2)(1993-12#1)(1993-3#1)(1994-11#1)(1995-8#1)(1996-8#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-5#1)(2013-1#1)
which produced a##2##3##(1991-11#1)(2007-10#1)
which produced##18##2##(1990-4#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-5#1)(1991-9#1)(1993-5#1)(1994-6#1)(1995-2#1)(1997-4#1)(2005-11#1)(2007-10#1)(2008-10#3)(2008-3#1)(2008-8#1)
which produces a##11##3##(1990-2#1)(1993-12#1)(1995-8#1)(2004-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)
which produces an##4##3##(1995-8#1)(2007-12#2)(2008-5#1)
which produces##33##2##(1990-2#1)(1990-4#1)(1992-7#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-7#1)(1995-8#2)(1997-3#1)(1997-4#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-8#2)(2007-12#3)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#1)(2013-7#1)
which product-line management##2##3##(1994-3#2)
which products are##2##3##(2011-12#1)(2011-2#1)
which products##5##2##(2008-11#1)(2011-12#2)(2011-2#2)
which progress##2##2##(1995-11#1)(2009-10#1)
which progressed to##3##3##(2009-6#1)(2010-6#1)(2012-2#1)
which progressive##2##2##(1991-6#1)(2010-6#1)
which prohibited##2##2##(1996-6#1)(2007-11#1)
which project##2##2##(1992-11#1)(1994-10#1)
which projects to the##3##4##(1992-8#2)(1994-2#1)
which prolonged the##3##3##(1994-9#1)(2010-12#1)(2012-2#1)
which prolonged##4##2##(1993-11#1)(1994-9#1)(2010-12#1)(2012-2#1)
which promise##2##2##(2007-8#1)(2008-10#1)
which promote the##2##3##(1995-6#1)(1996-4#1)
which promote##8##2##(1995-6#1)(1996-3#1)(1996-4#1)(1996-5#1)(2006-2#1)(2008-1#1)(2009-10#1)(2009-4#1)
which promoted##5##2##(1997-1#1)(2006-9#1)(2009-2#1)(2013-1#2)
which promotes##6##2##(1990-7#1)(1991-2#1)(1994-11#1)(2006-12#2)(2013-1#1)
which prompted us to##2##4##(2007-10#1)(2008-11#1)
which prompted##4##2##(2006-10#1)(2007-10#1)(2008-11#1)(2009-3#1)
which proposes that##4##3##(2005-8#1)(2007-12#1)(2009-4#1)(2010-2#1)
which proposes##5##2##(1996-3#1)(2005-8#1)(2007-12#1)(2009-4#1)(2010-2#1)
which protect against##3##3##(1994-3#1)(1995-11#1)(2009-4#1)
which protect the##3##3##(1995-2#1)(2007-11#1)(2013-8#1)
which protect##8##2##(1994-3#1)(1995-11#2)(1995-2#1)(1996-1#1)(2007-11#1)(2009-4#1)(2013-8#1)
which protected##2##2##(1992-11#1)(2009-7#1)
which protects against##2##3##(1995-3#1)(2005-7#1)
which protects the##2##3##(2007-12#1)(2008-9#1)
which protects##6##2##(1995-3#1)(2005-7#1)(2007-11#1)(2007-12#1)(2008-5#1)(2008-9#1)
which protein##4##2##(1990-10#1)(2009-5#1)(2010-4#1)(2011-2#1)
which proteins are##2##3##(2006-10#1)(2010-12#1)
which proteins##4##2##(1995-1#1)(2006-10#1)(2010-12#1)(2012-2#1)
which proved to be the most##2##6##(1995-12#1)(2008-10#1)
which proved to be##8##4##(1990-5#1)(1992-4#1)(1992-6#1)(1995-12#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#1)
which proved to##9##3##(1990-5#1)(1992-4#1)(1992-6#1)(1995-12#1)(1997-8#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#1)
which proved##16##2##(1990-5#1)(1992-4#1)(1992-6#1)(1995-12#1)(1996-6#1)(1997-8#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-3#1)(2012-2#1)
which proves that##2##3##(2010-4#1)(2011-2#1)
which proves the##2##3##(2008-5#1)(2009-7#1)
which proves##4##2##(2008-5#1)(2009-7#1)(2010-4#1)(2011-2#1)
which provide a##4##3##(1994-11#1)(1994-9#1)(2006-7#1)(2011-1#1)
which provide for##2##3##(2008-7#1)(2008-8#1)
which provide the##5##3##(2005-2#1)(2006-6#1)(2007-7#1)(2008-4#1)(2013-7#1)
which provide us##2##3##(1994-6#1)(2008-12#1)
which provide##24##2##(1990-7#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-9#1)(1996-1#1)(2005-2#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
which provided a##6##3##(1996-3#1)(2006-12#1)(2008-10#2)(2008-5#1)(2013-1#1)
which provided information on##2##4##(1994-2#1)(1996-9#1)
which provided the##3##3##(1995-6#1)(2008-10#1)(2011-12#1)
which provided##24##2##(1990-4#1)(1990-5#2)(1994-2#1)(1995-6#1)(1996-3#1)(1996-9#1)(1997-1#1)(2004-2#1)(2006-12#1)(2007-8#1)(2008-10#7)(2008-5#2)(2008-9#1)(2011-12#1)(2013-1#2)
which provider##2##2##(1995-2#1)(1996-12#1)
which providers##4##2##(1994-12#1)(1997-1#1)(2013-1#2)
which provides a##25##3##(1990-3#1)(1993-2#1)(1994-9#1)(1996-4#1)(2006-4#1)(2007-1#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-2#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-2#1)(2011-1#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
which provides an##6##3##(1995-5#1)(1995-6#1)(2005-10#1)(2007-12#2)(2011-1#1)
which provides both##3##3##(2008-10#1)(2008-7#1)(2010-11#1)
which provides evidence##2##3##(2008-11#1)(2008-5#1)
which provides excellent##2##3##(1991-12#1)(2012-2#1)
which provides high##3##3##(2008-1#1)(2008-11#1)(2008-6#1)
which provides insight##2##3##(2008-10#1)(2013-1#1)
which provides insights into##2##4##(2008-4#1)(2010-11#1)
which provides the##9##3##(1990-2#1)(1992-8#1)(1994-2#1)(1994-3#1)(2007-12#1)(2008-4#1)(2008-9#1)(2010-8#1)(2012-2#1)
which provides##89##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-12#1)(1991-3#1)(1992-8#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#1)(2005-10#1)(2005-11#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#6)(2007-2#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-11#2)(2010-2#1)(2010-8#1)(2011-1#4)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#2)
which psychological##2##2##(2008-5#1)(2008-7#1)
which public health##2##3##(1996-3#1)(1997-3#1)
which public##5##2##(1996-3#1)(1997-3#1)(2007-4#1)(2008-12#1)(2008-9#1)
which pulmonary##2##2##(1997-8#1)(2006-6#1)
which purportedly##2##2##(1992-4#1)(2012-2#1)
which put##2##2##(1993-9#1)(2013-7#1)
which puts##2##2##(2008-4#1)(2009-7#1)
which quantifies the##2##3##(2007-11#1)(2008-5#1)
which quantifies##3##2##(2007-11#1)(2008-5#2)
which quantify the##2##3##(2008-8#2)
which quantify##3##2##(2008-10#1)(2008-8#2)
which quantitative##2##2##(2011-1#1)(2012-3#1)
which questions##4##2##(1994-12#1)(2008-2#2)(2011-8#1)
which radial##2##2##(2007-12#1)(2008-3#1)
which radiation##2##2##(2008-2#2)
which radiologists##2##2##(2007-4#2)
which raised##2##2##(1995-11#1)(1997-2#1)
which raises the possibility of##2##5##(1990-7#1)(2006-10#1)
which raises the##4##3##(1990-7#1)(1993-2#1)(2006-10#1)(2012-3#1)
which raises##5##2##(1990-7#1)(1993-2#1)(2006-10#1)(2012-12#1)(2012-3#1)
which range between##2##3##(1993-2#1)(2007-11#1)
which range from##4##3##(1990-4#1)(1995-2#1)(2008-10#1)(2008-5#1)
which range##7##2##(1990-4#1)(1993-2#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-5#1)(2012-3#1)
which ranged between##2##3##(2008-10#1)(2012-12#1)
which ranged from 0##5##4##(2004-4#1)(2005-12#1)(2008-10#1)(2009-12#2)
which ranged from 6##2##4##(1993-12#1)(1993-8#1)
which ranged from##13##3##(1993-12#1)(1993-3#1)(1993-8#1)(1996-12#1)(2004-4#1)(2005-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-6#1)(2009-12#2)
which ranged##16##2##(1993-12#1)(1993-3#1)(1993-8#1)(1996-12#1)(2004-4#1)(2005-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-10#2)(2008-4#1)(2008-6#1)(2009-12#2)(2012-12#1)
which ranges from##5##3##(1990-10#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-2#1)
which rank##2##2##(1994-6#1)(2013-8#1)
which rapid##2##2##(2006-10#1)(2013-1#1)
which rapidly##5##2##(1991-11#1)(1994-9#1)(1995-2#1)(2006-10#1)(2008-10#1)
which rather##2##2##(1992-10#1)(1996-10#1)
which reached a maximum##3##4##(1990-10#1)(1991-1#1)(1996-2#1)
which reached a##6##3##(1990-10#1)(1990-4#1)(1991-1#1)(1993-12#1)(1996-2#1)(2013-1#1)
which reached the##2##3##(1993-6#1)(2006-8#1)
which reached##13##2##(1990-10#1)(1990-4#1)(1991-1#1)(1992-7#1)(1993-12#1)(1993-6#1)(1996-2#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-5#1)(2013-1#2)
which react with##3##3##(1995-2#1)(1996-5#2)
which react##5##2##(1994-10#1)(1995-2#1)(1996-5#2)(2005-11#1)
which reacted with a##2##4##(1993-3#1)(2008-5#1)
which reacted with##4##3##(1993-3#1)(2007-11#1)(2008-5#2)
which reacted##5##2##(1993-3#1)(1997-1#1)(2007-11#1)(2008-5#2)
which reacts in##2##3##(1991-7#1)(2008-10#1)
which reacts with a##2##4##(2008-8#1)(2010-6#1)
which reacts with##13##3##(1994-2#1)(1995-12#1)(1997-1#1)(1997-2#1)(2008-10#5)(2008-4#1)(2008-8#1)(2010-5#1)(2010-6#1)
which reacts##16##2##(1990-5#1)(1991-7#1)(1994-2#1)(1995-12#1)(1997-1#1)(1997-2#1)(2008-10#6)(2008-4#1)(2008-8#1)(2010-5#1)(2010-6#1)
which recapitulates the##2##3##(2006-3#1)(2012-12#1)
which recapitulates##3##2##(2006-3#1)(2012-12#2)
which receive##2##2##(1993-12#1)(2012-12#1)
which received a##3##3##(1997-4#1)(1997-6#1)(2007-12#1)
which received bilateral##2##3##(1994-3#2)
which received the##2##3##(1997-4#1)(2007-1#1)
which received##30##2##(1990-4#1)(1991-11#1)(1992-5#1)(1994-3#3)(1994-8#1)(1995-11#1)(1995-12#2)(1996-12#1)(1996-5#1)(1996-8#1)(1997-4#2)(1997-6#1)(2005-8#1)(2006-11#1)(2006-12#1)(2006-2#1)(2007-1#2)(2007-12#2)(2008-10#1)(2008-12#1)(2009-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
which recently##2##2##(2007-12#1)(2010-5#1)
which receptor##3##2##(1993-12#1)(1994-5#1)(2008-7#1)
which recognise##3##2##(1993-2#1)(1994-8#1)(1997-1#1)
which recognises##2##2##(1992-8#1)(1995-12#1)
which recognize the##2##3##(1996-11#1)(2006-7#1)
which recognize##10##2##(1990-7#1)(1992-6#1)(1992-8#1)(1995-11#1)(1995-6#1)(1996-11#1)(1996-12#1)(2006-7#1)(2008-11#1)(2008-4#1)
which recognized##6##2##(1991-3#1)(1993-11#1)(1993-9#1)(2006-10#1)(2008-10#1)(2008-8#1)
which recognizes an##2##3##(1996-2#1)(2008-10#1)
which recognizes human##2##3##(1994-12#1)(1995-3#1)
which recognizes specifically##2##3##(1994-8#1)(1995-12#1)
which recognizes the##6##3##(1992-7#1)(1992-9#1)(1993-7#1)(1994-5#2)(1997-4#1)
which recognizes##16##2##(1992-7#1)(1992-9#1)(1993-7#1)(1994-12#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-3#2)(1996-2#1)(1997-4#1)(1997-8#1)(2007-9#1)(2008-10#1)(2009-8#1)
which recombinant##3##2##(2006-10#1)(2008-11#1)(2013-1#1)
which recurred##2##2##(1993-6#1)(2013-1#1)
which reduce the##2##3##(2007-8#1)(2013-7#1)
which reduce##6##2##(1992-7#1)(1996-9#1)(2005-10#1)(2007-8#1)(2008-12#1)(2013-7#1)
which reduced the##7##3##(1990-3#1)(1990-6#1)(1996-4#1)(2008-10#2)(2008-5#1)(2013-8#1)
which reduced##16##2##(1990-3#1)(1990-6#1)(1992-11#1)(1993-11#1)(1994-3#1)(1996-3#1)(1996-4#1)(1996-7#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2012-2#1)(2013-8#1)
which reduces sample##2##3##(2008-10#1)(2010-11#1)
which reduces the##9##3##(1991-11#1)(1995-3#1)(1996-2#1)(1996-9#1)(2008-10#1)(2008-2#1)(2008-3#3)
which reduces##19##2##(1991-11#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-9#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2010-1#1)(2010-11#1)(2010-12#1)(2010-8#1)(2012-1#1)
which refer to##2##3##(2009-4#1)(2010-3#1)
which refer##3##2##(1996-1#1)(2009-4#1)(2010-3#1)
which refers to##5##3##(1994-3#1)(2007-7#1)(2012-12#1)(2012-2#1)(2013-7#1)
which reflect the##2##3##(1995-4#1)(2008-9#1)
which reflect##6##2##(1995-12#1)(1995-4#1)(1995-8#1)(2008-2#1)(2008-7#1)(2008-9#1)
which reflected##2##2##(1992-10#1)(2008-3#1)
which reflects the##9##3##(1993-2#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-12#1)
which reflects##14##2##(1990-3#1)(1993-2#1)(1994-9#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#3)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)
which regenerates##3##2##(1991-1#1)(1991-4#1)(2008-3#1)
which regulate##17##2##(1991-11#1)(1991-12#1)(1991-2#1)(1993-3#1)(1994-4#1)(2006-2#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-8#1)
which regulates the##6##3##(1990-4#1)(1993-6#1)(1994-12#1)(1995-3#1)(2008-10#1)(2008-5#1)
which regulates##15##2##(1990-4#1)(1991-10#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-3#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-9#1)(2011-2#1)
which relate to the##2##4##(2005-10#1)(2008-11#1)
which relate to##3##3##(2005-10#1)(2008-11#1)(2008-9#1)
which related to the##2##4##(2008-10#1)(2012-2#1)
which related to##3##3##(2008-10#2)(2012-2#1)
which relates the##5##3##(1990-2#1)(1992-6#1)(2005-11#1)(2008-10#1)(2008-3#1)
which relates to the##4##4##(1992-7#1)(1993-9#1)(2008-2#1)(2012-12#1)
which relates to##5##3##(1992-7#1)(1993-9#1)(2008-2#1)(2008-5#1)(2012-12#1)
which relates##11##2##(1990-2#1)(1992-6#1)(1992-7#1)(1993-9#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-12#1)
which relative##2##2##(1991-7#1)(1996-5#1)
which release##5##2##(1991-10#1)(1994-2#1)(1995-10#1)(2007-12#1)(2009-8#1)
which released##2##2##(2008-10#1)(2012-2#1)
which releases##6##2##(1990-4#1)(1992-7#2)(2008-10#2)(2009-2#1)
which relies on the##3##4##(1992-5#1)(2007-11#1)(2008-9#1)
which relies on##6##3##(1992-5#1)(1996-1#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-9#1)
which relies##7##2##(1992-5#1)(1995-12#1)(1996-1#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-9#1)
which rely on the##2##4##(1995-8#1)(2006-4#1)
which rely on##4##3##(1995-8#1)(2006-4#1)(2009-5#1)(2010-2#1)
which remain to be##2##4##(1996-2#1)(2011-2#1)
which remain##13##2##(1990-5#1)(1993-12#1)(1994-2#1)(1996-2#1)(1997-7#1)(2005-8#1)(2006-5#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)
which remained after##2##3##(1993-12#1)(1996-12#1)
which remained elevated throughout the##2##5##(1994-2#1)(2013-7#1)
which remained unchanged##2##3##(1991-10#1)(1993-9#1)
which remained##11##2##(1991-10#1)(1991-8#1)(1993-11#1)(1993-12#2)(1993-9#1)(1994-2#1)(1995-11#1)(1996-12#1)(1996-9#1)(2013-7#1)
which remains a##2##3##(2008-7#1)(2012-3#1)
which remains in the##2##4##(2005-11#1)(2010-5#1)
which remains to be elucidated##2##5##(1993-3#1)(1997-7#1)
which remains to be##3##4##(1993-3#1)(1995-12#1)(1997-7#1)
which remains unchanged##2##3##(2008-5#1)(2012-3#1)
which remains##19##2##(1993-1#1)(1993-3#1)(1995-10#1)(1995-12#1)(1997-7#1)(2004-11#1)(2005-11#1)(2007-10#1)(2008-5#1)(2008-7#1)(2010-10#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)
which removed##3##2##(1991-8#1)(1997-3#1)(2013-1#1)
which removes lesions##2##3##(2008-11#2)
which removes the##6##3##(1990-7#1)(2007-11#2)(2007-8#1)(2008-2#1)(2009-6#1)
which removes##10##2##(1990-7#1)(1992-3#1)(2005-8#1)(2007-11#2)(2007-8#1)(2008-11#2)(2008-2#1)(2009-6#1)
which renders the##3##3##(1995-2#1)(2005-7#1)(2008-2#1)
which renders##6##2##(1995-2#1)(2005-7#1)(2006-1#1)(2008-2#1)(2008-4#1)(2011-1#1)
which replace##2##2##(2008-10#1)(2008-12#1)
which replaced##2##2##(2012-2#1)(2013-8#1)
which replaces the##3##3##(1994-12#1)(2008-3#1)(2012-3#1)
which replaces##5##2##(1994-12#1)(1995-2#1)(1997-7#1)(2008-3#1)(2012-3#1)
which replicates##2##2##(2008-11#1)(2008-4#1)
which reported a##2##3##(2006-10#1)(2008-8#1)
which reported##6##2##(1990-12#1)(1990-8#1)(2006-10#1)(2008-8#1)(2010-11#1)(2012-12#1)
which reportedly##3##2##(1990-11#1)(1994-9#1)(2012-12#1)
which represent a##4##3##(1997-7#1)(2010-12#1)(2010-7#1)(2011-1#1)
which represent an##4##3##(1994-12#1)(2007-8#1)(2011-2#1)(2013-1#1)
which represent the##8##3##(1990-8#1)(1993-6#1)(1997-6#1)(2007-10#1)(2008-7#1)(2009-8#1)(2010-7#1)(2011-2#1)
which represent##30##2##(1990-8#1)(1992-7#1)(1993-6#1)(1994-12#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#2)(1997-6#1)(1997-7#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-7#2)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
which represented about##2##3##(1996-2#1)(2008-10#1)
which represented##8##2##(1996-2#1)(1996-9#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-6#1)(2013-7#1)
which represents a relatively##2##4##(2007-6#1)(2008-7#1)
which represents a##13##3##(1991-2#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-7#2)(2009-6#1)(2009-9#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-2#1)
which represents the##9##3##(1990-12#1)(1990-8#1)(1991-10#1)(1992-7#1)(2008-10#2)(2009-7#1)(2010-8#1)(2011-2#1)
which represents##30##2##(1990-12#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#1)(1992-7#2)(1997-2#1)(2007-12#1)(2007-6#1)(2008-10#3)(2008-2#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-3#1)
which reproduce the initial##2##4##(2005-4#2)
which reproduce the##3##3##(2005-4#2)(2012-1#1)
which reproduced##2##2##(2008-4#1)(2008-5#1)
which require a##4##3##(2007-12#1)(2008-6#1)(2012-3#1)(2013-1#1)
which require more##3##3##(2005-11#1)(2007-2#1)(2009-8#1)
which require only##2##3##(1993-6#1)(2008-9#1)
which require the##5##3##(1997-4#1)(2008-1#1)(2008-4#2)(2010-10#1)
which require##44##2##(1990-11#1)(1990-12#1)(1992-9#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-12#1)(1996-1#1)(1996-2#1)(1997-4#1)(2005-11#2)(2007-12#1)(2007-2#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#5)(2008-6#3)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
which required a##3##3##(2006-8#1)(2008-1#1)(2009-7#1)
which required##20##2##(1990-10#1)(1992-12#1)(1994-4#1)(1996-2#1)(2006-8#1)(2007-11#2)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-7#2)(2009-7#1)(2012-3#1)(2013-7#1)
which requires a##4##3##(1993-9#1)(1994-1#1)(2004-4#1)(2011-2#1)
which requires an##3##3##(2008-1#1)(2009-4#1)(2012-1#1)
which requires no##2##3##(2007-12#1)(2008-10#1)
which requires only##4##3##(1992-12#1)(1997-8#1)(2007-11#1)(2008-1#1)
which requires that##2##3##(2006-10#1)(2010-9#1)
which requires the##4##3##(1990-12#1)(1995-1#1)(1995-6#1)(2008-7#1)
which requires γ-TuRC function##2##4##(2012-12#2)
which requires##49##2##(1990-12#1)(1990-5#1)(1992-12#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-6#1)(1996-3#1)(1997-2#1)(1997-8#1)(2004-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-3#3)(2008-7#1)(2008-9#2)(2009-11#1)(2009-4#2)(2010-2#1)(2010-6#1)(2010-9#2)(2011-2#2)(2012-1#2)(2012-12#2)(2012-3#1)
which research##5##2##(2006-1#1)(2008-5#1)(2010-8#1)(2012-12#1)(2013-8#1)
which resemble the##2##3##(1991-3#1)(1994-6#1)
which resemble those##2##3##(1991-5#1)(1994-11#1)
which resemble##13##2##(1990-6#1)(1991-3#1)(1991-5#1)(1993-3#1)(1994-11#1)(1994-6#1)(1994-8#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-4#1)(2012-2#1)(2013-8#1)
which resembled that of##2##4##(1996-1#1)(2012-2#1)
which resembled##4##2##(1995-7#1)(1996-1#1)(1996-6#1)(2012-2#1)
which resembles##5##2##(1990-5#1)(1993-6#1)(2005-10#1)(2008-6#1)(2013-1#1)
which reside in##3##3##(1994-12#1)(1995-12#1)(2007-11#1)
which reside##4##2##(1990-4#1)(1994-12#1)(1995-12#1)(2007-11#1)
which resides in the##2##4##(1995-5#1)(2011-1#1)
which resides in##3##3##(1994-11#1)(1995-5#1)(2011-1#1)
which resides##4##2##(1994-11#1)(1995-5#1)(2009-5#1)(2011-1#1)
which resolvase##2##2##(1993-3#1)(1994-3#1)
which resolved after##4##3##(1992-11#1)(2006-8#1)(2007-12#1)(2007-8#1)
which resolved following##3##3##(2006-4#1)(2008-7#1)(2008-8#1)
which resolved##8##2##(1992-11#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-7#1)(2008-8#1)
which respectively##2##2##(2008-8#1)(2008-9#1)
which respects##3##2##(1990-11#1)(1991-11#1)(2011-2#1)
which respond selectively to##2##4##(1991-5#1)(2008-10#1)
which respond to##6##3##(1992-1#1)(1992-9#1)(1993-12#1)(1994-3#1)(1994-6#1)(2011-1#1)
which respond##9##2##(1991-5#1)(1992-1#1)(1992-9#1)(1993-12#1)(1994-3#1)(1994-6#1)(2007-11#1)(2008-10#1)(2011-1#1)
which responded to##2##3##(1993-6#1)(1994-10#1)
which responded##8##2##(1991-5#1)(1993-6#1)(1994-10#1)(1995-9#1)(2006-10#2)(2008-11#1)(2012-2#1)
which responds to##7##3##(1990-9#1)(1993-2#1)(2008-10#1)(2008-8#2)(2009-8#1)(2013-8#1)
which responds##8##2##(1990-9#1)(1993-2#1)(1996-2#1)(2008-10#1)(2008-8#2)(2009-8#1)(2013-8#1)
which restrict##4##2##(1992-12#1)(1992-4#1)(1994-2#1)(2008-5#1)
which restricted##3##2##(1997-6#1)(2007-5#1)(2008-8#1)
which restricts its##2##3##(1994-8#1)(2008-9#1)
which restricts##4##2##(1994-8#1)(2008-10#1)(2008-4#1)(2008-9#1)
which result from a##2##4##(1996-1#1)(1996-5#1)
which result from the##4##4##(1994-8#1)(1996-2#1)(2006-10#1)(2008-5#1)
which result from##10##3##(1994-8#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-8#1)(2006-10#2)(2008-5#1)(2011-1#1)
which result in a##3##4##(1994-12#1)(2007-12#1)(2008-3#1)
which result in the##3##4##(2007-10#1)(2009-10#1)(2010-9#1)
which result in##19##3##(1991-9#1)(1994-11#1)(1994-12#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-9#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-12#1)
which result##30##2##(1991-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-10#3)(2006-9#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-9#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
which resulted from the##2##4##(2008-3#1)(2012-12#1)
which resulted from##6##3##(1993-7#1)(2007-11#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-12#1)
which resulted in a sensitive fluorescence derivatizing##2##7##(2008-10#2)
which resulted in a##19##4##(1990-5#1)(1994-5#1)(1995-3#1)(1996-7#1)(1997-8#1)(2005-9#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-7#1)(2009-7#1)(2009-9#1)(2010-4#1)(2011-2#1)
which resulted in an increase in the##2##7##(1990-3#1)(2008-10#1)
which resulted in an##4##4##(1990-3#1)(1992-11#1)(1996-2#1)(2008-10#1)
which resulted in increased##2##4##(2006-9#1)(2008-10#1)
which resulted in less##3##4##(2006-12#2)(2013-1#1)
which resulted in the##11##4##(1991-1#1)(1993-3#1)(1994-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#1)
which resulted in##76##3##(1990-3#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-8#1)(1992-11#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-7#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-8#1)(2005-6#1)(2005-9#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-12#2)(2008-7#3)(2008-8#1)(2009-2#1)(2009-6#1)(2009-7#3)(2009-9#2)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#2)
which resulted##85##2##(1990-3#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-8#1)(1992-11#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-7#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-8#1)(2005-6#1)(2005-9#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-2#1)(2009-6#1)(2009-7#3)(2009-9#2)(2010-12#2)(2010-4#2)(2010-5#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#2)
which results are##2##3##(2008-2#2)
which results from a deficit##2##5##(2012-1#2)
which results from a##3##4##(2009-4#1)(2012-1#2)
which results from an##2##4##(1994-11#1)(2008-1#1)
which results from the##3##4##(1991-10#1)(2007-12#1)(2008-11#1)
which results from##14##3##(1991-10#1)(1993-11#1)(1993-6#1)(1994-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-4#1)(2009-4#1)(2012-1#2)
which results in a decrease of##2##6##(1996-7#1)(2008-2#1)
which results in a decrease##3##5##(1995-1#1)(1996-7#1)(2008-2#1)
which results in a lower##3##5##(1992-3#1)(2007-12#1)(2008-10#1)
which results in a##28##4##(1990-8#1)(1992-1#1)(1992-3#1)(1994-9#1)(1995-1#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-6#1)(2007-12#3)(2008-10#2)(2008-2#5)(2008-3#2)(2008-4#1)(2008-9#1)(2012-12#2)
which results in an increase in##2##6##(1992-8#1)(2008-1#1)
which results in an##7##4##(1992-8#2)(1997-2#1)(2005-11#1)(2008-1#1)(2008-3#1)(2008-7#1)
which results in enhanced##2##4##(2008-10#1)(2008-3#1)
which results in high##3##4##(1991-7#1)(1995-4#1)(2008-3#1)
which results in the formation of##3##6##(1996-5#1)(2008-10#1)(2012-2#1)
which results in the production of##2##6##(1996-5#1)(2012-1#1)
which results in the##21##4##(1990-5#2)(1992-3#1)(1993-7#1)(1994-12#1)(1994-8#1)(1994-9#1)(1996-5#2)(2004-10#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-4#1)(2009-4#1)(2010-12#1)(2012-1#1)(2012-2#2)
which results in##104##3##(1990-11#1)(1990-4#1)(1990-5#3)(1990-8#1)(1991-7#2)(1991-9#1)(1992-1#1)(1992-3#2)(1992-5#1)(1992-8#2)(1992-9#1)(1993-6#1)(1993-7#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-4#1)(1996-5#4)(1996-7#2)(1997-1#1)(1997-2#1)(1997-4#3)(1997-7#1)(2004-10#1)(2005-11#3)(2006-10#2)(2006-11#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#7)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-2#5)(2008-3#6)(2008-4#2)(2008-6#1)(2008-7#6)(2008-9#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-12#2)(2010-2#1)(2011-1#1)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#1)
which results##123##2##(1990-11#1)(1990-4#1)(1990-5#3)(1990-8#1)(1991-10#1)(1991-7#2)(1991-9#1)(1992-1#1)(1992-3#2)(1992-5#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-6#2)(1993-7#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-4#1)(1996-5#4)(1996-7#2)(1997-1#1)(1997-2#1)(1997-4#3)(1997-7#1)(2004-10#1)(2005-11#3)(2006-10#2)(2006-11#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#8)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#9)(2008-11#2)(2008-2#8)(2008-3#6)(2008-4#3)(2008-6#1)(2008-7#6)(2008-9#1)(2009-3#1)(2009-4#2)(2009-7#1)(2010-12#2)(2010-2#1)(2011-1#1)(2012-1#3)(2012-12#3)(2012-2#3)(2013-1#1)
which retain##3##2##(1991-3#1)(1995-8#1)(1997-6#1)
which retained##3##2##(1995-2#1)(2008-7#1)(2008-8#1)
which retains the##2##3##(1993-1#1)(1993-8#1)
which retains##6##2##(1991-8#1)(1992-9#1)(1993-1#1)(1993-8#1)(1994-6#1)(2008-7#1)
which returned to##3##3##(1992-3#1)(1992-4#1)(2013-1#1)
which reveal that##3##3##(1994-5#1)(1994-6#1)(2006-8#1)
which reveal##5##2##(1994-5#1)(1994-6#1)(1996-2#1)(2006-8#1)(2008-3#1)
which revealed a##11##3##(1990-9#1)(2005-8#1)(2006-4#2)(2007-11#1)(2007-8#1)(2008-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
which revealed significant##2##3##(1994-12#1)(2012-2#1)
which revealed that physicians' perceptions of iPad use in the ED stemmed from their personal use of iPads along with three perceived ease of use factors##2##26##(2013-1#2)
which revealed that the##2##4##(1992-7#1)(2012-3#1)
which revealed that##10##3##(1992-7#1)(1995-2#1)(2007-9#1)(2008-10#1)(2009-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
which revealed the##4##3##(1994-11#1)(2007-2#1)(2008-6#1)(2010-4#1)
which revealed##39##2##(1990-9#1)(1992-7#1)(1992-8#1)(1994-11#1)(1994-12#1)(1995-2#1)(1996-12#1)(2005-10#1)(2005-8#1)(2006-4#2)(2006-9#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-6#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)
which reveals the presence of two##2##6##(1991-12#1)(2007-3#1)
which reveals the##4##3##(1991-12#1)(2007-3#1)(2008-8#1)(2009-3#1)
which reveals##9##2##(1991-12#1)(1991-2#1)(1993-6#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-3#2)
which reverse##2##2##(1994-11#1)(2008-3#1)
which reversed##2##2##(1992-1#1)(1992-3#1)
which reverses##2##2##(1990-11#1)(1997-3#1)
which reviews##2##2##(2010-11#1)(2012-1#1)
which risk factors are##2##4##(2011-1#1)(2013-1#1)
which risk##4##2##(2005-10#1)(2008-7#1)(2011-1#1)(2013-1#1)
which rodent##2##2##(1995-6#1)(2010-6#1)
which runs##2##2##(1997-7#1)(2008-6#1)
which rural##2##2##(1996-3#2)
which samples##9##2##(2006-5#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#2)(2010-8#1)(2012-3#1)
which scales linearly with the##2##5##(2008-2#1)(2010-4#1)
which scales##3##2##(1991-3#1)(2008-2#1)(2010-4#1)
which scattering##2##2##(2008-2#1)(2008-3#1)
which school##3##2##(1992-8#1)(2009-9#1)(2012-12#1)
which scored##2##2##(2007-5#2)
which scores accuracy as null##2##5##(2013-1#2)
which scores##3##2##(2008-6#1)(2013-1#2)
which second##2##2##(1991-3#1)(1995-8#1)
which secrete##3##2##(1991-12#1)(1995-5#1)(1996-7#1)
which secreted##3##2##(1994-9#1)(1995-1#1)(2008-11#1)
which seek##2##2##(1991-6#1)(1991-7#1)
which seeks##2##2##(2008-11#1)(2008-4#1)
which seem to be##7##4##(1990-8#1)(1994-2#1)(1995-12#1)(2005-11#1)(2006-6#1)(2008-10#2)
which seem to##9##3##(1990-8#1)(1992-9#1)(1994-2#1)(1995-12#1)(2005-11#1)(2006-10#1)(2006-6#1)(2008-10#2)
which seemed to be##3##4##(1990-8#1)(1992-3#1)(2008-7#1)
which seemed##5##2##(1990-2#1)(1990-8#1)(1992-3#1)(2008-10#1)(2008-7#1)
which seems to be##5##4##(1992-3#1)(1994-9#1)(2007-11#1)(2008-10#2)
which seems to##11##3##(1990-4#1)(1992-3#1)(1993-11#1)(1994-9#1)(1997-8#1)(2005-7#1)(2007-11#1)(2008-10#2)(2008-7#1)(2012-2#1)
which seems##18##2##(1990-4#1)(1991-3#1)(1992-1#1)(1992-3#1)(1992-7#1)(1993-11#1)(1994-8#1)(1994-9#1)(1997-8#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2012-2#1)
which selected##3##2##(1995-5#1)(2006-10#1)(2007-12#1)
which selection##2##2##(2007-11#1)(2009-2#1)
which selective##3##2##(1993-11#1)(2007-10#1)(2008-5#1)
which selectively reduces##2##3##(1991-5#1)(1993-9#1)
which selectively##10##2##(1991-5#1)(1992-3#1)(1992-6#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-3#1)(1997-1#1)(2008-7#1)
which sense##2##2##(1994-12#1)(2008-7#1)
which separate##2##2##(2007-8#1)(2013-8#1)
which separates the##2##3##(1995-2#1)(2008-7#1)
which separates##5##2##(1995-2#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-5#1)
which serotonin##2##2##(1992-8#1)(2008-4#1)
which serve as##8##3##(1990-8#1)(1993-11#1)(1993-12#1)(1997-7#1)(2007-12#1)(2008-10#1)(2009-6#1)(2011-2#1)
which serve##13##2##(1990-11#1)(1990-8#1)(1991-12#1)(1993-11#1)(1993-12#1)(1995-5#1)(1997-7#1)(2007-12#2)(2008-10#2)(2009-6#1)(2011-2#1)
which served as a##2##4##(2008-3#1)(2009-10#1)
which served as##6##3##(1994-8#1)(1997-2#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#1)
which served to##2##3##(2005-11#1)(2008-10#1)
which served##8##2##(1994-8#1)(1997-2#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#1)
which serves as a##11##4##(1992-12#1)(1993-11#1)(2006-5#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-5#2)
which serves as the##4##4##(1993-2#1)(1995-8#1)(2008-7#1)(2010-2#1)
which serves as##16##3##(1992-12#1)(1993-11#1)(1993-2#1)(1995-8#1)(2006-5#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-7#1)(2010-2#1)(2012-2#1)
which serves to##7##3##(1990-5#2)(1990-9#1)(2008-4#1)(2008-6#1)(2010-4#1)(2013-8#1)
which serves##23##2##(1990-5#2)(1990-9#1)(1992-12#1)(1993-11#1)(1993-2#1)(1995-8#1)(2006-5#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-2#1)(2010-4#1)(2012-2#1)(2013-8#1)
which service##2##2##(1995-3#1)(2008-2#1)
which set the##2##3##(2007-5#1)(2008-11#1)
which sets the##2##3##(1992-1#1)(1997-4#1)
which sets##3##2##(1992-1#1)(1997-4#1)(2009-5#1)
which seven##9##2##(2007-5#1)(2007-8#5)(2008-4#1)(2008-8#1)(2011-2#1)
which several members##2##3##(2007-10#1)(2008-10#1)
which several of##2##3##(1996-5#1)(2007-12#1)
which several##15##2##(1993-6#1)(1996-5#1)(2006-1#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-4#1)(2009-5#1)(2012-2#1)(2012-3#1)
which severely##4##2##(1993-4#1)(2007-8#1)(2008-10#1)(2013-8#1)
which sex##2##2##(2008-8#1)(2008-9#1)
which shape##2##2##(2009-5#1)(2012-3#1)
which share a##2##3##(2012-12#2)
which share structural similarities##2##4##(1990-12#1)(2008-4#1)
which share##12##2##(1990-12#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-5#1)(1994-9#1)(1997-1#1)(2007-7#2)(2008-4#1)(2012-12#2)
which shared##2##2##(2008-11#1)(2010-4#1)
which shares a##2##3##(1991-6#1)(1997-6#1)
which shares##14##2##(1990-5#1)(1991-6#1)(1992-3#1)(1994-12#3)(1997-3#2)(1997-6#1)(1997-7#1)(2008-4#1)(2008-7#1)(2009-9#1)(2011-1#1)
which she##9##2##(1992-11#1)(2006-2#1)(2006-7#1)(2007-2#2)(2009-10#1)(2009-3#1)(2010-9#1)(2011-12#1)
which shifts##3##2##(1991-2#1)(1992-8#1)(2011-1#1)
which should be a##2##4##(2007-8#1)(2008-9#1)
which should be based on##2##5##(2008-6#1)(2012-2#1)
which should be considered in##2##5##(1991-8#1)(2012-3#1)
which should be considered##7##4##(1991-8#1)(2007-8#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
which should be evaluated in##2##5##(2011-1#1)(2013-7#1)
which should be performed in##2##5##(2010-6#1)(2011-2#1)
which should be performed##3##4##(1996-11#1)(2010-6#1)(2011-2#1)
which should be the##2##4##(1991-8#1)(1993-12#1)
which should be useful for##2##5##(2007-11#1)(2013-7#1)
which should be useful##3##4##(1994-6#1)(2007-11#1)(2013-7#1)
which should be##57##3##(1990-11#1)(1990-4#1)(1990-6#1)(1991-6#1)(1991-8#2)(1992-10#1)(1993-12#1)(1994-4#1)(1994-6#1)(1995-5#1)(1996-11#1)(1997-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#4)(2008-10#6)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#5)(2011-8#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#3)(2013-8#2)
which should facilitate##2##3##(1994-11#1)(2006-6#1)
which should help##2##3##(1991-12#1)(2006-10#1)
which should not be##4##4##(1994-7#1)(1997-3#1)(2006-5#1)(2011-2#1)
which should##92##2##(1990-11#1)(1990-4#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-6#1)(1991-8#2)(1992-10#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-11#1)(1994-4#1)(1994-6#1)(1994-7#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-12#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-12#1)(2005-6#1)(2005-7#1)(2006-10#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#2)(2007-8#4)(2008-10#7)(2008-11#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#6)(2011-8#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#3)(2013-8#3)
which show a delay in motor axon outgrowth##2##8##(2012-12#2)
which show a high##2##4##(2007-11#1)(2008-11#1)
which show a##12##3##(1990-6#1)(1994-5#1)(2005-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2011-2#1)(2012-12#2)(2013-8#1)
which show some##4##3##(1994-6#1)(1996-10#1)(1996-2#1)(2012-3#1)
which show that the##4##4##(1995-1#1)(1996-2#1)(2011-1#1)(2011-12#1)
which show that##11##3##(1990-1#1)(1991-5#1)(1993-4#1)(1994-8#1)(1995-1#1)(1996-2#1)(2006-10#1)(2007-8#1)(2008-2#1)(2011-1#1)(2011-12#1)
which show the existence of##2##5##(2008-10#2)
which show the##5##3##(2006-10#1)(2007-8#1)(2008-10#2)(2010-5#1)
which show##57##2##(1990-1#2)(1990-3#1)(1990-6#1)(1991-11#1)(1991-5#1)(1992-6#1)(1993-4#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1996-10#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-2#1)(2005-9#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-2#1)(2007-8#3)(2008-10#5)(2008-11#2)(2008-2#6)(2008-3#1)(2008-7#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#4)(2012-3#1)(2013-1#1)(2013-8#1)
which showed a clear time-dependence at higher concentrations##2##8##(2012-11#2)
which showed a significant##3##4##(1994-10#1)(1997-1#1)(2010-5#1)
which showed a##31##3##(1990-12#1)(1990-2#1)(1991-12#2)(1991-6#1)(1992-7#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-8#1)(1996-10#1)(1996-12#1)(1997-1#1)(1997-4#1)(1997-5#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#1)(2010-12#2)(2010-5#1)(2010-8#1)(2012-11#2)
which showed an##4##3##(1991-10#1)(1992-3#1)(2006-10#1)(2006-2#1)
which showed features##2##3##(2007-7#1)(2008-3#1)
which showed high##4##3##(1993-12#1)(1993-5#1)(2008-10#1)(2013-1#1)
which showed increased##2##3##(2008-10#1)(2008-6#1)
which showed low##2##3##(1996-12#1)(2008-10#1)
which showed moderate##2##3##(1997-2#1)(2008-10#1)
which showed no##7##3##(1990-3#1)(1990-5#1)(1991-5#1)(1992-6#1)(1993-12#1)(1996-9#1)(2008-10#1)
which showed relatively greater activity to thinking about##2##8##(2008-6#2)
which showed relatively##3##3##(2007-4#1)(2008-6#2)
which showed significant##2##3##(1990-5#1)(1994-12#1)
which showed that both the##3##5##(1990-12#1)(2005-11#2)
which showed that the##5##4##(1991-5#1)(1992-12#1)(1994-8#1)(2007-8#1)(2008-11#1)
which showed that##21##3##(1990-12#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-8#1)(1994-8#1)(1996-5#1)(1997-3#1)(2005-11#2)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-8#1)
which showed the##13##3##(1990-11#1)(1991-8#1)(1993-2#1)(1994-6#1)(1995-11#1)(1995-3#1)(1996-2#1)(1997-1#1)(2007-1#1)(2008-4#1)(2008-5#1)(2009-12#1)(2011-2#1)
which showed weaker##2##3##(1990-7#1)(1994-12#1)
which showed##154##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-10#1)(1991-12#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#5)(1994-2#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-7#1)(2007-1#1)(2007-12#4)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-10#10)(2008-11#7)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#2)(2009-5#1)(2009-8#1)(2010-10#2)(2010-12#4)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-11#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
which shows a##13##3##(1990-12#1)(1990-7#1)(1992-12#1)(1992-5#1)(1993-11#1)(1995-11#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-4#1)
which shows that the##8##4##(1990-11#1)(2005-11#1)(2005-4#1)(2007-12#1)(2007-8#1)(2008-2#3)
which shows that##16##3##(1990-11#1)(1995-8#1)(1996-4#1)(2005-11#2)(2005-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-8#1)(2012-2#1)
which shows the##8##3##(1997-8#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-8#1)(2008-9#1)
which shows##65##2##(1990-1#1)(1990-11#1)(1990-12#1)(1990-7#1)(1991-3#1)(1991-9#1)(1992-12#3)(1992-5#1)(1993-11#2)(1993-2#1)(1994-2#1)(1994-5#2)(1995-11#1)(1995-2#2)(1995-5#1)(1995-8#2)(1996-12#1)(1996-4#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#3)(2005-4#1)(2006-5#1)(2007-11#2)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-2#3)(2008-3#2)(2008-5#2)(2008-8#3)(2008-9#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-2#2)
which signals##3##2##(1997-7#1)(2008-11#1)(2008-2#1)
which significant##5##2##(1995-10#1)(1996-10#1)(2008-10#1)(2009-4#1)(2010-12#1)
which significantly increases the##2##4##(2008-10#1)(2008-9#1)
which significantly##8##2##(1994-2#1)(1994-9#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-9#1)
which similar##5##2##(1992-7#1)(1995-11#1)(1995-12#1)(2008-10#1)(2008-2#1)
which simple##2##2##(2008-3#1)(2008-8#1)
which simplifies the##2##3##(2006-6#1)(2010-5#1)
which simply##2##2##(2005-11#1)(2012-2#1)
which simulates the##4##3##(2008-8#1)(2010-4#1)(2012-1#2)
which simulates##7##2##(1996-3#1)(2008-8#1)(2009-10#1)(2010-4#1)(2011-1#1)(2012-1#2)
which simultaneously##11##2##(1996-2#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-2#2)
which six##5##2##(2006-3#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-5#1)
which small##6##2##(1994-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2010-9#1)
which social##2##2##(2008-11#1)(2008-5#1)
which solves##2##2##(1995-6#1)(2008-9#1)
which some##12##2##(1990-5#1)(1990-6#1)(1993-3#1)(1994-3#1)(1996-1#1)(1997-2#1)(2006-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-1#1)
which sometimes reveals##2##3##(2008-12#1)(2012-2#1)
which sometimes##5##2##(1990-9#1)(2007-2#1)(2008-12#1)(2012-2#2)
which sought to##2##3##(2008-11#1)(2009-4#1)
which sought##3##2##(2008-11#1)(2009-4#1)(2010-9#1)
which span##2##2##(1991-4#1)(1992-12#1)
which spanned the##2##3##(1991-10#1)(1997-1#1)
which species##6##2##(1991-12#1)(2008-10#2)(2008-4#1)(2008-8#1)(2012-3#1)
which specific##6##2##(1991-11#1)(1991-2#1)(1992-7#1)(1995-3#1)(2008-2#1)(2009-4#1)
which specifically binds##3##3##(1992-12#1)(1994-12#1)(1994-8#1)
which specifically inhibits##2##3##(1992-11#1)(1992-7#1)
which specifically recognize##2##3##(1994-6#1)(1995-1#1)
which specifically recognized##2##3##(1995-8#1)(2008-11#1)
which specifically##23##2##(1990-10#2)(1990-12#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-7#1)(1992-9#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-8#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)
which specifies##2##2##(1990-9#1)(2009-9#1)
which specify##2##2##(1994-4#1)(1995-2#1)
which spent##2##2##(2008-7#2)
which sperm##2##2##(1994-5#1)(2007-12#1)
which spontaneously##3##2##(1994-12#1)(1994-3#1)(2008-7#1)
which spread##4##2##(1990-5#1)(2009-6#1)(2011-1#1)(2011-2#1)
which stabilize DNA##2##3##(1995-5#2)
which stabilize##4##2##(1990-8#2)(1995-5#2)
which stabilizes##4##2##(1996-1#1)(2008-11#1)(2012-12#1)(2013-8#1)
which stable##4##2##(1991-5#1)(2007-11#1)(2008-5#1)(2013-1#1)
which stably##2##2##(1994-8#1)(2008-9#1)
which stacks##2##2##(1995-1#1)(2005-11#1)
which stained with##4##3##(2007-12#1)(2008-5#2)(2013-8#1)
which stained##7##2##(1991-7#1)(2006-11#1)(2007-12#2)(2008-5#2)(2013-8#1)
which stands for##3##3##(2008-2#2)(2013-8#1)
which started##6##2##(1991-2#2)(1997-7#1)(2007-11#1)(2009-7#1)(2012-12#1)
which starts with##2##3##(1990-9#1)(1992-9#1)
which starts##4##2##(1990-9#2)(1992-9#1)(1997-1#1)
which states that##3##3##(1997-4#1)(2012-2#1)(2013-8#1)
which statistical##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
which still have##2##3##(2005-7#1)(2008-9#1)
which still##4##2##(1995-4#1)(1997-7#1)(2005-7#1)(2008-9#1)
which stimulate the##2##3##(1994-6#1)(1997-4#1)
which stimulate##9##2##(1991-10#1)(1991-9#1)(1992-12#1)(1994-6#1)(1994-9#1)(1996-10#1)(1996-4#1)(1997-4#1)(2004-12#1)
which stimulated the##3##3##(1991-2#1)(1992-6#1)(1995-12#1)
which stimulated##6##2##(1991-2#1)(1992-6#1)(1994-11#1)(1995-12#1)(2008-4#1)(2010-5#1)
which stimulates DNA synthesis##2##4##(1991-10#1)(1997-1#1)
which stimulates the##3##3##(1990-3#1)(1991-2#1)(1997-6#1)
which stimulates##21##2##(1990-3#1)(1991-10#1)(1991-2#2)(1991-3#1)(1992-9#1)(1993-9#1)(1994-11#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-6#1)(2005-1#1)(2008-11#1)(2008-4#1)(2011-2#1)
which stipulates##2##2##(2009-11#1)(2012-1#1)
which stress##2##2##(2008-10#1)(2012-1#1)
which strongly hybridized to the##2##5##(1990-9#1)(2008-9#1)
which strongly suggests that##2##4##(1992-12#1)(1994-3#1)
which strongly##10##2##(1990-5#1)(1990-9#1)(1992-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(2005-3#1)(2008-10#1)(2008-9#1)(2009-2#1)
which structural and##2##3##(1996-5#1)(2012-2#1)
which structures##2##2##(2007-10#1)(2008-3#1)
which students##8##2##(1996-1#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-11#3)(2012-1#1)
which subjects##4##2##(2008-11#1)(2009-8#1)(2010-5#1)(2012-3#1)
which subsequently undergo##2##3##(1996-5#1)(2008-10#1)
which subsequently##15##2##(1996-12#1)(1996-5#1)(2005-3#1)(2006-5#1)(2007-7#1)(2008-10#6)(2008-12#1)(2008-8#1)(2010-2#1)(2012-12#1)
which subset of##2##3##(1992-12#1)(2006-8#1)
which substances##2##2##(2007-9#1)(2008-10#1)
which substantially improves the##2##4##(2007-11#1)(2012-12#1)
which substantially##5##2##(1991-9#1)(2005-11#1)(2007-11#1)(2008-8#1)(2012-12#1)
which successful##2##2##(2008-5#1)(2008-9#1)
which such##20##2##(1992-9#1)(1994-11#1)(1994-12#1)(1997-1#1)(2004-11#2)(2004-4#1)(2005-12#1)(2006-5#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-12#1)(2010-7#1)(2011-1#1)(2012-1#1)
which suffered from##2##3##(2008-5#1)(2011-2#1)
which sufficient##4##2##(1992-11#1)(2008-3#1)(2008-8#1)(2012-3#1)
which suggest that the##5##4##(1993-3#1)(1995-4#1)(2006-10#1)(2008-5#1)(2008-6#1)
which suggest that##11##3##(1991-3#1)(1993-3#1)(1995-4#1)(1997-4#1)(2005-12#1)(2006-10#1)(2006-5#1)(2008-10#1)(2008-5#1)(2008-6#2)
which suggest their##2##3##(2007-12#1)(2011-2#1)
which suggest##20##2##(1991-12#1)(1991-3#1)(1991-5#1)(1993-3#1)(1995-4#1)(1997-4#1)(1997-7#1)(2005-12#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-6#2)(2011-2#1)(2012-12#1)
which suggested a##3##3##(1996-8#1)(2006-7#1)(2008-7#1)
which suggested that some##2##4##(2005-11#1)(2008-11#1)
which suggested that the##6##4##(1995-5#1)(2008-10#2)(2008-12#1)(2008-9#1)(2011-12#1)
which suggested that##20##3##(1991-7#1)(1992-10#1)(1995-5#1)(1996-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2011-12#1)(2011-2#1)(2012-2#1)
which suggested the existence of##2##5##(1997-6#1)(2010-8#1)
which suggested the##6##3##(1993-7#1)(1997-6#1)(2005-11#1)(2008-10#1)(2010-12#1)(2010-8#1)
which suggested##40##2##(1991-7#1)(1992-10#1)(1993-7#1)(1993-8#1)(1995-5#1)(1996-10#1)(1996-8#1)(1997-6#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
which suggests a different##2##4##(1992-6#1)(1994-6#1)
which suggests a##9##3##(1991-5#1)(1992-6#1)(1994-6#1)(2006-10#2)(2006-12#1)(2008-10#1)(2008-2#1)(2012-1#1)
which suggests an##2##3##(2008-1#1)(2009-1#1)
which suggests some##2##3##(1994-3#1)(1996-2#1)
which suggests that S##2##4##(2008-10#1)(2008-8#1)
which suggests that both##2##4##(1991-4#1)(2012-12#1)
which suggests that gene##2##4##(1997-4#1)(2007-1#1)
which suggests that it##2##4##(1991-9#1)(2006-10#1)
which suggests that one##2##4##(1996-3#1)(2008-7#1)
which suggests that some##2##4##(2010-11#1)(2013-1#1)
which suggests that the##18##4##(1993-6#1)(1993-7#1)(1993-8#1)(1994-3#1)(1994-8#3)(1995-1#1)(1995-10#2)(1996-2#1)(1996-7#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#2)
which suggests that there may be two##2##7##(1994-9#1)(2009-11#1)
which suggests that there##4##4##(1990-7#1)(1994-9#1)(2008-8#1)(2009-11#1)
which suggests that these two##2##5##(1994-3#1)(1995-2#1)
which suggests that these##5##4##(1994-3#1)(1994-8#1)(1995-2#1)(2005-11#1)(2010-3#1)
which suggests that they are##2##5##(1990-6#1)(2008-5#1)
which suggests that they##4##4##(1990-6#1)(2008-11#1)(2008-5#1)(2013-1#1)
which suggests that this##6##4##(1992-3#1)(1994-3#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-1#1)
which suggests that##78##3##(1990-3#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-9#2)(1992-3#1)(1992-6#2)(1992-9#1)(1993-3#1)(1993-6#2)(1993-7#1)(1993-8#1)(1994-11#2)(1994-2#2)(1994-3#3)(1994-8#4)(1994-9#1)(1995-1#1)(1995-10#2)(1995-2#1)(1996-11#1)(1996-2#1)(1996-3#3)(1996-7#1)(1997-4#2)(2005-11#1)(2005-8#1)(2006-10#2)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#7)(2009-11#1)(2009-8#1)(2010-11#2)(2010-3#1)(2011-1#1)(2012-11#1)(2012-12#1)(2013-1#2)(2013-7#1)
which suggests the involvement of##2##5##(1992-6#1)(2011-2#1)
which suggests the##5##3##(1991-6#1)(1992-6#1)(2011-2#2)(2013-8#1)
which suggests##103##2##(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-3#1)(1992-6#4)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-7#1)(1993-8#1)(1994-11#2)(1994-2#3)(1994-3#4)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-10#2)(1995-2#1)(1996-11#1)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#2)(1996-7#1)(1997-4#2)(2005-11#1)(2005-8#1)(2006-10#4)(2006-12#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#7)(2009-1#1)(2009-11#1)(2009-8#1)(2010-11#2)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
which summarizes the##2##3##(2008-10#1)(2009-2#1)
which summarizes##4##2##(2008-10#3)(2009-2#1)
which supply the##2##3##(2007-12#2)
which support the##4##3##(2005-9#1)(2008-11#1)(2008-9#1)(2010-4#1)
which support##8##2##(1993-5#1)(2005-9#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-4#1)(2012-1#1)(2013-8#1)
which supports a##4##3##(1990-7#1)(1994-2#1)(1995-2#1)(2007-11#1)
which supports the idea that##2##5##(2007-5#1)(2010-4#1)
which supports the##9##3##(1997-4#2)(2007-5#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-4#1)(2013-7#1)(2013-8#1)
which supports##23##2##(1990-7#1)(1992-7#1)(1994-2#1)(1994-9#1)(1995-2#1)(1997-4#2)(1997-6#1)(2005-11#1)(2007-11#2)(2007-5#1)(2007-7#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-1#1)(2013-7#1)(2013-8#1)
which suppressed the dissolution and oxidation of Ag effectively##2##9##(2013-1#2)
which suppressed the##3##3##(1994-8#1)(2013-1#2)
which suppresses the##2##3##(1991-6#1)(1993-8#1)
which suppresses##5##2##(1991-6#1)(1993-8#1)(1994-3#1)(1997-1#1)(2008-7#1)
which surface##2##2##(2011-1#1)(2013-1#1)
which surgery##3##2##(1990-5#1)(2008-2#1)(2008-4#1)
which surgical##4##2##(1993-10#1)(2006-11#1)(2010-11#1)(2013-8#1)
which surrounds the##2##3##(2010-4#1)(2011-12#1)
which surrounds##3##2##(2008-7#1)(2010-4#1)(2011-12#1)
which survived##3##2##(1996-12#1)(2008-10#1)(2008-6#1)
which sustain##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
which symptoms##4##2##(2004-11#1)(2008-1#1)(2008-10#1)(2012-2#1)
which synthesized##2##2##(1995-8#1)(2008-5#1)
which synthesizes##2##2##(2006-12#1)(2008-5#1)
which take account of the##2##5##(1990-3#1)(1994-4#1)
which take part in##2##4##(1994-6#1)(2013-1#1)
which take place##3##3##(1995-4#1)(2012-2#2)
which take##11##2##(1990-3#1)(1994-4#1)(1994-6#1)(1995-4#1)(2008-10#1)(2009-12#1)(2011-2#1)(2012-2#3)(2013-1#1)
which takes advantage of the##3##5##(1993-8#1)(2008-3#1)(2011-1#1)
which takes into account the##5##5##(1992-4#1)(2005-11#1)(2007-2#1)(2008-3#1)(2010-8#1)
which takes into account##8##4##(1992-4#1)(1996-5#1)(2005-11#1)(2007-2#1)(2008-3#1)(2009-10#1)(2009-2#1)(2010-8#1)
which takes place##3##3##(2008-10#2)(2009-8#1)
which takes the##3##3##(2008-10#1)(2008-3#1)(2010-3#1)
which takes##24##2##(1992-4#1)(1993-8#1)(1996-3#1)(1996-5#1)(2005-11#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-1#1)(2013-8#1)
which target the##3##3##(2007-11#1)(2009-12#1)(2011-2#1)
which target##8##2##(2005-7#1)(2006-10#1)(2007-11#2)(2009-12#1)(2010-12#1)(2011-2#1)(2012-2#1)
which targeted##3##2##(1994-3#1)(2012-12#1)(2012-2#1)
which targets##4##2##(2008-3#1)(2009-8#1)(2010-12#2)
which technique##3##2##(2006-2#1)(2008-10#1)(2009-3#1)
which techniques are##2##3##(2007-11#1)(2007-7#1)
which techniques##3##2##(2006-10#1)(2007-11#1)(2007-7#1)
which tend to be##2##4##(2004-9#1)(2008-8#1)
which tend to develop##2##4##(1996-12#1)(2008-10#1)
which tend to##7##3##(1996-12#1)(2004-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#1)
which tended to##4##3##(1991-8#1)(1997-6#1)(2007-10#1)(2010-8#1)
which tends to##5##3##(2008-2#1)(2008-5#1)(2011-2#2)(2012-2#1)
which tends##6##2##(1990-2#1)(2008-2#1)(2008-5#1)(2011-2#2)(2012-2#1)
which terminates##2##2##(1994-3#1)(2008-2#1)
which test##4##2##(1993-1#1)(2006-7#1)(2008-10#1)(2008-2#1)
which tests##3##2##(1990-2#1)(2007-4#1)(2008-5#1)
which that##4##2##(1991-12#1)(1991-3#1)(2007-1#1)(2008-4#1)
which the DNA##2##3##(1995-1#1)(2006-6#1)
which the MICs were##2##4##(2007-7#1)(2008-11#1)
which the N-terminal##4##3##(1990-4#1)(1991-10#1)(1995-8#1)(1997-2#1)
which the absorption##2##3##(2007-11#1)(2008-3#1)
which the accuracy of##2##4##(2008-2#1)(2013-8#1)
which the accuracy##3##3##(2008-10#1)(2008-2#1)(2013-8#1)
which the amount of##3##4##(1991-11#1)(1994-12#1)(2008-12#1)
which the amount##5##3##(1991-11#1)(1994-12#1)(2007-1#1)(2008-12#1)(2012-3#1)
which the amplitude##2##3##(2008-2#1)(2008-7#1)
which the analyte##3##3##(2008-10#3)
which the animals were##2##4##(1994-3#1)(2009-3#1)
which the animals##5##3##(1993-3#1)(1994-3#1)(2008-8#1)(2009-3#1)(2013-8#1)
which the authors##4##3##(2007-11#1)(2008-3#1)(2008-4#1)(2010-5#1)
which the available##2##3##(2012-12#1)(2013-7#1)
which the bacteria##2##3##(1994-8#1)(2010-12#1)
which the benzene##2##3##(1993-11#1)(1997-2#1)
which the binding##2##3##(2005-11#1)(2006-12#1)
which the bone##2##3##(1995-6#1)(2011-1#1)
which the brain##5##3##(1994-11#2)(2007-8#1)(2008-4#1)(2008-9#1)
which the cavity##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
which the cell##4##3##(1996-4#1)(2008-11#1)(2008-3#1)(2009-11#1)
which the cells were##3##4##(1991-12#1)(1991-9#1)(2008-11#1)
which the cells##8##3##(1991-12#1)(1991-9#1)(1997-3#1)(2008-11#1)(2008-5#2)(2008-7#1)(2012-1#1)
which the chaperone##2##3##(2008-7#1)(2012-2#1)
which the characteristics of##2##4##(1991-12#1)(2006-2#1)
which the child##2##3##(2009-11#1)(2010-10#1)
which the circadian##2##3##(1994-2#1)(2008-5#1)
which the clinical##3##3##(2007-9#1)(2008-5#1)(2012-12#1)
which the concentrations of##2##4##(1995-2#1)(1997-4#1)
which the coupling##2##3##(2008-2#1)(2009-9#1)
which the crude##2##3##(2005-11#1)(2009-7#1)
which the crystal##2##3##(1990-9#1)(2007-12#1)
which the diagnosis##3##3##(1993-5#1)(2008-5#2)
which the different##2##3##(2007-10#1)(2008-10#1)
which the disease##2##3##(2007-6#1)(2008-7#1)
which the drug##5##3##(1994-3#1)(1994-8#1)(2006-12#1)(2007-9#1)(2010-5#1)
which the dynamic##2##3##(2007-12#1)(2008-10#1)
which the effect##3##3##(2009-7#1)(2011-2#1)(2012-1#1)
which the effective##2##3##(2008-10#1)(2008-3#1)
which the effects of##3##4##(1994-6#1)(2007-3#1)(2008-2#1)
which the effects##4##3##(1994-6#1)(2007-3#1)(2008-2#1)(2008-3#1)
which the efficiency##2##3##(1990-8#1)(2008-10#1)
which the enzyme is##2##4##(1990-2#1)(1991-2#1)
which the enzyme##7##3##(1990-2#1)(1991-2#1)(1991-8#1)(1992-8#1)(1993-8#1)(2008-10#1)(2009-5#1)
which the enzymes##2##3##(1991-11#1)(1995-3#1)
which the experimental##2##3##(2008-3#1)(2009-5#1)
which the exposure##2##3##(2008-3#1)(2008-7#1)
which the expression of##5##4##(1990-8#1)(1991-12#1)(1993-11#1)(1997-6#1)(2013-1#1)
which the expression##8##3##(1990-8#1)(1991-12#1)(1993-11#1)(1997-6#1)(2007-11#1)(2010-4#1)(2011-2#1)(2013-1#1)
which the fetus##3##3##(2005-10#1)(2009-9#1)(2013-1#1)
which the first##8##3##(1991-4#1)(1994-12#1)(1996-6#1)(1997-3#1)(2005-11#1)(2007-11#1)(2008-10#1)(2013-1#1)
which the frequency of##3##4##(2008-7#1)(2010-2#1)(2012-1#1)
which the full##2##3##(2007-12#1)(2009-7#1)
which the gamma 1(34##2##4##(1995-2#2)
which the gamma##3##3##(1995-2#2)(1995-3#1)
which the gene##7##3##(1990-11#1)(1995-11#1)(1996-2#1)(2006-10#1)(2008-10#1)(2008-4#2)
which the genome##2##3##(2013-8#2)
which the gray##2##3##(2006-10#1)(2008-3#1)
which the group##2##3##(2008-10#1)(2008-2#1)
which the health##2##3##(2006-9#1)(2012-2#1)
which the height##2##3##(2008-10#1)(2008-2#1)
which the hydrolysis of##2##4##(2008-10#1)(2010-3#1)
which the hydrophobic##2##3##(1991-5#1)(1992-3#1)
which the immune system##2##4##(2005-7#1)(2008-11#1)
which the impact of##2##4##(2010-9#1)(2012-12#1)
which the individual##2##3##(2008-1#1)(2010-11#1)
which the influence of##2##4##(2008-10#1)(2008-3#1)
which the influence##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
which the influences of##2##4##(2008-10#1)(2008-9#1)
which the information##2##3##(2006-8#1)(2008-3#1)
which the initial##2##3##(2007-2#1)(2011-2#1)
which the intensity##2##3##(2007-11#1)(2012-3#1)
which the interaction##2##3##(1992-6#1)(2008-10#1)
which the intracellular##2##3##(1995-6#1)(1997-7#1)
which the latter##2##3##(2008-8#1)(2011-2#1)
which the law##2##3##(1997-8#1)(2006-3#1)
which the ligand##2##3##(1993-8#1)(2010-5#1)
which the light##4##3##(1997-6#1)(2008-3#3)
which the lower##2##3##(1992-10#1)(2013-1#1)
which the main##3##3##(1997-8#2)(2008-10#1)
which the major##6##3##(1994-11#1)(1994-12#1)(2008-10#2)(2008-11#1)(2008-4#1)
which the majority of##6##4##(1990-2#1)(1992-4#1)(1996-5#1)(2006-8#1)(2008-4#1)(2010-5#1)
which the majority##7##3##(1990-2#1)(1992-4#1)(1996-5#1)(2006-8#1)(2008-4#1)(2008-8#1)(2010-5#1)
which the male##2##3##(2008-5#1)(2008-9#1)
which the maximum##10##3##(1993-8#1)(1994-3#1)(2005-11#1)(2005-4#1)(2006-4#1)(2007-10#1)(2008-10#1)(2008-2#2)(2008-3#1)
which the medical##3##3##(1995-3#1)(2006-4#1)(2013-1#1)
which the membrane##2##3##(1994-6#1)(2008-4#1)
which the method##3##3##(2008-10#2)(2008-2#1)
which the minimum##2##3##(2006-8#1)(2008-2#1)
which the molecular##4##3##(2007-12#1)(2008-11#1)(2008-2#1)(2009-3#1)
which the most##8##3##(1991-4#1)(1994-11#1)(1996-12#1)(1996-2#1)(2007-7#1)(2008-1#1)(2008-10#2)
which the name##10##3##(1992-5#1)(2008-10#7)(2012-2#2)
which the negative##2##3##(2008-2#1)(2008-8#1)
which the nonlinear##2##3##(2007-12#2)
which the number of##4##4##(2006-6#1)(2007-11#1)(2008-9#1)(2013-1#1)
which the object is##3##4##(2008-2#1)(2008-3#2)
which the only##4##3##(1994-12#1)(1997-7#1)(2008-10#1)(2008-4#1)
which the optimal##2##3##(1996-9#1)(2013-8#1)
which the organic##3##3##(1996-5#1)(2005-11#1)(2010-4#1)
which the origin of##3##4##(2006-10#1)(2006-6#1)(2008-6#1)
which the output##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
which the p53##2##3##(1995-6#1)(2008-9#1)
which the patient developed##2##4##(2006-4#1)(2011-2#1)
which the patient is##3##4##(1991-4#1)(2007-7#1)(2013-1#1)
which the patient was##3##4##(1993-2#1)(2006-2#1)(2008-7#1)
which the patient##23##3##(1991-1#1)(1991-4#2)(1991-8#1)(1991-9#1)(1993-2#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2007-5#1)(2007-7#1)(2008-7#1)(2010-8#1)(2011-2#4)(2012-2#2)(2013-1#2)
which the phase##4##3##(2006-5#1)(2007-12#1)(2008-2#1)(2008-3#1)
which the population##4##3##(1994-3#1)(2006-2#1)(2008-10#1)(2008-9#1)
which the presence of##3##4##(2007-7#1)(2008-2#1)(2008-8#1)
which the presence##4##3##(2007-7#1)(2008-2#1)(2008-5#1)(2008-8#1)
which the primary##2##3##(2008-10#1)(2008-5#1)
which the probe##3##3##(2005-11#1)(2006-10#1)(2008-1#1)
which the productive##2##3##(1992-6#1)(1993-11#1)
which the protein is##2##4##(1995-10#1)(2006-8#1)
which the protein##3##3##(1995-10#1)(2006-8#1)(2008-4#1)
which the proximal##3##3##(1994-5#1)(2006-3#1)(2009-3#1)
which the questionnaire##2##3##(2008-2#1)(2008-7#1)
which the reaction##4##3##(2005-12#1)(2006-10#1)(2008-10#1)(2008-7#1)
which the reader##2##3##(1992-2#1)(2008-7#1)
which the region##2##3##(1994-2#1)(1994-3#1)
which the regulation of##2##4##(1995-3#1)(2008-7#1)
which the relationship between the##2##5##(2007-1#1)(2008-2#1)
which the relationship between##3##4##(2007-1#1)(2008-2#1)(2009-7#1)
which the relevant##2##3##(2006-8#1)(2007-12#1)
which the required##2##3##(1995-1#1)(2008-10#1)
which the results of##2##4##(1991-12#1)(2009-4#1)
which the results##3##3##(1990-3#1)(1991-12#1)(2009-4#1)
which the sample##4##3##(1992-12#1)(2008-10#3)
which the scanning##2##3##(2007-12#1)(2008-3#1)
which the second##5##3##(1995-10#1)(1995-6#1)(2007-12#1)(2008-3#1)(2009-4#1)
which the sequence##4##3##(1992-11#1)(1992-2#1)(1993-11#1)(2007-12#1)
which the side##5##3##(1994-9#1)(1995-3#1)(1995-8#1)(2006-6#1)(2013-8#1)
which the signal##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
which the site##3##3##(1991-6#1)(1994-8#1)(2008-5#1)
which the six##2##3##(1996-2#1)(2006-1#1)
which the solution##2##3##(2008-10#2)
which the spatial##4##3##(2008-10#1)(2008-3#1)(2008-8#1)(2010-11#1)
which the specific##2##3##(1993-5#1)(2012-12#1)
which the spectral##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
which the stratum corneum was removed##2##6##(1992-8#2)
which the stratum corneum##3##4##(1991-9#1)(1992-8#2)
which the substituents on the##2##5##(1992-8#1)(1994-9#1)
which the surface##2##3##(2008-10#1)(2008-3#1)
which the surgeon##2##3##(2007-8#1)(2008-4#1)
which the surgical##2##3##(1993-9#1)(2013-8#1)
which the system##5##3##(1996-8#1)(2006-10#1)(2008-2#1)(2008-7#1)(2008-8#1)
which the target##8##3##(1994-2#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-11#1)(2011-1#1)
which the test##4##3##(2008-2#1)(2008-4#1)(2008-5#2)
which the theory##2##3##(1997-2#1)(2011-2#1)
which the three##4##3##(1996-2#1)(2008-10#2)(2009-2#1)
which the tubes##2##3##(1993-4#1)(2008-7#1)
which the two##11##3##(1992-1#1)(1996-2#1)(2007-1#1)(2007-12#3)(2008-3#1)(2008-9#1)(2011-1#2)(2013-1#1)
which the underlying##4##3##(2006-10#1)(2006-5#1)(2008-6#1)(2009-10#1)
which the use of##5##4##(1997-7#1)(2008-10#1)(2008-3#1)(2012-12#1)(2013-8#1)
which the values##2##3##(2008-10#1)(2010-4#1)
which the various##2##3##(1991-2#1)(1997-7#1)
which the virus##7##3##(1997-6#1)(2008-10#3)(2008-5#1)(2010-4#1)(2012-12#1)
which the whole##3##3##(2006-5#1)(2007-9#1)(2008-8#1)
which the wild-type##4##3##(1992-6#1)(1994-8#1)(1996-11#1)(2008-7#1)
which the##1584##2##(1990-10#2)(1990-11#3)(1990-12#7)(1990-2#6)(1990-3#2)(1990-4#2)(1990-5#5)(1990-6#1)(1990-7#1)(1990-8#6)(1990-9#4)(1991-1#2)(1991-10#2)(1991-11#5)(1991-12#13)(1991-2#7)(1991-3#3)(1991-4#12)(1991-5#12)(1991-6#3)(1991-7#4)(1991-8#5)(1991-9#9)(1992-1#7)(1992-10#4)(1992-11#2)(1992-12#9)(1992-2#5)(1992-3#6)(1992-4#1)(1992-5#7)(1992-6#4)(1992-7#2)(1992-8#9)(1992-9#2)(1993-1#1)(1993-11#8)(1993-12#3)(1993-2#7)(1993-3#12)(1993-4#1)(1993-5#5)(1993-6#4)(1993-7#1)(1993-8#7)(1993-9#6)(1994-1#1)(1994-11#9)(1994-12#13)(1994-2#8)(1994-3#8)(1994-5#4)(1994-6#7)(1994-7#1)(1994-8#14)(1994-9#7)(1995-1#5)(1995-10#4)(1995-11#9)(1995-12#4)(1995-2#6)(1995-3#16)(1995-4#1)(1995-5#9)(1995-6#8)(1995-8#9)(1995-9#1)(1996-1#2)(1996-10#2)(1996-11#3)(1996-12#6)(1996-2#11)(1996-3#3)(1996-4#6)(1996-5#8)(1996-6#4)(1996-7#5)(1996-8#2)(1996-9#3)(1997-1#3)(1997-2#10)(1997-3#9)(1997-4#6)(1997-5#1)(1997-6#8)(1997-7#14)(1997-8#6)(2004-10#1)(2004-11#1)(2004-12#1)(2004-4#1)(2004-9#3)(2005-10#2)(2005-11#30)(2005-12#1)(2005-4#1)(2005-5#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#4)(2006-10#26)(2006-11#2)(2006-12#9)(2006-2#9)(2006-3#7)(2006-4#5)(2006-5#10)(2006-6#5)(2006-7#7)(2006-8#12)(2006-9#2)(2007-1#10)(2007-10#5)(2007-11#33)(2007-12#56)(2007-2#5)(2007-3#1)(2007-4#5)(2007-5#3)(2007-6#4)(2007-7#10)(2007-8#14)(2007-9#9)(2008-1#19)(2008-10#145)(2008-11#30)(2008-12#3)(2008-2#87)(2008-3#88)(2008-4#41)(2008-5#42)(2008-6#5)(2008-7#32)(2008-8#30)(2008-9#20)(2009-1#2)(2009-10#7)(2009-11#3)(2009-12#3)(2009-2#2)(2009-3#6)(2009-4#4)(2009-5#3)(2009-6#2)(2009-7#6)(2009-8#3)(2009-9#5)(2010-1#1)(2010-10#3)(2010-11#4)(2010-12#10)(2010-2#5)(2010-3#1)(2010-4#8)(2010-5#12)(2010-6#3)(2010-7#5)(2010-8#5)(2010-9#4)(2011-1#12)(2011-12#6)(2011-2#29)(2011-3#1)(2012-1#9)(2012-11#7)(2012-12#15)(2012-2#18)(2012-3#5)(2013-1#30)(2013-7#2)(2013-8#17)
which their##17##2##(1990-5#1)(1995-11#1)(2006-11#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-3#1)
which themselves are##2##3##(1996-9#1)(2006-10#1)
which themselves##7##2##(1991-6#1)(1996-9#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-6#1)(2009-3#1)
which then can be##2##4##(1990-12#1)(2008-8#1)
which then reacts with##2##4##(2007-12#1)(2008-10#1)
which then reacts##3##3##(1997-7#1)(2007-12#1)(2008-10#1)
which then results in##2##4##(1996-4#1)(2013-7#1)
which then undergoes##2##3##(1990-5#1)(2009-10#1)
which then were##2##3##(1991-12#1)(2009-3#1)
which then##39##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-12#1)(1992-1#1)(1992-3#1)(1993-2#1)(1995-11#1)(1995-3#2)(1996-11#1)(1996-2#1)(1996-4#1)(1997-7#1)(2006-9#1)(2007-11#2)(2007-12#3)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-8#2)(2009-9#1)(2010-2#1)(2011-2#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-7#1)
which therapeutic##3##2##(2006-10#1)(2007-8#1)(2010-12#1)
which there are only##2##4##(1993-8#1)(2008-2#1)
which there are##16##3##(1992-6#1)(1993-12#1)(1993-8#1)(1995-5#1)(1997-8#1)(2005-10#1)(2005-6#1)(2005-7#1)(2006-7#1)(2008-10#2)(2008-2#1)(2008-3#3)(2012-12#1)
which there is a##9##4##(1995-2#1)(1997-3#1)(2005-7#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-3#1)(2011-1#1)
which there is an##5##4##(2005-9#1)(2006-5#1)(2007-11#1)(2008-3#1)(2012-12#1)
which there is no##8##4##(1994-11#1)(1994-9#1)(2006-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2012-2#1)(2013-1#1)
which there is##36##3##(1990-3#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-2#2)(1996-9#1)(1997-3#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-11#3)(2007-12#3)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-8#1)(2009-9#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
which there was no##2##4##(1994-11#1)(2012-12#1)
which there was##7##3##(1993-10#1)(1994-11#1)(1996-9#1)(1997-2#1)(2005-7#1)(2010-6#1)(2012-12#1)
which there were##5##3##(1993-6#1)(1997-6#1)(2008-5#1)(2009-10#1)(2011-12#1)
which there##68##2##(1990-3#1)(1992-6#1)(1993-10#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-9#1)(1995-2#2)(1995-5#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-6#1)(2005-7#3)(2005-9#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-7#1)(2007-11#3)(2007-12#3)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-8#1)(2009-9#2)(2010-6#1)(2011-1#1)(2011-12#1)(2012-12#3)(2012-2#3)(2013-1#1)
which thereby become##2##3##(2006-11#1)(2008-7#1)
which thereby##3##2##(1995-8#1)(2006-11#1)(2008-7#1)
which therefore##5##2##(1991-12#1)(1994-11#1)(2008-2#1)(2008-5#1)(2008-7#1)
which these agents##3##3##(1990-2#1)(1994-11#1)(1995-3#1)
which these antibodies##2##3##(1997-7#1)(2006-10#1)
which these methods##2##3##(1990-3#1)(2012-1#1)
which these##71##2##(1990-2#1)(1990-3#1)(1990-6#2)(1991-12#1)(1992-2#1)(1993-2#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#3)(1995-1#2)(1995-10#1)(1995-12#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-7#1)(2005-8#1)(2006-10#6)(2006-12#2)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#3)(2008-8#2)(2009-1#1)(2009-4#3)(2009-8#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-12#2)(2013-7#1)
which they are##30##3##(1991-8#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-9#1)(1994-3#1)(1995-1#1)(1996-1#1)(1996-12#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-8#3)(2008-9#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
which they can be##7##4##(1990-12#1)(2008-11#2)(2008-2#1)(2008-7#1)(2009-4#1)(2011-2#1)
which they can##11##3##(1990-12#1)(2008-11#2)(2008-2#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-9#1)(2011-2#3)
which they could##3##3##(1990-2#1)(1994-6#1)(2006-5#1)
which they exert their##2##4##(2008-4#1)(2013-8#1)
which they exert##4##3##(1990-11#1)(2008-4#1)(2013-8#2)
which they felt##2##3##(2007-9#1)(2009-12#1)
which they generate##2##3##(1995-2#1)(1996-2#1)
which they had previously##2##4##(2008-12#1)(2010-4#1)
which they had##8##3##(1991-2#1)(1996-3#1)(2007-10#1)(2007-2#1)(2008-12#1)(2008-8#1)(2010-4#1)(2013-7#1)
which they have been##6##4##(1991-12#1)(1997-5#1)(2006-8#1)(2008-5#1)(2010-5#1)(2011-2#1)
which they have##9##3##(1991-12#1)(1996-11#1)(1997-5#1)(2005-7#1)(2006-8#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-2#1)
which they may##3##3##(2008-10#1)(2008-12#1)(2009-5#1)
which they occur##4##3##(1996-4#1)(2012-3#1)(2013-1#2)
which they originated##4##3##(2008-10#1)(2008-11#1)(2008-6#1)(2010-7#1)
which they perceive##2##3##(2008-10#1)(2008-11#1)
which they perceived##2##3##(2010-7#1)(2012-3#1)
which they shared##2##3##(2008-10#1)(2010-11#1)
which they show##2##3##(2005-11#1)(2008-9#1)
which they use##2##3##(2006-7#1)(2012-2#1)
which they were##29##3##(1991-9#1)(1992-11#1)(1993-6#1)(1994-3#1)(1996-9#1)(1997-3#1)(1997-4#1)(2006-10#2)(2007-11#1)(2007-5#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-5#1)(2010-11#1)(2012-1#1)(2012-12#1)(2013-8#1)
which they will##3##3##(1996-3#2)(2008-9#1)
which they work##3##3##(1995-3#1)(2005-9#1)(2007-4#1)
which they##217##2##(1990-11#1)(1990-12#2)(1990-2#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#2)(1993-1#2)(1993-6#1)(1993-9#1)(1994-1#1)(1994-3#3)(1994-6#2)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-4#1)(1996-9#2)(1997-1#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-11#1)(2005-2#1)(2005-6#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#3)(2007-8#2)(2007-9#4)(2008-1#1)(2008-10#15)(2008-11#7)(2008-12#4)(2008-2#6)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#8)(2008-9#7)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#5)(2009-5#3)(2009-6#1)(2010-11#2)(2010-2#2)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#12)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#3)
which this can be##3##4##(2007-8#1)(2010-5#1)(2012-2#1)
which this effect##2##3##(2008-10#1)(2010-1#1)
which this occurs are##2##4##(2008-11#1)(2012-12#1)
which this occurs is##3##4##(1996-8#1)(2008-7#1)(2013-8#1)
which this occurs##10##3##(1992-9#1)(1993-7#1)(1996-8#1)(1997-4#1)(2008-11#2)(2008-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
which this paper##2##3##(2007-10#1)(2008-5#1)
which this##65##2##(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1992-3#1)(1992-9#1)(1993-10#1)(1993-7#1)(1994-3#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-8#2)(1997-3#1)(1997-4#1)(2004-9#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-1#2)(2010-11#2)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
which those##2##2##(2008-12#1)(2008-7#1)
which three were##3##3##(1994-2#1)(1996-8#1)(2011-1#1)
which three##13##2##(1993-11#1)(1994-2#1)(1995-6#1)(1996-8#1)(1997-4#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)(2012-12#1)(2013-1#1)
which thus##2##2##(1993-7#1)(1993-8#1)
which time the germ cells##2##5##(1997-1#2)
which time the##10##3##(1997-1#2)(2005-8#1)(2006-11#1)(2007-7#1)(2007-9#1)(2008-4#1)(2008-6#1)(2010-10#1)(2011-12#1)
which time##24##2##(1992-12#1)(1992-6#1)(1992-9#1)(1993-7#1)(1996-2#1)(1997-1#3)(2005-8#1)(2006-11#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#2)(2008-7#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-12#1)(2013-1#1)
which tissue##3##2##(1995-6#1)(2008-11#1)(2012-2#1)
which to achieve##2##3##(2005-7#1)(2006-5#1)
which to base future##2##4##(1993-3#1)(2008-1#1)
which to base##11##3##(1992-12#1)(1993-3#1)(1997-1#1)(2006-10#2)(2006-7#1)(2008-1#2)(2008-11#1)(2008-7#1)(2012-2#1)
which to build##2##3##(1996-1#1)(2007-12#1)
which to compare##6##3##(1993-7#1)(1997-4#1)(2005-8#1)(2008-8#1)(2013-1#2)
which to determine##2##3##(2007-4#1)(2008-3#1)
which to evaluate##2##3##(1991-3#1)(2006-11#1)
which to examine the##3##4##(1992-2#1)(2009-8#1)(2013-8#1)
which to examine##4##3##(1992-2#1)(2008-11#1)(2009-8#1)(2013-8#1)
which to explore the##3##4##(2008-3#1)(2009-10#1)(2009-7#1)
which to explore##4##3##(2008-3#1)(2009-10#1)(2009-7#1)(2012-12#1)
which to grow##2##3##(2004-3#1)(2008-10#1)
which to improve##3##3##(2008-1#1)(2008-3#1)(2013-8#1)
which to investigate the##3##4##(1996-2#1)(2008-7#1)(2009-5#1)
which to investigate##4##3##(1996-2#1)(2008-7#2)(2009-5#1)
which to make##3##3##(2008-2#1)(2008-3#1)(2011-8#1)
which to measure the##3##4##(1990-11#1)(1994-3#2)
which to measure##7##3##(1990-11#2)(1994-3#2)(2008-3#2)(2009-4#1)
which to our knowledge##3##4##(1997-2#1)(2007-12#1)(2008-11#1)
which to study the##9##4##(1991-5#1)(1994-8#1)(1995-2#1)(1997-3#1)(2005-12#1)(2007-8#1)(2008-4#1)(2009-6#1)(2013-8#1)
which to study##21##3##(1990-7#2)(1991-5#1)(1993-4#1)(1994-6#1)(1994-8#1)(1995-2#1)(1997-3#1)(2005-12#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-6#1)(2012-3#1)(2013-8#1)
which to the##2##3##(2007-11#1)(2012-12#1)
which to##151##2##(1990-11#2)(1990-7#2)(1991-3#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-3#1)(1993-4#1)(1993-7#1)(1994-10#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-4#1)(1996-1#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(2004-3#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#2)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#4)(2007-12#9)(2007-2#2)(2007-4#2)(2007-8#1)(2008-1#4)(2008-10#4)(2008-11#8)(2008-12#3)(2008-2#5)(2008-3#16)(2008-4#3)(2008-5#1)(2008-7#10)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-5#1)(2010-9#1)(2011-8#1)(2012-12#7)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#4)
which together constitute##2##3##(2008-4#1)(2008-8#1)
which together determine the data's scheduling priority##2##7##(2013-1#2)
which together form##2##3##(1994-3#1)(2008-3#1)
which together with the##4##4##(1997-7#1)(2009-10#1)(2009-2#1)(2011-2#1)
which together with##7##3##(1996-10#1)(1997-7#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-2#1)(2011-2#1)
which together##25##2##(1991-7#1)(1993-2#1)(1994-3#1)(1995-8#1)(1996-10#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-10#2)(2009-11#1)(2009-2#1)(2011-2#1)(2012-12#1)(2013-1#2)
which took into account##2##4##(1995-11#1)(2006-10#1)
which took place from##3##4##(2005-8#1)(2006-12#1)(2009-6#1)
which took place##5##3##(2005-8#1)(2006-12#1)(2008-5#1)(2009-2#1)(2009-6#1)
which took##12##2##(1990-5#1)(1995-11#1)(1996-3#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-12#1)(2008-5#1)(2009-2#1)(2009-6#1)(2012-12#1)
which total##4##2##(1995-12#1)(2007-12#1)(2008-10#1)(2008-12#1)
which traditional##3##2##(2007-11#1)(2007-8#1)(2012-12#1)
which training##2##2##(1996-3#1)(2013-8#1)
which transcription##3##2##(1991-8#1)(1995-11#1)(2008-2#1)
which transfer##2##2##(1990-8#1)(2008-10#1)
which transfers##2##2##(1994-8#1)(2011-1#1)
which transforms##2##2##(2005-10#1)(2006-10#1)
which translates##2##2##(2007-5#1)(2008-7#1)
which transmit##2##2##(1995-7#1)(2009-8#1)
which treatment is##2##3##(2010-12#1)(2013-1#1)
which treatment was##2##3##(1993-2#1)(2010-1#1)
which treatment##13##2##(1993-2#1)(1996-10#1)(2007-11#2)(2008-1#1)(2008-6#2)(2008-7#1)(2009-11#1)(2010-1#1)(2010-12#2)(2013-1#1)
which treats the##3##3##(2007-12#1)(2010-7#1)(2012-1#1)
which treats##5##2##(1995-1#1)(2006-3#1)(2007-12#1)(2010-7#1)(2012-1#1)
which trigger##6##2##(1990-5#1)(2005-9#1)(2008-10#1)(2010-2#1)(2013-1#2)
which triggers##5##2##(1995-12#1)(2008-7#1)(2011-1#1)(2012-3#2)
which tryptophan##2##2##(1992-6#1)(1997-4#1)
which tumor cells##3##3##(1995-5#1)(1996-4#1)(2006-10#1)
which tumor##8##2##(1990-10#1)(1995-5#1)(1996-10#1)(1996-4#1)(2006-10#1)(2010-12#1)(2013-1#2)
which turned out to be a##2##6##(2007-11#1)(2012-2#1)
which turned out to be##5##5##(2007-11#1)(2007-9#2)(2012-2#2)
which turned out to##6##4##(2006-8#1)(2007-11#1)(2007-9#2)(2012-2#2)
which turned##7##2##(2006-8#1)(2007-11#1)(2007-9#2)(2008-5#1)(2012-2#2)
which turns##2##2##(1993-2#1)(2008-11#1)
which two##33##2##(1990-12#1)(1991-2#1)(1992-12#2)(1992-6#1)(1992-8#1)(1992-9#1)(1994-12#1)(1995-5#1)(1995-6#1)(1997-6#1)(1997-7#1)(2006-8#1)(2007-12#1)(2007-8#2)(2008-10#4)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-12#1)(2010-2#1)(2012-3#1)
which type of##6##3##(1993-2#1)(2006-12#1)(2008-3#1)(2008-4#1)(2011-1#1)(2013-1#1)
which type##7##2##(1993-2#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-1#1)(2013-1#1)
which types of##3##3##(1994-2#1)(2008-11#1)(2008-4#1)
which typically##11##2##(1995-1#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-8#1)(2011-2#1)(2013-1#2)(2013-7#1)
which ultimately##12##2##(1992-10#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-12#2)(2012-12#1)(2012-2#1)
which under##5##2##(1995-2#1)(2007-10#1)(2008-10#2)(2008-11#1)
which undergo a##2##3##(2007-11#1)(2010-7#1)
which undergo##7##2##(1996-12#1)(1997-7#1)(2007-11#1)(2008-4#1)(2008-7#1)(2010-4#1)(2010-7#1)
which undergoes a##4##3##(1994-11#1)(1996-5#2)(2008-10#1)
which undergoes further##2##3##(1993-11#1)(1997-2#1)
which undergoes##14##2##(1991-5#1)(1993-11#1)(1993-3#1)(1994-11#1)(1995-3#1)(1996-5#2)(1997-2#1)(2006-10#1)(2007-11#1)(2008-10#1)(2009-8#1)(2010-5#1)(2011-2#1)
which underlie the##3##3##(2008-5#2)(2009-4#1)
which underlie##5##2##(1994-12#1)(2008-5#2)(2009-4#1)(2011-2#1)
which underlies the##2##3##(2008-4#1)(2008-8#1)
which underlies##3##2##(1997-2#1)(2008-4#1)(2008-8#1)
which underscores##2##2##(1990-12#1)(2011-2#1)
which underwent##6##2##(1990-6#1)(1990-7#2)(1992-7#1)(2007-11#1)(2007-7#1)
which uniquely##2##2##(1991-5#1)(1993-8#1)
which unlike the##2##3##(1992-10#1)(2009-8#1)
which until then had##2##4##(2009-2#2)
which up to now have been##2##6##(1990-8#1)(2007-9#1)
which up to now##3##4##(1990-8#1)(2007-9#1)(2013-8#1)
which up to##5##3##(1990-8#1)(1996-5#1)(2007-9#1)(2008-10#1)(2013-8#1)
which upon##5##2##(1990-11#1)(2005-11#1)(2007-11#2)(2008-10#1)
which use different##2##3##(1992-6#1)(2008-7#1)
which use the##3##3##(1996-10#1)(2008-1#1)(2008-3#1)
which use this##2##3##(2008-3#1)(2010-8#1)
which use##16##2##(1992-6#1)(1993-4#1)(1996-10#1)(2006-11#1)(2006-4#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-7#1)(2009-10#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-1#1)
which used a##3##3##(1997-7#1)(2007-9#1)(2010-10#1)
which used the##2##3##(1996-2#1)(2008-10#1)
which used##10##2##(1990-10#1)(1990-11#1)(1996-2#1)(1997-7#1)(2005-11#1)(2007-9#1)(2008-10#1)(2010-10#1)(2011-2#1)(2012-12#1)
which uses a##12##3##(1996-9#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-7#1)(2008-9#1)(2010-8#1)(2012-1#1)
which uses an##2##3##(1996-12#1)(2008-3#1)
which uses only##2##3##(1990-12#1)(2008-2#1)
which uses the##7##3##(1995-2#2)(2007-12#2)(2008-2#1)(2012-2#2)
which uses##47##2##(1990-12#1)(1991-2#1)(1991-3#1)(1992-3#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-6#3)(1996-12#2)(1996-4#1)(1996-9#1)(2005-8#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-2#5)(2008-3#4)(2008-4#1)(2008-7#1)(2008-9#2)(2010-8#2)(2012-1#1)(2012-2#3)
which usually is##2##3##(1997-6#1)(2008-10#1)
which usually occurs##3##3##(1990-6#1)(2006-2#1)(2012-3#1)
which usually starts##2##3##(2008-3#1)(2008-5#1)
which usually##27##2##(1990-5#1)(1990-6#1)(1992-2#1)(1994-5#1)(1995-9#1)(1996-6#1)(1997-6#1)(2004-12#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
which utilises the##2##3##(1996-10#1)(2008-10#1)
which utilize##4##2##(1993-6#1)(2006-1#1)(2008-10#1)(2008-11#1)
which utilizes a##5##3##(1993-12#1)(2006-10#1)(2008-10#1)(2008-2#1)(2011-1#1)
which utilizes the##5##3##(1990-11#1)(1990-4#1)(2008-10#1)(2008-6#1)(2013-1#1)
which utilizes##20##2##(1990-10#1)(1990-11#1)(1990-4#1)(1990-8#1)(1993-12#1)(1993-3#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-6#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
which variables are##2##3##(2008-5#1)(2010-1#1)
which variables##4##2##(2006-1#1)(2007-11#1)(2008-5#1)(2010-1#1)
which varied in##3##3##(1993-4#1)(2007-12#1)(2009-7#1)
which varied##9##2##(1992-3#1)(1993-4#1)(2004-10#1)(2004-11#1)(2007-12#1)(2007-3#1)(2008-1#1)(2009-7#1)(2013-7#1)
which varies depending on##2##4##(2006-6#1)(2010-12#1)
which varies from##2##3##(1995-11#1)(2008-10#1)
which varies in##2##3##(2006-9#1)(2009-9#1)
which varies##9##2##(1991-8#1)(1995-11#1)(1996-2#1)(2006-6#1)(2006-9#1)(2008-10#2)(2009-9#1)(2010-12#1)
which various##18##2##(1991-11#1)(1992-6#1)(1993-9#2)(1994-2#1)(1994-6#1)(1995-3#1)(2005-8#1)(2006-10#2)(2007-11#1)(2007-5#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-4#1)(2012-12#1)
which vary in##2##3##(1990-8#1)(1995-7#1)
which vary##4##2##(1990-8#1)(1991-5#1)(1995-7#1)(2010-3#1)
which very##2##2##(2008-2#1)(2008-7#1)
which virus##5##2##(1994-10#1)(1995-12#1)(1997-6#1)(2008-10#1)(2008-5#1)
which was 0##3##3##(1991-9#1)(2007-1#1)(2008-6#1)
which was 80##2##3##(2008-3#1)(2013-8#1)
which was a##19##3##(1994-11#1)(1995-8#1)(2005-11#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#2)(2009-2#2)(2010-1#1)(2010-6#2)(2011-2#1)(2012-3#1)(2013-7#1)
which was abolished by##2##4##(1995-12#1)(2013-1#1)
which was abolished##5##3##(1991-9#1)(1995-12#1)(1996-12#1)(2008-4#1)(2013-1#1)
which was about##6##3##(1992-5#1)(2004-4#1)(2008-11#3)(2010-12#1)
which was absent in the##2##5##(1994-11#1)(2006-8#1)
which was absent in##4##4##(1993-6#1)(1994-11#1)(2006-8#1)(2008-10#1)
which was absent##5##3##(1992-12#1)(1993-6#1)(1994-11#1)(2006-8#1)(2008-10#1)
which was accidentally##2##3##(2007-10#1)(2007-8#1)
which was accompanied by a##2##5##(1990-3#1)(2012-3#1)
which was accompanied by an increase##2##6##(1993-9#1)(2008-6#1)
which was accompanied by an##3##5##(1993-9#1)(2008-6#1)(2009-9#1)
which was accompanied by##9##4##(1990-3#1)(1993-9#1)(1994-3#1)(1995-6#1)(2007-7#1)(2008-6#1)(2009-9#1)(2011-12#1)(2012-3#1)
which was accompanied##10##3##(1990-3#1)(1993-9#1)(1994-3#1)(1995-6#1)(2007-7#1)(2008-6#1)(2009-9#1)(2010-6#1)(2011-12#1)(2012-3#1)
which was achieved by##2##4##(2008-10#1)(2008-5#1)
which was achieved##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
which was active##3##3##(1995-2#2)(1997-2#1)
which was added to the##2##5##(2008-10#2)
which was administered to##2##4##(1996-3#1)(2008-11#1)
which was administered##3##3##(1996-3#1)(2004-1#1)(2008-11#1)
which was adopted##2##3##(2008-10#1)(2011-2#1)
which was adversely affected##2##4##(1996-3#1)(2008-10#1)
which was almost##2##3##(1994-9#1)(2007-2#1)
which was already##2##3##(2008-2#1)(2009-2#1)
which was also associated with##2##5##(1995-1#1)(2007-10#1)
which was also ineffective##2##4##(1992-8#1)(2010-2#1)
which was also observed##2##4##(2008-10#1)(2011-2#1)
which was also##19##3##(1990-12#1)(1990-5#1)(1992-8#2)(1993-2#1)(1995-1#1)(1996-5#1)(2004-9#1)(2005-7#1)(2007-10#1)(2008-10#3)(2008-9#1)(2010-10#1)(2010-2#1)(2011-12#1)(2011-2#1)(2013-8#1)
which was antagonized by##4##4##(1990-2#1)(1990-5#2)(1993-6#1)
which was antagonized##5##3##(1990-2#1)(1990-5#2)(1992-8#1)(1993-6#1)
which was applied##2##3##(1991-12#1)(2008-10#1)
which was as##2##3##(1993-9#1)(2004-11#1)
which was assessed##3##3##(1994-3#1)(2004-12#1)(2011-1#1)
which was assigned to the##2##5##(2006-8#1)(2008-8#1)
which was associated with a##3##5##(1991-6#1)(2007-10#1)(2012-1#1)
which was associated with the##2##5##(2008-4#1)(2010-6#1)
which was associated with##15##4##(1991-6#1)(1992-8#1)(1993-9#1)(1994-6#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-8#1)(2010-6#1)(2011-1#1)(2012-1#1)(2013-1#2)
which was associated##16##3##(1991-6#1)(1992-8#1)(1993-9#1)(1994-6#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-8#1)(2010-6#1)(2011-1#1)(2012-1#1)(2013-1#2)
which was at##2##3##(1990-10#1)(1995-8#1)
which was attended by over##2##5##(2005-8#1)(2005-9#1)
which was attended by##3##4##(2005-8#1)(2005-9#1)(2008-5#1)
which was attributed to##6##4##(1992-5#1)(1992-8#1)(2008-12#1)(2009-1#1)(2010-12#1)(2011-12#1)
which was based on##7##4##(2008-10#3)(2008-7#1)(2008-9#1)(2010-5#1)(2013-1#1)
which was based upon##2##4##(2008-10#2)
which was based##9##3##(2008-10#5)(2008-7#1)(2008-9#1)(2010-5#1)(2013-1#1)
which was better than##2##4##(2007-6#1)(2011-1#1)
which was blocked by##11##4##(1991-9#1)(1992-7#1)(1993-3#1)(1993-4#1)(1995-11#1)(1995-12#1)(1996-9#1)(2005-8#1)(2007-12#1)(2008-4#1)(2012-2#1)
which was blocked##12##3##(1991-9#1)(1992-7#1)(1993-3#1)(1993-4#1)(1995-11#1)(1995-12#1)(1996-9#1)(2005-8#1)(2007-12#1)(2008-11#1)(2008-4#1)(2012-2#1)
which was brought to the##2##5##(1992-6#1)(1993-10#1)
which was brought to##3##4##(1990-10#1)(1992-6#1)(1993-10#1)
which was brought##4##3##(1990-10#1)(1992-6#1)(1993-10#1)(2006-9#1)
which was calculated##3##3##(2007-8#1)(2008-5#1)(2011-2#1)
which was carried out##4##4##(1990-3#1)(1991-5#1)(2008-1#1)(2013-1#1)
which was caused by the##3##5##(2005-11#1)(2008-8#1)(2012-3#1)
which was caused by##6##4##(2005-11#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-8#2)
which was characterized##2##3##(1996-11#1)(2008-10#1)
which was clinically diagnosed##2##4##(1996-5#1)(2007-7#1)
which was close to##3##4##(1993-2#1)(1994-8#1)(2008-5#1)
which was comparable with the##2##5##(1996-5#1)(2007-11#1)
which was comparable with##3##4##(1994-9#1)(1996-5#1)(2007-11#1)
which was comparable##4##3##(1994-9#1)(1996-5#1)(1996-7#1)(2007-11#1)
which was completed##2##3##(2006-5#1)(2008-11#1)
which was completely##2##3##(1994-9#1)(2012-11#1)
which was complicated by##2##4##(2005-12#1)(2007-7#1)
which was concerned with##2##4##(1991-5#1)(2012-12#1)
which was conducted in the##2##5##(2008-5#1)(2011-1#1)
which was conducted##4##3##(2008-1#1)(2008-5#1)(2011-1#1)(2013-8#1)
which was confirmed as##2##4##(2008-10#1)(2011-1#1)
which was confirmed by computed##2##5##(2008-8#1)(2010-10#1)
which was confirmed by the##2##5##(2008-10#2)
which was confirmed by##10##4##(1996-12#1)(1997-1#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#1)(2010-10#1)
which was confirmed##16##3##(1996-12#1)(1997-1#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-7#2)(2008-8#1)(2009-5#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
which was considerably##2##3##(1994-11#1)(2012-2#1)
which was considered to be##2##5##(2006-10#1)(2010-7#1)
which was considered to##3##4##(2006-10#1)(2007-7#1)(2010-7#1)
which was considered##5##3##(1996-6#1)(2006-10#1)(2007-11#1)(2007-7#1)(2010-7#1)
which was consistent with the observed##2##6##(2008-10#1)(2008-5#1)
which was consistent with the##5##5##(1995-5#1)(2008-10#2)(2008-5#1)(2008-9#1)
which was consistent with##10##4##(1990-5#1)(1995-10#1)(1995-11#1)(1995-5#2)(2008-10#2)(2008-5#1)(2008-9#1)(2010-6#1)
which was constructed##3##3##(1990-3#1)(2008-10#2)
which was converted to##2##4##(1991-5#1)(2007-11#1)
which was converted##3##3##(1991-5#1)(2007-11#1)(2008-10#1)
which was corrected##2##3##(2006-6#1)(2008-7#1)
which was decreased##2##3##(1991-9#1)(2012-2#1)
which was defined as a##2##5##(2006-10#1)(2007-7#1)
which was defined as##4##4##(2006-10#1)(2007-11#1)(2007-7#1)(2011-12#1)
which was demonstrated by##4##4##(2005-12#1)(2007-10#1)(2008-11#1)(2012-11#1)
which was demonstrated##6##3##(1991-4#1)(1996-3#1)(2005-12#1)(2007-10#1)(2008-11#1)(2012-11#1)
which was dependent on##2##4##(1992-5#1)(2008-8#1)
which was derived from##2##4##(1994-11#1)(2013-8#1)
which was derived##4##3##(1992-12#1)(1993-3#1)(1994-11#1)(2013-8#1)
which was designated as##2##4##(2007-9#2)
which was designated##3##3##(2005-11#1)(2007-9#2)
which was designed for##2##4##(2005-11#1)(2008-2#1)
which was designed to##6##4##(1996-1#1)(1996-7#1)(1997-4#1)(2008-2#1)(2008-5#1)(2010-3#1)
which was designed##9##3##(1996-1#1)(1996-7#1)(1997-4#1)(2005-11#1)(2008-2#2)(2008-5#1)(2010-3#1)(2012-3#1)
which was detected by##5##4##(1992-1#1)(1994-5#1)(1995-2#1)(2008-11#1)(2012-1#1)
which was detected in##2##4##(1996-4#1)(2009-7#1)
which was detected only##2##4##(1990-1#1)(1992-11#1)
which was detected##12##3##(1990-1#1)(1992-1#1)(1992-11#1)(1992-12#1)(1994-5#1)(1995-2#1)(1996-4#1)(1997-2#1)(2008-11#1)(2009-6#1)(2009-7#1)(2012-1#1)
which was determined by##3##4##(2006-12#1)(2008-2#1)(2012-1#1)
which was determined using##3##4##(1992-2#1)(1992-6#1)(1993-9#1)
which was determined##11##3##(1992-2#1)(1992-6#1)(1993-9#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-7#1)(2008-8#1)(2012-1#1)
which was developed by##2##4##(1990-12#1)(1990-8#1)
which was developed in##5##4##(1995-4#1)(2008-10#2)(2008-12#1)(2008-3#1)
which was developed to##2##4##(2008-10#2)
which was developed##11##3##(1990-12#1)(1990-8#1)(1995-4#1)(2007-2#1)(2008-10#5)(2008-12#1)(2008-3#1)
which was diagnosed as##3##4##(1990-6#1)(2007-11#1)(2012-2#1)
which was diagnosed##9##3##(1990-6#1)(1991-5#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-7#1)(2012-2#2)(2013-8#1)
which was different##2##3##(2008-8#1)(2009-10#1)
which was directly##2##3##(1996-4#1)(2005-11#1)
which was discovered by##2##4##(1990-5#1)(2008-1#1)
which was discovered##3##3##(1990-5#1)(2008-1#1)(2012-12#1)
which was due to##4##4##(1991-10#1)(1996-7#1)(2008-3#1)(2008-4#1)
which was elevated##2##3##(2012-2#2)
which was eluted with##2##4##(1990-11#1)(1993-6#1)
which was eluted##3##3##(1990-11#1)(1992-2#1)(1993-6#1)
which was enhanced##4##3##(1994-9#1)(1995-7#1)(1996-8#1)(2007-8#1)
which was essential for##2##4##(2008-8#1)(2011-2#1)
which was established##3##3##(1992-2#1)(2004-2#1)(2008-11#1)
which was evaluated by a##2##5##(2008-5#1)(2011-1#1)
which was evidenced by##2##4##(1996-12#1)(2008-11#1)
which was evident from the##2##5##(2013-1#2)
which was evident##4##3##(2008-6#1)(2008-8#1)(2013-1#2)
which was examined scientifically for the first time in Graz##2##10##(2008-10#2)
which was excised##2##3##(2009-3#1)(2013-8#1)
which was expressed##3##3##(1990-12#1)(1992-3#1)(2008-10#1)
which was first described in##2##5##(2008-10#1)(2008-2#1)
which was first##7##3##(1993-8#1)(1994-2#1)(1994-8#1)(2007-5#1)(2008-10#2)(2008-2#1)
which was flanked by##2##4##(2008-8#1)(2012-3#1)
which was followed by a##2##5##(1990-11#1)(2010-10#1)
which was followed by##8##4##(1990-11#1)(1991-1#1)(1991-6#1)(1993-7#1)(2008-1#2)(2010-10#1)(2013-8#1)
which was followed##9##3##(1990-11#1)(1991-1#1)(1991-6#1)(1993-7#1)(2008-1#2)(2010-10#1)(2013-8#2)
which was formed by##4##4##(2005-4#1)(2007-8#1)(2011-2#1)(2012-1#1)
which was found to be the most##2##7##(2008-10#1)(2008-9#1)
which was found to be the##3##6##(2008-10#2)(2008-9#1)
which was found to be##17##5##(1991-11#1)(1993-12#1)(1993-9#1)(1995-11#1)(1996-3#1)(1996-7#1)(1997-4#1)(2006-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)
which was found to have a##3##6##(1993-9#1)(2008-2#1)(2011-2#1)
which was found to have##6##5##(1993-9#1)(2006-9#1)(2008-2#1)(2010-9#1)(2011-2#2)
which was found to##29##4##(1991-11#1)(1993-12#1)(1993-6#1)(1993-9#3)(1995-11#1)(1996-3#1)(1996-7#2)(1997-4#1)(2006-11#1)(2006-9#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#1)(2010-9#1)(2011-2#2)(2012-3#1)
which was found##36##3##(1991-11#1)(1993-12#1)(1993-6#1)(1993-9#3)(1995-11#1)(1996-3#1)(1996-7#2)(1997-3#1)(1997-4#1)(2006-11#1)(2006-9#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-11#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
which was fully##2##3##(1990-2#1)(1997-2#1)
which was further supported by the##2##6##(1997-4#1)(2012-2#1)
which was further##9##3##(1993-11#1)(1996-5#2)(1996-8#1)(1997-4#1)(2008-10#1)(2010-10#1)(2012-2#1)(2013-1#1)
which was generally##3##3##(1995-10#1)(2007-9#1)(2008-6#1)
which was generated##3##3##(1991-4#1)(2007-12#1)(2012-2#1)
which was given##2##3##(2006-9#1)(2007-7#1)
which was greater in##2##4##(2008-10#1)(2009-11#1)
which was greater than that of##2##6##(2010-2#1)(2013-7#1)
which was greater than that##3##5##(1991-12#1)(2010-2#1)(2013-7#1)
which was greater than##4##4##(1991-12#1)(1991-5#1)(2010-2#1)(2013-7#1)
which was greater##6##3##(1991-12#1)(1991-5#1)(2008-10#1)(2009-11#1)(2010-2#1)(2013-7#1)
which was greatly##2##3##(1993-2#1)(2012-12#1)
which was grown##2##3##(1994-12#2)
which was higher than that##2##5##(1996-5#1)(2008-12#1)
which was higher##3##3##(1996-5#1)(1997-7#1)(2008-12#1)
which was highly##3##3##(1991-7#1)(1994-2#1)(2006-8#1)
which was identical in##2##4##(1990-4#1)(1994-12#1)
which was identified as##7##4##(1990-3#1)(1991-2#1)(1991-7#1)(1994-11#1)(1997-7#1)(2008-11#1)(2008-5#1)
which was identified##9##3##(1990-3#1)(1991-2#1)(1991-7#1)(1994-11#1)(1994-8#1)(1996-4#1)(1997-7#1)(2008-11#1)(2008-5#1)
which was immediately##3##3##(1990-9#1)(1992-2#1)(2012-2#1)
which was implemented##2##3##(2013-1#1)(2013-8#1)
which was improved##2##3##(1996-9#1)(2013-1#1)
which was in good agreement with##2##6##(2008-10#1)(2008-2#1)
which was in good##3##4##(2005-4#1)(2008-10#1)(2008-2#1)
which was in##8##3##(1990-8#1)(2005-4#1)(2005-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)
which was increased##2##3##(1992-11#1)(1996-7#1)
which was independent of##2##4##(1993-4#1)(2008-1#1)
which was induced by a##2##5##(2008-1#1)(2008-6#1)
which was induced by the##2##5##(1996-6#1)(2008-3#1)
which was induced by##6##4##(1990-12#1)(1996-6#1)(1997-8#1)(2008-1#1)(2008-3#1)(2008-6#1)
which was induced##7##3##(1990-12#1)(1992-8#1)(1996-6#1)(1997-8#1)(2008-1#1)(2008-3#1)(2008-6#1)
which was inhibited by##3##4##(1995-6#1)(1997-1#1)(1997-6#1)
which was inhibited##6##3##(1990-9#1)(1991-8#1)(1995-6#1)(1997-1#1)(1997-6#1)(2011-3#1)
which was initially diagnosed as##2##5##(2007-7#1)(2009-9#1)
which was initially##7##3##(1991-2#1)(1995-1#1)(1996-2#1)(2005-4#1)(2007-11#1)(2007-7#1)(2009-9#1)
which was initiated##3##3##(1995-3#1)(2009-8#1)(2010-12#1)
which was insensitive to##2##4##(1995-11#1)(2012-2#1)
which was introduced##5##3##(1993-10#1)(1997-7#1)(2007-7#1)(2008-10#1)(2009-12#1)
which was isolated from a##3##5##(1995-5#1)(2006-12#1)(2006-3#1)
which was isolated from##7##4##(1990-3#1)(1995-5#2)(1996-2#1)(2006-12#1)(2006-3#1)(2007-12#1)
which was isolated##9##3##(1990-3#1)(1992-5#1)(1995-5#2)(1996-2#1)(1996-5#1)(2006-12#1)(2006-3#1)(2007-12#1)
which was known##2##3##(2008-10#1)(2008-6#1)
which was later confirmed##2##4##(2008-4#1)(2010-2#1)
which was later##5##3##(1997-1#1)(2007-6#1)(2007-8#1)(2008-4#1)(2010-2#1)
which was launched aboard the##2##5##(2008-2#1)(2008-3#1)
which was less than##2##4##(1993-5#1)(2013-8#1)
which was likely##2##3##(1994-8#1)(2008-11#1)
which was limited##2##3##(2008-3#1)(2012-2#1)
which was localized##2##3##(2008-9#1)(2009-8#1)
which was located##3##3##(1990-7#1)(1997-3#1)(2013-8#1)
which was lower than##2##4##(2007-2#1)(2012-12#1)
which was lower##3##3##(2007-2#1)(2012-12#2)
which was made##4##3##(1995-6#1)(2004-2#1)(2008-10#1)(2013-8#1)
which was mainly##2##3##(2007-4#1)(2012-12#1)
which was maintained for##2##4##(1995-12#1)(2006-7#1)
which was maintained##3##3##(1995-12#1)(2006-7#1)(2008-6#1)
which was managed successfully##3##4##(2006-4#1)(2009-10#1)(2012-2#1)
which was managed with##2##4##(2008-1#1)(2011-2#1)
which was managed##6##3##(2006-4#1)(2008-1#1)(2008-10#1)(2009-10#1)(2011-2#1)(2012-2#1)
which was mapped##2##3##(1995-6#1)(2008-10#1)
which was measured as##2##4##(1990-10#1)(2008-3#1)
which was measured at##3##4##(2008-10#3)
which was measured by##5##4##(2007-11#1)(2008-11#1)(2012-1#1)(2012-3#1)(2013-8#1)
which was measured##14##3##(1990-10#1)(1997-1#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-10#4)(2008-11#1)(2008-3#1)(2012-1#1)(2012-3#1)(2013-8#1)
which was monitored##3##3##(2008-10#2)(2008-3#1)
which was more pronounced##3##4##(1991-2#1)(1996-1#1)(2010-6#1)
which was more##9##3##(1991-2#1)(1991-8#1)(1996-1#1)(2008-11#2)(2008-2#1)(2010-6#1)(2012-2#1)(2013-1#1)
which was most##2##3##(2010-10#1)(2013-8#1)
which was much##4##3##(2008-10#2)(2010-7#1)(2011-1#1)
which was named##3##3##(1993-11#1)(2008-10#1)(2008-8#1)
which was nearly##2##3##(1992-7#1)(2006-12#1)
which was never##2##3##(2008-5#1)(2012-3#1)
which was newly##2##3##(2010-7#1)(2013-8#1)
which was normal##2##3##(2006-10#1)(2012-3#1)
which was not achieved by##2##5##(1996-6#1)(2008-5#1)
which was not altered by##2##5##(1995-11#1)(1995-3#1)
which was not apparent in##2##5##(2006-9#1)(2012-12#1)
which was not detected##2##4##(2008-10#1)(2012-2#1)
which was not expressed##2##4##(1990-12#1)(1993-3#1)
which was not found in##4##5##(1991-7#1)(1994-12#1)(2008-10#1)(2008-9#1)
which was not found##6##4##(1991-7#1)(1994-12#1)(2008-10#2)(2008-9#1)(2012-12#1)
which was not observed in##2##5##(1991-8#1)(1994-11#1)
which was not observed##4##4##(1991-8#1)(1994-11#1)(2006-10#1)(2008-7#1)
which was not possible by##2##5##(1992-7#1)(2008-5#1)
which was not possible##3##4##(1992-7#1)(2008-3#1)(2008-5#1)
which was not present in##2##5##(1992-12#1)(2011-2#1)
which was not relieved by##2##5##(2006-12#1)(2012-12#1)
which was not statistically different from that##2##7##(1992-5#1)(2012-3#1)
which was not statistically##4##4##(1992-5#1)(2007-10#1)(2012-3#1)(2013-8#1)
which was not##68##3##(1990-12#3)(1990-3#1)(1990-7#1)(1991-4#1)(1991-5#2)(1991-7#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-7#2)(1993-3#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-3#1)(1996-6#1)(1996-8#1)(1997-6#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
which was noted##2##3##(2011-2#1)(2012-2#1)
which was observed in##5##4##(1990-5#1)(2007-12#1)(2008-5#1)(2008-6#1)(2013-8#1)
which was observed with##3##4##(1997-4#1)(2008-10#1)(2008-5#1)
which was observed##16##3##(1990-3#1)(1990-5#1)(1996-12#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-8#1)(2013-8#3)
which was obtained by##3##4##(1993-9#1)(1995-7#1)(2008-4#1)
which was obtained from##3##4##(1994-8#1)(1997-8#1)(2005-11#1)
which was obtained##8##3##(1991-9#1)(1993-9#1)(1994-8#1)(1995-7#1)(1997-8#1)(2005-11#1)(2008-3#1)(2008-4#1)
which was of##3##3##(1992-1#1)(2008-6#1)(2008-7#1)
which was only expressed in##2##5##(2008-8#1)(2012-3#1)
which was only partially##2##4##(1990-3#1)(1994-6#1)
which was only##11##3##(1990-3#1)(1993-10#1)(1993-3#1)(1994-6#1)(1995-5#1)(2006-8#1)(2008-3#1)(2008-5#2)(2008-8#1)(2012-3#1)
which was operated##2##3##(2007-11#1)(2007-9#1)
which was optimal for##2##4##(1995-2#1)(2008-10#1)
which was optimized##2##3##(2008-3#1)(2010-10#1)
which was originally##7##3##(1995-12#1)(1997-8#1)(2003-11#1)(2005-7#1)(2007-8#1)(2008-2#1)(2011-2#1)
which was packed with a molybdate-form ion exchange resin##2##9##(2008-10#2)
which was packed##3##3##(2008-10#3)
which was paralleled by##2##4##(1995-10#1)(2008-4#1)
which was partially purified##2##4##(1990-9#1)(1994-8#1)
which was partially##6##3##(1990-9#1)(1993-11#1)(1994-8#1)(2007-5#1)(2008-10#1)(2009-9#1)
which was particularly##2##3##(1993-3#1)(2010-4#1)
which was performed##5##3##(1995-10#1)(2007-5#1)(2007-8#2)(2008-10#1)
which was phosphorylated and##2##4##(1990-5#2)
which was positively##2##3##(2008-10#1)(2008-8#1)
which was predicted##2##3##(1993-2#1)(2006-12#1)
which was prepared##2##3##(2004-7#1)(2008-10#1)
which was present in##6##4##(1991-5#2)(1991-9#1)(1997-4#1)(2008-10#1)(2009-9#1)
which was present##7##3##(1991-5#2)(1991-8#1)(1991-9#1)(1997-4#1)(2008-10#1)(2009-9#1)
which was presented with##2##4##(2012-2#1)(2013-8#1)
which was presented##3##3##(2005-1#1)(2012-2#1)(2013-8#1)
which was prevented by##4##4##(1993-11#1)(1994-2#1)(1996-12#1)(2011-1#1)
which was prevented##5##3##(1993-11#1)(1994-2#1)(1996-12#1)(1997-7#1)(2011-1#1)
which was previously reported to##2##5##(1996-4#1)(2011-2#1)
which was previously##11##3##(1990-4#1)(1991-12#1)(1992-3#1)(1994-11#1)(1995-5#1)(1995-6#1)(1996-4#1)(2006-10#1)(2007-2#1)(2008-10#1)(2011-2#1)
which was produced##3##3##(1994-2#1)(1995-2#1)(2008-7#1)
which was proportional to the##3##5##(1990-10#1)(2008-10#1)(2008-7#1)
which was proved to be##3##5##(1996-2#1)(2004-9#1)(2007-7#1)
which was proved##4##3##(1996-2#1)(2004-9#1)(2007-7#1)(2008-10#1)
which was proven##2##3##(1991-5#1)(2007-8#1)
which was provided by the##2##5##(2008-8#1)(2013-8#1)
which was rapidly##2##3##(2006-12#1)(2008-10#1)
which was reacted with##3##4##(2007-11#2)(2008-11#1)
which was recently##6##3##(1992-3#1)(2006-10#2)(2007-10#1)(2008-10#1)(2008-3#1)
which was recovered##3##3##(1993-12#1)(2013-1#2)
which was reduced by##2##4##(2008-7#1)(2010-2#1)
which was reduced##6##3##(1990-10#1)(1992-7#1)(1994-5#1)(2008-7#1)(2010-2#1)(2013-1#1)
which was reflected##2##3##(2010-5#1)(2011-2#1)
which was related to the##2##5##(2008-10#1)(2012-11#1)
which was related to##4##4##(2008-10#2)(2010-12#1)(2012-11#1)
which was released##2##3##(1991-5#1)(1994-11#1)
which was relieved##2##3##(1996-10#1)(2007-11#1)
which was removed by##3##4##(2006-12#1)(2006-5#1)(2008-7#1)
which was removed##5##3##(2006-12#1)(2006-4#1)(2006-5#1)(2008-5#1)(2008-7#1)
which was repaired##2##3##(2009-6#1)(2012-3#1)
which was reported##2##3##(1991-2#1)(1996-8#1)
which was resected##4##3##(2006-10#1)(2007-10#1)(2007-8#2)
which was resistant to##2##4##(1991-8#1)(1992-7#1)
which was resistant##3##3##(1991-8#1)(1992-7#1)(2007-7#1)
which was responsible for##5##4##(1990-6#1)(1991-2#1)(2006-10#1)(2006-3#1)(2007-8#1)
which was revealed##2##3##(1992-11#1)(2012-2#1)
which was reversed by##2##4##(1994-6#1)(1997-4#1)
which was reversed##3##3##(1991-12#1)(1994-6#1)(1997-4#1)
which was secreted into the culture medium##2##7##(1993-9#1)(1996-3#1)
which was sensitive to##3##4##(1995-10#1)(1997-5#1)(2008-10#1)
which was sensitive##4##3##(1991-2#1)(1995-10#1)(1997-5#1)(2008-10#1)
which was sent to a##2##5##(2005-5#1)(2008-9#1)
which was sent to##4##4##(1992-12#1)(2005-5#1)(2005-8#1)(2008-9#1)
which was separated##2##3##(2005-12#2)
which was set##2##3##(2008-10#2)
which was shorter than##2##4##(1994-2#1)(2010-8#1)
which was shown by##4##4##(1992-12#1)(2007-11#1)(2008-5#1)(2009-7#1)
which was shown to be##3##5##(1990-4#1)(1997-1#1)(2008-5#1)
which was shown to##4##4##(1990-4#1)(1992-12#1)(1997-1#1)(2008-5#1)
which was shown##9##3##(1990-4#1)(1992-12#2)(1994-3#1)(1997-1#1)(2007-11#1)(2008-5#2)(2009-7#1)
which was significant##2##3##(1996-5#1)(2012-2#1)
which was significantly higher than in##2##6##(1991-11#1)(1996-4#1)
which was significantly higher than##5##5##(1991-11#1)(1994-6#1)(1996-4#1)(1997-2#1)(2007-8#1)
which was significantly higher##7##4##(1991-11#1)(1994-6#1)(1996-4#1)(1997-2#1)(2006-12#1)(2007-8#1)(2008-5#1)
which was significantly reduced##2##4##(1990-5#1)(1997-5#1)
which was significantly smaller than that in the 6(th) birth (465##2##11##(2012-12#2)
which was significantly##21##3##(1990-5#1)(1991-11#1)(1991-5#1)(1991-6#1)(1994-6#1)(1996-12#2)(1996-4#1)(1997-2#1)(1997-5#1)(2006-12#1)(2007-8#2)(2008-10#2)(2008-5#2)(2008-8#1)(2012-12#2)(2013-8#1)
which was similar in##2##4##(1991-6#1)(2008-11#1)
which was similar to that##3##5##(1993-8#1)(1995-12#1)(2009-4#1)
which was similar to the##4##5##(1994-3#1)(2009-10#2)(2012-2#1)
which was similar to##7##4##(1993-8#1)(1994-3#1)(1995-12#1)(2009-10#2)(2009-4#1)(2012-2#1)
which was similar##9##3##(1991-6#1)(1993-8#1)(1994-3#1)(1995-12#1)(2008-11#1)(2009-10#2)(2009-4#1)(2012-2#1)
which was simple##2##3##(2008-10#2)
which was slightly##2##3##(2008-11#1)(2010-8#1)
which was specifically##4##3##(1991-9#1)(2008-6#1)(2008-8#1)(2010-12#1)
which was spliced##2##3##(1996-5#1)(2007-11#1)
which was stable##4##3##(1990-2#1)(1991-5#1)(1992-2#1)(2007-12#1)
which was started##2##3##(2011-2#1)(2013-8#1)
which was statistically significant##4##4##(1996-6#1)(2008-4#1)(2008-5#1)(2008-7#1)
which was stimulated by##2##4##(2008-10#1)(2008-9#1)
which was stopped before##2##4##(2006-10#1)(2008-1#1)
which was strongly##2##3##(1991-2#1)(1993-12#1)
which was studied##4##3##(1994-3#1)(1996-8#1)(2006-12#1)(2010-7#1)
which was subsequently shown to##2##5##(1991-2#1)(2008-7#1)
which was subsequently##6##3##(1991-2#1)(2007-11#1)(2008-5#1)(2008-7#2)(2013-1#1)
which was successful##2##3##(2008-11#1)(2012-12#1)
which was successfully treated and reconstructed using full thickness skin graft with stable functional result after one year of treatment##2##20##(2013-1#2)
which was successfully treated with##5##5##(2008-10#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)
which was successfully treated##9##4##(2008-10#1)(2008-12#1)(2008-5#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#2)
which was successfully##15##3##(2007-8#2)(2008-10#1)(2008-12#1)(2008-5#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#3)
which was suggested##2##3##(1993-11#1)(1994-5#1)
which was suggestive of##2##4##(2007-7#1)(2013-8#1)
which was supplemented with##2##4##(2008-5#1)(2013-8#1)
which was supported by##2##4##(2007-11#1)(2008-12#1)
which was supported##3##3##(2007-11#1)(2008-10#1)(2008-12#1)
which was supposed to##2##4##(2012-2#1)(2013-7#1)
which was suspected##2##3##(2009-7#1)(2012-2#1)
which was tested##2##3##(2008-10#1)(2008-3#1)
which was the most##2##4##(1991-8#1)(2008-10#1)
which was the##9##3##(1991-8#1)(1996-11#1)(1997-1#1)(2007-12#1)(2008-10#2)(2011-1#1)(2012-3#1)(2013-1#1)
which was then merged with potassium##2##6##(2008-10#2)
which was then purified by##2##5##(1994-2#1)(1994-8#1)
which was then used to identify related terms for query expansion##2##11##(2013-1#2)
which was then used##3##4##(1995-2#1)(2013-1#2)
which was then##22##3##(1990-11#1)(1990-12#1)(1993-11#1)(1994-2#1)(1994-8#1)(1995-2#2)(1996-8#1)(2005-11#2)(2008-10#3)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2013-1#2)
which was to##3##3##(1994-12#1)(2009-4#1)(2010-1#1)
which was treated by##4##4##(1994-4#1)(2007-8#1)(2008-12#1)(2009-5#1)
which was treated conservatively##2##4##(2007-8#1)(2008-12#1)
which was treated medically##2##4##(2008-12#1)(2011-2#1)
which was treated successfully##2##4##(1990-9#1)(2007-7#1)
which was treated with##5##4##(1991-4#1)(2006-10#1)(2007-2#1)(2007-7#1)(2012-3#1)
which was treated##19##3##(1990-10#1)(1990-9#1)(1991-4#1)(1994-4#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#3)(2008-12#3)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
which was unaffected by##2##4##(1991-1#1)(1992-3#1)
which was unaltered##2##3##(1996-12#1)(2010-12#1)
which was used as a##5##5##(1991-7#1)(1993-8#1)(1995-11#1)(2008-10#1)(2009-3#1)
which was used as an##2##5##(1990-4#1)(1993-6#1)
which was used as the##3##5##(1995-6#1)(2008-10#2)
which was used as##10##4##(1990-4#1)(1991-7#1)(1993-6#1)(1993-8#1)(1995-11#1)(1995-6#1)(2008-10#3)(2009-3#1)
which was used for##2##4##(2008-10#1)(2008-3#1)
which was used in##5##4##(2006-10#1)(2008-10#3)(2010-5#1)
which was used to##9##4##(1991-3#1)(1991-9#1)(2006-6#1)(2008-10#3)(2008-2#1)(2009-10#1)(2012-2#1)
which was used##30##3##(1990-4#1)(1991-3#1)(1991-7#1)(1991-9#1)(1993-6#1)(1993-8#1)(1994-10#1)(1995-11#1)(1995-6#1)(2006-10#1)(2006-6#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-5#1)(2012-2#1)(2013-8#2)
which was varied##2##3##(1990-11#1)(2008-10#1)
which was verified by##3##4##(2005-11#1)(2008-10#2)
which was very close to##2##5##(2012-12#1)(2012-2#1)
which was very##4##3##(1990-12#1)(2006-10#1)(2012-12#1)(2012-2#1)
which was##1400##2##(1990-1#2)(1990-10#8)(1990-11#4)(1990-12#11)(1990-2#7)(1990-3#10)(1990-4#5)(1990-5#11)(1990-6#3)(1990-7#3)(1990-8#4)(1990-9#5)(1991-1#2)(1991-10#1)(1991-11#5)(1991-12#6)(1991-2#11)(1991-3#2)(1991-4#4)(1991-5#13)(1991-6#4)(1991-7#5)(1991-8#7)(1991-9#8)(1992-1#4)(1992-10#2)(1992-11#4)(1992-12#8)(1992-2#8)(1992-3#10)(1992-5#8)(1992-6#4)(1992-7#6)(1992-8#6)(1992-9#2)(1993-10#6)(1993-11#6)(1993-12#5)(1993-2#9)(1993-3#7)(1993-4#3)(1993-5#2)(1993-6#6)(1993-7#1)(1993-8#4)(1993-9#10)(1994-10#1)(1994-11#10)(1994-12#7)(1994-2#9)(1994-3#7)(1994-4#1)(1994-5#5)(1994-6#4)(1994-8#8)(1994-9#7)(1995-1#3)(1995-10#6)(1995-11#6)(1995-12#5)(1995-2#10)(1995-3#5)(1995-4#1)(1995-5#6)(1995-6#9)(1995-7#2)(1995-8#4)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#8)(1996-2#4)(1996-3#6)(1996-4#6)(1996-5#11)(1996-6#5)(1996-7#7)(1996-8#7)(1996-9#4)(1997-1#8)(1997-2#6)(1997-3#3)(1997-4#7)(1997-5#4)(1997-6#3)(1997-7#11)(1997-8#4)(2003-11#1)(2004-1#1)(2004-11#2)(2004-12#1)(2004-2#2)(2004-4#1)(2004-7#1)(2004-9#3)(2005-1#2)(2005-11#11)(2005-12#4)(2005-4#3)(2005-5#1)(2005-7#5)(2005-8#7)(2005-9#3)(2006-10#17)(2006-11#5)(2006-12#11)(2006-3#3)(2006-4#3)(2006-5#2)(2006-6#2)(2006-7#3)(2006-8#9)(2006-9#6)(2007-1#4)(2007-10#9)(2007-11#20)(2007-12#15)(2007-2#8)(2007-3#1)(2007-4#2)(2007-5#5)(2007-6#4)(2007-7#18)(2007-8#33)(2007-9#4)(2008-1#12)(2008-10#147)(2008-11#34)(2008-12#14)(2008-2#16)(2008-3#24)(2008-4#12)(2008-5#42)(2008-6#17)(2008-7#24)(2008-8#17)(2008-9#12)(2009-1#1)(2009-10#12)(2009-11#2)(2009-12#1)(2009-2#4)(2009-3#4)(2009-4#2)(2009-5#3)(2009-6#4)(2009-7#5)(2009-8#5)(2009-9#5)(2010-1#4)(2010-10#6)(2010-11#2)(2010-12#13)(2010-2#6)(2010-3#2)(2010-4#3)(2010-5#6)(2010-6#9)(2010-7#4)(2010-8#4)(2010-9#1)(2011-1#15)(2011-12#4)(2011-2#25)(2011-3#4)(2012-1#8)(2012-11#3)(2012-12#19)(2012-2#30)(2012-3#17)(2013-1#29)(2013-7#6)(2013-8#42)
which way##2##2##(1993-11#1)(1997-2#1)
which we are##3##3##(1995-8#1)(2007-12#1)(2011-1#1)
which we attribute to##4##4##(1992-8#1)(2008-1#1)(2008-3#1)(2008-7#1)
which we believe to be##2##5##(1994-3#1)(2007-12#1)
which we believe##6##3##(1994-3#1)(2006-12#1)(2007-12#2)(2008-7#1)(2008-9#1)
which we call the##4##4##(2007-11#1)(2008-2#1)(2008-3#1)(2008-9#1)
which we call##12##3##(1990-12#1)(1990-3#1)(1990-6#1)(1994-9#1)(1997-3#1)(2007-11#3)(2007-9#1)(2008-2#1)(2008-3#1)(2008-9#1)
which we called##2##3##(1993-4#1)(2008-5#1)
which we can##7##3##(1997-6#1)(2005-10#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-5#1)
which we consider##2##3##(2012-3#1)(2013-7#1)
which we deduce##2##3##(1990-7#1)(2007-11#1)
which we define as##2##4##(2008-10#1)(2012-2#1)
which we designate##2##3##(1993-6#1)(1994-11#1)
which we designated##2##3##(1997-1#1)(2008-10#1)
which we determine##2##3##(2007-11#1)(2008-2#1)
which we discuss##2##3##(2009-10#1)(2013-1#1)
which we found the##2##4##(2009-7#1)(2011-2#1)
which we found to be##2##5##(2009-5#1)(2012-3#1)
which we found##5##3##(1994-7#1)(2009-5#1)(2009-7#1)(2011-2#1)(2012-3#1)
which we had previously##2##4##(1994-12#1)(1996-10#1)
which we had##3##3##(1994-12#1)(1996-10#1)(2008-11#1)
which we have designated##4##4##(1990-4#1)(1991-7#1)(1996-5#1)(2007-11#1)
which we have named##6##4##(1994-12#1)(1996-10#1)(2007-11#1)(2008-10#1)(2008-3#2)
which we have previously##6##4##(1990-4#1)(1995-6#1)(1996-12#1)(2008-11#1)(2008-3#1)(2008-5#1)
which we have termed##3##4##(1995-8#1)(2008-10#1)(2008-7#1)
which we have used##2##4##(1993-11#1)(2008-11#1)
which we have##38##3##(1990-4#2)(1991-10#1)(1991-12#1)(1991-7#1)(1992-9#1)(1993-11#2)(1993-3#1)(1994-12#2)(1994-9#1)(1995-12#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-5#1)(2005-7#1)(2006-3#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#3)(2008-5#1)(2008-7#1)(2010-7#1)(2012-12#1)(2012-3#1)
which we identified##4##3##(1997-2#1)(2008-5#1)(2010-11#1)(2010-12#1)
which we identify##2##3##(1990-11#1)(2009-2#1)
which we interpret as##2##4##(2007-12#2)
which we interpret##3##3##(2007-12#2)(2008-2#1)
which we made##2##3##(2007-12#1)(2008-2#1)
which we measure##2##3##(2008-8#2)
which we now##3##3##(1993-3#1)(1994-12#1)(2013-1#1)
which we previously##3##3##(1990-10#1)(1993-3#1)(2008-4#1)
which we produced##2##3##(2007-12#1)(2008-3#1)
which we propose is the##2##5##(1994-12#1)(2008-11#1)
which we propose##4##3##(1994-12#2)(2008-10#1)(2008-11#1)
which we refer to as the##2##6##(1990-6#1)(1995-6#1)
which we refer to as##5##5##(1990-6#1)(1992-6#1)(1995-6#1)(1996-11#1)(2013-8#1)
which we refer to##6##4##(1990-6#1)(1992-6#1)(1995-6#1)(1996-11#1)(2011-2#1)(2013-8#1)
which we refer##7##3##(1990-6#1)(1992-6#1)(1995-6#1)(1996-11#1)(2007-12#1)(2011-2#1)(2013-8#1)
which we reported previously##2##4##(1992-12#1)(1997-2#1)
which we show to be##2##5##(2007-12#1)(2008-2#1)
which we show##4##3##(1990-5#1)(2007-12#1)(2008-2#1)(2008-7#1)
which we speculate##2##3##(2007-12#1)(2008-2#1)
which we tentatively##2##3##(1994-9#1)(2008-7#1)
which we term##5##3##(1991-12#1)(1991-5#1)(1995-3#2)(2010-4#1)
which we use##4##3##(2007-11#1)(2007-12#1)(2008-11#1)(2008-7#1)
which we used##2##3##(2005-10#1)(2008-3#1)
which we were##2##3##(1990-11#1)(2012-2#1)
which we##240##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#2)(1990-7#2)(1991-10#1)(1991-12#2)(1991-5#1)(1991-7#1)(1992-12#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-3#3)(1993-4#1)(1993-6#1)(1994-11#1)(1994-12#6)(1994-2#2)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#2)(1994-7#1)(1994-9#3)(1995-11#1)(1995-12#1)(1995-3#2)(1995-6#2)(1995-8#4)(1995-9#1)(1996-1#1)(1996-10#3)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#2)(1997-7#1)(2005-10#2)(2005-11#1)(2005-7#1)(2006-1#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-11#11)(2007-12#19)(2007-6#3)(2007-8#1)(2007-9#2)(2008-1#5)(2008-10#10)(2008-11#8)(2008-12#1)(2008-2#9)(2008-3#9)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#10)(2008-8#6)(2008-9#4)(2009-10#1)(2009-2#1)(2009-5#2)(2009-7#1)(2009-9#2)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#1)
which went##3##2##(1992-1#1)(2006-9#1)(2009-10#1)
which were able to##2##4##(2008-10#2)
which were abolished##3##3##(1993-11#1)(1995-6#1)(1997-4#1)
which were accompanied by##2##4##(1997-8#1)(2005-12#1)
which were achieved##2##3##(1992-1#1)(2007-11#1)
which were admitted to##3##4##(2006-8#1)(2009-6#1)(2011-1#1)
which were affected significantly by##2##5##(2007-4#1)(2008-9#1)
which were all##4##3##(1995-8#1)(2012-3#3)
which were also##6##3##(1992-6#1)(1994-7#1)(2006-4#1)(2008-10#2)(2011-1#1)
which were amplified by##3##4##(1996-12#1)(2008-10#1)(2008-11#1)
which were analyzed##5##3##(1995-12#1)(1996-11#1)(2005-4#1)(2011-2#1)(2013-7#1)
which were approximately##2##3##(1992-11#1)(2008-10#1)
which were assigned##3##3##(1991-2#1)(1996-8#1)(2008-10#1)
which were associated with##5##4##(1994-2#1)(1996-3#1)(2010-3#1)(2010-8#1)(2013-8#1)
which were associated##6##3##(1994-2#1)(1996-3#1)(2010-3#1)(2010-8#1)(2012-1#1)(2013-8#1)
which were attributed to##3##4##(1990-11#1)(2012-2#1)(2013-1#1)
which were based on the##2##5##(2011-1#1)(2012-3#1)
which were based on##3##4##(2006-10#1)(2011-1#1)(2012-3#1)
which were better explained by BII##2##6##(2013-1#2)
which were better##3##3##(1996-6#1)(2013-1#2)
which were both##5##3##(1990-8#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-8#1)
which were carried out##2##4##(1993-3#1)(2004-1#1)
which were carried##3##3##(1993-3#1)(2004-1#1)(2008-10#1)
which were categorized##2##3##(2008-5#1)(2010-10#1)
which were caused by##4##4##(1990-4#1)(1996-3#2)(2013-8#1)
which were characterized by##5##4##(1991-12#1)(2005-11#1)(2008-10#1)(2008-3#1)(2011-1#1)
which were characterized##7##3##(1991-12#1)(1992-9#1)(1997-8#1)(2005-11#1)(2008-10#1)(2008-3#1)(2011-1#1)
which were classified in two##2##5##(2008-10#2)
which were classified##3##3##(1994-12#1)(2008-10#2)
which were co-expressed in these lateral endodermal cells##2##8##(2012-12#2)
which were collected during##2##4##(2010-4#1)(2013-8#1)
which were collected from##3##4##(2008-11#1)(2010-4#1)(2013-8#1)
which were collected##7##3##(2008-11#1)(2009-6#1)(2010-12#1)(2010-4#2)(2013-8#2)
which were common to##2##4##(2008-5#1)(2012-2#1)
which were compared##3##3##(1996-11#1)(2005-11#1)(2008-10#1)
which were completely##3##3##(1990-5#1)(1990-7#1)(1995-2#1)
which were confirmed by##2##4##(2008-3#1)(2011-2#1)
which were confirmed##6##3##(1997-2#1)(2006-12#1)(2007-3#1)(2008-3#1)(2011-2#1)(2012-12#1)
which were considered##4##3##(1992-1#1)(1992-11#1)(2010-12#1)(2012-2#1)
which were consistent with##4##4##(1997-5#1)(2008-2#1)(2008-4#1)(2009-9#1)
which were converted to##3##4##(1994-9#1)(2006-10#1)(2012-2#1)
which were converted##4##3##(1991-9#1)(1994-9#1)(2006-10#1)(2012-2#1)
which were correctted following furosemide administration##2##6##(2013-1#2)
which were created##2##3##(2010-2#1)(2013-7#1)
which were decreased##2##3##(2006-7#1)(2011-2#1)
which were derived from a##3##5##(1997-3#1)(2008-10#1)(2013-8#1)
which were derived from##4##4##(1992-8#1)(1997-3#1)(2008-10#1)(2013-8#1)
which were described##2##3##(2007-8#1)(2008-10#1)
which were designated##2##3##(2008-9#1)(2013-1#1)
which were designed to##2##4##(1996-10#1)(2013-1#1)
which were detected in##2##4##(1990-3#1)(1994-8#1)
which were detected##5##3##(1990-3#1)(1994-8#1)(1994-9#1)(2007-10#1)(2008-11#1)
which were determined to##2##4##(1993-9#1)(1995-5#1)
which were determined##6##3##(1990-7#1)(1993-9#1)(1995-5#1)(1996-4#1)(1996-6#1)(2008-7#1)
which were developed in##3##4##(2006-5#1)(2008-10#1)(2008-2#1)
which were developed##5##3##(2004-3#1)(2006-5#1)(2008-10#2)(2008-2#1)
which were diagnosed##2##3##(2007-12#1)(2013-8#1)
which were distributed##2##3##(2007-11#1)(2008-9#1)
which were divided into##2##4##(1990-5#1)(1995-1#1)
which were divided##3##3##(1990-5#1)(1995-1#1)(2008-12#1)
which were done##2##3##(2013-8#2)
which were either##8##3##(1996-7#1)(1997-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2009-6#1)(2012-1#1)
which were eluted from the column through##2##7##(2008-10#2)
which were expressed##2##3##(2005-6#1)(2007-12#1)
which were fed with##2##4##(2006-12#1)(2012-2#1)
which were fed##3##3##(2006-12#1)(2007-5#1)(2012-2#1)
which were filled with##2##4##(1995-12#1)(2012-1#1)
which were first##3##3##(1997-8#1)(2005-7#1)(2012-1#1)
which were formed from##2##4##(1991-2#1)(2013-8#1)
which were formed##3##3##(1991-2#1)(2007-9#1)(2013-8#1)
which were found in##3##4##(1997-2#1)(1997-3#1)(2006-7#1)
which were found to be significantly##2##6##(2008-2#1)(2011-1#1)
which were found to be##7##5##(1994-3#1)(1994-9#1)(2008-2#1)(2008-4#1)(2008-5#2)(2011-1#1)
which were found to##10##4##(1994-3#1)(1994-9#1)(2008-2#1)(2008-4#1)(2008-5#2)(2010-11#1)(2010-7#1)(2011-1#1)(2012-3#1)
which were found##14##3##(1994-3#1)(1994-9#1)(1997-2#1)(1997-3#1)(2006-7#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#2)(2010-11#1)(2010-7#1)(2011-1#1)(2012-3#1)
which were from##3##3##(1997-8#1)(2008-10#2)
which were further##5##3##(1992-2#1)(1995-6#1)(2008-11#1)(2008-8#2)
which were generally##2##3##(2005-11#1)(2011-2#1)
which were generated by##3##4##(1991-7#2)(2008-10#1)
which were generated##4##3##(1991-7#2)(1994-12#1)(2008-10#1)
which were greater than those##2##5##(1996-3#1)(2011-2#1)
which were grouped##2##3##(1996-3#1)(2008-10#1)
which were identified as##6##4##(1991-2#2)(1991-5#1)(1994-3#1)(2007-12#1)(2008-10#1)
which were identified by the##2##5##(1997-2#1)(2013-8#1)
which were identified by##7##4##(1990-10#1)(1990-7#1)(1992-3#2)(1997-2#1)(2008-7#1)(2013-8#1)
which were identified##19##3##(1990-10#1)(1990-7#1)(1991-2#2)(1991-5#1)(1992-3#2)(1994-3#1)(1997-2#1)(1997-8#1)(2007-12#2)(2008-10#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
which were immunoreactive for##2##4##(1997-2#2)
which were in good agreement with##2##6##(2008-10#1)(2008-7#1)
which were in the##2##4##(2006-8#1)(2013-8#1)
which were in##9##3##(1990-11#1)(1991-12#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-8#1)
which were increased##3##3##(1990-10#1)(1993-8#1)(1994-6#1)
which were ineffective##2##3##(1996-1#1)(2008-1#1)
which were initially##2##3##(1997-3#1)(1997-8#1)
which were inserted##2##3##(1994-9#1)(2008-2#1)
which were interpreted##2##3##(1990-4#1)(2007-12#1)
which were introduced##2##3##(2008-10#1)(2012-1#1)
which were inversely##2##3##(1997-4#1)(2008-12#1)
which were isolated by##2##4##(1990-12#1)(1996-2#1)
which were isolated from##3##4##(2008-10#1)(2008-11#2)
which were isolated##6##3##(1990-12#1)(1992-5#1)(1996-2#1)(2008-10#1)(2008-11#2)
which were kept under##2##4##(2008-9#1)(2011-3#1)
which were located in the##2##5##(1990-7#1)(2005-4#1)
which were located on the##2##5##(1995-12#1)(1996-12#1)
which were located##4##3##(1990-7#1)(1995-12#1)(1996-12#1)(2005-4#1)
which were lower than the control##2##6##(1996-9#2)
which were lower##3##3##(1996-9#2)(2008-10#1)
which were made##3##3##(1991-9#1)(2006-10#1)(2012-3#1)
which were mainly##2##3##(1992-9#1)(1996-6#1)
which were maintained##3##3##(1992-6#2)(1994-2#1)
which were managed##2##3##(2007-9#1)(2008-7#1)
which were measured by##2##4##(2008-3#1)(2012-12#1)
which were measured##3##3##(1995-12#1)(2008-3#1)(2012-12#1)
which were mediated##2##3##(1992-9#1)(1997-5#1)
which were missed by##2##4##(2008-4#1)(2013-7#1)
which were modified##2##3##(1995-1#1)(1995-6#1)
which were more##5##3##(1995-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
which were most##2##3##(1995-3#1)(2008-10#1)
which were not exposed to##2##5##(1995-6#1)(2008-10#1)
which were not present##2##4##(2008-10#1)(2011-12#1)
which were not significantly different from those##2##7##(1996-9#1)(2012-3#1)
which were not significantly different from##3##6##(1996-9#1)(2008-10#1)(2012-3#1)
which were not##26##3##(1991-11#1)(1992-1#1)(1992-9#1)(1993-8#1)(1995-6#1)(1996-9#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#6)(2008-3#1)(2008-5#1)(2010-10#1)(2010-5#1)(2011-12#2)(2012-3#2)(2013-8#1)
which were obtained by##2##4##(1991-9#1)(2008-10#1)
which were obtained from##5##4##(1995-6#1)(2004-4#1)(2008-10#1)(2008-2#1)(2013-8#1)
which were obtained##8##3##(1991-9#1)(1995-6#1)(2004-4#1)(2008-10#2)(2008-2#1)(2010-3#1)(2013-8#1)
which were of##3##3##(1992-8#1)(2008-11#1)(2012-12#1)
which were often##2##3##(1996-2#1)(2006-10#1)
which were oxidized##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
which were packed##2##3##(2008-5#1)(2008-9#1)
which were part of##2##4##(1990-2#1)(1991-7#1)
which were positive for##2##4##(1993-10#1)(2009-6#1)
which were positive##3##3##(1993-10#2)(2009-6#1)
which were pre-incubated##2##3##(2008-5#2)
which were preceded by a##2##5##(1996-1#2)
which were predicted##2##3##(2011-2#1)(2012-2#1)
which were prepared by##2##4##(1992-5#1)(2008-12#1)
which were prepared from##2##4##(2005-11#1)(2008-10#1)
which were prepared##6##3##(1992-5#1)(2005-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2011-2#1)
which were present in##2##4##(2006-9#1)(2008-10#1)
which were present##5##3##(2006-10#1)(2006-9#1)(2008-10#2)(2010-12#1)
which were presented at the##2##5##(2008-6#1)(2013-8#1)
which were presented at##3##4##(2008-3#1)(2008-6#1)(2013-8#1)
which were previously##7##3##(1990-4#1)(1991-8#1)(2007-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-6#1)
which were processed##3##3##(1990-5#1)(2011-2#1)(2013-8#1)
which were published in##2##4##(2007-12#1)(2007-8#1)
which were published##3##3##(1990-8#1)(2007-12#1)(2007-8#1)
which were purified##2##3##(1990-7#1)(2008-6#1)
which were rarely##2##3##(2007-11#1)(2008-10#1)
which were recently##2##3##(1995-6#1)(2008-2#1)
which were recognized on##2##4##(1991-2#1)(2008-9#1)
which were recognized##3##3##(1991-2#1)(2008-10#1)(2008-9#1)
which were recorded##2##3##(1997-8#1)(2006-12#1)
which were reduced in##2##4##(2008-7#2)
which were reduced##4##3##(1994-5#1)(2007-10#1)(2008-7#2)
which were related to the##4##5##(1992-1#1)(2007-8#1)(2008-10#2)
which were related to##7##4##(1992-1#1)(2005-11#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-3#1)
which were released from autologous tissues and propagated under good manufacturing practice conditions (for example##2##15##(2012-12#2)
which were released from##3##4##(2008-10#1)(2012-12#2)
which were released##5##3##(2006-12#1)(2008-10#1)(2008-6#1)(2012-12#2)
which were removed##2##3##(1995-10#1)(2007-8#1)
which were required for##2##4##(2008-10#1)(2008-11#1)
which were resistant to##5##4##(1991-4#1)(2004-11#1)(2006-12#1)(2008-5#1)(2010-4#1)
which were responsible for the##4##5##(2007-8#1)(2009-9#1)(2013-1#1)(2013-8#1)
which were responsible for##5##4##(2007-8#1)(2009-9#1)(2010-1#1)(2013-1#1)(2013-8#1)
which were reviewed##2##3##(2011-1#1)(2013-1#1)
which were seen##2##3##(2005-12#1)(2012-12#1)
which were selected because##2##4##(2007-7#1)(2009-3#1)
which were selected##4##3##(2007-7#1)(2009-3#2)(2010-2#1)
which were separated by##2##4##(1990-11#1)(1997-5#1)
which were separated##4##3##(1990-11#1)(1990-6#1)(1993-5#1)(1997-5#1)
which were set##3##3##(1995-3#1)(2008-1#1)(2012-12#1)
which were shown to be##2##5##(1996-3#1)(2013-8#1)
which were shown to##5##4##(1994-12#1)(1994-8#1)(1996-3#1)(2009-4#1)(2013-8#1)
which were significantly different##2##4##(1994-5#1)(2010-8#1)
which were significantly higher##2##4##(2007-2#1)(2011-1#1)
which were significantly lower##2##4##(2009-5#1)(2013-1#1)
which were significantly##9##3##(1994-5#1)(1995-7#1)(2007-2#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
which were similar in both##2##5##(1996-1#1)(2012-3#1)
which were similar in##3##4##(1996-1#1)(2011-2#1)(2012-3#1)
which were similar to those observed in##2##7##(1990-2#1)(1997-8#1)
which were similar to those##3##5##(1990-2#1)(1997-8#1)(2008-10#1)
which were similar to##5##4##(1990-2#1)(1997-8#1)(2008-10#2)(2010-12#1)
which were similar##9##3##(1990-2#1)(1996-1#1)(1997-8#1)(2008-10#3)(2010-12#1)(2011-2#1)(2012-3#1)
which were stained##2##3##(1995-2#1)(2008-5#1)
which were statistically##3##3##(1993-3#1)(2004-9#1)(2013-1#1)
which were strongly##2##3##(2009-5#1)(2011-2#1)
which were studied##3##3##(1993-1#1)(2013-8#2)
which were subjected to##4##4##(1996-9#1)(1997-7#1)(2008-10#1)(2008-11#1)
which were submitted to a##2##5##(2009-7#1)(2011-2#1)
which were subsequently used in##2##5##(1997-7#1)(2008-8#1)
which were subsequently##5##3##(1993-6#1)(1997-7#1)(2005-12#1)(2008-8#1)(2011-1#1)
which were successfully treated by##2##5##(2008-7#1)(2012-1#1)
which were successfully treated with##2##5##(2006-4#1)(2012-12#1)
which were successfully treated##4##4##(2006-4#1)(2008-7#1)(2012-1#1)(2012-12#1)
which were successfully##7##3##(2006-4#1)(2007-1#1)(2008-7#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
which were suggestive of##2##4##(2013-8#2)
which were synthesized by##2##4##(1995-5#1)(2005-8#1)
which were synthesized##4##3##(1995-5#1)(2005-8#1)(2006-12#1)(2009-2#1)
which were tested for##2##4##(2008-8#1)(2011-2#1)
which were tested in##2##4##(1997-7#1)(2007-11#1)
which were tested##6##3##(1990-3#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-8#1)(2011-2#1)
which were the most##3##4##(1990-2#1)(2010-1#1)(2011-2#1)
which were the##9##3##(1990-2#1)(1991-2#1)(1993-4#1)(1995-12#1)(2005-11#1)(2007-1#1)(2008-10#1)(2010-1#1)(2011-2#1)
which were then##10##3##(1995-3#1)(1996-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2010-9#1)(2012-2#1)
which were thought to be##2##5##(1990-6#1)(2006-11#1)
which were thought##3##3##(1990-6#1)(2006-11#1)(2008-11#1)
which were to##2##3##(2006-2#1)(2008-10#1)
which were transfected##3##3##(1991-2#1)(1997-7#1)(2011-2#1)
which were treated by##3##4##(1990-3#1)(2008-11#1)(2012-2#1)
which were treated with##5##4##(1993-7#1)(1995-3#1)(2006-9#1)(2013-1#1)(2013-7#1)
which were treated##11##3##(1990-3#1)(1992-6#1)(1993-7#1)(1995-3#1)(2006-9#1)(2007-8#1)(2008-11#1)(2012-2#2)(2013-1#1)(2013-7#1)
which were used as##2##4##(2008-5#1)(2010-8#1)
which were used for##4##4##(1995-7#1)(1996-6#1)(2006-4#1)(2008-11#1)
which were used in##2##4##(1991-7#1)(2008-11#1)
which were used to##6##4##(1994-12#1)(1995-2#1)(1997-1#1)(2007-8#1)(2008-2#1)(2013-8#1)
which were used##17##3##(1991-7#1)(1994-12#1)(1995-2#1)(1995-7#1)(1996-6#1)(1997-1#1)(2006-4#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2010-8#1)(2012-2#1)(2013-8#2)
which were very##2##3##(2007-2#1)(2012-3#1)
which were widely##2##3##(2008-10#1)(2008-7#1)
which were##864##2##(1990-10#5)(1990-11#5)(1990-12#4)(1990-2#4)(1990-3#4)(1990-4#3)(1990-5#3)(1990-6#3)(1990-7#5)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#5)(1991-2#9)(1991-3#3)(1991-4#1)(1991-5#6)(1991-6#2)(1991-7#5)(1991-8#1)(1991-9#6)(1992-1#4)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#3)(1992-6#7)(1992-8#3)(1992-9#4)(1993-1#1)(1993-10#2)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#6)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#2)(1994-11#2)(1994-12#6)(1994-2#3)(1994-3#2)(1994-5#3)(1994-6#1)(1994-7#2)(1994-8#2)(1994-9#5)(1995-1#3)(1995-10#1)(1995-12#10)(1995-2#4)(1995-3#6)(1995-5#2)(1995-6#8)(1995-7#2)(1995-8#1)(1995-9#1)(1996-1#5)(1996-10#1)(1996-11#5)(1996-12#10)(1996-2#3)(1996-3#6)(1996-4#3)(1996-5#3)(1996-6#6)(1996-7#2)(1996-8#1)(1996-9#6)(1997-1#3)(1997-2#5)(1997-3#8)(1997-4#7)(1997-5#3)(1997-6#2)(1997-7#6)(1997-8#13)(2004-1#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-3#1)(2004-4#1)(2004-9#2)(2005-10#1)(2005-11#8)(2005-12#4)(2005-4#2)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#5)(2006-11#2)(2006-12#13)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#8)(2006-9#2)(2007-1#4)(2007-10#2)(2007-11#8)(2007-12#7)(2007-2#6)(2007-3#3)(2007-4#3)(2007-5#3)(2007-6#3)(2007-7#7)(2007-8#11)(2007-9#3)(2008-1#2)(2008-10#90)(2008-11#23)(2008-12#6)(2008-2#9)(2008-3#15)(2008-4#7)(2008-5#25)(2008-6#9)(2008-7#14)(2008-8#12)(2008-9#13)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#4)(2009-5#3)(2009-6#6)(2009-7#3)(2009-8#1)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#6)(2010-2#4)(2010-3#4)(2010-4#4)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#12)(2011-12#2)(2011-2#22)(2011-3#1)(2012-1#9)(2012-11#1)(2012-12#15)(2012-2#14)(2012-3#13)(2013-1#25)(2013-7#5)(2013-8#35)
which when administered##2##3##(2007-11#1)(2008-4#1)
which when used##2##3##(1994-5#1)(2008-11#1)
which when##11##2##(1993-11#1)(1994-5#1)(1996-12#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)
which will allow##4##3##(1994-6#1)(2008-1#1)(2008-7#1)(2013-8#1)
which will also##5##3##(2008-1#1)(2008-7#2)(2010-5#1)(2013-8#1)
which will appear in the next issue##2##7##(1992-3#1)(2010-5#1)
which will appear in the##3##5##(1992-3#1)(1995-1#1)(2010-5#1)
which will appear in##4##4##(1992-3#1)(1993-1#1)(1995-1#1)(2010-5#1)
which will appear##5##3##(1992-3#1)(1993-1#1)(1994-1#1)(1995-1#1)(2010-5#1)
which will be discussed##3##4##(2008-10#1)(2008-12#1)(2008-3#1)
which will be reviewed##3##4##(2005-8#1)(2008-1#1)(2010-12#1)
which will be the##2##4##(2005-8#1)(2008-2#1)
which will be used##3##4##(2012-12#1)(2012-2#1)(2013-8#1)
which will be##28##3##(1990-12#1)(1993-2#1)(1994-2#1)(1996-11#1)(1996-2#2)(1997-2#1)(1997-8#1)(2005-8#2)(2006-5#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
which will become##2##3##(2006-8#1)(2008-4#1)
which will enable##3##3##(1995-6#1)(2006-6#1)(2007-5#1)
which will facilitate##2##3##(2008-12#1)(2011-2#1)
which will greatly##2##3##(2006-6#1)(2009-2#1)
which will help##3##3##(1994-1#1)(2008-7#1)(2011-1#1)
which will hopefully##3##3##(1995-12#1)(2008-12#1)(2008-3#1)
which will improve the##2##4##(1997-7#1)(2005-8#1)
which will in##2##3##(2008-2#1)(2009-8#1)
which will lead to the##2##5##(1994-6#1)(1996-11#1)
which will limit##2##3##(1997-1#1)(2008-11#1)
which will not##3##3##(2006-11#1)(2008-8#1)(2010-4#1)
which will provide##5##3##(1991-11#1)(2007-1#1)(2010-5#1)(2012-3#1)(2013-8#1)
which will reduce##3##3##(2005-5#1)(2008-2#1)(2013-7#1)
which will require##2##3##(2011-1#1)(2011-2#1)
which will result in the##2##5##(2006-6#1)(2007-7#1)
which will result in##5##4##(2006-6#1)(2007-12#1)(2007-7#1)(2009-8#1)(2010-7#1)
which will then##2##3##(1991-10#1)(2010-12#1)
which will##144##2##(1990-12#2)(1990-3#1)(1991-10#1)(1991-11#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-1#2)(1993-2#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#1)(2005-10#1)(2005-5#2)(2005-6#1)(2005-8#5)(2005-9#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-5#2)(2006-6#3)(2006-8#1)(2007-1#2)(2007-11#4)(2007-12#2)(2007-5#2)(2007-7#1)(2008-1#4)(2008-10#2)(2008-11#5)(2008-12#5)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#5)(2008-7#7)(2008-8#2)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#3)(2010-4#1)(2010-5#3)(2010-7#1)(2011-1#4)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#2)(2013-7#2)(2013-8#5)
which works##4##2##(2005-11#1)(2007-8#1)(2008-1#1)(2008-10#1)
which would allow##2##3##(1995-6#1)(2007-12#1)
which would be expected##2##4##(2007-1#1)(2008-11#1)
which would be helpful to##2##5##(2011-1#1)(2013-8#1)
which would be helpful##3##4##(2010-7#1)(2011-1#1)(2013-8#1)
which would be required##2##4##(1991-9#1)(2010-7#1)
which would be##22##3##(1990-4#1)(1991-9#1)(1992-9#1)(1993-6#1)(1994-6#1)(1997-1#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-11#2)(2010-12#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#2)(2013-8#1)
which would enable the##2##4##(1992-8#1)(2008-10#1)
which would enable##3##3##(1992-8#1)(2007-9#1)(2008-10#1)
which would explain##2##3##(2005-10#1)(2007-9#1)
which would have##3##3##(2007-9#1)(2009-4#1)(2010-2#1)
which would lead to##2##4##(2008-3#1)(2008-5#1)
which would not be##2##4##(2011-2#1)(2012-12#1)
which would not##4##3##(1992-7#1)(2006-9#1)(2011-2#1)(2012-12#1)
which would provide##2##3##(2007-8#1)(2008-10#1)
which would result in a##2##5##(1993-9#1)(2008-10#1)
which would result in##6##4##(1993-9#1)(1994-9#1)(1995-5#1)(2006-9#1)(2008-10#1)(2010-8#1)
which would yield##2##3##(1997-1#1)(2012-1#1)
which would##94##2##(1990-2#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-9#1)(1992-11#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#2)(1997-5#1)(1997-7#1)(2005-10#1)(2006-4#1)(2006-9#2)(2007-1#1)(2007-12#4)(2007-8#2)(2007-9#3)(2008-10#5)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2009-4#2)(2009-7#1)(2010-12#2)(2010-2#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
which yield##4##2##(1992-7#1)(1994-9#1)(1995-10#1)(2012-2#1)
which yielded a##3##3##(1990-9#1)(1992-3#1)(2008-7#1)
which yielded four##2##3##(1995-6#1)(2009-10#1)
which yielded##15##2##(1990-9#1)(1991-7#1)(1992-3#1)(1993-11#1)(1995-6#1)(1997-4#1)(2004-12#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-10#1)(2013-1#1)(2013-7#1)
which yields a##4##3##(1990-4#1)(2008-10#1)(2008-3#1)(2009-10#1)
which yields an effective##2##4##(2006-10#1)(2007-11#1)
which yields an##3##3##(1996-12#1)(2006-10#1)(2007-11#1)
which yields##14##2##(1990-4#1)(1993-6#1)(1994-12#1)(1996-12#1)(1996-5#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)
which young##3##2##(2007-12#1)(2011-2#1)(2012-1#1)
which##28061##1##(1990-1#13)(1990-10#80)(1990-11#141)(1990-12#152)(1990-2#106)(1990-3#103)(1990-4#91)(1990-5#136)(1990-6#72)(1990-7#114)(1990-8#117)(1990-9#82)(1991-1#45)(1991-10#65)(1991-11#77)(1991-12#141)(1991-2#145)(1991-3#111)(1991-4#61)(1991-5#150)(1991-6#81)(1991-7#88)(1991-8#94)(1991-9#130)(1992-1#80)(1992-10#44)(1992-11#82)(1992-12#129)(1992-2#85)(1992-3#125)(1992-4#58)(1992-5#71)(1992-6#126)(1992-7#78)(1992-8#113)(1992-9#125)(1993-1#32)(1993-10#35)(1993-11#113)(1993-12#118)(1993-2#107)(1993-3#160)(1993-4#42)(1993-5#40)(1993-6#113)(1993-7#43)(1993-8#98)(1993-9#117)(1994-1#14)(1994-10#39)(1994-11#155)(1994-12#214)(1994-2#169)(1994-3#176)(1994-4#19)(1994-5#110)(1994-6#119)(1994-7#22)(1994-8#182)(1994-9#168)(1995-1#103)(1995-10#59)(1995-11#99)(1995-12#142)(1995-2#163)(1995-3#188)(1995-4#36)(1995-5#106)(1995-6#150)(1995-7#39)(1995-8#158)(1995-9#32)(1996-1#77)(1996-10#56)(1996-11#68)(1996-12#143)(1996-2#151)(1996-3#129)(1996-4#88)(1996-5#186)(1996-6#78)(1996-7#86)(1996-8#95)(1996-9#95)(1997-1#132)(1997-2#182)(1997-3#105)(1997-4#179)(1997-5#55)(1997-6#124)(1997-7#173)(1997-8#124)(1997-9#4)(2003-11#9)(2004-1#8)(2004-10#10)(2004-11#24)(2004-12#25)(2004-2#13)(2004-3#5)(2004-4#14)(2004-7#5)(2004-8#4)(2004-9#36)(2005-1#19)(2005-10#89)(2005-11#239)(2005-12#41)(2005-2#3)(2005-3#6)(2005-4#23)(2005-5#23)(2005-6#15)(2005-7#101)(2005-8#117)(2005-9#38)(2006-1#28)(2006-10#389)(2006-11#60)(2006-12#181)(2006-2#87)(2006-3#49)(2006-4#60)(2006-5#97)(2006-6#109)(2006-7#63)(2006-8#156)(2006-9#76)(2007-1#76)(2007-10#119)(2007-11#500)(2007-12#708)(2007-2#106)(2007-3#56)(2007-4#69)(2007-5#84)(2007-6#54)(2007-7#222)(2007-8#399)(2007-9#169)(2008-1#308)(2008-10#2230)(2008-11#706)(2008-12#201)(2008-2#620)(2008-3#749)(2008-4#497)(2008-5#706)(2008-6#194)(2008-7#604)(2008-8#478)(2008-9#343)(2009-1#16)(2009-10#123)(2009-11#47)(2009-12#79)(2009-2#84)(2009-3#90)(2009-4#100)(2009-5#131)(2009-6#89)(2009-7#93)(2009-8#165)(2009-9#104)(2010-1#43)(2010-10#75)(2010-11#81)(2010-12#239)(2010-2#140)(2010-3#76)(2010-4#119)(2010-5#135)(2010-6#63)(2010-7#104)(2010-8#155)(2010-9#82)(2011-1#335)(2011-10#3)(2011-11#1)(2011-12#74)(2011-2#610)(2011-3#32)(2011-7#4)(2011-8#4)(2011-9#1)(2012-1#208)(2012-10#3)(2012-11#77)(2012-12#374)(2012-2#502)(2012-3#295)(2012-5#2)(2012-6#1)(2012-7#2)(2012-8#1)(2012-9#1)(2013-1#600)(2013-7#136)(2013-8#421)
whichever##3##1##(1996-12#1)(2008-11#1)(2010-4#1)
whichis##2##1##(2008-11#2)
while &quot##3##2##(2005-11#1)(2010-3#1)(2011-1#1)
while 1##8##2##(1991-5#1)(1992-11#1)(1992-7#1)(1996-2#1)(1996-9#1)(2007-12#1)(2007-2#1)(2007-8#1)
while 10##2##2##(1994-7#1)(1997-4#1)
while 100 microM##3##3##(1990-8#1)(1991-3#1)(2009-6#1)
while 11##2##2##(1997-1#1)(2007-7#1)
while 12##2##2##(2006-3#1)(2012-12#1)
while 13##2##2##(1994-3#1)(2008-1#1)
while 14%##3##2##(1993-3#1)(1993-8#1)(2008-10#1)
while 15 patients##2##3##(2007-8#1)(2009-2#1)
while 16##4##2##(2007-12#2)(2008-12#1)(2011-2#1)
while 17##3##2##(2006-2#1)(2006-7#1)(2012-3#1)
while 19##2##2##(2007-7#1)(2007-8#1)
while 2 patients##2##3##(2007-7#2)
while 2##14##2##(1991-12#1)(1996-12#1)(1997-3#1)(2006-10#1)(2007-7#2)(2008-10#2)(2008-4#1)(2008-5#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-3#1)
while 20##2##2##(1994-6#1)(2011-1#1)
while 20% of##2##3##(1991-3#1)(2006-10#1)
while 20%##4##2##(1991-3#1)(1993-5#1)(1997-7#1)(2006-10#1)
while 21 patients##2##3##(1994-11#1)(2007-8#1)
while 22%##3##2##(1996-9#1)(2008-6#1)(2009-10#1)
while 24##2##2##(2008-1#1)(2008-5#1)
while 25##4##2##(1993-11#1)(2008-8#1)(2013-1#2)
while 27##2##2##(2007-12#1)(2012-1#1)
while 27%##2##2##(1992-9#1)(2007-7#1)
while 28%##2##2##(1994-6#1)(2008-10#1)
while 29##2##2##(2012-12#1)(2013-1#1)
while 3##5##2##(1990-11#1)(1991-11#1)(1992-12#1)(2008-10#1)(2008-12#1)
while 34##4##2##(1994-11#1)(2007-12#1)(2007-7#1)(2012-2#1)
while 4 had##2##3##(2007-7#1)(2008-1#1)
while 4##6##2##(1992-5#1)(2006-5#1)(2006-8#1)(2007-7#2)(2008-1#1)
while 40##2##2##(1991-3#1)(1996-9#1)
while 40%##2##2##(2006-10#1)(2007-11#1)
while 43##2##2##(2008-3#1)(2011-1#1)
while 46%##2##2##(2008-10#1)(2012-3#1)
while 5##6##2##(1992-12#1)(1996-2#1)(2006-10#1)(2008-10#1)(2008-7#1)(2013-8#1)
while 51%##2##2##(2006-2#1)(2011-1#1)
while 59##2##2##(1997-7#1)(2007-12#1)
while 6##3##2##(2006-12#1)(2008-11#1)(2008-8#1)
while 61##2##2##(2008-3#1)(2009-7#1)
while 7%##2##2##(2007-3#1)(2007-7#1)
while 74%##2##2##(1996-4#1)(1996-9#1)
while 78##2##2##(2006-10#1)(2012-2#1)
while 8##2##2##(2012-2#1)(2013-1#1)
while 84##2##2##(2008-1#1)(2008-3#1)
while 87##2##2##(2007-11#1)(2009-7#1)
while 88##2##2##(2007-3#1)(2013-7#1)
while 9##3##2##(2008-2#1)(2010-2#1)(2012-3#1)
while 98##2##2##(2007-7#1)(2013-1#1)
while ARA##2##2##(2012-1#2)
while ATP##2##2##(1990-5#1)(1995-3#1)
while Al##2##2##(2007-5#1)(2013-1#1)
while B##5##2##(2008-10#1)(2010-3#1)(2011-2#1)(2013-7#1)(2013-8#1)
while BII decreased further after applied tension techniques##2##8##(2013-1#2)
while C##2##2##(2008-3#2)
while CGRP-LI was##2##3##(1991-2#2)
while CMV infection##2##3##(2012-2#2)
while CT##2##2##(1990-3#1)(2006-1#1)
while Cd##2##2##(1995-3#1)(2008-10#1)
while Cr(VI) is##2##3##(2008-10#2)
while Cr(VI)##4##2##(2008-10#4)
while Cx32 had no effect on laterality##2##7##(2012-12#2)
while D-leucine did not##2##4##(2008-11#2)
while G##2##2##(2007-3#1)(2010-3#1)
while Group##3##2##(2007-7#1)(2008-6#1)(2009-5#1)
while H##2##2##(2011-1#1)(2012-2#1)
while H2##3##2##(2008-10#2)(2010-5#1)
while HA##2##2##(2007-8#1)(2008-10#1)
while HDL-cholesterol and##2##3##(1991-4#1)(2013-1#1)
while HDL-cholesterol##3##2##(1991-4#2)(2013-1#1)
while IgM##3##2##(1991-11#1)(1995-3#1)(2008-5#1)
while KGF acts as a paracrine##2##6##(1994-3#2)
while LIN-12##2##2##(2007-12#2)
while Lactobacillus##2##2##(2006-8#1)(2008-11#1)
while M##3##2##(2006-9#1)(2008-5#1)(2008-8#1)
while NO##2##2##(1994-5#1)(2005-10#1)
while P##3##2##(2006-5#2)(2013-1#1)
while PCR##2##2##(2008-4#2)
while PKC##2##2##(1993-3#1)(2008-11#1)
while PMA##2##2##(1994-2#1)(1996-5#1)
while Pseudomonas##2##2##(2008-10#1)(2009-5#1)
while QTc##2##2##(2006-12#2)
while SI##2##2##(1994-11#2)
while TGF-beta##2##2##(1993-12#1)(1994-6#1)
while TH##2##2##(1990-5#1)(1996-12#1)
while Western blotting##2##3##(2008-9#2)
while Western##3##2##(2008-9#2)(2009-9#1)
while Zn##2##2##(1997-4#1)(2008-10#1)
while a few##5##3##(1992-9#1)(2008-1#1)(2008-7#1)(2010-2#1)(2011-2#1)
while a high##4##3##(2006-2#1)(2007-12#1)(2008-1#1)(2008-3#1)
while a less##2##3##(1994-3#1)(2009-3#1)
while a locus##2##3##(1997-5#2)
while a low##2##3##(1994-2#1)(2008-3#1)
while a positive##2##3##(1992-8#1)(2006-11#1)
while a second##6##3##(1993-6#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)
while a significant##2##3##(2005-9#1)(2009-5#1)
while a similar##2##3##(1992-7#1)(1994-9#1)
while a smaller##2##3##(1996-5#1)(2009-6#1)
while a third##3##3##(1990-5#1)(2008-3#1)(2008-9#1)
while a##106##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-6#1)(1992-1#2)(1992-11#1)(1992-3#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#2)(1995-6#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-5#2)(1997-6#2)(1997-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#2)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#9)(2008-11#1)(2008-2#3)(2008-3#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#2)(2013-7#1)(2013-8#1)
while aPKCι remains unaffected##2##4##(2012-12#2)
while about##3##2##(1991-1#1)(1994-2#1)(1995-12#1)
while accounting for the##2##4##(2008-10#1)(2011-1#1)
while accounting for##3##3##(2008-10#1)(2008-6#1)(2011-1#1)
while acetate##2##2##(2006-8#1)(2008-7#1)
while achieving##3##2##(2006-1#1)(2008-2#2)
while activation of the##4##4##(1992-8#1)(2007-4#1)(2009-5#1)(2010-12#1)
while activation of##5##3##(1992-8#1)(2007-4#1)(2009-5#1)(2010-12#1)(2013-1#1)
while activity##2##2##(1992-6#1)(2008-11#1)
while addition of##8##3##(1990-3#1)(1996-2#1)(1996-7#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-4#1)
while adjusting for##4##3##(2007-8#1)(2012-3#1)(2013-1#2)
while adjusting##5##2##(2007-8#1)(2012-3#2)(2013-1#2)
while affecting##2##2##(1990-12#1)(2008-2#1)
while after##3##2##(1991-3#1)(1993-10#1)(2007-7#1)
while age##3##2##(2007-2#1)(2010-12#1)(2011-1#1)
while alendronate##4##2##(2008-8#1)(2009-3#3)
while alkaline##2##2##(2006-10#1)(2008-10#1)
while all other##3##3##(1994-11#1)(1995-10#1)(2012-12#1)
while all the##4##3##(1991-5#1)(1992-6#1)(2005-12#1)(2011-1#1)
while all##16##2##(1990-10#1)(1991-5#1)(1992-6#1)(1992-8#1)(1994-11#1)(1995-10#1)(1995-11#1)(2005-12#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
while allele B gave##2##4##(2010-2#2)
while allowing##12##2##(1991-3#1)(1994-2#1)(1994-9#1)(2006-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-3#1)
while almost no##2##3##(2005-4#1)(2011-2#1)
while almost##3##2##(2005-4#1)(2008-3#1)(2011-2#1)
while also enhancing patients' symptom management##2##6##(2013-1#2)
while also enhancing##3##3##(2008-8#1)(2013-1#2)
while also providing##3##3##(1994-4#1)(1997-8#1)(2005-10#1)
while also reducing##2##3##(2008-3#2)
while also serving as##2##4##(2006-5#1)(2008-10#1)
while also##30##2##(1990-3#1)(1991-9#1)(1992-6#1)(1994-4#1)(1995-1#1)(1997-8#1)(2005-10#1)(2006-3#1)(2006-5#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2009-1#1)(2010-12#1)(2012-1#1)(2012-12#2)(2013-1#4)(2013-8#1)
while among##3##2##(1996-8#1)(2008-4#1)(2011-1#1)
while an additional##2##3##(2007-11#1)(2008-9#1)
while an increase##2##3##(2007-8#1)(2008-8#1)
while an##25##2##(1991-12#1)(1991-2#1)(1991-3#1)(1994-3#1)(1994-6#1)(2006-1#1)(2006-10#2)(2006-3#1)(2007-1#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-12#1)(2012-11#1)
while another 15##2##3##(1992-9#1)(2007-2#1)
while another##10##2##(1992-9#1)(1994-12#1)(1994-8#1)(1997-2#1)(2005-11#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)
while applied tension technique was also described and practiced##2##9##(2013-1#2)
while approximately##3##2##(1996-10#1)(2006-10#1)(2008-10#1)
while assuring##2##2##(1994-2#1)(2007-11#1)
while at higher concentrations##2##4##(1991-2#1)(1996-12#1)
while at low##2##3##(1990-8#1)(2012-2#1)
while at pH 4##2##4##(1994-5#1)(2008-10#1)
while at pH##4##3##(1991-8#1)(1994-5#1)(2008-10#2)
while at the same time##15##5##(1995-1#1)(1995-12#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-10#1)(2009-8#1)
while at the##17##3##(1995-1#1)(1995-12#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-10#1)(2009-8#1)(2009-9#1)
while at##41##2##(1990-8#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-8#1)(1994-3#1)(1994-5#1)(1995-1#2)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-4#1)(2012-12#1)(2012-2#1)
while attached to##2##3##(1995-5#1)(1997-4#1)
while attempting##2##2##(1993-3#1)(2011-1#1)
while attenuating##2##2##(2008-4#1)(2009-12#1)
while avoiding the##5##3##(2005-10#1)(2006-1#1)(2006-4#1)(2008-2#1)(2010-12#1)
while avoiding##14##2##(1992-2#1)(1995-12#1)(1996-2#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-2#3)(2010-12#1)
while awaiting##2##2##(2007-10#1)(2009-10#1)
while balancing##2##2##(2008-11#1)(2008-8#1)
while being treated with##3##4##(2007-12#1)(2007-2#1)(2011-2#1)
while being##24##2##(1991-12#1)(1991-5#1)(1992-8#1)(1994-7#1)(1996-12#1)(1997-3#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#1)(2013-8#2)
while body##2##2##(1991-10#1)(2012-2#1)
while both the##4##3##(1994-4#1)(1997-2#1)(2008-9#1)(2010-9#1)
while both##20##2##(1991-5#2)(1992-4#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-8#1)(1994-9#1)(1996-12#1)(1996-7#1)(1997-2#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-9#1)(2013-1#1)
while bound to##2##3##(1992-11#1)(2008-4#1)
while broad##2##2##(2008-1#1)(2013-1#1)
while building##3##2##(2007-1#1)(2010-6#1)(2011-1#1)
while by##2##2##(1997-3#1)(2010-1#1)
while cAMP##2##2##(1993-7#1)(1995-6#1)
while cable formation requires Ush on both sides of the leading edge##2##12##(2012-12#2)
while camera navigation##2##3##(2010-3#2)
while carrying a##2##3##(2008-9#2)
while categorizing comments based on expert opinions from standard source##2##10##(2013-1#2)
while cell##6##2##(1995-8#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
while cells##8##2##(1994-8#1)(2008-11#5)(2008-4#1)(2009-4#1)
while chlorophyll##2##2##(2008-3#1)(2008-5#1)
while chronic##2##2##(2006-6#1)(2008-9#1)
while clinical data##2##3##(2007-10#1)(2008-1#1)
while clinical##3##2##(2007-10#1)(2008-1#1)(2011-1#1)
while collagen##2##2##(2006-12#1)(2009-8#1)
while combined##3##2##(2007-7#1)(2008-3#1)(2012-1#1)
while combining ICD-9 and NLP had the best PPV##2##9##(2013-1#2)
while complex 2##2##3##(2007-11#1)(2008-5#1)
while complying with##2##3##(2006-8#1)(2008-10#1)
while compound##2##2##(2008-5#1)(2008-8#1)
while concentrations##2##2##(2008-10#2)
while concomitantly##2##2##(2008-5#1)(2012-11#1)
while concurrently##3##2##(1991-11#1)(2008-6#1)(2012-1#1)
while conducting##2##2##(2005-11#1)(2013-1#1)
while conserving the##2##3##(2007-12#1)(2008-3#1)
while constraining##2##2##(2008-2#1)(2012-2#1)
while contralateral##2##2##(2007-12#1)(2013-1#1)
while control groups##2##3##(1993-3#1)(2012-3#1)
while controlling for##5##3##(2005-10#1)(2008-12#1)(2011-2#1)(2013-7#1)(2013-8#1)
while controls##4##2##(2008-9#1)(2009-5#1)(2011-1#1)(2013-8#1)
while corpus callosotomies frequently reduce##2##5##(1990-3#1)(1990-9#1)
while covalent immobilization##2##3##(2008-10#1)(2008-5#1)
while cutting##2##2##(1994-1#1)(1995-3#1)
while data are##2##3##(1991-5#1)(2009-9#1)
while data on##2##3##(1991-12#1)(1992-6#1)
while data##6##2##(1991-12#1)(1991-5#1)(1992-6#1)(2008-3#1)(2009-9#1)(2010-5#1)
while decreased##3##2##(1991-5#1)(1993-12#1)(2005-12#1)
while decreasing the##4##3##(2006-10#1)(2009-4#1)(2010-1#1)(2012-2#1)
while decreasing##14##2##(1994-10#1)(1996-2#1)(2006-10#1)(2007-12#1)(2008-11#2)(2008-5#1)(2009-4#1)(2010-1#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
while degradation##2##2##(1990-8#1)(2008-11#1)
while delaying##2##2##(2007-8#1)(2012-12#1)
while deletion of the##2##4##(1991-10#1)(1995-8#1)
while demographic##2##2##(2008-9#1)(2013-1#1)
while deprotonation##2##2##(2008-3#1)(2010-5#1)
while determining##2##2##(2008-10#1)(2011-1#1)
while developing##3##2##(2007-4#1)(2009-5#1)(2012-1#1)
while deviations of novices result mostly in error##2##8##(2013-1#2)
while dexamethasone##2##2##(1995-11#1)(1996-6#1)
while differences##2##2##(1993-1#1)(1994-3#1)
while diffraction-limited##2##2##(2007-12#1)(2008-3#1)
while direct##2##2##(2007-8#2)
while discussing##2##2##(2008-11#1)(2012-2#1)
while drinking##2##2##(1994-2#2)
while driving##5##2##(1996-11#1)(2008-12#1)(2012-12#2)(2013-7#1)
while each##3##2##(1991-2#1)(1995-2#1)(2011-3#1)
while early##3##2##(1992-5#1)(1997-8#1)(2006-5#1)
while easing the transition to ICD-10-CM##2##6##(2013-1#2)
while eating##3##2##(2003-11#1)(2007-8#1)(2011-2#1)
while eight##5##2##(2007-3#1)(2008-6#1)(2008-9#1)(2010-12#1)(2011-2#1)
while either##2##2##(2008-9#1)(2011-2#1)
while electron microscopy##2##3##(1992-9#1)(2005-11#1)
while electron##3##2##(1992-9#1)(2005-11#1)(2009-9#1)
while eliminating##2##2##(1992-8#1)(2008-2#1)
while emphasizing##2##2##(1994-12#1)(2009-4#1)
while enhancing the##2##3##(2008-5#1)(2011-1#1)
while enhancing##6##2##(1997-1#1)(2008-5#1)(2008-9#1)(2009-9#1)(2010-10#1)(2011-1#1)
while ensuring access##2##3##(1996-1#1)(2007-4#1)
while ensuring realistic##2##3##(2008-6#1)(2009-8#1)
while ensuring the safety of##2##5##(2005-5#1)(2011-2#1)
while ensuring the##4##3##(2005-5#1)(2007-11#1)(2011-2#1)(2012-2#1)
while ensuring##12##2##(1996-1#1)(2005-5#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-4#1)(2008-6#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#1)
while error analysis reveals challenges under certain contexts##2##8##(2013-1#2)
while establishing##2##2##(2010-5#1)(2013-7#1)
while ethanol and##2##3##(2009-12#2)
while ethanol##4##2##(2008-10#1)(2009-12#2)(2010-3#1)
while exerting##2##2##(2012-2#1)(2013-1#1)
while exposed to##2##3##(2004-4#1)(2008-8#1)
while exposure to##2##3##(1993-6#1)(1993-9#1)
while expression of the##2##4##(2008-11#1)(2013-7#1)
while expression of##4##3##(1997-7#1)(2008-11#1)(2010-12#1)(2013-7#1)
while expression##5##2##(1997-7#1)(1997-8#1)(2008-11#1)(2010-12#1)(2013-7#1)
while extending##2##2##(1995-1#1)(2007-12#1)
while external##3##2##(2007-8#1)(2009-6#1)(2011-1#1)
while federal reimbursement practices are migrating towards ICD-10##2##8##(2013-1#2)
while feeding on##3##3##(2008-10#2)(2008-5#1)
while fish were##2##3##(1992-8#1)(2008-10#1)
while five##4##2##(1994-12#1)(1995-12#1)(2007-12#1)(2013-1#1)
while flavonoids##2##2##(1992-8#1)(2008-10#1)
while focusing on##3##3##(1993-1#1)(2010-11#1)(2011-2#1)
while for EO and EGVGE##2##5##(2012-12#2)
while for a##2##3##(2004-4#1)(2008-10#1)
while for the off-lattice simulations they were##2##7##(2005-11#2)
while for the off-lattice simulations##3##5##(2005-11#3)
while for the off-lattice##4##4##(2005-11#4)
while for the other##4##4##(2007-7#1)(2008-10#2)(2013-1#1)
while for the##22##3##(1992-11#1)(1993-9#1)(1994-9#1)(1996-2#1)(1996-3#1)(2005-11#4)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-9#2)(2010-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
while for##53##2##(1991-2#1)(1992-11#1)(1993-9#1)(1994-1#1)(1994-9#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-4#1)(2004-1#1)(2004-4#1)(2005-11#6)(2006-5#1)(2006-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#2)(2010-1#1)(2010-10#1)(2010-12#1)(2012-12#2)(2012-2#4)(2013-1#2)(2013-7#3)
while four##7##2##(1990-4#1)(1996-6#1)(1997-3#1)(2007-7#2)(2008-4#1)(2010-3#1)
while free##4##2##(1994-11#1)(1994-3#1)(2005-11#1)(2007-8#1)
while friction##2##2##(2010-10#1)(2012-2#1)
while from##4##2##(2007-11#1)(2007-6#1)(2010-6#1)(2010-7#1)
while further##5##2##(1991-12#1)(1994-3#1)(2008-1#1)(2008-7#1)(2013-1#1)
while generally##2##2##(1991-1#1)(1993-10#1)
while genistein had a##2##4##(2008-4#2)
while girls##2##2##(1994-12#1)(2012-2#1)
while giving##3##2##(1993-1#1)(1993-11#1)(2007-11#1)
while glycine##2##2##(2005-11#1)(2010-8#1)
while group##6##2##(2006-6#1)(2007-1#1)(2009-5#2)(2010-7#2)
while groups##2##2##(2007-1#1)(2009-5#1)
while having no effect on the##2##6##(1990-8#1)(1996-12#1)
while having no effect on##3##5##(1990-7#1)(1990-8#1)(1996-12#1)
while having no significant effect on##2##6##(1992-7#1)(1997-1#1)
while having no##5##3##(1990-7#1)(1990-8#1)(1992-7#1)(1996-12#1)(1997-1#1)
while having normal##2##3##(1994-8#1)(2008-11#1)
while having##15##2##(1990-7#1)(1990-8#1)(1991-3#1)(1992-12#1)(1992-7#1)(1994-8#1)(1995-7#1)(1996-12#1)(1997-1#1)(1997-7#2)(2007-8#1)(2008-11#1)(2008-3#1)(2012-2#1)
while heart##2##2##(1991-12#1)(1993-2#1)
while helix##2##2##(1991-1#1)(1996-8#1)
while helping to##2##3##(2008-2#1)(2008-3#1)
while helping##3##2##(2008-2#1)(2008-3#1)(2013-1#1)
while high doses##4##3##(1993-3#1)(2008-7#1)(2009-3#2)
while high##13##2##(1992-11#1)(1993-3#1)(1994-11#1)(1997-8#1)(2007-12#1)(2008-7#1)(2009-3#2)(2010-5#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-6#1)
while higher concentrations##2##3##(1992-3#1)(1994-2#1)
while higher##11##2##(1992-3#1)(1993-8#1)(1994-2#1)(1997-2#1)(2004-9#1)(2008-10#2)(2008-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
while highlighting##2##2##(2008-1#1)(2010-2#1)
while his##3##2##(1991-3#1)(1992-6#1)(2006-1#1)
while holding##2##2##(2007-12#1)(2008-1#1)
while hospitalized##2##2##(1995-2#1)(2005-7#1)
while if##2##2##(2008-7#1)(2009-12#1)
while implantation of estrogen pellets##2##5##(1993-9#2)
while improving##7##2##(2007-8#2)(2010-5#1)(2013-1#4)
while in 2##3##3##(1991-9#1)(2007-7#1)(2008-3#1)
while in 7##2##3##(1990-12#1)(1991-6#1)
while in Group II##2##4##(2007-7#1)(2007-8#1)
while in Xenopus egg extracts##2##5##(2012-12#2)
while in a##3##3##(1992-8#1)(2010-2#1)(2012-1#1)
while in all##2##3##(2008-10#1)(2011-2#1)
while in another##2##3##(1993-6#1)(2008-4#1)
while in cases##2##3##(2008-8#1)(2011-2#1)
while in contact with##2##4##(2004-2#1)(2006-12#1)
while in group##3##3##(1991-10#1)(2007-7#1)(2007-8#1)
while in other##4##3##(1991-1#1)(1996-3#1)(1996-8#1)(2010-2#1)
while in others no##2##4##(2008-4#1)(2008-7#1)
while in others##5##3##(1992-3#1)(1996-10#1)(2008-12#1)(2008-4#1)(2008-7#1)
while in the absence of##2##5##(1996-2#1)(1997-4#1)
while in the case of##5##5##(1991-7#1)(1992-3#2)(1997-3#1)(2010-5#1)
while in the control group it##2##6##(2007-7#1)(2008-11#1)
while in the control##3##4##(2007-7#1)(2008-11#1)(2013-8#1)
while in the latter##2##4##(1995-5#1)(2005-11#1)
while in the other##5##4##(1993-7#1)(1993-8#1)(2007-6#1)(2008-10#1)(2008-4#1)
while in the post-I group##2##5##(2009-3#2)
while in the second##5##4##(1990-3#1)(1993-6#1)(1997-3#1)(2007-8#1)(2008-3#1)
while in the third##2##4##(2008-10#1)(2009-9#1)
while in the##71##3##(1990-10#1)(1990-12#2)(1990-3#1)(1990-9#1)(1991-2#1)(1991-7#1)(1992-2#1)(1992-3#2)(1993-6#1)(1993-7#2)(1993-8#1)(1995-4#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(2004-1#1)(2004-9#1)(2005-11#1)(2006-4#1)(2006-8#1)(2007-6#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#4)(2009-4#2)(2009-7#2)(2009-9#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
while in those##2##3##(1990-7#1)(2010-12#1)
while in two##2##3##(2005-12#1)(2008-6#1)
while in##194##2##(1990-10#1)(1990-12#4)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#2)(1990-9#2)(1991-1#1)(1991-10#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#3)(1992-8#3)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#3)(1993-7#2)(1993-8#1)(1993-9#1)(1994-11#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#3)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(2004-1#1)(2004-2#1)(2004-9#2)(2005-11#1)(2005-12#2)(2006-12#1)(2006-4#2)(2006-5#1)(2006-6#3)(2006-8#1)(2007-1#1)(2007-11#4)(2007-12#1)(2007-6#2)(2007-7#8)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-3#3)(2008-4#5)(2008-5#6)(2008-6#2)(2008-7#9)(2008-8#4)(2008-9#1)(2009-2#3)(2009-3#4)(2009-4#3)(2009-7#2)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#3)(2010-2#3)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#4)
while inactivation of##2##3##(1995-2#2)
while increased##6##2##(1995-12#1)(1995-2#1)(1995-8#1)(1997-7#1)(2008-10#1)(2011-2#1)
while increasing in##2##3##(1997-5#1)(2008-10#1)
while increasing the##7##3##(1991-7#1)(1995-2#1)(1996-12#1)(1996-5#1)(2007-12#2)(2008-2#1)
while increasing##17##2##(1991-7#1)(1992-5#1)(1993-12#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-5#1)(2005-10#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-2#1)(2011-11#1)(2012-12#1)(2013-1#1)
while incubation with##2##3##(1996-5#1)(2008-4#1)
while individuals of##2##3##(2008-8#2)
while individuals##3##2##(2008-11#1)(2008-8#2)
while infected##2##2##(1997-5#1)(2008-10#1)
while ingestion of##2##3##(2008-4#1)(2009-9#1)
while inhaled##2##2##(2007-11#1)(2008-3#1)
while inhibiting the##2##3##(1996-2#1)(2012-2#1)
while inhibiting##4##2##(1995-6#1)(1996-2#1)(2012-2#2)
while inorganic##2##2##(2008-10#1)(2010-11#1)
while interferon##2##2##(1991-5#1)(2006-2#1)
while it did not##3##4##(1993-11#1)(1995-3#1)(2008-8#1)
while it had no effect on##2##6##(1995-6#1)(1997-3#1)
while it had no effect##3##5##(1995-6#1)(1997-3#1)(2008-2#1)
while it had no##4##4##(1995-6#1)(1997-3#1)(2008-2#1)(2013-8#1)
while it had##6##3##(1995-6#1)(1996-1#1)(1997-3#1)(1997-6#1)(2008-2#1)(2013-8#1)
while it has##2##3##(2008-10#1)(2010-6#1)
while it increased##5##3##(1996-12#1)(1996-5#1)(2008-7#1)(2010-8#1)(2013-1#1)
while it inhibited##2##3##(1997-4#1)(2008-11#1)
while it is being##2##4##(2006-4#1)(2008-2#1)
while it is still##2##4##(1991-9#1)(2013-7#1)
while it is##21##3##(1990-4#1)(1991-9#1)(1995-11#1)(1996-12#1)(2006-2#1)(2006-4#1)(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-7#1)(2011-2#1)(2013-7#1)
while it potentiated##2##3##(1990-5#1)(1996-8#1)
while it remained##2##3##(1994-12#1)(2012-1#1)
while it seems##2##3##(1993-12#1)(2011-1#1)
while it significantly##2##3##(2011-1#1)(2012-2#1)
while it was not##2##4##(1993-4#1)(2008-4#1)
while it was##13##3##(1992-11#1)(1993-4#1)(1997-1#2)(2007-8#1)(2008-10#1)(2008-4#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
while it##78##2##(1990-4#1)(1990-5#1)(1991-12#1)(1991-9#1)(1992-11#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#3)(1996-5#1)(1996-8#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-6#1)(2006-2#1)(2006-4#1)(2006-6#2)(2007-1#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-11#2)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#2)
while its effect on##2##4##(1995-11#1)(2012-3#1)
while its function##2##3##(2008-8#1)(2011-2#1)
while its##22##2##(1990-3#1)(1991-2#1)(1993-8#1)(1994-11#1)(1995-11#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#1)(2006-10#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-3#1)
while keeping the##7##3##(1994-11#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)
while keeping their##2##3##(2005-11#1)(2010-4#1)
while keeping##14##2##(1992-12#1)(1994-11#1)(1996-2#1)(1997-6#1)(2005-11#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-12#1)(2010-4#1)
while knowledge of##2##3##(2011-2#1)(2012-12#1)
while knowledge##3##2##(2011-2#1)(2012-12#1)(2012-2#1)
while late##2##2##(2011-2#1)(2012-7#1)
while leaving the##7##3##(1991-4#1)(2007-12#1)(2008-10#1)(2008-6#1)(2010-4#1)(2012-1#1)(2012-2#1)
while leaving##12##2##(1990-4#1)(1991-4#1)(1992-11#1)(1992-7#1)(1993-3#1)(2007-12#1)(2008-10#1)(2008-6#1)(2010-4#1)(2012-1#1)(2012-2#2)
while left##3##2##(2006-12#2)(2012-2#1)
while lesions of##2##3##(1993-6#1)(1994-6#1)
while less potent##2##3##(1990-11#1)(2008-8#1)
while less than half##2##4##(2008-10#1)(2013-8#1)
while less##7##2##(1990-11#1)(1990-3#1)(1993-5#1)(2008-1#1)(2008-10#1)(2008-8#1)(2013-8#1)
while levels##3##2##(1995-7#1)(1996-11#1)(1997-5#1)
while limiting##6##2##(2007-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-1#1)(2012-2#1)
while little is known##2##4##(2007-5#1)(2010-12#1)
while little##4##2##(1991-7#1)(1992-9#1)(2007-5#1)(2010-12#1)
while living##2##2##(2006-2#1)(2012-3#1)
while long-term##2##2##(1995-12#1)(2012-1#1)
while low##5##2##(1992-3#1)(1993-2#1)(2008-10#1)(2013-1#1)(2013-7#1)
while lower##2##2##(2007-11#1)(2008-10#1)
while lowering the##3##3##(2007-11#1)(2008-3#1)(2010-4#1)
while maintaining a high##2##4##(2007-7#1)(2012-2#1)
while maintaining a##17##3##(1991-4#1)(2007-12#1)(2007-4#1)(2007-7#2)(2008-2#3)(2008-3#2)(2008-7#1)(2008-8#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
while maintaining an##2##3##(2008-2#1)(2009-10#1)
while maintaining excellent##4##3##(2007-12#1)(2008-2#1)(2012-12#1)(2012-2#1)
while maintaining good##2##3##(2008-10#2)
while maintaining high##2##3##(2008-10#2)
while maintaining low##2##3##(2007-12#1)(2008-5#1)
while maintaining patient##3##3##(2008-10#1)(2008-11#2)
while maintaining quality of care##2##5##(1994-1#1)(1996-1#1)
while maintaining quality##7##3##(1991-12#1)(1994-1#1)(1996-1#2)(1997-2#1)(2008-11#1)(2013-1#1)
while maintaining the ability to##2##5##(2007-12#1)(2008-4#1)
while maintaining the same##2##4##(1994-12#1)(2008-11#1)
while maintaining the##15##3##(1990-11#1)(1990-6#1)(1992-1#1)(1993-4#1)(1993-9#1)(1994-12#1)(1996-5#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-4#1)(2011-1#1)(2012-11#1)
while maintaining their##3##3##(1991-12#1)(1996-7#1)(2007-1#1)
while maintaining##94##2##(1990-11#1)(1990-6#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#1)(1993-4#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-6#1)(1996-1#2)(1996-5#1)(1996-7#1)(1997-2#1)(1997-6#1)(2005-10#1)(2007-1#1)(2007-11#1)(2007-12#9)(2007-4#1)(2007-7#2)(2008-10#9)(2008-11#6)(2008-2#7)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#3)
while making##3##2##(2008-11#1)(2008-5#1)(2011-1#1)
while male##3##2##(1995-12#1)(1995-8#1)(2008-8#1)
while males##2##2##(1997-3#1)(2008-6#1)
while managing##4##2##(2005-10#1)(2007-2#1)(2012-2#2)
while manipulating##2##2##(2008-7#1)(2013-1#1)
while many##4##2##(1995-2#1)(2007-6#1)(2010-12#1)(2012-12#1)
while maximal##2##2##(1993-5#1)(2008-8#1)
while maximizing##2##2##(1996-3#1)(2010-12#1)
while maximum##4##2##(2005-11#1)(2008-10#1)(2008-5#1)(2010-5#1)
while mean##4##2##(1995-12#1)(1995-6#1)(2007-7#1)(2012-2#1)
while median##2##2##(1997-6#1)(2006-6#1)
while medical##2##2##(1995-1#1)(1996-3#1)
while meeting##2##2##(2007-12#1)(2010-8#1)
while men##2##2##(1991-11#1)(2009-4#1)
while methylated##2##2##(1997-7#1)(2007-11#1)
while minimising##2##2##(1997-3#1)(2007-11#1)
while minimizing the impact##2##4##(2008-10#1)(2008-2#1)
while minimizing the##6##3##(1992-11#1)(2008-10#1)(2008-2#3)(2008-3#1)
while minimizing##17##2##(1992-11#1)(1996-9#1)(2008-10#4)(2008-2#3)(2008-3#1)(2008-9#1)(2012-3#1)(2013-1#5)
while minimum##2##2##(2008-12#1)(2012-12#1)
while minor##2##2##(1993-8#1)(2006-2#1)
while moderate##2##2##(1995-3#1)(2010-12#1)
while moisture##2##2##(2008-10#1)(2010-4#1)
while monitoring##3##2##(2004-1#1)(2008-7#1)(2012-12#1)
while more than##3##3##(2006-12#1)(2008-10#1)(2011-2#1)
while more##7##2##(1994-12#1)(2006-11#1)(2006-12#1)(2007-9#1)(2008-10#1)(2008-12#1)(2011-2#1)
while most of the##2##4##(2008-11#1)(2008-7#1)
while most of##5##3##(1997-6#1)(2007-3#1)(2008-11#1)(2008-7#1)(2010-4#1)
while most##14##2##(1990-4#1)(1991-6#1)(1993-2#1)(1997-6#1)(2006-8#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2010-4#1)(2013-8#2)
while moving##4##2##(2005-11#1)(2007-11#1)(2008-3#1)(2012-1#1)
while much lower##2##3##(2007-10#1)(2011-2#1)
while much##3##2##(1991-4#1)(2007-10#1)(2011-2#1)
while muscarinic##2##2##(1993-12#1)(1995-12#1)
while muscle##2##2##(2005-12#1)(2013-1#1)
while mutant##2##2##(1995-3#1)(2008-5#1)
while mutations##2##2##(1990-3#1)(1994-9#1)
while navigating##2##2##(2010-9#1)(2012-1#1)
while neither##3##2##(1990-7#1)(1992-10#1)(1997-5#1)
while new information##2##3##(1991-11#1)(2006-9#1)
while new##4##2##(1991-11#1)(1995-12#1)(2004-1#1)(2006-9#1)
while nine##2##2##(1993-4#1)(2008-11#1)
while no changes were observed in##2##6##(1994-8#1)(2008-7#1)
while no changes were##3##4##(1994-8#1)(2008-7#1)(2012-3#1)
while no difference##2##3##(2011-2#1)(2012-12#1)
while no differences were##2##4##(2008-7#1)(2010-12#1)
while no differences##5##3##(1992-4#1)(1994-2#1)(2006-10#1)(2008-7#1)(2010-12#1)
while no effect was##2##4##(1996-12#1)(2008-10#1)
while no effect##3##3##(1991-2#1)(1996-12#1)(2008-10#1)
while no or##3##3##(1992-12#1)(1995-11#1)(2008-10#1)
while no significant changes##3##4##(1997-8#1)(2003-11#1)(2007-11#1)
while no significant difference##2##4##(2007-1#1)(2008-7#1)
while no significant differences were##2##5##(2013-1#1)(2013-7#1)
while no significant##8##3##(1994-2#1)(1997-8#1)(2003-11#1)(2007-1#1)(2007-11#1)(2008-7#1)(2013-1#1)(2013-7#1)
while no specific##2##3##(1990-12#1)(2008-5#1)
while no such##3##3##(1990-3#1)(1993-2#1)(2006-6#1)
while no##51##2##(1990-12#1)(1990-3#1)(1990-6#1)(1991-12#2)(1991-2#1)(1991-9#1)(1992-12#1)(1992-4#1)(1993-2#1)(1994-10#1)(1994-11#1)(1994-2#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-8#2)(2003-11#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-1#1)(2009-4#1)(2010-11#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
while none of the##4##4##(2007-7#1)(2008-4#1)(2008-9#1)(2012-12#1)
while none##10##2##(1994-12#1)(1995-12#1)(1995-3#1)(2007-12#1)(2007-7#1)(2008-2#1)(2008-4#1)(2008-9#1)(2012-12#1)(2012-2#1)
while normal##3##2##(1996-11#1)(1996-2#1)(1996-4#1)
while not affecting the##2##4##(1990-7#1)(2007-10#1)
while not affecting##6##3##(1990-7#1)(1992-8#1)(1997-7#1)(2007-10#1)(2007-8#1)(2008-10#1)
while not significantly##6##3##(1990-11#1)(1990-6#1)(1996-10#1)(2008-9#1)(2012-11#2)
while not##27##2##(1990-10#1)(1990-11#1)(1990-6#1)(1990-7#1)(1992-3#1)(1992-8#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-4#1)(1997-1#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#2)(2010-3#1)(2012-11#2)(2012-3#1)
while nutritional rehabilitation improves overall health##2##6##(2010-7#2)
while of##2##2##(1991-12#1)(1991-8#1)
while offering##2##2##(2008-8#1)(2009-12#1)
while on cardiopulmonary bypass##3##4##(2007-8#3)
while on dialysis##2##3##(2007-7#1)(2008-1#1)
while on the other hand##4##5##(1991-11#1)(1991-3#1)(2009-2#1)(2012-12#1)
while on the##9##3##(1991-11#1)(1991-3#1)(1993-6#1)(1994-10#1)(1996-6#1)(2007-12#1)(2009-2#1)(2012-12#1)(2012-3#1)
while on therapy##2##3##(2006-2#1)(2008-1#1)
while on##30##2##(1991-11#1)(1991-3#1)(1993-6#1)(1994-10#1)(1996-6#1)(1997-5#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#3)(2007-8#5)(2008-1#2)(2008-11#1)(2008-12#1)(2008-6#2)(2009-2#1)(2010-1#1)(2010-4#1)(2010-7#1)(2012-12#1)(2012-3#1)
while one also had##2##4##(2007-11#1)(2007-12#1)
while one of the##3##4##(1990-5#1)(2007-6#1)(2008-10#1)
while one of##4##3##(1990-5#1)(1991-6#1)(2007-6#1)(2008-10#1)
while one patient##2##3##(2007-7#2)
while one was##2##3##(1993-7#1)(2005-12#1)
while one##25##2##(1990-5#1)(1991-6#1)(1992-10#1)(1993-7#1)(1994-6#1)(2005-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-7#2)(2008-8#1)(2009-8#1)(2010-12#1)(2012-1#1)(2013-7#1)
while only 1##2##3##(1996-1#1)(2012-2#1)
while only a##4##3##(1991-7#1)(1995-5#1)(1996-5#1)(2008-7#1)
while only one##4##3##(1991-9#1)(2007-3#1)(2008-10#1)(2010-5#1)
while only the##4##3##(1990-7#1)(1994-5#1)(2010-4#1)(2013-1#1)
while only##45##2##(1990-12#1)(1990-7#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#1)(1994-5#1)(1995-1#1)(1995-5#1)(1996-1#1)(1996-5#1)(1996-7#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-3#2)(2007-7#2)(2007-8#2)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#2)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
while operating at##2##3##(2008-10#1)(2008-3#1)
while optimizing the##3##3##(1996-6#1)(2008-6#1)(2011-12#1)
while optimizing##4##2##(1996-6#1)(2006-10#1)(2008-6#1)(2011-12#1)
while organic##2##2##(1994-5#1)(2008-5#1)
while other cells##2##3##(1996-5#1)(2008-11#1)
while other parameters##2##3##(2008-4#1)(2013-1#1)
while other##34##2##(1991-12#1)(1992-2#1)(1993-3#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-7#1)(2006-1#1)(2006-10#1)(2007-1#1)(2007-10#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#2)
while others are not##2##4##(2010-8#1)(2013-8#1)
while others are##13##3##(1993-6#1)(1994-8#1)(1996-2#1)(2006-12#1)(2008-11#1)(2008-7#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-12#1)(2012-2#2)(2013-8#1)
while others do not##5##4##(2007-6#1)(2008-1#1)(2008-10#1)(2008-9#1)(2012-3#1)
while others found the##2##4##(2008-11#1)(2008-3#1)
while others have##2##3##(1995-8#1)(2008-4#1)
while others may##3##3##(1996-12#1)(2006-10#1)(2008-10#1)
while others require##2##3##(2008-8#1)(2008-9#1)
while others will##2##3##(2008-2#1)(2012-2#1)
while others##56##2##(1991-12#1)(1992-5#1)(1993-6#1)(1993-7#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-12#2)(1996-2#1)(1997-2#2)(1997-6#1)(2005-12#1)(2006-10#4)(2006-12#1)(2007-12#1)(2007-2#2)(2007-6#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-5#2)(2009-6#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-12#1)(2012-2#3)(2012-3#2)(2013-8#1)
while our##4##2##(1995-3#1)(2012-12#2)(2012-2#1)
while overexpression of##3##3##(2009-8#2)(2012-12#1)
while overweight##3##2##(2006-9#1)(2007-8#1)(2011-2#1)
while oxidized##2##2##(1994-3#1)(2008-3#1)
while p-aminophenylalanine6 angiotensin II displays an IC50 of##2##8##(1990-6#2)
while partial##2##2##(2007-2#1)(2009-12#1)
while participants performed##2##3##(2009-2#1)(2010-5#1)
while patient survival##2##3##(2008-1#1)(2008-4#1)
while patients in the##2##4##(1990-10#1)(1997-8#1)
while patients receiving##2##3##(2006-12#2)
while patients##8##2##(1990-10#1)(1991-3#1)(1992-5#1)(1997-8#1)(2006-12#2)(2012-1#1)(2012-2#1)
while performing axillary##2##3##(2013-1#2)
while performing open##2##3##(2008-12#1)(2011-1#1)
while performing the##2##3##(2008-10#1)(2008-8#1)
while performing##14##2##(1992-7#1)(1993-9#1)(2006-8#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-10#1)(2009-4#1)(2011-1#1)(2013-1#2)(2013-7#1)
while peripheral##2##2##(1992-9#1)(2011-2#1)
while physical##2##2##(2011-2#1)(2013-8#1)
while placing##2##2##(2007-4#1)(2009-4#1)
while plant##2##2##(2008-10#2)
while plasma##3##2##(1994-12#1)(1997-7#1)(2008-1#1)
while playing a##3##3##(2007-10#2)(2008-11#1)
while playing##7##2##(1990-6#1)(2007-10#2)(2008-11#1)(2009-9#1)(2012-3#1)(2013-1#1)
while pointing##2##2##(2011-2#1)(2012-12#1)
while post##2##2##(2007-8#1)(2010-12#1)
while posterior##2##2##(2005-5#1)(2008-6#1)
while potentially##3##2##(2005-12#1)(2008-7#1)(2009-11#1)
while preliminary##2##2##(2005-11#1)(2008-12#1)
while presenting##2##2##(2008-5#1)(2011-1#1)
while preserving its##2##3##(2008-10#1)(2008-2#1)
while preserving normal##2##3##(2005-11#1)(2006-9#1)
while preserving the original##2##4##(2006-12#1)(2007-12#1)
while preserving the##11##3##(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)
while preserving their##3##3##(1990-12#1)(2010-8#2)
while preserving##30##2##(1990-12#1)(1991-1#1)(1992-7#1)(1997-8#1)(2005-11#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-6#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#1)
while preventing##2##2##(1990-5#1)(2008-7#1)
while producing##2##2##(1993-3#1)(2008-3#1)
while productivity in July in Costa Rica (4##2##8##(2008-5#1)(2011-2#1)
while productivity##3##2##(2007-5#1)(2008-5#1)(2011-2#1)
while progesterone##3##2##(1990-11#1)(1994-9#1)(2010-8#1)
while promoting##2##2##(1994-11#1)(2013-1#1)
while protecting##3##2##(1993-1#1)(2006-12#1)(2007-7#1)
while providing a##2##3##(2008-3#1)(2012-2#1)
while providing an##2##3##(1997-2#1)(1997-3#1)
while providing##19##2##(1994-2#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-10#1)(2008-11#5)(2008-12#2)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
while raising##3##2##(1997-7#1)(2009-8#1)(2011-2#1)
while rare##2##2##(2010-11#1)(2010-9#1)
while rats##2##2##(1995-12#1)(2008-11#1)
while reaction##2##2##(1996-5#1)(2010-2#1)
while reading##3##2##(2008-11#1)(2012-12#1)(2013-8#1)
while receiving##5##2##(1991-2#1)(1993-3#1)(2007-4#1)(2008-8#1)(2012-12#1)
while recent##2##2##(2008-1#1)(2013-1#1)
while recombinant##3##2##(1995-10#1)(2008-11#2)
while recording##5##2##(1992-3#1)(1992-9#1)(2008-10#1)(2009-5#1)(2012-1#1)
while recoveries##3##2##(2008-10#3)
while red##2##2##(2008-9#1)(2011-2#1)
while redacting sensitive information that they do not wish employers##2##10##(2013-1#2)
while reduced##3##2##(1992-10#1)(1993-12#1)(2011-2#1)
while reducing costs##2##3##(1996-2#1)(2008-11#1)
while reducing the##5##3##(1992-2#1)(2006-10#1)(2006-2#1)(2008-3#1)(2011-2#1)
while reducing##19##2##(1992-2#1)(1996-2#1)(1996-9#1)(1997-1#1)(2006-10#1)(2006-2#1)(2007-4#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2009-4#2)(2011-2#1)(2012-1#1)(2013-1#2)
while relatively higher##2##3##(1997-8#1)(2013-1#1)
while relatively##4##2##(1997-8#1)(2008-9#1)(2011-1#1)(2013-1#1)
while remaining##7##2##(1995-12#1)(2007-12#1)(2007-7#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-3#1)
while removing##2##2##(1990-9#1)(2008-2#1)
while requiring##2##2##(2007-7#1)(2008-10#1)
while resistant##2##2##(1991-8#1)(2008-10#1)
while retaining its##2##3##(2008-2#1)(2010-5#1)
while retaining sensitivity to##2##4##(1992-9#1)(2007-12#1)
while retaining the##4##3##(1994-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
while retaining##22##2##(1992-9#1)(1993-12#1)(1994-12#1)(1995-2#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#1)(2010-12#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-7#1)
while reverse##2##2##(2006-1#1)(2008-10#1)
while root##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
while sacrificing##2##2##(2008-2#1)(2009-9#1)
while sample##2##2##(2011-12#1)(2013-1#1)
while samples of##2##3##(1997-4#1)(2007-1#1)
while samples##4##2##(1997-4#1)(2005-11#1)(2007-1#1)(2008-5#1)
while satisfying##2##2##(1995-3#1)(2013-7#1)
while seated##3##2##(1993-9#1)(1995-8#1)(2006-6#1)
while secondary##2##2##(2008-1#1)(2008-11#1)
while sensitive##2##2##(2008-4#1)(2012-3#1)
while serum##9##2##(1993-12#1)(1996-9#1)(1997-5#1)(2008-7#2)(2011-1#1)(2011-11#1)(2013-7#1)(2013-8#1)
while serving##2##2##(2009-11#1)(2010-12#1)
while several##4##2##(2005-9#1)(2006-10#1)(2008-5#1)(2013-1#1)
while she was##4##3##(1994-11#1)(1996-12#1)(2007-7#1)(2010-11#1)
while showing a##2##3##(1995-12#1)(2006-3#1)
while showing##3##2##(1995-12#1)(2006-3#1)(2010-12#1)
while significant##5##2##(1992-6#1)(1993-8#1)(1995-2#1)(1996-11#1)(2009-4#1)
while significantly##2##2##(2008-2#1)(2012-2#1)
while similar##2##2##(1997-4#1)(2012-12#1)
while simultaneously##13##2##(2006-11#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2012-12#1)
while sitting##4##2##(2010-9#2)(2012-1#1)(2013-8#1)
while six##3##2##(1991-2#1)(2006-8#1)(2008-5#1)
while skin##2##2##(1996-11#1)(2008-5#1)
while sodium##2##2##(1996-12#1)(1996-9#1)
while soil##2##2##(2008-10#1)(2012-6#1)
while somatic##2##2##(2007-1#1)(2007-12#1)
while some of the##2##4##(1992-3#1)(2007-10#1)
while some of##4##3##(1992-3#1)(1993-12#1)(2007-10#1)(2011-1#1)
while some other##2##3##(1992-12#1)(1997-5#1)
while some##14##2##(1991-2#1)(1992-12#1)(1992-3#1)(1993-12#1)(1997-5#1)(2006-6#2)(2007-10#1)(2008-10#1)(2008-11#1)(2010-2#1)(2011-1#2)(2011-3#1)
while sparing normal##3##3##(1991-12#1)(1994-3#1)(1994-5#1)
while sparing the##2##3##(1994-2#1)(2012-3#1)
while sparing##5##2##(1991-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(2012-3#1)
while still allowing##2##3##(1995-4#1)(2012-2#1)
while still maintaining a##2##4##(1995-7#1)(2010-2#1)
while still maintaining##3##3##(1995-7#1)(2008-11#1)(2010-2#1)
while still paying##2##3##(2005-7#1)(2008-11#1)
while still preserving##2##3##(2008-1#1)(2008-3#1)
while still providing##2##3##(2008-2#1)(2008-3#1)
while still##20##2##(1991-12#1)(1995-3#1)(1995-4#2)(1995-7#1)(2004-11#1)(2005-7#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#3)(2010-2#1)(2012-2#2)
while strains##2##2##(2008-10#2)
while structured##2##2##(2013-1#2)
while subjects with##3##3##(2008-7#1)(2008-8#1)(2010-11#1)
while subjects##6##2##(1996-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-11#1)(2013-8#1)
while substantial##2##2##(1992-3#1)(1995-12#1)
while substitution of##2##3##(1994-2#1)(1994-9#1)
while sugar##2##2##(1991-4#1)(2008-1#1)
while suppressing##2##2##(2007-9#1)(2008-10#1)
while taking into account the##2##5##(1990-10#1)(2008-3#1)
while taking##8##2##(1990-10#1)(1993-12#2)(2007-12#1)(2007-8#1)(2008-3#1)(2010-4#1)(2011-1#1)
while taurine##2##2##(1990-7#1)(2011-2#1)
while temperature##3##2##(2008-10#2)(2008-9#1)
while ten##3##2##(1990-12#1)(2007-9#1)(2011-2#1)
while that for##8##3##(1990-12#1)(1991-5#1)(1995-12#1)(1996-12#1)(2007-3#1)(2008-10#1)(2008-7#1)(2012-12#1)
while that from the##2##4##(1991-3#1)(2008-10#1)
while that from##5##3##(1991-3#1)(1994-11#1)(1994-8#1)(1995-11#1)(2008-10#1)
while that in obese##2##4##(1991-1#2)
while that in the##2##4##(1997-1#1)(2010-5#1)
while that in##7##3##(1991-1#2)(1993-2#1)(1997-1#1)(2008-10#1)(2010-5#1)(2013-8#1)
while that of the##14##4##(1990-10#1)(1990-11#1)(1991-10#1)(1991-5#1)(1993-11#1)(1993-2#1)(1993-4#1)(1996-11#1)(1997-6#1)(2004-12#1)(2008-11#1)(2008-5#2)(2008-8#1)
while that of##43##3##(1990-10#1)(1990-11#1)(1991-10#1)(1991-5#2)(1992-1#1)(1992-11#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-4#1)(1994-10#1)(1994-8#1)(1995-7#1)(1996-11#1)(1997-2#1)(1997-6#1)(2004-12#1)(2004-4#1)(2005-11#1)(2006-1#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
while that##73##2##(1990-10#1)(1990-11#1)(1990-12#1)(1991-1#2)(1991-10#1)(1991-3#1)(1991-5#3)(1992-1#1)(1992-11#1)(1992-7#1)(1993-11#1)(1993-2#2)(1993-4#2)(1994-10#1)(1994-11#1)(1994-8#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(2004-12#1)(2004-4#1)(2005-11#1)(2006-1#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#6)(2008-11#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#3)
while the &quot##2##3##(1994-3#1)(2008-10#1)
while the A2##2##3##(2011-2#2)
while the C-terminal##2##3##(1993-12#1)(1996-8#1)
while the Cg1/Cg2 area##2##4##(1991-11#2)
while the ZRs contents of cotton roots##2##7##(2013-8#2)
while the absorption##3##3##(1994-9#1)(2005-4#1)(2007-12#1)
while the activated##2##3##(1990-7#1)(2005-11#1)
while the activities of##2##4##(1997-2#1)(2007-9#1)
while the activity of##2##4##(1990-4#1)(1990-7#1)
while the activity##3##3##(1990-10#1)(1990-4#1)(1990-7#1)
while the addition of##3##4##(1996-2#1)(2007-8#1)(2008-10#1)
while the amount of##2##4##(1997-2#2)
while the amount##3##3##(1997-2#2)(2013-8#1)
while the animal##2##3##(2009-8#1)(2011-2#1)
while the average##3##3##(1995-3#1)(2007-12#1)(2013-1#1)
while the best##2##3##(2008-10#2)
while the beta##2##3##(1990-7#2)
while the binding##2##3##(1991-4#1)(2008-10#1)
while the cells##2##3##(2008-11#1)(2013-1#1)
while the combined##4##3##(1991-9#1)(1992-11#1)(2006-5#1)(2008-6#1)
while the comparative##2##3##(1990-6#1)(2011-2#1)
while the concentration of##4##4##(1992-2#1)(2008-10#1)(2009-2#1)(2010-12#1)
while the concentration##5##3##(1992-2#1)(2007-8#1)(2008-10#1)(2009-2#1)(2010-12#1)
while the concentrations##2##3##(1991-7#1)(2012-1#1)
while the conductivity##2##3##(2008-10#1)(2009-11#1)
while the contralateral side was##2##5##(1997-8#1)(2011-12#1)
while the contralateral##3##3##(1997-8#1)(2011-12#1)(2013-1#1)
while the control group did not##2##6##(2007-10#1)(2008-3#1)
while the control group received##2##5##(2007-2#1)(2008-12#1)
while the control group was##2##5##(2008-12#1)(2009-10#1)
while the control group##6##4##(2007-10#1)(2007-2#1)(2008-12#2)(2008-3#1)(2009-10#1)
while the control##10##3##(2007-10#1)(2007-2#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-5#1)(2013-8#1)
while the corresponding values##2##4##(1991-4#1)(2010-4#1)
while the corresponding##6##3##(1991-4#1)(1991-8#1)(1992-2#1)(2007-8#1)(2010-4#2)
while the data##2##3##(2008-7#1)(2010-2#1)
while the detection limit##2##4##(2008-10#2)
while the detection##4##3##(1995-6#1)(2008-10#3)
while the difference in##2##4##(1994-11#1)(2007-8#1)
while the difference##4##3##(1990-8#1)(1994-11#1)(2007-8#1)(2009-7#1)
while the diffractive performance fundamentally surpasses conventional telescopes because of the absence of pupil obstruction##2##15##(2008-2#1)(2008-3#1)
while the effect on##2##4##(1996-2#1)(2006-10#1)
while the effect##3##3##(1996-2#1)(2006-10#1)(2008-10#1)
while the effects of##2##4##(1993-7#1)(2013-1#1)
while the error##2##3##(2013-1#1)(2013-8#1)
while the expression of##4##4##(1993-9#1)(1994-12#1)(2008-8#1)(2013-8#1)
while the expression##6##3##(1993-9#1)(1994-12#1)(2008-8#2)(2009-6#1)(2013-8#1)
while the extent of##2##4##(2012-12#1)(2013-1#1)
while the favourable outlook of a bicornuate uterus may be offset by the suboptimal implantation across the avascular septum##2##19##(2013-1#2)
while the females##2##3##(2006-9#1)(2013-8#1)
while the final##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2009-2#1)
while the firing rate##2##4##(1995-12#1)(2008-11#1)
while the fluorescence##2##3##(2007-12#1)(2008-4#1)
while the former##3##3##(1996-6#1)(2007-1#1)(2013-7#1)
while the fourth##4##3##(1992-3#1)(1997-5#1)(2008-1#2)
while the free##2##3##(1991-1#1)(1996-8#1)
while the full##2##3##(2007-11#1)(2008-10#1)
while the genetic##2##3##(2007-10#1)(2010-9#1)
while the hemin##2##3##(1994-9#2)
while the high##2##3##(1992-1#1)(2008-10#1)
while the holistic##2##3##(1997-6#2)
while the identity##2##3##(1991-4#1)(1992-9#1)
while the images of##2##4##(2007-12#1)(2009-12#1)
while the incidence of##4##4##(1993-10#1)(2006-2#1)(2010-12#1)(2013-1#1)
while the incidence##5##3##(1993-10#1)(2006-2#1)(2010-12#1)(2011-2#1)(2013-1#1)
while the increase##2##3##(1991-5#1)(2008-5#1)
while the inhibitory effect##2##4##(1993-11#1)(1995-11#1)
while the initial##4##3##(1995-4#1)(1996-10#1)(1997-7#1)(2008-3#1)
while the laser##3##3##(2007-11#1)(2008-3#2)
while the later##2##3##(2005-8#1)(2007-8#1)
while the latter does##2##4##(2006-12#1)(2008-2#1)
while the latter##15##3##(1992-1#1)(1992-2#1)(1992-6#1)(1993-12#1)(1995-6#1)(2006-12#1)(2006-4#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-10#1)(2010-4#1)(2012-2#1)
while the least##3##3##(1991-9#1)(2008-11#1)(2009-5#1)
while the level of##5##4##(1990-11#1)(1996-3#1)(2008-10#1)(2011-1#1)(2013-8#1)
while the levels of##3##4##(1997-7#1)(2007-8#1)(2008-11#1)
while the linear##2##3##(2007-11#1)(2007-8#1)
while the liver##2##3##(2008-4#1)(2008-5#1)
while the low##4##3##(2006-6#1)(2008-2#1)(2008-7#1)(2009-2#1)
while the lowest##7##3##(1996-3#1)(2008-10#2)(2008-11#1)(2008-5#2)(2013-8#1)
while the main##2##3##(1990-3#1)(2007-10#1)
while the majority of##3##4##(2007-8#1)(2008-8#1)(2009-6#1)
while the mean##4##3##(1996-3#1)(2007-10#1)(2007-8#1)(2008-4#1)
while the mid-depth zone decreased from##2##6##(1991-10#2)
while the monoesters##4##3##(1992-12#4)
while the more##2##3##(1990-5#1)(2009-5#1)
while the most common##2##4##(2007-8#1)(2011-2#1)
while the most frequent##2##4##(2008-11#1)(2013-1#1)
while the most##7##3##(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-6#1)(2011-2#1)(2013-1#1)
while the mutant##2##3##(1994-12#1)(1995-8#1)
while the neutral##2##3##(1991-1#1)(2008-10#1)
while the number of##11##4##(1991-8#2)(1994-6#1)(1995-12#1)(1997-7#1)(2007-2#1)(2007-4#1)(2008-11#1)(2008-9#1)(2011-2#1)(2011-7#1)
while the observed##2##3##(2006-10#1)(2008-12#1)
while the one##2##3##(1991-9#1)(2008-10#1)
while the other five##2##4##(2008-10#1)(2008-11#1)
while the other four##3##4##(1995-9#1)(2007-3#1)(2008-1#1)
while the other group of##2##5##(2006-4#1)(2008-5#1)
while the other group##3##4##(1996-2#1)(2006-4#1)(2008-5#1)
while the other half is##2##5##(1994-9#1)(1995-3#1)
while the other is##5##4##(1994-11#1)(2006-12#1)(2007-7#1)(2008-10#1)(2008-2#1)
while the other one is##2##5##(2006-2#1)(2008-11#1)
while the other one##4##4##(2006-2#1)(2008-11#1)(2011-1#1)(2012-1#1)
while the other three##3##4##(1992-4#1)(1997-5#1)(2007-8#1)
while the other two##4##4##(1990-2#1)(1993-4#1)(1995-6#1)(2011-1#1)
while the other with##2##4##(2009-10#1)(2010-11#1)
while the other##62##3##(1990-12#2)(1990-2#2)(1990-5#1)(1992-4#1)(1993-12#1)(1993-4#1)(1994-11#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#1)(1995-9#2)(1996-2#2)(1996-7#1)(1996-9#1)(1997-5#1)(1997-6#1)(2004-9#1)(2005-12#1)(2006-12#2)(2006-2#1)(2006-4#1)(2007-12#2)(2007-3#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-5#1)(2010-11#1)(2010-8#1)(2011-1#2)(2012-1#1)(2013-1#2)
while the others##7##3##(1994-6#1)(1995-2#1)(1997-8#1)(2004-4#1)(2006-10#1)(2007-12#1)(2008-10#1)
while the overall rate##2##4##(1991-11#1)(2007-3#1)
while the overall survival##2##4##(2006-10#1)(2010-3#1)
while the overall##4##3##(1991-11#1)(2006-10#1)(2007-3#1)(2010-3#1)
while the pH##2##3##(2007-3#1)(2008-12#1)
while the patient remains##2##4##(2008-7#1)(2010-7#1)
while the patient was##4##4##(2007-12#1)(2007-7#1)(2010-7#1)(2012-11#1)
while the patient##12##3##(1992-4#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-7#1)(2010-7#2)(2012-11#1)
while the peptide##3##3##(1990-7#1)(1996-7#1)(2008-8#1)
while the percentage of##4##4##(2008-10#1)(2008-11#2)(2011-11#1)
while the performance of the##2##5##(1994-3#1)(2006-11#1)
while the phase##4##3##(2007-11#2)(2008-10#1)(2012-1#1)
while the polar##2##3##(1995-3#1)(2008-10#1)
while the population size##2##4##(2008-10#1)(2008-8#1)
while the population##3##3##(1997-8#1)(2008-10#1)(2008-8#1)
while the potential##2##3##(1995-5#1)(2009-5#1)
while the predominant##3##3##(1991-11#1)(2006-12#1)(2007-3#1)
while the presence of##7##4##(2006-7#1)(2007-1#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2013-8#1)
while the present##2##3##(1990-12#1)(2013-8#1)
while the prevalence of the##2##5##(2013-1#2)
while the prevalence of##3##4##(2006-4#1)(2013-1#2)
while the prevalence##5##3##(1993-3#1)(1996-3#1)(2006-4#1)(2013-1#2)
while the production of##4##4##(1994-8#1)(1995-1#1)(2008-11#1)(2008-5#1)
while the proportions of##2##4##(1990-12#1)(2005-12#1)
while the protein##3##3##(1994-11#1)(1994-9#1)(2008-9#1)
while the rate of detected chromosome##2##6##(2012-3#2)
while the rate of##7##4##(1990-2#1)(1991-2#1)(2007-12#1)(2008-5#1)(2008-7#1)(2012-3#2)
while the rate##9##3##(1990-2#1)(1991-2#1)(1997-7#2)(2007-12#1)(2008-5#1)(2008-7#1)(2012-3#2)
while the reaction##2##3##(1996-5#1)(2008-11#1)
while the relative##3##3##(1991-7#1)(2007-8#1)(2008-10#1)
while the remainder##2##3##(1990-9#1)(1993-11#1)
while the remaining four##2##4##(1991-12#1)(2008-7#1)
while the remaining two##2##4##(1997-3#1)(2004-7#1)
while the remaining##25##3##(1990-4#1)(1991-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-8#1)(1996-10#1)(1996-2#2)(1997-3#1)(2004-7#1)(2004-9#1)(2006-12#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-8#1)
while the response to##3##4##(2008-10#1)(2008-6#1)(2008-8#1)
while the response##4##3##(2008-10#2)(2008-6#1)(2008-8#1)
while the rest were##2##4##(2007-2#1)(2012-12#1)
while the rest##7##3##(1991-7#1)(2006-8#1)(2007-2#1)(2007-7#1)(2010-4#1)(2010-8#1)(2012-12#1)
while the results##4##3##(1992-6#1)(2005-11#1)(2008-11#1)(2012-11#1)
while the right##2##3##(1996-9#1)(2008-11#1)
while the risk of##2##4##(1993-9#1)(2007-2#1)
while the risk##4##3##(1993-9#1)(2007-2#1)(2008-12#1)(2008-8#1)
while the role of##2##4##(2006-10#2)
while the same##4##3##(1996-10#1)(2008-10#1)(2008-11#2)
while the second group##2##4##(2005-10#1)(2009-7#1)
while the second is##5##4##(2006-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)
while the second one##2##4##(2008-10#1)(2008-8#1)
while the second was##2##4##(1993-1#1)(2006-2#1)
while the second##26##3##(1990-2#1)(1992-3#2)(1993-1#1)(1996-2#2)(1997-2#1)(2005-10#2)(2006-10#1)(2006-2#1)(2007-2#1)(2008-10#4)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#3)(2009-7#1)(2013-1#2)
while the secondary structure##2##4##(1991-5#1)(2005-11#1)
while the secondary##4##3##(1990-5#1)(1991-5#1)(2005-11#2)
while the sensitivity##3##3##(1997-3#1)(2008-10#1)(2008-5#1)
while the separation##2##3##(2008-3#1)(2013-1#1)
while the size##2##3##(1997-8#1)(2008-10#1)
while the sliding##2##3##(2006-11#1)(2007-12#1)
while the smaller##3##3##(2008-10#2)(2010-7#1)
while the soil available phosphorus content was##2##7##(2013-8#2)
while the specific##2##3##(2008-11#2)
while the stimulus##2##3##(1995-1#1)(2013-8#1)
while the subject is##3##4##(2008-7#2)(2010-8#1)
while the subject##4##3##(2007-10#1)(2008-7#2)(2010-8#1)
while the system##2##3##(1991-8#1)(2008-10#1)
while the systemic##2##3##(2006-10#1)(2007-8#1)
while the temperature##3##3##(2008-10#1)(2008-5#1)(2010-6#1)
while the third group##2##4##(2009-5#2)
while the third is##2##4##(1996-4#1)(1997-1#1)
while the third##11##3##(1992-3#1)(1993-4#1)(1996-4#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-5#2)(2012-11#1)
while the thoron concentration in the same dwellings varied from##2##10##(2008-1#2)
while the total number of##2##5##(1990-6#1)(1991-9#1)
while the total##5##3##(1990-6#1)(1991-9#1)(2004-2#1)(2008-10#2)
while the two##3##3##(1992-11#1)(2008-6#1)(2011-2#1)
while the upper##2##3##(2006-11#1)(2010-2#1)
while the uptake##2##3##(1993-12#1)(1995-11#1)
while the urine##2##3##(1992-7#1)(2007-8#1)
while the variation of transmission among ten gratings is 0##2##10##(2013-8#2)
while the water##2##3##(2004-4#1)(2008-10#1)
while the well-known##2##3##(1994-2#1)(1996-10#1)
while the wild type##2##4##(1991-7#1)(2008-10#1)
while the yeast##2##3##(2009-5#1)(2011-2#1)
while the##1168##2##(1990-1#1)(1990-10#3)(1990-11#3)(1990-12#8)(1990-2#5)(1990-3#3)(1990-4#3)(1990-5#5)(1990-6#2)(1990-7#8)(1990-8#2)(1990-9#2)(1991-1#4)(1991-10#5)(1991-11#7)(1991-12#3)(1991-2#10)(1991-3#1)(1991-4#5)(1991-5#4)(1991-7#4)(1991-8#6)(1991-9#5)(1992-1#2)(1992-10#1)(1992-11#4)(1992-12#7)(1992-2#5)(1992-3#5)(1992-4#3)(1992-6#5)(1992-7#4)(1992-8#2)(1992-9#4)(1993-1#1)(1993-10#1)(1993-11#9)(1993-12#11)(1993-2#1)(1993-3#6)(1993-4#2)(1993-5#1)(1993-7#2)(1993-8#3)(1993-9#4)(1994-10#1)(1994-11#6)(1994-12#4)(1994-2#4)(1994-3#6)(1994-5#1)(1994-6#5)(1994-7#1)(1994-8#5)(1994-9#11)(1995-1#5)(1995-10#1)(1995-11#5)(1995-12#7)(1995-2#9)(1995-3#6)(1995-4#2)(1995-5#5)(1995-6#7)(1995-8#4)(1995-9#2)(1996-10#5)(1996-11#3)(1996-12#4)(1996-2#10)(1996-3#13)(1996-4#1)(1996-5#4)(1996-6#4)(1996-7#6)(1996-8#5)(1996-9#4)(1997-1#3)(1997-2#10)(1997-3#7)(1997-4#2)(1997-5#4)(1997-6#8)(1997-7#10)(1997-8#11)(2004-2#1)(2004-4#3)(2004-7#1)(2004-9#4)(2005-10#2)(2005-11#13)(2005-12#3)(2005-4#6)(2005-5#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#15)(2006-11#10)(2006-12#9)(2006-2#5)(2006-4#6)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#7)(2006-9#1)(2007-1#4)(2007-10#8)(2007-11#13)(2007-12#23)(2007-2#8)(2007-3#13)(2007-4#6)(2007-5#3)(2007-6#2)(2007-7#11)(2007-8#28)(2007-9#6)(2008-1#12)(2008-10#107)(2008-11#36)(2008-12#10)(2008-2#18)(2008-3#11)(2008-4#15)(2008-5#35)(2008-6#9)(2008-7#18)(2008-8#26)(2008-9#15)(2009-10#6)(2009-11#3)(2009-12#1)(2009-2#6)(2009-3#6)(2009-4#2)(2009-5#9)(2009-6#6)(2009-7#7)(2009-8#6)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#9)(2010-2#6)(2010-3#2)(2010-4#5)(2010-5#6)(2010-6#2)(2010-7#4)(2010-8#4)(2010-9#4)(2011-1#10)(2011-11#1)(2011-12#1)(2011-2#21)(2011-3#1)(2011-7#1)(2012-1#9)(2012-11#5)(2012-12#5)(2012-2#15)(2012-3#4)(2013-1#32)(2013-7#8)(2013-8#28)
while their##19##2##(1990-4#1)(1991-12#1)(1993-12#2)(1993-7#1)(1995-1#2)(1997-2#1)(1997-4#1)(1997-5#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2010-12#1)(2011-1#1)
while there are##3##3##(1995-12#1)(2006-12#1)(2009-10#1)
while there have been##2##4##(1991-3#1)(2009-10#1)
while there is still##2##4##(2007-12#1)(2012-3#1)
while there is##6##3##(1993-11#1)(1997-5#1)(2007-12#1)(2007-3#1)(2009-6#1)(2012-3#1)
while there was a##7##4##(1990-12#1)(1992-7#1)(2006-8#1)(2008-11#1)(2009-5#1)(2009-6#1)(2011-2#1)
while there was no change in##3##6##(1991-8#1)(1992-1#1)(2013-8#1)
while there was no##8##4##(1990-3#1)(1991-8#1)(1992-1#1)(2008-11#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-8#1)
while there was##19##3##(1990-12#1)(1990-3#1)(1991-8#1)(1992-1#1)(1992-7#1)(2006-8#2)(2007-7#1)(2008-10#1)(2008-11#2)(2008-7#2)(2009-5#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
while there were##3##3##(1997-7#1)(2008-4#1)(2009-4#1)
while there##36##2##(1990-12#1)(1990-3#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-7#1)(1993-11#1)(1994-11#1)(1995-12#1)(1997-5#1)(1997-7#1)(2006-12#1)(2006-8#2)(2007-1#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#2)(2009-10#2)(2009-4#1)(2009-5#1)(2009-6#2)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
while these##5##2##(1993-9#1)(1994-11#1)(2008-11#1)(2008-12#1)(2011-10#1)
while they are##12##3##(1996-2#1)(1996-7#1)(1996-8#1)(1997-1#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-3#1)(2010-7#1)
while they did not##2##4##(1994-3#1)(2008-10#1)
while they have##2##3##(2006-2#1)(2013-8#1)
while they viewed##2##3##(2008-11#1)(2012-2#1)
while they were##10##3##(1992-9#1)(1994-3#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-4#1)(2007-6#1)(2013-8#2)
while they##48##2##(1990-11#1)(1990-8#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-3#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#2)(1997-4#1)(2006-2#1)(2006-9#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-10#5)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-8#3)
while this was##2##3##(2012-1#1)(2012-12#1)
while this##13##2##(1990-4#1)(1992-5#1)(1996-5#1)(1997-3#1)(2008-10#2)(2008-12#1)(2010-5#1)(2012-1#1)(2012-12#3)(2012-2#1)
while those for the##3##4##(1990-8#1)(1995-10#1)(1996-2#1)
while those for##4##3##(1990-6#1)(1990-8#1)(1995-10#1)(1996-2#1)
while those from the##2##4##(2008-10#1)(2013-8#1)
while those from##4##3##(2008-10#2)(2008-11#1)(2013-8#1)
while those in the##4##4##(1990-8#1)(1993-9#1)(1997-8#1)(2008-7#1)
while those in##8##3##(1990-8#1)(1993-9#1)(1997-8#1)(2007-2#1)(2008-10#2)(2008-7#1)(2012-3#1)
while those of the##3##4##(1990-3#1)(1992-3#1)(2008-2#1)
while those of##18##3##(1990-12#1)(1990-3#1)(1990-5#1)(1992-3#1)(1992-6#1)(1997-5#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-8#1)(2009-3#2)(2009-6#1)(2009-9#1)(2013-8#1)
while those who had##2##4##(2007-2#1)(2007-3#1)
while those who##3##3##(2007-2#1)(2007-3#1)(2007-9#1)
while those with##6##3##(1993-5#1)(1994-11#1)(1996-2#1)(2007-5#1)(2008-10#1)(2009-8#1)
while those without##2##3##(2008-3#1)(2008-7#1)
while those##65##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-11#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-10#1)(1995-12#1)(1996-2#3)(1996-5#1)(1997-5#1)(1997-8#1)(2004-2#1)(2007-2#2)(2007-3#1)(2007-5#1)(2007-9#3)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#2)(2008-8#1)(2009-3#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-8#1)(2012-2#1)(2012-3#2)(2013-8#2)
while three##8##2##(1992-2#1)(1993-6#1)(1994-3#1)(2007-3#1)(2007-8#1)(2008-10#2)(2013-1#1)
while time##2##2##(2006-6#1)(2008-5#1)
while tissue##3##2##(1992-3#1)(1996-12#1)(2009-3#1)
while total##8##2##(1993-12#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-8#1)(2007-5#1)(2008-5#1)(2012-7#1)
while traditional##2##2##(2007-7#1)(2008-5#1)
while transferrin##2##2##(1997-7#1)(2006-8#1)
while transporting##2##2##(1996-3#1)(2009-8#1)
while treating##2##2##(2011-2#1)(2013-8#1)
while treatment##2##2##(1995-1#1)(1996-3#1)
while trying to##2##3##(2008-5#1)(2010-12#1)
while two other##3##3##(1993-12#1)(1995-6#1)(2007-8#1)
while two others##2##3##(1991-4#1)(1996-5#1)
while two##20##2##(1991-3#1)(1991-4#1)(1993-12#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-5#1)(1996-9#1)(1997-8#1)(2006-5#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-8#2)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
while type##3##2##(1991-12#1)(1997-4#1)(2011-2#1)
while typically##2##2##(1991-9#1)(2009-4#1)
while under the influence of alcohol##2##6##(2008-7#1)(2013-8#1)
while under the influence of psilocybin##2##6##(2013-8#2)
while under the influence of##4##5##(2008-7#1)(2013-8#3)
while under##8##2##(1991-4#1)(2007-4#1)(2007-5#1)(2008-7#1)(2008-9#1)(2013-8#3)
while undergoing##6##2##(2006-2#1)(2007-5#1)(2009-12#1)(2010-11#1)(2010-12#1)(2013-1#1)
while unilateral##2##2##(1990-5#1)(1991-5#1)
while unladen##2##2##(2008-9#2)
while untreated##2##2##(1996-1#1)(2010-11#1)
while unwanted or exaggerated immune responses are prevented##2##8##(2008-3#1)(2008-4#1)
while upon##2##2##(1992-6#1)(1994-12#1)
while urine##2##2##(1993-4#1)(2009-12#1)
while using an##2##3##(2004-9#1)(2011-2#1)
while using the##3##3##(2004-3#1)(2010-10#1)(2012-1#1)
while using##19##2##(1992-11#1)(1992-2#1)(1993-2#1)(2004-3#1)(2004-9#1)(2007-1#1)(2007-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-9#1)(2011-2#3)(2012-1#2)(2012-2#1)(2013-8#1)
while values##2##2##(1990-2#1)(2008-12#1)
while various##2##2##(1991-4#1)(2011-3#1)
while varying the##4##3##(1993-5#1)(2008-10#2)(2008-8#1)
while varying##6##2##(1991-2#1)(1993-5#1)(2008-10#3)(2008-8#1)
while very low##3##3##(1996-8#1)(2005-8#1)(2011-2#1)
while very##4##2##(1996-8#1)(1997-3#1)(2005-8#1)(2011-2#1)
while waiting for##2##3##(2006-9#1)(2013-8#1)
while walking with##2##3##(2012-1#1)(2012-12#1)
while walking##3##2##(2012-1#2)(2012-12#1)
while we##4##2##(1996-6#1)(2008-11#1)(2008-3#1)(2011-1#1)
while wild-type##2##2##(2006-12#1)(2011-1#1)
while with the##2##3##(1992-3#1)(2008-10#1)
while with##5##2##(1990-2#1)(1992-3#1)(1996-3#1)(2007-10#1)(2008-10#1)
while witnessing violence##2##3##(2009-7#2)
while women##3##2##(2006-8#1)(2007-7#1)(2010-3#1)
while working##3##2##(2007-2#1)(2011-2#1)(2012-12#1)
while zinc##2##2##(1993-4#1)(2007-8#1)
while##5413##1##(1990-1#4)(1990-10#10)(1990-11#19)(1990-12#27)(1990-2#15)(1990-3#23)(1990-4#14)(1990-5#18)(1990-6#12)(1990-7#23)(1990-8#14)(1990-9#11)(1991-1#13)(1991-10#9)(1991-11#15)(1991-12#34)(1991-2#29)(1991-3#24)(1991-4#16)(1991-5#26)(1991-6#11)(1991-7#14)(1991-8#19)(1991-9#17)(1992-1#12)(1992-10#5)(1992-11#17)(1992-12#17)(1992-2#18)(1992-3#29)(1992-4#9)(1992-5#8)(1992-6#21)(1992-7#18)(1992-8#20)(1992-9#17)(1993-1#8)(1993-10#5)(1993-11#19)(1993-12#37)(1993-2#14)(1993-3#27)(1993-4#11)(1993-5#9)(1993-6#18)(1993-7#12)(1993-8#18)(1993-9#20)(1994-1#3)(1994-10#7)(1994-11#37)(1994-12#23)(1994-2#23)(1994-3#31)(1994-4#4)(1994-5#15)(1994-6#25)(1994-7#4)(1994-8#22)(1994-9#30)(1995-1#19)(1995-10#6)(1995-11#19)(1995-12#36)(1995-2#24)(1995-3#31)(1995-4#5)(1995-5#20)(1995-6#18)(1995-7#5)(1995-8#18)(1995-9#6)(1996-1#12)(1996-10#13)(1996-11#17)(1996-12#33)(1996-2#35)(1996-3#31)(1996-4#9)(1996-5#31)(1996-6#17)(1996-7#16)(1996-8#18)(1996-9#22)(1997-1#23)(1997-2#30)(1997-3#24)(1997-4#20)(1997-5#23)(1997-6#27)(1997-7#33)(1997-8#28)(2003-11#3)(2004-1#5)(2004-11#1)(2004-12#1)(2004-2#7)(2004-3#2)(2004-4#9)(2004-7#1)(2004-9#11)(2005-10#12)(2005-11#54)(2005-12#16)(2005-4#8)(2005-5#3)(2005-7#6)(2005-8#10)(2005-9#5)(2006-1#11)(2006-10#56)(2006-11#21)(2006-12#43)(2006-2#23)(2006-3#5)(2006-4#14)(2006-5#18)(2006-6#23)(2006-7#6)(2006-8#40)(2006-9#9)(2007-1#27)(2007-10#30)(2007-11#66)(2007-12#94)(2007-2#31)(2007-3#34)(2007-4#19)(2007-5#26)(2007-6#15)(2007-7#89)(2007-8#89)(2007-9#20)(2008-1#60)(2008-10#405)(2008-11#155)(2008-12#42)(2008-2#82)(2008-3#89)(2008-4#95)(2008-5#127)(2008-6#42)(2008-7#96)(2008-8#101)(2008-9#79)(2009-1#2)(2009-10#22)(2009-11#14)(2009-12#18)(2009-2#21)(2009-3#28)(2009-4#31)(2009-5#36)(2009-6#20)(2009-7#25)(2009-8#26)(2009-9#21)(2010-1#7)(2010-10#9)(2010-11#20)(2010-12#51)(2010-2#30)(2010-3#17)(2010-4#32)(2010-5#28)(2010-6#7)(2010-7#20)(2010-8#31)(2010-9#21)(2011-1#78)(2011-10#3)(2011-11#5)(2011-12#13)(2011-2#125)(2011-3#6)(2011-7#1)(2012-1#45)(2012-11#17)(2012-12#80)(2012-2#108)(2012-3#52)(2012-5#1)(2012-6#2)(2012-7#2)(2013-1#175)(2013-7#35)(2013-8#93)
whilst 18%##2##2##(2006-8#1)(2008-1#1)
whilst allowing##4##2##(1997-8#1)(2011-2#1)(2013-1#2)
whilst also##3##2##(1993-8#1)(2011-1#1)(2012-8#1)
whilst being##2##2##(1993-9#1)(2013-1#1)
whilst for the##3##3##(1996-9#1)(2008-10#1)(2012-12#1)
whilst having##2##2##(1995-11#1)(2010-8#1)
whilst in the##3##3##(1993-2#1)(2008-12#1)(2008-5#1)
whilst in##10##2##(1993-2#1)(1994-2#1)(1997-8#1)(2004-9#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2012-3#1)
whilst no##2##2##(1994-2#1)(1997-7#1)
whilst on##2##2##(2007-11#1)(2008-11#1)
whilst other##3##2##(2008-1#1)(2009-9#1)(2012-1#1)
whilst reducing##2##2##(1990-10#1)(2006-5#1)
whilst the##30##2##(1991-10#1)(1991-8#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-8#2)(1997-2#2)(1997-7#1)(2004-10#1)(2004-4#1)(2006-12#2)(2007-5#2)(2007-6#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2012-12#2)(2012-2#1)(2013-7#1)
whilst there are##2##3##(2007-8#2)
whilst there##3##2##(2007-8#2)(2012-3#1)
whilst those in##2##3##(2007-11#1)(2012-12#1)
whilst those##5##2##(1991-10#1)(1996-9#1)(2006-2#1)(2007-11#1)(2012-12#1)
whilst##179##1##(1990-10#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-10#2)(1991-2#2)(1991-8#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-2#4)(1994-3#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#3)(1995-9#1)(1996-11#1)(1996-12#1)(1996-9#2)(1997-2#4)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#4)(2004-10#1)(2004-2#1)(2004-4#2)(2004-7#1)(2004-9#1)(2005-12#1)(2006-10#1)(2006-12#3)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#4)(2007-11#3)(2007-2#1)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#13)(2008-11#8)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#9)(2008-6#4)(2008-7#2)(2008-8#6)(2009-2#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#3)(2012-12#7)(2012-2#3)(2012-3#3)(2012-8#1)(2013-1#4)(2013-7#2)(2013-8#1)
whining##2##1##(1993-11#1)(2007-4#1)
whiplash induced cervical radicular pain##3##5##(2006-8#3)
whiplash injuries##3##2##(1993-3#1)(2007-11#1)(2008-4#1)
whiplash injuries]##2##2##(1992-3#1)(1993-9#1)
whiplash injury##7##2##(1991-6#1)(2006-11#1)(2007-1#2)(2007-4#2)(2013-1#1)
whiplash protection##2##2##(2006-11#2)
whiplash syndrome##3##2##(2007-11#1)(2008-12#2)
whiplash##29##1##(1991-6#1)(1992-3#1)(1993-3#2)(1993-9#1)(2006-10#1)(2006-11#3)(2006-8#3)(2007-1#5)(2007-11#2)(2007-4#4)(2007-6#1)(2008-12#2)(2008-4#1)(2011-2#1)(2013-1#1)
whiplash&quot##3##1##(1994-4#1)(2007-11#2)
whirling disease##2##2##(2012-3#2)
whirlpool bath]##2##2##(1992-11#2)
whirlpool##5##1##(1992-11#2)(1997-1#3)
whirlpool-spas##2##1##(1992-11#2)
whirlpools should be##2##3##(1992-11#2)
whirlpools##5##1##(1992-11#4)(2005-12#1)
whisker stimulation##3##2##(1997-3#3)
whisker##8##1##(1995-5#2)(1997-3#3)(2009-7#3)
whiskers were##2##2##(1994-2#1)(1995-5#1)
whiskers##16##1##(1994-2#4)(1995-5#1)(1997-3#1)(2006-12#1)(2008-10#6)(2009-7#3)
whisking output##2##2##(2013-1#2)
whisking##6##1##(2013-1#6)
whispering gallery modes##4##3##(2006-12#1)(2007-12#2)(2008-3#1)
whispering gallery##5##2##(2006-12#2)(2007-12#2)(2008-3#1)
whispering##6##1##(2006-12#2)(2007-12#3)(2008-3#1)
whispering-gallery mode##3##2##(2007-12#1)(2011-1#2)
whispering-gallery modes (WGMs)##4##3##(2007-11#2)(2007-12#1)(2009-6#1)
whispering-gallery modes in##2##3##(2007-11#1)(2007-12#1)
whispering-gallery modes of##5##3##(2007-11#2)(2007-12#3)
whispering-gallery modes##25##2##(2007-11#9)(2007-12#15)(2009-6#1)
whispering-gallery##29##1##(2007-11#9)(2007-12#17)(2009-6#1)(2011-1#2)
whispering-gallery-mode##4##1##(2007-11#1)(2007-12#2)(2008-3#1)
whistleblowing##5##1##(2011-1#4)(2013-8#1)
whistling##3##1##(1996-3#1)(2008-2#2)
white American##2##2##(1994-2#1)(2008-6#1)
white Americans##2##2##(1996-2#1)(2010-7#1)
white Gaussian noise##4##3##(1991-12#1)(2007-12#1)(2008-2#1)(2008-3#1)
white Gaussian##6##2##(1991-12#1)(2007-12#3)(2008-2#1)(2008-3#1)
white MTA##2##2##(2010-8#1)(2013-1#1)
white New Zealand rabbits##3##4##(1992-3#2)(2011-2#1)
white adipose tissue##4##3##(2008-10#1)(2010-10#1)(2011-12#1)(2012-2#1)
white adults##5##2##(2007-8#2)(2011-1#1)(2011-2#2)
white and black##3##3##(2010-9#1)(2012-11#1)(2012-2#1)
white and gray matter##2##4##(1992-8#1)(2007-1#1)
white and gray##3##3##(1992-8#1)(2007-1#1)(2012-11#1)
white and minority##2##3##(2007-2#1)(2010-11#1)
white and red wines##2##4##(2008-10#2)
white and red##4##3##(1992-2#1)(2008-10#3)
white and yellow##2##3##(2008-12#1)(2009-10#1)
white and##24##2##(1991-12#1)(1992-2#1)(1992-8#1)(2007-1#1)(2007-2#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-11#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-2#1)
white background##3##2##(1993-5#1)(2006-8#1)(2008-2#1)
white blood cell (WBC) count and##2##6##(2007-10#1)(2007-9#1)
white blood cell (WBC) count##6##5##(1995-12#1)(2007-10#1)(2007-9#2)(2008-10#1)(2012-12#1)
white blood cell (WBC)##9##4##(1995-12#1)(2005-10#1)(2007-10#2)(2007-9#2)(2008-10#2)(2012-12#1)
white blood cell and##2##4##(1995-2#1)(2008-10#1)
white blood cell count (WBC)##4##5##(2012-12#1)(2013-1#3)
white blood cell count and##2##5##(1990-12#1)(2005-12#1)
white blood cell count of##3##5##(2006-4#1)(2008-10#1)(2008-7#1)
white blood cell count with##2##5##(2007-10#1)(2011-2#1)
white blood cell count##18##4##(1990-12#1)(1997-3#1)(2005-12#1)(2005-8#1)(2006-4#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#4)(2013-8#1)
white blood cell counts and##2##5##(2007-12#1)(2011-1#1)
white blood cell counts##8##4##(1997-3#1)(2006-10#3)(2007-12#1)(2008-5#1)(2009-7#1)(2011-1#1)
white blood cell differentials##3##4##(2008-10#3)
white blood cell##48##3##(1990-12#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-3#2)(2005-10#1)(2005-12#1)(2005-8#1)(2006-10#3)(2006-4#1)(2007-10#3)(2007-12#2)(2007-9#2)(2008-10#7)(2008-4#1)(2008-5#3)(2008-7#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#4)(2013-8#1)
white blood cells (WBC)##4##4##(1991-9#1)(1992-5#1)(2008-1#1)(2009-10#1)
white blood cells (WBCs)##3##4##(2007-9#1)(2009-11#1)(2009-4#1)
white blood cells and##3##4##(2008-9#1)(2012-12#1)(2013-7#1)
white blood cells as##2##4##(1994-8#1)(2009-4#1)
white blood cells in##4##4##(1990-12#1)(1996-9#1)(2008-9#1)(2012-1#1)
white blood cells or##2##4##(1991-11#1)(2005-6#1)
white blood cells##36##3##(1990-12#1)(1991-11#1)(1991-9#1)(1992-5#1)(1994-8#2)(1996-3#2)(1996-9#1)(1997-4#1)(2005-6#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#3)(2009-10#2)(2009-11#1)(2009-4#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#2)
white blood count##4##3##(1990-9#1)(2005-10#2)(2007-8#1)
white blood##89##2##(1990-12#2)(1990-9#1)(1991-11#1)(1991-9#1)(1992-4#1)(1992-5#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#2)(1996-9#1)(1997-3#2)(1997-4#1)(2005-10#3)(2005-12#1)(2005-6#1)(2005-8#1)(2006-10#4)(2006-4#1)(2006-7#1)(2007-10#3)(2007-12#3)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#8)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#3)(2009-10#2)(2009-11#1)(2009-4#2)(2009-7#1)(2010-12#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#3)
white boys##2##2##(2010-11#1)(2013-1#1)
white cell count##4##3##(1992-2#1)(1994-3#1)(2007-11#1)(2010-2#1)
white cell counts##5##3##(1997-6#1)(2006-10#3)(2009-5#1)
white cell##12##2##(1991-3#2)(1992-2#1)(1994-3#1)(1997-6#1)(2006-10#3)(2007-11#1)(2008-10#1)(2009-5#1)(2010-2#1)
white cells##5##2##(1991-3#1)(1997-6#1)(2008-4#1)(2008-5#1)(2008-9#1)
white cloud mountain minnow##4##4##(2010-5#4)
white coat effect##2##3##(2008-7#2)
white coat hypertension##2##3##(2008-7#2)
white coat##7##2##(2005-4#1)(2007-5#1)(2007-9#1)(2008-7#4)
white collar##2##2##(1991-8#1)(2007-10#1)
white counterparts##2##2##(2007-6#1)(2007-7#1)
white crests##3##2##(2008-9#3)
white female with##2##3##(2006-10#1)(2008-7#1)
white female##5##2##(2006-10#1)(2007-11#1)(2007-4#1)(2008-7#1)(2012-12#1)
white females##2##2##(1992-5#1)(2008-5#1)
white fir##9##2##(2008-10#9)
white follicles##4##2##(2008-12#4)
white forelock##2##2##(2008-7#1)(2008-9#1)
white gene##3##2##(1997-1#2)(2012-12#1)
white grubs in a Fraser fir##2##6##(2011-2#2)
white in##2##2##(1995-6#1)(2008-10#1)
white leaf##3##2##(2008-10#3)
white leghorn chickens##2##3##(1997-6#1)(2008-5#1)
white leghorn##3##2##(1997-6#2)(2008-5#1)
white lies##3##2##(2008-1#3)
white light and##2##3##(2008-2#1)(2008-5#1)
white light bronchoscopy (WLB)##2##4##(2007-8#1)(2008-5#1)
white light bronchoscopy##3##3##(2007-8#1)(2008-5#2)
white light endoscopy##2##3##(2008-5#2)
white light##32##2##(1992-7#2)(2006-5#1)(2007-11#3)(2007-12#5)(2007-8#1)(2008-1#1)(2008-2#5)(2008-3#3)(2008-5#6)(2009-4#1)(2011-1#1)(2012-2#1)(2013-1#2)
white maize food##2##3##(1997-4#2)
white male albino rats##2##4##(2008-10#2)
white male##8##2##(1992-6#1)(1994-12#2)(2006-10#1)(2006-12#1)(2008-1#1)(2008-10#2)
white man was##2##3##(2007-5#1)(2007-7#1)
white man with##2##3##(1992-2#1)(2007-9#1)
white man##6##2##(1992-2#1)(2007-5#1)(2007-7#1)(2007-9#1)(2011-2#1)(2012-12#1)
white matter abnormalities##4##3##(1996-3#1)(2008-8#1)(2012-12#2)
white matter and##8##3##(1991-12#1)(1992-7#1)(1995-5#1)(1995-8#1)(1996-5#1)(2007-11#1)(2008-7#1)(2012-1#1)
white matter atrophy##4##3##(1992-12#3)(2008-11#1)
white matter damage##2##3##(2005-10#1)(2007-9#1)
white matter hyperintensity##2##3##(2004-11#1)(2012-2#1)
white matter in the##2##4##(1991-12#1)(2011-1#1)
white matter lacunar##2##3##(2007-10#1)(2009-10#1)
white matter lesions##5##3##(1991-12#1)(2006-10#1)(2007-10#3)
white matter of patients with##2##5##(2007-10#2)
white matter of the##5##4##(1996-7#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)
white matter of##8##3##(1996-7#1)(2006-1#1)(2007-10#2)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)
white matter tracts##5##3##(1996-1#1)(1996-7#1)(2005-10#1)(2009-9#1)(2012-1#1)
white matter was##3##3##(1996-5#1)(2010-12#1)(2011-1#1)
white matter were##3##3##(1990-7#1)(1996-11#1)(2007-4#1)
white matter##122##2##(1990-5#1)(1990-7#2)(1991-10#1)(1991-12#3)(1992-12#4)(1992-7#3)(1992-8#2)(1993-12#2)(1993-6#1)(1995-11#1)(1995-12#1)(1995-5#2)(1995-8#4)(1996-1#1)(1996-11#2)(1996-3#2)(1996-5#3)(1996-7#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2004-11#1)(2004-12#1)(2005-10#3)(2005-7#1)(2006-1#1)(2006-10#1)(2007-1#2)(2007-10#12)(2007-11#2)(2007-12#1)(2007-4#1)(2007-5#3)(2007-9#1)(2008-11#2)(2008-3#2)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#5)(2009-12#1)(2009-7#1)(2009-9#4)(2010-12#10)(2010-6#1)(2010-9#1)(2011-1#4)(2012-1#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
white men##8##2##(1990-3#1)(1996-9#1)(2008-1#1)(2009-5#1)(2009-7#1)(2013-7#3)
white mineral trioxide aggregate##2##4##(2012-2#1)(2013-1#1)
white mold##4##2##(2008-10#2)(2012-2#2)
white muscle and##2##3##(1997-7#1)(2009-4#1)
white muscle of the##2##4##(1992-12#1)(2009-4#1)
white muscle of##4##3##(1992-12#1)(2008-8#2)(2009-4#1)
white muscle##12##2##(1992-12#1)(1997-7#1)(2008-8#2)(2009-4#4)(2010-1#1)(2010-8#1)(2013-1#2)
white mutant##2##2##(2008-8#1)(2009-10#1)
white noise##14##2##(1991-1#2)(1991-12#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-2#6)(2008-3#1)(2012-2#1)
white oak##4##2##(2004-4#3)(2005-10#1)
white or##3##2##(1997-7#1)(2008-5#1)(2011-2#1)
white paper##9##2##(2006-10#1)(2007-12#1)(2007-4#2)(2008-3#1)(2012-12#1)(2012-2#3)
white papers##2##2##(1996-2#2)
white patients with##2##3##(1992-2#1)(2007-9#1)
white patients##6##2##(1992-2#1)(1995-12#1)(2005-10#1)(2007-8#1)(2007-9#2)
white phenotype##3##2##(1995-2#1)(1997-5#1)(2005-11#1)
white pine (P##2##3##(2008-10#2)
white pine (Pinus##5##3##(2008-10#5)
white pine blister rust##17##4##(2008-10#17)
white pine blister##18##3##(2008-10#18)
white pine species##2##3##(2008-10#2)
white pine##38##2##(2008-10#38)
white plague##5##2##(2007-3#1)(2007-5#3)(2011-2#1)
white population##2##2##(2011-2#2)
white populations##2##2##(1995-12#1)(1995-4#1)
white powder##2##2##(2009-8#1)(2010-8#1)
white pulp##4##2##(1995-1#1)(2008-7#1)(2010-12#2)
white race##3##2##(2007-8#1)(2008-5#1)(2012-2#1)
white rat##2##2##(2005-10#1)(2006-7#1)
white rot fungus##4##3##(1991-2#1)(2005-12#1)(2008-6#1)(2009-9#1)
white rot##8##2##(1991-2#1)(2005-12#1)(2008-10#2)(2008-6#1)(2009-9#3)
white sea catfish##2##3##(2008-10#2)
white shrimp##5##2##(2007-3#2)(2008-5#3)
white spot lesion formation##3##4##(2009-7#3)
white spot lesion##4##3##(2009-7#4)
white spot##5##2##(2009-7#5)
white spruce##2##2##(2008-10#2)
white subjects##2##2##(1997-4#1)(2008-4#1)
white thrombi##4##2##(2008-5#4)
white to##3##2##(1993-5#1)(2008-10#2)
white were##2##2##(2008-10#1)(2010-11#1)
white wine samples##2##3##(2008-10#2)
white wine##7##2##(2008-10#7)
white wines by their##2##4##(2008-10#2)
white wines##12##2##(2008-10#12)
white woman##3##2##(2006-12#1)(2007-10#1)(2008-11#1)
white women in the##2##4##(2007-7#2)
white women in##3##3##(2007-7#2)(2009-10#1)
white women##7##2##(1996-9#1)(2006-1#1)(2007-2#1)(2007-7#2)(2009-10#1)(2011-2#1)
white zebra finches##4##3##(1996-1#4)
white##795##1##(1990-10#1)(1990-12#5)(1990-3#1)(1990-5#1)(1990-7#3)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#3)(1991-12#6)(1991-2#1)(1991-3#4)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#6)(1992-2#4)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#1)(1992-7#5)(1992-8#5)(1992-9#2)(1993-1#1)(1993-12#3)(1993-3#1)(1993-5#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#5)(1995-2#5)(1995-4#2)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#4)(1996-1#6)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#5)(1996-4#1)(1996-5#5)(1996-7#3)(1996-9#3)(1997-1#5)(1997-2#3)(1997-3#3)(1997-4#5)(1997-5#5)(1997-6#5)(1997-7#2)(1997-8#1)(2004-11#3)(2004-12#1)(2004-4#5)(2004-9#1)(2005-10#9)(2005-11#2)(2005-12#2)(2005-4#3)(2005-6#1)(2005-7#1)(2005-8#1)(2006-1#3)(2006-10#12)(2006-12#4)(2006-2#1)(2006-4#5)(2006-5#1)(2006-7#3)(2006-8#3)(2007-1#3)(2007-10#18)(2007-11#7)(2007-12#15)(2007-2#3)(2007-3#5)(2007-4#4)(2007-5#8)(2007-6#1)(2007-7#7)(2007-8#8)(2007-9#9)(2008-1#9)(2008-10#133)(2008-11#9)(2008-12#9)(2008-2#17)(2008-3#13)(2008-4#3)(2008-5#39)(2008-6#7)(2008-7#15)(2008-8#8)(2008-9#14)(2009-10#12)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#8)(2009-5#4)(2009-7#11)(2009-8#1)(2009-9#8)(2010-1#1)(2010-10#1)(2010-11#5)(2010-12#13)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#11)(2010-9#2)(2011-1#10)(2011-12#2)(2011-2#22)(2012-1#5)(2012-11#3)(2012-12#15)(2012-2#17)(2012-3#5)(2013-1#15)(2013-7#5)(2013-8#5)
white)##9##1##(1992-7#1)(1992-8#1)(2007-10#1)(2007-8#1)(2010-8#1)(2012-11#1)(2012-12#2)(2013-1#1)
white-collar##2##1##(2012-1#1)(2013-1#1)
white-light Mach-Zehnder interferometer##2##3##(2008-2#2)
white-light continuum pulses##3##3##(2007-12#3)
white-light continuum##12##2##(2007-11#3)(2007-12#7)(2008-1#1)(2008-2#1)
white-light illumination##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
white-light interferometer##4##2##(2008-2#3)(2008-3#1)
white-light interferometric sensors##2##3##(2008-2#2)
white-light interferometric##4##2##(2007-12#1)(2008-2#3)
white-light interferometry##11##2##(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#5)
white-light source##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
white-light##67##1##(2007-11#11)(2007-12#13)(2008-1#3)(2008-2#20)(2008-3#18)(2008-5#1)(2009-3#1)
white-lipped##4##1##(2007-2#1)(2008-5#3)
white-matter##3##1##(2008-9#1)(2009-10#1)(2010-9#1)
white-noise##3##1##(2007-11#1)(2008-3#1)(2008-7#1)
white-noise-like images##2##2##(2008-3#2)
white-noise-like##3##1##(2008-3#3)
white-pupil##2##1##(2008-3#2)
white-rot fungi##3##2##(1990-4#1)(2008-5#2)
white-rot fungus##6##2##(1991-8#2)(1997-7#1)(2006-3#1)(2008-11#1)(2011-1#1)
white-rot##9##1##(1990-4#1)(1991-8#2)(1997-7#1)(2006-3#1)(2008-11#1)(2008-5#2)(2011-1#1)
white-tailed deer##3##2##(2004-11#2)(2013-7#1)
white-tailed##4##1##(2004-11#2)(2008-5#1)(2013-7#1)
whitecaps##2##1##(2008-2#1)(2008-3#1)
whiteflies that##4##2##(2008-10#3)(2011-12#1)
whiteflies were##4##2##(2008-10#3)(2011-12#1)
whiteflies##29##1##(2007-6#2)(2008-10#21)(2011-12#4)(2011-2#2)
whitefly (Bemisia##3##2##(2008-10#2)(2011-12#1)
whitefly survival##2##2##(2008-10#2)
whitefly transmission##2##2##(2008-10#2)
whitefly vector##6##2##(2008-10#6)
whitefly##32##1##(2008-10#27)(2011-12#4)(2011-2#1)
whitefly-transmitted geminivirus from##2##3##(2008-10#2)
whitefly-transmitted geminivirus##5##2##(2008-10#5)
whitefly-transmitted##14##1##(2008-10#13)(2008-8#1)
whitemouth croaker Micropogonias furnieri in##2##5##(2010-8#2)
whitemouth croaker##3##2##(2010-8#3)
whitening agent##2##2##(2008-5#2)
whitening and##2##2##(2009-8#1)(2011-2#1)
whitening effect##3##2##(2008-5#3)
whitening formulation##2##2##(2008-5#2)
whitening##28##1##(2007-12#1)(2008-3#1)(2008-5#18)(2009-8#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-8#1)
whites and##2##2##(2011-2#1)(2012-2#1)
whites with##5##2##(1993-12#1)(2011-1#1)(2011-2#2)(2012-3#1)
whites##40##1##(1991-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-12#2)(1995-6#1)(1996-3#1)(1996-9#1)(1997-3#1)(2005-10#4)(2006-10#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-5#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-2#1)(2012-3#1)
whitish type##2##2##(2008-10#2)
whitish##9##1##(2005-11#1)(2007-2#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-8#1)(2012-12#1)(2012-3#1)
whittling##2##1##(2006-10#2)
whiz##2##1##(2007-9#1)(2009-9#1)
who achieved a##2##3##(2012-2#1)(2012-3#1)
who achieved##8##2##(1990-12#1)(1991-7#1)(2007-7#1)(2012-2#2)(2012-3#2)(2013-1#1)
who acquire the infection##2##4##(1990-9#1)(2007-2#1)
who acquire##4##2##(1990-9#1)(2006-2#1)(2007-2#1)(2008-8#1)
who actually##5##2##(1994-2#1)(1996-1#1)(2006-5#1)(2007-4#1)(2008-10#1)
who admitted##2##2##(2011-2#1)(2012-2#1)
who advocated##2##2##(2007-12#1)(2008-7#1)
who after voluntary intoxication with 12000 mg of quetiapine extended-release developed signs of acute rhabdomyolysis##2##14##(2013-1#2)
who after##3##2##(2008-5#1)(2013-1#2)
who agreed to##3##3##(1993-8#1)(2010-8#1)(2011-2#1)
who all had##2##3##(1996-9#1)(2006-8#1)
who all presented##2##3##(2007-7#1)(2008-7#1)
who all underwent##2##3##(1991-5#1)(2011-2#1)
who all##6##2##(1991-5#1)(1996-9#1)(2006-8#1)(2007-7#1)(2008-7#1)(2011-2#1)
who already have##2##3##(2005-6#1)(2009-8#1)
who already##5##2##(2005-6#1)(2005-7#1)(2007-2#1)(2008-5#1)(2009-8#1)
who also had a##3##4##(2006-10#1)(2007-9#1)(2009-4#1)
who also had##9##3##(1993-3#1)(2006-10#3)(2006-8#1)(2007-9#1)(2008-1#1)(2009-4#1)(2013-8#1)
who also received##2##3##(2010-11#1)(2010-7#1)
who also##24##2##(1990-11#1)(1993-3#1)(1994-5#1)(1995-9#1)(1997-1#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-2#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-5#1)(2009-4#1)(2010-11#1)(2010-3#1)(2010-7#1)(2012-2#1)(2013-8#1)
who answered##3##2##(2006-2#1)(2007-12#1)(2013-1#1)
who appear to have##2##4##(1995-2#1)(2006-10#1)
who appear to##4##3##(1995-2#1)(2006-10#1)(2008-8#1)(2009-5#1)
who applied##2##2##(2009-3#1)(2013-1#1)
who are &quot##4##3##(1992-2#1)(2009-6#2)(2011-1#1)
who are HIV##2##3##(2007-11#1)(2010-7#1)
who are HIV+##2##3##(2006-10#2)
who are HIV-positive##5##3##(1995-6#1)(2006-1#3)(2011-1#1)
who are able to##5##4##(1991-8#1)(2005-10#1)(2008-10#1)(2008-11#2)
who are addicted##2##3##(1991-7#1)(2008-6#1)
who are admitted##2##3##(2006-10#1)(2013-1#1)
who are affected##2##3##(2006-4#1)(2011-2#1)
who are already infected##2##4##(2008-6#1)(2011-1#1)
who are already##7##3##(1991-2#1)(2007-12#1)(2007-7#1)(2008-6#1)(2011-1#1)(2011-2#2)
who are also##4##3##(1993-5#1)(2008-9#1)(2013-1#2)
who are at an##2##4##(2008-12#1)(2012-3#1)
who are at high risk for cardiovascular events##2##8##(2013-1#2)
who are at high risk for cardiovascular##3##7##(2013-1#3)
who are at high risk for##7##6##(1997-7#1)(2005-12#1)(2005-7#1)(2009-3#1)(2013-1#3)
who are at high risk##8##5##(1997-7#1)(2005-12#1)(2005-7#1)(2006-10#1)(2009-3#1)(2013-1#3)
who are at increased risk for##3##6##(1994-12#1)(2007-12#1)(2010-10#1)
who are at increased risk of##3##6##(1993-9#1)(2005-11#1)(2006-10#1)
who are at increased risk##6##5##(1993-9#1)(1994-12#1)(2005-11#1)(2006-10#1)(2007-12#1)(2010-10#1)
who are at risk for##7##5##(1990-5#1)(2006-10#1)(2007-8#2)(2008-1#2)(2008-11#1)
who are at risk of##4##5##(1993-10#1)(2008-12#1)(2013-1#1)(2013-7#1)
who are at risk##14##4##(1990-5#1)(1990-9#1)(1993-10#1)(2006-10#2)(2007-7#1)(2007-8#2)(2008-1#2)(2008-11#1)(2008-12#1)(2013-1#1)(2013-7#1)
who are at the##3##4##(2007-1#1)(2008-7#1)(2011-2#1)
who are at##39##3##(1990-5#1)(1990-9#1)(1991-12#1)(1993-10#1)(1993-9#1)(1994-12#1)(1997-7#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#5)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2009-3#1)(2010-10#1)(2010-11#1)(2011-12#2)(2011-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
who are being##2##3##(2008-5#1)(2010-12#1)
who are candidates for##5##4##(2004-11#1)(2007-4#1)(2008-11#1)(2008-6#1)(2009-12#1)
who are committed to##3##4##(1994-2#1)(2009-4#1)(2012-3#1)
who are concerned about##3##4##(1993-11#1)(1993-3#1)(2008-12#1)
who are concerned##6##3##(1993-11#1)(1993-3#1)(2007-4#1)(2007-6#1)(2008-12#1)(2011-2#1)
who are considered##3##3##(1992-6#1)(2006-8#1)(2008-2#1)
who are deaf##4##3##(2006-11#2)(2011-2#2)
who are disabled##2##3##(2006-3#1)(2007-4#1)
who are either##4##3##(2006-10#1)(2007-2#1)(2007-7#1)(2010-11#1)
who are employed##2##3##(1995-1#1)(2008-2#1)
who are exposed to##4##4##(2007-12#1)(2008-10#1)(2009-7#1)(2011-2#1)
who are extremely##3##3##(2008-1#1)(2012-12#1)(2013-1#1)
who are faced with##2##4##(1993-3#1)(1997-1#1)
who are heterozygous##2##3##(1993-9#1)(2008-1#1)
who are immunocompromised##2##3##(2006-10#1)(2009-3#1)
who are immunosuppressed##2##3##(2007-12#1)(2009-8#1)
who are in need of##2##5##(2007-8#1)(2013-1#1)
who are in##6##3##(1993-6#1)(1995-9#1)(2005-6#1)(2007-8#1)(2008-5#1)(2013-1#1)
who are ineligible for##2##4##(1995-12#1)(2009-12#1)
who are infected with HIV##3##5##(2006-9#1)(2007-8#1)(2012-3#1)
who are infected##4##3##(2004-9#1)(2006-9#1)(2007-8#1)(2012-3#1)
who are interested in##2##4##(2006-3#1)(2009-5#1)
who are known to##2##4##(2004-10#1)(2012-1#1)
who are known##3##3##(1991-10#1)(2004-10#1)(2012-1#1)
who are less##4##3##(1990-12#1)(1996-2#1)(2005-11#1)(2007-11#1)
who are likely to be##5##5##(1997-3#1)(2005-3#1)(2007-12#1)(2008-11#1)(2008-3#1)
who are likely to##9##4##(1997-3#1)(2005-3#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-3#1)
who are living with##2##4##(1997-6#1)(2009-7#1)
who are living##3##3##(1997-6#1)(2009-7#1)(2013-1#1)
who are more##3##3##(1993-3#1)(2006-8#1)(2012-2#1)
who are most likely to benefit##3##6##(2006-10#2)(2011-12#1)
who are most##5##3##(1994-4#1)(2006-10#2)(2007-7#1)(2011-12#1)
who are not candidates for##3##5##(2007-7#1)(2009-8#1)(2013-1#1)
who are not on##2##4##(2008-5#1)(2012-1#1)
who are not receiving##2##4##(2007-2#1)(2008-7#1)
who are not##40##3##(1990-11#1)(1990-4#1)(1993-1#1)(1995-12#1)(1995-9#2)(1996-11#1)(2004-11#1)(2004-12#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#2)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
who are now##2##3##(1992-2#1)(2008-7#1)
who are obese##3##3##(2008-3#1)(2009-9#1)(2011-1#1)
who are often not##2##4##(1992-3#1)(2007-6#1)
who are often##3##3##(1992-3#1)(1996-11#1)(2007-6#1)
who are older than##2##4##(2007-8#1)(2012-3#1)
who are older##3##3##(2007-8#1)(2011-2#1)(2012-3#1)
who are on a ddI- and/or d4T-containing antiretroviral drug regimen##2##10##(2008-11#2)
who are on the##2##4##(2011-12#1)(2011-2#1)
who are on##11##3##(2006-9#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-6#1)(2009-2#1)(2011-12#1)(2011-2#1)
who are particularly##2##3##(2010-2#1)(2011-1#1)
who are physically##2##3##(1992-3#1)(2013-1#1)
who are planning##2##3##(2007-2#1)(2008-9#1)
who are predicted to have##2##5##(2006-7#1)(2010-12#1)
who are receiving##6##3##(1993-2#1)(2007-11#2)(2010-12#1)(2010-5#1)(2013-1#1)
who are refractory to##6##4##(2006-10#1)(2007-7#1)(2008-1#1)(2008-6#1)(2011-2#1)(2012-3#1)
who are relatively##2##3##(2009-10#1)(2011-2#1)
who are required to##2##4##(1990-4#1)(2006-8#1)
who are responsible for##5##4##(1993-3#1)(1997-2#1)(2005-5#1)(2006-8#1)(2008-12#1)
who are responsible##6##3##(1993-3#1)(1997-2#1)(2005-5#1)(2006-8#1)(2008-11#1)(2008-12#1)
who are suspected of having##4##5##(2007-8#1)(2010-12#1)(2010-9#1)(2012-12#1)
who are suspected of##5##4##(2007-8#1)(2010-12#1)(2010-9#1)(2012-12#1)(2013-7#1)
who are symptomatic##2##3##(2007-2#1)(2010-3#1)
who are the##3##3##(1996-2#1)(2008-10#1)(2009-2#1)
who are thus##2##3##(1995-9#1)(2005-10#1)
who are too##2##3##(2013-1#1)(2013-7#1)
who are treated with##2##4##(2007-8#1)(2009-7#1)
who are treated##4##3##(2006-10#1)(2007-8#2)(2009-7#1)
who are trying to##2##4##(2005-7#1)(2005-8#1)
who are typically##2##3##(2012-12#1)(2012-2#1)
who are unable to##6##4##(1994-12#1)(2005-8#1)(2006-8#1)(2007-12#1)(2009-10#1)(2009-6#1)
who are undergoing surgery##2##4##(2007-12#2)
who are undergoing##8##3##(2007-12#2)(2007-8#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
who are uninsured##2##3##(1995-1#1)(2011-2#1)
who are vulnerable to##2##4##(2004-3#1)(2008-3#1)
who are willing to##2##4##(1996-2#1)(2007-4#1)
who are working##2##3##(2006-1#1)(2008-10#1)
who are younger##2##3##(2007-8#1)(2011-2#1)
who are##484##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-10#1)(1992-2#5)(1992-3#4)(1992-5#1)(1992-6#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#7)(1993-5#1)(1993-6#1)(1993-9#2)(1994-1#2)(1994-12#3)(1994-2#2)(1994-4#1)(1994-7#1)(1995-1#3)(1995-12#5)(1995-2#2)(1995-3#1)(1995-6#2)(1995-9#4)(1996-11#3)(1996-12#1)(1996-2#4)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#3)(1997-3#3)(1997-6#1)(1997-7#2)(1997-8#2)(2004-10#2)(2004-11#3)(2004-12#1)(2004-3#1)(2004-9#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-3#1)(2005-5#1)(2005-6#1)(2005-7#3)(2005-8#4)(2006-1#5)(2006-10#25)(2006-11#3)(2006-12#3)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#9)(2006-9#4)(2007-1#2)(2007-10#2)(2007-11#6)(2007-12#10)(2007-2#5)(2007-3#2)(2007-4#4)(2007-6#3)(2007-7#7)(2007-8#19)(2008-1#7)(2008-10#11)(2008-11#16)(2008-12#7)(2008-2#5)(2008-3#7)(2008-4#5)(2008-5#5)(2008-6#7)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#3)(2009-2#3)(2009-3#2)(2009-4#5)(2009-5#3)(2009-6#4)(2009-7#3)(2009-8#3)(2009-9#2)(2010-10#2)(2010-11#5)(2010-12#9)(2010-2#5)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#13)(2011-12#5)(2011-2#25)(2012-1#4)(2012-11#1)(2012-12#8)(2012-2#7)(2012-3#9)(2013-1#22)(2013-7#4)(2013-8#8)
who arrive in##2##3##(1991-10#1)(2012-11#1)
who arrived##2##2##(2008-10#1)(2012-3#1)
who as a##2##3##(1993-10#1)(2005-10#1)
who asked for##2##3##(2006-7#1)(2009-6#1)
who asked##3##2##(2006-7#1)(2009-6#2)
who asks for##2##3##(2009-6#2)
who asserts that the##2##4##(2008-5#1)(2008-8#1)
who assist##2##2##(1993-3#1)(2008-8#1)
who ate##2##2##(1991-6#1)(2011-1#1)
who attained##2##2##(2007-4#1)(2013-1#1)
who attempted##2##2##(2004-10#1)(2006-10#1)
who attend##3##2##(2007-2#1)(2009-5#2)
who attended support groups##2##4##(2006-10#2)
who attended the class##2##4##(2007-10#2)
who attended the##17##3##(1993-6#1)(1995-1#1)(2007-10#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-3#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
who attended##29##2##(1993-6#1)(1995-1#1)(2006-10#2)(2006-9#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-3#1)(2008-8#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#5)
who became infected##2##3##(1996-5#1)(1997-5#1)
who became pregnant##3##3##(1995-2#1)(2013-1#2)
who became##16##2##(1990-2#2)(1992-10#1)(1995-2#1)(1996-5#1)(1997-5#1)(2006-10#1)(2006-11#1)(2006-4#1)(2007-2#1)(2008-10#1)(2008-3#1)(2010-7#1)(2012-2#1)(2013-1#2)
who become##4##2##(1994-1#1)(2004-3#1)(2008-12#1)(2013-1#1)
who began##3##2##(2006-10#1)(2007-1#1)(2011-2#1)
who believe##2##2##(1996-1#1)(2008-12#1)
who believed that##3##3##(2007-12#1)(2007-9#1)(2008-1#1)
who believed##4##2##(2006-7#1)(2007-12#1)(2007-9#1)(2008-1#1)
who benefit from##3##3##(2008-10#1)(2010-11#1)(2012-3#1)
who benefit##5##2##(2008-1#1)(2008-10#1)(2008-7#1)(2010-11#1)(2012-3#1)
who both##4##2##(1993-9#1)(2006-11#1)(2008-11#1)(2008-4#1)
who came for##4##3##(2006-10#1)(2006-7#1)(2011-1#1)(2012-2#1)
who came from##2##3##(1994-6#1)(2012-2#1)
who came to##2##3##(1991-4#1)(2012-2#1)
who came with##2##3##(2011-12#1)(2013-8#1)
who came##11##2##(1990-3#1)(1991-4#1)(1994-6#1)(2006-10#1)(2006-7#1)(2011-1#1)(2011-12#1)(2012-2#3)(2013-8#1)
who can afford##2##3##(1996-2#1)(2009-8#1)
who can be##3##3##(2007-10#1)(2008-3#1)(2011-1#1)
who can provide##2##3##(2007-3#1)(2008-11#1)
who can safely##2##3##(1991-4#1)(2010-5#1)
who can then##2##3##(2007-7#1)(2010-4#1)
who can##30##2##(1991-4#1)(1992-3#1)(1994-7#1)(1995-1#1)(1996-2#2)(1996-3#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-7#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-1#2)(2012-1#1)(2013-1#1)
who cannot afford##3##3##(2007-11#1)(2007-3#1)(2008-11#1)
who cannot be##3##3##(1996-4#1)(2006-7#1)(2011-2#1)
who cannot##11##2##(1994-2#1)(1996-4#1)(2005-10#1)(2006-7#1)(2007-11#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-11#1)(2010-7#1)(2011-2#1)
who care for children with complex##2##6##(2008-11#2)
who care for##11##3##(1992-3#1)(2007-12#1)(2007-3#1)(2008-11#3)(2008-12#1)(2008-7#1)(2010-5#1)(2012-11#1)(2012-3#1)
who cared for##3##3##(1991-6#1)(2006-2#1)(2010-11#1)
who cares for##2##3##(1995-2#1)(2011-1#1)
who carried##3##2##(1994-6#1)(2007-8#1)(2008-11#1)
who carry##3##2##(1993-7#1)(1996-6#1)(1997-4#1)
who ceased##2##2##(1997-4#1)(2006-10#1)
who choose to##11##3##(1990-12#1)(2006-10#8)(2006-2#1)(2007-2#1)
who choose##14##2##(1990-12#1)(2006-10#8)(2006-2#1)(2006-3#1)(2007-2#1)(2012-3#1)(2013-1#1)
who chose to##2##3##(2007-2#1)(2013-1#1)
who claim to have been tortured##2##6##(1995-11#1)(1996-9#1)
who claimed##6##2##(1993-7#1)(1995-12#2)(1995-6#2)(2008-9#1)
who collect##2##2##(1997-8#1)(2010-5#1)
who collectively looked after##2##4##(2007-7#1)(2008-1#1)
who collectively##3##2##(2007-7#1)(2008-1#1)(2013-1#1)
who come from##3##3##(2007-11#1)(2008-11#1)(2008-8#1)
who committed##2##2##(1993-7#1)(2013-1#1)
who complained of a##2##4##(2008-5#1)(2008-7#1)
who complained of an##2##4##(2008-5#1)(2013-8#1)
who complained of pain in##2##5##(1991-5#1)(2007-9#1)
who complained of##14##3##(1991-5#2)(2007-12#1)(2007-3#1)(2007-9#1)(2008-5#3)(2008-7#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
who completed a questionnaire##2##4##(2007-12#1)(2013-1#1)
who completed a##4##3##(2007-12#1)(2007-7#1)(2009-11#1)(2013-1#1)
who completed an##3##3##(2008-1#1)(2010-10#1)(2013-1#1)
who completed questionnaires at two points in time##2##8##(2006-9#1)(2007-12#1)
who completed the questionnaire##4##4##(1992-6#1)(1993-11#1)(2010-3#1)(2012-2#1)
who completed the study##3##4##(2006-12#1)(2007-2#1)(2008-7#1)
who completed the##19##3##(1992-6#1)(1993-11#1)(1995-11#1)(2006-10#1)(2006-12#1)(2007-2#2)(2007-7#1)(2008-2#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-3#1)(2012-2#3)(2013-1#3)
who completed their##2##3##(2007-1#1)(2007-3#1)
who completed##43##2##(1992-4#1)(1992-6#1)(1993-11#1)(1995-11#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-12#3)(2007-2#2)(2007-3#1)(2007-7#3)(2008-1#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#2)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#4)(2013-1#7)
who conceived after##2##3##(1994-3#1)(2011-1#1)
who conceived##3##2##(1994-3#1)(2009-6#1)(2011-1#1)
who conduct##4##2##(1995-3#1)(2006-8#1)(2009-3#1)(2012-12#1)
who consented##2##2##(2007-10#1)(2009-7#1)
who consulted##3##2##(1992-2#1)(2006-10#1)(2010-12#1)
who consume##2##2##(2005-10#1)(2008-7#1)
who consumed##2##2##(2005-11#1)(2010-9#1)
who contacted##2##2##(1994-2#1)(2012-3#1)
who continue to##5##3##(1993-11#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#1)
who continued with##2##3##(1991-3#1)(2005-9#1)
who continued##7##2##(1991-3#1)(2005-9#1)(2008-11#1)(2009-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
who contracted HIV##6##3##(1996-12#1)(1996-5#2)(1996-6#1)(1997-5#2)
who contracted the##2##3##(1996-5#1)(2007-3#1)
who contracted##9##2##(1996-12#1)(1996-5#3)(1996-6#1)(1997-4#1)(1997-5#2)(2007-3#1)
who contributed to##2##3##(2006-8#1)(2011-2#1)
who contributed##3##2##(1997-8#1)(2006-8#1)(2011-2#1)
who could be##3##3##(1995-5#1)(1997-2#1)(2007-8#1)
who could benefit from##2##4##(1992-12#1)(2008-11#1)
who could not be##4##4##(2007-8#2)(2008-3#1)(2008-6#1)
who could not##6##3##(2007-8#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)
who could##19##2##(1992-12#1)(1993-12#1)(1994-2#1)(1995-5#1)(1997-2#1)(2007-10#1)(2007-7#2)(2007-8#4)(2008-1#1)(2008-11#2)(2008-3#1)(2008-6#1)(2009-2#1)(2013-7#1)
who currently##3##2##(2006-10#1)(2009-4#1)(2010-3#1)
who decide to##2##3##(2009-4#1)(2011-2#1)
who decide##3##2##(2009-4#1)(2011-2#1)(2013-7#1)
who declined surgery and had##2##5##(2010-12#1)(2010-5#1)
who delivered##5##2##(1991-12#1)(1992-2#1)(2008-12#1)(2011-1#1)(2013-1#1)
who demonstrated that##2##3##(1991-1#1)(2010-1#1)
who demonstrated##8##2##(1991-1#1)(1992-3#1)(1994-2#1)(1997-8#1)(2005-4#1)(2010-1#1)(2010-2#1)(2012-1#1)
who describe##2##2##(1997-6#1)(2008-12#1)
who described##3##2##(1997-8#1)(2005-8#1)(2008-11#1)
who desire##3##2##(2007-8#1)(2008-7#1)(2008-9#1)
who develop acute##3##3##(1997-4#1)(2007-7#1)(2007-9#1)
who develop cancer##2##3##(2009-9#1)(2010-12#1)
who develop chronic##2##3##(2006-10#1)(2013-7#1)
who develop##33##2##(1990-12#1)(1991-9#1)(1993-11#1)(1993-5#1)(1995-7#1)(1997-1#1)(1997-4#1)(2004-11#1)(2006-10#3)(2006-5#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-10#1)(2008-3#1)(2008-6#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#1)
who developed a large##2##4##(1993-5#1)(2008-7#1)
who developed a##26##3##(1993-5#1)(1993-8#1)(1994-4#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-4#1)(2011-2#1)(2012-2#2)(2013-1#3)
who developed acute##4##3##(1992-10#1)(2010-4#1)(2012-12#1)(2013-1#1)
who developed an##7##3##(2007-12#1)(2008-10#1)(2008-6#2)(2008-7#1)(2012-2#1)(2013-7#1)
who developed bilateral##2##3##(2007-10#1)(2011-1#1)
who developed clinical##2##3##(2007-2#1)(2010-10#1)
who developed disseminated##3##3##(2007-9#1)(2008-10#1)(2012-2#1)
who developed infective endocarditis##2##4##(2008-1#1)(2009-8#1)
who developed metastatic##2##3##(2008-6#1)(2011-3#1)
who developed multiple##2##3##(2009-9#1)(2013-8#1)
who developed primary##2##3##(1997-3#1)(2007-5#1)
who developed progressive##3##3##(2006-10#2)(2007-11#1)
who developed rapidly##2##3##(2006-4#2)
who developed several##2##3##(1995-1#1)(2008-5#1)
who developed severe##9##3##(1992-11#1)(2004-3#1)(2007-3#1)(2009-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)
who developed significant##2##3##(2007-7#1)(2013-1#1)
who developed subacute##2##3##(2006-10#1)(2012-1#1)
who developed the##3##3##(2008-4#1)(2008-9#1)(2011-1#1)
who developed unusual##2##3##(2006-6#1)(2012-2#1)
who developed##190##2##(1990-11#1)(1990-3#1)(1990-6#1)(1991-12#1)(1991-9#1)(1992-10#2)(1992-11#2)(1992-2#1)(1992-3#1)(1992-8#1)(1993-5#1)(1993-8#1)(1994-4#1)(1995-1#2)(1997-1#1)(1997-3#1)(2004-10#1)(2004-12#1)(2004-3#1)(2005-11#2)(2006-10#12)(2006-11#3)(2006-12#2)(2006-3#1)(2006-4#2)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#7)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#10)(2007-9#5)(2008-1#3)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#6)(2008-7#12)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#11)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#7)
who did and did not##3##5##(1993-3#1)(2012-1#1)(2012-12#1)
who did not achieve##3##4##(2008-10#1)(2008-6#1)(2011-2#1)
who did not engage in##3##5##(2007-7#1)(2008-3#1)(2010-7#1)
who did not experience##3##4##(2007-9#1)(2008-7#1)(2009-9#1)
who did not fulfill##2##4##(2006-12#1)(2009-4#1)
who did not have##15##4##(1992-11#1)(1995-4#1)(1996-12#1)(2006-2#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-7#2)(2008-3#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
who did not participate in##2##5##(1997-2#1)(2011-2#1)
who did not receive any##5##5##(1992-5#1)(2008-1#1)(2008-3#1)(2008-7#1)(2012-3#1)
who did not receive##22##4##(1990-12#1)(1990-6#1)(1992-4#1)(1992-5#1)(1993-1#1)(1994-6#1)(1995-1#1)(2004-3#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-3#2)(2008-7#1)(2010-12#1)(2012-3#1)(2013-1#2)
who did not respond to##3##5##(1990-2#1)(1990-5#1)(1994-12#1)
who did not respond##5##4##(1990-2#1)(1990-5#1)(1994-12#1)(1996-4#1)(2004-3#1)
who did not show##3##4##(1996-2#1)(2007-7#1)(2011-2#1)
who did not smoke##3##4##(2007-2#1)(2011-2#2)
who did not undergo##2##4##(2011-2#1)(2012-3#1)
who did not##116##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#2)(1991-12#2)(1991-8#3)(1992-11#2)(1992-4#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-4#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-2#2)(2004-12#1)(2004-3#2)(2005-10#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-9#2)(2007-10#5)(2007-12#4)(2007-2#5)(2007-7#5)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#7)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#7)(2008-9#1)(2009-2#2)(2009-4#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-12#1)(2011-2#9)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#6)
who did receive##2##3##(1992-5#1)(1993-1#1)
who did the under-five##2##4##(2008-2#2)
who did##131##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#2)(1991-12#2)(1991-8#3)(1992-11#2)(1992-4#1)(1992-5#2)(1993-1#2)(1993-12#1)(1993-3#2)(1993-7#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-4#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-4#1)(1997-2#2)(2004-12#1)(2004-3#2)(2005-10#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-9#2)(2007-10#5)(2007-12#4)(2007-2#5)(2007-7#5)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#7)(2008-9#1)(2009-2#3)(2009-4#2)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#9)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#6)
who didn't##2##2##(1990-12#1)(2009-8#1)
who die##2##2##(1991-8#1)(1997-5#1)
who died at the age of##2##6##(1996-6#1)(2008-7#1)
who died at##3##3##(1991-8#1)(1996-6#1)(2008-7#1)
who died during the##2##4##(1997-4#1)(2013-1#1)
who died during##3##3##(1991-7#1)(1997-4#1)(2013-1#1)
who died from##10##3##(1990-4#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-9#1)(1994-11#1)(1994-9#1)(1995-6#1)(2006-10#1)(2012-12#1)
who died in##5##3##(1991-4#1)(1991-8#1)(1997-1#1)(2010-2#1)(2011-2#1)
who died of##8##3##(1991-2#1)(1992-4#1)(1994-7#1)(1995-11#1)(1996-1#1)(2007-3#1)(2011-2#2)
who died suddenly##2##3##(1991-8#1)(1991-9#1)
who died within##3##3##(1996-11#1)(2007-8#2)
who died##50##2##(1990-4#2)(1990-7#1)(1990-9#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-7#1)(1991-8#4)(1991-9#2)(1992-4#1)(1993-7#1)(1994-11#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-6#2)(1997-1#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-8#2)(2008-11#1)(2008-2#1)(2008-7#2)(2009-4#1)(2010-10#1)(2010-2#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
who discontinued treatment##3##3##(2011-2#3)
who display##3##2##(1992-6#1)(1996-12#1)(2012-1#1)
who do and do not##2##5##(1995-11#1)(2012-12#1)
who do not ask for##3##5##(2009-6#3)
who do not have a##2##5##(1997-5#1)(2007-7#1)
who do not have##11##4##(1996-1#1)(1997-5#1)(2005-10#2)(2005-7#1)(2006-2#1)(2006-9#1)(2007-7#1)(2008-4#1)(2008-5#1)(2009-10#1)
who do not qualify for##2##5##(1991-10#1)(2010-2#1)
who do not receive##2##4##(2007-11#1)(2008-6#1)
who do not respond to conventional##4##6##(2008-3#1)(2008-8#1)(2011-2#1)(2013-8#1)
who do not respond to##14##5##(1993-12#1)(1996-5#1)(1997-8#1)(2005-1#1)(2006-10#2)(2006-12#1)(2007-3#1)(2008-3#1)(2008-8#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-8#1)
who do not respond##15##4##(1993-12#1)(1996-5#1)(1997-8#1)(2005-1#1)(2006-10#2)(2006-12#1)(2006-3#1)(2007-3#1)(2008-3#1)(2008-8#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-8#1)
who do not##60##3##(1990-11#1)(1991-10#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-4#2)(1996-1#1)(1996-5#1)(1997-5#2)(1997-8#1)(2005-1#1)(2005-10#3)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#3)(2006-3#1)(2006-5#1)(2006-9#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-11#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#2)(2009-12#1)(2009-6#3)(2009-7#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-3#2)(2013-8#2)
who do show##2##3##(2008-12#1)(2008-8#1)
who do##70##2##(1990-11#1)(1991-10#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-3#1)(1994-4#2)(1995-11#1)(1996-1#1)(1996-5#1)(1997-5#2)(1997-8#1)(2005-1#1)(2005-10#4)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#3)(2006-3#1)(2006-5#1)(2006-9#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#2)(2009-12#1)(2009-6#3)(2009-7#1)(2010-2#2)(2010-4#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#3)(2013-8#2)
who does##2##2##(1991-3#1)(1994-2#1)
who don't##3##2##(1990-5#1)(1994-12#1)(2005-3#1)
who each##2##2##(1991-3#1)(2010-2#1)
who either##4##2##(2006-12#1)(2006-7#1)(2007-12#1)(2010-8#1)
who endorsed##4##2##(2007-12#3)(2012-12#1)
who engage in##6##3##(2006-7#1)(2007-7#1)(2008-6#1)(2010-12#1)(2012-2#1)(2013-1#1)
who engaged in sex##2##4##(2007-7#1)(2012-3#1)
who engaged in sexting##2##4##(2013-1#2)
who engaged in##8##3##(1996-5#1)(2006-7#1)(2007-7#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#2)
who engaged##9##2##(1996-5#1)(2006-7#1)(2007-7#1)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
who enjoyed##2##2##(2006-7#1)(2009-4#1)
who enter##3##2##(1995-1#1)(1996-9#1)(2010-2#1)
who entered the study##3##4##(1991-2#1)(1992-4#1)(1995-1#1)
who entered the##5##3##(1991-2#1)(1992-10#1)(1992-4#1)(1995-1#1)(2004-3#1)
who entered##6##2##(1991-2#1)(1992-10#1)(1992-4#1)(1992-6#1)(1995-1#1)(2004-3#1)
who evaluate##2##2##(2007-9#1)(2009-4#1)
who ever##3##2##(2006-2#1)(2011-1#1)(2012-3#1)
who examined##2##2##(1994-9#1)(1995-9#1)
who exercised##2##2##(2006-7#1)(2009-3#1)
who exhibit a##2##3##(1992-10#1)(1996-12#1)
who exhibit##5##2##(1992-10#1)(1996-12#1)(2008-11#1)(2012-1#1)(2012-12#1)
who exhibited a##3##3##(2007-10#1)(2008-9#1)(2013-8#1)
who exhibited the##2##3##(1997-3#1)(2006-10#1)
who exhibited##10##2##(1997-3#1)(1997-7#1)(2006-10#1)(2007-10#1)(2008-9#2)(2011-2#2)(2012-12#1)(2013-8#1)
who experience##17##2##(1991-11#1)(1993-10#1)(1995-5#1)(1997-5#1)(2006-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
who experienced a##4##3##(1995-11#1)(2007-10#1)(2007-5#1)(2012-11#1)
who experienced febrile neutropenia##2##4##(2008-7#2)
who experienced more##3##3##(2008-5#1)(2011-2#1)(2012-1#1)
who experienced several instances of academic sexism##2##7##(2011-1#2)
who experienced##33##2##(1992-1#1)(1993-12#1)(1995-11#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-5#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-4#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-11#3)(2012-12#2)(2012-2#3)(2013-1#2)
who expired##3##2##(1992-9#1)(2007-7#2)
who expose##2##2##(2008-12#1)(2008-7#1)
who expressed##5##2##(1991-2#2)(2007-8#1)(2011-1#1)(2012-2#1)
who face##3##2##(1991-5#1)(1996-6#1)(2009-5#1)
who fail to respond##2##4##(2006-8#1)(2007-11#1)
who fail to##6##3##(1993-12#1)(2006-8#1)(2007-11#1)(2007-7#1)(2011-3#1)(2012-2#1)
who fail##10##2##(1993-12#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-7#2)(2008-11#1)(2011-3#1)(2012-2#1)
who failed to##7##3##(1995-2#1)(2006-8#3)(2008-1#1)(2008-6#1)(2012-2#1)
who failed##15##2##(1995-2#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-8#3)(2008-1#1)(2008-11#2)(2008-3#1)(2008-6#1)(2012-2#2)(2013-8#1)
who fall and##2##3##(2008-7#1)(2009-3#1)
who fall##7##2##(1994-12#1)(2006-9#1)(2008-7#1)(2009-3#2)(2009-4#1)(2013-1#1)
who feel##3##2##(1993-5#1)(2006-12#1)(2010-2#1)
who fell##5##2##(1996-9#1)(2005-1#1)(2009-3#1)(2013-1#2)
who felt that there was an improvement in their wrinkles after##2##11##(2008-5#2)
who felt that##3##3##(1997-1#1)(2008-5#2)
who felt##10##2##(1991-4#1)(1995-9#1)(1997-1#1)(2008-5#2)(2009-4#1)(2010-7#2)(2013-1#1)(2013-7#1)
who find##2##2##(1995-2#1)(2004-12#1)
who first##4##2##(2006-7#1)(2007-2#1)(2007-3#1)(2013-7#1)
who fit the##2##3##(2006-12#1)(2011-2#1)
who fled##2##2##(1991-10#1)(1996-6#1)
who followed the##2##3##(1994-4#1)(2007-4#1)
who followed##5##2##(1994-4#2)(2007-4#1)(2007-6#1)(2008-9#1)
who for##2##2##(1994-4#1)(2007-9#1)
who formed##2##2##(2006-5#1)(2006-6#1)
who found##2##2##(2007-9#1)(2011-1#1)
who fulfilled the##3##3##(2008-3#1)(2008-7#1)(2011-2#1)
who gained##2##2##(2007-3#1)(2008-3#1)
who gave birth to##2##4##(1996-5#1)(2012-3#1)
who gave birth##4##3##(1996-5#1)(2009-11#1)(2009-2#1)(2012-3#1)
who gave##7##2##(1996-11#1)(1996-5#1)(2007-9#1)(2009-11#1)(2009-2#1)(2010-1#1)(2012-3#1)
who generally##2##2##(1997-7#1)(2008-9#1)
who give##4##2##(1990-5#1)(1991-5#1)(2009-9#1)(2013-8#1)
who go into atrial##2##4##(2007-8#2)
who go##3##2##(2007-8#2)(2011-1#1)
who got infected with##2##4##(1993-8#1)(2007-10#1)
who got##7##2##(1992-3#1)(1993-8#1)(2006-6#1)(2007-10#1)(2007-2#2)(2012-3#1)
who graduated in##2##3##(1990-5#1)(2006-5#1)
who graduated##3##2##(1990-5#1)(2006-5#1)(2007-10#1)
who grew up with and without siblings##2##7##(2011-12#2)
who grew up with##3##4##(2011-12#3)
who grew up without and with siblings vary by##2##9##(2011-12#2)
who grew up without##3##4##(2011-12#3)
who grew up##7##3##(2011-12#6)(2012-2#1)
who grew##9##2##(1996-6#1)(2006-1#1)(2011-12#6)(2012-2#1)
who had &gt##2##3##(2011-2#1)(2012-3#1)
who had a complete##2##4##(1990-8#1)(1993-2#1)
who had a diagnosis of##2##5##(1996-7#1)(2007-8#1)
who had a history of##6##5##(2004-12#1)(2005-12#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
who had a negative##2##4##(1996-8#1)(1996-9#1)
who had a positive##2##4##(2008-4#1)(2012-2#1)
who had a previous history of##2##6##(2007-10#1)(2007-11#1)
who had a previous##4##4##(2006-8#1)(2007-10#1)(2007-11#1)(2007-6#1)
who had a##76##3##(1990-11#1)(1990-8#1)(1991-11#1)(1991-5#1)(1992-5#1)(1993-12#1)(1993-2#1)(1996-12#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-8#1)(2004-12#1)(2005-12#1)(2006-1#1)(2006-10#4)(2006-8#1)(2006-9#1)(2007-10#4)(2007-11#1)(2007-2#1)(2007-6#1)(2007-8#2)(2007-9#2)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#5)(2009-4#1)(2009-6#2)(2009-7#1)(2010-12#1)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
who had access to##2##4##(2007-9#1)(2009-5#1)
who had acute##2##3##(2007-7#1)(2012-2#1)
who had already##2##3##(1992-10#1)(1996-1#1)
who had an inadequate response##2##5##(2008-3#1)(2008-8#1)
who had an##16##3##(1991-3#1)(1991-7#1)(1995-6#1)(1997-5#1)(2007-10#1)(2007-8#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-10#1)(2010-7#1)(2011-2#1)(2013-1#2)
who had attempted##2##3##(1992-1#1)(2008-11#1)
who had become##3##3##(1992-4#1)(1993-1#1)(2005-7#1)
who had been diagnosed##2##4##(1995-7#1)(2010-3#1)
who had been involved in an aggressive incident##2##8##(2012-12#2)
who had been notified##2##4##(2008-11#1)(2010-12#1)
who had been on##2##4##(2008-1#1)(2008-7#1)
who had been pregnant##2##4##(2004-10#1)(2011-1#1)
who had been previously##2##4##(1992-6#1)(2013-8#1)
who had been receiving##2##4##(2007-12#1)(2009-6#1)
who had been referred to##3##5##(2007-2#2)(2009-8#1)
who had been treated by##2##5##(2007-7#1)(2011-2#1)
who had been treated for##4##5##(2007-12#1)(2008-10#1)(2008-6#2)
who had been treated with the##2##6##(1991-5#1)(2011-2#1)
who had been treated with##5##5##(1991-5#1)(1995-11#1)(2008-7#1)(2011-2#2)
who had been treated##12##4##(1991-5#1)(1995-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-6#2)(2008-7#1)(2011-2#4)
who had been under##2##4##(2004-11#1)(2012-2#1)
who had been working##2##4##(1990-12#1)(2007-7#1)
who had been##77##3##(1990-10#1)(1990-12#2)(1990-2#1)(1990-4#2)(1991-12#1)(1991-3#1)(1991-5#2)(1991-8#1)(1992-1#1)(1992-5#1)(1992-6#1)(1992-9#1)(1994-6#1)(1994-7#1)(1995-11#1)(1995-4#1)(1995-7#2)(1995-9#1)(1996-11#1)(1996-12#2)(1996-6#2)(1997-1#1)(1997-5#1)(1997-6#1)(2004-10#1)(2004-11#2)(2005-12#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-3#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#2)(2008-7#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
who had both##4##3##(2007-10#1)(2007-9#1)(2008-12#1)(2008-4#1)
who had breast##2##3##(1993-11#1)(2008-7#1)
who had chronic##2##3##(1996-9#1)(2007-8#1)
who had complete##2##3##(2007-3#1)(2013-1#1)
who had completed the##2##4##(2010-8#1)(2011-2#1)
who had completed##4##3##(1993-2#1)(1996-3#1)(2010-8#1)(2011-2#1)
who had contact with##2##4##(2007-12#1)(2012-12#1)
who had coronary##2##3##(1993-12#1)(2007-8#1)
who had developed##3##3##(2007-7#1)(2008-4#1)(2013-8#1)
who had diabetes and were##2##5##(2007-8#2)
who had died##5##3##(1990-10#1)(1996-5#1)(1997-3#1)(2007-9#1)(2010-12#1)
who had done##2##3##(2007-2#1)(2012-12#1)
who had ever##3##3##(1993-2#1)(2008-12#2)
who had experienced the##2##4##(2007-11#1)(2008-9#1)
who had experienced##11##3##(1994-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-6#1)(2008-9#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
who had failed##3##3##(2005-7#1)(2012-12#1)(2013-1#1)
who had fever##2##3##(1996-12#1)(2012-3#1)
who had given##3##3##(1990-10#1)(2008-9#1)(2010-12#1)
who had good##2##3##(2007-3#1)(2007-7#1)
who had had##13##3##(1990-12#1)(1991-7#1)(1993-1#1)(1993-10#1)(1993-2#1)(1997-2#1)(2007-10#1)(2007-3#1)(2008-9#1)(2009-4#1)(2010-10#1)(2011-2#1)(2013-1#1)
who had higher##2##3##(2004-11#1)(2013-1#1)
who had history of##2##4##(2006-9#1)(2012-2#1)
who had intraplaque hemorrhage##2##4##(2007-10#2)
who had long Barrett's esophagus##2##5##(2013-8#2)
who had lost##2##3##(2008-5#1)(2009-5#1)
who had more##5##3##(1996-1#1)(2006-5#1)(2006-8#1)(2008-7#1)(2010-2#1)
who had multiple##4##3##(2006-10#1)(2010-7#1)(2011-12#1)(2011-2#1)
who had negative##2##3##(1994-12#1)(2007-2#1)
who had never used##2##4##(2013-1#1)(2013-8#1)
who had never##7##3##(1990-10#1)(1991-7#1)(1993-9#1)(2013-1#2)(2013-8#2)
who had no other##2##4##(2008-9#1)(2012-2#1)
who had no previous##2##4##(2006-10#1)(2007-12#1)
who had no##15##3##(1991-11#1)(1992-2#1)(1995-2#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-11#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
who had normal##6##3##(1992-12#1)(1993-12#1)(2004-2#1)(2006-9#1)(2007-9#1)(2008-1#1)
who had not been##2##4##(2006-10#1)(2012-12#1)
who had not received##2##4##(1992-10#1)(2007-8#1)
who had not responded to##3##5##(1997-7#1)(2006-10#2)
who had not taken any##2##5##(2008-3#1)(2013-1#1)
who had not undergone##2##4##(2008-11#1)(2012-3#1)
who had not used##2##4##(1993-2#1)(2013-8#1)
who had not##32##3##(1991-2#1)(1992-10#1)(1992-7#1)(1993-1#1)(1993-2#1)(1993-3#1)(1995-2#1)(1997-7#1)(2006-10#4)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-9#1)(2010-1#1)(2010-3#1)(2012-12#3)(2012-3#2)(2013-1#1)(2013-8#1)
who had one or more##2##5##(1995-12#1)(2008-11#1)
who had only##2##3##(1994-2#1)(2006-12#1)
who had participated in a##2##5##(2007-3#1)(2013-1#1)
who had participated in##5##4##(1991-12#1)(1991-7#1)(2007-3#1)(2009-6#1)(2013-1#1)
who had planned##2##3##(1992-1#1)(2007-2#1)
who had poor##2##3##(1994-6#1)(2007-3#1)
who had preoperative##2##3##(2007-8#2)
who had presented##2##3##(1997-2#1)(2010-5#1)
who had previously been active in sports##2##7##(2007-11#1)(2007-8#1)
who had previously been treated with##2##6##(2006-10#1)(2008-6#1)
who had previously been##5##4##(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-6#1)
who had previously failed##2##4##(2007-11#1)(2010-12#1)
who had previously had##2##4##(1993-5#1)(2008-5#1)
who had previously undergone##6##4##(1992-12#1)(1992-3#1)(1997-7#1)(2006-8#1)(2008-6#1)(2008-9#1)
who had previously##21##3##(1991-10#1)(1992-12#2)(1992-3#1)(1993-12#1)(1993-5#2)(1993-7#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#2)(2008-9#1)(2010-12#1)
who had primary##2##3##(2008-7#1)(2012-1#1)
who had received a##6##4##(1991-9#1)(1997-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2013-8#1)
who had received chemotherapy##2##4##(1990-2#1)(2008-7#1)
who had received##39##3##(1990-12#1)(1990-2#1)(1991-2#1)(1991-3#1)(1991-9#1)(1993-10#1)(1993-7#1)(1996-1#1)(1996-8#1)(1997-5#1)(2004-2#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-8#3)(2007-9#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2010-10#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-8#1)
who had recently given birth##2##5##(2006-4#1)(2007-9#1)
who had recently undergone##4##4##(1995-3#1)(2006-10#1)(2007-12#1)(2009-12#1)
who had recently##11##3##(1994-4#1)(1995-3#1)(1995-6#2)(2006-10#1)(2006-4#1)(2007-12#1)(2007-9#1)(2009-12#1)(2012-12#2)
who had recurrent##3##3##(2007-10#1)(2009-3#1)(2013-1#1)
who had residual##2##3##(1997-8#1)(2012-3#1)
who had returned from##2##4##(2007-2#2)
who had routinely##2##3##(1990-6#1)(2008-5#1)
who had severe##4##3##(1991-10#1)(2005-10#1)(2008-11#1)(2008-7#1)
who had sex with##3##4##(2010-12#1)(2012-3#2)
who had significant##3##3##(2008-7#1)(2008-8#1)(2012-12#1)
who had smoked##2##3##(1991-11#1)(1991-8#1)
who had stages##2##3##(2006-3#1)(2007-8#1)
who had stent##2##3##(2010-10#1)(2010-12#1)
who had suffered a##2##4##(2008-7#1)(2010-7#1)
who had suffered from##2##4##(1993-12#1)(2012-2#1)
who had suffered##5##3##(1993-12#1)(2008-5#1)(2008-7#1)(2010-7#1)(2012-2#1)
who had surgical##2##3##(1992-9#1)(2007-2#1)
who had sustained a##2##4##(2006-10#1)(2006-8#1)
who had sustained##4##3##(2006-10#1)(2006-8#1)(2008-12#1)(2010-12#1)
who had symptomatic##2##3##(2008-10#1)(2008-11#1)
who had taken the##2##4##(2010-12#1)(2011-2#1)
who had taken##5##3##(1992-7#1)(2006-8#1)(2007-10#1)(2010-12#1)(2011-2#1)
who had the##6##3##(1991-9#1)(1992-12#1)(2009-2#1)(2011-1#2)(2011-2#1)
who had their##5##3##(1990-4#1)(1993-2#1)(2007-10#1)(2013-1#1)(2013-8#1)
who had this##2##3##(2008-1#1)(2008-6#1)
who had to be##2##4##(1997-6#1)(2007-3#1)
who had to##3##3##(1995-9#1)(1997-6#1)(2007-3#1)
who had two##2##3##(2007-2#1)(2010-8#1)
who had undergone a total##2##5##(2009-10#1)(2011-12#1)
who had undergone a##8##4##(1990-11#1)(2006-9#1)(2007-2#1)(2008-9#3)(2009-10#1)(2011-12#1)
who had undergone an##3##4##(1992-6#1)(2006-8#1)(2008-5#1)
who had undergone coronary##3##4##(1996-6#1)(2007-8#1)(2013-8#1)
who had undergone liver##2##4##(1991-8#1)(2009-2#1)
who had undergone surgery for##3##5##(1992-10#1)(1996-3#1)(2006-2#1)
who had undergone##53##3##(1990-11#1)(1990-3#1)(1990-9#1)(1991-8#1)(1992-10#1)(1992-6#1)(1994-12#1)(1994-3#4)(1995-11#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-6#1)(2004-12#1)(2006-2#2)(2006-4#1)(2006-8#1)(2006-9#1)(2007-2#3)(2007-3#1)(2007-7#3)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#1)(2010-10#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
who had used##5##3##(2007-11#1)(2007-2#1)(2007-8#1)(2011-10#1)(2013-8#1)
who had visited##3##3##(1993-9#1)(1997-6#1)(2007-3#1)
who had worked##2##3##(1994-6#1)(2007-6#1)
who had##776##2##(1990-10#4)(1990-11#2)(1990-12#5)(1990-2#2)(1990-3#2)(1990-4#4)(1990-6#3)(1990-8#2)(1990-9#1)(1991-10#2)(1991-11#3)(1991-12#3)(1991-2#3)(1991-3#4)(1991-5#3)(1991-7#4)(1991-8#5)(1991-9#2)(1992-1#3)(1992-10#4)(1992-12#4)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#4)(1992-6#3)(1992-7#2)(1992-8#1)(1992-9#2)(1993-1#4)(1993-10#2)(1993-11#1)(1993-12#8)(1993-2#10)(1993-3#3)(1993-5#2)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#2)(1994-12#4)(1994-2#1)(1994-3#4)(1994-4#2)(1994-6#5)(1994-7#2)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#5)(1995-7#2)(1995-8#1)(1995-9#4)(1996-1#3)(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#4)(1996-5#2)(1996-6#6)(1996-7#1)(1996-8#3)(1996-9#3)(1997-1#3)(1997-2#2)(1997-3#3)(1997-4#2)(1997-5#3)(1997-6#4)(1997-7#3)(1997-8#3)(2004-1#2)(2004-10#1)(2004-11#4)(2004-12#2)(2004-2#2)(2005-1#2)(2005-10#1)(2005-12#2)(2005-7#2)(2005-8#2)(2005-9#1)(2006-1#2)(2006-10#25)(2006-11#4)(2006-12#1)(2006-2#3)(2006-3#2)(2006-4#4)(2006-5#2)(2006-6#1)(2006-8#10)(2006-9#4)(2007-1#1)(2007-10#16)(2007-11#10)(2007-12#10)(2007-2#23)(2007-3#12)(2007-5#3)(2007-6#2)(2007-7#24)(2007-8#25)(2007-9#17)(2008-1#8)(2008-10#7)(2008-11#16)(2008-12#10)(2008-2#2)(2008-3#6)(2008-4#11)(2008-5#11)(2008-6#13)(2008-7#23)(2008-8#3)(2008-9#15)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#4)(2009-5#2)(2009-6#5)(2009-7#2)(2009-8#1)(2010-1#2)(2010-10#5)(2010-12#12)(2010-2#2)(2010-3#4)(2010-4#2)(2010-5#2)(2010-6#4)(2010-7#6)(2010-8#5)(2011-1#9)(2011-10#1)(2011-12#5)(2011-2#28)(2012-1#4)(2012-11#1)(2012-12#14)(2012-2#16)(2012-3#15)(2013-1#31)(2013-7#4)(2013-8#22)
who harbor##2##2##(2006-5#1)(2006-8#1)
who harbored##4##2##(2006-2#1)(2006-5#2)(2006-8#1)
who has a##3##3##(1996-3#1)(1997-1#1)(2013-7#1)
who has asked for##2##4##(2009-6#2)
who has been suffering##2##4##(2005-10#1)(2007-7#1)
who has been##10##3##(2005-10#1)(2006-7#1)(2007-6#1)(2007-7#1)(2008-6#1)(2008-9#2)(2010-11#1)(2012-3#2)
who has failed##4##3##(2006-2#1)(2006-9#1)(2008-11#1)(2011-1#1)
who has suffered##2##3##(1996-3#1)(2007-11#1)
who has undergone##2##3##(2008-4#1)(2009-9#1)
who has used##3##3##(2007-8#1)(2008-3#1)(2012-1#1)
who has##54##2##(1991-3#1)(1991-4#1)(1991-8#1)(1993-3#1)(1994-7#1)(1996-1#1)(1996-11#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-4#1)(2005-10#1)(2006-11#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-6#2)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-9#2)(2009-4#1)(2009-6#2)(2009-9#1)(2010-11#1)(2010-5#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#1)(2013-7#1)
who have a history of##3##5##(2005-9#1)(2008-1#1)(2011-2#1)
who have a##22##3##(1990-10#1)(1993-12#1)(1994-4#1)(1996-2#1)(1997-3#1)(2005-9#1)(2006-10#2)(2007-7#1)(2008-1#1)(2008-11#2)(2008-7#2)(2009-10#1)(2009-12#1)(2009-7#1)(2011-12#1)(2011-2#2)(2012-2#2)
who have achieved##2##3##(1996-7#1)(2008-5#1)
who have already##5##3##(1991-10#1)(1993-12#1)(2006-5#1)(2008-4#1)(2012-12#1)
who have an interest##2##4##(2006-2#1)(2011-1#1)
who have an##5##3##(2005-5#1)(2006-2#1)(2007-8#1)(2010-12#1)(2011-1#1)
who have been exposed to##2##5##(1995-6#1)(2006-8#1)
who have been shown to##2##5##(1992-6#1)(2008-3#1)
who have been subjected to##2##5##(1993-5#1)(2004-1#1)
who have been treated##3##4##(1992-6#1)(2007-11#1)(2012-12#1)
who have been##34##3##(1990-4#1)(1991-12#1)(1992-6#2)(1993-5#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-6#1)(2004-1#1)(2005-8#1)(2006-8#2)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2010-2#1)(2010-3#2)(2010-9#1)(2011-2#1)(2012-12#2)(2012-3#1)
who have cancer##2##3##(1992-3#1)(2008-7#1)
who have complex##3##3##(1995-5#1)(2008-11#2)
who have developed##6##3##(1992-3#1)(2005-10#1)(2006-10#1)(2008-5#1)(2010-1#1)(2010-9#1)
who have diabetes##2##3##(2007-12#2)
who have died##2##3##(2008-6#1)(2009-5#1)
who have different##2##3##(1996-12#1)(2009-9#1)
who have existing##2##3##(1993-6#1)(2007-12#1)
who have experienced a##2##4##(1996-7#1)(2012-11#1)
who have experienced##10##3##(1996-7#1)(2004-3#1)(2007-3#1)(2007-8#1)(2008-2#1)(2010-12#1)(2011-1#1)(2012-11#1)(2013-1#2)
who have failed to respond to##2##6##(2006-8#1)(2008-3#1)
who have failed##9##3##(1994-5#1)(2006-10#2)(2006-8#1)(2006-9#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)
who have finished##2##3##(1992-1#1)(1996-8#1)
who have found##2##3##(2007-8#1)(2007-9#1)
who have gone##2##3##(2007-8#1)(2008-2#1)
who have had a negative##2##5##(2007-8#2)
who have had a stroke##2##5##(2007-7#1)(2011-1#1)
who have had a##5##4##(2006-10#1)(2007-7#1)(2007-8#2)(2011-1#1)
who have had an##3##4##(2004-1#1)(2007-10#1)(2008-3#1)
who have had limited##2##4##(1992-3#1)(1996-1#1)
who have had no##2##4##(1991-5#1)(1992-10#1)
who have had their disability##2##5##(2006-10#2)
who have had##27##3##(1991-5#1)(1992-10#1)(1992-3#1)(1996-1#1)(1996-9#1)(1997-6#1)(2004-1#1)(2006-10#4)(2006-7#1)(2007-10#1)(2007-11#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-12#1)(2008-3#1)(2008-6#2)(2009-3#1)(2011-1#1)(2012-2#1)
who have high levels of##3##5##(2010-2#1)(2011-12#1)(2012-2#1)
who have high##4##3##(1994-6#1)(2010-2#1)(2011-12#1)(2012-2#1)
who have higher##3##3##(2010-2#1)(2012-2#1)(2013-1#1)
who have inherited##2##3##(1990-11#1)(2008-4#1)
who have known##3##3##(2006-12#1)(2007-12#1)(2008-10#1)
who have limited##2##3##(1991-3#1)(2012-2#1)
who have lost##2##3##(1990-8#1)(2006-10#1)
who have made##2##3##(2007-9#1)(2010-11#1)
who have never##3##3##(1994-4#1)(2009-5#1)(2011-1#1)
who have no##3##3##(2008-5#1)(2009-6#1)(2013-8#1)
who have normal##2##3##(2008-1#1)(2011-2#1)
who have not received##2##4##(2006-6#1)(2012-12#1)
who have not responded to##2##5##(2008-5#2)
who have not##9##3##(1993-2#1)(1993-3#1)(2006-1#1)(2006-6#1)(2008-12#1)(2008-5#2)(2010-3#1)(2012-12#1)
who have or##3##3##(1992-2#1)(1995-12#1)(2006-9#1)
who have other##2##3##(2008-4#1)(2008-8#1)
who have persistent##2##3##(2007-12#1)(2007-8#1)
who have previously been##2##4##(2008-4#1)(2013-8#1)
who have previously##5##3##(1990-12#1)(1997-3#1)(2008-4#1)(2010-2#1)(2013-8#1)
who have received##7##3##(1991-8#1)(1994-9#1)(2008-12#1)(2008-3#1)(2008-9#1)(2012-2#1)(2013-8#1)
who have recovered##2##3##(2008-2#1)(2010-12#1)
who have sex with men (MSM)##7##6##(2008-11#1)(2009-5#4)(2010-12#1)(2011-2#1)
who have sex with men and##4##6##(2009-5#1)(2009-7#1)(2010-5#1)(2013-1#1)
who have sex with men##30##5##(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#2)(2009-5#10)(2009-7#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#3)
who have sex with##31##4##(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#2)(2009-5#10)(2009-7#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#3)
who have sex##32##3##(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#2)(2009-5#10)(2009-7#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#3)
who have suffered a##4##4##(2005-7#1)(2007-9#1)(2008-12#1)(2009-10#1)
who have suffered##7##3##(1995-11#1)(2005-7#1)(2006-10#1)(2007-9#2)(2008-12#1)(2009-10#1)
who have survived##3##3##(1990-5#1)(2009-5#1)(2009-6#1)
who have sustained##3##3##(2006-7#1)(2010-9#1)(2013-1#1)
who have taken##2##3##(1994-9#1)(2010-9#1)
who have the clinical##3##4##(1992-3#1)(2004-11#1)(2010-10#1)
who have the##14##3##(1992-3#1)(1996-2#1)(1997-3#1)(2004-11#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-2#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)
who have undergone##24##3##(1990-9#1)(1991-4#1)(1992-8#1)(1996-3#1)(2004-12#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-8#1)(2007-12#1)(2008-5#1)(2008-7#2)(2010-10#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
who have used##3##3##(2006-5#1)(2007-9#1)(2012-1#1)
who have worked in the##2##5##(2006-1#1)(2012-11#1)
who have worked##3##3##(2004-9#1)(2006-1#1)(2012-11#1)
who have##440##2##(1990-10#3)(1990-11#2)(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-10#2)(1992-2#1)(1992-3#5)(1992-6#2)(1992-8#2)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-5#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-4#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#2)(1995-1#2)(1995-11#2)(1995-12#3)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-6#1)(2004-1#3)(2004-11#1)(2004-12#1)(2004-3#2)(2004-9#2)(2005-10#1)(2005-5#2)(2005-6#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-1#4)(2006-10#19)(2006-11#2)(2006-12#1)(2006-2#1)(2006-5#3)(2006-6#1)(2006-7#3)(2006-8#4)(2006-9#9)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#15)(2007-2#4)(2007-3#3)(2007-4#1)(2007-5#1)(2007-7#7)(2007-8#12)(2007-9#13)(2008-1#5)(2008-10#5)(2008-11#9)(2008-12#7)(2008-2#10)(2008-3#8)(2008-4#7)(2008-5#11)(2008-6#4)(2008-7#9)(2008-8#3)(2008-9#3)(2009-10#3)(2009-12#2)(2009-3#1)(2009-5#16)(2009-6#4)(2009-7#4)(2009-9#2)(2010-1#3)(2010-10#4)(2010-11#2)(2010-12#7)(2010-2#4)(2010-3#4)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#5)(2011-1#11)(2011-12#2)(2011-2#12)(2012-1#4)(2012-11#4)(2012-12#13)(2012-2#9)(2012-3#7)(2013-1#15)(2013-8#5)
who heads##2##2##(1992-8#1)(1997-2#1)
who hear##2##2##(1996-5#1)(2006-3#1)
who held##3##2##(2007-11#1)(2012-2#1)(2013-1#1)
who helped##2##2##(1996-11#1)(2012-12#1)
who highly##2##2##(2005-1#1)(2007-12#1)
who hold##2##2##(2008-1#1)(2012-1#1)
who identified##2##2##(2007-12#1)(2008-5#1)
who identify with the##3##4##(2005-5#1)(2010-3#1)(2010-8#1)
who identify##6##2##(2005-5#1)(2008-11#1)(2008-12#1)(2010-3#1)(2010-8#1)(2012-3#1)
who implement##2##2##(1993-2#1)(1994-2#1)
who in turn##2##3##(1992-1#1)(1996-3#1)
who in##8##2##(1992-1#1)(1996-3#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-8#1)(2011-2#1)(2013-8#1)
who ingested##3##2##(1996-3#1)(2010-2#1)(2010-5#1)
who initially presented with##2##4##(2010-7#1)(2011-2#1)
who initially##4##2##(1993-8#1)(1996-6#1)(2010-7#1)(2011-2#1)
who initiated##4##2##(2007-3#1)(2012-2#2)(2013-1#1)
who inject drugs##5##3##(2008-3#1)(2010-12#1)(2013-1#3)
who intend to##3##3##(2008-2#1)(2010-12#1)(2011-2#1)
who introduced##2##2##(2006-10#1)(2007-1#1)
who is a##7##3##(1993-2#1)(2005-2#3)(2008-8#1)(2009-4#1)(2012-2#1)
who is also##2##3##(1992-12#1)(2010-9#1)
who is at##3##3##(1994-2#1)(1997-1#1)(2011-2#1)
who is familiar with##2##4##(2007-11#1)(2007-2#1)
who is likely to##2##4##(1990-8#1)(2007-10#1)
who is not##4##3##(1994-7#1)(2010-12#1)(2010-5#1)(2011-2#1)
who is responsible for##2##4##(1996-1#1)(2006-9#1)
who is responsible?##3##3##(1993-10#1)(1995-12#1)(2012-12#1)
who is seeking to develop or enhance his or her colposcopic skills##7##12##(2006-10#7)
who is seeking to develop or enhance his or her##8##10##(2006-10#8)
who is the##4##3##(1995-3#1)(2006-12#1)(2008-1#1)(2008-7#1)
who is to##2##3##(2007-8#1)(2010-12#1)
who is##86##2##(1990-11#1)(1990-12#1)(1990-8#2)(1991-4#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#1)(1993-10#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-12#2)(1995-3#1)(1995-9#1)(1996-1#2)(1996-11#2)(1997-1#1)(1997-2#1)(1997-4#2)(2005-2#3)(2005-8#1)(2006-10#9)(2006-12#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#3)(2010-5#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
who kept##3##2##(1995-8#3)
who knew their##2##3##(1990-6#1)(2012-3#1)
who knew##4##2##(1990-6#1)(2008-2#1)(2012-1#1)(2012-3#1)
who lack a##2##3##(1994-3#1)(2008-10#1)
who lack p67phox##2##3##(1994-3#2)
who lack the##2##3##(2007-12#1)(2007-8#1)
who lack##9##2##(1994-3#3)(1996-6#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-8#1)
who lacked##2##2##(2008-1#1)(2008-9#1)
who later underwent##2##3##(1994-2#1)(2008-6#1)
who later##7##2##(1990-8#1)(1991-12#1)(1994-2#1)(2007-10#1)(2008-6#1)(2010-12#1)(2013-8#1)
who learned##3##2##(2009-10#3)
who leave the##2##3##(1996-1#1)(2007-3#1)
who leave##5##2##(1992-3#1)(1993-7#1)(1996-1#1)(2007-3#1)(2009-4#1)
who left##3##2##(1994-3#1)(1994-6#1)(2011-2#1)
who live in##4##3##(1996-12#1)(2007-1#1)(2007-2#1)(2008-7#1)
who live with their##2##4##(1992-1#1)(2008-6#1)
who live with##3##3##(1992-1#1)(2008-6#1)(2009-7#1)
who live##10##2##(1992-1#1)(1996-12#1)(2006-10#1)(2007-1#1)(2007-2#1)(2008-6#1)(2008-7#1)(2009-7#1)(2013-1#2)
who lived in a##2##4##(2007-7#2)
who lived in the##2##4##(2006-7#2)
who lived in##5##3##(2006-7#2)(2007-7#2)(2010-9#1)
who lived##11##2##(1992-3#1)(1992-6#1)(1996-6#1)(2006-7#2)(2007-11#1)(2007-3#1)(2007-7#2)(2008-12#1)(2010-9#1)
who look##3##2##(1991-6#1)(2007-8#1)(2010-6#1)
who lose##2##2##(1995-6#1)(2010-9#1)
who lost his##2##3##(1996-11#1)(2010-12#1)
who lost##6##2##(1994-2#1)(1995-12#1)(1996-11#1)(2010-12#1)(2013-1#2)
who made##5##2##(1992-1#1)(2007-5#1)(2009-10#1)(2010-8#1)(2011-2#1)
who maintained##2##2##(2007-7#1)(2013-1#1)
who make##5##2##(1996-2#1)(1997-3#1)(2004-2#1)(2009-4#1)(2010-2#1)
who manage##3##2##(2006-5#1)(2009-3#1)(2013-8#1)
who manifested##3##2##(2007-7#1)(2009-4#1)(2013-8#1)
who may be at risk for##2##6##(1996-12#1)(2006-12#1)
who may be at risk##3##5##(1996-12#1)(2006-12#1)(2010-10#1)
who may be at##4##4##(1996-12#1)(2006-12#1)(2010-10#1)(2012-1#1)
who may be##13##3##(1996-12#1)(2004-10#1)(2005-10#1)(2006-12#1)(2007-4#1)(2008-11#2)(2008-7#1)(2010-10#1)(2012-1#2)(2013-1#1)(2013-8#1)
who may benefit from##6##4##(2006-10#1)(2006-2#1)(2013-8#4)
who may benefit##7##3##(2006-10#1)(2006-2#1)(2012-2#1)(2013-8#4)
who may develop##2##3##(2005-10#1)(2013-8#1)
who may have##5##3##(1992-3#1)(2006-12#1)(2006-7#1)(2008-7#2)
who may not have##2##4##(1993-12#1)(2008-6#1)
who may not##5##3##(1993-12#1)(2007-12#1)(2008-6#1)(2008-7#1)(2012-12#1)
who may wish to##3##4##(2008-11#1)(2009-1#1)(2012-12#1)
who may##46##2##(1991-4#1)(1992-3#2)(1993-12#1)(1995-12#1)(1996-12#1)(2004-10#1)(2005-10#2)(2006-10#2)(2006-12#2)(2006-2#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-4#2)(2008-11#3)(2008-3#2)(2008-6#1)(2008-7#4)(2009-1#1)(2010-10#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#6)
who meet##3##2##(1993-5#1)(2008-4#1)(2012-12#1)
who meets##2##2##(2011-2#1)(2012-12#1)
who met DSM-III-R criteria for##2##5##(1996-2#1)(2008-7#1)
who met DSM-IV criteria for##2##5##(2008-6#1)(2012-3#1)
who met the inclusion criteria were##2##6##(2010-6#1)(2012-3#1)
who met the inclusion criteria##4##5##(2008-4#1)(2010-6#2)(2012-3#1)
who met the same inclusion##2##5##(2006-10#1)(2012-2#1)
who met the##15##3##(2006-10#1)(2007-10#2)(2007-12#1)(2008-4#1)(2010-6#2)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)
who met##23##2##(1996-2#1)(1996-3#1)(2005-6#1)(2006-10#1)(2007-10#2)(2007-12#1)(2008-1#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-2#1)(2010-6#2)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#1)
who might be##2##3##(2010-3#1)(2013-7#1)
who might benefit##3##3##(1990-12#1)(2008-12#1)(2008-8#1)
who might##10##2##(1990-12#1)(1991-3#1)(1997-8#1)(2006-10#1)(2006-9#1)(2007-9#1)(2008-12#1)(2008-8#1)(2010-3#1)(2013-7#1)
who most often##2##3##(1994-2#1)(2007-6#1)
who most##3##2##(1994-2#1)(2007-6#1)(2008-2#1)
who move##2##2##(1996-1#1)(1997-1#1)
who moved to##2##3##(1991-5#1)(2012-2#1)
who must##10##2##(1991-6#1)(1992-6#1)(1994-1#1)(1995-12#1)(2004-3#1)(2005-5#1)(2006-6#1)(2007-5#1)(2008-12#1)(2008-9#1)
who need it##2##3##(1991-3#1)(1996-12#1)
who need to##5##3##(1993-2#1)(1996-6#1)(2008-2#1)(2008-3#1)(2012-3#1)
who need##19##2##(1990-8#1)(1991-3#1)(1992-10#1)(1993-2#1)(1994-2#1)(1995-1#1)(1996-12#2)(1996-6#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-2#1)(2008-3#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-7#1)
who needed##5##2##(1996-12#1)(2007-3#1)(2007-8#1)(2008-5#1)(2010-7#1)
who needs##5##2##(1993-8#1)(1996-1#1)(2008-4#1)(2008-9#1)(2012-11#1)
who never attended services were##2##5##(2009-5#2)
who never had##2##3##(1990-8#1)(2009-12#1)
who never##11##2##(1990-8#1)(1996-1#1)(1997-3#1)(2007-12#1)(2009-12#1)(2009-5#4)(2011-2#1)(2013-8#1)
who no longer##2##3##(2007-7#1)(2012-12#1)
who obtain##2##2##(2008-2#1)(2011-2#1)
who offer##2##2##(2006-1#1)(2007-2#1)
who often have##2##3##(1992-8#1)(1996-7#1)
who often##5##2##(1992-8#1)(1996-7#1)(1997-8#1)(2007-11#1)(2009-9#1)
who only##2##2##(1996-12#1)(2011-2#1)
who opt for##3##3##(2006-10#1)(2008-10#1)(2013-1#1)
who originate from##2##3##(1993-6#1)(2011-2#1)
who participate in##5##3##(1996-6#1)(1996-9#1)(2007-10#1)(2008-11#2)
who participated in a##9##4##(1995-4#2)(2007-11#1)(2007-2#1)(2008-7#1)(2009-11#1)(2012-1#1)(2012-12#1)(2012-3#1)
who participated in focus groups##2##5##(2008-6#1)(2011-1#1)
who participated in the study were##2##6##(1996-1#1)(2012-1#1)
who participated in the study##3##5##(1996-1#1)(2010-3#1)(2012-1#1)
who participated in the survey##2##5##(1992-11#1)(2008-9#1)
who participated in the##13##4##(1992-11#1)(1994-6#1)(1996-1#1)(2006-12#1)(2007-2#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-7#1)
who participated in this study##2##5##(2010-3#1)(2013-8#1)
who participated in##36##3##(1992-11#1)(1992-2#1)(1994-6#1)(1995-4#2)(1995-6#1)(1996-1#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-2#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-7#1)(2010-2#1)(2010-3#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
who participated##41##2##(1990-12#1)(1992-11#1)(1992-2#1)(1994-6#1)(1995-4#2)(1995-6#1)(1996-1#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-9#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-2#1)(2010-3#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
who participates in the##2##4##(1995-5#1)(1997-3#1)
who participates##3##2##(1995-1#1)(1995-5#1)(1997-3#1)
who pay##3##2##(1992-3#1)(1996-3#1)(2007-4#1)
who perceive##3##2##(1996-6#1)(2007-12#1)(2007-2#1)
who perceived the##3##3##(2009-5#1)(2010-11#1)(2012-12#1)
who perceived##6##2##(2009-5#1)(2009-7#1)(2010-1#1)(2010-11#1)(2012-12#1)(2013-1#1)
who perform##5##2##(1993-6#1)(1995-9#1)(1996-6#1)(1997-6#1)(2011-2#1)
who performed##8##2##(1996-8#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
who performs##2##2##(1995-9#1)(2006-7#1)
who plan##4##2##(2007-2#2)(2013-1#2)
who planned to breastfeed##2##4##(2007-2#2)
who planned to##3##3##(2007-2#3)
who possess##2##2##(1997-6#1)(2013-7#1)
who practice##4##2##(1994-7#1)(2008-8#1)(2008-9#1)(2012-3#1)
who practiced self-medication##2##3##(2007-7#2)
who practiced##4##2##(2004-12#1)(2007-5#1)(2007-7#2)
who predominantly binged on##2##4##(2006-12#2)
who prefer##2##2##(2004-4#1)(2010-5#1)
who present to a##2##4##(2006-8#1)(2007-11#1)
who present to the##2##4##(2007-5#1)(2008-3#1)
who present to##8##3##(2006-8#1)(2007-11#1)(2007-5#1)(2008-3#3)(2009-6#1)(2010-12#1)
who present with this##2##4##(2008-10#1)(2008-5#1)
who present with##31##3##(2004-3#1)(2005-12#1)(2006-10#4)(2007-2#1)(2007-4#1)(2007-7#4)(2008-10#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#2)(2009-11#1)(2009-3#1)(2009-6#1)(2009-7#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
who present##46##2##(1991-9#1)(1992-3#1)(2004-3#1)(2005-12#1)(2006-10#4)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#4)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#6)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-6#2)(2009-7#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
who presented a##2##3##(2006-2#1)(2011-2#1)
who presented at a##2##4##(2008-11#1)(2010-6#1)
who presented at the age of##2##6##(2007-7#2)
who presented at##8##3##(2007-2#1)(2007-6#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-12#1)(2010-6#1)
who presented for##4##3##(1993-4#1)(1993-7#1)(2006-8#1)(2011-1#1)
who presented in##2##3##(2012-2#1)(2013-1#1)
who presented severe##2##3##(2010-9#1)(2013-1#1)
who presented to our institution with##4##6##(2006-10#1)(2007-9#1)(2013-1#2)
who presented to our##9##4##(2006-10#2)(2007-7#1)(2007-9#1)(2008-7#1)(2010-4#1)(2013-1#2)(2013-8#1)
who presented to the emergency department with##2##7##(2007-3#1)(2007-5#1)
who presented to the emergency department##3##6##(2007-10#1)(2007-3#1)(2007-5#1)
who presented to the emergency##4##5##(2007-10#1)(2007-3#1)(2007-5#1)(2009-3#1)
who presented to the##10##4##(1993-6#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-5#2)(2008-10#1)(2009-3#1)(2009-6#1)(2009-9#1)
who presented to us with##2##5##(2007-7#1)(2012-3#1)
who presented to##26##3##(1993-6#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-5#2)(2007-7#2)(2007-9#1)(2008-10#1)(2008-7#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
who presented with a history of##4##6##(2007-2#1)(2008-12#1)(2011-1#1)(2012-2#1)
who presented with a painless swelling##2##6##(2007-7#1)(2011-2#1)
who presented with a painless##5##5##(2007-7#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-3#1)
who presented with a right##2##5##(2007-12#2)
who presented with a##40##4##(1991-12#1)(1992-10#1)(1993-12#1)(1996-6#1)(2006-10#2)(2006-2#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-3#1)(2009-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#3)
who presented with abdominal##3##4##(2010-9#1)(2013-1#2)
who presented with acute##6##4##(2006-9#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-6#1)(2010-8#1)
who presented with an acute##2##5##(2008-6#1)(2009-9#1)
who presented with an##11##4##(2006-10#1)(2008-10#1)(2008-6#1)(2009-9#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)
who presented with and without hepatic dysfunction##2##7##(2005-8#2)
who presented with asymptomatic##2##4##(1994-12#1)(2008-3#1)
who presented with bilateral##5##4##(2007-7#1)(2008-7#1)(2008-8#1)(2010-5#1)(2013-8#1)
who presented with complaints of##3##5##(2007-7#1)(2012-11#1)(2013-7#1)
who presented with diabetes##2##4##(1997-3#1)(2008-5#1)
who presented with elevated serum##3##5##(2009-4#1)(2013-1#2)
who presented with features of##4##5##(2009-10#1)(2009-5#1)(2010-4#1)(2012-2#1)
who presented with features##6##4##(2007-7#1)(2009-10#1)(2009-5#1)(2010-4#1)(2012-2#1)(2012-3#1)
who presented with fever##4##4##(2006-10#1)(2007-11#1)(2009-10#1)(2009-11#1)
who presented with headache and##2##5##(2006-12#1)(2008-12#1)
who presented with headache##3##4##(2006-12#1)(2008-12#1)(2012-12#1)
who presented with hepatosplenomegaly##2##4##(2008-12#1)(2012-2#1)
who presented with jaundice##2##4##(2012-2#1)(2013-1#1)
who presented with metastatic##2##4##(2006-8#1)(2008-6#1)
who presented with pain##2##4##(2006-7#1)(2011-1#1)
who presented with recurrent##4##4##(2008-6#1)(2011-1#1)(2012-12#1)(2012-2#1)
who presented with severe##8##4##(2007-10#1)(2008-5#1)(2009-1#1)(2010-4#1)(2010-5#2)(2011-2#1)(2012-2#1)
who presented with signs and symptoms##2##6##(2006-5#1)(2011-12#1)
who presented with subacute##2##4##(2006-8#1)(2008-10#1)
who presented with subarachnoid haemorrhage##2##5##(2008-7#2)
who presented with subarachnoid##3##4##(2007-9#1)(2008-7#2)
who presented with sudden##2##4##(2007-10#1)(2008-7#1)
who presented with symptoms of##2##5##(2008-6#1)(2012-12#1)
who presented with symptoms##3##4##(2006-10#1)(2008-6#1)(2012-12#1)
who presented with the##4##4##(2006-10#2)(2008-10#1)(2013-1#1)
who presented with visual##2##4##(2005-10#1)(2009-10#1)
who presented with##232##3##(1991-12#1)(1992-10#1)(1992-12#1)(1993-12#2)(1994-12#2)(1996-2#1)(1996-6#1)(1997-3#1)(2005-10#3)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#15)(2006-11#2)(2006-12#2)(2006-2#2)(2006-5#1)(2006-7#1)(2006-8#3)(2006-9#3)(2007-10#2)(2007-11#2)(2007-12#4)(2007-2#2)(2007-4#1)(2007-5#2)(2007-7#9)(2007-8#4)(2007-9#5)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#5)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#10)(2008-7#8)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#4)(2009-11#1)(2009-3#3)(2009-4#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#7)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#10)(2011-12#3)(2011-2#9)(2012-1#1)(2012-11#2)(2012-12#8)(2012-2#13)(2012-3#5)(2013-1#21)(2013-7#4)(2013-8#6)
who presented##298##2##(1990-3#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-10#1)(1992-12#1)(1992-4#1)(1993-12#2)(1993-4#1)(1993-6#1)(1993-7#1)(1994-12#2)(1994-6#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-3#1)(2005-10#3)(2005-8#4)(2005-9#2)(2006-1#1)(2006-10#17)(2006-11#2)(2006-12#4)(2006-2#3)(2006-5#2)(2006-7#1)(2006-8#6)(2006-9#3)(2007-10#3)(2007-11#2)(2007-12#4)(2007-2#4)(2007-3#1)(2007-4#1)(2007-5#4)(2007-6#2)(2007-7#13)(2007-8#7)(2007-9#6)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#6)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#10)(2008-7#10)(2008-8#4)(2008-9#1)(2009-1#1)(2009-10#4)(2009-11#1)(2009-3#4)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#3)(2010-5#7)(2010-6#4)(2010-8#1)(2010-9#2)(2011-1#12)(2011-12#3)(2011-2#11)(2012-1#1)(2012-11#2)(2012-12#10)(2012-2#15)(2012-3#6)(2013-1#27)(2013-7#4)(2013-8#7)
who presents with a##2##4##(1997-3#1)(2007-12#1)
who presents with##10##3##(1997-3#1)(2006-5#4)(2007-11#1)(2007-12#1)(2008-7#1)(2010-6#1)(2013-7#1)
who presents##14##2##(1991-4#1)(1997-3#1)(2006-5#6)(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#1)(2010-6#1)(2013-7#1)
who previously##2##2##(2007-8#1)(2008-7#1)
who primarily##2##2##(2007-11#1)(2013-8#1)
who produce##3##2##(1996-11#1)(2007-11#1)(2012-3#1)
who promoted the##3##3##(2011-2#2)(2012-3#1)
who provide care##2##3##(1991-2#1)(2008-9#1)
who provide outreach and services to Latinos##2##7##(2012-11#2)
who provide##13##2##(1991-2#1)(1993-12#1)(1995-3#1)(1997-1#1)(2007-2#2)(2007-4#1)(2008-11#1)(2008-9#2)(2009-11#1)(2012-11#2)
who provided##7##2##(1996-5#1)(1997-3#1)(2008-11#1)(2009-10#1)(2010-3#1)(2012-12#1)(2013-1#1)
who provides services##2##3##(1994-1#1)(2008-9#1)
who provides us with the##2##5##(2008-11#2)
who provides##5##2##(1994-1#1)(1997-3#1)(2008-11#2)(2008-9#1)
who purchase##2##2##(1993-3#1)(2012-12#1)
who quit smoking##2##3##(2008-11#1)(2013-1#1)
who quit##3##2##(2008-11#1)(2008-6#1)(2013-1#1)
who ranged##2##2##(2006-6#1)(2006-8#1)
who rarely##2##2##(1993-6#1)(2007-7#1)
who reached the##2##3##(2006-9#1)(2007-9#1)
who reached##4##2##(1993-9#1)(2006-9#1)(2007-9#1)(2008-6#1)
who read##2##2##(2007-12#1)(2010-11#1)
who receive adjuvant chemotherapy##2##4##(2006-9#2)
who receive the##2##3##(1994-6#1)(1997-8#1)
who receive them##2##3##(2008-2#1)(2008-4#1)
who receive##28##2##(1994-5#1)(1994-6#2)(1996-12#1)(1997-6#1)(1997-8#2)(2006-10#1)(2006-5#1)(2006-9#3)(2007-1#1)(2007-11#2)(2007-8#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-11#1)(2010-2#1)(2010-4#2)(2011-2#1)(2012-2#1)(2013-8#1)
who received a total##2##4##(2007-2#1)(2010-7#1)
who received a##15##3##(1992-10#1)(1993-1#1)(1995-9#1)(2006-8#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
who received an##5##3##(1995-4#1)(2007-10#1)(2007-8#2)(2012-2#1)
who received and##2##3##(1993-10#1)(2007-7#1)
who received antegrade##2##3##(2007-9#2)
who received general##2##3##(1993-4#1)(2010-7#1)
who received home care##2##4##(2006-7#1)(2011-2#1)
who received home##4##3##(1997-4#1)(2006-7#1)(2011-2#1)(2012-12#1)
who received injection##3##3##(2013-1#3)
who received multiple infusions of infliximab##2##6##(2007-11#2)
who received multiple##3##3##(2007-11#3)
who received no##3##3##(2007-8#1)(2011-1#1)(2013-1#1)
who received placebo##2##3##(2004-3#1)(2010-7#1)
who received prednisolone##2##3##(2007-8#2)
who received radiotherapy##3##3##(1992-12#1)(2008-6#2)
who received t-PA##2##3##(2007-9#2)
who received the intervention##2##4##(2008-12#1)(2010-3#1)
who received the##15##3##(1992-6#1)(2005-8#1)(2006-10#2)(2006-3#2)(2007-11#1)(2007-3#1)(2007-8#3)(2008-12#1)(2009-8#1)(2010-3#1)(2010-4#1)
who received various##2##3##(2007-11#1)(2008-11#1)
who received##195##2##(1990-11#1)(1990-12#1)(1990-6#3)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-1#3)(1993-10#1)(1993-3#1)(1993-4#2)(1993-7#1)(1994-6#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-6#1)(1997-4#1)(2004-2#1)(2004-3#1)(2005-10#2)(2005-6#3)(2005-8#2)(2006-10#4)(2006-11#2)(2006-12#3)(2006-3#2)(2006-5#1)(2006-7#1)(2006-8#5)(2007-10#2)(2007-11#10)(2007-12#3)(2007-2#3)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#17)(2007-9#6)(2008-1#8)(2008-10#2)(2008-11#6)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#7)(2008-7#9)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#3)(2011-2#9)(2012-12#1)(2012-2#8)(2012-3#2)(2013-1#7)(2013-8#3)
who refer##2##2##(2007-4#1)(2008-2#1)
who referred##2##2##(2008-3#1)(2011-1#1)
who refuse##4##2##(1990-12#1)(2007-11#1)(2008-12#2)
who refused to##3##3##(1992-12#1)(1995-6#1)(1996-11#1)
who refused##5##2##(1992-12#1)(1995-12#1)(1995-6#1)(1996-11#1)(2007-3#1)
who refuses##3##2##(1992-12#1)(1993-5#1)(2008-12#1)
who regularly##3##2##(1994-3#1)(1995-5#1)(2010-9#1)
who relapsed or did not respond##2##6##(2007-11#2)
who relapsed or##3##3##(2007-11#2)(2013-7#1)
who relapsed##8##2##(1990-8#1)(1997-4#1)(2007-10#1)(2007-11#3)(2011-2#1)(2013-7#1)
who remain##4##2##(1993-2#1)(1993-8#1)(2008-10#1)(2012-2#1)
who remained in##2##3##(1990-9#1)(2004-3#1)
who remained on##2##3##(1992-11#1)(2009-9#1)
who remained##6##2##(1990-9#1)(1992-11#1)(2004-3#1)(2006-10#1)(2008-10#1)(2009-9#1)
who remember##2##2##(2008-3#1)(2009-2#1)
who repeatedly##3##2##(2006-12#1)(2007-7#1)(2012-2#1)
who report##7##2##(1996-6#1)(2006-7#1)(2007-12#1)(2010-12#1)(2010-2#1)(2013-1#1)(2013-8#1)
who reported being##2##3##(2009-4#1)(2009-5#1)
who reported high##2##3##(2008-11#1)(2008-7#1)
who reported that##3##3##(1993-1#2)(2013-7#1)
who reported##37##2##(1990-8#1)(1993-1#4)(1993-5#1)(1993-9#1)(1994-1#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-11#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#2)(2009-5#2)(2009-8#1)(2010-1#1)(2010-12#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
who represented##2##2##(1991-8#1)(2008-12#1)
who requested##2##2##(2007-9#1)(2011-1#1)
who require long-term##3##3##(1990-12#1)(1992-1#1)(1993-6#1)
who require##23##2##(1990-12#1)(1992-1#2)(1993-6#1)(1994-6#1)(2005-6#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-9#1)(2010-10#1)(2010-7#1)(2013-8#1)
who required nasogastric tube##2##4##(1990-8#1)(2007-8#1)
who required surgery##2##3##(1993-2#1)(2012-2#1)
who required##26##2##(1990-8#2)(1993-1#1)(1993-2#1)(1994-1#1)(1994-12#1)(1995-8#1)(1996-12#1)(1996-3#1)(2006-4#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#1)(2011-2#1)(2012-2#2)(2013-1#1)
who requires##3##2##(1990-12#1)(2007-8#1)(2008-3#1)
who reside in##2##3##(1992-6#1)(2010-4#1)
who resided in##3##3##(2007-10#1)(2009-7#1)(2013-8#1)
who respond to##3##3##(1994-2#1)(2007-7#1)(2013-1#1)
who respond##4##2##(1993-11#1)(1994-2#1)(2007-7#1)(2013-1#1)
who responded to the survey##2##5##(2007-9#1)(2013-1#1)
who responded to the##4##4##(1992-8#1)(1996-4#1)(2007-9#1)(2013-1#1)
who responded to##11##3##(1992-8#1)(1993-12#1)(1996-4#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-9#1)(2010-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
who responded well to##2##4##(1991-2#1)(2006-10#1)
who responded##18##2##(1991-2#1)(1992-8#1)(1993-12#1)(1996-4#1)(2004-3#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-9#2)(2010-2#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
who return##2##2##(1995-5#1)(2013-1#1)
who returned from##2##3##(2007-2#1)(2011-1#1)
who returned##5##2##(2007-2#1)(2008-11#1)(2009-10#1)(2011-1#1)(2011-2#1)
who reviewed##2##2##(2005-8#1)(2011-2#1)
who routinely##3##2##(1995-9#1)(2006-10#1)(2009-4#1)
who said##4##2##(1995-6#1)(1996-11#1)(2008-10#1)(2009-4#1)
who saw a##2##3##(2008-7#1)(2010-11#1)
who say##2##2##(2007-9#2)
who score##2##2##(2009-7#1)(2011-2#1)
who scored at least 70 on the##2##7##(2008-1#2)
who scored##7##2##(2007-7#1)(2008-1#4)(2008-7#1)(2008-9#1)
who see##2##2##(2004-3#1)(2008-11#1)
who seek treatment##2##3##(2008-3#1)(2012-11#1)
who seek##10##2##(1993-2#1)(2004-12#1)(2008-3#1)(2009-5#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#1)
who seem to##2##3##(1990-3#1)(1995-1#1)
who selected##2##2##(1996-12#1)(2007-4#1)
who self-identified as##2##3##(2008-3#1)(2010-7#1)
who self-refer##2##2##(2007-4#2)
who self-reported##2##2##(2008-3#1)(2011-1#1)
who serve as##2##3##(1994-2#1)(2005-12#1)
who serve##3##2##(1994-2#2)(2005-12#1)
who served in##2##3##(2010-11#1)(2011-2#1)
who served##5##2##(1993-2#1)(1995-4#1)(2010-1#1)(2010-11#1)(2011-2#1)
who share##6##2##(2005-10#1)(2007-4#1)(2008-1#1)(2008-4#1)(2008-6#1)(2009-9#1)
who should be treated##2##4##(1991-8#1)(2012-3#1)
who should be##7##3##(1991-8#1)(2006-10#2)(2006-4#1)(2008-2#1)(2008-4#1)(2012-3#1)
who should do what?##2##4##(1993-12#1)(1993-7#1)
who should have a thorough understanding of how it works##3##10##(2008-4#2)(2008-9#1)
who should have##6##3##(1993-10#1)(1994-8#1)(2008-4#2)(2008-9#1)(2012-2#1)
who should undergo##3##3##(2012-2#1)(2013-1#2)
who should##25##2##(1991-8#1)(1993-10#1)(1993-12#1)(1993-7#1)(1994-8#1)(2006-10#2)(2006-2#1)(2006-4#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-9#1)(2010-5#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
who show that##2##3##(2007-9#2)
who show##4##2##(2007-9#2)(2008-5#1)(2013-1#1)
who showed a##4##3##(1992-10#1)(2007-8#1)(2009-8#1)(2012-12#1)
who showed no##3##3##(1995-10#1)(2006-12#1)(2007-7#1)
who showed##23##2##(1990-10#1)(1991-11#1)(1992-10#1)(1993-6#1)(1994-2#1)(1995-10#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-7#2)(2007-8#2)(2008-12#1)(2008-4#1)(2008-7#1)(2009-8#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
who simultaneously##2##2##(1994-4#1)(2013-8#1)
who smoke##6##2##(1993-6#1)(1993-8#1)(1994-7#2)(2007-1#1)(2008-1#1)
who smoked (2##2##3##(2011-2#2)
who smoked##7##2##(1990-12#1)(2007-2#1)(2009-9#1)(2011-2#3)(2013-8#1)
who sought medical advice##2##4##(2007-7#1)(2013-1#1)
who sought##7##2##(2006-8#1)(2007-2#1)(2007-7#1)(2008-3#1)(2009-9#1)(2011-2#1)(2013-1#1)
who speak##2##2##(2005-10#1)(2011-1#1)
who spent more time in##2##5##(2009-7#2)
who spent more time##3##4##(2009-7#2)(2010-4#1)
who spent more##4##3##(2006-8#1)(2009-7#2)(2010-4#1)
who spent##5##2##(2006-8#1)(2008-12#1)(2009-7#2)(2010-4#1)
who spoke##4##2##(1992-8#2)(2008-10#1)(2009-8#1)
who started sexual activity##2##4##(2013-8#2)
who started##7##2##(1996-4#1)(2006-8#1)(2007-2#1)(2011-2#2)(2013-8#2)
who stayed in##3##3##(2006-8#1)(2007-1#1)(2012-3#1)
who stayed##5##2##(1994-8#1)(2006-8#1)(2007-1#1)(2012-3#1)(2013-1#1)
who stopped##5##2##(1990-12#2)(1996-12#1)(2005-9#1)(2012-2#1)
who study the##4##3##(1991-7#1)(2007-3#1)(2007-9#2)
who study##6##2##(1991-7#1)(2007-3#1)(2007-9#2)(2008-8#1)(2013-8#1)
who stutter have##2##3##(2008-2#2)
who stutter##12##2##(2008-2#8)(2008-4#1)(2011-12#1)(2012-12#2)
who subsequently##9##2##(1994-3#1)(1995-2#1)(1996-8#1)(1997-1#1)(2006-10#1)(2007-6#1)(2008-6#1)(2010-6#1)(2012-11#1)
who successfully underwent##6##3##(1992-12#1)(2007-3#1)(2008-11#2)(2008-3#1)(2010-12#1)
who successfully##8##2##(1992-12#1)(2005-8#1)(2007-3#1)(2007-7#1)(2008-11#2)(2008-3#1)(2010-12#1)
who suffer from chronic##2##4##(2008-11#1)(2012-2#1)
who suffer from##18##3##(1990-5#1)(2005-3#1)(2006-10#1)(2006-7#1)(2007-10#2)(2007-5#1)(2008-1#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-3#2)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
who suffer serious##2##3##(2007-10#1)(2008-7#1)
who suffer##32##2##(1990-5#1)(1997-2#1)(2004-3#1)(2005-3#1)(2005-8#1)(2006-10#2)(2006-7#1)(2007-10#4)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#2)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
who suffered a##4##3##(1990-9#1)(1996-12#1)(1996-3#1)(2007-10#1)
who suffered an##3##3##(1991-3#1)(2007-8#1)(2013-8#1)
who suffered from acute##2##4##(2007-10#1)(2013-1#1)
who suffered from##23##3##(1990-11#1)(1990-12#1)(1991-11#1)(1992-8#1)(1993-7#1)(1993-9#1)(2005-10#1)(2006-4#1)(2007-10#4)(2007-2#1)(2007-4#1)(2007-8#2)(2008-7#2)(2009-4#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
who suffered##47##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-8#2)(1993-7#1)(1993-9#1)(1996-12#2)(1996-3#1)(1997-3#1)(2005-10#1)(2005-12#1)(2006-4#1)(2007-10#7)(2007-11#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#4)(2008-12#1)(2008-7#2)(2009-4#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
who supported##2##2##(2008-11#2)
who survive##3##2##(2007-10#1)(2008-5#1)(2012-3#1)
who survived after##2##3##(2006-4#1)(2007-8#1)
who survived at least##2##4##(1995-2#1)(1996-12#1)
who survived for##2##3##(2009-2#1)(2011-2#1)
who survived##18##2##(1991-8#2)(1992-6#1)(1993-2#2)(1993-7#1)(1995-2#1)(1995-9#1)(1996-12#1)(2006-10#1)(2006-4#1)(2007-3#1)(2007-8#1)(2008-11#1)(2009-2#1)(2009-6#1)(2011-2#1)(2011-3#1)
who sustain##4##2##(2007-4#1)(2008-7#1)(2009-5#1)(2013-8#1)
who sustained a##11##3##(2006-4#1)(2006-5#1)(2007-10#2)(2008-7#1)(2009-10#1)(2010-1#1)(2012-12#1)(2013-1#3)
who sustained an##2##3##(2012-2#1)(2013-1#1)
who sustained##25##2##(2006-11#1)(2006-4#2)(2006-5#1)(2007-10#4)(2007-3#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#6)
who systematically##2##2##(2006-9#1)(2011-1#1)
who take part in##2##4##(1992-3#1)(2008-11#1)
who take##11##2##(1990-5#1)(1992-3#1)(1995-1#2)(1995-9#1)(1996-2#2)(2007-12#2)(2008-11#1)(2009-12#1)
who tend to##2##3##(2009-12#1)(2010-9#1)
who tested##4##2##(1995-2#1)(2007-6#1)(2008-10#1)(2008-3#1)
who the##2##2##(1994-1#1)(1997-1#1)
who themselves##2##2##(1996-11#1)(2006-11#1)
who then##5##2##(1993-6#1)(2006-3#1)(2007-4#1)(2007-8#1)(2013-1#1)
who they##2##2##(1997-3#1)(2007-2#1)
who thought##4##2##(2007-11#1)(2008-10#1)(2009-3#1)(2012-3#1)
who took part in##2##4##(1995-6#1)(2012-12#1)
who took##14##2##(1995-6#1)(1996-6#1)(1996-7#2)(2007-10#2)(2007-7#1)(2007-8#1)(2008-3#2)(2010-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
who travel through states with##2##5##(2012-3#2)
who travel##4##2##(1992-12#1)(2010-3#1)(2012-3#2)
who treat and##2##3##(2007-8#1)(2011-2#1)
who treat##5##2##(1997-8#1)(2005-7#1)(2007-12#1)(2007-8#1)(2011-2#1)
who treats##2##2##(2006-3#1)(2007-5#1)
who tried##2##2##(1993-3#1)(1996-12#1)
who typically##3##2##(2008-11#1)(2008-9#1)(2012-1#1)
who ultimately##2##2##(1991-10#1)(2013-8#1)
who undergo##19##2##(1993-1#1)(1996-5#1)(2005-7#1)(2006-10#3)(2006-12#1)(2007-12#2)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#1)(2009-5#1)(2010-4#1)(2012-12#2)(2013-1#1)
who undertook##2##2##(1990-4#1)(2006-9#1)
who underwent LTx##2##3##(2013-7#2)
who underwent PD+HD therapy##2##4##(2011-2#2)
who underwent a total##4##4##(2010-12#1)(2010-3#1)(2011-12#2)
who underwent a##25##3##(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-7#1)(2007-8#1)(2008-6#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-12#4)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#1)
who underwent an endoscopic##2##4##(2011-2#2)
who underwent an##3##3##(2007-8#1)(2011-2#2)
who underwent atrial##2##3##(2008-11#1)(2012-2#1)
who underwent autologous BMT##2##4##(1995-9#2)
who underwent autologous##3##3##(1995-9#2)(2008-5#1)
who underwent biopsy##3##3##(2010-11#1)(2012-3#1)(2013-7#1)
who underwent cardiac##3##3##(2007-8#1)(2008-11#1)(2012-3#1)
who underwent common##2##3##(2008-7#1)(2013-8#1)
who underwent coronary artery bypass grafting##2##6##(2007-8#2)
who underwent coronary##9##3##(1993-12#1)(2007-8#4)(2007-9#1)(2008-7#1)(2013-4#1)(2013-8#1)
who underwent either##3##3##(2006-8#1)(2009-3#1)(2011-2#1)
who underwent endoscopic##3##3##(2006-5#1)(2011-2#1)(2012-2#1)
who underwent head##2##3##(2010-12#1)(2013-1#1)
who underwent lumbar##2##3##(2006-8#2)
who underwent pulmonary##2##3##(2007-8#1)(2010-8#1)
who underwent radical##4##3##(1994-7#1)(1997-7#1)(2007-11#2)
who underwent resection of##2##4##(2007-11#1)(2012-12#1)
who underwent similar##2##3##(2007-11#1)(2009-2#1)
who underwent simultaneous##2##3##(2007-8#1)(2008-7#1)
who underwent spinal##2##3##(2006-8#1)(2012-3#1)
who underwent successful##4##3##(2007-8#1)(2010-4#1)(2013-1#2)
who underwent surgery after##2##4##(2008-7#1)(2013-1#1)
who underwent surgery at##3##4##(2007-11#2)(2011-2#1)
who underwent surgery for a##2##5##(2008-8#1)(2010-2#1)
who underwent surgery for##8##4##(2006-11#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-8#1)(2009-2#1)(2010-2#1)(2011-1#1)
who underwent surgery in the##2##5##(2006-8#1)(2008-7#1)
who underwent surgery in##4##4##(2006-10#1)(2006-8#1)(2007-11#1)(2008-7#1)
who underwent surgery##24##3##(2006-10#1)(2006-11#1)(2006-8#2)(2007-11#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-2#1)(2010-6#1)(2011-1#2)(2011-2#2)(2013-1#2)
who underwent surgical treatment##2##4##(1993-6#1)(2011-2#1)
who underwent surgical##8##3##(1992-4#1)(1993-6#1)(1996-3#1)(2006-4#1)(2007-7#1)(2007-8#1)(2011-2#1)(2012-3#1)
who underwent the##6##3##(1990-8#1)(2005-5#1)(2006-12#1)(2007-7#1)(2011-2#1)(2012-12#1)
who underwent thoracic##4##3##(2007-8#2)(2008-6#1)(2012-2#1)
who underwent total##7##3##(2007-11#1)(2008-5#2)(2008-8#1)(2011-2#2)(2013-1#1)
who underwent treatment##2##3##(2006-10#1)(2007-11#1)
who underwent##308##2##(1990-10#1)(1990-8#2)(1991-1#2)(1991-11#1)(1991-12#1)(1991-6#2)(1991-8#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-9#2)(1994-3#1)(1994-7#1)(1995-10#1)(1995-9#4)(1996-3#2)(1996-7#1)(1996-9#2)(1997-7#1)(2004-1#1)(2005-10#1)(2005-12#1)(2005-5#4)(2006-10#4)(2006-11#6)(2006-12#7)(2006-4#2)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#11)(2007-10#7)(2007-11#14)(2007-3#3)(2007-7#7)(2007-8#30)(2007-9#6)(2008-1#4)(2008-10#2)(2008-11#4)(2008-3#3)(2008-4#2)(2008-5#7)(2008-6#6)(2008-7#6)(2008-8#2)(2008-9#4)(2009-10#1)(2009-2#2)(2009-3#5)(2009-6#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#3)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#6)(2011-2#31)(2012-1#2)(2012-12#14)(2012-2#10)(2012-3#9)(2013-1#20)(2013-4#1)(2013-7#3)(2013-8#5)
who until##2##2##(2008-2#2)
who use the##2##3##(1996-3#1)(2008-9#1)
who use tobacco##2##3##(1991-5#1)(2005-9#1)
who use##21##2##(1991-5#1)(1992-9#1)(1994-2#1)(1996-3#1)(1997-2#1)(1997-5#1)(2005-10#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#3)(2012-12#1)(2012-3#1)
who used a##2##3##(2008-11#1)(2013-1#1)
who used heroin##2##3##(2012-11#1)(2013-8#1)
who used the##4##3##(1994-5#2)(2008-1#1)(2009-7#1)
who used##25##2##(1994-5#2)(1995-1#1)(1997-4#1)(2005-10#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-7#1)(2010-11#1)(2010-8#1)(2011-12#1)(2012-11#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#3)
who uses##6##2##(1992-12#1)(1994-6#1)(1995-3#1)(2007-2#1)(2008-9#1)(2010-12#1)
who usually##3##2##(2006-10#1)(2007-6#1)(2010-12#1)
who utilized##3##2##(1996-2#2)(2012-3#1)
who view##2##2##(1996-3#1)(2009-12#1)
who viewed their##2##3##(2009-5#1)(2009-7#1)
who viewed##4##2##(2006-7#1)(2007-12#1)(2009-5#1)(2009-7#1)
who visit##2##2##(1992-2#1)(2011-2#1)
who visited the##5##3##(2007-10#1)(2008-2#1)(2010-12#1)(2010-8#1)(2013-8#1)
who visited##9##2##(1994-2#1)(2007-10#1)(2008-2#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
who volunteer##3##2##(1991-12#1)(1993-2#1)(1994-2#1)
who want to take##2##4##(1992-9#1)(1993-12#1)
who want to##12##3##(1992-9#1)(1993-12#1)(1993-3#1)(1994-1#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-7#1)(2010-12#1)(2012-12#1)(2013-8#1)
who wanted to##2##3##(2005-8#1)(2013-1#1)
who wants to##4##3##(2006-7#1)(2008-1#1)(2008-4#1)(2009-10#1)
who was a known##2##4##(2007-11#1)(2013-8#1)
who was a##6##3##(1990-3#1)(2006-11#1)(2007-11#1)(2008-8#1)(2009-7#1)(2013-8#1)
who was admitted for##2##4##(2007-8#1)(2009-4#1)
who was admitted to our##4##5##(2011-2#2)(2012-2#1)(2013-7#1)
who was admitted to##7##4##(1990-5#1)(2006-5#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-7#1)
who was admitted with##5##4##(1997-5#1)(2006-10#1)(2007-8#1)(2011-2#1)(2013-1#1)
who was admitted##15##3##(1990-5#1)(1997-5#1)(2006-10#1)(2006-5#1)(2007-8#2)(2009-4#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
who was awarded the##2##4##(2008-7#1)(2010-7#1)
who was diagnosed as##3##4##(2007-7#1)(2008-11#1)(2009-8#1)
who was diagnosed clinically##2##4##(2006-1#1)(2011-1#1)
who was diagnosed later##2##4##(2008-7#1)(2011-1#1)
who was diagnosed with##7##4##(1994-1#1)(2006-8#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
who was diagnosed##15##3##(1994-1#1)(2006-1#1)(2006-8#1)(2007-7#2)(2008-11#1)(2008-7#1)(2009-8#1)(2010-10#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
who was found to have a##3##6##(2007-8#2)(2008-7#1)
who was found to have##6##5##(2007-8#2)(2008-1#1)(2008-12#1)(2008-7#1)(2009-9#1)
who was found to##7##4##(2007-8#2)(2008-1#1)(2008-12#1)(2008-7#1)(2009-9#1)(2010-9#1)
who was found##9##3##(1997-3#1)(2004-12#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-7#1)(2009-9#1)(2010-9#1)
who was hospitalised##2##3##(2006-2#1)(2007-8#1)
who was hospitalized for##2##4##(1991-10#1)(2011-2#1)
who was hospitalized##4##3##(1991-10#1)(1996-12#1)(1996-3#1)(2011-2#1)
who was infected##2##3##(1996-5#1)(2004-9#1)
who was initially diagnosed with##2##5##(2012-12#1)(2012-3#1)
who was initially diagnosed##3##4##(2008-7#1)(2012-12#1)(2012-3#1)
who was involved in a##2##5##(2012-3#1)(2013-1#1)
who was involved in##3##4##(2012-12#1)(2012-3#1)(2013-1#1)
who was living##2##3##(1995-1#1)(2006-10#1)
who was misdiagnosed##2##3##(2008-7#1)(2009-4#1)
who was not##3##3##(1993-6#1)(1995-3#1)(2008-11#1)
who was on##6##3##(2006-1#1)(2010-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
who was operated on for##2##5##(2007-4#1)(2007-8#1)
who was operated on##3##4##(1996-12#1)(2007-4#1)(2007-8#1)
who was receiving##2##3##(1992-2#1)(2009-2#1)
who was recently##2##3##(2008-10#1)(2008-7#1)
who was referred to##3##4##(2008-12#1)(2009-8#1)(2010-8#1)
who was referred##6##3##(2008-12#2)(2009-7#1)(2009-8#1)(2010-8#1)(2011-2#1)
who was responsible for##2##4##(1997-5#1)(2012-11#1)
who was successfully treated by##3##5##(2008-6#1)(2013-1#2)
who was successfully treated with##4##5##(2007-8#1)(2011-2#2)(2012-3#1)
who was successfully treated##8##4##(1993-10#1)(2007-8#1)(2008-6#1)(2011-2#2)(2012-3#1)(2013-1#2)
who was treated for##2##4##(2009-5#1)(2010-3#1)
who was treated surgically##3##4##(2011-12#1)(2011-2#1)(2013-1#1)
who was treated with##5##4##(1991-9#1)(1997-8#1)(2009-9#1)(2012-12#1)(2012-2#1)
who was treated##13##3##(1991-9#1)(1997-8#1)(2007-8#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
who was##163##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1991-10#1)(1991-11#1)(1991-3#2)(1991-7#2)(1991-9#1)(1992-10#1)(1992-2#1)(1993-10#2)(1993-6#1)(1993-7#1)(1994-1#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-5#5)(1997-8#1)(2004-12#1)(2004-9#1)(2006-1#2)(2006-10#3)(2006-11#1)(2006-2#1)(2006-5#1)(2006-8#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#13)(2008-1#3)(2008-10#1)(2008-11#3)(2008-12#3)(2008-6#2)(2008-7#6)(2008-8#3)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#2)(2011-2#11)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#10)(2013-7#2)(2013-8#3)
who watch##2##2##(1995-2#1)(2009-7#1)
who weaned##2##2##(2009-7#2)
who went home##2##3##(1995-3#2)
who went##5##2##(1991-6#1)(1995-3#2)(2008-1#1)(2011-2#1)
who were &gt##3##3##(1997-3#1)(2007-8#2)
who were able to##2##4##(1996-9#1)(2006-12#1)
who were abstinent##2##3##(2007-2#1)(2013-8#1)
who were administered##3##3##(1992-6#1)(2007-7#1)(2013-1#1)
who were admitted for##3##4##(1991-8#1)(2008-6#1)(2008-7#1)
who were admitted in our##2##5##(2011-2#1)(2013-1#1)
who were admitted in##3##4##(2011-2#1)(2012-3#1)(2013-1#1)
who were admitted to a##2##5##(1990-12#1)(1993-10#1)
who were admitted to our department##2##6##(1991-8#1)(2007-8#1)
who were admitted to our##3##5##(1991-8#1)(2007-8#1)(2012-12#1)
who were admitted to the##5##5##(1992-10#1)(1995-11#1)(2006-6#1)(2007-2#2)
who were admitted to##14##4##(1990-12#1)(1991-8#1)(1992-10#1)(1993-10#1)(1995-11#1)(2006-6#1)(2007-10#1)(2007-2#2)(2007-8#2)(2012-12#1)(2012-2#1)(2013-8#1)
who were admitted with##2##4##(2007-10#1)(2011-2#1)
who were admitted##27##3##(1990-12#1)(1991-8#2)(1992-10#1)(1992-9#1)(1993-10#1)(1995-11#1)(2006-6#1)(2007-10#2)(2007-2#2)(2007-8#2)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
who were advised to discontinue treatment as per the protocol##2##10##(2007-7#2)
who were aged##4##3##(2007-8#1)(2013-8#3)
who were aggressive both online and offline##2##7##(2010-4#2)
who were aggressive##4##3##(2010-4#4)
who were already##2##3##(2007-2#1)(2013-8#1)
who were also##2##3##(1991-9#1)(1994-6#1)
who were and##3##3##(2007-5#1)(2008-5#2)
who were apparently##2##3##(2007-2#1)(2007-8#1)
who were assigned to##2##4##(1991-12#1)(1992-5#1)
who were asymptomatic##2##3##(2007-10#1)(2012-2#1)
who were at##5##3##(1991-11#1)(2006-7#1)(2007-8#1)(2008-11#1)(2008-12#1)
who were attending the##2##4##(2006-2#1)(2011-2#1)
who were being treated##2##4##(2007-2#1)(2008-9#1)
who were being##3##3##(2007-2#1)(2008-9#1)(2009-10#1)
who were born in##7##4##(2004-10#1)(2004-11#1)(2006-10#2)(2009-4#2)(2012-12#1)
who were born to##2##4##(1990-12#1)(2011-1#1)
who were born##12##3##(1990-12#1)(1994-1#1)(1997-8#1)(2004-10#1)(2004-11#1)(2006-10#2)(2008-10#1)(2009-4#2)(2011-1#1)(2012-12#1)
who were categorized##2##3##(2006-12#1)(2012-2#1)
who were classified as##2##4##(2006-10#1)(2009-7#1)
who were confirmed to have##2##5##(2011-2#1)(2013-1#1)
who were considered##5##3##(2007-10#1)(2007-8#1)(2008-12#1)(2008-3#1)(2011-12#1)
who were currently##2##3##(2007-12#1)(2012-3#1)
who were diagnosed as having##3##5##(1996-6#1)(2006-10#1)(2008-9#1)
who were diagnosed with##8##4##(1994-2#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-6#1)(2011-12#1)(2011-2#1)(2012-3#1)
who were diagnosed##13##3##(1994-2#1)(1996-6#1)(2006-10#2)(2006-3#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-6#1)(2008-9#1)(2011-12#1)(2011-2#1)(2012-3#1)
who were discharged from##4##4##(1992-11#1)(2012-2#1)(2013-1#2)
who were discharged with##2##4##(2006-1#1)(2012-12#1)
who were discharged##9##3##(1992-11#1)(1992-6#1)(2006-1#1)(2007-10#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#2)
who were divided into##4##4##(2008-9#1)(2011-1#1)(2011-2#1)(2013-7#1)
who were divided##5##3##(2007-11#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-7#1)
who were either treated##2##4##(2007-10#1)(2007-9#1)
who were either##7##3##(1992-2#1)(2007-10#1)(2007-2#1)(2007-9#1)(2008-6#1)(2010-11#1)(2013-8#1)
who were eligible for##2##4##(2007-10#1)(2012-3#1)
who were eligible##3##3##(1990-6#1)(2007-10#1)(2012-3#1)
who were employed##2##3##(1993-3#1)(1994-2#1)
who were enrolled in a##3##5##(2007-12#1)(2007-2#1)(2012-3#1)
who were enrolled in an##2##5##(2007-1#1)(2009-11#1)
who were enrolled in the##2##5##(2006-10#1)(2012-12#1)
who were enrolled in##10##4##(2006-10#1)(2007-1#1)(2007-12#1)(2007-2#1)(2008-7#1)(2009-11#1)(2012-12#2)(2012-3#1)(2013-1#1)
who were enrolled##11##3##(2006-10#1)(2007-1#1)(2007-12#1)(2007-2#1)(2008-7#1)(2009-11#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
who were examined for##2##4##(1993-3#1)(1994-6#1)
who were examined##5##3##(1991-3#1)(1993-3#2)(1994-6#1)(1996-6#1)
who were experiencing##3##3##(2007-8#1)(2008-7#1)(2011-2#1)
who were exposed to##5##4##(1991-7#1)(2008-8#1)(2009-12#1)(2009-7#1)(2012-12#1)
who were followed for##4##4##(1997-2#1)(2006-10#1)(2006-7#1)(2011-1#1)
who were followed up##3##4##(1995-12#1)(2006-10#1)(2008-10#1)
who were followed##10##3##(1991-9#1)(1995-12#1)(1997-2#1)(2006-10#2)(2006-7#1)(2007-12#1)(2008-10#1)(2011-1#1)(2012-3#1)
who were found to have##3##5##(1996-12#1)(2007-3#2)
who were found to##4##4##(1996-12#1)(2004-10#1)(2007-3#2)
who were free of##3##4##(2007-9#1)(2008-10#1)(2008-3#1)
who were generally##2##3##(1996-3#1)(2007-10#1)
who were given##6##3##(1997-8#1)(2005-10#1)(2007-12#1)(2008-5#1)(2012-2#1)(2012-3#1)
who were hospitalized for##2##4##(2006-7#1)(2009-12#1)
who were hospitalized##5##3##(2006-7#1)(2006-8#1)(2009-12#1)(2011-1#1)(2012-2#1)
who were identified as##2##4##(2006-8#1)(2008-12#1)
who were identified##3##3##(1990-6#1)(2006-8#1)(2008-12#1)
who were in stable##2##4##(1991-12#1)(2006-7#1)
who were in the age group of##2##7##(2013-8#2)
who were in the##3##4##(2010-11#1)(2013-8#2)
who were in##11##3##(1991-10#1)(1991-12#1)(1996-7#1)(2006-7#1)(2007-11#1)(2009-6#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-8#2)
who were included in the##2##5##(2007-7#1)(2008-12#1)
who were infected with##2##4##(1993-9#1)(2010-12#1)
who were infected##3##3##(1991-8#1)(1993-9#1)(2010-12#1)
who were interviewed##5##3##(2007-2#1)(2008-11#1)(2009-4#1)(2009-6#1)(2013-8#1)
who were investigated for##2##4##(2009-6#1)(2010-12#1)
who were investigated##3##3##(2008-7#1)(2009-6#1)(2010-12#1)
who were involuntarily##2##3##(2007-2#2)
who were involved in a##3##5##(2007-2#1)(2008-11#1)(2010-11#1)
who were involved in##4##4##(1995-1#1)(2007-2#1)(2008-11#1)(2010-11#1)
who were judged##2##3##(1990-8#1)(1995-2#1)
who were managed##2##3##(2008-3#1)(2009-10#1)
who were married##3##3##(1994-6#1)(2007-12#1)(2013-1#1)
who were more##4##3##(1994-1#1)(2007-12#2)(2008-12#1)
who were negative##3##3##(1991-7#1)(1991-9#1)(2007-8#1)
who were newly##2##3##(1995-2#1)(2008-3#1)
who were not exposed to##2##5##(2007-1#1)(2007-5#1)
who were not receiving##2##4##(2005-8#1)(2008-7#1)
who were not treated with##2##5##(1997-3#1)(2007-8#1)
who were not##34##3##(1991-8#1)(1992-10#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-5#1)(1993-8#1)(1996-3#1)(1997-3#1)(1997-7#1)(2005-8#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-2#2)(2007-5#2)(2007-7#1)(2007-8#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#2)(2010-6#1)(2011-1#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
who were obese##3##3##(2006-8#1)(2008-3#1)(2012-2#1)
who were observed##2##3##(2008-7#1)(2012-12#1)
who were of##2##3##(2006-8#1)(2009-11#1)
who were on##8##3##(2007-7#1)(2007-9#1)(2008-1#1)(2008-8#1)(2011-2#1)(2013-8#3)
who were operated##7##3##(1996-9#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-1#1)(2012-2#1)(2013-8#1)
who were overweight##3##3##(1995-12#1)(2008-10#2)
who were participants in an##2##5##(1995-1#1)(2011-2#1)
who were positive for##5##4##(1990-8#1)(1991-7#1)(1991-9#1)(1992-11#1)(2008-4#1)
who were postmenopausal##2##3##(1992-1#1)(2008-7#1)
who were prescribed##2##3##(2006-8#1)(2008-4#1)
who were questioned##2##3##(1996-8#1)(2012-12#1)
who were randomly##2##3##(2010-3#1)(2013-8#1)
who were raped##2##3##(1991-10#1)(2007-12#1)
who were receiving##9##3##(1993-10#1)(2006-10#1)(2006-7#1)(2007-8#4)(2012-3#1)(2013-1#1)
who were recruited##3##3##(2006-7#1)(2008-4#1)(2011-12#1)
who were referred for##2##4##(2006-9#1)(2007-9#1)
who were referred to our center##2##6##(2007-2#1)(2007-7#1)
who were referred to our##3##5##(1997-1#1)(2007-2#1)(2007-7#1)
who were referred to the##4##5##(2006-10#1)(2006-8#1)(2007-8#1)(2008-7#1)
who were referred to##10##4##(1997-1#1)(2006-10#2)(2006-8#1)(2007-2#3)(2007-7#1)(2007-8#1)(2008-7#1)
who were referred##12##3##(1997-1#1)(2006-10#2)(2006-8#1)(2006-9#1)(2007-2#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-7#1)
who were registered##3##3##(1990-10#1)(1993-1#1)(2007-10#1)
who were resistant to##2##4##(2007-4#1)(2010-12#1)
who were scheduled for##5##4##(1990-12#1)(1993-1#1)(1996-3#1)(2006-12#1)(2006-6#1)
who were scheduled##6##3##(1990-12#1)(1993-1#1)(1996-3#1)(2006-12#1)(2006-6#1)(2012-12#1)
who were seeking##3##3##(1996-1#1)(1997-2#1)(2012-12#1)
who were sent to##2##4##(2007-10#1)(2010-10#1)
who were severely##2##3##(2007-1#1)(2008-1#1)
who were sexually active##2##4##(2007-7#1)(2013-1#1)
who were sexually##3##3##(1996-11#1)(2007-7#1)(2013-1#1)
who were smokers##2##3##(2008-4#1)(2011-2#1)
who were still##4##3##(1994-6#2)(2006-7#1)(2007-1#1)
who were studied##2##3##(1994-4#1)(2008-4#1)
who were symptomatic at baseline##2##5##(2012-2#1)(2012-3#1)
who were symptomatic##3##3##(2008-1#1)(2012-2#1)(2012-3#1)
who were taking##4##3##(2006-7#1)(2006-8#1)(2007-8#1)(2013-1#1)
who were tested##2##3##(2008-8#1)(2010-8#1)
who were the##2##3##(1994-1#1)(2010-2#1)
who were then##2##3##(1996-3#1)(2008-9#1)
who were treated at the Clinic of##2##7##(2007-7#1)(2010-12#1)
who were treated at the##4##5##(1993-9#1)(2007-7#1)(2010-12#1)(2012-2#1)
who were treated at##7##4##(1993-9#1)(2007-3#1)(2007-7#2)(2010-12#1)(2012-2#2)
who were treated between##2##4##(2008-10#1)(2012-3#1)
who were treated by##6##4##(1995-11#1)(1996-11#1)(1996-3#1)(2006-5#1)(2007-11#1)(2008-7#1)
who were treated for##4##4##(1993-9#1)(2008-11#1)(2008-4#1)(2009-3#1)
who were treated in our department##2##6##(2008-1#1)(2012-2#1)
who were treated in##6##4##(2007-7#1)(2007-8#1)(2008-1#1)(2011-2#2)(2012-2#1)
who were treated successfully with##3##5##(2008-2#1)(2013-1#2)
who were treated with intensive##2##5##(1990-3#1)(2006-10#1)
who were treated with percutaneous##2##5##(2006-8#2)
who were treated with##20##4##(1990-3#1)(1991-12#1)(1992-4#1)(1995-11#2)(2006-10#1)(2006-8#3)(2007-4#1)(2007-7#1)(2007-8#1)(2008-6#1)(2008-7#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
who were treated##52##3##(1990-3#1)(1991-12#1)(1992-4#1)(1993-9#2)(1995-11#3)(1996-11#1)(1996-3#1)(2005-6#1)(2006-10#1)(2006-5#1)(2006-8#3)(2007-11#1)(2007-3#1)(2007-4#1)(2007-7#5)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-3#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#2)
who were unable to##3##4##(2008-8#1)(2011-2#1)(2013-1#1)
who were under psychological stress##2##5##(2008-10#2)
who were under##3##3##(2006-1#1)(2008-10#2)
who were undergoing##9##3##(1990-12#1)(1994-12#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2011-1#1)(2013-8#1)
who were using##3##3##(2007-6#1)(2008-11#1)(2011-1#1)
who were very##2##3##(1997-3#1)(2013-7#1)
who were well##3##3##(1992-7#1)(2009-4#1)(2012-2#1)
who were without##2##3##(1993-1#1)(2005-10#1)
who were younger than##2##4##(1991-2#1)(2007-10#1)
who were younger##4##3##(1991-2#1)(2007-10#1)(2011-2#1)(2012-2#1)
who were##660##2##(1990-10#1)(1990-12#5)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#2)(1990-8#2)(1990-9#1)(1991-10#3)(1991-11#2)(1991-12#3)(1991-2#3)(1991-3#1)(1991-7#3)(1991-8#5)(1991-9#8)(1992-1#1)(1992-10#3)(1992-11#2)(1992-2#5)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-1#3)(1993-10#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#6)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#4)(1994-1#3)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-4#1)(1994-6#6)(1995-1#3)(1995-11#5)(1995-12#4)(1995-2#4)(1995-3#1)(1995-5#1)(1995-7#1)(1996-1#3)(1996-11#2)(1996-12#1)(1996-3#6)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#3)(2004-10#3)(2004-11#1)(2004-2#1)(2005-10#4)(2005-6#1)(2005-8#1)(2006-1#4)(2006-10#18)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#3)(2006-7#11)(2006-8#13)(2006-9#1)(2007-1#5)(2007-10#16)(2007-11#5)(2007-12#13)(2007-2#25)(2007-3#4)(2007-4#3)(2007-5#4)(2007-6#3)(2007-7#17)(2007-8#25)(2007-9#5)(2008-1#10)(2008-10#10)(2008-11#8)(2008-12#7)(2008-2#1)(2008-3#8)(2008-4#8)(2008-5#7)(2008-6#6)(2008-7#13)(2008-8#10)(2008-9#8)(2009-10#2)(2009-11#2)(2009-12#4)(2009-2#3)(2009-3#1)(2009-4#5)(2009-5#6)(2009-6#3)(2009-7#4)(2009-9#2)(2010-10#3)(2010-11#3)(2010-12#8)(2010-2#4)(2010-3#2)(2010-4#6)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#13)(2011-12#4)(2011-2#28)(2012-1#4)(2012-11#1)(2012-12#19)(2012-2#22)(2012-3#13)(2012-5#1)(2013-1#20)(2013-7#6)(2013-8#23)
who will be##5##3##(1995-9#1)(2004-3#1)(2007-4#1)(2008-12#1)(2008-6#1)
who will benefit from the##2##5##(2006-10#1)(2008-10#1)
who will benefit most from##2##5##(1997-1#1)(2010-5#1)
who will benefit##5##3##(1997-1#1)(2006-10#2)(2008-10#1)(2010-5#1)
who will develop##2##3##(1993-11#1)(2008-3#1)
who will not##2##3##(1994-5#1)(2010-3#1)
who will perform##2##3##(1990-6#1)(1993-3#1)
who will progress##2##3##(2009-10#1)(2013-7#1)
who will receive##2##3##(1996-12#1)(2008-5#1)
who will suffer##2##3##(2006-10#1)(2008-7#1)
who will take##3##3##(1995-12#1)(2007-9#1)(2008-12#1)
who will work##2##3##(1994-1#1)(1995-6#1)
who will##52##2##(1990-6#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-1#3)(1994-2#1)(1994-5#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-9#1)(1997-1#1)(2004-3#1)(2005-6#1)(2006-10#3)(2006-5#1)(2007-11#1)(2007-4#2)(2007-9#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
who wish to use##3##4##(1991-5#1)(2008-12#1)(2010-5#1)
who wish to##17##3##(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-3#1)(1996-5#1)(2007-12#1)(2007-5#1)(2008-12#3)(2009-5#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
who wish##18##2##(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-3#1)(1996-5#1)(2007-12#1)(2007-5#1)(2008-12#3)(2009-10#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
who wishes to##2##3##(1995-7#1)(2012-3#1)
who witnessed the##3##3##(2008-7#2)(2010-11#1)
who wore the##2##3##(2013-1#2)
who work in##11##3##(1990-3#1)(1991-2#1)(1994-12#1)(1996-12#1)(2005-8#1)(2007-1#1)(2008-12#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
who work with infants##2##4##(2006-10#1)(2012-12#1)
who work with older people##2##5##(2010-10#2)
who work with older##3##4##(1991-12#1)(2010-10#2)
who work with##13##3##(1991-12#1)(1996-1#1)(2005-6#1)(2006-10#1)(2006-3#1)(2006-7#1)(2007-12#1)(2008-11#1)(2009-9#1)(2010-10#2)(2011-2#1)(2012-12#1)
who work within##3##3##(2007-7#1)(2008-1#1)(2010-10#1)
who work##31##2##(1990-3#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1994-12#1)(1996-1#1)(1996-12#1)(2005-6#1)(2005-8#1)(2006-10#1)(2006-3#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-5#1)(2009-9#1)(2010-10#3)(2011-2#3)(2012-12#2)(2013-1#2)
who worked in the##2##4##(2007-7#1)(2013-1#1)
who worked in##7##3##(1993-1#2)(1997-5#1)(2007-5#1)(2007-7#1)(2010-9#1)(2013-1#1)
who worked##11##2##(1993-1#2)(1994-6#1)(1997-3#1)(1997-5#1)(2007-5#1)(2007-7#1)(2008-11#1)(2010-9#1)(2013-1#2)
who works##2##2##(1993-12#1)(2007-8#1)
who would be##5##3##(1994-3#1)(2006-10#1)(2010-3#1)(2012-12#1)(2012-2#1)
who would benefit from##5##4##(2006-10#1)(2007-12#1)(2007-8#1)(2010-9#1)(2013-7#1)
who would benefit##6##3##(2006-10#1)(2007-12#1)(2007-8#1)(2010-4#1)(2010-9#1)(2013-7#1)
who would like to##2##4##(2007-7#1)(2008-5#1)
who would receive##2##3##(1996-12#1)(2006-9#1)
who would##31##2##(1991-7#2)(1993-3#1)(1994-3#1)(1995-12#1)(1996-12#1)(1997-5#1)(2005-9#1)(2006-10#2)(2006-8#1)(2006-9#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#4)(2008-11#1)(2008-5#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
who##6472##1##(1990-10#10)(1990-11#13)(1990-12#31)(1990-2#8)(1990-3#13)(1990-4#11)(1990-5#12)(1990-6#17)(1990-7#1)(1990-8#16)(1990-9#12)(1991-1#4)(1991-10#12)(1991-11#14)(1991-12#24)(1991-2#18)(1991-3#19)(1991-4#14)(1991-5#15)(1991-6#10)(1991-7#16)(1991-8#29)(1991-9#17)(1992-1#17)(1992-10#23)(1992-11#8)(1992-12#16)(1992-2#21)(1992-3#38)(1992-4#8)(1992-5#11)(1992-6#17)(1992-7#4)(1992-8#11)(1992-9#6)(1993-1#24)(1993-10#12)(1993-11#9)(1993-12#32)(1993-2#28)(1993-3#33)(1993-4#3)(1993-5#14)(1993-6#19)(1993-7#15)(1993-8#9)(1993-9#17)(1994-1#17)(1994-11#3)(1994-12#20)(1994-2#31)(1994-3#20)(1994-4#15)(1994-5#6)(1994-6#27)(1994-7#13)(1994-8#2)(1994-9#6)(1995-1#24)(1995-10#3)(1995-11#14)(1995-12#31)(1995-2#20)(1995-3#13)(1995-4#6)(1995-5#7)(1995-6#18)(1995-7#5)(1995-8#5)(1995-9#26)(1996-1#23)(1996-11#22)(1996-12#33)(1996-2#21)(1996-3#27)(1996-4#6)(1996-5#20)(1996-6#27)(1996-7#8)(1996-8#11)(1996-9#18)(1997-1#22)(1997-2#20)(1997-3#26)(1997-4#15)(1997-5#20)(1997-6#12)(1997-7#10)(1997-8#20)(2004-1#6)(2004-10#12)(2004-11#10)(2004-12#10)(2004-2#6)(2004-3#17)(2004-4#1)(2004-9#4)(2005-1#5)(2005-10#32)(2005-11#8)(2005-12#7)(2005-2#3)(2005-3#3)(2005-4#1)(2005-5#9)(2005-6#11)(2005-7#13)(2005-8#28)(2005-9#11)(2006-1#21)(2006-10#218)(2006-11#31)(2006-12#42)(2006-2#29)(2006-3#15)(2006-4#17)(2006-5#33)(2006-6#13)(2006-7#52)(2006-8#91)(2006-9#41)(2007-1#19)(2007-10#107)(2007-11#84)(2007-12#114)(2007-2#125)(2007-3#53)(2007-4#35)(2007-5#29)(2007-6#24)(2007-7#150)(2007-8#215)(2007-9#97)(2008-1#91)(2008-10#79)(2008-11#134)(2008-12#82)(2008-2#50)(2008-3#95)(2008-4#74)(2008-5#89)(2008-6#84)(2008-7#153)(2008-8#55)(2008-9#67)(2009-1#4)(2009-10#32)(2009-11#11)(2009-12#17)(2009-2#22)(2009-3#30)(2009-4#48)(2009-5#54)(2009-6#37)(2009-7#35)(2009-8#19)(2009-9#24)(2010-1#15)(2010-10#31)(2010-11#25)(2010-12#77)(2010-2#37)(2010-3#33)(2010-4#26)(2010-5#33)(2010-6#24)(2010-7#30)(2010-8#26)(2010-9#25)(2011-1#116)(2011-10#1)(2011-12#41)(2011-2#265)(2011-3#3)(2012-1#50)(2012-11#22)(2012-12#156)(2012-2#165)(2012-3#123)(2012-5#1)(2013-1#292)(2013-4#1)(2013-7#44)(2013-8#148)
who's##2##1##(1995-7#1)(2008-2#1)
who?##2##1##(1993-1#1)(2008-12#1)
whole abdomen##2##2##(1991-5#1)(2013-8#1)
whole analysis##3##2##(2008-10#3)
whole and##14##2##(1993-9#1)(1995-1#1)(1995-5#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2009-8#1)(2009-9#1)(2013-8#1)
whole animal##9##2##(1991-9#1)(1994-9#1)(2004-11#1)(2006-10#1)(2007-1#1)(2008-11#1)(2008-7#3)
whole aorta##2##2##(2007-4#2)
whole array of##2##3##(2008-10#1)(2009-2#1)
whole assay##2##2##(1991-5#1)(2008-10#1)
whole bacterial cells##2##3##(2008-10#1)(2008-7#1)
whole bacterial##3##2##(2008-10#1)(2008-7#2)
whole bitumen at pH##2##4##(2005-11#2)
whole blood and##8##3##(1992-4#1)(1994-10#1)(1996-9#2)(2006-6#2)(2008-10#1)(2013-1#1)
whole blood at##3##3##(1992-8#1)(1996-1#1)(2008-10#1)
whole blood by##6##3##(2007-2#1)(2008-10#3)(2008-2#1)(2013-1#1)
whole blood donation##3##3##(2007-9#3)
whole blood from patients with##2##5##(2007-2#1)(2008-4#1)
whole blood from##6##3##(1996-2#1)(2007-2#1)(2008-10#2)(2008-4#1)(2008-5#1)
whole blood in##4##3##(2006-6#1)(2007-2#1)(2007-4#1)(2010-4#1)
whole blood is presented##2##4##(1990-11#1)(1996-7#1)
whole blood is##5##3##(1990-11#1)(1996-7#1)(2007-11#1)(2007-8#1)(2008-10#1)
whole blood method##2##3##(1991-2#1)(2008-4#1)
whole blood of##4##3##(1992-4#1)(1996-11#1)(1996-12#1)(2010-5#1)
whole blood or##3##3##(1990-12#1)(2012-2#1)(2013-8#1)
whole blood relative viscosity and##2##5##(2007-1#2)
whole blood relative viscosity##3##4##(2007-1#3)
whole blood sample##3##3##(1992-7#1)(1995-2#1)(2008-10#1)
whole blood samples##6##3##(2008-10#4)(2008-3#1)(2010-5#1)
whole blood thrombi##3##3##(1990-12#3)
whole blood using##2##3##(2008-10#2)
whole blood was##9##3##(1992-4#1)(1992-8#2)(1996-7#1)(2006-8#1)(2007-9#2)(2008-10#1)(2012-1#1)
whole blood water##4##3##(1993-2#4)
whole blood were##5##3##(1990-12#1)(1994-10#1)(2008-10#2)(2009-4#1)
whole blood with##2##3##(1994-4#1)(2007-11#1)
whole blood##180##2##(1990-11#5)(1990-12#11)(1990-2#1)(1990-8#1)(1991-1#2)(1991-2#2)(1992-4#5)(1992-7#1)(1992-8#5)(1992-9#1)(1993-11#1)(1993-2#6)(1994-10#2)(1994-3#2)(1994-4#1)(1994-8#1)(1995-2#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#4)(1996-2#3)(1996-5#1)(1996-7#2)(1996-9#4)(1997-2#1)(1997-6#1)(2005-8#1)(2006-6#4)(2006-8#2)(2007-1#3)(2007-10#2)(2007-11#4)(2007-2#3)(2007-4#1)(2007-7#1)(2007-8#4)(2007-9#5)(2008-10#28)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#9)(2008-5#1)(2008-8#1)(2008-9#3)(2009-10#2)(2009-11#2)(2009-4#6)(2010-12#1)(2010-4#2)(2010-5#2)(2011-1#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-2#4)(2013-1#3)(2013-8#1)
whole body autoradiography##2##3##(1994-5#1)(2008-10#1)
whole body dose##2##3##(2008-7#2)
whole body glucose##2##3##(2008-1#2)
whole body imaging##2##3##(2012-1#1)(2012-12#1)
whole body in##2##3##(1996-5#1)(2008-1#1)
whole body inflammatory##2##3##(2007-9#1)(2008-10#1)
whole body radiation##2##3##(2009-12#2)
whole body sweat rate##3##4##(2008-5#3)
whole body##59##2##(1991-1#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-9#2)(1993-9#1)(1994-5#1)(1995-12#1)(1996-5#1)(1996-8#1)(1996-9#2)(2004-11#3)(2005-7#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-9#1)(2008-1#3)(2008-10#7)(2008-5#4)(2008-7#6)(2009-12#2)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)
whole bone##2##2##(2009-7#1)(2010-11#1)
whole brain irradiation##2##3##(2005-10#1)(2007-5#1)
whole brain of##2##3##(1996-3#1)(2013-7#1)
whole brain radiotherapy##2##3##(1992-4#1)(2008-6#1)
whole brain was##2##3##(1995-9#1)(2006-8#1)
whole brain##28##2##(1990-10#1)(1990-12#1)(1990-7#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-4#1)(1992-5#1)(1993-4#3)(1995-9#1)(1996-3#1)(1996-5#1)(1997-8#1)(2005-10#1)(2005-12#1)(2006-8#1)(2007-10#1)(2007-5#1)(2007-6#1)(2008-11#2)(2008-6#1)(2008-7#1)(2010-12#1)(2010-2#1)(2013-7#1)
whole brains of##2##3##(1990-7#1)(1991-6#1)
whole brains##3##2##(1990-7#1)(1991-6#1)(2008-11#1)
whole breast irradiation##2##3##(2011-2#1)(2013-1#1)
whole breast##3##2##(2007-11#1)(2011-2#1)(2013-1#1)
whole cell antigens##2##3##(1995-12#1)(2008-5#1)
whole cell current##3##3##(1994-2#1)(1994-3#2)
whole cell extracts##3##3##(1994-8#1)(2008-4#1)(2008-9#1)
whole cell lysates##4##3##(1991-5#1)(1996-5#1)(2008-4#2)
whole cell patch clamp##2##4##(1993-12#1)(1996-1#1)
whole cell patch##3##3##(1993-12#1)(1993-2#1)(1996-1#1)
whole cell patch-clamp##2##3##(1994-6#1)(1997-5#1)
whole cell recording##3##3##(1996-7#1)(2008-11#2)
whole cell##51##2##(1990-11#1)(1990-2#2)(1990-7#1)(1991-12#1)(1991-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#2)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-3#2)(1995-7#1)(1996-1#2)(1996-5#1)(1996-7#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-7#2)(2006-12#1)(2006-2#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-4#3)(2008-5#2)(2008-9#1)(2009-5#1)(2011-3#1)(2012-2#1)
whole cells and##4##3##(1991-8#1)(1995-12#1)(1995-5#1)(2008-1#1)
whole cells from##2##3##(2006-8#1)(2008-9#1)
whole cells were##2##3##(1995-3#1)(1995-7#1)
whole cells within##2##3##(2012-11#2)
whole cells##24##2##(1990-2#1)(1991-3#1)(1991-8#1)(1994-3#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-7#1)(1996-5#1)(1997-8#1)(2006-8#2)(2008-1#2)(2008-10#1)(2008-9#2)(2010-7#1)(2012-11#3)(2013-1#2)
whole chromosome painting##2##3##(2009-2#1)(2012-3#1)
whole chromosome##3##2##(2007-11#1)(2009-2#1)(2012-3#1)
whole chromosomes or##2##3##(1994-12#1)(2012-3#1)
whole coding region##2##3##(1995-10#1)(1997-4#1)
whole coding##3##2##(1995-10#1)(1997-4#1)(2008-8#1)
whole complex##3##2##(1993-8#1)(1997-1#2)
whole concentration range##3##3##(1990-11#1)(1994-9#1)(2008-10#1)
whole concentration##4##2##(1990-11#1)(1994-9#1)(2008-10#2)
whole egg and##2##3##(2011-2#2)
whole embryo culture##4##3##(1993-12#2)(1995-3#2)
whole enzyme##3##2##(1991-8#1)(1995-2#1)(2006-8#1)
whole experimental##2##2##(2008-11#1)(2008-3#1)
whole for part&quot##2##3##(2013-1#2)
whole for##3##2##(2008-2#1)(2013-1#2)
whole genome analysis##3##3##(2008-4#1)(2009-10#1)(2012-3#1)
whole genome of##3##3##(2007-3#1)(2010-3#1)(2011-1#1)
whole genome re-sequence data from##3##5##(2012-1#3)
whole genome scan##2##3##(1997-5#1)(2010-2#1)
whole genome sequence##4##3##(2008-8#1)(2010-10#1)(2011-1#2)
whole genome sequences##3##3##(2008-10#1)(2008-4#1)(2013-1#1)
whole genome sequencing of##3##4##(2012-3#1)(2013-1#2)
whole genome sequencing##6##3##(2008-8#1)(2009-9#1)(2010-5#1)(2012-3#1)(2013-1#2)
whole genome##51##2##(1990-9#1)(1996-5#1)(1997-5#1)(2007-10#1)(2007-3#1)(2008-10#2)(2008-4#2)(2008-7#8)(2008-8#5)(2009-10#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#4)(2012-1#4)(2012-12#2)(2012-3#4)(2013-1#3)(2013-8#2)
whole genomes##5##2##(2006-11#1)(2008-4#1)(2011-1#1)(2012-2#1)(2012-3#1)
whole genomic sequence##2##3##(2008-10#1)(2010-7#1)
whole grain content##2##3##(2010-2#2)
whole grain intake##3##3##(2010-1#1)(2010-2#2)
whole grain##12##2##(2010-1#4)(2010-2#7)(2012-12#1)
whole grains and##2##3##(2010-1#1)(2010-2#1)
whole grains##19##2##(2010-1#7)(2010-2#4)(2012-1#1)(2012-12#6)(2012-2#1)
whole hand prehension##5##3##(1993-7#3)(1996-2#2)
whole hand##6##2##(1992-9#1)(1993-7#3)(1996-2#2)
whole head##6##2##(1996-5#1)(2007-1#2)(2011-1#3)
whole human genome##2##3##(2007-6#1)(2011-2#1)
whole human##6##2##(1993-9#1)(1994-9#1)(2007-4#1)(2007-6#1)(2008-10#1)(2011-2#1)
whole in##4##2##(1991-2#1)(2008-10#1)(2009-8#1)(2012-3#1)
whole insect##2##2##(2011-12#1)(2011-2#1)
whole intact E##2##3##(2008-10#2)
whole intact##3##2##(2008-10#3)
whole is##9##2##(1992-3#1)(1992-4#1)(1993-2#1)(2005-6#1)(2007-10#1)(2007-9#2)(2008-7#1)(2009-10#1)
whole kidney##3##2##(2007-5#1)(2008-10#1)(2008-12#1)
whole larvae##2##2##(2008-7#1)(2008-8#1)
whole limb##4##2##(1993-11#1)(2007-4#1)(2010-3#2)
whole liver##2##2##(1991-1#1)(2010-12#1)
whole living cells##2##3##(2008-9#1)(2009-3#1)
whole lung lavage##4##3##(2010-7#2)(2012-2#2)
whole method was##2##3##(2008-10#2)
whole method##4##2##(2008-10#3)(2008-11#1)
whole milk##6##2##(2007-8#1)(2008-10#2)(2011-1#1)(2012-2#2)
whole milk)##2##2##(2008-10#2)
whole molecule##5##2##(1990-11#1)(1990-8#1)(1991-8#1)(1991-9#1)(1997-8#1)
whole mount embryos##2##3##(1996-1#1)(1997-7#1)
whole mount in situ hybridization##3##5##(2006-4#1)(2009-5#1)(2012-12#1)
whole mount##15##2##(1996-1#1)(1996-5#2)(1997-6#1)(1997-7#1)(2006-4#2)(2008-1#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#2)(2012-12#2)
whole mounts and##2##3##(1996-1#1)(2007-12#1)
whole mounts##5##2##(1992-8#1)(1996-1#1)(1997-6#1)(2007-12#1)(2008-9#1)
whole neck tolerance##2##3##(2006-11#2)
whole neck##3##2##(1991-8#1)(2006-11#2)
whole new##8##2##(1995-2#1)(2006-12#1)(2006-5#1)(2007-10#1)(2008-10#1)(2008-8#1)(2008-9#1)(2013-1#1)
whole of the##9##3##(2004-1#1)(2004-7#1)(2006-6#1)(2007-8#1)(2009-2#1)(2009-8#1)(2011-1#1)(2012-12#2)
whole of##22##2##(1990-7#1)(1991-11#1)(2004-1#1)(2004-7#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-5#1)(2007-8#1)(2008-10#2)(2009-2#2)(2009-4#1)(2009-8#1)(2010-6#1)(2010-9#3)(2011-1#1)(2012-12#2)
whole or##3##2##(1991-11#1)(2008-5#1)(2008-6#1)
whole organ##3##2##(1995-12#1)(1995-2#1)(2008-3#1)
whole organism##11##2##(2006-10#1)(2006-5#1)(2007-2#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-9#1)(2012-3#1)
whole pancreas##2##2##(1992-4#1)(2013-1#1)
whole peripheral blood##2##3##(2008-4#1)(2008-9#1)
whole plane##2##2##(2008-2#1)(2008-3#1)
whole plant##14##2##(2006-12#2)(2007-1#2)(2007-11#1)(2007-12#1)(2008-10#6)(2009-10#1)(2010-12#1)
whole plants of##5##3##(2007-1#3)(2008-10#1)(2011-12#1)
whole plants##13##2##(2007-1#4)(2008-10#8)(2011-12#1)
whole plasma##8##2##(1990-11#1)(1990-5#2)(1996-5#1)(2005-8#2)(2008-10#1)(2008-3#1)
whole population##17##2##(1992-5#1)(1993-5#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-8#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)
whole procedure were##2##3##(2008-10#2)
whole procedure##12##2##(1996-11#1)(2007-8#1)(2008-10#6)(2008-11#2)(2009-5#1)(2011-2#1)
whole process could be##3##4##(2007-8#1)(2008-10#2)
whole process of##10##3##(1995-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-10#2)(2012-2#1)(2013-8#1)
whole process##15##2##(1995-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-10#2)(2012-2#1)(2013-8#1)
whole protein##3##2##(2007-11#1)(2012-2#2)
whole range of##11##3##(2005-12#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-2#1)(2008-5#1)(2010-2#1)(2012-2#1)(2013-8#1)
whole rat##2##2##(1991-3#1)(1995-12#1)
whole saliva flow rate##3##4##(2013-8#3)
whole saliva##18##2##(1991-8#1)(1996-1#1)(2006-2#1)(2006-4#6)(2006-8#2)(2010-12#1)(2011-12#2)(2013-8#4)
whole samples##2##2##(2004-4#1)(2005-11#1)
whole series of##7##3##(1990-2#1)(1991-10#1)(1992-10#1)(2005-10#1)(2007-8#1)(2008-3#1)(2009-7#1)
whole series##8##2##(1990-2#1)(1991-10#1)(1992-10#1)(2005-10#1)(2006-7#1)(2007-8#1)(2008-3#1)(2009-7#1)
whole serum and the non-protein fraction of serum##2##8##(2008-7#2)
whole set of##8##3##(1994-11#1)(2008-10#3)(2008-3#1)(2012-2#1)(2013-1#2)
whole set##9##2##(1994-11#1)(2008-10#3)(2008-3#1)(2010-2#1)(2012-2#1)(2013-1#2)
whole skull##2##2##(2008-11#2)
whole spectrum of##4##3##(2006-9#1)(2008-10#1)(2008-4#1)(2008-5#1)
whole structure##3##2##(1994-12#1)(1995-2#1)(2005-10#1)
whole system is##2##3##(2007-8#1)(2010-8#1)
whole system##8##2##(1995-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-8#1)
whole the##3##2##(1997-6#1)(2006-8#1)(2009-4#1)
whole there##2##2##(2008-10#1)(2008-8#1)
whole thin##2##2##(1995-6#1)(2008-12#1)
whole tissue homogenates##2##3##(1995-12#1)(2008-4#1)
whole tissue##6##2##(1995-12#1)(1997-4#1)(2008-11#1)(2008-4#1)(2010-9#2)
whole transcriptome analysis##2##3##(2009-12#1)(2013-8#1)
whole transcriptome##3##2##(2009-12#2)(2013-8#1)
whole trees##2##2##(2008-5#1)(2011-2#1)
whole tumor cells##4##3##(2006-10#2)(2009-3#1)(2010-2#1)
whole virus##4##2##(2007-11#3)(2008-5#1)
whole was##2##2##(1995-9#1)(1997-3#1)
whole wheat##2##2##(2008-11#1)(2010-2#1)
whole##1394##1##(1990-10#1)(1990-11#10)(1990-12#13)(1990-2#8)(1990-3#2)(1990-4#3)(1990-5#3)(1990-6#1)(1990-7#4)(1990-8#7)(1990-9#2)(1991-1#4)(1991-10#1)(1991-11#4)(1991-12#3)(1991-2#4)(1991-3#2)(1991-4#1)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#6)(1991-9#6)(1992-1#2)(1992-10#2)(1992-12#1)(1992-2#3)(1992-3#3)(1992-4#9)(1992-5#6)(1992-7#3)(1992-8#7)(1992-9#4)(1993-1#1)(1993-11#6)(1993-12#6)(1993-2#11)(1993-3#2)(1993-4#4)(1993-5#2)(1993-7#4)(1993-8#4)(1993-9#4)(1994-10#3)(1994-11#4)(1994-12#5)(1994-2#7)(1994-3#12)(1994-4#1)(1994-5#3)(1994-6#4)(1994-8#2)(1994-9#7)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#10)(1995-2#7)(1995-3#7)(1995-5#5)(1995-6#3)(1995-7#3)(1995-8#3)(1995-9#3)(1996-1#7)(1996-11#3)(1996-12#10)(1996-2#8)(1996-3#4)(1996-4#1)(1996-5#10)(1996-6#2)(1996-7#4)(1996-8#3)(1996-9#7)(1997-1#5)(1997-2#4)(1997-3#3)(1997-4#9)(1997-5#3)(1997-6#5)(1997-7#4)(1997-8#6)(2004-1#1)(2004-11#5)(2004-4#3)(2004-7#1)(2005-1#1)(2005-10#3)(2005-11#9)(2005-12#2)(2005-6#1)(2005-7#3)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#8)(2006-11#6)(2006-12#7)(2006-2#4)(2006-4#9)(2006-5#3)(2006-6#11)(2006-7#2)(2006-8#16)(2006-9#4)(2007-1#15)(2007-10#9)(2007-11#29)(2007-12#22)(2007-2#7)(2007-3#3)(2007-4#7)(2007-5#4)(2007-6#5)(2007-7#12)(2007-8#21)(2007-9#13)(2008-1#14)(2008-10#148)(2008-11#27)(2008-12#8)(2008-2#31)(2008-3#31)(2008-4#31)(2008-5#31)(2008-6#7)(2008-7#35)(2008-8#25)(2008-9#20)(2009-10#7)(2009-11#4)(2009-12#5)(2009-2#4)(2009-3#4)(2009-4#18)(2009-5#7)(2009-6#1)(2009-7#3)(2009-8#8)(2009-9#3)(2010-1#13)(2010-10#6)(2010-11#2)(2010-12#14)(2010-2#18)(2010-3#6)(2010-4#4)(2010-5#9)(2010-6#3)(2010-7#8)(2010-8#15)(2010-9#8)(2011-1#21)(2011-12#6)(2011-2#28)(2011-3#1)(2011-7#1)(2012-1#12)(2012-11#7)(2012-12#24)(2012-2#31)(2012-3#12)(2012-9#1)(2013-1#31)(2013-7#2)(2013-8#21)
whole-blood##9##1##(1991-11#1)(2007-2#2)(2008-9#6)
whole-body concentrations of 11-ketotestosterone##2##4##(2010-8#2)
whole-body cryotherapy##3##2##(2007-7#3)
whole-body extracts##2##2##(2013-8#2)
whole-body irradiation##2##2##(1991-5#1)(2008-6#1)
whole-body sweat##2##2##(2013-7#2)
whole-body vibration##2##2##(2013-8#2)
whole-body##41##1##(1991-5#1)(1992-3#2)(1992-8#1)(1993-9#1)(1995-1#1)(1995-5#1)(1996-3#1)(1996-8#1)(2006-5#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-9#1)(2010-2#1)(2010-8#2)(2010-9#5)(2012-2#1)(2013-7#2)(2013-8#8)
whole-brain irradiation##3##2##(1997-4#3)
whole-brain radiotherapy##2##2##(2004-1#1)(2006-7#1)
whole-brain##9##1##(1997-3#1)(1997-4#3)(2004-1#1)(2006-7#1)(2012-1#1)(2013-1#1)(2013-7#1)
whole-cell and the##2##3##(1996-5#1)(2011-3#1)
whole-cell and##6##2##(1992-11#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-5#1)(2011-3#1)
whole-cell biocatalysis##2##2##(2011-1#1)(2012-2#1)
whole-cell biocatalysts##2##2##(2011-1#1)(2013-1#1)
whole-cell conductance##2##2##(1995-8#1)(1997-7#1)
whole-cell configuration##3##2##(1993-12#1)(1993-3#1)(1995-5#1)
whole-cell current##4##2##(1994-2#1)(1995-8#1)(2008-4#1)(2008-8#1)
whole-cell currents##6##2##(1993-3#1)(1993-7#1)(1995-8#2)(2008-8#2)
whole-cell extracts##8##2##(1992-3#1)(1994-8#1)(2008-2#2)(2008-4#4)
whole-cell lysates or##2##3##(2008-1#1)(2008-4#1)
whole-cell lysates##5##2##(1997-3#1)(2008-1#1)(2008-4#3)
whole-cell mode##4##2##(1994-11#1)(1994-2#1)(1995-8#1)(1997-8#1)
whole-cell patch clamp##8##3##(1990-7#1)(1991-2#1)(1996-1#1)(1996-10#1)(1996-3#1)(1996-5#1)(2009-12#1)(2011-2#1)
whole-cell patch##9##2##(1990-7#1)(1991-2#1)(1994-2#1)(1996-1#1)(1996-10#1)(1996-3#1)(1996-5#1)(2009-12#1)(2011-2#1)
whole-cell patch-clamp method##4##3##(1990-7#1)(1996-9#1)(1997-5#1)(2008-8#1)
whole-cell patch-clamp recordings##2##3##(1995-12#1)(2008-4#1)
whole-cell patch-clamp study in##2##4##(1997-8#2)
whole-cell patch-clamp technique##3##3##(1994-3#1)(1995-10#1)(1996-10#1)
whole-cell patch-clamp##14##2##(1990-5#1)(1990-7#1)(1994-3#1)(1995-10#1)(1995-12#2)(1996-10#1)(1996-9#1)(1997-5#1)(1997-8#2)(2008-4#1)(2008-8#2)
whole-cell recording##5##2##(1995-12#1)(1996-1#1)(2008-4#1)(2008-8#2)
whole-cell recordings from##2##3##(1994-3#1)(1997-7#1)
whole-cell recordings in##2##3##(1995-12#1)(2008-1#1)
whole-cell recordings##8##2##(1991-9#1)(1993-11#1)(1994-3#1)(1995-12#1)(1997-7#1)(2008-1#1)(2008-11#1)(2012-2#1)
whole-cell voltage-clamp technique##3##3##(1991-5#1)(1997-5#1)(2009-12#1)
whole-cell voltage-clamp##8##2##(1991-5#1)(1991-8#1)(1995-11#1)(1997-1#1)(1997-2#1)(1997-5#1)(2008-8#1)(2009-12#1)
whole-cell##121##1##(1990-5#1)(1990-7#2)(1991-2#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-11#4)(1992-3#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-7#3)(1994-11#1)(1994-2#6)(1994-3#2)(1994-8#2)(1995-10#1)(1995-11#2)(1995-12#6)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#5)(1996-1#2)(1996-10#2)(1996-12#2)(1996-3#1)(1996-5#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#2)(1997-8#4)(2006-10#1)(2006-12#1)(2007-11#3)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-4#12)(2008-5#1)(2008-8#9)(2009-12#2)(2011-1#4)(2011-2#1)(2011-3#2)(2012-2#3)(2012-3#1)(2013-1#1)
whole-exome and##2##2##(2012-3#2)
whole-exome sequencing##3##2##(2012-2#1)(2012-3#2)
whole-exome##5##1##(2012-2#1)(2012-3#4)
whole-field visual##2##2##(1992-9#1)(2006-7#1)
whole-field##10##1##(1992-9#1)(2006-7#1)(2007-11#2)(2007-12#3)(2008-3#2)(2008-8#1)
whole-genome amplification##2##2##(2008-4#1)(2012-2#1)
whole-genome and##2##2##(2009-12#1)(2010-3#1)
whole-genome expression##2##2##(2008-4#2)
whole-genome microarray##3##2##(2008-5#1)(2008-6#1)(2008-7#1)
whole-genome sequences##2##2##(2008-4#1)(2008-7#1)
whole-genome sequencing##2##2##(2011-1#1)(2012-3#1)
whole-genome shotgun##2##2##(2008-4#1)(2008-7#1)
whole-genome##31##1##(2006-9#1)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#8)(2009-12#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#4)
whole-head##2##1##(1994-3#1)(1996-5#1)
whole-leaf##2##1##(2008-10#2)
whole-lung##2##1##(1994-2#1)(2007-8#1)
whole-mount immunocytochemistry##2##2##(2008-4#1)(2008-5#1)
whole-mount in situ hybridization##3##4##(1995-8#1)(2008-2#1)(2013-8#1)
whole-mount preparations##2##2##(1992-8#1)(2008-5#1)
whole-mount##14##1##(1992-8#1)(1995-11#1)(1995-8#1)(1996-1#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#2)(2010-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
whole-organism##7##1##(1994-3#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-5#1)
whole-plant##7##1##(2008-10#6)(2009-8#1)
whole-slide images##3##2##(2011-12#1)(2012-1#2)
wholesale##8##1##(2005-7#1)(2006-8#1)(2008-12#2)(2011-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
wholesalers##2##1##(2010-2#1)(2012-12#1)
wholesome diet##2##2##(2010-6#2)
wholesome##6##1##(2005-5#2)(2007-11#2)(2010-6#2)
wholly or partially##2##3##(1994-8#1)(2007-8#1)
wholly or##3##2##(1994-8#1)(2007-8#1)(2008-11#1)
wholly##19##1##(1990-6#1)(1994-8#1)(1997-8#1)(2004-4#1)(2005-11#1)(2006-7#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-1#1)(2010-8#1)(2011-1#1)
whom 37##2##2##(2008-11#1)(2010-4#1)
whom a diagnosis of##4##4##(2005-12#1)(2006-7#1)(2007-2#1)(2008-5#1)
whom a##31##2##(1990-3#1)(1991-2#1)(1991-9#1)(1992-7#1)(1993-2#1)(1995-5#1)(1996-1#2)(1996-3#1)(2004-2#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-5#1)(2008-7#2)(2009-6#1)(2010-8#1)(2011-12#1)(2011-3#1)(2013-1#1)
whom an##11##2##(1990-12#1)(1991-8#1)(1997-6#1)(2005-10#1)(2006-10#1)(2006-9#1)(2008-5#2)(2011-2#2)(2013-1#1)
whom clinical and##2##3##(1993-2#1)(2013-8#1)
whom clinical##3##2##(1993-2#1)(2007-10#1)(2013-8#1)
whom combined##2##2##(2007-9#1)(2010-2#1)
whom he##2##2##(1995-6#1)(2012-3#1)
whom influenza##2##2##(1997-6#1)(2013-1#1)
whom it is##2##3##(2008-5#1)(2012-3#1)
whom it was##2##3##(1990-3#1)(2012-3#1)
whom it##11##2##(1990-3#1)(1991-11#1)(1994-4#1)(2008-1#2)(2008-5#1)(2008-7#1)(2010-7#1)(2012-2#1)(2012-3#2)
whom no##9##2##(1990-2#1)(1992-3#1)(2006-8#1)(2006-9#1)(2007-8#1)(2010-12#1)(2010-6#1)(2012-12#1)(2013-8#1)
whom only##2##2##(2007-7#1)(2008-1#1)
whom serum##2##2##(1991-3#1)(1992-3#1)
whom surgery##2##2##(2007-8#1)(2013-1#1)
whom the drug##2##3##(2005-11#1)(2010-12#1)
whom the##73##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#1)(1991-11#1)(1991-2#1)(1992-2#1)(1992-3#1)(1993-10#1)(1993-11#1)(1993-6#1)(1993-7#1)(1994-3#1)(1995-2#1)(1996-9#1)(2005-11#1)(2006-10#2)(2006-4#1)(2006-5#1)(2007-11#2)(2007-3#1)(2007-4#1)(2007-7#6)(2007-8#7)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2009-2#1)(2010-11#1)(2010-12#3)(2011-2#3)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#6)
whom there is##4##3##(1990-4#1)(2010-11#1)(2013-1#2)
whom there##8##2##(1990-4#1)(2006-5#1)(2006-9#1)(2007-1#1)(2008-7#1)(2010-11#1)(2013-1#2)
whom they work##2##3##(1995-1#1)(2012-2#1)
whom they##7##2##(1995-1#1)(2006-10#1)(2007-8#1)(2008-6#1)(2010-4#1)(2011-2#1)(2012-2#1)
whom this##2##2##(1993-5#1)(2009-7#1)
whom to treat##2##3##(1995-5#1)(2006-9#1)
whom two##2##2##(1991-8#1)(1995-6#1)
whom we have##2##3##(1996-12#1)(2008-6#1)
whom we##5##2##(1996-12#1)(2008-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
whom##589##1##(1990-1#1)(1990-11#1)(1990-12#8)(1990-2#2)(1990-3#5)(1990-4#4)(1990-5#2)(1990-6#2)(1990-8#4)(1990-9#1)(1991-10#1)(1991-11#8)(1991-12#1)(1991-2#4)(1991-3#4)(1991-4#3)(1991-5#4)(1991-6#1)(1991-7#4)(1991-8#5)(1991-9#4)(1992-10#2)(1992-12#1)(1992-2#7)(1992-3#5)(1992-5#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-11#2)(1993-2#3)(1993-5#3)(1993-6#3)(1993-7#1)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#4)(1994-3#2)(1994-4#3)(1994-6#2)(1994-7#1)(1995-1#2)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#4)(1995-9#1)(1996-1#3)(1996-12#2)(1996-2#4)(1996-3#4)(1996-4#1)(1996-5#1)(1996-6#3)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#2)(1997-5#1)(1997-6#6)(1997-7#1)(1997-8#1)(2004-10#1)(2004-11#2)(2004-2#3)(2004-3#1)(2005-10#3)(2005-11#3)(2005-12#2)(2005-5#2)(2005-7#3)(2005-8#5)(2006-10#13)(2006-11#4)(2006-12#5)(2006-2#1)(2006-4#1)(2006-5#12)(2006-6#6)(2006-7#7)(2006-8#6)(2006-9#9)(2007-1#2)(2007-10#3)(2007-11#8)(2007-12#4)(2007-2#6)(2007-3#3)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#23)(2007-8#29)(2007-9#6)(2008-1#12)(2008-10#8)(2008-11#8)(2008-2#1)(2008-3#6)(2008-4#5)(2008-5#12)(2008-6#11)(2008-7#19)(2008-8#3)(2008-9#5)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#3)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#9)(2010-2#3)(2010-3#2)(2010-4#4)(2010-6#2)(2010-7#5)(2010-8#4)(2010-9#1)(2011-1#8)(2011-11#1)(2011-12#2)(2011-2#18)(2011-3#1)(2012-1#1)(2012-12#19)(2012-2#10)(2012-3#7)(2013-1#28)(2013-7#2)(2013-8#4)
whom?##4##1##(1991-1#1)(1991-12#1)(1992-12#1)(2008-4#1)
whom?]##4##1##(1992-2#1)(1992-4#1)(1992-5#1)(1993-5#1)
whooping cough in##4##3##(1990-2#3)(2007-2#1)
whooping cough##18##2##(1990-2#11)(1990-6#1)(1995-5#1)(1997-8#2)(2007-2#1)(2008-8#2)
whooping##19##1##(1990-2#11)(1990-6#1)(1995-5#1)(1997-8#2)(2004-10#1)(2007-2#1)(2008-8#2)
whorl##5##1##(2008-10#1)(2011-2#3)(2012-2#1)
whorled##2##1##(2010-12#1)(2012-11#1)
whorls and##4##2##(2006-12#1)(2007-2#1)(2009-7#1)(2010-12#1)
whorls##7##1##(2006-12#1)(2007-2#1)(2008-7#2)(2009-7#2)(2010-12#1)
whose 24-h urines##2##3##(1995-7#2)
whose CA##2##2##(1991-4#1)(2005-12#1)
whose DNA##2##2##(1992-9#1)(1995-2#1)
whose IM fields were treated with Co60##2##7##(2007-10#2)
whose absence##2##2##(1992-5#1)(2011-2#1)
whose abundance##3##2##(1990-6#1)(2009-8#2)
whose access to##2##3##(2004-11#1)(2006-2#1)
whose actions are##2##3##(1992-2#1)(2005-7#1)
whose actions##4##2##(1991-6#1)(1992-2#1)(2005-7#2)
whose activity can be##2##4##(2007-11#1)(2008-10#1)
whose activity depends on the##2##5##(1991-2#1)(1997-6#1)
whose activity has been##2##4##(1990-4#1)(2008-6#1)
whose activity is regulated by##4##5##(1990-8#1)(1992-12#1)(1992-8#1)(2009-8#1)
whose activity is regulated##6##4##(1990-8#1)(1992-12#1)(1992-8#1)(1993-6#1)(2005-8#1)(2009-8#1)
whose activity is##15##3##(1990-11#2)(1990-8#1)(1991-3#1)(1992-12#1)(1992-8#2)(1993-6#1)(1995-1#1)(2005-7#1)(2005-8#1)(2008-11#1)(2009-7#1)(2009-8#1)(2012-12#1)
whose activity was##2##3##(1993-7#1)(1997-2#1)
whose activity##28##2##(1990-11#2)(1990-4#2)(1990-8#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-8#2)(1993-6#1)(1993-7#1)(1995-1#1)(1995-5#2)(1997-2#1)(1997-6#1)(2005-7#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-7#1)(2009-8#1)(2012-12#1)
whose adolescent##3##2##(2010-4#1)(2013-1#2)
whose advantages##2##2##(1994-6#1)(2008-5#1)
whose age at first sexual intercourse was##2##7##(2012-12#2)
whose age at##3##3##(2012-12#2)(2013-8#1)
whose age##7##2##(1990-12#1)(2007-7#1)(2010-12#2)(2012-12#2)(2013-8#1)
whose ages ranged from 18 to##2##6##(2007-3#1)(2008-9#1)
whose ages ranged from##4##4##(2006-11#1)(2007-3#1)(2008-6#1)(2008-9#1)
whose ages##6##2##(1995-3#1)(2006-11#1)(2007-3#1)(2008-6#1)(2008-9#1)(2009-3#1)
whose aim##3##2##(2005-10#1)(2007-8#1)(2008-11#1)
whose amino acid sequence##2##4##(1991-2#1)(1993-11#1)
whose amino acid##3##3##(1991-2#1)(1993-11#1)(2008-6#1)
whose amino##4##2##(1991-2#1)(1993-11#1)(1995-4#1)(2008-6#1)
whose amplitude##3##2##(2008-3#1)(2008-8#1)(2008-9#1)
whose apparent##2##2##(1992-12#1)(1996-7#1)
whose appearance##2##2##(1992-10#1)(2008-12#1)
whose arteries##2##2##(1990-3#2)
whose average##2##2##(2008-11#1)(2008-4#1)
whose axes##2##2##(2007-12#1)(2007-5#1)
whose back electrochemical reduction was detected on glassy carbon electrode surface at -150mV##2##13##(2007-8#1)(2008-10#1)
whose back electrochemical reduction was detected on##3##7##(2007-8#1)(2008-10#2)
whose binding##7##2##(1990-6#1)(1991-5#1)(1994-6#1)(1995-5#1)(1996-8#1)(2008-10#1)(2010-11#1)
whose biochemical##2##2##(1992-12#1)(1995-7#1)
whose biological##2##2##(1994-2#1)(1996-5#1)
whose body##2##2##(1991-7#1)(2011-2#1)
whose bottom##2##2##(2006-10#1)(2010-4#1)
whose cDNA##2##2##(1992-8#1)(1995-10#1)
whose care##3##2##(1996-2#1)(2007-2#1)(2007-5#1)
whose cause is##3##3##(1993-11#1)(2009-6#1)(2010-5#1)
whose cellular##3##2##(1995-11#1)(2011-1#1)(2011-2#1)
whose central##4##2##(1994-1#1)(1995-12#1)(2007-11#1)(2010-5#1)
whose cerebellar##3##2##(1994-2#1)(2011-2#2)
whose cerebral##2##2##(2007-9#1)(2008-7#1)
whose characteristics##3##2##(2006-7#1)(2008-10#1)(2008-4#1)
whose chief complaint was##2##4##(2006-9#1)(2009-6#1)
whose child##2##2##(2005-6#1)(2008-11#1)
whose children had##3##3##(2006-12#1)(2007-8#1)(2009-6#1)
whose children##8##2##(1991-3#1)(1996-12#1)(2005-7#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-9#1)(2009-6#1)
whose clinical presentation##2##3##(2006-10#1)(2007-2#1)
whose clinical##8##2##(1990-9#1)(1997-1#1)(2006-10#3)(2007-10#1)(2007-2#1)(2010-11#1)
whose complex##2##2##(1997-4#1)(2008-2#1)
whose complexity##2##2##(2006-5#1)(2013-1#1)
whose composition is##2##3##(2006-5#1)(2008-10#1)
whose concentration##3##2##(1996-9#1)(2008-5#1)(2009-8#1)
whose concentrations##3##2##(1997-4#1)(2007-5#1)(2013-8#1)
whose condition##2##2##(2012-12#2)
whose corresponding##3##2##(1992-11#1)(1997-5#2)
whose crystal structure##2##3##(1993-3#1)(1997-7#1)
whose crystal##3##2##(1993-3#1)(1997-7#1)(2007-12#1)
whose deduced amino acid sequence##3##5##(1990-1#1)(1994-9#1)(1995-6#1)
whose deduced##5##2##(1990-1#1)(1994-9#1)(1995-6#2)(1997-1#1)
whose deletion##3##2##(1994-12#1)(1996-2#1)(2010-2#1)
whose development has been##2##4##(1994-11#1)(2005-10#1)
whose development##4##2##(1992-7#1)(1994-11#1)(2005-10#1)(2006-8#1)
whose diagnosis is##3##3##(2006-2#1)(2010-9#1)(2012-2#1)
whose diagnosis##4##2##(2006-2#1)(2010-7#1)(2010-9#1)(2012-2#1)
whose dimensions are comparable##2##4##(2008-10#1)(2008-3#1)
whose disease has##2##3##(2007-11#1)(2008-5#1)
whose disease##7##2##(1990-8#1)(2006-9#1)(2007-11#1)(2008-5#2)(2011-2#1)(2012-12#1)
whose donors were mismatched for##2##5##(1990-11#2)
whose early##2##2##(2009-12#1)(2010-4#1)
whose effect is##2##3##(1991-5#1)(1996-8#1)
whose effect##4##2##(1991-5#1)(1996-8#1)(2008-8#1)(2013-8#1)
whose efficacy##2##2##(2008-4#1)(2009-3#1)
whose electrochemical reduction back to##2##5##(2008-10#2)
whose epitope##2##2##(1997-7#1)(2006-6#1)
whose exact##2##2##(1997-6#1)(2013-8#1)
whose existence##2##2##(1994-8#1)(2007-8#1)
whose expression is##11##3##(1990-11#1)(1990-4#1)(1993-11#1)(1993-2#1)(1994-2#1)(1995-11#1)(1996-7#1)(1997-7#1)(2008-10#1)(2008-8#1)(2009-4#1)
whose expression was##8##3##(1992-11#1)(1993-6#1)(1994-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-12#1)
whose expression##29##2##(1990-11#1)(1990-4#1)(1991-7#1)(1992-11#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-11#1)(1996-7#1)(1997-7#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2012-12#2)(2012-3#1)(2013-1#1)
whose family##2##2##(2010-11#1)(2012-2#1)
whose father##2##2##(2007-10#1)(2012-12#1)
whose features are##2##3##(1991-6#1)(2007-11#1)
whose final##2##2##(1994-9#1)(2006-10#1)
whose fitness##2##2##(2005-8#1)(2008-9#1)
whose formation##6##2##(1992-4#1)(1994-9#1)(1996-2#1)(1996-5#1)(2007-5#1)(2008-7#1)
whose frequencies##2##2##(2007-12#1)(2008-10#1)
whose function is to##4##4##(2009-8#2)(2010-12#1)(2013-7#1)
whose function is unknown##2##4##(1996-4#1)(2008-8#1)
whose function is##6##3##(1996-4#1)(2008-8#1)(2009-8#2)(2010-12#1)(2013-7#1)
whose function##11##2##(1990-8#1)(1992-5#1)(1996-4#1)(1997-2#1)(2008-8#1)(2009-5#1)(2009-8#2)(2010-12#1)(2012-2#1)(2013-7#1)
whose functional##2##2##(2012-12#1)(2012-3#1)
whose functions are##3##3##(1996-12#1)(2006-10#1)(2008-5#1)
whose functions##5##2##(1994-12#1)(1996-12#1)(2006-10#1)(2008-5#1)(2009-8#1)
whose gene##3##2##(1990-12#1)(2008-4#1)(2011-1#1)
whose genome##4##2##(2008-4#1)(2008-7#2)(2011-10#1)
whose goal##2##2##(1990-10#1)(2008-7#1)
whose growth##3##2##(2008-8#1)(2009-9#1)(2012-3#1)
whose high##3##2##(2008-11#1)(2008-9#1)(2009-8#1)
whose illness##2##2##(2005-8#1)(2008-7#1)
whose in##2##2##(1990-7#1)(1991-7#1)
whose incidence##3##2##(2006-10#1)(2007-7#1)(2011-2#1)
whose individual##2##2##(2008-10#1)(2008-8#1)
whose influence##2##2##(1992-1#1)(2008-5#1)
whose initial##4##2##(1993-5#1)(2006-10#1)(2006-11#1)(2009-5#1)
whose intensity##3##2##(2007-11#1)(2008-3#2)
whose interests##2##2##(2007-1#1)(2009-4#1)
whose last##3##2##(1994-5#1)(2008-9#2)
whose length##2##2##(2007-1#1)(2008-10#1)
whose lesions regressed##2##3##(2006-10#2)
whose lesions##3##2##(2006-10#2)(2009-4#1)
whose levels##6##2##(1991-10#1)(1991-12#1)(1992-11#1)(1996-5#1)(2008-10#1)(2008-11#1)
whose location##2##2##(1994-5#1)(2008-7#1)
whose mRNA##2##2##(1991-6#1)(1997-5#1)
whose magnitude depends on the##2##5##(2008-3#2)
whose magnitude##3##2##(1995-10#1)(2008-3#2)
whose main##6##2##(1992-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-7#1)(2013-8#1)
whose mandate is to##2##4##(1992-9#1)(1996-3#1)
whose mandate##3##2##(1991-3#1)(1992-9#1)(1996-3#1)
whose manifestations##2##2##(1997-3#1)(2012-2#1)
whose mean IFD##2##3##(1991-9#2)
whose mean age was##3##4##(2006-10#1)(2008-12#1)(2008-3#1)
whose mean##7##2##(1991-9#2)(1995-12#1)(1996-1#1)(2006-10#1)(2008-12#1)(2008-3#1)
whose median##2##2##(1996-1#1)(2007-2#1)
whose members##6##2##(2005-8#1)(2008-10#1)(2009-8#1)(2011-1#2)(2011-2#1)
whose models##3##2##(2011-12#1)(2013-1#2)
whose molecular weight##2##3##(1992-8#1)(1994-9#1)
whose molecular##7##2##(1990-5#1)(1992-8#1)(1994-9#1)(1995-4#1)(2008-11#1)(2008-4#1)(2011-3#1)
whose mothers did not have pre-eclampsia##3##6##(2011-2#3)
whose mothers did not have##4##5##(2009-4#1)(2011-2#3)
whose mothers had pre-eclampsia were##2##5##(2011-2#2)
whose mothers were##6##3##(2008-7#1)(2009-5#2)(2011-2#1)(2013-1#1)(2013-7#1)
whose mothers##17##2##(2007-2#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#2)(2009-9#3)(2011-2#6)(2013-1#1)(2013-7#1)
whose multiple##2##2##(1991-6#1)(2008-5#1)
whose nodes represent class variables##2##5##(2013-1#2)
whose nodes##3##2##(1990-6#1)(2013-1#2)
whose normal function is##2##4##(1997-8#1)(2008-4#1)
whose nuclear##2##2##(1991-3#1)(1994-5#1)
whose number##2##2##(2008-4#1)(2012-3#1)
whose only##5##2##(1991-12#1)(1995-9#1)(2006-12#1)(2007-10#1)(2008-2#1)
whose orientation##2##2##(2007-12#1)(2008-3#1)
whose origin is##2##3##(1990-4#1)(2008-10#1)
whose outcome##2##2##(2006-10#1)(2008-10#1)
whose output##3##2##(2007-8#1)(2008-2#1)(2008-3#1)
whose overexpression##3##2##(1991-12#1)(1994-11#1)(2008-5#1)
whose pain##3##2##(1993-10#1)(2006-10#1)(2011-2#1)
whose parameters are##3##3##(2008-1#1)(2008-2#1)(2008-5#1)
whose parameters##5##2##(2005-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)
whose parents had##6##3##(2005-10#1)(2006-9#1)(2010-11#1)(2012-12#2)(2013-1#1)
whose parents were##6##3##(1994-6#3)(2008-1#1)(2008-11#1)(2013-8#1)
whose parents##20##2##(1991-2#1)(1992-5#1)(1994-6#3)(2005-10#2)(2006-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-11#3)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#1)
whose partner##2##2##(2009-5#1)(2012-3#1)
whose partners##2##2##(2007-2#1)(2008-10#1)
whose pathogenesis##2##2##(1994-6#1)(2006-6#1)
whose performance##3##2##(2007-10#1)(2008-11#1)(2012-1#1)
whose permeability##2##2##(2005-10#1)(2006-10#1)
whose plasma LCAT activity were##2##5##(1991-7#2)
whose predicted response is##2##4##(2012-2#2)
whose predicted##5##2##(1991-11#1)(1994-12#2)(2012-2#2)
whose preparatory work was initiated on##3##6##(2010-12#3)
whose presence##6##2##(1993-8#1)(1994-2#1)(1997-7#1)(2006-6#1)(2008-7#1)(2009-5#1)
whose prevalence##2##2##(2011-2#1)(2013-1#1)
whose primary##7##2##(1990-10#1)(1994-2#1)(1995-1#1)(2008-3#1)(2008-5#1)(2011-2#2)
whose principal##2##2##(1991-3#1)(2007-4#1)
whose product is##3##3##(1991-11#1)(1995-2#1)(1995-6#1)
whose product##8##2##(1990-1#1)(1990-3#1)(1991-11#1)(1994-9#1)(1995-2#2)(1995-6#1)(1997-1#1)
whose products are##6##3##(1994-8#1)(1994-9#1)(2007-12#2)(2008-11#1)(2012-12#1)
whose progeny##3##2##(2005-7#1)(2012-12#2)
whose prognosis##2##2##(1993-1#1)(2005-11#1)
whose properties are##2##3##(2006-10#1)(2007-12#1)
whose properties##5##2##(2006-10#1)(2006-11#1)(2007-12#1)(2008-3#2)
whose recognition##2##2##(1991-5#1)(1994-12#1)
whose refractive index is##2##4##(2008-3#2)
whose refractive##3##2##(2008-2#1)(2008-3#2)
whose regulated##2##2##(2007-12#1)(2012-2#1)
whose reports##2##2##(1997-3#1)(2012-11#1)
whose respiratory failure##2##3##(2007-2#2)
whose response##3##2##(1996-9#1)(1997-5#1)(2013-8#1)
whose results##2##2##(1993-12#1)(1994-4#1)
whose role##2##2##(1990-4#1)(2007-3#1)
whose second##2##2##(2008-2#1)(2012-2#1)
whose selective##2##2##(1995-3#1)(2010-5#1)
whose self-worth is##2##3##(2007-12#2)
whose self-worth##3##2##(2007-12#2)(2009-9#1)
whose sequence is similar to##2##5##(1990-6#1)(1990-9#1)
whose sequence is##3##3##(1990-6#1)(1990-9#1)(2007-6#1)
whose sequence##9##2##(1990-6#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-8#1)(1995-1#1)(1996-7#1)(2007-6#1)(2008-8#1)
whose sequences had been##2##4##(1997-4#1)(2005-11#1)
whose sequences##6##2##(1992-7#1)(1994-12#1)(1994-8#1)(1995-6#1)(1997-4#1)(2005-11#1)
whose serum##2##2##(1993-2#1)(2004-10#1)
whose shape##3##2##(2007-12#1)(2008-2#1)(2008-4#1)
whose side chains##2##3##(1991-9#1)(1995-1#1)
whose side##3##2##(1991-9#1)(1995-1#1)(2008-4#1)
whose significance##2##2##(2008-3#1)(2009-8#1)
whose size##3##2##(2007-11#1)(2008-3#1)(2009-2#1)
whose sizes##3##2##(1991-8#1)(2008-2#1)(2008-7#1)
whose source of skill acquisition was##2##6##(2011-1#2)
whose source of##3##3##(2007-12#1)(2011-1#2)
whose source##4##2##(2007-12#1)(2007-9#1)(2011-1#2)
whose specific##2##2##(1990-4#1)(2008-9#1)
whose specificity##2##2##(1990-4#1)(1996-9#1)
whose stability##2##2##(1994-12#1)(2005-11#1)
whose status was known##2##4##(2012-12#2)
whose strength##2##2##(1991-1#1)(2012-1#1)
whose structure is##2##3##(2008-7#1)(2012-1#1)
whose structure was learned by the MC(3) algorithm##2##8##(2013-1#2)
whose structure was##4##3##(1997-7#1)(2005-7#1)(2013-1#2)
whose structure##11##2##(1991-12#1)(1992-7#1)(1997-7#1)(2005-7#1)(2006-10#1)(2008-1#1)(2008-3#1)(2008-7#1)(2012-1#1)(2013-1#2)
whose structures have##2##3##(2008-10#1)(2008-7#1)
whose surface##2##2##(1994-5#1)(2008-2#1)
whose surfaces##2##2##(2005-4#1)(2009-7#1)
whose survival is dependent##2##4##(1991-1#1)(2008-9#1)
whose survival##4##2##(1991-1#1)(1993-1#1)(2008-1#1)(2008-9#1)
whose symptoms##8##2##(1991-3#1)(2006-5#1)(2007-10#1)(2007-6#1)(2008-6#1)(2010-7#1)(2013-1#2)
whose synthesis is##2##3##(1995-2#1)(2006-11#1)
whose synthesis##3##2##(1990-6#1)(1995-2#1)(2006-11#1)
whose temporal##3##2##(1995-12#1)(2006-5#1)(2008-3#1)
whose tertiary structure##2##3##(1992-4#1)(2008-4#1)
whose therapy##2##2##(2008-1#1)(2012-10#1)
whose thickness can##2##3##(2006-4#1)(2007-12#1)
whose thickness##3##2##(2006-4#1)(2007-12#1)(2008-5#1)
whose time has come##3##4##(1990-12#1)(1991-2#1)(1996-12#1)
whose time has come?##3##4##(2006-7#2)(2008-2#1)
whose time has##7##3##(1990-12#1)(1991-2#1)(1996-12#1)(2005-9#1)(2006-7#2)(2008-2#1)
whose transcription is##2##3##(1991-5#1)(2008-10#1)
whose transcription##3##2##(1991-5#1)(1994-3#1)(2008-10#1)
whose transverse##2##2##(2007-12#1)(2008-2#1)
whose tumors##5##2##(1993-1#1)(2008-5#1)(2010-3#1)(2012-12#2)
whose ultimate##2##2##(1992-8#1)(2012-2#1)
whose values##4##2##(1990-7#1)(2008-5#1)(2008-7#1)(2009-4#1)
whose volume##2##2##(2007-12#1)(2009-11#1)
whose wavelength##2##2##(2007-12#1)(2008-2#1)
whose width##2##2##(2007-11#1)(2008-11#1)
whose work##3##2##(2005-7#1)(2006-6#1)(2009-2#1)
whose##1172##1##(1990-1#2)(1990-10#2)(1990-11#6)(1990-12#5)(1990-2#1)(1990-3#6)(1990-4#9)(1990-5#2)(1990-6#5)(1990-7#4)(1990-8#5)(1990-9#2)(1991-1#4)(1991-10#2)(1991-11#3)(1991-12#9)(1991-2#9)(1991-3#10)(1991-4#3)(1991-5#7)(1991-6#6)(1991-7#7)(1991-8#3)(1991-9#9)(1992-1#2)(1992-10#3)(1992-11#3)(1992-12#6)(1992-2#4)(1992-3#2)(1992-4#3)(1992-5#4)(1992-6#1)(1992-7#3)(1992-8#7)(1992-9#2)(1993-1#4)(1993-10#2)(1993-11#7)(1993-12#3)(1993-2#3)(1993-3#4)(1993-4#1)(1993-5#4)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#5)(1994-12#12)(1994-2#6)(1994-3#2)(1994-4#1)(1994-5#6)(1994-6#7)(1994-7#2)(1994-8#4)(1994-9#7)(1995-1#10)(1995-10#2)(1995-11#3)(1995-12#5)(1995-2#9)(1995-3#4)(1995-4#3)(1995-5#6)(1995-6#8)(1995-7#3)(1995-8#1)(1995-9#2)(1996-1#3)(1996-11#2)(1996-12#7)(1996-2#7)(1996-3#4)(1996-4#2)(1996-5#9)(1996-6#2)(1996-7#5)(1996-8#2)(1996-9#3)(1997-1#5)(1997-2#5)(1997-3#7)(1997-4#7)(1997-5#5)(1997-6#5)(1997-7#7)(1997-8#3)(2003-11#1)(2004-10#1)(2004-11#1)(2005-10#5)(2005-11#9)(2005-12#1)(2005-4#1)(2005-5#1)(2005-6#1)(2005-7#8)(2005-8#7)(2005-9#1)(2006-10#29)(2006-11#5)(2006-12#7)(2006-2#6)(2006-3#1)(2006-4#4)(2006-5#8)(2006-6#5)(2006-7#5)(2006-8#4)(2006-9#4)(2007-1#3)(2007-10#11)(2007-11#16)(2007-12#42)(2007-2#10)(2007-3#3)(2007-4#3)(2007-5#7)(2007-6#2)(2007-7#8)(2007-8#12)(2007-9#8)(2008-1#12)(2008-10#52)(2008-11#22)(2008-12#6)(2008-2#33)(2008-3#34)(2008-4#20)(2008-5#30)(2008-6#6)(2008-7#29)(2008-8#19)(2008-9#16)(2009-10#4)(2009-11#2)(2009-12#4)(2009-2#5)(2009-3#2)(2009-4#6)(2009-5#10)(2009-6#5)(2009-7#4)(2009-8#13)(2009-9#7)(2010-10#1)(2010-11#6)(2010-12#9)(2010-2#5)(2010-3#2)(2010-4#4)(2010-5#5)(2010-7#5)(2010-8#1)(2010-9#4)(2011-1#13)(2011-10#1)(2011-12#1)(2011-2#32)(2011-3#1)(2012-1#5)(2012-10#1)(2012-11#4)(2012-12#24)(2012-2#20)(2012-3#10)(2013-1#22)(2013-7#3)(2013-8#16)
why Islam rejects secularization and this is not because the ethical principles embedded in Islam's teachings are archaic and out of touch with current realities##2##25##(2007-10#1)(2007-12#1)
why a particular##2##3##(2008-9#1)(2013-7#1)
why a##10##2##(1993-9#1)(1994-2#1)(1996-12#1)(1996-6#1)(2008-9#1)(2009-7#1)(2010-4#1)(2010-6#1)(2012-12#1)(2013-7#1)
why an##3##2##(1991-3#1)(2006-12#1)(2008-3#1)
why and how##3##3##(2006-1#1)(2007-11#1)(2008-1#1)
why and how?##2##3##(2007-11#2)
why and when##2##3##(2007-8#1)(2008-11#1)
why and##7##2##(2006-1#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-11#1)
why are they##2##3##(1996-12#1)(2012-12#1)
why are we##2##3##(1996-8#1)(2009-10#1)
why are##7##2##(1996-12#1)(1996-8#1)(1997-4#1)(2006-12#1)(2008-10#1)(2009-10#1)(2012-12#1)
why cancer##2##2##(2007-12#1)(2008-11#1)
why certain##5##2##(2008-10#2)(2011-2#2)(2013-8#1)
why classical##3##2##(1993-11#1)(2009-5#1)(2010-11#1)
why did##2##2##(2007-8#1)(2008-5#1)
why do##7##2##(1991-6#1)(1995-2#1)(1997-6#2)(2006-10#1)(2007-4#1)(2010-2#1)
why does##4##2##(1995-9#1)(2006-10#1)(2008-6#1)(2012-12#1)
why he##5##2##(1994-1#1)(1996-2#1)(2011-1#1)(2012-12#1)(2012-2#1)
why health##2##2##(1997-3#1)(2012-3#1)
why healthcare##3##2##(1991-9#1)(1992-12#1)(1996-12#1)
why individuals##2##2##(2006-10#1)(2008-10#1)
why is##4##2##(2006-12#1)(2009-10#1)(2010-12#1)(2012-3#1)
why it is important for##2##5##(2009-9#1)(2011-2#1)
why it is necessary to##2##5##(1991-1#1)(2011-1#1)
why it is##8##3##(1991-1#1)(1991-2#1)(1997-9#1)(2006-12#1)(2008-4#1)(2009-9#1)(2011-1#1)(2011-2#1)
why it##12##2##(1991-1#1)(1991-2#1)(1997-9#1)(2006-12#1)(2006-6#1)(2008-4#1)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
why knowing the difference is important to nutrition research##2##9##(2012-1#2)
why lesion or stimulation of the##2##6##(2008-11#2)
why long##2##2##(1991-8#1)(1997-6#1)
why might##2##2##(2006-10#1)(2008-8#1)
why no##2##2##(2008-10#1)(2012-2#1)
why our##2##2##(1996-3#1)(2010-2#1)
why pain##2##2##(1993-9#1)(2007-12#1)
why patients##3##2##(1991-9#1)(2005-11#1)(2011-12#1)
why people##4##2##(2009-6#2)(2012-12#1)(2013-8#1)
why physicians##2##2##(1991-2#1)(2008-2#1)
why should##2##2##(2007-5#1)(2009-4#1)
why so##2##2##(2008-8#1)(2008-9#1)
why some##12##2##(1993-11#1)(1993-3#1)(1994-4#2)(2006-10#2)(2007-9#1)(2008-12#1)(2008-8#1)(2009-5#1)(2012-12#1)(2012-3#1)
why the authors##3##3##(2006-12#1)(2006-6#1)(2008-3#1)
why the number of##2##4##(2008-2#1)(2013-8#1)
why the two##2##3##(2008-7#1)(2008-9#1)
why the##60##2##(1991-12#1)(1991-6#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-12#2)(1994-7#1)(1994-8#1)(1995-2#2)(1996-4#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#2)(2006-9#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2010-2#1)(2010-4#1)(2011-12#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
why their##3##2##(2007-4#1)(2009-10#1)(2012-3#1)
why there is##2##3##(2007-2#1)(2011-2#1)
why these##7##2##(1996-10#1)(2006-8#1)(2008-10#2)(2008-4#1)(2009-5#1)(2009-8#1)
why they are##5##3##(1993-6#1)(2004-10#1)(2008-4#1)(2009-11#1)(2012-2#1)
why they work##3##3##(1996-3#1)(2010-12#1)(2012-2#1)
why they##18##2##(1993-6#1)(1995-9#1)(1996-3#1)(1997-5#1)(2004-10#1)(2004-3#1)(2007-4#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-11#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
why this is so##2##4##(1996-3#1)(2005-10#1)
why this##6##2##(1995-8#1)(1996-3#1)(2005-10#1)(2006-10#1)(2009-4#1)(2013-8#1)
why to##2##2##(2007-7#1)(2010-12#1)
why we need##2##3##(2007-4#1)(2008-8#1)
why we##11##2##(1991-2#1)(1997-2#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)
why women with apocrine##2##4##(1993-1#1)(2008-4#1)
why women##8##2##(1993-1#1)(2007-2#1)(2007-4#2)(2007-9#1)(2008-4#1)(2008-9#1)(2012-2#1)
why##436##1##(1990-1#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-9#2)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#4)(1992-2#2)(1992-5#2)(1992-9#1)(1993-1#3)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-12#4)(1994-2#3)(1994-3#1)(1994-4#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#4)(1995-1#2)(1995-12#2)(1995-2#5)(1995-3#1)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#2)(1996-12#4)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#4)(1997-9#1)(2004-10#1)(2004-11#1)(2004-3#1)(2005-10#2)(2005-11#1)(2005-5#1)(2005-7#1)(2006-1#1)(2006-10#12)(2006-11#1)(2006-12#6)(2006-2#2)(2006-4#1)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#3)(2006-9#2)(2007-10#1)(2007-11#4)(2007-12#6)(2007-2#3)(2007-3#1)(2007-4#9)(2007-5#1)(2007-7#2)(2007-8#6)(2007-9#6)(2008-1#8)(2008-10#18)(2008-11#16)(2008-12#5)(2008-2#5)(2008-3#3)(2008-4#6)(2008-5#3)(2008-6#3)(2008-7#9)(2008-8#11)(2008-9#7)(2009-10#4)(2009-11#4)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#7)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#3)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#6)(2010-3#1)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#6)(2011-12#3)(2011-2#16)(2012-1#4)(2012-11#2)(2012-12#9)(2012-2#16)(2012-3#8)(2013-1#12)(2013-7#1)(2013-8#10)
why?##4##1##(1991-3#1)(2006-7#1)(2006-8#1)(2009-10#1)
wich##3##1##(2006-6#1)(2007-8#2)
wicked##2##1##(2010-8#2)
wide QRS##4##2##(1991-3#1)(2006-9#1)(2009-10#1)(2012-3#1)
wide a##2##2##(2008-10#1)(2008-8#1)
wide acceptance of##3##3##(2007-11#1)(2008-7#1)(2009-9#1)
wide acceptance##11##2##(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-9#1)
wide access##2##2##(2006-12#1)(2006-6#1)
wide agreement##3##2##(1997-5#1)(2007-8#2)
wide and##16##2##(1991-12#1)(1993-2#1)(1993-7#1)(1994-3#1)(1996-12#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)
wide angle##6##2##(2005-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)
wide angular##2##2##(2007-11#1)(2008-1#1)
wide applicability of##3##3##(1996-11#1)(1997-2#1)(2008-7#1)
wide applicability##7##2##(1992-2#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-5#1)(2008-7#1)(2009-4#1)
wide application of##3##3##(1994-3#1)(2008-10#1)(2011-2#1)
wide application##4##2##(1994-3#1)(2008-10#2)(2011-2#1)
wide applications in##4##3##(2008-10#2)(2008-3#1)(2012-3#1)
wide applications##6##2##(1995-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2012-3#1)
wide approach##2##2##(2007-8#1)(2010-11#1)
wide area network##2##3##(1993-2#1)(2008-10#1)
wide area of##4##3##(2005-8#1)(2007-7#1)(2008-10#1)(2008-3#1)
wide area##7##2##(1990-4#1)(1993-2#1)(2005-8#1)(2007-7#1)(2008-10#2)(2008-3#1)
wide areas of the##2##4##(2007-1#1)(2008-2#1)
wide areas##4##2##(1990-6#1)(2007-1#1)(2008-2#1)(2013-1#1)
wide array of##25##3##(1993-2#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-8#1)(1997-2#1)(2005-11#1)(2005-7#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-7#1)
wide association##4##2##(2010-2#1)(2010-8#1)(2012-12#1)(2012-2#1)
wide availability and##3##3##(2008-4#1)(2009-1#2)
wide availability##4##2##(2008-4#1)(2009-1#2)(2011-2#1)
wide bandwidth of the##2##4##(2007-12#1)(2008-3#1)
wide bandwidth##6##2##(2007-12#2)(2008-3#3)(2013-7#1)
wide channels##3##2##(2006-4#1)(2008-10#1)(2008-11#1)
wide clinical##5##2##(1992-12#1)(2006-8#1)(2007-11#1)(2009-5#1)(2012-3#1)
wide collection angle##3##3##(1993-7#3)
wide complex tachycardia##2##3##(2006-4#2)
wide complex##3##2##(2006-4#2)(2006-9#1)
wide concentration range (1##9##4##(2008-10#9)
wide concentration range of##4##4##(2008-10#4)
wide concentration range##34##3##(1993-8#1)(2007-11#1)(2008-10#32)
wide concentration ranges##3##3##(2008-10#3)
wide concentration##37##2##(1993-8#1)(2007-11#1)(2008-10#35)
wide dissection##2##2##(2009-2#1)(2011-2#1)
wide distribution of##7##3##(1994-11#1)(1996-4#1)(2005-11#2)(2007-4#1)(2008-5#1)(2010-10#1)
wide distribution##16##2##(1994-11#1)(1994-9#1)(1996-12#1)(1996-4#1)(2005-11#2)(2007-4#2)(2008-5#5)(2008-9#1)(2010-10#1)(2011-2#1)
wide diversity of##7##3##(1995-11#1)(2006-10#2)(2008-10#1)(2010-3#1)(2010-4#1)(2011-1#1)
wide dynamic range neurones##2##4##(1996-12#2)
wide dynamic range of##3##4##(2007-12#1)(2008-10#1)(2010-5#1)
wide dynamic range##14##3##(1996-12#2)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)(2010-11#1)(2010-5#1)(2011-1#1)
wide dynamic##15##2##(1996-12#2)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)(2010-11#1)(2010-5#1)(2010-7#1)(2011-1#1)
wide enough##3##2##(1992-2#1)(2006-5#1)(2012-2#1)
wide excision and##2##3##(2004-1#1)(2010-11#1)
wide excision in##2##3##(2007-11#1)(2008-6#1)
wide excision of breast##2##4##(1995-4#2)
wide excision of the##3##4##(1992-2#1)(2008-6#2)
wide excision of##8##3##(1992-2#2)(1995-4#2)(2008-6#2)(2010-9#1)(2011-12#1)
wide excision with##2##3##(1996-6#1)(2013-8#1)
wide excision##23##2##(1992-2#2)(1995-4#2)(1996-6#2)(2004-1#8)(2007-11#1)(2008-6#4)(2010-11#1)(2010-9#1)(2011-12#1)(2013-8#1)
wide experimental##2##2##(2008-10#1)(2010-11#1)
wide expression##2##2##(2008-4#1)(2012-12#1)
wide field of##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
wide field##4##2##(2008-2#1)(2008-3#1)(2011-1#1)(2013-1#1)
wide geographic##5##2##(1997-4#1)(2007-12#1)(2008-10#2)(2008-3#1)
wide geographical distribution##2##3##(1994-2#1)(2008-10#1)
wide geographical scales##2##3##(2013-7#2)
wide geographical##5##2##(1994-2#1)(2008-10#1)(2012-5#1)(2013-7#2)
wide group of##2##3##(2007-7#1)(2008-10#1)
wide implementation of##3##3##(2013-1#3)
wide interindividual##2##2##(1993-12#1)(2008-12#1)
wide linear dynamic##2##3##(2008-10#2)
wide linear range and##3##4##(2008-10#3)
wide linear range from 0##2##5##(2008-10#1)(2013-1#1)
wide linear range from##3##4##(2008-10#2)(2013-1#1)
wide linear range##12##3##(2007-8#1)(2008-10#9)(2010-4#1)(2013-1#1)
wide linear response##2##3##(2008-10#1)(2013-1#1)
wide linear##17##2##(2007-8#1)(2008-10#13)(2010-4#1)(2013-1#2)
wide local excision and##2##4##(2006-10#1)(2008-6#1)
wide local excision followed by##2##5##(1990-2#1)(1991-10#1)
wide local excision of##2##4##(1994-12#1)(2012-2#1)
wide local excision##17##3##(1990-2#1)(1991-10#1)(1994-12#1)(2006-10#5)(2008-6#3)(2008-9#2)(2009-5#1)(2010-8#1)(2012-2#2)
wide longitudinal##2##2##(2008-1#1)(2012-12#1)
wide lower##2##2##(2007-11#1)(2011-2#1)
wide margins##2##2##(2008-6#1)(2011-2#1)
wide neck##2##2##(1997-3#2)
wide open##2##2##(2007-9#1)(2012-12#1)
wide optical##3##2##(1992-2#1)(2007-12#2)
wide or marginal resection##2##4##(2008-6#2)
wide or marginal##3##3##(2008-6#3)
wide or##4##2##(2008-11#1)(2008-6#3)
wide pH range of 3##2##5##(2008-10#2)
wide pH range of##5##4##(2008-10#4)(2010-2#1)
wide pH range##18##3##(1993-8#1)(2008-10#16)(2010-2#1)
wide pH##21##2##(1993-8#1)(2008-10#19)(2010-2#1)
wide panel of##2##3##(2008-9#1)(2009-10#1)
wide parameter##2##2##(2007-12#1)(2012-2#1)
wide range Euclidean distance##2##4##(2008-2#2)
wide range from##4##3##(1994-6#1)(2007-11#1)(2007-8#1)(2008-10#1)
wide range in##4##3##(1991-4#1)(1997-3#1)(2008-10#2)
wide range of 1##2##4##(2008-2#1)(2012-12#1)
wide range of aggressiveness##2##4##(2008-10#1)(2012-2#1)
wide range of applications##15##4##(1996-5#1)(2006-12#1)(2006-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2010-12#2)(2012-2#1)
wide range of biological##7##4##(1991-2#1)(1993-12#1)(2008-11#1)(2009-4#1)(2010-3#1)(2012-2#1)(2012-3#1)
wide range of cancers##3##4##(2008-3#1)(2009-11#1)(2011-2#1)
wide range of clinical##8##4##(1990-2#1)(1996-3#1)(2006-8#1)(2007-11#1)(2007-7#2)(2008-11#1)(2011-2#1)
wide range of concentration##2##4##(2008-10#2)
wide range of concentrations##11##4##(1997-3#1)(2005-11#1)(2008-10#5)(2008-3#1)(2008-6#1)(2008-7#1)(2012-1#1)
wide range of conditions##9##4##(1990-8#1)(1993-4#1)(2008-10#3)(2008-8#1)(2009-7#1)(2010-5#1)(2012-2#1)
wide range of different##4##4##(1997-6#1)(2007-12#1)(2009-10#1)(2011-1#1)
wide range of environmental conditions##2##5##(2008-10#1)(2008-5#1)
wide range of environmental##3##4##(2008-10#1)(2008-5#1)(2009-9#1)
wide range of experimental##3##4##(2005-11#1)(2008-11#1)(2009-2#1)
wide range of lesions##2##4##(2009-2#2)
wide range of medical##3##4##(2005-7#1)(2007-10#1)(2008-11#1)
wide range of methods##3##4##(2009-7#1)(2012-1#1)(2012-12#1)
wide range of pH values##2##5##(2005-11#1)(2008-10#1)
wide range of pH##11##4##(1994-3#1)(2005-11#1)(2008-10#6)(2008-5#2)(2013-1#1)
wide range of parameters##3##4##(2008-2#1)(2008-8#1)(2008-9#1)
wide range of patient##3##4##(2008-1#1)(2010-4#1)(2012-2#1)
wide range of strategic##3##4##(1994-2#1)(2008-12#1)(2010-2#1)
wide range of studies##2##4##(2006-10#1)(2013-8#1)
wide range of therapeutic##2##4##(1991-11#1)(2008-5#1)
wide range of topics##4##4##(2007-5#1)(2008-5#2)(2012-2#1)
wide range of##506##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-7#2)(1990-8#1)(1991-10#2)(1991-11#2)(1991-12#1)(1991-2#5)(1991-4#1)(1992-1#1)(1992-11#2)(1992-3#1)(1992-4#2)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#4)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-8#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#5)(1996-4#2)(1996-5#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#4)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#8)(2005-4#1)(2005-7#3)(2006-10#9)(2006-12#4)(2006-2#5)(2006-3#1)(2006-5#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#3)(2007-11#14)(2007-12#9)(2007-2#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#6)(2007-9#3)(2008-1#10)(2008-10#66)(2008-11#16)(2008-12#4)(2008-2#20)(2008-3#22)(2008-4#11)(2008-5#16)(2008-6#5)(2008-7#22)(2008-8#13)(2008-9#7)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#4)(2009-3#2)(2009-4#5)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#4)(2009-9#4)(2010-10#1)(2010-11#4)(2010-12#3)(2010-2#3)(2010-3#2)(2010-4#3)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#11)(2011-12#3)(2011-2#11)(2012-1#8)(2012-11#1)(2012-12#11)(2012-2#14)(2012-3#4)(2013-1#9)(2013-8#4)
wide range##537##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-7#2)(1990-8#1)(1991-10#3)(1991-11#2)(1991-12#1)(1991-2#5)(1991-4#2)(1992-1#1)(1992-11#2)(1992-3#1)(1992-4#2)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#5)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-8#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#5)(1996-4#2)(1996-5#2)(1996-7#2)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#5)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#8)(2005-4#1)(2005-7#3)(2006-10#9)(2006-12#4)(2006-2#5)(2006-3#1)(2006-5#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#3)(2007-11#17)(2007-12#10)(2007-2#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#9)(2007-9#3)(2008-1#11)(2008-10#72)(2008-11#16)(2008-12#4)(2008-2#29)(2008-3#25)(2008-4#11)(2008-5#16)(2008-6#5)(2008-7#22)(2008-8#13)(2008-9#7)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#4)(2009-3#2)(2009-4#5)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#4)(2009-9#4)(2010-10#1)(2010-11#4)(2010-12#3)(2010-2#3)(2010-3#2)(2010-4#3)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#11)(2011-12#3)(2011-2#11)(2012-1#8)(2012-11#1)(2012-12#11)(2012-2#14)(2012-3#4)(2013-1#9)(2013-8#4)
wide ranges##2##2##(1992-8#1)(2012-3#1)
wide ranging##4##2##(2006-12#1)(2009-1#1)(2009-8#1)(2011-2#1)
wide resection and##2##3##(2008-9#1)(2012-1#1)
wide resection with##2##3##(1992-9#1)(2008-6#1)
wide resection##8##2##(1992-9#1)(2006-10#1)(2008-6#1)(2008-9#2)(2011-2#2)(2012-1#1)
wide resections##2##2##(2007-8#1)(2010-2#1)
wide scale##3##2##(2009-12#1)(2010-6#1)(2013-8#1)
wide scope and##2##3##(1992-12#1)(2007-10#1)
wide scope##4##2##(1992-12#1)(2007-10#1)(2007-12#1)(2009-8#1)
wide search##2##2##(2008-3#1)(2010-2#1)
wide selection of##2##3##(2006-4#1)(2007-8#1)
wide size##3##2##(2007-12#1)(2008-10#1)(2010-8#1)
wide spectral range with##3##4##(2007-12#1)(2008-2#2)
wide spectral range##16##3##(2007-12#3)(2008-10#1)(2008-2#4)(2008-3#8)
wide spectral##21##2##(2006-12#1)(2007-12#5)(2008-10#1)(2008-2#5)(2008-3#9)
wide spectrum of clinical presentations##2##5##(2008-11#1)(2013-8#1)
wide spectrum of clinical##6##4##(2006-10#1)(2006-2#1)(2008-11#1)(2008-3#1)(2013-1#1)(2013-8#1)
wide spectrum of therapeutic##2##4##(1990-6#1)(2005-7#1)
wide spectrum of##51##3##(1990-3#1)(1990-6#2)(1991-2#1)(1991-5#1)(1992-4#1)(1992-9#1)(1993-3#1)(1996-10#1)(1996-12#1)(1997-1#1)(1997-5#1)(2005-1#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-11#4)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
wide spectrum##60##2##(1990-12#1)(1990-3#1)(1990-6#2)(1991-2#1)(1991-5#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-3#1)(1996-10#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-5#1)(2005-1#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-11#4)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#1)(2011-1#2)(2011-2#3)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
wide spread##4##2##(2008-10#1)(2008-7#1)(2011-1#1)(2011-12#1)
wide substrate##2##2##(1990-4#1)(2012-2#1)
wide surgical excision of##3##4##(2007-3#1)(2013-1#2)
wide surgical excision##8##3##(2007-11#1)(2007-3#1)(2008-5#1)(2008-6#1)(2010-7#1)(2013-1#3)
wide surgical resection##2##3##(2012-2#1)(2013-7#1)
wide surgical##12##2##(2006-6#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-5#1)(2008-6#1)(2010-7#1)(2012-2#1)(2013-1#3)(2013-7#1)
wide temperature range##3##3##(1993-8#1)(2008-2#1)(2008-3#1)
wide temperature##4##2##(1993-8#1)(2007-12#1)(2008-2#1)(2008-3#1)
wide tissue distribution##2##3##(1994-9#1)(1995-3#1)
wide tissue##3##2##(1994-9#1)(1995-3#1)(1997-8#1)
wide to##3##2##(1990-12#1)(2007-12#1)(2008-8#1)
wide tuning##2##2##(2007-11#1)(2008-3#1)
wide usage##2##2##(2007-6#1)(2010-8#1)
wide use in##5##3##(2007-11#1)(2008-10#1)(2008-3#1)(2011-12#1)(2012-12#1)
wide use of the##2##4##(2007-8#1)(2012-12#1)
wide use of##6##3##(1992-5#1)(1994-4#1)(2007-8#1)(2008-1#1)(2008-2#1)(2012-12#1)
wide use##15##2##(1991-11#1)(1992-5#1)(1994-4#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#1)(2010-12#1)(2011-12#1)(2012-12#2)
wide variability in##3##3##(2007-10#1)(2007-12#1)(2008-8#1)
wide variability of##3##3##(1993-6#1)(1996-3#2)
wide variability##9##2##(1993-6#1)(1996-3#2)(2007-10#1)(2007-12#1)(2007-4#1)(2008-5#1)(2008-8#1)(2010-11#1)
wide variation in##20##3##(1996-12#1)(1996-3#1)(1997-3#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-2#1)(2009-7#1)(2010-1#1)(2010-8#1)(2012-12#1)(2012-3#2)
wide variation of##2##3##(1997-6#1)(2008-3#1)
wide variation##25##2##(1994-4#1)(1996-12#1)(1996-3#1)(1997-3#2)(1997-6#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-2#1)(2009-7#1)(2010-1#1)(2010-8#1)(2012-12#1)(2012-3#2)
wide variations in##5##3##(1992-1#1)(1994-8#1)(1997-3#1)(2008-11#1)(2012-12#1)
wide variations##10##2##(1992-1#1)(1994-8#1)(1997-3#1)(1997-8#1)(2006-7#1)(2007-12#1)(2008-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
wide variety of bacterial##2##4##(2007-12#1)(2009-8#1)
wide variety of disorders##2##4##(2008-1#1)(2008-11#1)
wide variety of neuropsychiatric##2##4##(2007-11#1)(2008-8#1)
wide variety of organisms##5##4##(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-7#1)
wide variety of other metal ions##6##6##(2008-10#6)
wide variety of other##13##4##(1994-12#1)(2008-10#11)(2011-3#1)
wide variety of sequence##3##4##(2008-2#1)(2008-4#2)
wide variety of signals##3##4##(2005-10#1)(2008-3#1)(2008-4#1)
wide variety of##248##3##(1990-10#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-11#2)(1991-8#2)(1992-1#1)(1992-11#1)(1992-3#2)(1992-7#1)(1993-12#1)(1993-2#1)(1993-4#2)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-2#1)(1995-3#4)(1995-4#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-5#1)(1996-7#1)(1997-2#3)(1997-4#2)(1997-6#1)(1997-8#1)(2004-3#1)(2005-10#3)(2005-11#2)(2005-8#1)(2006-10#7)(2006-12#3)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-11#3)(2007-12#8)(2007-2#3)(2007-3#3)(2007-4#2)(2007-9#2)(2008-1#7)(2008-10#24)(2008-11#9)(2008-12#2)(2008-2#8)(2008-3#7)(2008-4#16)(2008-5#7)(2008-6#4)(2008-7#3)(2008-8#4)(2008-9#5)(2009-10#3)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#2)(2009-8#3)(2009-9#2)(2010-12#3)(2010-2#2)(2010-4#5)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-8#2)
wide viewing angle and##2##4##(2010-4#1)(2010-8#1)
wide virulence##2##2##(2008-10#2)
wide wavelength##3##2##(2007-12#1)(2008-1#1)(2008-2#1)
wide working##2##2##(2008-10#2)
wide world##2##2##(2008-6#1)(2010-11#1)
wide##1593##1##(1990-10#3)(1990-11#2)(1990-12#5)(1990-2#4)(1990-3#1)(1990-4#3)(1990-5#1)(1990-6#3)(1990-7#2)(1990-8#2)(1991-10#4)(1991-11#5)(1991-12#2)(1991-2#7)(1991-3#4)(1991-4#2)(1991-5#3)(1991-6#1)(1991-8#2)(1991-9#2)(1992-1#3)(1992-10#1)(1992-11#3)(1992-12#2)(1992-2#6)(1992-3#4)(1992-4#5)(1992-5#3)(1992-7#1)(1992-8#1)(1992-9#4)(1993-10#1)(1993-12#3)(1993-2#5)(1993-3#4)(1993-4#5)(1993-5#1)(1993-6#4)(1993-7#4)(1993-8#3)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#4)(1994-3#6)(1994-4#2)(1994-5#1)(1994-6#7)(1994-7#1)(1994-8#3)(1994-9#6)(1995-1#3)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#7)(1995-4#3)(1995-6#2)(1995-8#3)(1996-1#1)(1996-10#3)(1996-11#2)(1996-12#9)(1996-2#4)(1996-3#11)(1996-4#4)(1996-5#4)(1996-6#4)(1996-7#3)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#8)(1997-3#11)(1997-4#3)(1997-5#4)(1997-6#5)(1997-7#1)(1997-8#4)(2004-1#8)(2004-11#1)(2004-3#1)(2005-1#1)(2005-10#4)(2005-11#18)(2005-4#1)(2005-7#6)(2005-8#3)(2006-1#1)(2006-10#31)(2006-11#1)(2006-12#14)(2006-2#9)(2006-3#1)(2006-4#7)(2006-5#3)(2006-6#14)(2006-7#2)(2006-8#11)(2006-9#6)(2007-1#2)(2007-10#7)(2007-11#41)(2007-12#54)(2007-2#6)(2007-3#8)(2007-4#8)(2007-5#4)(2007-6#2)(2007-7#12)(2007-8#22)(2007-9#7)(2008-1#27)(2008-10#225)(2008-11#33)(2008-12#12)(2008-2#63)(2008-3#75)(2008-4#35)(2008-5#44)(2008-6#30)(2008-7#44)(2008-8#25)(2008-9#21)(2009-1#3)(2009-10#9)(2009-11#1)(2009-12#5)(2009-2#9)(2009-3#5)(2009-4#9)(2009-5#10)(2009-6#2)(2009-7#4)(2009-8#13)(2009-9#7)(2010-1#1)(2010-10#4)(2010-11#13)(2010-12#11)(2010-2#9)(2010-3#4)(2010-4#14)(2010-5#9)(2010-6#4)(2010-7#9)(2010-8#13)(2010-9#4)(2011-1#28)(2011-12#6)(2011-2#36)(2011-3#1)(2012-1#10)(2012-11#4)(2012-12#23)(2012-2#32)(2012-3#13)(2012-5#1)(2013-1#28)(2013-7#5)(2013-8#11)
wide)##5##1##(1990-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-10#1)
wide-angle X-ray diffraction##2##3##(2005-11#1)(2013-7#1)
wide-angle X-ray scattering##2##3##(2006-5#2)
wide-angle X-ray##4##2##(2005-11#1)(2006-5#2)(2013-7#1)
wide-angle##19##1##(2005-11#1)(2006-5#3)(2007-11#1)(2008-2#3)(2008-3#9)(2008-5#1)(2013-7#1)
wide-area network##2##2##(1992-2#1)(1996-12#1)
wide-area##4##1##(1992-2#1)(1996-12#1)(2008-2#1)(2013-1#1)
wide-band##3##1##(1995-12#1)(2006-5#1)(2007-5#1)
wide-field and##2##2##(2008-3#1)(2008-9#1)
wide-field excitation##2##2##(2011-1#2)
wide-field fluorescence lifetime images of##2##5##(2011-1#2)
wide-field fluorescence lifetime##3##3##(2007-11#1)(2011-1#2)
wide-field interferometric##2##2##(2011-1#2)
wide-field##17##1##(1990-12#1)(2007-11#1)(2008-1#2)(2008-2#3)(2008-3#2)(2008-8#1)(2008-9#1)(2011-1#6)
wide-gap semiconductors##3##2##(2006-12#3)
wide-pore##2##1##(1990-12#2)
wide-range##7##1##(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2012-2#1)
wide-ranging##12##1##(1991-3#1)(1995-12#1)(1996-1#1)(1997-1#1)(2005-11#2)(2007-8#1)(2008-3#1)(2010-3#1)(2010-7#1)(2013-1#1)(2013-8#1)
wide-scale##4##1##(2007-11#1)(2008-10#2)(2008-2#1)
wide-spectrum protein kinase inhibitor##2##4##(1990-12#1)(1995-5#1)
wide-spectrum##7##1##(1990-12#1)(1990-7#1)(1992-9#1)(1995-5#1)(2008-3#1)(2008-5#1)(2013-1#1)
wide-spread use of##3##3##(2009-10#1)(2009-4#1)(2012-1#1)
wide-spread##10##1##(1991-6#1)(1992-3#1)(1992-6#1)(1994-10#1)(2008-1#1)(2009-10#1)(2009-4#1)(2012-1#1)(2013-1#1)(2013-8#1)
wideband antireflection coatings with##2##4##(2008-2#2)
wideband emission##2##2##(2007-11#1)(2007-12#1)
wideband nulls##2##2##(2008-2#2)
wideband ultrasound detection##2##3##(2009-5#2)
wideband##23##1##(2007-11#3)(2007-12#6)(2008-2#8)(2008-3#3)(2009-5#2)(2013-7#1)
widely abused##2##2##(1997-2#1)(2010-4#1)
widely accepted among##2##3##(2008-11#1)(2008-7#1)
widely accepted and##2##3##(2005-7#1)(2006-5#1)
widely accepted as a##4##4##(2008-11#1)(2009-5#2)(2013-1#1)
widely accepted as the##3##4##(1993-12#1)(2007-7#1)(2008-11#1)
widely accepted as##8##3##(1993-12#1)(2007-7#1)(2008-11#2)(2009-5#2)(2009-8#1)(2013-1#1)
widely accepted by##4##3##(2006-2#1)(2009-3#1)(2011-2#1)(2013-7#1)
widely accepted for##4##3##(2005-11#1)(2007-11#1)(2007-12#1)(2008-5#1)
widely accepted is the##2##4##(2006-12#1)(2011-2#1)
widely accepted is##3##3##(1990-9#1)(2006-12#1)(2011-2#1)
widely accepted standard for the##2##5##(2004-1#1)(2012-12#1)
widely accepted that the##3##4##(2008-4#1)(2009-7#1)(2013-8#1)
widely accepted that##16##3##(1990-11#1)(1994-9#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-4#1)(2009-7#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
widely accepted theory##3##3##(2005-11#1)(2008-1#1)(2008-4#1)
widely accepted##86##2##(1990-10#1)(1990-11#1)(1990-9#1)(1991-3#1)(1991-6#1)(1993-12#2)(1993-8#1)(1994-9#1)(2004-1#1)(2005-11#2)(2005-7#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#3)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#6)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#3)
widely acknowledged as##2##3##(2007-9#1)(2009-4#1)
widely acknowledged in the literature##2##5##(2008-11#2)
widely acknowledged that##2##3##(2008-5#1)(2013-1#1)
widely acknowledged##9##2##(1993-12#1)(1997-5#1)(2007-9#1)(2008-11#2)(2008-5#2)(2009-4#1)(2013-1#1)
widely across##5##2##(1994-2#1)(2009-4#1)(2012-1#1)(2013-1#1)(2013-7#1)
widely adapted##2##2##(1993-2#1)(2012-1#1)
widely administered##2##2##(1995-1#1)(2008-3#1)
widely adopted##11##2##(1995-7#1)(1996-2#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-5#1)(2013-1#2)
widely advocated##2##2##(2006-7#1)(2008-11#1)
widely among##5##2##(1994-9#1)(2007-4#1)(2009-5#1)(2010-12#1)(2011-1#1)
widely and routinely##2##3##(2008-5#1)(2012-11#1)
widely and##8##2##(1993-12#1)(1994-6#1)(2006-6#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-5#1)(2012-11#1)
widely applicable##9##2##(1990-9#1)(1992-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-10#1)(2011-2#1)(2013-1#1)
widely applied for##2##3##(2008-11#1)(2012-2#1)
widely applied in the##2##4##(2008-4#1)(2013-8#1)
widely applied in##8##3##(1990-9#1)(2008-4#1)(2008-5#1)(2008-8#1)(2013-8#4)
widely applied to##2##3##(2008-4#1)(2010-12#1)
widely applied##15##2##(1990-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-8#4)
widely appreciated##3##2##(1997-8#1)(2008-10#1)(2008-8#1)
widely as##5##2##(2006-3#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)
widely assumed that##4##3##(1997-3#1)(2008-8#1)(2010-12#1)(2010-7#1)
widely assumed##7##2##(1990-6#1)(1997-3#1)(2008-8#1)(2010-12#1)(2010-7#1)(2013-1#2)
widely available and##6##3##(2006-12#1)(2006-6#1)(2008-7#1)(2009-1#1)(2009-6#1)(2012-2#1)
widely available for##2##3##(2007-11#1)(2008-11#1)
widely available in the##2##4##(1996-6#1)(2007-11#1)
widely available in##4##3##(1996-6#1)(2006-10#1)(2007-11#1)(2013-1#1)
widely available##45##2##(1990-11#1)(1991-12#2)(1993-11#1)(1993-9#1)(1996-12#1)(1996-6#1)(1997-4#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#2)(2006-7#1)(2007-11#3)(2007-12#2)(2007-3#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-6#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-2#3)(2012-2#2)(2013-1#3)
widely believed that##3##3##(1995-12#1)(2006-8#1)(2008-5#1)
widely believed to be##3##4##(1996-1#1)(2009-11#1)(2009-5#1)
widely believed to##6##3##(1990-11#1)(1996-1#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)
widely believed##11##2##(1990-11#1)(1995-12#1)(1996-1#1)(2006-7#1)(2006-8#1)(2008-5#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2013-7#1)
widely between the##2##3##(2008-11#1)(2012-3#1)
widely between##10##2##(1994-3#1)(2005-8#1)(2006-10#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-12#1)(2011-1#1)(2012-3#1)
widely by##3##2##(1993-11#1)(2006-12#1)(2008-10#1)
widely comparable##3##2##(2008-10#2)(2012-3#1)
widely considered a##2##3##(2009-4#1)(2009-6#1)
widely considered##6##2##(1994-8#1)(2008-7#1)(2009-4#1)(2009-6#1)(2012-3#2)
widely consumed##4##2##(1996-3#1)(2007-7#1)(2013-1#2)
widely cultivated in##3##3##(2008-10#1)(2012-11#1)(2012-2#1)
widely cultivated##4##2##(2008-10#1)(2008-12#1)(2012-11#1)(2012-2#1)
widely debated##2##2##(2008-9#1)(2009-3#1)
widely demonstrated##2##2##(1993-12#1)(2008-6#1)
widely different##10##2##(1993-8#1)(1994-5#1)(1995-11#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#2)
widely differing##2##2##(2008-10#1)(2008-9#1)
widely diffused##2##2##(1990-6#1)(2006-2#1)
widely discussed##9##2##(1994-2#1)(2005-10#1)(2005-8#1)(2008-11#2)(2009-6#1)(2009-9#1)(2013-1#2)
widely dispersed##6##2##(2007-2#1)(2008-11#1)(2009-7#1)(2011-2#1)(2013-1#2)
widely disseminated to##2##3##(1996-1#1)(1996-2#1)
widely disseminated##5##2##(1992-2#1)(1995-6#1)(1996-1#1)(1996-2#1)(2007-2#1)
widely distributed across##2##3##(1994-6#1)(2008-11#1)
widely distributed along the##2##4##(1997-4#1)(2013-7#1)
widely distributed among##4##3##(1996-7#2)(2008-12#1)(2008-8#1)
widely distributed enzymes##2##3##(2009-8#1)(2013-1#1)
widely distributed in the##10##4##(1991-4#1)(1993-11#1)(1994-3#1)(2005-11#1)(2006-7#1)(2008-7#1)(2009-12#1)(2011-12#2)(2012-11#1)
widely distributed in##32##3##(1991-4#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-3#1)(1996-5#1)(2004-4#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-7#1)(2007-7#1)(2008-10#4)(2008-7#1)(2008-8#1)(2009-12#1)(2011-12#2)(2011-2#2)(2012-11#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
widely distributed species##2##3##(2012-3#1)(2013-7#1)
widely distributed throughout the##7##4##(1995-11#1)(2007-11#1)(2008-8#1)(2009-9#1)(2010-5#1)(2010-8#1)(2012-2#1)
widely distributed throughout##9##3##(1995-11#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-8#1)(2012-2#1)
widely distributed toxic##2##3##(2008-10#1)(2008-6#1)
widely distributed##90##2##(1990-8#1)(1991-4#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#2)(1996-5#1)(1996-7#3)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#1)(2004-4#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-7#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-8#2)(2009-9#1)(2010-2#1)(2010-5#1)(2010-8#2)(2011-12#2)(2011-2#3)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#3)(2013-8#3)
widely divergent##2##2##(1991-3#1)(1994-3#1)
widely diverse##2##2##(2006-10#1)(2010-4#1)
widely documented##3##2##(1990-7#1)(1993-12#1)(2008-11#1)
widely employed as##2##3##(2007-9#1)(2008-10#1)
widely employed for##2##3##(2007-11#1)(2009-5#1)
widely employed in##3##3##(2006-5#1)(2008-11#1)(2008-2#1)
widely employed##14##2##(2005-11#2)(2006-5#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-5#1)
widely established##2##2##(2005-7#1)(2012-11#1)
widely exploited in##2##3##(2009-12#1)(2009-3#1)
widely expressed in human tissues##2##5##(1994-6#1)(2009-5#1)
widely expressed in the##2##4##(1997-7#1)(2008-3#1)
widely expressed in##7##3##(1994-6#1)(1995-12#1)(1996-10#1)(1997-7#1)(2008-3#1)(2009-5#1)(2012-3#1)
widely expressed##15##2##(1991-7#1)(1992-5#1)(1993-12#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-10#1)(1997-4#1)(1997-7#2)(2008-3#1)(2009-5#1)(2012-12#1)(2012-3#1)
widely for the##3##3##(2006-8#1)(2007-12#1)(2008-4#1)
widely for##7##2##(1997-8#1)(2006-8#1)(2007-12#1)(2007-8#2)(2008-4#1)(2009-6#1)
widely found##2##2##(2007-5#1)(2010-11#1)
widely from##8##2##(1990-12#1)(1991-1#1)(1994-12#1)(1997-3#1)(2006-9#1)(2007-8#1)(2008-10#1)(2012-3#1)
widely grown in the United States##2##6##(2008-10#2)
widely grown in##4##3##(2008-10#3)(2011-2#1)
widely grown##8##2##(2006-12#2)(2008-10#5)(2011-2#1)
widely held view is that##2##5##(1994-3#1)(1995-5#1)
widely held view that##3##4##(1994-2#1)(1994-6#1)(2007-11#1)
widely held view##6##3##(1991-6#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-5#1)(2007-11#1)
widely held##11##2##(1991-6#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-5#1)(2007-11#2)(2007-5#1)(2008-7#1)(2010-10#1)
widely implemented##5##2##(1992-1#1)(2005-8#1)(2006-5#1)(2008-7#1)(2008-9#1)
widely in human##2##3##(2008-5#1)(2008-9#1)
widely in the##6##3##(1991-7#1)(1996-12#1)(2006-10#1)(2008-11#1)(2011-3#1)(2012-12#1)
widely in their ability to##2##5##(1991-2#1)(2008-5#1)
widely in their response to##2##5##(2008-8#1)(2008-9#1)
widely in their##8##3##(1991-2#1)(1995-8#1)(2004-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)
widely in##40##2##(1990-10#1)(1991-2#1)(1991-7#1)(1992-7#1)(1993-11#1)(1993-5#1)(1994-11#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(2004-2#1)(2005-11#1)(2005-7#1)(2006-10#2)(2007-11#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
widely investigated in##3##3##(2008-2#1)(2009-8#1)(2012-2#1)
widely investigated##10##2##(1990-7#1)(1993-4#1)(1997-7#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
widely involved in##2##3##(2008-6#1)(2011-2#1)
widely known and##2##3##(2008-2#1)(2012-2#1)
widely known as##2##3##(1994-3#1)(2007-9#1)
widely known that##2##3##(2011-1#1)(2012-2#1)
widely known##15##2##(1994-3#1)(1996-1#1)(2007-11#2)(2007-3#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-2#2)(2008-4#1)(2009-5#1)(2011-1#1)(2012-2#2)
widely observed##3##2##(1996-7#1)(1997-6#1)(2009-8#1)
widely occurring##2##2##(1995-2#1)(2010-2#1)
widely perceived##2##2##(1992-10#1)(2008-5#1)
widely performed##3##2##(2005-11#1)(2010-12#1)(2010-8#1)
widely practised##2##2##(2006-12#1)(2007-6#1)
widely prescribed for##2##3##(1990-5#1)(1991-12#1)
widely prescribed##13##2##(1990-5#1)(1991-12#1)(1991-4#1)(1996-2#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2013-1#1)
widely present in##3##3##(2008-10#1)(2008-4#2)
widely prevalent##3##2##(2006-12#1)(2012-2#1)(2013-8#1)
widely recognised as an##2##4##(2007-11#1)(2008-11#1)
widely recognised as##3##3##(2005-12#1)(2007-11#1)(2008-11#1)
widely recognised##6##2##(2005-12#1)(2005-5#1)(2007-11#2)(2008-11#2)
widely recognized as the##3##4##(2008-12#1)(2008-9#1)(2010-12#1)
widely recognized as##7##3##(1996-12#1)(1996-3#1)(2008-12#1)(2008-9#1)(2010-12#1)(2010-6#1)(2013-1#1)
widely recognized##15##2##(1991-12#1)(1992-5#1)(1996-12#1)(1996-3#2)(2007-2#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
widely regarded as##5##3##(2008-10#1)(2008-8#1)(2010-2#1)(2012-11#1)(2012-2#1)
widely reported in##5##3##(2007-12#1)(2008-4#1)(2008-9#1)(2009-3#1)(2013-1#1)
widely reported to##2##3##(1991-3#1)(1996-8#1)
widely reported##14##2##(1991-3#2)(1996-2#1)(1996-8#1)(2006-10#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-9#1)(2009-3#1)(2012-12#1)(2013-1#1)
widely researched##2##2##(2008-10#1)(2009-2#1)
widely separated##6##2##(1994-9#2)(1995-2#1)(1995-5#1)(2008-11#1)(2008-4#1)
widely sold##2##2##(1992-10#1)(2008-12#1)
widely spaced##6##2##(1992-2#1)(2008-2#3)(2009-8#1)(2010-6#1)
widely spread##4##2##(2007-12#1)(2010-8#1)(2012-1#1)(2013-8#1)
widely studied in##2##3##(1991-4#1)(2009-6#1)
widely studied##21##2##(1991-4#1)(1997-3#1)(2006-10#1)(2007-1#1)(2007-9#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#2)(2009-6#1)(2010-12#2)(2010-4#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
widely throughout##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
widely to##5##2##(1993-11#1)(2008-10#1)(2008-3#1)(2010-10#1)(2013-8#1)
widely tunable##18##2##(2007-11#2)(2007-12#9)(2008-1#2)(2008-2#4)(2008-3#1)
widely use##2##2##(2008-10#1)(2013-1#1)
widely used analytical##2##3##(2008-4#1)(2010-11#1)
widely used and##5##3##(2006-10#1)(2006-2#1)(2008-1#1)(2011-2#1)(2013-1#1)
widely used as a marker##2##5##(2010-7#1)(2012-2#1)
widely used as a model##4##5##(2008-9#1)(2009-9#1)(2010-1#1)(2012-11#1)
widely used as a##17##4##(1992-11#1)(1997-2#1)(1997-4#1)(2005-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#1)(2009-9#1)(2010-1#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-2#1)
widely used as an##5##4##(1996-8#1)(2008-1#1)(2008-5#1)(2010-11#1)(2010-8#1)
widely used as##37##3##(1990-1#1)(1992-11#1)(1993-12#1)(1994-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(2004-1#1)(2005-11#1)(2005-12#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
widely used because##2##3##(2010-8#1)(2013-1#1)
widely used by##6##3##(1997-4#1)(2007-3#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-4#1)
widely used clinically##2##3##(1996-12#1)(2006-12#1)
widely used drug in##2##4##(2008-1#1)(2008-7#1)
widely used drug##5##3##(2006-10#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-8#1)
widely used for both##2##4##(2008-1#1)(2008-10#1)
widely used for carrying out automatic##2##6##(2008-4#1)(2008-9#1)
widely used for patients##2##4##(1995-3#1)(2008-6#1)
widely used for the control of##2##6##(1997-6#1)(2008-10#1)
widely used for the production of recombinant proteins##2##8##(2008-11#2)
widely used for the treatment of##5##6##(2005-3#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-7#1)
widely used for the##21##4##(1994-6#1)(1996-8#1)(1997-6#1)(1997-8#1)(2005-3#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#1)(2008-7#2)(2013-8#2)
widely used for treatment of##3##5##(1996-11#1)(2004-4#1)(2006-10#1)
widely used for##53##3##(1994-6#1)(1995-3#1)(1996-11#1)(1996-7#1)(1996-8#1)(1997-6#1)(1997-8#1)(2004-4#1)(2004-9#1)(2005-3#1)(2006-10#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#7)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#3)(2013-1#1)(2013-8#2)
widely used herbicide##5##3##(1995-8#1)(2008-10#4)
widely used in Japan##3##4##(2008-10#2)(2010-6#1)
widely used in biomedical##2##4##(1994-8#1)(2010-2#1)
widely used in clinical practice and research##2##7##(2010-11#1)(2012-12#1)
widely used in clinical practice in##2##6##(2008-1#1)(2009-10#1)
widely used in clinical practice##4##5##(2008-1#1)(2009-10#1)(2010-11#1)(2012-12#1)
widely used in clinical##9##4##(1990-10#1)(2006-10#1)(2008-1#1)(2008-10#1)(2009-10#1)(2010-11#1)(2012-12#1)(2013-1#2)
widely used in cosmetics and##2##5##(2008-5#2)
widely used in food##2##4##(2008-6#1)(2012-3#1)
widely used in industry##2##4##(1994-12#1)(1994-3#1)
widely used in many##2##4##(2009-12#1)(2010-5#1)
widely used in research##4##4##(1995-12#1)(2008-4#1)(2008-8#1)(2012-2#1)
widely used in the diagnosis of##2##6##(1992-10#1)(2012-12#1)
widely used in the treatment of##5##6##(2007-10#1)(2008-8#1)(2010-11#1)(2010-12#1)(2010-8#1)
widely used in the##22##4##(1992-10#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-8#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#2)(2013-7#1)(2013-8#1)
widely used in various##3##4##(2006-6#1)(2008-9#1)(2009-3#1)
widely used in##114##3##(1990-10#1)(1990-11#1)(1990-6#1)(1991-4#2)(1992-10#1)(1992-2#1)(1993-5#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-4#1)(2006-10#3)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#12)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#2)(2009-12#4)(2009-3#1)(2009-4#1)(2009-7#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#5)(2012-2#3)(2012-3#4)(2013-1#5)(2013-7#3)(2013-8#2)
widely used industrial##2##3##(2007-7#1)(2008-11#1)
widely used measures##3##3##(2008-8#1)(2009-12#1)(2010-2#1)
widely used method##8##3##(1995-1#1)(1995-2#1)(2005-11#1)(2005-7#1)(2006-12#1)(2008-4#1)(2011-1#1)(2013-8#1)
widely used methods##2##3##(1992-6#1)(2008-4#1)
widely used model of##2##4##(1996-10#1)(2010-12#1)
widely used rodent##2##3##(2011-1#1)(2012-3#1)
widely used technique for##3##4##(2008-3#1)(2010-5#1)(2013-1#1)
widely used technique##9##3##(1996-8#1)(1997-6#1)(2008-11#1)(2008-3#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
widely used tests##2##3##(2008-8#1)(2012-2#1)
widely used to assess##4##4##(2008-11#1)(2010-5#1)(2013-1#2)
widely used to characterize##2##4##(2008-1#1)(2010-12#1)
widely used to evaluate##3##4##(1990-12#1)(1994-3#1)(2007-4#1)
widely used to monitor patients##2##5##(1990-2#1)(2008-10#1)
widely used to monitor##3##4##(1990-2#1)(1994-4#1)(2008-10#1)
widely used to study the##3##5##(2008-11#2)(2009-9#1)
widely used to study##6##4##(1996-5#1)(2008-11#3)(2009-9#1)(2012-3#1)
widely used to##37##3##(1990-12#1)(1990-2#1)(1990-8#1)(1994-3#1)(1994-4#1)(1994-6#1)(1996-5#1)(2007-1#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#4)
widely used treatment for##2##4##(2006-11#1)(2008-5#1)
widely used treatment##3##3##(2006-11#1)(2007-7#1)(2008-5#1)
widely used##462##2##(1990-1#1)(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#1)(1990-6#1)(1990-8#1)(1991-12#2)(1991-3#1)(1991-4#2)(1991-5#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#4)(1992-6#2)(1993-1#1)(1993-12#2)(1993-2#1)(1993-5#2)(1993-6#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-6#4)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#3)(1997-6#2)(1997-8#2)(2004-1#1)(2004-4#1)(2004-9#1)(2005-11#4)(2005-12#2)(2005-3#1)(2005-7#2)(2005-9#1)(2006-10#14)(2006-11#1)(2006-12#5)(2006-2#1)(2006-6#2)(2006-7#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#6)(2007-9#2)(2008-1#11)(2008-10#41)(2008-11#21)(2008-12#4)(2008-2#11)(2008-3#13)(2008-4#21)(2008-5#11)(2008-6#7)(2008-7#5)(2008-8#10)(2008-9#10)(2009-10#2)(2009-12#5)(2009-3#2)(2009-4#2)(2009-7#1)(2009-9#2)(2010-1#1)(2010-11#5)(2010-12#9)(2010-2#5)(2010-4#2)(2010-5#5)(2010-6#3)(2010-7#3)(2010-8#6)(2011-1#11)(2011-2#10)(2012-1#3)(2012-11#2)(2012-12#8)(2012-2#10)(2012-3#11)(2013-1#21)(2013-7#8)(2013-8#10)
widely utilized for##2##3##(2008-10#1)(2008-9#1)
widely utilized##8##2##(2006-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#2)(2009-11#1)(2010-8#1)
widely variable clinical##2##3##(1997-1#1)(2008-4#1)
widely varied##3##2##(1996-2#1)(2009-4#1)(2012-12#1)
widely varying##6##2##(1990-8#1)(1991-11#1)(1992-2#1)(1995-3#1)(1996-12#1)(2008-3#1)
widely with##5##2##(1991-11#1)(2007-5#2)(2008-10#1)(2011-12#1)
widely##1274##1##(1990-1#2)(1990-10#4)(1990-11#4)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#3)(1990-7#2)(1990-8#3)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#7)(1991-2#1)(1991-3#5)(1991-4#5)(1991-5#1)(1991-6#2)(1991-7#2)(1992-1#1)(1992-10#3)(1992-11#3)(1992-12#1)(1992-2#8)(1992-3#1)(1992-5#4)(1992-6#2)(1992-7#2)(1992-8#1)(1993-1#1)(1993-11#6)(1993-12#10)(1993-2#3)(1993-3#1)(1993-4#1)(1993-5#3)(1993-6#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#4)(1994-3#8)(1994-4#2)(1994-5#1)(1994-6#10)(1994-8#3)(1994-9#5)(1995-1#2)(1995-11#3)(1995-12#5)(1995-2#6)(1995-3#3)(1995-5#4)(1995-6#1)(1995-7#1)(1995-8#4)(1996-1#5)(1996-10#2)(1996-11#3)(1996-12#6)(1996-2#7)(1996-3#4)(1996-4#2)(1996-5#2)(1996-6#2)(1996-7#6)(1996-8#4)(1996-9#3)(1997-1#3)(1997-2#4)(1997-3#6)(1997-4#9)(1997-5#2)(1997-6#4)(1997-7#3)(1997-8#6)(2004-1#2)(2004-2#1)(2004-4#2)(2004-9#1)(2005-10#1)(2005-11#11)(2005-12#3)(2005-3#1)(2005-4#1)(2005-5#1)(2005-7#5)(2005-8#5)(2005-9#1)(2006-10#34)(2006-11#2)(2006-12#16)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#8)(2006-6#8)(2006-7#8)(2006-8#3)(2006-9#3)(2007-1#2)(2007-10#4)(2007-11#26)(2007-12#21)(2007-2#8)(2007-3#5)(2007-4#4)(2007-5#6)(2007-6#3)(2007-7#11)(2007-8#12)(2007-9#7)(2008-1#20)(2008-10#89)(2008-11#55)(2008-12#15)(2008-2#33)(2008-3#33)(2008-4#43)(2008-5#29)(2008-6#14)(2008-7#19)(2008-8#21)(2008-9#24)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#7)(2009-2#2)(2009-3#11)(2009-4#10)(2009-5#9)(2009-6#6)(2009-7#4)(2009-8#7)(2009-9#4)(2010-1#1)(2010-10#5)(2010-11#9)(2010-12#17)(2010-2#8)(2010-4#9)(2010-5#9)(2010-6#5)(2010-7#5)(2010-8#13)(2010-9#3)(2011-1#22)(2011-12#3)(2011-2#26)(2011-3#1)(2012-1#7)(2012-11#9)(2012-12#19)(2012-2#30)(2012-3#25)(2013-1#51)(2013-7#15)(2013-8#27)
widely-used##10##1##(1994-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#2)(2008-8#1)(2010-8#1)(2011-2#1)
widen the horizon of##2##4##(2008-12#1)(2010-8#1)
widen the therapeutic##2##3##(2008-3#1)(2008-5#1)
widen the##11##2##(1997-4#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#1)
widen##17##1##(1997-4#1)(2006-2#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-8#1)(2011-2#1)
widened arterial pulse pressure##2##4##(2007-7#2)
widened pulse pressure##2##3##(1990-5#1)(2007-7#1)
widened the##5##2##(2005-6#1)(2005-9#1)(2006-10#1)(2007-7#1)(2011-1#1)
widened##20##1##(1990-11#1)(1990-5#1)(1991-11#1)(1995-8#1)(1996-3#1)(2005-11#1)(2005-6#1)(2005-9#1)(2006-10#1)(2007-7#4)(2007-8#1)(2008-10#1)(2008-11#2)(2011-1#1)(2011-12#1)(2012-3#1)
widening gap between##3##3##(2007-2#1)(2007-7#1)(2008-9#1)
widening gap##4##2##(2007-2#1)(2007-7#1)(2008-9#1)(2010-8#1)
widening in##4##2##(2011-2#4)
widening of the##10##3##(1991-5#1)(1992-11#1)(1996-7#1)(2005-11#1)(2007-8#1)(2008-1#1)(2008-7#1)(2010-1#1)(2012-1#1)(2012-2#1)
widening of##12##2##(1991-5#1)(1992-11#1)(1996-7#1)(2005-11#1)(2007-8#1)(2008-1#1)(2008-7#1)(2010-1#1)(2012-1#1)(2012-2#1)(2013-1#2)
widening the##4##2##(2005-5#1)(2007-8#1)(2008-10#1)(2008-8#1)
widening##40##1##(1991-11#1)(1991-12#1)(1991-5#1)(1992-11#1)(1996-7#1)(1997-8#3)(2005-11#1)(2005-5#1)(2007-11#1)(2007-2#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-1#1)(2010-3#1)(2010-8#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-2#2)(2013-1#3)
widens the##3##2##(1997-4#1)(2007-11#1)(2008-8#1)
widens##6##1##(1991-4#1)(1997-4#1)(2007-11#1)(2008-12#1)(2008-5#1)(2008-8#1)
wider acceptance##2##2##(1997-7#1)(2010-7#1)
wider and the##3##3##(2008-10#2)(2013-1#1)
wider and##7##2##(2006-5#1)(2007-10#1)(2008-10#2)(2008-11#1)(2009-11#1)(2013-1#1)
wider applicability##2##2##(2008-2#1)(2012-2#1)
wider application of##2##3##(2008-9#1)(2011-2#1)
wider application##3##2##(2006-10#1)(2008-9#1)(2011-2#1)
wider area of##2##3##(1990-2#1)(1996-9#1)
wider availability of##2##3##(2006-5#1)(2010-8#1)
wider availability##3##2##(2006-5#1)(2010-8#1)(2012-12#1)
wider clinical##2##2##(2005-9#1)(2010-11#1)
wider context of##2##3##(2008-2#1)(2008-6#1)
wider discussion##2##2##(2008-7#1)(2012-2#1)
wider dissemination##3##2##(2008-11#1)(2010-9#1)(2012-12#1)
wider dynamic range##5##3##(1991-10#1)(2008-10#2)(2008-3#2)
wider issues##2##2##(1996-11#1)(2008-11#1)
wider linear##2##2##(2007-8#1)(2008-10#1)
wider population##2##2##(2006-2#1)(2013-8#1)
wider range of##31##3##(1991-12#1)(1992-7#1)(1994-12#2)(1996-1#1)(1996-10#1)(1997-1#2)(2005-12#1)(2005-7#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
wider range##34##2##(1991-12#1)(1992-7#1)(1993-11#1)(1994-12#2)(1996-1#1)(1996-10#1)(1997-1#2)(2005-12#1)(2005-7#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
wider research##2##2##(2006-5#1)(2008-11#1)
wider role##2##2##(2006-12#1)(2012-2#1)
wider side of the face##2##5##(2012-12#2)
wider spectrum of##2##3##(1991-12#1)(2013-8#1)
wider spectrum##3##2##(1991-12#1)(2008-9#1)(2013-8#1)
wider than the range of##2##5##(2008-8#2)
wider than the##3##3##(2008-3#1)(2008-8#2)
wider than##7##2##(1991-6#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#2)
wider use in##2##3##(2007-12#1)(2007-8#1)
wider use of the##3##4##(1992-3#1)(1997-2#1)(2013-8#1)
wider use of these techniques in years to come##2##9##(2006-10#2)
wider use of##10##3##(1992-3#1)(1997-2#1)(2006-10#3)(2008-11#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
wider use##15##2##(1992-1#1)(1992-3#1)(1997-2#1)(2006-10#3)(2007-12#2)(2007-8#2)(2008-11#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
wider virulence##2##2##(2008-10#2)
wider working##2##2##(2006-12#1)(2008-10#1)
wider##234##1##(1990-10#1)(1990-2#1)(1991-10#1)(1991-12#3)(1991-6#2)(1992-1#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-12#2)(1994-1#1)(1994-12#2)(1994-3#1)(1994-8#2)(1994-9#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-4#1)(1997-7#1)(2005-11#3)(2005-12#1)(2005-7#3)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#7)(2006-12#3)(2006-2#1)(2006-4#3)(2006-5#4)(2006-6#1)(2006-7#3)(2007-10#2)(2007-11#4)(2007-12#6)(2007-3#1)(2007-4#2)(2007-5#1)(2007-8#5)(2008-1#1)(2008-10#20)(2008-11#8)(2008-12#4)(2008-2#14)(2008-3#10)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#2)(2009-11#1)(2009-3#2)(2009-5#1)(2009-7#2)(2009-8#4)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#3)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#8)(2012-2#6)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#6)
widespread acceptance of##3##3##(1996-12#1)(2004-2#1)(2007-3#1)
widespread acceptance##7##2##(1996-12#1)(1997-8#1)(2004-2#1)(2006-10#1)(2006-9#1)(2007-3#1)(2008-7#1)
widespread adoption of##3##3##(1995-1#1)(2010-12#1)(2012-12#1)
widespread adoption##8##2##(1995-1#1)(2007-5#1)(2010-12#1)(2010-8#1)(2012-12#4)
widespread among##9##2##(1992-2#1)(1993-3#1)(1994-8#1)(1995-8#1)(2007-12#1)(2008-7#1)(2011-2#1)(2012-11#1)(2012-12#1)
widespread and##21##2##(1991-9#1)(1995-5#1)(1997-3#1)(2005-8#2)(2006-10#2)(2006-2#1)(2006-8#1)(2007-10#1)(2007-3#1)(2008-1#1)(2008-10#2)(2010-6#2)(2011-2#1)(2012-3#2)(2013-1#2)
widespread application in the##3##4##(2008-1#1)(2010-7#1)(2011-2#1)
widespread application in##4##3##(2008-1#1)(2008-7#1)(2010-7#1)(2011-2#1)
widespread application of##3##3##(2006-10#1)(2006-11#1)(2008-1#1)
widespread application##8##2##(1997-1#1)(2006-10#1)(2006-11#1)(2008-1#2)(2008-7#1)(2010-7#1)(2011-2#1)
widespread applications in##2##3##(2007-12#1)(2008-5#1)
widespread applications##3##2##(2007-12#1)(2008-5#1)(2010-2#1)
widespread attention##5##2##(2008-5#1)(2008-6#1)(2009-9#1)(2010-12#1)(2011-2#1)
widespread availability##3##2##(2006-12#1)(2006-6#1)(2011-2#1)
widespread but##3##2##(1992-8#1)(2008-5#1)(2010-2#1)
widespread changes##2##2##(1993-12#1)(2012-1#1)
widespread class of##2##3##(2008-9#1)(2013-1#1)
widespread clinical use##3##3##(2005-7#1)(2006-10#1)(2008-10#1)
widespread clinical##4##2##(2005-7#1)(2006-10#1)(2007-11#1)(2008-10#1)
widespread contamination of##2##3##(1997-3#1)(2008-10#1)
widespread cortical##2##2##(1994-3#1)(1997-6#1)
widespread cutaneous necrosis##2##3##(2006-10#2)
widespread cutaneous##3##2##(2006-10#2)(2012-12#1)
widespread deployment of##3##3##(2008-10#3)
widespread deployment##4##2##(2008-10#4)
widespread disease in##2##3##(2006-10#1)(2008-10#1)
widespread disease##9##2##(1993-10#1)(2006-10#2)(2008-10#4)(2008-3#2)
widespread dissemination of##2##3##(2008-7#1)(2012-1#1)
widespread distribution and##2##3##(1995-5#1)(2012-3#1)
widespread distribution of##13##3##(1991-10#1)(1992-8#1)(1993-6#1)(2004-11#2)(2008-10#2)(2008-11#1)(2008-4#3)(2012-3#1)(2013-1#1)
widespread distribution##18##2##(1991-10#1)(1992-8#1)(1993-6#1)(1995-5#1)(1996-5#1)(2004-11#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#3)(2012-3#2)(2013-1#1)
widespread environmental##4##2##(1994-3#1)(2005-8#1)(2008-10#2)
widespread exposure##2##2##(1990-7#1)(1993-3#1)
widespread expression of##2##3##(1995-5#1)(2010-12#1)
widespread expression##4##2##(1995-5#1)(1995-8#1)(1996-12#1)(2010-12#1)
widespread gene##2##2##(1997-4#1)(2008-10#1)
widespread genetic testing##2##3##(1997-8#2)
widespread genetic##3##2##(1997-8#2)(2008-8#1)
widespread implementation of##3##3##(1996-2#1)(2007-11#1)(2008-5#1)
widespread in all countries##2##4##(2005-7#1)(2012-1#1)
widespread in all##3##3##(2005-7#1)(2007-3#1)(2012-1#1)
widespread in nature##2##3##(2013-1#2)
widespread in southern##2##3##(2008-10#1)(2013-1#1)
widespread in the##4##3##(1994-6#1)(2005-8#1)(2006-12#1)(2008-10#1)
widespread in##31##2##(1990-11#1)(1990-4#1)(1994-6#1)(2005-7#1)(2005-8#1)(2006-12#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#4)(2009-6#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#1)
widespread increases in##2##3##(1996-9#1)(1997-8#1)
widespread influenza activity##2##3##(1992-1#1)(1992-6#1)
widespread influenza##3##2##(1992-1#1)(1992-6#1)(2009-12#1)
widespread interest in##2##3##(1996-2#1)(2006-10#1)
widespread interest##4##2##(1996-2#1)(2005-7#1)(2006-10#1)(2010-4#1)
widespread introduction of##3##3##(2004-1#1)(2008-4#1)(2011-1#1)
widespread involvement##2##2##(2007-5#1)(2007-7#1)
widespread knowledge##2##2##(1990-6#1)(2013-1#1)
widespread lack of##2##3##(2008-12#1)(2008-6#1)
widespread loss of##4##3##(2008-11#1)(2008-7#1)(2013-1#2)
widespread metastasis##3##2##(2007-7#1)(2011-1#1)(2012-1#1)
widespread metastatic disease##2##3##(2008-6#1)(2011-3#1)
widespread neuronal##3##2##(1996-7#1)(1997-4#1)(2008-11#1)
widespread occurrence in##2##3##(2008-10#1)(2008-9#1)
widespread occurrence of##5##3##(1996-12#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-9#1)
widespread occurrence##7##2##(1996-12#1)(1997-4#1)(1997-7#1)(2008-10#2)(2008-9#2)
widespread of##2##2##(2013-8#2)
widespread on##2##2##(2008-10#1)(2010-12#1)
widespread over##2##2##(2010-1#1)(2013-1#1)
widespread pain and##2##3##(2006-10#1)(2006-8#1)
widespread pain##10##2##(1997-4#2)(2006-10#3)(2006-8#1)(2009-7#2)(2011-1#1)(2011-2#1)
widespread popularity##2##2##(2006-5#1)(2012-12#1)
widespread problems##2##2##(1997-6#1)(2008-12#1)
widespread public##2##2##(2008-12#1)(2011-1#1)
widespread recognition of##2##3##(2006-9#1)(2011-2#1)
widespread role in##2##3##(1990-11#1)(2012-2#1)
widespread systemic disease##2##3##(1992-3#1)(2006-12#1)
widespread systemic##3##2##(1992-3#1)(2006-12#1)(2009-4#1)
widespread than##6##2##(1996-3#1)(2007-9#1)(2008-10#2)(2008-8#1)(2010-2#1)
widespread throughout the##4##3##(1995-11#1)(2007-11#1)(2007-3#1)(2013-8#1)
widespread throughout##7##2##(1995-11#1)(1996-4#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-10#1)(2013-8#1)
widespread tissue distribution##3##3##(1995-6#1)(1995-8#1)(1997-2#1)
widespread use as##2##3##(2004-4#1)(2012-12#1)
widespread use in the##2##4##(2006-10#1)(2007-12#1)
widespread use in##5##3##(1997-5#1)(2005-7#1)(2006-10#1)(2007-12#1)(2013-1#1)
widespread use is hampered by##2##5##(1990-2#1)(2009-3#1)
widespread use is##3##3##(1990-2#1)(2006-10#1)(2009-3#1)
widespread use of computerized##2##4##(2007-1#1)(2013-1#1)
widespread use of the##4##4##(1993-12#1)(2008-2#1)(2011-2#1)(2012-2#1)
widespread use of these##3##4##(1991-4#1)(2005-8#1)(2012-1#1)
widespread use of this##2##4##(2006-10#1)(2007-11#1)
widespread use of##58##3##(1990-2#1)(1991-4#1)(1993-12#1)(1995-5#1)(1996-11#1)(1996-2#1)(1997-6#1)(1997-8#2)(2004-12#1)(2005-8#3)(2005-9#2)(2006-10#3)(2006-3#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#5)(2008-8#1)(2009-11#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#3)(2013-8#1)
widespread use##86##2##(1990-2#2)(1990-4#1)(1991-12#1)(1991-4#1)(1993-12#1)(1993-3#1)(1995-5#1)(1996-11#1)(1996-2#1)(1997-5#1)(1997-6#1)(1997-8#3)(2004-12#1)(2004-4#1)(2005-7#1)(2005-8#3)(2005-9#2)(2006-10#6)(2006-3#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#1)
widespread##550##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-4#3)(1990-6#2)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-2#2)(1992-3#2)(1992-6#1)(1992-8#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#4)(1993-6#2)(1993-8#1)(1994-3#2)(1994-4#1)(1994-6#1)(1994-7#2)(1994-8#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-5#4)(1995-6#3)(1995-7#1)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#5)(1996-3#2)(1996-4#2)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#7)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#10)(2004-1#1)(2004-11#3)(2004-12#1)(2004-2#1)(2004-3#1)(2004-4#1)(2004-9#1)(2005-1#1)(2005-11#2)(2005-12#1)(2005-7#5)(2005-8#8)(2005-9#3)(2006-10#25)(2006-11#2)(2006-12#6)(2006-2#3)(2006-3#1)(2006-5#4)(2006-6#2)(2006-7#2)(2006-8#6)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#10)(2007-12#5)(2007-2#2)(2007-3#4)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#8)(2007-9#3)(2008-1#6)(2008-10#55)(2008-11#8)(2008-12#6)(2008-2#3)(2008-3#4)(2008-4#10)(2008-5#8)(2008-6#5)(2008-7#19)(2008-8#12)(2008-9#11)(2009-10#1)(2009-11#3)(2009-12#4)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#8)(2010-2#5)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#13)(2011-10#1)(2011-12#2)(2011-2#17)(2011-3#1)(2012-1#8)(2012-11#2)(2012-12#14)(2012-2#11)(2012-3#9)(2013-1#27)(2013-7#4)(2013-8#6)
widow##8##1##(2007-12#1)(2007-9#1)(2008-10#1)(2009-4#2)(2010-12#3)
widow's##2##1##(1992-8#1)(1996-6#1)
widowbird##2##1##(2008-8#2)
widowed##6##1##(2007-2#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#2)
width S##2##2##(2008-2#2)
width after##2##2##(2007-12#2)
width and height##2##3##(2007-12#1)(2013-1#1)
width and length##2##3##(1993-4#1)(2005-9#1)
width and of##2##3##(2007-12#1)(2008-10#1)
width and output power##2##4##(2008-2#2)
width and the##3##3##(2007-11#1)(2008-3#1)(2008-7#1)
width and##36##2##(1993-4#1)(1993-6#1)(1994-11#1)(2005-9#1)(2007-11#2)(2007-12#11)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#6)(2008-7#2)(2009-4#1)(2010-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
width as well as##2##4##(2008-1#1)(2012-12#1)
width as##3##2##(2008-1#1)(2008-3#1)(2012-12#1)
width at half##5##3##(1991-6#1)(1994-8#1)(2008-5#1)(2011-2#1)(2012-12#1)
width at half-maximum##15##3##(2006-5#1)(2007-12#4)(2008-10#1)(2008-2#4)(2008-3#3)(2013-8#2)
width at##26##2##(1991-6#1)(1994-8#1)(2005-10#1)(2006-5#1)(2007-11#1)(2007-12#5)(2008-10#2)(2008-2#5)(2008-3#4)(2008-5#1)(2011-2#1)(2012-12#1)(2013-8#2)
width between##4##2##(2005-11#1)(2007-12#1)(2008-10#1)(2008-11#1)
width change##2##2##(2007-12#1)(2007-3#1)
width effect##2##2##(2010-7#2)
width for##4##2##(1997-7#1)(2008-10#1)(2008-3#1)(2012-3#1)
width in the##2##3##(2007-11#1)(2008-5#1)
width in##7##2##(2007-11#4)(2008-2#1)(2008-5#1)(2011-12#1)
width is approximately##2##3##(2008-2#1)(2008-3#1)
width is##13##2##(1993-6#1)(1997-1#1)(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#4)
width of 0##2##3##(2007-12#1)(2008-2#1)
width of 3##3##3##(1993-2#1)(2007-12#1)(2008-3#1)
width of 5##2##3##(2008-2#1)(2008-3#1)
width of 7 nm##2##4##(1991-12#1)(2008-3#1)
width of 7##5##3##(1991-12#1)(1991-3#1)(2008-3#1)(2012-11#2)
width of a##2##3##(2008-2#1)(2008-3#1)
width of attached gingiva and##2##5##(2013-7#2)
width of attached gingiva##3##4##(2013-7#3)
width of the beam##3##4##(2006-4#1)(2008-1#1)(2008-2#1)
width of the generated##2##4##(2007-11#1)(2007-12#1)
width of the##79##3##(1990-3#1)(1990-5#1)(1991-1#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-12#1)(1993-12#1)(1993-9#1)(1994-8#1)(1995-10#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-7#1)(2005-11#1)(2005-9#1)(2006-4#1)(2007-11#6)(2007-12#10)(2007-3#1)(2008-1#3)(2008-10#7)(2008-11#1)(2008-2#7)(2008-3#15)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
width of##140##2##(1990-3#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-12#1)(1992-7#1)(1993-12#1)(1993-2#2)(1993-9#1)(1994-8#1)(1994-9#1)(1995-10#1)(1996-2#1)(1996-4#2)(1997-1#1)(1997-3#1)(1997-7#1)(2005-11#2)(2005-9#1)(2006-12#2)(2006-4#2)(2007-11#8)(2007-12#24)(2007-3#1)(2008-1#5)(2008-10#12)(2008-11#1)(2008-2#11)(2008-3#27)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2011-2#2)(2012-11#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#4)(2013-8#1)
width on the##2##3##(2008-2#2)
width on##4##2##(2008-2#2)(2012-2#2)
width or##3##2##(2008-2#1)(2008-3#1)(2008-5#1)
width that is##3##3##(2007-11#1)(2008-3#1)(2008-7#1)
width to##3##2##(2008-2#2)(2008-8#1)
width was##8##2##(2007-11#2)(2007-12#3)(2008-10#2)(2012-2#1)
width were##4##2##(2008-10#2)(2008-3#1)(2012-11#1)
width when the##2##3##(2008-10#1)(2008-2#1)
width when##5##2##(2008-10#1)(2008-2#1)(2008-3#3)
width##420##1##(1990-3#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#2)(1992-12#1)(1992-2#1)(1992-7#1)(1993-12#3)(1993-2#2)(1993-4#1)(1993-6#4)(1993-9#1)(1994-11#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-5#1)(1996-2#1)(1996-4#2)(1996-6#1)(1997-1#2)(1997-3#1)(1997-5#1)(1997-7#2)(1997-8#1)(2005-10#3)(2005-11#5)(2005-9#2)(2006-10#2)(2006-12#2)(2006-4#2)(2006-5#1)(2006-6#1)(2007-11#30)(2007-12#74)(2007-3#3)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#8)(2008-10#38)(2008-11#4)(2008-12#1)(2008-2#42)(2008-3#72)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-1#2)(2009-12#1)(2009-4#1)(2009-5#1)(2010-10#5)(2010-11#1)(2010-12#1)(2010-7#3)(2010-8#2)(2011-12#3)(2011-2#4)(2012-1#4)(2012-11#3)(2012-12#12)(2012-2#4)(2012-3#1)(2012-8#1)(2013-1#5)(2013-7#6)(2013-8#5)
width)##6##1##(2007-12#1)(2008-11#1)(2009-11#1)(2010-12#1)(2010-8#1)(2012-1#1)
widths and##6##2##(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
widths are##4##2##(2007-12#2)(2008-3#2)
widths as##2##2##(2008-1#1)(2008-3#1)
widths of the##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2012-2#1)
widths of##13##2##(1991-12#1)(1994-9#1)(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#1)(2009-5#1)(2012-11#2)(2012-2#1)
widths on##2##2##(2007-8#1)(2008-7#1)
widths were##6##2##(1993-7#1)(2007-12#1)(2008-1#1)(2008-7#2)(2009-5#1)
widths##67##1##(1991-12#1)(1991-8#1)(1992-3#1)(1993-6#1)(1993-7#1)(1994-9#1)(1995-3#1)(1995-5#1)(2005-12#1)(2006-3#1)(2007-11#8)(2007-12#8)(2007-8#2)(2008-1#2)(2008-10#2)(2008-2#7)(2008-3#13)(2008-7#5)(2008-8#1)(2009-2#1)(2009-5#2)(2010-8#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#1)
wield##2##1##(2007-3#1)(2007-5#1)
wields##2##1##(1992-1#1)(2005-8#1)
wife and I##2##3##(2010-5#1)(2012-2#1)
wife and##3##2##(1990-12#1)(2010-5#1)(2012-2#1)
wife##21##1##(1990-11#1)(1990-12#1)(1991-7#1)(1992-6#2)(1996-5#1)(1997-6#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-9#1)(2009-1#1)(2009-2#1)(2010-5#1)(2012-2#1)(2013-8#1)
wife's##2##1##(1993-7#1)(2007-12#1)
wife-beating among both men and women##3##6##(2007-3#3)
wife-beating among##4##2##(2007-3#4)
wife-beating##13##1##(2007-3#13)
wiggler and##2##2##(1990-12#1)(2006-5#1)
wiggler beamline##2##2##(2006-4#1)(2006-5#1)
wiggler##9##1##(1990-12#1)(2006-4#2)(2006-5#5)(2008-3#1)
wigs after xenogeneic hair transplantation##2##5##(2012-3#2)
wigs##9##1##(2012-3#9)
wih##2##1##(2008-2#1)(2012-12#1)
wild APP##2##2##(1991-9#2)
wild H##3##2##(2006-12#3)
wild P##2##2##(2008-10#2)
wild Ricord's iguanas (Cyclura ricordii) and##2##6##(2007-2#2)
wild Ricord's iguanas##4##3##(2007-2#4)
wild Senegal doves##2##3##(2008-5#2)
wild Solanum spp##5##3##(2008-10#5)
wild Solanum##7##2##(2008-10#7)
wild and captive##4##3##(1996-12#1)(2008-5#2)(2008-8#1)
wild and cultivated##7##3##(2007-1#1)(2008-10#5)(2013-8#1)
wild and domestic animals##2##4##(1990-3#1)(2012-2#1)
wild and domestic##6##3##(1990-3#1)(2007-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
wild and##27##2##(1990-3#1)(1995-1#1)(1996-12#2)(1997-7#1)(2006-10#1)(2006-7#1)(2007-1#2)(2007-3#1)(2008-10#5)(2008-5#2)(2008-8#1)(2009-2#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
wild animal##3##2##(1991-11#1)(2007-2#1)(2008-8#1)
wild animals##6##2##(1996-12#1)(2008-5#1)(2012-2#1)(2013-7#2)(2013-8#1)
wild annual sunflowers (Helianthus spp##2##5##(2008-8#2)
wild barley##3##2##(2005-10#2)(2008-10#1)
wild birds in##2##3##(2008-5#1)(2011-2#1)
wild birds##13##2##(2004-4#2)(2005-7#1)(2007-2#1)(2007-3#1)(2008-4#1)(2008-5#4)(2011-2#3)
wild boar (Sus##2##3##(2010-4#2)
wild boar##7##2##(2008-9#1)(2010-4#4)(2013-8#2)
wild chimpanzees##3##2##(2007-12#2)(2012-2#1)
wild chokecherry##2##2##(2008-10#2)
wild fish##2##2##(2009-2#1)(2010-8#1)
wild grass-infecting##2##2##(2008-10#2)
wild host plants##2##3##(2007-6#1)(2008-10#1)
wild host##4##2##(2007-6#1)(2008-10#3)
wild in##4##2##(2007-1#2)(2007-2#2)
wild individuals##2##2##(2008-5#2)
wild isolates of##3##3##(2007-12#3)
wild males##3##2##(2008-8#1)(2012-12#2)
wild mammals kept in##2##4##(1996-12#2)
wild mammals##3##2##(1996-12#2)(2012-12#1)
wild mice##3##2##(1995-9#1)(1997-5#2)
wild mouse##4##2##(1994-12#1)(1997-5#2)(2008-10#1)
wild oats##4##2##(2008-10#4)
wild olive##2##2##(2008-10#2)
wild or##3##2##(2005-7#1)(2010-12#1)(2010-4#1)
wild plants##3##2##(2008-10#2)(2008-2#1)
wild poliovirus##3##2##(1994-12#1)(1997-1#2)
wild population##2##2##(1996-12#1)(2007-1#1)
wild populations of##3##3##(2008-2#2)(2008-5#1)
wild populations##10##2##(2008-2#2)(2008-5#1)(2008-9#1)(2009-2#3)(2013-1#1)(2013-8#2)
wild potato##2##2##(2006-12#1)(2011-12#1)
wild radish##2##2##(1990-6#1)(2008-8#1)
wild relative##3##2##(2010-10#2)(2012-11#1)
wild relatives##4##2##(2008-10#1)(2008-5#1)(2010-10#2)
wild rhinoceros iguanas (Cyclura cornuta cornuta)##2##6##(2007-2#2)
wild rhinoceros iguanas##4##3##(2007-2#4)
wild rice species##3##3##(2007-3#2)(2008-8#1)
wild rice##4##2##(2007-3#2)(2008-5#1)(2008-8#1)
wild rodents##2##2##(1993-7#1)(2008-10#1)
wild rye##2##2##(2008-5#2)
wild soybean##4##2##(2012-11#4)
wild species of##4##3##(2008-5#2)(2008-7#1)(2011-2#1)
wild species##13##2##(2008-10#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2011-12#1)(2011-2#1)(2012-11#1)(2013-1#1)
wild strain and##2##3##(1997-2#1)(2010-8#1)
wild strain##7##2##(1997-2#2)(2005-11#1)(2007-7#1)(2008-10#1)(2009-3#1)(2010-8#1)
wild strains of Aspergilla##2##4##(2009-3#2)
wild strains of##4##3##(2008-12#1)(2009-3#3)
wild strains##5##2##(2005-11#1)(2008-12#1)(2009-3#3)
wild sulphur-crested cockatoos##2##3##(2008-5#2)
wild sunflowers##2##2##(2006-12#1)(2008-8#1)
wild type (WT) and##2##4##(2008-10#1)(2008-8#1)
wild type (WT)##8##3##(1995-11#1)(1997-1#1)(2008-10#1)(2008-8#2)(2009-8#1)(2013-1#1)(2013-8#1)
wild type (wt)##2##3##(1992-8#1)(2009-8#1)
wild type AR##2##3##(1995-3#2)
wild type alpha2M##2##3##(2008-11#2)
wild type and latently infected strains##2##6##(2008-10#2)
wild type and mutant##5##4##(1990-3#1)(1991-7#1)(2008-8#2)(2012-12#1)
wild type and the##5##4##(1991-7#1)(2006-8#1)(2008-10#1)(2008-6#1)(2008-8#1)
wild type and two##2##4##(1991-7#1)(2005-11#1)
wild type and##28##3##(1990-3#2)(1991-4#1)(1991-7#4)(1993-3#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-6#1)(2005-11#1)(2006-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#2)(2008-8#3)(2009-4#1)(2010-12#1)(2012-12#1)
wild type c-erbB-2##2##3##(1991-7#2)
wild type cells##5##3##(1991-8#1)(1994-3#1)(1994-9#2)(2010-4#1)
wild type cerebellum##3##3##(1994-10#3)
wild type enzyme##9##3##(1991-4#1)(1991-7#2)(1991-8#3)(1993-11#1)(1997-7#1)(2008-6#1)
wild type in##3##3##(2008-10#2)(2008-4#1)
wild type is##3##3##(1992-1#1)(2008-8#2)
wild type mice##5##3##(1996-8#1)(1997-7#1)(2009-8#1)(2010-3#1)(2013-1#1)
wild type on##2##3##(1997-3#1)(2008-10#1)
wild type or mutant##3##4##(1994-12#2)(1994-9#1)
wild type or##6##3##(1994-10#1)(1994-12#2)(1994-9#1)(1995-6#1)(2012-12#1)
wild type p53##4##3##(2005-12#2)(2008-5#1)(2009-5#1)
wild type receptor##5##3##(1995-10#1)(1996-11#1)(1996-5#1)(1996-8#2)
wild type strain##15##3##(1991-2#1)(1992-12#1)(1993-11#1)(1994-6#1)(2006-11#1)(2006-8#2)(2008-10#1)(2008-12#1)(2008-8#4)(2008-9#2)
wild type strains##6##3##(1990-12#1)(1990-5#1)(1991-9#1)(1997-6#1)(1997-8#1)(2006-11#1)
wild type were##2##3##(1995-2#1)(2008-10#1)
wild type##295##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#3)(1990-7#1)(1990-8#2)(1991-12#1)(1991-2#4)(1991-4#5)(1991-5#1)(1991-7#15)(1991-8#6)(1991-9#2)(1992-1#1)(1992-12#1)(1992-6#3)(1992-8#3)(1993-11#7)(1993-3#6)(1993-6#2)(1993-8#2)(1994-10#5)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#3)(1994-6#1)(1994-9#5)(1995-1#4)(1995-10#7)(1995-11#3)(1995-2#2)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#1)(1996-10#1)(1996-11#4)(1996-4#1)(1996-5#5)(1996-8#5)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#7)(1997-6#4)(1997-7#4)(1997-8#4)(2005-11#1)(2005-12#2)(2006-11#3)(2006-12#2)(2006-2#1)(2006-8#4)(2007-12#5)(2008-1#2)(2008-10#26)(2008-11#9)(2008-12#2)(2008-3#4)(2008-4#3)(2008-5#4)(2008-6#5)(2008-8#18)(2008-9#5)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#5)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#3)
wild type)##4##2##(1992-9#1)(1995-2#1)(1997-4#1)(2008-10#1)
wild vegetation without trees##2##4##(2013-1#2)
wild vegetation##5##2##(2011-2#1)(2013-1#4)
wild virus##2##2##(1997-6#1)(2007-2#1)
wild wolves##2##2##(1996-12#2)
wild##632##1##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#3)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#3)(1991-11#1)(1991-12#1)(1991-2#4)(1991-4#5)(1991-5#1)(1991-7#15)(1991-8#7)(1991-9#4)(1992-1#1)(1992-11#1)(1992-12#1)(1992-6#3)(1992-8#3)(1992-9#1)(1993-11#7)(1993-3#6)(1993-6#2)(1993-7#1)(1993-8#2)(1994-10#5)(1994-11#1)(1994-12#5)(1994-2#2)(1994-3#3)(1994-6#1)(1994-9#5)(1995-1#5)(1995-10#7)(1995-11#3)(1995-2#3)(1995-3#3)(1995-4#1)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#4)(1996-12#9)(1996-4#1)(1996-5#6)(1996-8#5)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#3)(1997-4#8)(1997-5#4)(1997-6#6)(1997-7#5)(1997-8#4)(2004-2#1)(2004-4#5)(2005-10#2)(2005-11#4)(2005-12#2)(2005-7#5)(2005-9#1)(2006-10#3)(2006-11#3)(2006-12#7)(2006-2#1)(2006-7#1)(2006-8#4)(2007-1#7)(2007-12#10)(2007-2#17)(2007-3#5)(2007-6#2)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#87)(2008-11#16)(2008-12#5)(2008-2#4)(2008-3#4)(2008-4#7)(2008-5#38)(2008-6#6)(2008-7#2)(2008-8#34)(2008-9#10)(2009-2#5)(2009-3#4)(2009-4#4)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#5)(2010-10#6)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#10)(2010-5#1)(2010-8#7)(2011-1#3)(2011-12#3)(2011-2#10)(2012-1#1)(2012-11#7)(2012-12#12)(2012-2#8)(2012-3#4)(2013-1#13)(2013-7#2)(2013-8#16)
wild)##2##1##(2008-10#1)(2009-9#1)
wild-caught individuals##2##2##(2009-5#2)
wild-caught##11##1##(2004-11#2)(2007-12#1)(2007-2#1)(2008-8#1)(2009-5#2)(2010-4#1)(2010-8#1)(2013-1#2)
wild-derived mouse stocks##3##3##(2009-5#3)
wild-derived##6##1##(2009-11#2)(2009-5#3)(2012-3#1)
wild-type (WT) and##3##3##(2008-7#1)(2012-3#1)(2013-1#1)
wild-type (WT) mice##2##3##(2007-10#1)(2010-2#1)
wild-type (WT) plants##2##3##(2006-11#1)(2012-3#1)
wild-type (WT)##15##2##(1997-4#1)(1997-6#1)(2006-11#1)(2007-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
wild-type (wt)##7##2##(1990-3#1)(1990-5#2)(1993-12#1)(1997-2#1)(1997-7#1)(2012-2#1)
wild-type Arc##2##2##(1995-1#1)(2007-11#1)
wild-type CAT##2##2##(1990-12#1)(1990-2#1)
wild-type CHIP28k##2##2##(1993-3#2)
wild-type CHO cells##2##3##(1993-9#1)(1995-6#1)
wild-type CHO##3##2##(1993-9#1)(1995-6#1)(2008-11#1)
wild-type CN##3##2##(2008-9#3)
wild-type DHFR##2##2##(1992-6#1)(1994-3#1)
wild-type DnaK##2##2##(1994-9#2)
wild-type E##5##2##(1992-2#1)(1994-11#1)(1994-9#2)(2011-2#1)
wild-type Escherichia coli##3##3##(1992-2#1)(1994-9#1)(2008-11#1)
wild-type FGFR##2##2##(1992-2#2)
wild-type FGFRs##5##2##(1992-2#5)
wild-type Fe protein##4##3##(1995-8#4)
wild-type GLUT1##4##2##(1991-4#1)(1992-4#2)(1995-11#1)
wild-type H-NS##2##2##(2011-1#2)
wild-type Hx##2##2##(1994-8#2)
wild-type MRP##2##2##(2008-11#2)
wild-type MalFGK2##2##2##(1996-11#2)
wild-type Mb##3##2##(1994-5#3)
wild-type P##2##2##(2008-10#2)
wild-type Philippine strain##2##3##(2008-10#2)
wild-type RNA##2##2##(1991-11#1)(2009-2#1)
wild-type RNA1##2##2##(2008-10#2)
wild-type TGF-beta##2##2##(1995-2#1)(1995-3#1)
wild-type TR beta##2##3##(1995-10#2)
wild-type TR##3##2##(1995-10#2)(1995-8#1)
wild-type TRbeta1##3##2##(1995-8#3)
wild-type Tth##2##2##(1996-4#2)
wild-type X##2##2##(2008-10#2)
wild-type activity##5##2##(1990-3#1)(1994-5#1)(1995-10#2)(1996-11#1)
wild-type and Del 49 enzymes were##2##6##(1995-2#2)
wild-type and Del 49 enzymes##3##5##(1995-2#3)
wild-type and Del 49##4##4##(1995-2#4)
wild-type and a##3##3##(1996-10#1)(1997-5#1)(2013-1#1)
wild-type and in##3##3##(1990-5#1)(1997-4#2)
wild-type and mutant enzymes##2##4##(1990-12#1)(1995-2#1)
wild-type and mutant mouse##2##4##(1990-5#1)(2008-2#1)
wild-type and mutant##20##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-6#1)(1992-4#1)(1992-8#1)(1993-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#1)(1997-2#1)(1997-3#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-7#2)(2009-10#1)
wild-type and mutated##3##3##(1994-11#1)(2008-10#1)(2008-8#1)
wild-type and rtN236T mutant##2##4##(2013-1#2)
wild-type and rtN236T##3##3##(2013-1#3)
wild-type and squid##2##3##(1994-3#2)
wild-type and##88##2##(1990-12#2)(1990-5#2)(1990-8#1)(1991-1#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-8#1)(1994-11#5)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#5)(1995-3#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-8#1)(1997-2#1)(1997-3#3)(1997-4#4)(1997-5#1)(1997-6#2)(1997-8#1)(2006-10#1)(2007-10#2)(2007-12#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#2)(2009-3#1)(2009-5#2)(2010-10#1)(2010-12#1)(2011-3#1)(2012-12#2)(2013-1#4)
wild-type animals##6##2##(1994-12#1)(1996-2#1)(1997-7#2)(2009-8#1)(2012-3#1)
wild-type bR##6##2##(1992-11#2)(1993-11#1)(1995-11#3)
wild-type background##4##2##(1990-11#1)(1996-11#1)(2008-9#2)
wild-type bacteria##2##2##(2008-5#1)(2008-7#1)
wild-type barley##2##2##(2008-10#2)
wild-type but not##3##3##(1990-8#1)(1996-3#1)(2007-12#1)
wild-type calbindin##2##2##(1990-3#1)(1994-11#1)
wild-type cells and##4##3##(1990-6#1)(1995-6#1)(2008-5#1)(2008-7#1)
wild-type cells are##3##3##(1994-8#1)(1995-8#2)
wild-type cells##21##2##(1990-3#1)(1990-6#1)(1991-7#1)(1991-8#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-2#2)(1995-4#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-3#1)(2006-8#1)(2007-12#1)(2008-5#1)(2008-7#1)(2009-9#1)
wild-type colonies##2##2##(2008-10#2)
wild-type controls##3##2##(1995-5#1)(2007-12#1)(2008-7#1)
wild-type counterparts##5##2##(1994-11#1)(2004-1#1)(2007-9#1)(2008-10#1)(2008-3#1)
wild-type derivative##2##2##(1991-2#1)(2008-10#1)
wild-type enzyme and##2##3##(1992-3#1)(1997-7#1)
wild-type enzyme with##2##3##(1992-3#1)(1994-9#1)
wild-type enzyme##78##2##(1990-10#4)(1990-12#2)(1990-8#3)(1991-12#2)(1991-5#1)(1992-3#6)(1992-6#4)(1992-9#4)(1993-6#2)(1993-8#1)(1994-11#4)(1994-2#1)(1994-3#1)(1994-5#2)(1994-9#7)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#3)(1995-6#7)(1995-8#6)(1996-11#1)(1996-2#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-4#2)
wild-type gene##5##2##(1990-5#1)(1991-12#1)(1992-9#1)(1993-3#1)(1994-12#1)
wild-type histidase##4##2##(1994-11#1)(1994-5#2)(1994-6#1)
wild-type human##3##2##(1990-5#1)(2008-3#1)(2008-9#1)
wild-type isolate##6##2##(2008-10#6)
wild-type isolates##9##2##(1997-4#1)(2008-10#7)(2012-1#1)
wild-type level##8##2##(1990-5#1)(1995-2#2)(1997-1#1)(1997-4#2)(2006-11#1)(2009-6#1)
wild-type levels of##2##3##(1991-12#1)(1995-2#1)
wild-type levels##5##2##(1991-12#1)(1995-2#1)(1995-6#1)(1996-7#1)(1997-4#1)
wild-type lysozyme##3##2##(1991-2#3)
wild-type mice##15##2##(1993-12#1)(1994-12#1)(1996-10#3)(1996-12#1)(1996-6#1)(1996-8#1)(1997-7#2)(2007-10#1)(2007-12#1)(2009-5#1)(2010-11#1)(2011-2#1)
wild-type or an Alzheimer's disease mutant Presenilin 1##2##8##(1997-1#2)
wild-type or kinase-negative receptors##2##4##(1997-7#2)
wild-type or mutant##4##3##(1994-11#1)(1995-6#1)(1997-1#1)(2008-1#1)
wild-type or##17##2##(1992-7#1)(1994-11#1)(1994-9#2)(1995-6#1)(1996-10#1)(1997-1#3)(1997-7#3)(2006-12#1)(2008-1#1)(2008-9#1)(2009-10#1)(2010-2#1)
wild-type p53 cells##3##3##(2007-11#1)(2007-9#2)
wild-type p53 protein##3##3##(1990-12#1)(1991-5#1)(1994-9#1)
wild-type p53##24##2##(1990-12#1)(1990-8#3)(1991-5#3)(1993-11#2)(1993-4#2)(1993-9#3)(1994-9#1)(1995-8#1)(1996-4#1)(2003-11#1)(2007-11#1)(2007-9#4)(2012-12#1)
wild-type parent##2##2##(1995-2#1)(2008-10#1)
wild-type phenotype##3##2##(1997-4#1)(1997-6#1)(2008-9#1)
wild-type plant##3##2##(1995-8#1)(2006-9#2)
wild-type plantlets##2##2##(2006-12#2)
wild-type plants##9##2##(2006-12#4)(2007-12#1)(2008-5#1)(2008-9#1)(2009-10#2)
wild-type pol##4##2##(1995-8#4)
wild-type pol-specific CTL##2##3##(1995-8#2)
wild-type poliovirus##2##2##(2006-10#1)(2007-2#1)
wild-type protein##25##2##(1990-2#1)(1990-5#3)(1990-8#1)(1991-2#1)(1991-4#1)(1992-3#2)(1992-6#1)(1992-9#1)(1994-11#3)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1997-4#1)(1997-5#3)(2011-1#1)(2011-2#1)
wild-type receptor##3##2##(1993-12#1)(1995-10#1)(1995-3#1)
wild-type receptors##3##2##(1995-3#1)(1995-6#1)(1996-5#1)
wild-type recombinant##3##2##(1994-11#1)(1995-5#2)
wild-type regulatory subunit##2##3##(1995-2#2)
wild-type strain and##2##3##(1996-7#1)(2008-6#1)
wild-type strain of##4##3##(1992-3#1)(2008-10#3)
wild-type strain##40##2##(1992-3#1)(1993-2#1)(1993-3#1)(1996-7#3)(1997-4#1)(1997-6#1)(2006-8#2)(2006-9#1)(2008-10#23)(2008-6#2)(2008-7#2)(2009-6#1)(2010-12#1)
wild-type strains and##4##3##(2008-10#3)(2011-1#1)
wild-type strains in##2##3##(2008-10#2)
wild-type strains##20##2##(1990-12#1)(1995-4#1)(1996-4#1)(1997-6#1)(2008-10#10)(2008-5#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
wild-type thioredoxin with##2##3##(1991-7#2)
wild-type thioredoxin##4##2##(1991-7#4)
wild-type tissue##2##2##(2007-11#1)(2008-9#1)
wild-type to##2##2##(1993-6#1)(1997-1#1)
wild-type tomato##3##2##(2008-10#1)(2008-5#2)
wild-type virus##9##2##(1993-6#1)(1996-4#1)(2008-10#5)(2011-3#1)(2013-1#1)
wild-type viruses##2##2##(2008-10#1)(2013-1#1)
wild-type yeast##8##2##(1995-2#1)(1995-8#1)(1996-5#2)(1997-4#2)(1997-6#2)
wild-type##884##1##(1990-10#4)(1990-11#1)(1990-12#8)(1990-2#2)(1990-3#7)(1990-5#11)(1990-6#2)(1990-7#1)(1990-8#10)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#6)(1991-2#8)(1991-4#3)(1991-5#7)(1991-6#2)(1991-7#5)(1991-8#3)(1991-9#3)(1992-1#1)(1992-11#4)(1992-12#1)(1992-2#10)(1992-3#10)(1992-4#5)(1992-6#12)(1992-7#3)(1992-8#1)(1992-9#10)(1993-11#5)(1993-12#5)(1993-2#1)(1993-3#7)(1993-4#2)(1993-6#5)(1993-8#7)(1993-9#4)(1994-11#27)(1994-12#5)(1994-2#3)(1994-3#6)(1994-5#13)(1994-6#5)(1994-8#9)(1994-9#26)(1995-1#11)(1995-10#7)(1995-11#6)(1995-12#3)(1995-2#30)(1995-3#8)(1995-4#2)(1995-5#10)(1995-6#16)(1995-8#35)(1995-9#3)(1996-10#6)(1996-11#10)(1996-12#1)(1996-2#8)(1996-3#3)(1996-4#7)(1996-5#5)(1996-6#1)(1996-7#11)(1996-8#6)(1996-9#1)(1997-1#9)(1997-2#8)(1997-3#9)(1997-4#23)(1997-5#6)(1997-6#12)(1997-7#10)(1997-8#3)(2003-11#1)(2004-1#1)(2006-10#3)(2006-11#3)(2006-12#19)(2006-3#1)(2006-8#3)(2006-9#3)(2007-10#6)(2007-11#8)(2007-12#13)(2007-2#1)(2007-6#1)(2007-9#7)(2008-1#1)(2008-10#102)(2008-11#6)(2008-2#5)(2008-3#2)(2008-4#2)(2008-5#9)(2008-6#6)(2008-7#14)(2008-8#12)(2008-9#14)(2009-10#8)(2009-2#3)(2009-3#1)(2009-5#3)(2009-6#4)(2009-8#4)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#7)(2010-2#3)(2011-1#8)(2011-2#7)(2011-3#2)(2012-1#3)(2012-12#10)(2012-2#5)(2012-3#6)(2013-1#11)(2013-7#1)(2013-8#5)
wildfires##3##1##(1994-7#1)(2009-4#2)
wildlife and##2##2##(2012-12#1)(2013-1#1)
wildlife conservation##5##2##(2006-7#3)(2012-2#1)(2013-1#1)
wildlife crime##2##2##(2011-1#2)
wildlife forensic##2##2##(2008-12#2)
wildlife in##4##2##(1990-3#1)(2010-5#1)(2012-2#1)(2013-8#1)
wildlife population##2##2##(2013-8#2)
wildlife research and##2##3##(2013-8#2)
wildlife research##7##2##(2013-8#7)
wildlife species##2##2##(2008-12#2)
wildlife zoonotic##2##2##(2011-1#2)
wildlife##60##1##(1990-3#4)(2004-4#1)(2005-7#1)(2006-7#3)(2007-2#1)(2008-10#1)(2008-11#2)(2008-12#7)(2008-7#3)(2008-9#1)(2010-5#1)(2011-1#4)(2012-12#2)(2012-2#7)(2013-1#3)(2013-7#1)(2013-8#18)
wildly##3##1##(2007-8#1)(2008-7#1)(2011-1#1)
wildtype and##2##2##(2008-7#1)(2012-2#1)
wildtype mu##2##2##(1991-9#2)
wildtype##20##1##(1990-5#1)(1991-9#2)(1992-12#2)(1992-6#1)(1994-12#1)(1995-7#1)(2008-10#2)(2008-4#2)(2008-7#3)(2009-11#1)(2009-4#1)(2010-11#1)(2012-2#2)
wiley##4##1##(2008-7#3)(2011-2#1)
will &quot##3##2##(1994-3#1)(2008-10#1)(2011-1#1)
will accelerate##2##2##(2012-2#1)(2013-1#1)
will accept##2##2##(1995-5#1)(2009-9#1)
will accommodate##2##2##(2008-1#1)(2011-2#1)
will accomplish##3##2##(1997-7#1)(2007-5#1)(2008-10#1)
will account for##4##3##(1990-10#1)(2007-11#1)(2010-12#1)(2012-12#1)
will achieve its##2##3##(1991-12#1)(1994-1#1)
will achieve the##2##3##(2007-5#1)(2008-8#1)
will achieve##16##2##(1991-12#1)(1994-1#3)(2004-2#1)(2005-9#2)(2007-5#1)(2008-1#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-5#1)
will activate##4##2##(1990-4#1)(2006-10#1)(2007-8#1)(2008-7#1)
will actively##3##2##(1995-3#1)(2013-1#2)
will actually##2##2##(2007-9#1)(2008-4#1)
will adapt##2##2##(1994-1#1)(1997-6#1)
will add##3##2##(1996-1#1)(2005-10#1)(2008-8#1)
will address some of the issues##2##6##(1991-12#1)(1993-11#1)
will address the need for##2##5##(2005-5#1)(2007-11#1)
will address the various##3##4##(1994-3#2)(1995-3#1)
will address the##15##3##(1991-1#1)(1994-3#2)(1995-3#1)(1996-1#1)(1997-8#1)(2005-5#1)(2006-4#1)(2007-11#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-7#1)
will address##27##2##(1991-1#1)(1991-12#1)(1992-1#1)(1992-3#1)(1993-11#1)(1994-3#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-8#1)(2005-5#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2010-12#1)
will advance our understanding of##2##5##(2009-9#1)(2012-1#1)
will advance##5##2##(2006-10#1)(2009-3#1)(2009-9#1)(2012-1#1)(2012-2#1)
will affect the##16##3##(1991-1#1)(1993-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#2)(2009-5#2)(2010-8#1)(2010-9#1)(2013-1#1)(2013-8#1)
will affect##30##2##(1991-1#1)(1993-1#1)(1993-2#2)(1994-3#1)(2004-9#1)(2005-11#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#3)(2010-2#2)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
will aid in the development of##3##6##(2008-11#1)(2008-7#1)(2012-2#1)
will aid in the##7##4##(1993-9#1)(1995-5#1)(1996-4#1)(2008-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
will aid in##15##3##(1993-9#1)(1995-1#1)(1995-5#1)(1996-4#1)(2004-4#1)(2005-11#1)(2008-11#1)(2008-6#1)(2008-7#2)(2009-7#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
will aid the##3##3##(1991-5#1)(1992-12#1)(2009-7#1)
will aid##24##2##(1991-3#1)(1991-5#1)(1992-12#1)(1993-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-4#1)(1997-2#1)(2004-4#1)(2005-11#1)(2008-11#1)(2008-6#1)(2008-7#2)(2009-7#2)(2009-8#1)(2010-9#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
will alert the##2##3##(2004-3#1)(2012-12#1)
will all##3##2##(2008-1#1)(2008-2#1)(2013-1#1)
will allow a##5##3##(1990-12#1)(1993-5#1)(1996-3#1)(1997-8#1)(2008-11#1)
will allow an##3##3##(2006-6#1)(2008-8#1)(2012-1#1)
will allow clinicians to##2##4##(1996-7#1)(2011-1#1)
will allow for more##2##4##(2005-8#1)(2008-10#1)
will allow for the##3##4##(2008-10#1)(2009-8#1)(2013-8#1)
will allow for##12##3##(1995-1#1)(1997-3#1)(2005-8#1)(2007-4#1)(2008-10#2)(2008-12#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-7#1)(2013-8#1)
will allow more##2##3##(2007-10#1)(2013-8#1)
will allow patients##2##3##(2007-7#1)(2008-7#1)
will allow physicians to##2##4##(2007-3#1)(2007-4#1)
will allow researchers to##2##4##(2007-1#1)(2010-4#1)
will allow the development of##2##5##(2007-11#1)(2009-1#1)
will allow the##21##3##(1990-9#1)(1991-2#1)(1992-12#1)(1993-12#1)(1994-3#1)(1994-5#2)(1996-2#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-1#1)(2009-7#1)(2010-9#1)(2011-2#1)
will allow to##4##3##(1994-6#1)(1995-10#1)(2008-11#1)(2012-12#1)
will allow us to##9##4##(1993-2#1)(1994-3#1)(1994-8#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-7#1)
will allow us##10##3##(1993-2#1)(1994-3#1)(1994-8#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-7#1)
will allow##115##2##(1990-12#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#5)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-1#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#5)(2012-12#3)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
will almost##2##2##(2006-10#1)(2006-12#1)
will also affect the##2##4##(2008-3#1)(2008-6#1)
will also affect##3##3##(2006-5#1)(2008-3#1)(2008-6#1)
will also allow the##2##4##(1991-12#1)(2012-11#1)
will also allow##5##3##(1991-12#1)(1993-9#1)(2005-5#1)(2008-2#1)(2012-11#1)
will also be addressed##3##4##(1995-12#1)(2008-8#1)(2010-12#1)
will also be considered##3##4##(2006-10#1)(2008-7#1)(2010-8#1)
will also be discussed##16##4##(2007-11#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-7#1)
will also be highlighted##4##4##(1992-3#1)(1997-1#1)(2012-11#2)
will also be presented##5##4##(1997-6#1)(2006-10#1)(2008-3#1)(2008-5#1)(2010-8#1)
will also be used##3##4##(1992-2#1)(2006-6#1)(2008-7#1)
will also be useful in##2##5##(2008-5#1)(2013-8#1)
will also be##58##3##(1992-2#2)(1992-3#1)(1993-3#1)(1995-12#1)(1996-12#1)(1997-1#1)(1997-6#1)(2005-5#1)(2006-10#4)(2006-6#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-1#4)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#1)(2009-11#1)(2009-3#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-8#2)(2011-2#3)(2012-11#2)(2012-12#2)(2013-7#1)(2013-8#2)
will also depend on the##3##5##(1992-3#1)(1992-6#1)(2008-2#1)
will also describe##3##3##(1994-3#1)(2008-4#1)(2013-1#1)
will also discuss the##3##4##(1993-12#1)(2008-10#1)(2010-6#1)
will also discuss##7##3##(1993-12#1)(2005-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-6#1)(2013-8#1)
will also have##2##3##(1993-3#1)(2011-2#1)
will also help to##3##4##(1994-9#1)(2008-11#1)(2008-9#1)
will also help##5##3##(1994-12#1)(1994-9#1)(2008-11#1)(2008-8#1)(2008-9#1)
will also improve##2##3##(1997-8#1)(2010-4#1)
will also look at##2##4##(2008-1#1)(2008-7#1)
will also provide##2##3##(2012-3#2)
will also require##2##3##(2006-5#1)(2013-8#1)
will also review##5##3##(2006-4#1)(2008-1#1)(2010-8#1)(2011-1#1)(2011-2#1)
will also##147##2##(1991-12#1)(1992-2#2)(1992-3#2)(1992-6#1)(1993-12#1)(1993-3#2)(1993-9#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-6#2)(1997-8#1)(2005-10#1)(2005-5#2)(2005-8#1)(2006-10#5)(2006-4#1)(2006-5#2)(2006-6#1)(2007-11#3)(2007-2#1)(2007-6#1)(2007-9#1)(2008-1#11)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#3)(2008-5#7)(2008-6#3)(2008-7#10)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-3#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#6)(2012-1#1)(2012-11#3)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#5)
will alter the##2##3##(2010-8#1)(2012-2#1)
will alter##3##2##(2010-2#1)(2010-8#1)(2012-2#1)
will always be an##2##4##(1995-1#1)(2007-8#1)
will always be##3##3##(1991-2#1)(1995-1#1)(2007-8#1)
will always##6##2##(1991-2#1)(1992-4#1)(1995-1#1)(2006-10#1)(2007-8#1)(2008-3#1)
will ameliorate##2##2##(2006-10#1)(2007-8#1)
will and durable power of attorney##2##6##(1992-1#1)(2010-8#1)
will and##10##2##(1992-1#1)(1992-5#1)(1993-10#1)(1993-6#1)(2007-12#1)(2008-1#1)(2008-12#1)(2010-12#2)(2010-8#1)
will appear in the##4##4##(1992-3#1)(1995-1#1)(2007-4#1)(2010-5#1)
will appear in##7##3##(1992-3#2)(1993-1#1)(1994-1#1)(1995-1#1)(2007-4#1)(2010-5#1)
will appear##12##2##(1992-3#2)(1993-1#1)(1993-12#2)(1994-1#2)(1995-1#1)(2005-7#1)(2007-4#1)(2008-7#1)(2010-5#1)
will apply##4##2##(1994-3#1)(2006-8#1)(2008-10#1)(2009-4#1)
will appreciate##2##2##(1992-1#1)(2008-9#1)
will approach##2##2##(2010-7#1)(2011-2#1)
will argue that the##2##4##(2010-12#1)(2011-1#1)
will argue that##4##3##(1996-2#1)(2010-12#1)(2010-3#1)(2011-1#1)
will arise##4##2##(1993-1#1)(1996-11#1)(2008-6#1)(2010-10#1)
will arrive at##2##3##(1996-3#1)(2008-3#1)
will assess##3##2##(1991-9#1)(2008-5#1)(2012-1#1)
will assist in defining the##2##5##(1992-8#1)(2007-11#1)
will assist in the##2##4##(2008-10#1)(2008-5#1)
will assist in##10##3##(1992-8#1)(2005-11#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-5#1)(2009-7#1)(2013-7#1)
will assist the##2##3##(2008-10#1)(2008-2#1)
will assist##18##2##(1992-8#1)(1995-1#2)(1995-2#1)(2005-11#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#1)(2009-12#1)(2009-7#1)(2013-7#1)
will at##2##2##(1992-12#1)(1996-3#1)
will attempt to##6##3##(1996-5#1)(2006-10#1)(2007-4#1)(2008-1#1)(2008-5#1)(2012-2#1)
will attract##2##2##(1996-3#1)(2009-9#1)
will automatically##2##2##(1996-2#1)(2008-5#1)
will be 1##2##3##(2007-9#1)(2008-5#1)
will be a challenge to##2##5##(2008-10#1)(2008-2#1)
will be a major##2##4##(1993-11#1)(2005-11#1)
will be a promising##2##4##(2007-12#1)(2013-8#1)
will be a useful tool for##2##6##(1994-9#1)(2008-11#1)
will be a useful tool##4##5##(1994-9#1)(2006-2#1)(2008-10#1)(2008-11#1)
will be a useful##5##4##(1994-9#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
will be a##51##3##(1993-1#1)(1993-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-4#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-8#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-11#1)(2012-12#2)(2013-8#2)
will be able to interpret##2##5##(1991-3#1)(2008-7#1)
will be able to##30##4##(1991-12#1)(1991-3#1)(1993-2#1)(1994-12#1)(1996-1#1)(1996-9#1)(1997-7#1)(1997-8#1)(2005-7#1)(2006-2#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-7#2)(2008-9#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
will be achieved by the##2##5##(2006-6#1)(2008-5#1)
will be achieved by##3##4##(2006-10#1)(2006-6#1)(2008-5#1)
will be achieved in##3##4##(2006-4#1)(2007-10#1)(2012-1#1)
will be achieved##8##3##(2006-10#1)(2006-4#1)(2006-6#1)(2007-10#1)(2008-2#1)(2008-5#1)(2011-2#1)(2012-1#1)
will be activated##2##3##(1994-12#1)(2008-4#1)
will be added##2##3##(1994-3#1)(2008-11#1)
will be addressed in##2##4##(1996-8#1)(2011-2#1)
will be addressed##11##3##(1996-8#1)(2004-11#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-12#1)(2009-2#1)(2010-5#1)(2011-2#2)
will be administered##4##3##(1990-6#1)(2006-6#1)(2008-5#2)
will be adopted by##2##4##(1992-4#1)(2008-10#1)
will be adopted to##2##4##(2006-8#1)(2007-4#1)
will be adopted##5##3##(1990-12#1)(1992-4#1)(2006-8#1)(2007-4#1)(2008-10#1)
will be affected##2##3##(2007-11#1)(2008-5#1)
will be allowed to##2##4##(1996-11#1)(2010-12#1)
will be also discussed##3##4##(2007-12#1)(2008-11#2)
will be also##8##3##(2007-12#1)(2008-11#2)(2008-12#2)(2009-5#1)(2011-2#1)(2012-12#1)
will be an important step##2##5##(2008-11#1)(2008-8#1)
will be an important##7##4##(2005-7#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-9#1)
will be an invaluable tool in##2##6##(2008-9#1)(2012-3#1)
will be an##17##3##(1996-1#1)(2005-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-9#1)(2012-2#1)(2012-3#1)
will be analyzed using##2##4##(2007-8#1)(2007-9#1)
will be analyzed##3##3##(1996-1#1)(2007-8#1)(2007-9#1)
will be applicable to##2##4##(2008-10#2)
will be applicable##3##3##(2008-10#3)
will be applied to##3##4##(1990-5#1)(1994-2#1)(2008-7#1)
will be applied##5##3##(1990-5#1)(1994-2#1)(2008-6#1)(2008-7#1)(2009-4#1)
will be asked##2##3##(2006-5#1)(2008-4#1)
will be assigned to the##2##5##(1995-12#1)(2005-8#1)
will be associated with##3##4##(2006-11#1)(2006-12#1)(2008-7#1)
will be assumed##2##3##(2005-5#1)(2007-4#1)
will be at##4##3##(1992-6#1)(1995-2#1)(2008-5#1)(2012-2#1)
will be available in the##2##5##(1990-11#1)(1997-1#1)
will be available##8##3##(1990-1#1)(1990-11#1)(1996-2#1)(1997-1#2)(2004-11#1)(2005-8#1)(2008-11#1)
will be based on the##2##5##(2007-12#1)(2008-6#1)
will be based on##6##4##(2005-8#1)(2006-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-6#1)
will be beneficial for##2##4##(2008-10#1)(2012-12#1)
will be beneficial in##3##4##(1996-11#1)(2008-10#1)(2008-3#1)
will be beneficial##8##3##(1996-11#1)(2008-10#2)(2008-3#1)(2009-5#1)(2010-8#1)(2012-12#1)(2012-2#1)
will be best##2##3##(1997-3#1)(2008-2#1)
will be better able to##3##5##(1992-12#1)(1997-3#1)(2008-11#1)
will be better prepared to##2##5##(1994-1#1)(1997-1#1)
will be better##9##3##(1992-12#1)(1994-1#1)(1997-1#1)(1997-3#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-8#1)(2010-2#1)
will be biased##3##3##(1995-6#1)(1996-3#1)(1997-6#1)
will be briefly##5##3##(2006-6#1)(2008-1#1)(2008-7#1)(2010-8#1)(2012-12#1)
will be brought##2##3##(2011-2#1)(2013-7#1)
will be capable##2##3##(1993-2#1)(2009-9#1)
will be carried##3##3##(2005-5#1)(2008-3#1)(2012-3#1)
will be characterized##2##3##(2006-6#1)(2006-8#1)
will be classified as##2##4##(1995-6#2)
will be classified##3##3##(1995-6#2)(2006-4#1)
will be clinically##5##3##(1992-10#1)(1997-1#1)(2006-9#1)(2008-6#1)(2012-12#1)
will be combined##2##3##(2008-5#1)(2009-3#1)
will be compared with##2##4##(1992-7#1)(2008-10#1)
will be compared##5##3##(1992-7#1)(1995-2#1)(2008-10#1)(2012-12#1)(2013-8#1)
will be completed in##2##4##(2007-11#1)(2007-8#1)
will be completed##3##3##(2005-5#1)(2007-11#1)(2007-8#1)
will be complex##2##3##(2006-10#1)(2010-2#1)
will be compromised##2##3##(1996-1#1)(2012-1#1)
will be conducted in##2##4##(1997-6#1)(2008-5#1)
will be conducted##3##3##(1997-6#1)(2008-5#2)
will be considered a##2##4##(1994-12#1)(1994-2#1)
will be considered##3##3##(1994-12#1)(1994-2#1)(2010-2#1)
will be continued##2##3##(2008-8#1)(2012-3#1)
will be created##2##3##(2005-5#1)(2011-3#1)
will be critical for##2##4##(1995-5#1)(2006-10#1)
will be critical to##3##4##(1993-1#1)(1993-12#1)(2007-7#1)
will be critical##6##3##(1993-1#1)(1993-12#1)(1995-5#1)(2005-8#1)(2006-10#1)(2007-7#1)
will be crucial##2##3##(2008-1#1)(2012-3#1)
will be dealt##2##3##(2007-3#1)(2009-10#1)
will be defined##2##3##(1995-12#1)(1997-3#1)
will be delayed##2##3##(1993-3#1)(1995-9#1)
will be demonstrated##5##3##(1995-2#1)(2008-10#2)(2011-1#1)(2011-2#1)
will be dependent on##3##4##(1991-12#1)(1995-1#1)(2010-11#1)
will be dependent##6##3##(1991-12#1)(1995-1#1)(1997-8#1)(2007-11#1)(2008-8#1)(2010-11#1)
will be described in detail in this##2##7##(2009-2#1)(2011-1#1)
will be described in detail##3##5##(2008-5#1)(2009-2#1)(2011-1#1)
will be described in##6##4##(1995-3#1)(1995-9#1)(2008-3#1)(2008-5#1)(2009-2#1)(2011-1#1)
will be described##28##3##(1990-4#1)(1991-5#1)(1995-3#1)(1995-9#1)(1997-4#1)(1997-8#1)(2005-10#1)(2006-2#1)(2006-5#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-2#1)(2010-11#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)
will be designed##2##3##(2007-4#1)(2008-2#1)
will be desirable##2##3##(2007-2#1)(2012-12#1)
will be detected##2##3##(1992-3#1)(1995-8#1)
will be determined by the##2##5##(2008-6#1)(2010-4#1)
will be determined by##3##4##(2008-3#1)(2008-6#1)(2010-4#1)
will be determined##5##3##(1995-8#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-4#1)
will be developed in##2##4##(2008-11#1)(2009-4#1)
will be developed to##2##4##(2007-6#1)(2008-1#1)
will be developed##8##3##(1997-1#1)(2006-8#1)(2007-6#1)(2008-1#1)(2008-11#2)(2009-4#1)(2011-2#1)
will be dictated by the##2##5##(2006-10#1)(2008-3#1)
will be difficult to##3##4##(1991-7#1)(2007-9#2)
will be difficult##6##3##(1991-7#1)(1994-12#1)(1997-6#1)(2007-9#2)(2008-6#1)
will be directed##2##3##(1992-3#1)(2011-2#1)
will be discussed along with##3##5##(2007-11#1)(2009-5#1)(2010-8#1)
will be discussed as well as##2##6##(2008-5#1)(2009-10#1)
will be discussed as##5##4##(2006-2#1)(2008-1#1)(2008-5#1)(2009-10#1)(2010-11#1)
will be discussed in the context of##4##7##(2005-7#1)(2006-11#1)(2007-2#1)(2008-2#1)
will be discussed in this review##3##6##(2004-11#1)(2008-3#1)(2010-7#1)
will be discussed in this##8##5##(2004-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)
will be discussed in##18##4##(2004-11#1)(2005-7#1)(2006-11#1)(2006-2#2)(2007-2#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#2)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#2)
will be discussed with##3##4##(2006-11#1)(2008-1#1)(2013-1#1)
will be discussed##106##3##(1990-3#1)(1992-12#1)(1994-12#1)(1995-3#1)(1995-4#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-7#3)(2006-10#2)(2006-11#3)(2006-2#3)(2006-4#2)(2007-1#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-1#6)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#4)(2009-10#3)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#5)(2010-4#2)(2010-6#1)(2010-7#3)(2010-8#1)(2011-12#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#4)(2013-1#1)(2013-7#1)(2013-8#1)
will be done##2##3##(2007-4#1)(2008-2#1)
will be emphasized##3##3##(2006-10#1)(2008-5#1)(2011-3#1)
will be encountered##2##3##(2008-10#1)(2012-1#1)
will be enhanced##2##3##(2006-12#1)(2006-9#1)
will be especially useful##2##4##(1991-12#1)(2008-10#1)
will be essential for##6##4##(1996-10#1)(2007-12#1)(2009-7#1)(2010-8#1)(2011-2#2)
will be essential to##4##4##(2007-2#1)(2008-10#1)(2011-1#2)
will be essential##14##3##(1992-3#1)(1996-10#1)(1996-3#1)(1997-3#1)(2007-12#1)(2007-2#1)(2008-10#1)(2009-7#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#2)
will be evaluated and##2##4##(2008-1#1)(2008-10#1)
will be evaluated##9##3##(1996-9#1)(2006-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2013-1#1)(2013-7#1)
will be examined##7##3##(1990-4#1)(1991-1#1)(1996-1#1)(1996-12#1)(2008-1#1)(2008-11#1)(2008-4#1)
will be expected to##3##4##(2008-6#1)(2010-8#1)(2013-8#1)
will be explained##3##3##(1997-3#1)(2007-6#1)(2008-7#1)
will be explored in##3##4##(2007-10#1)(2008-11#1)(2008-6#1)
will be explored##6##3##(2007-10#1)(2008-1#1)(2008-11#2)(2008-6#1)(2012-12#1)
will be extremely useful##2##4##(1991-9#1)(1995-8#1)
will be facilitated by the##3##5##(1995-1#1)(1995-12#1)(2006-10#1)
will be facilitated by##4##4##(1995-1#1)(1995-12#1)(2006-10#1)(2007-11#1)
will be focused on the##2##5##(2007-5#2)
will be followed by##2##4##(2007-10#1)(2008-8#1)
will be followed##5##3##(1997-5#1)(2007-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
will be formed##3##3##(1997-2#1)(2008-3#2)
will be found##5##3##(1993-12#1)(1993-5#1)(1995-8#1)(2007-11#1)(2007-8#1)
will be further##5##3##(2005-5#1)(2005-9#1)(2008-5#1)(2013-1#1)(2013-8#1)
will be generated##2##3##(1996-2#1)(2013-8#1)
will be given to##6##4##(1992-12#1)(1995-9#1)(2008-11#1)(2009-4#1)(2010-7#1)(2012-12#1)
will be given##13##3##(1991-5#1)(1992-12#2)(1995-9#1)(2007-2#1)(2007-8#1)(2008-11#3)(2009-3#1)(2009-4#1)(2010-7#1)(2012-12#1)
will be granted##3##3##(1996-8#1)(2012-11#2)
will be greatly##2##3##(1997-4#1)(2010-4#1)
will be hampered by##2##4##(1992-8#1)(1995-2#1)
will be held in##3##4##(1994-6#1)(2005-7#1)(2008-10#1)
will be helpful for##3##4##(2007-8#1)(2010-7#1)(2012-2#1)
will be helpful in##2##4##(2006-10#1)(2008-5#1)
will be helpful to##5##4##(2007-8#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)
will be helpful##10##3##(2006-10#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-7#1)(2012-2#1)
will be highlighted in each article##2##6##(1994-12#1)(1995-1#1)
will be highlighted in##3##4##(1994-12#1)(1995-1#1)(2008-1#1)
will be highlighted##11##3##(1994-12#1)(1995-1#1)(2007-1#1)(2008-1#2)(2008-2#1)(2008-7#1)(2008-8#1)(2010-7#1)(2012-12#1)(2012-2#1)
will be identified as##3##4##(1997-2#1)(2012-3#2)
will be identified##7##3##(1997-2#1)(2005-10#1)(2005-8#1)(2008-11#1)(2011-1#1)(2012-3#2)
will be illustrated by##2##4##(1991-9#1)(2010-9#1)
will be illustrated using##2##4##(1995-4#1)(2007-8#1)
will be illustrated##8##3##(1991-9#1)(1995-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-9#1)
will be implemented##5##3##(1991-2#1)(1996-8#1)(2006-6#1)(2007-12#1)(2012-12#1)
will be important for##2##4##(1995-12#1)(1996-2#1)
will be important in##3##4##(1993-12#1)(2008-6#1)(2010-10#1)
will be important to determine##2##5##(1992-5#1)(2008-10#1)
will be important to##10##4##(1990-12#1)(1992-5#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-5#1)(2012-11#1)(2012-2#1)
will be important##16##3##(1990-12#1)(1992-5#1)(1993-12#1)(1995-12#1)(1996-2#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-10#1)(2010-12#1)(2012-11#1)(2012-2#1)
will be improved##4##3##(1993-11#1)(1993-5#1)(2008-7#1)(2012-2#1)
will be in a##5##4##(2007-12#2)(2007-3#1)(2007-9#1)(2008-4#1)
will be in##9##3##(1990-12#1)(1996-1#1)(2007-12#2)(2007-3#1)(2007-9#1)(2008-4#1)(2011-1#1)(2013-1#1)
will be inadequate to##2##4##(1993-3#1)(2012-3#1)
will be inadequate##3##3##(1993-3#1)(2008-8#1)(2012-3#1)
will be included in##2##4##(2007-11#1)(2008-10#1)
will be included to##2##4##(2008-12#1)(2008-4#1)
will be included##6##3##(2007-11#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-7#1)
will be incorporated into##2##4##(1993-3#1)(2007-4#1)
will be increased##2##3##(2008-11#1)(2011-2#1)
will be increasingly important##2##4##(1996-2#1)(2009-8#1)
will be increasingly##4##3##(1996-2#1)(2008-3#1)(2009-10#1)(2009-8#1)
will be informative##2##3##(2008-8#1)(2009-5#1)
will be inhibited##2##3##(2006-12#1)(2008-8#1)
will be instrumental##2##3##(1996-3#1)(2012-2#1)
will be introduced and##2##4##(2005-7#1)(2013-1#1)
will be introduced##9##3##(1992-7#1)(2005-7#1)(2007-2#1)(2008-10#1)(2010-11#1)(2010-8#1)(2011-3#1)(2012-2#1)(2013-1#1)
will be invaluable##2##3##(1995-1#1)(2008-7#1)
will be investigated##3##3##(1992-11#1)(2008-3#1)(2013-8#1)
will be key to##2##4##(2008-11#1)(2010-10#1)
will be key##3##3##(2008-1#1)(2008-11#1)(2010-10#1)
will be largely dependent on the##2##6##(2006-7#1)(2008-10#1)
will be launched in Japan##2##5##(2008-5#2)
will be launched##3##3##(2008-3#1)(2008-5#2)
will be less than##2##4##(2007-11#1)(2008-5#1)
will be less##6##3##(1993-1#1)(1996-11#1)(2007-11#1)(2008-10#2)(2008-5#1)
will be limited##3##3##(1995-12#1)(2006-10#1)(2008-11#1)
will be made##8##3##(1990-3#1)(2005-9#1)(2006-6#1)(2006-8#1)(2008-2#1)(2008-5#1)(2008-7#1)(2013-7#1)
will be measured##4##3##(1995-3#1)(2007-9#1)(2008-11#1)(2011-2#1)
will be minimized##3##3##(1995-9#1)(2006-10#1)(2008-3#1)
will be more effective##2##4##(2006-11#1)(2006-8#1)
will be more efficient##2##4##(1997-3#1)(2013-1#1)
will be more useful for##2##5##(1997-3#1)(2008-5#1)
will be more##27##3##(1994-3#1)(1997-3#2)(1997-7#1)(2005-11#1)(2006-11#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-8#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
will be most##4##3##(2007-11#1)(2007-12#1)(2008-11#1)(2008-8#1)
will be much##4##3##(1991-11#1)(1991-6#1)(2008-1#1)(2012-3#1)
will be named##2##3##(1995-6#1)(1996-7#1)
will be necessary for##2##4##(1992-3#1)(2005-7#1)
will be necessary to clarify the##2##6##(2009-7#1)(2013-1#1)
will be necessary to determine##2##5##(2006-10#2)
will be necessary to##24##4##(1991-11#1)(1991-3#1)(1995-3#1)(2006-10#3)(2006-6#1)(2006-8#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-5#1)(2009-7#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#2)
will be necessary##34##3##(1991-11#1)(1991-3#1)(1992-3#3)(1993-5#1)(1995-3#1)(2005-7#1)(2006-10#3)(2006-6#1)(2006-8#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-5#2)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
will be needed for##2##4##(2008-11#1)(2009-3#1)
will be needed to address##3##5##(2008-8#1)(2009-1#1)(2010-5#1)
will be needed to clarify the##3##6##(1992-8#1)(2008-10#2)
will be needed to##15##4##(1991-12#1)(1992-8#1)(2006-5#1)(2006-6#1)(2008-10#4)(2008-7#1)(2008-8#1)(2009-1#1)(2009-11#1)(2009-12#1)(2010-5#1)(2011-1#1)
will be needed##26##3##(1990-12#1)(1990-6#1)(1991-12#1)(1992-8#1)(1994-7#1)(1997-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-5#1)(2011-1#1)
will be no##3##3##(1995-8#1)(2008-10#1)(2011-2#1)
will be observed##3##3##(2006-5#1)(2008-10#1)(2013-8#1)
will be obtained##2##3##(1993-6#1)(2008-11#1)
will be of general##2##4##(2006-7#1)(2010-11#1)
will be of great assistance in##2##6##(1990-12#1)(2008-10#1)
will be of great##4##4##(1990-12#1)(1995-2#1)(2008-10#1)(2009-5#1)
will be of interest to##3##5##(1993-5#1)(2005-7#1)(2011-1#1)
will be of use in##2##5##(2005-8#1)(2009-2#1)
will be of value in##2##5##(2006-10#1)(2006-11#1)
will be of value##3##4##(2006-10#1)(2006-11#1)(2010-8#1)
will be of##17##3##(1990-12#1)(1993-5#1)(1995-2#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-8#1)(2008-10#2)(2009-2#1)(2009-5#1)(2010-11#1)(2010-8#1)(2011-1#1)(2013-8#1)
will be offered##2##3##(2008-5#1)(2011-2#1)
will be offset in##2##4##(1990-12#1)(1994-9#1)
will be on the##6##4##(1996-5#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-11#1)(2012-12#1)
will be on##10##3##(1996-5#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-11#1)(2011-1#1)(2012-12#2)
will be one of the##2##5##(1996-2#1)(2007-7#1)
will be one##3##3##(1990-6#1)(1996-2#1)(2007-7#1)
will be outlined##7##3##(2005-7#1)(2008-11#1)(2008-12#1)(2009-10#1)(2009-5#1)(2010-5#1)(2012-2#1)
will be paid to the##2##5##(2006-12#1)(2010-12#1)
will be particularly useful for##2##5##(2008-10#1)(2008-4#1)
will be particularly useful##5##4##(2008-10#1)(2008-4#1)(2008-5#1)(2012-12#2)
will be particularly##7##3##(2006-4#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-12#2)
will be performed##5##3##(1990-4#1)(2006-6#1)(2007-11#1)(2008-5#1)(2008-7#1)
will be placed on the##3##5##(2004-11#1)(2008-4#1)(2009-3#1)
will be possible##14##3##(1991-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-9#1)(2006-10#1)(2007-4#2)(2008-1#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)
will be presented and##4##4##(2007-1#1)(2008-11#1)(2009-2#1)(2012-2#1)
will be presented in this##3##5##(1993-9#1)(2006-11#1)(2007-8#1)
will be presented in##5##4##(1993-9#1)(2006-11#1)(2007-8#1)(2008-3#1)(2010-8#1)
will be presented##34##3##(1991-5#1)(1993-9#1)(1994-9#1)(1996-2#1)(1997-6#1)(2006-10#1)(2006-11#1)(2006-4#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2009-10#1)(2009-2#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-8#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
will be proposed##3##3##(1997-1#1)(2008-3#1)(2009-7#1)
will be protected##2##3##(2007-10#1)(2011-1#1)
will be provided##6##3##(1995-12#1)(1997-2#1)(2006-8#1)(2008-12#1)(2008-8#1)(2012-3#1)
will be published in the summer##2##6##(1995-1#1)(1996-1#1)
will be published in the##4##5##(1993-2#1)(1995-1#1)(1995-2#1)(1996-1#1)
will be published in##5##4##(1993-2#1)(1995-1#1)(1995-2#1)(1996-1#1)(2008-4#1)
will be published on December 31##2##6##(2010-12#2)
will be published on##3##4##(2010-12#3)
will be published##8##3##(1993-2#1)(1995-1#1)(1995-2#1)(1996-1#1)(2008-4#1)(2010-12#3)
will be randomized into##2##4##(2007-9#2)
will be randomized to##4##4##(1995-9#1)(2007-9#2)(2008-5#1)
will be randomized##6##3##(1995-9#1)(2007-9#4)(2008-5#1)
will be randomly assigned##2##4##(2007-10#1)(2007-8#1)
will be randomly##3##3##(2007-10#1)(2007-8#1)(2008-7#1)
will be ready for##2##4##(1994-3#1)(2011-2#1)
will be realized##3##3##(1993-1#1)(2007-4#1)(2012-12#1)
will be recruited##2##3##(2007-8#1)(2008-5#1)
will be reported##3##3##(2004-12#1)(2008-10#1)(2012-1#1)
will be required and##2##4##(1990-6#1)(2011-2#1)
will be required before##3##4##(2007-1#1)(2007-11#1)(2008-1#1)
will be required for##2##4##(2007-12#1)(2012-2#1)
will be required to manage##2##5##(1993-12#1)(2007-12#1)
will be required to##19##4##(1990-12#1)(1992-2#1)(1993-12#1)(1994-11#1)(1995-12#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2010-4#1)(2012-12#1)(2013-1#2)
will be required##36##3##(1990-12#1)(1990-6#1)(1992-2#1)(1993-12#1)(1994-11#1)(1994-9#1)(1995-12#1)(1996-2#1)(1996-4#1)(1996-9#1)(2006-10#3)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)
will be restricted to##3##4##(2006-10#1)(2006-7#1)(2010-8#1)
will be reviewed along with##2##5##(2009-5#1)(2010-3#1)
will be reviewed and##4##4##(2005-7#2)(2009-10#1)(2009-5#1)
will be reviewed briefly##2##4##(2006-5#1)(2008-1#1)
will be reviewed here##3##4##(2008-10#1)(2008-11#1)(2010-11#1)
will be reviewed in this article##4##6##(2006-4#1)(2007-5#1)(2008-7#1)(2010-12#1)
will be reviewed in this##5##5##(2006-2#1)(2006-4#1)(2007-5#1)(2008-7#1)(2010-12#1)
will be reviewed in##6##4##(1991-4#1)(2006-2#1)(2006-4#1)(2007-5#1)(2008-7#1)(2010-12#1)
will be reviewed##47##3##(1991-4#1)(1993-12#1)(1995-4#1)(1996-5#1)(2005-7#4)(2005-8#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-5#1)(2007-6#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-5#3)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
will be seen in##2##4##(1995-2#1)(2007-11#1)
will be seen##4##3##(1995-2#1)(2007-11#1)(2009-5#1)(2010-9#1)
will be sent to##2##4##(2009-12#1)(2011-3#1)
will be shared##2##3##(2009-6#1)(2012-2#1)
will be shown to be##2##5##(1992-9#1)(2008-10#1)
will be shown to##4##4##(1991-1#1)(1992-9#1)(1996-12#1)(2008-10#1)
will be shown##8##3##(1991-1#1)(1992-9#1)(1993-4#1)(1996-12#1)(2008-10#3)(2008-3#1)
will be significantly##2##3##(2007-2#1)(2012-2#1)
will be smaller than that##2##5##(2006-7#1)(2008-3#1)
will be starting##2##3##(2008-6#2)
will be strongly##2##3##(1990-10#1)(2006-6#1)
will be subject##2##3##(2006-6#1)(2008-10#1)
will be subsequently##2##3##(2007-9#1)(2008-10#1)
will be successful##3##3##(2006-10#1)(2006-12#1)(2007-8#1)
will be sufficient##2##3##(2007-9#1)(2008-9#1)
will be suitable for##2##4##(2005-9#1)(2012-12#1)
will be suitable##3##3##(1991-6#1)(2005-9#1)(2012-12#1)
will be summarized##9##3##(1993-2#1)(1997-1#1)(2006-10#2)(2007-2#1)(2007-6#1)(2010-10#1)(2010-4#1)(2013-7#1)
will be taken##3##3##(1992-1#1)(2008-11#1)(2008-7#1)
will be the development of##2##5##(1996-3#2)
will be the first##2##4##(2008-12#1)(2008-5#1)
will be the focus of this review##2##7##(2008-2#1)(2008-4#1)
will be the greatest##2##4##(2008-10#1)(2012-12#1)
will be the key to##2##5##(1994-3#1)(2011-9#1)
will be the key##3##4##(1994-3#1)(2009-8#1)(2011-9#1)
will be the main##2##4##(2005-8#1)(2005-9#1)
will be the most##2##4##(2008-7#1)(2008-9#1)
will be the subject of##2##5##(2010-2#1)(2012-12#1)
will be the##47##3##(1991-12#3)(1994-1#1)(1994-3#1)(1995-12#1)(1996-11#1)(1996-3#2)(1996-4#1)(2004-3#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-8#1)(2010-10#2)(2010-2#1)(2011-1#1)(2011-2#1)(2011-9#1)(2012-12#2)(2012-2#1)
will be those who##2##4##(1993-12#1)(2008-5#1)
will be those##3##3##(1993-12#1)(2007-4#1)(2008-5#1)
will be to develop##2##4##(2008-1#1)(2008-7#1)
will be to##14##3##(1994-9#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-7#1)(2009-10#1)(2010-10#1)(2012-2#1)
will be treated##4##3##(1994-9#1)(2006-12#2)(2008-10#1)
will be unable to##2##4##(1992-2#1)(1997-7#1)
will be under##2##3##(2005-11#1)(2012-12#1)
will be updated with##2##4##(2005-7#2)
will be updated##4##3##(2005-7#2)(2008-4#1)(2012-3#1)
will be used as a##2##5##(2011-1#1)(2012-2#1)
will be used as##6##4##(1990-3#1)(2008-10#1)(2008-7#2)(2011-1#1)(2012-2#1)
will be used for risk-selection##2##5##(2008-7#2)
will be used for##8##4##(2006-5#1)(2007-6#1)(2008-3#1)(2008-7#2)(2010-2#1)(2012-1#1)(2013-8#1)
will be used in the##2##5##(2008-3#1)(2013-1#1)
will be used in##6##4##(1994-11#1)(2007-10#1)(2008-3#1)(2012-12#2)(2013-1#1)
will be used to design##2##5##(2007-4#1)(2012-1#1)
will be used to investigate##2##5##(1994-12#1)(2008-9#1)
will be used to##25##4##(1992-2#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-7#1)(1997-1#1)(2006-10#1)(2006-11#1)(2007-10#2)(2007-11#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-9#1)(2012-1#1)(2012-11#1)
will be used##51##3##(1990-3#1)(1992-2#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-7#1)(1997-1#3)(2006-10#1)(2006-11#1)(2006-5#2)(2007-10#3)(2007-11#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-5#2)(2008-7#5)(2008-9#1)(2009-10#1)(2009-9#1)(2010-2#1)(2011-1#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
will be useful as##3##4##(1991-1#1)(1994-5#1)(2008-5#1)
will be useful for further##2##5##(2008-10#1)(2011-1#1)
will be useful for studying the##3##6##(1990-2#1)(1992-12#1)(2008-11#1)
will be useful for studying##5##5##(1990-2#1)(1992-12#1)(1995-2#1)(2007-12#1)(2008-11#1)
will be useful for the##7##5##(1990-3#1)(1992-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-11#1)
will be useful for##31##4##(1990-2#1)(1990-3#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-8#2)(1995-2#1)(1996-11#1)(1996-12#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-11#1)(2011-1#1)(2012-11#1)(2012-2#2)
will be useful in studying##2##5##(1996-8#1)(2006-10#1)
will be useful in the##4##5##(1991-5#1)(1997-8#1)(2006-11#2)
will be useful in##24##4##(1991-5#1)(1992-2#1)(1992-3#1)(1992-5#1)(1994-2#1)(1996-8#1)(1997-8#2)(2005-11#1)(2006-10#1)(2006-11#2)(2006-2#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-8#1)
will be useful to##7##4##(1990-6#1)(2008-11#2)(2008-4#1)(2008-8#1)(2012-2#1)(2013-7#1)
will be useful##68##3##(1990-2#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-8#2)(1994-2#1)(1994-5#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-8#2)(2005-11#1)(2006-10#1)(2006-11#2)(2006-2#1)(2007-11#2)(2007-12#2)(2007-8#2)(2008-10#9)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2010-10#1)(2010-11#1)(2011-1#3)(2011-2#1)(2012-11#2)(2012-2#3)(2013-7#1)(2013-8#1)
will be using##2##3##(2007-10#1)(2011-12#1)
will be valuable for future##2##5##(2008-10#1)(2012-3#1)
will be valuable in##2##4##(2006-10#1)(2008-2#1)
will be valuable to##2##4##(1995-12#1)(2010-2#1)
will be valuable tools for##2##5##(1997-2#1)(2008-8#1)
will be valuable##8##3##(1995-12#1)(1997-2#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-2#1)(2012-3#1)
will be very useful for##2##5##(2005-11#1)(2007-2#1)
will be very useful in##2##5##(1993-11#1)(2009-2#1)
will be very useful##5##4##(1993-11#1)(2005-11#1)(2007-2#1)(2009-2#1)(2012-2#1)
will be very##6##3##(1993-11#1)(2005-11#1)(2007-2#1)(2008-1#1)(2009-2#1)(2012-2#1)
will be widely used##2##4##(2007-1#1)(2008-10#1)
will be willing to##3##4##(2006-10#1)(2008-10#1)(2008-8#1)
will be##1624##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#9)(1990-2#1)(1990-3#5)(1990-4#4)(1990-5#1)(1990-6#5)(1991-1#4)(1991-10#2)(1991-11#4)(1991-12#10)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#6)(1991-6#4)(1991-7#1)(1991-9#3)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#8)(1992-2#5)(1992-3#16)(1992-4#1)(1992-5#5)(1992-6#2)(1992-7#2)(1992-8#5)(1992-9#3)(1993-1#6)(1993-11#4)(1993-12#13)(1993-2#6)(1993-3#6)(1993-4#1)(1993-5#5)(1993-6#2)(1993-9#3)(1994-1#4)(1994-11#2)(1994-12#11)(1994-2#9)(1994-3#6)(1994-5#3)(1994-6#1)(1994-7#2)(1994-8#1)(1994-9#8)(1995-1#9)(1995-12#11)(1995-2#11)(1995-3#6)(1995-4#6)(1995-5#1)(1995-6#5)(1995-7#1)(1995-8#6)(1995-9#5)(1996-1#7)(1996-10#1)(1996-11#6)(1996-12#7)(1996-2#7)(1996-3#9)(1996-4#6)(1996-5#2)(1996-6#3)(1996-7#2)(1996-8#4)(1996-9#5)(1997-1#11)(1997-2#10)(1997-3#12)(1997-4#5)(1997-5#2)(1997-6#5)(1997-7#5)(1997-8#8)(2004-1#1)(2004-11#4)(2004-12#2)(2004-3#2)(2004-4#1)(2005-10#3)(2005-11#7)(2005-5#6)(2005-7#16)(2005-8#9)(2005-9#8)(2006-10#37)(2006-11#12)(2006-12#14)(2006-2#10)(2006-3#4)(2006-4#9)(2006-5#11)(2006-6#17)(2006-7#6)(2006-8#17)(2006-9#5)(2007-1#6)(2007-10#13)(2007-11#28)(2007-12#16)(2007-2#12)(2007-3#3)(2007-4#16)(2007-5#7)(2007-6#8)(2007-7#12)(2007-8#26)(2007-9#16)(2008-1#33)(2008-10#93)(2008-11#61)(2008-12#19)(2008-2#29)(2008-3#33)(2008-4#24)(2008-5#65)(2008-6#16)(2008-7#44)(2008-8#38)(2008-9#14)(2009-1#1)(2009-10#13)(2009-11#1)(2009-12#6)(2009-2#7)(2009-3#6)(2009-4#6)(2009-5#15)(2009-6#3)(2009-7#4)(2009-8#5)(2009-9#6)(2010-1#1)(2010-10#10)(2010-11#10)(2010-12#16)(2010-2#7)(2010-3#12)(2010-4#9)(2010-5#7)(2010-6#2)(2010-7#6)(2010-8#17)(2010-9#5)(2011-1#22)(2011-12#4)(2011-2#37)(2011-3#7)(2011-9#1)(2012-1#8)(2012-11#8)(2012-12#32)(2012-2#32)(2012-3#18)(2013-1#27)(2013-7#13)(2013-8#16)
will become a powerful tool##3##5##(2007-4#1)(2008-10#2)
will become a##10##3##(1992-2#1)(1995-4#1)(1997-2#1)(2005-7#1)(2006-6#1)(2007-4#1)(2008-10#2)(2009-5#1)(2012-2#1)
will become active##2##3##(1995-9#1)(2011-2#1)
will become an effective##2##4##(2008-2#1)(2010-3#1)
will become an##7##3##(2005-1#1)(2006-1#1)(2008-1#1)(2008-2#1)(2008-3#1)(2009-5#1)(2010-3#1)
will become available##3##3##(1993-11#1)(2006-10#1)(2013-1#1)
will become even more critical##2##5##(1992-12#1)(1995-5#1)
will become even more##3##4##(1992-12#1)(1995-5#1)(1997-1#1)
will become ever more important##2##5##(1995-12#1)(1995-2#1)
will become important##2##3##(2008-7#1)(2010-1#1)
will become increasingly important to##2##5##(1994-3#1)(2007-5#1)
will become more and more##2##5##(2006-10#1)(2009-11#1)
will become more##7##3##(1995-3#1)(1997-4#1)(2006-10#1)(2006-6#1)(2006-8#1)(2009-11#1)(2010-8#1)
will become standard##2##3##(1997-8#1)(2010-12#1)
will become the##6##3##(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
will become##66##2##(1990-2#1)(1992-12#1)(1992-2#1)(1993-11#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-3#1)(2005-1#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#3)(2006-5#1)(2006-6#2)(2006-8#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-5#1)(2008-1#4)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-7#2)(2009-11#1)(2009-5#2)(2010-1#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
will begin##5##2##(1996-12#1)(1996-3#1)(2008-5#1)(2010-12#1)(2011-1#1)
will benefit from the##3##4##(2006-10#1)(2007-5#1)(2008-10#1)
will benefit from##7##3##(1990-3#1)(1993-5#1)(2006-10#1)(2007-5#1)(2008-10#1)(2008-6#1)(2009-8#1)
will benefit the##3##3##(1992-3#1)(2006-10#1)(2009-4#1)
will benefit##25##2##(1990-3#1)(1992-3#1)(1993-5#1)(1995-4#1)(1996-2#1)(1997-1#2)(2005-11#1)(2006-10#3)(2006-9#1)(2007-5#1)(2008-10#4)(2008-5#1)(2008-6#1)(2009-4#1)(2009-8#1)(2010-5#1)(2011-1#2)(2012-12#1)
will better##4##2##(2006-7#1)(2007-11#1)(2008-3#1)(2008-6#1)
will bind to##2##3##(1993-4#1)(2008-11#1)
will briefly describe the##2##4##(2008-7#2)
will briefly describe##3##3##(2008-7#3)
will briefly discuss##2##3##(2010-5#1)(2012-1#1)
will briefly summarize the##3##4##(2008-2#1)(2008-8#1)(2012-2#1)
will briefly##13##2##(1996-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-7#3)(2008-8#1)(2010-5#1)(2012-1#1)(2012-2#1)
will bring about##2##3##(1994-8#1)(2011-2#1)
will bring##9##2##(1991-6#1)(1993-8#1)(1994-8#1)(2008-11#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-7#1)
will cause a##2##3##(1993-11#1)(2008-3#1)
will cause##14##2##(1992-3#1)(1992-9#1)(1993-11#1)(1993-7#1)(1994-12#1)(1996-12#1)(1997-7#1)(2005-11#1)(2007-5#1)(2008-3#2)(2008-9#1)(2011-2#2)
will cease to exist##2##4##(1994-3#1)(1995-9#1)
will center##3##2##(1992-3#1)(1995-1#1)(1997-1#1)
will centre on##2##3##(2008-10#2)
will certainly##14##2##(1995-5#1)(1996-10#1)(1996-12#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#2)(2009-11#1)(2011-1#1)
will challenge##3##2##(1994-12#1)(2008-11#1)(2012-1#1)
will change in##2##3##(2005-12#1)(2008-8#1)
will change the##2##3##(1995-2#1)(2009-12#1)
will change with##2##3##(1992-6#1)(2013-8#1)
will change##11##2##(1992-6#1)(1995-2#1)(1996-4#1)(2005-12#1)(2006-2#1)(2008-8#2)(2009-12#1)(2010-11#1)(2012-12#1)(2013-8#1)
will characterize##2##2##(2008-8#1)(2008-9#1)
will choose##2##2##(1997-3#1)(2006-9#1)
will clarify##3##2##(1992-1#1)(2010-11#1)(2011-2#1)
will clearly be##2##3##(1993-11#1)(2008-6#1)
will clearly##5##2##(1993-11#1)(2005-11#1)(2006-10#1)(2008-6#1)(2012-2#1)
will come from##5##3##(2006-10#1)(2007-11#2)(2007-9#1)(2012-3#1)
will come into##2##3##(2008-11#2)
will come to##3##3##(2006-2#1)(2006-5#1)(2009-3#1)
will come with##2##3##(2007-5#1)(2008-10#1)
will come##15##2##(1992-3#1)(1994-12#1)(1995-3#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-11#2)(2007-5#1)(2007-9#1)(2008-10#1)(2008-11#2)(2009-3#1)(2012-3#1)
will commence##2##2##(2008-5#1)(2012-1#1)
will compare the##3##3##(1990-1#1)(2006-11#1)(2011-1#1)
will compare##6##2##(1990-1#1)(2006-10#1)(2006-11#1)(2007-7#1)(2008-5#1)(2011-1#1)
will complete##2##2##(2008-11#1)(2010-9#1)
will concentrate on##4##3##(1994-9#1)(2005-8#1)(2010-12#1)(2010-4#1)
will conclude by##3##3##(1994-1#2)(2012-2#1)
will conclude with a discussion of##2##6##(2008-1#2)
will conclude with a summary of##2##6##(2005-10#1)(2008-1#1)
will conclude with a##4##4##(2005-10#1)(2008-1#3)
will conclude with##5##3##(2005-10#1)(2008-1#3)(2008-7#1)
will conclude##11##2##(1994-1#2)(2005-10#1)(2008-1#4)(2008-4#1)(2008-7#1)(2012-2#2)
will consider the##6##3##(2006-12#1)(2008-10#1)(2008-6#1)(2008-7#2)(2011-2#1)
will consider##12##2##(1994-1#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#3)(2010-12#2)(2011-2#1)(2013-8#1)
will considerably##2##2##(1991-11#1)(1994-5#1)
will consist of##4##3##(2006-10#1)(2006-6#1)(2008-2#1)(2008-5#1)
will consist##5##2##(1995-6#1)(2006-10#1)(2006-6#1)(2008-2#1)(2008-5#1)
will constitute##3##2##(1996-1#1)(2006-12#1)(2008-3#1)
will consumers##2##2##(1996-3#1)(2008-7#1)
will contain##2##2##(1993-11#1)(2007-11#1)
will continue in##2##3##(2007-8#1)(2008-4#1)
will continue to be a##2##5##(2008-6#1)(2008-9#1)
will continue to be used##2##5##(1993-12#1)(2007-11#1)
will continue to be##13##4##(1993-12#1)(1995-2#1)(1996-3#1)(1997-1#1)(2006-10#1)(2006-6#1)(2007-11#2)(2008-2#1)(2008-6#1)(2008-9#1)(2010-9#1)(2012-3#1)
will continue to do so##4##5##(2006-5#1)(2007-11#1)(2008-11#1)(2012-6#1)
will continue to evolve##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
will continue to grow##2##4##(1990-9#1)(1993-1#1)
will continue to increase##2##4##(1990-11#1)(1994-6#1)
will continue to occur##3##4##(2005-12#1)(2013-1#2)
will continue to offer##2##4##(1997-8#1)(2010-7#1)
will continue to provide the##2##5##(1997-2#1)(2008-4#1)
will continue to provide##3##4##(1990-12#1)(1997-2#1)(2008-4#1)
will continue to require##3##4##(1992-3#1)(2006-10#1)(2008-1#1)
will continue to rise##3##4##(2005-8#1)(2008-3#1)(2008-9#1)
will continue to##67##3##(1990-11#2)(1990-12#1)(1990-9#1)(1991-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-8#2)(2005-12#1)(2005-8#1)(2006-10#4)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#4)(2007-12#3)(2007-5#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-9#2)(2009-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-3#1)(2012-6#1)(2013-1#2)(2013-8#1)
will continue##80##2##(1990-11#2)(1990-12#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-3#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-8#2)(2005-12#1)(2005-8#1)(2006-10#5)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#4)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-6#2)(2008-9#2)(2009-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-3#1)(2012-6#1)(2013-1#2)(2013-8#1)
will contribute to our understanding of the##2##7##(2005-11#1)(2008-11#1)
will contribute to our understanding of##4##6##(2005-11#1)(2008-11#1)(2008-8#1)(2010-11#1)
will contribute to the understanding of##2##6##(2008-9#1)(2010-5#1)
will contribute to the##6##4##(2008-10#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-1#1)(2013-8#1)
will contribute to understanding##2##4##(2008-11#1)(2012-9#1)
will contribute to##18##3##(1996-12#1)(2005-11#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#2)(2008-9#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-9#1)(2013-8#1)
will contribute##23##2##(1996-12#1)(2005-11#1)(2006-10#2)(2007-8#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#2)(2012-9#1)(2013-8#1)
will control the##2##3##(2008-9#1)(2011-12#1)
will control##3##2##(1996-2#1)(2008-9#1)(2011-12#1)
will convert##2##2##(1990-12#1)(1990-3#1)
will cover##7##2##(2004-11#1)(2007-7#1)(2008-1#2)(2008-10#1)(2009-4#1)(2011-2#1)
will create##4##2##(1993-2#1)(1994-12#1)(1995-3#1)(2008-9#1)
will cure##2##2##(2008-11#1)(2008-6#1)
will deal with##4##3##(2005-7#1)(2007-9#1)(2008-11#1)(2012-3#1)
will decide the##2##3##(2006-10#1)(2013-7#1)
will decide whether to##2##4##(1993-10#1)(2008-1#1)
will decide whether##3##3##(1993-10#1)(2007-11#1)(2008-1#1)
will decide##7##2##(1992-10#1)(1993-10#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2013-7#1)
will decline with##2##3##(1996-3#1)(2008-8#1)
will decline##3##2##(1996-3#1)(1996-5#1)(2008-8#1)
will decrease as##2##3##(1996-9#1)(2008-8#1)
will decrease the##4##3##(2004-11#1)(2006-10#1)(2008-3#1)(2008-8#1)
will decrease##12##2##(1991-8#1)(1993-12#1)(1993-2#1)(1996-2#1)(1996-9#1)(2004-11#1)(2006-10#1)(2008-3#2)(2008-8#2)(2008-9#1)
will define the##2##3##(2008-5#1)(2009-3#1)
will define##6##2##(1994-1#2)(2005-6#1)(2008-5#1)(2009-3#1)(2012-2#1)
will deliver##3##2##(1996-9#1)(2007-2#1)(2012-12#1)
will demand##5##2##(1992-3#1)(1993-12#1)(2010-10#1)(2010-2#1)(2011-2#1)
will demonstrate that##5##3##(1994-1#1)(2008-10#1)(2008-5#2)(2011-2#1)
will demonstrate the##2##3##(2008-12#1)(2008-2#1)
will demonstrate##11##2##(1994-1#1)(1995-12#1)(2004-11#1)(2005-7#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-5#2)(2011-2#1)
will depend largely on##2##4##(1992-3#1)(2006-10#1)
will depend on a##2##4##(2010-3#1)(2012-3#1)
will depend on our##2##4##(1994-12#1)(2013-1#1)
will depend on the##18##4##(1990-2#1)(1994-12#1)(1994-4#1)(1995-4#1)(1996-1#1)(1997-1#1)(1997-7#1)(2006-3#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#2)(2008-4#1)(2008-8#1)(2012-11#1)(2012-2#1)
will depend on##34##3##(1990-2#1)(1991-12#1)(1994-12#2)(1994-4#1)(1995-12#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-7#2)(2006-3#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
will depend upon##2##3##(2006-7#1)(2010-9#1)
will depend##40##2##(1990-2#1)(1991-11#1)(1991-12#1)(1992-3#1)(1993-2#1)(1994-12#2)(1994-4#1)(1995-12#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-7#2)(2006-10#1)(2006-3#1)(2006-7#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#2)(2010-9#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
will describe one##2##3##(2008-10#1)(2008-8#1)
will describe some##3##3##(2007-11#1)(2008-5#1)(2013-8#1)
will describe the##19##3##(1992-12#1)(1994-3#1)(1995-12#1)(1995-3#1)(2006-11#1)(2006-9#1)(2007-10#1)(2008-1#4)(2008-4#3)(2008-9#2)(2010-10#1)(2010-7#1)(2013-7#1)
will describe this##2##3##(2008-10#1)(2008-5#1)
will describe##34##2##(1992-12#1)(1994-3#1)(1995-12#1)(1995-3#1)(1997-2#1)(2006-11#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#2)(2008-4#3)(2008-5#2)(2008-8#1)(2008-9#2)(2010-10#1)(2010-11#1)(2010-7#1)(2013-7#1)(2013-8#2)
will detect##4##2##(2005-3#1)(2008-10#2)(2008-4#1)
will determine how##2##3##(1990-3#1)(2010-8#1)
will determine the##9##3##(1993-2#1)(1994-5#1)(1995-3#1)(1997-2#1)(2004-12#1)(2007-4#2)(2007-6#1)(2013-8#1)
will determine whether##3##3##(2007-11#1)(2007-8#1)(2008-1#1)
will determine##18##2##(1990-12#1)(1990-3#1)(1992-12#1)(1993-2#1)(1994-5#1)(1995-3#1)(1997-2#1)(2004-12#1)(2007-11#2)(2007-4#2)(2007-6#1)(2007-8#1)(2008-1#1)(2010-8#1)(2012-12#1)(2013-8#1)
will develop a##3##3##(1994-12#1)(1996-1#1)(2010-11#1)
will develop the##3##3##(2006-10#1)(2006-2#1)(2008-8#1)
will develop##27##2##(1992-2#1)(1993-11#1)(1994-12#1)(1996-1#2)(1997-3#1)(2005-6#1)(2006-10#2)(2006-2#1)(2006-6#2)(2007-6#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-3#1)(2010-11#1)(2011-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
will dictate##2##2##(1996-12#1)(2007-11#1)
will die of##3##3##(2006-2#1)(2008-6#1)(2009-3#1)
will die##7##2##(2006-2#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-3#1)(2009-6#1)
will differ in##2##3##(2008-8#1)(2012-6#1)
will differ##5##2##(1994-10#1)(2008-8#2)(2010-6#1)(2012-6#1)
will differentiate##2##2##(2006-12#1)(2013-7#1)
will direct##5##2##(1994-8#1)(2006-9#1)(2007-1#1)(2007-4#1)(2009-10#1)
will discuss a##2##3##(2006-12#1)(2011-2#1)
will discuss about##2##3##(2012-3#2)
will discuss how##6##3##(2008-10#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-5#1)(2012-2#1)
will discuss new##2##3##(2006-10#1)(2008-7#1)
will discuss recent##3##3##(2005-10#1)(2009-6#1)(2011-2#1)
will discuss several##2##3##(2008-10#1)(2010-12#1)
will discuss some of the##4##5##(2006-10#1)(2009-7#1)(2009-9#1)(2013-8#1)
will discuss the clinical##2##4##(2008-8#1)(2012-2#1)
will discuss the current##2##4##(2007-1#1)(2008-11#1)
will discuss the development of##2##5##(2008-10#1)(2008-11#1)
will discuss the early##2##4##(2008-11#1)(2011-2#1)
will discuss the epidemiology##2##4##(2005-9#1)(2006-8#1)
will discuss the evidence that##2##5##(2007-11#1)(2009-8#1)
will discuss the implications for future##2##6##(2009-4#1)(2010-8#1)
will discuss the latest advances in the##2##7##(2008-1#1)(2009-9#1)
will discuss the latest##3##4##(2008-1#2)(2009-9#1)
will discuss the molecular mechanisms of these##2##7##(2008-1#1)(2008-9#1)
will discuss the potential##2##4##(2009-5#2)
will discuss the recent progress##2##5##(2005-7#1)(2011-1#1)
will discuss the recent##3##4##(2005-7#1)(2011-1#1)(2012-1#1)
will discuss the role of##3##5##(2009-4#1)(2012-12#1)(2012-3#1)
will discuss the role##4##4##(2009-4#1)(2012-12#1)(2012-3#1)(2013-1#1)
will discuss the various##2##4##(2006-11#1)(2009-12#1)
will discuss the##71##3##(1991-1#1)(2005-10#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#2)(2008-1#6)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#4)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#6)
will discuss these##2##3##(2007-8#1)(2010-11#1)
will discuss various##3##3##(2006-8#1)(2008-12#1)(2010-8#1)
will discuss why##2##3##(2007-10#1)(2008-12#1)
will discuss##128##2##(1990-12#1)(1991-1#1)(1992-3#1)(1993-1#1)(2005-10#4)(2005-11#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-3#1)(2006-4#1)(2006-8#3)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#7)(2008-10#5)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#2)(2009-12#2)(2009-3#3)(2009-4#3)(2009-5#5)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#2)(2010-4#2)(2010-5#2)(2010-8#2)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#6)(2013-8#1)
will display##2##2##(1991-1#1)(2009-10#1)
will do##4##2##(1993-7#1)(1994-3#1)(2008-11#1)(2008-5#1)
will double##4##2##(1990-6#1)(1993-8#1)(2007-8#1)(2011-2#1)
will doubtless##3##2##(2007-11#3)
will dramatically##2##2##(1997-3#1)(2008-11#1)
will draw##2##2##(2008-1#1)(2008-11#1)
will each##2##2##(1990-8#1)(2008-11#1)
will effect##3##2##(1997-3#1)(2008-10#1)(2008-12#1)
will either##3##2##(1993-1#1)(2006-8#1)(2010-12#1)
will eliminate##3##2##(1994-3#1)(1997-1#1)(2011-2#1)
will elucidate##2##2##(2009-5#1)(2011-2#1)
will emerge##2##2##(2008-11#1)(2010-2#1)
will emphasize##2##2##(2008-4#1)(2013-1#1)
will enable a##4##3##(1993-2#1)(2006-6#1)(2008-10#1)(2013-1#1)
will enable an##2##3##(2008-11#1)(2008-12#1)
will enable better##2##3##(2006-10#1)(2012-2#1)
will enable clinicians to##2##4##(2012-12#1)(2013-1#1)
will enable more##2##3##(2006-4#1)(2008-1#1)
will enable new##2##3##(2008-4#1)(2012-2#1)
will enable the##18##3##(1995-6#1)(1996-1#1)(1996-9#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#2)(2010-9#2)(2011-1#1)(2011-2#2)
will enable us to##4##4##(1992-7#1)(2008-5#1)(2010-4#1)(2010-5#1)
will enable##64##2##(1992-7#1)(1993-2#2)(1994-6#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-3#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-4#1)(2006-6#2)(2007-10#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#3)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
will encounter many##2##3##(2007-7#1)(2011-1#1)
will encounter patients##2##3##(2007-12#1)(2011-2#1)
will encounter##7##2##(2007-11#1)(2007-12#1)(2007-7#1)(2008-6#2)(2011-1#1)(2011-2#1)
will encourage##3##2##(1992-12#1)(2008-12#1)(2008-3#1)
will end with##2##3##(2011-1#1)(2013-8#1)
will end##4##2##(1990-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
will enhance our ability to##3##5##(2008-4#1)(2008-7#1)(2012-12#1)
will enhance our understanding of the##2##6##(1991-3#1)(2008-7#1)
will enhance our understanding of##3##5##(1991-3#1)(2008-7#1)(2013-1#1)
will enhance our##8##3##(1991-3#1)(1995-12#1)(1996-2#1)(2008-4#1)(2008-7#2)(2012-12#1)(2013-1#1)
will enhance the effectiveness of##2##5##(2004-3#1)(2007-7#1)
will enhance the##13##3##(1992-11#1)(1992-12#1)(1993-3#1)(1995-1#1)(1997-1#1)(2004-3#1)(2006-12#1)(2006-2#1)(2007-12#1)(2007-7#1)(2009-6#1)(2010-4#1)(2011-2#1)
will enhance##26##2##(1991-3#1)(1992-11#1)(1992-12#1)(1993-3#1)(1995-1#1)(1995-12#1)(1996-2#1)(1997-1#1)(2004-3#1)(2006-12#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-6#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
will enroll up to##2##4##(2008-5#2)
will enroll##3##2##(2008-5#3)
will ensure that##2##3##(1991-3#1)(1993-2#1)
will ensure##10##2##(1991-3#1)(1993-2#2)(1994-2#1)(2005-7#1)(2006-10#1)(2008-11#1)(2008-3#1)(2011-1#1)(2011-2#1)
will entail##2##2##(2007-2#1)(2011-1#1)
will enter into##2##3##(2007-3#1)(2008-1#1)
will enter the##2##3##(2008-11#1)(2008-5#1)
will enter##4##2##(2007-3#1)(2008-1#1)(2008-11#1)(2008-5#1)
will establish a##4##3##(1990-12#1)(2006-8#2)(2008-7#1)
will establish the##3##3##(1995-11#1)(2007-5#1)(2008-7#1)
will establish##7##2##(1990-12#1)(1995-11#1)(2006-8#2)(2007-5#1)(2008-7#2)
will evaluate##5##2##(2008-11#1)(2008-5#1)(2008-7#1)(2009-7#1)(2011-2#1)
will eventually be##5##3##(1992-3#1)(1992-6#1)(2006-12#1)(2007-5#1)(2008-12#1)
will eventually become##4##3##(2006-10#1)(2008-10#2)(2009-8#1)
will eventually develop##2##3##(2007-12#1)(2008-5#1)
will eventually need##2##3##(2005-7#1)(2011-2#1)
will eventually##27##2##(1990-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-12#1)(1995-2#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-5#2)(2009-8#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-11#2)(2013-8#1)
will evolve into##2##3##(1992-12#1)(1997-2#1)
will evolve##4##2##(1992-12#1)(1997-2#1)(2008-7#1)(2008-8#1)
will exacerbate##2##2##(2008-5#1)(2012-12#1)
will examine the##9##3##(2005-7#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-2#1)(2012-2#1)
will examine##20##2##(1990-12#1)(1993-6#1)(1996-3#1)(2005-7#1)(2006-11#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2009-6#1)(2010-2#1)(2012-12#1)(2012-2#2)
will exhibit##6##2##(1991-2#1)(1992-9#1)(1995-3#1)(1996-6#1)(2009-11#1)(2009-7#1)
will expand the##3##3##(2008-1#1)(2010-11#1)(2011-1#1)
will expand##9##2##(1995-1#1)(1997-2#1)(1997-3#1)(2005-8#1)(2008-1#1)(2008-7#2)(2010-11#1)(2011-1#1)
will expect##2##2##(2007-4#1)(2008-5#1)
will expedite##3##2##(2008-10#1)(2008-5#1)(2011-1#1)
will experience##12##2##(1990-12#1)(1993-10#1)(1993-5#1)(2007-8#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
will explain##3##2##(1993-12#1)(2008-9#1)(2011-2#1)
will exploit##3##2##(2008-7#1)(2009-3#1)(2010-9#1)
will explore a##2##3##(1994-12#1)(2008-11#1)
will explore the##7##3##(1991-12#1)(1996-1#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-4#1)
will explore##18##2##(1991-12#1)(1991-5#1)(1994-1#3)(1994-12#1)(1996-1#1)(1996-2#1)(2005-10#1)(2007-8#2)(2008-1#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-4#1)
will express##3##2##(2007-6#1)(2008-2#1)(2008-8#1)
will extend the##3##3##(1994-5#1)(2008-11#1)(2008-3#1)
will extend##6##2##(1994-5#1)(2008-10#1)(2008-11#1)(2008-3#2)(2010-5#1)
will face challenges in##3##4##(1997-3#1)(2007-3#1)(2007-9#1)
will face challenges##4##3##(1997-3#1)(2007-3#1)(2007-9#1)(2008-7#1)
will face##9##2##(1994-1#1)(1997-1#1)(1997-3#1)(2007-3#1)(2007-9#1)(2008-4#1)(2008-7#1)(2010-2#1)(2010-3#1)
will facilitate comparisons across##2##4##(2006-5#1)(2011-2#1)
will facilitate further##4##3##(1995-3#1)(2008-10#1)(2008-9#1)(2013-8#1)
will facilitate map-based cloning of the##2##6##(2008-8#1)(2008-9#1)
will facilitate the development of##4##5##(1994-6#1)(2007-11#1)(2008-1#1)(2008-7#1)
will facilitate the identification of##2##5##(2008-10#1)(2012-12#1)
will facilitate the positional cloning##2##5##(1995-6#1)(2008-9#1)
will facilitate the study of##2##5##(2008-1#1)(2009-10#1)
will facilitate the##25##3##(1992-10#1)(1994-6#1)(1994-9#1)(1995-6#1)(1997-8#1)(2004-12#1)(2007-11#1)(2007-2#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-7#3)(2008-9#1)(2009-10#1)(2010-6#1)(2011-2#1)(2012-12#2)(2013-1#2)
will facilitate##61##2##(1992-10#1)(1993-3#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-3#1)(1995-6#1)(1997-8#1)(2004-12#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#6)(2008-8#2)(2008-9#3)(2009-10#1)(2010-12#1)(2010-6#3)(2011-2#3)(2012-12#2)(2012-3#3)(2013-1#3)(2013-8#2)
will fail to##2##3##(1997-4#1)(2011-2#1)
will fail##4##2##(1997-4#1)(2006-6#1)(2007-8#1)(2011-2#1)
will fall##4##2##(2006-10#1)(2008-10#1)(2008-4#1)(2008-5#1)
will finally##3##2##(1996-2#1)(2007-8#1)(2012-2#1)
will find a##4##3##(2005-12#1)(2006-5#1)(2006-7#1)(2013-1#1)
will find wide##2##3##(2007-11#1)(2012-3#1)
will find##16##2##(1994-1#2)(1995-2#1)(1995-7#1)(2005-12#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-1#1)(2010-2#1)(2012-3#1)(2013-1#1)
will first##11##2##(2006-10#1)(2007-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-8#2)
will focus in##2##3##(2008-9#1)(2013-8#1)
will focus on chief technologists and will be published in the##2##11##(1995-1#1)(1995-2#1)
will focus on incorporating##3##4##(1997-2#1)(2013-1#2)
will focus on recent##3##4##(2008-1#2)(2013-1#1)
will focus on some of the##2##6##(1993-6#1)(2008-7#1)
will focus on the clinical##2##5##(2005-6#1)(2009-8#1)
will focus on the recent##2##5##(2008-1#1)(2011-2#1)
will focus on the role of##3##6##(2009-3#1)(2009-9#1)(2011-1#1)
will focus on the##41##4##(1993-9#1)(1994-3#1)(1995-12#1)(1996-3#1)(1997-8#1)(2005-6#1)(2007-7#1)(2007-9#2)(2008-1#3)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2009-10#2)(2009-12#1)(2009-3#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)
will focus on three##2##4##(2008-1#1)(2008-10#1)
will focus on##86##3##(1991-12#1)(1993-6#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-8#1)(2005-6#1)(2006-10#4)(2007-10#1)(2007-12#1)(2007-7#1)(2007-9#2)(2008-1#10)(2008-10#3)(2008-11#4)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#4)(2008-7#7)(2008-8#3)(2009-10#2)(2009-12#1)(2009-3#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#1)
will focus##92##2##(1991-12#1)(1993-6#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-8#1)(2005-6#1)(2006-10#5)(2007-10#1)(2007-12#1)(2007-7#1)(2007-9#2)(2008-1#11)(2008-10#3)(2008-11#4)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#4)(2008-7#7)(2008-8#3)(2008-9#2)(2009-10#2)(2009-12#1)(2009-3#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#2)
will follow##5##2##(1991-3#1)(2005-8#1)(2005-9#1)(2010-1#1)(2011-2#1)
will force##3##2##(1994-3#1)(2008-8#1)(2010-2#1)
will form an##2##3##(2008-2#1)(2008-4#1)
will form##8##2##(1994-3#2)(2008-2#1)(2008-4#1)(2008-7#3)(2012-2#1)
will foster##4##2##(2004-3#1)(2008-10#1)(2008-7#1)(2012-3#1)
will function as a##2##4##(1991-4#1)(2013-8#1)
will function##3##2##(1991-4#1)(1993-1#1)(2013-8#1)
will fund##2##2##(2007-9#1)(2008-5#1)
will further increase##2##3##(1994-6#1)(2006-6#1)
will further provide##2##3##(2008-7#1)(2013-8#1)
will further reduce the##2##4##(2007-7#1)(2008-11#1)
will further##16##2##(1993-1#1)(1994-3#1)(1994-6#1)(1994-7#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-8#1)
will gain more##2##3##(2008-4#1)(2011-2#1)
will gain##4##2##(1996-2#1)(2008-4#2)(2011-2#1)
will generally##2##2##(2008-10#2)
will generate##5##2##(1994-6#1)(2007-2#1)(2008-7#2)(2010-10#1)
will get##3##2##(1991-2#1)(1996-5#1)(2008-11#1)
will give a brief##2##4##(1995-7#1)(2007-12#1)
will give a##5##3##(1995-7#1)(2005-8#1)(2007-12#1)(2008-4#1)(2011-1#1)
will give an##5##3##(1996-4#1)(2008-5#1)(2009-3#1)(2010-12#1)(2013-1#1)
will give birth to##2##4##(1990-9#1)(2006-7#1)
will give rise to##3##4##(1995-8#1)(2008-2#1)(2008-6#1)
will give the##4##3##(1990-5#1)(1991-12#1)(1997-1#1)(2007-10#1)
will give##29##2##(1990-1#1)(1990-5#1)(1990-9#1)(1991-12#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-4#1)(1997-1#1)(2005-8#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-4#1)(2008-5#1)(2008-6#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-7#1)
will go a long way in##2##6##(2007-1#1)(2013-8#1)
will go away##2##3##(1993-2#1)(2007-6#1)
will go to##2##3##(1994-3#1)(1996-12#1)
will go##10##2##(1990-12#1)(1993-2#1)(1994-3#1)(1996-12#1)(2007-1#1)(2007-11#1)(2007-6#1)(2008-4#1)(2010-8#1)(2013-8#1)
will greatly enhance our##2##4##(2008-10#1)(2009-2#1)
will greatly enhance##4##3##(2006-12#1)(2008-10#2)(2009-2#1)
will greatly facilitate the##2##4##(1996-8#1)(2009-9#1)
will greatly facilitate##3##3##(1996-8#1)(2006-10#1)(2009-9#1)
will greatly##11##2##(1994-1#1)(1996-8#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-6#1)(2008-10#2)(2008-2#1)(2009-2#1)(2009-9#1)
will grow as##2##3##(2007-10#1)(2008-8#1)
will grow in##2##3##(1994-3#1)(2008-7#1)
will grow##6##2##(1994-3#1)(2004-11#1)(2007-10#1)(2007-4#1)(2008-7#1)(2008-8#1)
will guide clinicians##2##3##(2008-5#1)(2011-2#1)
will guide##7##2##(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2011-2#1)
will have a significant effect on##2##6##(1994-3#1)(2008-4#1)
will have a significant##3##4##(1994-3#1)(2006-4#1)(2008-4#1)
will have a##35##3##(1990-12#1)(1991-6#1)(1992-1#1)(1992-2#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-9#1)(1996-3#1)(1997-2#1)(1997-3#1)(2004-11#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-11#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-9#1)(2011-12#1)(2011-2#2)(2012-3#2)
will have adverse##2##3##(1992-2#1)(2005-3#1)
will have an important##3##4##(1996-4#1)(2004-7#1)(2008-1#1)
will have an##5##3##(1996-4#1)(2004-7#1)(2007-3#1)(2008-1#1)(2009-12#1)
will have applications##2##3##(2007-11#1)(2007-12#1)
will have at least##2##4##(2006-2#1)(2012-3#1)
will have general##2##3##(1993-3#1)(2008-10#1)
will have important implications for##2##5##(2006-5#1)(2006-9#1)
will have major##2##3##(2008-7#2)
will have on the##3##4##(2007-2#1)(2008-10#1)(2008-2#1)
will have on##5##3##(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)
will have properties##2##3##(2008-3#1)(2008-8#1)
will have some##2##3##(2007-4#1)(2009-2#1)
will have the##10##3##(1992-3#1)(1993-12#1)(1994-1#1)(2006-5#1)(2007-3#1)(2008-10#1)(2008-4#2)(2008-8#1)(2013-8#1)
will have to be##22##4##(1990-10#1)(1990-6#1)(1992-11#2)(1994-12#1)(1995-11#1)(1995-3#1)(1997-2#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-1#1)(2012-2#2)
will have to demonstrate##2##4##(1994-2#1)(2008-7#1)
will have to make##2##4##(1993-3#1)(1995-2#1)
will have to##42##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1992-11#2)(1992-2#1)(1993-3#1)(1994-10#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-8#1)(2005-11#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2011-1#1)(2011-12#1)(2012-2#2)(2013-1#1)
will have##167##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#2)(1990-7#1)(1991-11#1)(1991-6#1)(1992-1#1)(1992-11#2)(1992-2#3)(1992-3#2)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#2)(1994-1#1)(1994-10#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-9#2)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#2)(2004-7#1)(2005-11#1)(2005-3#1)(2006-10#4)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-8#1)(2006-9#3)(2007-11#3)(2007-12#2)(2007-2#2)(2007-3#2)(2007-4#2)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#9)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#4)(2012-2#5)(2012-3#3)(2013-1#1)(2013-7#2)(2013-8#1)
will help determine##2##3##(2007-10#1)(2009-5#1)
will help direct the##2##4##(2005-10#1)(2008-8#1)
will help elucidate the mechanisms of##2##6##(2009-3#1)(2012-2#1)
will help elucidate the##4##4##(1995-12#1)(1997-7#1)(2009-3#1)(2012-2#1)
will help elucidate##5##3##(1995-12#1)(1997-7#1)(2009-3#1)(2009-6#1)(2012-2#1)
will help improve##2##3##(1992-3#1)(2012-1#1)
will help in the##5##4##(1995-6#1)(1996-1#1)(2005-11#1)(2009-1#1)(2011-1#1)
will help in##20##3##(1995-6#1)(1996-1#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2009-1#1)(2009-12#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
will help physicians##2##3##(2008-11#1)(2008-3#1)
will help provide##2##3##(2008-10#1)(2008-6#1)
will help researchers in##2##4##(2008-10#1)(2010-6#1)
will help the clinician##3##4##(1993-1#1)(2005-11#1)(2007-4#1)
will help the surgeon##2##4##(2007-12#1)(2007-5#1)
will help the##9##3##(1993-1#1)(2005-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)
will help to determine the##2##5##(2009-5#1)(2009-8#1)
will help to develop##3##4##(1994-5#1)(2008-10#1)(2008-6#1)
will help to elucidate the##2##5##(2008-10#2)
will help to focus##2##4##(2005-11#1)(2006-12#1)
will help to improve##2##4##(2006-10#1)(2008-10#1)
will help to understand the##4##5##(1996-7#1)(2007-12#1)(2008-7#1)(2008-8#1)
will help to understand##5##4##(1996-7#1)(2007-12#1)(2008-7#1)(2008-8#1)(2009-6#1)
will help to##34##3##(1994-5#1)(1996-7#1)(1997-4#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-7#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2011-12#1)(2011-2#3)(2012-12#2)(2013-1#1)
will help us to##3##4##(1992-2#1)(2008-3#1)(2010-5#1)
will help us##8##3##(1992-2#1)(2008-1#1)(2008-3#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
will help you##2##3##(1993-1#1)(1995-2#1)
will help##120##2##(1990-8#1)(1991-12#1)(1992-2#1)(1992-3#1)(1993-1#2)(1993-2#2)(1994-1#1)(1994-5#1)(1994-7#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-4#1)(1997-7#1)(2005-10#2)(2005-11#3)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#4)(2008-3#3)(2008-4#1)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#3)(2009-8#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#6)(2012-1#3)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#1)
will highlight important##3##3##(2006-10#1)(2010-2#1)(2011-1#1)
will highlight the role of##2##5##(2009-11#1)(2010-5#1)
will highlight the##6##3##(1995-2#1)(2009-11#1)(2010-1#1)(2010-5#1)(2012-12#1)(2013-1#1)
will highlight##16##2##(1995-2#1)(2006-10#1)(2006-12#1)(2008-1#2)(2008-11#1)(2009-11#1)(2009-3#1)(2010-1#1)(2010-2#1)(2010-5#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#1)
will hold##2##2##(1996-5#1)(2008-3#1)
will hopefully contribute to##2##4##(1996-12#1)(2012-11#1)
will hopefully improve##2##3##(2008-10#1)(2010-8#1)
will hopefully stimulate##3##3##(2007-11#1)(2008-12#1)(2012-2#1)
will hopefully##18##2##(1992-8#1)(1993-2#1)(1995-12#1)(1996-12#1)(2006-10#1)(2007-11#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-8#1)(2010-9#1)(2012-11#1)(2012-2#1)
will identify the##4##3##(2008-11#1)(2008-2#1)(2009-2#1)(2009-5#1)
will identify##12##2##(1991-2#1)(1997-1#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-11#1)
will illustrate the##2##3##(1993-3#1)(2012-3#1)
will illustrate##3##2##(1993-3#1)(2006-5#1)(2012-3#1)
will impact##5##2##(1990-12#1)(1994-1#1)(1996-3#1)(2006-10#1)(2013-8#1)
will implement##2##2##(1994-12#1)(1997-1#1)
will improve our understanding of##2##5##(2007-10#1)(2009-6#1)
will improve our##3##3##(2006-12#1)(2007-10#1)(2009-6#1)
will improve quality of##2##4##(2006-8#1)(2012-12#1)
will improve quality##3##3##(1996-2#1)(2006-8#1)(2012-12#1)
will improve the outcome of##2##5##(2008-3#1)(2010-3#1)
will improve the quality of##2##5##(1991-11#1)(2008-3#1)
will improve the##21##3##(1991-11#1)(1993-8#1)(1994-2#1)(1997-2#1)(1997-7#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-3#4)(2008-8#1)(2010-3#1)(2010-7#1)(2012-2#1)
will improve##44##2##(1991-11#1)(1993-12#1)(1993-8#1)(1994-1#1)(1994-2#1)(1995-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-3#4)(2008-7#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)
will in the future play an important role in the##2##10##(1993-11#2)
will in the future##3##4##(1993-11#2)(2012-3#1)
will in turn##3##3##(2008-5#1)(2009-8#1)(2011-1#1)
will in##9##2##(1992-12#1)(1992-6#1)(1993-11#2)(2008-2#1)(2008-5#1)(2009-8#1)(2011-1#1)(2012-3#1)
will include a##3##3##(1996-1#1)(2008-5#1)(2012-2#1)
will include the##7##3##(1996-9#1)(1997-3#1)(2005-7#1)(2007-8#1)(2008-11#2)(2008-12#1)
will include##20##2##(1996-1#1)(1996-3#1)(1996-9#1)(1997-3#1)(2005-10#1)(2005-7#1)(2005-8#1)(2005-9#2)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#2)(2012-2#1)
will increase as##2##3##(1990-3#1)(2007-10#1)
will increase by##2##3##(1991-1#1)(1992-2#1)
will increase in the##2##4##(1991-12#1)(2012-12#1)
will increase in##5##3##(1991-11#1)(1991-12#1)(2006-2#1)(2008-3#1)(2012-12#1)
will increase our##2##3##(2008-10#1)(2011-1#1)
will increase the number of##2##5##(1993-11#1)(2007-11#1)
will increase the##21##3##(1990-3#1)(1992-9#1)(1993-11#1)(1993-2#1)(1995-1#1)(1996-12#1)(2006-10#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-12#1)
will increase their economic leverage with##2##6##(1994-1#2)
will increase their##3##3##(1994-1#2)(2008-11#1)
will increase to##2##3##(1990-12#1)(2009-2#1)
will increase##68##2##(1990-12#2)(1990-3#2)(1991-1#1)(1991-11#1)(1991-12#1)(1992-1#1)(1992-2#2)(1992-9#1)(1993-11#1)(1993-2#1)(1994-1#2)(1994-2#2)(1995-1#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-4#1)(2004-12#1)(2005-1#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-8#2)(2007-9#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-2#1)(2009-4#1)(2010-10#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-10#1)(2012-12#1)(2012-2#3)(2013-8#1)
will increasingly##5##2##(1990-12#1)(1991-3#1)(2010-11#1)(2011-2#1)(2013-8#1)
will indeed##3##2##(1990-12#1)(2007-6#1)(2007-8#1)
will indicate##3##2##(2008-4#1)(2008-9#1)(2012-12#1)
will induce##3##2##(1991-2#1)(1996-8#1)(2007-11#1)
will inevitably result in##2##4##(2011-2#1)(2013-7#1)
will inevitably##6##2##(1993-12#1)(2008-3#1)(2011-2#1)(2012-5#1)(2013-1#1)(2013-7#1)
will influence the##7##3##(1994-9#1)(2005-10#1)(2007-7#1)(2007-8#1)(2011-3#1)(2012-12#1)(2012-6#1)
will influence##15##2##(1990-12#1)(1994-9#1)(2005-1#1)(2005-10#1)(2005-6#1)(2006-10#1)(2006-12#1)(2007-7#1)(2007-8#1)(2009-3#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-6#1)
will inform##3##2##(2012-1#1)(2012-11#1)(2012-3#1)
will inhibit##2##2##(1996-12#1)(1997-4#1)
will initially be##2##3##(1997-7#1)(2010-12#1)
will initially##4##2##(1992-12#1)(1997-7#1)(2005-11#1)(2010-12#1)
will introduce the##4##3##(2006-10#1)(2008-4#1)(2010-11#1)(2011-2#1)
will introduce##7##2##(1991-12#1)(2005-7#1)(2006-10#1)(2008-4#1)(2010-11#1)(2010-4#1)(2011-2#1)
will investigate##2##2##(2008-7#1)(2010-7#1)
will involve the##3##3##(1992-6#1)(2008-10#1)(2008-7#1)
will involve##11##2##(1992-6#1)(1993-11#1)(1994-6#1)(1995-3#1)(1997-8#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#1)(2013-1#1)
will it be possible to reduce##2##6##(1997-8#1)(2013-1#1)
will it be##3##3##(1997-8#1)(2008-9#1)(2013-1#1)
will it##5##2##(1997-3#1)(1997-8#1)(2008-11#1)(2008-9#1)(2013-1#1)
will keep##3##2##(1994-3#2)(2008-10#1)
will know##4##2##(1994-1#1)(1997-3#1)(1997-4#1)(2013-1#1)
will land##2##2##(1994-1#1)(2012-2#1)
will largely##3##2##(2005-7#1)(2008-9#1)(2012-3#1)
will later##3##2##(2005-6#1)(2008-2#1)(2008-4#1)
will lay##2##2##(1992-12#1)(2010-10#1)
will lead to a better##2##5##(2010-3#1)(2011-2#1)
will lead to a reduction##2##5##(2006-2#1)(2006-6#1)
will lead to a##17##4##(1990-3#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-2#1)
will lead to an##2##4##(1995-6#1)(2010-4#1)
will lead to further##2##4##(2006-10#1)(2008-11#1)
will lead to higher##2##4##(2007-5#1)(2007-9#1)
will lead to improved##2##4##(2008-1#1)(2011-10#1)
will lead to improvements in##2##5##(2007-12#1)(2011-2#1)
will lead to new##3##4##(1996-4#1)(2005-8#1)(2008-11#1)
will lead to the development of##2##6##(2006-10#1)(2012-2#1)
will lead to the##12##4##(1991-10#1)(1994-6#1)(1994-8#1)(1996-11#1)(2006-10#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-11#1)(2012-2#1)
will lead to##63##3##(1990-3#1)(1991-10#1)(1994-6#1)(1994-8#1)(1995-6#1)(1996-11#1)(1996-4#1)(1997-2#1)(1997-8#2)(2004-11#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-10#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#3)
will lead us to##3##4##(1993-4#1)(2007-2#1)(2007-8#1)
will lead##70##2##(1990-3#1)(1991-10#1)(1991-3#1)(1993-4#1)(1994-6#1)(1994-8#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-8#2)(2004-11#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-10#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#3)
will learn to##3##3##(1992-1#1)(1995-12#1)(2011-12#1)
will learn##4##2##(1992-1#1)(1995-12#1)(2009-1#1)(2011-12#1)
will leave##3##2##(1996-11#2)(2013-7#1)
will likely be useful in##2##5##(1994-9#1)(2007-12#1)
will likely be##10##3##(1994-9#1)(2006-10#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-11#1)(2010-12#1)(2011-2#1)
will likely benefit from##2##4##(2010-12#1)(2012-2#1)
will likely continue to increase##2##5##(2008-3#1)(2010-5#1)
will likely continue##3##3##(2007-3#1)(2008-3#1)(2010-5#1)
will likely improve the##2##4##(1995-2#1)(2006-12#1)
will likely improve##3##3##(1995-2#1)(1996-3#1)(2006-12#1)
will likely not be##5##4##(2006-10#1)(2009-9#1)(2013-1#2)(2013-8#1)
will likely result in##3##4##(1996-2#1)(1997-1#1)(2009-3#1)
will likely##57##2##(1992-12#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#2)(1996-2#1)(1996-3#1)(1997-1#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-11#3)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
will limit the##4##3##(1993-9#1)(2008-11#2)(2008-3#1)
will limit##7##2##(1993-2#1)(1993-9#1)(1997-1#1)(2008-11#2)(2008-3#1)(2013-1#1)
will link##2##2##(1994-10#1)(1996-3#1)
will list##2##2##(1996-2#1)(2011-1#1)
will look at the##2##4##(2008-1#1)(2008-10#1)
will look at##5##3##(2008-1#1)(2008-10#1)(2008-12#1)(2013-1#1)(2013-8#1)
will lose##2##2##(2006-8#1)(2008-9#1)
will lower##2##2##(2005-10#1)(2008-8#1)
will mainly##2##2##(1992-8#1)(2009-5#1)
will make a##3##3##(2007-4#1)(2008-10#1)(2009-10#1)
will make it easier##2##4##(1995-1#1)(2006-10#1)
will make it possible to##3##5##(1997-1#1)(2008-10#1)(2010-12#1)
will make it##8##3##(1995-1#1)(1996-5#1)(1997-1#2)(2006-10#1)(2008-10#1)(2009-8#1)(2010-12#1)
will make the##2##3##(1996-3#1)(2011-1#1)
will make##33##2##(1990-5#1)(1992-3#1)(1993-12#1)(1995-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#3)(2011-2#1)(2013-7#1)
will manage##2##2##(1994-2#1)(2007-3#1)
will mature##3##2##(1994-2#1)(2008-10#1)(2012-2#1)
will maximize the##2##3##(2008-5#1)(2012-2#1)
will maximize##4##2##(1994-5#1)(2008-5#1)(2012-2#1)(2012-3#1)
will mean##3##2##(2007-9#1)(2008-3#1)(2012-2#1)
will measure##4##2##(1995-2#1)(2007-4#1)(2008-3#2)
will meet the##4##3##(1993-2#1)(1994-12#1)(2008-11#1)(2008-3#1)
will meet##8##2##(1993-2#2)(1994-1#1)(1994-12#1)(1996-2#1)(2005-10#1)(2008-11#1)(2008-3#1)
will migrate##2##2##(1996-5#1)(2004-11#1)
will mimic the##2##3##(2008-9#2)
will more readily##2##3##(2007-2#1)(2008-4#1)
will more##7##2##(1992-12#1)(1994-1#1)(1995-12#1)(2007-2#1)(2008-4#1)(2011-2#1)(2012-5#1)
will most often##2##3##(2007-12#1)(2011-3#1)
will most probably##3##3##(1994-11#1)(1997-8#1)(2007-10#1)
will most##8##2##(1994-11#1)(1996-1#1)(1997-8#1)(2007-10#1)(2007-12#1)(2008-1#1)(2011-3#1)(2012-3#1)
will move##3##2##(2008-11#1)(2009-5#1)(2011-1#1)
will naturally##3##2##(1996-12#1)(1996-3#2)
will necessarily##2##2##(1992-12#1)(2012-11#1)
will necessitate##2##2##(2008-8#1)(2011-1#1)
will need a##3##3##(1992-8#1)(1995-1#1)(2011-2#1)
will need to be adapted##2##5##(2008-8#1)(2012-12#1)
will need to be addressed##3##5##(1992-9#1)(2007-7#1)(2008-8#1)
will need to be given##2##5##(2006-10#1)(2008-7#1)
will need to be##22##4##(1990-12#1)(1992-9#1)(2005-5#1)(2006-10#2)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#2)(2010-2#1)(2012-12#1)(2013-8#1)
will need to develop##4##4##(1992-2#1)(1994-1#1)(1994-12#1)(1994-3#1)
will need to##45##3##(1990-12#1)(1992-2#1)(1992-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(2005-10#1)(2005-5#1)(2006-10#2)(2006-2#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#6)(2008-8#2)(2009-12#1)(2009-9#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
will need##57##2##(1990-12#1)(1991-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#3)(1995-1#2)(1995-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(2005-10#1)(2005-5#1)(2006-10#3)(2006-2#1)(2006-6#1)(2007-11#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#6)(2008-8#2)(2009-12#1)(2009-9#1)(2010-2#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-8#1)
will never be##3##3##(1990-12#1)(2006-12#1)(2011-12#1)
will never##6##2##(1990-12#1)(1992-2#1)(1996-8#1)(2006-12#1)(2011-12#1)(2013-8#1)
will no doubt be##2##4##(1995-5#1)(2008-12#1)
will no doubt##6##3##(1992-1#1)(1995-5#1)(2006-10#1)(2008-12#1)(2009-3#1)(2013-8#1)
will no longer be##4##4##(1994-12#1)(1994-4#1)(1996-6#1)(2006-8#1)
will no longer##5##3##(1994-12#1)(1994-4#1)(1996-6#1)(2006-8#1)(2013-1#1)
will no##11##2##(1992-1#1)(1994-12#1)(1994-4#1)(1995-5#1)(1996-6#1)(2006-10#1)(2006-8#1)(2008-12#1)(2009-3#1)(2013-1#1)(2013-8#1)
will not affect the angular##2##5##(2008-2#2)
will not affect##5##3##(1997-8#1)(2006-11#1)(2008-12#1)(2008-2#2)
will not be able to##4##5##(1991-3#1)(2006-4#1)(2007-4#1)(2008-11#1)
will not be available##2##4##(1997-8#1)(2008-10#1)
will not be completed##2##4##(1997-1#1)(2009-7#1)
will not be effective##2##4##(2008-7#1)(2012-1#1)
will not be known for##2##5##(1990-12#1)(2007-4#1)
will not be realized until##2##5##(2008-10#1)(2009-4#1)
will not be the##2##4##(1996-12#1)(2008-10#1)
will not be##50##3##(1990-12#2)(1991-3#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-8#1)(1994-1#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-8#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-4#3)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-4#1)(2009-7#1)(2010-3#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
will not come from the##3##5##(1995-6#1)(1996-2#1)(2008-6#1)
will not lead to##2##4##(2010-2#1)(2011-3#1)
will not necessarily##4##3##(2006-10#1)(2007-8#1)(2008-10#1)(2010-8#1)
will not only##9##3##(1990-1#1)(1994-2#1)(1997-1#1)(2005-8#1)(2008-10#1)(2008-2#1)(2010-4#1)(2013-1#2)
will not receive##2##3##(1991-10#1)(1994-5#1)
will not significantly##2##3##(1995-10#1)(2007-11#1)
will not survive##3##3##(1993-3#1)(1996-4#1)(2011-12#1)
will not##137##2##(1990-1#2)(1990-10#1)(1990-12#2)(1990-3#1)(1990-5#1)(1991-10#1)(1991-12#2)(1991-3#1)(1991-8#1)(1992-11#1)(1992-3#2)(1992-8#1)(1993-2#1)(1993-3#3)(1994-1#2)(1994-2#2)(1994-3#2)(1994-5#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#2)(1997-1#3)(1997-6#1)(1997-8#2)(2005-4#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#5)(2007-4#3)(2007-5#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#2)(2009-2#1)(2009-4#2)(2009-7#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-12#2)(2011-3#2)(2012-1#2)(2012-12#1)(2012-3#1)(2012-5#1)(2013-1#4)(2013-8#1)
will now be##4##3##(1990-1#1)(1997-1#1)(2006-8#1)(2011-2#1)
will now##6##2##(1990-1#1)(1996-6#1)(1997-1#1)(2006-8#1)(2008-4#1)(2011-2#1)
will occur at##3##3##(1994-3#1)(2008-10#1)(2011-2#1)
will occur in##3##3##(1996-1#1)(2007-11#1)(2008-3#1)
will occur##22##2##(1993-9#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-2#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#2)(2011-2#3)(2012-12#1)(2012-2#1)
will of##3##2##(1994-7#1)(2009-11#1)(2012-3#1)
will offer a##2##3##(2008-3#1)(2010-12#1)
will offer##8##2##(2005-6#1)(2006-6#1)(2007-11#1)(2008-2#1)(2008-3#1)(2010-11#1)(2010-12#2)
will often be##8##3##(1991-8#1)(2007-3#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-12#1)(2013-1#1)(2013-8#1)
will often have##2##3##(1996-12#1)(2011-1#1)
will often##19##2##(1991-8#1)(1996-12#1)(1996-3#1)(2007-3#1)(2007-5#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
will one day##2##3##(2006-9#1)(2007-11#1)
will only be achieved##2##4##(1997-7#1)(2006-10#1)
will only be possible##2##4##(1991-2#1)(1996-6#1)
will only be##13##3##(1991-2#1)(1996-6#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)
will only increase##2##3##(1993-2#1)(1995-1#1)
will only##28##2##(1991-2#1)(1993-2#1)(1995-1#1)(1995-2#1)(1996-6#1)(1997-3#1)(1997-7#1)(2005-5#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-7#1)(2007-9#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-7#1)(2010-2#1)(2011-2#1)(2013-8#1)
will open a##2##3##(1997-4#1)(2009-8#1)
will open##5##2##(1995-4#1)(1997-4#1)(2008-9#1)(2009-8#1)(2011-1#1)
will operate in##2##3##(2008-9#1)(2010-12#1)
will operate##5##2##(2008-2#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-3#1)
will optimize the##2##3##(2007-12#1)(2007-8#1)
will optimize##6##2##(2005-8#1)(2005-9#1)(2007-12#1)(2007-8#1)(2008-2#1)(2012-2#1)
will organize##2##2##(1994-1#1)(1997-8#1)
will outline a##4##3##(1994-1#2)(2008-1#1)(2008-7#1)
will outline the##4##3##(1993-6#1)(2008-7#1)(2010-6#1)(2011-12#1)
will outline##8##2##(1993-6#1)(1994-1#2)(2008-1#1)(2008-7#2)(2010-6#1)(2011-12#1)
will pass through the##2##4##(2008-10#1)(2008-3#1)
will pass##5##2##(2006-10#1)(2008-10#1)(2008-3#2)(2008-7#1)
will pave the way##2##4##(2010-12#1)(2012-2#1)
will pay##9##2##(1992-12#1)(1995-6#2)(1996-6#1)(1997-2#1)(2007-4#1)(2007-9#1)(2008-1#1)(2010-4#1)
will perform##4##2##(1990-6#1)(1993-3#1)(2007-3#1)(2012-1#1)
will permit##12##2##(1991-10#1)(1994-3#1)(2006-6#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)
will persist##2##2##(2008-1#1)(2011-1#1)
will place##2##2##(2008-10#1)(2008-3#1)
will play a critical role in##2##6##(2009-6#1)(2012-3#1)
will play a larger role in##2##6##(2009-8#1)(2010-11#1)
will play a role in##3##5##(1994-3#1)(2008-10#1)(2010-5#1)
will play a##13##3##(1991-12#1)(1994-3#1)(2005-7#1)(2006-5#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-5#1)(2012-3#1)
will play an important role in##3##6##(2006-6#1)(2008-3#1)(2010-12#1)
will play an important role##5##5##(2006-6#1)(2008-3#1)(2008-7#1)(2010-12#1)(2012-2#1)
will play an important##6##4##(2006-6#1)(2007-12#1)(2008-3#1)(2008-7#1)(2010-12#1)(2012-2#1)
will play an##8##3##(2006-6#1)(2007-12#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-7#1)(2012-2#1)(2012-3#1)
will play##24##2##(1991-12#1)(1994-3#1)(2005-7#1)(2006-5#1)(2006-6#3)(2007-12#2)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-7#1)(2012-2#1)(2012-3#3)
will point out##3##3##(2007-10#1)(2009-5#1)(2010-11#1)
will possibly##4##2##(1992-6#1)(1993-8#1)(2005-8#1)(2008-8#1)
will present a case##2##4##(2007-12#1)(2013-1#1)
will present a##6##3##(1994-3#1)(2005-3#1)(2007-12#1)(2008-10#1)(2009-6#1)(2013-1#1)
will present some##2##3##(1994-6#1)(2006-10#1)
will present the##9##3##(1993-2#1)(1997-6#1)(2006-4#1)(2007-11#1)(2008-1#2)(2009-12#1)(2010-7#1)(2013-1#1)
will present##30##2##(1993-2#2)(1994-3#1)(1994-6#1)(1997-6#1)(2005-3#1)(2006-10#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-7#1)(2012-1#1)(2013-1#4)
will preserve##2##2##(1993-11#1)(1994-1#1)
will prevent##10##2##(1991-10#1)(1996-10#1)(1996-4#1)(2005-8#1)(2006-7#1)(2008-3#1)(2009-6#1)(2009-8#1)(2011-1#1)(2012-11#1)
will probably be more##2##4##(2008-3#1)(2010-1#1)
will probably be##11##3##(1990-10#1)(1992-2#1)(1994-6#1)(1997-6#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-1#1)(2012-2#1)
will probably become##2##3##(1996-4#1)(2008-10#1)
will probably continue##3##3##(1990-12#1)(1995-2#1)(2011-2#1)
will probably have##2##3##(1992-6#1)(1993-2#1)
will probably increase##3##3##(1992-6#1)(1995-5#1)(2009-10#1)
will probably represent##2##3##(2008-7#1)(2012-2#1)
will probably require##2##3##(2006-1#1)(2007-11#1)
will probably##36##2##(1990-10#1)(1990-12#1)(1991-12#1)(1992-2#1)(1992-6#2)(1993-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-4#1)(1996-9#1)(1997-6#2)(2006-1#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-1#1)(2009-10#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#2)
will produce a##2##3##(2006-10#1)(2008-6#1)
will produce##13##2##(1991-1#1)(1995-12#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-8#1)(2010-2#1)
will profoundly affect##2##3##(1997-5#1)(2010-2#1)
will progress to##2##3##(2008-6#1)(2013-7#1)
will progress##6##2##(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#2)(2013-7#1)
will promote the##4##3##(2008-10#1)(2008-11#1)(2013-1#2)
will promote##15##2##(1994-12#1)(1995-5#1)(2005-5#1)(2006-12#1)(2008-10#2)(2008-11#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
will prompt the##2##3##(2006-10#1)(2009-5#1)
will propose a##2##3##(2008-1#1)(2008-11#1)
will protect##2##2##(2007-2#1)(2009-5#1)
will prove to be##4##4##(2005-11#1)(2007-11#1)(2011-3#1)(2013-8#1)
will prove to##5##3##(2005-11#1)(2007-11#1)(2008-12#1)(2011-3#1)(2013-8#1)
will prove useful##2##3##(2008-2#1)(2012-3#1)
will prove##15##2##(1992-8#1)(2005-11#1)(2006-10#2)(2007-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
will provide a basis for##2##5##(1994-11#1)(2010-5#1)
will provide a basis##3##4##(1994-11#1)(2007-1#1)(2010-5#1)
will provide a brief summary of##2##6##(2010-6#1)(2012-2#1)
will provide a comprehensive##2##4##(2008-7#1)(2011-2#1)
will provide a more##2##4##(1995-1#1)(2006-11#1)
will provide a powerful tool##2##5##(1991-8#1)(1993-11#1)
will provide a review of##2##5##(2006-9#1)(2010-10#1)
will provide a valuable##2##4##(2007-12#1)(2008-1#1)
will provide a##44##3##(1991-8#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#5)(1994-8#1)(1995-1#1)(1996-5#1)(2006-11#1)(2006-9#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#1)
will provide additional##2##3##(1995-1#1)(2012-2#1)
will provide an effective##2##4##(2008-10#1)(2012-11#1)
will provide an outline of##2##5##(2010-3#1)(2012-1#1)
will provide an overview of some##2##6##(1995-1#1)(2010-11#1)
will provide an overview of the current##3##7##(2009-4#1)(2012-12#1)(2013-8#1)
will provide an overview of the##7##6##(1991-1#1)(2006-10#1)(2009-4#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-8#1)
will provide an overview of##11##5##(1991-1#1)(1995-1#1)(2006-10#1)(2009-4#1)(2010-11#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
will provide an update on##3##5##(2006-10#1)(2012-11#2)
will provide an##28##3##(1991-1#1)(1995-1#1)(2006-10#2)(2006-6#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-11#4)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
will provide further##2##3##(2008-7#1)(2010-2#1)
will provide guidance to##2##4##(2006-8#1)(2008-11#1)
will provide guidance##4##3##(2006-8#1)(2008-11#1)(2009-10#1)(2009-12#1)
will provide important##3##3##(2007-1#1)(2011-2#1)(2013-1#1)
will provide information to##2##4##(1996-2#1)(2012-2#1)
will provide information##3##3##(1995-3#1)(1996-2#1)(2012-2#1)
will provide insights into the##2##5##(2006-10#1)(2012-3#1)
will provide insights into##5##4##(1995-8#1)(2006-10#1)(2007-12#1)(2008-4#1)(2012-3#1)
will provide more##3##3##(1991-1#1)(1991-12#1)(2012-2#1)
will provide new##7##3##(1996-11#1)(2006-10#1)(2008-11#2)(2008-4#1)(2009-12#1)(2010-3#1)
will provide reports on##2##4##(1994-1#1)(1994-2#1)
will provide researchers with##2##4##(2007-1#1)(2010-5#1)
will provide some##2##3##(2006-10#1)(2009-4#1)
will provide the basis for##2##5##(2008-9#1)(2009-8#1)
will provide the basis##3##4##(2008-9#1)(2009-8#1)(2012-11#1)
will provide the means to##2##5##(1990-11#1)(1994-6#1)
will provide the reader with an##2##6##(1997-3#1)(2009-12#1)
will provide the reader with##3##5##(1997-3#1)(2006-9#1)(2009-12#1)
will provide the required##2##4##(2005-5#1)(2008-1#1)
will provide the##19##3##(1990-11#1)(1994-6#1)(1995-2#1)(1996-3#1)(1997-3#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#2)(2011-10#1)(2012-11#1)
will provide useful information##3##4##(2008-10#1)(2008-5#1)(2008-7#1)
will provide valuable##4##3##(2008-1#1)(2008-3#1)(2010-4#1)(2013-8#1)
will provide##184##2##(1990-11#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#3)(1994-3#5)(1994-6#2)(1994-8#1)(1995-1#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-5#1)(2004-9#1)(2005-10#2)(2005-5#1)(2005-7#1)(2006-10#10)(2006-11#2)(2006-6#1)(2006-8#1)(2006-9#2)(2007-1#6)(2007-10#1)(2007-11#4)(2007-12#5)(2007-2#2)(2007-4#1)(2007-9#1)(2008-1#5)(2008-10#4)(2008-11#6)(2008-12#2)(2008-3#3)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#4)(2009-4#2)(2009-5#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#3)(2010-6#3)(2010-7#1)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#6)(2012-1#2)(2012-11#5)(2012-12#2)(2012-2#9)(2012-3#2)(2013-1#3)(2013-8#2)
will provoke##2##2##(1991-1#1)(2006-8#1)
will quickly##2##2##(2008-4#2)
will raise##2##2##(2007-8#1)(2012-10#1)
will reach the##2##3##(1997-6#1)(2011-1#1)
will reach##8##2##(1993-3#1)(1994-9#1)(1996-5#1)(1997-6#1)(2005-9#1)(2007-11#1)(2011-1#1)(2013-8#1)
will readily##2##2##(1991-10#1)(2012-11#1)
will receive either GS-4104 or placebo for##2##7##(2008-5#2)
will receive the##2##3##(1993-3#1)(1996-12#1)
will receive##15##2##(1991-11#1)(1993-12#1)(1993-3#1)(1995-1#1)(1996-12#2)(1997-5#2)(2006-4#1)(2008-5#3)(2009-3#1)(2009-5#1)(2011-12#1)
will recognize##6##2##(1994-3#1)(1994-6#1)(1996-1#1)(1997-4#1)(2008-2#1)(2013-7#1)
will redefine##2##2##(1994-1#1)(2005-7#1)
will reduce the number of##3##5##(2008-1#1)(2008-11#1)(2012-2#1)
will reduce the##16##3##(1991-2#1)(1992-10#1)(1994-11#1)(2006-10#1)(2006-7#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2012-12#3)(2012-2#1)(2012-3#1)
will reduce##32##2##(1991-2#1)(1991-3#1)(1992-10#1)(1992-2#1)(1993-11#1)(1994-11#1)(1996-9#1)(2005-5#1)(2006-10#1)(2006-7#1)(2007-3#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-7#1)
will reflect##2##2##(1992-8#1)(2012-2#1)
will relapse##2##2##(2008-5#1)(2011-1#1)
will rely##2##2##(2007-9#1)(2012-1#1)
will remain asymptomatic##2##3##(2005-10#1)(2011-1#1)
will remain essential##2##3##(1992-3#1)(2006-10#1)
will remain the##4##3##(1991-12#1)(1993-8#1)(1994-2#1)(2006-9#1)
will remain##28##2##(1991-12#1)(1992-3#1)(1993-5#1)(1993-8#2)(1994-2#1)(1996-1#1)(1996-3#1)(1997-1#2)(1997-4#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-9#2)(2007-12#1)(2007-2#1)(2007-4#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-1#1)(2012-3#1)
will remove##2##2##(2008-12#1)(2008-8#1)
will render the##2##3##(2006-12#1)(2011-2#1)
will replace the##2##3##(2007-11#1)(2008-7#1)
will replace##5##2##(1990-12#1)(2005-10#1)(2006-5#1)(2007-11#1)(2008-7#1)
will report##5##2##(1994-3#1)(1996-10#1)(2007-1#1)(2007-7#1)(2008-1#1)
will represent a##2##3##(2007-10#1)(2008-3#1)
will represent##4##2##(2006-1#1)(2007-10#1)(2007-3#1)(2008-3#1)
will require a##14##3##(1992-3#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-1#2)(1997-7#1)(2006-7#1)(2008-2#1)(2008-5#1)(2009-11#1)(2011-2#2)(2012-12#1)
will require additional##2##3##(1996-10#1)(2009-8#1)
will require an integrated approach##2##5##(2007-7#1)(2009-3#1)
will require better##2##3##(1997-3#1)(2011-2#1)
will require extensive##2##3##(1993-2#1)(1994-12#1)
will require further##4##3##(2008-8#1)(2010-8#1)(2011-1#1)(2012-2#1)
will require greater##2##3##(2007-12#1)(2007-9#1)
will require more##7##3##(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-1#1)
will require new##2##3##(2007-8#1)(2008-3#1)
will require substantial##2##3##(1994-12#1)(1994-9#1)
will require the use of##3##5##(1995-5#1)(2008-4#1)(2008-7#1)
will require the##9##3##(1995-5#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-9#1)(2011-12#1)(2013-1#1)
will require years of##2##4##(2006-9#1)(2012-12#1)
will require##101##2##(1990-12#1)(1992-3#2)(1993-2#2)(1993-3#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-1#3)(1995-12#1)(1995-5#1)(1996-10#1)(1996-12#2)(1996-3#3)(1997-3#1)(1997-4#1)(1997-7#1)(2004-10#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-6#1)(2006-7#2)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#3)(2007-8#3)(2007-9#4)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2009-11#1)(2009-3#1)(2009-8#1)(2009-9#2)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-12#3)(2012-2#3)(2013-1#5)(2013-8#1)
will resolve the##2##3##(1993-6#1)(2005-10#1)
will resolve##4##2##(1993-6#1)(2005-10#1)(2008-4#1)(2010-5#1)
will respond to##4##3##(1996-3#1)(2005-10#1)(2008-4#1)(2010-3#1)
will respond##6##2##(1990-11#1)(1996-3#1)(2005-10#1)(2008-4#1)(2009-4#1)(2010-3#1)
will rest##2##2##(1997-2#1)(2006-10#1)
will result from the##2##4##(1994-9#1)(2009-3#1)
will result from##4##3##(1993-2#1)(1994-9#1)(2005-10#1)(2009-3#1)
will result in a higher##2##5##(1994-12#1)(2012-1#1)
will result in a##11##4##(1991-2#1)(1994-12#1)(2004-9#1)(2006-10#1)(2008-10#2)(2008-4#1)(2009-7#1)(2012-1#1)(2013-1#1)(2013-8#1)
will result in increased##2##4##(1996-6#1)(2007-12#1)
will result in the##4##4##(2006-6#1)(2007-7#1)(2008-3#1)(2011-2#1)
will result in##37##3##(1991-2#1)(1993-12#1)(1994-12#1)(1994-3#2)(1996-6#1)(1996-8#1)(1997-4#1)(2004-9#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
will result##44##2##(1991-2#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#2)(1994-9#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-4#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
will return to##3##3##(2006-8#1)(2013-1#2)
will return##6##2##(2006-8#1)(2007-5#1)(2013-1#4)
will reveal the##2##3##(2006-10#1)(2010-12#1)
will reveal##4##2##(1997-7#1)(2006-10#1)(2009-8#1)(2010-12#1)
will reverse##2##2##(1995-6#1)(1997-8#1)
will review recent##6##3##(2006-10#3)(2006-9#1)(2008-1#1)(2010-5#1)
will review some of the##2##5##(1995-7#1)(2008-1#1)
will review some of##3##4##(1995-7#1)(2006-10#1)(2008-1#1)
will review some##4##3##(1995-7#1)(2006-10#1)(2008-1#1)(2010-1#1)
will review the current##7##4##(2004-3#1)(2008-1#1)(2008-5#2)(2008-9#1)(2010-12#1)(2012-2#1)
will review the present##2##4##(2007-8#1)(2011-1#1)
will review the rationale and evidence##2##6##(2005-10#1)(2005-8#1)
will review the recent##2##4##(2006-10#1)(2008-1#1)
will review the role of##3##5##(2008-1#1)(2011-1#1)(2011-12#1)
will review the role##4##4##(2008-1#1)(2010-2#1)(2011-1#1)(2011-12#1)
will review the state of the art##2##7##(2006-6#1)(2008-5#1)
will review the##50##3##(1992-3#1)(1994-3#1)(1995-2#1)(1997-1#2)(2004-3#1)(2005-10#2)(2005-8#1)(2006-10#3)(2006-2#1)(2006-5#2)(2006-6#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#1)(2009-12#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)
will review these##3##3##(1995-1#1)(2008-7#1)(2010-3#1)
will review this##2##3##(1994-3#1)(2009-5#1)
will review##85##2##(1991-2#1)(1992-3#1)(1994-3#2)(1995-1#1)(1995-2#1)(1995-7#1)(1996-1#1)(1996-7#1)(1997-1#2)(2004-3#1)(2005-10#3)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#8)(2006-2#1)(2006-5#2)(2006-6#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-1#8)(2008-10#1)(2008-11#1)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#2)(2009-5#1)(2009-9#3)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#1)
will revolutionize##2##2##(1993-5#1)(2010-3#1)
will save##3##2##(1997-8#1)(2009-3#1)(2009-6#1)
will see a##2##3##(1996-12#1)(2010-8#1)
will see##6##2##(1996-12#1)(2006-4#1)(2008-11#1)(2009-4#2)(2010-8#1)
will seek##2##2##(2007-8#1)(2011-2#1)
will select##2##2##(2007-9#1)(2013-7#1)
will serve as a##6##4##(1991-6#1)(1994-6#1)(2006-2#1)(2006-4#1)(2008-7#1)(2009-11#1)
will serve as##9##3##(1991-6#1)(1994-6#1)(1996-12#1)(1997-6#1)(2006-2#1)(2006-4#1)(2008-7#1)(2009-10#1)(2009-11#1)
will serve to##2##3##(1992-4#1)(2008-11#1)
will serve##14##2##(1991-6#1)(1992-4#1)(1993-9#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-6#1)(2006-2#1)(2006-4#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-11#1)
will set##2##2##(1991-2#1)(1994-12#1)
will share##3##2##(1997-2#1)(2012-2#1)(2012-3#1)
will shed new light on##2##5##(2010-12#1)(2012-3#1)
will shed##5##2##(1992-9#1)(2010-12#1)(2011-12#1)(2012-2#1)(2012-3#1)
will shift##3##2##(1996-3#1)(2007-7#1)(2008-2#1)
will show how##3##3##(2007-8#1)(2008-7#1)(2013-1#1)
will show that##8##3##(1994-1#2)(1994-3#2)(1996-1#1)(2008-11#1)(2008-5#1)(2012-2#1)
will show the##4##3##(2006-2#1)(2007-1#1)(2008-4#1)(2010-8#1)
will show##21##2##(1994-1#2)(1994-3#2)(1996-1#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#2)
will significantly affect the##2##4##(2004-9#1)(2012-2#1)
will significantly##5##2##(1997-1#1)(2004-9#1)(2007-11#1)(2008-11#1)(2012-2#1)
will slow##2##2##(2008-9#1)(2009-8#1)
will soon be able to##3##5##(2006-6#1)(2007-11#1)(2012-3#1)
will soon be##11##3##(1994-2#1)(2006-6#2)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-6#1)(2012-1#1)(2012-3#1)
will soon##19##2##(1990-12#1)(1994-2#1)(2006-6#2)(2007-11#1)(2007-3#1)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-6#1)(2011-2#1)(2012-1#1)(2012-3#1)
will spend##4##2##(1992-3#1)(1996-2#1)(2008-7#1)(2011-2#1)
will spontaneously##5##2##(2005-11#1)(2006-2#1)(2008-6#1)(2009-5#1)(2010-8#1)
will start by##2##3##(2010-12#1)(2012-2#1)
will start##5##2##(2005-10#1)(2006-10#1)(2007-9#1)(2010-12#1)(2012-2#1)
will steadily##2##2##(1994-2#1)(2006-10#1)
will still##4##2##(1992-3#1)(1996-6#1)(2006-8#1)(2009-10#1)
will stimulate##7##2##(1992-2#1)(1994-1#1)(2004-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2012-12#1)
will strengthen##2##2##(2012-12#1)(2012-3#1)
will stress the##2##3##(1997-6#1)(2012-1#1)
will subsequently##2##2##(1990-11#1)(2012-1#1)
will substantially##2##2##(2008-8#2)
will succeed in##2##3##(1997-2#1)(2008-11#1)
will succeed##4##2##(1997-2#1)(2008-11#1)(2008-3#1)(2009-7#1)
will suffer from##3##3##(2008-2#1)(2008-7#2)
will suffer##6##2##(1991-11#1)(2006-10#1)(2008-2#1)(2008-7#2)(2008-9#1)
will suggest that##3##3##(1996-11#1)(2008-12#1)(2013-1#1)
will suggest##4##2##(1994-6#1)(1996-11#1)(2008-12#1)(2013-1#1)
will summarise the##2##3##(2008-1#1)(2009-5#1)
will summarise##3##2##(2007-11#1)(2008-1#1)(2009-5#1)
will summarize the structural##2##4##(1994-11#1)(2013-1#1)
will summarize the##13##3##(1994-11#1)(2007-7#1)(2008-7#2)(2009-10#1)(2009-11#2)(2009-3#1)(2010-12#2)(2011-1#1)(2012-3#1)(2013-1#1)
will summarize these##3##3##(2008-7#1)(2011-1#1)(2013-1#1)
will summarize what is known about##2##6##(2006-8#1)(2007-11#1)
will summarize##29##2##(1994-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-11#2)(2009-3#1)(2010-12#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
will support a##3##3##(1993-12#1)(1994-1#1)(2007-12#1)
will support the##3##3##(1995-12#1)(2008-7#1)(2008-9#1)
will support##12##2##(1993-12#1)(1994-1#1)(1994-3#1)(1995-12#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#2)
will suppress##2##2##(1992-3#1)(2008-8#1)
will survey the##2##3##(2010-2#1)(2013-1#1)
will survive##5##2##(1994-12#1)(2007-8#1)(2008-10#1)(2010-12#1)(2010-5#1)
will take a##3##3##(1992-3#1)(1994-12#1)(2007-8#1)
will take place##3##3##(2008-11#1)(2008-3#1)(2008-6#1)
will take that##2##3##(2008-12#1)(2009-10#1)
will take time and##2##4##(1997-2#1)(2007-12#1)
will take time##3##3##(1996-3#1)(1997-2#1)(2007-12#1)
will take##19##2##(1992-3#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-12#1)(1996-3#2)(1997-2#1)(1997-3#1)(2005-7#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-10#1)
will tend to##3##3##(1993-3#1)(2006-10#1)(2007-9#1)
will test##5##2##(1992-12#1)(1993-2#1)(1995-10#1)(2004-7#1)(2012-3#1)
will the##9##2##(1993-2#1)(1994-9#1)(1995-1#1)(1997-1#1)(2006-5#1)(2006-6#1)(2008-7#1)(2009-4#1)(2010-9#1)
will their##2##2##(1996-2#1)(2008-1#1)
will then be##8##3##(2007-8#1)(2007-9#1)(2008-2#2)(2008-8#1)(2010-11#1)(2010-12#1)(2011-2#1)
will then review##2##3##(2010-8#1)(2013-8#1)
will then##21##2##(1991-10#1)(1993-3#1)(1995-6#1)(1996-2#1)(2005-10#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-8#1)
will theoretically##2##2##(2007-2#1)(2008-10#1)
will therefore be useful to##2##5##(1995-10#1)(2008-11#1)
will therefore be##3##3##(1995-10#1)(2008-11#2)
will therefore##14##2##(1994-9#1)(1995-10#1)(1997-1#1)(2006-10#1)(2006-2#1)(2007-9#1)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#1)(2010-4#1)(2013-1#2)
will they##3##2##(2008-10#1)(2008-2#1)(2012-3#1)
will this##2##2##(2007-11#1)(2008-9#1)
will thus be##2##3##(2006-6#1)(2010-12#1)
will thus##6##2##(1994-6#1)(1995-10#1)(1996-2#1)(2006-6#1)(2010-12#1)(2013-8#1)
will to##10##2##(2007-8#1)(2008-11#1)(2008-4#2)(2009-4#1)(2009-7#1)(2011-2#2)(2012-1#1)(2013-8#1)
will translate into##4##3##(2006-10#1)(2006-11#1)(2009-3#1)(2009-4#1)
will translate##7##2##(2006-10#1)(2006-11#1)(2009-3#1)(2009-4#1)(2013-1#2)(2013-8#1)
will travel##3##2##(1996-1#1)(1996-7#1)(2008-10#1)
will try to##7##3##(1995-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-1#2)(2013-1#1)
will typically##4##2##(2008-4#1)(2008-7#1)(2010-10#1)(2011-2#1)
will ultimately be used##2##4##(1992-12#1)(2009-3#1)
will ultimately be##5##3##(1992-12#1)(2005-8#1)(2009-10#1)(2009-3#1)(2013-8#1)
will ultimately provide##2##3##(2010-9#1)(2011-1#1)
will ultimately##18##2##(1992-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1996-2#1)(1997-3#1)(2005-8#1)(2007-6#1)(2009-10#1)(2009-3#1)(2009-6#1)(2010-12#2)(2010-2#1)(2010-9#1)(2011-1#2)(2013-8#1)
will uncover the##2##3##(1993-5#1)(2009-8#1)
will uncover##3##2##(1993-5#1)(1996-6#1)(2009-8#1)
will undergo##11##2##(1990-9#1)(1996-11#1)(2007-4#1)(2007-8#1)(2008-4#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-1#1)(2013-1#1)(2013-7#1)
will undermine##3##2##(1995-1#1)(1996-11#1)(2007-2#1)
will undertake##2##2##(2005-5#1)(2007-4#1)
will undoubtedly be##4##3##(1990-5#1)(1995-10#1)(1995-12#1)(1996-11#1)
will undoubtedly##13##2##(1990-5#1)(1991-12#2)(1995-10#1)(1995-12#2)(1996-11#1)(2007-1#1)(2007-11#1)(2008-7#2)(2008-8#1)(2012-11#1)
will use the##6##3##(2006-10#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)
will use##14##2##(1991-1#1)(1992-6#1)(1995-5#1)(2006-10#1)(2006-6#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#2)(2012-12#1)
will usher in##2##3##(1991-5#1)(2009-5#1)
will usually##6##2##(1993-10#1)(1995-1#1)(1997-6#1)(2007-3#1)(2008-8#1)(2013-8#1)
will validate##2##2##(1995-9#1)(2012-1#1)
will vary depending on the##2##5##(2008-11#1)(2008-9#1)
will vary##10##2##(1994-1#1)(1997-1#1)(2005-10#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-3#1)(2011-2#1)(2013-7#1)
will want##2##2##(1992-3#1)(2008-4#1)
will we##2##2##(1995-4#1)(2008-7#1)
will work##6##2##(1994-1#1)(1994-12#1)(1995-6#1)(2008-2#2)(2008-5#1)
will yield a##2##3##(2008-7#1)(2008-8#1)
will yield the##4##3##(2007-12#1)(2008-2#1)(2009-6#1)(2010-12#1)
will yield##12##2##(1991-12#1)(2005-7#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)
will##6117##1##(1990-1#6)(1990-10#6)(1990-11#8)(1990-12#42)(1990-2#4)(1990-3#13)(1990-4#5)(1990-5#8)(1990-6#9)(1990-7#1)(1990-8#3)(1990-9#4)(1991-1#15)(1991-10#9)(1991-11#14)(1991-12#34)(1991-2#16)(1991-3#11)(1991-4#2)(1991-5#10)(1991-6#8)(1991-7#1)(1991-8#4)(1991-9#4)(1992-1#9)(1992-10#5)(1992-11#8)(1992-12#30)(1992-2#22)(1992-3#47)(1992-4#3)(1992-5#7)(1992-6#11)(1992-7#3)(1992-8#12)(1992-9#12)(1993-1#20)(1993-10#4)(1993-11#18)(1993-12#32)(1993-2#38)(1993-3#27)(1993-4#3)(1993-5#11)(1993-6#10)(1993-7#2)(1993-8#6)(1993-9#13)(1994-1#52)(1994-10#3)(1994-11#7)(1994-12#41)(1994-2#29)(1994-3#59)(1994-4#2)(1994-5#14)(1994-6#20)(1994-7#6)(1994-8#8)(1994-9#19)(1995-1#40)(1995-10#7)(1995-11#2)(1995-12#40)(1995-2#37)(1995-3#23)(1995-4#14)(1995-5#12)(1995-6#21)(1995-7#4)(1995-8#12)(1995-9#12)(1996-1#31)(1996-10#5)(1996-11#16)(1996-12#39)(1996-2#36)(1996-3#51)(1996-4#14)(1996-5#20)(1996-6#18)(1996-7#6)(1996-8#9)(1996-9#15)(1997-1#47)(1997-2#34)(1997-3#38)(1997-4#20)(1997-5#12)(1997-6#20)(1997-7#18)(1997-8#29)(2004-1#2)(2004-10#1)(2004-11#14)(2004-12#6)(2004-2#1)(2004-3#7)(2004-4#2)(2004-7#2)(2004-9#4)(2005-1#3)(2005-10#32)(2005-11#28)(2005-12#3)(2005-2#1)(2005-3#3)(2005-4#1)(2005-5#16)(2005-6#6)(2005-7#39)(2005-8#34)(2005-9#18)(2006-1#6)(2006-10#177)(2006-11#24)(2006-12#36)(2006-2#33)(2006-3#9)(2006-4#22)(2006-5#34)(2006-6#55)(2006-7#21)(2006-8#40)(2006-9#22)(2007-1#22)(2007-10#35)(2007-11#116)(2007-12#73)(2007-2#33)(2007-3#24)(2007-4#54)(2007-5#28)(2007-6#23)(2007-7#51)(2007-8#86)(2007-9#57)(2008-1#154)(2008-10#275)(2008-11#190)(2008-12#61)(2008-2#95)(2008-3#130)(2008-4#99)(2008-5#168)(2008-6#58)(2008-7#210)(2008-8#132)(2008-9#82)(2009-1#8)(2009-10#34)(2009-11#17)(2009-12#27)(2009-2#13)(2009-3#33)(2009-4#34)(2009-5#52)(2009-6#22)(2009-7#20)(2009-8#28)(2009-9#26)(2010-1#10)(2010-10#23)(2010-11#31)(2010-12#70)(2010-2#37)(2010-3#42)(2010-4#30)(2010-5#34)(2010-6#14)(2010-7#21)(2010-8#57)(2010-9#22)(2011-1#92)(2011-10#3)(2011-12#25)(2011-2#155)(2011-3#12)(2011-7#1)(2011-9#1)(2012-1#44)(2012-10#2)(2012-11#26)(2012-12#94)(2012-2#125)(2012-3#76)(2012-5#3)(2012-6#3)(2012-9#1)(2013-1#124)(2013-7#36)(2013-8#79)
will-power##2##1##(1993-11#1)(2008-9#1)
willful##3##1##(1996-5#1)(2010-4#2)
willing and able to##2##4##(2006-10#1)(2006-7#1)
willing and##4##2##(2006-10#1)(2006-4#1)(2006-7#1)(2010-8#1)
willing provider laws##4##3##(2006-8#4)
willing provider##5##2##(2006-8#5)
willing to accept##2##3##(2006-8#1)(2007-10#1)
willing to change##3##3##(2006-8#1)(2007-2#2)
willing to participate in the##4##5##(1994-12#1)(1994-2#1)(2012-2#1)(2013-8#1)
willing to participate in##8##4##(1994-12#1)(1994-2#1)(2008-1#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
willing to participate##9##3##(1994-12#1)(1994-2#1)(2008-1#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
willing to pay for##4##4##(1994-1#1)(2006-10#1)(2007-2#1)(2008-10#1)
willing to pay##7##3##(1994-1#1)(2006-10#2)(2006-12#1)(2007-2#1)(2007-7#1)(2008-10#1)
willing to provide##2##3##(1996-3#1)(2009-5#1)
willing to take on##2##4##(1997-6#1)(2006-10#1)
willing to use##2##3##(2007-12#1)(2007-7#1)
willing to##60##2##(1991-2#1)(1991-5#1)(1992-12#2)(1994-1#2)(1994-12#1)(1994-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-10#3)(2006-12#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#2)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#2)(2009-4#1)(2009-5#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
willing##74##1##(1991-2#1)(1991-5#1)(1992-12#2)(1994-1#2)(1994-12#1)(1994-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-10#4)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#8)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#3)(2007-3#1)(2007-4#2)(2007-7#2)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-4#1)(2009-5#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
willingness and##3##2##(2010-8#1)(2011-1#1)(2012-2#1)
willingness of a young child to cooperate##2##7##(1996-2#2)
willingness of##13##2##(1996-2#2)(2006-12#2)(2007-10#2)(2007-7#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)
willingness to embrace##2##3##(1994-1#1)(2012-3#1)
willingness to experience emotional distress##2##5##(2011-1#2)
willingness to experience##4##3##(2007-10#1)(2011-1#3)
willingness to mate##2##3##(2009-9#2)
willingness to participate##2##3##(2013-1#2)
willingness to pay for##2##4##(2006-12#1)(2012-12#1)
willingness to pay in##2##4##(2006-5#1)(2012-12#1)
willingness to pay##11##3##(2006-12#1)(2006-5#1)(2007-7#4)(2012-12#4)(2013-8#1)
willingness to use##3##3##(1997-7#1)(2007-3#1)(2011-1#1)
willingness to##54##2##(1993-12#3)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-9#1)(1996-11#1)(1997-7#1)(2005-12#1)(2006-12#1)(2006-5#2)(2007-1#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-7#4)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-1#1)(2010-8#1)(2011-1#6)(2012-12#5)(2012-3#1)(2013-1#5)(2013-8#1)
willingness##70##1##(1993-12#3)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-9#1)(1996-11#1)(1996-2#2)(1997-7#1)(2005-12#1)(2006-12#3)(2006-5#2)(2007-1#1)(2007-10#3)(2007-12#2)(2007-3#1)(2007-7#5)(2007-9#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-1#1)(2010-12#1)(2010-8#2)(2011-1#7)(2011-2#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
willingness-to-pay##3##1##(1994-2#1)(2006-12#1)(2007-7#1)
willow and##2##2##(2008-6#1)(2008-8#1)
willow##10##1##(2008-2#2)(2008-5#1)(2008-6#4)(2008-8#2)(2012-3#1)
wills##4##1##(1990-7#1)(1991-10#1)(2005-10#1)(2012-12#1)
wilt and canker##2##3##(2008-10#2)
wilt and the##3##3##(2008-10#1)(2013-8#2)
wilt and##12##2##(2008-10#9)(2013-8#3)
wilt by##2##2##(2008-10#2)
wilt caused by##3##3##(2008-10#3)
wilt development##5##2##(2008-10#5)
wilt disease and##2##3##(2008-10#2)
wilt disease of##2##3##(2008-10#2)
wilt disease##15##2##(2008-10#12)(2008-12#3)
wilt diseases##4##2##(2008-10#4)
wilt epidemics##5##2##(2008-10#5)
wilt in some##2##3##(2008-10#2)
wilt in##7##2##(2008-10#7)
wilt incidence and severity##4##4##(2008-10#4)
wilt incidence##6##2##(2008-10#6)
wilt of chickpea##4##3##(2008-10#4)
wilt of cucumber by##2##4##(2008-10#2)
wilt of cucumber##3##3##(2008-10#3)
wilt of radish##2##3##(2008-10#2)
wilt of tomato##6##3##(2008-10#6)
wilt of##31##2##(2008-10#31)
wilt on##3##2##(2008-10#3)
wilt pathogen##5##2##(2008-10#5)
wilt resistance in##2##3##(2008-10#2)
wilt resistance##4##2##(2008-10#4)
wilt symptom development##2##3##(2008-10#2)
wilt symptom##3##2##(2008-10#3)
wilt symptoms in response to##2##5##(2008-10#2)
wilt symptoms in##5##3##(2008-10#5)
wilt symptoms were##2##3##(2008-10#2)
wilt symptoms when##2##3##(2008-10#2)
wilt symptoms##15##2##(2008-10#15)
wilt virus##35##2##(2008-10#35)
wilt was##5##2##(2008-10#5)
wilt##214##1##(2008-10#204)(2008-12#3)(2011-1#1)(2013-8#6)
wilt&quot##2##1##(2008-10#2)
wilt-resistant##6##1##(2008-10#6)
wilt-susceptible and wilt-resistant##2##3##(2008-10#2)
wilt-susceptible##6##1##(2008-10#6)
wilted##3##1##(2008-10#3)
wilting in##3##2##(2008-10#3)
wilting of##2##2##(2008-10#2)
wilting symptoms##2##2##(2008-10#2)
wilting##15##1##(2008-10#13)(2008-12#1)(2011-12#1)
win support##2##2##(1995-10#1)(2008-12#1)
win the##2##2##(2010-8#1)(2013-8#1)
win their##2##2##(1991-3#1)(1996-1#1)
win##29##1##(1990-5#1)(1990-8#1)(1991-3#1)(1992-2#2)(1993-2#1)(1994-10#1)(1995-10#1)(1995-12#1)(1996-1#3)(2007-9#4)(2008-11#1)(2008-12#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-7#1)(2009-9#1)(2010-8#1)(2012-1#1)(2013-7#1)(2013-8#1)
win&quot##2##1##(2008-11#1)(2008-8#1)
win-stay##4##1##(1990-7#2)(1991-1#2)
win-win situation##2##2##(1993-1#1)(2006-5#1)
win-win##4##1##(1992-1#1)(1993-1#1)(1994-1#1)(2006-5#1)
winch##5##1##(2008-6#1)(2012-11#4)
wind and temperature##4##3##(2008-2#1)(2008-3#3)
wind and##13##2##(2006-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#5)(2008-5#2)(2008-8#1)(2013-7#1)
wind currents##2##2##(2008-10#1)(2012-2#1)
wind data##4##2##(2008-5#3)(2010-10#1)
wind direction##10##2##(2006-12#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#3)
wind fields##3##2##(2008-11#1)(2008-2#2)
wind from##2##2##(2008-10#1)(2008-3#1)
wind lidar##7##2##(2007-12#1)(2008-2#1)(2008-3#5)
wind measurement##3##2##(2008-2#3)
wind measurements with##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
wind measurements##9##2##(2007-12#3)(2008-1#1)(2008-2#2)(2008-3#3)
wind patterns##4##2##(2008-10#1)(2008-8#1)(2011-2#1)(2012-2#1)
wind profiles##2##2##(2007-12#2)
wind speed and direction are##2##5##(2007-12#1)(2008-5#1)
wind speed and direction##3##4##(2007-12#1)(2008-5#1)(2010-5#1)
wind speed and##6##3##(1992-6#1)(2007-12#1)(2008-10#1)(2008-5#2)(2010-5#1)
wind speed is##3##3##(2007-12#1)(2008-3#2)
wind speed##33##2##(1992-6#1)(2006-12#1)(2007-12#3)(2007-6#1)(2008-10#7)(2008-2#3)(2008-3#9)(2008-5#5)(2009-7#1)(2010-10#1)(2010-5#1)
wind speeds##10##2##(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#5)
wind trajectories##4##2##(2008-8#4)
wind tunnel##6##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2009-6#1)
wind velocity##8##2##(2007-3#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)
wind##180##1##(1992-6#1)(2006-12#2)(2006-7#1)(2007-11#1)(2007-12#14)(2007-3#3)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#31)(2008-11#4)(2008-12#1)(2008-2#23)(2008-3#48)(2008-5#19)(2008-8#11)(2009-12#1)(2009-6#1)(2009-7#2)(2010-1#1)(2010-10#3)(2010-5#1)(2011-12#2)(2011-2#1)(2012-2#2)(2013-7#2)(2013-8#1)
wind-dispersed ascospores##3##2##(2008-10#3)
wind-dispersed##5##1##(2008-10#4)(2009-8#1)
wind-driven rains##2##2##(2008-10#2)
wind-driven##3##1##(2008-10#2)(2008-2#1)
wind-speed##4##1##(2008-2#2)(2008-3#2)
wind-tunnel##2##1##(2008-2#1)(2008-3#1)
windbeutel##2##1##(1991-5#2)
windborne ascospores##2##2##(2008-10#2)
windborne##6##1##(1990-6#1)(2008-10#4)(2013-8#1)
windbreak net##2##2##(2010-10#2)
windbreak##4##1##(2010-10#3)(2013-8#1)
windbreaks##5##1##(2010-10#5)
winding##6##1##(1995-10#1)(1996-8#1)(2006-6#1)(2007-10#1)(2008-1#1)(2008-3#1)
window (i##2##2##(2008-10#1)(2012-2#1)
window and training size considerations##2##5##(2013-1#2)
window and##8##2##(1992-7#1)(1997-8#1)(2007-11#1)(2008-3#1)(2009-7#1)(2012-2#1)(2013-1#2)
window by##2##2##(2008-3#1)(2013-8#1)
window during which##2##3##(2008-7#1)(2012-2#1)
window for the##2##3##(2010-12#1)(2012-2#1)
window for##11##2##(1997-1#1)(2006-6#1)(2007-10#1)(2007-5#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-12#1)(2012-2#1)(2013-7#1)
window in a##3##3##(1994-10#1)(2013-1#2)
window in the##6##3##(2008-11#1)(2008-2#2)(2010-4#1)(2010-9#1)(2011-2#1)
window in which the##2##4##(2007-12#1)(2008-2#1)
window in which##3##3##(2007-12#1)(2008-2#1)(2008-5#1)
window in##15##2##(1994-10#1)(2006-12#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-2#3)(2008-4#1)(2008-5#1)(2010-4#1)(2010-9#1)(2011-2#1)(2013-1#2)
window into##2##2##(2008-10#1)(2013-8#1)
window is a##3##3##(2007-12#1)(2008-4#1)(2012-2#1)
window is##11##2##(2006-11#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-11#1)(2008-2#1)(2008-4#1)(2011-1#1)(2012-1#1)(2012-2#1)
window materials##2##2##(2007-12#1)(2008-2#1)
window of approximately##3##3##(2008-3#3)
window of opportunity for##8##4##(2007-11#1)(2008-3#1)(2009-10#3)(2010-6#1)(2010-8#1)(2013-1#1)
window of opportunity##12##3##(2007-11#1)(2008-3#2)(2009-10#3)(2009-4#1)(2009-8#1)(2010-5#1)(2010-6#1)(2010-8#1)(2013-1#1)
window of the##8##3##(1992-7#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-8#1)(2012-7#1)
window of##44##2##(1992-7#1)(1993-7#1)(1994-11#1)(1996-9#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#9)(2008-5#1)(2009-10#3)(2009-4#1)(2009-8#2)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-2#2)(2012-7#1)(2013-1#1)(2013-8#1)
window on##7##2##(1991-11#1)(1993-7#1)(1993-9#1)(2005-8#1)(2006-3#1)(2006-4#1)(2007-9#1)
window period##2##2##(1996-11#2)
window regions##2##2##(2008-2#1)(2008-3#1)
window size and orientation##4##4##(2013-1#4)
window technique##2##2##(1990-5#1)(2013-1#1)
window the##2##2##(2007-11#1)(2008-2#1)
window to##2##2##(2008-10#1)(2012-3#1)
window was not##2##3##(2007-10#1)(2008-10#1)
window was##4##2##(2007-10#1)(2008-10#3)
window with##4##2##(2008-2#2)(2009-8#1)(2010-5#1)
window##259##1##(1990-12#1)(1990-5#1)(1991-11#1)(1991-9#1)(1992-7#2)(1993-12#1)(1993-5#1)(1993-7#4)(1993-9#1)(1994-10#1)(1994-11#2)(1994-5#1)(1994-6#1)(1995-12#1)(1996-11#2)(1996-2#2)(1996-9#1)(1997-1#2)(1997-5#1)(1997-8#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-3#2)(2006-4#2)(2006-6#3)(2006-7#1)(2006-9#4)(2007-10#6)(2007-11#10)(2007-12#12)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#4)(2008-1#1)(2008-10#16)(2008-11#7)(2008-2#28)(2008-3#23)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#4)(2009-10#3)(2009-11#1)(2009-2#1)(2009-4#2)(2009-7#2)(2009-8#4)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#4)(2012-2#10)(2012-3#2)(2012-5#1)(2012-7#1)(2013-1#19)(2013-7#2)(2013-8#5)
window&quot##9##1##(1995-5#1)(2007-3#5)(2008-9#1)(2013-1#2)
window)##3##1##(2006-9#2)(2008-10#1)
window-homogeneity##2##1##(1996-8#2)
windowed##9##1##(1995-6#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-2#1)(2008-5#1)(2012-2#1)
windowing##3##1##(2008-2#1)(2008-3#1)(2009-2#1)
windows and##4##2##(2006-4#1)(2008-10#1)(2008-6#1)(2012-2#1)
windows are##6##2##(2007-3#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-12#1)(2011-12#1)
windows at##2##2##(2008-6#1)(2011-1#1)
windows for##3##2##(2007-12#1)(2008-8#1)(2009-12#1)
windows in##2##2##(1995-4#1)(2008-2#1)
windows is##2##2##(2006-5#1)(2011-1#1)
windows of the##3##3##(2008-7#1)(2011-1#1)(2013-1#1)
windows of##6##2##(1996-5#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#1)(2013-1#1)
windows with##2##2##(2008-2#1)(2008-4#1)
windows##71##1##(1992-2#1)(1995-4#1)(1996-5#1)(2005-12#1)(2005-4#1)(2006-4#1)(2006-5#4)(2007-11#1)(2007-12#4)(2007-3#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#12)(2008-3#14)(2008-4#1)(2008-6#4)(2008-7#2)(2008-8#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-1#3)(2011-12#1)(2012-2#7)(2012-3#1)(2013-1#1)
windows&quot##4##1##(2007-3#3)(2007-9#1)
winds and##3##2##(1996-4#1)(2011-12#2)
winds from##2##2##(2008-2#1)(2008-3#1)
winds in the##2##3##(1990-6#1)(2008-3#1)
winds in##3##2##(1990-6#1)(1992-7#1)(2008-3#1)
winds of##2##2##(1994-1#1)(2007-9#1)
winds##27##1##(1990-6#1)(1992-3#1)(1992-5#1)(1992-7#2)(1994-1#1)(1994-3#1)(1996-4#2)(2006-7#2)(2007-9#1)(2008-2#2)(2008-3#10)(2011-12#2)(2012-2#1)
windshields##3##1##(2008-10#2)(2008-3#1)
wine and beer samples##3##4##(2007-8#2)(2008-10#1)
wine and beer##4##3##(2007-8#2)(2008-10#1)(2009-7#1)
wine and oil##2##3##(2006-2#1)(2012-10#1)
wine and##24##2##(1992-1#2)(2006-2#1)(2007-1#3)(2007-8#4)(2008-10#8)(2008-7#1)(2009-7#1)(2010-9#1)(2011-1#1)(2012-10#1)(2013-1#1)
wine by##2##2##(2008-10#2)
wine fermentation##2##2##(2012-3#2)
wine is due to##2##4##(2005-10#1)(2008-7#1)
wine may##3##2##(1995-3#1)(2005-10#1)(2008-7#1)
wine or##4##2##(2011-2#2)(2012-12#1)(2013-1#1)
wine phenolics##2##2##(1995-3#2)
wine polyphenols##4##2##(2009-3#4)
wine quality and##2##3##(2008-10#2)
wine quality##5##2##(2008-10#5)
wine samples by##2##3##(2008-10#2)
wine samples from##2##3##(2008-10#2)
wine samples##27##2##(2007-8#3)(2008-10#24)
wine type##2##2##(2008-10#2)
wine using##4##2##(2008-10#4)
wine vinegar##3##2##(1997-3#2)(2008-10#1)
wine was##2##2##(2008-10#2)
wine yeast##3##2##(2012-3#3)
wine##185##1##(1992-1#5)(1993-9#1)(1994-1#1)(1995-3#4)(1996-1#1)(1996-11#1)(1996-3#3)(1997-1#1)(1997-3#3)(2005-10#3)(2006-2#1)(2007-1#4)(2007-11#1)(2007-8#7)(2008-1#1)(2008-10#100)(2008-6#2)(2008-7#11)(2009-2#1)(2009-3#6)(2009-4#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#6)(2012-10#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#2)
wine-growing##2##1##(2008-10#1)(2012-2#1)
winemaking##2##1##(2008-10#1)(2011-1#1)
wines according to their##2##4##(2008-10#2)
wines according to##5##3##(2008-10#5)
wines and##11##2##(1992-1#2)(2008-10#8)(2011-1#1)
wines are##3##2##(1995-3#1)(2008-10#2)
wines based on##2##3##(2008-10#2)
wines by their##3##3##(2008-10#3)
wines by##6##2##(2008-10#6)
wines from the##4##3##(2008-10#4)
wines from##11##2##(2007-8#1)(2008-10#10)
wines of##2##2##(2008-10#2)
wines using a##2##3##(2008-10#2)
wines using the##2##3##(2008-10#2)
wines using##7##2##(2008-10#6)(2011-1#1)
wines was determined##3##3##(2008-10#3)
wines was##4##2##(2008-10#4)
wines were##3##2##(2008-10#2)(2008-6#1)
wines with##2##2##(2007-8#2)
wines##103##1##(1992-1#2)(1995-3#2)(2007-8#4)(2008-10#89)(2008-6#3)(2011-1#3)
wing and##2##2##(2007-12#1)(2007-7#1)
wing base of##2##3##(2007-12#2)
wing base sclerites##2##3##(2007-12#2)
wing base##7##2##(2007-12#7)
wing disc##3##2##(2012-12#3)
wing discs##4##2##(1990-11#1)(2008-11#1)(2008-9#1)(2012-12#1)
wing fanning##2##2##(2013-8#2)
wing folding##3##2##(2007-12#3)
wing imaginal##2##2##(2007-3#1)(2009-5#1)
wing in##3##2##(2005-10#3)
wing is##2##2##(1997-7#1)(2007-3#1)
wing membrane##2##2##(2007-12#2)
wing motion##2##2##(2007-12#2)
wing of the##3##3##(1996-11#1)(2007-12#1)(2008-2#1)
wing of##4##2##(1996-11#1)(2007-12#1)(2007-9#1)(2008-2#1)
wing scales##3##2##(2008-2#2)(2008-3#1)
wing surface##3##2##(2007-12#1)(2012-11#2)
wing with##2##2##(1997-7#1)(2008-6#1)
wing##86##1##(1990-11#1)(1991-11#2)(1996-11#1)(1997-7#2)(2005-10#7)(2006-12#1)(2007-12#32)(2007-3#3)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-6#2)(2008-8#1)(2008-9#6)(2009-12#2)(2009-4#1)(2009-5#1)(2010-3#1)(2012-11#2)(2012-12#6)(2012-2#1)(2013-1#1)(2013-8#3)
winged insects (Pterygota)##2##3##(2007-12#1)(2008-5#1)
winged##5##1##(2007-12#2)(2008-5#1)(2012-12#1)(2013-1#1)
wingless##5##1##(1990-8#1)(2006-11#1)(2007-12#3)
wings and##5##2##(2005-10#1)(2007-12#2)(2007-4#1)(2013-8#1)
wings are##2##2##(2008-12#1)(2009-12#1)
wings clipped##2##2##(2008-11#1)(2013-8#1)
wings of the butterfly##2##4##(2008-11#1)(2008-3#1)
wings of the##9##3##(1995-5#1)(2006-7#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#2)
wings of##14##2##(1995-5#1)(2006-7#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#3)(2008-3#2)(2013-1#2)(2013-8#1)
wings with##2##2##(2006-11#1)(2013-8#1)
wings##46##1##(1990-9#1)(1991-12#1)(1995-5#1)(2005-10#1)(2006-11#1)(2006-7#1)(2007-11#1)(2007-12#8)(2007-4#1)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#2)(2012-2#2)(2013-1#3)(2013-8#7)
winner and loser effects##2##4##(2007-9#2)
winner of the##2##3##(1993-3#1)(2013-8#1)
winner##14##1##(1993-3#1)(1993-4#1)(1996-12#1)(2005-8#1)(2007-9#5)(2008-5#1)(2008-7#2)(2012-3#1)(2013-8#1)
winner's##5##1##(1997-4#1)(2011-2#2)(2012-3#2)
winners and losers##2##3##(2007-11#1)(2007-4#1)
winners in##3##2##(2007-9#1)(2009-9#1)(2013-7#1)
winners##22##1##(1991-1#1)(1991-3#1)(1992-3#1)(1993-1#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-3#2)(2006-7#1)(2007-11#1)(2007-4#1)(2007-9#2)(2008-8#1)(2009-5#2)(2009-9#3)(2013-7#1)
winning the##3##2##(1992-11#1)(2008-7#1)(2009-9#1)
winning##20##1##(1991-10#1)(1991-3#1)(1992-11#1)(1993-3#1)(1995-1#1)(1996-3#1)(2007-9#2)(2008-7#2)(2008-9#2)(2009-10#1)(2009-9#3)(2012-1#1)(2013-1#2)(2013-8#1)
wins the##2##2##(1992-9#1)(1993-12#1)
wins##19##1##(1991-11#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-10#1)(1992-9#1)(1993-1#1)(1993-12#1)(1994-10#1)(1995-1#1)(1995-2#1)(1995-7#1)(1996-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2009-6#1)(2010-9#1)(2011-2#1)
winter and spring##7##3##(1996-8#1)(2008-10#3)(2008-11#1)(2010-12#1)(2013-7#1)
winter and summer##3##3##(2008-5#2)(2011-1#1)
winter and##20##2##(1992-3#2)(1995-11#1)(1996-8#1)(2006-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#2)(2010-12#2)(2011-1#1)(2013-7#1)(2013-8#1)
winter barley (Hordeum##2##3##(2008-10#1)(2008-11#1)
winter barley cv##2##3##(2008-10#2)
winter barley##9##2##(2008-10#7)(2008-11#2)
winter cereals##3##2##(2008-10#3)
winter flounder##4##2##(1990-11#2)(1991-10#1)(2008-8#1)
winter in##5##2##(2006-12#1)(2010-12#1)(2013-1#2)(2013-8#1)
winter months and##3##3##(1991-8#1)(1996-11#1)(2011-1#1)
winter months##16##2##(1991-8#2)(1992-10#1)(1996-11#1)(1996-3#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-5#2)(2008-9#1)(2009-11#1)(2009-4#1)(2011-1#1)
winter of 2000-2001##2##3##(2006-8#1)(2007-2#1)
winter of##10##2##(1991-8#1)(1992-6#1)(1996-9#1)(2006-8#1)(2007-2#1)(2007-6#1)(2008-2#1)(2008-5#1)(2010-8#1)(2013-8#1)
winter oilseed rape##3##3##(2008-10#3)
winter on##2##2##(2007-4#1)(2010-8#1)
winter period##2##2##(2008-10#1)(2011-2#1)
winter rye##2##2##(2008-10#1)(2008-12#1)
winter season##8##2##(2007-1#1)(2008-1#1)(2008-10#1)(2008-5#4)(2010-8#1)
winter seasons##3##2##(1997-6#1)(2008-7#1)(2011-2#1)
winter survival##4##2##(2008-10#3)(2008-8#1)
winter temperature##2##2##(2008-10#1)(2008-7#1)
winter temperatures prevailing##2##3##(2008-10#2)
winter temperatures##6##2##(1996-11#1)(2008-10#4)(2010-8#1)
winter to##5##2##(2008-10#2)(2008-5#1)(2009-4#1)(2012-2#1)
winter wheat (Triticum aestivum L##2##5##(1990-11#1)(2008-5#1)
winter wheat (Triticum aestivum)##3##4##(2008-10#2)(2008-12#1)
winter wheat (Triticum##5##3##(1990-11#1)(2008-10#2)(2008-12#1)(2008-5#1)
winter wheat as##3##3##(1992-3#1)(2008-10#1)(2008-12#1)
winter wheat biomass estimation##2##4##(2013-8#2)
winter wheat biomass##3##3##(2013-8#3)
winter wheat cultivar##2##3##(2008-10#2)
winter wheat cultivars##5##3##(2008-10#5)
winter wheat genotypes##3##3##(2008-10#3)
winter wheat were##2##3##(2008-10#2)
winter wheat##55##2##(1990-11#2)(1992-3#1)(2008-10#36)(2008-12#3)(2008-5#2)(2012-2#1)(2013-8#10)
winter##273##1##(1990-11#4)(1991-10#1)(1991-2#1)(1991-8#3)(1992-10#2)(1992-3#3)(1992-6#1)(1993-3#1)(1994-12#1)(1995-11#5)(1995-2#1)(1996-1#2)(1996-11#3)(1996-2#1)(1996-3#2)(1996-8#1)(1996-9#1)(1997-3#1)(1997-6#4)(2004-11#1)(2004-4#1)(2006-12#2)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-2#4)(2007-3#3)(2007-4#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#93)(2008-11#5)(2008-12#9)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#18)(2008-7#4)(2008-8#5)(2008-9#1)(2009-11#1)(2009-4#3)(2009-5#1)(2009-9#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#8)(2011-1#4)(2011-2#3)(2012-12#1)(2012-2#7)(2012-4#1)(2013-1#5)(2013-7#4)(2013-8#22)
winter) at##2##2##(2008-10#2)
winter)##5##1##(2004-4#1)(2008-10#3)(2011-2#1)
winter/spring##6##1##(1992-12#2)(1996-8#1)(2011-2#2)(2012-3#1)
winterform and summerform pear psylla##2##5##(2008-10#2)
winters##6##1##(2008-10#2)(2008-7#1)(2008-9#1)(2010-8#1)(2012-4#1)
wintertime solar##2##2##(2010-7#2)
wintertime##5##1##(2007-10#1)(2008-2#1)(2010-7#3)
wipe##3##1##(2008-3#2)(2008-5#1)
wiped##2##1##(2006-2#1)(2008-10#1)
wipes##11##1##(2008-5#11)
wiping##2##1##(1990-10#1)(2008-3#1)
wire and a##2##3##(2008-10#2)
wire and cable extrusion##2##4##(2008-9#2)
wire and##11##2##(2008-10#2)(2008-9#2)(2009-2#1)(2009-3#3)(2009-7#2)(2012-2#1)
wire as##3##2##(2008-10#3)
wire electrode##3##2##(2008-10#3)
wire electrodes##4##2##(2008-10#3)(2012-12#1)
wire fixation##7##2##(2008-9#1)(2009-3#3)(2011-2#3)
wire grid polarizer##3##3##(2008-3#3)
wire grid polarizers##2##3##(2008-3#2)
wire grid##5##2##(2008-3#5)
wire in the##3##3##(1996-6#1)(2008-11#1)(2009-11#1)
wire in##4##2##(1996-6#1)(2007-11#1)(2008-11#1)(2009-11#1)
wire is##5##2##(2007-8#1)(2008-10#2)(2008-3#1)(2009-11#1)
wire nuts##2##2##(2011-2#2)
wire placed in##2##3##(2006-8#1)(2007-8#1)
wire placement in the sternoclavicular joint##2##6##(2007-8#2)
wire technique##4##2##(2007-8#4)
wire twists##8##2##(2007-8#8)
wire was##10##2##(2007-8#3)(2008-10#2)(2010-10#1)(2012-1#2)(2013-8#2)
wire with##2##2##(2008-10#1)(2012-1#1)
wire##160##1##(1990-4#1)(1990-5#1)(1992-11#1)(1996-2#1)(1996-6#1)(1997-5#1)(2004-9#3)(2005-7#1)(2006-3#1)(2006-6#1)(2006-8#2)(2007-11#3)(2007-12#1)(2007-5#1)(2007-7#4)(2007-8#28)(2007-9#1)(2008-10#32)(2008-11#3)(2008-2#1)(2008-3#10)(2008-4#1)(2008-7#2)(2008-9#3)(2009-11#3)(2009-2#3)(2009-3#11)(2009-5#1)(2009-7#4)(2010-10#4)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#12)(2012-1#6)(2012-12#1)(2012-2#1)(2013-8#7)
wire)##3##1##(2008-10#3)
wire-to-wire##2##1##(2008-7#2)
wired##6##1##(2007-8#2)(2008-6#1)(2008-7#2)(2011-2#1)
wireless ECG##3##2##(2010-8#3)
wireless capsule endoscopy##2##3##(2007-5#1)(2009-8#1)
wireless hospital networks##4##3##(2013-1#4)
wireless link##4##2##(2007-12#1)(2010-10#2)(2013-7#1)
wireless network##2##2##(2008-7#1)(2010-8#1)
wireless personal digital##2##3##(2008-12#2)
wireless power transmission##3##3##(2010-10#1)(2010-12#2)
wireless power##6##2##(2008-4#1)(2010-10#1)(2010-12#2)(2013-7#2)
wireless technology##2##2##(2010-8#1)(2013-1#1)
wireless telephone system##2##3##(2010-2#2)
wireless telephone##4##2##(2010-2#4)
wireless##57##1##(2006-6#2)(2007-12#2)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-12#4)(2008-2#3)(2008-3#3)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#2)(2009-8#1)(2010-10#3)(2010-12#2)(2010-2#4)(2010-3#1)(2010-5#1)(2010-8#9)(2012-3#1)(2013-1#5)(2013-7#3)
wirelessly##6##1##(2006-6#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-5#1)(2012-3#1)
wires and##5##2##(2007-11#1)(2008-2#2)(2009-7#1)(2011-2#1)
wires are##2##2##(2009-2#2)
wires in a##2##3##(2008-4#1)(2012-2#1)
wires in##4##2##(2007-11#1)(2008-4#2)(2012-2#1)
wires of##3##2##(2006-12#1)(2007-8#1)(2009-11#1)
wires or##3##2##(1992-3#1)(2008-5#1)(2011-2#1)
wires to the##2##3##(2007-8#1)(2010-12#1)
wires were##5##2##(2008-10#2)(2008-11#1)(2012-2#1)(2013-8#1)
wires##78##1##(1991-11#1)(1991-8#1)(1992-3#1)(1992-8#1)(1994-6#1)(1995-10#1)(1996-6#1)(2006-12#2)(2006-3#1)(2006-6#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#9)(2007-9#4)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#2)(2009-11#2)(2009-2#2)(2009-3#2)(2009-7#3)(2009-9#2)(2010-10#1)(2010-12#2)(2010-7#2)(2011-12#1)(2011-2#4)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#4)
wires)##2##1##(1991-11#1)(2008-10#1)
wireworm populations##2##2##(2011-2#2)
wireworm##5##1##(2011-2#5)
wiring and##2##2##(2008-2#1)(2009-3#1)
wiring for chronic total##2##4##(2008-11#2)
wiring of the##2##3##(1991-3#1)(2010-2#1)
wiring##14##1##(1991-3#1)(2006-7#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#1)(2009-3#2)(2010-1#1)(2010-2#1)(2011-1#1)
wisdom and##3##2##(2006-7#1)(2007-2#1)(2008-1#1)
wisdom in##3##2##(2007-8#1)(2008-9#1)(2011-12#1)
wisdom is##2##2##(1992-5#1)(2008-11#1)
wisdom of##2##2##(2005-10#1)(2010-8#1)
wisdom##45##1##(1992-5#1)(1993-12#1)(1994-6#1)(1995-4#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-12#4)(2007-2#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-10#12)(2010-12#1)(2010-5#1)(2010-8#2)(2011-12#1)(2011-2#1)(2012-3#1)
wise to##3##2##(1994-2#1)(1996-1#1)(2013-1#1)
wise##18##1##(1992-2#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-1#1)(2006-10#1)(2006-4#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-8#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
wisely##9##1##(1991-9#1)(1993-3#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-3#1)
wish and##3##2##(1993-3#1)(2010-5#1)(2012-3#1)
wish of the##2##3##(1991-11#1)(2005-7#1)
wish to be##3##3##(1991-12#1)(2009-8#1)(2012-11#1)
wish to draw##2##3##(2011-2#1)(2012-2#1)
wish to have##3##3##(1992-2#1)(1997-8#1)(2012-12#1)
wish to know##2##3##(2007-5#1)(2013-1#1)
wish to pursue##3##3##(1992-1#1)(2008-11#1)(2012-2#1)
wish to take##2##3##(2007-8#1)(2008-5#1)
wish to use##4##3##(1991-5#1)(1991-6#1)(2008-12#1)(2010-5#1)
wish to##65##2##(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-6#1)(1994-1#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-8#2)(2005-12#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-7#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-12#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#2)
wish##82##1##(1990-4#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-3#2)(1993-6#1)(1994-1#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#2)(1996-9#1)(1997-8#2)(2004-12#1)(2005-12#1)(2005-7#2)(2006-10#2)(2006-12#1)(2006-4#1)(2006-7#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-12#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#8)(2013-8#2)
wished to continue its use##2##5##(2012-3#2)
wished to continue##3##3##(1993-9#1)(2012-3#2)
wished to determine whether##2##4##(1995-12#1)(2004-1#1)
wished to determine##4##3##(1992-7#1)(1995-12#1)(2004-1#1)(2008-9#1)
wished to test##2##3##(1990-11#1)(2008-11#1)
wished to##19##2##(1990-11#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-9#2)(1995-12#1)(1995-5#1)(1996-1#1)(2004-1#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#2)
wished##21##1##(1990-11#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-9#2)(1995-12#1)(1995-5#1)(1996-1#1)(2004-1#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#2)
wishes and##4##2##(1992-4#1)(1996-2#1)(2006-10#1)(2011-2#1)
wishes of##5##2##(1990-11#1)(1991-2#1)(1993-3#1)(1997-4#1)(2006-6#1)
wishes to##12##2##(1993-12#1)(1995-7#1)(1997-2#2)(2008-4#1)(2008-7#1)(2010-10#1)(2010-3#1)(2010-9#1)(2012-12#1)(2012-3#2)
wishes##38##1##(1990-11#1)(1990-6#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-4#1)(1993-12#1)(1993-3#1)(1995-7#1)(1996-2#1)(1997-2#3)(1997-4#1)(2005-4#1)(2006-10#3)(2006-6#2)(2006-7#1)(2006-8#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-3#1)(2010-9#2)(2011-2#1)(2012-11#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
wishing to preserve their##2##4##(2009-7#1)(2012-2#1)
wishing to##18##2##(1990-6#1)(1993-11#1)(1994-2#1)(1995-2#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-3#1)(2012-12#2)(2012-2#1)
wistar albino rats##2##3##(2008-4#2)
wistar rat##2##2##(2007-9#1)(2012-12#1)
wistar rats##7##2##(2007-4#1)(2008-12#2)(2009-5#1)(2010-2#1)(2012-12#1)(2013-1#1)
wistar##11##1##(2007-4#1)(2007-9#1)(2008-12#2)(2008-4#2)(2009-5#1)(2010-2#1)(2012-12#2)(2013-1#1)
wit##7##1##(1997-3#1)(2005-1#1)(2007-7#2)(2008-10#2)(2011-2#1)
witch##2##1##(2007-11#1)(2008-10#1)
witchcraft and##3##2##(2008-10#2)(2008-12#1)
witchcraft##8##1##(1993-11#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2009-10#1)
witches' broom##9##2##(2008-10#9)
witches'-broom disease##3##2##(2008-10#3)
witches'-broom in##2##2##(2008-10#2)
witches'-broom##17##1##(2008-10#17)
with % protection of##3##4##(2011-1#3)
with %##4##2##(1990-8#1)(2011-1#3)
with &gt##29##2##(1993-4#1)(1993-6#1)(1993-9#2)(1995-3#1)(1996-8#1)(1996-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-2#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#3)
with &lt##20##2##(1996-9#2)(2005-9#1)(2006-5#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#2)(2010-3#1)(2011-1#1)(2012-2#4)(2012-3#1)
with &quot##60##2##(1990-11#1)(1990-3#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-12#3)(1995-1#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-7#1)(1997-1#1)(1997-5#1)(2004-3#1)(2005-5#1)(2005-7#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
with 'no option' angina?##2##4##(2007-8#2)
with 'no option'##3##3##(2007-8#3)
with 'no##4##2##(2007-8#3)(2008-7#1)
with (1##2##2##(1997-2#1)(2006-5#1)
with (1)##2##2##(1991-2#1)(2009-8#1)
with (131)I##2##2##(2006-9#1)(2007-11#1)
with (2S##2##2##(1996-4#1)(2009-9#1)
with (I)##2##2##(1990-5#2)
with (NH4)2SO4##2##2##(1990-2#1)(2005-4#1)
with (R##2##2##(1996-2#2)
with (R)-(+)-alpha-methoxy-alpha-(trifluoromethyl)phenylacetic acid##2##3##(1990-10#1)(1995-2#1)
with (i)##5##2##(1991-2#1)(2008-10#2)(2008-11#1)(2009-4#1)
with (p-SC(6)H(4)Cl)(2)##2##2##(2008-5#2)
with -0##3##2##(2007-12#1)(2008-10#1)(2011-2#1)
with 0##249##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#4)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#2)(1992-1#1)(1992-2#1)(1992-4#1)(1992-7#2)(1992-8#1)(1992-9#2)(1993-1#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-6#2)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-8#1)(2003-11#1)(2004-9#1)(2005-11#2)(2005-12#1)(2006-1#1)(2006-12#1)(2006-3#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#2)(2007-11#4)(2007-12#5)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#73)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#8)(2008-6#5)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#1)(2009-3#2)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#4)(2010-7#3)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#9)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#8)(2013-7#3)(2013-8#1)
with 0%##2##2##(2006-8#1)(2008-7#1)
with 1 %##2##3##(2008-6#1)(2010-10#1)
with 1 M NaCl##3##4##(1992-3#1)(1993-3#1)(1994-12#1)
with 1 M##8##3##(1992-3#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-6#1)(2008-10#3)
with 1 and##7##3##(1990-11#1)(1995-12#1)(2007-10#1)(2007-7#1)(2008-10#3)
with 1 mM##8##3##(1990-7#1)(1991-3#1)(1993-6#1)(1993-8#1)(1995-8#1)(1996-9#1)(2008-5#1)(2012-12#1)
with 1 microM of##2##4##(1991-4#1)(2007-1#1)
with 1 microM##10##3##(1991-4#1)(1992-12#1)(1992-5#1)(1993-6#1)(1994-8#1)(1996-11#1)(1997-6#1)(1997-7#1)(2003-11#1)(2007-1#1)
with 1 ml of##4##4##(1990-9#1)(1992-3#1)(2008-10#2)
with 1 ml##7##3##(1990-9#1)(1992-3#1)(1996-12#1)(2008-10#3)(2011-12#1)
with 1 mm of##2##4##(2008-9#1)(2009-8#1)
with 1 mm##5##3##(2007-3#1)(2007-5#1)(2008-9#1)(2009-8#1)(2011-2#1)
with 1 muM indirubin-3'-monoxime or carrier control##4##7##(2008-10#4)
with 1 nM##4##3##(1990-12#1)(1995-12#3)
with 1 or##2##3##(1995-9#1)(2006-10#1)
with 1 x##5##3##(2005-11#1)(2008-10#3)(2008-8#1)
with 1##231##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#2)(1991-10#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#2)(1992-6#1)(1992-9#1)(1993-1#2)(1993-12#3)(1993-3#2)(1993-6#2)(1993-7#1)(1993-8#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#5)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-5#1)(1996-9#1)(1997-1#1)(1997-6#3)(1997-7#1)(2003-11#1)(2004-11#1)(2005-11#2)(2005-4#2)(2006-10#1)(2006-12#1)(2006-5#1)(2007-1#2)(2007-10#5)(2007-11#3)(2007-12#6)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#57)(2008-11#4)(2008-12#3)(2008-2#5)(2008-3#4)(2008-4#3)(2008-5#10)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-11#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#4)(2011-1#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-3#5)(2013-1#2)(2013-7#2)(2013-8#1)
with 1%##19##2##(1990-11#1)(1993-6#1)(1993-7#1)(1994-12#1)(1996-2#1)(1997-3#1)(2006-7#1)(2006-9#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#1)(2009-6#1)(2012-2#1)(2012-3#1)(2013-7#1)
with 1- and##4##3##(2011-2#3)(2012-12#1)
with 1-##5##2##(2008-7#1)(2011-2#3)(2012-12#1)
with 1-(2-pyridylazo)-2-naphthol (PAN)##4##3##(2008-10#4)
with 1-(2-pyridylazo)-2-naphthol##7##2##(2008-10#7)
with 1-(2-thiasolylazo)-2-naphthol##2##2##(2008-10#2)
with 1-10##2##2##(1992-12#1)(1995-3#1)
with 1-2##2##2##(1994-2#1)(2006-10#1)
with 1-D##2##2##(1995-11#1)(2008-3#1)
with 1-W##2##2##(2007-11#2)
with 1-aminobenzotriazole pre-treatment##2##3##(2009-4#2)
with 1-anilinonaphthalene-8-sulfonic acid##2##3##(1991-9#1)(2006-10#1)
with 1-methyl-4-phenyl-1##3##2##(1990-5#1)(2008-3#1)(2008-7#1)
with 1-phenylethyl##2##2##(1994-5#2)
with 1-year##2##2##(2007-8#1)(2010-8#1)
with 10 &lt##4##3##(2008-7#4)
with 10 injections##2##3##(1993-3#1)(2008-10#1)
with 10 lung##2##3##(2008-8#1)(2009-11#1)
with 10 mM##5##3##(1992-1#1)(1992-4#1)(1993-3#1)(2006-10#1)(2008-6#1)
with 10 microM##8##3##(1991-5#1)(1991-9#1)(1992-11#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(2008-11#1)
with 10 ml of 0##2##5##(1992-2#1)(2008-10#1)
with 10 ml of##8##4##(1991-8#1)(1992-2#1)(2008-10#6)
with 10 ml##9##3##(1991-8#1)(1992-2#1)(1995-2#1)(2008-10#6)
with 10 nM##9##3##(1990-10#1)(1991-4#1)(1991-6#1)(1992-3#1)(1993-3#2)(1994-5#1)(1994-6#1)(1995-12#1)
with 10 nematodes##3##3##(2008-10#3)
with 10 ng/ml##3##3##(1990-6#1)(1991-1#1)(1993-6#1)
with 10 nm##2##3##(2011-1#2)
with 10 or more##2##4##(2006-7#1)(2008-9#1)
with 10 or##5##3##(1990-6#1)(1991-6#1)(2006-7#1)(2008-10#1)(2008-9#1)
with 10 to##2##3##(2006-12#1)(2006-8#1)
with 10##116##2##(1990-10#1)(1990-3#1)(1990-5#1)(1990-6#2)(1991-1#1)(1991-4#1)(1991-5#2)(1991-6#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-3#4)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-12#1)(1995-2#2)(1996-12#1)(1996-4#1)(1997-6#1)(2004-11#1)(2004-2#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-8#1)(2008-10#23)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
with 10% FBS##3##3##(2007-11#1)(2008-11#2)
with 10% HCl##2##3##(2008-10#1)(2008-3#1)
with 10% fat##3##3##(2010-4#3)
with 10% fetal calf serum##4##5##(1990-7#1)(1994-9#1)(2006-9#1)(2011-2#1)
with 10% fetal##5##3##(1990-7#1)(1994-9#1)(2006-9#1)(2008-11#1)(2011-2#1)
with 10% of##3##3##(2007-11#1)(2008-10#1)(2011-1#1)
with 10%##27##2##(1990-7#1)(1990-8#1)(1991-8#1)(1994-9#1)(2006-9#1)(2007-11#2)(2007-8#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-5#1)(2009-12#1)(2010-2#1)(2010-4#4)(2011-1#1)(2011-2#1)
with 10(-4) M##3##3##(1992-12#2)(1996-5#1)
with 10(-6) M##3##3##(1991-8#2)(1997-4#1)
with 10(-7)##4##2##(1993-11#1)(1994-3#1)(2008-11#2)
with 10(-8) M##2##3##(1993-4#1)(1993-6#1)
with 10(-8)##3##2##(1993-4#1)(1993-6#1)(1993-9#1)
with 10(3)##2##2##(1990-7#1)(1995-12#1)
with 10(5)##2##2##(2008-3#1)(2008-5#1)
with 10- and##3##3##(2008-10#1)(2008-3#1)(2010-12#1)
with 10-15%##2##2##(1992-1#1)(2007-8#1)
with 10-20##3##2##(1996-11#1)(1996-2#1)(2004-1#1)
with 10-fold##3##2##(1992-6#1)(1996-6#1)(2011-1#1)
with 100 and##2##3##(1995-11#1)(1996-7#1)
with 100 lice##2##3##(1996-12#2)
with 100 mM##5##3##(1990-11#2)(1992-1#1)(1992-7#1)(1997-2#1)
with 100 mg of##2##4##(2008-10#1)(2008-5#1)
with 100 mg##3##3##(2007-7#1)(2008-10#1)(2008-5#1)
with 100 mg/kg##2##3##(1991-3#1)(1992-3#1)
with 100 microM acetylcholine##2##4##(1995-11#2)
with 100 microM##7##3##(1990-12#1)(1992-4#1)(1994-10#1)(1995-11#2)(1995-7#1)(1997-7#1)
with 100 microg##3##3##(2009-3#3)
with 100 micrograms##3##3##(1990-6#1)(1991-12#1)(1992-8#1)
with 100 mul##2##3##(2008-10#2)
with 100 nM alpha-MSH for##2##5##(1995-2#2)
with 100 nM alpha-MSH##3##4##(1995-2#3)
with 100 nM##6##3##(1992-3#1)(1994-9#1)(1995-2#3)(1996-5#1)
with 100##58##2##(1990-11#3)(1990-12#1)(1990-6#1)(1991-12#2)(1991-3#1)(1992-1#1)(1992-3#2)(1992-4#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-3#1)(1994-10#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#3)(1995-2#3)(1995-7#1)(1996-12#2)(1996-5#1)(1996-7#1)(1997-2#1)(1997-7#1)(2006-5#1)(2006-8#2)(2007-12#2)(2007-7#1)(2008-10#5)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#3)(2011-1#1)(2011-2#1)(2013-1#2)
with 100% accuracy##3##3##(2008-10#1)(2008-3#1)(2010-3#1)
with 100% adherence##2##3##(2012-2#2)
with 100% efficiency##2##3##(2007-12#2)
with 100%##14##2##(2007-12#2)(2008-10#4)(2008-3#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)
with 100-fs pulses at##2##4##(2007-12#2)
with 100-fs pulses##3##3##(2007-12#3)
with 100-fs##4##2##(2007-11#1)(2007-12#3)
with 100-km##2##2##(2007-12#1)(2008-1#1)
with 1000##4##2##(1992-8#1)(2008-3#1)(2009-2#1)(2013-8#1)
with 10000##3##2##(2006-8#2)(2008-2#1)
with 102##2##2##(1992-4#1)(1993-1#1)
with 104##2##2##(1997-3#1)(2012-3#1)
with 105##2##2##(2008-12#1)(2010-2#1)
with 1064-nm excitation##3##3##(2006-12#3)
with 1064-nm##5##2##(2006-12#3)(2007-12#2)
with 10mM##2##2##(2006-5#1)(2011-2#1)
with 11##15##2##(1991-9#1)(1993-2#1)(1994-2#1)(2006-7#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-9#1)(2011-1#1)(2013-1#1)
with 11%##2##2##(2006-8#1)(2012-12#1)
with 11-mercaptoundecanoic acid##2##3##(2008-10#2)
with 110 microm##2##3##(2009-8#2)
with 110##4##2##(1994-11#1)(2006-4#1)(2009-8#2)
with 114##2##2##(1992-5#1)(1995-11#1)
with 11C-raclopride##2##2##(1996-5#2)
with 12##39##2##(1990-12#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-5#1)(1995-1#1)(1995-12#1)(1997-5#1)(1997-7#1)(2004-12#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-7#4)(2008-9#1)(2009-3#1)(2009-9#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2013-1#1)
with 12-##2##2##(2008-10#2)
with 12-O-tetradecanoylphorbol 13-acetate (TPA)##2##4##(1990-2#1)(1996-12#1)
with 12-O-tetradecanoylphorbol##3##2##(1990-2#1)(1990-4#1)(1996-12#1)
with 120##8##2##(1990-12#1)(1993-3#1)(1996-3#1)(1997-1#1)(2006-4#1)(2008-5#1)(2011-2#1)(2013-1#1)
with 123##2##2##(2007-12#1)(2007-3#1)
with 1250-nm light##2##3##(2008-2#2)
with 125I and##2##3##(1991-3#1)(1996-12#1)
with 125I##4##2##(1991-2#1)(1991-3#1)(1992-4#1)(1996-12#1)
with 125I-EGF##2##2##(1991-7#1)(1993-9#1)
with 125I-TSST-1 for binding to class II MHC##2##8##(1993-3#2)
with 125I-bFGF##2##2##(1991-12#1)(1995-10#1)
with 128##2##2##(2008-2#1)(2013-7#1)
with 13##14##2##(1990-12#1)(1993-7#1)(1996-7#1)(2004-2#1)(2006-8#1)(2007-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-7#1)(2013-8#1)
with 13%##3##2##(1996-1#1)(2006-8#1)(2008-1#1)
with 131I##2##2##(1990-4#1)(1994-9#1)
with 132##2##2##(1995-2#1)(2008-11#1)
with 133##2##2##(1995-3#1)(2006-10#1)
with 13C##4##2##(1990-10#1)(1993-11#1)(1995-10#1)(1996-4#1)
with 14 and##3##3##(1995-3#1)(2008-10#2)
with 14##21##2##(1990-2#1)(1995-3#1)(1997-5#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-12#2)(2007-8#3)(2008-10#4)(2008-7#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-11#1)
with 14% of the##2##4##(2006-8#1)(2011-1#1)
with 14%##4##2##(1991-8#1)(2006-8#1)(2007-9#1)(2011-1#1)
with 14-##3##2##(1993-3#1)(1995-3#1)(2005-7#1)
with 140##2##2##(1995-12#1)(2008-10#1)
with 147##2##2##(1991-12#1)(2008-3#1)
with 14C##2##2##(1991-3#1)(1994-3#1)
with 15 cases##2##3##(2006-10#1)(2011-2#1)
with 15 isolates##2##3##(2008-10#2)
with 15 mM##2##3##(1990-2#1)(2008-5#1)
with 15 ml of##2##4##(2008-10#2)
with 15 ml/kg##2##3##(2011-12#2)
with 15##31##2##(1990-2#1)(1990-6#1)(1992-1#1)(1992-5#1)(1994-9#1)(1996-8#1)(2004-10#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2008-10#7)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#1)(2009-12#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
with 15%##5##2##(2008-5#1)(2010-4#2)(2012-12#1)(2013-1#1)
with 15-crown-5##2##2##(2008-10#2)
with 150##3##2##(1997-7#1)(2007-7#1)(2010-7#1)
with 15N##2##2##(1990-10#1)(1992-3#1)
with 16 and##2##3##(2006-2#1)(2010-7#1)
with 16##20##2##(1993-8#1)(1994-9#1)(1996-11#1)(1996-8#3)(2004-9#1)(2006-2#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
with 16%##5##2##(1995-2#1)(2006-8#1)(2008-2#1)(2008-5#2)
with 16-membered cyclic tetrathioether##2##4##(2008-10#2)
with 160##4##2##(1997-7#1)(2008-2#1)(2011-2#1)(2013-1#1)
with 162##3##2##(2012-12#1)(2013-1#2)
with 16S##3##2##(2006-12#1)(2006-5#1)(2006-8#1)
with 17 beta-estradiol##2##3##(1993-9#1)(1995-10#1)
with 17##10##2##(1992-8#1)(1993-9#1)(1995-10#1)(2005-11#1)(2005-12#1)(2006-6#1)(2008-1#1)(2008-12#1)(2008-6#1)(2013-7#1)
with 17%##2##2##(1996-1#1)(2013-1#1)
with 17-AAG##2##2##(2012-1#1)(2013-8#1)
with 175##2##2##(2006-12#1)(2011-2#1)
with 18 patients##3##3##(1995-9#1)(1996-4#1)(2007-9#1)
with 18##20##2##(1990-6#1)(1991-2#2)(1991-8#1)(1991-9#1)(1992-6#1)(1995-3#1)(1995-9#2)(1996-4#1)(1997-8#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-6#1)(2011-2#1)(2013-8#1)
with 180##3##2##(2008-10#1)(2008-5#1)(2011-1#1)
with 186##2##2##(2008-8#1)(2010-5#1)
with 19 patients##2##3##(1990-10#1)(2008-6#1)
with 19##11##2##(1990-10#1)(1995-3#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-2#2)(2008-6#1)(2009-5#1)(2010-4#1)
with 19% of##2##3##(2007-7#1)(2012-2#1)
with 19%##4##2##(1996-4#1)(2007-7#1)(2008-6#1)(2012-2#1)
with 193-nm##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
with 1H NMR and##2##4##(1991-2#1)(2011-3#1)
with 1H NMR##3##3##(1991-2#1)(2005-11#1)(2011-3#1)
with 1H##4##2##(1991-2#1)(1996-5#1)(2005-11#1)(2011-3#1)
with 1M nitric acid##2##4##(2008-10#2)
with 1M##5##2##(2007-8#1)(2008-10#3)(2008-3#1)
with 1O2*##2##2##(1994-12#2)
with 1mM##3##2##(1991-1#1)(1992-8#1)(1994-2#1)
with 1ml##2##2##(2008-10#1)(2008-8#1)
with 1moll(-1)##2##2##(2008-10#2)
with 2 &lt##2##3##(2009-2#2)
with 2 M##3##3##(2008-10#3)
with 2 children##2##3##(1992-4#2)
with 2 equiv##3##3##(2010-5#3)
with 2 kN axial preload##2##5##(2006-11#2)
with 2 kN##3##3##(2006-11#3)
with 2 mM##5##3##(1990-7#1)(1992-8#1)(1996-3#1)(2004-2#1)(2005-11#1)
with 2 mg of oral granisetron##2##6##(2010-12#2)
with 2 mg##4##3##(1997-5#1)(2010-12#2)(2011-2#1)
with 2 ml of##2##4##(2008-10#1)(2008-11#1)
with 2 ml##3##3##(1996-12#1)(2008-10#1)(2008-11#1)
with 2 mol l(-1)##6##4##(2008-10#6)
with 2 months##2##3##(1996-12#2)
with 2 or 3##2##4##(2008-10#1)(2013-1#1)
with 2 x##3##3##(1992-3#1)(1993-1#1)(2005-11#1)
with 2##165##2##(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-3#1)(1992-4#2)(1992-8#2)(1993-1#1)(1993-11#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-9#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1997-2#3)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-2#2)(2004-9#1)(2005-11#5)(2006-10#2)(2006-11#3)(2006-4#1)(2006-8#1)(2007-10#5)(2007-11#4)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#38)(2008-11#7)(2008-12#5)(2008-2#1)(2008-3#3)(2008-5#8)(2008-7#2)(2008-8#4)(2009-12#1)(2009-2#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#2)
with 2% of##2##3##(2008-10#1)(2008-11#1)
with 2%##17##2##(1992-6#2)(1993-1#1)(1997-6#1)(2007-7#1)(2008-10#4)(2008-11#4)(2008-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
with 2'##4##2##(1990-7#1)(1991-4#1)(2008-10#1)(2008-4#1)
with 2(2+)##2##2##(1996-2#2)
with 2-##2##2##(2008-5#2)
with 2-(5-bromo-2-pyridylazo)-5-diethylaminophenol (5-Br-PADAP)##2##3##(2008-10#2)
with 2-(5-bromo-2-pyridylazo)-5-diethylaminophenol##4##2##(2008-10#4)
with 2-3##2##2##(1997-6#1)(2008-8#1)
with 2-5##2##2##(2007-9#1)(2012-12#1)
with 2-acetylpyridine-4-phenyl-3-thiosemicarbazone##2##2##(2008-10#2)
with 2-aminothiophenol##2##2##(2008-10#1)(2012-2#1)
with 2-chloro-1-methylpyridinium iodide##2##3##(2008-10#2)
with 2-ethylhexyl phosphonic acid mono-2-ethylhexyl ester (PC-88A)##2##7##(2008-10#2)
with 2-fold symmetry##2##3##(1994-12#1)(1994-3#1)
with 2-fold##3##2##(1991-2#1)(1994-12#1)(1994-3#1)
with 2-methacryloyloxyethyl##2##2##(2008-11#2)
with 2-methyl-8-quinolinol (HMQ)##3##3##(2008-10#3)
with 2-methyl-8-quinolinol##5##2##(2008-10#5)
with 2-methylbutyric acid##2##3##(1994-9#1)(2008-7#1)
with 2-naphthol-3##2##2##(2008-10#2)
with 2-nitroso- napthol-4- sulphonic acid##2##5##(2010-2#2)
with 2-oxoglutarate##4##2##(1990-3#2)(1992-6#1)(2008-10#1)
with 20 and##2##3##(2008-10#1)(2009-7#1)
with 20 mM##4##3##(1991-8#1)(1992-9#1)(1994-8#1)(2008-10#1)
with 20 mg of##2##4##(1993-9#1)(2006-4#1)
with 20 mg##6##3##(1993-9#1)(1997-3#2)(1997-6#1)(2006-4#1)(2009-10#1)
with 20 microM##4##3##(1990-11#1)(1990-5#1)(1991-2#1)(1996-2#1)
with 20 microg##2##3##(1997-4#1)(2010-8#1)
with 20 subjects##2##3##(2008-5#1)(2013-8#1)
with 20##46##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-8#2)(1992-2#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-10#1)(1996-11#1)(1996-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(2004-11#1)(2006-10#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-6#1)(2009-7#2)(2010-8#1)(2011-1#1)(2013-7#1)(2013-8#4)
with 20% of the##2##4##(2008-10#2)
with 20% of##3##3##(1996-11#1)(2008-10#2)
with 20%##17##2##(1991-4#1)(1994-7#2)(1996-11#1)(2007-11#1)(2008-10#7)(2008-5#1)(2008-7#2)(2009-3#1)(2010-6#1)
with 20-25%##2##2##(1996-4#1)(2012-2#1)
with 20-s##3##2##(2008-12#1)(2008-2#1)(2008-3#1)
with 200 mg/kg##2##3##(2007-1#1)(2008-4#1)
with 200 microM milrinone##2##4##(1997-7#2)
with 200##21##2##(1990-6#1)(1992-5#1)(1993-2#1)(1993-9#2)(1996-5#1)(1997-7#2)(2006-5#1)(2007-1#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2009-11#1)(2009-3#1)(2011-2#2)(2012-1#1)
with 2000##3##2##(2004-4#1)(2010-2#1)(2012-3#1)
with 2009 pandemic influenza A (H1N1)##2##6##(2011-1#1)(2012-2#1)
with 2009##3##2##(2011-1#1)(2012-12#1)(2012-2#1)
with 20mM##4##2##(2008-10#3)(2009-11#1)
with 20ml##2##2##(2008-10#2)
with 21 patients##2##3##(2007-6#1)(2007-7#1)
with 21##11##2##(1990-4#1)(1993-2#1)(2007-6#1)(2007-7#2)(2008-10#2)(2010-10#2)(2011-1#1)(2011-2#1)
with 211##2##2##(1991-3#1)(2007-10#1)
with 218##2##2##(2008-10#1)(2010-4#1)
with 22 patients##2##3##(2006-8#1)(2008-6#1)
with 22##9##2##(1995-6#1)(2005-9#1)(2006-8#1)(2007-1#1)(2008-2#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
with 22%##3##2##(2006-8#1)(2008-5#1)(2009-5#1)
with 23##9##2##(1997-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-8#1)(2010-9#1)(2011-2#1)
with 230##3##2##(2008-12#1)(2009-7#1)(2012-2#1)
with 235##3##2##(2005-10#1)(2007-4#1)(2011-2#1)
with 24##13##2##(1997-2#1)(1997-3#1)(2004-1#1)(2005-7#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-12#2)(2011-2#1)(2013-1#1)(2013-8#1)
with 24-h##2##2##(1995-11#1)(2008-10#1)
with 24-mum##2##2##(2007-12#1)(2008-2#1)
with 25 mM##4##3##(1991-9#1)(1994-12#1)(2008-10#2)
with 25 microM##2##3##(1994-9#1)(2010-3#1)
with 25 patients##3##3##(2006-8#1)(2011-2#2)
with 25##21##2##(1991-9#1)(1993-12#1)(1994-12#1)(1994-9#1)(1997-3#1)(2005-8#1)(2006-8#1)(2008-10#6)(2008-2#2)(2009-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)
with 25% of##2##3##(2008-5#1)(2012-2#1)
with 25%##8##2##(1995-2#1)(2006-4#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-9#1)(2012-2#1)
with 250##10##2##(1993-1#1)(1993-11#1)(1993-12#1)(1996-11#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-6#1)(2009-3#1)
with 252##2##2##(2005-4#1)(2007-2#1)
with 255##2##2##(1994-10#1)(1996-11#1)
with 25mg of##3##3##(2008-10#2)(2010-4#1)
with 26##6##2##(1995-2#1)(1995-3#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)
with 26%##2##2##(2008-8#1)(2011-1#1)
with 27##11##2##(1990-7#1)(1994-2#1)(1997-6#1)(2006-10#1)(2007-12#3)(2007-2#1)(2008-1#1)(2008-5#1)(2013-8#1)
with 270##2##2##(2008-10#1)(2008-3#1)
with 28##6##2##(1990-12#1)(1995-1#1)(2006-7#1)(2008-10#1)(2008-5#1)(2008-8#1)
with 29##6##2##(1992-11#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-5#1)(2013-1#1)
with 29%##2##2##(2008-10#1)(2008-6#1)
with 293##2##2##(2008-11#1)(2011-2#1)
with 2D##2##2##(2008-5#1)(2013-1#1)
with 2moll(-1) HCl##2##3##(2008-10#2)
with 3 and##2##3##(1995-8#1)(2008-10#1)
with 3 cycles of##2##4##(1991-10#1)(1992-12#1)
with 3 induction courses##2##4##(2007-4#2)
with 3 mL acetone##2##4##(2007-8#2)
with 3 mL of 2##2##5##(2013-1#2)
with 3 mL##4##3##(2007-8#2)(2013-1#2)
with 3 mM K(+)##2##4##(2006-5#2)
with 3 mM##6##3##(1990-3#1)(1994-2#1)(1994-5#1)(2006-5#2)(2008-10#1)
with 3 mm##2##3##(2007-11#1)(2012-12#1)
with 3 of##2##3##(1997-8#1)(2011-1#1)
with 3 or 4##2##4##(1993-12#1)(2007-10#1)
with 3 or##3##3##(1993-12#1)(2007-10#1)(2008-4#1)
with 3 replications##2##3##(2006-5#1)(2008-12#1)
with 3##96##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-10#1)(1991-8#1)(1992-12#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-2#4)(1994-5#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-5#3)(2006-8#1)(2006-9#1)(2007-10#4)(2007-11#2)(2007-12#4)(2007-4#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#3)(2008-5#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-6#2)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
with 3% of##2##3##(1994-9#1)(1995-2#1)
with 3%##9##2##(1994-9#1)(1995-2#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-4#2)
with 3(1-imidazolyl)propyl##2##2##(2008-10#2)
with 3- and##2##3##(2007-8#2)
with 3-##4##2##(1997-4#1)(2007-8#2)(2008-7#1)
with 3-4##3##2##(1995-5#1)(2009-3#1)(2011-2#1)
with 3-hydroxy-3-methylglutaric aciduria##2##3##(1990-8#2)
with 3-methyl##2##2##(2008-10#1)(2008-11#1)
with 3-mum##2##2##(2007-12#1)(2008-2#1)
with 30 and##2##3##(1993-11#1)(2008-10#1)
with 30 mM##3##3##(1993-6#1)(2007-8#1)(2011-2#1)
with 30 mg##2##3##(1995-1#1)(2008-10#1)
with 30 microM 7 beta-OHC##3##5##(1991-2#3)
with 30 microM##5##3##(1990-11#1)(1991-2#3)(1997-8#1)
with 30 minutes##2##3##(1991-12#1)(2007-8#1)
with 30 nM##2##3##(1990-10#1)(1992-4#1)
with 30 ng/ml##3##3##(1991-2#1)(1993-12#1)(2006-5#1)
with 30##37##2##(1990-10#1)(1990-11#1)(1991-12#1)(1991-2#4)(1992-4#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-9#1)(1995-1#1)(1996-7#1)(1996-8#1)(1997-8#1)(2006-11#1)(2006-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-7#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#3)
with 30% H2O2##2##3##(2007-11#2)
with 30% of##2##3##(2008-10#1)(2013-1#1)
with 30% rat liver S9##2##5##(2008-8#2)
with 30%##13##2##(1994-9#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-5#2)(2008-6#1)(2008-8#2)(2013-1#1)
with 300 mg##4##3##(1990-2#1)(1991-11#1)(1994-3#1)(1995-5#1)
with 300##12##2##(1990-2#1)(1991-11#1)(1994-12#1)(1994-3#1)(1995-11#2)(1995-5#1)(2006-5#1)(2008-10#2)(2008-2#1)(2011-1#1)
with 3000##2##2##(2005-9#1)(2007-8#1)
with 31##10##2##(1991-12#1)(1997-8#2)(2006-10#1)(2007-7#1)(2008-12#2)(2008-2#1)(2008-5#1)(2011-2#1)
with 31%##3##2##(2006-8#1)(2007-8#1)(2008-2#1)
with 315##2##2##(1991-8#1)(1995-11#1)
with 31P##3##2##(1990-5#1)(1996-7#2)
with 32 protein##3##3##(1994-12#3)
with 32##15##2##(1994-12#3)(1995-6#1)(1996-3#1)(1996-9#2)(2006-12#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-7#2)(2008-8#1)(2010-10#1)
with 32P##3##2##(1990-7#1)(1996-2#1)(1997-3#1)
with 32Pi##4##2##(1994-9#1)(1996-5#1)(1997-4#1)(1997-6#1)
with 33##3##2##(1991-8#1)(2008-5#1)(2008-9#1)
with 34##3##2##(1992-3#1)(2009-10#1)(2013-1#1)
with 349##2##2##(2008-5#1)(2013-1#1)
with 35##7##2##(1991-12#1)(1993-9#1)(2006-10#1)(2008-10#1)(2009-10#1)(2010-10#1)(2011-2#1)
with 35% of##2##3##(1995-2#1)(2008-3#1)
with 35%##3##2##(1995-2#1)(2008-12#1)(2008-3#1)
with 355-nm##2##2##(2007-12#1)(2008-2#1)
with 35S##2##2##(1992-4#1)(1993-12#1)
with 35S-labeled##3##2##(1995-2#1)(1997-4#1)(1997-8#1)
with 36##6##2##(2007-9#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#1)
with 36%##3##2##(2006-8#1)(2007-11#1)(2008-6#1)
with 360##3##2##(2007-12#1)(2007-3#1)(2013-8#1)
with 37##9##2##(1992-11#1)(1992-3#1)(1996-2#1)(2005-7#1)(2007-7#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#1)
with 37%##3##2##(1992-8#1)(2008-2#1)(2008-4#1)
with 38 residues (PACAP38)##2##4##(1990-7#2)
with 38##6##2##(1990-7#2)(2011-1#1)(2012-3#1)(2013-1#2)
with 38%##3##2##(1996-3#1)(2008-10#1)(2008-5#1)
with 39##2##2##(1992-5#1)(2007-8#1)
with 3D##12##2##(1995-11#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-7#1)(2009-10#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)
with 3D-CRT to##2##3##(2008-6#2)
with 3D-CRT##3##2##(2008-6#2)(2013-1#1)
with 4 M HCl##2##4##(2008-10#2)
with 4 M##4##3##(1990-8#1)(1993-6#1)(2008-10#2)
with 4 and##2##3##(2007-11#1)(2008-10#1)
with 4 children##3##3##(1992-4#3)
with 4 different##3##3##(1990-12#1)(2006-5#1)(2007-6#1)
with 4 of##2##3##(2011-2#1)(2012-12#1)
with 4 or##2##3##(2007-4#1)(2008-12#1)
with 4##71##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-8#1)(1992-11#1)(1992-4#3)(1992-6#1)(1993-6#1)(1994-2#1)(1995-3#2)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-4#2)(2006-5#1)(2007-1#1)(2007-11#2)(2007-4#1)(2007-6#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
with 4% (v/v)##2##3##(2008-10#2)
with 4%##6##2##(1997-4#1)(2006-5#1)(2008-10#4)
with 4-(2-pyridylazo)-resorcinol (PAR)##2##3##(2008-10#2)
with 4-(2-pyridylazo)-resorcinol##4##2##(2008-10#4)
with 4-aminoantipyrine in the presence of##2##6##(2008-10#2)
with 4-aminoantipyrine in##3##3##(2008-10#3)
with 4-aminoantipyrine##4##2##(2008-10#4)
with 4-bromomethyl-7-methoxycoumarin##2##2##(1993-2#2)
with 4-dimethylaminoazobenzene-4'-sulphonyl chloride##2##3##(1992-7#2)
with 4-fluoro-7-nitro-2##3##2##(1997-2#1)(2012-12#2)
with 40 mM##2##3##(1991-8#1)(1997-8#1)
with 40 patients who did not##2##6##(2006-11#1)(2007-7#1)
with 40##21##2##(1991-3#1)(1991-8#1)(1992-2#1)(1993-9#1)(1994-2#1)(1997-8#1)(2005-10#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-3#1)(2010-9#1)(2011-1#1)(2013-1#1)
with 40% (v/v)##2##3##(2007-1#1)(2007-8#1)
with 40%##9##2##(1990-11#1)(1992-12#1)(2004-9#1)(2007-1#1)(2007-8#1)(2008-10#2)(2008-6#1)(2010-9#1)
with 400##6##2##(1992-5#1)(1994-5#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)
with 41##3##2##(1994-11#1)(1995-5#1)(2005-9#1)
with 41%##2##2##(2007-4#1)(2008-1#1)
with 42##7##2##(1993-1#1)(2006-2#1)(2006-8#1)(2008-10#2)(2008-2#1)(2009-4#1)
with 42%##3##2##(2007-2#1)(2013-1#1)(2013-7#1)
with 43##4##2##(2008-9#1)(2009-12#1)(2011-2#1)(2012-12#1)
with 43%##2##2##(2007-3#1)(2012-12#1)
with 430##2##2##(2007-11#1)(2008-4#1)
with 44##5##2##(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)
with 44%##2##2##(1991-12#1)(2008-5#1)
with 45##4##2##(1992-2#1)(1997-4#1)(2011-2#2)
with 45%##3##2##(1994-9#1)(2007-12#1)(2013-1#1)
with 45Ca##2##2##(1992-2#1)(1993-7#1)
with 47 XYY##2##3##(2004-11#2)
with 47 to##2##3##(1992-3#1)(2006-3#1)
with 47##10##2##(1992-3#1)(2004-11#2)(2006-3#1)(2007-7#1)(2008-5#1)(2010-11#1)(2012-12#1)(2013-1#1)(2013-7#1)
with 48##2##2##(2004-12#1)(2013-1#1)
with 48%##3##2##(1990-3#1)(2007-12#1)(2011-1#1)
with 49##2##2##(2010-7#1)(2013-8#1)
with 5 different##2##3##(1994-12#1)(2006-2#1)
with 5 mM glycine##2##4##(1997-1#2)
with 5 mM##6##3##(1990-8#1)(1994-2#1)(1997-1#3)(2008-10#1)
with 5 mg/kg##4##3##(1997-2#1)(2008-6#2)(2011-2#1)
with 5 microM##4##3##(1995-5#1)(1995-6#1)(1995-7#1)(1997-4#1)
with 5 ml of dimethylformamide (DMF) and the##4##8##(2008-10#4)
with 5 ml of##7##4##(2004-9#1)(2008-10#6)
with 5 ng/ml of glyburide for##2##6##(1994-2#2)
with 5 x 10(3)##3##4##(1996-12#2)(2008-10#1)
with 5 x##5##3##(1996-12#2)(2008-10#1)(2008-3#1)(2008-7#1)
with 5 years##3##3##(1995-2#1)(2005-9#1)(2007-7#1)
with 5##94##2##(1990-12#1)(1990-8#1)(1991-7#1)(1992-10#1)(1992-3#1)(1993-1#1)(1993-10#1)(1993-7#1)(1993-9#1)(1994-12#2)(1994-2#3)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#3)(1995-7#1)(1996-1#1)(1996-12#2)(1996-5#1)(1997-1#3)(1997-2#1)(1997-4#1)(1997-6#2)(1997-8#1)(2004-1#1)(2004-9#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-1#2)(2007-11#2)(2007-12#3)(2007-7#1)(2008-10#23)(2008-11#2)(2008-3#2)(2008-5#2)(2008-6#4)(2008-7#2)(2008-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
with 5% formalin##4##3##(1995-11#2)(1996-12#2)
with 5% of##2##3##(1997-4#1)(2008-10#1)
with 5%##27##2##(1990-11#1)(1991-5#1)(1992-3#1)(1994-3#1)(1995-11#2)(1995-12#1)(1996-12#2)(1997-4#1)(2006-8#2)(2007-12#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#1)(2012-2#2)(2013-1#1)
with 5'##3##2##(1994-8#1)(1996-11#1)(2008-9#1)
with 5-Br-PADAP and##2##3##(2008-10#2)
with 5-Br-PADAP##3##2##(2008-10#3)
with 5-FU##4##2##(1993-8#1)(2007-6#1)(2008-10#1)(2008-11#1)
with 5-HT##5##2##(1991-2#1)(1995-12#2)(1996-12#1)(2007-1#1)
with 5-NO(2)##2##2##(2008-10#2)
with 5-azacytidine##2##2##(1992-3#1)(1997-4#1)
with 5-fluorouracil##10##2##(1990-2#1)(1992-12#2)(1992-2#1)(1993-1#1)(1997-8#1)(2005-7#1)(2008-10#1)(2008-5#1)(2008-7#1)
with 5-hydroxytryptamine##2##2##(1992-5#1)(1996-3#1)
with 5-microns##2##2##(1990-6#1)(1991-8#1)
with 50 % of##2##4##(2011-1#1)(2012-12#1)
with 50 healthy##2##3##(2011-2#2)
with 50 mM##6##3##(1990-12#1)(1992-8#1)(1994-2#2)(1994-9#1)(1996-5#1)
with 50 mg/kg##2##3##(2008-4#1)(2008-9#1)
with 50 microM PQ##2##4##(1995-8#2)
with 50 microM of##2##4##(1992-8#1)(1994-9#1)
with 50 microM##7##3##(1992-6#1)(1992-8#1)(1994-3#1)(1994-9#1)(1995-8#2)(2005-10#1)
with 50 muM##2##3##(2008-10#1)(2008-11#1)
with 50 patients##2##3##(2006-8#1)(2009-3#1)
with 50 to##2##3##(2008-10#1)(2008-6#1)
with 50##43##2##(1990-12#1)(1991-2#2)(1991-5#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1994-2#2)(1994-3#1)(1994-9#2)(1995-8#3)(1996-5#1)(1997-6#2)(2005-10#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
with 50% inhibition at##4##4##(1993-11#3)(1994-3#1)
with 50% inhibition##5##3##(1993-11#3)(1994-3#1)(2013-7#1)
with 50%##20##2##(1990-11#1)(1992-6#1)(1993-11#3)(1993-2#1)(1994-3#1)(1994-5#1)(1996-2#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-12#1)(2013-7#2)
with 500 mM##2##3##(1993-11#1)(1994-8#1)
with 500 mg##4##3##(1990-7#1)(2008-1#1)(2008-11#1)(2012-2#1)
with 500 mg/kg##2##3##(1990-12#1)(1995-3#1)
with 500 microM##2##3##(1990-8#1)(1996-9#1)
with 500 microns##2##3##(1994-5#2)
with 500##24##2##(1990-12#1)(1990-7#1)(1990-8#1)(1992-7#1)(1993-11#1)(1994-5#2)(1994-8#1)(1995-3#1)(1996-9#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-6#1)(2009-3#1)(2010-1#1)(2010-2#1)(2012-2#1)(2013-1#2)
with 51##2##2##(2007-10#1)(2011-2#1)
with 51%##2##2##(1996-6#1)(2011-2#1)
with 52##2##2##(2009-6#1)(2012-2#1)
with 53##4##2##(1994-5#1)(1997-8#1)(2008-5#1)(2008-7#1)
with 54##2##2##(2006-8#1)(2008-5#1)
with 54% identity##2##3##(1994-9#1)(1995-8#1)
with 54%##4##2##(1994-9#1)(1995-8#2)(2007-8#1)
with 56##5##2##(1996-11#1)(2008-5#2)(2008-6#1)(2011-2#1)
with 58##3##2##(2007-8#1)(2008-10#1)(2008-5#1)
with 58%##3##2##(1990-6#1)(1997-2#1)(2013-1#1)
with 59##2##2##(2008-5#1)(2011-2#1)
with 59%##3##2##(1995-12#1)(2007-4#1)(2013-8#1)
with 5mum##2##2##(2008-10#2)
with 6 DoF##2##3##(2006-6#2)
with 6 MV and##2##4##(2012-1#1)(2013-1#1)
with 6 MV##4##3##(2008-3#1)(2012-1#1)(2012-12#1)(2013-1#1)
with 6 and##2##3##(2006-5#1)(2013-1#1)
with 6##39##2##(1990-11#1)(1991-4#1)(1991-6#1)(1992-10#1)(1993-7#1)(1994-2#1)(1994-8#1)(2006-10#1)(2006-5#1)(2006-6#3)(2006-9#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#6)(2013-8#2)
with 6-benzyl amino purine##2##4##(2010-2#2)
with 6-hydroxydopamine##7##2##(1990-5#1)(1993-2#1)(1993-4#2)(1995-12#2)(2010-2#1)
with 6-month##4##2##(2006-8#1)(2007-9#2)(2009-10#1)
with 60##11##2##(1993-3#1)(2006-8#2)(2007-1#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2013-8#1)
with 60% of##3##3##(1993-4#1)(2008-5#1)(2012-12#1)
with 60%##5##2##(1992-2#1)(1993-4#1)(2008-5#1)(2009-11#1)(2012-12#1)
with 60-ps##2##2##(2007-12#2)
with 600##5##2##(1994-6#1)(1995-6#1)(1996-4#1)(2007-11#1)(2007-12#1)
with 61##3##2##(2007-8#1)(2010-2#1)(2011-2#1)
with 61%##2##2##(2006-8#1)(2008-6#1)
with 62##3##2##(1996-3#1)(2008-11#1)(2008-12#1)
with 63##2##2##(1997-3#1)(2010-2#1)
with 64##7##2##(1996-3#1)(1996-9#1)(2006-12#1)(2007-9#1)(2008-4#1)(2009-5#1)(2011-2#1)
with 65##4##2##(1990-11#1)(1994-8#1)(2005-8#1)(2007-12#1)
with 65%##4##2##(1992-11#1)(1993-11#1)(2006-10#1)(2008-12#1)
with 66##4##2##(2008-6#1)(2012-2#1)(2012-3#2)
with 67%##3##2##(2006-8#1)(2008-3#1)(2013-7#1)
with 670##2##2##(2007-5#1)(2010-10#1)
with 68##5##2##(2007-10#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-2#1)
with 68%##2##2##(2006-12#1)(2008-7#1)
with 69##4##2##(2007-5#1)(2008-12#1)(2008-2#1)(2012-11#1)
with 69%##2##2##(2007-7#1)(2008-12#1)
with 6MP##3##2##(1996-3#1)(2008-10#2)
with 7##17##2##(1990-6#1)(1991-5#1)(1992-7#1)(1995-3#1)(2006-12#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2010-3#1)(2010-5#1)(2013-1#1)
with 7%##2##2##(2007-12#1)(2008-2#1)
with 7-amino-3-(2-bromoethoxy)-4-chloroisocoumarin##2##2##(1991-3#2)
with 7-chloro-4-nitro[14C]benzofurazan##2##2##(1991-3#2)
with 7-mx##2##2##(2010-1#2)
with 70##6##2##(1991-11#1)(1991-5#1)(1993-9#1)(2005-11#1)(2008-10#1)(2010-4#1)
with 70% ethanol and then with##2##6##(2008-5#1)(2012-1#1)
with 70% ethanol##5##3##(2008-11#1)(2008-5#1)(2010-2#1)(2012-1#1)(2013-8#1)
with 70%##8##2##(1990-6#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-2#1)(2012-1#1)(2013-8#1)
with 700##2##2##(2008-11#1)(2008-5#1)
with 71%##5##2##(1990-9#1)(1991-12#1)(1995-4#1)(2004-4#1)(2008-7#1)
with 73##3##2##(1993-9#1)(2013-1#2)
with 73%##2##2##(2008-10#1)(2008-7#1)
with 74##2##2##(2007-8#2)
with 74% of##2##3##(2006-10#1)(2008-11#1)
with 75##6##2##(1992-9#1)(1996-9#1)(2006-12#1)(2007-2#1)(2008-3#1)(2011-2#1)
with 75% ethanol##2##3##(2008-11#1)(2008-4#1)
with 75%##5##2##(1997-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-3#1)
with 750##3##2##(1997-3#1)(2006-5#1)(2007-11#1)
with 76##2##2##(2004-10#1)(2008-10#1)
with 77##3##2##(1990-5#1)(1991-3#1)(2007-8#1)
with 78##3##2##(1995-4#1)(2008-12#1)(2013-8#1)
with 79% of##2##3##(2008-12#1)(2013-1#1)
with 79%##4##2##(1992-12#1)(1996-1#1)(2008-12#1)(2013-1#1)
with 8 ml of##2##4##(1993-4#1)(2008-10#1)
with 8##22##2##(1993-4#1)(1993-5#1)(1996-2#1)(1997-2#1)(2004-9#2)(2006-8#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-10#1)(2009-5#3)(2012-12#1)(2013-1#1)(2013-8#1)
with 8%##5##2##(1991-11#1)(1993-4#1)(2007-9#1)(2008-7#1)(2008-8#1)
with 8-10##2##2##(1995-2#1)(2008-10#1)
with 8-Cl-cAMP##2##2##(1991-6#1)(1994-8#1)
with 8-[(4-bromo-2##2##2##(1990-7#2)
with 8-hydroxyquinoline and##2##3##(2008-10#2)
with 8-hydroxyquinoline immobilized polyacrylonitrile##2##4##(2008-10#2)
with 8-hydroxyquinoline immobilized##3##3##(2008-10#3)
with 8-hydroxyquinoline##8##2##(1990-2#1)(2008-10#7)
with 8-methoxypsoralen##2##2##(1991-12#1)(1997-4#1)
with 80##9##2##(1991-3#1)(2007-10#1)(2008-10#1)(2008-5#3)(2010-12#1)(2010-8#1)(2013-8#1)
with 80% accuracy##3##3##(2012-1#1)(2013-1#2)
with 80% ethanol##2##3##(1997-8#1)(2008-12#1)
with 80% of the##2##4##(2004-11#1)(2010-4#1)
with 80% of##4##3##(1993-4#1)(2004-11#1)(2010-3#1)(2010-4#1)
with 80%##13##2##(1993-4#1)(1997-8#1)(2004-11#1)(2007-8#1)(2008-12#1)(2008-3#1)(2010-3#1)(2010-4#2)(2012-1#1)(2013-1#3)
with 800##3##2##(2007-11#1)(2008-10#1)(2011-2#1)
with 81% of##2##3##(2008-5#1)(2011-1#1)
with 82%##2##2##(1996-12#1)(2008-7#1)
with 83##2##2##(1993-12#1)(2008-5#1)
with 83%##3##2##(1991-8#1)(2007-3#1)(2008-10#1)
with 84##3##2##(1996-10#1)(2008-5#1)(2012-12#1)
with 84%##3##2##(1990-7#1)(1995-3#1)(1995-4#1)
with 85##11##2##(1995-8#1)(1997-2#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-12#1)(2013-1#1)
with 85%##2##2##(1991-10#1)(2006-6#1)
with 87%##4##2##(1991-10#1)(2007-3#1)(2008-1#1)(2012-3#1)
with 89##4##2##(2007-2#1)(2007-7#1)(2008-10#1)(2009-11#1)
with 9##13##2##(1992-6#1)(1995-12#1)(1995-3#1)(1996-10#1)(2005-10#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2010-3#1)
with 9%##3##2##(2006-10#1)(2007-11#1)(2011-2#1)
with 9-cis-RA##2##2##(1995-1#2)
with 90##4##2##(2007-11#1)(2007-8#2)(2008-11#1)
with 90% and##2##3##(2007-11#1)(2011-2#1)
with 90% of the##2##4##(2007-3#1)(2010-3#1)
with 90% of##3##3##(2007-3#1)(2010-3#2)
with 90%##10##2##(1992-11#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-8#1)(2010-3#2)(2011-2#1)
with 90Y##3##2##(1995-9#1)(2007-7#1)(2011-2#1)
with 92##2##2##(1993-7#1)(1996-3#1)
with 92%##2##2##(2009-3#1)(2012-12#1)
with 93##2##2##(2007-8#1)(2009-8#1)
with 93%##3##2##(2012-12#1)(2013-1#2)
with 94##4##2##(2007-10#1)(2007-3#1)(2009-9#1)(2011-2#1)
with 94% of##2##3##(2006-8#1)(2008-1#1)
with 95##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
with 95% confidence interval (CI)##3##5##(2007-10#1)(2008-6#1)(2010-4#1)
with 95% confidence intervals (CI) were calculated##2##7##(2010-9#1)(2011-2#1)
with 95% confidence intervals##5##4##(2010-11#1)(2010-3#1)(2010-9#1)(2011-2#2)
with 95% confidence##8##3##(2007-10#1)(2008-6#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#2)
with 95%##14##2##(1990-10#1)(1990-12#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#3)(2013-1#1)
with 96##2##2##(2007-1#1)(2007-8#1)
with 96%##2##2##(2007-11#1)(2008-10#1)
with 97##3##2##(1993-7#1)(2008-4#1)(2012-3#1)
with 98%##3##2##(2008-10#1)(2008-4#1)(2010-12#1)
with 99##4##2##(2007-12#1)(2007-8#1)(2008-3#1)(2011-1#1)
with 99%##2##2##(2008-10#1)(2010-4#1)
with 99mTc##3##2##(1990-12#1)(1995-8#1)(2008-7#1)
with A and##2##3##(1997-3#1)(2004-11#1)
with A##26##2##(1991-5#1)(1993-5#1)(1996-2#1)(1997-3#1)(1997-5#2)(2004-11#1)(2005-8#1)(2007-12#1)(2007-2#2)(2008-10#7)(2009-3#1)(2010-4#1)(2012-2#3)(2012-3#1)(2013-8#2)
with A- and B-type##2##4##(1990-10#1)(1993-9#1)
with A/Sydney/5/97##3##2##(2011-1#3)
with A1 + A2 sporangia##3##5##(2008-10#3)
with A1##4##2##(1992-9#1)(2008-10#3)
with A2##2##2##(1992-9#1)(1996-5#1)
with A23187##7##2##(1990-2#1)(1990-6#1)(1991-3#1)(1992-6#1)(1994-6#1)(1995-11#2)
with AA##7##2##(1993-8#2)(2005-4#2)(2007-11#1)(2007-8#1)(2008-10#1)
with AAA##2##2##(2008-10#1)(2011-2#1)
with AAL-TA##2##2##(2008-10#2)
with AARR syndrome##2##3##(2011-1#2)
with AAS and##2##3##(2008-10#1)(2008-4#1)
with AAS##4##2##(2007-9#1)(2008-10#2)(2008-4#1)
with AAT##2##2##(2008-5#1)(2009-1#1)
with ABA##2##2##(2007-9#1)(2008-10#1)
with ABT-737##2##2##(2012-12#2)
with ABVD##2##2##(1994-12#1)(2013-1#1)
with AC##2##2##(1993-7#1)(2005-11#1)
with ACC##2##2##(1991-11#1)(2013-1#1)
with ACD##2##2##(2009-8#2)
with ACE inhibitors##8##3##(1992-12#1)(1993-12#1)(1996-6#1)(2006-10#1)(2007-1#2)(2008-5#1)(2010-12#1)
with ACE##11##2##(1990-11#1)(1992-12#1)(1993-12#1)(1996-6#1)(2005-7#1)(2006-10#1)(2007-1#2)(2008-5#1)(2008-9#1)(2010-12#1)
with ACE-inhibitors##2##2##(1990-2#1)(1993-2#1)
with ACL##3##2##(2007-11#1)(2007-7#1)(2013-1#1)
with ACPC##2##2##(1996-1#1)(1996-12#1)
with ACR##2##2##(2007-8#1)(2008-10#1)
with ACS and##4##3##(2008-3#1)(2010-4#1)(2011-12#2)
with ACS##12##2##(2006-6#2)(2008-3#5)(2010-4#1)(2011-12#3)(2013-8#1)
with AD and##2##3##(2008-6#1)(2008-7#1)
with AD compared with##2##4##(1996-1#1)(1997-4#1)
with AD##26##2##(1991-1#2)(1993-11#4)(1995-12#1)(1996-1#1)(1996-2#1)(1997-4#2)(2004-12#1)(2007-6#1)(2007-9#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-11#1)(2009-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)
with ADHD and##9##3##(1995-1#1)(2005-10#2)(2009-8#1)(2010-8#1)(2011-12#1)(2012-2#3)
with ADHD were##2##3##(2011-2#1)(2013-8#1)
with ADHD##34##2##(1995-1#4)(1996-6#1)(2004-10#1)(2005-10#7)(2006-2#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-2#3)(2013-8#1)
with ADP##5##2##(1990-5#1)(1991-4#1)(1992-12#1)(1995-7#1)(1997-4#1)
with ADPKD##6##2##(2007-8#1)(2013-1#5)
with AE1##2##2##(1991-8#2)
with AF who are##2##4##(2013-1#2)
with AF who##3##3##(2007-8#1)(2013-1#2)
with AF##12##2##(2007-10#5)(2007-8#1)(2010-6#2)(2012-3#1)(2013-1#3)
with AFB1##2##2##(1997-3#1)(2008-12#1)
with AFP##4##2##(2008-10#3)(2013-1#1)
with AG##2##2##(1996-6#1)(2012-4#1)
with AI##2##2##(2011-2#2)
with AIDS and other##2##4##(1994-3#1)(2006-11#1)
with AIDS and that##2##4##(2008-11#2)
with AIDS and##12##3##(1994-3#1)(1995-6#2)(1996-11#2)(2006-10#1)(2006-11#1)(2008-11#2)(2009-2#1)(2011-2#1)(2012-12#1)
with AIDS dementia##2##3##(2005-4#1)(2013-7#1)
with AIDS had##2##3##(1993-8#1)(2005-7#1)
with AIDS in the##2##4##(1996-3#1)(1997-3#1)
with AIDS in##5##3##(1993-8#2)(1996-3#1)(1997-3#1)(2006-7#1)
with AIDS or##2##3##(1991-6#1)(1991-8#1)
with AIDS was##2##3##(1995-12#1)(2007-10#1)
with AIDS will##2##3##(1995-12#1)(2008-5#1)
with AIDS##100##2##(1990-11#3)(1990-12#1)(1990-2#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-8#2)(1992-12#1)(1992-2#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#7)(1994-3#1)(1994-4#2)(1994-7#1)(1995-12#4)(1995-2#4)(1995-6#6)(1996-1#1)(1996-11#4)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#2)(1996-7#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#2)(1997-7#1)(2005-10#1)(2005-4#1)(2005-7#1)(2006-10#5)(2006-11#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#2)(2008-10#1)(2008-11#4)(2008-5#3)(2009-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#4)(2013-7#1)
with AIDS-related##3##2##(1991-12#2)(1991-2#1)
with AII##2##2##(1990-7#2)
with AIS##4##2##(2006-10#2)(2007-11#1)(2008-5#1)
with AIs##2##2##(2008-5#1)(2011-1#1)
with AL##2##2##(2010-4#1)(2013-7#1)
with ALA and light##2##4##(1992-8#2)
with ALA-induced porphyrins##2##3##(1992-9#2)
with ALCL##3##2##(1997-3#1)(2011-2#2)
with ALD##2##2##(1993-12#1)(2004-11#1)
with ALI##3##2##(2005-11#1)(2011-2#2)
with ALL and##4##3##(2011-2#4)
with ALL treated in##2##4##(2011-2#2)
with ALL##13##2##(1990-10#1)(1995-9#1)(1996-3#2)(2010-6#1)(2011-2#7)(2012-2#1)
with ALL-L2##2##2##(2011-2#2)
with AM1##2##2##(1997-7#2)
with AMBER##2##2##(1995-7#1)(1997-2#1)
with AMD##4##2##(2005-7#1)(2011-2#2)(2013-1#1)
with AMI##13##2##(1990-12#2)(1995-12#2)(1997-6#1)(2006-8#1)(2007-11#2)(2008-3#2)(2008-5#1)(2011-1#1)(2013-1#1)
with AML##7##2##(1992-10#1)(2007-3#1)(2008-10#1)(2008-5#1)(2010-1#1)(2011-2#2)
with AMPA##2##2##(1997-7#2)
with AMPPNP at 23 degrees C##2##6##(1996-11#2)
with AN##11##2##(2005-11#3)(2006-1#4)(2006-7#1)(2007-7#1)(2013-1#2)
with ANG II##2##3##(1991-8#1)(1996-8#1)
with ANOVA##2##2##(2007-11#1)(2008-12#1)
with AOD and##2##3##(2012-12#1)(2012-3#1)
with AOD##4##2##(2012-12#3)(2012-3#1)
with AP##5##2##(1994-2#1)(1995-6#1)(1996-12#3)
with AP3-PL##3##2##(1990-12#2)(1994-8#1)
with APC##4##2##(1994-8#3)(1997-6#1)
with APDC and##2##3##(2008-10#2)
with APDC##9##2##(2007-8#3)(2008-10#6)
with APP and##2##3##(1995-12#1)(2008-11#1)
with APP##3##2##(1994-9#1)(1995-12#1)(2008-11#1)
with APS##5##2##(1991-12#1)(2006-10#3)(2012-3#1)
with AR##12##2##(1995-2#1)(1995-3#5)(2007-2#2)(2008-10#1)(2011-2#3)
with AR-mediated##2##2##(2008-9#1)(2010-12#1)
with ARDS and##2##3##(1997-1#1)(2008-8#1)
with ARDS##9##2##(1990-2#1)(1991-9#2)(1997-1#2)(2005-11#1)(2005-8#1)(2008-8#1)(2009-6#1)
with ARF##4##2##(1993-6#1)(1997-4#1)(2006-7#1)(2008-4#1)
with ARIS##2##2##(1992-8#2)
with AS and##2##3##(2006-10#1)(2011-2#1)
with AS##5##2##(2006-10#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-12#1)
with ASA##2##2##(2012-2#1)(2013-7#1)
with ASAD##2##2##(2012-2#2)
with ASCUS##2##2##(2006-10#2)
with ASD and##4##3##(2009-10#1)(2009-4#1)(2010-2#1)(2012-2#1)
with ASD may##3##3##(2012-2#2)(2013-7#1)
with ASD##29##2##(2007-8#2)(2009-10#1)(2009-4#6)(2010-12#1)(2010-2#3)(2011-2#1)(2012-2#10)(2013-1#2)(2013-7#3)
with ASLD##3##2##(1993-11#3)
with ASM##5##2##(2008-10#5)
with ATD##2##2##(2007-1#2)
with ATG##3##2##(1990-1#1)(2007-5#1)(2007-7#1)
with ATP and ADP##2##4##(1991-9#1)(1992-12#1)
with ATP and the##2##4##(1996-2#1)(1997-6#1)
with ATP and##7##3##(1990-4#1)(1991-9#1)(1992-12#1)(1995-11#1)(1996-2#1)(1997-6#1)(2008-4#1)
with ATP or##2##3##(1992-11#1)(1995-11#1)
with ATP##30##2##(1990-3#4)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#3)(1991-1#1)(1991-9#1)(1992-11#1)(1992-12#2)(1993-6#1)(1994-9#1)(1995-11#2)(1995-4#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-4#1)(1997-6#1)(2008-4#2)(2009-7#2)(2010-10#1)
with ATRA##2##2##(2007-4#1)(2013-1#1)
with AVIM##5##2##(2013-8#5)
with AZT##4##2##(1995-6#1)(1995-7#1)(1995-9#2)
with Abeta##2##2##(2012-12#2)
with Aboriginal##2##2##(2008-12#1)(2009-4#1)
with Absidia corymbifera##2##3##(2008-5#2)
with AcLDL##3##2##(1990-4#2)(1994-9#1)
with Acro-LDL were##2##3##(2013-1#2)
with Acute##4##2##(2008-10#1)(2008-8#1)(2011-12#1)(2012-3#1)
with Addison's disease##3##3##(2006-9#2)(2010-12#1)
with African##3##2##(2008-3#2)(2008-4#1)
with Ag##3##2##(1990-5#1)(1993-1#1)(2007-12#1)
with Ag(+)##3##2##(2008-10#3)
with Ag-NOR counts and##2##4##(1994-7#2)
with Agrobacterium tumefaciens##2##3##(2008-10#1)(2008-9#1)
with Agrobacterium##4##2##(2006-12#1)(2008-10#1)(2008-9#1)(2012-11#1)
with Al##2##2##(1996-8#1)(2008-10#1)
with Al(2)(SO(4))(3)##4##2##(2008-10#4)
with AlH(3)##2##2##(1996-2#2)
with Ala##8##2##(1990-3#1)(1990-7#1)(1992-3#1)(1992-6#1)(1994-9#2)(1995-3#1)(1997-4#1)
with Alagille syndrome and##2##4##(1996-6#1)(2007-8#1)
with Alagille syndrome##4##3##(1996-6#1)(2007-8#3)
with Alcian blue##2##3##(1994-9#1)(1996-7#1)
with Alizarin Red S (ARS)##3##5##(2007-8#1)(2008-10#2)
with Alizarin Red S##8##4##(2007-8#1)(2008-10#7)
with Alport syndrome##3##3##(2011-2#2)(2012-12#1)
with Alport##4##2##(2011-2#3)(2012-12#1)
with Alu##2##2##(1991-9#1)(1994-5#1)
with Alzheimer disease##5##3##(1990-3#1)(1994-8#2)(1995-1#1)(2008-8#1)
with Alzheimer disease]##3##3##(1995-5#1)(2008-8#1)(2013-8#1)
with Alzheimer paired helical filaments##2##5##(1992-6#2)
with Alzheimer##10##2##(1990-3#1)(1992-6#2)(1994-8#2)(1995-1#1)(1995-5#1)(2008-8#2)(2013-8#1)
with Alzheimer's Disease##5##3##(1993-12#1)(1995-11#1)(1996-1#1)(2008-10#1)(2011-2#1)
with Alzheimer's disease (AD)##11##4##(1991-3#1)(1995-12#1)(1995-3#1)(1996-5#1)(2007-6#1)(2008-1#1)(2008-6#1)(2008-7#2)(2012-12#1)(2012-2#1)
with Alzheimer's disease and##5##4##(1991-1#1)(1994-5#1)(1996-1#1)(2009-3#1)(2010-2#1)
with Alzheimer's disease##58##3##(1990-10#2)(1990-7#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-3#1)(1991-7#2)(1991-9#1)(1992-12#2)(1992-8#1)(1993-12#2)(1994-12#1)(1994-5#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#2)(1996-1#1)(1996-12#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-6#1)(2005-4#2)(2006-1#2)(2007-11#1)(2007-6#2)(2007-8#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
with Alzheimer's##66##2##(1990-10#2)(1990-7#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-3#1)(1991-7#2)(1991-9#1)(1992-12#2)(1992-8#2)(1993-12#3)(1993-4#1)(1994-12#1)(1994-5#2)(1995-10#1)(1995-11#3)(1995-12#1)(1995-3#1)(1995-5#2)(1996-1#2)(1996-12#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-6#1)(2005-4#2)(2006-1#2)(2007-11#1)(2007-6#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
with Amberlite XAD-2 coated with 1-(2-pyridylazo)-2-naphthol##2##6##(2008-10#2)
with Amberlite XAD-2##3##3##(2008-10#3)
with Amberlite XAD-4 resin##2##4##(2008-10#2)
with Amberlite XAD-4##5##3##(2008-10#5)
with Amberlite##12##2##(2008-10#11)(2011-1#1)
with Amberlyst 36##2##3##(2008-10#2)
with Amberlyst##3##2##(2007-11#1)(2008-10#2)
with American##3##2##(2007-3#1)(2012-2#1)(2013-1#1)
with Ampicillin##2##2##(2008-8#1)(2009-12#1)
with An##3##2##(2004-11#2)(2007-12#1)
with Angelman syndrome##2##3##(1996-12#1)(2008-4#1)
with Anorexia##2##2##(2008-11#2)
with Antega stem##2##3##(2013-1#2)
with Antega##3##2##(2013-1#3)
with Apert##2##2##(2007-12#1)(2009-8#1)
with Applications to##2##3##(2011-1#1)(2012-3#1)
with Applications##3##2##(2009-12#1)(2011-1#1)(2012-3#1)
with Ar = 2##2##4##(2010-5#2)
with Ar =##4##3##(2010-5#4)
with Ar as the sputter gas##2##6##(2008-2#2)
with Ar##6##2##(2008-2#2)(2010-5#4)
with ArF excimer laser##3##4##(2007-12#1)(2008-2#2)
with ArF excimer##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
with ArF laser pulses##2##4##(2007-12#1)(2008-2#1)
with ArF##6##2##(2007-12#2)(2008-2#3)(2008-3#1)
with Arabidopsis##3##2##(2008-7#1)(2009-8#1)(2013-7#1)
with Arg did not affect##2##5##(1997-2#2)
with Arsenazo III##4##3##(2008-10#4)
with AsA and##2##3##(1992-3#1)(2008-11#1)
with AsA##3##2##(1992-3#1)(2008-11#2)
with Asian##3##2##(2008-5#1)(2009-10#1)(2010-7#1)
with Asp at##2##3##(1995-1#1)(1997-4#1)
with Asp##8##2##(1990-8#1)(1991-7#1)(1993-11#1)(1995-1#1)(1995-3#2)(1997-4#1)(1997-6#1)
with Asperger's disorder##2##3##(2012-2#2)
with Aspergillus flavus and##2##4##(2008-10#2)
with Aspergillus fumigatus##2##3##(2006-10#1)(2007-12#1)
with Aspergillus##7##2##(2006-10#1)(2007-12#1)(2008-10#3)(2008-7#1)(2009-3#1)
with Asthma##5##2##(2009-4#1)(2012-1#1)(2013-1#3)
with Attention Deficit Hyperactivity Disorder (ADHD)##2##6##(2005-10#1)(2012-1#1)
with Attention##3##2##(2005-10#2)(2012-1#1)
with Au##5##2##(2007-8#1)(2008-10#3)(2008-2#1)
with Australian##2##2##(2007-11#1)(2008-10#1)
with Autism Spectrum Disorders##2##4##(2010-2#1)(2012-11#1)
with Autism##3##2##(2009-10#1)(2010-2#1)(2012-11#1)
with Avahan##4##2##(2012-3#4)
with B cells##2##3##(1995-9#1)(2008-4#1)
with B##42##2##(1991-11#1)(1992-12#1)(1995-6#1)(1995-9#1)(1996-12#2)(2005-10#3)(2006-5#1)(2007-12#2)(2008-10#15)(2008-3#2)(2008-4#2)(2008-9#2)(2009-2#1)(2010-6#3)(2011-1#2)(2012-3#1)(2013-1#2)
with B18C6##2##2##(2008-10#2)
with BA##3##2##(2008-10#1)(2008-7#1)(2010-5#1)
with BABA##4##2##(2008-10#4)
with BAC##2##2##(2008-8#1)(2012-2#1)
with BAL##2##2##(1990-3#1)(2011-2#1)
with BB##3##2##(2008-8#1)(2010-12#2)
with BBP##3##2##(1993-3#3)
with BC##2##2##(2004-2#1)(2013-1#1)
with BCG##4##2##(2008-8#1)(2010-12#3)
with BCGC cocultures##2##3##(2008-11#2)
with BCNU or adriamycin##2##4##(1995-5#2)
with BCNU##4##2##(1994-11#1)(1995-5#3)
with BD##12##2##(2007-10#2)(2007-11#3)(2007-12#1)(2008-11#1)(2011-2#1)(2013-8#4)
with BDM##2##2##(1996-9#2)
with BDNF##3##2##(1995-12#1)(1996-3#1)(2008-7#1)
with BED##2##2##(1992-10#1)(2008-6#1)
with BF##2##2##(2008-10#2)
with BFA##4##2##(1994-6#3)(1994-9#1)
with BI##2##2##(2007-10#1)(2012-3#1)
with BII phobia##2##3##(2012-2#2)
with BLNC##2##2##(2008-4#2)
with BMI &gt##2##3##(2008-6#1)(2008-9#1)
with BMI of##2##3##(2008-3#2)
with BMI##18##2##(2006-1#1)(2006-9#1)(2007-12#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#1)(2013-1#2)
with BMP-2##2##2##(2012-12#1)(2012-3#1)
with BN##4##2##(1990-2#2)(2007-12#2)
with BNR 48 h prior to their challenge##2##8##(2008-10#2)
with BNR##5##2##(2008-10#5)
with BOS##2##2##(2012-2#2)
with BP##2##2##(1995-3#1)(2010-4#1)
with BPD##9##2##(1997-5#5)(2009-8#2)(2009-9#1)(2010-5#1)
with BPI##2##2##(1997-5#1)(2008-5#1)
with BQ123##3##2##(1993-11#3)
with BRAF mutation##2##3##(2008-5#1)(2009-4#1)
with BRAF##5##2##(2008-5#1)(2009-4#3)(2013-8#1)
with BSA##6##2##(2004-9#1)(2008-10#2)(2008-11#1)(2009-9#1)(2013-8#1)
with BSO##2##2##(1991-7#1)(1995-1#1)
with BT##3##2##(2004-10#3)
with BYDV##4##2##(2008-10#3)(2008-8#1)
with Ba2+##2##2##(1995-2#2)
with Bacillus thuringiensis##2##3##(2008-10#2)
with Bacillus##4##2##(2008-10#2)(2008-3#1)(2013-1#1)
with BamHI##2##2##(1990-5#1)(2008-2#1)
with Barrett's esophagus##5##3##(1991-5#1)(2006-2#1)(2013-1#3)
with Barrett's##7##2##(1991-5#1)(2006-2#1)(2008-6#1)(2011-12#1)(2013-1#3)
with Baxter##2##2##(1993-6#1)(1994-2#1)
with Bay 11-7082##2##3##(2010-12#2)
with Bay##4##2##(1996-2#1)(1996-9#1)(2010-12#2)
with Bayer##2##2##(2008-10#1)(2008-5#1)
with Bayesian##6##2##(2008-10#2)(2008-7#1)(2008-8#1)(2013-1#2)
with Beet##2##2##(2008-10#2)
with Behçet disease##2##3##(2006-10#2)
with Behçet's disease##3##3##(1997-8#3)
with Behçet's##4##2##(1997-8#3)(2013-7#1)
with BiP##3##2##(1995-2#1)(1997-6#2)
with Bioglass##3##2##(2008-5#3)
with Biological Control##2##3##(2008-10#2)
with Bipolar Disorder##2##3##(2009-9#1)(2012-12#1)
with Bmax##2##2##(1991-5#1)(1995-8#1)
with Bone##2##2##(2006-4#1)(2007-7#1)
with Bortezomib##3##2##(2010-8#1)(2012-12#2)
with Botryosphaeria dothidea##2##3##(2008-10#2)
with Botryosphaeria##3##2##(2008-10#2)(2011-10#1)
with Botrytis cinerea##2##3##(2008-10#2)
with Brachyspira##2##2##(2006-8#2)
with Bragg gratings##2##3##(2007-12#1)(2008-3#1)
with Bragg##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
with Breast Cancer##2##3##(1994-12#1)(2013-1#1)
with Brewster##2##2##(2005-11#1)(2007-12#1)
with Brownian##2##2##(2008-8#1)(2009-4#1)
with Brucella##3##2##(2007-8#1)(2010-4#2)
with Brugada syndrome##2##3##(2009-10#1)(2012-12#1)
with BuLi##2##2##(1996-5#1)(2009-8#1)
with Buerger's disease##3##3##(1997-8#3)
with Burkitt's lymphoma##3##3##(2005-10#1)(2008-1#1)(2009-2#1)
with C##56##2##(1991-2#1)(1991-4#1)(1991-8#1)(1992-3#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-3#2)(2006-10#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#20)(2008-12#2)(2008-3#1)(2008-5#3)(2008-8#2)(2008-9#2)(2010-10#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#3)
with C(18)##3##2##(2008-10#3)
with C(60)##2##2##(2008-10#1)(2008-2#1)
with C(60)-SIMS##2##2##(2012-12#2)
with C-terminal##4##2##(1994-11#2)(1994-9#1)(1997-5#1)
with C-type##2##2##(1992-6#1)(2012-3#1)
with C1##2##2##(1997-5#1)(2012-3#1)
with C3##3##2##(1991-2#1)(1993-6#1)(2008-10#1)
with C5a##2##2##(1990-7#1)(1991-9#1)
with C60##3##2##(1992-8#1)(2008-3#1)(2009-2#1)
with CA##10##2##(1991-2#1)(1992-12#1)(1994-5#1)(2008-10#1)(2011-1#3)(2011-2#2)(2013-1#1)
with CA15##3##2##(1990-8#3)
with CAA##3##2##(1991-10#1)(2007-8#2)
with CAC##3##2##(1995-12#2)(2006-6#1)
with CACO estimates##2##3##(2012-1#2)
with CAD (A##2##3##(2008-4#2)
with CAD##23##2##(1991-10#2)(1991-7#1)(1996-1#1)(1997-8#1)(2005-12#1)(2006-6#2)(2006-9#1)(2007-5#1)(2008-3#3)(2008-4#5)(2010-3#1)(2010-4#2)(2011-1#1)(2012-2#1)
with CAI##4##2##(1995-2#2)(2013-1#2)
with CAM##2##2##(2013-1#2)
with CAPD##3##2##(1992-5#1)(1995-3#1)(2008-1#1)
with CAS##5##2##(2009-10#2)(2011-1#2)(2012-12#1)
with CAT##2##2##(1993-9#1)(2007-8#1)
with CAV and IBDV at day 21##3##7##(2005-9#3)
with CAV and IBDV##4##4##(2005-9#4)
with CAV and##5##3##(2005-9#5)
with CBE or##2##3##(1991-5#2)
with CBE##4##2##(1991-5#4)
with CBF-A and CBF-B##2##4##(1995-2#2)
with CBF-A##3##2##(1995-2#3)
with CBP##2##2##(1995-3#1)(2008-4#1)
with CBT##3##2##(2007-6#2)(2008-6#1)
with CC##4##2##(1991-8#2)(2008-10#1)(2013-8#1)
with CCA##6##2##(2008-4#5)(2010-1#1)
with CCD##2##2##(2008-5#1)(2008-9#1)
with CCEs##2##2##(2008-10#2)
with CCK##2##2##(1992-4#1)(1995-11#1)
with CCl4##2##2##(1990-9#1)(1991-5#1)
with CD##11##2##(1994-3#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-4#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
with CD22##2##2##(1995-3#1)(2005-10#1)
with CD4 counts##4##3##(1994-11#1)(2007-7#1)(2011-1#1)(2012-12#1)
with CD4##8##2##(1992-4#2)(1994-11#1)(2007-7#2)(2009-8#1)(2011-1#1)(2012-12#1)
with CD4(+)##2##2##(2008-10#1)(2008-4#1)
with CD4+ counts of##3##4##(1992-8#1)(1993-8#1)(2010-8#1)
with CD4+ counts##4##3##(1992-8#1)(1993-8#1)(2007-11#1)(2010-8#1)
with CD73##2##2##(2008-4#2)
with CD8(+) T cell exhaustion##2##5##(2010-5#2)
with CDC##3##2##(1997-2#1)(2012-12#1)(2012-2#1)
with CDDP##2##2##(2008-4#1)(2013-1#1)
with CDGP and##2##3##(2011-2#2)
with CDGP##8##2##(2011-1#4)(2011-2#4)
with CDH and##2##3##(2004-12#2)
with CDH##6##2##(2004-12#4)(2007-2#1)(2012-2#1)
with CE##4##2##(1993-9#2)(2008-10#1)(2008-5#1)
with CEA##2##2##(1996-11#1)(2005-12#1)
with CECT##2##2##(2012-12#2)
with CEUS##2##2##(2010-12#2)
with CF in##2##3##(2008-5#1)(2013-1#1)
with CF##6##2##(1992-10#1)(1997-1#1)(2008-5#1)(2012-12#1)(2013-1#2)
with CFC##2##2##(1996-1#1)(1996-2#1)
with CGD##2##2##(1994-3#1)(2007-2#1)
with CGRP##6##2##(1991-2#1)(1991-9#2)(1992-6#3)
with CGRP-like immunoreactivity##2##3##(1992-6#1)(1997-3#1)
with CH(2)Cl(2)##2##2##(2008-10#2)
with CHARGE##2##2##(2008-9#2)
with CHB infection##2##3##(2009-11#1)(2011-2#1)
with CHB##10##2##(2008-5#2)(2009-11#5)(2010-12#2)(2011-2#1)
with CHC and##2##3##(2008-8#1)(2011-1#1)
with CHCl(3) and##2##3##(2008-10#2)
with CHD##13##2##(1990-7#2)(1995-9#1)(2005-10#1)(2006-8#2)(2010-10#1)(2010-12#2)(2010-9#2)(2013-1#2)
with CHF##8##2##(2005-12#1)(2007-11#2)(2010-11#1)(2010-7#1)(2010-8#1)(2012-3#2)
with CHO cells##3##3##(1995-7#1)(2008-11#2)
with CHO##5##2##(1995-7#1)(2008-11#2)(2012-3#2)
with CHX and##3##3##(2006-5#2)(2013-1#1)
with CHX##4##2##(2006-5#2)(2013-1#2)
with CI##4##2##(1996-2#1)(2008-5#3)
with CIFN##2##2##(2007-11#2)
with CIMT##4##2##(2012-1#4)
with CIN##4##2##(1990-12#1)(1995-9#1)(2006-10#1)(2012-3#1)
with CJC##2##2##(2008-7#2)
with CKD and##2##3##(2010-4#1)(2013-8#1)
with CKD##10##2##(2007-8#2)(2008-5#1)(2009-1#1)(2010-4#2)(2011-2#3)(2013-8#1)
with CL reagent##2##3##(2008-10#2)
with CL##4##2##(2008-10#4)
with CLL##4##2##(1991-4#1)(2008-8#2)(2009-10#1)
with CM-glucan##2##2##(2008-5#2)
with CML##7##2##(2007-11#2)(2008-6#1)(2009-3#3)(2010-11#1)
with CMOS##2##2##(2008-7#1)(2013-7#1)
with CMT##4##2##(2009-10#1)(2013-7#3)
with CMT1A##2##2##(1997-3#1)(2013-1#1)
with CMV##6##2##(1996-12#1)(2008-10#4)(2009-2#1)
with CN##2##2##(1993-12#1)(2008-9#1)
with CNBr##4##2##(1990-5#1)(1992-12#1)(1993-8#1)(1995-8#1)
with CNS involvement##2##3##(2011-2#2)
with CNS##8##2##(1997-3#1)(2006-12#1)(2007-7#1)(2008-7#2)(2011-2#3)
with CO##6##2##(1991-2#1)(1992-12#1)(1994-11#1)(1994-9#1)(1996-12#1)(1996-2#1)
with CO(2)##10##2##(2007-10#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#1)(2012-2#2)(2012-3#1)
with CO2 laser laparoscopy##2##4##(1995-2#2)
with CO2 laser##6##3##(1991-6#1)(1995-2#2)(1996-1#1)(2006-10#1)(2008-4#1)
with CO2##8##2##(1991-6#1)(1995-2#2)(1996-1#1)(2006-10#1)(2007-12#1)(2008-4#1)(2008-6#1)
with COMT inhibitors##2##3##(1997-8#1)(2008-11#1)
with COMb##2##2##(2010-4#2)
with COPD##30##2##(1991-4#1)(1997-1#1)(1997-4#1)(1997-7#2)(2006-5#3)(2006-9#1)(2008-12#1)(2008-7#3)(2009-1#1)(2010-10#5)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-7#2)(2013-8#5)
with COX-2##3##2##(2005-11#1)(2006-10#1)(2007-7#1)
with CP is##2##3##(2011-2#2)
with CP##20##2##(1994-9#1)(2005-10#2)(2006-10#2)(2008-10#1)(2008-3#2)(2009-4#3)(2011-2#6)(2012-1#3)
with CPB##4##2##(2007-8#3)(2008-6#1)
with CPL##2##2##(2010-12#2)
with CPT-11##2##2##(2012-1#1)(2013-8#1)
with CQ##3##2##(2005-8#3)
with CQI##2##2##(1994-2#1)(1995-1#1)
with CR##6##2##(1991-6#1)(1995-10#1)(2006-6#1)(2008-10#2)(2009-5#1)
with CRC##3##2##(2009-12#1)(2012-3#2)
with CRF##12##2##(1995-3#2)(2007-11#2)(2007-7#2)(2008-1#2)(2009-2#1)(2009-3#1)(2011-2#2)
with CRPS##4##2##(2006-10#1)(2006-7#1)(2008-12#2)
with CRS and##2##3##(2010-12#2)
with CS and##3##3##(2008-11#2)(2013-1#1)
with CS##7##2##(2008-10#1)(2008-11#2)(2011-2#1)(2012-2#1)(2013-1#2)
with CS-20##2##2##(2008-10#2)
with CSCs##2##2##(2009-9#1)(2012-12#1)
with CT and MRI##3##4##(2008-1#1)(2008-2#1)(2012-2#1)
with CT and##4##3##(2008-1#1)(2008-2#1)(2011-2#1)(2012-2#1)
with CT as##2##3##(1996-10#1)(2006-4#1)
with CT scans##2##3##(2008-6#1)(2011-2#1)
with CT##22##2##(1991-8#1)(1996-10#1)(1997-8#1)(2005-8#1)(2006-4#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#6)(2012-11#1)(2012-2#1)(2013-7#1)
with CTA##2##2##(2008-7#1)(2011-2#1)
with CUA##2##2##(2007-8#2)
with CUS had##2##3##(2006-6#2)
with CUS##4##2##(2006-6#4)
with CVD##9##2##(1995-12#1)(2008-7#2)(2009-9#1)(2010-12#1)(2011-1#2)(2012-2#1)(2012-3#1)
with CVRM##3##2##(2013-8#3)
with CWM treatments##2##3##(2008-10#2)
with CWM##3##2##(2008-10#3)
with CYC##2##2##(2010-12#2)
with CYP2A6##2##2##(2008-8#2)
with CYP2E1##2##2##(1995-3#1)(1997-3#1)
with CYP3A4##2##2##(1994-12#1)(2012-3#1)
with Ca##2##2##(1993-10#1)(2011-1#1)
with Ca2+##16##2##(1990-7#1)(1991-4#1)(1991-7#1)(1991-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-8#2)(1997-2#1)(2008-5#1)
with CaCl2##2##2##(1991-2#1)(1992-12#1)
with CaM##2##2##(1992-12#1)(1994-6#1)
with Caco-2##2##2##(2007-8#1)(2008-11#1)
with Calf##2##2##(2008-5#2)
with Campylobacter fetus##2##3##(1991-10#1)(2006-10#1)
with Campylobacter jejuni##2##3##(2005-9#1)(2006-10#1)
with Campylobacter##5##2##(1991-10#1)(2005-9#1)(2006-10#2)(2008-7#1)
with Cancer##3##2##(2009-7#1)(2010-7#1)(2012-2#1)
with Candida albicans##3##3##(2006-10#1)(2008-5#2)
with Candida parapsilosis##2##3##(2006-4#1)(2012-2#1)
with Candida##14##2##(2006-10#1)(2006-4#1)(2008-10#1)(2008-12#1)(2008-5#4)(2008-7#2)(2012-2#3)(2013-1#1)
with Castleman disease##2##3##(2011-2#2)
with Castleman's disease##2##3##(1991-3#1)(2005-12#1)
with Catholic##2##2##(1997-3#1)(2010-2#1)
with Caucasian##3##2##(2008-5#1)(2009-9#1)(2010-8#1)
with Cbfib1##2##2##(1992-5#2)
with Cd and##2##3##(2008-6#1)(2013-1#1)
with Cd##6##2##(1990-5#1)(2008-10#1)(2008-6#3)(2013-1#1)
with Cd(2+)##4##2##(2008-10#4)
with Cd(II)##2##2##(2008-10#2)
with CdCl2 or Cd-MT##2##4##(1995-3#2)
with CdCl2##5##2##(1995-3#4)(1997-2#1)
with Cdc24##2##2##(1997-4#2)
with Ce##3##2##(2008-10#2)(2008-3#1)
with Ce(4+)##2##2##(2008-6#2)
with Ceftazidime##2##2##(1991-3#1)(2008-8#1)
with Cerebral##3##2##(2006-10#2)(2012-2#1)
with Cervical##2##2##(2006-10#1)(2011-2#1)
with Chelex-100##3##2##(1990-8#1)(2008-10#2)
with Chiari I malformation##11##4##(2005-10#1)(2006-5#10)
with Chiari I##13##3##(2005-10#1)(2006-5#12)
with Chiari##16##2##(2005-10#1)(2006-5#12)(2006-9#2)(2010-12#1)
with Child-Pugh class##2##3##(2011-2#2)
with Chinese##5##2##(1994-3#1)(1995-7#1)(2007-12#1)(2008-9#1)(2013-1#1)
with Chlamydia trachomatis##7##3##(1990-6#1)(1995-6#1)(2006-10#3)(2007-8#1)(2010-8#1)
with Chronic Renal Failure##2##4##(2007-7#1)(2008-12#1)
with Chronic##5##2##(2007-2#2)(2007-7#1)(2008-12#1)(2012-1#1)
with Ciprofloxacin against##2##3##(2008-8#2)
with Citrus##2##2##(2008-10#2)
with Class##2##2##(2010-8#1)(2013-7#1)
with Claude##2##2##(1996-2#1)(2008-4#1)
with Clone30##2##2##(2008-5#2)
with Clostridium botulinum##2##3##(1992-3#1)(2008-5#1)
with Clostridium sp##2##3##(2013-7#2)
with Clostridium##8##2##(1992-3#1)(1995-4#1)(2007-7#1)(2008-5#1)(2008-6#1)(2013-1#1)(2013-7#2)
with Co##2##2##(2008-10#2)
with Co(II) and##3##3##(2008-10#2)(2008-5#1)
with Co(II) in the presence of##3##6##(1992-9#1)(2008-10#2)
with Co(II)##7##2##(1990-12#1)(1992-9#1)(2008-10#4)(2008-5#1)
with Co2+##2##2##(1993-4#2)
with Co60##8##2##(2007-10#8)
with CoQ10##5##2##(1991-5#3)(2013-1#2)
with Colletotrichum##2##2##(2008-10#2)
with Community-acquired##2##2##(2008-4#1)(2013-8#1)
with Complex##2##2##(2008-10#1)(2008-12#1)
with ConA and##2##3##(1995-12#2)
with ConA##4##2##(1993-12#1)(1995-12#3)
with Concanavalin A (ConA)##2##4##(1995-12#1)(2008-10#1)
with Concanavalin A##4##3##(1992-11#1)(1993-4#1)(1995-12#1)(2008-10#1)
with Concanavalin##5##2##(1992-11#1)(1993-4#1)(1995-12#1)(1996-9#1)(2008-10#1)
with Concurrent##2##2##(2008-10#1)(2010-8#1)
with Congenital##2##2##(2012-2#1)(2012-3#1)
with Congo##2##2##(1992-3#1)(2008-7#1)
with Conventional##2##2##(2007-12#1)(2013-1#1)
with Coomassie##4##2##(1993-8#1)(2008-4#2)(2009-6#1)
with Cor Pulmonale##2##3##(2012-12#2)
with Coronary Artery Disease##2##4##(2013-1#2)
with Cotrel-Dubousset instrumentation##2##3##(2007-7#2)
with Cotrel-Dubousset##3##2##(2007-7#3)
with Coulter##2##2##(1991-8#1)(2007-6#1)
with Coxsakievirus A16##2##3##(2008-8#2)
with Cr##3##2##(2006-5#1)(2007-11#1)(2010-5#1)
with Cr(4+)##4##2##(2008-2#1)(2008-3#3)
with Cr(III)##2##2##(2008-10#1)(2011-2#1)
with Cremophor-containing paclitaxel##2##3##(2008-3#2)
with Crohn disease##4##3##(2006-10#4)
with Crohn's disease (CD)##2##4##(2004-7#1)(2011-2#1)
with Crohn's disease and##5##4##(2010-12#2)(2011-1#1)(2013-8#2)
with Crohn's disease who was##2##5##(1997-5#1)(2010-12#1)
with Crohn's disease who##6##4##(1991-8#1)(1997-5#1)(2008-10#1)(2008-5#1)(2010-12#2)
with Crohn's disease##36##3##(1991-8#2)(1994-2#1)(1997-5#1)(2004-7#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-11#7)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-12#9)(2011-1#2)(2011-2#1)(2012-2#2)(2013-8#2)
with Crohn's##39##2##(1991-8#2)(1994-2#1)(1997-5#1)(2004-7#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-11#7)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-12#9)(2011-1#2)(2011-2#1)(2012-11#2)(2012-2#2)(2013-8#3)
with Cronbach's##2##2##(2010-10#1)(2012-3#1)
with Cryptosporidium##2##2##(1996-12#1)(2007-7#1)
with Cs##2##2##(1992-9#2)
with Cu##5##2##(2005-4#1)(2008-10#1)(2008-11#2)(2008-5#1)
with Cu(2+)##2##2##(2008-10#1)(2009-8#1)
with Cu(I)##5##2##(1992-9#1)(2008-10#2)(2008-3#1)(2010-5#1)
with Cu(II) and##4##3##(2008-10#3)(2008-3#1)
with Cu(II)##12##2##(1990-8#1)(1992-8#1)(1992-9#1)(1995-2#1)(2008-10#6)(2008-3#1)(2008-5#1)
with Cu2+ ions##2##3##(1994-3#1)(1997-2#1)
with Cucumber mosaic virus (CMV)##2##5##(2008-10#2)
with CupPrint##2##2##(2013-8#2)
with Cushing's disease##5##3##(1990-3#1)(1995-12#1)(2006-9#1)(2009-4#1)(2011-2#1)
with Cushing's##8##2##(1990-3#1)(1995-12#1)(2006-6#2)(2006-9#1)(2009-4#1)(2011-2#2)
with Cutaneous##2##2##(2007-2#1)(2010-12#1)
with Cyanex 923##3##3##(2008-10#3)
with Cyanex##4##2##(2008-10#4)
with Cys##9##2##(1993-11#1)(1993-3#6)(1994-9#1)(1997-2#1)
with D##14##2##(1991-8#1)(2006-8#1)(2008-10#6)(2008-12#2)(2008-3#1)(2008-5#1)(2013-7#2)
with D-##2##2##(1994-12#1)(2008-10#1)
with D-Asp did not increase##2##5##(1997-3#2)
with D-Pro##3##2##(1997-3#3)
with D-Squame##2##2##(2008-5#2)
with D2##3##2##(1993-12#1)(1996-5#1)(2008-3#1)
with DA##5##2##(1990-10#1)(1995-6#1)(1996-10#2)(2007-2#1)
with DAPI##3##2##(2007-12#1)(2009-12#1)(2009-5#1)
with DB18C6##2##2##(2008-10#2)
with DBA##3##2##(1990-2#1)(2008-6#2)
with DBMBSA##2##2##(2008-10#2)
with DC##3##2##(1995-2#1)(2005-11#1)(2008-11#1)
with DCA##3##2##(1995-3#2)(2008-10#1)
with DCD##3##2##(2006-10#2)(2008-11#1)
with DDD##2##2##(2011-2#1)(2012-2#1)
with DDT##2##2##(1994-3#1)(2006-4#1)
with DDTC##2##2##(2008-10#2)
with DEB##2##2##(2008-4#1)(2008-7#1)
with DENA (at 15 days of age)##2##7##(1990-4#2)
with DENA (at##3##3##(1990-4#3)
with DEPC##3##2##(1992-6#2)(2006-12#1)
with DF##2##2##(2009-10#1)(2010-7#1)
with DG extract##2##3##(2011-1#2)
with DI##3##2##(1997-8#1)(2008-10#1)(2012-12#1)
with DIC##3##2##(2010-3#2)(2012-3#1)
with DM##4##2##(2007-12#1)(2007-7#1)(2008-7#1)(2012-2#1)
with DM2##4##2##(2006-9#1)(2008-7#1)(2011-2#1)(2012-3#1)
with DMARDs##2##2##(2008-3#1)(2012-3#1)
with DMD##3##2##(2007-8#3)
with DMEM##2##2##(2008-11#1)(2012-3#1)
with DMF##2##2##(2006-10#1)(2007-8#1)
with DMI history##2##3##(2008-10#2)
with DMI##3##2##(2008-10#3)
with DMPC##3##2##(1991-5#1)(1994-11#1)(2010-7#1)
with DMPM##2##2##(2010-12#2)
with DMSO##8##2##(1991-9#1)(1995-2#1)(1996-9#2)(2004-9#1)(2008-10#3)
with DNA and##7##3##(1990-8#1)(1994-5#1)(1997-4#1)(2005-11#1)(2006-6#1)(2008-10#1)(2008-4#1)
with DNA as##2##3##(1997-5#1)(2005-11#1)
with DNA damage##3##3##(1994-8#1)(2008-4#1)(2012-12#1)
with DNA encoding##2##3##(2005-7#1)(2008-2#1)
with DNA fingerprint##2##3##(2008-10#2)
with DNA forms##2##3##(1994-9#1)(2008-10#1)
with DNA fragments##2##3##(1990-7#1)(1995-5#1)
with DNA from##9##3##(1990-4#1)(1993-6#1)(1995-8#1)(2008-10#5)(2013-8#1)
with DNA hybridization##2##3##(1993-3#1)(2008-10#1)
with DNA in##3##3##(1991-11#1)(1992-6#1)(2008-3#1)
with DNA is##4##3##(1992-3#1)(2008-10#2)(2008-9#1)
with DNA ligase III##2##4##(1997-4#2)
with DNA ligase##4##3##(1993-3#1)(1997-4#2)(1997-7#1)
with DNA methylation##3##3##(2008-7#1)(2012-12#2)
with DNA microarray##2##3##(2008-7#1)(2011-2#1)
with DNA microarrays##2##3##(2007-12#1)(2008-7#1)
with DNA polymerase##5##3##(1993-3#1)(1994-2#1)(1994-7#1)(2006-10#1)(2006-12#1)
with DNA recombination##2##3##(2008-9#2)
with DNA repair enzymes##2##4##(1995-5#1)(2006-12#1)
with DNA sequences in##2##4##(1992-2#1)(1995-2#1)
with DNA through##2##3##(1995-11#1)(2006-10#1)
with DNA was##3##3##(1991-5#1)(1994-6#1)(1995-5#1)
with DNA##146##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-11#2)(1992-2#2)(1992-3#3)(1992-6#4)(1993-3#3)(1993-6#2)(1993-7#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#3)(1995-10#2)(1995-11#2)(1995-2#3)(1995-5#3)(1995-6#1)(1995-8#1)(1997-3#2)(1997-4#5)(1997-5#2)(1997-7#1)(2005-10#1)(2005-11#4)(2005-7#1)(2006-10#3)(2006-12#3)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#23)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#6)(2008-8#2)(2008-9#4)(2009-12#2)(2009-2#1)(2009-3#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
with DNA-binding properties##2##3##(1994-3#1)(1995-7#1)
with DNAbeta##6##2##(2008-10#6)
with DNase##2##2##(1992-12#1)(1996-11#1)
with DO##3##2##(1997-1#1)(2008-10#2)
with DOC##2##2##(1992-9#2)
with DON##4##2##(2008-10#2)(2012-3#2)
with DP##3##2##(1990-12#1)(2013-1#2)
with DPPC and##2##3##(1990-2#1)(1993-9#1)
with DPPC##4##2##(1990-2#1)(1993-9#1)(2005-11#1)(2011-2#1)
with DRB1##2##2##(1997-8#1)(2007-5#1)
with DRGs##3##2##(1991-12#1)(1992-10#1)(2008-5#1)
with DS and##2##3##(1991-1#1)(2011-1#1)
with DS##6##2##(1991-1#2)(2010-12#1)(2011-1#3)
with DSM-IV schizophrenia##2##3##(2004-3#2)
with DSM-IV##4##2##(2004-3#3)(2013-8#1)
with DSP##3##2##(2006-12#2)(2008-3#1)
with DTI##2##2##(2011-1#1)(2013-7#1)
with DWM##3##2##(2010-11#3)
with DZP##2##2##(1993-12#2)
with DeBakey##2##2##(2007-8#1)(2008-12#1)
with Deflux##3##2##(2008-10#2)(2008-6#1)
with Delta##2##2##(2008-10#1)(2013-8#1)
with DeltaFerrin(TM)##2##2##(2008-11#2)
with DeltaHcal of##3##3##(1997-7#3)
with Dementia##3##2##(2008-11#1)(2011-2#2)
with Dependent##5##2##(1992-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(2010-8#1)
with Depression##3##2##(2009-12#1)(2012-2#2)
with Dex##2##2##(1990-12#1)(1992-4#1)
with Diabetes Mellitus##2##3##(2010-9#1)(2011-2#1)
with Diabetes##6##2##(2010-9#1)(2011-2#1)(2012-3#2)(2013-1#2)
with Different##5##2##(2008-10#2)(2008-11#1)(2009-9#1)(2011-2#1)
with Differential##3##2##(2009-10#1)(2011-1#1)(2012-12#1)
with Disabilities##35##2##(1991-12#1)(1992-12#1)(1993-1#3)(1993-12#1)(1993-3#2)(1994-1#3)(1994-2#1)(1995-1#1)(1995-12#5)(1995-6#2)(1996-1#2)(1996-11#2)(1996-12#1)(1996-5#1)(1996-6#1)(1997-5#3)(2005-10#1)(2008-12#1)(2008-9#1)(2012-2#1)(2013-8#1)
with Doppler##4##2##(2006-10#1)(2008-10#1)(2009-5#1)(2013-8#1)
with Dorr##2##2##(2009-3#2)
with Down Syndrome##3##3##(2009-3#1)(2010-4#1)(2013-1#1)
with Down syndrome##23##3##(1990-3#1)(1992-5#1)(1993-2#1)(1993-9#1)(2008-11#1)(2008-12#2)(2008-4#1)(2009-3#1)(2010-4#3)(2012-12#6)(2013-1#5)
with Down##26##2##(1990-3#1)(1992-5#1)(1993-2#1)(1993-9#1)(2008-11#1)(2008-12#2)(2008-4#1)(2009-3#2)(2010-4#4)(2012-12#6)(2013-1#6)
with Down's syndrome and##4##4##(1990-7#1)(1996-5#1)(2006-9#1)(2007-8#1)
with Down's syndrome in the##2##5##(1990-2#2)
with Down's syndrome##10##3##(1990-2#2)(1990-7#1)(1991-1#1)(1996-5#1)(2006-9#3)(2007-8#1)(2008-7#1)
with Down's syndrome]##2##3##(1991-8#1)(1995-9#1)
with Down's##12##2##(1990-2#2)(1990-7#1)(1991-1#1)(1991-8#1)(1995-9#1)(1996-5#1)(2006-9#3)(2007-8#1)(2008-7#1)
with Dr Weed##2##3##(2010-8#2)
with Dr##9##2##(2004-3#1)(2005-8#1)(2006-8#1)(2007-6#1)(2008-6#1)(2010-8#2)(2012-3#1)(2013-1#1)
with Drosophila melanogaster##2##3##(1993-2#1)(2008-7#1)
with Drosophila##3##2##(1993-2#1)(2008-10#1)(2008-7#1)
with Duchenne muscular dystrophy##4##4##(1993-10#1)(1995-12#1)(2008-7#1)(2011-2#1)
with Duchenne##6##2##(1993-10#1)(1995-12#1)(2007-8#1)(2008-4#1)(2008-7#1)(2011-2#1)
with Dutch##2##2##(2008-6#1)(2010-9#1)
with E##33##2##(1990-10#1)(1990-12#1)(1993-11#1)(1996-4#1)(1996-7#2)(1996-9#1)(1997-2#1)(1997-4#1)(2004-11#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2011-2#1)(2012-12#1)(2013-1#3)
with E-cadherin##3##2##(1991-11#1)(1991-12#1)(1991-5#1)
with E2##4##2##(1990-11#2)(2010-5#1)(2012-11#1)
with E2F##3##2##(1992-8#1)(2012-2#2)
with EA##3##2##(2008-5#1)(2013-7#2)
with EAE##3##2##(2008-11#3)
with EBV##8##2##(1993-8#1)(1993-9#1)(1995-2#1)(1996-10#1)(1997-7#2)(2008-9#1)(2011-12#1)
with EC law##2##3##(2008-7#2)
with EC##4##2##(2008-7#2)(2009-6#1)(2011-2#1)
with EC50 of##2##3##(1994-11#1)(2011-3#1)
with EC50 values##3##3##(1992-7#1)(2008-11#2)
with EC50##6##2##(1992-7#1)(1994-11#1)(2008-11#2)(2011-3#2)
with EC50s of##2##3##(1994-11#1)(1994-5#1)
with ECB##2##2##(2008-10#2)
with ECG##4##2##(1996-3#1)(2006-4#1)(2007-8#1)(2008-3#1)
with ECMO support##2##3##(2007-8#2)
with ECMO##6##2##(2006-4#1)(2007-8#3)(2011-3#1)(2012-1#1)
with ECT##3##2##(2008-12#2)(2011-2#1)
with ED##4##2##(2005-7#1)(2009-5#1)(2013-1#2)
with ED50 values##2##3##(1991-8#1)(1993-4#1)
with ED50##3##2##(1991-8#1)(1993-4#1)(1994-8#1)
with EDS##4##2##(1990-2#1)(2006-10#2)(2008-5#1)
with EDTA and##2##3##(1996-1#1)(2008-10#1)
with EDTA##32##2##(1991-1#1)(1991-9#2)(1992-12#2)(1993-6#1)(1994-3#1)(1995-12#1)(1996-1#1)(2005-4#1)(2008-10#19)(2008-5#1)(2010-3#1)(2010-4#1)
with EE##2##2##(2009-11#1)(2013-8#1)
with EF##3##2##(2008-4#3)
with EFNs##3##2##(2011-12#3)
with EGF or##2##3##(1990-7#1)(1990-8#1)
with EGF##15##2##(1990-7#1)(1990-8#1)(1991-12#1)(1992-3#1)(1992-7#1)(1993-3#2)(1994-6#1)(1994-8#1)(1996-11#1)(1996-5#1)(1996-8#1)(2006-5#1)(2008-11#1)(2008-4#1)
with EGFR##6##2##(2006-10#1)(2010-12#1)(2010-5#2)(2010-8#1)(2013-1#1)
with EGT##2##2##(2009-6#2)
with EGTA##7##2##(1990-3#1)(1990-8#1)(1992-11#1)(1992-6#1)(1994-6#2)(1997-2#1)
with EGVGE being consumed early in the copolymerization##2##8##(2012-12#2)
with ELISA##3##2##(1992-7#1)(2007-2#1)(2008-3#1)
with EN##3##2##(2007-8#1)(2013-1#2)
with EPI##2##2##(2008-9#2)
with EPP##2##2##(1990-1#1)(1993-12#1)
with EPSP##2##2##(1994-11#2)
with ER and##2##3##(1990-7#1)(1996-5#1)
with ER content##2##3##(1996-3#2)
with ER##12##2##(1990-7#1)(1991-12#1)(1993-9#1)(1996-11#1)(1996-3#2)(1996-5#1)(1997-7#1)(2004-2#1)(2007-10#1)(2008-8#1)(2009-4#1)
with ER-positive##2##2##(1995-1#1)(2007-11#1)
with ERCP##2##2##(2008-2#1)(2013-1#1)
with ERK##2##2##(2009-2#1)(2013-8#1)
with ERs##3##2##(2008-10#1)(2008-8#2)
with ES##2##2##(2010-5#2)
with ESRD##17##2##(2007-7#4)(2007-8#8)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-1#1)
with ESWL##3##2##(1990-12#2)(2007-7#1)
with ET and##2##3##(2011-2#1)(2012-3#1)
with ET##4##2##(1995-11#1)(2008-10#1)(2011-2#1)(2012-3#1)
with ET-1##2##2##(1993-3#1)(1994-12#1)
with ETAAS##3##2##(2007-8#1)(2008-10#2)
with Eb cotreatment##2##3##(2008-4#2)
with EcoRI##3##2##(1993-2#1)(1996-9#1)(2008-10#1)
with Ehlers-Danlos syndrome##3##3##(2006-10#1)(2007-2#1)(2013-8#1)
with Ellman's reagent##2##3##(1992-1#1)(1994-11#1)
with Enalapril##2##2##(2008-4#2)
with Ender##3##2##(2007-11#1)(2007-8#2)
with English as an additional language##3##6##(2008-2#3)
with English##5##2##(2008-2#3)(2008-8#1)(2013-1#1)
with Enigma##2##2##(1996-5#2)
with Entecavir 0##2##3##(2013-1#2)
with Epstein-Barr virus (EBV)##2##4##(1992-2#1)(2008-2#1)
with Epstein-Barr virus##3##3##(1991-12#1)(1992-2#1)(2008-2#1)
with Epstein-Barr##4##2##(1991-12#1)(1992-2#1)(2008-2#1)(2009-6#1)
with Er##2##2##(2011-1#1)(2013-1#1)
with Er(3+)##2##2##(2007-12#2)
with Eriochrome##2##2##(2008-10#2)
with Erwinia amylovora##2##3##(2008-10#2)
with Escherichia coli##13##3##(1992-12#1)(1993-9#1)(1994-8#1)(1995-12#1)(1996-10#1)(1997-3#1)(2006-8#1)(2008-11#1)(2008-5#1)(2012-2#1)(2013-1#2)(2013-7#1)
with Essential##2##2##(2011-2#1)(2013-1#1)
with Eu3+##2##2##(1995-2#1)(2008-4#1)
with Euclidean##2##2##(2008-6#1)(2013-8#1)
with European corn borer##3##4##(2008-10#1)(2011-2#2)
with European##9##2##(2008-10#1)(2008-7#1)(2010-5#1)(2011-2#4)(2012-2#1)(2013-8#1)
with Evans blue##5##3##(1994-2#1)(2008-5#1)(2012-2#3)
with Evans##6##2##(1994-2#1)(2008-5#1)(2010-5#1)(2012-2#3)
with Ewing's##3##2##(2008-6#3)
with Exosurf##2##2##(1997-1#2)
with F##13##2##(1995-8#1)(1997-2#1)(2008-10#8)(2008-12#1)(2011-10#1)(2012-2#1)
with F(-)##2##2##(2008-10#1)(2010-5#1)
with F(2)##2##2##(2007-12#1)(2008-10#1)
with F(ab')2##2##2##(1990-12#1)(1994-3#1)
with F-actin##5##2##(1990-9#1)(1993-8#1)(1993-9#3)
with F-scores ranging from 0##2##5##(2013-1#2)
with F0##2##2##(1997-4#2)
with F1##2##2##(1991-10#1)(2010-8#1)
with FA##10##2##(1992-7#2)(1992-8#1)(1994-9#1)(1997-2#1)(2007-3#1)(2008-10#1)(2008-8#1)(2012-12#2)
with FAP##2##2##(2008-4#1)(2009-12#1)
with FAs##2##2##(2008-10#2)
with FCA##2##2##(1995-7#2)
with FCM clustered##3##3##(2010-8#3)
with FFA##2##2##(1996-5#1)(2010-12#1)
with FGF-2##3##2##(2008-11#3)
with FGFs##2##2##(2008-7#2)
with FGS had##2##3##(1996-12#2)
with FGS##5##2##(1996-12#5)
with FH##3##2##(1993-9#2)(1997-2#1)
with FHP##2##2##(2010-9#2)
with FI-FAAS##2##2##(2008-10#2)
with FID detection##2##3##(2008-10#1)(2008-6#1)
with FID##3##2##(2005-12#1)(2008-10#1)(2008-6#1)
with FIGO##3##2##(1994-4#2)(2007-4#1)
with FISH##2##2##(1997-3#1)(2008-9#1)
with FITC##3##2##(2008-4#2)(2012-3#1)
with FITC-ConA##3##2##(2006-5#3)
with FITC-NTXamine##2##2##(1997-2#2)
with FITC-conjugated##3##2##(2006-6#1)(2008-5#1)(2008-8#1)
with FITC-labeled##2##2##(1992-12#1)(2012-1#1)
with FLEC##2##2##(2006-6#2)
with FM##5##2##(2006-10#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-12#1)
with FMLP##2##2##(1993-6#1)(1997-8#1)
with FMO3##2##2##(1997-8#2)
with FMS with##2##3##(2006-10#2)
with FMS##6##2##(2006-10#5)(2009-7#1)
with FN##6##2##(1994-9#1)(2008-7#2)(2012-12#2)(2012-2#1)
with FOP##2##2##(2007-7#2)
with FPG##3##2##(1994-12#3)
with FSBA##2##2##(1994-11#2)
with FSH##2##2##(2006-5#1)(2012-12#1)
with FSWs##2##2##(2010-8#1)(2012-3#1)
with FSWs' husband or cohabiting partner##2##6##(2012-3#2)
with FSWs'##5##2##(2012-3#5)
with FTD##3##2##(2008-4#1)(2008-9#1)(2012-2#1)
with FXS##7##2##(2009-10#4)(2010-4#3)
with Fabry-Perot arms##2##3##(2008-3#2)
with Fabry-Perot##4##2##(2008-2#2)(2008-3#2)
with Fanconi##2##2##(1997-3#1)(2007-8#1)
with Fasciola hepatica##2##3##(2011-2#2)
with Fe at 56 and 112 mug/ml compared with##2##9##(2008-10#2)
with Fe##3##2##(2008-10#3)
with Fe(II)##4##2##(2008-10#3)(2008-5#1)
with Fe(III) in the##2##4##(2008-10#2)
with Fe(III)##7##2##(2006-8#1)(2008-10#6)
with Fe2+##3##2##(1990-2#1)(1990-3#1)(1991-7#1)
with Fe3+##2##2##(1990-3#1)(1991-5#1)
with Federal##2##2##(1997-3#1)(2008-9#1)
with Fever of##2##3##(2006-10#1)(2007-12#1)
with Fever##3##2##(2006-10#1)(2007-12#1)(2012-12#1)
with Fisher##2##2##(2006-11#1)(2008-2#1)
with Fisher's##2##2##(2012-3#2)
with Fluorescent##4##2##(2007-2#1)(2008-10#1)(2008-6#1)(2009-7#1)
with Foc-5##3##2##(2008-10#3)
with Fontan##4##2##(2008-10#1)(2010-5#1)(2013-7#2)
with Forestier's##3##2##(2007-8#2)(2008-12#1)
with Fourier transform infrared##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
with Fourier##13##2##(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#2)(2010-4#1)(2011-1#1)
with Fourier-transform##2##2##(2007-12#1)(2008-3#1)
with Frejka pillow##3##3##(2007-8#3)
with Freund's adjuvant##2##3##(1992-8#1)(1997-2#1)
with Freund's##3##2##(1992-8#1)(1997-2#1)(2008-5#1)
with Fru(2##2##2##(1991-2#2)
with Full Text##2##3##(2013-1#2)
with Fura-2##2##2##(1990-12#1)(1995-8#1)
with Fusarium graminearum##4##3##(2008-10#4)
with Fusarium oxysporum f##3##4##(2008-10#3)
with Fusarium##12##2##(2005-11#1)(2008-10#11)
with G and C##2##4##(1993-3#1)(1994-2#1)
with G betagamma and##2##4##(2007-12#2)
with G protein##3##3##(1991-1#1)(1995-6#1)(1996-5#1)
with G##17##2##(1991-1#1)(1993-3#1)(1994-2#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-2#1)(2006-3#1)(2007-12#2)(2007-2#1)(2008-10#4)(2008-4#1)
with G-CSF##2##2##(2008-6#1)(2008-7#1)
with G-protein##2##2##(1992-6#1)(1993-7#1)
with G-proteins and##2##3##(1990-11#1)(2013-1#1)
with G-proteins##3##2##(1990-11#1)(1997-7#1)(2013-1#1)
with G1##2##2##(1995-8#1)(2010-6#1)
with GA##4##2##(2007-8#1)(2008-10#2)(2008-5#1)
with GABA##2##2##(1995-11#1)(2008-8#1)
with GAP##3##2##(1991-12#1)(1992-12#2)
with GB##2##2##(2013-8#2)
with GBS##8##2##(2006-7#1)(2007-11#5)(2012-3#2)
with GC by the HapticMaster##2##5##(2012-1#2)
with GC##5##2##(2008-4#1)(2012-1#2)(2013-1#2)
with GC/ECD##2##2##(2008-10#2)
with GCS##3##2##(2006-8#1)(2007-10#1)(2011-2#1)
with GD##2##2##(2007-2#2)
with GD3##2##2##(1991-5#2)
with GDM##6##2##(2008-1#2)(2009-3#2)(2011-2#2)
with GDNF##2##2##(1995-12#1)(1996-1#1)
with GDP##2##2##(1991-12#1)(2008-6#1)
with GDP/GTP exchange##2##3##(1995-3#1)(2006-10#1)
with GE7##2##2##(2008-8#2)
with GERD##6##2##(2006-10#1)(2008-5#1)(2010-10#3)(2011-2#1)
with GF##2##2##(1997-7#1)(2006-10#1)
with GFP at the##3##4##(2006-12#2)(2008-7#1)
with GFP##8##2##(2006-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-10#1)
with GGT &gt##2##3##(2007-2#2)
with GH deficiency##2##3##(1997-8#1)(2008-4#1)
with GH##4##2##(1997-8#1)(2006-1#1)(2008-4#1)(2013-7#1)
with GHD##2##2##(2012-3#2)
with GHR##2##2##(1995-3#2)
with GI##2##2##(2011-2#1)(2012-12#1)
with GL##2##2##(2008-6#1)(2012-1#1)
with GM-CSF##4##2##(1991-6#1)(1991-8#1)(1992-3#1)(2008-8#1)
with GM1 ganglioside##3##3##(1990-5#1)(1993-5#1)(1996-3#1)
with GM1##11##2##(1990-5#1)(1993-3#1)(1993-5#1)(1995-5#2)(1996-3#1)(2008-10#1)(2012-3#4)
with GPs##2##2##(2011-1#1)(2011-2#1)
with GR##4##2##(1994-3#2)(2011-2#2)
with GRP##2##2##(1991-4#1)(1992-6#1)
with GSH were##2##3##(1997-8#1)(2008-10#1)
with GSH##5##2##(1992-9#1)(1994-9#1)(1997-7#1)(1997-8#1)(2008-10#1)
with GSP##2##2##(2006-6#2)
with GST##3##2##(2005-11#1)(2008-1#1)(2011-10#1)
with GSTM1 null##2##3##(2008-10#1)(2008-12#1)
with GSTM3*A/*A##2##2##(2008-10#2)
with GTN##2##2##(2007-10#2)
with GTP or##4##3##(1990-8#1)(1997-7#1)(2008-6#1)(2011-1#1)
with GTP##8##2##(1990-3#1)(1990-7#1)(1990-8#1)(1997-7#1)(2006-12#2)(2008-6#1)(2011-1#1)
with Gaucher disease##3##3##(1993-9#1)(1994-11#1)(2008-10#1)
with Gaussian error##2##3##(1996-8#2)
with Gaussian##11##2##(1996-8#2)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#4)
with Gd-DTPA contrast enhanced allows##2##5##(2007-11#2)
with General##3##2##(2008-10#1)(2008-3#1)(2012-12#1)
with German##2##2##(2008-4#1)(2011-12#1)
with Gibbs sampling##2##3##(2011-12#1)(2012-1#1)
with Giemsa##2##2##(2008-5#1)(2011-1#1)
with Gilles de la Tourette syndrome##2##6##(2006-3#2)
with Ginkgo biloba##2##3##(1990-6#1)(2011-2#1)
with Glomerella##2##2##(2008-10#2)
with Glomus##2##2##(2011-1#2)
with Glu##8##2##(1991-7#1)(1992-3#1)(1992-9#1)(1994-2#1)(1994-6#1)(1995-1#1)(1996-5#2)
with Glucolevel##2##2##(2008-10#2)
with GnRH##2##2##(1995-10#1)(2008-5#1)
with Golgi##4##2##(1996-5#1)(1997-4#2)(2012-2#1)
with Grade##2##2##(2006-8#1)(2008-6#1)
with Gram positive##2##3##(1993-4#1)(1994-9#1)
with Gram-negative##2##2##(1991-2#1)(2005-11#1)
with Grave's disease##2##3##(2006-10#1)(2007-1#1)
with Graves' disease##12##3##(1990-7#1)(1990-8#3)(1991-12#1)(1991-7#1)(1991-8#2)(1991-9#1)(1994-11#1)(2007-7#1)(2008-5#1)
with Graves' eye disease##2##4##(2008-7#1)(2009-2#1)
with Graves'##18##2##(1990-7#1)(1990-8#3)(1991-12#1)(1991-7#1)(1991-8#2)(1991-9#1)(1994-11#1)(2007-2#1)(2007-7#1)(2008-5#1)(2008-7#1)(2009-2#3)(2011-2#1)
with Grb2##9##2##(1994-12#3)(1995-3#2)(1996-8#3)(2008-6#1)
with Grignard reagents##2##3##(2009-3#2)
with Group I##4##3##(2006-8#1)(2010-7#3)
with Group P##3##3##(2010-7#3)
with Group##8##2##(2006-8#1)(2007-1#1)(2010-7#6)
with Gs##2##2##(1994-6#1)(1996-8#1)
with Gt alpha##3##3##(1994-9#3)
with Gt##5##2##(1994-9#4)(1996-5#1)
with Guillain-Barre##2##2##(1994-10#1)(2009-10#1)
with H##22##2##(1991-12#1)(1995-5#1)(1997-7#1)(2006-10#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2011-1#1)(2011-12#2)
with H(+)##2##2##(2008-10#2)
with H(2)##5##2##(2006-10#1)(2007-12#2)(2008-7#1)(2011-2#1)
with H(2)O(2)##5##2##(2008-10#5)
with H(2)SO(4)##3##2##(2008-10#3)
with H(2)SiPh(2)##2##2##(1996-2#2)
with H+/K(+)-ATPase##3##2##(1994-2#2)(1997-1#1)
with H-kininogen##2##2##(1996-5#2)
with H-ras##2##2##(1990-7#2)
with H120##3##2##(1997-3#1)(2008-5#2)
with H1N1pdm2009##3##2##(2013-1#3)
with H2##3##2##(1992-10#1)(1992-11#1)(1993-4#1)
with H2O##2##2##(2005-11#1)(2006-12#1)
with H2O2 in##3##3##(1991-9#1)(1995-8#1)(1997-8#1)
with H2O2##18##2##(1990-12#1)(1990-2#1)(1991-9#1)(1992-11#1)(1992-9#2)(1994-10#1)(1994-2#1)(1994-9#1)(1995-10#1)(1995-8#3)(1997-3#1)(1997-6#1)(1997-8#2)(2013-1#1)
with HA and##3##3##(2008-10#2)(2013-8#1)
with HA##7##2##(2006-12#2)(2008-10#2)(2009-7#1)(2013-7#1)(2013-8#1)
with HAART##4##2##(2007-11#1)(2007-12#1)(2009-11#1)(2010-5#1)
with HBV and##2##3##(2012-1#1)(2013-1#1)
with HBV in##2##3##(1995-2#1)(2011-1#1)
with HBV infection##4##3##(2007-11#1)(2008-10#1)(2010-12#1)(2012-3#1)
with HBV##16##2##(1992-5#1)(1995-2#1)(2007-11#1)(2008-10#2)(2009-11#1)(2009-8#1)(2010-12#2)(2011-1#1)(2012-1#2)(2012-3#1)(2013-1#3)
with HBsAg-negative and anti-HCV-positive HCC##2##5##(2008-4#2)
with HC##6##2##(2008-11#1)(2008-5#1)(2012-3#4)
with HCB##2##2##(1993-2#1)(1994-6#1)
with HCC in##2##3##(1993-2#1)(2006-10#1)
with HCC##15##2##(1992-3#1)(1993-2#1)(1993-7#2)(2006-10#1)(2008-10#2)(2009-3#2)(2010-12#2)(2011-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
with HCMV##2##2##(1997-3#2)
with HCTZ##2##2##(1996-9#1)(2009-9#1)
with HCV and##2##3##(2008-8#2)
with HCV infection##2##3##(2006-2#2)
with HCV infections##2##3##(1994-8#1)(2006-2#1)
with HCV##25##2##(1994-8#1)(2006-10#3)(2006-2#4)(2008-1#1)(2008-8#4)(2009-7#1)(2009-8#2)(2009-9#1)(2011-1#1)(2011-12#1)(2012-12#4)(2013-1#2)
with HCl and HNO(3)##2##4##(2008-10#2)
with HCl and##4##3##(2008-10#4)
with HCl##9##2##(1994-9#1)(2007-11#1)(2008-10#7)
with HD##10##2##(1993-9#1)(1995-3#2)(1996-6#1)(1996-8#1)(2006-4#1)(2008-11#1)(2008-7#1)(2011-2#2)
with HDL##6##2##(1992-2#1)(1995-5#1)(2005-7#1)(2008-3#1)(2008-4#1)(2012-2#1)
with HEL##2##2##(1990-2#1)(1995-2#1)
with HELLP syndrome##3##3##(2008-4#2)(2009-1#1)
with HELLP##4##2##(2008-4#3)(2009-1#1)
with HER2##4##2##(1993-1#1)(1995-3#2)(2012-12#1)
with HF##5##2##(2005-7#1)(2007-1#1)(2008-10#1)(2010-6#1)(2013-1#1)
with HFA134a##3##2##(1996-1#2)(1996-2#1)
with HGF##4##2##(1991-10#1)(1991-11#1)(1994-12#1)(2007-11#1)
with HHBIM-NTf2 and HOBIM-NTf2##2##4##(2011-1#2)
with HIPAA rules##2##3##(2007-3#2)
with HIPAA##5##2##(2006-8#3)(2007-3#2)
with HIPAA's NPI##3##3##(2008-4#2)(2008-6#1)
with HIPAA's##4##2##(2006-8#1)(2008-4#2)(2008-6#1)
with HIT##4##2##(2007-11#3)(2010-3#1)
with HIV Infection##3##3##(2006-10#1)(2007-11#1)(2008-1#1)
with HIV and AIDS in##3##5##(1994-4#1)(2007-7#1)(2007-9#1)
with HIV and AIDS##6##4##(1994-4#1)(1995-12#1)(2007-7#2)(2007-9#1)(2010-8#1)
with HIV and TB##2##4##(1993-5#1)(2010-4#1)
with HIV and other##2##4##(1995-9#1)(2011-2#1)
with HIV and##21##3##(1993-3#1)(1993-5#1)(1994-4#1)(1995-12#1)(1995-9#1)(1996-1#1)(2006-10#1)(2007-11#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-4#1)(2009-10#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)
with HIV are##3##3##(2007-11#1)(2008-10#1)(2012-3#1)
with HIV can##2##3##(2009-7#1)(2011-1#1)
with HIV could##2##3##(1997-5#1)(2012-3#1)
with HIV disease##6##3##(1992-1#1)(1995-6#1)(2007-11#1)(2007-12#1)(2010-4#1)(2011-1#1)
with HIV encephalitis##2##3##(2007-11#2)
with HIV has##3##3##(1995-12#1)(2006-10#1)(2013-1#1)
with HIV in##6##3##(1991-6#2)(2007-7#1)(2008-4#1)(2009-10#1)(2011-1#1)
with HIV infection and##7##4##(1996-11#1)(2005-10#1)(2005-7#1)(2010-4#2)(2010-9#1)(2013-1#1)
with HIV infection in##2##4##(1996-8#1)(2011-1#1)
with HIV infection##39##3##(1990-6#2)(1992-9#1)(1993-1#1)(1993-3#1)(1994-4#1)(1996-11#2)(1996-3#1)(1996-6#1)(1996-8#1)(2005-10#1)(2005-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-7#3)(2007-8#2)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#2)(2010-4#2)(2010-9#1)(2011-1#2)(2012-12#1)(2013-1#2)(2013-8#1)
with HIV or AIDS##2##4##(1995-6#1)(2007-1#1)
with HIV or##5##3##(1991-6#1)(1993-1#1)(1995-6#1)(2005-7#1)(2007-1#1)
with HIV to##2##3##(2006-10#1)(2007-7#1)
with HIV##178##2##(1990-11#1)(1990-5#1)(1990-6#3)(1991-1#1)(1991-11#2)(1991-6#3)(1992-1#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-4#4)(1995-1#1)(1995-12#5)(1995-3#1)(1995-6#4)(1995-9#1)(1996-1#3)(1996-11#6)(1996-12#2)(1996-3#1)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#1)(2005-10#1)(2005-11#1)(2005-7#3)(2006-10#4)(2006-8#1)(2006-9#3)(2007-1#1)(2007-11#8)(2007-12#5)(2007-2#3)(2007-7#10)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#3)(2009-10#3)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#5)(2010-3#1)(2010-4#4)(2010-5#2)(2010-8#2)(2010-9#2)(2011-1#5)(2011-2#6)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#6)(2013-8#4)
with HIV-1 infection##11##3##(1990-2#2)(1991-9#1)(2007-11#3)(2008-11#1)(2008-2#2)(2010-11#2)
with HIV-1 viral load##2##4##(2012-2#2)
with HIV-1##32##2##(1990-12#1)(1990-2#3)(1990-6#1)(1991-9#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-3#2)(1995-12#1)(1997-3#2)(2005-10#1)(2007-11#3)(2008-11#1)(2008-12#1)(2008-2#2)(2010-11#2)(2011-3#1)(2012-2#4)(2013-1#1)
with HIV-2##2##2##(1996-4#1)(1997-3#1)
with HIV-AIDS##2##2##(2007-12#1)(2010-8#1)
with HIV-associated##7##2##(2005-10#1)(2007-11#6)
with HIV-infected patients##2##3##(1994-4#1)(1996-9#1)
with HIV-infected##8##2##(1992-7#1)(1993-1#1)(1993-6#1)(1994-4#2)(1996-12#1)(1996-9#1)(2011-1#1)
with HIV-infection##2##2##(1993-1#1)(1993-3#1)
with HIV/AIDS and##8##3##(2005-10#1)(2009-7#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#2)(2013-1#1)
with HIV/AIDS in Jamaica##3##4##(2007-1#1)(2009-7#2)
with HIV/AIDS in Nigeria##2##4##(2007-12#2)
with HIV/AIDS in##11##3##(2007-1#1)(2007-12#2)(2007-7#1)(2009-7#3)(2011-1#2)(2012-12#1)(2013-7#1)
with HIV/AIDS infection##3##3##(1996-10#1)(2007-7#1)(2013-1#1)
with HIV/AIDS##75##2##(1992-12#1)(1995-3#2)(1996-10#1)(1997-5#1)(2005-10#4)(2005-7#2)(2006-2#1)(2007-1#5)(2007-12#9)(2007-7#6)(2008-1#1)(2008-10#1)(2008-12#3)(2008-4#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#7)(2010-12#3)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#9)(2012-11#1)(2012-12#5)(2013-1#4)(2013-7#1)
with HLA class##2##3##(1997-9#1)(2006-10#1)
with HLA##6##2##(1997-9#1)(2006-10#2)(2007-11#1)(2008-1#1)(2012-12#1)
with HLA-B52##3##2##(1997-8#3)
with HLE##2##2##(1992-12#1)(1993-8#1)
with HMC##2##2##(1992-11#2)
with HMO(4)Q##3##2##(2008-10#3)
with HMOs##2##2##(1995-12#1)(1997-1#1)
with HMQ into##2##3##(2008-10#2)
with HN2##2##2##(2008-4#2)
with HNE##2##2##(1992-3#1)(2010-4#1)
with HNO(3) alone##2##3##(2008-10#2)
with HNO(3) and H(2)O(2)##2##4##(2008-10#2)
with HNO(3) and##3##3##(2008-10#3)
with HNO(3)##9##2##(2008-10#9)
with HNSCC##3##2##(2010-7#3)
with HOMA-IR##2##2##(2008-3#2)
with HOMC##2##2##(1990-11#2)
with HPE##3##2##(2011-1#2)(2013-1#1)
with HPLC##11##2##(1990-4#1)(1996-5#1)(2007-8#3)(2008-10#3)(2008-11#1)(2008-8#1)(2011-3#1)
with HPTLC##2##2##(2008-10#1)(2010-4#1)
with HPV##7##2##(1991-2#1)(1993-9#1)(1994-1#1)(2010-7#1)(2011-1#1)(2011-2#2)
with HPV-16##2##2##(1993-9#1)(2011-1#1)
with HQ##2##2##(1992-3#1)(2008-10#1)
with HRP##6##2##(1990-4#1)(1991-6#2)(1991-8#1)(2008-10#2)
with HRS-1##2##2##(2008-5#2)
with HRS-2 and##2##3##(2008-5#2)
with HS##2##2##(1995-10#1)(2013-8#1)
with HSA##9##2##(1997-8#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-5#2)
with HSP70-peptides##2##2##(2008-9#2)
with HSV-1##5##2##(2007-12#1)(2008-10#1)(2008-8#1)(2009-12#2)
with HT##2##2##(2008-4#1)(2008-8#1)
with HTG (0##2##3##(1997-2#2)
with HTG##6##2##(1997-2#6)
with HTLV-I##2##2##(1993-12#1)(2008-4#1)
with HU##2##2##(1997-6#1)(2008-10#1)
with HUS##4##2##(2013-1#4)
with HVT##3##2##(2013-8#3)
with Hartmann's procedure##3##3##(1996-2#1)(2009-1#1)(2011-11#1)
with HbA1c##3##2##(2012-4#1)(2012-5#2)
with Hba1c##2##2##(2011-1#2)
with HeLa cell##3##3##(1990-4#1)(1991-3#1)(1994-8#1)
with HeLa##4##2##(1990-4#1)(1991-3#1)(1994-8#1)(1997-2#1)
with Helicobacter pylori##11##3##(1996-11#1)(1997-1#1)(2006-10#6)(2007-3#1)(2008-12#1)(2013-8#1)
with Helicobacter##12##2##(1996-11#1)(1997-1#1)(2006-10#6)(2007-3#1)(2008-12#1)(2008-4#1)(2013-8#1)
with Hg(2+)##2##2##(2008-10#2)
with Hg(II)##5##2##(2008-10#5)
with Hg2+##2##2##(1993-12#2)
with Hgb &gt##2##3##(2008-7#2)
with Hib vaccine##2##3##(2008-4#2)
with Hib##3##2##(2006-8#1)(2008-4#2)
with High##5##2##(1997-3#1)(2008-10#1)(2008-3#1)(2010-2#1)(2012-12#1)
with Highly Active Anti Retroviral##2##5##(2007-12#2)
with Hill##2##2##(1995-3#1)(1997-1#1)
with Hirschprung's disease##2##3##(1993-6#1)(2006-10#1)
with His##5##2##(1994-11#1)(1995-3#1)(1996-7#1)(1997-2#2)
with Hodgkin's disease (HD)##4##4##(1997-7#1)(2008-1#1)(2011-2#2)
with Hodgkin's disease##9##3##(1990-4#1)(1992-6#1)(1997-7#2)(2008-1#1)(2008-3#1)(2011-2#3)
with Hodgkin's##11##2##(1990-4#1)(1992-6#1)(1997-7#2)(2008-1#1)(2008-3#1)(2008-7#2)(2011-2#3)
with Hoechst##2##2##(2005-11#1)(2008-4#1)
with Host##2##2##(2008-10#2)
with HpaG(Xooc)##2##2##(2008-10#2)
with HrpZ##2##2##(2011-1#2)
with Human Immunodeficiency##2##3##(2009-2#1)(2011-2#1)
with Human##4##2##(2008-4#1)(2009-2#1)(2010-8#1)(2011-2#1)
with Huntington's disease##4##3##(2006-8#1)(2008-7#1)(2010-2#1)(2011-2#1)
with Huntington's##5##2##(1991-6#1)(2006-8#1)(2008-7#1)(2010-2#1)(2011-2#1)
with I and##2##3##(1993-2#1)(2008-10#1)
with I##11##2##(1993-2#1)(1996-2#3)(1997-7#2)(2004-11#1)(2007-5#2)(2008-10#2)
with I-B4##2##2##(1997-2#2)
with IABP##2##2##(2006-12#1)(2010-12#1)
with IADL##2##2##(2006-7#1)(2013-1#1)
with IBA##2##2##(2008-10#1)(2008-12#1)
with IBD##7##2##(2006-10#4)(2006-2#1)(2010-12#2)
with IBDV##3##2##(2005-9#1)(2013-1#2)
with IBD]##2##2##(2012-11#2)
with IBS##2##2##(1997-6#1)(2013-1#1)
with IBV##5##2##(1997-3#1)(1997-6#2)(2008-5#2)
with IC (50) values of##2##5##(2007-1#2)
with IC (50)##3##3##(2007-1#3)
with IC##8##2##(1992-11#4)(2007-1#3)(2008-5#1)
with IC(50) at##2##3##(2008-11#1)(2012-12#1)
with IC(50) of 8##2##4##(2008-10#1)(2012-11#1)
with IC(50) of##4##3##(2008-10#1)(2009-4#1)(2010-12#1)(2012-11#1)
with IC(50) values of 11##2##5##(2008-10#1)(2013-1#1)
with IC(50) values of 16##2##5##(2010-6#1)(2013-1#1)
with IC(50) values of##6##4##(2008-10#1)(2008-4#1)(2010-6#1)(2011-2#1)(2013-1#2)
with IC(50) values##9##3##(2008-10#4)(2008-4#1)(2010-6#1)(2011-2#1)(2013-1#2)
with IC(50)##17##2##(2008-10#7)(2008-11#1)(2008-4#1)(2009-4#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#2)
with IC50 =##2##3##(1997-2#1)(1997-8#1)
with IC50 of 1##2##4##(1994-3#1)(1996-11#1)
with IC50 of##4##3##(1990-5#1)(1994-2#1)(1994-3#1)(1996-11#1)
with IC50 values for##2##4##(1994-2#1)(1996-11#1)
with IC50 values in the##2##5##(1990-5#1)(2006-12#1)
with IC50 values in##3##4##(1990-12#1)(1990-5#1)(2006-12#1)
with IC50 values of 0##3##5##(1991-8#1)(1995-11#1)(2007-5#1)
with IC50 values of 1##3##5##(1990-8#1)(1992-11#1)(1992-12#1)
with IC50 values of 2##5##5##(1992-11#1)(1995-1#1)(1995-12#1)(2006-12#2)
with IC50 values of approximately 1##2##6##(1990-8#1)(1992-5#1)
with IC50 values of##25##4##(1990-8#2)(1991-2#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-5#2)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-5#1)(1996-11#1)(1996-6#3)(2006-12#2)(2007-5#1)
with IC50 values##33##3##(1990-12#1)(1990-5#1)(1990-8#2)(1991-2#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-5#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-5#1)(1996-11#2)(1996-6#3)(2006-12#6)(2007-5#1)
with IC50##44##2##(1990-12#1)(1990-5#2)(1990-8#2)(1991-2#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-5#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-11#3)(1996-6#3)(1997-2#1)(1997-8#1)(2006-12#6)(2007-5#1)(2007-8#1)(2008-11#1)(2011-3#2)
with IC50s of approx##2##4##(1991-3#2)
with IC50s of##3##3##(1991-3#2)(1995-3#1)
with IC50s##5##2##(1991-3#2)(1995-3#1)(1995-5#1)(1997-1#1)
with ICG scores##2##3##(1995-11#2)
with ICH##2##2##(2007-10#1)(2012-12#1)
with ICP-AES##2##2##(2005-4#1)(2008-10#1)
with ICP-MS detection##2##3##(2008-10#2)
with ICP-MS##7##2##(2007-8#1)(2008-10#6)
with ICP-OES##2##2##(2008-10#1)(2010-5#1)
with ICS 205-930 (0##2##4##(1990-2#2)
with ID and##2##3##(2010-2#1)(2012-12#1)
with ID##4##2##(2010-2#1)(2012-12#3)
with IDC##3##2##(1997-3#2)(2005-10#1)
with IDDM##4##2##(1990-4#1)(1995-3#3)
with IFN gamma##2##3##(1995-5#2)
with IFN##7##2##(1992-2#1)(1995-5#2)(2009-8#4)
with IFN-gamma##3##2##(1990-11#1)(1993-12#1)(1995-6#1)
with IFNalpha##2##2##(2007-11#2)
with IFNalpha-2b##2##2##(2007-11#2)
with IGF-1##2##2##(1992-12#1)(2010-8#1)
with IGF-I##4##2##(1991-5#1)(2006-9#1)(2008-6#1)(2010-5#1)
with IGHD##2##2##(2008-1#2)
with IGT##3##2##(2007-9#1)(2008-3#1)(2011-1#1)
with IHD##5##2##(2005-1#1)(2005-6#3)(2012-3#1)
with IIP##2##2##(2005-8#2)
with IL-1 beta##3##3##(1991-3#1)(1993-3#1)(1995-12#1)
with IL-1##9##2##(1990-12#3)(1991-3#1)(1993-3#1)(1995-12#2)(1995-6#1)(2007-12#1)
with IL-10##2##2##(1996-10#1)(2007-11#1)
with IL-12##5##2##(1996-10#2)(2007-2#1)(2008-4#2)
with IL-1ra##2##2##(1992-3#1)(1995-2#1)
with IL-2 and##4##3##(1993-7#1)(1994-9#1)(1995-12#1)(2008-11#1)
with IL-2##9##2##(1991-6#2)(1993-7#1)(1994-11#1)(1994-9#1)(1995-12#1)(1996-10#1)(1996-9#1)(2008-11#1)
with IL-4##5##2##(1992-5#1)(1994-8#1)(1995-5#2)(2012-1#1)
with IL-6##3##2##(1994-3#1)(1996-12#1)(2011-2#1)
with IL-8##2##2##(1994-3#1)(1996-5#1)
with IL-treated cellulose##2##3##(2008-5#2)
with IM fields treated with Co60##3##6##(2007-10#3)
with IM##4##2##(2007-10#3)(2007-2#1)
with IMP(A)##2##2##(2008-2#2)
with IMP(B)##2##2##(2008-2#2)
with IMRT##2##2##(2008-6#2)
with IMT##2##2##(2008-1#1)(2013-1#1)
with IP##6##2##(2006-10#1)(2008-10#1)(2008-7#2)(2011-1#2)
with IP6##2##2##(2008-10#2)
with IPSB##2##2##(1996-1#2)
with IR and##2##3##(2008-10#1)(2008-3#1)
with IR##7##2##(2006-5#1)(2008-10#1)(2008-3#2)(2011-2#2)(2013-8#1)
with ISIS 12449##2##3##(2008-10#2)
with ITS##2##2##(2008-10#2)
with IV##2##2##(2006-10#1)(2008-8#1)
with IVH##2##2##(2006-8#1)(2008-7#1)
with IVIG has been shown##2##5##(2007-12#2)
with IVIG##5##2##(2005-11#1)(2006-4#2)(2007-12#2)
with IVIg##3##2##(2006-10#1)(2007-8#1)(2010-2#1)
with Ig alpha and Ig beta##3##6##(1994-9#3)
with Ig##6##2##(1991-9#1)(1994-9#3)(1997-1#2)
with IgA deficiency##4##3##(2006-10#2)(2006-2#1)(2007-2#1)
with IgA nephropathy##5##3##(2007-8#3)(2009-6#1)(2013-8#1)
with IgA##13##2##(1996-12#1)(2006-10#2)(2006-2#1)(2007-11#1)(2007-2#1)(2007-8#4)(2009-6#1)(2012-2#1)(2013-8#1)
with IgE##3##2##(1996-2#1)(2008-10#1)(2008-5#1)
with IgG anti-Toxoplasma titers##2##4##(2007-10#2)
with IgG subclass deficiency##2##4##(2007-2#2)
with IgG##7##2##(1990-2#1)(1991-6#1)(1994-5#1)(2007-10#2)(2007-2#2)
with Igp##2##2##(1990-7#2)
with Ile##2##2##(1991-7#1)(1992-3#1)
with Ilizarov##2##2##(2007-8#2)
with Impaired Glucose Tolerance##2##4##(2008-3#1)(2012-3#1)
with Impaired##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
with Implications##2##2##(1996-12#1)(2011-1#1)
with In##2##2##(2008-10#1)(2008-3#1)
with Indian standard series##2##4##(2007-7#2)
with Indian##3##2##(2006-8#1)(2007-7#2)
with Infliximab##2##2##(2010-12#2)
with Insulin##2##2##(2010-8#1)(2011-1#1)
with Interferon-gamma##2##2##(1990-11#1)(1992-7#1)
with International##2##2##(2008-9#1)(2012-3#1)
with J =##2##3##(2008-10#1)(2010-5#1)
with J2##2##2##(2008-10#1)(2009-3#1)
with JH##2##2##(1992-6#1)(1995-11#1)
with JIA##2##2##(2007-11#2)
with JRA##6##2##(2006-10#2)(2007-11#2)(2012-2#1)(2012-3#1)
with Japanese cedar pollinosis##2##4##(2008-11#1)(2012-12#1)
with Japanese##4##2##(1995-12#1)(2008-10#1)(2008-11#1)(2012-12#1)
with John##2##2##(2008-7#1)(2010-7#1)
with K##3##2##(1991-1#1)(2008-10#1)(2008-4#1)
with K(2)S(2)O(8)##2##2##(2008-10#2)
with K562##2##2##(1995-11#1)(2008-11#1)
with KBr##2##2##(2008-10#2)
with KBrO(3)##2##2##(2008-10#2)
with KCN##5##2##(1990-7#1)(1991-1#1)(1995-3#1)(2008-10#1)(2010-2#1)
with KCl##8##2##(1991-10#1)(1992-1#1)(1992-4#1)(1996-10#1)(1996-2#1)(1996-9#1)(2008-10#1)(2008-5#1)
with KD values of##2##4##(1990-3#1)(1995-3#1)
with KD##3##2##(1990-3#1)(1990-7#1)(1995-3#1)
with KI##3##2##(2008-10#3)
with KLH##3##2##(1996-10#1)(2008-11#1)(2008-4#1)
with KMnO(4)##3##2##(2008-10#3)
with KOH##4##2##(2005-11#1)(2007-7#1)(2008-10#1)(2008-5#1)
with KP1 and##2##3##(1991-2#2)
with KS##7##2##(1991-12#1)(1992-2#1)(1995-5#2)(2007-4#1)(2013-1#2)
with KT##3##2##(2011-2#1)(2013-1#2)
with KTX##2##2##(1994-12#2)
with Ka##2##2##(1991-8#1)(1996-11#1)
with Kallmann syndrome##2##3##(1995-5#2)
with Kaposi's sarcoma##2##3##(1992-3#1)(1994-4#1)
with Karnofsky##2##2##(1992-10#1)(2006-12#1)
with Kasabach-Merritt syndrome##2##3##(2008-7#2)
with Kasabach-Merritt##3##2##(2007-10#1)(2008-7#2)
with Kawasaki disease in##2##4##(1993-12#1)(2011-2#1)
with Kawasaki syndrome and##2##4##(1996-3#1)(2006-10#1)
with Kawasaki##4##2##(1993-12#1)(1996-3#1)(2006-10#1)(2011-2#1)
with Kd =##2##3##(1990-5#1)(1997-1#1)
with Kd approximately##2##3##(1994-3#1)(1995-6#1)
with Kd values of 0##2##5##(1994-2#1)(1994-3#1)
with Kd values of##3##4##(1994-2#1)(1994-3#1)(1996-10#1)
with Kd##8##2##(1990-5#1)(1991-6#1)(1994-2#1)(1994-3#2)(1995-6#1)(1996-10#1)(1997-1#1)
with Kds of##2##3##(1990-2#1)(1996-10#1)
with Kds##3##2##(1990-2#1)(1991-10#1)(1996-10#1)
with Ki = 2##2##4##(1990-7#1)(1993-11#1)
with Ki =##6##3##(1990-7#2)(1993-11#1)(1994-5#1)(1994-8#1)(1997-1#1)
with Ki of##2##3##(1990-4#1)(1992-6#1)
with Ki values in the micromolar##2##6##(1990-2#1)(2006-12#1)
with Ki values in the##3##5##(1990-2#1)(2006-12#1)(2007-11#1)
with Ki values of##3##4##(1993-4#1)(1995-3#1)(1996-5#1)
with Ki values##9##3##(1990-2#1)(1990-7#1)(1991-2#1)(1993-4#1)(1995-3#1)(1996-10#1)(1996-5#1)(2006-12#1)(2007-11#1)
with Ki##18##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#3)(1991-2#1)(1992-6#1)(1993-11#1)(1993-4#1)(1994-5#1)(1994-8#1)(1995-3#1)(1996-10#1)(1996-5#1)(1997-1#1)(2006-12#1)(2007-11#1)
with Kikuchi's##2##2##(2007-9#1)(2011-2#1)
with Kirschner wires##2##3##(2007-8#1)(2009-3#1)
with Klebsiella pneumoniae was significantly better##2##6##(2006-8#2)
with Klebsiella pneumoniae##9##3##(2006-10#2)(2006-8#7)
with Km =##2##3##(1991-5#1)(1991-7#1)
with Km values for##2##4##(1991-9#1)(1995-6#1)
with Km values##3##3##(1991-9#1)(1994-11#1)(1995-6#1)
with Km##7##2##(1991-5#1)(1991-7#1)(1991-9#1)(1994-11#1)(1995-2#1)(1995-6#1)(1997-8#1)
with Kombucha##2##2##(1990-2#2)
with KrF excimer laser##2##4##(2007-11#1)(2008-2#1)
with Krebs##2##2##(1990-2#2)
with L##15##2##(1994-10#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-7#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-4#1)(2010-3#1)(2010-4#1)(2012-2#1)
with L-NAME##4##2##(2007-1#1)(2008-11#1)(2008-4#1)(2011-2#1)
with L-NMMA##3##2##(1990-6#1)(1996-3#2)
with L-PAM##2##2##(1991-7#1)(2006-6#1)
with L-arginine##8##2##(1990-10#1)(1991-6#1)(1993-6#1)(1995-12#1)(1997-2#2)(1997-7#2)
with L-asparaginase##2##2##(2012-12#1)(2012-3#1)
with L-cysteine and oxygen##2##4##(1994-11#2)
with L-cysteine##3##2##(1994-11#2)(2005-11#1)
with L-deprenyl##6##2##(1994-6#2)(1995-6#1)(1996-7#3)
with L-phenylalanine##2##2##(1991-7#1)(1995-8#1)
with L-triiodothyronine##2##2##(1994-9#2)
with LA##4##2##(2008-11#2)(2010-4#2)
with LAK cells##3##3##(1990-12#2)(2007-11#1)
with LBP and##2##3##(2007-11#1)(2012-12#1)
with LBP##9##2##(2004-10#2)(2007-11#2)(2009-12#1)(2012-12#2)(2012-2#2)
with LC and##2##3##(2008-10#2)
with LC##3##2##(2008-10#3)
with LCM##2##2##(2010-12#2)
with LChD##5##2##(2008-10#5)
with LDH##2##2##(2008-10#1)(2012-12#1)
with LDL##4##2##(1991-12#1)(1992-10#1)(1994-11#1)(1995-12#1)
with LDLT (p##2##3##(2009-2#2)
with LED##5##2##(2007-9#3)(2008-11#1)(2008-7#1)
with LFS##2##2##(1990-12#2)
with LGBTQ parents##2##3##(2009-7#2)
with LH-RH##2##2##(1991-2#1)(1993-1#1)
with LIF##6##2##(1996-5#1)(2008-11#3)(2008-3#2)
with LJ and MGIT##2##4##(2013-1#2)
with LMA##2##2##(2008-8#1)(2010-7#1)
with LN##3##2##(2008-1#3)
with LNA##3##2##(2009-3#3)
with LP##2##2##(2006-10#1)(2007-7#1)
with LPL##3##2##(1991-12#2)(1993-8#1)
with LPS + IFN gamma##2##5##(1993-3#2)
with LPS##15##2##(1992-8#1)(1993-3#2)(1993-9#1)(1994-3#1)(1995-12#1)(2006-8#2)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2010-4#1)(2011-2#1)
with LPS-A##6##2##(2006-8#6)
with LS##2##2##(2010-12#1)(2012-3#1)
with LVH##2##2##(2010-8#2)
with La(3+)##2##2##(2008-8#1)(2008-9#1)
with Lactobacillus##3##2##(2008-11#3)
with Laron syndrome##3##3##(2006-9#1)(2008-1#1)(2008-4#1)
with Laron##4##2##(2006-9#1)(2008-1#2)(2008-4#1)
with Latent Semantic Analysis##2##4##(2008-8#2)
with Latin American##2##3##(2010-4#2)
with Lc3##2##2##(1993-12#2)
with LcS##2##2##(2009-9#2)
with Leber hereditary optic neuropathy##2##5##(1992-9#2)
with Leigh syndrome##3##3##(1994-8#2)(2005-8#1)
with Leishmania major##2##3##(2007-2#1)(2012-2#1)
with Leishmania##8##2##(2005-8#2)(2005-9#1)(2006-10#1)(2007-2#3)(2012-2#1)
with Leptospira interrogans serovar hardjo##2##5##(1991-8#2)
with Leu##3##2##(1992-6#2)(1993-4#1)
with Lewis##2##2##(1996-6#1)(2010-12#1)
with Lewy bodies##10##3##(1996-11#2)(2008-11#2)(2008-7#5)(2009-3#1)
with Li metal in absolute ethanol-tetrahydrofuran mixture to##2##8##(2007-11#2)
with Li##3##2##(2007-11#2)(2008-2#1)
with LiCl##2##2##(1992-6#1)(1993-12#1)
with LiNbO(3)##2##2##(2007-11#1)(2008-3#1)
with Listeria monocytogenes##6##3##(1994-6#1)(1996-12#2)(2008-4#2)(2012-2#1)
with Listeria##7##2##(1994-6#1)(1996-12#2)(2008-4#2)(2012-2#2)
with Local##2##2##(1996-6#1)(2006-11#1)
with Localized##2##2##(2008-10#1)(2010-12#1)
with Low##4##2##(2007-8#1)(2008-10#1)(2010-8#1)(2011-2#1)
with Lp(a)##3##2##(1993-1#1)(1995-6#1)(1996-8#1)
with Lr34##2##2##(2008-10#2)
with Lys##2##2##(1990-5#1)(2008-11#1)
with M##32##2##(1992-5#1)(1996-4#1)(1997-7#1)(2007-7#1)(2008-10#15)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#3)(2010-12#1)(2011-2#1)(2012-3#2)
with M(2)##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
with M(r)##2##2##(1995-11#1)(2012-3#1)
with M8##2##2##(1992-8#2)
with MA##2##2##(1995-11#1)(2012-3#1)
with MAF##3##2##(2010-11#1)(2012-3#2)
with MAG##2##2##(1993-8#1)(2006-9#1)
with MAP##3##2##(1996-10#2)(1997-7#1)
with MAPK##2##2##(1996-5#1)(2008-11#1)
with MAb##3##2##(1991-7#1)(1994-12#1)(2013-8#1)
with MB##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
with MBP-RT##2##2##(1997-6#2)
with MBS##2##2##(1990-2#1)(1997-7#1)
with MBTH##2##2##(2008-10#2)
with MC##2##2##(2008-5#1)(2012-12#1)
with MCAD deficiency##4##3##(1990-8#2)(1992-7#2)
with MCI##3##2##(2009-10#2)(2013-8#1)
with MCOs##2##2##(2007-1#1)(2008-6#1)
with MCT##2##2##(1993-3#2)
with MDEA##2##2##(2009-10#2)
with MEKC##2##2##(2008-10#2)
with MEL##4##2##(2007-8#1)(2008-11#2)(2008-9#1)
with MG were##2##3##(1994-3#1)(2008-5#1)
with MG##10##2##(1991-9#1)(1994-3#1)(1997-6#1)(2007-8#2)(2007-9#1)(2008-5#1)(2012-2#3)
with MGR586##2##2##(2008-10#2)
with MHC class I molecules##2##5##(1992-4#1)(1997-4#1)
with MHC class I##3##4##(1992-4#1)(1997-4#1)(2008-9#1)
with MHC class II##3##4##(1992-4#1)(1995-5#1)(2008-9#1)
with MHC class##6##3##(1992-4#2)(1995-5#1)(1997-4#1)(2008-9#2)
with MI##5##2##(1994-9#2)(1997-1#2)(2010-10#1)
with MIC##2##2##(1993-4#1)(2006-12#1)
with MICs of##2##3##(2005-7#1)(2008-5#1)
with MICs##3##2##(2005-7#1)(2008-5#1)(2011-1#1)
with MIMS##2##2##(2008-10#2)
with MINTEQA2##2##2##(2008-10#2)
with MK-801 (0##2##3##(1990-5#1)(1991-2#1)
with MK-801 (1##2##3##(1991-2#1)(1994-10#1)
with MK-801##6##2##(1990-5#1)(1991-2#2)(1992-8#1)(1994-10#1)(1996-10#1)
with MM and##2##3##(2008-1#1)(2008-7#1)
with MM##8##2##(1991-12#1)(1996-9#1)(2007-12#1)(2008-1#2)(2008-7#1)(2010-4#1)(2011-1#1)
with MMC##4##2##(1995-5#3)(2006-6#1)
with MMF##2##2##(2007-8#1)(2008-1#1)
with MND##2##2##(2008-9#2)
with MP##2##2##(2008-6#1)(2013-1#1)
with MPA##2##2##(1995-2#1)(2008-10#1)
with MPO implants##2##3##(1994-2#2)
with MPO##3##2##(1994-2#2)(2007-8#1)
with MPS##7##2##(1991-9#1)(2006-8#1)(2007-8#5)
with MPTP in##2##3##(2005-8#1)(2008-3#1)
with MPTP or DPM individually##2##5##(2008-7#2)
with MPTP##13##2##(1990-5#1)(1994-2#1)(1995-7#1)(2005-8#1)(2008-3#2)(2008-7#6)(2013-8#1)
with MR imaging##3##3##(1991-11#1)(2006-5#1)(2008-8#1)
with MR##12##2##(1991-11#1)(1995-3#4)(1996-3#1)(2006-5#1)(2007-11#1)(2008-8#1)(2010-11#2)(2011-1#1)
with MRI##13##2##(1997-7#1)(2005-11#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-8#1)(2012-12#1)(2012-2#2)(2013-1#2)
with MRSA##7##2##(2005-8#1)(2008-5#1)(2011-2#4)(2012-2#1)
with MS in##2##3##(2008-5#1)(2013-1#1)
with MS##38##2##(1990-12#1)(1993-5#2)(1994-7#1)(1995-12#1)(2005-4#1)(2006-12#4)(2007-11#3)(2007-2#1)(2008-10#2)(2008-3#8)(2008-5#1)(2008-7#1)(2010-12#4)(2011-2#2)(2012-1#1)(2012-3#4)(2013-1#1)
with MT##2##2##(2008-10#1)(2012-1#1)
with MTAS##2##2##(1991-9#2)
with MTX##3##2##(2006-10#1)(2008-8#1)(2010-1#1)
with MTs##3##2##(2008-10#2)(2008-11#1)
with MV-Edmonston##2##2##(1997-4#2)
with Mab##2##2##(1991-9#1)(1996-12#1)
with Magnetic Induction (MAT-MI)##2##4##(2007-12#2)
with Marek's disease (MD)##2##4##(1997-6#1)(2013-8#1)
with Marek's disease##5##3##(1997-6#2)(2008-5#1)(2013-8#2)
with Marfan syndrome##9##3##(2007-8#2)(2008-4#1)(2008-8#2)(2009-3#2)(2009-4#1)(2009-7#1)
with Marfan##10##2##(2007-8#2)(2008-4#1)(2008-8#3)(2009-3#2)(2009-4#1)(2009-7#1)
with Marfan's syndrome##2##3##(2007-8#2)
with Markov##2##2##(2008-2#1)(2009-12#1)
with MboI##2##2##(1990-9#1)(2008-2#1)
with Medicaid##5##2##(1992-1#1)(1994-1#1)(1994-3#1)(1995-1#1)(1997-2#1)
with Medical##3##2##(1994-3#1)(1995-1#1)(2008-1#1)
with Medicare managed care##2##4##(1995-12#1)(1997-3#1)
with Medicare##11##2##(1990-12#2)(1994-1#1)(1995-12#3)(1997-1#1)(1997-3#1)(2007-8#2)(2009-9#1)
with Merck &amp##2##3##(2005-8#1)(2013-1#1)
with Merck##3##2##(2005-8#1)(2012-12#1)(2013-1#1)
with MetS and##4##3##(2008-3#1)(2010-9#1)(2012-2#1)(2013-1#1)
with MetS##10##2##(2008-3#1)(2010-10#1)(2010-9#1)(2011-1#2)(2012-2#1)(2013-1#3)(2013-8#1)
with Metastatic##4##2##(2008-11#1)(2008-6#1)(2008-7#1)(2010-6#1)
with Mg levels##2##3##(2008-10#2)
with Mg##5##2##(1990-5#1)(2007-12#1)(2008-10#3)
with Mg2+ and##3##3##(1991-8#1)(1995-10#1)(1995-2#1)
with Mg2+##9##2##(1990-10#1)(1990-5#1)(1991-8#1)(1992-3#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-6#2)
with MgO##2##2##(2007-11#1)(2007-12#1)
with Microsoft##2##2##(2008-10#2)
with Microsphaeropsis sp##4##3##(2008-10#4)
with Mie scattering##2##3##(2007-12#1)(2008-2#1)
with Mie theory##4##3##(2008-2#1)(2008-3#3)
with Mie##6##2##(2007-12#1)(2008-2#2)(2008-3#3)
with Mitomycin C##2##3##(1997-7#1)(2006-6#1)
with Mn##3##2##(2007-12#1)(2007-8#1)(2013-8#1)
with Mn2+##6##2##(1990-10#1)(1992-5#1)(1993-4#1)(1994-9#1)(1996-5#1)(1996-7#1)
with Mojave toxin##3##3##(2012-2#3)
with Monilinia fructicola##2##3##(2008-10#2)
with Monte Carlo simulations and##2##5##(2008-2#1)(2008-3#1)
with Monte Carlo simulations##8##4##(2008-12#1)(2008-2#4)(2008-3#3)
with Monte Carlo##16##3##(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#5)(2008-3#6)(2009-5#1)(2010-2#1)
with More##2##2##(2008-4#1)(2013-1#1)
with Mr =##3##3##(1990-11#1)(1990-12#2)
with Mr##8##2##(1990-10#1)(1990-11#1)(1990-12#2)(1991-8#1)(1994-3#1)(2008-10#1)(2008-11#1)
with Mrs##2##2##(1990-7#1)(1991-2#1)
with Multiple Sclerosis##3##3##(2012-1#1)(2013-1#2)
with Multiple##7##2##(1996-2#1)(2007-11#1)(2007-12#1)(2008-9#1)(2012-1#1)(2013-1#2)
with Musculoskeletal##2##2##(2006-10#1)(2008-6#1)
with Mycobacterium tuberculosis##3##3##(1996-11#1)(2008-7#1)(2011-1#1)
with Mycobacterium##8##2##(1990-5#1)(1991-11#1)(1996-11#1)(1997-8#1)(2008-7#1)(2010-10#1)(2011-1#2)
with Mycoplasma##5##2##(1997-3#1)(2005-7#1)(2008-5#1)(2012-3#1)(2013-1#1)
with Mycosphaerella graminicola##2##3##(2008-10#2)
with N at##2##3##(2008-10#2)
with N##36##2##(1990-10#1)(1990-8#1)(1991-8#1)(1991-9#1)(1995-2#1)(1995-3#1)(2005-12#1)(2006-8#2)(2008-10#21)(2008-2#2)(2008-5#1)(2008-6#1)(2009-11#1)(2010-4#1)
with N(2)##5##2##(1997-6#1)(2006-1#1)(2006-10#1)(2008-3#2)
with N-(1-naphthyl)ethylenediamine##4##2##(2008-10#3)(2008-5#1)
with N-acetylcysteine##6##2##(1991-11#1)(1991-9#2)(1992-6#1)(2008-10#1)(2012-3#1)
with N-acetylglucosamine##3##2##(1990-12#1)(1990-2#1)(1991-5#1)
with N-bromosuccinimide##4##2##(2008-10#4)
with N-ethylmaleimide##2##2##(1990-2#1)(1995-6#1)
with N-fatty acyl##2##3##(1990-12#2)
with N-methyl-N'-nitro-N-nitrosoguanidine##2##2##(1997-3#1)(1997-4#1)
with N-myc##2##2##(1994-10#2)
with N-n-octylaniline##4##2##(2008-10#4)
with N-nitrosodiethylamine##2##2##(1993-7#1)(2008-10#1)
with N-terminal sequence##2##3##(1992-8#1)(1996-9#1)
with N-terminal##4##2##(1991-10#1)(1992-8#1)(1994-11#1)(1996-9#1)
with N0##2##2##(2008-8#1)(2013-8#1)
with N3##2##2##(1996-6#1)(1997-1#1)
with NAA##3##2##(2007-1#1)(2008-12#1)(2008-6#1)
with NAD##3##2##(1990-5#2)(1992-6#1)
with NAD+ and##3##3##(1996-7#3)
with NAD+##8##2##(1992-3#1)(1994-9#1)(1995-5#1)(1996-7#4)(2007-11#1)
with NADH and##2##3##(1995-10#2)
with NADH##8##2##(1993-8#1)(1994-12#1)(1995-10#2)(1995-5#1)(1997-8#1)(2010-2#2)
with NADP##2##2##(1990-7#1)(1995-5#1)
with NADPH##4##2##(1990-7#1)(1991-2#1)(1994-9#1)(1996-6#1)
with NADPH-cytochrome##2##2##(1993-9#1)(1994-8#1)
with NAFLD have##2##3##(2010-12#1)(2013-1#1)
with NAFLD##3##2##(2010-12#1)(2010-6#1)(2013-1#1)
with NBL##2##2##(2011-2#2)
with NCA##2##2##(1994-2#1)(2011-2#1)
with NCMs in##2##3##(2006-1#1)(2010-3#1)
with NE##4##2##(1992-8#1)(1994-6#2)(2008-4#1)
with NEM##2##2##(1990-11#1)(2005-10#1)
with NF##2##2##(1995-5#1)(2008-11#1)
with NF-kappa B##3##3##(1995-12#3)
with NF1##5##2##(1995-7#1)(1996-12#3)(2012-3#1)
with NF2##4##2##(2006-11#2)(2006-12#1)(2008-10#1)
with NFPAH##6##2##(2010-10#6)
with NGF and##2##3##(1995-3#1)(1996-5#1)
with NGF treatment##2##3##(1992-12#2)
with NGF##7##2##(1992-12#2)(1994-3#2)(1994-8#1)(1995-3#1)(1996-5#1)
with NH2-terminal##2##2##(1997-2#2)
with NHL##4##2##(1990-10#2)(2008-7#1)(2013-1#1)
with NIDDM##5##2##(1991-1#1)(1991-7#2)(1994-2#1)(1996-2#1)
with NIHG750##2##2##(2005-11#2)
with NIPRD-AM1##2##2##(2011-2#2)
with NIRS##2##2##(2008-10#2)
with NL-3 D##2##3##(2008-10#2)
with NL-3##3##2##(2008-10#3)
with NLE##2##2##(1993-5#1)(2010-6#1)
with NMDA receptor##2##3##(1992-3#1)(2007-9#1)
with NMDA##10##2##(1992-3#1)(1992-8#1)(1993-11#1)(1993-5#1)(1994-2#1)(1994-9#2)(1995-12#1)(2007-9#1)(2008-7#1)
with NMS##3##2##(1996-5#1)(2008-1#1)(2012-3#1)
with NO(2)(-) in##2##3##(1996-2#1)(2010-5#1)
with NP##3##2##(2007-11#1)(2007-8#1)(2012-12#1)
with NPC##2##2##(1991-7#1)(1992-6#1)
with NSAIDs##6##2##(1991-4#2)(1993-11#1)(1996-6#1)(2007-11#1)(2011-2#1)
with NSCLC##12##2##(1991-2#1)(2004-1#4)(2007-4#1)(2010-8#2)(2012-1#1)(2012-3#2)(2013-8#1)
with NSIP##3##2##(2005-8#3)
with NSTEMI##2##2##(2006-6#1)(2011-2#1)
with NT-3##2##2##(1996-1#1)(1996-3#1)
with NT-SDH##3##2##(2007-10#3)
with NTG##2##2##(1991-9#1)(1992-6#1)
with Na##3##2##(1991-6#1)(2006-4#2)
with Na+##2##2##(1990-4#1)(1995-5#1)
with NaB and##2##3##(1990-3#1)(1992-3#1)
with NaB##3##2##(1990-3#1)(1992-3#2)
with NaBH(4)##3##2##(1996-5#1)(2007-10#1)(2008-10#1)
with NaBH4 to##2##3##(2007-11#2)
with NaBH4##5##2##(1992-3#1)(1995-3#1)(2007-11#3)
with NaCl and KCl solutions##2##5##(2005-11#2)
with NaCl and##4##3##(2005-11#4)
with NaCl##18##2##(1992-3#1)(1993-8#1)(1995-11#1)(2005-11#5)(2007-3#5)(2007-7#1)(2008-10#4)
with NaH##2##2##(1996-2#1)(1996-5#1)
with NaI scintillation##2##3##(2012-2#2)
with NaIO(4)##2##2##(1996-5#1)(2008-11#1)
with NaNO(2)##2##2##(2008-10#2)
with NaOH##4##2##(2007-11#1)(2007-8#1)(2008-10#1)(2012-2#1)
with Nafion##3##2##(2008-10#3)
with National Institute##2##3##(2008-12#1)(2008-3#1)
with National##4##2##(2008-10#1)(2008-12#1)(2008-3#1)(2013-1#1)
with Nck in##2##3##(1995-3#2)
with Nd##4##2##(2007-12#3)(2008-2#1)
with Ne##2##2##(2007-12#2)
with Negative##2##2##(2008-6#1)(2012-3#1)
with Nernstian compliance (29##3##4##(2008-10#3)
with Nernstian slope of##3##4##(2008-10#3)
with Nernstian##6##2##(2008-10#6)
with Nervoheel N##2##3##(2008-10#2)
with New##2##2##(2007-11#1)(2008-10#1)
with Ni##3##2##(1994-8#1)(2008-10#1)(2008-2#1)
with Ni(2+)##2##2##(1996-2#1)(2008-10#1)
with Ni(II)##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
with Ni2+ at##2##3##(2005-11#2)
with Ni2+##3##2##(2005-11#2)(2008-11#1)
with Ni3S2##3##2##(1994-5#2)(1995-3#1)
with NifA##4##2##(2008-4#2)(2008-9#2)
with Noninvasive##2##2##(1994-7#1)(2013-8#1)
with Norwegian##2##2##(1993-1#1)(1996-4#1)
with NpP##2##2##(1991-2#2)
with O##10##2##(1991-3#1)(2007-11#1)(2007-3#2)(2008-10#5)(2009-2#1)
with O(2)##3##2##(2008-10#1)(2009-5#1)(2010-7#1)
with O2##6##2##(1990-10#1)(1990-2#1)(1993-6#1)(1996-4#1)(2007-9#1)(2010-7#1)
with O2- to form##2##4##(1994-6#2)
with O4##2##2##(1995-2#1)(2008-3#1)
with OA (p##2##3##(1992-3#1)(1993-2#1)
with OA##9##2##(1992-3#2)(1993-2#1)(1993-6#1)(1994-11#1)(2006-10#1)(2008-9#1)(2010-11#2)
with OCD##5##2##(2006-9#1)(2007-10#1)(2007-6#1)(2008-6#1)(2009-4#1)
with OCT##6##2##(1997-4#1)(2007-11#1)(2011-2#3)(2011-7#1)
with OH radicals##2##3##(1997-2#1)(2007-11#1)
with OH##5##2##(1993-9#1)(1997-2#1)(2007-11#1)(2008-3#2)
with OH-##2##2##(2005-11#2)
with OK-432##2##2##(1995-9#1)(2011-2#1)
with OM##3##2##(2008-7#3)
with OMP##2##2##(2008-12#2)
with OMS##2##2##(2011-2#2)
with OPA##2##2##(2007-8#1)(2008-10#1)
with OPV##4##2##(1995-5#3)(2008-8#1)
with OR##2##2##(2012-2#2)
with OSCC##2##2##(2011-1#2)
with OVA##5##2##(1993-12#2)(2008-11#3)
with Oasis##2##2##(2008-10#2)
with Ophiostoma##2##2##(2008-10#2)
with Org 10172##2##3##(1997-2#2)
with Org##4##2##(1994-10#2)(1997-2#2)
with Oridermyl(®)##2##2##(2013-1#2)
with Oriental##2##2##(2008-3#1)(2013-8#1)
with Other##2##2##(2008-10#1)(2012-3#1)
with P value##2##3##(2009-6#1)(2011-1#1)
with P values as 0##2##5##(2011-1#2)
with P##76##2##(1992-5#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-9#1)(1996-10#1)(1996-9#1)(1997-5#1)(2004-11#1)(2005-10#1)(2006-10#1)(2006-2#2)(2006-8#3)(2007-1#3)(2007-7#2)(2008-10#35)(2008-4#1)(2008-5#1)(2009-6#1)(2010-3#1)(2011-1#3)(2011-2#3)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#1)
with P-gp##3##2##(1993-6#1)(2009-4#1)(2012-3#1)
with P1##2##2##(1991-7#1)(2008-4#1)
with P450##2##2##(1991-4#1)(1995-1#1)
with PA##2##2##(1990-11#1)(2008-10#1)
with PAA##2##2##(2005-10#1)(2005-11#1)
with PACNS##2##2##(2006-10#1)(2012-3#1)
with PACS##2##2##(1996-2#1)(2004-9#1)
with PAD##4##2##(1992-8#2)(2008-8#2)
with PAF-acether alone or in association with BN 52021 did not##2##11##(1990-2#2)
with PAF-acether##3##2##(1990-2#3)
with PAH##2##2##(2010-10#2)
with PAHs##2##2##(2008-10#2)
with PAI-1##3##2##(1992-12#1)(2008-4#1)(2011-2#1)
with PAN##4##2##(2008-10#4)
with PANI##2##2##(2005-11#1)(2008-10#1)
with PAR##4##2##(2005-4#1)(2008-10#3)
with PAULA##2##2##(2009-3#2)
with PBC##4##2##(1993-9#1)(2006-10#1)(2007-11#1)(2008-12#1)
with PBG##2##2##(1997-7#2)
with PBMC##2##2##(2008-4#1)(2009-4#1)
with PBN##3##2##(1993-3#1)(1993-6#2)
with PBS##2##2##(2008-8#1)(2009-6#1)
with PC##3##2##(2010-12#2)(2012-3#1)
with PCA##4##2##(2008-10#2)(2008-5#1)(2010-5#1)
with PCE##2##2##(2009-2#1)(2012-12#1)
with PCL##2##2##(2007-1#1)(2013-1#1)
with PCNA##4##2##(1994-8#1)(1995-6#1)(2009-8#2)
with PCOS had##4##3##(2008-3#3)(2011-1#1)
with PCOS is##2##3##(2010-10#1)(2012-11#1)
with PCOS##27##2##(2008-3#11)(2008-4#2)(2010-10#5)(2010-11#1)(2010-4#5)(2011-1#2)(2012-11#1)
with PCP##2##2##(1991-1#1)(1991-6#1)
with PCR in##2##3##(1997-7#1)(1997-8#1)
with PCR##16##2##(1990-9#1)(1991-4#2)(1991-9#1)(1993-10#1)(1994-3#1)(1994-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-7#1)(2008-10#2)(2008-12#2)(2013-8#1)
with PCV-2b##2##2##(2012-3#2)
with PD and##8##3##(2006-9#1)(2007-5#1)(2008-7#2)(2010-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
with PD who##2##3##(2008-7#1)(2012-1#1)
with PD##43##2##(1990-4#1)(1990-6#1)(1994-12#1)(2006-4#1)(2006-9#2)(2007-5#3)(2008-10#1)(2008-11#4)(2008-7#12)(2010-10#3)(2010-12#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#4)(2013-8#3)
with PDA##3##2##(2007-8#1)(2008-10#1)(2008-2#1)
with PDBu##3##2##(1995-3#3)
with PDD##4##2##(2012-2#4)
with PDGF##4##2##(1990-3#3)(1995-3#1)
with PDS##3##2##(1994-8#1)(2011-1#2)
with PDV##2##2##(1993-12#1)(1996-9#1)
with PE##4##2##(1993-2#1)(2006-5#1)(2012-2#1)(2013-8#1)
with PEG 6000##3##3##(2004-9#1)(2008-12#2)
with PEG##7##2##(1991-4#1)(2004-9#1)(2008-12#2)(2008-5#1)(2008-7#1)(2010-12#1)
with PEGylated phospholipids##2##3##(2010-2#2)
with PER##2##2##(1994-3#1)(2008-3#1)
with PET##8##2##(1993-9#1)(1996-5#1)(2005-8#1)(2007-8#1)(2008-10#1)(2008-8#1)(2011-1#1)(2012-12#1)
with PF-68##2##2##(2011-2#2)
with PGF 2alpha##2##3##(2006-5#2)
with PGF##3##2##(2006-5#3)
with PGRN##3##2##(2011-1#3)
with PH##2##2##(2009-4#1)(2011-1#1)
with PHA##6##2##(1995-2#1)(1995-8#1)(2007-2#1)(2013-1#3)
with PHN##2##2##(2006-7#2)
with PID##2##2##(2007-2#1)(2013-8#1)
with PIP2##2##2##(1990-3#1)(2008-8#1)
with PIs and##2##3##(2007-11#2)
with PIs##3##2##(2007-11#3)
with PKB##2##2##(1997-6#2)
with PKC##5##2##(1994-3#1)(1994-5#1)(1994-8#1)(2012-2#2)
with PKD1##2##2##(1996-5#1)(2007-8#1)
with PKU is##2##3##(2010-2#2)
with PKU##6##2##(1990-12#2)(2010-2#3)(2012-2#1)
with PLP in the presence of##2##6##(1996-10#2)
with PLP##5##2##(1991-12#1)(1996-10#2)(2007-10#1)(2012-2#1)
with PLS immersion time##2##4##(2009-9#2)
with PLS##6##2##(2005-11#1)(2008-10#2)(2009-9#2)(2013-8#1)
with PLSVC##3##2##(2010-11#2)(2011-2#1)
with PMA (100 nM)##2##4##(1992-4#1)(1997-1#1)
with PMA and##2##3##(1995-2#1)(1996-7#1)
with PMA##15##2##(1990-5#1)(1991-4#1)(1991-9#1)(1992-4#1)(1992-6#1)(1993-6#1)(1993-7#2)(1994-12#1)(1994-2#1)(1995-2#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-8#1)
with PMMA##3##2##(2008-10#2)(2010-4#1)
with PMMV-k##2##2##(1997-6#2)
with PMP##5##2##(2006-6#3)(2009-5#2)
with PMS##3##2##(2008-10#1)(2009-6#2)
with PMSF##2##2##(1991-1#1)(2012-2#1)
with PN##2##2##(2011-1#1)(2012-12#1)
with PNRSV##2##2##(2008-10#2)
with POPC##2##2##(1991-9#1)(1995-8#1)
with PPA##2##2##(2008-7#1)(2010-8#1)
with PPD##3##2##(2006-12#1)(2013-1#1)(2013-8#1)
with PPHP##2##2##(2010-6#2)
with PPK as##2##3##(2007-7#2)
with PPV-D##2##2##(2008-10#2)
with PPy-calcion film as the active part##2##7##(2008-10#2)
with PPy-calcion##3##2##(2008-10#3)
with PRCA##2##2##(2007-10#2)
with PRL##3##2##(1991-4#1)(1996-8#2)
with PRRSV##2##2##(1997-6#2)
with PRV##2##2##(2007-8#2)
with PRV-SH##2##2##(2005-11#2)
with PS##2##2##(2008-10#1)(2013-1#1)
with PS-1##2##2##(1997-5#2)
with PSC##3##2##(2006-10#1)(2006-2#1)(2008-12#1)
with PSII##2##2##(1994-8#1)(2008-4#1)
with PSP##3##2##(2007-8#2)(2008-11#1)
with PSS##3##2##(2007-10#2)(2007-9#1)
with PSV##3##2##(2008-10#3)
with PSVT##2##2##(2006-4#2)
with PTA and##2##3##(2006-8#1)(2007-7#1)
with PTDM##3##2##(2008-1#3)
with PTH##3##2##(2005-3#1)(2008-8#1)(2013-8#1)
with PTSD##14##2##(2005-10#2)(2007-7#2)(2008-6#1)(2008-9#3)(2009-11#3)(2010-2#2)(2012-12#1)
with PTZ##2##2##(1996-2#2)
with PVA##4##2##(1997-6#1)(2012-3#2)(2013-7#1)
with PVC##2##2##(2008-10#2)
with PVX##7##2##(2008-10#7)
with PWS##5##2##(2006-10#4)(2009-4#1)
with Paget's disease##4##3##(1990-6#1)(1991-5#1)(1994-12#1)(2007-11#1)
with Pantoea##3##2##(2008-10#3)
with Parineb##3##2##(1996-12#3)
with Parkinson disease##4##3##(2006-8#1)(2013-1#1)(2013-8#2)
with Parkinson##7##2##(2006-8#1)(2012-12#1)(2013-1#1)(2013-8#4)
with Parkinson's disease (PD)##16##4##(1991-4#1)(1994-2#1)(1995-3#1)(2007-10#1)(2008-11#3)(2008-7#8)(2013-1#1)
with Parkinson's disease##50##3##(1991-4#2)(1991-5#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-4#2)(1995-3#1)(2005-12#3)(2006-8#1)(2007-10#2)(2008-11#6)(2008-7#17)(2009-10#1)(2011-2#1)(2012-1#2)(2012-12#4)(2013-1#3)
with Parkinson's##54##2##(1991-4#2)(1991-5#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-4#2)(1995-3#1)(2005-10#1)(2005-12#3)(2006-8#1)(2007-10#2)(2008-11#6)(2008-7#17)(2009-10#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-1#2)(2012-12#4)(2013-1#3)
with Patent Blue V##2##4##(2008-10#2)
with Patient##2##2##(1993-12#1)(2011-2#1)
with Patients##3##2##(2012-3#1)(2013-1#2)
with Pb##2##2##(2007-10#1)(2008-10#1)
with Pb(II)##2##2##(2008-10#2)
with PbB##2##2##(1992-4#1)(1997-4#1)
with Pearson##2##2##(2010-12#1)(2012-12#1)
with Peers##2##2##(2012-12#1)(2013-1#1)
with Peg-Interferon and##2##3##(2013-1#2)
with Percutaneous##2##2##(1990-2#1)(2010-8#1)
with Phe##6##2##(1990-8#1)(1994-9#1)(1995-2#2)(1995-6#1)(1997-7#1)
with Phellinus##2##2##(2008-10#1)(2008-8#1)
with Phytophthora cinnamomi##2##3##(2008-10#2)
with Phytophthora sojae f##2##4##(1997-6#2)
with Phytophthora##5##2##(1997-6#2)(2008-10#3)
with Pierre Robin anomaly##2##4##(1996-3#2)
with Pk##2##2##(1991-7#2)
with Plasmodium falciparum##3##3##(1995-9#1)(2008-8#1)(2012-12#1)
with Plasmodium##5##2##(1993-8#1)(1995-9#1)(2005-8#1)(2008-8#1)(2012-12#1)
with PoBH##2##2##(1997-6#2)
with Poly-lys##2##2##(1990-6#2)
with Potato##2##2##(2008-10#2)
with Practice Nurses##2##3##(2008-11#2)
with Prader-Willi Syndrome##2##3##(2006-10#2)
with Prader-Willi##3##2##(1996-12#1)(2006-10#2)
with Pro in region##2##4##(1994-9#2)
with Pro##4##2##(1993-3#1)(1994-9#2)(1995-3#1)
with Prolonged##2##2##(2010-1#1)(2010-5#1)
with Protein##2##2##(1990-11#1)(2005-6#1)
with Przhevalskiana larvae##2##3##(2008-12#2)
with Ps95##2##2##(2008-10#2)
with Pseudomonas aeruginosa elastase##2##4##(1991-8#2)
with Pseudomonas aeruginosa##4##3##(1991-8#2)(2010-2#1)(2013-1#1)
with Pseudomonas fluorescens B5##2##4##(2008-10#2)
with Pseudomonas fluorescens##5##3##(2008-10#4)(2008-2#1)
with Pseudomonas putida##2##3##(1997-2#1)(2004-4#1)
with Pseudomonas##13##2##(1991-8#2)(1997-2#1)(2004-4#1)(2008-10#6)(2008-2#1)(2010-2#1)(2013-1#1)
with Pseudostat##2##2##(2008-5#2)
with Psoriasis and##2##3##(2010-6#1)(2013-1#1)
with Purified##2##2##(2008-10#1)(2008-4#1)
with Pythium##4##2##(2008-10#4)
with Q##2##2##(2007-10#1)(2012-5#1)
with Q1 and##2##3##(2012-3#2)
with Q1##4##2##(2012-3#4)
with QCT##2##2##(1994-8#2)
with QRS durations##2##3##(2008-10#2)
with QRS##3##2##(2008-10#3)
with R##48##2##(1996-5#1)(2005-11#1)(2007-12#1)(2007-8#3)(2008-10#41)(2009-6#1)
with R(2)##2##2##(2008-10#1)(2008-3#1)
with R-PIA##4##2##(1997-1#4)
with R358 alpha 1-AT##2##4##(1995-5#2)
with RA and##3##3##(1992-7#1)(1994-3#1)(2006-10#1)
with RA or##3##3##(1992-1#1)(1993-3#1)(2008-11#1)
with RA was##2##3##(1992-7#1)(2008-11#1)
with RA##44##2##(1991-9#1)(1992-1#1)(1992-7#3)(1993-2#1)(1993-3#1)(1993-9#2)(1994-3#1)(1994-9#1)(1995-10#1)(2005-10#2)(2006-10#16)(2007-3#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#3)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)
with RAPD##2##2##(2007-1#1)(2008-10#1)
with RAPs##2##2##(2008-10#2)
with RCC##3##2##(2007-8#1)(2011-2#1)(2013-1#1)
with RDS##2##2##(1995-5#1)(2009-2#1)
with RH##2##2##(2008-10#2)
with RHD##3##2##(2010-12#1)(2012-3#2)
with RI##2##2##(2013-1#2)
with RIA##2##2##(1994-10#1)(2008-7#1)
with RLS##3##2##(2008-10#1)(2010-3#1)(2012-12#1)
with RM##4##2##(1994-12#3)(2011-2#1)
with RNA and##3##3##(1990-5#1)(1992-3#2)
with RNA or DNA##2##4##(1990-11#1)(2008-4#1)
with RNA##26##2##(1990-11#2)(1990-5#1)(1991-6#1)(1992-3#7)(1992-5#1)(1994-3#2)(1995-3#1)(1995-5#2)(1996-4#1)(1996-8#1)(1997-2#1)(1997-6#1)(2006-8#1)(2008-4#1)(2009-7#1)(2009-8#1)(2013-1#1)
with RNase A##2##3##(1991-2#1)(2008-9#1)
with RNase##3##2##(1991-2#1)(1993-11#1)(2008-9#1)
with ROS##2##2##(2009-3#1)(2011-2#1)
with RRs in the upper tertile##2##6##(1991-5#2)
with RSD =##2##3##(2008-10#2)
with RSD##6##2##(2005-4#1)(2007-11#1)(2008-10#3)(2012-1#1)
with RSDs##2##2##(2005-12#1)(2008-10#1)
with RT##5##2##(1995-8#1)(1997-6#1)(2008-7#1)(2011-2#2)
with RT-PCR were##2##3##(2008-8#1)(2013-1#1)
with RT-PCR##4##2##(2008-8#2)(2012-2#1)(2013-1#1)
with RTX##3##2##(2013-1#2)(2013-8#1)
with RU##2##2##(1991-6#1)(1995-4#1)
with RU1##2##2##(2008-10#2)
with Raman spectroscopy##3##3##(2007-11#1)(2008-10#1)(2013-7#1)
with Raman##6##2##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)(2013-7#1)
with Ras##4##2##(1994-12#2)(1995-5#1)(1997-6#1)
with RasMol##2##2##(2008-4#2)
with Raynaud's phenomenon##5##3##(2006-10#2)(2007-7#1)(2008-12#1)(2009-8#1)
with Reduced Secondary Spectrum##2##4##(2008-3#2)
with Reduced##3##2##(2008-10#1)(2008-3#2)
with Regard to##2##3##(2006-11#1)(2008-5#1)
with RehabRoby##2##2##(2012-1#2)
with Related##2##2##(2008-10#2)
with Relation to##2##3##(1995-4#1)(2008-5#1)
with Resistance to##3##3##(2008-10#3)
with Rett syndrome##3##3##(1997-5#2)(2007-10#1)
with Review of the Literature##2##5##(2007-12#1)(2013-8#1)
with Review of##3##3##(2007-12#1)(2010-12#1)(2013-8#1)
with Revolution(®)##2##2##(2013-1#2)
with Rh##2##2##(1992-9#1)(2008-10#1)
with Rhizobium##3##2##(2008-11#1)(2011-1#1)(2012-2#1)
with Rhizoctonia solani##4##3##(2008-10#4)
with Rhizopus##2##2##(1994-12#1)(2007-11#1)
with Rhodamine##4##2##(2007-11#1)(2008-10#1)(2008-3#2)
with Rib##2##2##(2006-11#1)(2012-1#1)
with RsaI##2##2##(2008-10#2)
with Ru(II)##2##2##(2009-9#1)(2010-5#1)
with S##49##2##(1990-3#1)(1990-8#1)(1991-6#1)(1992-1#2)(1993-6#1)(1993-7#1)(1995-9#1)(1996-12#1)(1996-8#1)(2005-8#1)(2006-9#3)(2007-12#1)(2007-7#2)(2008-10#13)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-3#5)
with S222 preferred over S218##2##5##(1995-2#2)
with S9##3##2##(1992-8#1)(1993-4#1)(1996-12#1)
with SA##4##2##(2008-10#1)(2009-6#1)(2013-1#1)(2013-8#1)
with SAD##2##2##(1995-11#1)(2010-8#1)
with SAH##6##2##(1994-10#1)(1995-11#1)(1995-5#1)(2007-10#1)(2008-7#1)(2013-8#1)
with SAM-R/1##2##2##(1991-12#1)(1992-10#1)
with SAP##5##2##(2006-6#5)
with SAP102##2##2##(1996-8#2)
with SARS##4##2##(2007-7#2)(2008-10#1)(2008-4#1)
with SBI##3##2##(2006-5#1)(2007-10#2)
with SBP##3##2##(2010-4#1)(2013-1#2)
with SBWMV##2##2##(2008-10#1)(2008-8#1)
with SCA##2##2##(2009-4#1)(2010-1#1)
with SCD and##3##3##(2007-2#1)(2007-7#1)(2009-4#1)
with SCD##6##2##(2007-2#1)(2007-3#3)(2007-7#1)(2009-4#1)
with SCH 23390##3##3##(1990-5#1)(1993-9#1)(1996-10#1)
with SCI##4##2##(2007-10#1)(2012-1#3)
with SCN(-)##3##2##(2008-10#2)(2008-5#1)
with SD##4##2##(2008-10#1)(2013-8#3)
with SDS and##3##3##(2008-2#1)(2008-4#1)(2013-8#1)
with SDS for 24 h##2##5##(2004-9#2)
with SDS##9##2##(1990-12#1)(1996-5#1)(2004-9#3)(2008-11#1)(2008-2#1)(2008-4#1)(2013-8#1)
with SDS-PAGE##2##2##(1995-12#1)(2005-11#1)
with SGP##3##2##(1994-11#2)(2013-1#1)
with SH##2##2##(2008-10#2)
with SHC proteins##2##3##(1995-3#2)
with SHLI##2##2##(2011-2#2)
with SIJ##2##2##(2010-1#1)(2012-2#1)
with SIV-PBj14##3##2##(1997-3#3)
with SK##3##2##(1990-12#1)(1993-8#2)
with SKF 38393##2##3##(1990-5#1)(1996-1#1)
with SLCV-E##2##2##(2008-10#2)
with SLE and##3##3##(2006-10#2)(2011-2#1)
with SLE reported##2##3##(2006-10#2)
with SLE was##2##3##(1990-6#1)(2006-10#1)
with SLE##28##2##(1990-6#2)(1990-8#1)(1994-3#1)(2005-10#1)(2006-10#16)(2007-8#3)(2008-9#1)(2011-2#2)(2012-12#1)
with SLEDAI##2##2##(2008-8#2)
with SLI##5##2##(2009-1#1)(2009-7#1)(2011-1#3)
with SLOS##7##2##(1995-4#3)(1997-1#2)(2010-7#2)
with SMA type 1##2##4##(2013-1#2)
with SMA type##3##3##(2007-7#1)(2013-1#2)
with SMA##6##2##(1996-9#1)(2007-7#2)(2011-1#1)(2013-1#2)
with SMGN##2##2##(2007-8#2)
with SMI##5##2##(2009-6#1)(2010-8#4)
with SMMCI##2##2##(2012-2#2)
with SMV##2##2##(2008-10#2)
with SO4(2-)##2##2##(1996-9#1)(1997-6#1)
with SO4*-##3##2##(2005-4#3)
with SOD##3##2##(2006-2#1)(2006-5#2)
with SP##4##2##(1991-6#1)(1993-12#1)(1995-5#1)(1997-4#1)
with SPE clean-up and##2##4##(2008-10#2)
with SPECT in##2##3##(2007-9#1)(2011-2#1)
with SPECT##5##2##(2007-9#1)(2008-11#1)(2009-2#1)(2010-12#1)(2011-2#1)
with SPIOs##2##2##(2012-12#2)
with SPSS##8##2##(1990-8#1)(2009-7#1)(2010-12#1)(2011-2#2)(2013-1#2)(2013-8#1)
with SR##3##2##(1993-5#2)(1995-6#1)
with SRP##5##2##(1992-6#2)(2012-3#3)
with SS##11##2##(2005-10#1)(2007-1#1)(2007-10#2)(2007-11#6)(2009-11#1)
with SSRIs##3##2##(2004-3#1)(2012-2#1)(2013-8#1)
with SSc##5##2##(2006-10#4)(2012-12#1)
with ST elevation##4##3##(2008-10#3)(2008-3#1)
with ST segment elevation##3##4##(2006-9#1)(2008-3#2)
with ST segment##4##3##(2006-9#1)(2008-3#2)(2010-2#1)
with ST##9##2##(2006-9#1)(2008-10#4)(2008-3#3)(2010-2#1)
with ST-elevation myocardial infarction##2##4##(2008-3#1)(2009-7#1)
with ST-segment elevation myocardial infarction##5##5##(2008-3#1)(2009-12#1)(2009-5#3)
with ST-segment elevation myocardial##6##4##(2008-12#1)(2008-3#1)(2009-12#1)(2009-5#3)
with ST-segment elevation##7##3##(2008-12#1)(2008-3#1)(2009-12#1)(2009-5#4)
with ST-segment##8##2##(2008-12#1)(2008-3#1)(2009-12#1)(2009-5#4)(2010-9#1)
with STDs##2##2##(2007-7#1)(2009-10#1)
with STM##2##2##(2008-7#1)(2008-8#1)
with STS and synchronous metastases should##2##6##(2008-6#2)
with STS and synchronous metastases##3##5##(2008-6#3)
with STS and##4##3##(2008-6#4)
with STS markers##2##3##(1996-6#1)(2008-7#1)
with STS##11##2##(1996-6#1)(2008-10#1)(2008-11#1)(2008-6#7)(2008-7#1)
with SUVs##2##2##(1996-7#1)(2008-10#1)
with SV-40##3##2##(2010-12#3)
with SV40##2##2##(1997-7#1)(2008-11#1)
with SWNTs##3##2##(2006-12#1)(2008-7#2)
with SacI##2##2##(1990-3#1)(2008-10#1)
with Saccharomyces cerevisiae##4##3##(2006-10#1)(2008-10#1)(2012-3#1)(2013-1#1)
with Saccharomyces##5##2##(1993-3#1)(2006-10#1)(2008-10#1)(2012-3#1)(2013-1#1)
with Salicylate ointment##2##3##(2012-2#2)
with Salmonella gallinarum##2##3##(2005-9#2)
with Salmonella typhimurium##2##3##(1990-6#1)(2008-5#1)
with Salmonella##11##2##(1990-12#1)(1990-2#2)(1990-6#1)(1991-8#1)(1997-3#2)(2005-9#2)(2008-5#1)(2011-1#1)
with Sau3AI##2##2##(1990-9#1)(1991-6#1)
with Schiff##2##2##(2008-10#1)(2010-5#1)
with Schistosoma haematobium##2##3##(1996-12#1)(2010-12#1)
with Schistosoma japonicum was##2##4##(2008-8#1)(2012-3#1)
with Schistosoma##6##2##(1996-12#1)(2006-10#1)(2008-8#1)(2010-12#1)(2011-12#1)(2012-3#1)
with Sclerotinia sclerotiorum##2##3##(2008-10#2)
with Se##2##2##(2008-7#1)(2011-2#1)
with Selected##2##2##(2008-10#1)(2012-3#1)
with Sephadex##3##2##(2008-10#3)
with Ser##2##2##(1991-9#1)(2012-2#1)
with Sertoli##3##2##(2009-10#2)(2011-2#1)
with Severin##2##2##(2007-7#1)(2007-8#1)
with Sevoflurane##2##2##(2012-3#2)
with Shc##2##2##(2012-2#2)
with Shh##2##2##(2006-4#2)
with Shigella##2##2##(2006-10#2)
with Si##3##2##(2008-10#3)
with Sjogren's syndrome##2##3##(2006-4#2)
with Sjögren's syndrome##3##3##(2006-4#1)(2007-11#1)(2009-8#1)
with Sjögren's##4##2##(2006-4#2)(2007-11#1)(2009-8#1)
with Small##2##2##(1996-9#1)(2013-1#1)
with Smith-Lemli-Opitz syndrome (SLOS)##2##4##(1995-4#1)(1997-1#1)
with Smith-Lemli-Opitz##4##2##(1995-4#1)(1997-1#3)
with SmithKline Beecham##3##3##(2006-4#1)(2008-5#2)
with SmithKline##4##2##(2005-8#1)(2006-4#1)(2008-5#2)
with SnCl(2)##2##2##(2008-10#1)(2008-5#1)
with SonoVue##2##2##(2008-7#2)
with Southern blot##3##3##(1997-2#1)(2008-8#1)(2008-9#1)
with Southern##4##2##(1997-2#1)(2008-4#1)(2008-8#1)(2008-9#1)
with Soxhlet##2##2##(2008-10#2)
with Soybean##2##2##(2008-10#2)
with Sp1##4##2##(1990-6#1)(1995-3#2)(2013-1#1)
with Special Reference to##5##4##(1996-9#1)(2008-1#1)(2008-5#1)(2008-6#1)(2012-12#1)
with Special##10##2##(1994-3#1)(1996-9#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-10#1)(2012-12#1)(2013-1#2)
with Specific Language Impairment##2##4##(2009-8#1)(2011-1#1)
with Specific##4##2##(2008-2#1)(2009-8#1)(2011-1#1)(2013-1#1)
with Src and##2##3##(1994-5#1)(1995-6#1)
with SsEno##2##2##(2009-6#2)
with St##3##2##(2008-10#1)(2011-2#2)
with Stage##3##2##(1996-3#1)(1997-7#1)(2013-7#1)
with Staphylococcus aureus V8 proteinase##2##5##(1990-5#2)
with Staphylococcus aureus V8##3##4##(1990-5#2)(1991-7#1)
with Staphylococcus aureus and##2##4##(2007-7#1)(2010-6#1)
with Staphylococcus aureus##10##3##(1990-2#1)(1990-5#3)(1991-7#1)(1992-1#1)(2006-2#1)(2006-9#1)(2007-7#1)(2010-6#1)
with Staphylococcus##12##2##(1990-2#1)(1990-5#3)(1991-7#1)(1992-1#1)(1994-9#1)(2006-2#1)(2006-9#1)(2007-7#1)(2008-2#1)(2010-6#1)
with Still's disease##2##3##(2006-10#2)
with StrAph##2##2##(2012-11#2)
with Streptococcus bovis##2##3##(1997-6#1)(2011-2#1)
with Streptococcus pneumoniae serotype 3##2##5##(2006-8#2)
with Streptococcus pneumoniae##3##3##(2006-8#3)
with Streptococcus pyogenes##2##3##(1995-8#1)(2011-2#1)
with Streptococcus##10##2##(1995-8#1)(1996-9#1)(1997-6#1)(2006-8#3)(2009-6#1)(2011-2#2)(2012-12#1)
with Sweet's syndrome##2##3##(1994-5#1)(2010-6#1)
with Symptoms##2##2##(2008-10#1)(2010-8#1)
with Systemic##3##2##(2010-12#1)(2012-1#1)(2012-2#1)
with SzS##2##2##(1996-10#2)
with T and##2##3##(1993-3#1)(2007-8#1)
with T antigen##2##3##(1993-8#2)
with T beta R-I##2##4##(1995-3#2)
with T beta R-II##2##4##(1995-3#2)
with T beta##4##3##(1995-3#4)
with T cell receptor##3##4##(1991-12#1)(1991-9#1)(2005-10#1)
with T cell receptor-like specificity##2##5##(1997-4#2)
with T cell##10##3##(1991-12#1)(1991-9#1)(1994-11#1)(1994-8#1)(1997-4#2)(2005-10#1)(2007-11#1)(2008-4#1)(2008-9#1)
with T cells##5##3##(1990-6#1)(2008-11#1)(2009-3#1)(2012-12#2)
with T##48##2##(1990-12#1)(1990-6#1)(1991-12#1)(1991-8#1)(1991-9#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-3#1)(1994-8#1)(1995-3#4)(1997-1#2)(1997-4#2)(2005-10#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)
with T-cell acute lymphoblastic##2##4##(2008-5#1)(2012-12#1)
with T-cell acute##3##3##(1994-8#1)(2008-5#1)(2012-12#1)
with T-cell##8##2##(1993-12#1)(1994-8#1)(1996-4#1)(2006-10#1)(2007-2#1)(2008-5#2)(2012-12#1)
with T1##8##2##(1991-12#1)(1991-4#1)(2004-1#1)(2007-8#1)(2008-10#2)(2008-12#2)
with T1D##8##2##(2006-1#2)(2007-5#3)(2013-8#3)
with T2##4##2##(2007-8#1)(2008-12#2)(2013-1#1)
with T2-weighted##2##2##(1996-5#1)(2011-2#1)
with T2D##3##2##(2012-12#2)(2012-6#1)
with T2DM is##2##3##(2011-11#1)(2013-1#1)
with T2DM##8##2##(2008-1#1)(2011-11#1)(2012-1#2)(2013-1#4)
with T2HCA##2##2##(2013-1#2)
with T3##5##2##(1994-12#1)(2006-9#1)(2008-10#2)(2008-12#1)
with T311##2##2##(1995-8#2)
with T4##7##2##(1994-12#1)(1995-8#2)(2008-10#1)(2008-12#2)(2011-1#1)
with T7 RNA polymerase##4##4##(1993-11#1)(1995-1#1)(1996-4#1)(2008-8#1)
with T7##6##2##(1993-11#1)(1995-1#1)(1995-8#1)(1996-4#1)(2008-4#1)(2008-8#1)
with TA##7##2##(1997-8#2)(2006-10#4)(2008-10#1)
with TAFII250##2##2##(1995-8#2)
with TAH##2##2##(1996-2#2)
with TAM##2##2##(1993-11#1)(2008-12#1)
with TAN##2##2##(2008-10#2)
with TB and##3##3##(1996-11#1)(2007-2#1)(2013-8#1)
with TB##12##2##(1996-11#2)(2007-1#1)(2007-2#1)(2007-4#1)(2008-1#2)(2010-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
with TBI##4##2##(2008-10#1)(2008-9#1)(2011-1#1)(2013-1#1)
with TBP##8##2##(1990-10#2)(1992-5#2)(1993-8#1)(1995-8#1)(1996-4#1)(2012-3#1)
with TBTCl on days 7-9##2##5##(1995-2#2)
with TBTCl on days##3##4##(1995-2#3)
with TC/LEC lesions##2##3##(1994-10#2)
with TCA or##2##3##(1995-3#2)
with TCA##3##2##(1995-3#2)(2007-8#1)
with TCD##4##2##(1996-6#2)(2007-10#1)(2007-9#1)
with TCR##2##2##(2005-10#1)(2013-1#1)
with TD##2##2##(1996-1#1)(2010-12#1)
with TE##5##2##(1997-4#1)(1997-5#2)(2007-11#1)(2008-3#1)
with TEF##2##2##(1996-6#2)
with TF##2##2##(2005-10#1)(2008-5#1)
with TFDA##3##2##(2010-2#3)
with TFIIB##3##2##(1995-2#1)(1995-3#1)(1995-8#1)
with TFIID##2##2##(1994-9#2)
with TGA##3##2##(1994-9#2)(2009-6#1)
with TGF-beta 1##6##3##(1990-5#1)(1991-10#1)(1992-3#1)(1993-9#1)(1995-3#2)
with TGF-beta##10##2##(1990-5#1)(1991-10#1)(1992-3#1)(1993-12#1)(1993-9#1)(1995-3#3)(2008-11#2)
with TH##2##2##(1990-6#1)(1994-12#1)
with TIMP-2##3##2##(1992-6#1)(1993-11#2)
with TKAs that used##2##4##(2013-1#2)
with TKIs##2##2##(2012-12#1)(2012-2#1)
with TLS##2##2##(2008-10#1)(2008-7#1)
with TM increases of##2##4##(1991-8#2)
with TM##4##2##(1991-8#2)(1995-1#1)(2007-12#1)
with TMA dust##2##3##(2008-10#2)
with TMA##9##2##(1992-9#5)(1995-11#1)(1997-2#1)(2008-10#2)
with TMAH##2##2##(2008-10#2)
with TMD-hypermobility##2##2##(2008-10#2)
with TMV##2##2##(1993-5#1)(1997-3#1)
with TMV-OM##2##2##(1997-6#2)
with TNF alpha##2##3##(1995-2#1)(2008-6#1)
with TNF##8##2##(1995-2#1)(1995-3#1)(1997-5#1)(1997-7#1)(2006-6#2)(2008-6#1)(2013-7#1)
with TNF-alpha##8##2##(1992-3#2)(1995-12#1)(2008-8#1)(2008-9#1)(2009-9#2)(2013-7#1)
with TNFalpha and cisplatin##2##4##(2008-6#2)
with TNFalpha and##3##3##(2006-6#1)(2008-6#2)
with TNFalpha##8##2##(1996-5#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-6#3)
with TNM##3##2##(1996-3#1)(2007-6#1)(2011-1#1)
with TNP##2##2##(2007-8#1)(2008-10#1)
with TPA for##2##3##(1990-4#1)(1993-4#1)
with TPA or##3##3##(1993-6#1)(1994-12#1)(1995-8#1)
with TPA resulted in##2##4##(1990-2#1)(1996-5#1)
with TPA##20##2##(1990-10#2)(1990-12#1)(1990-2#2)(1990-4#1)(1990-9#1)(1992-6#1)(1993-4#1)(1993-6#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-7#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-3#1)(2005-9#1)
with TPRO##3##2##(1990-4#3)
with TRH in a##2##4##(1991-10#2)
with TRH in##3##3##(1991-10#2)(2013-7#1)
with TRH##5##2##(1991-10#2)(1992-2#1)(2013-7#2)
with TRTV and##2##3##(1997-6#2)
with TRTV##5##2##(1997-6#4)(2008-5#1)
with TS##3##2##(1996-5#1)(2006-3#1)(2008-7#1)
with TSH##7##2##(1991-10#1)(1991-7#1)(1991-8#1)(1993-8#1)(2006-11#1)(2011-1#1)(2012-3#1)
with TSH-binding##2##2##(1991-9#1)(1994-11#1)
with TSP##3##2##(1990-7#1)(1991-2#1)(2007-3#1)
with TT##2##2##(1990-4#1)(2007-10#1)
with TTA in##2##3##(2007-11#1)(2008-10#1)
with TTA##3##2##(2007-11#1)(2008-10#2)
with TTCP/DCPA molar ratios##2##4##(2004-9#1)(2009-9#1)
with TTCP/DCPA molar##3##3##(2004-9#2)(2009-9#1)
with TTCP/DCPA##5##2##(2004-9#3)(2009-9#2)
with TV shearography##2##3##(2008-3#2)
with TV##3##2##(2008-2#1)(2008-3#2)
with TYLCV##4##2##(2008-10#4)
with Taiwan strains##3##3##(2008-8#3)
with Takayasu arteritis##8##3##(1997-8#7)(2006-10#1)
with Takayasu's arteritis and##2##4##(2006-10#1)(2010-7#1)
with Takayasu's arteritis##4##3##(2006-10#2)(2010-7#2)
with Takayasu's##6##2##(2006-10#2)(2007-7#2)(2010-7#2)
with Taq DNA polymerase##2##4##(1997-4#1)(2008-5#1)
with Taq##3##2##(1990-5#1)(1997-4#1)(2008-5#1)
with TaqI##2##2##(1993-2#1)(2008-10#1)
with TaqMan probes##2##3##(2008-10#1)(2012-2#1)
with TaqMan##3##2##(2008-10#2)(2012-2#1)
with Tat##3##2##(1990-6#1)(1991-3#1)(2009-8#1)
with Taxol##3##2##(1994-5#1)(2008-5#1)(2013-8#1)
with Taxotere##2##2##(1994-8#2)
with Teflon##2##2##(2007-8#1)(2010-8#1)
with Those of##2##3##(2008-10#2)
with Thyrogen##2##2##(2006-9#2)
with TiO(2)##4##2##(2007-12#1)(2013-1#3)
with TiO2##2##2##(2008-10#2)
with Tomato spotted wilt virus (TSWV)##2##6##(2008-10#2)
with Tomato spotted wilt virus##4##5##(2008-10#4)
with Tomato##5##2##(2008-10#5)
with Total##2##2##(2007-7#1)(2011-1#1)
with Toxocara eggs##2##3##(2011-1#2)
with Toxocara##3##2##(2011-1#3)
with Toxoplasma gondii##2##3##(1997-3#1)(2008-4#1)
with Toxoplasma##3##2##(1992-2#1)(1997-3#1)(2008-4#1)
with Treacher Collins syndrome##4##4##(2007-12#2)(2012-12#1)(2012-2#1)
with Treatment##2##2##(2008-7#2)
with Trichinella##2##2##(1990-12#1)(1996-12#1)
with Trichoderma##8##2##(2008-10#7)(2008-6#1)
with Tris##2##2##(1991-2#1)(1994-8#1)
with Triton X-100##10##3##(1990-11#1)(1990-7#2)(1991-2#1)(1991-8#1)(1992-6#1)(1994-3#1)(1996-5#1)(2008-4#1)(2008-7#1)
with Triton X-114##4##3##(1991-9#1)(1992-3#1)(1995-5#1)(1997-1#1)
with Triton##19##2##(1990-11#1)(1990-7#2)(1991-2#1)(1991-8#3)(1991-9#2)(1992-3#1)(1992-6#1)(1994-3#1)(1995-5#1)(1996-5#1)(1997-1#1)(2008-4#1)(2008-7#2)(2010-12#1)
with Trypanosoma brucei brucei##2##4##(1994-2#2)
with Trypanosoma##4##2##(1994-2#2)(1997-4#1)(2012-12#1)
with TuMV##3##2##(2008-10#3)
with Turner syndrome##3##3##(2008-4#2)(2008-6#1)
with Turner##4##2##(2007-12#1)(2008-4#2)(2008-6#1)
with Tween##2##2##(1992-10#1)(2010-1#1)
with Two##3##2##(2008-2#1)(2008-3#2)
with Type 1 diabetes##3##4##(2008-1#1)(2010-9#1)(2011-1#1)
with Type 1##4##3##(2008-1#1)(2010-9#1)(2011-1#1)(2013-1#1)
with Type 2 Diabetes Mellitus##4##5##(2008-3#1)(2011-11#1)(2012-1#1)(2013-1#1)
with Type 2 Diabetes##8##4##(2008-3#1)(2011-11#1)(2012-1#1)(2013-1#4)(2013-7#1)
with Type 2 diabetes##3##4##(1994-12#2)(2006-1#1)
with Type 2##12##3##(1994-12#2)(2006-1#1)(2008-3#2)(2011-11#1)(2012-1#1)(2013-1#4)(2013-7#1)
with Type II##3##3##(2006-7#2)(2012-12#1)
with Type##23##2##(1994-12#2)(2006-1#1)(2006-7#2)(2007-8#2)(2008-1#1)(2008-3#3)(2010-9#1)(2011-1#1)(2011-11#1)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#5)(2013-7#1)
with U##9##2##(1994-1#1)(2005-10#1)(2007-12#1)(2008-10#6)
with UA##2##2##(2013-8#2)
with UA/NSTEMI##2##2##(2008-3#2)
with UC##3##2##(1995-2#1)(2012-2#2)
with UCS##2##2##(2008-11#2)
with UES##2##2##(2013-8#2)
with UI##2##2##(2011-1#2)
with UIP##3##2##(2005-8#3)
with UN##3##2##(2006-4#1)(2009-2#2)
with US##4##2##(1991-12#1)(1996-1#1)(2007-7#1)(2008-8#1)
with UV absorbance and##3##4##(2007-8#1)(2008-10#2)
with UV absorbance detection##2##4##(1996-5#1)(2008-10#1)
with UV absorbance##5##3##(1996-5#1)(2007-8#1)(2008-10#3)
with UV and##3##3##(1996-8#1)(2008-10#2)
with UV at##3##3##(2008-10#2)(2008-9#1)
with UV detection at##7##4##(1990-12#1)(2008-10#5)(2010-3#1)
with UV detection for##2##4##(1993-2#1)(2008-10#1)
with UV detection was developed##2##5##(2007-1#1)(2008-10#1)
with UV detection was##3##4##(2007-1#1)(2008-10#2)
with UV detection##36##3##(1990-12#1)(1992-1#1)(1992-2#1)(1993-2#3)(1994-9#1)(1997-3#3)(2004-12#1)(2007-1#1)(2007-8#1)(2008-10#21)(2010-3#1)(2011-1#1)
with UV irradiation##3##3##(2007-12#1)(2007-8#1)(2010-4#1)
with UV light and##2##4##(1994-6#1)(2008-10#1)
with UV light##14##3##(1994-6#1)(1995-3#1)(1995-5#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-4#1)
with UV##71##2##(1990-12#1)(1992-1#1)(1992-2#1)(1993-2#3)(1994-6#1)(1994-9#1)(1995-3#1)(1995-5#2)(1996-5#2)(1996-8#1)(1997-3#3)(2004-12#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-8#3)(2008-10#32)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-3#1)(2010-4#2)(2011-1#1)
with UV-vis##2##2##(2008-10#2)
with UVA##4##2##(1992-6#1)(1994-3#1)(2008-8#2)
with UVB##3##2##(1996-6#1)(2008-11#1)(2008-5#1)
with UVB-irradiated##2##2##(1996-6#1)(2008-5#1)
with Ultrabithorax##2##2##(1995-1#2)
with University##3##2##(2008-11#1)(2010-11#1)(2010-3#1)
with Upper Gastrointestinal bleeding##2##4##(2013-1#2)
with V##13##2##(1993-12#1)(1995-5#1)(2008-10#8)(2008-6#2)(2011-1#1)
with V(IV)##2##2##(2008-10#1)(2008-5#1)
with V108LRUH1##2##2##(2008-10#2)
with V4 lesions##8##3##(1992-11#3)(1992-9#2)(1993-2#3)
with VAD##2##2##(2010-6#1)(2012-3#1)
with VCG##3##2##(2008-10#3)
with VEGF##3##2##(2007-8#1)(2009-11#1)(2013-1#1)
with VIIa##3##2##(1994-11#3)
with VIP##3##2##(1993-9#1)(1995-6#1)(2006-7#1)
with VLDL##4##2##(1992-12#3)(1993-11#1)
with VP##2##2##(2007-10#1)(2008-5#1)
with VPA in##2##3##(2007-11#1)(2010-10#1)
with VPA##7##2##(2007-11#1)(2010-10#1)(2011-2#5)
with VS recruitment by##2##4##(2012-1#2)
with VS##3##2##(1993-3#1)(2012-1#2)
with VTG##3##2##(1994-9#2)(2009-4#1)
with Variable##3##2##(1996-7#1)(2010-1#1)(2010-4#1)
with Variofill##2##2##(2013-1#2)
with Vf##2##2##(2008-10#1)(2008-5#1)
with Vibrio##3##2##(1995-5#2)(2008-10#1)
with Viral##2##2##(2008-10#1)(2010-7#1)
with Virulence in##2##3##(2008-10#2)
with Vitamin D##2##3##(2012-12#2)
with Vitamin##3##2##(2012-12#2)(2013-1#1)
with Vmax##2##2##(1994-11#1)(2009-2#1)
with Von Recklinghausen's##2##3##(1994-6#1)(2008-10#1)
with WD##5##2##(2007-12#2)(2008-10#1)(2008-8#2)
with WG##5##2##(2006-10#4)(2007-8#1)
with WHO##7##2##(2006-4#1)(2007-11#2)(2007-2#1)(2007-7#2)(2010-12#1)
with WS##3##2##(2009-4#2)(2010-2#1)
with WT##2##2##(2013-1#1)(2013-7#1)
with Waardenburg syndrome##5##3##(2008-9#5)
with Wegener's granulomatosis##4##3##(1996-1#1)(2006-10#1)(2008-5#2)
with Wegener's##6##2##(1991-3#1)(1996-1#1)(2006-10#1)(2008-5#3)
with Weill-Marchesani syndrome and##2##4##(2007-8#2)
with Werner syndrome##2##3##(1992-9#1)(2012-8#1)
with Western blotting##3##3##(1993-11#1)(2010-12#1)(2011-3#1)
with Western##7##2##(1993-11#1)(2005-8#1)(2007-12#1)(2010-12#1)(2010-9#1)(2011-2#1)(2011-3#1)
with Williams syndrome (WS)##2##4##(2009-4#1)(2010-2#1)
with Williams syndrome##4##3##(2008-11#1)(2008-4#1)(2009-4#1)(2010-2#1)
with Williams##5##2##(2008-11#1)(2008-4#1)(2009-4#1)(2010-2#2)
with Wilson disease##4##3##(1993-11#1)(1995-3#1)(2007-12#1)(2008-3#1)
with X##5##2##(1997-7#1)(2008-10#4)
with X-Linked##2##2##(2007-2#1)(2007-7#1)
with X-linked##6##2##(1992-1#1)(1992-4#1)(1995-3#1)(1996-11#2)(2007-2#1)
with X-ray diffraction (XRD)##2##4##(2005-11#1)(2008-10#1)
with X-ray diffraction##4##3##(1995-8#1)(2005-11#1)(2008-10#1)(2013-1#1)
with X-ray##12##2##(1991-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(2005-11#1)(2006-5#1)(2007-8#1)(2008-10#2)(2010-4#1)(2011-2#1)(2013-1#1)
with X-rays and##2##3##(1996-6#1)(2011-2#1)
with X-rays##5##2##(1996-6#1)(2006-4#1)(2008-4#1)(2011-2#1)(2013-1#1)
with XACML##2##2##(2010-8#2)
with XPA##2##2##(1996-11#1)(1997-1#1)
with XRCC1##2##2##(1997-4#2)
with XRCC4##2##2##(1997-7#2)
with XRD##2##2##(2005-11#1)(2013-8#1)
with Xanthomonas campestris pv##2##4##(2008-10#2)
with Xanthomonas##4##2##(2007-12#1)(2008-10#3)
with Xenopus##2##2##(1992-11#1)(1994-8#1)
with Y##8##2##(1992-11#1)(2008-10#2)(2008-5#2)(2010-4#2)(2013-1#1)
with YAC clones##2##3##(1996-10#1)(1996-12#1)
with YACs##2##2##(1996-10#1)(1997-2#1)
with Yb(3+)##3##2##(2008-1#2)(2012-12#1)
with Zeeman##2##2##(2008-10#2)
with Zeeman-effect background##2##3##(2008-10#2)
with Zileuton##4##2##(2010-5#4)
with Zn##3##2##(1993-12#1)(2008-5#2)
with Zn(+2)##3##2##(2008-5#3)
with Zn(2+)##4##2##(2008-10#3)(2012-12#1)
with Zn(II)##3##2##(2008-3#1)(2010-11#2)
with Zn2+##3##2##(1996-10#1)(1997-4#1)(1997-7#1)
with ZnS##2##2##(2007-11#1)(2008-10#1)
with ZnSO(4) prevented##2##3##(2008-10#2)
with ZnSO(4)##3##2##(2008-10#3)
with Zr##2##2##(2008-10#1)(2008-3#1)
with Zymomonas mobilis##2##3##(1991-9#1)(2011-2#1)
with [1##3##2##(1991-8#1)(1996-2#2)
with [14C]Nbf-Cl and##2##3##(1991-3#2)
with [35S]GTP gamma S##2##4##(1990-7#1)(1992-6#1)
with [35S]methionine##5##2##(1990-12#1)(1993-11#1)(1995-3#1)(1996-2#1)(1997-4#1)
with [35S]sulfate and##2##3##(1990-3#2)
with [35S]sulfate##4##2##(1990-3#3)(1994-12#1)
with [3H]FSBI##2##2##(1991-3#2)
with [3H]SCH 23390##3##3##(1993-2#1)(1994-2#1)(1996-3#1)
with [3H]choline##2##2##(1991-6#1)(1997-2#1)
with [3H]inositol##3##2##(1990-2#1)(1991-2#1)(1993-6#1)
with [gamma-32P]ATP##5##2##(1990-2#1)(1994-12#1)(1994-3#2)(1995-6#1)
with [poly(dA-dT)]2##2##2##(1993-3#2)
with a &quot##17##3##(1993-11#1)(1994-9#1)(1995-5#1)(1996-2#1)(1997-6#1)(2006-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-3#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-1#3)
with a 0##20##3##(1994-3#1)(1996-5#1)(1997-1#1)(2007-12#2)(2007-5#2)(2007-8#1)(2008-10#6)(2008-2#1)(2008-3#3)(2012-2#2)
with a 1 mm##3##4##(2007-1#1)(2008-10#2)
with a 1##26##3##(1990-9#1)(1991-7#1)(1993-8#1)(1993-9#2)(1995-2#1)(1995-3#1)(2006-12#1)(2007-1#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#1)(2009-2#1)(2013-1#1)
with a 1-bit analog-to-digital##2##4##(2008-3#2)
with a 1-bit##3##3##(2008-3#3)
with a 1-min##2##3##(1993-2#1)(2008-2#1)
with a 1-mm-thick##2##3##(2007-12#1)(2008-3#1)
with a 1-year history of##2##5##(2006-10#1)(2013-8#1)
with a 10##8##3##(1992-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-9#1)(2012-2#1)
with a 10%##3##3##(1990-3#1)(2007-7#1)(2008-4#1)
with a 10-##3##3##(2007-11#2)(2008-10#1)
with a 10-fold lower##3##4##(1994-6#1)(1995-10#1)(1996-12#1)
with a 10-fold##7##3##(1993-11#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-9#1)(1996-12#1)(2010-1#1)
with a 10-year history of##2##5##(2010-6#1)(2012-12#1)
with a 10-year history##3##4##(2006-1#1)(2010-6#1)(2012-12#1)
with a 10-year##4##3##(2006-1#1)(2010-6#1)(2011-1#1)(2012-12#1)
with a 100% water mobile phase##2##6##(2008-10#2)
with a 100%##5##3##(2007-12#1)(2007-7#1)(2008-10#2)(2013-1#1)
with a 1000-fold##2##3##(1990-3#1)(1996-12#1)
with a 1064-nm##3##3##(2006-12#1)(2007-12#2)
with a 12##3##3##(2007-1#1)(2008-11#1)(2008-2#1)
with a 120##2##3##(1992-12#1)(2008-10#1)
with a 13##2##3##(1990-1#1)(2008-10#1)
with a 13-year history of##2##5##(2006-4#1)(2008-7#1)
with a 13-year##3##3##(2006-4#1)(2008-7#1)(2009-3#1)
with a 15##3##3##(1990-10#1)(1991-4#1)(2008-5#1)
with a 15-day##2##3##(2008-5#1)(2011-1#1)
with a 2##19##3##(1990-5#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-5#1)(1997-1#1)(2004-11#1)(2004-12#1)(2007-12#2)(2007-5#1)(2008-10#3)(2008-2#1)(2010-6#1)
with a 2%##2##3##(1991-8#1)(2008-10#1)
with a 2-##2##3##(1995-1#1)(2008-7#1)
with a 2-3##2##3##(1991-2#1)(2008-1#1)
with a 2-acetamido-2-deoxy-alpha-D-galactopyranosyl group##2##4##(1991-7#2)
with a 2-week##3##3##(1991-2#1)(2008-10#2)
with a 2-year history of##4##5##(2007-11#1)(2008-5#1)(2008-6#1)(2012-12#1)
with a 2-year##5##3##(2007-11#1)(2008-5#1)(2008-6#1)(2012-1#1)(2012-12#1)
with a 20##3##3##(1990-10#1)(2008-10#2)
with a 20%##3##3##(2008-2#1)(2008-5#1)(2013-8#1)
with a 20-year history of##2##5##(2006-7#1)(2007-8#1)
with a 21##4##3##(1993-8#1)(1995-2#1)(2013-1#2)
with a 24-hour##2##3##(2007-9#1)(2008-6#1)
with a 24-hr##2##3##(2007-2#1)(2009-11#1)
with a 28%##2##3##(1990-10#1)(2013-1#1)
with a 3##18##3##(1990-11#1)(1990-7#1)(1992-3#1)(1995-11#1)(1996-2#1)(2007-11#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2009-8#1)(2010-9#2)(2011-12#1)(2012-2#1)(2013-1#1)
with a 3'##3##3##(1993-12#1)(2010-2#2)
with a 3-4-fold##2##3##(1994-8#1)(2008-10#1)
with a 3-D##3##3##(2008-2#2)(2008-3#1)
with a 3-cm(-1) passband##2##4##(2008-2#2)
with a 3-ns##2##3##(2007-12#1)(2008-3#1)
with a 30##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
with a 30%##3##3##(1994-12#1)(2006-8#1)(2008-7#1)
with a 31%##2##3##(2007-11#1)(2008-7#1)
with a 37-element adaptive optics system##2##6##(2008-2#2)
with a 3D##5##3##(2007-11#2)(2007-12#1)(2008-5#1)(2009-12#1)
with a 4##7##3##(1990-5#1)(2007-4#1)(2008-10#1)(2008-2#1)(2011-12#1)(2013-1#2)
with a 4-month##2##3##(2005-10#1)(2007-8#1)
with a 4-year history of##4##5##(2006-10#1)(2006-2#1)(2010-6#1)(2012-3#1)
with a 40##3##3##(1990-5#1)(2008-3#1)(2009-2#1)
with a 40%##2##3##(1994-9#1)(2010-4#1)
with a 400##2##3##(2005-7#1)(2006-5#1)
with a 45 degrees##2##4##(2008-3#2)
with a 5##7##3##(1990-12#1)(1992-1#1)(1997-2#1)(2007-12#1)(2008-10#2)(2011-2#1)
with a 5%##4##3##(1991-2#1)(2008-10#1)(2008-5#1)(2010-9#1)
with a 5-mm##2##3##(2006-7#1)(2008-7#1)
with a 5-s##2##3##(1993-2#1)(2008-2#1)
with a 5-year##3##3##(2008-6#1)(2010-12#1)(2012-3#1)
with a 50% reduction##2##4##(2008-6#1)(2012-12#1)
with a 50%##10##3##(1992-10#1)(1994-6#1)(1995-11#1)(2007-11#1)(2008-5#1)(2008-6#2)(2011-12#1)(2011-2#1)(2012-12#1)
with a 50-fold##3##3##(1995-11#1)(1996-8#1)(1997-4#1)
with a 50/50##2##3##(2007-12#2)
with a 6##5##3##(1995-2#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-3#1)
with a 6-fold##2##3##(1996-9#1)(2009-6#1)
with a 6-month##2##3##(2010-10#1)(2012-2#1)
with a 60##2##3##(1992-1#1)(2008-10#1)
with a 60%##2##3##(1994-12#1)(2008-3#1)
with a 64##2##3##(1995-8#1)(2011-2#1)
with a 670-nm##2##3##(2007-12#1)(2008-3#1)
with a 7##9##3##(1990-7#1)(1991-10#1)(1991-6#1)(1992-3#1)(1994-5#1)(1996-6#1)(2007-10#1)(2007-8#1)(2008-2#1)
with a 7-fold##2##3##(1992-12#1)(2007-10#1)
with a 9##6##3##(1990-12#1)(1994-12#1)(1997-2#1)(2008-10#2)(2012-2#1)
with a 90%##4##3##(2008-10#2)(2008-2#1)(2010-5#1)
with a 94##2##3##(1993-1#1)(1994-3#1)
with a 95% confidence interval of##2##6##(1991-7#1)(2007-2#1)
with a 95% confidence##3##4##(1991-7#1)(2007-2#1)(2008-3#1)
with a 95%##4##3##(1991-7#1)(2007-2#1)(2008-3#1)(2013-1#1)
with a = 10##3##4##(1996-2#3)
with a = 11##5##4##(1996-2#3)(1997-7#2)
with a = 13##4##4##(1996-2#1)(1997-7#3)
with a = 15##3##4##(1996-2#3)
with a = 21##2##4##(1996-2#1)(1997-7#1)
with a = 7##2##4##(2007-10#1)(2007-11#1)
with a = 8##4##4##(1996-2#2)(1997-7#2)
with a = 9##3##4##(1996-2#1)(2007-11#2)
with a =##36##3##(1990-8#1)(1992-12#1)(1992-9#1)(1995-6#1)(1996-2#18)(1997-7#9)(2007-10#1)(2007-11#3)(2008-4#1)
with a B##3##3##(1995-6#2)(2008-5#1)
with a Bmax##2##3##(1990-5#1)(1993-8#1)
with a Bragg grating##2##4##(2008-3#2)
with a C##4##3##(1997-3#2)(2008-10#2)
with a C(18)##3##3##(2008-10#3)
with a C-terminal##3##3##(1995-8#1)(1997-7#1)(2009-10#1)
with a C18##2##3##(1996-5#1)(2011-1#1)
with a CCD array is##2##5##(2008-2#1)(2008-3#1)
with a CCD camera##9##4##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#4)
with a CCD detector##2##4##(2008-2#1)(2008-3#1)
with a CCD##15##3##(2007-11#3)(2007-12#1)(2008-2#3)(2008-3#8)
with a CD4##3##3##(1995-9#1)(2007-7#1)(2013-1#1)
with a CO(2) laser##6##4##(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#1)
with a Chiari##3##3##(2005-5#1)(2006-9#1)(2008-7#1)
with a Class##2##3##(2012-2#2)
with a Co(2+)##3##3##(2007-11#1)(2008-3#2)
with a Cr(4+)##3##3##(2007-12#3)
with a DNA fragment containing##2##5##(1990-5#1)(1995-2#1)
with a DNA fragment##4##4##(1990-4#1)(1990-5#1)(1995-2#1)(2008-8#1)
with a DNA##9##3##(1990-4#1)(1990-5#1)(1992-11#1)(1993-11#1)(1994-9#1)(1995-2#1)(1996-7#1)(2008-11#1)(2008-8#1)
with a DSM-III-R diagnosis of schizophrenia##2##6##(1997-8#1)(2004-11#1)
with a European American##2##4##(2009-11#2)
with a European##3##3##(2009-11#2)(2011-2#1)
with a FWHM of##3##4##(2007-11#1)(2008-3#2)
with a FWHM##7##3##(2007-11#3)(2007-12#1)(2008-1#1)(2008-3#2)
with a Fabry-Perot interferometer##3##4##(2008-3#3)
with a Fabry-Perot##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
with a Finn Chamber##2##4##(1992-6#2)
with a Fourier transform infrared (FT-IR)##2##6##(2008-10#1)(2008-2#1)
with a Fourier transform infrared spectrometer##2##6##(2008-2#1)(2008-3#1)
with a Fourier transform infrared##4##5##(2008-10#1)(2008-2#2)(2008-3#1)
with a Fourier transform##5##4##(2008-10#1)(2008-2#2)(2008-3#2)
with a Fourier##6##3##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#2)
with a Fourier-transform spectrometer##3##4##(2008-2#1)(2008-3#2)
with a Fourier-transform##5##3##(2008-2#2)(2008-3#3)
with a G protein##4##4##(1990-7#3)(1993-6#1)
with a GaAs##2##3##(2008-2#1)(2008-3#1)
with a Gaussian power-density profile are##2##6##(2008-2#1)(2008-3#1)
with a Gaussian##13##3##(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#4)(2008-7#1)(2009-6#1)
with a Gires-Tournois##2##3##(2007-12#2)
with a GnRH##3##3##(1996-2#1)(2006-9#1)(2008-5#1)
with a Hartmann-Shack wave-front sensor##2##5##(2007-12#1)(2008-2#1)
with a He-Ne laser##4##4##(2007-12#1)(2008-3#3)
with a Hill coefficient of 1##2##6##(1990-2#1)(1995-3#1)
with a Hill##3##3##(1990-2#1)(1995-3#1)(2012-2#1)
with a Hybrid III##2##4##(2007-4#2)
with a KD of 1##2##5##(1993-12#1)(1995-1#1)
with a KD of##5##4##(1991-7#1)(1991-8#1)(1993-12#1)(1995-1#1)(1995-3#1)
with a KD##7##3##(1990-7#1)(1991-7#1)(1991-8#1)(1993-12#1)(1995-1#1)(1995-3#1)(1996-5#1)
with a Kd in the##2##5##(1990-11#1)(1992-12#1)
with a Kd of 0##2##5##(1994-8#1)(1995-11#1)
with a Kd of##17##4##(1990-10#1)(1990-2#1)(1991-5#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-3#2)(1994-8#2)(1995-11#1)(1995-8#1)(1996-10#2)(1997-5#1)
with a Kd##23##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-7#1)(1991-5#3)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-3#2)(1994-8#2)(1995-11#1)(1995-3#1)(1995-8#1)(1996-10#2)(1997-5#2)
with a Kerr-lens mode-locked##2##4##(2007-12#2)
with a Ki = 3##2##5##(1991-12#2)
with a Ki =##3##4##(1991-12#3)
with a Ki of 1##3##5##(1990-11#2)(1994-12#1)
with a Ki of 6##2##5##(1990-11#1)(1993-8#1)
with a Ki of##11##4##(1990-11#3)(1991-5#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-12#2)
with a Ki value of##5##5##(1990-7#1)(1993-4#1)(1996-10#2)(1996-5#1)
with a Ki##19##3##(1990-11#3)(1990-7#1)(1991-12#3)(1991-5#1)(1993-4#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-10#2)(1996-12#2)(1996-5#1)
with a Km of##5##4##(1991-3#1)(1992-6#1)(1995-1#1)(1997-1#1)(2008-7#1)
with a KrF excimer laser##2##5##(2007-12#1)(2008-2#1)
with a LOD##2##3##(2008-10#2)
with a M(r)##2##3##(1993-11#1)(1995-8#1)
with a Mach-Zehnder##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
with a Michelson interferometer##2##4##(2007-12#1)(2008-2#1)
with a Monte Carlo simulation##2##5##(1995-8#1)(2008-3#1)
with a Monte Carlo##4##4##(1995-8#1)(2008-3#3)
with a Mr of##5##4##(1991-7#1)(1992-1#2)(1994-11#1)(1994-8#1)
with a Mr##7##3##(1990-7#1)(1991-7#1)(1991-9#1)(1992-1#2)(1994-11#1)(1994-8#1)
with a NA of##2##4##(2007-12#1)(2008-3#1)
with a Nafion(R)-membrane##2##3##(2008-10#2)
with a Nd##2##3##(2007-12#1)(2008-1#1)
with a Nernstian slope of 29##3##6##(2008-10#3)
with a Nernstian slope of 59##3##6##(2008-10#3)
with a Nernstian slope of##12##5##(2008-10#12)
with a PCR##2##3##(1990-8#1)(2008-10#1)
with a PCR-based##2##3##(1997-8#1)(2008-10#1)
with a PRAL(+)##2##3##(2012-1#2)
with a PRAL(-)##2##3##(2012-1#2)
with a Palm computer##2##4##(2009-11#2)
with a QTL##2##3##(2008-10#1)(2008-8#1)
with a R##10##3##(1997-2#1)(2008-10#8)(2011-1#1)
with a RSD##2##3##(2008-10#2)
with a Rasch model##2##4##(2012-2#2)
with a SD of##3##4##(2013-8#3)
with a Soret##2##3##(1990-10#1)(1995-5#1)
with a Staphylococcus aureus infection##2##5##(2008-5#1)(2013-1#1)
with a Stokes radius of##2##5##(1992-12#1)(1995-6#1)
with a Swedish##2##3##(1993-6#1)(2006-10#1)
with a T1##2##3##(2007-8#1)(2008-10#1)
with a TM of##2##4##(1991-8#2)
with a Tm##2##3##(1992-1#1)(2008-3#1)
with a UTI##2##3##(2007-10#1)(2008-6#1)
with a UV##2##3##(1997-4#1)(2008-11#1)
with a Vmax of##2##4##(1991-8#2)
with a World##2##3##(2007-9#1)(2010-7#1)
with a baculovirus expressing##2##4##(2008-11#1)(2008-7#1)
with a baculovirus expression vector system##2##6##(2008-11#2)
with a baculovirus##4##3##(2008-11#3)(2008-7#1)
with a ball##2##3##(2007-1#1)(2011-1#1)
with a balloon##3##3##(1996-6#1)(2013-1#2)
with a bandwidth of##5##4##(2007-11#3)(2007-12#1)(2007-9#1)
with a bare silica##2##4##(1996-5#1)(2008-10#1)
with a bare##4##3##(1996-5#1)(2007-12#1)(2008-10#1)(2008-3#1)
with a barrier of##2##4##(1994-11#1)(1996-2#1)
with a baseline established between##2##5##(2008-10#2)
with a baseline##9##3##(1996-1#1)(2007-12#1)(2008-10#3)(2008-6#1)(2013-1#3)
with a basic##4##3##(1995-4#1)(2008-10#2)(2013-8#1)
with a beam quality of##2##5##(2007-11#1)(2007-12#1)
with a beam quality##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
with a beam##10##3##(2007-11#3)(2007-12#1)(2008-3#6)
with a beam-quality factor M(2)##2##5##(2007-12#1)(2008-2#1)
with a bending##2##3##(1997-2#1)(2007-12#1)
with a benign##2##3##(2005-11#1)(2008-9#1)
with a best##3##3##(2010-10#1)(2011-2#1)(2012-2#1)
with a beta##3##3##(1991-2#1)(1994-10#1)(2008-10#1)
with a better prognosis##4##4##(1994-6#1)(2006-10#1)(2008-6#1)(2011-2#1)
with a better understanding of##3##5##(2006-10#1)(2009-10#1)(2011-1#1)
with a better##26##3##(1994-6#1)(1995-9#1)(2004-11#1)(2005-10#1)(2005-8#1)(2006-10#3)(2007-7#1)(2008-10#2)(2008-11#2)(2008-6#2)(2008-7#2)(2009-10#2)(2009-12#1)(2011-1#2)(2011-2#1)(2012-3#2)(2013-1#1)
with a bicarbonate##2##3##(1995-7#1)(2006-6#1)
with a bilateral##4##3##(1994-6#1)(2007-8#1)(2007-9#1)(2009-1#1)
with a bile acid##2##4##(1991-6#1)(2008-10#1)
with a biliary##2##3##(2006-6#1)(2009-4#1)
with a bimodal distribution of##2##5##(2010-2#1)(2012-1#1)
with a bimodal##6##3##(1997-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-2#1)(2012-1#1)
with a binary##12##3##(1992-2#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#4)(2012-2#2)
with a binding constant##3##4##(1990-4#1)(1992-9#1)(1994-11#1)
with a binding##5##3##(1990-4#1)(1992-11#1)(1992-9#1)(1994-11#1)(2008-9#1)
with a bioadhesive##2##3##(2010-4#2)
with a biological##2##3##(1992-11#1)(2009-8#1)
with a biologically active##3##4##(1990-5#1)(1994-11#1)(1994-8#1)
with a biopsy##2##3##(1997-5#1)(2007-5#1)
with a biotinylated##2##3##(2008-1#1)(2008-4#1)
with a biphasic##4##3##(1990-2#1)(1993-11#1)(1997-7#1)(2008-7#1)
with a bipolar##2##3##(1993-8#1)(1997-5#1)
with a birth weight##2##4##(1992-2#1)(2007-12#1)
with a bit##2##3##(2007-12#1)(2008-3#1)
with a blood pressure##3##4##(1997-2#1)(2008-7#1)(2011-1#1)
with a blood##9##3##(1991-8#1)(1997-2#1)(2005-9#1)(2008-10#1)(2008-7#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-7#1)
with a blue##2##3##(2007-11#1)(2008-10#1)
with a body mass index (BMI)##3##6##(2007-8#1)(2008-7#1)(2012-12#1)
with a body mass index##5##5##(2005-10#2)(2007-8#1)(2008-7#1)(2012-12#1)
with a body##8##3##(1996-9#1)(2005-10#2)(2007-8#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)
with a bolus##2##3##(1993-1#1)(2006-6#1)
with a bone##4##3##(1995-12#1)(2007-7#1)(2008-6#2)
with a branched electron##2##4##(1994-5#1)(1995-6#1)
with a branched##3##3##(1994-5#1)(1995-6#1)(2007-12#1)
with a breast lump##2##4##(1990-10#1)(1991-12#1)
with a brief discussion of##4##5##(1994-4#1)(2006-5#1)(2010-11#1)(2012-12#1)
with a brief discussion on##2##5##(2008-2#1)(2008-6#1)
with a brief discussion##6##4##(1994-4#1)(2006-5#1)(2008-2#1)(2008-6#1)(2010-11#1)(2012-12#1)
with a brief introduction to##2##5##(2008-7#1)(2012-2#1)
with a brief overview of##2##5##(2007-7#1)(2008-4#1)
with a brief review of the literature##3##7##(2008-8#1)(2009-5#1)(2010-12#1)
with a brief review of the##5##6##(2008-8#1)(2009-5#2)(2010-12#1)(2010-2#1)
with a brief review of##6##5##(2008-6#1)(2008-8#1)(2009-5#2)(2010-12#1)(2010-2#1)
with a brief##28##3##(1990-7#1)(1993-3#1)(1994-4#1)(2006-5#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-8#1)(2012-12#1)(2012-2#1)
with a bright##2##3##(2006-9#1)(2008-3#1)
with a broad range of##8##5##(1993-9#1)(1997-7#1)(2007-11#1)(2007-6#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-3#1)
with a broad range##9##4##(1993-9#1)(1997-7#1)(2007-11#1)(2007-6#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-3#1)
with a broad spectrum of##8##5##(2005-8#1)(2007-2#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-12#1)(2013-7#1)
with a broad##28##3##(1993-9#1)(1997-7#1)(2005-8#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-10#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
with a broad-spectrum##2##3##(2005-9#1)(2008-10#1)
with a broadband##3##3##(2008-1#1)(2008-2#1)(2011-2#1)
with a broader##3##3##(1997-7#1)(2007-12#1)(2008-5#1)
with a buffer##2##3##(1996-5#1)(2007-12#1)
with a bulk acoustic wave sensor##2##6##(2008-10#2)
with a bulk acoustic##3##4##(2008-10#3)
with a cDNA for##2##4##(1991-7#1)(1995-8#1)
with a cDNA##8##3##(1991-12#1)(1991-7#1)(1991-9#1)(1995-2#2)(1995-8#1)(1997-7#1)(2006-12#1)
with a calcium##4##3##(1990-2#1)(1991-6#1)(2006-10#1)(2008-11#1)
with a calculated M(r) of##5##5##(1993-6#1)(1993-9#1)(1994-12#1)(1995-2#2)
with a calculated Mr of##3##5##(1990-11#1)(1991-1#1)(1991-9#1)
with a calculated molecular mass of##10##6##(1990-12#1)(1991-8#1)(1992-11#1)(1993-3#1)(1994-9#2)(1996-10#1)(1996-6#1)(1997-1#1)(1997-2#1)
with a calculated molecular weight of##4##6##(1990-12#1)(1992-1#1)(1995-6#1)(1996-7#1)
with a calculated molecular##14##4##(1990-12#2)(1991-8#1)(1992-1#1)(1992-11#1)(1993-3#1)(1994-9#2)(1995-6#1)(1996-10#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)
with a calculated##29##3##(1990-11#1)(1990-12#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-9#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-10#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#2)(2007-8#1)(2008-10#1)
with a camera##2##3##(2008-2#1)(2008-3#1)
with a canonical##2##3##(1994-9#1)(2008-3#1)
with a capacity##2##3##(2008-10#1)(2009-7#1)
with a carbon fiber##2##4##(2008-10#2)
with a carbon##8##3##(1992-2#1)(2008-10#5)(2008-5#1)(2008-7#1)
with a cardiac##2##3##(2008-12#1)(2011-2#1)
with a careful##2##3##(2008-10#1)(2012-12#1)
with a carrier protein##2##4##(1995-11#1)(2013-8#1)
with a carrier##8##3##(1990-2#1)(1995-11#1)(1997-3#1)(2008-1#1)(2008-10#2)(2009-9#1)(2013-8#1)
with a case of##3##4##(2007-6#1)(2008-9#1)(2009-5#1)
with a case report of##2##5##(2005-11#1)(2008-11#1)
with a case report##3##4##(2005-11#1)(2008-11#1)(2012-2#1)
with a case##7##3##(1996-12#1)(2005-11#1)(2007-6#1)(2008-11#1)(2008-9#1)(2009-5#1)(2012-2#1)
with a casual partner##2##4##(2007-7#1)(2012-3#1)
with a catalytic amount of##3##5##(1997-1#1)(2009-10#1)(2010-6#1)
with a catalytic##7##3##(1990-2#1)(1994-3#1)(1997-1#1)(2008-10#1)(2008-8#1)(2009-10#1)(2010-6#1)
with a cationic slope of##3##5##(2008-10#3)
with a cationic##9##3##(2008-10#8)(2008-5#1)
with a cell##6##3##(1994-11#1)(1994-9#1)(2008-10#1)(2008-11#2)(2008-9#1)
with a cellular##2##3##(1991-9#1)(1997-1#1)
with a cellulose acetate##2##4##(2008-10#2)
with a cellulose##4##3##(2008-10#3)(2008-7#1)
with a cemented##4##3##(1993-8#1)(2007-7#1)(2009-3#1)(2013-1#1)
with a center wavelength of##2##5##(2007-12#1)(2008-3#1)
with a center##6##3##(2007-12#2)(2008-10#2)(2008-3#2)
with a central##14##3##(1994-9#1)(1995-11#1)(1995-12#1)(1996-4#1)(2005-8#1)(2007-10#1)(2007-12#2)(2008-10#2)(2008-5#1)(2009-4#1)(2012-2#1)(2013-7#1)
with a centrifugal##2##3##(2007-8#1)(2010-8#1)
with a cerebral##3##3##(1990-12#1)(1997-3#1)(2011-2#1)
with a certain##9##3##(1996-3#1)(2004-12#1)(2007-1#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-8#1)(2011-2#1)
with a certified reference material##3##5##(2008-10#2)(2011-2#1)
with a certified##4##3##(2008-10#3)(2011-2#1)
with a cervical anastomosis##2##4##(1993-2#2)
with a cervical##9##3##(1993-2#2)(2006-10#1)(2006-7#1)(2007-8#2)(2009-10#2)(2012-12#1)
with a chain##2##3##(1993-7#1)(2007-12#1)
with a challenge##3##3##(1993-7#1)(2005-10#1)(2006-5#1)
with a challenging##3##3##(2008-10#1)(2013-8#2)
with a change in the refractive index##2##7##(2008-2#2)
with a change in the##8##5##(1991-7#1)(1991-9#1)(1992-4#1)(2008-10#1)(2008-2#2)(2009-2#1)(2012-2#1)
with a change in##14##4##(1991-7#1)(1991-9#2)(1992-4#1)(1995-5#1)(1997-2#1)(1997-8#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#2)(2009-2#1)(2012-2#1)
with a change of##2##4##(2008-2#1)(2013-7#1)
with a change##16##3##(1991-7#1)(1991-9#2)(1992-4#1)(1995-5#1)(1997-2#1)(1997-8#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#3)(2009-2#1)(2012-2#1)(2013-7#1)
with a channel##5##3##(1990-11#1)(2006-2#1)(2007-8#1)(2008-3#1)(2012-2#1)
with a chaotic##2##3##(2007-12#1)(2012-2#1)
with a characteristic size of the order of##2##8##(1996-4#1)(2007-11#1)
with a characteristic##13##3##(1991-10#1)(1991-2#1)(1991-9#1)(1993-6#1)(1995-5#1)(1996-4#1)(2005-10#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-4#1)(2011-2#1)
with a charged##2##3##(1997-2#1)(2009-1#1)
with a chelating##2##3##(1995-3#1)(2008-10#1)
with a chemical##7##3##(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2009-7#1)(2009-8#1)
with a chemically##2##3##(2007-12#1)(2008-3#1)
with a chemiluminescence##4##3##(2008-10#3)(2008-5#1)
with a chemotactic##2##3##(1990-12#1)(1991-7#1)
with a chief complaint of##7##5##(1996-6#1)(2008-12#2)(2008-3#1)(2010-12#1)(2011-1#1)(2012-12#1)
with a child##4##3##(1993-5#1)(2008-8#1)(2012-3#1)(2013-1#1)
with a child's##2##3##(2006-10#1)(2013-8#1)
with a chimeric##2##3##(1997-2#2)
with a chiral##2##3##(2005-8#1)(2007-10#1)
with a chirped fiber##3##4##(2007-12#3)
with a choice##3##3##(2008-4#1)(2008-9#2)
with a chronic condition##2##4##(1992-12#1)(2009-5#1)
with a chronic##16##3##(1990-4#1)(1992-12#1)(1992-3#1)(1992-5#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-2#1)(2007-7#1)(2008-7#2)(2008-8#2)(2009-5#1)(2011-1#1)(2012-2#1)
with a circular##5##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
with a citrate##2##3##(1990-4#1)(1992-2#1)
with a classical##5##3##(2007-11#1)(2008-1#1)(2008-3#1)(2008-7#1)(2011-2#1)
with a clear##13##3##(1990-6#1)(1990-7#1)(1991-1#1)(1996-1#1)(2006-10#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
with a cleft##2##3##(1994-3#1)(2012-3#1)
with a clinical diagnosis of##5##5##(2006-8#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)
with a clinical history##2##4##(2007-8#1)(2013-8#1)
with a clinical picture of##6##5##(1990-3#1)(1992-10#1)(2006-10#1)(2006-12#1)(2007-11#1)(2011-2#1)
with a clinical picture##7##4##(1990-3#1)(1992-10#1)(2006-10#1)(2006-12#1)(2007-11#1)(2009-3#1)(2011-2#1)
with a clinical##29##3##(1990-3#1)(1992-10#1)(1992-2#1)(1996-12#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-9#1)(2011-1#2)(2011-2#3)(2013-1#2)(2013-8#1)
with a close##2##3##(1990-9#1)(1997-8#1)
with a closed##3##3##(2005-11#1)(2006-4#1)(2012-2#1)
with a cluster##2##3##(2006-9#1)(2009-11#1)
with a coarse##3##3##(2008-6#1)(2009-7#1)(2012-3#1)
with a cochlear implant##7##4##(2007-3#1)(2008-9#6)
with a cocktail of##2##4##(1990-7#1)(2008-11#1)
with a coefficient of variation of less than##2##8##(1996-11#1)(2008-10#1)
with a coefficient of variation of##3##6##(1996-11#1)(1997-8#1)(2008-10#1)
with a coefficient of variation##4##5##(1996-11#1)(1997-8#1)(2008-10#2)
with a coefficient of##7##4##(1990-2#1)(1996-11#1)(1997-8#1)(2006-6#1)(2008-10#3)
with a coexisting tic disorder##2##5##(1996-2#2)
with a coherent##3##3##(1990-12#1)(2007-11#1)(2008-3#1)
with a cohesive##2##3##(1993-11#1)(2008-12#1)
with a collection of##3##4##(2008-10#2)(2013-7#1)
with a collection##4##3##(2008-10#2)(2008-2#1)(2013-7#1)
with a college##2##3##(2008-12#1)(2008-7#1)
with a collimated##3##3##(1996-2#1)(2007-12#1)(2008-3#1)
with a collinear configuration##2##4##(2007-12#2)
with a colloid##2##3##(2006-10#1)(2008-7#1)
with a colorimetric method##2##4##(2008-10#2)
with a colorimetric##3##3##(2008-10#3)
with a column##3##3##(1990-8#1)(2008-10#2)
with a combination of self-phase modulation and##2##7##(2007-11#1)(2008-1#1)
with a combination of the##4##5##(1992-3#1)(1992-5#1)(2005-11#1)(2013-8#1)
with a combination of these##2##5##(2009-12#1)(2013-7#1)
with a combination of##67##4##(1990-10#1)(1990-7#1)(1991-2#2)(1991-3#2)(1991-6#1)(1992-3#1)(1992-5#1)(1993-8#3)(1994-8#2)(1995-10#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-4#2)(2005-7#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
with a combination##70##3##(1990-10#1)(1990-2#1)(1990-7#1)(1991-2#2)(1991-3#2)(1991-6#1)(1992-10#1)(1992-3#1)(1992-5#1)(1993-8#3)(1994-8#2)(1995-10#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-4#2)(2005-7#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
with a combined standard uncertainty of 0##2##7##(2008-3#2)
with a combined##9##3##(1992-8#1)(1993-9#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-3#2)
with a commercial##29##3##(1990-2#1)(1993-12#1)(1994-7#1)(1995-2#1)(2004-1#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-6#1)(2008-10#7)(2008-2#5)(2008-3#1)(2008-5#3)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#1)
with a commercially available instrument##2##5##(2007-12#1)(2008-10#1)
with a commercially available##14##4##(1991-12#1)(1992-8#1)(1993-8#1)(1995-6#1)(1996-9#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#1)
with a common interest in##2##5##(2008-7#1)(2008-8#1)
with a common##27##3##(1990-7#1)(1991-3#1)(1991-6#1)(1991-9#1)(1993-12#1)(1993-8#1)(1994-9#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-12#1)(2006-12#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-3#1)
with a community##2##3##(2011-1#1)(2011-12#1)
with a compact disc pickup##2##5##(2008-2#1)(2008-3#1)
with a compact##9##3##(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#4)
with a comparable##5##3##(1993-12#1)(2006-8#1)(2008-11#1)(2008-4#1)(2013-1#1)
with a comparative##3##3##(2006-8#1)(2008-10#1)(2008-2#1)
with a comparison##3##3##(2007-1#1)(2007-12#1)(2012-1#1)
with a compartmental##3##3##(1992-9#1)(2008-5#1)(2010-10#1)
with a compatible##4##3##(2007-12#1)(2008-10#2)(2012-11#1)
with a competitive##4##3##(1991-3#1)(2008-10#1)(2010-4#1)(2011-2#1)
with a compilation##2##3##(1997-4#1)(2008-7#1)
with a complaint of##6##4##(1996-7#1)(2006-12#1)(2012-12#2)(2012-2#1)(2012-3#1)
with a complementary##6##3##(1991-12#1)(1991-6#1)(1997-5#1)(2008-3#1)(2008-4#1)(2011-1#1)
with a complete remission##2##4##(1991-4#1)(2007-7#1)
with a complete##14##3##(1991-4#1)(1996-2#1)(1996-5#1)(1997-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-9#1)(2011-2#2)
with a complex etiology including##2##5##(1995-6#1)(2008-11#1)
with a complex etiology##3##4##(1995-6#1)(2008-11#1)(2008-4#1)
with a complex of##2##4##(2008-10#1)(2008-4#1)
with a complex##21##3##(1990-3#1)(1991-5#1)(1992-11#1)(1995-12#1)(1995-6#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2009-4#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-11#1)
with a complicated##3##3##(2007-10#1)(2008-11#1)(2013-1#1)
with a complimentary##2##3##(2007-11#1)(2008-5#1)
with a component of##2##4##(1995-5#1)(2012-12#1)
with a composite diatomite##2##4##(2012-12#2)
with a composite##6##3##(2007-12#1)(2008-9#1)(2012-12#2)(2012-2#2)
with a composition##3##3##(2007-11#1)(2008-10#1)(2010-4#1)
with a compound##3##3##(2008-10#1)(2008-3#1)(2009-8#1)
with a comprehensive##8##3##(1991-8#1)(1995-12#1)(2008-12#1)(2008-2#1)(2009-11#1)(2009-3#1)(2013-1#2)
with a compromised HPAA##2##4##(1995-12#2)
with a compromised##4##3##(1995-12#2)(2008-6#1)(2008-9#1)
with a computational model##2##4##(2008-11#1)(2008-2#1)
with a computationally efficient##2##4##(2006-11#1)(2008-2#1)
with a computer and##2##4##(2007-8#1)(2008-1#1)
with a computer program##2##4##(1994-9#1)(2008-10#1)
with a computer##7##3##(1994-9#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)
with a computerized##3##3##(1993-6#1)(2008-10#1)(2008-9#1)
with a concave##2##3##(2007-11#1)(2008-3#1)
with a concentration gradient##2##4##(2008-10#1)(2012-2#1)
with a concentration of##13##4##(1990-8#1)(1991-6#1)(1993-12#1)(1994-5#1)(2007-12#1)(2008-10#5)(2011-1#1)(2011-2#2)
with a concentration##22##3##(1990-8#1)(1991-6#1)(1992-8#1)(1993-12#1)(1994-5#1)(1994-8#1)(2005-8#1)(2007-12#1)(2008-10#9)(2011-1#1)(2011-2#3)(2012-2#1)
with a conceptual##2##3##(2006-10#1)(2012-12#1)
with a concerted##3##3##(1995-5#1)(2005-8#1)(2007-8#1)
with a concomitant decrease in##5##5##(1991-7#1)(1992-11#1)(1995-1#1)(1995-3#1)(2006-11#1)
with a concomitant decrease##6##4##(1991-7#1)(1992-11#1)(1994-2#1)(1995-1#1)(1995-3#1)(2006-11#1)
with a concomitant increase in the##5##6##(1991-6#1)(1993-9#1)(1996-11#1)(2008-11#1)(2009-5#1)
with a concomitant increase in##8##5##(1990-12#1)(1991-6#1)(1993-9#1)(1996-11#1)(1997-6#1)(2008-11#1)(2009-5#1)(2013-8#1)
with a concomitant##22##3##(1990-11#1)(1990-12#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-3#1)(1996-11#1)(1996-6#1)(1997-6#1)(1997-8#1)(2006-11#1)(2008-11#1)(2008-5#1)(2009-5#1)(2010-2#1)(2013-8#1)
with a concurrent##2##3##(1994-12#2)
with a conditionally processed##2##4##(1993-8#2)
with a conductance decrease##2##4##(1990-7#1)(1991-9#1)
with a conductance##3##3##(1990-7#1)(1991-9#1)(1994-2#1)
with a confidence##3##3##(2007-8#1)(2008-10#1)(2011-2#1)
with a confirmed##2##3##(1997-1#1)(2004-11#1)
with a confocal laser scanning microscope##3##6##(1991-9#1)(1996-9#1)(2008-3#1)
with a confocal microscope##4##4##(2007-12#2)(2008-2#1)(2008-3#1)
with a confocal##13##3##(1991-9#1)(1996-9#1)(2007-11#2)(2007-12#4)(2008-2#1)(2008-3#4)
with a congenital pelvic kidney##2##5##(2005-10#2)
with a congenital##3##3##(1993-10#1)(2005-10#2)
with a conidial suspension##4##4##(2008-10#4)
with a conjugated##2##3##(1996-5#1)(2009-11#1)
with a consensus##4##3##(1990-8#1)(1991-12#1)(2008-6#2)
with a consequent##6##3##(1995-12#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-3#1)
with a considerable risk of##2##5##(2007-11#1)(2012-1#1)
with a considerable risk##3##4##(1992-1#1)(2007-11#1)(2012-1#1)
with a considerable##7##3##(1990-4#1)(1992-1#1)(1994-8#1)(2007-11#1)(2007-8#1)(2010-2#1)(2012-1#1)
with a considerably##3##3##(1995-6#1)(2008-10#1)(2013-1#1)
with a consistent##2##3##(1990-11#1)(1995-8#1)
with a consolidation pattern on##2##5##(2013-1#2)
with a conspicuous##2##3##(2007-12#1)(2008-5#1)
with a constant##23##3##(1990-11#1)(1991-11#2)(1991-8#1)(1993-2#1)(1994-2#1)(1995-2#1)(1995-8#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-4#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#4)
with a constitutive##3##3##(1991-1#1)(1994-5#1)(2008-7#1)
with a constitutively##2##3##(2008-7#2)
with a construct containing##2##4##(1994-3#1)(1995-8#1)
with a construct##4##3##(1990-5#1)(1993-2#1)(1994-3#1)(1995-8#1)
with a continuous##12##3##(1997-7#1)(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#4)
with a continuous-wave (cw) laser##2##5##(2008-2#1)(2008-3#1)
with a continuous-wave optical parametric oscillator##2##6##(2007-12#2)
with a continuous-wave##10##3##(2007-11#1)(2007-12#4)(2008-2#3)(2008-3#2)
with a continuously variable##2##4##(2007-12#2)
with a continuously varying degree of fractionality##2##7##(2007-12#1)(2008-3#1)
with a continuously##5##3##(2007-12#3)(2008-2#1)(2008-3#1)
with a contralateral##2##3##(1996-11#1)(2008-9#1)
with a control group of##5##5##(1992-1#1)(1993-3#1)(2007-7#1)(2008-3#1)(2011-2#1)
with a control group##17##4##(1991-2#1)(1992-1#1)(1993-3#1)(1997-1#1)(2004-10#1)(2005-1#1)(2005-10#2)(2006-9#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
with a control##25##3##(1990-8#1)(1991-2#1)(1992-1#1)(1993-3#1)(1996-9#1)(1997-1#1)(1997-7#1)(2004-10#1)(2005-1#1)(2005-10#2)(2006-9#1)(2007-7#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
with a convenient##2##3##(2008-10#1)(2008-11#1)
with a conventional length electrode##3##5##(2012-2#3)
with a conventional optical##2##4##(2007-12#1)(2008-2#1)
with a conventional##29##3##(2005-12#1)(2005-4#1)(2005-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2008-10#3)(2008-12#1)(2008-2#7)(2008-3#2)(2008-5#1)(2009-2#1)(2009-4#1)(2011-2#1)(2012-2#3)(2013-1#1)
with a conventionally##3##3##(1993-4#1)(2008-10#1)(2008-3#1)
with a conversion efficiency of##2##5##(2007-12#2)
with a conversion efficiency##3##4##(2007-11#1)(2007-12#2)
with a copper##4##3##(1992-9#1)(1997-1#1)(2008-10#1)(2008-11#1)
with a cordlike middle glenohumeral ligament##2##6##(2009-3#2)
with a core##3##3##(1996-3#1)(2007-12#2)
with a corneometer##2##3##(2008-5#2)
with a correlation coefficient (R(2))##2##5##(2008-10#2)
with a correlation coefficient 0##2##5##(2008-10#2)
with a correlation coefficient of 0##28##6##(1990-10#1)(2007-8#1)(2008-10#22)(2010-4#1)(2011-1#1)(2012-12#2)
with a correlation coefficient of linear regression of 0##2##9##(2008-10#2)
with a correlation coefficient of##31##5##(1990-10#1)(2006-10#1)(2007-8#1)(2008-10#24)(2010-4#1)(2011-1#1)(2012-12#2)
with a correlation coefficient##39##4##(1990-10#1)(1990-8#1)(2006-10#1)(2007-8#2)(2008-10#29)(2008-8#1)(2010-4#1)(2011-1#1)(2012-12#2)
with a correlation factor of 0##3##6##(2008-10#3)
with a correlation factor##4##4##(2008-10#4)
with a correlation##45##3##(1990-10#1)(1990-8#1)(2006-10#1)(2007-8#2)(2008-10#34)(2008-8#1)(2010-4#2)(2011-1#1)(2012-12#2)
with a corresponding increase in the##2##6##(1991-3#1)(1991-4#1)
with a corresponding increase in##4##5##(1991-3#1)(1991-4#1)(2008-5#1)(2008-7#1)
with a corresponding##14##3##(1991-3#1)(1991-4#1)(1993-5#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-5#3)(2008-7#1)(2013-8#1)
with a cortical infarction volume of##2##6##(2007-9#2)
with a cortical##3##3##(2007-9#2)(2012-12#1)
with a coupled##3##3##(2008-10#2)(2008-3#1)
with a course of##2##4##(2006-10#1)(2007-8#1)
with a course##3##3##(2006-10#1)(2007-8#2)
with a coverage factor##2##4##(2008-10#1)(2008-2#1)
with a critical##6##3##(1990-4#1)(1994-4#1)(2008-2#1)(2008-5#1)(2008-9#1)(2013-8#1)
with a cross-leg##2##3##(2011-2#1)(2012-12#1)
with a cross-sectional##2##3##(1995-6#1)(2013-8#1)
with a crude##2##3##(1991-9#1)(1994-12#1)
with a cubic##3##3##(2007-12#2)(2008-10#1)
with a current##3##3##(2007-12#1)(2008-7#1)(2011-3#1)
with a curved##2##3##(2007-12#1)(2008-3#1)
with a cutaneous##5##3##(2007-11#2)(2008-12#2)(2013-8#1)
with a cuticle##3##3##(2007-12#2)(2009-8#1)
with a cutoff##5##3##(2004-8#1)(2009-6#1)(2010-2#1)(2011-3#1)(2012-2#1)
with a cw##3##3##(2007-12#3)
with a cyclic##2##3##(2005-8#1)(2007-10#1)
with a cyclodextrin##2##3##(1996-8#1)(2008-10#1)
with a cylindrical##3##3##(1993-4#1)(2007-12#2)
with a cytotoxic agent##2##4##(1990-4#1)(1992-10#1)
with a cytotoxic##3##3##(1990-4#1)(1992-10#1)(1992-8#1)
with a daily dose of##3##5##(1990-11#1)(1990-5#1)(2008-10#1)
with a daily##4##3##(1990-11#1)(1990-5#1)(2008-10#1)(2008-5#1)
with a damaged##2##3##(1996-11#1)(2007-11#1)
with a data##4##3##(1997-3#1)(2007-12#1)(2008-1#1)(2010-8#1)
with a dc##2##3##(2007-11#1)(2008-2#1)
with a decay##2##3##(1992-2#1)(1994-8#1)
with a decline in##3##4##(2006-12#1)(2007-2#1)(2013-1#1)
with a decline##4##3##(2006-12#1)(2007-2#1)(2013-1#1)(2013-7#1)
with a declining##2##3##(1991-4#1)(2011-1#1)
with a decrease in the amount of##2##7##(2006-3#1)(2008-10#1)
with a decrease in the##17##5##(1990-7#1)(1994-11#2)(1994-9#1)(1995-10#1)(1995-12#1)(1997-7#1)(2005-11#2)(2006-3#1)(2008-10#3)(2008-4#1)(2008-7#1)(2010-4#1)(2012-2#1)
with a decrease in##46##4##(1990-12#1)(1990-7#1)(1993-12#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-5#1)(1997-7#1)(2005-10#2)(2005-11#2)(2006-3#1)(2007-9#2)(2008-10#5)(2008-4#1)(2008-7#3)(2009-8#1)(2009-9#1)(2010-4#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-7#2)
with a decrease of the##3##5##(1996-6#1)(1997-1#1)(2005-11#1)
with a decrease of##11##4##(1996-10#1)(1996-6#1)(1997-1#1)(2004-9#1)(2005-11#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-2#1)
with a decrease##60##3##(1990-12#1)(1990-7#1)(1991-6#1)(1993-12#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-5#1)(1997-7#1)(2004-9#1)(2005-10#2)(2005-11#3)(2006-3#1)(2007-11#1)(2007-9#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#4)(2008-8#1)(2009-8#1)(2009-9#1)(2010-4#2)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#2)
with a decreased risk for##2##5##(1993-12#1)(2007-4#1)
with a decreased risk of##4##5##(1996-9#1)(2007-9#1)(2011-2#1)(2013-7#1)
with a decreased risk##6##4##(1993-12#1)(1996-9#1)(2007-4#1)(2007-9#1)(2011-2#1)(2013-7#1)
with a decreased##22##3##(1990-2#1)(1991-9#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-11#1)(1995-8#1)(1996-9#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-11#1)(2009-12#1)(2010-11#1)(2011-2#3)(2013-1#1)(2013-7#1)
with a deduced Mr of##2##5##(1990-9#1)(1991-7#1)
with a deduced molecular mass of##2##6##(1995-8#1)(1997-1#1)
with a deduced##9##3##(1990-11#1)(1990-9#1)(1991-7#1)(1993-12#1)(1995-8#1)(1997-1#1)(1997-5#1)(1997-9#1)(2005-6#1)
with a deep LMS##2##4##(2008-6#2)
with a deep##4##3##(1991-5#1)(1994-6#1)(2008-6#2)
with a defect in##3##4##(1994-10#1)(1996-5#1)(2007-7#1)
with a defect##4##3##(1994-10#1)(1996-5#1)(2007-12#1)(2007-7#1)
with a defective##3##3##(1995-2#1)(2008-10#1)(2008-9#1)
with a deficiency of##2##4##(1990-1#1)(1994-4#1)
with a deficient mandible##2##4##(2012-12#2)
with a deficit##2##3##(1995-1#1)(1997-8#1)
with a defined##6##3##(1990-12#1)(1994-3#1)(2008-3#1)(2009-8#1)(2011-2#1)(2013-1#1)
with a definite##4##3##(1992-7#1)(2007-9#1)(2008-6#1)(2012-2#1)
with a definitive##2##3##(1997-8#1)(2013-1#1)
with a deformable mirror##5##4##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
with a deformable##6##3##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)
with a degree of##2##4##(1995-5#1)(2006-9#1)
with a degree##4##3##(1991-2#1)(1995-5#1)(2006-9#1)(2008-12#1)
with a delay in##3##4##(1991-8#1)(1996-5#1)(2008-10#1)
with a delay of##2##4##(1990-2#1)(2008-6#1)
with a delay##7##3##(1990-2#1)(1991-8#1)(1996-5#1)(2008-10#1)(2008-5#2)(2008-6#1)
with a delayed##4##3##(1994-2#1)(1996-12#1)(2006-1#1)(2008-3#1)
with a deletion of##2##4##(1991-10#1)(2008-9#1)
with a deletion##4##3##(1991-10#1)(1994-5#1)(2008-10#1)(2008-9#1)
with a delusion of##2##4##(2006-3#1)(2007-7#1)
with a demand dose of##2##5##(2007-2#2)
with a demand##3##3##(2007-2#2)(2008-7#1)
with a demonstrable##2##3##(1995-12#1)(2008-5#1)
with a dense##4##3##(1996-1#1)(2008-4#1)(2008-9#1)(2010-6#1)
with a density##2##3##(2006-12#1)(2012-12#1)
with a depression##2##3##(2008-3#1)(2013-7#1)
with a depth of##2##4##(2006-10#1)(2008-10#1)
with a depth resolution of##2##5##(2008-3#2)
with a depth##5##3##(2006-10#1)(2007-12#1)(2008-10#1)(2008-3#2)
with a derivative of##2##4##(1992-10#1)(2007-11#1)
with a derivative##3##3##(1992-10#1)(1994-11#1)(2007-11#1)
with a derivatization##2##3##(1995-3#1)(2008-10#1)
with a description of the##5##5##(2006-10#1)(2007-12#1)(2007-2#1)(2011-2#1)(2013-1#1)
with a description of##13##4##(1991-2#1)(1992-1#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2011-2#1)(2013-1#1)
with a desired##3##3##(1992-9#1)(2007-12#1)(2008-2#1)
with a desolvating##2##3##(2007-8#2)
with a detailed description of##2##5##(2007-8#1)(2008-4#1)
with a detailed##10##3##(1992-8#1)(1994-3#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-9#2)(2010-8#1)(2011-11#1)(2011-2#1)
with a detectable##2##3##(2005-7#1)(2006-9#1)
with a detection limit (3sigma) of 0##4##7##(2008-10#4)
with a detection limit (LD) of 0##2##7##(2008-10#2)
with a detection limit (S/N=3) of 0##2##7##(2008-10#2)
with a detection limit (S/N=3) of##3##6##(2007-8#1)(2008-10#2)
with a detection limit 1##2##5##(2008-10#2)
with a detection limit down to##2##6##(2008-10#2)
with a detection limit of 0##48##6##(1992-1#1)(1992-11#1)(1992-4#1)(2007-8#1)(2008-10#42)(2008-11#1)(2010-4#1)
with a detection limit of 1 muM##2##7##(2008-10#2)
with a detection limit of 1##27##6##(1996-5#1)(2007-8#2)(2008-10#24)
with a detection limit of 12##2##6##(1991-8#1)(2008-10#1)
with a detection limit of 1ppm##2##6##(2008-10#2)
with a detection limit of 2##7##6##(2008-10#7)
with a detection limit of 20##2##6##(2008-10#1)(2008-4#1)
with a detection limit of 3##4##6##(2008-10#4)
with a detection limit of 4##7##6##(2007-8#1)(2008-10#6)
with a detection limit of 5##6##6##(2008-10#6)
with a detection limit of 6##6##6##(2008-10#4)(2010-5#2)
with a detection limit of 8##4##6##(2008-10#4)
with a detection limit of 9##2##6##(2008-10#2)
with a detection limit of c(L)=0##2##6##(2008-10#2)
with a detection limit of##139##5##(1990-11#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-4#1)(1996-5#1)(1997-8#1)(2005-12#1)(2007-8#4)(2008-10#120)(2008-11#2)(2008-3#1)(2008-4#1)(2010-4#1)(2010-5#2)
with a detection limit##160##4##(1990-11#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-4#1)(1993-8#1)(1996-5#2)(1997-8#1)(2005-12#1)(2007-8#5)(2008-10#138)(2008-11#2)(2008-3#1)(2008-4#1)(2010-4#1)(2010-5#2)
with a detection sensitivity of##2##5##(2008-10#1)(2008-3#1)
with a detection##165##3##(1990-11#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-4#1)(1993-8#1)(1996-5#2)(1997-8#1)(2005-12#1)(2007-8#5)(2008-10#139)(2008-11#2)(2008-3#5)(2008-4#1)(2010-4#1)(2010-5#2)
with a detector##2##3##(2008-2#1)(2008-3#1)
with a detergent##2##3##(1990-10#1)(1994-11#1)
with a determined##3##3##(1990-11#1)(2008-4#2)
with a deviation##2##3##(2007-12#1)(2008-2#1)
with a diagnosis of anorexia nervosa##2##6##(2005-10#1)(2007-12#1)
with a diagnosis of spinal cord##2##6##(2007-2#1)(2007-7#1)
with a diagnosis of##49##4##(1991-8#1)(1993-10#1)(1993-8#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-8#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#4)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
with a diagnosis##50##3##(1991-8#1)(1993-10#1)(1993-8#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-8#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#4)(2010-10#1)(2010-12#2)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
with a diagnostic delay of##2##5##(2007-2#2)
with a diagnostic##3##3##(2007-2#2)(2007-5#1)
with a diameter of 1##2##5##(2006-9#1)(2008-11#1)
with a diameter of about##3##5##(1991-9#1)(2007-12#1)(2008-1#1)
with a diameter of##23##4##(1991-9#1)(1994-2#1)(1997-7#1)(2005-11#6)(2006-9#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-2#1)(2012-1#1)(2013-1#1)
with a diameter##30##3##(1991-9#1)(1994-2#1)(1997-7#1)(2005-11#6)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-2#1)(2011-1#1)(2012-1#1)(2013-1#1)
with a diamond##2##3##(2008-3#1)(2013-1#1)
with a dielectric##2##3##(2007-12#2)
with a diet##3##3##(1995-3#1)(2008-12#1)(2008-5#1)
with a difference in##2##4##(1990-11#2)
with a difference##3##3##(1990-11#2)(2008-3#1)
with a different dye##2##4##(2006-12#2)
with a different##31##3##(1991-4#1)(1992-11#1)(1992-8#1)(1993-2#1)(1994-11#1)(1995-1#1)(2005-1#1)(2005-11#1)(2006-12#2)(2006-5#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#2)(2009-4#1)(2010-10#1)(2010-2#2)(2012-2#1)
with a differential##7##3##(1997-3#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-2#1)
with a difficult airway##2##4##(2006-10#1)(2010-7#1)
with a diffraction efficiency of##2##5##(2008-2#1)(2008-3#1)
with a diffraction grating##3##4##(2007-12#2)(2008-2#1)
with a diffraction##5##3##(2007-12#2)(2008-2#2)(2008-3#1)
with a diffractive optical element##3##5##(2007-12#2)(2008-3#1)
with a diffractive##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
with a diffusion-only##2##3##(2005-11#1)(2008-3#1)
with a digital camera##2##4##(2007-12#1)(2008-3#1)
with a digital##7##3##(1992-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2013-7#1)
with a dilated##3##3##(2008-10#1)(2012-11#1)(2013-8#1)
with a dilution##2##3##(2008-10#1)(2011-1#1)
with a diminution of##2##4##(1990-3#1)(2008-4#1)
with a diode array detector##3##5##(1997-8#1)(2008-10#2)
with a diode array##4##4##(1996-7#1)(1997-8#1)(2008-10#2)
with a diode##5##3##(1996-7#1)(1997-8#1)(2008-10#2)(2008-2#1)
with a diode-pumped##2##3##(2007-11#1)(2007-12#1)
with a direct##10##3##(1991-11#1)(1992-6#1)(1992-9#1)(1994-11#1)(1996-5#1)(1996-6#1)(1997-1#1)(2007-11#1)(2007-8#1)(2012-12#1)
with a disability##2##3##(2007-3#1)(2010-9#1)
with a discussion about##2##4##(2006-7#1)(2011-1#1)
with a discussion of how##3##5##(1997-7#1)(2008-11#1)(2008-9#1)
with a discussion of issues##2##5##(1992-3#1)(1997-8#1)
with a discussion of some of the##3##7##(1997-3#1)(2008-4#1)(2008-8#1)
with a discussion of some of##4##6##(1997-3#1)(1997-4#1)(2008-4#1)(2008-8#1)
with a discussion of the##17##5##(1992-3#1)(1993-2#1)(1994-3#1)(1995-3#1)(2007-7#1)(2008-1#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2009-6#1)(2010-5#1)(2010-9#1)(2012-1#1)(2012-2#2)
with a discussion of their##2##5##(2007-12#1)(2008-4#1)
with a discussion of##40##4##(1991-11#1)(1992-3#2)(1993-2#1)(1994-3#1)(1995-3#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-7#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-12#3)(2008-3#2)(2008-4#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#2)(2009-8#1)(2010-4#1)(2010-5#1)(2010-9#1)(2012-1#2)(2012-2#3)
with a discussion on the##4##5##(2005-8#1)(2006-2#1)(2008-1#1)(2008-11#1)
with a discussion on##5##4##(2005-8#1)(2006-2#1)(2008-1#1)(2008-11#1)(2008-8#1)
with a discussion##48##3##(1991-11#1)(1992-3#2)(1993-2#1)(1994-3#1)(1995-3#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-2#1)(2006-7#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-11#2)(2008-12#3)(2008-3#2)(2008-4#4)(2008-6#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#2)(2009-8#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-1#2)(2012-2#3)(2013-1#1)
with a disease##7##3##(1992-10#1)(2005-11#1)(2008-10#2)(2011-1#1)(2012-3#1)(2013-8#1)
with a disease-free##2##3##(2006-6#1)(2010-3#1)
with a dismal prognosis##2##4##(1993-5#1)(2008-8#1)
with a disorder##2##3##(1994-8#1)(2009-9#1)
with a dispersion of##2##4##(1997-1#1)(2008-3#1)
with a disproportionate##2##3##(1991-12#1)(2009-9#1)
with a dissociation constant (Kd)##2##5##(1991-4#1)(1991-5#1)
with a dissociation constant of 3##2##6##(1991-8#1)(1993-7#1)
with a dissociation constant of##6##5##(1990-7#2)(1991-8#1)(1992-6#1)(1993-7#1)(1995-11#1)
with a dissociation constant##9##4##(1990-7#2)(1991-4#1)(1991-5#1)(1991-8#1)(1992-6#1)(1993-7#1)(1995-11#1)(1996-5#1)
with a distal##6##3##(1994-6#1)(1997-4#2)(2007-10#1)(2008-6#1)(2008-9#1)
with a distance of 1##2##5##(2007-8#1)(2008-9#1)
with a distance of##3##4##(2007-8#1)(2008-2#1)(2008-9#1)
with a distance##5##3##(2007-8#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-3#1)
with a distant##2##3##(1994-8#1)(2008-10#1)
with a distinct##10##3##(1991-1#1)(1995-8#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-4#1)(2011-12#1)(2013-7#1)
with a distinctive##2##3##(1994-8#1)(2007-7#1)
with a distorted diffraction grating##2##5##(2008-3#2)
with a distorted##3##3##(2006-3#1)(2008-3#2)
with a distributed##3##3##(2007-12#1)(2010-2#1)(2011-9#1)
with a distributed-feedback laser##2##4##(2007-11#2)
with a distributed-feedback##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
with a distribution of##2##4##(1991-2#1)(1994-2#1)
with a distribution##4##3##(1991-2#1)(1994-2#1)(1996-5#1)(2007-2#1)
with a disulfide bond##2##4##(1992-3#1)(1993-3#1)
with a diuretic and##2##4##(1991-2#1)(1993-2#1)
with a diverse group of##2##5##(1990-12#1)(2006-10#1)
with a diverse##4##3##(1990-12#1)(1990-8#1)(2006-10#1)(2013-1#1)
with a domain arrangement of##2##5##(1990-5#2)
with a dominant##4##3##(2007-8#1)(2008-11#1)(2008-2#1)(2012-3#1)
with a dorsal##2##3##(2008-9#2)
with a dose of##7##4##(2007-11#2)(2007-12#2)(2008-12#1)(2011-2#1)(2013-8#1)
with a dose##11##3##(1991-6#1)(1992-10#1)(1996-5#1)(2007-11#2)(2007-12#2)(2008-12#1)(2009-11#1)(2011-2#1)(2013-8#1)
with a dose-dependent##3##3##(1993-3#1)(1997-5#1)(2006-7#1)
with a double membrane##2##4##(2008-10#1)(2008-9#1)
with a double##11##3##(1992-11#2)(2006-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)(2011-1#1)(2013-7#1)
with a double-etalon##2##3##(2008-2#2)
with a double-focusing mass##2##4##(2008-10#1)(2008-4#1)
with a doubling time of##2##5##(2008-11#2)
with a doubling##4##3##(1990-12#1)(1997-1#1)(2008-11#2)
with a dramatic##6##3##(1992-4#1)(1995-12#1)(2007-8#1)(2008-12#1)(2011-2#1)(2013-8#1)
with a drop in the##2##5##(1994-11#1)(1996-2#1)
with a drop in##4##4##(1994-11#1)(1996-2#1)(2008-10#1)(2008-7#1)
with a dry##3##3##(2007-11#1)(2007-12#1)(2008-5#1)
with a dual enzyme electrode##2##5##(2008-10#2)
with a dual source##2##4##(2012-1#1)(2012-12#1)
with a dual##10##3##(2006-9#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#2)(2011-2#1)(2012-1#1)(2012-12#1)
with a dural##2##3##(1996-9#1)(2005-5#1)
with a duration of##3##4##(1995-5#1)(1997-8#1)(2008-9#1)
with a duration##5##3##(1995-5#1)(1997-8#1)(2007-12#1)(2008-9#1)(2013-1#1)
with a dye##4##3##(2005-12#1)(2006-12#1)(2008-11#1)(2008-9#1)
with a dye-doped##2##3##(2007-12#2)
with a dynamic flat-panel detector##2##5##(2010-9#2)
with a dynamic range of##6##5##(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#1)
with a dynamic range##7##4##(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#1)(2010-5#1)
with a dynamic##15##3##(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2010-5#1)(2010-9#3)
with a fabricated##2##3##(2006-2#1)(2008-2#1)
with a failure##4##3##(1992-10#1)(2007-12#1)(2007-4#1)(2008-4#1)
with a fair degree of##2##5##(2006-12#1)(2008-2#1)
with a fair##3##3##(2006-12#1)(2008-2#1)(2010-5#1)
with a false positive rate of##3##6##(2006-12#1)(2006-8#2)
with a false##4##3##(2006-12#1)(2006-5#1)(2006-8#2)
with a false-positive rate of##2##5##(2006-8#2)
with a familial history of##2##5##(1991-5#1)(2012-12#1)
with a familial##3##3##(1991-5#1)(2012-12#2)
with a family history of atherosclerosis##3##6##(1997-8#3)
with a family history of##12##5##(1993-11#1)(1997-8#3)(2005-11#1)(2006-10#1)(2008-3#2)(2009-9#1)(2013-1#2)(2013-8#1)
with a family history##13##4##(1993-11#1)(1997-8#3)(2005-11#1)(2006-10#1)(2008-3#2)(2008-8#1)(2009-9#1)(2013-1#2)(2013-8#1)
with a family of##3##4##(1993-3#1)(1994-12#1)(1996-10#1)
with a family##19##3##(1993-11#1)(1993-3#1)(1994-12#1)(1996-10#1)(1997-8#3)(2005-11#1)(2006-10#1)(2007-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-9#1)(2012-2#1)(2013-1#2)(2013-8#1)
with a far##2##3##(1994-10#1)(2009-8#1)
with a fast algorithm##2##4##(2007-11#1)(2008-2#1)
with a fast response time##4##5##(2007-12#1)(2008-10#3)
with a fast response##6##4##(2007-12#1)(2008-10#5)
with a fast##14##3##(1996-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#4)
with a faster##2##3##(1997-7#1)(2008-8#1)
with a fatal##4##3##(2005-9#1)(2008-12#1)(2008-2#1)(2013-1#1)
with a favorable long-term prognosis##2##5##(2008-12#1)(2008-6#1)
with a favorable##9##3##(1995-10#1)(1997-5#1)(2006-8#1)(2008-12#1)(2008-6#1)(2010-7#1)(2012-3#2)(2013-1#1)
with a favourable##4##3##(1995-6#1)(2007-8#1)(2008-3#1)(2010-11#1)
with a febrile##2##3##(2006-12#1)(2006-9#1)
with a fellow##2##3##(1996-12#1)(2009-11#1)
with a female predominance##2##4##(2009-9#1)(2010-7#1)
with a female##8##3##(2006-12#1)(2006-3#1)(2007-12#1)(2009-11#1)(2009-6#1)(2009-9#1)(2010-7#1)(2012-3#1)
with a femtosecond laser##3##4##(2007-12#3)
with a femtosecond##4##3##(2007-12#3)(2008-2#1)
with a ferroelectric liquid crystal##2##5##(2008-2#2)
with a ferroelectric liquid-crystal spatial light modulator##3##7##(2008-2#2)(2008-3#1)
with a ferroelectric liquid-crystal##4##4##(2008-2#3)(2008-3#1)
with a ferroelectric##6##3##(2008-2#5)(2008-3#1)
with a fetal##2##3##(2008-11#1)(2013-1#1)
with a fever##2##3##(2007-12#1)(2012-12#1)
with a few exceptions##4##4##(2009-9#1)(2011-1#1)(2012-1#1)(2012-3#1)
with a few noted exceptions##2##5##(2008-10#2)
with a few##28##3##(1990-5#1)(1993-12#1)(1995-6#1)(1995-9#1)(1996-9#1)(1997-6#1)(2006-10#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-9#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#2)(2013-8#1)
with a fiber bragg grating##2##5##(2008-2#2)
with a fiber##8##3##(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)
with a fiber-optic##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
with a fibrate##2##3##(2008-1#1)(2008-5#1)
with a field of view##3##5##(2008-2#2)(2008-3#1)
with a field##4##3##(2007-5#1)(2008-2#2)(2008-3#1)
with a final diagnosis of##2##5##(1990-3#1)(1993-10#1)
with a final##10##3##(1990-3#1)(1991-3#1)(1993-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-1#1)(2013-8#1)
with a finding##2##3##(2010-5#1)(2013-1#1)
with a fine##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
with a finite number of##3##5##(2007-11#1)(2007-12#1)(2007-9#1)
with a finite##6##3##(2007-11#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-3#2)
with a firearm##3##3##(1992-5#2)(2009-2#1)
with a firm##2##3##(1997-5#1)(2007-7#1)
with a first peak##2##4##(1992-8#1)(1995-12#1)
with a first##7##3##(1992-2#1)(1992-8#1)(1995-12#1)(2007-10#1)(2008-10#1)(2011-1#1)(2013-8#1)
with a first-order##4##3##(1995-6#1)(2007-12#1)(2008-10#1)(2008-2#1)
with a fistula##2##3##(1993-3#1)(2012-12#1)
with a five##3##3##(2006-4#1)(2008-9#1)(2013-8#1)
with a five-mirror cavity##2##4##(2007-12#2)
with a fixed dose##2##4##(1993-11#1)(2013-1#1)
with a fixed number of##2##5##(2007-11#1)(2009-5#1)
with a fixed##24##3##(1992-7#1)(1993-11#1)(1994-5#1)(1995-3#1)(1995-8#1)(1996-11#1)(2007-11#1)(2007-12#4)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-9#1)(2009-5#1)(2012-11#2)(2012-12#1)(2013-1#1)
with a flat##7##3##(1991-2#1)(2005-11#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-5#1)
with a flexible##5##3##(1995-8#1)(1996-1#1)(2008-2#1)(2010-7#1)(2011-1#1)
with a flow injection (FI) system##2##6##(2008-10#2)
with a flow injection system##2##5##(2008-10#2)
with a flow injection##5##4##(2008-10#5)
with a flow rate of 1 ml/min and##3##8##(2010-12#1)(2010-2#2)
with a flow rate of 1 ml/min##4##7##(2008-10#1)(2010-12#1)(2010-2#2)
with a flow rate of 1##8##6##(2005-12#1)(2008-10#3)(2008-5#1)(2010-12#1)(2010-2#2)
with a flow rate of##9##5##(2005-12#1)(2008-10#4)(2008-5#1)(2010-12#1)(2010-2#2)
with a flow##17##3##(2005-12#1)(2007-1#1)(2008-10#9)(2008-5#1)(2008-9#1)(2010-12#1)(2010-2#2)(2012-2#1)
with a flow-rate of##2##4##(1992-2#1)(1996-6#1)
with a flow-through##3##3##(2008-10#2)(2013-1#1)
with a fluid##3##3##(2005-11#1)(2008-10#1)(2008-7#1)
with a fluid-fluid level##2##4##(2011-2#2)
with a fluorescein derivative##2##4##(2008-10#2)
with a fluorescein##3##3##(2008-10#2)(2008-2#1)
with a fluorescence detector##2##4##(2008-10#2)
with a fluorescence##7##3##(1990-9#1)(1997-3#1)(2006-10#1)(2008-10#2)(2008-3#1)(2012-11#1)
with a fluorescent dye##2##4##(2008-3#1)(2008-4#1)
with a fluorescent marker##3##4##(1990-4#1)(1994-2#1)(2007-11#1)
with a fluorescent probe##3##4##(1992-6#1)(1997-6#1)(2008-4#1)
with a fluorescent##14##3##(1990-4#1)(1990-5#1)(1990-6#1)(1992-6#1)(1994-2#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-7#1)
with a fluorinated##2##3##(1992-12#1)(2008-10#1)
with a fluorophore##2##3##(1992-3#1)(2008-2#1)
with a focal length##2##4##(2007-11#1)(2008-2#1)
with a focal##6##3##(2007-11#1)(2008-10#1)(2008-2#1)(2009-4#1)(2011-1#1)(2013-1#1)
with a focus on the##9##5##(1995-12#1)(2006-10#1)(2007-7#1)(2008-10#2)(2010-7#1)(2011-1#1)(2011-10#1)(2013-1#1)
with a focus on their##4##5##(2009-4#1)(2011-1#2)(2011-2#1)
with a focus on##56##4##(1994-1#1)(1994-2#1)(1995-12#1)(1996-7#1)(1997-3#1)(2004-12#1)(2005-7#2)(2005-9#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#2)(2009-12#1)(2009-4#1)(2010-10#1)(2010-11#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-10#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
with a focus##57##3##(1994-1#1)(1994-2#1)(1995-12#1)(1996-7#1)(1997-3#1)(2004-12#1)(2005-7#2)(2005-9#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#2)(2009-12#1)(2009-4#1)(2010-10#1)(2010-11#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-10#1)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
with a focused##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
with a follow-up##2##3##(2007-10#1)(2011-2#1)
with a food##4##3##(2008-10#1)(2008-5#3)
with a foot##2##3##(2006-10#1)(2013-8#1)
with a force transducer##2##4##(1996-9#1)(1997-5#1)
with a foreign##2##3##(2008-8#1)(2010-9#1)
with a form of##3##4##(1991-12#1)(1995-8#1)(2008-9#1)
with a four##2##3##(1996-5#1)(2008-10#1)
with a fractional##2##3##(1996-12#1)(2008-3#1)
with a frame##3##3##(1990-11#1)(2007-12#1)(2008-3#1)
with a framework for understanding##2##5##(2008-12#1)(2010-4#1)
with a framework for##4##4##(2007-12#1)(2008-12#1)(2010-4#1)(2012-1#1)
with a framework##5##3##(2007-12#1)(2008-12#1)(2010-4#1)(2011-2#1)(2012-1#1)
with a free spectral range of##3##6##(2007-11#2)(2007-12#1)
with a free##9##3##(1995-5#1)(1996-5#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-5#1)(2011-2#2)
with a frequency in the##2##5##(2004-11#2)
with a frequency of 1##2##5##(2008-11#1)(2008-3#1)
with a frequency of##13##4##(1996-3#1)(1997-8#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#2)(2010-2#1)(2013-1#1)
with a frequency##18##3##(1991-6#1)(1996-3#1)(1997-8#1)(2004-11#2)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#2)(2010-2#1)(2013-1#1)
with a frequency-doubled##3##3##(2008-2#2)(2008-3#1)
with a frequency-modulated##2##3##(2008-3#2)
with a full width at half-maximum of##4##7##(2007-12#3)(2008-3#1)
with a full width at##6##5##(1994-8#1)(2007-11#1)(2007-12#3)(2008-3#1)
with a full##14##3##(1991-1#1)(1994-8#2)(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#1)(2008-3#2)(2013-1#2)
with a fully##5##3##(2007-5#1)(2008-10#1)(2008-3#2)(2008-8#1)
with a functional##4##3##(1991-5#1)(1997-6#1)(2008-11#1)(2008-6#1)
with a functioning##3##3##(1995-2#1)(2007-11#1)(2013-1#1)
with a fungicide##3##3##(2008-10#3)
with a further increase in##2##5##(2006-7#1)(2007-12#1)
with a further##6##3##(2004-2#1)(2006-12#1)(2006-7#1)(2007-12#1)(2007-8#1)(2011-2#1)
with a fused-silica microsphere##2##4##(2007-12#2)
with a fused-silica##3##3##(2007-11#1)(2007-12#2)
with a gain##5##3##(1991-5#1)(2007-11#2)(2008-3#1)(2010-9#1)
with a galvanic hydrogen cyanide sensor##2##6##(2008-10#2)
with a gas##7##3##(1992-9#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2013-8#1)
with a gene coding for##2##5##(1994-2#1)(2006-10#1)
with a gene##6##3##(1991-7#1)(1994-2#1)(1995-1#1)(2006-10#1)(2006-6#1)(2008-4#1)
with a general practitioner##2##4##(1993-6#1)(2010-1#1)
with a general##9##3##(1993-3#1)(1993-6#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-4#1)(2010-1#1)
with a generalized##2##3##(2008-10#1)(2012-3#1)
with a genetic algorithm##2##4##(2008-2#1)(2008-3#1)
with a genetic##7##3##(1996-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)
with a genetically##4##3##(1995-1#1)(2008-10#1)(2008-12#1)(2010-8#1)
with a genomic##2##3##(2007-12#1)(2008-10#1)
with a geometric mean of##2##5##(2008-5#2)
with a giant##8##3##(1993-6#1)(2006-12#1)(2007-3#1)(2009-8#1)(2010-6#1)(2011-2#2)(2012-2#1)
with a given##16##3##(1997-2#1)(2005-10#1)(2006-12#1)(2006-4#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-2#3)(2008-3#3)(2008-9#1)(2010-3#1)(2012-2#1)
with a glass impact bead##2##5##(2008-10#2)
with a glass##7##3##(1996-10#1)(2007-12#2)(2008-10#3)(2013-1#1)
with a glassy carbon electrode##2##5##(2008-10#1)(2009-3#1)
with a global##7##3##(2007-11#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-1#1)
with a glucocorticoid##2##3##(1993-12#1)(2008-5#1)
with a glucose##4##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)
with a glutathione S-transferase (GST)##2##5##(1994-12#1)(1994-9#1)
with a glutathione##3##3##(1994-12#1)(1994-3#1)(1994-9#1)
with a gold##3##3##(2008-10#2)(2008-3#1)
with a good clinical response##2##5##(2010-12#1)(2013-8#1)
with a good outcome##2##4##(2007-8#1)(2008-7#1)
with a good precision##3##4##(2008-10#3)
with a good prognosis##4##4##(2008-10#1)(2012-2#1)(2012-3#1)(2013-8#1)
with a good safety profile##2##5##(2006-10#1)(2009-9#1)
with a good signal-to-noise ratio##3##5##(2007-12#2)(2011-2#1)
with a good##44##3##(1993-4#1)(1994-6#1)(1997-1#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#5)
with a grade V lipoatrophy##2##5##(2013-1#2)
with a grade##3##3##(1991-2#1)(2013-1#2)
with a gradient elution##5##4##(2005-12#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-12#1)
with a gradient of##2##4##(2008-2#1)(2008-4#1)
with a gradient solvent system of##2##6##(2008-10#1)(2012-3#1)
with a gradient##11##3##(2005-12#1)(2006-1#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-5#1)(2011-1#1)(2012-12#1)(2012-3#1)
with a gradual decrease in##2##5##(1991-8#1)(2008-10#1)
with a gradual decrease##4##4##(1991-8#1)(2007-11#1)(2007-7#1)(2008-10#1)
with a gradual##9##3##(1991-8#1)(1994-9#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2010-11#1)
with a graft##2##3##(2007-11#1)(2009-5#1)
with a graphite##2##3##(2008-10#2)
with a grating period##2##4##(2007-12#1)(2008-3#1)
with a grating##8##3##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#3)
with a grave##2##3##(2006-6#1)(2009-10#1)
with a great deal of##3##5##(1993-9#1)(2007-7#1)(2012-12#1)
with a great potential for the##2##6##(1997-8#1)(2009-10#1)
with a great variety of##2##5##(1997-6#1)(2008-7#1)
with a great##13##3##(1990-10#1)(1993-9#1)(1997-6#1)(1997-8#1)(2005-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-10#1)(2010-3#1)(2012-11#1)(2012-12#1)
with a greater ability to##2##5##(1995-2#1)(1995-8#1)
with a greater extent##2##4##(1997-8#1)(2012-12#1)
with a greater number of##4##5##(1991-1#1)(2008-12#1)(2008-7#1)(2009-7#1)
with a greater potential##2##4##(2006-12#1)(2013-8#1)
with a greater proportion of##2##5##(1995-6#1)(2008-4#1)
with a greater than##2##4##(2007-1#1)(2008-2#1)
with a greater##31##3##(1991-1#1)(1992-1#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-7#1)(1997-1#1)(1997-8#1)(2004-11#1)(2006-12#2)(2007-1#1)(2007-11#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-6#1)(2011-2#2)(2012-12#3)(2013-1#1)(2013-8#3)
with a green fluorescent protein (GFP)##2##6##(2008-10#2)
with a grid##2##3##(2006-10#1)(2008-5#1)
with a groove density##2##4##(2008-3#2)
with a groove##3##3##(2006-3#1)(2008-3#2)
with a group of##16##4##(1991-3#1)(1992-8#1)(1997-1#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#2)
with a group##23##3##(1990-12#1)(1991-11#1)(1991-3#1)(1992-8#1)(1997-1#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#1)
with a growing##5##3##(1993-1#1)(1996-3#1)(1997-6#1)(2008-4#1)(2013-1#1)
with a growth##4##3##(1994-8#1)(1996-12#1)(2008-5#1)(2013-1#1)
with a guide##3##3##(2007-2#1)(2008-10#1)(2008-3#1)
with a gyrotropic##2##3##(2008-2#2)
with a half##3##3##(1992-7#1)(1994-3#1)(1997-8#1)
with a half-life of 1##2##5##(1990-11#1)(1994-9#1)
with a half-life of 4##3##5##(1990-11#1)(1994-9#1)(2010-6#1)
with a half-life of approximately##2##5##(1996-4#1)(1996-5#1)
with a half-life of##12##4##(1990-11#2)(1994-9#5)(1996-4#1)(1996-5#1)(2004-9#1)(2008-3#1)(2010-6#1)
with a half-life##13##3##(1990-11#2)(1994-9#5)(1996-4#1)(1996-5#1)(1997-4#1)(2004-9#1)(2008-3#1)(2010-6#1)
with a half-maximal##4##3##(1991-8#2)(1994-8#1)(1994-9#1)
with a half-time of approximately##2##5##(1992-12#1)(1992-6#1)
with a half-time of##4##4##(1990-3#1)(1992-12#1)(1992-6#1)(1996-8#1)
with a half-time##5##3##(1990-3#1)(1992-12#1)(1992-6#1)(1994-11#1)(1996-8#1)
with a hand-held##2##3##(2007-8#1)(2008-10#1)
with a hanging mercury drop electrode##2##6##(2008-10#2)
with a hanging##3##3##(2008-10#2)(2008-11#1)
with a hapten##2##3##(1992-8#1)(1994-8#1)
with a hard##3##3##(2007-12#1)(2008-2#1)(2008-5#1)
with a hazard ratio##2##4##(1993-9#1)(2013-1#1)
with a head##4##3##(2006-10#1)(2006-11#1)(2006-4#2)
with a health##2##3##(1994-12#1)(2007-2#1)
with a healthy##2##3##(1995-5#1)(1996-3#1)
with a hemispherical##2##3##(2008-3#1)(2009-5#1)
with a hemocytometer##2##3##(1991-2#1)(1996-3#1)
with a hemoglobin##2##3##(1996-11#1)(2010-12#1)
with a hepatic##2##3##(1995-2#1)(1996-4#1)
with a herd##2##3##(1992-5#1)(1996-12#1)
with a hereditary##5##3##(1990-11#1)(2006-10#1)(2012-11#2)(2013-8#1)
with a heterobifunctional##2##3##(1992-11#1)(2008-7#1)
with a heterogeneous distribution of##3##5##(1992-6#1)(2013-1#2)
with a heterogeneous##7##3##(1992-6#1)(2008-8#1)(2010-3#2)(2011-2#1)(2013-1#2)
with a high Km##2##4##(1992-3#1)(1997-8#1)
with a high abundance of##2##5##(2007-5#1)(2009-5#1)
with a high accuracy of a few nanometers##2##8##(2008-2#1)(2008-3#1)
with a high accuracy##5##4##(2008-2#1)(2008-3#2)(2011-2#1)(2013-8#1)
with a high affinity and##2##5##(1995-10#1)(1995-5#1)
with a high affinity for##4##5##(1991-10#1)(1991-12#1)(1992-11#1)(1994-2#1)
with a high affinity##8##4##(1990-2#1)(1991-10#1)(1991-12#1)(1992-11#1)(1994-2#1)(1995-10#1)(1995-5#1)(2008-10#1)
with a high average##2##4##(1994-2#1)(2006-12#1)
with a high case fatality rate##2##6##(2008-8#1)(2013-1#1)
with a high concentration of##3##5##(1992-5#1)(2008-3#1)(2012-12#1)
with a high correlation coefficient##3##5##(2004-9#1)(2006-12#1)(2011-2#1)
with a high correlation##4##4##(2004-9#1)(2006-12#1)(2008-10#1)(2011-2#1)
with a high degree of accuracy##7##6##(1990-9#1)(1993-5#1)(2007-11#2)(2008-3#1)(2008-5#1)(2013-1#1)
with a high degree of certainty##2##6##(1997-2#1)(2008-6#1)
with a high degree of confidence##2##6##(2008-10#1)(2008-3#1)
with a high degree of homology##2##6##(1990-4#1)(1997-6#1)
with a high degree of precision##3##6##(2007-11#1)(2008-11#1)(2010-12#1)
with a high degree of selectivity##3##6##(2008-10#2)(2008-7#1)
with a high degree of sensitivity and specificity##2##8##(1990-12#1)(2007-12#1)
with a high degree of sensitivity and##3##7##(1990-12#1)(2007-12#1)(2008-10#1)
with a high degree of sensitivity##5##6##(1990-12#1)(2007-12#2)(2008-10#2)
with a high degree of##41##5##(1990-12#1)(1990-4#1)(1990-9#1)(1992-3#1)(1992-7#2)(1993-5#1)(1994-8#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-11#4)(2007-12#2)(2007-6#1)(2008-10#5)(2008-11#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-3#1)(2012-2#1)(2013-1#1)
with a high density of##2##5##(1990-4#1)(2010-7#1)
with a high dose of##5##5##(1995-3#2)(1995-8#1)(2013-1#1)(2013-8#1)
with a high flow##2##4##(1995-3#1)(1996-9#1)
with a high frequency of##3##5##(1991-8#1)(1997-5#1)(2006-10#1)
with a high frequency##4##4##(1991-8#1)(1997-5#1)(2006-10#1)(2007-8#1)
with a high incidence of##10##5##(1994-4#1)(2006-2#1)(2007-10#2)(2007-7#1)(2007-8#1)(2008-5#2)(2008-6#1)(2009-5#1)
with a high index of##2##5##(2006-9#1)(2007-7#1)
with a high level of##16##5##(1992-9#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-4#1)(1996-11#1)(2006-12#1)(2006-3#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-12#1)(2010-11#1)(2013-8#1)
with a high likelihood##2##4##(2006-12#1)(2008-8#1)
with a high molecular weight##3##5##(1995-6#1)(1996-12#1)(2008-10#1)
with a high mortality rate##11##5##(1992-9#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-6#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#1)
with a high mortality##14##4##(1992-9#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#1)
with a high number of##6##5##(2007-11#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-4#1)
with a high numerical aperture##4##5##(2007-12#1)(2008-2#2)(2008-3#1)
with a high percentage of##4##5##(1996-3#1)(2006-11#1)(2008-11#1)(2012-3#1)
with a high prevalence of##7##5##(1993-9#1)(2007-8#1)(2007-9#1)(2008-1#2)(2009-1#1)(2011-2#1)
with a high prevalence##9##4##(1993-9#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2009-1#1)(2010-12#1)(2011-2#1)
with a high probability of##5##5##(1991-2#1)(2006-9#1)(2007-11#1)(2008-11#1)(2008-3#1)
with a high probability##7##4##(1991-2#1)(2005-10#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
with a high proportion of##3##5##(2007-11#1)(2008-10#1)(2008-7#1)
with a high rate of recurrence##2##6##(1990-4#1)(2008-6#1)
with a high rate of##16##5##(1990-4#1)(1991-6#1)(1993-6#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
with a high resolution##2##4##(2007-12#1)(2011-1#1)
with a high risk of recurrence##2##6##(2013-7#1)(2013-8#1)
with a high risk of##9##5##(1990-3#1)(2006-6#1)(2008-5#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
with a high risk##11##4##(1990-3#1)(1993-9#1)(2006-6#1)(2008-5#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
with a high sensitivity and specificity##3##6##(2008-4#1)(2012-12#1)(2013-1#1)
with a high sensitivity##4##4##(2008-10#1)(2008-4#1)(2012-12#1)(2013-1#1)
with a high signal-to-noise ratio##3##5##(2007-12#2)(2008-3#1)
with a high success rate and##2##6##(1990-10#1)(1996-11#1)
with a high success rate##5##5##(1990-10#1)(1995-3#1)(1996-11#1)(2012-12#1)(2013-8#1)
with a high yield##4##4##(1990-12#1)(1994-3#1)(2008-5#1)(2013-1#1)
with a high##314##3##(1990-10#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#3)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#3)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#2)(1992-5#1)(1992-7#2)(1992-9#2)(1993-11#1)(1993-5#2)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-4#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#5)(1995-4#1)(1995-5#5)(1995-6#2)(1995-8#1)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-1#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-3#1)(2006-10#3)(2006-11#1)(2006-12#4)(2006-2#3)(2006-3#2)(2006-4#1)(2006-6#1)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#13)(2007-12#12)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#8)(2007-9#1)(2008-1#4)(2008-10#26)(2008-11#8)(2008-12#2)(2008-2#5)(2008-3#15)(2008-4#7)(2008-5#8)(2008-6#4)(2008-7#6)(2008-8#4)(2008-9#4)(2009-1#1)(2009-10#2)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#6)(2011-2#9)(2012-1#1)(2012-12#7)(2012-2#4)(2012-3#3)(2013-1#10)(2013-7#1)(2013-8#6)
with a high-affinity##3##3##(1990-11#1)(2009-10#1)(2012-2#1)
with a high-finesse Fabry-Perot cavity##2##5##(2007-12#1)(2008-3#1)
with a high-finesse Fabry-Perot##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
with a high-finesse##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
with a high-grade##2##3##(1997-1#1)(2008-6#1)
with a high-intensity##3##3##(2006-5#1)(2007-11#1)(2008-3#1)
with a high-numerical-aperture objective##2##4##(2007-12#1)(2008-2#1)
with a high-performance liquid##2##4##(1992-2#1)(1997-3#1)
with a high-performance##3##3##(1992-2#1)(1995-2#1)(1997-3#1)
with a high-power##2##3##(2007-12#1)(2008-2#1)
with a high-resolution##3##3##(2008-2#1)(2008-3#1)(2010-9#1)
with a high-speed##4##3##(2007-1#1)(2007-11#1)(2007-12#1)(2008-3#1)
with a higher affinity than##2##5##(1992-6#1)(1995-2#1)
with a higher affinity##3##4##(1990-11#1)(1992-6#1)(1995-2#1)
with a higher concentration of##2##5##(1991-12#1)(1997-5#1)
with a higher frequency##2##4##(1996-11#1)(2008-12#1)
with a higher incidence in##4##5##(2005-8#1)(2007-11#1)(2010-3#1)(2011-2#1)
with a higher incidence of##6##5##(2006-10#1)(2007-10#1)(2008-10#1)(2009-1#1)(2013-1#1)(2013-8#1)
with a higher incidence##10##4##(2005-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#1)(2009-1#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
with a higher level of##3##5##(1997-8#1)(2006-12#1)(2008-7#1)
with a higher number of##2##5##(1996-1#1)(2007-1#1)
with a higher probability of##2##5##(2007-3#1)(2009-5#1)
with a higher proportion##3##4##(1996-2#1)(1997-7#1)(2008-9#1)
with a higher risk of developing##2##6##(2008-3#1)(2013-1#1)
with a higher risk of relapse##2##6##(1996-4#1)(2009-5#1)
with a higher risk of##10##5##(1996-4#1)(2004-4#1)(2007-8#1)(2008-3#1)(2009-5#1)(2010-9#1)(2012-2#1)(2013-1#2)(2013-8#1)
with a higher risk##11##4##(1996-4#1)(2004-4#1)(2007-8#1)(2008-3#1)(2008-8#1)(2009-5#1)(2010-9#1)(2012-2#1)(2013-1#2)(2013-8#1)
with a higher##78##3##(1990-11#1)(1990-2#1)(1990-6#1)(1991-12#2)(1991-3#1)(1992-6#1)(1993-5#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-5#2)(1997-7#1)(1997-8#1)(2004-4#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#2)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-5#2)(2009-8#1)(2010-11#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-11#2)(2011-2#3)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#5)
with a highest##2##3##(2009-9#1)(2013-8#1)
with a highly conserved##3##4##(1994-10#1)(1995-8#1)(1996-8#1)
with a highly mobile##2##4##(1991-7#1)(2010-12#1)
with a highly sensitive##2##4##(1994-3#1)(2008-10#1)
with a highly variable##2##4##(2008-3#1)(2008-8#1)
with a highly##22##3##(1991-7#1)(1992-2#1)(1992-8#1)(1993-2#1)(1994-10#1)(1994-12#1)(1994-3#1)(1995-8#2)(1996-8#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#2)(2010-12#1)
with a histidine##2##3##(2008-10#1)(2008-4#1)
with a histologic diagnosis of##2##5##(1990-10#1)(1995-3#1)
with a histological diagnosis of##2##5##(2012-1#1)(2013-1#1)
with a historical control group##3##5##(1993-2#1)(2007-11#1)(2008-5#1)
with a historical##6##3##(1991-8#1)(1993-2#1)(2006-12#1)(2007-11#1)(2008-5#1)(2011-2#1)
with a history of Kawasaki disease##2##6##(1997-1#1)(2009-3#1)
with a history of SLI##4##5##(2012-3#4)
with a history of a##2##5##(2008-6#1)(2012-3#1)
with a history of breast##3##5##(1994-7#1)(2008-1#1)(2010-12#1)
with a history of chest pain##2##6##(2005-1#2)
with a history of chronic##2##5##(1992-10#1)(2012-1#1)
with a history of depression##3##5##(2004-3#1)(2012-12#1)(2013-8#1)
with a history of drug##2##5##(2005-11#1)(2009-11#1)
with a history of familial##2##5##(1993-6#1)(2007-10#1)
with a history of hysterectomy##2##5##(2010-12#1)(2012-3#1)
with a history of lateral ligament sprain##3##7##(2007-11#3)
with a history of multiple##3##5##(2008-11#1)(2013-7#1)(2013-8#1)
with a history of myocardial##2##5##(1992-10#1)(1996-8#1)
with a history of previous MAP psychosis##2##7##(1996-10#1)(1996-7#1)
with a history of previous##6##5##(1996-10#1)(1996-7#1)(2007-11#2)(2008-11#1)(2008-4#1)
with a history of recent##2##5##(1992-3#1)(2012-3#1)
with a history of recurrent##2##5##(2007-2#1)(2008-4#1)
with a history of significant##2##5##(2007-8#1)(2011-2#1)
with a history of##173##4##(1990-12#1)(1990-3#2)(1992-10#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-6#1)(1993-7#1)(1994-2#1)(1994-6#2)(1994-7#1)(1995-11#1)(1995-6#1)(1996-10#1)(1996-12#2)(1996-3#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-5#1)(2004-12#2)(2004-3#1)(2005-1#2)(2005-11#1)(2005-9#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#7)(2007-11#10)(2007-12#2)(2007-2#3)(2007-4#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-4#1)(2010-7#2)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#7)(2012-3#12)(2012-8#1)(2013-1#10)(2013-7#2)(2013-8#7)
with a history##176##3##(1990-12#1)(1990-3#2)(1992-10#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-6#1)(1993-7#1)(1994-2#1)(1994-6#2)(1994-7#1)(1995-11#1)(1995-6#1)(1996-10#1)(1996-12#2)(1996-3#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-5#1)(2004-12#2)(2004-3#1)(2005-1#2)(2005-11#1)(2005-9#1)(2006-1#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#7)(2007-11#10)(2007-12#2)(2007-2#3)(2007-4#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-4#1)(2010-7#2)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#7)(2012-3#12)(2012-8#1)(2013-1#10)(2013-7#2)(2013-8#9)
with a hitherto##2##3##(1995-6#1)(2013-1#1)
with a hollow##4##3##(2007-11#1)(2008-2#1)(2008-7#2)
with a homogeneous##7##3##(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-1#1)
with a horseradish peroxidase##2##4##(1990-12#1)(2008-10#1)
with a hospital##4##3##(1993-12#1)(1996-3#2)(1997-3#1)
with a host of##4##4##(2006-8#1)(2007-10#1)(2011-2#1)(2012-12#1)
with a huge##8##3##(1993-10#1)(2007-8#1)(2008-1#1)(2008-3#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)
with a human c-myc gene##2##5##(1993-3#1)(2008-11#1)
with a human ovarian##2##4##(1994-6#1)(2008-8#1)
with a human##15##3##(1992-12#1)(1992-3#1)(1993-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-10#1)(2007-12#1)(2007-2#1)(2008-11#2)(2008-7#1)(2008-8#1)
with a hybrid##6##3##(1992-8#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)
with a hydatid##2##3##(2010-2#1)(2011-2#1)
with a hydrogen##2##3##(2008-10#1)(2008-5#1)
with a hydrophilic matrix (Asahipak##2##5##(1990-8#2)
with a hydrophilic##3##3##(1990-8#2)(2010-4#1)
with a hydrophobic##4##3##(1993-6#1)(1997-4#1)(2005-7#1)(2008-10#1)
with a hydroxyl group##2##4##(2008-11#2)
with a hypoplastic##3##3##(2007-8#2)(2008-4#1)
with a hypothesis##5##3##(1997-4#1)(2005-10#1)(2008-11#1)(2009-5#1)(2013-8#1)
with a hypothetical protein##2##4##(1995-9#1)(1996-3#1)
with a hypothetical##3##3##(1995-11#1)(1995-9#1)(1996-3#1)
with a joint##2##3##(2006-10#1)(2008-3#1)
with a juvenile hormone##2##4##(1995-11#1)(2008-8#1)
with a kcat/Km##3##3##(1990-10#1)(1993-8#1)(1995-2#1)
with a key##3##3##(2006-10#1)(2008-4#1)(2009-2#1)
with a keyword##2##3##(2006-6#1)(2011-2#1)
with a known and##2##4##(2005-11#1)(2008-10#1)
with a known concentration##2##4##(2008-6#2)
with a known##20##3##(1991-12#1)(1992-8#1)(1996-8#1)(2005-11#1)(2007-1#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-7#1)(2011-2#2)
with a laboratory##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
with a lack of##7##4##(2008-10#1)(2008-7#1)(2009-8#1)(2010-1#1)(2012-2#2)(2013-8#1)
with a lag of##2##4##(1994-12#1)(2007-6#1)
with a lag##3##3##(1994-12#1)(2007-6#1)(2013-8#1)
with a large amount of##2##5##(2008-12#1)(2008-6#1)
with a large and##2##4##(1992-11#1)(2011-2#1)
with a large area of##2##5##(1992-5#1)(2008-10#1)
with a large complex##2##4##(1993-2#1)(2008-1#1)
with a large dispersion of the##2##6##(1990-3#1)(2008-3#1)
with a large excess of##3##5##(1991-11#1)(1995-2#1)(2008-2#1)
with a large left##2##4##(2006-9#1)(2012-2#1)
with a large number of##8##5##(1996-8#1)(1997-6#1)(2007-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-1#1)
with a large proportion of##4##5##(1992-12#1)(1994-5#1)(1997-4#1)(2008-10#1)
with a large range of##2##5##(1990-9#1)(2007-11#1)
with a large range##3##4##(1990-9#1)(2006-11#1)(2007-11#1)
with a large variety of##4##5##(1997-7#1)(2008-10#1)(2008-3#1)(2009-8#1)
with a large volume##2##4##(2008-8#1)(2009-8#1)
with a large##116##3##(1990-1#1)(1990-3#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-4#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-9#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#5)(2007-4#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#11)(2008-12#1)(2008-2#9)(2008-3#8)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-4#1)(2009-5#2)(2009-8#3)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#7)(2013-7#1)
with a larger number of subjects##2##6##(2005-11#1)(2006-6#1)
with a larger number of##4##5##(2005-11#1)(2006-6#1)(2008-10#1)(2012-1#1)
with a larger sample##2##4##(2008-12#1)(2009-9#1)
with a larger##15##3##(1991-4#1)(1996-8#1)(2005-11#1)(2006-6#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-12#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
with a laryngectomy##3##3##(2007-8#1)(2011-1#2)
with a laser beam##3##4##(2007-12#2)(2008-3#1)
with a laser diode##7##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)
with a laser guide star##2##5##(2007-12#1)(2008-3#1)
with a laser##23##3##(1991-11#1)(1995-6#1)(1996-1#1)(2005-11#2)(2006-4#1)(2007-11#2)(2007-12#4)(2008-2#2)(2008-3#7)(2008-4#1)(2012-3#1)
with a laser-diode-pumped##3##3##(2007-12#3)
with a late##4##3##(1995-8#1)(2006-3#1)(2007-12#1)(2008-1#1)
with a lateral##6##3##(2007-12#2)(2008-2#2)(2009-1#1)(2012-2#1)
with a layer of##6##4##(1991-2#1)(2005-11#1)(2008-10#1)(2008-3#2)(2008-5#1)
with a learning##4##3##(1990-12#1)(2008-10#1)(2008-11#2)
with a left##12##3##(2006-11#1)(2006-4#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-6#1)(2008-7#1)(2010-12#1)(2012-2#1)
with a legal##3##3##(1996-11#1)(2006-7#1)(2008-11#1)
with a length of##7##4##(1992-12#1)(1995-2#1)(1997-8#1)(2006-8#1)(2007-12#1)(2008-3#2)
with a lens##3##3##(2005-12#1)(2008-10#1)(2011-1#1)
with a lenslet array##2##4##(2007-12#1)(2008-2#1)
with a lesion##2##3##(1996-2#1)(2013-1#1)
with a less##10##3##(1992-5#1)(1993-12#1)(1995-10#1)(1995-6#1)(1996-11#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#1)
with a lesser degree of##2##5##(1991-5#1)(1997-1#1)
with a lesser##8##3##(1990-8#1)(1991-12#1)(1991-5#1)(1993-3#1)(1997-1#1)(2006-12#1)(2008-3#1)(2011-2#1)
with a lethal dose of##2##5##(1993-9#1)(2010-4#1)
with a lethal##3##3##(1993-9#1)(2008-10#1)(2010-4#1)
with a life-threatening##2##3##(1990-8#1)(2011-3#1)
with a lifetime of##2##4##(1996-5#2)
with a lifetime##4##3##(1996-5#2)(2006-8#1)(2008-3#1)
with a ligand##2##3##(1991-2#1)(1996-2#1)
with a light##5##3##(1992-3#1)(2007-3#1)(2008-10#1)(2012-2#1)(2012-3#1)
with a likelihood ratio##2##4##(2008-3#1)(2013-1#1)
with a likely##2##3##(2006-2#1)(2010-8#1)
with a limit of detection and quantitation of 0##2##9##(2010-12#1)(2010-2#1)
with a limit of detection of 0##5##7##(2007-8#1)(2008-10#4)
with a limit of detection of 1##2##7##(2008-10#2)
with a limit of detection of##12##6##(2007-8#1)(2008-10#11)
with a limit of detection##20##5##(2007-8#1)(2008-10#17)(2010-12#1)(2010-2#1)
with a limit of##21##4##(2007-8#1)(2008-10#18)(2010-12#1)(2010-2#1)
with a limit##22##3##(2007-8#1)(2008-10#19)(2010-12#1)(2010-2#1)
with a limited amount of tissue##2##6##(2008-4#1)(2010-8#1)
with a limited number of##6##5##(1991-7#1)(1993-9#1)(2006-1#1)(2006-10#1)(2008-5#1)(2012-2#1)
with a limited##18##3##(1990-12#1)(1991-7#1)(1993-3#1)(1993-9#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#2)(2010-8#2)(2012-12#1)(2012-2#1)
with a limiting##2##3##(1994-8#1)(2007-9#1)
with a line of##2##4##(2008-10#1)(2008-3#1)
with a linear calibration##2##4##(2008-10#2)
with a linear concentration range of##2##6##(2008-10#1)(2010-5#1)
with a linear correlation coefficient of 0##3##7##(1992-11#1)(2008-10#2)
with a linear dynamic range of##2##6##(2008-10#1)(2012-3#1)
with a linear dynamic range##5##5##(2008-10#4)(2012-3#1)
with a linear free energy relationship##2##6##(2005-11#2)
with a linear range between 1##2##6##(2008-10#2)
with a linear range between##3##5##(2007-8#1)(2008-10#2)
with a linear range from##5##5##(2007-8#2)(2008-10#3)
with a linear range of 0##2##6##(2008-10#2)
with a linear range of##4##5##(2008-10#4)
with a linear range##12##4##(2007-8#3)(2008-10#9)
with a linear response over##2##5##(2008-10#1)(2010-3#1)
with a linear response##4##4##(1996-12#1)(2008-10#2)(2010-3#1)
with a linear##40##3##(1992-11#1)(1996-12#1)(2005-11#2)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#4)(2008-10#23)(2008-11#1)(2008-8#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-3#1)
with a linearly polarized##2##4##(2007-12#1)(2008-2#1)
with a linearly##3##3##(2007-12#2)(2008-2#1)
with a linewidth of##2##4##(2007-11#1)(2008-2#1)
with a linker##4##3##(1993-3#1)(1993-5#1)(2008-4#2)
with a lipid##5##3##(2005-11#1)(2007-11#1)(2008-4#1)(2011-2#2)
with a liquid##7##3##(2005-11#2)(2006-12#1)(2008-3#4)
with a liquid-crystal spatial light modulator##2##6##(2007-12#1)(2008-3#1)
with a liquid-crystal##7##3##(2007-12#4)(2008-3#3)
with a list of##5##4##(1993-4#1)(2008-10#1)(2008-2#1)(2009-12#1)(2013-7#1)
with a literature review##5##4##(2008-6#1)(2009-8#1)(2010-11#1)(2010-8#1)(2012-11#1)
with a lithium##2##3##(2008-3#1)(2010-5#1)
with a little##2##3##(2011-1#1)(2012-3#1)
with a live##9##3##(1995-9#1)(2007-2#1)(2008-10#1)(2008-5#2)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
with a liver##2##3##(2012-2#1)(2013-7#1)
with a load##3##3##(2007-4#2)(2008-11#1)
with a local##8##3##(1996-5#1)(2005-2#1)(2006-10#1)(2007-11#1)(2008-3#1)(2009-10#1)(2010-8#1)(2012-2#1)
with a localized##2##3##(2007-12#1)(2008-10#1)
with a logarithmic##2##3##(2008-10#1)(2009-7#1)
with a logistic##2##3##(2008-10#1)(2010-8#1)
with a long duration of##2##5##(2008-11#1)(2008-5#1)
with a long history of##9##5##(1995-9#1)(2005-11#1)(2006-10#2)(2006-9#1)(2007-7#1)(2008-10#3)
with a long##30##3##(1991-12#1)(1991-6#1)(1993-2#1)(1995-9#1)(1997-1#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-9#1)(2007-11#2)(2007-3#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
with a long-lasting##3##3##(1991-2#1)(2007-11#1)(2008-4#1)
with a long-term##2##3##(2008-6#1)(2010-3#1)
with a longer duration of##2##5##(2005-9#1)(2008-11#1)
with a longer duration##3##4##(2005-9#1)(2008-11#1)(2012-3#1)
with a longer half-life##2##4##(1995-2#1)(2007-11#1)
with a longer##12##3##(1990-12#1)(1990-8#1)(1992-9#1)(1993-11#1)(1995-2#1)(1996-4#1)(2005-9#1)(2006-1#1)(2007-11#1)(2008-11#1)(2012-2#1)(2012-3#1)
with a loop sequence complementary to the TAR loop##2##9##(1994-8#2)
with a loop##4##3##(1994-8#2)(1996-11#1)(1997-4#1)
with a loss of##8##4##(1990-12#1)(1992-3#1)(1994-3#1)(1995-7#1)(2007-12#1)(2008-11#1)(2011-2#1)(2013-8#1)
with a loss##10##3##(1990-12#1)(1992-3#1)(1994-3#1)(1995-12#1)(1995-7#1)(1996-3#1)(2007-12#1)(2008-11#1)(2011-2#1)(2013-8#1)
with a lot of##2##4##(2007-12#1)(2013-1#1)
with a low complication rate##2##5##(1993-6#1)(2007-8#1)
with a low concentration of##3##5##(1994-11#1)(1996-6#1)(2008-5#1)
with a low degree of##6##5##(1991-6#1)(1995-2#1)(1996-3#1)(2004-2#1)(2007-6#1)(2011-2#1)
with a low detection limit of##3##6##(2008-10#2)(2013-1#1)
with a low detection limit##4##5##(2008-10#3)(2013-1#1)
with a low dielectric constant##2##5##(2005-11#2)
with a low dose of##2##5##(2008-7#1)(2013-1#1)
with a low dose##4##4##(2007-11#1)(2008-7#2)(2013-1#1)
with a low grade##2##4##(2006-6#1)(2012-2#1)
with a low incidence of early##2##6##(2007-11#1)(2013-1#1)
with a low incidence of##6##5##(2007-11#1)(2008-5#1)(2008-6#1)(2011-2#2)(2013-1#1)
with a low level of##2##5##(2008-10#1)(2012-1#1)
with a low level##3##4##(1992-9#1)(2008-10#1)(2012-1#1)
with a low molecular weight heparin##2##6##(1990-12#1)(1997-2#1)
with a low molecular weight##4##5##(1990-12#1)(1990-9#1)(1991-3#1)(1997-2#1)
with a low potential for##2##5##(2008-5#1)(2011-1#1)
with a low prevalence##2##4##(2008-1#1)(2012-3#1)
with a low rate of##5##5##(1993-6#1)(2006-9#1)(2007-5#1)(2007-7#1)(2009-12#1)
with a low recurrence##2##4##(2010-12#1)(2012-12#1)
with a low risk of##5##5##(1992-5#1)(2008-3#2)(2008-6#1)(2012-2#1)
with a low risk##6##4##(1992-5#1)(2008-3#2)(2008-6#1)(2009-3#1)(2012-2#1)
with a low##109##3##(1990-12#1)(1990-2#3)(1990-5#1)(1990-9#3)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#2)(1992-11#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#2)(1993-7#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-5#1)(2004-2#1)(2005-11#2)(2005-9#1)(2006-10#1)(2006-6#2)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#2)(2009-12#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#2)
with a low-cost##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
with a low-grade##3##3##(1995-12#1)(2005-5#1)(2007-12#1)
with a low-power##2##3##(2007-11#1)(2008-2#1)
with a low-volume##3##3##(1997-8#1)(2008-10#1)(2008-3#1)
with a lower detection limit of##3##6##(2008-10#3)
with a lower frequency of##3##5##(2007-5#1)(2008-10#1)(2012-3#1)
with a lower incidence of##4##5##(2006-10#1)(2007-8#1)(2011-1#1)(2013-1#1)
with a lower limit of detection of##2##7##(2008-10#2)
with a lower limit of##4##5##(1996-5#1)(2008-10#2)(2011-2#1)
with a lower number of##2##5##(2007-11#1)(2007-3#1)
with a lower rate of##4##5##(1992-4#1)(2006-5#1)(2013-1#2)
with a lower risk of##3##5##(1996-12#1)(2008-10#1)(2013-1#1)
with a lower risk##4##4##(1996-12#1)(2005-10#1)(2008-10#1)(2013-1#1)
with a lower##57##3##(1990-9#1)(1991-11#1)(1991-12#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-2#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#2)(2008-7#2)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
with a macroscopic##2##3##(2007-5#1)(2009-11#1)
with a magnetic stirrer##2##4##(2008-10#1)(2008-11#1)
with a magnetic##3##3##(2008-10#1)(2008-11#1)(2010-3#1)
with a magnification ratio of##2##5##(2008-2#1)(2008-3#1)
with a major gene effect##2##5##(1995-11#1)(1996-5#1)
with a major impact on##3##5##(2005-8#1)(2007-2#1)(2008-3#1)
with a major##16##3##(1990-6#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-5#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-3#1)(2009-9#1)(2011-1#1)(2013-7#1)
with a majority of##2##4##(1990-3#1)(2007-6#1)
with a majority##3##3##(1990-3#1)(2007-6#1)(2012-12#1)
with a malaria##2##3##(2006-4#2)
with a male predominance##2##4##(2006-1#1)(2008-1#1)
with a male##6##3##(1995-11#1)(2006-1#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-5#1)
with a malignant##6##3##(1995-4#1)(2007-8#1)(2010-10#1)(2010-5#1)(2010-7#1)(2013-7#1)
with a manual##5##3##(1993-9#1)(1994-12#1)(2006-6#1)(2007-7#1)(2008-10#1)
with a margin##2##3##(1997-5#1)(2012-12#1)
with a marked decrease in the##2##6##(1994-3#1)(1997-7#1)
with a marked decrease in##3##5##(1994-3#1)(1997-7#1)(2008-7#1)
with a marked increase in##3##5##(1996-9#1)(1997-3#1)(2008-3#1)
with a marked reduction in##2##5##(1992-3#1)(2008-10#1)
with a marked##19##3##(1990-12#1)(1990-7#1)(1992-3#1)(1994-3#1)(1994-6#1)(1996-9#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#3)(2009-5#1)(2013-8#1)
with a mass in##2##4##(1990-5#1)(2007-5#1)
with a mass of##6##4##(1990-7#1)(1991-10#1)(1992-12#1)(2007-12#1)(2007-4#1)(2009-2#1)
with a mass spectrometer##2##4##(2008-10#2)
with a mass##16##3##(1990-5#1)(1990-7#1)(1991-10#1)(1992-12#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#5)(2009-2#1)(2010-12#1)(2013-7#1)
with a massive##4##3##(2007-11#1)(2007-8#1)(2008-12#1)(2008-6#1)
with a master's##2##3##(1994-12#2)
with a matched##3##3##(1993-8#1)(1997-1#1)(2013-1#1)
with a mathematical model of##2##5##(2009-11#1)(2010-9#1)
with a mathematical model##4##4##(2008-10#1)(2008-3#1)(2009-11#1)(2010-9#1)
with a maximal increase##3##4##(1990-10#1)(1993-3#1)(1994-3#1)
with a maximal viable cell density##2##6##(2008-11#2)
with a maximal##15##3##(1990-10#2)(1990-2#2)(1991-2#1)(1991-4#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(1996-2#1)(2008-10#1)(2008-11#2)(2011-2#1)
with a maximum after##2##4##(1992-6#1)(2009-4#1)
with a maximum at##12##4##(1990-6#1)(1991-2#2)(1991-7#1)(1993-4#1)(1993-6#1)(1994-12#1)(1997-2#1)(2008-10#2)(2009-4#1)(2013-8#1)
with a maximum diameter of##3##5##(1993-9#1)(2007-8#1)(2008-12#1)
with a maximum effect at##3##5##(1991-4#1)(2004-12#1)(2008-4#1)
with a maximum effect##6##4##(1991-4#1)(1992-3#1)(1995-10#1)(1996-6#1)(2004-12#1)(2008-4#1)
with a maximum of##4##4##(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)
with a maximum overall##2##4##(2008-2#1)(2008-3#1)
with a maximum value of##2##5##(2008-10#1)(2009-4#1)
with a maximum##58##3##(1990-6#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-6#2)(1993-12#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-10#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#2)(2004-12#1)(2005-11#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#8)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-4#3)(2009-5#1)(2013-7#1)(2013-8#1)
with a mean (SD)##2##4##(2012-12#1)(2013-1#1)
with a mean age at##2##5##(2011-12#1)(2011-2#1)
with a mean age of 11##2##6##(2008-7#1)(2010-1#1)
with a mean age of 14##2##6##(2009-8#1)(2013-1#1)
with a mean age of 32##3##6##(1994-6#1)(2008-1#1)(2010-3#1)
with a mean age of 33##3##6##(1995-10#1)(2006-8#1)(2008-9#1)
with a mean age of 34##2##6##(1991-4#1)(1994-6#1)
with a mean age of 39##2##6##(2006-6#1)(2007-7#1)
with a mean age of 40##2##6##(2011-2#1)(2012-2#1)
with a mean age of 43##3##6##(2007-9#1)(2008-1#1)(2008-4#1)
with a mean age of 45##2##6##(2007-7#1)(2007-8#1)
with a mean age of 50##2##6##(2007-8#1)(2011-2#1)
with a mean age of 57##2##6##(2007-8#1)(2008-7#1)
with a mean age of 62##3##6##(1993-10#1)(2013-1#2)
with a mean age of 64##2##6##(2007-10#1)(2012-2#1)
with a mean age of 65##2##6##(2007-10#1)(2011-2#1)
with a mean age of##64##5##(1991-1#1)(1991-4#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-10#1)(1994-6#2)(1995-10#1)(1996-2#1)(2005-10#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#4)(2007-8#7)(2007-9#1)(2008-1#5)(2008-12#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#2)
with a mean age##68##4##(1991-1#1)(1991-4#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-10#1)(1994-6#2)(1995-10#1)(1996-2#1)(2005-10#1)(2006-6#1)(2006-8#1)(2007-10#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#4)(2007-8#7)(2007-9#1)(2008-1#5)(2008-12#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#1)
with a mean difference##2##4##(2008-7#1)(2009-12#1)
with a mean duration of##3##5##(1991-2#1)(2008-6#1)(2012-2#1)
with a mean duration##4##4##(1991-2#1)(2008-6#1)(2008-7#1)(2012-2#1)
with a mean follow-up of##3##5##(1993-9#1)(1996-6#1)(2008-10#1)
with a mean follow-up##5##4##(1993-9#1)(1996-6#1)(2006-5#1)(2007-8#1)(2008-10#1)
with a mean of 1##2##5##(2007-5#1)(2011-2#1)
with a mean of 18##2##5##(1991-9#1)(2007-8#1)
with a mean of 20##2##5##(2006-5#1)(2011-11#1)
with a mean of 51##2##5##(1991-9#1)(2008-4#1)
with a mean of##23##4##(1990-2#2)(1991-9#5)(1992-1#2)(1993-8#1)(2005-12#1)(2006-5#1)(2006-6#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-4#2)(2008-5#1)(2011-11#2)(2011-2#1)
with a mean relative error of e(r)&lt##2##7##(2008-10#2)
with a mean relative error of##3##6##(2008-10#3)
with a mean survival of##2##5##(1992-4#1)(2007-6#1)
with a mean survival period of##2##6##(2008-6#1)(2008-7#1)
with a mean survival##5##4##(1992-4#1)(2007-6#1)(2008-6#1)(2008-7#1)(2012-12#1)
with a mean value of##7##5##(1991-12#1)(1996-7#1)(2008-8#3)(2013-8#2)
with a mean##182##3##(1990-2#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-9#6)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-10#1)(1993-11#2)(1993-2#3)(1993-8#1)(1993-9#1)(1994-6#2)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-5#1)(2004-1#1)(2004-10#1)(2005-10#2)(2005-11#1)(2005-12#2)(2006-1#1)(2006-10#1)(2006-12#2)(2006-5#2)(2006-6#2)(2006-8#3)(2007-10#3)(2007-12#1)(2007-2#2)(2007-3#2)(2007-5#2)(2007-6#1)(2007-7#6)(2007-8#11)(2007-9#1)(2008-1#6)(2008-10#10)(2008-12#3)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#1)(2009-1#2)(2009-12#1)(2009-3#1)(2009-8#2)(2010-1#1)(2010-12#2)(2010-3#1)(2010-8#2)(2011-11#2)(2011-12#1)(2011-2#8)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#1)(2013-1#10)(2013-7#3)(2013-8#3)
with a means to##3##4##(2005-10#1)(2008-9#1)(2012-2#1)
with a measurable##2##3##(1994-12#1)(2005-7#1)
with a measure of##2##4##(2008-10#1)(2008-9#1)
with a measure##3##3##(2008-10#1)(2008-9#1)(2012-1#1)
with a measured##2##3##(2008-2#2)
with a measurement##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
with a mechanical##5##3##(2007-8#2)(2008-2#1)(2009-12#1)(2010-1#1)
with a mechanism involving##2##4##(1990-2#1)(1990-3#1)
with a mechanism that##2##4##(1990-7#1)(1994-5#1)
with a mechanism##7##3##(1990-2#1)(1990-3#1)(1990-7#1)(1992-5#1)(1994-10#1)(1994-5#1)(1995-1#1)
with a medial##2##3##(1995-2#1)(2009-9#1)
with a median age of 56 years##2##7##(2007-11#1)(2008-6#1)
with a median age of##11##5##(1992-5#1)(1993-10#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-6#1)(2011-1#2)(2011-2#1)(2013-1#1)
with a median duration of##2##5##(1992-4#1)(2008-6#1)
with a median follow-up of##4##5##(1990-12#1)(1990-2#1)(2008-6#2)
with a median follow-up##5##4##(1990-12#1)(1990-2#1)(2008-6#2)(2013-1#1)
with a median of##8##4##(1995-10#1)(1997-2#1)(2008-10#3)(2008-6#1)(2008-7#1)(2013-1#1)
with a median survival of 13 months##2##7##(2005-11#1)(2006-12#1)
with a median survival of 13##3##6##(1991-4#1)(2005-11#1)(2006-12#1)
with a median survival of##4##5##(1991-4#1)(2005-11#1)(2006-12#1)(2012-12#1)
with a median survival##6##4##(1991-4#1)(2005-11#1)(2006-12#1)(2008-10#1)(2010-12#1)(2012-12#1)
with a median time##2##4##(2010-3#1)(2013-1#1)
with a median##49##3##(1990-12#1)(1990-2#1)(1991-4#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-10#1)(1993-9#1)(1995-10#1)(1997-2#1)(2005-11#1)(2005-7#1)(2006-12#2)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-6#6)(2008-7#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#6)
with a mediastinal##3##3##(2009-9#1)(2010-12#1)(2012-2#1)
with a medical condition##2##4##(2006-9#1)(2012-2#1)
with a medical##8##3##(1994-12#1)(1995-1#1)(2006-9#1)(2007-10#1)(2007-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
with a medium##4##3##(1990-6#1)(2005-10#1)(2005-11#1)(2008-10#1)
with a membrane##7##3##(2007-8#1)(2008-10#4)(2008-11#1)(2009-5#1)
with a membrane-permeable##2##3##(1994-2#1)(2008-8#1)
with a mental##3##3##(1994-1#1)(1995-12#1)(2013-8#1)
with a mercury film##2##4##(2008-10#2)
with a mercury##6##3##(1990-2#1)(2007-10#1)(2007-12#1)(2008-10#3)
with a metabolic##4##3##(1996-12#1)(2007-2#1)(2008-11#1)(2008-7#1)
with a metal##2##3##(2008-10#2)
with a metallic##2##3##(2007-12#1)(2008-10#1)
with a metastatic##3##3##(1992-6#1)(2007-5#1)(2008-4#1)
with a methionine##2##3##(1991-12#1)(1993-3#1)
with a method derived from##2##5##(2004-10#2)
with a method of##2##4##(2008-12#1)(2008-2#1)
with a method that##2##4##(1990-12#1)(2008-4#1)
with a method##8##3##(1990-12#1)(2004-10#2)(2008-10#1)(2008-12#1)(2008-2#2)(2008-4#1)
with a micellar##2##3##(2008-10#1)(2009-8#1)
with a microfabricated##2##3##(2007-11#1)(2008-10#1)
with a microlens##2##3##(2007-11#1)(2007-12#1)
with a micromachined##2##3##(2008-2#1)(2008-3#1)
with a microsatellite##2##3##(1991-12#1)(2008-7#1)
with a microscope##6##3##(2006-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#2)
with a microsphere##2##3##(1996-6#1)(2007-11#1)
with a middle##2##3##(2008-6#1)(2012-12#1)
with a midpoint of##2##4##(1992-6#1)(1996-9#1)
with a midpoint##3##3##(1992-6#1)(1993-3#1)(1996-9#1)
with a mild##6##3##(1990-2#1)(1992-1#1)(1992-10#2)(2008-5#1)(2013-8#1)
with a mildly##2##3##(2008-4#1)(2013-1#1)
with a mineral##2##3##(2008-5#1)(2008-7#1)
with a miniature##3##3##(2006-6#1)(2008-10#1)(2008-3#1)
with a minimal number of##2##5##(2007-11#1)(2007-7#1)
with a minimal##15##3##(1995-5#1)(1996-8#1)(1997-4#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2012-12#2)
with a minimally##2##3##(2010-9#1)(2011-2#1)
with a minimum acquisition time of##2##6##(2007-12#1)(2008-3#1)
with a minimum detectability (S/N=3) of##2##6##(2008-10#2)
with a minimum follow-up of##3##5##(2008-3#1)(2008-6#1)(2008-8#1)
with a minimum number of##2##5##(2007-12#2)
with a minimum of 2##2##5##(2007-7#1)(2010-7#1)
with a minimum of##11##4##(2006-10#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-5#1)(2010-7#1)(2012-12#1)
with a minimum##36##3##(1990-11#1)(1992-7#1)(1994-12#1)(1994-5#1)(1996-6#2)(2005-11#1)(2006-10#1)(2007-12#5)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-5#1)(2010-7#1)(2012-12#1)(2012-3#1)
with a minor##8##3##(1991-7#1)(1991-8#1)(1994-9#1)(1995-2#1)(1996-7#1)(1996-8#1)(1997-5#1)(2012-12#1)
with a mirrorless##2##3##(2007-11#2)
with a mitochondrial##5##3##(1992-9#1)(1993-3#1)(1994-11#1)(2008-10#1)(2012-2#1)
with a mixed##7##3##(1995-5#1)(1997-4#1)(2006-1#1)(2006-8#1)(2008-10#1)(2009-3#1)(2009-6#1)
with a mixture of acetonitrile and##2##6##(1996-8#1)(2008-10#1)
with a mixture of nitric##3##5##(2007-5#1)(2008-10#2)
with a mixture of the##2##5##(2007-6#1)(2008-8#1)
with a mixture of water and##2##6##(2007-12#1)(2008-3#1)
with a mixture of##48##4##(1990-12#1)(1992-10#1)(1992-8#1)(1993-2#1)(1994-3#2)(1995-1#1)(1995-12#1)(1996-6#1)(1996-8#2)(1997-8#1)(2005-12#1)(2005-8#1)(2006-8#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#20)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2013-1#1)
with a mixture##49##3##(1990-12#1)(1992-10#1)(1992-8#1)(1993-2#1)(1994-3#2)(1995-1#1)(1995-12#1)(1996-6#1)(1996-8#2)(1997-8#1)(2005-12#1)(2005-8#1)(2006-8#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#20)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2013-1#1)
with a mobile phase consisting of##10##6##(1990-11#1)(1990-6#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-6#1)(2010-2#1)(2012-3#1)
with a mobile phase containing##3##5##(1990-8#1)(2008-10#2)
with a mobile phase of##8##5##(1993-2#1)(1996-8#1)(1997-3#1)(1997-8#1)(2007-8#2)(2008-10#2)
with a mobile phase##23##4##(1990-11#1)(1990-6#1)(1990-8#1)(1993-2#1)(1996-6#1)(1996-8#2)(1997-3#2)(1997-8#2)(2007-8#2)(2008-10#6)(2008-6#1)(2010-2#1)(2012-3#1)(2013-7#1)
with a mobile##27##3##(1990-11#1)(1990-6#1)(1990-8#1)(1993-2#1)(1996-6#1)(1996-8#2)(1997-3#2)(1997-4#1)(1997-8#2)(2005-11#1)(2007-8#2)(2008-10#6)(2008-6#1)(2008-7#1)(2010-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
with a mode-locked laser##2##4##(2007-12#2)
with a mode-locked##4##3##(2007-12#3)(2008-3#1)
with a mode-mismatched##2##3##(2008-3#2)
with a model based on the##2##6##(2007-12#1)(2008-3#1)
with a model in which##9##5##(1990-2#1)(1991-4#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-11#1)(1994-8#1)(2008-10#1)(2008-2#1)
with a model of the##2##5##(2007-5#1)(2008-1#1)
with a model of##10##4##(1990-3#1)(1990-9#1)(1992-6#1)(1995-3#1)(2006-9#1)(2007-5#1)(2008-1#1)(2008-3#1)(2010-12#1)(2012-1#1)
with a model system##2##4##(1994-9#1)(2007-12#1)
with a model that##3##4##(2007-12#1)(2008-11#1)(2008-2#1)
with a model##39##3##(1990-2#1)(1990-3#1)(1990-9#1)(1991-4#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-11#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#2)(1996-5#1)(1996-7#1)(1997-7#1)(2005-11#1)(2006-9#1)(2007-1#1)(2007-12#3)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#1)(2009-12#1)(2009-2#1)(2010-12#1)(2012-1#1)
with a moderate##9##3##(1993-6#1)(1997-4#1)(2006-10#1)(2007-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#1)(2012-3#1)
with a moderately##3##3##(1996-2#1)(2008-10#1)(2008-6#1)
with a modest##2##3##(2006-10#1)(2008-2#1)
with a modification##2##3##(1992-4#1)(2008-10#1)
with a modified ring A##2##5##(2007-11#2)
with a modified##30##3##(1991-9#1)(1996-12#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-8#2)(2008-10#5)(2008-2#6)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#3)
with a modulation##2##3##(2008-3#2)
with a moisturizing##2##3##(2007-7#1)(2008-5#1)
with a molar absorptivity of##2##5##(2008-10#2)
with a molar absorptivity##3##4##(2008-10#3)
with a molar mass of##2##5##(2008-10#1)(2010-12#1)
with a molar mass##3##4##(2008-10#1)(2010-12#1)(2013-1#1)
with a molar ratio##2##4##(2008-10#2)
with a molar##9##3##(2008-10#6)(2010-12#1)(2012-2#1)(2013-1#1)
with a molecular mass of 27##2##6##(1994-12#1)(1996-5#1)
with a molecular mass of 70 kDa##2##7##(1990-3#1)(1994-5#1)
with a molecular mass of about##4##6##(1992-12#1)(1992-8#1)(1993-11#1)(1994-8#1)
with a molecular mass of approximately##2##6##(1994-9#1)(2008-10#1)
with a molecular mass of##30##5##(1990-3#1)(1990-4#1)(1990-7#1)(1991-2#3)(1991-7#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#3)(1996-5#1)(1997-7#1)(2004-8#1)(2008-10#4)(2008-11#1)
with a molecular mass##33##4##(1990-3#1)(1990-4#1)(1990-7#1)(1991-2#3)(1991-7#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#3)(1996-5#1)(1997-7#1)(2004-8#1)(2008-10#6)(2008-11#1)
with a molecular size of##4##5##(1991-3#1)(1991-8#1)(1994-9#1)(2008-10#1)
with a molecular weight of 70 kDa##3##7##(2010-12#1)(2012-1#2)
with a molecular weight of about 35##2##7##(1991-5#1)(1993-3#1)
with a molecular weight of about##4##6##(1991-5#1)(1993-3#1)(1994-9#1)(1997-7#1)
with a molecular weight of approximately##2##6##(1991-6#1)(2006-8#1)
with a molecular weight of##34##5##(1990-11#1)(1990-5#2)(1990-7#3)(1990-9#2)(1991-11#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-9#1)(1996-2#1)(1997-5#1)(1997-7#1)(2006-8#1)(2007-11#1)(2008-11#1)(2010-12#2)(2012-1#5)(2012-2#1)
with a molecular weight##37##4##(1990-11#1)(1990-5#2)(1990-7#3)(1990-9#2)(1991-11#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-9#1)(1996-2#1)(1997-5#1)(1997-7#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-11#3)(2010-12#2)(2012-1#5)(2012-2#1)
with a molecular##77##3##(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#4)(1990-9#2)(1991-11#3)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1992-11#2)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#2)(1994-11#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#5)(1995-12#1)(1996-2#1)(1996-5#1)(1997-5#1)(1997-7#2)(2004-8#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#8)(2008-11#4)(2010-12#2)(2012-1#5)(2012-2#1)
with a molecularly##3##3##(2008-10#1)(2013-1#2)
with a monochromatic##2##3##(2007-12#1)(2008-3#1)
with a monoclonal antibody against the##2##6##(1993-8#1)(1993-9#1)
with a monoclonal antibody against##4##5##(1992-11#1)(1993-8#1)(1993-9#1)(1995-12#1)
with a monoclonal antibody specific for##3##6##(1990-12#1)(1994-2#1)(2008-10#1)
with a monoclonal antibody to CRF##2##6##(1993-7#1)(1994-2#1)
with a monoclonal antibody##16##4##(1990-12#1)(1990-7#1)(1991-10#1)(1991-4#1)(1991-5#1)(1992-11#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#3)(1995-12#1)(2008-10#1)(2010-4#1)
with a mood disorder##3##4##(2004-3#1)(2008-11#1)(2010-12#1)
with a moral##2##3##(2008-11#1)(2010-10#1)
with a more accurate##2##4##(2008-2#1)(2008-9#1)
with a more advanced##2##4##(2006-11#1)(2007-8#1)
with a more pronounced effect##2##5##(2005-11#1)(2008-10#1)
with a more severe##2##4##(2007-7#1)(2009-8#1)
with a more##47##3##(1990-12#1)(1990-2#1)(1990-8#1)(1991-4#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-3#1)(1996-11#1)(1997-5#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#3)(2008-3#3)(2008-5#1)(2008-6#3)(2008-8#2)(2008-9#1)(2009-2#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
with a morphological##2##3##(1991-4#1)(2008-2#1)
with a mortality rate of##4##5##(1993-5#1)(1996-5#1)(2013-1#1)(2013-7#1)
with a mortality rate##6##4##(1993-5#1)(1996-5#1)(2007-12#1)(2010-12#1)(2013-1#1)(2013-7#1)
with a motion##2##3##(2008-3#1)(2012-1#1)
with a motorized shaver##2##4##(2008-9#2)
with a motorized##3##3##(2008-11#1)(2008-9#2)
with a mouse##4##3##(1993-7#1)(1994-11#1)(1997-2#1)(2008-9#1)
with a much higher##3##4##(1994-9#1)(2007-11#1)(2008-10#1)
with a much lower affinity##2##5##(1996-5#1)(1997-7#1)
with a much lower##3##4##(1993-6#1)(1996-5#1)(1997-7#1)
with a much##8##3##(1993-6#1)(1994-5#1)(1994-9#1)(1996-5#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-10#1)
with a multichannel##4##3##(2008-2#1)(2008-3#3)
with a multidrug-resistant##2##3##(1995-11#1)(2007-11#1)
with a multilevel##2##3##(2007-12#1)(2008-2#1)
with a multimode deformable##2##4##(2008-2#1)(2008-3#1)
with a multimode##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
with a multiple pregnancy##5##4##(2007-2#5)
with a multiple##8##3##(1992-9#1)(1994-2#1)(2007-2#5)(2008-3#1)
with a multitude of##6##4##(2006-10#2)(2006-8#1)(2011-2#1)(2012-1#1)(2012-12#1)
with a multivariate##2##3##(2008-10#1)(2009-12#1)
with a murine MAb##2##4##(1991-5#1)(1997-2#1)
with a murine##4##3##(1991-5#1)(1997-2#1)(1997-4#2)
with a mutant##5##3##(1994-11#1)(1996-5#1)(1997-8#1)(2006-12#1)(2007-9#1)
with a mutation##4##3##(1991-1#1)(1991-12#1)(1993-12#1)(2009-10#1)
with a myocardial infarction##2##4##(2008-11#1)(2013-1#1)
with a myxoid##2##3##(2008-6#1)(2012-3#1)
with a narrow##10##3##(2006-6#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-11#1)(2010-12#1)(2013-1#1)
with a nasal hemangiopericytoma##2##4##(2006-10#2)
with a national##3##3##(1993-2#1)(1996-1#1)(2008-1#1)
with a natural##4##3##(1992-12#1)(1994-12#1)(2008-1#1)(2010-1#1)
with a near infrared##2##4##(2008-10#1)(2011-1#1)
with a near##4##3##(2008-10#2)(2011-1#1)(2011-2#1)
with a near-Nernstian slope##2##4##(2008-10#2)
with a near-Nernstian##3##3##(2008-10#3)
with a near-field scanning optical microscope##2##6##(2007-12#2)
with a near-field##3##3##(2007-12#3)
with a nearly##7##3##(1992-8#1)(1993-3#1)(2007-11#1)(2007-12#2)(2008-2#1)(2009-1#1)
with a need for##3##4##(2007-11#1)(2007-7#1)(2007-8#1)
with a need##4##3##(1992-12#1)(2007-11#1)(2007-7#1)(2007-8#1)
with a needle##5##3##(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(2010-12#1)
with a negative effect on##2##5##(1992-2#1)(2010-7#1)
with a negative leishmanin skin test##2##6##(2008-7#2)
with a negative predictive value of##2##6##(2005-10#1)(2008-5#1)
with a negative##22##3##(1991-6#1)(1992-2#1)(1992-6#1)(1993-11#1)(1995-5#1)(2005-1#3)(2005-10#1)(2006-4#1)(2006-9#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-7#1)(2012-1#1)(2013-1#1)
with a negligible##2##3##(2007-12#1)(2008-3#1)
with a nested##2##3##(1990-7#1)(1992-2#1)
with a net##2##3##(2007-3#1)(2008-6#1)
with a network of##3##4##(2008-10#1)(2008-4#1)(2008-5#1)
with a network##4##3##(2008-10#1)(2008-4#1)(2008-5#2)
with a neural##3##3##(1995-12#1)(2007-12#1)(2009-10#1)
with a neurological deficit##2##4##(1996-8#1)(2006-11#1)
with a neurological##3##3##(1996-8#1)(2006-11#1)(2010-12#1)
with a neuroprotective##2##3##(2007-9#1)(2008-11#1)
with a neutral##5##3##(1991-12#1)(2007-12#1)(2008-10#2)(2012-9#1)
with a new fluorescent probe 1##2##6##(2008-10#2)
with a new method##2##4##(2008-2#2)
with a new procedure##2##4##(1992-3#1)(2011-2#1)
with a new structure##2##4##(1996-2#1)(2008-12#1)
with a new##79##3##(1990-10#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-5#1)(1995-5#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-8#1)(2006-3#1)(2007-11#2)(2007-12#2)(2007-8#4)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#8)(2008-3#4)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#2)(2009-7#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
with a newly designed##2##4##(2008-10#2)
with a newly developed##4##4##(1994-12#1)(2007-5#1)(2008-2#2)
with a newly##11##3##(1992-11#1)(1994-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2011-2#1)(2012-11#1)
with a non-diagnostic##3##3##(2005-10#3)
with a non-functioning pituitary macroadenoma##2##5##(2008-8#2)
with a non-ionic surfactant##3##4##(1994-9#1)(2008-10#1)(2008-5#1)
with a non-ionic##4##3##(1994-9#1)(2008-10#1)(2008-5#2)
with a non-linear##2##3##(1991-6#1)(1993-5#1)
with a non-polar##2##3##(2006-10#1)(2012-1#1)
with a non-selective##2##3##(2008-7#1)(2009-8#1)
with a noncollinear##2##3##(2008-3#2)
with a nonlinear optical loop mirror (NOLM)##2##7##(2007-11#1)(2007-12#1)
with a nonlinear optical loop mirror##4##6##(2007-11#2)(2007-12#2)
with a nonlinear optical##5##4##(2007-11#2)(2007-12#3)
with a nonlinear##13##3##(1996-2#1)(2007-11#4)(2007-12#6)(2008-2#1)(2008-3#1)
with a nonselective##2##3##(2006-10#1)(2008-2#1)
with a nontrivial##2##3##(1993-3#1)(2007-11#1)
with a normal ejection fraction##2##5##(1990-7#1)(2013-1#1)
with a normal##31##3##(1990-7#1)(1991-5#1)(1992-7#1)(1993-10#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-8#1)(2007-10#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-12#2)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#1)
with a normalization##2##3##(1997-7#1)(2008-2#1)
with a nose##2##3##(1995-4#1)(2008-1#1)
with a novel double##2##4##(2008-10#2)
with a novel interferometer##2##4##(2007-11#1)(2007-12#1)
with a novel##44##3##(1991-9#1)(1992-8#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-12#1)(1996-12#1)(1996-8#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#7)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#2)(2008-5#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-5#2)(2011-1#1)(2013-1#1)(2013-8#1)
with a nucleotide diversity of 0##2##6##(2008-10#2)
with a nucleotide##3##3##(2008-10#3)
with a number needed to treat of only seven to prevent##2##11##(2007-8#2)
with a number needed to treat of only##3##8##(2007-8#3)
with a number needed to treat of##5##7##(2007-8#5)
with a number of additional##2##5##(2008-7#1)(2010-5#1)
with a number of drugs##2##5##(1993-12#1)(2008-8#1)
with a number of other##2##5##(1992-4#1)(2007-11#1)
with a number of previous##2##5##(1994-10#1)(2006-10#1)
with a number of serious##2##5##(1993-11#1)(2013-1#1)
with a number of##47##4##(1990-8#1)(1991-12#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-10#1)(1994-3#1)(1995-2#1)(1997-1#1)(1997-4#2)(2005-12#2)(2005-7#1)(2005-9#1)(2006-10#1)(2006-5#1)(2007-11#2)(2007-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-1#1)(2010-2#2)(2010-5#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#2)
with a number##52##3##(1990-8#1)(1991-12#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-10#1)(1994-3#1)(1995-2#1)(1997-1#1)(1997-4#2)(2005-12#2)(2005-7#1)(2005-9#1)(2006-10#1)(2006-5#1)(2007-11#2)(2007-6#1)(2007-8#5)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-1#1)(2010-2#2)(2010-5#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#2)
with a numerical aperture of 0##3##6##(2007-12#1)(2008-3#2)
with a numerical aperture of 1##2##6##(2008-2#1)(2008-3#1)
with a numerical aperture of##5##5##(2007-12#1)(2008-2#1)(2008-3#3)
with a numerical simulation##2##4##(2007-12#2)
with a numerical##12##3##(2006-2#1)(2007-12#5)(2008-10#1)(2008-2#2)(2008-3#3)
with a nutrient##2##3##(2004-4#2)
with a nutritional##2##3##(2010-12#1)(2012-12#1)
with a one year history of##3##6##(2005-12#1)(2008-12#1)(2008-7#1)
with a one year##4##4##(2005-12#1)(2006-8#1)(2008-12#1)(2008-7#1)
with a one##6##3##(1996-9#1)(2005-12#1)(2006-8#1)(2007-2#1)(2008-12#1)(2008-7#1)
with a one-dimensional##5##3##(2008-2#2)(2008-3#3)
with a pH of##4##4##(1992-2#1)(1993-3#1)(1997-3#1)(2008-10#1)
with a pH optimum##3##4##(1990-2#1)(1991-9#1)(2008-9#1)
with a pH##11##3##(1990-2#1)(1991-9#1)(1992-2#1)(1993-3#1)(1997-3#1)(2005-10#1)(2007-2#1)(2008-10#2)(2008-5#1)(2008-9#1)
with a pI of##3##4##(1990-12#1)(1991-8#1)(1994-8#1)
with a pI##5##3##(1990-12#1)(1991-8#1)(1994-8#1)(1995-3#1)(2008-6#1)
with a pK of##3##4##(1992-7#1)(1993-8#1)(1995-8#1)
with a pK##4##3##(1990-5#1)(1992-7#1)(1993-8#1)(1995-8#1)
with a pKa of##2##4##(1991-4#1)(1991-5#1)
with a pKa value of##2##5##(1991-7#1)(1992-6#1)
with a pKa##5##3##(1991-4#1)(1991-5#1)(1991-7#1)(1992-6#1)(1995-2#1)
with a pacemaker##2##3##(2010-2#1)(2011-2#1)
with a packed##2##3##(2008-10#1)(2008-7#1)
with a painful##5##3##(2006-10#1)(2007-7#1)(2008-12#1)(2009-3#2)
with a painless swelling##3##4##(2007-7#1)(2008-12#1)(2011-2#1)
with a painless##9##3##(2007-7#1)(2008-12#1)(2008-7#2)(2009-4#1)(2009-7#2)(2011-2#1)(2012-3#1)
with a pair of##8##4##(1993-11#1)(1996-1#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)
with a palpable##4##3##(2007-6#1)(2013-1#2)(2013-7#1)
with a panel of monoclonal antibodies##5##6##(1990-12#1)(1991-2#1)(1993-9#1)(1995-2#1)(2005-9#1)
with a panel of##14##4##(1990-12#1)(1990-7#1)(1991-2#1)(1993-7#1)(1993-9#1)(1994-6#2)(1994-8#1)(1995-12#1)(1995-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(2005-9#1)
with a panel##15##3##(1990-12#1)(1990-7#1)(1991-2#1)(1993-7#1)(1993-9#1)(1994-6#2)(1994-8#1)(1995-12#1)(1995-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(2005-9#1)(2006-12#1)
with a parabolic##2##3##(2008-2#1)(2008-3#1)
with a parallel decrease in##2##5##(1993-3#1)(2008-11#1)
with a parallel##10##3##(1993-3#1)(1994-11#1)(1995-3#1)(2005-11#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)
with a parametric##2##3##(2008-2#1)(2010-12#1)
with a parasite##2##3##(1994-11#1)(2006-4#1)
with a parasite-host list as well as a host-parasite list##2##10##(2007-3#2)
with a partial##8##3##(1992-3#1)(1993-11#1)(1994-3#1)(1997-1#1)(1997-7#2)(2008-10#1)(2011-2#1)
with a partially##5##3##(1991-12#1)(1994-7#1)(2007-12#1)(2007-5#1)(2010-8#1)
with a particle size of##2##5##(1996-6#1)(2008-10#1)
with a particle size##3##4##(1996-6#1)(2005-11#1)(2008-10#1)
with a particle##5##3##(1996-6#1)(2005-11#2)(2008-10#1)(2008-2#1)
with a particular emphasis on lithium and valproate##2##8##(2009-8#2)
with a particular emphasis on the use of##2##8##(1994-9#1)(2008-5#1)
with a particular emphasis on the##4##6##(1994-9#1)(2006-10#1)(2007-3#1)(2008-5#1)
with a particular emphasis on##10##5##(1994-9#1)(2006-10#1)(2007-3#1)(2008-4#1)(2008-5#1)(2009-8#2)(2010-12#1)(2011-1#1)(2011-2#1)
with a particular emphasis##12##4##(1994-9#1)(2006-10#1)(2007-3#1)(2008-4#1)(2008-5#1)(2009-8#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
with a particular focus on the##4##6##(1996-2#1)(2008-9#1)(2009-2#1)(2010-11#1)
with a particular focus on their##2##6##(2008-1#1)(2009-5#1)
with a particular focus on##9##5##(1996-2#1)(2007-1#1)(2008-1#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-11#1)(2010-12#1)(2012-12#1)
with a particular interest in##2##5##(2005-8#1)(2007-2#1)
with a particular interest##3##4##(2005-8#2)(2007-2#1)
with a particular##39##3##(1992-7#1)(1994-9#1)(1996-2#1)(1997-8#1)(2005-8#2)(2006-10#1)(2007-1#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#3)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
with a particularly##2##3##(2005-8#1)(2007-9#1)
with a passive##5##3##(2007-12#3)(2008-10#1)(2008-7#1)
with a patch##3##3##(2006-3#3)
with a patent##4##3##(1996-9#1)(2007-8#1)(2009-3#1)(2012-2#1)
with a pathogenic##3##3##(2008-10#1)(2008-2#1)(2013-8#1)
with a pathological##2##3##(1992-6#1)(2008-12#1)
with a patient suffering from##2##5##(2009-6#1)(2013-8#1)
with a patient with##2##4##(2007-4#1)(2013-7#1)
with a patient##8##3##(1994-1#1)(2007-4#1)(2007-5#1)(2007-7#1)(2009-6#1)(2010-8#1)(2013-7#1)(2013-8#1)
with a pattern##3##3##(2008-1#1)(2008-6#1)(2009-6#1)
with a peak at##3##4##(1991-2#1)(1993-9#1)(1994-6#1)
with a peak of##2##4##(1994-6#1)(2007-7#1)
with a peak power of##2##5##(2007-11#1)(2007-12#1)
with a peak##24##3##(1991-12#1)(1991-2#1)(1993-9#1)(1994-6#2)(1995-11#1)(1996-1#1)(1997-7#1)(2005-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-4#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-2#2)(2011-1#1)(2012-12#1)
with a peculiar##2##3##(1990-4#1)(1992-8#1)
with a pelvic mass##2##4##(2004-10#1)(2013-1#1)
with a pelvic##7##3##(2004-10#1)(2006-11#1)(2008-6#1)(2012-1#1)(2013-1#3)
with a penetrating##2##3##(2007-8#1)(2010-12#1)
with a peptide##3##3##(1994-11#1)(2008-4#1)(2010-12#1)
with a percentage of##2##4##(2008-11#1)(2013-1#1)
with a percutaneous##5##3##(1993-5#1)(2004-9#3)(2006-7#1)
with a performance##2##3##(2008-10#1)(2008-3#1)
with a pericardial patch##2##4##(2007-8#2)
with a perimesencephalic##2##3##(2008-7#2)
with a period length of##3##5##(2006-1#1)(2008-7#1)(2009-9#1)
with a period of##9##4##(1994-9#1)(1996-9#2)(2007-12#4)(2008-2#1)(2008-3#1)
with a period##15##3##(1994-9#1)(1996-9#2)(2006-1#1)(2007-11#1)(2007-12#4)(2008-2#3)(2008-3#1)(2008-7#1)(2009-9#1)
with a periodic##2##3##(2007-12#2)
with a periodically poled lithium niobate crystal##2##7##(2008-1#1)(2008-3#1)
with a periodically##3##3##(2008-1#1)(2008-10#1)(2008-3#1)
with a peripheral##3##3##(1991-11#1)(2008-7#1)(2011-2#1)
with a peritoneal##2##3##(1991-8#1)(2010-12#1)
with a permanent##3##3##(2008-2#1)(2008-5#1)(2011-2#1)
with a persistence##2##3##(1991-4#1)(2008-8#1)
with a persistent##8##3##(1991-6#1)(1991-9#1)(1996-5#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-7#1)(2013-1#1)
with a personal##4##3##(1990-11#1)(2008-2#1)(2009-6#1)(2010-2#1)
with a pest control agent##2##5##(2004-11#2)
with a petrous##2##3##(2005-5#1)(2010-3#1)
with a phase##8##3##(1993-11#1)(1995-7#1)(2007-11#3)(2007-12#1)(2009-10#1)(2010-5#1)
with a phase-conjugate##3##3##(2008-2#2)(2008-3#1)
with a phase-modulated##2##3##(2007-12#1)(2008-3#1)
with a phase-only##2##3##(2008-3#2)
with a phase-shifting##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
with a phenotype of##2##4##(1996-6#1)(2008-9#1)
with a phenotype##5##3##(1995-1#1)(1996-6#1)(2008-9#1)(2012-3#2)
with a phorbol ester##2##4##(1992-11#1)(1994-12#1)
with a photo-diode array detector##3##5##(2008-10#3)
with a photo-diode array##4##4##(2008-10#4)
with a photoconductive##2##3##(2008-1#1)(2008-2#1)
with a photodiode array detector##4##5##(2008-10#4)
with a photodiode##5##3##(2008-10#5)
with a photodiode-array detector##2##4##(1993-2#1)(1996-8#1)
with a photon scanning tunneling microscope##3##6##(2007-12#3)
with a photoreactive##2##3##(1990-11#1)(1994-8#1)
with a photorefractive##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
with a photoresist##2##3##(2008-2#1)(2008-7#1)
with a photothermal##2##3##(1994-3#1)(2008-3#1)
with a picosecond pulsed laser##2##5##(2007-11#2)
with a picosecond##3##3##(2007-11#2)(2008-1#1)
with a pigmented##2##3##(2007-11#1)(2010-6#1)
with a pituitary macroadenoma##2##4##(1991-6#1)(1994-5#1)
with a pituitary##3##3##(1991-6#1)(1994-5#1)(2006-12#1)
with a placebo##6##3##(1995-1#1)(1995-5#1)(2008-5#2)(2008-7#2)
with a plain##2##3##(2007-8#1)(2010-7#1)
with a planar##6##3##(2007-12#1)(2008-2#2)(2008-3#3)
with a plant##4##3##(2008-10#3)(2008-8#1)
with a plasma##2##3##(1993-5#1)(2008-11#1)
with a plasmid containing##3##4##(1990-12#1)(1990-6#1)(1996-8#1)
with a plasmid encoding##2##4##(2010-11#1)(2010-6#1)
with a plasmid##11##3##(1990-12#1)(1990-6#1)(1993-3#1)(1993-5#1)(1993-8#1)(1996-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2010-11#1)(2010-6#1)
with a plastic##3##3##(2007-8#2)(2008-3#1)
with a platinum electrode##2##4##(1991-5#1)(2008-10#1)
with a platinum##3##3##(1991-5#1)(2008-10#2)
with a plethora of##4##4##(2006-12#1)(2007-11#1)(2007-2#1)(2009-3#1)
with a plug##3##3##(2008-10#2)(2011-2#1)
with a point##3##3##(2008-3#1)(2009-9#1)(2010-5#1)
with a polar##2##3##(2008-10#1)(2012-1#1)
with a polarization##3##3##(2007-11#1)(2008-2#2)
with a polarized laser beam##3##5##(2007-12#1)(2008-3#2)
with a polarized##4##3##(2007-12#2)(2008-3#2)
with a polyclonal antibody raised against##2##6##(1992-3#1)(1994-2#1)
with a polyclonal antibody to##2##5##(1995-8#1)(2005-12#1)
with a polyclonal antibody##6##4##(1991-2#1)(1992-3#1)(1993-3#1)(1994-2#1)(1995-8#1)(2005-12#1)
with a polyclonal antiserum to##2##5##(1992-5#1)(2008-10#1)
with a polyclonal antiserum##3##4##(1992-5#1)(2008-10#2)
with a polyclonal##11##3##(1991-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-3#1)(1994-2#1)(1995-8#1)(1997-1#1)(2005-12#1)(2008-10#2)
with a polymer##4##3##(2005-11#1)(2008-2#1)(2010-4#1)(2010-7#1)
with a polymerase chain reaction##2##5##(1992-5#1)(1997-3#1)
with a polymeric##3##3##(1990-11#1)(1996-8#1)(2008-2#1)
with a polypeptide##2##3##(1990-7#1)(1991-3#1)
with a poor outcome in##2##5##(2007-10#1)(2011-2#1)
with a poor outcome##9##4##(1990-9#1)(2004-10#1)(2007-10#2)(2008-8#1)(2011-2#2)(2012-3#1)(2013-7#1)
with a poor prognosis in##2##5##(2011-2#2)
with a poor prognosis##22##4##(1994-12#1)(1994-6#1)(1997-5#1)(2006-1#1)(2006-2#1)(2006-6#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-5#1)(2009-8#2)(2010-6#1)(2011-2#3)(2013-1#1)
with a poor##41##3##(1990-9#1)(1992-10#1)(1993-10#1)(1994-12#1)(1994-6#1)(1995-9#1)(1997-5#1)(2004-10#1)(2005-8#2)(2006-1#1)(2006-2#1)(2006-6#2)(2007-10#2)(2007-12#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-5#2)(2009-7#1)(2009-8#2)(2010-6#1)(2011-2#5)(2012-3#1)(2013-1#1)(2013-7#1)
with a poorly understood##2##4##(2010-11#1)(2012-3#1)
with a population of##3##4##(2008-7#2)(2011-2#1)
with a population##6##3##(2006-12#1)(2007-3#1)(2008-6#1)(2008-7#2)(2011-2#1)
with a porcine##2##3##(1991-6#1)(1994-11#1)
with a porous##2##3##(2008-5#1)(2012-11#1)
with a porphyrin##2##3##(1990-7#1)(2008-10#1)
with a portable##4##3##(2006-6#1)(2008-10#2)(2008-3#1)
with a position-sensitive detector##2##4##(2007-11#1)(2007-12#1)
with a position-sensitive##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
with a positional##2##3##(1994-12#1)(2012-12#1)
with a positive direct antiglobulin test##2##6##(1992-9#1)(1994-3#1)
with a positive family history##5##5##(1993-9#1)(1997-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
with a positive leishmanin skin test##2##6##(2008-7#2)
with a positive torsion angle phi##4##6##(1991-10#4)
with a positive zeta potential##2##5##(2008-5#2)
with a positive##36##3##(1990-6#1)(1991-10#4)(1992-3#1)(1992-4#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-3#2)(1995-10#1)(1997-5#1)(2005-1#1)(2006-6#1)(2007-12#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#2)(2010-10#1)(2010-8#1)(2011-2#4)(2013-1#2)
with a possibility of##2##4##(1991-10#1)(2008-10#1)
with a possibility##3##3##(1991-10#1)(1996-12#1)(2008-10#1)
with a possible##10##3##(1993-12#1)(1994-11#1)(1994-12#1)(1994-6#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-5#1)(2011-2#1)(2012-1#1)
with a postoperative##4##3##(2007-8#1)(2008-5#1)(2013-1#2)
with a posttraumatic##2##3##(2006-8#1)(2009-3#1)
with a potassium##2##3##(1992-3#1)(2011-2#1)
with a potency comparable to that of##2##7##(1991-3#1)(2008-5#1)
with a potency similar to that of##2##7##(1992-12#1)(2008-5#1)
with a potency similar to##3##5##(1992-12#2)(2008-5#1)
with a potency##7##3##(1991-3#1)(1992-12#2)(1992-9#1)(1993-11#1)(2008-5#2)
with a potent##2##3##(1995-6#1)(1995-7#1)
with a potential for##2##4##(2006-3#1)(2011-2#1)
with a potential to promote##2##5##(2007-10#1)(2008-10#1)
with a potential to##7##4##(1993-10#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2012-12#1)(2013-8#1)
with a potential##17##3##(1993-10#1)(1997-2#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2011-2#2)(2012-12#1)(2013-8#1)
with a potentially##7##3##(1991-8#1)(1995-2#1)(1996-6#1)(2007-8#1)(2008-11#1)(2010-7#1)(2011-12#1)
with a potentiometric##3##3##(2008-10#3)
with a power of##3##4##(2007-12#1)(2007-8#1)(2008-10#1)
with a power##5##3##(2007-12#3)(2007-8#1)(2008-10#1)
with a powerful##2##3##(2006-6#1)(2008-2#1)
with a practical##3##3##(1990-7#1)(2008-4#1)(2011-12#1)
with a pre-concentration##2##3##(2008-10#2)
with a precise##3##3##(1990-7#1)(2007-11#1)(2010-12#1)
with a precision better than##2##5##(2008-10#1)(2008-2#1)
with a precision error ranging from 5% to 10%##2##9##(2008-3#2)
with a precision of 2##2##5##(2008-10#2)
with a precision of approximately##4##5##(2006-10#1)(2008-3#3)
with a precision of##15##4##(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#5)
with a precision##24##3##(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-2#2)(2008-3#9)(2012-2#1)
with a preconcentration##3##3##(2008-10#3)
with a predefined##2##3##(2008-1#1)(2008-4#1)
with a predicted Mr of##4##5##(1990-1#1)(1990-12#1)(1991-5#1)(2008-10#1)
with a predicted molecular mass of##7##6##(1990-12#1)(1994-12#1)(1996-10#1)(1997-1#2)(1997-6#1)(2008-10#1)
with a predicted molecular weight of##3##6##(1992-12#1)(1997-2#1)(2008-10#1)
with a predicted molecular##10##4##(1990-12#1)(1992-12#1)(1994-12#1)(1996-10#1)(1997-1#2)(1997-2#1)(1997-6#1)(2008-10#2)
with a predicted##19##3##(1990-1#1)(1990-12#2)(1991-5#1)(1991-9#1)(1992-12#1)(1994-12#1)(1994-6#1)(1994-8#1)(1996-10#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-6#1)(2008-10#3)
with a predilection for the##2##5##(2004-1#1)(2009-9#1)
with a predilection##3##3##(2004-1#1)(2006-10#1)(2009-9#1)
with a predisposition to##3##4##(1997-8#1)(2006-4#1)(2011-2#1)
with a predominance of##3##4##(1993-5#1)(2013-8#2)
with a predominant##3##3##(1992-8#1)(2008-4#1)(2009-7#1)
with a predominantly##6##3##(1991-5#1)(1994-3#1)(2007-11#1)(2007-12#1)(2010-12#1)(2011-1#1)
with a preference for##2##4##(1995-6#1)(1996-7#1)
with a preoperative##2##3##(2007-6#1)(2013-8#1)
with a preponderance##3##3##(1995-5#1)(2008-5#1)(2010-12#1)
with a preselected##2##3##(2008-10#1)(2008-2#1)
with a pressure##2##3##(2011-1#1)(2013-1#1)
with a pressurized##2##3##(2008-10#1)(2011-1#1)
with a presumed##3##3##(2005-5#1)(2008-4#1)(2012-2#1)
with a presumptive diagnosis of##2##5##(2007-10#1)(2010-10#1)
with a prevalence of 7##2##5##(2007-2#1)(2008-5#1)
with a prevalence of##9##4##(1994-6#1)(1997-7#1)(2006-9#1)(2007-2#1)(2007-7#1)(2008-5#1)(2008-6#2)(2012-12#1)
with a prevalence##11##3##(1994-6#1)(1997-7#1)(2006-8#1)(2006-9#1)(2007-2#1)(2007-7#2)(2008-5#1)(2008-6#2)(2012-12#1)
with a previous diagnosis of##2##5##(2007-3#1)(2007-8#1)
with a previous history of##7##5##(2006-10#2)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-8#1)
with a previous report##2##4##(1994-9#1)(2010-4#1)
with a previous##24##3##(1991-8#1)(1992-6#1)(1994-9#1)(1996-7#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
with a previously described##2##4##(2008-10#1)(2008-5#1)
with a previously published##4##4##(2005-11#1)(2006-9#1)(2008-10#1)(2010-10#1)
with a previously reported##5##4##(1992-1#1)(1994-10#1)(1995-2#1)(2008-10#1)(2008-2#1)
with a previously##20##3##(1992-1#1)(1994-10#1)(1995-2#1)(1996-3#1)(1997-5#1)(2005-11#1)(2006-9#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#1)(2009-10#1)(2010-10#1)(2010-5#1)(2013-1#2)
with a primary diagnosis of##3##5##(2006-8#1)(2007-10#1)(2007-3#1)
with a primary diagnosis##4##4##(2006-8#1)(2007-10#1)(2007-3#1)(2008-11#1)
with a primary##26##3##(1990-10#1)(1991-10#1)(1992-3#1)(1993-6#1)(1994-9#1)(1996-2#1)(1997-3#1)(2006-10#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#2)(2008-9#1)(2010-2#1)(2011-1#2)(2011-2#2)
with a primer pair##2##4##(1992-2#1)(2008-10#1)
with a primer##3##3##(1992-2#1)(2008-10#1)(2008-5#1)
with a prior history of##5##5##(2006-2#1)(2006-9#1)(2007-7#1)(2008-12#1)(2013-8#1)
with a prior##11##3##(1997-3#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2010-12#1)(2013-8#1)
with a prism##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
with a probabilistic##2##3##(2009-11#1)(2011-1#1)
with a probability of##2##4##(2008-5#1)(2009-4#1)
with a probability##4##3##(1990-3#1)(2008-5#1)(2009-4#1)(2012-7#1)
with a probe DNA##3##4##(1990-5#1)(1990-9#1)(1996-7#1)
with a probe##9##3##(1990-5#1)(1990-9#1)(1991-9#1)(1994-5#1)(1996-5#1)(1996-7#1)(2007-12#1)(2008-10#1)(2008-4#1)
with a procedure##3##3##(1990-9#1)(1992-8#1)(2008-10#1)
with a productivity##2##3##(1996-1#1)(2005-11#1)
with a profile of##3##4##(1995-2#1)(2013-1#2)
with a profile##4##3##(1995-2#1)(1996-12#1)(2013-1#2)
with a program of##2##4##(1995-10#1)(2011-2#1)
with a programmable##2##3##(2006-8#1)(2007-12#1)
with a progressive##10##3##(1990-12#1)(1991-6#1)(1992-9#2)(1994-8#1)(2006-4#1)(2007-8#1)(2008-7#1)(2008-9#1)(2009-12#1)
with a progressively increasing##2##4##(2007-7#1)(2012-2#1)
with a progressively##3##3##(2006-5#1)(2007-7#1)(2012-2#1)
with a prolapsed##2##3##(1993-9#1)(2007-2#1)
with a prolonged plasma##2##4##(1992-4#1)(1993-8#1)
with a prolonged##8##3##(1992-4#1)(1993-8#1)(1994-3#1)(2007-1#1)(2007-2#1)(2009-12#1)(2012-2#1)(2013-1#1)
with a prominent##2##3##(1995-5#1)(2010-9#1)
with a pronounced##5##3##(1993-7#1)(1996-12#1)(2006-10#1)(2008-10#2)
with a propensity to##2##4##(2008-9#1)(2009-5#1)
with a propensity##3##3##(2007-8#1)(2008-9#1)(2009-5#1)
with a proper##3##3##(1995-9#1)(2008-5#1)(2013-8#1)
with a properly selected##2##4##(2007-12#1)(2009-12#1)
with a proportional##2##3##(2008-10#1)(2008-3#1)
with a proposed##3##3##(2005-8#1)(2008-3#1)(2009-9#1)
with a proprietary##2##3##(2008-10#1)(2010-5#1)
with a prosthesis##2##3##(2007-6#1)(2011-2#1)
with a protecting##3##3##(2008-10#2)(2009-7#1)
with a protein of##2##4##(1992-8#1)(1993-12#1)
with a protein##7##3##(1991-2#1)(1992-8#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2013-8#1)
with a proteinaceous##2##3##(2008-10#1)(2009-8#1)
with a protocol##2##3##(1991-4#1)(2008-4#1)
with a proton residing on the##2##6##(1996-7#2)
with a proton##3##3##(1992-6#1)(1996-7#2)
with a prototype##2##3##(2008-2#1)(2011-1#1)
with a proven##4##3##(1995-10#1)(1997-2#1)(2007-1#1)(2007-4#1)
with a proximal##2##3##(2009-5#1)(2009-9#1)
with a pulse duration of##5##5##(2007-12#1)(2007-8#1)(2008-2#2)(2008-3#1)
with a pulse energy of##3##5##(2007-11#2)(2007-12#1)
with a pulse of##3##4##(1992-9#1)(2007-12#1)(2008-1#1)
with a pulse width of##5##5##(2007-11#1)(2007-12#4)
with a pulse width##7##4##(2007-11#1)(2007-12#5)(2008-3#1)
with a pulse##23##3##(1992-9#1)(2007-11#3)(2007-12#9)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)
with a pulsed signal beam##2##5##(2007-12#2)
with a pulsed##9##3##(2007-12#3)(2008-10#1)(2008-3#4)(2011-1#1)
with a pump peak##2##4##(2007-12#2)
with a pump##3##3##(2007-11#1)(2007-12#2)
with a pure##5##3##(1992-3#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-3#1)
with a purified protein##2##4##(1991-11#1)(2007-4#1)
with a purified##6##3##(1991-11#1)(1992-11#1)(1992-3#1)(2007-4#1)(2008-4#1)(2012-2#1)
with a purity of &gt##2##5##(1994-6#1)(2009-3#1)
with a purity of 99##2##5##(2005-4#2)
with a purity of##5##4##(1991-8#1)(1994-6#1)(2005-4#2)(2009-3#1)
with a purity##7##3##(1991-8#1)(1994-3#1)(1994-6#1)(2005-4#2)(2008-5#1)(2009-3#1)
with a purposive sample of##2##5##(2008-12#1)(2011-1#1)
with a putative signal sequence##2##5##(1990-3#1)(1991-11#1)
with a putative signal##3##4##(1990-3#1)(1991-11#1)(1992-5#1)
with a putative##8##3##(1990-3#1)(1991-11#1)(1992-5#1)(1995-10#1)(1996-8#1)(1997-1#1)(1997-2#1)(2009-8#1)
with a pyramidal##2##3##(1995-4#1)(2007-12#1)
with a pyroelectric##2##3##(2007-12#1)(2011-1#1)
with a quadratic##2##3##(2007-11#1)(2008-10#1)
with a quadrupole mass##2##4##(2008-10#2)
with a qualitative##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
with a quality of life##2##5##(2011-1#1)(2011-2#1)
with a quality##3##3##(2009-5#1)(2011-1#1)(2011-2#1)
with a quantitative##3##3##(2008-3#1)(2008-8#1)(2011-2#1)
with a quantum yield of##2##5##(1995-8#1)(2008-10#1)
with a quantum##3##3##(1995-8#1)(2007-11#1)(2008-10#1)
with a quartet of##3##4##(1995-12#1)(2008-5#2)
with a quartz crystal microbalance##3##5##(2005-11#1)(2008-10#1)(2010-4#1)
with a quartz##5##3##(2005-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-4#1)
with a quaternary##2##3##(1997-2#1)(2008-10#1)
with a questionnaire##3##3##(2008-7#1)(2010-4#1)(2012-2#1)
with a rabbit##2##3##(1990-3#1)(1990-7#1)
with a radial##5##3##(2005-1#1)(2007-11#1)(2008-10#1)(2011-2#1)(2012-1#1)
with a radical##2##3##(1995-6#1)(2007-8#1)
with a radiolabeled##4##3##(1993-8#1)(2008-2#1)(2008-4#2)
with a radius of##2##4##(2007-11#1)(2009-5#1)
with a rain##2##3##(2007-8#1)(2008-10#1)
with a random coil conformation##2##5##(1994-9#1)(1996-2#1)
with a random distribution of##2##5##(2008-12#1)(2008-3#1)
with a random sample of##2##5##(1992-5#1)(2010-8#1)
with a random##15##3##(1991-3#1)(1992-5#1)(1994-9#1)(1995-8#1)(1996-2#1)(1996-5#1)(2008-12#1)(2008-2#3)(2008-3#1)(2010-8#1)(2013-1#2)(2013-8#1)
with a randomized##2##3##(1992-2#1)(2008-12#1)
with a randomly##5##3##(1991-6#1)(2007-12#2)(2008-3#2)
with a range 0##2##4##(1992-12#2)
with a range from##2##4##(1996-9#1)(2008-8#1)
with a range of 0##3##5##(1992-12#1)(2008-10#1)(2013-1#1)
with a range of health##3##5##(2008-10#1)(2008-12#1)(2013-1#1)
with a range of linearity##2##5##(2008-10#2)
with a range of neurological##2##5##(1994-10#1)(2013-1#1)
with a range of physical##2##5##(2007-12#1)(2008-10#1)
with a range of##47##4##(1990-5#1)(1991-4#1)(1992-12#2)(1993-2#1)(1994-10#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-4#1)(1995-8#1)(1996-9#1)(2006-2#1)(2007-12#1)(2007-2#3)(2008-10#11)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#4)
with a range##56##3##(1990-5#1)(1991-4#1)(1992-12#4)(1993-2#1)(1994-10#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-4#1)(1995-8#1)(1996-9#2)(2006-2#1)(2007-12#2)(2007-2#3)(2008-10#12)(2008-12#1)(2008-2#1)(2008-3#3)(2008-6#2)(2008-8#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#4)
with a rank order of##2##5##(1994-8#1)(1995-1#1)
with a rapid and##4##4##(1991-3#1)(1996-12#1)(2007-9#1)(2008-10#1)
with a rapid decline in##2##5##(1991-4#1)(2010-12#1)
with a rapid increase of##3##5##(1990-2#1)(2013-1#2)
with a rapid increase##4##4##(1990-2#1)(1995-10#1)(2013-1#2)
with a rapid initial##2##4##(1996-7#1)(2011-2#1)
with a rapid onset##2##4##(1996-10#1)(1996-4#1)
with a rapid##27##3##(1990-2#1)(1990-5#2)(1991-1#1)(1991-3#1)(1991-4#1)(1993-3#1)(1995-10#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-7#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-3#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-7#1)
with a rapidly growing##3##4##(2010-8#1)(2011-1#2)
with a rapidly##7##3##(1993-2#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-8#1)(2011-1#2)
with a rare##9##3##(2007-4#1)(2007-6#1)(2007-8#2)(2009-11#1)(2010-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
with a rash##2##3##(1995-11#1)(2007-2#1)
with a rat##8##3##(1990-11#2)(1993-2#1)(1993-9#1)(1995-2#1)(1996-5#1)(1996-9#1)(2008-11#1)
with a rate constant of##8##5##(1990-5#2)(1992-6#2)(2008-10#1)(2010-5#2)(2010-7#1)
with a rate constant##10##4##(1990-5#2)(1992-6#2)(1995-1#1)(2008-10#1)(2008-7#1)(2010-5#2)(2010-7#1)
with a rate of##3##4##(2008-12#1)(2008-4#1)(2008-8#1)
with a rate##16##3##(1990-5#2)(1992-6#2)(1993-6#1)(1995-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-5#2)(2010-7#1)(2011-1#1)
with a rather##2##3##(2008-8#1)(2013-8#1)
with a ratio of##3##4##(1993-11#1)(2008-6#1)(2009-9#1)
with a ray-tracing##2##3##(2008-3#2)
with a reagent stream##2##4##(2008-10#2)
with a reagent##3##3##(2008-10#3)
with a real##4##3##(1996-8#1)(2007-12#1)(2008-3#1)(2008-5#1)
with a real-time##6##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2013-1#2)
with a recent history of##3##5##(2005-7#1)(2012-2#1)(2013-1#1)
with a recent##13##3##(1992-10#1)(1992-9#1)(1995-9#1)(1996-3#1)(1996-9#1)(2005-7#1)(2007-12#2)(2007-8#1)(2008-1#1)(2012-2#1)(2013-1#2)
with a recently reported##2##4##(1992-9#1)(2007-9#1)
with a recently##6##3##(1992-5#1)(1992-9#1)(2007-9#1)(2008-10#1)(2008-5#1)(2011-2#1)
with a recombinant adenovirus##2##4##(1996-1#1)(1996-4#1)
with a recombinant baculovirus##5##4##(1993-6#1)(1993-8#1)(1997-2#1)(2008-10#1)(2008-7#1)
with a recombinant vaccinia virus containing the##2##7##(1991-9#2)
with a recombinant vaccinia virus##3##5##(1991-5#1)(1991-9#2)
with a recombinant##17##3##(1991-5#1)(1991-9#3)(1992-9#1)(1993-6#1)(1993-8#1)(1994-6#1)(1994-8#1)(1996-1#1)(1996-4#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)
with a recommendation##3##3##(2005-7#1)(2012-11#1)(2013-7#1)
with a recovery of##8##4##(1990-12#1)(1995-12#1)(1997-5#1)(2008-10#3)(2008-7#1)(2010-4#1)
with a recovery##11##3##(1990-12#1)(1995-12#1)(1997-5#1)(2008-10#6)(2008-7#1)(2010-4#1)
with a rectangular##3##3##(2008-2#3)
with a recurrence##2##3##(2006-4#1)(2009-2#1)
with a recurrent##2##3##(2008-7#1)(2009-8#1)
with a red##4##3##(2008-10#1)(2008-2#1)(2010-6#1)(2012-12#1)
with a redox##4##3##(1995-2#1)(2008-10#3)
with a reduced expression of##2##5##(1991-11#1)(2008-7#1)
with a reduced##19##3##(1990-7#1)(1991-11#1)(1993-3#1)(1993-8#1)(1996-4#1)(1997-4#1)(2005-10#2)(2006-12#1)(2008-1#1)(2008-10#1)(2008-3#4)(2008-7#1)(2010-12#1)(2012-3#1)(2013-1#1)
with a reducing##2##3##(2008-10#1)(2012-12#1)
with a reduction in the##9##5##(1994-3#1)(1994-7#1)(1997-5#1)(2006-4#1)(2008-10#3)(2010-4#1)(2011-2#1)
with a reduction in##33##4##(1990-11#1)(1993-11#1)(1994-3#1)(1994-7#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-5#1)(2006-4#1)(2007-8#1)(2008-10#5)(2008-3#2)(2008-4#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
with a reduction of the##2##5##(2008-10#1)(2009-3#1)
with a reduction of##13##4##(1990-12#1)(1993-11#1)(1993-12#1)(1995-6#1)(2006-6#1)(2008-10#2)(2008-4#1)(2009-10#1)(2009-3#1)(2009-7#1)(2012-3#1)(2013-1#1)
with a reduction##48##3##(1990-11#1)(1990-12#1)(1993-11#2)(1993-12#1)(1994-3#1)(1994-7#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-6#1)(1997-5#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-3#2)(2008-4#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
with a reference plane wave##2##5##(2007-11#1)(2008-3#1)
with a reference##20##3##(1993-9#1)(1996-12#1)(2007-11#2)(2007-12#2)(2008-10#4)(2008-2#4)(2008-3#5)(2008-5#1)
with a reflective##5##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)
with a refractive##2##3##(2007-12#2)
with a regimen##2##3##(2008-1#1)(2009-8#1)
with a region of##4##4##(1992-4#1)(1997-4#1)(2008-10#1)(2008-6#1)
with a region##6##3##(1990-10#1)(1992-4#1)(1997-4#1)(2008-10#1)(2008-5#1)(2008-6#1)
with a regression coefficient of##2##5##(2008-10#2)
with a regression##3##3##(2007-8#1)(2008-10#2)
with a regular##2##3##(1991-12#1)(2007-11#1)
with a regularized phase-tracking##2##4##(2008-2#1)(2008-3#1)
with a regulated##2##3##(1991-1#1)(2008-10#1)
with a relapse of##2##4##(1997-2#1)(2013-1#1)
with a relapsing and remitting##2##5##(2006-1#1)(2009-8#1)
with a relative decrease in##2##5##(1995-1#1)(1997-2#1)
with a relative error of##3##5##(2008-10#3)
with a relative error##4##4##(2008-10#4)
with a relative molecular mass of##5##6##(1991-12#1)(1992-3#1)(1993-8#1)(1997-6#1)(2008-11#1)
with a relative molecular##6##4##(1991-12#1)(1992-3#1)(1993-8#1)(1994-11#1)(1997-6#1)(2008-11#1)
with a relative standard deviation (R##5##6##(2008-10#5)
with a relative standard deviation (RSD) of##2##7##(2008-10#2)
with a relative standard deviation 1##2##6##(1990-9#1)(2008-10#1)
with a relative standard deviation for##3##6##(2008-10#3)
with a relative standard deviation of &lt##2##7##(2008-10#2)
with a relative standard deviation of 0##3##7##(2008-10#3)
with a relative standard deviation of 1##6##7##(2008-10#6)
with a relative standard deviation of 2##7##7##(2008-10#7)
with a relative standard deviation of 3##3##7##(2005-4#1)(2007-8#1)(2008-10#1)
with a relative standard deviation of 4##2##7##(2008-10#2)
with a relative standard deviation of less than##5##8##(2008-10#5)
with a relative standard deviation of##31##6##(2005-4#1)(2007-8#1)(2008-10#29)
with a relative standard deviation##46##5##(1990-9#1)(2005-4#1)(2007-8#2)(2008-10#42)
with a relative uncertainty of##5##5##(2007-12#2)(2008-3#3)
with a relative##85##3##(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-3#1)(1992-9#1)(1993-8#1)(1994-11#1)(1995-1#1)(1997-2#1)(1997-6#1)(2005-10#1)(2005-12#1)(2005-4#1)(2007-11#1)(2007-12#3)(2007-8#2)(2008-10#51)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#2)
with a relatively high##2##4##(1997-4#1)(2006-10#1)
with a relatively low potency##2##5##(2008-3#1)(2008-4#1)
with a relatively low##7##4##(2007-11#1)(2007-12#2)(2008-3#1)(2008-4#2)(2012-2#1)
with a relatively simple##2##4##(2006-10#1)(2012-1#1)
with a relatively small##3##4##(2005-11#1)(2008-3#1)(2012-11#1)
with a relatively##28##3##(1990-11#1)(1991-5#1)(1994-9#1)(1996-4#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-10#2)(2007-11#1)(2007-12#4)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-8#1)(2010-12#1)(2010-9#1)(2012-1#1)(2012-11#1)(2012-2#1)
with a relaxation##2##3##(1990-7#1)(2008-3#1)
with a relaxed##2##3##(1992-11#1)(2007-11#1)
with a release of##2##4##(1994-3#1)(2008-10#1)
with a release##3##3##(1992-3#1)(1994-3#1)(2008-10#1)
with a relevant##2##3##(1992-11#1)(1993-8#1)
with a reliable##2##3##(2006-6#1)(2008-10#1)
with a remarkable##3##3##(1991-2#1)(1995-10#1)(2006-10#1)
with a remarkably##2##3##(1995-9#1)(2010-5#1)
with a removal##2##3##(2008-5#1)(2008-7#1)
with a renal##3##3##(1994-3#1)(1995-2#1)(2009-8#1)
with a repeatability of##2##4##(2008-10#1)(2008-2#1)
with a repeatability##3##3##(2008-10#2)(2008-2#1)
with a repetition rate as##2##5##(2007-11#1)(2008-3#1)
with a repetition rate of##7##5##(1991-8#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-3#1)
with a repetition rate##9##4##(1991-8#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-3#2)
with a repetition##10##3##(1991-8#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-3#2)
with a repetitive DNA probe##2##5##(2008-10#2)
with a repetitive##3##3##(1990-11#1)(2008-10#2)
with a reported##5##3##(1994-3#1)(1994-9#1)(2008-10#2)(2010-8#1)
with a reporter gene under the control of##2##8##(1994-5#2)
with a reporter gene##3##4##(1990-11#1)(1994-5#2)
with a reporter##5##3##(1990-11#1)(1994-12#1)(1994-5#2)(1994-8#1)
with a representative sample of the##2##6##(2011-2#1)(2013-7#1)
with a representative##3##3##(2008-10#1)(2011-2#1)(2013-7#1)
with a reproducibility of##4##4##(1992-4#1)(1994-9#1)(2008-2#1)(2008-5#1)
with a reproducibility##5##3##(1992-4#1)(1994-9#1)(1995-9#1)(2008-2#1)(2008-5#1)
with a residual##2##3##(1990-6#1)(2006-10#1)
with a resistance##2##3##(2008-10#1)(2012-12#1)
with a resolution of 0##5##5##(2007-11#1)(2007-12#2)(2008-1#1)(2008-3#1)
with a resolution of 1##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
with a resolution of 2##2##5##(2008-10#1)(2008-3#1)
with a resolution of approximately##2##5##(2007-12#1)(2008-3#1)
with a resolution of the order of##2##7##(2007-12#1)(2008-3#1)
with a resolution of##26##4##(2006-5#1)(2007-11#2)(2007-12#5)(2008-1#2)(2008-10#1)(2008-2#4)(2008-3#11)
with a resolution##29##3##(1997-1#1)(2006-5#1)(2007-11#2)(2007-12#5)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#4)(2008-3#12)
with a response rate of##8##5##(1992-2#1)(2004-10#1)(2007-1#2)(2007-11#1)(2010-12#1)(2011-2#1)(2012-2#1)
with a response time of##5##5##(2007-11#1)(2008-10#3)(2008-2#1)
with a response time##6##4##(2007-11#1)(2008-10#4)(2008-2#1)
with a response##18##3##(1992-2#1)(2004-10#1)(2007-1#2)(2007-11#2)(2008-10#7)(2008-2#1)(2010-12#1)(2011-2#1)(2012-2#2)
with a restricted##2##3##(1990-7#1)(2006-10#1)
with a restriction enzyme that##2##5##(1996-12#1)(1997-7#1)
with a restriction enzyme##4##4##(1990-3#1)(1990-9#1)(1996-12#1)(1997-7#1)
with a resultant##4##3##(2005-12#1)(2008-4#1)(2009-3#1)(2013-8#1)
with a resulting##2##3##(1996-12#1)(2010-12#1)
with a retrovirus##2##3##(1994-5#1)(2008-11#1)
with a return to##3##4##(1993-11#1)(1997-3#1)(2011-2#1)
with a return##4##3##(1993-11#1)(1997-3#1)(2008-12#1)(2011-2#1)
with a reverse##5##3##(2008-12#2)(2008-8#2)(2009-9#1)
with a review of the literature on##2##7##(1996-3#1)(2008-9#1)
with a review of the literature##21##6##(1991-6#1)(1995-11#1)(1996-3#1)(2006-12#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
with a review of the relevant literature##4##7##(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
with a review of the relevant##5##6##(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
with a review of the##31##5##(1991-2#1)(1991-6#1)(1995-11#1)(1996-3#1)(2006-12#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#1)
with a review of##37##4##(1991-2#1)(1991-6#1)(1995-11#1)(1996-3#1)(2006-12#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#3)(2013-7#1)(2013-8#1)
with a review##38##3##(1991-2#1)(1991-6#1)(1995-11#1)(1996-3#1)(2006-12#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#3)(2013-7#1)(2013-8#1)
with a rich##4##3##(2006-11#1)(2007-12#1)(2008-7#1)(2013-1#1)
with a right bundle##2##4##(2008-4#2)
with a right##13##3##(1993-3#1)(1995-8#1)(1996-3#1)(1996-5#1)(2007-12#3)(2007-8#1)(2008-4#2)(2008-8#1)(2010-11#1)(2012-2#1)
with a rigid interface##2##4##(2006-11#1)(2007-4#1)
with a rigid##7##3##(2006-11#1)(2006-8#1)(2007-1#1)(2007-4#1)(2007-8#2)(2013-7#1)
with a rigorous##2##3##(2008-10#1)(2008-2#1)
with a ring##4##3##(2008-10#1)(2008-3#3)
with a rise in the##2##5##(1990-7#1)(2008-10#1)
with a rise in##7##4##(1990-11#2)(1990-7#1)(1994-10#1)(2008-10#3)
with a rise of##2##4##(1990-6#1)(2008-10#1)
with a rise##9##3##(1990-11#2)(1990-6#1)(1990-7#1)(1994-10#1)(2008-10#4)
with a risk of##6##4##(2008-1#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-12#2)
with a risk##9##3##(1996-12#1)(2008-1#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-12#2)
with a rms##2##3##(2008-2#1)(2008-3#1)
with a robotic##2##3##(2007-8#2)
with a robust##2##3##(2008-2#1)(2008-6#1)
with a role for##14##4##(1990-3#1)(1991-2#1)(1993-12#1)(1995-12#1)(1996-12#1)(1997-2#1)(1997-4#1)(2006-10#1)(2006-4#1)(2008-8#1)(2009-12#1)(2011-1#1)(2012-2#2)
with a role in amino-acid metabolism##2##6##(2010-10#2)
with a role in##7##4##(1990-11#1)(2009-10#1)(2009-6#1)(2010-10#2)(2012-2#1)(2012-3#1)
with a role of##3##4##(1990-3#1)(1996-3#1)(2013-8#1)
with a role##24##3##(1990-11#1)(1990-3#2)(1991-2#1)(1993-12#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-4#1)(2006-10#1)(2006-4#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-6#1)(2010-10#2)(2011-1#1)(2012-2#3)(2012-3#1)(2013-8#1)
with a room-temperature##3##3##(2007-12#2)(2008-3#1)
with a rotating##2##3##(1990-12#1)(2008-3#1)
with a rotational##3##3##(1990-7#1)(2008-2#1)(2008-3#1)
with a rough##2##3##(2008-2#2)
with a round##4##3##(2005-10#1)(2008-5#1)(2009-5#1)(2013-8#1)
with a ruptured diaphragm##2##4##(2007-3#2)
with a ruptured##5##3##(1995-12#1)(2007-10#1)(2007-3#2)(2008-7#1)
with a safe##2##3##(2012-2#2)
with a sample of##16##4##(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-7#1)(2010-2#2)(2013-1#3)(2013-8#1)
with a sample throughput of##4##5##(2008-10#4)
with a sample##33##3##(2006-10#1)(2007-12#3)(2007-2#1)(2007-8#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-8#1)(2009-7#1)(2010-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
with a sampling frequency of##9##5##(2008-10#8)(2010-9#1)
with a sampling rate of about##2##6##(2008-10#2)
with a sampling rate of##7##5##(2008-10#6)(2008-3#1)
with a sampling time of##2##5##(2008-10#1)(2008-3#1)
with a sampling##22##3##(1995-6#1)(2008-10#16)(2008-3#3)(2010-9#1)(2012-2#1)
with a sandwich-type##3##3##(1990-3#1)(2007-12#1)(2008-3#1)
with a satellite##2##3##(2008-10#1)(2008-2#1)
with a satisfactory inter-rater reliability for the first two##2##9##(2013-1#2)
with a satisfactory##6##3##(2007-8#1)(2008-4#1)(2011-2#1)(2013-1#3)
with a saturable##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
with a saturating concentration##2##4##(1993-6#1)(1994-10#1)
with a saturating##3##3##(1993-6#1)(1994-10#1)(1996-5#1)
with a scalar##2##3##(2008-2#1)(2008-3#1)
with a scalpel##3##3##(1992-3#2)(2006-12#1)
with a scan rate of##2##5##(2008-1#1)(2008-10#1)
with a scanning confocal##2##4##(2007-12#1)(2008-3#1)
with a scanning electron microscope##2##5##(2013-8#2)
with a scanning##14##3##(1992-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#4)(2013-8#2)
with a scenario of##3##4##(2008-10#3)
with a scenario##5##3##(2007-7#1)(2008-10#3)(2010-2#1)
with a score of##2##4##(1997-5#1)(2007-8#1)
with a score##3##3##(1997-5#1)(2006-10#1)(2007-8#1)
with a seasonal component##2##4##(1994-8#1)(2007-5#1)
with a seasonal##3##3##(1994-8#1)(2007-5#1)(2011-2#1)
with a second##25##3##(1990-12#2)(1991-7#1)(1993-2#2)(1995-1#1)(1996-4#1)(1997-7#1)(2004-12#1)(2005-7#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-6#1)(2009-11#1)(2010-12#1)(2010-5#1)
with a second-order rate constant kobs/[I] =##2##7##(1992-3#2)
with a second-order rate constant##5##5##(1992-3#2)(1994-5#1)(1995-11#1)(1996-7#1)
with a second-order##8##3##(1992-3#2)(1994-5#1)(1995-11#1)(1996-5#1)(1996-7#1)(2008-3#2)
with a secondary##8##3##(1990-9#1)(1992-12#1)(1993-9#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-8#1)(2011-2#1)
with a segment of##2##4##(1991-4#1)(1994-3#1)
with a segment##3##3##(1991-4#1)(1994-3#2)
with a segmented##3##3##(2007-12#2)(2008-3#1)
with a selection medium##2##4##(2012-2#2)
with a selection of##2##4##(1990-4#1)(2006-10#1)
with a selection##5##3##(1990-4#1)(1997-4#1)(2006-10#1)(2012-2#2)
with a selective##10##3##(1990-6#1)(1994-2#1)(1995-12#1)(1996-6#1)(2007-8#2)(2008-10#1)(2008-4#2)(2012-1#1)
with a self-assembled monolayer of an##2##6##(2007-8#1)(2008-3#1)
with a self-assembled monolayer of##4##5##(2007-8#1)(2008-10#2)(2008-3#1)
with a self-assembled monolayer##5##4##(2007-8#1)(2008-10#3)(2008-3#1)
with a self-assembled##6##3##(2007-8#2)(2008-10#3)(2008-3#1)
with a self-pumped phase-conjugate mirror##4##5##(2008-2#2)(2008-3#2)
with a semantic##2##3##(1993-2#1)(2009-9#1)
with a semiconductor saturable-absorber mirror##3##5##(2007-12#2)(2008-3#1)
with a semiconductor##8##3##(2007-12#4)(2007-8#1)(2008-2#1)(2008-3#2)
with a sense of##3##4##(2006-9#1)(2007-8#1)(2008-12#1)
with a sensitive##6##3##(1990-4#1)(1997-5#1)(2005-11#1)(2007-8#1)(2008-3#1)(2008-7#1)
with a sensitivity of 0##4##5##(2008-1#1)(2008-10#2)(2008-3#1)
with a sensitivity of 2##2##5##(2008-10#2)
with a sensitivity of 3##2##5##(2008-10#1)(2008-3#1)
with a sensitivity of 91##2##5##(1990-9#1)(1997-8#1)
with a sensitivity of##25##4##(1990-6#1)(1990-9#1)(1991-9#1)(1992-8#1)(1997-8#1)(2005-9#2)(2006-2#1)(2007-11#1)(2007-3#2)(2008-1#2)(2008-10#5)(2008-3#4)(2008-6#1)(2011-1#1)(2013-8#1)
with a sensitivity that##2##4##(2008-10#2)
with a sensitivity##30##3##(1990-6#1)(1990-9#1)(1991-9#1)(1992-8#1)(1997-8#1)(2005-9#2)(2006-2#1)(2007-11#1)(2007-3#2)(2007-8#1)(2008-1#2)(2008-10#9)(2008-3#4)(2008-6#1)(2011-1#1)(2013-8#1)
with a sensor##3##3##(2007-12#1)(2008-3#2)
with a separate##3##3##(1994-12#1)(1995-4#1)(2006-12#1)
with a separation##3##3##(1996-5#1)(2008-10#1)(2011-2#1)
with a sequence of##2##4##(1990-2#1)(1992-7#1)
with a sequence##7##3##(1990-2#1)(1992-5#1)(1992-7#1)(1994-12#1)(1994-8#1)(2013-1#2)
with a sequential injection##3##4##(2008-10#3)
with a sequential##7##3##(1990-7#1)(2004-12#1)(2006-10#1)(2008-10#3)(2008-2#1)
with a series of group##2##5##(1997-7#1)(2007-2#1)
with a series of##30##4##(1991-12#1)(1991-3#2)(1995-7#1)(1996-12#1)(1997-2#2)(1997-7#1)(2005-8#2)(2006-10#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-9#1)(2009-12#1)(2010-2#1)(2012-2#1)
with a serine##2##3##(1991-1#1)(1995-8#1)
with a serious##2##3##(1990-11#1)(2007-1#1)
with a serum##2##3##(1990-3#1)(2010-8#1)
with a set of##25##4##(1993-6#1)(1994-8#1)(1995-12#1)(2005-11#1)(2007-11#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
with a set##27##3##(1993-6#1)(1994-8#1)(1995-12#1)(2005-11#1)(2007-11#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
with a severe mental illness##2##5##(2008-6#1)(2011-1#1)
with a severe##23##3##(1995-1#1)(1996-1#1)(1996-12#1)(1997-1#1)(2005-10#1)(2006-4#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
with a sex ratio##2##4##(1990-4#1)(2007-2#1)
with a sex##4##3##(1990-4#1)(2007-2#1)(2010-8#1)(2011-2#1)
with a shallow random rough##2##5##(2008-3#2)
with a shallow##5##3##(2008-10#1)(2008-3#2)(2008-4#1)(2012-1#1)
with a shape##2##3##(2008-2#2)
with a sharp increase##2##4##(2008-10#1)(2008-11#1)
with a sharp##4##3##(2006-6#1)(2007-9#1)(2008-10#1)(2008-11#1)
with a shift from##2##4##(1993-1#1)(2009-9#1)
with a shift in##3##4##(1993-8#1)(1996-11#1)(1996-3#1)
with a shift##7##3##(1993-1#1)(1993-8#1)(1995-3#1)(1996-11#1)(1996-3#1)(2008-10#1)(2009-9#1)
with a short elimination half-life##2##5##(1991-12#1)(2004-3#1)
with a short history of##2##5##(1993-12#1)(2008-7#1)
with a short postoperative rehabilitation and excellent functional results##2##9##(2013-1#2)
with a short time separation##3##5##(2008-3#3)
with a short##40##3##(1990-9#1)(1991-10#1)(1991-12#2)(1992-1#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-8#1)(1997-9#1)(2004-3#1)(2005-11#1)(2006-10#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#5)(2008-7#1)(2008-9#2)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#2)
with a short-term##2##3##(2007-7#1)(2008-11#1)
with a shortened##2##3##(2010-3#1)(2012-12#1)
with a shortening##2##3##(1994-3#1)(2007-11#1)
with a shorter length of##2##5##(2008-9#1)(2013-1#1)
with a shorter##10##3##(1993-11#1)(1993-3#1)(1997-2#1)(2008-2#1)(2008-9#1)(2011-1#1)(2012-2#2)(2013-1#2)
with a shot-per-shot##2##3##(2008-2#2)
with a side##2##3##(2006-6#1)(2008-11#1)
with a signal peptide of##2##5##(1992-8#1)(1997-2#1)
with a signal peptide##3##4##(1992-8#1)(1997-2#1)(2008-10#1)
with a signal##6##3##(1992-8#2)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#1)
with a signal-to-noise ratio of 3##3##6##(2007-12#1)(2008-10#1)(2008-3#1)
with a signal-to-noise ratio of 5##2##6##(2008-10#1)(2008-3#1)
with a signal-to-noise ratio of##10##5##(2007-12#3)(2008-10#2)(2008-3#5)
with a signal-to-noise ratio##12##4##(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#5)
with a signal-to-noise##13##3##(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#6)
with a significant decrease in the##3##6##(1990-4#1)(1996-8#1)(2008-10#1)
with a significant decrease in##9##5##(1990-4#1)(1992-4#1)(1996-8#1)(1996-9#1)(1997-1#1)(2008-10#1)(2008-3#1)(2012-3#1)(2013-8#1)
with a significant decrease of##3##5##(2011-1#1)(2012-12#1)(2013-8#1)
with a significant decrease##13##4##(1990-4#1)(1992-4#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#1)(2008-10#1)(2008-3#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#2)
with a significant difference between##2##5##(1991-9#1)(2007-7#1)
with a significant impact on##2##5##(2007-12#1)(2008-12#1)
with a significant increase in the##8##6##(1991-10#1)(1992-11#1)(1995-6#1)(1997-6#1)(2007-12#1)(2007-9#1)(2008-1#2)
with a significant increase in##13##5##(1991-10#1)(1992-11#1)(1994-6#1)(1995-12#1)(1995-6#1)(1997-6#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#2)(2008-3#1)(2012-1#1)
with a significant increase of##4##5##(1990-12#1)(1990-9#1)(2008-8#2)
with a significant increase##19##4##(1990-12#1)(1990-9#1)(1991-10#1)(1992-11#1)(1994-6#1)(1995-12#1)(1995-6#1)(1997-6#2)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#2)(2008-3#1)(2008-8#2)(2012-1#1)(2012-12#1)
with a significant mean##2##4##(2005-7#1)(2012-12#1)
with a significant number of##2##5##(2005-8#1)(2007-8#1)
with a significant percentage of##2##5##(1994-11#1)(1997-7#1)
with a significant reduction in##10##5##(2006-10#1)(2007-10#1)(2007-2#2)(2008-3#1)(2008-4#2)(2010-5#1)(2010-6#1)(2010-8#1)
with a significant reduction of##2##5##(1997-4#1)(2007-10#1)
with a significant reduction##13##4##(1997-4#1)(2006-10#1)(2007-10#2)(2007-2#2)(2008-3#1)(2008-4#2)(2009-6#1)(2010-5#1)(2010-6#1)(2010-8#1)
with a significant rise in##2##5##(2008-12#1)(2013-8#1)
with a significant##93##3##(1990-12#2)(1990-4#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-4#1)(1993-7#1)(1994-11#2)(1994-3#1)(1994-6#2)(1995-1#1)(1995-12#1)(1995-6#1)(1996-4#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-4#1)(1997-6#2)(1997-7#1)(2005-7#1)(2005-8#1)(2006-10#2)(2007-10#5)(2007-11#2)(2007-12#2)(2007-2#3)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#3)(2008-12#2)(2008-3#3)(2008-4#4)(2008-5#2)(2008-8#3)(2009-10#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#4)
with a significantly greater##2##4##(1995-3#1)(2006-8#1)
with a significantly higher##4##4##(2005-11#1)(2008-5#1)(2009-3#1)(2012-12#1)
with a significantly increased##5##4##(1992-10#1)(2005-10#1)(2008-1#1)(2008-9#2)
with a significantly lower##3##4##(2006-11#1)(2008-5#1)(2013-1#1)
with a significantly reduced##3##4##(1996-5#1)(2007-9#1)(2012-2#1)
with a significantly##20##3##(1992-10#1)(1995-3#1)(1996-5#1)(2005-10#1)(2005-11#1)(2006-11#1)(2006-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
with a silica##3##3##(1997-3#1)(2008-10#2)
with a silica-based C4 column##2##5##(1991-3#2)
with a similar clinical##3##4##(1992-4#1)(2011-2#1)(2013-1#1)
with a similar lesion##2##4##(1993-3#1)(2007-2#1)
with a similar potency and##2##5##(1993-8#2)
with a similar potency##3##4##(1993-8#2)(1994-8#1)
with a similar time##2##4##(1996-3#1)(2007-10#1)
with a similar##44##3##(1990-12#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-4#1)(1993-3#1)(1993-8#3)(1994-1#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-6#1)(1996-1#1)(1996-12#3)(1996-3#2)(1996-5#2)(1997-7#1)(2005-9#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#6)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
with a simple and##2##4##(2007-7#1)(2008-3#1)
with a simple diffusion model##2##5##(2009-12#1)(2011-12#1)
with a simple experimental##2##4##(2007-12#1)(2008-5#1)
with a simple model##2##4##(2007-12#1)(2008-7#1)
with a simple##48##3##(1991-2#1)(1991-6#1)(1994-3#1)(1994-9#1)(1995-8#1)(1996-12#2)(1997-1#1)(2007-11#2)(2007-12#8)(2007-7#1)(2007-8#1)(2008-10#5)(2008-2#3)(2008-3#8)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-12#1)(2010-5#1)(2011-12#1)(2012-12#2)
with a simplified##3##3##(1990-6#1)(1994-2#1)(2008-3#1)
with a simulated##3##3##(2008-3#2)(2008-5#1)
with a simultaneous##3##3##(1990-12#1)(2007-2#1)(2010-12#1)
with a simultaneously##2##3##(2007-12#1)(2011-2#1)
with a single amino acid##2##5##(1991-5#1)(1997-4#1)
with a single and##2##4##(1990-5#1)(2008-8#1)
with a single block##2##4##(2006-8#2)
with a single copy of##2##5##(1990-7#1)(1991-7#1)
with a single copy##3##4##(1990-7#1)(1991-7#1)(1992-1#1)
with a single diffractive##2##4##(2007-12#1)(2008-2#1)
with a single disease##2##4##(2005-12#1)(2012-2#1)
with a single dose of##7##5##(1991-2#1)(1994-6#1)(1997-5#1)(1997-7#1)(2006-2#1)(2007-11#1)(2007-8#1)
with a single oral##2##4##(2010-12#1)(2012-2#1)
with a single patch##3##4##(2007-8#2)(2012-2#1)
with a single pump##2##4##(2007-12#2)
with a single screw##2##4##(2008-8#1)(2008-9#1)
with a single source##2##4##(2008-10#1)(2012-1#1)
with a single transmembrane##2##4##(1992-11#1)(1993-2#1)
with a single two-dimensional##2##4##(2008-2#1)(2008-3#1)
with a single##159##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1994-11#2)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-8#1)(1996-9#2)(1997-4#1)(1997-5#1)(1997-7#1)(2004-1#1)(2005-11#2)(2005-12#1)(2006-2#1)(2006-8#3)(2007-11#4)(2007-12#13)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#4)(2008-1#2)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#12)(2008-3#14)(2008-4#3)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-4#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#6)(2013-2#1)(2013-8#2)
with a single-copy##2##3##(1996-7#1)(2008-5#1)
with a single-photon-counting##2##3##(2006-4#1)(2008-2#1)
with a site##2##3##(1995-3#1)(2008-9#1)
with a six##5##3##(1993-4#1)(2006-4#2)(2007-7#1)(2008-10#1)
with a size of 1##2##5##(1992-6#1)(1996-6#1)
with a size of 10##2##5##(2005-11#1)(2007-11#1)
with a size of##7##4##(1992-6#1)(1996-6#1)(2005-11#1)(2007-11#1)(2008-8#1)(2010-12#1)(2011-12#1)
with a size range of##2##5##(1997-3#1)(2010-12#1)
with a size range##3##4##(1997-3#1)(2010-12#1)(2013-7#1)
with a size##15##3##(1992-6#1)(1994-9#1)(1995-3#1)(1996-6#1)(1997-3#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-8#1)(2010-12#2)(2011-12#1)(2013-7#1)
with a slab optical waveguide##2##5##(2008-10#2)
with a slight decrease in##3##5##(1994-12#1)(1996-10#2)
with a slight decrease##4##4##(1994-12#1)(1996-10#2)(2006-7#1)
with a slight increase in##4##5##(1995-4#1)(2008-7#1)(2009-8#1)(2009-9#1)
with a slight##16##3##(1992-8#1)(1994-12#1)(1995-4#1)(1995-9#1)(1996-10#2)(2006-7#1)(2007-6#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#2)(2009-9#1)(2011-2#1)(2012-3#1)
with a slightly higher##6##4##(1994-3#1)(2010-12#2)(2010-9#1)(2012-12#1)(2013-1#1)
with a slightly##14##3##(1991-8#1)(1994-3#1)(1994-9#1)(1996-6#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-9#1)(2010-12#2)(2010-5#1)(2010-9#1)(2012-12#1)(2013-1#1)
with a slit##4##3##(2007-11#1)(2007-8#1)(2008-3#1)(2008-9#1)
with a slit-beam-profile reflectometer##2##4##(2007-12#2)
with a slope efficiency of##8##5##(2007-12#5)(2008-2#2)(2008-3#1)
with a slope efficiency##9##4##(2007-12#5)(2008-1#1)(2008-2#2)(2008-3#1)
with a slope of -0##3##5##(1994-12#1)(2008-10#2)
with a slope of 28##2##5##(2008-10#2)
with a slope of 29##5##5##(2008-10#5)
with a slope of 58##2##5##(2008-10#2)
with a slope of##34##4##(1990-8#1)(1994-12#1)(1994-8#1)(1995-6#1)(2006-10#1)(2007-8#1)(2008-10#28)
with a slope##48##3##(1990-8#1)(1994-12#1)(1994-8#1)(1995-6#1)(1996-2#1)(2006-10#1)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#31)(2008-2#2)(2008-3#2)
with a slow##7##3##(1991-3#1)(1997-4#1)(2007-11#1)(2008-3#1)(2009-2#1)(2010-5#1)(2012-12#1)
with a slower##4##3##(1990-2#1)(1994-7#1)(1996-5#1)(2004-11#1)
with a slowly##3##3##(2008-3#2)(2012-3#1)
with a small amount of##4##5##(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#1)
with a small angle between##3##5##(2007-12#2)(2008-2#1)
with a small aperture##2##4##(2008-2#2)
with a small number of cases##2##6##(1994-9#1)(2010-12#1)
with a small number of patients##2##6##(2006-10#1)(2009-8#1)
with a small number of##12##5##(1991-2#1)(1991-7#1)(1994-9#1)(1995-11#1)(2006-10#1)(2008-10#1)(2008-3#4)(2009-8#1)(2010-12#1)
with a small number##14##4##(1991-2#1)(1991-7#1)(1993-3#1)(1994-9#1)(1995-11#1)(2006-10#1)(2008-10#1)(2008-3#4)(2008-5#1)(2009-8#1)(2010-12#1)
with a small radius##2##4##(2008-2#1)(2008-3#1)
with a small volume of##7##5##(2008-10#7)
with a small##78##3##(1991-2#1)(1991-4#1)(1991-7#1)(1993-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-10#1)(2006-10#2)(2007-12#7)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#13)(2008-11#1)(2008-2#9)(2008-3#11)(2008-5#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-12#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
with a smaller number of##4##5##(1995-10#1)(2006-1#1)(2008-3#1)(2012-2#1)
with a smaller##18##3##(1990-3#1)(1994-8#1)(1995-10#1)(1997-1#1)(1997-3#1)(1997-4#1)(2006-1#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-3#2)(2009-10#1)(2010-2#1)(2011-2#1)(2012-2#3)
with a smooth surface##4##4##(1994-7#1)(2004-9#1)(2008-8#1)(2010-1#1)
with a smooth##8##3##(1994-7#1)(2004-9#1)(2007-12#1)(2007-8#1)(2008-8#1)(2010-1#1)(2011-1#1)(2012-12#1)
with a sodium##2##3##(2008-10#1)(2010-4#1)
with a soft##2##3##(2008-12#1)(2013-8#1)
with a software##2##3##(2007-8#1)(2011-2#1)
with a solid immersion lens##2##5##(2008-3#2)
with a solid phase##2##4##(2008-10#2)
with a solid##13##3##(1994-3#1)(2006-7#1)(2007-12#1)(2007-4#1)(2008-10#5)(2008-3#2)(2012-2#1)(2013-1#1)
with a solid-phase##3##3##(1991-8#1)(2008-2#1)(2008-4#1)
with a solitary##7##3##(2007-7#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-6#2)(2012-12#1)
with a solution containing##2##4##(1991-1#1)(2008-10#1)
with a solution of bupivacaine 0##3##6##(1996-8#3)
with a solution of##13##4##(1991-8#1)(1996-6#1)(1996-8#4)(2008-10#5)(2008-2#1)(2008-5#1)
with a solution##17##3##(1991-1#1)(1991-8#1)(1996-6#1)(1996-8#5)(2008-10#7)(2008-2#1)(2008-5#1)
with a solvent extraction##2##4##(2008-10#2)
with a solvent##3##3##(1993-3#1)(2008-10#2)
with a sound##3##3##(2010-12#1)(2011-2#1)(2012-2#1)
with a source of##2##4##(2008-3#1)(2012-3#1)
with a spacer device##3##4##(1996-1#2)(2008-3#1)
with a spacer##12##3##(1996-1#3)(2005-11#2)(2007-11#2)(2008-10#2)(2008-3#1)(2008-8#1)(2013-1#1)
with a spacing of##2##4##(1995-8#1)(2005-4#1)
with a spatial frequency of##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
with a spatial resolution of approximately##2##6##(2006-5#1)(2008-2#1)
with a spatial resolution of##11##5##(2006-5#1)(2007-11#1)(2007-12#3)(2008-2#4)(2008-3#1)(2008-5#1)
with a spatial resolution##13##4##(2006-5#1)(2007-11#1)(2007-12#3)(2008-2#5)(2008-3#2)(2008-5#1)
with a spatial##23##3##(2006-5#1)(2007-11#1)(2007-12#4)(2008-2#9)(2008-3#4)(2008-5#1)(2011-3#1)(2012-1#1)(2012-2#1)
with a spatially##4##3##(1992-9#1)(2007-12#1)(2008-3#2)
with a special emphasis on the##3##6##(2006-8#1)(2007-11#1)(2007-2#1)
with a special emphasis on##7##5##(2006-8#1)(2007-11#1)(2007-2#2)(2008-9#1)(2010-1#1)(2011-2#1)
with a special focus on##7##5##(1992-4#1)(2003-11#1)(2007-2#1)(2008-4#1)(2008-8#1)(2009-7#1)(2011-2#1)
with a special interest##2##4##(2007-2#1)(2008-10#1)
with a special reference to##5##5##(1993-8#1)(1996-2#1)(2007-7#2)(2008-7#1)
with a special regard to the##2##6##(1994-5#1)(2008-10#1)
with a special##35##3##(1990-4#1)(1990-9#1)(1992-4#1)(1993-4#1)(1993-8#1)(1994-5#1)(1996-2#1)(2003-11#1)(2006-8#1)(2007-11#1)(2007-2#4)(2007-7#2)(2008-10#4)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#1)
with a specialist##2##3##(1992-2#1)(2006-5#1)
with a specially designed##5##4##(2006-6#1)(2007-4#1)(2008-2#1)(2008-3#1)(2009-4#1)
with a specially##7##3##(1994-5#1)(2006-6#1)(2007-4#1)(2008-2#2)(2008-3#1)(2009-4#1)
with a species##2##3##(1995-2#1)(2008-10#1)
with a specific activity of 1##2##6##(1993-9#1)(1994-12#1)
with a specific activity of##9##5##(1990-8#2)(1993-9#2)(1994-12#1)(1994-5#2)(1995-1#1)(2009-9#1)
with a specific antibody##2##4##(1994-9#1)(2008-4#1)
with a specific approach##2##4##(2006-6#1)(2012-2#1)
with a specific genetic##2##4##(2008-4#1)(2011-2#1)
with a specific monoclonal antibody##4##5##(1990-11#1)(1991-10#1)(1994-10#1)(2008-10#1)
with a specific primary antibody##2##5##(2008-11#2)
with a specific probe for##2##5##(1990-12#1)(1991-9#1)
with a specific##63##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-6#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-12#1)(1993-6#1)(1993-9#2)(1994-1#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-5#2)(1994-9#2)(1995-1#1)(1995-12#1)(1995-5#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-8#1)(2006-6#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-4#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
with a specificity of##3##4##(1993-2#1)(1997-3#1)(2005-8#1)
with a specificity##4##3##(1993-2#1)(1995-2#1)(1997-3#1)(2005-8#1)
with a speckle interferometer##2##4##(2007-11#1)(2008-3#1)
with a spectral resolution of##2##5##(2007-12#2)
with a spectral resolution##3##4##(2007-12#2)(2008-2#1)
with a spectral##6##3##(2007-12#3)(2008-2#2)(2008-3#1)
with a spectrograph and##3##4##(2007-12#2)(2008-10#1)
with a spectrometer##3##3##(2006-12#1)(2008-3#2)
with a spectrophotometer##5##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-2#1)
with a spectrophotometric reference method##2##5##(2008-10#2)
with a spectrum of##4##4##(1996-8#1)(2006-10#1)(2007-2#1)(2007-8#1)
with a spectrum##6##3##(1996-8#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-5#1)
with a spherical##6##3##(2008-2#3)(2008-3#3)
with a spin##2##3##(2005-11#1)(2008-11#1)
with a spontaneous##4##3##(2006-10#1)(2007-3#1)(2008-8#1)(2012-2#1)
with a spouse##3##3##(1990-2#1)(1994-2#1)(2012-12#1)
with a square wave##3##4##(2006-1#1)(2007-12#2)
with a square##5##3##(2006-1#1)(2007-11#1)(2007-12#2)(2008-2#1)
with a stable##11##3##(2004-4#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#1)(2010-4#1)
with a stack of##2##4##(2008-3#2)
with a standard deviation of 0##3##6##(2006-5#1)(2008-3#1)(2009-2#1)
with a standard deviation of 5##2##6##(1997-8#1)(2008-10#1)
with a standard deviation of##7##5##(1997-8#1)(2006-5#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-2#1)
with a standard deviation##10##4##(1997-8#1)(2006-5#1)(2007-5#1)(2008-10#2)(2008-2#2)(2008-3#1)(2009-2#1)(2011-2#1)
with a standard error of##2##5##(2008-10#1)(2008-2#1)
with a standard reference##2##4##(2008-10#2)
with a standard##49##3##(1990-6#1)(1994-2#1)(1997-2#1)(1997-8#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#15)(2008-2#10)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
with a standardized##4##3##(1993-6#1)(2007-3#1)(2008-7#1)(2011-1#1)
with a stapler##2##3##(2006-6#2)
with a static##2##3##(2007-12#1)(2008-10#1)
with a statin##5##3##(2006-10#1)(2009-11#3)(2012-3#1)
with a stationary##2##3##(2007-11#1)(2008-3#1)
with a statistical##7##3##(2006-5#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)
with a statistically significant##3##4##(1995-12#1)(2006-8#1)(2008-5#1)
with a steady##3##3##(2006-8#1)(2010-4#1)(2010-8#1)
with a steady-state##5##3##(1991-4#2)(2008-10#2)(2008-3#1)
with a steep##2##3##(2006-10#1)(2008-10#1)
with a step##3##3##(1997-4#1)(2008-10#1)(2008-3#1)
with a sterile##3##3##(2007-7#2)(2008-12#1)
with a stimulus##3##3##(1991-3#1)(2008-7#1)(2012-3#1)
with a stochastic##2##3##(2008-8#1)(2011-2#1)
with a stoichiometry of##5##4##(1990-2#1)(1990-7#2)(1994-11#1)(1994-6#1)
with a strain of##2##4##(2004-11#1)(2008-5#1)
with a strategy##4##3##(1993-2#1)(1996-9#1)(2006-1#1)(2006-10#1)
with a streak camera and a##2##6##(2008-2#2)
with a stream of##3##4##(2008-10#3)
with a strict##4##3##(1997-6#1)(2008-3#1)(2008-4#1)(2008-9#1)
with a strictly##3##3##(2007-12#1)(2008-10#2)
with a stroke##2##3##(1992-2#1)(2007-9#1)
with a strong emphasis on##2##5##(1993-12#1)(2008-1#1)
with a strong emphasis##3##4##(1993-12#1)(2008-1#2)
with a strong tendency to##2##5##(2012-1#1)(2013-1#1)
with a strong##29##3##(1992-1#3)(1992-7#1)(1993-12#1)(1994-12#1)(1995-12#1)(1996-4#1)(1997-1#1)(2006-6#1)(2007-11#2)(2007-12#2)(2008-1#2)(2008-10#2)(2008-5#1)(2009-12#1)(2009-6#2)(2009-7#1)(2010-1#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
with a strongly##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2013-8#1)
with a structural##2##3##(2007-12#1)(2011-2#1)
with a structurally##2##3##(1991-6#1)(1994-8#1)
with a structure##3##3##(1995-6#1)(2008-3#1)(2008-5#1)
with a structured interview##2##4##(2006-10#1)(2010-8#1)
with a structured##3##3##(2006-10#1)(2006-12#1)(2010-8#1)
with a study of##2##4##(1990-9#1)(2009-2#1)
with a sub-sample of##3##4##(2008-1#1)(2008-10#1)(2008-12#1)
with a subcutaneous##4##3##(1993-9#1)(1997-5#1)(2011-1#1)(2012-3#1)
with a subpopulation##2##3##(1995-11#1)(2008-11#1)
with a subsequent##9##3##(1991-9#1)(1992-5#1)(1992-7#1)(1993-11#1)(1997-7#1)(2008-10#1)(2009-7#1)(2011-2#1)(2012-12#1)
with a subset of the##3##5##(2012-3#1)(2013-1#2)
with a subset of##4##4##(2008-8#1)(2012-3#1)(2013-1#2)
with a substance##3##3##(2008-4#1)(2008-6#1)(2008-9#1)
with a substantial number of##2##5##(2007-2#1)(2007-7#1)
with a substantial##13##3##(1991-5#1)(1991-8#1)(1993-1#1)(1993-11#1)(1996-11#1)(1997-3#1)(2007-2#1)(2007-7#1)(2009-5#1)(2010-7#1)(2012-3#1)(2013-1#2)
with a substantially##2##3##(1992-2#1)(2006-10#1)
with a substitution##3##3##(1994-3#1)(1996-5#1)(2009-5#1)
with a substrate##2##3##(1994-3#1)(2006-7#1)
with a subunit molecular##2##4##(1992-12#1)(1997-2#1)
with a subunit##6##3##(1990-12#1)(1992-12#1)(1995-10#1)(1997-2#1)(2007-11#2)
with a successful outcome##4##4##(2007-8#1)(2009-6#1)(2010-7#1)(2012-2#1)
with a successful##7##3##(2006-10#1)(2007-8#1)(2008-6#1)(2009-10#1)(2009-6#1)(2010-7#1)(2012-2#1)
with a sudden##3##3##(2006-12#1)(2009-4#1)(2011-2#1)
with a sufficient##4##3##(2005-11#1)(2006-10#1)(2008-2#1)(2012-12#1)
with a suitable choice of##2##5##(2007-12#1)(2010-2#1)
with a suitable##15##3##(1992-2#1)(1992-7#1)(1992-8#1)(2007-12#2)(2007-7#1)(2008-10#5)(2008-4#1)(2008-6#1)(2010-2#1)(2012-12#1)
with a suitably##2##3##(2007-12#1)(2008-4#1)
with a summary of##4##4##(2005-10#1)(2008-1#1)(2008-10#1)(2011-2#1)
with a summary##5##3##(1993-7#1)(2005-10#1)(2008-1#1)(2008-10#1)(2011-2#1)
with a superficial LMS##2##4##(2008-6#2)
with a superficial##3##3##(2008-6#3)
with a superior##3##3##(1997-6#1)(2007-12#1)(2009-12#1)
with a superluminescent diode##3##4##(2008-2#2)(2008-3#1)
with a supportive##2##3##(1993-2#1)(2007-7#1)
with a surface##9##3##(1990-2#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-8#1)(2012-3#1)
with a surgical##4##3##(2012-3#1)(2013-1#2)(2013-7#1)
with a survival##2##3##(1996-2#1)(2012-12#1)
with a susceptible##3##3##(2008-10#2)(2009-3#1)
with a suspected##4##3##(1991-10#1)(1994-5#1)(2008-4#1)(2010-9#1)
with a suspension containing##2##4##(2008-10#1)(2008-5#1)
with a suspension of##2##4##(1993-3#1)(2008-10#1)
with a suspension##4##3##(1993-3#1)(2008-10#2)(2008-5#1)
with a suspicion of##2##4##(1994-7#1)(2007-3#1)
with a sustained##3##3##(1995-5#1)(1996-9#1)(2009-8#1)
with a swelling##5##3##(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-9#1)
with a symmetric##2##3##(1994-8#1)(2008-2#1)
with a symmetrical##4##3##(1990-8#1)(1991-2#1)(2007-12#1)(2008-10#1)
with a symptomatic##3##3##(1992-9#1)(2008-8#1)(2011-2#1)
with a synchronous##2##3##(2007-8#1)(2008-3#1)
with a synchrotron##3##3##(2006-5#1)(2008-4#1)(2008-5#1)
with a syndrome##4##3##(1996-3#1)(2005-7#1)(2008-7#1)(2010-3#1)
with a synthetic aperture##2##4##(2007-11#1)(2008-3#1)
with a synthetic##17##3##(1990-3#1)(1991-7#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-9#1)(1995-11#1)(1995-6#1)(1995-8#1)(1997-1#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-2#1)(2010-4#1)
with a syringe##2##3##(2008-10#1)(2008-5#1)
with a system of##2##4##(2007-12#2)
with a system##3##3##(2007-12#2)(2008-3#1)
with a systematic##2##3##(2008-2#1)(2011-12#1)
with a systemic##4##3##(1993-5#1)(1994-9#1)(2012-2#1)(2013-7#1)
with a t1/2 of##3##4##(1990-2#1)(1990-5#1)(1995-6#1)
with a t1/2##4##3##(1990-2#1)(1990-5#1)(1995-5#1)(1995-6#1)
with a tabletop##3##3##(2007-12#3)
with a tailored##2##3##(2007-12#2)
with a tapered##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
with a target DNA##2##4##(2007-8#1)(2008-10#1)
with a target protein##2##4##(1991-4#1)(2008-10#1)
with a target##10##3##(1991-4#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-9#1)(2009-9#1)(2011-1#1)(2011-2#1)
with a targeted##4##3##(1993-9#1)(1994-9#1)(1995-5#1)(2008-3#1)
with a technique##3##3##(1993-3#1)(2008-2#1)(2008-5#1)
with a temperature##7##3##(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#3)(2008-5#1)
with a temperature-sensitive##2##3##(1995-6#1)(1995-9#1)
with a temporal resolution##2##4##(2008-10#1)(2008-2#1)
with a temporal##3##3##(1991-3#1)(2008-10#1)(2008-2#1)
with a ten-year follow-up period##2##5##(2009-8#2)
with a tendency for local recurrence##2##6##(2007-7#1)(2010-7#1)
with a tendency for##4##4##(1997-5#1)(2007-7#1)(2009-5#1)(2010-7#1)
with a tendency of##2##4##(2013-8#2)
with a tendency to##6##4##(1990-4#1)(1990-5#1)(2008-5#2)(2010-2#1)(2011-2#1)
with a tendency toward##2##4##(1992-9#1)(2011-2#1)
with a tendency##14##3##(1990-4#1)(1990-5#1)(1992-9#1)(1997-5#1)(2007-7#1)(2008-5#2)(2009-5#1)(2010-2#1)(2010-7#1)(2011-2#2)(2013-8#2)
with a terahertz (THz)##2##4##(2007-12#2)
with a test##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
with a theoretical model##5##4##(2007-11#1)(2007-12#1)(2008-3#2)(2011-1#1)
with a theoretical value##2##4##(2007-12#1)(2008-2#1)
with a theoretical##8##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)(2011-1#1)
with a therapeutic##3##3##(2005-8#1)(2006-8#1)(2007-11#1)
with a thermal##2##3##(2007-12#1)(2007-7#1)
with a thermally##2##3##(2008-10#1)(2008-2#1)
with a thick stalk##2##4##(2010-2#1)(2010-5#1)
with a thick##4##3##(2008-2#1)(2010-2#1)(2010-5#2)
with a thickness of 3##2##5##(1993-2#1)(2009-2#1)
with a thickness of##8##4##(1993-2#1)(2007-12#1)(2007-8#1)(2008-3#1)(2009-2#1)(2009-7#1)(2010-3#1)(2012-12#1)
with a thickness##9##3##(1993-2#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2009-2#1)(2009-7#1)(2010-3#1)(2012-12#1)
with a thin film of##2##5##(2008-10#1)(2008-5#1)
with a thin film##3##4##(2008-10#2)(2008-5#1)
with a thin layer of##2##5##(2008-10#1)(2008-4#1)
with a thin silicone##2##4##(2008-2#1)(2008-5#1)
with a thin##22##3##(1991-6#1)(2005-11#1)(2006-6#1)(2007-12#3)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-7#1)
with a third party##2##4##(2008-10#1)(2012-12#1)
with a third##7##3##(1990-3#1)(2004-12#1)(2006-5#1)(2007-12#1)(2008-10#1)(2012-12#1)(2012-3#1)
with a third-generation cephalosporin##2##4##(2011-2#2)
with a thoracic intramedullary##2##4##(1997-6#1)(2007-10#1)
with a thoracic##3##3##(1997-6#1)(2007-10#1)(2009-3#1)
with a thorough##2##3##(2006-5#1)(2007-9#1)
with a three##6##3##(1993-4#1)(2005-12#2)(2008-10#1)(2012-1#1)(2012-2#1)
with a three-dimensional##6##3##(1995-7#1)(2006-10#1)(2008-2#1)(2008-3#2)(2010-3#1)
with a three-month history of##2##5##(2010-12#1)(2012-3#1)
with a three-panel runway##2##4##(1993-12#1)(1996-12#1)
with a threefold increase in##2##5##(2007-12#1)(2008-5#1)
with a threshold concentration of##2##5##(1995-11#1)(2008-5#1)
with a threshold##8##3##(1995-11#1)(1996-9#1)(2007-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2012-2#1)
with a throughput of##2##4##(2008-10#1)(2008-5#1)
with a throughput##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
with a time constant of##6##5##(1995-1#1)(1995-5#1)(1996-10#1)(1996-5#1)(2007-12#1)(2008-10#1)
with a time resolution of##6##5##(1996-7#1)(2006-4#1)(2007-11#1)(2008-3#3)
with a time resolution##8##4##(1996-7#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-3#4)
with a time##19##3##(1995-1#2)(1995-5#1)(1996-10#1)(1996-5#1)(1996-7#1)(1997-7#1)(2006-4#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#1)
with a time-resolved##2##3##(2008-10#1)(2008-2#1)
with a titanium##2##3##(2004-9#1)(2005-11#1)
with a titer of 1##2##5##(1992-9#2)
with a titer##3##3##(1992-9#2)(2008-10#1)
with a tone##2##3##(1996-6#1)(2008-9#1)
with a tool guided in the operating room##2##8##(2012-12#2)
with a tool##6##3##(2010-9#1)(2012-12#2)(2012-2#1)(2013-1#2)
with a top##2##3##(2007-11#1)(2008-2#1)
with a topical##3##3##(2006-2#1)(2006-8#1)(2010-12#1)
with a torque between 25 to 35 Ncm##2##8##(2013-1#2)
with a torque##3##3##(2013-1#3)
with a total dose of##2##5##(1992-11#1)(2008-6#1)
with a total length of##4##5##(2007-12#1)(2007-5#1)(2013-8#2)
with a total of 10##2##5##(1990-3#1)(2007-12#1)
with a total of 11##2##5##(2006-4#1)(2011-2#1)
with a total of 19##2##5##(1991-11#1)(1994-8#1)
with a total of##33##4##(1990-3#1)(1990-4#1)(1991-11#1)(1992-12#1)(1994-12#1)(1994-8#1)(1994-9#1)(1997-3#1)(2006-12#2)(2006-2#1)(2006-4#2)(2007-12#2)(2007-2#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2009-4#1)(2009-5#1)(2010-5#1)(2011-2#3)(2012-3#2)(2013-1#1)(2013-8#3)
with a total run time of##3##6##(1996-5#1)(2008-10#1)(2008-3#1)
with a total##65##3##(1990-3#1)(1990-4#1)(1991-11#1)(1992-11#1)(1992-12#1)(1994-12#1)(1994-8#1)(1994-9#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-12#3)(2006-2#1)(2006-4#2)(2007-11#1)(2007-12#6)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#2)(2009-4#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#5)
with a trace##3##3##(2008-5#3)
with a traditional##5##3##(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)
with a transcriptional##2##3##(1997-4#1)(2012-12#1)
with a transforming##2##3##(1996-5#1)(2012-12#1)
with a transgene##2##3##(2008-11#1)(2012-2#1)
with a transient increase##2##4##(1991-7#1)(2010-12#1)
with a transient##8##3##(1991-7#1)(1994-8#1)(1997-7#1)(2006-10#1)(2007-10#2)(2008-5#1)(2010-12#1)
with a transmission##3##3##(2006-10#1)(2008-2#1)(2008-5#1)
with a transparent##4##3##(2008-10#1)(2008-3#1)(2008-5#2)
with a transverse##2##3##(2007-12#1)(2012-12#1)
with a transversely##3##3##(2007-11#1)(2008-10#2)
with a treatment##3##3##(2007-12#1)(2007-2#1)(2012-3#1)
with a trend of##2##4##(2008-11#1)(2013-1#1)
with a trend towards an##2##5##(1995-6#1)(2007-9#1)
with a trend towards##5##4##(1995-5#1)(1995-6#1)(2007-9#1)(2010-3#1)(2012-11#1)
with a trend##11##3##(1995-5#1)(1995-6#1)(1997-1#1)(2006-9#1)(2007-9#1)(2008-11#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-11#1)(2013-1#1)
with a triangular##2##3##(2008-3#1)(2010-6#1)
with a triple##4##3##(1992-2#1)(1994-9#1)(1995-8#1)(2013-8#1)
with a triplet##2##3##(2008-3#1)(2010-5#1)
with a tritiated##2##3##(1992-6#1)(1992-8#1)
with a tryptophan##3##3##(1991-4#1)(1991-5#1)(1992-6#1)
with a tumor of##2##4##(2011-2#1)(2013-1#1)
with a tumor size of##2##5##(1995-4#1)(1996-6#1)
with a tumor size##3##4##(1995-4#1)(1996-6#2)
with a tumor##14##3##(1990-12#1)(1990-6#1)(1994-12#1)(1995-4#1)(1996-6#2)(2007-8#4)(2011-2#1)(2013-1#3)
with a tumorigenic##2##3##(1996-2#1)(2008-10#1)
with a tunable##6##3##(2007-12#2)(2008-2#1)(2008-3#3)
with a tungsten tube atomizer##2##5##(2008-10#2)
with a tungsten##5##3##(1997-8#1)(2008-10#4)
with a tuning range of##2##5##(2007-12#1)(2008-2#1)
with a tuning##3##3##(2007-12#1)(2008-2#2)
with a turn##2##3##(1990-7#1)(1993-6#1)
with a turnover number of about##2##6##(1990-7#1)(1996-5#1)
with a twist##2##3##(2007-12#1)(2007-4#1)
with a twisted-nematic liquid-crystal display##2##5##(2007-12#2)
with a two##6##3##(1991-12#1)(1992-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-7#1)
with a two-dimensional photonic crystal##2##5##(2007-11#1)(2007-12#1)
with a two-dimensional##11##3##(2007-11#3)(2007-12#5)(2008-1#1)(2008-2#1)(2008-3#1)
with a two-month history of##2##5##(2005-12#1)(2009-9#1)
with a two-state##2##3##(1994-5#1)(1995-6#1)
with a two-step##3##3##(1997-4#1)(1997-7#1)(2008-10#1)
with a two-wavelength##2##3##(2008-2#1)(2008-3#1)
with a two-week##2##3##(2005-12#1)(2010-4#1)
with a two-year history of##2##5##(2011-2#1)(2012-2#1)
with a two-year##3##3##(1993-11#1)(2011-2#1)(2012-2#1)
with a twofold increase in sensitivity##2##6##(2008-2#2)
with a type##4##3##(1992-4#1)(2007-12#1)(2008-3#1)(2012-12#1)
with a typical##5##3##(1991-9#1)(1994-8#1)(2008-1#1)(2008-3#1)(2012-2#1)
with a tyrosine##2##3##(1990-3#1)(1995-5#1)
with a ubiquitous##2##3##(1995-1#1)(1996-9#1)
with a unidirectional##2##3##(1997-4#1)(2008-2#1)
with a uniform##6##3##(2007-11#1)(2007-2#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-7#1)
with a unilateral##3##3##(1995-12#1)(2008-3#1)(2008-4#1)
with a unique tissue##2##4##(1993-9#1)(2008-5#1)
with a unique##24##3##(1992-1#1)(1993-1#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-9#1)(1995-2#1)(1996-7#1)(1997-8#1)(2005-7#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-12#1)
with a universal promoter and##2##5##(2007-1#2)
with a universal##3##3##(2005-12#1)(2007-1#2)
with a use of##3##4##(2006-3#1)(2007-8#2)
with a useful##3##3##(1991-4#1)(1997-5#1)(2008-3#1)
with a vaccine##2##3##(1993-4#1)(2008-8#1)
with a vacuum##2##3##(2008-10#1)(2008-5#1)
with a validated##2##3##(2006-11#1)(2013-1#1)
with a value of 0##2##5##(1994-11#1)(2008-3#1)
with a value of##6##4##(1993-3#1)(1994-11#1)(2008-10#1)(2008-3#2)(2010-12#1)
with a variable degree of##2##5##(2009-8#1)(2011-2#1)
with a variable density of##2##5##(2008-2#2)
with a variable##17##3##(1990-10#1)(1990-3#1)(1990-4#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-2#6)(2008-3#1)(2009-11#1)(2009-8#1)(2011-2#1)(2013-1#1)
with a variety of agents##2##5##(2005-8#1)(2008-5#1)
with a variety of medical##2##5##(2010-8#1)(2012-3#1)
with a variety of new challenges##2##6##(1995-3#1)(2007-2#1)
with a variety of techniques##2##5##(2008-10#1)(2012-2#1)
with a variety of##93##4##(1990-4#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#2)(1996-5#1)(1997-8#1)(2004-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#3)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#1)
with a vascular##4##3##(2008-4#1)(2009-3#1)(2009-8#1)(2010-5#1)
with a vast##2##3##(2011-1#1)(2013-7#1)
with a vector##5##3##(1994-5#1)(1996-7#1)(2008-11#1)(2008-3#1)(2008-7#1)
with a venous##2##3##(2007-7#1)(2007-9#1)
with a verrucous##2##3##(2010-6#2)
with a vertical resolution of 3 km##2##7##(2008-3#2)
with a vertical##4##3##(2008-11#1)(2008-3#2)(2008-7#1)
with a very complex##2##4##(2007-12#1)(2008-4#1)
with a very fast##2##4##(2007-12#1)(2008-10#1)
with a very high probability of##2##6##(1997-6#1)(2006-11#1)
with a very high##11##4##(1990-12#1)(1996-3#1)(1997-4#1)(1997-6#2)(2006-11#1)(2008-5#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-12#1)
with a very large##2##4##(2008-1#1)(2008-2#1)
with a very low##9##4##(1990-5#1)(1992-11#1)(1992-9#1)(1995-9#1)(2006-1#1)(2008-10#2)(2008-5#1)(2012-2#1)
with a very poor prognosis##3##5##(2007-2#1)(2010-6#1)(2010-9#1)
with a very small##5##4##(1992-9#1)(1995-12#1)(2008-3#1)(2008-5#1)(2010-8#1)
with a very virulent##3##4##(2005-9#1)(2008-5#1)(2013-8#1)
with a very##55##3##(1990-12#1)(1990-5#1)(1991-8#1)(1992-11#1)(1992-6#1)(1992-9#2)(1995-12#1)(1995-9#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-6#2)(2005-1#1)(2005-9#1)(2006-1#1)(2006-11#1)(2007-11#2)(2007-12#7)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-8#1)(2009-12#1)(2009-4#2)(2009-9#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
with a viability##2##3##(2008-11#2)
with a view to defining##3##5##(1991-6#1)(1997-4#1)(2007-3#1)
with a view to determine##2##5##(2007-7#1)(2008-10#1)
with a view to developing##3##5##(2007-11#1)(2008-5#1)(2011-1#1)
with a view to enhance patient compliance##3##7##(2010-2#1)(2010-3#2)
with a view to identifying##3##5##(2006-10#1)(2009-9#1)(2011-1#1)
with a view to improving the##3##6##(1995-12#1)(2006-10#1)(2011-1#1)
with a view to improving##7##5##(1993-5#1)(1995-12#1)(2006-10#1)(2007-6#1)(2010-12#1)(2011-1#1)(2013-8#1)
with a view to the##3##5##(1991-5#1)(1992-7#1)(2008-2#1)
with a view to##51##4##(1991-3#1)(1991-5#1)(1991-6#1)(1992-7#1)(1992-8#1)(1993-5#1)(1995-12#1)(1997-4#1)(2005-10#1)(2006-10#2)(2006-5#1)(2006-9#1)(2007-11#1)(2007-3#2)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
with a view toward##2##4##(2008-12#1)(2009-3#1)
with a view##55##3##(1991-3#1)(1991-5#1)(1991-6#1)(1992-7#1)(1992-8#1)(1993-4#1)(1993-5#1)(1995-12#1)(1997-4#1)(2005-10#1)(2006-10#2)(2006-5#1)(2006-9#1)(2007-11#2)(2007-3#2)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#2)(2009-5#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
with a virulent##2##3##(2008-10#1)(2008-5#1)
with a virus titer of 10(6##2##6##(2008-11#2)
with a virus##5##3##(1996-4#1)(1997-1#1)(2008-10#1)(2008-11#2)
with a visible##2##3##(2007-11#1)(2008-2#1)
with a vision##2##3##(2007-2#1)(2008-10#1)
with a visual##5##3##(1996-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)
with a volume of##6##4##(1996-2#1)(2006-10#1)(2008-11#1)(2008-2#2)(2010-8#1)
with a volume##10##3##(1996-2#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2010-8#1)(2012-1#1)
with a waist-to-hip ratio##2##4##(1990-9#2)
with a wall-jet##4##3##(2008-10#4)
with a water##8##3##(1991-2#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-7#1)
with a water-soluble##3##3##(2008-5#1)(2008-9#1)(2012-2#1)
with a waveguide##2##3##(2008-3#2)
with a wavelength near##2##4##(2007-12#1)(2008-3#1)
with a wavelength of##4##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
with a wavelength##10##3##(2007-11#1)(2007-12#3)(2008-10#1)(2008-3#4)(2010-8#1)
with a weak##5##3##(1992-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)
with a weakly basic##2##4##(2008-10#2)
with a weakly##4##3##(2007-12#1)(2008-10#2)(2010-3#1)
with a week##2##3##(1994-6#1)(2008-12#1)
with a weight loss##2##4##(1992-4#1)(1992-8#1)
with a weight##4##3##(1992-4#1)(1992-8#1)(2008-6#1)(2012-2#1)
with a well##3##3##(2009-6#1)(2012-12#1)(2012-2#1)
with a well-defined##5##3##(1997-5#1)(2007-10#1)(2008-2#1)(2010-6#1)(2011-2#1)
with a well-differentiated##3##3##(2007-12#1)(2008-6#1)(2010-8#1)
with a white-light continuum##2##4##(2007-11#1)(2008-2#1)
with a white-light##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
with a whole##2##3##(2005-7#1)(2007-11#1)
with a wide distribution##3##4##(2005-11#1)(2008-5#2)
with a wide dynamic range##3##5##(2007-12#1)(2008-2#2)
with a wide range of##24##5##(1994-6#1)(1995-2#1)(1996-3#1)(1997-3#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
with a wide spectrum of##5##5##(2008-3#1)(2008-7#2)(2009-5#1)(2013-1#1)
with a wide variety of##8##5##(1994-5#1)(1996-7#1)(2008-4#3)(2009-12#1)(2009-5#1)(2009-9#1)
with a wide##51##3##(1990-12#1)(1991-9#1)(1994-5#1)(1994-6#1)(1995-2#1)(1996-3#1)(1996-7#1)(1997-3#1)(2005-11#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#3)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-9#1)(2010-4#2)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
with a widely##2##3##(1996-2#1)(2008-5#1)
with a widening##2##3##(2008-3#1)(2011-3#1)
with a wider##3##3##(1994-3#1)(2005-7#1)(2008-10#1)
with a width of##5##4##(1996-4#1)(2007-11#1)(2007-12#3)
with a width##7##3##(1996-4#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-8#1)
with a wild-type##4##3##(1997-4#1)(2008-11#1)(2011-1#1)(2012-12#1)
with a working##7##3##(1993-8#1)(2007-1#1)(2008-10#3)(2008-5#1)(2010-7#1)
with a worldwide##3##3##(2007-2#1)(2008-10#1)(2010-12#1)
with a worse prognosis##3##4##(2008-10#1)(2011-1#1)(2012-2#1)
with a wrist##4##3##(2006-3#1)(2008-9#2)(2009-6#1)
with a written##2##3##(2007-2#1)(2012-1#1)
with a yeast##3##3##(1995-11#1)(1995-2#1)(2006-12#1)
with a yield of 1##3##5##(1993-11#1)(1993-3#1)(1997-6#1)
with a yield of##11##4##(1990-3#1)(1990-4#1)(1992-8#1)(1993-11#1)(1993-3#1)(1996-11#1)(1997-3#1)(1997-6#2)(1997-8#1)(2013-1#1)
with a yield##12##3##(1990-3#1)(1990-4#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-6#1)(1996-11#1)(1997-3#1)(1997-6#2)(1997-8#1)(2013-1#1)
with a younger brother##2##4##(2004-11#2)
with a younger sister##2##4##(2004-11#2)
with a younger##6##3##(1996-7#1)(2004-11#4)(2007-9#1)
with a##13699##2##(1990-1#5)(1990-10#27)(1990-11#50)(1990-12#65)(1990-2#46)(1990-3#44)(1990-4#26)(1990-5#39)(1990-6#24)(1990-7#56)(1990-8#32)(1990-9#38)(1991-1#14)(1991-10#21)(1991-11#23)(1991-12#42)(1991-2#55)(1991-3#33)(1991-4#33)(1991-5#41)(1991-6#39)(1991-7#36)(1991-8#40)(1991-9#50)(1992-1#29)(1992-10#26)(1992-11#37)(1992-12#38)(1992-2#36)(1992-3#47)(1992-4#21)(1992-5#23)(1992-6#39)(1992-7#23)(1992-8#50)(1992-9#41)(1993-1#14)(1993-10#12)(1993-11#41)(1993-12#39)(1993-2#45)(1993-3#50)(1993-4#16)(1993-5#21)(1993-6#33)(1993-7#17)(1993-8#47)(1993-9#44)(1994-1#5)(1994-10#14)(1994-11#47)(1994-12#67)(1994-2#31)(1994-3#53)(1994-4#6)(1994-5#35)(1994-6#40)(1994-7#8)(1994-8#64)(1994-9#64)(1995-1#33)(1995-10#20)(1995-11#38)(1995-12#56)(1995-2#57)(1995-3#45)(1995-4#13)(1995-5#47)(1995-6#47)(1995-7#9)(1995-8#45)(1995-9#21)(1996-1#25)(1996-10#25)(1996-11#26)(1996-12#55)(1996-2#61)(1996-3#41)(1996-4#17)(1996-5#60)(1996-6#42)(1996-7#34)(1996-8#43)(1996-9#44)(1997-1#55)(1997-2#58)(1997-3#50)(1997-4#52)(1997-5#43)(1997-6#29)(1997-7#71)(1997-8#55)(1997-9#2)(2003-11#1)(2004-1#6)(2004-10#7)(2004-11#16)(2004-12#10)(2004-2#2)(2004-3#4)(2004-4#4)(2004-7#2)(2004-8#2)(2004-9#11)(2005-1#11)(2005-10#47)(2005-11#99)(2005-12#27)(2005-2#1)(2005-3#1)(2005-4#10)(2005-5#7)(2005-6#1)(2005-7#23)(2005-8#28)(2005-9#23)(2006-1#18)(2006-10#161)(2006-11#21)(2006-12#82)(2006-2#32)(2006-3#22)(2006-4#38)(2006-5#45)(2006-6#53)(2006-7#20)(2006-8#61)(2006-9#30)(2007-1#38)(2007-10#71)(2007-11#362)(2007-12#761)(2007-2#96)(2007-3#44)(2007-4#34)(2007-5#39)(2007-6#29)(2007-7#106)(2007-8#271)(2007-9#60)(2008-1#147)(2008-10#1690)(2008-11#220)(2008-12#100)(2008-2#658)(2008-3#851)(2008-4#187)(2008-5#283)(2008-6#132)(2008-7#225)(2008-8#131)(2008-9#128)(2009-1#11)(2009-10#36)(2009-11#31)(2009-12#29)(2009-2#25)(2009-3#57)(2009-4#40)(2009-5#58)(2009-6#35)(2009-7#33)(2009-8#64)(2009-9#57)(2010-1#22)(2010-10#31)(2010-11#21)(2010-12#106)(2010-2#52)(2010-3#40)(2010-4#58)(2010-5#56)(2010-6#32)(2010-7#38)(2010-8#53)(2010-9#36)(2011-1#143)(2011-10#1)(2011-11#5)(2011-12#21)(2011-2#308)(2011-3#9)(2011-9#1)(2012-1#82)(2012-11#30)(2012-12#166)(2012-2#203)(2012-3#125)(2012-6#1)(2012-7#2)(2012-8#1)(2012-9#1)(2013-1#341)(2013-2#1)(2013-7#68)(2013-8#159)
with abasic site##3##3##(1992-9#1)(2007-8#1)(2008-10#1)
with abciximab during coronary##2##4##(2007-11#2)
with abciximab##5##2##(2005-7#1)(2007-11#4)
with abdominal aneurysms##2##3##(1990-8#1)(2008-8#1)
with abdominal aortic##2##3##(2010-10#1)(2013-1#1)
with abdominal distension##2##3##(2008-11#1)(2010-9#1)
with abdominal pain and##5##4##(2005-10#1)(2006-10#1)(2010-12#2)(2011-1#1)
with abdominal pain associated##2##4##(1993-9#1)(2010-1#1)
with abdominal pain##30##3##(1991-4#1)(1993-6#1)(1993-9#1)(1995-3#1)(1997-8#1)(2004-2#1)(2005-10#1)(2006-10#2)(2008-3#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-1#1)(2010-12#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#6)(2013-8#1)
with abdominal symptoms##2##3##(2004-12#1)(2013-1#1)
with abdominal tuberculosis##2##3##(2011-1#2)
with abdominal##60##2##(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-4#3)(1993-6#1)(1993-9#1)(1995-12#1)(1995-3#1)(1997-8#1)(2004-12#1)(2004-2#1)(2005-10#1)(2006-10#2)(2006-6#1)(2007-4#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-9#1)(2011-1#3)(2011-2#7)(2012-12#3)(2012-2#2)(2013-1#9)(2013-8#1)
with aberrant##9##2##(2005-8#1)(2006-10#1)(2007-12#1)(2008-6#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-3#2)
with ability to##6##3##(1991-3#1)(2008-12#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
with ability##7##2##(1990-12#1)(1991-3#1)(2008-12#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
with abiotic##2##2##(2006-11#1)(2008-10#1)
with abiraterone acetate##2##3##(2013-7#2)
with abnormal cytology##2##3##(2011-2#1)(2012-12#1)
with abnormal growth##2##3##(2005-11#1)(2007-12#1)
with abnormal karyotype##2##3##(1993-1#1)(2012-1#1)
with abnormal liquor volume##3##4##(2012-12#3)
with abnormal liver##2##3##(2004-11#1)(2006-10#1)
with abnormal results##2##3##(2007-8#1)(2011-2#1)
with abnormal sleep##2##3##(1992-11#1)(2007-12#1)
with abnormal uterine bleeding##2##4##(1995-3#1)(2006-1#1)
with abnormal vaginal##2##3##(2006-10#1)(2007-7#1)
with abnormal##74##2##(1990-11#1)(1990-6#2)(1990-8#1)(1991-11#2)(1991-7#1)(1991-8#2)(1992-11#1)(1992-12#1)(1993-1#1)(1993-11#4)(1993-12#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-3#2)(1996-4#1)(1997-7#2)(2004-11#1)(2005-11#2)(2005-8#1)(2006-1#1)(2006-10#2)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
with abnormalities of##4##3##(1991-5#1)(2006-7#1)(2008-6#1)(2011-12#1)
with abnormalities##12##2##(1991-5#1)(1993-12#1)(1993-2#1)(1995-12#1)(1997-1#1)(2006-7#1)(2007-9#1)(2008-6#2)(2011-12#1)(2011-2#1)(2012-2#1)
with abnormally##6##2##(1990-12#1)(1997-1#1)(1997-5#1)(2006-10#1)(2007-8#1)(2008-4#1)
with abortion##2##2##(1991-1#1)(2006-8#1)
with about 1##2##3##(1990-7#1)(2005-8#1)
with about 80% of the##2##5##(1991-11#1)(2008-12#1)
with about a##3##3##(1992-11#1)(1994-12#1)(2005-10#1)
with about one##2##3##(1995-5#1)(2008-9#1)
with about##29##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-11#1)(1992-11#1)(1992-5#1)(1992-6#1)(1994-12#1)(1994-9#1)(1995-5#1)(1995-6#2)(2005-10#2)(2005-11#1)(2005-8#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-3#1)(2013-8#1)
with above-average##2##2##(2008-10#1)(2008-8#1)
with absence of the##4##4##(1997-3#1)(2008-10#1)(2008-7#1)(2008-8#1)
with absence of##9##3##(1997-3#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#2)
with absence##11##2##(1993-7#1)(1997-3#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-12#1)(2011-2#1)(2013-1#2)
with absent or &lt##2##4##(2013-1#2)
with absolute and##2##3##(1995-6#1)(2010-12#1)
with absolute##3##2##(1995-6#1)(2010-12#1)(2013-1#1)
with absorbance##3##2##(1990-12#1)(1992-8#1)(2006-2#1)
with absorption and##4##3##(2008-2#1)(2008-3#1)(2008-4#2)
with absorption bands##3##3##(2008-10#2)(2008-3#1)
with absorption coefficients##2##3##(2008-2#2)
with absorption##16##2##(1995-1#1)(2007-12#2)(2008-10#4)(2008-2#5)(2008-3#2)(2008-4#2)
with abundant##7##2##(1996-3#1)(2007-12#2)(2008-1#2)(2008-10#1)(2009-8#1)
with ac and##2##3##(2005-11#1)(2008-3#1)
with academic outcomes##2##3##(2004-3#1)(2011-1#1)
with academic performance##2##3##(2011-2#2)
with academic##10##2##(2004-3#1)(2007-4#1)(2008-12#2)(2008-2#1)(2011-1#2)(2011-2#2)(2012-1#1)
with acanthosis nigricans##4##3##(2007-7#3)(2012-12#1)
with acarbose##3##2##(1994-12#3)
with accelerated##6##2##(1991-7#1)(1992-2#1)(1997-7#2)(2008-10#1)(2008-7#1)
with accelerometers##2##2##(2006-11#1)(2013-1#1)
with acceptable accuracy and precision##2##5##(2008-10#2)
with acceptable accuracy##4##3##(1990-6#1)(2008-10#2)(2012-2#1)
with acceptable complication rates##2##4##(2006-12#1)(2008-7#1)
with acceptable levels of##2##4##(2011-1#1)(2012-12#1)
with acceptable morbidity and mortality##3##5##(2006-8#1)(2007-8#1)(2008-10#1)
with acceptable morbidity##4##3##(2006-8#1)(2007-8#1)(2008-10#1)(2012-2#1)
with acceptable results##3##3##(2006-8#1)(2011-3#1)(2012-12#1)
with acceptable toxicity##2##3##(2004-1#1)(2008-6#1)
with acceptable##32##2##(1990-6#1)(2004-1#1)(2006-10#1)(2006-12#2)(2006-8#2)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#5)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#3)
with accepted##2##2##(2008-10#1)(2009-5#1)
with acceptor##2##2##(1996-2#1)(2013-8#1)
with access of##2##3##(1991-10#1)(2011-2#1)
with access to the##6##4##(1994-12#1)(2006-10#1)(2010-2#1)(2012-3#1)(2013-1#2)
with access to##14##3##(1994-12#1)(1995-7#1)(2006-10#1)(2007-12#1)(2007-9#2)(2008-4#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
with access##17##2##(1991-10#1)(1994-12#1)(1995-7#1)(2006-10#1)(2007-12#1)(2007-9#2)(2008-2#1)(2008-4#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
with accessibility##2##2##(1995-1#1)(2013-1#1)
with accessory##2##2##(1995-6#1)(2009-9#1)
with accidental##3##2##(1991-8#1)(2010-3#1)(2013-1#1)
with accompanying##12##2##(1993-2#1)(1994-12#1)(1994-9#1)(2005-11#1)(2006-7#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-3#1)(2012-2#1)(2013-1#1)
with accumulated##3##2##(2008-10#1)(2011-1#1)(2012-12#1)
with accumulation of cells in##2##5##(1994-9#1)(1996-6#1)
with accumulation of##7##3##(1991-9#1)(1994-9#1)(1996-6#1)(2007-4#1)(2012-1#1)(2012-11#1)(2013-1#1)
with accumulation time##2##3##(2008-10#2)
with accumulation##10##2##(1991-9#1)(1994-9#1)(1996-6#1)(2007-4#1)(2008-10#3)(2012-1#1)(2012-11#1)(2013-1#1)
with accuracies of##2##3##(2008-3#1)(2010-4#1)
with accuracies##3##2##(2008-3#2)(2010-4#1)
with accuracy of##5##3##(1997-6#1)(2007-11#1)(2007-5#1)(2008-10#2)
with accuracy##12##2##(1991-9#1)(1997-6#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-3#1)(2009-5#1)(2013-1#2)
with accurate##7##2##(1991-5#1)(2006-10#1)(2007-2#1)(2009-5#1)(2010-3#1)(2013-7#1)(2013-8#1)
with acepromazine and##3##3##(2012-2#1)(2012-3#1)(2013-1#1)
with acetabular bone##2##3##(2007-7#1)(2008-3#1)
with acetabular##5##2##(1993-8#1)(2007-7#3)(2008-3#1)
with acetamide##2##2##(2008-10#1)(2008-6#1)
with acetaminophen##3##2##(2006-10#1)(2008-5#1)(2010-6#1)
with acetate##5##2##(1993-6#1)(1996-5#1)(2008-10#1)(2008-3#2)
with acetazolamide##3##2##(2007-2#1)(2007-9#1)(2012-12#1)
with acetic acid gradients in water##4##6##(1991-3#4)
with acetic acid##11##3##(1991-3#4)(1997-4#1)(2008-10#2)(2008-6#2)(2012-12#1)(2013-1#1)
with acetic anhydride in pyridine afforded the##2##7##(2005-7#2)
with acetic anhydride in pyridine##3##5##(2005-7#3)
with acetic anhydride##5##3##(2005-7#3)(2008-10#1)(2008-11#1)
with acetic##17##2##(1991-3#4)(1997-4#1)(2005-7#3)(2008-10#3)(2008-11#1)(2008-6#2)(2012-12#2)(2013-1#1)
with acetone##9##2##(1994-8#1)(1994-9#1)(1995-3#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-5#1)(2012-12#2)
with acetonitrile and##4##3##(1990-6#1)(1992-2#1)(1996-6#1)(2008-10#1)
with acetonitrile gradients in##2##4##(1991-3#2)
with acetonitrile##23##2##(1990-6#1)(1991-3#2)(1992-2#1)(1993-2#2)(1996-6#1)(1996-8#1)(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#9)(2008-5#1)(2010-5#1)(2012-12#1)
with acetonitrile-based##3##2##(1991-3#1)(2008-10#2)
with acetonitrile-water mixtures##2##3##(2008-10#2)
with acetonitrile-water##6##2##(2008-10#5)(2011-1#1)
with acetyl-L-carnitine##4##2##(1990-7#1)(1992-1#3)
with acetylated##2##2##(1991-5#1)(2012-12#1)
with acetylcholine##3##2##(1990-6#1)(2007-9#1)(2008-8#1)
with acetylcholinesterase (AChE)##3##3##(1995-3#1)(1997-3#1)(2008-10#1)
with acetylcholinesterase##6##2##(1994-9#1)(1995-3#1)(1997-3#2)(2008-10#2)
with acetylsalicylic acid##2##3##(1990-12#1)(1994-2#1)
with achalasia##4##2##(1990-12#1)(1992-9#1)(2006-10#1)(2013-1#1)
with achieving##3##2##(2004-12#1)(2007-12#1)(2011-2#1)
with achondroplasia and##2##3##(2008-5#2)
with achondroplasia##8##2##(1996-3#1)(2008-5#5)(2011-1#1)(2013-1#1)
with acid and##2##3##(1990-11#1)(2007-8#1)
with acid##11##2##(1990-11#1)(1990-6#1)(1996-3#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-6#1)
with acidic molybdate##2##3##(2008-10#2)
with acidic potassium permanganate in the presence of##2##8##(2008-10#2)
with acidic potassium permanganate##5##4##(2008-10#5)
with acidic##15##2##(1990-2#1)(2006-8#1)(2008-1#1)(2008-10#9)(2008-8#1)(2009-10#1)(2012-12#1)
with acidification##2##2##(1994-6#1)(2008-10#1)
with acidified methanol##2##3##(1992-7#1)(2008-10#1)
with acidified##7##2##(1992-7#1)(2006-12#1)(2008-10#3)(2011-2#1)(2013-1#1)
with acitretin##2##2##(1996-8#1)(2012-12#1)
with acne compared to##2##4##(2010-5#2)
with acne##7##2##(2006-10#1)(2008-2#1)(2010-5#3)(2010-8#1)(2011-2#1)
with acoustic##6##2##(1991-12#2)(2006-11#1)(2007-5#1)(2008-4#1)(2008-7#1)
with acquired focal myasthenia gravis##2##5##(2012-2#2)
with acquired immune deficiency syndrome##3##5##(1994-3#1)(2006-7#1)(2011-2#1)
with acquired immune##4##3##(1994-3#1)(1996-10#1)(2006-7#1)(2011-2#1)
with acquired immunodeficiency syndrome (AIDS) in##2##6##(1991-12#1)(1992-2#1)
with acquired immunodeficiency syndrome (AIDS)##6##5##(1991-12#1)(1992-2#1)(1994-6#1)(2005-10#1)(2007-2#1)(2009-8#1)
with acquired immunodeficiency syndrome##9##4##(1991-12#2)(1992-2#1)(1994-6#1)(2005-10#1)(2007-12#1)(2007-2#1)(2008-2#1)(2009-8#1)
with acquired prosopagnosia##2##3##(2009-4#2)
with acquired##26##2##(1991-12#2)(1992-2#1)(1994-3#2)(1994-6#1)(1996-10#1)(2005-10#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-2#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)
with acquisition of##4##3##(1993-6#1)(1994-8#1)(2004-1#1)(2012-2#1)
with acquisition##5##2##(1993-6#2)(1994-8#1)(2004-1#1)(2012-2#1)
with acridine orange##2##3##(2008-2#1)(2008-9#1)
with acridone-N-acetyl chloride##2##3##(2008-10#2)
with acrolein##2##2##(2013-1#2)
with acrylic glue##4##3##(1997-3#2)(1997-6#2)
with acrylic##5##2##(1997-3#2)(1997-6#2)(2010-4#1)
with actin filaments##4##3##(1995-8#1)(1997-6#1)(1997-7#1)(2008-10#1)
with actin##21##2##(1990-4#3)(1991-2#1)(1991-5#1)(1994-8#2)(1995-8#2)(1997-4#2)(1997-6#2)(1997-7#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#2)(2012-2#1)
with actinomycin D##6##3##(1992-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(1997-4#1)(2008-11#1)
with activated alkynes##2##3##(2007-11#2)
with activated carbon##5##3##(2008-10#5)
with activated##26##2##(1990-11#2)(1991-10#1)(1991-12#1)(1991-9#1)(1993-11#1)(1993-5#1)(1994-9#1)(1995-12#1)(1996-10#1)(2006-10#1)(2007-11#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-6#1)(2009-9#1)
with activation and##3##3##(1992-2#1)(2008-7#1)(2012-12#1)
with activation energies##2##3##(2006-3#1)(2008-5#1)
with activation of the##7##4##(1990-5#1)(1994-6#1)(1995-6#1)(2008-5#1)(2010-12#2)(2011-2#1)
with activation of##21##3##(1990-5#2)(1991-6#1)(1993-3#1)(1993-6#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-7#1)(2005-11#1)(2006-12#1)(2006-7#1)(2008-4#2)(2008-5#1)(2010-10#1)(2010-12#2)(2011-2#1)(2012-3#1)
with activation parameters##2##3##(1990-2#1)(2006-3#1)
with activation##31##2##(1990-2#1)(1990-5#2)(1991-6#1)(1992-2#1)(1993-3#1)(1993-6#2)(1994-6#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-7#1)(2005-11#1)(2006-12#1)(2006-3#2)(2006-7#1)(2008-4#2)(2008-5#3)(2008-7#1)(2010-10#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-3#1)
with active TB##4##3##(2007-4#1)(2012-2#3)
with active controls##2##3##(2011-12#1)(2012-3#1)
with active disease and##2##4##(1990-3#1)(1993-7#1)
with active disease##9##3##(1990-3#1)(1991-5#1)(1993-7#2)(1996-4#1)(2006-10#1)(2008-7#3)
with active form##2##3##(1995-3#1)(2013-1#1)
with active methylene and##2##4##(2007-11#1)(2008-11#1)
with active phase locking##2##4##(2007-12#2)
with active pulmonary TB##2##4##(2010-5#1)(2010-7#1)
with active pulmonary sarcoidosis##2##4##(2007-11#1)(2010-6#1)
with active pulmonary##5##3##(2007-11#1)(2010-5#1)(2010-6#1)(2010-7#2)
with active rheumatoid arthritis##3##4##(2008-3#1)(2010-4#1)(2012-12#1)
with active systemic lupus erythematosus##2##5##(2006-10#2)
with active trachoma##2##3##(2006-2#1)(2013-7#1)
with active tuberculosis##3##3##(2007-12#1)(2011-1#2)
with active##82##2##(1990-3#1)(1991-5#1)(1991-6#1)(1993-11#1)(1993-7#3)(1994-8#1)(1994-9#1)(1995-3#1)(1996-1#1)(1996-4#1)(1997-2#1)(1997-4#1)(2005-4#1)(2006-10#4)(2006-2#1)(2006-4#1)(2006-9#1)(2007-11#3)(2007-12#4)(2007-2#2)(2007-3#4)(2007-4#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#2)(2009-10#1)(2009-11#1)(2009-6#2)(2009-9#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#2)(2013-7#1)
with activities of daily living##2##5##(2008-7#1)(2012-1#1)
with activities##4##2##(1996-9#1)(2006-12#1)(2008-7#1)(2012-1#1)
with activity and##2##3##(1992-2#1)(1993-5#1)
with activity at##2##3##(1997-8#1)(2008-10#1)
with activity in the##3##4##(2008-11#2)(2010-3#1)
with activity in##5##3##(1993-11#1)(1994-6#1)(2008-11#2)(2010-3#1)
with activity of##3##3##(1995-12#1)(2006-7#1)(2006-8#1)
with activity##20##2##(1992-2#1)(1992-6#1)(1993-11#1)(1993-5#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#1)(1997-8#1)(2006-7#1)(2006-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-12#1)
with actual conditions##2##3##(2008-2#1)(2008-7#1)
with actual measurements##2##3##(2005-11#1)(2008-3#1)
with actual##19##2##(1992-12#1)(1995-2#1)(1996-3#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-6#2)(2008-2#5)(2008-3#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-7#1)
with acupuncture and##2##3##(2006-4#1)(2007-12#1)
with acute abdomen##4##3##(2006-2#1)(2007-3#1)(2007-7#1)(2013-1#1)
with acute abdominal pain and##2##5##(1992-8#1)(2008-12#1)
with acute abdominal pain##5##4##(1992-8#1)(2006-2#1)(2007-2#1)(2008-12#1)(2013-1#1)
with acute abdominal##7##3##(1990-10#1)(1992-8#1)(1993-10#1)(2006-2#1)(2007-2#1)(2008-12#1)(2013-1#1)
with acute and chronic liver disease##2##6##(2013-1#2)
with acute and chronic##5##4##(1992-5#1)(2007-8#1)(2013-1#2)(2013-8#1)
with acute and potential ACS##2##5##(2008-3#2)
with acute and potential##4##4##(2008-3#4)
with acute and##11##3##(1992-5#1)(2007-8#2)(2008-3#4)(2008-7#1)(2013-1#2)(2013-8#1)
with acute aortic##2##3##(2007-8#1)(2012-1#1)
with acute appendicitis in##2##4##(2008-8#1)(2009-2#1)
with acute appendicitis##5##3##(2008-8#1)(2009-2#2)(2010-2#1)(2010-8#1)
with acute asthma##2##3##(2008-1#1)(2008-10#1)
with acute cerebral infarction]##2##4##(2005-9#1)(2013-8#1)
with acute cerebral##3##3##(2005-9#1)(2012-3#1)(2013-8#1)
with acute chest pain##8##4##(1990-3#4)(1991-9#1)(2008-3#2)(2011-2#1)
with acute coronary syndrome in the##3##6##(2008-3#2)(2008-7#1)
with acute coronary syndrome with##2##5##(2008-10#1)(2008-3#1)
with acute coronary syndrome##27##4##(2007-8#3)(2008-10#3)(2008-11#5)(2008-3#7)(2008-7#3)(2011-12#2)(2011-2#3)(2012-2#1)
with acute coronary syndromes##23##4##(2005-12#1)(2005-6#1)(2005-7#2)(2006-10#1)(2006-6#1)(2008-10#1)(2008-3#11)(2008-4#1)(2008-7#1)(2009-12#2)(2011-1#1)
with acute coronary##56##3##(2005-12#1)(2005-6#1)(2005-7#2)(2006-10#1)(2006-6#2)(2007-8#4)(2008-10#6)(2008-11#5)(2008-3#18)(2008-4#1)(2008-7#4)(2009-10#1)(2009-12#2)(2011-1#1)(2011-12#2)(2011-2#3)(2012-2#1)(2013-8#1)
with acute decompensated##2##3##(2008-3#2)
with acute diarrhea in Tehran##3##5##(2010-9#3)
with acute diarrhea##5##3##(2007-2#1)(2010-9#3)(2012-12#1)
with acute diarrhoea##5##3##(2007-6#1)(2007-7#1)(2007-8#3)
with acute exacerbation##6##3##(2007-11#1)(2008-10#1)(2011-2#1)(2012-2#3)
with acute exacerbations of chronic##2##5##(1991-7#1)(2012-12#1)
with acute exacerbations##3##3##(1991-7#1)(2012-12#1)(2013-8#1)
with acute febrile illness##2##4##(2006-2#1)(2013-8#1)
with acute hepatic##3##3##(1991-11#1)(2010-12#2)
with acute hepatitis A##2##4##(1996-4#1)(2012-12#1)
with acute hepatitis and##2##4##(1990-8#1)(2005-12#1)
with acute hepatitis##9##3##(1990-8#1)(1996-3#1)(1996-4#1)(2005-12#2)(2006-2#1)(2012-12#1)(2012-3#2)
with acute ischaemic stroke##4##4##(1997-5#1)(2007-11#1)(2008-8#1)(2009-11#1)
with acute ischemic stroke and##3##5##(2007-9#2)(2008-10#1)
with acute ischemic stroke##22##4##(2007-10#7)(2007-9#8)(2008-10#1)(2009-6#1)(2012-11#1)(2012-12#2)(2013-1#1)(2013-7#1)
with acute ischemic##23##3##(2007-10#8)(2007-9#8)(2008-10#1)(2009-6#1)(2012-11#1)(2012-12#2)(2013-1#1)(2013-7#1)
with acute leukemia##6##3##(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#2)(2012-3#1)
with acute liver necrosis##2##4##(1992-6#1)(1992-9#1)
with acute liver##5##3##(1992-6#1)(1992-9#1)(1993-7#1)(2009-8#1)(2010-12#1)
with acute lung##5##3##(2006-10#4)(2012-3#1)
with acute lymphoblastic leukaemia##3##4##(1995-9#2)(2008-7#1)
with acute lymphoblastic leukemia (ALL) and##2##6##(2005-8#1)(2009-8#1)
with acute lymphoblastic leukemia who##2##5##(2008-10#1)(2012-12#1)
with acute lymphoblastic leukemia##13##4##(1996-11#1)(1997-5#1)(2005-8#1)(2008-10#1)(2009-4#1)(2009-8#2)(2011-2#3)(2012-12#2)(2012-2#1)
with acute lymphoblastic##17##3##(1995-9#2)(1996-11#1)(1997-5#1)(2005-8#1)(2008-10#1)(2008-7#1)(2009-4#1)(2009-8#2)(2011-2#4)(2012-12#2)(2012-2#1)
with acute myelocytic leukemia##2##4##(1991-2#1)(2011-2#1)
with acute myelogenous leukemia##4##4##(1994-12#2)(2009-8#1)(2010-11#1)
with acute myeloid leukemia##11##4##(1994-5#1)(2005-10#1)(2007-7#1)(2008-11#1)(2010-11#1)(2011-2#4)(2012-12#1)(2013-7#1)
with acute myeloid##13##3##(1994-5#1)(2005-10#1)(2006-4#1)(2007-7#1)(2008-11#1)(2010-11#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-7#1)
with acute myocardial infarction (AMI)##6##5##(1992-3#1)(1995-12#1)(1997-6#1)(2008-3#1)(2008-5#1)(2013-1#1)
with acute myocardial infarction in##2##5##(2006-10#1)(2008-10#1)
with acute myocardial infarction##48##4##(1990-3#1)(1990-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-12#1)(1995-12#2)(1995-9#2)(1997-3#1)(1997-6#1)(1997-8#4)(2005-7#1)(2006-10#1)(2007-11#2)(2008-10#3)(2008-3#7)(2008-5#3)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-11#1)(2010-7#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-1#3)
with acute myocardial##52##3##(1990-12#1)(1990-3#1)(1990-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-10#1)(1993-12#1)(1995-12#2)(1995-9#2)(1997-3#1)(1997-6#1)(1997-8#4)(2005-7#1)(2006-10#1)(2007-11#2)(2008-10#3)(2008-3#8)(2008-5#3)(2008-6#2)(2008-7#1)(2009-10#1)(2009-5#1)(2010-11#1)(2010-7#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-1#3)
with acute myocarditis and##2##4##(2008-4#2)
with acute myocarditis##3##3##(2008-4#3)
with acute neurological##4##3##(1994-10#1)(2006-4#1)(2006-9#1)(2010-12#1)
with acute obstruction of the##4##5##(1990-5#1)(1991-8#1)(2008-8#1)(2008-9#1)
with acute onset of##7##4##(1997-3#1)(2006-10#2)(2008-7#1)(2009-2#1)(2011-2#1)(2012-2#1)
with acute onset##14##3##(1997-3#1)(2006-10#2)(2007-12#1)(2008-7#1)(2009-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
with acute or chronic##2##4##(2008-7#1)(2012-2#1)
with acute otitis##4##3##(2007-9#4)
with acute pancreatitis and##2##4##(2008-12#1)(2008-3#1)
with acute pancreatitis have##2##4##(2005-10#1)(2009-2#1)
with acute pancreatitis##11##3##(1990-3#1)(2005-10#1)(2006-10#1)(2006-6#1)(2006-7#2)(2008-12#1)(2008-3#1)(2009-2#2)(2009-8#1)
with acute promyelocytic leukemia (APL)##2##5##(2007-4#1)(2008-8#1)
with acute promyelocytic leukemia##5##4##(1991-11#1)(2007-12#1)(2007-4#2)(2008-8#1)
with acute pulmonary edema##2##4##(2011-2#1)(2013-1#1)
with acute pulmonary##5##3##(1993-2#1)(1997-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
with acute rejection##3##3##(1995-2#1)(2007-8#1)(2007-9#1)
with acute renal failure (ARF)##3##5##(2006-2#1)(2008-4#1)(2012-3#1)
with acute renal failure in##2##5##(2006-8#1)(2008-4#1)
with acute renal failure##18##4##(2006-2#1)(2006-7#2)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#4)(2007-8#1)(2008-1#2)(2008-4#4)(2012-3#1)
with acute renal##21##3##(2006-2#1)(2006-4#1)(2006-7#2)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#4)(2007-8#1)(2008-1#2)(2008-4#4)(2009-6#1)(2011-2#1)(2012-3#1)
with acute respiratory failure##9##4##(1997-4#1)(2005-8#2)(2006-10#2)(2006-4#1)(2006-9#1)(2008-6#1)(2012-2#1)
with acute respiratory##15##3##(1997-4#1)(2005-8#2)(2006-10#2)(2006-4#1)(2006-9#1)(2008-11#1)(2008-6#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
with acute right##3##3##(2008-5#1)(2013-1#2)
with acute sinusitis##3##3##(1993-2#1)(2006-8#1)(2011-1#1)
with acute stroke##20##3##(1994-6#1)(2006-10#1)(2007-10#11)(2007-11#1)(2007-9#3)(2008-8#2)(2010-11#1)
with acute symptoms##2##3##(1991-6#1)(2007-7#1)
with acute uncomplicated##2##3##(2005-8#1)(2007-12#1)
with acute##510##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#6)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#3)(1991-2#1)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#2)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#3)(1992-8#3)(1992-9#3)(1993-10#2)(1993-12#2)(1993-2#3)(1993-3#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-12#2)(1994-2#2)(1994-5#2)(1994-6#2)(1995-12#3)(1995-2#2)(1995-4#1)(1995-9#4)(1996-11#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#7)(2005-10#2)(2005-12#3)(2005-6#1)(2005-7#4)(2005-8#5)(2005-9#1)(2006-1#1)(2006-10#15)(2006-12#1)(2006-2#5)(2006-4#4)(2006-6#4)(2006-7#6)(2006-8#2)(2006-9#2)(2007-10#23)(2007-11#12)(2007-12#6)(2007-2#5)(2007-3#1)(2007-4#2)(2007-6#2)(2007-7#10)(2007-8#16)(2007-9#17)(2008-1#4)(2008-10#15)(2008-11#7)(2008-12#2)(2008-3#38)(2008-4#10)(2008-5#9)(2008-6#3)(2008-7#15)(2008-8#9)(2008-9#4)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#5)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#5)(2010-11#5)(2010-12#5)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#4)(2011-1#9)(2011-12#2)(2011-2#30)(2012-1#1)(2012-11#2)(2012-12#10)(2012-2#17)(2012-3#10)(2013-1#17)(2013-7#3)(2013-8#11)
with acyclovir##3##2##(2005-12#1)(2006-2#1)(2008-5#1)
with acyl chains##3##3##(2006-10#2)(2013-1#1)
with acyl##4##2##(1996-2#1)(2006-10#2)(2013-1#1)
with adalimumab is##2##3##(2012-12#2)
with adalimumab##4##2##(2012-12#4)
with adaptive optics##3##3##(2007-11#2)(2008-3#1)
with adaptive parameters##2##3##(2008-2#2)
with adaptive##13##2##(1997-3#1)(2006-1#1)(2007-11#2)(2007-12#1)(2008-2#4)(2008-3#2)(2008-8#1)(2012-2#1)
with added##13##2##(1990-5#1)(1991-1#1)(1993-8#1)(1994-8#1)(1996-5#1)(1997-3#1)(2007-11#2)(2008-10#1)(2008-11#1)(2010-4#2)(2013-1#1)
with addiction##3##2##(2008-8#1)(2012-2#1)(2013-8#1)
with addictive disorders##3##3##(2005-6#1)(2006-11#1)(2009-6#1)
with addition of a##2##4##(1995-3#1)(2004-4#1)
with addition of##15##3##(1991-8#1)(1995-3#1)(2004-4#1)(2005-10#1)(2005-11#1)(2006-4#1)(2008-10#4)(2008-11#2)(2009-8#1)(2010-3#1)(2011-1#1)
with additional information##2##3##(2007-2#1)(2007-5#1)
with additional psychiatric##2##3##(2007-4#1)(2009-7#1)
with additional risk factors##2##4##(1995-9#1)(2008-3#1)
with additional support needs##2##4##(2012-12#2)
with additional##83##2##(1990-3#1)(1990-8#1)(1991-4#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-9#1)(1996-3#1)(1996-5#1)(1997-5#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#2)(2007-1#2)(2007-10#2)(2007-11#1)(2007-2#1)(2007-3#2)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#4)(2009-7#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#5)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#1)
with additions of##2##3##(1997-5#1)(2012-1#1)
with additive and##2##3##(2008-10#1)(2009-4#1)
with additive effects##3##3##(2008-10#3)
with additive##8##2##(2008-10#4)(2008-2#2)(2008-3#1)(2009-4#1)
with adenine##2##2##(1995-1#1)(1996-11#1)
with adenocarcinoma##3##2##(1995-3#1)(1995-9#1)(2007-3#1)
with adenocarcinomas##2##2##(1990-5#1)(1993-9#1)
with adenoma##3##2##(1991-3#1)(1992-5#1)(1992-7#1)
with adenoregulin##2##2##(1994-5#2)
with adenosine to##2##3##(1990-6#1)(2008-5#1)
with adenosine##10##2##(1990-12#1)(1990-6#1)(1994-11#1)(1997-6#1)(2005-8#1)(2008-10#2)(2008-5#3)
with adenoviral vectors##2##3##(2007-11#1)(2008-6#1)
with adenovirus##3##2##(2007-12#1)(2008-11#1)(2008-8#1)
with adenylate##2##2##(1990-10#1)(1991-7#1)
with adequate margins##2##3##(1992-9#1)(2013-8#1)
with adequate##38##2##(1990-12#1)(1990-2#1)(1990-9#1)(1992-9#2)(1993-2#1)(1993-6#1)(1994-11#1)(1996-4#1)(1997-3#1)(2005-8#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-7#3)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
with adherence to treatment##3##4##(2012-1#1)(2012-12#1)(2012-3#1)
with adherence to##5##3##(2010-8#1)(2012-1#1)(2012-12#2)(2012-3#1)
with adherence##10##2##(1996-3#1)(2008-9#1)(2010-11#1)(2010-8#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
with adhesion to##2##3##(1994-6#1)(2007-8#1)
with adhesion##5##2##(1993-6#1)(1994-6#1)(2007-8#2)(2008-4#1)
with adhesive##5##2##(1992-11#1)(1994-3#1)(2006-6#2)(2009-8#1)
with adipose-derived stem cells##2##4##(2012-3#1)(2013-8#1)
with adiposity##3##2##(2006-9#2)(2013-8#1)
with adjacent G##2##3##(1991-7#2)
with adjacent cells##2##3##(2008-3#1)(2009-10#1)
with adjacent skin invasion##2##4##(2009-5#2)
with adjacent##16##2##(1991-7#2)(1992-3#1)(1993-1#1)(1993-9#1)(1994-12#1)(2006-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#2)(2009-5#2)(2010-6#1)(2011-2#1)
with adjunctive##2##2##(1996-3#1)(2010-12#1)
with adjustable##6##2##(1995-5#1)(2007-12#2)(2007-8#1)(2008-2#1)(2008-3#1)
with adjustment for##2##3##(2007-10#1)(2011-1#1)
with adjustment##4##2##(2007-10#1)(2007-9#1)(2010-5#1)(2011-1#1)
with adjustments for##3##3##(2008-10#1)(2009-10#1)(2012-3#1)
with adjuvant chemotherapy##3##3##(2008-7#1)(2010-3#2)
with adjuvant radiotherapy##4##3##(1994-4#1)(2008-6#1)(2011-1#1)(2013-1#1)
with adjuvant##18##2##(1990-12#1)(1991-4#1)(1991-8#1)(1992-2#1)(1992-7#1)(1994-4#1)(1997-4#1)(2004-2#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-3#2)(2011-1#1)(2012-2#1)(2013-1#1)
with adjuvants##2##2##(2006-9#1)(2007-11#1)
with administration of the##2##4##(1995-5#1)(2011-2#1)
with administration of##7##3##(1995-3#1)(1995-5#1)(1996-1#1)(2007-2#1)(2010-3#1)(2011-2#1)(2012-3#1)
with administration##9##2##(1991-10#1)(1991-5#1)(1995-3#1)(1995-5#1)(1996-1#1)(2007-2#1)(2010-3#1)(2011-2#1)(2012-3#1)
with administrators##2##2##(1996-12#1)(2010-2#1)
with adolescent girls##2##3##(2007-12#2)
with adolescent##12##2##(1991-2#1)(1994-12#1)(2006-7#1)(2007-12#2)(2007-2#1)(2007-6#1)(2008-6#1)(2008-7#1)(2010-2#2)(2013-7#1)
with adolescents##6##2##(2005-6#1)(2006-4#1)(2008-11#1)(2008-7#2)(2008-9#1)
with adrenal##3##2##(1990-3#1)(1991-10#1)(2006-9#1)
with adrenaline##5##2##(1993-4#1)(1993-7#1)(2013-1#3)
with adrenocorticotropic hormone##2##3##(1996-8#1)(2011-2#1)
with adriamycin##3##2##(1993-12#1)(2008-7#1)(2010-3#1)
with adsorbed##5##2##(2005-11#2)(2008-11#1)(2010-9#1)(2013-8#1)
with adsorption##2##2##(2004-9#1)(2008-10#1)
with adsorptive##4##2##(2008-10#4)
with adult learning##2##3##(1995-2#1)(1995-3#1)
with adult onset Still's disease##3##5##(2006-10#3)
with adult onset##5##3##(1992-8#1)(1997-3#1)(2006-10#3)
with adult rats##2##3##(1994-6#1)(1995-1#1)
with adult##28##2##(1991-1#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-4#1)(1997-3#1)(2004-11#1)(2006-10#3)(2006-11#1)(2006-7#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-4#1)(2011-2#1)(2012-12#1)
with adult-onset Still's disease##2##4##(2006-10#2)
with adult-onset##7##2##(1991-1#1)(2006-10#3)(2008-7#1)(2009-4#1)(2012-1#1)
with adulterated gasoline##2##3##(2007-10#2)
with adults and##2##3##(2009-7#1)(2012-12#1)
with adults##6##2##(1992-11#1)(2007-11#1)(2008-12#1)(2009-7#1)(2012-12#2)
with advanced EOC##2##3##(2010-12#2)
with advanced GIST##2##3##(2008-6#2)
with advanced HIV disease##2##4##(2007-11#1)(2013-1#1)
with advanced HIV##3##3##(2007-11#2)(2013-1#1)
with advanced age##2##3##(1990-6#1)(2007-11#1)
with advanced and##4##3##(2004-1#2)(2006-2#1)(2013-1#1)
with advanced breast cancer##16##4##(1990-10#1)(1990-6#1)(1991-4#1)(1991-6#2)(1991-8#1)(1992-2#1)(1993-12#1)(1994-8#1)(1997-7#1)(2004-1#2)(2005-10#1)(2006-11#1)(2006-4#1)(2008-7#1)
with advanced breast##17##3##(1990-10#1)(1990-6#1)(1991-4#1)(1991-6#2)(1991-8#1)(1992-2#1)(1993-12#1)(1994-8#1)(1997-7#1)(2004-1#2)(2005-10#1)(2006-11#1)(2006-4#1)(2008-7#1)(2011-2#1)
with advanced cancer and##3##4##(2006-12#1)(2007-11#1)(2009-4#1)
with advanced cancer##11##3##(1992-5#1)(2006-12#1)(2007-11#2)(2007-6#1)(2008-7#3)(2009-4#1)(2012-3#2)
with advanced disease and##2##4##(2010-2#1)(2011-1#1)
with advanced disease at##2##4##(2012-11#1)(2012-12#1)
with advanced disease##16##3##(1991-8#1)(2005-12#1)(2006-10#1)(2006-9#1)(2007-11#2)(2008-3#1)(2008-9#1)(2010-12#2)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-11#1)(2012-12#1)
with advanced heart failure##2##4##(2007-1#1)(2009-10#1)
with advanced heart##3##3##(2007-1#1)(2009-10#1)(2011-12#1)
with advanced immunosuppression##2##3##(2006-10#2)
with advanced lung cancer##2##4##(2005-9#1)(2010-2#1)
with advanced lung##3##3##(2005-9#1)(2008-5#1)(2010-2#1)
with advanced measurable##2##3##(1990-8#1)(1991-4#1)
with advanced neoplastic disease##2##4##(1993-10#1)(2007-11#1)
with advanced ovarian cancer##4##4##(1991-8#2)(1992-2#2)
with advanced pulmonary fibrosis##2##4##(2006-10#2)
with advanced pulmonary##3##3##(2006-10#2)(2008-9#1)
with advanced solid tumors##3##4##(1992-10#1)(2006-6#2)
with advanced stage disease##3##4##(2006-10#1)(2010-12#1)(2012-12#1)
with advanced stage##8##3##(1991-10#1)(1991-12#1)(2006-10#1)(2008-4#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-12#1)
with advanced stages of##3##4##(1992-9#1)(1997-6#1)(2011-2#1)
with advanced##202##2##(1990-1#1)(1990-10#4)(1990-12#1)(1990-2#2)(1990-6#2)(1990-8#3)(1991-1#1)(1991-10#1)(1991-12#2)(1991-4#2)(1991-6#3)(1991-8#4)(1992-10#1)(1992-2#3)(1992-5#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-4#1)(1994-6#2)(1994-8#1)(1995-3#2)(1995-8#1)(1995-9#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-1#5)(2005-10#3)(2005-12#1)(2005-7#1)(2005-8#3)(2005-9#2)(2006-10#12)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#4)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#10)(2007-12#1)(2007-6#2)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#12)(2008-7#5)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#2)(2009-2#1)(2009-4#2)(2009-8#4)(2010-1#1)(2010-10#1)(2010-12#6)(2010-2#3)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#2)(2011-12#3)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#5)(2013-1#5)(2013-7#3)
with advanced-stage##11##2##(2008-1#1)(2008-7#3)(2010-8#2)(2011-2#1)(2013-8#4)
with advances in##7##3##(2005-9#1)(2006-10#1)(2008-3#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)
with advances##8##2##(2005-9#1)(2006-10#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-12#1)
with advancing age and##2##4##(1993-3#1)(1996-5#1)
with advancing age##16##3##(1990-3#1)(1993-11#1)(1993-3#1)(1994-5#1)(1994-6#1)(1995-10#1)(1996-5#1)(2006-10#1)(2006-9#1)(2007-9#1)(2008-7#2)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
with advancing##19##2##(1990-3#1)(1993-11#1)(1993-3#1)(1994-5#1)(1994-6#1)(1995-10#1)(1996-5#1)(2006-10#2)(2006-9#1)(2007-9#1)(2008-7#2)(2008-9#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
with advantages##2##2##(2006-11#1)(2008-9#1)
with adverse drug reactions##2##4##(2008-11#1)(2013-8#1)
with adverse effects##7##3##(2004-12#1)(2006-8#1)(2008-7#1)(2008-9#1)(2013-1#2)(2013-8#1)
with adverse outcomes##7##3##(1994-1#1)(2004-10#1)(2007-12#1)(2012-2#3)(2013-1#1)
with adverse##34##2##(1994-1#1)(1994-9#1)(1995-5#1)(2004-10#1)(2004-12#1)(2006-2#1)(2006-8#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-4#1)(2009-5#2)(2011-2#2)(2012-2#4)(2013-1#4)(2013-8#2)
with aerobic##5##2##(1992-9#3)(2007-7#1)(2011-1#1)
with aerosol##2##2##(2008-3#1)(2008-7#1)
with aerosolized##2##2##(2005-10#1)(2007-12#1)
with aerosols##4##2##(1997-1#1)(2006-10#1)(2008-10#1)(2008-3#1)
with affected##3##2##(2007-11#1)(2008-4#1)(2011-1#1)
with affection of##3##3##(1994-11#1)(2006-6#2)
with affiliation##2##2##(1995-1#1)(2008-10#1)
with affinities similar to##2##4##(1996-8#1)(2009-12#1)
with affinities##8##2##(1995-11#1)(1995-7#3)(1996-8#1)(1997-1#1)(2008-7#1)(2009-12#1)
with affinity constants of##2##4##(2008-8#2)
with affinity constants##3##3##(1994-8#1)(2008-8#2)
with affinity for dopamine##2##4##(1993-8#2)
with affinity for the##2##4##(1993-8#1)(2008-10#1)
with affinity for##9##3##(1991-2#1)(1993-8#3)(1995-2#1)(1996-12#1)(2008-10#2)(2008-11#1)
with affinity##16##2##(1991-2#1)(1993-8#3)(1994-8#1)(1995-2#1)(1996-12#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-8#2)(2008-9#1)
with affinity-purified##2##2##(1990-6#1)(1997-4#1)
with aflatoxin content##2##3##(2008-10#2)
with aflatoxin##4##2##(2008-10#4)
with aflatoxins##2##2##(2008-10#1)(2013-8#1)
with agar##2##2##(2008-10#1)(2012-2#1)
with agarose gel##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
with age (P &lt##2##4##(1993-2#1)(2010-12#1)
with age (P##3##3##(1991-9#1)(1993-2#1)(2010-12#1)
with age (p##2##3##(1995-11#1)(2013-7#1)
with age (r = 0##2##5##(2010-10#1)(2013-1#1)
with age (r =##3##4##(2007-10#1)(2010-10#1)(2013-1#1)
with age after##3##3##(1990-12#1)(2007-7#1)(2008-4#1)
with age and with##2##4##(1993-11#1)(2009-9#1)
with age and##26##3##(1991-4#1)(1992-12#1)(1992-9#1)(1993-11#1)(1994-6#1)(1995-1#1)(1995-3#1)(2005-11#1)(2006-11#1)(2006-2#1)(2006-7#1)(2008-1#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-9#2)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
with age as##2##3##(1995-8#1)(2010-4#1)
with age at##5##3##(1991-9#1)(1992-9#1)(1997-3#1)(2009-12#1)(2011-2#1)
with age for##5##3##(1991-10#1)(2008-12#1)(2008-3#1)(2011-2#2)
with age from##4##3##(1992-3#1)(2007-7#1)(2010-8#1)(2012-3#1)
with age in a##2##4##(1994-11#1)(1997-6#1)
with age in both sexes##3##5##(1995-12#1)(2008-4#1)(2008-7#1)
with age in both##7##4##(1991-3#1)(1995-12#1)(2007-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-5#1)
with age in brain##2##4##(1990-3#2)
with age in the##5##4##(1990-11#1)(1990-4#1)(1997-5#1)(2008-7#1)(2011-1#1)
with age in##30##3##(1990-11#1)(1990-3#4)(1990-4#1)(1990-8#1)(1991-3#1)(1992-2#1)(1994-11#1)(1995-12#1)(1995-8#1)(1995-9#1)(1997-5#1)(1997-6#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#2)(2009-5#2)(2011-1#1)
with age of the##3##4##(1995-6#1)(1997-8#1)(2007-12#1)
with age of##8##3##(1995-6#1)(1997-1#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)
with age range of##2##4##(2009-5#2)
with age range##3##3##(2008-7#1)(2009-5#2)
with age was##3##3##(1990-2#1)(1995-12#1)(2008-8#1)
with age whereas##2##3##(1996-3#1)(2008-2#1)
with age while##2##3##(1997-7#1)(2012-3#1)
with age##342##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#9)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-10#7)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-5#2)(1993-9#4)(1994-10#2)(1994-11#2)(1994-5#3)(1994-6#1)(1994-8#1)(1995-1#2)(1995-11#3)(1995-12#4)(1995-3#3)(1995-4#2)(1995-6#6)(1995-7#1)(1995-8#4)(1995-9#5)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-5#5)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-3#1)(1997-5#3)(1997-6#2)(1997-7#2)(1997-8#1)(2004-1#1)(2004-2#1)(2005-10#2)(2005-11#1)(2006-10#2)(2006-11#1)(2006-2#5)(2006-4#1)(2006-6#1)(2006-7#2)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#3)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#4)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#6)(2008-5#16)(2008-6#1)(2008-7#21)(2008-8#4)(2008-9#6)(2009-12#2)(2009-2#3)(2009-4#1)(2009-5#5)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#4)(2010-5#1)(2010-8#3)(2011-1#11)(2011-11#1)(2011-12#4)(2011-2#13)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#4)(2013-1#9)(2013-3#2)(2013-7#3)(2013-8#4)
with age- and##2##3##(2011-2#2)
with age-matched controls##6##3##(1992-8#1)(1994-5#1)(1995-6#1)(1996-6#1)(2007-10#1)(2013-8#1)
with age-matched##9##2##(1992-8#2)(1994-5#1)(1995-6#1)(1996-6#1)(2006-10#1)(2007-10#1)(2012-12#1)(2013-8#1)
with age-related macular degeneration (ARMD)##2##5##(2011-1#1)(2011-2#1)
with age-related macular degeneration##4##4##(2011-1#2)(2011-2#2)
with age-related macular##6##3##(2011-1#2)(2011-2#3)(2013-8#1)
with age-related##7##2##(2011-1#2)(2011-2#3)(2012-1#1)(2013-8#1)
with aged##4##2##(1990-11#1)(1990-5#1)(1996-6#1)(2008-10#1)
with ageing##12##2##(1990-8#1)(1991-5#1)(1996-5#1)(1997-7#2)(2006-12#1)(2006-8#1)(2008-11#1)(2008-5#2)(2010-4#2)
with agenesis of##4##3##(2006-1#1)(2008-7#3)
with agents such as##2##4##(2005-10#1)(2008-6#1)
with agents that##5##3##(1990-6#1)(1992-8#1)(1995-8#1)(2005-7#1)(2008-3#1)
with agents##9##2##(1990-6#1)(1992-8#1)(1995-8#1)(2005-10#1)(2005-7#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-6#1)
with ages between 20 and##2##5##(2007-10#1)(2011-2#1)
with ages ranging from##3##4##(1992-3#1)(2007-3#1)(2008-10#1)
with ages##7##2##(1992-3#1)(2007-10#1)(2007-3#1)(2008-10#1)(2010-9#1)(2011-1#1)(2011-2#1)
with aggregated##2##2##(2006-12#1)(2007-10#1)
with aggression##2##2##(2008-12#1)(2013-1#1)
with aggressive cancer##2##3##(2007-11#2)
with aggressive management##3##3##(2011-2#1)(2013-1#2)
with aggressive##17##2##(1992-6#1)(2006-10#1)(2006-6#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-6#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
with aggressiveness##2##2##(2008-10#1)(2010-7#1)
with aging and##5##3##(1992-12#1)(1993-12#1)(1995-1#1)(2008-6#1)(2012-3#1)
with aging are##2##3##(2011-2#1)(2013-7#1)
with aging in the##2##4##(1996-7#1)(1997-5#1)
with aging in##8##3##(1992-12#1)(1993-2#1)(1995-12#1)(1995-9#1)(1996-7#1)(1997-5#1)(2007-12#1)(2008-7#1)
with aging were##2##3##(1995-9#1)(2008-7#1)
with aging##68##2##(1990-12#1)(1990-4#1)(1991-1#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-8#1)(1993-1#3)(1993-12#1)(1993-2#2)(1994-6#1)(1994-8#1)(1995-1#5)(1995-12#1)(1995-9#9)(1996-7#2)(1996-9#1)(1997-5#2)(2005-12#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#7)(2009-12#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-7#2)
with agitation##3##2##(2008-11#1)(2008-6#1)(2011-2#1)
with agonistic##2##2##(1992-9#1)(1993-4#1)
with agoraphobia##6##2##(1995-1#3)(2005-7#2)(2008-2#1)
with agranulocytosis##2##2##(2007-11#1)(2012-12#1)
with agraphia##2##2##(2008-9#1)(2009-7#1)
with air and##2##3##(2008-10#1)(2008-4#1)
with air##25##2##(1991-12#2)(1993-2#1)(1997-6#1)(1997-8#1)(2005-11#1)(2007-10#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2010-12#1)(2013-1#1)(2013-8#2)
with airbag##3##2##(2006-11#3)
with airbags##2##2##(2006-11#1)(2007-4#1)
with airborne##2##2##(2008-3#1)(2009-6#1)
with airway obstruction##2##3##(2007-8#1)(2012-12#1)
with airway##8##2##(1997-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-2#1)(2010-10#1)(2010-5#1)(2012-12#1)
with alanine##10##2##(1991-2#1)(1994-11#4)(1994-8#1)(1994-9#2)(1995-6#1)(2009-11#1)
with alanine) was##2##3##(1993-6#1)(1994-9#1)
with alanines substituted at positions 128##2##6##(1991-2#2)
with alanines substituted at##4##4##(1991-2#2)(1995-2#2)
with alanines##6##2##(1991-2#2)(1992-6#1)(1995-2#3)
with albendazole##3##2##(2009-10#1)(2010-12#1)(2011-2#1)
with albumin and##2##3##(1995-2#1)(2011-1#1)
with albumin for##2##3##(1990-6#1)(2008-7#1)
with albumin##10##2##(1990-2#1)(1990-6#1)(1992-6#1)(1993-9#1)(1995-2#1)(2004-11#1)(2008-1#1)(2008-7#2)(2011-1#1)
with alcalase##2##2##(2010-2#2)
with alcohol abuse##2##3##(1994-2#1)(2008-9#1)
with alcohol and##5##3##(1990-5#1)(1992-12#1)(2008-4#1)(2008-9#1)(2009-5#1)
with alcohol consumption##2##3##(1993-11#1)(1994-2#1)
with alcohol dependence##5##3##(2008-10#1)(2008-2#3)(2010-1#1)
with alcohol##32##2##(1990-5#1)(1991-5#1)(1991-9#2)(1992-12#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-2#3)(1997-8#3)(2005-10#1)(2006-10#1)(2008-10#1)(2008-2#3)(2008-4#1)(2008-6#1)(2008-9#2)(2009-5#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)
with alcohol-related##3##2##(1990-5#2)(1992-11#1)
with alcoholic cirrhosis##5##3##(1990-4#3)(1993-12#1)(2008-5#1)
with alcoholic fatty liver##2##4##(1990-4#2)
with alcoholic liver disease##7##4##(1990-4#1)(1992-4#1)(1993-12#1)(1994-7#2)(2008-8#1)(2010-12#1)
with alcoholic liver##9##3##(1990-4#3)(1992-4#1)(1993-12#1)(1994-7#2)(2008-8#1)(2010-12#1)
with alcoholic##19##2##(1990-4#8)(1992-4#1)(1993-12#2)(1994-7#2)(2006-9#2)(2007-2#1)(2008-5#1)(2008-8#1)(2010-12#1)
with alcoholism##3##2##(1997-5#1)(2008-7#1)(2012-12#1)
with alcohols##2##2##(2007-10#1)(2008-5#1)
with aldehyde reductase##2##3##(1993-5#1)(1995-1#1)
with aldehydes##4##2##(1996-5#2)(2008-7#2)
with aldosterone##3##2##(1992-12#1)(1993-11#1)(1995-10#1)
with alendronate##5##2##(2006-6#1)(2008-11#3)(2008-8#1)
with alfalfa##3##2##(2007-2#1)(2008-10#1)(2008-11#1)
with alignment##2##2##(2008-3#1)(2008-7#1)
with aliphatic##2##2##(1992-12#1)(2007-8#1)
with alkali##4##2##(2004-8#1)(2008-10#2)(2008-5#1)
with alkaline earth and##2##4##(2008-10#1)(2009-7#1)
with alkaline earth##3##3##(2008-10#2)(2009-7#1)
with alkaline phosphatase##9##3##(1991-2#1)(1991-5#1)(1992-8#1)(1994-12#2)(1996-6#1)(2008-10#2)(2008-2#1)
with alkaline sodium##2##3##(2008-10#2)
with alkaline##24##2##(1991-2#1)(1991-3#1)(1991-5#1)(1992-8#1)(1993-6#1)(1994-12#2)(1996-6#1)(1997-6#1)(2007-1#1)(2007-8#1)(2008-10#10)(2008-2#1)(2008-9#1)(2009-7#1)
with alkyl bromides##3##3##(2007-10#1)(2008-5#1)(2008-8#1)
with alkyl##6##2##(1990-11#1)(2005-10#1)(2007-10#1)(2008-4#1)(2008-5#1)(2008-8#1)
with alkylating agents##2##3##(1993-9#1)(2008-11#1)
with alkylating##3##2##(1993-9#1)(2008-11#2)
with alkynes##2##2##(2010-6#1)(2012-2#1)
with all clients and##2##4##(2012-3#2)
with all clients##3##3##(2012-3#3)
with all four##4##3##(1993-2#1)(1995-5#1)(2008-10#1)(2013-7#1)
with all of the##4##4##(1992-3#1)(1995-2#1)(1995-5#1)(1996-6#1)
with all of these##2##4##(2005-11#1)(2008-8#1)
with all of##8##3##(1992-3#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-6#1)(2005-11#1)(2008-8#2)
with all other##16##3##(1995-6#1)(1996-10#1)(1996-3#1)(2007-2#1)(2008-10#3)(2009-1#1)(2009-2#1)(2009-4#3)(2009-8#2)(2011-2#1)(2013-8#1)
with all possible##6##3##(1994-12#1)(1995-5#1)(2007-7#1)(2008-10#1)(2008-4#1)(2009-9#1)
with all the other##2##4##(2008-12#1)(2013-1#1)
with all the##21##3##(1990-12#1)(1990-8#1)(1991-4#1)(1996-9#1)(2006-1#1)(2006-2#1)(2006-8#2)(2006-9#1)(2007-12#1)(2007-3#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#2)
with all three##11##3##(1990-3#1)(1992-7#1)(1995-11#1)(1995-12#1)(2008-10#4)(2008-5#1)(2008-8#1)(2009-10#1)
with all types of##5##4##(1990-12#1)(1992-3#1)(2007-7#1)(2012-3#1)(2013-7#1)
with all##184##2##(1990-12#3)(1990-3#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-2#1)(1992-3#3)(1992-6#1)(1992-7#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-5#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#3)(1995-11#3)(1995-12#2)(1995-2#1)(1995-5#4)(1995-6#2)(1995-9#1)(1996-10#1)(1996-3#2)(1996-6#1)(1996-8#2)(1996-9#1)(1997-2#2)(1997-5#1)(1997-7#1)(2004-3#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-10#2)(2007-12#4)(2007-2#1)(2007-3#3)(2007-7#4)(2007-8#2)(2008-10#17)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#3)(2009-1#1)(2009-10#2)(2009-2#3)(2009-4#3)(2009-6#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-5#2)(2010-6#3)(2010-8#1)(2011-1#3)(2011-2#4)(2012-1#3)(2012-11#2)(2012-2#2)(2012-3#4)(2013-1#6)(2013-7#3)(2013-8#3)
with all-trans-retinoic acid##2##3##(1995-1#1)(2008-4#1)
with allele##3##2##(1993-3#1)(2008-10#1)(2009-4#1)
with allele-specific oligonucleotides##2##3##(1990-5#1)(1991-1#1)
with allergic rhinitis and##2##4##(2007-2#1)(2013-1#1)
with allergic rhinitis in##5##4##(2007-2#2)(2012-2#2)(2013-1#1)
with allergic rhinitis##15##3##(1992-8#1)(2007-2#5)(2008-4#1)(2011-1#1)(2012-12#2)(2012-2#2)(2013-1#3)
with allergic##26##2##(1992-8#1)(1996-2#1)(2006-10#4)(2007-11#1)(2007-2#7)(2007-7#1)(2008-4#1)(2009-6#1)(2010-5#1)(2011-1#1)(2012-12#2)(2012-2#2)(2013-1#3)
with allergy##3##2##(2006-10#1)(2007-2#1)(2012-1#1)
with allodynia##2##2##(1996-6#1)(2008-9#1)
with allogeneic major histocompatibility complex class I-matched##2##7##(2006-7#2)
with allogeneic##5##2##(1994-9#1)(2006-7#2)(2008-9#1)(2012-3#1)
with allograft##8##2##(1995-2#3)(2008-7#1)(2009-10#1)(2009-3#1)(2010-12#1)(2012-3#1)
with alloplastic##2##2##(2007-12#2)
with allopurinol##2##2##(1996-8#1)(2006-10#1)
with allosteric##4##2##(1990-8#1)(2006-10#1)(2009-12#1)(2012-2#1)
with almitrine##2##2##(2006-10#2)
with almost 100%##2##3##(2008-2#1)(2008-4#1)
with almost 50% of the##2##5##(1996-9#1)(2007-7#1)
with almost all##2##3##(1992-12#1)(2011-1#1)
with almost equal affinity##2##4##(1990-4#1)(1997-2#1)
with almost equal effectiveness##2##4##(1996-5#2)
with almost equal##4##3##(1990-4#1)(1996-5#2)(1997-2#1)
with almost half##2##3##(2006-10#1)(2007-11#1)
with almost identical##2##3##(1991-5#1)(2008-10#1)
with almost no##5##3##(1990-11#1)(1994-12#1)(2008-2#1)(2008-5#1)(2012-3#1)
with almost normal##3##3##(1992-11#1)(1995-11#1)(2010-12#1)
with almost##30##2##(1990-11#1)(1990-4#1)(1991-11#1)(1991-5#1)(1992-11#1)(1992-12#1)(1994-12#1)(1995-11#1)(1996-3#1)(1996-5#2)(1996-9#1)(1997-2#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#3)(2008-4#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
with alopecia areata were##3##4##(2007-7#2)(2007-8#1)
with alopecia areata##6##3##(2007-7#3)(2007-8#3)
with alpha 1-antitrypsin##2##3##(1990-12#1)(1995-5#1)
with alpha and##2##3##(1993-3#1)(2010-2#1)
with alpha##27##2##(1990-12#4)(1990-8#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-3#3)(1994-3#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-7#2)(2007-10#1)(2007-2#1)(2007-7#1)(2010-2#1)(2011-2#1)
with alpha-##3##2##(1992-8#1)(2004-12#1)(2008-10#1)
with alpha-(2-benzimidazolyl)-alpha'##2##2##(2008-10#2)
with alpha-actinin##4##2##(1990-11#2)(1993-8#1)(1997-6#1)
with alpha-amylase##2##2##(2008-6#1)(2013-1#1)
with alpha-chymotrypsin and##2##3##(1993-11#1)(1996-12#1)
with alpha-chymotrypsin##3##2##(1993-11#1)(1996-12#1)(1996-5#1)
with alpha-difluoromethylornithine##2##2##(1992-9#1)(1994-8#1)
with alpha-interferon##2##2##(1996-9#1)(2008-7#1)
with alpha-ketoglutarate##2##2##(1990-4#2)
with alpha-lytic protease##5##3##(1991-2#1)(1992-12#2)(1993-11#2)
with alpha-subunits##3##2##(1990-4#1)(1991-4#2)
with alpha-tocopherol##7##2##(1991-12#1)(1994-9#1)(1995-5#1)(1997-8#2)(2006-10#1)(2008-10#1)
with already established##2##3##(1992-5#1)(2008-11#1)
with already##3##2##(1992-5#1)(1994-1#1)(2008-11#1)
with alteplase##3##2##(1997-5#1)(2007-11#2)
with alteration of the host hyphae prior to contact with the antagonist##2##12##(2008-10#2)
with alteration of the##3##4##(1993-10#1)(2008-10#2)
with alteration##4##2##(1993-10#1)(2008-10#2)(2008-11#1)
with alterations in the expression of##3##6##(1994-2#1)(2007-5#1)(2013-8#1)
with alterations in the##6##4##(1993-12#1)(1994-2#1)(2006-4#1)(2006-8#1)(2007-5#1)(2013-8#1)
with alterations in##15##3##(1991-10#1)(1993-12#2)(1994-2#1)(1995-11#2)(1996-5#1)(1996-8#1)(2006-4#1)(2006-8#1)(2007-5#1)(2008-1#1)(2008-4#1)(2012-1#1)(2013-8#1)
with alterations##19##2##(1991-10#1)(1992-3#1)(1993-12#2)(1994-2#1)(1995-11#2)(1995-12#1)(1995-6#1)(1996-5#1)(1996-8#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-4#1)(2012-1#1)(2013-8#1)
with altered expression##2##3##(2008-7#1)(2009-9#1)
with altered mental status##2##4##(2004-2#1)(2006-10#1)
with altered##39##2##(1990-1#1)(1991-10#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-2#1)(1993-3#1)(1994-3#1)(1995-11#1)(1995-8#1)(1996-11#1)(1997-5#1)(2003-11#1)(2004-2#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-9#2)(2010-11#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
with alternate methods##2##3##(2006-9#1)(2008-8#1)
with alternate##5##2##(2006-9#1)(2007-11#1)(2007-12#2)(2008-8#1)
with alternating layers of##2##4##(2008-10#1)(2008-2#1)
with alternating##7##2##(1990-2#1)(1991-5#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-5#1)
with alternative splicing##2##3##(1990-2#1)(1993-2#1)
with alternative##17##2##(1990-2#2)(1993-10#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1995-2#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-4#1)(2012-2#1)(2013-7#1)
with altitude##8##2##(2006-2#2)(2008-3#3)(2008-5#2)(2008-8#1)
with alumina##3##2##(2005-11#2)(2008-10#1)
with aluminium##9##2##(1992-1#1)(1992-2#1)(1994-10#1)(2005-10#1)(2008-10#4)(2010-7#1)
with aluminon##2##2##(2008-10#2)
with aluminum##5##2##(1991-5#1)(1992-4#1)(2005-11#1)(2008-10#1)(2010-12#1)
with alveolar##2##2##(1990-6#1)(2009-8#1)
with amalgam##2##2##(1993-9#1)(1996-2#1)
with ambiguous genitalia##5##3##(2007-7#1)(2008-10#4)
with ambiguous##11##2##(1993-6#1)(1997-8#1)(2007-7#1)(2008-10#4)(2008-11#1)(2010-3#1)(2011-2#2)
with amblyopia##2##2##(1992-7#1)(2011-1#1)
with ambulatory##4##2##(1991-10#1)(1991-9#1)(1996-3#1)(2008-7#1)
with amiloride##2##2##(1990-9#1)(1994-6#1)
with amine##3##2##(2007-8#1)(2008-10#1)(2008-3#1)
with amines and##2##3##(1995-3#1)(2007-11#1)
with amines to form##2##4##(2005-11#1)(2008-10#1)
with amines##5##2##(1995-3#1)(2005-11#1)(2007-11#1)(2008-10#2)
with amino acid sequences of##2##5##(1994-11#1)(2008-10#1)
with amino acid sequences##3##4##(1994-11#1)(1995-9#1)(2008-10#1)
with amino acid substitutions##2##4##(1995-3#1)(1995-5#1)
with amino acid##12##3##(1992-11#1)(1994-11#1)(1994-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1997-7#1)(2007-7#1)(2008-10#1)(2009-9#1)(2010-11#1)(2011-2#1)
with amino acids##6##3##(1992-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-9#1)
with amino##21##2##(1992-11#1)(1992-6#1)(1994-11#1)(1994-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-5#1)(2009-9#2)(2010-11#1)(2010-6#1)(2011-2#1)
with aminoglutethimide##2##2##(1993-1#1)(2007-11#1)
with aminooxyacetic acid##2##3##(1991-2#1)(1992-9#1)
with aminopenicillins##2##2##(1995-3#1)(1996-3#1)
with amiodarone##5##2##(1990-5#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-4#1)
with amlodipine##4##2##(2008-3#1)(2009-9#1)(2012-12#1)(2013-7#1)
with ammonia and##4##3##(1994-2#1)(2008-10#2)(2009-8#1)
with ammonia as##2##3##(2005-11#1)(2008-10#1)
with ammonia##10##2##(1994-2#1)(2005-11#1)(2008-10#7)(2009-8#1)
with ammonium and##2##3##(2008-10#1)(2010-4#1)
with ammonium chloride##2##3##(2008-10#1)(2008-6#1)
with ammonium diethyl dithiophosphate##2##4##(2008-10#2)
with ammonium molybdate##2##3##(2008-10#2)
with ammonium nitrate##2##3##(1991-12#1)(2008-5#1)
with ammonium pyrrolidine dithiocarbamate (APDC) and##3##6##(2008-10#3)
with ammonium pyrrolidine dithiocarbamate (APDC)##7##5##(2007-8#1)(2008-10#6)
with ammonium pyrrolidine dithiocarbamate##8##4##(2007-8#1)(2008-10#7)
with ammonium thiocyanate solution##2##4##(2008-10#2)
with ammonium##31##2##(1990-11#1)(1990-6#1)(1991-12#1)(1991-7#1)(1992-8#1)(1997-8#1)(2005-4#1)(2007-8#1)(2008-10#20)(2008-5#1)(2008-6#1)(2010-4#1)
with amniotic membrane##2##3##(2011-1#2)
with amoxycillin##2##2##(1991-3#1)(1997-3#1)
with amperometric detection at a##2##5##(2008-10#2)
with amperometric detection at anodized##2##5##(2008-10#2)
with amperometric detection at##6##4##(2008-10#6)
with amperometric detection for##2##4##(1990-11#1)(2008-10#1)
with amperometric detection using##3##4##(2008-10#3)
with amperometric detection was##3##4##(1997-3#1)(2008-10#2)
with amperometric detection were##2##4##(1996-8#1)(2008-10#1)
with amperometric detection##30##3##(1990-11#1)(1990-6#1)(1996-8#1)(1997-3#2)(2008-10#25)
with amphetamine##7##2##(1993-11#1)(1993-6#1)(1996-10#1)(1996-6#1)(1997-7#1)(2005-8#1)(2008-4#1)
with amphotericin B and fluconazole##2##5##(2006-4#1)(2007-8#1)
with amphotericin B and##4##4##(2006-10#1)(2006-4#1)(2007-8#1)(2012-2#1)
with amphotericin B##7##3##(1990-11#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-12#1)(2012-2#1)
with ampicillin##3##2##(2006-10#1)(2009-12#2)
with amplification##2##2##(2006-8#1)(2008-10#1)
with amplified fragment length polymorphism (AFLP) markers##2##7##(2008-10#2)
with amplified fragment length polymorphism (AFLP)##4##6##(2008-10#4)
with amplified fragment length polymorphism##5##5##(2008-10#5)
with amplified sensitivity##2##3##(2008-10#2)
with amplified##8##2##(2008-10#7)(2008-8#1)
with amplitude##2##2##(2008-3#2)
with amplitudes of##2##3##(1996-5#1)(2008-3#1)
with amplitudes##3##2##(1996-5#1)(2008-3#2)
with amputation##3##2##(2008-6#1)(2010-3#1)(2013-1#1)
with amputation's##2##2##(2013-1#2)
with amygdala##2##2##(2008-11#1)(2008-4#1)
with amyloid##4##2##(1993-11#3)(2005-7#1)
with amyloidosis##3##2##(1991-9#1)(1993-2#1)(2011-2#1)
with an 18##2##3##(1996-2#1)(2006-10#1)
with an 8-year history of##2##5##(2010-9#1)(2011-1#1)
with an ACE inhibitor##2##4##(1993-12#1)(2007-1#1)
with an AVM##2##3##(2008-7#2)
with an African##3##3##(1993-6#2)(2009-11#1)
with an Apo-B/A1 ratio in the upper quartile##2##8##(2010-4#2)
with an Ar##3##3##(2008-10#2)(2008-2#1)
with an Asp##2##3##(1992-3#1)(1997-4#1)
with an E(0) ~ 1##2##5##(2006-3#2)
with an EC(50)##3##3##(2006-12#1)(2012-2#1)(2013-1#1)
with an EC50 of 0##2##5##(1990-10#1)(1994-8#1)
with an EC50 of about##2##5##(1995-12#1)(1997-2#1)
with an EC50 of##9##4##(1990-10#1)(1992-8#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-1#1)(1997-1#1)(1997-2#1)
with an EC50 value of##3##5##(1990-11#2)(1996-1#1)
with an EC50##13##3##(1990-10#1)(1990-11#2)(1992-8#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-1#2)(1996-5#1)(1997-1#1)(1997-2#1)
with an ED50 of 0##2##5##(1993-11#1)(1996-3#1)
with an ED50 of 2##2##5##(1992-3#1)(1996-3#1)
with an ED50 of##7##4##(1992-3#1)(1993-11#1)(1994-8#1)(1996-3#3)(1997-5#1)
with an ED50 value of##2##5##(1996-2#1)(1997-5#1)
with an ED50##10##3##(1990-10#1)(1992-3#1)(1993-11#1)(1994-8#1)(1996-2#1)(1996-3#3)(1997-5#2)
with an ELISA##4##3##(1992-4#1)(1995-8#1)(2008-10#2)
with an ESR spectrometer##2##4##(2008-10#2)
with an H score##2##4##(2007-2#2)
with an H##3##3##(2007-2#2)(2008-3#1)
with an IC(50) value##2##4##(2011-2#1)(2013-1#1)
with an IC(50)##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
with an IC50 =##2##4##(1992-9#1)(1996-6#1)
with an IC50 of 0##2##5##(1991-9#1)(1993-11#1)
with an IC50 of 1##4##5##(1993-12#2)(1994-12#1)(1995-8#1)
with an IC50 of 2##2##5##(1990-10#1)(1995-11#1)
with an IC50 of 20 microM##2##6##(1994-8#2)
with an IC50 of##30##4##(1990-10#1)(1990-2#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-5#1)(1993-11#1)(1993-12#2)(1994-12#1)(1994-3#2)(1994-8#3)(1994-9#3)(1995-11#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#2)(1997-4#1)(2010-11#1)
with an IC50 value of##9##5##(1990-5#1)(1991-1#1)(1991-9#2)(1996-10#1)(1996-6#1)(2006-12#2)(2008-5#1)
with an IC50 value##10##4##(1990-5#1)(1991-1#1)(1991-9#2)(1996-10#1)(1996-6#1)(2006-12#3)(2008-5#1)
with an IC50##44##3##(1990-10#1)(1990-2#1)(1990-5#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#3)(1992-1#2)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#2)(1994-12#1)(1994-3#2)(1994-8#3)(1994-9#3)(1995-11#1)(1995-8#1)(1996-1#1)(1996-10#2)(1996-2#2)(1996-6#3)(1997-4#1)(2006-12#3)(2008-12#1)(2008-5#1)(2010-11#1)
with an IC50-value of##2##4##(1994-11#2)
with an ID50 of##3##4##(1994-2#1)(1995-1#1)(1996-2#1)
with an M(2) value of##2##5##(2007-12#2)
with an M(r) of##3##4##(1992-12#1)(1995-5#1)(1996-9#1)
with an Mr of##2##4##(1990-1#1)(1996-2#1)
with an N-terminal##5##3##(1993-11#1)(1995-3#1)(1995-5#1)(2006-12#1)(2008-10#1)
with an OR##2##3##(2008-11#1)(2013-1#1)
with an R##3##3##(2008-10#3)
with an RNA##2##3##(1996-8#1)(2006-7#1)
with an STI##2##3##(2008-12#2)
with an X-ray##2##3##(1992-11#1)(2005-11#1)
with an abdominal aortic aneurysm##2##5##(1990-5#1)(1992-5#1)
with an abdominal##6##3##(1990-5#1)(1992-5#1)(1993-3#1)(2008-7#1)(2010-1#1)(2010-12#1)
with an abduction device##2##4##(2007-7#2)
with an ability to resist conventional therapies##2##7##(2012-12#2)
with an ability to##5##4##(1992-11#1)(1994-2#1)(2009-6#1)(2012-12#2)
with an ability##6##3##(1992-11#1)(1994-2#1)(2008-10#1)(2009-6#1)(2012-12#2)
with an abnormal##12##3##(1990-5#1)(1990-7#1)(1993-11#1)(1994-11#1)(1997-3#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-9#1)(2010-11#1)(2010-2#1)
with an abnormally##2##3##(1990-10#1)(2008-6#1)
with an abrupt##3##3##(1991-1#1)(2008-11#1)(2010-11#1)
with an absence of##3##4##(1994-11#1)(2006-10#1)(2010-7#1)
with an absolute accuracy of##2##5##(2008-3#2)
with an absolute##5##3##(2008-2#2)(2008-3#3)
with an absorbance##2##3##(2008-10#1)(2010-5#1)
with an absorbed##2##3##(2008-1#1)(2008-2#1)
with an absorbing##2##3##(2007-12#1)(2008-2#1)
with an absorption coefficient of##2##5##(2008-2#1)(2008-3#1)
with an absorption##7##3##(1990-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2012-2#1)
with an abundance of##2##4##(2008-2#1)(2008-7#1)
with an accelerated##2##3##(1992-2#1)(2011-1#1)
with an acceleration##2##3##(2008-1#1)(2013-1#1)
with an acceptable degree of##2##5##(1993-11#1)(2006-11#1)
with an acceptable morbidity##2##4##(2006-6#1)(2011-11#1)
with an acceptable##15##3##(1991-3#1)(1993-11#1)(1997-6#1)(2006-10#1)(2006-11#1)(2006-6#2)(2007-8#4)(2008-3#1)(2008-5#1)(2010-7#1)(2011-11#1)
with an acceptably low##2##4##(2010-4#1)(2011-2#1)
with an accumulation of##2##4##(1994-5#1)(2008-6#1)
with an accumulation##5##3##(1994-5#1)(2008-10#2)(2008-3#1)(2008-6#1)
with an accuracy better than##2##5##(2007-12#1)(2008-3#1)
with an accuracy of +/-0##2##5##(2007-11#1)(2008-3#1)
with an accuracy of 0##3##5##(2007-12#1)(2008-2#2)
with an accuracy of 89%##2##5##(1993-8#1)(2008-11#1)
with an accuracy of 94##2##5##(2008-7#1)(2011-2#1)
with an accuracy of better than 5% and##2##8##(2008-2#1)(2008-3#1)
with an accuracy of better than##5##6##(2007-12#1)(2008-2#2)(2008-3#2)
with an accuracy of the order of##2##7##(2008-2#1)(2008-3#1)
with an accuracy of##29##4##(1993-8#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-2#6)(2008-3#9)(2008-7#2)(2011-2#1)(2012-1#1)
with an accuracy##32##3##(1993-8#1)(2007-11#1)(2007-12#4)(2008-10#4)(2008-11#1)(2008-2#6)(2008-3#10)(2008-7#2)(2008-9#1)(2011-2#1)(2012-1#1)
with an accurate##3##3##(1991-11#1)(2008-10#1)(2008-6#1)
with an achromatic phase shifter##2##5##(2007-11#2)
with an achromatic##3##3##(2007-11#2)(2008-3#1)
with an acid buffer##2##4##(1996-11#1)(2007-8#1)
with an acid##5##3##(1996-11#1)(2007-8#1)(2008-10#2)(2009-10#1)
with an acidic##2##3##(1992-2#1)(2008-8#1)
with an acidified methanolic solution##2##5##(2008-10#2)
with an acousto-optic modulator##2##4##(2007-11#1)(2008-2#1)
with an acousto-optic##5##3##(2007-11#2)(2008-2#2)(2008-3#1)
with an acrophase##3##3##(2008-11#1)(2010-8#2)
with an action##2##3##(1992-12#1)(1997-5#1)
with an activated carbon##2##4##(2008-10#2)
with an activated##6##3##(1993-6#1)(1997-3#1)(2008-10#2)(2008-7#1)(2011-1#1)
with an activation of the##2##5##(1993-3#1)(1995-6#1)
with an activation##4##3##(1993-3#1)(1994-5#1)(1995-6#1)(2012-2#1)
with an active##15##3##(1990-12#1)(1990-5#1)(1994-11#1)(1995-4#1)(1997-8#1)(2006-11#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-6#1)(2009-6#1)(2013-7#1)
with an activity##3##3##(1990-12#1)(2008-5#1)(2012-3#1)
with an actuarial survival of##2##5##(1993-9#1)(1996-11#1)
with an acute abdomen##4##4##(1991-6#1)(2006-4#1)(2008-6#1)(2009-9#1)
with an acute myocardial infarction (AMI)##2##6##(2006-1#1)(2008-3#1)
with an acute myocardial infarction##5##5##(2006-1#1)(2008-11#2)(2008-3#1)(2009-5#1)
with an acute onset of##3##5##(2008-11#1)(2010-4#1)(2012-12#1)
with an acute onset##4##4##(2008-11#1)(2010-4#1)(2012-12#1)(2013-8#1)
with an acute##25##3##(1991-6#1)(1994-12#1)(2006-1#1)(2006-4#2)(2006-9#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-12#1)(2012-12#1)(2013-8#1)
with an adaptive##4##3##(1990-11#1)(2007-12#1)(2008-3#1)(2012-2#1)
with an added##2##3##(2008-2#1)(2011-1#1)
with an addition of##2##4##(2008-5#1)(2012-12#1)
with an addition##3##3##(1994-5#1)(2008-5#1)(2012-12#1)
with an additional##25##3##(1990-4#1)(1992-5#1)(1994-6#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-4#1)(2007-11#1)(2007-7#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-3#1)(2009-8#1)(2012-3#1)(2013-8#1)
with an additive##2##3##(1994-9#1)(2008-3#1)
with an adenovirus vector containing the##2##6##(2007-3#2)
with an adenovirus vector containing##3##5##(1996-4#1)(2007-3#2)
with an adequate##15##3##(1991-3#1)(1993-12#1)(1994-3#1)(1996-2#1)(2006-2#1)(2006-6#1)(2008-10#3)(2008-2#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
with an adjacent##2##3##(1992-12#1)(2007-8#1)
with an adjusted##3##3##(2007-10#1)(2007-8#1)(2011-2#1)
with an adjustment##2##3##(2008-10#1)(2012-3#1)
with an adjuvant##3##3##(1991-5#1)(1995-5#1)(2005-7#1)
with an adolescent with##2##4##(2010-9#1)(2012-12#1)
with an adult##2##3##(2007-7#1)(2012-12#1)
with an advanced stage##3##4##(1991-8#1)(2013-1#2)
with an advanced##7##3##(1991-8#1)(2006-12#1)(2006-8#1)(2007-12#1)(2008-10#1)(2013-1#2)
with an affinity comparable to that##2##6##(1994-3#1)(1996-5#1)
with an affinity##8##3##(1990-3#1)(1992-9#1)(1994-3#1)(1994-5#1)(1995-11#1)(1996-5#1)(1996-8#1)(2008-10#1)
with an age range of##3##5##(1997-6#1)(2005-8#1)(2007-2#1)
with an age##4##3##(1997-6#1)(2005-8#1)(2007-2#1)(2008-7#1)
with an age-related##2##3##(1993-7#1)(1995-1#1)
with an agent that##2##4##(1993-4#1)(2007-9#1)
with an agent##3##3##(1993-4#1)(2007-9#1)(2008-5#1)
with an aggressive##7##3##(1993-3#1)(2006-10#1)(2008-10#1)(2008-5#2)(2009-9#1)(2010-12#1)
with an agreement between##2##4##(2011-2#1)(2012-2#1)
with an agrocin##2##3##(2008-10#2)
with an aim to##4##4##(2006-9#1)(2007-10#1)(2007-6#1)(2013-1#1)
with an air stream##2##4##(2008-5#1)(2008-6#1)
with an air##5##3##(2005-11#1)(2006-11#1)(2007-11#1)(2008-5#1)(2008-6#1)
with an alanine##6##3##(1992-6#3)(1995-11#1)(1997-4#1)(2007-6#1)
with an algorithm based on##2##5##(2007-8#1)(2008-1#1)
with an algorithm##3##3##(2007-8#1)(2008-1#1)(2008-3#1)
with an aliphatic##2##3##(2008-4#1)(2010-8#1)
with an alkaline##4##3##(1990-8#1)(1995-3#1)(2007-1#1)(2008-10#1)
with an all-fiber##3##3##(2007-12#2)(2008-3#1)
with an all-solid-state##2##3##(2008-10#1)(2008-3#1)
with an almost##4##3##(2006-4#1)(2007-10#1)(2008-7#1)(2009-4#1)
with an alpha##3##3##(1996-9#1)(2006-4#1)(2011-1#1)
with an already##3##3##(2006-11#1)(2013-1#2)
with an alteration in##2##4##(2010-12#2)
with an alteration##3##3##(1994-3#1)(2010-12#2)
with an altered##7##3##(1995-8#1)(1996-5#1)(2008-10#1)(2008-12#1)(2012-1#1)(2012-2#1)(2013-8#1)
with an alternative##4##3##(2008-10#2)(2008-8#1)(2008-9#1)
with an aluminum##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
with an amino acid##3##4##(1992-9#1)(1994-12#1)(1995-3#1)
with an amino group##2##4##(1997-2#1)(2008-10#1)
with an amino##7##3##(1992-9#1)(1994-12#1)(1995-3#1)(1997-2#1)(2008-10#1)(2008-11#2)
with an amino-terminal##2##3##(1992-2#1)(1996-5#1)
with an ammonium##2##3##(2008-10#2)
with an amplitude of approximately##2##5##(1991-8#1)(2007-12#1)
with an amplitude of##3##4##(1991-8#1)(2007-12#1)(2008-6#1)
with an amplitude##6##3##(1991-8#1)(1994-6#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)
with an analogous##3##3##(1991-2#1)(2007-12#1)(2010-5#1)
with an analysis of the##3##5##(2008-8#1)(2009-5#1)(2012-2#1)
with an analysis of##8##4##(1992-6#1)(1993-1#1)(1997-2#1)(2008-1#1)(2008-6#1)(2008-8#1)(2009-5#1)(2012-2#1)
with an analysis time of##2##5##(2008-10#2)
with an analysis##12##3##(1992-6#1)(1993-1#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-6#1)(2008-8#1)(2009-10#1)(2009-5#1)(2012-2#1)
with an analytic##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
with an analytical##3##3##(1996-4#1)(2008-10#2)
with an anatomically##2##3##(2007-11#1)(2010-10#1)
with an aneurysm##2##3##(2009-9#1)(2010-4#1)
with an aneurysmal##2##3##(2008-7#1)(2008-9#1)
with an angiotensin converting enzyme inhibitor##2##6##(1991-2#1)(1991-6#1)
with an angiotensin##3##3##(1991-2#1)(1991-6#1)(1995-10#1)
with an angiotensin-converting enzyme (ACE) inhibitor##2##6##(1996-9#2)
with an angle of##2##4##(1997-7#1)(2008-2#1)
with an angle##4##3##(1997-7#1)(2005-11#1)(2008-2#2)
with an angular##2##3##(2007-4#1)(2007-7#1)
with an anion exchange resin and##2##6##(1990-11#1)(2008-10#1)
with an anion exchanger##2##4##(1992-2#1)(2008-10#1)
with an anion##4##3##(1990-11#1)(1992-2#1)(2008-10#2)
with an anion-exchange column##2##4##(1997-3#1)(2008-10#1)
with an anion-exchange##3##3##(1997-3#1)(2008-10#2)
with an anionic##3##3##(2005-9#1)(2008-10#1)(2008-5#1)
with an annual##3##3##(2008-10#1)(2011-1#1)(2012-12#1)
with an annular##2##3##(2008-3#1)(2009-6#1)
with an anomalous##3##3##(1996-2#1)(2008-4#1)(2009-11#1)
with an anterior##3##3##(2008-8#1)(2009-9#1)(2013-7#1)
with an antibiotic##4##3##(1996-6#1)(2008-10#1)(2008-11#1)(2011-2#1)
with an antibody against##6##4##(1992-4#1)(1992-9#1)(1995-11#1)(2007-9#2)(2012-2#1)
with an antibody raised against##2##5##(1992-7#1)(2008-11#1)
with an antibody specific for the##2##6##(1994-11#1)(1995-2#1)
with an antibody specific##3##4##(1994-11#1)(1995-2#1)(1996-8#1)
with an antibody to##2##4##(1996-10#1)(2008-10#1)
with an antibody##21##3##(1990-5#1)(1991-7#1)(1992-4#1)(1992-7#1)(1992-9#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-10#1)(1996-8#1)(2007-9#2)(2008-10#3)(2008-11#1)(2008-4#1)(2010-12#2)(2012-2#1)
with an antiphosphotyrosine##2##3##(1995-3#1)(2008-4#1)
with an antisense RNA transcript##2##5##(1994-11#1)(1995-2#1)
with an antisense##3##3##(1990-9#1)(1994-11#1)(1995-2#1)
with an antiserum directed against##2##5##(1990-5#1)(1996-8#1)
with an antiserum##4##3##(1990-5#1)(1992-2#1)(1995-8#1)(1996-8#1)
with an aortic##2##3##(2005-12#1)(2007-8#1)
with an aperture size of 100 nm##2##7##(2007-12#1)(2008-3#1)
with an aperture##3##3##(2006-5#1)(2007-12#1)(2008-3#1)
with an apparent KD of##3##5##(1991-7#2)(1995-1#1)
with an apparent KI of##2##5##(1991-4#2)
with an apparent Kd of##5##5##(1990-5#2)(1991-12#1)(1991-5#1)(1992-9#1)
with an apparent Kd##6##4##(1990-5#2)(1991-12#1)(1991-5#1)(1992-9#1)(1994-5#1)
with an apparent Ki##2##4##(1991-3#1)(1996-6#1)
with an apparent Km of##3##5##(1991-3#1)(1992-2#1)(1992-3#1)
with an apparent Km##4##4##(1991-1#1)(1991-3#1)(1992-2#1)(1992-3#1)
with an apparent Mr of##2##5##(1990-6#1)(1996-2#1)
with an apparent dissociation constant of##4##6##(1990-7#1)(1991-4#1)(1993-9#1)(1996-8#1)
with an apparent inhibition##2##4##(1991-2#1)(2008-10#1)
with an apparent mass of##2##5##(1992-8#1)(1994-9#1)
with an apparent molar absorptivity of 6##2##7##(2005-4#1)(2008-10#1)
with an apparent molar absorptivity of##5##6##(2005-4#2)(2008-10#3)
with an apparent molecular mass of##6##6##(1993-11#1)(1994-11#1)(1995-3#1)(1996-10#1)(1996-8#1)(1997-2#1)
with an apparent molecular mass##7##5##(1990-12#1)(1993-11#1)(1994-11#1)(1995-3#1)(1996-10#1)(1996-8#1)(1997-2#1)
with an apparent molecular weight of##4##6##(1990-11#1)(1990-6#1)(1994-11#1)(1994-5#1)
with an apparent molecular##12##4##(1990-11#1)(1990-12#1)(1990-6#1)(1993-11#1)(1994-11#2)(1994-5#1)(1995-3#1)(1996-10#1)(1996-8#1)(1997-2#1)(2008-10#1)
with an apparent size of##2##5##(1993-3#1)(1996-5#1)
with an apparent##67##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#3)(1990-6#3)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-4#4)(1991-5#2)(1991-7#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#3)(1997-2#1)(1997-4#1)(2005-4#2)(2006-12#1)(2008-10#7)(2008-7#1)(2009-9#1)(2010-5#1)
with an application in##2##4##(1992-9#1)(1997-8#1)
with an application to yellow rust##2##6##(2008-10#2)
with an application to##4##4##(1992-2#1)(2008-10#2)(2013-7#1)
with an application##7##3##(1992-2#1)(1992-9#1)(1997-8#1)(2006-2#1)(2008-10#2)(2013-7#1)
with an applied voltage of##2##5##(2007-8#1)(2008-2#1)
with an applied##5##3##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)
with an appreciable##2##3##(1994-8#1)(2005-11#1)
with an appreciation##2##3##(1997-3#1)(2005-10#1)
with an approach##2##3##(2007-8#1)(2010-4#1)
with an appropriate##18##3##(2004-12#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-6#2)(2008-7#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-3#1)
with an approximate molecular weight of##4##6##(1990-12#1)(1991-6#1)(1994-11#1)(1996-5#1)
with an approximate##8##3##(1990-12#1)(1990-3#1)(1991-6#1)(1992-12#1)(1992-6#1)(1994-11#1)(1996-5#1)(1997-7#1)
with an approximately##6##3##(1992-1#1)(1994-3#2)(1994-8#1)(1995-6#1)(2008-1#1)
with an aqueous solution##2##4##(1997-8#1)(2011-2#1)
with an aqueous##8##3##(1997-8#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-4#1)(2011-2#1)
with an arbitrary number of##2##5##(2008-1#1)(2008-2#1)
with an arbitrary number##3##4##(2008-1#1)(2008-2#2)
with an arbitrary##8##3##(2007-12#3)(2008-1#1)(2008-2#4)
with an area of##2##4##(2008-3#1)(2008-5#1)
with an area##3##3##(2008-3#1)(2008-5#1)(2009-10#1)
with an argon##2##3##(2008-9#1)(2009-11#1)
with an argon-ion laser##2##4##(2008-2#1)(2008-3#1)
with an arm##2##3##(2012-1#2)
with an array of##6##4##(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
with an array##7##3##(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)
with an artificial##8##3##(1992-8#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2012-2#2)
with an aspect ratio##2##4##(2007-12#2)
with an aspect##3##3##(1994-6#1)(2007-12#2)
with an assay##2##3##(2008-10#1)(2008-6#1)
with an assessment of##2##4##(2007-1#1)(2008-6#1)
with an associated##2##3##(2007-8#1)(2011-10#1)
with an association constant of##2##5##(1990-4#1)(1995-3#1)
with an association constant##3##4##(1990-4#1)(1995-3#1)(1996-5#1)
with an association##6##3##(1990-4#1)(1990-8#1)(1995-3#1)(1996-5#1)(2010-1#1)(2012-3#1)
with an associative##3##3##(1991-7#1)(2008-5#1)(2009-10#1)
with an asymmetric##2##3##(2007-12#2)
with an asymptomatic##4##3##(2007-7#1)(2008-5#1)(2010-6#1)(2012-3#1)
with an atomic force microscope##5##5##(2007-11#1)(2007-2#1)(2008-3#3)
with an atomic##6##3##(2007-11#1)(2007-2#1)(2008-11#1)(2008-3#3)
with an attempt to##2##4##(2011-12#1)(2013-8#1)
with an attractive##4##3##(2008-10#2)(2008-11#1)(2009-9#1)
with an atypical##6##3##(1993-10#1)(1995-1#1)(2007-10#1)(2008-5#1)(2009-3#1)(2012-3#1)
with an atypically##2##3##(2008-10#1)(2012-3#1)
with an autoimmune disease##2##4##(1997-4#1)(2008-11#1)
with an autologous##2##3##(2011-2#1)(2013-1#1)
with an automated##6##3##(1993-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-9#1)
with an automatic##3##3##(1990-8#1)(2005-11#1)(2012-3#1)
with an autosomal dominant##4##4##(1996-6#1)(1997-6#1)(2008-7#1)(2008-8#1)
with an autosomal recessive##7##4##(1993-7#1)(1996-4#1)(1997-7#1)(2007-2#1)(2008-1#1)(2008-4#1)(2013-1#1)
with an autosomal##11##3##(1993-7#1)(1996-4#1)(1996-6#1)(1997-6#1)(1997-7#1)(2007-2#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-1#1)
with an auxiliary##3##3##(2007-12#3)
with an average age of 34##2##6##(2008-9#1)(2013-1#1)
with an average age of 43 years##3##7##(2006-8#1)(2008-9#1)(2013-1#1)
with an average age of##15##5##(1990-12#1)(1994-12#1)(2006-3#1)(2006-8#1)(2007-2#1)(2007-8#3)(2008-7#1)(2008-9#3)(2009-10#1)(2013-1#2)
with an average age##17##4##(1990-12#1)(1994-12#1)(2006-3#1)(2006-8#1)(2007-2#1)(2007-8#3)(2008-7#1)(2008-9#3)(2009-10#1)(2009-9#1)(2011-1#1)(2013-1#2)
with an average diameter of##5##5##(1994-8#1)(2005-11#1)(2008-5#1)(2010-6#1)(2010-7#1)
with an average error of##3##5##(2007-12#1)(2010-2#1)(2013-8#1)
with an average follow-up of##2##5##(2008-6#1)(2009-10#1)
with an average follow-up##3##4##(2008-6#1)(2008-7#1)(2009-10#1)
with an average insert size of##3##6##(1997-2#1)(1997-6#1)(2008-8#1)
with an average insert##4##4##(1996-10#1)(1997-2#1)(1997-6#1)(2008-8#1)
with an average lifetime of##2##5##(1997-1#1)(1997-4#1)
with an average molecular weight of##2##6##(2008-10#2)
with an average molecular##3##4##(1990-5#1)(2008-10#2)
with an average of 0##3##5##(2008-10#2)(2013-7#1)
with an average of 16##2##5##(2009-6#1)(2013-1#1)
with an average of 3##2##5##(1990-7#1)(1996-3#1)
with an average of 4##2##5##(1990-7#1)(2008-9#1)
with an average of##23##4##(1990-7#4)(1996-3#1)(2008-1#3)(2008-10#6)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-6#1)(2013-1#2)(2013-7#1)
with an average output power of##2##6##(2007-11#1)(2007-12#1)
with an average output power##3##5##(2007-11#1)(2007-12#2)
with an average particle size of##2##6##(2008-10#1)(2008-8#1)
with an average power of 1##2##6##(2007-12#2)
with an average power of##9##5##(2007-11#2)(2007-12#7)
with an average power##10##4##(2007-11#2)(2007-12#7)(2008-3#1)
with an average relative error of##2##6##(2008-10#1)(2013-8#1)
with an average relative##3##4##(2008-10#2)(2013-8#1)
with an average specific##3##4##(2008-11#2)(2008-6#1)
with an average survival of##2##5##(2006-2#1)(2007-10#1)
with an average value of##3##5##(1990-8#1)(1997-4#1)(2008-10#1)
with an average weight of##2##5##(2008-12#1)(2008-7#1)
with an average##135##3##(1990-12#1)(1990-5#1)(1990-7#4)(1990-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#1)(1996-10#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-5#2)(1997-6#2)(2005-11#1)(2005-9#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#2)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#12)(2007-2#1)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#17)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#6)(2009-10#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-9#2)(2010-2#1)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#6)(2013-7#1)(2013-8#4)
with an avidin-biotin and enzyme amplification system##2##7##(1992-8#2)
with an avirulent##2##3##(2008-10#1)(2008-5#1)
with an axial pore##2##4##(1995-8#2)
with an axial##4##3##(1995-8#2)(2007-12#1)(2011-1#1)
with an axillary##2##3##(2006-4#1)(2010-12#1)
with an eGFR &gt##3##4##(2012-2#3)
with an eGFR &lt##3##4##(2012-2#3)
with an eGFR##6##3##(2012-2#6)
with an earlier##7##3##(1991-5#1)(1994-9#1)(1995-3#1)(2008-1#1)(2008-10#1)(2013-1#1)(2013-8#1)
with an early appearance of sterile pustules on erythematous swollen skin of trunk##2##13##(2013-1#2)
with an early##11##3##(1990-8#1)(1995-1#1)(1997-1#1)(2006-2#1)(2007-10#1)(2007-7#2)(2008-5#1)(2013-1#2)(2013-8#1)
with an eating disorder##4##4##(2006-7#2)(2011-2#2)
with an ectopic##2##3##(2011-2#1)(2013-1#1)
with an educational##2##3##(1995-1#1)(2007-10#1)
with an effect on##3##4##(1994-12#1)(1994-8#2)
with an effective area of just##2##6##(2007-11#1)(2007-12#1)
with an effective area of##3##5##(2007-11#2)(2007-12#1)
with an effective##11##3##(2006-10#2)(2007-11#2)(2007-12#1)(2008-10#2)(2008-3#1)(2009-6#1)(2011-1#1)(2013-8#1)
with an efficiency of##6##4##(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-6#1)
with an efficiency that##2##4##(2008-10#1)(2009-5#1)
with an efficiency##10##3##(1990-4#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2009-5#1)
with an efficient##4##3##(1993-3#1)(2007-12#1)(2008-2#1)(2012-2#1)
with an elastic##4##3##(2007-8#1)(2008-11#1)(2010-4#1)(2011-2#1)
with an electrical##2##3##(1991-9#1)(2008-2#1)
with an electrically##2##3##(2008-3#1)(2009-2#1)
with an electro-optic modulator##2##4##(2008-3#2)
with an electro-optic##5##3##(2007-12#2)(2008-3#3)
with an electrochemical##2##3##(2008-10#1)(2008-6#1)
with an electromagnetic##2##3##(1992-1#1)(2011-2#1)
with an electron capture detector (GC-ECD)##2##6##(2008-10#2)
with an electron capture detector##3##5##(2008-10#3)
with an electron##6##3##(2008-10#5)(2008-7#1)
with an electronic##6##3##(1990-2#1)(1996-3#1)(2008-10#2)(2008-5#1)(2008-8#1)
with an elemental##2##3##(2005-10#1)(2006-5#1)
with an elevated level of##2##5##(1990-5#1)(1993-9#1)
with an elevated risk of##2##5##(2009-10#1)(2012-2#1)
with an elevated##12##3##(1990-5#1)(1992-9#1)(1993-9#1)(1994-8#1)(2005-7#1)(2008-5#1)(2009-10#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#1)
with an elevation of##2##4##(1990-6#1)(1991-12#1)
with an elevation##3##3##(1990-6#1)(1991-12#1)(2008-10#1)
with an emission maximum at##2##5##(2007-11#1)(2008-3#1)
with an emission wavelength##2##4##(2007-12#1)(2008-3#1)
with an emission##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
with an emphasis on diabetes##2##5##(2013-8#2)
with an emphasis on its##3##5##(2006-12#1)(2006-2#1)(2007-2#1)
with an emphasis on the##11##5##(1991-3#1)(2005-10#1)(2006-12#1)(2007-12#1)(2008-7#1)(2010-11#1)(2010-4#1)(2010-9#1)(2011-1#1)(2012-2#2)
with an emphasis on their##2##5##(2007-12#1)(2010-12#1)
with an emphasis on##45##4##(1991-3#1)(1991-8#1)(1992-12#1)(2005-10#1)(2005-5#1)(2006-10#3)(2006-12#2)(2006-2#2)(2006-3#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-6#1)(2008-1#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#2)
with an emphasis##49##3##(1991-3#1)(1991-8#1)(1992-1#1)(1992-12#1)(1996-6#1)(2005-10#1)(2005-5#1)(2006-10#4)(2006-12#2)(2006-2#2)(2006-3#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-6#1)(2008-1#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#2)
with an empty##2##3##(1991-11#1)(2010-11#1)
with an endometrial##2##3##(1990-6#1)(1994-8#1)
with an endoperio lesion in##2##5##(2010-4#2)
with an energy dispersive##2##4##(2008-5#1)(2012-2#1)
with an energy of##3##4##(2007-11#1)(2008-1#1)(2012-2#1)
with an energy##10##3##(2005-11#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-5#1)(2010-12#1)(2012-2#2)
with an enhanced##13##3##(1991-5#1)(1992-3#1)(1992-7#1)(1993-4#1)(1996-3#1)(1997-4#1)(2006-12#1)(2007-2#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-1#2)
with an enhancement##2##3##(2008-10#1)(2008-3#1)
with an enlarged##2##3##(2012-12#2)
with an enterovirus##2##3##(1993-4#2)
with an environment##3##3##(1997-7#1)(2012-1#1)(2013-1#1)
with an enzyme##5##3##(1992-12#1)(1993-6#2)(1995-2#1)(2008-10#1)
with an epifluorescence microscope##2##4##(1994-5#1)(2008-10#1)
with an episode of##2##4##(2006-10#1)(2006-2#1)
with an episode##3##3##(2006-10#1)(2006-2#1)(2011-1#1)
with an equal number of##3##5##(1991-7#1)(2008-4#1)(2012-2#1)
with an equal##5##3##(1991-7#1)(1992-6#1)(2008-2#1)(2008-4#1)(2012-2#1)
with an equilibrium constant##2##4##(1994-5#1)(2008-10#1)
with an equilibrium dissociation constant of##2##6##(1994-5#1)(1995-3#1)
with an equilibrium##6##3##(1992-7#1)(1994-5#2)(1995-3#1)(2008-10#2)
with an equimolar##3##3##(1996-12#1)(1996-6#2)
with an equivalent##4##3##(1991-2#1)(2008-2#1)(2008-3#1)(2010-12#1)
with an error of less than##2##6##(2007-12#1)(2008-2#1)
with an error of##5##4##(2007-12#2)(2008-10#2)(2008-2#1)
with an error##12##3##(2007-12#3)(2008-10#3)(2008-2#5)(2008-7#1)
with an erythematous##2##3##(2005-11#1)(2011-2#1)
with an essential role##2##4##(2007-9#1)(2008-5#1)
with an essential##3##3##(2007-9#1)(2008-5#1)(2009-4#1)
with an established##9##3##(1991-3#1)(1992-9#1)(1997-7#1)(2006-12#1)(2007-8#1)(2008-3#1)(2009-9#1)(2010-6#1)(2011-2#1)
with an estimated detection##2##4##(2008-10#2)
with an estimated incidence of##2##5##(2012-3#1)(2013-7#1)
with an estimated incidence##4##4##(2008-6#1)(2011-2#1)(2012-3#1)(2013-7#1)
with an estimated molecular weight of##3##6##(1993-11#1)(2008-10#1)(2009-9#1)
with an estimated molecular##4##4##(1993-11#1)(1995-2#1)(2008-10#1)(2009-9#1)
with an estimated overall worldwide prevalence of 5-10% of the population##2##11##(2012-12#2)
with an estimated overall##3##4##(2007-5#1)(2012-12#2)
with an estimated prevalence of##3##5##(1996-2#1)(2008-11#1)(2011-2#1)
with an estimated##36##3##(1990-6#1)(1991-4#1)(1992-5#1)(1993-11#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-1#1)(2005-9#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-12#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-7#1)
with an estrogen receptor##2##4##(1991-2#1)(2013-1#1)
with an ethylene spacer##2##4##(2005-11#1)(2008-10#1)
with an evaluation##2##3##(2008-10#1)(2012-1#1)
with an even##4##3##(1995-12#1)(2005-11#1)(2010-12#1)(2012-12#1)
with an eventual##2##3##(1994-10#1)(2008-10#1)
with an evident##2##3##(2006-6#1)(2008-2#1)
with an exact ray trace##2##5##(2008-3#2)
with an exact##6##3##(2007-11#1)(2008-2#2)(2008-3#3)
with an example##4##3##(1993-5#1)(1995-6#1)(2006-4#1)(2007-12#1)
with an excellent correlation##2##4##(2008-10#1)(2008-5#1)
with an excellent outcome##3##4##(2006-10#1)(2007-9#1)(2012-12#1)
with an excellent##17##3##(1996-5#1)(2006-10#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-5#1)(2008-9#2)(2012-12#1)(2012-2#1)(2013-1#2)
with an exception##2##3##(2008-10#1)(2012-3#1)
with an excess of##9##4##(1990-12#1)(1992-7#1)(1996-11#1)(1996-5#2)(2008-10#1)(2008-2#1)(2008-8#1)(2009-11#1)
with an excess##10##3##(1990-12#1)(1992-7#1)(1996-11#1)(1996-5#2)(2008-10#1)(2008-2#1)(2008-8#2)(2009-11#1)
with an excessive##3##3##(1991-12#1)(2006-2#1)(2011-2#1)
with an excitation wavelength of##3##5##(1997-2#1)(2008-10#2)
with an excitation wavelength##4##4##(1997-2#1)(2008-10#2)(2008-2#1)
with an excitation##5##3##(1997-2#1)(2008-10#3)(2008-2#1)
with an existing##3##3##(2008-2#2)(2008-6#1)
with an expanded##5##3##(2008-10#1)(2008-11#1)(2008-2#1)(2013-1#2)
with an expected##3##3##(1990-10#1)(1995-9#1)(2008-6#1)
with an experienced##2##3##(2008-11#1)(2011-2#1)
with an experimental painful peripheral neuropathy##2##6##(1996-5#2)
with an experimental##4##3##(1996-5#2)(2007-8#1)(2008-10#1)
with an exposure##2##3##(2008-3#1)(2012-3#1)
with an expression plasmid containing##2##5##(1992-12#1)(1994-2#1)
with an expression##3##3##(1992-12#1)(1992-5#1)(1994-2#1)
with an extended##7##3##(1994-6#1)(1997-6#1)(2006-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)
with an extensive##9##3##(1992-12#1)(1996-1#1)(2007-8#2)(2008-3#1)(2008-7#1)(2010-10#1)(2013-8#2)
with an external medium of##2##5##(2008-2#2)
with an external##12##3##(2006-12#1)(2006-8#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-4#2)(2010-3#1)(2010-6#1)
with an extra##4##3##(1997-4#1)(2007-8#1)(2008-10#1)(2013-8#1)
with an extracellular##2##3##(1991-8#1)(1992-5#1)
with an extract of##2##4##(1990-6#1)(1994-10#1)
with an extract##3##3##(1990-5#1)(1990-6#1)(1994-10#1)
with an extraction efficiency of##4##5##(2007-12#1)(2007-8#1)(2008-10#2)
with an extraction##6##3##(1991-8#1)(2007-12#1)(2007-8#1)(2008-10#3)
with an extreme##4##3##(1993-8#1)(2006-10#1)(2007-8#1)(2010-3#1)
with an extremely large##2##4##(2008-3#1)(2011-2#1)
with an extremely rare##3##4##(2012-2#1)(2013-1#2)
with an extremely##12##3##(1994-8#1)(2006-12#1)(2008-11#1)(2008-3#2)(2008-6#1)(2009-4#1)(2011-2#2)(2012-2#1)(2013-1#2)
with an eye on##2##4##(2008-11#1)(2008-12#1)
with an eye toward##7##4##(1993-3#1)(1996-3#1)(2006-12#1)(2007-12#1)(2008-4#1)(2009-12#1)(2011-2#1)
with an eye##12##3##(1993-3#1)(1996-3#1)(2006-12#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-12#1)(2011-2#1)(2012-1#1)(2013-1#2)
with an heterologous##2##3##(1996-3#1)(1996-7#1)
with an i##2##3##(1994-2#1)(1995-5#1)
with an ideal##2##3##(2008-3#1)(2008-7#1)
with an identical##6##3##(1990-1#2)(1991-2#1)(2008-10#1)(2009-3#1)(2011-2#1)
with an illness##2##3##(1992-12#1)(2010-10#1)
with an imaging##5##3##(2007-11#2)(2008-2#1)(2008-3#1)(2008-7#1)
with an immediate##3##3##(1997-5#1)(2005-11#1)(2012-2#1)
with an immobilized enzyme reactor##2##5##(1992-1#2)
with an immobilized##3##3##(1990-12#1)(1992-1#2)
with an immunoassay##2##3##(2007-8#1)(2008-10#1)
with an immunohistochemical##2##3##(1994-3#1)(1997-7#1)
with an impact on the##2##5##(2005-1#1)(2005-11#1)
with an impact on##3##4##(2005-1#1)(2005-11#1)(2010-12#1)
with an impaired##3##3##(2007-8#1)(2008-11#1)(2008-7#1)
with an impalpable##3##3##(2007-8#1)(2008-10#2)
with an important##5##3##(1990-8#1)(1993-8#1)(1995-5#1)(2006-10#1)(2008-5#1)
with an improved safety profile##3##5##(2008-2#1)(2008-4#1)(2008-8#1)
with an improved##17##3##(1992-3#1)(1994-11#1)(1997-1#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)
with an improvement in the##2##5##(1995-10#1)(2013-1#1)
with an improvement in##7##4##(1991-12#1)(1991-8#1)(1995-10#1)(2006-10#1)(2008-6#1)(2011-2#1)(2013-1#1)
with an improvement of##2##4##(1993-2#1)(2012-1#1)
with an improvement##10##3##(1991-12#1)(1991-8#1)(1993-2#1)(1995-10#1)(2006-10#1)(2007-2#1)(2008-6#1)(2011-2#1)(2012-1#1)(2013-1#1)
with an in situ##5##4##(2004-4#1)(2007-8#1)(2008-3#3)
with an in vitro model##2##5##(2006-11#1)(2008-5#1)
with an in vitro##4##4##(1996-2#1)(2006-11#1)(2008-4#1)(2008-5#1)
with an in vivo##3##4##(1993-9#1)(1994-11#1)(1996-12#1)
with an in##12##3##(1993-9#1)(1994-11#1)(1996-12#1)(1996-2#1)(2004-4#1)(2006-11#1)(2007-8#1)(2008-3#3)(2008-4#1)(2008-5#1)
with an in-depth##2##3##(2007-11#1)(2012-2#1)
with an in-house##2##3##(1993-12#1)(2007-8#1)
with an inadequate##2##3##(1992-12#1)(2008-7#1)
with an incidence of 0##3##5##(2009-6#1)(2013-1#2)
with an incidence of##8##4##(2007-5#1)(2007-8#1)(2009-6#1)(2010-10#1)(2013-1#3)(2013-8#1)
with an incidence##15##3##(1992-8#1)(2007-5#1)(2007-8#1)(2008-3#1)(2008-5#1)(2009-2#1)(2009-6#1)(2009-9#1)(2010-10#1)(2012-2#1)(2013-1#4)(2013-8#1)
with an incident##2##3##(2007-12#1)(2008-2#1)
with an incipient##2##3##(2007-12#1)(2007-3#1)
with an incoherent##2##3##(1990-2#1)(2007-12#1)
with an incomplete##2##3##(2007-12#1)(2008-7#1)
with an increase in DMF concentration##5##6##(2006-10#5)
with an increase in both##3##5##(1990-7#1)(1991-8#1)(2008-5#1)
with an increase in extracellular##2##5##(1995-12#1)(1997-5#1)
with an increase in fluorescence intensity##2##6##(1993-9#1)(1997-4#1)
with an increase in fluorescence##5##5##(1993-9#1)(1996-1#1)(1996-12#2)(1997-4#1)
with an increase in leaf##2##5##(2008-10#1)(2012-9#1)
with an increase in temperature##3##5##(1993-3#1)(1997-2#2)
with an increase in the maximum rate of resource##2##9##(2008-8#2)
with an increase in the number of##5##7##(1992-9#2)(2008-10#1)(2008-5#1)(2010-4#1)
with an increase in the ratio of##2##7##(2008-6#1)(2011-1#1)
with an increase in the##43##5##(1990-5#1)(1991-4#1)(1991-9#1)(1992-1#2)(1992-9#2)(1993-11#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-5#1)(2005-11#2)(2006-10#3)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#2)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-7#1)(2013-8#3)
with an increase in##125##4##(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#2)(1991-10#1)(1991-2#2)(1991-4#2)(1991-8#1)(1991-9#1)(1992-1#2)(1992-3#2)(1992-9#3)(1993-11#3)(1993-12#1)(1993-3#2)(1993-7#1)(1993-9#2)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#3)(1996-5#1)(1997-2#2)(1997-4#1)(1997-5#2)(2005-11#2)(2006-10#8)(2007-1#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-8#1)(2010-2#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#1)(2012-9#1)(2013-1#2)(2013-7#1)(2013-8#4)
with an increase of the##3##5##(1997-1#1)(2008-10#1)(2008-8#1)
with an increase of##16##4##(1990-8#1)(1991-4#1)(1991-5#1)(1991-6#1)(1994-3#1)(1997-1#1)(2005-11#2)(2007-12#1)(2008-10#2)(2008-12#2)(2008-8#1)(2011-1#1)(2013-1#1)
with an increase##143##3##(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-10#1)(1991-2#2)(1991-4#3)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-3#2)(1992-9#3)(1993-11#3)(1993-12#1)(1993-3#2)(1993-7#1)(1993-9#2)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#3)(1996-5#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#2)(2005-11#4)(2006-10#8)(2006-2#1)(2007-1#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-10#8)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#4)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-8#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#1)(2012-9#1)(2013-1#3)(2013-7#1)(2013-8#4)
with an increased density##2##4##(2008-11#1)(2008-7#1)
with an increased expression of##4##5##(1991-6#1)(1994-3#1)(1996-4#1)(2008-11#1)
with an increased intracellular##2##4##(1993-6#1)(2010-4#1)
with an increased mortality##2##4##(2007-9#1)(2010-6#1)
with an increased production of##2##5##(2008-7#1)(2009-5#1)
with an increased rate of##5##5##(1991-2#1)(1991-5#1)(1997-6#1)(2008-10#1)(2012-12#1)
with an increased rate##6##4##(1991-2#1)(1991-5#1)(1992-7#1)(1997-6#1)(2008-10#1)(2012-12#1)
with an increased risk for##10##5##(2008-3#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)
with an increased risk of cardiovascular events##2##7##(2006-10#1)(2010-12#1)
with an increased risk of cardiovascular##7##6##(1992-8#1)(1996-9#1)(2006-10#1)(2007-1#1)(2008-7#1)(2010-12#1)(2010-4#1)
with an increased risk of type 2 diabetes and##2##9##(2008-1#1)(2012-2#1)
with an increased risk of##59##5##(1990-11#2)(1992-11#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-3#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-9#1)(1997-3#1)(2004-11#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-5#3)(2007-7#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#2)(2009-7#1)(2010-10#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#4)(2013-7#1)
with an increased risk##70##4##(1990-11#2)(1992-11#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-3#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-9#1)(1997-3#1)(2004-11#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-5#3)(2007-7#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-3#4)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#2)(2009-7#1)(2010-10#1)(2010-12#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#8)(2013-7#1)
with an increased##142##3##(1990-11#3)(1990-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-2#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-3#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-10#2)(2005-12#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-8#2)(2007-1#3)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-5#3)(2007-7#3)(2007-9#2)(2008-1#5)(2008-10#3)(2008-11#4)(2008-3#4)(2008-5#1)(2008-7#4)(2008-9#1)(2009-10#2)(2009-2#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#7)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#11)(2013-7#2)
with an increasing incidence projected through 2020##4##7##(2013-8#4)
with an increasing number of##4##5##(1992-6#1)(1993-3#1)(2006-10#1)(2011-1#1)
with an increasing tendency to##2##5##(1991-2#1)(1997-4#1)
with an increasing##24##3##(1990-9#1)(1991-2#1)(1992-6#1)(1992-9#1)(1993-3#1)(1997-4#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-2#3)(2008-3#1)(2009-4#2)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#4)
with an independent measure of##2##5##(1996-7#2)
with an independent##10##3##(1996-7#2)(2007-11#1)(2007-12#2)(2008-10#2)(2008-6#1)(2009-10#1)(2012-2#1)
with an index of refraction##2##5##(2008-3#2)
with an index##5##3##(2005-6#1)(2007-11#2)(2008-3#2)
with an indication##3##3##(2008-1#1)(2010-8#1)(2010-9#1)
with an indirect##3##3##(2006-5#1)(2008-10#1)(2012-2#1)
with an individual##2##3##(2007-2#1)(2010-10#1)
with an individual's##2##3##(2007-2#1)(2008-11#1)
with an indwelling##2##3##(1997-2#1)(2005-10#1)
with an inexpensive##2##3##(2007-11#1)(2008-10#1)
with an infarction##2##3##(2007-9#1)(2008-12#1)
with an infected##2##3##(1997-3#1)(2007-2#1)
with an infectious##2##3##(1994-4#1)(1996-12#1)
with an infinite##3##3##(2008-2#2)(2011-1#1)
with an inflammatory component##3##4##(1991-8#2)(2005-8#1)
with an inflammatory response##5##4##(2008-9#4)(2012-1#1)
with an inflammatory##9##3##(1991-8#2)(2004-3#1)(2005-8#1)(2008-9#4)(2012-1#1)
with an infrared##2##3##(2008-3#1)(2008-7#1)
with an inherited##2##3##(1993-2#1)(1994-11#1)
with an inhibition constant of##2##5##(1991-12#1)(2011-2#1)
with an inhibition constant##3##4##(1991-12#1)(1991-5#1)(2011-2#1)
with an inhibition##4##3##(1991-12#1)(1991-5#1)(2009-9#1)(2011-2#1)
with an inhibitor of##3##4##(1992-3#1)(1997-5#1)(2012-2#1)
with an inhibitor##4##3##(1990-11#1)(1992-3#1)(1997-5#1)(2012-2#1)
with an initial focus on##2##5##(2008-7#2)
with an initial##19##3##(1992-1#1)(1995-1#1)(1995-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#2)(2010-12#1)(2011-2#2)(2012-2#1)
with an initially##2##3##(2007-12#1)(2008-11#1)
with an injection of##2##4##(1993-1#1)(2007-8#1)
with an injection##4##3##(1993-1#1)(1994-9#1)(2007-8#1)(2008-10#1)
with an inner##2##3##(2007-12#2)
with an inoperable##2##3##(1993-2#1)(2007-6#1)
with an input##2##3##(1992-7#1)(2008-3#1)
with an insertion##3##3##(1992-6#1)(1993-6#1)(2013-1#1)
with an insidious##2##3##(2006-10#1)(2007-5#1)
with an insight##3##3##(2007-12#1)(2008-7#1)(2010-8#1)
with an instrument##3##3##(2006-12#1)(2007-1#1)(2007-11#1)
with an intact##19##3##(1991-2#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-5#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-8#2)(2007-9#2)(2008-9#1)(2009-10#1)(2009-12#1)(2012-12#2)
with an integrated##6##3##(2006-5#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-7#1)
with an integrating##2##3##(1992-1#1)(2008-2#1)
with an intense##4##3##(2007-12#1)(2008-6#1)(2010-2#1)(2011-2#1)
with an intensity of 1##2##5##(2007-12#1)(2008-3#1)
with an intensity of##3##4##(1990-12#1)(2007-12#1)(2008-3#1)
with an intensity##5##3##(1990-12#1)(2007-12#2)(2008-2#1)(2008-3#1)
with an intensity-recording device##2##4##(2008-3#2)
with an intensive##4##3##(1992-8#1)(1997-3#1)(2008-10#1)(2013-7#1)
with an intention to##2##4##(2006-7#1)(2011-1#1)
with an interaction length of 1##2##6##(2007-12#1)(2008-3#1)
with an interaction length of##3##5##(2007-12#2)(2008-3#1)
with an interaction##4##3##(2006-5#1)(2007-12#2)(2008-3#1)
with an intercalation binding mode##2##5##(1992-3#2)
with an interest in##2##4##(2006-10#1)(2006-12#1)
with an interest##3##3##(2005-7#1)(2006-10#1)(2006-12#1)
with an interference##5##3##(1997-7#1)(2008-2#1)(2008-3#2)(2009-10#1)
with an interferometer##2##3##(2007-12#1)(2008-3#1)
with an intermediate##5##3##(2005-11#1)(2008-2#1)(2008-8#1)(2009-2#1)(2011-1#1)
with an internal diameter of##2##5##(2008-10#1)(2013-1#1)
with an internal standard solution##2##5##(1990-6#1)(2007-8#1)
with an internal standard##4##4##(1990-12#1)(1990-6#1)(2007-8#1)(2008-10#1)
with an internal##15##3##(1990-12#1)(1990-6#1)(1991-5#1)(1994-5#1)(1995-1#1)(1995-3#1)(1996-2#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-2#1)(2011-2#1)(2013-1#1)
with an international##3##3##(1992-2#1)(2006-10#1)(2010-3#1)
with an interval of##7##4##(1991-6#2)(1993-7#1)(1996-12#1)(1997-4#1)(2007-2#1)(2008-6#1)
with an intervening##2##3##(1991-5#1)(1991-7#1)
with an intracavity electro-optic crystal##2##5##(2007-12#1)(2008-3#1)
with an intracavity electro-optic##3##4##(2007-12#2)(2008-3#1)
with an intracavity##12##3##(2007-11#3)(2007-12#7)(2008-2#1)(2008-3#1)
with an intracerebral##2##3##(1991-3#1)(2008-7#1)
with an intracranial##3##3##(2006-12#1)(2006-4#1)(2008-5#1)
with an intraductal##2##3##(1995-10#1)(1996-11#1)
with an intramuscular##2##3##(2009-3#1)(2012-12#1)
with an intrathoracic anastomosis and in only##2##7##(1993-2#2)
with an intrathoracic##3##3##(1993-2#2)(2007-6#1)
with an intrinsic##2##3##(1990-5#1)(1996-1#1)
with an introduction to the##2##5##(2010-7#1)(2011-2#1)
with an introduction##3##3##(1992-1#1)(2010-7#1)(2011-2#1)
with an invasive##2##3##(1993-12#1)(1994-6#1)
with an inversion scheme##2##4##(2008-3#2)
with an inversion##3##3##(2008-2#1)(2008-3#2)
with an inverted repeat at the 5' and 3' ends and two open reading frames##2##15##(2008-10#2)
with an inverted##5##3##(1994-6#1)(2008-10#2)(2009-11#1)(2013-1#1)
with an ion trap mass spectrometer##2##6##(2007-8#1)(2008-10#1)
with an ion##4##3##(2007-8#1)(2008-10#3)
with an irreducible##2##3##(2008-1#1)(2008-2#1)
with an irregular##3##3##(2006-10#1)(2007-4#1)(2012-12#1)
with an isoelectric point##2##4##(1996-5#1)(2008-10#1)
with an isogenic##2##3##(1995-1#1)(2008-7#1)
with an isolate##2##3##(2006-11#1)(2008-10#1)
with an isolated##13##3##(1994-5#1)(1996-5#1)(2006-12#2)(2008-10#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
with an isometric##2##3##(2008-5#1)(2011-2#1)
with an iterative##7##3##(2007-12#1)(2008-2#2)(2008-3#3)(2010-10#1)
with an object##2##3##(2007-12#1)(2009-6#1)
with an objective##4##3##(1992-2#1)(2006-6#2)(2009-6#1)
with an observed rate constant of##2##6##(1990-5#2)
with an observed##4##3##(1990-5#2)(1995-3#1)(2004-11#1)
with an ocular##2##3##(2008-3#1)(2013-8#1)
with an odds ratio of##2##5##(2011-1#2)
with an odds ratio##3##4##(2007-8#1)(2011-1#2)
with an offset##2##3##(2008-3#2)
with an older brother##2##4##(2004-11#2)
with an older sister##2##4##(2004-11#2)
with an older##5##3##(2004-11#4)(2006-10#1)
with an oligodeoxyribonucleotide##2##3##(1990-5#1)(2005-11#1)
with an oligonucleotide probe##2##4##(1990-5#1)(1996-5#1)
with an oligonucleotide##3##3##(1990-5#1)(1992-2#1)(1996-5#1)
with an on-line sample##2##4##(2008-10#2)
with an on-line##6##3##(1997-8#1)(2007-12#1)(2008-10#3)(2010-5#1)
with an ongoing##3##3##(1993-3#1)(1994-12#1)(2007-4#1)
with an opaque##2##3##(2008-3#2)
with an open reading frame encoding##2##6##(1990-7#1)(1991-12#1)
with an open reading frame of##5##6##(1990-4#1)(1991-12#1)(1991-4#1)(1995-2#1)(1997-7#1)
with an open reading frame##11##5##(1990-4#1)(1990-7#1)(1991-12#2)(1991-4#1)(1995-2#1)(1996-10#1)(1997-7#1)(2008-7#3)
with an open technique##2##4##(2007-8#2)
with an open##19##3##(1990-4#1)(1990-7#1)(1991-12#2)(1991-4#1)(1991-6#1)(1995-2#1)(1996-10#1)(1996-8#1)(1997-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#3)(2008-8#1)
with an opening##4##3##(1992-9#1)(2008-2#1)(2008-3#1)(2008-9#1)
with an opportunity to##7##4##(1993-3#1)(1995-1#1)(1997-3#1)(2008-11#2)(2008-7#1)(2012-3#1)
with an optical fiber##2##4##(2008-10#1)(2008-3#1)
with an optical microscope##2##4##(2007-12#1)(2008-10#1)
with an optical ring##3##4##(2008-3#3)
with an optical slope efficiency of##2##6##(2008-2#2)
with an optical slope efficiency##3##5##(2007-12#1)(2008-2#2)
with an optical##34##3##(2005-11#1)(2007-11#1)(2007-12#8)(2008-1#1)(2008-10#3)(2008-2#7)(2008-3#11)(2008-4#1)(2008-5#1)
with an optical-to-optical##2##3##(2007-11#1)(2007-12#1)
with an optically##5##3##(1992-1#1)(2008-1#1)(2008-10#1)(2008-3#2)
with an optimal##5##3##(1991-12#1)(1992-8#1)(1995-2#1)(2008-10#1)(2008-2#1)
with an optimized##5##3##(1992-11#1)(2007-12#1)(2007-4#1)(2008-7#1)(2009-8#1)
with an optimum at##3##4##(1990-3#1)(2008-10#2)
with an optimum pH##2##4##(1990-6#1)(1994-8#1)
with an optimum range##2##4##(2008-10#2)
with an optimum##13##3##(1990-3#1)(1990-6#1)(1993-6#1)(1994-8#1)(1996-3#1)(2007-11#1)(2008-10#6)(2008-3#1)
with an option to##2##4##(1993-4#1)(2008-10#1)
with an oral ED50 =##2##5##(1995-3#2)
with an oral formulation##2##4##(2008-5#2)
with an oral##9##3##(1990-8#1)(1994-6#1)(1995-3#2)(2006-5#1)(2007-11#2)(2008-5#2)
with an order of potency##3##5##(1991-5#1)(1994-3#2)
with an order of##4##4##(1991-5#1)(1994-3#3)
with an order##5##3##(1991-5#1)(1994-3#3)(2008-10#1)
with an organic solvent##4##4##(1990-12#1)(1992-3#1)(2004-12#1)(2008-10#1)
with an organic##10##3##(1990-12#1)(1992-2#1)(1992-3#1)(1994-9#1)(2004-12#1)(2007-12#1)(2008-10#3)(2008-2#1)
with an orientation##2##3##(1994-5#1)(2008-8#1)
with an original##3##3##(2007-1#1)(2008-3#1)(2010-4#1)
with an oscillating##2##3##(2006-12#2)
with an osmotic##2##3##(1995-12#1)(2009-8#1)
with an outbreak of##2##4##(1997-4#1)(2012-2#1)
with an outbreak##3##3##(1997-4#1)(2012-12#1)(2012-2#1)
with an outer diameter of about##2##6##(1995-4#1)(1995-6#1)
with an outer diameter of##5##5##(1995-4#1)(1995-6#1)(2008-2#1)(2008-8#1)(2012-2#1)
with an outer##7##3##(1995-4#1)(1995-6#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2012-2#1)
with an outlier##2##3##(1993-12#1)(1993-3#1)
with an outline of the##2##5##(1993-2#1)(2006-7#1)
with an outline of##3##4##(1993-2#1)(2006-10#1)(2006-7#1)
with an output of##3##4##(2007-12#2)(2008-1#1)
with an output power of 1 W##3##7##(2007-12#2)(2008-3#1)
with an output power of##8##5##(2007-11#2)(2007-12#4)(2008-3#2)
with an output##14##3##(2007-11#2)(2007-12#7)(2008-1#1)(2008-3#4)
with an overall accuracy of##2##5##(2007-5#1)(2010-5#1)
with an overall incidence of 0##2##6##(2008-1#1)(2012-2#1)
with an overall incidence of##3##5##(2008-1#1)(2010-4#1)(2012-2#1)
with an overall incidence##4##4##(2007-8#1)(2008-1#1)(2010-4#1)(2012-2#1)
with an overall mortality of##2##5##(2007-8#1)(2012-2#1)
with an overall mortality##3##4##(2007-8#1)(2012-12#1)(2012-2#1)
with an overall prevalence of##4##5##(2007-8#1)(2008-1#1)(2008-4#1)(2011-1#1)
with an overall response rate of##2##6##(2005-7#1)(2008-10#1)
with an overall response##3##4##(2005-7#1)(2008-10#1)(2008-3#1)
with an overall yield of about##2##6##(1990-3#1)(1992-1#1)
with an overall yield of##4##5##(1990-12#1)(1990-3#1)(1992-1#1)(2005-11#1)
with an overall##43##3##(1990-12#1)(1990-3#1)(1992-1#1)(1992-10#1)(1997-1#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-12#1)(2006-2#1)(2007-5#1)(2007-8#3)(2008-1#3)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-12#1)(2010-10#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-8#1)
with an overinstrumented apex##2##4##(2013-1#2)
with an overpotential##2##3##(2008-10#2)
with an overview of the##4##5##(2005-10#1)(2007-5#1)(2008-5#1)(2008-9#1)
with an overview of##6##4##(2005-10#1)(2007-5#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-11#1)
with an overview##7##3##(2005-10#1)(2007-5#1)(2008-4#1)(2008-5#2)(2008-9#1)(2012-11#1)
with an oxidized##2##3##(2008-10#1)(2008-4#1)
with an oxygen sensitive##2##4##(1994-6#1)(2007-8#1)
with an oxygen##3##3##(1994-6#1)(1997-7#1)(2007-8#1)
with an ultranarrow##2##3##(2007-12#1)(2008-2#1)
with an ultrashort##2##3##(2007-12#1)(2008-3#1)
with an ultrasonic scalpel##2##4##(2007-8#2)
with an ultrasonic##5##3##(1990-9#1)(2007-11#1)(2007-8#2)(2008-10#1)
with an ultraviolet##2##3##(2008-10#1)(2008-2#1)
with an uncertainty of approximately##2##5##(1992-2#1)(2008-2#1)
with an uncertainty of##5##4##(1992-2#1)(2006-4#1)(2007-11#1)(2008-2#1)(2008-3#1)
with an uncertainty##7##3##(1992-2#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)
with an uncoated##5##3##(2007-12#3)(2008-1#1)(2008-3#1)
with an underlying diagnosis of##2##5##(2013-7#1)(2013-8#1)
with an underlying diagnosis##3##4##(2008-5#1)(2013-7#1)(2013-8#1)
with an underlying##10##3##(1993-4#1)(2007-10#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
with an understanding of the##3##5##(1993-2#1)(2007-7#1)(2008-10#1)
with an understanding of##4##4##(1993-2#1)(2007-4#1)(2007-7#1)(2008-10#1)
with an uneventful##3##3##(2010-6#1)(2011-2#1)(2012-12#1)
with an unexplained##2##3##(1997-3#1)(2013-7#1)
with an unfavorable##6##3##(1995-12#1)(2007-8#1)(2008-6#1)(2008-8#1)(2010-5#1)(2011-2#1)
with an unfavourable##2##3##(2013-1#1)(2013-8#1)
with an unknown etiology##3##4##(2008-5#1)(2010-10#1)(2012-3#1)
with an unknown##9##3##(1990-11#1)(1995-4#1)(2007-7#2)(2008-2#1)(2008-5#1)(2010-10#1)(2012-12#1)(2012-3#1)
with an unmodified##2##3##(1997-1#1)(2007-12#1)
with an unstable##2##3##(2009-5#1)(2013-8#1)
with an unusual presentation##4##4##(1997-8#1)(2008-7#1)(2010-9#1)(2012-3#1)
with an unusual##11##3##(1990-6#1)(1992-9#1)(1993-8#1)(1995-1#1)(1997-8#1)(2007-5#1)(2008-7#1)(2009-9#1)(2010-9#1)(2011-2#1)(2012-3#1)
with an unusually long##2##4##(1990-12#1)(1994-8#1)
with an unusually##4##3##(1990-12#1)(1994-8#1)(2006-2#1)(2008-5#1)
with an upper respiratory##3##4##(2006-10#2)(2013-8#1)
with an upper##5##3##(1991-10#1)(2006-10#2)(2007-4#1)(2013-8#1)
with an upside-down tapered lens##2##5##(2008-3#2)
with an##3345##2##(1990-1#3)(1990-10#5)(1990-11#11)(1990-12#20)(1990-2#6)(1990-3#8)(1990-4#4)(1990-5#23)(1990-6#14)(1990-7#12)(1990-8#15)(1990-9#4)(1991-1#6)(1991-10#6)(1991-11#8)(1991-12#12)(1991-2#17)(1991-3#11)(1991-4#10)(1991-5#12)(1991-6#14)(1991-7#13)(1991-8#13)(1991-9#8)(1992-1#17)(1992-10#3)(1992-11#7)(1992-12#13)(1992-2#16)(1992-3#16)(1992-4#2)(1992-5#7)(1992-6#11)(1992-7#9)(1992-8#14)(1992-9#18)(1993-1#6)(1993-10#2)(1993-11#15)(1993-12#11)(1993-2#7)(1993-3#18)(1993-4#6)(1993-5#2)(1993-6#11)(1993-7#4)(1993-8#8)(1993-9#13)(1994-10#2)(1994-11#19)(1994-12#17)(1994-2#14)(1994-3#24)(1994-4#1)(1994-5#15)(1994-6#13)(1994-7#1)(1994-8#21)(1994-9#11)(1995-1#12)(1995-10#5)(1995-11#6)(1995-12#11)(1995-2#10)(1995-3#22)(1995-4#3)(1995-5#9)(1995-6#7)(1995-7#3)(1995-8#8)(1995-9#3)(1996-1#8)(1996-10#7)(1996-11#8)(1996-12#13)(1996-2#17)(1996-3#10)(1996-4#7)(1996-5#19)(1996-6#11)(1996-7#8)(1996-8#15)(1996-9#10)(1997-1#12)(1997-2#16)(1997-3#14)(1997-4#19)(1997-5#11)(1997-6#10)(1997-7#12)(1997-8#14)(2004-11#8)(2004-12#2)(2004-2#1)(2004-3#1)(2004-4#1)(2005-1#3)(2005-10#11)(2005-11#29)(2005-12#2)(2005-4#2)(2005-5#1)(2005-6#1)(2005-7#4)(2005-8#6)(2005-9#3)(2006-1#2)(2006-10#47)(2006-11#10)(2006-12#29)(2006-2#16)(2006-3#5)(2006-4#14)(2006-5#10)(2006-6#11)(2006-7#7)(2006-8#8)(2006-9#2)(2007-1#13)(2007-10#14)(2007-11#71)(2007-12#159)(2007-2#18)(2007-3#8)(2007-4#8)(2007-5#16)(2007-6#8)(2007-7#22)(2007-8#74)(2007-9#15)(2008-1#41)(2008-10#303)(2008-11#63)(2008-12#23)(2008-2#133)(2008-3#181)(2008-4#34)(2008-5#82)(2008-6#41)(2008-7#66)(2008-8#39)(2008-9#31)(2009-10#20)(2009-11#7)(2009-12#5)(2009-2#8)(2009-3#7)(2009-4#8)(2009-5#13)(2009-6#11)(2009-7#4)(2009-8#9)(2009-9#17)(2010-1#4)(2010-10#16)(2010-11#8)(2010-12#33)(2010-2#11)(2010-3#8)(2010-4#25)(2010-5#13)(2010-6#9)(2010-7#11)(2010-8#11)(2010-9#12)(2011-1#35)(2011-10#1)(2011-11#2)(2011-12#3)(2011-2#70)(2011-3#2)(2012-1#16)(2012-11#2)(2012-12#33)(2012-2#59)(2012-3#29)(2012-5#1)(2012-9#1)(2013-1#94)(2013-7#19)(2013-8#40)
with anabolic##2##2##(1991-3#2)
with anaemia##2##2##(2008-3#1)(2009-8#1)
with anaerobic##5##2##(2006-8#2)(2007-12#1)(2011-2#1)(2013-1#1)
with anaesthetic##2##2##(2006-10#2)
with anal##3##2##(1991-6#1)(1992-10#2)
with analgesia##2##2##(1993-4#1)(2012-12#1)
with analgesic##6##2##(2006-10#1)(2007-2#1)(2008-10#1)(2008-6#1)(2010-6#1)(2013-1#1)
with analog##2##2##(2008-2#2)
with analogous##6##2##(2008-10#2)(2008-3#1)(2008-5#1)(2010-5#1)(2011-1#1)
with analyses of##3##3##(1990-12#1)(1995-12#1)(1997-7#1)
with analyses##5##2##(1990-12#1)(1995-12#1)(1997-7#1)(2008-10#1)(2008-11#1)
with analysis and##3##3##(2007-12#1)(2008-10#1)(2011-1#1)
with analysis by##3##3##(2007-8#1)(2008-10#2)
with analysis of the##2##4##(2008-8#1)(2010-12#1)
with analysis of variance##2##4##(2007-5#1)(2012-2#1)
with analysis of##11##3##(1994-12#1)(1995-8#1)(1996-8#1)(2007-5#1)(2008-2#1)(2008-8#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
with analysis##21##2##(1991-2#1)(1994-12#1)(1995-8#1)(1996-8#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-8#1)(2009-9#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)
with analyte##3##2##(1997-2#1)(2008-10#2)
with analytic results##2##3##(2006-10#1)(2008-3#1)
with analytical##14##2##(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-6#1)(2012-11#1)
with anaphylactic##2##2##(2007-12#1)(2011-1#1)
with anaphylaxis##3##2##(2008-8#1)(2013-1#2)
with anaplastic##4##2##(1996-4#1)(2009-5#1)(2012-1#2)
with anatomic##2##2##(2008-1#1)(2011-7#1)
with anatomical and##2##3##(1992-9#1)(2008-4#1)
with anatomical spatula##2##3##(2011-2#2)
with anatomical##7##2##(1992-5#1)(1992-9#1)(2007-11#1)(2008-4#1)(2011-2#2)(2012-12#1)
with anatomy##2##2##(2007-11#1)(2010-9#1)
with anchor##2##2##(2008-7#1)(2010-9#1)
with ancillary##2##2##(1994-6#1)(2008-6#1)
with and activate##2##3##(1994-3#1)(2008-1#1)
with and as an##2##4##(1994-2#1)(2011-2#1)
with and one##2##3##(1990-3#1)(2007-5#1)
with and the##3##3##(1995-1#1)(2007-8#1)(2009-7#1)
with and to##2##3##(2008-11#1)(2008-4#1)
with and without a family history of alcoholism##2##8##(1991-1#1)(1994-2#1)
with and without a family history of##3##7##(1991-1#1)(1994-2#1)(2008-3#1)
with and without a history of##3##6##(2007-10#1)(2012-3#2)
with and without a##23##4##(1990-3#1)(1990-7#1)(1991-1#1)(1991-12#1)(1992-12#1)(1994-2#2)(1994-7#1)(2004-9#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-6#1)(2008-2#1)(2008-3#4)(2012-1#1)(2012-2#1)(2012-3#2)
with and without added##3##4##(1995-7#1)(2005-11#1)(2008-10#1)
with and without an##3##4##(2007-12#1)(2007-6#1)(2008-10#1)
with and without cholesterol##2##4##(1995-8#1)(2006-10#1)
with and without cirrhosis##3##4##(2007-11#1)(2011-1#2)
with and without contrast##2##4##(2008-7#1)(2013-7#1)
with and without dementia in##3##5##(2008-7#2)(2012-3#1)
with and without dementia##4##4##(2008-7#3)(2012-3#1)
with and without detergent##2##4##(2008-4#2)
with and without diabetes##2##4##(2007-12#1)(2008-3#1)
with and without endothelium##2##4##(1993-11#1)(1994-2#1)
with and without familial risk for dyslexia##2##7##(2007-9#2)
with and without familial##3##4##(1991-1#1)(2007-9#2)
with and without half-visors##2##4##(2010-1#2)
with and without hepatic dysfunction##3##5##(2005-8#2)(2012-3#1)
with and without large-volume sample stacking##2##6##(2008-10#2)
with and without left ventricular##2##5##(2008-3#1)(2008-4#1)
with and without oesophageal varices##2##5##(2009-8#1)(2013-1#1)
with and without oral##2##4##(1991-2#1)(2008-5#1)
with and without osteoporosis##3##4##(2010-3#3)
with and without previous##5##4##(1992-3#1)(2007-8#2)(2008-10#1)(2010-11#1)
with and without renal##2##4##(1990-3#1)(2005-10#1)
with and without symptoms##2##4##(2007-7#1)(2008-3#1)
with and without syringomyelia##3##4##(2006-5#3)
with and without the addition of##4##6##(1995-2#1)(2008-10#1)(2008-5#1)(2010-4#1)
with and without the extract##2##5##(2008-5#1)(2009-5#1)
with and without the presence of##2##6##(1996-7#1)(2007-12#1)
with and without the##26##4##(1991-8#1)(1994-11#2)(1995-2#1)(1996-7#1)(1996-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#5)(2008-5#2)(2008-6#1)(2009-11#1)(2009-5#1)(2010-4#1)(2011-1#1)(2013-1#2)
with and without tobacco##2##4##(1992-8#1)(2013-1#1)
with and without wavelet##2##4##(2011-1#2)
with and without##359##3##(1990-10#2)(1990-11#1)(1990-2#1)(1990-3#2)(1990-4#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#3)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#4)(1991-4#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-9#2)(1994-11#3)(1994-2#4)(1994-3#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-2#3)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#2)(1996-11#1)(1996-12#2)(1996-5#1)(1996-7#1)(1996-8#2)(1997-2#1)(1997-6#1)(1997-7#1)(2004-12#2)(2004-4#1)(2004-8#1)(2004-9#2)(2005-1#1)(2005-10#2)(2005-11#1)(2005-8#2)(2005-9#2)(2006-10#6)(2006-11#1)(2006-12#4)(2006-2#1)(2006-5#6)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#4)(2007-12#14)(2007-2#1)(2007-4#1)(2007-6#4)(2007-7#6)(2007-8#8)(2007-9#3)(2008-10#32)(2008-11#5)(2008-12#3)(2008-2#7)(2008-3#24)(2008-4#3)(2008-5#8)(2008-6#2)(2008-7#7)(2008-8#5)(2008-9#7)(2009-10#2)(2009-11#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#2)(2010-3#6)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#12)(2011-12#3)(2011-2#5)(2012-1#3)(2012-12#5)(2012-2#8)(2012-3#9)(2013-1#22)(2013-7#4)(2013-8#6)
with and##430##2##(1990-10#2)(1990-11#1)(1990-2#1)(1990-3#4)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#3)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#5)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-9#2)(1994-11#3)(1994-12#1)(1994-2#6)(1994-3#2)(1994-7#1)(1994-8#2)(1995-1#2)(1995-2#4)(1995-3#2)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#2)(1996-11#1)(1996-12#4)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#2)(1997-2#1)(1997-6#1)(1997-7#1)(2004-12#2)(2004-4#1)(2004-8#1)(2004-9#2)(2005-1#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-8#2)(2005-9#2)(2006-10#7)(2006-11#2)(2006-12#4)(2006-2#1)(2006-5#7)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#4)(2007-12#14)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#4)(2007-7#7)(2007-8#9)(2007-9#3)(2008-1#1)(2008-10#38)(2008-11#7)(2008-12#3)(2008-2#7)(2008-3#25)(2008-4#5)(2008-5#10)(2008-6#2)(2008-7#9)(2008-8#6)(2008-9#10)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#3)(2010-1#2)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#6)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#13)(2011-12#3)(2011-2#9)(2012-1#3)(2012-12#6)(2012-2#10)(2012-3#9)(2013-1#24)(2013-7#4)(2013-8#8)
with androgen##10##2##(1991-3#3)(1995-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-8#1)
with androgens##3##2##(1990-9#1)(1994-9#1)(2009-4#1)
with anemia and##2##3##(2007-8#1)(2012-12#1)
with anemia##8##2##(1992-6#1)(2007-8#1)(2008-7#1)(2009-10#1)(2011-2#2)(2012-12#1)(2012-2#1)
with aneurysm##2##2##(1995-11#1)(2010-8#1)
with aneurysmal##9##2##(1995-11#1)(2005-10#1)(2006-11#2)(2007-10#1)(2013-1#4)
with aneurysms of##2##3##(2007-8#1)(2012-12#1)
with aneurysms##8##2##(2005-5#1)(2006-10#1)(2007-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
with angina pectoris##6##3##(1992-4#1)(1997-2#1)(2007-8#2)(2008-5#1)(2012-2#1)
with angina##12##2##(1990-4#1)(1992-4#1)(1997-2#1)(2007-8#5)(2008-3#1)(2008-5#1)(2010-8#1)(2012-2#1)
with angiogenesis and##3##3##(2009-4#1)(2010-6#1)(2010-8#1)
with angiogenesis##8##2##(1991-3#1)(1996-10#1)(2008-6#1)(2009-11#1)(2009-4#1)(2010-12#1)(2010-6#1)(2010-8#1)
with angiographic##3##2##(1991-7#1)(2006-10#1)(2006-11#1)
with angiographically##9##2##(1990-8#1)(1993-12#1)(1994-11#1)(1995-4#1)(1996-8#1)(2006-10#1)(2007-9#1)(2008-12#1)(2012-2#1)
with angiography and##2##3##(1993-6#1)(2011-12#1)
with angiography##4##2##(1991-3#1)(1993-6#1)(2011-12#1)(2011-2#1)
with angiomas##2##2##(2007-11#1)(2013-7#1)
with angioplasty and##2##3##(1997-8#1)(2006-11#1)
with angiotensin II##5##3##(1990-11#1)(1995-11#2)(1996-5#1)(1996-8#1)
with angiotensin converting enzyme##3##4##(1992-12#1)(1992-9#1)(2010-12#1)
with angiotensin##12##2##(1990-11#1)(1992-12#1)(1992-9#1)(1995-11#2)(1995-12#1)(1996-5#1)(1996-8#1)(2007-1#1)(2007-8#1)(2008-1#1)(2010-12#1)
with angiotensin-converting enzyme inhibitors##3##4##(1992-4#1)(2006-10#1)(2007-8#1)
with angiotensin-converting enzyme##4##3##(1992-3#1)(1992-4#1)(2006-10#1)(2007-8#1)
with angle##5##2##(2007-12#1)(2008-2#3)(2008-3#1)
with angled##3##2##(2006-3#1)(2007-11#1)(2010-3#1)
with angular multiplexing##2##3##(2008-2#1)(2008-3#1)
with angular perturbations##2##3##(2013-1#2)
with angular##8##2##(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2013-1#2)
with anhydrosis##3##2##(2012-2#3)
with anhydrous##3##2##(1991-7#1)(2008-10#1)(2013-8#1)
with animal cells##3##3##(2008-11#2)(2011-1#1)
with animal experimentation##2##3##(1990-12#1)(2005-10#1)
with animal models##7##3##(1992-1#1)(1996-10#1)(2006-10#1)(2007-11#1)(2008-7#1)(2010-12#1)(2011-2#1)
with animal##17##2##(1990-12#1)(1990-5#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-3#1)(1996-10#1)(2005-10#1)(2006-10#1)(2007-11#1)(2008-11#2)(2008-7#1)(2009-2#1)(2010-12#1)(2011-1#1)(2011-2#1)
with animals##12##2##(1995-8#1)(2007-2#3)(2007-4#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-12#1)(2012-12#2)(2013-1#1)
with anion##2##2##(2008-10#2)
with anion-exchange##2##2##(2008-10#2)
with anionic sites##2##3##(2008-10#2)
with anionic##7##2##(2008-10#4)(2008-5#2)(2010-5#1)
with aniracetam (50 nmol/mouse)##2##4##(1995-12#2)
with aniridia##4##2##(1990-12#2)(2006-11#1)(2010-7#1)
with anisotropic##2##2##(2008-2#1)(2010-5#1)
with ankylosing spondylitis (AS)##3##4##(2006-10#1)(2008-10#1)(2011-2#1)
with ankylosing spondylitis##12##3##(2006-10#2)(2007-11#2)(2007-6#1)(2008-10#1)(2008-4#1)(2010-4#1)(2011-2#4)
with ankylosing##13##2##(2006-10#2)(2007-11#2)(2007-6#1)(2008-10#2)(2008-4#1)(2010-4#1)(2011-2#4)
with annual##3##2##(2005-7#1)(2007-8#1)(2009-4#1)
with annuloaortic ectasia##4##3##(2007-8#1)(2008-5#2)(2009-4#1)
with annulus##2##2##(2007-8#1)(2008-5#1)
with anodic stripping##2##3##(2007-8#1)(2008-10#1)
with anomalous##9##2##(1995-5#1)(2007-12#1)(2007-8#3)(2008-2#1)(2008-7#1)(2011-2#1)(2013-8#1)
with anoplasty##2##2##(1990-3#2)
with anorectal##2##2##(2010-2#1)(2010-5#1)
with anorectic##2##2##(1997-7#1)(2008-4#1)
with anorexia nervosa (AN)##2##4##(2007-7#2)
with anorexia nervosa##22##3##(1991-11#1)(1995-11#2)(1996-1#2)(2005-12#1)(2005-6#2)(2006-6#5)(2006-7#4)(2007-12#1)(2007-7#2)(2011-12#1)(2011-2#1)
with anorexia##27##2##(1991-11#1)(1995-11#2)(1996-1#2)(1996-6#1)(2005-12#1)(2005-6#2)(2006-6#6)(2006-7#4)(2007-12#1)(2007-7#2)(2011-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
with another DNA##2##3##(1993-12#1)(1994-8#1)
with another group of##2##4##(1992-12#1)(1997-4#1)
with another protein##2##3##(1997-4#1)(2008-4#1)
with another##66##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-6#1)(1994-2#2)(1994-8#1)(1994-9#1)(1995-2#1)(1996-1#1)(1996-10#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-4#2)(1997-5#2)(2005-11#1)(2006-2#2)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#5)(2008-3#2)(2008-4#4)(2008-6#1)(2008-9#2)(2009-5#2)(2009-6#1)(2009-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
with antagonist##5##2##(1991-3#1)(2006-12#1)(2008-10#2)(2012-1#1)
with antagonistic activity##2##3##(1990-2#1)(2008-10#1)
with antagonistic##3##2##(1990-2#1)(2008-10#1)(2010-3#1)
with antagonists##3##2##(2007-12#1)(2008-10#2)
with anterior and posterior##4##4##(2006-10#1)(2007-1#1)(2007-11#1)(2012-3#1)
with anterior stabilization##2##3##(2007-11#2)
with anterior##15##2##(2006-10#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-8#1)(2008-7#1)(2009-4#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#1)
with anterograde##3##2##(1990-4#1)(2007-10#1)(2010-12#1)
with anthropometric##3##2##(2007-1#1)(2007-8#1)(2013-1#1)
with anti##9##2##(1990-11#1)(1991-6#1)(1995-3#1)(2007-2#2)(2008-10#1)(2010-1#1)(2010-6#1)(2012-12#1)
with anti-(BCOADC) serum##2##3##(1991-2#2)
with anti-A##4##2##(1992-12#1)(1995-12#3)
with anti-CD3##2##2##(1991-12#1)(2005-8#1)
with anti-CD36##2##2##(1991-2#1)(1991-6#1)
with anti-CD4##3##2##(1990-2#1)(1991-8#1)(1994-11#1)
with anti-CD8##2##2##(1994-9#1)(2013-1#1)
with anti-D##2##2##(1991-10#1)(2013-8#1)
with anti-Fas antibody##2##3##(2008-8#2)
with anti-Fas##3##2##(2008-8#2)(2009-9#1)
with anti-HIV##4##2##(1994-12#2)(2007-1#1)(2011-3#1)
with anti-Hu##2##2##(1996-11#1)(2009-3#1)
with anti-IL-6##3##2##(2008-10#1)(2013-1#2)
with anti-IgG##7##2##(1992-3#1)(1993-6#1)(1994-12#1)(1997-4#1)(2007-2#3)
with anti-P450##3##2##(1991-1#1)(1995-3#2)
with anti-Ro##2##2##(2008-7#2)
with anti-angiogenic therapies##2##3##(1997-1#1)(2013-8#1)
with anti-asialo GM1##2##3##(1994-2#2)
with anti-cancer##2##2##(2009-3#1)(2012-12#1)
with anti-human##6##2##(1991-10#1)(1991-8#1)(1994-9#1)(1997-2#1)(1997-5#1)(2008-2#1)
with anti-infective##2##2##(2011-2#1)(2012-11#1)
with anti-inflammatory##6##2##(2007-2#1)(2008-10#2)(2008-8#1)(2012-12#1)(2013-1#1)
with anti-insulin##2##2##(1991-12#1)(2007-8#1)
with anti-kinectin##2##2##(1996-6#2)
with anti-neutrophil cytoplasmic##2##3##(1996-1#1)(2010-4#1)
with anti-peptide antibodies##2##3##(1991-10#1)(2008-4#1)
with anti-phosphotyrosine antibody##2##3##(1995-2#1)(1997-1#1)
with anti-phosphotyrosine##4##2##(1992-12#1)(1992-9#1)(1995-2#1)(1997-1#1)
with anti-platelet##2##2##(2005-11#1)(2008-12#1)
with anti-psychotic medications##2##3##(2012-3#1)(2013-8#1)
with anti-psychotic##3##2##(2012-3#1)(2013-8#2)
with anti-rat##2##2##(1990-11#1)(1991-3#1)
with anti-reflux##2##2##(1992-10#1)(2010-12#1)
with anti-serum##2##2##(1991-12#1)(1991-8#1)
with anti-snake venom##2##3##(2012-2#2)
with anti-tubercular chemotherapy##2##3##(2008-7#2)
with anti-tumor##4##2##(2010-12#2)(2011-2#2)
with antiHBc##3##2##(2012-2#3)
with antibacterial activity##2##3##(2006-12#1)(2007-1#1)
with antibacterial##4##2##(2005-7#1)(2006-12#1)(2007-1#1)(2013-1#1)
with antibiotic therapy##2##3##(2008-12#1)(2012-12#1)
with antibiotic##10##2##(1991-3#1)(1993-5#1)(2006-8#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
with antibiotics alone##4##3##(1990-10#1)(1991-1#1)(2007-7#1)(2010-5#1)
with antibiotics and##6##3##(1996-11#2)(2007-12#1)(2007-7#1)(2011-2#2)
with antibiotics for##2##3##(1996-1#1)(2008-6#1)
with antibiotics in##2##3##(1994-12#1)(2011-2#1)
with antibiotics##41##2##(1990-10#1)(1990-5#1)(1991-1#1)(1991-4#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1995-11#2)(1996-1#1)(1996-11#2)(1996-4#1)(1996-6#1)(2005-10#1)(2007-12#1)(2007-2#1)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#1)(2008-6#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
with antibodies against the##5##4##(1990-11#1)(1991-9#1)(1992-12#1)(1997-1#1)(1997-7#1)
with antibodies against##31##3##(1990-11#2)(1990-6#1)(1991-10#1)(1991-4#1)(1991-9#1)(1992-12#2)(1992-4#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-8#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2008-10#2)(2008-4#3)(2008-9#1)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#1)
with antibodies and##2##3##(2008-10#1)(2008-9#1)
with antibodies directed against##4##4##(1993-3#1)(1994-12#1)(1994-8#1)(1997-3#1)
with antibodies raised##3##3##(1990-2#1)(1992-6#1)(1996-11#1)
with antibodies specific for##5##4##(1993-6#1)(1995-12#1)(1995-3#1)(2008-11#1)(2008-7#1)
with antibodies specific##6##3##(1993-6#1)(1995-12#1)(1995-3#1)(2008-11#1)(2008-7#1)(2008-9#1)
with antibodies that##3##3##(1995-2#1)(1995-6#1)(2008-10#1)
with antibodies to antigens##2##4##(1992-9#1)(2012-12#1)
with antibodies to the##2##4##(1993-12#1)(1996-6#1)
with antibodies to##26##3##(1990-11#1)(1990-8#1)(1990-9#1)(1991-10#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-9#1)(1993-12#1)(1994-2#1)(1995-1#1)(1995-11#1)(1996-12#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-6#1)(2005-8#1)(2006-11#1)(2007-6#1)(2008-5#1)(2008-7#1)(2012-12#1)
with antibodies##82##2##(1990-11#3)(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-4#1)(1991-9#1)(1992-1#1)(1992-12#4)(1992-3#1)(1992-4#2)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-11#1)(1996-12#2)(1996-5#3)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#3)(1997-7#1)(2005-8#1)(2006-11#1)(2007-6#1)(2008-10#4)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#3)(2009-5#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
with antibody against##4##3##(1991-5#2)(1993-11#1)(1994-5#1)
with antibody and##2##3##(1991-5#1)(2008-4#1)
with antibody to##5##3##(1992-8#1)(1992-9#1)(1994-5#1)(2008-10#1)(2008-5#1)
with antibody##31##2##(1990-2#1)(1991-5#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-5#2)(1995-5#1)(1996-5#1)(1997-7#1)(2005-11#2)(2007-11#1)(2007-2#6)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-2#1)
with anticancer drugs##2##3##(2006-8#1)(2008-3#1)
with anticancer##5##2##(1993-1#1)(2006-8#1)(2008-3#1)(2009-9#1)(2012-2#1)
with anticholinergics##2##2##(1993-10#1)(2011-1#1)
with anticipated body image dissatisfaction##2##5##(2007-12#2)
with anticipated##6##2##(1996-12#1)(2005-5#1)(2006-10#1)(2007-12#2)(2007-9#1)
with anticipation##3##2##(1996-5#1)(1997-5#1)(2005-7#1)
with anticipatory##2##2##(1992-12#1)(2007-2#1)
with anticoagulant##2##2##(2006-10#1)(2008-10#1)
with anticoagulants##6##2##(1995-4#1)(2006-10#2)(2008-7#2)(2013-1#1)
with anticoagulation##3##2##(1990-2#1)(1997-2#1)(2010-6#1)
with anticonvulsant medication##2##3##(1997-3#1)(2006-8#1)
with anticonvulsant##4##2##(1994-2#1)(1997-3#1)(2006-8#1)(2008-9#1)
with anticonvulsants##3##2##(2008-6#1)(2012-2#1)(2013-7#1)
with antidepressant##4##2##(2005-6#1)(2009-8#1)(2009-9#1)(2011-2#1)
with antidepressants or##2##3##(1997-6#1)(2008-3#1)
with antidepressants##9##2##(1993-12#1)(1997-6#1)(2005-6#1)(2006-9#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-7#1)(2013-8#1)
with antidiabetic##2##2##(1990-2#1)(2013-1#1)
with antiestrogen binding sites##2##4##(1990-2#1)(1991-9#1)
with antiestrogen##5##2##(1990-2#1)(1991-9#1)(1992-5#2)(1996-4#1)
with antifungal agents##3##3##(2007-7#1)(2011-2#1)(2013-8#1)
with antifungal##7##2##(2007-12#1)(2007-7#1)(2008-5#1)(2011-2#2)(2012-3#1)(2013-8#1)
with antigen##15##2##(1990-12#1)(1990-6#1)(1990-8#1)(1991-12#1)(1992-7#1)(1993-3#1)(1995-5#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)
with antigen-specific##2##2##(2008-4#1)(2012-2#1)
with antigenic##2##2##(1994-11#1)(2012-3#1)
with antigens##4##2##(1990-12#1)(1992-5#1)(2008-10#1)(2008-4#1)
with antihypertensive agents##2##3##(2008-3#1)(2011-1#1)
with antihypertensive drugs##6##3##(1990-9#1)(1992-2#1)(2008-3#2)(2008-7#1)(2010-5#1)
with antihypertensive therapy##2##3##(2010-12#2)
with antihypertensive##14##2##(1990-9#1)(1992-2#1)(2008-1#1)(2008-3#5)(2008-7#1)(2009-6#1)(2010-12#2)(2010-5#1)(2011-1#1)
with antimalarial##3##2##(1996-7#1)(1997-5#1)(2008-4#1)
with antimalarials##2##2##(2008-2#1)(2010-12#1)
with antimicrobial activity##3##3##(2007-1#1)(2009-6#1)(2010-4#1)
with antimicrobial potential##2##3##(2008-2#1)(2013-7#1)
with antimicrobial therapy##2##3##(1993-6#1)(2011-2#1)
with antimicrobial##10##2##(1993-6#1)(2006-8#1)(2007-1#1)(2008-2#1)(2008-5#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-7#1)
with antimicrobials##4##2##(2007-3#1)(2007-7#1)(2008-5#1)(2012-3#1)
with antimycin A##2##3##(1992-11#1)(2010-12#1)
with antineoplastic activity##2##3##(2003-11#1)(2007-1#1)
with antineoplastic##4##2##(1991-6#1)(2003-11#1)(2007-1#1)(2012-3#1)
with antioxidant properties##5##3##(1994-9#1)(2005-1#1)(2007-8#1)(2008-4#1)(2009-8#1)
with antioxidant##12##2##(1991-9#1)(1994-9#1)(2005-1#1)(2005-10#1)(2006-12#1)(2006-2#1)(2007-8#1)(2008-4#1)(2008-5#1)(2009-8#1)(2012-1#1)(2013-1#1)
with antioxidants such as glutathione##2##5##(2008-5#2)
with antioxidants##14##2##(1991-9#1)(1994-3#1)(1996-2#1)(2005-1#1)(2007-7#1)(2008-1#2)(2008-5#2)(2012-1#3)(2012-12#1)(2012-2#1)
with antiphospholipid antibodies and##2##4##(2006-10#1)(2011-1#1)
with antiphospholipid antibodies##4##3##(1992-5#1)(2006-10#2)(2011-1#1)
with antiphospholipid syndrome##4##3##(1997-8#1)(2006-10#2)(2012-3#1)
with antiphospholipid##9##2##(1992-5#1)(1997-8#1)(2006-10#4)(2007-2#1)(2011-1#1)(2012-3#1)
with antiplatelet agents##2##3##(2007-10#1)(2013-8#1)
with antiplatelet drugs##3##3##(1990-11#1)(2008-5#1)(2008-8#1)
with antiplatelet therapy##2##3##(2007-10#2)
with antiplatelet##7##2##(1990-11#1)(2007-10#3)(2008-5#1)(2008-8#1)(2013-8#1)
with antiproliferative##3##2##(1995-2#2)(1997-2#1)
with antipsychotic##2##2##(1995-2#1)(2008-3#1)
with antireflux##3##2##(2006-10#1)(2010-12#1)(2013-8#1)
with antiretroviral therapy##6##3##(2006-10#1)(2008-3#1)(2008-8#1)(2009-5#1)(2010-8#1)(2012-12#1)
with antiretroviral##9##2##(2006-10#1)(2007-11#1)(2008-3#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-8#2)(2012-12#1)
with antiretrovirals##4##2##(2007-2#2)(2008-8#1)(2009-2#1)
with antisense RNA complementary to##2##5##(1991-9#2)
with antisense RNA##3##3##(1991-9#2)(1997-1#1)
with antisense oligonucleotides##2##3##(1996-3#1)(2004-1#1)
with antisense##8##2##(1991-9#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#1)(2004-1#1)
with antisera to##2##3##(2008-10#1)(2008-5#1)
with antisera##4##2##(1992-8#1)(1994-6#1)(2008-10#1)(2008-5#1)
with antiserum against##4##3##(1993-11#1)(1996-5#1)(2007-12#2)
with antiserum raised against the##2##5##(1993-5#1)(1997-4#1)
with antiserum raised against##3##4##(1993-5#1)(1997-4#1)(1997-7#1)
with antiserum to##4##3##(1990-11#1)(1993-11#1)(1994-2#1)(2008-5#1)
with antiserum##13##2##(1990-11#3)(1993-11#2)(1993-5#1)(1994-2#1)(1996-5#1)(1997-4#1)(1997-7#1)(2007-12#2)(2008-5#1)
with antisocial personality disorder##2##4##(1991-1#1)(2011-2#1)
with antisocial personality##3##3##(1991-1#1)(1994-2#1)(2011-2#1)
with antisocial##4##2##(1991-1#1)(1994-2#1)(2007-9#1)(2011-2#1)
with antithrombin III##4##3##(1990-11#2)(1995-2#2)
with antithyroid drugs##4##3##(2006-11#1)(2011-2#2)(2012-3#1)
with antituberculosis drugs##3##3##(2007-7#1)(2012-2#2)
with antituberculous therapy##2##3##(2007-12#1)(2008-1#1)
with antitumor##6##2##(1991-4#1)(1994-5#1)(2006-10#1)(2007-11#1)(2008-9#1)(2009-12#1)
with antiviral activity##2##3##(1997-2#1)(1997-4#1)
with antiviral agents##2##3##(1995-9#1)(2007-11#1)
with antiviral##10##2##(1991-3#1)(1993-8#1)(1995-9#1)(1997-2#1)(1997-4#1)(2007-11#1)(2009-8#1)(2010-12#1)(2012-2#1)(2012-3#1)
with ants##2##2##(2008-5#1)(2012-2#1)
with anxiety and depression##6##4##(2007-2#1)(2008-12#1)(2009-3#1)(2011-12#1)(2013-1#2)
with anxiety and##8##3##(1996-10#1)(2007-2#1)(2008-12#1)(2009-10#1)(2009-3#1)(2011-12#1)(2013-1#2)
with anxiety disorders##3##3##(1996-1#1)(2013-8#2)
with anxiety##20##2##(1991-12#1)(1994-3#1)(1996-1#1)(1996-10#1)(1996-2#1)(2004-3#1)(2006-10#1)(2007-2#1)(2008-12#1)(2008-4#1)(2009-10#1)(2009-3#1)(2009-5#1)(2011-12#1)(2013-1#4)(2013-8#2)
with anxious##2##2##(1991-4#1)(2011-2#1)
with any cancer diagnosed when younger than 45 years##2##9##(2010-3#2)
with any known##5##3##(1990-4#1)(1995-3#1)(1996-12#1)(2008-10#1)(2008-9#1)
with any of the other##2##5##(1990-5#1)(2008-10#1)
with any of the##26##4##(1990-5#1)(1992-7#1)(1992-9#1)(1993-3#1)(1994-11#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-8#2)(2006-9#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#2)(2009-4#1)(2012-1#1)(2012-3#1)
with any of these##2##4##(1991-2#1)(1997-2#1)
with any of##30##3##(1990-5#1)(1991-2#1)(1992-7#1)(1992-9#1)(1993-3#1)(1994-11#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-8#2)(2006-9#1)(2007-11#2)(2007-12#1)(2008-10#7)(2008-12#1)(2008-5#1)(2008-7#2)(2009-4#1)(2012-1#1)(2012-3#1)
with any one of##2##4##(2008-10#1)(2008-4#1)
with any other##18##3##(1991-2#1)(1992-2#1)(1992-7#1)(1993-11#2)(1994-3#1)(1995-11#1)(1995-8#1)(1996-2#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-12#1)
with any previously##2##3##(1990-7#1)(1994-12#1)
with any significant##2##3##(1995-6#1)(2006-8#1)
with any treatment##2##3##(2006-9#1)(2008-10#1)
with any##114##2##(1990-4#1)(1990-5#1)(1990-7#1)(1991-2#2)(1991-3#1)(1992-12#1)(1992-2#1)(1992-7#2)(1992-9#1)(1993-11#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-11#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-4#2)(1997-8#2)(2006-10#2)(2006-6#1)(2006-8#1)(2006-9#2)(2007-11#4)(2007-12#6)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#16)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#3)(2008-9#4)(2009-10#1)(2009-4#2)(2009-6#2)(2010-12#1)(2010-3#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
with anyone##3##2##(1995-6#1)(2006-7#1)(2009-9#1)
with aortic arch##3##3##(2007-8#2)(2008-8#1)
with aortic dissection##2##3##(2012-1#1)(2012-2#1)
with aortic regurgitation##2##3##(1995-3#1)(2008-11#1)
with aortic root##3##3##(2007-8#2)(2007-9#1)
with aortic stenosis and##2##4##(2012-2#2)
with aortic stenosis##5##3##(1990-8#1)(2011-2#1)(2012-2#3)
with aortic valve##3##3##(1991-10#1)(2007-8#1)(2012-2#1)
with aortic##28##2##(1990-12#1)(1990-8#1)(1991-10#1)(1992-8#1)(1995-3#1)(2007-4#1)(2007-8#9)(2007-9#1)(2008-11#1)(2008-4#1)(2008-8#1)(2011-2#2)(2012-1#2)(2012-2#5)
with aortocaval##2##2##(1990-5#1)(1993-3#1)
with aortoiliacal atherosclerosis##2##3##(1992-8#2)
with aortopulmonary##2##2##(2008-11#1)(2009-8#1)
with aphasia and##2##3##(2006-4#1)(2013-8#1)
with aphasia experience having conversations##2##5##(2012-3#2)
with aphasia##12##2##(2006-4#1)(2007-7#2)(2012-2#1)(2012-3#5)(2013-1#1)(2013-7#1)(2013-8#1)
with aphid##2##2##(2008-10#2)
with aphidicolin##2##2##(2003-11#1)(2012-2#1)
with aplastic anaemia##2##3##(2012-2#2)
with aplastic anemia##2##3##(2006-10#2)
with aplastic##4##2##(2006-10#2)(2012-2#2)
with apo##3##2##(1990-4#1)(1993-11#1)(1993-12#1)
with apoE##4##2##(1991-12#1)(1992-2#1)(1997-4#2)
with apocrine changes##2##3##(1993-1#1)(2008-4#1)
with apocrine differentiation##2##3##(2004-1#1)(2012-2#1)
with apocrine##7##2##(1992-8#1)(1993-1#2)(2004-1#1)(2008-12#1)(2008-4#1)(2012-2#1)
with apolipoprotein E##4##3##(1991-12#1)(1994-8#1)(1995-3#1)(1997-4#1)
with apolipoprotein##8##2##(1990-5#1)(1991-12#1)(1993-6#1)(1994-8#1)(1995-3#1)(1995-5#1)(1997-4#1)(2013-1#1)
with apoptosis in##2##3##(1994-10#1)(1995-2#1)
with apoptosis##8##2##(1994-10#1)(1995-2#1)(2008-10#2)(2008-9#2)(2009-9#1)(2010-5#1)
with apoptotic##3##2##(2008-5#1)(2011-1#1)(2013-1#1)
with apparent Km =##2##4##(1990-11#2)
with apparent Km##3##3##(1990-11#2)(1995-8#1)
with apparent M(r)##2##3##(1992-11#1)(1994-6#1)
with apparent clinical##2##3##(2006-5#1)(2006-6#1)
with apparent molecular mass##2##4##(1995-3#1)(1996-12#1)
with apparent molecular masses of##4##5##(1994-12#1)(1996-4#1)(1997-4#1)(2008-10#1)
with apparent molecular masses##6##4##(1994-12#1)(1996-4#1)(1997-2#1)(1997-4#1)(2008-10#1)(2009-4#1)
with apparent molecular sizes##2##4##(1994-12#1)(1997-7#1)
with apparent molecular weights of##2##5##(1990-5#1)(1994-11#1)
with apparent molecular##12##3##(1990-5#1)(1994-11#1)(1994-12#2)(1995-3#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#1)(2009-4#1)
with apparent##34##2##(1990-11#2)(1990-12#1)(1990-5#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-4#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#2)(1994-9#1)(1995-3#1)(1995-8#1)(1996-12#3)(1996-4#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-5#1)(2006-6#1)(2008-10#1)(2008-4#1)(2009-4#1)(2012-3#1)(2013-1#1)
with apparently intact membranes##2##4##(1996-9#2)
with apparently##7##2##(1996-9#2)(1997-4#1)(2005-7#1)(2008-11#1)(2008-5#1)(2012-2#1)
with appendicitis##2##2##(2006-8#1)(2013-1#1)
with apple##3##2##(2008-10#3)
with application in##3##3##(1995-8#1)(2008-10#1)(2008-3#1)
with application of##11##3##(1995-6#1)(2007-11#1)(2007-6#1)(2008-10#5)(2011-1#1)(2013-1#2)
with application to the##2##4##(1991-7#1)(2008-10#1)
with application to##17##3##(1991-7#2)(1992-6#1)(1993-12#1)(1997-2#1)(1997-4#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#2)(2009-10#1)(2009-11#1)
with application##32##2##(1991-7#2)(1992-6#1)(1993-12#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-4#1)(2005-11#1)(2007-11#2)(2007-12#2)(2007-6#1)(2008-10#7)(2008-2#2)(2008-3#3)(2009-10#1)(2009-11#1)(2011-1#1)(2013-1#3)
with applications in##9##3##(2006-2#1)(2008-11#1)(2008-3#2)(2008-8#1)(2009-11#1)(2010-11#1)(2011-1#2)
with applications to##10##3##(1994-6#1)(1994-8#1)(1995-2#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-6#1)
with applications##21##2##(1994-6#1)(1994-8#1)(1995-2#1)(1997-2#1)(1997-8#1)(2006-2#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-8#1)(2009-11#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-1#2)
with applied##2##2##(2007-12#1)(2008-10#1)
with appropriate analytical##2##3##(2008-10#2)
with appropriate antibiotics##5##3##(2005-8#1)(2007-7#2)(2013-1#2)
with appropriate boundary##2##3##(2007-12#1)(2008-3#1)
with appropriate control##2##3##(2008-3#1)(2008-4#1)
with appropriate drugs##2##3##(2006-10#1)(2011-2#1)
with appropriate information##2##3##(1995-12#1)(2007-2#1)
with appropriate therapy##2##3##(2006-10#1)(2010-5#1)
with appropriate treatment##2##3##(2006-10#1)(2011-1#1)
with appropriate##85##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1991-10#1)(1991-7#1)(1992-3#1)(1993-5#1)(1993-8#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-8#1)(2005-8#3)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#7)(2008-4#2)(2008-6#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#1)
with approximate molecular weights of##3##5##(1990-12#1)(1992-11#2)
with approximate##4##2##(1990-12#1)(1991-4#1)(1992-11#2)
with approximately 2##2##3##(2006-8#1)(2008-3#1)
with approximately 25%##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
with approximately 3##2##3##(1990-3#1)(2008-3#1)
with approximately 50%##3##3##(1991-3#1)(2008-10#1)(2008-11#1)
with approximately 70%##2##3##(1995-1#1)(1995-2#1)
with approximately equal##3##3##(1992-3#1)(1993-11#1)(2008-11#1)
with approximately the same##2##4##(1994-8#1)(2004-9#1)
with approximately the##3##3##(1990-2#1)(1994-8#1)(2004-9#1)
with approximately##67##2##(1990-2#1)(1990-3#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-8#2)(1993-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-12#1)(1997-4#1)(2004-9#1)(2005-10#1)(2005-7#1)(2005-9#1)(2006-8#1)(2007-11#3)(2007-12#3)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#10)(2008-5#1)(2008-7#2)(2008-9#1)(2009-7#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#1)(2011-2#2)(2012-2#1)(2013-8#1)
with aprepitant##2##2##(2008-7#2)
with aqua regia##2##3##(2008-10#2)
with aquatic##3##2##(2004-4#1)(2007-4#1)(2008-5#1)
with aqueous acetonitrile##3##3##(2008-10#3)
with aqueous ammonia##3##3##(2007-11#1)(2008-5#2)
with aqueous formaldehyde in##3##4##(2007-11#3)
with aqueous solutions of##2##4##(2008-10#1)(2008-6#1)
with aqueous solutions##5##3##(2008-10#2)(2008-6#1)(2010-3#1)(2011-2#1)
with aqueous standards##6##3##(2005-4#1)(2008-10#5)
with aqueous suspensions of##2##4##(2008-10#2)
with aqueous##32##2##(1994-11#1)(1996-5#2)(2005-4#1)(2007-11#4)(2008-10#18)(2008-5#2)(2008-6#1)(2010-3#1)(2011-2#2)
with arachidonic acid as##2##4##(1990-10#1)(2010-1#1)
with arachidonic acid##8##3##(1990-10#1)(1991-2#1)(1994-12#2)(1995-11#2)(1996-2#1)(2010-1#1)
with arbitrarily##3##2##(2007-11#2)(2009-5#1)
with arbitrary location and##2##4##(2008-2#1)(2008-3#1)
with arbitrary orientation##2##3##(2007-12#1)(2008-3#1)
with arbitrary##22##2##(1990-10#1)(2007-11#2)(2007-12#3)(2007-5#1)(2008-10#1)(2008-2#8)(2008-3#4)(2008-6#1)(2011-1#1)
with arbuscular##2##2##(2008-5#2)
with are##2##2##(2010-11#1)(2011-2#1)
with area##5##2##(1995-12#2)(2007-2#1)(2010-10#1)(2012-3#1)
with areas of##3##3##(1995-7#1)(2007-8#1)(2008-1#1)
with areas##4##2##(1995-7#1)(2007-8#1)(2008-1#1)(2008-10#1)
with arginine##6##2##(1990-7#1)(1991-4#1)(1996-2#1)(2008-9#1)(2012-1#1)(2012-12#1)
with arm cavities##2##3##(2008-2#2)
with arm##5##2##(2008-2#2)(2008-3#1)(2008-5#1)(2012-1#1)
with armodafinil##2##2##(2012-12#2)
with aromatic amino##2##3##(2006-12#1)(2008-8#1)
with aromatic##8##2##(1994-8#1)(1996-5#1)(2005-4#1)(2006-12#1)(2008-10#2)(2008-8#1)(2011-2#1)
with arousal##2##2##(1993-5#1)(2008-11#1)
with arrhythmias##2##2##(1993-2#1)(1996-8#1)
with arrhythmogenic right ventricular cardiomyopathy##2##5##(2008-6#1)(2009-2#1)
with arrhythmogenic right ventricular##3##4##(2008-12#1)(2008-6#1)(2009-2#1)
with arsenic##2##2##(2008-10#2)
with arsenobetaine##2##2##(2008-10#2)
with arterial hypertension##8##3##(1990-6#1)(1991-4#1)(1992-7#1)(1996-5#1)(2006-10#1)(2008-7#1)(2011-1#1)(2012-12#1)
with arterial##15##2##(1990-6#1)(1991-4#1)(1992-7#2)(1995-7#1)(1996-5#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-12#1)(2008-7#1)(2009-12#1)(2011-1#1)(2012-12#1)(2013-8#1)
with arteriovenous fistulae##2##3##(1996-9#2)
with arteriovenous##8##2##(1996-6#1)(1996-9#2)(1997-6#1)(2007-7#1)(2007-9#1)(2008-7#1)(2012-3#1)
with artesunate##4##2##(2005-8#1)(2009-6#2)(2009-9#1)
with arthralgia##2##2##(1995-2#1)(2006-4#1)
with arthritis##8##2##(1992-3#1)(2006-10#2)(2006-3#1)(2008-1#1)(2008-9#1)(2012-2#1)(2013-8#1)
with articles##2##2##(2007-7#1)(2012-1#1)
with articular##3##2##(1991-8#1)(1992-11#1)(1993-2#1)
with artificial neural network##2##4##(2008-10#2)
with artificial neural##4##3##(2008-10#4)
with artificial##18##2##(1991-9#1)(1992-3#1)(1994-11#1)(1995-12#1)(1996-1#1)(2005-11#1)(2006-3#1)(2008-10#4)(2008-5#2)(2008-8#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-3#1)
with aryl##3##2##(2008-7#1)(2009-3#1)(2009-5#1)
with as few as##3##4##(2011-2#1)(2012-12#1)(2013-8#1)
with as few##5##3##(2008-3#1)(2009-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
with as little as 1##2##5##(2008-4#1)(2008-5#1)
with as little as##6##4##(1993-9#1)(1994-12#1)(1996-7#1)(2008-4#1)(2008-5#1)(2011-2#1)
with as many as four##2##5##(1995-2#1)(2008-1#1)
with as many as##5##4##(1992-12#1)(1995-2#1)(2007-12#1)(2008-1#1)(2008-3#1)
with as many##6##3##(1992-12#1)(1995-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)
with as much as 0##2##5##(2007-11#1)(2007-12#1)
with as much as##11##4##(1994-8#1)(2007-11#4)(2007-12#4)(2008-1#1)(2008-10#1)
with as much##12##3##(1994-8#1)(1995-9#1)(2007-11#4)(2007-12#4)(2008-1#1)(2008-10#1)
with as##33##2##(1992-1#1)(1992-12#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-9#1)(1996-7#1)(2004-8#1)(2007-11#4)(2007-12#5)(2008-1#2)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#1)(2009-10#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
with asbestos exposure##2##3##(1991-12#1)(2008-6#1)
with asbestos##5##2##(1991-12#1)(1992-11#1)(1992-9#1)(2008-6#1)(2010-9#1)
with asbestos-containing##3##2##(1991-12#2)(2010-9#1)
with ascending tetraparesis##2##3##(2007-10#2)
with ascending##3##2##(1997-5#1)(2007-10#2)
with ascites and##5##3##(1994-6#1)(2007-12#1)(2008-10#2)(2008-6#1)
with ascites##15##2##(1991-4#2)(1994-6#1)(2005-12#1)(2005-9#1)(2007-12#4)(2008-10#2)(2008-6#1)(2011-2#2)(2013-8#1)
with ascorbate in##2##3##(1997-8#1)(2008-10#1)
with ascorbate##4##2##(1991-6#1)(1997-8#1)(2008-10#1)(2008-11#1)
with ascorbic acid and##2##4##(2008-10#2)
with ascorbic acid##6##3##(1993-12#1)(1996-9#1)(2008-10#3)(2008-5#1)
with ascospores##2##2##(2008-10#2)
with ash##2##2##(2005-4#1)(2008-4#1)
with asparagine by site-directed mutagenesis##2##5##(1990-12#1)(1990-2#1)
with asparagine by##3##3##(1990-12#1)(1990-2#1)(1995-6#1)
with asparagine##6##2##(1990-12#1)(1990-2#1)(1991-2#2)(1995-6#1)(2007-12#1)
with aspartate in the##2##4##(1995-6#2)
with aspartate##5##2##(1992-6#1)(1992-7#1)(1995-6#3)
with aspect ratios##3##3##(1991-12#1)(2008-3#1)(2009-11#1)
with aspects of the##2##4##(1992-2#1)(1994-3#1)
with aspects of##5##3##(1990-10#1)(1992-2#1)(1994-3#1)(2005-10#1)(2012-12#1)
with aspects##6##2##(1990-10#1)(1992-2#1)(1994-3#1)(2005-10#1)(2008-5#1)(2012-12#1)
with aspiration##2##2##(1993-5#2)
with aspirin and##3##3##(2006-10#3)
with aspirin in##2##3##(2007-10#1)(2008-11#1)
with aspirin##24##2##(1990-11#1)(1993-11#1)(1993-7#1)(1996-11#1)(1996-2#1)(1997-6#1)(2005-7#1)(2006-10#4)(2007-10#3)(2007-8#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#1)(2011-1#1)(2011-12#1)(2013-8#1)
with assays##3##2##(1992-8#1)(2008-10#1)(2008-4#1)
with assessing##2##2##(1996-2#1)(2009-2#1)
with assessment of##5##3##(1995-5#1)(1996-1#1)(2008-11#1)(2008-5#1)(2011-2#1)
with assessments##2##2##(2008-11#1)(2008-8#1)
with assistance from##2##3##(2006-12#1)(2009-4#1)
with assistance##3##2##(1995-1#1)(2006-12#1)(2009-4#1)
with associated syringomyelia##2##3##(2006-5#1)(2010-2#1)
with associated##53##2##(1991-10#1)(1991-2#1)(1992-10#1)(1993-3#1)(1993-7#1)(1995-12#1)(1996-1#1)(1997-1#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-5#1)(2007-11#4)(2007-2#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#5)(2008-7#1)(2008-8#1)(2009-3#2)(2009-9#1)(2010-2#2)(2010-5#1)(2010-7#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
with association##3##2##(1993-11#1)(2005-11#1)(2008-10#1)
with associations##3##2##(2008-10#1)(2013-1#2)
with asthma and allergic##2##4##(2011-2#1)(2013-1#1)
with asthma and##13##3##(1996-7#1)(2005-11#1)(2007-11#1)(2010-6#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#4)
with asthma in##4##3##(1993-12#1)(2008-11#1)(2009-8#1)(2013-1#1)
with asthma or##5##3##(2006-10#2)(2007-11#1)(2007-2#1)(2008-3#1)
with asthma should##2##3##(2006-10#1)(2012-12#1)
with asthma were##2##3##(1995-6#1)(2010-3#1)
with asthma##77##2##(1992-1#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-9#1)(1995-6#1)(1996-2#2)(1996-6#1)(1996-7#2)(2005-11#1)(2006-10#4)(2006-5#1)(2007-11#8)(2007-2#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#3)(2008-8#2)(2009-4#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#4)(2010-6#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#3)(2012-12#6)(2012-2#2)(2013-1#9)
with asthmatic##2##2##(1992-1#1)(2007-11#1)
with astrocytes##5##2##(1992-2#2)(1993-7#1)(1994-6#1)(2008-7#1)
with asymmetric##8##2##(1994-11#1)(1995-2#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-3#1)(2012-2#1)
with asymptomatic HIV##2##3##(1993-3#1)(1996-12#1)
with asymptomatic bacteriuria##2##3##(2008-5#1)(2009-1#1)
with asymptomatic carotid##2##3##(2007-10#1)(2008-8#1)
with asymptomatic erythrocyturia##2##3##(2007-9#2)
with asymptomatic severe##2##3##(2008-8#1)(2011-2#1)
with asymptomatic##34##2##(1993-2#2)(1993-3#1)(1994-12#1)(1996-12#2)(1996-3#1)(1997-7#1)(2006-4#1)(2006-9#1)(2007-10#2)(2007-7#4)(2007-8#1)(2007-9#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-1#1)(2009-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#3)
with asymptotic##3##2##(2007-12#1)(2008-9#1)(2009-6#1)
with at least a##4##4##(1997-3#1)(2007-11#1)(2007-8#1)(2010-8#1)
with at least four##2##4##(1993-6#1)(2008-10#1)
with at least one child##2##5##(2012-12#2)
with at least one follow-up##2##5##(2007-9#1)(2012-2#1)
with at least one##18##4##(1991-12#1)(1993-5#1)(1995-12#2)(2006-10#1)(2006-4#1)(2007-2#1)(2007-9#1)(2009-11#1)(2010-12#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
with at least three##4##4##(1991-11#1)(1992-8#1)(2006-5#1)(2007-12#1)
with at least two##7##4##(1992-4#1)(1996-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
with at least##56##3##(1990-3#1)(1991-10#1)(1991-11#1)(1991-12#1)(1992-4#2)(1992-8#1)(1993-5#1)(1993-6#1)(1995-12#2)(1996-6#1)(1997-3#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#2)(2009-11#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#5)(2013-8#1)
with at##62##2##(1990-3#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-4#2)(1992-8#1)(1993-5#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-12#2)(1996-6#1)(1997-3#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#2)(2009-11#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#5)(2013-8#1)
with ataxia telangiectasia##2##3##(2008-7#2)
with ataxia##4##2##(2008-11#1)(2008-7#3)
with atenolol##2##2##(2005-12#1)(2008-10#1)
with atherogenic##2##2##(1997-8#1)(2008-1#1)
with atherosclerosis##10##2##(1991-9#1)(2006-6#1)(2007-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-2#2)(2010-10#1)(2011-1#1)
with atherosclerotic lesions in##3##4##(2006-6#2)(2011-1#1)
with atherosclerotic lesions##4##3##(2006-6#3)(2011-1#1)
with atherosclerotic plaque##2##3##(2008-10#1)(2009-12#1)
with atherosclerotic##14##2##(1990-9#1)(2006-11#1)(2006-6#3)(2007-10#2)(2007-8#1)(2008-10#1)(2008-4#1)(2009-12#1)(2010-12#1)(2011-1#1)(2013-8#1)
with athletes##3##2##(2006-6#2)(2010-1#1)
with atlantoaxial##4##2##(2006-9#1)(2008-12#2)(2012-12#1)
with atmospheric air##2##3##(2013-8#2)
with atmospheric pressure chemical ionization##4##5##(1996-8#2)(1997-3#1)(2012-2#1)
with atmospheric pressure chemical##5##4##(1996-8#2)(1997-3#1)(2007-8#1)(2012-2#1)
with atmospheric##11##2##(1995-11#1)(1996-8#2)(1997-3#1)(2007-8#1)(2008-3#2)(2012-2#1)(2013-8#3)
with atomic absorption spectrometry##7##4##(1991-3#1)(2008-10#6)
with atomic absorption##11##3##(1990-4#1)(1991-3#1)(1992-3#1)(2008-10#8)
with atomic fluorescence spectrometry##2##4##(2008-10#2)
with atomic fluorescence##3##3##(2008-10#3)
with atomic force microscopy (AFM)##2##5##(2008-10#2)
with atomic force microscopy and##2##5##(2008-10#1)(2008-2#1)
with atomic force microscopy##5##4##(2008-10#3)(2008-2#1)(2009-9#1)
with atomic precision##2##3##(2009-2#2)
with atomic##30##2##(1990-4#1)(1991-3#1)(1992-3#1)(1996-11#1)(2007-11#2)(2007-12#1)(2008-10#16)(2008-2#1)(2008-7#1)(2008-9#1)(2009-2#2)(2009-9#1)(2010-7#1)
with atomic-scale##2##2##(2008-7#2)
with atopic dermatitis (AD)##2##4##(2011-1#1)(2012-1#1)
with atopic dermatitis were##2##4##(1992-9#1)(2011-1#1)
with atopic dermatitis##14##3##(1992-10#1)(1992-9#1)(2007-11#1)(2007-8#1)(2008-5#1)(2010-8#1)(2011-1#3)(2012-1#4)(2013-1#1)
with atopic eczema##4##3##(1991-10#1)(2005-11#1)(2007-8#1)(2008-5#1)
with atopic##21##2##(1991-10#1)(1992-10#1)(1992-9#1)(2005-11#1)(2007-11#1)(2007-8#2)(2008-5#2)(2008-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2012-1#4)(2012-3#1)(2013-1#1)
with atopy or positive intracutaneous test but##2##7##(2007-7#1)(2007-8#1)
with atopy##3##2##(2007-7#1)(2007-8#1)(2008-1#1)
with atorvastatin 80 mg/day##2##4##(2008-5#2)
with atorvastatin 80##3##3##(2008-5#3)
with atorvastatin##9##2##(2008-5#4)(2011-1#5)
with atracurium##2##2##(2010-7#2)
with atraumatic##3##2##(1994-8#1)(1996-2#1)(2007-5#1)
with atrazine##3##2##(2013-1#3)
with atrial fibrillation (AF)##4##4##(2007-10#2)(2008-5#1)(2012-12#1)
with atrial fibrillation and##2##4##(2007-10#1)(2008-12#1)
with atrial fibrillation were##2##4##(2006-8#2)
with atrial fibrillation##25##3##(1996-6#1)(1997-3#1)(2006-10#2)(2006-8#6)(2007-10#5)(2007-8#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-12#1)(2012-12#1)(2013-1#2)
with atrial septal defect##2##4##(2007-8#1)(2013-1#1)
with atrial##28##2##(1996-6#1)(1997-3#1)(2006-10#2)(2006-8#6)(2007-10#5)(2007-8#2)(2007-9#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-12#1)(2010-7#1)(2012-12#1)(2013-1#3)
with atrioventricular##4##2##(1995-6#1)(2006-8#1)(2008-11#1)(2008-7#1)
with atrophic##2##2##(2008-3#1)(2012-3#1)
with atrophy##5##2##(1995-11#1)(1997-1#1)(2007-7#1)(2009-9#1)(2012-2#1)
with atropine ointment##2##3##(2007-7#2)
with atropine##11##2##(1991-4#1)(1991-5#1)(1993-9#1)(1994-8#1)(1996-12#1)(1997-7#1)(1997-8#1)(2007-7#2)(2008-7#1)(2008-8#1)
with attached carbohydrate recognition structures at##2##6##(2005-11#2)
with attached##6##2##(1990-7#1)(2005-11#2)(2007-11#1)(2008-5#2)
with attendant##3##2##(2007-12#1)(2008-11#1)(2008-4#1)
with attention deficit hyperactivity disorder##8##5##(1994-2#1)(1995-1#1)(2006-2#1)(2008-11#1)(2008-9#1)(2009-12#1)(2010-1#1)(2013-7#1)
with attention deficit##9##3##(1994-2#1)(1995-1#1)(2006-2#1)(2008-11#1)(2008-9#2)(2009-12#1)(2010-1#1)(2013-7#1)
with attention deficit/hyperactivity disorder##4##4##(1997-8#1)(2008-9#2)(2011-2#1)
with attention to##5##3##(1993-10#1)(1996-2#1)(2008-5#1)(2010-3#1)(2012-3#1)
with attention##21##2##(1993-10#1)(1994-2#1)(1995-1#1)(1996-2#1)(1997-8#1)(2006-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#4)(2009-12#1)(2010-1#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-7#1)
with attention-deficit/hyperactivity disorder (ADHD)##3##4##(2004-10#1)(2008-2#2)
with attention-deficit/hyperactivity disorder##6##3##(2004-10#1)(2008-2#4)(2011-2#1)
with attenuated##5##2##(1996-9#1)(2007-11#1)(2009-9#1)(2013-1#2)
with attenuation of##3##3##(2006-10#1)(2008-2#1)(2008-9#1)
with attitudes##3##2##(2009-7#1)(2011-1#1)(2013-1#1)
with atypia##2##2##(2009-8#1)(2011-2#1)
with atypical features##2##3##(2007-10#1)(2008-12#1)
with atypical pneumonia##2##3##(2006-10#2)
with atypical symptoms##4##3##(2006-10#1)(2008-10#1)(2010-2#1)(2012-12#1)
with atypical##26##2##(1990-3#1)(1995-6#1)(2004-11#1)(2005-8#1)(2006-10#5)(2007-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
with auditory hallucinations##2##3##(2009-4#1)(2012-1#1)
with auditory##7##2##(1996-2#1)(2008-9#3)(2009-4#1)(2012-1#1)(2012-3#1)
with augmented##2##2##(1995-12#1)(2008-7#1)
with authentic##9##2##(1990-10#1)(1990-2#3)(1991-5#1)(1993-11#1)(1994-8#1)(1995-8#1)(2012-3#1)
with authority##2##2##(1994-12#1)(2007-8#1)
with authors##2##2##(2006-6#1)(2007-3#1)
with autism and##3##3##(2009-4#2)(2011-2#1)
with autism are##3##3##(2006-2#1)(2008-11#1)(2012-11#1)
with autism at##2##3##(2009-4#1)(2010-12#1)
with autism exhibit##2##3##(2007-8#1)(2009-4#1)
with autism have##3##3##(2006-10#1)(2009-4#2)
with autism spectrum disorder (ASD)##4##5##(2009-10#1)(2009-4#1)(2013-1#1)(2013-7#1)
with autism spectrum disorder##7##4##(2009-10#1)(2009-4#2)(2013-1#2)(2013-7#2)
with autism spectrum disorders (ASD)##5##5##(2009-4#1)(2010-2#1)(2012-2#1)(2013-7#2)
with autism spectrum disorders##14##4##(2009-4#5)(2010-2#1)(2012-2#5)(2013-7#3)
with autism spectrum##21##3##(2009-10#1)(2009-4#7)(2010-2#1)(2012-2#5)(2013-1#2)(2013-7#5)
with autism was##2##3##(2006-3#1)(2009-4#1)
with autism##60##2##(1997-8#1)(2006-10#2)(2006-2#1)(2006-3#6)(2007-8#2)(2008-11#2)(2009-10#2)(2009-4#21)(2009-9#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-11#2)(2012-12#1)(2012-2#5)(2013-1#5)(2013-7#5)
with autistic disorder and##2##4##(2007-6#1)(2012-2#1)
with autistic disorder##3##3##(2007-6#2)(2012-2#1)
with autistic spectrum disorders (ASD)##2##5##(2010-12#1)(2013-1#1)
with autistic spectrum disorders##4##4##(2009-2#1)(2009-4#1)(2010-12#1)(2013-1#1)
with autistic spectrum##5##3##(2009-2#1)(2009-4#1)(2010-11#1)(2010-12#1)(2013-1#1)
with autistic##11##2##(1997-8#1)(2007-6#2)(2009-2#1)(2009-4#1)(2010-11#1)(2010-12#1)(2012-1#1)(2012-2#2)(2013-1#1)
with autoantibodies in##2##3##(1992-8#1)(2005-10#1)
with autoantibodies##4##2##(1992-8#1)(1996-1#1)(2005-10#1)(2008-4#1)
with autogenous bone##2##3##(2007-7#1)(2010-5#1)
with autogenous tissues##2##3##(2007-12#1)(2007-8#1)
with autogenous##8##2##(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-7#1)(2010-5#1)(2012-3#1)
with autoimmune cholangitis##2##3##(2004-11#2)
with autoimmune diabetes##2##3##(1997-4#1)(2008-10#1)
with autoimmune diseases##5##3##(1996-11#1)(2006-10#1)(2006-5#1)(2012-1#2)
with autoimmune disorders##5##3##(1991-12#1)(2006-10#1)(2007-11#2)(2011-2#1)
with autoimmune hepatitis and##2##4##(2011-1#1)(2011-12#1)
with autoimmune hepatitis in##2##4##(2006-10#1)(2008-12#1)
with autoimmune hepatitis##11##3##(1996-11#1)(2006-10#3)(2008-12#1)(2010-6#2)(2011-1#2)(2011-12#1)(2012-2#1)
with autoimmune polyglandular syndrome type##4##5##(2006-6#1)(2012-3#1)(2013-1#2)
with autoimmune##39##2##(1990-3#1)(1991-12#1)(1991-8#1)(1994-3#1)(1996-11#2)(1997-4#1)(2004-11#2)(2006-10#7)(2006-5#1)(2006-6#1)(2007-11#3)(2007-5#1)(2008-10#1)(2008-12#1)(2010-6#3)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#3)
with autologous bone##5##3##(1996-3#1)(2006-8#2)(2011-2#1)(2012-2#1)
with autologous stem cell##2##4##(1997-3#1)(2007-11#1)
with autologous##15##2##(1990-12#1)(1996-3#1)(1997-3#1)(2005-1#1)(2006-7#1)(2006-8#2)(2007-11#2)(2007-8#1)(2008-11#1)(2010-11#1)(2011-2#1)(2012-2#2)
with automated##12##2##(1992-2#1)(1993-2#1)(1996-8#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#2)(2011-2#2)(2013-7#1)
with automatic##7##2##(1990-3#1)(1990-9#1)(1997-8#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#1)
with automation##5##2##(2008-10#5)
with autonomic dysfunction##2##3##(2008-12#2)
with autonomic nerve differentiation##2##4##(2009-7#2)
with autonomic##7##2##(1990-9#1)(2008-12#2)(2009-6#1)(2009-7#2)(2011-2#1)
with autoradiography##2##2##(1990-11#1)(1993-12#1)
with autoregressive##2##2##(1996-7#1)(2013-1#1)
with autosomal dominant inheritance are##2##5##(1996-12#1)(2008-7#1)
with autosomal dominant inheritance##3##4##(1996-12#1)(1996-8#1)(2008-7#1)
with autosomal dominant polycystic kidney disease (ADPKD)##6##7##(1993-12#1)(1997-1#2)(2013-1#3)
with autosomal dominant polycystic kidney##7##5##(1993-12#1)(1997-1#2)(2013-1#4)
with autosomal dominant##14##3##(1993-12#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-5#1)(1997-8#1)(2007-2#1)(2008-7#1)(2013-1#4)
with autosomal recessive##3##3##(1996-3#1)(2008-5#1)(2011-1#1)
with autosomal##19##2##(1993-12#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-5#1)(1997-8#1)(2007-2#1)(2008-5#1)(2008-7#2)(2011-1#1)(2013-1#4)(2013-7#1)
with autosomal-dominant##2##2##(1997-5#2)
with auxin##2##2##(2008-7#1)(2009-8#1)
with available data on##3##4##(2008-12#1)(2010-8#1)(2012-2#1)
with available data##4##3##(1995-8#1)(2008-12#1)(2010-8#1)(2012-2#1)
with available experimental##4##3##(1995-9#1)(2006-11#1)(2009-3#1)(2013-1#1)
with available therapy##2##3##(2005-7#1)(2008-7#1)
with available##33##2##(1992-3#1)(1992-9#1)(1995-8#1)(1995-9#1)(1996-2#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-11#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-8#1)(2011-12#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
with avascular necrosis of the##2##5##(2006-8#1)(2008-3#1)
with avascular necrosis##3##3##(2006-8#1)(2007-11#1)(2008-3#1)
with avascular##4##2##(2006-3#1)(2006-8#1)(2007-11#1)(2008-3#1)
with average age of##2##4##(2006-7#1)(2008-9#1)
with average age##3##3##(2006-7#1)(2008-9#1)(2011-2#1)
with average output powers##2##4##(2007-11#1)(2007-12#1)
with average power##2##3##(2007-11#1)(2008-1#1)
with average recovery##2##3##(2008-10#2)
with average##59##2##(1990-3#1)(1991-12#1)(1992-7#1)(1993-11#1)(1993-3#1)(1994-3#1)(1995-3#2)(1995-8#1)(1996-12#1)(1996-4#1)(1997-4#1)(2005-10#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#4)(2007-12#3)(2007-3#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#8)(2008-3#3)(2008-5#2)(2008-7#2)(2008-9#4)(2009-3#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-2#1)
with avian influenza##4##3##(2005-11#1)(2005-9#1)(2009-5#1)(2012-1#1)
with avian##10##2##(1997-3#1)(1997-6#1)(2005-11#1)(2005-9#1)(2008-5#4)(2009-5#1)(2012-1#1)
with avulsion of##2##3##(2012-1#1)(2012-12#1)
with axial symmetry##3##3##(1993-11#1)(2007-11#1)(2008-3#1)
with axial##13##2##(1991-2#1)(1993-11#1)(1995-6#1)(2007-11#2)(2007-4#1)(2007-8#1)(2008-3#3)(2008-7#1)(2008-8#1)(2010-3#1)
with axillary dissection (level 2) was performed as the margin of the nipple side was negative##2##16##(1996-6#2)
with axillary dissection##3##3##(1993-8#1)(1996-6#2)
with axillary lymph node##2##4##(1995-10#1)(2004-1#1)
with axillary node##3##3##(1990-4#1)(2008-10#1)(2008-4#1)
with axillary##10##2##(1990-4#1)(1993-8#1)(1995-10#1)(1995-4#1)(1996-6#2)(2004-1#1)(2005-8#1)(2008-10#1)(2008-4#1)
with axis##3##2##(1994-6#1)(2007-8#1)(2008-10#1)
with axonal##2##2##(1996-9#1)(2008-5#1)
with axons##2##2##(1996-12#1)(2008-7#1)
with azathioprine and##2##3##(2007-12#1)(2008-1#1)
with azathioprine##7##2##(2007-11#1)(2007-12#1)(2007-8#3)(2008-1#1)(2010-12#1)
with azide and##2##3##(1993-11#1)(2010-5#1)
with azide##3##2##(1993-11#1)(1994-5#1)(2010-5#1)
with azithromycin##5##2##(2006-4#1)(2007-12#1)(2008-10#1)(2013-1#1)(2013-8#1)
with azobenzene##2##2##(2007-11#1)(2008-3#1)
with azole##2##2##(2007-11#1)(2008-5#1)
with azomethine-H##2##2##(2008-10#2)
with azoxystrobin##2##2##(2008-10#2)
with azygos continuation##2##3##(2007-8#2)
with bFGF##9##2##(1990-12#1)(1992-7#1)(1994-11#1)(1994-8#2)(2008-11#2)(2008-5#1)(2011-2#1)
with bPL##2##2##(1995-11#2)
with back pain and##3##4##(2008-12#2)(2008-6#1)
with back pain or##2##4##(2006-12#1)(2008-11#1)
with back pain##15##3##(2006-12#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-6#2)(2008-7#1)(2009-1#1)(2010-12#2)(2012-2#1)(2013-1#2)
with back propagation##3##3##(2008-10#1)(2010-8#2)
with back##19##2##(1996-6#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-6#2)(2008-7#1)(2009-1#1)(2010-12#2)(2010-8#2)(2012-2#1)(2013-1#2)
with backbone##2##2##(1995-8#1)(1997-7#1)
with background noise##2##3##(2008-2#1)(2008-9#1)
with background##9##2##(2008-10#1)(2008-2#3)(2008-6#1)(2008-9#1)(2009-11#1)(2012-1#1)(2012-11#1)
with bacteremia##6##2##(1990-3#1)(2005-8#1)(2007-12#1)(2008-7#1)(2012-12#1)(2013-1#1)
with bacteria##11##2##(1995-4#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2011-12#2)(2012-12#1)(2013-1#1)
with bacterial WRS##2##3##(1993-6#2)
with bacterial and##2##3##(1993-5#1)(2007-11#1)
with bacterial components##3##3##(1996-12#2)(2008-11#1)
with bacterial culture##2##3##(2008-10#1)(2008-12#1)
with bacterial meningitis##5##3##(1991-5#1)(1992-11#1)(2006-8#1)(2008-11#1)(2011-2#1)
with bacterial populations##2##3##(2008-10#2)
with bacterial##42##2##(1990-12#1)(1990-9#1)(1991-5#1)(1992-11#1)(1992-6#1)(1993-5#1)(1993-6#2)(1993-9#1)(1996-12#2)(1997-3#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-11#1)(2007-7#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
with bactericidal##2##2##(1990-11#1)(2008-4#1)
with bacteriological##3##2##(1991-5#1)(1996-1#1)(2006-3#1)
with bacteriorhodopsin##3##2##(2007-12#2)(2008-2#1)
with baculovirus##4##2##(1995-1#2)(2008-11#1)(2008-7#1)
with bad##4##2##(1992-9#1)(1995-8#1)(2007-7#1)(2011-3#1)
with balance##2##2##(2012-12#1)(2013-1#1)
with balanced##4##2##(1995-12#2)(2008-3#1)(2010-4#1)
with balloon angioplasty##3##3##(2007-9#2)(2008-11#1)
with balloon##7##2##(1991-3#1)(1994-11#1)(2007-9#2)(2008-11#1)(2008-3#1)(2008-5#1)
with band ligation##4##3##(2013-1#4)
with band##5##2##(1993-11#1)(2013-1#4)
with bands of##3##3##(2007-12#1)(2008-10#1)(2012-2#1)
with bands##5##2##(1990-8#1)(1992-12#1)(2007-12#1)(2008-10#1)(2012-2#1)
with bandwidths##2##2##(2007-12#2)
with bare glassy carbon##2##4##(2007-8#1)(2008-10#1)
with bare metal stents##2##4##(2008-11#1)(2009-1#1)
with bare metal##3##3##(2008-11#1)(2009-1#1)(2009-6#1)
with bare##11##2##(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2009-1#1)(2009-11#1)(2009-6#1)
with bariatric##2##2##(2010-12#1)(2012-12#1)
with barium##7##2##(1993-10#1)(1993-9#1)(1996-1#1)(2008-10#2)(2008-7#1)(2009-6#1)
with barley##2##2##(2008-10#1)(2008-8#1)
with basal and peripheral predominance##2##5##(2005-8#2)
with basal cell carcinoma##4##4##(2007-7#1)(2010-6#2)(2011-2#1)
with basal forebrain lesions were##2##5##(1993-11#2)
with basal forebrain lesions##3##4##(1993-11#3)
with basal##15##2##(1993-11#3)(1997-7#1)(2005-8#2)(2007-7#1)(2008-11#1)(2009-3#1)(2009-7#1)(2010-11#1)(2010-6#2)(2011-2#1)(2012-2#1)
with base##5##2##(1992-3#1)(1994-5#1)(1995-8#1)(1996-7#1)(1997-7#1)
with baseline peritoneal##2##3##(2011-2#2)
with baseline resolution##2##3##(2008-10#2)
with baseline values##10##3##(1996-1#1)(1997-3#1)(2006-6#1)(2007-12#1)(2007-2#1)(2012-12#4)(2013-1#1)
with baseline##38##2##(1996-1#1)(1996-6#1)(1996-9#1)(1997-3#1)(2004-3#1)(2005-8#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#7)(2012-12#5)(2012-3#1)(2012-5#1)(2013-1#4)
with basic FGF##2##3##(1990-7#1)(1995-1#1)
with basic fibroblast growth factor##3##5##(1990-7#1)(1994-8#1)(2008-11#1)
with basic groups##2##3##(1991-2#1)(2005-11#1)
with basic##21##2##(1990-2#1)(1990-7#2)(1990-8#1)(1991-2#1)(1992-2#1)(1994-8#1)(1995-1#1)(2005-11#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-11#1)(2008-2#1)(2008-7#1)(2010-5#1)(2011-1#2)(2012-2#1)
with basilar artery##4##3##(2007-10#1)(2007-9#1)(2008-8#1)(2012-12#1)
with basilar##7##2##(2006-9#1)(2007-10#1)(2007-9#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-12#1)
with basolateral##2##2##(2006-10#1)(2008-11#1)
with bcl-2##2##2##(2008-11#2)
with bead injection##4##3##(2008-10#4)
with beam##4##2##(1995-9#1)(2007-11#1)(2008-2#1)(2008-3#1)
with bean##2##2##(2006-3#1)(2008-10#1)
with becaplermin##2##2##(2006-2#1)(2011-2#1)
with beef##3##2##(1990-5#1)(1993-9#1)(2010-4#1)
with behavior##5##2##(2008-11#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
with behavioral disorders##2##3##(1990-11#1)(2010-5#1)
with behavioral outcomes##2##3##(1997-5#1)(2013-8#1)
with behavioral##13##2##(1990-11#2)(1997-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
with behaviors that were##2##4##(2008-11#1)(2009-4#1)
with behaviors that##3##3##(2008-11#1)(2008-2#1)(2009-4#1)
with behaviors##4##2##(2008-11#1)(2008-2#1)(2009-4#1)(2009-5#1)
with behaviour##2##2##(1991-5#1)(2006-2#1)
with behavioural disturbances in##2##4##(2011-1#2)
with behavioural##4##2##(1992-9#1)(2011-1#2)(2012-12#1)
with being##10##2##(1996-5#1)(2005-12#1)(2007-12#1)(2008-6#1)(2009-9#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-8#1)
with beneficial##3##2##(2008-10#1)(2010-2#1)(2012-1#1)
with benefit##2##2##(1996-12#1)(2008-3#1)
with benefits for##2##3##(2006-6#1)(2007-5#1)
with benefits##6##2##(2006-6#1)(2007-5#1)(2008-10#2)(2012-3#1)(2013-1#1)
with benign and malignant##5##4##(1992-9#1)(2006-10#1)(2007-2#1)(2013-1#2)
with benign and##6##3##(1992-9#1)(2005-12#1)(2006-10#1)(2007-2#1)(2013-1#2)
with benign conditions##4##3##(1990-4#1)(1991-10#1)(1992-12#1)(2007-2#1)
with benign endometrial tissue##2##4##(1995-3#2)
with benign lesions##2##3##(2007-7#1)(2007-8#1)
with benign ovarian cysts##2##4##(1991-5#2)
with benign ovarian##3##3##(1991-5#2)(1992-12#1)
with benign prostatic##7##3##(1990-11#1)(1990-9#2)(1992-8#1)(2006-8#1)(2006-9#2)
with benign tumors##2##3##(2006-10#1)(2008-3#1)
with benign##56##2##(1990-11#1)(1990-4#1)(1990-9#4)(1991-10#1)(1991-4#1)(1991-5#2)(1991-8#1)(1992-12#2)(1992-5#1)(1992-8#1)(1992-9#3)(1993-5#1)(1994-8#1)(1994-9#2)(1995-3#2)(2004-2#1)(2005-10#1)(2005-12#1)(2005-5#1)(2006-10#2)(2006-8#1)(2006-9#2)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#5)(2008-12#1)(2008-3#2)(2008-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-12#1)(2013-1#4)(2013-7#1)
with benzaldehyde##3##2##(1997-2#2)(2008-3#1)
with benzene##5##2##(1993-11#1)(2005-4#1)(2008-10#2)(2008-9#1)
with benzo-18-crown-6##2##2##(2008-10#2)
with benzodiazepines##3##2##(1991-12#1)(2008-3#1)(2011-12#1)
with benzoic##2##2##(1992-2#1)(2008-10#1)
with benzophenone##2##2##(1994-3#1)(2008-10#1)
with benzyl##5##2##(1992-3#1)(1996-2#1)(2007-10#1)(2012-11#2)
with berberine##3##2##(2007-8#3)
with berry age##2##3##(2008-10#2)
with best practice##2##3##(2006-9#1)(2008-3#1)
with best##8##2##(2006-9#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-6#1)(2010-12#1)(2013-1#1)
with beta 1##4##3##(1994-9#1)(1995-6#3)
with beta 2 and gamma 2L subunits##2##7##(1995-11#2)
with beta 2##3##3##(1994-9#1)(1995-11#2)
with beta E2##2##3##(1995-10#2)
with beta and##2##3##(1995-3#1)(1995-6#1)
with beta gamma subunits##2##4##(1990-7#1)(1993-3#1)
with beta gamma##4##3##(1990-7#1)(1993-3#3)
with beta##27##2##(1990-5#1)(1990-7#1)(1991-5#1)(1993-1#1)(1993-3#3)(1993-8#1)(1994-8#1)(1994-9#2)(1995-10#3)(1995-11#2)(1995-3#1)(1995-6#5)(1997-6#1)(2008-10#1)(2008-2#1)(2011-2#1)(2013-1#1)
with beta-CD##10##2##(1994-3#1)(2008-10#5)(2008-11#1)(2008-6#3)
with beta-D-galactosidase##3##2##(1991-9#2)(1994-2#1)
with beta-D-xyloside##2##2##(1990-5#2)
with beta-blockers##4##2##(1991-11#1)(2006-10#1)(2006-6#2)
with beta-carotene##6##2##(1990-5#2)(1993-12#1)(2006-12#1)(2006-4#1)(2007-8#1)
with beta-cyclodextrin (beta-CD)##6##3##(2007-8#1)(2008-10#5)
with beta-cyclodextrin##16##2##(1991-5#1)(2007-11#1)(2007-8#1)(2008-10#11)(2008-5#2)
with beta-galactosidase##5##2##(1990-3#2)(1991-8#1)(1992-8#1)(1994-2#1)
with beta-gludosidase treatment##2##3##(2008-10#2)
with beta-mercaptoethanol##5##2##(1990-3#1)(1990-7#1)(1997-6#1)(1997-8#1)(2008-5#1)
with beta-naphthoflavone##2##2##(1992-12#1)(1994-3#1)
with beta-phase predominance##2##3##(2007-11#2)
with beta-thal##5##2##(2006-10#5)
with beta-thalassemia major##3##3##(2006-12#1)(2013-8#2)
with beta-thalassemia##4##2##(1997-4#1)(2006-12#1)(2013-8#2)
with beta1##2##2##(1997-6#1)(2008-11#1)
with betahistine##2##2##(2008-2#2)
with betamethasone##4##2##(1991-1#1)(2007-7#2)(2008-7#1)
with better adherence to##2##4##(2008-11#1)(2012-2#1)
with better adherence##3##3##(2008-11#1)(2009-7#1)(2012-2#1)
with better bioavailability##2##3##(2005-7#1)(2009-12#1)
with better disease##2##3##(2006-6#1)(2009-4#1)
with better outcome##3##3##(2007-7#1)(2009-11#1)(2011-12#1)
with better performance##2##3##(2008-11#1)(2012-1#1)
with better prognosis##5##3##(2008-12#1)(2008-6#1)(2011-2#1)(2012-2#2)
with better response##2##3##(2006-10#1)(2009-8#1)
with better social##3##3##(1995-10#2)(2010-11#1)
with better surgical##2##3##(1995-8#1)(2011-3#1)
with better than##4##3##(2005-8#1)(2007-11#1)(2008-1#1)(2008-3#1)
with better##78##2##(1993-1#1)(1995-10#4)(1995-8#1)(1997-8#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#3)(2007-3#1)(2007-7#3)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
with between##2##2##(2010-12#1)(2013-8#1)
with bevacizumab and##2##3##(2008-7#2)
with bevacizumab##3##2##(2008-7#2)(2010-12#1)
with bias current modulation##2##4##(2007-12#2)
with biased##2##2##(1997-6#1)(2008-9#1)
with bicarbonate##3##2##(1990-11#1)(1994-11#1)(2008-11#1)
with bicuculline##3##2##(1990-2#1)(1992-11#1)(1994-2#1)
with biexponential##2##2##(1996-2#1)(2006-1#1)
with big ET-3##2##3##(1992-6#2)
with big##5##2##(1990-7#1)(1992-6#2)(2009-8#1)(2011-2#1)
with bilateral Perthes disease##2##4##(2007-7#2)
with bilateral adnexectomy##2##3##(1994-7#1)(2008-10#1)
with bilateral breast##2##3##(1992-2#1)(1995-4#1)
with bilateral carotid protection##2##4##(2010-12#2)
with bilateral disease##2##3##(2012-2#2)
with bilateral horizontal##2##3##(2007-10#1)(2011-1#1)
with bilateral involvement##2##3##(2007-8#1)(2013-1#1)
with bilateral multiple##2##3##(2007-10#1)(2007-5#1)
with bilateral occipital##3##3##(1993-7#1)(2006-12#1)(2006-2#1)
with bilateral ptosis##2##3##(2006-10#1)(2007-10#1)
with bilateral##90##2##(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-2#1)(1992-9#2)(1993-12#1)(1993-6#1)(1993-7#1)(1994-2#2)(1994-7#1)(1995-12#2)(1995-3#1)(1995-4#1)(1996-1#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-6#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2007-10#4)(2007-11#1)(2007-5#1)(2007-7#6)(2007-8#6)(2007-9#2)(2008-1#2)(2008-10#3)(2008-12#1)(2008-4#2)(2008-7#3)(2008-8#2)(2009-4#2)(2010-11#1)(2010-12#4)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#5)(2013-1#7)(2013-8#2)
with bilaterally##2##2##(2008-9#1)(2013-1#1)
with bilayers##3##2##(2008-10#3)
with bile acid##2##3##(1995-8#1)(1997-1#1)
with bile duct##3##3##(2006-2#1)(2007-3#1)(2008-5#1)
with bile##9##2##(1990-8#2)(1995-8#1)(1997-1#1)(2005-12#1)(2006-2#1)(2007-3#2)(2008-5#1)
with biliary##5##2##(1992-8#1)(1994-6#1)(2006-2#1)(2012-2#1)(2013-1#1)
with bilious##2##2##(2009-6#1)(2011-1#1)
with binary##10##2##(1993-1#2)(1994-6#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-4#1)(2012-2#1)
with binding of the##2##4##(1994-5#1)(1996-8#1)
with binding of##3##3##(1994-11#1)(1994-5#1)(1996-8#1)
with binding sites##3##3##(1996-9#1)(2008-10#1)(2008-11#1)
with binding to##2##3##(1994-9#1)(1995-3#1)
with binding##12##2##(1994-11#1)(1994-5#1)(1994-9#2)(1995-3#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#1)
with binge eating disorder##4##4##(2008-6#3)(2011-2#1)
with binge eating##6##3##(2005-6#1)(2008-4#1)(2008-6#3)(2011-2#1)
with binge##7##2##(2005-6#1)(2008-4#1)(2008-6#3)(2009-5#1)(2011-2#1)
with binge-eating##2##2##(1990-4#1)(2006-2#1)
with bioactive##5##2##(2011-2#1)(2012-1#1)(2012-11#2)(2012-2#1)
with bioactivity##3##2##(1996-5#1)(2008-10#1)(2008-11#1)
with biochemical and##6##3##(1990-9#1)(1994-10#2)(1996-7#1)(2010-12#1)(2013-1#1)
with biochemical##11##2##(1990-9#1)(1993-11#1)(1994-10#2)(1996-7#1)(2006-9#2)(2007-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
with biocompatible##2##2##(2008-10#1)(2012-11#1)
with biocontrol agents##2##3##(2008-10#2)
with biodegradable##3##2##(2007-12#1)(2007-8#1)(2010-5#1)
with biogenic##3##2##(1991-5#1)(1996-8#1)(2007-5#1)
with biologic##3##2##(2005-7#1)(2009-8#1)(2012-12#1)
with biological activity##4##3##(2006-12#1)(2007-2#1)(2007-7#1)(2008-7#1)
with biological agents##3##3##(2007-11#3)
with biological control##3##3##(2008-10#3)
with biological data##2##3##(2008-10#1)(2011-2#1)
with biological systems##4##3##(2006-12#1)(2011-1#1)(2012-11#2)
with biological##34##2##(1991-1#2)(1993-9#1)(1994-3#1)(1997-6#1)(2005-8#1)(2006-12#3)(2006-2#1)(2007-11#3)(2007-2#1)(2007-7#1)(2008-10#5)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-11#4)
with biologically active##3##3##(1990-10#1)(1994-9#1)(2008-5#1)
with biologically##4##2##(1990-10#1)(1994-9#1)(2008-11#1)(2008-5#1)
with biologics##4##2##(2006-10#1)(2012-2#3)
with biomass##3##2##(2008-10#1)(2008-6#1)(2012-2#1)
with biomechanical##2##2##(2008-12#1)(2009-7#1)
with biomedical##2##2##(2009-4#1)(2012-2#1)
with biomolecular##2##2##(1997-6#1)(2012-2#1)
with biomolecules##2##2##(2008-10#1)(2008-7#1)
with biopolymer##2##2##(2008-10#2)
with biopsies##2##2##(1992-3#1)(2013-8#1)
with biopsy proven##5##3##(2007-7#2)(2008-1#1)(2012-2#2)
with biopsy##18##2##(1990-11#1)(1991-6#1)(1993-3#1)(1997-8#1)(2006-10#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-8#2)
with biopsy-confirmed##2##2##(2012-3#1)(2013-1#1)
with biopsy-proven##5##2##(1995-4#1)(1997-3#1)(2007-11#2)(2012-12#1)
with biosynthetic##2##2##(1995-12#1)(2008-5#1)
with biotic##2##2##(2008-10#1)(2008-8#1)
with biotin##3##2##(1992-6#1)(1994-9#1)(2008-4#1)
with biotinylated protein##2##3##(1990-12#2)
with biotinylated##7##2##(1990-12#2)(1992-11#1)(1992-8#1)(1993-6#1)(1995-2#1)(2008-4#1)
with biphasic kinetics following##2##4##(1991-2#1)(1993-7#1)
with biphasic##5##2##(1991-2#1)(1992-4#1)(1993-7#1)(2008-10#1)(2012-1#1)
with bipolar coagulation##2##3##(1995-3#1)(2006-12#1)
with bipolar disorder and##2##4##(1997-2#1)(2013-8#1)
with bipolar disorder who##3##4##(1995-11#1)(2004-11#1)(2010-7#1)
with bipolar disorder##26##3##(1995-11#2)(1997-2#1)(1997-8#1)(2004-11#1)(2005-6#1)(2008-6#1)(2008-8#1)(2009-11#3)(2009-3#1)(2009-7#1)(2010-5#1)(2010-7#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-8#4)
with bipolar disorders##2##3##(2005-10#1)(2010-12#1)
with bipolar##41##2##(1995-1#1)(1995-11#5)(1995-3#1)(1996-1#1)(1996-7#1)(1997-2#1)(1997-5#1)(1997-8#2)(2004-11#1)(2005-10#2)(2005-6#1)(2006-12#1)(2007-11#1)(2008-6#1)(2008-8#1)(2009-11#3)(2009-3#1)(2009-7#1)(2010-12#1)(2010-5#1)(2010-7#2)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-8#4)
with birch##3##2##(1994-2#2)(2012-1#1)
with birefringent##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
with birth weight of##4##4##(1991-7#1)(2006-8#2)(2012-3#1)
with birth weight##10##3##(1991-7#1)(1992-2#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-12#1)(2011-1#2)(2012-3#1)
with birth weights##5##3##(1993-5#2)(2008-11#2)(2012-2#1)
with birth##17##2##(1991-7#1)(1992-2#1)(1993-5#2)(1995-10#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-12#1)(2008-11#2)(2009-2#1)(2011-1#2)(2012-2#1)(2012-3#1)
with birthing##2##2##(1996-12#1)(2009-6#1)
with bis(2##2##2##(1990-8#1)(2008-10#1)
with bismuth film##2##3##(2008-10#2)
with bismuth oxide##3##3##(1993-8#3)
with bismuth##9##2##(1993-8#3)(1995-4#1)(2008-10#4)(2010-11#1)
with bisoprolol##2##2##(2008-5#2)
with bisphosphonate therapy##3##3##(2008-11#1)(2008-7#1)(2012-12#1)
with bisphosphonate##5##2##(2007-11#1)(2008-11#1)(2008-7#1)(2012-12#1)(2013-1#1)
with bisphosphonates or##2##3##(2007-11#1)(2008-8#1)
with bisphosphonates##10##2##(2007-11#1)(2008-1#1)(2008-6#1)(2008-8#2)(2010-1#1)(2010-3#2)(2010-4#1)(2013-1#1)
with bitter##2##2##(2008-10#1)(2011-2#1)
with bizarre##3##2##(1994-6#1)(2010-3#1)(2011-2#1)
with black and##3##3##(2008-5#1)(2011-2#2)
with black##8##2##(2007-7#1)(2008-5#1)(2011-1#1)(2011-2#3)(2013-7#2)
with bladder exstrophy##4##3##(2008-10#4)
with bladder##14##2##(1995-2#1)(2005-8#1)(2007-7#3)(2007-9#1)(2008-10#6)(2008-2#1)(2013-1#1)
with bleeding and##4##3##(1992-9#1)(2006-11#1)(2007-9#1)(2013-7#1)
with bleeding into##2##3##(1991-11#1)(2008-3#1)
with bleeding##25##2##(1991-11#1)(1991-9#1)(1992-9#1)(1995-4#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-4#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-12#1)(2011-1#4)(2012-2#1)(2013-1#4)(2013-7#1)
with blight##2##2##(2008-10#2)
with blind##2##2##(2007-7#1)(2008-4#1)
with blindsight##2##2##(1995-8#1)(1996-2#1)
with blocked##2##2##(2008-10#1)(2012-12#1)
with blockers of##2##3##(2008-4#1)(2009-3#1)
with blocking##4##2##(1993-4#1)(2007-11#1)(2008-11#1)(2008-2#1)
with blood and##5##3##(2005-7#1)(2006-10#1)(2010-12#1)(2013-1#2)
with blood cells##2##3##(2009-11#1)(2012-1#1)
with blood circulation##3##3##(2004-9#1)(2012-12#2)
with blood cultures remaining positive##2##5##(2006-4#2)
with blood flow##3##3##(2005-8#1)(2008-4#2)
with blood from##3##3##(1997-8#1)(2005-8#1)(2012-12#1)
with blood glucose##2##3##(2008-1#1)(2009-11#1)
with blood or##2##3##(1990-2#2)
with blood pressure##2##3##(2005-10#1)(2008-1#1)
with blood transfusion##2##3##(1996-3#1)(2012-2#1)
with blood vessels##3##3##(1993-12#1)(1995-11#1)(2012-3#1)
with blood##54##2##(1990-2#2)(1990-3#1)(1992-6#1)(1993-11#1)(1993-12#2)(1995-11#1)(1996-3#1)(1997-1#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-7#1)(2005-8#3)(2006-10#1)(2006-12#1)(2006-4#2)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-12#1)(2008-4#2)(2008-5#1)(2009-11#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-9#2)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)
with blue diode lasers##2##4##(2007-8#1)(2008-3#1)
with blue light##5##3##(1994-5#1)(2008-5#2)(2012-12#1)(2013-1#1)
with blue##10##2##(1990-12#1)(1990-7#1)(1994-5#1)(2005-12#1)(2007-8#1)(2008-3#1)(2008-5#2)(2012-12#1)(2013-1#1)
with blueberry extract##2##3##(2009-5#2)
with boceprevir##4##2##(2012-1#4)
with body composition##3##3##(2008-5#1)(2008-7#1)(2011-2#1)
with body fat##2##3##(2005-1#1)(2008-1#1)
with body fluids##2##3##(1990-6#1)(1994-8#1)
with body image##6##3##(2006-12#1)(2007-12#5)
with body mass index (BMI)##4##5##(2008-11#1)(2008-4#1)(2011-1#1)(2011-2#1)
with body mass index##10##4##(1993-11#1)(2006-7#1)(2006-9#1)(2008-11#1)(2008-4#1)(2011-1#1)(2011-2#3)(2013-1#1)
with body mass##13##3##(1993-11#1)(2006-7#1)(2006-9#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
with body shape##4##3##(2007-7#4)
with body size##6##3##(1991-7#1)(2007-12#1)(2008-5#1)(2008-8#1)(2009-8#1)(2012-1#1)
with body weight and shape##2##5##(2007-12#1)(2007-7#1)
with body weight of##2##4##(2005-10#1)(2011-1#1)
with body weight##5##3##(2005-10#1)(2007-12#1)(2007-7#1)(2008-7#1)(2011-1#1)
with body##46##2##(1990-6#1)(1991-7#1)(1993-11#1)(1994-8#1)(2005-1#1)(2005-10#1)(2006-12#1)(2006-7#2)(2006-9#1)(2007-12#8)(2007-7#6)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-5#1)(2009-8#1)(2010-2#1)(2011-1#2)(2011-2#4)(2012-1#1)(2013-1#1)(2013-8#1)
with boiling acetic anhydride##2##4##(2005-7#2)
with boiling##5##2##(2005-7#2)(2007-1#1)(2007-11#1)(2008-10#1)
with bolus##3##2##(1996-11#1)(2006-6#1)(2011-2#1)
with bombesin##3##2##(1990-11#1)(1991-7#1)(1994-3#1)
with bone cement##3##3##(2006-8#1)(2007-11#1)(2007-8#1)
with bone grafting##2##3##(1996-3#1)(2011-2#1)
with bone loss##3##3##(2008-9#1)(2010-5#1)(2011-1#1)
with bone marrow edema##2##4##(2006-10#1)(2007-11#1)
with bone marrow fibrosis##2##4##(2009-8#2)
with bone marrow involvement##2##4##(1990-9#1)(2006-10#1)
with bone marrow##15##3##(1990-9#1)(1992-2#1)(2006-10#2)(2007-11#1)(2007-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-6#1)(2010-7#1)(2012-12#1)(2013-1#2)
with bone metastases are##3##4##(2007-11#1)(2007-7#1)(2011-2#1)
with bone metastases from solid##2##5##(2008-7#1)(2013-7#1)
with bone metastases from##6##4##(2008-10#1)(2008-7#4)(2013-7#1)
with bone metastases in##3##4##(2007-11#1)(2008-7#2)
with bone metastases##26##3##(1990-2#1)(1991-10#1)(1994-7#1)(2007-11#8)(2007-7#1)(2008-10#2)(2008-7#8)(2011-2#3)(2013-7#1)
with bone metastasis##2##3##(1990-2#1)(1994-12#1)
with bone mineral density##2##4##(1995-4#1)(2008-1#1)
with bone mineral##3##3##(1995-4#1)(2008-1#1)(2008-4#1)
with bone tumors##2##3##(2011-1#2)
with bone##88##2##(1990-2#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-5#1)(1992-2#1)(1994-12#1)(1994-2#1)(1994-7#1)(1995-1#1)(1995-4#1)(1996-3#2)(1997-8#1)(2006-10#2)(2006-6#2)(2006-8#1)(2007-11#15)(2007-7#6)(2007-8#3)(2008-1#1)(2008-10#2)(2008-4#1)(2008-6#2)(2008-7#8)(2008-9#1)(2009-10#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#6)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)
with bony##6##2##(2006-4#1)(2006-9#1)(2007-11#1)(2007-12#1)(2012-2#1)(2012-3#1)
with bootstrap##3##2##(2006-10#1)(2008-10#2)
with borate##3##2##(2006-12#1)(2008-10#2)
with borderline personality disorder##4##4##(1997-5#2)(2012-2#2)
with borderline personality##5##3##(1997-5#2)(2009-9#1)(2012-2#2)
with borderline##10##2##(1992-1#1)(1993-12#1)(1997-5#2)(2007-7#1)(2008-1#1)(2008-6#1)(2009-9#1)(2012-2#2)
with boron##5##2##(1994-3#1)(1997-2#1)(2008-10#1)(2009-4#1)(2009-5#1)
with bortezomib##2##2##(2011-2#1)(2012-2#1)
with botanical##2##2##(2008-12#1)(2013-8#1)
with both ATP##2##3##(1990-4#1)(1990-7#1)
with both UV##2##3##(1996-5#1)(2008-10#1)
with both a##9##3##(1991-2#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-3#3)(2012-1#1)(2012-12#1)
with both age##2##3##(1991-10#1)(2008-7#1)
with both an##2##3##(1996-9#1)(2007-12#1)
with both antibodies##2##3##(1991-2#1)(2013-8#1)
with both benign and##2##4##(2007-5#1)(2012-2#1)
with both clinical and##2##4##(2006-5#1)(2013-8#1)
with both clinical##3##3##(1997-1#1)(2006-5#1)(2013-8#1)
with both conventional##2##3##(2008-10#1)(2008-3#1)
with both devices##2##3##(2008-3#1)(2008-5#1)
with both diseases##2##3##(2006-8#1)(2008-10#1)
with both disorders##2##3##(1994-6#1)(2012-2#1)
with both drugs##2##3##(1990-9#1)(1992-3#1)
with both fluorescence##2##3##(2006-12#1)(2011-2#1)
with both fluoroionophores##2##3##(2008-10#2)
with both high##2##3##(1996-3#1)(2008-3#1)
with both in vitro##2##4##(1991-11#1)(2011-1#1)
with both lasers##2##3##(1992-9#1)(2008-3#1)
with both low and high##2##5##(1990-12#1)(2009-8#1)
with both low##3##3##(1990-12#1)(2007-11#1)(2009-8#1)
with both methods##4##3##(1990-12#1)(1990-8#1)(2008-10#2)
with both microsatellite markers##2##4##(1994-6#2)
with both moderate and##2##4##(2008-1#1)(2010-12#1)
with both normal##2##3##(1993-6#1)(2013-8#1)
with both of the##2##4##(1990-10#1)(2008-10#1)
with both of them##2##4##(1996-3#1)(2008-10#1)
with both of these##4##4##(1993-6#1)(1997-2#1)(2007-5#1)(2008-11#1)
with both of##8##3##(1990-10#1)(1993-6#1)(1996-3#1)(1997-2#1)(2007-5#1)(2008-10#2)(2008-11#1)
with both parents##3##3##(2011-12#1)(2011-2#1)(2013-1#1)
with both pathogens##2##3##(2008-10#2)
with both positive and negative##2##5##(2006-7#1)(2007-11#1)
with both sexual and asexual reproduction##2##6##(2008-10#2)
with both sexual and asexual##3##5##(2008-10#2)(2013-7#1)
with both simulated and##2##4##(2008-3#2)
with both simulated##3##3##(2008-3#2)(2011-1#1)
with both solid-phase and peroxidase-labeled antibodies##3##6##(1993-11#1)(1996-1#2)
with both species##3##3##(2006-8#1)(2008-8#1)(2011-2#1)
with both substrates##4##3##(1991-2#3)(1994-6#1)
with both surgery and##2##4##(1992-2#1)(2012-1#1)
with both techniques##6##3##(1997-8#1)(2006-8#1)(2007-8#1)(2008-10#1)(2012-12#1)(2013-7#1)
with both the##47##3##(1990-10#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-10#1)(1991-8#1)(1992-11#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-7#1)(2006-10#2)(2006-3#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#2)(2010-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
with both together##2##3##(1994-12#1)(1994-6#1)
with both type 1 and type 2 diabetes##4##8##(2008-1#1)(2008-8#1)(2013-1#2)
with both type 1##5##4##(2008-1#1)(2008-8#1)(2009-11#1)(2013-1#2)
with both types of##5##4##(1996-11#1)(2008-10#3)(2011-2#1)
with both undergraduate and##2##4##(2008-1#1)(2008-11#1)
with both vectors##3##3##(2009-10#3)
with both viruses##5##3##(1995-12#1)(2008-10#4)
with both##491##2##(1990-10#4)(1990-11#1)(1990-12#5)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#5)(1990-8#3)(1990-9#2)(1991-1#1)(1991-10#4)(1991-11#1)(1991-2#5)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#3)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-4#2)(1993-6#4)(1993-7#1)(1993-8#3)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#5)(1994-6#5)(1994-8#2)(1994-9#4)(1995-10#2)(1995-11#4)(1995-12#2)(1995-2#3)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#3)(1995-8#4)(1996-1#3)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#6)(1997-3#1)(1997-4#1)(1997-6#6)(1997-7#3)(1997-8#4)(2004-11#1)(2004-2#1)(2004-3#1)(2005-11#6)(2005-12#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#5)(2006-12#2)(2006-2#2)(2006-3#2)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#3)(2007-1#3)(2007-10#6)(2007-11#8)(2007-12#11)(2007-2#3)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#3)(2007-8#7)(2007-9#2)(2008-1#4)(2008-10#60)(2008-11#16)(2008-12#5)(2008-2#6)(2008-3#17)(2008-5#9)(2008-6#2)(2008-7#3)(2008-8#10)(2008-9#2)(2009-10#4)(2009-11#4)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#1)(2011-1#9)(2011-12#1)(2011-2#8)(2011-7#1)(2012-1#8)(2012-12#7)(2012-2#7)(2012-3#5)(2013-1#10)(2013-7#3)(2013-8#7)
with both)##2##2##(2008-6#2)
with bottom##4##2##(2007-5#1)(2008-10#1)(2008-5#1)(2011-2#1)
with botulinum toxin type##2##4##(1990-9#1)(2005-11#1)
with botulinum toxin##5##3##(1990-9#1)(2005-11#3)(2007-7#1)
with botulinum##11##2##(1990-9#1)(1992-8#1)(1996-5#1)(1997-5#1)(2005-11#3)(2006-11#3)(2007-7#1)
with bound##8##2##(1990-5#1)(1991-12#1)(1991-3#1)(1992-12#1)(1996-11#1)(1997-6#1)(2008-2#1)(2010-4#1)
with bovine papillomavirus##2##3##(2007-2#2)
with bovine pericardium##3##3##(2007-8#1)(2012-2#1)(2013-1#1)
with bovine serum albumin (BSA) in##2##6##(2008-10#1)(2010-11#1)
with bovine serum albumin (BSA)##11##5##(1991-6#1)(2004-9#1)(2008-10#6)(2008-11#1)(2009-9#1)(2010-11#1)
with bovine serum albumin##21##4##(1991-6#1)(1992-11#1)(1992-2#1)(1996-11#2)(2004-9#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-5#1)(2009-9#1)(2010-11#2)(2013-1#1)
with bovine trypsin##2##3##(1995-2#1)(2009-4#1)
with bovine##49##2##(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-6#2)(1992-11#1)(1992-2#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-11#2)(1996-5#1)(1997-5#1)(2004-9#1)(2006-5#1)(2007-11#1)(2007-2#2)(2007-8#1)(2008-10#9)(2008-11#2)(2008-3#3)(2008-5#1)(2008-7#1)(2009-4#1)(2009-9#1)(2010-11#2)(2010-3#1)(2012-2#1)(2013-1#2)
with bowel obstruction##3##3##(1993-9#1)(2008-5#1)(2011-2#1)
with bowel perforation##3##3##(2008-6#1)(2011-12#1)(2013-8#1)
with bowel##7##2##(1992-8#1)(1993-9#1)(2008-5#1)(2008-6#1)(2011-12#1)(2011-2#1)(2013-8#1)
with boys##2##2##(2007-12#1)(2011-2#1)
with brachial plexus##3##3##(1996-8#1)(2013-1#2)
with brachydactyly##2##2##(1996-6#1)(1997-1#1)
with bradycardia##3##2##(1992-5#1)(2006-4#1)(2006-9#1)
with bradykinin##6##2##(1991-12#3)(1991-7#1)(1995-3#1)(1996-5#1)
with brain damage##4##3##(1995-8#1)(2007-10#1)(2007-7#1)(2009-4#1)
with brain function##2##3##(2006-7#1)(2011-1#1)
with brain injury##5##3##(1991-12#1)(1993-5#1)(1993-8#1)(2006-12#2)
with brain lesions and##2##4##(1994-3#1)(2009-4#1)
with brain lesions##4##3##(1991-2#1)(1993-7#1)(1994-3#1)(2009-4#1)
with brain metastases##2##3##(1991-2#1)(2010-8#1)
with brain stem infarction##2##4##(2007-9#2)
with brain stem##3##3##(1996-4#1)(2007-9#2)
with brain tumor##2##3##(1997-7#1)(2006-12#1)
with brain tumors##6##3##(1997-5#1)(2006-12#1)(2006-7#1)(2006-8#1)(2008-12#1)(2012-1#1)
with brain##51##2##(1990-7#1)(1991-12#1)(1991-2#3)(1991-9#1)(1993-11#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-3#2)(1995-11#1)(1995-8#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-5#1)(1997-7#1)(2006-12#4)(2006-7#3)(2006-8#1)(2007-10#2)(2007-7#1)(2007-9#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#1)(2009-4#2)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-3#1)(2013-1#2)
with brainstem##2##2##(2008-11#1)(2008-9#1)
with breaks##2##2##(1990-8#1)(2006-10#1)
with breast cancer and primary biliary cirrhosis##2##7##(1992-12#2)
with breast cancer and their##4##5##(1994-3#1)(1996-3#1)(2007-6#1)(2013-1#1)
with breast cancer and with unknown primary site of cancer##2##10##(2007-11#2)
with breast cancer and##19##4##(1990-12#1)(1990-2#1)(1992-12#2)(1992-2#1)(1993-11#1)(1994-3#1)(1994-4#1)(1996-3#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-6#1)(2008-7#1)(2011-1#1)(2013-1#1)
with breast cancer in##2##4##(2004-2#1)(2012-1#1)
with breast cancer is##2##4##(2012-1#1)(2013-1#1)
with breast cancer risk##2##4##(1995-9#1)(2009-12#1)
with breast cancer treated with adjuvant##2##6##(2008-7#1)(2013-1#1)
with breast cancer who##3##4##(2012-3#1)(2013-1#2)
with breast cancer##103##3##(1990-1#1)(1990-12#2)(1990-2#1)(1990-8#1)(1992-10#1)(1992-12#2)(1992-2#3)(1992-4#1)(1993-1#1)(1993-11#4)(1993-12#1)(1993-8#1)(1994-12#3)(1994-3#2)(1994-4#2)(1995-12#1)(1995-9#1)(1996-3#1)(1996-6#1)(1997-7#1)(1997-8#3)(2004-2#3)(2005-12#1)(2006-10#3)(2007-1#2)(2007-10#1)(2007-11#5)(2007-2#1)(2007-4#1)(2007-6#2)(2008-10#2)(2008-4#2)(2008-5#1)(2008-7#8)(2008-8#1)(2009-12#2)(2009-2#1)(2011-1#3)(2011-12#2)(2011-2#6)(2012-1#2)(2012-12#3)(2012-3#2)(2013-1#14)(2013-7#1)
with breast carcinoma##3##3##(1991-4#1)(1993-2#1)(2012-1#1)
with breast or prostate cancer##2##5##(2008-7#2)
with breast reconstruction##3##3##(1996-3#1)(2009-2#1)(2013-1#1)
with breast##132##2##(1990-1#1)(1990-12#2)(1990-2#1)(1990-8#2)(1991-4#1)(1991-6#1)(1992-10#1)(1992-12#2)(1992-2#3)(1992-4#2)(1993-1#1)(1993-11#5)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#3)(1994-3#2)(1994-4#2)(1995-12#1)(1995-5#1)(1995-9#1)(1996-3#2)(1996-6#1)(1997-7#1)(1997-8#3)(2004-2#4)(2005-12#1)(2006-10#3)(2007-1#3)(2007-10#1)(2007-11#7)(2007-2#1)(2007-4#1)(2007-6#2)(2008-10#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#12)(2008-8#1)(2009-12#2)(2009-2#2)(2011-1#4)(2011-12#2)(2011-2#8)(2012-1#4)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#17)(2013-7#1)(2013-8#2)
with breast-conserving surgery and##2##4##(1992-2#1)(1994-8#1)
with breathing##2##2##(2008-7#1)(2012-2#1)
with breeding##2##2##(2009-10#1)(2012-3#1)
with brefeldin A##3##3##(1990-7#1)(1997-7#1)(2009-8#1)
with brief##11##2##(1991-2#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-11#1)(2010-10#1)(2010-12#1)(2012-12#3)(2012-3#1)
with bright##2##2##(2008-3#1)(2008-6#1)
with bright-field microscopy##2##3##(1995-7#1)(2013-7#1)
with brimonidine##2##2##(2008-3#2)
with broad based##2##3##(1992-6#1)(2007-11#1)
with broad##14##2##(1990-12#1)(1992-6#1)(1997-4#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#2)(2009-3#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-2#1)
with broad-spectrum antibiotics##2##3##(1992-1#1)(2012-2#1)
with broad-spectrum##3##2##(1992-1#1)(2008-10#1)(2012-2#1)
with broadband##9##2##(1992-3#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#3)(2012-1#1)
with broadened##2##2##(2007-12#1)(2011-2#1)
with broader##2##2##(2006-5#1)(2009-1#1)
with broccoli##2##2##(2008-10#2)
with bromate##2##2##(2008-10#2)
with bromide##3##2##(2005-11#1)(2008-10#2)
with bromine in CCl(4)##2##4##(1996-5#2)
with bromine in##3##3##(1996-5#2)(2008-10#1)
with bromine##8##2##(1996-5#2)(1997-2#1)(2008-10#5)
with bromoalkanes##2##2##(1991-8#1)(2012-11#1)
with bromobenzene##4##2##(1992-3#4)
with bromocresol green##2##3##(2008-10#2)
with bromocriptine##3##2##(1991-1#1)(1993-2#1)(2013-8#1)
with bromodeoxyuridine##3##2##(1993-11#1)(1997-8#1)(2008-4#1)
with bronchial obstruction##2##3##(2008-7#1)(2013-1#1)
with bronchial##10##2##(1990-10#1)(1992-9#2)(1996-9#1)(2006-6#1)(2007-8#1)(2008-7#1)(2013-1#2)(2013-8#1)
with bronchiectasis##3##2##(1994-12#1)(2005-11#1)(2008-5#1)
with bronchiolitis##6##2##(2005-8#1)(2007-2#3)(2012-12#2)
with bronchoalveolar lavage##2##3##(1994-6#1)(2008-9#1)
with bronchogenic carcinoma##3##3##(2007-7#2)(2010-5#1)
with bronchopleural##2##2##(1995-11#1)(2012-2#1)
with bronchopulmonary dysplasia##4##3##(1993-5#1)(2010-12#1)(2010-5#2)
with buccal mucosa##2##3##(2011-12#1)(2012-2#1)
with buccal##4##2##(2010-3#1)(2011-12#1)(2012-2#1)(2013-1#1)
with buffer containing##2##3##(1990-12#1)(1993-11#1)
with buffer solution##2##3##(2011-1#1)(2012-3#1)
with buffer##10##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-9#1)(1993-11#1)(1993-5#1)(2007-12#1)(2008-4#1)(2011-1#1)(2012-3#1)
with buffered saline##2##3##(1994-11#2)
with built-in##3##2##(1994-11#1)(2010-4#2)
with bulimia nervosa (BN)##2##4##(1995-11#1)(2007-12#1)
with bulimia nervosa##12##3##(1995-11#1)(2006-7#6)(2007-12#3)(2007-7#1)(2011-12#1)
with bulimia##22##2##(1990-4#1)(1991-1#1)(1995-11#1)(1997-7#1)(2006-2#1)(2006-7#12)(2007-12#3)(2007-7#1)(2011-12#1)
with bulk##5##2##(1992-9#1)(2007-5#1)(2008-1#1)(2008-2#1)(2008-7#1)
with bulky cations##2##3##(2008-10#2)
with bulky##8##2##(1991-4#1)(1993-2#1)(1996-11#1)(2006-6#2)(2008-10#2)(2010-2#1)
with bullying##2##2##(2008-11#1)(2009-7#1)
with bupivacaine 0##2##3##(2006-12#1)(2008-7#1)
with bupivacaine##6##2##(1993-7#1)(2006-12#1)(2006-8#2)(2008-7#2)
with bupropion SR##3##3##(2004-3#3)
with bupropion##5##2##(2004-3#3)(2008-6#1)(2013-8#1)
with burnout##3##2##(2008-9#1)(2011-2#2)
with burns##3##2##(2005-7#1)(2008-12#1)(2008-5#1)
with buserelin##2##2##(1990-2#1)(1994-6#1)
with business##2##2##(1994-2#1)(1997-2#1)
with but##3##2##(1993-9#1)(2009-5#1)(2011-12#1)
with butorphanol##2##2##(1996-10#1)(2007-2#1)
with butterfly##2##2##(2012-3#1)(2013-1#1)
with butyrate##2##2##(1993-6#1)(2008-11#1)
with by the##2##3##(1990-8#1)(1996-6#1)
with by##8##2##(1990-8#1)(1993-11#1)(1993-8#1)(1996-2#1)(1996-6#1)(2004-10#1)(2008-3#1)(2008-5#1)
with c-Rel##2##2##(1993-9#1)(1995-3#1)
with c-myc amplification##2##3##(1991-4#1)(1994-6#1)
with c-myc##6##2##(1991-4#2)(1992-8#1)(1994-6#1)(1995-5#1)(1997-7#1)
with cAMP##8##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-3#1)(1991-4#1)(1992-6#1)(1994-12#1)(2010-12#1)
with cANCA##4##2##(2007-2#4)
with cDNA for##3##3##(1995-5#1)(1996-2#1)(1997-7#1)
with cDNA##8##2##(1990-12#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-7#1)(2008-10#1)(2008-7#1)(2008-9#1)
with cDNAs encoding##2##3##(1994-2#1)(1994-8#1)
with cGH##2##2##(1995-10#2)
with ca##2##2##(2008-10#1)(2009-9#1)
with cabergoline##4##2##(1995-4#1)(2008-7#2)(2011-1#1)
with cachexia##2##2##(2007-12#2)
with cadherins##2##2##(1994-8#2)
with cadmium and##2##3##(1993-2#1)(2007-12#1)
with cadmium##9##2##(1992-12#1)(1993-2#1)(1993-4#1)(1995-5#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#2)
with caffeine in##2##3##(1995-8#1)(2009-3#1)
with caffeine##8##2##(1990-4#1)(1995-8#3)(1996-5#1)(2008-8#1)(2009-3#1)(2013-7#1)
with calcein##4##2##(2008-10#2)(2008-5#1)(2009-4#1)
with calcific aortic stenosis##2##4##(2007-8#1)(2008-5#1)
with calcific##4##2##(1995-7#1)(2006-10#1)(2007-8#1)(2008-5#1)
with calcification and##2##3##(2007-8#1)(2011-1#1)
with calcification in##2##3##(2008-7#1)(2013-7#1)
with calcification##7##2##(1990-6#1)(2007-8#1)(2008-7#1)(2011-1#1)(2012-3#2)(2013-7#1)
with calcifications##5##2##(1995-9#1)(1997-8#2)(2011-1#1)(2011-2#1)
with calcifications)##3##2##(1994-7#3)
with calcineurin##3##2##(1995-6#1)(2008-8#2)
with calcitonin gene-related peptide##4##4##(1991-2#1)(1992-6#2)(1995-5#1)
with calcitonin##7##2##(1991-2#2)(1992-6#2)(1995-5#1)(1996-1#1)(2007-8#1)
with calcitriol##2##2##(1993-3#1)(2008-3#1)
with calcium antagonists##2##3##(1995-10#1)(1995-12#1)
with calcium channel blockers##3##4##(1993-9#1)(1995-2#1)(1996-6#1)
with calcium chloride##2##3##(2007-7#1)(2008-11#1)
with calcium dobesilate##2##3##(1990-3#2)
with calcium hydroxide##2##3##(2012-2#1)(2013-8#1)
with calcium ionophore##3##3##(1991-7#1)(1995-11#2)
with calcium or##2##3##(2005-1#1)(2008-10#1)
with calcium phosphate##2##3##(2008-5#1)(2012-1#1)
with calcium##43##2##(1990-3#2)(1990-7#1)(1990-9#1)(1991-11#1)(1991-7#1)(1992-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-6#1)(2005-1#2)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-4#2)(2008-5#5)(2008-9#1)(2009-12#1)(2010-4#1)(2012-1#1)(2012-2#1)(2013-8#1)
with calcium-channel blockers##2##3##(1992-12#1)(2008-11#1)
with calculated##14##2##(1990-9#1)(1993-8#1)(1993-9#1)(1996-2#1)(2007-12#1)(2008-2#6)(2008-8#1)(2010-9#1)(2013-8#1)
with calculation##3##2##(1997-1#1)(2006-4#1)(2008-2#1)
with calculations based on##2##4##(2007-12#2)
with calculations of##2##3##(2007-12#1)(2008-3#1)
with calculations##11##2##(2006-12#1)(2006-5#1)(2007-12#4)(2008-3#5)
with calculous cholecystitis##2##3##(2010-5#1)(2013-8#1)
with calf thymus DNA was##2##5##(2008-5#1)(2009-3#1)
with calf thymus DNA##12##4##(1990-8#1)(1991-4#1)(1994-11#2)(1995-1#1)(2008-10#1)(2008-3#1)(2008-5#4)(2009-3#1)
with calibrated##4##2##(2007-12#1)(2008-3#3)
with calibration##5##2##(1991-1#1)(2008-10#3)(2008-5#1)
with calmodulin##8##2##(1992-7#1)(1993-6#4)(1994-3#1)(1994-9#1)(1995-6#1)
with calphostin C##2##3##(1992-6#2)
with calponin and##2##3##(1990-9#1)(2008-11#1)
with calponin##3##2##(1990-9#2)(2008-11#1)
with calsequestrine##2##2##(1994-9#2)
with can-opener style##2##3##(2007-3#2)
with cancellous##4##2##(2005-3#1)(2007-7#2)(2010-3#1)
with cancer and their##3##4##(1992-12#1)(1995-2#1)(2005-10#1)
with cancer and those##2##4##(1993-9#1)(2007-4#1)
with cancer and##22##3##(1992-12#1)(1993-3#1)(1993-9#3)(1994-8#1)(1995-2#1)(1996-1#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-11#1)(2008-7#3)(2008-8#2)(2012-11#1)(2012-12#1)(2012-2#1)
with cancer are##3##3##(2005-10#1)(2010-11#1)(2012-2#1)
with cancer experience##3##3##(2008-7#1)(2013-1#2)
with cancer have##2##3##(2008-11#1)(2008-7#1)
with cancer in##5##3##(1992-8#1)(2005-12#1)(2011-2#2)(2013-1#1)
with cancer is##6##3##(2007-8#1)(2007-9#1)(2008-2#1)(2008-7#2)(2011-2#1)
with cancer living in##2##4##(1994-4#1)(2012-3#1)
with cancer may be##2##4##(1991-9#1)(2008-7#1)
with cancer may##3##3##(1991-9#1)(1996-1#1)(2008-7#1)
with cancer of the##24##4##(1990-9#3)(1991-2#2)(1991-8#1)(1992-11#1)(2006-1#1)(2008-7#15)(2012-3#1)
with cancer of##25##3##(1990-9#3)(1991-12#1)(1991-2#2)(1991-8#1)(1992-11#1)(2006-1#1)(2008-7#15)(2012-3#1)
with cancer patients##4##3##(1991-2#2)(1993-3#1)(2008-10#1)
with cancer patients?]##2##3##(1991-2#1)(2009-2#1)
with cancer should##2##3##(2007-6#1)(2012-2#1)
with cancer susceptibility##2##3##(1993-7#1)(2008-8#1)
with cancer who are##2##4##(2008-7#1)(2009-7#1)
with cancer who##6##3##(2008-7#4)(2008-8#1)(2009-7#1)
with cancer##224##2##(1990-6#1)(1990-9#3)(1991-12#2)(1991-2#6)(1991-4#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-8#1)(1993-1#2)(1993-3#3)(1993-7#1)(1993-9#3)(1994-4#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-2#1)(1996-1#4)(1996-10#1)(1996-11#1)(1996-9#2)(1997-7#1)(2004-2#2)(2005-10#3)(2005-11#1)(2005-12#2)(2006-1#1)(2006-10#3)(2006-2#1)(2006-6#1)(2007-11#2)(2007-2#2)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#5)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#69)(2008-8#6)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-11#10)(2010-12#1)(2010-4#1)(2010-7#2)(2010-8#1)(2010-9#5)(2011-1#2)(2011-2#10)(2012-1#3)(2012-11#4)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#8)(2013-8#1)
with cancer-related##2##2##(2008-11#1)(2008-7#1)
with cancer]##3##2##(1994-7#1)(1996-9#1)(2012-3#1)
with candidate##3##2##(2008-8#1)(2013-1#2)
with canine##2##2##(1991-10#1)(2013-1#1)
with canonical##2##2##(2008-10#1)(2013-1#1)
with canopy size##2##3##(2008-10#2)
with cap##2##2##(2008-5#2)
with capability of##2##3##(2008-10#1)(2010-7#1)
with capecitabine and##2##3##(2008-3#1)(2008-5#1)
with capecitabine in##3##3##(2009-5#1)(2010-12#1)(2013-1#1)
with capecitabine##9##2##(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-12#2)(2013-1#2)
with capecitabine/RT##2##2##(2008-7#2)
with capillary electrophoresis##9##3##(1991-8#1)(1996-5#1)(1997-5#1)(2008-10#6)
with capillary gas chromatography##4##4##(1990-6#1)(1994-9#2)(2008-10#1)
with capillary isotachophoresis##2##3##(2008-10#2)
with capillary zone electrophoresis##2##4##(1990-8#1)(2008-10#1)
with capillary##19##2##(1990-6#1)(1990-8#1)(1991-8#1)(1994-9#2)(1996-5#1)(1997-5#1)(1997-8#1)(2007-8#1)(2008-10#10)
with capsaicin##7##2##(1991-9#1)(1992-6#1)(1993-4#1)(1997-2#1)(2008-11#2)(2012-3#1)
with capsaicin-sensitive##2##2##(1992-6#1)(1995-7#1)
with capsular##2##2##(1990-5#1)(2007-10#1)
with captopril and##2##3##(1992-3#1)(1995-8#1)
with captopril##6##2##(1990-11#1)(1991-5#1)(1992-12#1)(1992-3#1)(1994-5#1)(1995-8#1)
with capture##2##2##(2007-8#1)(2008-9#1)
with carbachol##6##2##(1991-5#1)(1992-6#1)(1994-8#3)(2008-10#1)
with carbamazepine##4##2##(1992-8#1)(1993-9#1)(1997-5#1)(2009-4#1)
with carbidopa##2##2##(1996-2#1)(1997-8#1)
with carbodiimide##2##2##(2006-12#1)(2008-10#1)
with carbohydrate##6##2##(1990-2#2)(2004-11#1)(2006-10#1)(2009-12#1)(2011-2#1)
with carbohydrates##2##2##(1991-7#1)(2006-10#1)
with carbon dioxide (CO2)##2##4##(1996-12#1)(2007-8#1)
with carbon dioxide##6##3##(1996-12#1)(2007-8#2)(2008-10#1)(2011-2#2)
with carbon disulfide##2##3##(2007-10#2)
with carbon monoxide##3##3##(1994-11#1)(1996-5#2)
with carbon nanotubes and##2##4##(2008-7#2)
with carbon nanotubes##6##3##(2007-11#1)(2008-10#1)(2008-7#3)(2010-2#1)
with carbon##28##2##(1992-6#1)(1994-11#1)(1996-12#2)(1996-5#2)(2007-10#2)(2007-11#2)(2007-8#2)(2008-10#6)(2008-3#1)(2008-4#1)(2008-7#3)(2010-2#1)(2011-1#2)(2011-2#2)
with carbon-13##3##2##(2008-10#3)
with carbonyl##3##2##(2005-8#1)(2007-11#1)(2008-10#1)
with carboplatin##8##2##(1995-9#1)(2005-11#1)(2006-12#1)(2009-8#1)(2011-2#2)(2013-7#1)(2013-8#1)
with carbosulfan##2##2##(2007-8#2)
with carboxyl##2##2##(2007-8#1)(2008-5#1)
with carboxylate groups##3##3##(1990-10#1)(1993-6#2)
with carboxylate oxygen##2##3##(2008-5#2)
with carboxylate##7##2##(1990-10#1)(1993-6#2)(1995-11#1)(2008-5#2)(2012-12#1)
with carboxylic groups##4##3##(2005-11#2)(2008-10#2)
with carboxylic ligands##3##3##(2008-10#3)
with carboxylic##7##2##(2005-11#2)(2008-10#5)
with carboxymethyl##2##2##(2006-8#1)(2008-7#1)
with carboxypeptidase B##2##3##(1991-7#1)(1997-2#1)
with carboxypeptidase##3##2##(1991-7#2)(1997-2#1)
with carcinogenesis##4##2##(1997-4#1)(2011-1#1)(2012-2#2)
with carcinoid syndrome##2##3##(2013-1#1)(2013-8#1)
with carcinoid##10##2##(1992-11#4)(1993-11#2)(2008-8#1)(2009-5#1)(2013-1#1)(2013-8#1)
with carcinoma in situ##3##4##(2006-10#1)(2009-5#2)
with carcinoma in##4##3##(1995-8#1)(2006-10#1)(2009-5#2)
with carcinoma of the gallbladder##2##5##(2009-3#1)(2010-12#1)
with carcinoma of the##9##4##(1993-12#1)(1994-3#2)(1994-7#1)(2006-6#1)(2007-3#1)(2008-8#1)(2009-3#1)(2010-12#1)
with carcinoma of##10##3##(1993-12#1)(1994-3#2)(1994-7#1)(2006-6#1)(2007-11#1)(2007-3#1)(2008-8#1)(2009-3#1)(2010-12#1)
with carcinoma##20##2##(1992-5#2)(1993-12#1)(1993-2#1)(1994-3#2)(1994-7#1)(1995-8#1)(2006-10#1)(2006-6#3)(2007-11#1)(2007-3#1)(2008-8#1)(2009-3#1)(2009-5#2)(2010-12#1)(2013-1#1)
with cardiac and##2##3##(2007-7#1)(2008-10#1)
with cardiac arrest##3##3##(1991-9#1)(1993-8#2)
with cardiac conduction##2##3##(2007-2#1)(2008-3#1)
with cardiac disease##6##3##(1990-11#1)(2004-10#1)(2007-11#1)(2007-12#1)(2013-1#2)
with cardiac herniation##3##3##(2007-4#3)
with cardiac index (r =##2##5##(1991-3#2)
with cardiac injuries##3##3##(2007-8#2)(2008-1#1)
with cardiac magnetic resonance imaging##3##5##(2008-3#2)(2013-3#1)
with cardiac magnetic resonance##5##4##(2008-3#3)(2009-10#1)(2013-3#1)
with cardiac sarcoidosis##2##3##(2009-4#1)(2012-2#1)
with cardiac surgery##3##3##(2007-8#1)(2008-10#1)(2011-2#1)
with cardiac tamponade##4##3##(1991-6#1)(2007-5#1)(2011-2#2)
with cardiac troponin##2##3##(1991-12#1)(2011-2#1)
with cardiac##67##2##(1990-11#1)(1990-12#2)(1991-12#2)(1991-3#2)(1991-6#1)(1991-9#1)(1993-8#2)(1994-3#1)(1995-11#1)(1996-9#1)(2004-10#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#3)(2008-12#2)(2008-3#5)(2008-6#1)(2008-8#1)(2009-10#1)(2009-4#2)(2010-10#1)(2010-9#1)(2011-2#6)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-3#1)
with cardiogenic shock##4##3##(1997-5#1)(2007-9#1)(2008-11#1)(2009-4#1)
with cardiometabolic risk factors and mortality##2##6##(2012-12#2)
with cardiometabolic risk factors##3##4##(2012-12#3)
with cardiomyopathy##5##2##(2009-4#4)(2013-8#1)
with cardiopulmonary bypass (CPB)##2##4##(2007-8#1)(2007-9#1)
with cardiopulmonary bypass##9##3##(1993-8#1)(2007-8#4)(2007-9#1)(2011-2#1)(2013-1#2)
with cardiopulmonary##11##2##(1993-2#1)(1993-8#1)(2007-8#4)(2007-9#1)(2011-2#1)(2013-1#3)
with cardiovascular disease (CVD)##2##4##(2008-3#2)
with cardiovascular disease in##3##4##(1993-6#1)(2008-10#1)(2013-8#1)
with cardiovascular disease##18##3##(1993-12#1)(1993-6#2)(2005-10#1)(2006-10#1)(2006-5#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-3#2)(2009-10#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
with cardiovascular diseases##5##3##(1994-2#1)(1995-12#1)(2008-10#1)(2011-1#1)(2012-12#1)
with cardiovascular risk factors##6##4##(1997-2#1)(2008-11#1)(2011-2#1)(2013-1#1)(2013-8#2)
with cardiovascular risk##10##3##(1997-2#1)(2008-11#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#3)
with cardiovascular##52##2##(1993-12#1)(1993-5#1)(1993-6#2)(1994-2#1)(1995-12#1)(1996-3#1)(1997-2#1)(2005-10#1)(2006-10#4)(2006-5#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#1)(2008-8#1)(2009-10#1)(2010-4#4)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#4)
with care of the##2##4##(2008-11#1)(2013-1#1)
with care provided in##2##4##(1996-2#1)(1997-1#1)
with care##24##2##(1993-8#1)(1994-4#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#3)(2005-12#1)(2006-2#1)(2006-7#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#2)(2009-1#1)(2009-10#1)(2009-6#2)(2013-1#1)
with careful attention to##2##4##(2007-9#1)(2010-1#1)
with careful planning##2##3##(1992-3#1)(2007-8#1)
with careful##14##2##(1991-3#1)(1992-3#1)(1995-3#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-9#1)(2009-4#1)(2010-1#1)(2012-12#1)(2013-8#1)
with carefully##3##2##(2008-1#1)(2008-11#1)(2009-5#1)
with caregivers of##2##3##(2009-12#1)(2011-2#1)
with caregivers##4##2##(2008-7#1)(2009-12#1)(2011-2#2)
with carotid artery##6##3##(2006-11#1)(2007-10#1)(2007-8#1)(2009-8#1)(2010-11#1)(2012-1#1)
with carotid endarterectomy##2##3##(2007-10#1)(2008-11#1)
with carotid stenosis##4##3##(1991-11#1)(2006-10#1)(2007-10#1)(2010-11#1)
with carotid##21##2##(1990-12#1)(1991-11#1)(1991-12#1)(2006-10#1)(2006-11#1)(2007-10#5)(2007-8#1)(2007-9#2)(2008-1#1)(2008-11#1)(2009-10#1)(2009-8#1)(2010-11#2)(2012-1#1)(2013-7#1)
with carpal tunnel syndrome##2##4##(2007-8#1)(2008-9#1)
with carpal tunnel##3##3##(2007-8#1)(2008-9#2)
with carpal##4##2##(2007-8#1)(2008-9#3)
with carrier proteins##2##3##(1994-11#1)(1994-12#1)
with carrier##5##2##(1994-11#1)(1994-12#1)(1996-3#1)(2008-11#1)(2008-7#1)
with cartap##2##2##(2012-2#2)
with cartilage grafts##2##3##(2007-11#1)(2010-8#1)
with cartilage##6##2##(2007-11#1)(2008-9#1)(2009-1#1)(2010-10#1)(2010-8#1)(2012-1#1)
with carvacrol##2##2##(2008-11#2)
with case##3##2##(1993-12#1)(2010-7#1)(2011-2#1)
with casein##2##2##(1990-8#1)(2007-11#1)
with cases of##3##3##(1990-5#1)(2011-2#1)(2013-8#1)
with cases##6##2##(1990-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
with caspofungin##2##2##(2006-4#1)(2008-3#1)
with castor bean##2##3##(2008-6#1)(2013-8#1)
with castor##3##2##(2004-9#1)(2008-6#1)(2013-8#1)
with catalase##2##2##(1997-4#1)(2008-10#1)
with catalytic activity##2##3##(1990-7#1)(2013-8#1)
with catalytic converter##2##3##(2007-10#2)
with catalytic##16##2##(1990-7#2)(1995-1#1)(2007-10#2)(2008-10#5)(2008-11#2)(2008-5#1)(2009-10#1)(2010-2#1)(2013-8#1)
with cataract##3##2##(1997-3#1)(2008-3#1)(2013-1#1)
with catastrophic##2##2##(2006-10#1)(2013-1#1)
with catatonia##6##2##(2007-6#2)(2008-1#1)(2010-12#2)(2010-7#1)
with catatonic schizophrenia##2##3##(1995-11#1)(2011-2#1)
with catatonic##3##2##(1995-11#1)(2010-7#1)(2011-2#1)
with catechol derivatives##2##3##(1992-2#1)(2008-10#1)
with catechol##7##2##(1992-2#1)(2004-8#1)(2005-4#1)(2008-10#4)
with catecholamine##2##2##(1991-8#1)(1997-6#1)
with catecholamines##2##2##(2007-9#1)(2008-10#1)
with cathepsin G##2##3##(1992-5#1)(1994-11#1)
with cathepsin K inhibitor##3##4##(2009-3#3)
with cathepsin##7##2##(1990-6#1)(1992-5#1)(1994-11#1)(1995-2#1)(2009-3#3)
with catheter##4##2##(1995-11#1)(2006-1#1)(2008-7#1)(2010-12#1)
with catheters##4##2##(1992-1#1)(2007-7#1)(2007-8#1)(2008-8#1)
with cathodic##2##2##(2008-10#2)
with cation##2##2##(2008-10#2)
with cationic slopes of##2##4##(2008-10#2)
with cationic##15##2##(1994-5#1)(1995-2#1)(2005-11#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-12#1)(2011-2#1)(2013-1#1)
with cattle##2##2##(2007-6#1)(2010-4#1)
with causal##2##2##(2009-7#1)(2012-3#1)
with caution as##3##3##(2011-1#1)(2013-1#2)
with caution because of##2##4##(1991-9#1)(1996-6#1)
with caution in patients with##2##5##(2006-10#1)(2006-12#1)
with caution in##8##3##(1990-5#1)(1992-12#1)(2006-10#1)(2006-12#1)(2007-2#1)(2008-2#1)(2008-3#1)(2012-2#1)
with caveolin##3##2##(1995-6#3)
with cavernous##3##2##(2004-11#1)(2008-7#1)(2009-10#1)
with cefazolin##2##2##(2011-2#2)
with cefotetan##2##2##(1994-6#2)
with ceftazidime##2##2##(1991-3#1)(1991-5#1)
with ceftriaxone##2##2##(1992-10#1)(1992-12#1)
with celecoxib and##2##3##(2006-10#1)(2007-12#1)
with celecoxib##6##2##(2006-10#2)(2007-12#4)
with celiac disease##10##3##(1991-4#1)(1995-3#1)(2006-10#1)(2007-5#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
with cell and##2##3##(1991-1#1)(2009-3#1)
with cell bodies located in##2##5##(1997-3#1)(2007-11#1)
with cell cycle progression##3##4##(1992-10#1)(2007-11#1)(2010-4#1)
with cell cycle##7##3##(1992-10#1)(1995-9#1)(1996-4#1)(1997-7#1)(2007-11#1)(2010-4#1)(2013-1#1)
with cell dimensions a =##4##5##(1990-8#1)(1994-9#3)
with cell dimensions a##5##4##(1990-8#1)(1994-9#4)
with cell dimensions##8##3##(1990-8#1)(1994-9#4)(1997-7#1)(2005-7#1)(2007-11#1)
with cell growth##5##3##(1995-8#1)(1996-1#1)(1997-1#1)(1997-2#1)(2010-12#1)
with cell lines##2##3##(1994-8#1)(2008-6#1)
with cell membranes##3##3##(1990-8#1)(2008-11#2)
with cell migration##2##3##(2011-1#1)(2012-12#1)
with cell number##2##3##(1996-12#1)(2008-11#1)
with cell proliferation##3##3##(1991-8#1)(2006-6#1)(2010-12#1)
with cell surface receptors##2##4##(2005-9#1)(2007-3#1)
with cell surface##5##3##(1991-12#1)(1994-6#1)(1996-8#1)(2005-9#1)(2007-3#1)
with cell survival##2##3##(2008-7#1)(2010-8#1)
with cell wall##5##3##(2007-6#1)(2008-10#2)(2008-5#1)(2012-1#1)
with cell##80##2##(1990-10#2)(1990-2#1)(1990-8#2)(1991-1#2)(1991-12#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-4#1)(1994-11#1)(1994-6#2)(1994-8#1)(1994-9#4)(1995-1#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#2)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#2)(2005-7#2)(2005-9#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#3)(2007-3#1)(2007-6#1)(2007-8#2)(2008-10#3)(2008-11#6)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#2)
with cell-free supernatants from##2##4##(1991-9#1)(1993-6#1)
with cell-free##4##2##(1990-3#1)(1991-9#1)(1992-11#1)(1993-6#1)
with cell-surface##2##2##(1990-12#1)(1991-5#1)
with cells cultured##2##3##(2008-11#1)(2012-1#1)
with cells expressing the##2##4##(1994-5#1)(1995-3#1)
with cells from##4##3##(1992-1#1)(1992-12#1)(1997-4#1)(2008-9#1)
with cells of##3##3##(1996-1#1)(2007-12#1)(2008-5#1)
with cells under##2##3##(2008-10#1)(2008-4#1)
with cells##33##2##(1990-10#1)(1990-4#1)(1991-4#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-5#1)(1995-12#2)(1995-3#1)(1996-1#1)(1997-3#1)(1997-4#1)(1997-7#2)(2007-12#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-6#1)(2012-1#1)(2012-12#2)
with cellular DNA##2##3##(1997-1#1)(2008-5#1)
with cellular factors##2##3##(1991-3#1)(2012-12#1)
with cellular proteins##2##3##(1994-3#1)(2012-1#1)
with cellular##24##2##(1991-3#1)(1994-11#2)(1994-3#2)(1994-9#1)(1996-10#1)(1996-8#1)(1997-1#1)(2005-7#1)(2005-8#1)(2007-3#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-3#2)(2012-1#1)(2012-12#1)(2012-3#1)
with cellulase##3##2##(2008-5#2)(2008-9#1)
with cellulite##2##2##(2008-5#2)
with cement##5##2##(1997-6#1)(2007-11#2)(2007-7#2)
with cemented acetabular##2##3##(2008-11#1)(2008-8#1)
with cemented##3##2##(2008-11#2)(2008-8#1)
with central and##3##3##(2006-3#1)(2010-11#1)(2010-8#1)
with central auditory disorders##2##4##(2008-9#2)
with central depression##2##3##(2008-5#2)
with central nervous system##5##4##(1994-9#1)(2007-3#1)(2011-1#1)(2011-2#1)(2012-1#1)
with central venous catheters##3##4##(2005-8#1)(2008-7#1)(2012-12#1)
with central venous##4##3##(2005-8#1)(2008-7#2)(2012-12#1)
with central##33##2##(1993-11#1)(1994-9#1)(1997-1#2)(2005-11#1)(2005-8#1)(2006-3#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#3)(2009-2#1)(2009-4#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)
with cephalosporin##6##2##(1994-6#1)(2011-1#1)(2011-2#4)
with ceramic##2##2##(2008-10#1)(2013-8#1)
with ceramide##3##2##(1994-12#1)(1996-9#1)(2008-5#1)
with cercariae##2##2##(2006-8#1)(2008-4#1)
with cerebellar##6##2##(1995-6#1)(1996-1#1)(2006-7#1)(2008-7#2)(2012-3#1)
with cerebral infarction##8##3##(1990-3#1)(1994-9#1)(2007-10#1)(2007-9#4)(2010-12#1)
with cerebral palsy (CP)##6##4##(2006-10#1)(2009-4#1)(2011-2#2)(2012-1#2)
with cerebral palsy and##7##4##(1993-8#1)(2006-10#1)(2008-12#1)(2009-3#1)(2011-2#1)(2012-1#2)
with cerebral palsy##43##3##(1993-8#1)(2005-8#1)(2006-10#10)(2006-12#2)(2006-3#1)(2007-11#1)(2007-7#1)(2008-12#1)(2008-8#1)(2009-2#1)(2009-3#4)(2009-4#1)(2009-8#1)(2011-12#2)(2011-2#3)(2012-1#10)(2012-12#2)
with cerebral perfusion##2##3##(2006-4#1)(2006-7#1)
with cerebral sequelae##2##3##(1990-12#2)
with cerebral##84##2##(1990-12#2)(1990-3#1)(1992-7#1)(1993-2#1)(1993-8#2)(1994-9#1)(1995-6#1)(1997-8#1)(2005-8#1)(2006-10#13)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#2)(2006-7#1)(2007-10#5)(2007-11#1)(2007-7#2)(2007-9#6)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2011-12#2)(2011-2#3)(2012-1#12)(2012-12#2)(2013-1#4)
with cerebroside B##2##3##(2008-10#2)
with cerebrospinal fluid (CSF) pleocytosis##2##5##(2006-1#1)(2009-10#1)
with cerebrospinal fluid (CSF)##4##4##(2006-1#1)(2006-12#1)(2008-7#1)(2009-10#1)
with cerebrospinal fluid##8##3##(1997-5#1)(2006-1#1)(2006-12#2)(2006-5#1)(2008-7#1)(2009-10#1)(2011-2#1)
with cerebrovascular##14##2##(1990-6#1)(1991-11#1)(1991-4#1)(1992-4#2)(1996-11#1)(2005-1#1)(2006-1#1)(2006-7#1)(2007-10#3)(2008-7#1)(2011-1#1)
with cerium##3##2##(2005-11#1)(2008-10#2)
with cerium(IV) in sulfuric acid media##2##6##(2008-10#2)
with cerium(IV) in sulfuric acid##3##5##(2008-10#3)
with cerium(IV) in##4##3##(2008-10#4)
with cerium(IV)##6##2##(2008-10#6)
with certain lipids##2##3##(2006-10#1)(2009-7#1)
with certain specific##2##3##(2005-7#1)(2010-12#1)
with certain types of##6##4##(1993-9#1)(2006-10#1)(2008-11#1)(2008-5#1)(2009-3#1)(2011-2#1)
with certain##61##2##(1990-4#1)(1990-8#2)(1992-2#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-7#1)(2005-7#1)(2006-10#3)(2006-12#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-12#3)(2010-3#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)
with certainty##7##2##(1990-2#1)(1990-4#1)(1991-11#1)(1991-4#1)(1996-12#1)(2006-8#1)(2007-9#1)
with certificated seeds of improved varieties##2##6##(2008-12#2)
with certified values at##2##4##(2008-10#2)
with certified values of standard reference materials##3##7##(2008-10#3)
with certified values##17##3##(2007-8#1)(2008-10#16)
with certified##22##2##(2007-8#1)(2008-10#20)(2008-3#1)
with ceruloplasmin##2##2##(1991-10#1)(2008-5#1)
with cervical cancer##6##3##(2006-10#1)(2007-8#1)(2007-9#2)(2010-6#1)(2011-2#1)
with cervical intraepithelial neoplasia (CIN)##2##5##(1991-2#1)(2011-2#1)
with cervical intraepithelial neoplasia##6##4##(1991-2#1)(1992-3#1)(2006-10#1)(2011-2#3)
with cervical lymph node##2##4##(1997-3#1)(2008-6#1)
with cervical lymphadenopathy##2##3##(2009-9#1)(2011-12#1)
with cervical spine injury##2##4##(2006-10#1)(2011-2#1)
with cervical spine##5##3##(2006-10#1)(2007-11#3)(2011-2#1)
with cervical##53##2##(1991-2#1)(1991-5#1)(1992-3#1)(1997-3#1)(2005-10#1)(2005-9#1)(2006-10#9)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#5)(2007-12#2)(2007-4#1)(2007-8#2)(2007-9#2)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-2#2)(2012-3#2)
with cervicogenic headache##4##3##(2008-12#4)
with cesarean##2##2##(2007-2#1)(2011-2#1)
with cesium##3##2##(1993-4#1)(2007-12#1)(2008-10#1)
with cessation of##2##3##(1997-4#1)(2006-4#1)
with cessation##6##2##(1997-4#1)(2006-4#1)(2010-2#2)(2013-1#2)
with cetirizine##2##2##(2007-7#2)
with cetuximab##4##2##(2008-7#1)(2009-5#1)(2011-2#2)
with cetyltrimethylammonium bromide##2##3##(2005-4#1)(2007-8#1)
with cetyltrimethylammonium##3##2##(2005-4#1)(2007-8#1)(2008-10#1)
with chain##2##2##(1994-8#1)(2013-8#1)
with challenges##4##2##(2009-11#1)(2012-1#1)(2013-1#2)
with challenging##4##2##(2008-3#1)(2011-1#1)(2012-12#2)
with change in 4 &quot##2##5##(1991-8#2)
with change in##7##3##(1991-8#2)(1994-3#1)(1996-11#1)(1996-8#1)(2011-1#1)(2012-12#1)
with change of##4##3##(1993-12#1)(2006-4#1)(2007-11#2)
with change##13##2##(1991-8#2)(1993-12#1)(1994-3#1)(1996-11#1)(1996-8#1)(2006-4#1)(2007-11#2)(2007-6#1)(2008-9#1)(2011-1#1)(2012-12#1)
with changed##4##2##(1991-11#1)(1992-11#1)(1992-3#1)(1995-5#1)
with changes from##2##3##(1995-11#1)(1997-7#1)
with changes in the##20##4##(1993-5#1)(1994-7#1)(1995-6#1)(2005-5#2)(2006-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-9#1)(2008-10#2)(2008-7#2)(2009-7#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#1)
with changes in##53##3##(1990-10#1)(1990-12#2)(1990-2#1)(1991-11#1)(1991-12#1)(1992-1#1)(1993-5#1)(1994-7#1)(1995-6#1)(1996-9#1)(1997-2#2)(2005-10#1)(2005-12#1)(2005-5#2)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-7#1)(2010-10#1)(2010-7#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-2#3)(2012-7#1)(2013-1#1)(2013-8#1)
with changes of the##2##4##(1994-3#1)(2008-3#1)
with changes of##3##3##(1994-3#1)(2007-12#1)(2008-3#1)
with changes##65##2##(1990-10#1)(1990-12#2)(1990-2#1)(1991-11#1)(1991-12#1)(1992-1#1)(1993-5#1)(1994-3#2)(1994-7#1)(1995-11#1)(1995-6#1)(1995-7#1)(1996-9#1)(1997-2#2)(1997-7#1)(2005-10#1)(2005-12#1)(2005-5#2)(2006-10#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-12#4)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-7#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-2#3)(2012-7#1)(2013-1#1)(2013-7#1)(2013-8#1)
with changing##7##2##(1990-6#1)(1991-4#1)(1993-3#1)(1996-2#1)(1997-3#1)(2007-12#1)(2011-1#1)
with channel##5##2##(1994-12#1)(1995-5#1)(2007-11#1)(2008-11#1)(2008-3#1)
with chaotic##2##2##(1992-8#1)(1994-2#1)
with chaperones##3##2##(1995-4#2)(2009-10#1)
with characteristic morphology##3##3##(2007-8#1)(2008-10#1)(2009-7#1)
with characteristic##19##2##(1992-12#1)(1993-2#1)(1993-3#1)(1995-6#1)(1997-5#1)(1997-6#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#2)(2009-7#1)(2010-4#1)(2011-2#1)
with characteristics of a##4##4##(1992-6#1)(1995-8#1)(1996-9#1)(2008-2#1)
with characteristics of##12##3##(1992-6#1)(1992-9#1)(1994-2#1)(1994-9#1)(1995-8#1)(1996-10#1)(1996-9#1)(2007-10#1)(2008-10#1)(2008-2#1)(2013-7#1)(2013-8#1)
with characteristics that##2##3##(2008-10#1)(2008-5#1)
with characteristics typical of##2##4##(1990-5#1)(1995-8#1)
with characteristics##20##2##(1990-5#1)(1992-6#1)(1992-9#1)(1994-2#1)(1994-9#1)(1995-7#1)(1995-8#2)(1996-10#1)(1996-9#1)(2006-10#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-5#2)(2013-1#1)(2013-7#1)(2013-8#1)
with characterization of##2##3##(2007-2#1)(2008-10#1)
with charged##3##2##(2005-11#1)(2007-8#1)(2008-10#1)
with cheap and##2##3##(2008-10#2)
with cheese##2##2##(1991-5#1)(2006-10#1)
with chelating agent##2##3##(2007-8#1)(2010-8#1)
with chelating##4##2##(2007-8#2)(2008-10#1)(2010-8#1)
with chemical processes##2##3##(2008-2#1)(2008-5#1)
with chemical sensors##2##3##(2008-10#2)
with chemical##32##2##(1990-7#1)(1991-3#1)(1992-6#1)(1995-1#1)(2004-4#1)(2006-12#1)(2007-1#1)(2008-10#7)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-12#1)(2010-10#2)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#1)
with chemically##7##2##(1994-12#1)(2004-9#1)(2008-10#1)(2008-5#2)(2009-8#1)(2013-1#1)
with chemicals##2##2##(1994-3#1)(2008-10#1)
with chemiluminescence (CL) detection##3##4##(1995-3#1)(2008-10#2)
with chemiluminescence (CL)##4##3##(1995-3#1)(2008-10#3)
with chemiluminescence detection is##2##4##(2008-10#2)
with chemiluminescence detection##12##3##(1990-8#1)(2008-10#11)
with chemiluminescence##17##2##(1990-8#1)(1995-3#1)(2008-10#15)
with chemiluminescent##2##2##(1992-9#1)(2008-10#1)
with chemometric##4##2##(2008-10#3)(2013-8#1)
with chemometrics##6##2##(2008-6#2)(2010-2#1)(2012-11#1)(2013-8#2)
with chemopreventive##2##2##(1993-9#1)(2009-11#1)
with chemotactic responsiveness to##2##4##(1994-6#2)
with chemotactic##3##2##(1994-6#2)(1996-2#1)
with chemotherapeutic drugs##2##3##(2007-12#1)(2010-11#1)
with chemotherapeutic##3##2##(1997-1#1)(2007-12#1)(2010-11#1)
with chemotherapy and radiation##3##4##(1993-2#1)(2007-6#1)(2012-2#1)
with chemotherapy and radiotherapy##2##4##(2007-7#1)(2007-9#1)
with chemotherapy and##9##3##(1992-8#1)(1993-2#1)(2005-11#1)(2007-6#1)(2007-7#1)(2007-9#1)(2010-7#1)(2011-2#1)(2012-2#1)
with chemotherapy for##9##3##(1991-2#1)(1995-9#1)(2004-1#1)(2007-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-3#1)(2012-2#1)
with chemotherapy in##7##3##(2005-8#1)(2008-5#1)(2010-8#1)(2012-1#2)(2012-2#1)(2012-3#1)
with chemotherapy only##2##3##(1992-2#1)(2011-2#1)
with chemotherapy plus##2##3##(1994-6#1)(2010-11#1)
with chemotherapy to##2##3##(1990-4#1)(2006-10#1)
with chemotherapy was##2##3##(2005-8#1)(2007-11#1)
with chemotherapy##80##2##(1990-10#2)(1990-4#1)(1991-2#2)(1991-4#1)(1991-6#2)(1992-10#2)(1992-12#1)(1992-2#1)(1992-8#1)(1993-2#1)(1994-6#1)(1995-9#1)(2004-1#3)(2005-11#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-6#2)(2007-7#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#3)(2008-6#5)(2008-7#7)(2009-7#1)(2009-8#2)(2010-11#1)(2010-3#3)(2010-7#1)(2010-8#1)(2011-2#6)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#2)
with chest pain and##9##4##(1993-12#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-3#2)(2010-10#1)(2013-8#2)
with chest pain in##3##4##(1991-3#1)(2008-3#2)
with chest pain##30##3##(1991-3#1)(1992-6#1)(1993-12#1)(2006-10#1)(2006-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-3#13)(2010-10#1)(2011-1#1)(2012-2#2)(2013-7#1)(2013-8#3)
with chest trauma##2##3##(2007-3#1)(2007-8#1)
with chest##43##2##(1991-12#1)(1991-3#1)(1991-4#3)(1992-6#1)(1993-12#1)(1997-8#1)(2006-10#3)(2006-12#1)(2007-3#2)(2007-5#1)(2007-7#2)(2007-8#4)(2008-3#13)(2010-10#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#3)
with chicken anaemia virus (CAV)##2##5##(2005-9#1)(2008-5#1)
with chicken anaemia##3##3##(2005-9#2)(2008-5#1)
with chicken##8##2##(1991-8#1)(1994-9#1)(2004-11#1)(2005-9#2)(2006-8#1)(2008-5#1)(2008-6#1)
with chief complaint of##2##4##(2011-2#1)(2013-7#1)
with chief##4##2##(1997-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
with child abuse##2##3##(1994-3#1)(1996-2#1)
with child delinquency##2##3##(2009-12#2)
with child##9##2##(1994-3#1)(1996-2#1)(1997-4#1)(2007-4#1)(2007-8#1)(2008-6#1)(2009-10#1)(2009-12#2)
with childhood##7##2##(1994-2#1)(2006-11#1)(2008-10#1)(2010-6#1)(2011-1#2)(2011-2#1)
with children and adolescents##2##4##(2010-5#2)
with children and##6##3##(1990-12#1)(1995-6#2)(2010-5#2)(2013-1#1)
with children from heterosexual##2##4##(2005-9#2)
with children in##2##3##(1992-1#1)(2008-9#1)
with children were believed to be more##2##7##(2009-4#2)
with children were##3##3##(2009-4#3)
with children who##3##3##(1996-3#1)(2006-10#1)(2013-7#1)
with children with special needs##3##5##(1997-2#1)(2005-12#2)
with children with##7##3##(1997-2#1)(2005-12#2)(2008-11#1)(2008-9#1)(2012-1#1)(2013-1#1)
with children##50##2##(1990-12#1)(1991-7#1)(1992-1#1)(1993-4#1)(1993-6#1)(1995-1#1)(1995-5#1)(1995-6#2)(1996-3#2)(1997-2#1)(2005-12#2)(2005-9#2)(2006-10#1)(2006-2#1)(2006-5#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-6#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-4#3)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
with children's##8##2##(1996-12#1)(2008-11#1)(2009-10#1)(2010-11#3)(2011-2#1)(2013-1#1)
with chimeric##4##2##(1997-1#1)(1997-3#1)(1997-9#1)(2008-10#1)
with chimpanzees##2##2##(2008-7#1)(2012-12#1)
with chinolon group antibiotics##2##4##(2007-11#2)
with chiral##3##2##(1990-6#1)(2007-11#1)(2011-2#1)
with chirped##2##2##(2007-11#1)(2007-12#1)
with chitin##3##2##(2006-6#1)(2008-10#1)(2009-8#1)
with chitosan##3##2##(2005-11#1)(2008-10#1)(2008-5#1)
with chloramphenicol##3##2##(1993-7#1)(2008-10#1)(2013-1#1)
with chloride in##3##3##(2008-10#3)
with chloride ions##2##3##(2008-10#1)(2009-8#1)
with chloride##8##2##(1996-12#1)(2008-10#6)(2009-8#1)
with chlorinated##4##2##(1991-8#1)(1992-6#1)(2007-8#1)(2008-10#1)
with chlorine and##2##3##(1992-6#1)(2008-10#1)
with chlorine##6##2##(1992-6#1)(2008-1#1)(2008-10#4)
with chlorisondamine##2##2##(1991-11#1)(1996-12#1)
with chloroform and##2##3##(2008-10#2)
with chloroform##14##2##(1993-8#1)(1994-10#1)(2005-11#1)(2007-8#1)(2008-10#9)(2008-7#1)
with chlorophyll##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
with chloroquine phosphate##3##3##(2008-4#3)
with chloroquine##14##2##(1992-5#1)(1992-9#1)(1993-8#1)(1994-3#1)(2006-2#1)(2007-11#2)(2008-4#4)(2009-4#1)(2011-2#2)
with chlorpromazine##2##2##(1997-1#1)(2011-1#1)
with cholangiocarcinoma##2##2##(2012-3#1)(2013-7#1)
with cholecystokinin##3##2##(1991-2#1)(1992-8#1)(1993-11#1)
with choledocholithiasis##3##2##(2005-12#1)(2008-5#2)
with cholelithiasis and##2##3##(1992-2#1)(2008-6#1)
with cholelithiasis##3##2##(1992-2#1)(2007-8#1)(2008-6#1)
with cholera toxin B subunit##2##5##(2008-11#2)
with cholera toxin B##3##4##(1996-5#1)(2008-11#2)
with cholera toxin##6##3##(1990-3#2)(1993-9#1)(1996-5#1)(2008-11#2)
with cholera##8##2##(1990-3#2)(1993-9#2)(1996-5#1)(2008-11#2)(2012-11#1)
with cholestasis##5##2##(1996-4#3)(2004-11#1)(2006-10#1)
with cholestatic##3##2##(1995-3#2)(2012-2#1)
with cholesterol oxidase##2##3##(2008-10#2)
with cholesterol##18##2##(1991-3#2)(1993-9#1)(1994-12#1)(1994-9#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-10#1)(2007-2#2)(2008-10#3)(2008-6#1)(2009-4#1)(2011-1#1)
with cholestyramine##2##2##(1992-11#1)(2008-10#1)
with choline##2##2##(1990-4#1)(2010-6#1)
with cholinergic agonists##2##3##(1993-11#1)(1995-12#1)
with cholinergic##6##2##(1992-6#1)(1993-11#1)(1994-8#1)(1995-12#1)(1996-1#1)(1997-6#1)
with chondroitinase ABC##2##3##(1994-9#1)(1997-8#1)
with chorea##4##2##(2006-10#1)(2008-7#3)
with choroidal metastases##2##3##(1990-12#1)(1996-3#1)
with chromatin##5##2##(1990-11#1)(1992-11#1)(1992-4#1)(1994-8#1)(2011-12#1)
with chromatographic##3##2##(1997-2#1)(2007-8#2)
with chromatomembrane cell and##2##4##(2008-10#2)
with chromatomembrane##4##2##(2008-10#4)
with chromium##3##2##(2007-11#2)(2007-12#1)
with chromium(VI)##3##2##(2008-10#3)
with chromogenic##2##2##(1990-10#1)(2008-10#1)
with chromosomal##10##2##(1990-9#1)(1991-7#1)(1997-4#1)(2006-2#1)(2007-6#1)(2008-4#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-3#1)
with chromosome##12##2##(1990-8#1)(1991-5#1)(1994-8#1)(1997-6#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-7#1)(2012-1#1)(2012-12#1)
with chromotropic acid (CA)##2##4##(2008-10#2)
with chromotropic acid##6##3##(2008-10#6)
with chronic HBV infection##4##4##(2009-11#1)(2009-8#1)(2010-8#1)(2012-3#1)
with chronic HBV##7##3##(2007-12#1)(2009-11#2)(2009-8#1)(2010-8#1)(2011-12#1)(2012-3#1)
with chronic HCV infection is##2##5##(2006-10#1)(2006-6#1)
with chronic HCV infection##9##4##(1996-9#1)(2006-10#1)(2006-6#3)(2008-8#2)(2009-4#1)(2009-8#1)
with chronic HCV##17##3##(1996-9#1)(2005-8#1)(2006-10#1)(2006-2#2)(2006-6#3)(2008-8#3)(2009-4#5)(2009-8#1)
with chronic LBP##2##3##(2010-12#2)
with chronic abdominal pain##2##4##(1995-2#1)(2009-6#1)
with chronic and##2##3##(1997-3#1)(2012-3#1)
with chronic ankle instability##5##4##(2009-10#4)(2013-1#1)
with chronic ankle##6##3##(2009-10#4)(2010-7#1)(2013-1#1)
with chronic atrial fibrillation##2##4##(1995-11#1)(2007-8#1)
with chronic atrial##3##3##(1994-11#1)(1995-11#1)(2007-8#1)
with chronic bronchitis and##2##4##(1990-5#1)(1993-10#1)
with chronic bronchitis##10##3##(1990-5#1)(1993-10#1)(1994-3#1)(2008-11#1)(2008-5#1)(2013-1#5)
with chronic conditions in##2##4##(2011-1#1)(2012-1#1)
with chronic conditions##10##3##(1997-1#2)(1997-2#2)(2010-3#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#1)
with chronic constipation##2##3##(1995-9#1)(2008-9#1)
with chronic cough##2##3##(2008-4#1)(2012-12#1)
with chronic disease##4##3##(2004-4#1)(2005-10#1)(2005-4#1)(2009-12#1)
with chronic diseases##6##3##(2006-10#1)(2009-9#2)(2011-2#2)(2012-1#1)
with chronic empyema##3##3##(2009-8#1)(2010-1#2)
with chronic functionally##2##3##(2006-8#2)
with chronic gastric fistulas##2##4##(1993-11#1)(2008-5#1)
with chronic gastritis##5##3##(1993-4#1)(2005-12#1)(2009-8#1)(2012-12#2)
with chronic granulomatous disease##8##4##(1994-3#2)(2007-12#3)(2007-2#1)(2012-11#2)
with chronic granulomatous##9##3##(1994-3#2)(2007-12#3)(2007-2#1)(2007-8#1)(2012-11#2)
with chronic health problems##2##4##(2009-10#1)(2012-3#1)
with chronic health##4##3##(1993-1#2)(2009-10#1)(2012-3#1)
with chronic heart failure##16##4##(1991-3#1)(1996-1#1)(2005-1#2)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#3)(2011-1#1)(2012-2#1)(2013-1#1)
with chronic heart##20##3##(1991-3#1)(1996-1#1)(2005-1#2)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#3)(2011-1#2)(2012-2#1)(2013-1#3)(2013-8#1)
with chronic hemiparesis##2##3##(2007-10#1)(2012-1#1)
with chronic hepatic##2##3##(1991-3#1)(2008-4#1)
with chronic hepatitis B virus (HBV)##2##6##(2009-8#1)(2012-12#1)
with chronic hepatitis B virus##3##5##(2009-11#1)(2009-8#1)(2012-12#1)
with chronic hepatitis B##24##4##(2006-10#1)(2007-11#2)(2009-11#4)(2009-8#5)(2010-12#3)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-7#1)
with chronic hepatitis C infection##3##5##(2006-10#1)(2007-3#1)(2009-7#1)
with chronic hepatitis C virus infection##6##6##(2006-10#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
with chronic hepatitis C virus##10##5##(2006-10#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
with chronic hepatitis C##46##4##(1992-9#1)(1994-8#1)(2006-10#3)(2006-2#1)(2007-11#13)(2007-3#3)(2008-8#3)(2009-10#1)(2009-2#1)(2009-4#2)(2009-7#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#5)(2013-7#1)
with chronic hepatitis##80##3##(1992-9#1)(1994-8#1)(2005-11#1)(2006-10#5)(2006-2#2)(2007-11#15)(2007-2#1)(2007-3#3)(2008-8#3)(2009-10#1)(2009-11#4)(2009-2#1)(2009-4#2)(2009-7#1)(2009-8#6)(2009-9#3)(2010-12#5)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#2)
with chronic idiopathic##4##3##(2007-11#1)(2007-7#1)(2008-8#1)(2012-3#1)
with chronic illness and##2##4##(1996-3#1)(1997-2#1)
with chronic illness or##2##4##(1992-2#1)(1997-1#1)
with chronic illness##15##3##(1992-12#1)(1992-2#1)(1993-1#1)(1993-3#1)(1996-3#1)(1997-1#3)(1997-2#3)(2005-4#1)(2007-9#1)(2009-9#1)(2012-12#1)
with chronic illnesses##10##3##(1991-8#1)(1992-3#1)(1993-3#3)(1995-12#2)(1996-3#2)(2006-10#1)
with chronic inflammatory demyelinating polyneuropathy##2##5##(2008-1#1)(2012-12#1)
with chronic inflammatory demyelinating##3##4##(2008-1#1)(2012-12#2)
with chronic inflammatory##8##3##(1994-2#1)(2005-1#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-9#1)(2012-12#2)
with chronic interstitial lung##2##4##(1991-2#1)(2006-8#1)
with chronic kidney disease (CKD)##5##5##(2008-3#1)(2008-5#1)(2011-2#2)(2013-7#1)
with chronic kidney disease##14##4##(2007-8#2)(2008-11#1)(2008-3#1)(2008-5#1)(2010-4#1)(2011-2#4)(2012-12#1)(2012-3#2)(2013-7#1)
with chronic kidney##16##3##(2007-8#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-4#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)
with chronic liver disease who are at risk for##2##9##(2008-1#2)
with chronic liver disease##22##4##(1991-11#1)(1991-2#1)(1991-3#1)(1991-8#1)(1993-7#1)(1996-4#1)(2006-10#3)(2007-8#2)(2008-1#3)(2008-10#1)(2009-2#3)(2009-4#1)(2009-7#1)(2009-8#1)(2011-1#1)
with chronic liver diseases##7##4##(1990-10#1)(1997-8#1)(2006-2#1)(2008-4#4)
with chronic liver##29##3##(1990-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-8#1)(1993-7#1)(1996-4#1)(1997-8#1)(2006-10#3)(2006-2#1)(2007-8#2)(2008-1#3)(2008-10#1)(2008-4#4)(2009-2#3)(2009-4#1)(2009-7#1)(2009-8#1)(2011-1#1)
with chronic low back pain of##2##6##(2006-8#2)
with chronic low back pain treated##2##6##(2006-8#1)(2013-1#1)
with chronic low back pain##22##5##(1993-11#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#13)(2007-6#1)(2008-10#1)(2012-12#2)(2013-1#1)
with chronic low back##23##4##(1993-11#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#14)(2007-6#1)(2008-10#1)(2012-12#2)(2013-1#1)
with chronic lung disease##2##4##(2008-1#1)(2009-3#1)
with chronic lymphatic##2##3##(1990-6#1)(2008-11#1)
with chronic lymphocytic leukemia##4##4##(1993-2#1)(2005-10#1)(2010-12#2)
with chronic lymphocytic##5##3##(1993-2#1)(2005-10#1)(2010-12#2)(2012-2#1)
with chronic medical conditions##5##4##(2007-5#1)(2008-7#1)(2010-2#1)(2012-2#1)(2013-8#1)
with chronic medical##7##3##(1995-1#1)(1996-12#1)(2007-5#1)(2008-7#1)(2010-2#1)(2012-2#1)(2013-8#1)
with chronic mental illness##2##4##(1994-2#1)(2006-5#1)
with chronic mental##3##3##(1993-3#1)(1994-2#1)(2006-5#1)
with chronic moderate##2##3##(2010-7#1)(2012-1#1)
with chronic myelogenous##2##3##(2005-10#1)(2006-10#1)
with chronic myeloid leukemia##9##4##(1996-2#2)(2005-12#1)(2007-12#1)(2008-1#1)(2008-4#1)(2009-3#2)(2010-4#1)
with chronic myeloid##10##3##(1996-2#2)(2005-12#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-4#1)(2009-3#2)(2010-4#1)
with chronic neck pain##7##4##(2006-8#2)(2007-6#1)(2010-12#4)
with chronic neck##9##3##(2006-8#4)(2007-6#1)(2010-12#4)
with chronic nonmalignant pain##3##4##(2006-12#1)(2010-3#2)
with chronic obstructive lung##2##4##(1993-8#1)(2008-1#1)
with chronic obstructive pulmonary disease (COPD) and##2##7##(2007-3#1)(2011-2#1)
with chronic obstructive pulmonary disease (COPD)##7##6##(1995-12#1)(1997-7#1)(2007-3#1)(2007-8#1)(2008-7#1)(2011-2#2)
with chronic obstructive pulmonary disease in##2##6##(2010-8#1)(2012-2#1)
with chronic obstructive pulmonary disease##26##5##(1991-9#1)(1995-12#1)(1997-7#2)(2006-10#1)(2006-2#1)(2007-11#1)(2007-3#1)(2007-8#4)(2008-4#2)(2008-7#3)(2010-10#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#1)
with chronic obstructive pulmonary##28##4##(1991-9#1)(1993-11#1)(1995-12#1)(1997-7#2)(2006-10#1)(2006-2#1)(2007-11#2)(2007-3#1)(2007-8#4)(2008-4#2)(2008-7#3)(2010-10#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#1)
with chronic obstructive##36##3##(1991-9#1)(1993-11#1)(1993-8#1)(1995-12#1)(1997-7#2)(2006-10#1)(2006-2#1)(2006-6#1)(2007-11#2)(2007-3#1)(2007-8#4)(2008-1#1)(2008-4#6)(2008-7#4)(2010-10#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#1)
with chronic or##6##3##(1996-3#1)(1997-2#1)(2005-12#1)(2006-8#1)(2007-12#1)(2008-12#1)
with chronic otitis##2##3##(1991-3#1)(1995-4#1)
with chronic pain and##2##4##(1997-6#1)(2008-10#1)
with chronic pain##30##3##(1992-9#1)(1993-5#1)(1995-9#1)(1996-7#1)(1997-6#1)(2006-12#4)(2006-3#1)(2006-8#4)(2007-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-9#1)(2009-4#3)(2009-7#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#2)
with chronic pancreatitis and##5##4##(1991-2#2)(1992-11#1)(2006-6#1)(2008-9#1)
with chronic pancreatitis##28##3##(1991-2#3)(1991-8#1)(1992-11#2)(1993-5#1)(1994-10#1)(1994-7#1)(1995-7#2)(2005-1#2)(2005-10#5)(2006-10#2)(2006-6#5)(2008-3#2)(2008-9#1)
with chronic pancreatitis]##2##3##(2006-6#2)
with chronic pelvic pain##3##4##(1991-2#1)(2008-8#2)
with chronic periodontitis##8##3##(2008-12#3)(2010-4#1)(2012-3#1)(2013-1#2)(2013-7#1)
with chronic progressive##2##3##(2007-11#1)(2010-2#1)
with chronic pyelonephritis##2##3##(2006-7#1)(2011-2#1)
with chronic recurrent##2##3##(2011-2#2)
with chronic renal failure (CRF)##6##5##(2007-11#1)(2007-7#3)(2011-2#1)(2012-1#1)
with chronic renal failure and secondary hyperparathyroidism##2##7##(1991-5#1)(1993-3#1)
with chronic renal failure and##3##5##(1991-5#1)(1993-11#1)(1993-3#1)
with chronic renal failure##40##4##(1990-10#1)(1990-11#1)(1990-8#1)(1991-1#1)(1991-5#1)(1991-8#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-5#1)(1996-8#2)(2005-1#1)(2005-9#1)(2006-6#3)(2006-7#1)(2007-11#1)(2007-7#4)(2007-8#1)(2008-1#3)(2008-4#2)(2008-5#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#1)
with chronic renal insufficiency##4##4##(2005-10#1)(2006-10#2)(2008-1#1)
with chronic renal tubular malfunction##2##5##(1991-8#2)
with chronic renal##53##3##(1990-10#1)(1990-11#1)(1990-8#1)(1991-1#1)(1991-5#1)(1991-8#3)(1992-6#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-5#1)(1996-8#2)(2005-1#1)(2005-10#1)(2005-9#1)(2006-10#2)(2006-6#3)(2006-7#2)(2007-11#1)(2007-7#5)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#1)(2008-4#2)(2008-5#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#1)
with chronic respiratory failure##2##4##(2008-1#1)(2013-1#1)
with chronic respiratory##3##3##(2008-1#1)(2013-1#2)
with chronic rhinosinusitis##2##3##(2010-6#1)(2012-1#1)
with chronic schizophrenia##6##3##(1996-1#1)(1997-8#2)(2009-10#1)(2011-2#1)(2012-1#1)
with chronic stable##6##3##(2008-1#2)(2008-3#1)(2009-4#1)(2010-10#1)(2012-11#1)
with chronic stroke##4##3##(2007-10#2)(2012-1#2)
with chronic thromboembolic pulmonary hypertension (CTEPH)##2##6##(2010-6#2)
with chronic thromboembolic pulmonary hypertension##5##5##(2010-6#2)(2013-1#2)(2013-7#1)
with chronic thromboembolic pulmonary##7##4##(2010-6#4)(2013-1#2)(2013-7#1)
with chronic thromboembolic##8##3##(2010-10#1)(2010-6#4)(2013-1#2)(2013-7#1)
with chronic tophaceous gout##2##4##(2006-10#1)(2010-4#1)
with chronic total occlusion##2##4##(2008-12#1)(2008-5#1)
with chronic venous insufficiency##5##4##(2005-10#1)(2013-1#4)
with chronic venous##6##3##(2005-10#1)(2010-7#1)(2013-1#4)
with chronic wrist pain##4##4##(2008-9#4)
with chronic##761##2##(1990-10#2)(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#3)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#6)(1991-3#6)(1991-4#2)(1991-5#2)(1991-6#2)(1991-8#6)(1991-9#1)(1992-10#1)(1992-11#4)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#2)(1992-7#1)(1992-9#2)(1993-1#4)(1993-10#2)(1993-11#4)(1993-2#3)(1993-3#6)(1993-4#1)(1993-5#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#3)(1994-3#4)(1994-4#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-1#3)(1995-11#2)(1995-12#4)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-7#2)(1995-8#1)(1995-9#2)(1996-1#2)(1996-12#1)(1996-2#3)(1996-3#4)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#8)(1997-2#6)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#4)(2004-4#2)(2005-1#10)(2005-10#11)(2005-11#3)(2005-12#3)(2005-4#2)(2005-7#1)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#22)(2006-11#2)(2006-12#10)(2006-2#7)(2006-3#1)(2006-5#1)(2006-6#16)(2006-7#6)(2006-8#26)(2006-9#1)(2007-10#5)(2007-11#25)(2007-12#8)(2007-2#5)(2007-3#4)(2007-5#1)(2007-6#2)(2007-7#7)(2007-8#13)(2007-9#4)(2008-1#16)(2008-10#10)(2008-11#3)(2008-12#8)(2008-3#7)(2008-4#26)(2008-5#17)(2008-7#15)(2008-8#13)(2008-9#8)(2009-10#10)(2009-11#6)(2009-12#1)(2009-2#6)(2009-3#3)(2009-4#14)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#14)(2009-9#6)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#16)(2010-2#3)(2010-3#5)(2010-4#5)(2010-5#2)(2010-6#8)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#7)(2011-11#1)(2011-12#2)(2011-2#32)(2012-1#13)(2012-11#5)(2012-12#13)(2012-2#15)(2012-3#14)(2013-1#41)(2013-7#5)(2013-8#6)
with chronically##3##2##(1990-10#1)(1992-11#1)(1992-9#1)
with chylous effusion##2##3##(2011-1#2)
with chymotrypsin##3##2##(1992-11#2)(1994-12#1)
with cigarette smoking##7##3##(1990-12#1)(1991-5#1)(2005-8#1)(2008-10#2)(2010-5#1)(2013-1#1)
with cigarette##9##2##(1990-12#1)(1991-5#1)(1993-8#1)(2005-8#1)(2008-10#2)(2010-5#1)(2013-1#2)
with cigarettes##4##2##(1993-10#1)(2005-10#1)(2006-7#1)(2011-2#1)
with cilioretinal artery obstruction##2##4##(2009-8#2)
with cilostazol##6##2##(2007-10#6)
with ciprofloxacin##10##2##(1991-12#1)(1991-4#2)(1993-1#1)(1997-6#1)(2006-8#1)(2007-7#1)(2008-5#1)(2011-2#2)
with circadian##2##2##(1992-10#1)(2011-1#1)
with circular dichroism##3##3##(2006-10#1)(2006-12#1)(2009-5#1)
with circular gratings##3##3##(2008-3#3)
with circular or##2##3##(2005-10#1)(2008-3#1)
with circular##20##2##(1990-4#1)(1995-2#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-2#1)(2008-3#7)(2008-4#1)(2009-2#1)(2009-5#1)
with circulating##6##2##(2006-9#1)(2008-10#1)(2008-6#1)(2008-7#2)(2008-9#1)
with circulatory##2##2##(2007-9#1)(2010-2#1)
with circumferential spine fusion##2##4##(2008-8#2)
with circumferential##3##2##(2008-11#1)(2008-8#2)
with cirrhosis and##9##3##(1993-2#1)(2008-12#1)(2009-4#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#3)
with cirrhosis of the liver##2##5##(1991-5#1)(2006-6#1)
with cirrhosis of##3##3##(1991-5#1)(2006-6#1)(2012-3#1)
with cirrhosis##38##2##(1991-5#1)(1991-9#1)(1992-9#1)(1993-2#1)(1994-7#1)(1995-3#2)(1995-9#1)(2004-11#1)(2006-10#2)(2006-2#1)(2006-6#1)(2007-11#1)(2007-2#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-4#3)(2010-12#2)(2010-5#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#5)
with cis-acting##2##2##(1993-3#1)(2009-4#1)
with cisplatin and etoposide##2##4##(1994-12#1)(2007-3#1)
with cisplatin and##4##3##(1993-2#1)(1994-12#1)(2007-3#1)(2010-12#1)
with cisplatin on##2##3##(2013-1#1)(2013-8#1)
with cisplatin resistance##2##3##(1995-5#1)(2008-4#1)
with cisplatin##35##2##(1990-7#1)(1992-12#2)(1992-2#1)(1992-7#2)(1992-8#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-7#1)(1995-5#1)(2007-10#1)(2007-3#1)(2008-2#1)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#1)(2009-4#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
with cisplatin]##2##2##(1990-6#1)(1991-8#1)
with citrate##4##2##(1992-11#1)(1996-8#1)(2005-8#1)(2008-10#1)
with citric acid##4##3##(2006-12#2)(2008-10#2)
with claims##2##2##(1992-3#1)(1996-2#1)
with clamping##2##2##(2007-8#1)(2008-5#1)
with clarity##4##2##(1993-12#1)(2008-11#1)(2008-12#1)(2009-5#1)
with class I molecules##3##4##(1990-5#2)(2007-5#1)
with class I##6##3##(1990-11#1)(1990-5#2)(2007-5#1)(2008-5#1)(2010-12#1)
with class II##5##3##(1993-3#1)(1995-8#1)(2011-2#3)
with class IV or##3##4##(2008-1#2)(2008-5#1)
with class IV##5##3##(1993-2#1)(2008-1#3)(2008-5#1)
with class##17##2##(1990-11#1)(1990-5#2)(1993-2#1)(1993-3#1)(1995-8#1)(2007-5#1)(2008-1#4)(2008-5#2)(2010-12#1)(2011-2#3)
with classic CAH##3##3##(2010-2#3)
with classic##19##2##(1992-2#1)(1996-12#1)(2005-7#1)(2006-10#4)(2007-3#1)(2008-10#1)(2008-3#1)(2009-10#1)(2009-6#1)(2010-2#4)(2011-1#1)(2011-2#1)(2012-3#1)
with classical PKU##2##3##(2012-2#2)
with classical clinical##2##3##(2007-7#1)(2012-11#1)
with classical methods##2##3##(2008-10#1)(2009-9#1)
with classical##36##2##(1990-3#1)(1991-12#2)(1992-12#1)(1992-2#1)(1993-11#1)(1994-11#1)(1997-5#1)(1997-7#1)(2005-4#1)(2006-10#1)(2006-11#1)(2007-12#4)(2007-4#1)(2007-7#2)(2008-10#5)(2008-11#1)(2008-3#2)(2008-8#1)(2009-8#1)(2009-9#2)(2012-11#1)(2012-2#3)(2012-3#1)
with classification##2##2##(1990-3#1)(2007-4#1)
with clavulanic acid##5##3##(1990-3#3)(2006-8#1)(2007-7#1)
with clay##3##2##(2007-5#1)(2008-10#2)
with clean##2##2##(2008-10#1)(2012-10#1)
with cleaning##2##2##(2005-11#1)(2008-4#1)
with cleansing##2##2##(1992-10#1)(2013-1#1)
with clear cell##2##3##(2008-6#1)(2013-1#1)
with clear##21##2##(1991-8#1)(2006-10#2)(2007-11#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-5#1)(2009-8#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
with clearly##4##2##(1991-2#1)(1994-3#1)(2007-11#1)(2008-5#1)
with cleavable##2##2##(1993-3#1)(2008-12#1)
with cleavage##2##2##(2008-4#1)(2009-6#1)
with cleft lip and palate##2##5##(2007-12#1)(2013-1#1)
with cleft lip and/or palate##2##5##(2007-12#1)(2013-1#1)
with cleft lip##6##3##(2007-12#2)(2011-2#1)(2012-12#1)(2013-1#2)
with cleft lip/palate and##2##4##(1996-3#1)(2011-2#1)
with cleft lip/palate##3##3##(1996-3#1)(2011-2#2)
with cleft palate##3##3##(2007-12#1)(2012-12#1)(2013-1#1)
with cleft##16##2##(1993-12#1)(1996-3#1)(2007-12#3)(2010-11#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#4)
with clenbuterol##3##2##(2010-6#3)
with clients and##2##3##(2007-9#1)(2012-3#1)
with clients##8##2##(1993-2#1)(2007-9#1)(2008-11#1)(2011-1#1)(2011-12#2)(2012-3#2)
with climacteric blooding##2##3##(2008-11#2)
with climacteric##3##2##(1991-8#1)(2008-11#2)
with climate##3##2##(2008-8#1)(2010-9#1)(2012-9#1)
with clinic##2##2##(2008-6#1)(2011-2#1)
with clinical and radiological##3##4##(1997-1#1)(2006-12#1)(2012-2#1)
with clinical and##22##3##(1994-2#1)(1994-7#1)(1996-3#1)(1997-1#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-6#1)(2011-2#2)(2012-2#2)(2013-1#3)
with clinical assessment##3##3##(1990-10#1)(2008-3#1)(2009-4#1)
with clinical benefit##2##3##(2006-10#1)(2010-5#1)
with clinical diagnosis##2##3##(2007-8#1)(2013-8#1)
with clinical disease##2##3##(1991-6#1)(2008-10#1)
with clinical evidence of##4##4##(2006-10#1)(2008-4#1)(2009-10#1)(2009-12#1)
with clinical experience##4##3##(2007-11#1)(2007-8#2)(2008-11#1)
with clinical features of##2##4##(1996-2#1)(2007-8#1)
with clinical features##6##3##(1990-12#1)(1990-3#1)(1993-11#1)(1996-2#1)(2007-8#1)(2009-6#1)
with clinical improvement##2##3##(2005-10#1)(2007-7#1)
with clinical judgement##2##3##(1996-9#1)(2008-3#1)
with clinical manifestation of##2##4##(2007-8#1)(2008-6#1)
with clinical manifestations##5##3##(1991-12#1)(2006-10#1)(2008-4#1)(2010-2#1)(2013-1#1)
with clinical observations##5##3##(1991-11#1)(1991-12#1)(2007-4#1)(2008-5#2)
with clinical outcome##4##3##(2006-12#1)(2007-11#2)(2008-6#1)
with clinical parameters##2##3##(1993-7#1)(2008-8#1)
with clinical presentation of##2##4##(2007-4#1)(2008-1#1)
with clinical presentation##4##3##(2007-4#1)(2007-6#1)(2008-1#1)(2013-1#1)
with clinical response##3##3##(2006-12#1)(2008-1#1)(2011-2#1)
with clinical significance##2##3##(2008-12#1)(2011-1#1)
with clinical signs of##7##4##(2007-7#1)(2008-5#2)(2011-2#1)(2012-12#1)(2013-1#2)
with clinical signs##12##3##(1992-9#1)(2007-7#1)(2007-8#1)(2008-5#4)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
with clinical suspicion of##2##4##(1990-2#1)(2007-5#1)
with clinical symptoms and##3##4##(2006-8#1)(2008-3#1)(2013-1#1)
with clinical symptoms##8##3##(2006-10#1)(2006-11#1)(2006-8#1)(2007-9#2)(2008-12#1)(2008-3#1)(2013-1#1)
with clinical trials##3##3##(2006-10#1)(2007-11#1)(2012-12#1)
with clinical##171##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-7#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-7#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#2)(1997-4#1)(2005-10#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#7)(2006-11#1)(2006-12#4)(2006-2#1)(2006-5#2)(2006-7#1)(2006-8#2)(2007-11#7)(2007-12#1)(2007-2#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#6)(2007-9#2)(2008-1#3)(2008-10#2)(2008-11#4)(2008-12#4)(2008-3#4)(2008-4#2)(2008-5#8)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#3)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#10)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#16)(2013-7#2)(2013-8#5)
with clinically diagnosed Alzheimer's disease (AD)##2##6##(1994-2#1)(2008-7#1)
with clinically diagnosed##6##3##(1994-2#1)(1995-3#1)(1996-11#1)(2008-7#1)(2009-2#1)(2013-1#1)
with clinically localized disease##2##4##(2007-11#2)
with clinically localized##3##3##(2007-11#2)(2007-12#1)
with clinically relevant##2##3##(2007-11#1)(2007-6#1)
with clinically significant##3##3##(1992-6#1)(2006-10#1)(2010-7#1)
with clinically##32##2##(1990-2#1)(1992-3#1)(1992-6#1)(1994-10#1)(1994-2#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-3#1)(2004-1#1)(2006-10#2)(2006-11#1)(2007-11#3)(2007-12#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-12#1)(2010-7#1)(2010-9#1)(2012-12#2)(2012-3#1)(2013-1#1)
with clinicians and##4##3##(1991-12#1)(2008-6#1)(2009-11#1)(2010-4#1)
with clinicians##9##2##(1991-12#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-4#1)(2013-1#4)
with clinicopathologic##3##2##(2006-9#1)(2010-1#1)(2011-1#1)
with clofibrate##2##2##(1990-12#1)(1992-11#1)
with clofibric acid##2##3##(1992-4#1)(1995-3#1)
with clomethiazole##2##2##(2005-9#1)(2007-9#1)
with clonal##2##2##(2008-7#1)(2011-2#1)
with clone##2##2##(1990-11#1)(2008-9#1)
with cloned##5##2##(1991-6#1)(1994-12#1)(1994-9#1)(2008-10#2)
with clonidine##2##2##(1993-12#1)(2006-10#1)
with cloning##2##2##(1990-3#1)(1991-12#1)
with close##8##2##(1997-4#1)(2005-9#1)(2007-10#1)(2007-12#1)(2011-12#1)(2011-2#1)(2013-1#2)
with closed reduction and##2##4##(2008-12#1)(2009-3#1)
with closed##9##2##(2006-6#1)(2007-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#1)(2009-3#1)(2012-2#1)
with closed-loop##3##2##(2008-2#2)(2013-1#1)
with closely related##3##3##(1991-7#1)(1995-1#1)(2009-2#1)
with closely##9##2##(1991-11#1)(1991-7#1)(1993-3#2)(1995-1#1)(2005-7#1)(2009-2#1)(2009-8#1)(2012-2#1)
with clotrimazole##4##2##(2007-7#3)(2008-5#1)
with clozapine and##2##3##(2007-7#1)(2008-12#1)
with clozapine in##3##3##(1997-8#1)(2005-8#1)(2008-12#1)
with clozapine##11##2##(1996-12#1)(1997-8#2)(2005-8#1)(2007-7#3)(2008-12#3)(2008-3#1)
with cluster##7##2##(2007-12#1)(2007-7#3)(2008-7#1)(2011-1#1)(2013-1#1)
with clustering##3##2##(2010-2#1)(2012-3#2)
with clusters of##3##3##(2008-5#1)(2008-8#1)(2013-8#1)
with clusters##5##2##(1991-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-8#1)
with co-occurring mental##2##3##(2008-6#1)(2012-12#1)
with co-occurring##9##2##(2008-10#1)(2008-6#1)(2012-12#2)(2012-3#1)(2013-8#4)
with co-workers##2##2##(1993-2#1)(2007-8#1)
with coadministration of##2##3##(1991-12#1)(2009-11#1)
with coagulation##4##2##(1993-9#1)(1996-8#1)(2006-10#1)(2011-1#1)
with coagulopathy##3##2##(2007-10#2)(2009-1#1)
with coarctation of the##2##4##(2007-11#1)(2007-8#1)
with coarctation of##3##3##(2007-11#1)(2007-8#2)
with coarctation##4##2##(1990-8#1)(2007-11#1)(2007-8#2)
with coarse##3##2##(2008-6#1)(2010-12#1)(2012-12#1)
with coat protein##2##3##(1996-10#1)(2008-8#1)
with coat##3##2##(1994-12#1)(1996-10#1)(2008-8#1)
with coated pits##3##3##(1995-3#3)
with coated##8##2##(1991-3#1)(1995-3#4)(2005-4#1)(2008-10#1)(2011-2#1)
with coatomer subunit beta##2##4##(1997-4#2)
with cobalamin##3##2##(2007-12#1)(2013-1#2)
with cobalt##12##2##(1990-11#1)(1992-1#1)(1994-6#6)(2008-10#2)(2008-11#1)(2010-2#1)
with cobalt(II) and##2##3##(2008-10#2)
with cobalt(II)##3##2##(2008-10#3)
with cobalt-60##2##2##(2007-8#1)(2008-7#1)
with cocaine abuse##3##3##(2006-11#1)(2009-11#2)
with cocaine dependence##3##3##(2004-3#1)(2009-11#2)
with cocaine use##4##3##(2004-3#4)
with cocaine##21##2##(1994-12#1)(1994-2#1)(1994-8#1)(1995-10#1)(1996-10#2)(1996-3#1)(1996-8#1)(2004-3#5)(2006-11#1)(2007-12#1)(2009-11#4)(2009-7#1)(2011-2#1)
with cochlear implant##3##3##(2008-9#3)
with cochlear implants in the##2##5##(2008-9#2)
with cochlear implants in##3##4##(2008-9#3)
with cochlear implants##31##3##(2008-9#28)(2010-10#1)(2012-2#2)
with cochlear##35##2##(2008-9#32)(2010-10#1)(2012-2#2)
with coding##5##2##(2006-8#2)(2008-12#1)(2008-2#1)(2012-12#1)
with coefficients of &gt##2##4##(2008-10#2)
with coefficients of variation less than##2##6##(2008-10#1)(2012-12#1)
with coefficients of variation##5##4##(2008-10#3)(2008-5#1)(2012-12#1)
with coefficients of##9##3##(2007-8#1)(2008-10#5)(2008-5#1)(2010-9#1)(2012-12#1)
with coefficients##12##2##(2007-8#1)(2008-10#5)(2008-3#3)(2008-5#1)(2010-9#1)(2012-12#1)
with coeliac disease##6##3##(1991-11#3)(1992-12#1)(2006-2#2)
with coenzyme Q10##2##3##(1996-9#1)(2012-1#1)
with coexistent##9##2##(1992-3#1)(1993-1#1)(1994-11#1)(1995-6#2)(2007-12#1)(2007-7#1)(2011-2#1)(2012-2#1)
with coexisting##13##2##(2004-10#1)(2005-10#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2011-1#1)(2013-1#3)
with cofactor binding##2##3##(1990-7#1)(1992-11#1)
with cofactor##4##2##(1990-7#2)(1992-11#1)(1992-12#1)
with coffee consumption##2##3##(1990-6#2)
with coffee##4##2##(1990-6#2)(1993-9#1)(2006-8#1)
with cognitive impairment##8##3##(2005-10#1)(2006-8#2)(2008-11#2)(2008-7#1)(2010-7#1)(2010-9#1)
with cognitive impairments##4##3##(1990-8#1)(1991-1#1)(2008-12#1)(2013-7#1)
with cognitive##21##2##(1990-8#1)(1991-1#1)(1991-5#1)(1992-9#1)(2005-10#1)(2006-8#2)(2008-11#2)(2008-12#1)(2008-7#2)(2009-8#1)(2010-2#1)(2010-7#1)(2010-9#2)(2011-12#1)(2012-1#1)(2013-1#1)(2013-7#1)
with coherent light##2##3##(2007-11#1)(2008-3#1)
with coherent##6##2##(2007-11#1)(2008-3#4)(2008-6#1)
with coil embolization##4##3##(2008-1#1)(2012-12#2)(2012-3#1)
with coil##5##2##(1993-10#1)(2008-1#1)(2012-12#2)(2012-3#1)
with coils or##2##3##(2008-4#1)(2010-12#1)
with coils##8##2##(1997-8#4)(2007-8#1)(2008-4#1)(2010-12#2)
with coincident##2##2##(2007-8#1)(2008-10#1)
with colchicine##2##2##(1995-5#1)(1997-6#1)
with cold##16##2##(1990-9#1)(1992-6#1)(1993-12#2)(1993-2#1)(1993-5#1)(1995-6#2)(2006-12#1)(2006-4#2)(2007-8#1)(2008-10#2)(2008-5#2)
with cold-vapor atomic absorption spectrometry##2##5##(2007-8#1)(2008-10#1)
with collagen##13##2##(1991-5#1)(1996-10#2)(2006-2#1)(2007-11#1)(2008-10#1)(2008-5#2)(2008-8#1)(2009-7#1)(2010-12#1)(2012-12#1)(2012-3#1)
with collapse of##2##3##(1995-2#1)(2008-10#1)
with collapse##4##2##(1991-11#1)(1991-8#1)(1995-2#1)(2008-10#1)
with collateral##3##2##(1992-10#1)(1997-8#2)
with colleagues and##2##3##(2010-8#1)(2013-8#1)
with colleagues##5##2##(1997-3#1)(2007-8#1)(2010-8#1)(2011-2#1)(2013-8#1)
with collection##2##2##(2008-10#1)(2008-2#1)
with college##2##2##(2007-12#1)(2013-8#1)
with collision acceleration##2##3##(2007-1#2)
with collision##3##2##(2007-1#3)
with collocated##2##2##(2008-2#1)(2008-3#1)
with colloidal##4##2##(1992-12#1)(2008-10#1)(2010-11#1)(2012-12#1)
with colon cancer##6##3##(1990-8#1)(2006-8#2)(2009-3#1)(2010-6#1)(2010-8#1)
with colon##12##2##(1990-8#2)(1991-3#1)(1996-2#1)(1997-4#1)(2006-8#4)(2009-3#1)(2010-6#1)(2010-8#1)
with colonic carcinoma##2##3##(1993-5#2)
with colonic##11##2##(1991-9#1)(1993-5#2)(2006-8#1)(2008-6#1)(2009-12#2)(2010-12#2)(2011-2#2)
with colonization##2##2##(2008-10#2)
with colony size##3##3##(2008-9#3)
with colony##6##2##(1990-4#1)(2008-10#2)(2008-9#3)
with color Doppler##3##3##(2006-10#2)(2007-12#1)
with color##8##2##(2006-10#2)(2007-12#2)(2008-2#2)(2008-4#1)(2011-1#1)
with colorectal cancer have an##2##5##(2009-12#1)(2010-11#1)
with colorectal cancer is##2##4##(2010-11#1)(2011-2#1)
with colorectal cancer##21##3##(1991-7#1)(1996-1#1)(1996-10#1)(2006-10#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-12#2)(2010-11#2)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2013-1#1)
with colorectal liver metastases##3##4##(2008-3#1)(2010-11#1)(2012-1#1)
with colorectal##42##2##(1991-3#2)(1991-7#1)(1992-8#4)(1993-9#2)(1994-6#1)(1996-1#1)(1996-10#1)(1997-5#1)(2006-10#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#2)(2010-11#3)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#6)(2012-2#1)(2013-1#2)
with colorimetric##4##2##(2008-10#3)(2011-2#1)
with colostomy##2##2##(2006-8#1)(2011-2#1)
with column switching##2##3##(1990-6#2)
with column##7##2##(1990-6#2)(1997-2#1)(2007-5#1)(2008-10#3)
with coma##2##2##(1991-12#1)(2010-3#1)
with combination chemotherapy##4##3##(2006-10#1)(2007-10#1)(2007-6#1)(2008-6#1)
with combination drugs##2##3##(1990-8#1)(2012-2#1)
with combination of##7##3##(1996-3#1)(1997-6#1)(2007-2#2)(2007-7#1)(2012-3#1)(2013-8#1)
with combination therapy##6##3##(2005-9#1)(2006-10#1)(2007-10#2)(2007-11#1)(2008-7#1)
with combination##25##2##(1990-6#1)(1990-8#1)(1996-3#1)(1997-6#1)(2005-8#1)(2005-9#1)(2006-10#4)(2007-10#3)(2007-11#1)(2007-2#2)(2007-6#1)(2007-7#1)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
with combinations of##9##3##(1994-8#1)(1995-12#1)(1996-5#1)(2007-3#1)(2008-10#1)(2008-5#1)(2012-1#2)(2012-2#1)
with combinatorial##2##2##(1997-7#1)(2009-12#1)
with combined day and night capability for tropospheric water-vapor profile measurements##2##11##(2008-2#2)
with combined infection##3##3##(2007-2#1)(2012-1#2)
with combined therapy##3##3##(1992-6#1)(2007-6#1)(2007-8#1)
with combined##44##2##(1990-11#1)(1992-6#1)(1993-6#1)(1994-3#1)(2006-5#2)(2006-8#2)(2007-11#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-10#1)(2008-2#2)(2008-5#3)(2008-7#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-2#3)(2012-1#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
with combining##3##2##(1994-8#1)(2007-3#1)(2012-12#1)
with comments on##3##3##(2007-12#1)(2008-3#1)(2008-8#1)
with comments##4##2##(1992-3#1)(2007-12#1)(2008-3#1)(2008-8#1)
with commercial clients##2##3##(2012-3#2)
with commercial##16##2##(2004-8#1)(2007-2#1)(2007-9#1)(2008-10#3)(2008-3#2)(2008-5#3)(2010-4#1)(2011-2#1)(2012-3#3)
with commercially available##8##3##(1991-12#1)(1992-2#1)(1994-9#1)(2008-10#3)(2010-12#1)(2013-8#1)
with commercially##9##2##(1991-12#1)(1992-2#1)(1994-9#1)(2008-10#3)(2009-7#1)(2010-12#1)(2013-8#1)
with comminuted##2##2##(2007-1#1)(2009-2#1)
with common arterial trunk##2##4##(2007-8#2)
with common variable immunodeficiency##3##4##(2007-2#2)(2012-3#1)
with common##49##2##(1990-3#1)(1990-7#1)(1990-8#1)(1991-10#1)(1992-3#1)(1993-5#1)(1994-6#1)(1995-1#1)(1995-10#1)(1996-6#1)(1997-8#1)(2005-8#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-8#2)(2007-9#1)(2008-10#9)(2008-11#1)(2008-5#2)(2008-6#2)(2008-7#2)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#6)
with commonly used##5##3##(1996-12#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
with commonly##7##2##(1995-4#1)(1996-12#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
with communication##4##2##(2008-5#1)(2011-1#2)(2012-12#1)
with communities##2##2##(2007-10#1)(2012-3#1)
with community health##2##3##(1991-4#1)(1997-2#1)
with community pharmacists in error prevention and management##2##8##(2011-1#2)
with community pharmacists##8##3##(2011-1#8)
with community##20##2##(1991-4#1)(1995-1#1)(1997-2#2)(2006-1#1)(2007-10#1)(2008-11#1)(2009-8#1)(2010-8#1)(2011-1#8)(2012-2#1)(2013-1#2)
with community-acquired pneumonia and##4##4##(2013-1#4)
with community-acquired pneumonia##6##3##(2007-4#1)(2013-1#5)
with community-acquired##8##2##(1993-2#1)(2006-2#1)(2007-4#1)(2013-1#5)
with community-based##3##2##(2007-1#1)(2008-6#2)
with comorbid depression and##2##4##(2008-1#1)(2009-9#1)
with comorbid##8##2##(2005-7#1)(2008-1#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-9#1)(2010-2#1)(2011-2#1)
with comorbidities##3##2##(2009-5#1)(2011-2#1)(2012-2#1)
with compact##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
with comparable##23##2##(1990-2#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-7#1)(1993-12#1)(1994-9#1)(1995-9#1)(1997-2#2)(2006-10#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-1#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-8#1)
with comparative##3##2##(2008-3#1)(2008-9#1)(2010-12#1)
with comparatively##4##2##(2008-2#1)(2008-4#1)(2011-2#2)
with comparison##4##2##(1990-9#1)(2008-7#1)(2009-4#1)(2010-12#1)
with comparisons made##2##3##(2008-4#1)(2010-8#1)
with comparisons##5##2##(2008-10#1)(2008-2#1)(2008-4#1)(2010-8#1)(2012-3#1)
with compensated##6##2##(1991-10#1)(1997-4#1)(2008-10#1)(2011-1#1)(2013-1#1)(2013-8#1)
with compensation##2##2##(2008-3#2)
with compensatory##3##2##(2007-11#2)(2011-1#1)
with competing##2##2##(1995-2#1)(2012-11#1)
with competitive##7##2##(1990-12#1)(1996-6#1)(2008-10#2)(2008-8#1)(2008-9#1)(2012-2#1)
with competitors##2##2##(1992-3#1)(1995-12#1)
with complaint of##3##3##(2007-3#2)(2008-9#1)
with complaints of an##2##4##(2007-7#1)(2008-10#1)
with complaints of fever##2##4##(2006-4#1)(2008-1#1)
with complaints of##25##3##(1992-2#1)(1994-10#1)(1994-3#1)(2005-12#1)(2006-4#1)(2006-8#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2012-11#1)(2013-1#2)(2013-7#1)(2013-8#3)
with complaints##26##2##(1992-2#1)(1994-10#1)(1994-3#1)(1997-3#1)(2005-12#1)(2006-4#1)(2006-8#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2012-11#1)(2013-1#2)(2013-7#1)(2013-8#3)
with complement##7##2##(1991-4#1)(1992-12#1)(1992-3#1)(1994-11#1)(1994-6#1)(2008-10#1)(2008-4#1)
with complementary DNA sequences##2##4##(2008-10#1)(2009-4#1)
with complementary DNA##3##3##(2008-10#2)(2009-4#1)
with complementary##13##2##(1990-7#1)(1993-5#1)(1994-12#1)(1994-8#1)(2006-12#1)(2008-10#4)(2008-3#1)(2008-9#1)(2009-4#1)(2012-2#1)
with complete clinical##2##3##(2006-10#1)(2010-9#1)
with complete closure of the##2##5##(2012-2#1)(2013-1#1)
with complete data##2##3##(2005-10#1)(2009-5#1)
with complete healing of the##2##5##(2007-11#1)(2007-7#1)
with complete loss of##2##4##(1997-8#1)(2007-11#1)
with complete recovery of##2##4##(1991-11#1)(1994-11#1)
with complete recovery##5##3##(1991-11#1)(1991-8#1)(1992-2#1)(1994-11#1)(2010-7#1)
with complete remission##4##3##(1990-10#1)(1993-1#1)(2007-7#1)(2007-8#1)
with complete resistance to##4##4##(2008-10#4)
with complete resolution of symptoms##2##5##(2007-6#1)(2009-10#1)
with complete resolution of##5##4##(2006-10#1)(2007-6#1)(2008-7#1)(2009-10#1)(2013-8#1)
with complete resolution##6##3##(2004-2#1)(2006-10#1)(2007-6#1)(2008-7#1)(2009-10#1)(2013-8#1)
with complete response##4##3##(1997-7#1)(2007-11#1)(2007-8#1)(2013-1#1)
with complete responses##2##3##(1992-2#1)(2007-11#1)
with complete suppression of the##2##5##(2007-12#2)
with complete suppression##3##3##(1997-8#1)(2007-12#2)
with complete uncoupling##3##3##(1997-2#3)
with complete##99##2##(1990-10#1)(1990-6#1)(1991-11#1)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-4#1)(1993-1#1)(1993-12#1)(1993-7#1)(1994-11#1)(1994-2#1)(1995-11#1)(1996-5#2)(1997-2#3)(1997-5#1)(1997-7#1)(1997-8#2)(2004-1#1)(2004-2#1)(2005-10#1)(2006-10#5)(2006-12#1)(2007-10#1)(2007-11#6)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#4)(2007-8#4)(2008-10#9)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#3)(2010-9#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#2)
with completely different##3##3##(1991-5#1)(1995-10#1)(2006-8#1)
with completely resected##2##3##(2008-3#1)(2008-6#1)
with completely##7##2##(1990-10#1)(1991-5#1)(1995-10#1)(1996-3#1)(2006-8#1)(2008-3#1)(2008-6#1)
with complex and##3##3##(2006-4#1)(2008-11#1)(2010-8#1)
with complex congenital heart disease##4##5##(2010-3#2)(2011-2#1)(2013-1#1)
with complex matrices##2##3##(2008-10#1)(2011-1#1)
with complex medical conditions##2##4##(2008-10#1)(2010-8#1)
with complex pharmacology##2##3##(2008-11#1)(2013-1#1)
with complex reflection coefficients##2##4##(2008-3#2)
with complex##65##2##(1992-6#1)(1993-12#1)(1994-8#1)(1995-12#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-4#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-8#2)(2008-10#3)(2008-11#6)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#3)(2010-7#1)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#2)
with complexes##4##2##(1990-2#1)(1990-5#1)(2008-10#1)(2010-2#1)
with complicated malaria##2##3##(2012-12#2)
with complicated urinary infection##2##4##(2007-12#2)
with complicated##14##2##(1991-6#1)(2007-12#2)(2008-10#1)(2008-3#3)(2008-4#1)(2010-12#1)(2011-2#1)(2012-12#2)(2013-7#2)
with complication##2##2##(2010-12#1)(2010-5#1)
with complications in##3##3##(2008-2#1)(2011-2#1)(2012-3#1)
with complications like##3##3##(2006-3#1)(2008-7#1)(2011-1#1)
with complications of##2##3##(2006-2#1)(2007-5#1)
with complications such as##5##4##(1991-6#1)(1996-11#1)(2006-10#1)(2007-12#1)(2012-12#1)
with complications##29##2##(1991-6#1)(1992-2#1)(1996-11#1)(1997-2#1)(2005-9#1)(2006-10#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-2#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
with component##2##2##(2008-10#1)(2008-9#1)
with components of the##4##4##(1991-5#1)(1994-12#1)(1995-12#1)(1995-8#1)
with components of##6##3##(1991-3#1)(1991-5#1)(1994-12#1)(1995-12#1)(1995-8#1)(2012-12#1)
with components##7##2##(1990-5#1)(1991-3#1)(1991-5#1)(1994-12#1)(1995-12#1)(1995-8#1)(2012-12#1)
with composite##9##2##(1990-9#1)(2007-8#2)(2008-10#1)(2013-1#5)
with composition##5##2##(2008-10#4)(2008-5#1)
with compost##5##2##(2008-10#5)
with composted##2##2##(2008-10#2)
with compound##7##2##(1990-2#1)(1992-3#1)(1994-5#1)(1996-6#1)(2007-11#1)(2012-2#2)
with compounds that##3##3##(1995-1#1)(2008-10#1)(2011-1#1)
with compounds##7##2##(1990-2#1)(1995-1#1)(1996-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-1#1)
with comprehensive##6##2##(1992-2#1)(1997-8#1)(2006-8#1)(2007-11#1)(2008-12#1)(2008-7#1)
with compression fracture##2##3##(2006-6#1)(2011-12#1)
with compression of the##2##4##(1993-8#1)(2006-8#1)
with compression of##3##3##(1993-8#1)(2006-8#1)(2007-12#1)
with compression##6##2##(1993-8#1)(2006-6#1)(2006-8#1)(2007-12#1)(2009-2#1)(2011-12#1)
with compressive or non compressive radicular symptoms##2##7##(2007-11#2)
with compromised##6##2##(2005-10#1)(2007-12#1)(2007-9#1)(2008-9#1)(2009-8#1)(2013-8#1)
with compulsive##4##2##(1996-8#3)(2007-7#1)
with computational##4##2##(2007-11#1)(2008-11#2)(2008-7#1)
with computed tomography (CT)##4##4##(2007-4#1)(2007-9#2)(2012-2#1)
with computed tomography and##2##4##(2006-1#1)(2006-12#1)
with computed tomography##15##3##(1990-3#1)(1990-9#1)(2006-1#1)(2006-12#1)(2007-10#1)(2007-4#1)(2007-9#2)(2008-3#1)(2008-7#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
with computed##17##2##(1990-3#1)(1990-9#1)(2006-1#1)(2006-12#1)(2007-10#1)(2007-4#1)(2007-9#2)(2008-3#2)(2008-7#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
with computer simulations##6##3##(2007-11#1)(2007-12#2)(2008-3#3)
with computer##18##2##(1997-6#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#4)(2008-7#1)(2012-2#1)(2013-1#1)
with computer-aided##2##2##(1996-5#1)(2008-6#1)
with computer-assisted##2##2##(2006-7#1)(2008-11#1)
with computer-based##2##2##(2008-2#1)(2008-3#1)
with computer-generated##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
with computer-simulated##2##2##(2008-2#1)(2008-3#1)
with computerized tomography##2##3##(2006-12#1)(2008-2#1)
with computerized##4##2##(1991-12#1)(2006-12#1)(2008-12#1)(2008-2#1)
with concanavalin A##7##3##(1991-8#1)(1995-12#1)(2008-11#1)(2008-4#1)(2012-1#3)
with concentrated acids##2##3##(1996-6#2)
with concentrated nitric acid##3##4##(2007-5#1)(2008-10#2)
with concentrated##12##2##(1994-10#1)(1996-6#2)(2007-5#1)(2008-10#5)(2008-6#1)(2010-1#1)(2011-1#1)
with concentration and##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
with concentration of##2##3##(2008-10#2)
with concentration##18##2##(1993-3#1)(1997-4#1)(2005-11#1)(2006-12#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
with concentration-dependent##2##2##(1990-8#1)(1996-5#1)
with concentrations greater than##3##4##(1996-9#1)(2008-10#1)(2008-5#1)
with concentrations in##3##3##(1991-3#1)(1993-12#1)(2004-4#1)
with concentrations of##5##3##(1993-7#2)(2004-4#1)(2008-10#1)(2011-2#1)
with concentrations##18##2##(1991-3#1)(1992-1#1)(1993-12#1)(1993-7#2)(1995-11#1)(1996-9#1)(2004-4#2)(2008-10#5)(2008-5#2)(2011-2#1)(2013-1#1)
with concentric##5##2##(2007-11#1)(2007-12#1)(2008-3#1)(2012-11#2)
with concern##2##2##(2012-2#2)
with concerns##2##2##(1996-1#1)(2011-2#1)
with conclusions reached##2##3##(2008-2#1)(2008-3#1)
with conclusions##3##2##(1995-2#1)(2008-2#1)(2008-3#1)
with concomitant increase##2##3##(1994-10#1)(1994-11#1)
with concomitant increases in##2##4##(1995-5#1)(2010-4#1)
with concomitant increases##3##3##(1991-3#1)(1995-5#1)(2010-4#1)
with concomitant liver##2##3##(2011-2#1)(2013-8#1)
with concomitant morphological##2##3##(1994-8#1)(2012-2#1)
with concomitant reduction##2##3##(1992-2#1)(1992-8#1)
with concomitant use of##2##4##(1996-9#1)(2013-8#1)
with concomitant##52##2##(1990-10#1)(1990-2#1)(1990-3#1)(1991-12#1)(1991-3#1)(1992-10#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-8#1)(1995-5#2)(1996-7#1)(1996-9#1)(2005-12#1)(2005-7#1)(2006-12#1)(2007-3#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-7#1)(2009-8#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-11#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#3)
with concurrent changes in##2##4##(1995-12#1)(2010-4#1)
with concurrent##28##2##(1990-2#1)(1992-12#1)(1995-12#1)(1997-1#1)(1997-5#1)(2005-10#1)(2006-6#1)(2007-11#1)(2007-4#1)(2007-6#1)(2008-10#4)(2008-2#2)(2008-6#2)(2008-7#1)(2008-9#2)(2009-5#1)(2009-8#2)(2010-4#1)(2010-6#1)(2012-3#1)(2013-8#1)
with condensed##2##2##(1995-3#1)(2008-5#1)
with conditional##2##2##(1995-3#1)(2008-9#1)
with conditioned reinforcement##3##3##(1993-6#3)
with conditioned##5##2##(1992-5#1)(1993-6#3)(2012-12#1)
with conditions that##3##3##(2007-12#1)(2008-6#1)(2009-2#1)
with conditions##8##2##(2006-5#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-6#1)(2009-2#1)(2011-2#1)(2013-1#1)
with conducting polymer##2##3##(1990-4#1)(2008-10#1)
with conducting##3##2##(1990-4#1)(2008-10#1)(2009-1#1)
with conduction##2##2##(2008-4#1)(2013-7#1)
with conductive##2##2##(1993-8#1)(2008-2#1)
with conductivity detection##2##3##(2008-10#2)
with conductivity##4##2##(2008-10#3)(2008-5#1)
with confidence##9##2##(1996-11#1)(1997-8#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
with confidentiality##2##2##(1997-1#1)(2011-2#1)
with confirmed diagnosis of##2##4##(2007-3#1)(2011-2#1)
with confirmed diagnosis##3##3##(2006-2#1)(2007-3#1)(2011-2#1)
with confirmed##22##2##(1991-3#1)(1992-10#1)(1996-3#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-6#2)(2009-11#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
with conflict##2##2##(2005-8#1)(2008-8#1)
with conflicting and##2##3##(2008-8#1)(2009-11#1)
with conflicting results##2##3##(2007-11#1)(2013-1#1)
with conflicting##5##2##(2007-11#1)(2008-8#1)(2009-10#1)(2009-11#1)(2013-1#1)
with conflicts##2##2##(1992-7#1)(1994-3#1)
with confocal microscopy##3##3##(2008-2#1)(2008-5#2)
with confocal##10##2##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#2)(2008-5#2)(2008-9#1)(2010-4#1)
with conformational##2##2##(2006-4#1)(2012-2#1)
with congenital adrenal hyperplasia##5##4##(2004-10#1)(2006-1#2)(2008-8#1)(2012-3#1)
with congenital and acquired heart##2##5##(2009-12#1)(2012-2#1)
with congenital and acquired##3##4##(2009-12#1)(2012-2#1)(2013-1#1)
with congenital anomalies##5##3##(1997-1#1)(2006-12#1)(2008-11#3)
with congenital diaphragmatic hernia (CDH)##2##5##(2007-2#1)(2012-2#1)
with congenital diaphragmatic hernia##4##4##(2007-2#1)(2010-7#1)(2011-1#1)(2012-2#1)
with congenital heart defects##3##4##(1993-10#1)(2009-10#1)(2010-12#1)
with congenital heart disease (CHD)##6##5##(2010-10#1)(2010-9#1)(2012-1#1)(2012-2#2)(2013-1#1)
with congenital heart disease and a systemic ventricular ejection fraction less than 30%##3##13##(2009-10#3)
with congenital heart disease and##5##5##(2009-10#4)(2009-5#1)
with congenital heart disease in##2##5##(2008-11#1)(2008-12#1)
with congenital heart disease##45##4##(1990-11#1)(1995-6#2)(2006-10#2)(2007-12#1)(2007-3#1)(2008-11#1)(2008-12#4)(2008-4#4)(2008-9#1)(2009-10#7)(2009-5#1)(2010-10#3)(2010-12#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-9#2)(2011-2#2)(2012-1#2)(2012-2#4)(2013-1#2)
with congenital heart##51##3##(1990-11#1)(1993-10#1)(1995-6#2)(1996-1#1)(2006-10#2)(2007-12#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-12#4)(2008-4#4)(2008-9#1)(2009-10#8)(2009-5#1)(2010-10#3)(2010-12#3)(2010-3#1)(2010-5#2)(2010-6#1)(2010-9#2)(2011-2#2)(2012-1#2)(2012-2#4)(2013-1#2)
with congenital left##2##3##(1990-8#1)(2007-8#1)
with congenital malformations##2##3##(1995-8#1)(2011-2#1)
with congenital nephrogenic diabetes insipidus##2##5##(1994-11#2)
with congenital or##2##3##(1990-11#1)(1992-5#1)
with congenital##115##2##(1990-11#2)(1990-12#1)(1990-8#2)(1992-5#1)(1992-6#1)(1993-10#1)(1994-11#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-3#2)(2004-10#1)(2006-1#2)(2006-10#3)(2006-12#1)(2006-7#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#6)(2008-1#2)(2008-11#5)(2008-12#4)(2008-4#6)(2008-8#1)(2008-9#4)(2009-10#8)(2009-12#1)(2009-4#1)(2009-5#1)(2010-10#3)(2010-12#3)(2010-2#3)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#3)(2011-2#4)(2012-1#3)(2012-12#1)(2012-2#10)(2012-3#2)(2013-1#5)
with congestive cardiac failure##2##4##(1996-6#2)
with congestive heart failure (CHF)##2##5##(2005-10#1)(2010-11#1)
with congestive heart failure##14##4##(1991-11#1)(1993-9#1)(1994-2#1)(1996-1#1)(1996-9#1)(1997-1#1)(2005-10#1)(2007-8#1)(2008-3#1)(2008-5#2)(2010-11#1)(2010-12#1)(2012-3#1)
with congestive##17##2##(1991-11#1)(1991-9#1)(1993-9#1)(1994-2#1)(1996-1#1)(1996-6#2)(1996-9#1)(1997-1#1)(2005-10#1)(2007-8#1)(2008-3#1)(2008-5#2)(2010-11#1)(2010-12#1)(2012-3#1)
with conidia of##4##3##(2008-10#4)
with conidia##5##2##(2008-10#5)
with conidial suspensions of##4##4##(2008-10#4)
with conidial suspensions##5##3##(2008-10#5)
with conidial##7##2##(2008-10#7)
with conjugate##2##2##(2006-6#1)(2010-8#1)
with conjugated##5##2##(1994-6#1)(1994-8#1)(2005-3#1)(2009-10#2)
with conjunctival##2##2##(2009-8#1)(2011-1#1)
with conjunctivitis##2##2##(2005-7#1)(2008-2#1)
with connections##2##2##(1991-5#1)(1997-8#1)
with connective tissue##5##3##(2005-8#1)(2006-10#1)(2006-4#1)(2012-1#1)(2012-2#1)
with consecutive##8##2##(1991-8#2)(2006-1#1)(2008-10#2)(2010-11#1)(2012-12#1)(2013-8#1)
with consensus##3##2##(1993-12#1)(1994-12#1)(2008-9#1)
with consequences for##3##3##(2008-8#1)(2011-2#1)(2012-12#1)
with consequent increase in##2##4##(2007-10#1)(2008-2#1)
with consequent increase of##2##4##(1991-5#1)(2011-2#1)
with consequent increase##4##3##(1991-5#1)(2007-10#1)(2008-2#1)(2011-2#1)
with consequent##18##2##(1991-5#2)(1994-9#1)(1995-2#1)(2005-10#1)(2007-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#1)
with conservation of##3##3##(1991-7#1)(1995-8#1)(2012-1#1)
with conservation##4##2##(1991-7#1)(1995-8#1)(1996-6#1)(2012-1#1)
with conservative management##5##3##(2007-6#1)(2008-10#1)(2008-6#1)(2013-1#1)(2013-8#1)
with conservative surgery and##3##4##(1995-8#1)(2008-6#1)(2011-2#1)
with conservative therapy##2##3##(1997-3#1)(2007-8#1)
with conservative treatment##4##3##(1991-6#1)(2007-9#1)(2008-7#1)(2011-2#1)
with conservative##17##2##(1991-6#1)(1995-8#1)(1997-3#1)(2006-8#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-6#2)(2008-7#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
with conserved##5##2##(1991-7#1)(1993-12#1)(1997-3#1)(2008-10#1)(2009-5#1)
with considerable morbidity and##4##4##(2007-8#1)(2011-1#1)(2011-2#2)
with considerable morbidity##8##3##(2007-11#1)(2007-8#2)(2009-9#1)(2011-1#1)(2011-2#2)(2012-3#1)
with considerable##33##2##(1990-8#1)(1992-10#1)(1992-9#1)(1993-3#2)(1996-12#1)(1997-6#1)(2005-8#3)(2006-10#1)(2006-8#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-2#2)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)
with considerably less##2##3##(1996-9#1)(2006-12#1)
with considerably##6##2##(1990-3#1)(1996-9#1)(2006-12#1)(2008-10#2)(2008-8#1)
with consideration for##2##3##(2011-2#1)(2012-1#1)
with consideration of the##2##4##(2007-11#1)(2013-7#1)
with consideration of##3##3##(2007-11#1)(2008-3#1)(2013-7#1)
with consideration to##2##3##(2007-11#1)(2012-2#1)
with consideration##8##2##(1990-3#1)(2007-11#2)(2008-3#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#1)
with considerations for##3##3##(2008-2#1)(2008-9#1)(2013-1#1)
with considerations of##3##3##(2008-8#1)(2011-1#1)(2013-1#1)
with considerations##6##2##(2008-2#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-1#2)
with consistent##10##2##(1991-12#1)(2007-1#1)(2007-7#1)(2008-10#2)(2008-7#2)(2010-12#1)(2011-1#1)(2012-3#1)
with conspecific##3##2##(2008-8#1)(2009-9#1)(2011-12#1)
with conspicuous##2##2##(1990-8#1)(2011-12#1)
with constant current##2##3##(1993-2#1)(2011-2#1)
with constant values##2##3##(2008-10#1)(2012-2#1)
with constant##17##2##(1990-9#1)(1993-2#1)(2007-11#3)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#3)(2011-2#1)(2012-2#1)(2013-1#1)
with constipation##5##2##(1994-3#1)(2005-8#1)(2008-3#2)(2009-3#1)
with constitutional symptoms##3##3##(2007-12#1)(2007-5#1)(2008-9#1)
with constitutional##6##2##(2007-12#1)(2007-5#1)(2008-9#1)(2011-1#2)(2011-2#1)
with constitutive##3##2##(1992-12#1)(1997-4#1)(2012-12#1)
with constrained##3##2##(1990-12#1)(2008-3#1)(2012-1#1)
with constraints##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
with constrictive pericarditis##2##3##(2007-8#1)(2012-12#1)
with constructs##4##2##(1993-9#1)(1997-2#1)(2008-10#1)(2011-1#1)
with consumers to##2##3##(2008-1#1)(2010-7#1)
with consumers##4##2##(2008-1#1)(2010-7#1)(2011-1#1)(2013-1#1)
with consumption of##12##3##(1991-5#1)(1992-1#1)(1992-5#2)(1994-4#1)(1996-8#2)(2007-12#1)(2007-7#1)(2008-10#1)(2013-1#2)
with contact avoidance##3##3##(2011-12#3)
with contact dermatitis##2##3##(1997-2#1)(2012-3#1)
with contact lenses##4##3##(1993-11#2)(2009-8#2)
with contact##17##2##(1993-11#2)(1993-9#1)(1995-11#1)(1997-2#2)(2005-10#1)(2005-11#1)(2009-8#2)(2010-11#1)(2010-12#1)(2011-12#4)(2012-3#1)
with contaminated##3##2##(1996-9#1)(2012-12#1)(2013-7#1)
with contamination##5##2##(2005-8#1)(2006-10#1)(2008-4#1)(2008-6#1)(2013-8#1)
with contemporary##7##2##(1990-12#1)(1992-6#1)(1993-5#1)(2007-7#1)(2008-6#1)(2010-3#1)(2010-8#1)
with content of##2##3##(2008-10#1)(2010-6#1)
with content##6##2##(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-6#1)(2013-1#1)
with continued use##2##3##(1992-3#1)(2008-5#1)
with continued##11##2##(1992-3#1)(1993-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-12#1)(2012-2#2)
with continuing sutures##5##3##(2008-11#5)
with continuing##8##2##(2005-11#1)(2006-8#1)(2008-11#5)(2010-12#1)
with continuous ambulatory peritoneal dialysis##3##5##(1990-6#1)(1992-5#1)(2007-12#1)
with continuous ambulatory##4##3##(1990-6#1)(1992-5#1)(1997-8#1)(2007-12#1)
with continuous and##2##3##(2008-10#1)(2013-1#1)
with continuous epidural##3##3##(1993-4#1)(2006-4#1)(2007-8#1)
with continuous infusion of##3##4##(1994-10#1)(2007-2#1)(2009-6#1)
with continuous infusion##4##3##(1994-10#1)(2006-10#1)(2007-2#1)(2009-6#1)
with continuous positive##2##3##(1993-5#1)(2013-8#1)
with continuous##52##2##(1990-6#1)(1990-9#1)(1991-11#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-4#1)(1993-5#1)(1994-10#1)(1995-2#1)(1997-2#1)(1997-8#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-4#1)(2007-12#3)(2007-2#2)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
with continuous-flow##3##2##(2008-10#1)(2010-6#2)
with continuous-wave laser light##2##4##(2007-12#2)
with continuous-wave##7##2##(2007-12#5)(2008-3#2)
with continuum##3##2##(1997-2#1)(2008-10#1)(2009-7#1)
with contralateral##5##2##(1995-10#1)(2004-10#1)(2007-5#1)(2008-11#1)(2013-1#1)
with contrapropagating sound##2##3##(2008-2#2)
with contrast and##2##3##(2007-7#1)(2011-1#1)
with contrast showed a##2##4##(2009-7#1)(2012-2#1)
with contrast was##2##3##(1990-9#1)(2013-8#1)
with contrast##18##2##(1990-9#1)(1993-2#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-7#1)(2009-10#1)(2009-4#2)(2009-6#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
with contrast-enhanced##4##2##(2006-8#1)(2008-1#1)(2010-12#1)(2012-12#1)
with contrasting life histories##2##4##(2008-9#1)(2010-8#1)
with contrasting##11##2##(2007-5#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-8#2)(2010-8#1)(2013-1#1)
with control animals##5##3##(1990-5#1)(1995-12#1)(1995-8#1)(2005-10#1)(2008-7#1)
with control cases##2##3##(1996-9#1)(2007-9#1)
with control group##7##3##(2006-6#1)(2007-2#1)(2008-4#1)(2011-3#1)(2012-2#2)(2013-7#1)
with control groups##4##3##(2005-10#2)(2008-5#1)(2010-12#1)
with control of##5##3##(1990-2#1)(2005-11#1)(2007-12#1)(2008-1#1)(2011-2#1)
with control over##2##3##(2009-10#1)(2010-2#1)
with control plants##3##3##(2008-10#3)
with control rats##5##3##(1990-7#1)(1994-9#1)(1995-12#1)(1996-3#1)(2008-9#1)
with control subjects##5##3##(1993-12#1)(1995-11#1)(1997-2#1)(2006-10#1)(2008-6#1)
with control##90##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-10#1)(1993-10#1)(1993-12#2)(1993-7#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-8#1)(1995-9#1)(1996-3#1)(1996-5#1)(1996-8#3)(1996-9#2)(1997-2#2)(1997-4#1)(2004-2#1)(2005-10#4)(2005-11#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-2#2)(2007-3#3)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#3)(2010-12#1)(2010-2#1)(2011-2#3)(2011-3#1)(2012-2#4)(2013-7#1)
with controllable##8##2##(1996-12#1)(2006-10#1)(2008-10#1)(2008-3#2)(2009-12#1)(2010-8#1)(2011-2#1)
with controlled phase##2##3##(2008-3#1)(2009-7#1)
with controlled structure##2##3##(2007-8#1)(2010-7#1)
with controlled##28##2##(1997-5#1)(2005-10#1)(2006-5#2)(2006-7#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-2#1)(2008-3#3)(2008-7#2)(2009-7#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-11#3)(2013-1#1)
with controls and##3##3##(1995-3#1)(2011-2#1)(2012-11#1)
with controls that##2##3##(2008-10#1)(2010-7#1)
with controls##89##2##(1990-11#1)(1991-9#1)(1992-6#1)(1993-12#1)(1993-5#1)(1993-7#1)(1994-3#1)(1994-6#3)(1994-8#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#2)(1995-7#1)(1996-1#2)(1996-3#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-5#1)(1997-8#1)(2004-11#5)(2006-10#4)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#2)(2007-2#3)(2007-8#2)(2008-10#6)(2008-11#1)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-11#2)(2012-12#2)(2013-7#1)(2013-8#1)
with convective##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
with conventional ELISA##2##3##(1994-9#1)(2008-10#1)
with conventional ODS##2##3##(1996-6#1)(2008-10#1)
with conventional Soxhlet##2##3##(2008-10#2)
with conventional and##2##3##(2008-3#1)(2011-2#1)
with conventional antibiotics##2##3##(2008-5#2)
with conventional approaches##2##3##(2007-12#1)(2008-10#1)
with conventional drugs##2##3##(1997-2#1)(2008-12#1)
with conventional expression##2##3##(1996-12#1)(2006-11#1)
with conventional extraction##2##3##(2008-10#1)(2013-1#1)
with conventional imaging##2##3##(2008-2#2)
with conventional ion-selective electrodes##2##4##(2008-10#2)
with conventional methods##6##3##(1994-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)
with conventional osteosarcoma##2##3##(2010-3#2)
with conventional preadjusted straight wire brackets##2##6##(2009-7#2)
with conventional technique##2##3##(2007-8#1)(2008-10#1)
with conventional techniques##4##3##(1994-3#1)(1997-7#1)(2008-11#1)(2008-2#1)
with conventional therapy##5##3##(2005-7#1)(2007-8#1)(2008-1#2)(2011-2#1)
with conventional tillage##2##3##(2008-10#2)
with conventional treatment##4##3##(2007-11#1)(2007-6#1)(2008-10#1)(2008-6#1)
with conventional treatments##3##3##(1997-5#1)(2008-6#1)(2013-1#1)
with conventional##194##2##(1990-12#2)(1990-8#1)(1990-9#1)(1991-5#2)(1992-10#1)(1993-1#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-4#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-7#1)(1997-8#1)(2004-3#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-4#1)(2006-5#2)(2006-6#3)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#7)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#6)(2007-9#3)(2008-1#4)(2008-10#30)(2008-11#2)(2008-12#1)(2008-2#14)(2008-3#16)(2008-4#4)(2008-5#6)(2008-6#3)(2008-7#2)(2008-8#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#2)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#4)(2011-2#8)(2011-7#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#1)
with conventionally##2##2##(2008-10#2)
with conversion##4##2##(1996-3#1)(2007-12#1)(2008-7#1)(2010-4#1)
with cooperative##2##2##(1991-5#1)(2008-8#1)
with coordinating##4##2##(1994-1#2)(1997-2#1)(2009-2#1)
with coordination of the##3##4##(1996-7#1)(2012-12#2)
with coordination##4##2##(1996-7#1)(1997-7#1)(2012-12#2)
with coping##3##2##(1994-2#2)(2012-1#1)
with copper and##4##3##(1997-7#1)(2008-10#1)(2011-12#1)(2012-1#1)
with copper bactericides##2##3##(2008-10#2)
with copper deficiency##2##3##(1991-2#2)
with copper ions##4##3##(2008-10#3)(2012-2#1)
with copper oxide##2##3##(2005-7#1)(2008-2#1)
with copper sulfate##2##3##(2008-10#2)
with copper##33##2##(1990-5#1)(1991-2#2)(1997-7#2)(2004-4#1)(2005-4#1)(2005-7#1)(2008-10#16)(2008-2#1)(2008-5#4)(2011-12#2)(2012-1#1)(2012-2#1)
with copper(II) and##2##3##(2008-10#1)(2010-5#1)
with copper(II)##7##2##(1996-2#1)(2007-8#2)(2008-10#3)(2010-5#1)
with copra oil##2##3##(2013-1#2)
with cord compression##2##3##(2007-8#1)(2009-4#1)
with cord##5##2##(2007-8#1)(2009-3#1)(2009-4#1)(2011-1#1)(2012-12#1)
with core promoter##2##3##(1995-6#1)(2008-12#1)
with core##11##2##(1990-8#2)(1994-12#1)(1995-2#1)(1995-6#1)(1997-4#1)(2007-6#1)(2008-12#1)(2008-2#1)(2008-5#1)(2012-1#1)
with core-shell structure##2##3##(2009-3#1)(2013-1#1)
with core-shell##3##2##(2007-8#1)(2009-3#1)(2013-1#1)
with coregistration##2##2##(2011-1#2)
with corn##4##2##(2006-5#1)(2008-5#1)(2008-6#1)(2013-1#1)
with corneal##7##2##(2005-7#1)(2006-8#1)(2007-3#1)(2008-11#1)(2009-10#1)(2009-2#1)(2012-12#1)
with coronal##2##2##(2013-1#2)
with coronary artery bypass##2##4##(2007-8#1)(2010-8#1)
with coronary artery disease (CAD)##5##5##(1996-1#1)(2008-3#1)(2008-7#2)(2012-2#1)
with coronary artery disease in##2##5##(2007-8#1)(2013-7#1)
with coronary artery disease treated with beta-blockers and nitrates##2##9##(2006-6#2)
with coronary artery disease##51##4##(1990-3#1)(1993-11#2)(1993-12#3)(1995-3#1)(1995-6#2)(1996-1#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-6#3)(2007-8#4)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-6#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
with coronary artery##65##3##(1990-3#1)(1993-11#2)(1993-12#7)(1995-3#1)(1995-6#3)(1996-1#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-6#4)(2007-8#6)(2008-1#2)(2008-10#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#2)(2009-6#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)
with coronary bypass surgery##2##4##(1996-9#1)(2008-3#1)
with coronary bypass##4##3##(1995-3#1)(1996-9#2)(2008-3#1)
with coronary disease##6##3##(1993-3#1)(1993-9#1)(1995-11#1)(1995-6#1)(2008-3#1)(2011-2#1)
with coronary heart disease (CHD)##5##5##(1990-3#1)(1990-7#1)(2007-11#1)(2008-10#1)(2011-12#1)
with coronary heart disease in##2##5##(2008-12#1)(2013-7#1)
with coronary heart disease##30##4##(1990-3#1)(1990-7#1)(1990-8#2)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#2)(1997-6#2)(2005-12#1)(2007-11#3)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-10#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
with coronary heart##31##3##(1990-3#1)(1990-7#1)(1990-8#2)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#2)(1997-6#2)(2005-12#1)(2007-11#4)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-10#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
with coronary##121##2##(1990-3#2)(1990-7#1)(1990-8#2)(1992-5#1)(1992-9#1)(1993-11#2)(1993-12#8)(1993-2#2)(1993-3#1)(1993-9#1)(1995-11#1)(1995-3#2)(1995-6#4)(1996-1#1)(1996-5#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-12#1)(2006-10#2)(2006-6#4)(2007-11#4)(2007-2#1)(2007-8#8)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#5)(2008-4#5)(2008-5#2)(2008-7#7)(2009-10#1)(2009-6#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#1)
with corporate##2##2##(1991-3#1)(1997-1#1)
with correct##7##2##(1990-9#1)(1994-6#1)(2006-7#1)(2006-8#1)(2008-2#1)(2011-2#1)(2012-2#1)
with correction for##3##3##(2007-12#1)(2007-8#1)(2008-3#1)
with correction of the##4##4##(2007-9#1)(2011-2#1)(2013-1#2)
with correction of##7##3##(2007-9#1)(2008-4#1)(2011-2#1)(2013-1#4)
with correction##12##2##(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-1#1)(2011-2#1)(2013-1#4)
with corrections##4##2##(2007-11#1)(2007-12#1)(2007-7#1)(2008-7#1)
with correlated##5##2##(1990-7#1)(1997-7#1)(2007-1#1)(2008-2#1)(2008-7#1)
with correlation coefficient of 0##6##5##(2007-8#1)(2008-10#5)
with correlation coefficient##11##3##(2007-8#1)(2008-10#7)(2009-3#1)(2010-12#1)(2013-8#1)
with correlation coefficients (r)##2##4##(2008-10#2)
with correlation coefficients of 0##2##5##(2008-10#1)(2010-2#1)
with correlation coefficients##7##3##(2005-12#1)(2008-10#5)(2010-2#1)
with correlation factor of 0##2##5##(2008-10#2)
with correlation##22##2##(1995-9#1)(2005-12#1)(2007-8#1)(2008-10#15)(2009-3#1)(2010-12#1)(2010-2#1)(2013-8#1)
with correlations##2##2##(2012-2#1)(2013-8#1)
with corresponding detection limits of 0##2##6##(2008-10#2)
with corresponding relative##2##3##(1991-5#1)(2007-2#1)
with corresponding values##2##3##(1990-11#1)(2008-10#1)
with corresponding##38##2##(1990-11#1)(1990-2#2)(1991-12#1)(1991-5#1)(1994-2#1)(1996-11#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-10#1)(2006-9#1)(2007-2#1)(2008-10#10)(2008-11#1)(2008-3#3)(2008-5#2)(2009-2#1)(2010-12#1)(2010-2#1)(2010-4#1)(2012-2#1)(2012-3#2)(2013-1#1)
with cortical##15##2##(1993-3#1)(1995-11#1)(1995-5#1)(1996-9#1)(1997-6#1)(2006-12#1)(2007-10#1)(2008-7#1)(2008-9#3)(2009-3#1)(2013-1#1)(2013-7#2)
with corticosteroid therapy##3##3##(1993-2#1)(2008-1#1)(2010-6#1)
with corticosteroid##9##2##(1993-2#2)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#2)(2010-6#1)(2013-8#1)
with corticosteroids and cyclophosphamide##3##4##(2006-10#2)(2008-4#1)
with corticosteroids and cytotoxic##2##4##(2007-7#1)(2008-7#1)
with corticosteroids and##11##3##(1994-6#1)(2006-10#4)(2007-11#1)(2007-6#1)(2007-7#1)(2008-4#1)(2008-7#1)(2011-1#1)
with corticosteroids##28##2##(1993-5#1)(1993-6#1)(1994-6#1)(1996-6#1)(2004-3#2)(2006-10#6)(2007-11#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#2)(2008-9#1)(2011-1#2)(2011-2#1)(2012-2#2)
with corticosterone pellets##2##3##(1995-7#1)(1997-1#1)
with corticosterone##6##2##(1994-11#2)(1994-5#1)(1995-7#1)(1997-1#1)(2013-1#1)
with corticotrophin-releasing##3##2##(2008-3#1)(2008-4#2)
with cortisone##2##2##(1992-2#1)(2008-4#1)
with cosmetic##2##2##(2007-12#1)(2008-5#1)
with cosmetics##2##2##(2006-12#1)(2008-5#1)
with cost##6##2##(1991-12#1)(1992-2#2)(2005-10#1)(2006-8#1)(2011-1#1)
with costly##2##2##(2011-2#1)(2013-8#1)
with costs of##2##3##(1995-1#1)(2008-8#1)
with costs##5##2##(1995-1#1)(2006-12#1)(2008-7#1)(2008-8#1)(2013-8#1)
with cotton leafworm##2##3##(2008-6#1)(2010-10#1)
with cotton##5##2##(2008-10#2)(2008-6#1)(2008-7#1)(2010-10#1)
with cough and##2##3##(2007-2#1)(2007-8#1)
with cough##6##2##(2007-12#1)(2007-2#1)(2007-8#2)(2010-3#1)(2013-8#1)
with coulometric##4##2##(1992-2#1)(2004-11#1)(2008-10#1)(2009-8#1)
with counselling##2##2##(2008-10#1)(2008-4#1)
with counterpropagating##2##2##(2007-12#2)
with counterrotating##2##2##(2007-12#2)
with counts &lt##2##3##(2006-10#2)
with counts##4##2##(2006-10#3)(2006-8#1)
with county population##2##3##(1991-3#1)(1996-3#1)
with coupled##2##2##(2007-9#1)(2008-2#1)
with couples##2##2##(2011-2#1)(2012-1#1)
with coupling##2##2##(2007-12#1)(2008-2#1)
with course and outcome of TBI##2##6##(2011-1#2)
with covalent##2##2##(1996-7#1)(2009-12#1)
with covalently##2##2##(2004-9#1)(2008-5#1)
with coverage##2##2##(1997-4#1)(2008-1#1)
with cow##2##2##(2011-12#1)(2012-1#1)
with cranial nerve##2##3##(2007-12#1)(2008-7#1)
with cranial##5##2##(2006-10#1)(2007-12#1)(2008-7#1)(2008-9#1)(2011-2#1)
with craniofacial anomalies##2##3##(2007-12#1)(2007-8#1)
with craniofacial##4##2##(2007-12#3)(2007-8#1)
with cranioplasty##3##2##(2004-12#2)(2010-2#1)
with crash##2##2##(1995-2#1)(2007-4#1)
with creatine##2##2##(1993-11#1)(1994-4#1)
with creating a##2##3##(2007-2#1)(2013-7#1)
with creating##3##2##(2007-2#1)(2008-8#1)(2013-7#1)
with creatinine clearance##2##3##(2006-2#1)(2007-8#1)
with creatinine##8##2##(1995-4#1)(1997-2#1)(2005-10#2)(2005-12#1)(2006-2#1)(2007-8#1)(2008-10#1)
with criteria for##3##3##(1990-4#1)(2008-1#1)(2011-2#1)
with critical tracheal stenosis##2##4##(2007-8#2)
with critical##11##2##(1996-8#1)(1996-9#1)(2007-8#4)(2008-2#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)
with crop##2##2##(2008-10#1)(2013-1#1)
with cross gratings##2##3##(2008-3#2)
with cross##5##2##(2008-10#1)(2008-3#2)(2010-4#1)(2010-6#1)
with cross-leg free transfer of##2##5##(2011-2#2)
with cross-linking##2##2##(1991-10#1)(1992-2#1)
with crossed##4##2##(1992-4#1)(2007-8#1)(2008-3#2)
with crossing##2##2##(2005-11#1)(2013-1#1)
with crown##3##2##(2008-10#2)(2012-2#1)
with crude##6##2##(1990-5#1)(1991-9#1)(1995-1#1)(1996-8#1)(2006-12#1)(2008-10#1)
with crush##2##2##(2007-7#2)
with crushed grains under the pigment layer##2##7##(2008-10#2)
with crushed##4##2##(1992-6#1)(2008-10#2)(2008-11#1)
with cryogenic##2##2##(2008-10#1)(2008-3#1)
with cryopreserved##2##2##(1997-1#1)(2008-11#1)
with cryosurgery##2##2##(2007-7#2)
with cryptogenic epilepsy##2##3##(2008-8#2)
with cryptogenic##3##2##(2005-8#1)(2008-8#2)
with cryptorchidism##2##2##(2008-6#2)
with crystal structures##2##3##(1996-11#1)(1997-5#1)
with crystal violet##3##3##(2005-4#1)(2008-10#2)
with crystal##7##2##(1991-7#1)(1996-11#1)(1997-5#1)(2005-4#1)(2008-10#2)(2008-3#1)
with cultural##3##2##(2008-1#1)(2012-12#1)(2013-8#1)
with culturally diverse##3##3##(2004-12#1)(2005-10#1)(2012-2#1)
with culture##6##2##(1993-8#1)(2006-7#1)(2007-6#1)(2008-1#1)(2008-3#1)(2011-2#1)
with cultured##3##2##(1996-1#1)(1996-5#1)(2008-11#1)
with cultures of##2##3##(1996-5#1)(2008-10#1)
with cultures##7##2##(1996-12#1)(1996-5#1)(1997-4#1)(2008-10#2)(2008-6#1)(2013-8#1)
with cumulative exposure to ultraviolet radiation##2##6##(2007-11#2)
with cumulative##6##2##(1994-6#1)(1995-9#1)(2007-11#2)(2008-10#1)(2011-2#1)
with cupferron##2##2##(2008-10#2)
with cupric##2##2##(1997-8#1)(2011-2#1)
with curative intent##2##3##(2008-1#1)(2008-6#1)
with curative potential##2##3##(2008-10#1)(2010-5#1)
with curative surgery##2##3##(1992-6#1)(2006-8#1)
with curative##8##2##(1991-2#1)(1992-6#1)(2006-2#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2010-5#1)
with cure##2##2##(2008-1#1)(2010-8#1)
with curettage##2##2##(2008-6#1)(2008-9#1)
with current UOS evaluation##2##4##(2012-3#2)
with current and##3##3##(1995-12#1)(2008-4#1)(2012-12#1)
with current imaging techniques##2##4##(2008-7#1)(2010-12#1)
with current imaging##3##3##(2008-7#2)(2010-12#1)
with current therapies##4##3##(2005-7#1)(2006-10#1)(2007-11#1)(2013-1#1)
with current##72##2##(1990-12#1)(1992-10#1)(1994-6#1)(1995-12#1)(1995-2#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-5#1)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#6)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#8)(2013-1#3)
with currently available materials##2##4##(2007-12#2)
with currently available##3##3##(1997-3#1)(2007-12#2)
with currently##5##2##(1997-3#1)(2007-12#3)(2008-3#1)
with custom##4##2##(2007-11#1)(2008-9#1)(2009-10#1)(2012-1#1)
with cut##2##2##(2008-9#1)(2011-2#1)
with cutaneous lesions##3##3##(2008-12#1)(2012-12#1)(2012-3#1)
with cutaneous##20##2##(1992-2#1)(1996-9#1)(1997-4#1)(2005-7#1)(2007-2#1)(2007-8#2)(2008-12#2)(2008-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
with cutoff##2##2##(2008-3#1)(2008-5#1)
with cutting or##2##3##(2006-12#1)(2008-10#1)
with cutting##3##2##(2006-12#1)(2008-10#1)(2008-7#1)
with cv##3##2##(2008-10#3)
with cw##4##2##(2007-12#1)(2008-1#1)(2008-2#2)
with cyanex 302##2##3##(2008-10#2)
with cyanex##3##2##(2008-10#3)
with cyanide##5##2##(1991-7#2)(1991-9#2)(2006-12#1)
with cyanine##2##2##(2007-12#1)(2008-10#1)
with cyanogen bromide and##2##4##(1991-3#1)(1997-2#1)
with cyanogen bromide##9##3##(1990-2#1)(1990-5#2)(1991-3#2)(1991-7#1)(1991-9#1)(1994-5#1)(1997-2#1)
with cyanosis##2##2##(2009-9#1)(2010-9#1)
with cyanotic congenital heart disease##3##5##(1993-5#2)(2008-4#1)
with cyanotic##4##2##(1993-5#3)(2008-4#1)
with cyclic AMP##3##3##(1993-5#1)(1994-12#2)
with cyclic neutropenia##2##3##(2007-2#2)
with cyclic voltammetry##3##3##(2008-10#2)(2008-3#1)
with cyclic##15##2##(1993-5#1)(1993-8#1)(1994-11#1)(1994-12#2)(2007-11#1)(2007-2#2)(2008-10#3)(2008-3#2)(2009-5#1)(2010-2#1)
with cyclin##5##2##(1993-12#1)(1994-8#1)(1997-6#1)(2007-8#2)
with cyclodextrin and##2##3##(2008-10#1)(2008-5#1)
with cyclodextrin##4##2##(1995-11#1)(2008-10#2)(2008-5#1)
with cyclodextrins##5##2##(1996-5#1)(2004-12#1)(2008-10#3)
with cycloheximide and##2##3##(1993-3#1)(1996-11#1)
with cycloheximide##12##2##(1991-10#1)(1991-12#1)(1992-6#1)(1993-3#4)(1994-11#1)(1996-11#1)(1997-1#1)(1997-6#1)(2009-8#1)
with cyclophosphamide 50 mg##2##4##(2007-7#2)
with cyclophosphamide and##6##3##(1992-10#1)(1994-4#1)(2008-1#1)(2008-5#1)(2011-1#2)
with cyclophosphamide##21##2##(1991-8#1)(1992-10#2)(1993-2#1)(1993-4#1)(1993-9#1)(1994-4#1)(1995-12#1)(1997-7#1)(1997-8#1)(2004-2#1)(2007-7#3)(2008-1#2)(2008-10#1)(2008-5#1)(2011-1#2)(2013-8#1)
with cyclosporin A (CsA)##2##4##(1997-2#1)(2008-8#1)
with cyclosporin A##3##3##(1991-5#1)(1997-2#1)(2008-8#1)
with cyclosporin and corticosteroids##3##4##(2007-11#3)
with cyclosporin and methotrexate##2##4##(2007-11#2)
with cyclosporin and##7##3##(1997-3#1)(2007-11#6)
with cyclosporin##18##2##(1991-5#1)(1991-9#1)(1997-2#1)(1997-3#1)(2007-11#9)(2008-1#3)(2008-8#1)(2012-1#1)
with cyclosporine A##3##3##(1990-5#1)(1997-7#1)(2008-1#1)
with cyclosporine or tacrolimus##2##4##(2006-5#2)
with cyclosporine##12##2##(1990-5#1)(1993-11#1)(1997-7#1)(2006-10#1)(2006-5#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-8#1)(2010-6#1)
with cylinder##2##2##(2008-10#1)(2008-2#1)
with cylindrical symmetry##3##3##(2007-12#3)
with cylindrical##6##2##(2007-12#3)(2008-10#2)(2008-3#1)
with cyst type in##3##4##(1997-3#1)(1997-8#2)
with cyst##7##2##(1993-12#1)(1997-3#1)(1997-8#2)(2006-10#1)(2007-12#1)(2013-1#1)
with cysteine and##3##3##(1990-2#1)(1992-12#1)(2008-4#1)
with cysteine synthase in##2##4##(1993-12#2)
with cysteine##17##2##(1990-2#1)(1990-9#1)(1992-1#1)(1992-12#1)(1993-12#2)(1995-2#1)(1996-9#1)(1997-8#3)(2008-10#5)(2008-4#1)
with cysteines##2##2##(1992-12#1)(1995-10#1)
with cystic areas##2##3##(2007-8#1)(2008-5#1)
with cystic fibrosis and##2##4##(1991-12#1)(1993-7#1)
with cystic fibrosis##42##3##(1991-12#2)(1991-2#1)(1993-1#1)(1993-2#1)(1993-7#3)(1994-12#1)(1994-5#1)(1995-9#1)(1996-2#2)(2006-10#5)(2006-6#3)(2007-11#3)(2007-6#1)(2007-8#2)(2008-10#1)(2008-5#1)(2010-12#1)(2010-5#2)(2011-1#2)(2012-1#1)(2012-12#3)(2013-1#4)
with cystic fibrosis]##4##3##(1996-2#1)(1997-6#1)(2007-6#1)(2007-9#1)
with cystic hyperplasia##3##3##(1994-3#2)(2006-5#1)
with cystic##58##2##(1991-12#2)(1991-2#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-7#3)(1994-12#1)(1994-3#2)(1994-5#1)(1995-9#1)(1996-2#3)(1997-6#1)(2006-10#6)(2006-5#1)(2006-6#3)(2007-11#3)(2007-12#2)(2007-6#2)(2007-8#3)(2007-9#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-12#1)(2010-5#2)(2011-1#2)(2012-1#1)(2012-12#3)(2013-1#4)(2013-7#1)
with cystinuria##2##2##(1990-6#1)(2007-7#1)
with cytochalasin B##2##3##(1990-3#1)(1991-4#1)
with cytochalasin D##6##3##(1994-12#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-7#1)(2009-5#1)
with cytochalasin##8##2##(1990-3#1)(1991-4#1)(1994-12#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-7#1)(2009-5#1)
with cytochrome P450##2##3##(2011-1#1)(2012-3#1)
with cytochrome##13##2##(1991-8#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-6#2)(2009-10#1)(2011-1#1)(2012-3#1)
with cytokine##3##2##(2007-11#1)(2007-2#1)(2007-9#1)
with cytokines##7##2##(1990-8#1)(2005-8#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-2#1)
with cytological##4##2##(1993-5#1)(2011-1#1)(2013-1#2)
with cytology##3##2##(2007-12#1)(2008-1#1)(2011-2#1)
with cytomegalovirus (CMV)##3##3##(1996-12#1)(2009-10#1)(2010-7#1)
with cytomegalovirus##6##2##(1992-11#1)(1996-12#1)(2009-10#1)(2010-7#1)(2012-11#1)(2012-2#1)
with cytoplasmic##8##2##(1991-12#1)(1991-5#1)(1993-11#1)(1995-2#1)(1997-3#1)(2009-5#1)(2012-1#1)(2012-3#1)
with cytosine arabinoside##2##3##(1990-9#1)(2007-1#1)
with cytosine##4##2##(1990-9#1)(1992-8#1)(1997-1#1)(2007-1#1)
with cytoskeletal##3##2##(1993-4#1)(1994-8#1)(2008-11#1)
with cytosolic##4##2##(1992-10#1)(1993-6#1)(1996-8#1)(2007-8#1)
with cytotoxic agents##3##3##(1991-9#1)(2007-11#1)(2012-3#1)
with cytotoxic therapy##2##3##(2005-10#1)(2009-12#1)
with cytotoxic##16##2##(1991-2#1)(1991-9#2)(1993-12#1)(1994-12#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-11#1)(2008-11#1)(2008-5#1)(2009-12#1)(2009-3#1)(2009-8#1)(2012-3#1)
with cytotoxicity##3##2##(1995-3#1)(1997-1#1)(2008-5#1)
with daily activities##3##3##(2008-11#1)(2009-11#1)(2013-7#1)
with daily##18##2##(1990-6#1)(1991-5#1)(1996-10#1)(1997-6#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-7#1)(2009-11#1)(2009-12#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-7#1)
with damage to##5##3##(1995-8#1)(2007-11#2)(2007-9#1)(2008-4#1)
with damage##7##2##(1995-12#1)(1995-8#1)(2007-11#3)(2007-9#1)(2008-4#1)
with damaged##2##2##(1996-4#1)(2006-2#1)
with dandruff or##3##3##(2007-7#2)(2008-5#1)
with dandruff##4##2##(2007-7#2)(2008-5#2)
with dansyl chloride##3##3##(1990-8#1)(1996-5#1)(2005-4#1)
with dansyl##6##2##(1990-8#1)(1995-6#1)(1996-11#1)(1996-5#1)(2005-4#1)(2008-10#1)
with dapsone and##2##3##(2007-7#1)(2009-6#1)
with dapsone##5##2##(2007-7#2)(2007-8#2)(2009-6#1)
with daptomycin##2##2##(2005-7#1)(2008-5#1)
with dark##3##2##(2008-10#1)(2008-5#1)(2009-9#1)
with darker skin##3##3##(2006-12#1)(2008-5#1)(2010-8#1)
with darker##4##2##(2006-12#1)(2008-5#1)(2010-8#2)
with darodipine##3##2##(1995-1#3)
with data available##2##3##(1994-6#1)(2004-4#1)
with data for the##3##4##(1996-2#1)(2004-4#1)(2008-10#1)
with data for##5##3##(1995-3#1)(1996-2#1)(2004-4#1)(2008-1#1)(2008-10#1)
with data from a study of##2##6##(1994-2#1)(1994-5#1)
with data from a##8##4##(1994-2#1)(1994-5#1)(1994-9#1)(1996-12#1)(1997-3#1)(2004-4#1)(2008-5#1)(2012-3#1)
with data from other##3##4##(1996-8#1)(2008-3#1)(2008-7#1)
with data from psychiatric##2##4##(1993-12#1)(2008-8#1)
with data from the literature##2##5##(1990-3#1)(2008-2#1)
with data from the##11##4##(1990-12#1)(1990-3#1)(1994-6#1)(1994-7#1)(1996-7#1)(1996-8#2)(2008-2#1)(2008-3#1)(2010-6#1)(2013-7#1)
with data from##43##3##(1990-12#2)(1990-3#1)(1991-9#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-5#1)(1996-12#1)(1996-7#1)(1996-8#3)(1997-3#1)(1997-4#1)(1997-6#1)(2004-4#1)(2007-4#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-9#1)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
with data in the literature##3##5##(1993-2#1)(1997-4#1)(2008-4#1)
with data measured##2##3##(2005-11#1)(2008-10#1)
with data obtained by atomic absorption##2##6##(2008-10#2)
with data obtained by##7##4##(1990-12#1)(1992-2#1)(2008-10#4)(2008-2#1)
with data obtained from##3##4##(2008-2#1)(2008-5#1)(2010-5#1)
with data obtained in##3##4##(1993-12#1)(2008-11#1)(2008-2#1)
with data obtained using the standard##2##6##(2007-8#1)(2008-10#1)
with data obtained using##5##4##(2007-8#1)(2008-10#4)
with data obtained##21##3##(1990-12#1)(1992-2#1)(1993-12#1)(1995-2#1)(2004-4#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#4)(2008-5#1)(2010-5#1)
with data of##4##3##(1994-1#1)(2008-3#1)(2009-12#1)(2011-2#1)
with data on patch##2##4##(2008-9#2)
with data on the##2##4##(1994-5#1)(2008-8#1)
with data on##17##3##(1992-10#1)(1994-5#2)(1994-8#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-7#1)(2011-2#1)(2011-8#1)(2012-1#1)(2013-1#2)
with data reported in##2##4##(1993-10#1)(1994-6#1)
with data##133##2##(1990-12#3)(1990-3#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-7#1)(1996-8#3)(1997-3#1)(1997-4#2)(1997-6#1)(2004-4#4)(2005-11#1)(2005-8#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#20)(2008-11#3)(2008-12#1)(2008-2#8)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#3)(2009-12#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2011-8#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
with data-driven##2##2##(2007-11#1)(2010-10#1)
with database##2##2##(2006-5#1)(2013-8#1)
with databases##2##2##(2007-12#1)(2008-1#1)
with dating##3##2##(1992-10#1)(2004-12#1)(2008-9#1)
with daunomycin##3##2##(2008-10#2)(2008-7#1)
with daunorubicin##2##2##(1996-1#1)(2011-2#1)
with day##3##2##(2006-5#1)(2011-2#1)(2013-8#1)
with dc##2##2##(1996-1#1)(2007-12#1)
with de novo##5##3##(2008-10#1)(2008-5#1)(2010-1#1)(2011-1#1)(2011-2#1)
with dead##2##2##(2007-12#1)(2008-9#1)
with death certificates##2##3##(1991-2#1)(2011-2#1)
with death##11##2##(1990-5#1)(1991-2#1)(2005-12#1)(2007-10#2)(2007-11#1)(2008-11#3)(2008-8#1)(2011-2#1)
with deaths##2##2##(1991-2#1)(2008-7#1)
with debilitating##3##2##(1993-9#1)(2005-11#1)(2008-7#1)
with decay##2##2##(1992-2#1)(2008-10#1)
with decision##2##2##(2005-7#1)(2010-8#1)
with decision-makers##4##2##(2009-4#3)(2011-2#1)
with decisions##2##2##(1990-3#1)(2009-4#1)
with decline in##2##3##(2012-1#1)(2013-1#1)
with declining mobility##2##3##(2008-7#2)
with declining##7##2##(1992-12#1)(2008-7#2)(2011-2#1)(2012-3#1)(2013-1#2)
with decompensated cirrhosis##2##3##(2009-2#1)(2012-3#1)
with decompensated heart failure##2##4##(2008-1#1)(2010-6#1)
with decompensated##5##2##(2008-1#1)(2009-2#1)(2009-8#1)(2010-6#1)(2012-3#1)
with decompression##2##2##(2007-11#1)(2012-12#1)
with decortication##2##2##(2007-8#2)
with decrease in##8##3##(1992-7#1)(2005-11#1)(2007-1#1)(2007-10#2)(2007-8#1)(2008-10#1)(2008-7#1)
with decrease##9##2##(1992-7#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-10#2)(2007-8#1)(2008-10#1)(2008-7#1)
with decreased lung##2##3##(2011-2#1)(2012-2#1)
with decreased maternal age##3##4##(1997-3#3)
with decreased pain intensity scores##2##5##(2006-8#1)(2009-12#1)
with decreased pain##3##3##(2006-8#1)(2007-8#1)(2009-12#1)
with decreased renal##3##3##(1991-12#1)(2009-11#1)(2012-12#1)
with decreased risk##2##3##(2008-3#1)(2013-8#1)
with decreased vision##4##3##(2006-10#1)(2007-2#1)(2010-10#1)(2011-1#1)
with decreased##78##2##(1991-10#1)(1991-12#1)(1991-8#1)(1991-9#1)(1993-3#1)(1993-9#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-7#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#3)(2004-1#1)(2004-10#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-12#2)(2006-8#1)(2007-11#4)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2010-10#2)(2010-4#1)(2010-8#1)(2011-1#5)(2011-2#3)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
with decreases in##4##3##(2008-10#1)(2008-9#1)(2009-10#1)(2013-1#1)
with decreases##5##2##(2008-10#1)(2008-9#1)(2009-10#1)(2011-12#1)(2013-1#1)
with decreasing pH and##3##4##(1995-2#1)(2008-5#1)(2013-1#1)
with decreasing pH##7##3##(1991-8#1)(1995-2#1)(1997-1#1)(2005-11#1)(2007-8#1)(2008-5#1)(2013-1#1)
with decreasing size of##2##4##(1995-6#1)(2007-8#1)
with decreasing##44##2##(1990-4#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-8#1)(1993-8#1)(1993-9#1)(1994-5#2)(1994-8#1)(1995-2#1)(1995-6#2)(1996-1#2)(1997-1#1)(1997-2#1)(1997-8#1)(2005-11#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#2)(2009-9#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-1#1)
with dedicated##3##2##(2008-7#1)(2012-2#1)(2013-7#1)
with deep brain stimulation (DBS)##2##5##(2008-11#1)(2012-3#1)
with deep brain stimulation##3##4##(2008-11#1)(2011-1#1)(2012-3#1)
with deep vein thrombosis##3##4##(1995-4#1)(2007-11#1)(2007-12#1)
with deep##23##2##(1992-5#1)(1994-2#1)(1995-4#1)(2005-7#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)
with defect##2##2##(2008-9#1)(2011-1#1)
with defective##8##2##(1991-2#1)(1993-9#1)(1994-11#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#1)
with defects in##8##3##(1990-8#1)(1991-7#1)(1992-6#1)(1995-2#1)(1995-3#1)(1997-2#1)(2008-10#1)(2012-3#1)
with deficiencies##2##2##(1991-10#1)(2007-12#1)
with deficiency of mitochondrial##2##4##(1993-3#1)(2005-8#1)
with deficiency of##4##3##(1993-3#1)(1995-8#1)(2005-8#1)(2008-5#1)
with deficient##7##2##(1992-11#1)(1993-2#1)(1995-12#1)(1996-7#1)(1997-7#1)(2005-8#1)(2009-7#1)
with deficits in##8##3##(1993-12#1)(2007-9#1)(2008-2#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
with deficits of##2##3##(2007-10#1)(2007-9#1)
with deficits##11##2##(1993-12#1)(2007-10#1)(2007-9#3)(2008-2#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
with defined properties##3##3##(2006-12#1)(2012-12#2)
with defined##13##2##(1992-2#1)(1995-5#2)(2005-11#1)(2006-10#1)(2006-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2012-12#2)
with definite##2##2##(2006-11#1)(2007-9#1)
with definition##2##2##(1990-9#1)(1991-12#1)
with definitive##6##2##(1991-4#1)(1993-5#1)(2009-4#1)(2010-12#1)(2011-2#1)(2013-1#1)
with defocus is##2##3##(2007-12#1)(2008-2#1)
with defocus##3##2##(2007-12#1)(2008-2#2)
with deformable##4##2##(2005-11#2)(2007-4#1)(2010-12#1)
with deformed##4##2##(1992-5#1)(2007-11#2)(2008-3#1)
with degenerate primers##5##3##(1993-2#1)(1996-7#1)(1997-5#1)(1997-7#1)(2008-10#1)
with degenerate##7##2##(1993-2#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-7#1)(2008-10#1)(2008-8#1)
with degenerated##2##2##(1994-10#1)(2008-11#1)
with degeneration of##2##3##(1992-10#1)(2007-11#1)
with degeneration##7##2##(1992-10#1)(1994-3#1)(2006-11#1)(2007-11#1)(2007-8#3)
with degenerative changes in the##2##5##(2007-7#2)
with degenerative changes##4##3##(2007-7#2)(2007-8#2)
with degenerative disc disease##2##4##(2008-11#1)(2011-1#1)
with degenerative disease##4##3##(1997-7#1)(2007-11#2)(2012-12#1)
with degenerative##27##2##(1993-2#1)(1997-7#1)(2006-3#1)(2006-8#1)(2007-11#2)(2007-7#2)(2007-8#5)(2008-11#1)(2008-7#1)(2008-8#1)(2009-3#2)(2010-11#2)(2010-7#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
with degloving##2##2##(2011-12#1)(2013-1#1)
with degradable##2##2##(2007-3#1)(2007-8#1)
with degradation of##4##3##(1991-9#1)(1992-11#1)(2007-1#1)(2007-10#1)
with degradation##5##2##(1991-9#1)(1992-11#1)(2006-12#1)(2007-1#1)(2007-10#1)
with deionized water and##3##4##(1997-8#1)(2008-10#1)(2013-7#1)
with deionized water##4##3##(1997-8#1)(2008-10#2)(2013-7#1)
with delay in the##3##4##(2007-11#1)(2013-1#2)
with delay##5##2##(2007-11#1)(2013-1#2)(2013-8#2)
with delayed diagnosis##3##3##(2008-11#1)(2010-12#2)
with delayed graft function##2##4##(2007-8#1)(2011-2#1)
with delayed##18##2##(1990-12#1)(1991-2#1)(1992-8#1)(2004-1#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-12#2)(2011-12#1)(2011-2#3)
with deletion of##4##3##(1994-12#1)(1996-3#1)(2008-3#1)(2008-7#1)
with deletion##7##2##(1991-10#2)(1994-12#1)(1996-3#1)(1997-2#1)(2008-3#1)(2008-7#1)
with deletions at##2##3##(1996-4#1)(1997-2#1)
with deletions in the##3##4##(1991-10#1)(1996-4#1)(2007-11#1)
with deletions of##2##3##(1996-3#1)(2008-9#1)
with deletions were##2##3##(1990-7#1)(1996-3#1)
with deletions##11##2##(1990-7#1)(1991-10#1)(1996-3#2)(1996-4#2)(1997-2#1)(1997-3#1)(2007-11#1)(2008-4#1)(2008-9#1)
with deliberate##2##2##(2011-12#1)(2012-12#1)
with delirium##6##2##(2004-3#1)(2010-10#3)(2012-2#1)(2013-1#1)
with delivery of a##2##4##(2007-7#1)(2008-11#1)
with delivery of##4##3##(2007-12#1)(2007-7#1)(2008-11#1)(2013-1#1)
with delivery##5##2##(2007-12#1)(2007-7#1)(2008-11#1)(2010-11#1)(2013-1#1)
with delta and kappa sites##2##5##(1991-5#2)
with delta##6##2##(1990-9#1)(1991-5#2)(1992-3#1)(1994-3#1)(1995-3#1)
with deltamethrin##2##2##(2008-8#2)
with delusions and hallucinations##2##4##(2008-4#1)(2012-2#1)
with delusions##3##2##(2006-2#1)(2008-4#1)(2012-2#1)
with demands##2##2##(1994-12#1)(2006-4#1)
with dementia and##12##3##(2006-8#3)(2008-11#1)(2008-6#1)(2010-10#1)(2010-11#1)(2010-2#1)(2011-2#2)(2013-8#2)
with dementia can##2##3##(2011-2#1)(2013-8#1)
with dementia in residential care##4##5##(2011-2#3)(2013-1#1)
with dementia in the##2##4##(2008-6#1)(2013-8#1)
with dementia in##8##3##(2006-8#1)(2008-6#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
with dementia showed##2##3##(1996-1#1)(2007-3#1)
with dementia##74##2##(1991-1#2)(1991-11#1)(1992-3#2)(1994-11#1)(1994-2#1)(1995-11#1)(1996-1#1)(1996-11#1)(1996-12#1)(2006-3#1)(2006-8#4)(2007-11#2)(2007-3#1)(2008-1#1)(2008-11#2)(2008-6#4)(2008-7#5)(2008-8#1)(2009-4#1)(2010-10#3)(2010-11#1)(2010-2#1)(2010-8#3)(2011-1#3)(2011-2#20)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#7)
with demersal eggs and##2##4##(2008-8#2)
with demographic and##4##3##(2006-10#1)(2007-10#1)(2008-12#1)(2011-11#1)
with demographic##8##2##(2006-10#1)(2007-10#1)(2008-12#1)(2008-6#1)(2008-8#1)(2010-11#1)(2010-2#1)(2011-11#1)
with demonstrated severe neglect##2##4##(1993-9#2)
with demonstrated##5##2##(1993-9#2)(1995-11#1)(2008-10#1)(2011-1#1)
with denaturing##2##2##(1992-11#1)(2006-12#1)
with dendrites of##2##3##(1994-2#1)(1995-11#1)
with dendritic cells##2##3##(2006-10#1)(2008-9#1)
with dendritic##14##2##(1991-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1996-5#1)(1997-2#2)(2006-10#2)(2008-4#1)(2008-9#1)(2010-12#1)(2013-1#1)
with dengue##5##2##(2008-11#1)(2009-10#2)(2011-2#1)(2012-12#1)
with dense breasts##2##3##(1990-10#1)(2007-4#1)
with dense mycelium##2##3##(2008-10#2)
with dense##8##2##(1990-10#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-2#1)
with densely##2##2##(1995-2#1)(2008-7#1)
with density functional##3##3##(2012-12#2)(2012-2#1)
with density##8##2##(1990-7#2)(2008-11#1)(2008-8#2)(2012-12#2)(2012-2#1)
with dental implants##3##3##(1993-2#1)(1996-8#1)(2008-12#1)
with dental##12##2##(1993-1#1)(1993-12#2)(1993-2#1)(1996-8#1)(2006-2#2)(2008-11#1)(2008-12#1)(2008-9#1)(2011-1#1)(2013-1#1)
with dependence on the##2##4##(1993-12#1)(1994-9#1)
with dependent##2##2##(2008-10#1)(2012-2#1)
with deployment##2##2##(2007-8#1)(2008-7#1)
with depolarization##4##2##(1995-12#1)(1995-6#1)(2008-3#2)
with deposition of##2##3##(2008-10#1)(2008-11#1)
with deposition##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
with depressed##6##2##(1991-9#1)(2008-6#1)(2011-2#4)
with depression and anxiety disorders##2##5##(2009-10#1)(2013-1#1)
with depression and##10##3##(1996-11#1)(2006-12#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#2)(2009-10#1)(2013-1#1)
with depression in##3##3##(2007-10#1)(2007-12#1)(2011-2#1)
with depression##36##2##(1991-1#1)(1993-10#1)(1995-11#1)(1996-11#1)(2006-12#1)(2006-8#2)(2007-10#3)(2007-11#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-12#2)(2009-6#1)(2010-2#2)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#2)
with depression-like##2##2##(2010-12#1)(2013-1#1)
with depressive symptoms##10##3##(2007-12#2)(2010-1#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-1#3)(2012-11#1)
with depressive##15##2##(1992-2#1)(2007-12#2)(2008-4#1)(2008-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-1#3)(2012-11#1)(2012-2#1)
with deprivation of##2##3##(2007-1#1)(2008-10#1)
with depsipeptide##2##2##(2008-6#2)
with depth##12##2##(1996-3#1)(2004-4#1)(2005-12#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-1#2)
with depths##2##2##(2007-11#1)(2008-3#1)
with dequalinium##2##2##(1996-8#1)(2008-10#1)
with derivatives of##4##3##(1992-5#1)(1993-4#1)(1994-5#1)(1997-2#1)
with derivatives##5##2##(1992-5#1)(1993-4#1)(1994-5#1)(1997-2#1)(2008-11#1)
with derivatization##3##2##(1991-3#1)(2007-8#1)(2008-10#1)
with derived##2##2##(2007-9#1)(2008-3#1)
with dermal##4##2##(1993-2#1)(2008-9#2)(2012-2#1)
with dermatitis were##2##3##(1990-3#2)
with dermatitis##6##2##(1990-3#2)(1992-9#1)(2006-10#1)(2011-1#1)(2012-1#1)
with dermatological##2##2##(2006-12#1)(2013-7#1)
with dermatomyositis##5##2##(1994-8#3)(2006-10#2)
with descending##3##2##(2008-8#1)(2008-9#2)
with description of a##2##4##(1993-5#1)(2008-5#1)
with description of##5##3##(1993-5#1)(2004-11#1)(2006-8#1)(2007-8#1)(2008-5#1)
with description##6##2##(1993-5#1)(2004-11#1)(2006-8#1)(2007-8#1)(2008-5#1)(2008-7#1)
with descriptions of##2##3##(2006-12#1)(2008-10#1)
with descriptions##3##2##(2006-12#1)(2008-10#1)(2008-4#1)
with descriptive##4##2##(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
with desferrioxamine##3##2##(1994-3#1)(1996-6#1)(2012-2#1)
with desflurane##3##2##(2006-10#2)(2013-7#1)
with design##5##2##(2006-4#1)(2007-12#1)(2013-1#3)
with designs##2##2##(2008-10#1)(2008-2#1)
with desipramine##6##2##(1990-2#3)(1995-12#2)(2008-7#1)
with desirable##4##2##(2008-11#1)(2008-8#1)(2009-7#1)(2012-2#1)
with desired##8##2##(1992-3#1)(2006-1#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-11#1)(2012-12#1)
with destruction of##3##3##(2007-12#1)(2011-1#2)
with destructive##4##2##(1995-9#1)(2006-6#1)(2007-12#1)(2012-3#1)
with detached##2##2##(2008-10#2)
with detail##2##2##(1996-12#1)(2008-10#1)
with detailed data##2##3##(1990-3#1)(1995-1#1)
with detailed##17##2##(1990-3#1)(1993-1#1)(1993-2#1)(1995-1#1)(2007-12#1)(2007-9#1)(2008-11#2)(2008-2#2)(2008-4#4)(2008-9#2)(2012-1#1)
with details##3##2##(2008-11#1)(2008-4#1)(2011-2#1)
with detectable serum IL-6##2##4##(1997-7#2)
with detectable##9##2##(1990-5#1)(1995-2#1)(1997-5#1)(1997-7#2)(2007-9#1)(2008-10#2)(2008-7#1)
with detection at##8##3##(1990-12#1)(1992-1#1)(1992-2#1)(1996-5#1)(2008-10#3)(2010-12#1)
with detection by inductively coupled plasma mass spectrometry##2##8##(2008-10#2)
with detection by##5##3##(1992-1#1)(2008-10#4)
with detection limit of 0##5##5##(2008-10#5)
with detection limit of 1##2##5##(2008-10#2)
with detection limit of##13##4##(2008-10#13)
with detection limit##18##3##(2008-10#18)
with detection limits (S/N=3)##3##4##(2008-10#3)
with detection limits of 0##12##5##(1997-4#1)(2007-8#1)(2008-10#10)
with detection limits of 1##2##5##(1997-4#1)(2008-10#1)
with detection limits of##22##4##(1992-2#1)(1997-4#2)(2007-8#1)(2008-10#18)
with detection limits ranging from 2##2##6##(2007-8#1)(2008-10#1)
with detection limits ranging from##3##5##(2007-8#1)(2008-10#2)
with detection limits within##2##4##(2008-10#2)
with detection limits##38##3##(1992-2#1)(1997-4#2)(2007-8#2)(2008-10#33)
with detection of##4##3##(2007-11#1)(2008-10#2)(2010-4#1)
with detection wavelength##2##3##(2005-12#1)(2013-7#1)
with detection##80##2##(1990-12#1)(1992-1#2)(1992-2#2)(1996-5#1)(1997-4#2)(2005-12#1)(2007-11#1)(2007-8#2)(2008-10#62)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2013-7#1)
with detergent##4##2##(1994-8#1)(2008-4#1)(2008-5#1)(2010-5#1)
with detergents##5##2##(1990-4#1)(1993-11#1)(1994-3#1)(1995-2#1)(2008-10#1)
with determination of##4##3##(1990-12#1)(1997-2#1)(2008-10#1)(2008-7#1)
with determination##10##2##(1990-12#1)(1995-9#1)(1997-2#1)(2007-11#1)(2008-10#5)(2008-7#1)
with determinations##2##2##(1990-8#1)(1992-2#1)
with deterministic##2##2##(2008-2#2)
with devastating consequences##2##3##(2007-11#1)(2009-2#1)
with devastating##5##2##(2006-12#1)(2007-11#1)(2007-8#1)(2009-2#1)(2011-2#1)
with developed##2##2##(2007-7#1)(2008-10#1)
with developing a##2##3##(2007-4#1)(2008-2#1)
with developing##6##2##(1994-2#1)(2005-10#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-2#1)
with development and##2##3##(2005-8#1)(2011-1#1)
with development of an##2##4##(1991-6#1)(2008-9#1)
with development of##19##3##(1991-6#1)(1992-8#1)(1993-10#1)(1996-5#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-1#2)(2012-2#1)
with development##24##2##(1991-6#1)(1992-8#1)(1993-10#1)(1996-5#1)(1997-7#1)(2005-8#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-1#3)(2012-2#1)
with developmental delay##2##3##(1996-5#1)(2011-2#1)
with developmental disabilities##9##3##(1991-12#1)(1993-1#1)(1993-3#1)(1997-2#1)(2007-9#4)(2010-12#1)
with developmental disorders##5##3##(1993-1#1)(1995-1#2)(2006-10#1)(2010-9#1)
with developmental dyslexia##5##3##(2008-4#1)(2008-9#1)(2010-5#1)(2012-2#2)
with developmental##32##2##(1991-12#1)(1992-1#1)(1993-1#2)(1993-3#1)(1995-1#2)(1995-2#1)(1996-5#1)(1997-2#1)(2006-10#4)(2007-9#4)(2008-11#1)(2008-4#1)(2008-9#1)(2009-4#2)(2009-8#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#3)(2012-3#1)
with developments in##4##3##(2005-5#1)(2006-10#1)(2008-11#1)(2008-5#1)
with deviant##2##2##(2009-7#1)(2013-7#1)
with dexamethasone alone##2##3##(1997-1#1)(2008-7#1)
with dexamethasone and##2##3##(1997-6#1)(2008-3#1)
with dexamethasone in##2##3##(1994-11#1)(2008-5#1)
with dexamethasone or##2##3##(1993-2#1)(1994-3#1)
with dexamethasone##26##2##(1990-11#1)(1990-5#2)(1992-5#1)(1993-2#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-8#1)(1997-1#1)(1997-4#1)(1997-6#2)(2007-7#1)(2008-10#1)(2008-3#2)(2008-5#4)(2008-7#2)(2013-1#1)
with dexrazoxane##2##2##(2008-11#2)
with dextran##2##2##(1993-11#1)(2006-10#1)
with dextran-conjugated calcium indicators in##2##5##(2008-4#2)
with dextrocardia is##2##3##(2007-8#1)(2008-7#1)
with dextrocardia##6##2##(2007-8#1)(2008-7#3)(2010-8#2)
with diabetes and hypertension##2##4##(1996-9#1)(2005-8#1)
with diabetes and other##4##4##(2007-10#1)(2013-8#3)
with diabetes and their##2##4##(2010-9#1)(2013-1#1)
with diabetes and##17##3##(1995-2#1)(1996-9#1)(2005-8#1)(2007-10#2)(2007-7#1)(2008-5#1)(2009-4#1)(2010-10#1)(2010-9#1)(2011-1#1)(2013-1#3)(2013-8#3)
with diabetes are##7##3##(1997-3#1)(2005-10#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-4#1)
with diabetes attempt to control##2##5##(2008-1#2)
with diabetes from the##2##4##(2007-12#1)(2009-11#1)
with diabetes from##4##3##(2007-12#1)(2008-6#1)(2009-11#1)(2010-4#1)
with diabetes have##6##3##(1996-11#1)(2008-1#3)(2009-4#1)(2010-10#1)
with diabetes in the##2##4##(2009-5#1)(2011-2#1)
with diabetes in##7##3##(1994-12#1)(2008-1#1)(2008-8#1)(2009-10#1)(2009-5#1)(2011-2#1)(2013-1#1)
with diabetes mellitus and##9##4##(1996-3#1)(1996-9#1)(2006-6#1)(2007-10#1)(2009-11#2)(2011-2#1)(2012-12#1)(2013-8#1)
with diabetes mellitus are##5##4##(2005-10#2)(2008-1#1)(2008-10#1)(2008-3#1)
with diabetes mellitus in##4##4##(1994-6#1)(2006-6#1)(2008-8#1)(2012-12#1)
with diabetes mellitus is##3##4##(1992-5#1)(2008-3#2)
with diabetes mellitus was##2##4##(1992-5#1)(1994-6#1)
with diabetes mellitus##71##3##(1990-4#1)(1991-8#2)(1992-5#2)(1994-11#1)(1994-6#2)(1996-3#3)(1996-9#1)(1997-3#1)(2005-10#2)(2005-8#1)(2005-9#1)(2006-10#1)(2006-6#3)(2007-1#1)(2007-10#1)(2007-7#1)(2008-1#4)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#7)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#2)(2009-2#1)(2009-6#1)(2010-4#2)(2010-6#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
with diabetes mellitus]##3##3##(1994-6#1)(1996-11#1)(2006-6#1)
with diabetes or##3##3##(1995-3#1)(2007-7#1)(2013-8#1)
with diabetes should##2##3##(2010-4#1)(2011-1#1)
with diabetes type##3##3##(1990-3#1)(2008-6#2)
with diabetes##228##2##(1990-3#1)(1990-4#1)(1991-6#1)(1991-8#3)(1992-5#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-6#3)(1995-2#3)(1995-3#1)(1996-11#3)(1996-3#3)(1996-9#2)(1997-3#4)(2005-10#4)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#2)(2006-2#3)(2006-6#4)(2007-1#3)(2007-10#6)(2007-11#2)(2007-12#2)(2007-7#6)(2007-8#3)(2008-1#24)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#10)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#6)(2008-8#5)(2009-1#1)(2009-10#2)(2009-11#5)(2009-12#1)(2009-2#2)(2009-4#2)(2009-5#2)(2009-6#1)(2010-10#5)(2010-12#1)(2010-4#9)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#8)(2011-2#9)(2012-1#1)(2012-12#6)(2012-2#4)(2012-3#8)(2013-1#17)(2013-7#1)(2013-8#11)
with diabetic ketoacidosis##2##3##(2011-1#1)(2011-2#1)
with diabetic nephropathy##11##3##(1996-12#2)(2007-8#2)(2008-1#2)(2008-3#2)(2010-12#2)(2011-2#1)
with diabetic retinopathy##3##3##(1991-9#1)(2012-1#2)
with diabetic##29##2##(1991-9#1)(1994-12#1)(1996-12#2)(1996-9#1)(2005-10#1)(2005-7#1)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-3#2)(2010-12#2)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)
with diagnosed##10##2##(1992-12#1)(1993-6#1)(2006-10#1)(2008-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
with diagnoses of##5##3##(1990-7#1)(1994-2#1)(1996-8#1)(2008-9#1)(2011-2#1)
with diagnosis of##13##3##(1997-8#1)(2006-8#1)(2007-8#1)(2008-12#1)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
with diagnosis##17##2##(1997-8#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
with diagnostic##15##2##(1991-5#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-5#1)
with dialysis##7##2##(2007-8#3)(2008-10#1)(2008-4#2)(2010-4#1)
with diameter##4##2##(2005-10#1)(2008-7#1)(2010-4#1)(2012-1#1)
with diameters of##5##3##(2005-11#1)(2007-12#1)(2008-3#2)(2010-4#1)
with diameters ranging between##2##4##(2008-3#1)(2009-2#1)
with diameters ranging from##3##4##(2007-9#1)(2008-1#1)(2008-3#1)
with diameters ranging##5##3##(2007-9#1)(2008-1#1)(2008-3#2)(2009-2#1)
with diameters##15##2##(1997-4#1)(2005-10#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#4)(2009-2#1)(2010-4#1)(2010-8#1)
with diamond##5##2##(1994-6#2)(2006-12#1)(2006-5#1)(2008-10#1)
with diarrhea##3##2##(2007-10#1)(2010-12#1)(2012-2#1)
with diarrhoea and##2##3##(1992-12#1)(1995-4#1)
with diarrhoea##9##2##(1990-9#1)(1992-12#1)(1995-4#1)(1997-3#1)(2007-2#1)(2007-7#1)(2008-1#1)(2010-4#1)(2013-8#1)
with diazepam##5##2##(1991-3#1)(1996-10#1)(2011-2#1)(2012-12#1)(2012-3#1)
with diazomethane##5##2##(2005-12#2)(2008-10#3)
with diazotized##2##2##(2008-10#1)(2008-5#1)
with dichloromethane and##4##3##(1990-9#1)(1997-3#1)(2008-10#1)(2011-1#1)
with dichloromethane##19##2##(1990-9#2)(1996-6#1)(1996-8#1)(1997-3#2)(1997-8#2)(2005-12#1)(2006-3#1)(2008-10#7)(2008-6#1)(2011-1#1)
with diclofenac##5##2##(1997-1#1)(2008-10#1)(2010-12#1)(2010-8#2)
with dielectric##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
with diesel##2##2##(2004-4#1)(2008-10#1)
with diet alone##3##3##(1991-2#1)(1996-1#2)
with diet and##5##3##(1991-7#2)(1991-8#1)(1994-12#1)(2008-3#1)
with diet##12##2##(1991-2#1)(1991-7#2)(1991-8#1)(1994-12#2)(1996-1#2)(2006-2#1)(2007-11#1)(2008-3#1)(2013-7#1)
with dietary therapy##2##3##(1990-8#1)(1993-9#1)
with dietary##11##2##(1990-8#1)(1991-11#1)(1991-8#1)(1993-9#1)(1995-12#1)(2007-8#1)(2008-1#1)(2008-4#1)(2009-2#1)(2011-1#1)(2013-1#1)
with diethyl L-glutamate followed by ester hydrolysis##2##7##(1997-1#2)
with diethyl ether##6##3##(1990-11#1)(1992-2#1)(1997-2#1)(2008-10#1)(2008-11#2)
with diethyl pyrocarbonate##3##3##(1990-12#1)(1991-8#1)(1996-7#1)
with diethyl##12##2##(1990-11#1)(1990-12#1)(1991-8#1)(1992-2#1)(1996-7#1)(1997-1#2)(1997-2#1)(2008-10#1)(2008-11#2)(2008-2#1)
with diethyldithiocarbamate##3##2##(1997-8#2)(2008-10#1)
with diethylpyrocarbonate##4##2##(1990-11#1)(1990-2#1)(1992-7#1)(1994-11#1)
with diethylstilbestrol (DES)##2##3##(2008-4#1)(2008-5#1)
with diets##2##2##(1991-2#1)(1993-9#1)
with differences among##2##3##(1994-9#1)(2008-10#1)
with differences in the##7##4##(1996-8#1)(2004-4#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
with differences in##18##3##(1996-8#1)(1997-6#1)(2004-4#1)(2005-10#1)(2008-10#4)(2008-3#1)(2008-9#1)(2009-12#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#2)
with differences##26##2##(1993-1#1)(1994-9#1)(1996-8#1)(1997-6#1)(2004-4#1)(2005-10#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-12#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#2)
with different affinities##3##3##(1990-8#1)(1997-2#1)(2008-7#1)
with different affinity##2##3##(1994-9#1)(1996-3#1)
with different ages##2##3##(2008-3#1)(2012-11#1)
with different alkyl chain length##2##5##(1997-5#1)(2008-8#1)
with different amounts of each chemical##2##6##(2008-10#2)
with different amounts of##8##4##(2008-10#5)(2008-3#1)(2008-9#1)(2010-4#1)
with different analytical##2##3##(2008-10#2)
with different anion ions##2##4##(2005-4#2)
with different anions and##2##4##(1993-12#2)
with different aspect ratios##3##4##(2007-11#1)(2008-2#1)(2009-9#1)
with different aspects of##2##4##(2007-12#1)(2008-11#1)
with different background##3##3##(2008-2#1)(2013-1#2)
with different batches##2##3##(2008-10#1)(2011-2#1)
with different behaviors##2##3##(2008-3#1)(2008-4#1)
with different body##2##3##(2008-6#1)(2012-1#1)
with different catalytic##2##3##(1992-4#1)(1995-3#1)
with different cell##2##3##(2008-11#1)(2012-3#1)
with different cellular##2##3##(1991-6#1)(2008-11#1)
with different characteristics##2##3##(2007-3#1)(2007-8#1)
with different chemical properties##2##4##(1993-4#1)(2011-1#1)
with different chemical structures and##2##5##(1992-3#1)(2008-10#1)
with different chemical structures##4##4##(1992-3#1)(1995-11#1)(2008-10#1)(2011-1#1)
with different chemical##10##3##(1992-3#1)(1993-4#1)(1995-11#1)(2005-4#1)(2008-10#3)(2008-11#1)(2011-1#2)
with different classes of##2##4##(2005-10#1)(2012-2#1)
with different clinical forms##2##4##(2008-5#1)(2013-1#1)
with different clinical##8##3##(2006-8#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#2)
with different combinations of##3##4##(1995-4#1)(1996-7#1)(2008-9#1)
with different concentrations and##2##4##(2008-10#1)(2013-1#1)
with different concentrations of##14##4##(1991-4#1)(1993-8#1)(1996-5#1)(1997-2#2)(2007-8#1)(2008-10#4)(2008-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
with different concentrations##17##3##(1991-4#1)(1993-8#1)(1996-5#1)(1997-2#2)(2007-8#2)(2008-10#5)(2008-3#1)(2012-3#1)(2013-1#2)(2013-8#1)
with different conditions##2##3##(2005-11#1)(2013-1#1)
with different contents##2##3##(2007-11#1)(2008-10#1)
with different degrees of##14##4##(1991-5#2)(1995-7#1)(1997-2#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-8#1)(2011-1#1)(2013-8#1)
with different detection##5##3##(2008-10#2)(2010-5#1)(2012-11#2)
with different diameters##2##3##(2008-10#1)(2008-2#1)
with different diseases##3##3##(1996-2#1)(2008-1#1)(2008-11#1)
with different distributions of##2##4##(2008-3#1)(2008-8#1)
with different doping##2##3##(2008-3#1)(2013-8#1)
with different doses and##2##4##(1992-2#1)(2012-2#1)
with different doses of##7##4##(1990-10#1)(1992-8#1)(2008-10#1)(2010-3#1)(2012-11#1)(2012-12#1)(2013-1#1)
with different doses##11##3##(1990-10#1)(1992-2#1)(1992-8#1)(2008-10#1)(2008-7#1)(2010-3#1)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#1)
with different efficiencies##4##3##(1990-8#1)(1992-2#1)(1994-5#2)
with different efficiency##2##3##(2008-11#1)(2012-1#1)
with different features##2##3##(2007-8#1)(2008-10#1)
with different feeding habits##2##4##(2008-8#1)(2013-7#1)
with different forms of##6##4##(1992-2#1)(1997-2#1)(1997-6#1)(2006-10#1)(2008-12#1)(2008-7#1)
with different fractions of##2##4##(1997-1#1)(2008-10#1)
with different frequencies##5##3##(2007-12#1)(2008-3#1)(2013-1#3)
with different genetic backgrounds##2##4##(1996-6#1)(2012-2#1)
with different genetic##4##3##(1996-6#1)(2008-10#1)(2009-10#1)(2012-2#1)
with different genotypes##2##3##(1997-7#1)(2008-4#1)
with different indications##2##3##(2008-12#1)(2011-2#1)
with different isolates of##2##4##(2008-10#2)
with different kinds of##3##4##(2009-11#1)(2009-3#1)(2011-3#1)
with different kinds##4##3##(2008-12#1)(2009-11#1)(2009-3#1)(2011-3#1)
with different kinetics##3##3##(1993-6#1)(1996-11#1)(2007-11#1)
with different layer##2##3##(2005-11#1)(2008-2#1)
with different levels of##16##4##(1992-9#1)(1996-3#1)(2007-3#2)(2007-8#1)(2008-10#3)(2008-3#1)(2008-8#1)(2009-4#1)(2009-7#1)(2011-12#1)(2013-1#3)
with different levels##17##3##(1992-9#1)(1996-3#1)(2007-3#2)(2007-8#1)(2008-10#3)(2008-3#1)(2008-8#1)(2009-4#1)(2009-7#1)(2011-12#1)(2013-1#3)(2013-8#1)
with different localizations##2##3##(1993-6#1)(2007-11#1)
with different magnitude##2##3##(2008-10#1)(2011-12#1)
with different maximum luminance settings##2##5##(2010-9#2)
with different mean##2##3##(1991-12#1)(2007-12#1)
with different mechanisms of action##4##5##(1993-6#1)(2007-11#2)(2008-8#1)
with different mechanisms##5##3##(1993-6#1)(1995-11#1)(2007-11#2)(2008-8#1)
with different methods##3##3##(2006-12#1)(2008-4#1)(2010-12#1)
with different modes of action##3##5##(1995-2#1)(2007-11#1)(2008-8#1)
with different modes of##5##4##(1995-2#1)(2007-11#1)(2008-7#1)(2008-8#1)(2011-12#1)
with different molar ratios of##2##5##(1992-8#1)(2007-11#1)
with different molar ratios##3##4##(1992-8#1)(2007-11#1)(2008-10#1)
with different molar##4##3##(1992-8#1)(1996-2#1)(2007-11#1)(2008-10#1)
with different molecular##3##3##(1996-2#2)(1997-2#1)
with different numbers of##4##4##(2008-10#1)(2008-3#1)(2008-7#1)(2010-11#1)
with different orientations of the##3##5##(1992-6#1)(1995-3#1)(2012-2#1)
with different orientations##4##3##(1992-6#1)(1995-3#1)(2008-3#1)(2012-2#1)
with different oxidation states##2##4##(2007-11#1)(2008-10#1)
with different parameters##2##3##(2007-11#1)(2008-3#1)
with different partners##2##3##(1997-4#1)(2008-6#1)
with different patterns of##5##4##(1994-2#1)(2008-11#1)(2009-8#1)(2010-2#1)(2011-1#1)
with different patterns##9##3##(1994-2#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)(2010-2#1)(2011-1#1)(2012-1#1)
with different permanent modifiers##2##4##(2008-10#2)
with different peroxisomal defects##2##4##(1996-7#2)
with different phases##2##3##(1994-12#1)(2008-3#1)
with different phenotypes##3##3##(1997-3#1)(2007-2#1)(2008-10#1)
with different phenotypic##2##3##(2007-2#1)(2009-4#1)
with different physical##2##3##(2007-6#1)(2008-10#1)
with different polarization##2##3##(2007-11#1)(2008-3#1)
with different presentations##2##3##(1994-11#1)(2008-2#1)
with different properties##7##3##(1996-2#1)(2006-10#1)(2008-5#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-12#1)
with different protein##2##3##(2007-2#1)(2007-8#1)
with different ratios##2##3##(2005-11#1)(2008-10#1)
with different resistance##2##3##(1995-12#1)(2008-10#1)
with different respiratory metabolisms##2##4##(2008-5#2)
with different respiratory##3##3##(1996-3#1)(2008-5#2)
with different responses to##2##4##(1991-2#1)(2008-10#1)
with different seed##2##3##(2008-12#1)(2013-7#1)
with different severities of##2##4##(2008-7#1)(2010-12#1)
with different shapes##3##3##(2008-3#1)(2008-7#1)(2013-1#1)
with different side##2##3##(2005-3#1)(2008-10#1)
with different sites##3##3##(1991-8#1)(1994-9#1)(2007-11#1)
with different size##4##3##(1997-6#1)(2005-11#1)(2008-3#1)(2011-2#1)
with different sizes##2##3##(2008-5#1)(2010-4#1)
with different snow##2##3##(2008-3#2)
with different solutions##3##3##(1992-9#1)(2008-5#1)(2013-1#1)
with different specificities##4##3##(1991-4#2)(1993-6#1)(1996-5#1)
with different spectral characteristics##2##4##(2006-12#1)(2008-2#1)
with different spectral##5##3##(2006-12#1)(2007-12#1)(2008-2#1)(2008-3#2)
with different stages of cervical##2##5##(2010-12#2)
with different stages of##3##4##(2010-12#2)(2011-2#1)
with different strains of##2##4##(2006-10#1)(2008-5#1)
with different strains##3##3##(2006-10#1)(2008-5#1)(2013-8#1)
with different subpupil forms##2##4##(2008-3#2)
with different substrate##2##3##(2008-10#1)(2011-2#1)
with different substrates##2##3##(1993-11#1)(2008-10#1)
with different subtypes of##2##4##(1996-3#1)(2008-12#1)
with different subtypes##3##3##(1996-3#1)(2008-12#1)(2008-6#1)
with different surface##2##3##(2004-9#1)(2012-2#1)
with different surgical techniques##3##4##(1991-10#1)(2008-6#2)
with different target##2##3##(2008-10#1)(2008-11#1)
with different techniques##5##3##(1994-11#1)(2006-4#1)(2008-10#2)(2008-11#1)
with different therapeutic##2##3##(2008-3#1)(2009-2#1)
with different time courses##2##4##(1991-2#1)(1996-11#1)
with different transition##3##3##(2010-11#1)(2012-12#2)
with different treatment##3##3##(2008-3#2)(2008-9#1)
with different type of##3##4##(2012-3#2)(2013-1#1)
with different type##4##3##(2008-10#1)(2012-3#2)(2013-1#1)
with different types of##14##4##(2005-11#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#1)
with different types##16##3##(1993-9#1)(2005-11#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#1)
with different versions of the##2##5##(2007-10#1)(2008-10#1)
with different wavelengths##4##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
with different##817##2##(1990-10#2)(1990-11#4)(1990-12#4)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#6)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#3)(1993-11#2)(1993-12#4)(1993-2#1)(1993-4#2)(1993-5#1)(1993-6#5)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#5)(1994-5#4)(1994-6#3)(1994-8#2)(1994-9#4)(1995-1#1)(1995-10#2)(1995-11#3)(1995-12#2)(1995-2#2)(1995-3#2)(1995-4#2)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#2)(1996-10#2)(1996-11#2)(1996-12#1)(1996-2#8)(1996-3#5)(1996-4#2)(1996-5#3)(1996-6#1)(1996-7#3)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#9)(1997-3#3)(1997-4#2)(1997-5#5)(1997-6#2)(1997-7#8)(2004-9#1)(2005-10#2)(2005-11#10)(2005-12#1)(2005-3#1)(2005-4#4)(2006-10#8)(2006-11#1)(2006-12#5)(2006-2#2)(2006-4#2)(2006-8#3)(2007-1#1)(2007-10#6)(2007-11#24)(2007-12#16)(2007-2#6)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#14)(2007-9#2)(2008-1#4)(2008-10#130)(2008-11#20)(2008-12#10)(2008-2#23)(2008-3#42)(2008-4#7)(2008-5#29)(2008-6#9)(2008-7#11)(2008-8#17)(2008-9#10)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#6)(2009-4#4)(2009-5#2)(2009-6#1)(2009-7#4)(2009-8#6)(2009-9#2)(2010-10#2)(2010-11#5)(2010-12#9)(2010-2#2)(2010-3#3)(2010-4#10)(2010-5#6)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#14)(2011-12#8)(2011-2#14)(2011-3#1)(2012-1#10)(2012-11#5)(2012-12#7)(2012-2#12)(2012-3#14)(2013-1#30)(2013-7#5)(2013-8#13)
with differential absorption##2##3##(2008-3#2)
with differential pulse voltammetry (DPV)##2##5##(2008-10#2)
with differential pulse##3##3##(2008-10#3)
with differential##24##2##(1995-8#1)(1996-3#1)(1997-3#1)(2004-12#1)(2005-4#1)(2006-10#1)(2006-8#1)(2008-10#8)(2008-3#2)(2008-7#1)(2008-9#1)(2010-7#1)(2011-1#1)(2012-11#1)(2013-7#2)
with differentiated##4##2##(1992-9#1)(1993-10#1)(1994-11#1)(2013-1#1)
with differentiating##3##2##(2008-9#1)(2009-10#1)(2011-1#1)
with differentiation##3##2##(2008-5#1)(2008-8#1)(2009-2#1)
with differently##3##2##(2007-12#1)(2009-12#1)(2013-1#1)
with differing##13##2##(1993-7#1)(1996-2#1)(1997-3#1)(2006-10#1)(2006-5#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-12#2)(2010-10#1)(2010-11#1)
with difficult##8##2##(1995-6#1)(2006-3#1)(2007-4#1)(2008-10#1)(2010-8#1)(2012-3#1)(2013-7#2)
with difficult-to-control##3##2##(2009-6#1)(2010-8#1)(2012-2#1)
with difficulties##3##2##(2005-8#1)(2008-12#1)(2008-4#1)
with difficulty in##2##3##(2006-3#1)(2012-2#1)
with difficulty##6##2##(2006-3#1)(2008-1#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
with diffraction##2##2##(2007-11#1)(2008-3#1)
with diffraction-limited beam quality##2##4##(2007-12#2)
with diffraction-limited##5##2##(2007-12#3)(2008-2#2)
with diffractive optical elements##3##4##(2008-2#3)
with diffractive optics##4##3##(2008-3#4)
with diffractive##9##2##(2008-2#4)(2008-3#5)
with diffuse large B-cell lymphoma##2##5##(2005-10#1)(2013-8#1)
with diffuse leptomeningeal spread##2##4##(2012-12#2)
with diffuse leptomeningeal##3##3##(2012-12#2)(2012-2#1)
with diffuse osteomyelitis of##2##4##(1992-3#1)(2008-9#1)
with diffuse systemic sclerosis##5##4##(2006-10#1)(2009-8#4)
with diffuse##40##2##(1990-9#1)(1991-6#1)(1992-3#1)(1993-8#1)(1994-11#1)(2005-10#1)(2005-4#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)(2009-10#1)(2009-2#2)(2009-8#5)(2010-12#2)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
with diffusion##6##2##(1992-3#1)(2005-11#1)(2006-10#1)(2008-2#1)(2008-3#1)(2013-8#1)
with digital holography##3##3##(2008-3#3)
with digital speckle photography##2##4##(2008-3#2)
with digital##13##2##(1991-12#1)(2007-11#1)(2008-2#2)(2008-3#6)(2008-7#1)(2008-9#1)(2013-7#1)
with digitonin##5##2##(1990-2#1)(1990-7#1)(1992-6#1)(2005-7#1)(2008-4#1)
with dignity##9##2##(1991-11#1)(1993-1#1)(1994-6#1)(1997-3#1)(2005-12#1)(2008-1#1)(2012-12#2)(2013-1#1)
with digoxigenin##4##2##(1997-6#1)(2008-12#1)(2008-4#1)(2008-5#1)
with dihydrogen##2##2##(2006-4#2)
with dihydropyridine binding##3##3##(1990-7#1)(1995-11#2)
with dihydropyridine##4##2##(1990-7#1)(1995-11#2)(2010-12#1)
with diiodofluorescein iodacetamide##2##3##(1994-2#2)
with diisopropyl##2##2##(1990-11#1)(2008-7#1)
with dilatation of the##2##4##(1990-9#1)(2010-12#1)
with dilatation##4##2##(1990-9#1)(1993-2#1)(2006-2#1)(2010-12#1)
with dilated cardiomyopathy##9##3##(1993-2#3)(1993-7#1)(1995-6#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
with dilated##10##2##(1993-2#3)(1993-7#1)(1995-6#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-8#2)
with dilation##3##2##(2010-12#3)
with dilute aqueous##2##3##(2008-10#1)(2008-5#1)
with dilute##5##2##(2004-8#1)(2006-1#1)(2008-10#1)(2008-5#2)
with diluted##5##2##(2005-7#1)(2008-10#3)(2013-8#1)
with dilution##3##2##(2005-11#2)(2008-10#1)
with dimensions comparable##2##3##(2008-3#1)(2008-7#1)
with dimensions in the##2##4##(2006-12#1)(2008-2#1)
with dimensions of##2##3##(1991-11#1)(2006-2#1)
with dimensions##11##2##(1991-11#1)(2006-12#1)(2006-2#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-7#1)(2010-12#1)
with dimerization##2##2##(1993-4#1)(2008-10#1)
with dimethyl suberimidate##2##3##(1990-7#1)(1991-5#1)
with dimethyl##11##2##(1990-12#1)(1990-7#1)(1991-5#1)(1996-5#3)(2004-9#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-9#1)
with dimethyldioxirane##2##2##(1990-5#1)(1990-6#1)
with dimethylformamide##2##2##(1992-2#1)(2008-10#1)
with dimethylglyoxime##2##2##(2008-10#2)
with dimethylsulfoxide##2##2##(2008-6#1)(2008-7#1)
with diminished##11##2##(1990-2#1)(1995-12#1)(1995-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-3#1)(2011-2#1)(2012-5#1)(2013-1#1)
with diminishing##2##2##(1992-6#1)(2008-3#1)
with dimyristoylphosphatidylcholine (DMPC)##2##3##(1993-9#1)(1995-8#1)
with diode array detection##6##4##(1997-1#1)(2008-10#4)(2011-1#1)
with diode array detector##3##4##(2008-10#3)
with diode array##9##3##(1997-1#1)(2008-10#7)(2011-1#1)
with diode lasers##2##3##(2008-2#1)(2008-3#1)
with diode##11##2##(1997-1#1)(2008-10#7)(2008-2#1)(2008-3#1)(2011-1#1)
with diode-array detection##3##3##(1992-2#1)(2008-10#1)(2010-12#1)
with diode-array detector##2##3##(2007-8#1)(2008-10#1)
with diode-array##5##2##(1992-2#1)(2007-8#1)(2008-10#2)(2010-12#1)
with dioxygen##3##2##(1995-1#1)(1997-7#1)(2008-10#1)
with dipalmitoyl phosphatidylcholine (DPPC)##3##4##(2008-10#2)(2011-2#1)
with diphtheria##3##2##(2007-11#1)(2008-7#1)(2010-12#1)
with diplegia and##2##3##(2007-11#2)
with diploid##3##2##(2006-12#1)(2008-10#1)(2011-2#1)
with diplopia##3##2##(1996-9#1)(2008-7#1)(2011-1#1)
with dipole##3##2##(2007-11#1)(2007-12#1)(2008-11#1)
with dipyridamole##3##2##(1993-7#1)(1996-12#1)(1997-8#1)
with direct and indirect##2##4##(2005-9#1)(2008-8#1)
with direct conductivity detection##4##4##(2008-10#4)
with direct determination##2##3##(1992-12#1)(2008-10#1)
with direct experience##2##3##(2010-11#1)(2011-1#1)
with direct measurement of##2##4##(1994-9#1)(2008-10#1)
with direct measurements##2##3##(2008-2#1)(2008-3#1)
with direct numerical##4##3##(2007-11#1)(2007-12#3)
with direct sample injection##5##4##(1990-12#1)(1990-8#1)(1992-2#1)(2008-10#2)
with direct suture##2##3##(2007-8#1)(2011-3#1)
with direct##67##2##(1990-12#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-9#1)(1994-8#1)(1994-9#1)(1996-1#1)(1996-4#1)(1996-9#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#2)(2007-8#1)(2008-10#13)(2008-2#2)(2008-3#4)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-1#1)(2010-11#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#2)(2013-1#3)
with directed##2##2##(1992-9#1)(2008-7#1)
with directly##3##2##(1990-8#1)(2007-5#1)(2007-8#1)
with disabilities and##4##3##(1994-2#1)(1996-1#1)(2010-12#1)(2012-1#1)
with disabilities are##2##3##(1996-1#1)(2010-2#1)
with disabilities has##2##3##(1995-12#1)(2010-2#1)
with disabilities have##2##3##(1997-2#1)(2010-7#1)
with disabilities in Medicare and Medicaid##2##6##(1997-2#2)
with disabilities in##6##3##(1995-6#1)(1996-1#2)(1997-2#2)(2010-2#1)
with disabilities to##4##3##(1994-1#1)(2010-2#1)(2011-2#1)(2013-1#1)
with disabilities##71##2##(1993-3#1)(1994-1#2)(1994-2#1)(1995-1#1)(1995-12#3)(1995-6#2)(1996-1#9)(1997-1#1)(1997-2#3)(2005-11#3)(2006-10#4)(2006-8#2)(2007-10#1)(2007-2#1)(2007-3#3)(2008-7#1)(2008-8#1)(2009-6#3)(2010-11#3)(2010-12#2)(2010-2#17)(2010-7#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#1)
with disability##7##2##(1993-6#1)(1994-7#1)(1996-12#1)(1997-1#2)(2006-7#1)(2007-7#1)
with disabling##6##2##(1996-12#1)(1997-5#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-5#1)
with disappearance of the##2##4##(1990-3#1)(1995-9#1)
with disc##5##2##(2007-12#1)(2007-8#1)(2008-7#1)(2011-2#1)(2012-2#1)
with discitis due to common pathogens##2##6##(1993-11#2)
with discitis##4##2##(1993-11#4)
with disclosing their HIV status##2##5##(2004-9#1)(2010-4#1)
with discogenic low back pain##2##5##(2006-12#1)(2006-8#1)
with discogenic##3##2##(2006-12#1)(2006-8#1)(2007-8#1)
with discontinuation of##2##3##(1996-5#1)(2009-5#1)
with discontinuous##4##2##(1990-9#1)(2007-12#1)(2008-2#1)(2012-2#1)
with discordant##5##2##(2007-12#1)(2008-8#1)(2010-6#1)(2011-1#1)(2012-3#1)
with discrepancies in##2##3##(2008-10#1)(2012-2#1)
with discrete##12##2##(1992-9#1)(1994-2#1)(1995-11#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#1)
with discriminating##2##2##(2008-6#1)(2009-4#1)
with discrimination##2##2##(1996-12#1)(2011-2#1)
with discriminative thermal washes##2##4##(1990-7#2)
with discussion of how##2##4##(2007-11#1)(2008-4#1)
with discussion of##6##3##(2007-11#1)(2007-8#1)(2008-4#1)(2009-3#1)(2011-12#1)(2013-8#1)
with discussion##8##2##(1996-11#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-4#1)(2009-3#1)(2011-12#1)(2013-8#1)
with disease activity and##2##4##(2006-10#1)(2012-2#1)
with disease activity##4##3##(1992-3#1)(2006-10#1)(2009-6#1)(2012-2#1)
with disease and##3##3##(1996-12#1)(2008-10#1)(2010-2#1)
with disease duration##2##3##(1997-3#1)(2011-2#1)
with disease in##3##3##(2007-12#1)(2010-12#1)(2012-3#1)
with disease incidence##5##3##(2008-10#5)
with disease management##2##3##(1995-3#1)(2008-10#1)
with disease prevalence##2##3##(2008-10#1)(2008-8#1)
with disease progression and##2##4##(1990-12#1)(2013-1#1)
with disease progression##7##3##(1990-12#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-4#1)(2013-1#1)
with disease severity##8##3##(1990-3#1)(1995-10#1)(2007-11#1)(2008-10#3)(2009-2#1)(2013-1#1)
with disease status##3##3##(1991-8#1)(2012-2#1)(2012-3#1)
with disease suppressiveness##2##3##(2008-10#2)
with disease symptoms##2##3##(1991-9#1)(2008-10#1)
with disease##76##2##(1990-12#2)(1990-3#2)(1991-10#2)(1991-2#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-1#1)(1994-3#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-7#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-4#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#2)
with disease-modifying##2##2##(2006-10#1)(2013-7#1)
with diseased##6##2##(2007-5#1)(2008-10#5)
with diseases that require##2##4##(2005-7#1)(2008-3#1)
with diseases that##4##3##(1990-8#1)(2005-7#1)(2008-3#1)(2012-12#1)
with diseases##10##2##(1990-10#1)(1990-8#1)(2005-7#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-3#1)(2012-1#1)(2012-12#1)(2012-3#1)
with dislocation##3##2##(1993-8#1)(2007-8#1)(2011-1#1)
with disodium##5##2##(1997-6#1)(2007-8#1)(2008-10#2)(2008-2#1)
with disordered##5##2##(1997-2#1)(2006-7#3)(2008-1#1)
with disorders of##7##3##(1991-12#1)(1991-5#1)(1991-6#1)(1992-6#1)(1993-12#2)(2007-11#1)
with disorders##12##2##(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-6#1)(1993-12#2)(1993-2#1)(2007-11#1)(2012-12#1)(2012-2#1)
with dispersal##3##2##(2008-9#2)(2010-4#1)
with dispersion management and##2##4##(2007-12#1)(2008-1#1)
with dispersion management##3##3##(2007-12#2)(2008-1#1)
with dispersion##8##2##(2007-11#1)(2007-12#3)(2008-1#3)(2012-3#1)
with dispersion-managed##2##2##(2007-11#1)(2007-12#1)
with dispersive##2##2##(2007-11#1)(2008-1#1)
with displaced fractures##2##3##(2013-1#2)
with displaced##4##2##(2006-7#1)(2012-2#1)(2013-1#2)
with displacement##4##2##(1991-4#1)(1991-7#1)(2008-11#1)(2008-3#1)
with disruption##2##2##(2007-9#1)(2012-3#1)
with dissection##2##2##(1993-10#1)(2008-8#1)
with disseminated intravascular coagulation##3##4##(2006-8#1)(2007-11#1)(2010-3#1)
with disseminated##16##2##(1996-12#4)(1997-8#1)(2006-1#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-6#1)(2007-7#3)(2008-7#1)(2010-3#1)
with dissimilar##4##2##(1994-2#1)(2007-11#1)(2008-10#1)(2008-8#1)
with dissipation##3##2##(2005-11#2)(2011-1#1)
with dissociation constants##4##3##(1990-5#1)(1990-8#1)(1992-2#1)(1996-11#1)
with dissociation##6##2##(1990-5#1)(1990-8#1)(1992-2#1)(1995-5#1)(1996-11#1)(2009-3#1)
with dissolved##2##2##(2008-10#1)(2008-5#1)
with distal femoral##2##3##(2007-11#1)(2013-1#1)
with distal metaphyseal##2##3##(2013-1#2)
with distal##19##2##(1991-12#1)(1992-5#1)(1996-12#1)(1997-3#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
with distance from the##6##4##(1991-1#1)(1995-11#1)(2007-8#1)(2008-10#3)
with distance from##8##3##(1991-1#1)(1995-11#1)(2007-8#1)(2008-10#3)(2012-2#2)
with distance geometry##2##3##(1991-4#1)(1991-8#1)
with distance##16##2##(1991-1#1)(1991-4#1)(1991-5#1)(1991-8#1)(1995-11#1)(2006-10#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-9#1)(2012-2#2)
with distant metastases##7##3##(1991-10#1)(1991-8#1)(1993-1#2)(2006-1#1)(2008-6#2)
with distant metastasis##3##3##(1992-4#1)(1993-8#1)(2008-6#1)
with distant##12##2##(1991-10#1)(1991-8#1)(1992-4#1)(1993-1#2)(1993-8#1)(2006-1#1)(2008-6#5)
with distilled water and##2##4##(2008-10#1)(2008-12#1)
with distilled water##7##3##(1996-12#1)(2008-10#1)(2008-12#1)(2010-1#1)(2010-4#1)(2010-5#1)(2013-1#1)
with distilled##8##2##(1996-12#1)(2008-10#2)(2008-12#1)(2010-1#1)(2010-4#1)(2010-5#1)(2013-1#1)
with distinct characteristics##2##3##(2007-5#1)(2008-8#1)
with distinct cytokine##2##3##(2008-4#1)(2013-8#1)
with distinct spectral##2##3##(1995-10#1)(2008-4#1)
with distinct##44##2##(1990-12#1)(1991-1#1)(1991-7#1)(1994-3#2)(1994-6#1)(1995-10#1)(1995-11#1)(1995-12#1)(1996-10#1)(1996-4#1)(1996-8#1)(1997-6#1)(2006-10#4)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-4#3)(2008-6#2)(2008-8#2)(2009-4#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-11#4)(2012-12#1)(2013-8#1)
with distinctive##5##2##(1991-12#1)(2005-12#1)(2006-10#1)(2007-7#1)(2009-8#1)
with distinguished##2##2##(2010-11#1)(2010-8#1)
with distressing##2##2##(2006-12#1)(2009-9#1)
with distributed feedback##2##3##(2008-2#1)(2008-3#1)
with distributed##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
with distribution##2##2##(2007-8#1)(2008-10#1)
with distributions##3##2##(1997-3#1)(1997-7#1)(2013-1#1)
with disturbances in##2##3##(1991-2#1)(2011-12#1)
with disturbances of the catecholaminergic##2##5##(1997-2#2)
with disturbances##4##2##(1991-2#1)(1997-2#2)(2011-12#1)
with disturbed##5##2##(1992-8#1)(1994-5#1)(2006-7#1)(2008-12#1)(2012-3#1)
with disuccinimidyl suberate (DSS)##2##4##(1990-3#1)(1994-2#1)
with disulfide##2##2##(2007-7#1)(2008-4#1)
with dithionite##7##2##(1990-3#2)(1991-2#1)(1991-3#2)(1993-11#1)(1995-10#1)
with dithiothreitol (DTT)##3##3##(1990-11#1)(1990-12#1)(2012-2#1)
with dithiothreitol##8##2##(1990-11#1)(1990-12#2)(1994-2#1)(1995-5#1)(1996-9#1)(2008-5#1)(2012-2#1)
with dithizone and zinc dithizonate##2##5##(2008-10#2)
with dithizone and##3##3##(2008-10#3)
with dithizone##5##2##(2008-10#5)
with diuretics and##2##3##(1991-8#1)(2010-12#1)
with diuretics##10##2##(1991-2#1)(1991-8#1)(1992-4#1)(1996-9#2)(2007-9#1)(2009-9#1)(2010-12#1)(2010-6#1)(2013-7#1)
with diurnal##5##2##(2008-10#1)(2008-7#2)(2013-1#2)
with divalent##4##2##(1995-11#1)(2008-10#3)
with divergence timing information##2##4##(2008-1#2)
with divergence##3##2##(2008-1#2)(2009-2#1)
with divergent differentiation##3##3##(2012-12#3)
with divergent##5##2##(1992-3#1)(1995-2#1)(2012-12#3)
with diverse functions##2##3##(2007-12#1)(2008-10#1)
with diverse populations##4##3##(2005-10#1)(2008-6#1)(2010-8#1)(2012-2#1)
with diverse stakeholders##2##3##(2009-4#1)(2012-12#1)
with diverse structural##2##3##(1995-8#1)(2012-2#1)
with diverse##31##2##(1990-12#1)(1991-2#1)(1991-5#1)(1995-3#1)(1995-8#1)(2005-10#1)(2005-8#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
with diversity##2##2##(2008-7#1)(2011-2#1)
with division of labor##2##4##(2008-8#2)
with division##3##2##(2008-8#2)(2012-12#1)
with dizocilpine maleate##2##3##(1996-12#1)(1997-5#1)
with dizocilpine##3##2##(1995-7#1)(1996-12#1)(1997-5#1)
with dizziness and##3##3##(2010-12#1)(2011-1#1)(2013-1#1)
with dizziness##4##2##(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
with dobutamine##3##2##(1994-11#2)(1996-2#1)
with docetaxel##6##2##(2005-7#1)(2008-6#2)(2011-1#1)(2013-1#1)(2013-7#1)
with docking##2##2##(1996-11#1)(2008-8#1)
with doctorate##2##2##(1994-12#1)(2013-8#1)
with doctors##6##2##(1992-10#1)(2005-7#1)(2008-11#2)(2008-7#1)(2012-2#1)
with documented##20##2##(1990-3#1)(1991-3#1)(1993-2#1)(1993-8#1)(1995-6#1)(1996-12#1)(2004-10#1)(2005-8#1)(2006-10#3)(2006-8#1)(2008-11#1)(2008-9#1)(2009-7#2)(2010-2#1)(2010-3#1)(2012-11#1)(2012-2#1)
with dodecyl##2##2##(1992-9#1)(2008-10#1)
with dog##2##2##(1992-8#1)(2012-3#1)
with domestic##3##2##(2007-2#1)(2008-7#1)(2009-4#1)
with dominant expression of##3##4##(1992-11#1)(1992-2#2)
with dominant##14##2##(1990-3#1)(1991-5#1)(1992-11#1)(1992-2#2)(1995-11#1)(1995-6#1)(1995-9#1)(2007-12#1)(2007-7#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
with domperidone##2##2##(2008-7#2)
with donepezil##2##2##(2008-7#1)(2011-12#1)
with donor##5##2##(1994-9#1)(2007-9#1)(2009-6#1)(2011-2#2)
with donors##2##2##(2008-10#1)(2012-12#1)
with dopamine agonist##2##3##(1994-2#1)(2008-7#1)
with dopamine##11##2##(1990-1#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-11#1)(1996-12#1)(2008-7#1)(2009-10#1)
with dopaminergic##5##2##(1993-2#1)(1997-2#1)(2008-7#2)(2012-1#1)
with doramectin##2##2##(1996-11#1)(2007-6#1)
with dorsal##3##2##(2006-10#1)(2008-9#1)(2010-11#1)
with dose##11##2##(1993-10#1)(1993-8#1)(1996-6#1)(2006-6#1)(2008-3#1)(2008-7#4)(2012-12#1)(2013-1#1)
with doses between##2##3##(1991-7#1)(2011-2#1)
with doses of##4##3##(1990-2#1)(1992-1#1)(1997-3#1)(2008-10#1)
with doses##7##2##(1990-2#1)(1991-7#1)(1992-1#1)(1997-3#1)(2006-6#1)(2008-10#1)(2011-2#1)
with double stranded DNA##3##4##(1990-12#1)(2007-11#1)(2008-5#1)
with double stranded##5##3##(1990-12#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-5#1)
with double##31##2##(1990-12#1)(1991-4#1)(1991-5#1)(1994-10#1)(2005-12#1)(2005-4#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
with double-focusing##2##2##(2008-10#2)
with double-stranded DNA in large excess##2##6##(2008-10#2)
with double-stranded DNA##3##3##(1990-2#1)(2008-10#2)
with double-stranded##7##2##(1990-2#1)(1995-6#1)(1997-2#1)(2008-10#3)(2010-4#1)
with doubly##2##2##(2008-10#1)(2008-3#1)
with doxorubicin (12 mg/kg##2##4##(2011-2#2)
with doxorubicin and cisplatin##2##4##(1995-12#1)(2008-6#1)
with doxorubicin and##4##3##(1995-12#1)(2006-6#1)(2008-6#1)(2013-8#1)
with doxorubicin##17##2##(1995-12#1)(2005-11#1)(2005-7#1)(2006-6#3)(2008-11#1)(2008-6#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-11#1)(2013-8#1)
with doxycycline##5##2##(1997-4#1)(1997-7#1)(2007-12#1)(2007-2#1)(2008-2#1)
with drainage##3##2##(2008-4#2)(2012-2#1)
with dramatic##4##2##(1995-1#1)(1997-5#1)(2005-8#1)(2007-9#1)
with dried##2##2##(2008-10#1)(2010-1#1)
with drinking water##4##3##(1994-5#1)(2005-11#1)(2006-12#1)(2008-10#1)
with drip##2##2##(2008-10#1)(2010-4#1)
with drought##2##2##(2012-7#2)
with drug abuse##3##3##(2006-7#2)(2008-3#1)
with drug addiction##4##3##(2009-7#3)(2011-1#1)
with drug resistance##2##3##(1995-7#1)(2008-5#1)
with drug treatment##5##3##(1993-6#1)(1994-6#1)(2007-7#1)(2008-4#1)(2013-8#1)
with drug##36##2##(1990-2#1)(1990-7#1)(1990-8#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-6#1)(1995-7#1)(2005-10#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-7#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-7#3)(2010-11#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-11#1)(2013-8#1)
with drug-eluting stents##5##3##(2007-5#1)(2008-12#1)(2008-8#1)(2009-12#2)
with drug-eluting##7##2##(2007-5#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-12#3)
with drug-induced##3##2##(2004-11#1)(2007-11#1)(2008-8#1)
with drug-resistant##2##2##(1993-10#1)(1995-8#1)
with drugs and##5##3##(1993-10#1)(1994-9#1)(2008-4#1)(2011-1#1)(2013-1#1)
with drugs other than##2##4##(1991-3#1)(2011-12#1)
with drugs that##4##3##(1996-10#1)(2007-10#1)(2010-12#1)(2012-12#1)
with drugs##35##2##(1990-10#1)(1990-2#2)(1991-3#1)(1991-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-12#1)(1996-10#1)(1997-8#1)(2007-10#1)(2007-11#2)(2008-10#2)(2008-3#2)(2008-4#1)(2008-7#1)(2010-10#1)(2010-12#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
with dry skin##4##3##(2008-5#4)
with dry##7##2##(2008-10#1)(2008-5#4)(2008-8#1)(2010-2#1)
with ds-DNA##2##2##(2006-10#1)(2008-2#1)
with dsDNA and##2##3##(2008-10#2)
with dsDNA##3##2##(2008-10#3)
with dsRNA##2##2##(1991-8#1)(2008-2#1)
with dual energy X-ray absorptiometry (DXA)##2##6##(2006-8#1)(2010-12#1)
with dual##16##2##(1993-9#1)(1994-9#1)(1995-3#1)(1996-7#1)(1997-3#1)(2005-11#1)(2006-8#1)(2008-10#1)(2008-2#2)(2009-8#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#2)
with dual-energy x-ray absorptiometry##2##4##(2008-12#1)(2008-3#1)
with dual-energy##3##2##(2008-12#1)(2008-3#1)(2008-7#1)
with dual-frequency##2##2##(2007-11#2)
with dual-grating##2##2##(2007-12#1)(2008-2#1)
with due regard##2##3##(1992-12#1)(2007-8#1)
with due##4##2##(1990-12#1)(1992-12#1)(2007-7#1)(2007-8#1)
with dummy##2##2##(2006-11#1)(2008-10#1)
with duodenal ulcer in Iceland##2##5##(2006-8#2)
with duodenal ulcer is##2##4##(1992-11#1)(2008-12#1)
with duodenal ulcer##9##3##(1992-10#1)(1992-11#1)(2006-10#2)(2006-2#1)(2006-8#3)(2008-12#1)
with duodenal##18##2##(1992-10#1)(1992-11#1)(1993-3#1)(1995-3#1)(1997-1#1)(2006-10#2)(2006-2#2)(2006-8#4)(2008-12#2)(2008-3#1)(2012-3#1)(2013-8#1)
with duplex DNA##2##3##(1992-11#1)(1994-9#1)
with duplex##6##2##(1992-11#1)(1994-9#1)(2005-10#1)(2007-7#1)(2008-7#1)(2011-5#1)
with duplications##2##2##(1995-11#1)(1997-3#1)
with durable resistance to##2##4##(2008-10#2)
with durable resistance##3##3##(2008-10#3)
with dural arteriovenous##3##3##(1996-9#3)
with dural##4##2##(1996-9#4)
with duration of diabetes##3##4##(1994-6#1)(2006-6#1)(2010-4#1)
with duration of disease##2##4##(2007-7#1)(2008-7#1)
with duration of ethanol exposure##2##5##(2011-2#2)
with duration of life##2##4##(2007-8#2)
with duration of##18##3##(1991-9#1)(1994-6#1)(2006-6#1)(2006-8#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-7#1)(2008-9#1)(2010-12#2)(2010-4#2)(2010-8#1)(2011-2#3)
with duration##21##2##(1991-9#1)(1994-6#1)(1995-3#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#2)(2010-4#2)(2010-8#1)(2011-2#3)
with durations##6##2##(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
with dye##3##2##(2005-12#1)(2006-12#1)(2008-4#1)
with dynamic surface tension detection##2##5##(2008-10#2)
with dynamic##14##2##(1991-11#1)(1992-12#1)(1994-8#1)(1997-6#1)(2005-11#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-7#1)(2010-10#1)(2010-8#1)(2012-2#1)
with dynamically##3##2##(1996-4#1)(2007-12#1)(2008-3#1)
with dynamics##2##2##(1996-4#1)(2011-2#1)
with dysarthria##2##2##(2007-10#1)(2007-8#1)
with dysglycemia##2##2##(2008-7#2)
with dyslexia may##2##3##(2008-12#2)
with dyslexia##11##2##(2007-9#1)(2008-12#6)(2008-4#3)(2008-9#1)
with dyslipidaemia##2##2##(2008-8#1)(2010-12#1)
with dyslipidemia being##2##3##(2011-1#1)(2013-7#1)
with dyslipidemia##6##2##(1990-5#1)(2010-12#1)(2011-1#2)(2013-7#1)(2013-8#1)
with dyspepsia##6##2##(1993-10#1)(1993-8#2)(1995-10#1)(2006-10#1)(2008-8#1)
with dyspeptic symptoms##2##3##(2006-10#1)(2008-12#1)
with dysphagia and##4##3##(1997-8#1)(2008-1#1)(2012-3#1)(2013-1#1)
with dysphagia##17##2##(1994-8#1)(1995-9#1)(1997-8#1)(2007-10#2)(2007-3#1)(2007-7#1)(2008-1#2)(2010-2#1)(2010-7#1)(2012-3#3)(2013-1#1)(2013-8#2)
with dysplasia##6##2##(1993-2#1)(2007-11#1)(2011-2#1)(2013-1#3)
with dysplastic hips##2##3##(2007-7#1)(2007-8#1)
with dysplastic##4##2##(2007-7#2)(2007-8#1)(2010-7#1)
with dyspnea and##3##3##(2006-8#1)(2009-1#1)(2009-6#1)
with dyspnea##10##2##(1997-4#1)(2006-8#1)(2007-8#1)(2008-3#1)(2009-1#1)(2009-10#3)(2009-6#1)(2011-1#1)
with dyspnoea##5##2##(2008-1#1)(2009-4#1)(2011-2#3)
with dystocia##2##2##(2006-10#1)(2006-5#1)
with dystonia##3##2##(1994-4#1)(1996-3#2)
with ePTFE##3##2##(2007-7#1)(2007-8#1)(2011-3#1)
with each acute administration##2##4##(1996-10#2)
with each antibiotic##2##3##(1996-6#2)
with each cell division##2##4##(1990-5#1)(2006-10#1)
with each chemical##2##3##(1997-2#1)(2008-8#1)
with each condition##2##3##(2007-2#1)(2007-6#1)
with each method##2##3##(1996-12#1)(2007-12#1)
with each of four##3##4##(2008-4#2)(2013-7#1)
with each of the##14##4##(1990-12#1)(1991-2#1)(1992-3#1)(1992-4#1)(1993-4#1)(1995-2#1)(1995-3#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-6#1)(2010-2#1)
with each of these##5##4##(2005-7#1)(2008-10#1)(2012-12#2)(2012-2#1)
with each of##29##3##(1990-12#1)(1991-2#1)(1992-3#1)(1992-4#2)(1993-4#1)(1995-2#1)(1995-3#1)(1997-4#1)(2005-7#1)(2007-11#1)(2007-6#1)(2008-10#5)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-4#1)(2010-2#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#1)
with each other and with the##7##6##(1992-4#1)(1996-3#1)(1997-4#1)(2008-10#2)(2010-6#1)(2010-7#1)
with each other and with##13##5##(1992-4#1)(1994-1#1)(1994-5#1)(1996-3#1)(1997-4#1)(2007-5#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-6#1)(2010-7#1)
with each other and##22##4##(1992-1#1)(1992-4#1)(1994-1#1)(1994-5#1)(1996-2#1)(1996-3#1)(1997-4#1)(1997-6#1)(2007-5#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-2#1)
with each other as well as with##2##7##(1993-8#1)(2006-10#1)
with each other as well as##3##6##(1993-8#1)(2006-10#1)(2008-10#1)
with each other as##5##4##(1993-8#1)(1997-6#1)(2006-10#1)(2008-10#1)(2011-2#1)
with each other at##2##4##(1994-9#1)(2010-7#1)
with each other by##5##4##(2007-10#1)(2007-11#1)(2010-2#1)(2010-7#1)(2010-8#1)
with each other for##4##4##(1995-6#1)(1997-7#1)(2005-12#1)(2008-4#1)
with each other in a##4##5##(1995-2#1)(2010-2#1)(2012-12#1)(2013-1#1)
with each other in the##7##5##(1992-4#1)(1992-8#1)(1996-2#1)(1996-5#1)(2006-11#1)(2008-2#1)(2008-7#1)
with each other in##14##4##(1992-2#1)(1992-4#1)(1992-8#1)(1995-2#1)(1996-2#1)(1996-5#1)(2006-10#1)(2006-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-12#1)(2013-1#1)
with each other is##2##4##(2007-4#1)(2013-1#1)
with each other on##2##4##(1997-1#1)(2008-7#1)
with each other or##3##4##(1994-6#1)(2008-11#1)(2009-3#1)
with each other to form a##2##6##(1995-2#1)(2008-8#1)
with each other to form##3##5##(1995-2#1)(2008-4#1)(2008-8#1)
with each other to##7##4##(1991-1#1)(1995-2#1)(2006-10#1)(2008-4#1)(2008-8#1)(2011-1#1)(2012-3#1)
with each other##148##3##(1990-10#1)(1991-1#1)(1991-10#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-4#2)(1992-6#1)(1992-8#2)(1993-8#1)(1994-1#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-2#2)(1995-3#3)(1995-6#1)(1995-8#1)(1996-2#2)(1996-3#1)(1996-5#4)(1996-7#1)(1997-1#1)(1997-4#3)(1997-6#5)(1997-7#1)(1997-8#1)(2004-10#1)(2004-11#1)(2005-12#1)(2006-10#8)(2006-11#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-5#3)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#2)(2008-5#5)(2008-7#5)(2008-8#3)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
with each pathogen##2##3##(2008-10#1)(2008-3#1)
with each pixel##2##3##(2008-3#1)(2011-1#1)
with each probe##2##3##(2008-10#1)(2008-8#1)
with each sample##3##3##(2008-10#2)(2008-7#1)
with each syndrome##2##3##(1996-11#1)(2009-12#1)
with each training##2##3##(1995-10#1)(2010-9#1)
with each treatment##3##3##(1993-3#1)(1997-5#1)(2006-1#1)
with each type of##2##4##(1990-5#1)(2011-2#1)
with each type##3##3##(1990-5#1)(1991-5#1)(2011-2#1)
with each##291##2##(1990-10#1)(1990-12#1)(1990-5#2)(1990-6#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#5)(1992-6#1)(1992-8#2)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#4)(1995-3#5)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#3)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#4)(1996-6#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#4)(1997-5#2)(1997-6#5)(1997-7#2)(1997-8#1)(2004-10#1)(2004-11#2)(2004-4#1)(2005-11#1)(2005-12#1)(2005-7#2)(2006-1#1)(2006-10#9)(2006-11#3)(2006-12#1)(2006-2#2)(2006-4#1)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#3)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#36)(2008-11#4)(2008-12#1)(2008-2#11)(2008-3#7)(2008-4#5)(2008-5#8)(2008-6#1)(2008-7#6)(2008-8#8)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-6#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#7)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#3)(2013-8#2)
with ear##2##2##(2007-7#1)(2008-7#1)
with earlier findings##3##3##(1990-11#1)(1995-6#1)(2008-7#1)
with earlier observations##2##3##(1991-4#1)(1993-4#1)
with earlier predictions##3##3##(2007-12#1)(2007-3#1)(2009-5#1)
with earlier reports##3##3##(1991-7#1)(1993-6#1)(1996-6#1)
with earlier work##2##3##(2008-10#2)
with earlier##36##2##(1990-10#2)(1990-11#1)(1990-8#1)(1991-4#1)(1991-7#1)(1992-10#1)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#1)(1994-9#1)(1995-10#1)(1995-6#1)(1996-2#1)(1996-6#1)(2007-12#2)(2007-3#1)(2007-9#1)(2008-10#5)(2008-3#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-12#1)(2013-1#1)(2013-8#1)
with early &quot##2##3##(1992-6#1)(2008-1#1)
with early age##2##3##(1991-9#1)(2013-7#1)
with early and##3##3##(2008-3#1)(2009-9#1)(2011-1#1)
with early breast cancer##9##4##(1991-8#2)(1994-12#1)(1996-3#2)(2004-2#1)(2011-2#3)
with early cervical cancer##2##4##(2010-11#1)(2012-3#1)
with early devices##2##3##(2007-8#2)
with early disease##2##3##(2010-12#1)(2011-2#1)
with early failure##2##3##(2007-8#1)(2009-10#1)
with early gastric cancer]##2##4##(1990-9#1)(2005-10#1)
with early gastric##4##3##(1990-9#1)(2005-10#1)(2008-5#1)(2012-2#1)
with early manifestations of##3##4##(1990-9#2)(2006-10#1)
with early onset AD##2##4##(1995-12#1)(1996-1#1)
with early onset conduct problems##3##5##(2006-3#3)
with early onset##10##3##(1994-11#1)(1995-12#1)(1996-1#1)(1996-6#1)(2006-3#3)(2006-8#1)(2008-8#1)(2012-12#1)
with early postoperative##2##3##(2010-12#1)(2011-2#1)
with early psychosis##5##3##(2008-1#1)(2011-1#3)(2011-2#1)
with early sexual##4##3##(2012-1#1)(2013-8#3)
with early stage##5##3##(2008-10#1)(2008-5#1)(2009-5#1)(2011-1#1)(2013-1#1)
with early##114##2##(1990-9#3)(1991-12#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-6#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-3#2)(1996-4#3)(1996-6#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-2#1)(2005-10#1)(2005-9#1)(2006-10#5)(2006-3#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-8#5)(2008-1#4)(2008-10#7)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#2)(2009-10#1)(2009-4#2)(2009-5#2)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-8#1)(2011-1#6)(2011-2#11)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#2)(2013-7#2)(2013-8#3)
with early-onset##4##2##(2008-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
with early-stage disease##8##3##(2013-8#8)
with early-stage##11##2##(2007-11#1)(2008-11#1)(2009-8#1)(2013-8#8)
with ease of##2##3##(2007-12#1)(2012-12#1)
with ease##4##2##(2007-12#1)(2008-2#1)(2008-6#1)(2012-12#1)
with easily##2##2##(2008-10#2)
with easy##4##2##(1990-11#1)(1992-12#1)(2010-5#1)(2012-12#1)
with eating concerns##2##3##(2007-12#2)
with eating disorder##4##3##(2006-7#1)(2007-12#2)(2013-1#1)
with eating disorders completed##2##4##(2007-12#1)(2008-11#1)
with eating disorders##22##3##(1997-3#1)(1997-7#1)(2005-6#2)(2006-6#1)(2006-7#7)(2007-12#1)(2007-7#1)(2008-11#3)(2008-4#1)(2011-2#4)
with eating##32##2##(1997-3#1)(1997-7#1)(2005-6#2)(2006-6#1)(2006-7#9)(2007-12#5)(2007-7#1)(2008-11#4)(2008-4#1)(2010-7#1)(2011-2#4)(2012-1#1)(2013-1#1)
with echocardiography##6##2##(2006-8#1)(2007-8#1)(2008-10#1)(2009-1#1)(2010-7#1)(2013-1#1)
with eclampsia##3##2##(2004-10#1)(2007-10#1)(2007-7#1)
with ecological relevance##2##3##(2008-10#1)(2012-12#1)
with ecological##4##2##(2007-3#1)(2008-10#1)(2008-9#1)(2012-12#1)
with economic##2##2##(2005-9#1)(2009-2#1)
with ectopic ACTH##3##3##(1990-3#1)(2011-2#2)
with ectopic##11##2##(1990-3#1)(1991-2#1)(2007-7#1)(2009-12#1)(2010-12#2)(2011-2#2)(2013-1#2)(2013-8#1)
with eczema##5##2##(2006-10#1)(2007-7#1)(2008-3#1)(2010-6#1)(2013-1#1)
with edema and##3##3##(1993-8#1)(2007-2#1)(2013-8#1)
with edema##7##2##(1993-8#1)(2005-11#1)(2006-10#1)(2007-12#2)(2007-2#1)(2013-8#1)
with education and##2##3##(1990-12#1)(1993-1#1)
with education##9##2##(1990-12#1)(1991-7#1)(1993-1#1)(1994-4#1)(1995-1#1)(1996-5#1)(2008-9#1)(2011-12#1)(2011-2#1)
with educational##7##2##(1990-12#1)(1990-9#1)(2006-10#1)(2007-6#1)(2008-11#1)(2009-7#1)(2012-3#1)
with efavirenz##3##2##(2008-5#2)(2009-12#1)
with effect of strengthening Qi##4##5##(2012-3#4)
with effect##7##2##(2008-7#1)(2008-9#1)(2012-3#4)(2013-1#1)
with effective##14##2##(1990-4#1)(1992-1#1)(1993-11#1)(1997-1#1)(2005-10#1)(2006-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-4#1)(2012-1#1)
with effects being##2##3##(1995-3#1)(2010-8#1)
with effects of##2##3##(1991-8#1)(2008-2#1)
with effects that##2##3##(2008-10#1)(2010-10#1)
with effects##12##2##(1991-2#1)(1991-8#1)(1995-3#2)(2006-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-10#1)(2010-8#1)(2013-1#1)
with efficacy##4##2##(2005-7#1)(2006-10#1)(2007-11#1)(2011-12#1)
with efficiency##4##2##(1993-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
with efficient##7##2##(1994-6#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-2#2)(2012-12#1)
with effort##3##2##(2008-10#1)(2008-6#1)(2008-8#1)
with efforts##2##2##(1995-11#1)(2006-10#1)
with effusion##9##2##(1996-12#3)(2006-10#1)(2007-2#2)(2008-9#1)(2011-2#1)(2013-8#1)
with egg##4##2##(1990-3#1)(1996-10#1)(2008-12#1)(2010-8#1)
with eight runs##2##3##(2008-10#2)
with eight##40##2##(1991-8#1)(1992-12#1)(1994-11#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-12#2)(2006-5#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-2#1)(2010-3#1)(2010-8#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
with either 0##6##3##(1990-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1996-10#1)(2006-8#1)
with either 2##3##3##(1990-11#1)(1990-2#1)(2006-8#1)
with either ACh or (1S##2##5##(1996-5#2)
with either HIV##2##3##(1996-1#1)(2007-2#1)
with either S##2##3##(1995-5#1)(2008-10#1)
with either a commercial##2##4##(2004-9#1)(2007-9#1)
with either a fixed##2##4##(2008-10#1)(2008-8#1)
with either a##33##3##(1992-3#1)(1993-5#1)(1996-2#1)(1996-5#2)(2004-9#1)(2005-8#1)(2006-1#1)(2006-3#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-9#1)
with either agent alone##2##4##(1994-8#1)(1995-6#1)
with either an##2##3##(1991-10#1)(2008-3#1)
with either estradiol##2##3##(1992-5#1)(1993-6#1)
with either frozen-thawed or fresh semen##2##6##(2006-5#2)
with either hypo- or##2##4##(2006-10#1)(2013-1#1)
with either laminectomy##2##3##(1996-9#2)
with either low##2##3##(1995-10#1)(2012-2#1)
with either neuraminidase##2##3##(1990-5#2)
with either no or##2##4##(2008-3#1)(2010-1#1)
with either of the##3##4##(1990-6#1)(2008-10#1)(2008-5#1)
with either of two##2##4##(1997-7#1)(2008-10#1)
with either of##6##3##(1990-6#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-5#1)
with either oxidized##2##3##(1993-11#1)(2008-3#1)
with either pathogen##2##3##(2008-10#2)
with either protein##2##3##(1991-2#1)(2005-8#1)
with either recombinant##2##3##(1995-6#1)(2013-8#1)
with either short##2##3##(2006-3#1)(2009-5#1)
with either tert-butyl##2##3##(1995-11#1)(2006-12#1)
with either the##23##3##(1991-5#1)(1991-7#1)(1994-5#1)(1995-11#2)(1995-5#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-5#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-6#1)
with either trypsin or##2##4##(1991-1#1)(1995-6#1)
with either type of##2##4##(2012-1#1)(2012-12#1)
with either wild-type or##2##4##(1997-1#1)(2006-12#1)
with either##394##2##(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#3)(1990-5#2)(1990-6#3)(1990-7#2)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#3)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#5)(1992-11#2)(1992-12#4)(1992-3#1)(1992-4#3)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#4)(1993-11#4)(1993-12#1)(1993-3#2)(1993-4#2)(1993-5#2)(1993-6#4)(1993-8#2)(1993-9#1)(1994-11#4)(1994-12#4)(1994-2#3)(1994-3#6)(1994-5#2)(1994-6#3)(1994-8#1)(1994-9#4)(1995-10#5)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#5)(1995-6#5)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#1)(1996-12#4)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#10)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#4)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#2)(2004-3#1)(2004-9#3)(2005-11#2)(2005-7#1)(2005-8#5)(2005-9#1)(2006-1#2)(2006-10#2)(2006-11#2)(2006-12#4)(2006-3#2)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#9)(2007-10#1)(2007-11#10)(2007-12#4)(2007-2#3)(2007-7#2)(2007-8#2)(2007-9#3)(2008-1#2)(2008-10#48)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#14)(2008-4#10)(2008-5#7)(2008-6#5)(2008-7#9)(2008-8#2)(2008-9#4)(2009-10#3)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#3)(2011-2#7)(2012-1#2)(2012-12#5)(2012-2#3)(2013-1#5)(2013-8#5)
with elastic##6##2##(2008-3#2)(2008-5#1)(2008-9#1)(2010-4#1)(2012-2#1)
with elastin##2##2##(1990-8#1)(2006-5#1)
with elbow##4##2##(2007-11#1)(2008-1#1)(2008-8#1)(2012-1#1)
with elderly##4##2##(1991-12#1)(1995-5#1)(2006-10#1)(2011-2#1)
with electric eel AChE##2##4##(2008-10#1)(2009-8#1)
with electric##5##2##(1996-8#1)(2005-11#1)(2008-10#2)(2009-8#1)
with electrical current##2##3##(2006-7#1)(2008-11#1)
with electrical stimulation of the##2##5##(1993-5#2)
with electrical stimulation##3##3##(1993-5#2)(2012-1#1)
with electrical##13##2##(1993-5#2)(1994-5#3)(2006-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-4#1)(2011-2#1)(2012-1#1)
with electrically##3##2##(2007-10#1)(2008-10#1)(2008-7#1)
with electrocardiographic##2##2##(2008-7#1)(2009-7#1)
with electrochemical detection for##2##4##(1991-5#1)(2008-10#1)
with electrochemical detection of##2##4##(2008-10#2)
with electrochemical detection##34##3##(1990-11#1)(1990-2#1)(1990-6#2)(1990-9#1)(1991-10#1)(1991-2#1)(1991-5#4)(1993-4#1)(1995-11#1)(1996-12#1)(1996-8#2)(1996-9#1)(1997-3#1)(1997-5#1)(2006-11#1)(2008-10#14)
with electrochemical##45##2##(1990-11#1)(1990-2#1)(1990-6#2)(1990-9#1)(1991-10#1)(1991-2#1)(1991-5#4)(1993-4#1)(1995-11#1)(1996-12#1)(1996-8#3)(1996-9#1)(1997-3#1)(1997-5#1)(2006-11#1)(2006-6#1)(2007-8#2)(2008-10#19)(2008-3#1)(2010-11#1)
with electrochemiluminescence##3##2##(2007-8#2)(2008-10#1)
with electrode I and##2##4##(2008-10#2)
with electrode##8##2##(2007-10#1)(2007-8#1)(2008-10#5)(2010-2#1)
with electrodes##3##2##(1992-1#1)(2008-9#1)(2009-3#1)
with electrogenerated##2##2##(2008-10#2)
with electromagnetic##4##2##(2007-12#1)(2008-8#1)(2013-1#2)
with electron beams##4##3##(2007-10#2)(2008-1#1)(2012-1#1)
with electron capture detection##5##4##(2008-10#5)
with electron capture detector##2##4##(2008-10#1)(2012-12#1)
with electron capture##8##3##(2008-10#6)(2012-12#2)
with electron ionization##2##3##(2008-10#1)(2013-7#1)
with electron microscopy##2##3##(1990-11#1)(2005-11#1)
with electron##31##2##(1990-11#1)(1993-9#1)(1994-5#1)(1995-5#1)(1995-9#1)(1996-1#1)(2005-11#1)(2005-8#1)(2007-10#3)(2007-5#2)(2008-1#1)(2008-10#10)(2008-5#1)(2009-9#1)(2010-7#1)(2012-1#1)(2012-12#2)(2013-7#1)
with electron-capture detection##3##3##(1990-6#1)(1996-7#1)(1997-8#1)
with electronic speckle pattern interferometry##4##5##(2008-2#2)(2008-3#2)
with electronic##12##2##(1990-11#1)(2004-12#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#5)
with electronically##4##2##(2007-12#1)(2008-1#1)(2009-12#2)
with electrons##4##2##(1994-3#1)(2007-10#1)(2007-12#1)(2008-7#1)
with electrophysiological recordings##2##3##(2007-12#1)(2008-4#1)
with electrophysiological##3##2##(2007-12#1)(2008-12#1)(2008-4#1)
with electropolymerized##2##2##(2008-10#2)
with electrospray MS detection##2##4##(2008-10#2)
with electrospray ionization mass spectrometry##2##5##(2008-10#2)
with electrospray ionization##5##3##(2007-8#1)(2008-10#2)(2010-9#1)(2011-3#1)
with electrospray mass spectrometry##2##4##(1994-12#1)(2008-10#1)
with electrospray tandem mass##2##4##(2007-8#2)
with electrospray##11##2##(1994-12#1)(2007-8#3)(2008-10#5)(2010-9#1)(2011-3#1)
with electrosurgery##2##2##(1996-1#2)
with electrothermal atomic absorption spectrometry (ETAAS)##2##6##(2008-10#2)
with electrothermal atomic absorption spectrometry##4##5##(2007-10#1)(2008-10#3)
with electrothermal##5##2##(2007-10#1)(2008-10#4)
with elemental##3##2##(2007-11#2)(2007-12#1)
with elements from the##2##4##(2008-3#1)(2011-2#1)
with elements of active movement##3##5##(2007-7#3)
with elements of the##3##4##(1991-6#1)(2008-3#2)
with elements of##6##3##(1991-6#1)(2007-7#3)(2008-3#2)
with elements##9##2##(1991-6#1)(2005-4#1)(2007-7#3)(2008-3#3)(2011-2#1)
with elevated blood pressure##2##4##(2007-9#1)(2008-7#1)
with elevated blood##4##3##(1993-6#2)(2007-9#1)(2008-7#1)
with elevated concentrations of##6##4##(1991-6#1)(1992-3#1)(2008-10#2)(2011-1#1)(2013-1#1)
with elevated concentrations##7##3##(1991-6#1)(1992-3#1)(2006-12#1)(2008-10#2)(2011-1#1)(2013-1#1)
with elevated levels of creatinine##2##5##(2013-1#2)
with elevated levels of##14##4##(1990-12#1)(1990-2#1)(1990-9#1)(1991-9#1)(1994-2#1)(2006-10#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#2)
with elevated maternal##2##3##(2009-4#1)(2009-5#1)
with elevated risk##2##3##(1991-1#1)(1994-11#1)
with elevated serum level of##2##5##(1996-6#1)(2009-4#1)
with elevated serum levels of##2##5##(2006-10#1)(2013-1#1)
with elevated serum##12##3##(1991-8#1)(1996-6#1)(2006-10#1)(2006-9#1)(2007-12#1)(2008-3#1)(2009-4#1)(2010-12#1)(2012-5#1)(2013-1#3)
with elevated##99##2##(1990-12#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-6#2)(1994-11#1)(1994-2#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-5#1)(2004-4#1)(2005-12#1)(2006-10#3)(2006-12#3)(2006-6#4)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#7)(2008-8#1)(2009-11#1)(2009-4#2)(2009-5#1)(2009-8#2)(2010-12#4)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-5#1)(2012-7#2)(2013-1#6)
with elevation in##3##3##(1995-6#1)(2009-2#1)(2010-8#1)
with elevation of the ST##2##5##(2008-10#2)
with elevation of the##3##4##(2008-10#3)
with elevation of##7##3##(1990-5#1)(1995-3#1)(2008-10#3)(2010-1#2)
with elevation##14##2##(1990-5#1)(1995-2#1)(1995-3#1)(1995-6#1)(2008-10#3)(2008-5#2)(2009-2#2)(2010-1#2)(2010-8#1)
with eleven##4##2##(1991-8#1)(2008-6#1)(2010-10#1)(2012-3#1)
with elimination of##4##3##(1990-5#1)(2006-10#1)(2008-3#1)(2010-5#1)
with elimination##6##2##(1990-5#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-5#1)
with elliptical##2##2##(2007-11#1)(2008-3#1)
with elongated##2##2##(2007-9#1)(2013-1#1)
with elongation##2##2##(1992-8#1)(2008-10#1)
with embedded##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2009-8#1)
with embolectomy of the superior mesenteric##2##6##(1992-8#2)
with embolization##3##2##(1993-6#1)(2006-12#1)(2009-9#1)
with embryonal##2##2##(2006-7#1)(2013-1#1)
with embryonic##3##2##(1995-12#1)(1996-4#1)(2010-12#1)
with embryos##2##2##(2006-5#1)(2010-8#1)
with emergence of##2##3##(2007-2#1)(2011-1#1)
with emergence##3##2##(2007-2#1)(2011-1#1)(2011-2#1)
with emergency##6##2##(1993-12#1)(1994-12#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)
with emerging##3##2##(1994-12#1)(1996-3#1)(2009-10#1)
with emission##3##2##(2007-12#1)(2008-3#1)(2009-12#1)
with emodin##2##2##(1993-6#2)
with emotion##3##2##(2009-12#1)(2012-12#1)(2013-8#1)
with emotional and##2##3##(2012-3#1)(2013-7#1)
with emotional distress##2##3##(2008-6#1)(2013-1#1)
with emotional##9##2##(1997-5#1)(2006-12#1)(2008-11#1)(2008-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
with emotionally challenging##2##3##(2008-11#1)(2008-7#1)
with emotionally##5##2##(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-7#1)
with empenthrin##2##2##(1996-4#2)
with emphasis in##2##3##(2007-3#1)(2008-5#1)
with emphasis on depression##3##4##(1995-1#1)(1995-2#1)(1995-3#1)
with emphasis on recent##2##4##(2008-3#1)(2011-2#1)
with emphasis on studies##2##4##(2007-12#1)(2008-11#1)
with emphasis on the role of##3##6##(2007-9#1)(2008-10#1)(2008-11#1)
with emphasis on the##30##4##(1990-8#1)(1990-9#1)(1991-3#1)(1991-8#1)(1993-2#1)(1993-6#1)(1995-5#1)(1995-8#1)(1996-8#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-4#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-4#1)(2011-1#1)(2013-1#1)
with emphasis on their##3##4##(2005-10#1)(2005-11#1)(2008-2#1)
with emphasis on those##2##4##(2006-10#1)(2007-6#1)
with emphasis on##99##3##(1990-10#1)(1990-12#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-8#1)(1992-2#1)(1992-4#1)(1993-2#1)(1993-6#2)(1994-12#1)(1994-8#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-8#1)(1997-2#1)(2004-11#2)(2005-1#1)(2005-10#1)(2005-11#2)(2006-10#3)(2006-11#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-4#1)(2007-6#2)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#4)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#4)(2013-1#4)(2013-8#1)
with emphasis placed on the##2##5##(2008-11#1)(2008-2#1)
with emphasis##104##2##(1990-10#1)(1990-12#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-2#1)(1993-6#2)(1994-12#1)(1994-8#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-8#1)(1997-2#1)(2004-11#2)(2005-1#1)(2005-10#1)(2005-11#2)(2006-10#3)(2006-11#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-3#1)(2007-4#1)(2007-6#2)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#5)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#4)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#4)(2013-1#4)(2013-8#1)
with emphysema##3##2##(1992-12#1)(2006-9#1)(2010-5#1)
with emphysematous##3##2##(1991-12#1)(2009-6#1)(2012-3#1)
with empirical results##2##3##(2009-12#1)(2012-1#1)
with empirical##6##2##(2006-7#1)(2008-10#3)(2009-12#1)(2012-1#1)
with employers##3##2##(1992-11#2)(1995-1#1)
with employment##2##2##(1990-4#1)(1995-5#1)
with empty##4##2##(1991-11#1)(2008-5#2)(2009-2#1)
with encephalitis##4##2##(1994-4#1)(2006-10#1)(2008-1#1)(2008-8#1)
with encephalopathy##3##2##(1993-7#1)(1994-3#1)(2013-1#1)
with encouraging preliminary results##2##4##(2006-10#1)(2008-6#1)
with encouraging preliminary##3##3##(2006-10#1)(2008-5#1)(2008-6#1)
with encouraging##6##2##(2006-10#1)(2007-8#1)(2008-5#1)(2008-6#1)(2010-5#1)(2011-2#1)
with end stage renal disease (ESRD)##4##6##(1995-1#1)(2006-5#1)(2007-7#2)
with end stage renal disease##6##5##(1995-1#1)(2006-10#1)(2006-5#1)(2007-7#2)(2009-5#1)
with end stage renal failure##2##5##(1997-8#1)(2008-1#1)
with end stage renal##8##4##(1995-1#1)(1997-8#1)(2006-10#1)(2006-5#1)(2007-7#2)(2008-1#1)(2009-5#1)
with end stage##10##3##(1995-1#1)(1997-8#1)(2006-10#1)(2006-5#1)(2007-7#2)(2008-1#1)(2008-3#1)(2009-5#1)(2011-1#1)
with end##11##2##(1994-10#1)(1995-1#1)(1997-8#1)(2006-10#1)(2006-5#1)(2007-7#2)(2008-1#1)(2008-3#1)(2009-5#1)(2011-1#1)
with end-stage PDR##4##3##(2013-1#4)
with end-stage heart failure##2##4##(2007-8#1)(2010-8#1)
with end-stage liver disease##3##4##(2008-12#1)(2011-2#1)(2013-8#1)
with end-stage renal disease (ESRD) in##2##6##(2007-7#1)(2008-1#1)
with end-stage renal disease (ESRD)##9##5##(2007-7#6)(2008-1#2)(2013-1#1)
with end-stage renal disease and##2##5##(2006-10#1)(2008-1#1)
with end-stage renal disease##25##4##(2006-10#2)(2007-12#1)(2007-7#9)(2007-8#2)(2007-9#1)(2008-1#6)(2009-4#1)(2012-12#1)(2013-1#2)
with end-stage renal failure (ESRF) on dialysis##2##7##(2008-1#1)(2008-4#1)
with end-stage renal failure (ESRF) on##3##6##(2008-1#2)(2008-4#1)
with end-stage renal failure (ESRF)##4##5##(2007-7#1)(2008-1#2)(2008-4#1)
with end-stage renal failure##9##4##(1991-11#1)(2007-1#1)(2007-7#1)(2008-1#3)(2008-4#1)(2013-1#2)
with end-stage renal##35##3##(1991-11#1)(2006-10#2)(2007-1#1)(2007-12#1)(2007-7#10)(2007-8#2)(2007-9#1)(2008-1#9)(2008-4#1)(2008-7#1)(2009-4#1)(2012-12#1)(2013-1#4)
with end-stage##58##2##(1991-11#1)(1994-3#1)(2006-10#3)(2006-2#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#10)(2007-8#4)(2007-9#1)(2008-1#9)(2008-12#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#10)(2013-8#1)
with end-to-end##2##2##(2007-7#1)(2007-8#1)
with endemic##2##2##(2008-10#1)(2010-8#1)
with endobronchial stent##2##3##(2008-5#2)
with endobronchial##3##2##(2007-8#1)(2008-5#2)
with endochitinase##2##2##(2006-12#1)(2008-10#1)
with endocrine differentiation##2##3##(1991-8#1)(1992-2#1)
with endocrine##4##2##(1991-8#1)(1992-2#1)(2008-5#1)(2010-2#1)
with endogenous##14##2##(1990-2#1)(1993-6#1)(1994-5#1)(1995-12#1)(1996-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-12#2)
with endogenously generated##2##3##(1995-3#1)(1996-8#1)
with endoluminal##3##2##(1990-9#1)(2005-10#1)(2010-12#1)
with endometrial cancer##2##3##(1991-7#1)(2011-2#1)
with endometrial##12##2##(1990-6#1)(1991-12#1)(1991-7#1)(1995-3#2)(2006-10#1)(2006-7#1)(2008-3#2)(2009-10#1)(2011-2#1)(2012-3#1)
with endometriosis##12##2##(1991-11#1)(1992-9#4)(1995-2#2)(2007-10#3)(2009-6#1)(2012-3#1)
with endonexin##2##2##(1993-9#2)
with endoproteinase Glu-C##2##3##(1990-7#2)
with endoproteinase##4##2##(1990-7#2)(1990-8#1)(1992-12#1)
with endorectal##2##2##(1992-4#1)(2006-10#1)
with endoscopic findings##3##3##(2007-3#1)(2011-12#2)
with endoscopic submucosal dissection##2##4##(2013-1#1)(2013-8#1)
with endoscopic##19##2##(1992-10#1)(2006-10#2)(2006-12#1)(2006-6#2)(2006-8#1)(2007-3#1)(2007-8#1)(2008-4#1)(2008-5#1)(2010-9#1)(2011-12#2)(2012-2#1)(2013-1#2)(2013-8#2)
with endoscopically##3##2##(2005-1#1)(2006-10#1)(2006-5#1)
with endoscopy##6##2##(1993-3#1)(2006-8#1)(2007-12#1)(2008-7#1)(2011-1#1)(2012-1#1)
with endosseous implants##2##3##(2011-7#1)(2012-11#1)
with endothelial cells##8##3##(1990-3#1)(1991-9#1)(1993-3#1)(1996-8#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-9#1)
with endothelial dysfunction##3##3##(2004-12#1)(2009-5#2)
with endothelial##14##2##(1990-3#1)(1991-9#1)(1993-3#1)(1996-8#1)(2004-12#1)(2006-6#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-5#3)
with endothelin##3##2##(1990-10#1)(1994-11#1)(2010-10#1)
with endothelin-1 (ET-1)##2##3##(1991-4#1)(1995-1#1)
with endothelin-1##4##2##(1990-2#1)(1991-4#1)(1992-3#1)(1995-1#1)
with endothelin-3##2##2##(1993-11#1)(1994-3#1)
with endotoxemia##3##2##(2006-10#1)(2011-2#1)(2012-1#1)
with endotoxin##5##2##(1990-2#1)(1994-2#1)(1994-9#1)(1996-10#1)(2008-10#1)
with endovascular coiling##2##3##(2007-10#2)
with endovascular embolization##3##3##(2008-12#1)(2010-12#1)(2012-12#1)
with endovascular##10##2##(1997-2#1)(2007-10#3)(2007-7#1)(2007-8#1)(2008-12#2)(2010-12#1)(2012-12#1)
with ends##2##2##(2008-5#1)(2009-5#1)
with energetic##2##2##(1995-7#1)(2008-2#1)
with energies as##5##3##(2007-11#1)(2007-12#2)(2008-1#2)
with energies of##8##3##(2007-11#2)(2007-12#4)(2008-3#1)(2008-7#1)
with energies##13##2##(2007-11#3)(2007-12#6)(2008-1#2)(2008-3#1)(2008-7#1)
with energy demand##2##3##(1997-2#1)(2011-1#1)
with energy dispersive X-ray analysis##2##5##(2008-5#1)(2013-7#1)
with energy dispersive X-ray##4##4##(1993-9#1)(2008-5#1)(2010-8#1)(2013-7#1)
with energy intake##2##3##(1995-12#1)(2006-1#1)
with energy of 3##2##4##(2007-11#2)
with energy of##3##3##(2007-11#2)(2007-12#1)
with energy##19##2##(1993-11#1)(1993-9#1)(1995-12#1)(1997-2#1)(2006-1#1)(2006-12#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-2#1)(2008-5#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-7#1)
with energy-dispersive##2##2##(2006-5#1)(2006-7#1)
with engineered##8##2##(1995-3#1)(1996-5#3)(2006-5#1)(2006-8#1)(2007-8#1)(2008-2#1)
with enhanced antimicrobial##2##3##(2005-7#1)(2011-1#1)
with enhanced clinical##2##3##(2008-12#1)(2009-4#1)
with enhanced expression of##4##4##(1995-3#1)(1996-10#1)(2012-1#1)(2012-2#1)
with enhanced sensitivity##3##3##(2007-12#1)(2008-3#1)(2008-5#1)
with enhanced stability##2##3##(1992-11#1)(2011-2#1)
with enhanced surface##2##3##(1994-5#1)(2008-11#1)
with enhanced tolerance##2##3##(2008-7#1)(2011-2#1)
with enhanced##80##2##(1990-12#2)(1991-12#1)(1991-4#1)(1991-9#2)(1992-11#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-6#1)(2004-9#1)(2005-7#1)(2006-11#1)(2006-5#1)(2007-11#3)(2007-12#3)(2007-5#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2009-4#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
with enhancement of##4##3##(1991-5#1)(1994-6#1)(2008-10#1)(2010-11#1)
with enlarged##5##2##(2006-10#1)(2007-6#1)(2008-1#1)(2008-6#1)(2012-12#1)
with enlargement of the##3##4##(1992-11#1)(2007-12#1)(2011-2#1)
with enough##3##2##(1992-3#1)(2009-9#1)(2011-2#1)
with enriched stable isotopes##3##4##(2010-8#3)
with enriched##4##2##(2010-8#4)
with enrichment factor of##2##4##(2008-10#2)
with enrichment##8##2##(1997-8#1)(2008-10#4)(2008-8#2)(2013-1#1)
with enrofloxacin##2##2##(1997-3#2)
with ensuring##2##2##(1996-12#1)(1997-5#1)
with entecavir##3##2##(2009-8#1)(2012-2#1)(2013-1#1)
with enteral nutrition##2##3##(2013-1#2)
with enteral##3##2##(2005-10#1)(2013-1#2)
with enteric##2##2##(2006-10#1)(2013-8#1)
with entering##2##2##(1992-8#2)
with enthesopathy of the##2##4##(2007-7#2)
with entirely##2##2##(1990-12#1)(2011-1#1)
with entrapment of##2##3##(2008-10#1)(2008-4#1)
with entrapment##3##2##(2008-10#1)(2008-4#1)(2010-1#1)
with entrapped doxorubicin##2##3##(1990-3#2)
with entrapped##3##2##(1990-3#2)(2008-10#1)
with enuresis##2##2##(2007-7#2)
with environment##2##2##(2008-8#1)(2011-1#1)
with environmental and##3##3##(2005-11#1)(2008-10#1)(2008-7#1)
with environmental factors##5##3##(2008-1#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
with environmental##23##2##(1991-12#2)(1992-12#1)(1993-7#1)(1994-2#1)(1994-6#1)(2005-11#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
with enzymatic##2##2##(1991-2#1)(1994-5#1)
with enzyme activity##3##3##(1990-5#1)(1995-10#1)(1995-3#1)
with enzyme##13##2##(1990-5#1)(1991-7#1)(1993-6#1)(1994-12#1)(1995-10#1)(1995-3#1)(1996-8#1)(2008-10#4)(2008-3#1)(2011-3#1)
with enzyme-treated##2##2##(1994-12#1)(2013-1#1)
with enzymes##6##2##(1993-1#1)(1993-5#1)(2005-11#1)(2008-10#2)(2010-10#1)
with eosinophilia##3##2##(1995-9#1)(2008-10#1)(2011-1#1)
with eosinophilic##5##2##(1990-11#1)(2006-10#1)(2007-7#1)(2007-9#1)(2010-7#1)
with epichlorohydrin##2##2##(1991-7#1)(2007-11#1)
with epidemics##2##2##(2006-10#1)(2008-10#1)
with epidemiological data##2##3##(2012-2#1)(2013-1#1)
with epidemiological##8##2##(1994-3#1)(2008-10#2)(2008-11#3)(2012-2#1)(2013-1#1)
with epidermal growth factor (EGF)##5##5##(1992-3#1)(1992-9#1)(1995-10#1)(1995-2#1)(2006-10#1)
with epidermal growth factor##7##4##(1992-2#1)(1992-3#1)(1992-9#1)(1995-10#1)(1995-2#1)(1995-8#1)(2006-10#1)
with epidermal##9##2##(1992-2#1)(1992-3#1)(1992-9#1)(1995-10#1)(1995-2#1)(1995-8#2)(2006-10#1)(2008-5#1)
with epidermoid##2##2##(2007-7#1)(2007-8#1)
with epidermolysis bullosa##4##3##(2007-7#1)(2012-3#3)
with epidural##7##2##(1992-11#1)(1993-10#1)(1993-4#1)(2006-8#1)(2012-3#2)(2013-7#1)
with epigastric pain##3##3##(1996-8#1)(2008-5#1)(2013-1#1)
with epilepsy and##2##3##(1997-8#1)(2005-8#1)
with epilepsy##21##2##(1995-1#1)(1996-3#1)(1997-8#1)(2004-11#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2010-12#1)(2010-2#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
with epileptic seizure##2##3##(2010-12#1)(2010-4#1)
with epileptic seizures##2##3##(2008-7#1)(2010-11#1)
with epileptic##4##2##(2008-7#1)(2010-11#1)(2010-12#1)(2010-4#1)
with epinephrine and##2##3##(2008-10#1)(2010-1#1)
with epinephrine##7##2##(1990-5#1)(1991-12#1)(1993-1#2)(2008-10#1)(2008-8#1)(2010-1#1)
with epirubicin##7##2##(1990-10#2)(1991-2#1)(1991-6#1)(1994-10#1)(2006-6#1)(2008-6#1)
with episodes of##4##3##(2007-2#1)(2008-10#1)(2008-7#1)(2009-4#1)
with episodic##4##2##(2005-11#1)(2011-1#2)(2012-3#1)
with epistaxis and##3##3##(2011-1#2)(2011-12#1)
with epistaxis##5##2##(1994-3#1)(2007-7#1)(2011-1#2)(2011-12#1)
with epithelial and myoepithelial differentiation##2##5##(2007-5#2)
with epithelial##7##2##(1994-12#1)(1994-7#1)(2007-5#2)(2008-5#1)(2008-6#1)(2010-9#1)
with epithelioid##3##2##(1993-2#1)(2005-12#1)(2009-7#1)
with epoetin alfa##3##3##(2008-5#1)(2008-7#2)
with epoetin##7##2##(2007-11#1)(2008-5#1)(2008-7#5)
with epoxy##3##2##(2008-10#2)(2009-7#1)
with epsilon##4##2##(1990-9#1)(1991-4#1)(1991-8#1)(2006-8#1)
with equal affinity to##2##4##(1990-2#1)(1994-5#1)
with equal affinity##3##3##(1990-2#1)(1994-5#1)(1996-4#1)
with equal efficiency##4##3##(1995-1#1)(1995-3#1)(1997-1#1)(2008-10#1)
with equal variances##2##3##(2008-10#1)(2012-1#1)
with equal##38##2##(1990-2#1)(1991-7#1)(1992-8#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#2)(1995-3#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-4#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-12#1)(2012-1#5)(2012-2#1)
with equalized##2##2##(2007-11#1)(2008-5#1)
with equally##3##2##(1992-3#1)(2006-5#1)(2008-1#1)
with equations for##2##3##(2008-2#1)(2012-3#1)
with equimolar amounts of##2##4##(2007-10#1)(2008-10#1)
with equimolar concentrations of##2##4##(1990-5#1)(1994-12#1)
with equimolar doses of##2##4##(1994-5#1)(2008-10#1)
with equimolar doses##3##3##(1990-5#1)(1994-5#1)(2008-10#1)
with equimolar##8##2##(1990-5#2)(1994-12#1)(1994-5#1)(2007-10#2)(2008-10#2)
with equine##2##2##(1996-10#1)(2013-1#1)
with equipment##5##2##(1996-12#1)(2009-2#1)(2011-1#2)(2011-2#1)
with equivalent conventional##2##3##(2008-3#2)
with equivalent frequency##2##3##(1994-11#1)(2009-5#1)
with equivalent##13##2##(1991-7#1)(1991-8#1)(1994-11#1)(1995-3#1)(1997-1#1)(2007-11#1)(2008-10#2)(2008-3#2)(2009-5#1)(2012-2#1)(2012-3#1)
with equivocal##4##2##(1996-9#1)(1997-2#1)(2007-8#1)(2010-11#1)
with eradication##2##2##(1990-6#1)(2012-12#1)
with erbium hydroxide##2##3##(2008-10#2)
with erectile dysfunction##4##3##(1990-6#1)(1996-9#1)(2006-7#1)(2011-2#1)
with ergosterol##2##2##(1997-2#2)
with erosion##2##2##(2008-1#1)(2012-2#1)
with error##5##2##(1995-6#1)(2010-2#1)(2012-1#2)(2012-12#1)
with errors and##2##3##(2008-10#1)(2010-8#1)
with errors in##2##3##(2007-12#1)(2008-3#1)
with errors##8##2##(1996-8#1)(1997-2#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-3#1)(2010-2#1)(2010-8#1)
with erythema nodosum##4##3##(1991-4#2)(2007-11#1)(2008-8#1)
with erythema of the distal extremities##2##6##(2005-11#1)(2008-7#1)
with erythema##6##2##(1991-4#2)(2005-11#1)(2007-11#1)(2008-7#1)(2008-8#1)
with erythrocyte##5##2##(1991-9#1)(1992-6#1)(1993-11#1)(2005-1#1)(2008-8#1)
with erythromycin##2##2##(2007-12#1)(2007-7#1)
with erythropoietic agents##2##3##(2008-7#2)
with erythropoietic##3##2##(1990-1#1)(2008-7#2)
with erythropoietin##7##2##(1991-6#1)(1995-1#1)(2005-10#1)(2006-5#1)(2008-1#1)(2008-11#2)
with esophageal cancer##7##3##(1990-4#1)(2007-8#1)(2008-12#2)(2008-2#1)(2009-3#1)(2010-12#1)
with esophageal##16##2##(1990-4#1)(1993-5#1)(1993-7#1)(1996-6#1)(2007-6#1)(2007-8#5)(2008-12#2)(2008-2#1)(2009-3#1)(2010-1#1)(2010-12#1)
with esophagus and bronchus##2##4##(2007-8#2)
with especially##2##2##(2007-3#1)(2008-8#1)
with essential hypertension##15##3##(1990-10#1)(1992-12#2)(1992-6#1)(1992-7#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2010-4#1)(2012-1#1)(2013-7#1)
with essential##25##2##(1990-10#1)(1992-12#2)(1992-6#1)(1992-7#1)(1993-3#1)(1995-10#1)(1997-1#1)(1997-7#1)(2006-6#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2010-2#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
with essentially##3##2##(1997-8#1)(2006-12#1)(2008-3#1)
with established coronary heart disease##3##5##(2006-5#1)(2008-3#1)(2010-6#1)
with established coronary##5##3##(2006-5#1)(2008-1#1)(2008-3#1)(2009-12#1)(2010-6#1)
with established##48##2##(1990-5#1)(1991-9#1)(1993-11#3)(1994-2#1)(1996-4#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#6)(2008-6#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
with estimated##12##2##(1990-10#1)(1990-11#1)(1991-11#1)(2006-9#2)(2008-10#1)(2008-3#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
with estimates of the##2##4##(1992-6#1)(2008-3#1)
with estimates of##4##3##(1992-6#1)(2008-3#1)(2008-8#1)(2012-1#1)
with estimates##8##2##(1992-6#1)(1993-3#1)(1997-4#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-3#1)(2012-1#1)
with estimating##2##2##(2008-3#1)(2010-9#1)
with estradiol##6##2##(1991-1#1)(1992-12#1)(1992-5#3)(2009-2#1)
with estrogen receptor alpha##2##4##(2008-7#1)(2011-2#1)
with estrogen receptor##6##3##(1996-11#1)(2007-11#1)(2008-11#2)(2008-7#1)(2011-2#1)
with estrogen receptors##3##3##(1995-1#1)(1996-7#1)(2008-11#1)
with estrogen##16##2##(1993-9#1)(1995-1#1)(1995-10#1)(1996-11#1)(1996-7#1)(1996-9#1)(1997-7#2)(2007-11#1)(2008-11#4)(2008-7#1)(2011-2#1)(2012-1#1)
with estrogenic##2##2##(2008-10#1)(2008-11#1)
with etanercept##3##2##(2007-8#1)(2008-8#1)(2012-2#1)
with ethanol extract of##3##4##(2010-12#1)(2012-2#2)
with ethanol extract##4##3##(2008-10#1)(2010-12#1)(2012-2#2)
with ethanol or##2##3##(1994-8#1)(2008-10#1)
with ethanol##40##2##(1991-1#1)(1992-9#1)(1994-10#1)(1994-2#1)(1994-7#1)(1994-8#1)(1995-3#2)(1995-6#1)(1996-2#1)(1997-8#1)(2006-10#2)(2007-1#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-5#1)(2009-7#1)(2009-8#3)(2010-12#3)(2011-2#1)(2012-2#2)(2013-8#1)
with ethanol-induced##2##2##(1995-3#1)(2009-8#1)
with ethanol/water##2##2##(2008-10#1)(2008-5#1)
with ethanolic##2##2##(2008-10#1)(2008-11#1)
with ethaverine##2##2##(1994-3#2)
with ethephon##2##2##(2006-11#1)(2009-8#1)
with ether extracts##2##3##(2007-7#2)
with ether##7##2##(2006-10#1)(2007-7#2)(2008-2#1)(2008-4#1)(2008-5#1)(2010-4#1)
with ethical##6##2##(1995-1#1)(1995-5#1)(1996-2#1)(2007-9#1)(2011-2#1)(2013-1#1)
with ethidium bromide##6##3##(1990-2#1)(1990-7#1)(1997-6#1)(2005-8#1)(2005-9#1)(2006-8#1)
with ethnic and##2##3##(2008-1#1)(2008-3#1)
with ethnic##5##2##(1996-2#1)(2007-8#1)(2008-1#1)(2008-3#2)
with ethnicity##2##2##(1994-7#1)(2008-3#1)
with ethosuximide##2##2##(1993-7#1)(1995-12#1)
with ethyl acetate as the##2##5##(2008-10#2)
with ethyl acetate##11##3##(1991-8#1)(1996-2#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-6#1)(2011-3#1)(2012-1#1)
with ethyl iodide##4##3##(1996-2#1)(1997-1#1)(2007-8#1)(2008-11#1)
with ethyl##23##2##(1991-8#1)(1992-3#1)(1996-2#2)(1996-5#3)(1997-1#1)(1997-3#1)(2005-12#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-6#1)(2010-5#1)(2011-3#1)(2012-1#1)
with ethylcellulose##2##2##(2010-12#2)
with ethylene##5##2##(1990-11#1)(1993-12#1)(2007-11#2)(2009-8#1)
with ethylenediamine##4##2##(1990-5#1)(2006-12#1)(2008-10#2)
with ethylenediaminetetraacetic##2##2##(2008-10#2)
with etiologic##2##2##(2007-10#2)
with etiology and##2##3##(1991-5#1)(1995-7#1)
with etoposide##4##2##(1992-6#1)(2004-1#1)(2007-6#1)(2008-6#1)
with eukaryotic##5##2##(1992-6#1)(1994-8#1)(1995-6#1)(1997-7#1)(2010-4#1)
with europium and##2##3##(2005-4#1)(2007-12#1)
with europium##4##2##(1995-2#1)(2005-4#1)(2007-12#1)(2008-3#1)
with evaluating##3##2##(2007-1#1)(2007-2#1)(2013-1#1)
with evaluation of##3##3##(1994-5#1)(2006-8#1)(2007-7#1)
with evaluation##5##2##(1994-5#1)(2006-8#1)(2007-7#1)(2007-8#1)(2011-2#1)
with evanescent##2##2##(2008-3#2)
with evaporative light scattering detection##3##5##(2008-10#3)
with evaporative light scattering##4##4##(2008-10#3)(2013-7#1)
with evaporative##5##2##(1995-3#1)(2008-10#3)(2013-7#1)
with even##3##2##(1990-8#1)(1997-2#1)(2008-3#1)
with events##2##2##(1991-12#1)(1996-7#1)
with ever-increasing##3##2##(1996-5#1)(2005-5#1)(2009-3#1)
with everolimus##2##2##(2009-11#1)(2010-12#1)
with every other##2##3##(1997-2#1)(1997-8#1)
with every##13##2##(1991-12#1)(1993-2#1)(1995-5#1)(1996-3#1)(1997-2#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2011-3#1)(2012-6#1)
with evidence from##3##3##(2008-11#1)(2010-5#1)(2011-1#1)
with evidence of progressive##2##4##(2006-5#1)(2012-2#1)
with evidence of##28##3##(1991-12#2)(1992-2#1)(1993-9#1)(1994-6#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-12#2)(2010-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-7#1)
with evidence that the##2##4##(2005-7#1)(2006-10#1)
with evidence that##5##3##(1990-8#1)(2005-7#1)(2006-10#1)(2012-4#1)(2013-7#1)
with evidence##43##2##(1990-8#1)(1991-12#2)(1992-2#1)(1993-9#1)(1994-6#1)(1996-4#1)(1996-9#1)(2005-7#1)(2006-10#2)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2012-4#1)(2013-7#2)
with evidence-based medicine##2##3##(2007-12#1)(2008-11#1)
with evidence-based##5##2##(2007-12#2)(2008-11#1)(2008-12#1)(2008-8#1)
with evolution##2##2##(1994-12#1)(1997-8#1)
with evolutionary##2##2##(2008-8#1)(2010-8#1)
with evolving##2##2##(2008-1#2)
with exact solutions##2##3##(2007-12#1)(2008-6#1)
with exact##13##2##(1993-12#1)(1994-5#2)(1995-4#1)(2006-8#1)(2007-12#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-6#1)
with exactly##2##2##(2007-7#1)(2012-3#1)
with exaggerated insect bite##2##4##(2007-8#2)
with exaggerated##5##2##(1996-12#1)(2006-10#1)(2007-7#1)(2007-8#2)
with examples from the##3##4##(2008-10#1)(2008-7#1)(2011-1#1)
with examples from##6##3##(2007-2#1)(2007-7#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)
with examples including##2##3##(2011-1#2)
with examples of##8##3##(1991-3#1)(1996-2#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-7#1)(2009-4#1)(2011-2#1)
with examples##26##2##(1991-3#1)(1992-2#1)(1996-2#1)(1997-8#1)(2006-4#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-7#2)(2009-12#1)(2009-4#1)(2010-10#1)(2010-4#1)(2011-1#3)(2011-2#2)
with excellent agreement##2##3##(2006-8#1)(2008-2#1)
with excellent cosmetic##3##3##(2006-12#1)(2008-10#1)(2008-9#1)
with excellent diabetic control and stable renal function (eGFR &gt##2##9##(2013-1#2)
with excellent function##2##3##(2008-6#1)(2008-9#1)
with excellent results##8##3##(1990-6#1)(1991-4#1)(1996-3#1)(2004-3#1)(2006-3#1)(2007-7#1)(2010-12#1)(2011-3#1)
with excellent safety##2##3##(2008-3#1)(2012-12#1)
with excellent sensitivity##3##3##(2007-8#1)(2008-10#1)(2008-9#1)
with excellent uniformity##2##3##(2006-5#1)(2007-12#1)
with excellent yields##2##3##(2006-12#1)(2008-5#1)
with excellent##62##2##(1990-6#1)(1991-4#1)(1991-9#1)(1993-12#1)(1996-3#1)(2004-3#1)(2005-5#1)(2006-10#1)(2006-12#3)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#5)(2007-7#1)(2007-8#4)(2007-9#1)(2008-10#9)(2008-2#1)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#3)(2009-12#1)(2009-2#1)(2010-10#1)(2010-12#2)(2010-4#1)(2011-3#1)(2012-12#1)(2013-1#4)(2013-7#1)
with exception of##10##3##(1991-10#1)(1992-3#1)(1996-12#1)(1996-7#1)(1997-2#1)(2006-10#1)(2006-6#1)(2008-10#1)(2012-12#1)(2012-2#1)
with exception##12##2##(1991-10#1)(1992-3#1)(1996-12#1)(1996-7#1)(1997-2#1)(2006-10#1)(2006-6#1)(2008-10#2)(2009-4#1)(2012-12#1)(2012-2#1)
with exceptionally high##2##3##(1994-9#1)(2009-10#1)
with excess Mg2+##2##3##(1992-12#1)(1992-3#1)
with excess iodide in acidic medium##2##6##(2008-10#2)
with excess of##2##3##(1992-3#1)(2008-10#1)
with excess##30##2##(1990-8#2)(1991-3#1)(1991-9#1)(1992-12#1)(1992-3#4)(1992-9#1)(1995-3#1)(1997-4#1)(1997-5#1)(2007-11#2)(2008-10#9)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#2)(2012-2#1)
with excessive or##2##3##(2008-12#1)(2012-1#1)
with excessive sleepiness associated with shift work disorder##3##8##(2012-12#3)
with excessive##16##2##(1990-9#1)(1992-3#1)(2004-12#1)(2006-4#1)(2007-8#2)(2008-12#1)(2010-2#1)(2011-12#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-4#1)(2013-1#1)
with exchange of##2##3##(2008-8#1)(2013-1#1)
with excimer##2##2##(2008-2#1)(2008-3#1)
with excipient##2##2##(2008-5#2)
with excised##2##2##(2008-10#1)(2008-5#1)
with excision of the##6##4##(2007-8#1)(2008-10#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
with excision of##10##3##(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
with excision##11##2##(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-7#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
with excitation and emission##2##4##(1990-8#1)(2008-10#1)
with excitation at##12##3##(1990-8#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#4)(2008-2#2)(2008-3#1)(2011-1#1)
with excitation##16##2##(1990-8#2)(1997-2#1)(1997-3#1)(1997-8#1)(2006-12#1)(2007-11#1)(2008-10#5)(2008-2#2)(2008-3#1)(2011-1#1)
with excited delirium##2##3##(2010-1#2)
with excited##3##2##(2010-1#2)(2012-2#1)
with exclusion of##2##3##(1994-7#1)(2007-8#1)
with exclusion##3##2##(1994-7#1)(1997-6#1)(2007-8#1)
with executive##2##2##(2009-10#1)(2010-6#1)
with exercise intolerance##2##3##(2005-12#1)(2008-4#1)
with exercise##14##2##(1991-2#1)(1996-6#1)(2005-12#1)(2006-10#1)(2006-6#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-5#2)(2011-12#1)(2013-8#1)
with exercise-induced##2##2##(1997-1#1)(2008-7#1)
with exhaustive##2##2##(1991-2#1)(2008-1#1)
with existing drugs##2##3##(2005-7#1)(2005-8#1)
with existing laboratory##2##3##(2008-2#1)(2008-3#1)
with existing methods##2##3##(2008-2#1)(2012-12#1)
with existing resources##2##3##(2007-2#1)(2007-7#1)
with existing techniques##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
with existing##54##2##(1991-9#1)(1994-5#1)(1995-3#1)(1996-12#1)(2005-12#1)(2005-6#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-11#3)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#6)(2008-3#5)(2008-5#4)(2008-6#1)(2008-7#3)(2009-12#1)(2009-4#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#2)(2013-1#3)
with exocrine##2##2##(1991-2#1)(1994-11#1)
with exogenous##21##2##(1992-8#1)(1993-8#2)(1994-11#1)(1994-8#1)(1995-10#1)(1995-12#2)(1996-3#1)(1996-9#2)(1997-2#1)(2005-8#1)(2007-12#1)(2007-6#2)(2008-4#1)(2008-8#2)(2010-11#1)(2011-1#1)
with exon##2##2##(1993-6#1)(1996-5#1)
with expanded##3##2##(2006-12#1)(2007-9#1)(2008-10#1)
with expanding##7##2##(1997-5#1)(2005-10#1)(2006-3#1)(2007-6#1)(2008-11#1)(2009-10#1)(2012-3#1)
with expectation##3##2##(1996-6#1)(2010-3#1)(2012-2#1)
with expectations for##2##3##(2008-10#1)(2008-8#1)
with expectations##7##2##(1997-2#1)(2004-2#1)(2007-4#1)(2008-10#2)(2008-8#1)(2008-9#1)
with expected values##2##3##(2008-10#1)(2008-2#1)
with expected##7##2##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)(2011-2#1)
with experience and##4##3##(1996-1#1)(2007-10#1)(2009-8#1)(2013-8#1)
with experience in##4##3##(1991-12#1)(2007-11#1)(2007-5#1)(2007-7#1)
with experience of##4##3##(1993-10#1)(1996-8#1)(2010-6#1)(2012-12#1)
with experience##14##2##(1991-12#1)(1993-10#1)(1995-1#1)(1996-1#1)(1996-8#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2009-8#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-8#1)
with experienced##2##2##(2008-3#1)(2011-2#1)
with experiment##8##2##(1991-2#1)(1992-1#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
with experimental and##3##3##(2008-3#2)(2008-7#1)
with experimental animal##2##3##(2008-12#1)(2010-2#1)
with experimental data and##2##4##(1996-12#1)(2008-2#1)
with experimental data for##3##4##(2007-9#1)(2008-2#1)(2008-3#1)
with experimental data obtained##2##4##(2008-3#2)
with experimental data of##2##4##(2008-2#2)
with experimental data on the##2##5##(1996-2#1)(2010-10#1)
with experimental data##31##3##(1995-8#1)(1996-12#1)(1996-2#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-10#1)(2008-2#9)(2008-3#4)(2008-4#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
with experimental diabetes##2##3##(1992-3#1)(2008-1#1)
with experimental measurements for a##2##5##(2007-12#1)(2009-7#1)
with experimental measurements of##2##4##(2008-3#1)(2010-10#1)
with experimental measurements##15##3##(1994-3#1)(2007-12#5)(2008-2#1)(2008-3#4)(2008-5#1)(2009-4#1)(2009-7#1)(2010-10#1)
with experimental observation##2##3##(2007-12#1)(2008-3#1)
with experimental observations##5##3##(2005-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
with experimental results for##3##4##(1996-5#1)(2008-2#2)
with experimental results obtained from##2##5##(2007-11#1)(2008-2#1)
with experimental results obtained##5##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-4#1)
with experimental results##36##3##(1996-5#1)(2005-10#1)(2007-11#2)(2007-12#7)(2008-1#1)(2008-2#13)(2008-3#6)(2009-3#1)(2009-4#1)(2010-2#1)(2013-1#2)
with experimental studies##2##3##(2006-11#1)(2007-11#1)
with experimental values##5##3##(1993-11#1)(1995-8#1)(2005-4#1)(2008-11#1)(2008-6#1)
with experimental##134##2##(1990-2#1)(1992-3#1)(1993-11#2)(1994-3#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(2005-10#1)(2005-11#1)(2005-4#1)(2005-7#1)(2006-10#2)(2006-11#2)(2006-5#1)(2007-11#4)(2007-12#18)(2007-4#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#24)(2008-3#22)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-7#1)(2010-10#2)(2010-12#4)(2010-2#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#4)(2013-1#3)(2013-8#2)
with experimentally induced##4##3##(1993-11#1)(1995-12#1)(2008-1#1)(2013-1#1)
with experimentally observed##3##3##(2007-12#1)(2008-2#1)(2012-2#1)
with experimentally##11##2##(1993-11#1)(1995-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-5#1)(2012-2#1)(2013-1#1)
with experiments##13##2##(1990-8#1)(1993-7#1)(1995-4#1)(2006-7#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#4)(2010-10#1)
with expert##4##2##(1991-2#1)(1993-12#1)(1996-6#1)(2010-9#1)
with expertise in##3##3##(2006-7#1)(2007-3#1)(2010-2#1)
with expertise##9##2##(1993-9#1)(2006-7#1)(2007-3#1)(2008-8#1)(2010-2#1)(2011-1#1)(2011-2#3)
with experts##3##2##(2009-2#1)(2012-12#1)(2012-2#1)
with explanations##3##2##(2012-2#1)(2013-1#1)(2013-8#1)
with explants##2##2##(1996-3#1)(2008-5#1)
with explicit##5##2##(1993-11#1)(1995-1#1)(2006-10#1)(2007-3#1)(2008-11#1)
with exploratory##3##2##(1993-9#1)(1996-10#1)(2009-12#1)
with exponential##3##2##(1994-6#1)(1996-8#1)(2013-8#1)
with exposed##3##2##(2009-9#1)(2010-4#1)(2012-12#1)
with exposure of##2##3##(1997-2#1)(2008-11#1)
with exposure to environmental##2##4##(2011-1#1)(2013-1#1)
with exposure to##18##3##(1991-12#1)(1994-6#1)(1997-6#1)(2005-11#1)(2006-10#1)(2007-12#3)(2008-10#1)(2008-6#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
with exposure##26##2##(1991-12#1)(1994-6#1)(1997-2#1)(1997-6#1)(2005-11#1)(2006-10#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2010-11#2)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)
with exposures##2##2##(1996-6#1)(2010-8#1)
with expression of##11##3##(1992-6#1)(1995-2#2)(1996-8#1)(2008-10#1)(2008-6#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
with expression plasmids##2##3##(1995-6#1)(1996-10#1)
with expression vectors##5##3##(1994-10#1)(1994-12#1)(1997-1#1)(2008-11#1)(2008-9#1)
with expression##24##2##(1990-6#1)(1991-4#1)(1992-6#1)(1993-8#1)(1994-10#1)(1994-12#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-10#1)(1996-8#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-4#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
with exstrophy##4##2##(2008-10#4)
with extended##17##2##(1991-4#1)(1992-3#2)(1992-9#1)(1994-8#1)(1995-3#1)(1996-1#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-8#1)(2009-5#1)(2010-2#2)(2012-12#1)
with extended-release##2##2##(2010-4#2)
with extension into the third ventricle##2##6##(2012-1#2)
with extension into the##7##4##(2007-10#1)(2008-7#2)(2009-8#1)(2010-3#1)(2012-1#2)
with extension##9##2##(2005-1#1)(2007-10#1)(2008-7#2)(2009-8#1)(2010-3#1)(2012-1#2)(2013-8#1)
with extensive disease##2##3##(1992-10#1)(2010-5#1)
with extensive hemispheric##2##3##(2007-9#2)
with extensive local##3##3##(2006-12#1)(2011-12#1)(2012-1#1)
with extensive##70##2##(1991-11#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#2)(1993-11#1)(1993-2#1)(1993-8#1)(1994-6#1)(1995-11#1)(1995-6#1)(1997-2#1)(2004-1#2)(2006-10#1)(2006-12#2)(2006-6#3)(2007-11#1)(2007-7#4)(2007-8#7)(2007-9#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#4)(2009-12#1)(2009-7#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#1)(2013-7#3)
with external beam##3##3##(2006-12#1)(2008-6#1)(2009-2#1)
with external drainage##2##3##(1990-10#1)(1993-8#1)
with external fixation##2##3##(2006-3#1)(2007-8#1)
with external##41##2##(1990-10#2)(1990-12#1)(1990-9#1)(1991-11#1)(1992-12#1)(1992-9#1)(1993-2#2)(1993-3#1)(1993-8#1)(1994-8#1)(1995-6#2)(1997-1#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-2#2)(2010-3#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
with extinction##5##2##(2007-8#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-12#1)
with extra##4##2##(1994-3#1)(1994-4#1)(2008-10#1)(2008-5#1)
with extracardiac conduit##2##3##(2007-8#2)
with extracellular matrix##2##3##(1992-6#1)(2008-4#1)
with extracellular recordings##2##3##(1996-5#1)(1997-2#1)
with extracellular##8##2##(1990-12#1)(1992-6#1)(1994-10#1)(1996-5#1)(1997-2#1)(2007-9#1)(2008-4#1)(2008-8#1)
with extracorporeal circulation##4##3##(2007-8#1)(2010-6#1)(2012-3#2)
with extracorporeal shock wave lithotripsy (ESWL)##4##6##(1991-12#1)(1996-12#2)(2007-7#1)
with extracorporeal##14##2##(1991-12#1)(1996-12#2)(2006-10#1)(2007-12#2)(2007-7#1)(2007-8#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-3#3)
with extracted##4##2##(1995-2#1)(2008-8#1)(2010-5#2)
with extraction##3##2##(2008-10#2)(2013-1#1)
with extracts from##4##3##(1994-8#2)(2008-10#1)(2008-2#1)
with extracts of##3##3##(1992-7#1)(2008-11#1)(2008-5#1)
with extracts##9##2##(1992-7#1)(1994-8#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)
with extradural##3##2##(2006-12#1)(2006-5#1)(2008-12#1)
with extrahepatic##7##2##(1993-9#2)(2006-10#1)(2006-2#1)(2010-2#1)(2012-2#1)(2013-1#1)
with extraintestinal##2##2##(2005-12#1)(2008-4#1)
with extramedullary##2##2##(2011-2#1)(2012-2#1)
with extraneous##2##2##(1991-2#1)(2006-10#1)
with extraordinary##4##2##(2008-2#2)(2008-7#1)(2012-2#1)
with extrapulmonary##2##2##(1996-11#1)(2005-10#1)
with extreme values in##2##4##(2008-5#1)(2012-3#1)
with extreme##19##2##(1991-6#1)(1992-5#1)(1994-9#1)(1995-3#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-10#1)(2011-7#1)(2012-2#1)(2012-3#3)(2013-8#2)
with extremely high##7##3##(1991-9#1)(1993-3#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-7#1)
with extremely long##2##3##(1997-3#1)(2007-12#1)
with extremely low##4##3##(2006-10#2)(2008-5#1)(2012-2#1)
with extremely##18##2##(1991-9#1)(1992-3#1)(1993-3#1)(1997-3#1)(2006-10#2)(2006-2#1)(2007-12#3)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-4#1)(2012-2#1)(2013-1#1)
with extremes##2##2##(2007-2#1)(2008-3#1)
with exuberant##2##2##(2005-11#1)(2011-2#1)
with eye##5##2##(1997-8#1)(2007-5#1)(2008-10#2)(2012-3#1)
with eyes closed##5##3##(2008-7#2)(2011-1#3)
with fMLP##3##2##(1991-6#1)(1996-5#2)
with fMRI##5##2##(1995-12#1)(2008-11#1)(2009-8#1)(2011-1#1)(2013-8#1)
with face##5##2##(1997-1#1)(1997-8#1)(2009-3#1)(2009-4#1)(2009-7#1)
with facet##2##2##(2006-8#1)(2007-1#1)
with facial nerve palsy##2##4##(2007-8#1)(2011-2#1)
with facial nerve##5##3##(2007-8#1)(2008-7#1)(2008-9#1)(2011-2#2)
with facial##14##2##(1996-12#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-4#1)(2011-2#2)(2013-1#2)
with factor VIII##3##3##(1991-6#1)(2007-8#1)(2008-5#1)
with factor Va##2##3##(1990-12#1)(1994-5#1)
with factor Xa##2##3##(1994-5#2)
with factor##17##2##(1990-12#1)(1990-5#1)(1991-6#1)(1994-11#1)(1994-5#3)(1995-12#1)(1995-2#1)(1996-6#1)(2004-10#1)(2004-11#2)(2007-8#1)(2008-3#1)(2008-5#1)(2009-6#1)
with factors of##2##3##(1992-2#1)(2007-6#1)
with factors##7##2##(1992-2#1)(1995-1#1)(1995-9#1)(2007-6#1)(2008-2#1)(2009-4#1)(2012-1#1)
with faeces##2##2##(1991-4#1)(2006-8#1)
with failed##10##2##(2006-8#1)(2007-8#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-3#2)(2013-1#2)
with failing##2##2##(2006-10#1)(2007-8#1)
with failure of##5##3##(1992-12#1)(1993-9#1)(2007-7#1)(2008-1#1)(2010-12#1)
with failure to##3##3##(2007-3#1)(2010-6#1)(2012-2#1)
with failure##11##2##(1992-12#1)(1993-9#1)(1994-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-1#1)(2010-12#1)(2010-6#1)(2012-2#1)(2012-3#1)
with falling asleep##2##3##(2007-6#1)(2008-8#1)
with falls in##4##3##(1993-2#1)(1996-1#1)(2013-1#2)
with falls##6##2##(1993-11#1)(1993-2#1)(1996-1#1)(2008-11#1)(2013-1#2)
with false##3##2##(1996-6#2)(2013-8#1)
with false-negative##2##2##(2006-10#1)(2007-4#1)
with familial AD##2##3##(1994-8#1)(1996-5#1)
with familial Alzheimer's disease##4##4##(1991-10#1)(1992-3#3)
with familial Mediterranean fever##2##4##(2013-1#2)
with familial Mediterranean##3##3##(1993-7#1)(2013-1#2)
with familial amyloidotic polyneuropathy##6##4##(1990-6#2)(1992-1#2)(1992-8#2)
with familial and sporadic##2##4##(1992-12#1)(2010-12#1)
with familial and##3##3##(1992-12#1)(1997-5#1)(2010-12#1)
with familial breast cancer##2##4##(2007-6#2)
with familial hypercholesterolemia##5##3##(1990-2#1)(1992-8#1)(1993-9#2)(2006-10#1)
with familial##43##2##(1990-2#1)(1990-6#3)(1991-10#1)(1992-1#2)(1992-12#1)(1992-3#3)(1992-8#4)(1993-12#1)(1993-7#1)(1993-9#2)(1994-8#1)(1995-1#1)(1995-3#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-5#1)(2006-10#1)(2007-10#2)(2007-6#2)(2008-1#1)(2008-12#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
with families##8##2##(2006-10#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-3#2)(2013-1#1)
with family and##2##3##(2009-7#1)(2012-1#1)
with family history of##2##4##(2008-7#1)(2013-7#1)
with family members##4##3##(1993-1#1)(2007-11#1)(2010-11#1)(2013-1#1)
with family##14##2##(1990-12#1)(1993-1#1)(2007-11#1)(2007-7#1)(2008-7#2)(2008-9#2)(2009-7#1)(2010-11#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
with far less##2##3##(2010-2#1)(2011-2#1)
with far##5##2##(1997-4#1)(2007-9#1)(2008-2#1)(2010-2#1)(2011-2#1)
with far-reaching##2##2##(2007-7#1)(2012-2#1)
with farm animals##4##3##(2009-7#2)(2011-1#2)
with fascia lata##2##3##(2008-12#1)(2011-2#1)
with fast furnace analysis##2##4##(2008-10#2)
with fast response##2##3##(2007-8#1)(2008-10#1)
with fast##20##2##(1994-6#1)(1995-8#1)(1996-3#1)(2006-6#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-3#3)(2008-6#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)
with faster##5##2##(1993-2#1)(2008-10#1)(2008-8#1)(2010-2#1)(2010-4#1)
with fasting glucose##2##3##(2008-3#2)
with fasting##8##2##(1990-12#1)(1992-6#1)(1995-2#1)(1995-6#1)(2008-1#1)(2008-3#3)
with fat grafting##4##3##(2012-12#3)(2013-1#1)
with fat necrosis##2##3##(2006-4#1)(2013-1#1)
with fat##11##2##(1991-5#1)(2006-12#1)(2006-4#1)(2008-8#1)(2012-12#3)(2013-1#4)
with fatal infantile##2##3##(1991-4#1)(1996-3#1)
with fatal outcome##3##3##(2007-8#1)(2009-1#1)(2011-2#1)
with fatal trauma in##2##4##(2012-12#2)
with fatal##13##2##(1991-4#1)(1993-2#2)(1993-6#1)(1996-3#1)(1997-3#1)(2006-10#1)(2007-8#1)(2009-1#1)(2011-2#2)(2012-12#2)
with fatigue##6##2##(1993-9#3)(2005-12#1)(2010-8#1)(2011-1#1)
with fatty acid binding protein##2##5##(1994-8#2)
with fatty acid##6##3##(1994-8#2)(1996-4#1)(2008-10#1)(2009-8#1)(2012-2#1)
with fatty acids##2##3##(1992-6#1)(1995-2#1)
with fatty liver##3##3##(1990-4#2)(1997-3#1)
with fatty##13##2##(1990-4#2)(1992-6#1)(1994-8#2)(1994-9#1)(1995-2#1)(1996-4#1)(1997-3#1)(2008-10#1)(2009-8#1)(2012-2#1)(2013-7#1)
with favorable outcomes##2##3##(2006-10#1)(2008-3#1)
with favorable##8##2##(1992-12#1)(1993-10#1)(2006-10#1)(2006-12#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
with favourable##6##2##(1993-8#1)(2008-5#1)(2009-5#1)(2010-5#1)(2011-1#1)(2012-2#1)
with fear##2##2##(2010-4#1)(2012-2#1)
with features consistent with an##2##5##(2005-8#1)(2008-3#1)
with features consistent with##3##4##(2005-8#1)(2008-10#1)(2008-3#1)
with features indeterminate for MDS versus MPN&quot##3##7##(2009-8#3)
with features of congestive##2##4##(2008-11#1)(2011-1#1)
with features of##25##3##(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-4#2)(2010-5#1)(2011-1#3)(2011-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
with features such as##2##4##(2008-2#1)(2010-2#1)
with features##44##2##(1993-12#1)(1993-8#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#3)(2011-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
with febrile##11##2##(1990-3#1)(1993-11#1)(1995-9#1)(1996-3#1)(2007-11#1)(2011-2#2)(2012-12#4)
with fecal##2##2##(2009-12#1)(2011-1#1)
with feedback##3##2##(2007-11#1)(2007-12#1)(2012-2#1)
with feeding##7##2##(1994-2#1)(2007-10#1)(2009-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
with fellow##2##2##(1990-5#1)(1996-1#1)
with felodipine##2##2##(1992-4#1)(1995-11#1)
with female L(S)##2##3##(2010-8#2)
with female rats##2##3##(1991-3#1)(2007-6#1)
with female##18##2##(1991-3#1)(1997-3#1)(1997-7#1)(2006-12#1)(2007-12#1)(2007-6#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#2)(2010-8#2)(2011-1#1)(2012-12#2)
with females##6##2##(2009-5#1)(2010-8#1)(2012-12#4)
with femoral neck##3##3##(2005-12#1)(2007-8#1)(2010-3#1)
with femoral##7##2##(2005-12#1)(2007-11#1)(2007-5#1)(2007-8#1)(2010-3#1)(2013-1#2)
with femtosecond laser pulses in##2##5##(2007-12#1)(2008-3#1)
with femtosecond laser pulses##8##4##(2007-12#6)(2008-3#2)
with femtosecond pulses##7##3##(2007-11#1)(2007-12#5)(2008-2#1)
with femtosecond##19##2##(2007-11#3)(2007-12#13)(2008-2#1)(2008-3#2)
with fenofibrate##2##2##(2009-11#2)
with fentanyl 2##6##3##(2012-2#1)(2013-7#5)
with fentanyl##11##2##(1993-1#1)(1993-7#2)(2010-7#1)(2012-2#1)(2013-7#6)
with ferbam##2##2##(2008-10#2)
with ferric##4##2##(1990-2#1)(1991-7#1)(2007-12#1)(2008-4#1)
with ferroelectric##2##2##(2008-2#2)
with ferroprotoporphyrin IX##3##3##(1997-2#3)
with ferrous iron##2##3##(1992-3#2)
with ferrous##3##2##(1992-3#2)(2008-11#1)
with ferrozine by flow-injection analysis##2##5##(2008-10#2)
with ferrozine##3##2##(2008-10#3)
with fertility##4##2##(2007-11#1)(2008-9#1)(2011-1#1)(2013-8#1)
with ferulic acid##2##3##(1994-5#1)(2007-8#1)
with fetal chromosomal abnormalities##2##4##(1995-8#2)
with fetal rat spinal cord##2##5##(1991-11#2)
with fetal##24##2##(1991-1#1)(1991-11#2)(1991-2#1)(1992-12#1)(1992-6#1)(1993-5#1)(1993-7#1)(1994-3#1)(1994-5#1)(1995-8#5)(2005-11#1)(2006-10#1)(2006-8#1)(2008-11#1)(2008-3#2)(2010-3#1)(2012-2#1)(2012-3#1)
with fever and##16##3##(1990-12#2)(1992-4#1)(1992-6#1)(2006-10#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2009-10#1)(2009-9#1)(2011-1#1)(2013-1#1)
with fever of unknown origin##2##5##(1991-5#1)(2006-10#1)
with fever of##3##3##(1991-5#1)(2006-10#1)(2012-2#1)
with fever##48##2##(1990-10#1)(1990-11#1)(1990-12#3)(1991-5#1)(1992-4#1)(1992-6#1)(1993-1#1)(1994-6#1)(1996-12#1)(1997-6#1)(2005-12#1)(2006-10#4)(2006-4#1)(2006-5#2)(2006-7#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-11#1)(2009-10#1)(2009-11#2)(2009-3#1)(2009-9#1)(2010-12#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#3)
with fevers and##2##3##(2005-11#1)(2010-8#1)
with few adverse##2##3##(2006-10#1)(2008-10#1)
with few cases##3##3##(2008-10#1)(2013-1#2)
with few cells##2##3##(1991-10#1)(1995-12#1)
with few exceptions##5##3##(1996-8#1)(2006-1#1)(2006-10#1)(2007-8#1)(2008-7#1)
with few if any##2##4##(2007-4#1)(2011-3#1)
with few patients##2##3##(2006-10#1)(2008-3#1)
with few side effects##3##4##(2008-2#1)(2009-8#1)(2010-5#1)
with few##49##2##(1991-10#1)(1992-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-8#1)(1997-3#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-4#1)(2007-10#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-8#1)(2008-10#5)(2008-2#3)(2008-3#2)(2008-6#2)(2008-7#1)(2008-9#2)(2009-3#2)(2009-4#2)(2009-7#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#3)
with fewer complications##3##3##(2007-9#1)(2008-7#1)(2012-3#1)
with fewer deaths##2##3##(2005-12#1)(2012-2#1)
with fewer resources##2##3##(1993-2#1)(2008-11#1)
with fewer side effects##8##4##(1997-3#1)(2005-6#1)(2006-10#1)(2008-5#1)(2008-8#1)(2009-12#2)(2011-2#1)
with fewer than##5##3##(2006-10#1)(2006-7#1)(2008-1#1)(2011-2#2)
with fewer##50##2##(1990-12#1)(1991-9#1)(1992-8#1)(1993-2#1)(1996-4#1)(1997-3#1)(2004-11#1)(2005-12#1)(2005-6#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#2)(2006-7#1)(2007-11#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#3)(2012-3#2)(2013-8#1)
with fiber Bragg grating##3##4##(2007-11#2)(2008-2#1)
with fiber Bragg gratings##2##4##(2007-12#1)(2008-2#1)
with fiber Bragg##5##3##(2007-11#2)(2007-12#1)(2008-2#2)
with fiber##16##2##(1992-11#1)(1995-11#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#5)
with fiber-optic##5##2##(2008-2#3)(2008-3#2)
with fibers##3##2##(2008-11#1)(2010-12#1)(2012-2#1)
with fibre##2##2##(1995-12#1)(2008-7#1)
with fibres in the detection area##2##6##(1993-9#2)
with fibres##3##2##(1993-9#2)(2008-5#1)
with fibrin glue##2##3##(2007-8#1)(2008-3#1)
with fibrin##7##2##(1996-12#1)(2007-8#1)(2008-11#4)(2008-3#1)
with fibrinogen##7##2##(1990-11#1)(1991-8#1)(2006-6#1)(2006-9#1)(2007-7#1)(2008-11#1)(2008-5#1)
with fibrinogenase activity indicated that##2##5##(1992-8#1)(1994-6#1)
with fibrinolitic##2##2##(2008-10#2)
with fibrinolysis##3##2##(1995-9#1)(2008-3#2)
with fibroblast growth factor##2##4##(2008-11#1)(2012-12#1)
with fibroblast##7##2##(1990-8#1)(1991-10#1)(2007-12#1)(2008-11#1)(2009-8#1)(2011-2#1)(2012-12#1)
with fibroblasts##2##2##(1991-6#1)(1994-6#1)
with fibroids##2##2##(1994-2#1)(2010-11#1)
with fibromuscular dysplasia##2##3##(1991-8#1)(2007-9#1)
with fibromyalgia and##2##3##(1991-5#1)(2006-8#1)
with fibromyalgia as##2##3##(2006-8#2)
with fibromyalgia##13##2##(1991-5#3)(1996-2#1)(2006-10#5)(2006-8#3)(2010-4#1)
with fibronectin##5##2##(1991-5#1)(2008-11#2)(2010-1#1)(2013-8#1)
with fibrosis##5##2##(2005-11#1)(2006-10#1)(2006-6#1)(2009-8#1)(2011-2#1)
with fibrous##9##2##(1991-12#1)(2005-10#1)(2005-11#1)(2007-12#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#2)
with field data##3##3##(2004-11#1)(2008-10#2)
with field observations##2##3##(2008-8#1)(2008-9#1)
with field##10##2##(2004-11#1)(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-8#1)
with fifteen##2##2##(2006-8#1)(2008-2#1)
with figures##3##2##(1993-10#1)(2008-9#1)(2011-7#1)
with filamentous##4##2##(1997-6#1)(2008-10#1)(2012-11#2)
with filariasis##3##2##(2007-6#1)(2007-7#2)
with files and##2##3##(2008-12#1)(2008-9#1)
with filgrastim##2##2##(2008-7#2)
with fill factors##2##3##(2007-12#1)(2008-2#1)
with fill##3##2##(2007-12#1)(2008-2#2)
with films of##2##3##(2007-5#1)(2008-10#1)
with films##4##2##(1997-8#1)(2007-11#1)(2007-5#1)(2008-10#1)
with filtering##4##2##(2004-9#1)(2005-9#1)(2007-12#2)
with filters##2##2##(1997-1#1)(2008-6#1)
with final##9##2##(1992-2#1)(1996-5#1)(2007-10#1)(2008-10#2)(2008-12#2)(2008-4#1)(2011-2#1)
with financial incentives##2##3##(1994-2#1)(2007-4#1)
with financial support##2##3##(2008-4#1)(2010-10#1)
with financial##9##2##(1993-12#1)(1994-1#1)(1994-12#1)(1994-2#1)(2007-4#1)(2008-11#1)(2008-4#1)(2009-2#1)(2010-10#1)
with finasteride##2##2##(2013-1#2)
with finding##2##2##(1991-7#1)(1995-12#1)
with findings from##3##3##(1994-6#1)(2006-11#1)(2007-12#1)
with findings in##6##3##(1990-12#1)(1990-5#1)(1990-6#1)(1997-3#1)(2007-5#1)(2008-3#1)
with findings of##6##3##(1993-12#1)(1997-3#1)(2005-12#1)(2006-10#2)(2007-10#1)
with findings on conventional##2##4##(2008-5#1)(2008-7#1)
with findings on##4##3##(1997-2#1)(2008-5#1)(2008-7#1)(2010-9#1)
with findings##21##2##(1990-12#1)(1990-5#1)(1990-6#1)(1993-12#1)(1994-6#1)(1997-2#1)(1997-3#2)(2005-12#1)(2006-10#2)(2006-11#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-9#1)(2012-12#1)(2012-3#1)
with fine temporal resolution##2##4##(2007-12#1)(2010-8#1)
with fine##7##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-4#1)(2010-8#1)
with fine-needle aspiration##2##3##(2007-5#1)(2012-2#1)
with finely granular##2##3##(2008-7#1)(2012-1#1)
with finely##4##2##(1995-2#1)(2004-2#1)(2008-7#1)(2012-1#1)
with finite##3##2##(2007-12#2)(2008-2#1)
with fire##2##2##(1996-8#1)(2004-9#1)
with firm##3##2##(1992-1#1)(1993-3#1)(2007-7#1)
with first ischemic stroke##2##4##(2007-10#2)
with first##12##2##(1990-12#1)(2005-8#1)(2007-10#3)(2007-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-6#1)(2011-1#1)(2013-8#1)
with first-degree##2##2##(2007-7#1)(2013-8#1)
with first-episode schizophrenia##2##3##(2008-6#1)(2011-1#1)
with first-ever stroke##2##3##(2007-10#2)
with first-ever##3##2##(2007-10#2)(2009-10#1)
with first-order##3##2##(1994-8#1)(1995-8#1)(2007-12#1)
with fish oil##3##3##(1990-2#1)(1991-2#1)(2008-7#1)
with fish##11##2##(1990-2#1)(1991-2#1)(1992-1#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)
with fish-oil##3##2##(2006-8#3)
with fistula##2##2##(2007-8#2)
with fitness##3##2##(1995-2#1)(2008-8#2)
with five cases of##2##4##(2008-6#1)(2013-8#1)
with five different##8##3##(1992-12#1)(1993-11#1)(2004-11#1)(2008-10#1)(2008-8#1)(2009-9#1)(2010-4#1)(2012-1#1)
with five injections##2##3##(2008-10#2)
with five primary##2##3##(1990-12#1)(1996-12#1)
with five restriction enzymes##2##4##(2008-10#2)
with five strands##2##3##(1994-8#1)(1995-11#1)
with five##57##2##(1990-12#1)(1990-9#1)(1991-5#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-11#2)(1996-12#1)(1996-2#1)(1996-6#1)(1997-6#1)(2004-11#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#2)(2008-10#16)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-9#1)(2010-11#1)(2010-4#1)(2012-1#2)(2012-12#1)(2013-7#2)(2013-8#1)
with fivefold##2##2##(1992-6#1)(2008-2#1)
with fixed and random##2##4##(1995-12#1)(2008-10#1)
with fixed appliances##4##3##(2012-12#2)(2013-1#1)(2013-8#1)
with fixed##21##2##(1992-2#1)(1992-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-9#1)(2010-12#1)(2010-6#1)(2011-12#1)(2012-12#2)(2013-1#3)(2013-8#1)
with flame atomic absorption spectrometry (FAAS)##6##6##(2007-8#1)(2008-10#5)
with flame atomic absorption spectrometry##11##5##(2007-8#1)(2008-10#9)(2013-8#1)
with flame atomic absorption##12##4##(2007-8#1)(2008-10#10)(2013-8#1)
with flame ionisation detection##2##4##(2008-10#2)
with flame ionization detection##3##4##(1990-9#1)(2008-5#2)
with flame ionization detector##2##4##(2008-10#1)(2012-1#1)
with flame ionization##5##3##(1990-9#1)(2008-10#1)(2008-5#2)(2012-1#1)
with flame photometric detection##3##4##(1993-1#2)(2008-10#1)
with flame photometric##4##3##(1993-1#2)(2008-10#2)
with flame##26##2##(1990-9#1)(1993-1#2)(2007-5#1)(2007-8#1)(2008-10#17)(2008-5#2)(2012-1#1)(2013-8#1)
with flanking##3##2##(1993-12#1)(1994-12#2)
with flap##2##2##(2008-2#1)(2013-8#1)
with flapless surgery##3##3##(2013-1#3)
with flapless##4##2##(2008-4#1)(2013-1#3)
with flat surfaces##3##3##(2008-3#2)(2008-5#1)
with flat##10##2##(1995-2#1)(1995-6#1)(2008-3#3)(2008-5#1)(2010-4#2)(2012-1#2)
with flexible##8##2##(1993-12#1)(2005-4#1)(2006-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)(2012-1#1)
with flexion##2##2##(2006-8#1)(2008-8#1)
with flow cytometer##3##3##(2006-8#3)
with flow cytometry##5##3##(1991-10#1)(2007-9#1)(2008-9#1)(2011-3#1)(2012-11#1)
with flow injection (FI)##4##4##(2007-8#1)(2008-10#3)
with flow injection analysis (FIA)##2##5##(2008-10#2)
with flow injection analysis##7##4##(2008-10#7)
with flow injection##17##3##(2005-4#1)(2007-8#1)(2008-10#15)
with flow rate##3##3##(2008-5#1)(2010-12#1)(2011-2#1)
with flow##32##2##(1991-10#1)(2004-9#1)(2005-4#1)(2006-8#3)(2007-8#2)(2007-9#1)(2008-10#16)(2008-5#1)(2008-9#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-11#1)(2013-7#1)
with flow-injection analysis (FIA)##2##4##(2008-10#2)
with flow-injection analysis##3##3##(2008-10#3)
with flow-injection##6##2##(2008-10#5)(2010-4#1)
with flower##4##2##(2008-10#2)(2009-12#2)
with flows##3##2##(2004-11#1)(2007-7#1)(2008-10#1)
with fluconazole##5##2##(1991-2#1)(1992-11#1)(2006-8#1)(2007-7#1)(2008-5#1)
with fluence rates of##2##4##(2008-7#2)
with fluence##4##2##(2007-12#2)(2008-7#2)
with fluid##12##2##(1993-8#1)(1995-11#1)(2006-4#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-12#2)
with fluocinonide 0##3##3##(2010-8#3)
with fluorescamine##2##2##(1992-1#1)(2008-10#1)
with fluorescein##9##2##(1993-6#1)(1995-1#1)(1995-5#1)(1996-1#1)(1996-5#1)(2007-8#1)(2008-10#2)(2008-9#1)
with fluorescence detection (HPLC-FD)##2##4##(2008-10#2)
with fluorescence detection and##4##4##(2008-10#4)
with fluorescence detection##31##3##(1990-11#1)(1990-8#4)(1991-5#1)(1992-2#1)(1993-2#2)(1996-5#1)(1996-8#1)(1997-8#1)(2006-10#1)(2008-10#16)(2008-11#1)(2010-12#1)
with fluorescence microscopy##3##3##(1995-5#1)(1996-9#1)(2008-11#1)
with fluorescence polarization##2##3##(2008-2#1)(2008-4#1)
with fluorescence quantum##2##3##(2008-10#1)(2008-7#1)
with fluorescence spectroscopy and multivariate calibration##2##6##(2008-10#2)
with fluorescence spectroscopy##3##3##(2008-10#2)(2009-11#1)
with fluorescence##53##2##(1990-11#1)(1990-8#4)(1991-5#1)(1992-2#1)(1993-2#3)(1994-8#1)(1995-5#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-8#1)(2006-10#1)(2008-10#24)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-12#1)(2012-2#1)(2013-1#1)
with fluorescent dye##2##3##(2006-12#1)(2008-3#1)
with fluorescent dyes##2##3##(2006-6#1)(2008-10#1)
with fluorescent##17##2##(1993-11#1)(1993-8#1)(2004-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-4#2)(2010-12#1)(2012-1#1)(2012-12#1)
with fluorescently labeled##3##3##(2008-3#1)(2008-4#1)(2012-3#1)
with fluoride and 2-(5-bromo-2-pyridylazo)-5-diethylaminophenol##2##4##(2008-10#2)
with fluoride##10##2##(1990-9#1)(1993-11#1)(1995-11#1)(2008-10#6)(2009-5#1)
with fluorimetric detection##13##3##(1990-6#1)(1990-8#2)(1997-3#1)(1997-8#1)(2008-10#8)
with fluorimetric##14##2##(1990-6#1)(1990-8#2)(1997-3#1)(1997-8#1)(2008-10#9)
with fluorinated side chains##2##4##(2009-7#2)
with fluorinated##4##2##(2009-7#3)(2013-1#1)
with fluorine in##2##3##(2007-12#1)(2009-9#1)
with fluorine##8##2##(1992-5#1)(2007-12#4)(2009-9#2)(2010-12#1)
with fluorochromes##3##2##(2008-1#1)(2008-11#1)(2008-4#1)
with fluorometric detection##3##3##(1991-10#1)(1993-2#1)(1995-11#1)
with fluorometric##4##2##(1991-10#1)(1993-2#1)(1995-11#1)(2008-10#1)
with fluorophores##2##2##(2008-4#2)
with fluoropyrimidine##2##2##(1992-8#2)
with fluoroquinolones##2##2##(1991-12#1)(2010-4#1)
with fluorosis##2##2##(2011-2#2)
with fluorouracil##4##2##(1992-8#2)(1994-4#1)(2008-5#1)
with fluoxetine hydrochloride##2##3##(2005-10#2)
with fluoxetine##7##2##(1993-2#1)(1996-12#1)(1997-5#1)(2005-10#2)(2013-1#2)
with fluvoxamine##2##2##(1996-8#1)(2004-3#1)
with flying##3##2##(1990-8#1)(1992-3#1)(2008-2#1)
with foamy macrophages##2##3##(2010-3#1)(2012-3#1)
with focal 6-o'-clock Nd##2##4##(2011-2#2)
with focal brain##2##3##(2007-2#1)(2008-11#1)
with focal left hemisphere##2##4##(1996-5#1)(2008-9#1)
with focal lengths##2##3##(2007-12#1)(2008-3#1)
with focal##28##2##(1996-5#1)(1997-3#3)(1997-8#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-11#1)(2008-3#2)(2008-9#1)(2010-8#1)(2011-2#4)(2012-2#1)(2013-1#3)(2013-8#1)
with foci of##4##3##(2008-6#1)(2010-12#1)(2013-1#2)
with focus on##13##3##(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-4#1)(2011-1#1)(2013-1#1)
with focus##15##2##(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-1#1)
with focused##7##2##(1995-5#1)(2006-5#1)(2007-11#2)(2007-12#2)(2008-10#1)
with foetal##3##2##(1993-1#1)(2007-7#1)(2012-2#1)
with folate deficiency##2##3##(1992-9#1)(2008-7#1)
with folate##7##2##(1991-2#1)(1991-5#1)(1992-9#1)(1995-2#2)(2008-7#1)(2012-1#1)
with folic acid##10##3##(1992-9#1)(1993-2#1)(2005-10#2)(2006-2#1)(2008-3#2)(2008-7#1)(2011-1#1)(2012-1#1)
with follicular##6##2##(1991-10#1)(2005-8#1)(2010-11#2)(2010-3#1)(2012-3#1)
with follow-up of##2##3##(2008-7#1)(2012-12#1)
with follow-up##13##2##(1994-12#1)(2004-2#1)(2005-9#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-7#1)(2009-10#1)(2012-12#1)(2012-2#1)(2013-1#2)
with following##2##2##(1990-11#1)(2008-10#1)
with food supply##2##3##(2009-3#1)(2012-12#1)
with food##22##2##(1991-5#1)(1993-6#2)(1995-10#1)(2005-8#1)(2007-12#2)(2007-2#1)(2007-3#1)(2008-1#1)(2009-3#1)(2011-1#2)(2011-2#1)(2012-1#3)(2012-12#3)(2012-2#1)(2013-1#1)
with food-related##5##2##(2006-10#1)(2012-2#4)
with foods##3##2##(1997-4#1)(2007-12#1)(2008-11#1)
with for##3##2##(1994-11#1)(2008-11#1)(2012-12#1)
with for-profit##2##2##(1994-5#1)(2008-11#1)
with force##3##2##(2008-2#2)(2010-2#1)
with forced##3##2##(2006-12#1)(2007-12#1)(2007-7#1)
with forceps##2##2##(2007-8#1)(2008-2#1)
with forearm##2##2##(2007-7#1)(2008-5#1)
with forebrain##3##2##(1991-3#1)(1993-7#1)(2013-1#1)
with foreign body##3##3##(2006-10#1)(2012-12#2)
with foreign##8##2##(1990-10#1)(1990-3#1)(1994-12#1)(1997-6#1)(2006-10#1)(2007-12#1)(2012-12#2)
with forensic##2##2##(1996-6#1)(2005-6#1)
with forest##3##2##(1995-3#1)(2008-10#1)(2012-12#1)
with formal##5##2##(2006-3#1)(2007-6#1)(2008-10#1)(2013-1#2)
with formaldehyde and##3##3##(2008-10#3)
with formaldehyde was##2##3##(2007-11#1)(2008-10#1)
with formaldehyde##19##2##(1995-2#1)(1997-4#1)(2007-11#3)(2008-1#1)(2008-10#4)(2008-2#3)(2008-4#1)(2008-8#3)(2010-12#1)(2011-2#1)
with formalin##3##2##(1996-12#1)(2008-5#1)(2010-2#1)
with formation of a##5##4##(1993-11#1)(1994-5#1)(2005-11#1)(2008-10#1)(2009-2#1)
with formation of the##2##4##(1994-3#1)(1996-5#1)
with formation of##19##3##(1990-2#1)(1990-3#1)(1990-7#1)(1991-5#1)(1992-3#1)(1993-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-5#1)(2005-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)(2009-2#1)(2010-3#1)
with formic acid##5##3##(1990-7#1)(1992-4#1)(2007-11#1)(2008-10#1)(2008-11#1)
with formic##6##2##(1990-7#1)(1992-4#1)(2007-11#1)(2008-10#2)(2008-11#1)
with forms##2##2##(2008-4#1)(2008-7#1)
with formyl-methionyl-leucyl-phenylalanine##2##2##(1990-7#1)(1996-2#1)
with forskolin or##2##3##(1995-5#1)(2008-11#1)
with forskolin##11##2##(1990-3#1)(1992-6#2)(1994-12#1)(1995-12#1)(1995-5#1)(1995-8#2)(1997-1#1)(1997-5#1)(2008-11#1)
with forward##4##2##(2008-3#1)(2008-9#1)(2012-1#1)(2012-11#1)
with fosfomycin##4##2##(2008-10#1)(2008-5#1)(2012-2#2)
with foundational##2##2##(2007-2#1)(2012-12#1)
with four different strains of##2##5##(2008-5#2)
with four different##14##3##(1990-12#1)(1993-9#1)(2005-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2010-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
with four enzymes##2##3##(2008-10#2)
with four grades (A##3##4##(2013-4#3)
with four human IgG##2##4##(2013-1#2)
with four major##2##3##(2006-5#1)(2008-10#1)
with four or five##2##4##(2008-10#1)(2008-5#1)
with four or more##2##4##(1995-5#1)(1997-7#1)
with four or##4##3##(1995-5#1)(1997-7#1)(2008-10#1)(2008-5#1)
with four other##4##3##(1992-3#1)(1993-9#1)(2008-10#2)
with four oximate##2##3##(1997-7#2)
with four pairs of##3##4##(1992-3#1)(2008-2#1)(2010-7#1)
with four replications##5##3##(2008-10#1)(2008-12#4)
with four restriction enzymes##2##4##(1997-2#1)(2008-10#1)
with four to##2##3##(2008-10#1)(2008-5#1)
with four water##2##3##(2006-1#1)(2008-10#1)
with four##123##2##(1990-12#1)(1991-7#1)(1992-2#1)(1992-3#2)(1993-12#1)(1993-7#1)(1993-9#2)(1994-3#3)(1994-8#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-4#1)(1997-2#1)(1997-6#2)(1997-7#3)(2004-10#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-5#2)(2006-7#1)(2007-1#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-5#1)(2008-10#23)(2008-12#6)(2008-2#7)(2008-3#4)(2008-5#8)(2008-6#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#2)(2012-9#1)(2013-1#3)(2013-4#3)(2013-7#1)(2013-8#3)
with four-wave mixing in bismuth silicon oxide crystal by use of moving gratings##2##13##(2008-3#2)
with fractal dimensions##2##3##(2005-11#1)(2008-3#1)
with fractal##5##2##(2005-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-2#1)
with fracture of##3##3##(2008-7#1)(2011-2#1)(2013-8#1)
with fracture##7##2##(1991-11#1)(2008-3#1)(2008-7#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
with fractures of##3##3##(2007-11#1)(2008-9#2)
with fractures##6##2##(2007-11#2)(2008-9#3)(2011-12#1)
with fragile X syndrome##2##4##(2006-12#1)(2009-10#1)
with fragile##4##2##(2006-12#1)(2007-9#1)(2009-10#1)(2013-1#1)
with fragility##2##2##(2012-11#2)
with fragmented DNA##2##3##(1996-1#1)(1997-4#1)
with fragments of##2##3##(2006-7#1)(2010-5#1)
with fragments##4##2##(1990-5#1)(1992-3#1)(2006-7#1)(2010-5#1)
with frame##2##2##(2005-10#1)(2008-11#1)
with free access to##2##4##(1992-12#1)(2008-7#1)
with free radical##2##3##(2008-1#1)(2008-8#1)
with free radicals##2##3##(1992-9#1)(1993-12#1)
with free silk##2##3##(2011-1#2)
with free standing##2##3##(2008-10#2)
with free text data entry and limited structure##2##8##(2011-1#2)
with free vascularized##3##3##(1996-8#2)(2008-9#1)
with free##40##2##(1990-2#1)(1990-4#1)(1990-5#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-8#1)(1996-1#1)(1996-7#1)(1996-8#2)(2006-8#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2011-1#4)(2012-2#1)
with free-living##2##2##(1997-6#1)(2006-10#1)
with free-space##3##2##(2008-2#1)(2008-3#2)
with freezing##2##2##(2008-8#1)(2010-12#1)
with frequencies##4##2##(1993-3#1)(1994-11#1)(2007-12#1)(2010-8#1)
with frequency combs##2##3##(2007-11#2)
with frequency of##4##3##(1997-8#1)(2007-12#1)(2007-9#1)(2008-10#1)
with frequency##9##2##(1997-8#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2012-1#1)(2013-1#1)
with frequency-dependent##2##2##(2007-12#1)(2008-10#1)
with frequency-domain photon migration##2##4##(2008-3#2)
with frequency-domain##3##2##(2008-3#3)
with frequency-doubled##2##2##(2007-11#1)(2008-3#1)
with frequency-modulated##2##2##(2008-3#2)
with frequency-resolved optical gating##2##4##(2007-12#2)
with frequent##32##2##(1991-4#1)(1994-3#1)(1997-6#1)(2005-7#1)(2006-5#1)(2006-9#2)(2007-11#5)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#2)(2009-6#2)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
with fresh frozen##2##3##(1991-7#1)(2008-8#1)
with fresh medium##2##3##(1990-3#1)(2008-11#1)
with fresh or##2##3##(2006-5#1)(2012-5#1)
with fresh semen##3##3##(2006-5#3)
with fresh water##3##3##(2008-10#2)(2012-5#1)
with fresh##25##2##(1990-3#1)(1991-2#1)(1991-7#1)(1992-6#1)(1995-3#1)(1996-1#1)(1996-9#1)(2006-5#5)(2007-12#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-5#2)
with freshly isolated##2##3##(1990-12#1)(1994-11#1)
with freshly##4##2##(1990-12#1)(1992-6#1)(1994-11#1)(2006-5#1)
with friends and family##4##4##(1997-2#1)(2010-8#1)(2013-1#2)
with friends and##7##3##(1997-2#1)(2010-4#1)(2010-8#2)(2011-2#1)(2013-1#2)
with friends##8##2##(1993-10#1)(1997-2#1)(2010-4#1)(2010-8#2)(2011-2#1)(2013-1#2)
with fringe##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
with frontal##8##2##(1994-6#1)(2006-11#1)(2008-4#1)(2008-9#2)(2009-6#1)(2012-12#1)(2013-1#1)
with frontotemporal##3##2##(2008-9#2)(2009-9#1)
with frozen##2##2##(1995-2#1)(2006-5#1)
with frozen-thawed##3##2##(2006-5#3)
with fructose##3##2##(1991-2#1)(1997-2#2)
with fruit##5##2##(1991-11#1)(1992-1#1)(2008-10#3)
with full disability pension##2##4##(2006-8#2)
with full length##2##3##(1992-9#1)(1995-3#1)
with full##38##2##(1990-12#1)(1991-9#1)(1992-7#1)(1992-9#1)(1994-2#2)(1995-3#1)(1996-3#1)(2006-8#2)(2007-11#3)(2008-10#4)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#3)(2011-2#5)(2012-1#1)(2012-11#1)(2013-1#4)
with full- and reduced-resolution correlators##2##5##(2008-3#2)
with full-blown##2##2##(1995-9#1)(2008-1#1)
with full-length##5##2##(1992-9#1)(1993-1#1)(1995-10#1)(2006-12#1)(2008-9#1)
with fullerene##2##2##(2008-12#1)(2010-7#1)
with fully##9##2##(1990-8#1)(1991-8#1)(1996-5#1)(1997-5#1)(2007-8#1)(2008-4#1)(2008-6#1)(2010-2#1)(2011-1#1)
with fulminant##6##2##(1990-10#1)(1990-8#1)(2006-10#1)(2007-5#1)(2008-11#1)(2013-1#1)
with fumaric acid##4##3##(1990-6#2)(2007-8#1)(2012-3#1)
with fumigated##2##2##(2008-10#1)(2008-11#1)
with fumonisin##2##2##(2008-10#2)
with fumonisins##2##2##(2008-10#1)(2013-8#1)
with function##3##2##(1990-10#1)(2009-2#1)(2012-2#1)
with functional imaging##2##3##(2006-3#1)(2009-12#1)
with functional or##2##3##(1995-3#1)(2007-12#1)
with functional##36##2##(1990-10#1)(1990-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-2#1)(1995-3#1)(1995-8#1)(1996-7#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-3#2)(2013-1#2)(2013-8#1)
with functionalized##2##2##(2008-10#1)(2010-2#1)
with functionally##4##2##(2006-10#1)(2007-8#1)(2008-11#1)(2008-9#1)
with functioning graft##2##3##(2007-7#1)(2008-1#1)
with functioning##6##2##(1997-1#1)(2007-7#1)(2008-1#1)(2008-8#1)(2010-2#1)(2012-12#1)
with functions##4##2##(1994-3#1)(2008-5#1)(2008-9#1)(2011-1#1)
with fundamental##2##2##(2006-3#1)(2008-10#1)
with funding from the##2##4##(2008-5#1)(2010-3#1)
with funding from##3##3##(2008-5#1)(2010-10#1)(2010-3#1)
with funding##5##2##(2008-11#2)(2008-5#1)(2010-10#1)(2010-3#1)
with fungal infection##2##3##(2008-10#2)
with fungal##9##2##(1997-4#1)(2007-8#1)(2008-10#5)(2009-2#1)(2010-7#1)
with fungicide##2##2##(2008-10#2)
with fungicides##4##2##(2008-10#3)(2008-12#1)
with fura-2##3##2##(1992-5#1)(1992-6#1)(1994-2#1)
with furosemide##8##2##(1991-8#1)(1992-8#5)(2008-10#1)(2012-2#1)
with furrow##3##2##(2008-10#3)
with further development##2##3##(2005-8#1)(2008-12#1)
with further evidence##2##3##(2006-10#1)(2013-7#1)
with further increases in##2##4##(1994-8#1)(2008-10#1)
with further reduction##2##3##(1996-3#1)(2008-7#1)
with further##36##2##(1991-1#1)(1993-10#1)(1994-8#1)(1995-3#1)(1996-3#1)(1996-4#1)(2004-1#1)(2005-11#1)(2005-8#1)(2006-10#3)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)(2011-1#2)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
with fused##2##2##(1996-6#1)(2010-5#1)
with fusion for##2##3##(2008-10#1)(2012-12#1)
with fusion##11##2##(1992-1#1)(1996-9#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-10#1)(2012-12#4)
with future experiments##2##3##(2010-12#1)(2012-3#1)
with future##16##2##(1995-12#1)(1996-2#1)(2006-7#1)(2008-11#1)(2008-2#1)(2008-3#2)(2010-12#1)(2010-5#1)(2010-8#2)(2012-1#2)(2012-3#1)(2013-1#2)
with g = 2##2##4##(1991-7#1)(2007-11#1)
with g##3##2##(1991-7#1)(1997-7#1)(2007-11#1)
with gadolinium##3##2##(1991-12#1)(1996-2#1)(2006-1#1)
with gain##6##2##(2007-11#1)(2008-1#1)(2008-3#3)(2012-1#1)
with galactose##2##2##(1990-2#2)
with gallbladder##3##2##(1991-8#1)(2008-5#1)(2010-1#1)
with gallstones##5##2##(1991-3#1)(2006-2#1)(2006-6#1)(2009-3#1)(2010-5#1)
with gamma knife##2##3##(2006-12#1)(2013-8#1)
with gamma##9##2##(1990-11#1)(1994-9#1)(2005-11#1)(2006-12#2)(2008-8#2)(2010-6#1)(2013-8#1)
with gamma-aminobutyric acid##2##3##(1990-8#1)(1995-11#1)
with gamma-aminobutyric##3##2##(1990-8#1)(1992-3#1)(1995-11#1)
with gamma-globulin##2##2##(1993-11#1)(2008-10#1)
with gamma-interferon##2##2##(1990-11#1)(2009-12#1)
with gamma-knife##2##2##(2008-7#2)
with gamma-tubulin##2##2##(2008-5#2)
with ganciclovir##2##2##(1991-8#1)(2010-7#1)
with ganglioside##2##2##(1991-5#1)(1992-3#1)
with gangrene##2##2##(2007-7#1)(2012-2#1)
with gas cell measurements and##2##5##(2008-3#2)
with gas chromatography##6##3##(2007-8#1)(2008-10#3)(2008-2#1)(2011-12#1)
with gas chromatography-mass spectrometry (GC-MS)##4##5##(2008-10#4)
with gas chromatography-mass spectrometry##5##4##(2008-10#5)
with gas##25##2##(2007-12#1)(2007-8#1)(2008-10#16)(2008-2#1)(2008-3#2)(2011-12#1)(2012-12#2)(2013-1#1)
with gaseous##2##2##(2007-8#1)(2008-3#1)
with gasoline##2##2##(2008-10#1)(2012-12#1)
with gastric cancer in##2##4##(2007-11#1)(2011-2#1)
with gastric cancer##17##3##(1992-6#1)(1996-5#1)(2006-10#2)(2007-11#1)(2007-3#1)(2008-6#1)(2009-6#1)(2010-12#3)(2011-2#6)
with gastric carcinoma##2##3##(2006-2#1)(2007-11#1)
with gastric disorders##2##3##(2006-10#1)(2012-12#1)
with gastric metaplasia##2##3##(2008-5#2)
with gastric ulcer##3##3##(2007-8#1)(2008-11#1)(2008-12#1)
with gastric##40##2##(1990-2#2)(1992-6#1)(1992-9#1)(1993-8#1)(1996-5#1)(2005-8#1)(2006-10#3)(2006-2#2)(2007-10#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-12#3)(2008-5#2)(2008-6#1)(2009-6#1)(2010-12#3)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
with gastritis##3##2##(2006-10#1)(2006-8#1)(2008-9#1)
with gastroesophageal reflux disease##7##4##(2006-10#1)(2006-2#1)(2009-11#1)(2009-2#1)(2010-12#1)(2013-8#2)
with gastroesophageal reflux##11##3##(2006-10#1)(2006-2#1)(2008-4#2)(2009-11#1)(2009-2#1)(2010-12#1)(2013-1#1)(2013-8#3)
with gastroesophageal##12##2##(2006-10#1)(2006-2#1)(2008-4#2)(2009-11#1)(2009-2#1)(2010-12#1)(2013-1#2)(2013-8#3)
with gastrointestinal (GI)##3##3##(2005-10#1)(2008-10#1)(2012-1#1)
with gastrointestinal bleeding##3##3##(2007-8#1)(2008-12#1)(2013-8#1)
with gastrointestinal disorders##2##3##(2006-8#1)(2009-6#1)
with gastrointestinal symptoms##5##3##(1991-10#1)(1997-8#1)(2006-10#1)(2006-8#1)(2008-2#1)
with gastrointestinal tract##5##3##(1990-3#1)(2006-10#1)(2007-4#2)(2009-4#1)
with gastrointestinal##33##2##(1990-3#1)(1990-6#1)(1990-8#1)(1991-10#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-8#1)(2005-10#1)(2006-10#3)(2006-8#3)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-12#1)(2009-4#1)(2009-6#1)(2012-1#1)(2013-7#1)(2013-8#1)
with gated##2##2##(2007-11#1)(2012-2#1)
with gefitinib##2##2##(2010-5#1)(2010-8#1)
with gel##4##2##(1990-4#1)(2005-11#1)(2008-10#1)(2011-1#1)
with gelatin using glutaraldehyde and fixed on##2##7##(2008-10#2)
with gelatin##8##2##(2007-10#1)(2008-10#5)(2008-4#1)(2011-2#1)
with gemcitabine##5##2##(2006-6#1)(2008-3#3)(2010-12#1)
with gender and age##2##4##(2011-2#2)
with gender and##4##3##(2008-12#1)(2011-1#1)(2011-2#2)
with gender dysphoria##2##3##(2012-2#2)
with gender stereotypes##2##3##(2011-1#2)
with gender##14##2##(2006-9#1)(2008-12#1)(2008-7#1)(2011-1#3)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
with gene constructs##2##3##(2008-10#1)(2008-11#1)
with gene expression data##2##4##(2006-10#1)(2008-7#1)
with gene expression in##3##4##(2008-10#1)(2008-11#1)(2009-4#1)
with gene expression##9##3##(1994-3#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-4#1)(2011-12#1)(2012-2#1)
with gene therapy in##2##4##(2005-11#1)(2008-4#1)
with gene therapy##7##3##(2005-11#1)(2007-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-12#1)
with gene##26##2##(1990-12#1)(1994-3#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-3#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#2)
with general anaesthesia results in##2##5##(2007-8#2)
with general anaesthesia##6##3##(1993-4#2)(2006-10#1)(2007-8#3)
with general anesthesia##4##3##(1990-12#1)(2006-4#1)(2011-2#1)(2012-3#1)
with general##32##2##(1990-12#2)(1993-1#1)(1993-4#2)(1993-8#1)(1994-11#1)(1995-8#2)(1996-4#1)(1997-3#1)(2005-5#1)(2005-8#1)(2006-10#3)(2006-4#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-8#3)(2008-3#3)(2008-5#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
with generalised##5##2##(2005-7#1)(2007-7#1)(2008-11#1)(2008-7#1)(2011-2#1)
with generalized anxiety disorder##5##4##(2006-8#3)(2009-2#1)(2010-2#1)
with generalized convulsive##2##3##(2012-2#1)(2013-8#1)
with generalized estimating equations##2##4##(1995-2#1)(1996-8#1)
with generalized linear##2##3##(2008-10#2)
with generalized resistance to thyroid hormone##3##6##(1995-10#2)(1995-8#1)
with generalized weakness and##2##4##(2010-8#1)(2012-2#1)
with generalized##39##2##(1990-3#1)(1993-10#1)(1995-10#2)(1995-2#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-8#1)(1997-1#1)(2005-11#1)(2006-8#3)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-7#2)(2009-11#1)(2009-2#1)(2009-6#2)(2010-2#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
with generally higher##2##3##(1991-2#1)(2005-10#1)
with generally##8##2##(1991-11#1)(1991-2#1)(1992-6#1)(1996-8#1)(2005-10#1)(2007-10#1)(2008-2#1)(2012-12#1)
with generating##2##2##(1993-3#1)(2010-5#1)
with generation of##3##3##(1992-12#2)(2011-12#1)
with generation##6##2##(1992-12#2)(2008-1#1)(2008-10#1)(2011-12#2)
with genes encoding##3##3##(1993-3#1)(2006-12#1)(2008-10#1)
with genes from other organisms##2##5##(1996-3#1)(1997-6#1)
with genes involved in##2##4##(2008-10#1)(2009-12#1)
with genes##14##2##(1993-3#1)(1993-9#1)(1994-12#1)(1996-3#1)(1997-3#1)(1997-6#1)(2006-12#1)(2006-2#1)(2008-10#2)(2008-9#1)(2009-12#1)(2011-2#1)(2012-1#1)
with genetic algorithms##2##3##(2008-3#2)
with genetic and##5##3##(2006-10#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-12#1)
with genetic diseases##2##3##(1996-4#1)(2008-9#1)
with genetic##41##2##(1991-3#1)(1993-7#1)(1994-3#1)(1996-2#1)(1996-4#1)(2004-11#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
with genetically##3##2##(1991-10#1)(1994-11#1)(1996-6#1)
with genistein##3##2##(2008-10#2)(2008-4#1)
with genital herpes##3##3##(2007-12#1)(2008-10#1)(2008-8#1)
with genital lesions##2##3##(2007-7#1)(2008-10#1)
with genital prolapse##4##3##(2006-4#3)(2007-4#1)
with genital##18##2##(1990-12#1)(1996-12#1)(2005-10#1)(2006-4#3)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#5)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
with genitourinary##3##2##(2006-9#1)(2008-10#1)(2009-10#1)
with genome##2##2##(2007-12#1)(2007-6#1)
with genome-wide##3##2##(2009-5#1)(2010-12#1)(2010-5#1)
with genomic DNA##5##3##(1990-12#1)(1997-7#1)(2008-10#2)(2008-2#1)
with genomic##12##2##(1990-12#1)(1993-2#1)(1995-6#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)(2010-10#1)(2012-12#1)(2012-2#1)
with genomics##3##2##(2008-7#2)(2012-12#1)
with genotype 1##4##3##(2006-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
with genotype A##2##3##(2008-12#1)(2010-12#1)
with genotype##10##2##(2006-10#1)(2008-1#1)(2008-12#1)(2010-12#1)(2010-4#1)(2012-11#1)(2012-12#1)(2013-1#2)(2013-8#1)
with genotypes##4##2##(2008-5#1)(2009-3#1)(2011-2#1)(2012-1#1)
with genotypic##2##2##(2008-10#1)(2010-3#1)
with gentamicin##5##2##(2007-7#1)(2008-5#1)(2009-12#1)(2011-2#1)(2013-8#1)
with gentle##3##2##(2006-8#1)(2009-5#1)(2013-7#1)
with genuine##3##2##(1995-5#1)(2008-7#1)(2012-3#1)
with geographic##5##2##(2006-10#1)(2008-10#3)(2012-3#1)
with geographical##4##2##(2007-7#1)(2008-10#1)(2008-9#1)(2011-2#1)
with geography##2##2##(2007-12#1)(2012-3#1)
with geometry##2##2##(2008-10#1)(2012-1#1)
with geriatric clients##2##3##(1991-12#2)
with germanosilicate##3##2##(2007-12#3)
with germline##2##2##(2008-6#1)(2012-3#1)
with gestational age##2##3##(1995-8#1)(2011-1#1)
with gestational diabetes mellitus##7##4##(1992-12#3)(2008-10#2)(2008-3#1)(2011-2#1)
with gestational hypertension and##2##4##(2012-2#2)
with gestational##12##2##(1992-12#3)(1995-8#1)(2008-10#2)(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#3)
with giant cell arteritis##2##4##(2006-10#2)
with giant cell##3##3##(2006-10#2)(2012-3#1)
with giant##17##2##(1990-4#1)(1993-9#1)(1995-5#1)(1996-9#1)(2005-9#1)(2006-10#2)(2007-12#1)(2008-4#1)(2008-7#1)(2009-2#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-3#1)
with gingival enlargement##2##3##(2012-12#1)(2013-7#1)
with gingival##5##2##(2008-8#1)(2012-12#2)(2013-7#2)
with girls'##3##2##(2007-12#3)
with given##4##2##(2007-11#1)(2008-3#1)(2012-3#2)
with glass wool##2##3##(2010-8#1)(2013-1#1)
with glass##7##2##(1990-2#1)(2005-10#1)(2007-2#1)(2008-10#2)(2010-8#1)(2013-1#1)
with glassy carbon electrode##3##4##(2008-10#3)
with glaucoma##4##2##(1990-7#1)(2009-8#1)(2010-8#1)(2011-2#1)
with glia##2##2##(2007-12#1)(2008-7#1)
with glial##2##2##(1994-2#1)(2008-12#1)
with glibenclamide##3##2##(1992-3#1)(1993-7#1)(1996-9#1)
with glioblastoma##10##2##(1994-4#1)(1996-4#1)(2008-11#1)(2010-9#1)(2011-2#2)(2012-3#4)
with glioma##2##2##(1994-3#1)(2006-12#1)
with gliomas##3##2##(1997-7#1)(2006-12#1)(2007-5#1)
with gliosis##2##2##(2008-7#2)
with global budgets##2##3##(2008-11#2)
with global##18##2##(1993-4#1)(1994-2#1)(1994-9#1)(2007-8#1)(2008-11#4)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
with glomerulonephritis or##2##3##(1992-7#1)(2007-7#1)
with glucagon##2##2##(1990-3#1)(1991-3#1)
with glucocorticoid treatment##2##3##(1993-2#1)(1996-12#1)
with glucocorticoid##6##2##(1991-11#1)(1991-5#1)(1992-5#1)(1993-2#1)(1995-12#1)(1996-12#1)
with glucocorticoids##5##2##(1994-6#1)(1996-12#1)(2006-10#1)(2008-1#1)(2011-2#1)
with glucose and##6##3##(1994-12#1)(1995-8#1)(2008-10#2)(2008-11#2)
with glucose as the##2##4##(1996-2#1)(2005-12#1)
with glucose as##4##3##(1996-2#1)(2005-12#1)(2008-10#1)(2010-4#1)
with glucose concentration##2##3##(2008-10#2)
with glucose in##2##3##(1996-9#1)(2008-7#1)
with glucose intolerance##2##3##(1991-5#1)(1993-8#1)
with glucose or##2##3##(1990-2#1)(2008-11#1)
with glucose oxidase##3##3##(2008-10#3)
with glucose##50##2##(1990-2#1)(1991-5#2)(1991-7#1)(1991-8#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-8#2)(1996-10#1)(1996-2#1)(1996-9#1)(1997-2#1)(2005-12#1)(2006-12#1)(2006-7#1)(2007-1#3)(2007-10#1)(2007-2#1)(2008-10#10)(2008-11#6)(2008-5#1)(2008-6#1)(2008-7#3)(2010-11#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-4#1)(2013-1#1)
with glucose-free##2##2##(1991-5#1)(1995-8#1)
with glutamate##14##2##(1990-2#1)(1990-7#1)(1993-12#1)(1993-2#1)(1996-5#1)(1997-8#1)(2005-7#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2009-11#1)
with glutamic acid##3##3##(1991-3#1)(1992-6#1)(1996-5#1)
with glutamine##5##2##(1993-9#1)(1996-9#1)(1997-7#1)(2006-10#1)(2009-2#1)
with glutaraldehyde 0##4##3##(2008-5#4)
with glutaraldehyde and##4##3##(1991-5#1)(2008-10#2)(2008-11#1)
with glutaraldehyde##35##2##(1990-12#1)(1991-5#1)(1992-12#1)(2004-9#4)(2005-10#2)(2005-11#1)(2008-10#16)(2008-11#1)(2008-5#6)(2008-6#1)(2013-1#1)
with glutathione S-transferase (GST)##2##4##(1993-4#1)(1997-6#1)
with glutathione S-transferase##3##3##(1993-4#1)(1995-6#1)(1997-6#1)
with glutathione##11##2##(1990-12#1)(1992-8#1)(1992-9#2)(1993-4#1)(1993-6#1)(1995-3#1)(1995-6#1)(1997-6#1)(2012-2#1)(2013-1#1)
with gluteal muscle weakness##2##4##(2012-2#2)
with gluteal##3##2##(2012-2#3)
with glyburide plus##2##3##(2010-4#2)
with glyburide##3##2##(1994-2#1)(2010-4#2)
with glycemic status##3##3##(2012-2#3)
with glycemic##6##2##(2007-3#1)(2009-11#1)(2011-1#1)(2012-2#3)
with glyceraldehyde##2##2##(2006-10#2)
with glycerol and##2##3##(1990-2#1)(1992-6#1)
with glycerol##7##2##(1990-10#1)(1990-2#1)(1992-6#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-6#1)
with glycine##11##2##(1991-11#1)(1992-2#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-5#1)(1995-3#1)(2008-10#2)(2010-2#1)
with glycogen storage disease type##2##5##(1994-9#1)(2008-7#1)
with glycogen##6##2##(1992-5#1)(1993-8#1)(1994-9#1)(2005-12#1)(2008-10#1)(2008-7#1)
with glycolipids##2##2##(1991-9#1)(1994-9#1)
with glycoprotein##3##2##(1994-11#1)(2005-7#1)(2007-11#1)
with glycoproteins##2##2##(1990-12#1)(1994-9#1)
with goat##3##2##(1990-11#1)(1992-12#1)(2008-11#1)
with goblet##3##2##(1990-2#1)(2013-1#2)
with gold nanoparticles##4##3##(2008-10#2)(2008-7#1)(2010-5#1)
with gold##15##2##(1991-12#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-5#2)(2008-7#1)(2010-5#1)(2010-6#1)(2012-12#1)(2012-2#1)
with gold-labeled##2##2##(2008-10#1)(2008-5#1)
with gonadal dysgenesis##2##3##(1990-11#2)
with gonadal##6##2##(1990-11#2)(1991-4#2)(1996-6#1)(2013-8#1)
with good accuracy and precision##2##5##(2008-10#2)
with good accuracy and##4##4##(2007-11#1)(2008-10#2)(2008-3#1)
with good accuracy##11##3##(2007-1#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#2)
with good agreement##6##3##(2005-4#1)(2007-8#1)(2008-10#2)(2008-3#2)
with good autocorrelation##2##3##(2008-2#1)(2008-3#1)
with good clinical outcome##2##4##(2007-8#1)(2010-5#1)
with good clinical results##3##4##(1997-6#1)(2008-6#1)(2013-1#1)
with good clinical##7##3##(1997-6#1)(2007-8#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-5#1)(2013-1#1)
with good compliance##2##3##(2012-2#1)(2013-1#1)
with good contrast##2##3##(2007-12#1)(2008-1#1)
with good control##2##3##(1993-2#1)(1996-9#1)
with good correlation properties##2##4##(2008-2#2)
with good correlation with##2##4##(2007-8#1)(2008-10#1)
with good correlation##4##3##(2007-8#1)(2008-10#1)(2008-2#2)
with good effect##3##3##(1992-8#1)(2008-1#1)(2009-9#1)
with good evolution##2##3##(2009-1#1)(2013-1#1)
with good glycemic control##2##4##(2007-3#2)
with good long-term##2##3##(1990-6#1)(2007-7#1)
with good oral##2##3##(2005-9#1)(2008-5#1)
with good outcomes##3##3##(1994-12#1)(2005-5#1)(2007-9#1)
with good overall##2##3##(1996-6#1)(2010-4#1)
with good performance##5##3##(2007-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2012-12#1)
with good practice##2##3##(2008-8#1)(2011-2#1)
with good precision and accuracy##2##5##(2008-10#2)
with good precision and##3##4##(2008-10#2)(2008-3#1)
with good precision##7##3##(1997-3#1)(2008-10#5)(2008-3#1)
with good prognosis##4##3##(1995-11#1)(2007-11#1)(2011-12#1)(2013-1#1)
with good quality##3##3##(2008-8#1)(2011-2#1)(2013-1#1)
with good recoveries##2##3##(2008-10#2)
with good repeatability##3##3##(2008-10#3)
with good reproducibility##12##3##(2008-10#12)
with good resolution##2##3##(2008-10#2)
with good response in##3##4##(1992-6#1)(2011-2#2)
with good response##7##3##(1992-6#1)(2010-12#1)(2011-2#3)(2013-1#2)
with good results in##2##4##(2008-10#2)
with good results##23##3##(1990-6#1)(1991-3#1)(1991-5#1)(1991-9#1)(1994-9#1)(2005-4#1)(2006-3#1)(2007-11#1)(2007-8#2)(2008-10#7)(2008-4#1)(2008-5#1)(2008-9#1)(2010-2#1)(2010-7#1)(2012-2#1)
with good sensitivity and##4##4##(1990-6#1)(2006-10#1)(2008-10#1)(2011-2#1)
with good sensitivity##7##3##(1990-6#1)(1997-8#1)(2006-10#1)(2008-10#3)(2011-2#1)
with good signal##2##3##(2007-12#1)(2008-3#1)
with good sources of protein##2##5##(1992-2#1)(2006-4#1)
with good stability##2##3##(2008-10#1)(2012-2#1)
with good##216##2##(1990-10#2)(1990-6#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#1)(2004-7#1)(2004-9#1)(2005-11#1)(2005-4#2)(2005-5#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#2)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#5)(2007-2#1)(2007-3#4)(2007-4#1)(2007-7#1)(2007-8#9)(2007-9#1)(2008-1#3)(2008-10#52)(2008-11#1)(2008-2#5)(2008-3#9)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#1)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#3)(2010-2#2)(2010-4#3)(2010-5#1)(2010-7#1)(2011-12#2)(2011-2#9)(2011-3#1)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#9)
with gout##3##2##(2009-6#1)(2010-4#1)(2012-12#1)
with government##9##2##(1994-12#1)(1995-1#1)(2005-11#1)(2007-12#1)(2009-4#1)(2010-9#1)(2012-3#2)(2013-7#1)
with gp120##2##2##(1994-6#1)(2013-1#1)
with grade 1##2##3##(2012-2#2)
with grade 2##2##3##(2008-7#1)(2012-2#1)
with grade III in##2##4##(2008-8#2)
with grade III##4##3##(2004-2#1)(2008-7#1)(2008-8#2)
with grade IV##3##3##(1997-8#1)(2008-7#1)(2011-2#1)
with grade V##3##3##(1997-8#2)(2008-7#1)
with grade##22##2##(1990-8#1)(1997-8#3)(2004-2#1)(2007-6#1)(2008-7#9)(2008-8#2)(2009-2#1)(2011-2#1)(2012-2#3)
with grade-II##4##2##(2007-7#4)
with graded doses of##2##4##(1992-11#1)(2012-2#1)
with graded##3##2##(1992-11#1)(2010-4#1)(2012-2#1)
with grades##3##2##(2005-10#1)(2007-12#1)(2012-2#1)
with gradient elution##7##3##(2005-12#1)(2008-10#4)(2011-1#1)(2012-12#1)
with gradient##10##2##(2005-12#1)(2008-10#7)(2011-1#1)(2012-12#1)
with gradual increase in##3##4##(2005-11#1)(2009-6#2)
with gradual##5##2##(1995-10#1)(2004-12#1)(2005-11#1)(2009-6#2)
with gradually##3##2##(2008-3#1)(2010-3#1)(2013-1#1)
with graft##5##2##(1991-7#1)(1995-2#2)(1996-2#1)(2007-11#1)
with graft-versus-host##2##2##(2010-11#1)(2012-2#1)
with grafted##2##2##(2008-1#1)(2010-2#1)
with grain##3##2##(2007-9#1)(2008-9#1)(2010-4#1)
with gram-negative##2##2##(1991-11#1)(1996-12#1)
with grandmother##2##2##(2006-3#2)
with granisetron##3##2##(1991-11#3)
with granulocyte colony-stimulating factor (G-CSF)##4##5##(2006-10#1)(2007-3#1)(2008-7#1)(2011-1#1)
with granulomatous lesions##2##3##(2007-2#1)(2008-5#1)
with granulomatous##4##2##(1997-8#1)(2007-2#1)(2008-5#1)(2011-1#1)
with granulosa##2##2##(1993-10#1)(2008-11#1)
with grapevine##2##2##(2008-10#2)
with graphite furnace atomic absorption spectrometry##2##6##(2008-10#2)
with graphite##3##2##(2008-10#3)
with grass pollen##2##3##(2011-2#2)
with grasses##2##2##(2007-6#1)(2008-8#1)
with great accuracy##2##3##(1994-8#1)(1996-5#1)
with great care##4##3##(2006-3#1)(2006-8#1)(2012-12#2)
with great caution##3##3##(1991-4#1)(1994-8#1)(2012-12#1)
with great potential##2##3##(1993-2#1)(2008-9#1)
with great precision##2##3##(2010-3#1)(2011-1#1)
with great success##3##3##(2005-4#1)(2008-3#1)(2008-9#1)
with great##31##2##(1990-4#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-4#1)(1993-2#1)(1994-2#1)(1994-8#2)(1995-2#2)(1996-2#1)(1996-5#1)(2005-11#1)(2005-4#1)(2006-3#1)(2006-8#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#2)(2010-3#1)(2011-1#1)(2012-12#3)(2012-3#1)(2013-1#2)
with greater activity##3##3##(1995-6#1)(2007-11#1)(2013-8#1)
with greater affinity than##2##4##(1996-5#1)(2006-12#1)
with greater affinity##3##3##(1996-5#2)(2006-12#1)
with greater amounts##2##3##(1992-12#1)(2010-8#1)
with greater clarity##2##3##(2005-7#1)(2010-12#1)
with greater confidence##2##3##(2008-2#1)(2008-9#1)
with greater degree of mobility reported significantly more often than the FSWs with lesser degree of mobility that they##2##19##(2011-12#2)
with greater depressive symptoms##4##4##(2010-4#4)
with greater efficacy##2##3##(2008-3#2)
with greater efficiency##2##3##(1992-8#1)(2009-12#1)
with greater frequency##3##3##(1991-4#1)(1996-11#1)(2005-8#1)
with greater levels of##2##4##(2005-10#1)(2007-12#1)
with greater numbers##2##3##(1997-2#1)(2010-2#1)
with greater past##2##3##(1994-6#1)(2010-9#1)
with greater precision##3##3##(2004-2#1)(2008-10#1)(2008-3#1)
with greater preoperative##2##3##(2010-6#1)(2013-1#1)
with greater risk of##3##4##(2011-12#1)(2013-1#2)
with greater risk##4##3##(2011-12#1)(2012-1#1)(2013-1#2)
with greater success##2##3##(2008-7#1)(2009-7#1)
with greater than 50%##3##4##(2006-11#1)(2006-8#1)(2007-12#1)
with greater than##9##3##(1991-12#1)(1991-2#1)(2006-11#2)(2006-8#1)(2007-11#1)(2007-12#1)(2008-4#1)(2010-12#1)
with greater##136##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-8#1)(1994-6#1)(1995-1#2)(1995-5#1)(1995-6#1)(1996-11#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-3#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#2)(2006-12#1)(2006-2#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#8)(2007-3#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#4)(2009-11#1)(2009-12#3)(2009-5#2)(2009-7#3)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#6)(2010-4#5)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#3)(2011-2#2)(2012-1#3)(2012-11#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#4)
with greatest activity##2##3##(1994-9#1)(1997-8#1)
with greatest##8##2##(1994-9#1)(1995-12#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-10#1)(2010-9#1)
with greatly enhanced##4##3##(1995-1#1)(2007-12#1)(2008-10#2)
with greatly improved##3##3##(2006-10#1)(2008-3#2)
with greatly##10##2##(1991-12#1)(1991-4#1)(1995-1#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-3#2)
with green and##2##3##(2007-11#1)(2008-10#1)
with green light##2##3##(2007-12#1)(2008-2#1)
with green##8##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-6#1)(2009-5#1)(2010-6#1)
with grooming##2##2##(1994-8#1)(1995-9#1)
with groove##2##2##(2008-11#1)(2008-2#1)
with gross cystic disease##3##4##(1994-7#2)(1997-3#1)
with gross hematuria##6##3##(2007-7#1)(2008-10#2)(2008-11#3)
with gross##17##2##(1992-2#1)(1994-7#2)(1997-3#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-11#3)(2009-9#1)(2011-12#1)(2012-12#1)(2012-3#2)(2013-8#1)
with gross-exposure constraint##2##3##(2012-12#1)(2013-1#1)
with ground##2##2##(2004-11#1)(2008-3#1)
with ground-based##4##2##(2006-10#1)(2008-2#3)
with group A##3##3##(2004-11#1)(2010-7#2)
with group B##4##3##(1993-10#1)(1995-12#1)(2004-11#1)(2010-1#1)
with group I##5##3##(1997-7#1)(2006-8#2)(2008-10#2)
with group four or fourteen##2##5##(2008-5#2)
with group##24##2##(1991-5#1)(1993-10#1)(1994-12#1)(1995-12#1)(1997-7#1)(2004-11#2)(2006-8#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-1#1)(2010-7#2)(2013-1#1)
with groups##3##2##(1992-1#1)(2008-10#1)(2008-11#1)
with growing##7##2##(1993-6#1)(1996-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-1#1)
with growth and##3##3##(2007-11#1)(2010-10#1)(2010-11#1)
with growth factor##4##3##(1994-5#1)(2008-5#1)(2012-11#2)
with growth factors##10##3##(1991-5#1)(1993-6#1)(2007-11#1)(2008-11#2)(2008-5#1)(2008-8#1)(2011-2#3)
with growth hormone deficiency##4##4##(2007-11#3)(2012-3#1)
with growth hormone##8##3##(1994-2#1)(2007-11#4)(2008-4#2)(2012-3#1)
with growth of##3##3##(1992-1#1)(2007-12#1)(2008-10#1)
with growth##52##2##(1991-5#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1996-6#1)(2007-11#6)(2007-12#3)(2007-7#1)(2008-10#3)(2008-11#4)(2008-2#2)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#1)(2009-2#1)(2010-10#1)(2010-11#1)(2011-1#2)(2011-2#4)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#1)
with guanidine hydrochloride##2##3##(1994-12#1)(1995-10#1)
with guanidine##3##2##(1993-3#1)(1994-12#1)(1995-10#1)
with guanidinium##4##2##(1993-2#1)(1996-4#1)(1997-8#1)(2010-5#1)
with guanine residues##2##3##(1993-8#1)(1996-11#1)
with guanine##5##2##(1990-7#1)(1993-8#1)(1996-11#1)(2007-8#1)(2010-12#1)
with guanosine 5'-[gamma-thio]triphosphate##2##3##(1995-2#1)(1995-8#1)
with guanosine##10##2##(1992-10#1)(1992-7#1)(1993-8#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-5#1)(2008-4#2)(2012-3#1)
with guest##2##2##(2008-10#2)
with guidance##3##2##(2006-2#2)(2009-5#1)
with guided##3##2##(2007-12#1)(2008-2#1)(2012-12#1)
with guidelines for##2##3##(1995-8#1)(2010-12#1)
with guidelines##6##2##(1995-8#1)(2007-4#1)(2010-12#1)(2013-1#2)(2013-8#1)
with guinea-pig##3##2##(1990-12#2)(1997-3#1)
with gutkha##2##2##(2013-1#1)(2013-8#1)
with hCG##7##2##(1993-6#1)(1994-5#2)(1995-10#1)(1995-5#1)(2008-6#1)(2010-10#1)
with hFH##7##2##(1993-9#7)
with habitat##3##2##(2007-5#1)(2008-8#2)
with habitual##2##2##(2007-2#1)(2007-7#1)
with haem##2##2##(1990-2#1)(1994-2#1)
with haematological##6##2##(1990-10#1)(2007-11#2)(2008-5#1)(2009-3#1)(2012-12#1)
with haematology##2##2##(1994-12#1)(2005-10#1)
with haematopoietic growth factors##2##4##(2007-11#2)
with haematopoietic##3##2##(2007-11#2)(2012-12#1)
with haematuria##4##2##(1996-6#1)(2008-10#2)(2009-1#1)
with haemoglobin##2##2##(1993-5#1)(1997-7#1)
with haemoglobinopathies##2##2##(1993-9#1)(2009-4#1)
with haemophilia##9##2##(1990-5#1)(1991-6#1)(2007-11#5)(2009-3#1)(2013-1#1)
with haemoptysis##2##2##(2006-6#1)(2007-8#1)
with haemorrhage from##2##3##(1992-10#1)(2008-10#1)
with haemorrhage##5##2##(1992-10#1)(2005-7#1)(2007-11#1)(2008-10#1)(2010-12#1)
with haemostasis##2##2##(2006-10#1)(2013-8#1)
with hair##6##2##(2007-7#1)(2008-5#2)(2010-3#1)(2011-12#1)(2012-11#1)
with half life##2##3##(1991-8#1)(2009-4#1)
with half maximal##2##3##(1992-8#1)(1993-8#1)
with half of the##2##4##(2006-5#1)(2008-7#1)
with half of##3##3##(2006-5#1)(2006-6#1)(2008-7#1)
with half##12##2##(1991-4#1)(1991-8#1)(1992-8#1)(1993-8#1)(2006-5#1)(2006-6#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-7#1)(2009-4#1)
with half-beam##2##2##(2007-10#2)
with half-lives##2##2##(1995-3#1)(2008-11#1)
with half-maximal inhibition at##2##4##(1991-6#1)(1991-7#1)
with half-maximal##7##2##(1990-3#1)(1991-6#1)(1991-7#1)(1994-6#1)(1994-9#1)(1996-10#1)(2008-6#1)
with half-times##3##2##(1991-9#1)(1993-3#1)(1994-5#1)
with half-zone-plate processing##2##3##(2008-3#2)
with hallux valgus##2##3##(2010-11#1)(2012-2#1)
with haloperidol##15##2##(1990-2#1)(1995-12#5)(1996-12#3)(1996-8#1)(1997-1#2)(2004-3#1)(2006-12#1)(2007-8#1)
with halothane hepatitis##2##3##(1995-3#2)
with halothane##7##2##(1991-12#1)(1995-3#2)(1995-7#2)(2007-9#1)(2009-12#1)
with hamstrings##6##2##(2008-6#1)(2009-9#1)(2013-1#4)
with hand OA##2##3##(2013-1#2)
with hand hygiene##2##3##(2007-4#1)(2010-4#1)
with hand##8##2##(2006-10#1)(2007-4#1)(2008-12#1)(2010-3#1)(2010-4#1)(2013-1#3)
with hands-on##2##2##(2007-4#1)(2009-4#1)
with hard metal##3##3##(1994-6#2)(2008-3#1)
with hard##8##2##(1993-12#1)(1994-6#2)(2006-4#1)(2008-3#2)(2008-5#1)(2011-2#1)
with harmful##3##2##(1993-10#1)(2007-11#1)(2012-2#1)
with harmonic##2##2##(2007-11#1)(2008-3#1)
with having a##2##3##(2007-12#1)(2013-1#1)
with having##9##2##(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-6#1)(2009-4#1)(2009-5#1)(2012-3#1)(2013-1#1)
with hazardous##2##2##(2008-11#1)(2008-6#1)
with head and neck cancer##3##5##(2010-4#1)(2011-2#2)
with head and neck##8##4##(1994-6#1)(1995-8#1)(2007-10#1)(2009-10#2)(2010-4#1)(2011-2#2)
with head and##9##3##(1994-6#1)(1995-8#1)(2007-10#1)(2009-10#2)(2010-4#1)(2011-2#2)(2012-1#1)
with head injuries##6##3##(1990-3#1)(1991-5#1)(1996-8#1)(2007-7#1)(2008-7#2)
with head injury and##3##4##(1995-5#1)(1996-9#1)(2008-7#1)
with head injury##9##3##(1995-5#1)(1996-9#1)(2006-10#2)(2006-2#1)(2006-4#1)(2008-7#2)(2013-8#1)
with head trauma##3##3##(2005-10#1)(2005-7#1)(2008-7#1)
with head##29##2##(1990-3#1)(1991-5#1)(1993-2#1)(1994-6#1)(1995-5#1)(1995-8#1)(1996-8#1)(1996-9#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-4#1)(2007-10#1)(2007-7#1)(2008-7#5)(2009-10#2)(2010-4#1)(2010-8#1)(2011-2#2)(2012-1#1)(2013-8#1)
with headache and##5##3##(2006-12#1)(2006-5#1)(2008-12#1)(2008-5#1)(2012-3#1)
with headache##13##2##(2004-12#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-5#1)(2009-6#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
with headaches##7##2##(2006-10#1)(2007-8#1)(2008-12#1)(2009-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
with healing##3##2##(2006-9#2)(2010-4#1)
with health and##5##3##(1997-2#1)(2008-7#1)(2008-9#2)(2012-1#1)
with health authorities##2##3##(2008-11#1)(2012-3#1)
with health care leaders##2##4##(1994-1#1)(2008-1#1)
with health care##19##3##(1991-2#1)(1991-3#1)(1993-1#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-3#1)(2008-6#1)(2010-1#1)(2013-7#2)
with health insurance##2##3##(2009-5#1)(2012-12#1)
with health professionals and##2##4##(1997-1#1)(2012-2#1)
with health services##3##3##(1996-1#1)(2012-12#1)(2012-3#1)
with health##54##2##(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-11#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#2)(2010-1#1)(2010-2#1)(2010-5#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-7#2)(2013-8#1)
with healthcare##4##2##(2009-4#1)(2009-8#1)(2011-1#1)(2012-3#1)
with healthy control subjects##2##4##(1995-1#1)(2013-1#1)
with healthy control##4##3##(1995-1#1)(2005-10#1)(2007-6#1)(2013-1#1)
with healthy controls##6##3##(1997-8#1)(2008-10#1)(2008-6#1)(2010-4#1)(2012-1#1)(2013-7#1)
with healthy individuals##3##3##(1991-7#1)(2010-12#2)
with healthy subjects##5##3##(1990-11#1)(1995-1#1)(1995-11#1)(1996-8#1)(2013-1#1)
with healthy volunteers##3##3##(2008-5#2)(2010-10#1)
with healthy##34##2##(1990-11#1)(1990-6#1)(1991-7#1)(1991-8#2)(1995-1#2)(1995-11#1)(1996-8#1)(1997-8#1)(2005-10#1)(2006-2#1)(2007-12#1)(2007-6#1)(2008-10#3)(2008-5#2)(2008-6#1)(2008-8#1)(2010-10#1)(2010-12#2)(2010-4#1)(2012-1#5)(2012-2#1)(2013-1#2)(2013-7#1)
with hearing aids##3##3##(1990-12#1)(2011-12#1)(2013-1#1)
with hearing loss##4##3##(2008-1#1)(2011-12#2)(2011-2#1)
with hearing##10##2##(1990-12#1)(2006-11#1)(2008-1#1)(2008-4#1)(2008-9#1)(2011-12#3)(2011-2#1)(2013-1#1)
with heart disease##10##3##(1995-8#1)(2006-10#1)(2007-2#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-4#1)(2011-2#1)
with heart failure##29##3##(1990-3#1)(1993-2#1)(1996-8#1)(2005-10#2)(2005-8#1)(2006-10#1)(2006-6#1)(2006-9#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#3)(2009-9#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-8#1)
with heart rate##2##3##(2005-11#1)(2008-6#1)
with heart valve##3##3##(1990-12#1)(1990-6#1)(2007-8#1)
with heart##55##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1993-2#1)(1993-6#1)(1995-8#1)(1996-8#1)(2005-10#2)(2005-11#1)(2005-6#1)(2005-8#1)(2006-10#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-2#2)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#3)(2009-7#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
with heat shock proteins##2##4##(1993-11#1)(1993-8#1)
with heat shock##4##3##(1993-11#1)(1993-8#2)(1997-6#1)
with heat##13##2##(1993-11#1)(1993-8#2)(1995-3#1)(1996-1#1)(1997-6#1)(2006-10#1)(2006-4#1)(2007-1#1)(2007-12#1)(2008-3#1)(2011-1#1)(2013-8#1)
with heating##2##2##(2007-10#1)(2008-10#1)
with heavier##3##2##(1997-7#1)(2007-12#1)(2009-9#1)
with heavily##2##2##(1992-2#1)(2008-10#1)
with heavy metal##3##3##(1994-11#1)(2008-10#1)(2013-1#1)
with heavy##18##2##(1991-12#1)(1993-12#1)(1993-9#2)(1994-11#1)(1995-11#2)(1995-3#1)(1997-4#2)(2007-7#2)(2007-8#1)(2008-10#1)(2010-12#1)(2011-1#1)(2012-1#1)(2013-1#1)
with height##5##2##(2007-1#1)(2007-12#1)(2008-2#1)(2008-9#1)(2011-1#1)
with heightened##2##2##(1992-4#1)(2010-5#1)
with helium##2##2##(2006-6#1)(2008-10#1)
with help from##2##3##(1993-9#1)(2007-3#1)
with help of##2##3##(1997-1#1)(1997-4#1)
with help##4##2##(1993-9#1)(1997-1#1)(1997-4#1)(2007-3#1)
with helper##2##2##(1990-5#1)(2008-10#1)
with helpers##2##2##(2008-8#1)(2008-9#1)
with hematologic disorders##2##3##(1994-12#1)(2007-12#1)
with hematologic malignancies##17##3##(2007-12#1)(2008-7#13)(2012-12#2)(2013-1#1)
with hematologic##24##2##(1994-12#1)(2007-12#3)(2007-2#1)(2008-7#13)(2012-12#5)(2013-1#1)
with hematological##7##2##(1992-1#1)(1993-2#1)(2007-2#1)(2008-6#1)(2010-12#1)(2011-2#1)(2012-2#1)
with hematoma##2##2##(2006-7#1)(2007-10#1)
with hematopoietic growth factors##2##4##(1991-6#1)(2009-7#1)
with hematopoietic##5##2##(1991-6#1)(1995-3#1)(2008-8#1)(2008-9#1)(2009-7#1)
with hematoxylin and eosin##4##4##(2007-10#1)(2009-2#1)(2011-2#1)(2013-1#1)
with hematoxylin##6##2##(1991-2#1)(2007-10#1)(2007-12#1)(2009-2#1)(2011-2#1)(2013-1#1)
with hematuria were##2##3##(2007-2#1)(2012-2#1)
with hematuria##5##2##(2007-2#2)(2008-1#1)(2008-10#1)(2012-2#1)
with heme oxygenase##2##3##(1993-6#1)(1994-3#1)
with heme##7##2##(1993-6#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-2#1)(1996-3#1)
with hemifacial microsomia##2##3##(2012-2#2)
with hemin##4##2##(1994-9#1)(1995-7#1)(2008-10#2)
with hemiparesis##2##2##(2008-7#1)(2012-1#1)
with hemodialysis and##2##3##(2008-10#1)(2009-5#1)
with hemodialysis##9##2##(1993-8#1)(2007-7#2)(2008-10#1)(2008-4#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#1)
with hemodynamic instability##2##3##(2007-7#1)(2011-2#1)
with hemodynamic##3##2##(2007-7#1)(2007-8#1)(2011-2#1)
with hemoglobin (Hb)##2##3##(2008-10#1)(2008-7#1)
with hemoglobin and##2##3##(2006-8#1)(2008-10#1)
with hemoglobin##13##2##(1992-12#1)(1992-8#1)(2006-8#2)(2007-12#1)(2008-10#4)(2008-7#3)(2012-1#1)
with hemolysis##3##2##(1992-2#1)(2013-1#2)
with hemolytic##2##2##(1996-3#1)(2006-1#1)
with hemophagocytic lymphohistiocytosis##2##3##(2011-2#1)(2012-3#1)
with hemophagocytic##3##2##(2006-4#1)(2011-2#1)(2012-3#1)
with hemophilia A##2##3##(2007-10#2)
with hemophilia##7##2##(1996-5#1)(2007-10#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-11#1)
with hemoptysis and##2##3##(2012-12#1)(2013-7#1)
with hemoptysis##3##2##(2007-8#1)(2012-12#1)(2013-7#1)
with hemorrhage##6##2##(2006-10#1)(2008-12#1)(2008-7#2)(2009-8#1)(2010-12#1)
with hemorrhagic##12##2##(1991-5#1)(1992-8#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-9#1)(2009-12#1)(2009-9#1)(2010-5#1)(2013-1#3)
with heparan sulfate proteoglycans##3##4##(1994-8#1)(1995-6#1)(1997-4#1)
with heparan sulfate##6##3##(1992-5#1)(1994-8#1)(1995-6#1)(1997-4#2)(2008-5#1)
with heparin and##5##3##(1993-6#1)(2005-1#1)(2005-12#1)(2005-7#1)(2013-8#1)
with heparin as##2##3##(2008-10#1)(2010-3#1)
with heparin is##2##3##(1995-5#1)(1997-4#1)
with heparin##24##2##(1991-6#1)(1993-6#1)(1994-6#2)(1995-10#1)(1995-5#2)(1997-4#2)(1997-5#1)(2005-1#1)(2005-12#1)(2005-7#1)(2007-10#2)(2007-11#2)(2008-10#3)(2010-3#2)(2012-12#1)(2013-8#1)
with heparin-induced thrombocytopenia (HIT)##3##4##(1997-2#1)(2007-11#2)
with heparin-induced thrombocytopenia##10##3##(1994-4#1)(1997-2#2)(2006-10#2)(2006-12#1)(2007-11#2)(2009-8#1)(2011-2#1)
with heparinase##3##2##(1992-2#1)(1993-3#1)(1995-10#1)
with heparinized##2##2##(1991-9#1)(1996-12#1)
with hepatic and##2##3##(2006-4#1)(2013-7#1)
with hepatic dysfunction##3##3##(2005-7#1)(2005-8#2)
with hepatic encephalopathy##4##3##(1990-4#2)(1991-5#1)(2005-10#1)
with hepatic metastases##2##3##(2007-6#1)(2008-1#1)
with hepatic metastasis##2##3##(2009-3#1)(2009-8#1)
with hepatic##35##2##(1990-4#2)(1990-5#1)(1990-8#1)(1991-5#2)(1992-1#1)(1993-2#2)(1993-5#1)(1994-8#1)(2004-7#1)(2005-10#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-4#1)(2006-6#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-3#1)(2009-8#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
with hepatitis A##2##3##(2006-2#1)(2012-2#1)
with hepatitis B or C##2##5##(2007-11#1)(2007-9#1)
with hepatitis B or##3##4##(2007-11#2)(2007-9#1)
with hepatitis B virus##5##4##(2005-8#1)(2006-10#1)(2011-1#1)(2012-3#1)(2013-8#1)
with hepatitis B##14##3##(1992-8#1)(2005-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-7#1)(2007-9#1)(2011-1#1)(2012-3#2)(2013-8#1)
with hepatitis C virus (HCV) infection##2##6##(2005-6#1)(2008-1#1)
with hepatitis C virus (HCV)##4##5##(2005-6#1)(2006-10#1)(2008-1#1)(2011-12#1)
with hepatitis C virus infection who##3##6##(2006-10#1)(2013-1#2)
with hepatitis C virus infection##10##5##(2006-10#1)(2006-2#2)(2006-9#1)(2008-1#1)(2011-2#1)(2013-1#4)
with hepatitis C virus##21##4##(1990-3#1)(1993-10#1)(2005-6#1)(2006-10#4)(2006-2#2)(2006-9#1)(2008-1#2)(2009-2#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#4)(2013-8#1)
with hepatitis C##25##3##(1990-3#1)(1993-10#1)(2005-6#1)(2006-10#5)(2006-2#2)(2006-9#1)(2007-12#1)(2008-1#3)(2009-2#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#4)(2013-8#1)
with hepatitis E##2##3##(2006-2#1)(2007-2#1)
with hepatitis and##2##3##(2008-1#1)(2009-6#1)
with hepatitis##52##2##(1990-3#1)(1991-5#1)(1992-8#1)(1993-10#1)(1996-11#1)(2005-6#1)(2005-8#1)(2006-10#7)(2006-2#4)(2006-9#1)(2007-11#2)(2007-12#3)(2007-2#3)(2007-7#1)(2007-9#1)(2008-1#4)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#2)
with hepatocellular carcinoma (HCC)##2##4##(1991-9#1)(2010-12#1)
with hepatocellular carcinoma##19##3##(1991-9#1)(1992-3#1)(1995-4#2)(2006-10#2)(2006-6#1)(2008-12#1)(2008-5#1)(2009-9#1)(2010-12#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#2)
with hepatocellular##24##2##(1991-9#1)(1992-3#1)(1995-3#2)(1995-4#2)(2006-10#2)(2006-6#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-8#1)(2009-9#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#2)
with hepatocyte growth factor##3##4##(1994-12#1)(2008-9#1)(2010-12#1)
with hepatocyte##5##2##(1991-1#1)(1992-3#1)(1994-12#1)(2008-9#1)(2010-12#1)
with hepatocytes##2##2##(1994-8#1)(2006-10#1)
with hepatorenal##3##2##(1993-12#1)(2006-8#1)(2008-5#1)
with hepatosplenic##5##2##(2011-1#2)(2012-2#1)(2013-8#2)
with hepatosplenomegaly##4##2##(2008-12#1)(2010-12#1)(2012-2#2)
with hepatotoxicity##2##2##(1997-2#1)(2010-2#1)
with heptafluorobutyric anhydride##3##3##(1990-6#1)(1997-3#1)(2008-10#1)
with her##15##2##(1996-12#1)(2006-10#1)(2006-7#1)(2007-2#2)(2008-2#1)(2009-11#1)(2009-3#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
with herbal##2##2##(2006-10#1)(2008-11#1)
with herbicide##2##2##(2006-12#1)(2008-9#1)
with herbicides##2##2##(2008-11#1)(2011-2#1)
with hereditary spherocytosis##4##3##(2006-9#1)(2008-12#3)
with hereditary##20##2##(1990-4#1)(1992-3#1)(1993-1#2)(1995-5#1)(1997-3#1)(2006-10#1)(2006-4#1)(2006-9#1)(2008-1#1)(2008-12#3)(2008-3#1)(2010-3#1)(2010-8#2)(2010-9#1)(2012-3#1)(2013-8#1)
with heredity##2##2##(2008-9#1)(2009-9#1)
with heritable##3##2##(1990-3#1)(1990-6#1)(1993-2#1)
with heroin##2##2##(1997-7#1)(2006-8#1)
with herpes simplex virus##5##4##(1990-4#1)(1990-7#1)(1996-12#1)(2012-2#1)(2013-1#1)
with herpes simplex##6##3##(1990-4#1)(1990-7#1)(1996-12#1)(2007-11#1)(2012-2#1)(2013-1#1)
with herpes zoster##3##3##(2007-7#2)(2008-5#1)
with herpes##10##2##(1990-4#1)(1990-7#1)(1995-5#1)(1996-12#1)(2007-11#1)(2007-7#2)(2008-5#1)(2012-2#1)(2013-1#1)
with herpesvirus##3##2##(1992-11#1)(2008-5#1)(2013-8#1)
with heterodyne detection##3##3##(2007-12#2)(2008-3#1)
with heterogeneous##7##2##(1991-3#1)(1992-12#1)(2006-1#1)(2006-10#1)(2007-4#1)(2008-12#1)(2011-2#1)
with heterologous elements##2##3##(2007-3#1)(2009-5#1)
with heterologous##5##2##(2007-3#1)(2008-10#2)(2008-7#1)(2009-5#1)
with heterosexual##2##2##(2008-12#2)
with heterotrimeric G proteins##2##4##(1995-6#1)(2008-4#1)
with heterozygosity##2##2##(2008-10#1)(2008-4#1)
with heterozygous FH##3##3##(1993-9#2)(1997-2#1)
with heterozygous familial hypercholesterolaemia##2##4##(1997-2#1)(2012-2#1)
with heterozygous familial hypercholesterolemia (FH)##2##5##(1993-9#2)
with heterozygous familial hypercholesterolemia##5##4##(1990-12#1)(1993-9#4)
with heterozygous familial##7##3##(1990-12#1)(1993-9#4)(1997-2#1)(2012-2#1)
with heterozygous##11##2##(1990-12#1)(1993-9#6)(1997-2#2)(2008-4#1)(2012-2#1)
with hexadecanoic acid##2##3##(2005-11#1)(2007-11#1)
with hexagonal##2##2##(2009-2#2)
with hexagonally##2##2##(2008-3#1)(2010-7#1)
with hexamethonium##3##2##(1991-3#1)(1992-3#1)(1997-8#1)
with hexane and##2##3##(2008-11#1)(2013-8#1)
with hexane##7##2##(2008-10#4)(2008-11#1)(2011-1#1)(2013-8#1)
with hiatal hernia##2##3##(2006-10#1)(2013-1#1)
with hiatal##3##2##(2006-10#2)(2013-1#1)
with hidradenitis suppurativa##2##3##(2006-10#2)
with high As##2##3##(2008-10#1)(2010-5#1)
with high Ca2+##2##3##(1991-5#1)(1992-6#1)
with high EIA##2##3##(2007-3#2)
with high HCV##2##3##(2007-7#1)(2013-1#1)
with high ICA titers##2##4##(1994-12#2)
with high IgG##2##3##(1990-3#1)(2008-7#1)
with high SPF##2##3##(1993-11#1)(2008-5#1)
with high accuracy and precision##2##5##(2008-10#2)
with high accuracy and##8##4##(2008-10#3)(2008-2#1)(2008-7#1)(2009-2#1)(2011-2#2)
with high accuracy by##2##4##(2007-12#1)(2008-3#1)
with high accuracy##27##3##(2006-7#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#6)(2008-2#3)(2008-3#5)(2008-7#1)(2009-2#1)(2009-4#1)(2011-2#3)(2013-1#2)
with high activity##4##3##(1993-3#1)(1994-8#1)(2011-2#1)(2012-11#1)
with high affinities##2##3##(1995-11#1)(1995-2#1)
with high affinity (IC50 =##3##5##(1993-11#1)(1994-12#1)(2010-12#1)
with high affinity (Kd = 0##2##6##(1993-11#1)(1997-1#1)
with high affinity (Kd =##5##5##(1990-7#1)(1991-9#1)(1993-11#1)(1996-2#1)(1997-1#1)
with high affinity (Kd##9##4##(1990-11#1)(1990-7#1)(1991-9#1)(1993-11#1)(1993-4#1)(1995-11#1)(1996-2#1)(1996-8#1)(1997-1#1)
with high affinity and selectivity for##2##6##(2006-12#1)(2008-4#1)
with high affinity and selectivity##4##5##(2006-12#1)(2007-8#1)(2008-4#1)(2012-2#1)
with high affinity and specificity and##2##6##(1994-5#1)(2009-2#1)
with high affinity and specificity##4##5##(1994-5#1)(2007-11#1)(2007-8#1)(2009-2#1)
with high affinity and##17##4##(1990-11#1)(1991-2#1)(1993-1#1)(1993-3#1)(1994-5#1)(1995-11#2)(1995-12#1)(1995-2#1)(1997-2#1)(2006-12#1)(2007-11#1)(2007-8#2)(2008-4#1)(2009-2#1)(2012-2#1)
with high affinity for##9##4##(1990-2#1)(1991-11#1)(1995-3#1)(1996-11#1)(1997-5#1)(2008-11#2)(2008-4#1)(2008-5#1)
with high affinity to a##4##5##(1996-8#1)(2008-2#1)(2008-4#2)
with high affinity to the##6##5##(1990-5#1)(1991-7#1)(1994-5#1)(1995-3#1)(1996-12#2)
with high affinity to##26##4##(1990-2#2)(1990-3#1)(1990-5#1)(1990-8#1)(1991-3#1)(1991-7#1)(1992-12#1)(1992-3#1)(1993-6#1)(1994-11#1)(1994-5#3)(1995-3#1)(1996-12#2)(1996-8#1)(1997-5#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#2)
with high affinity##94##3##(1990-11#2)(1990-12#1)(1990-2#5)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-3#1)(1993-4#1)(1993-6#2)(1994-11#1)(1994-12#3)(1994-5#4)(1994-8#2)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#2)(1995-8#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-5#2)(1997-7#1)(2006-10#1)(2006-12#2)(2006-6#1)(2007-11#2)(2007-8#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#1)(2008-8#2)(2009-2#1)(2010-12#1)(2012-2#1)
with high and low levels of##2##6##(1992-8#1)(1995-6#1)
with high and low##9##4##(1992-8#1)(1995-6#1)(1996-5#1)(1996-7#1)(2007-12#1)(2007-4#1)(2008-10#2)(2012-2#1)
with high and##14##3##(1992-8#1)(1995-6#2)(1996-5#1)(1996-7#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2009-5#2)(2012-2#1)
with high avidity##2##3##(1991-12#1)(2008-4#1)
with high binding affinity##2##4##(2008-8#1)(2012-2#1)
with high binding##3##3##(2008-5#1)(2008-8#1)(2012-2#1)
with high blood pressure##5##4##(2006-6#1)(2008-3#1)(2009-1#1)(2010-9#1)(2013-1#1)
with high blood##8##3##(1995-11#1)(1997-7#1)(2006-6#1)(2007-10#1)(2008-3#1)(2009-1#1)(2010-9#1)(2013-1#1)
with high bone turnover##2##4##(2005-3#1)(2007-8#1)
with high concentration of##3##4##(2012-1#1)(2012-2#1)(2013-8#1)
with high concentration##6##3##(2007-12#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-8#2)
with high concentrations of##11##4##(1990-2#1)(1991-2#1)(1994-11#1)(1994-2#1)(1995-10#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
with high concentrations##13##3##(1990-2#1)(1991-2#1)(1993-12#1)(1994-11#1)(1994-2#1)(1995-10#1)(1995-12#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
with high confidence##3##3##(2007-12#1)(2007-5#1)(2011-1#1)
with high contrast##6##3##(2008-3#1)(2008-5#1)(2008-7#1)(2010-1#2)(2010-6#1)
with high correlation##2##3##(2008-10#1)(2011-1#1)
with high density##3##3##(2004-11#1)(2008-11#1)(2008-7#1)
with high diffraction efficiency##2##4##(2007-11#1)(2008-3#1)
with high diffraction##4##3##(2007-11#1)(2008-3#2)(2008-8#1)
with high discrimination##2##3##(2007-12#1)(2008-2#1)
with high disease##3##3##(1990-8#1)(2008-10#2)
with high dispersal##3##3##(2008-8#3)
with high dosages of vitamin E##2##6##(2008-10#2)
with high dose of##2##4##(1992-5#1)(2013-1#1)
with high dose rate##3##4##(1994-3#1)(2007-11#1)(2011-2#1)
with high dose##14##3##(1990-12#1)(1991-9#1)(1992-5#2)(1994-3#1)(2005-7#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-7#1)(2010-12#1)(2011-2#2)(2013-1#1)
with high doses of epirubicin##2##5##(1990-10#1)(1991-6#1)
with high doses of##13##4##(1990-10#1)(1991-6#1)(1993-3#1)(1994-3#1)(1997-4#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-11#1)(2012-12#1)(2012-2#1)
with high efficiency and##5##4##(1997-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
with high efficiency is##2##4##(2007-12#1)(2008-3#1)
with high efficiency to##2##4##(1994-5#1)(2008-10#1)
with high efficiency##25##3##(1993-11#1)(1994-12#1)(1994-5#1)(1996-8#1)(1996-9#1)(1997-5#1)(2007-11#1)(2007-12#4)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#3)(2009-2#1)(2010-2#1)(2012-12#2)(2013-1#1)
with high enantioselectivity##3##3##(1995-6#1)(2005-11#1)(2009-10#1)
with high energy##2##3##(2008-2#1)(2012-2#1)
with high enough##2##3##(2008-2#1)(2010-12#1)
with high expression levels##2##4##(2006-11#1)(2012-3#1)
with high expression##4##3##(2006-11#1)(2009-9#2)(2012-3#1)
with high fatality##2##3##(1990-2#1)(2008-5#1)
with high fever##3##3##(2006-10#1)(2008-2#1)(2012-2#1)
with high fidelity##3##3##(2007-12#1)(2008-11#1)(2010-1#1)
with high frequency##12##3##(1993-11#1)(1994-6#2)(1995-12#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2009-5#1)(2010-7#1)(2011-2#1)(2013-8#1)
with high glass transition temperatures##2##5##(1995-3#1)(2010-4#1)
with high grade dysplasia##3##4##(1993-3#1)(1994-2#1)(2006-2#1)
with high grade##7##3##(1990-5#1)(1993-3#1)(1994-2#1)(2006-2#1)(2008-6#2)(2010-3#1)
with high homology to the##3##5##(1992-8#1)(1994-8#1)(1995-8#1)
with high homology to##4##4##(1992-8#1)(1994-8#1)(1995-8#1)(1996-10#1)
with high homology##5##3##(1992-8#1)(1994-8#1)(1995-8#1)(1996-10#1)(2008-4#1)
with high hydrophobic##2##3##(1993-4#2)
with high incidence of##5##4##(1994-2#1)(2008-10#2)(2010-12#1)(2011-2#1)
with high incidence##7##3##(1994-2#1)(2007-5#1)(2008-10#2)(2010-12#1)(2011-2#1)(2013-8#1)
with high level of##7##4##(1992-2#1)(1992-3#1)(2005-8#1)(2008-12#1)(2011-2#3)
with high levels of##32##4##(1990-11#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-2#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-3#1)(1997-2#1)(1997-7#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-7#1)
with high levels##35##3##(1990-11#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-2#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-3#1)(1997-2#1)(1997-5#1)(1997-7#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-7#1)
with high lipid##2##3##(2008-9#1)(2013-1#1)
with high local##2##3##(2008-8#1)(2010-3#1)
with high metal##2##3##(2007-6#1)(2008-10#1)
with high metastatic potential##3##4##(1991-9#1)(2008-6#1)(2008-9#1)
with high molecular weight##5##4##(1992-8#1)(1995-2#1)(2007-11#1)(2007-12#1)(2010-4#1)
with high molecular##6##3##(1992-8#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2010-4#1)
with high morbidity and mortality##11##5##(1996-3#1)(2006-10#1)(2008-1#1)(2008-12#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
with high morbidity and##13##4##(1996-3#1)(2006-10#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
with high morbidity rates##2##4##(2007-7#1)(2007-8#1)
with high morbidity##15##3##(1996-3#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
with high mortality and##2##4##(2007-8#1)(2012-12#1)
with high mortality##17##3##(2007-2#3)(2007-7#2)(2007-8#2)(2008-10#1)(2009-3#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-8#2)
with high numbers of##3##4##(1996-1#1)(2006-5#1)(2009-9#1)
with high numbers##4##3##(1996-1#1)(2006-5#1)(2008-12#1)(2009-9#1)
with high numerical aperture##2##4##(2007-12#1)(2012-2#1)
with high optical##2##3##(2008-3#2)
with high or##2##3##(2006-7#1)(2008-5#1)
with high packing##2##3##(2008-2#1)(2010-4#1)
with high patient satisfaction and##2##5##(2006-10#1)(2009-10#1)
with high patient##3##3##(2006-10#1)(2009-10#1)(2010-11#1)
with high peak##3##3##(2008-3#2)(2012-2#1)
with high performance liquid chromatography (HPLC)##8##6##(2005-12#1)(2008-10#5)(2008-8#1)(2010-4#1)
with high performance liquid chromatography##15##5##(1991-4#1)(1995-3#1)(2005-12#1)(2007-8#1)(2008-10#8)(2008-8#1)(2010-4#1)(2013-8#1)
with high performance liquid##16##4##(1991-4#1)(1995-3#1)(2005-12#1)(2007-8#1)(2008-10#8)(2008-8#1)(2010-4#1)(2013-8#2)
with high plasma concentrations of##2##5##(1992-3#1)(1997-4#1)
with high plasma##3##3##(1992-3#1)(1997-4#1)(2008-7#1)
with high plasmatic clearance and main biliary escretion (8##2##9##(2006-6#2)
with high population##2##3##(2008-10#1)(2008-8#1)
with high potency##2##3##(2007-11#1)(2012-11#1)
with high potential for##2##4##(2007-12#1)(2013-1#1)
with high potential##3##3##(2007-12#1)(2011-2#1)(2013-1#1)
with high precision and accuracy##3##5##(2008-10#3)
with high precision and##6##4##(2007-5#1)(2008-10#4)(2008-3#1)
with high precision##15##3##(2007-12#1)(2007-5#2)(2008-10#6)(2008-3#4)(2013-1#2)
with high predictive##4##3##(2008-6#2)(2011-2#1)(2012-3#1)
with high pressure liquid##2##4##(1993-7#1)(2008-10#1)
with high pressure##3##3##(1993-7#1)(2008-10#2)
with high prevalence##2##3##(2012-2#1)(2013-1#1)
with high probability##2##3##(1996-4#1)(2011-3#1)
with high production##2##3##(1994-2#1)(2006-12#1)
with high quality##3##3##(1991-12#1)(2006-6#1)(2008-3#1)
with high rates of##9##4##(2006-11#2)(2007-7#1)(2008-1#1)(2008-8#2)(2009-10#1)(2010-12#1)(2012-2#1)
with high recoveries##3##3##(2008-10#1)(2011-1#1)(2012-12#1)
with high recovery and##2##4##(1996-6#1)(2008-10#1)
with high reflectance##2##3##(2008-2#1)(2008-3#1)
with high refractive##2##3##(2008-10#1)(2008-3#1)
with high reliability##2##3##(2008-10#2)
with high resistance to##2##4##(1997-2#1)(2008-10#1)
with high resolution and accuracy##2##5##(2007-11#1)(2008-3#1)
with high resolution at##2##4##(2006-5#1)(2008-3#1)
with high resolution##14##3##(1995-3#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#1)(2011-3#1)
with high risk for##2##4##(2007-3#1)(2013-1#1)
with high risk of##6##4##(1991-11#1)(2007-7#1)(2011-2#2)(2012-12#1)(2013-1#1)
with high risk##18##3##(1990-3#1)(1991-11#1)(1997-3#1)(2006-8#1)(2007-3#1)(2007-6#1)(2007-7#1)(2008-11#1)(2008-7#1)(2010-2#1)(2010-3#2)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#2)
with high salt##2##3##(1996-5#1)(2012-11#1)
with high selectivity and sensitivity##3##5##(2008-10#2)(2010-1#1)
with high selectivity and##6##4##(2008-10#2)(2008-9#1)(2009-12#1)(2010-1#1)(2013-8#1)
with high selectivity for##3##4##(1991-3#1)(1994-3#1)(2008-1#1)
with high selectivity##12##3##(1991-3#1)(1994-3#1)(2008-1#1)(2008-10#3)(2008-9#1)(2009-12#1)(2010-1#1)(2010-12#1)(2013-7#1)(2013-8#1)
with high sensitivity and selectivity##2##5##(2008-10#1)(2008-9#1)
with high sensitivity and specificity##4##5##(2006-2#1)(2007-8#1)(2007-9#1)(2013-7#1)
with high sensitivity and##13##4##(1996-9#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-9#1)(2011-1#1)(2013-7#1)
with high sensitivity##25##3##(1993-1#1)(1993-10#1)(1996-9#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2011-1#1)(2013-7#2)
with high sequence identity to##2##5##(1995-3#1)(2008-10#1)
with high sequence identity##3##4##(1995-3#2)(2008-10#1)
with high sequence##4##3##(1995-3#2)(1997-2#1)(2008-10#1)
with high serum##5##3##(1991-3#2)(1991-7#1)(1996-6#1)(1997-7#1)
with high signal to noise ratio##2##6##(2005-4#2)
with high signal##4##3##(2005-4#2)(2008-2#2)
with high signal-to-noise##2##3##(1996-6#1)(2011-1#1)
with high similarity##2##3##(1997-2#1)(2008-9#1)
with high spatial and temporal resolution##2##6##(2008-11#1)(2010-12#1)
with high spatial and temporal##3##5##(2008-10#1)(2008-11#1)(2010-12#1)
with high spatial and##4##4##(2008-10#1)(2008-11#1)(2008-3#1)(2010-12#1)
with high spatial resolution##8##4##(1992-7#1)(2007-11#1)(2007-12#2)(2008-2#1)(2009-1#1)(2009-4#1)(2009-9#1)
with high spatial##14##3##(1992-7#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-1#1)(2009-4#1)(2009-9#1)(2010-12#1)
with high specific activity and##2##5##(1995-1#1)(1995-3#1)
with high specific activity##4##4##(1990-10#2)(1995-1#1)(1995-3#1)
with high specific surface##3##4##(2008-10#1)(2013-8#2)
with high specific##8##3##(1990-10#2)(1995-1#1)(1995-3#1)(1996-8#1)(2008-10#1)(2013-8#2)
with high specificity and##3##4##(1993-8#1)(1996-5#1)(2010-2#1)
with high specificity for##3##4##(2008-10#1)(2008-5#1)(2008-7#1)
with high specificity##15##3##(1991-5#1)(1993-8#3)(1995-1#1)(1996-5#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-2#1)(2010-7#1)
with high spectral purity and##2##5##(2008-1#1)(2008-2#1)
with high spectral##4##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
with high spontaneous discharge rates to increments in intensity##2##9##(1993-7#2)
with high stability against external disturbances##2##6##(2007-12#1)(2008-3#1)
with high stability##7##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)
with high statistical##2##3##(2006-2#1)(2008-7#1)
with high success##2##3##(1993-5#1)(2009-4#1)
with high surface area##2##4##(2008-10#1)(2008-6#1)
with high surface areas##2##4##(2008-10#2)
with high surface##7##3##(2005-11#1)(2006-10#1)(2008-10#3)(2008-3#1)(2008-6#1)
with high temporal and spatial resolution##3##6##(2007-8#1)(2010-12#1)(2011-1#1)
with high temporal##4##3##(2007-12#1)(2007-8#1)(2010-12#1)(2011-1#1)
with high therapeutic potential##2##4##(2012-12#1)(2012-3#1)
with high throughput##2##3##(2010-12#1)(2010-4#1)
with high titers##2##3##(1990-12#1)(2006-4#1)
with high total##2##3##(1990-12#1)(2009-6#1)
with high transverse resolution##2##4##(2007-12#2)
with high values of##2##4##(2008-2#1)(2008-5#1)
with high viability##2##3##(1994-9#1)(2008-11#1)
with high viral load and histological##2##6##(2013-8#2)
with high viral loads##2##4##(2005-8#1)(2007-11#1)
with high viral##4##3##(2005-8#1)(2007-11#1)(2013-8#2)
with high volume##3##3##(1995-8#1)(2009-4#1)(2009-9#1)
with high water##2##3##(2007-3#1)(2008-5#1)
with high yield##4##3##(1990-5#1)(1996-7#1)(2008-10#2)
with high yields##3##3##(1996-7#1)(2007-11#1)(2008-5#1)
with high##1017##2##(1990-1#1)(1990-10#3)(1990-11#4)(1990-12#4)(1990-2#9)(1990-3#4)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#3)(1991-11#2)(1991-12#4)(1991-2#5)(1991-3#4)(1991-4#2)(1991-5#5)(1991-6#1)(1991-7#2)(1991-9#3)(1992-12#4)(1992-2#2)(1992-3#3)(1992-5#3)(1992-6#1)(1992-7#1)(1992-8#6)(1992-9#4)(1993-1#2)(1993-10#1)(1993-11#7)(1993-12#2)(1993-3#5)(1993-4#5)(1993-5#1)(1993-6#2)(1993-7#3)(1993-8#3)(1993-9#2)(1994-11#2)(1994-12#7)(1994-2#4)(1994-3#4)(1994-4#1)(1994-5#7)(1994-6#4)(1994-8#4)(1994-9#1)(1995-1#3)(1995-10#2)(1995-11#8)(1995-12#4)(1995-2#5)(1995-3#11)(1995-4#1)(1995-5#2)(1995-6#4)(1995-8#5)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#9)(1996-6#4)(1996-7#3)(1996-8#6)(1996-9#2)(1997-1#2)(1997-2#6)(1997-3#1)(1997-4#3)(1997-5#6)(1997-6#2)(1997-7#4)(2004-11#5)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#7)(2005-12#1)(2005-3#1)(2005-4#2)(2005-7#1)(2005-8#5)(2005-9#1)(2006-1#2)(2006-10#14)(2006-11#3)(2006-12#4)(2006-2#3)(2006-4#2)(2006-5#2)(2006-6#8)(2006-7#4)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#28)(2007-12#39)(2007-2#5)(2007-3#7)(2007-4#2)(2007-5#5)(2007-6#3)(2007-7#11)(2007-8#15)(2007-9#2)(2008-1#8)(2008-10#91)(2008-11#18)(2008-12#5)(2008-2#25)(2008-3#47)(2008-4#12)(2008-5#24)(2008-6#9)(2008-7#20)(2008-8#23)(2008-9#13)(2009-1#3)(2009-10#5)(2009-12#1)(2009-2#5)(2009-3#3)(2009-4#5)(2009-5#6)(2009-6#4)(2009-7#2)(2009-8#2)(2009-9#6)(2010-1#5)(2010-10#2)(2010-11#1)(2010-12#16)(2010-2#7)(2010-3#4)(2010-4#9)(2010-5#2)(2010-6#2)(2010-7#4)(2010-8#4)(2010-9#2)(2011-1#20)(2011-11#1)(2011-12#2)(2011-2#32)(2011-3#2)(2012-1#4)(2012-11#5)(2012-12#13)(2012-2#19)(2012-3#13)(2013-1#25)(2013-7#4)(2013-8#28)
with high-affinity##3##2##(1992-6#1)(1994-8#1)(2010-5#1)
with high-density lipoprotein##2##3##(2008-10#1)(2011-1#1)
with high-density##4##2##(1992-12#1)(2008-10#1)(2008-7#1)(2011-1#1)
with high-dose chemotherapy##3##3##(2006-11#1)(2008-7#2)
with high-dose##22##2##(1991-6#1)(1992-2#1)(1993-7#1)(1994-10#1)(1994-4#1)(2004-11#1)(2006-10#2)(2006-11#1)(2007-11#3)(2008-1#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
with high-energy##2##2##(2006-4#1)(2009-11#1)
with high-functioning autism##2##3##(2006-3#1)(2007-8#1)
with high-grade carotid##2##3##(2007-10#2)
with high-grade dysplasia##4##3##(2009-4#1)(2010-12#1)(2010-7#1)(2012-12#1)
with high-grade##21##2##(1992-6#1)(2005-10#1)(2006-10#1)(2007-10#3)(2008-2#1)(2008-4#1)(2008-6#6)(2009-4#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
with high-index##2##2##(2007-11#1)(2008-3#1)
with high-level##5##2##(2006-8#1)(2008-2#1)(2009-6#1)(2013-7#1)(2013-8#1)
with high-numerical-aperture lenses##2##3##(2008-3#2)
with high-numerical-aperture objectives##2##3##(2007-11#1)(2007-12#1)
with high-numerical-aperture##6##2##(2007-11#2)(2007-12#2)(2008-3#2)
with high-order##3##2##(2007-11#3)
with high-performance liquid chromatography (HPLC)##4##5##(2008-10#3)(2008-6#1)
with high-performance liquid chromatography##9##4##(1990-8#1)(2008-10#7)(2008-6#1)
with high-performance##10##2##(1990-8#1)(2008-10#8)(2008-6#1)
with high-power##3##2##(1993-2#1)(2007-12#1)(2011-2#1)
with high-quality##3##2##(2008-2#1)(2008-3#1)(2011-2#1)
with high-resolution##14##2##(1991-11#1)(1995-8#1)(2008-10#3)(2008-3#3)(2008-9#1)(2009-4#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)
with high-risk HPV##2##3##(2011-2#2)
with high-risk acute##3##3##(2008-3#1)(2011-2#2)
with high-risk##20##2##(1997-1#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-8#1)(2011-2#6)(2012-12#1)(2013-1#4)
with high-sensitivity##2##2##(1995-10#1)(2008-2#1)
with high-speed##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-5#1)
with high-throughput##2##2##(2008-8#1)(2012-3#1)
with higher BLLs##2##3##(2013-1#2)
with higher NaF concentration##2##4##(2013-8#2)
with higher TSH##2##3##(2009-12#1)(2011-12#1)
with higher absolute##2##3##(1997-4#1)(2012-3#1)
with higher accuracy##2##3##(2007-7#1)(2008-3#1)
with higher affinity##8##3##(1990-12#1)(1992-6#1)(1995-11#1)(1995-6#1)(1997-6#2)(2007-11#1)(2008-8#1)
with higher degree of dementia##2##5##(2006-7#2)
with higher density##2##3##(2008-7#1)(2010-8#1)
with higher dimensional##3##3##(2008-10#3)
with higher doses##4##3##(1996-9#1)(2005-7#1)(2007-11#1)(2008-10#1)
with higher education were more##2##5##(2006-10#1)(2011-1#1)
with higher education##5##3##(2006-10#2)(2008-9#1)(2010-8#1)(2011-1#1)
with higher educational##2##3##(2009-10#1)(2012-1#1)
with higher incidence of##3##4##(2008-6#1)(2010-3#1)(2013-8#1)
with higher incidence##4##3##(2008-10#1)(2008-6#1)(2010-3#1)(2013-8#1)
with higher level of##2##4##(1995-10#1)(2008-8#1)
with higher levels of##16##4##(1991-1#1)(1994-2#1)(2006-10#2)(2007-8#2)(2008-10#3)(2008-11#1)(2008-8#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-4#1)
with higher levels##19##3##(1991-1#1)(1994-2#1)(2006-10#2)(2007-8#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-12#2)(2010-2#1)(2010-4#1)
with higher likelihood##2##3##(2008-12#1)(2012-3#1)
with higher lipid##2##3##(1991-11#1)(2006-2#1)
with higher mean##2##3##(2008-4#1)(2013-8#1)
with higher precision##3##3##(2007-5#1)(2008-10#1)(2009-12#1)
with higher prevalence##2##3##(2011-2#1)(2013-8#1)
with higher rates of##7##4##(2008-10#2)(2008-11#1)(2008-7#1)(2009-8#1)(2010-4#1)(2013-1#1)
with higher resolution##3##3##(2007-12#1)(2008-2#1)(2008-7#1)
with higher risk of##3##4##(1996-6#1)(2011-1#2)
with higher risk##6##3##(1996-6#1)(2010-12#1)(2011-1#2)(2011-2#1)(2013-1#1)
with higher stress##2##3##(2008-8#1)(2012-1#1)
with higher##277##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-9#1)(1992-3#2)(1992-6#1)(1993-1#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-4#1)(1995-6#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#2)(2004-2#1)(2004-4#1)(2004-9#1)(2005-11#2)(2005-3#1)(2005-7#1)(2006-10#7)(2006-2#1)(2006-4#1)(2006-7#3)(2007-1#1)(2007-10#3)(2007-11#6)(2007-12#6)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#26)(2008-11#6)(2008-12#1)(2008-2#6)(2008-3#3)(2008-4#2)(2008-5#8)(2008-6#2)(2008-7#10)(2008-8#7)(2008-9#4)(2009-10#1)(2009-12#5)(2009-2#3)(2009-4#3)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#1)(2010-8#5)(2011-1#9)(2011-12#3)(2011-2#10)(2011-3#1)(2012-1#2)(2012-12#6)(2012-2#7)(2012-3#9)(2012-7#1)(2013-1#13)(2013-7#1)(2013-8#8)
with highest levels##2##3##(1996-7#1)(1997-1#1)
with highest##21##2##(1990-11#1)(1991-10#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-7#1)(2006-12#1)(2006-9#1)(2007-1#2)(2007-6#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2011-2#1)(2013-7#1)
with highly active antiretroviral therapy (HAART)##3##6##(2007-11#2)(2010-5#1)
with highly active antiretroviral##5##4##(2007-11#2)(2007-7#1)(2008-10#1)(2010-5#1)
with highly active##7##3##(1995-8#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#1)(2010-5#1)
with highly increased##2##3##(1993-5#1)(1994-11#1)
with highly purified##3##3##(1991-12#1)(1991-9#1)(1995-10#1)
with highly selective angiotensin II (Ang II) receptor blockers (ARBs)##2##10##(2007-1#2)
with highly specific##4##3##(1996-9#1)(2004-1#1)(2007-8#1)(2013-1#1)
with highly variable##2##3##(2008-3#1)(2013-7#1)
with highly virulent##3##3##(2008-10#1)(2008-5#2)
with highly##54##2##(1990-6#1)(1991-12#1)(1991-2#1)(1991-9#1)(1993-3#1)(1993-5#1)(1994-11#1)(1995-10#1)(1995-8#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-6#1)(2004-1#1)(2005-12#1)(2007-1#2)(2007-11#2)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
with hilar##6##2##(1992-5#2)(2007-8#2)(2012-2#1)(2013-1#1)
with him##2##2##(1992-4#1)(1996-12#1)
with hip fractures##3##3##(1990-2#1)(2011-2#2)
with hip##8##2##(1990-2#1)(1993-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-10#1)(2011-2#2)
with hippocampal##3##2##(1993-5#1)(1993-6#1)(2004-11#1)
with hirsutism##2##2##(2007-11#1)(2008-4#1)
with hirudin##2##2##(1990-11#1)(2008-10#1)
with his family and##2##4##(2009-3#1)(2011-12#1)
with his or her##4##4##(2004-3#1)(2006-7#1)(2009-10#1)(2010-10#1)
with his##24##2##(1991-2#1)(1992-12#1)(1995-1#1)(1995-6#1)(1995-8#1)(2004-12#1)(2004-3#1)(2006-7#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-3#1)(2010-10#1)(2010-3#1)(2010-5#1)(2011-12#1)(2011-2#1)
with histamine immobilized on##2##4##(2007-8#2)
with histamine in the##2##4##(2007-8#2)
with histamine##12##2##(1990-7#1)(1992-6#1)(1993-8#1)(1994-6#1)(2007-1#1)(2007-2#1)(2007-8#6)
with histidine and##2##3##(1992-2#1)(2008-10#1)
with histidine##5##2##(1992-2#1)(2008-10#3)(2011-2#1)
with histidines##2##2##(1995-2#1)(2010-5#1)
with histologic evidence of##3##4##(1992-8#1)(2008-5#2)
with histologic features##3##3##(1994-12#1)(2007-10#1)(2007-2#1)
with histologic##12##2##(1991-12#1)(1992-8#1)(1994-12#1)(2006-10#2)(2007-10#1)(2007-2#1)(2007-6#1)(2008-5#3)(2012-2#1)
with histological activity##2##3##(2006-2#1)(2009-9#1)
with histological and##2##3##(2007-4#1)(2008-7#1)
with histological correlation##2##3##(2005-12#1)(2007-3#1)
with histological diagnosis##2##3##(2007-6#1)(2013-1#1)
with histological examination##2##3##(2010-5#1)(2011-1#1)
with histological findings and##2##4##(2008-10#1)(2013-8#1)
with histological findings##3##3##(2008-10#1)(2011-1#1)(2013-8#1)
with histological##24##2##(1994-10#2)(2005-12#1)(2006-2#2)(2007-1#1)(2007-3#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-9#1)(2010-5#1)(2011-1#2)(2012-1#2)(2013-1#1)(2013-8#1)
with histologically confirmed common malignant epithelial tumors of the ovary##2##10##(1993-9#2)
with histologically confirmed first diagnosis of##2##6##(1993-9#2)
with histologically confirmed##7##3##(1992-9#1)(1993-9#4)(1994-12#1)(2011-2#1)
with histologically or##2##3##(1992-9#1)(2008-10#1)
with histologically proven##12##3##(1990-2#1)(1990-8#1)(1991-2#1)(1991-4#1)(1994-1#1)(2004-1#1)(2007-10#1)(2007-6#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-3#1)
with histologically##23##2##(1990-2#1)(1990-8#1)(1991-2#1)(1991-4#1)(1992-9#2)(1993-9#4)(1994-1#1)(1994-12#1)(1994-2#1)(1996-6#1)(2004-1#1)(2007-10#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-3#1)(2011-2#1)
with histology##3##2##(1991-12#1)(1997-4#1)(2005-11#1)
with histone##2##2##(1993-3#1)(2008-10#1)
with histopathological findings##3##3##(2011-2#2)(2012-2#1)
with histopathological##11##2##(2007-8#1)(2008-6#1)(2009-1#1)(2009-5#1)(2010-5#1)(2011-2#4)(2012-12#1)(2012-2#1)
with histopathologically##2##2##(1991-12#1)(1997-8#1)
with histopathology##3##2##(2005-12#1)(2008-7#1)(2012-2#1)
with histoplasmin##2##2##(2008-5#2)
with historical controls##3##3##(1991-8#1)(2007-11#1)(2008-2#1)
with historical##9##2##(1991-8#1)(1992-12#1)(1996-8#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-5#1)
with histories of##5##3##(1995-11#1)(2006-10#2)(2006-12#1)(2006-2#1)
with history and##2##3##(2007-7#1)(2008-10#1)
with history of chronic##2##4##(2007-7#1)(2010-9#1)
with history of previous##2##4##(2006-8#1)(2013-1#1)
with history of##27##3##(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#4)(2007-7#2)(2008-1#2)(2009-6#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
with history##32##2##(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#4)(2007-7#3)(2008-1#3)(2008-10#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
with hoarseness##2##2##(2008-11#1)(2009-9#1)
with holes##2##2##(2008-3#1)(2008-6#1)
with hollow##2##2##(2008-12#1)(2010-11#1)
with holoprosencephaly (HPE)##2##3##(1996-12#1)(2013-1#1)
with home##6##2##(1995-2#2)(2007-2#1)(2011-2#1)(2012-12#2)
with homeless people##3##3##(2008-2#2)(2012-12#1)
with homeless##5##2##(2008-2#2)(2009-5#1)(2012-12#2)
with homoallylic alcohols##2##3##(2007-11#1)(2009-6#1)
with homocystinuria##2##2##(2005-10#1)(2012-12#1)
with homogeneous T1-SI identical to the SI of subcutaneous fat##2##10##(2012-2#2)
with homogeneous##5##2##(1990-11#1)(2007-12#1)(2008-10#1)(2012-2#2)
with homologous and##2##3##(1997-2#1)(2006-12#1)
with homologous##9##2##(1994-8#1)(1995-1#2)(1995-3#1)(1997-2#1)(2006-12#1)(2008-12#1)(2008-5#1)(2008-9#1)
with homology to the##5##4##(1992-8#1)(1997-1#1)(1997-6#1)(2006-11#1)(2008-7#1)
with homology to##15##3##(1990-2#1)(1992-8#1)(1993-4#1)(1993-6#1)(1994-8#2)(1995-11#1)(1996-10#1)(1997-1#2)(1997-6#1)(2006-10#1)(2006-11#1)(2008-6#1)(2008-7#1)
with homology##17##2##(1990-2#1)(1991-9#1)(1992-8#1)(1993-4#1)(1993-6#1)(1994-8#2)(1995-11#1)(1996-10#1)(1997-1#2)(1997-6#1)(2006-10#1)(2006-11#1)(2008-6#1)(2008-7#1)(2008-8#1)
with homozygous SCD##2##3##(2009-4#2)
with homozygous sickle cell##2##4##(1992-8#1)(2009-10#1)
with homozygous##7##2##(1992-8#1)(1994-12#1)(2009-10#1)(2009-4#2)(2011-2#1)(2013-8#1)
with honey##2##2##(2008-10#1)(2008-6#1)
with hook##2##2##(2008-3#1)(2013-7#1)
with horizontal##3##2##(2007-8#1)(2008-10#1)(2008-3#1)
with horizontally##2##2##(2004-11#1)(2008-11#1)
with hormonal##4##2##(1992-2#1)(2006-2#1)(2008-8#1)(2011-1#1)
with hormone receptor##2##3##(1996-11#1)(2013-1#1)
with hormone##8##2##(1991-4#1)(1991-6#1)(1996-11#1)(1996-7#1)(2007-11#1)(2008-11#1)(2011-12#1)(2013-1#1)
with hormones and##2##3##(2009-5#1)(2010-8#1)
with hormones##5##2##(1990-11#1)(1991-9#1)(2009-5#1)(2010-8#1)(2012-2#1)
with horseradish peroxidase (HRP)##4##4##(1990-5#1)(1995-11#1)(2008-10#1)(2012-2#1)
with horseradish peroxidase##14##3##(1990-5#1)(1992-1#1)(1995-11#1)(1996-12#1)(1997-3#1)(2008-10#4)(2008-2#1)(2008-4#2)(2010-5#1)(2012-2#1)
with hospital##14##2##(1991-4#1)(1993-6#2)(1994-2#1)(1995-1#2)(1997-1#1)(2006-1#1)(2006-8#1)(2008-4#1)(2011-2#2)(2012-2#1)(2013-8#1)
with hospitalization##2##2##(2007-7#1)(2008-3#1)
with hospitalized children##2##3##(1992-3#1)(2013-1#1)
with hospitalized##3##2##(1992-3#1)(1997-3#1)(2013-1#1)
with hospitals and##3##3##(1991-12#1)(1995-2#1)(2007-4#1)
with hospitals##9##2##(1991-12#1)(1993-12#1)(1993-3#1)(1995-2#1)(1996-3#1)(2007-4#2)(2007-9#1)(2010-5#1)
with host cell##2##3##(2007-7#1)(2008-4#1)
with host cells##4##3##(2007-12#1)(2008-5#1)(2008-9#1)(2010-12#1)
with host or##2##3##(2008-10#2)
with host plants##2##3##(2008-10#1)(2013-7#1)
with host size##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
with host##33##2##(1995-3#1)(1995-9#1)(2005-8#1)(2006-10#3)(2006-6#1)(2007-12#1)(2007-7#1)(2008-10#12)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-4#1)(2010-12#1)(2010-8#1)(2013-1#2)(2013-7#1)
with hosts##2##2##(1990-11#1)(2009-2#1)
with hot water##6##3##(2008-10#1)(2008-5#1)(2008-6#1)(2013-1#3)
with hot##10##2##(1995-3#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2013-1#3)(2013-8#1)
with house dust mite allergens##2##5##(2011-2#2)
with households##2##2##(2007-7#1)(2008-9#1)
with how to##2##3##(2008-12#1)(2012-11#1)
with how##3##2##(2008-12#1)(2010-10#1)(2012-11#1)
with hsp90##3##2##(1990-11#1)(1993-8#1)(1996-5#1)
with human B cell line##2##5##(2008-8#2)
with human T-cell leukemia virus##2##5##(1995-5#1)(2008-11#1)
with human T-cell##3##3##(1993-6#1)(1995-5#1)(2008-11#1)
with human and bovine##2##4##(1991-10#1)(1996-6#1)
with human and mouse##2##4##(2008-4#1)(2012-2#1)
with human and##7##3##(1991-10#1)(1991-2#1)(1993-4#1)(1996-6#1)(1997-8#1)(2008-4#1)(2012-2#1)
with human blood##3##3##(1994-12#1)(1994-8#1)(2009-11#1)
with human breast cancer##2##4##(1996-7#1)(2013-1#1)
with human cadavers##2##3##(2006-11#1)(2007-4#1)
with human chorionic gonadotropin##3##4##(1993-6#1)(2008-1#1)(2008-4#1)
with human chromosome##2##3##(1993-2#1)(2008-7#1)
with human dCK##2##3##(1994-9#2)
with human disease##3##3##(2005-7#1)(2006-10#1)(2009-5#1)
with human endoglin##2##3##(1992-11#2)
with human factor##2##3##(1990-7#1)(1994-3#1)
with human immunodeficiency virus (HIV) infection##4##6##(1991-8#1)(1993-7#1)(1997-8#1)(2013-1#1)
with human immunodeficiency virus (HIV)##11##5##(1991-8#1)(1993-7#1)(1995-12#1)(1997-8#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-11#1)(2009-12#1)(2010-12#1)(2013-1#1)
with human immunodeficiency virus (HIV-1)##2##5##(2009-7#1)(2010-11#1)
with human immunodeficiency virus infection##9##5##(1993-2#1)(1993-6#1)(1995-3#1)(1996-2#1)(2007-10#1)(2007-3#1)(2009-12#1)(2010-12#1)(2010-6#1)
with human immunodeficiency virus type 1 (HIV-1) infection##2##8##(2008-2#2)
with human immunodeficiency virus type 1 (HIV-1)##4##7##(2008-2#4)
with human immunodeficiency virus type 1##7##6##(1991-2#1)(1995-1#1)(2006-10#1)(2008-2#4)
with human immunodeficiency virus##37##4##(1991-2#2)(1991-8#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-7#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-2#1)(1997-8#1)(2006-10#3)(2007-10#2)(2007-11#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-2#4)(2009-12#2)(2009-7#1)(2010-11#1)(2010-12#2)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
with human immunodeficiency##38##3##(1991-2#2)(1991-8#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-7#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-2#1)(1997-8#1)(2006-10#3)(2007-10#2)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-2#4)(2009-12#2)(2009-7#1)(2010-11#1)(2010-12#2)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
with human insulin##6##3##(1991-8#2)(2007-11#1)(2008-4#1)(2008-6#1)(2011-1#1)
with human liver##3##3##(1990-10#1)(2009-4#1)(2010-12#1)
with human monoclonal##2##3##(1992-2#1)(1994-3#1)
with human neutrophils##2##3##(1993-6#1)(2008-10#1)
with human papilloma virus (HPV)##2##5##(1991-2#1)(1996-12#1)
with human papilloma##3##3##(1991-2#1)(1996-12#1)(2012-12#1)
with human papillomavirus##4##3##(1991-9#1)(1994-4#1)(2007-4#1)(2008-4#1)
with human peripheral blood lymphocytes##4##5##(1994-2#2)(2010-12#2)
with human plasma##2##3##(1993-6#1)(1994-11#1)
with human recombinant##2##3##(1994-9#1)(1995-5#1)
with human serum albumin (HSA)##2##5##(2006-12#1)(2007-8#1)
with human serum##5##3##(1992-3#1)(1997-2#1)(2006-12#1)(2007-8#1)(2012-1#1)
with human thrombin##2##3##(1992-2#1)(1996-7#1)
with human umbilical vein endothelial cells##2##6##(1994-2#1)(2008-9#1)
with human volunteers##3##3##(2007-4#1)(2008-11#1)(2008-5#1)
with human##224##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-10#2)(1991-12#1)(1991-2#6)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#4)(1991-9#2)(1992-11#2)(1992-2#3)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#3)(1993-11#1)(1993-12#1)(1993-2#3)(1993-4#1)(1993-6#7)(1993-7#3)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#6)(1994-3#2)(1994-4#1)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#5)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#3)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#2)(1996-8#1)(1997-2#3)(1997-4#1)(1997-7#2)(1997-8#3)(1997-9#1)(2004-7#1)(2005-11#1)(2005-7#1)(2006-10#5)(2006-11#2)(2006-12#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#7)(2007-2#1)(2007-3#1)(2007-4#5)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#9)(2008-2#5)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#6)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#4)(2013-7#1)(2013-8#2)
with humans##9##2##(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-12#1)(2012-12#1)(2012-2#1)
with humic acids##3##3##(2008-10#3)
with humic##5##2##(2008-10#5)
with humoral##4##2##(1993-9#1)(1995-12#1)(2007-2#1)(2011-2#1)
with hundreds of##3##3##(2007-9#1)(2008-10#1)(2008-2#1)
with hyaline cartilage##2##3##(2007-11#1)(2008-5#1)
with hyaline##4##2##(2007-11#1)(2007-2#1)(2008-5#1)(2011-2#1)
with hyaluronic acid##2##3##(1991-10#1)(2013-1#1)
with hybrid##5##2##(1991-4#1)(1994-5#1)(2006-5#1)(2008-10#1)(2010-4#1)
with hybridization##2##2##(1992-12#1)(2013-1#1)
with hydranencephaly##3##2##(1997-3#3)
with hydrazine afforded##2##3##(1997-2#2)
with hydrazine hydrate##3##3##(2008-11#1)(2011-1#2)
with hydrazine##11##2##(1997-2#4)(2005-11#2)(2007-11#1)(2008-10#1)(2008-11#1)(2011-1#2)
with hydrazines##4##2##(2007-11#4)
with hydride generation and##2##4##(2005-4#1)(2008-10#1)
with hydride generation atomic##2##4##(2008-10#2)
with hydride generation##7##3##(2005-4#1)(2008-10#6)
with hydride##9##2##(2005-4#1)(2008-10#7)(2013-1#1)
with hydrocephalus and##4##3##(2005-10#1)(2006-5#2)(2012-12#1)
with hydrocephalus##10##2##(2005-10#3)(2006-12#2)(2006-5#4)(2012-12#1)
with hydrochloric acid##7##3##(2007-11#1)(2008-10#6)
with hydrocortisone##4##2##(1993-1#1)(2006-1#1)(2008-11#2)
with hydrodynamic##2##2##(2008-10#1)(2008-11#1)
with hydrogen peroxide and##3##4##(2008-10#2)(2013-1#1)
with hydrogen peroxide as product##2##5##(2008-10#2)
with hydrogen peroxide as##3##4##(1992-9#1)(2008-10#2)
with hydrogen peroxide in a##2##5##(2008-10#2)
with hydrogen peroxide in aqueous##2##5##(2008-10#1)(2009-5#1)
with hydrogen peroxide in##7##4##(1995-8#1)(2008-10#5)(2009-5#1)
with hydrogen peroxide or##2##4##(1990-4#1)(2008-10#1)
with hydrogen peroxide showed increased##2##5##(1990-4#1)(2008-11#1)
with hydrogen peroxide solution##2##4##(2005-11#1)(2010-2#1)
with hydrogen peroxide##35##3##(1990-4#2)(1991-9#1)(1992-9#1)(1994-5#1)(1995-8#1)(2005-11#1)(2007-8#1)(2008-10#22)(2008-11#1)(2008-3#1)(2009-5#1)(2010-2#1)(2013-1#1)
with hydrogen##43##2##(1990-4#2)(1991-9#1)(1992-9#1)(1993-1#1)(1993-11#1)(1994-5#1)(1995-8#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-3#2)(2009-5#1)(2010-11#1)(2010-2#1)(2012-2#1)(2013-1#2)
with hydrolysis of##2##3##(1993-8#1)(1997-4#1)
with hydrolysis##3##2##(1993-8#1)(1997-4#1)(2008-4#1)
with hydronephrosis and##2##3##(2009-5#2)
with hydronephrosis##4##2##(2008-10#1)(2008-7#1)(2009-5#2)
with hydrophilic##4##2##(1996-2#1)(1997-8#1)(2006-10#1)(2012-1#1)
with hydrophobic acyl chains##2##4##(2006-10#2)
with hydrophobic##13##2##(1992-2#1)(1993-11#1)(1993-3#1)(1995-8#1)(2006-10#2)(2007-8#1)(2008-10#2)(2008-6#1)(2010-4#1)(2011-1#1)(2012-2#1)
with hydroquinone##3##2##(2008-10#2)(2008-5#1)
with hydroxy##2##2##(2008-5#1)(2013-1#1)
with hydroxyapatite##3##2##(2008-3#1)(2008-5#1)(2010-12#1)
with hydroxychloroquine##3##2##(1997-5#1)(2005-11#1)(2006-10#1)
with hydroxyl##4##2##(2008-10#2)(2008-4#2)
with hydroxylamine led to##2##4##(1992-7#1)(1994-3#1)
with hydroxylamine##7##2##(1991-7#1)(1992-5#1)(1992-7#1)(1994-3#1)(1995-8#1)(2007-10#1)(2009-9#1)
with hydroxyurea##2##2##(1992-10#1)(1992-4#1)
with hyperbilirubinemia##3##2##(1990-8#2)(1997-1#1)
with hyperbranched##2##2##(2008-1#1)(2012-3#1)
with hypercalcemia##4##2##(1990-2#1)(1996-9#1)(2006-8#1)(2008-6#1)
with hypercholesterolemia##9##2##(1990-11#1)(1991-6#1)(1997-4#1)(2007-2#1)(2008-1#2)(2008-7#1)(2008-8#1)(2013-1#1)
with hypereosinophilia##3##2##(2008-11#2)(2010-12#1)
with hypereosinophilic syndrome##2##3##(2008-7#2)
with hyperglycemia##4##2##(2007-10#1)(2008-3#1)(2010-6#1)(2013-1#1)
with hyperhidrosis##3##2##(2007-7#1)(2007-8#2)
with hyperinsulinemia and##2##3##(2005-10#1)(2008-3#1)
with hyperinsulinemia##3##2##(1996-8#1)(2005-10#1)(2008-3#1)
with hyperkeratosis##2##2##(2006-12#1)(2008-5#1)
with hyperlipidemia##3##2##(1990-4#1)(2007-7#1)(2008-3#1)
with hyperlipidemia]##3##2##(1990-3#1)(1990-6#1)(2013-1#1)
with hypermethylation##2##2##(1996-10#1)(2008-7#1)
with hyperparathyroidism##5##2##(1991-3#2)(1996-12#1)(1996-9#1)(2009-2#1)
with hyperpigmentation##2##2##(2011-1#1)(2013-7#1)
with hyperplasia##2##2##(2005-12#1)(2012-3#1)
with hyperprolactinemia##5##2##(2006-9#1)(2008-5#1)(2008-7#1)(2010-10#2)
with hypersensitivity##2##2##(2007-11#1)(2008-8#1)
with hypertension and diabetes##4##4##(1997-8#1)(2007-10#1)(2011-2#1)(2013-1#1)
with hypertension and##9##3##(1996-9#1)(1997-8#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-7#1)(2009-9#1)(2011-2#1)(2013-1#1)
with hypertension had##2##3##(1997-2#1)(2013-1#1)
with hypertension in##2##3##(2007-7#1)(2012-3#1)
with hypertension or##2##3##(1992-6#1)(2008-8#1)
with hypertension##45##2##(1992-5#1)(1992-6#1)(1993-9#1)(1996-12#1)(1996-9#2)(1997-2#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-5#1)(2006-7#1)(2007-1#2)(2007-10#3)(2007-11#1)(2007-7#3)(2007-8#1)(2008-1#3)(2008-3#1)(2008-7#2)(2008-8#3)(2009-9#1)(2010-12#1)(2010-4#2)(2011-2#2)(2012-3#3)(2013-1#5)
with hypertensive##2##2##(2008-5#1)(2008-8#1)
with hyperthermia##4##2##(1994-5#1)(2005-8#1)(2006-4#1)(2008-4#1)
with hyperthyroidism##7##2##(1993-11#1)(2006-11#1)(2007-8#1)(2007-9#2)(2008-4#1)(2011-1#1)
with hypertonic saline neurolysis##3##4##(2006-8#3)
with hypertonic saline##5##3##(2006-8#3)(2010-1#1)(2010-12#1)
with hypertonic##7##2##(1994-8#1)(1995-1#1)(2006-8#3)(2010-1#1)(2010-12#1)
with hypertriglyceridemia##7##2##(1993-11#1)(1997-2#2)(1997-7#1)(2007-2#2)(2008-8#1)
with hypertrophic obstructive cardiomyopathy##7##4##(1991-12#1)(1992-5#2)(2007-8#3)(2010-12#1)
with hypertrophic##12##2##(1990-7#1)(1991-12#1)(1992-5#2)(1993-5#1)(2007-8#3)(2008-7#2)(2009-5#1)(2010-12#1)
with hypertrophy of the##3##4##(1993-12#1)(2006-5#1)(2007-9#1)
with hypertrophy##4##2##(1993-12#1)(2006-5#1)(2007-9#1)(2008-7#1)
with hyphal growth##2##3##(2008-10#2)
with hypoalbuminemia##3##2##(2007-7#1)(2013-1#2)
with hypobromite##3##2##(2008-10#3)
with hypochlorite and##3##3##(2008-10#3)
with hypochlorite##4##2##(2007-7#1)(2008-10#3)
with hypofractionated radiotherapy##3##3##(1992-10#2)(2008-6#1)
with hypogammaglobulinemia##3##2##(1990-6#1)(2006-10#1)(2011-2#1)
with hypokalemia##5##2##(1991-10#1)(1997-8#1)(2006-8#2)(2011-2#1)
with hypokalemic##3##2##(2007-3#1)(2008-1#2)
with hypolipidemic##2##2##(1990-12#1)(2005-8#1)
with hyponatraemia and##2##3##(1990-6#1)(2006-4#1)
with hyponatremia##2##2##(2010-6#1)(2011-2#1)
with hypopituitarism##2##2##(1996-3#1)(2008-7#1)
with hypoplastic left##2##3##(2008-4#1)(2011-1#1)
with hypoplastic##6##2##(1994-6#1)(2008-10#3)(2008-4#1)(2011-1#1)
with hyporeflexia##2##2##(2008-4#2)
with hypospadias and##2##3##(2008-10#2)
with hypospadias##5##2##(2008-10#4)(2009-5#1)
with hypotension##4##2##(1996-12#1)(2006-1#1)(2007-12#1)(2010-7#1)
with hypothermia##5##2##(1990-9#1)(1994-5#1)(2008-8#1)(2010-12#2)
with hypotheses##3##2##(2008-6#1)(2009-5#1)(2011-1#1)
with hypothyroidism##6##2##(2006-11#1)(2006-2#1)(2008-4#1)(2008-7#1)(2009-12#1)(2011-11#1)
with hypotonia##2##2##(1996-3#1)(2006-10#1)
with hypoxanthine##2##2##(2008-11#2)
with hypoxia##3##2##(1990-12#1)(1997-5#1)(2006-4#1)
with hysterectomy and##2##3##(2008-3#1)(2011-2#1)
with hysteresis##2##2##(2005-11#1)(2008-2#1)
with i =##2##3##(1995-11#1)(2008-2#1)
with i##13##2##(1990-7#2)(1991-6#1)(1993-11#1)(1995-11#1)(1995-8#1)(1996-8#1)(2007-6#3)(2008-2#1)(2008-5#1)(2008-7#1)
with iatrogenic##4##2##(2007-7#1)(2007-8#1)(2008-7#2)
with ibuprofen##3##2##(1993-11#1)(2012-12#2)
with ice##2##2##(1990-12#1)(2008-2#1)
with idarubicin##2##2##(1990-10#1)(2007-4#1)
with ideas##2##2##(2009-10#1)(2009-4#1)
with identical amino acid composition##2##5##(1994-9#2)
with identical##30##2##(1991-4#1)(1991-7#1)(1992-8#1)(1994-11#1)(1994-9#2)(1995-5#1)(1997-3#1)(2005-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-11#1)
with identification of##5##3##(1992-9#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)
with identified##4##2##(1994-2#1)(2008-7#1)(2012-11#1)(2013-1#1)
with identifying the##2##3##(1995-12#1)(2007-12#1)
with identifying##3##2##(1992-11#1)(1995-12#1)(2007-12#1)
with identities##3##2##(1990-12#1)(2008-10#1)(2008-2#1)
with idiopathic Parkinson's disease##3##4##(2006-8#1)(2008-7#2)
with idiopathic cardiomyopathy belong to the same mitochondrial DNA gene family of Parkinson's disease and mitochondrial##2##16##(1991-5#2)
with idiopathic central##3##3##(1997-8#2)(2007-6#1)
with idiopathic dilated cardiomyopathy##4##4##(2005-10#1)(2007-11#1)(2010-8#1)(2011-2#1)
with idiopathic hypercalciuria##3##3##(2008-10#1)(2008-7#1)(2012-1#1)
with idiopathic pulmonary fibrosis##4##4##(2005-8#2)(2009-10#1)(2010-6#1)
with idiopathic pulmonary##5##3##(2005-8#2)(2009-10#1)(2010-6#1)(2013-1#1)
with idiopathic scoliosis##7##3##(2006-10#1)(2007-7#2)(2007-8#3)(2012-1#1)
with idiopathic##70##2##(1990-8#1)(1991-5#3)(1992-7#1)(1995-10#2)(1995-2#1)(1995-6#4)(1997-8#2)(2005-10#1)(2005-12#1)(2005-8#4)(2006-10#4)(2006-8#4)(2007-11#4)(2007-6#1)(2007-7#4)(2007-8#5)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#6)(2009-10#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-2#1)(2012-1#2)(2012-2#2)(2013-1#4)(2013-8#1)
with ifosfamide##6##2##(1993-1#1)(1994-10#1)(1994-3#1)(2007-12#1)(2008-6#2)
with ileal##3##2##(1991-11#1)(1991-5#1)(2006-10#1)
with ileostomy##2##2##(2006-10#1)(2008-8#1)
with illegal##2##2##(2012-12#1)(2013-7#1)
with illicit##3##2##(1990-11#1)(2006-7#1)(2006-8#1)
with illness##4##2##(1994-2#1)(1995-12#1)(2009-11#2)
with illustrations##6##2##(1994-4#1)(2007-2#5)
with illustrative examples##2##3##(1997-2#1)(2012-1#1)
with iloprost##3##2##(2007-8#1)(2009-7#2)
with image analysis and##2##4##(2008-7#1)(2012-12#1)
with image analysis software##2##4##(2005-11#1)(2008-10#1)
with image analysis##10##3##(1993-7#1)(1996-7#1)(1997-5#1)(2005-11#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-12#1)
with image##20##2##(1993-7#1)(1996-7#1)(1997-5#1)(2004-9#1)(2005-11#2)(2006-3#1)(2006-8#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2012-12#2)
with images of##3##3##(2008-5#1)(2009-4#1)(2012-1#1)
with images##6##2##(2008-2#1)(2008-3#2)(2008-5#1)(2009-4#1)(2012-1#1)
with imaging##11##2##(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-11#2)(2008-3#1)(2008-6#1)(2009-4#1)(2011-1#1)
with imatinib in##2##3##(2012-2#1)(2013-8#1)
with imatinib mesylate##3##3##(2008-1#1)(2008-6#2)
with imatinib##11##2##(2007-12#1)(2008-1#1)(2008-6#2)(2009-3#3)(2009-7#2)(2012-2#1)(2013-8#1)
with imidazole##2##2##(1996-7#1)(2005-4#1)
with imidazoline##2##2##(1995-11#1)(2005-10#1)
with imiglucerase##3##2##(2008-10#3)
with iminodiacetic##2##2##(1997-2#1)(2008-10#1)
with imipramine##3##2##(1991-5#1)(1996-12#1)(2012-12#1)
with immature##4##2##(2008-10#1)(2009-3#1)(2010-6#1)(2011-2#1)
with immediate gastric pull-up procedures##2##5##(2007-3#2)
with immediate gastric pull-up##3##4##(2007-3#3)
with immediate##11##2##(2007-3#3)(2009-3#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#3)
with immobilised##4##2##(1994-12#1)(2008-10#3)
with immobilized cells##2##3##(2008-6#2)
with immobilized oligonucleotides##2##3##(2012-1#2)
with immobilized reagents##2##3##(2008-10#2)
with immobilized##24##2##(1991-9#1)(1992-11#1)(1992-7#1)(1995-3#2)(1996-3#1)(2006-12#1)(2008-10#12)(2008-6#2)(2008-7#1)(2012-1#2)
with immune dysfunction##3##3##(2007-3#1)(2008-10#1)(2008-12#1)
with immune##17##2##(1994-6#1)(1996-12#2)(2006-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-12#1)(2009-12#1)(2010-12#1)(2010-6#1)(2011-2#1)(2013-1#2)(2013-8#1)
with immunity##3##2##(1995-5#1)(2008-8#1)(2012-3#1)
with immunization##4##2##(1996-12#1)(2008-4#1)(2008-9#1)(2013-1#1)
with immunoblot##2##2##(1996-2#1)(2011-2#1)
with immunocompetent##2##2##(1997-4#1)(2007-2#1)
with immunocytochemical##2##2##(1991-1#1)(2008-7#1)
with immunocytochemistry in##3##3##(1991-10#1)(1993-12#1)(2008-4#1)
with immunocytochemistry##8##2##(1990-5#1)(1991-10#1)(1993-12#2)(1997-6#1)(2008-4#2)(2008-6#1)
with immunodeficiency##6##2##(1992-12#1)(1997-3#1)(2006-1#1)(2007-2#2)(2011-2#1)
with immunodepression##2##2##(2007-6#1)(2009-2#1)
with immunofluorescence##3##2##(1995-10#1)(1996-9#1)(2010-11#1)
with immunoglobulin A nephropathy##2##4##(2008-8#1)(2013-1#1)
with immunoglobulin##4##2##(1994-3#1)(2008-8#1)(2009-8#1)(2013-1#1)
with immunogold##3##2##(1997-2#1)(2008-4#1)(2008-5#1)
with immunohistochemical findings##2##3##(1994-8#1)(2013-7#1)
with immunohistochemical staining##2##3##(1991-7#1)(2006-4#1)
with immunohistochemical##8##2##(1991-7#1)(1994-8#1)(2006-4#1)(2007-2#1)(2008-6#1)(2008-9#1)(2010-11#1)(2013-7#1)
with immunohistochemistry and##2##3##(1997-7#1)(2011-3#1)
with immunohistochemistry markers##2##3##(2007-11#2)
with immunohistochemistry##10##2##(1991-3#1)(1997-7#2)(2007-11#2)(2007-8#1)(2008-5#1)(2011-2#2)(2011-3#1)
with immunological##5##2##(1991-11#1)(1994-5#1)(1996-12#1)(2007-8#1)(2008-8#1)
with immunoreactive##2##2##(1992-8#1)(1992-9#1)
with immunosuppression##3##2##(1996-8#1)(2007-2#1)(2010-10#1)
with immunosuppressive agents##5##3##(2005-11#1)(2006-10#1)(2010-12#1)(2010-6#1)(2013-7#1)
with immunosuppressive drugs##2##3##(2006-10#1)(2007-11#1)
with immunosuppressive therapy##3##3##(2006-10#1)(2007-11#2)
with immunosuppressive##11##2##(2005-11#1)(2006-10#3)(2007-11#3)(2009-8#1)(2010-12#1)(2010-6#1)(2013-7#1)
with immunotherapy##6##2##(1993-11#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-3#1)(2010-12#1)
with impact##2##2##(2006-11#1)(2012-12#1)
with impacted teeth##2##3##(2007-12#2)
with impacted##3##2##(2007-12#2)(2012-12#1)
with impaired cardiac function##2##4##(2005-7#1)(2007-11#1)
with impaired glucose tolerance (IGT)##3##5##(1994-12#1)(2008-3#1)(2012-3#1)
with impaired glucose tolerance##6##4##(1994-12#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-4#1)(2012-3#1)
with impaired glucose##8##3##(1991-10#1)(1994-12#1)(2008-3#1)(2008-7#2)(2010-10#1)(2010-4#1)(2012-3#1)
with impaired growth##2##3##(1996-6#1)(2008-10#1)
with impaired left ventricular function##2##5##(2006-10#2)
with impaired renal function##5##4##(1994-4#1)(2006-10#1)(2008-3#1)(2009-8#1)(2011-2#1)
with impaired vision##3##3##(2009-3#3)
with impaired##60##2##(1990-1#1)(1990-9#1)(1991-10#1)(1991-4#1)(1991-9#1)(1992-5#1)(1992-9#1)(1994-12#1)(1994-4#1)(1994-5#1)(1994-9#1)(1996-6#1)(1997-1#1)(1997-7#2)(2005-10#1)(2005-11#1)(2005-7#2)(2006-10#3)(2007-11#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-7#4)(2009-3#3)(2009-4#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
with impairment of##3##3##(1994-12#1)(2008-7#1)(2010-7#1)
with impairment##4##2##(1994-12#1)(1996-3#1)(2008-7#1)(2010-7#1)
with impedance recordings##2##3##(1996-5#2)
with imperfect##3##2##(1992-12#1)(2008-3#1)(2013-1#1)
with imperforate anus and##2##4##(2009-5#1)(2010-2#1)
with implant##4##2##(2008-9#2)(2012-12#2)
with implantable##4##2##(2005-7#1)(2006-12#2)(2010-5#1)
with implantation of##7##3##(1990-5#1)(1991-3#1)(2006-8#1)(2007-3#1)(2008-8#1)(2009-4#1)(2013-7#1)
with implantation##9##2##(1990-5#1)(1991-3#1)(2006-8#1)(2007-3#1)(2008-8#1)(2008-9#2)(2009-4#1)(2013-7#1)
with implanted##3##2##(2006-9#1)(2011-2#1)(2012-1#1)
with implants##3##2##(1992-5#1)(2008-11#1)(2008-5#1)
with implementation of##3##3##(2004-9#1)(2007-2#1)(2012-3#1)
with implementing##6##2##(1991-1#1)(1992-1#1)(1993-12#1)(1994-1#1)(1996-1#1)(2008-11#1)
with implications for##14##3##(1992-6#1)(1994-3#1)(2004-12#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2011-1#1)(2011-12#1)(2011-2#1)
with implications##16##2##(1992-6#1)(1994-3#1)(2004-12#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)
with important information about##2##4##(1993-8#1)(2013-1#1)
with important##23##2##(1992-3#1)(1993-8#1)(1994-6#1)(1996-3#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-12#1)(2010-4#1)(2012-11#2)(2012-2#1)(2013-1#3)(2013-8#2)
with impressive##2##2##(1993-3#1)(2006-10#1)
with improved accuracy##2##3##(1995-11#1)(2008-10#1)
with improved biological##2##3##(1994-9#1)(2008-10#1)
with improved mechanical##2##3##(2008-8#1)(2012-2#1)
with improved or##2##3##(1995-7#1)(2011-1#1)
with improved outcomes##6##3##(2007-8#1)(2008-12#1)(2008-3#1)(2012-2#1)(2013-1#2)
with improved patient##2##3##(2006-10#1)(2008-6#1)
with improved selectivity##4##3##(1994-2#1)(1997-3#1)(2008-10#1)(2010-7#1)
with improved sensitivity and##2##4##(1990-2#1)(1996-2#1)
with improved sensitivity##8##3##(1990-2#1)(1996-2#1)(2006-2#1)(2007-8#1)(2008-10#3)(2008-3#1)
with improved tolerability##2##3##(2009-3#1)(2013-1#1)
with improved understanding of##2##4##(1997-1#1)(2008-10#1)
with improved##111##2##(1990-2#1)(1992-2#1)(1993-11#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-7#1)(1995-8#1)(1996-2#3)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(2005-12#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-6#1)(2007-7#2)(2007-8#6)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#7)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#2)(2009-3#2)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#3)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#6)(2013-8#1)
with improvement in##5##3##(2006-8#1)(2007-2#1)(2013-1#3)
with improvement of signs and symptoms##2##6##(1991-10#1)(2006-10#1)
with improvement of##5##3##(1990-11#1)(1991-10#1)(2006-10#1)(2008-5#1)(2009-11#1)
with improvement##13##2##(1990-11#1)(1991-10#1)(1996-3#1)(2006-10#2)(2006-8#2)(2007-2#1)(2008-5#1)(2009-11#1)(2013-1#3)
with improvements in##17##3##(1992-7#1)(2004-3#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#3)(2008-7#4)(2011-2#2)
with improving the quality of##2##5##(2010-12#1)(2012-3#1)
with improving the##4##3##(2008-1#1)(2010-12#1)(2012-3#1)(2013-1#1)
with improving##6##2##(2007-4#1)(2008-1#1)(2010-12#1)(2012-3#1)(2013-1#2)
with impulse control##2##3##(2012-12#1)(2013-8#1)
with impunity##2##2##(1995-2#1)(2007-11#1)
with in situ hybridization##2##4##(1995-8#1)(1997-7#1)
with in situ measurements##2##4##(2008-2#2)
with in situ##23##3##(1991-12#1)(1994-11#1)(1995-1#1)(1995-8#1)(1996-6#1)(1997-7#1)(2007-5#1)(2008-10#2)(2008-2#3)(2008-3#7)(2010-2#1)(2011-1#1)(2012-12#1)(2013-1#1)
with in the##5##3##(1990-7#1)(2008-10#1)(2008-2#1)(2010-7#1)(2011-2#1)
with in vitro activity##3##4##(1995-5#1)(2008-5#1)(2011-2#1)
with in vitro passage##2##4##(1991-7#2)
with in vitro transcribed##2##4##(1993-6#1)(1993-8#1)
with in vitro transcripts of##2##5##(2008-10#2)
with in vitro transcripts##3##4##(2008-10#3)
with in vitro##24##3##(1990-2#1)(1991-7#2)(1993-11#1)(1993-6#1)(1993-8#1)(1994-10#1)(1995-5#1)(1995-6#1)(1997-1#1)(2005-7#1)(2006-12#1)(2006-5#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2010-5#1)(2011-2#1)
with in vivo and##2##4##(2004-9#1)(2008-5#1)
with in vivo##18##3##(1991-1#1)(1995-1#2)(1997-2#1)(2004-9#1)(2005-7#1)(2006-10#1)(2008-10#1)(2008-5#4)(2008-7#1)(2010-6#1)(2012-12#1)(2013-1#2)(2013-8#1)
with in##87##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-7#2)(1991-9#1)(1993-11#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#1)(1995-1#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-7#1)(2004-9#1)(2005-7#2)(2006-10#1)(2006-12#1)(2006-5#2)(2007-11#1)(2007-5#1)(2007-8#2)(2008-10#12)(2008-11#2)(2008-2#4)(2008-3#7)(2008-4#3)(2008-5#5)(2008-7#2)(2008-9#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#5)(2013-8#1)
with in-depth##3##2##(2011-1#1)(2012-12#1)(2013-1#1)
with in-fiber##2##2##(2008-3#2)
with in-home##2##2##(2010-2#2)
with in-line##9##2##(2007-12#3)(2007-8#1)(2008-10#4)(2008-2#1)
with in-phase##2##2##(1997-8#2)
with in-situ##2##2##(2008-10#1)(2013-8#1)
with in-valve column##2##3##(2008-10#2)
with inactivated##6##2##(1990-2#1)(1996-12#1)(1997-6#1)(2008-5#1)(2008-7#1)(2012-2#1)
with inactivation of##2##3##(1995-2#1)(2005-7#1)
with inactivation##4##2##(1990-5#1)(1991-5#1)(1995-2#1)(2005-7#1)
with inactive disease##4##3##(2007-3#3)(2008-7#1)
with inactive##6##2##(2007-3#3)(2008-7#2)(2010-6#1)
with inadequate response##2##3##(2008-1#1)(2012-3#1)
with inadequate##12##2##(1993-12#1)(1994-6#1)(1996-11#2)(2007-2#1)(2008-1#2)(2008-7#2)(2009-10#1)(2010-8#1)(2012-3#1)
with inappropriate use##2##3##(2006-10#1)(2006-7#1)
with inappropriate##6##2##(1990-12#1)(2006-10#2)(2006-7#1)(2010-3#1)(2013-1#1)
with inborn errors of##2##4##(1992-7#1)(2009-4#1)
with inbreeding##2##2##(2007-2#1)(2008-9#1)
with incapacitating##2##2##(1994-5#1)(2012-12#1)
with incarceration of##4##3##(2008-12#1)(2008-3#1)(2011-2#2)
with incentives##2##2##(1996-3#1)(2008-1#1)
with incidence and##2##3##(1994-9#1)(2008-10#1)
with incidence of##4##3##(2007-12#1)(2008-10#1)(2011-12#1)(2013-1#1)
with incidence##9##2##(1994-2#1)(1994-9#1)(2007-12#1)(2008-10#3)(2008-3#1)(2011-12#1)(2013-1#1)
with incident##4##2##(2007-11#2)(2007-12#1)(2013-7#1)
with incidental##2##2##(2007-8#1)(2012-1#1)
with incipient##2##2##(2005-10#1)(2007-12#1)
with inclusion of##2##3##(2008-3#2)
with inclusion##4##2##(2007-8#1)(2008-3#2)(2009-8#1)
with inclusions##7##2##(1997-5#1)(2007-12#2)(2008-3#4)
with inclusive##2##2##(1993-8#1)(2008-10#1)
with incoherent light##3##3##(1997-6#1)(2007-11#2)
with incoherent##4##2##(1997-6#1)(2007-11#2)(2008-3#1)
with income##2##2##(1992-1#1)(2010-8#1)
with incompatible strains of##2##4##(2008-10#2)
with incompatible strains##3##3##(2008-10#2)(2008-9#1)
with incomplete SCI##3##3##(2012-1#3)
with incomplete data##3##3##(2010-8#1)(2011-2#1)(2013-8#1)
with incomplete##22##2##(1994-8#1)(1995-3#1)(2005-2#1)(2006-10#2)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#4)(2012-2#1)(2013-1#2)(2013-8#1)
with inconsistent results##2##3##(2010-7#2)
with inconsistent##4##2##(2008-5#1)(2010-2#1)(2010-7#2)
with incorporated##2##2##(2008-10#2)
with incorporation of##2##3##(1995-3#1)(2008-10#1)
with incorrect##4##2##(2005-8#1)(2007-7#1)(2009-5#1)(2009-7#1)
with increase in age##3##4##(2008-3#1)(2013-1#2)
with increase in concentration##2##4##(2005-11#1)(2008-5#1)
with increase in nCDHA##2##4##(2012-2#2)
with increase in sample##2##4##(2008-10#2)
with increase in temperature##2##4##(2005-11#2)
with increase in the##8##4##(1994-9#1)(2005-11#2)(2007-12#1)(2008-10#3)(2010-12#1)
with increase in##38##3##(1991-2#1)(1992-7#1)(1994-2#1)(1994-9#1)(2005-11#8)(2007-10#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-6#1)(2010-12#1)(2011-12#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
with increase of##3##3##(2007-11#1)(2008-8#1)(2012-1#1)
with increase##43##2##(1991-2#1)(1992-7#1)(1994-2#1)(1994-9#1)(1995-3#1)(2005-11#8)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-12#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
with increased ICP##2##3##(2008-12#2)
with increased accuracy##3##3##(2007-5#1)(2008-10#1)(2012-2#1)
with increased anxiety##2##3##(2008-8#1)(2011-2#1)
with increased apoptosis##2##3##(2011-2#1)(2013-1#1)
with increased blood loss##3##4##(2007-8#1)(2011-2#2)
with increased blood##4##3##(2007-8#1)(2008-11#1)(2011-2#2)
with increased body##3##3##(2006-9#1)(2008-11#1)(2011-1#1)
with increased concentrations of##2##4##(2007-7#1)(2008-10#1)
with increased content of##2##4##(1992-5#1)(2008-4#1)
with increased disease severity##2##4##(2008-10#2)
with increased efficiency##2##3##(1995-8#1)(2007-12#1)
with increased exposure##2##3##(1995-3#1)(2008-12#1)
with increased expression of##4##4##(1991-3#1)(1994-11#1)(2005-8#1)(2012-12#1)
with increased expression##5##3##(1990-9#1)(1991-3#1)(1994-11#1)(2005-8#1)(2012-12#1)
with increased frequency in##2##4##(1993-5#1)(2007-9#1)
with increased frequency##3##3##(1993-5#1)(2007-11#1)(2007-9#1)
with increased incidence of##2##4##(2007-11#1)(2010-12#1)
with increased incidence##3##3##(2007-11#1)(2008-7#1)(2010-12#1)
with increased incubation##2##3##(1993-8#1)(2004-9#1)
with increased intensity of##2##4##(2005-10#1)(2008-1#1)
with increased intracellular##2##3##(1990-8#1)(2008-10#1)
with increased intracranial pressure##3##4##(2008-12#1)(2011-2#1)(2013-1#1)
with increased iron##2##3##(2006-4#1)(2010-4#1)
with increased length##2##3##(2006-10#1)(2012-2#1)
with increased levels of##5##4##(1996-12#1)(2007-1#1)(2010-6#1)(2011-1#1)(2012-12#1)
with increased morbidity and##8##4##(2005-10#2)(2006-10#2)(2006-2#1)(2010-3#1)(2010-6#1)(2011-2#1)
with increased morbidity##9##3##(2005-10#2)(2006-10#2)(2006-2#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#1)
with increased mortality##6##3##(1990-6#1)(1991-2#1)(2005-12#1)(2010-12#1)(2011-2#2)
with increased muscle##2##3##(2008-12#1)(2010-6#1)
with increased plasma##5##3##(1992-11#1)(1993-6#1)(2007-11#1)(2009-12#1)(2011-1#1)
with increased potency##3##3##(1994-5#1)(2009-8#1)(2012-2#1)
with increased production of##4##4##(1994-3#1)(2008-2#1)(2008-4#1)(2011-2#1)
with increased proliferation##2##3##(1993-8#1)(1994-12#1)
with increased rates of##6##4##(1994-7#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-2#1)
with increased receptor##2##3##(1991-9#1)(2011-2#1)
with increased resistance to##2##4##(1995-6#1)(2008-1#1)
with increased risk for cardiovascular events##2##6##(2010-4#1)(2013-8#1)
with increased risk for##14##4##(1993-12#2)(1993-3#1)(1997-7#1)(2007-10#1)(2008-1#1)(2008-4#2)(2009-2#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
with increased risk of coronary heart##2##6##(2011-1#1)(2013-1#1)
with increased risk of##30##4##(1990-6#1)(1990-8#1)(1992-1#1)(1996-2#1)(1996-9#1)(2005-12#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
with increased risk##48##3##(1990-6#1)(1990-8#1)(1992-1#1)(1993-12#2)(1993-3#1)(1993-9#1)(1996-2#1)(1996-9#1)(1997-7#1)(2005-12#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
with increased risks of##5##4##(2007-11#1)(2008-1#1)(2008-8#1)(2013-1#1)(2013-7#1)
with increased specific##3##3##(1991-1#2)(2008-8#1)
with increased susceptibility to##3##4##(2006-8#1)(2008-10#1)(2013-1#1)
with increased time##2##3##(1995-5#1)(2006-10#1)
with increased transmission##2##3##(2006-10#1)(2013-1#1)
with increased vascular##2##3##(2007-1#1)(2007-10#1)
with increased waist circumference##2##4##(2008-11#1)(2011-1#1)
with increased wetness duration at##2##5##(2008-10#2)
with increased##421##2##(1990-3#1)(1990-4#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-4#2)(1992-5#1)(1992-8#4)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#3)(1993-6#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#3)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#6)(1995-2#2)(1995-3#2)(1995-5#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#2)(1996-9#2)(1997-1#1)(1997-5#1)(1997-6#1)(1997-7#3)(2004-1#1)(2004-12#1)(2004-9#2)(2005-10#6)(2005-12#4)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#10)(2006-11#1)(2006-12#1)(2006-2#3)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#4)(2007-10#5)(2007-11#11)(2007-12#7)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#7)(2007-9#1)(2008-1#5)(2008-10#24)(2008-11#10)(2008-12#6)(2008-2#4)(2008-3#4)(2008-4#7)(2008-5#3)(2008-6#4)(2008-7#11)(2008-8#12)(2008-9#5)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#3)(2010-10#3)(2010-12#7)(2010-2#5)(2010-3#3)(2010-4#6)(2010-5#2)(2010-6#4)(2010-8#5)(2010-9#1)(2011-1#12)(2011-2#20)(2012-1#2)(2012-11#1)(2012-12#14)(2012-2#15)(2012-3#12)(2012-6#2)(2013-1#15)(2013-7#4)(2013-8#9)
with increases in the##7##4##(1991-5#1)(1993-12#1)(1996-4#2)(2005-11#1)(2008-10#1)(2008-3#1)
with increases in##25##3##(1990-6#1)(1991-1#1)(1991-5#1)(1993-12#1)(1993-3#1)(1994-8#1)(1996-4#2)(1996-9#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-7#1)(2009-9#1)(2010-5#1)(2012-11#1)
with increases of##4##3##(2005-11#1)(2008-11#1)(2008-5#1)(2008-7#1)
with increases##30##2##(1990-6#1)(1991-1#1)(1991-5#1)(1993-12#1)(1993-3#1)(1994-8#1)(1995-12#1)(1996-4#2)(1996-9#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-11#2)(2006-10#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-9#1)(2010-5#1)(2012-11#1)
with increasing BMI##2##3##(1994-12#1)(2011-1#1)
with increasing N##3##3##(2008-10#1)(2008-2#1)(2010-7#1)
with increasing NaCl concentration##2##4##(2008-5#2)
with increasing PEG concentrations##2##4##(2008-12#2)
with increasing [NaOH](T)##2##3##(2008-10#2)
with increasing age and this##2##5##(1993-2#1)(1996-12#1)
with increasing age and##6##4##(1990-2#1)(1993-2#1)(1996-12#1)(2008-7#1)(2009-10#1)(2012-12#1)
with increasing age as the##2##5##(1990-11#1)(2008-1#1)
with increasing age in the##2##5##(1994-4#1)(2008-7#1)
with increasing age in##4##4##(1994-4#1)(1996-12#1)(2008-7#1)(2013-7#1)
with increasing age##47##3##(1990-11#1)(1990-2#1)(1990-3#1)(1991-10#2)(1992-6#3)(1993-11#1)(1993-2#1)(1994-11#1)(1994-4#1)(1994-6#2)(1996-12#2)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(2005-8#1)(2006-10#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-9#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)
with increasing amount of##2##4##(1996-8#1)(2005-11#1)
with increasing amounts of##4##4##(1997-8#1)(2008-10#2)(2008-7#1)
with increasing atomic number##2##4##(2008-10#2)
with increasing cell##3##3##(1997-1#1)(2008-11#1)(2013-8#1)
with increasing concentration of the##2##5##(1990-2#1)(1995-6#1)
with increasing concentration of##5##4##(1990-2#1)(1990-4#1)(1995-6#1)(2005-11#1)(2008-10#1)
with increasing concentration##8##3##(1990-2#1)(1990-4#1)(1990-8#1)(1995-6#2)(2005-11#1)(2008-10#1)(2008-11#1)
with increasing concentrations of##13##4##(1990-10#1)(1990-5#1)(1992-11#1)(1994-8#1)(1996-12#1)(1996-8#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-3#1)
with increasing concentrations##15##3##(1990-10#1)(1990-5#1)(1992-11#1)(1994-8#1)(1996-12#1)(1996-8#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-3#1)(2011-3#1)
with increasing conversion##2##3##(2010-4#1)(2013-1#1)
with increasing degrees of##2##4##(1991-2#2)
with increasing depth##6##3##(2004-10#1)(2007-5#2)(2008-3#1)(2011-1#1)(2013-8#1)
with increasing dilution rate##2##4##(2008-6#2)
with increasing distance from the##5##5##(1996-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-7#1)
with increasing distance##6##3##(1996-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2013-7#1)
with increasing doses of##4##4##(1990-5#1)(1991-1#1)(1997-4#1)(2008-7#1)
with increasing doses##5##3##(1990-5#1)(1991-1#1)(1997-4#1)(2008-7#2)
with increasing duration##2##3##(1995-3#1)(2008-11#1)
with increasing economic##2##3##(2005-11#1)(2010-12#1)
with increasing experience##3##3##(2007-12#1)(2008-10#1)(2009-2#1)
with increasing exposure concentration##3##4##(2008-9#3)
with increasing exposure time##2##4##(2008-3#1)(2008-7#1)
with increasing exposure##7##3##(2005-10#1)(2007-11#1)(2008-3#1)(2008-7#1)(2008-9#3)
with increasing flower age at inoculation##2##6##(2008-10#2)
with increasing frequency and##2##4##(1995-5#1)(2009-5#1)
with increasing frequency in patients with##2##6##(2008-6#1)(2013-8#1)
with increasing frequency in patients##3##5##(2008-3#1)(2008-6#1)(2013-8#1)
with increasing frequency in##6##4##(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2013-8#1)
with increasing frequency##20##3##(1991-12#1)(1992-4#1)(1993-9#1)(1995-5#1)(2006-10#2)(2006-8#2)(2007-3#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-4#1)(2009-5#1)(2013-1#1)(2013-8#1)
with increasing fringe##2##3##(2007-12#1)(2008-2#1)
with increasing humidity##3##3##(2005-11#1)(2008-10#2)
with increasing incidence##4##3##(1994-7#1)(2006-2#1)(2006-6#1)(2013-1#1)
with increasing initial##2##3##(1995-5#1)(2008-11#1)
with increasing inoculum##2##3##(2008-10#2)
with increasing intensity of##2##4##(2005-11#1)(2011-2#1)
with increasing interest##3##3##(2007-4#1)(2008-5#2)
with increasing ionic strength##6##4##(1991-9#1)(1995-1#1)(1997-6#1)(2005-11#3)
with increasing ionic##7##3##(1991-9#1)(1995-1#1)(1997-6#1)(1997-7#1)(2005-11#3)
with increasing larval density##2##4##(2009-10#2)
with increasing latency##2##3##(2009-12#2)
with increasing latitude##2##3##(2008-8#1)(2010-8#1)
with increasing leaf age##2##4##(2008-10#2)
with increasing leaf##5##3##(2008-10#5)
with increasing length of##2##4##(1992-8#1)(2008-8#1)
with increasing levels of##5##4##(2007-12#1)(2007-3#1)(2008-10#1)(2010-10#1)(2011-12#1)
with increasing load##2##3##(2009-7#1)(2010-12#1)
with increasing malignant potential##2##4##(1992-9#2)
with increasing methanol##2##3##(1996-5#1)(2005-11#1)
with increasing molecular weight of##2##5##(2004-9#1)(2008-10#1)
with increasing mu##3##3##(2008-10#3)
with increasing number of fluoro-substituents##2##5##(1990-12#2)
with increasing number of##9##4##(1990-12#3)(1997-7#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-8#1)(2013-8#1)
with increasing numbers of##5##4##(1995-2#1)(2007-12#1)(2008-11#1)(2008-9#1)(2010-12#1)
with increasing numbers##6##3##(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-12#1)
with increasing orchard block age##2##5##(2008-10#2)
with increasing osmolarity##4##3##(1991-11#4)
with increasing pCO2##2##3##(2008-11#2)
with increasing pH and##3##4##(2005-11#1)(2008-10#2)
with increasing pH##10##3##(1990-12#1)(1990-5#1)(1993-8#2)(1997-5#1)(2005-11#2)(2008-10#2)(2008-11#1)
with increasing particle size##2##4##(1997-1#1)(2005-11#1)
with increasing pi acceptor##2##4##(1997-7#2)
with increasing population density##2##4##(2008-9#1)(2011-2#1)
with increasing population##3##3##(2008-9#2)(2011-2#1)
with increasing pressure##3##3##(1991-6#1)(2008-2#2)
with increasing proportion of the##2##5##(2008-10#1)(2010-4#1)
with increasing proportion of##3##4##(2006-10#1)(2008-10#1)(2010-4#1)
with increasing protein concentration in the##2##6##(1990-7#2)
with increasing pulse##2##3##(2007-11#1)(2008-3#1)
with increasing rates of##2##4##(2008-1#1)(2008-10#1)
with increasing root length##2##4##(2008-10#2)
with increasing salt##3##3##(2008-10#1)(2008-12#2)
with increasing size of the mineral##2##6##(2005-11#2)
with increasing size of the##4##5##(1990-11#1)(2005-11#2)(2008-10#1)
with increasing size##7##3##(1990-11#1)(1992-5#1)(1995-5#1)(2005-11#2)(2008-10#1)(2008-8#1)
with increasing soil depth##2##4##(2013-8#2)
with increasing soil##4##3##(2008-10#2)(2013-8#2)
with increasing solution##3##3##(2005-11#2)(2008-10#1)
with increasing speed##2##3##(1994-8#1)(2008-9#1)
with increasing stand age##3##4##(2013-8#3)
with increasing stand##4##3##(2013-8#4)
with increasing stocking rate##2##4##(1996-12#2)
with increasing strain##2##3##(2009-7#2)
with increasing temperature##23##3##(1990-9#1)(1992-1#2)(1993-8#1)(1997-1#1)(1997-4#1)(2005-11#2)(2006-10#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#2)
with increasing temperatures##3##3##(1996-5#1)(2008-10#2)
with increasing the atomic number##2##5##(2008-10#2)
with increasing the climbazole##2##4##(2008-5#2)
with increasing the concentration of cell inoculation##2##7##(2008-9#2)
with increasing the concentration of##3##5##(2008-9#2)(2012-12#1)
with increasing the number of##3##5##(2007-8#1)(2008-10#2)
with increasing the##18##3##(1996-8#1)(2007-8#1)(2008-10#6)(2008-5#2)(2008-9#2)(2012-1#2)(2012-12#2)(2013-8#2)
with increasing time since##2##4##(1991-12#1)(2010-11#1)
with increasing time##8##3##(1990-12#1)(1991-12#1)(1992-9#1)(1997-4#1)(2008-10#2)(2008-9#1)(2010-11#1)
with increasing values of##2##4##(2008-3#1)(2008-7#1)
with increasing water activity##2##4##(2008-7#2)
with increasing water content##2##4##(1991-2#1)(2005-11#1)
with increasing water##5##3##(1991-2#1)(2005-11#1)(2008-7#3)
with increasing wavelength and##2##4##(2008-1#1)(2008-4#1)
with increasing wavelength##4##3##(1992-4#1)(2008-1#1)(2008-3#1)(2008-4#1)
with increasing years of work##2##5##(2009-6#2)
with increasing##578##2##(1990-10#2)(1990-11#3)(1990-12#6)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#4)(1990-7#3)(1990-8#1)(1990-9#3)(1991-1#1)(1991-10#2)(1991-11#6)(1991-12#2)(1991-2#4)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#3)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#2)(1992-5#2)(1992-6#4)(1992-7#1)(1992-8#3)(1992-9#4)(1993-11#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-7#1)(1993-8#4)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#5)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#4)(1995-6#4)(1996-12#5)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#4)(1996-9#1)(1997-1#5)(1997-2#2)(1997-4#4)(1997-5#2)(1997-6#1)(1997-7#4)(1997-8#1)(2004-10#2)(2004-11#2)(2004-9#5)(2005-10#1)(2005-11#31)(2005-4#1)(2005-8#3)(2006-10#10)(2006-2#3)(2006-3#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#4)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#12)(2007-3#2)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#15)(2007-9#2)(2008-1#5)(2008-10#90)(2008-11#17)(2008-12#10)(2008-2#9)(2008-3#22)(2008-4#3)(2008-5#15)(2008-6#5)(2008-7#16)(2008-8#10)(2008-9#16)(2009-10#4)(2009-11#1)(2009-12#4)(2009-2#1)(2009-4#2)(2009-5#2)(2009-6#3)(2009-7#5)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-3#1)(2010-4#5)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-10#1)(2011-12#2)(2011-2#5)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#5)(2012-2#6)(2012-3#2)(2013-1#7)(2013-7#4)(2013-8#16)
with increasingly##5##2##(1992-6#2)(1997-5#1)(2008-7#1)(2010-10#1)
with incubation period##2##3##(1991-5#1)(2006-5#1)
with incubation##5##2##(1991-5#1)(1994-3#1)(2004-11#1)(2006-5#1)(2008-9#1)
with incurable disease##2##3##(2006-10#1)(2012-2#1)
with incurable##4##2##(1995-9#1)(2006-10#1)(2012-12#1)(2012-2#1)
with independent measurements##3##3##(2008-2#1)(2008-3#1)(2009-2#1)
with independent##17##2##(1994-6#1)(1996-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#1)(2009-2#1)(2012-2#1)
with independently##6##2##(1992-10#1)(2007-12#1)(2008-10#2)(2008-2#1)(2009-7#1)
with indeterminate##3##2##(2008-10#1)(2010-8#1)(2013-7#1)
with indications for##2##3##(2007-7#1)(2008-4#1)
with indications of##3##3##(2006-10#1)(2007-8#1)(2013-8#1)
with indications##6##2##(2006-10#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-4#1)(2013-8#1)
with indices of##3##3##(1991-5#1)(1995-11#1)(2010-7#1)
with indinavir##5##2##(1997-3#1)(2008-5#2)(2008-8#2)
with indirect absorbance detection##2##4##(1996-5#2)
with indirect photometric detection##2##4##(1994-9#1)(2008-10#1)
with indirect##11##2##(1990-8#1)(1994-9#1)(1996-5#3)(2005-8#1)(2006-2#1)(2008-10#3)(2013-8#1)
with indium##3##2##(2007-12#1)(2008-10#2)
with individual characteristics##3##3##(2008-8#1)(2010-9#1)(2011-2#1)
with individual differences in##2##4##(1992-12#1)(2012-1#1)
with individual differences##3##3##(1992-12#1)(2012-1#1)(2013-1#1)
with individual practices##2##3##(1993-1#1)(2007-12#1)
with individual##32##2##(1992-12#1)(1992-8#1)(1993-1#1)(1993-12#1)(1995-2#1)(1996-9#1)(2005-4#1)(2007-12#1)(2007-6#1)(2008-10#4)(2008-12#2)(2008-3#1)(2008-6#1)(2008-8#2)(2009-11#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#3)
with individualized##2##2##(1991-3#1)(2008-7#1)
with individually##3##2##(1991-1#1)(1993-5#1)(1994-6#1)
with individuals from a##2##4##(2011-2#1)(2012-3#1)
with individuals with##3##3##(2006-7#1)(2007-10#1)(2010-2#1)
with individuals##12##2##(1997-5#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-6#1)(2009-7#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-8#1)
with indolent##2##2##(2007-7#1)(2010-11#1)
with indomethacin and##2##3##(1993-11#1)(2010-6#1)
with indomethacin##9##2##(1992-2#1)(1993-11#1)(1994-8#1)(1995-6#1)(1995-7#1)(1996-12#1)(1997-6#1)(2010-2#1)(2010-6#1)
with indoor##4##2##(1991-3#2)(1992-4#1)(2008-2#1)
with induced resistance##2##3##(2008-10#1)(2008-5#1)
with induced##10##2##(1993-4#1)(1993-9#1)(1996-1#1)(2006-2#1)(2008-10#2)(2008-4#1)(2008-5#2)(2010-10#1)
with inducible##4##2##(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#1)
with induction of##8##3##(1991-12#1)(1992-6#1)(1994-5#1)(1995-6#1)(1996-1#1)(1996-6#1)(2008-6#1)(2013-1#1)
with induction##11##2##(1991-12#1)(1992-6#1)(1994-5#1)(1995-6#1)(1996-1#1)(1996-6#1)(2005-11#1)(2008-11#1)(2008-6#1)(2011-2#1)(2013-1#1)
with inductively coupled mass##2##4##(2008-10#2)
with inductively coupled plasma atomic emission spectrometry##2##7##(2008-10#2)
with inductively coupled plasma mass spectrometry (ICP-MS)##3##7##(2008-10#2)(2010-11#1)
with inductively coupled plasma mass spectrometry##9##6##(2008-10#5)(2008-3#1)(2010-11#2)(2010-12#1)
with inductively coupled plasma##15##4##(2007-8#1)(2008-10#10)(2008-3#1)(2010-11#2)(2010-12#1)
with inductively coupled##19##3##(2007-8#2)(2008-10#13)(2008-3#1)(2010-11#2)(2010-12#1)
with industrial and##2##3##(2008-10#1)(2008-7#1)
with industrial##5##2##(2008-10#2)(2008-5#1)(2008-7#2)
with industry##3##2##(2007-1#1)(2009-4#1)(2010-7#1)
with indwelling##4##2##(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
with inefficient##3##2##(2010-5#1)(2011-1#2)
with infantile##8##2##(1991-2#1)(1991-3#1)(1993-4#2)(2009-4#2)(2009-8#1)(2012-3#1)
with infants##6##2##(1991-11#1)(1991-12#1)(2006-10#1)(2006-3#1)(2012-1#1)(2012-12#1)
with infarct##2##2##(1997-1#1)(2007-9#1)
with infected##16##2##(1991-7#1)(1993-8#1)(2005-7#1)(2007-11#2)(2007-3#1)(2008-10#4)(2008-12#2)(2008-5#1)(2008-6#1)(2010-8#1)(2013-8#1)
with infection and##2##3##(2005-3#1)(2008-10#1)
with infection##20##2##(1995-8#1)(1996-9#1)(2005-3#1)(2005-9#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#1)
with infections##5##2##(2006-4#1)(2008-7#1)(2009-2#1)(2011-2#2)
with infectious bursal disease virus##5##5##(2008-5#3)(2013-1#2)
with infectious disease specialists##2##4##(2005-7#1)(2011-2#1)
with infectious##22##2##(1990-9#1)(1997-8#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-2#2)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#4)(2010-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
with infective endocarditis##4##3##(2007-8#2)(2010-9#1)(2012-12#1)
with infective##6##2##(1995-7#1)(2007-8#2)(2010-9#1)(2011-2#1)(2012-12#1)
with inferior##4##2##(1990-6#1)(2007-2#1)(2010-8#1)(2011-2#1)
with infertility##4##2##(1992-1#1)(2009-2#1)(2011-1#1)(2012-3#1)
with infestation##2##2##(1990-3#1)(1991-7#1)
with infiltrating##2##2##(1995-12#1)(2007-5#1)
with infiltration of the##2##4##(2010-12#1)(2011-1#1)
with infiltration of##5##3##(1994-5#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#1)
with inflammation and##4##3##(1996-4#1)(2006-10#1)(2007-8#1)(2013-1#1)
with inflammation##15##2##(1993-12#1)(1996-3#1)(1996-4#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-3#1)(2009-5#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
with inflammatory arthritis##2##3##(2006-10#2)
with inflammatory bowel disease (IBD)##4##5##(2010-12#2)(2011-2#1)(2013-8#1)
with inflammatory bowel disease and##4##5##(2006-2#1)(2007-11#1)(2007-8#1)(2010-12#1)
with inflammatory bowel disease##29##4##(1992-6#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-12#7)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#4)
with inflammatory bowel disease]##5##4##(2012-11#5)
with inflammatory bowel diseases##5##4##(2006-10#1)(2010-12#1)(2011-1#1)(2012-2#2)
with inflammatory bowel##40##3##(1992-6#1)(2006-10#3)(2006-2#1)(2006-4#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-12#8)(2010-6#1)(2011-1#1)(2011-2#2)(2012-11#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#4)
with inflammatory cells##2##3##(1994-6#1)(1996-7#1)
with inflammatory myopathy##2##3##(2006-10#1)(2012-2#1)
with inflammatory##67##2##(1992-12#1)(1992-6#1)(1993-10#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-7#1)(1996-7#1)(2005-7#1)(2006-10#7)(2006-2#1)(2006-4#1)(2006-9#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#8)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-11#5)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#4)
with infliximab##27##2##(2005-7#2)(2006-10#5)(2007-11#1)(2008-5#2)(2008-8#2)(2010-12#2)(2010-9#2)(2011-2#5)(2013-7#1)(2013-8#5)
with influenza A and##2##4##(2005-8#1)(2008-5#1)
with influenza A/H1N1 and A/H3N2 viruses##2##6##(2011-2#2)
with influenza A/H5N1##2##3##(2010-12#2)
with influenza infection##2##3##(2013-1#2)
with influenza virus##3##3##(2008-10#1)(2008-4#2)
with influenza##18##2##(2005-8#1)(2007-11#1)(2008-10#2)(2008-4#2)(2008-5#1)(2009-5#1)(2010-12#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
with influenza-like illness##3##3##(2011-2#3)
with influenza-like##4##2##(2007-11#1)(2011-2#3)
with informal##2##2##(1994-1#1)(1996-3#1)
with information about the##3##4##(2006-8#1)(2011-2#1)(2013-1#1)
with information about##7##3##(1991-1#1)(2006-8#1)(2007-2#1)(2008-4#1)(2011-2#1)(2013-1#2)
with information from X-ray##2##4##(1995-8#1)(2005-11#1)
with information from##5##3##(1990-2#1)(1995-8#1)(2005-11#1)(2008-10#1)(2008-2#1)
with information obtained from##2##4##(2008-10#1)(2013-1#1)
with information on the##3##4##(1997-2#1)(2010-12#1)(2011-2#1)
with information on##7##3##(1997-2#1)(2006-7#1)(2007-2#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
with information that##3##3##(1997-3#1)(2006-8#1)(2008-7#1)
with information##30##2##(1990-2#1)(1991-1#1)(1992-12#1)(1995-8#1)(1997-2#1)(1997-3#2)(2005-11#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-2#2)(2008-10#3)(2008-2#1)(2008-4#2)(2008-7#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#4)
with informed consent##2##3##(2006-3#1)(2007-10#1)
with informed##3##2##(2006-3#1)(2007-10#1)(2007-2#1)
with infrared (IR)##2##3##(2007-12#1)(2008-3#1)
with infrared##8##2##(1990-12#1)(2006-12#1)(2007-12#2)(2008-10#1)(2008-3#2)(2013-7#1)
with infrarenal##2##2##(2008-10#1)(2011-2#1)
with infrequent##3##2##(1995-5#1)(1997-6#1)(2008-9#1)
with inguinal lymph node##2##4##(2007-5#1)(2013-7#1)
with inguinal##3##2##(2007-5#1)(2008-6#1)(2013-7#1)
with inhaled corticosteroids##6##3##(1996-7#1)(2007-11#2)(2008-11#2)(2011-2#1)
with inhaled insulin##3##3##(2008-8#3)
with inhaled##16##2##(1990-5#1)(1990-9#1)(1993-5#1)(1996-7#1)(2007-11#4)(2008-11#2)(2008-4#1)(2008-8#3)(2010-2#1)(2011-2#1)
with inherent##8##2##(1991-11#1)(1996-11#1)(1996-2#1)(2006-9#1)(2007-8#1)(2008-2#2)(2008-5#1)
with inherited##7##2##(1994-2#1)(1994-8#1)(1997-7#2)(2007-2#1)(2008-10#1)(2011-2#1)
with inhibin##3##2##(1992-6#1)(1994-3#1)(1995-9#1)
with inhibition of##14##3##(1991-9#1)(1992-3#1)(1992-6#1)(1993-7#1)(1994-3#1)(1995-7#1)(1996-12#1)(1996-6#1)(1997-7#1)(2007-4#1)(2008-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
with inhibition##19##2##(1990-2#1)(1991-9#1)(1992-3#1)(1992-6#2)(1993-7#1)(1994-3#1)(1995-2#1)(1995-7#1)(1996-12#1)(1996-6#1)(1997-7#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-4#1)(2012-2#1)(2013-1#1)(2013-7#1)
with inhibitors of the##2##4##(2006-6#1)(2008-4#1)
with inhibitors of##8##3##(1994-11#1)(1995-11#1)(1997-6#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-4#1)
with inhibitors##18##2##(1991-3#1)(1994-11#1)(1995-11#1)(1997-6#1)(1997-7#1)(2005-10#3)(2006-6#1)(2007-11#1)(2008-10#2)(2008-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)
with inhibitory activity##3##3##(1991-10#1)(1993-4#1)(1994-5#1)
with inhibitory##6##2##(1990-12#1)(1991-10#1)(1991-12#1)(1993-4#1)(1994-5#1)(2012-1#1)
with initial drug resistance##2##4##(2013-1#2)
with initial##36##2##(1990-6#1)(1993-8#1)(1996-5#1)(1997-1#1)(2005-11#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-7#4)(2008-8#3)(2009-10#1)(2009-3#2)(2009-5#1)(2009-8#2)(2010-12#2)(2010-8#1)(2011-2#2)(2012-11#1)(2013-1#4)
with initially##4##2##(1996-1#1)(2008-10#1)(2008-3#1)(2012-1#1)
with initiation##2##2##(1991-12#1)(2008-12#1)
with injectable##3##2##(2005-11#2)(2012-2#1)
with injection of##3##3##(2008-10#1)(2009-3#1)(2013-8#1)
with injection##9##2##(2007-3#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-8#1)(2009-3#1)(2013-1#1)(2013-8#1)
with injections of##2##3##(1996-3#1)(2006-10#1)
with injections##3##2##(1996-3#1)(2006-10#1)(2006-8#1)
with injured##3##2##(1990-7#1)(2006-3#1)(2007-11#1)
with injuries to other##2##4##(1991-4#1)(2012-2#1)
with injuries to##6##3##(1991-4#1)(1992-2#1)(1992-6#1)(2007-11#2)(2012-2#1)
with injuries##8##2##(1991-4#1)(1992-2#1)(1992-6#1)(1993-1#1)(2007-11#2)(2012-2#1)(2013-1#1)
with injury to##2##3##(2008-4#1)(2008-7#1)
with injury##7##2##(2006-11#1)(2006-3#1)(2007-4#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-11#1)
with innate##3##2##(2008-10#1)(2008-6#1)(2008-9#1)
with innovative##2##2##(2010-4#1)(2011-1#1)
with inoculated##2##2##(2008-10#2)
with inoculum##2##2##(2008-10#2)
with inoperable##10##2##(1990-8#1)(1991-2#1)(1992-5#1)(1993-6#2)(1996-2#1)(2006-2#1)(2007-4#1)(2008-5#1)(2008-6#1)
with inorganic pigments##2##3##(2007-8#1)(2008-10#1)
with inorganic thioanions##2##3##(2008-10#2)
with inorganic##15##2##(1990-5#1)(1990-8#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-4#1)(2010-7#1)
with inosine##3##2##(1992-3#1)(2008-10#1)(2011-2#1)
with inositol 1##2##3##(1991-2#1)(1995-2#1)
with inotropic##2##2##(1996-3#1)(2006-10#1)
with inpatient##6##2##(1995-2#1)(2006-10#1)(2007-3#1)(2011-2#1)(2013-1#2)
with input##6##2##(2007-10#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2009-4#1)
with insect traps##2##3##(2004-11#2)
with insect##4##2##(1990-4#1)(2004-11#2)(2008-5#1)
with insecticide##3##2##(1990-6#1)(1997-7#1)(2011-2#1)
with insert sizes##2##3##(1997-2#1)(2008-5#1)
with insertion of##3##3##(1991-12#1)(2009-3#1)(2012-2#1)
with insertion##5##2##(1991-12#1)(2007-7#1)(2009-3#1)(2012-2#1)(2013-1#1)
with inserts##2##2##(1993-3#1)(2008-4#1)
with insights into##2##3##(2008-6#1)(2009-3#1)
with insights##3##2##(2008-6#1)(2009-3#1)(2011-1#1)
with insoluble##3##2##(1992-6#1)(1994-6#1)(1996-3#1)
with insomnia and##2##3##(2008-7#1)(2012-11#1)
with insomnia##8##2##(1993-5#1)(2004-3#2)(2008-10#1)(2008-7#1)(2012-1#1)(2012-11#1)(2012-12#1)
with instantaneous##2##2##(2008-11#1)(2012-2#1)
with instent restenosis in patients##2##5##(2009-6#2)
with institutional##2##2##(2008-9#1)(2013-8#1)
with instructions##4##2##(1990-2#2)(1996-12#1)(2005-11#1)
with instrumental##4##2##(2006-7#1)(2008-10#1)(2008-5#1)(2008-6#1)
with instrumentation and##2##3##(2008-8#1)(2012-12#1)
with instrumentation##4##2##(2007-7#1)(2008-8#2)(2012-12#1)
with instruments##3##2##(2007-6#2)(2013-1#1)
with insufficient information##2##3##(1997-6#1)(2007-12#1)
with insufficient##9##2##(1991-12#1)(1997-3#1)(1997-6#1)(2006-10#2)(2007-12#1)(2007-9#1)(2008-7#1)(2010-1#1)
with insulin and##2##3##(1990-9#1)(2006-6#1)
with insulin dependent diabetes mellitus##2##5##(1997-5#1)(2012-12#1)
with insulin dependent diabetes##3##4##(1990-9#1)(1997-5#1)(2012-12#1)
with insulin in##3##3##(1991-10#1)(1992-6#1)(1993-4#1)
with insulin receptor##3##3##(1992-12#1)(1994-2#1)(1997-6#1)
with insulin resistance (IR)##2##4##(2008-3#1)(2013-1#1)
with insulin resistance and type 2 diabetes##2##7##(2011-1#1)(2011-12#1)
with insulin resistance and##10##4##(2006-9#1)(2008-3#1)(2008-4#1)(2010-10#1)(2010-9#1)(2011-1#3)(2011-12#1)(2013-1#1)
with insulin resistance in##2##4##(2008-3#1)(2011-1#1)
with insulin resistance##26##3##(2005-8#1)(2006-9#1)(2008-1#4)(2008-3#6)(2008-4#1)(2008-7#1)(2009-7#1)(2010-10#1)(2010-9#1)(2011-1#6)(2011-12#1)(2013-1#2)
with insulin signaling##2##3##(1996-5#1)(2008-1#1)
with insulin therapy##2##3##(1993-12#1)(2011-1#1)
with insulin##79##2##(1990-2#1)(1990-9#2)(1991-10#2)(1991-12#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-7#1)(1993-12#2)(1993-4#1)(1993-6#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-11#1)(1996-5#1)(1996-8#2)(1997-5#1)(1997-6#1)(1997-8#1)(2005-8#2)(2006-6#1)(2006-9#1)(2007-5#1)(2008-1#6)(2008-11#1)(2008-3#10)(2008-4#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-8#1)(2010-9#1)(2011-1#8)(2011-12#1)(2012-12#4)(2012-2#1)(2013-1#3)(2013-8#1)
with insulin-dependent diabetes mellitus (IDDM)##3##5##(1990-4#1)(1995-3#1)(2006-6#1)
with insulin-dependent diabetes mellitus##5##4##(1990-4#1)(1995-3#1)(1995-9#1)(2006-6#1)(2007-3#1)
with insulin-dependent diabetes##9##3##(1990-10#1)(1990-4#1)(1992-10#1)(1995-3#1)(1995-9#1)(2006-6#1)(2007-3#2)(2007-9#1)
with insulin-dependent##10##2##(1990-10#1)(1990-4#1)(1992-10#1)(1995-3#1)(1995-9#1)(2006-6#1)(2007-11#1)(2007-3#2)(2007-9#1)
with insulinomas##2##2##(1997-8#1)(2012-2#1)
with insurance##4##2##(1996-2#1)(1996-3#1)(2007-11#1)(2010-2#1)
with intact and##3##3##(1991-7#1)(1995-6#1)(1996-12#1)
with intact apoE3##2##3##(1995-8#2)
with intact cells##3##3##(1990-10#1)(1990-11#1)(2005-12#1)
with intact holoenzyme##2##3##(1994-12#2)
with intact membranes##2##3##(1993-1#1)(1996-9#1)
with intact or##2##3##(1997-4#1)(2009-4#1)
with intact##37##2##(1990-10#1)(1990-11#1)(1991-7#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-12#2)(1994-8#1)(1995-1#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-12#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-4#1)(2009-5#1)(2011-12#1)(2013-1#2)
with integral##5##2##(1990-9#1)(1991-4#1)(1994-12#1)(1995-5#1)(2010-9#1)
with integrated pulsed amperometric detection##3##5##(2005-12#1)(2008-10#2)
with integrated pulsed amperometric##4##4##(2005-12#2)(2008-10#2)
with integrated##18##2##(1990-5#1)(1997-1#1)(2005-12#2)(2007-12#2)(2008-10#4)(2008-11#2)(2008-3#2)(2008-7#1)(2010-12#1)(2010-4#2)
with integration##3##2##(2008-10#1)(2008-2#1)(2009-9#1)
with integrative##2##2##(2008-11#1)(2012-2#1)
with integrin##2##2##(1991-6#1)(2008-1#1)
with integrity##2##2##(2007-4#1)(2012-3#1)
with intellectual and developmental disabilities##2##5##(2010-10#1)(2010-2#1)
with intellectual disabilities##6##3##(2009-2#1)(2010-2#2)(2011-1#1)(2012-2#1)(2013-7#1)
with intellectual disability and##2##4##(2011-12#1)(2013-7#1)
with intellectual disability##8##3##(2011-12#1)(2012-12#2)(2013-1#1)(2013-7#4)
with intellectual##16##2##(2009-2#1)(2010-10#1)(2010-2#3)(2011-1#1)(2011-12#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#5)
with intense##14##2##(1991-6#1)(1997-7#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-8#2)(2010-6#1)(2011-1#1)(2013-8#1)
with intensified##3##2##(1996-6#1)(2007-5#1)(2008-1#1)
with intensities##2##2##(2008-10#1)(2008-5#1)
with intensity##2##2##(2007-12#1)(2009-9#1)
with intensive care##2##3##(2011-2#1)(2012-2#1)
with intensive chemotherapy##3##3##(1990-3#1)(1991-4#1)(2008-10#1)
with intensive##18##2##(1990-3#2)(1990-9#1)(1991-4#1)(1996-3#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-6#1)(2009-11#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
with interaction##2##2##(1995-5#1)(1996-7#1)
with interactions between##4##3##(1996-3#1)(1997-2#1)(1997-6#1)(2008-10#1)
with interactions##7##2##(1990-2#1)(1992-4#1)(1996-3#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-9#1)
with interbody##2##2##(2006-8#1)(2007-8#1)
with intercellular##3##2##(1990-7#1)(1995-2#1)(1996-3#1)
with interdigitated##2##2##(2008-10#2)
with interdisciplinary##2##2##(2006-1#1)(2012-2#1)
with interest##4##2##(1997-8#1)(2005-10#1)(2007-12#1)(2012-3#1)
with interesting##4##2##(1997-1#1)(2005-8#1)(2007-12#2)
with interference##5##2##(2006-4#1)(2007-12#1)(2008-2#2)(2013-1#1)
with interferometric##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
with interferon alpha##4##3##(1997-1#1)(1997-3#2)(2005-1#1)
with interferon gamma##3##3##(1991-3#1)(2007-2#1)(2012-2#1)
with interferon##18##2##(1991-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#2)(2005-1#1)(2006-10#1)(2007-11#2)(2007-2#1)(2007-5#1)(2009-3#1)(2009-8#1)(2010-12#2)(2012-2#1)(2013-1#1)
with interferon-alpha and interleukin-2##2##4##(2008-6#2)
with interferon-alpha and##3##3##(2008-6#3)
with interferon-alpha##8##2##(2007-11#5)(2008-6#3)
with interferon-alpha-2a##5##2##(2007-11#4)(2010-6#1)
with interferon-gamma##6##2##(1992-7#1)(1993-8#1)(1994-11#1)(1994-5#1)(1996-2#1)(1997-1#1)
with interim##3##2##(1994-9#1)(1997-6#1)(2007-10#1)
with interleukin##4##2##(1994-5#1)(2007-2#1)(2010-2#1)(2013-1#1)
with interleukin-1 beta (IL-1 beta)##2##5##(1992-4#1)(1994-11#1)
with interleukin-1 beta##3##3##(1992-4#1)(1994-11#1)(1994-12#1)
with interleukin-1##4##2##(1992-1#1)(1992-4#1)(1994-11#1)(1994-12#1)
with interleukin-2 and##2##3##(1991-10#1)(2007-11#1)
with interleukin-2##9##2##(1990-12#1)(1991-10#1)(1991-12#1)(1993-8#1)(1994-6#1)(1994-8#1)(2007-11#1)(2008-4#1)(2008-6#1)
with interleukin-4##2##2##(1994-12#1)(1997-1#1)
with interlocking intramedullary nail##4##4##(2008-12#1)(2013-1#3)
with interlocking##6##2##(1997-3#1)(2008-12#1)(2013-1#4)
with intermediate levels of##2##4##(2008-5#1)(2008-8#1)
with intermediate or##2##3##(2006-10#1)(2008-9#1)
with intermediate sensitivity##2##3##(2007-7#1)(2008-10#1)
with intermediate##21##2##(1990-2#1)(1991-4#1)(1993-5#1)(1996-2#1)(2006-10#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#3)(2008-8#2)(2008-9#1)(2010-11#1)(2010-6#1)(2012-3#2)(2013-1#1)
with intermittent ultrasounds (1 MHz)##2##5##(2007-8#2)
with intermittent##25##2##(1991-9#1)(1992-4#1)(1993-7#1)(1993-9#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-8#1)(1996-9#1)(2004-12#1)(2005-9#1)(2006-1#1)(2006-2#1)(2006-4#2)(2006-5#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-8#1)(2009-7#1)(2010-9#1)(2012-2#1)
with intermolecular##3##2##(1995-1#1)(2007-12#1)(2008-5#1)
with internal carotid artery##3##4##(2007-9#1)(2008-8#1)(2011-2#1)
with internal cystic##2##3##(2011-2#1)(2013-8#1)
with internal fixation##4##3##(2008-6#1)(2010-12#1)(2012-2#1)(2013-1#1)
with internal organ involvement##2##4##(2005-11#1)(2008-5#1)
with internal osteosynthesis##2##3##(2007-11#2)
with internal##47##2##(1990-2#1)(1990-5#1)(1991-5#1)(1992-12#1)(1992-2#2)(1992-6#1)(1993-1#1)(1995-12#1)(1996-2#1)(1996-3#1)(2005-11#2)(2006-1#1)(2007-1#2)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
with international##14##2##(1990-8#1)(1996-2#1)(2005-12#1)(2005-5#1)(2006-10#1)(2006-2#1)(2007-2#1)(2007-5#1)(2008-1#2)(2008-11#1)(2008-9#1)(2010-3#1)(2012-3#1)
with interpersonal##4##2##(2006-7#1)(2007-1#1)(2008-12#1)(2012-3#1)
with interrupted##3##2##(1994-12#1)(2007-7#1)(2009-8#1)
with interstitial deletion of##2##4##(1997-3#1)(2012-12#1)
with interstitial lung##3##3##(1991-2#1)(1994-6#1)(2010-12#1)
with interstitial nephritis##2##3##(1997-6#1)(2008-4#1)
with interstitial##12##2##(1991-2#1)(1994-6#1)(1996-6#1)(1997-3#1)(1997-6#1)(2006-12#1)(2006-4#1)(2007-9#1)(2008-4#1)(2008-7#1)(2010-12#1)(2012-12#1)
with intertrochanteric fractures##2##3##(2012-12#1)(2013-1#1)
with intertrochanteric##3##2##(2008-12#1)(2012-12#1)(2013-1#1)
with intervention##6##2##(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
with interventional techniques##4##3##(2006-8#2)(2012-12#2)
with interventional##5##2##(2006-8#2)(2008-7#1)(2012-12#2)
with intestinal malrotation##5##3##(1996-3#1)(2009-6#1)(2011-12#1)(2012-3#2)
with intestinal metaplasia in##2##4##(2006-10#2)
with intestinal metaplasia##3##3##(1997-1#1)(2006-10#2)
with intestinal obstruction due to##2##5##(1990-10#1)(2012-2#1)
with intestinal perforation##2##3##(2008-6#1)(2012-2#1)
with intestinal polyps##2##3##(1993-9#1)(2009-12#1)
with intestinal##27##2##(1990-10#1)(1990-4#1)(1990-7#1)(1991-10#1)(1992-12#1)(1993-9#1)(1995-10#1)(1996-3#1)(1997-1#1)(2005-10#1)(2006-10#3)(2006-2#1)(2007-11#1)(2008-12#1)(2008-6#1)(2009-12#1)(2009-6#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
with intraarterial##3##2##(2006-11#2)(2007-9#1)
with intracaval##2##2##(2006-10#2)
with intracavity##5##2##(2007-11#2)(2007-12#3)
with intracellular##16##2##(1991-1#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-7#1)(1993-12#1)(1994-8#1)(1995-11#1)(1995-5#1)(1996-5#1)(1997-6#1)(2006-6#1)(2007-12#1)(2008-9#1)(2011-2#1)
with intracerebral hemorrhage##4##3##(2007-10#3)(2007-9#1)
with intracerebral##8##2##(1991-11#1)(2007-10#3)(2007-11#1)(2007-9#1)(2008-7#2)
with intracoronary##3##2##(1994-11#1)(2011-1#1)(2012-2#1)
with intracranial##19##2##(1990-9#1)(1991-2#1)(1995-11#1)(1996-6#1)(1997-3#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-7#3)(2011-12#1)(2011-2#1)(2012-12#2)(2013-8#1)
with intractable##7##2##(1993-1#1)(1996-2#1)(2005-4#1)(2006-7#1)(2006-8#1)(2006-9#1)(2009-9#1)
with intracystic##4##2##(1994-7#3)(2007-8#1)
with intradural##2##2##(2008-9#1)(2012-3#1)
with intrahepatic##5##2##(1997-8#1)(2005-8#1)(2008-7#1)(2009-8#1)(2010-12#1)
with intralesional##2##2##(2007-7#1)(2013-8#1)
with intraluminal##2##2##(2007-8#1)(2013-1#1)
with intramedullary nail##2##3##(2007-11#1)(2013-1#1)
with intramedullary##5##2##(1990-9#1)(2007-11#1)(2012-3#1)(2013-1#2)
with intramural##2##2##(1990-3#1)(2009-10#1)
with intramuscular##6##2##(2006-8#1)(2007-11#1)(2008-6#1)(2012-3#1)(2013-1#2)
with intranasal##5##2##(2007-10#2)(2007-11#1)(2008-8#1)(2013-1#1)
with intraocular lens implantation]##2##4##(1991-2#1)(2007-3#1)
with intraocular lens##3##3##(1991-2#1)(2007-3#1)(2011-2#1)
with intraocular##6##2##(1991-2#1)(2007-3#1)(2011-1#1)(2011-2#2)(2013-1#1)
with intraoperative MRI##2##3##(2006-6#2)
with intraoperative endoscopy##2##3##(2007-3#1)(2010-5#1)
with intraoperative findings##2##3##(2007-11#2)
with intraoperative##17##2##(1990-12#1)(1994-3#1)(2006-12#1)(2006-6#2)(2006-9#1)(2007-11#2)(2007-3#1)(2007-7#1)(2007-8#2)(2008-7#1)(2010-5#1)(2011-2#2)(2013-1#1)
with intraperitoneal hyperthermic perfusion##2##4##(2006-6#2)
with intraperitoneal##7##2##(1995-1#1)(1995-12#1)(1995-7#1)(2006-6#2)(2008-12#1)(2010-7#1)
with intrapleural##4##2##(1991-6#2)(1992-1#1)(2007-8#1)
with intrathecal##4##2##(1990-7#1)(2006-10#1)(2006-9#1)(2011-2#1)
with intrathoracic##5##2##(1991-4#1)(2007-8#3)(2013-1#1)
with intrauterine##2##2##(1994-12#1)(1996-3#1)
with intravaginal##4##2##(1990-10#1)(2004-10#1)(2006-5#1)(2008-12#1)
with intravascular lymphomatosis##2##3##(2006-4#2)
with intravascular##5##2##(2005-9#1)(2006-4#2)(2007-8#1)(2008-7#1)
with intravenous and oral##2##4##(2011-12#1)(2012-12#1)
with intravenous ganciclovir##2##3##(2006-10#1)(2010-12#1)
with intravenous immunoglobulin##7##3##(2006-10#4)(2007-10#1)(2010-8#2)
with intravenous infusion##2##3##(2007-11#1)(2008-4#1)
with intravenous mannitol##2##3##(2008-1#2)
with intravenous midazolam##2##3##(1993-1#2)
with intravenous pulse cyclophosphamide##2##4##(2007-7#2)
with intravenous quinine##2##3##(2009-6#1)(2012-12#1)
with intravenous thiamine##2##3##(2006-4#2)
with intravenous##58##2##(1990-12#1)(1991-6#1)(1993-1#2)(1993-11#1)(1993-5#1)(1994-2#1)(1995-11#1)(1997-7#1)(1997-8#1)(2006-10#8)(2006-4#3)(2007-10#2)(2007-11#2)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-3#1)(2013-1#3)
with intraventricular##6##2##(2006-5#1)(2007-10#3)(2007-9#1)(2008-7#1)
with intravesical##2##2##(2006-6#1)(2007-7#1)
with intravitreal bevacizumab##2##3##(2009-8#1)(2011-2#1)
with intravitreal##3##2##(2007-3#1)(2009-8#1)(2011-2#1)
with intriguing##3##2##(2007-11#1)(2008-4#1)(2012-3#1)
with intrinsic##9##2##(1993-6#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-2#1)(1997-8#1)(2005-8#1)(2008-5#1)(2011-1#1)
with intrinsically##3##2##(1995-5#1)(2008-2#1)(2012-1#1)
with introducing##2##2##(1992-3#1)(2012-3#1)
with intussusception##3##2##(2008-8#2)(2013-1#1)
with invasion of the##4##4##(1991-10#1)(2004-1#1)(2007-6#1)(2008-7#1)
with invasion of##5##3##(1991-10#1)(1995-1#1)(2004-1#1)(2007-6#1)(2008-7#1)
with invasion to##3##3##(2007-2#1)(2012-2#2)
with invasion##10##2##(1991-10#1)(1995-1#1)(2004-1#1)(2007-2#1)(2007-6#1)(2008-7#1)(2012-2#3)(2013-8#1)
with invasive breast cancer##2##4##(2007-11#1)(2008-7#1)
with invasive breast##3##3##(2004-2#1)(2007-11#1)(2008-7#1)
with invasive fungal##3##3##(2007-11#1)(2012-2#2)
with invasive growth and##2##4##(1990-11#1)(2007-8#1)
with invasive growth##3##3##(1990-11#1)(2007-8#1)(2011-1#1)
with invasive##31##2##(1990-11#1)(1991-2#1)(1992-8#1)(2004-2#2)(2005-10#1)(2006-10#3)(2006-6#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)(2011-1#2)(2012-2#4)(2013-1#2)
with inverse##3##2##(1995-2#1)(2005-11#1)(2008-2#1)
with inversion of configuration##2##4##(1996-5#1)(1997-2#1)
with inversion of##3##3##(1994-3#1)(1996-5#1)(1997-2#1)
with inversion##5##2##(1992-7#1)(1994-3#1)(1996-5#1)(1997-2#1)(2008-3#1)
with inverted helper/suppressor ratio##2##4##(1994-6#2)
with inverted papilloma##2##3##(2010-7#2)
with inverted##9##2##(1994-6#2)(2009-4#1)(2010-12#1)(2010-7#2)(2011-1#1)(2013-1#2)
with investigation times##2##3##(1994-3#2)
with investigation##3##2##(1994-3#2)(2008-12#1)
with involvement of the##4##4##(1994-5#1)(2007-11#1)(2008-11#1)(2011-2#1)
with involvement of##20##3##(1993-11#1)(1994-5#1)(1996-7#1)(2004-2#1)(2006-10#1)(2006-7#3)(2006-8#2)(2007-11#1)(2007-7#1)(2008-11#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
with involvement##21##2##(1993-11#1)(1994-5#1)(1996-7#1)(2004-2#1)(2006-10#1)(2006-7#3)(2006-8#2)(2007-11#1)(2007-7#1)(2008-11#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
with iodide in##2##3##(2008-10#2)
with iodide##11##2##(2008-10#9)(2010-10#2)
with iodinated##3##2##(1991-5#1)(1997-2#1)(2007-2#1)
with iodine and##2##3##(2007-12#1)(2008-10#1)
with iodine##9##2##(2007-12#1)(2008-10#5)(2008-4#1)(2008-8#1)(2013-1#1)
with iodoacetamide##4##2##(1990-12#1)(1994-6#3)
with iodoform gauze##3##3##(2007-8#3)
with ion chromatography for##2##4##(2008-10#2)
with ion chromatography##6##3##(2005-12#1)(2008-10#5)
with ion exchange##2##3##(2008-10#2)
with ion trap##2##3##(2007-8#1)(2008-11#1)
with ion##19##2##(1990-8#1)(1992-12#1)(2005-12#1)(2007-8#2)(2008-10#9)(2008-11#1)(2008-3#1)(2008-4#1)(2009-6#1)(2011-2#1)
with ion-pair##3##2##(1992-1#1)(1995-6#1)(2008-10#1)
with ion-selective##4##2##(2008-10#4)
with ionic strength##2##3##(2008-10#1)(2009-3#1)
with ionic##4##2##(1996-8#1)(2008-10#2)(2009-3#1)
with ionizing radiation##3##3##(1992-4#1)(1995-1#1)(2007-11#1)
with ions##2##2##(1995-8#1)(2008-10#1)
with ipsilateral##13##2##(1992-1#1)(1992-8#2)(2006-10#1)(2008-10#1)(2008-6#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-3#2)(2013-1#2)
with iron deficiency anaemia##2##4##(1997-6#1)(2006-2#1)
with iron deficiency##4##3##(1997-6#1)(2006-2#1)(2012-1#1)(2012-11#1)
with iron in##3##3##(1993-2#2)(2008-1#1)
with iron ions##3##3##(1993-8#3)
with iron to##2##3##(1994-9#1)(2006-4#1)
with iron##25##2##(1993-10#1)(1993-2#2)(1993-6#1)(1993-8#3)(1994-9#1)(1995-2#1)(1995-6#1)(1997-6#1)(2006-10#1)(2006-2#1)(2006-4#2)(2008-1#1)(2008-10#3)(2008-3#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)
with iron(II) in hydrochloric acid##2##5##(2008-10#2)
with iron(II)##6##2##(2008-10#6)
with iron(III) in the presence of 1##2##7##(2008-10#2)
with iron(III) in##3##3##(2008-10#3)
with iron(III)##5##2##(2008-10#5)
with iron-chelating##4##2##(2012-2#1)(2013-8#3)
with iron-dextran##3##2##(2008-5#3)
with irradiated##4##2##(1993-9#2)(2007-11#1)(2008-7#1)
with irradiation##3##2##(2007-10#1)(2007-4#1)(2008-6#1)
with irregular outlines##2##3##(1992-7#1)(1996-5#1)
with irregular##15##2##(1992-7#1)(1996-12#1)(1996-5#1)(1997-1#1)(2005-11#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-2#1)(2009-9#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#1)
with irreparable##3##2##(2008-6#1)(2008-9#2)
with irreversible##8##2##(1996-1#1)(2005-8#2)(2007-7#2)(2008-11#1)(2008-3#1)(2010-1#1)
with irritable bowel syndrome##4##4##(1990-8#1)(2005-12#1)(2007-12#1)(2010-5#1)
with irritable bowel##5##3##(1990-8#1)(2005-12#1)(2006-8#1)(2007-12#1)(2010-5#1)
with irritable##6##2##(1990-8#2)(2005-12#1)(2006-8#1)(2007-12#1)(2010-5#1)
with ischaemic heart disease##7##4##(1990-9#1)(2006-1#1)(2007-8#1)(2008-5#1)(2008-7#2)(2012-2#1)
with ischaemic heart##8##3##(1990-9#1)(2006-1#1)(2007-8#2)(2008-5#1)(2008-7#2)(2012-2#1)
with ischaemic##12##2##(1990-9#1)(2006-1#1)(2007-8#3)(2008-5#1)(2008-7#2)(2008-8#2)(2012-2#1)(2013-8#1)
with ischemia##3##2##(1996-12#1)(2006-11#1)(2012-2#1)
with ischemic heart disease##13##4##(1996-6#1)(1996-9#4)(1997-6#1)(2006-6#2)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-3#1)
with ischemic stroke##20##3##(2007-10#12)(2007-9#4)(2008-8#1)(2008-9#1)(2010-8#1)(2013-7#1)
with ischemic##44##2##(1996-2#1)(1996-6#1)(1996-9#4)(1997-6#1)(2005-10#1)(2006-6#2)(2006-7#1)(2007-10#12)(2007-7#1)(2007-8#2)(2007-9#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-7#1)
with ischemic-type##2##2##(2006-11#1)(2008-8#1)
with islets)##2##2##(1995-2#2)
with isobaric bypivacain (5mg/ml)##2##4##(2012-3#2)
with isobaric bypivacain##3##3##(2012-3#3)
with isobutyl methyl ketone (IBMK)##3##5##(2008-10#3)
with isobutyl methyl ketone##4##4##(2008-10#4)
with isocratic elution and##2##4##(1990-8#1)(1990-9#1)
with isocratic elution##3##3##(1990-8#1)(1990-9#1)(2010-11#1)
with isocratic##4##2##(1990-8#1)(1990-9#1)(2008-10#1)(2010-11#1)
with isoelectric points##2##3##(1992-2#1)(2009-4#1)
with isoflurane##5##2##(2007-2#3)(2010-7#1)(2012-2#1)
with isolate##2##2##(1997-3#1)(2008-5#1)
with isolated ACTH##2##3##(2006-9#2)
with isolated Broca's##2##3##(2007-10#2)
with isolated COA##2##3##(2007-3#2)
with isolated abnormal chords of the left ventricle##2##8##(2011-1#2)
with isolated antiHBc##2##3##(2012-2#2)
with isolated left##2##3##(2007-8#1)(2011-2#1)
with isolated metastasis##2##3##(2007-11#2)
with isolated rat##3##3##(1994-11#1)(1995-6#1)(1997-4#1)
with isolated systolic hypertension##3##4##(1995-10#1)(2011-1#2)
with isolated trisomy 14##3##4##(2011-2#3)
with isolated##59##2##(1990-4#1)(1990-8#1)(1991-12#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-8#1)(1995-10#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-9#2)(2007-10#3)(2007-11#4)(2007-3#3)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-1#5)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
with isolates from##9##3##(2008-10#6)(2008-5#2)(2011-2#1)
with isolates of C##2##4##(2008-10#2)
with isolates of morphotype A##3##5##(2008-10#3)
with isolates of##11##3##(2008-10#11)
with isolates##28##2##(2008-10#21)(2008-5#4)(2011-2#2)(2013-8#1)
with isolation and##2##3##(2008-6#1)(2012-2#1)
with isolation##3##2##(2008-6#1)(2012-2#1)(2013-7#1)
with isomer B##2##3##(1991-2#2)
with isometric##2##2##(2010-7#1)(2012-1#1)
with isoniazid##8##2##(1993-7#1)(1994-7#1)(1997-3#1)(2007-2#1)(2008-10#2)(2008-5#1)(2010-12#1)
with isonicotinic acid##3##3##(1992-2#1)(2010-12#2)
with isopropyl##2##2##(1990-5#1)(1991-12#1)
with isopropyl-beta-D-thiogalactopyranoside##2##2##(1990-5#1)(2010-6#1)
with isoproterenol##4##2##(1991-10#1)(1995-5#1)(1995-6#1)(2011-2#1)
with isotonic##3##2##(1990-3#1)(1994-8#1)(2008-10#1)
with isotretinoin##6##2##(2007-11#1)(2009-6#1)(2010-5#4)
with issues of##2##3##(2008-2#1)(2010-11#1)
with issues##4##2##(2007-12#1)(2008-2#1)(2009-8#1)(2010-11#1)
with it a##3##3##(2006-10#1)(2008-10#1)(2013-1#1)
with it and##2##3##(2006-2#1)(2011-2#1)
with it the##3##3##(1995-2#1)(2006-7#1)(2008-3#1)
with it##42##2##(1990-3#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-10#1)(1993-10#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-3#4)(2008-7#1)(2008-9#1)(2009-9#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
with itraconazole##5##2##(2007-7#2)(2008-1#1)(2008-5#2)
with its 5##3##3##(2011-2#3)
with its ability to increase##2##5##(1990-2#1)(1991-5#1)
with its ability to inhibit##2##5##(1993-4#1)(2011-2#1)
with its ability to##12##4##(1990-2#1)(1991-5#1)(1993-2#1)(1993-4#1)(1995-5#1)(1996-5#1)(1997-4#1)(2006-1#1)(2006-8#1)(2011-1#1)(2011-2#2)
with its actions##2##3##(1994-9#1)(2012-3#1)
with its activation##2##3##(1994-12#1)(2012-12#1)
with its application in##2##4##(2007-5#1)(2011-1#1)
with its associated##2##3##(1994-3#1)(2007-12#1)
with its attendant##3##3##(2005-10#1)(2008-12#1)(2011-2#1)
with its cellular receptor##2##4##(1996-7#1)(2008-8#1)
with its clinical##4##3##(2005-7#1)(2008-11#1)(2010-12#1)(2013-8#1)
with its cognate##3##3##(1991-4#1)(1995-8#1)(2011-1#1)
with its complementary strand##2##4##(1992-1#1)(2008-5#1)
with its concentration##2##3##(1991-2#1)(2008-8#1)
with its degradation##2##3##(2008-10#1)(2012-12#1)
with its degree##2##3##(1990-6#1)(2008-11#1)
with its emphasis on##2##4##(1993-1#1)(2008-8#1)
with its environment##2##3##(1994-1#1)(2006-11#1)
with its expression##2##3##(2007-9#1)(2010-4#1)
with its fast##2##3##(2006-10#1)(2007-12#1)
with its focus on##2##4##(2008-7#1)(2010-10#1)
with its function in##2##4##(1991-5#1)(1997-4#1)
with its host##3##3##(1991-1#1)(1993-12#1)(2008-10#1)
with its human counterpart##2##4##(1992-12#1)(2009-5#1)
with its human##3##3##(1992-12#1)(1993-8#1)(2009-5#1)
with its improved##2##3##(2008-10#1)(2011-7#1)
with its ligand##2##3##(1995-10#1)(2008-8#1)
with its long##2##3##(1990-11#1)(2008-5#1)
with its main##4##3##(2005-7#1)(2008-10#2)(2008-3#1)
with its natural##2##3##(1990-7#1)(1997-1#1)
with its own##7##3##(1990-2#1)(1994-10#1)(1995-1#1)(1997-5#1)(2005-11#1)(2007-12#1)(2012-12#1)
with its performance##2##3##(2007-7#1)(2008-10#1)
with its physical and##2##4##(2007-11#1)(2013-1#1)
with its physiological##2##3##(1994-8#1)(1995-2#1)
with its primary##2##3##(1991-12#1)(2007-5#1)
with its protein##2##3##(1992-12#1)(1994-11#1)
with its receptor##5##3##(1990-7#1)(1992-3#1)(1994-8#1)(1995-6#1)(2011-1#1)
with its receptors##3##3##(1991-9#1)(1995-3#1)(2008-8#1)
with its relatively##2##3##(2009-5#1)(2012-1#1)
with its respective##3##3##(2011-2#1)(2012-12#1)(2013-1#1)
with its resultant##2##3##(2006-8#1)(2009-2#1)
with its role as a##2##5##(2008-10#1)(2010-7#1)
with its role as##3##4##(1990-8#1)(2008-10#1)(2010-7#1)
with its role##4##3##(1990-8#1)(2008-10#1)(2010-3#1)(2010-7#1)
with its substrate##2##3##(1990-11#1)(1992-5#1)
with its tangential plane coincident with the##2##7##(2008-3#2)
with its tangential##3##3##(2008-3#3)
with its target##3##3##(1991-4#1)(1992-2#1)(2011-1#1)
with its typical##2##3##(2007-11#1)(2011-3#1)
with its unique##3##3##(2008-3#2)(2008-4#1)
with its use##8##3##(1993-1#1)(2007-10#1)(2007-8#1)(2008-1#1)(2010-12#1)(2010-7#1)(2010-8#1)(2013-1#1)
with its various##2##3##(2008-10#1)(2012-12#1)
with its##421##2##(1990-1#1)(1990-11#5)(1990-2#4)(1990-5#1)(1990-6#1)(1990-7#6)(1990-8#1)(1991-1#2)(1991-12#3)(1991-2#2)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#2)(1992-8#2)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#3)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-3#4)(1994-6#2)(1994-8#5)(1994-9#4)(1995-1#3)(1995-10#2)(1995-11#1)(1995-2#4)(1995-3#5)(1995-5#2)(1995-6#4)(1995-7#1)(1995-8#6)(1996-10#2)(1996-12#4)(1996-2#3)(1996-3#2)(1996-5#3)(1996-6#2)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#3)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-3#1)(2005-7#2)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#2)(2007-1#2)(2007-10#2)(2007-11#6)(2007-12#8)(2007-2#1)(2007-3#5)(2007-4#1)(2007-5#5)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#29)(2008-11#5)(2008-12#5)(2008-2#3)(2008-3#13)(2008-4#2)(2008-5#13)(2008-7#4)(2008-8#13)(2008-9#4)(2009-10#4)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-9#1)(2010-10#2)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#3)(2011-1#11)(2011-2#53)(2011-3#2)(2011-7#1)(2012-1#2)(2012-11#2)(2012-12#9)(2012-2#5)(2012-3#1)(2013-1#11)(2013-8#2)
with itself##3##2##(1992-1#1)(1992-3#1)(1996-7#1)
with jaundice##10##2##(1990-8#1)(1992-9#2)(2008-11#1)(2008-6#1)(2009-8#1)(2012-2#2)(2013-1#2)
with joint pain##2##3##(2011-1#1)(2013-8#1)
with joint##8##2##(1996-9#2)(1997-4#1)(2006-10#1)(2007-8#1)(2008-7#1)(2011-1#1)(2013-8#1)
with judicious use of##4##4##(2006-10#1)(2006-2#1)(2006-6#1)(2011-2#1)
with juice reward##2##3##(1993-2#1)(1993-6#1)
with just a##2##3##(2008-7#1)(2012-3#1)
with just one##2##3##(2008-4#1)(2011-2#1)
with just##8##2##(2007-9#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-9#1)(2011-2#2)(2012-3#1)
with juvenile idiopathic arthritis##3##4##(2007-11#1)(2012-12#1)(2012-3#1)
with juvenile rheumatoid arthritis (JRA)##2##5##(2006-10#1)(2007-11#1)
with juvenile rheumatoid arthritis##4##4##(2006-10#3)(2007-11#1)
with juvenile##9##2##(2006-10#3)(2007-11#2)(2010-12#1)(2012-12#1)(2012-3#1)(2013-8#1)
with juvenile-onset##4##2##(1991-1#1)(2006-10#1)(2013-1#2)
with kainate##2##2##(1993-2#1)(1995-5#1)
with kainic acid##4##3##(1991-4#1)(1993-12#2)(1993-2#1)
with kainic##5##2##(1991-4#1)(1993-12#2)(1993-2#1)(1996-1#1)
with kanamycin##4##2##(1995-8#2)(2008-10#1)(2008-4#1)
with kcat##4##2##(1990-2#2)(1994-9#1)(1995-10#1)
with keeping##2##2##(2008-10#2)
with keratoconjunctivitis##5##2##(2011-2#5)
with ketamine##4##2##(2005-7#1)(2006-4#1)(2012-12#1)(2012-3#1)
with ketoconazole##4##2##(1991-2#1)(2007-7#3)
with ketone##2##2##(1996-5#1)(2010-6#1)
with ketoprofen##4##2##(2007-7#4)
with key informants from##2##4##(2008-1#1)(2008-4#1)
with key informants##4##3##(1996-3#1)(2007-7#1)(2008-1#1)(2008-4#1)
with key words##2##3##(2012-2#1)(2013-1#1)
with key##22##2##(1995-2#1)(1995-5#1)(1996-3#2)(2005-11#1)(2006-9#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-12#2)(2008-4#2)(2009-10#1)(2009-4#1)(2010-12#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
with keywords##2##2##(2008-10#1)(2008-4#1)
with kidney disease##5##3##(1996-12#2)(2007-12#1)(2007-8#1)(2010-12#1)
with kidney function##2##3##(1991-3#1)(2007-2#1)
with kidney transplantation##2##3##(2007-11#1)(2013-1#1)
with kidney##21##2##(1991-3#1)(1992-5#1)(1996-12#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#4)(2007-8#1)(2008-6#1)(2008-7#2)(2009-10#1)(2010-12#2)(2010-4#2)(2013-1#1)
with kin##2##2##(2008-10#1)(2009-10#1)
with kinase##2##2##(1992-7#1)(2011-1#1)
with kinesitherapy##2##2##(2007-11#1)(2007-7#1)
with kinetic##5##2##(1994-8#1)(1995-3#1)(1997-6#1)(2008-4#1)(2012-1#1)
with kinetics##3##2##(1996-11#1)(2008-10#1)(2011-1#1)
with knee osteoarthritis##6##3##(2006-10#2)(2012-2#2)(2013-1#2)
with knee pain##2##3##(2007-8#1)(2012-3#1)
with knee##14##2##(2006-10#3)(2007-8#2)(2008-1#1)(2010-4#1)(2012-2#2)(2012-3#1)(2013-1#4)
with knowledge about the##2##4##(2006-9#1)(2007-9#1)
with knowledge of the##4##4##(1993-1#1)(2008-10#1)(2012-3#2)
with knowledge of##5##3##(1993-1#1)(2008-10#1)(2012-2#1)(2012-3#2)
with knowledge on##2##3##(2008-9#1)(2011-1#1)
with knowledge##12##2##(1992-2#1)(1993-1#1)(2006-2#1)(2006-9#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#2)
with known AF##2##3##(2008-5#2)
with known AP-induced bronchospasm##2##4##(1996-12#2)
with known amounts of##5##4##(1993-6#1)(2008-10#4)
with known causes##2##3##(2007-9#1)(2008-11#1)
with known concentrations##3##3##(2008-10#1)(2008-3#1)(2010-5#1)
with known genes##2##3##(2008-10#1)(2008-9#1)
with known genetic##2##3##(1992-1#1)(2006-5#1)
with known kinetic##2##3##(2006-10#1)(2008-10#1)
with known or##3##3##(1997-6#1)(1997-8#1)(2013-1#1)
with known properties##2##3##(2009-7#1)(2010-9#1)
with known risk factors##2##4##(2005-7#1)(2006-8#1)
with known sequence##2##3##(1990-9#1)(1995-8#1)
with known##134##2##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-12#2)(1996-7#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2005-11#2)(2005-12#1)(2005-7#1)(2006-10#2)(2006-12#4)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#3)(2007-1#2)(2007-11#1)(2007-12#5)(2007-6#2)(2007-9#1)(2008-1#1)(2008-10#21)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-5#2)(2010-7#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
with l-cysteine##4##2##(2008-10#4)
with lab-at-valve (LAV) approach for on-line liquid-liquid micro-extraction##2##8##(2008-10#2)
with lab-at-valve (LAV) approach for##3##5##(2008-10#3)
with labeled DNA##5##3##(1990-5#1)(2008-2#1)(2008-4#3)
with labeled##18##2##(1990-5#1)(1991-5#1)(1992-12#1)(1993-9#1)(1994-11#1)(1997-4#1)(2005-12#2)(2006-7#1)(2008-10#2)(2008-2#3)(2008-4#3)(2008-7#1)
with labeling of the##3##4##(1994-11#1)(1995-6#2)
with labeling##4##2##(1994-11#1)(1995-6#2)(2008-4#1)
with labelled cDNA from##2##4##(2008-7#2)
with labelled##7##2##(1992-8#1)(1996-3#1)(1997-6#1)(2008-4#1)(2008-7#2)(2012-1#1)
with labile##2##2##(1996-2#1)(2012-2#1)
with laboratory and##2##3##(2007-9#1)(2013-1#1)
with laboratory##12##2##(1990-11#1)(1994-12#1)(2005-10#1)(2006-7#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-2#2)(2011-2#1)(2013-1#1)
with laccase##2##2##(2008-10#2)
with lack of##6##3##(1993-6#1)(2008-3#1)(2008-9#1)(2009-10#1)(2012-3#1)(2013-1#1)
with lactate dehydrogenase##2##3##(1992-7#1)(1997-8#1)
with lactate##6##2##(1991-2#1)(1992-7#1)(1994-8#1)(1997-8#1)(2008-10#1)(2009-4#1)
with lactation##2##2##(1994-7#1)(2013-8#1)
with lactic acid bacteria##2##4##(2009-2#1)(2010-4#1)
with lactic acid##8##3##(2004-9#2)(2008-5#2)(2009-2#1)(2010-4#2)(2013-7#1)
with lactic acidosis and##3##4##(1990-3#2)(2007-11#1)
with lactic##11##2##(1990-3#2)(2004-9#2)(2007-11#1)(2008-5#2)(2009-2#1)(2010-4#2)(2013-7#1)
with lactobacilli##2##2##(1991-3#1)(2006-5#1)
with lactose##2##2##(1994-6#1)(1997-8#1)
with lacunar infarct##2##3##(2007-10#2)
with lacunar##5##2##(2007-10#5)
with lambda =##2##3##(2006-4#1)(2008-3#1)
with lambda##7##2##(1990-3#1)(1990-5#1)(1992-1#1)(1992-2#1)(1994-6#1)(2006-4#1)(2008-3#1)
with lamin##2##2##(1993-8#1)(1995-5#1)
with laminectomy followed by radiotherapy##3##5##(1991-9#1)(1996-9#2)
with laminin##2##2##(1991-3#1)(2013-8#1)
with lamivudine##7##2##(1996-11#1)(1996-2#1)(2006-10#2)(2008-5#1)(2009-8#1)(2011-2#1)
with land##2##2##(2008-3#1)(2008-5#1)
with language impairment##2##3##(2008-11#1)(2009-7#1)
with language##5##2##(2007-4#1)(2008-11#1)(2009-7#1)(2010-2#1)(2011-1#1)
with lanoteplase##2##2##(2007-11#2)
with lansoprazole##2##2##(2008-11#1)(2008-5#1)
with lanthanide##3##2##(2008-10#2)(2010-3#1)
with laparoscopic procedures##3##3##(2004-2#1)(2011-2#2)
with laparoscopic surgery##2##3##(2010-11#1)(2013-1#1)
with laparoscopic##14##2##(1996-9#1)(2004-2#1)(2006-6#2)(2008-3#1)(2009-6#1)(2010-11#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)
with laparotomy and##2##3##(1994-3#1)(2008-9#1)
with laparotomy##5##2##(1991-3#1)(1994-3#1)(1996-1#1)(1996-3#1)(2008-9#1)
with large amount of##2##4##(2008-10#2)
with large amounts of##2##4##(1990-6#1)(2007-12#1)
with large and small##2##4##(2008-2#1)(2009-9#1)
with large and##4##3##(1992-1#1)(2008-2#2)(2009-9#1)
with large areas##2##3##(2008-7#1)(2008-8#1)
with large effects##3##3##(2008-8#1)(2012-3#2)
with large intestine##2##3##(2009-8#1)(2013-1#1)
with large number of##4##4##(2008-4#1)(2011-1#3)
with large numbers of##5##4##(1997-5#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)
with large numerical aperture##2##4##(2008-3#2)
with large or##2##3##(2008-3#1)(2008-9#1)
with large populations##2##3##(1997-6#1)(2010-2#1)
with large pulmonary##3##3##(2007-8#3)
with large quantities of##3##4##(2008-11#1)(2008-9#1)(2009-7#1)
with large tumors##5##3##(1992-7#2)(2007-8#1)(2013-1#2)
with large volumes of##2##4##(2006-2#1)(2009-4#1)
with large##158##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-2#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-7#2)(1993-10#1)(1993-3#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-2#1)(1995-2#2)(1995-6#1)(1996-4#1)(1996-8#1)(1997-3#1)(1997-5#2)(1997-6#1)(2005-10#1)(2005-11#2)(2005-9#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-7#1)(2007-11#4)(2007-12#9)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#5)(2007-9#4)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#8)(2008-3#17)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#5)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#2)
with large-scale##3##2##(1994-12#1)(2008-4#1)(2008-7#1)
with larger numbers of##3##4##(1995-12#1)(2010-5#1)(2012-2#1)
with larger sample##2##3##(2007-10#1)(2008-12#1)
with larger samples##2##3##(2008-12#1)(2013-1#1)
with larger##38##2##(1992-12#1)(1993-6#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2007-10#2)(2007-8#1)(2008-10#3)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
with largest##2##2##(2010-7#1)(2012-5#1)
with larvae of M##2##4##(2007-3#2)
with larvae of##4##3##(2007-3#2)(2008-2#1)(2008-9#1)
with larvae##6##2##(2007-3#2)(2008-2#1)(2008-7#1)(2008-9#1)(2010-10#1)
with larval##3##2##(2004-11#2)(2007-7#1)
with laryngeal lesions##2##3##(2008-5#1)(2009-10#1)
with laryngeal##5##2##(1990-6#1)(2008-5#1)(2009-10#2)(2012-2#1)
with laser laparoscopy##2##3##(1995-2#2)
with laser light##2##3##(2008-1#1)(2012-2#1)
with laser pulses##2##3##(2008-3#2)
with laser sampling##2##3##(2008-10#2)
with laser##38##2##(1990-12#1)(1991-9#1)(1995-2#2)(1995-3#1)(1997-2#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#2)(2008-2#4)(2008-3#6)(2008-5#2)(2008-7#1)(2008-8#1)(2009-4#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
with laser-induced fluorescence detection##10##4##(1996-11#2)(1996-12#1)(1997-2#3)(2007-8#2)(2008-10#2)
with laser-induced fluorescence##13##3##(1996-11#2)(1996-12#1)(1997-2#3)(2006-12#1)(2007-8#2)(2008-10#4)
with laser-induced##19##2##(1996-11#2)(1996-12#1)(1997-2#3)(2006-12#1)(2007-8#3)(2008-10#6)(2008-2#1)(2008-3#2)
with late onset##2##3##(1995-3#1)(1995-4#1)
with late##20##2##(1993-6#1)(1995-3#1)(1995-4#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-4#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
with late-onset schizophrenia##2##3##(1996-7#1)(2008-9#1)
with late-onset##9##2##(1990-11#1)(1996-5#1)(1996-7#1)(1997-4#1)(2005-8#1)(2008-7#1)(2008-9#1)(2009-8#2)
with late-stage##3##2##(1997-1#1)(2006-10#1)(2007-11#1)
with latent period##2##3##(2008-10#1)(2009-2#1)
with latent porphyria##2##3##(1990-2#2)
with latent##8##2##(1990-2#2)(1995-3#1)(2008-10#2)(2008-4#1)(2009-2#2)
with later##10##2##(1992-12#1)(1992-7#2)(1994-5#1)(2006-3#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-2#1)(2012-1#1)
with lateral##13##2##(1990-10#1)(2007-11#1)(2007-12#1)(2008-12#2)(2008-3#2)(2008-5#1)(2009-4#1)(2012-12#1)(2012-2#1)(2013-7#2)
with latest##2##2##(2006-6#1)(2010-8#1)
with latex##4##2##(1992-8#1)(2007-10#1)(2008-3#1)(2011-2#1)
with latitude##3##2##(1996-5#1)(2007-5#1)(2008-8#1)
with lattice constants a =##2##5##(1996-2#2)
with lattice parameters a =##3##5##(1997-6#1)(1997-7#1)(2007-11#1)
with lattice parameters##4##3##(1997-6#1)(1997-7#2)(2007-11#1)
with lattice##6##2##(1996-2#2)(1997-6#1)(1997-7#2)(2007-11#1)
with laxity##2##2##(2006-3#1)(2007-7#1)
with lead##11##2##(1995-11#1)(1995-3#1)(1996-3#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-1#1)(2012-2#1)
with lead(II)##3##2##(2008-10#3)
with leaf rust##3##3##(2008-10#3)
with leaf##9##2##(2006-12#1)(2008-10#7)(2008-9#1)
with learning and memory##2##4##(2008-10#1)(2010-10#1)
with learning and##5##3##(2004-12#1)(2006-8#1)(2008-10#1)(2008-11#1)(2010-10#1)
with learning difficulties##6##3##(2008-11#6)
with learning disabilities##9##3##(1996-9#1)(2008-12#1)(2011-1#5)(2011-2#2)
with learning##24##2##(1996-9#1)(1997-7#1)(2004-12#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-11#7)(2008-12#1)(2008-2#1)(2010-10#1)(2011-1#6)(2011-2#2)
with least##2##2##(2008-10#1)(2012-12#1)
with lectin##2##2##(1997-2#1)(2008-10#1)
with leflunomide##2##2##(2006-10#2)
with left anterior##3##3##(1993-10#1)(2008-7#2)
with left atrial thrombus##3##4##(1997-1#2)(2010-12#1)
with left atrial##7##3##(1997-1#3)(2006-4#1)(2007-8#1)(2008-11#1)(2010-12#1)
with left flank pain##2##4##(2009-5#1)(2011-2#1)
with left heart##2##3##(1990-8#1)(2006-6#1)
with left hemisphere##4##3##(1993-12#2)(2008-6#1)(2013-1#1)
with left internal##2##3##(2007-10#1)(2007-8#1)
with left lung hypoplasia##4##4##(2013-1#4)
with left lung##6##3##(2007-8#2)(2013-1#4)
with left main##3##3##(2008-7#1)(2009-12#1)(2011-2#1)
with left sided##4##3##(1997-6#1)(2010-11#1)(2013-1#2)
with left ventricular dysfunction##5##4##(1993-2#1)(2007-8#2)(2008-8#1)(2010-6#1)
with left ventricular ejection fraction##3##5##(1997-8#3)
with left ventricular hypertrophy##2##4##(2008-12#1)(2013-1#1)
with left ventricular tumor##2##4##(2007-8#2)
with left ventricular##18##3##(1993-2#1)(1995-6#1)(1997-8#3)(2005-10#1)(2006-9#1)(2007-8#5)(2008-12#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-6#1)(2013-1#1)
with left##81##2##(1990-10#1)(1990-8#1)(1991-8#1)(1993-10#1)(1993-12#2)(1993-2#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-1#3)(1997-3#1)(1997-6#1)(1997-8#3)(2004-10#1)(2005-10#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#11)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#3)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-6#2)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#11)
with left- than with right-side key-presses and faster responses to##2##10##(2008-4#2)
with left-sided##4##2##(2008-10#1)(2010-5#1)(2012-1#1)(2012-2#1)
with leg##6##2##(1996-7#1)(2007-11#1)(2007-8#1)(2009-5#1)(2013-1#1)(2013-8#1)
with legal##3##2##(1991-4#1)(2008-10#1)(2009-9#1)
with leiomyosarcoma##2##2##(1991-4#1)(1991-9#1)
with length##3##2##(2008-4#1)(2011-2#1)(2013-7#1)
with lengths of##2##3##(1991-12#1)(2006-4#1)
with lengthy##2##2##(2008-10#1)(2008-3#1)
with lens##2##2##(2005-11#1)(2013-7#1)
with lepirudin##3##2##(2007-11#2)(2009-8#1)
with leprosy and##3##3##(2007-7#1)(2011-2#1)(2013-8#1)
with leprosy##10##2##(2007-7#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#5)(2013-8#1)
with leptin##3##2##(1997-4#1)(2007-11#1)(2008-4#1)
with lesbian##3##2##(2008-12#1)(2012-2#2)
with lesbian/bisexual mothers##2##3##(2009-7#2)
with lesion##5##2##(2007-7#1)(2008-10#2)(2010-6#1)(2012-2#1)
with lesions in the##4##4##(1993-8#1)(2007-11#1)(2008-10#1)(2008-11#1)
with lesions in##9##3##(1990-3#1)(1993-8#1)(1994-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
with lesions of the amygdala##2##5##(1996-5#1)(2008-4#1)
with lesions of the##6##4##(1990-10#1)(1992-1#1)(1993-12#1)(1996-5#1)(1997-7#1)(2008-4#1)
with lesions of##11##3##(1990-10#1)(1992-1#1)(1993-12#1)(1993-2#1)(1996-5#1)(1996-9#1)(1997-7#1)(2007-2#1)(2007-8#1)(2008-4#1)(2009-11#1)
with lesions that##2##3##(2008-4#1)(2009-4#1)
with lesions were##2##3##(2007-2#1)(2008-10#1)
with lesions##37##2##(1990-10#1)(1990-3#1)(1991-2#1)(1992-1#1)(1992-11#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-6#1)(1995-12#1)(1996-11#2)(1996-5#1)(1996-9#1)(1997-7#1)(2005-10#1)(2006-10#3)(2007-11#2)(2007-12#1)(2007-2#4)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)(2009-11#1)(2009-4#1)
with less cognitive##2##3##(1996-1#1)(2012-2#1)
with less deviant friends##3##4##(2006-3#3)
with less morbidity##2##3##(2005-5#1)(2008-7#1)
with less severe##3##3##(2007-7#1)(2009-11#1)(2011-2#1)
with less side effects##2##4##(1990-3#1)(2008-5#1)
with less than 0##3##4##(1990-8#1)(2008-3#1)(2012-2#1)
with less than 1%##2##4##(1992-2#1)(2008-2#1)
with less than 10%##4##4##(1994-11#1)(2007-12#1)(2008-3#2)
with less than 100##2##4##(1993-9#1)(2008-3#1)
with less than 25%##2##4##(1993-11#1)(1994-9#1)
with less than optimal##2##4##(1996-11#1)(2013-1#1)
with less than or equal to##2##6##(1992-7#1)(2013-8#1)
with less than##36##3##(1990-8#1)(1991-6#1)(1992-2#1)(1992-7#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-12#1)(1996-11#1)(1997-1#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-8#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#5)(2008-8#1)(2009-5#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
with less##131##2##(1990-10#1)(1990-3#1)(1990-8#1)(1991-12#2)(1991-6#2)(1992-2#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-4#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#2)(2005-1#1)(2005-11#1)(2005-5#1)(2006-10#3)(2006-3#3)(2006-5#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-3#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#7)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#3)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#4)(2013-7#2)(2013-8#2)
with lesser amounts##3##3##(1991-5#1)(2008-11#1)(2008-7#1)
with lesser##10##2##(1990-9#1)(1991-5#1)(1993-6#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-7#1)(2011-12#2)
with lethal intent##2##3##(2006-7#2)
with lethal##6##2##(1990-8#1)(2006-7#2)(2006-9#1)(2011-2#1)(2012-12#1)
with leucine##3##2##(1995-1#1)(1995-4#1)(1995-5#1)
with leucovorin rescue##2##3##(1991-10#1)(2010-3#1)
with leucovorin##3##2##(1990-2#1)(1991-10#1)(2010-3#1)
with leukemia##9##2##(1992-3#2)(1996-2#1)(2008-1#1)(2008-10#1)(2010-11#1)(2010-4#1)(2012-12#1)(2012-3#1)
with leukoaraiosis##4##2##(2007-10#4)
with leukocytes##3##2##(2008-1#2)(2008-5#1)
with leukotriene receptor##2##3##(2008-1#1)(2012-12#1)
with leukotriene##4##2##(1990-11#1)(2007-11#1)(2008-1#1)(2012-12#1)
with leupeptin##2##2##(1992-11#1)(1995-9#1)
with levamisole##2##2##(1991-8#1)(1996-6#1)
with levator##2##2##(2010-6#1)(2011-12#1)
with level of##5##3##(1997-2#1)(2006-10#1)(2011-1#3)
with level##9##2##(1993-3#1)(1994-12#1)(1997-2#1)(2006-10#1)(2011-1#3)(2011-2#1)(2013-1#1)
with levels of##13##3##(1990-12#1)(1995-12#1)(1996-12#1)(1997-8#1)(2006-10#1)(2006-5#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-2#1)(2010-11#1)(2010-2#2)
with levels##17##2##(1990-12#1)(1994-2#1)(1995-12#1)(1996-12#1)(1997-8#1)(2006-10#1)(2006-5#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-11#1)(2010-2#2)
with levodopa##3##2##(2008-3#1)(2008-7#2)
with levonorgestrel##2##2##(1995-11#1)(1996-6#1)
with lichen planus##3##3##(2007-7#1)(2009-6#1)(2012-1#1)
with lidar##4##2##(2008-2#3)(2008-3#1)
with lidocaine (2%)##2##3##(1990-9#1)(2010-12#1)
with lidocaine##10##2##(1990-9#1)(1991-3#1)(1993-12#1)(1995-12#1)(1996-10#1)(2006-8#2)(2007-5#1)(2010-12#1)(2010-2#1)
with life in general##3##4##(1991-4#1)(1993-6#1)(2007-10#1)
with life in##4##3##(1991-4#1)(1993-6#1)(1994-11#1)(2007-10#1)
with life span##2##3##(2008-3#1)(2012-1#1)
with life##21##2##(1990-5#1)(1991-4#1)(1993-6#1)(1994-11#1)(1995-1#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-5#1)(2010-10#1)(2010-9#1)(2012-1#1)(2012-11#1)(2012-2#1)
with life-threatening complications##2##3##(2008-6#1)(2012-2#1)
with life-threatening conditions##2##3##(2007-8#1)(2011-2#1)
with life-threatening##11##2##(1996-9#1)(2006-10#2)(2007-8#2)(2008-6#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
with lifestyle##4##2##(2008-1#1)(2008-8#2)(2010-10#1)
with lifetime##2##2##(2008-10#1)(2012-1#1)
with lifetimes of##2##3##(1996-2#1)(2008-10#1)
with ligand binding to##2##4##(1993-3#1)(1996-11#1)
with ligand binding##3##3##(1993-3#1)(1995-10#1)(1996-11#1)
with ligand was##2##3##(1991-8#1)(1995-10#1)
with ligand##7##2##(1990-8#2)(1991-8#1)(1993-3#1)(1995-10#2)(1996-11#1)
with ligands of##3##3##(1991-11#1)(1991-5#1)(2008-10#1)
with ligands##5##2##(1991-11#1)(1991-5#1)(2007-11#1)(2008-10#1)(2008-4#1)
with light and##6##3##(1995-7#1)(1997-6#1)(2008-10#3)(2008-9#1)
with light chain##3##3##(2005-5#2)(2011-2#1)
with light microscopy and##2##4##(2007-7#1)(2008-10#1)
with light microscopy##3##3##(2007-7#1)(2008-10#1)(2008-5#1)
with light##40##2##(1992-2#1)(1993-3#1)(1995-7#1)(1996-2#1)(1997-6#1)(2005-5#2)(2005-7#2)(2006-10#1)(2006-11#2)(2006-12#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-10#10)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
with lignin##3##2##(1993-4#1)(2008-10#1)(2008-6#1)
with like##2##2##(1996-2#1)(2011-2#1)
with likely##3##2##(1991-12#2)(2008-4#1)
with limb##5##2##(1991-8#1)(2008-10#1)(2008-6#1)(2011-12#1)(2012-2#1)
with limbic##2##2##(1993-6#1)(1996-12#1)
with limit##2##2##(2006-10#1)(2008-10#1)
with limited English proficiency##4##4##(2008-12#1)(2010-8#2)(2011-1#1)
with limited ability to##2##4##(2006-1#1)(2007-6#1)
with limited access to##5##4##(2005-7#1)(2008-2#1)(2008-4#1)(2010-10#1)(2013-1#1)
with limited access##7##3##(2005-7#1)(2007-12#1)(2007-7#1)(2008-2#1)(2008-4#1)(2010-10#1)(2013-1#1)
with limited health##2##3##(2005-9#1)(2010-9#1)
with limited maximum##3##3##(2008-3#3)
with limited resources##7##3##(1993-2#1)(2006-2#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-7#1)(2012-12#1)
with limited success##4##3##(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
with limited support for preparatory activities such as information seeking and organization##2##12##(2013-1#2)
with limited treatment##2##3##(2007-7#1)(2010-12#1)
with limited##92##2##(1992-10#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-6#1)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-12#3)(2007-6#2)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#3)(2008-8#2)(2008-9#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-12#2)(2010-3#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#2)(2012-12#3)(2012-2#3)(2012-3#2)(2012-8#1)(2013-1#5)(2013-7#3)
with limiting##2##2##(1994-8#1)(2005-4#1)
with limits of detection in the##3##6##(2004-11#1)(2008-10#2)
with limits of detection##6##4##(2004-11#1)(2008-10#3)(2008-3#1)(2010-11#1)
with lineage##5##2##(2008-10#2)(2008-8#1)(2010-8#2)
with linear and##7##3##(1993-2#1)(1997-3#1)(2008-10#2)(2008-3#2)(2012-12#1)
with linear best fit##2##4##(2008-10#2)
with linear calibration##2##3##(2008-10#1)(2008-3#1)
with linear corrugated reflectors##2##4##(2008-2#2)
with linear##38##2##(1990-4#1)(1990-5#1)(1993-2#1)(1995-11#1)(1997-3#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#6)(2008-3#7)(2008-4#1)(2012-12#1)
with linearized##3##2##(1991-6#1)(1997-6#1)(2008-2#1)
with linearly polarized light##2##4##(2007-11#1)(2008-2#1)
with linearly polarized##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
with linearly##5##2##(2007-11#1)(2007-12#2)(2008-2#2)
with linewidths of##2##3##(2008-2#2)
with linezolid##3##2##(2006-8#1)(2007-12#1)(2009-6#1)
with linkage##4##2##(1996-3#2)(2008-1#1)(2012-11#1)
with linked##3##2##(2008-11#2)(2009-11#1)
with linoleic acid##4##3##(1994-12#1)(1995-10#1)(2008-11#2)
with linseed oil##4##3##(1991-2#2)(2010-4#2)
with lipase activity##3##3##(1992-7#1)(2010-10#2)
with lipase##4##2##(1992-7#1)(1995-5#1)(2010-10#2)
with lipid bilayers##7##3##(1990-5#1)(1992-6#1)(1993-3#1)(1997-4#1)(2005-11#1)(2008-10#2)
with lipid membrane##2##3##(2005-11#1)(2008-10#1)
with lipid membranes##3##3##(1993-5#1)(1994-12#1)(2010-5#1)
with lipid vesicles##3##3##(1990-11#1)(1995-10#1)(2006-10#1)
with lipid##34##2##(1990-11#1)(1990-2#3)(1990-3#1)(1990-5#1)(1992-6#1)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-12#1)(1995-10#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-4#1)(2005-11#2)(2006-10#2)(2006-5#1)(2008-10#5)(2008-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2011-2#1)
with lipid-lowering##2##2##(2009-6#1)(2011-1#1)
with lipids and##2##3##(1994-11#1)(1996-2#1)
with lipids in##2##3##(1990-3#1)(1993-3#1)
with lipids##11##2##(1990-2#2)(1990-3#1)(1993-3#1)(1994-11#1)(1994-8#1)(1996-2#3)(1997-2#1)(2008-10#1)
with lipocortin##2##2##(1991-2#2)
with lipofilling technique##4##3##(2013-1#4)
with lipophilic##5##2##(1995-3#1)(2008-10#4)
with lipopolysaccharide (LPS)##3##3##(1991-1#1)(1993-3#1)(1993-9#1)
with lipopolysaccharide##14##2##(1991-1#1)(1991-2#1)(1992-3#1)(1993-3#2)(1993-9#1)(1994-9#2)(1995-3#1)(1996-12#2)(2006-10#1)(2006-8#1)(2010-5#1)
with lipoprotein lipase##4##3##(1991-10#2)(1993-8#1)(1997-4#1)
with lipoprotein##5##2##(1991-10#2)(1993-8#1)(1994-9#1)(1997-4#1)
with lipoproteins##2##2##(1996-5#1)(2010-4#1)
with liposarcoma##2##2##(2007-2#1)(2008-6#1)
with liposomal amphotericin B and##2##5##(2005-9#1)(2008-5#1)
with liposomal amphotericin B##5##4##(2005-9#1)(2008-10#1)(2008-5#2)(2012-12#1)
with liposomal##7##2##(1990-2#1)(2005-9#1)(2008-10#1)(2008-5#2)(2010-3#1)(2012-12#1)
with liposome-encapsulated doxorubicin##2##3##(2007-8#2)
with liposomes containing##3##3##(1991-5#1)(1994-10#1)(1996-9#1)
with liposomes##9##2##(1991-5#1)(1992-6#1)(1994-10#1)(1994-9#1)(1996-2#1)(1996-9#2)(1997-5#1)(2008-10#1)
with liquid chromatography##4##3##(2008-10#4)
with liquid nitrogen##4##3##(2007-11#1)(2008-7#1)(2010-12#1)(2010-6#1)
with liquid##23##2##(1992-8#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-10#8)(2008-2#1)(2008-3#1)(2008-7#2)(2010-1#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)
with liquid-crystal SLM's##2##3##(2008-3#2)
with liquid-crystal##5##2##(2007-12#1)(2008-3#4)
with liquid-liquid extraction##3##3##(1990-12#1)(2008-10#2)
with listeriosis##2##2##(2006-10#1)(2010-12#1)
with literature data##7##3##(1990-5#1)(2005-10#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-7#1)
with literature review##11##3##(2007-10#3)(2007-11#1)(2007-3#1)(2007-4#1)(2008-12#1)(2010-11#2)(2013-1#2)
with literature values##8##3##(1996-7#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-7#1)(2009-4#2)
with literature##32##2##(1990-5#1)(1991-6#1)(1992-3#1)(1993-5#1)(1996-7#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-10#3)(2007-11#3)(2007-3#1)(2007-4#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2009-4#2)(2010-11#2)(2011-2#1)(2012-12#2)(2013-1#2)(2013-7#1)
with lithiasis##2##2##(2006-2#1)(2011-2#1)
with lithium for##2##3##(2004-11#1)(2009-8#1)
with lithium##15##2##(1990-5#1)(1994-5#1)(1995-11#2)(1996-12#1)(1996-5#1)(1996-9#1)(2004-11#1)(2007-11#2)(2008-10#1)(2008-2#2)(2009-8#1)(2009-9#1)
with little activity##2##3##(1992-3#1)(1994-8#1)
with little bias##2##3##(2008-10#1)(2009-7#1)
with little change in##2##4##(1996-11#1)(2007-11#1)
with little change##3##3##(1996-11#1)(1996-9#1)(2007-11#1)
with little computational##3##3##(2008-2#1)(2013-1#2)
with little effect on the##3##5##(1990-3#1)(2009-4#1)(2010-2#1)
with little effect on##6##4##(1990-3#1)(1992-8#1)(1995-3#1)(1997-6#1)(2009-4#1)(2010-2#1)
with little effect##7##3##(1990-3#1)(1992-8#1)(1993-3#1)(1995-3#1)(1997-6#1)(2009-4#1)(2010-2#1)
with little evidence of##2##4##(1994-4#1)(1995-12#1)
with little loss of##3##4##(2007-6#1)(2008-2#1)(2010-12#1)
with little loss##4##3##(1990-7#1)(2007-6#1)(2008-2#1)(2010-12#1)
with little or no experience in##2##6##(2008-11#1)(2012-3#1)
with little or no programming##3##5##(2008-4#2)(2012-3#1)
with little or no##23##4##(1990-2#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-7#1)(1994-3#1)(1995-2#1)(1995-9#1)(1996-8#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-4#4)(2008-5#1)(2009-6#1)(2010-4#1)(2010-6#1)(2012-3#2)(2013-1#1)
with little risk##2##3##(2007-6#1)(2008-2#1)
with little success##5##3##(1993-11#1)(2007-11#1)(2010-1#1)(2010-11#1)(2010-3#1)
with little to no##2##4##(2007-12#1)(2013-7#1)
with little##117##2##(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-3#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-4#1)(1994-8#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-9#1)(1996-11#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-6#1)(2005-4#1)(2006-10#3)(2006-12#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-6#2)(2007-7#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#2)(2008-4#6)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-1#2)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#2)(2010-6#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#1)
with live attenuated##3##3##(1995-5#1)(2007-11#1)(2008-4#1)
with live birth##2##3##(1994-2#1)(2011-2#1)
with live related##3##3##(2008-10#1)(2008-4#2)
with live##20##2##(1991-8#1)(1994-2#1)(1995-12#1)(1995-5#2)(2005-9#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#3)(2008-5#4)(2009-5#1)(2011-2#1)
with liver abscesses##2##3##(2004-7#1)(2007-2#1)
with liver biopsy##2##3##(1996-9#1)(2008-1#1)
with liver cirrhosis in##2##4##(1995-1#1)(2007-8#1)
with liver cirrhosis##32##3##(1990-11#2)(1990-8#1)(1991-10#1)(1991-2#1)(1992-12#1)(1992-2#1)(1995-1#1)(1995-4#3)(1995-7#1)(1996-4#2)(2005-9#2)(2006-6#1)(2006-8#1)(2007-8#3)(2008-1#2)(2008-10#1)(2010-12#2)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
with liver cirrhosis]##2##3##(1991-11#1)(2006-8#1)
with liver disease##15##3##(1990-8#1)(1996-1#4)(1996-5#1)(2006-10#1)(2007-12#1)(2008-1#1)(2009-4#1)(2010-2#1)(2010-5#1)(2013-1#2)(2013-8#1)
with liver diseases##5##3##(1995-4#1)(1996-4#1)(2007-7#1)(2008-10#1)(2008-4#1)
with liver failure##3##3##(1994-7#2)(2005-10#1)
with liver fibrosis##3##3##(1996-4#1)(2006-2#1)(2013-8#1)
with liver involvement##3##3##(2011-1#1)(2013-1#2)
with liver metastases and##2##4##(1991-4#1)(2010-12#1)
with liver metastases##7##3##(1991-4#1)(1995-4#1)(2006-6#2)(2007-11#1)(2008-3#1)(2010-12#1)
with liver metastasis##6##3##(2006-6#2)(2007-5#1)(2008-8#1)(2011-2#1)(2013-7#1)
with liver microsomes##4##3##(1990-12#2)(1995-6#1)(2011-3#1)
with liver##105##2##(1990-11#2)(1990-12#2)(1990-5#1)(1990-8#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-4#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-9#1)(1994-6#1)(1994-7#2)(1995-1#1)(1995-4#5)(1995-6#2)(1995-7#1)(1996-1#4)(1996-4#4)(1996-5#1)(1996-8#1)(1996-9#1)(1997-7#1)(2004-7#1)(2005-10#1)(2005-12#1)(2005-9#2)(2006-10#1)(2006-2#1)(2006-6#5)(2006-8#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#4)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-11#1)(2012-12#1)(2013-1#6)(2013-7#1)(2013-8#3)
with living cells##3##3##(1993-6#1)(2008-11#1)(2010-12#1)
with living##10##2##(1993-3#1)(1993-6#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2010-12#1)(2011-2#1)(2012-3#1)
with load##2##2##(1993-5#1)(2007-7#1)
with loaded##2##2##(2007-12#1)(2008-10#1)
with loading##2##2##(2005-11#1)(2009-12#1)
with lobular##2##2##(2006-10#1)(2007-5#1)
with local and national##3##4##(2004-9#1)(2008-4#1)(2008-9#1)
with local and##4##3##(2004-9#1)(2008-1#1)(2008-4#1)(2008-9#1)
with local anesthesia##4##3##(1993-1#1)(2007-12#1)(2008-8#1)(2013-1#1)
with local anesthetic##2##3##(2006-12#1)(2006-7#1)
with local anesthetics##2##3##(1996-12#1)(2005-8#1)
with local control##2##3##(1993-9#1)(2008-6#1)
with local recurrence and##2##4##(1991-8#1)(2008-6#1)
with local recurrence##4##3##(1991-8#1)(2008-6#2)(2012-1#1)
with local service##2##3##(1995-3#1)(2012-3#1)
with local##81##2##(1990-10#1)(1990-11#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-6#1)(1993-9#1)(1995-11#1)(1995-3#1)(1995-4#1)(1996-12#2)(1996-4#1)(2004-9#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#6)(2008-7#2)(2008-8#2)(2008-9#4)(2009-10#1)(2009-9#1)(2010-8#1)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#4)(2013-1#6)(2013-8#2)
with localised##3##2##(1997-4#1)(2012-12#2)
with localized scleroderma##3##3##(2011-2#3)
with localized##30##2##(1990-4#1)(1990-9#1)(1995-12#1)(1996-12#1)(1997-5#1)(2007-7#1)(2007-8#2)(2008-3#2)(2008-6#1)(2008-7#1)(2010-11#1)(2010-12#2)(2010-3#4)(2010-4#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2013-7#1)
with locally advanced breast##3##4##(1990-5#1)(1991-4#1)(2013-8#1)
with locally advanced stage##2##4##(2007-4#1)(2008-10#1)
with locally advanced##24##3##(1990-5#1)(1990-6#1)(1991-10#3)(1991-4#1)(1994-7#1)(1997-7#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-6#4)(2008-7#2)(2009-5#1)(2009-9#1)(2011-3#1)(2012-2#1)(2013-8#1)
with locally##30##2##(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#3)(1991-4#1)(1994-7#1)(1997-7#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-6#5)(2008-7#2)(2009-5#1)(2009-9#1)(2010-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
with located##2##2##(2007-12#1)(2011-2#1)
with location##3##2##(2007-5#1)(2008-10#1)(2008-12#1)
with loci##2##2##(1993-12#1)(1995-5#1)
with lock-in##2##2##(2007-11#1)(2008-2#1)
with locking plate osteosynthesis##2##4##(2009-3#2)
with locking##3##2##(2008-4#1)(2009-3#2)
with locomotor activity scores##2##4##(1996-10#2)
with locoregional##3##2##(1993-5#1)(2006-6#2)
with log beta(pqr) = -2##2##5##(2008-10#2)
with log##4##2##(1997-2#1)(2008-10#2)(2009-7#1)
with logarithmic##2##2##(2008-3#2)
with lomefloxacin##2##2##(2008-10#2)
with long alkyl##2##3##(2008-10#1)(2008-5#1)
with long exposure##2##3##(2006-2#1)(2006-6#1)
with long histories##2##3##(1991-8#1)(2013-8#1)
with long history of##4##4##(2007-11#1)(2008-10#1)(2008-6#1)(2008-7#1)
with long lasting##2##3##(2009-3#1)(2010-9#1)
with long standing##4##3##(2006-10#1)(2007-7#1)(2012-2#2)
with long term##6##3##(2007-11#2)(2007-12#1)(2008-10#1)(2012-2#2)
with long wavelength##2##3##(2007-8#1)(2008-10#1)
with long##55##2##(1990-4#2)(1990-8#1)(1991-8#1)(1991-9#1)(1992-1#1)(1993-10#1)(1993-2#1)(1994-2#1)(1994-7#1)(1995-6#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-11#7)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#1)(2010-9#1)(2012-12#1)(2012-2#5)(2013-1#1)(2013-8#2)
with long-acting agents##2##3##(2009-9#2)
with long-acting##3##2##(2008-3#1)(2009-9#2)
with long-bone fractures##2##3##(2013-1#2)
with long-chain##5##2##(1996-5#1)(2007-8#2)(2008-10#2)
with long-period fiber gratings##2##4##(2007-11#1)(2007-12#1)
with long-range##3##2##(1992-12#1)(1996-4#1)(2012-2#1)
with long-standing##14##2##(1993-6#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-9#2)(2007-10#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#2)(2010-1#1)(2013-1#1)
with long-term follow-up##9##3##(2008-10#2)(2008-9#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)
with long-term psychiatric backgrounds##2##4##(1993-1#2)
with long-term survival##6##3##(1992-8#1)(1997-8#2)(2007-3#1)(2008-7#1)(2009-2#1)
with long-term treatment##2##3##(1992-11#1)(2008-3#1)
with long-term use##3##3##(1997-2#1)(2005-10#1)(2008-2#1)
with long-term##53##2##(1990-4#1)(1992-11#1)(1992-8#1)(1993-1#3)(1993-2#1)(1993-3#1)(1995-11#1)(1996-8#2)(1997-2#1)(1997-8#2)(2005-10#1)(2006-10#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#2)(2010-5#1)(2010-8#2)(2011-2#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#2)
with longer duration##2##3##(2011-2#1)(2012-1#1)
with longer follow-up##5##3##(2011-2#4)(2012-12#1)
with longer pulses##2##3##(2007-12#1)(2008-1#1)
with longer##36##2##(1991-7#1)(1991-9#1)(1994-9#1)(1995-11#1)(1996-2#1)(1997-5#1)(2005-11#1)(2006-10#2)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-2#2)(2010-8#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
with longitudinal data##3##3##(2006-4#1)(2013-1#2)
with longitudinal##7##2##(1996-3#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2013-1#2)
with longstanding limited cutaneous scleroderma who##2##6##(2006-10#2)
with longstanding##8##2##(2005-8#1)(2006-1#1)(2006-10#3)(2008-12#1)(2012-3#1)(2012-4#1)
with lonidamine##3##2##(1992-4#3)
with loop##3##2##(1996-1#1)(2008-11#1)(2008-2#1)
with loose abrasives for##2##4##(2008-3#2)
with loose##4##2##(2008-3#2)(2008-5#1)(2009-3#1)
with losartan##4##2##(2011-1#1)(2011-2#3)
with loss in##2##3##(2009-2#1)(2009-3#1)
with loss of consciousness##2##4##(2006-12#1)(2012-12#1)
with loss of the normal##3##5##(1995-1#2)(2012-11#1)
with loss of the##7##4##(1995-1#2)(1997-3#1)(2005-10#1)(2008-10#1)(2012-11#1)(2012-3#1)
with loss of##33##3##(1993-3#1)(1995-1#4)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-4#2)(2008-7#1)(2008-8#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
with loss##41##2##(1992-5#1)(1993-3#1)(1995-1#4)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
with losses##5##2##(2007-11#3)(2007-12#1)(2008-7#1)
with lovastatin##5##2##(1991-7#2)(1992-11#2)(1994-3#1)
with low CD4/CD8 ratio##2##4##(1990-2#2)
with low HCV##2##3##(2006-2#1)(2008-1#1)
with low Na+##2##3##(1994-12#1)(1996-9#1)
with low activity##2##3##(1997-7#1)(2006-10#1)
with low affinity for##3##4##(1991-11#1)(2008-1#1)(2008-11#1)
with low affinity##6##3##(1990-5#1)(1991-11#1)(1995-10#1)(1996-10#1)(2008-1#1)(2008-11#1)
with low and high##3##4##(1997-7#1)(2008-10#1)(2012-3#1)
with low and##5##3##(1997-5#1)(1997-7#1)(2008-10#1)(2009-2#1)(2012-3#1)
with low antibody##3##3##(1994-3#1)(1994-9#1)(2007-11#1)
with low back pain##23##4##(1993-11#1)(2005-10#1)(2006-12#2)(2006-7#3)(2006-8#3)(2007-11#3)(2007-7#1)(2008-12#4)(2008-6#1)(2010-1#1)(2010-12#1)(2011-1#1)(2013-1#1)
with low back##26##3##(1993-11#1)(2005-10#1)(2006-12#2)(2006-7#4)(2006-8#3)(2007-11#3)(2007-7#2)(2008-12#4)(2008-6#1)(2010-1#1)(2010-12#2)(2011-1#1)(2013-1#1)
with low birth weight##2##4##(1996-11#1)(2012-3#1)
with low birth weights##2##4##(1993-5#1)(1994-6#1)
with low birth##4##3##(1993-5#1)(1994-6#1)(1996-11#1)(2012-3#1)
with low body##4##3##(2008-7#1)(2009-5#1)(2009-9#1)(2013-1#1)
with low bone mass##3##4##(2011-1#2)(2011-12#1)
with low bone mineral density##2##5##(2012-2#2)
with low bone##6##3##(2007-8#1)(2011-1#2)(2011-12#1)(2012-2#2)
with low complexity##2##3##(2007-5#1)(2008-2#1)
with low complication rates##2##4##(2011-2#2)
with low complications##3##3##(2007-11#1)(2007-8#1)(2012-3#1)
with low concentration of##2##4##(1997-1#1)(2008-9#1)
with low concentrations of the##2##5##(1991-5#1)(2008-5#1)
with low concentrations of##6##4##(1991-5#1)(1996-8#1)(2005-10#1)(2008-4#1)(2008-5#2)
with low concentrations##7##3##(1991-5#1)(1996-8#1)(2005-10#1)(2008-4#1)(2008-5#3)
with low contrast##2##3##(2008-2#1)(2008-3#1)
with low cost##4##3##(2008-10#1)(2009-1#1)(2010-12#1)(2012-3#1)
with low detection limits##4##4##(2007-8#1)(2008-10#3)
with low detection##5##3##(2005-4#1)(2007-8#1)(2008-10#3)
with low disease##3##3##(2008-10#3)
with low dose##2##3##(2008-7#1)(2010-4#1)
with low doses of##10##4##(1990-10#2)(1991-7#1)(1993-4#1)(1996-5#1)(2006-10#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-8#1)
with low doses##11##3##(1990-10#2)(1991-7#1)(1992-11#1)(1993-4#1)(1996-5#1)(2006-10#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-8#1)
with low education##2##3##(2013-1#2)
with low educational##2##3##(2006-2#1)(2013-1#1)
with low efficiency##2##3##(1993-11#1)(1995-2#1)
with low erythrocyte mean corpuscular volume##2##6##(1993-3#2)
with low fertility##2##3##(2010-8#2)
with low fluorescence##2##3##(2008-10#2)
with low frequency##5##3##(1990-11#1)(1991-6#1)(2008-3#1)(2008-4#1)(2009-2#1)
with low glucose degradation products##2##5##(2011-2#2)
with low grade##7##3##(1994-4#1)(2006-2#1)(2007-10#2)(2008-4#1)(2011-1#1)(2013-1#1)
with low heat##2##3##(2008-11#1)(2008-2#1)
with low incidence##2##3##(2007-5#1)(2007-8#1)
with low income##2##3##(2011-1#1)(2012-12#1)
with low initial##4##3##(1991-3#1)(2008-10#1)(2008-9#1)(2010-12#1)
with low level of##2##4##(1992-3#1)(2011-2#1)
with low level##3##3##(1992-3#1)(2008-10#1)(2011-2#1)
with low levels of##18##4##(1994-12#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-3#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-1#1)(2010-12#2)(2012-2#1)
with low levels##19##3##(1992-11#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-3#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-1#1)(2010-12#2)(2012-2#1)
with low long-term survival##2##4##(2010-6#1)(2012-1#1)
with low loss##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
with low mechanical##2##3##(1993-8#1)(2008-8#1)
with low melting##2##3##(1996-2#1)(2009-11#1)
with low molecular weight heparin for##2##6##(1996-6#1)(2008-8#1)
with low molecular weight heparin##3##5##(1996-6#1)(2008-8#1)(2011-12#1)
with low molecular weight##4##4##(1991-3#1)(1996-6#1)(2008-8#1)(2011-12#1)
with low molecular##5##3##(1991-3#1)(1996-6#1)(2008-2#1)(2008-8#1)(2011-12#1)
with low morbidity and mortality##2##5##(2007-8#1)(2008-6#1)
with low morbidity and##4##4##(1993-8#1)(2004-1#1)(2007-8#1)(2008-6#1)
with low morbidity##7##3##(1993-8#1)(1995-1#1)(2004-1#1)(2007-8#1)(2008-6#1)(2008-7#1)(2013-1#1)
with low mortality and morbidity##2##5##(2007-8#2)
with low or##3##3##(1991-12#1)(2007-2#1)(2008-5#1)
with low performance status##2##4##(1993-12#1)(1994-8#1)
with low plasma levels of##2##5##(1995-4#1)(2007-11#1)
with low plasma##3##3##(1995-4#1)(1997-3#1)(2007-11#1)
with low potency##3##3##(1993-11#2)(1997-2#1)
with low power##4##3##(2008-10#1)(2008-2#1)(2009-4#1)(2009-7#1)
with low rates of##3##4##(1995-2#1)(2007-7#1)(2012-12#1)
with low rates##4##3##(1992-10#1)(1995-2#1)(2007-7#1)(2012-12#1)
with low risk##6##3##(2006-10#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-11#1)(2011-2#1)
with low sample##4##3##(2008-10#3)(2011-1#1)
with low serum##2##3##(2008-1#1)(2008-7#1)
with low similarity##3##3##(2005-11#1)(2008-9#2)
with low symptoms##2##3##(2007-8#2)
with low toxicity##2##3##(2006-6#1)(2011-2#1)
with low virulence##2##3##(2008-10#2)
with low vision##4##3##(2010-8#3)(2012-12#1)
with low water##2##3##(1990-4#1)(2008-10#1)
with low##442##2##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#3)(1990-4#1)(1990-5#3)(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-11#3)(1992-3#1)(1992-8#4)(1992-9#1)(1993-1#1)(1993-11#5)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-8#4)(1994-11#1)(1994-12#3)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-4#1)(1995-5#1)(1995-7#1)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#2)(1996-8#2)(1996-9#2)(1997-1#4)(1997-2#2)(1997-3#2)(1997-5#3)(1997-7#2)(1997-8#2)(2004-1#1)(2004-9#1)(2005-10#3)(2005-11#1)(2005-12#3)(2005-3#1)(2005-4#1)(2006-1#1)(2006-10#4)(2006-12#3)(2006-2#3)(2006-6#4)(2006-7#7)(2006-8#4)(2007-10#2)(2007-11#12)(2007-12#11)(2007-2#2)(2007-3#2)(2007-5#2)(2007-7#4)(2007-8#13)(2007-9#1)(2008-1#5)(2008-10#49)(2008-11#6)(2008-12#4)(2008-2#8)(2008-3#13)(2008-4#7)(2008-5#7)(2008-6#3)(2008-7#9)(2008-8#5)(2008-9#8)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#5)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#4)(2010-12#9)(2010-4#3)(2010-6#2)(2010-8#7)(2010-9#1)(2011-1#12)(2011-12#4)(2011-2#14)(2011-3#2)(2012-1#5)(2012-12#5)(2012-2#7)(2012-3#5)(2012-6#2)(2013-1#14)(2013-7#2)(2013-8#5)
with low-coherence##2##2##(2007-11#1)(2008-3#1)
with low-dose alpha-2b interferon##2##4##(1990-6#2)
with low-dose interleukin-2##2##3##(1992-12#1)(1993-12#1)
with low-dose methotrexate##2##3##(2012-12#1)(2012-2#1)
with low-dose phentolamine##2##3##(2007-7#2)
with low-dose subcutaneous interleukin-2 plus##2##5##(1993-10#1)(1994-12#1)
with low-dose##25##2##(1990-6#2)(1992-12#2)(1993-10#1)(1993-12#1)(1994-12#1)(1995-2#1)(1996-9#4)(2006-10#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#1)(2009-9#1)(2011-2#3)(2012-12#1)(2012-2#2)
with low-grade##12##2##(1990-12#1)(1993-6#1)(1997-1#2)(1997-7#1)(2006-12#3)(2007-10#1)(2007-8#1)(2009-7#1)(2011-2#1)
with low-income##3##2##(2007-2#1)(2008-11#1)(2010-2#1)
with low-level##2##2##(1996-12#1)(2006-10#1)
with low-molecular-weight##3##2##(2005-11#1)(2006-10#1)(2007-1#1)
with low-power##3##2##(2007-12#2)(2008-3#1)
with low-risk##5##2##(2010-7#1)(2011-2#3)(2013-1#1)
with lower abdominal pain##2##4##(1993-9#1)(2007-12#1)
with lower abdominal##3##3##(1993-9#1)(2007-12#1)(2011-2#1)
with lower affinity than##3##4##(1994-8#1)(1995-6#1)(1996-12#1)
with lower affinity##8##3##(1990-3#1)(1990-4#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-12#1)(1997-7#1)
with lower area##2##3##(2008-10#1)(2010-4#1)
with lower body mass##2##4##(2007-12#1)(2013-1#1)
with lower concentrations##2##3##(2008-10#2)
with lower cost##2##3##(1996-12#1)(2006-6#1)
with lower detection limit of##2##5##(2008-10#2)
with lower doses##2##3##(2007-2#1)(2007-7#1)
with lower education##2##3##(1991-11#1)(2006-10#1)
with lower extremity##3##3##(2007-11#1)(2007-8#1)(2008-8#1)
with lower intensity of##2##4##(2008-7#1)(2012-12#1)
with lower intensity##3##3##(2007-9#1)(2008-7#1)(2012-12#1)
with lower levels of##12##4##(1995-3#1)(1996-5#1)(2008-12#1)(2008-9#1)(2009-12#1)(2009-5#2)(2009-7#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-2#1)
with lower levels##15##3##(1994-2#1)(1995-12#1)(1995-3#1)(1996-5#1)(2006-12#1)(2008-12#1)(2008-9#1)(2009-12#1)(2009-5#2)(2009-7#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-2#1)
with lower limits of##2##4##(2008-10#2)
with lower moral judgment competence##2##5##(2008-11#2)
with lower motor neuron##2##4##(2006-8#1)(2012-2#1)
with lower odds of##2##4##(2010-7#1)(2012-3#1)
with lower resistance##3##3##(2012-3#2)(2013-8#1)
with lower respiratory tract infections##2##5##(2009-2#1)(2009-3#1)
with lower risk for graft failure##2##6##(2007-8#2)
with lower risk of##3##4##(2008-10#1)(2009-3#1)(2013-1#1)
with lower risk##5##3##(2007-8#2)(2008-10#1)(2009-3#1)(2013-1#1)
with lower total##2##3##(2008-10#1)(2008-7#1)
with lower##178##2##(1990-3#3)(1990-4#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-10#3)(2005-11#1)(2005-3#2)(2006-10#1)(2006-12#2)(2006-5#2)(2006-6#1)(2006-7#3)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-10#15)(2008-11#4)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#3)(2009-7#2)(2009-9#4)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#3)(2011-2#8)(2011-3#1)(2012-1#4)(2012-12#4)(2012-2#5)(2012-3#6)(2013-1#9)(2013-8#2)
with lower-limb##2##2##(2007-7#1)(2011-2#1)
with lowered##2##2##(1992-9#1)(2008-5#1)
with lowest##7##2##(1991-10#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-9#1)(2012-5#1)
with lumbar lateral recess syndrome##2##5##(2011-2#2)
with lumbar pain##2##3##(2006-12#1)(2006-3#1)
with lumbar spinal##2##3##(2012-12#1)(2012-2#1)
with lumbar##17##2##(1992-5#1)(1993-1#1)(2005-2#1)(2006-12#1)(2006-3#2)(2006-7#1)(2006-8#1)(2008-12#1)(2011-2#2)(2012-12#4)(2012-2#1)(2013-1#1)
with lumbosacral##3##2##(2008-7#2)(2012-3#1)
with luminal##2##2##(1993-6#1)(2008-4#1)
with luminescence##4##2##(2008-10#2)(2008-2#1)(2011-1#1)
with luminol##4##2##(1995-3#1)(2008-10#3)
with lung cancer and other##2##5##(2008-7#1)(2009-7#1)
with lung cancer and##3##4##(2007-2#1)(2008-7#1)(2009-7#1)
with lung cancer with##2##4##(2009-11#1)(2011-2#1)
with lung cancer##26##3##(1990-10#4)(1990-12#1)(1990-4#1)(1991-12#1)(1991-2#1)(1991-8#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2008-7#2)(2009-10#1)(2009-11#1)(2009-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2013-1#1)(2013-7#1)
with lung disease##3##3##(1996-2#2)(2008-10#1)
with lung metastases##3##3##(2007-11#1)(2008-6#2)
with lung transplantation##2##3##(2006-10#1)(2007-8#1)
with lung##55##2##(1990-10#4)(1990-12#1)(1990-4#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-2#1)(1992-9#1)(1996-2#2)(1996-9#1)(1997-4#1)(2005-11#1)(2005-12#2)(2006-10#2)(2007-11#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-6#2)(2008-7#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-7#2)(2010-3#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)
with lupus nephritis and##2##4##(2006-10#2)
with lupus nephritis##7##3##(2006-10#4)(2007-7#1)(2008-1#1)(2011-1#1)
with lupus##11##2##(2006-10#5)(2007-7#1)(2008-1#1)(2010-6#1)(2011-1#1)(2013-1#2)
with lymph node dissection##2##4##(2010-8#1)(2013-8#1)
with lymph node metastases##3##4##(2008-9#1)(2010-7#1)(2013-8#1)
with lymph node metastasis##3##4##(2006-10#1)(2013-1#2)
with lymph node##13##3##(1990-10#1)(1991-6#1)(1996-6#1)(2006-10#1)(2006-8#1)(2008-9#1)(2010-7#1)(2010-8#1)(2013-1#2)(2013-8#3)
with lymph##14##2##(1990-10#1)(1991-6#1)(1996-6#1)(2006-10#1)(2006-8#1)(2008-9#1)(2009-2#1)(2010-7#1)(2010-8#1)(2013-1#2)(2013-8#3)
with lymph-node##2##2##(1991-7#1)(2006-6#1)
with lymphadenectomy##4##2##(1992-9#1)(1993-3#1)(2007-6#1)(2011-2#1)
with lymphadenopathy##2##2##(2007-11#1)(2011-1#1)
with lymphatic##3##2##(2008-6#1)(2008-7#1)(2010-8#1)
with lymphedema of##3##3##(1996-12#1)(2010-2#2)
with lymphedema##4##2##(1996-12#1)(2010-2#2)(2011-1#1)
with lymphnode metastasis##2##3##(2008-6#1)(2010-11#1)
with lymphocytic infiltrates##2##3##(2011-2#2)
with lymphocytic##5##2##(2008-4#1)(2010-12#2)(2011-2#2)
with lymphoma##14##2##(1991-3#1)(1997-8#1)(2005-10#1)(2006-12#1)(2007-11#1)(2008-4#1)(2008-5#2)(2009-2#1)(2011-2#5)
with lysine##5##2##(1992-9#1)(1993-8#1)(1994-10#1)(1995-2#1)(2008-4#1)
with lysosomal##2##2##(1990-11#1)(2010-2#1)
with lysozyme##2##2##(1992-8#1)(2006-8#1)
with m##2##2##(2005-11#1)(2008-10#1)
with m-chloroperbenzoic acid##2##3##(1994-6#1)(1996-5#1)
with m/z =##2##3##(1996-5#2)
with mAb##3##2##(1991-2#1)(1997-4#1)(2008-8#1)
with mEGF or insulin##2##4##(1990-11#2)
with mRNA expression##2##3##(2008-10#1)(2012-1#1)
with mRNA from##2##3##(1991-10#1)(1994-8#1)
with mRNA##10##2##(1991-10#1)(1994-11#1)(1994-8#2)(1995-2#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-11#1)(2012-1#1)
with machine learning##3##3##(2012-3#1)(2013-1#2)
with machines##2##2##(2008-1#1)(2009-10#1)
with macrocephaly##2##2##(2012-12#2)
with macrocyclic##2##2##(2008-10#2)
with macrophage##3##2##(1995-3#1)(2011-1#1)(2012-2#1)
with macrophages##7##2##(1991-9#1)(1995-3#1)(1997-4#1)(2008-4#1)(2010-12#1)(2011-1#1)(2013-8#1)
with macroscopic hematuria##2##3##(2007-10#1)(2008-1#1)
with macroscopic##8##2##(1993-1#1)(1993-10#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2012-11#1)
with macular edema##3##3##(2007-3#2)(2009-8#1)
with macular##5##2##(2007-3#2)(2008-12#1)(2009-8#1)(2011-2#1)
with magnesium##12##2##(1990-7#1)(1991-12#1)(1991-3#1)(1991-5#1)(1996-6#1)(2005-1#1)(2007-8#1)(2008-2#1)(2008-5#1)(2010-4#1)(2010-8#2)
with magnetic flux##2##3##(2008-7#1)(2010-7#1)
with magnetic resonance imaging (MRI)##2##5##(2010-9#1)(2012-2#1)
with magnetic resonance imaging##10##4##(1991-8#1)(1992-3#1)(1995-12#1)(2007-11#1)(2008-2#1)(2010-4#1)(2010-9#1)(2012-11#1)(2012-2#1)(2013-1#1)
with magnetic resonance##13##3##(1991-8#1)(1992-3#1)(1995-12#1)(2006-10#1)(2007-11#1)(2008-2#1)(2008-4#1)(2009-1#1)(2010-4#1)(2010-9#1)(2012-11#1)(2012-2#1)(2013-1#1)
with magnetic##24##2##(1991-8#1)(1992-3#1)(1992-8#1)(1994-2#1)(1995-12#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-1#1)(2009-11#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-9#1)(2012-11#1)(2012-2#1)(2013-1#1)
with magnification of##2##3##(2005-11#1)(2008-2#1)
with magnification##3##2##(2005-11#1)(2008-2#1)(2011-1#1)
with magnitudes##3##2##(2007-5#2)(2008-1#1)
with main##9##2##(1991-9#1)(1994-8#1)(2005-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-1#1)(2010-12#1)(2012-2#1)
with mainly##3##2##(1995-5#1)(1997-8#1)(2011-1#1)
with maintained##2##2##(2007-8#1)(2012-2#1)
with maintenance of##3##3##(1994-3#1)(1994-7#1)(2010-12#1)
with maintenance##6##2##(1994-3#1)(1994-7#1)(2007-11#1)(2007-7#1)(2010-12#1)(2011-2#1)
with maize##4##2##(2008-10#3)(2012-2#1)
with major changes in##2##4##(1993-11#1)(2009-10#1)
with major changes##3##3##(1990-7#1)(1993-11#1)(2009-10#1)
with major depression##10##3##(1995-11#1)(1996-2#2)(1996-7#1)(2004-3#1)(2008-6#1)(2009-8#2)(2010-7#1)(2011-1#1)
with major depressive disorder##7##4##(1996-7#2)(2010-7#1)(2011-2#1)(2013-1#1)(2013-7#2)
with major depressive##10##3##(1996-7#2)(1997-5#1)(2005-9#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
with major emphasis on##2##4##(1990-11#1)(1991-6#1)
with major histocompatibility complex (MHC)##2##5##(1992-5#1)(1995-2#1)
with major histocompatibility complex##3##4##(1992-5#1)(1995-2#1)(2007-7#1)
with major##69##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-5#1)(1993-11#1)(1993-9#1)(1995-11#1)(1995-2#3)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-7#3)(1997-5#1)(2004-3#1)(2005-7#1)(2005-9#1)(2006-10#3)(2006-2#1)(2007-3#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#4)(2008-12#1)(2008-3#2)(2008-6#1)(2008-8#2)(2009-1#1)(2009-10#1)(2009-8#2)(2010-7#2)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#1)
with majority##3##2##(2007-6#1)(2010-5#1)(2012-2#1)
with making##2##2##(1995-2#1)(2007-7#1)
with malaria##13##2##(1993-7#1)(2005-8#3)(2007-2#3)(2008-1#1)(2008-2#1)(2008-4#1)(2012-12#3)
with male and female##2##4##(1993-5#1)(2006-5#1)
with male gender##3##3##(2008-4#1)(2012-2#1)(2013-1#1)
with male predominance##2##3##(2008-1#1)(2011-1#1)
with male##24##2##(1993-12#1)(1993-5#1)(1995-1#1)(1995-5#1)(1996-5#1)(2006-5#1)(2008-1#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
with maleic anhydride##3##3##(1996-5#1)(2007-11#2)
with maleimide##2##2##(1994-11#1)(2008-6#1)
with males##10##2##(1994-6#1)(1995-6#1)(2005-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-8#1)(2010-3#1)(2012-11#1)(2012-12#1)
with malformations##2##2##(1992-11#1)(1993-12#1)
with malignancies and##3##3##(2006-10#1)(2007-4#1)(2011-2#1)
with malignancies##10##2##(1992-12#1)(2006-10#1)(2006-8#1)(2007-3#1)(2007-4#1)(2008-5#1)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
with malignancy##12##2##(1991-12#1)(1991-8#1)(2005-12#2)(2005-3#1)(2007-5#1)(2008-7#1)(2009-12#1)(2011-2#1)(2012-1#1)(2013-8#2)
with malignant ascites##3##3##(1995-7#1)(2008-6#2)
with malignant disease##4##3##(1990-6#1)(2004-10#2)(2012-2#1)
with malignant diseases##2##3##(1990-11#1)(1990-2#1)
with malignant melanoma##10##3##(1990-6#1)(1991-5#1)(1993-8#1)(1996-11#1)(2006-12#1)(2007-5#1)(2011-2#2)(2012-12#1)(2012-2#1)
with malignant peripheral nerve sheath tumour developing in a patient with##2##11##(2008-6#2)
with malignant transformation##2##3##(1991-10#1)(2007-7#1)
with malignant tumors##6##3##(1993-8#1)(1994-12#1)(2007-11#1)(2008-3#2)(2013-8#1)
with malignant##71##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#2)(1990-8#1)(1991-10#1)(1991-5#1)(1992-12#1)(1992-9#1)(1993-8#2)(1993-9#1)(1994-12#2)(1994-3#1)(1995-7#1)(1995-9#1)(1996-11#1)(1997-2#1)(2004-10#2)(2005-12#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#2)(2008-6#7)(2008-7#3)(2008-8#2)(2009-1#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-5#2)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-7#2)(2013-8#3)
with malnutrition##6##2##(2007-7#2)(2008-2#1)(2010-12#2)(2012-12#1)
with malondialdehyde##2##2##(1990-4#1)(2008-10#1)
with maltose binding protein##3##4##(1992-11#1)(1997-4#1)(1997-6#1)
with mammalian cells##5##3##(1996-4#1)(2008-5#1)(2008-9#3)
with mammalian##20##2##(1990-5#1)(1991-1#1)(1991-10#2)(1991-6#1)(1991-7#1)(1993-9#1)(1994-9#2)(1995-12#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#1)(2008-11#1)(2008-5#1)(2008-9#4)
with mammals##4##2##(2008-10#1)(2008-5#1)(2008-8#2)
with mammary##3##2##(1996-3#1)(2007-6#1)(2007-8#1)
with mammography and##2##3##(1990-12#1)(2006-10#1)
with mammography##4##2##(1990-12#1)(1997-8#1)(2006-10#1)(2006-7#1)
with manageable toxicities##2##3##(2008-10#1)(2008-3#1)
with manageable##4##2##(2008-10#1)(2008-3#2)(2009-8#1)
with managed care organizations##3##4##(1997-1#1)(1997-3#1)(2007-1#1)
with managed care plans##3##4##(1994-2#1)(1995-12#2)
with managed care##15##3##(1994-1#1)(1994-12#1)(1994-2#1)(1995-12#2)(1996-2#3)(1996-3#2)(1997-1#1)(1997-3#1)(2006-10#1)(2007-1#1)(2007-2#1)
with managed##16##2##(1994-1#1)(1994-12#1)(1994-2#1)(1995-12#2)(1996-1#1)(1996-2#3)(1996-3#2)(1997-1#1)(1997-3#1)(2006-10#1)(2007-1#1)(2007-2#1)
with management##6##2##(1993-1#1)(1993-2#1)(1995-3#1)(2008-3#1)(2008-6#1)(2011-2#1)
with managing##2##2##(2009-5#1)(2010-5#1)
with mandibular##2##2##(2012-2#1)(2013-1#1)
with manganese dioxide##2##3##(2008-10#1)(2009-3#1)
with manganese##5##2##(2007-12#1)(2008-10#2)(2008-3#1)(2009-3#1)
with manifest##3##2##(2005-7#1)(2009-10#1)(2012-2#1)
with manifestations in the##2##4##(1992-8#1)(2011-2#1)
with manifestations in##3##3##(1992-8#1)(1995-11#1)(2011-2#1)
with manifestations of##4##3##(1996-3#1)(2006-2#1)(2008-4#1)(2009-7#1)
with manifestations##8##2##(1992-8#1)(1995-11#1)(1996-3#1)(2006-2#1)(2008-4#1)(2009-7#1)(2011-2#1)(2013-7#1)
with manipulation##4##2##(1992-9#1)(1997-5#1)(2007-11#1)(2008-12#1)
with mantle cell lymphoma##2##4##(2009-7#1)(2010-12#1)
with manual##8##2##(1995-2#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-3#1)(2012-2#2)(2013-1#1)
with many advantages##2##3##(1994-3#1)(2012-12#1)
with many aspects of##2##4##(2009-11#1)(2010-5#1)
with many common##2##3##(2008-10#1)(2012-12#1)
with many conditions##2##3##(1995-2#1)(2005-8#1)
with many different##2##3##(1992-12#1)(2006-3#1)
with many more##2##3##(1994-2#1)(2008-7#1)
with many of the##7##4##(1996-1#1)(2007-10#1)(2008-10#3)(2008-5#2)
with many of##8##3##(1996-1#1)(2007-10#1)(2008-10#3)(2008-5#2)(2010-2#1)
with many other##11##3##(2005-8#1)(2006-10#1)(2007-4#1)(2008-10#2)(2008-11#1)(2009-10#1)(2010-5#1)(2010-8#1)(2012-3#1)(2013-1#1)
with many possible etiologies##2##4##(2006-8#2)
with many possible##3##3##(1996-6#1)(2006-8#2)
with many potential applications in##2##5##(2006-12#1)(2008-10#1)
with many potential##4##3##(1995-9#1)(2004-9#1)(2006-12#1)(2008-10#1)
with many problems##2##3##(2008-1#1)(2008-2#1)
with many types of##2##4##(1995-12#1)(2008-7#1)
with many##134##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-12#1)(1993-1#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-4#1)(1996-6#2)(1996-7#1)(1996-9#2)(1997-4#1)(1997-6#1)(2004-9#1)(2005-8#4)(2006-10#8)(2006-12#3)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#3)(2007-10#2)(2007-12#4)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#2)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-2#1)(2010-5#3)(2010-8#4)(2011-12#1)(2011-2#2)(2011-3#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
with marginal##3##2##(1996-9#1)(2011-12#1)(2012-12#1)
with marital##3##2##(2007-10#1)(2008-12#1)(2008-2#1)
with marked elevation##2##3##(2006-10#1)(2012-3#1)
with marked##48##2##(1991-12#1)(1991-5#2)(1991-7#1)(1992-4#1)(1992-8#2)(1993-11#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-7#2)(1996-2#1)(1996-3#1)(1996-5#1)(2005-12#1)(2006-10#1)(2007-10#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-7#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#1)
with markedly elevated##2##3##(1993-9#1)(1995-4#1)
with markedly##7##2##(1990-2#1)(1993-7#1)(1993-9#1)(1995-4#1)(1997-4#1)(2006-4#1)(2007-11#1)
with markers for##3##3##(1991-8#1)(1995-6#1)(1997-4#1)
with markers of##5##3##(1990-3#1)(1996-9#1)(2009-4#1)(2012-1#1)(2012-12#1)
with markers##10##2##(1990-3#1)(1991-8#1)(1995-6#1)(1996-9#1)(1997-4#1)(1997-5#1)(2007-5#1)(2009-4#1)(2012-1#1)(2012-12#1)
with marketed##2##2##(2010-5#1)(2012-2#1)
with marketing##3##2##(1992-3#1)(1993-12#1)(1995-1#1)
with marrow##2##2##(2009-8#1)(2011-2#1)
with mass spectrometric detection##5##4##(2008-10#4)(2008-4#1)
with mass spectrometric##6##3##(2008-10#5)(2008-4#1)
with mass spectrometry (LC-MS)##2##4##(2008-10#1)(2010-4#1)
with mass spectrometry to##2##4##(2008-4#1)(2008-7#1)
with mass spectrometry##18##3##(1993-11#1)(1997-4#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-2#1)
with mass##35##2##(1993-11#1)(1996-6#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-8#2)(2008-1#2)(2008-10#10)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2012-2#1)
with massive gastrointestinal##2##3##(2010-5#1)(2011-12#1)
with massive##27##2##(1991-4#1)(1991-6#2)(1993-10#1)(1993-12#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-5#1)(2007-7#2)(2007-9#3)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-7#1)(2010-2#2)(2010-5#1)(2010-7#1)(2011-12#1)(2011-2#1)(2013-8#2)
with mastitis##2##2##(2012-1#2)
with matched##7##2##(1992-8#1)(2005-10#1)(2006-10#1)(2008-7#1)(2010-12#2)(2012-5#1)
with matching##4##2##(1993-4#1)(2008-10#1)(2010-10#1)(2012-12#1)
with material##3##2##(2007-11#1)(2008-7#1)(2011-1#1)
with materials##3##2##(2008-2#1)(2008-3#1)(2009-4#1)
with maternal age##3##3##(1996-7#1)(2004-10#1)(2008-1#1)
with maternal##27##2##(1990-10#1)(1992-1#1)(1994-6#1)(1995-1#2)(1995-8#1)(1996-12#1)(1996-7#1)(2004-10#1)(2004-11#1)(2006-10#2)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)
with maternally derived##2##3##(1997-3#2)
with mathematical##2##2##(2008-3#1)(2013-8#1)
with mating##5##2##(1993-6#1)(1997-6#1)(2007-12#1)(2008-8#1)(2008-9#1)
with matrix##5##2##(2005-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-2#1)
with maturation##2##2##(1996-5#1)(2007-12#1)
with mature##8##2##(1991-2#1)(1992-7#1)(2005-10#1)(2008-10#2)(2008-5#2)(2010-10#1)
with maxillary##2##2##(2007-10#1)(2007-7#1)
with maxima##4##2##(1993-11#1)(1996-3#1)(1996-5#1)(2011-2#1)
with maximal binding##3##3##(1991-12#2)(1993-7#1)
with maximal levels##2##3##(1995-11#1)(2007-8#1)
with maximal##27##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#2)(1991-9#1)(1993-7#1)(1994-8#1)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-5#1)(2006-6#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-8#1)(2012-12#1)
with maximizing##3##2##(1991-11#1)(2008-9#2)
with maximum absolute temperature##2##4##(2008-8#2)
with maximum adsorption capacity##2##4##(2008-10#2)
with maximum levels##3##3##(1996-12#1)(1996-9#1)(2008-5#1)
with maximum likelihood##4##3##(2012-1#2)(2012-3#2)
with maximum striga##3##3##(2008-10#3)
with maximum values##2##3##(1992-11#1)(2007-12#1)
with maximum##46##2##(1992-11#1)(1994-11#1)(1994-12#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#1)(2005-11#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-1#1)(2008-10#12)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2010-11#1)(2010-7#1)(2012-1#2)(2012-2#1)(2012-3#2)
with me##2##2##(2008-6#2)
with meal format interviews##2##4##(2006-5#2)
with meal##3##2##(1997-1#1)(2006-5#2)
with mean BMI##2##3##(2006-9#1)(2008-1#1)
with mean Ks/fp values (calculated from quantum yields) of##2##9##(1990-4#2)
with mean age of 32##2##5##(2007-6#1)(2011-2#1)
with mean age of##14##4##(2007-6#2)(2008-1#1)(2008-12#1)(2008-4#1)(2009-8#2)(2011-2#2)(2012-2#2)(2013-1#3)
with mean age##17##3##(1991-7#1)(2007-6#2)(2007-7#1)(2008-1#1)(2008-12#1)(2008-4#1)(2009-8#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#3)
with mean body##2##3##(2008-1#1)(2008-5#1)
with mean value of##2##4##(1991-12#1)(2008-8#1)
with mean values of##2##4##(1995-2#1)(2008-7#1)
with mean##69##2##(1990-3#1)(1990-4#2)(1991-12#1)(1991-7#1)(1992-6#1)(1992-7#1)(1993-12#1)(1995-2#1)(1995-6#1)(1996-6#1)(1997-5#1)(1997-6#2)(2006-9#2)(2007-6#2)(2007-7#2)(2008-1#5)(2008-10#12)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#2)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-12#1)(2012-2#5)(2013-1#4)
with meaningful##2##2##(1997-2#1)(2008-3#1)
with measurable##4##2##(1990-12#1)(2007-11#1)(2008-6#1)(2013-8#1)
with measured data##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2011-1#1)
with measured##15##2##(2006-10#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#7)(2011-1#1)
with measurement error##3##3##(1997-4#1)(2012-1#2)
with measurement of the##2##4##(1992-9#1)(1993-11#1)
with measurement of##8##3##(1992-9#1)(1993-11#1)(1994-5#1)(2006-5#1)(2007-7#1)(2008-9#2)(2010-7#1)
with measurement##14##2##(1992-9#1)(1993-11#1)(1994-5#1)(1997-4#1)(2006-5#1)(2007-7#1)(2008-2#1)(2008-9#2)(2010-7#1)(2012-1#3)(2013-7#1)
with measurements from##3##3##(2008-10#1)(2008-3#1)(2009-7#1)
with measurements of##13##3##(1991-3#1)(1993-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2010-4#1)
with measurements on##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
with measurements##30##2##(1991-3#1)(1992-9#1)(1993-11#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#6)(2008-3#6)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-4#1)(2012-2#1)
with measures of body##2##4##(2007-12#1)(2008-7#1)
with measures of##12##3##(2004-3#1)(2006-3#1)(2006-9#1)(2007-12#1)(2007-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2012-12#1)(2013-1#3)
with measures##16##2##(1995-1#1)(1996-1#1)(2004-3#1)(2006-3#1)(2006-9#1)(2007-12#1)(2007-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2011-1#1)(2012-12#1)(2013-1#3)
with measuring##3##2##(1994-3#1)(2007-4#1)(2008-9#1)
with meat##2##2##(1993-2#1)(2013-1#1)
with mechanical circulatory support##2##4##(2010-8#1)(2011-2#1)
with mechanical jaundice of nonneoplastic##2##5##(2011-1#2)
with mechanical jaundice##3##3##(2011-1#3)
with mechanical neck pain##3##4##(2008-12#3)
with mechanical ventilation##5##3##(1995-5#1)(2005-8#1)(2006-4#1)(2012-2#2)
with mechanical##27##2##(1990-3#1)(1995-11#1)(1995-5#1)(1996-9#1)(2005-8#1)(2006-4#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#3)(2008-2#1)(2008-5#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
with mechanisms of##2##3##(2006-5#1)(2006-7#1)
with media##3##2##(2007-12#1)(2008-7#1)(2011-7#1)
with medial temporal lobe##3##4##(1992-11#1)(1995-7#2)
with medial temporal##5##3##(1992-11#1)(1995-7#2)(2004-11#2)
with medial##9##2##(1992-11#1)(1992-8#1)(1995-7#2)(2004-11#2)(2008-6#1)(2008-7#1)(2009-3#1)
with median follow-up of##3##4##(2008-6#1)(2011-2#1)(2013-1#1)
with median survival##2##3##(2008-10#1)(2012-1#1)
with median##10##2##(1997-8#1)(2008-10#3)(2008-3#1)(2008-6#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
with mediastinal##7##2##(1996-6#1)(2007-8#1)(2008-10#1)(2008-7#2)(2009-8#1)(2012-2#1)
with medical care##5##3##(1996-2#2)(1996-3#2)(2008-8#1)
with medical catatonias##3##3##(2008-1#3)
with medical management##2##3##(1993-7#1)(2006-9#1)
with medical practitioners##2##3##(2009-4#1)(2010-12#1)
with medical procedures##3##3##(2008-11#1)(2009-9#1)(2010-4#1)
with medical students##3##3##(2010-4#1)(2013-1#2)
with medical therapy alone##2##4##(2007-9#1)(2008-7#1)
with medical therapy##9##3##(1990-11#1)(1992-10#1)(2004-3#1)(2007-9#1)(2008-7#1)(2009-12#1)(2012-1#1)(2013-1#2)
with medical treatment##7##3##(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)
with medical##65##2##(1990-11#1)(1992-10#2)(1992-3#1)(1993-7#1)(1994-12#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-3#2)(2004-3#1)(2005-11#1)(2006-9#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-4#1)(2009-6#1)(2009-9#3)(2010-12#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#15)
with medically refractory##2##3##(1997-3#1)(2008-6#1)
with medically##7##2##(1990-3#1)(1992-2#2)(1997-3#1)(2006-8#1)(2008-6#1)(2012-2#1)
with medication##9##2##(2004-3#1)(2005-7#1)(2005-9#1)(2008-1#1)(2008-3#1)(2010-11#1)(2011-1#2)(2013-8#1)
with medications##5##2##(1993-9#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-1#1)
with medicinal##3##2##(2007-1#1)(2007-7#1)(2009-10#1)
with medicines and##2##3##(2008-7#1)(2011-1#1)
with medicines##3##2##(1996-3#1)(2008-7#1)(2011-1#1)
with medium and##3##3##(1991-1#1)(2008-11#1)(2013-8#1)
with medium containing##2##3##(1990-7#1)(2008-4#1)
with medium to##3##3##(2007-5#1)(2008-10#1)(2008-5#1)
with medium##18##2##(1990-7#1)(1991-1#1)(1992-7#1)(2006-10#1)(2007-5#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#1)(2009-4#2)(2011-2#1)(2013-1#2)(2013-8#1)
with medullary compression##2##3##(2008-4#2)
with medullary##6##2##(1992-8#1)(1996-11#1)(1997-6#1)(2008-4#2)(2012-12#1)
with medulloblastoma and##2##3##(1997-3#1)(2006-8#1)
with medulloblastoma##6##2##(1994-3#1)(1997-3#4)(2006-8#1)
with meeting##3##2##(2009-5#2)(2011-1#1)
with megestrol##2##2##(1995-4#1)(2012-2#1)
with meiotic##2##2##(2007-9#1)(2008-12#1)
with melamine##2##2##(2012-12#2)
with melanin##4##2##(2008-11#1)(2008-3#1)(2012-2#1)(2013-1#1)
with melena##3##2##(1992-6#1)(2008-7#1)(2013-8#1)
with members of the hsp70##2##5##(1993-3#1)(1995-6#1)
with members of the##15##4##(1991-11#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-6#1)(1995-6#1)(1997-8#1)(2006-4#1)(2006-8#3)(2008-1#1)(2008-10#1)(2008-4#1)(2013-8#1)
with members of##22##3##(1991-1#1)(1991-11#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-6#1)(1995-6#1)(1997-2#1)(1997-8#1)(2006-4#1)(2006-8#3)(2008-1#1)(2008-10#4)(2008-4#2)(2009-9#1)(2013-8#1)
with members##23##2##(1991-1#1)(1991-11#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-6#1)(1995-6#1)(1997-2#1)(1997-8#1)(2006-11#1)(2006-4#1)(2006-8#3)(2008-1#1)(2008-10#4)(2008-4#2)(2009-9#1)(2013-8#1)
with membrane lipids##3##3##(1990-2#1)(1990-9#1)(1994-2#1)
with membrane vesicles##2##3##(1997-6#1)(2008-8#1)
with membrane##24##2##(1990-12#1)(1990-2#1)(1990-9#1)(1991-11#1)(1991-6#1)(1991-8#1)(1992-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1997-6#1)(2007-3#1)(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-1#1)
with membranes containing##2##3##(2008-10#2)
with membranes##12##2##(1991-11#1)(1994-5#2)(1994-6#1)(1994-9#1)(1997-5#1)(1997-6#1)(2006-8#1)(2008-1#1)(2008-10#2)(2009-10#1)
with membranous##4##2##(1995-1#1)(2007-11#1)(2008-1#1)(2009-10#1)
with memory##3##2##(1995-12#1)(2006-10#1)(2007-8#1)
with men and##5##3##(2008-11#1)(2009-5#1)(2009-7#1)(2010-5#1)(2013-1#1)
with men in##2##3##(1990-2#1)(2009-5#1)
with men undergoing AS for prostate cancer##2##7##(2010-10#2)
with men who##2##3##(1992-2#1)(2009-5#1)
with men with##2##3##(1991-7#1)(2011-1#1)
with men##51##2##(1990-2#1)(1991-7#1)(1992-2#1)(1994-6#1)(1996-5#1)(2006-8#2)(2006-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#1)(2009-1#1)(2009-11#1)(2009-5#11)(2009-7#1)(2010-10#2)(2010-12#3)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#4)
with meningioma##3##2##(2007-12#1)(2010-11#1)(2013-7#1)
with meningiomas##2##2##(1997-7#1)(2008-7#1)
with meningitis##8##2##(1992-9#2)(1993-1#2)(1993-2#1)(2007-3#1)(2012-12#1)(2012-2#1)
with meningococcal disease in##2##4##(1991-8#1)(2007-12#1)
with meningococcal disease##4##3##(1991-6#1)(1991-8#1)(1993-9#1)(2007-12#1)
with meningococcal##5##2##(1991-6#1)(1991-8#1)(1993-9#2)(2007-12#1)
with meningothelial-like##2##2##(2009-7#2)
with menstrual##2##2##(2008-3#1)(2008-4#1)
with menstruation##2##2##(1991-3#1)(2013-1#1)
with mental disorders##7##3##(1991-8#1)(2007-7#1)(2008-2#3)(2012-11#1)(2012-12#1)
with mental health disorders##2##4##(2005-10#1)(2008-2#1)
with mental health problems##16##4##(1992-1#1)(1993-1#3)(1997-5#1)(2008-11#3)(2008-2#1)(2009-8#1)(2011-1#5)(2012-12#1)
with mental health##27##3##(1992-1#1)(1993-1#3)(1997-2#1)(1997-5#1)(2005-10#1)(2007-1#2)(2008-11#3)(2008-2#3)(2008-3#1)(2009-8#1)(2010-10#1)(2010-6#1)(2011-1#5)(2011-2#1)(2012-12#2)
with mental illness and##2##4##(2011-2#1)(2012-12#1)
with mental illness##22##3##(2005-9#1)(2006-5#1)(2006-9#2)(2007-3#2)(2007-5#1)(2008-11#1)(2008-2#3)(2009-5#1)(2010-9#1)(2011-1#5)(2011-2#3)(2012-12#1)
with mental illnesses##2##3##(2009-7#1)(2011-7#1)
with mental retardation in##2##4##(1993-3#1)(1996-6#1)
with mental retardation##15##3##(1990-8#1)(1991-12#1)(1992-7#1)(1993-3#3)(1995-1#1)(1995-11#2)(1996-12#1)(1996-6#1)(1997-8#1)(2006-4#1)(2006-9#1)(2010-12#1)
with mental##82##2##(1990-8#1)(1990-9#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-7#1)(1993-1#3)(1993-3#3)(1995-1#1)(1995-11#2)(1996-12#1)(1996-6#1)(1997-2#2)(1997-5#1)(1997-8#2)(2005-10#1)(2005-9#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-9#3)(2007-1#2)(2007-3#2)(2007-5#1)(2007-7#1)(2008-11#4)(2008-2#10)(2008-3#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#10)(2011-2#4)(2011-7#1)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-8#1)
with mentally ill##2##3##(1992-3#1)(2008-4#1)
with mercuric##2##2##(2008-10#2)
with mercury coated##2##3##(2008-10#2)
with mercury##11##2##(1991-3#1)(1993-8#1)(2004-9#1)(2007-11#1)(2008-10#7)
with mesalazine##3##2##(2006-2#2)(2010-12#1)
with mesangial proliferative glomerulonephritis##2##4##(2007-7#2)
with mesenchymal stem##2##3##(2008-4#1)(2012-2#1)
with mesenteric##4##2##(1996-2#1)(2006-4#2)(2008-3#1)
with mesh##3##2##(2007-8#1)(2013-1#2)
with mesothelioma##4##2##(1990-12#1)(1991-12#1)(1992-11#2)
with metabolic and##2##3##(2006-1#1)(2007-10#1)
with metabolic control##2##3##(2011-1#1)(2011-2#1)
with metabolic diseases##2##3##(2008-1#1)(2009-4#1)
with metabolic syndrome (MetS)##3##4##(2008-3#1)(2012-2#1)(2013-8#1)
with metabolic syndrome and type 2 diabetes##2##7##(2008-1#2)
with metabolic syndrome at##2##4##(2008-3#1)(2010-4#1)
with metabolic syndrome or##2##4##(2008-5#1)(2013-8#1)
with metabolic syndrome##26##3##(2008-1#3)(2008-11#1)(2008-3#10)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#2)(2012-2#3)(2013-8#4)
with metabolic##53##2##(1990-3#1)(1993-8#2)(1996-7#1)(1997-1#1)(2004-11#1)(2006-1#1)(2007-1#1)(2007-10#1)(2007-5#1)(2007-9#1)(2008-1#4)(2008-10#1)(2008-11#2)(2008-3#10)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#5)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#4)
with metabolism##2##2##(2006-10#1)(2013-1#1)
with metabolite##2##2##(2008-7#1)(2011-2#1)
with metachromatic##4##2##(1991-9#1)(1997-3#2)(2008-5#1)
with metachronous##2##2##(2007-7#1)(2008-6#1)
with metal ions and##2##4##(2007-3#1)(2008-10#1)
with metal ions##8##3##(1996-5#1)(2007-3#1)(2008-10#3)(2008-4#1)(2008-5#2)
with metal##24##2##(1990-4#1)(1996-4#1)(1996-5#1)(1997-3#1)(2006-10#1)(2006-12#2)(2007-3#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-11#1)(2011-1#2)
with metallic thin film##2##4##(2008-3#2)
with metallic##5##2##(2008-10#1)(2008-3#3)(2010-7#1)
with metalloporphyrins##2##2##(1996-1#2)
with metals and##3##3##(2007-8#1)(2008-2#1)(2008-5#1)
with metals##4##2##(2006-10#1)(2007-8#1)(2008-2#1)(2008-5#1)
with metastases in the##3##4##(2007-11#2)(2011-2#1)
with metastases in##6##3##(1991-10#1)(2007-11#4)(2011-2#1)
with metastases##21##2##(1990-10#1)(1990-12#1)(1990-8#1)(1991-10#1)(1997-7#1)(2006-8#1)(2006-9#1)(2007-11#7)(2007-6#1)(2008-6#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#2)
with metastasis in##4##3##(2008-4#1)(2008-6#1)(2013-1#2)
with metastasis to the right##2##5##(2007-2#1)(2009-10#1)
with metastasis to the##6##4##(1992-2#1)(1997-8#1)(2007-2#2)(2008-6#1)(2009-10#1)
with metastasis to##7##3##(1992-2#1)(1997-8#1)(2007-2#2)(2008-6#1)(2009-10#1)(2011-1#1)
with metastasis##20##2##(1992-2#1)(1992-5#1)(1992-9#1)(1997-8#1)(2007-2#3)(2007-6#1)(2008-3#1)(2008-4#1)(2008-6#3)(2008-9#1)(2009-10#1)(2010-3#2)(2011-1#1)(2013-1#2)
with metastatic adamantinoma##2##3##(2008-6#2)
with metastatic breast cancer who had##2##6##(1992-10#1)(2006-8#1)
with metastatic breast cancer who##3##5##(1992-10#2)(2006-8#1)
with metastatic breast cancer##11##4##(1990-1#3)(1992-10#2)(2006-8#1)(2007-11#1)(2008-3#1)(2008-7#2)(2010-8#1)
with metastatic colorectal cancer##4##4##(1991-4#1)(2007-6#1)(2009-2#1)(2011-2#1)
with metastatic colorectal##7##3##(1990-2#1)(1991-4#1)(2007-6#2)(2009-2#1)(2011-2#1)(2012-1#1)
with metastatic disease and##2##4##(1990-11#1)(2010-3#1)
with metastatic disease at##3##4##(2006-8#1)(2008-6#2)
with metastatic disease##27##3##(1990-11#1)(2004-2#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-7#1)(2008-5#1)(2008-6#7)(2008-7#1)(2009-11#1)(2010-3#4)(2011-1#1)(2011-12#2)(2013-1#1)
with metastatic disease)##2##3##(2010-3#2)
with metastatic melanoma##8##3##(1990-6#1)(1992-2#1)(1997-2#1)(2007-11#3)(2008-3#1)(2012-2#1)
with metastatic potential##5##3##(1991-12#1)(1992-9#1)(1993-9#2)(2010-3#1)
with metastatic prostate cancer##5##4##(1992-4#1)(1995-11#1)(2007-5#2)(2008-11#1)
with metastatic renal cell carcinoma##6##5##(1991-8#1)(2008-6#3)(2010-12#1)(2012-12#1)
with metastatic renal##8##3##(1990-12#1)(1991-8#1)(2007-11#1)(2008-6#3)(2010-12#1)(2012-12#1)
with metastatic tumours##2##3##(1992-10#1)(2007-11#1)
with metastatic##112##2##(1990-1#3)(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-10#4)(1992-2#1)(1992-4#1)(1992-9#1)(1993-10#1)(1993-5#1)(1993-9#2)(1994-10#1)(1994-6#1)(1994-8#1)(1995-11#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-2#1)(2006-2#1)(2006-8#4)(2006-9#1)(2007-10#1)(2007-11#11)(2007-12#2)(2007-5#2)(2007-6#3)(2007-7#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#13)(2008-7#4)(2009-1#1)(2009-11#2)(2009-2#1)(2009-8#1)(2010-12#5)(2010-3#7)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
with metformin treatment##2##3##(2010-4#1)(2013-1#1)
with metformin##8##2##(2008-3#1)(2010-4#1)(2012-3#2)(2013-1#2)(2013-8#2)
with methadone##3##2##(2007-2#2)(2010-5#1)
with methamphetamine##3##2##(1996-10#2)(2012-2#1)
with methanol and water##3##4##(2008-10#1)(2011-1#1)(2013-8#1)
with methanol and##6##3##(1992-2#1)(2006-3#1)(2008-10#1)(2008-5#1)(2011-1#1)(2013-8#1)
with methanol as##2##3##(2008-10#1)(2012-2#1)
with methanol by##2##3##(2008-10#1)(2008-5#1)
with methanol in##3##3##(1996-5#1)(2007-8#1)(2008-10#1)
with methanol##29##2##(1990-8#1)(1992-2#2)(1996-5#1)(1997-4#1)(1997-8#1)(2005-12#1)(2006-3#1)(2007-12#1)(2007-8#1)(2008-10#10)(2008-4#1)(2008-5#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#2)
with methanol-phosphate buffer##2##3##(2008-10#2)
with methanol-water##2##2##(2008-10#1)(2010-12#1)
with methanolic##3##2##(1996-8#1)(2008-10#1)(2008-4#1)
with methicillin-resistant Staphylococcus aureus##3##4##(1995-9#1)(2007-8#1)(2010-9#1)
with methimazole##5##2##(1997-2#2)(1997-8#1)(2012-12#2)
with methodology##2##2##(2008-10#1)(2011-2#1)
with methods for##2##3##(2008-4#1)(2008-9#1)
with methods##8##2##(2007-5#1)(2008-4#3)(2008-9#2)(2009-8#1)(2013-7#1)
with methotrexate and##3##3##(1990-9#1)(1993-12#1)(2007-11#1)
with methotrexate or##2##3##(1992-8#1)(2008-3#1)
with methotrexate##23##2##(1990-9#1)(1991-2#1)(1992-8#2)(1993-12#3)(1995-2#1)(1995-5#1)(1997-3#1)(1997-8#1)(2007-11#7)(2008-11#1)(2008-3#2)(2008-6#1)(2013-1#1)
with methyl bromide##5##3##(2008-10#5)
with methyl jasmonate##4##3##(1992-11#1)(2008-10#1)(2011-10#1)(2012-11#1)
with methyl methacrylate##5##3##(2007-10#1)(2007-11#1)(2008-7#2)(2009-10#1)
with methyl prednisolone##2##3##(2006-4#1)(2010-4#1)
with methyl##38##2##(1990-10#1)(1990-3#1)(1992-11#1)(1992-2#1)(1994-9#1)(1995-11#1)(1996-10#2)(1996-4#2)(1996-5#4)(1996-8#2)(2005-8#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-10#9)(2008-7#2)(2009-10#1)(2010-4#1)(2010-8#1)(2011-10#1)(2012-11#1)
with methyl-tert##2##2##(1996-8#1)(1997-3#1)
with methylamine to##2##3##(1997-1#1)(1997-6#1)
with methylamine##4##2##(1997-1#1)(1997-6#1)(2007-11#1)(2008-10#1)
with methylation analysis##3##3##(1991-2#1)(1991-9#1)(1992-9#1)
with methylation##4##2##(1991-2#1)(1991-9#1)(1992-9#1)(1994-3#1)
with methylene blue##5##3##(1990-6#1)(2008-10#3)(2009-2#1)
with methylene chloride##2##3##(1992-2#1)(2008-10#1)
with methylene##9##2##(1990-6#1)(1992-1#1)(1992-2#1)(2005-12#1)(2008-10#4)(2009-2#1)
with methylglyoxal##2##2##(2007-11#2)
with methylprednisolone##9##2##(1990-9#1)(1993-6#1)(2006-4#1)(2008-1#1)(2008-5#1)(2010-12#1)(2013-8#3)
with methylthiosalicylate (TS-gel)##2##3##(2008-10#2)
with methylthymol blue##2##3##(2008-10#2)
with metoclopramide##4##2##(1990-6#1)(1990-9#1)(1993-4#1)(2011-12#1)
with metoprolol##4##2##(1994-9#1)(1996-3#1)(2006-6#1)(2010-4#1)
with metronidazole##6##2##(1996-6#1)(1997-7#2)(2006-10#1)(2007-6#1)(2008-4#1)
with mianserin in New Zealand##2##5##(1990-9#2)
with mianserin##9##2##(1990-9#3)(2008-6#6)
with micafungin##2##2##(2008-10#2)
with mice##5##2##(1990-2#1)(1990-5#1)(2008-11#1)(2008-4#1)(2011-1#1)
with micellar##3##2##(1996-5#1)(2005-11#1)(2008-10#1)
with miconazole##3##2##(2008-5#1)(2009-8#2)
with micro##4##2##(2008-5#1)(2010-2#1)(2013-1#2)
with microalbuminuria and##3##3##(2005-10#2)(2008-3#1)
with microalbuminuria##7##2##(1993-11#1)(2005-10#2)(2008-1#1)(2008-3#1)(2010-4#2)
with microalgae##2##2##(2007-5#1)(2013-1#1)
with microarray##7##2##(2008-1#1)(2008-2#2)(2008-7#1)(2011-1#1)(2012-1#1)(2012-2#1)
with microbial antagonists##2##3##(2008-10#2)
with microbial##9##2##(2007-12#1)(2008-10#2)(2008-4#2)(2008-7#1)(2009-6#1)(2010-2#1)(2010-4#1)
with microcephaly##3##2##(1996-12#1)(2008-1#1)(2012-3#1)
with microchip##2##2##(2008-10#1)(2008-12#1)
with microcrystalline naphthalene##2##3##(2008-10#2)
with microcrystalline phenolphthalein modified by crystal violet##2##7##(2008-10#2)
with microcrystalline##5##2##(2008-10#4)(2010-2#1)
with microdialysis and##2##3##(1995-12#1)(2008-10#1)
with microdialysis probes in the##2##5##(1995-5#1)(1996-4#1)
with microdialysis sampling##2##3##(2008-10#2)
with microdialysis##12##2##(1993-2#1)(1993-4#1)(1995-12#1)(1995-5#1)(1996-4#1)(2008-10#5)(2008-7#1)(2010-2#1)
with microelectrodes##3##2##(2008-10#2)(2010-6#1)
with microfluidic capillary electrophoresis##2##4##(2008-10#2)
with microfluidic##5##2##(2008-10#2)(2011-1#2)(2011-2#1)
with microgrooved##3##2##(2008-11#3)
with microhematuria##2##2##(1997-7#2)
with micrometer##4##2##(2007-12#1)(2008-11#1)(2009-4#1)(2011-1#1)
with micrometer-scale resolution##2##3##(2007-12#1)(2008-1#1)
with micrometer-sized##2##2##(2007-11#1)(2012-12#1)
with micromolar##2##2##(1994-12#1)(1995-8#1)
with micronutrients##2##2##(2006-10#1)(2007-3#1)
with microorganisms##3##2##(1996-12#1)(2008-11#1)(2011-1#1)
with micropenis##2##2##(2010-7#2)
with microreaction chamber##2##3##(2008-10#2)
with microsatellite##2##2##(2008-10#2)
with microscopic##8##2##(1990-11#1)(2005-5#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-8#1)(2012-2#1)(2013-8#1)
with microscopically##2##2##(2006-10#1)(2008-6#1)
with microscopy##3##2##(2007-7#1)(2008-11#1)(2011-2#1)
with microsomal membranes##3##3##(1993-3#1)(1994-12#1)(1994-9#1)
with microsomal##5##2##(1992-11#1)(1993-3#1)(1994-12#1)(1994-6#1)(1994-9#1)
with microsomes##4##2##(1992-4#1)(1993-2#1)(1993-4#1)(1996-3#1)
with microsurgery##5##2##(1996-2#2)(2005-5#2)(2008-7#1)
with microsurgical##2##2##(1991-4#1)(2011-2#1)
with microtubule##2##2##(1990-7#1)(2006-10#1)
with microtubules##4##2##(1990-8#1)(1993-8#1)(1997-4#1)(2012-12#1)
with microvascular##7##2##(1994-8#1)(1995-11#1)(2006-12#1)(2007-12#1)(2011-2#3)
with microvilli##4##2##(2007-12#2)(2008-5#1)(2008-6#1)
with microwave heating##2##3##(2008-10#2)
with microwave plasma##2##3##(2006-4#1)(2008-10#1)
with microwave##10##2##(2006-4#1)(2007-8#1)(2008-10#8)
with microwave-assisted##4##2##(2008-10#3)(2008-5#1)
with microwaves##4##2##(1996-7#1)(2008-10#3)
with midazolam##2##2##(1993-1#1)(2013-8#1)
with middle ear##2##3##(2006-4#1)(2013-8#1)
with middle##4##2##(2005-10#1)(2006-4#1)(2007-9#1)(2013-8#1)
with midline##4##2##(1991-11#1)(1996-12#2)(2008-7#1)
with midwives##2##2##(2013-1#2)
with migraine and##2##3##(2004-3#1)(2012-2#1)
with migraine may##2##3##(2004-12#1)(2011-1#1)
with migraine with aura##3##4##(2008-9#2)(2011-2#1)
with migraine##17##2##(2004-12#4)(2004-3#1)(2007-10#1)(2007-2#2)(2008-12#1)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
with migration of##3##3##(2012-12#2)(2012-3#1)
with migration##10##2##(2008-3#1)(2008-7#1)(2008-8#3)(2009-10#1)(2010-6#1)(2012-12#2)(2012-3#1)
with mild TBI##3##3##(2008-6#1)(2013-8#2)
with mild and moderate##3##4##(1991-9#1)(2007-3#1)(2008-4#1)
with mild and##4##3##(1991-9#1)(2007-3#1)(2008-4#1)(2011-2#1)
with mild anemia##4##3##(2008-7#4)
with mild asthma##2##3##(2008-11#1)(2008-7#1)
with mild blood pressure elevation##2##5##(2009-5#2)
with mild forms of von Willebrand's##2##6##(2011-1#2)
with mild forms of##3##4##(2008-5#1)(2011-1#2)
with mild motor##2##3##(2006-10#1)(2007-10#1)
with mild multiple##2##3##(1996-8#1)(2010-12#1)
with mild renal##2##3##(1990-4#1)(2008-1#1)
with mild to moderate##19##4##(1992-4#1)(1993-2#1)(1994-11#1)(2005-10#1)(2005-6#1)(2006-10#1)(2006-4#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-10#1)(2010-5#1)(2011-12#1)(2011-2#1)(2013-8#1)
with mild to moderately severe##2##5##(2006-6#1)(2007-4#1)
with mild to##22##3##(1992-4#1)(1993-2#1)(1994-11#1)(2005-10#1)(2005-6#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-12#1)(2011-2#1)(2013-8#1)
with mild##107##2##(1990-12#1)(1990-4#1)(1991-3#1)(1991-9#1)(1992-2#2)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-3#2)(1997-4#2)(2005-10#1)(2005-5#1)(2005-6#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-4#4)(2006-6#1)(2006-7#1)(2007-10#3)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#1)(2009-5#2)(2010-10#3)(2010-12#1)(2010-2#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#6)
with mild-to-moderate##10##2##(1991-6#1)(1992-8#4)(1993-12#2)(1993-9#1)(2007-11#1)(2013-1#1)
with mildly##2##2##(1992-6#1)(2012-2#1)
with military##3##2##(2004-7#1)(2007-8#1)(2012-2#1)
with milk##4##2##(1995-10#1)(2007-11#1)(2012-1#2)
with mineral oil##2##3##(2010-4#1)(2013-7#1)
with mineral trioxide aggregate##3##4##(2012-12#1)(2013-1#2)
with mineral##6##2##(2006-3#1)(2010-4#1)(2012-12#1)(2013-1#2)(2013-7#1)
with mineral-depleted mud##2##3##(2006-10#2)
with minimal adverse effects##2##4##(2006-9#1)(2009-5#1)
with minimal amount of##4##4##(2008-10#2)(2009-2#2)
with minimal change disease##2##4##(2007-7#1)(2008-1#1)
with minimal change##3##3##(2007-11#1)(2007-7#1)(2008-1#1)
with minimal complications##3##3##(2006-8#1)(2011-2#1)(2012-12#1)
with minimal donor site morbidity##2##5##(2006-3#1)(2008-12#1)
with minimal effect on##2##4##(2008-4#1)(2010-4#1)
with minimal effects on##2##4##(1995-6#1)(2013-8#1)
with minimal loss##2##3##(1994-8#1)(2007-12#1)
with minimal manipulation##2##3##(1990-8#1)(2008-9#1)
with minimal morbidity##10##3##(1997-6#1)(2006-10#1)(2007-12#1)(2009-5#1)(2010-5#1)(2011-2#3)(2013-1#2)
with minimal motor##2##3##(2006-10#1)(2008-1#1)
with minimal or no##4##4##(2004-3#1)(2007-9#1)(2008-12#1)(2009-12#1)
with minimal or##7##3##(1996-8#1)(2004-3#1)(2006-12#1)(2006-2#1)(2007-9#1)(2008-12#1)(2009-12#1)
with minimal overlap##3##3##(1994-2#1)(1995-7#1)(2008-7#1)
with minimal residual##2##3##(2007-11#1)(2012-3#1)
with minimal risk of##6##4##(2005-9#1)(2006-12#1)(2007-7#1)(2007-8#1)(2011-1#1)(2013-1#1)
with minimal risk##7##3##(2005-9#1)(2006-12#1)(2007-7#1)(2007-8#1)(2010-6#1)(2011-1#1)(2013-1#1)
with minimal sample##3##3##(2008-10#3)
with minimal side effects##6##4##(1994-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2008-1#1)(2012-12#1)
with minimal surgical##2##3##(2008-10#1)(2013-1#1)
with minimal to no##2##4##(2005-10#1)(2007-6#1)
with minimal to##3##3##(2005-10#1)(2007-6#1)(2008-10#1)
with minimal##159##2##(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-5#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-6#1)(1994-8#1)(1995-3#2)(1995-6#2)(1995-7#1)(1996-11#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-6#1)(1997-7#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#4)(2006-12#5)(2006-2#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#15)(2008-12#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#3)(2009-5#3)(2009-6#1)(2009-9#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#10)(2012-12#6)(2012-2#2)(2012-3#3)(2013-1#11)(2013-7#1)(2013-8#2)
with minimally invasive operations##2##4##(2013-1#2)
with minimally invasive##8##3##(2009-9#1)(2010-8#1)(2011-2#2)(2013-1#4)
with minimally##9##2##(1997-6#1)(2009-9#1)(2010-8#1)(2011-2#2)(2013-1#4)
with minimized##2##2##(2008-10#1)(2012-2#1)
with minimum inhibitory concentrations in the range of 0##2##9##(2008-5#2)
with minimum inhibitory##3##3##(2008-10#1)(2008-5#2)
with minimum##31##2##(1992-9#1)(1993-6#1)(1996-12#1)(1996-6#1)(1997-2#1)(2006-12#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#6)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-12#2)(2013-1#1)
with minocycline##2##2##(2007-10#1)(2012-3#1)
with minor adaptations##2##3##(2008-5#1)(2011-2#1)
with minor allele frequency##2##4##(2012-3#2)
with minor differences##3##3##(2008-6#1)(2009-3#1)(2011-12#1)
with minor modifications##2##3##(2006-10#1)(2008-5#1)
with minor##44##2##(1990-6#2)(1990-9#1)(1991-3#1)(1992-6#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-11#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-3#1)(2005-7#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-7#3)(2007-9#1)(2008-10#3)(2008-3#1)(2008-5#3)(2008-6#1)(2009-2#1)(2009-3#1)(2010-11#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-3#2)(2013-1#1)
with minute##4##2##(2008-10#1)(2008-5#1)(2010-12#1)(2010-4#1)
with misaligned##3##2##(2008-2#1)(2012-12#2)
with missense mutations in##2##4##(1995-12#1)(1995-8#1)
with missing data##2##3##(2006-7#1)(2010-2#1)
with missing##8##2##(1997-8#1)(2006-7#1)(2008-6#1)(2010-2#3)(2011-1#1)(2012-3#1)
with mitochondria##12##2##(1993-8#1)(1994-8#1)(1995-6#1)(1996-5#1)(1997-3#1)(2005-8#6)(2007-12#1)
with mitochondrial Phe-tRNA##2##3##(2006-12#2)
with mitochondrial disease##3##3##(1997-2#1)(2010-12#1)(2012-11#1)
with mitochondrial myopathy##2##3##(1991-4#1)(1994-11#1)
with mitochondrial##21##2##(1991-4#2)(1994-11#1)(1994-8#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-6#1)(2005-8#2)(2006-11#1)(2006-12#3)(2008-1#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-12#1)(2012-11#1)(2013-8#1)
with mitogen-activated protein##2##3##(1995-3#1)(2011-2#1)
with mitogenic##3##2##(1990-8#1)(1994-6#1)(1995-3#1)
with mitogens##3##2##(1994-9#1)(2008-11#1)(2008-4#1)
with mitomycin C or##2##4##(1994-8#1)(2008-9#1)
with mitomycin C##4##3##(1993-8#1)(1994-8#1)(1996-11#1)(2008-9#1)
with mitotic##5##2##(1991-8#1)(2003-11#1)(2008-10#1)(2008-7#1)(2010-5#1)
with mitoxantrone##4##2##(1991-10#1)(1991-6#2)(1994-12#1)
with mitral valve surgery##2##4##(2007-8#2)
with mitral valve##7##3##(1995-6#1)(2007-8#3)(2007-9#1)(2008-4#1)(2011-2#1)
with mitral##9##2##(1995-3#1)(1995-6#1)(2006-12#1)(2007-8#3)(2007-9#1)(2008-4#1)(2011-2#1)
with mixed chronic##2##3##(2005-1#1)(2008-9#1)
with mixed cryoglobulinemia##2##3##(2006-2#2)
with mixed dentition affected by##2##5##(2008-5#2)
with mixed dentition##3##3##(2008-5#2)(2011-2#1)
with mixed infections##2##3##(2008-10#1)(2011-2#1)
with mixed##34##2##(1992-12#1)(1993-9#1)(1996-12#1)(1997-5#1)(2004-4#1)(2005-1#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-2#2)(2007-1#1)(2007-10#1)(2007-5#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-5#3)(2008-6#1)(2008-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
with mixing##2##2##(1991-2#1)(2008-6#1)
with mixtures of##13##3##(1995-8#2)(1996-7#1)(2006-3#1)(2008-10#7)(2008-2#2)
with mixtures##16##2##(1995-8#2)(1996-7#1)(2006-3#1)(2008-10#10)(2008-2#2)
with mo(p40)2##2##2##(1996-10#2)
with mobile phase##4##3##(2008-10#1)(2008-5#1)(2010-2#1)(2010-3#1)
with mobile##13##2##(1991-4#1)(1996-5#1)(2006-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-3#1)(2010-8#1)(2012-12#1)
with mobility##7##2##(2007-6#2)(2007-7#1)(2008-7#1)(2008-9#3)
with modal##5##2##(2007-12#3)(2008-2#1)(2010-12#1)
with modalities##2##2##(2007-11#1)(2007-4#1)
with model calculations##2##3##(2008-2#2)
with model lipid##2##3##(2008-10#1)(2008-5#1)
with model membranes##4##3##(1993-3#3)(2008-10#1)
with model predictions##3##3##(2008-10#1)(2008-2#1)(2008-7#1)
with model##24##2##(1990-4#1)(1991-9#1)(1993-3#3)(1994-12#1)(1994-5#1)(2005-4#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2013-7#1)
with modeled##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)
with modeling##3##2##(2008-2#1)(2008-4#1)(2013-8#1)
with models based on##2##4##(2007-11#1)(2008-3#1)
with models##7##2##(1994-12#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-8#1)(2010-9#1)
with modem##2##2##(1991-12#1)(2008-8#1)
with moderate activities being found##2##5##(2013-1#2)
with moderate affinity to##2##4##(1990-2#2)
with moderate affinity##3##3##(1990-2#2)(1996-5#1)
with moderate and severe##3##4##(2007-10#1)(2008-7#2)
with moderate and##7##3##(1993-8#1)(2007-10#2)(2008-7#2)(2011-2#1)(2013-8#1)
with moderate effect##2##3##(1995-11#1)(2012-3#1)
with moderate or severe asthma##3##5##(2008-11#3)
with moderate or severe##5##4##(2006-10#1)(2007-11#1)(2008-11#3)
with moderate size parameters##2##4##(2008-3#2)
with moderate to high##2##4##(2012-3#2)
with moderate to severe asthma##3##5##(2008-3#2)(2008-5#1)
with moderate to severe psoriasis##2##5##(2008-5#2)
with moderate to severe##18##4##(1990-3#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#4)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)
with moderate to##21##3##(1990-3#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#4)(2009-5#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)
with moderate##92##2##(1990-2#2)(1990-3#1)(1990-8#1)(1991-6#2)(1991-7#3)(1992-11#1)(1992-12#1)(1993-11#2)(1993-3#2)(1993-8#1)(1994-12#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-4#1)(2004-9#1)(2006-10#2)(2006-11#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#3)(2007-11#4)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#5)(2008-7#2)(2009-11#1)(2009-5#2)(2009-8#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#2)(2013-8#1)
with moderate-to-severe##3##2##(2005-8#1)(2009-2#1)(2013-1#1)
with moderately##9##2##(1993-3#1)(1994-11#1)(1995-4#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
with modern analytical##2##3##(2008-10#1)(2010-7#1)
with modern##22##2##(1993-6#1)(1997-6#1)(2006-7#1)(2007-11#2)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#2)(2010-6#1)(2010-7#1)(2012-2#4)(2012-9#1)(2013-1#4)
with modest##6##2##(1990-9#1)(2008-10#1)(2008-2#1)(2010-9#1)(2012-1#1)(2012-3#1)
with modifiable##2##2##(2007-10#1)(2010-5#1)
with modification of the##2##4##(2006-12#1)(2006-3#1)
with modification of##5##3##(1990-11#1)(2006-12#1)(2006-3#1)(2008-10#1)(2008-9#1)
with modifications of the##3##4##(1994-9#1)(1997-4#1)(2008-11#1)
with modifications of##5##3##(1994-9#1)(1996-12#1)(1997-4#1)(2008-11#1)(2008-7#1)
with modifications##9##2##(1990-7#1)(1994-12#1)(1994-9#1)(1996-12#1)(1997-4#1)(2007-12#1)(2008-11#1)(2008-7#1)(2012-12#1)
with modified Tupman plate##2##4##(2012-2#2)
with modified##25##2##(1990-3#1)(1990-4#1)(1990-7#1)(1992-7#1)(1994-2#1)(1996-5#1)(1997-2#1)(2006-12#1)(2006-2#1)(2007-9#1)(2008-10#5)(2008-7#1)(2009-4#1)(2009-6#1)(2009-8#2)(2012-2#3)(2012-3#1)(2013-8#1)
with modifier##3##2##(2008-10#3)
with modular##3##2##(2007-7#1)(2008-3#1)(2012-2#1)
with modulated##2##2##(2007-11#1)(2008-2#1)
with modulation##3##2##(2008-3#3)
with moisture##2##2##(2006-12#1)(2012-2#1)
with mol##4##2##(1991-3#2)(1995-5#1)(2005-11#1)
with molar absorptivity being##2##4##(2008-10#2)
with molar absorptivity of 1##2##5##(2008-10#2)
with molar absorptivity of##4##4##(2008-10#3)(2010-2#1)
with molar absorptivity##9##3##(2008-10#8)(2010-2#1)
with molar##11##2##(1992-4#1)(2008-10#9)(2010-2#1)
with molecular and##3##3##(2009-10#1)(2009-8#1)(2011-12#1)
with molecular conformation and##2##4##(1990-9#2)
with molecular dynamics simulations##3##4##(1990-10#1)(1995-5#1)(2008-7#1)
with molecular dynamics##5##3##(1990-10#1)(1991-2#1)(1994-7#1)(1995-5#1)(2008-7#1)
with molecular mass of##2##4##(1991-10#1)(1997-4#1)
with molecular mass##3##3##(1991-10#1)(1997-4#1)(2004-9#1)
with molecular masses of##14##4##(1990-2#1)(1990-5#1)(1991-10#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-5#1)(1994-9#1)(2008-10#3)(2008-8#1)(2013-1#2)
with molecular masses ranging from##2##5##(1990-12#1)(1992-8#1)
with molecular masses##22##3##(1990-12#2)(1990-2#1)(1990-5#1)(1991-10#1)(1992-12#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-5#1)(1994-9#1)(2008-10#4)(2008-11#1)(2008-8#1)(2013-1#2)
with molecular weight of##12##4##(1993-8#1)(1994-12#1)(1996-9#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-3#2)
with molecular weights of##14##4##(1990-11#2)(1990-12#2)(1990-7#1)(1991-7#1)(1992-8#1)(1996-2#1)(1997-7#1)(2004-9#1)(2008-2#1)(2008-8#1)(2012-11#2)
with molecular weights##16##3##(1990-11#2)(1990-12#2)(1990-7#1)(1991-7#1)(1992-8#1)(1996-2#1)(1997-2#1)(1997-7#1)(2004-9#1)(2008-2#1)(2008-5#1)(2008-8#1)(2012-11#2)
with molecular##94##2##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-9#2)(1991-10#2)(1991-2#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-12#2)(1992-4#1)(1992-8#3)(1993-11#1)(1993-12#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-5#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-9#2)(2005-11#1)(2006-10#1)(2006-4#1)(2007-12#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-5#2)(2011-12#1)(2011-2#2)(2012-11#2)(2012-12#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
with molecules of larger##2##4##(2008-10#2)
with molecules##4##2##(2007-11#1)(2008-10#2)(2010-7#1)
with molybdate##6##2##(1993-12#1)(2008-10#5)
with monensin##2##2##(1992-8#1)(2005-8#1)
with monitored##2##2##(2008-10#1)(2012-2#1)
with monitoring of##2##3##(1994-6#1)(2006-12#1)
with monitoring##5##2##(1994-6#1)(2006-12#1)(2008-10#2)(2010-7#1)
with mono- and##4##3##(1995-6#1)(1997-2#1)(2005-12#1)(2006-10#1)
with mono-##5##2##(1992-11#1)(1995-6#1)(1997-2#1)(2005-12#1)(2006-10#1)
with monoamine##3##2##(1994-8#1)(1995-7#1)(1996-7#1)
with monoarthritis of##2##3##(2008-12#2)
with monoarthritis##3##2##(1992-8#1)(2008-12#2)
with monochromatic##2##2##(2007-11#1)(2008-11#1)
with monoclonal antibodies directed against##2##5##(1994-3#1)(2008-9#1)
with monoclonal antibodies to##4##4##(1991-12#1)(1992-3#1)(1992-6#1)(2008-10#1)
with monoclonal antibodies##26##3##(1991-12#2)(1992-12#1)(1992-3#1)(1992-6#2)(1993-3#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-4#1)(1997-3#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-8#1)
with monoclonal antibody to##4##4##(1991-7#1)(1995-11#1)(1997-2#2)
with monoclonal antibody##12##3##(1990-11#1)(1991-7#1)(1991-9#2)(1992-11#2)(1995-11#1)(1997-2#2)(1997-8#1)(2006-6#1)(2008-10#1)
with monoclonal gammopathy of undetermined significance##2##6##(1991-7#1)(2006-10#1)
with monoclonal##52##2##(1990-11#1)(1991-10#1)(1991-12#2)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-11#2)(1992-12#2)(1992-3#2)(1992-6#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-4#1)(1997-2#3)(1997-3#1)(1997-5#1)(1997-8#1)(2006-10#2)(2006-6#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-8#1)(2009-9#1)
with monocytes##4##2##(1991-2#1)(1992-2#1)(1994-2#1)(2012-2#1)
with monodansylcadaverine (MDC)##2##3##(1990-8#1)(2008-4#1)
with monodansylcadaverine##3##2##(1990-8#2)(2008-4#1)
with monodisperse LDL##2##3##(1995-6#2)
with monodisperse##4##2##(1990-6#1)(1995-6#2)(2010-12#1)
with monolithic##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
with monomeric##3##2##(1990-5#1)(1995-12#1)(2008-8#1)
with monosodium##2##2##(1994-3#1)(2013-1#1)
with monosomy 7##3##3##(2008-3#1)(2013-1#2)
with monosomy##5##2##(1992-12#1)(2008-3#1)(2008-7#1)(2013-1#2)
with monospecific##2##2##(1992-12#1)(1997-8#1)
with monotherapy##4##2##(1997-5#1)(2007-10#1)(2007-11#1)(2009-8#1)
with monounsaturated fatty acids##2##4##(2006-9#1)(2012-12#1)
with monovalent##2##2##(2008-10#1)(2012-3#1)
with monthly##3##2##(1993-1#1)(2006-10#1)(2013-7#1)
with montmorillonite##2##2##(2005-11#1)(2008-10#1)
with mood disorders##7##3##(1996-2#2)(2004-11#1)(2008-7#1)(2010-2#2)(2013-7#1)
with mood##13##2##(1996-1#1)(1996-2#2)(2004-11#1)(2008-3#1)(2008-7#3)(2010-2#2)(2012-12#1)(2013-7#1)(2013-8#1)
with moral##3##2##(2004-12#1)(2008-11#1)(2013-8#1)
with morbid obesity##2##3##(2006-2#1)(2012-12#1)
with morbidity##4##2##(1991-12#1)(2006-12#1)(2007-7#1)(2007-8#1)
with more advanced disease##3##4##(1990-4#1)(2006-1#1)(2006-10#1)
with more advanced##4##3##(1990-4#1)(2004-1#1)(2006-1#1)(2006-10#1)
with more complete##2##3##(2008-10#1)(2011-2#1)
with more complex##3##3##(1995-3#1)(2008-10#2)
with more detailed##2##3##(2008-2#2)
with more efficient##2##3##(2008-10#2)
with more extensive##4##3##(1995-3#1)(2007-10#1)(2007-8#1)(2012-1#1)
with more focal##2##3##(1994-2#1)(2009-4#1)
with more frequent##6##3##(2004-3#1)(2006-2#1)(2007-10#1)(2008-7#1)(2009-5#1)(2012-12#1)
with more or less##2##4##(2009-8#1)(2013-8#1)
with more or##3##3##(1993-3#1)(2009-8#1)(2013-8#1)
with more positive##2##3##(2010-2#1)(2011-1#1)
with more rapid##2##3##(1995-2#1)(2008-10#1)
with more recent##5##3##(1991-6#1)(2007-10#1)(2008-3#1)(2010-11#1)(2012-12#1)
with more serious##2##3##(2010-11#1)(2011-2#1)
with more severe##8##3##(2007-11#1)(2008-10#1)(2008-4#3)(2008-6#1)(2012-11#1)(2013-1#1)
with more species##2##3##(2008-8#1)(2013-7#1)
with more stable##2##3##(2008-10#1)(2010-10#1)
with more than 1##3##4##(2007-12#1)(2008-10#1)(2008-11#1)
with more than 100##2##4##(1997-3#1)(2007-11#1)
with more than 20##3##4##(2004-1#1)(2007-12#1)(2008-11#1)
with more than 200##2##4##(1993-2#1)(1997-2#1)
with more than 30##2##4##(2006-10#1)(2010-7#1)
with more than 50##3##4##(2008-10#2)(2012-3#1)
with more than 95% of##2##5##(2008-10#1)(2012-2#1)
with more than four##3##4##(1990-12#1)(2012-12#2)
with more than one pregnancy##3##5##(2012-12#3)
with more than one##23##4##(1992-1#1)(1992-2#1)(1994-4#1)(1995-1#1)(1997-2#1)(2005-12#1)(2006-10#1)(2006-8#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-8#2)(2011-1#1)(2011-2#1)(2012-12#5)(2013-1#2)
with more than ten##2##4##(2005-12#1)(2008-3#1)
with more than two##3##4##(1991-11#1)(1995-6#1)(2011-1#1)
with more than##83##3##(1990-12#2)(1991-11#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-4#1)(1993-10#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-4#1)(1995-1#1)(1995-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(2004-1#1)(2005-12#2)(2006-10#2)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-6#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#4)(2009-2#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#9)(2012-2#3)(2012-3#2)(2013-1#4)
with more to##2##3##(2006-10#1)(2008-10#1)
with more traditional##2##3##(2006-7#1)(2008-7#1)
with more variation##2##3##(2008-10#1)(2011-2#1)
with more##244##2##(1990-12#2)(1990-2#2)(1990-4#1)(1991-11#2)(1991-2#2)(1991-3#3)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-10#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#3)(1994-4#2)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#3)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#3)(1997-3#1)(2004-1#3)(2004-12#1)(2004-3#1)(2004-9#1)(2005-11#1)(2005-12#2)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#5)(2006-2#1)(2006-3#2)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#4)(2007-12#5)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#3)(2007-9#4)(2008-1#3)(2008-10#23)(2008-11#5)(2008-12#3)(2008-2#5)(2008-3#7)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#6)(2008-9#6)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#2)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#10)(2011-2#8)(2011-3#1)(2012-1#2)(2012-11#2)(2012-12#12)(2012-2#5)(2012-3#3)(2013-1#10)(2013-7#1)(2013-8#1)
with morin##2##2##(2008-10#2)
with morphine and##2##3##(1995-12#1)(1995-6#1)
with morphine for##2##3##(2007-11#1)(2009-5#1)
with morphine inhibited##2##3##(2008-12#2)
with morphine or##2##3##(1996-10#1)(1996-2#1)
with morphine##17##2##(1991-1#1)(1991-8#1)(1995-12#2)(1995-6#1)(1996-10#2)(1996-2#1)(2006-10#1)(2007-11#2)(2008-12#3)(2008-5#1)(2008-7#1)(2009-5#1)
with morphologic##3##2##(2007-5#1)(2008-10#1)(2008-5#1)
with morphological and##2##3##(2008-6#1)(2010-12#1)
with morphological identification##2##3##(2008-10#2)
with morphological##15##2##(1993-12#1)(1995-11#1)(1996-6#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-6#1)(2010-12#1)(2010-8#4)(2013-1#1)
with morphology##3##2##(2008-8#1)(2010-6#1)(2012-3#1)
with mortality in##2##3##(2008-7#1)(2011-1#1)
with mortality##15##2##(2006-6#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-7#2)(2011-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
with mosaicism##2##2##(1996-12#1)(1996-3#1)
with most isolates##2##3##(2008-10#2)
with most of the##15##4##(1990-3#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-7#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
with most of##19##3##(1990-3#1)(1995-11#1)(1997-1#1)(2006-10#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-7#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-1#1)
with most##61##2##(1990-3#2)(1991-11#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-11#1)(1994-12#1)(1995-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#9)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-1#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
with mostly viable myocardium##2##4##(2007-8#2)
with mostly##5##2##(2007-12#1)(2007-8#2)(2009-10#1)(2009-5#1)
with mothers and##2##3##(2005-7#1)(2008-6#1)
with mothers##14##2##(1993-12#1)(2005-7#1)(2006-2#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-6#1)(2009-7#3)(2010-1#1)(2011-2#1)(2012-2#1)
with motilin##2##2##(1994-11#2)
with motion##4##2##(2008-11#1)(2008-4#1)(2008-7#1)(2012-2#1)
with motoneurones##2##2##(1996-3#1)(1997-2#1)
with motor and##2##3##(1992-12#1)(2008-7#1)
with motor neurone disease##2##4##(1994-10#1)(2011-2#1)
with motor neurone##3##3##(1994-10#1)(1995-3#1)(2011-2#1)
with motor##18##2##(1991-1#1)(1992-12#1)(1992-7#1)(1993-12#1)(1993-4#1)(1994-10#2)(1995-2#1)(1995-3#1)(1996-11#1)(2007-7#1)(2008-11#2)(2008-2#1)(2008-7#1)(2011-2#2)(2012-1#1)
with mouse IgG##2##3##(2008-10#1)(2008-12#1)
with mouse and##2##3##(1991-6#1)(1997-7#1)
with mouse myeloma cells##3##4##(1990-2#1)(2008-11#2)
with mouse myeloma##4##3##(1990-2#1)(2008-11#3)
with mouse##21##2##(1990-2#1)(1991-6#1)(1992-11#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-4#1)(1993-6#1)(1996-4#1)(1997-2#2)(1997-7#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-5#1)(2011-2#1)
with movement disorders##3##3##(1997-5#1)(2008-11#1)(2013-7#1)
with movement in##2##3##(2008-8#1)(2013-7#1)
with movement##8##2##(1993-12#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2013-7#2)
with movements##3##2##(2006-11#1)(2006-12#1)(2007-7#1)
with moving##3##2##(1992-2#1)(2008-10#1)(2008-11#1)
with moyamoya disease##14##3##(2006-11#10)(2007-8#2)(2008-7#2)
with moyamoya##15##2##(2006-11#11)(2007-8#2)(2008-7#2)
with mu##5##2##(1992-5#1)(1994-9#1)(1995-6#1)(1997-8#1)(2007-11#1)
with much greater##2##3##(1991-12#1)(2008-3#1)
with much higher##6##3##(1996-8#1)(1996-9#1)(1997-4#1)(2007-11#1)(2008-10#1)(2011-1#1)
with much less##3##3##(1995-12#1)(2008-12#1)(2013-1#1)
with much lower##5##3##(1994-12#1)(1996-8#1)(2007-11#1)(2008-10#1)(2008-5#1)
with much##26##2##(1991-12#1)(1992-3#1)(1994-11#1)(1994-12#1)(1995-12#1)(1996-8#2)(1996-9#1)(1997-4#1)(2006-7#1)(2007-11#3)(2008-10#2)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
with mucosal dissection##2##3##(2008-5#2)
with mucosal##7##2##(1990-3#1)(2006-4#1)(2008-3#1)(2008-5#4)
with mucus-producing glands##2##3##(2009-3#2)
with mud compresses##4##3##(2006-10#4)
with multi##2##2##(2007-11#1)(2010-7#1)
with multi-drug##3##2##(2008-6#1)(2011-3#1)(2012-2#1)
with multi-organ failure##2##3##(2005-10#1)(2009-9#1)
with multicentric##4##2##(1993-9#1)(2007-7#1)(2008-9#1)(2011-2#1)
with multichannel##2##2##(2007-12#1)(2008-2#1)
with multidetector CT and##2##4##(2007-4#1)(2007-8#1)
with multidetector CT##4##3##(2007-4#1)(2007-8#1)(2008-7#1)(2012-2#1)
with multidimensional##2##2##(2008-11#1)(2010-7#1)
with multidisciplinary##3##2##(2011-1#2)(2011-2#1)
with multidrug resistance##2##3##(2012-12#1)(2012-3#1)
with multidrug##4##2##(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
with multidrug-resistant##2##2##(1995-11#1)(2006-4#1)
with multifocal##7##2##(2004-1#1)(2007-10#1)(2008-7#1)(2010-12#1)(2010-5#1)(2011-2#2)
with multilamellar vesicles##2##3##(1991-9#1)(1996-1#1)
with multilayer and gold coatings##3##5##(2008-2#2)(2008-3#1)
with multilayer##7##2##(2008-2#4)(2008-3#2)(2008-6#1)
with multilevel##6##2##(2008-3#1)(2009-3#1)(2012-12#4)
with multimodality##3##2##(2012-11#1)(2013-1#2)
with multimode fiber##2##3##(2007-12#1)(2008-3#1)
with multimode fibers##2##3##(2008-3#2)
with multimode##6##2##(2007-12#2)(2008-3#4)
with multimorbidity##4##2##(2008-4#1)(2011-2#1)(2012-3#2)
with multinodular##2##2##(1990-9#1)(2010-12#1)
with multinucleated##2##2##(2007-12#1)(2009-8#1)
with multiorgan##2##2##(2006-10#1)(2008-7#1)
with multiparity##2##2##(1992-5#1)(2007-11#1)
with multipass geometries in a polymer laser dye saturable amplifier##2##10##(2007-12#2)
with multiplanar##4##2##(2007-7#2)(2011-2#2)
with multiple applications##2##3##(2008-1#1)(2011-2#1)
with multiple biological effects##2##4##(2008-4#1)(2008-9#1)
with multiple bone metastases##4##4##(2007-11#3)(2010-12#1)
with multiple bone##5##3##(2005-10#1)(2007-11#3)(2010-12#1)
with multiple brain##8##3##(2006-7#6)(2007-7#1)(2008-6#1)
with multiple cardiac lesions##2##4##(2008-7#2)
with multiple chronic##3##3##(2006-9#1)(2008-10#2)
with multiple components##3##3##(2006-8#2)(2008-10#1)
with multiple congenital anomalies##3##4##(1990-3#1)(2013-1#2)
with multiple congenital melanocytic naevi##2##5##(2007-7#2)
with multiple congenital##6##3##(1990-3#1)(2007-7#2)(2010-7#1)(2013-1#2)
with multiple covariates##3##3##(2008-8#1)(2012-1#1)(2013-1#1)
with multiple cutaneous##2##3##(1992-12#1)(2007-8#1)
with multiple cysts##2##3##(1992-6#1)(2013-1#1)
with multiple degrees of freedom##2##5##(2006-6#1)(2012-1#1)
with multiple disabilities##2##3##(2008-1#2)
with multiple endocrine neoplasia##2##4##(2008-5#1)(2009-4#1)
with multiple endocrine##4##3##(2008-5#1)(2009-4#3)
with multiple functions##2##3##(2007-12#1)(2009-8#1)
with multiple independent sources##2##4##(2012-1#2)
with multiple injuries##3##3##(1991-2#1)(2006-10#2)
with multiple lesions##3##3##(2007-7#2)(2013-8#1)
with multiple lithiasis##2##3##(1993-5#2)
with multiple males##2##3##(2008-8#2)
with multiple medical##4##3##(1994-3#1)(2006-10#1)(2008-1#1)(2013-1#1)
with multiple myeloma (MM)##2##4##(2008-1#1)(2008-7#1)
with multiple myeloma and##2##4##(1992-10#1)(2006-12#1)
with multiple myeloma who##2##4##(2007-5#1)(2013-8#1)
with multiple myeloma##29##3##(1990-10#1)(1992-10#1)(1996-9#1)(2005-1#2)(2005-12#5)(2006-10#1)(2006-12#1)(2006-6#1)(2007-12#1)(2007-5#2)(2008-1#1)(2008-7#4)(2011-1#1)(2011-2#5)(2012-3#1)(2013-8#1)
with multiple neurofibromas##3##3##(2006-10#1)(2012-12#2)
with multiple organ##3##3##(1995-8#1)(1997-1#1)(2007-8#1)
with multiple outputs##2##3##(2008-10#2)
with multiple partners##4##3##(1997-3#1)(2009-5#2)(2013-1#1)
with multiple phleboliths##2##3##(2012-12#2)
with multiple primary##2##3##(2008-6#1)(2011-2#1)
with multiple rare variants##2##4##(2012-3#2)
with multiple rare##3##3##(2012-3#3)
with multiple recurrences and##2##4##(1990-9#1)(2010-7#1)
with multiple region##2##3##(2006-7#1)(2011-2#1)
with multiple sclerosis (MS)##6##4##(2007-11#1)(2011-7#1)(2012-12#1)(2012-3#2)(2013-1#1)
with multiple sclerosis##29##3##(1991-12#1)(1991-8#2)(1994-10#1)(1995-4#3)(2006-8#1)(2007-11#3)(2007-2#1)(2009-10#1)(2010-12#3)(2011-1#1)(2011-2#3)(2011-7#1)(2012-1#1)(2012-12#2)(2012-3#4)(2013-1#1)
with multiple skin##2##3##(1996-6#1)(2007-11#1)
with multiple small-angle##2##3##(2007-12#1)(2008-2#1)
with multiple stenoses##2##3##(1992-5#2)
with multiple supernumerary teeth##2##4##(2013-1#2)
with multiple tendinous xanthomas##2##4##(1997-8#2)
with multiple##382##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-5#6)(1993-6#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-4#4)(1995-8#2)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-3#1)(1997-5#1)(1997-8#2)(2005-1#2)(2005-10#2)(2005-11#2)(2005-12#6)(2005-8#1)(2006-10#11)(2006-12#1)(2006-2#4)(2006-3#2)(2006-4#1)(2006-6#3)(2006-7#8)(2006-8#6)(2006-9#1)(2007-1#2)(2007-10#5)(2007-11#13)(2007-12#11)(2007-2#3)(2007-4#1)(2007-5#2)(2007-7#16)(2007-8#6)(2008-1#8)(2008-10#15)(2008-11#3)(2008-12#3)(2008-2#7)(2008-3#5)(2008-4#6)(2008-5#9)(2008-6#7)(2008-7#8)(2008-8#5)(2008-9#5)(2009-10#2)(2009-3#1)(2009-4#4)(2009-5#3)(2009-6#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#6)(2010-2#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#8)(2011-2#23)(2011-3#1)(2011-7#1)(2012-1#5)(2012-12#15)(2012-2#3)(2012-3#10)(2013-1#14)(2013-7#1)(2013-8#6)
with multiple-choice questions##2##3##(2008-11#1)(2012-1#1)
with multiple-scattering##3##2##(2008-2#1)(2008-3#2)
with multiples##2##2##(2008-11#2)
with multiplex##3##2##(1997-5#1)(2007-11#1)(2013-1#1)
with multiply##2##2##(1993-8#1)(1995-11#1)
with multislice computed tomography##2##4##(2008-7#1)(2009-4#1)
with multislice##3##2##(2006-4#1)(2008-7#1)(2009-4#1)
with multistage##2##2##(2007-12#1)(2011-2#1)
with multisystem##3##2##(1996-12#1)(2012-12#2)
with multivalent##2##2##(1991-12#1)(2006-12#1)
with multivariate calibration##4##3##(2008-10#3)(2010-5#1)
with multivariate##10##2##(1992-12#1)(2008-10#6)(2008-11#1)(2010-5#1)(2013-7#1)
with multiwall carbon##2##3##(2007-11#1)(2008-10#1)
with multiwavelength##2##2##(2007-12#1)(2008-3#1)
with municipal##2##2##(1995-9#1)(2010-1#1)
with mupirocin##3##2##(2007-7#2)(2013-7#1)
with mural nodule##2##3##(2012-12#2)
with murine##7##2##(1990-5#1)(1995-3#1)(1997-4#1)(2006-4#1)(2008-10#1)(2008-4#2)
with muscarinic receptor##2##3##(1994-9#1)(2010-12#1)
with muscarinic##4##2##(1994-9#1)(1997-7#1)(2006-10#1)(2010-12#1)
with muscle fibers##2##3##(1991-11#1)(1995-3#1)
with muscle weakness##2##3##(2006-4#1)(2006-8#1)
with muscle##12##2##(1991-11#1)(1995-3#1)(2005-10#1)(2006-4#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-2#1)
with muscular atrophy##3##3##(1990-4#3)
with muscular##8##2##(1990-4#4)(1990-5#1)(1992-10#1)(2012-2#1)(2012-3#1)
with musculoskeletal complaints##3##3##(2007-3#1)(2007-7#1)(2008-7#1)
with musculoskeletal disorders##3##3##(2007-8#1)(2008-5#1)(2010-5#1)
with musculoskeletal##15##2##(1992-9#1)(1996-7#1)(2006-10#4)(2007-3#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-5#1)(2010-5#1)
with mushroom##2##2##(2008-10#1)(2008-6#1)
with music##4##2##(2007-6#3)(2008-9#1)
with muskmelon##2##2##(2008-10#2)
with mutant##9##2##(1990-3#1)(1994-12#1)(1996-11#1)(1997-1#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-12#1)
with mutated##5##2##(1996-4#2)(1997-2#1)(1997-5#1)(2008-11#1)
with mutations at the##2##4##(1992-9#1)(2008-10#1)
with mutations in the##7##4##(1996-7#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-12#1)(2011-2#1)(2012-1#1)
with mutations in##11##3##(1996-3#2)(1996-7#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
with mutations of##2##3##(2007-10#1)(2008-5#1)
with mutations within the##2##4##(1992-9#1)(2009-3#1)
with mutations##21##2##(1992-9#2)(1995-1#1)(1996-3#2)(1996-7#1)(2007-10#1)(2007-9#1)(2008-10#2)(2008-5#2)(2008-8#2)(2009-12#1)(2009-3#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
with mutual##6##2##(1990-12#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-7#1)
with mutually##2##2##(1994-9#1)(2007-12#1)
with my##5##2##(1992-3#1)(2010-1#2)(2010-10#1)(2010-8#1)
with myasthenia gravis##13##3##(1991-2#1)(1991-4#1)(2006-10#1)(2007-8#6)(2012-2#2)(2012-3#1)(2013-7#1)
with myc##2##2##(1991-5#1)(2008-11#1)
with mycelial compatibility##2##3##(2008-10#2)
with mycelial##4##2##(1993-4#1)(2008-10#3)
with mycelium of##2##3##(2008-10#2)
with mycelium##7##2##(1994-8#1)(2008-10#6)
with mycobacteria##4##2##(1996-10#1)(2008-4#2)(2011-2#1)
with mycophenolate mofetil##4##3##(2005-8#1)(2007-11#2)(2007-8#1)
with mycosis fungoides##2##3##(1992-5#1)(2007-8#1)
with mycotoxins##3##2##(2008-10#2)(2010-7#1)
with myelodysplastic syndrome##5##3##(2005-7#1)(2006-10#2)(2007-9#2)
with myelodysplastic syndromes##2##3##(1992-12#1)(2008-11#1)
with myelodysplastic##9##2##(1992-12#1)(2005-7#1)(2006-10#2)(2007-9#2)(2008-11#1)(2008-5#1)(2012-2#1)
with myeloid##3##2##(1991-3#1)(2009-8#1)(2010-11#1)
with myeloma##9##2##(1990-9#1)(1996-9#1)(1997-4#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-4#1)
with myelomeningocele##2##2##(2009-3#1)(2010-3#1)
with myelosuppressive chemotherapy##2##3##(2005-11#1)(2010-9#1)
with myocardial infarction (MI)##3##4##(2010-12#1)(2012-12#1)(2013-1#1)
with myocardial infarction and stroke in##2##6##(2009-9#2)
with myocardial infarction and stroke##3##5##(2009-9#3)
with myocardial infarction and##7##4##(1996-9#1)(2008-8#1)(2009-9#3)(2011-1#1)(2012-1#1)
with myocardial infarction can##2##4##(1994-3#1)(2012-1#1)
with myocardial infarction##28##3##(1990-6#1)(1993-9#1)(1994-3#1)(1996-2#3)(1996-9#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-9#4)(2010-12#1)(2010-7#1)(2011-1#1)(2012-1#6)(2012-12#1)(2013-1#1)
with myocardial ischemia##4##3##(2007-8#1)(2008-5#1)(2010-12#1)(2012-3#1)
with myocardial##37##2##(1990-6#1)(1991-9#1)(1993-9#1)(1994-3#1)(1996-2#3)(1996-7#1)(1996-9#3)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-9#4)(2010-12#2)(2010-7#1)(2011-1#1)(2012-1#6)(2012-12#1)(2012-3#1)(2013-1#1)
with myocarditis##2##2##(2009-4#1)(2013-1#1)
with myofascial##3##2##(2007-11#1)(2010-12#2)
with myogenic##2##2##(1995-6#1)(2008-11#1)
with myosin subfragment-1##2##3##(1995-2#1)(1995-3#1)
with myosin##10##2##(1990-7#1)(1992-5#2)(1994-5#1)(1995-2#3)(1995-3#1)(1996-11#1)(2011-2#1)
with myxoid##3##2##(1993-2#2)(2006-10#1)
with n =##2##3##(1994-12#1)(1996-2#1)
with n##8##2##(1994-12#1)(1996-2#1)(2007-9#2)(2008-10#2)(2008-2#1)(2008-3#1)
with n-3##4##2##(2010-4#3)(2012-1#1)
with n-butanol##2##2##(2008-10#1)(2008-5#1)
with n-butyl##2##2##(1992-2#1)(2008-10#1)
with n-hexane and##4##3##(2005-12#1)(2008-10#3)
with n-hexane##10##2##(1990-8#1)(1992-2#1)(2005-12#2)(2008-10#6)
with nafamostat mesilate##4##3##(2012-12#4)
with nail##5##2##(2007-7#1)(2007-8#2)(2012-2#2)
with nanometer##5##2##(2006-12#1)(2007-12#2)(2008-10#1)(2008-3#1)
with nanomolar affinities##2##3##(1996-11#1)(2008-5#1)
with nanomolar##3##2##(1994-3#1)(1996-11#1)(2008-5#1)
with nanoparticle##4##2##(2007-12#2)(2009-11#1)(2010-7#1)
with nanoparticles##4##2##(2008-10#1)(2008-7#2)(2009-11#1)
with nanoscale##3##2##(2008-7#3)
with nanostructured##4##2##(2006-5#3)(2007-2#1)
with nanotechnology##4##2##(2008-11#1)(2008-7#1)(2010-12#1)(2010-7#1)
with naphthalene##2##2##(1994-9#1)(2008-10#1)
with naphthalene-2##3##2##(1996-12#1)(2008-10#2)
with naproxen##3##2##(1990-9#1)(1994-3#1)(2008-10#1)
with narcotics##2##2##(1990-10#1)(2005-10#1)
with narrow bandwidth##2##3##(2007-11#1)(2008-2#1)
with narrow linewidth##2##3##(2007-12#1)(2008-2#1)
with narrow therapeutic index##2##4##(2008-7#1)(2011-1#1)
with narrow##18##2##(1990-12#1)(1990-4#1)(2007-11#1)(2007-12#1)(2007-5#2)(2008-10#3)(2008-2#4)(2008-5#1)(2008-7#1)(2010-3#1)(2011-1#1)(2011-2#1)
with narrow-band##6##2##(2007-12#1)(2008-2#2)(2008-3#1)(2011-1#2)
with narrow-bandwidth##2##2##(2007-11#1)(2007-12#1)
with nasal##15##2##(1993-2#1)(1997-4#1)(2007-6#1)(2007-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
with nascent polypeptide chains##3##4##(1996-4#3)
with nascent##5##2##(1990-12#1)(1996-4#3)(2008-6#1)
with nasopharyngeal carcinoma (NPC)##2##4##(1990-5#1)(1991-7#1)
with nasopharyngeal carcinoma##4##3##(1990-5#1)(1991-7#1)(2008-9#1)(2009-9#1)
with nasopharyngeal##5##2##(1990-5#1)(1991-7#1)(2008-9#1)(2009-9#1)(2013-8#1)
with national and international##2##4##(2012-3#1)(2013-8#1)
with national and##3##3##(2012-12#1)(2012-3#1)(2013-8#1)
with national##13##2##(1993-9#1)(2006-5#1)(2007-12#2)(2008-11#1)(2008-7#1)(2010-8#3)(2012-12#1)(2012-3#1)(2013-8#2)
with native and##3##3##(1990-4#1)(1990-7#1)(1997-2#1)
with native enzyme##3##3##(1990-12#1)(1992-3#1)(1995-2#1)
with native##35##2##(1990-12#1)(1990-2#2)(1990-4#1)(1990-7#2)(1992-1#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-11#1)(1996-4#1)(1997-2#1)(1997-4#1)(2007-7#1)(2008-10#6)(2008-4#2)(2008-9#1)(2009-8#1)(2013-1#1)
with natural light##2##3##(2008-3#2)
with natural stimuli##2##3##(2008-7#2)
with natural##34##2##(1990-12#1)(1991-2#1)(1994-8#1)(1995-12#1)(1996-4#1)(1997-2#1)(2005-10#1)(2006-10#2)(2007-10#2)(2007-8#1)(2008-10#3)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-9#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
with naturally occurring##2##3##(2008-10#2)
with naturally##7##2##(2008-10#5)(2008-7#1)(2012-2#1)
with nature##5##2##(1991-6#1)(1994-3#1)(2010-12#1)(2012-2#2)
with nausea and vomiting##4##4##(1995-7#2)(1996-1#1)(2007-8#1)
with nausea##8##2##(1990-6#1)(1995-7#2)(1996-1#1)(2007-8#1)(2008-7#1)(2011-1#1)(2012-2#1)
with near infrared##3##3##(2008-10#1)(2011-1#2)
with near##6##2##(2007-12#1)(2008-10#1)(2010-3#1)(2011-1#3)
with near-Nernstian slope of##2##4##(2008-10#2)
with near-Nernstian##3##2##(2008-10#3)
with near-field scanning optical microscopy##2##5##(2008-3#2)
with near-infrared light##2##3##(2007-12#1)(2008-3#1)
with near-infrared spectroscopy##2##3##(1997-6#1)(2011-1#1)
with near-infrared##10##2##(1997-6#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#4)(2011-1#1)
with near-unity conversion efficiency##2##4##(2007-11#2)
with nearby amino##2##3##(1990-7#1)(1995-11#1)
with nearby##5##2##(1990-7#1)(1995-11#1)(2007-12#1)(2008-10#1)(2012-2#1)
with nearly 100%##3##3##(1996-6#1)(2007-12#1)(2008-10#1)
with nearly equal affinity##2##4##(1990-2#1)(1990-4#1)
with nearly equal##4##3##(1990-12#1)(1990-2#1)(1990-4#1)(2009-12#1)
with nearly identical##2##3##(1992-2#1)(2011-1#1)
with nearly##25##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-9#1)(1991-3#1)(1992-2#1)(1996-6#1)(2005-11#1)(2007-11#1)(2007-12#5)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-8#1)(2009-12#1)(2010-4#1)(2010-9#1)(2011-1#1)
with necessary##3##2##(2005-11#1)(2007-8#1)(2012-12#1)
with neck pain and##3##4##(1991-8#1)(2008-12#1)(2009-3#1)
with neck pain##11##3##(1991-8#1)(2005-10#1)(2007-7#1)(2008-11#1)(2008-12#4)(2009-3#1)(2009-9#1)(2010-12#1)
with neck##24##2##(1991-8#2)(2005-10#1)(2007-1#1)(2007-11#1)(2007-7#2)(2008-10#1)(2008-11#3)(2008-12#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-12#1)(2012-3#1)(2013-1#2)
with necrosis and##5##3##(2007-11#1)(2008-10#1)(2008-12#1)(2008-9#2)
with necrosis of##2##3##(1997-6#1)(2009-6#1)
with necrosis##9##2##(1997-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-9#2)(2009-6#1)(2012-1#1)
with necrotic##4##2##(2008-10#1)(2008-5#1)(2008-9#1)(2010-12#1)
with necrotizing##7##2##(1991-11#1)(2005-9#1)(2006-10#1)(2007-2#1)(2011-1#1)(2012-2#1)(2012-3#1)
with nectar##3##2##(2007-12#2)(2008-10#1)
with need of##2##3##(1991-6#1)(2013-1#1)
with need##4##2##(1991-6#1)(1996-11#1)(2007-8#1)(2013-1#1)
with needle electrodes##2##3##(1996-12#1)(2006-12#1)
with needle##6##2##(1996-12#1)(2006-12#1)(2006-7#1)(2008-10#2)(2013-1#1)
with needles##2##2##(2007-9#1)(2008-10#1)
with negative blood cultures##3##4##(1992-4#1)(2006-4#2)
with negative blood##4##3##(1992-4#1)(2006-4#2)(2007-9#1)
with negative charges##3##3##(2007-8#1)(2008-10#1)(2008-5#1)
with negative consequences for##2##4##(2007-12#1)(2008-9#1)
with negative ion electrospray##2##4##(2008-10#1)(2011-1#1)
with negative margins##3##3##(1994-6#1)(2011-2#1)(2012-12#1)
with negative nodes##2##3##(1990-3#1)(2011-2#1)
with negative nonlinear phase##2##4##(2007-12#2)
with negative symptoms##5##3##(1996-2#1)(1997-2#1)(1997-8#1)(2008-6#1)(2009-11#1)
with negative viscosity##2##3##(2012-1#2)
with negative##55##2##(1990-1#1)(1990-3#1)(1990-7#1)(1991-4#1)(1991-5#1)(1992-4#1)(1993-4#1)(1994-12#1)(1994-6#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-8#2)(2006-10#1)(2006-3#1)(2006-4#2)(2006-7#1)(2006-8#1)(2007-12#4)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#1)(2010-2#1)(2010-3#2)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#1)
with negatively charged##3##3##(2008-10#1)(2010-5#2)
with neglect##3##2##(1995-12#1)(2006-3#1)(2007-3#1)
with negligible##13##2##(1991-7#1)(1995-2#1)(1996-6#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2010-12#1)(2012-2#2)
with neighboring##8##2##(1991-4#1)(1992-9#1)(1994-3#1)(1995-11#1)(1997-7#1)(2008-11#1)(2008-12#1)(2010-12#1)
with neither##9##2##(1996-3#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-4#1)(2009-2#1)(2011-1#1)(2011-12#1)
with nematode##3##2##(2008-10#1)(2008-12#2)
with nematodes##2##2##(2008-10#2)
with neoadjuvant chemotherapy##3##3##(1990-12#1)(1994-2#1)(2009-4#1)
with neoadjuvant##6##2##(1990-12#1)(1994-2#2)(2009-4#3)
with neodymium##3##2##(2006-10#1)(2008-10#1)(2008-2#1)
with neonatal##12##2##(1991-1#1)(1993-5#2)(1994-3#1)(1994-6#1)(1997-1#2)(2008-1#1)(2008-5#1)(2010-6#1)(2012-1#1)(2012-12#1)
with neoplasia##5##2##(1991-8#1)(1996-4#1)(2011-2#1)(2013-8#2)
with neoplasms of##2##3##(1993-9#1)(2007-7#1)
with neoplasms##4##2##(1993-5#1)(1993-9#1)(2004-1#1)(2007-7#1)
with neoplastic disease##5##3##(1991-2#1)(1992-10#1)(2007-11#2)(2007-7#1)
with neoplastic lesions##2##3##(1993-9#1)(2012-3#1)
with neoplastic transformation##3##3##(1990-8#1)(2007-12#2)
with neoplastic##17##2##(1990-8#1)(1991-2#1)(1992-10#1)(1992-3#1)(1992-4#3)(1993-9#1)(2006-12#1)(2007-11#2)(2007-12#2)(2007-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
with neovascular AMD##2##3##(2009-8#1)(2010-2#1)
with neovascular ARMD##2##3##(2011-1#2)
with neovascular age-related##2##3##(2009-8#1)(2010-2#1)
with neovascular##6##2##(2009-8#2)(2010-2#2)(2011-1#2)
with nephrolithiasis##5##2##(1996-12#3)(2007-11#1)(2011-2#1)
with nephrology##2##2##(2006-5#1)(2007-7#1)
with nephropathy##3##2##(2008-1#1)(2009-2#1)(2010-12#1)
with nephrotic range of proteinuria##2##5##(2008-5#2)
with nephrotic syndrome##7##3##(2007-11#1)(2007-3#1)(2008-1#3)(2009-6#2)
with nephrotic##10##2##(2006-7#1)(2007-11#1)(2007-3#1)(2008-1#3)(2008-5#2)(2009-6#2)
with nerve growth factor (NGF)##3##5##(1991-2#1)(1993-11#1)(1996-8#1)
with nerve growth factor##5##4##(1991-2#1)(1993-11#1)(1994-8#1)(1995-5#1)(1996-8#1)
with nerve##15##2##(1991-2#1)(1993-11#1)(1993-9#1)(1994-8#1)(1995-5#1)(1995-9#1)(1996-3#1)(1996-8#2)(1997-2#1)(2007-8#1)(2008-11#2)(2008-5#1)(2008-9#1)
with nesiritide##2##2##(2008-3#2)
with nested##2##2##(1992-9#1)(1994-12#1)
with net positive##2##3##(2007-11#1)(2007-12#1)
with net##8##2##(1990-9#1)(1996-5#1)(2007-11#1)(2007-12#2)(2008-11#1)(2013-8#2)
with network##3##2##(2008-1#1)(2008-7#1)(2009-7#1)
with neural blockade##2##3##(2006-7#1)(2006-8#1)
with neural network##3##3##(1994-9#1)(2008-10#1)(2013-7#1)
with neural tube##2##3##(2008-8#1)(2010-5#1)
with neural##13##2##(1992-8#1)(1994-9#1)(2006-7#1)(2006-8#2)(2008-10#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-5#1)(2012-1#2)(2013-7#1)
with neural-network##2##2##(2008-3#2)
with neuraminidase##5##2##(1990-11#1)(1990-4#1)(1994-12#1)(1994-8#1)(1995-11#1)
with neurites##2##2##(2008-11#2)
with neuroacanthocytosis##2##2##(2008-7#2)
with neurobiotin##2##2##(1996-9#1)(2007-12#1)
with neuroblastoma##6##2##(1995-7#1)(2008-2#1)(2009-1#1)(2009-12#1)(2011-2#2)
with neurodegenerative##2##2##(1996-8#1)(2012-1#1)
with neurodevelopmental##2##2##(2009-9#1)(2011-1#1)
with neuroendocrine##11##2##(1990-11#1)(1990-8#1)(1992-11#2)(1995-12#1)(2007-11#1)(2008-11#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-9#1)
with neurofibromatosis type 1##9##4##(2007-12#1)(2007-8#1)(2009-1#2)(2011-1#1)(2013-1#4)
with neurofibromatosis##14##2##(1991-12#1)(1997-3#1)(2006-11#1)(2007-12#1)(2007-8#1)(2008-6#2)(2009-1#2)(2011-1#1)(2013-1#4)
with neurogenic##4##2##(1995-9#1)(2007-7#1)(2008-10#1)(2009-3#1)
with neurohormonal##2##2##(1996-6#1)(2008-2#1)
with neurologic##9##2##(1994-5#1)(2006-10#3)(2007-11#1)(2008-7#1)(2010-12#2)(2013-7#1)
with neurological and##2##3##(2009-10#1)(2012-12#1)
with neurological complications##2##3##(2007-11#1)(2011-2#1)
with neurological deficit due to##2##5##(2008-12#1)(2013-1#1)
with neurological deficits##3##3##(1993-12#1)(2007-7#1)(2011-2#1)
with neurological deterioration##2##3##(1996-9#1)(2012-12#1)
with neurological disease##2##3##(2008-7#1)(2010-12#1)
with neurological symptoms##5##3##(1991-8#1)(1994-4#1)(1997-6#1)(2007-11#1)(2008-6#1)
with neurological##30##2##(1990-2#2)(1991-8#1)(1993-12#1)(1993-2#1)(1994-10#1)(1994-4#1)(1994-8#1)(1996-9#1)(1997-6#1)(2007-11#3)(2007-7#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-10#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
with neurologists##2##2##(1993-10#1)(2008-1#1)
with neurology##2##2##(2007-10#1)(2010-12#1)
with neuromuscular disease##3##3##(2006-10#1)(2007-10#1)(2008-7#1)
with neuromuscular disorders##3##3##(2007-10#1)(2009-3#1)(2010-3#1)
with neuromuscular##11##2##(2006-10#1)(2006-8#2)(2007-10#2)(2008-7#4)(2009-3#1)(2010-3#1)
with neuronal properties##2##3##(1992-6#2)
with neuronal##15##2##(1991-8#1)(1992-6#2)(1994-2#1)(1995-11#1)(1995-3#1)(1996-1#1)(2008-7#2)(2008-8#1)(2009-6#1)(2009-8#1)(2010-12#1)(2012-1#1)(2012-12#1)
with neurons in##2##3##(1996-2#1)(2011-2#1)
with neurons##5##2##(1996-12#1)(1996-2#1)(2009-3#1)(2011-2#2)
with neuropathic pain##3##3##(2005-8#1)(2008-6#1)(2008-9#1)
with neuropathic symptoms##3##3##(2006-10#1)(2013-1#2)
with neuropathic##9##2##(2005-8#1)(2006-10#2)(2008-6#1)(2008-7#1)(2008-9#2)(2013-1#2)
with neuropathological studies##2##3##(2008-11#1)(2008-7#1)
with neuropathological##3##2##(2008-11#1)(2008-7#1)(2012-12#1)
with neuropathology##2##2##(2008-2#1)(2008-7#1)
with neuropathy##4##2##(1990-9#1)(1997-2#1)(2009-8#1)(2012-12#1)
with neuropeptide Y##2##3##(1995-12#1)(1997-5#1)
with neuropeptide##3##2##(1995-12#1)(1996-12#1)(1997-5#1)
with neuropsychiatric##2##2##(2008-2#1)(2008-9#1)
with neuropsychological##3##2##(2005-10#1)(2006-2#1)(2009-10#1)
with neurotensin##3##2##(1991-5#1)(1996-6#2)
with neurotransmitter##2##2##(1993-2#1)(2008-11#1)
with neurotrophins##2##2##(1996-5#1)(2009-10#1)
with neutral red##3##3##(1995-12#1)(2010-5#2)
with neutral##10##2##(1995-12#1)(2006-10#1)(2008-10#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
with neutralizing##3##2##(2008-4#1)(2008-5#1)(2008-6#1)
with neutron##2##2##(2007-8#1)(2008-5#1)
with neutron-induced (186)Os and (188)Os##2##5##(2008-10#2)
with neutropenia##4##2##(2007-2#1)(2012-12#3)
with neutrophil##2##2##(1994-11#1)(2010-4#1)
with neutrophilia##2##2##(2008-4#1)(2013-1#1)
with never##2##2##(2006-2#1)(2007-12#1)
with nevoid basal-cell carcinoma syndrome##2##5##(1994-10#2)
with nevoid##3##2##(1994-10#2)(1997-3#1)
with nevus of Ito##2##4##(2007-7#2)
with new and more##2##4##(2006-10#1)(2008-11#1)
with new and##3##3##(2006-10#2)(2008-11#1)
with new data##3##3##(2008-7#1)(2009-11#1)(2009-5#1)
with new dimensions##2##3##(2008-10#1)(2012-12#1)
with new information##2##3##(2008-10#1)(2013-7#1)
with new onset##2##3##(2010-3#1)(2011-1#1)
with new procedures##2##3##(2008-10#1)(2008-7#1)
with new records for##2##4##(2008-10#1)(2008-6#1)
with new technologies##2##3##(2008-11#1)(2010-2#1)
with new ways of##2##4##(2008-10#1)(2010-12#1)
with new##88##2##(1990-10#1)(1990-11#1)(1990-5#1)(1990-7#1)(1990-8#1)(1992-3#1)(1993-11#1)(1994-3#1)(1995-5#2)(1996-12#1)(1996-3#1)(1997-4#1)(2004-4#1)(2005-8#2)(2006-10#4)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-4#2)(2007-9#1)(2008-10#7)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2011-3#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
with new-onset##2##2##(2007-2#1)(2012-3#1)
with newborn screening##2##3##(2006-7#1)(2008-5#1)
with newer##10##2##(2005-11#1)(2005-3#1)(2006-10#2)(2007-7#1)(2008-7#1)(2009-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
with newly designed##2##3##(2008-7#1)(2008-9#1)
with newly developed##2##3##(1992-6#1)(1995-12#1)
with newly diagnosed diabetes##2##4##(2012-3#1)(2013-1#1)
with newly diagnosed type 1 diabetes##2##6##(2009-8#1)(2011-1#1)
with newly diagnosed type##3##4##(2009-8#1)(2011-1#1)(2012-3#1)
with newly diagnosed##25##3##(1991-7#1)(1993-1#2)(1994-12#1)(1996-11#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
with newly##36##2##(1990-11#1)(1991-7#1)(1992-6#1)(1993-1#2)(1994-12#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-11#1)(1997-1#1)(2005-1#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
with newly-diagnosed SpLD##2##3##(2013-1#2)
with nickel##4##2##(2007-10#1)(2008-10#3)
with nickel(II)##4##2##(1997-7#2)(2007-11#1)(2008-10#1)
with nicotine (10##2##3##(1990-2#1)(2010-8#1)
with nicotine##8##2##(1990-2#1)(1993-2#1)(1996-10#1)(2007-10#1)(2010-4#1)(2010-8#1)(2011-1#1)(2013-1#1)
with nicotinic acetylcholine##2##3##(1996-1#1)(2008-8#1)
with nicotinic##3##2##(1994-6#1)(1996-1#1)(2008-8#1)
with nifedipine in##2##3##(1990-8#1)(1991-5#1)
with nifedipine##7##2##(1990-8#2)(1991-5#1)(1992-2#1)(1994-11#1)(2008-3#1)(2011-2#1)
with nighttime##2##2##(2008-10#1)(2008-3#1)
with nikkomycin##2##2##(1992-8#1)(1997-4#1)
with nimodipine##6##2##(1990-12#1)(1993-11#2)(1996-12#1)(1997-8#1)(2004-12#1)
with nine known##2##3##(2013-1#2)
with nine##14##2##(1990-12#1)(1990-9#1)(1996-8#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#3)(2008-9#1)(2010-11#1)(2013-1#2)
with ninhydrin##2##2##(2008-9#1)(2010-2#1)
with niobium(V) oxide##5##3##(2008-10#3)(2008-3#2)
with nitrates##2##2##(2005-1#1)(2010-7#1)
with nitric acid and hydrogen peroxide##3##6##(2008-10#2)(2013-7#1)
with nitric acid and##7##4##(1996-3#1)(2008-10#4)(2008-5#1)(2013-7#1)
with nitric acid to##2##4##(2008-10#2)
with nitric acid##15##3##(1995-6#1)(1996-3#1)(2008-10#11)(2008-5#1)(2013-7#1)
with nitric oxide##4##3##(1992-3#1)(1994-11#1)(1994-5#1)(2006-10#1)
with nitric##19##2##(1992-3#1)(1994-11#1)(1994-5#1)(1995-6#1)(1996-3#1)(2006-10#1)(2008-10#11)(2008-5#1)(2013-7#1)
with nitrite in##2##3##(1990-6#1)(2008-10#1)
with nitrite##8##2##(1990-6#2)(1996-2#1)(2008-10#4)(2012-2#1)
with nitrogen adsorption##2##3##(2005-11#2)
with nitrogen fixation##4##3##(1990-6#2)(2009-7#2)
with nitrogen##14##2##(1990-6#2)(1997-8#1)(2005-11#2)(2008-10#3)(2008-3#1)(2008-6#1)(2008-9#1)(2009-7#2)(2013-1#1)
with no added##2##3##(2004-11#1)(2010-2#1)
with no additional##4##3##(2006-8#1)(2007-12#1)(2008-10#1)(2011-12#1)
with no age##2##3##(2005-8#1)(2007-11#1)
with no antecedent##2##3##(2007-7#1)(2008-9#1)
with no apparent change in the##2##6##(1990-3#1)(1997-7#1)
with no apparent##11##3##(1990-3#1)(1992-7#1)(1993-8#1)(1994-3#1)(1995-2#1)(1995-7#1)(1997-7#1)(2006-8#1)(2007-11#1)(2008-5#1)(2010-12#1)
with no appreciable##2##3##(2008-11#1)(2008-3#1)
with no cardiovascular risk factors##2##5##(2013-1#1)(2013-8#1)
with no cases##3##3##(2007-10#1)(2007-7#1)(2011-1#1)
with no change in KD##2##5##(1995-7#2)
with no change in the percentage of##2##7##(1990-11#1)(1993-11#1)
with no change in the##6##5##(1990-11#1)(1992-2#1)(1993-11#1)(2008-6#1)(2010-5#1)(2013-8#1)
with no change in##17##4##(1990-11#1)(1992-2#3)(1992-6#1)(1993-11#2)(1995-11#1)(1995-12#1)(1995-7#2)(1996-10#1)(1996-5#1)(2006-12#1)(2008-6#1)(2010-5#1)(2013-8#1)
with no change##18##3##(1990-11#1)(1992-2#3)(1992-6#1)(1993-11#2)(1995-11#1)(1995-12#1)(1995-7#2)(1996-10#1)(1996-5#1)(2006-12#1)(2008-6#1)(2009-11#1)(2010-5#1)(2013-8#1)
with no changes in the##2##5##(1996-4#1)(2005-7#1)
with no changes in##4##4##(1992-2#1)(1996-4#1)(2005-7#1)(2012-3#1)
with no changes##6##3##(1992-2#1)(1994-5#1)(1996-4#1)(2005-7#1)(2012-3#1)(2013-8#1)
with no clear##5##3##(2006-10#1)(2009-6#1)(2010-2#1)(2010-8#1)(2013-8#1)
with no clinical symptoms##2##4##(1994-5#1)(2006-8#1)
with no clinical##7##3##(1994-5#1)(2006-10#1)(2006-8#1)(2006-9#1)(2012-3#1)(2013-1#2)
with no close affected relatives##2##5##(2008-1#2)
with no complications##8##3##(1996-9#1)(2004-10#1)(2006-3#1)(2007-1#1)(2007-8#1)(2008-7#1)(2012-2#1)(2013-1#1)
with no correlation##2##3##(1991-2#1)(1993-5#1)
with no curative##2##3##(2008-5#2)
with no detectable##12##3##(1991-9#1)(1992-10#1)(1992-12#2)(1993-12#1)(1993-7#1)(1995-4#1)(1996-5#1)(2008-10#3)(2008-7#1)
with no difference between the##4##5##(1993-4#1)(1995-8#1)(1996-7#1)(2011-2#1)
with no difference in the##5##5##(1991-6#1)(2006-10#1)(2008-7#1)(2010-12#1)(2012-12#1)
with no difference in##11##4##(1991-6#1)(1993-2#1)(1995-11#1)(2006-10#2)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
with no difference##16##3##(1991-6#1)(1993-2#1)(1993-4#1)(1995-11#1)(1995-8#1)(1996-7#1)(2006-10#2)(2008-4#1)(2008-7#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
with no differences between 2% fat level and control group##2##10##(2012-2#2)
with no differences between##3##4##(1996-12#1)(2012-2#2)
with no differences in##2##4##(1992-4#1)(1996-5#1)
with no differences##5##3##(1992-4#1)(1996-12#1)(1996-5#1)(2012-2#2)
with no direct##2##3##(1990-2#1)(1995-10#1)
with no disease##2##3##(2009-2#1)(2012-12#1)
with no distinct##2##3##(1991-4#1)(2013-1#1)
with no distinction##2##3##(1991-7#1)(2009-5#1)
with no effect on the##3##5##(1993-3#1)(2007-11#1)(2013-8#1)
with no effect on##14##4##(1990-4#1)(1991-2#1)(1991-3#1)(1993-3#1)(1994-6#1)(1994-8#1)(1995-6#2)(1996-1#1)(2007-11#2)(2008-4#1)(2008-8#1)(2013-8#1)
with no effect##15##3##(1990-4#1)(1991-2#1)(1991-3#1)(1993-3#1)(1994-6#1)(1994-8#1)(1995-6#2)(1996-1#1)(1996-3#1)(2007-11#2)(2008-4#1)(2008-8#1)(2013-8#1)
with no effective treatment##2##4##(2007-8#1)(2013-1#1)
with no effective##3##3##(1990-9#1)(2007-8#1)(2013-1#1)
with no evidence for##2##4##(1995-2#1)(2008-9#1)
with no evidence of adverse##2##5##(2007-11#1)(2007-12#1)
with no evidence of disease for##2##6##(2007-8#1)(2008-10#1)
with no evidence of disease##7##5##(1992-9#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-6#2)(2012-3#1)
with no evidence of recurrence##5##5##(1993-1#1)(2006-10#1)(2007-8#1)(2008-5#1)(2013-8#1)
with no evidence of recurrent##2##5##(2007-8#1)(2008-4#1)
with no evidence of##36##4##(1992-9#2)(1993-1#1)(1994-12#1)(1994-3#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#4)(2008-10#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-11#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
with no evidence##39##3##(1992-9#2)(1993-1#1)(1994-12#1)(1994-3#1)(1995-2#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#4)(2008-10#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-11#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
with no exposure##2##3##(1994-2#1)(2011-2#1)
with no expression in##2##4##(1991-2#1)(2006-12#1)
with no external##3##3##(2005-10#1)(2007-11#1)(2010-11#1)
with no family history of##2##5##(2011-1#1)(2011-2#1)
with no family##4##3##(2007-7#1)(2008-7#1)(2011-1#1)(2011-2#1)
with no food##2##3##(1993-6#1)(2005-7#1)
with no formal##2##3##(2008-7#1)(2011-1#1)
with no functional##2##3##(2007-11#1)(2010-3#1)
with no further##6##3##(2008-10#1)(2008-8#1)(2009-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
with no heterogeneity between trials##2##5##(2013-8#2)
with no history of diabetes##2##5##(2007-2#1)(2009-6#1)
with no history of head##2##5##(2005-9#1)(2010-1#1)
with no history of##18##4##(2005-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-7#2)(2009-10#1)(2009-6#1)(2010-1#1)(2010-9#2)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
with no homology to##2##4##(1991-11#1)(1997-2#1)
with no homology##3##3##(1991-11#1)(1997-2#1)(2008-10#1)
with no identifiable risk##2##4##(1992-9#1)(2009-5#1)
with no identifiable##4##3##(1992-9#1)(1995-1#1)(2007-10#1)(2009-5#1)
with no incidence of##2##4##(2008-7#1)(2009-12#1)
with no interference from##3##4##(2008-10#2)(2011-1#1)
with no interference##5##3##(2008-10#4)(2011-1#1)
with no known##10##3##(1992-11#1)(1997-4#1)(2006-10#1)(2006-3#1)(2008-10#2)(2008-11#1)(2010-12#1)(2010-3#1)(2012-3#1)
with no local recurrence##2##4##(2010-7#1)(2013-8#1)
with no loss of##5##4##(1996-2#1)(2005-8#1)(2008-10#1)(2008-7#1)(2010-3#1)
with no loss##6##3##(1996-2#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-3#1)
with no major##2##3##(1990-11#1)(1993-3#1)
with no measurable##3##3##(1992-1#1)(2008-10#1)(2008-2#1)
with no migration##2##3##(2007-9#2)
with no more than 30 case reports so far (Chadha et al##2##12##(2013-1#2)
with no more than##3##4##(2011-1#1)(2013-1#2)
with no more##4##3##(2007-7#1)(2011-1#1)(2013-1#2)
with no mortality##2##3##(2007-3#1)(2008-5#1)
with no moving parts##3##4##(2007-12#1)(2008-11#1)(2008-3#1)
with no moving##4##3##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)
with no need for##7##4##(2007-8#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-1#1)
with no need##9##3##(2007-8#3)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-1#1)
with no negative##3##3##(1992-4#1)(2006-10#1)(2007-12#1)
with no neurological deficits##3##4##(2008-7#1)(2009-3#1)(2011-1#1)
with no new##3##3##(2006-11#1)(2008-3#2)
with no noticeable##2##3##(1992-7#1)(2007-2#1)
with no observed##2##3##(2007-7#1)(2008-8#1)
with no obvious##2##3##(1996-1#1)(2011-2#1)
with no occupational exposure to##2##5##(2008-10#1)(2013-1#1)
with no occupational##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
with no or##5##3##(1995-11#1)(1997-2#1)(1997-6#1)(2004-2#1)(2009-9#1)
with no other##9##3##(1992-9#1)(2006-6#1)(2006-8#1)(2007-7#1)(2009-1#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
with no overt##2##3##(1995-12#1)(2011-11#1)
with no postoperative complications##2##4##(2006-3#1)(2007-12#1)
with no previous##3##3##(2007-3#1)(2008-10#1)(2012-12#1)
with no previously##3##3##(1993-12#1)(2012-3#1)(2013-1#1)
with no prior##8##3##(2006-9#1)(2008-10#3)(2010-12#1)(2011-2#2)(2013-1#1)
with no recurrence##4##3##(2007-8#1)(2008-5#1)(2011-2#1)(2012-3#1)
with no reference##3##3##(1995-4#1)(2008-3#1)(2012-3#1)
with no reported##3##3##(2008-10#1)(2009-10#1)(2011-2#1)
with no reports of##2##4##(2006-9#1)(2008-12#1)
with no response##2##3##(2007-7#1)(2010-12#1)
with no restrictions##2##3##(2007-12#1)(2008-10#1)
with no sample##2##3##(2008-10#2)
with no sign of##4##4##(1990-4#1)(1992-9#1)(1994-3#1)(2007-12#1)
with no significant change##2##4##(1991-2#1)(2013-7#1)
with no significant changes in##3##5##(1994-9#1)(2008-5#1)(2009-5#1)
with no significant changes##4##4##(1994-9#1)(2008-5#1)(2009-5#1)(2010-1#1)
with no significant difference between the two groups##2##8##(2010-8#1)(2011-1#1)
with no significant difference between the##4##6##(1993-7#1)(2006-2#1)(2010-8#1)(2011-1#1)
with no significant difference between##5##5##(1993-7#1)(2006-2#1)(2008-10#1)(2010-8#1)(2011-1#1)
with no significant difference in##2##5##(1991-9#1)(2010-9#1)
with no significant difference##7##4##(1991-9#1)(1993-7#1)(2006-2#1)(2008-10#1)(2010-8#1)(2010-9#1)(2011-1#1)
with no significant differences between provinces (P = 0##2##9##(2013-8#2)
with no significant differences between##5##5##(2004-12#1)(2007-2#1)(2009-2#1)(2013-8#2)
with no significant differences in##2##5##(2008-5#1)(2010-12#1)
with no significant differences##10##4##(1992-9#1)(2004-12#1)(2006-8#1)(2007-2#1)(2008-5#1)(2009-12#1)(2009-2#1)(2010-12#1)(2013-8#2)
with no significant effect##2##4##(1991-3#1)(1997-5#1)
with no significant improvement of##2##5##(2008-10#1)(2012-2#1)
with no significant loss of##2##5##(2008-10#1)(2011-2#1)
with no significant loss##3##4##(1997-8#1)(2008-10#1)(2011-2#1)
with no significant##44##3##(1990-11#1)(1990-3#1)(1991-2#2)(1991-3#1)(1991-9#1)(1992-9#1)(1993-7#1)(1994-9#1)(1995-12#2)(1997-5#1)(1997-8#1)(2004-12#1)(2004-4#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-2#2)(2007-9#1)(2008-10#5)(2008-11#1)(2008-5#2)(2009-12#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-7#1)(2013-8#2)
with no signs of recurrence##3##5##(2007-2#1)(2011-12#1)(2012-12#1)
with no signs of##8##4##(1991-6#1)(1995-4#1)(2006-6#1)(2007-2#1)(2008-3#1)(2011-12#1)(2012-12#1)(2012-3#1)
with no signs##9##3##(1991-4#1)(1991-6#1)(1995-4#1)(2006-6#1)(2007-2#1)(2008-3#1)(2011-12#1)(2012-12#1)(2012-3#1)
with no similarity to##3##4##(1993-6#1)(1997-4#1)(2013-1#1)
with no specific##4##3##(2007-11#1)(2008-10#1)(2013-1#2)
with no statistically significant difference##2##5##(2012-3#1)(2013-1#1)
with no statistically significant differences##2##5##(1997-7#1)(2007-7#1)
with no statistically significant##4##4##(1997-7#1)(2007-7#1)(2012-3#1)(2013-1#1)
with no such##2##3##(2006-8#1)(2011-1#1)
with no time##2##3##(2011-2#1)(2013-8#1)
with no treatment for##2##4##(2008-10#1)(2013-1#1)
with no treatment##7##3##(1997-2#1)(2007-8#1)(2008-10#2)(2008-5#1)(2013-1#2)
with no underlying disease##2##4##(1991-2#1)(2011-1#1)
with no wavelength shift##2##4##(2008-1#2)
with no##727##2##(1990-10#1)(1990-11#5)(1990-2#2)(1990-3#2)(1990-4#2)(1990-6#1)(1990-7#2)(1990-9#2)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#8)(1991-3#3)(1991-4#2)(1991-5#4)(1991-6#3)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#2)(1992-2#6)(1992-3#2)(1992-4#2)(1992-6#2)(1992-7#4)(1992-9#6)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#2)(1993-2#3)(1993-3#2)(1993-4#1)(1993-5#3)(1993-6#2)(1993-7#4)(1993-8#2)(1994-12#2)(1994-2#2)(1994-3#4)(1994-5#2)(1994-6#4)(1994-8#3)(1994-9#2)(1995-1#2)(1995-10#2)(1995-11#4)(1995-12#6)(1995-2#3)(1995-4#3)(1995-5#1)(1995-6#3)(1995-7#3)(1995-8#1)(1996-1#3)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#3)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#4)(1997-3#1)(1997-4#4)(1997-5#2)(1997-6#1)(1997-7#4)(1997-8#2)(2004-10#1)(2004-11#2)(2004-12#1)(2004-2#2)(2004-4#2)(2005-10#4)(2005-11#1)(2005-7#2)(2005-8#3)(2005-9#2)(2006-1#1)(2006-10#13)(2006-11#3)(2006-12#7)(2006-2#2)(2006-3#3)(2006-4#1)(2006-6#4)(2006-7#1)(2006-8#7)(2006-9#4)(2007-1#1)(2007-10#6)(2007-11#13)(2007-12#16)(2007-2#6)(2007-3#2)(2007-4#3)(2007-5#2)(2007-7#18)(2007-8#15)(2007-9#6)(2008-1#7)(2008-10#57)(2008-11#9)(2008-12#6)(2008-2#8)(2008-3#19)(2008-4#8)(2008-5#17)(2008-6#6)(2008-7#21)(2008-8#6)(2008-9#6)(2009-1#2)(2009-10#4)(2009-11#2)(2009-12#3)(2009-2#4)(2009-3#2)(2009-4#2)(2009-5#4)(2009-6#2)(2009-7#1)(2009-9#1)(2010-1#4)(2010-10#3)(2010-11#6)(2010-12#9)(2010-2#4)(2010-3#4)(2010-4#1)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#6)(2010-9#5)(2011-1#12)(2011-11#2)(2011-12#4)(2011-2#26)(2012-1#3)(2012-12#11)(2012-2#13)(2012-3#12)(2013-1#26)(2013-7#2)(2013-8#23)
with noble metals##3##3##(2008-10#2)(2010-4#1)
with noble##5##2##(2007-12#2)(2008-10#2)(2010-4#1)
with nocodazole##2##2##(1991-9#1)(1996-3#1)
with nocturnal##3##2##(2010-9#1)(2013-8#2)
with nodal##4##2##(1990-3#1)(2008-10#2)(2010-4#1)
with node##3##2##(2004-1#1)(2008-10#1)(2008-8#1)
with nodular##6##2##(2006-2#1)(2006-4#1)(2008-5#1)(2010-12#1)(2011-12#1)(2012-2#1)
with nodules##2##2##(2012-3#1)(2013-7#1)
with noise exposure##2##3##(2005-11#1)(2013-1#1)
with noise##4##2##(2005-11#1)(2007-12#1)(2008-2#1)(2013-1#1)
with noisy##2##2##(2008-3#1)(2008-6#1)
with nominal##4##2##(2004-9#1)(2008-3#2)(2009-7#1)
with nominally##2##2##(2007-4#1)(2008-3#1)
with non variceal##2##3##(2011-2#2)
with non##25##2##(1990-12#1)(1990-8#1)(1991-11#1)(1992-11#1)(1994-2#1)(1994-8#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-8#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-2#4)(2012-3#1)
with non-Aboriginal##2##2##(2007-8#1)(2008-4#1)
with non-Bayesian and Bayesian##2##4##(2008-10#2)
with non-Bayesian##3##2##(2008-10#3)
with non-HLA-B27##2##2##(2008-9#1)(2012-12#1)
with non-Hodgkin lymphoma##3##3##(1990-11#1)(2009-10#1)(2010-11#1)
with non-Hodgkin##4##2##(1990-11#1)(2009-10#1)(2010-11#1)(2011-2#1)
with non-Hodgkin's lymphoma##4##3##(1991-3#1)(2007-6#1)(2008-7#2)
with non-Hodgkin's##9##2##(1991-3#1)(1991-6#1)(1992-6#1)(1993-1#1)(2007-6#1)(2008-7#2)(2010-12#2)
with non-ST elevation##2##3##(2010-2#1)(2013-8#1)
with non-ST segment elevation##2##4##(2006-10#1)(2008-3#1)
with non-ST##4##2##(2006-10#1)(2008-3#1)(2010-2#1)(2013-8#1)
with non-Stx-HUS##2##2##(2007-8#2)
with non-cleavable##2##2##(1991-6#1)(1997-5#1)
with non-commercial partners##3##3##(2012-3#3)
with non-coronary atherosclerosis##2##3##(1997-8#2)
with non-coronary chest pain##3##4##(2013-8#3)
with non-coronary##5##2##(1997-8#2)(2013-8#3)
with non-diabetic##2##2##(2006-7#1)(2011-2#1)
with non-drinkers##2##2##(1991-9#1)(2013-1#1)
with non-human primates##2##3##(2008-10#1)(2008-3#1)
with non-human##4##2##(1993-12#1)(2008-10#1)(2008-3#1)(2010-10#1)
with non-inferiority##2##2##(2012-3#2)
with non-insulin dependent diabetes##6##4##(1993-7#1)(1994-12#1)(1995-6#2)(1996-2#1)(2008-7#1)
with non-insulin-dependent diabetes mellitus##5##4##(1991-1#1)(1992-12#1)(1992-9#1)(1995-8#1)(1996-2#1)
with non-invasive##3##2##(1997-8#1)(2012-2#1)(2013-1#1)
with non-ionic surfactant##2##3##(2008-5#1)(2012-12#1)
with non-ionic##3##2##(1990-5#1)(2008-5#1)(2012-12#1)
with non-linear##4##2##(2006-10#2)(2007-9#1)(2008-10#1)
with non-malignant##6##2##(1990-2#2)(1993-2#1)(2005-12#1)(2007-8#1)(2012-12#1)
with non-native##2##2##(1997-4#1)(2009-2#1)
with non-obstructive##2##2##(2011-1#1)(2012-12#1)
with non-operative treatment##2##3##(2009-5#2)
with non-overlapping##2##2##(1990-12#1)(1995-11#1)
with non-physiological##3##2##(1996-8#1)(2006-8#2)
with non-pregnant##3##2##(1993-11#2)(1994-10#1)
with non-small cell lung cancer##9##5##(1990-10#1)(2007-8#3)(2008-1#1)(2009-3#1)(2012-3#1)(2013-1#2)
with non-small cell lung##10##4##(1990-10#1)(1990-5#1)(2007-8#3)(2008-1#1)(2009-3#1)(2012-3#1)(2013-1#2)
with non-small##11##2##(1990-10#1)(1990-5#1)(2007-8#3)(2008-1#1)(2009-3#1)(2009-4#1)(2012-3#1)(2013-1#2)
with non-specific##10##2##(1990-11#1)(1991-11#1)(1992-8#1)(2006-8#1)(2007-12#2)(2007-9#1)(2008-10#2)(2010-2#1)
with non-steroidal anti-inflammatory drugs##2##4##(1997-6#1)(2007-12#1)
with non-ulcer##3##2##(2005-1#2)(2007-3#1)
with nonactin as ionophore##2##4##(2008-10#2)
with noncollinear##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
with noncommunicating syringomyelia##2##3##(2006-5#2)
with noncommunicating##3##2##(2006-5#3)
with noncystic GBMs##2##3##(2007-12#2)
with noncystic##3##2##(2007-12#3)
with none of the##3##4##(2006-7#1)(2008-9#1)(2013-8#1)
with none of##4##3##(2006-7#1)(2008-10#1)(2008-9#1)(2013-8#1)
with none##6##2##(1991-7#1)(2006-7#1)(2008-10#1)(2008-9#1)(2010-7#1)(2013-8#1)
with nonfunctional tumors##2##3##(2008-3#2)
with nonfunctional##3##2##(2008-3#2)(2012-3#1)
with nonidentical##2##2##(2005-11#1)(2007-12#1)
with nonimaging##2##2##(2008-2#2)
with noninfectious##2##2##(1990-12#1)(1990-9#1)
with nonionic##2##2##(1991-4#1)(2008-8#1)
with nonketotic hyperglycinemia##2##3##(1990-12#2)
with nonlinear optical##2##3##(2007-12#1)(2008-3#1)
with nonlinear##14##2##(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#4)(2008-4#1)(2009-7#1)(2009-8#1)
with nonmetastatic disease and##2##4##(2010-3#2)
with nonmetastatic disease##4##3##(2010-3#4)
with nonmetastatic##5##2##(2010-3#5)
with nonmigrant##2##2##(2007-1#1)(2012-3#1)
with nonmyeloid malignancies##2##3##(2008-7#2)
with nonoverlapping##2##2##(2008-10#1)(2008-8#1)
with nonpathogenic##3##2##(2008-10#3)
with nonprescription##2##2##(1995-2#1)(2013-8#1)
with nonreactive##3##2##(1992-3#1)(2007-12#1)(2007-7#1)
with nonspecific##8##2##(1993-8#1)(1997-2#1)(2005-12#1)(2006-10#1)(2006-8#1)(2011-2#2)(2013-7#1)
with nonsteroidal anti-inflammatory##2##3##(2011-1#1)(2011-2#1)
with nonsteroidal antiinflammatory drugs##2##4##(2006-10#1)(2012-2#1)
with nonsteroidal##4##2##(2006-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
with nonsyndromic hearing impairment##2##4##(2006-10#2)
with nonsyndromic hearing loss##2##4##(2008-4#2)
with nonsyndromic hearing##4##3##(2006-10#2)(2008-4#2)
with nontreated##3##2##(2008-10#3)
with nonuniform duty ratios##2##4##(2008-3#2)
with nonuniform##5##2##(2008-2#1)(2008-3#2)(2010-4#1)(2010-6#1)
with nonunion##2##2##(2007-11#2)
with nonvascularized##2##2##(2010-6#1)(2011-2#1)
with nonverbal##3##2##(1997-5#1)(2005-10#1)(2008-11#1)
with nonviral##3##2##(1997-3#2)(2008-8#1)
with nonzero##2##2##(2007-12#1)(2010-4#1)
with nootropic##2##2##(1990-3#1)(1995-3#1)
with noradrenaline##7##2##(1990-11#1)(1994-12#1)(1995-12#3)(1996-2#2)
with norepinephrine in##2##3##(1994-12#1)(2008-11#1)
with norepinephrine##6##2##(1992-1#1)(1994-12#2)(1997-6#1)(2008-11#1)(2013-8#1)
with norfloxacin (P##2##3##(1993-2#2)
with norfloxacin##3##2##(1993-2#2)(2008-10#1)
with normal BMD##2##3##(2010-3#1)(2012-2#1)
with normal aging##2##3##(2008-10#1)(2008-5#1)
with normal and##13##3##(1991-9#1)(1994-3#1)(1995-12#1)(1997-4#1)(1997-8#1)(2005-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
with normal angiograms##2##3##(2006-10#1)(2008-7#1)
with normal aortic##2##3##(2007-8#2)
with normal arterial##2##3##(2006-4#1)(2008-7#1)
with normal blood##2##3##(2005-10#1)(2010-10#1)
with normal body weight##2##4##(1992-8#1)(2008-3#1)
with normal body##5##3##(1992-8#1)(2008-10#1)(2008-3#2)(2010-3#1)
with normal bowel##2##3##(2011-12#1)(2012-2#1)
with normal cell##2##3##(2008-11#1)(2008-6#1)
with normal cells##3##3##(1993-7#1)(1994-10#1)(2011-2#1)
with normal chromosomes##5##3##(1993-1#1)(1996-6#1)(2008-4#3)
with normal control##3##3##(2006-5#1)(2007-6#2)
with normal controls##5##3##(1997-5#1)(1997-8#1)(2005-12#1)(2006-9#1)(2008-7#1)
with normal dispersion##2##3##(2007-11#1)(2007-12#1)
with normal echocardiography##2##3##(1991-11#1)(2007-8#1)
with normal fasting##2##3##(1990-8#1)(2011-1#1)
with normal glucose tolerance##4##4##(1994-12#1)(2006-9#1)(2009-6#1)(2012-7#1)
with normal glucose##6##3##(1994-12#1)(2006-9#1)(2007-10#2)(2009-6#1)(2012-7#1)
with normal growth##3##3##(1994-8#1)(2011-1#1)(2011-12#1)
with normal healthy##2##3##(2007-2#2)
with normal hearing##4##3##(2008-9#3)(2010-10#1)
with normal human##4##3##(1991-9#1)(1993-11#1)(1996-4#1)(2009-8#1)
with normal individuals##2##3##(1990-12#1)(2008-7#1)
with normal karyotype##3##3##(2008-11#1)(2008-5#1)(2011-2#1)
with normal left##2##3##(2007-8#1)(2007-9#1)
with normal life expectancy##2##4##(2012-12#1)(2013-8#1)
with normal life##3##3##(2008-7#1)(2012-12#1)(2013-8#1)
with normal liver function##2##4##(1993-11#1)(2005-9#1)
with normal lung function##2##4##(1994-6#1)(1996-2#1)
with normal lung##3##3##(1994-6#1)(1996-2#2)
with normal melanocytes##2##3##(1991-7#2)
with normal mucosa##3##3##(1991-11#2)(2007-6#1)
with normal or##5##3##(1995-11#1)(1995-12#1)(1996-6#1)(2008-1#1)(2008-4#1)
with normal outcome##2##3##(2004-10#1)(2007-8#1)
with normal plasma##2##3##(1997-1#1)(2010-12#1)
with normal pregnancy##2##3##(2010-3#1)(2011-2#1)
with normal preoperative##2##3##(2007-7#1)(2007-8#1)
with normal renal function##9##4##(2006-10#1)(2007-2#2)(2008-3#1)(2009-2#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
with normal saline##6##3##(1990-8#2)(2007-1#1)(2008-11#1)(2011-2#1)(2012-12#1)
with normal serum##4##3##(2008-4#2)(2011-1#1)(2011-12#1)
with normal singleton pregnancy##2##4##(2004-10#1)(2011-1#1)
with normal skin and##3##4##(1990-3#2)(2008-5#1)
with normal skin##4##3##(1990-3#2)(2008-5#2)
with normal sowing##2##3##(2013-8#2)
with normal subjects##4##3##(1990-6#1)(1991-8#1)(1995-11#1)(1995-5#1)
with normal thyroid##2##3##(2009-4#1)(2013-8#1)
with normal urinary##3##3##(1997-8#1)(2006-9#1)(2008-10#1)
with normal values##3##3##(1990-2#1)(1991-9#1)(1993-11#1)
with normal vital signs##2##4##(2006-10#1)(2008-12#1)
with normal volunteers##5##3##(1990-2#1)(1995-11#1)(1996-2#1)(2006-5#1)(2008-7#1)
with normal weight##3##3##(2006-8#1)(2007-11#1)(2011-2#1)
with normal##296##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#5)(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#1)(1990-8#3)(1990-9#1)(1991-11#3)(1991-12#2)(1991-4#2)(1991-5#1)(1991-7#2)(1991-8#2)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#4)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#2)(1994-10#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#3)(1995-11#3)(1995-12#2)(1995-5#3)(1995-6#1)(1995-8#1)(1996-2#5)(1996-4#3)(1996-6#3)(1996-7#1)(1996-8#1)(1997-1#1)(1997-4#2)(1997-5#1)(1997-8#4)(2004-10#2)(2004-2#1)(2005-10#2)(2005-12#1)(2005-4#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#2)(2006-8#1)(2006-9#3)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#3)(2007-2#5)(2007-6#3)(2007-7#1)(2007-8#8)(2007-9#4)(2008-1#1)(2008-10#8)(2008-11#8)(2008-12#5)(2008-2#1)(2008-3#4)(2008-4#10)(2008-5#6)(2008-6#2)(2008-7#10)(2008-8#3)(2008-9#5)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-12#1)(2010-3#3)(2010-5#2)(2010-7#3)(2010-8#2)(2011-1#11)(2011-12#3)(2011-2#10)(2012-1#2)(2012-12#6)(2012-2#8)(2012-3#5)(2012-7#1)(2013-1#2)(2013-7#1)(2013-8#7)
with normalization of the##2##4##(2007-11#1)(2010-5#1)
with normalization of##4##3##(2007-11#1)(2007-8#1)(2010-5#1)(2011-12#1)
with normalization##5##2##(2007-11#1)(2007-8#1)(2008-7#1)(2010-5#1)(2011-12#1)
with normative data##2##3##(1994-12#1)(1994-4#1)
with normative##4##2##(1994-12#1)(1994-4#1)(2006-7#1)(2009-10#1)
with normothermic##2##2##(1995-12#1)(1996-9#1)
with norms##2##2##(1992-7#1)(2010-2#1)
with nosocomial pneumonia##2##3##(1990-9#1)(2005-11#1)
with nosocomial##5##2##(1990-9#1)(2005-11#1)(2005-8#1)(2011-2#1)(2012-2#1)
with not only##3##3##(1993-11#1)(1997-6#1)(2008-10#1)
with not##7##2##(1993-11#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)(2012-12#1)
with notable##2##2##(1996-2#1)(2009-10#1)
with notes on##2##3##(2007-12#1)(2010-8#1)
with noticeable##2##2##(2007-12#1)(2008-5#1)
with novel influenza##2##3##(2010-12#1)(2012-2#1)
with novel properties##2##3##(2008-4#1)(2009-2#1)
with novel specificities##2##3##(1991-11#1)(1995-7#1)
with novel structural##3##3##(2007-7#2)(2008-5#1)
with novel##45##2##(1991-11#1)(1993-9#1)(1995-5#1)(1995-7#1)(2004-1#1)(2005-8#1)(2005-9#1)(2006-2#1)(2006-6#1)(2007-11#2)(2007-5#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#2)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#3)
with np-BNR and infected with R##2##6##(2008-10#2)
with np-BNR##7##2##(2008-10#7)
with nu 3 near##3##4##(1994-9#3)
with nu##4##2##(1994-9#3)(2008-2#1)
with nuclear DNA##2##3##(1991-12#1)(2012-11#1)
with nuclear extracts from##3##4##(1993-6#1)(1995-3#1)(2008-10#1)
with nuclear extracts##5##3##(1992-12#1)(1993-6#1)(1995-3#1)(1995-8#1)(2008-10#1)
with nuclear factor##2##3##(1995-1#1)(2010-8#1)
with nuclear factors##2##3##(1995-3#1)(2008-10#1)
with nuclear magnetic resonance (NMR)##2##5##(1992-9#1)(1997-5#1)
with nuclear magnetic resonance##5##4##(1992-9#1)(1993-11#1)(1997-5#1)(2011-2#1)(2012-2#1)
with nuclear proteins##3##3##(1995-3#3)
with nuclear##37##2##(1991-12#2)(1991-3#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1995-1#1)(1995-3#5)(1995-8#1)(1997-5#1)(2005-8#1)(2008-10#2)(2008-4#1)(2008-7#5)(2008-8#1)(2008-9#2)(2010-3#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#1)(2013-8#1)
with nuclei##3##2##(1992-3#1)(1993-7#1)(2006-12#1)
with nucleic acid bases##2##4##(1990-2#1)(2008-4#1)
with nucleic acid##4##3##(1990-2#1)(1995-8#1)(1996-2#1)(2008-4#1)
with nucleic acids and##4##4##(1990-8#1)(1991-5#1)(2008-10#1)(2008-9#1)
with nucleic acids was##2##4##(2008-10#2)
with nucleic acids##14##3##(1990-8#1)(1991-4#2)(1991-5#1)(1992-3#1)(1997-4#1)(2008-10#6)(2008-9#2)
with nucleic##19##2##(1990-2#1)(1990-8#1)(1991-4#2)(1991-5#1)(1992-3#1)(1995-8#1)(1996-2#1)(1997-4#1)(2008-10#6)(2008-4#1)(2008-8#1)(2008-9#2)
with nucleoside analogues##2##3##(1996-11#1)(2009-11#1)
with nucleoside##5##2##(1995-3#1)(1996-11#1)(2008-10#1)(2008-4#1)(2009-11#1)
with nucleotide##5##2##(1990-4#1)(1992-3#1)(1997-4#1)(2008-10#2)
with nucleotides##3##2##(1991-10#1)(1996-4#1)(2008-5#1)
with null##4##2##(2008-12#1)(2009-8#1)(2010-2#1)(2012-2#1)
with number of##6##3##(1990-10#1)(1990-12#1)(1994-6#1)(1997-3#1)(2007-12#1)(2009-4#1)
with numbers of##2##3##(2008-10#1)(2008-9#1)
with numbers##4##2##(1994-6#1)(1996-12#1)(2008-10#1)(2008-9#1)
with numerical apertures##2##3##(2007-12#1)(2008-3#1)
with numerical integration##2##3##(1990-11#1)(2007-11#1)
with numerical results##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
with numerical simulations that##2##4##(2007-12#2)
with numerical simulations##12##3##(2007-11#1)(2007-12#6)(2008-1#1)(2008-2#1)(2008-3#2)(2013-1#1)
with numerical solutions of the##2##5##(2007-11#1)(2008-10#1)
with numerical##28##2##(1990-11#1)(1997-1#1)(2007-11#4)(2007-12#10)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#5)(2013-1#1)
with numerically simulated##2##3##(2008-3#1)(2009-11#1)
with numerically##4##2##(2007-12#1)(2008-3#2)(2009-11#1)
with numerous oculocutaneous##2##3##(2007-7#2)
with numerous proteins##3##3##(1994-12#1)(2009-9#2)
with numerous##37##2##(1991-7#1)(1994-12#2)(1994-2#1)(2005-11#3)(2005-9#1)(2006-7#1)(2006-9#1)(2007-12#1)(2007-5#1)(2007-7#3)(2008-10#4)(2008-11#2)(2008-2#2)(2008-7#1)(2009-5#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-3#2)(2013-1#4)
with nurse##5##2##(2008-1#1)(2008-11#1)(2008-12#1)(2012-3#2)
with nurses and##3##3##(2006-10#1)(2008-11#1)(2011-2#1)
with nurses from##2##3##(2007-11#1)(2012-11#1)
with nurses##8##2##(1995-10#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2011-2#2)(2012-11#1)
with nurses'##2##2##(1991-11#1)(1993-12#1)
with nursing home##3##3##(2008-11#1)(2008-12#1)(2011-2#1)
with nursing##7##2##(1997-3#1)(2006-9#1)(2008-11#1)(2008-12#3)(2011-2#1)
with nutrients##2##2##(2007-11#1)(2011-1#1)
with nutrition##3##2##(1994-3#1)(2008-10#1)(2008-5#1)
with nutritional##8##2##(1991-6#1)(2005-1#1)(2005-10#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-7#1)
with nymphs##2##2##(2007-3#1)(2013-7#1)
with o-NPOE##3##2##(2008-10#3)
with o-dinitrobenzene##2##2##(1990-10#2)
with o-phenylenediamine##3##2##(1991-5#1)(2005-7#1)(2008-10#1)
with o-phosphoric acid##2##3##(2010-2#1)(2010-5#1)
with o-phthaladehyde##2##2##(1997-8#1)(2008-10#1)
with o-phthalaldehyde (OPA)##4##3##(2007-8#1)(2008-10#3)
with o-phthalaldehyde##11##2##(1991-12#1)(1993-2#2)(1996-5#1)(2007-8#1)(2008-10#6)
with o-phthaldialdehyde##5##2##(1992-2#1)(1993-1#1)(1996-6#1)(2008-10#1)(2010-12#1)
with o-tolidine##2##2##(2008-10#2)
with oat##3##2##(2006-8#1)(2008-10#2)
with obesity and##4##3##(2005-8#1)(2006-9#1)(2008-1#1)(2011-1#1)
with obesity##32##2##(1991-7#1)(1994-6#1)(1996-2#1)(1996-5#1)(1997-4#1)(2005-1#1)(2005-8#1)(2006-9#2)(2008-1#2)(2008-10#1)(2008-12#3)(2008-3#1)(2008-9#1)(2009-5#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#2)
with object##3##2##(2008-1#1)(2008-2#1)(2010-2#1)
with objective##10##2##(1990-3#1)(1994-3#1)(2006-6#1)(2007-10#1)(2007-6#1)(2008-5#1)(2008-7#2)(2010-7#1)(2012-12#1)
with oblique##4##2##(2008-2#1)(2008-3#3)
with obliquely##2##2##(2008-2#1)(2008-3#1)
with obscure##2##2##(2011-2#1)(2013-8#1)
with observation##3##2##(1991-6#1)(2008-9#1)(2013-1#1)
with observational##2##2##(2007-10#1)(2009-4#1)
with observations made in##2##4##(1990-2#1)(1995-8#1)
with observations of##2##3##(1995-6#1)(1996-11#1)
with observations on##3##3##(1996-2#1)(2005-10#1)(2007-8#1)
with observations##16##2##(1990-2#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(2005-10#1)(2006-5#1)(2007-3#1)(2007-8#2)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2013-1#1)
with observed##12##2##(1993-6#1)(1995-1#1)(1997-4#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-1#1)
with obsessive compulsive disorder##2##4##(2009-7#1)(2012-2#1)
with obsessive-compulsive disorder (OCD) and##2##5##(1996-2#1)(2010-2#1)
with obsessive-compulsive disorder (OCD)##3##4##(1996-2#1)(2008-3#1)(2010-2#1)
with obsessive-compulsive disorder##6##3##(1996-2#2)(2008-1#1)(2008-3#2)(2010-2#1)
with obstetric anal sphincter rupture##2##5##(2011-2#2)
with obstetric anal sphincter##3##4##(2011-2#3)
with obstetric##6##2##(1996-8#1)(2011-2#3)(2013-1#2)
with obstruction of the##2##4##(2004-9#1)(2009-4#1)
with obstruction##3##2##(2004-9#1)(2009-4#1)(2013-8#1)
with obstructive coronary##2##3##(2011-2#1)(2012-2#1)
with obstructive hydrocephalus##2##3##(2008-7#1)(2011-1#1)
with obstructive jaundice and##4##4##(2005-12#1)(2007-4#1)(2008-3#2)
with obstructive jaundice##8##3##(2005-10#1)(2005-12#2)(2007-4#1)(2008-12#1)(2008-3#2)(2010-9#1)
with obstructive uropathy##2##3##(2007-7#1)(2009-5#1)
with obstructive##25##2##(1997-4#1)(2005-10#1)(2005-12#2)(2006-10#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#3)(2013-1#1)
with obtaining##2##2##(2011-2#2)
with occasional clients##6##3##(2012-3#6)
with occasional##17##2##(1992-10#1)(1994-10#1)(1994-11#1)(2004-11#1)(2005-11#1)(2005-8#1)(2008-10#1)(2008-7#1)(2012-3#9)
with occluded retinal##2##3##(1990-7#2)
with occluded##4##2##(1990-7#2)(1997-8#2)
with occlusion of the##3##4##(1996-6#1)(2008-5#1)(2013-8#1)
with occlusion of##5##3##(1996-6#1)(2008-5#1)(2013-1#2)(2013-8#1)
with occlusive##3##2##(2007-9#2)(2008-5#1)
with occult primary##2##3##(2007-7#1)(2010-9#1)
with occult##8##2##(1990-6#1)(2006-10#2)(2007-7#1)(2008-10#1)(2008-12#1)(2010-8#1)(2010-9#1)
with occupational asthma##2##3##(1990-3#1)(1994-6#1)
with occupational history##3##3##(2008-8#3)
with occupational##14##2##(1990-3#1)(1990-6#1)(1992-1#2)(1994-6#1)(2007-10#1)(2007-12#1)(2008-8#3)(2010-9#4)
with occurrence and##2##3##(2007-3#1)(2013-7#1)
with occurrence##3##2##(2007-3#1)(2011-2#1)(2013-7#1)
with octadecanoic acid##2##3##(1996-4#2)
with octadecyl##2##2##(1996-2#1)(2008-10#1)
with octahedral geometry##3##3##(1996-2#1)(1996-7#1)(2007-11#1)
with octahedral##4##2##(1996-2#1)(1996-7#1)(1997-1#1)(2007-11#1)
with octreotide##4##2##(1991-8#1)(2006-10#1)(2006-12#1)(2012-12#1)
with ocular##12##2##(1992-7#1)(2006-10#1)(2007-2#1)(2007-3#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-8#2)(2013-7#1)(2013-8#2)
with odds ratio of##2##4##(2008-3#1)(2011-1#1)
with odds ratio##3##3##(2008-3#1)(2011-1#1)(2012-2#1)
with odds ratios ranging from##2##5##(1990-12#1)(2006-10#1)
with odds ratios##3##3##(1990-12#1)(2006-10#1)(2010-12#1)
with odds##7##2##(1990-12#1)(2006-10#1)(2008-3#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-2#1)
with oedema of##2##3##(1990-9#1)(2011-1#1)
with oedema##3##2##(1990-9#1)(2011-1#1)(2013-1#1)
with oesophageal##5##2##(2005-10#1)(2006-6#1)(2008-11#1)(2010-11#1)(2011-2#1)
with oesophagitis##4##2##(2005-1#3)(2008-11#1)
with of##2##2##(2007-7#1)(2008-1#1)
with off-label use##2##3##(2009-5#1)(2011-12#1)
with off-label##3##2##(2009-5#1)(2011-12#2)
with off-line##2##2##(1996-5#1)(2008-11#1)
with off-site backup##2##3##(2008-3#2)
with off-site##5##2##(2008-3#5)
with off-the-shelf##3##2##(2008-11#1)(2008-3#2)
with offspring##2##2##(2007-6#1)(2008-8#1)
with ofloxacin##6##2##(1991-7#4)(1994-3#1)(2008-5#1)
with often##3##2##(1993-12#1)(2012-11#1)(2013-1#1)
with oil##5##2##(1996-10#1)(2004-4#1)(2008-10#1)(2010-4#1)(2011-2#1)
with okadaic acid##7##3##(1992-8#1)(1993-12#1)(1994-11#2)(1995-3#1)(2008-2#1)(2008-4#1)
with olanzapine##6##2##(2005-10#1)(2006-12#1)(2008-3#2)(2008-6#2)
with old age##2##3##(1995-5#1)(2013-1#1)
with old##6##2##(1995-5#1)(2008-10#1)(2011-2#3)(2013-1#1)
with older adults##3##3##(1991-12#1)(2008-9#1)(2010-11#1)
with older age##4##3##(2007-1#1)(2007-7#1)(2010-4#1)(2011-2#1)
with older patients##2##3##(2008-3#1)(2011-2#1)
with older people in##2##4##(2010-10#2)
with older people##5##3##(1994-12#1)(2010-10#4)
with older women##3##3##(2008-3#1)(2010-10#1)(2011-1#1)
with older##32##2##(1991-12#1)(1994-12#1)(1997-3#1)(1997-6#1)(2006-10#2)(2006-3#1)(2006-7#1)(2007-1#1)(2007-7#1)(2008-3#2)(2008-6#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-10#6)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
with oleate##2##2##(1990-8#1)(2005-11#1)
with oleic acid##8##3##(1990-4#1)(1992-2#2)(1996-5#1)(1996-6#1)(2004-11#1)(2004-8#2)
with oligodeoxyribonucleotides (oligos)##2##3##(1991-12#1)(1995-2#1)
with oligonucleotide primers##2##3##(1992-3#1)(1992-5#1)
with oligonucleotide probes##2##3##(1992-3#1)(1997-2#1)
with oligonucleotide##5##2##(1992-3#2)(1992-5#1)(1993-12#1)(1997-2#1)
with oligonucleotides containing the##2##4##(1994-9#1)(1997-5#1)
with oligonucleotides containing##4##3##(1994-9#1)(1995-2#1)(1997-5#1)(2008-5#1)
with oligonucleotides##12##2##(1992-8#1)(1993-8#2)(1994-11#1)(1994-9#1)(1995-2#1)(1995-3#1)(1997-5#1)(2006-12#2)(2008-4#1)(2008-5#1)
with olive oil##3##3##(2008-10#1)(2010-4#2)
with olive##4##2##(2006-8#1)(2008-10#1)(2010-4#2)
with omega-3##2##2##(2010-4#1)(2013-7#1)
with omentum##2##2##(1995-11#2)
with omeprazole##2##2##(2008-5#2)
with omphalocele##2##2##(1997-3#2)
with on##4##2##(2006-6#1)(2006-8#1)(2009-10#1)(2011-1#1)
with on-board##2##2##(2008-11#1)(2012-1#1)
with on-chip##4##2##(2008-2#2)(2010-8#1)(2012-1#1)
with on-line UV##2##3##(1996-5#1)(2008-10#1)
with on-line atomic##2##3##(2008-10#2)
with on-line detection by##2##4##(2008-10#2)
with on-line detection##3##3##(2008-10#3)
with on-line preconcentration##2##3##(2008-10#2)
with on-line sample##2##3##(2008-10#2)
with on-line solid-phase extraction##2##4##(2008-10#2)
with on-line##38##2##(1990-8#1)(1993-12#1)(1993-7#1)(1996-5#1)(2006-5#1)(2007-8#1)(2008-10#28)(2008-11#1)(2008-4#2)(2013-1#1)
with once-a-day dosing##2##3##(1995-2#2)
with once-a-day##3##2##(1995-2#3)
with once-daily##3##2##(2005-7#1)(2008-3#1)(2013-1#1)
with oncogenic##4##2##(1994-11#1)(1996-11#1)(1996-8#1)(2008-12#1)
with oncological##3##2##(2007-5#1)(2011-2#1)(2013-8#1)
with oncologists##2##2##(2008-6#1)(2013-1#1)
with ondansetron##4##2##(1996-2#1)(1996-8#1)(2008-5#1)(2008-7#1)
with one additional##3##3##(2005-10#1)(2007-2#1)(2008-12#1)
with one and##2##3##(2008-10#1)(2012-1#1)
with one another and with the##2##6##(2008-11#1)(2012-11#1)
with one another and##5##4##(2007-10#1)(2008-11#1)(2008-3#1)(2010-5#1)(2012-11#1)
with one another##34##3##(1991-3#1)(1992-12#1)(1992-2#1)(1992-9#1)(1994-9#1)(1995-12#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-5#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#2)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#2)(2012-1#1)(2012-11#1)(2013-1#1)(2013-8#2)
with one another&quot##2##3##(2007-9#2)
with one case of##4##4##(2007-5#1)(2008-12#1)(2008-4#1)(2011-1#1)
with one day##2##3##(2006-1#1)(2011-2#1)
with one dose of##2##4##(1990-2#1)(1994-7#1)
with one dose##3##3##(1990-2#1)(1994-7#1)(2004-12#1)
with one enzyme##2##3##(1992-6#1)(2008-4#1)
with one exception##4##3##(1991-8#1)(2008-10#2)(2008-4#1)
with one group of##2##4##(1991-9#1)(2008-9#1)
with one hidden layer##2##4##(1994-9#1)(2008-6#1)
with one isolate##2##3##(2008-10#2)
with one molecule of##2##4##(1991-2#1)(1994-5#1)
with one molecule##3##3##(1991-2#1)(1994-5#1)(1994-9#1)
with one of four different##2##5##(1997-3#1)(2008-7#1)
with one of four##3##4##(1997-3#1)(2008-7#1)(2013-8#1)
with one of several##2##4##(1996-1#1)(2006-10#1)
with one of the highest##2##5##(2008-5#1)(2013-8#1)
with one of the two##3##5##(2006-2#1)(2008-10#1)(2008-2#1)
with one of the##19##4##(1991-7#1)(1992-4#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#3)(2010-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
with one of these##3##4##(1993-8#1)(2006-7#1)(2012-2#1)
with one of three##3##4##(2008-10#2)(2008-4#1)
with one of two##7##4##(1997-3#1)(1997-4#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#1)(2013-8#1)
with one of##42##3##(1991-7#1)(1992-4#1)(1993-8#1)(1994-12#1)(1996-1#1)(1997-1#1)(1997-3#2)(1997-4#1)(2006-10#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#5)(2008-2#1)(2008-4#2)(2008-5#4)(2008-7#3)(2009-8#1)(2010-12#1)(2010-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#4)
with one or both##3##4##(2007-9#1)(2008-2#1)(2009-4#1)
with one or more doses of##3##6##(1995-5#3)
with one or more##20##4##(1991-4#1)(1991-7#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-5#3)(1996-9#1)(2008-1#2)(2008-10#3)(2008-7#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#2)
with one or two##10##4##(1991-2#1)(1993-12#1)(1995-3#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-9#2)(2010-5#1)
with one or##37##3##(1991-2#1)(1991-4#1)(1991-7#1)(1993-12#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#3)(1996-9#1)(2005-8#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-6#1)(2010-4#1)(2010-5#1)(2011-11#1)(2011-2#1)(2012-2#1)(2013-1#2)
with one particular##2##3##(1991-11#1)(2008-9#1)
with one polarization##2##3##(2008-3#1)(2008-7#1)
with one population##2##3##(2008-10#1)(2008-8#1)
with one strand##2##3##(1992-12#1)(2008-2#1)
with one to five##2##4##(2008-10#1)(2012-12#1)
with one to##4##3##(2006-8#1)(2008-10#1)(2012-12#2)
with one##302##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-10#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#5)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-7#1)(1993-8#2)(1994-11#2)(1994-12#1)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#5)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-5#3)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#3)(1996-5#3)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#2)(1997-7#1)(1997-8#1)(2004-11#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-3#1)(2006-6#1)(2006-7#3)(2006-8#3)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#7)(2007-2#2)(2007-5#2)(2007-8#5)(2007-9#4)(2008-1#4)(2008-10#46)(2008-11#3)(2008-12#4)(2008-2#11)(2008-3#10)(2008-4#9)(2008-5#4)(2008-6#1)(2008-7#11)(2008-8#5)(2008-9#4)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#2)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#2)(2011-1#4)(2011-11#1)(2011-2#4)(2012-1#5)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#7)(2013-8#9)
with one's##3##2##(2007-2#1)(2008-10#1)(2012-3#1)
with one-dimensional##6##2##(2007-11#1)(2007-12#2)(2008-3#2)(2008-6#1)
with one-photon and two-photon##2##4##(2008-3#2)
with one-third##2##2##(2005-10#1)(2008-2#1)
with one-way##2##2##(1997-1#1)(2008-7#1)
with ones##2##2##(2005-11#1)(2008-2#1)
with ongoing##14##2##(1996-7#1)(1997-4#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-11#1)(2010-11#1)(2010-2#1)(2013-1#1)
with only 0##2##3##(2007-10#1)(2008-10#1)
with only 1 case##2##4##(2007-7#1)(2012-3#1)
with only 1##4##3##(1996-3#1)(2007-7#1)(2010-5#1)(2012-3#1)
with only 15##2##3##(2009-3#1)(2013-1#1)
with only 3##2##3##(2008-5#1)(2008-6#1)
with only 4##2##3##(2006-12#1)(2008-5#1)
with only a few##13##4##(1994-3#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2010-5#1)(2013-1#1)
with only a minor##3##4##(2007-12#1)(2009-9#1)(2011-2#1)
with only a single##2##4##(1997-6#1)(2008-3#1)
with only a slight##4##4##(1995-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
with only a small decrease##2##5##(2006-5#1)(2007-12#1)
with only a small##5##4##(1995-11#1)(2006-5#1)(2007-12#1)(2008-7#1)(2009-5#1)
with only a##44##3##(1991-4#1)(1992-4#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-6#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-9#2)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
with only about##2##3##(1992-2#1)(2013-1#1)
with only an##2##3##(1995-11#1)(2008-1#1)
with only few cases##2##4##(2009-5#1)(2013-1#1)
with only five##2##3##(1996-10#1)(2008-3#1)
with only low##2##3##(1994-6#1)(2006-7#1)
with only mild##4##3##(2006-3#1)(2007-10#1)(2008-4#1)(2008-7#1)
with only minor##8##3##(1990-3#1)(1995-5#1)(2007-11#2)(2007-5#1)(2008-10#1)(2008-4#1)(2010-4#1)
with only moderate##2##3##(2008-3#1)(2012-3#1)
with only moderately##2##3##(1995-5#1)(1997-1#1)
with only modest##3##3##(1996-5#1)(2005-12#1)(2006-5#1)
with only one layer of##2##5##(2008-2#1)(2008-9#1)
with only one of the two##2##6##(1997-1#1)(1997-4#1)
with only one of##3##4##(1991-8#1)(1997-1#1)(1997-4#1)
with only one##33##3##(1990-9#1)(1991-8#1)(1992-8#1)(1995-8#1)(1997-1#1)(1997-4#1)(1997-8#1)(2004-9#1)(2005-4#1)(2006-10#2)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-2#2)(2008-3#2)(2008-9#2)(2009-5#1)(2010-1#1)(2010-2#1)(2010-5#1)(2012-2#1)(2012-3#1)
with only the##10##3##(1992-11#1)(1993-12#1)(2005-11#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-4#1)(2012-1#1)(2012-3#1)
with only three##5##3##(1990-2#1)(2007-7#1)(2011-2#1)(2012-2#2)
with only two##8##3##(1990-10#1)(1993-1#1)(1994-9#1)(2008-10#2)(2008-2#1)(2008-8#1)(2012-1#1)
with only##234##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-9#2)(1995-11#2)(1995-12#1)(1995-4#1)(1995-5#2)(1995-8#1)(1995-9#1)(1996-10#2)(1996-12#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#3)(1997-6#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-12#2)(2005-4#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-3#1)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#2)(2006-9#2)(2007-10#6)(2007-11#9)(2007-12#7)(2007-5#2)(2007-7#5)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#30)(2008-11#1)(2008-12#3)(2008-2#7)(2008-3#10)(2008-4#3)(2008-5#6)(2008-6#4)(2008-7#4)(2008-8#4)(2008-9#3)(2009-11#1)(2009-3#2)(2009-5#3)(2009-6#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#3)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#7)(2012-3#6)(2013-1#5)(2013-7#1)
with onset after##3##3##(1996-7#1)(2007-10#1)(2008-7#1)
with onset before##3##3##(1997-7#1)(2007-8#1)(2011-2#1)
with onset in##3##3##(1992-8#1)(2007-7#1)(2008-7#1)
with onset of##3##3##(2007-7#1)(2009-10#1)(2012-12#1)
with onset or##3##3##(2008-1#1)(2009-3#1)(2013-1#1)
with onset##21##2##(1990-3#1)(1992-8#1)(1993-9#2)(1996-6#1)(1996-7#1)(1997-7#1)(2004-11#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-7#2)(2009-10#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
with oocyte##3##2##(2012-12#2)(2012-3#1)
with opaque cytoplasm##2##3##(2012-2#2)
with opaque##3##2##(2012-2#3)
with open surgery##2##3##(2008-10#1)(2010-11#1)
with open##23##2##(2006-5#2)(2007-1#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-9#1)(2010-11#1)(2011-2#3)(2012-3#1)(2013-1#5)
with open-ended questions and##2##4##(2008-3#1)(2009-5#1)
with open-ended questions##3##3##(2008-3#1)(2009-5#2)
with opening##2##2##(1991-5#1)(2006-12#1)
with operable breast cancer##4##4##(1991-12#1)(1991-8#1)(2004-1#2)
with operable breast##5##3##(1991-12#1)(1991-8#1)(1994-12#1)(2004-1#2)
with operable##8##2##(1991-12#1)(1991-8#1)(1994-12#1)(1996-9#1)(2004-1#2)(2007-11#1)(2012-12#1)
with operation##2##2##(2008-6#1)(2009-9#1)
with operational##2##2##(2006-9#1)(2008-2#1)
with operative##2##2##(1994-3#1)(2006-7#1)
with operator##3##2##(1991-6#1)(1992-4#1)(1995-1#1)
with opiate##2##2##(1991-1#1)(2007-11#1)
with opioid receptor antagonists##2##4##(1995-11#1)(2009-7#1)
with opioid receptor##3##3##(1995-11#1)(1997-2#1)(2009-7#1)
with opioid##9##2##(1991-1#1)(1992-4#1)(1995-11#1)(1995-3#1)(1997-2#1)(2006-11#1)(2007-2#2)(2009-7#1)
with opioids##3##2##(2006-10#1)(2006-7#1)(2010-4#1)
with opportunistic##6##2##(1996-11#1)(1996-6#1)(2007-11#1)(2009-7#1)(2010-5#1)(2013-1#1)
with opportunities to##2##3##(2012-12#1)(2013-1#1)
with opportunities##4##2##(2007-2#1)(2009-7#1)(2012-12#1)(2013-1#1)
with opposing##4##2##(1994-12#1)(2008-2#1)(2008-4#1)(2009-7#1)
with opposite##9##2##(1996-6#1)(1997-3#1)(2007-12#2)(2008-2#1)(2008-3#1)(2010-2#1)(2010-3#1)(2012-1#1)
with opsonized##3##2##(1991-2#2)(1992-8#1)
with optic atrophy##2##3##(2012-2#1)(2013-1#1)
with optic nerve head##2##4##(2012-12#1)(2012-2#1)
with optic nerve##3##3##(2011-1#1)(2012-12#1)(2012-2#1)
with optic neuritis##3##3##(1995-12#1)(2011-1#1)(2012-3#1)
with optic##10##2##(1995-12#1)(2008-7#1)(2011-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
with optical I/O##2##3##(2008-3#2)
with optical coherence tomography##3##4##(2007-11#1)(2008-3#1)(2011-7#1)
with optical coherence##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2011-7#1)
with optical densities##2##3##(2008-2#2)
with optical feedback##5##3##(2007-11#1)(2007-12#2)(2008-3#2)
with optical fiber##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
with optical fibers##5##3##(2008-2#3)(2008-3#2)
with optical scatterometry##2##3##(2008-3#2)
with optical signals##3##3##(2006-4#3)
with optical techniques##2##3##(2008-3#1)(2009-9#1)
with optical tweezers##2##3##(2008-3#1)(2009-12#1)
with optical##62##2##(1990-7#1)(2006-11#1)(2006-4#4)(2007-11#6)(2007-12#7)(2008-1#1)(2008-10#2)(2008-2#12)(2008-3#20)(2009-12#1)(2009-5#2)(2009-9#1)(2011-1#2)(2011-7#1)(2013-8#1)
with optical-fiber##2##2##(2008-2#2)
with optically##3##2##(1996-9#1)(2007-11#1)(2008-10#1)
with optimal treatment##2##3##(2009-11#1)(2010-1#1)
with optimal##21##2##(1990-11#1)(1994-11#1)(1994-3#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-11#2)(2010-1#1)(2010-12#1)(2011-3#2)(2012-3#2)(2013-1#1)
with optimization##2##2##(2008-3#1)(2010-2#1)
with optimized##4##2##(2008-2#1)(2008-3#1)(2008-9#1)(2010-1#1)
with optimum##18##2##(1991-2#1)(1991-9#1)(1992-2#1)(1993-4#1)(1993-8#1)(2006-6#2)(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-4#1)
with optional##2##2##(1993-8#1)(2008-3#1)
with options for##2##3##(2007-11#1)(2007-5#1)
with options##3##2##(2007-10#1)(2007-11#1)(2007-5#1)
with optoelectronic##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
with or at risk for##2##5##(2007-12#1)(2008-11#1)
with or at risk##3##4##(2007-12#1)(2008-11#1)(2010-9#1)
with or better than##3##4##(2007-11#1)(2008-10#1)(2008-5#1)
with or without 1##2##4##(2008-11#1)(2012-12#1)
with or without A1 pulley release##2##6##(2008-9#2)
with or without PTH##3##4##(2009-3#3)
with or without a tracheal tube##2##6##(2006-10#2)
with or without a##15##4##(1993-9#2)(1996-7#1)(2006-10#2)(2006-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#1)
with or without added##3##4##(1992-8#1)(1995-12#1)(1997-1#1)
with or without addition of##3##5##(1992-2#1)(1993-9#1)(2008-10#1)
with or without additional##2##4##(1996-2#1)(2012-3#1)
with or without an##5##4##(1994-6#1)(1995-4#1)(2006-8#1)(2007-8#1)(2010-6#1)
with or without associated##5##4##(1997-8#1)(2006-11#1)(2008-4#1)(2008-9#1)(2013-1#1)
with or without bevacizumab##2##4##(2008-5#1)(2008-7#1)
with or without cirrhosis##2##4##(1994-7#1)(2011-1#1)
with or without cleft palate##3##5##(2007-9#1)(2009-6#1)(2012-12#1)
with or without concomitant##4##4##(1990-2#1)(1993-9#1)(2008-12#1)(2013-1#1)
with or without continuous covariates##2##5##(2010-12#2)
with or without depression or##2##5##(2006-8#1)(2007-9#1)
with or without depression##3##4##(2006-8#2)(2007-9#1)
with or without desferrioxamine##2##4##(2008-5#2)
with or without elevated##2##4##(2007-11#1)(2008-6#1)
with or without evidence of##2##5##(2006-8#1)(2009-8#1)
with or without internal##2##4##(2008-1#1)(2008-4#1)
with or without its##2##4##(1991-5#1)(1992-9#1)
with or without leg pain##4##5##(2006-8#4)
with or without oral##2##4##(2009-4#1)(2013-8#1)
with or without other##2##4##(2007-11#1)(2008-3#1)
with or without pain##2##4##(2006-8#1)(2011-1#1)
with or without phenobarbital##2##4##(1993-7#2)
with or without prior##4##4##(1991-2#1)(1992-6#1)(2012-12#1)(2013-7#1)
with or without rare variants##2##5##(2012-3#2)
with or without renal##2##4##(1991-4#1)(1993-8#1)
with or without renaturation##2##4##(2008-10#2)
with or without the addition of##5##6##(2004-9#1)(2008-10#2)(2008-5#1)(2009-6#1)
with or without the presence of##3##6##(1990-4#1)(2008-10#1)(2008-11#1)
with or without the##20##4##(1990-4#1)(1991-10#1)(1995-8#1)(1996-9#1)(2004-9#2)(2005-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2009-6#2)(2012-2#1)(2013-8#1)
with or without vitamin C##2##5##(1997-3#1)(2011-1#1)
with or without vitamin##3##4##(1997-3#1)(2011-1#1)(2013-1#1)
with or without##382##3##(1990-11#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-1#2)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#2)(1991-5#2)(1991-6#2)(1991-8#3)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#3)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-4#2)(1993-7#2)(1993-8#2)(1993-9#6)(1994-11#1)(1994-12#1)(1994-2#3)(1994-6#4)(1994-7#2)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#3)(1996-1#1)(1996-11#2)(1996-2#3)(1996-3#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-8#3)(2004-12#1)(2004-2#1)(2004-9#2)(2005-10#1)(2005-11#2)(2005-12#1)(2005-8#2)(2006-10#10)(2006-11#3)(2006-12#3)(2006-3#1)(2006-5#2)(2006-6#4)(2006-7#2)(2006-8#18)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#2)(2007-2#4)(2007-3#2)(2007-6#1)(2007-7#5)(2007-8#5)(2007-9#5)(2008-1#9)(2008-10#23)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#8)(2008-4#9)(2008-5#12)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#10)(2009-10#1)(2009-3#5)(2009-4#4)(2009-5#1)(2009-6#6)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#10)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#6)(2011-11#1)(2011-12#1)(2011-2#8)(2012-1#1)(2012-12#7)(2012-2#8)(2012-3#5)(2012-4#1)(2013-1#6)(2013-7#2)(2013-8#11)
with or##408##2##(1990-10#1)(1990-11#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#2)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#2)(1991-8#3)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#3)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-4#2)(1993-7#2)(1993-8#2)(1993-9#7)(1994-11#1)(1994-12#1)(1994-2#3)(1994-6#4)(1994-7#2)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#3)(1996-1#1)(1996-10#1)(1996-11#3)(1996-2#3)(1996-3#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-8#3)(2004-12#1)(2004-2#1)(2004-9#2)(2005-10#1)(2005-11#2)(2005-12#1)(2005-8#2)(2006-10#12)(2006-11#3)(2006-12#4)(2006-3#1)(2006-5#2)(2006-6#4)(2006-7#2)(2006-8#18)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#8)(2007-12#5)(2007-2#6)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#5)(2007-9#5)(2008-1#9)(2008-10#24)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#10)(2008-4#9)(2008-5#13)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#10)(2009-10#1)(2009-3#5)(2009-4#4)(2009-5#1)(2009-6#6)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#10)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#6)(2011-11#1)(2011-12#1)(2011-2#9)(2012-1#1)(2012-12#7)(2012-2#8)(2012-3#5)(2012-4#1)(2013-1#6)(2013-7#2)(2013-8#11)
with oral and topical##2##4##(1992-6#1)(2012-12#1)
with oral and##4##3##(1992-6#1)(2006-2#1)(2008-12#1)(2012-12#1)
with oral antibiotics##3##3##(2007-7#1)(2010-8#1)(2013-8#1)
with oral anticoagulants##4##3##(1990-12#1)(1996-6#1)(2004-12#1)(2013-1#1)
with oral cavity##3##3##(2008-1#1)(2009-10#2)
with oral contraceptive##2##3##(2012-3#1)(2013-7#1)
with oral corticosteroids##2##3##(2007-7#1)(2012-2#1)
with oral lesions##3##3##(2006-10#1)(2007-2#1)(2012-3#1)
with oral mucosal involvement##2##4##(2007-7#1)(2009-5#1)
with oral or##2##3##(1990-6#1)(2008-1#1)
with oral poliovirus##2##3##(1995-3#2)
with oral potassium##2##3##(1997-8#1)(2007-7#1)
with oral prednisone##2##3##(2007-7#1)(2013-8#1)
with oral squamous cell carcinoma##2##5##(2011-1#1)(2013-1#1)
with oral valganciclovir##2##3##(2010-12#2)
with oral##103##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-6#1)(1991-4#1)(1991-5#1)(1992-2#2)(1992-6#2)(1994-9#2)(1995-3#2)(1996-10#1)(1996-6#1)(1996-8#3)(1997-8#1)(2004-12#2)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#5)(2007-5#1)(2007-7#6)(2007-8#4)(2008-1#3)(2008-10#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-10#3)(2009-5#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-5#1)(2010-7#3)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#3)
with orbital complications##2##3##(2013-1#2)
with orbital##10##2##(1991-6#1)(2007-12#1)(2008-10#1)(2008-8#1)(2013-1#6)
with orbitofrontal##3##2##(2006-12#1)(2007-9#1)(2008-11#1)
with ordered##2##2##(2006-5#1)(2008-9#1)
with ordinary##4##2##(1992-6#1)(2008-10#2)(2008-3#1)
with organ##3##2##(2008-12#1)(2009-8#1)(2010-12#1)
with organic matter and##2##4##(2008-12#1)(2008-2#1)
with organic matter##3##3##(2008-10#1)(2008-12#1)(2008-2#1)
with organic solvent and##2##4##(2008-10#1)(2008-8#1)
with organic solvents##4##3##(1994-9#1)(2008-10#3)
with organic##26##2##(1990-7#1)(1990-8#1)(1994-9#1)(1995-1#2)(2006-12#1)(2008-10#9)(2008-12#1)(2008-2#2)(2008-5#2)(2008-8#1)(2009-4#1)(2010-4#1)(2011-2#2)(2013-8#1)
with organisms##3##2##(2005-9#1)(2008-10#1)(2008-8#1)
with organizational##2##2##(2006-3#1)(2008-12#1)
with organizations##2##2##(1993-12#1)(1995-3#1)
with organizing pneumonia##5##3##(2005-8#1)(2006-10#2)(2008-1#1)(2010-12#1)
with organizing##6##2##(2005-8#1)(2006-10#2)(2008-1#1)(2010-12#1)(2013-1#1)
with organophosphate compounds##2##3##(2012-1#1)(2013-1#1)
with organophosphate##4##2##(1997-7#1)(2008-5#1)(2012-1#1)(2013-1#1)
with orientation##2##2##(1995-12#1)(2008-8#1)
with original##4##2##(1996-2#1)(2008-10#1)(2008-7#1)(2008-8#1)
with origins##2##2##(1995-1#1)(2008-11#1)
with ornithine##2##2##(1990-5#1)(1992-7#1)
with orofacial myofunctional##2##3##(2008-10#2)
with orofacial##3##2##(2008-10#2)(2011-2#1)
with oropharyngeal##4##2##(2005-8#1)(2008-5#1)(2009-10#1)(2010-7#1)
with orthogonal##5##2##(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#1)
with orthogonally polarized beams in a##3##6##(2007-12#1)(2008-3#2)
with orthogonally##4##2##(1995-11#1)(2007-12#1)(2008-3#2)
with orthophosphoric acid)##2##3##(1996-5#1)(2008-5#1)
with orthophosphoric##3##2##(1996-5#2)(2008-5#1)
with orthovanadate##2##2##(1994-12#1)(1995-6#1)
with osmium##3##2##(2008-10#2)(2010-11#1)
with osmotic##4##2##(1992-10#1)(1997-1#1)(2012-7#1)(2013-7#1)
with osseous##4##2##(1991-11#1)(2008-7#2)(2012-12#1)
with ossified cochleae##3##3##(2008-9#3)
with osteoarthritis (OA)##2##3##(2006-5#1)(2008-10#1)
with osteoarthritis of the knee##7##5##(2006-10#2)(2007-11#1)(2008-5#1)(2010-12#2)(2011-2#1)
with osteoarthritis of the##10##4##(1993-11#1)(2006-10#3)(2007-11#1)(2008-5#2)(2010-12#2)(2011-2#1)
with osteoarthritis of##12##3##(1993-11#1)(2006-10#4)(2007-11#1)(2008-5#3)(2010-12#2)(2011-2#1)
with osteoarthritis was##3##3##(1991-5#1)(2006-10#1)(2006-7#1)
with osteoarthritis##27##2##(1991-5#1)(1993-11#2)(2006-10#5)(2006-5#1)(2006-7#1)(2007-11#4)(2007-8#1)(2008-10#1)(2008-5#3)(2010-11#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)
with osteoarthrosis##3##2##(2006-6#1)(2010-10#1)(2011-2#1)
with osteoblastic properties##2##3##(1992-12#1)(1994-2#1)
with osteoblastic##3##2##(1992-12#1)(1994-2#1)(2007-11#1)
with osteoclast-like giant cells##2##4##(2012-1#1)(2012-3#1)
with osteogenesis imperfecta##3##3##(2006-10#1)(2007-8#2)
with osteogenic##3##2##(2008-11#1)(2008-5#1)(2011-1#1)
with osteolytic##2##2##(1991-5#1)(2010-12#1)
with osteomyelitis##4##2##(1991-10#1)(2005-9#3)
with osteopenia##3##2##(2005-3#1)(2009-3#1)(2013-1#1)
with osteoporosis and##2##3##(2007-11#1)(2010-3#1)
with osteoporosis or##3##3##(2006-12#1)(2008-4#1)(2012-12#1)
with osteoporosis##28##2##(1997-6#1)(2005-1#1)(2006-10#1)(2006-12#1)(2007-11#6)(2007-8#1)(2008-11#1)(2008-4#1)(2008-8#5)(2010-3#3)(2011-12#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
with osteoporotic##5##2##(1991-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-8#1)
with osteosarcoma are##2##3##(2008-6#1)(2010-3#1)
with osteosarcoma##13##2##(2008-1#1)(2008-6#2)(2010-3#10)
with other Gulf populations and##2##5##(2007-2#2)
with other active##3##3##(1991-4#1)(2007-11#1)(2008-10#1)
with other agents##10##3##(1995-12#1)(2005-11#1)(2006-4#1)(2007-11#3)(2008-3#1)(2009-8#1)(2010-12#1)(2010-3#1)
with other algorithms##2##3##(2008-2#1)(2009-3#1)
with other amino acids##4##4##(1994-9#1)(1996-8#1)(2008-10#2)
with other analytical##2##3##(2008-10#1)(2008-5#1)
with other antihypertensive drugs##3##4##(1995-11#1)(2008-3#2)
with other antihypertensive##5##3##(1990-1#1)(1995-11#1)(2008-3#2)(2012-3#1)
with other antimalarials##3##3##(2007-2#1)(2009-6#2)
with other antirheumatics##2##3##(2007-11#2)
with other anxiety disorders##2##4##(2008-4#1)(2011-2#1)
with other approaches##4##3##(2004-4#1)(2006-10#1)(2007-11#1)(2008-2#1)
with other areas of##4##4##(2007-3#1)(2007-8#1)(2013-1#2)
with other areas##6##3##(2005-9#1)(2007-3#1)(2007-8#1)(2012-12#1)(2013-1#2)
with other aspects of##3##4##(2008-2#1)(2008-5#1)(2012-2#1)
with other authors##3##3##(1990-10#1)(1990-4#1)(2011-2#1)
with other autoimmune diseases##2##4##(2013-8#2)
with other autoimmune##3##3##(2007-11#1)(2013-8#2)
with other bacterial##2##3##(2006-5#1)(2007-5#1)
with other behavioral risk factors for##2##6##(2008-3#1)(2011-1#1)
with other biochemical##2##3##(1990-2#1)(1992-8#1)
with other biological##2##3##(1992-9#1)(2008-9#1)
with other cardiac##6##3##(2007-3#2)(2007-8#1)(2008-12#1)(2008-4#1)(2012-3#1)
with other causes of##3##4##(1996-11#1)(2008-1#1)(2011-1#1)
with other causes##4##3##(1996-11#1)(2007-7#1)(2008-1#1)(2011-1#1)
with other cell##2##3##(1993-6#1)(2008-1#1)
with other cells##2##3##(2008-4#1)(2008-7#1)
with other chromosomal##2##3##(1994-4#1)(1995-2#1)
with other chronic##2##3##(1994-12#1)(2006-2#1)
with other clinical##9##3##(1992-2#1)(1996-5#1)(2006-12#1)(2008-11#1)(2012-1#1)(2012-11#2)(2013-1#2)
with other common##2##3##(2008-10#2)
with other commonly##2##3##(2008-7#1)(2012-3#1)
with other complexes##2##3##(1997-1#1)(2008-5#1)
with other components##3##3##(1995-5#1)(2008-5#2)
with other conditions##4##3##(1997-3#1)(2007-11#1)(2008-5#1)(2013-1#1)
with other conventional##4##3##(2007-10#1)(2007-11#1)(2008-10#1)(2008-2#1)
with other countries##5##3##(1990-11#1)(2008-12#2)(2009-6#1)(2012-2#1)
with other cytokines##3##3##(1992-12#1)(1992-8#1)(1996-10#1)
with other cytoskeletal proteins##2##4##(1993-4#1)(1997-6#1)
with other cytoskeletal##3##3##(1993-4#1)(1994-8#1)(1997-6#1)
with other data in the literature##2##6##(1994-3#1)(2008-9#1)
with other data##6##3##(1990-10#2)(1994-12#1)(1994-3#1)(1995-8#1)(2008-9#1)
with other developmental##2##3##(2007-10#1)(2009-4#1)
with other devices##2##3##(2007-11#1)(2010-10#1)
with other diagnoses##4##3##(2006-8#1)(2008-4#1)(2008-7#1)(2012-2#1)
with other diagnostic##2##3##(2006-9#1)(2009-4#1)
with other disciplines##2##3##(1990-6#1)(2011-2#1)
with other disease##3##3##(1997-7#1)(2008-10#1)(2008-8#1)
with other diseases##5##3##(1997-1#1)(1997-5#1)(2007-8#1)(2008-4#1)(2011-2#1)
with other disorders##4##3##(1992-4#1)(2004-3#1)(2006-10#1)(2008-8#1)
with other drug##2##3##(1996-1#1)(2005-7#1)
with other drugs##9##3##(1990-2#1)(1991-8#1)(1993-11#1)(2005-7#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-11#1)
with other embolic##2##3##(1996-9#1)(2007-9#1)
with other emerging##2##3##(2005-8#1)(2013-1#1)
with other established##2##3##(2008-9#1)(2012-1#1)
with other etiologies of renal failure##4##6##(2013-1#4)
with other etiologies##5##3##(2013-1#4)(2013-8#1)
with other exercises##2##3##(2013-1#2)
with other existing##3##3##(2008-4#1)(2013-1#2)
with other experimental##3##3##(1997-2#1)(2008-10#1)(2012-11#1)
with other factors for##2##4##(2012-6#2)
with other factors##7##3##(1995-3#1)(2005-7#1)(2007-11#1)(2008-4#1)(2009-4#1)(2012-6#2)
with other features of##2##4##(1991-6#1)(2009-7#1)
with other findings##2##3##(1996-12#1)(2006-10#1)
with other first-line agents##2##4##(1996-9#1)(2008-9#1)
with other food##4##3##(2007-11#4)
with other forms of##5##4##(1993-10#1)(2005-6#1)(2006-12#1)(2006-9#1)(2007-12#1)
with other four##2##3##(2008-10#2)
with other genes##4##3##(1996-2#1)(2008-10#2)(2008-4#1)
with other groups of##2##4##(1992-11#1)(1994-11#1)
with other groups##6##3##(1992-11#1)(1993-12#1)(1994-11#1)(2009-10#1)(2009-9#1)(2011-2#1)
with other health care##3##4##(1995-2#1)(2007-6#1)(2008-11#1)
with other health##6##3##(1990-4#1)(1994-6#1)(1995-2#1)(2007-6#1)(2008-11#1)(2010-3#1)
with other immunosuppressive agents##2##4##(2006-10#1)(2013-7#1)
with other individuals##2##3##(2012-1#1)(2012-12#1)
with other inflammatory markers##2##4##(1995-7#1)(2013-7#1)
with other inhibitors##2##3##(1994-11#1)(1995-3#1)
with other inorganic##2##3##(1991-2#1)(2008-10#1)
with other interferons##2##3##(2007-11#2)
with other isolates##2##3##(2008-10#1)(2011-2#1)
with other isolates/species##2##3##(2013-1#2)
with other known##16##3##(1991-2#2)(1991-8#1)(1992-11#1)(1992-2#1)(1993-8#1)(1994-8#1)(1995-4#1)(1996-2#1)(1997-7#1)(2006-12#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
with other lipid##2##3##(1992-8#1)(2008-6#1)
with other locusts##3##3##(2012-2#3)
with other mammalian##2##3##(1991-6#1)(1992-9#1)
with other mammals##2##3##(1992-12#1)(2013-1#1)
with other markers##2##3##(2006-12#1)(2013-7#1)
with other materials##2##3##(2008-10#1)(2009-4#1)
with other measures of##2##4##(1996-8#1)(2010-9#1)
with other mechanisms of##2##4##(2005-8#1)(2008-4#1)
with other mechanisms##3##3##(2005-8#1)(2008-10#1)(2008-4#1)
with other medical##2##3##(2007-3#1)(2009-7#1)
with other medications##7##3##(2007-11#1)(2007-8#1)(2008-1#2)(2010-12#1)(2011-1#1)(2012-3#1)
with other members of the##8##5##(1992-3#1)(1995-8#1)(1996-3#1)(1997-7#1)(2008-10#3)(2008-11#1)
with other members of##10##4##(1992-3#1)(1994-8#1)(1995-8#1)(1996-3#1)(1997-7#1)(2008-10#3)(2008-11#1)(2012-2#1)
with other membranes##3##3##(1990-3#1)(2007-7#1)(2008-1#1)
with other mental disorders##2##4##(2009-10#1)(2010-2#1)
with other methods of##2##4##(2007-12#1)(2008-8#1)
with other methods##17##3##(1991-11#1)(1993-12#1)(1994-8#1)(1995-4#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2013-8#1)
with other modalities##3##3##(2007-1#1)(2007-6#1)(2013-1#1)
with other molecules##4##3##(1995-2#1)(2008-5#1)(2013-1#2)
with other more##2##3##(2008-10#1)(2008-6#1)
with other neurological##2##3##(2012-2#1)(2013-1#1)
with other optical##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
with other oral##2##3##(1994-4#1)(2012-3#1)
with other organic##2##3##(2008-11#1)(2013-8#1)
with other organizations##2##3##(1994-12#1)(2012-2#1)
with other pathologies##2##3##(2008-7#1)(2012-2#1)
with other patients##4##3##(2008-7#2)(2010-2#1)(2010-3#1)
with other people##4##3##(2005-7#1)(2008-4#1)(2010-12#2)
with other peptides##3##3##(1991-12#1)(1991-2#1)(1997-4#1)
with other phospholipids##3##3##(1990-3#1)(1996-4#1)(2011-1#1)
with other physical##2##3##(1995-6#1)(2005-12#1)
with other plant##2##3##(2008-8#1)(2008-9#1)
with other plants##2##3##(2008-5#1)(2011-2#1)
with other polynucleotidyl transferases##2##4##(2007-3#2)
with other populations##4##3##(1996-5#1)(2007-2#1)(2011-1#1)(2013-7#1)
with other primary##2##3##(1997-8#1)(2007-4#1)
with other procedures##6##3##(1990-10#1)(1993-8#1)(2005-9#1)(2006-8#1)(2008-4#1)(2012-11#1)
with other professional##3##3##(2007-4#1)(2008-3#1)(2012-12#1)
with other protein##2##3##(1994-8#1)(1997-6#1)
with other proteins in##2##4##(2006-10#1)(2008-4#1)
with other proteins##17##3##(1990-6#1)(1993-3#1)(1994-11#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-3#1)(1996-10#1)(1997-6#1)(1997-7#2)(2006-10#1)(2007-8#1)(2008-3#1)(2008-4#2)(2009-5#1)
with other psychiatric disorders##4##4##(2005-10#1)(2008-1#1)(2009-11#1)(2011-1#1)
with other published data##2##4##(1992-10#1)(1994-7#1)
with other published##8##3##(1991-12#1)(1992-10#1)(1994-7#1)(2008-2#1)(2008-5#1)(2010-10#1)(2013-1#1)(2013-8#1)
with other recent results##2##4##(1996-9#1)(2006-6#1)
with other recent##4##3##(1995-7#1)(1996-9#1)(2006-6#1)(2011-2#1)
with other reported##5##3##(1991-6#1)(1992-12#1)(1996-9#1)(2008-10#1)(2008-11#1)
with other reports of##2##4##(1991-6#1)(1993-1#1)
with other reports##8##3##(1990-3#1)(1991-6#1)(1993-1#1)(1994-6#1)(1996-11#1)(1997-4#1)(2007-2#1)(2007-9#1)
with other risk factors##6##4##(1991-10#1)(1991-9#1)(1996-9#1)(2007-10#1)(2008-1#1)(2010-10#1)
with other risk##7##3##(1991-10#1)(1991-9#1)(1996-9#1)(2007-10#1)(2008-1#1)(2010-10#1)(2010-12#1)
with other sarcomas##3##3##(2008-6#3)
with other seasonal allergens##2##4##(2011-2#2)
with other service##2##3##(2008-11#1)(2012-3#1)
with other signaling pathways##2##4##(2006-10#1)(2007-12#1)
with other species of this##2##5##(2007-3#1)(2008-10#1)
with other species of##4##4##(2007-3#1)(2008-10#1)(2008-12#1)(2008-6#1)
with other species##6##3##(2007-3#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-6#1)
with other standard##2##3##(2008-10#1)(2010-5#1)
with other structural##2##3##(1992-7#1)(2007-12#1)
with other structurally related##2##4##(1997-8#1)(2008-7#1)
with other studies demonstrating that##2##5##(2008-12#1)(2011-1#1)
with other studies in##2##4##(1994-1#1)(2013-8#1)
with other studies##16##3##(1991-12#1)(1992-9#2)(1994-1#1)(1997-4#1)(1997-9#1)(2008-1#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-8#1)
with other supportive##2##3##(2007-7#1)(2013-1#1)
with other surgical##2##3##(1990-6#1)(2006-12#1)
with other symptoms##3##3##(1991-4#1)(2006-10#1)(2007-7#1)
with other systems##5##3##(2007-4#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#1)
with other techniques##6##3##(1995-4#1)(2005-11#1)(2008-10#1)(2008-7#1)(2010-4#1)(2012-12#1)
with other technologies##2##3##(2008-7#1)(2011-2#1)
with other tests##3##3##(2006-8#1)(2007-3#1)(2007-7#1)
with other therapeutic agents##2##4##(2008-5#1)(2013-1#1)
with other therapeutic##3##3##(2008-11#1)(2008-5#1)(2013-1#1)
with other therapies##2##3##(2010-8#1)(2012-3#1)
with other tospoviruses##2##3##(2008-10#2)
with other transcription factors##2##4##(2011-2#1)(2012-2#1)
with other treatment modalities##2##4##(2004-1#1)(2007-4#1)
with other treatment##4##3##(2004-1#1)(2004-3#1)(2007-4#1)(2012-2#1)
with other tumor##4##3##(1993-11#1)(2008-6#1)(2009-3#1)(2009-6#1)
with other tumors##4##3##(1997-8#1)(2007-8#1)(2008-1#1)(2011-2#1)
with other types of fixation##2##5##(2013-8#2)
with other types of##16##4##(1991-10#1)(1993-11#1)(2005-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
with other vaccines##2##3##(1994-9#1)(2007-2#1)
with other variables##4##3##(2007-11#1)(2008-4#1)(2010-8#1)(2013-1#1)
with other variants##2##3##(2007-11#1)(2008-10#1)
with other viruses##2##3##(2008-10#1)(2008-5#1)
with other##1025##2##(1990-1#1)(1990-10#5)(1990-11#2)(1990-12#5)(1990-2#4)(1990-3#5)(1990-4#2)(1990-5#2)(1990-6#7)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#9)(1991-2#8)(1991-3#1)(1991-4#3)(1991-5#1)(1991-6#4)(1991-7#2)(1991-8#4)(1991-9#2)(1992-10#1)(1992-11#4)(1992-12#5)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#3)(1992-9#5)(1993-1#1)(1993-10#2)(1993-11#8)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#2)(1993-8#5)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#5)(1994-2#5)(1994-3#3)(1994-4#2)(1994-6#4)(1994-7#1)(1994-8#5)(1994-9#5)(1995-1#1)(1995-10#1)(1995-11#5)(1995-12#3)(1995-2#4)(1995-3#7)(1995-4#4)(1995-5#3)(1995-6#2)(1995-7#2)(1995-8#4)(1995-9#1)(1996-1#2)(1996-10#4)(1996-11#2)(1996-12#8)(1996-2#3)(1996-3#6)(1996-4#2)(1996-5#7)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#5)(1997-1#5)(1997-2#3)(1997-3#4)(1997-4#8)(1997-5#1)(1997-6#3)(1997-7#5)(1997-8#5)(1997-9#1)(2004-1#1)(2004-11#1)(2004-3#2)(2004-4#1)(2005-10#4)(2005-11#5)(2005-12#2)(2005-5#1)(2005-6#1)(2005-7#7)(2005-8#4)(2005-9#3)(2006-10#23)(2006-11#3)(2006-12#13)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#7)(2006-9#3)(2007-1#3)(2007-10#6)(2007-11#32)(2007-12#7)(2007-2#10)(2007-3#11)(2007-4#4)(2007-5#3)(2007-6#4)(2007-7#11)(2007-8#11)(2007-9#6)(2008-1#16)(2008-10#71)(2008-11#22)(2008-12#10)(2008-2#14)(2008-3#24)(2008-4#27)(2008-5#35)(2008-6#12)(2008-7#23)(2008-8#13)(2008-9#10)(2009-1#1)(2009-10#6)(2009-11#4)(2009-12#1)(2009-3#4)(2009-4#7)(2009-5#4)(2009-6#4)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#4)(2010-11#1)(2010-12#10)(2010-2#4)(2010-3#3)(2010-4#3)(2010-5#3)(2010-6#2)(2010-7#3)(2010-8#10)(2010-9#1)(2011-1#14)(2011-12#4)(2011-2#38)(2011-3#1)(2011-9#1)(2012-1#7)(2012-11#4)(2012-12#13)(2012-2#18)(2012-3#18)(2012-6#2)(2013-1#34)(2013-7#6)(2013-8#21)
with others and##3##3##(2005-7#1)(2011-2#1)(2012-1#1)
with others in the##3##4##(2006-1#1)(2007-4#1)(2011-1#1)
with others in##5##3##(2006-1#1)(2007-2#1)(2007-4#1)(2008-10#1)(2011-1#1)
with others##44##2##(1991-5#1)(1991-8#1)(1992-1#1)(1994-9#1)(1995-12#1)(1995-9#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(2005-10#1)(2005-7#1)(2006-1#1)(2006-2#1)(2006-9#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)
with otherwise##4##2##(1995-12#1)(1996-9#1)(2007-3#1)(2007-8#1)
with ouabain##5##2##(1991-2#1)(1994-2#1)(2005-8#1)(2006-5#1)(2008-8#1)
with our data##3##3##(1993-4#1)(2005-11#1)(2008-2#1)
with our earlier##3##3##(1991-6#1)(1994-9#1)(2013-8#1)
with our experimental##3##3##(2005-11#1)(2008-3#2)
with our hypothesis##4##3##(1991-12#1)(1992-3#1)(1995-11#1)(2005-11#1)
with our model##4##3##(1995-3#1)(2007-11#1)(2008-1#1)(2008-3#1)
with our optimized##2##3##(2008-11#1)(2008-5#1)
with our own##2##3##(2006-6#1)(2008-7#1)
with our previous demonstration that##2##5##(1994-11#1)(1995-1#1)
with our previous finding that##2##5##(1996-12#1)(1996-6#1)
with our previous findings##3##4##(1995-12#1)(1996-5#1)(2008-8#1)
with our previous observations##3##4##(1991-4#1)(1992-6#1)(1994-3#1)
with our previous report##2##4##(2010-12#1)(2012-12#1)
with our previous results on##3##5##(1990-8#1)(1992-4#1)(2008-12#1)
with our previous results##4##4##(1990-8#1)(1992-4#1)(1996-10#1)(2008-12#1)
with our previous studies##2##4##(1994-2#1)(2008-8#1)
with our previous##28##3##(1990-5#1)(1990-8#1)(1991-4#1)(1992-4#1)(1992-6#1)(1993-5#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(2007-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-8#2)(2010-10#1)(2010-12#1)(2012-12#1)
with our recent##3##3##(1991-8#1)(1992-5#1)(2012-2#1)
with our results##2##3##(1995-6#1)(2008-10#1)
with our simple##3##3##(2007-12#1)(2008-2#1)(2008-6#1)
with our smoothing technologies##2##4##(2007-12#2)
with our##112##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#2)(1996-10#2)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#1)(1996-6#2)(1997-4#1)(2005-11#3)(2006-12#2)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#6)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#8)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-8#2)
with out##2##2##(1994-12#1)(2008-7#1)
with outcome data##2##3##(2006-8#1)(2013-1#1)
with outcome##13##2##(1992-1#1)(1993-2#1)(2004-2#1)(2006-10#1)(2006-6#1)(2006-8#1)(2006-9#3)(2007-9#3)(2013-1#1)
with outcomes##7##2##(1996-2#1)(2007-8#1)(2008-12#2)(2008-9#1)(2009-3#1)(2012-1#1)
with outer##3##2##(2007-2#2)(2008-12#1)
with outpatient##2##2##(1995-12#1)(1996-3#1)
with output power of##3##4##(2007-12#3)
with output powers of several##2##5##(2007-11#2)
with output powers of##4##4##(2007-11#4)
with output powers##5##3##(2007-11#4)(2007-12#1)
with output##10##2##(2007-11#4)(2007-12#4)(2007-9#1)(2008-1#1)
with outside##3##2##(1991-12#1)(1992-2#1)(1997-2#1)
with outstanding##3##2##(2008-1#1)(2008-3#1)(2008-8#1)
with ovalbumin##5##2##(1994-9#2)(1996-10#1)(2008-10#1)(2008-11#1)
with ovarian carcinoma##6##3##(1991-4#1)(1991-5#1)(1992-1#1)(1993-9#1)(2005-11#1)(2012-2#1)
with ovarian##29##2##(1990-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-8#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-11#2)(1996-1#1)(1996-10#1)(2005-11#1)(2006-10#3)(2007-10#1)(2008-1#1)(2010-12#3)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#3)
with over 100##2##3##(1993-9#1)(2005-7#1)
with over 1000##2##3##(2005-7#1)(2007-6#1)
with over 30##2##3##(1995-3#1)(2006-11#1)
with over half of##2##4##(2010-3#1)(2011-2#1)
with over the counter##2##4##(2006-12#1)(2008-2#1)
with over the##3##3##(1991-1#1)(2006-12#1)(2008-2#1)
with over##25##2##(1991-1#1)(1991-3#1)(1991-7#1)(1992-11#1)(1993-9#1)(1994-10#1)(1995-3#1)(1997-4#1)(2005-7#2)(2006-11#1)(2006-12#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-2#1)
with overall survival##2##3##(1996-11#1)(2008-10#1)
with overall##13##2##(1990-8#1)(1992-6#1)(1994-3#1)(1996-11#1)(1997-2#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-3#1)(2011-2#2)
with overexpression of P-glycoprotein##2##4##(1992-11#1)(1992-12#1)
with overexpression of##6##3##(1990-9#1)(1992-11#1)(1992-12#2)(1995-8#1)(2008-11#1)
with overexpression##8##2##(1990-9#1)(1992-11#1)(1992-12#2)(1995-8#1)(2008-10#1)(2008-11#1)(2009-8#1)
with overlapping features##2##3##(2010-12#1)(2012-3#1)
with overlapping peaks##2##3##(2008-10#1)(2011-1#1)
with overlapping##10##2##(1996-5#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
with overnight##2##2##(2011-2#1)(2012-8#1)
with overt##6##2##(2006-10#1)(2008-1#2)(2010-6#1)(2010-8#1)(2011-2#1)
with overweight##7##2##(2008-4#1)(2012-2#1)(2012-3#1)(2013-8#4)
with oxaloacetate##2##2##(1990-3#1)(1995-11#1)
with oxidant##3##2##(2008-10#3)
with oxidative stress and##2##4##(2010-7#1)(2012-12#1)
with oxidative stress##12##3##(1991-9#1)(2005-9#1)(2006-4#1)(2008-1#1)(2008-10#1)(2008-5#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
with oxidative##17##2##(1991-9#1)(2005-9#1)(2006-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-8#1)(2009-9#2)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
with oxidized LDL##2##3##(1996-2#2)
with oxidized flavodoxin##2##3##(1994-8#2)
with oxidized##5##2##(1994-8#2)(1995-12#1)(1996-2#2)
with oxine was##2##3##(2007-8#1)(2008-10#1)
with oxine##3##2##(2007-8#1)(2008-10#2)
with oxotremorine##2##2##(1991-2#1)(1995-12#1)
with oxygen and##2##3##(2007-11#1)(2011-2#1)
with oxygen saturation##2##3##(2010-7#2)
with oxygen##26##2##(1990-3#1)(1990-8#1)(1990-9#1)(1991-8#1)(1992-8#1)(1993-3#1)(1995-11#2)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#5)(2010-7#2)(2011-1#1)(2011-2#2)
with oxytetracycline##2##2##(1991-3#2)
with ozone resulted in##2##4##(1997-2#1)(2013-1#1)
with ozone##9##2##(1995-7#1)(1996-1#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2013-1#1)
with p beta##2##3##(2006-10#2)
with p##4##2##(2006-10#2)(2006-9#1)(2010-7#1)
with p-CMBS (or NBD-Cl)##2##4##(1992-6#2)
with p-CMBS##3##2##(1992-6#3)
with p-aminoacetophenone##2##2##(2008-10#2)
with p-nitrophenyl phosphate##2##3##(1991-2#1)(1997-2#1)
with p-nitrophenyl##6##2##(1990-10#1)(1991-2#1)(1995-2#1)(1997-2#1)(2005-11#1)(2011-1#1)
with p21##4##2##(1995-6#2)(1996-5#2)
with p47-phox deficiency##2##3##(1994-3#2)
with p53 mutations##2##3##(2011-2#1)(2012-12#1)
with p53##15##2##(1993-8#1)(1993-9#1)(1994-3#1)(1996-4#1)(2005-12#1)(2008-7#3)(2008-9#1)(2009-2#1)(2010-8#1)(2011-2#3)(2012-12#1)
with p65##2##2##(1995-3#2)
with p67phox##3##2##(1994-3#3)
with pANCA##2##2##(2007-2#2)
with pH 3##3##3##(2008-10#1)(2010-12#1)(2011-12#1)
with pH 4##2##3##(2008-10#1)(2010-2#1)
with pH 5##2##3##(1996-5#1)(2008-10#1)
with pH 7##3##3##(1990-2#1)(2008-10#2)
with pH and##5##3##(1993-6#1)(1996-11#1)(1997-8#1)(2008-10#1)(2011-2#1)
with pH in##2##3##(1991-7#1)(2010-4#1)
with pH##47##2##(1990-11#1)(1990-2#2)(1991-7#1)(1992-12#1)(1992-7#1)(1993-6#1)(1994-8#1)(1996-11#1)(1996-5#1)(1997-3#1)(1997-8#3)(2007-10#1)(2008-10#17)(2008-11#1)(2008-5#4)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#2)
with pH=7##2##2##(2008-10#1)(2008-5#1)
with pI &gt##2##3##(1993-8#2)
with pI##6##2##(1992-11#1)(1992-12#1)(1993-8#2)(1996-12#1)(1996-5#1)
with pKa approximately##2##3##(1991-4#2)
with pKa##3##2##(1991-4#2)(1995-5#1)
with pSV2neo##2##2##(1992-5#1)(1996-6#1)
with pT3##2##2##(2011-2#2)
with pacemakers##4##2##(1992-10#1)(2006-9#2)(2008-4#1)
with packaging##2##2##(1990-5#1)(1992-8#1)
with paclitaxel and carboplatin##2##4##(2005-8#1)(2013-1#1)
with paclitaxel and##4##3##(2005-8#1)(2008-2#1)(2012-2#1)(2013-1#1)
with paclitaxel##11##2##(2005-11#1)(2005-8#1)(2007-11#1)(2008-2#1)(2008-8#1)(2009-4#1)(2010-11#2)(2011-2#1)(2012-2#1)(2013-1#1)
with paediatric##4##2##(2007-9#1)(2008-11#1)(2008-9#1)(2010-7#1)
with paid##4##2##(1992-12#1)(2012-3#3)
with pain and##12##3##(1990-6#1)(1992-11#1)(2006-8#1)(2007-3#1)(2007-7#1)(2009-3#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
with pain in the##6##4##(1990-3#1)(2007-6#1)(2007-8#1)(2009-3#1)(2010-12#1)(2013-8#1)
with pain in##7##3##(1990-3#1)(1997-8#1)(2007-6#1)(2007-8#1)(2009-3#1)(2010-12#1)(2013-8#1)
with pain management##2##3##(2006-10#1)(2010-11#1)
with pain##48##2##(1990-12#1)(1990-3#1)(1990-6#1)(1992-11#1)(1993-5#1)(1994-3#1)(1996-7#1)(1997-8#1)(2005-10#1)(2006-10#2)(2006-4#1)(2006-7#1)(2006-8#2)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-12#3)(2009-3#3)(2010-1#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
with painful neuropathy##2##3##(2008-3#1)(2011-2#1)
with painful##12##2##(1991-3#1)(1991-4#1)(1997-1#2)(2006-7#1)(2007-11#1)(2007-3#1)(2008-3#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-1#1)
with painless##7##2##(2006-8#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#2)
with paint##2##2##(2007-12#1)(2013-8#1)
with pair##2##2##(2006-6#1)(2008-8#1)
with paired helical filaments##2##4##(1992-1#1)(1995-10#1)
with paired##9##2##(1991-9#1)(1992-1#1)(1995-10#1)(2005-10#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-7#1)
with pairwise##4##2##(1994-5#1)(1995-10#1)(2008-10#2)
with palladium chloride##2##3##(2007-11#2)
with palladium##5##2##(2007-11#2)(2008-10#3)
with palladium(II)##3##2##(2007-11#1)(2008-10#2)
with palliative##13##2##(1990-9#1)(2007-2#1)(2007-4#2)(2008-5#1)(2008-7#2)(2012-11#4)(2012-12#1)(2012-2#1)
with palm##2##2##(2007-3#1)(2008-6#1)
with palmar##4##2##(1994-10#1)(1994-8#1)(2006-3#1)(2008-12#1)
with palmitate##3##2##(1990-4#1)(2008-5#1)(2010-10#1)
with palmitoyl##2##2##(1995-2#1)(1996-4#1)
with palpable breast##2##3##(2006-1#1)(2008-12#1)
with palpable##7##2##(1990-9#1)(1991-4#1)(1995-9#1)(2006-1#1)(2007-8#2)(2008-12#1)
with pamidronate##3##2##(2008-6#1)(2008-7#2)
with pancreatic cancer##8##3##(1991-2#1)(1993-11#1)(1997-7#1)(2008-9#2)(2011-2#1)(2013-8#2)
with pancreatic enzymes##2##3##(2006-6#2)
with pancreatic##26##2##(1990-2#1)(1991-2#1)(1992-12#1)(1992-6#2)(1992-9#1)(1993-11#1)(1995-12#1)(1997-7#1)(2006-6#3)(2008-1#1)(2008-10#1)(2008-3#4)(2008-5#1)(2008-9#2)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
with pancreatitis##3##2##(1996-9#1)(2005-10#1)(2011-2#1)
with pandemic (H1N1) 2009##2##4##(2011-1#1)(2012-1#1)
with pandemic##5##2##(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#2)
with panic disorder and##2##4##(1990-11#1)(1996-1#1)
with panic disorder##17##3##(1990-11#1)(1993-12#2)(1995-11#1)(1996-1#1)(1996-3#1)(1996-7#2)(2005-7#1)(2006-3#1)(2006-9#1)(2007-1#1)(2007-10#1)(2013-7#1)(2013-8#3)
with panic##19##2##(1990-11#1)(1993-12#2)(1995-11#1)(1996-1#1)(1996-3#1)(1996-7#2)(2005-7#1)(2006-3#1)(2006-9#1)(2007-1#1)(2007-10#2)(2010-2#1)(2013-7#1)(2013-8#3)
with papain##3##2##(1990-2#1)(1991-12#1)(2008-1#1)
with papaverine##2##2##(2007-9#2)
with paper##3##2##(1992-3#1)(2007-8#1)(2013-1#1)
with papillary carcinoma##2##3##(1990-9#1)(1996-6#1)
with papillary thyroid##3##3##(2008-10#2)(2012-3#1)
with papillary##8##2##(1990-9#1)(1996-6#1)(2008-10#2)(2008-12#1)(2008-6#1)(2010-6#1)(2012-3#1)
with para- and##4##3##(2006-5#2)(2007-11#2)
with parabolic##4##2##(2005-10#3)(2008-3#1)
with paracetamol##10##2##(1990-10#1)(1990-2#1)(1995-11#5)(2008-10#1)(2008-4#1)(2011-2#1)
with paraffin##2##2##(2005-11#1)(2008-10#1)
with parallel##15##2##(1990-5#1)(1992-12#1)(1996-4#1)(1997-7#1)(2006-10#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-5#1)(2009-7#1)(2011-1#1)
with paralysis##2##2##(2007-3#1)(2012-12#1)
with paramagnetic contrast##2##3##(1992-12#1)(1995-6#1)
with paramagnetic##3##2##(1992-12#1)(1995-6#1)(1996-12#1)
with parameter estimation##4##3##(2008-10#2)(2012-3#1)(2013-7#1)
with parameter##5##2##(2008-10#2)(2008-4#1)(2012-3#1)(2013-7#1)
with parameters of##2##3##(2010-10#1)(2012-1#1)
with parameters##7##2##(1996-2#1)(2008-10#2)(2008-2#2)(2010-10#1)(2012-1#1)
with paraneoplastic##5##2##(1994-3#2)(1997-7#1)(2011-2#1)(2013-1#1)
with paranoid schizophrenia who##2##4##(2007-7#1)(2009-9#1)
with paranoid schizophrenia##6##3##(1997-8#1)(2007-7#2)(2009-9#1)(2010-6#1)(2011-2#1)
with paranoid##7##2##(1997-8#1)(2005-7#1)(2007-7#2)(2009-9#1)(2010-6#1)(2011-2#1)
with paraplegia##4##2##(2007-10#3)(2013-1#1)
with parasagittal##2##2##(1996-4#1)(2008-7#1)
with parasite virulence##2##3##(2008-8#2)
with parasite##4##2##(2008-4#1)(2008-8#2)(2008-9#1)
with parasites##4##2##(2006-2#1)(2007-7#1)(2008-5#1)(2012-12#1)
with parasitic##2##2##(2008-9#1)(2012-12#1)
with parathyroid##3##2##(1991-5#1)(2008-5#1)(2010-12#1)
with parenchymal##7##2##(2006-2#1)(2006-7#1)(2008-4#1)(2008-8#1)(2010-9#2)(2011-2#1)
with parent and##2##3##(1996-2#1)(2009-11#1)
with parent##5##2##(1990-9#1)(1995-2#1)(1996-2#1)(2009-11#1)(2011-1#1)
with parental##9##2##(1991-7#1)(1992-8#1)(1993-12#1)(1994-2#1)(1995-7#1)(1996-2#1)(1996-6#1)(2008-10#2)
with parenteral##4##2##(2005-10#1)(2007-3#1)(2008-7#1)(2010-12#1)
with parenting stress##2##3##(1995-1#1)(2007-10#1)
with parenting##4##2##(1995-1#1)(2007-10#2)(2009-11#1)
with parents and##2##3##(1991-8#1)(2013-8#1)
with parents in##2##3##(1994-2#1)(2013-1#1)
with parents of children##3##4##(1992-2#1)(2006-2#1)(2012-2#1)
with parents of high-risk infants##2##5##(2008-11#2)
with parents of##5##3##(1992-2#1)(2006-2#1)(2008-11#2)(2012-2#1)
with parents were##2##3##(1990-12#1)(1991-8#1)
with parents who##2##3##(2008-12#1)(2009-8#1)
with parents##27##2##(1990-12#2)(1990-6#1)(1991-8#2)(1992-11#1)(1992-2#1)(1994-2#1)(2006-2#1)(2007-2#1)(2008-11#3)(2008-12#2)(2008-9#1)(2009-7#3)(2009-8#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
with parkinsonism##4##2##(1990-11#1)(1997-8#1)(2008-11#1)(2008-7#1)
with paroxetine##2##2##(1996-1#1)(2012-3#1)
with paroxysmal##8##2##(2006-9#1)(2007-8#1)(2008-7#1)(2009-10#2)(2010-12#1)(2012-2#1)(2012-3#1)
with part of the##2##4##(1991-2#1)(1991-6#1)
with partial agonist/antagonist##2##3##(1996-5#2)
with partial least squares (PLS)##2##5##(2007-11#1)(2008-10#1)
with partial least squares regression (PLS-R)##2##6##(2007-11#1)(2008-10#1)
with partial least squares regression##4##5##(2007-11#1)(2008-10#3)
with partial least squares##7##4##(2007-11#2)(2008-10#5)
with partial least-squares##2##3##(2008-10#2)
with partial removal of the pulmonary artery##2##7##(2013-7#2)
with partial resistance to##5##4##(2008-10#5)
with partial resistance##9##3##(2008-10#9)
with partial response##2##3##(1994-10#1)(1997-7#1)
with partial##65##2##(1990-5#1)(1992-4#1)(1992-6#2)(1994-10#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-2#1)(1996-2#2)(1996-5#3)(1997-6#1)(1997-7#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#16)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-2#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#2)
with partially coherent light##2##4##(2007-12#1)(2008-2#1)
with partially coherent##3##3##(2007-12#2)(2008-2#1)
with partially purified##2##3##(2008-10#2)
with partially##16##2##(1990-3#1)(1994-12#1)(1995-2#1)(1997-8#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-3#1)
with participants who##3##3##(2006-11#3)
with participants##8##2##(2006-11#3)(2007-10#1)(2010-5#1)(2010-9#1)(2012-11#1)(2012-2#1)
with participating##4##2##(1991-2#1)(2004-2#1)(2012-3#1)(2013-1#1)
with participation of##2##3##(1990-2#1)(1997-6#1)
with participation##3##2##(1990-2#1)(1997-6#1)(2011-1#1)
with particle size##3##3##(1991-10#2)(2008-10#1)
with particle##10##2##(1991-10#2)(1992-6#1)(1993-2#1)(2005-11#1)(2006-2#1)(2008-10#2)(2008-3#2)
with particles of##2##3##(1996-3#1)(2008-10#1)
with particles with##2##3##(2007-11#1)(2008-3#1)
with particles##11##2##(1995-11#1)(1996-3#1)(2007-11#2)(2008-10#1)(2008-3#4)(2008-5#2)
with particular attention given to##2##5##(2007-8#1)(2008-9#1)
with particular attention paid to the##3##6##(2007-11#1)(2008-1#1)(2008-2#1)
with particular attention to the use of##2##7##(2004-1#1)(2011-2#1)
with particular attention to the##10##5##(1990-3#1)(1990-4#1)(1994-1#1)(2004-1#1)(2005-11#1)(2006-12#1)(2007-11#2)(2008-6#1)(2011-2#1)
with particular attention to##24##4##(1990-3#1)(1990-4#1)(1991-7#1)(1993-12#1)(1994-1#1)(1995-10#1)(2004-1#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#6)(2007-8#1)(2008-6#1)(2008-8#1)(2011-2#2)(2012-2#1)
with particular attention##31##3##(1990-3#1)(1990-4#1)(1991-7#1)(1993-12#1)(1993-5#1)(1994-1#1)(1995-10#1)(2004-1#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#7)(2007-8#2)(2008-1#1)(2008-2#2)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-2#1)
with particular emphasis on examining##2##5##(1994-2#1)(2005-10#1)
with particular emphasis on its##2##5##(1993-10#1)(2005-7#1)
with particular emphasis on the control##2##6##(2008-5#1)(2009-5#1)
with particular emphasis on the##17##5##(1992-12#1)(1993-1#1)(1993-6#1)(1995-3#1)(1996-5#1)(2007-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2009-5#1)(2010-9#1)(2012-12#2)(2012-3#1)
with particular emphasis on those##2##5##(2006-1#1)(2011-12#1)
with particular emphasis on##38##4##(1990-4#1)(1992-12#1)(1993-1#1)(1993-10#1)(1993-6#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-5#1)(2005-10#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#1)(2009-5#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-12#1)(2012-11#1)(2012-12#2)(2012-3#1)
with particular emphasis##39##3##(1990-4#1)(1992-12#1)(1993-1#1)(1993-10#1)(1993-6#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-5#1)(2005-10#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#1)(2009-5#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-12#1)(2012-11#1)(2012-12#2)(2012-3#1)
with particular focus on the##2##5##(2008-7#1)(2010-5#1)
with particular focus on##10##4##(1993-12#1)(2005-7#1)(2007-10#1)(2008-1#1)(2008-7#2)(2010-1#1)(2010-5#1)(2011-2#1)(2012-3#1)
with particular reference to the different##2##6##(2007-8#1)(2011-12#1)
with particular reference to the##11##5##(1994-6#1)(1996-6#1)(2007-4#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-10#1)(2011-12#2)(2012-12#1)
with particular reference to their##2##5##(2008-7#1)(2008-8#1)
with particular reference to##29##4##(1990-5#1)(1991-4#1)(1992-2#1)(1993-2#1)(1993-7#1)(1993-9#1)(1994-6#1)(1996-6#1)(2004-7#1)(2005-5#1)(2006-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-12#1)(2011-12#2)(2012-12#1)
with particular regard to the##2##5##(1991-12#2)
with particular regard to##6##4##(1991-12#2)(2008-1#1)(2008-11#1)(2008-5#1)(2012-1#1)
with particular##141##2##(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#1)(1991-12#2)(1991-4#1)(1991-7#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-1#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-7#1)(2004-1#1)(2004-7#1)(2005-10#2)(2005-11#1)(2005-5#1)(2005-7#2)(2006-1#2)(2006-10#3)(2006-12#2)(2006-2#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#7)(2007-4#2)(2007-8#5)(2008-1#4)(2008-10#3)(2008-11#6)(2008-2#5)(2008-3#2)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-12#3)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#3)
with particularly high activity##2##4##(1991-9#1)(1994-8#1)
with particularly high##5##3##(1991-9#1)(1994-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
with particularly##6##2##(1991-9#1)(1994-8#1)(2008-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
with partly clustered erbium ions##2##5##(2007-12#2)
with partner##2##2##(2009-4#1)(2011-2#1)
with partners##7##2##(1995-12#1)(2008-7#1)(2008-8#1)(2009-5#2)(2010-2#1)(2012-2#1)
with parvovirus B19 infection##2##4##(2006-10#1)(2007-11#1)
with passage##3##2##(2007-8#1)(2008-5#1)(2010-7#1)
with passive and##2##3##(2006-11#1)(2007-12#1)
with passive demodulation##2##3##(2008-3#2)
with passive dosimeters##2##3##(1993-1#2)
with passive##11##2##(1993-1#2)(1994-2#1)(2006-11#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-3#2)(2008-7#1)
with past HBV infection##2##4##(2007-8#2)
with past##12##2##(1990-10#1)(1994-2#1)(1996-3#1)(2007-8#2)(2008-8#1)(2009-10#1)(2010-9#1)(2011-1#2)(2012-1#2)
with pasteurized##2##2##(2008-6#2)
with patch closure##2##3##(2007-8#1)(2011-2#1)
with patch##4##2##(1990-7#1)(2007-8#1)(2008-8#1)(2011-2#1)
with patellar tendon##3##3##(2009-9#2)(2012-12#1)
with patellar##4##2##(2007-7#1)(2009-9#2)(2012-12#1)
with patent ductus arteriosus (PDA)##2##5##(2006-8#1)(2007-7#1)
with patent ductus arteriosus##4##4##(2006-8#1)(2007-7#1)(2010-12#1)(2013-1#1)
with patent foramen ovale##2##4##(2006-8#1)(2007-10#1)
with patent##9##2##(1990-3#1)(2006-8#2)(2007-10#1)(2007-7#1)(2010-12#1)(2010-2#1)(2011-2#1)(2013-1#1)
with paternal MS were significantly higher than in controls (P &lt##2##11##(2011-1#2)
with paternal##5##2##(1990-10#1)(2008-8#1)(2011-1#3)
with paternally derived deletions##2##4##(1997-3#2)
with path##2##2##(2007-12#1)(2008-3#1)
with pathogenic bacteria##3##3##(1996-12#1)(2007-7#1)(2010-5#1)
with pathogenic microorganisms##2##3##(2009-5#1)(2013-7#1)
with pathogenic##16##2##(1996-12#1)(1997-6#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-9#2)(2009-5#1)(2010-5#1)(2012-3#1)(2013-7#1)
with pathogens and##2##3##(2006-10#1)(2008-10#1)
with pathogens##5##2##(2006-10#2)(2008-10#2)(2010-12#1)
with pathologic##9##2##(1993-9#1)(2008-1#1)(2008-4#1)(2008-9#1)(2009-3#2)(2012-2#2)(2013-1#1)
with pathological changes##2##3##(1990-2#1)(2007-11#1)
with pathological fracture##2##3##(2007-7#2)
with pathological fractures##3##3##(2007-11#2)(2010-7#1)
with pathological##16##2##(1990-2#1)(1992-5#1)(2006-10#1)(2007-11#3)(2007-7#2)(2007-8#2)(2008-11#1)(2008-9#1)(2010-7#1)(2010-8#1)(2012-3#1)(2013-7#1)
with pathologically##4##2##(1995-3#1)(2008-6#1)(2009-12#1)(2009-2#1)
with pathology##3##2##(1990-6#1)(2006-4#1)(2012-2#1)
with pathophysiological##2##2##(1990-2#1)(2008-1#1)
with pathways##2##2##(2008-4#1)(2011-1#1)
with patient age##3##3##(1990-1#1)(2008-4#1)(2013-1#1)
with patient controlled##2##3##(1992-2#1)(2012-3#1)
with patient satisfaction##3##3##(1993-3#1)(1996-3#1)(2008-12#1)
with patient survival##2##3##(1992-6#1)(2011-2#1)
with patient##32##2##(1990-1#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-3#1)(1995-2#1)(1996-3#1)(2006-10#1)(2006-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#3)(2008-6#2)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
with patient's general condition##2##4##(2007-11#2)
with patient's##4##2##(2007-11#3)(2008-1#1)
with patients and their relatives##2##5##(2006-8#1)(2008-11#1)
with patients and their##3##4##(2006-8#1)(2008-11#1)(2011-2#1)
with patients and##12##3##(1992-5#1)(1993-3#1)(2006-8#1)(2007-12#2)(2007-9#1)(2008-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
with patients at##4##3##(2007-8#2)(2011-1#1)(2011-2#1)
with patients before##2##3##(2006-10#1)(2009-3#1)
with patients from##2##3##(1996-3#1)(2010-2#1)
with patients in the##4##4##(2007-10#1)(2008-12#1)(2008-7#1)(2011-2#1)
with patients in##7##3##(2006-5#1)(2007-10#1)(2008-12#1)(2008-7#2)(2011-2#2)
with patients is##2##3##(1994-12#1)(2006-3#1)
with patients of##5##3##(2007-7#1)(2010-2#4)
with patients receiving##4##3##(1991-12#1)(1996-12#1)(2006-10#1)(2008-7#1)
with patients suffering from##3##4##(2006-12#1)(2010-10#1)(2010-9#1)
with patients undergoing##4##3##(1996-3#1)(2010-2#1)(2012-12#1)(2012-2#1)
with patients who are##2##4##(2006-4#1)(2008-3#1)
with patients who have##2##4##(2006-1#1)(2008-7#1)
with patients who were##3##4##(2006-7#1)(2008-4#1)(2009-9#1)
with patients who##17##3##(1990-12#1)(1995-9#1)(1996-2#1)(2004-3#1)(2005-7#1)(2006-1#1)(2006-4#1)(2006-7#1)(2007-3#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-9#1)(2011-1#1)(2011-2#1)
with patients with FMS##2##4##(2006-10#2)
with patients with##23##3##(1990-1#1)(1990-5#1)(1995-4#1)(2005-6#1)(2006-10#2)(2007-11#2)(2007-2#1)(2008-12#1)(2008-7#2)(2009-10#1)(2009-7#1)(2010-10#1)(2010-12#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#1)
with patients without##5##3##(1991-7#1)(1997-7#1)(2008-7#1)(2010-12#1)(2013-1#1)
with patients##147##2##(1990-1#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-7#1)(1992-3#2)(1992-5#1)(1993-3#2)(1994-12#1)(1994-6#2)(1995-11#1)(1995-2#1)(1995-4#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#2)(1997-8#1)(2004-3#1)(2004-5#1)(2005-12#1)(2005-6#1)(2005-7#2)(2006-1#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#7)(2007-12#5)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-7#1)(2009-9#2)(2010-10#2)(2010-12#2)(2010-2#6)(2010-3#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#9)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#4)
with patients'##9##2##(1991-12#1)(1995-3#1)(2006-10#1)(2006-9#1)(2007-4#1)(2010-7#1)(2012-2#1)(2012-4#1)(2013-1#1)
with pattern recognition##2##3##(2007-8#1)(2008-10#1)
with patterns##2##2##(2008-11#1)(2013-1#1)
with paxillin##4##2##(1997-4#4)
with pay##3##2##(1991-8#1)(1993-2#1)(2011-2#1)
with payment##2##2##(1997-8#1)(2013-1#1)
with payments##2##2##(1992-1#1)(1992-2#1)
with payors##2##2##(1992-12#1)(1994-1#1)
with peak incidence##2##3##(2007-1#1)(2007-2#1)
with peak levels##2##3##(1990-12#1)(2010-8#1)
with peak##27##2##(1990-12#1)(1990-3#1)(1994-2#1)(1996-10#1)(1996-9#1)(1997-8#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
with peaks at##3##3##(1990-5#1)(2007-2#1)(2008-10#1)
with peaks in the##2##4##(2007-2#1)(2013-7#1)
with peaks in##3##3##(2007-2#1)(2007-3#1)(2013-7#1)
with peaks##6##2##(1990-5#1)(2007-2#2)(2007-3#1)(2008-10#1)(2013-7#1)
with peanut##3##2##(2006-9#1)(2007-12#1)(2008-10#1)
with peculiar##3##2##(2008-10#1)(2009-7#2)
with pediatric##5##2##(1991-8#1)(1994-1#1)(1996-1#2)(2006-11#1)
with peer##4##2##(1995-12#1)(2005-10#1)(2008-12#1)(2008-2#1)
with peers##9##2##(1991-8#1)(1992-9#1)(2005-10#1)(2006-3#1)(2006-5#1)(2010-10#1)(2012-12#2)(2013-1#1)
with peginterferon##2##2##(2008-3#1)(2012-12#1)
with pegylated interferon##3##3##(2010-2#2)(2011-2#1)
with pegylated##7##2##(2008-1#1)(2009-7#1)(2010-12#1)(2010-2#3)(2011-2#1)
with pelagic eggs (CV = 3##2##6##(2008-8#2)
with pelvic pain and##2##4##(1991-2#1)(2013-7#1)
with pelvic pain##3##3##(1991-2#1)(1992-1#1)(2013-7#1)
with pelvic peritoneal and bowel##2##5##(2012-12#2)
with pelvic phased array coil##2##5##(2011-2#2)
with pelvic##26##2##(1991-2#1)(1992-1#2)(1993-2#1)(1994-1#1)(1994-2#2)(2006-11#1)(2007-8#2)(2008-6#4)(2009-2#3)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#3)(2013-7#1)
with pendant##3##2##(1997-8#1)(2010-12#1)(2010-4#1)
with pending##2##2##(2008-5#1)(2012-12#1)
with penetrating cardiac injuries##3##4##(2007-8#1)(2008-1#2)
with penetrating##9##2##(2006-10#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-9#1)(2010-10#1)(2010-7#1)
with penetration##2##2##(2007-8#1)(2008-3#1)
with penicillamine##3##2##(1991-8#1)(2008-10#2)
with penicillin G##2##3##(1993-7#1)(2007-12#1)
with penicillin for##2##3##(1991-7#1)(2013-1#1)
with penicillin##12##2##(1990-9#1)(1991-7#2)(1993-7#1)(1995-7#1)(2005-11#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-8#1)(2013-1#1)
with penicillinase##2##2##(1992-2#1)(2008-10#1)
with penile##3##2##(2008-10#1)(2008-6#1)(2013-8#1)
with penoscrotal elephantiasis##2##3##(2007-7#2)
with pentaerythritol triacrylate##2##3##(2008-9#2)
with pentane##2##2##(2008-10#2)
with pentobarbital##3##2##(1992-4#1)(1993-2#1)(2006-11#1)
with people who have##2##4##(1992-3#1)(2008-2#1)
with people who##4##3##(1992-3#1)(2008-2#1)(2009-6#1)(2013-8#1)
with people with a dual diagnosis of##2##7##(2006-9#1)(2008-2#1)
with people with a##3##4##(2006-9#1)(2008-11#1)(2008-2#1)
with people with schizophrenia##2##4##(1995-11#1)(2009-6#1)
with people with##7##3##(1995-11#1)(1995-12#1)(2006-9#1)(2007-9#1)(2008-11#1)(2008-2#1)(2009-6#1)
with people##15##2##(1992-3#1)(1995-11#1)(1995-12#1)(2006-9#1)(2007-9#1)(2008-11#2)(2008-2#3)(2009-6#2)(2010-7#1)(2013-8#2)
with pepsin##4##2##(1992-4#1)(1996-12#1)(2008-1#1)(2008-4#1)
with peptic ulcer disease##3##4##(2006-10#3)
with peptic ulcer##8##3##(1995-10#1)(2006-10#3)(2006-8#1)(2008-12#1)(2009-2#1)(2012-12#1)
with peptic##9##2##(1995-10#1)(2006-10#3)(2006-6#1)(2006-8#1)(2008-12#1)(2009-2#1)(2012-12#1)
with peptide thioester substrates##2##4##(1991-2#2)
with peptide##20##2##(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#2)(1992-12#2)(1992-6#1)(1992-8#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-10#1)
with peptides##5##2##(1992-12#1)(1997-4#1)(2006-11#1)(2007-1#1)(2008-4#1)
with perceived stress and depressive symptoms##2##6##(2012-11#2)
with perceived stress##3##3##(2012-11#3)
with perceived##5##2##(2008-10#1)(2008-9#1)(2012-11#3)
with percent##2##2##(2008-10#1)(2011-12#1)
with percentage##5##2##(1990-9#1)(2007-5#1)(2008-10#2)(2012-1#1)
with percentages of##2##3##(2008-11#1)(2011-2#1)
with percentages##3##2##(1992-9#1)(2008-11#1)(2011-2#1)
with perchlorate##3##2##(2008-10#3)
with perchloric acid##4##3##(1990-2#1)(1993-2#1)(2008-10#2)
with perchloric##5##2##(1990-2#1)(1993-2#1)(2008-10#3)
with percutaneous nephrolithotomy##3##3##(2006-6#2)(2011-2#1)
with percutaneous transluminal##2##3##(2007-5#1)(2011-2#1)
with percutaneous##26##2##(1990-12#1)(1991-3#1)(2006-10#1)(2006-6#3)(2006-8#3)(2007-10#2)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#2)(2010-7#1)(2011-2#2)(2013-8#1)
with perennial##2##2##(2007-11#1)(2012-2#1)
with perfect coupling##2##3##(1997-2#2)
with perfect odd-periodic##2##3##(2008-2#1)(2008-3#1)
with perfect repeats##2##3##(2008-3#2)
with perfect##17##2##(1997-2#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#5)(2008-8#2)(2009-2#1)(2010-8#1)
with perforated pyloric ulcer##2##4##(1990-6#2)
with performance on##4##3##(1993-12#2)(1996-3#1)(2009-10#1)
with performance##15##2##(1993-12#3)(1993-3#1)(1996-3#2)(1997-3#1)(2006-10#1)(2008-2#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#2)
with perinatal##8##2##(2004-10#1)(2007-2#2)(2008-10#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
with periodate##2##2##(1991-1#1)(2008-10#1)
with periodic##15##2##(1995-11#1)(1997-1#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2009-2#1)(2011-12#1)(2012-2#1)(2013-1#2)
with periodical##2##2##(1997-2#1)(2008-1#1)
with periodically poled##6##3##(2007-12#4)(2008-3#2)
with periodicities##2##2##(1990-11#1)(2008-2#1)
with periodontal disease in##2##4##(2011-1#1)(2013-1#1)
with periodontal disease##3##3##(2006-10#1)(2011-1#1)(2013-1#1)
with periodontal##7##2##(1991-1#1)(1996-1#1)(2006-10#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#1)
with periodontitis##7##2##(2005-3#1)(2006-2#1)(2006-8#2)(2010-4#1)(2013-1#2)
with periods as small as##2##5##(2008-2#1)(2008-3#1)
with periods as##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
with periods from##2##3##(2007-12#1)(2008-3#1)
with periods of##5##3##(1990-6#1)(1995-8#1)(2005-10#1)(2007-12#2)
with periods##14##2##(1990-6#1)(1995-8#1)(2005-10#1)(2007-12#6)(2008-2#2)(2008-3#2)(2011-2#1)
with perioperative##4##2##(2007-8#2)(2012-12#1)(2012-2#1)
with peripheral and##2##3##(1991-12#1)(2009-3#1)
with peripheral blood##4##3##(1997-7#1)(2007-8#1)(2008-11#1)(2008-8#1)
with peripheral nerve##2##3##(1995-7#1)(2011-1#1)
with peripheral nervous system##2##4##(1992-4#1)(2007-8#1)
with peripheral##37##2##(1991-12#1)(1991-7#1)(1992-4#1)(1993-12#3)(1993-2#1)(1995-2#1)(1995-7#1)(1996-8#1)(1996-9#1)(1997-7#1)(2005-11#2)(2006-10#2)(2006-12#1)(2007-11#1)(2007-8#4)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-3#1)(2011-1#3)(2012-3#1)(2013-1#3)(2013-8#1)
with periprosthetic fracture##2##3##(2007-7#1)(2013-1#1)
with periprosthetic##3##2##(2007-7#2)(2013-1#1)
with peritoneal dialysis##4##3##(2007-8#1)(2008-7#1)(2011-2#2)
with peritoneal mesothelioma##2##3##(2006-6#1)(2010-12#1)
with peritoneal##16##2##(2006-6#3)(2007-12#1)(2007-8#1)(2008-7#1)(2010-12#4)(2011-2#3)(2012-12#2)(2012-2#1)
with peritonectomy##3##2##(2006-6#2)(2010-12#1)
with peritonitis##6##2##(1991-9#1)(1993-10#1)(2006-12#1)(2008-6#1)(2009-2#1)(2011-2#1)
with permanent green cover##2##4##(2011-12#2)
with permanent##20##2##(1990-7#1)(1992-4#1)(1993-10#1)(1997-8#1)(2006-9#1)(2007-7#2)(2007-8#2)(2008-10#1)(2011-1#1)(2011-12#4)(2011-2#2)(2012-2#1)(2013-8#2)
with permanently##2##2##(2005-11#1)(2009-10#1)
with permanganate##2##2##(2008-10#2)
with permutation##2##2##(2008-3#1)(2008-7#1)
with peroxidase##5##2##(1995-3#1)(2008-10#4)
with peroxisomal disorders##2##3##(1990-11#2)
with peroxisomal##3##2##(1990-11#2)(1993-8#1)
with peroxisome##5##2##(1990-12#1)(1995-3#2)(1997-4#2)
with peroxyl radicals##2##3##(2008-10#2)
with peroxynitrite##2##2##(1994-9#1)(2008-10#1)
with persistence or##2##3##(2006-10#1)(2008-7#1)
with persistent clinical and##2##4##(2008-3#1)(2009-4#1)
with persistent left superior vena cava##2##6##(2007-8#1)(2010-11#1)
with persistent left##3##3##(2007-8#1)(2010-11#1)(2012-1#1)
with persistent or##3##3##(2006-8#1)(2009-3#1)(2010-12#1)
with persistent purulent##2##3##(2005-11#1)(2013-8#1)
with persistent##47##2##(1990-9#1)(1991-8#1)(1992-5#1)(1994-3#1)(1996-10#2)(1996-11#1)(1996-7#2)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#4)(2013-1#1)(2013-8#2)
with persistently##4##2##(2009-8#1)(2010-2#1)(2012-1#2)
with persisting##6##2##(1992-5#1)(2007-9#1)(2008-1#1)(2010-12#1)(2011-12#1)(2013-1#1)
with personal and##2##3##(2007-11#1)(2008-11#1)
with personal##7##2##(1994-6#1)(1997-2#1)(2007-11#1)(2008-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
with personality disorder##2##3##(2011-2#2)
with personality traits##2##3##(2008-7#1)(2010-12#1)
with personality##7##2##(1995-11#1)(2005-7#1)(2006-3#1)(2008-7#1)(2010-12#1)(2011-2#2)
with persons##3##2##(1996-1#1)(2004-11#1)(2011-2#1)
with perturbations in##2##3##(1994-10#1)(2008-3#1)
with pertussis toxin abolished the##2##5##(1991-7#1)(1996-8#1)
with pertussis toxin##12##3##(1990-3#1)(1991-7#1)(1992-3#2)(1993-8#1)(1994-2#1)(1995-3#1)(1996-10#1)(1996-5#1)(1996-8#1)(1997-7#1)(2008-4#1)
with perylene##2##2##(2008-10#1)(2009-2#1)
with pesticides##6##2##(1991-6#1)(1996-4#1)(2005-11#1)(2007-10#2)(2008-12#1)
with petechial##2##2##(2005-7#1)(2012-2#1)
with petroleum ether##2##3##(2005-12#1)(2008-12#1)
with petroleum##4##2##(2005-12#1)(2005-4#1)(2008-10#1)(2008-12#1)
with petrous##2##2##(2005-9#1)(2011-2#1)
with phage##4##2##(1990-1#1)(2008-8#2)(2012-2#1)
with phagocytic##2##2##(2006-10#1)(2008-5#1)
with phantom##2##2##(2005-8#1)(2008-2#1)
with pharmaceutical##5##2##(2008-1#1)(2009-5#1)(2011-3#1)(2013-7#1)(2013-8#1)
with pharmacists##2##2##(2011-1#2)
with pharmacokinetic##2##2##(2007-11#1)(2011-1#1)
with pharmacologic##3##2##(1996-9#1)(2008-3#1)(2009-4#1)
with pharmacological treatment##5##3##(1997-5#1)(2008-8#1)(2010-12#1)(2012-12#1)(2012-3#1)
with pharmacological##11##2##(1997-5#1)(1997-6#1)(2006-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#2)(2012-12#1)(2012-3#1)(2013-1#1)
with pharmacologically##2##2##(1993-11#1)(1994-3#1)
with pharmacotherapy##6##2##(1992-9#1)(1993-11#2)(1996-12#1)(2007-8#1)(2011-2#1)
with pharmacy##2##2##(2007-12#1)(2010-8#1)
with pharyngeal##2##2##(1993-2#1)(2013-1#1)
with phase jump##3##3##(2008-3#3)
with phase##15##2##(1991-5#1)(2005-7#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-2#1)(2008-3#5)(2011-2#1)
with phase-only##3##2##(2007-12#1)(2008-3#2)
with phase-shifting##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
with phenobarbital and##2##3##(1993-11#1)(1994-8#1)
with phenobarbital##5##2##(1990-7#1)(1993-11#1)(1994-3#1)(1994-8#1)(1995-2#1)
with phenol##6##2##(2006-12#1)(2006-8#1)(2008-10#2)(2010-5#2)
with phenol-chloroform##2##2##(1996-7#1)(2008-4#1)
with phenolic##4##2##(2008-10#2)(2009-8#1)(2011-2#1)
with phenotype##5##2##(1994-10#1)(1996-11#1)(1997-3#1)(2011-2#1)(2012-3#1)
with phenotypes p53/Ki-67##2##3##(2012-1#2)
with phenotypes##9##2##(1991-1#1)(1993-11#1)(1993-2#1)(1997-6#1)(2008-10#1)(2012-1#2)(2012-3#2)
with phenotypic##3##2##(1990-9#1)(2008-5#1)(2013-1#1)
with phenprocoumon##3##2##(1991-8#1)(2005-11#1)(2007-8#1)
with phenyl##6##2##(1990-3#1)(1997-7#1)(2007-11#1)(2008-10#3)
with phenylalanine##2##2##(1991-7#1)(1997-4#1)
with phenylarsine oxide at levels ranging from 0##2##8##(1991-7#2)
with phenylarsine oxide##4##3##(1991-7#2)(1993-6#1)(1995-5#1)
with phenylephrine##11##2##(1991-1#1)(1991-3#2)(1994-12#2)(1996-10#1)(2005-7#1)(2008-11#1)(2009-11#1)(2010-6#1)(2011-2#1)
with phenylglyoxal##3##2##(1990-11#1)(1990-2#1)(1993-2#1)
with pheochromocytoma##6##2##(1995-12#1)(1995-6#2)(1995-7#1)(2009-1#1)(2012-12#1)
with phorbol 12##2##3##(1990-7#1)(1995-2#1)
with phorbol 12-myristate 13-acetate (PMA) and##2##6##(1991-5#1)(1994-3#1)
with phorbol 12-myristate 13-acetate (PMA)##11##5##(1991-5#1)(1991-9#1)(1992-9#1)(1993-7#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-5#1)(1996-8#1)(2008-11#1)(2008-5#1)
with phorbol 12-myristate 13-acetate##14##4##(1991-5#1)(1991-9#1)(1992-9#1)(1993-7#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-5#1)(1996-4#1)(1996-8#2)(2008-11#2)(2008-5#1)
with phorbol 12-myristate##15##3##(1991-5#1)(1991-9#1)(1992-9#1)(1993-7#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-5#1)(1996-4#1)(1996-8#2)(2008-11#2)(2008-5#1)
with phorbol ester##7##3##(1991-2#1)(1992-5#1)(1993-11#1)(1993-4#2)(1994-11#1)(1994-9#1)
with phorbol esters##6##3##(1990-10#2)(1991-5#1)(1993-6#1)(1994-9#1)(2010-12#1)
with phorbol myristate acetate (PMA)##4##5##(1991-4#1)(1993-6#1)(1994-2#1)(1994-6#1)
with phorbol myristate##5##3##(1991-4#1)(1991-5#1)(1993-6#1)(1994-2#1)(1994-6#1)
with phorbol##36##2##(1990-10#2)(1990-7#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#3)(1991-9#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-4#2)(1993-6#2)(1993-7#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-2#1)(1995-5#1)(1996-4#1)(1996-8#2)(2008-11#2)(2008-5#1)(2010-12#1)
with phorbol-12-myristate-13-acetate (PMA)##2##3##(1991-9#1)(2008-11#1)
with phosphate analogs##2##3##(1997-4#2)
with phosphate##12##2##(1991-2#1)(1991-9#1)(1994-5#1)(1995-7#1)(1996-5#1)(1997-1#1)(1997-4#2)(2006-10#1)(2008-10#1)(2009-5#1)(2013-1#1)
with phosphate-buffered saline##3##3##(1992-11#1)(2006-9#1)(2008-10#1)
with phosphatidic acid##4##3##(1990-4#1)(1994-5#1)(2008-11#1)(2011-1#1)
with phosphatidyl##2##2##(2006-10#1)(2008-10#1)
with phosphatidylcholine##4##2##(1995-8#1)(1996-2#1)(1997-7#1)(2012-1#1)
with phosphatidylethanolamine (PE)##2##3##(1990-3#1)(1995-8#1)
with phosphatidylethanolamine##3##2##(1990-3#1)(1994-5#1)(1995-8#1)
with phosphatidylinositol 3-kinase##2##3##(1992-12#2)
with phosphatidylinositol##3##2##(1992-12#2)(2008-8#1)
with phosphatidylserine##3##2##(1990-11#1)(1990-6#1)(1994-5#1)
with phosphoenolpyruvate##2##2##(1991-4#1)(1995-2#1)
with phosphoinositides##2##2##(1993-6#1)(2006-10#1)
with phospholipase A2##3##3##(1991-12#1)(1994-5#1)(1997-1#1)
with phospholipase C and##2##4##(1990-9#1)(1992-2#1)
with phospholipase C##3##3##(1990-9#1)(1992-2#1)(1997-5#1)
with phospholipase##11##2##(1990-9#1)(1991-12#1)(1992-2#1)(1992-5#1)(1994-3#1)(1994-5#1)(1996-5#1)(1997-1#1)(1997-5#1)(2006-10#1)(2010-6#1)
with phospholipid bilayers##2##3##(1992-3#1)(2008-11#1)
with phospholipid membranes##2##3##(1990-2#1)(1994-11#1)
with phospholipid monolayers and##2##4##(1994-5#2)
with phospholipid monolayers##3##3##(1994-5#3)
with phospholipid vesicles##4##3##(1990-4#1)(1991-9#2)(1994-11#1)
with phospholipid##15##2##(1990-2#1)(1990-4#1)(1991-9#2)(1992-3#1)(1992-6#1)(1994-11#2)(1994-5#4)(1997-2#1)(2008-11#1)(2008-5#1)
with phosphomolybdic acid##2##3##(2007-9#1)(2008-10#1)
with phosphonoacetate##2##2##(2008-4#2)
with phosphorescence##2##2##(1991-8#1)(2008-10#1)
with phosphoric acid##7##3##(1990-2#1)(1997-3#1)(2005-11#2)(2008-10#1)(2010-12#1)(2010-2#1)
with phosphoric##8##2##(1990-2#1)(1997-3#1)(2005-11#2)(2008-10#1)(2010-12#1)(2010-2#1)(2011-1#1)
with phosphorus##4##2##(1990-2#1)(1990-5#1)(1991-11#1)(2007-6#1)
with phosphorylated##3##2##(1992-5#1)(1995-1#1)(2010-10#1)
with phosphorylation at##2##3##(2010-8#2)
with phosphorylation##3##2##(1993-9#1)(2010-8#2)
with phosphotungstic acid##2##3##(2006-5#1)(2008-10#1)
with phosphotyrosine##2##2##(1994-9#1)(2012-12#1)
with photoacoustic##2##2##(2007-11#2)
with photodiode array detection##3##4##(1997-2#1)(2007-8#1)(2008-10#1)
with photodiode array##6##3##(1997-2#2)(2007-8#1)(2008-10#3)
with photodiode-array detection##6##3##(1990-11#1)(1990-3#1)(1992-2#4)
with photodiode-array##8##2##(1990-11#1)(1990-3#1)(1992-2#4)(1997-2#1)(2008-10#1)
with photodynamic therapy (PDT) of##2##5##(2006-10#1)(2012-12#1)
with photodynamic therapy (PDT)##4##4##(2006-10#1)(2008-5#2)(2012-12#1)
with photodynamic therapy##9##3##(1994-1#1)(2006-10#1)(2008-5#3)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
with photographic##4##2##(2008-11#1)(2008-2#2)(2008-4#1)
with photoinactivated effector T##2##4##(1991-12#2)
with photoinactivated##3##2##(1991-12#3)
with photoinduced##2##2##(2008-3#1)(2012-1#1)
with photon echoes##2##3##(2007-12#2)
with photon##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
with photoreactive derivatives of##2##4##(1990-11#1)(1994-8#1)
with photorefractive##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
with photosynthetic##2##2##(1996-4#1)(2010-6#1)
with photosystem II##3##3##(1994-12#1)(2008-10#1)(2008-8#1)
with photothermal deflection spectroscopy##2##4##(2008-2#1)(2008-3#1)
with photothermal deflection##3##3##(2008-2#2)(2008-3#1)
with phthalic acid in##2##4##(2008-3#1)(2008-5#1)
with phthalic acid##4##3##(2008-3#1)(2008-5#3)
with physical activity##6##3##(1996-4#1)(2008-3#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
with physical and psychological##2##4##(1997-5#1)(2007-9#1)
with physical disabilities##8##3##(1995-12#2)(1995-5#2)(2006-10#1)(2010-12#3)
with physical illnesses##3##3##(2009-12#1)(2009-4#1)(2010-12#1)
with physical or##2##3##(2008-11#1)(2008-4#1)
with physical therapy##3##3##(2006-12#1)(2006-8#2)
with physical##42##2##(1990-12#1)(1993-9#1)(1995-12#2)(1995-5#2)(1996-12#1)(1996-4#1)(1997-5#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-8#3)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#1)(2010-12#4)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#1)
with physician and patient##2##4##(1993-11#1)(2012-3#1)
with physician and##3##3##(1993-11#1)(2012-3#1)(2013-1#1)
with physician##7##2##(1993-1#1)(1993-11#1)(2007-9#1)(2012-3#1)(2013-1#3)
with physician's##2##2##(1992-6#1)(2006-8#1)
with physicians and patients##3##4##(1993-3#1)(1995-2#1)(1996-1#1)
with physicians and##5##3##(1993-3#1)(1994-3#1)(1995-2#1)(1996-1#1)(2013-8#1)
with physicians in##2##3##(2007-1#1)(2008-8#1)
with physicians within##2##3##(1995-3#1)(2009-7#1)
with physicians##25##2##(1993-3#2)(1993-5#1)(1994-3#2)(1995-2#1)(1995-3#1)(1996-1#2)(1996-3#1)(2005-2#1)(2007-1#1)(2007-11#1)(2008-11#1)(2008-8#1)(2009-7#2)(2010-5#1)(2010-7#1)(2011-1#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
with physicians'##2##2##(1996-2#1)(2007-2#1)
with physiologic##5##2##(1993-6#1)(2008-2#1)(2008-9#1)(2013-1#2)
with physiological fluids##2##3##(2008-7#1)(2010-12#1)
with physiological##10##2##(1990-12#1)(1991-11#1)(1994-3#1)(1997-2#1)(1997-8#1)(2006-6#1)(2008-7#1)(2010-12#2)(2013-1#1)
with physiologically relevant##2##3##(1993-8#1)(2009-12#1)
with physiologically##3##2##(1993-8#1)(2008-10#1)(2009-12#1)
with physiotherapy##2##2##(2007-11#2)
with phytohemagglutinin (PHA)##2##3##(1990-4#1)(1994-4#1)
with phytoplankton##2##2##(2008-3#1)(2008-9#1)
with phytoplasma##2##2##(2005-11#1)(2008-10#1)
with picolinic and##2##3##(2008-5#2)
with picomolar##2##2##(1990-10#1)(1990-7#1)
with picosecond laser pulses##2##4##(2007-12#1)(2008-2#1)
with picosecond pulses at##2##4##(2007-11#1)(2007-12#1)
with picosecond pulses##3##3##(2007-11#1)(2007-12#2)
with picosecond resolution##5##3##(2007-11#1)(2007-12#3)(2008-3#1)
with picosecond##13##2##(2007-11#3)(2007-12#8)(2008-2#1)(2008-3#1)
with picrate anion##2##3##(2008-10#2)
with piecewise##2##2##(2006-10#1)(2008-2#1)
with piezoelectric quartz crystal##2##4##(2008-10#2)
with piezoelectric##7##2##(1990-8#1)(2008-1#1)(2008-10#5)
with pigeon##2##2##(1993-8#1)(2008-6#1)
with pigment##2##2##(2010-2#1)(2012-3#1)
with pilocytic##2##2##(2006-12#1)(2008-5#1)
with pindolol##2##2##(1995-1#1)(2005-9#1)
with pineal##5##2##(2008-5#1)(2012-1#2)(2012-2#2)
with pineapple##2##2##(2012-2#2)
with piroxicam##3##2##(1992-3#2)(1994-2#1)
with pituitary resistance to thyroid hormone##2##6##(1995-8#2)
with pituitary##10##2##(1990-4#1)(1991-6#1)(1995-8#2)(1997-1#1)(2009-2#1)(2011-2#1)(2013-1#1)(2013-8#2)
with pityriasis##5##2##(2007-7#2)(2008-5#2)(2011-2#1)
with placebo in the##2##4##(1992-12#1)(2010-1#1)
with placebo in##6##3##(1992-12#1)(1992-4#1)(2008-3#1)(2010-1#1)(2010-12#1)(2012-12#1)
with placebo or##5##3##(1996-8#1)(1996-9#1)(2007-11#2)(2008-3#1)
with placebo was##3##3##(2004-3#1)(2007-11#1)(2007-9#1)
with placebo##50##2##(1990-12#3)(1990-6#1)(1991-2#1)(1992-12#1)(1992-4#1)(1996-1#1)(1996-8#1)(1996-9#2)(2004-11#1)(2004-3#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-11#6)(2007-5#1)(2007-9#4)(2008-1#1)(2008-2#2)(2008-3#3)(2008-5#4)(2008-7#4)(2009-11#1)(2010-1#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
with placebo)##2##2##(2008-3#1)(2008-8#1)
with placement of a##5##4##(1993-11#1)(2006-8#1)(2008-7#1)(2009-4#1)(2010-5#1)
with placement of##6##3##(1993-11#1)(2006-8#1)(2008-7#1)(2009-4#1)(2010-5#1)(2012-2#1)
with placental##3##2##(1991-2#1)(1994-5#1)(1994-6#1)
with plain soup##5##3##(2008-4#5)
with plain##10##2##(2005-2#1)(2007-7#2)(2008-10#1)(2008-4#5)(2009-3#1)
with planar##3##2##(1993-8#1)(2006-2#1)(2012-2#1)
with plane-parallel Gaussian cavities##2##4##(2008-2#2)
with planktonic##4##2##(1995-12#1)(2006-11#1)(2010-9#2)
with planned##2##2##(1991-3#1)(2013-1#1)
with plant growth##2##3##(2008-10#2)
with plant leaf##2##3##(2013-8#2)
with plant material##2##3##(2008-9#2)
with plant providing##2##3##(2008-6#2)
with plant##26##2##(2005-12#1)(2007-12#1)(2008-10#10)(2008-12#1)(2008-6#2)(2008-9#6)(2010-10#1)(2010-2#1)(2013-8#3)
with planting density in##2##4##(2008-10#2)
with planting##3##2##(2008-10#2)(2008-9#1)
with plants##13##2##(2006-12#1)(2008-10#8)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)
with plaque##6##2##(2005-1#1)(2007-10#2)(2008-5#1)(2010-5#1)(2011-1#1)
with plasma PAI-1##2##3##(2007-9#2)
with plasma cholesterol##2##3##(1991-2#1)(1996-8#1)
with plasma concentration of##2##4##(2008-8#1)(2009-10#1)
with plasma levels##3##3##(2006-9#1)(2007-9#1)(2013-1#1)
with plasma lipid levels##2##4##(1993-9#1)(1997-8#1)
with plasma membrane##5##3##(1991-9#1)(1995-7#1)(1997-4#1)(2008-9#1)(2009-10#1)
with plasma membranes##2##3##(1991-2#1)(1993-3#1)
with plasma proteins##5##3##(1990-8#2)(1992-3#1)(2008-5#2)
with plasma##50##2##(1990-12#1)(1990-8#2)(1991-2#2)(1991-8#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-4#1)(1995-5#1)(1995-7#2)(1996-8#3)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#2)(2005-11#1)(2006-12#1)(2006-9#3)(2007-12#1)(2007-8#2)(2007-9#3)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2010-12#1)(2012-2#1)(2013-1#1)
with plasmapheresis##3##2##(1995-3#1)(2007-8#1)(2010-11#1)
with plasmid DNA and##2##4##(1994-9#1)(2008-10#1)
with plasmid DNA##8##3##(1990-9#1)(1991-8#1)(1994-9#2)(2008-10#2)(2008-11#1)(2008-5#1)
with plasmid##14##2##(1990-5#1)(1990-9#1)(1991-8#1)(1993-3#1)(1994-12#1)(1994-9#2)(1997-4#1)(2008-10#2)(2008-11#2)(2008-5#1)(2010-12#1)
with plasmids carrying the##2##4##(1993-12#1)(2008-10#1)
with plasmids carrying##3##3##(1993-12#1)(1997-1#1)(2008-10#1)
with plasmids encoding the##3##4##(1996-1#1)(2008-1#1)(2008-2#1)
with plasmids encoding##5##3##(1996-1#1)(1996-11#1)(2008-1#1)(2008-2#1)(2010-12#1)
with plasmids##13##2##(1990-11#1)(1993-12#1)(1994-8#1)(1996-1#1)(1996-11#1)(1997-1#1)(2006-11#1)(2008-1#1)(2008-10#2)(2008-2#2)(2010-12#1)
with plasmin##2##2##(1996-7#1)(1997-2#1)
with plasminogen##4##2##(1993-2#1)(1995-2#2)(1997-2#1)
with plastic##12##2##(1995-3#1)(1997-7#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#2)(2011-12#1)
with plastocyanin##3##2##(1996-9#2)(2009-10#1)
with plate and##3##3##(2007-7#1)(2008-12#1)(2012-2#1)
with plate##6##2##(2007-11#2)(2007-7#1)(2008-10#1)(2008-12#1)(2012-2#1)
with platelet aggregation##3##3##(1991-12#1)(2008-5#1)(2013-8#1)
with platelet transfusions##3##3##(2006-10#1)(2008-11#1)(2008-3#1)
with platelet##14##2##(1990-1#1)(1990-3#1)(1991-12#1)(1992-11#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-12#1)(2013-8#1)
with platelet-activating factor##2##3##(1997-3#1)(1997-7#1)
with platelet-activating##3##2##(1991-8#1)(1997-3#1)(1997-7#1)
with platelet-derived growth factor (PDGF)##2##5##(1994-12#1)(1995-11#1)
with platelet-derived##3##2##(1991-6#1)(1994-12#1)(1995-11#1)
with platelets##2##2##(2005-8#1)(2011-2#1)
with plates##2##2##(2007-11#1)(2007-7#1)
with platinum##3##2##(2007-7#2)(2008-10#1)
with pleiotropic##2##2##(1995-2#1)(2008-7#1)
with pleural effusion##7##3##(2007-8#1)(2008-7#1)(2012-1#2)(2013-1#2)(2013-8#1)
with pleural space disease##3##4##(2011-2#3)
with pleural##12##2##(2007-8#2)(2008-10#1)(2008-7#1)(2011-2#3)(2012-1#2)(2013-1#2)(2013-8#1)
with pleurisy##3##2##(2006-10#1)(2013-1#2)
with pneumatic##2##2##(2008-10#1)(2011-1#1)
with pneumococcal and##2##3##(2008-7#1)(2011-2#1)
with pneumococcal meningitis##4##3##(1996-3#1)(2011-2#3)
with pneumococcal vaccine##2##3##(2007-11#2)
with pneumococcal##8##2##(1996-3#1)(2007-11#2)(2008-7#1)(2011-2#4)
with pneumonia in##2##3##(2005-11#2)
with pneumonia##18##2##(1990-9#1)(2005-11#3)(2007-11#1)(2007-2#1)(2007-7#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#5)
with pneumoperitoneum##2##2##(1993-6#1)(2007-5#1)
with point##4##2##(2008-2#1)(2008-3#2)(2008-9#1)
with polar##4##2##(1994-11#1)(2008-11#1)(2008-3#1)(2009-8#1)
with polarimetric##2##2##(2008-10#1)(2008-3#1)
with polarity##2##2##(1991-5#1)(1996-5#1)
with polarization mode dispersion##4##4##(2007-11#1)(2007-12#3)
with polarization modulation##2##3##(2007-11#1)(2008-1#1)
with polarization##14##2##(2007-11#3)(2007-12#4)(2008-1#1)(2008-2#1)(2008-3#4)(2009-4#1)
with polarization-dependent loss##3##3##(2007-11#2)(2008-3#1)
with polarization-dependent##6##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)
with polarized##4##2##(2007-8#1)(2008-10#2)(2008-2#1)
with polarizing activity##2##3##(1993-12#2)
with polarizing##5##2##(1993-12#3)(2008-3#2)
with policies##2##2##(1995-3#1)(2010-8#1)
with policy##5##2##(1996-1#1)(2006-7#2)(2008-9#1)(2010-8#1)
with poliomyelitis##2##2##(2009-3#1)(2010-12#1)
with poly (A)##2##3##(2008-11#1)(2010-4#1)
with poly##8##2##(1992-6#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-3#1)(2010-4#1)
with poly(acrylic acid)##2##3##(2004-9#1)(2013-1#1)
with poly(ethylene glycol) (PEG)##2##4##(2008-11#1)(2008-8#1)
with poly(ethylene glycol)##4##3##(2005-11#1)(2008-11#1)(2008-8#1)(2010-6#1)
with poly(ethylene##7##2##(1993-3#1)(2005-11#2)(2008-11#1)(2008-5#1)(2008-8#1)(2010-6#1)
with poly(lactic-co-glycolic acid) (PLGA)##2##4##(2008-5#1)(2009-7#1)
with poly-L-lysine##4##2##(1992-8#3)(2005-11#1)
with polyacrylamide##2##2##(1991-10#1)(2010-9#1)
with polyclonal antibodies raised against##3##5##(1990-5#1)(1990-7#1)(1993-12#1)
with polyclonal antibodies##6##3##(1990-5#1)(1990-7#1)(1993-12#1)(1993-6#1)(1994-3#1)(2006-10#1)
with polyclonal antibody##5##3##(1996-11#2)(1997-6#1)(2008-10#1)(2010-7#1)
with polyclonal antisera##2##3##(2008-10#2)
with polyclonal or monoclonal##2##4##(1991-6#1)(1996-6#1)
with polyclonal##23##2##(1990-3#1)(1990-5#1)(1990-7#1)(1991-6#1)(1993-12#2)(1993-6#1)(1994-12#2)(1994-3#1)(1996-11#3)(1996-6#1)(1997-6#1)(2006-10#1)(2006-8#1)(2008-10#3)(2008-2#1)(2008-4#1)(2010-7#1)
with polycystic ovarian syndrome (PCOS)##2##5##(2013-8#2)
with polycystic ovarian syndrome##5##4##(2008-1#1)(2008-3#1)(2010-11#1)(2013-8#2)
with polycystic ovarian##7##3##(2008-1#1)(2008-11#1)(2008-3#1)(2010-11#1)(2013-1#1)(2013-8#2)
with polycystic ovary syndrome (PCOS)##5##5##(2008-3#3)(2010-10#1)(2011-1#1)
with polycystic ovary syndrome##13##4##(2005-8#1)(2008-3#4)(2010-10#3)(2011-1#2)(2012-12#1)(2012-3#1)(2013-8#1)
with polycystic ovary##15##3##(2005-8#2)(2008-3#4)(2009-2#1)(2010-10#3)(2011-1#2)(2012-12#1)(2012-3#1)(2013-8#1)
with polycystic##22##2##(2005-8#2)(2008-1#1)(2008-11#1)(2008-3#5)(2009-2#1)(2010-10#3)(2010-11#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
with polydimethylsiloxane##2##2##(1996-12#1)(2010-8#1)
with polyelectrolyte##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
with polyelectrolytes##2##2##(2008-10#1)(2010-9#1)
with polyethylene glycol##3##3##(1990-12#1)(2011-2#1)(2013-7#1)
with polyethylene##8##2##(1990-12#1)(1994-2#1)(1996-11#1)(1997-3#1)(2008-10#1)(2009-5#1)(2011-2#1)(2013-7#1)
with polyethyleneimine (PEI)##3##3##(1994-5#1)(1997-1#1)(2009-11#1)
with polyionic ligands##2##3##(2007-8#2)
with polymer##10##2##(2005-11#1)(2006-9#3)(2007-11#1)(2007-12#1)(2009-7#1)(2010-4#1)(2011-3#1)(2012-12#1)
with polymerase chain reaction##3##4##(1992-8#1)(1996-6#1)(2008-10#1)
with polymerase chain##4##3##(1992-8#1)(1996-6#1)(2008-10#1)(2009-7#1)
with polymerase##5##2##(1992-8#1)(1995-2#1)(1996-6#1)(2008-10#1)(2009-7#1)
with polymers##5##2##(1993-12#1)(2004-9#1)(2008-10#1)(2009-12#1)(2011-1#1)
with polymorphic markers##3##3##(1994-12#1)(1996-5#1)(2008-7#1)
with polymorphic##4##2##(1994-12#1)(1994-3#1)(1996-5#1)(2008-7#1)
with polymyalgia rheumatica and temporal arteritis##2##6##(2006-10#2)
with polymyalgia rheumatica##5##3##(1994-11#1)(2006-10#4)
with polymyositis##2##2##(2008-7#1)(2010-12#1)
with polymyxin B##2##3##(1992-8#1)(2008-11#1)
with polyneuropathy##2##2##(1992-12#1)(2013-7#1)
with polypeptides##2##2##(1993-11#1)(1994-11#1)
with polypoid##2##2##(2008-1#1)(2008-5#1)
with polypropylene##2##2##(2005-11#1)(2008-10#1)
with polyps##8##2##(2006-2#1)(2008-3#1)(2009-12#1)(2010-6#4)(2011-2#1)
with polysaccharides##2##2##(1992-11#1)(2008-2#1)
with polysomes and##2##3##(1994-9#1)(2008-12#1)
with polysomes##4##2##(1990-11#1)(1994-9#1)(2008-12#1)(2012-2#1)
with polysorbate 80##2##3##(2007-1#1)(2008-10#1)
with polystyrene##6##2##(2008-10#3)(2008-2#1)(2008-3#1)(2010-4#1)
with polytetrafluoroethylene (PTFE)##3##3##(2007-7#1)(2008-10#2)
with polyunsaturated fatty##2##3##(1997-1#1)(2012-12#1)
with polyurethane foam##3##3##(2008-10#3)
with polyvinyl alcohol (PVA)##3##4##(2008-10#1)(2008-5#1)(2012-3#1)
with polyvinyl alcohol##4##3##(2008-10#1)(2008-5#1)(2012-3#2)
with polyvinyl##6##2##(2008-10#1)(2008-5#1)(2012-2#2)(2012-3#2)
with pooled##6##2##(2005-7#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-4#1)(2012-2#1)
with poor adaptation to##2##4##(2008-11#1)(2009-12#1)
with poor and##2##3##(2012-3#1)(2013-1#1)
with poor differentiation and##2##4##(1993-9#1)(2011-1#1)
with poor differentiation##3##3##(1992-2#1)(1993-9#1)(2011-1#1)
with poor glycemic control##3##4##(2007-3#2)(2013-7#1)
with poor graft##2##3##(1995-2#1)(2005-10#1)
with poor health status##2##4##(2005-10#1)(2009-5#1)
with poor hygiene##3##3##(1992-2#1)(2010-12#1)(2013-1#1)
with poor outcome in##2##4##(2007-12#1)(2011-2#1)
with poor outcome##10##3##(1994-12#1)(2005-10#1)(2007-10#1)(2007-12#1)(2008-7#2)(2011-1#1)(2011-2#2)(2012-12#1)
with poor outcomes##5##3##(2007-10#1)(2009-1#1)(2009-8#1)(2010-6#1)(2013-8#1)
with poor performance##3##3##(2006-9#1)(2008-8#1)(2011-2#1)
with poor prognosis in##2##4##(2007-8#1)(2013-1#1)
with poor prognosis##23##3##(1994-11#1)(1997-5#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-8#2)(2008-1#1)(2009-3#1)(2009-5#2)(2010-11#1)(2010-12#1)(2011-1#2)(2011-11#1)(2011-2#3)(2011-3#1)(2012-12#1)(2013-1#2)
with poor prognostic##2##3##(2007-6#1)(2010-12#1)
with poor quality of##2##4##(2007-11#1)(2008-5#1)
with poor remyelination##2##3##(2008-12#2)
with poor response##2##3##(2011-2#2)
with poor risk##2##3##(2008-3#1)(2010-12#1)
with poor sanitation##2##3##(2007-2#1)(2007-7#1)
with poor survival##3##3##(1991-2#1)(2008-7#1)(2012-2#1)
with poor##127##2##(1990-10#1)(1990-6#1)(1991-2#1)(1991-7#1)(1992-10#1)(1992-2#3)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-7#1)(1995-2#1)(1996-10#2)(1996-9#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-10#4)(2006-10#2)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#3)(2007-3#2)(2007-6#1)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-3#2)(2010-6#1)(2010-9#1)(2011-1#4)(2011-11#1)(2011-12#1)(2011-2#11)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#2)
with poorer health##3##3##(1996-2#1)(2007-12#1)(2008-1#1)
with poorer performance on##2##4##(2009-7#1)(2011-2#1)
with poorer performance##3##3##(2009-7#1)(2011-2#1)(2012-1#1)
with poorer prognostic features##2##4##(2011-1#2)
with poorer##23##2##(1996-2#1)(2004-2#1)(2005-7#1)(2007-12#4)(2007-3#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-9#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#1)(2013-1#3)
with poorly##5##2##(2008-10#1)(2008-9#1)(2010-7#1)(2012-2#1)(2012-3#1)
with popular##2##2##(2005-10#1)(2010-9#1)
with population health status##2##4##(2010-11#2)
with population health##3##3##(2010-11#2)(2011-2#1)
with population norms##3##3##(2006-10#1)(2008-6#1)(2010-10#1)
with population##13##2##(1996-2#1)(1997-7#2)(2006-10#1)(2008-12#2)(2008-6#1)(2008-9#1)(2010-10#1)(2010-11#2)(2011-2#1)(2013-1#1)
with populations from##3##3##(2008-10#3)
with populations that##2##3##(2008-10#2)
with populations##9##2##(2005-7#1)(2007-6#1)(2008-10#6)(2008-9#1)
with porcine##6##2##(1991-1#1)(1991-2#1)(1991-8#2)(2009-5#1)(2012-2#1)
with pore##4##2##(2005-11#1)(2008-3#1)(2008-4#1)(2011-2#1)
with pores##2##2##(2008-10#1)(2008-5#1)
with pork##2##2##(2007-6#1)(2009-4#1)
with porous microcarrier##2##3##(2008-11#2)
with porous##3##2##(2008-11#3)
with portable##3##2##(1993-11#1)(2007-10#1)(2007-8#1)
with portal hypertension##2##3##(2006-2#1)(2011-2#1)
with portal vein##2##3##(1997-1#1)(2012-2#1)
with portal##6##2##(1990-8#1)(1997-1#1)(2006-2#1)(2006-4#1)(2011-2#1)(2012-2#1)
with posatirelin##2##2##(2008-7#2)
with position##3##2##(1993-11#1)(2008-8#2)
with positional##2##2##(2008-10#2)
with positioning##2##2##(1993-10#1)(2012-12#1)
with positive HBsAg##2##3##(2008-4#2)
with positive chemical ionization##2##4##(2008-10#2)
with positive discography##4##3##(2012-12#4)
with positive expression##2##3##(2007-6#1)(2010-12#1)
with positive findings##2##3##(2007-10#1)(2012-2#1)
with positive gains##2##3##(2006-7#1)(2012-2#1)
with positive margins##2##3##(2008-6#1)(2012-2#1)
with positive refractive-index perturbation##2##4##(2007-12#2)
with positive results##5##3##(1993-3#2)(1997-2#1)(2006-10#1)(2008-11#1)
with positive stool##2##3##(2007-12#1)(2012-3#1)
with positive##98##2##(1991-4#1)(1991-6#1)(1992-12#1)(1992-3#2)(1993-3#2)(1993-7#1)(1994-3#1)(1994-9#1)(1997-2#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#1)(2006-10#4)(2006-12#1)(2006-3#1)(2006-6#1)(2006-7#2)(2007-10#1)(2007-11#1)(2007-12#8)(2007-2#3)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#3)(2011-12#2)(2011-2#9)(2012-1#2)(2012-12#5)(2012-2#6)(2012-3#2)(2013-1#1)(2013-8#1)
with positively charged##4##3##(1995-2#1)(2006-12#1)(2008-4#1)(2009-2#1)
with positron emission tomography (PET)##3##5##(1995-2#1)(1996-5#2)
with positron emission tomography##12##4##(1993-11#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-2#2)(1996-5#3)(1997-5#1)(2013-8#1)
with positron##13##2##(1993-11#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-2#2)(1996-5#3)(1997-5#1)(2013-8#1)
with positron-emission tomography##2##3##(2009-10#1)(2011-2#1)
with possibilities for##3##3##(1991-5#1)(1993-6#1)(2008-12#1)
with possibility of##3##3##(1990-6#1)(1993-3#1)(2011-1#1)
with possibility##4##2##(1990-6#1)(1993-3#1)(2008-1#1)(2011-1#1)
with possible serious complications##2##4##(1996-1#1)(2007-8#1)
with possible solutions##2##3##(2005-10#1)(2009-7#1)
with possible##35##2##(1990-11#1)(1990-12#1)(1991-9#1)(1995-7#1)(1996-1#1)(1996-2#1)(1997-1#1)(2005-10#1)(2006-10#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-6#2)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
with possibly##4##2##(1991-10#1)(2007-11#1)(2008-5#1)(2011-1#1)
with post##4##2##(2004-1#1)(2008-10#1)(2008-9#1)(2013-8#1)
with post-column derivatization##3##3##(2008-10#1)(2012-12#2)
with post-column##8##2##(1990-8#2)(2008-10#3)(2012-12#2)(2013-7#1)
with post-ischemic##2##2##(1994-10#1)(1994-2#1)
with post-menopausal bleeding##2##3##(2007-3#2)
with post-op##3##2##(2011-1#1)(2013-1#2)
with post-transfusion##2##2##(1991-3#1)(2006-2#1)
with post-traumatic stress##4##3##(1996-11#1)(2008-6#1)(2010-12#2)
with post-traumatic##5##2##(1996-11#1)(2007-11#1)(2008-6#1)(2010-12#2)
with postcardiotomy phrenic nerve paresis##3##5##(2013-1#3)
with posterior circulation##2##3##(2007-9#1)(2012-3#1)
with posterior lumbar-instrumented fusion##2##4##(2008-11#2)
with posterior reversible encephalopathy syndrome##2##5##(2012-12#1)(2012-2#1)
with posterior urethral valve##2##4##(2008-10#1)(2011-11#1)
with posterior urethral valves##2##4##(2008-1#1)(2008-10#1)
with posterior urethral##4##3##(2008-1#1)(2008-10#2)(2011-11#1)
with posterior##22##2##(1991-2#1)(2006-8#3)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-7#1)(2009-3#1)(2011-11#1)(2012-12#1)(2012-2#2)(2012-3#1)
with posterolateral fusion##2##3##(2007-7#2)
with postlingual##3##2##(2008-9#3)
with postmeningitic deafness##2##3##(2008-9#2)
with postmenopausal bleeding and##2##4##(1990-6#2)
with postmenopausal osteoporosis##3##3##(2005-1#1)(2007-8#1)(2007-9#1)
with postmenopausal##7##2##(1990-6#2)(1992-12#1)(2005-1#1)(2007-8#1)(2007-9#1)(2008-7#1)
with postnatal##5##2##(1992-12#1)(1995-8#1)(2006-9#1)(2008-4#1)(2011-2#1)
with postoperative complications##2##3##(2007-7#1)(2012-2#1)
with postoperative irradiation##2##3##(1994-7#1)(2009-5#1)
with postoperative pain##3##3##(2007-12#1)(2010-7#2)
with postoperative radiotherapy##2##3##(2009-3#1)(2012-2#1)
with postoperative##34##2##(1990-8#1)(1991-8#1)(1993-10#1)(1994-3#1)(1994-7#1)(1995-2#1)(1996-3#1)(2005-5#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-7#4)(2007-8#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-7#3)(2011-2#1)(2012-1#1)(2012-2#4)(2013-7#1)
with postpartum##5##2##(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
with postsurgical##2##2##(1990-2#1)(2011-3#1)
with posttraumatic stress disorder##3##4##(1996-7#1)(2012-12#2)
with posttraumatic stress##4##3##(1996-7#1)(2010-12#1)(2012-12#2)
with posttraumatic##11##2##(1991-5#1)(1996-7#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-9#1)(2010-12#1)(2012-12#2)
with postural##3##2##(1992-9#1)(2006-10#1)(2011-2#1)
with posture##3##2##(2007-7#3)
with potassium chloride##3##3##(1993-7#1)(1996-6#1)(2010-4#1)
with potassium citrate##2##3##(1997-7#1)(2007-7#1)
with potassium dichromate##2##3##(2008-10#2)
with potassium ferricyanide##2##3##(2008-10#1)(2010-2#1)
with potassium hydroxide##2##3##(2007-7#1)(2008-10#1)
with potassium iodide##3##3##(2008-10#3)
with potassium permanganate in##4##4##(2008-10#4)
with potassium permanganate##6##3##(2007-8#1)(2008-10#5)
with potassium phosphate##2##3##(1993-3#1)(1996-4#1)
with potassium##47##2##(1993-3#1)(1993-7#1)(1994-11#1)(1996-4#1)(1996-5#2)(1996-6#1)(1997-7#1)(2005-11#1)(2007-10#2)(2007-12#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#28)(2010-2#1)(2010-4#2)
with potassium-dihydro-bispyrazolyl-borate##2##2##(2008-10#2)
with potato##9##2##(1994-9#1)(1996-9#1)(2008-10#6)(2008-12#1)
with potent antiviral activity##2##4##(2008-1#1)(2012-2#1)
with potent##17##2##(1992-9#1)(1994-5#1)(1996-2#1)(1996-3#1)(2005-7#1)(2006-12#1)(2008-1#1)(2008-3#2)(2008-8#2)(2011-3#2)(2012-2#1)(2012-3#2)(2013-1#1)
with potential application in the##2##5##(2006-10#1)(2008-7#1)
with potential application in##5##4##(1994-6#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#1)
with potential application##6##3##(1994-6#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-11#1)
with potential applications in##2##4##(2008-7#1)(2008-8#1)
with potential as##3##3##(1992-3#1)(2008-2#1)(2013-1#1)
with potential benefits for##2##4##(2007-5#1)(2013-1#1)
with potential benefits##4##3##(1995-12#1)(2007-5#1)(2013-1#2)
with potential clinical##5##3##(1994-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2013-7#1)
with potential complications##3##3##(2004-2#1)(2006-3#1)(2013-8#1)
with potential for the##2##4##(2008-10#1)(2008-5#1)
with potential for##15##3##(1996-9#1)(1997-7#1)(2005-8#1)(2006-10#2)(2007-11#1)(2008-10#2)(2008-5#1)(2009-12#1)(2009-4#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)
with potential of##2##3##(2011-2#2)
with potential relevance to##2##4##(2010-3#1)(2013-8#1)
with potential roles in##3##4##(2009-8#1)(2012-12#2)
with potential therapeutic##3##3##(2006-10#1)(2012-2#2)
with potential to##6##3##(2005-8#1)(2007-1#1)(2008-10#2)(2008-7#1)(2009-12#1)
with potential use in##2##4##(2008-11#1)(2008-5#1)
with potential##110##2##(1990-7#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-1#1)(1994-11#2)(1994-12#1)(1994-6#2)(1995-12#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-7#1)(2004-12#1)(2004-2#1)(2005-8#2)(2006-10#6)(2006-3#1)(2007-1#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#7)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#2)(2009-4#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#3)(2011-3#1)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
with potentially curable##2##3##(1990-8#1)(2006-9#1)
with potentially##19##2##(1990-10#1)(1990-8#1)(1992-3#1)(2004-11#1)(2005-8#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#2)(2009-2#1)(2009-4#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-7#1)
with potentiometric##2##2##(2008-10#1)(2010-5#1)
with powdered##2##2##(2007-10#1)(2008-10#1)
with power supply##2##3##(2008-2#1)(2012-1#1)
with power##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2012-1#1)
with powerful##2##2##(2007-12#1)(2012-3#1)
with practical applications##2##3##(1995-3#1)(2010-7#1)
with practical##11##2##(1990-12#1)(1995-3#1)(2005-6#1)(2006-12#1)(2008-10#2)(2008-5#1)(2009-12#1)(2009-7#1)(2010-7#2)
with practically##2##2##(2008-10#1)(2010-7#1)
with practice##5##2##(1991-2#1)(1993-12#1)(1994-3#1)(2008-11#1)(2010-10#1)
with practitioners to##3##3##(1996-3#1)(2008-12#2)
with practitioners##8##2##(1991-12#1)(1995-12#1)(1996-3#1)(2005-8#1)(2008-1#1)(2008-12#3)
with praseodymium##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
with pravastatin##3##2##(2007-11#1)(2008-5#1)(2011-1#1)
with praziquantel##5##2##(1996-12#1)(2005-8#1)(2006-10#1)(2007-2#1)(2010-12#1)
with pre- and##2##3##(2005-7#1)(2007-8#1)
with pre-##4##2##(1996-6#1)(2005-7#1)(2007-8#1)(2010-12#1)
with pre-column fluorescence derivatization##2##4##(1993-2#1)(2008-10#1)
with pre-column##3##2##(1990-6#1)(1993-2#1)(2008-10#1)
with pre-eclampsia##3##2##(2011-2#3)
with pre-existing##11##2##(1990-2#1)(1991-8#1)(1994-4#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-4#1)(2007-7#1)
with pre-post-post designs##2##3##(2010-3#2)
with pre-treatment measurements##2##3##(2012-1#2)
with pre-treatment##4##2##(1991-2#1)(2007-11#1)(2012-1#2)
with precise##4##2##(2006-4#1)(2007-12#1)(2007-9#1)(2012-3#1)
with precisely##2##2##(2008-5#1)(2008-8#1)
with precision##10##2##(2007-8#1)(2008-10#5)(2008-2#1)(2008-5#1)(2009-4#1)(2010-2#1)
with preclinical##2##2##(2006-11#1)(2011-2#1)
with preconcentration##3##2##(2008-10#3)
with precursor##2##2##(2007-12#1)(2008-4#1)
with predefined##4##2##(1997-6#1)(2011-2#1)(2013-1#2)
with predetermined##2##2##(2008-10#1)(2008-3#1)
with predialysis##3##2##(2007-8#1)(2008-12#2)
with predictable##4##2##(1995-12#1)(2008-11#1)(2013-1#1)(2013-7#1)
with predicted molecular##2##3##(1994-2#1)(1995-3#1)
with predicted##5##2##(1993-3#1)(1994-2#1)(1995-3#1)(2007-11#1)(2011-1#1)
with predictions based on##2##4##(1991-9#1)(2008-2#1)
with predictions for##2##3##(1997-5#1)(2008-2#1)
with predictions from##4##3##(1991-7#1)(2008-2#1)(2008-3#1)(2008-8#1)
with predictions of a##3##4##(1994-8#1)(2008-2#1)(2009-2#1)
with predictions of the##3##4##(2008-10#1)(2008-3#1)(2008-8#1)
with predictions of##10##3##(1994-8#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#1)(2009-2#1)
with predictions##23##2##(1991-7#1)(1991-9#1)(1994-8#1)(1997-5#1)(2005-11#1)(2007-12#6)(2008-10#1)(2008-2#4)(2008-3#4)(2008-8#2)(2009-2#1)
with predictive##2##2##(2005-10#1)(2013-1#1)
with predisposing##6##2##(2007-12#1)(2007-7#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-12#1)
with prednisolone##7##2##(2006-10#1)(2006-4#1)(2006-9#1)(2007-8#1)(2009-8#1)(2011-1#1)(2013-1#1)
with prednisone##9##2##(1990-11#2)(1992-2#1)(1993-9#1)(1994-12#1)(2006-10#1)(2008-7#1)(2011-2#1)(2013-8#1)
with predominance of the##2##4##(2011-2#1)(2012-3#1)
with predominance of##8##3##(2007-7#1)(2008-12#1)(2010-12#1)(2011-2#3)(2012-3#1)(2013-1#1)
with predominance##9##2##(1991-9#1)(2007-7#1)(2008-12#1)(2010-12#1)(2011-2#3)(2012-3#1)(2013-1#1)
with predominant##7##2##(1995-9#1)(1996-2#1)(2009-6#1)(2010-12#1)(2010-2#1)(2013-8#2)
with predominantly negative symptoms##2##4##(2009-11#2)
with predominantly##7##2##(1992-1#1)(1993-11#1)(2006-10#1)(2007-12#1)(2008-2#1)(2009-11#2)
with preeclampsia or##2##3##(2006-10#1)(2008-3#1)
with preeclampsia##7##2##(2006-10#1)(2007-9#1)(2008-11#1)(2008-3#1)(2009-8#2)(2011-2#1)
with preexisting##5##2##(1992-3#1)(1992-8#1)(1996-9#1)(2006-10#1)(2007-9#1)
with preference##2##2##(1992-8#1)(2006-6#1)
with preferential affinity for##2##4##(1991-2#1)(1995-12#1)
with preferential##7##2##(1991-2#1)(1992-9#1)(1993-8#1)(1995-12#1)(1995-2#1)(1997-4#1)(2012-2#1)
with pregnancy and##2##3##(2007-9#1)(2008-10#1)
with pregnancy##11##2##(2004-10#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-10#1)(2009-3#2)(2009-5#1)(2012-12#1)(2012-3#1)
with pregnancy-induced hypertension##4##3##(1990-3#1)(1992-2#2)(2011-2#1)
with pregnant women##2##3##(1995-6#1)(2009-4#1)
with pregnant##3##2##(1995-6#1)(2007-2#1)(2009-4#1)
with preimmune serum##2##3##(1990-11#1)(1991-9#1)
with preliminary results##2##3##(2007-12#1)(2008-3#1)
with preliminary##4##2##(2007-12#1)(2008-3#3)
with prelingual deafness##2##3##(2008-9#2)
with premalignant##2##2##(2004-10#1)(2008-2#1)
with premature##9##2##(1993-9#1)(1997-2#1)(2006-6#1)(2008-4#3)(2009-3#1)(2011-2#1)(2012-2#1)
with premolar extractions##3##3##(2010-3#1)(2013-8#2)
with prenatal##5##2##(1995-5#1)(2006-10#1)(2008-12#1)(2011-5#1)(2012-2#1)
with preoperative embolization##2##3##(2008-7#2)
with preoperative##22##2##(1992-3#2)(1993-8#1)(2006-10#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-8#1)(2008-7#3)(2008-9#1)(2009-10#1)(2012-3#2)(2013-1#5)(2013-7#1)
with preparations##2##2##(2008-10#1)(2009-4#1)
with preparing##2##2##(2007-4#1)(2010-4#1)
with preschool children##2##3##(1993-3#1)(2006-4#1)
with prescribing##2##2##(1995-8#1)(2008-8#1)
with prescription drug##2##3##(1995-1#1)(2013-8#1)
with prescription##4##2##(1995-1#1)(2006-5#1)(2008-8#1)(2013-8#1)
with presence of##6##3##(1996-2#1)(2008-5#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-1#1)
with presence or##2##3##(2007-9#1)(2008-10#1)
with presence##8##2##(1996-2#1)(2007-9#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-1#1)
with present##4##2##(1993-9#1)(1996-5#1)(2006-7#1)(2013-1#1)
with preservation of the##5##4##(1992-10#1)(2006-10#1)(2006-12#1)(2008-6#1)(2009-3#1)
with preservation of##18##3##(1990-4#1)(1990-9#1)(1992-10#2)(1994-6#1)(1996-9#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-11#1)(2008-6#1)(2009-1#1)(2009-3#1)
with preserved left ventricular##2##4##(2007-8#1)(2008-11#1)
with preserved systolic function##2##4##(2007-1#1)(2012-2#1)
with preserved##13##2##(1990-2#1)(1997-8#1)(2007-1#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-11#2)(2011-2#2)(2012-1#1)(2012-2#1)
with preserving##2##2##(2005-10#1)(2012-3#1)
with preset##2##2##(2007-12#2)
with press##2##2##(1994-2#1)(2008-3#1)
with pressure##13##2##(1991-4#1)(1992-1#1)(1995-1#1)(1996-1#1)(1996-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2013-8#1)
with presumably##3##2##(2008-7#1)(2010-8#1)(2013-1#1)
with presumed cardioembolic stroke##3##4##(2007-10#3)
with presumed##9##2##(1990-12#1)(1997-3#1)(2007-10#3)(2007-9#1)(2008-7#2)(2012-12#1)
with presumptive##2##2##(2005-10#1)(2008-7#1)
with preterm delivery##3##3##(2007-12#1)(2012-12#1)(2013-1#1)
with preterm##6##2##(1997-2#1)(2007-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
with pretreatment of##2##3##(2008-10#2)
with pretreatment##9##2##(1990-12#1)(1991-5#1)(1997-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2013-1#1)
with prevailing##2##2##(2008-5#1)(2011-2#1)
with prevalence of##3##3##(2012-3#2)(2013-8#1)
with prevalence##4##2##(2007-4#1)(2012-3#2)(2013-8#1)
with prevention of##3##3##(1995-5#1)(2009-3#1)(2011-2#1)
with preventive##6##2##(1992-4#2)(2007-2#1)(2008-11#1)(2010-9#1)(2012-2#1)
with previous SR##2##3##(1993-5#2)
with previous caesarean section##2##4##(1992-8#1)(2009-1#1)
with previous data that##2##4##(1990-8#1)(2010-11#1)
with previous data##3##3##(1990-8#1)(2008-10#1)(2010-11#1)
with previous estimates##2##3##(2008-10#1)(2008-9#1)
with previous experimental data##2##4##(2007-4#1)(2008-2#1)
with previous experimental##4##3##(2007-4#1)(2008-2#1)(2008-3#1)(2009-9#1)
with previous findings in##3##4##(1992-5#1)(2008-7#1)(2013-8#1)
with previous findings of##2##4##(1993-7#1)(2008-6#1)
with previous findings that##2##4##(1994-5#1)(2008-8#1)
with previous findings##20##3##(1991-11#2)(1992-5#1)(1993-12#1)(1993-7#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-2#1)(1997-6#1)(2008-1#1)(2008-6#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
with previous history of##2##4##(2006-10#1)(2010-8#1)
with previous life-threatening penicillin##2##4##(1996-3#2)
with previous measurements##2##3##(2008-11#1)(2008-8#1)
with previous observations that##3##4##(1993-12#1)(2008-10#1)(2010-8#1)
with previous observations##10##3##(1991-9#1)(1993-12#1)(1996-10#1)(1996-2#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-6#1)(2009-8#1)(2010-8#1)
with previous reports##12##3##(1990-6#1)(1991-5#1)(1992-5#1)(1995-12#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2012-3#1)
with previous research##9##3##(1996-1#1)(2006-8#1)(2008-11#1)(2008-2#1)(2009-2#1)(2009-5#2)(2009-7#1)(2012-12#1)
with previous results indicating that##2##5##(1994-11#1)(2008-11#1)
with previous results obtained##3##4##(1991-4#1)(1992-1#1)(1994-2#1)
with previous results##15##3##(1990-5#1)(1991-2#1)(1991-4#2)(1992-1#1)(1993-3#2)(1994-11#1)(1994-2#1)(1997-8#1)(2005-11#2)(2008-11#2)(2010-4#1)
with previous studies of##4##4##(1991-7#1)(1995-11#1)(1997-5#1)(2010-2#1)
with previous studies with##2##4##(2008-4#1)(2009-8#1)
with previous studies##25##3##(1991-10#1)(1991-7#1)(1993-7#1)(1994-10#1)(1995-11#2)(1995-2#1)(1997-5#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-8#2)(2011-2#1)(2012-3#2)
with previous suggestions##2##3##(1997-2#1)(2006-10#1)
with previous theoretical predictions##2##4##(2008-3#2)
with previous treatment##3##3##(2007-11#1)(2013-8#2)
with previous work##6##3##(1992-9#1)(1996-12#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-11#1)
with previous works##2##3##(2008-10#1)(2013-7#1)
with previous##207##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-5#2)(1992-8#3)(1992-9#1)(1993-12#2)(1993-3#2)(1993-5#2)(1993-7#2)(1994-10#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#2)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-11#2)(2005-8#1)(2006-10#4)(2006-12#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#6)(2008-12#1)(2008-2#7)(2008-3#9)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#3)(2009-1#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#2)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#5)(2011-1#7)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#3)(2013-7#2)(2013-8#4)
with previously characterized##2##3##(2008-10#2)
with previously demonstrated##2##3##(2007-11#1)(2008-5#1)
with previously described##3##3##(1990-11#1)(1993-11#1)(1993-6#1)
with previously identified##2##3##(2008-9#1)(2012-12#1)
with previously mapped##2##3##(2008-10#1)(2009-9#1)
with previously proposed##2##3##(2006-11#1)(2008-2#1)
with previously published data on##4##5##(1991-7#1)(1993-11#1)(1996-5#1)(2007-12#1)
with previously published data##7##4##(1990-4#1)(1991-7#1)(1993-11#1)(1996-5#1)(2007-12#1)(2008-5#1)(2008-7#1)
with previously published results##2##4##(2007-11#1)(2008-3#1)
with previously published##18##3##(1990-4#1)(1991-1#1)(1991-7#1)(1993-11#1)(1994-9#1)(1996-3#1)(1996-5#1)(1996-8#1)(2007-11#1)(2007-12#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-2#1)(2010-8#1)
with previously reported data##5##4##(1991-1#1)(1991-9#1)(1996-7#1)(2008-4#1)(2012-2#1)
with previously reported results##5##4##(1993-9#1)(2007-11#1)(2008-10#1)(2008-3#1)(2012-2#1)
with previously reported values##2##4##(1991-7#1)(2008-10#1)
with previously reported##26##3##(1990-4#1)(1991-1#1)(1991-5#1)(1991-7#2)(1991-9#1)(1993-6#1)(1993-9#1)(1996-7#2)(2005-11#1)(2007-11#2)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#1)(2011-1#1)(2012-2#2)(2012-3#1)
with previously##81##2##(1990-11#1)(1990-4#2)(1991-1#2)(1991-5#1)(1991-7#3)(1991-8#1)(1991-9#1)(1993-11#2)(1993-12#1)(1993-6#2)(1993-9#1)(1994-9#1)(1996-3#1)(1996-5#3)(1996-7#2)(1996-8#1)(2004-1#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-3#1)(2008-10#13)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
with pricing##2##2##(1997-6#2)
with primarily##2##2##(1994-2#1)(2013-1#1)
with primary CMV##2##3##(2009-10#1)(2010-12#1)
with primary and secondary##5##4##(2006-7#1)(2008-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
with primary and##7##3##(2006-7#1)(2008-10#1)(2011-1#2)(2012-2#1)(2013-1#2)
with primary angioplasty##2##3##(2008-3#2)
with primary antibody deficiency##5##4##(1992-8#2)(2007-2#3)
with primary antibody##6##3##(1992-8#2)(2007-2#4)
with primary antiphospholipid syndrome##3##4##(2006-10#2)(2011-2#1)
with primary biliary cirrhosis (PBC)##3##5##(1992-6#1)(1992-8#1)(2007-11#1)
with primary biliary cirrhosis##13##4##(1990-3#1)(1991-1#3)(1991-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-2#1)(1996-4#1)(2004-11#1)(2007-11#2)
with primary carcinoma##2##3##(1993-8#1)(2006-2#1)
with primary care physicians##2##4##(2010-3#1)(2013-8#1)
with primary care##4##3##(1991-2#1)(1992-2#1)(2010-3#1)(2013-8#1)
with primary chemotherapy##2##3##(1992-6#1)(1993-2#1)
with primary closure##2##3##(2011-12#2)
with primary gastric##2##3##(1992-8#1)(2013-1#1)
with primary health care##3##4##(1991-4#2)(1991-6#1)
with primary hyperoxaluria##2##3##(1993-9#2)
with primary hyperparathyroidism##9##3##(1990-2#1)(1991-12#1)(1991-5#1)(2005-9#1)(2007-2#1)(2010-7#2)(2013-1#2)
with primary immunodeficiency##4##3##(2006-5#1)(2008-10#1)(2012-12#1)(2012-3#1)
with primary infertility##2##3##(2009-6#1)(2012-2#1)
with primary lung##3##3##(2007-8#1)(2008-11#1)(2011-1#1)
with primary open-angle glaucoma##2##4##(2011-1#1)(2011-2#1)
with primary or secondary##5##4##(1995-10#1)(2007-8#1)(2008-1#3)
with primary or##8##3##(1990-9#1)(1993-8#1)(1995-10#1)(2007-8#1)(2008-1#3)(2008-5#1)
with primary patency of##2##4##(2007-7#2)
with primary renal##3##3##(2013-1#1)(2013-7#2)
with primary repair##2##3##(1994-2#1)(2011-2#1)
with primary sclerosing cholangitis##2##4##(2004-11#1)(2005-12#1)
with primary sclerosing##3##3##(1996-4#1)(2004-11#1)(2005-12#1)
with primary tumors##3##3##(1995-8#1)(2007-7#1)(2012-2#1)
with primary tumours of the##2##5##(2008-6#2)
with primary tumours##4##3##(1997-3#1)(2008-6#3)
with primary##205##2##(1990-11#3)(1990-2#1)(1990-3#1)(1990-8#1)(1990-9#3)(1991-1#3)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#2)(1991-5#2)(1991-6#5)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#2)(1992-2#1)(1992-6#2)(1992-8#5)(1992-9#1)(1993-2#2)(1993-8#2)(1993-9#2)(1994-2#3)(1994-5#2)(1994-7#1)(1995-10#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-3#2)(1996-4#5)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2004-11#2)(2005-12#2)(2005-9#1)(2006-10#6)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#4)(2007-2#8)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#5)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#6)(2008-5#3)(2008-6#6)(2008-7#2)(2008-8#4)(2009-10#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-5#3)(2010-7#2)(2010-8#1)(2011-1#8)(2011-12#2)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#10)(2012-3#3)(2013-1#11)(2013-7#3)(2013-8#1)
with primer##6##2##(1997-4#1)(2008-10#2)(2008-4#1)(2008-5#2)
with primers designed##3##3##(1994-12#1)(2007-6#1)(2008-9#1)
with primers for##2##3##(2008-10#1)(2008-4#1)
with primers from##3##3##(1994-11#1)(2008-10#2)
with primers that amplify##3##4##(2008-10#2)(2010-5#1)
with primers that##4##3##(1996-3#1)(2008-10#2)(2010-5#1)
with primers##16##2##(1994-11#1)(1994-12#1)(1996-3#1)(2007-6#1)(2008-10#9)(2008-4#1)(2008-9#1)(2010-5#1)
with primitive##2##2##(2007-7#1)(2011-1#1)
with principal component analysis##2##4##(1996-5#1)(2008-10#1)
with principal component##3##3##(1996-5#1)(2008-10#1)(2012-3#1)
with principal##5##2##(1996-5#1)(2008-10#1)(2008-6#2)(2012-3#1)
with principles##3##2##(1994-5#1)(2009-4#1)(2012-12#1)
with printed##2##2##(2006-10#1)(2008-3#1)
with prior induction-repression studies##2##4##(1994-11#2)
with prior information##2##3##(2008-8#1)(2010-2#1)
with prior reports of##2##4##(1996-1#1)(2008-1#1)
with prior research##2##3##(2008-9#1)(2009-4#1)
with prior##35##2##(1994-11#2)(1995-2#1)(1996-1#1)(1996-3#1)(1996-5#2)(1997-6#1)(2006-10#1)(2006-6#2)(2006-9#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#2)(2012-12#2)(2012-2#1)(2013-8#1)
with priority##3##2##(2007-11#1)(2008-7#1)(2010-2#1)
with pristine##2##2##(2007-11#1)(2010-7#1)
with privacy##2##2##(2010-11#1)(2012-3#1)
with private health insurance##2##4##(2005-10#1)(2006-1#1)
with private insurance##2##3##(1996-3#1)(1997-2#1)
with private sector##3##3##(1996-12#1)(2013-1#2)
with private##14##2##(1992-3#1)(1994-1#1)(1996-12#1)(1996-3#2)(1997-2#1)(1997-5#1)(2005-10#1)(2006-1#1)(2007-4#1)(2007-9#1)(2013-1#3)
with pro-inflammatory##3##2##(1995-3#1)(1996-5#1)(2009-7#1)
with pro-opiomelanocortin##2##2##(1991-9#1)(2012-1#1)
with probability##2##2##(2008-2#1)(2008-8#1)
with probable Alzheimer's disease##2##4##(2008-7#1)(2012-2#1)
with probable Alzheimer's##3##3##(1995-11#1)(2008-7#1)(2012-2#1)
with probable chronic migraine and probable medication-overuse headache##2##8##(2006-12#2)
with probable or possible##2##4##(2008-4#1)(2008-7#1)
with probable##12##2##(1991-12#1)(1995-11#2)(2006-12#2)(2007-12#1)(2007-8#1)(2008-4#1)(2008-7#2)(2012-2#1)(2013-1#1)
with probe RG57##2##3##(2008-10#2)
with probe##9##2##(2005-4#1)(2007-9#1)(2008-10#5)(2010-2#1)(2012-3#1)
with probes that##2##3##(1996-12#1)(2008-10#1)
with probes##7##2##(1994-12#1)(1996-12#1)(1997-2#1)(2008-10#2)(2008-4#1)(2010-5#1)
with problem based learning##2##4##(2008-11#1)(2008-12#1)
with problem use##2##3##(2006-3#1)(2013-1#1)
with problem##5##2##(2006-3#1)(2008-11#1)(2008-12#2)(2013-1#1)
with problems in##2##3##(1992-2#1)(2008-12#1)
with problems of##2##3##(2008-9#1)(2012-1#1)
with problems that##3##3##(2004-3#1)(2007-2#1)(2008-11#1)
with problems##10##2##(1990-10#1)(1992-2#1)(2004-3#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2011-1#1)(2012-1#1)
with procalcitonin##2##2##(2010-12#1)(2013-1#1)
with procedures##3##2##(2008-10#1)(2008-4#2)
with processed##3##2##(1993-2#1)(2007-7#1)(2008-10#1)
with processes##3##2##(1991-10#1)(2005-5#1)(2013-1#1)
with processing##2##2##(1993-7#1)(2010-4#1)
with product##6##2##(2005-12#1)(2008-10#1)(2008-5#1)(2010-4#1)(2011-2#1)(2012-2#1)
with production of##7##3##(1992-12#1)(1993-4#1)(1995-1#1)(1996-5#1)(2008-10#1)(2008-12#1)(2010-2#1)
with production##9##2##(1992-12#1)(1993-4#1)(1995-1#1)(1996-5#1)(2008-10#2)(2008-12#1)(2010-2#1)(2012-2#1)
with productivity##7##2##(2008-8#5)(2008-9#2)
with products##3##2##(1994-12#1)(2007-12#1)(2008-10#1)
with professional##8##2##(1990-12#1)(1991-3#1)(1993-3#1)(1994-2#1)(1997-2#1)(2009-9#1)(2011-2#1)(2013-8#1)
with professionals##2##2##(2005-5#1)(2011-2#1)
with profiles##3##2##(1996-8#1)(2008-12#1)(2010-12#1)
with profound hearing loss##3##4##(2008-9#3)
with profound##9##2##(1990-8#1)(2006-10#1)(2007-3#1)(2008-9#4)(2011-2#2)
with profuse##3##2##(1991-9#1)(2005-10#1)(2007-8#1)
with progeny##3##2##(2008-10#2)(2013-8#1)
with progesterone##5##2##(1991-11#1)(1995-7#1)(2005-6#1)(2005-7#2)
with progestins##2##2##(1993-6#1)(2006-5#1)
with prognosis##9##2##(1993-9#1)(1994-10#1)(2007-10#1)(2007-12#1)(2007-8#1)(2009-5#1)(2012-12#1)(2012-3#2)
with prognostic##4##2##(1990-9#1)(1995-9#1)(2006-8#1)(2008-2#1)
with programmable##2##2##(2006-8#1)(2008-2#1)
with programmed##3##2##(2008-10#1)(2009-2#2)
with programming##2##2##(2009-5#1)(2013-8#1)
with progress of##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
with progress##4##2##(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
with progression of disease##2##4##(1991-6#1)(1992-2#1)
with progression of##13##3##(1991-6#1)(1992-10#1)(1992-2#1)(1995-12#1)(2007-10#1)(2007-6#1)(2007-8#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
with progression to metastatic##2##4##(2009-8#1)(2010-12#1)
with progression##21##2##(1990-3#1)(1991-6#1)(1992-10#1)(1992-2#1)(1995-12#1)(2006-10#2)(2007-10#1)(2007-6#1)(2007-7#2)(2007-8#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
with progressive disease despite##2##4##(1995-10#1)(2013-1#1)
with progressive disease##7##3##(1992-12#1)(1995-10#1)(2007-7#1)(2007-8#1)(2009-3#1)(2010-11#1)(2013-1#1)
with progressive muscular##2##3##(2007-8#1)(2012-2#1)
with progressive neurological##2##3##(2008-7#1)(2011-2#1)
with progressive right-sided##2##3##(2010-2#1)(2012-12#1)
with progressive scoliosis##2##3##(2007-7#1)(2007-8#1)
with progressive##53##2##(1990-7#1)(1991-3#1)(1992-12#1)(1992-8#2)(1994-9#1)(1995-10#1)(2006-10#2)(2006-12#3)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-3#1)(2007-7#4)(2007-8#6)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-11#3)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
with progressively increasing##2##3##(2008-4#1)(2011-12#1)
with progressively##5##2##(1996-5#1)(2007-8#1)(2008-4#1)(2008-9#1)(2011-12#1)
with projected##3##2##(1994-3#1)(2008-3#1)(2008-8#1)
with prokaryotic##4##2##(1990-1#1)(1990-11#1)(1994-2#1)(2011-1#1)
with prolactinomas##2##2##(1993-2#1)(2008-5#1)
with prolapsed##2##2##(2009-6#1)(2013-1#1)
with proliferating cell nuclear antigen##2##5##(1994-8#1)(2008-6#1)
with proliferating endothelium##2##3##(2004-1#2)
with proliferating periodontal##2##3##(2010-2#2)
with proliferating##7##2##(1994-10#1)(1994-8#1)(2004-1#2)(2008-6#1)(2010-2#2)
with proliferation and##2##3##(1994-5#1)(2011-2#1)
with proliferation of##3##3##(1991-1#1)(2008-10#1)(2012-3#1)
with proliferation##8##2##(1991-1#1)(1994-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
with proliferative diabetic retinopathy##2##4##(1997-7#1)(2013-1#1)
with proline and##2##3##(1990-7#1)(1991-7#1)
with proline##4##2##(1990-7#1)(1991-7#1)(1992-4#1)(2013-1#1)
with prolonged fever##2##3##(2008-11#1)(2011-1#1)
with prolonged use of##2##4##(2008-1#1)(2008-8#1)
with prolonged##32##2##(1991-2#1)(1992-12#1)(1994-12#1)(1995-6#1)(1997-6#1)(2004-1#1)(2005-10#1)(2006-10#3)(2006-4#2)(2007-10#1)(2007-11#1)(2007-8#3)(2008-1#1)(2008-11#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-1#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)
with prominent##4##2##(1994-10#1)(2006-4#1)(2007-12#1)(2012-3#1)
with promising results##4##3##(2004-1#1)(2006-10#1)(2012-12#1)(2012-3#1)
with promising##8##2##(2004-1#1)(2006-10#1)(2008-5#2)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
with prompt##4##2##(1991-6#1)(1997-8#1)(2005-10#1)(2007-7#1)
with pronounced##7##2##(1996-5#1)(2006-1#1)(2007-12#1)(2008-10#2)(2008-3#1)(2013-8#1)
with propagation##2##2##(2007-12#1)(2008-10#1)
with proper use of##3##4##(2007-10#1)(2012-2#2)
with proper##19##2##(1990-11#1)(1993-6#2)(2006-5#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
with properly##2##2##(2007-11#1)(2008-4#1)
with properties of##3##3##(1991-1#1)(1991-10#1)(2008-1#1)
with properties that##4##3##(1991-9#1)(1994-9#1)(2008-7#2)
with properties##14##2##(1990-5#1)(1991-1#1)(1991-10#1)(1991-9#1)(1993-2#1)(1993-9#1)(1994-5#1)(1994-9#1)(2008-1#1)(2008-3#1)(2008-7#2)(2010-9#1)(2012-2#1)
with prophylactic##6##2##(2006-10#1)(2011-1#1)(2011-2#3)(2012-3#1)
with prophylaxis##2##2##(1995-5#1)(2008-7#1)
with propidium iodide##3##3##(1992-8#1)(1994-2#1)(2008-9#1)
with propofol and##2##3##(2011-2#1)(2012-2#1)
with propofol or a##2##4##(2009-6#1)(2013-1#1)
with propofol or##4##3##(2006-10#1)(2009-6#1)(2013-1#2)
with propofol##17##2##(1992-6#2)(2006-10#2)(2009-6#1)(2010-7#4)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
with proportional##4##2##(1991-2#1)(1996-1#2)(2011-2#1)
with proposals##2##2##(1997-3#1)(2008-2#1)
with proposed##3##2##(2007-4#1)(2008-10#1)(2010-8#1)
with propranolol##4##2##(1996-12#1)(2008-10#1)(2010-6#1)(2012-2#1)
with proprioceptive##2##2##(1995-12#1)(2012-1#1)
with proptosis##2##2##(2008-8#1)(2011-1#1)
with propylene##3##2##(2007-10#1)(2007-11#2)
with prosopagnosia##2##2##(1991-11#1)(2008-4#1)
with prospective payment##2##3##(1990-12#1)(1995-1#1)
with prospective##3##2##(1990-12#1)(1995-1#1)(2011-2#1)
with prostaglandin##7##2##(1991-4#1)(1992-11#1)(1992-8#1)(1993-8#1)(1994-6#1)(1995-12#1)(1995-5#1)
with prostate cancer and##3##4##(2007-11#2)(2008-7#1)
with prostate cancer than##3##4##(2006-10#1)(2009-5#1)(2012-11#1)
with prostate cancer##30##3##(2006-10#1)(2006-9#3)(2007-11#2)(2007-2#2)(2008-1#2)(2008-4#1)(2008-7#6)(2008-8#1)(2009-5#6)(2010-10#1)(2010-12#1)(2012-11#1)(2012-3#2)(2013-1#1)
with prostate##36##2##(2006-10#1)(2006-9#3)(2007-11#2)(2007-2#2)(2008-1#2)(2008-4#1)(2008-7#7)(2008-8#1)(2009-4#1)(2009-5#7)(2010-10#1)(2010-12#1)(2012-11#2)(2012-3#2)(2013-1#3)
with prostatic cancer##6##3##(1990-9#2)(1995-11#1)(1995-12#2)(2007-3#1)
with prostatic##12##2##(1990-3#1)(1990-9#2)(1993-6#1)(1995-11#1)(1995-12#2)(2005-12#1)(2007-10#1)(2007-3#1)(2008-9#1)(2011-1#1)
with prostatitis##2##2##(2008-6#2)
with prostheses##2##2##(1990-8#1)(1991-4#1)
with prosthesis##5##2##(1992-5#1)(1993-11#1)(1993-3#1)(2008-1#1)(2012-1#1)
with prosthetic##5##2##(2007-8#3)(2008-6#1)(2013-1#1)
with prostitution##2##2##(1997-5#1)(2011-2#1)
with protean manifestations##2##3##(2006-10#1)(2011-2#1)
with protean##4##2##(2006-10#1)(2008-7#1)(2009-7#1)(2011-2#1)
with protease inhibitors##3##3##(1990-11#1)(1992-9#1)(1996-1#1)
with proteasome##2##2##(1994-12#1)(2008-8#1)
with protected##3##2##(1996-5#2)(2008-3#1)
with protection from##3##3##(1996-1#1)(2008-1#1)(2008-5#1)
with protection##10##2##(1990-3#1)(1994-1#1)(1994-9#1)(1996-1#1)(1996-4#1)(2008-1#1)(2008-5#1)(2010-3#1)(2012-12#1)(2013-8#1)
with protective##7##2##(1993-9#1)(1994-11#1)(1994-2#1)(1996-12#1)(2006-10#1)(2006-3#1)(2008-6#1)
with protein C##2##3##(2005-1#2)
with protein antigens##2##3##(2006-10#1)(2011-12#1)
with protein disulfide isomerase##4##4##(1996-7#3)(2013-1#1)
with protein disulfide##5##3##(1996-7#4)(2013-1#1)
with protein kinase A##2##4##(1992-11#1)(2010-12#1)
with protein kinase C zeta##2##5##(1994-11#2)
with protein kinase C##4##4##(1990-9#1)(1994-11#2)(1994-9#1)
with protein kinase##7##3##(1990-10#1)(1990-9#1)(1992-11#1)(1994-11#2)(1994-9#1)(2010-12#1)
with protein phosphatase 2A##2##4##(1996-5#2)
with protein phosphatase##3##3##(1995-8#1)(1996-5#2)
with protein##51##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-9#1)(1991-10#1)(1991-5#1)(1992-11#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-5#2)(1996-7#4)(1996-8#2)(2005-1#2)(2006-10#2)(2007-8#2)(2008-10#4)(2008-11#4)(2008-4#2)(2009-10#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-12#1)(2013-1#1)(2013-7#1)
with proteinase K and##2##4##(1996-12#1)(2008-10#1)
with proteinase K##6##3##(1996-12#2)(2008-10#3)(2013-1#1)
with proteinase##7##2##(1996-12#2)(2008-10#4)(2013-1#1)
with proteinaseK##2##2##(2008-8#2)
with proteins and##6##3##(1994-9#1)(2006-12#1)(2008-10#1)(2008-5#1)(2009-8#1)(2011-1#1)
with proteins containing##2##3##(1996-10#1)(2008-10#1)
with proteins in##4##3##(1991-1#1)(1991-9#1)(1993-11#1)(2006-10#1)
with proteins of##2##3##(1993-8#1)(2008-10#1)
with proteins that##2##3##(1993-4#1)(1997-3#1)
with proteins##33##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-11#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-3#1)(1994-9#1)(1996-10#1)(1996-11#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-10#1)(2006-12#1)(2008-10#5)(2008-5#1)(2008-7#1)(2009-8#1)(2010-2#1)(2011-1#3)
with proteinuria##4##2##(1992-12#1)(2007-7#2)(2007-8#1)
with proteolytic##2##2##(2006-12#1)(2008-11#1)
with proteomic##2##2##(2008-7#2)
with protocols##2##2##(2008-3#1)(2008-4#1)
with protoheme XIII##2##3##(1990-8#2)
with proton pump inhibitors##2##4##(2006-10#1)(2012-2#1)
with proton pump##5##3##(1996-3#1)(2005-1#1)(2005-12#1)(2006-10#1)(2012-2#1)
with proton##11##2##(1992-11#1)(1993-6#1)(1995-5#1)(1996-3#1)(2005-1#1)(2005-12#1)(2006-10#1)(2010-12#1)(2010-2#1)(2010-9#1)(2012-2#1)
with protons##2##2##(2007-11#1)(2008-4#1)
with protoporphyrin##2##2##(1990-1#1)(1991-5#1)
with prototype##2##2##(2008-3#2)
with protracted##3##2##(1994-2#1)(2006-10#1)(2008-7#1)
with protruding##3##2##(1990-9#2)(2008-5#1)
with protrusion##2##2##(2008-10#1)(2008-5#1)
with proven efficacy in##2##4##(2008-3#1)(2008-9#1)
with proven efficacy##3##3##(2008-3#1)(2008-9#1)(2010-12#1)
with proven##18##2##(1992-4#1)(1997-7#1)(2005-7#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-1#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
with providing##2##2##(1997-2#1)(2007-12#1)
with provisional##2##2##(2008-10#1)(2009-5#1)
with provocative##4##2##(1992-10#1)(2006-10#1)(2007-11#1)(2012-12#1)
with proximal and distal##2##4##(2007-12#1)(2008-7#1)
with proximal femur##3##3##(2007-11#2)(2007-8#1)
with proximal humeral##2##3##(2007-11#1)(2013-1#1)
with proximal##12##2##(1994-12#1)(2006-10#1)(2007-11#5)(2007-12#1)(2007-5#1)(2007-8#1)(2008-7#1)(2013-1#1)
with pruritic rashes##2##3##(2007-2#2)
with pruritic##3##2##(2007-2#2)(2010-6#1)
with pseudomonic acid##2##3##(1994-9#2)
with pseudomyxoma peritonei##5##3##(2006-6#2)(2009-5#2)(2009-6#1)
with pseudoxanthoma elasticum##2##3##(2006-10#2)
with psittacine beak and feather disease##2##6##(2008-5#2)
with psoriasis and##4##3##(1992-10#2)(2013-1#2)
with psoriasis were##2##3##(2007-8#2)
with psoriasis##19##2##(1992-10#3)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#3)(2008-3#1)(2008-6#1)(2012-12#2)(2012-2#2)(2013-1#4)
with psoriatic arthritis##5##3##(2006-10#3)(2007-8#1)(2011-2#1)
with psoriatic##7##2##(2006-10#4)(2007-8#1)(2008-9#1)(2011-2#1)
with psychiatric disabilities##8##3##(1993-3#1)(1997-1#3)(2009-6#4)
with psychiatric disorders##7##3##(1995-11#1)(2007-8#1)(2011-1#2)(2012-2#1)(2013-7#2)
with psychiatric##27##2##(1993-3#1)(1995-11#1)(1997-1#3)(2004-3#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-2#2)(2008-7#1)(2009-6#4)(2010-10#1)(2010-2#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)
with psychoactive##2##2##(1990-3#1)(2011-2#1)
with psychological##9##2##(1993-10#1)(2006-8#3)(2007-6#1)(2008-6#1)(2010-12#1)(2012-12#1)(2012-2#1)
with psychosis##10##2##(1996-7#1)(2011-1#1)(2011-2#7)(2012-1#1)
with psychosocial##4##2##(2007-12#1)(2008-2#1)(2008-6#1)(2013-8#1)
with psychotherapy##2##2##(2004-3#1)(2013-1#1)
with psychotic disorders##4##3##(2008-11#1)(2009-10#1)(2009-8#2)
with psychotic features##3##3##(2007-7#2)(2012-2#1)
with psychotic symptoms##4##3##(2007-6#1)(2009-6#1)(2009-7#1)(2013-8#1)
with psychotic##12##2##(2007-6#1)(2007-7#2)(2008-11#1)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#2)(2011-2#1)(2012-2#1)(2013-8#1)
with psychotropic##2##2##(2005-7#1)(2013-1#1)
with public health professionals##2##4##(2013-1#2)
with public health##3##3##(2007-2#1)(2013-1#2)
with public##7##2##(1994-2#1)(1995-8#1)(1997-3#1)(2007-2#1)(2012-3#1)(2013-1#2)
with published data for##3##4##(1992-7#1)(2006-8#1)(2008-10#1)
with published data on##5##4##(1995-8#1)(1997-2#1)(2008-5#2)(2012-1#1)
with published data##14##3##(1990-3#1)(1992-7#1)(1994-3#1)(1995-8#1)(1997-2#1)(1997-7#1)(2006-8#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-9#1)(2012-1#1)
with published experimental##2##3##(2007-9#1)(2008-2#1)
with published reports##2##3##(2007-7#1)(2008-10#1)
with published results##2##3##(2007-12#1)(2008-8#1)
with published sequences##2##3##(1994-11#1)(2008-10#1)
with published##35##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-9#1)(1992-7#1)(1994-11#1)(1994-3#1)(1995-8#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-7#2)(2005-8#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#4)(2008-2#3)(2008-5#3)(2008-8#1)(2008-9#1)(2012-1#1)
with pulmonary and##2##3##(2007-12#1)(2009-10#1)
with pulmonary artery##4##3##(1993-12#1)(2006-10#3)
with pulmonary disease##2##3##(2006-8#1)(2010-5#1)
with pulmonary edema##4##3##(1997-4#1)(2006-10#1)(2008-11#1)(2010-5#1)
with pulmonary embolism##5##3##(1991-3#1)(2008-7#2)(2011-2#1)(2013-8#1)
with pulmonary function tests##2##4##(2009-6#1)(2010-6#1)
with pulmonary function##4##3##(1997-3#1)(2006-12#1)(2009-6#1)(2010-6#1)
with pulmonary hypertension and##2##4##(2006-10#1)(2008-5#1)
with pulmonary hypertension##13##3##(1992-7#1)(2005-11#1)(2006-10#2)(2008-12#1)(2008-5#2)(2008-7#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-12#1)(2012-3#1)
with pulmonary metastases##2##3##(2008-10#1)(2010-11#1)
with pulmonary metastasis in a##2##5##(2008-5#1)(2012-1#1)
with pulmonary metastasis##3##3##(2008-5#1)(2011-1#1)(2012-1#1)
with pulmonary tuberculosis##8##3##(2006-6#3)(2007-12#1)(2011-1#1)(2011-11#1)(2012-2#1)(2013-1#1)
with pulmonary##78##2##(1991-3#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-9#1)(1994-6#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-5#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#6)(2006-12#1)(2006-6#3)(2006-8#1)(2007-12#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#5)(2008-7#7)(2009-10#1)(2009-4#2)(2009-6#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-5#2)(2010-6#1)(2011-1#3)(2011-11#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#3)
with pulsatile tinnitus##2##3##(2006-12#1)(2007-9#1)
with pulsatile##4##2##(2006-12#1)(2007-9#1)(2008-7#1)(2010-6#1)
with pulse durations##2##3##(2007-12#1)(2008-3#1)
with pulse lengths##3##3##(2007-12#2)(2008-1#1)
with pulse##23##2##(1992-3#1)(1993-1#1)(1993-2#1)(2006-10#1)(2007-11#2)(2007-12#6)(2007-7#2)(2008-1#2)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2009-9#1)
with pulsed amperometric detection for##2##5##(2008-10#2)
with pulsed amperometric detection##9##4##(1991-7#2)(1992-1#1)(1993-11#1)(2008-10#4)(2008-6#1)
with pulsed digital holography##3##4##(2008-3#3)
with pulsed lasers##2##3##(2008-3#2)
with pulsed##18##2##(1991-7#2)(1992-1#1)(1993-11#1)(2006-12#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#5)(2008-6#1)(2010-2#1)
with pulses##4##2##(2007-12#3)(2008-1#1)
with pump##9##2##(2007-12#6)(2007-8#1)(2008-1#1)(2008-3#1)
with pure alexia##2##3##(2008-4#1)(2008-9#1)
with pure red cell##3##4##(2008-12#2)(2013-1#1)
with pure red##4##3##(2008-12#2)(2013-1#2)
with pure##23##2##(1990-12#1)(1997-3#1)(1997-6#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#1)(2008-9#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-12#1)(2013-1#3)
with purified RNA##2##3##(1994-3#1)(2008-9#1)
with purified bacterial##2##3##(1992-3#1)(1992-8#1)
with purified enzyme##2##3##(1995-1#1)(2007-11#1)
with purified human##2##3##(1991-3#1)(1992-6#1)
with purified rabbit##2##3##(1991-2#1)(1996-5#1)
with purified rat##3##3##(1990-5#1)(1994-8#1)(1995-6#1)
with purified##45##2##(1990-11#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-4#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-6#1)(2004-11#1)(2005-10#1)(2006-3#1)(2007-11#2)(2008-10#5)(2008-4#3)(2008-8#1)(2008-9#1)
with purine analogues##2##3##(2007-5#1)(2011-2#1)
with purine##4##2##(1992-8#1)(1997-2#1)(2007-5#1)(2011-2#1)
with purity##2##2##(2007-10#1)(2010-2#1)
with puromycin##2##2##(1997-1#1)(2009-6#1)
with purple##2##2##(1990-3#1)(2011-2#1)
with purulent##3##2##(2008-10#1)(2010-2#1)(2011-2#1)
with push HIE##6##3##(2013-1#6)
with putA gene##2##3##(1996-2#2)
with putative##8##2##(1991-6#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-9#1)(1996-4#1)(1997-3#1)(2008-10#1)
with putrescine##4##2##(1994-11#1)(1997-1#1)(1997-8#2)
with puzzling##2##2##(1996-11#1)(2006-10#1)
with pycnidia##2##2##(2008-10#2)
with pycnodysostosis##2##2##(2009-1#2)
with pyoderma gangrenosum##2##3##(2006-10#2)
with pyogenic##4##2##(2006-10#2)(2007-8#1)(2010-6#1)
with pyramidal##2##2##(2007-12#1)(2008-2#1)
with pyrene##4##2##(1995-5#1)(2008-10#1)(2008-4#2)
with pyrexia##2##2##(2007-8#2)
with pyridine and##2##3##(2007-11#1)(2008-10#1)
with pyridine##4##2##(2007-11#1)(2008-10#3)
with pyridinium poly(hydrogen fluoride)##2##4##(1992-12#2)
with pyridoxal 5'-diphospho-5'-adenosine##2##3##(1991-12#2)
with pyridoxal 5'-phosphate##2##3##(2006-12#2)
with pyridoxal##5##2##(1991-12#2)(1996-7#1)(2006-12#2)
with pyridoxal-P##2##2##(1994-9#2)
with pyridylazo##2##2##(2008-10#2)
with pyrocatechol violet and rhodamine B##2##6##(2005-4#2)
with pyrocatechol violet and rhodamine##3##5##(2005-4#3)
with pyrocatechol##4##2##(2005-4#3)(2008-10#1)
with pyroglutamate aminopeptidase##2##3##(1992-3#1)(1997-8#1)
with pyrrole##3##2##(1996-5#1)(2008-5#2)
with pyruvate##6##2##(1993-11#1)(1994-12#1)(1994-8#1)(1997-1#1)(2011-12#1)(2011-2#1)
with quadrat size##2##3##(2008-10#2)
with quadratic##2##2##(2008-3#1)(2008-6#1)
with quadrature##2##2##(2007-11#1)(2008-3#1)
with quadrupole##2##2##(2008-10#2)
with qualitative##3##2##(2008-10#1)(2011-1#1)(2012-12#1)
with quality of life and##2##5##(2006-10#1)(2008-6#1)
with quality of life##3##4##(1996-2#1)(2006-10#1)(2008-6#1)
with quality of##5##3##(1990-1#1)(1990-12#1)(1996-2#1)(2006-10#1)(2008-6#1)
with quality##12##2##(1990-1#1)(1990-12#2)(1994-12#1)(1995-2#1)(1996-2#2)(2006-10#1)(2008-1#1)(2008-6#1)(2011-12#1)(2012-12#1)
with quantal response data##2##4##(2009-5#1)(2010-2#1)
with quantal##4##2##(1997-7#1)(2009-5#1)(2010-2#2)
with quantitation##2##2##(1990-12#1)(2007-8#1)
with quantitative and qualitative##3##4##(2012-3#1)(2013-1#2)
with quantitative autoradiography##2##3##(1991-5#1)(1996-9#1)
with quantitative phenotypes##2##3##(2012-3#2)
with quantitative traits##7##3##(2008-10#1)(2012-3#6)
with quantitative##32##2##(1990-9#1)(1991-5#1)(1995-1#1)(1996-2#1)(1996-7#1)(1996-9#2)(2006-12#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-10#1)(2009-5#1)(2012-1#2)(2012-3#11)(2013-1#5)
with quantized##2##2##(1993-8#1)(2008-3#1)
with quantum chemical##2##3##(2008-10#1)(2010-10#1)
with quantum dot##2##3##(2010-12#1)(2011-2#1)
with quantum dots##2##3##(2008-3#1)(2008-7#1)
with quantum##10##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#2)(2008-7#1)(2010-10#1)(2010-12#1)(2011-2#1)
with quartz crystal##2##3##(2007-8#1)(2008-10#1)
with quartz##4##2##(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)
with quasi-phase-matching gratings##2##3##(2007-11#2)
with quaternary ammonium cations (Q(+))##2##5##(2008-10#2)
with quaternary ammonium counter ions##2##5##(2008-10#2)
with quaternary ammonium ions##2##4##(2008-10#2)
with quaternary ammonium##6##3##(2008-10#6)
with quaternary##8##2##(1993-11#1)(2008-10#6)(2008-6#1)
with queer and trans patients##2##5##(2012-11#2)
with quenching##2##2##(1991-7#1)(1997-1#1)
with quercetin##3##2##(2005-4#1)(2008-10#2)
with questionable##2##2##(2006-10#1)(2008-11#1)
with questionnaires##3##2##(2009-5#1)(2011-1#1)(2013-7#1)
with questions##2##2##(1995-8#1)(2013-1#1)
with quick##2##2##(2008-2#1)(2013-8#1)
with quinine modified resin##2##4##(2008-10#2)
with quinine##3##2##(1993-8#1)(2008-10#2)
with quinoline-8-ol##2##2##(2008-10#2)
with quinolinic acid##4##3##(1992-1#1)(1994-8#1)(1995-12#1)(2008-5#1)
with quinolones##2##2##(1991-12#2)
with quinone##2##2##(1992-7#1)(2011-1#1)
with quinpirole##2##2##(1990-5#1)(1996-12#1)
with quite##2##2##(2008-1#1)(2008-10#1)
with quitting##2##2##(1995-6#1)(2010-2#1)
with r values##2##3##(1990-12#1)(2008-10#1)
with r##4##2##(1990-12#1)(1995-2#1)(2008-10#2)
with r(2) = 0##2##4##(2008-10#1)(2011-2#1)
with r(2) values of &gt##2##5##(2008-10#2)
with r(2)##5##2##(2008-10#4)(2011-2#1)
with r(2)=0##8##2##(2008-10#8)
with r2 values##2##3##(1996-6#1)(2006-12#1)
with r=0##2##2##(2008-10#2)
with rAAV##2##2##(2008-5#1)(2008-9#1)
with rDNA##2##2##(1991-12#1)(2008-10#1)
with rIL-2##2##2##(1990-12#1)(2007-11#1)
with rRNA##4##2##(2006-11#1)(2006-5#1)(2008-8#1)(2008-9#1)
with rTMS##2##2##(2008-4#1)(2012-2#1)
with rabbit antibodies to##2##4##(1992-8#2)
with rabbit##14##2##(1990-12#1)(1990-4#1)(1990-5#1)(1991-10#1)(1992-8#2)(1993-2#1)(1994-9#2)(2005-7#1)(2008-10#1)(2008-11#2)(2008-5#1)
with rabies vaccine##2##3##(1996-11#1)(2008-8#1)
with rabies##3##2##(1996-11#1)(2008-8#1)(2013-1#1)
with race 7##2##3##(2008-10#2)
with race##12##2##(2007-3#1)(2007-8#1)(2008-10#10)
with racemic##2##2##(1990-6#1)(2007-8#1)
with races 1 and##2##4##(2008-10#2)
with races 1##3##3##(2008-10#3)
with races##5##2##(2008-10#5)
with racial##3##2##(1994-3#2)(2009-7#1)
with radial artery##2##3##(2007-8#1)(2008-9#1)
with radial forearm free##2##4##(2011-2#2)
with radial##13##2##(1990-9#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#2)(2009-8#1)(2011-2#3)(2013-8#1)
with radiation and##4##3##(1994-2#1)(2008-6#1)(2010-5#1)(2013-1#1)
with radiation at##2##3##(2008-3#1)(2008-6#1)
with radiation in##2##3##(1993-9#1)(2011-2#1)
with radiation therapy and chemotherapy##2##5##(2006-11#1)(2013-8#1)
with radiation therapy and##4##4##(2006-11#1)(2010-3#1)(2012-2#1)(2013-8#1)
with radiation therapy##10##3##(1990-4#1)(2006-11#1)(2006-12#1)(2008-3#1)(2010-12#1)(2010-3#1)(2012-1#1)(2012-2#2)(2013-8#1)
with radiation##28##2##(1990-4#1)(1991-12#1)(1993-9#1)(1994-2#2)(2006-11#1)(2006-12#2)(2007-11#1)(2008-3#2)(2008-6#4)(2008-7#2)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#2)(2013-8#1)
with radiative##2##2##(2008-2#2)
with radical resection of the##2##5##(2006-12#1)(2007-11#1)
with radical resection##3##3##(2006-12#1)(2007-11#2)
with radical surgery##3##3##(1991-4#1)(2011-2#2)
with radical##16##2##(1990-12#1)(1991-4#1)(1992-8#1)(1993-8#1)(1997-7#1)(2004-1#1)(2006-12#1)(2006-9#1)(2007-11#3)(2011-2#4)(2013-1#1)
with radicular symptoms##3##3##(2006-7#1)(2006-8#1)(2007-11#1)
with radicular##5##2##(1991-11#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-7#1)
with radiculopathy##5##2##(2006-8#1)(2007-1#1)(2008-12#1)(2012-12#1)(2012-3#1)
with radii of##2##3##(2006-10#1)(2008-3#1)
with radii##4##2##(2006-10#1)(2006-12#1)(2008-2#1)(2008-3#1)
with radio##2##2##(2008-1#1)(2013-1#1)
with radio-frequency##2##2##(1995-11#1)(2008-7#1)
with radioactive iodine##2##3##(2006-1#1)(2013-1#1)
with radioactive sugars##2##3##(2008-1#2)
with radioactive##13##2##(1990-11#1)(1992-8#1)(1993-11#1)(1994-3#1)(1994-8#1)(1997-2#1)(1997-6#1)(2006-1#1)(2006-10#1)(2008-1#2)(2008-10#1)(2013-1#1)
with radiochemical##3##2##(1991-4#1)(1992-4#1)(2007-8#1)
with radiofrequency ablation##2##3##(2007-8#1)(2010-5#1)
with radiofrequency lesions##2##3##(1992-11#1)(1994-3#1)
with radiofrequency##6##2##(1992-11#1)(1994-3#1)(2006-12#1)(2007-8#1)(2010-5#1)(2011-1#1)
with radiographic##3##2##(2008-6#1)(2009-3#1)(2013-7#1)
with radioisotopes or##2##3##(2007-11#1)(2008-4#1)
with radiolabeled PCR##2##3##(1990-2#1)(1993-3#1)
with radiolabeled##9##2##(1990-2#1)(1992-4#1)(1993-3#1)(1994-12#1)(1994-9#1)(1997-5#1)(2008-11#1)(2008-4#1)(2009-2#1)
with radiolabelled MIBG##2##3##(2006-9#2)
with radiolabelled##6##2##(1992-12#1)(2006-9#2)(2007-11#1)(2007-2#1)(2008-8#1)
with radiologic##2##2##(1994-6#1)(2012-2#1)
with radiological##6##2##(1990-3#1)(1993-1#1)(2007-7#2)(2010-7#1)(2012-2#1)
with radiologically##4##2##(2007-8#2)(2007-9#1)(2008-7#1)
with radiosondes##2##2##(2008-2#1)(2008-3#1)
with radiosurgery##7##2##(1997-4#1)(2005-5#3)(2006-11#1)(2008-7#2)
with radiotherapy alone##3##3##(1990-6#1)(1995-9#1)(2006-2#1)
with radiotherapy and chemotherapy##2##4##(2008-11#1)(2013-7#1)
with radiotherapy and##8##3##(1992-10#1)(1996-2#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-7#1)(2013-7#1)
with radiotherapy and/or chemotherapy##2##4##(1990-5#1)(2012-3#1)
with radiotherapy as the##2##4##(1991-9#1)(1997-6#1)
with radiotherapy for##3##3##(1994-7#1)(1995-4#1)(1997-3#1)
with radiotherapy was##2##3##(1992-8#1)(2006-2#1)
with radiotherapy##43##2##(1990-5#1)(1990-6#1)(1991-5#1)(1991-9#1)(1992-10#2)(1992-8#2)(1993-6#1)(1993-9#1)(1994-7#1)(1995-4#1)(1995-9#2)(1996-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-2#2)(2007-11#2)(2008-11#2)(2008-5#1)(2008-6#2)(2008-7#2)(2009-3#1)(2010-3#1)(2011-1#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
with radius##2##2##(1996-5#1)(2008-3#1)
with rainfall##6##2##(1991-11#1)(2008-10#3)(2010-2#1)(2013-7#1)
with raised blood##2##3##(1990-5#1)(2010-12#1)
with raised plasma##2##3##(2005-10#1)(2010-12#1)
with raised##9##2##(1990-5#1)(1991-12#1)(1991-2#1)(1993-1#1)(2005-10#1)(2007-7#1)(2007-8#1)(2010-12#2)
with random amplified polymorphic DNA (RAPD)##3##6##(2008-10#3)
with random amplified polymorphic DNA##4##5##(2008-10#4)
with random and##2##3##(2008-2#1)(2012-2#1)
with random effects##3##3##(1996-3#1)(2011-1#1)(2012-2#1)
with random sequences##2##3##(1996-4#1)(2008-11#1)
with random tilt errors##2##4##(2008-2#2)
with random zeta potential##2##4##(2005-11#2)
with random##40##2##(1992-9#1)(1994-10#1)(1995-9#1)(1996-3#1)(1996-4#1)(1997-8#1)(2005-11#2)(2007-11#1)(2007-12#6)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#6)(2011-1#2)(2011-2#1)(2012-2#3)(2013-1#1)
with randomized##3##2##(1993-12#1)(2005-3#1)(2008-5#1)
with randomly distributed##2##3##(2007-12#1)(2008-10#1)
with randomly##3##2##(2007-12#1)(2008-10#2)
with range of##2##3##(2007-3#1)(2007-7#1)
with range##3##2##(2007-3#1)(2007-7#1)(2008-2#1)
with ranges##2##2##(2008-10#2)
with rapid and##2##3##(2006-10#1)(2009-8#1)
with rapid progression##4##3##(2006-10#1)(2008-1#1)(2009-10#1)(2011-2#1)
with rapid##46##2##(1991-12#1)(1992-10#1)(1994-6#1)(1995-10#1)(1995-2#2)(1995-5#1)(1995-7#1)(1996-11#1)(1996-4#1)(1997-3#1)(1997-8#2)(2006-10#2)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-6#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#1)
with rapid-acting insulin analogues##2##4##(2006-1#1)(2007-11#1)
with rapid-cycling bipolar disorder##3##4##(1996-7#3)
with rapidly##5##2##(1990-6#1)(1992-10#1)(1992-6#1)(2011-2#1)(2012-12#1)
with rapsyn##2##2##(1996-1#2)
with rare and common variants##2##5##(2012-3#2)
with rare and common##5##4##(2010-5#1)(2012-3#4)
with rare exceptions##2##3##(2008-12#1)(2012-3#1)
with rare variants in##3##4##(2012-3#3)
with rare variants##5##3##(2012-3#5)
with rare##30##2##(1992-6#1)(1993-6#1)(1996-4#1)(2006-3#1)(2006-6#1)(2007-12#2)(2008-10#2)(2008-12#1)(2009-5#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#13)(2013-8#1)
with ras##3##2##(1992-11#1)(1995-8#1)(2008-11#1)
with rat ALR##2##3##(2008-8#2)
with rat and human##2##4##(1994-12#1)(1996-12#1)
with rat and##5##3##(1990-12#1)(1990-7#1)(1991-4#1)(1994-12#1)(1996-12#1)
with rat hepatic##2##3##(1990-11#1)(1995-2#1)
with rat liver microsomes in the presence of##2##8##(1991-5#1)(1995-6#1)
with rat liver microsomes##3##4##(1991-5#1)(1991-7#1)(1995-6#1)
with rat liver##8##3##(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1993-12#1)(1994-8#1)(1995-6#1)
with rat type##2##3##(1996-4#1)(1997-5#1)
with rat##32##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#2)(1990-7#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-4#1)(1997-4#1)(1997-5#1)(2008-11#1)(2008-4#1)(2008-8#2)(2009-9#1)
with rate constant##3##3##(1997-1#3)
with rate##10##2##(1997-1#3)(2008-10#3)(2008-5#1)(2010-11#1)(2010-2#2)
with rates of##4##3##(1992-12#1)(2008-5#1)(2011-1#1)(2011-2#1)
with rates##9##2##(1992-12#1)(1992-6#1)(1994-11#1)(2008-10#1)(2008-5#1)(2009-6#1)(2011-1#1)(2011-2#2)
with rather high##2##3##(1991-11#1)(2008-10#1)
with rather##5##2##(1991-11#1)(2005-11#1)(2008-10#1)(2008-4#1)(2012-11#1)
with rational##3##2##(2008-7#1)(2010-11#1)(2011-2#1)
with ratios##2##2##(1992-3#1)(2008-2#1)
with rats##6##2##(1990-5#2)(2008-11#1)(2008-5#3)
with raw##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
with ray blight in##2##4##(2008-10#2)
with ray blight##7##3##(2008-10#7)
with ray tracing##2##3##(2008-2#1)(2008-3#1)
with ray##11##2##(2008-10#8)(2008-2#2)(2008-3#1)
with ray-tracing##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
with reaching##3##2##(1996-2#1)(2011-2#1)(2012-1#1)
with reaction time##2##3##(2008-5#1)(2013-1#1)
with reaction##7##2##(1996-7#1)(1997-4#1)(2008-5#1)(2010-2#2)(2010-6#1)(2013-1#1)
with reactions##3##2##(2008-10#2)(2008-2#1)
with reactive oxygen species##4##4##(1993-11#1)(2008-4#1)(2008-7#1)(2011-1#1)
with reactive oxygen##6##3##(1993-11#1)(1994-3#1)(2008-4#1)(2008-7#1)(2009-8#1)(2011-1#1)
with reactive##11##2##(1990-12#1)(1993-11#2)(1994-3#1)(1995-6#1)(2004-9#1)(2008-4#1)(2008-7#1)(2009-8#2)(2011-1#1)
with reading##7##2##(2004-10#4)(2010-2#2)(2011-2#1)
with reagent##7##2##(1992-3#1)(2007-8#2)(2008-10#3)(2009-10#1)
with real data##2##3##(2008-2#1)(2008-3#1)
with real time##2##3##(2011-2#1)(2013-1#1)
with real##18##2##(1993-2#1)(2004-12#1)(2005-11#1)(2008-10#1)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
with real-time PCR and##3##4##(2008-10#2)(2012-2#1)
with real-time PCR##6##3##(2008-10#4)(2010-4#1)(2012-2#1)
with real-time data##2##3##(2008-4#1)(2008-8#1)
with real-time polymerase chain reaction##4##5##(2008-10#2)(2013-1#2)
with real-time quantitative polymerase chain reaction##2##6##(2007-12#1)(2008-10#1)
with real-time##25##2##(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#7)(2008-3#1)(2008-4#2)(2008-8#1)(2009-2#1)(2009-4#1)(2010-4#1)(2012-2#2)(2012-3#1)(2013-1#3)
with realistic##6##2##(2007-12#2)(2008-2#2)(2008-3#2)
with reasonable accuracy##2##3##(2008-2#1)(2008-7#1)
with reasonable##14##2##(1993-11#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-7#1)(2012-2#1)(2012-3#1)(2013-1#2)
with reasonably##2##2##(2007-12#1)(2008-10#1)
with receiver operating characteristic##2##4##(2008-10#2)
with recent advances in##2##4##(2006-10#1)(2010-5#1)
with recent advances##3##3##(2006-10#1)(2008-8#1)(2010-5#1)
with recent developments in##3##4##(2005-7#1)(2006-10#1)(2008-2#1)
with recent experimental results##2##4##(2007-11#1)(2008-10#1)
with recent experimental##4##3##(1996-8#1)(2007-11#1)(2007-12#1)(2008-10#1)
with recent onset of##3##4##(2012-12#1)(2013-1#2)
with recent onset##4##3##(1997-8#1)(2012-12#1)(2013-1#2)
with recent published##2##3##(1995-11#1)(2006-6#1)
with recent reports##4##3##(1990-5#1)(1991-2#1)(1993-12#1)(2007-8#1)
with recent studies##2##3##(1994-8#1)(2006-10#1)
with recent theoretical predictions##3##4##(2007-12#2)(2007-5#1)
with recent theoretical##4##3##(2007-12#2)(2007-5#1)(2008-3#1)
with recent##70##2##(1990-3#1)(1990-5#1)(1991-2#1)(1991-6#2)(1993-12#1)(1994-8#1)(1995-11#1)(1996-2#1)(1996-6#2)(1996-8#1)(1997-8#1)(2005-12#1)(2005-7#1)(2006-10#4)(2006-11#1)(2006-6#1)(2007-10#3)(2007-11#1)(2007-12#5)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-10#2)(2008-2#3)(2008-3#2)(2008-5#1)(2008-8#3)(2008-9#2)(2009-2#1)(2009-3#2)(2009-8#1)(2010-5#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#2)
with recent-onset##3##2##(2007-7#1)(2008-11#2)
with recently developed##2##3##(2007-12#1)(2012-3#1)
with recently diagnosed##2##3##(1994-2#1)(2006-10#1)
with recently discovered##2##3##(1994-6#1)(2011-12#1)
with recently published##2##3##(2008-2#1)(2012-3#1)
with recently##15##2##(1994-2#1)(1994-6#1)(1996-4#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-2#1)(2008-6#1)(2009-6#1)(2010-8#1)(2011-12#1)(2012-3#2)
with receptive##2##2##(1993-7#1)(2007-9#1)
with receptor##8##2##(1990-11#1)(1990-4#1)(1992-3#1)(1993-6#1)(1995-3#1)(1996-12#1)(2008-4#1)(2008-8#1)
with receptors for##2##3##(1994-2#1)(2008-4#1)
with receptors##8##2##(1991-1#1)(1991-5#1)(1992-12#1)(1994-2#1)(1997-6#1)(2008-4#2)(2012-1#1)
with recessive##3##2##(1992-2#1)(2011-1#1)(2012-3#1)
with recipient##3##2##(2008-1#1)(2013-1#2)
with reciprocal##2##2##(2007-8#1)(2008-5#1)
with recognition of##2##3##(2008-4#1)(2012-11#1)
with recognition##4##2##(2006-7#1)(2007-2#1)(2008-4#1)(2012-11#1)
with recombinant baculovirus##5##3##(1994-10#1)(1995-5#1)(1997-4#1)(2008-2#1)(2010-2#1)
with recombinant baculoviruses##3##3##(1992-8#1)(1997-8#1)(2008-7#1)
with recombinant human erythropoietin##3##4##(2005-10#1)(2007-11#1)(2007-7#1)
with recombinant human insulin-like growth factor-I##2##6##(1993-9#1)(2006-9#1)
with recombinant human interleukin-1##2##4##(1992-1#2)
with recombinant human##13##3##(1992-1#2)(1992-9#1)(1993-9#1)(1995-12#1)(1995-2#1)(2005-10#2)(2006-9#1)(2007-11#2)(2007-7#1)(2011-2#1)
with recombinant tissue plasminogen activator##4##5##(2007-10#1)(2007-7#1)(2009-11#1)(2013-7#1)
with recombinant tissue-type plasminogen activator##2##5##(1990-11#1)(1992-10#1)
with recombinant virus##2##3##(1994-11#1)(1997-4#1)
with recombinant##73##2##(1990-11#1)(1990-2#1)(1991-10#1)(1991-12#2)(1991-5#1)(1991-8#1)(1992-1#2)(1992-10#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-5#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-4#5)(1997-7#1)(1997-8#2)(2005-10#2)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-7#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#2)(2009-12#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-7#1)
with recombination##2##2##(2008-10#2)
with recommendations for future research##2##5##(2006-1#1)(2012-12#1)
with recommendations for future##3##4##(1996-12#1)(2006-1#1)(2012-12#1)
with recommendations for##8##3##(1996-12#1)(2006-1#1)(2008-11#1)(2008-2#1)(2010-5#1)(2011-2#2)(2012-12#1)
with recommendations to##2##3##(2009-4#1)(2013-1#1)
with recommendations##17##2##(1995-12#1)(1996-12#1)(2005-11#1)(2006-1#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-2#2)(2009-4#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#2)
with reconstituted##3##2##(1990-3#1)(1994-12#1)(2013-1#1)
with reconstruction of the##3##4##(1990-6#1)(2007-7#1)(2013-8#1)
with reconstruction##7##2##(1990-6#1)(2007-7#1)(2008-7#1)(2009-2#1)(2009-3#1)(2011-2#1)(2013-8#1)
with recorded##3##2##(2004-10#1)(2007-12#1)(2008-5#1)
with recording##2##2##(2007-12#1)(2008-11#1)
with recoveries between##3##3##(2008-10#3)
with recoveries of##4##3##(2008-10#4)
with recoveries ranging from##2##4##(2008-10#2)
with recoveries ranging##3##3##(2008-10#3)
with recoveries##15##2##(1994-5#1)(2008-10#14)
with recovery of##4##3##(1990-3#1)(1995-11#1)(2008-1#1)(2008-10#1)
with recovery##15##2##(1990-3#1)(1995-11#1)(2008-1#1)(2008-10#7)(2008-3#1)(2008-8#2)(2009-8#1)(2012-12#1)
with rectal cancer##6##3##(2006-8#1)(2007-4#1)(2008-10#2)(2009-9#1)(2013-8#1)
with rectal##11##2##(1990-2#1)(1993-5#1)(2006-8#2)(2007-4#1)(2008-10#2)(2009-9#1)(2010-2#1)(2012-2#1)(2013-8#1)
with rectangular##3##2##(1996-2#1)(2008-3#1)(2012-2#1)
with recurrence after##2##3##(2008-3#1)(2011-2#1)
with recurrence and##4##3##(1995-4#1)(1996-6#1)(2006-10#1)(2010-7#1)
with recurrence##16##2##(1995-10#2)(1995-4#1)(1996-6#2)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-7#3)(2011-2#1)(2012-2#1)
with recurrences##2##2##(1997-8#1)(2006-6#1)
with recurrent abdominal pain##4##4##(1990-8#1)(1991-10#1)(1993-8#2)
with recurrent acute otitis media and##5##6##(2007-9#5)
with recurrent acute otitis media##7##5##(2007-9#7)
with recurrent acute otitis##8##4##(2007-9#8)
with recurrent acute##9##3##(2007-9#8)(2010-7#1)
with recurrent atrial fibrillation##2##4##(2007-8#2)
with recurrent bouts of abdominal pain##2##6##(1991-2#1)(2011-2#1)
with recurrent bouts of##3##4##(1991-2#1)(2011-2#2)
with recurrent disease##3##3##(2007-7#1)(2007-8#1)(2011-12#1)
with recurrent episodes of##9##4##(2005-11#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-6#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
with recurrent episodes##10##3##(1996-7#1)(2005-11#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-6#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
with recurrent epistaxis##2##3##(2007-10#2)
with recurrent head and neck##2##5##(2007-7#1)(2008-5#1)
with recurrent herpes##2##3##(2005-11#1)(2013-1#1)
with recurrent infections##2##3##(1991-6#1)(2007-11#1)
with recurrent major depression##4##4##(1995-11#1)(1996-3#1)(1996-7#2)
with recurrent meningitis##2##3##(2013-7#2)
with recurrent or##5##3##(2008-1#1)(2008-5#1)(2008-6#1)(2010-5#1)(2013-1#1)
with recurrent pregnancy loss##3##4##(2011-2#3)
with recurrent respiratory infections##4##4##(2005-11#3)(2011-2#1)
with recurrent respiratory##6##3##(2005-11#3)(2006-2#1)(2011-2#1)(2013-8#1)
with recurrent severe##2##3##(2007-7#1)(2012-12#1)
with recurrent transient ischemic attacks##2##5##(2007-8#1)(2012-3#1)
with recurrent urinary tract##3##4##(1990-11#1)(2008-10#1)(2013-1#1)
with recurrent vulvovaginal##2##3##(2007-10#1)(2008-5#1)
with recurrent##144##2##(1990-11#1)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-2#1)(1991-4#1)(1991-6#2)(1992-5#2)(1993-2#1)(1993-8#2)(1994-1#1)(1994-12#2)(1994-8#1)(1995-1#1)(1995-11#1)(1996-3#1)(1996-7#3)(2004-10#2)(2005-11#6)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-7#3)(2006-8#2)(2006-9#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#4)(2007-5#1)(2007-7#5)(2007-8#8)(2007-9#8)(2008-1#4)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#4)(2008-6#5)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#6)(2011-12#2)(2011-2#8)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#3)
with recurring##2##2##(1996-2#1)(2010-2#1)
with recycling##2##2##(1996-1#1)(2008-10#1)
with red and##2##3##(2007-11#1)(2007-8#1)
with red blood cell##2##4##(1993-3#1)(2006-4#1)
with red blood##3##3##(1993-3#1)(2006-4#1)(2008-2#1)
with red cells##5##3##(1990-12#1)(1992-9#1)(1993-12#1)(1994-3#2)
with red light in##3##4##(2007-12#2)(2008-5#1)
with red light##10##3##(1990-11#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-5#1)(2012-2#1)
with red##33##2##(1990-11#1)(1990-12#1)(1992-9#1)(1993-12#2)(1993-3#1)(1994-3#2)(2006-4#1)(2007-11#2)(2007-12#5)(2007-8#4)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#4)(2009-2#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
with redox##3##2##(1994-3#1)(2008-10#1)(2011-2#1)
with reduced activity##2##3##(1992-9#1)(2009-10#1)
with reduced affinity##3##3##(1990-11#1)(1993-8#1)(2013-7#1)
with reduced doses of##3##4##(1993-8#1)(2007-11#1)(2011-1#1)
with reduced expression of##2##4##(1996-3#1)(2010-7#1)
with reduced function##2##3##(1994-3#1)(2006-10#1)
with reduced growth##2##3##(2010-4#1)(2011-1#1)
with reduced incidence of##2##4##(2008-10#1)(2010-1#1)
with reduced levels of##2##4##(2010-12#1)(2011-2#1)
with reduced morbidity and##2##4##(2008-7#1)(2009-4#1)
with reduced risk of##5##4##(2005-10#1)(2008-7#1)(2010-1#1)(2012-1#1)(2012-2#1)
with reduced toxicity##2##3##(1995-8#1)(2008-8#1)
with reduced##131##2##(1990-11#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-12#1)(1992-12#1)(1992-9#1)(1993-8#5)(1994-11#2)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-8#1)(2004-4#1)(2005-10#2)(2005-12#2)(2006-10#5)(2006-6#1)(2007-11#1)(2007-12#5)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#7)(2008-7#6)(2008-8#3)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-11#1)(2011-2#6)(2012-1#3)(2012-12#5)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#1)(2013-7#4)(2013-8#1)
with reducing##3##2##(1992-12#1)(2006-8#1)(2008-10#1)
with reduction in serum##2##4##(2010-8#1)(2011-2#1)
with reduction in##6##3##(2008-10#2)(2008-7#1)(2010-5#1)(2010-8#1)(2011-2#1)
with reduction of haemoglobin##2##4##(2013-1#2)
with reduction of the##6##4##(1992-6#1)(1993-10#1)(1995-11#1)(2007-8#1)(2008-1#1)(2008-10#1)
with reduction of##15##3##(1992-5#1)(1992-6#1)(1993-10#1)(1995-11#1)(2007-8#1)(2008-1#2)(2008-10#2)(2009-8#1)(2010-12#2)(2013-1#3)
with reduction##26##2##(1992-5#1)(1992-6#1)(1993-10#1)(1995-11#1)(1995-2#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#3)(2013-8#1)
with reductions in the##4##4##(2005-7#1)(2008-10#2)(2008-5#1)
with reductions in##9##3##(1995-8#1)(2005-7#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
with reductions##10##2##(1995-8#1)(2005-7#1)(2008-10#3)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
with redundant##2##2##(1996-3#1)(2007-5#1)
with reference data##2##3##(2007-8#1)(2011-2#1)
with reference to a##5##4##(1992-6#1)(1993-2#1)(1996-12#1)(2006-8#1)(2008-1#1)
with reference to recent##3##4##(1990-5#1)(1997-7#1)(2007-12#1)
with reference to the literature##3##5##(2006-2#1)(2008-10#1)(2008-11#1)
with reference to the##20##4##(1990-3#1)(1990-4#1)(1990-5#1)(1991-6#1)(1993-7#1)(1996-9#1)(1997-1#1)(2005-7#1)(2006-11#1)(2006-2#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-9#1)(2012-11#1)
with reference to##66##3##(1990-3#1)(1990-4#1)(1990-5#3)(1991-4#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-7#1)(1994-11#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-7#2)(2004-4#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-8#1)(2007-12#3)(2007-7#3)(2008-1#4)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#1)(2008-7#5)(2008-8#3)(2008-9#2)(2010-2#1)(2011-1#2)(2011-2#1)(2012-11#1)(2013-7#2)
with reference values##5##3##(1992-2#1)(2007-12#1)(2008-10#2)(2010-9#1)
with reference##86##2##(1990-3#1)(1990-4#1)(1990-5#3)(1991-4#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-6#2)(1993-2#1)(1993-7#1)(1994-11#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-7#2)(2004-4#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-12#4)(2007-7#3)(2007-8#1)(2008-1#4)(2008-10#9)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#3)(2008-7#5)(2008-8#3)(2008-9#2)(2009-2#1)(2010-2#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-11#1)(2013-7#2)
with references##4##2##(1992-11#1)(2008-4#1)(2008-7#1)(2011-2#1)
with referral##2##2##(2005-10#1)(2006-8#1)
with referred pain##2##3##(2006-1#1)(2006-8#1)
with referred##3##2##(2006-1#1)(2006-12#1)(2006-8#1)
with referring physicians and##2##4##(1990-12#1)(2007-4#1)
with referring physicians will##2##4##(1995-12#1)(2006-10#1)
with referring physicians##6##3##(1990-12#1)(1995-1#1)(1995-12#1)(2006-10#1)(2007-4#2)
with refined##2##2##(2005-11#1)(2007-6#1)
with reflection##2##2##(2008-2#2)
with reflections on##2##3##(2009-4#1)(2011-2#1)
with reflections##3##2##(1996-9#1)(2009-4#1)(2011-2#1)
with reflex sympathetic dystrophy syndrome##2##5##(1992-11#1)(1992-3#1)
with reflex sympathetic dystrophy##8##4##(1992-11#3)(1992-3#1)(2006-10#1)(2007-11#2)(2008-7#1)
with reflux esophagitis##3##3##(2008-12#1)(2008-5#1)(2013-8#1)
with reflux symptoms##3##3##(1990-10#1)(1993-3#1)(2006-2#1)
with reflux##8##2##(1990-10#2)(1993-3#1)(2006-2#1)(2008-12#1)(2008-4#1)(2008-5#1)(2013-8#1)
with reform##2##2##(1993-12#1)(1995-2#1)
with refractive index##3##3##(1991-7#1)(1992-1#1)(2008-3#1)
with refractive indices##4##3##(2008-1#1)(2008-2#3)
with refractive##10##2##(1991-7#1)(1992-1#1)(2007-12#1)(2008-1#1)(2008-2#3)(2008-3#2)(2010-8#1)
with refractory angina##2##3##(2008-12#1)(2010-6#1)
with refractory hypertension##2##3##(1990-9#1)(2008-1#1)
with refractory non-insulin mediated hypoglycaemia##2##5##(2011-1#2)
with refractory##33##2##(1990-3#1)(1990-9#1)(1995-6#1)(1996-1#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-5#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#3)(2012-12#1)(2013-1#3)
with regard to a##2##4##(1997-7#1)(2005-11#1)
with regard to age##5##4##(1995-9#1)(2008-4#1)(2008-6#2)(2011-2#1)
with regard to basic##2##4##(2006-9#1)(2007-12#1)
with regard to both##2##4##(1996-10#1)(2007-12#1)
with regard to clinical##2##4##(1993-11#1)(2007-2#1)
with regard to drinking##2##4##(1994-2#1)(2007-2#1)
with regard to future research##2##5##(1996-8#1)(2008-12#1)
with regard to future##4##4##(1996-8#1)(2008-12#1)(2012-1#1)(2013-8#1)
with regard to how##2##4##(2006-10#1)(2008-10#1)
with regard to improved##2##4##(2008-3#1)(2011-2#1)
with regard to its##9##4##(1990-2#1)(1990-5#1)(1990-6#1)(1992-11#1)(1993-4#1)(2006-6#1)(2008-2#1)(2012-3#1)(2013-1#1)
with regard to other##2##4##(2006-12#1)(2008-2#1)
with regard to pain##2##4##(2008-12#1)(2012-2#1)
with regard to previous##2##4##(2006-4#1)(2008-12#1)
with regard to prognosis##2##4##(1993-9#1)(2010-11#1)
with regard to psychiatric##2##4##(2007-9#2)
with regard to pulmonary##2##4##(2007-10#1)(2010-9#1)
with regard to risk##2##4##(2006-10#1)(2011-2#1)
with regard to the development##2##5##(2007-11#2)
with regard to the introduction##2##5##(2006-10#1)(2008-12#1)
with regard to the use of##2##6##(2006-10#1)(2011-2#1)
with regard to the##75##4##(1990-10#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#2)(1991-5#1)(1991-7#1)(1992-1#1)(1992-8#1)(1993-3#2)(1994-11#2)(1995-1#1)(1995-10#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-4#1)(2006-10#6)(2006-11#2)(2006-2#1)(2006-6#2)(2007-11#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-3#2)(2010-5#2)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#3)
with regard to their ability to##2##6##(2009-8#1)(2010-12#1)
with regard to their low##2##5##(1996-1#1)(2010-4#1)
with regard to their##19##4##(1995-1#1)(1995-12#1)(1995-5#1)(1996-1#1)(2006-10#2)(2006-11#1)(2007-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-4#1)
with regard to therapeutic##2##4##(2006-10#1)(2012-12#1)
with regard to these##3##4##(1995-2#1)(2008-9#1)(2011-1#1)
with regard to what##2##4##(1994-6#1)(2008-12#1)
with regard to##340##3##(1990-10#3)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#3)(1990-8#2)(1990-9#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-4#2)(1992-8#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-3#3)(1993-4#1)(1993-6#2)(1993-9#1)(1994-11#4)(1994-2#1)(1994-3#2)(1994-6#2)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#3)(1995-9#3)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#3)(1996-9#2)(1997-2#2)(1997-4#1)(1997-7#3)(1997-8#2)(2004-10#1)(2004-11#1)(2004-2#1)(2005-11#2)(2005-4#1)(2005-8#1)(2006-10#15)(2006-11#4)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#4)(2006-7#2)(2006-8#5)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#8)(2007-2#3)(2007-3#2)(2007-4#4)(2007-5#1)(2007-7#4)(2007-8#3)(2007-9#4)(2008-1#2)(2008-10#23)(2008-11#15)(2008-12#8)(2008-2#8)(2008-3#5)(2008-4#4)(2008-5#5)(2008-6#5)(2008-7#5)(2008-8#2)(2008-9#6)(2009-10#1)(2009-11#3)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#4)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#4)(2011-10#1)(2011-2#9)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#4)(2012-3#4)(2012-9#1)(2013-1#4)(2013-8#6)
with regard##341##2##(1990-10#3)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#3)(1990-8#2)(1990-9#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-4#2)(1992-8#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-3#3)(1993-4#1)(1993-6#2)(1993-9#1)(1994-11#4)(1994-2#1)(1994-3#2)(1994-6#2)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#3)(1995-9#3)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#3)(1996-9#2)(1997-2#2)(1997-4#1)(1997-7#3)(1997-8#2)(2004-10#1)(2004-11#1)(2004-2#1)(2005-11#2)(2005-4#1)(2005-8#1)(2006-10#15)(2006-11#4)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#4)(2006-7#2)(2006-8#5)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#8)(2007-2#3)(2007-3#2)(2007-4#4)(2007-5#1)(2007-7#4)(2007-8#3)(2007-9#4)(2008-1#2)(2008-10#23)(2008-11#15)(2008-12#8)(2008-2#8)(2008-3#5)(2008-4#4)(2008-5#5)(2008-6#5)(2008-7#5)(2008-8#2)(2008-9#6)(2009-10#1)(2009-11#3)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#4)(2010-4#3)(2010-5#4)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#4)(2011-10#1)(2011-2#9)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#4)(2012-3#4)(2012-9#1)(2013-1#4)(2013-8#6)
with regards to its##2##4##(2008-7#1)(2013-8#1)
with regards to the##11##4##(1996-9#1)(2006-2#1)(2006-8#1)(2008-6#1)(2009-10#1)(2009-3#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-8#1)
with regards to their##3##4##(2007-12#1)(2008-10#1)(2009-3#1)
with regards to##37##3##(1993-4#1)(1996-9#1)(2006-2#1)(2006-5#1)(2006-8#3)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-3#2)(2009-8#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
with regeneration##2##2##(1991-3#1)(1991-4#1)
with regional anesthesia##3##3##(1990-12#2)(2006-10#1)
with regional##14##2##(1990-12#3)(1992-6#1)(1994-3#1)(2006-10#1)(2010-8#3)(2011-1#1)(2012-12#2)(2013-1#1)(2013-7#1)
with regions of##4##3##(1990-7#1)(2008-3#1)(2013-1#2)
with regions##6##2##(1990-7#1)(2008-11#1)(2008-3#1)(2012-1#1)(2013-1#2)
with registered nurses##2##3##(2008-12#1)(2008-7#1)
with regression coefficients##3##3##(2008-10#3)
with regression##7##2##(2007-10#1)(2008-10#3)(2008-6#1)(2008-9#1)(2010-2#1)
with regular and##2##3##(2009-7#1)(2010-10#1)
with regular clients and non-paying partners##2##6##(2012-3#2)
with regular##29##2##(1990-3#1)(1991-12#1)(1996-11#1)(1996-6#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-12#1)(2008-2#2)(2008-5#1)(2009-2#2)(2009-7#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#4)(2013-8#1)
with regulated##4##2##(1995-12#1)(2008-10#1)(2008-2#2)
with regulation of##4##3##(1991-3#1)(1995-11#1)(2006-12#1)(2007-11#1)
with regulations##3##2##(2006-8#2)(2009-11#1)
with regulatory agencies##2##3##(1992-3#1)(2007-11#1)
with regulatory##6##2##(1992-3#1)(1992-8#1)(1993-9#1)(2007-11#1)(2007-5#1)(2008-7#1)
with rehabilitation##2##2##(2006-3#1)(2012-1#1)
with reimplantation##2##2##(2006-9#1)(2008-9#1)
with reinforcement##2##2##(2011-2#1)(2012-1#1)
with rejection##4##2##(1995-2#3)(1995-5#1)
with relapse of##2##3##(2007-11#1)(2007-8#1)
with relapse##6##2##(1993-11#1)(2007-11#1)(2007-8#2)(2009-11#1)(2010-4#1)
with relapsed##12##2##(1992-10#1)(2007-10#2)(2007-11#1)(2008-1#1)(2008-6#1)(2009-4#1)(2010-11#3)(2010-4#2)
with relapses##2##2##(1995-8#1)(2010-12#1)
with relapsing polychondritis##3##3##(2006-10#3)
with relapsing##5##2##(2006-10#3)(2007-11#1)(2010-12#1)
with related members of the##2##5##(1994-2#1)(2008-5#1)
with related##20##2##(1990-7#1)(1991-8#1)(1992-3#1)(1994-2#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-2#1)(2005-7#1)(2006-10#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-9#1)(2010-12#1)(2012-2#1)(2013-1#1)
with relation to##6##3##(2007-11#1)(2008-10#2)(2008-7#1)(2009-3#1)(2013-1#1)
with relationships##3##2##(2007-3#1)(2008-7#1)(2011-12#1)
with relative S##2##3##(2008-10#2)
with relative body weights##4##4##(1992-4#4)
with relative ease##3##3##(2007-8#1)(2008-7#1)(2011-2#1)
with relative error##3##3##(2008-10#3)
with relative errors##2##3##(2008-10#2)
with relative molecular masses##3##4##(1990-11#1)(1990-5#1)(1994-6#1)
with relative risk##2##3##(1997-5#1)(2011-2#1)
with relative standard deviation (RSD)##3##5##(2008-10#3)
with relative standard deviation of 2##2##6##(2008-10#2)
with relative standard deviation of 3##2##6##(2005-4#1)(2008-10#1)
with relative standard deviation of##4##5##(2005-4#1)(2008-10#3)
with relative standard deviation##11##4##(2005-4#1)(2008-10#10)
with relative standard deviations (R##4##5##(1996-8#2)(2007-8#1)(2008-10#1)
with relative standard deviations (RSDs)##2##5##(2008-10#1)(2011-1#1)
with relative standard deviations of 2##3##6##(2008-10#3)
with relative standard deviations of less than 1##2##8##(2007-10#1)(2008-10#1)
with relative standard deviations of less than##3##7##(2007-10#1)(2008-10#2)
with relative standard deviations of##8##5##(1992-1#1)(2007-10#1)(2008-10#6)
with relative standard deviations##19##4##(1992-1#1)(1994-9#1)(1996-8#2)(2007-10#1)(2007-8#2)(2008-10#10)(2008-5#1)(2011-1#1)
with relative standard##30##3##(1992-1#1)(1994-9#1)(1996-8#2)(2005-4#1)(2007-10#1)(2007-8#2)(2008-10#20)(2008-5#1)(2011-1#1)
with relative##70##2##(1990-11#1)(1990-12#1)(1990-5#2)(1991-5#1)(1991-8#1)(1992-1#1)(1992-4#4)(1993-6#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-8#2)(1997-5#1)(2005-4#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-8#3)(2008-10#27)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2009-3#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#3)(2013-7#1)
with relatively advanced disease##2##4##(1996-11#1)(2006-10#1)
with relatively few##5##3##(1991-12#1)(2008-3#1)(2008-8#1)(2010-5#1)(2011-1#1)
with relatively good##2##3##(2008-1#1)(2009-11#1)
with relatively high sensitivity##3##4##(2008-10#3)
with relatively high##13##3##(1990-4#1)(2006-5#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-8#1)(2010-9#1)(2012-3#1)
with relatively large##2##3##(1994-12#1)(2008-3#1)
with relatively little##3##3##(1995-1#1)(1996-12#1)(2007-3#1)
with relatively low##13##3##(1992-7#1)(1996-12#1)(2005-12#1)(2005-8#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2010-10#1)(2010-5#1)(2012-2#1)
with relatively minor##4##3##(2006-12#1)(2008-10#1)(2010-2#1)(2012-2#1)
with relatively short##6##3##(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#2)
with relatively simple##2##3##(2008-3#1)(2008-7#1)
with relatively small numbers of patients##2##6##(2007-5#1)(2008-1#1)
with relatively small##7##3##(2007-5#1)(2008-1#1)(2008-10#2)(2008-3#1)(2013-1#2)
with relatively##72##2##(1990-2#1)(1990-4#1)(1991-12#1)(1991-5#1)(1992-7#1)(1994-12#1)(1995-1#1)(1996-11#1)(1996-12#2)(2004-12#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#12)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2009-11#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
with relatives##3##2##(1993-8#1)(2008-7#1)(2011-12#1)
with relaxation##5##2##(1990-5#1)(1994-8#1)(1997-7#1)(2009-10#1)(2010-7#1)
with release of##8##3##(1990-3#1)(1991-4#1)(1993-7#1)(1994-8#1)(1996-7#1)(2008-4#1)(2008-7#1)(2010-11#1)
with release##9##2##(1990-3#1)(1991-4#1)(1992-3#1)(1993-7#1)(1994-8#1)(1996-7#1)(2008-4#1)(2008-7#1)(2010-11#1)
with relevance to the##2##4##(2008-11#1)(2008-4#1)
with relevance to##8##3##(1991-7#1)(2005-10#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-4#1)(2009-4#1)(2012-8#1)
with relevance##9##2##(1991-7#1)(2005-10#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-4#1)(2009-4#1)(2012-2#1)(2012-8#1)
with relevant clinical##2##3##(2012-1#1)(2012-2#1)
with relevant##18##2##(1992-4#1)(1993-5#1)(1996-10#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#2)
with reliability##2##2##(2008-10#1)(2009-7#1)
with reliable##3##2##(2011-2#1)(2012-1#1)(2013-8#1)
with relief##2##2##(1992-3#1)(2006-10#1)
with remarkable##12##2##(1991-2#1)(1994-3#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-5#1)(2009-12#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
with remarks on the##2##4##(2006-7#1)(2007-12#1)
with remembering##2##2##(2013-7#2)
with remifentanil##2##2##(2006-10#1)(2012-12#1)
with remote##4##2##(2004-9#1)(2008-10#1)(2008-8#1)(2009-5#1)
with removal of the##6##4##(1991-8#1)(1992-4#1)(2007-8#1)(2008-7#1)(2009-6#1)(2009-9#1)
with removal of##11##3##(1990-2#1)(1991-8#1)(1992-4#1)(1993-10#1)(1995-2#1)(2007-8#2)(2008-5#1)(2008-7#1)(2009-6#1)(2009-9#1)
with renal autotransplants##2##3##(2008-6#2)
with renal cell cancer##3##4##(2006-10#1)(2007-10#1)(2012-1#1)
with renal cell carcinoma##13##4##(1990-5#1)(1991-8#1)(1995-12#2)(1997-6#1)(2006-9#6)(2007-8#1)(2008-1#1)
with renal cell##17##3##(1990-5#1)(1991-8#1)(1995-12#2)(1997-6#1)(2006-10#1)(2006-9#6)(2007-10#1)(2007-8#1)(2008-1#1)(2011-1#1)(2012-1#1)
with renal damage##2##3##(1997-5#1)(1997-8#1)
with renal disease##6##3##(2006-10#1)(2007-12#2)(2007-7#2)(2013-1#1)
with renal dysfunction##3##3##(2006-10#1)(2012-3#2)
with renal failure and##3##4##(1994-9#1)(1997-3#1)(2009-6#1)
with renal failure##19##3##(1991-5#1)(1994-9#1)(1995-4#1)(1996-3#2)(1996-8#1)(1997-3#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-4#1)(2008-7#3)(2009-6#1)(2011-1#1)(2011-12#1)(2012-1#1)(2013-1#1)
with renal function##2##3##(2008-10#1)(2009-3#1)
with renal impairment##6##3##(1993-12#1)(1996-2#2)(2007-11#1)(2008-1#1)(2013-1#1)
with renal insufficiency are##2##4##(2006-10#1)(2007-11#1)
with renal insufficiency##7##3##(1990-1#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-11#1)(2013-1#2)
with renal or hepatic##2##4##(2005-7#1)(2012-3#1)
with renal or##3##3##(1994-6#1)(2005-7#1)(2012-3#1)
with renal replacement therapy##2##4##(2006-4#1)(2010-3#1)
with renal transplantation##2##3##(1997-3#1)(2008-1#1)
with renal##124##2##(1990-1#1)(1990-11#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1993-12#1)(1993-7#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-4#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-6#1)(1996-8#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-8#1)(2005-10#4)(2005-11#1)(2005-7#1)(2006-10#10)(2006-2#1)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#6)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#5)(2008-10#1)(2008-11#1)(2008-4#3)(2008-6#4)(2008-7#5)(2008-8#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#3)(2011-12#1)(2012-1#3)(2012-2#1)(2012-3#3)(2013-1#16)
with renewed##5##2##(1990-9#1)(1992-1#1)(2006-10#2)(2010-1#1)
with renin##2##2##(1991-5#1)(2008-11#1)
with renovascular hypertension##4##3##(1995-7#1)(2007-7#1)(2008-1#1)(2010-4#1)
with repair##2##2##(1991-8#1)(1995-1#1)
with repaired##3##2##(2009-8#2)(2013-1#1)
with repeat##6##2##(2006-8#1)(2008-11#4)(2009-10#1)
with repeated attacks of##2##4##(2005-8#1)(2006-10#1)
with repeated injections##2##3##(1991-5#1)(2013-8#1)
with repeated measures##4##3##(1996-2#2)(2008-9#1)(2010-12#1)
with repeated##32##2##(1991-5#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-6#1)(1996-10#1)(1996-2#2)(1996-6#1)(1997-6#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-5#1)(2008-9#1)(2010-12#2)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#5)
with reperfusion##4##2##(1991-9#1)(1997-1#1)(2006-10#1)(2008-3#1)
with repetition##2##2##(1997-7#1)(2007-12#1)
with repetitive anoxia##2##3##(1996-9#2)
with repetitive##14##2##(1991-5#1)(1996-9#2)(2006-10#1)(2007-11#1)(2008-10#3)(2008-11#3)(2008-4#1)(2011-2#1)(2012-3#1)
with replacement of the##2##4##(2007-8#2)
with replacement of##4##3##(2005-12#1)(2007-8#2)(2010-4#1)
with replacement##7##2##(1997-8#1)(2005-12#1)(2007-8#2)(2008-6#1)(2010-4#1)(2012-3#1)
with replica correlation functions##2##4##(2010-2#2)
with replicates##2##2##(2008-10#1)(2008-11#1)
with replication fork##2##3##(2012-3#2)
with replication##4##2##(1991-8#1)(2009-10#1)(2012-3#2)
with reported data##2##3##(1992-5#1)(2013-8#1)
with reported values##2##3##(2008-10#1)(2009-11#1)
with reported##14##2##(1992-5#1)(1993-6#1)(1996-12#1)(1996-5#1)(2008-10#2)(2008-9#1)(2009-11#2)(2009-3#1)(2012-1#1)(2012-2#1)(2013-8#2)
with reporter gene##2##3##(1997-1#1)(2008-9#1)
with reporter##6##2##(1997-1#1)(2008-10#1)(2008-11#2)(2008-9#1)(2013-8#1)
with reporting##2##2##(2005-9#1)(2007-11#1)
with reports from##2##3##(2012-1#1)(2013-8#1)
with reports of##7##3##(1997-3#1)(2006-7#1)(2008-8#1)(2010-2#1)(2010-4#1)(2012-12#2)
with reports##11##2##(1995-12#1)(1997-3#1)(2006-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-4#1)(2012-1#1)(2012-12#2)(2013-8#1)
with representative##7##2##(2006-12#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#3)
with representatives from##4##3##(2004-10#1)(2005-8#1)(2007-2#1)(2008-10#1)
with representatives of##3##3##(1996-6#1)(1997-2#1)(2008-10#1)
with representatives##7##2##(1996-6#1)(1997-2#1)(2004-10#1)(2005-8#1)(2007-2#1)(2008-10#2)
with reproducible##2##2##(2008-8#1)(2008-9#1)
with reproduction##2##2##(2007-1#1)(2013-1#1)
with reproductive##10##2##(1990-6#1)(1992-12#1)(2007-5#1)(2009-7#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)
with research and##2##3##(1990-11#1)(2005-7#1)
with research##10##2##(1990-11#1)(1996-1#1)(1996-2#1)(2005-7#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-2#1)(2011-2#1)
with researchers##2##2##(2008-11#1)(2010-11#1)
with resectable disease##2##3##(2008-3#1)(2012-2#1)
with resectable gastrointestinal##2##3##(2007-4#2)
with resectable##8##2##(1990-10#1)(1992-10#1)(2005-11#1)(2007-4#2)(2007-8#1)(2008-3#1)(2012-2#1)
with resected##6##2##(1993-10#1)(2007-4#2)(2007-8#1)(2008-5#1)(2010-11#1)
with resection of the##2##4##(1991-9#1)(2007-8#1)
with resection of##6##3##(1991-9#1)(2006-5#2)(2007-8#1)(2010-9#1)(2012-2#1)
with resection##13##2##(1991-9#1)(2006-10#1)(2006-5#2)(2007-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-2#1)(2010-9#1)(2012-2#1)(2012-3#2)
with reserpine or##2##3##(1990-5#1)(1993-2#1)
with reserpine##6##2##(1990-5#2)(1991-8#1)(1993-2#1)(1996-2#1)(1996-9#1)
with reservation##2##2##(1990-2#1)(2007-2#1)
with reservations##2##2##(1991-3#1)(1991-4#1)
with residential histories##2##3##(2008-6#2)
with residential proximity to the##2##5##(2005-11#1)(2006-12#1)
with residential##5##2##(2005-11#1)(2006-12#1)(2008-6#2)(2012-12#1)
with residents##6##2##(1992-1#1)(2008-11#3)(2011-1#1)(2011-2#1)
with residual bilinearization##3##3##(2010-5#3)
with residual or##2##3##(2006-12#1)(2011-2#1)
with residual##18##2##(1992-10#1)(1992-8#1)(1993-3#1)(2006-12#2)(2007-3#1)(2007-5#1)(2007-8#1)(2008-2#1)(2008-5#1)(2009-3#1)(2010-5#3)(2010-6#1)(2011-12#1)(2011-2#2)
with residues of the##2##4##(1994-8#1)(2008-10#1)
with residues of##6##3##(1990-10#1)(1994-8#1)(2007-7#1)(2008-10#3)
with residues##12##2##(1990-10#1)(1993-12#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#2)(1996-7#1)(2007-7#1)(2008-10#3)
with resilience##2##2##(2009-8#1)(2012-4#1)
with resin##2##2##(2008-10#1)(2008-5#1)
with resistance and tolerance##2##4##(2011-10#2)
with resistance and##3##3##(2008-10#1)(2011-10#2)
with resistance from##2##3##(2007-4#1)(2009-3#1)
with resistance to other NNRTIs##2##5##(2009-11#2)
with resistance to tan spot##2##5##(2008-10#2)
with resistance to the##2##4##(2008-10#1)(2013-8#1)
with resistance to two##2##4##(2008-10#2)
with resistance to##37##3##(1993-4#1)(1994-8#1)(1995-12#1)(1996-11#1)(2008-1#1)(2008-10#22)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#2)(2009-5#1)(2012-2#1)(2013-8#1)
with resistance##64##2##(1990-12#1)(1993-4#1)(1994-8#1)(1995-12#1)(1996-11#1)(2006-10#1)(2006-9#1)(2007-4#1)(2008-1#1)(2008-10#39)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-11#2)(2009-3#1)(2009-5#1)(2011-10#2)(2012-2#1)(2013-1#1)(2013-8#1)
with resistant genotypes##2##3##(2008-10#2)
with resistant##13##2##(1995-12#1)(2005-10#1)(2006-10#3)(2007-7#1)(2008-10#4)(2009-11#1)(2012-3#1)(2013-8#1)
with resolution of##8##3##(1990-3#1)(1994-11#1)(2006-8#1)(2008-2#1)(2008-3#1)(2011-2#2)(2012-12#1)
with resolution##10##2##(1990-3#1)(1994-11#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#2)(2012-12#1)
with resonance##2##2##(1996-7#1)(2008-2#1)
with resonant optical##2##3##(2007-12#2)
with resonant sideband extraction##3##4##(2008-2#3)
with resonant##8##2##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#2)
with resource##3##2##(1992-3#1)(2008-8#1)(2013-7#1)
with respect of##2##3##(1991-3#1)(2008-10#1)
with respect to (1)##2##4##(2007-8#1)(2010-2#1)
with respect to ATP##2##4##(1990-3#1)(1994-8#1)
with respect to DNA##3##4##(1995-2#1)(1996-7#1)(2010-2#1)
with respect to OS##2##4##(1992-10#2)
with respect to T##2##4##(2008-10#2)
with respect to W##2##4##(2008-10#2)
with respect to a large number of inorganic##2##8##(2008-10#2)
with respect to a large##4##5##(1990-12#1)(2008-10#3)
with respect to a reference##2##5##(2008-3#1)(2009-9#1)
with respect to a##19##4##(1990-12#1)(1992-3#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-2#1)(2006-12#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-12#1)(2012-2#1)(2012-3#1)
with respect to absorbed power##2##5##(2008-1#1)(2008-2#1)
with respect to absorbed##3##4##(2007-11#1)(2008-1#1)(2008-2#1)
with respect to absorption##2##4##(2008-10#1)(2008-2#1)
with respect to accuracy##3##4##(1996-3#1)(2008-10#1)(2008-7#1)
with respect to age##7##4##(1991-2#1)(1992-8#1)(1994-2#1)(1997-1#1)(2008-7#1)(2012-2#1)(2013-8#1)
with respect to all other##2##5##(1992-12#1)(2004-10#1)
with respect to all##3##4##(1992-12#1)(1996-12#1)(2004-10#1)
with respect to an##5##4##(1995-12#1)(1996-1#1)(2004-9#1)(2006-10#1)(2006-11#1)
with respect to another##2##4##(2008-3#1)(2009-10#1)
with respect to baseline##2##4##(2006-6#1)(2008-7#1)
with respect to both##16##4##(1991-12#1)(1991-3#2)(1992-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-5#1)(1997-7#1)(2005-11#1)(2007-1#2)(2008-5#1)(2009-8#1)(2012-1#1)
with respect to changes in the##2##6##(1991-6#1)(2008-3#1)
with respect to clinical and laboratory##2##6##(2006-8#1)(2011-1#1)
with respect to clinical and##3##5##(2006-8#1)(2008-6#1)(2011-1#1)
with respect to clinical presentation##2##5##(2007-6#1)(2008-1#1)
with respect to clinical##9##4##(1993-12#1)(2006-8#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-3#1)(2008-6#1)(2011-1#2)
with respect to common##3##4##(2008-10#3)
with respect to control animals##3##5##(2006-6#1)(2009-4#1)(2013-1#1)
with respect to control of##2##5##(1992-3#1)(2010-8#1)
with respect to control##6##4##(1992-3#1)(2006-6#1)(2009-4#1)(2009-5#1)(2010-8#1)(2013-1#1)
with respect to cortical space##2##5##(2008-1#2)
with respect to data##4##4##(2008-10#1)(2009-10#1)(2013-1#2)
with respect to different##5##4##(1993-8#1)(2008-6#2)(2008-7#1)(2013-8#1)
with respect to distance##2##4##(2007-11#1)(2009-6#1)
with respect to drug##2##4##(2008-10#1)(2008-4#1)
with respect to each other##5##5##(2006-12#1)(2007-11#2)(2008-3#1)(2011-1#1)
with respect to each##8##4##(2006-12#1)(2007-1#1)(2007-11#2)(2008-10#1)(2008-3#1)(2011-1#1)(2012-12#1)
with respect to educational requirements##2##5##(2007-6#2)
with respect to escalation##2##4##(2009-10#2)
with respect to existing##2##4##(2007-9#1)(2008-10#1)
with respect to exposure##2##4##(1994-2#1)(2008-2#1)
with respect to external##2##4##(2008-2#1)(2012-1#1)
with respect to female breast cancer##2##6##(1990-12#2)
with respect to gender distribution##2##5##(1991-12#1)(2008-9#1)
with respect to gender##5##4##(1991-12#1)(2007-9#1)(2008-9#1)(2011-2#1)(2012-12#1)
with respect to glucose##2##4##(1993-8#1)(1996-7#1)
with respect to gravity##3##4##(2008-11#3)
with respect to growth##2##4##(2008-10#1)(2011-2#1)
with respect to healthy##3##4##(1990-4#2)(2010-12#1)
with respect to human health##2##5##(2008-10#1)(2012-2#1)
with respect to important##2##4##(2007-8#1)(2011-2#1)
with respect to incidence##2##4##(1991-11#1)(2008-10#1)
with respect to increasing##2##4##(2008-3#1)(2010-3#1)
with respect to its ability to##2##6##(1995-12#1)(2008-10#1)
with respect to its biochemistry and##2##6##(2007-12#1)(2008-8#1)
with respect to its##19##4##(1990-12#1)(1992-12#2)(1993-8#2)(1995-12#1)(1995-7#1)(1996-2#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
with respect to localization##2##4##(2006-2#1)(2011-2#1)
with respect to noise##2##4##(2007-11#1)(2008-2#1)
with respect to normal controls##2##5##(1995-12#2)
with respect to normal##5##4##(1995-12#2)(2009-10#1)(2013-1#2)
with respect to number of##2##5##(2008-10#1)(2008-5#1)
with respect to one another##2##5##(1996-8#1)(2007-12#1)
with respect to one##4##4##(1994-5#1)(1996-8#1)(2007-12#1)(2008-10#1)
with respect to optical##2##4##(2008-2#2)
with respect to other##2##4##(2006-10#1)(2008-10#1)
with respect to pH##2##4##(1990-7#1)(2008-11#1)
with respect to pain and functional outcomes##2##7##(2012-12#2)
with respect to pain##3##4##(2008-9#1)(2012-12#2)
with respect to patient##2##4##(2008-11#1)(2011-2#1)
with respect to performance##2##4##(1996-3#1)(2011-1#1)
with respect to pipe length##2##5##(2008-3#2)
with respect to plasma##3##4##(1995-10#1)(2007-11#1)(2008-7#1)
with respect to random noise##2##5##(2008-2#1)(2008-3#1)
with respect to random##3##4##(2008-2#2)(2008-3#1)
with respect to recovery##2##4##(1990-12#1)(2008-9#1)
with respect to sex##3##4##(1993-10#1)(1994-6#1)(2009-5#1)
with respect to simplicity##2##4##(2008-10#1)(2008-11#1)
with respect to specific##3##4##(2006-12#1)(2009-3#1)(2009-4#1)
with respect to stability##2##4##(2005-11#1)(2012-2#1)
with respect to substitution##2##4##(1996-2#1)(2011-1#1)
with respect to substrate##2##4##(1991-7#1)(1996-6#1)
with respect to survival##3##4##(2006-8#2)(2012-3#1)
with respect to that of the##3##6##(1990-4#1)(2007-12#1)(2008-3#1)
with respect to that##4##4##(1990-4#1)(1994-3#1)(2007-12#1)(2008-3#1)
with respect to the R and D of new##2##9##(2005-7#1)(2008-5#1)
with respect to the absorbed pump power##5##7##(2007-11#2)(2007-12#3)
with respect to the absorbed##6##5##(2007-11#2)(2007-12#4)
with respect to the amount of##2##6##(1995-3#1)(2008-2#1)
with respect to the angle of incidence##2##7##(2008-3#2)
with respect to the background##2##5##(2007-12#1)(2008-2#1)
with respect to the beam##2##5##(2006-4#1)(2008-2#1)
with respect to the bilayer normal and##2##7##(1995-10#2)
with respect to the body##3##5##(2011-2#1)(2012-12#2)
with respect to the cavity##2##5##(2007-12#1)(2008-1#1)
with respect to the channel##2##5##(1995-10#1)(2008-2#1)
with respect to the clinical##2##5##(2006-10#1)(2013-8#1)
with respect to the concentration##2##5##(1994-12#1)(2007-1#1)
with respect to the control##3##5##(2008-2#1)(2009-6#1)(2012-2#1)
with respect to the corresponding##2##5##(2008-10#2)
with respect to the demands##2##5##(1995-12#1)(2008-3#1)
with respect to the development##2##5##(2006-8#1)(2013-1#1)
with respect to the expression##2##5##(1992-6#1)(2008-11#1)
with respect to the fiber axis##2##6##(2007-12#1)(2008-3#1)
with respect to the functional##2##5##(1990-12#1)(1994-8#1)
with respect to the fundamental##2##5##(2008-3#2)
with respect to the growth##2##5##(2010-10#1)(2010-3#1)
with respect to the human##2##5##(1991-6#1)(1992-6#1)
with respect to the incident beam##2##6##(2008-2#1)(2008-3#1)
with respect to the incident##6##5##(2007-12#1)(2008-2#1)(2008-3#4)
with respect to the initial##4##5##(2007-10#1)(2008-3#1)(2010-8#1)(2012-1#1)
with respect to the intensity##3##5##(1991-12#1)(2007-11#1)(2008-2#1)
with respect to the interfacial##2##5##(2005-11#1)(2006-12#1)
with respect to the length##2##5##(1991-10#1)(2010-7#1)
with respect to the long-term##2##5##(2008-4#1)(2012-3#1)
with respect to the medium##2##5##(2008-2#2)
with respect to the membrane##3##5##(1991-2#1)(1991-3#1)(1993-8#1)
with respect to the memory##2##5##(1990-11#1)(2008-11#1)
with respect to the nature##2##5##(2012-1#1)(2012-2#1)
with respect to the normal##2##5##(2006-7#1)(2008-3#1)
with respect to the optical##2##5##(2008-3#2)
with respect to the optimum##2##5##(1991-11#1)(2007-12#1)
with respect to the original##2##5##(2007-11#1)(2008-3#1)
with respect to the other##8##5##(2007-11#1)(2008-10#3)(2008-3#1)(2008-5#3)
with respect to the plane of incidence##4##7##(2008-2#1)(2008-3#3)
with respect to the plane of##5##6##(2008-2#2)(2008-3#3)
with respect to the plane##6##5##(2007-11#1)(2008-2#2)(2008-3#3)
with respect to the presence or absence of overweight##2##9##(2008-10#2)
with respect to the presence##3##5##(2007-12#1)(2008-10#2)
with respect to the primary##2##5##(1993-9#1)(2008-5#1)
with respect to the quality of##2##6##(1993-4#1)(2008-3#1)
with respect to the real##2##5##(2008-2#1)(2008-4#1)
with respect to the regulation of##2##6##(2007-8#1)(2010-9#1)
with respect to the relative##3##5##(1992-3#1)(2006-2#1)(2008-3#1)
with respect to the simulated##2##5##(2012-3#2)
with respect to the size##2##5##(1991-4#1)(2006-10#1)
with respect to the skull##2##5##(2006-11#1)(2007-4#1)
with respect to the substrate##2##5##(1991-5#1)(1995-5#1)
with respect to the surfaces##3##5##(2006-12#1)(2013-8#2)
with respect to the type##2##5##(1992-3#1)(2012-2#1)
with respect to the untreated##2##5##(2007-7#1)(2008-5#1)
with respect to the use of##3##6##(2006-10#2)(2012-1#1)
with respect to the##387##4##(1990-11#4)(1990-12#4)(1990-3#2)(1990-5#2)(1990-8#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-3#2)(1992-4#1)(1992-6#6)(1992-7#2)(1992-8#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#2)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#2)(1995-10#4)(1995-11#2)(1995-12#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#2)(1996-12#1)(1996-2#4)(1996-5#2)(1996-8#2)(1996-9#1)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#3)(1997-9#1)(2004-9#1)(2005-10#2)(2005-11#4)(2005-7#1)(2005-8#1)(2006-10#6)(2006-11#4)(2006-12#6)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#13)(2007-12#21)(2007-2#2)(2007-4#3)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#32)(2008-11#4)(2008-12#1)(2008-2#38)(2008-3#43)(2008-4#5)(2008-5#8)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#2)(2009-2#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-1#4)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#4)(2013-8#7)
with respect to their ability to##2##6##(1994-11#1)(2008-5#1)
with respect to their effects on the##2##7##(1993-6#1)(1993-9#1)
with respect to their##49##4##(1990-11#1)(1991-2#1)(1992-10#1)(1992-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-6#1)(1997-2#1)(1997-8#1)(2004-11#1)(2004-9#1)(2006-11#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#3)(2009-7#1)(2010-4#1)(2010-8#2)(2011-2#2)(2012-3#1)(2013-1#1)
with respect to these properties##2##5##(2008-7#1)(2010-1#1)
with respect to these##5##4##(2008-2#1)(2008-4#1)(2008-7#1)(2010-1#1)(2012-2#1)
with respect to those obtained##3##5##(2008-10#3)
with respect to those##5##4##(1991-6#1)(1996-3#1)(2008-10#3)
with respect to time to##2##5##(2007-8#1)(2008-2#1)
with respect to time##6##4##(2004-1#1)(2007-2#1)(2007-8#1)(2008-2#2)(2008-3#1)
with respect to total##4##4##(1995-10#1)(2008-10#1)(2010-11#1)(2011-2#1)
with respect to##1077##3##(1990-11#5)(1990-12#15)(1990-2#3)(1990-3#4)(1990-4#4)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#2)(1991-11#3)(1991-12#6)(1991-2#7)(1991-3#5)(1991-4#4)(1991-5#5)(1991-6#4)(1991-7#4)(1991-8#1)(1991-9#1)(1992-10#3)(1992-11#3)(1992-12#4)(1992-2#1)(1992-3#6)(1992-4#2)(1992-5#3)(1992-6#7)(1992-7#2)(1992-8#4)(1992-9#2)(1993-1#2)(1993-10#2)(1993-12#3)(1993-3#6)(1993-4#2)(1993-5#1)(1993-6#3)(1993-7#2)(1993-8#8)(1993-9#3)(1994-10#1)(1994-11#4)(1994-12#7)(1994-2#7)(1994-3#6)(1994-5#4)(1994-6#3)(1994-7#1)(1994-8#7)(1994-9#5)(1995-1#3)(1995-10#7)(1995-11#3)(1995-12#8)(1995-2#3)(1995-3#6)(1995-4#1)(1995-5#6)(1995-6#2)(1995-7#3)(1995-8#3)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#4)(1996-2#10)(1996-3#3)(1996-5#5)(1996-6#2)(1996-7#4)(1996-8#6)(1996-9#3)(1997-1#2)(1997-2#4)(1997-3#7)(1997-4#8)(1997-5#2)(1997-6#7)(1997-7#4)(1997-8#2)(1997-9#1)(2004-1#1)(2004-10#1)(2004-11#1)(2004-9#3)(2005-10#3)(2005-11#8)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#17)(2006-11#8)(2006-12#11)(2006-2#3)(2006-3#2)(2006-4#1)(2006-5#2)(2006-6#5)(2006-7#3)(2006-8#6)(2006-9#1)(2007-1#7)(2007-10#2)(2007-11#31)(2007-12#39)(2007-2#3)(2007-3#1)(2007-4#5)(2007-5#2)(2007-6#5)(2007-7#3)(2007-8#11)(2007-9#5)(2008-1#10)(2008-10#108)(2008-11#17)(2008-12#7)(2008-2#75)(2008-3#61)(2008-4#12)(2008-5#25)(2008-6#8)(2008-7#23)(2008-8#12)(2008-9#9)(2009-1#1)(2009-10#7)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#7)(2009-5#3)(2009-6#4)(2009-7#4)(2009-8#5)(2009-9#2)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#5)(2010-2#5)(2010-3#2)(2010-4#4)(2010-6#2)(2010-7#5)(2010-8#5)(2010-9#2)(2011-1#11)(2011-12#1)(2011-2#26)(2012-1#8)(2012-11#2)(2012-12#14)(2012-2#14)(2012-3#10)(2012-5#1)(2012-7#1)(2013-1#21)(2013-8#12)
with respect##1084##2##(1990-11#5)(1990-12#15)(1990-2#3)(1990-3#4)(1990-4#5)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#2)(1991-11#3)(1991-12#6)(1991-2#7)(1991-3#6)(1991-4#4)(1991-5#5)(1991-6#4)(1991-7#4)(1991-8#1)(1991-9#1)(1992-10#3)(1992-11#3)(1992-12#4)(1992-2#1)(1992-3#6)(1992-4#2)(1992-5#3)(1992-6#7)(1992-7#2)(1992-8#4)(1992-9#2)(1993-1#2)(1993-10#2)(1993-12#3)(1993-3#6)(1993-4#2)(1993-5#1)(1993-6#4)(1993-7#2)(1993-8#8)(1993-9#3)(1994-10#1)(1994-11#4)(1994-12#7)(1994-2#7)(1994-3#6)(1994-5#4)(1994-6#3)(1994-7#1)(1994-8#7)(1994-9#5)(1995-1#3)(1995-10#7)(1995-11#3)(1995-12#8)(1995-2#3)(1995-3#6)(1995-4#1)(1995-5#6)(1995-6#2)(1995-7#3)(1995-8#3)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#4)(1996-2#10)(1996-3#3)(1996-5#5)(1996-6#2)(1996-7#4)(1996-8#6)(1996-9#3)(1997-1#2)(1997-2#4)(1997-3#7)(1997-4#8)(1997-5#2)(1997-6#7)(1997-7#4)(1997-8#2)(1997-9#1)(2004-1#1)(2004-10#1)(2004-11#1)(2004-9#3)(2005-10#3)(2005-11#8)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#17)(2006-11#8)(2006-12#11)(2006-2#3)(2006-3#2)(2006-4#2)(2006-5#2)(2006-6#5)(2006-7#3)(2006-8#6)(2006-9#1)(2007-1#7)(2007-10#2)(2007-11#31)(2007-12#39)(2007-2#3)(2007-3#1)(2007-4#5)(2007-5#2)(2007-6#5)(2007-7#3)(2007-8#11)(2007-9#5)(2008-1#10)(2008-10#110)(2008-11#18)(2008-12#7)(2008-2#75)(2008-3#61)(2008-4#12)(2008-5#25)(2008-6#8)(2008-7#23)(2008-8#12)(2008-9#9)(2009-1#1)(2009-10#7)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#7)(2009-5#3)(2009-6#4)(2009-7#4)(2009-8#5)(2009-9#2)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#5)(2010-2#5)(2010-3#2)(2010-4#4)(2010-6#2)(2010-7#5)(2010-8#5)(2010-9#2)(2011-1#11)(2011-12#1)(2011-2#26)(2012-1#8)(2012-11#2)(2012-12#14)(2012-2#14)(2012-3#10)(2012-5#1)(2012-7#1)(2013-1#21)(2013-8#12)
with respective values##2##3##(1991-10#1)(1994-11#1)
with respective##16##2##(1991-10#1)(1991-12#1)(1992-1#1)(1992-8#1)(1994-11#1)(1994-8#1)(1997-4#1)(1997-5#1)(2007-12#1)(2007-6#2)(2008-1#1)(2008-10#3)(2008-7#1)
with respiratory disease##5##3##(1991-8#1)(1994-10#1)(1997-1#1)(2012-12#1)(2012-2#1)
with respiratory distress and##2##4##(2010-1#1)(2011-2#1)
with respiratory distress syndrome##4##4##(1990-12#2)(2008-12#1)(2008-6#1)
with respiratory distress##12##3##(1990-11#1)(1990-12#2)(1991-3#1)(2008-12#1)(2008-6#1)(2009-6#1)(2010-1#1)(2011-12#1)(2011-2#3)
with respiratory failure and##2##4##(2006-4#1)(2013-1#1)
with respiratory failure##3##3##(2006-4#1)(2008-1#1)(2013-1#1)
with respiratory infections##5##3##(2012-2#5)
with respiratory symptoms were##2##4##(2010-9#1)(2011-1#1)
with respiratory symptoms##4##3##(2010-4#1)(2010-9#1)(2011-1#2)
with respiratory syncytial virus (RSV)##2##5##(1992-10#1)(2012-2#1)
with respiratory syncytial virus##5##4##(1992-10#3)(1994-6#1)(2012-2#1)
with respiratory##58##2##(1990-11#1)(1990-12#2)(1990-3#1)(1991-3#1)(1991-8#1)(1992-10#3)(1992-4#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-6#1)(1996-7#1)(1997-1#1)(1997-4#2)(2006-10#1)(2006-4#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-6#1)(2009-3#1)(2009-5#2)(2009-6#1)(2010-1#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#9)(2013-1#3)(2013-7#1)
with response rates##3##3##(2007-7#1)(2008-3#1)(2008-6#1)
with response times of##2##4##(2007-8#1)(2008-10#1)
with response to##5##3##(1993-2#1)(1995-2#1)(2006-10#2)(2012-2#1)
with response##16##2##(1990-2#1)(1993-2#1)(1995-2#1)(1996-1#1)(1997-8#1)(2006-10#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2012-2#1)(2013-1#1)
with responses of##2##3##(1990-12#1)(2009-8#1)
with responses to##2##3##(1993-6#1)(1996-2#1)
with responses##5##2##(1990-12#1)(1990-2#1)(1993-6#1)(1996-2#1)(2009-8#1)
with responsive##2##2##(1996-8#1)(2010-4#1)
with restenosis##2##2##(1994-10#1)(2008-11#1)
with resting##3##2##(2010-8#1)(2011-2#1)(2013-7#1)
with restoration of##6##3##(1992-10#1)(1995-8#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-9#1)
with restoration##7##2##(1990-12#1)(1992-10#1)(1995-8#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-9#1)
with restrained##2##2##(1990-10#1)(2007-4#1)
with restricted##5##2##(1993-7#1)(2008-10#2)(2008-3#1)(2008-5#1)
with restriction endonucleases##2##3##(2006-8#1)(2008-4#1)
with restriction enzymes##4##3##(1990-3#1)(2008-10#2)(2008-5#1)
with restriction fragment length polymorphism (RFLP) markers##2##7##(2008-10#2)
with restriction fragment length polymorphism##3##5##(2008-10#3)
with restriction##12##2##(1990-3#1)(1993-6#1)(1995-6#1)(2006-8#1)(2008-10#6)(2008-4#1)(2008-5#1)
with restrictive lung##3##3##(1997-4#1)(2006-10#1)(2012-1#1)
with restrictive##6##2##(1997-4#1)(2006-10#1)(2006-12#1)(2008-7#1)(2008-8#1)(2012-1#1)
with restructuring##2##2##(1992-1#1)(2012-2#1)
with resultant##11##2##(1991-11#1)(1991-9#1)(1994-9#1)(1997-4#1)(2006-12#1)(2006-8#1)(2008-8#1)(2009-1#1)(2011-2#2)(2012-2#1)
with resulting##5##2##(1993-1#1)(2006-10#1)(2008-11#1)(2013-1#2)
with results comparable to those##2##5##(1991-2#1)(2008-10#1)
with results determined by##2##4##(2008-10#2)
with results for##6##3##(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-8#1)
with results from other##2##4##(2006-10#1)(2008-10#1)
with results from the##3##4##(2008-2#1)(2008-5#1)(2009-9#1)
with results from##20##3##(1991-2#1)(1993-9#1)(1995-9#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-2#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2009-9#1)(2011-2#1)(2012-3#1)
with results in##3##3##(1994-10#1)(2006-10#1)(2008-10#1)
with results indicating##3##3##(1991-7#1)(2007-12#1)(2008-10#1)
with results obtained by##4##4##(1991-9#1)(2008-10#2)(2008-2#1)
with results obtained from##2##4##(2008-3#1)(2008-5#1)
with results obtained in##2##4##(2007-12#1)(2008-8#1)
with results obtained using##4##4##(1997-6#1)(2008-10#3)
with results obtained##15##3##(1991-9#1)(1997-6#1)(2006-6#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)
with results of##6##3##(1994-5#1)(1995-5#1)(2005-1#1)(2007-12#1)(2008-9#1)(2011-1#1)
with results reported in the literature##2##6##(2006-8#1)(2008-2#1)
with results reported##3##3##(1994-3#1)(2006-8#1)(2008-2#1)
with results that##2##3##(1994-5#1)(2008-10#1)
with results##79##2##(1991-2#2)(1991-7#1)(1991-9#1)(1993-9#1)(1994-10#1)(1994-3#1)(1994-5#2)(1995-5#1)(1995-9#1)(1997-3#1)(1997-4#1)(1997-6#2)(2005-1#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#2)(2007-8#2)(2007-9#1)(2008-10#17)(2008-11#2)(2008-2#5)(2008-3#9)(2008-5#2)(2008-8#3)(2008-9#1)(2009-4#1)(2009-9#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-8#1)
with resveratrol##5##2##(2008-10#2)(2011-2#1)(2012-4#1)(2013-1#1)
with retained##3##2##(1991-3#1)(2010-5#1)(2012-2#1)
with retention of the##2##4##(2010-7#1)(2012-1#1)
with retention of viability##2##4##(1995-8#1)(2007-6#1)
with retention of##13##3##(1991-12#1)(1991-2#1)(1992-3#1)(1992-7#1)(1995-8#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-2#2)(2009-5#1)(2010-7#1)(2012-1#1)
with retention times of##2##4##(2008-10#2)
with retention times##3##3##(1990-12#1)(2008-10#2)
with retention##19##2##(1990-12#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-7#1)(1993-12#1)(1995-8#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-2#2)(2009-11#1)(2009-5#1)(2010-3#1)(2010-7#1)(2012-1#1)
with reteplase##4##2##(2006-4#2)(2007-11#1)(2007-9#1)
with retinal##8##2##(1991-7#1)(1992-3#1)(1995-1#1)(2009-12#1)(2009-4#1)(2011-1#1)(2013-1#2)
with retinex coding##3##3##(2008-3#3)
with retinoic acid (RA)##2##4##(1994-9#1)(2008-5#1)
with retinoic acid and cyclic AMP##2##6##(1992-9#2)
with retinoic acid##8##3##(1990-8#1)(1992-9#2)(1993-12#1)(1994-9#2)(2008-5#2)
with retinoid X receptor##2##4##(2005-11#1)(2012-12#1)
with retinoid X##3##3##(1995-8#1)(2005-11#1)(2012-12#1)
with retinopathy##3##2##(1991-12#1)(1993-1#1)(2013-1#1)
with retrograde##10##2##(1991-9#1)(1996-5#2)(2006-12#1)(2007-8#2)(2007-9#2)(2013-1#2)
with retrogradely##2##2##(1992-1#1)(1997-6#1)
with retroperitoneal##4##2##(1990-9#1)(1992-12#1)(2008-6#2)
with retrosternal##3##2##(2005-12#1)(2011-1#2)
with retroviral##4##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
with retrovirus##2##2##(1990-9#1)(2008-11#1)
with return of##2##3##(2006-7#1)(2008-5#1)
with return to##2##3##(1991-11#1)(2007-10#1)
with return##4##2##(1991-11#1)(2006-7#1)(2007-10#1)(2008-5#1)
with revascularization and in##2##4##(2005-1#2)
with revascularization##4##2##(2005-1#4)
with revenue##2##2##(1992-12#2)
with reverse transcriptase##2##3##(1994-12#1)(1995-8#1)
with reverse transcriptase-polymerase chain reaction##2##5##(1995-3#1)(1997-7#1)
with reverse transcription-polymerase chain reaction##3##5##(1992-11#1)(1993-3#1)(2007-10#1)
with reverse##13##2##(1992-11#1)(1992-9#1)(1993-3#1)(1994-12#1)(1995-3#1)(1995-8#1)(1997-7#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
with reverse-phase##2##2##(1996-9#1)(2008-10#1)
with reversed##3##2##(2007-8#1)(2008-10#2)
with reversed-phase high-performance liquid chromatography (RP-HPLC)##2##6##(1996-8#2)
with reversed-phase liquid chromatography##2##4##(1990-12#1)(2008-10#1)
with reversed-phase##4##2##(1990-12#1)(1996-8#2)(2008-10#1)
with reversible##8##2##(1992-2#1)(1992-6#1)(1996-1#1)(2008-10#1)(2008-8#1)(2009-11#1)(2010-9#1)(2012-3#1)
with review of literature##10##4##(2007-11#1)(2008-11#1)(2008-12#1)(2008-4#2)(2009-4#1)(2009-5#1)(2012-12#1)(2012-2#1)(2012-3#1)
with review of the literature##8##5##(2006-10#1)(2007-4#2)(2007-5#1)(2007-6#1)(2008-12#1)(2012-2#2)
with review of the##10##4##(1997-2#1)(2006-10#1)(2007-4#2)(2007-5#1)(2007-6#1)(2008-12#2)(2012-2#2)
with review of##22##3##(1997-2#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2008-11#1)(2008-12#3)(2008-4#2)(2009-4#1)(2009-5#1)(2012-12#1)(2012-2#3)(2012-3#1)
with reward##2##2##(1992-12#1)(2008-4#1)
with rhBMP-2##4##2##(2011-2#1)(2013-7#3)
with rhFKBP12##2##2##(2008-9#2)
with rhabdomyolysis##4##2##(2008-10#2)(2011-2#2)
with rheological##2##2##(2005-11#1)(2011-1#1)
with rhesus monkey##2##3##(2007-11#1)(2010-2#1)
with rheumatic disease##5##3##(2006-10#5)
with rheumatic heart disease##2##4##(2007-7#2)
with rheumatic mitral valve disease##2##5##(2007-8#2)
with rheumatic mitral##3##3##(2007-8#2)(2010-7#1)
with rheumatic##17##2##(1990-6#1)(1990-8#1)(2006-10#6)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#2)(2010-7#1)(2013-1#1)
with rheumatoid arthritis (RA)##8##4##(2006-10#4)(2007-11#1)(2008-8#2)(2010-12#1)
with rheumatoid arthritis and ankylosing spondylitis##2##6##(2006-10#1)(2012-12#1)
with rheumatoid arthritis and##5##4##(2006-10#2)(2007-11#1)(2007-12#1)(2012-12#1)
with rheumatoid arthritis treated with##4##5##(2006-10#2)(2011-2#1)(2012-2#1)
with rheumatoid arthritis who##5##4##(2006-10#2)(2006-9#1)(2008-9#1)(2010-8#1)
with rheumatoid arthritis##77##3##(1990-2#1)(1991-12#1)(1992-11#4)(1993-1#1)(1993-11#1)(1993-2#1)(1996-1#2)(2006-10#27)(2006-9#1)(2007-11#8)(2007-12#1)(2007-7#3)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2010-12#3)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
with rheumatoid##79##2##(1990-2#1)(1991-12#1)(1992-11#4)(1993-1#1)(1993-11#1)(1993-2#1)(1996-1#2)(2006-10#28)(2006-9#1)(2007-11#9)(2007-12#1)(2007-7#3)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2010-12#3)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
with rho##5##2##(1992-5#2)(1995-7#1)(2005-8#1)(2013-8#1)
with rhodamine 6G##2##3##(2008-10#2)
with rhodamine B##2##3##(2007-8#1)(2008-10#1)
with rhodamine##9##2##(1991-12#1)(1994-12#1)(1994-2#1)(2006-10#1)(2007-8#1)(2008-10#4)
with rhodopsin##2##2##(1990-5#1)(1997-7#1)
with rib##2##2##(2006-11#1)(2009-10#1)
with ribavirin##5##2##(1990-10#1)(1994-6#1)(2005-6#1)(2006-10#1)(2008-6#1)
with ribonuclease##2##2##(1992-10#1)(1997-2#1)
with ribosome-inactivating proteins##2##3##(1991-2#1)(1994-2#1)
with ribosome-inactivating##3##2##(1991-2#1)(1994-2#1)(2008-10#1)
with ribosomes##4##2##(1990-2#1)(1990-4#1)(1995-6#2)
with rice##6##2##(1993-11#1)(2008-10#1)(2008-6#1)(2008-9#1)(2010-2#1)(2012-12#1)
with rich {100} facets##2##4##(2013-1#2)
with rich##4##2##(2008-6#1)(2012-2#1)(2013-1#2)
with ricin##3##2##(1991-2#1)(2012-11#2)
with rifampicin##3##2##(1993-9#1)(2008-10#1)(2008-8#1)
with rifampin##3##2##(2005-8#1)(2008-5#1)(2009-4#1)
with right atrial##6##3##(1994-3#1)(1997-5#1)(2007-8#1)(2010-7#2)(2012-12#1)
with right hemisphere##4##3##(1993-12#1)(1996-5#1)(2008-2#1)(2012-3#1)
with right lower quadrant##2##4##(2006-1#1)(2013-1#1)
with right parietal##2##3##(1993-7#1)(2007-10#1)
with right sciatica##2##3##(2008-7#1)(2012-2#1)
with right upper##2##3##(2007-8#1)(2011-2#1)
with right ventricular##3##3##(1992-5#1)(1993-8#1)(2008-4#1)
with right##34##2##(1991-10#1)(1991-8#1)(1992-5#1)(1993-12#1)(1993-7#1)(1993-8#1)(1994-3#1)(1996-2#1)(1996-5#1)(1997-5#1)(2006-1#1)(2007-10#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#2)(2009-10#1)(2010-2#1)(2010-7#4)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
with right- than with left-side key-presses##2##6##(2008-4#2)
with right-side##3##2##(2007-8#1)(2008-4#2)
with right-sided##4##2##(1997-2#1)(1997-8#1)(2011-2#1)(2012-8#1)
with rigid bronchoscope##2##3##(2007-8#1)(2007-9#1)
with rigid##8##2##(2006-12#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2013-7#1)
with rigorous numerical##2##3##(2007-11#1)(2007-12#1)
with rigorous##6##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-6#1)
with rimalkalim##4##2##(1997-7#4)
with rise##2##2##(2006-1#1)(2010-9#1)
with rising of##2##3##(1991-3#1)(2013-8#1)
with rising##8##2##(1991-3#1)(1993-8#1)(2006-2#1)(2007-11#1)(2008-2#1)(2008-9#1)(2012-2#1)(2013-8#1)
with risk factors for##6##4##(2007-11#1)(2007-8#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
with risk factors##15##3##(1996-3#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
with risk of##20##3##(1990-12#1)(1991-9#1)(1993-9#1)(1994-2#1)(1996-2#1)(1996-6#1)(2005-10#1)(2006-10#1)(2007-3#1)(2008-11#1)(2008-12#1)(2008-6#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
with risk##43##2##(1990-12#1)(1991-3#1)(1991-9#1)(1993-9#1)(1994-2#1)(1996-2#1)(1996-3#1)(1996-6#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#3)(2013-8#2)
with risks##3##2##(1991-5#1)(2010-12#1)(2012-12#1)
with risky##3##2##(2007-8#1)(2008-10#1)(2010-5#1)
with risperidone##3##2##(2008-3#1)(2008-8#1)(2009-9#1)
with rituximab##12##2##(2005-10#1)(2005-11#1)(2006-10#2)(2009-8#1)(2010-12#1)(2012-2#2)(2013-1#4)
with rival##2##2##(2008-10#1)(2008-8#1)
with rivastigmine##3##2##(2004-3#1)(2011-12#1)(2011-2#1)
with rms##2##2##(2007-12#1)(2008-3#1)
with road traffic##4##3##(1993-5#3)(2008-4#1)
with road##6##2##(1993-5#3)(2008-4#1)(2012-12#1)(2013-8#1)
with robotic assistance##4##3##(2006-6#1)(2007-8#1)(2011-1#2)
with robotic##7##2##(2006-6#2)(2007-8#2)(2011-1#2)(2012-1#1)
with robust##5##2##(1996-8#1)(2008-3#1)(2010-2#2)(2011-1#1)
with rocuronium##2##2##(2012-12#1)(2013-7#1)
with rodent##2##2##(2008-4#2)
with rodents in##2##3##(1993-7#1)(2004-11#1)
with rodents##4##2##(1993-7#1)(2004-11#1)(2008-4#1)(2011-2#1)
with rofecoxib and##2##3##(2007-12#2)
with rofecoxib##8##2##(2006-10#1)(2007-12#5)(2007-8#1)(2008-8#1)
with roles##2##2##(1993-2#1)(2011-1#1)
with romantic##2##2##(2008-12#1)(2013-1#1)
with room temperature##2##3##(1990-11#1)(2007-11#1)
with root mean##2##3##(1997-4#1)(2008-10#1)
with root##6##2##(1997-4#1)(2007-8#1)(2008-10#3)(2012-8#1)
with root-knot##2##2##(2008-10#2)
with root-mean-square##2##2##(1994-9#1)(1996-6#1)
with roots##2##2##(2008-10#2)
with ropinirole##3##2##(2008-7#3)
with ropivacain##2##2##(2012-3#2)
with ropivacaine##2##2##(2012-3#1)(2013-7#1)
with rose Bengal##2##3##(2008-10#1)(2013-7#1)
with rosiglitazone##3##2##(2008-3#1)(2010-4#2)
with rosuvastatin##3##2##(2010-12#1)(2011-1#2)
with rotation##4##2##(1995-8#1)(1996-2#1)(2008-3#1)(2008-6#1)
with rotational symmetry##2##3##(2007-11#1)(2008-2#1)
with rotational##9##2##(1990-8#1)(2006-2#1)(2007-11#2)(2008-2#3)(2008-7#1)(2011-2#1)
with rotator cuff##3##3##(2006-10#1)(2008-7#1)(2009-9#1)
with rotenone##3##2##(1990-8#1)(1994-8#1)(2005-8#1)
with rough##2##2##(2007-11#1)(2008-3#1)
with round##5##2##(1991-8#1)(1995-12#1)(1997-2#1)(2008-12#1)(2012-1#1)
with routine clinical##2##3##(1995-9#1)(2008-7#1)
with routine##14##2##(1995-9#1)(1997-3#1)(2005-11#1)(2007-10#1)(2007-2#1)(2007-9#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
with rt-PA##3##2##(2007-10#2)(2008-7#1)
with rubeanic acid##3##3##(2008-10#3)
with rubella vaccine##3##3##(2010-10#3)
with rubidium##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
with rubisco activase##4##3##(1991-9#4)
with running sutures##2##3##(2006-6#1)(2012-3#1)
with running##3##2##(2006-6#1)(2008-10#1)(2012-3#1)
with rupture of the##4##4##(1990-11#1)(2006-3#1)(2008-11#1)(2012-3#1)
with rupture##6##2##(1990-11#1)(1990-5#1)(2006-3#1)(2008-11#1)(2010-7#1)(2012-3#1)
with ruptured##5##2##(2007-10#3)(2010-7#1)(2011-2#1)
with ruptures##3##2##(1991-11#1)(1996-11#1)(2006-3#1)
with rural##4##2##(1997-7#1)(2008-11#1)(2010-3#1)(2013-1#1)
with ruthenium##3##2##(2006-8#1)(2007-8#1)(2008-10#1)
with ryanodine##2##2##(1993-2#1)(1996-5#1)
with s##4##2##(2005-11#3)(2008-10#1)
with s(L)=0##2##2##(2008-10#2)
with sDON##2##2##(1995-12#2)
with sacroiliac joint dysfunction##2##4##(2012-2#2)
with sacroiliac joint##4##3##(2010-4#1)(2011-12#1)(2012-2#2)
with sacroiliitis##2##2##(2006-10#1)(2011-2#1)
with sadomasochism associated##2##3##(2011-1#2)
with safe##2##2##(2013-1#2)
with safety##6##2##(1995-3#1)(2005-11#1)(2007-6#1)(2007-9#1)(2008-4#1)(2008-8#1)
with sagittal##2##2##(2006-5#1)(2007-8#1)
with salicylate##2##2##(2008-2#1)(2012-2#1)
with salicylic acid##4##3##(1994-6#1)(2008-10#2)(2008-5#1)
with saline and##3##3##(1993-12#1)(1993-3#1)(2007-2#1)
with saline or 50% ethanol##2##5##(2013-8#2)
with saline or##9##3##(1991-11#1)(1995-11#1)(1995-12#1)(1996-4#1)(1997-7#1)(2008-10#1)(2008-5#1)(2013-8#2)
with saline water##7##3##(2007-12#1)(2008-10#6)
with saline##44##2##(1990-5#1)(1991-11#1)(1991-2#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-3#1)(1996-4#1)(1997-7#1)(2004-10#1)(2006-10#1)(2006-12#3)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#7)(2008-12#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
with salinity##3##2##(2007-8#1)(2008-5#1)(2013-7#1)
with saliva##5##2##(2008-12#3)(2009-8#1)(2010-5#1)
with salmon calcitonin##2##3##(1991-7#1)(1993-11#1)
with salt##8##2##(1993-6#1)(1995-1#1)(2006-9#1)(2007-7#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-2#1)
with salvage##2##2##(2012-2#2)
with samarium hydroxide##2##3##(2008-10#2)
with samarium##3##2##(2008-10#3)
with same##10##2##(1996-12#1)(2007-11#1)(2007-8#1)(2008-3#1)(2011-1#3)(2012-3#2)(2013-8#1)
with same-sex desire##2##3##(2009-7#2)
with sample depth##2##3##(2008-2#2)
with sample sizes##2##3##(2008-10#1)(2012-3#1)
with sample##25##2##(1993-11#1)(1995-1#1)(2006-8#1)(2007-8#2)(2008-10#9)(2008-12#1)(2008-2#2)(2008-9#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
with samples containing##2##3##(2008-2#1)(2009-10#1)
with samples from##7##3##(1993-1#1)(1997-3#1)(2006-3#1)(2007-12#1)(2008-10#1)(2008-12#1)(2013-8#1)
with samples of##5##3##(2004-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2012-1#1)
with samples##20##2##(1990-8#1)(1993-1#1)(1997-3#1)(2004-11#1)(2006-2#1)(2006-3#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-6#2)(2008-7#2)(2009-10#1)(2012-1#1)(2012-12#1)(2013-8#1)
with sampling rate of about##2##5##(2008-10#2)
with sampling##6##2##(1996-3#1)(2008-10#3)(2008-5#1)(2008-7#1)
with sand substrate##2##3##(2008-5#2)
with sand##7##2##(2007-3#1)(2008-10#1)(2008-5#3)(2008-7#1)(2008-8#1)
with sanitizer##2##2##(1996-9#2)
with saphenous vein##2##3##(2005-10#1)(2007-8#1)
with saponin##2##2##(1992-5#1)(1993-4#1)
with sarcoidosis##12##2##(2005-8#1)(2007-10#1)(2007-11#2)(2010-10#1)(2010-6#6)(2012-2#1)
with sarcoma##10##2##(1997-7#1)(2008-6#8)(2010-3#1)
with sarcomatoid##2##2##(2012-3#2)
with sarcomatous##5##2##(2006-9#2)(2008-5#3)
with sarcoplasmic reticulum##2##3##(1990-7#1)(1996-1#1)
with satellites##2##2##(2007-9#1)(2008-10#1)
with satisfaction##5##2##(2006-6#1)(2008-8#1)(2009-3#1)(2010-2#1)(2010-5#1)
with satisfactory accuracy and precision in the presence of##2##9##(2008-10#2)
with satisfactory accuracy and precision##4##5##(2008-10#4)
with satisfactory accuracy##5##3##(2008-10#4)(2008-3#1)
with satisfactory recovery##2##3##(2006-10#1)(2008-10#1)
with satisfactory results and##2##4##(2008-10#2)
with satisfactory results in##2##4##(2006-10#1)(2008-10#1)
with satisfactory results##88##3##(2005-4#4)(2006-10#1)(2007-8#2)(2008-1#1)(2008-10#77)(2008-8#1)(2011-2#1)(2012-12#1)
with satisfactory##105##2##(1992-2#1)(2005-4#4)(2006-10#2)(2007-8#4)(2008-1#1)(2008-10#86)(2008-3#1)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
with saturated##4##2##(1995-5#1)(1997-2#1)(2007-8#1)(2008-10#1)
with saturating##2##2##(1994-12#1)(1994-8#1)
with sawdust##4##2##(2008-12#4)
with scRNA##2##2##(1994-3#1)(1996-5#1)
with scab##2##2##(2008-10#2)
with scabies##2##2##(2006-10#1)(2010-6#1)
with scaffolding##2##2##(2007-8#1)(2009-3#1)
with scaffolds##2##2##(1992-2#1)(2011-2#1)
with scalar##3##2##(2006-4#1)(2007-12#1)(2008-2#1)
with scaling and##2##3##(2006-10#1)(2007-7#1)
with scalp##3##2##(2007-8#1)(2008-4#1)(2012-12#1)
with scanning electron microscopy##7##4##(1997-1#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-5#2)(2013-1#1)
with scanning##14##2##(1991-3#1)(1997-1#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2009-4#1)(2013-1#1)
with scanty cytoplasm##2##3##(2009-5#1)(2011-1#1)
with scar##2##2##(2007-6#1)(2011-2#1)
with scarce##3##2##(2007-12#1)(2007-3#1)(2008-10#1)
with scattered light##2##3##(2008-2#1)(2011-2#1)
with scattered##4##2##(2008-1#1)(2008-2#1)(2008-7#1)(2011-2#1)
with scattering##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
with sceletal cancer metastases and pathological fracture of##2##8##(2007-11#2)
with scenarios##2##2##(2010-3#1)(2013-8#1)
with scheme##2##2##(2007-6#2)
with schistosome##2##2##(2008-4#1)(2012-3#1)
with schistosomiasis##5##2##(1992-4#2)(1996-12#1)(2008-8#2)
with schizoaffective disorder##2##3##(1997-5#1)(1997-8#1)
with schizophrenia (n =##3##4##(1996-2#1)(1996-7#1)(1997-8#1)
with schizophrenia and 20##2##4##(1996-7#1)(2013-1#1)
with schizophrenia and##15##3##(1996-5#1)(1996-7#3)(2004-3#1)(2008-3#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-6#1)(2011-1#3)(2013-1#1)
with schizophrenia appear to have##2##5##(1996-3#1)(1997-8#1)
with schizophrenia because##2##3##(1997-8#1)(2009-9#1)
with schizophrenia have##3##3##(1995-1#1)(1995-12#1)(2009-6#1)
with schizophrenia in##5##3##(1996-2#1)(2006-12#1)(2006-2#1)(2006-9#1)(2009-6#1)
with schizophrenia on##3##3##(1997-8#1)(2008-11#1)(2013-1#1)
with schizophrenia or schizoaffective disorder##2##5##(1995-1#1)(2009-9#1)
with schizophrenia or##7##3##(1995-1#1)(1995-11#1)(2009-9#1)(2011-2#4)
with schizophrenia treated with##2##4##(2008-7#2)
with schizophrenia treated##3##3##(2008-7#2)(2012-3#1)
with schizophrenia##148##2##(1991-9#1)(1995-1#2)(1995-11#4)(1995-12#7)(1995-5#1)(1996-2#3)(1996-3#3)(1996-5#7)(1996-7#10)(1996-8#5)(1997-2#6)(1997-5#2)(1997-8#9)(2004-3#1)(2005-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-9#4)(2007-7#3)(2007-8#1)(2008-11#2)(2008-3#3)(2008-6#2)(2008-7#2)(2009-10#2)(2009-11#1)(2009-12#2)(2009-6#2)(2009-7#4)(2009-9#6)(2010-1#2)(2010-12#1)(2010-6#3)(2011-1#7)(2011-2#14)(2012-1#3)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#7)(2013-8#3)
with schizophrenia)##2##2##(1993-8#1)(1997-8#1)
with schizophrenic patients##3##3##(1997-6#1)(2006-3#1)(2008-6#1)
with schizophrenic##5##2##(1997-6#1)(2006-3#1)(2008-6#1)(2012-12#2)
with school##5##2##(2006-4#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-12#1)
with schools##2##2##(2010-2#1)(2012-12#1)
with scientific##5##2##(2006-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-12#1)
with scleroderma and##2##3##(2006-10#2)
with scleroderma renal##2##3##(1992-12#1)(2006-10#1)
with scleroderma##13##2##(1992-12#1)(1992-8#1)(2004-10#1)(2006-10#7)(2006-4#1)(2008-10#1)(2012-2#1)
with sclerosis##2##2##(2005-11#1)(2007-2#1)
with sclerotherapy##3##2##(2013-1#3)
with sclerotia##4##2##(2007-7#1)(2008-10#3)
with sclerotized##2##2##(2007-12#1)(2008-5#1)
with scoliosis and a##3##4##(2007-8#1)(2008-4#2)
with scoliosis and##4##3##(2006-10#1)(2007-8#1)(2008-4#2)
with scoliosis##20##2##(1997-4#1)(2006-10#1)(2007-7#4)(2007-8#9)(2008-4#2)(2010-12#2)(2013-1#1)
with scoliosis]##2##2##(2006-6#1)(2007-7#1)
with scores on the##2##4##(1996-7#1)(2007-12#1)
with scores on##3##3##(1996-7#1)(2007-12#1)(2012-1#1)
with scores##7##2##(1992-1#1)(1996-7#1)(1997-5#1)(2007-12#1)(2009-3#1)(2012-1#1)(2012-11#1)
with scorpion##2##2##(2008-8#1)(2008-9#1)
with screening##4##2##(2008-11#1)(2008-4#1)(2011-2#1)(2013-1#1)
with screws##6##2##(2008-6#1)(2011-2#4)(2012-2#1)
with scurvy##2##2##(2005-10#2)
with sea surface temperature##2##4##(2008-5#1)(2012-2#1)
with sea##3##2##(2008-5#1)(2010-8#1)(2012-2#1)
with season##3##2##(2007-3#1)(2010-8#2)
with seasonal allergens##2##3##(2011-2#2)
with seasonal influenza##3##3##(2010-4#1)(2011-2#2)
with seasonal variation##2##3##(1997-3#1)(2012-3#1)
with seasonal##17##2##(1995-11#1)(1997-3#1)(2007-2#1)(2007-9#1)(2008-11#1)(2008-8#2)(2009-7#1)(2010-4#1)(2010-8#2)(2011-2#4)(2012-3#1)(2013-8#1)
with seat belt##2##3##(2007-4#2)
with seated##2##2##(2007-4#1)(2010-2#1)
with sebaceous##3##2##(2010-5#1)(2010-8#2)
with second##4##2##(2008-10#1)(2008-6#1)(2008-7#1)(2009-6#1)
with second-harmonic generation in##2##4##(2007-12#2)
with second-harmonic generation##4##3##(2007-12#3)(2008-3#1)
with second-harmonic##6##2##(2007-12#4)(2008-3#2)
with second-order calibration##2##3##(2008-10#2)
with second-order rate constants of##2##5##(1990-2#1)(1996-7#1)
with second-order rate constants##3##4##(1990-2#1)(1995-6#1)(1996-7#1)
with second-order##8##2##(1990-2#1)(1995-6#1)(1996-7#1)(2008-10#2)(2008-2#2)(2011-1#1)
with secondary changes##2##3##(2007-2#1)(2008-9#1)
with secondary data##2##3##(2008-9#1)(2011-2#1)
with secondary infertility##2##3##(2011-1#2)
with secondary osteoarthritis##2##3##(2013-1#2)
with secondary syphilis##3##3##(1993-3#3)
with secondary##50##2##(1991-11#2)(1991-3#1)(1991-4#1)(1991-9#1)(1993-3#4)(1993-6#1)(1995-12#1)(1995-4#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-3#2)(1997-2#1)(2006-10#3)(2006-2#1)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#2)(2009-8#1)(2009-9#1)(2010-3#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
with secreted##3##2##(1995-1#1)(2008-10#1)(2008-5#1)
with secretion##3##2##(1995-8#1)(2007-12#1)(2013-7#1)
with secretory##4##2##(1997-6#1)(2007-12#1)(2007-2#1)(2007-9#1)
with sedation##3##2##(2006-3#1)(2008-4#1)(2010-7#1)
with sedative properties##2##3##(2007-9#1)(2013-7#1)
with sedative##4##2##(2006-10#1)(2007-9#1)(2013-7#1)(2013-8#1)
with sedentary##2##2##(2011-12#1)(2011-2#1)
with seed##5##2##(2006-12#1)(2008-10#2)(2008-5#1)(2009-10#1)
with seeds##2##2##(1997-4#1)(2007-3#1)
with seeking##2##2##(1995-12#1)(2008-8#1)
with seemingly##2##2##(2010-2#1)(2012-12#1)
with segmental##3##2##(1997-2#1)(2007-8#1)(2009-3#1)
with segments##4##2##(2008-10#3)(2008-4#1)
with seizure##4##2##(2008-12#1)(2008-2#1)(2010-1#1)(2012-3#1)
with seizures and##2##3##(2009-9#1)(2011-1#1)
with seizures##5##2##(1997-3#1)(2008-4#1)(2009-9#1)(2011-1#1)(2011-2#1)
with selected ion monitoring##4##4##(1992-7#1)(2004-2#1)(2008-10#2)
with selected##32##2##(1990-12#1)(1991-8#1)(1992-4#1)(1992-7#1)(2004-11#1)(2004-2#1)(2007-11#1)(2007-8#1)(2008-10#10)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
with selection##8##2##(1990-7#1)(1992-2#1)(1996-6#1)(2007-11#1)(2007-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
with selective angiotensin II receptor blocker##2##6##(2007-1#2)
with selective angiotensin##3##3##(2007-1#3)
with selective hypersensitivity##2##3##(2013-1#2)
with selective##36##2##(1991-2#1)(1991-5#1)(1992-10#1)(1992-8#1)(1994-5#1)(1996-10#1)(1996-6#1)(1997-2#1)(2004-12#1)(2005-8#1)(2006-10#2)(2007-1#4)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-11#2)(2009-9#1)(2012-1#1)(2013-1#3)(2013-7#1)
with selectivity for##3##3##(1992-8#1)(1995-6#1)(2008-10#1)
with selectivity##5##2##(1991-11#1)(1992-8#1)(1995-6#1)(2007-11#1)(2008-10#1)
with selenite##2##2##(2008-10#1)(2010-11#1)
with selenium dioxide##2##3##(2007-11#1)(2008-4#1)
with selenium##9##2##(1993-3#1)(1994-3#1)(1995-7#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2011-2#1)
with self##2##2##(1995-9#1)(2011-2#1)
with self-assembled##4##2##(2008-10#3)(2009-2#1)
with self-concept##2##2##(2008-9#1)(2009-7#1)
with self-injection of##2##3##(2009-3#2)
with self-organized##2##2##(2008-1#1)(2008-7#1)
with self-report measures##2##3##(2008-8#1)(2013-1#1)
with self-report##3##2##(2008-8#1)(2011-2#1)(2013-1#1)
with self-reported##5##2##(1990-9#1)(1995-1#1)(2008-8#1)(2009-10#1)(2012-12#1)
with sellar##2##2##(2007-1#1)(2013-8#1)
with semantic dementia##3##3##(2008-4#3)
with semantic##5##2##(2007-8#1)(2008-4#3)(2008-5#1)
with semen##7##2##(2006-5#3)(2008-7#1)(2009-6#2)(2013-1#1)
with semi-rigid##2##2##(2007-7#2)
with semicarbazide and##2##3##(2007-11#1)(2008-10#1)
with semicarbazide##3##2##(2007-11#2)(2008-10#1)
with semiconductor optical amplifiers and in-line filters##2##7##(2007-12#2)
with semiconductor optical amplifiers##3##4##(2007-12#2)(2008-1#1)
with semiconductor##4##2##(2007-12#3)(2008-1#1)
with semilobar##2##2##(1996-12#1)(2011-1#1)
with senescence##3##2##(1994-5#1)(1995-8#1)(2013-1#1)
with senile##5##2##(1992-8#1)(1993-4#1)(1993-8#1)(1996-1#1)(2013-1#1)
with senior##3##2##(1993-2#1)(1997-3#1)(2008-12#1)
with sensilla##3##2##(2007-12#3)
with sensitive##4##2##(1992-3#1)(1993-3#1)(1997-4#1)(1997-7#1)
with sensitivities of##2##3##(2007-11#1)(2008-3#1)
with sensitivity 2##2##3##(2007-12#1)(2008-10#1)
with sensitivity and specificity##2##4##(1991-10#1)(2012-12#1)
with sensitivity and##3##3##(1991-10#1)(2008-10#1)(2012-12#1)
with sensitivity of##3##3##(2007-12#1)(2008-10#2)
with sensitivity to trastuzumab##2##4##(2012-3#2)
with sensitivity to##5##3##(1991-7#1)(1996-2#1)(1997-2#1)(2012-3#2)
with sensitivity##19##2##(1991-10#2)(1991-7#1)(1994-2#1)(1996-2#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#6)(2011-1#1)(2012-12#1)(2012-3#2)
with sensitized##2##2##(2008-10#2)
with sensitizing##2##2##(1995-2#1)(1997-7#1)
with sensor##2##2##(1997-4#1)(2008-10#1)
with sensorineural##3##2##(1992-2#1)(2007-7#1)(2008-9#1)
with sensors on##2##3##(2006-10#1)(2008-3#1)
with sensors##4##2##(2006-10#1)(2006-2#1)(2008-10#1)(2008-3#1)
with sensory loss##4##3##(2008-7#1)(2012-1#3)
with sensory##13##2##(1992-4#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)(2012-1#5)(2012-2#1)
with sentence##2##2##(2008-9#1)(2009-9#1)
with sentinel lymph##2##3##(2008-8#1)(2011-2#1)
with separate##14##2##(1992-12#1)(1995-5#1)(1996-12#1)(2005-9#1)(2008-11#1)(2008-3#3)(2008-4#2)(2008-7#1)(2009-7#1)(2011-2#1)(2012-3#1)
with separated##4##2##(1990-6#1)(1996-7#1)(2008-3#1)(2008-5#1)
with separation##5##2##(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)
with sepsis and respiratory##2##4##(2012-12#1)(2013-1#1)
with sepsis and septic shock##2##5##(1993-12#2)
with sepsis and##7##3##(1992-12#2)(1993-12#2)(1993-2#1)(2012-12#1)(2013-1#1)
with sepsis##20##2##(1992-12#2)(1992-2#1)(1993-12#2)(1993-2#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-5#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#4)
with septal##3##2##(1994-2#1)(1995-6#1)(2008-10#1)
with septic arthritis caused by##2##5##(2006-10#2)
with septic arthritis##7##3##(1993-11#2)(2006-10#3)(2008-7#1)(2013-8#1)
with septic shock##4##3##(1995-2#1)(1996-9#1)(2006-10#1)(2011-2#1)
with septic##15##2##(1993-10#1)(1993-11#2)(1994-12#1)(1995-2#1)(1996-9#1)(2006-10#4)(2008-7#1)(2011-2#1)(2013-1#2)(2013-8#1)
with septo-optic dysplasia##2##3##(2011-1#2)
with sequelae of##4##3##(1990-12#1)(1991-4#1)(2009-4#1)(2010-12#1)
with sequence conservation##2##3##(2012-3#2)
with sequence homology to##2##4##(1994-12#1)(1995-7#1)
with sequence similarity to##5##4##(1990-6#1)(1991-11#1)(1991-12#2)(2008-4#1)
with sequence##20##2##(1990-6#1)(1991-11#1)(1991-12#2)(1993-8#1)(1994-12#1)(1994-9#1)(1995-3#1)(1995-7#1)(1995-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-11#1)(2011-1#1)(2012-3#2)(2013-8#1)
with sequence-specific##2##2##(1995-6#1)(2008-4#1)
with sequences derived from##2##4##(1990-7#1)(1992-4#1)
with sequences in##3##3##(1991-6#1)(1991-7#1)(1992-5#1)
with sequences##19##2##(1990-11#1)(1990-7#1)(1991-6#1)(1991-7#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-3#2)(1995-9#1)(1996-10#1)(1997-5#1)(2007-3#1)(2008-10#2)(2008-7#1)
with sequencing and##2##3##(1991-10#1)(2007-12#1)
with sequencing##3##2##(1991-10#1)(1991-2#1)(2007-12#1)
with sequential injection##2##3##(2008-10#2)
with sequential##16##2##(1994-10#1)(2007-1#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-4#1)(2009-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
with sera from##3##3##(1996-11#1)(1997-3#1)(2008-4#1)
with serial dilutions of##2##4##(1994-3#2)
with serial section##2##3##(1996-9#1)(2009-11#1)
with serial##12##2##(1994-10#1)(1994-3#2)(1996-9#1)(2005-5#1)(2006-12#1)(2007-10#1)(2007-2#1)(2008-11#1)(2008-7#1)(2009-11#1)(2013-1#1)
with series##3##2##(1990-8#1)(2008-10#2)
with serine##6##2##(1990-11#1)(1990-7#1)(1993-6#1)(1995-7#1)(1996-5#1)(2012-2#1)
with serious and persistent mental illness##3##6##(2010-2#1)(2013-1#2)
with serious and##4##3##(2010-2#1)(2011-2#1)(2013-1#2)
with serious clinical##2##3##(2005-1#1)(2008-7#1)
with serious complications##7##3##(1990-6#1)(1992-2#1)(2005-8#1)(2006-10#1)(2007-8#1)(2013-1#2)
with serious consequences##3##3##(2007-4#1)(2008-5#1)(2012-2#1)
with serious disease##2##3##(1992-2#1)(1993-9#1)
with serious gastrointestinal bleeding##2##4##(1991-4#1)(2011-12#1)
with serious mental illness##6##4##(2004-3#1)(2009-6#1)(2010-2#1)(2011-2#3)
with serious mental##9##3##(1997-3#1)(2004-3#1)(2008-2#1)(2009-6#1)(2010-2#1)(2011-2#3)(2013-1#1)
with serious##53##2##(1990-6#2)(1991-4#1)(1992-12#1)(1992-2#2)(1993-8#2)(1993-9#2)(1996-1#1)(1997-3#1)(2004-10#1)(2004-3#1)(2005-1#1)(2005-8#1)(2006-10#2)(2006-6#1)(2007-11#2)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-6#2)(2010-2#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#5)(2012-2#1)(2013-1#7)(2013-8#1)
with serologic##2##2##(1993-3#1)(2010-7#1)
with serological##4##2##(1994-4#1)(1997-3#1)(2007-8#1)(2008-10#1)
with seronegative rheumatoid arthritis##2##4##(2006-10#1)(2013-1#1)
with seronegative##7##2##(1991-9#1)(1994-6#1)(2006-10#3)(2008-5#1)(2013-1#1)
with seropositive##2##2##(2006-10#2)
with serotonin##8##2##(1993-12#1)(1993-9#1)(1995-12#1)(1995-7#1)(2005-7#1)(2007-8#1)(2012-12#1)(2013-8#1)
with serum MPA concentrations lower than 25 ng/ml##2##8##(1995-10#2)
with serum creatinine##7##3##(1991-8#1)(1995-7#1)(2008-1#3)(2008-4#1)(2013-1#1)
with serum levels of##3##4##(1990-10#1)(2008-6#1)(2011-1#1)
with serum levels##6##3##(1990-10#1)(1995-10#1)(1997-5#1)(2006-10#1)(2008-6#1)(2011-1#1)
with serum markers of##2##4##(2009-11#1)(2011-2#1)
with serum or##2##3##(1991-10#1)(1995-3#1)
with serum samples##2##3##(1997-4#1)(2008-5#1)
with serum starvation##2##3##(2012-2#2)
with serum##64##2##(1990-10#1)(1990-3#1)(1991-10#3)(1991-12#2)(1991-8#1)(1992-11#1)(1992-12#1)(1994-5#1)(1995-10#3)(1995-2#1)(1995-3#2)(1995-7#2)(1996-12#1)(1996-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#1)(2007-2#1)(2007-3#1)(2008-1#3)(2008-10#1)(2008-11#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#1)(2010-12#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#4)(2013-1#1)(2013-8#1)
with serum-free medium##3##3##(2008-11#2)(2012-12#1)
with serum-free##4##2##(1994-6#1)(2008-11#2)(2012-12#1)
with service personnel who##2##4##(2012-12#2)
with service providers##2##3##(2012-3#2)
with service users and##2##4##(2009-6#1)(2012-11#1)
with service##9##2##(1993-12#1)(2008-11#1)(2009-6#1)(2011-1#1)(2012-11#1)(2012-12#2)(2012-3#2)
with services##8##2##(1992-1#1)(1992-5#1)(1996-2#1)(2008-12#1)(2009-7#1)(2009-9#1)(2012-3#2)
with sets of##3##3##(1997-8#1)(2011-2#1)(2012-1#1)
with seven different##2##3##(2008-3#1)(2008-6#1)
with seven##28##2##(1991-5#1)(1992-12#1)(1994-2#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-7#1)(1997-6#1)(1997-8#1)(2007-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
with sever hemophilia A##2##4##(2008-12#2)
with several agents##3##3##(1992-12#1)(1992-6#1)(2008-8#1)
with several aspects##2##3##(2008-10#1)(2012-3#1)
with several autoimmune##3##3##(2005-8#1)(2008-10#1)(2011-1#1)
with several biological##2##3##(2008-10#1)(2012-12#1)
with several clinical##2##3##(2011-2#1)(2013-1#1)
with several different##3##3##(1993-3#1)(1993-9#1)(2008-4#1)
with several examples##3##3##(2006-5#1)(2008-11#1)(2011-1#1)
with several independent##3##3##(2006-12#1)(2008-10#1)(2012-3#1)
with several metabolic##3##3##(2010-12#1)(2012-12#1)(2013-8#1)
with several molecular##2##3##(1997-6#1)(2008-10#1)
with several of the##2##4##(1990-11#1)(2008-10#1)
with several other proteins##2##4##(2009-7#1)(2012-2#1)
with several other##11##3##(1990-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-7#1)(2011-1#1)(2012-2#2)(2013-1#1)
with several previously##2##3##(1997-5#1)(2008-10#1)
with several regions of##2##4##(1992-9#1)(1993-11#1)
with several sexual partners##2##4##(2008-5#1)(2013-1#1)
with several statistical##2##3##(2008-10#1)(2011-2#1)
with several structural##3##3##(1994-8#1)(1996-4#1)(2006-10#1)
with several symptoms##2##3##(2011-2#1)(2012-2#1)
with several types of##2##4##(1994-11#1)(1994-3#1)
with several##195##2##(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-8#1)(1991-2#1)(1991-4#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#2)(1993-3#2)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-4#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-4#2)(1996-5#3)(1997-4#6)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#4)(2006-11#1)(2006-12#3)(2006-5#2)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#26)(2008-11#7)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#6)(2008-8#5)(2009-10#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#5)(2011-2#3)(2012-12#6)(2012-2#6)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#1)
with severe abdominal pain##2##4##(2011-2#1)(2013-8#1)
with severe acute asthma##3##4##(1992-3#1)(1997-1#1)(2007-2#1)
with severe acute##12##3##(1990-12#1)(1992-3#1)(1995-2#1)(1997-1#1)(2006-10#1)(2007-2#1)(2008-11#1)(2008-5#1)(2009-8#1)(2010-5#1)(2013-1#1)(2013-8#1)
with severe and persistent mental illness##3##6##(2006-5#1)(2006-7#2)
with severe and persistent mental##4##5##(2006-5#1)(2006-7#2)(2008-2#1)
with severe and##10##3##(1997-2#2)(2006-4#1)(2006-5#1)(2006-7#2)(2007-2#1)(2008-2#1)(2010-1#1)(2011-2#1)
with severe anemia##2##3##(1992-3#1)(2012-3#1)
with severe aortic stenosis##4##4##(2007-8#4)
with severe aortic##8##3##(2007-8#5)(2008-11#1)(2009-5#1)(2013-1#1)
with severe aplastic##2##3##(2009-2#1)(2012-3#1)
with severe burns##3##3##(2008-10#1)(2008-7#1)(2012-12#1)
with severe cardiac##2##3##(2012-12#1)(2012-3#1)
with severe chronic##6##3##(1990-12#1)(1991-3#1)(2006-10#2)(2008-3#1)(2008-4#1)
with severe congestive##2##3##(2010-5#1)(2010-7#1)
with severe coronary artery##2##4##(2011-2#1)(2013-1#1)
with severe coronary##4##3##(2008-12#1)(2008-5#1)(2011-2#1)(2013-1#1)
with severe deficits##2##3##(1994-12#1)(2007-9#1)
with severe disability##2##3##(1997-1#1)(2008-6#1)
with severe disease##6##3##(1990-8#1)(2006-10#1)(2011-2#2)(2012-2#1)(2013-1#1)
with severe effects on##2##4##(1995-11#1)(2008-9#1)
with severe fibrosis##2##3##(2013-1#1)(2013-8#1)
with severe haemophilia##2##3##(2009-3#2)
with severe headache##2##3##(2007-9#1)(2012-12#1)
with severe heart failure##3##4##(2005-10#1)(2007-8#1)(2010-5#1)
with severe hemophilia A##2##4##(2012-12#1)(2012-2#1)
with severe hemophilia##5##3##(1990-11#2)(2009-3#1)(2012-12#1)(2012-2#1)
with severe hypercholesterolemia##2##3##(1994-12#1)(1997-7#1)
with severe hypertension##2##3##(1990-12#1)(1995-11#1)
with severe hypothermia##2##3##(1993-3#1)(2011-2#1)
with severe hypoxaemia##3##3##(1994-7#2)(2007-8#1)
with severe left ventricular dysfunction##3##5##(1997-1#2)(2012-2#1)
with severe limb##2##3##(1991-3#1)(2009-7#1)
with severe limitations##2##3##(1991-9#1)(2006-10#1)
with severe liver##2##3##(2006-10#1)(2013-8#1)
with severe lower respiratory tract##2##5##(1996-3#1)(2009-3#1)
with severe lupus nephritis##2##4##(2007-7#1)(2008-1#1)
with severe malnutrition##5##3##(2008-2#5)
with severe mental illness##12##4##(1992-5#1)(2006-5#2)(2008-2#4)(2010-8#2)(2010-9#2)(2011-1#1)
with severe mental retardation##5##4##(1991-3#1)(1992-1#1)(1992-2#1)(1993-3#1)(1996-3#1)
with severe mental##28##3##(1991-3#1)(1992-1#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-3#1)(1996-3#1)(2005-8#1)(2006-5#2)(2008-2#10)(2010-1#1)(2010-8#2)(2010-9#3)(2011-1#2)
with severe mitral regurgitation and##2##5##(2007-8#1)(2010-5#1)
with severe mitral##3##3##(2007-8#1)(2009-5#1)(2010-5#1)
with severe neurological impairment##2##4##(1991-2#1)(2012-12#1)
with severe neurological##7##3##(1991-2#1)(2004-11#1)(2005-12#1)(2006-10#1)(2007-3#1)(2010-12#1)(2012-12#1)
with severe neutropenia##3##3##(2007-11#2)(2012-12#1)
with severe obesity##3##3##(2006-8#3)
with severe pain##3##3##(2006-7#1)(2009-3#2)
with severe pelvic##2##3##(1991-3#1)(2012-12#1)
with severe perinatal asphyxia##2##4##(2012-12#2)
with severe preeclampsia and neurologic deficits##2##6##(2007-10#2)
with severe preeclampsia##5##3##(2007-10#3)(2012-2#2)
with severe problems##2##3##(1990-5#1)(2009-11#1)
with severe prune belly syndrome##2##5##(2008-7#2)
with severe pulmonary hypertension##5##4##(1993-8#1)(2006-10#2)(2010-6#1)(2012-3#1)
with severe pulmonary##7##3##(1993-8#1)(2006-10#2)(2006-4#1)(2010-6#1)(2011-2#1)(2012-3#1)
with severe refractory##5##3##(2007-11#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
with severe respiratory failure##3##4##(1997-3#1)(2006-10#1)(2012-2#1)
with severe respiratory syncytial virus bronchiolitis##2##6##(1994-6#2)
with severe respiratory##7##3##(1994-6#2)(1996-6#1)(1997-3#1)(2006-10#1)(2012-12#1)(2012-2#1)
with severe sepsis##19##3##(2006-4#2)(2007-12#2)(2007-7#1)(2009-5#1)(2009-6#5)(2011-1#2)(2011-2#3)(2012-2#2)(2013-1#1)
with severe stroke##2##3##(2007-10#1)(2007-9#1)
with severe symptomatic thyroid storm##2##5##(2012-12#2)
with severe symptomatic##3##3##(2008-5#1)(2012-12#2)
with severe underlying##2##3##(2008-5#1)(2011-2#1)
with severe##432##2##(1990-10#1)(1990-11#2)(1990-12#5)(1990-3#1)(1990-5#1)(1990-8#2)(1990-9#3)(1991-10#1)(1991-2#1)(1991-3#5)(1991-6#1)(1991-9#2)(1992-1#2)(1992-2#1)(1992-3#3)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#4)(1993-7#1)(1993-8#2)(1993-9#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#3)(1994-7#2)(1995-11#2)(1995-2#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#3)(1996-5#1)(1996-6#2)(1996-8#1)(1997-1#6)(1997-2#2)(1997-3#1)(1997-4#5)(1997-7#1)(1997-8#1)(2004-11#2)(2005-10#1)(2005-11#1)(2005-12#3)(2005-8#3)(2005-9#1)(2006-10#21)(2006-11#2)(2006-12#1)(2006-3#1)(2006-4#8)(2006-5#3)(2006-6#1)(2006-7#6)(2006-8#3)(2006-9#1)(2007-10#8)(2007-11#8)(2007-12#5)(2007-2#5)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#18)(2007-9#9)(2008-1#4)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#20)(2008-3#4)(2008-4#5)(2008-5#10)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#4)(2009-1#1)(2009-11#1)(2009-2#2)(2009-3#7)(2009-4#1)(2009-5#4)(2009-6#7)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#6)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#5)(2011-1#6)(2011-2#27)(2012-1#7)(2012-12#14)(2012-2#18)(2012-3#6)(2013-1#13)(2013-7#1)(2013-8#7)
with severely impaired##3##3##(2007-9#1)(2008-7#1)(2009-6#1)
with severely reduced##2##3##(1992-9#1)(2007-9#1)
with severely##9##2##(1992-9#1)(1995-3#1)(2007-11#1)(2007-8#1)(2007-9#2)(2008-4#1)(2008-7#1)(2009-6#1)
with severity and outcome##2##4##(2007-10#2)
with severity and##3##3##(2005-8#1)(2007-10#2)
with severity of atherosclerosis##2##4##(1991-9#1)(2008-1#1)
with severity of##15##3##(1991-9#1)(1993-11#1)(1995-11#1)(1996-12#1)(1996-3#1)(1996-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#3)
with severity##19##2##(1991-9#1)(1993-11#1)(1995-11#1)(1996-12#1)(1996-3#1)(1996-7#1)(2005-8#1)(2006-11#1)(2007-10#2)(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#3)
with sevoflurane and##2##3##(2012-12#1)(2013-8#1)
with sevoflurane in##2##3##(2006-10#1)(2007-2#1)
with sevoflurane##11##2##(2006-10#2)(2007-2#3)(2007-9#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-8#1)
with sex and age##2##4##(2005-10#1)(2011-2#1)
with sex chromosomes##2##3##(2008-8#1)(2010-3#1)
with sex reversal##2##3##(1990-11#1)(1991-11#1)
with sex workers##4##3##(2011-2#1)(2012-3#3)
with sex##19##2##(1990-11#1)(1991-11#1)(1991-3#1)(1991-6#1)(1994-12#1)(1995-8#1)(1996-1#1)(2005-10#1)(2007-12#1)(2008-4#1)(2008-8#1)(2010-10#1)(2010-3#1)(2011-2#3)(2012-3#3)
with sexual abuse##2##3##(1993-5#1)(2010-4#1)
with sexual behavior and##2##4##(2012-11#1)(2013-1#1)
with sexual maturation##2##3##(1990-7#1)(1995-6#1)
with sexual practices##3##3##(1996-5#1)(2008-2#2)
with sexual##18##2##(1990-7#1)(1991-8#1)(1992-2#1)(1993-5#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-5#1)(2006-7#1)(2008-2#2)(2009-5#2)(2009-7#1)(2010-4#1)(2012-11#1)(2013-1#2)
with sexually receptive female rats##2##5##(2013-8#2)
with sexually transmitted diseases##3##4##(1991-6#1)(1996-12#1)(2006-10#1)
with sexually transmitted##7##3##(1991-6#1)(1996-12#2)(2006-10#1)(2007-7#3)
with sexually##10##2##(1991-6#1)(1996-12#2)(1996-5#1)(2006-10#1)(2007-7#3)(2013-8#2)
with shaking##2##2##(1996-12#2)
with sham##2##2##(1993-3#1)(2012-3#1)
with sham-operated controls##3##3##(1990-10#1)(1993-6#1)(1997-7#1)
with sham-operated##4##2##(1990-10#1)(1993-6#1)(1997-7#1)(2013-1#1)
with shampoo##2##2##(2008-5#2)
with shape##4##2##(1993-4#1)(2006-6#1)(2008-10#1)(2011-1#1)
with sharp##9##2##(1991-3#1)(1993-2#1)(2008-3#2)(2009-11#1)(2010-1#1)(2010-11#1)(2010-7#1)(2012-3#1)
with shaving##2##2##(2006-12#1)(2008-5#1)
with shear##4##2##(2005-11#1)(2008-11#1)(2008-2#1)(2009-7#1)
with shedding##2##2##(1996-2#1)(2012-3#1)
with sheep red blood cells (SRBC)##4##6##(1995-2#1)(2008-10#1)(2008-4#1)(2008-7#1)
with sheep red blood cells##8##5##(1995-2#1)(2008-10#3)(2008-4#1)(2008-7#2)(2013-1#1)
with sheep##10##2##(1993-8#1)(1995-2#1)(2008-10#3)(2008-4#1)(2008-7#2)(2010-4#1)(2013-1#1)
with shift work disorder##4##4##(2012-12#4)
with shift##5##2##(2011-1#1)(2012-12#4)
with shifts in##2##3##(2010-3#1)(2012-1#1)
with shifts##3##2##(1995-5#1)(2010-3#1)(2012-1#1)
with shock and##2##3##(1993-10#1)(2007-7#1)
with shock##6##2##(1993-10#1)(2006-10#1)(2007-7#1)(2009-11#3)
with short acting beta agonist use##2##6##(2012-1#2)
with short and##2##3##(2008-5#1)(2011-1#1)
with short laser##2##3##(1993-8#1)(2008-2#1)
with short latency##2##3##(1992-8#1)(1994-6#1)
with short peptides##3##3##(2008-4#2)(2012-2#1)
with short stature##7##3##(2007-11#1)(2007-8#1)(2008-9#1)(2010-12#2)(2011-1#1)(2012-2#1)
with short##52##2##(1990-10#1)(1992-8#1)(1993-12#1)(1993-7#1)(1993-8#1)(1994-1#1)(1994-2#2)(1994-6#1)(1996-11#1)(1996-9#1)(2005-11#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-9#2)(2009-12#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-8#1)(2011-1#2)(2012-1#2)(2012-2#5)(2013-1#1)
with short-bowel##2##2##(1994-3#1)(2008-9#1)
with short-range##2##2##(1992-5#1)(2008-8#1)
with short-scale dispersion##2##3##(2007-12#2)
with short-term##9##2##(1990-11#1)(1995-5#1)(1996-5#1)(2006-12#1)(2006-8#1)(2007-8#1)(2008-11#1)(2010-2#1)(2013-1#1)
with shortening##3##2##(2012-2#1)(2013-1#2)
with shorter time##2##3##(2007-11#1)(2008-4#1)
with shorter ventilatory support##2##4##(2007-8#2)
with shorter##22##2##(1990-11#1)(1993-10#1)(1993-3#1)(1995-4#1)(1996-4#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2010-12#1)(2013-1#2)
with shortness of##2##3##(2006-6#1)(2012-3#1)
with shot-noise-limited##2##2##(2007-12#1)(2008-2#1)
with shoulder pain and##2##4##(2006-10#1)(2007-11#1)
with shoulder pain##4##3##(1996-2#1)(2006-10#1)(2006-12#1)(2007-11#1)
with shoulder##14##2##(1996-2#1)(1996-9#1)(2006-10#1)(2006-12#1)(2007-11#3)(2007-7#2)(2008-12#1)(2009-3#1)(2009-7#1)(2013-1#2)
with shrinking##3##2##(1992-3#1)(1996-2#1)(2008-12#1)
with shunt##2##2##(2012-12#2)
with sialidase##2##2##(1992-9#1)(1993-11#1)
with siblings##5##2##(2006-10#1)(2008-8#1)(2011-12#3)
with sicca##2##2##(2006-10#1)(2007-7#1)
with sickle cell anaemia and##2##5##(2009-4#2)
with sickle cell anaemia##4##4##(1992-8#1)(2009-4#3)
with sickle cell disease and##4##5##(1992-3#2)(2012-12#1)(2013-8#1)
with sickle cell disease##20##4##(1992-3#4)(2005-10#1)(2006-7#1)(2007-2#1)(2007-3#3)(2009-2#1)(2009-4#1)(2010-11#1)(2011-2#1)(2012-12#3)(2013-1#1)(2013-8#2)
with sickle cell##26##3##(1992-3#4)(1992-8#1)(2005-10#1)(2006-7#1)(2007-2#2)(2007-3#3)(2009-2#1)(2009-4#4)(2010-11#1)(2011-2#1)(2012-12#4)(2013-1#1)(2013-8#2)
with sickle-cell disease##3##3##(2006-5#1)(2008-10#2)
with sickle-cell##6##2##(2006-5#1)(2008-10#2)(2008-7#1)(2009-10#1)(2013-1#1)
with side effects##3##3##(2008-10#1)(2008-8#1)(2012-1#1)
with side##7##2##(2007-11#2)(2008-10#1)(2008-8#1)(2011-12#1)(2011-2#1)(2012-1#1)
with side-chain##2##2##(2006-12#1)(2009-3#1)
with sideband##2##2##(2007-11#1)(2007-12#1)
with signal transduction##2##3##(2008-11#2)
with signal##8##2##(2008-10#2)(2008-11#2)(2008-3#1)(2008-9#1)(2010-5#1)(2011-2#1)
with signaling##4##2##(2007-12#1)(2008-1#1)(2009-6#1)(2011-2#1)
with signals##4##2##(1995-6#1)(2008-2#1)(2012-12#2)
with significant (&gt##2##3##(2007-10#1)(2009-6#1)
with significant (P&lt##3##3##(2008-5#1)(2010-5#2)
with significant anti##2##3##(2008-1#1)(2011-1#1)
with significant changes in##4##4##(1991-7#1)(1993-12#1)(2008-3#1)(2010-6#1)
with significant changes##5##3##(1991-7#1)(1993-12#1)(1997-2#1)(2008-3#1)(2010-6#1)
with significant clinical and##2##4##(2006-10#1)(2010-8#1)
with significant clinical##4##3##(2006-10#1)(2007-10#1)(2008-4#1)(2010-8#1)
with significant decreases##4##3##(1993-12#1)(1995-2#1)(1996-12#1)(2007-8#1)
with significant delays in this group (median 135 vs##2##9##(2013-1#2)
with significant difference##2##3##(2006-8#1)(2013-8#1)
with significant differences between##3##4##(1993-2#1)(2006-10#1)(2013-7#1)
with significant differences in the##2##5##(1992-1#1)(1995-1#1)
with significant differences in##3##4##(1992-1#1)(1995-1#1)(2010-2#1)
with significant differences##11##3##(1992-1#1)(1993-2#1)(1995-1#1)(2006-10#1)(2006-9#1)(2008-5#2)(2010-2#1)(2011-2#1)(2012-2#1)(2013-7#1)
with significant elevation of##2##4##(1995-3#1)(2006-10#1)
with significant homology to##2##4##(1997-1#1)(1997-6#1)
with significant impact##2##3##(1990-12#1)(2008-4#1)
with significant improvement in##4##4##(2006-7#1)(2008-1#1)(2008-3#1)(2012-1#1)
with significant increases in##4##4##(1995-5#1)(2008-1#1)(2010-12#1)(2010-8#1)
with significant increases##5##3##(1995-5#1)(2008-1#1)(2008-10#1)(2010-12#1)(2010-8#1)
with significant interaction##2##3##(2012-6#2)
with significant medical comorbidities##2##4##(2007-12#1)(2010-9#1)
with significant medical##3##3##(2005-6#1)(2007-12#1)(2010-9#1)
with significant morbidity and mortality##15##5##(2005-11#1)(2006-10#3)(2007-10#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#1)(2012-1#1)(2012-2#1)(2013-8#2)
with significant morbidity and##18##4##(2005-11#1)(2006-10#3)(2006-4#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-2#1)(2012-1#1)(2012-2#1)(2013-8#2)
with significant morbidity##25##3##(2005-11#1)(2006-10#3)(2006-4#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-6#1)(2010-2#1)(2010-7#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#2)
with significant reduction in##3##4##(1990-5#1)(1996-12#1)(2011-1#1)
with significant reductions in##5##4##(1994-6#1)(1995-1#1)(2007-8#1)(2008-10#2)
with significant reductions##6##3##(1994-6#1)(1995-1#1)(1995-5#1)(2007-8#1)(2008-10#2)
with significant risk##4##3##(2004-3#1)(2007-11#1)(2008-7#1)(2011-2#1)
with significant sequence##3##3##(1995-3#1)(1996-12#1)(1996-5#1)
with significant side effects##2##4##(1993-9#1)(2013-8#1)
with significant similarity to##2##4##(1991-6#1)(1994-12#1)
with significant structural##2##3##(1996-2#1)(2012-2#1)
with significant success in##2##4##(2007-11#1)(2012-2#1)
with significant success##3##3##(1995-5#1)(2007-11#1)(2012-2#1)
with significant therapeutic##2##3##(2010-2#1)(2010-7#1)
with significant##211##2##(1990-12#1)(1990-5#2)(1990-6#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-4#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-1#2)(1995-2#1)(1995-3#2)(1995-5#3)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-5#2)(1997-6#1)(2004-3#1)(2005-11#1)(2005-6#1)(2005-8#2)(2005-9#1)(2006-10#8)(2006-2#2)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#4)(2007-11#7)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#7)(2007-9#4)(2008-1#4)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#8)(2008-5#7)(2008-6#1)(2008-7#6)(2008-9#2)(2009-10#2)(2009-3#1)(2009-6#3)(2009-7#1)(2009-9#1)(2010-10#3)(2010-12#4)(2010-2#5)(2010-5#3)(2010-6#1)(2010-7#5)(2010-8#4)(2010-9#1)(2011-1#5)(2011-2#9)(2012-1#4)(2012-11#1)(2012-12#2)(2012-2#6)(2012-3#2)(2012-6#2)(2012-7#1)(2013-1#5)(2013-7#1)(2013-8#5)
with significantly better results by##2##5##(2012-2#2)
with significantly better##4##3##(1993-9#1)(2008-3#1)(2012-2#2)
with significantly different##7##3##(1991-12#1)(1994-9#1)(2007-2#1)(2008-10#2)(2009-6#1)(2012-3#1)
with significantly fewer##3##3##(2005-7#1)(2006-10#2)
with significantly greater##3##3##(2008-10#2)(2012-3#1)
with significantly high##3##3##(2008-10#1)(2010-5#1)(2013-8#1)
with significantly higher##8##3##(1994-2#1)(2007-12#1)(2007-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2012-12#1)(2013-8#1)
with significantly improved##4##3##(2008-1#1)(2010-12#1)(2013-1#2)
with significantly increased##3##3##(1997-1#1)(2008-9#1)(2012-2#1)
with significantly longer##3##3##(2006-8#1)(2011-2#2)
with significantly lower##7##3##(2007-12#1)(2007-5#1)(2007-9#1)(2008-1#1)(2009-5#1)(2009-9#1)(2013-1#1)
with significantly more##3##3##(2005-9#1)(2008-10#1)(2012-2#1)
with significantly reduced##2##3##(1993-9#1)(2008-2#1)
with significantly##56##2##(1990-2#1)(1991-12#1)(1993-3#1)(1993-9#2)(1994-2#1)(1994-9#1)(1997-1#1)(1997-7#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#2)(2007-9#1)(2008-1#2)(2008-10#7)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#2)
with signs and symptoms of##4##5##(2006-10#1)(2008-11#1)(2008-4#1)(2011-12#1)
with signs and symptoms suggesting##2##5##(2007-7#1)(2011-1#1)
with signs and symptoms##10##4##(2006-10#1)(2006-5#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-4#1)(2011-1#1)(2011-12#1)(2013-1#1)
with signs and##12##3##(2006-10#1)(2006-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#1)(2011-1#1)(2011-12#1)(2013-1#1)
with signs of cholinergic stimulation##3##5##(2011-12#3)
with signs of##16##3##(1990-8#1)(1991-11#1)(1993-5#1)(1994-10#1)(1995-3#1)(2005-10#1)(2006-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-12#3)(2013-1#1)
with signs##28##2##(1990-8#1)(1991-11#1)(1993-5#1)(1994-10#1)(1995-3#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2011-1#2)(2011-12#4)(2013-1#2)
with silane coupling agents##2##4##(2005-11#1)(2009-7#1)
with silent myocardial ischemia##3##4##(1992-6#1)(2008-7#2)
with silent##7##2##(1990-11#1)(1991-11#1)(1992-6#1)(2008-7#3)(2009-8#1)
with silica by##2##3##(2005-11#2)
with silica gel modified with niobium(V) oxide##2##7##(2008-10#1)(2008-3#1)
with silica gel modified with##5##5##(2008-10#4)(2008-3#1)
with silica gel##11##3##(2007-8#1)(2008-10#9)(2008-3#1)
with silica##22##2##(2005-11#2)(2007-8#1)(2008-10#11)(2008-12#1)(2008-3#1)(2009-7#2)(2009-8#1)(2010-3#1)(2010-7#1)(2013-1#1)
with silicic##2##2##(2005-11#1)(2010-4#1)
with silicon##6##2##(2007-11#1)(2008-10#3)(2008-3#1)(2010-4#1)
with silicone catheters##2##3##(2007-7#2)
with silicone##7##2##(2007-1#2)(2007-10#1)(2007-7#2)(2008-10#1)(2008-9#1)
with silicotungstic acid in acidic medium to form a##2##9##(2008-10#2)
with silver ions##2##3##(2008-10#1)(2010-7#1)
with silver nanoparticles##2##3##(2008-10#1)(2013-7#1)
with silver nitrate##3##3##(1997-8#1)(2007-10#1)(2008-10#1)
with silver staining##2##3##(2005-8#1)(2008-8#1)
with silver##23##2##(1991-1#1)(1997-8#1)(2005-11#2)(2005-8#1)(2007-10#1)(2007-12#1)(2008-10#8)(2008-2#2)(2008-8#1)(2009-3#1)(2010-4#1)(2010-7#1)(2012-2#1)(2013-7#1)
with silylated bases##2##3##(1996-5#2)
with silylated thymine##2##3##(1996-5#2)
with silylated##4##2##(1996-5#4)
with simian immunodeficiency virus##3##4##(1993-9#1)(1995-2#1)(2007-11#1)
with simian##4##2##(1993-9#1)(1995-2#1)(2007-11#1)(2013-1#1)
with similar IC50##2##3##(1990-6#1)(1993-3#1)
with similar affinities##2##3##(1995-6#1)(1996-12#1)
with similar binding##3##3##(1991-5#1)(1993-6#1)(2012-2#1)
with similar characteristics to##2##4##(2007-4#1)(2007-5#1)
with similar characteristics##5##3##(1990-8#1)(1994-12#1)(2007-4#1)(2007-5#1)(2010-12#1)
with similar clinical##3##3##(1995-2#1)(2008-3#1)(2013-8#1)
with similar data from##2##4##(1991-12#1)(1997-1#1)
with similar data##3##3##(1991-12#1)(1997-1#1)(2007-8#1)
with similar efficacy##2##3##(1994-3#1)(2008-10#1)
with similar efficiency##4##3##(1997-5#1)(2008-10#1)(2008-12#1)(2008-3#1)
with similar expression profiles##2##4##(2008-2#2)
with similar frequencies##2##3##(1992-9#1)(2012-2#1)
with similar frequency##2##3##(1991-7#1)(2008-10#1)
with similar kinetics##2##3##(1990-5#1)(1996-8#1)
with similar levels of##2##4##(1993-4#1)(2006-11#1)
with similar levels##3##3##(1993-4#1)(2006-11#1)(2012-1#1)
with similar magnitude##3##3##(2008-10#1)(2008-11#2)
with similar mechanisms##2##3##(2008-10#1)(2011-1#1)
with similar molecular##2##3##(1990-12#1)(1994-6#1)
with similar patterns##2##3##(1996-3#1)(2010-4#1)
with similar potency##5##3##(1990-2#1)(1990-7#1)(1995-12#1)(1997-1#1)(2008-12#1)
with similar problems##2##3##(1997-3#1)(2004-3#1)
with similar protein##2##3##(2011-1#1)(2013-8#1)
with similar results##6##3##(1990-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2013-1#1)
with similar structures to##2##4##(2007-8#1)(2008-10#1)
with similar studies##3##3##(1995-10#1)(2008-11#1)(2008-5#1)
with similar symptoms##3##3##(1993-8#1)(2005-8#1)(2010-12#1)
with similar##191##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#2)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-5#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#4)(1994-3#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#2)(1995-10#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#2)(1996-12#2)(1996-3#2)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-3#2)(2005-10#2)(2005-11#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-11#2)(2006-12#2)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#5)(2008-10#22)(2008-11#4)(2008-12#4)(2008-2#6)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#2)(2009-5#3)(2009-7#3)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#3)(2010-5#1)(2011-1#5)(2011-2#2)(2012-1#1)(2012-2#4)(2012-3#3)(2012-6#1)(2013-1#3)(2013-8#3)
with similarities to##2##3##(1994-9#1)(2004-11#1)
with similarity to##4##3##(1994-10#1)(1994-9#1)(2008-10#2)
with similarity##5##2##(1994-10#1)(1994-9#1)(2008-10#2)(2012-2#1)
with similarly##2##2##(1997-7#1)(2005-11#1)
with simple and complex##2##4##(1994-2#1)(2008-12#1)
with simple and##3##3##(1994-2#1)(2008-12#1)(2008-5#1)
with simple sequence repeat markers##2##5##(1996-3#1)(2008-10#1)
with simple sequence repeat##3##4##(1996-3#1)(2008-10#1)(2008-9#1)
with simple suture##2##3##(1990-6#1)(1996-2#1)
with simple##41##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-4#2)(1993-8#1)(1994-2#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-2#4)(2008-3#4)(2008-5#2)(2008-7#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-2#2)(2010-8#1)(2011-1#2)(2011-2#1)(2013-1#1)
with simplicity##2##2##(2005-12#1)(2008-8#1)
with simulated and real data##2##5##(2008-3#1)(2009-9#1)
with simulated and real##3##4##(2008-10#1)(2008-3#1)(2009-9#1)
with simulated and##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2009-9#1)
with simulated data##9##3##(1995-6#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2011-1#1)
with simulated##26##2##(1995-6#1)(2007-12#1)(2008-10#4)(2008-2#6)(2008-3#7)(2008-7#1)(2009-10#1)(2009-9#1)(2010-3#1)(2011-1#1)(2012-3#2)
with simulation results##2##3##(2007-8#1)(2009-10#1)
with simulation##4##2##(2007-8#1)(2009-10#1)(2009-2#1)(2012-12#1)
with simulations and##4##3##(1994-9#1)(2008-2#1)(2010-1#1)(2010-8#1)
with simulations of##2##3##(2008-2#1)(2010-2#1)
with simulations that##2##3##(2007-11#1)(2007-12#1)
with simulations##20##2##(1992-12#1)(1994-9#1)(1995-2#1)(2007-11#2)(2007-12#4)(2008-11#1)(2008-2#3)(2008-3#2)(2009-5#1)(2010-1#2)(2010-2#1)(2010-8#1)
with simultaneous addition of three analytes##2##6##(2008-10#2)
with simultaneous##39##2##(1990-3#1)(1994-7#1)(1995-6#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-2#1)(2008-3#4)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
with simultaneously##5##2##(1991-9#1)(2008-10#1)(2008-3#1)(2013-7#2)
with simvastatin is##2##3##(1991-1#1)(1997-6#1)
with simvastatin##12##2##(1991-1#2)(1991-6#1)(1997-2#1)(1997-5#1)(1997-6#1)(2008-4#3)(2008-7#1)(2012-2#2)
with since##2##2##(2006-7#1)(2013-1#1)
with single amino acid substitutions##2##5##(1994-2#1)(1994-5#1)
with single amino acid##3##4##(1994-2#1)(1994-5#1)(2008-8#1)
with single and##3##3##(2006-2#1)(2008-3#1)(2008-4#1)
with single blocks##2##3##(2006-7#1)(2006-8#1)
with single dose##2##3##(1993-2#2)
with single doses of##2##4##(1994-5#1)(1996-8#1)
with single extraction##2##3##(2008-10#2)
with single or multiple##3##4##(2006-10#1)(2007-11#1)(2009-3#1)
with single or##5##3##(2006-10#1)(2007-11#1)(2008-2#1)(2009-3#1)(2009-9#1)
with single output##2##3##(2008-10#2)
with single particles##2##3##(2007-3#1)(2008-10#1)
with single ventricle physiology##2##4##(2005-12#1)(2013-7#1)
with single ventricle##3##3##(2005-12#1)(2008-9#1)(2013-7#1)
with single##74##2##(1991-7#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-2#2)(1994-2#1)(1994-5#2)(1996-4#1)(1996-8#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2009-9#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
with single-agent##4##2##(2006-10#1)(2008-6#2)(2012-1#1)
with single-base resolution using soft-clipping information##2##6##(2012-3#2)
with single-base##4##2##(2008-10#1)(2008-9#1)(2012-3#2)
with single-gene##2##2##(2009-5#2)
with single-level C-ADR##2##3##(2012-12#2)
with single-level##3##2##(2012-12#3)
with single-mode##3##2##(2007-12#2)(2008-2#1)
with single-neuron##2##2##(1994-2#1)(2008-4#1)
with single-particle##2##2##(2008-3#1)(2008-7#1)
with single-pass##3##2##(2007-12#1)(2008-2#2)
with single-photon##3##2##(2007-12#1)(2008-3#1)(2012-2#1)
with single-site##2##2##(1990-8#1)(1996-5#1)
with single-stage##3##2##(2007-11#1)(2007-12#1)(2008-8#1)
with single-stranded (ss)##2##3##(2008-10#1)(2008-2#1)
with single-stranded##6##2##(1990-2#2)(1994-11#1)(1997-2#1)(2008-10#1)(2008-2#1)
with single-use##2##2##(2007-2#2)
with single-walled##2##2##(2008-7#2)
with singlet##3##2##(1992-9#1)(2007-8#1)(2010-5#1)
with singular##2##2##(2008-2#1)(2008-3#1)
with sinonasal##2##2##(2010-2#1)(2013-1#1)
with sinus##7##2##(1997-1#1)(2007-9#1)(2008-1#1)(2008-7#2)(2011-2#1)(2012-12#1)
with sinusitis##4##2##(1993-2#2)(2008-5#2)
with sinusoidal phase modulation##2##4##(2007-12#1)(2008-2#1)
with sinusoidal##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
with site##6##2##(1992-12#1)(1993-3#1)(2007-1#1)(2008-10#1)(2008-4#1)(2012-12#1)
with site-directed mutagenesis##2##3##(1994-11#1)(2008-4#1)
with site-directed##3##2##(1994-11#1)(1995-2#1)(2008-4#1)
with sites of##2##3##(1996-5#1)(2008-10#1)
with sites##4##2##(1996-5#1)(2008-10#3)
with situs inversus##6##3##(1993-9#1)(2008-7#1)(2009-8#1)(2012-12#3)
with situs##8##2##(1993-9#1)(2007-8#1)(2008-7#1)(2009-8#1)(2012-12#4)
with six primary##2##3##(1990-12#1)(2013-8#1)
with six##32##2##(1990-12#1)(1990-8#1)(1990-9#1)(1991-8#1)(1993-1#1)(1995-3#1)(1996-10#1)(1997-4#2)(1997-7#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-10#8)(2008-2#3)(2008-3#1)(2008-7#1)(2009-9#1)(2010-10#1)(2010-7#1)(2011-12#1)(2013-1#1)(2013-8#1)
with size of##3##3##(1997-3#1)(2007-8#1)(2013-7#1)
with size parameters##2##3##(2008-2#1)(2008-3#1)
with size##15##2##(1995-6#1)(1997-3#1)(2006-10#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#2)(2009-5#1)(2010-4#1)(2013-7#1)
with sizes distributed according to##2##5##(2008-2#2)
with sizes of##3##3##(1993-2#1)(2008-7#1)(2010-4#1)
with sizes##9##2##(1992-8#1)(1993-2#1)(1995-4#1)(2007-12#1)(2008-2#2)(2008-7#1)(2010-4#1)(2013-7#1)
with skeletal metastases##5##3##(2007-11#2)(2008-7#1)(2009-8#2)
with skeletal muscle##3##3##(1994-6#1)(1995-2#1)(2011-1#1)
with skeletal##13##2##(1994-6#1)(1995-2#1)(2007-11#2)(2008-7#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-2#1)(2011-1#1)(2013-8#1)
with skepticism##2##2##(2008-4#1)(2009-3#1)
with skilled##4##2##(1994-6#1)(1995-5#1)(2008-11#1)(2011-1#1)
with skills##2##2##(2006-8#1)(2008-10#1)
with skimmer interface##3##3##(2008-10#3)
with skin and umbilical metastasis##2##5##(2010-9#2)
with skin and##7##3##(2007-10#1)(2007-3#1)(2008-2#1)(2009-4#1)(2010-7#1)(2010-9#2)
with skin diseases##3##3##(2005-11#1)(2008-12#1)(2010-7#1)
with skin involvement##2##3##(1996-11#1)(2006-10#1)
with skin necrosis##3##3##(1991-8#1)(2008-9#1)(2010-2#1)
with skin types I##2##4##(2008-5#1)(2011-2#1)
with skin ulceration##2##3##(1996-11#1)(2006-9#1)
with skin##45##2##(1990-2#1)(1991-8#1)(1991-9#1)(1992-8#1)(1994-6#1)(1996-11#2)(1996-6#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-12#2)(2008-2#1)(2008-5#4)(2008-9#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-6#1)(2010-7#2)(2010-9#3)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
with skull base##2##3##(2006-12#1)(2006-6#1)
with skull##6##2##(2006-11#1)(2006-12#1)(2006-6#1)(2006-9#1)(2008-8#1)(2010-12#1)
with slanted##2##2##(2007-12#1)(2008-3#1)
with sleep and##4##3##(1993-11#1)(1993-3#1)(1994-2#1)(2011-2#1)
with sleep apnea##3##3##(2006-10#2)(2012-1#1)
with sleep##13##2##(1993-11#1)(1993-3#1)(1994-2#1)(1994-4#1)(2006-10#4)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
with slight modifications##2##3##(1996-3#1)(2008-5#1)
with slight##4##2##(1996-3#1)(2006-4#1)(2008-10#1)(2008-5#1)
with slightly##11##2##(1994-11#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2010-4#1)(2010-6#1)(2011-1#1)
with slope##6##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-9#1)
with slopes of##3##3##(1994-8#1)(2008-10#2)
with slopes##4##2##(1994-8#1)(2008-10#3)
with slow##15##2##(1991-9#1)(1994-3#2)(1995-11#1)(1996-1#1)(2006-10#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-8#1)(2013-1#3)
with slow-release##2##2##(2007-2#1)(2008-8#1)
with slower##8##2##(1991-4#1)(1991-8#1)(1993-12#1)(1995-3#1)(1996-12#1)(2006-10#1)(2007-12#1)(2009-8#1)
with slowly##3##2##(2008-8#1)(2013-1#2)
with slurry sampling##2##3##(2005-4#1)(2008-10#1)
with slurry##5##2##(2005-4#1)(2008-10#3)(2008-6#1)
with small bowel##5##3##(2010-12#3)(2013-1#2)
with small cell carcinoma##4##4##(2009-1#1)(2009-3#2)(2009-5#1)
with small cell lung cancer##3##5##(1994-10#1)(1996-2#1)(2013-8#1)
with small cell##8##3##(1990-10#1)(1994-10#1)(1996-2#1)(2009-1#1)(2009-3#2)(2009-5#1)(2013-8#1)
with small changes in##2##4##(2010-7#1)(2012-1#1)
with small collagen fragments##2##4##(2011-1#2)
with small doses of##2##4##(1990-6#1)(2008-7#1)
with small doses##3##3##(1990-6#1)(2008-7#1)(2011-1#1)
with small intestinal##3##3##(2010-6#1)(2012-2#1)(2013-1#1)
with small ionised molecules##2##4##(2010-5#2)
with small molecule##2##3##(2010-3#1)(2010-5#1)
with small or##2##3##(1996-12#1)(2008-9#1)
with small sample size##2##4##(1996-12#2)
with small sample sizes##2##4##(2009-4#1)(2010-2#1)
with small sample##4##3##(1996-12#2)(2009-4#1)(2010-2#1)
with small surface##3##3##(1990-8#1)(2008-3#1)(2010-4#1)
with small unilamellar##2##3##(1990-2#1)(1993-8#1)
with small##122##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#2)(1992-10#2)(1992-12#1)(1992-7#2)(1992-8#1)(1993-11#1)(1993-8#1)(1994-10#1)(1994-3#1)(1995-9#1)(1996-12#4)(1996-2#1)(1996-9#1)(1997-4#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-5#2)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#9)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-1#1)(2009-3#2)(2009-4#1)(2009-5#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#1)(2011-1#6)(2011-2#4)(2012-1#2)(2012-2#3)(2013-1#4)(2013-8#3)
with small-bowel atresia##2##3##(2008-9#2)
with small-bowel##4##2##(2008-9#4)
with small-cell lung##3##3##(1992-9#2)(1993-7#1)
with smaller amounts of##2##4##(1990-2#1)(2007-10#1)
with smaller ones##2##3##(1993-9#1)(2008-10#1)
with smaller##29##2##(1990-12#2)(1990-2#1)(1991-11#1)(1991-4#1)(1993-9#1)(1994-12#1)(1995-3#1)(2005-11#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2010-8#2)(2012-12#2)
with smokers##3##2##(1993-11#1)(2009-7#1)(2013-1#1)
with smoking and##3##3##(1991-8#1)(2006-8#1)(2013-1#1)
with smoking cessation##2##3##(2008-7#1)(2010-2#1)
with smoking habit (p &lt##2##5##(2006-8#1)(2010-5#1)
with smoking habits##2##3##(1994-6#1)(2011-1#1)
with smoking in the##2##4##(2012-2#1)(2013-1#1)
with smoking status##2##3##(2008-12#1)(2010-12#1)
with smoking##29##2##(1990-9#1)(1991-8#1)(1994-6#1)(1996-3#1)(1996-7#1)(2006-8#2)(2007-11#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#3)
with smooth muscle cells##3##4##(1995-1#1)(2010-12#1)(2012-2#1)
with smooth muscle##7##3##(1991-6#1)(1995-1#1)(1997-8#1)(2010-12#3)(2012-2#1)
with smooth##15##2##(1991-6#1)(1995-1#1)(1997-8#1)(2004-9#1)(2005-11#1)(2007-12#2)(2007-7#1)(2008-3#1)(2009-11#1)(2010-12#3)(2012-2#1)(2013-8#1)
with snow##2##2##(2008-3#2)
with so-called##2##2##(1990-8#1)(2008-10#1)
with soap and water##2##4##(2007-2#1)(2008-5#1)
with soap##3##2##(1996-6#1)(2007-2#1)(2008-5#1)
with soapsuds enema##2##3##(1990-8#2)
with social and##2##3##(1991-12#1)(2011-12#1)
with social phobia##6##3##(1996-1#1)(2004-11#1)(2006-6#1)(2008-4#3)
with social##28##2##(1991-12#2)(1993-3#1)(1996-1#1)(1996-11#1)(1997-8#1)(2004-11#1)(2006-2#1)(2006-6#1)(2006-7#2)(2007-1#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-6#1)(2009-10#1)(2010-10#1)(2010-2#2)(2010-4#1)(2011-12#1)(2012-2#1)(2013-1#1)
with society##2##2##(1994-2#1)(2008-12#1)
with socio-demographic##4##2##(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
with socio-economic##2##2##(1992-2#1)(2011-12#1)
with socioeconomic status##4##3##(2011-1#1)(2011-2#2)(2013-1#1)
with socioeconomic##5##2##(2006-10#1)(2011-1#1)(2011-2#2)(2013-1#1)
with sociosexual##2##2##(1995-5#1)(1997-5#1)
with sodium acetate##2##3##(2006-10#2)
with sodium azide##3##3##(2007-10#2)(2008-5#1)
with sodium benzoate##2##3##(2005-4#1)(2008-8#1)
with sodium bicarbonate##2##3##(2008-3#1)(2010-3#1)
with sodium borohydride##8##3##(1990-12#1)(1990-7#1)(1995-2#1)(1995-8#1)(2008-10#3)(2008-5#1)
with sodium bromide##2##3##(1991-5#1)(2008-9#1)
with sodium carbonate-sodium bicarbonate as##3##5##(2005-12#3)
with sodium chloride##2##3##(1990-5#1)(1990-8#1)
with sodium cyclotetramethylenedithiocarbamate##2##3##(2008-10#2)
with sodium diethyldithiocarbamate##4##3##(2008-10#2)(2009-6#2)
with sodium dodecyl sulfate##3##4##(1991-12#1)(2005-11#1)(2008-10#1)
with sodium dodecyl##5##3##(1991-12#1)(1994-2#1)(2005-11#1)(2008-10#2)
with sodium dodecylsulfate##2##3##(1991-12#1)(2013-8#1)
with sodium fluoride##4##3##(1990-2#1)(1991-11#2)(1996-2#1)
with sodium hydroxide and##2##4##(2008-10#1)(2013-1#1)
with sodium hydroxide in##2##4##(2005-11#1)(2008-10#1)
with sodium hydroxide##8##3##(2005-11#1)(2008-10#5)(2010-2#1)(2013-1#1)
with sodium hypochlorite##2##3##(2006-10#1)(2008-10#1)
with sodium periodate##3##3##(1992-3#1)(2006-8#1)(2007-11#1)
with sodium stibogluconate##2##3##(2005-8#1)(2005-9#1)
with sodium tetrahydroborate##2##3##(1992-2#1)(2008-10#1)
with sodium tetraphenyl borate##2##4##(2008-10#2)
with sodium tetraphenylborate##2##3##(2008-10#2)
with sodium##107##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-11#2)(1991-12#2)(1991-3#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-3#2)(1993-11#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#2)(1995-8#1)(1996-1#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-11#3)(2005-12#3)(2005-4#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-3#1)(2008-10#29)(2008-3#1)(2008-4#1)(2008-5#6)(2008-8#2)(2008-9#2)(2009-6#2)(2010-11#1)(2010-2#1)(2010-3#2)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
with soft tissue sarcoma (STS)##2##5##(2008-6#2)
with soft tissue sarcoma##6##4##(2008-6#6)
with soft tissue sarcomas##11##4##(2008-6#11)
with soft tissue##28##3##(1995-2#1)(2006-4#1)(2007-7#2)(2008-12#1)(2008-4#1)(2008-6#17)(2008-9#1)(2009-3#1)(2010-2#1)(2012-12#1)(2013-1#1)
with soft##36##2##(1991-2#1)(1995-2#1)(1997-2#1)(2006-4#1)(2007-7#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-6#17)(2008-9#1)(2009-3#1)(2010-2#1)(2012-12#2)(2013-1#1)(2013-7#2)
with soft-tissue sarcoma##2##3##(1991-8#1)(2008-6#1)
with soft-tissue##4##2##(1991-8#1)(2006-3#1)(2008-6#1)(2013-7#1)
with software##3##2##(2009-12#1)(2010-5#1)(2011-2#1)
with soil concentrations##2##3##(2005-11#2)
with soil##17##2##(1995-11#1)(2004-4#1)(2005-11#2)(2008-10#3)(2008-11#2)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-7#1)(2013-8#3)
with soils##3##2##(2006-3#1)(2008-10#2)
with sol-gel##3##2##(2006-12#1)(2008-10#2)
with solar##2##2##(2008-2#1)(2010-1#1)
with solid phase extraction##5##4##(2007-8#1)(2008-10#4)
with solid phase##8##3##(2007-8#3)(2008-10#4)(2011-2#1)
with solid tumors##8##3##(2006-6#1)(2008-3#1)(2008-7#4)(2010-10#1)(2010-11#1)
with solid##24##2##(1990-12#1)(1992-12#1)(2006-6#1)(2007-8#3)(2008-10#6)(2008-3#1)(2008-4#1)(2008-7#5)(2008-9#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-2#1)
with solid-phase extraction##5##3##(1990-9#1)(1997-3#1)(2008-10#2)(2012-12#1)
with solid-phase##9##2##(1990-9#1)(1997-3#1)(1997-4#1)(2007-8#1)(2008-10#4)(2012-12#1)
with solid-state##2##2##(2008-10#1)(2008-3#1)
with solids##2##2##(1991-6#1)(2007-11#1)
with solitary##10##2##(1990-12#1)(2005-1#1)(2006-11#4)(2007-8#1)(2010-3#1)(2013-1#2)
with solubilized microsomes##2##3##(1992-6#2)
with soluble##12##2##(1992-8#1)(1993-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)(2010-4#1)
with solution##4##2##(2007-8#1)(2008-4#1)(2008-7#1)(2011-2#1)
with solutions of##8##3##(1995-7#1)(1996-11#1)(2005-11#2)(2008-10#3)(2012-11#1)
with solutions##10##2##(1995-7#1)(1996-11#1)(2005-11#2)(2008-10#4)(2008-5#1)(2012-11#1)
with solvent extraction##2##3##(2005-4#1)(2008-10#1)
with solvent##9##2##(1990-11#1)(1991-2#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-2#1)(2005-4#1)(2008-10#2)
with solvents##3##2##(2006-10#2)(2008-10#1)
with somatic##5##2##(1991-11#1)(1997-2#1)(2008-9#1)(2011-1#1)(2012-1#1)
with somatization##2##2##(2006-8#2)
with somatosensory##2##2##(1996-1#1)(2011-2#1)
with somatostatin##2##2##(1990-5#1)(1997-4#1)
with somatropin##4##2##(2007-11#4)
with some advantages and##2##4##(2008-10#1)(2009-2#1)
with some aromatic##2##3##(2008-10#1)(2011-3#1)
with some aspects##2##3##(2007-12#1)(2009-2#1)
with some degree of##2##4##(2006-7#1)(2013-1#1)
with some evidence of##3##4##(2006-9#1)(2008-3#1)(2008-5#1)
with some evidence##5##3##(2005-8#1)(2006-9#1)(2008-3#1)(2008-5#1)(2008-6#1)
with some form of##3##4##(2008-4#1)(2009-3#1)(2011-12#1)
with some interesting##5##3##(1996-4#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-9#1)
with some minor##2##3##(1990-7#1)(2006-9#1)
with some modifications##2##3##(2007-2#1)(2009-4#1)
with some observations##2##3##(1996-1#1)(2012-1#1)
with some of the other##2##5##(2006-12#1)(2010-3#1)
with some of the##11##4##(1996-8#1)(1997-2#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2009-12#1)(2010-3#1)(2011-2#1)
with some of these##2##4##(1991-11#1)(2008-5#1)
with some of##18##3##(1991-11#1)(1995-1#1)(1996-8#1)(1997-1#1)(1997-2#1)(2006-12#1)(2007-1#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-12#1)(2010-3#1)(2011-1#1)(2011-2#1)
with some other##6##3##(1990-6#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)
with some others##3##3##(1992-11#1)(1995-3#1)(2007-8#1)
with some patients##3##3##(2004-11#1)(2009-4#1)(2012-12#1)
with some plant##2##3##(2008-11#1)(2013-1#1)
with some practical##2##3##(1993-2#1)(2013-8#1)
with some previous##2##3##(2008-12#1)(2012-1#1)
with some promising results##2##4##(1992-3#1)(2012-2#1)
with some promising##3##3##(1992-3#1)(2011-3#1)(2012-2#1)
with some recent##2##3##(2006-6#1)(2008-10#1)
with some risk##2##3##(2009-4#1)(2013-8#1)
with some specificity for##2##4##(1994-2#1)(1994-8#1)
with some success##6##3##(1991-9#1)(2005-10#1)(2009-5#1)(2010-6#1)(2012-12#1)(2012-3#1)
with some thoughts on##2##4##(2008-6#1)(2010-11#1)
with some thoughts##4##3##(2008-2#1)(2008-6#1)(2010-11#2)
with some types of##2##4##(2008-10#1)(2008-7#1)
with some##278##2##(1990-11#3)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-1#2)(1991-10#1)(1991-11#3)(1991-2#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#2)(1997-7#2)(1997-8#1)(2004-11#1)(2004-4#1)(2005-1#1)(2005-10#1)(2005-4#1)(2005-7#1)(2005-8#4)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#5)(2006-3#1)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#3)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#2)(2007-2#3)(2007-3#1)(2007-4#1)(2007-6#2)(2007-8#5)(2007-9#3)(2008-1#2)(2008-10#36)(2008-11#6)(2008-12#6)(2008-2#10)(2008-3#3)(2008-4#1)(2008-5#11)(2008-6#7)(2008-7#6)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#6)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-11#3)(2010-3#1)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#3)(2011-3#2)(2012-1#4)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#3)(2012-7#1)(2013-1#6)(2013-7#4)(2013-8#3)
with someone##3##2##(1994-2#1)(2008-6#1)(2012-12#1)
with sonography##2##2##(1997-8#1)(2008-8#1)
with sophisticated##5##2##(2004-9#1)(2007-12#1)(2008-10#1)(2008-9#1)(2012-2#1)
with sorbitol##3##2##(1991-5#2)(2008-11#1)
with sources##2##2##(1997-1#1)(2008-3#1)
with soy##2##2##(1996-2#1)(2010-12#1)
with soya flour##2##3##(1993-12#1)(1997-2#1)
with soybean PC##2##3##(1995-8#2)
with soybean resulted##2##3##(2008-10#1)(2008-12#1)
with soybean##9##2##(1990-12#1)(1990-2#1)(1995-8#2)(2008-10#2)(2008-12#1)(2012-11#1)(2012-2#1)
with space group##4##3##(1991-7#1)(1992-8#1)(2008-8#1)(2013-1#1)
with spacers##2##2##(1992-3#1)(2009-4#1)
with spacing##3##2##(2007-12#2)(2012-2#1)
with sparing of##2##3##(1992-3#1)(2008-9#1)
with sparse##5##2##(1997-6#1)(2007-9#1)(2008-10#2)(2012-1#1)
with spastic##3##2##(2006-10#1)(2007-10#1)(2009-9#1)
with spatial##19##2##(1991-5#1)(1991-6#2)(1993-12#1)(1993-2#1)(1994-2#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#2)(2009-10#1)(2011-1#1)
with spatially incoherent##2##3##(2008-3#2)
with spatially##13##2##(1997-6#1)(2007-11#3)(2007-12#3)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-8#1)
with special attention being##2##4##(1993-11#1)(2012-2#1)
with special attention paid to##2##5##(2007-1#1)(2012-12#1)
with special attention to the##6##5##(1993-12#1)(1993-6#1)(2006-7#1)(2008-7#1)(2013-7#1)(2013-8#1)
with special attention to##19##4##(1990-6#1)(1991-5#1)(1993-12#1)(1993-6#1)(1995-12#1)(1996-6#1)(2006-2#1)(2006-7#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-3#1)(2013-7#1)(2013-8#1)
with special attention##26##3##(1990-6#1)(1991-5#1)(1993-11#1)(1993-12#1)(1993-6#1)(1995-12#1)(1996-6#1)(2006-2#1)(2006-7#2)(2007-1#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
with special consideration being given to##2##6##(1990-6#1)(2009-6#1)
with special consideration##5##3##(1990-6#1)(1993-3#1)(2008-2#1)(2008-6#1)(2009-6#1)
with special emphasis on the##18##5##(1991-2#1)(1993-3#1)(1995-7#1)(1997-1#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-10#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-10#1)(2009-2#1)(2010-7#1)(2012-2#1)
with special emphasis on##51##4##(1990-11#1)(1990-2#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-6#1)(1993-11#2)(1993-3#1)(1994-12#1)(1994-5#1)(1995-7#2)(1996-12#1)(1997-1#1)(2006-10#3)(2006-12#1)(2006-7#3)(2007-10#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-2#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#1)
with special emphasis##52##3##(1990-11#1)(1990-2#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-6#1)(1993-11#2)(1993-3#1)(1994-12#1)(1994-5#1)(1995-7#2)(1996-12#1)(1997-1#1)(2006-10#3)(2006-12#1)(2006-7#3)(2007-10#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-2#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#1)
with special focus on the##4##5##(1997-6#1)(2010-12#1)(2010-3#1)(2011-2#1)
with special focus on##6##4##(1990-6#1)(1997-6#1)(2007-8#1)(2010-12#1)(2010-3#1)(2011-2#1)
with special health care needs##20##5##(1991-12#1)(1991-3#1)(1993-1#1)(1993-12#1)(1995-1#1)(1995-12#4)(1995-3#2)(1997-2#2)(2005-9#1)(2007-9#1)(2008-11#1)(2008-5#1)(2011-1#1)(2013-1#2)
with special health needs##2##4##(1992-2#1)(1994-3#1)
with special health##22##3##(1991-12#1)(1991-3#1)(1992-2#1)(1993-1#1)(1993-12#1)(1994-3#1)(1995-1#1)(1995-12#4)(1995-3#2)(1997-2#2)(2005-9#1)(2007-9#1)(2008-11#1)(2008-5#1)(2011-1#1)(2013-1#2)
with special interest in##2##4##(2007-11#1)(2013-1#1)
with special interest##3##3##(1991-3#1)(2007-11#1)(2013-1#1)
with special needs in##2##4##(1997-2#1)(2012-3#1)
with special needs##15##3##(1991-12#1)(1991-3#1)(1997-2#2)(2005-11#1)(2005-12#3)(2008-12#1)(2009-11#1)(2009-12#1)(2010-7#1)(2012-3#3)
with special reference to domain evolution##2##6##(1994-6#2)
with special reference to the fluoroquinolones##2##6##(1991-12#1)(2013-8#1)
with special reference to the##13##5##(1990-5#1)(1991-12#1)(1994-6#1)(1995-1#1)(1995-11#1)(1996-5#1)(1996-9#1)(2004-4#1)(2006-5#1)(2008-5#1)(2011-2#1)(2013-8#2)
with special reference to##38##4##(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1994-6#3)(1995-1#1)(1995-11#1)(1996-5#1)(1996-9#1)(1997-5#1)(2004-4#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-3#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
with special regard to the##4##5##(1991-6#1)(1996-6#1)(2008-10#1)(2010-2#1)
with special regard to##6##4##(1991-6#1)(1996-6#1)(2007-11#2)(2008-10#1)(2010-2#1)
with special##190##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#3)(1990-9#1)(1991-12#3)(1991-2#2)(1991-3#4)(1991-5#2)(1991-6#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#2)(1993-1#1)(1993-11#3)(1993-12#2)(1993-3#2)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#3)(1995-1#2)(1995-11#1)(1995-12#5)(1995-3#2)(1995-7#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#4)(1997-4#1)(1997-5#1)(1997-6#1)(2004-4#1)(2005-11#1)(2005-12#3)(2005-9#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#5)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#2)(2007-3#1)(2007-5#3)(2007-7#1)(2007-8#4)(2007-9#3)(2008-1#2)(2008-10#13)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#2)(2011-1#1)(2011-2#5)(2011-3#1)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#4)
with specialised##2##2##(2008-11#1)(2011-2#1)
with specialized services##2##3##(1996-1#1)(1997-3#1)
with specialized##12##2##(1991-3#1)(1996-1#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-11#1)(2008-4#2)(2008-6#1)(2010-4#1)(2010-7#1)(2012-2#1)
with specially designed##2##3##(2008-3#1)(2009-2#1)
with species##7##2##(1992-8#1)(2007-5#1)(2008-6#1)(2008-9#1)(2009-5#1)(2011-1#1)(2013-8#1)
with species-specific##3##2##(2008-12#1)(2012-2#1)(2012-8#1)
with specific DNA sequences to##2##5##(1991-11#1)(1994-8#1)
with specific DNA##3##3##(1991-11#1)(1994-8#1)(2013-1#1)
with specific affinity##2##3##(2006-12#1)(2010-1#1)
with specific amino acid##2##4##(1994-9#1)(1997-4#1)
with specific antagonists##2##3##(1993-10#1)(2008-10#1)
with specific antibodies##5##3##(1996-5#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#1)
with specific emphasis##2##3##(1995-11#1)(2012-12#1)
with specific examples##5##3##(1990-6#1)(1994-12#1)(2008-8#1)(2011-2#1)(2012-12#1)
with specific features##2##3##(2007-11#1)(2008-3#1)
with specific focus on the##2##5##(2007-8#1)(2008-10#1)
with specific focus on##5##4##(2006-5#1)(2007-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
with specific host##2##3##(2008-10#1)(2011-12#1)
with specific indications##2##3##(2006-3#1)(2007-8#1)
with specific language impairment (SLI)##2##5##(2009-1#1)(2009-8#1)
with specific mutations##2##3##(2009-3#1)(2010-12#1)
with specific patterns##2##3##(1996-2#1)(2010-2#1)
with specific primers##4##3##(1997-8#1)(2008-10#2)(2008-5#1)
with specific probes##2##3##(1993-6#1)(1994-12#1)
with specific recommendations##2##3##(2009-4#1)(2010-6#1)
with specific reference to the##3##5##(1993-10#1)(2006-11#1)(2008-2#1)
with specific reference to##6##4##(1991-3#1)(1992-12#1)(1993-1#1)(1993-10#1)(2006-11#1)(2008-2#1)
with specific reference##7##3##(1991-3#1)(1992-12#1)(1993-1#1)(1993-10#1)(2006-11#1)(2007-11#1)(2008-2#1)
with specific sequence##2##3##(2008-10#1)(2013-8#1)
with specific stress##2##3##(1990-6#1)(2011-2#1)
with specific virulence to major resistance genes##2##7##(2008-10#2)
with specific virulence to##3##4##(2008-10#3)
with specific##180##2##(1990-12#1)(1990-5#1)(1990-6#3)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-1#2)(1993-10#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#3)(1995-7#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-10#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#6)(2008-10#24)(2008-11#2)(2008-12#1)(2008-2#8)(2008-3#1)(2008-4#5)(2008-5#7)(2008-7#4)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#2)(2009-12#2)(2009-3#3)(2009-4#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#8)(2012-12#2)(2012-3#1)(2013-1#6)(2013-8#2)
with specifically##2##2##(2010-9#1)(2011-2#1)
with specificity and##2##3##(2005-7#1)(2008-6#1)
with specificity for##7##3##(1992-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(2007-8#1)(2008-4#1)
with specificity##15##2##(1992-8#2)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-8#1)(2005-7#1)(2006-8#1)(2007-12#2)(2007-8#1)(2008-4#1)(2008-6#1)(2009-4#1)
with specified##3##2##(2005-5#1)(2007-12#1)(2010-12#1)
with speckle##2##2##(2008-2#1)(2008-3#1)
with spectra##4##2##(2007-11#1)(2008-10#1)(2008-3#2)
with spectral filters and precision tinted ophthalmic lenses##3##8##(2013-1#3)
with spectral holography##2##3##(2008-3#2)
with spectral overlapping##2##3##(2008-10#2)
with spectral##17##2##(1995-10#1)(1995-5#1)(1996-7#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#3)(2013-1#3)
with spectrally##3##2##(2007-12#2)(2008-2#1)
with spectrophotometric detection is##2##4##(2008-10#2)
with spectrophotometric detection using##2##4##(2008-10#2)
with spectrophotometric detection##13##3##(2008-10#13)
with spectrophotometric determination##2##3##(2005-4#1)(2008-10#1)
with spectrophotometric##19##2##(2005-4#1)(2008-10#18)
with spectrophotometry##4##2##(2008-10#4)
with spectroscopic data##3##3##(1995-6#1)(2008-3#1)(2011-2#1)
with spectroscopic ellipsometry##2##3##(2008-2#1)(2008-3#1)
with spectroscopic##6##2##(1995-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-2#1)
with speech##3##2##(1991-11#1)(2008-11#1)(2009-11#1)
with speed##4##2##(2006-9#1)(2008-11#1)(2012-12#2)
with sperm##5##2##(1994-12#1)(1997-6#1)(2006-5#1)(2009-5#1)(2012-2#1)
with spermatogenesis##2##2##(2008-3#1)(2008-7#1)
with spermatozoa from##2##3##(2006-5#1)(2013-1#1)
with spermatozoa##3##2##(2006-5#1)(2007-12#1)(2013-1#1)
with spherical surfaces and##2##4##(2008-2#1)(2008-3#1)
with spherical##8##2##(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#2)
with sphingosine was##2##3##(2010-7#2)
with sphingosine##4##2##(1992-11#1)(2010-7#3)
with spike##3##2##(1990-4#1)(2007-8#1)(2009-12#1)
with spiked##8##2##(1992-8#1)(2007-8#3)(2008-10#4)
with spikes##2##2##(1996-1#1)(2007-12#1)
with spina bifida##6##3##(2006-10#1)(2008-10#1)(2009-7#2)(2010-12#1)(2012-2#1)
with spinal cord damage##2##4##(1991-6#1)(2007-11#1)
with spinal cord injuries##7##4##(1991-6#2)(2007-10#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-8#1)
with spinal cord injury##11##4##(1993-2#1)(2007-11#1)(2007-7#5)(2008-7#2)(2013-1#2)
with spinal cord stimulation##2##4##(2006-12#1)(2006-8#1)
with spinal cord##26##3##(1991-6#4)(1993-2#2)(1995-9#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-7#6)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2013-1#2)
with spinal fusion##3##3##(2006-8#1)(2012-12#1)(2012-3#1)
with spinal infections##2##3##(2006-7#1)(2006-8#1)
with spinal metastases##6##3##(2006-2#1)(2007-11#5)
with spinal pain##2##3##(2006-7#1)(2008-12#1)
with spinal##64##2##(1991-6#4)(1992-11#1)(1993-10#1)(1993-2#2)(1994-10#1)(1994-2#1)(1995-9#1)(2006-12#1)(2006-2#3)(2006-5#1)(2006-7#2)(2006-8#5)(2007-10#1)(2007-11#11)(2007-7#7)(2007-8#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#4)
with spindle cell##2##3##(2010-12#1)(2011-2#1)
with spine##3##2##(2007-11#2)(2009-5#1)
with spleen##2##2##(1996-2#1)(1997-8#1)
with splenectomy##4##2##(2007-2#1)(2009-2#1)(2010-1#1)(2010-12#1)
with splenic##8##2##(1992-2#1)(2006-1#2)(2006-6#2)(2006-8#1)(2008-7#1)(2011-2#1)
with splicing##2##2##(1993-9#1)(1997-4#1)
with split##2##2##(1995-5#1)(1997-3#1)
with spondyloarthritis##2##2##(2012-12#2)
with spondylolisthesis##5##2##(2006-8#1)(2007-11#2)(2007-7#1)(2007-8#1)
with spondylolysis##2##2##(2007-7#1)(2009-3#1)
with spontaneous clearance of hepatitis C virus##2##7##(2012-2#2)
with spontaneous clearance of##3##4##(2012-2#3)
with spontaneous pneumothorax##7##3##(1991-6#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-6#1)(2012-11#1)
with spontaneous ventilation and##2##4##(2006-4#1)(2008-8#1)
with spontaneous ventricular fibrillation##2##4##(2005-1#2)
with spontaneous ventricular##3##3##(2005-1#3)
with spontaneous##47##2##(1990-11#1)(1991-11#1)(1991-4#1)(1991-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-7#1)(1997-1#1)(2005-1#3)(2006-10#2)(2006-4#1)(2006-6#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-6#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-7#2)
with sporadic AD##4##3##(1994-8#2)(1997-1#1)(1997-5#1)
with sporadic ALS##2##3##(2013-8#2)
with sporadic Alzheimer disease##2##4##(1990-3#2)
with sporadic##17##2##(1990-3#2)(1994-8#2)(1994-9#1)(1997-1#1)(1997-5#1)(2006-2#1)(2007-7#1)(2008-1#2)(2008-8#1)(2011-2#1)(2012-1#2)(2013-8#2)
with spore##2##2##(1995-3#1)(2008-10#1)
with spores of##2##3##(2008-10#1)(2011-2#1)
with spores##4##2##(2008-10#1)(2010-10#1)(2011-2#2)
with sports##2##2##(1993-3#1)(2007-7#1)
with sporulating lesions##2##3##(2008-10#2)
with sporulation##2##2##(2008-10#2)
with spot urinary##3##3##(2007-3#1)(2008-5#2)
with spot##6##2##(2007-11#1)(2007-3#1)(2008-3#1)(2008-4#1)(2008-5#2)
with spotted##2##2##(1994-12#1)(2008-7#1)
with spread to##2##3##(1990-3#2)
with spread##4##2##(1990-3#2)(1995-6#1)(2009-2#1)
with spreading##2##2##(2004-12#1)(2010-6#1)
with spring##2##2##(2008-10#2)
with squamous cell carcinoma in##2##5##(2005-11#1)(2012-1#1)
with squamous cell carcinoma of the esophagus##3##7##(1993-8#1)(2010-12#1)(2013-8#1)
with squamous cell carcinoma of the##4##6##(1993-8#1)(2007-2#1)(2010-12#1)(2013-8#1)
with squamous cell carcinoma of##5##5##(1993-8#1)(2007-2#1)(2010-12#1)(2011-2#1)(2013-8#1)
with squamous cell carcinoma##13##4##(1990-5#1)(1993-8#1)(2005-11#1)(2007-1#1)(2007-2#1)(2007-7#2)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-8#1)
with squamous##17##2##(1990-5#1)(1993-8#1)(1994-9#1)(2005-11#1)(2007-1#1)(2007-2#1)(2007-7#2)(2009-5#1)(2009-6#1)(2010-12#2)(2010-8#1)(2011-2#1)(2012-1#1)(2013-7#1)(2013-8#1)
with square-wave##2##2##(2008-10#2)
with ssDNA##4##2##(2008-10#2)(2008-4#2)
with stability##3##2##(2006-10#1)(2008-10#1)(2010-4#1)
with stabilization##2##2##(2007-11#1)(2007-7#1)
with stabilized##2##2##(1995-2#1)(2008-10#1)
with stable angina pectoris##4##4##(1993-12#1)(2006-6#1)(2008-10#2)
with stable angina##20##3##(1993-12#1)(2005-8#2)(2006-6#1)(2007-9#8)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#2)(2013-1#1)(2013-8#1)
with stable disease##4##3##(1990-2#1)(1992-12#1)(2006-12#2)
with stable or##2##3##(1994-8#1)(1997-6#1)
with stable resonators##3##3##(2008-2#3)
with stable##63##2##(1990-2#1)(1992-12#1)(1993-12#2)(1994-8#1)(1995-2#1)(1996-9#2)(1997-1#1)(1997-6#1)(2005-1#1)(2005-6#1)(2005-7#1)(2005-8#2)(2006-12#4)(2006-6#1)(2007-11#2)(2007-7#1)(2007-8#2)(2007-9#10)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#1)(2010-12#2)(2010-9#1)(2011-1#1)(2013-1#4)(2013-7#4)(2013-8#1)
with staff in##2##3##(2006-5#1)(2010-10#1)
with staff##9##2##(1996-1#1)(2006-5#1)(2008-11#1)(2010-10#2)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
with stage 1 disease##2##4##(2008-8#1)(2009-10#1)
with stage 1##6##3##(1996-9#1)(2008-6#1)(2008-8#3)(2009-10#1)
with stage 4##2##3##(2009-10#1)(2011-2#1)
with stage I KJOA##2##4##(2006-6#2)
with stage I##5##3##(2006-10#1)(2006-6#2)(2007-11#1)(2012-2#1)
with stage II##5##3##(1997-7#1)(2005-8#1)(2006-10#1)(2012-2#1)(2013-7#1)
with stage III##8##3##(1990-9#1)(1991-11#1)(1997-6#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-6#1)
with stage IIIC and IV disease##2##6##(2011-2#2)
with stage IIIC and IV ovarian cancer##2##7##(2011-2#2)
with stage IIIC and IV##4##5##(2011-2#4)
with stage IIIC##5##3##(2011-2#5)
with stage IV ovarian##2##4##(1990-6#1)(2013-7#1)
with stage IV##6##3##(1990-6#1)(2008-3#1)(2009-8#1)(2011-12#1)(2012-2#1)(2013-7#1)
with stage##57##2##(1990-6#2)(1990-9#1)(1991-11#1)(1991-12#1)(1992-12#1)(1995-9#1)(1996-9#1)(1997-6#1)(1997-7#1)(2004-1#1)(2005-8#1)(2006-10#4)(2006-6#3)(2006-9#2)(2007-11#3)(2007-8#3)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-8#4)(2009-10#2)(2009-8#1)(2010-4#1)(2011-12#3)(2011-2#6)(2012-1#2)(2012-2#3)(2013-1#1)(2013-7#2)
with stages##3##2##(2006-6#1)(2007-2#1)(2007-8#1)
with staghorn##2##2##(2007-7#2)
with staining##3##2##(1992-12#1)(2005-8#1)(2008-4#1)
with stainless steel##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2009-3#1)
with stakeholders##4##2##(2010-7#2)(2013-1#2)
with standard and##2##3##(2008-7#1)(2012-1#1)
with standard base##3##3##(2008-10#1)(2010-2#2)
with standard cell##2##3##(1993-12#1)(2011-2#1)
with standard clinical predictors##2##4##(2007-9#2)
with standard clinical##3##3##(1994-3#1)(2007-9#2)
with standard deviation##2##3##(2008-10#1)(2010-5#1)
with standard deviations##4##3##(2008-10#1)(2008-3#1)(2008-8#1)(2010-1#1)
with standard heparin##3##3##(1994-4#1)(1996-2#1)(2007-8#1)
with standard medical##3##3##(2006-10#1)(2011-1#2)
with standard methods for the##2##5##(2008-5#1)(2009-11#1)
with standard methods##8##3##(1992-1#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-11#1)
with standard or##2##3##(2007-2#1)(2009-8#1)
with standard regimens##2##3##(1996-11#1)(2013-1#1)
with standard solutions##3##3##(2007-8#1)(2008-10#2)
with standard techniques##2##3##(2008-1#1)(2011-2#1)
with standard##146##2##(1990-10#1)(1992-1#1)(1992-4#1)(1993-10#1)(1993-12#1)(1993-9#1)(1994-3#1)(1994-4#1)(1994-8#1)(1995-8#1)(1996-11#2)(1996-2#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-12#1)(2005-5#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#3)(2007-2#2)(2007-3#1)(2007-6#2)(2007-7#3)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#20)(2008-11#3)(2008-2#2)(2008-3#12)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#4)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#2)
with standardized##10##2##(2006-10#1)(2008-12#1)(2008-3#2)(2008-8#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
with standards in##2##3##(2008-10#2)
with standards of##2##3##(1991-8#1)(2013-1#1)
with standards##9##2##(1990-12#1)(1991-8#1)(2007-1#1)(2008-10#3)(2013-1#3)
with standing##4##2##(1992-10#1)(1995-1#1)(2005-12#1)(2006-8#1)
with staphylococcal##2##2##(2005-8#1)(2008-10#1)
with state##6##2##(1990-12#1)(1992-2#1)(1996-12#1)(1997-1#1)(2007-6#1)(2008-11#1)
with state-of-the-art##5##2##(1997-8#1)(2005-12#1)(2008-2#1)(2008-3#1)(2012-2#1)
with static##4##2##(2008-10#1)(2008-2#1)(2011-2#2)
with statin##3##2##(2006-10#1)(2013-1#1)(2013-8#1)
with statins##14##2##(2006-10#1)(2006-5#1)(2008-1#2)(2008-3#1)(2008-4#1)(2009-11#1)(2009-4#1)(2010-2#1)(2010-4#3)(2012-2#1)(2013-8#1)
with stationary##2##2##(2008-10#1)(2008-9#1)
with statistical regression##2##3##(2008-10#1)(2011-1#1)
with statistical significance##6##3##(1991-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)
with statistical##18##2##(1990-2#1)(1991-4#1)(1994-2#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-7#1)(2011-1#2)(2011-2#1)(2013-1#1)
with statistically significant differences##2##4##(1994-2#1)(2011-2#1)
with statistically##4##2##(1994-2#1)(2008-10#1)(2010-7#1)(2011-2#1)
with status##4##2##(2007-2#1)(2008-7#1)(2010-8#1)(2011-1#1)
with statutory##2##2##(1992-12#1)(2012-1#1)
with staurosporine##4##2##(1990-12#1)(1993-6#1)(1995-3#1)(2008-11#1)
with steady##2##2##(2007-4#1)(2007-8#1)
with steady-state##2##2##(1992-6#1)(2008-2#1)
with stearic acid##2##3##(1991-3#1)(2008-10#1)
with stem cell##5##3##(1996-11#1)(2008-7#1)(2012-12#2)(2013-8#1)
with stem cells##2##3##(2006-10#1)(2013-8#1)
with stem##9##2##(1996-11#1)(2006-10#1)(2008-10#2)(2008-7#1)(2012-12#2)(2013-8#2)
with stenosis##6##2##(1990-3#1)(1990-9#1)(1993-8#2)(2007-8#1)(2008-3#1)
with stent implantation##3##3##(2007-9#2)(2009-12#1)
with stent placement in##2##4##(2005-10#1)(2009-6#1)
with stent placement##3##3##(2005-10#1)(2009-6#2)
with stent##8##2##(1990-12#1)(2005-10#1)(2007-9#2)(2009-12#1)(2009-6#2)(2010-5#1)
with stent-assisted##2##2##(2012-3#2)
with stenting##6##2##(2007-8#1)(2008-11#1)(2008-6#1)(2009-12#2)(2010-12#1)
with stereotactically##2##2##(2006-6#1)(2007-1#1)
with sterile##8##2##(1997-3#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-5#2)
with sternal cleft##2##3##(2007-8#2)
with sternal##3##2##(2007-8#3)
with steroid##12##2##(1991-11#1)(1992-11#1)(1993-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-7#3)(2008-8#1)(2010-7#2)
with steroid-dependent autoimmune hemolytic anemia##2##5##(2012-2#2)
with steroid-dependent##3##2##(2006-10#1)(2012-2#2)
with steroids and##5##3##(1991-8#1)(2008-1#1)(2009-6#1)(2012-2#1)(2013-8#1)
with steroids##13##2##(1991-8#1)(1992-5#1)(1994-5#1)(1996-11#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2009-3#1)(2009-6#1)(2012-2#1)(2013-7#1)(2013-8#1)
with sterols##3##2##(1992-3#1)(1994-2#1)(2009-7#1)
with stiff-man syndrome##2##3##(1990-5#2)
with stimulation of##3##3##(1994-3#1)(2007-11#1)(2008-4#1)
with stock##3##2##(1993-3#1)(2011-2#1)(2013-7#1)
with stomach cancer##3##3##(1993-11#1)(1997-3#2)
with stomach##5##2##(1992-5#1)(1993-11#1)(1997-3#2)(2007-8#1)
with stones##4##2##(1992-5#3)(2010-5#1)
with stool##2##2##(1993-7#1)(2011-2#1)
with storage##3##2##(1994-12#1)(2007-12#1)(2008-10#1)
with stored red cells##2##4##(1994-3#2)
with stored##6##2##(1994-3#3)(1996-7#1)(2008-11#1)(2008-2#1)
with straight back syndrome##4##4##(2007-7#2)(2007-8#2)
with straight##6##2##(1992-3#1)(1992-8#1)(2007-7#2)(2007-8#2)
with strain 2##2##3##(1991-8#2)
with strain LB400 and biostimulation with α-tocopherol or berry extract##2##10##(2011-12#2)
with strain LB400##4##3##(2011-12#4)
with strain##19##2##(1991-8#4)(1996-1#1)(2007-11#1)(2008-10#5)(2008-3#1)(2008-5#2)(2008-9#1)(2011-12#4)
with strained##2##2##(2007-11#1)(2012-2#1)
with strains from##5##3##(2008-10#4)(2011-2#1)
with strains in##2##3##(2008-5#1)(2012-3#1)
with strains of##4##3##(2006-10#1)(2008-10#3)
with strains##16##2##(1996-2#1)(1997-3#1)(1997-7#1)(2006-10#1)(2008-10#9)(2008-5#1)(2011-2#1)(2012-3#1)
with strategies for##3##3##(2008-10#1)(2008-4#1)(2012-12#1)
with strategies##5##2##(2008-10#1)(2008-4#3)(2012-12#1)
with streamlined##2##2##(2008-7#1)(2009-10#1)
with streptavidin##4##2##(1995-11#2)(1995-8#1)(2008-4#1)
with streptokinase##3##2##(1990-10#1)(1993-8#1)(1995-6#1)
with streptomycin sulfate##2##3##(2008-10#1)(2008-8#1)
with streptomycin##6##2##(1994-7#1)(2008-10#3)(2008-8#1)(2010-3#1)
with stress and##2##3##(1996-10#1)(2006-9#1)
with stress levels##2##3##(2008-7#1)(2010-10#1)
with stress urinary incontinence##3##4##(2006-10#1)(2011-1#1)(2013-1#1)
with stress##20##2##(1994-6#1)(1995-12#2)(1995-5#1)(1996-10#1)(1997-7#1)(2006-10#1)(2006-9#1)(2007-2#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-10#2)(2011-1#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)
with stress-induced birefringence##3##3##(2008-2#1)(2008-3#2)
with striatal##2##2##(1995-12#1)(2008-11#1)
with striated skeletal muscle##2##4##(1993-12#2)
with striated##3##2##(1993-12#2)(1995-12#1)
with strict##7##2##(1991-8#1)(1993-11#1)(2007-11#1)(2008-3#1)(2009-3#1)(2010-11#1)(2010-12#1)
with strictly##4##2##(1990-6#1)(1992-3#1)(2008-5#1)(2009-4#1)
with striking##8##2##(1990-5#1)(1993-11#1)(2008-10#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#2)
with stringent##5##2##(1995-1#1)(1995-7#1)(2006-10#1)(2008-10#1)(2008-7#1)
with stripe##2##2##(2008-10#1)(2012-12#1)
with stroke and##9##3##(1990-3#1)(1995-3#1)(2007-10#2)(2008-5#2)(2010-9#2)(2013-1#1)
with stroke in##4##3##(1996-6#1)(2007-2#1)(2013-1#2)
with stroke or##3##3##(2007-10#2)(2008-2#1)
with stroke risk##2##3##(2007-10#1)(2007-9#1)
with stroke##59##2##(1990-3#1)(1995-3#1)(1996-6#1)(2005-10#1)(2007-10#29)(2007-2#1)(2007-9#6)(2008-2#1)(2008-5#2)(2008-8#1)(2010-9#3)(2011-1#1)(2012-1#5)(2012-11#1)(2013-1#4)(2013-8#1)
with strong absorption##3##3##(2008-2#2)(2008-3#1)
with strong and##2##3##(2008-3#1)(2013-8#1)
with strong connections to##2##4##(1996-2#1)(2013-1#1)
with strong dispersion management##9##4##(2007-12#7)(2008-1#2)
with strong homology to##2##4##(1996-6#1)(1997-7#1)
with strong peer connections##2##4##(2013-1#2)
with strong positive##2##3##(1997-6#1)(2006-10#1)
with strong##92##2##(1991-7#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-3#1)(1994-12#1)(1995-11#2)(1996-2#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-7#2)(2004-2#2)(2005-10#1)(2006-10#1)(2006-12#1)(2006-4#2)(2007-11#2)(2007-12#14)(2007-2#1)(2007-4#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#5)(2008-9#1)(2009-2#2)(2009-3#1)(2009-6#1)(2010-2#1)(2010-5#2)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
with stronger##14##2##(1990-7#1)(1995-3#1)(1997-2#1)(2005-11#1)(2008-6#1)(2009-11#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-2#5)
with strongly##5##2##(1993-6#1)(1997-7#1)(2005-4#1)(2007-12#1)(2011-1#1)
with structural and functional##2##4##(1991-9#1)(2012-12#1)
with structural and##3##3##(1991-9#1)(2009-9#1)(2012-12#1)
with structural changes##3##3##(1995-11#1)(2007-6#1)(2013-7#1)
with structural defects##2##3##(2008-10#1)(2008-3#1)
with structural##26##2##(1990-10#1)(1991-9#1)(1992-6#1)(1995-11#1)(1995-3#2)(1995-8#1)(1996-12#1)(1997-8#1)(1997-9#1)(2006-10#1)(2007-6#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-9#2)(2010-10#1)(2012-12#1)(2013-7#1)
with structurally normal heart##2##4##(2008-12#1)(2008-7#1)
with structurally normal##3##3##(1996-4#1)(2008-12#1)(2008-7#1)
with structurally##4##2##(1996-4#1)(2008-10#1)(2008-12#1)(2008-7#1)
with structure##6##2##(1990-7#1)(1992-8#1)(2007-3#1)(2008-8#1)(2010-4#1)(2010-8#1)
with structured##2##2##(2008-11#1)(2008-2#1)
with structures##6##2##(1990-7#1)(1997-6#1)(2006-1#1)(2007-12#2)(2012-2#1)
with strychnine##2##2##(1990-7#1)(1991-10#1)
with students and##3##3##(1990-12#1)(2007-12#1)(2008-12#1)
with students from##3##3##(2006-5#1)(2006-7#1)(2010-4#1)
with students in the##2##4##(2007-3#1)(2012-11#1)
with students who##3##3##(2008-11#2)(2011-2#1)
with students##20##2##(1990-12#1)(2006-5#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#3)(2008-4#1)(2008-8#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-11#1)(2012-3#1)
with studies from other countries is difficult because of different methods and different study##2##14##(2006-10#2)
with studies from##3##3##(2006-10#2)(2008-10#1)
with studies in##3##3##(1993-12#1)(2006-1#1)(2008-7#1)
with studies of##2##3##(1991-5#1)(2008-8#1)
with studies on the##2##4##(1991-2#1)(2008-5#1)
with studies##15##2##(1990-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-12#1)(1995-12#1)(2006-1#1)(2006-10#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)
with study##5##2##(2007-10#1)(2007-8#1)(2008-7#1)(2009-11#1)(2009-12#1)
with styrene##4##2##(1996-5#1)(2005-11#1)(2008-10#1)(2008-12#1)
with sub-Doppler##2##2##(2007-12#2)
with sub-optimal##2##2##(2009-10#1)(2011-12#1)
with subacute or##2##3##(2006-10#1)(2006-8#1)
with subacute##7##2##(1996-10#1)(2005-8#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-7#1)(2012-3#1)
with subarachnoid haemorrhage (SAH)##4##4##(2008-7#4)
with subarachnoid haemorrhage is##2##4##(2006-4#1)(2008-7#1)
with subarachnoid haemorrhage##12##3##(1996-9#1)(1997-3#1)(2006-4#1)(2008-7#9)
with subarachnoid hemorrhage (SAH)##2##4##(2005-9#1)(2013-8#1)
with subarachnoid hemorrhage##11##3##(1991-8#1)(1995-11#1)(2005-9#1)(2006-4#1)(2007-10#1)(2007-9#3)(2012-12#1)(2013-8#2)
with subarachnoid hemorrhages##2##3##(2008-12#1)(2011-2#1)
with subarachnoid##25##2##(1991-8#1)(1995-11#1)(1996-9#1)(1997-3#1)(2005-9#1)(2006-4#2)(2007-10#1)(2007-9#3)(2008-12#1)(2008-7#9)(2011-2#1)(2012-12#1)(2013-8#2)
with subclinical hypothyroidism##2##3##(2006-9#1)(2012-2#1)
with subclinical##6##2##(2006-9#1)(2007-11#1)(2008-3#2)(2008-8#1)(2012-2#1)
with subcutaneous##7##2##(1992-12#1)(2006-10#1)(2007-11#3)(2009-12#1)(2010-2#1)
with subcycle##2##2##(2007-11#1)(2007-12#1)
with subdivision##2##2##(2008-6#1)(2008-8#1)
with subdural hematomas##2##3##(2006-12#1)(2006-8#1)
with subdural##4##2##(2006-12#1)(2006-8#1)(2008-11#1)(2009-9#1)
with subglottic##2##2##(2007-9#1)(2011-2#1)
with subgroup##2##2##(2006-8#1)(2008-10#1)
with subject age##3##3##(1991-1#2)(2007-1#1)
with subjective and objective##3##4##(1992-9#1)(2008-9#1)(2009-10#1)
with subjective physical changes##2##4##(2007-12#2)
with subjective##8##2##(1992-9#1)(1995-8#1)(2007-12#2)(2008-7#1)(2008-9#1)(2009-10#1)(2012-1#1)
with subjects who##2##3##(1993-9#1)(2008-12#1)
with subjects##9##2##(1993-9#1)(1995-9#1)(1996-2#1)(2006-10#1)(2007-12#1)(2008-12#2)(2010-5#1)(2013-1#1)
with submicrometer resolution##5##3##(2006-12#1)(2007-12#2)(2008-3#2)
with submicrometer##11##2##(2006-12#1)(2007-12#4)(2008-1#1)(2008-2#1)(2008-3#4)
with submillimeter##3##2##(2008-2#2)(2008-3#1)
with submucosal##2##2##(2010-5#1)(2012-1#1)
with subnanometer##2##2##(2007-2#1)(2008-3#1)
with subnanosecond##2##2##(2007-12#1)(2008-3#1)
with suboptimal doses of##2##4##(1990-6#1)(1996-10#1)
with suboptimal##4##2##(1990-6#1)(1996-10#1)(2009-12#1)(2010-3#1)
with subpixel##2##2##(2008-2#2)
with subsequent acute##2##3##(2009-9#1)(2012-1#1)
with subsequent attachment of##2##4##(2008-10#2)
with subsequent determination##2##3##(2008-10#2)
with subsequent development of##2##4##(2008-10#1)(2009-2#1)
with subsequent expansion of##2##4##(2007-12#1)(2013-7#1)
with subsequent fibrosis##2##3##(1992-5#1)(2013-1#1)
with subsequent increase in##2##4##(2008-5#1)(2010-7#1)
with subsequent joint exchange##3##4##(2007-11#3)
with subsequent joint##4##3##(2007-11#4)
with subsequent release of##2##4##(1991-5#1)(2006-6#1)
with subsequent##106##2##(1990-12#3)(1990-3#1)(1990-5#1)(1991-5#1)(1991-9#1)(1992-5#1)(1993-11#1)(1993-9#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-4#1)(1996-5#1)(1996-6#3)(1997-3#1)(1997-5#1)(2004-10#1)(2005-11#1)(2006-10#2)(2006-11#2)(2006-6#3)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#9)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#10)(2008-12#1)(2008-3#4)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#2)(2009-9#1)(2010-12#1)(2010-4#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#2)(2013-7#1)
with substance P##3##3##(1991-8#1)(1992-6#1)(1995-5#1)
with substance abuse##8##3##(1994-2#1)(1995-12#1)(1996-5#2)(2008-4#1)(2008-6#2)(2008-9#1)
with substance misuse##2##3##(2010-2#1)(2012-12#1)
with substance use disorders##5##4##(2008-6#2)(2009-10#1)(2009-9#1)(2010-6#1)
with substance use##11##3##(2008-5#1)(2008-6#2)(2009-10#1)(2009-11#2)(2009-9#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-7#1)
with substance##25##2##(1991-8#1)(1992-6#1)(1994-2#1)(1995-12#1)(1995-5#1)(1996-5#2)(2008-4#1)(2008-5#1)(2008-6#4)(2008-9#1)(2009-10#1)(2009-11#2)(2009-9#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
with substantial morbidity and mortality##3##5##(2006-8#1)(2007-8#1)(2008-7#1)
with substantial##22##2##(1991-2#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-3#2)(1997-8#1)(2005-12#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-7#1)(2010-2#1)(2010-5#1)(2011-2#1)(2013-8#1)
with substantially different##2##3##(1993-4#1)(2008-10#1)
with substantially##6##2##(1993-4#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
with substituents##4##2##(1991-4#1)(1992-1#1)(1995-6#1)(2009-10#1)
with substituted##6##2##(1993-11#1)(1996-8#1)(2008-10#3)(2012-3#1)
with substitution of##2##3##(1991-9#1)(2008-11#1)
with substitutions at the##2##4##(1995-1#1)(2009-3#1)
with substitutions at##4##3##(1994-8#1)(1995-1#1)(1995-8#1)(2009-3#1)
with substitutions##6##2##(1990-7#1)(1992-6#1)(1994-8#1)(1995-1#1)(1995-8#1)(2009-3#1)
with substrate and##4##3##(1990-7#1)(1992-12#1)(2011-1#2)
with substrate binding##2##3##(1994-5#1)(2009-9#1)
with substrate##15##2##(1990-7#1)(1990-9#1)(1992-12#1)(1992-6#1)(1992-9#1)(1994-11#2)(1994-5#1)(2008-2#1)(2008-7#1)(2009-12#1)(2009-9#1)(2011-1#3)
with substrates##8##2##(1990-8#1)(1991-1#1)(1992-6#2)(2005-11#1)(2007-3#1)(2008-4#1)(2013-1#1)
with subtilisin##2##2##(1994-12#1)(1996-9#1)
with subtle##5##2##(1992-12#1)(2008-7#1)(2011-2#2)(2013-1#1)
with subtotal##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
with subtrochanteric femoral shortening osteotomy fixed with##2##7##(2013-1#2)
with subtrochanteric##3##2##(2009-3#1)(2013-1#2)
with subunit a##2##3##(2008-4#2)
with subunit##6##2##(1990-8#1)(1994-10#1)(1994-8#1)(1997-3#1)(2008-4#2)
with subwavelength##9##2##(2007-12#6)(2008-2#1)(2008-3#2)
with success in##5##3##(2006-5#1)(2007-11#2)(2008-5#1)(2012-11#1)
with success##18##2##(1991-5#1)(1992-11#1)(1992-3#2)(1993-3#2)(2006-2#1)(2006-5#1)(2007-11#3)(2008-5#1)(2008-6#1)(2009-2#1)(2010-2#1)(2011-2#1)(2012-11#1)(2013-8#1)
with successful##20##2##(1990-3#1)(1994-3#1)(1996-12#1)(2004-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
with successive##2##2##(1992-3#1)(2008-11#1)
with succinate as##2##3##(1993-8#1)(1994-3#1)
with succinate##4##2##(1993-8#3)(1994-3#1)
with such a##20##3##(1992-1#1)(1993-11#1)(1996-3#1)(2006-12#1)(2006-6#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#3)(2008-3#2)(2012-2#1)(2012-3#1)(2013-1#1)
with such an##2##3##(2007-11#1)(2008-3#1)
with such drugs##3##3##(1991-6#1)(1991-8#1)(1992-11#1)
with such issues##2##3##(2007-4#1)(2012-12#1)
with such patients##3##3##(2008-1#1)(2011-3#1)(2013-1#1)
with such##71##2##(1990-12#1)(1990-6#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-2#2)(1996-3#1)(1996-8#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#6)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-3#1)(2010-5#1)(2011-2#2)(2011-3#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)
with sucrolytic activity##3##3##(1994-10#3)
with sucrose and##3##3##(2008-10#1)(2011-2#2)
with sucrose##5##2##(2007-11#1)(2007-6#1)(2008-10#1)(2011-2#2)
with sudden cardiac##2##3##(2008-11#1)(2013-8#1)
with sudden death##2##3##(2007-10#1)(2008-3#1)
with sudden gains##2##3##(2009-11#2)
with sudden infant death syndrome##3##5##(1991-11#1)(1991-8#1)(1994-4#1)
with sudden onset of##6##4##(2008-10#2)(2008-7#3)(2012-1#1)
with sudden onset##10##3##(2008-10#2)(2008-7#4)(2011-1#1)(2012-1#1)(2013-1#2)
with sudden vision##3##3##(2011-2#1)(2012-12#2)
with sudden weakness##2##3##(2008-12#2)
with sudden##38##2##(1990-11#1)(1991-11#1)(1991-8#1)(1992-11#1)(1992-12#1)(1994-4#1)(1995-1#1)(2007-10#3)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#4)(2009-11#3)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#2)(2013-8#2)
with sufficient accuracy##6##3##(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)
with sufficient sensitivity##2##3##(1992-6#1)(2005-8#1)
with sufficient signal##2##3##(2008-3#2)
with sufficient##32##2##(1990-12#1)(1991-12#1)(1992-6#1)(1993-6#1)(1994-3#1)(1994-6#1)(1994-9#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#5)(2008-7#2)(2009-7#1)(2010-8#1)(2011-12#1)(2011-2#1)
with sufficiently##2##2##(1996-4#1)(2008-3#1)
with sugar and##2##3##(1995-4#1)(2009-9#1)
with sugar##8##2##(1991-8#1)(1995-4#1)(2008-10#2)(2008-8#1)(2009-8#1)(2009-9#1)(2012-2#1)
with sugars##2##2##(1994-9#1)(2008-12#1)
with suggestions for##8##3##(1997-2#1)(2006-10#1)(2006-2#1)(2007-12#1)(2008-2#1)(2009-9#1)(2010-8#2)
with suggestions##11##2##(1996-8#1)(1997-2#1)(2006-10#1)(2006-2#1)(2007-12#1)(2008-2#1)(2008-8#1)(2009-9#1)(2010-8#2)(2011-1#1)
with suggestive symptoms##2##3##(1996-9#1)(2012-12#1)
with suggestive##3##2##(1996-9#1)(2008-3#1)(2012-12#1)
with suicidal behavior##2##3##(2012-12#1)(2013-8#1)
with suicidal##8##2##(1992-1#1)(1993-2#1)(2007-11#1)(2009-7#2)(2011-2#1)(2012-12#1)(2013-8#1)
with suicide attempts##2##3##(2006-7#2)
with suitable##11##2##(1994-9#1)(2005-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#2)(2009-10#1)(2010-4#1)(2012-1#1)
with suitably chosen##2##3##(2007-11#1)(2008-3#1)
with suitably##4##2##(1996-4#1)(2007-11#1)(2008-2#1)(2008-3#1)
with sulfadoxine-pyrimethamine##3##2##(2005-8#1)(2006-2#2)
with sulfanilamide and##2##3##(2008-10#2)
with sulfanilamide##3##2##(2008-10#3)
with sulfasalazine and##2##3##(2007-7#2)
with sulfasalazine##4##2##(2007-11#2)(2007-7#2)
with sulfate groups of heparin##2##5##(2008-10#2)
with sulfate groups##3##3##(2008-10#3)
with sulfate##6##2##(1997-6#1)(2008-10#3)(2012-2#1)(2013-1#1)
with sulfhydryl##4##2##(1996-2#1)(1997-1#1)(2008-10#1)(2008-5#1)
with sulforhodamine##2##2##(1993-6#1)(2008-10#1)
with sulfur##2##2##(2005-11#1)(2008-10#1)
with sulfuric acid##3##3##(2008-10#2)(2008-5#1)
with sulphonylurea##2##2##(1994-12#1)(2010-4#1)
with sulphur##2##2##(2006-12#1)(2008-4#1)
with sulphuric acid and##2##4##(2008-10#1)(2008-5#1)
with sulphuric acid##4##3##(1990-6#1)(2008-10#2)(2008-5#1)
with sulpiride##5##2##(1991-1#1)(1992-9#2)(1996-12#1)(1997-3#1)
with sunitinib##3##2##(2008-6#1)(2013-1#2)
with sunlight##2##2##(2011-12#2)
with supercritical carbon dioxide##6##4##(1990-8#2)(2007-1#1)(2008-10#3)
with supercritical fluid extraction##2##4##(2008-10#2)
with supercritical fluid##5##3##(2008-10#5)
with supercritical##12##2##(1990-8#2)(2007-1#1)(2008-10#9)
with superficial##3##2##(2007-7#1)(2007-9#1)(2010-12#1)
with superhydrophobic surface##3##3##(2011-1#3)
with superhydrophobic##4##2##(2008-7#1)(2011-1#3)
with superimposed##4##2##(1996-1#1)(2007-7#1)(2008-3#1)(2010-12#1)
with superior vena cava##2##4##(2007-7#1)(2008-7#1)
with superior##9##2##(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
with supernatants of##2##3##(1992-3#1)(2008-10#1)
with superoxide radical##2##3##(1995-1#1)(1996-5#1)
with superoxide##6##2##(1991-9#1)(1994-6#1)(1995-1#1)(1995-6#1)(1996-5#1)(2011-2#1)
with supervision##2##2##(1994-3#1)(2007-10#1)
with supplemental##2##2##(2006-8#1)(2007-8#1)
with supplementation##3##2##(2006-10#1)(2006-2#1)(2012-2#1)
with suppliers##2##2##(1994-1#1)(1995-2#1)
with support##2##2##(2005-1#1)(2012-12#1)
with supported entry##2##3##(2008-11#2)
with supporting##2##2##(1994-12#1)(2008-3#1)
with supportive care##2##3##(2008-6#1)(2011-2#1)
with supportive##7##2##(1995-10#1)(2007-7#1)(2008-11#1)(2008-6#1)(2008-8#1)(2010-3#1)(2011-2#1)
with suppressed conductivity##2##3##(2008-10#1)(2013-7#1)
with suppressed##3##2##(2008-10#2)(2013-7#1)
with suppression of##7##3##(1993-12#2)(1995-12#1)(1997-4#1)(2006-8#1)(2007-5#1)(2008-10#1)
with suppression##10##2##(1993-12#2)(1995-12#1)(1997-4#1)(2006-8#1)(2007-5#1)(2008-10#2)(2010-10#1)(2012-3#1)
with suppressiveness##2##2##(2008-10#2)
with supraventricular##5##2##(1991-11#1)(1995-6#1)(2005-7#1)(2006-8#1)(2008-10#1)
with suramin##2##2##(1993-11#1)(1994-9#1)
with surface area##3##3##(1997-7#1)(2010-2#1)(2012-2#1)
with surface plasmons##2##3##(2007-12#1)(2008-7#1)
with surface tension##3##3##(1990-4#1)(1996-1#1)(2008-12#1)
with surface##32##2##(1990-10#1)(1990-4#1)(1990-6#1)(1992-6#1)(1995-12#1)(1995-5#1)(1996-1#1)(1997-7#1)(1997-8#1)(2005-11#4)(2006-5#1)(2007-12#3)(2007-7#2)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-7#2)(2009-11#1)(2010-2#1)(2012-2#2)
with surface-breaking##2##2##(2007-11#2)
with surfaces and matrices##2##4##(1990-2#2)
with surfaces##4##2##(1990-2#2)(2009-12#1)(2010-4#1)
with surfactant##8##2##(1990-11#1)(1997-2#1)(2005-11#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-6#1)
with surgery alone##6##3##(1991-8#1)(1993-5#1)(1995-5#1)(2012-3#2)(2013-8#1)
with surgery and chemotherapy##2##4##(2012-3#2)
with surgery and##10##3##(2006-10#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
with surgery for breast##2##4##(2009-2#2)
with surgery##45##2##(1991-8#1)(1992-10#1)(1992-11#1)(1993-4#1)(1993-5#1)(1995-5#1)(2004-1#1)(2005-11#1)(2006-10#3)(2006-11#1)(2006-12#1)(2007-11#4)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-2#2)(2009-6#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#4)(2013-8#2)
with surgical debridement##2##3##(2006-10#1)(2013-1#1)
with surgical excision##8##3##(2008-10#1)(2008-2#1)(2009-4#1)(2010-5#1)(2012-1#2)(2012-12#1)(2012-3#1)
with surgical procedures##3##3##(2007-11#1)(2008-6#1)(2010-9#1)
with surgical removal of##2##4##(1996-9#1)(2011-2#1)
with surgical resection of##2##4##(2005-12#1)(2007-2#1)
with surgical resection##6##3##(2005-12#1)(2007-11#1)(2007-2#1)(2008-3#1)(2008-6#1)(2012-3#1)
with surgical treatment##2##3##(2007-11#1)(2012-12#1)
with surgical##45##2##(1996-9#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#4)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#2)(2008-8#1)(2009-2#1)(2009-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-12#2)(2012-3#2)(2013-1#6)(2013-8#1)
with surgically resected##2##3##(2010-12#1)(2012-1#1)
with surgically##8##2##(1990-2#1)(1992-9#1)(1997-5#1)(2008-11#1)(2010-12#1)(2010-3#2)(2012-1#1)
with surprising##2##2##(1996-2#1)(2007-8#1)
with surrounding structures##2##3##(2006-12#1)(2009-10#1)
with surrounding##11##2##(1990-11#1)(1994-8#1)(1996-4#1)(1997-8#1)(2005-11#1)(2006-12#1)(2007-8#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#1)
with survival in##2##3##(1991-4#1)(2011-12#1)
with survival rates##3##3##(2008-10#1)(2008-7#1)(2013-8#1)
with survival##19##2##(1991-4#1)(1995-2#1)(1995-8#1)(2007-11#1)(2007-9#2)(2008-10#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-8#1)
with survivors##2##2##(2008-11#1)(2011-2#1)
with susceptibility to tuberculosis##2##4##(2012-2#1)(2013-1#1)
with susceptibility to##10##3##(1995-5#1)(1997-4#1)(2006-9#1)(2008-1#1)(2008-10#3)(2010-12#1)(2012-2#1)(2013-1#1)
with susceptibility##13##2##(1995-5#1)(1997-4#1)(2006-10#1)(2006-9#1)(2008-1#1)(2008-10#3)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
with susceptible cvs##2##3##(2008-10#2)
with susceptible##12##2##(2008-10#10)(2008-12#2)
with suspect##2##2##(2006-8#1)(2008-5#1)
with suspected CAD##2##3##(2009-10#1)(2012-3#1)
with suspected acute coronary##2##4##(2008-3#1)(2010-9#1)
with suspected acute##7##3##(1996-11#1)(2008-3#3)(2010-9#1)(2011-2#2)
with suspected coronary artery disease##3##5##(1991-9#1)(2009-10#1)(2012-2#1)
with suspected malignant##2##3##(1990-4#1)(2011-2#1)
with suspected or known##3##4##(2006-10#1)(2006-12#1)(2010-7#1)
with suspected or##5##3##(2006-10#1)(2006-12#1)(2007-11#1)(2010-7#1)(2012-2#1)
with suspected retroperitoneal##2##3##(2008-6#1)(2011-2#1)
with suspected scaphoid##3##3##(2006-3#1)(2008-9#2)
with suspected##83##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-3#1)(1991-4#1)(1991-9#1)(1993-10#1)(1993-2#1)(1993-9#1)(1995-6#2)(1996-11#1)(1996-9#3)(1997-1#1)(1997-8#1)(2005-10#1)(2006-10#2)(2006-12#2)(2006-2#4)(2006-3#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#3)(2009-10#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#1)
with suspended mirrors##3##3##(2008-3#3)
with suspended##4##2##(2008-3#3)(2013-1#1)
with suspensions of##2##3##(1994-5#1)(2007-7#1)
with suspicion of##6##3##(1992-2#1)(2007-11#1)(2008-12#1)(2010-10#1)(2010-12#1)(2012-2#1)
with suspicious##4##2##(1992-4#1)(2007-4#2)(2008-3#1)
with sustainable##2##2##(1992-5#1)(1994-9#1)
with sustained long-term##2##3##(2010-12#1)(2013-1#1)
with sustained##10##2##(1990-3#1)(1991-3#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2010-12#1)(2013-1#2)
with sustained-release##3##2##(2005-10#1)(2007-8#1)(2011-2#1)
with suture##3##2##(2008-7#1)(2013-7#2)
with sutures##3##2##(1994-2#1)(2008-9#1)(2013-7#1)
with sweet potato##3##3##(2008-10#3)
with swelling of the##2##4##(2008-1#1)(2009-2#1)
with swelling##6##2##(2008-1#1)(2008-7#1)(2009-2#1)(2010-9#1)(2013-1#2)
with switching##2##2##(2007-12#2)
with swollen head syndrome##3##4##(1997-3#1)(2008-5#2)
with swollen##5##2##(1997-3#1)(2007-12#1)(2008-5#2)(2011-2#1)
with symmetric##2##2##(1993-8#1)(2008-10#1)
with symmetrical peak and##2##4##(2008-10#2)
with symmetrical uptake on the renogram phase and delayed excretion on the left##2##13##(2013-1#2)
with symmetrical##9##2##(2007-7#1)(2008-10#5)(2012-2#1)(2013-1#2)
with sympathetic##4##2##(1991-6#1)(1996-6#1)(2011-2#1)(2013-1#1)
with sympathovagal##2##2##(2012-2#1)(2013-8#1)
with symptom##9##2##(1991-4#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-8#1)(2008-9#1)(2011-1#1)
with symptomatic Chiari##2##3##(2006-5#2)
with symptomatic treatment##3##3##(1996-9#1)(1997-4#1)(2007-6#1)
with symptomatic##46##2##(1991-6#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-2#3)(1995-2#2)(1996-9#1)(1997-4#1)(2005-10#1)(2006-10#1)(2006-11#2)(2006-4#1)(2006-5#2)(2006-8#1)(2006-9#1)(2007-10#3)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-1#1)(2009-2#1)(2009-8#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
with symptoms and clinical##2##4##(2005-12#1)(2011-1#1)
with symptoms and signs of##4##5##(1990-8#1)(2007-7#1)(2008-11#1)(2011-2#1)
with symptoms and##11##3##(1990-3#1)(1990-8#1)(2005-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#2)(2011-1#1)(2011-2#1)(2012-12#1)
with symptoms from##3##3##(1992-12#1)(2006-10#1)(2008-3#1)
with symptoms of allergic rhinitis##2##5##(2007-2#2)
with symptoms of fever##2##4##(2011-2#1)(2012-2#1)
with symptoms of##44##3##(1993-10#1)(1993-11#1)(1995-5#1)(1996-12#2)(1996-7#1)(1997-1#1)(2005-10#1)(2006-11#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-7#2)(2007-8#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#2)(2013-8#2)
with symptoms similar to##2##4##(1991-7#1)(2007-2#1)
with symptoms such as##3##4##(2006-8#1)(2008-3#1)(2012-12#1)
with symptoms suggestive of##3##4##(2006-10#1)(2011-1#1)(2011-2#1)
with symptoms##87##2##(1990-3#1)(1990-8#1)(1991-7#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-10#1)(1993-11#1)(1995-2#1)(1995-5#1)(1996-12#2)(1996-7#1)(1997-1#1)(1997-4#1)(2004-2#1)(2005-10#1)(2005-12#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-8#2)(2007-11#1)(2007-2#4)(2007-3#1)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-6#2)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#7)(2012-2#2)(2013-1#1)(2013-8#4)
with synaptic plasticity##2##3##(2009-8#1)(2011-2#1)
with synaptic vesicles##7##3##(1990-12#1)(1993-8#1)(1994-12#4)(1995-8#1)
with synaptic##10##2##(1990-12#1)(1993-8#1)(1994-12#4)(1995-3#1)(1995-8#1)(2009-8#1)(2011-2#1)
with synchronous##9##2##(1990-6#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-6#1)(2009-1#1)(2012-12#1)(2013-7#1)
with synchrotron radiation at##2##4##(2006-4#1)(2006-5#1)
with synchrotron radiation##13##3##(2006-4#2)(2006-5#3)(2007-11#2)(2008-2#3)(2008-3#3)
with syncope##2##2##(2006-12#1)(2008-4#1)
with syndrome of differentiated dysplasia of connective##2##7##(2013-1#2)
with syndrome of##3##3##(2010-12#1)(2013-1#2)
with syndrome##5##2##(1996-6#1)(2008-12#1)(2010-12#1)(2013-1#2)
with syndromes of##2##3##(1995-12#1)(2007-8#1)
with syndromic##3##2##(2007-12#1)(2007-8#1)(2013-1#1)
with syngeneic spinal cord and incomplete Freund's adjuvant##2##8##(1995-12#2)
with syngeneic##5##2##(1995-12#2)(1995-2#1)(1997-4#1)(1997-7#1)
with synovial##6##2##(2006-10#1)(2008-6#5)
with synthesized data##2##3##(2008-2#2)
with synthesized##6##2##(1990-3#1)(1996-8#1)(2008-11#2)(2008-2#2)
with synthetic fertilizers##2##3##(2008-10#2)
with synthetic materials##2##3##(2007-1#1)(2009-3#1)
with synthetic peptide##3##3##(2005-7#1)(2007-11#1)(2011-1#1)
with synthetic peptides##4##3##(1991-12#1)(1992-1#1)(2008-4#1)(2010-11#1)
with synthetic##41##2##(1990-10#1)(1990-2#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#1)(1996-5#2)(2004-11#1)(2004-4#1)(2005-7#1)(2006-5#1)(2007-1#1)(2007-11#1)(2008-10#8)(2008-2#1)(2008-4#1)(2008-6#1)(2009-3#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
with syphilis##5##2##(1993-3#1)(2007-7#1)(2009-8#1)(2009-9#1)(2011-2#1)
with syringe##3##2##(2008-10#3)
with syringomyelia##7##2##(2005-8#2)(2006-5#3)(2007-8#2)
with systematic##6##2##(1991-7#1)(1995-11#1)(2012-11#1)(2013-1#1)(2013-8#2)
with systemic antibiotics##3##3##(1994-12#2)(2013-8#1)
with systemic chemotherapy and##2##4##(2005-11#1)(2006-6#1)
with systemic chemotherapy##6##3##(2005-11#1)(2006-6#3)(2008-5#1)(2008-6#1)
with systemic complaints##2##3##(2006-10#1)(2007-7#1)
with systemic corticosteroids##2##3##(2008-5#1)(2013-1#1)
with systemic diseases##2##3##(2007-7#1)(2012-2#1)
with systemic inflammatory##2##3##(2008-5#1)(2008-7#1)
with systemic lupus erythematosus (SLE)##18##5##(1990-12#1)(1990-6#1)(1994-3#1)(2006-10#6)(2007-3#2)(2007-7#1)(2007-8#1)(2007-9#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
with systemic lupus erythematosus and##4##5##(2006-10#4)
with systemic lupus erythematosus##52##4##(1990-10#1)(1990-12#1)(1990-6#1)(1991-5#1)(1992-5#1)(1993-11#1)(1994-3#1)(1994-9#2)(1997-8#1)(2006-10#21)(2007-11#1)(2007-12#1)(2007-3#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-9#1)(2010-11#1)(2010-12#2)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
with systemic lupus##57##3##(1990-10#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-5#1)(1992-5#1)(1993-11#1)(1994-3#1)(1994-9#2)(1997-8#1)(2006-10#21)(2007-11#1)(2007-12#1)(2007-3#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-9#1)(2010-11#1)(2010-12#2)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#2)
with systemic manifestations##2##3##(2007-11#1)(2009-6#1)
with systemic methotrexate##2##3##(2004-10#1)(2011-2#1)
with systemic onset##2##3##(2006-10#2)
with systemic sclerosis in##2##4##(2006-10#1)(2012-2#1)
with systemic sclerosis##12##3##(2006-10#3)(2008-8#1)(2009-8#1)(2010-10#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#2)
with systemic therapy##2##3##(2007-8#1)(2013-1#1)
with systemic vasculitis##2##3##(2007-2#1)(2008-1#1)
with systemic##124##2##(1990-10#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-5#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-5#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-9#2)(1995-12#1)(1996-11#1)(1996-6#1)(1997-8#1)(2004-10#1)(2005-11#1)(2006-1#1)(2006-10#30)(2006-6#4)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#3)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#4)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-9#1)(2011-12#1)(2011-2#10)(2012-1#2)(2012-12#2)(2012-2#5)(2013-1#7)(2013-8#3)
with systems##5##2##(1997-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)
with systolic and diastolic blood pressure##2##6##(2006-4#1)(2008-3#1)
with systolic and diastolic##3##4##(2006-4#1)(2008-3#1)(2010-12#1)
with systolic dysfunction##2##3##(2010-7#1)(2013-7#1)
with systolic##10##2##(1992-2#1)(2006-4#1)(2007-8#1)(2008-3#2)(2010-10#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-7#1)
with t(11##2##2##(2005-11#1)(2007-12#1)
with t(2##2##2##(1993-2#1)(2009-2#1)
with t(7##2##2##(1997-1#1)(2012-2#1)
with t-PA in##2##3##(1990-11#1)(2007-9#1)
with t-PA##6##2##(1990-11#1)(2007-10#3)(2007-9#2)
with t-butyl hydroperoxide##2##3##(1992-1#1)(1997-8#1)
with t-test##2##2##(2005-12#1)(2012-12#1)
with tRNA##2##2##(1991-10#1)(2006-11#1)
with tachypnea##2##2##(2006-10#1)(2012-3#1)
with tacrolimus##8##2##(2004-12#2)(2007-11#3)(2008-10#1)(2008-3#1)(2012-2#1)
with tailorable##2##2##(2007-12#1)(2008-12#1)
with tailored##3##2##(2008-10#1)(2009-7#1)(2013-8#1)
with talc##2##2##(2006-10#1)(2008-5#1)
with tall stature and##2##4##(2004-11#1)(2008-10#1)
with tall##3##2##(2004-11#1)(2008-10#2)
with tamoxifen and##3##3##(1992-2#2)(2007-11#1)
with tamoxifen##20##2##(1991-8#1)(1992-2#2)(1993-10#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-6#1)(1994-7#1)(1996-4#2)(2004-1#3)(2007-11#1)(2008-5#4)(2012-2#1)
with tamponade and cardiogenic shock in##2##6##(2007-8#2)
with tamponade and##3##3##(2007-8#2)(2010-4#1)
with tamponade##4##2##(2006-10#1)(2007-8#2)(2010-4#1)
with tandem mass spectrometric##2##4##(1997-3#1)(2010-4#1)
with tandem mass spectrometry##8##4##(1990-1#1)(1994-12#1)(1996-8#2)(2007-8#1)(2008-10#1)(2009-8#1)(2012-3#1)
with tandem mass##11##3##(1990-1#1)(1994-12#1)(1996-8#2)(1997-3#1)(2007-8#1)(2008-10#1)(2009-8#1)(2010-4#2)(2012-3#1)
with tandem##15##2##(1990-1#1)(1994-12#1)(1996-10#1)(1996-8#2)(1997-3#1)(2007-8#1)(2008-10#1)(2009-8#1)(2010-11#1)(2010-4#2)(2011-3#1)(2012-12#1)(2012-3#1)
with tangential##2##2##(2008-10#1)(2008-6#1)
with tap water##8##3##(1990-4#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-5#1)(2011-12#1)
with tap##9##2##(1990-4#1)(1996-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-5#1)(2011-12#1)
with tapered##3##2##(1990-7#1)(2008-4#1)(2010-4#1)
with tardive##2##2##(1997-8#1)(2012-3#1)
with target cells##2##3##(2008-11#2)
with target##13##2##(1990-11#1)(1992-7#1)(1993-7#1)(1994-5#1)(1997-6#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-2#1)(2009-4#1)
with targeted##15##2##(1997-3#1)(1997-4#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-11#1)(2008-5#2)(2009-3#1)(2010-12#2)(2010-9#2)(2011-2#1)(2012-3#1)
with tasks##2##2##(2008-4#1)(2011-2#1)
with tattoos##2##2##(2007-12#1)(2010-6#1)
with tau##3##2##(1992-11#1)(1992-6#1)(1995-11#1)
with taurine##2##2##(2009-10#2)
with tax##2##2##(1991-9#1)(1995-7#1)
with tax-exempt##3##2##(1992-8#1)(1994-3#1)(2008-11#1)
with taxol##3##2##(1993-8#1)(2009-10#1)(2011-2#1)
with teachers##7##2##(2007-12#1)(2008-12#2)(2011-2#2)(2012-12#2)
with teaching##2##2##(2008-12#1)(2009-2#1)
with tear##3##2##(2005-11#2)(2012-2#1)
with technetium##2##2##(1992-2#1)(2008-5#1)
with technetium-99m (99mTc)##2##3##(1990-12#1)(1995-8#1)
with technetium-99m##4##2##(1990-12#1)(1995-8#1)(1996-5#1)(2008-5#1)
with technical##6##2##(2005-5#1)(2006-8#1)(2008-1#1)(2008-5#1)(2012-12#1)(2012-3#1)
with technique##3##2##(2010-7#1)(2011-2#2)
with techniques##4##2##(2008-10#1)(2008-2#1)(2008-8#1)(2009-4#1)
with technology##8##2##(1996-1#1)(1996-11#1)(2006-8#1)(2007-12#2)(2008-1#1)(2008-11#1)(2010-3#1)
with teenagers##2##2##(2008-9#1)(2013-1#1)
with tegaserod##3##2##(2008-3#2)(2010-6#1)
with telomerase##2##2##(1995-6#1)(2008-11#1)
with temafloxacin##2##2##(1991-12#2)
with temozolomide##3##2##(2006-6#1)(2011-2#1)(2011-3#1)
with temperature and##5##3##(1997-1#1)(2005-11#1)(2008-10#1)(2008-5#1)(2011-12#1)
with temperature are##2##3##(2008-10#1)(2008-2#1)
with temperature as the##2##4##(2008-10#1)(2008-3#1)
with temperature as##3##3##(1990-8#1)(2008-10#1)(2008-3#1)
with temperature in##2##3##(1990-11#1)(2006-10#1)
with temperature is##2##3##(2008-2#2)
with temperature of##2##3##(2008-12#1)(2011-12#1)
with temperature up to##2##4##(2008-10#2)
with temperature were##2##3##(2009-3#1)(2010-4#1)
with temperature##58##2##(1990-11#2)(1990-7#1)(1990-8#1)(1991-5#1)(1992-1#1)(1996-2#2)(1997-1#1)(1997-4#1)(2005-11#2)(2006-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#2)(2008-10#17)(2008-12#1)(2008-2#3)(2008-3#6)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-4#1)(2011-12#2)(2011-2#1)(2013-7#2)
with temperature-dependent sex determination##2##4##(1997-5#1)(2008-8#1)
with temperatures##6##2##(1996-8#1)(2007-3#1)(2008-10#2)(2008-2#1)(2008-3#1)
with temporal arteritis##2##3##(1996-9#1)(2006-10#1)
with temporal lobe##4##3##(1991-12#1)(1996-7#1)(2008-4#1)(2011-1#1)
with temporal##13##2##(1991-12#1)(1996-7#1)(1996-9#1)(2006-10#1)(2006-2#1)(2008-2#3)(2008-4#1)(2009-10#1)(2009-8#2)(2011-1#1)
with temporary or permanent##2##4##(2010-4#2)
with temporary or##3##3##(2009-2#1)(2010-4#2)
with temporary##8##2##(2007-7#1)(2008-12#1)(2009-2#1)(2009-9#1)(2010-4#2)(2012-1#1)(2013-7#1)
with temporomandibular joint##2##3##(2007-12#1)(2007-6#1)
with temporomandibular##4##2##(2007-12#1)(2007-6#1)(2008-9#1)(2013-1#1)
with ten or##2##3##(1996-12#1)(2004-1#1)
with ten##10##2##(1992-11#1)(1996-12#2)(1997-1#1)(2004-1#1)(2007-1#1)(2008-12#1)(2010-3#1)(2012-11#2)
with tenderness##2##2##(2008-3#1)(2012-12#1)
with tenofovir##3##2##(2007-1#1)(2010-12#1)(2013-1#1)
with tense##2##2##(2011-1#1)(2012-12#1)
with terahertz##3##2##(2007-11#1)(2007-12#2)
with terbium##2##2##(2008-10#1)(2010-3#1)
with terbium(III)##2##2##(2007-8#1)(2008-10#1)
with terbutaline##2##2##(1991-12#1)(2008-10#1)
with terminal##16##2##(1990-7#1)(1990-8#1)(1992-5#1)(1993-12#1)(1993-7#1)(1994-12#1)(1994-6#1)(1996-11#1)(1997-7#1)(2005-11#1)(2006-4#1)(2007-12#1)(2007-2#1)(2010-12#1)(2010-6#1)(2012-3#1)
with terrestrial##3##2##(2006-4#1)(2007-12#1)(2012-2#1)
with tert-butyl##3##2##(1990-4#1)(1996-8#1)(2010-2#1)
with tertiary##3##2##(1996-11#1)(2008-6#1)(2012-12#1)
with test##5##2##(1993-2#1)(1996-12#1)(2008-10#2)(2008-3#1)
with tester isolates##2##3##(2008-10#2)
with tester strains of##2##4##(2008-10#2)
with tester##4##2##(2008-10#4)
with testicular cancer##7##3##(2006-7#3)(2009-5#2)(2012-2#2)
with testicular##13##2##(1994-5#1)(2006-7#3)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2009-5#2)(2012-2#3)
with testing##4##2##(1991-4#1)(1994-6#1)(2006-8#1)(2010-12#1)
with testosterone and##2##3##(1994-8#1)(2012-12#1)
with testosterone##9##2##(1990-11#2)(1990-4#1)(1994-8#2)(1996-11#1)(2008-1#1)(2008-5#1)(2012-12#1)
with tests of##2##3##(2007-3#2)
with tests##6##2##(1994-6#1)(2007-3#2)(2008-10#1)(2008-12#1)(2008-4#1)
with tetanus toxin##2##3##(1990-9#1)(1995-2#1)
with tetanus##4##2##(1990-9#1)(1995-2#1)(1996-8#1)(2007-8#1)
with tethered cord##2##3##(2006-5#1)(2007-8#1)
with tethered##4##2##(2006-5#1)(2007-8#1)(2012-2#1)(2012-3#1)
with tetra-substituted sulphonated aluminum phthalocyanine##2##5##(2008-10#2)
with tetra-substituted##3##2##(2008-10#3)
with tetrabutylammonium##7##2##(1997-3#1)(2007-11#2)(2008-10#3)(2008-4#1)
with tetracycline##5##2##(1993-2#1)(2008-10#3)(2011-2#1)
with tetradecylthioacetic acid##2##3##(2009-4#2)
with tetraethylammonium##2##2##(1991-1#1)(2008-10#1)
with tetralogy of Fallot and##2##5##(1997-1#1)(2009-9#1)
with tetralogy of Fallot##5##4##(1997-1#3)(1997-3#1)(2009-9#1)
with tetramethylammonium hydroxide (TMAH)##4##4##(2008-10#3)(2013-1#1)
with tetramethylammonium hydroxide##6##3##(2008-10#5)(2013-1#1)
with tetramethylammonium##7##2##(2008-10#6)(2013-1#1)
with tetramethylrhodamine-dextran amine##2##3##(1997-1#1)(1997-3#1)
with tetraplegia##5##2##(2006-3#1)(2007-11#2)(2012-1#1)(2012-2#1)
with tetrodotoxin##4##2##(1991-10#1)(1991-11#1)(1993-3#1)(1995-12#1)
with texture##2##2##(2008-2#1)(2008-6#1)
with thalassemia##6##2##(1995-12#1)(2006-10#2)(2007-10#1)(2007-2#1)(2012-11#1)
with thalidomide and##2##3##(2011-1#2)
with thalidomide##7##2##(2006-10#2)(2007-10#3)(2011-1#2)
with than without##3##3##(1993-5#1)(2006-5#1)(2011-2#1)
with thapsigargin##3##2##(1990-10#1)(1997-2#1)(2006-6#1)
with that achieved##2##3##(2008-10#1)(2008-7#1)
with that at the##2##4##(2008-10#1)(2012-2#1)
with that at##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
with that by##3##3##(1996-8#1)(2007-11#1)(2008-10#1)
with that calculated from##3##4##(1990-8#1)(2008-10#1)(2008-3#1)
with that determined by##4##4##(1996-7#2)(2008-10#2)
with that determined##6##3##(1994-11#1)(1996-7#2)(1997-7#1)(2008-10#2)
with that expected from##2##4##(1992-8#1)(2008-3#1)
with that expected##3##3##(1992-8#1)(2008-3#1)(2008-7#1)
with that for the##5##4##(1990-7#1)(1995-3#1)(2006-10#1)(2007-12#1)(2008-2#1)
with that for##10##3##(1990-5#1)(1990-7#1)(1992-7#1)(1995-3#1)(2006-10#1)(2007-12#2)(2008-2#1)(2008-5#1)(2012-3#1)
with that found in##2##4##(2008-11#1)(2011-1#1)
with that found##3##3##(1992-6#1)(2008-11#1)(2011-1#1)
with that from other##2##4##(1990-6#1)(2008-4#1)
with that from the##6##4##(1992-11#1)(1993-3#1)(1995-11#1)(1995-6#1)(2007-12#1)(2008-3#1)
with that from##14##3##(1990-6#1)(1992-11#1)(1993-3#1)(1993-8#1)(1995-11#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-6#1)(2012-2#1)
with that in a##3##4##(2008-2#3)
with that in primary##2##4##(2008-11#2)
with that in the##15##4##(1990-2#1)(1992-8#1)(1993-1#1)(1996-3#1)(1996-7#1)(2006-5#2)(2007-8#2)(2008-10#2)(2008-8#1)(2009-2#1)(2010-8#1)(2011-3#1)
with that in##54##3##(1990-2#1)(1992-1#1)(1992-8#1)(1993-1#1)(1994-10#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-7#2)(1997-5#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-5#3)(2007-12#1)(2007-8#2)(2008-10#8)(2008-11#3)(2008-2#3)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-2#2)(2009-6#1)(2010-8#1)(2011-12#1)(2011-3#1)(2012-1#1)(2013-1#2)(2013-8#1)
with that measured by##3##4##(2008-10#1)(2012-11#1)(2013-1#1)
with that measured##5##3##(2008-10#1)(2008-2#1)(2008-3#1)(2012-11#1)(2013-1#1)
with that observed at##2##4##(2008-10#2)
with that observed for##4##4##(1990-3#1)(1992-3#1)(2008-10#1)(2008-11#1)
with that observed in##3##4##(1995-3#1)(1996-12#1)(2008-10#1)
with that observed##10##3##(1990-3#1)(1992-3#1)(1995-3#1)(1996-12#1)(1996-5#1)(2008-10#4)(2008-11#1)
with that obtained##6##3##(1995-5#1)(2005-11#1)(2007-12#1)(2008-10#3)
with that of Escherichia coli##2##5##(1990-9#1)(1995-3#1)
with that of PS##2##4##(1993-11#1)(1995-10#1)
with that of PTH##2##4##(1991-5#1)(1991-8#1)
with that of a control##2##5##(2007-9#1)(2008-4#1)
with that of a conventional##4##5##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
with that of a similar lyophilized formulation##2##7##(2008-5#2)
with that of a##39##4##(1991-3#1)(1994-7#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-8#1)(2004-9#1)(2006-10#1)(2007-11#2)(2007-12#4)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
with that of an##4##4##(1994-2#1)(2007-11#1)(2007-12#1)(2008-10#1)
with that of controls##3##4##(1992-2#1)(2009-4#1)(2013-1#1)
with that of conventional##7##4##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)
with that of dry##2##4##(2008-10#1)(2008-12#1)
with that of human##4##4##(1991-7#1)(1995-12#1)(1996-7#1)(2012-2#1)
with that of its##4##4##(1997-2#1)(1997-7#1)(2007-12#1)(2012-3#1)
with that of normal##2##4##(1994-11#1)(1996-3#1)
with that of other##14##4##(1991-4#1)(1992-11#1)(1993-11#1)(1993-6#1)(1997-3#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-8#1)(2011-2#1)
with that of recombinant##2##4##(1994-11#1)(1995-6#1)
with that of standard##2##4##(1995-2#1)(2010-5#1)
with that of the IMCT model##2##6##(2010-2#2)
with that of the UV##2##5##(2005-11#1)(2008-10#1)
with that of the classical##2##5##(1991-12#1)(1995-12#1)
with that of the conventional##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
with that of the corresponding##2##5##(1995-3#1)(2008-3#1)
with that of the general population##3##6##(1991-2#1)(1993-1#1)(2008-12#1)
with that of the general##4##5##(1991-2#1)(1993-1#1)(2007-7#1)(2008-12#1)
with that of the human##5##5##(1990-4#1)(1991-12#1)(1993-11#1)(1996-5#1)(2008-8#1)
with that of the local##2##5##(2008-2#2)
with that of the marketed##3##5##(2010-12#1)(2012-2#1)(2013-7#1)
with that of the native enzyme##2##6##(1990-11#1)(1995-3#1)
with that of the original##2##5##(1990-10#1)(2010-7#1)
with that of the previously##2##5##(2007-11#1)(2010-4#1)
with that of the rat##2##5##(1996-5#1)(2008-8#1)
with that of the##116##4##(1990-10#1)(1990-11#2)(1990-12#1)(1990-4#2)(1990-5#4)(1990-6#1)(1990-8#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-11#2)(1993-3#3)(1993-6#1)(1994-11#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-3#2)(1995-6#2)(1995-8#1)(1996-12#1)(1996-5#2)(1996-7#2)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#2)(2005-11#2)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#5)(2007-7#1)(2007-8#1)(2008-10#9)(2008-12#1)(2008-2#7)(2008-3#7)(2008-8#5)(2008-9#2)(2009-8#1)(2010-12#2)(2010-2#2)(2010-4#2)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
with that of their##2##4##(1997-1#1)(2007-1#1)
with that of two##4##4##(1991-8#1)(1993-1#1)(2008-10#1)(2008-2#1)
with that of wild-type##2##4##(1990-2#1)(2008-10#1)
with that of##400##3##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#4)(1990-4#2)(1990-5#6)(1990-6#1)(1990-7#5)(1990-8#4)(1990-9#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#3)(1991-9#2)(1992-11#2)(1992-2#2)(1992-3#1)(1992-4#2)(1992-5#2)(1992-6#3)(1992-7#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#6)(1993-2#1)(1993-3#3)(1993-6#3)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#4)(1995-10#3)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#5)(1995-4#2)(1995-6#5)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#2)(1996-7#3)(1996-8#3)(1996-9#2)(1997-1#2)(1997-2#4)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#1)(2004-10#1)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-4#2)(2006-10#3)(2006-12#3)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#8)(2007-12#16)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#41)(2008-11#4)(2008-12#2)(2008-2#18)(2008-3#24)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#6)(2008-8#7)(2008-9#4)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#2)(2010-12#3)(2010-2#3)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#7)
with that on##5##3##(1990-2#1)(2006-5#1)(2008-10#3)
with that particular##2##3##(2008-8#1)(2009-8#1)
with that predicted by the##2##5##(2008-3#2)
with that predicted by##4##4##(2008-2#1)(2008-3#3)
with that predicted##6##3##(1991-2#1)(1993-6#1)(2008-2#1)(2008-3#3)
with that previously##4##3##(1995-3#1)(2007-12#1)(2008-10#1)(2012-2#1)
with that provided by##2##4##(2008-10#2)
with that reported##7##3##(1991-2#2)(1991-3#1)(1994-2#2)(1994-6#1)(2007-7#1)
with that seen in##3##4##(1992-10#1)(1992-3#1)(2007-8#1)
with that to##2##3##(2005-7#1)(2008-10#1)
with that under##3##3##(2008-1#1)(2008-2#1)(2012-1#1)
with that using##3##3##(1994-10#1)(2007-8#1)(2013-1#1)
with that which##2##3##(2008-10#1)(2008-3#1)
with that##605##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#3)(1990-3#5)(1990-4#2)(1990-5#7)(1990-6#2)(1990-7#6)(1990-8#5)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#5)(1991-3#4)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#2)(1991-8#3)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#3)(1992-4#2)(1992-5#2)(1992-6#4)(1992-7#4)(1992-8#3)(1992-9#1)(1993-1#5)(1993-11#6)(1993-2#1)(1993-3#4)(1993-6#4)(1993-8#1)(1994-10#2)(1994-11#6)(1994-12#2)(1994-2#4)(1994-3#1)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#5)(1995-10#3)(1995-11#3)(1995-12#4)(1995-2#5)(1995-3#9)(1995-4#2)(1995-5#1)(1995-6#7)(1995-8#2)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#3)(1996-4#2)(1996-5#3)(1996-6#1)(1996-7#7)(1996-8#4)(1996-9#2)(1997-1#2)(1997-2#5)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#4)(1997-7#3)(1997-8#1)(2004-10#1)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#6)(2005-4#2)(2005-5#1)(2005-7#1)(2006-10#5)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#7)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#9)(2007-12#23)(2007-2#1)(2007-4#1)(2007-7#4)(2007-8#8)(2007-9#1)(2008-1#3)(2008-10#75)(2008-11#12)(2008-12#2)(2008-2#27)(2008-3#39)(2008-4#3)(2008-5#10)(2008-6#2)(2008-7#11)(2008-8#13)(2008-9#5)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#3)(2009-8#3)(2009-9#2)(2010-12#3)(2010-2#3)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#3)(2011-12#1)(2011-2#8)(2011-3#1)(2012-1#4)(2012-11#2)(2012-12#3)(2012-2#10)(2012-3#6)(2013-1#10)(2013-7#2)(2013-8#8)
with the &quot##23##3##(1990-12#1)(1991-3#1)(1994-12#1)(1994-3#1)(1994-9#2)(1995-5#1)(1995-6#1)(1996-7#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-3#3)(2007-8#3)(2008-3#1)(2008-5#1)(2012-2#1)(2013-1#1)
with the 0##4##3##(2008-10#2)(2008-2#1)(2008-7#1)
with the 1##5##3##(1992-9#1)(2007-12#2)(2008-2#1)(2008-5#1)
with the 10##4##3##(1992-1#1)(2007-11#1)(2008-10#1)(2008-3#1)
with the 12##3##3##(1992-1#1)(2008-10#1)(2011-2#1)
with the 18q- syndrome##2##4##(1997-3#2)
with the 2##6##3##(1990-7#1)(1991-12#1)(1996-6#1)(2004-11#1)(2007-10#1)(2008-3#1)
with the 20##2##3##(2008-10#1)(2008-8#1)
with the 22-kDa##2##3##(1995-8#1)(2008-10#1)
with the 2nd antibody##2##4##(2008-10#2)
with the 3##6##3##(1995-3#2)(2007-11#1)(2008-10#1)(2008-5#1)(2012-2#1)
with the 3'##3##3##(1997-6#1)(2008-4#1)(2011-2#1)
with the 30##2##3##(1990-7#1)(1997-7#1)
with the 32P-postlabeling assay##2##4##(1992-7#2)
with the 3D##4##3##(1996-7#1)(2006-12#1)(2007-11#1)(2008-11#1)
with the 40-kDa##2##3##(1993-9#1)(1997-1#1)
with the 5##2##3##(1993-4#1)(1997-5#1)
with the 5' half##2##4##(2008-10#1)(2008-8#1)
with the 5'##7##3##(1991-5#1)(1992-11#2)(1997-7#1)(2008-10#2)(2008-8#1)
with the 5-HT1A receptor##2##4##(1994-2#1)(1997-1#1)
with the 5-HT1A##3##3##(1994-2#1)(1997-1#2)
with the 5S RNA gene##2##5##(1995-11#2)
with the 67 K protein##2##5##(1995-12#2)
with the A##3##3##(1997-2#1)(2008-6#1)(2010-6#1)
with the ACR##2##3##(2007-4#2)
with the AFLP##3##3##(2008-10#3)
with the AIDS virus##3##4##(1990-5#1)(1991-5#1)(1993-1#1)
with the AIDS##5##3##(1990-5#1)(1991-5#1)(1993-1#1)(1994-1#1)(1994-6#1)
with the ATP##2##3##(1993-8#1)(2007-10#1)
with the Ag##3##3##(1990-5#1)(1995-2#1)(2013-1#1)
with the Ah receptor##3##4##(1994-8#1)(1997-3#1)(1997-4#1)
with the American Association##2##4##(1991-1#1)(2008-5#1)
with the American##7##3##(1991-1#1)(1996-5#1)(2008-11#1)(2008-3#3)(2008-5#1)
with the Arabidopsis##2##3##(2006-12#1)(2008-9#1)
with the Atlantic##2##3##(1995-11#1)(2007-3#1)
with the B##5##3##(1997-3#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-5#1)
with the B3LYP and##2##4##(2008-8#1)(2010-7#1)
with the BCR procedure##2##4##(2008-10#2)
with the Babyhaler##2##3##(2004-12#2)
with the Bessel##2##3##(2008-2#1)(2008-3#1)
with the Bratton-Marshall reagent##2##4##(2008-10#2)
with the C##3##3##(1990-2#1)(2008-10#2)
with the C-D method##3##4##(2007-7#3)
with the C-D##4##3##(2007-7#4)
with the C-terminal##11##3##(1990-2#1)(1992-3#1)(1992-8#1)(1993-3#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-8#1)(2006-5#1)(2008-7#1)(2011-2#1)
with the C/EBP##2##3##(1995-3#1)(1996-10#1)
with the CB##2##3##(2008-2#1)(2009-12#1)
with the CD##2##3##(2007-7#2)
with the CD4000##3##3##(2008-10#3)
with the CEA##3##3##(1991-4#1)(1993-4#1)(2009-11#1)
with the CHOP regimen for diffuse large B cell lymphoma##2##10##(2009-8#2)
with the CMV vector##2##4##(2009-10#2)
with the CMV##3##3##(1992-6#1)(2009-10#2)
with the COOH-terminal##2##3##(1995-6#1)(1997-4#1)
with the COX-2 inhibitors##2##4##(2008-8#1)(2009-1#1)
with the CT##2##3##(2007-9#2)
with the Ca2+##2##3##(1992-1#1)(1997-1#1)
with the Canadian##2##3##(2007-12#1)(2009-4#1)
with the Commission##2##3##(2010-9#1)(2012-2#1)
with the Converge##2##3##(2007-8#2)
with the D##2##3##(2008-10#1)(2008-9#1)
with the D12##2##3##(1994-9#2)
with the D2##2##3##(1993-3#1)(2008-7#1)
with the DNA binding##2##4##(1993-3#1)(1993-6#1)
with the DNA sequence##2##4##(1992-3#1)(1996-5#1)
with the DNA template##2##4##(1995-1#1)(1995-5#1)
with the DNA##20##3##(1990-12#1)(1991-2#1)(1992-3#1)(1993-3#2)(1993-6#1)(1995-1#1)(1995-5#2)(1996-5#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2011-2#1)(2012-12#1)
with the Dermatology Life Quality Index##2##6##(2007-7#1)(2012-12#1)
with the Directorate of Health##2##5##(1990-10#1)(2006-10#1)
with the Disc Unloader brace on##4##6##(2006-7#4)
with the Drosophila##3##3##(1990-7#1)(1996-5#1)(1997-1#1)
with the E##6##3##(1990-10#1)(1990-11#1)(1991-5#1)(1994-9#1)(1997-4#1)(2008-1#1)
with the ELISA##3##3##(1991-12#1)(1992-5#1)(1995-2#1)
with the ER##3##3##(1994-8#2)(1996-4#1)
with the ES-2 dummy##2##4##(2006-11#2)
with the El Niño##2##4##(2008-9#1)(2010-8#1)
with the Endotoxin Standard##2##4##(2007-8#2)
with the Escherichia coli##2##4##(1990-1#1)(1990-10#1)
with the Eurasian##2##3##(2008-9#1)(2010-8#1)
with the European Union##2##4##(2007-8#1)(2010-9#1)
with the European##8##3##(2007-8#1)(2007-9#1)(2008-10#3)(2010-8#1)(2010-9#1)(2012-12#1)
with the FDA##3##3##(2005-7#1)(2005-8#1)(2005-9#1)
with the FIA##2##3##(2008-10#2)
with the Fourier##2##3##(2007-12#1)(2008-3#1)
with the G protein-coupled##2##4##(1991-5#1)(2009-7#1)
with the GABAA##2##3##(1990-10#1)(1992-3#1)
with the GC##2##3##(2005-8#1)(2007-1#1)
with the GDS##2##3##(2006-10#1)(2007-9#1)
with the GM modified PLGA particles##2##6##(2009-7#2)
with the GSM##2##3##(2008-3#2)
with the GUS##2##3##(1997-2#1)(2008-10#1)
with the Gamma##2##3##(1997-4#1)(2007-8#1)
with the German##2##3##(2005-8#1)(2007-8#1)
with the Glasgow##2##3##(2011-2#1)(2012-3#1)
with the GnRH##2##3##(1996-2#1)(2008-5#1)
with the Golgi##2##3##(1993-12#1)(1995-2#1)
with the Gram##2##3##(2006-8#2)
with the Grb2 adaptor protein##2##5##(1996-5#2)
with the HASYLAB reflectometer##2##4##(2008-2#2)
with the HBV##2##3##(2008-8#2)
with the HIPAA privacy##2##4##(2005-8#1)(2006-8#1)
with the HIPAA##3##3##(2005-8#1)(2006-7#1)(2006-8#1)
with the HIV##2##3##(2007-11#1)(2010-5#1)
with the HLA##2##3##(2006-10#2)
with the HPLC method##3##4##(2008-10#2)(2009-8#1)
with the HPLC##7##3##(1993-1#1)(2008-10#5)(2009-8#1)
with the Helicobacter pylori extract##2##5##(1996-11#2)
with the Human##2##3##(1996-5#1)(2007-3#1)
with the Hybrid III and##2##5##(2006-11#2)
with the Hybrid III##5##4##(2006-11#2)(2007-4#3)
with the Hybrid##6##3##(2006-11#2)(2007-4#3)(2011-2#1)
with the ICP-MS##2##3##(2008-10#2)
with the IGF-I##2##3##(1996-2#2)
with the IGFIR##2##3##(1995-6#2)
with the IL##3##3##(2010-4#3)
with the IMx##2##3##(1992-6#1)(1996-4#1)
with the Icelandic##2##3##(2006-10#1)(2012-1#1)
with the Ilizarov technique##2##4##(2008-4#1)(2009-3#1)
with the Ilizarov##4##3##(2006-4#1)(2007-8#1)(2008-4#1)(2009-3#1)
with the Indiana##3##3##(2008-10#1)(2013-1#2)
with the International##6##3##(2005-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)
with the JCAHO's##2##3##(1993-2#1)(1995-1#1)
with the Kaplan-Meier method##2##4##(2007-8#1)(2012-1#1)
with the Kd##2##3##(1990-7#1)(1993-12#1)
with the Kirchhoff##2##3##(2008-2#1)(2008-3#1)
with the L##2##3##(1994-3#1)(1996-9#1)
with the LCR##2##3##(1993-2#2)
with the LGB community##2##4##(2010-8#2)
with the Leksell##2##3##(1993-8#1)(2005-1#1)
with the Lewis##2##3##(1994-2#1)(2013-8#1)
with the LifeSite System##2##4##(2007-7#2)
with the LifeSite##3##3##(2007-7#3)
with the Local##2##3##(2008-7#1)(2011-2#1)
with the M##4##3##(1996-9#1)(1997-5#1)(2008-10#1)(2011-10#1)
with the MAPK##3##3##(2012-3#3)
with the MAbs##2##3##(1994-3#1)(2008-10#1)
with the MS##5##3##(2008-3#5)
with the Maquet##2##3##(2008-12#1)(2011-2#1)
with the Mayo##2##3##(2008-1#1)(2009-7#1)
with the Mie##2##3##(2008-2#1)(2008-3#1)
with the Monte Carlo##3##4##(2008-2#2)(2008-3#1)
with the N##4##3##(1994-5#1)(1994-9#1)(2008-10#1)(2012-3#1)
with the N-methyl-D-aspartate (NMDA)##2##4##(1992-8#1)(1993-2#1)
with the N-methyl-D-aspartate##3##3##(1992-8#1)(1993-2#1)(1994-2#1)
with the N-terminal amino##2##4##(1990-4#1)(1994-11#1)
with the N-terminal domain##2##4##(1990-11#1)(2010-10#1)
with the N-terminal portion of the##2##6##(1990-9#1)(1991-7#1)
with the N-terminal sequence of the##6##6##(1990-2#1)(1990-3#1)(1990-6#1)(1991-11#1)(1993-3#1)(1994-12#1)
with the N-terminal sequence of##7##5##(1990-2#1)(1990-3#1)(1990-6#1)(1991-11#1)(1993-3#1)(1994-12#1)(1997-8#1)
with the N-terminal##24##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-7#1)(1992-11#1)(1992-9#1)(1993-3#1)(1994-11#2)(1994-12#3)(1995-8#1)(1996-10#1)(1997-7#1)(1997-8#2)(2010-10#1)
with the NIST lamps##2##4##(2008-3#2)
with the NMR data##2##4##(1995-3#1)(2008-7#1)
with the NMR##4##3##(1995-10#1)(1995-3#1)(2008-10#1)(2008-7#1)
with the NO##2##3##(1992-6#1)(1995-2#1)
with the National Cancer##2##4##(2008-5#1)(2008-7#1)
with the National Institute of Neurological Disorders and Stroke (NINDS)##2##10##(2007-9#2)
with the National Institute of Neurological##3##6##(2005-8#1)(2007-9#2)
with the National Institute##4##4##(1996-4#1)(2005-8#1)(2007-9#2)
with the National##14##3##(1996-4#1)(2005-11#1)(2005-8#1)(2006-12#1)(2007-10#1)(2007-9#2)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
with the Nd##3##3##(1991-3#2)(1994-2#1)
with the New##2##3##(1997-3#1)(2008-10#1)
with the Nucleus##7##3##(2008-9#3)(2012-2#4)
with the ODA##2##3##(1995-12#1)(2005-11#1)
with the OIE##2##3##(2011-2#2)
with the OVA/IL12 protein produced##2##5##(2008-11#2)
with the P1##2##3##(1994-3#1)(1995-8#1)
with the PCT##2##3##(2007-11#1)(2007-7#1)
with the PDGF receptor##3##4##(1996-8#3)
with the PKC##4##3##(1995-3#1)(1995-8#1)(2012-2#2)
with the Peabody##2##3##(2006-10#2)
with the QTL##2##3##(2008-10#2)
with the R##2##3##(1993-6#1)(2008-10#1)
with the RIA##3##3##(1992-7#1)(1993-9#1)(1994-10#1)
with the RT##2##3##(1997-3#2)
with the Raman##6##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-7#1)
with the Roman##2##3##(1997-2#1)(2010-1#1)
with the Rubini vaccine##2##4##(1997-6#2)
with the Rubini##3##3##(1997-6#3)
with the S##4##3##(1993-2#1)(1996-6#1)(2004-11#1)(2008-5#1)
with the S-phase##2##3##(1994-12#2)
with the S2 state##2##4##(1997-7#2)
with the S6##2##3##(2006-2#1)(2008-5#1)
with the SE-9000##2##3##(2008-10#2)
with the SPR##2##3##(2008-10#1)(2008-2#1)
with the Saccharomyces cerevisiae##2##4##(1995-4#1)(1995-9#1)
with the Saint##2##3##(2011-1#1)(2011-2#1)
with the Semliki Forest Virus##2##5##(2008-11#2)
with the SmartWire##2##3##(1996-6#2)
with the Spanish##2##3##(1997-6#1)(2008-10#1)
with the Spectra Optia compared with the MCS+ procedures##2##9##(2011-2#2)
with the T##8##3##(1991-5#2)(1993-8#1)(1994-11#1)(1995-2#1)(1995-8#1)(2008-10#1)(2008-5#1)
with the T4##2##3##(1994-12#1)(1995-8#1)
with the T7 A1 promoter##2##5##(2007-6#2)
with the T7##3##3##(1990-4#1)(2007-6#2)
with the TATA box binding protein##2##6##(1994-3#1)(1996-4#1)
with the TATA box##3##4##(1994-3#1)(1996-4#1)(1997-2#1)
with the TEM##2##3##(2005-11#1)(2006-6#1)
with the TEMPO+##3##3##(2008-9#3)
with the Tn5##2##3##(2013-8#2)
with the U##8##3##(1993-2#1)(1994-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-9#1)(2013-1#2)
with the UK##2##3##(1997-4#1)(2012-1#1)
with the US FDA##2##4##(2008-5#2)
with the US##3##3##(2008-11#1)(2008-5#2)
with the USA##2##3##(2008-5#1)(2009-4#1)
with the USP##2##3##(2008-10#1)(2008-5#1)
with the Unified##4##3##(2008-7#2)(2011-2#1)(2013-8#1)
with the United States##3##4##(2008-7#1)(2012-12#1)(2012-2#1)
with the University of##5##4##(1996-2#1)(2007-6#1)(2008-12#1)(2008-7#1)(2012-3#1)
with the VNS##2##3##(2006-12#1)(2011-2#1)
with the VR##3##3##(1992-6#3)
with the WHO##3##3##(1990-11#1)(1991-2#1)(2008-8#1)
with the WOMAC pain##2##4##(2010-9#2)
with the WOMAC physical function##2##5##(2010-9#2)
with the WOMAC##4##3##(2010-9#4)
with the Wechsler Memory Scale (WMS)##2##6##(1995-11#1)(2008-7#1)
with the Wolff-Parkinson-White##2##3##(1995-6#1)(2006-9#1)
with the World Health##3##4##(2008-1#1)(2008-8#1)(2011-2#1)
with the X-ray##3##3##(1993-8#1)(2008-5#1)(2013-7#1)
with the XE-2100##2##3##(2008-10#2)
with the Zeeman##2##3##(2008-2#2)
with the a##3##3##(1996-12#1)(2007-11#1)(2008-11#1)
with the aa sequences##2##4##(1990-3#1)(1993-12#1)
with the aa##4##3##(1990-3#2)(1993-12#1)(1993-5#1)
with the ability of the##5##5##(1991-2#1)(1995-2#1)(1995-3#1)(2009-5#1)(2009-9#1)
with the ability of##14##4##(1991-2#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-3#1)(1997-5#2)(2007-11#1)(2008-10#1)(2008-7#1)(2009-5#1)(2009-9#2)
with the ability to cleave##2##5##(1994-5#2)
with the ability to decrease##2##5##(2007-7#1)(2008-1#1)
with the ability to form##2##5##(1990-11#1)(1992-10#1)
with the ability to measure##2##5##(2008-10#1)(2013-8#1)
with the ability to##21##4##(1990-11#1)(1992-10#1)(1994-5#2)(1997-6#1)(2006-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-3#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
with the ability##35##3##(1990-11#1)(1991-2#1)(1992-10#1)(1994-12#1)(1994-5#2)(1994-6#1)(1995-11#1)(1995-2#1)(1995-3#1)(1997-5#2)(1997-6#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-3#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
with the abnormalities##2##3##(1991-6#1)(2005-1#1)
with the above mentioned##2##4##(1993-5#1)(2007-7#1)
with the above##14##3##(1993-5#1)(1994-3#1)(1997-2#1)(2006-6#4)(2007-1#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-9#1)
with the above-mentioned##5##3##(1993-3#1)(1995-6#1)(1997-8#1)(2006-12#2)
with the absence of a##2##5##(1991-7#1)(2010-10#1)
with the absence of the##3##5##(2005-7#1)(2007-7#1)(2013-1#1)
with the absence of##11##4##(1991-7#1)(1997-8#1)(2005-7#1)(2007-1#1)(2007-7#1)(2008-3#1)(2008-9#1)(2010-10#1)(2010-4#1)(2013-1#2)
with the absolute##2##3##(1990-12#1)(1991-10#1)
with the absorption spectrum of##2##5##(2008-10#1)(2008-2#1)
with the absorption spectrum##3##4##(2005-4#1)(2008-10#1)(2008-2#1)
with the absorption##6##3##(2005-4#2)(2008-10#2)(2008-2#1)(2008-7#1)
with the academic##3##3##(1990-2#1)(2013-8#2)
with the accelerated##2##3##(2008-10#1)(2013-7#1)
with the accepted##3##3##(1991-11#1)(1991-8#1)(2008-9#1)
with the accessory##2##3##(1993-3#1)(1997-2#1)
with the accompanying##3##3##(1997-8#1)(2006-10#1)(2008-4#1)
with the accumulation of##4##4##(1996-11#1)(2008-10#1)(2008-11#1)(2012-11#1)
with the accuracy##2##3##(2007-5#1)(2012-3#1)
with the acetoxymethyl ester##2##4##(1992-5#2)
with the acid phosphatase##2##4##(1992-12#1)(2007-3#1)
with the acid##3##3##(1992-12#1)(2007-3#1)(2008-10#1)
with the acidic##2##3##(1995-1#1)(2008-5#1)
with the acinar##2##3##(1990-5#1)(2008-7#1)
with the acoustic##2##3##(2007-12#1)(2008-3#1)
with the acquired immune##2##4##(1994-10#1)(2010-9#1)
with the acquired immunodeficiency syndrome##4##5##(1990-9#1)(1991-12#1)(1992-2#1)(1993-9#1)
with the acquired resistance to##2##5##(1997-2#2)
with the acquired##9##3##(1990-9#1)(1991-12#1)(1992-2#1)(1993-9#1)(1994-10#1)(1997-2#2)(2010-9#1)(2012-1#1)
with the acquisition of##3##4##(1991-3#1)(1997-6#1)(2008-1#1)
with the acquisition##4##3##(1991-3#1)(1997-6#1)(2008-1#1)(2013-8#1)
with the acronym##3##3##(1996-12#1)(2008-3#2)
with the actin cytoskeleton##2##4##(1995-3#1)(2011-12#1)
with the action##2##3##(1991-10#1)(2006-10#1)
with the actions of##2##4##(1993-2#1)(1995-3#1)
with the actions##3##3##(1993-2#1)(1995-3#1)(2008-9#1)
with the activated##2##3##(1990-7#1)(1995-3#1)
with the activation of##8##4##(1994-5#1)(1994-8#1)(2006-12#1)(2008-10#1)(2008-6#1)(2009-12#1)(2009-8#1)(2012-2#1)
with the activation##10##3##(1990-2#1)(1991-4#1)(1994-5#1)(1994-8#1)(2006-12#1)(2008-10#1)(2008-6#1)(2009-12#1)(2009-8#1)(2012-2#1)
with the active site in##2##5##(1992-5#1)(2006-12#1)
with the active site of##4##5##(1994-5#2)(1995-6#1)(2008-8#1)
with the active site##14##4##(1991-5#1)(1992-12#1)(1992-5#1)(1993-6#1)(1994-11#1)(1994-5#2)(1995-6#1)(1997-7#2)(2004-12#1)(2006-12#1)(2008-8#2)
with the active##17##3##(1991-5#1)(1991-6#1)(1992-12#1)(1992-5#1)(1993-6#1)(1994-11#1)(1994-5#2)(1995-6#1)(1997-7#2)(2004-12#1)(2004-9#1)(2006-12#1)(2008-8#2)(2010-9#1)
with the activity of the##6##5##(1991-12#1)(1991-5#1)(1997-1#1)(1997-7#1)(2008-6#1)(2012-3#1)
with the activity of##14##4##(1991-12#1)(1991-3#1)(1991-5#1)(1993-8#1)(1994-6#1)(1997-1#1)(1997-5#1)(1997-7#1)(2008-12#1)(2008-2#1)(2008-6#1)(2009-2#1)(2012-1#1)(2012-3#1)
with the activity##20##3##(1991-10#1)(1991-12#1)(1991-3#1)(1991-5#2)(1993-5#1)(1993-8#1)(1994-12#1)(1994-6#1)(1997-1#1)(1997-5#1)(1997-7#1)(2006-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2009-2#2)(2012-1#1)(2012-3#1)
with the actual##8##3##(1992-2#1)(2006-10#1)(2007-5#1)(2008-10#1)(2008-2#1)(2009-4#1)(2009-8#1)(2012-1#1)
with the acute phase##2##4##(1992-12#1)(1993-12#1)
with the acute##8##3##(1992-12#1)(1993-12#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-2#1)(2012-11#1)
with the acyl##2##3##(1991-3#1)(2009-2#1)
with the adaptation##2##3##(1997-1#1)(2012-3#1)
with the added##7##3##(1990-8#1)(1991-12#1)(1996-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-1#1)
with the addition of 0##2##5##(2008-10#1)(2012-12#1)
with the addition of 5##2##5##(1995-6#1)(1996-6#1)
with the addition of a##3##5##(2007-8#1)(2008-3#1)(2010-12#1)
with the addition of an##2##5##(1992-9#1)(2011-1#1)
with the addition of the##3##5##(1995-1#1)(2008-8#1)(2013-8#1)
with the addition of##53##4##(1990-3#1)(1991-10#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-6#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(2005-11#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#8)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
with the additional##3##3##(1995-11#1)(2008-7#1)(2012-2#1)
with the adenovirus##2##3##(1992-8#1)(2008-11#1)
with the adjacent##8##3##(1990-5#1)(1994-9#1)(1995-2#1)(1995-6#1)(2008-12#1)(2008-5#1)(2010-12#1)(2012-1#1)
with the administration of##7##4##(1994-3#1)(1996-5#1)(1997-3#1)(2006-8#1)(2006-9#1)(2008-3#1)(2008-4#1)
with the administration##8##3##(1991-12#1)(1994-3#1)(1996-5#1)(1997-3#1)(2006-8#1)(2006-9#1)(2008-3#1)(2008-4#1)
with the adoption of##2##4##(1991-12#1)(1993-3#1)
with the adsorbate##2##3##(2005-11#1)(2007-12#1)
with the adsorption##2##3##(2005-11#2)
with the adult##2##3##(1994-2#1)(1996-2#1)
with the advancement of##2##4##(2008-10#1)(2008-8#1)
with the advances in##4##4##(2006-6#1)(2008-5#2)(2013-1#1)
with the advantage of##7##4##(1996-8#1)(1997-4#1)(2008-3#1)(2008-5#1)(2010-12#1)(2012-3#1)(2013-1#1)
with the advantage that##2##4##(2007-8#1)(2008-10#1)
with the advantage##9##3##(1996-8#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-12#1)(2012-3#1)(2013-1#1)
with the advantages of##5##4##(1990-9#1)(1991-3#1)(1992-8#1)(2007-12#1)(2008-10#1)
with the advantages##7##3##(1990-9#1)(1991-3#1)(1992-2#1)(1992-8#1)(2007-12#1)(2008-10#1)(2012-1#1)
with the advent of new##2##5##(2008-5#1)(2009-10#1)
with the advent of##18##4##(1991-2#1)(2005-11#1)(2005-12#1)(2006-3#2)(2006-4#1)(2007-11#1)(2007-3#1)(2008-5#1)(2009-10#1)(2009-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
with the affected##4##3##(1995-1#1)(2006-3#1)(2008-8#1)(2011-2#1)
with the affinity##2##3##(1991-8#1)(1995-3#1)
with the aforementioned##7##3##(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-5#1)
with the agar##2##3##(2008-10#1)(2011-12#1)
with the age of the animal##2##6##(1992-12#1)(1996-6#1)
with the age of the patients##2##6##(1994-6#1)(2007-10#1)
with the age of the##9##5##(1990-6#1)(1992-12#1)(1993-1#1)(1994-6#1)(1996-6#1)(2004-2#1)(2007-10#1)(2008-10#1)(2012-2#1)
with the age of##13##4##(1990-6#1)(1992-12#1)(1993-1#1)(1994-6#1)(1996-6#1)(2004-2#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
with the age##17##3##(1990-6#1)(1992-12#1)(1993-1#1)(1994-6#1)(1996-3#1)(1996-6#1)(2004-2#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
with the aged##2##3##(1992-2#1)(2008-3#1)
with the agent##2##3##(1991-3#1)(2008-7#1)
with the aggressive##3##3##(2009-3#1)(2011-2#1)(2012-2#1)
with the aging of the##2##5##(1996-3#1)(2009-9#1)
with the aging of##3##4##(1996-3#1)(2009-9#1)(2013-8#1)
with the agonist##2##3##(1992-3#1)(1996-2#1)
with the aid of a microscope##2##6##(2008-3#1)(2008-5#1)
with the aid of a##12##5##(1990-12#1)(1993-8#1)(1997-6#1)(2006-5#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#1)
with the aid of an##5##5##(1990-5#1)(2008-10#1)(2008-3#2)(2012-2#1)
with the aid of chemometrics##2##5##(2008-10#2)
with the aid of computational##2##5##(2008-5#1)(2010-12#1)
with the aid of the##13##5##(1990-4#1)(1992-9#1)(2006-6#5)(2007-12#1)(2008-10#2)(2008-2#3)
with the aid of##70##4##(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#2)(1991-6#1)(1992-3#1)(1992-9#1)(1993-8#1)(1994-11#1)(1997-6#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#5)(2007-11#2)(2007-12#3)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#18)(2008-11#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#3)(2009-2#1)(2009-5#1)(2010-12#1)(2010-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
with the aim of detecting##2##5##(2008-5#1)(2010-6#1)
with the aim of determining the##4##6##(1995-5#1)(1996-11#2)(2007-7#1)
with the aim of determining##5##5##(1991-2#1)(1995-5#1)(1996-11#2)(2007-7#1)
with the aim of developing##3##5##(2005-7#1)(2007-10#1)(2011-2#1)
with the aim of establishing##2##5##(2008-8#2)
with the aim of evaluating the##3##6##(1996-8#1)(2007-7#1)(2007-8#1)
with the aim of evaluating##4##5##(1996-8#1)(1997-3#1)(2007-7#1)(2007-8#1)
with the aim of identifying##5##5##(1994-12#1)(1995-8#1)(2008-6#1)(2008-9#1)(2011-1#1)
with the aim of improving the##3##6##(2004-12#1)(2008-10#1)(2008-7#1)
with the aim of improving##4##5##(2004-12#1)(2008-10#1)(2008-7#1)(2010-3#1)
with the aim of increasing##2##5##(2008-12#1)(2008-7#1)
with the aim of measuring##2##5##(2008-10#1)(2010-12#1)
with the aim of obtaining##5##5##(1994-11#1)(1996-1#1)(2007-11#1)(2008-10#2)
with the aim of providing##4##5##(2007-10#1)(2007-7#1)(2008-11#1)(2008-3#1)
with the aim of reducing the##2##6##(2005-8#1)(2008-2#1)
with the aim of reducing##5##5##(2005-8#1)(2006-8#1)(2008-2#1)(2011-1#1)(2013-1#1)
with the aim of studying##3##5##(2007-12#1)(2007-6#1)(2010-3#1)
with the aim of##99##4##(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#2)(1991-2#1)(1992-2#2)(1992-8#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#1)(2004-12#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-10#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-3#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#2)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
with the aim to identify the##2##6##(2011-2#1)(2012-12#1)
with the aim to identify##3##5##(2010-11#1)(2011-2#1)(2012-12#1)
with the aim to increase the##2##6##(1996-1#1)(2007-2#1)
with the aim to obtain##2##5##(2008-10#1)(2013-7#1)
with the aim to reduce the##2##6##(2007-7#1)(2011-2#1)
with the aim to reduce##4##5##(2007-7#1)(2008-1#1)(2011-2#1)(2013-1#1)
with the aim to##30##4##(1990-9#1)(1992-6#1)(1996-1#1)(2005-10#1)(2005-11#1)(2006-4#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-8#1)(2010-11#1)(2010-12#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#2)
with the aim##131##3##(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-2#1)(1992-2#2)(1992-6#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#2)(1996-11#2)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#2)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-3#1)(2010-11#2)(2010-12#3)(2010-3#2)(2010-4#2)(2010-6#1)(2011-1#2)(2011-12#2)(2011-2#7)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#3)
with the aims of##6##4##(2006-10#1)(2007-4#2)(2008-10#1)(2010-4#1)(2012-1#1)
with the aims##7##3##(2006-10#1)(2007-4#2)(2008-10#1)(2008-8#1)(2010-4#1)(2012-1#1)
with the airway##3##3##(1994-2#1)(1997-2#1)(2010-12#1)
with the algorithm##2##3##(1991-12#1)(2008-3#1)
with the alkali metal##3##4##(2008-10#3)
with the alkali##4##3##(2008-10#4)
with the alkaline##2##3##(1990-12#1)(1997-1#1)
with the almost##2##3##(1995-2#1)(2010-2#1)
with the alpha subunit of##2##5##(1991-8#1)(1994-8#1)
with the alpha subunit##3##4##(1991-8#1)(1994-8#2)
with the alpha##12##3##(1990-5#2)(1991-5#1)(1991-8#1)(1993-2#1)(1994-8#2)(1995-2#1)(1996-8#1)(1997-7#1)(2006-8#1)(2007-12#1)
with the alteration##2##3##(1994-12#1)(2008-10#1)
with the altered##2##3##(1994-10#1)(2008-10#1)
with the alternative##3##3##(1993-8#1)(2006-10#1)(2006-5#1)
with the ambient##2##3##(2008-10#1)(2008-7#1)
with the amine##3##3##(1996-2#1)(1997-7#1)(2008-10#1)
with the amino acid sequence of##2##6##(1990-4#1)(1991-2#1)
with the amino acid sequence##3##5##(1990-4#1)(1991-2#1)(2011-2#1)
with the amino acid##6##4##(1990-4#1)(1991-2#1)(1994-6#1)(2006-8#1)(2010-2#1)(2011-2#1)
with the amino acids##2##4##(1995-12#1)(2007-8#1)
with the amino##11##3##(1990-11#1)(1990-4#1)(1991-2#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(2006-8#1)(2007-8#1)(2010-2#1)(2011-2#1)
with the ammonia##2##3##(2005-12#1)(2007-12#1)
with the ammonium salt of##2##5##(2008-10#2)
with the ammonium##3##3##(1992-9#1)(2008-10#2)
with the amount of the##2##5##(1994-12#1)(2008-10#1)
with the amount of##26##4##(1990-12#1)(1990-3#1)(1990-9#1)(1991-11#1)(1991-12#1)(1992-7#2)(1994-12#1)(1995-12#1)(1996-5#1)(1996-9#1)(2005-10#1)(2005-11#2)(2007-12#1)(2008-10#2)(2008-4#2)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2011-2#1)(2013-8#2)
with the amplification##2##3##(1996-3#1)(2008-5#1)
with the amyloid##3##3##(1990-3#1)(1992-3#1)(2010-11#1)
with the analogous##5##3##(1996-5#2)(2008-10#1)(2008-3#1)(2009-3#1)
with the analogue##2##3##(1991-7#1)(1994-8#1)
with the analysis of the##2##5##(2006-6#1)(2011-2#1)
with the analysis of##11##4##(2006-6#1)(2008-10#5)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
with the analysis##15##3##(1997-2#1)(2006-6#1)(2008-10#7)(2008-3#1)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
with the analyte##8##3##(1997-3#1)(2006-12#1)(2008-10#6)
with the analytic##2##3##(2008-3#1)(2012-11#1)
with the analytical##5##3##(1993-2#1)(2005-11#1)(2008-10#3)
with the anatomical##6##3##(1995-6#1)(1996-12#1)(2006-11#1)(2007-1#1)(2011-1#1)(2011-2#1)
with the androgen##2##3##(2008-9#1)(2009-4#1)
with the angle##3##3##(1995-3#1)(2007-12#1)(2008-4#1)
with the animal##2##3##(1991-5#1)(2013-1#1)
with the anion##3##3##(1991-6#1)(1996-5#1)(2008-10#1)
with the anionic surfactant##2##4##(2008-10#2)
with the anionic##3##3##(2008-10#3)
with the antagonist##5##3##(1994-9#1)(2008-10#4)
with the antecedent##2##3##(1994-9#1)(2010-12#1)
with the anterior approach##5##4##(2006-8#2)(2007-11#2)(2007-7#1)
with the anterior##8##3##(2006-8#3)(2007-11#2)(2007-7#1)(2008-7#1)(2009-3#1)
with the anti-TNF-alpha mAb##2##4##(2008-10#2)
with the anti-angiogenic agents##4##4##(1995-5#4)
with the anti-inflammatory##2##3##(1990-6#1)(2012-1#1)
with the antibiotic##5##3##(1991-11#1)(1994-5#1)(1995-6#1)(2007-7#1)(2008-10#1)
with the antibodies of##2##4##(2006-8#2)
with the antibodies##6##3##(1990-7#1)(1994-2#1)(1995-11#1)(1995-6#1)(2006-8#2)
with the antibody to##2##4##(1990-3#1)(1991-5#1)
with the antibody##12##3##(1990-3#1)(1990-4#1)(1990-7#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#1)(1995-8#1)(2004-9#1)(2006-10#1)(2008-8#1)(2010-4#1)
with the anticoagulant##3##3##(1990-12#2)(2012-11#1)
with the antigen receptor##2##4##(1995-6#2)
with the antigen##10##3##(1992-1#1)(1993-8#1)(1995-6#2)(2007-2#1)(2008-10#3)(2008-11#1)(2008-8#1)
with the antihypertensive##2##3##(1997-5#1)(2008-10#1)
with the antioxidant##6##3##(1993-12#1)(1993-6#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-12#1)
with the antisense-Rb oligomer##3##4##(1991-8#3)
with the antisera##2##3##(1994-6#1)(1995-8#1)
with the antiserum##4##3##(1991-3#1)(1993-11#1)(1994-8#1)(1997-5#1)
with the antitumor##2##3##(1993-8#1)(2008-5#1)
with the antiviral##2##3##(1994-11#1)(2008-5#1)
with the aortic##2##3##(1991-10#1)(2008-10#1)
with the apical##4##3##(2006-10#2)(2008-9#1)(2012-2#1)
with the apolipoprotein##2##3##(1991-2#1)(1995-3#1)
with the apoprotein##2##3##(1991-12#1)(1997-7#1)
with the apparatus##2##3##(1990-10#1)(2007-8#1)
with the apparent##6##3##(1990-9#1)(1994-11#1)(1995-3#1)(1996-11#1)(1997-2#1)(2009-7#1)
with the appearance of a##5##5##(1992-10#1)(1997-3#1)(2006-10#1)(2007-12#1)(2009-3#1)
with the appearance of an##2##5##(1990-2#1)(2007-12#1)
with the appearance of the##4##5##(1994-11#1)(1995-9#1)(2007-11#1)(2007-8#1)
with the appearance of##23##4##(1990-2#1)(1990-8#1)(1992-10#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-8#1)(1995-9#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
with the appearance##25##3##(1990-2#1)(1990-8#1)(1992-10#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-7#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
with the appendix##2##3##(1992-2#1)(2008-9#1)
with the apple##3##3##(2008-10#3)
with the application of a##3##5##(2008-10#1)(2008-7#1)(2011-1#1)
with the application of the##3##5##(2008-10#2)(2010-11#1)
with the application of##25##4##(2005-10#1)(2006-7#1)(2007-2#1)(2007-4#1)(2008-10#7)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-11#2)(2010-9#1)(2011-1#1)(2012-2#1)
with the application##29##3##(1992-5#1)(2005-10#1)(2006-7#1)(2007-2#1)(2007-4#1)(2008-10#8)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-11#2)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#2)
with the applied bias voltage##2##5##(2007-12#1)(2008-3#1)
with the applied voltage##2##4##(2009-7#2)
with the applied##7##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-5#1)(2009-7#2)
with the approach##2##3##(1994-1#1)(1995-12#1)
with the appropriate alkyl##2##4##(1997-1#1)(2007-11#1)
with the appropriate##25##3##(1991-5#2)(1993-4#1)(1994-11#1)(1994-9#2)(1995-12#1)(1997-1#1)(1997-6#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#2)(2010-3#1)(2011-1#1)(2011-2#1)
with the aqueous##5##3##(1995-10#1)(2008-10#2)(2009-5#1)(2011-1#1)
with the area of##3##4##(1990-9#1)(2008-11#1)(2013-8#1)
with the area##4##3##(1990-9#1)(2005-8#1)(2008-11#1)(2013-8#1)
with the arm##3##3##(1996-9#1)(2008-2#1)(2012-1#1)
with the arrival of##3##4##(1991-3#1)(2007-2#1)(2009-8#1)
with the artificial##2##3##(2011-12#1)(2012-1#1)
with the assay##5##3##(1995-1#1)(1996-9#1)(1997-3#1)(2008-10#2)
with the assembly of##2##4##(1990-12#1)(2008-8#1)
with the assembly##4##3##(1990-12#1)(1990-3#1)(1994-11#1)(2008-8#1)
with the assessment of##4##4##(1991-1#1)(2005-8#1)(2008-8#1)(2010-11#1)
with the assessment##5##3##(1991-1#1)(2005-8#1)(2007-2#1)(2008-8#1)(2010-11#1)
with the assistance of##10##4##(1990-4#1)(1990-6#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-12#1)(2010-5#1)(2011-1#2)(2012-1#1)
with the associated##7##3##(1992-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2013-1#1)(2013-8#2)
with the association##6##3##(2006-2#1)(2006-4#1)(2008-10#2)(2010-2#2)
with the assumption of##3##4##(1995-6#1)(2008-3#1)(2011-2#1)
with the assumption that##10##4##(1996-3#1)(1997-1#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#1)(2012-1#1)(2013-1#1)
with the assumption##13##3##(1995-6#1)(1996-3#1)(1997-1#1)(2008-2#1)(2008-3#3)(2008-7#2)(2008-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
with the asymmetric##2##3##(1996-7#1)(2007-8#1)
with the atmospheric##3##3##(2008-2#2)(2008-3#1)
with the atomic##4##3##(2006-10#2)(2008-10#1)(2008-3#1)
with the attachment##2##3##(2008-4#1)(2012-2#1)
with the autologous##2##3##(1997-7#1)(2007-9#1)
with the automatic##4##3##(1990-8#1)(2008-10#2)(2008-11#1)
with the availability of more##2##5##(1991-12#1)(2008-2#1)
with the availability of##8##4##(1991-12#1)(2006-4#1)(2007-1#1)(2008-2#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-12#1)
with the available##8##3##(1993-1#1)(1996-2#1)(2007-8#1)(2008-2#1)(2008-3#3)(2012-12#1)
with the average age of##3##5##(2007-11#2)(2011-2#1)
with the average of##2##4##(2008-2#1)(2011-1#1)
with the average##15##3##(1992-12#1)(1995-8#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-8#4)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
with the background##4##3##(2007-5#2)(2008-10#1)(2008-3#1)
with the bacterial cell membrane##2##5##(1993-12#1)(2011-1#1)
with the bacterial##10##3##(1991-2#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-8#1)(2006-8#1)(2008-10#1)(2008-9#1)(2009-2#1)(2011-1#1)
with the bacterium##4##3##(2008-10#1)(2009-12#1)(2012-3#1)(2013-1#1)
with the balance##3##3##(1993-9#1)(2008-3#1)(2008-8#1)
with the balloon##2##3##(2006-8#1)(2008-4#1)
with the bare##2##3##(2008-10#2)
with the barley##2##3##(1997-3#1)(2008-5#1)
with the basal transcription machinery to##2##6##(1995-6#1)(1995-8#1)
with the basal transcription##4##4##(1995-2#1)(1995-6#2)(1995-8#1)
with the basal##10##3##(1993-7#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-2#1)(2008-11#1)(2008-12#1)(2008-3#1)(2012-12#1)
with the baseline##9##3##(2006-6#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)(2013-1#2)
with the basic protein##2##4##(1997-4#2)
with the basic science##2##4##(2008-6#1)(2010-11#1)
with the basic##13##3##(1991-2#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-11#1)(1997-4#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-6#1)(2010-11#1)(2013-1#1)
with the basolateral##2##3##(1990-5#1)(2008-11#1)
with the batch##2##3##(2008-10#1)(2012-2#1)
with the beam propagation method##3##5##(2007-11#2)(2008-2#1)
with the beam quality##2##4##(2008-3#2)
with the beam##6##3##(2007-11#2)(2008-2#2)(2008-3#2)
with the behavior of##3##4##(2008-10#1)(2011-2#1)(2012-12#1)
with the behavior##4##3##(2005-11#1)(2008-10#1)(2011-2#1)(2012-12#1)
with the benefit of##2##4##(2009-8#1)(2012-2#1)
with the benefits of##4##4##(2008-11#2)(2008-2#1)(2008-5#1)
with the best available##2##4##(2008-3#2)
with the best density functional performance obtained by hybrid meta-GGAs##2##10##(2012-12#2)
with the best information##2##4##(1990-4#1)(2011-1#1)
with the best performance##2##4##(2008-11#1)(2008-2#1)
with the best##27##3##(1990-4#1)(1995-5#1)(1997-3#1)(1997-8#1)(2005-10#2)(2006-10#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)
with the beta 1##2##4##(1990-11#1)(1996-10#1)
with the beta subunit##2##4##(1993-12#1)(1997-1#1)
with the beta##7##3##(1990-11#1)(1993-12#1)(1994-9#1)(1996-10#1)(1997-1#1)(2006-1#1)(2010-6#1)
with the beta-sheet##2##3##(1995-1#1)(1995-5#1)
with the better##4##3##(1994-6#1)(2008-10#1)(2008-12#1)(2010-8#1)
with the bifocal than with the single vision glasses##2##9##(2007-4#2)
with the biggest##2##3##(1990-2#1)(2007-9#1)
with the bilayer##2##3##(1991-2#1)(1993-8#1)
with the binding affinity##2##4##(1994-9#1)(1997-5#1)
with the binding of the##3##5##(1990-5#1)(2006-12#1)(2013-1#1)
with the binding of##13##4##(1990-5#1)(1991-2#1)(1991-8#1)(1995-2#1)(1995-3#1)(1997-5#1)(2006-12#3)(2006-6#1)(2008-8#1)(2010-10#1)(2013-1#1)
with the binding##18##3##(1990-5#1)(1991-2#1)(1991-8#1)(1993-11#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-5#2)(2006-12#3)(2006-6#1)(2008-8#1)(2010-10#1)(2013-1#1)
with the biocontrol##2##3##(2008-10#2)
with the biological##10##3##(1990-9#1)(1992-8#1)(1996-3#1)(2008-12#1)(2008-4#1)(2008-5#2)(2009-3#1)(2013-7#1)(2013-8#1)
with the biosensor##2##3##(2008-10#2)
with the biosynthesis of##2##4##(1994-8#1)(2008-5#1)
with the birds##2##3##(1991-11#2)
with the birth weight of##2##5##(2011-1#2)
with the birth##3##3##(2011-1#2)(2012-2#1)
with the bivalent vaccine##3##4##(2011-2#3)
with the bivalent##5##3##(2011-2#4)(2013-8#1)
with the bleeding##2##3##(1993-9#1)(2006-11#1)
with the blood##6##3##(1994-3#1)(1995-9#1)(1997-5#1)(2005-1#1)(2007-12#1)(2011-2#1)
with the body and##3##4##(1991-6#1)(2008-11#1)(2008-9#1)
with the body##6##3##(1991-6#1)(1997-1#1)(2005-9#1)(2008-11#1)(2008-9#1)(2012-1#1)
with the bone##2##3##(1995-2#1)(2009-8#1)
with the both##2##3##(1997-1#1)(2004-11#1)
with the boundaries##3##3##(1993-9#1)(2008-5#1)(2012-3#1)
with the bovine and##2##4##(1991-10#2)
with the bovine##7##3##(1990-2#1)(1991-10#2)(1993-2#1)(1995-11#1)(1996-12#2)
with the brain##6##3##(1994-10#1)(1994-12#1)(2006-11#1)(2008-7#1)(2010-5#2)
with the breaking##2##3##(1996-2#1)(2005-11#1)
with the broader##2##3##(1993-1#1)(2007-10#1)
with the brush border##2##4##(1990-11#1)(1994-12#1)
with the buffer##2##3##(2008-10#2)
with the bulk of##2##4##(1992-6#1)(2007-11#1)
with the bulk##5##3##(1992-1#1)(1992-6#1)(1997-3#1)(2007-11#1)(2010-8#1)
with the bulky##2##3##(1994-9#1)(1996-2#1)
with the bundle##2##3##(2008-10#1)(2008-3#1)
with the c-myc gene##2##4##(1993-3#1)(2008-11#1)
with the c-myc##3##3##(1993-3#1)(1997-1#1)(2008-11#1)
with the cDNA sequence of##2##5##(1990-8#1)(1995-8#1)
with the cDNA sequence##3##4##(1990-8#1)(1995-8#1)(1997-6#1)
with the cDNA##10##3##(1990-8#1)(1992-6#1)(1992-7#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-6#1)(1995-8#1)(1997-6#1)
with the calcium ionophore##4##4##(1993-3#1)(2006-5#1)(2012-12#2)
with the calcium##5##3##(1992-4#1)(1993-3#1)(2006-5#1)(2012-12#2)
with the calculated values##2##4##(2007-11#1)(2008-3#1)
with the calculated##14##3##(1997-8#1)(2005-11#2)(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#3)(2010-6#1)(2012-12#2)
with the calculation of##2##4##(2008-10#1)(2008-3#1)
with the calibration##3##3##(2008-10#3)
with the capability of the##2##5##(2008-10#1)(2008-4#1)
with the capability of##5##4##(2008-10#3)(2008-4#1)(2010-12#1)
with the capability to##3##4##(2007-11#1)(2008-10#1)(2011-2#1)
with the capability##9##3##(1995-12#1)(2007-11#1)(2008-10#4)(2008-4#1)(2010-12#1)(2011-2#1)
with the capacity to##5##4##(1996-2#1)(2008-10#1)(2009-6#1)(2009-8#1)(2010-10#1)
with the capacity##8##3##(1996-2#1)(1997-8#1)(2008-10#3)(2009-6#1)(2009-8#1)(2010-10#1)
with the capillary##3##3##(2005-11#2)(2008-10#1)
with the capsid##2##3##(1994-9#1)(2008-10#1)
with the carbon##5##3##(1990-5#1)(1993-8#1)(2005-11#1)(2008-10#1)(2008-9#1)
with the carboxyl groups of the##2##6##(1993-6#1)(2008-10#1)
with the carboxyl##3##3##(1993-3#1)(1993-6#1)(2008-10#1)
with the cardiac##2##3##(2008-4#1)(2013-1#1)
with the cardiovascular##6##3##(1994-3#1)(2005-7#1)(2006-10#1)(2010-6#1)(2013-7#1)(2013-8#1)
with the care of##3##4##(2007-12#1)(2008-12#1)(2012-12#1)
with the care##7##3##(1990-10#1)(1992-2#1)(1996-3#1)(2007-12#1)(2008-12#1)(2011-2#1)(2012-12#1)
with the carotenoid##2##3##(2006-12#1)(2008-8#1)
with the carrier##10##3##(1990-11#1)(1990-3#1)(1992-3#2)(1992-6#1)(2007-12#1)(2008-10#2)(2008-3#1)(2010-7#1)
with the case of##2##4##(2008-2#1)(2008-5#1)
with the case##4##3##(1993-3#1)(2008-1#1)(2008-2#1)(2008-5#1)
with the catalytic domain of##6##5##(1991-10#1)(1991-11#1)(1994-2#1)(1994-8#1)(1995-6#2)
with the catalytic subunit of##3##5##(1996-2#1)(1996-6#1)(1997-1#1)
with the catalytic##16##3##(1991-10#1)(1991-11#1)(1991-5#1)(1993-11#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-6#2)(1996-2#3)(1996-6#1)(1997-1#1)(2008-10#1)
with the catastrophic##2##3##(2006-10#1)(2007-3#1)
with the cationic##3##3##(2005-11#2)(2007-11#1)
with the causal##2##3##(2005-8#1)(2008-10#1)
with the caveat that the##2##5##(1991-7#1)(2012-12#1)
with the caveat that##3##4##(1991-4#1)(1991-7#1)(2012-12#1)
with the cell cycle##2##4##(2006-10#1)(2008-8#1)
with the cell surface##4##4##(1994-6#1)(1995-2#1)(2008-4#2)
with the cell wall##2##4##(2008-4#1)(2008-5#1)
with the cell##20##3##(1990-2#1)(1990-3#1)(1992-7#1)(1994-2#1)(1994-6#1)(1995-10#1)(1995-2#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-8#1)
with the cells##4##3##(1994-9#1)(1996-5#1)(2008-11#1)(2013-8#1)
with the cells'##2##3##(1990-3#1)(2008-7#1)
with the cellular##6##3##(1990-2#1)(1996-10#2)(2005-7#1)(2008-9#1)(2009-5#1)
with the central##8##3##(1992-6#1)(1995-6#1)(1995-7#1)(1996-1#1)(1997-1#1)(1997-4#1)(2007-8#1)(2013-8#1)
with the certified ones##4##4##(2008-10#4)
with the certified or recommended values##2##6##(2008-10#2)
with the certified value of##3##5##(2008-10#3)
with the certified value##12##4##(2008-10#12)
with the certified values and the##2##6##(2008-10#2)
with the certified values and##6##5##(2007-8#1)(2008-10#5)
with the certified values##24##4##(1993-11#1)(2005-4#1)(2007-8#2)(2008-10#20)
with the certified##46##3##(1993-11#1)(2005-4#1)(2007-8#2)(2008-10#42)
with the cervical spine##3##4##(2007-4#1)(2008-12#2)
with the chain length##2##4##(2005-11#2)
with the challenge of##7##4##(1991-12#1)(1996-1#1)(2007-4#1)(2008-12#1)(2008-3#1)(2010-5#1)(2012-2#1)
with the challenge##8##3##(1991-12#1)(1996-1#1)(2007-4#1)(2007-7#1)(2008-12#1)(2008-3#1)(2010-5#1)(2012-2#1)
with the change in##5##4##(1991-5#1)(1995-11#1)(2011-12#1)(2011-2#1)(2012-12#1)
with the change of chemical structure have been##2##8##(2005-4#2)
with the change of the##2##5##(2007-5#1)(2008-10#1)
with the change of##6##4##(1990-2#1)(2005-4#2)(2007-5#1)(2008-10#1)(2010-7#1)
with the change##11##3##(1990-2#1)(1991-5#1)(1995-11#1)(2005-4#2)(2007-5#1)(2008-10#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-12#1)
with the changes in the##5##5##(1991-12#1)(1994-12#1)(1994-3#1)(1996-11#1)(2008-7#1)
with the changes in##12##4##(1991-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-11#1)(1997-5#1)(2007-11#1)(2007-2#1)(2008-7#1)(2009-4#2)(2010-4#1)
with the changes##16##3##(1991-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-11#1)(1997-5#1)(2006-11#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-7#1)(2009-4#2)(2010-4#1)(2013-1#2)
with the channel##3##3##(1991-9#1)(1996-12#1)(2008-3#1)
with the characteristic features##2##4##(1997-6#1)(2009-11#1)
with the characteristic##5##3##(1997-6#1)(2006-10#1)(2008-4#1)(2009-11#1)(2013-8#1)
with the characteristics of the##2##5##(2006-2#1)(2008-8#1)
with the characteristics of##6##4##(1994-3#1)(1996-2#1)(2006-2#1)(2008-8#1)(2009-12#1)(2013-8#1)
with the characteristics##7##3##(1994-3#1)(1996-2#1)(2006-2#1)(2007-12#1)(2008-8#1)(2009-12#1)(2013-8#1)
with the charge##2##3##(2008-10#1)(2008-3#1)
with the chemical##7##3##(1993-11#1)(2008-10#2)(2008-11#2)(2008-2#1)(2012-12#1)
with the chemically##2##3##(1990-5#1)(1991-9#1)
with the chemistry of##2##4##(1992-6#1)(2008-5#1)
with the chick##2##3##(1991-9#1)(1995-5#1)
with the chicken##3##3##(1992-2#1)(1997-1#1)(2008-5#1)
with the chief complaint of##5##5##(2007-7#1)(2008-5#1)(2010-5#1)(2013-1#2)
with the chief##7##3##(2007-7#1)(2008-5#1)(2010-5#1)(2013-1#4)
with the child##6##3##(2007-2#1)(2008-11#1)(2009-11#1)(2009-4#1)(2009-9#1)(2012-2#1)
with the children##2##3##(2010-9#1)(2013-1#1)
with the children's##3##3##(1996-1#1)(2007-8#1)(2009-9#1)
with the chlorophyll concentration##2##4##(2008-3#2)
with the chloroplast##2##3##(1992-6#1)(2009-10#1)
with the choice of##3##4##(2007-11#1)(2010-11#1)(2010-12#1)
with the choice##4##3##(2006-1#1)(2007-11#1)(2010-11#1)(2010-12#1)
with the cholesterol##2##3##(1992-6#1)(1997-2#1)
with the cholinergic##5##3##(1990-3#1)(1997-5#1)(1997-8#2)(2008-5#1)
with the cholinesterase inhibitor##2##4##(1993-11#1)(2011-12#1)
with the chromogen##2##3##(1991-3#1)(1994-2#1)
with the chromogenic reagent##2##4##(2008-10#2)
with the chromophoric##2##3##(1990-2#2)
with the chronic##2##3##(2006-9#1)(2007-10#1)
with the claimed values##2##4##(2008-10#2)
with the classic##3##3##(1995-4#1)(1996-3#1)(2008-2#1)
with the classical##20##3##(1990-12#1)(1990-3#1)(1994-3#1)(1996-6#1)(2006-8#1)(2007-11#2)(2007-7#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#2)(2012-2#1)(2013-1#1)
with the classification of##2##4##(2008-3#1)(2011-2#1)
with the classification##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
with the click##2##3##(2007-8#1)(2009-11#1)
with the clinical and##5##4##(1990-2#1)(2006-10#1)(2007-4#1)(2009-8#1)(2013-8#1)
with the clinical features of exfoliative dermatitis##2##7##(2010-6#2)
with the clinical features of##3##5##(2008-3#1)(2010-6#2)
with the clinical findings##2##4##(1992-2#1)(2004-1#1)
with the clinical picture##2##4##(1990-6#1)(2012-12#1)
with the clinical profile##2##4##(2006-10#1)(2009-11#1)
with the clinical signs##2##4##(1994-7#2)
with the clinical stage##2##4##(1990-9#1)(2008-1#1)
with the clinical status of##2##5##(1995-11#1)(2009-5#1)
with the clinical symptoms##3##4##(1991-8#1)(1994-6#1)(2013-1#1)
with the clinical##46##3##(1990-2#1)(1990-6#1)(1990-9#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-11#1)(1994-6#1)(1994-7#2)(1995-11#2)(1995-2#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-4#1)(2004-1#1)(2005-10#1)(2006-1#2)(2006-10#2)(2007-1#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
with the cloned##4##3##(1991-7#1)(1991-9#1)(1992-6#1)(2008-10#1)
with the coarse-grained##2##3##(2008-9#2)
with the coat protein##3##4##(2008-10#3)
with the coat##4##3##(1997-5#1)(2008-10#3)
with the coefficient##2##3##(1990-2#1)(2013-8#1)
with the coexistence of##2##4##(2013-1#1)(2013-7#1)
with the cognate##2##3##(1991-2#1)(1997-2#1)
with the cognitive##2##3##(2007-12#1)(2008-11#1)
with the collagen##2##3##(2006-12#1)(2008-5#1)
with the colloidal##2##3##(2005-11#1)(2008-10#1)
with the colorimetric method##2##4##(2008-10#2)
with the colorimetric##3##3##(2008-10#3)
with the column##4##3##(2008-10#3)(2013-8#1)
with the combination of##22##4##(1990-1#1)(1990-9#1)(1992-8#1)(1993-8#1)(1994-8#1)(1995-6#1)(1997-7#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2013-8#1)
with the combination##29##3##(1990-1#1)(1990-9#1)(1992-8#1)(1993-8#1)(1993-9#2)(1994-8#1)(1995-6#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2013-8#1)
with the combined use of##2##5##(2008-3#1)(2013-8#1)
with the combined##11##3##(1997-7#1)(2007-3#1)(2008-11#1)(2008-3#2)(2008-6#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
with the coming##2##3##(1993-2#1)(1995-4#1)
with the comment##2##3##(2007-12#1)(2008-5#1)
with the commercial software##2##4##(2008-10#1)(2010-2#1)
with the commercial##4##3##(2004-1#1)(2008-10#1)(2008-5#1)(2010-2#1)
with the common##13##3##(1992-5#1)(1992-8#2)(1997-5#1)(2005-9#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-8#1)(2012-3#1)
with the commonest##3##3##(2004-10#1)(2011-2#2)
with the commonly used##2##4##(2006-12#1)(2008-10#1)
with the commonly##4##3##(1997-7#1)(2006-12#1)(2008-10#1)(2011-1#1)
with the community##8##3##(1991-2#1)(1992-1#1)(1996-3#1)(1996-8#1)(2005-12#1)(2008-12#1)(2009-4#1)(2012-12#1)
with the company's##2##3##(2010-9#1)(2011-2#1)
with the competitive##3##3##(1992-8#1)(1995-11#1)(1995-8#1)
with the compiled##3##3##(1991-6#1)(1996-10#2)
with the complaint of##2##4##(2008-1#1)(2012-3#1)
with the complaints of##2##4##(2011-2#1)(2013-8#1)
with the complementary##2##3##(2007-8#1)(2008-10#1)
with the complete##29##3##(1993-3#1)(1997-4#1)(2008-9#1)(2011-2#24)(2012-3#2)
with the completion of the##2##5##(2006-10#1)(2008-4#1)
with the completion of##3##4##(2006-10#1)(2008-4#1)(2010-7#1)
with the complex and##2##4##(2007-7#1)(2010-5#1)
with the complex##14##3##(1991-10#1)(1997-1#1)(2005-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2010-5#1)(2011-1#1)
with the complexation##2##3##(2008-10#2)
with the complexity of##2##4##(2008-12#1)(2011-1#1)
with the complexity##3##3##(2008-12#1)(2011-1#1)(2013-1#1)
with the components of the##2##5##(2008-10#1)(2013-1#1)
with the components of##3##4##(2008-10#1)(2011-2#1)(2013-1#1)
with the composition of##3##4##(2008-10#1)(2008-11#1)(2012-2#1)
with the composition##5##3##(1994-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#1)
with the compound##2##3##(2005-7#1)(2008-8#1)
with the computer##3##3##(1993-3#1)(1997-2#1)(2008-2#1)
with the concentration of the##3##5##(1992-4#1)(1997-7#1)(2008-5#1)
with the concentration of##26##4##(1992-4#1)(1997-7#1)(2005-11#1)(2008-10#18)(2008-12#1)(2008-5#1)(2009-6#2)(2013-8#1)
with the concentration##34##3##(1990-5#1)(1992-4#1)(1997-7#1)(2005-11#3)(2008-10#23)(2008-12#1)(2008-5#1)(2009-6#2)(2013-8#1)
with the concentrations in the blood and milk being##2##9##(2013-8#2)
with the concentrations of##2##4##(2008-10#2)
with the concentrations##6##3##(2007-8#1)(2008-10#3)(2013-8#2)
with the concept of##7##4##(1997-1#2)(2005-11#1)(2007-9#1)(2012-1#1)(2012-12#1)(2013-8#1)
with the concept that##5##4##(1990-12#1)(1992-3#1)(1992-6#1)(2004-12#1)(2006-10#1)
with the concept##12##3##(1990-12#1)(1992-3#1)(1992-6#1)(1997-1#2)(2004-12#1)(2005-11#1)(2006-10#1)(2007-9#1)(2012-1#1)(2012-12#1)(2013-8#1)
with the conceptual disorganization scores##2##5##(1997-2#2)
with the conclusion of##2##4##(2007-8#1)(2010-8#1)
with the conclusion that##11##4##(1990-12#1)(1991-12#1)(1991-2#1)(1992-12#1)(1993-3#1)(1993-6#1)(1995-12#1)(1996-5#1)(1997-4#1)(1997-7#1)(2008-12#1)
with the conclusion##13##3##(1990-12#1)(1991-12#1)(1991-2#1)(1992-12#1)(1993-3#1)(1993-6#1)(1995-12#1)(1996-5#1)(1997-4#1)(1997-7#1)(2007-8#1)(2008-12#1)(2010-8#1)
with the concomitant use of##2##5##(2008-8#1)(2011-2#1)
with the concomitant##6##3##(1994-12#1)(1995-3#1)(1996-10#1)(2005-12#1)(2008-8#1)(2011-2#1)
with the condition##5##3##(2006-9#1)(2008-10#1)(2008-6#2)(2013-1#1)
with the conditional##2##3##(1997-6#1)(2008-7#1)
with the conditions for##2##4##(2007-11#1)(2010-9#1)
with the conditions##3##3##(2007-11#1)(2007-12#1)(2010-9#1)
with the conductivity##2##3##(2008-10#2)
with the conjugate##2##3##(1990-9#1)(2007-12#1)
with the consensus sequence##2##4##(1993-6#1)(1997-4#1)
with the consensus##4##3##(1993-6#1)(1995-1#1)(1997-4#1)(2012-3#1)
with the consequences of##4##4##(1993-12#1)(2008-11#1)(2012-3#1)(2013-1#1)
with the consequent##4##3##(1997-8#1)(2005-10#1)(2008-1#1)(2008-10#1)
with the conserved##5##3##(1994-11#1)(1994-2#1)(1994-9#2)(2012-12#1)
with the constant##4##3##(1994-2#1)(1997-2#1)(2008-10#1)(2008-2#1)
with the constitutional##3##3##(1995-10#1)(2012-3#1)(2013-8#1)
with the constraints of##3##4##(2007-8#1)(2008-10#2)
with the construction of##3##4##(2008-2#1)(2009-4#1)(2009-7#1)
with the consumption of##4##4##(1990-6#1)(1993-9#1)(2008-10#1)(2012-1#1)
with the content of##3##4##(2008-11#1)(2008-2#1)(2012-12#1)
with the content##4##3##(2008-11#1)(2008-2#1)(2009-5#1)(2012-12#1)
with the contents of##2##4##(2007-1#1)(2011-1#1)
with the contents##4##3##(1996-12#1)(2007-1#1)(2008-10#1)(2011-1#1)
with the continuous##2##3##(1995-6#1)(2008-11#1)
with the contralateral##5##3##(1991-9#1)(1992-10#1)(1993-7#1)(1997-8#1)(2009-3#1)
with the contribution from##3##4##(2007-12#1)(2008-3#2)
with the contribution of##2##4##(1992-8#1)(2012-2#1)
with the contribution##5##3##(1992-8#1)(2007-12#1)(2008-3#2)(2012-2#1)
with the control adenovirus##2##4##(1994-9#2)
with the control and##2##4##(2008-10#1)(2010-12#1)
with the control group##38##4##(1991-3#1)(1993-3#1)(1994-3#1)(1995-1#1)(1995-11#1)(1997-8#1)(2004-11#1)(2006-10#2)(2006-5#1)(2007-10#1)(2007-11#3)(2007-8#1)(2007-9#3)(2008-10#2)(2008-3#3)(2008-4#1)(2008-5#2)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
with the control of##2##4##(1994-2#1)(1996-6#1)
with the control##108##3##(1990-2#1)(1990-6#1)(1991-3#1)(1992-4#2)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-3#3)(1994-12#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-6#2)(1997-2#1)(1997-6#1)(1997-8#1)(2004-11#1)(2004-2#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-5#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-8#1)(2007-9#4)(2008-10#13)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#2)(2009-4#1)(2010-12#2)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#8)(2012-3#1)(2013-1#3)(2013-8#4)
with the controlled and##2##4##(2008-10#1)(2011-2#1)
with the controlled##3##3##(2008-10#1)(2008-6#1)(2011-2#1)
with the controls##23##3##(1991-8#1)(1993-12#1)(1994-12#1)(2004-11#1)(2006-5#2)(2007-7#1)(2008-10#4)(2008-5#1)(2008-7#2)(2010-4#1)(2011-2#2)(2012-12#4)(2012-3#1)(2013-8#1)
with the conventional method##3##4##(2007-11#1)(2007-12#1)(2008-10#1)
with the conventional methods##2##4##(2008-10#1)(2013-8#1)
with the conventional##47##3##(1995-10#1)(1995-3#1)(1997-6#1)(2005-9#1)(2006-10#2)(2006-8#1)(2007-11#2)(2007-12#5)(2007-8#2)(2008-1#1)(2008-10#16)(2008-2#3)(2008-3#3)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
with the conversion of##2##4##(1996-7#1)(2006-3#1)
with the cooperation of##3##4##(1990-5#1)(2009-12#1)(2012-1#1)
with the coping##3##3##(1993-3#1)(2009-4#1)(2009-7#1)
with the core##5##3##(1994-11#1)(1995-1#1)(1997-4#1)(2008-8#1)(2013-1#1)
with the correct##5##3##(1996-5#1)(2007-2#1)(2008-3#1)(2008-5#1)(2008-9#1)
with the correlation coefficient of##2##5##(2008-10#1)(2011-1#1)
with the correlation coefficient##3##4##(2008-10#1)(2011-1#1)(2012-12#1)
with the correlation coefficients of 0##3##6##(2005-12#1)(2011-1#2)
with the correlation coefficients##8##4##(2005-12#1)(2007-8#1)(2011-1#3)(2012-12#2)(2013-8#1)
with the correlation##11##3##(2005-12#1)(2007-8#1)(2008-10#1)(2011-1#4)(2012-12#3)(2013-8#1)
with the corresponding data##2##4##(2008-2#1)(2008-8#1)
with the corresponding rates##2##4##(2008-11#1)(2008-7#1)
with the corresponding regions of##3##5##(1994-12#1)(1996-5#1)(1997-5#1)
with the corresponding regions##4##4##(1994-12#1)(1995-7#1)(1996-5#1)(1997-5#1)
with the corresponding theoretical##2##4##(2008-2#2)
with the corresponding values in the##2##6##(2008-2#1)(2008-5#1)
with the corresponding values##3##4##(2008-2#2)(2008-5#1)
with the corresponding##69##3##(1990-3#1)(1990-4#1)(1991-2#1)(1991-8#1)(1991-9#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-12#3)(1994-2#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#2)(1996-5#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-2#9)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
with the costs of##2##4##(1995-12#1)(2007-12#1)
with the coupling##3##3##(2008-10#1)(2008-4#2)
with the course of the##2##5##(1991-4#1)(2008-10#1)
with the course of##3##4##(1991-4#1)(1991-9#1)(2008-10#1)
with the course##5##3##(1991-4#1)(1991-9#1)(2008-10#1)(2008-11#1)(2013-8#1)
with the craniofacial##2##3##(2007-12#2)
with the creation of the##2##5##(2007-7#1)(2011-1#1)
with the creation of##4##4##(2007-7#1)(2008-12#1)(2008-3#1)(2011-1#1)
with the criteria##3##3##(1991-9#1)(2006-7#1)(2006-8#1)
with the critical##4##3##(1997-5#1)(2008-10#2)(2010-12#1)
with the crude##5##3##(1990-5#1)(1991-4#1)(1994-9#1)(2005-11#1)(2007-1#1)
with the crush##2##3##(1990-4#1)(2009-12#1)
with the crystal structure##3##4##(1991-11#1)(2007-11#1)(2011-1#1)
with the crystal structures of##3##5##(1994-5#1)(1994-8#1)(1995-1#1)
with the crystal##8##3##(1991-11#1)(1994-5#1)(1994-8#1)(1995-1#1)(2007-11#1)(2008-10#2)(2011-1#1)
with the culture##6##3##(1991-7#1)(2006-10#1)(2006-9#1)(2008-11#2)(2011-2#1)
with the cumulative##3##3##(2008-10#1)(2009-7#1)(2012-2#1)
with the current IRP for u-PA##2##6##(1990-11#2)
with the current standard##2##4##(2006-6#1)(2010-12#1)
with the current understanding of##2##5##(1997-5#1)(2012-2#1)
with the current##31##3##(1990-11#2)(1992-3#1)(1992-4#1)(1993-12#1)(1993-9#1)(1994-5#1)(1996-1#2)(1996-4#1)(1996-5#1)(1996-6#1)(1997-5#1)(2005-7#1)(2006-6#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
with the currently available##2##4##(1996-2#1)(2010-3#1)
with the currently##3##3##(1996-2#1)(2010-3#1)(2010-8#1)
with the cysteine##3##3##(1990-2#1)(1992-5#1)(1994-11#1)
with the cytochrome P-450##2##4##(1992-11#1)(2008-3#1)
with the cytochrome##3##3##(1992-11#1)(1994-5#1)(2008-3#1)
with the cytokine##2##3##(1994-3#1)(1996-12#1)
with the cytokines##2##3##(1992-8#1)(1997-4#1)
with the cytolytic##2##3##(1990-6#1)(2008-5#1)
with the cytoplasmic domain of##2##5##(1996-5#1)(1996-8#1)
with the cytoplasmic membrane##2##4##(1994-2#1)(2009-10#1)
with the cytoplasmic tail of##3##5##(1994-9#1)(2008-9#1)(2011-1#1)
with the cytoplasmic##11##3##(1990-8#1)(1994-2#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2011-1#1)
with the cytoskeletal##2##3##(1994-9#1)(1997-2#1)
with the cytoskeleton and##2##4##(1992-11#1)(1997-6#1)
with the cytoskeleton##4##3##(1992-11#1)(1993-11#1)(1997-6#1)(2008-11#1)
with the cytosolic form of##2##5##(1992-11#1)(1996-3#1)
with the cytosolic##5##3##(1991-2#1)(1992-11#1)(1993-8#1)(1996-3#1)(2012-12#1)
with the da Vinci##3##4##(2006-6#1)(2007-5#2)
with the daily##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
with the data for##2##4##(2008-11#1)(2008-2#1)
with the data obtained by##3##5##(1994-5#1)(2008-10#2)
with the data obtained with##2##5##(1994-9#1)(2008-2#1)
with the data obtained##7##4##(1994-5#1)(1994-9#1)(2008-10#3)(2008-2#1)(2013-1#1)
with the data of airborne lidar measurements for lambda = 0##2##11##(2008-2#2)
with the data##30##3##(1990-8#1)(1991-5#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-8#1)(1997-5#1)(2005-11#2)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#3)(2008-7#2)(2008-8#1)(2010-12#1)(2011-1#1)(2013-1#2)
with the day of##2##4##(1992-1#2)
with the de novo##2##4##(1994-6#1)(2007-11#1)
with the death of a##2##5##(2009-7#1)(2010-2#1)
with the death of##4##4##(1995-6#1)(2009-7#1)(2010-2#1)(2011-2#1)
with the decision to##2##4##(2005-10#1)(2008-8#1)
with the decision##4##3##(2005-10#1)(2008-6#1)(2008-8#1)(2008-9#1)
with the decrease in##10##4##(1992-12#1)(1992-5#1)(1992-7#1)(1992-9#1)(1994-3#1)(1994-4#1)(2006-10#1)(2007-9#1)(2008-10#1)(2009-7#1)
with the decrease of##9##4##(1990-12#1)(1991-2#1)(1991-3#1)(1992-3#1)(1995-3#1)(2008-12#1)(2008-2#1)(2009-10#1)(2010-8#1)
with the decrease##19##3##(1990-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#1)(1994-3#1)(1994-4#1)(1995-3#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-10#1)(2009-7#1)(2010-8#1)
with the deduced##3##3##(1991-6#1)(1994-8#1)(1995-6#1)
with the deep##2##3##(1995-3#1)(2013-1#1)
with the deficiency##2##3##(2004-11#1)(2006-6#1)
with the definition of##5##4##(1991-2#1)(2007-1#1)(2008-10#1)(2008-3#1)(2013-8#1)
with the degenerate primers##2##4##(1996-8#1)(2008-10#1)
with the degeneration of##2##4##(1991-9#1)(2007-11#1)
with the degree of resistance##2##5##(1994-3#1)(2008-10#1)
with the degree of stenosis##2##5##(2007-10#2)
with the degree of##45##4##(1991-1#1)(1991-10#1)(1991-7#1)(1991-9#1)(1992-12#2)(1993-11#1)(1993-9#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-2#1)(2007-10#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-2#1)(2011-2#1)(2012-11#1)(2012-5#1)(2013-1#1)(2013-8#1)
with the degree to which##2##5##(1990-5#1)(1992-6#1)
with the degree##47##3##(1990-5#1)(1991-1#1)(1991-10#1)(1991-7#1)(1991-9#1)(1992-12#2)(1992-6#1)(1993-11#1)(1993-9#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-2#1)(2007-10#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-2#1)(2011-2#1)(2012-11#1)(2012-5#1)(2013-1#1)(2013-8#1)
with the delay in t(is) and##2##6##(2008-10#2)
with the delay in##3##4##(1992-3#1)(2008-10#2)
with the delay introduced in the##2##6##(2013-8#2)
with the delay##8##3##(1992-3#1)(1993-7#1)(2008-10#2)(2013-8#4)
with the deletion##3##3##(1990-5#1)(1995-2#1)(1997-5#1)
with the delivery of##5##4##(1993-3#1)(1994-1#1)(2005-8#1)(2007-3#1)(2008-7#1)
with the demographic##2##3##(1990-4#1)(2009-2#1)
with the demonstration that##2##4##(2006-10#1)(2008-10#1)
with the demonstration##3##3##(1993-8#1)(2006-10#1)(2008-10#1)
with the depletion##2##3##(1991-8#1)(1992-3#1)
with the deposition of##4##4##(2005-7#1)(2008-10#2)(2010-4#1)
with the deposition##6##3##(2005-7#1)(2007-12#1)(2008-10#3)(2010-4#1)
with the depth of the##2##5##(2007-12#1)(2013-8#1)
with the depth of##5##4##(2007-10#1)(2007-12#1)(2009-9#1)(2013-8#2)
with the depth##6##3##(2007-10#1)(2007-12#1)(2008-10#1)(2009-9#1)(2013-8#2)
with the derived##2##3##(1995-5#1)(2008-3#1)
with the described##3##3##(1994-12#1)(1995-1#1)(2008-10#1)
with the design##4##3##(2007-12#1)(2007-8#1)(2008-11#1)(2008-9#1)
with the desirable##2##3##(2008-1#1)(2008-10#1)
with the desire to##3##4##(2005-11#1)(2007-7#1)(2008-3#1)
with the desire##4##3##(2005-11#1)(2007-7#1)(2008-10#1)(2008-3#1)
with the desired##3##3##(2006-12#1)(2008-10#1)(2008-5#1)
with the detection limit of 0##4##6##(2005-12#1)(2008-10#3)
with the detection limit of 1##4##6##(2008-10#4)
with the detection limit of##11##5##(2005-12#1)(2008-10#10)
with the detection limit##14##4##(2005-12#1)(2008-10#13)
with the detection limits of 0##2##6##(2008-10#2)
with the detection limits of##3##5##(2007-8#1)(2008-10#2)
with the detection limits##4##4##(2007-8#1)(2008-10#3)
with the detection of##10##4##(1996-6#1)(1997-6#1)(2005-10#1)(2007-8#1)(2008-3#1)(2008-9#1)(2010-12#1)(2010-2#1)(2013-1#2)
with the detection##31##3##(1996-6#1)(1997-6#1)(2005-10#1)(2005-12#1)(2006-10#1)(2007-8#2)(2008-10#17)(2008-3#1)(2008-9#1)(2010-12#1)(2010-2#1)(2012-12#1)(2013-1#2)
with the detectors##2##3##(2008-3#1)(2008-9#1)
with the determination of##12##4##(1994-6#1)(2005-4#2)(2007-12#1)(2008-1#1)(2008-10#6)(2010-11#1)
with the determination##18##3##(1994-6#1)(2005-12#1)(2005-4#2)(2007-12#1)(2008-1#1)(2008-10#11)(2010-11#1)
with the developed##6##3##(2008-1#1)(2008-10#3)(2008-2#1)(2011-2#1)
with the development and##4##4##(2006-7#1)(2007-11#1)(2007-4#1)(2011-2#1)
with the development of a##13##5##(1993-6#1)(1994-3#2)(1995-1#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#1)(2010-8#1)(2011-2#1)(2011-7#1)(2012-3#1)
with the development of cancer##2##5##(2007-10#1)(2008-8#1)
with the development of hypertension##2##5##(1991-12#1)(1991-6#1)
with the development of new##5##5##(2007-10#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-6#1)
with the development of novel##2##5##(2006-11#1)(2009-2#1)
with the development of the##11##5##(1993-3#1)(1997-6#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
with the development of##115##4##(1990-12#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-6#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#2)(1995-1#1)(1995-2#3)(1995-6#1)(1996-1#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-10#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#3)(2006-11#1)(2006-6#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-4#2)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#3)(2011-3#1)(2011-7#1)(2012-12#3)(2012-2#2)(2012-3#4)(2013-7#1)(2013-8#3)
with the development##120##3##(1990-12#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-6#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#2)(1995-1#1)(1995-2#3)(1995-6#1)(1996-1#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-10#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#3)(2006-11#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-4#3)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#3)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#4)(2011-3#1)(2011-7#1)(2012-12#3)(2012-2#2)(2012-3#4)(2013-7#1)(2013-8#3)
with the developmental##4##3##(1990-5#1)(1993-3#1)(1995-2#1)(2006-6#1)
with the device##8##3##(2006-6#2)(2007-12#1)(2008-10#2)(2008-5#1)(2008-9#1)(2012-3#1)
with the diagnoses of##4##4##(1991-9#1)(2011-2#1)(2013-1#2)
with the diagnoses##5##3##(1991-9#1)(2007-9#1)(2011-2#1)(2013-1#2)
with the diagnosis and treatment of##2##6##(1992-3#1)(2010-5#1)
with the diagnosis and##3##4##(1992-3#1)(2008-4#1)(2010-5#1)
with the diagnosis of acute##3##5##(2007-10#1)(2013-1#2)
with the diagnosis of##23##4##(1990-4#1)(1993-9#1)(2005-1#1)(2007-10#2)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
with the diagnosis##32##3##(1990-4#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-9#1)(2005-1#1)(2006-10#1)(2006-12#1)(2007-10#2)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#2)(2008-7#1)(2009-2#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
with the diagnostic and therapeutic##2##5##(2008-10#1)(2008-9#1)
with the diagnostic##3##3##(1991-3#1)(2008-10#1)(2008-9#1)
with the dialysis##2##3##(2007-12#1)(2008-10#1)
with the diet##2##3##(1994-11#1)(1994-9#1)
with the dietary##3##3##(1997-7#1)(2006-4#1)(2008-10#1)
with the difference##3##3##(1997-2#1)(2008-8#1)(2009-5#1)
with the differences##4##3##(1996-7#1)(1997-2#1)(2005-8#1)(2008-2#1)
with the different##38##3##(1990-10#1)(1990-5#1)(1990-6#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-3#1)(1996-2#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-6#1)(2007-12#2)(2008-10#8)(2008-11#2)(2008-8#2)(2008-9#1)(2009-2#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-2#1)(2013-1#1)(2013-8#2)
with the differential##3##3##(2005-11#1)(2008-3#1)(2012-1#1)
with the differentiation of these##2##5##(1991-10#1)(1996-8#1)
with the differentiation of##4##4##(1991-10#1)(1993-6#1)(1996-8#1)(1997-6#1)
with the differentiation##5##3##(1991-10#1)(1993-6#1)(1996-8#1)(1997-6#1)(2008-7#1)
with the difficulties##3##3##(1997-6#1)(2006-10#1)(2007-11#1)
with the difficulty in##2##4##(2009-6#1)(2012-12#1)
with the difficulty##5##3##(2006-12#1)(2008-11#1)(2008-5#1)(2009-6#1)(2012-12#1)
with the diffraction##2##3##(1991-2#1)(2008-3#1)
with the diffusion##6##3##(1996-5#1)(2007-12#2)(2008-2#1)(2008-3#1)(2009-4#1)
with the dihydropyridine receptor##2##4##(1991-1#2)
with the dihydropyridine##3##3##(1991-1#2)(1995-1#1)
with the dilemma of##4##4##(1992-1#1)(2007-2#1)(2008-11#1)(2012-12#1)
with the dilemma##5##3##(1992-1#1)(2007-2#1)(2007-8#1)(2008-11#1)(2012-12#1)
with the dimensions##2##3##(2008-3#2)
with the diploid##2##3##(1993-4#1)(2013-8#1)
with the direct injection of##2##5##(1992-2#1)(2008-10#1)
with the direct##7##3##(1991-12#1)(1992-2#1)(2007-12#1)(2008-10#2)(2008-3#1)(2010-12#1)
with the direction of##6##4##(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
with the disappearance of##3##4##(1990-5#1)(1991-7#1)(1994-3#1)
with the discharge##3##3##(2006-10#1)(2008-10#2)
with the discovery of the##2##5##(2006-10#1)(2010-3#1)
with the discovery of##8##4##(1997-3#1)(2006-10#2)(2008-11#1)(2008-9#1)(2010-3#2)(2013-7#1)
with the disease and##2##4##(1990-5#1)(2013-7#1)
with the disease in##2##4##(1996-5#1)(2010-2#1)
with the disease##46##3##(1990-5#1)(1991-2#1)(1992-3#1)(1993-11#1)(1993-5#1)(1994-9#1)(1995-3#1)(1996-1#1)(1996-5#1)(2005-12#1)(2005-8#1)(2006-10#4)(2007-11#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-9#2)(2009-10#2)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
with the disorder##7##3##(1991-3#1)(2006-2#1)(2008-12#1)(2008-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
with the dissociation##3##3##(1993-8#1)(1995-1#1)(2008-10#1)
with the distal##2##3##(1990-5#1)(1992-9#1)
with the distance between the##2##5##(2007-11#1)(2008-10#1)
with the distribution of the##5##5##(1991-9#2)(1992-9#1)(2005-8#1)(2009-2#1)
with the distribution of##11##4##(1990-7#1)(1991-9#2)(1992-9#1)(1993-9#1)(2005-11#1)(2005-8#1)(2008-10#1)(2008-8#1)(2009-2#1)(2010-8#1)
with the distribution##12##3##(1990-7#1)(1991-9#2)(1992-9#1)(1993-9#1)(2005-11#1)(2005-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-2#1)(2010-8#1)
with the diurnal schedule of##2##5##(2008-6#2)
with the diurnal##4##3##(2008-6#2)(2011-1#1)(2013-8#1)
with the diversity##2##3##(2007-2#1)(2008-10#1)
with the dominant##6##3##(1994-1#1)(1997-5#1)(2006-3#1)(2007-7#1)(2011-2#1)(2013-8#1)
with the donor s##3##4##(2008-11#3)
with the donor##8##3##(1993-12#1)(1994-11#1)(1995-8#1)(1997-4#1)(2008-11#3)(2011-2#1)
with the dopamine##3##3##(1993-3#1)(1996-2#1)(1996-5#1)
with the dopaminergic agent##2##4##(1994-4#2)
with the dopaminergic system##2##4##(1996-5#1)(2012-1#1)
with the dopaminergic##5##3##(1994-4#2)(1996-5#1)(2008-7#1)(2012-1#1)
with the dorsal##4##3##(1995-12#1)(1997-3#1)(2006-4#1)(2007-11#1)
with the dose##3##3##(1995-12#1)(2005-12#1)(2013-1#1)
with the double-layer##2##3##(2005-11#1)(2008-2#1)
with the dramatic##3##3##(1996-2#1)(1997-4#1)(2007-12#1)
with the drop rate of critical data as a performance measure##2##11##(2013-1#2)
with the drug in##3##4##(2007-3#1)(2007-7#1)(2010-11#1)
with the drug##24##3##(1990-10#1)(1990-2#2)(1990-7#1)(1991-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-5#2)(1997-7#1)(2005-7#1)(2006-8#1)(2007-11#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-8#1)(2010-11#1)
with the duplex##2##3##(2008-5#2)
with the duration of ambient drying##2##6##(2005-11#2)
with the duration of motility##2##5##(2008-7#2)
with the duration of the##4##5##(1991-12#1)(1993-4#1)(1996-3#1)(2008-8#1)
with the duration of##14##4##(1991-11#1)(1991-12#1)(1993-4#1)(1995-3#1)(1996-3#1)(2005-11#2)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#1)(2009-7#1)
with the duration##15##3##(1991-11#1)(1991-12#1)(1993-4#1)(1995-3#1)(1996-3#1)(2005-11#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#1)(2009-7#1)
with the dye##2##3##(1990-3#1)(2010-5#1)
with the dynamic##2##3##(1997-8#1)(2008-10#1)
with the dynamics of##2##4##(2008-10#1)(2008-5#1)
with the dynamics##3##3##(1997-4#1)(2008-10#1)(2008-5#1)
with the earlier##9##3##(1991-12#1)(1994-3#2)(1997-7#1)(2008-10#2)(2009-12#1)(2012-2#1)(2013-1#1)
with the earliest##2##3##(2008-10#1)(2011-2#1)
with the early##4##3##(2006-10#1)(2007-10#1)(2008-10#1)(2008-4#1)
with the earth##2##3##(2008-12#1)(2009-6#1)
with the educational##2##3##(2011-2#1)(2013-1#1)
with the effect of##14##4##(1990-5#2)(1990-8#1)(1991-5#1)(1995-6#1)(1996-2#1)(1996-5#1)(2006-1#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
with the effect##18##3##(1990-5#2)(1990-8#1)(1991-5#1)(1992-8#1)(1995-6#1)(1996-2#1)(1996-4#1)(1996-5#1)(2006-1#1)(2006-5#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
with the effectiveness##2##3##(1990-5#1)(1992-10#1)
with the effector cells##2##4##(1990-12#1)(1993-6#1)
with the effects of the##3##5##(1993-8#1)(1996-12#1)(2008-2#1)
with the effects of##17##4##(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#1)(1995-12#1)(1996-12#1)(1997-7#1)(2006-3#1)(2007-12#2)(2008-10#1)(2008-2#1)(2009-2#1)
with the effects on##2##4##(1991-7#1)(1994-9#1)
with the effects##21##3##(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-7#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-7#1)(2006-3#1)(2007-12#2)(2008-10#1)(2008-2#1)(2009-2#1)(2010-2#1)
with the efficacy##2##3##(2005-12#1)(2006-12#1)
with the efficiency##3##3##(1996-4#1)(2008-10#1)(2008-2#1)
with the egg##2##3##(1995-10#1)(1997-6#1)
with the eight##3##3##(2008-10#2)(2009-8#1)
with the elderly population##2##4##(2006-1#1)(2007-9#1)
with the elderly##4##3##(2006-1#1)(2007-9#1)(2008-11#1)(2011-2#1)
with the electrical##2##3##(1992-9#1)(1997-8#1)
with the electron microscope##3##4##(1997-3#1)(2007-12#1)(2007-9#1)
with the electron##5##3##(1991-6#1)(1997-3#1)(2007-12#1)(2007-9#1)(2008-8#1)
with the electronic##2##3##(1994-6#1)(2012-11#1)
with the elements of##2##4##(2008-10#1)(2008-3#1)
with the elongation##2##3##(1994-12#1)(1997-5#1)
with the embryonic##3##3##(2010-12#1)(2012-12#2)
with the emergence of a##2##5##(2008-10#1)(2008-12#1)
with the emergence of##16##4##(1993-3#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-2#1)(2012-12#2)(2013-7#1)(2013-8#1)
with the emergence##17##3##(1993-3#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-2#1)(2012-12#2)(2012-3#1)(2013-7#1)(2013-8#1)
with the emerging##3##3##(2007-8#1)(2008-4#1)(2011-2#1)
with the emission spectra of##2##5##(2008-10#1)(2013-8#1)
with the emission##4##3##(1993-4#1)(2008-10#2)(2013-8#1)
with the emphasis on##3##4##(1990-12#1)(1991-11#1)(2005-7#1)
with the emphasis##4##3##(1990-12#1)(1991-11#1)(1996-7#1)(2005-7#1)
with the empirical##2##3##(2008-10#1)(2010-3#1)
with the employment of##2##4##(2006-12#1)(2013-1#1)
with the end of the##2##5##(1993-2#1)(2007-12#1)
with the end of##3##4##(1993-2#1)(1994-9#1)(2007-12#1)
with the end##4##3##(1993-2#1)(1994-9#1)(2007-12#1)(2012-3#1)
with the endogenous##6##3##(1990-7#1)(1992-6#1)(1992-8#1)(1997-4#1)(2008-9#1)(2009-8#1)
with the endoplasmic reticulum##3##4##(1990-8#1)(1993-8#1)(2011-2#1)
with the endoscope##2##3##(2006-6#1)(2009-8#1)
with the endoscopic##2##3##(2006-5#2)
with the endothelial cell##2##4##(1995-2#1)(1996-8#1)
with the energetic##2##3##(1994-11#1)(2008-9#1)
with the energy##5##3##(1991-2#1)(1993-9#1)(1997-8#1)(2008-2#1)(2008-5#1)
with the enhanced##7##3##(1993-4#1)(1993-8#1)(1994-11#1)(1997-8#1)(2006-10#1)(2007-11#1)(2011-2#1)
with the enhancement of the##2##5##(1994-2#1)(2008-8#1)
with the enhancement of##6##4##(1994-2#1)(1996-2#1)(1997-6#1)(2008-10#1)(2008-8#1)(2013-8#1)
with the enrichment##2##3##(1992-9#1)(2008-10#1)
with the entire##4##3##(1995-12#1)(2007-8#1)(2008-10#1)(2012-2#1)
with the environment and##6##4##(1997-8#1)(2006-7#1)(2007-11#1)(2010-5#1)(2012-12#1)(2012-2#1)
with the environment##17##3##(1990-10#1)(1997-8#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-6#1)(2008-1#1)(2008-6#1)(2010-4#1)(2010-5#1)(2010-7#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)
with the enzymatic##3##3##(1991-1#1)(2008-10#2)
with the enzyme from##5##4##(1992-3#4)(1996-2#1)
with the enzyme in##2##4##(1991-2#1)(1996-7#1)
with the enzyme##37##3##(1990-2#1)(1991-12#1)(1991-2#5)(1991-4#1)(1991-8#1)(1992-3#5)(1992-4#1)(1992-6#1)(1992-8#2)(1993-3#2)(1994-11#1)(1994-9#2)(1995-2#1)(1995-5#1)(1996-2#1)(1996-7#3)(2004-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)
with the enzyme-linked immunosorbent assay (ELISA)##2##6##(1996-9#1)(2008-10#1)
with the enzyme-linked immunosorbent##3##4##(1996-9#1)(2008-10#2)
with the enzyme-linked##4##3##(1991-8#1)(1996-9#1)(2008-10#2)
with the enzymes##4##3##(1991-9#1)(2008-1#1)(2008-5#1)(2011-1#1)
with the epidemic##3##3##(1991-12#1)(1994-4#1)(2007-7#1)
with the equipment used##2##4##(1992-7#1)(2007-8#1)
with the equipment##3##3##(1992-7#1)(2007-8#1)(2010-12#1)
with the equivalent##3##3##(2007-12#1)(2008-3#1)(2013-8#1)
with the error##2##3##(2008-3#1)(2010-12#1)
with the errors##2##3##(2008-10#2)
with the eruption of##2##4##(2005-9#1)(2008-2#1)
with the established standard input function##2##6##(2008-2#2)
with the established##8##3##(1992-3#1)(2007-8#1)(2008-2#2)(2008-6#1)(2009-11#1)(2012-12#1)(2013-8#1)
with the establishment of the##2##5##(2006-5#1)(2011-2#1)
with the establishment of##3##4##(2006-5#1)(2008-11#1)(2011-2#1)
with the esterase##2##3##(1995-2#1)(2012-2#1)
with the estimated##6##3##(1997-3#1)(2004-4#1)(2006-12#1)(2008-10#1)(2008-2#1)(2012-3#1)
with the estimation##3##3##(2010-8#1)(2012-2#1)(2013-8#1)
with the estrogen receptor##4##4##(1991-1#1)(2008-11#3)
with the ethanol##3##3##(1995-4#1)(2006-3#1)(2008-10#1)
with the ethical##2##3##(2012-3#1)(2013-8#1)
with the etiology of##2##4##(1992-2#1)(2008-10#1)
with the evaluation of##2##4##(2007-5#1)(2013-8#1)
with the evaluation##3##3##(2007-5#1)(2013-1#1)(2013-8#1)
with the evidence##3##3##(1997-4#1)(2010-11#1)(2011-2#1)
with the evolution of human language##2##6##(1997-8#1)(2007-3#1)
with the evolution of the##2##5##(2007-3#1)(2008-2#1)
with the evolution of##7##4##(1997-8#1)(2006-11#1)(2006-9#1)(2007-3#2)(2008-2#1)(2008-6#1)
with the evolution##8##3##(1997-8#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-3#2)(2008-2#1)(2008-6#1)
with the exact solution##2##4##(1991-5#1)(2008-3#1)
with the exact##7##3##(1991-5#1)(2008-2#1)(2008-3#3)(2009-9#1)(2010-12#1)
with the example of##4##4##(1990-6#1)(2005-11#1)(2009-3#1)(2012-1#1)
with the exception of L-687##2##5##(1993-11#2)
with the exception of M##2##5##(2007-6#1)(2008-10#1)
with the exception of a##4##5##(1991-9#1)(1992-2#1)(1996-5#1)(2008-12#1)
with the exception of mancozeb##3##5##(2008-10#3)
with the exception of one##3##5##(1991-12#1)(1993-10#1)(1993-6#1)
with the exception of that##3##5##(1993-12#1)(1994-6#1)(2013-1#1)
with the exception of the##21##5##(1990-5#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-5#1)(1996-5#1)(1997-7#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-5#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-9#1)(2010-12#1)(2011-2#1)
with the exception of those##4##5##(1990-3#1)(1994-3#1)(2008-10#2)
with the exception of##124##4##(1990-3#1)(1990-5#2)(1990-8#2)(1991-12#3)(1991-2#2)(1991-4#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-10#2)(1993-11#3)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-3#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-5#1)(1996-11#1)(1996-12#1)(1996-5#2)(1997-3#1)(1997-7#1)(2004-11#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#20)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2010-12#2)(2010-4#1)(2010-8#2)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#3)
with the exception that the##2##5##(1992-8#1)(2007-11#1)
with the exception that women##2##5##(2006-8#2)
with the exception that##12##4##(1990-4#1)(1992-2#1)(1992-3#1)(1992-8#1)(2006-8#2)(2007-11#1)(2008-10#2)(2008-4#1)(2009-9#1)(2010-12#1)
with the exception##137##3##(1990-3#1)(1990-4#1)(1990-5#2)(1990-8#2)(1991-12#3)(1991-2#2)(1991-4#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-8#2)(1993-10#2)(1993-11#3)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-5#1)(1996-11#1)(1996-12#1)(1996-5#2)(1997-3#1)(1997-7#1)(2004-11#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#22)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#3)(2008-5#5)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-9#1)(2010-12#3)(2010-4#1)(2010-8#2)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#3)
with the exceptions of##4##4##(1997-2#1)(2008-10#3)
with the excitation##2##3##(1995-3#1)(1996-2#1)
with the exercise##2##3##(2007-6#1)(2008-11#1)
with the existence of##6##4##(1990-4#1)(1994-8#1)(2006-2#1)(2006-3#1)(2008-10#1)(2008-2#1)
with the existence##7##3##(1990-4#1)(1994-8#1)(2006-2#1)(2006-3#1)(2008-10#1)(2008-2#1)(2008-8#1)
with the existing##7##3##(2006-10#1)(2008-10#2)(2008-7#1)(2009-6#1)(2012-12#1)(2013-1#1)
with the expansion of##3##4##(2007-4#1)(2008-10#1)(2012-1#1)
with the expectation that they##2##5##(2007-3#1)(2010-3#1)
with the expectation that##5##4##(1992-8#1)(2006-10#1)(2007-3#1)(2008-8#1)(2010-3#1)
with the expectation##6##3##(1990-10#1)(1992-8#1)(2006-10#1)(2007-3#1)(2008-8#1)(2010-3#1)
with the expected##14##3##(1992-3#1)(1992-7#1)(1992-8#1)(1994-11#1)(1994-2#1)(1997-5#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2010-4#1)(2013-8#1)
with the experience of##2##4##(1994-12#1)(2008-3#1)
with the experiences##2##3##(1994-11#1)(2013-1#1)
with the experimental data##21##4##(1996-5#1)(1996-7#1)(1996-9#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#2)(2008-7#1)(2009-6#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
with the experimental observations##2##4##(2008-2#2)
with the experimental results for##2##5##(2006-11#1)(2007-11#1)
with the experimental results##26##4##(1995-3#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-2#5)(2008-3#5)(2008-5#1)(2010-2#1)(2010-5#1)(2011-2#1)(2013-8#1)
with the experimental values##2##4##(1995-6#1)(2008-10#1)
with the experimental##66##3##(1990-6#1)(1995-3#1)(1995-6#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-7#1)(2005-11#3)(2006-10#3)(2006-11#1)(2006-2#1)(2007-10#1)(2007-11#4)(2007-12#3)(2008-1#1)(2008-10#4)(2008-2#14)(2008-3#9)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-2#2)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#2)
with the experimentally determined##3##4##(1996-11#1)(2008-1#1)(2008-10#1)
with the experimentally observed##2##4##(1997-8#1)(2004-9#1)
with the experimentally##8##3##(1993-3#1)(1996-11#1)(1997-8#1)(2004-9#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-2#1)
with the experiments##6##3##(2008-10#1)(2008-2#3)(2010-7#1)(2013-8#1)
with the explanatory variables##2##4##(1992-6#2)
with the expressed##3##3##(1990-9#1)(1996-11#1)(2008-8#1)
with the expression of the##3##5##(1990-7#1)(1991-9#1)(1995-6#1)
with the expression of these##2##5##(1994-7#1)(2009-9#1)
with the expression of##16##4##(1990-7#1)(1991-9#1)(1992-12#2)(1993-4#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#1)
with the expression##23##3##(1990-7#1)(1991-9#1)(1992-12#2)(1993-4#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-6#1)(1996-3#1)(1997-7#1)(2005-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#1)
with the extended##3##3##(2007-11#1)(2007-8#1)(2011-2#1)
with the extent of##9##4##(1992-10#1)(1996-4#1)(1997-2#1)(2008-7#1)(2009-9#1)(2010-4#1)(2012-11#1)(2012-12#1)(2013-8#1)
with the external diameter##2##4##(2005-10#2)
with the external environment##2##4##(2008-11#1)(2009-6#1)
with the external##5##3##(2005-10#2)(2007-12#1)(2008-11#1)(2009-6#1)
with the extracellular matrix##7##4##(1991-8#1)(1992-11#1)(1992-4#1)(1994-12#1)(2006-1#1)(2008-11#1)(2012-3#1)
with the extracellular##11##3##(1991-8#1)(1992-11#1)(1992-4#1)(1994-12#1)(1995-3#1)(1995-8#1)(2006-1#1)(2007-3#1)(2008-11#1)(2011-2#1)(2012-3#1)
with the extract of##2##4##(2008-4#1)(2013-1#1)
with the extract##5##3##(1990-2#1)(1994-2#1)(2008-10#1)(2008-4#1)(2013-1#1)
with the extracted##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
with the extraction##5##3##(2007-8#1)(2008-10#3)(2012-2#1)
with the extracts##3##3##(2008-10#1)(2013-1#2)
with the eyes closed##2##4##(1990-2#1)(1996-5#1)
with the eyes##3##3##(1990-2#2)(1996-5#1)
with the fabricated##2##3##(2008-2#1)(2008-3#1)
with the fact that the##3##5##(1990-8#1)(2008-11#1)(2008-5#1)
with the fact that##13##4##(1990-11#1)(1990-8#1)(1991-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-4#1)(1995-8#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
with the fact##14##3##(1990-11#1)(1990-8#1)(1991-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-4#1)(1995-8#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
with the factor sera##2##4##(1994-5#2)
with the factor##5##3##(1991-3#1)(1994-5#2)(1997-8#1)(2007-3#1)
with the factors##2##3##(1995-4#1)(2010-2#1)
with the fair##2##3##(2006-4#1)(2008-4#1)
with the fall in##3##4##(1991-5#1)(2013-1#2)
with the fall##5##3##(1991-5#1)(2013-1#4)
with the family##7##3##(1995-2#1)(1996-2#1)(2007-10#1)(2008-10#1)(2009-2#1)(2012-2#2)
with the fast##3##3##(1991-7#1)(2008-2#1)(2008-9#1)
with the fastest##3##3##(1990-9#1)(2007-5#1)(2008-10#1)
with the fatty acid##4##4##(1992-10#1)(1992-11#1)(2006-10#1)(2008-10#1)
with the features##2##3##(2008-3#1)(2008-7#1)
with the feedback sensitivity of the##2##6##(2006-10#2)
with the feedback##4##3##(2006-10#2)(2007-12#1)(2008-5#1)
with the female##3##3##(2006-1#1)(2008-5#1)(2008-6#1)
with the fetal##3##3##(1990-5#1)(2009-2#1)(2012-2#1)
with the fewest##5##3##(1992-4#1)(2006-10#1)(2008-10#1)(2008-7#1)(2008-8#1)
with the fiber##2##3##(2007-11#1)(2008-10#1)
with the fibril##2##3##(2008-3#1)(2009-8#1)
with the fibroblast##2##3##(1991-8#1)(2009-7#1)
with the field strength##2##4##(2005-11#1)(2008-10#1)
with the field##6##3##(2005-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#1)
with the filtration##2##3##(2005-11#1)(2008-9#1)
with the final##6##3##(2006-12#1)(2007-10#1)(2008-3#1)(2012-2#1)(2013-8#2)
with the finding of##3##4##(1990-2#1)(2013-1#2)
with the finding that##5##4##(1991-5#1)(1995-6#1)(1996-12#1)(2005-8#1)(2008-10#1)
with the finding##8##3##(1990-2#1)(1991-5#1)(1995-6#1)(1996-12#1)(2005-8#1)(2008-10#1)(2013-1#2)
with the findings of##3##4##(2008-5#1)(2008-9#1)(2013-8#1)
with the findings##8##3##(1991-2#1)(1994-3#1)(1997-8#1)(2008-11#2)(2008-5#1)(2008-9#1)(2013-8#1)
with the finite-difference time-domain##2##4##(2008-3#2)
with the first dose of##2##5##(2007-10#1)(2007-11#1)
with the first generation##2##4##(2007-11#1)(2012-1#1)
with the first of##3##4##(1996-2#1)(1996-6#1)(2008-7#1)
with the first phase##2##4##(2006-10#1)(2008-1#1)
with the first tumor occurring##2##5##(1997-3#2)
with the first##44##3##(1991-2#1)(1993-5#1)(1993-7#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#2)(1997-4#1)(2004-3#1)(2006-10#2)(2006-8#1)(2007-10#2)(2007-11#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#2)(2008-4#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-1#2)(2013-7#1)(2013-8#1)
with the fish and##2##4##(1990-2#1)(1996-5#1)
with the fish oil diet##2##5##(1991-2#2)
with the fish oil##3##4##(1991-2#2)(1994-2#1)
with the fish##8##3##(1990-2#1)(1991-2#2)(1994-2#1)(1996-5#1)(2008-11#1)(2008-7#1)(2009-4#1)
with the five##3##3##(1990-12#1)(1993-12#1)(2008-4#1)
with the flexibility##2##3##(1993-12#1)(2006-10#1)
with the flexible##2##3##(1996-7#1)(2007-10#1)
with the flow injection##2##4##(2008-10#2)
with the flow rate of##2##5##(1996-6#1)(2012-12#1)
with the flow rate##4##4##(1991-9#1)(1996-6#1)(2008-10#1)(2012-12#1)
with the flow##13##3##(1991-9#1)(1996-6#1)(2007-8#1)(2008-10#8)(2009-7#1)(2012-12#1)
with the flowering##2##3##(1990-7#1)(2008-10#1)
with the fluorescence of##2##4##(2008-10#1)(2008-2#1)
with the fluorescence##7##3##(1990-7#1)(2008-10#2)(2008-2#3)(2010-4#1)
with the fluorescent calcium indicator##3##5##(1990-3#1)(1992-7#2)
with the fluorescent dye##2##4##(1995-7#1)(2009-7#1)
with the fluorescent indicator##3##4##(1992-7#1)(1994-12#1)(1994-6#1)
with the fluorescent probe##3##4##(1993-9#1)(1994-9#1)(2008-8#1)
with the fluorescent##16##3##(1990-3#1)(1991-6#1)(1992-3#1)(1992-7#3)(1993-9#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-5#1)(1995-6#1)(1995-7#1)(2008-4#1)(2008-8#1)(2009-7#1)
with the fluorochrome##2##3##(2007-5#1)(2008-12#1)
with the fluorogenic reagent##3##4##(2008-10#3)
with the fluorogenic##4##3##(1990-8#1)(2008-10#3)
with the flux##2##3##(1995-3#1)(2009-6#1)
with the focus on##3##4##(2005-11#1)(2008-10#2)
with the focus##4##3##(2005-11#1)(2008-10#2)(2013-8#1)
with the following questions##2##4##(1997-8#1)(2004-4#1)
with the following rank order of potency##2##7##(1993-6#1)(1995-7#1)
with the following results##3##4##(2008-6#1)(2011-2#1)(2012-3#1)
with the following##36##3##(1991-5#1)(1991-7#1)(1992-2#1)(1992-8#1)(1993-6#1)(1994-12#2)(1995-12#2)(1995-7#1)(1996-2#1)(1997-8#1)(2004-4#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
with the food##2##3##(2007-12#1)(2013-1#1)
with the forearm##2##3##(2008-4#1)(2008-5#1)
with the forehead flap##3##4##(2008-8#3)
with the formation of a##6##5##(1990-5#1)(1991-9#1)(2005-11#1)(2006-12#1)(2007-12#1)(2008-10#1)
with the formation of the##8##5##(1994-11#1)(1994-12#1)(1994-8#1)(1995-8#1)(1997-7#1)(2008-10#2)(2008-5#1)
with the formation of transversal gastroenteroanastomosis##2##6##(2009-2#2)
with the formation of##46##4##(1990-5#1)(1991-11#1)(1991-4#1)(1991-9#1)(1992-2#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-7#1)(2005-11#2)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-8#1)(2009-2#3)(2009-7#1)(2010-3#1)(2010-5#1)(2013-1#1)(2013-8#1)
with the formation##48##3##(1990-5#1)(1991-11#1)(1991-4#1)(1991-9#1)(1992-2#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-7#1)(2005-11#2)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#3)(2009-7#1)(2010-3#1)(2010-5#1)(2013-1#1)(2013-8#1)
with the former being##2##4##(2007-12#1)(2011-2#1)
with the former##11##3##(1994-8#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-7#1)
with the formula##3##3##(1996-2#2)(2008-5#1)
with the four##4##3##(2007-4#1)(2008-10#1)(2008-2#1)(2012-3#1)
with the fourth##2##3##(1993-8#1)(2006-10#1)
with the fraction of##3##4##(1995-8#1)(1996-12#1)(1997-4#1)
with the fraction##5##3##(1990-2#1)(1995-8#1)(1996-12#1)(1996-8#1)(1997-4#1)
with the fractional##2##3##(2008-2#1)(2008-3#1)
with the free drug##2##4##(1995-5#1)(2008-5#1)
with the free##5##3##(1991-4#1)(1993-11#1)(1995-3#1)(1995-5#1)(2008-5#1)
with the frequency of##4##4##(2006-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
with the frequency##6##3##(2006-10#1)(2007-12#1)(2011-2#1)(2012-3#1)(2013-8#2)
with the full range of##2##5##(1995-11#1)(2012-2#1)
with the full##12##3##(1994-12#1)(1995-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2012-2#1)(2012-3#2)
with the full-length##4##3##(1992-5#1)(1994-8#2)(1995-6#1)
with the fully##3##3##(1994-12#1)(1997-4#1)(2008-7#1)
with the function of the##2##5##(1996-9#1)(2007-11#1)
with the function of##6##4##(1991-1#1)(1995-3#1)(1996-9#1)(2007-11#1)(2007-9#1)(2008-4#1)
with the functional##7##3##(1994-8#1)(1994-9#1)(1996-6#1)(2005-1#1)(2007-12#1)(2008-8#2)
with the functionally##2##3##(2006-6#1)(2009-9#1)
with the fundamental##3##3##(2005-4#1)(2008-12#1)(2008-2#1)
with the fungus##4##3##(2008-10#2)(2008-11#2)
with the fusion protein##3##4##(1993-6#1)(1995-1#1)(1997-6#1)
with the gallbladder##2##3##(2007-5#1)(2008-3#1)
with the gamma##3##3##(1994-2#1)(2008-2#1)(2008-7#1)
with the gel##2##3##(1990-3#1)(1991-5#1)
with the gelatin##4##3##(2008-2#1)(2011-2#3)
with the gene encoding##3##4##(1992-12#1)(1993-2#1)(2007-11#1)
with the gene for##2##4##(2006-12#1)(2009-3#1)
with the gene of##2##4##(1995-11#1)(1996-7#1)
with the gene##18##3##(1990-11#1)(1990-8#1)(1991-12#1)(1992-12#1)(1993-2#1)(1995-11#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-3#1)
with the general formula##3##4##(1994-9#1)(2005-4#1)(2008-10#1)
with the general population##5##4##(1992-2#2)(2006-10#2)(2010-8#1)
with the general##25##3##(1992-12#1)(1992-2#2)(1993-2#1)(1994-9#1)(1995-1#1)(2005-11#1)(2005-4#1)(2006-10#2)(2006-2#1)(2006-9#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-8#1)
with the generalized##6##3##(1993-10#1)(2007-12#1)(2008-10#1)(2008-2#2)(2012-3#1)
with the generated##2##3##(2008-10#1)(2008-2#1)
with the generation of##6##4##(1990-11#1)(1994-3#1)(2008-10#1)(2010-7#1)(2011-2#1)(2012-1#1)
with the generation##7##3##(1990-11#1)(1993-12#1)(1994-3#1)(2008-10#1)(2010-7#1)(2011-2#1)(2012-1#1)
with the genes##3##3##(1990-5#1)(2006-8#1)(2008-9#1)
with the genetic##8##3##(1995-12#1)(1995-4#1)(1996-3#1)(1997-8#1)(2006-1#1)(2006-5#1)(2008-4#1)(2008-9#1)
with the genome##2##3##(1991-5#1)(2008-4#1)
with the genomic##6##3##(1990-12#1)(1991-4#1)(2008-12#1)(2008-5#1)(2008-7#1)(2013-1#1)
with the genus##2##3##(1997-4#1)(2008-10#1)
with the geographic##2##3##(2008-10#1)(2009-8#1)
with the given##2##3##(2008-10#1)(2008-3#1)
with the glass##4##3##(1995-3#1)(2008-10#1)(2008-11#1)(2010-4#1)
with the global##6##3##(1996-7#2)(2007-12#1)(2008-10#1)(2008-12#1)(2013-7#1)
with the glucocorticoid##3##3##(1991-6#2)(1997-7#1)
with the glucose##3##3##(2006-10#1)(2008-10#2)
with the glutamate##2##3##(1991-9#1)(1996-1#1)
with the glycolytic##2##3##(2008-7#1)(2012-2#1)
with the glycosidic##2##3##(1993-11#1)(1995-1#1)
with the goal of creating##2##5##(2008-7#1)(2012-2#1)
with the goal of determining##3##5##(1992-12#1)(2008-9#1)(2010-8#1)
with the goal of developing a##2##6##(2007-11#1)(2011-8#1)
with the goal of facilitating##3##5##(2007-6#1)(2008-7#1)(2012-12#1)
with the goal of preventing##2##5##(2006-10#1)(2008-10#1)
with the goal of producing##2##5##(2010-12#1)(2012-11#1)
with the goal of providing##2##5##(2008-4#1)(2012-1#1)
with the goal of supporting state and local customization##2##9##(2013-1#2)
with the goal of understanding##4##5##(1995-10#1)(2005-8#1)(2013-1#2)
with the goal of##47##4##(1991-4#1)(1992-12#1)(1994-1#1)(1995-10#1)(1995-8#1)(1996-2#1)(1997-1#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#1)(2007-1#1)(2007-11#2)(2007-6#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-8#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#4)(2013-7#1)
with the goal to##2##4##(2007-2#1)(2010-9#1)
with the goal##50##3##(1991-4#1)(1992-12#1)(1994-1#1)(1995-10#1)(1995-8#1)(1996-2#1)(1997-1#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#1)(2007-1#1)(2007-11#2)(2007-2#1)(2007-6#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#1)(2011-8#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
with the goals of##2##4##(1996-3#1)(2006-10#1)
with the goals##4##3##(1993-8#1)(1994-12#1)(1996-3#1)(2006-10#1)
with the gold##2##3##(2007-12#1)(2009-12#1)
with the government##2##3##(1993-3#1)(1994-9#1)
with the grade of##2##4##(2007-6#1)(2008-2#1)
with the gradient elution##2##4##(2011-1#1)(2012-12#1)
with the gradual##3##3##(2008-6#1)(2008-9#1)(2009-10#1)
with the grating##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
with the great##3##3##(1995-11#1)(2007-9#1)(2008-8#1)
with the greater##4##3##(2006-2#1)(2008-10#1)(2008-7#1)(2013-1#1)
with the greatest number of##2##5##(1990-12#1)(2008-6#1)
with the greatest potential##2##4##(1996-3#1)(2008-5#1)
with the greatest##29##3##(1990-12#1)(1991-9#1)(1992-2#1)(1993-9#1)(1995-10#1)(1996-3#1)(2004-2#1)(2005-7#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-7#1)(2012-12#1)
with the green##4##3##(2008-10#1)(2008-2#2)(2008-7#1)
with the ground state##2##4##(2009-9#1)(2012-2#1)
with the ground##3##3##(2009-9#1)(2012-1#1)(2012-2#1)
with the group of##3##4##(1994-4#1)(2011-2#1)(2012-12#1)
with the group treated with##2##5##(1995-12#1)(2008-5#1)
with the group##8##3##(1994-4#1)(1995-12#1)(2007-11#1)(2007-3#1)(2008-5#1)(2010-3#1)(2011-2#1)(2012-12#1)
with the grouping##2##3##(2012-12#1)(2013-1#1)
with the growing number of##2##5##(2007-11#1)(2007-8#1)
with the growing##6##3##(1995-2#1)(2005-10#1)(2005-11#1)(2007-11#1)(2007-8#1)(2013-8#1)
with the growth and##2##4##(2008-11#1)(2009-4#1)
with the growth of##4##4##(1997-3#1)(2007-12#1)(2007-7#1)(2008-10#1)
with the growth##13##3##(1995-12#1)(1995-2#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-9#1)(2009-4#1)(2010-4#1)(2010-7#1)
with the guanine##3##3##(1990-12#2)(1990-2#1)
with the guidance of##4##4##(2008-3#2)(2011-2#2)
with the guidelines##2##3##(2008-10#1)(2008-5#1)
with the habit of##2##4##(2006-8#1)(2007-8#1)
with the handling##2##3##(1994-6#1)(2004-9#1)
with the hands##3##3##(1995-5#1)(2010-5#1)(2013-7#1)
with the head held##2##4##(1992-7#1)(1993-3#1)
with the head##5##3##(1992-7#1)(1993-3#1)(2006-10#1)(2007-12#1)(2009-9#1)
with the health care system##2##5##(2006-8#1)(2007-2#1)
with the health care team##2##5##(1995-2#1)(2008-7#1)
with the health care##8##4##(1994-12#2)(1995-2#1)(1997-3#1)(2006-8#1)(2007-2#1)(2008-7#2)
with the health##15##3##(1990-12#1)(1994-12#2)(1995-2#1)(1995-9#2)(1997-3#2)(2006-2#1)(2006-8#1)(2007-2#1)(2008-7#3)(2013-7#1)
with the healthcare##2##3##(1992-6#1)(2011-2#1)
with the healthy##9##3##(1997-8#1)(2006-6#1)(2008-7#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-11#2)(2013-1#1)
with the heart##3##3##(1990-9#1)(2006-12#1)(2013-1#1)
with the heat##5##3##(1991-5#1)(1994-3#1)(2006-12#2)(2008-2#1)
with the heated##2##3##(2008-10#2)
with the heavy chains of##2##5##(1994-11#1)(1997-4#1)
with the heavy##4##3##(1994-11#1)(1997-4#1)(2008-4#1)(2013-8#1)
with the helical##2##3##(1993-11#1)(1996-4#1)
with the helix repeat##2##4##(1990-2#1)(1991-4#1)
with the help of a##17##5##(1990-9#1)(1991-7#1)(2006-6#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-5#1)(2009-5#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#1)
with the help of simple##2##5##(2006-10#1)(2008-7#1)
with the help of the##5##5##(1995-4#1)(2006-10#1)(2008-3#1)(2011-1#2)
with the help of##66##4##(1990-9#1)(1991-7#1)(1992-5#1)(1993-8#1)(1994-10#1)(1995-4#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-5#1)(2005-11#1)(2005-7#1)(2006-10#4)(2006-2#1)(2006-6#1)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-2#5)(2008-3#5)(2008-5#3)(2008-7#3)(2009-5#2)(2010-12#3)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#4)(2012-12#1)(2012-3#2)(2013-8#1)
with the heme##2##3##(1992-9#1)(1997-6#1)
with the hepatic##3##3##(1990-4#1)(1991-2#1)(2008-8#1)
with the hepatitis B virus (HBV)##3##6##(2009-11#2)(2012-3#1)
with the hepatitis B##4##4##(1991-6#1)(2009-11#2)(2012-3#1)
with the hepatitis##6##3##(1991-6#1)(1993-3#1)(2009-11#2)(2009-7#1)(2012-3#1)
with the herbicide##3##3##(2008-10#2)(2009-6#1)
with the herbicides##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
with the heterologous##4##3##(1990-12#1)(1990-8#1)(2008-10#2)
with the heterotrimeric G protein##2##5##(1996-5#2)
with the hierarchy##2##3##(2009-11#1)(2012-2#1)
with the high affinity of the##2##6##(1991-7#1)(2010-1#1)
with the high affinity##5##4##(1991-2#1)(1991-7#1)(1996-5#1)(1997-2#1)(2010-1#1)
with the high cost##2##4##(2004-9#1)(2008-2#1)
with the high initial##2##4##(1990-3#1)(2008-10#1)
with the high level of##2##5##(2008-10#2)
with the high performance liquid chromatography (HPLC)##3##7##(1995-7#1)(2008-10#1)(2011-1#1)
with the high throughput##2##4##(2008-4#1)(2008-5#1)
with the high##33##3##(1990-3#1)(1990-8#1)(1991-2#1)(1991-7#1)(1992-9#1)(1993-1#1)(1995-7#1)(1996-5#1)(1997-2#1)(2004-9#1)(2005-1#1)(2005-8#1)(2007-10#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#2)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
with the high-affinity##2##3##(1990-2#1)(1990-7#1)
with the high-level##2##3##(2008-8#1)(2010-7#1)
with the higher dose##4##4##(1995-9#1)(1996-1#1)(1997-4#1)(2007-11#1)
with the higher##20##3##(1992-5#1)(1993-12#1)(1994-2#1)(1995-7#1)(1995-9#1)(1996-1#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-7#1)(2008-8#1)(2010-2#2)(2011-2#1)(2012-2#1)
with the highest and##2##4##(2008-10#1)(2008-3#1)
with the highest being##2##4##(2006-11#1)(2008-12#1)
with the highest concentration##3##4##(1992-8#1)(2008-5#1)(2013-1#1)
with the highest concentrations##3##4##(1991-8#1)(1997-1#1)(2007-5#1)
with the highest disease##2##4##(2008-10#2)
with the highest expression##2##4##(2008-9#1)(2012-2#1)
with the highest frequency of##2##5##(1991-3#1)(2008-10#1)
with the highest frequency##4##4##(1991-3#1)(1995-5#1)(2008-10#1)(2008-12#1)
with the highest incidence in##2##5##(1994-9#1)(2011-2#1)
with the highest incidence##4##4##(1993-9#1)(1994-9#1)(2010-12#1)(2011-2#1)
with the highest levels in##2##5##(1997-4#1)(2008-8#1)
with the highest levels of##3##5##(1991-12#1)(1994-5#1)(2008-10#1)
with the highest levels##5##4##(1991-12#1)(1994-5#1)(1997-4#1)(2008-10#1)(2008-8#1)
with the highest mortality##2##4##(1992-5#1)(2008-4#1)
with the highest number of##2##5##(2010-4#1)(2011-2#1)
with the highest number##3##4##(2010-4#1)(2011-12#1)(2011-2#1)
with the highest possible##2##4##(2007-11#1)(2008-2#1)
with the highest prevalence##7##4##(1990-6#1)(2006-9#1)(2008-5#1)(2011-2#1)(2013-8#3)
with the highest rate of##2##5##(1997-8#1)(2006-2#1)
with the highest rate##3##4##(1997-8#1)(2006-2#1)(2012-2#1)
with the highest rates##3##4##(2005-8#1)(2006-10#1)(2006-2#1)
with the highest risk##4##4##(2006-8#1)(2007-2#1)(2008-4#1)(2010-5#1)
with the highest specific##2##4##(1992-6#1)(2008-10#1)
with the highest value##2##4##(2010-4#2)
with the highest values##4##4##(1994-12#1)(1994-2#1)(2008-10#1)(2013-1#1)
with the highest##113##3##(1990-11#1)(1990-12#1)(1990-5#2)(1990-6#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#2)(1993-9#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-8#2)(2005-8#1)(2006-10#1)(2006-11#1)(2006-2#3)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#3)(2008-8#1)(2008-9#2)(2010-1#1)(2010-12#1)(2010-4#4)(2010-5#1)(2011-1#1)(2011-12#2)(2011-2#4)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#4)
with the highly fluorescent##2##4##(1991-9#1)(1992-8#1)
with the highly selective##2##4##(1996-2#1)(2007-1#1)
with the highly##13##3##(1991-9#1)(1992-8#1)(1993-2#1)(1994-9#1)(1996-2#1)(2005-9#1)(2007-1#1)(2008-10#2)(2009-6#1)(2011-2#1)(2013-1#2)
with the hip joint##3##4##(2006-11#2)(2008-6#1)
with the hip##5##3##(2006-10#1)(2006-11#3)(2008-6#1)
with the hippocampal##2##3##(1993-9#1)(1994-11#1)
with the hippocampus##4##3##(1997-7#1)(2005-9#1)(2009-2#1)(2013-8#1)
with the histidine residue##2##4##(1994-11#2)
with the histidine##6##3##(1992-12#1)(1992-4#1)(1994-11#2)(2005-4#2)
with the histological grading##3##4##(2013-8#3)
with the histological##6##3##(2007-7#1)(2007-8#1)(2009-7#1)(2013-8#3)
with the histopathologic##2##3##(2005-8#1)(2010-3#1)
with the histopathological findings##3##4##(2008-5#1)(2011-2#1)(2012-2#1)
with the histopathological##5##3##(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
with the history of##6##4##(2006-6#1)(2007-5#1)(2007-7#2)(2009-2#1)(2013-1#1)
with the history##9##3##(2005-8#1)(2006-6#1)(2007-5#1)(2007-7#2)(2008-12#1)(2008-7#1)(2009-2#1)(2013-1#1)
with the hologram##2##3##(2007-12#1)(2008-2#1)
with the homocysteine##2##3##(2008-10#1)(2008-3#1)
with the homologous##12##3##(1990-4#1)(1992-4#1)(1992-8#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-9#1)(1996-9#1)(2008-10#3)(2008-5#1)
with the hope of##4##4##(2006-10#1)(2008-7#1)(2011-7#1)(2013-8#1)
with the hope that##4##4##(2007-7#1)(2008-5#1)(2010-2#1)(2013-8#1)
with the hope##9##3##(2006-10#1)(2007-7#1)(2008-5#1)(2008-7#2)(2010-2#1)(2011-7#1)(2013-8#2)
with the horizontal##2##3##(1990-7#1)(2004-11#1)
with the hormone##2##3##(1996-11#1)(2008-3#1)
with the hospital##5##3##(1991-11#1)(1996-2#1)(2007-4#1)(2011-3#1)(2012-3#1)
with the hospital's##2##3##(1993-1#1)(2007-4#1)
with the host and##5##4##(2006-10#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-1#1)
with the host of origin##2##5##(2008-10#2)
with the host##22##3##(1994-12#1)(1994-5#1)(1997-7#1)(2005-11#1)(2006-10#1)(2008-10#4)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-3#1)(2010-12#1)(2011-2#3)(2012-1#2)(2013-1#1)
with the hot##2##3##(1991-2#1)(2007-7#1)
with the hot-plate and the tail-flick test##2##7##(1993-5#2)
with the htrA gene product##2##5##(1991-4#2)
with the human TSH receptor cDNA##2##6##(1992-2#1)(1993-3#1)
with the human TSH receptor##3##5##(1992-2#1)(1993-3#1)(1996-5#1)
with the human and##4##4##(1991-6#1)(1993-2#1)(1996-12#2)
with the human enzyme##3##4##(1990-11#1)(1994-5#1)(1994-8#1)
with the human immunodeficiency virus (HIV)##3##6##(1991-2#1)(2005-10#1)(2007-11#1)
with the human immunodeficiency virus##12##5##(1990-6#1)(1991-2#1)(1992-2#1)(1993-6#2)(2005-10#1)(2006-10#2)(2007-11#1)(2007-7#2)(2012-1#1)
with the human immunodeficiency virus]##3##5##(1993-10#1)(1996-6#1)(1996-9#1)
with the human immunodeficiency##16##4##(1990-6#1)(1991-2#1)(1992-2#1)(1993-10#1)(1993-6#2)(1996-6#1)(1996-9#1)(2005-10#1)(2006-10#2)(2007-11#2)(2007-7#2)(2012-1#1)
with the human##58##3##(1990-11#2)(1990-6#1)(1991-1#1)(1991-2#1)(1991-6#2)(1991-7#1)(1992-1#1)(1992-11#1)(1992-2#3)(1992-8#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#3)(1993-8#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-8#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-4#2)(2005-10#1)(2006-10#2)(2007-11#2)(2007-7#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-4#1)(2010-5#1)(2011-2#1)(2012-1#3)
with the hybrid##3##3##(1997-7#1)(2008-3#1)(2010-5#1)
with the hydrogen##2##3##(2008-10#2)
with the hydrolysis of##2##4##(1990-3#1)(2008-8#1)
with the hydrophilic##5##3##(1997-4#1)(2005-11#3)(2006-10#1)
with the hydrophobic##11##3##(1990-5#1)(1990-8#1)(1991-12#1)(1992-12#1)(1993-3#1)(1994-12#1)(1995-5#1)(1997-6#1)(2005-11#2)(2008-3#1)
with the hypertensive##2##3##(2007-1#1)(2008-1#1)
with the hypotensive##2##3##(1991-5#1)(1992-9#1)
with the hypotheses##4##3##(1994-3#1)(2008-10#1)(2009-11#1)(2012-2#1)
with the hypothesis of##8##4##(1991-1#1)(2008-10#4)(2009-10#1)(2011-2#1)(2013-8#1)
with the hypothesis that a##3##5##(1990-5#1)(1992-11#1)(2008-8#1)
with the hypothesis that the##13##5##(1991-7#1)(1992-2#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-2#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-12#1)(2012-1#1)
with the hypothesis that##68##4##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1993-12#3)(1993-2#1)(1993-4#1)(1993-6#2)(1993-7#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-1#1)(1996-5#2)(1996-7#1)(1997-3#1)(2006-2#1)(2006-8#2)(2007-12#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#3)(2009-1#1)(2009-4#2)(2009-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
with the hypothesis##76##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1993-12#3)(1993-2#1)(1993-4#1)(1993-6#2)(1993-7#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-1#1)(1996-5#2)(1996-7#1)(1997-3#1)(2006-2#1)(2006-8#2)(2007-12#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#3)(2009-1#1)(2009-10#1)(2009-4#2)(2009-8#1)(2010-12#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
with the hypovirulent Pn117 and##2##5##(2008-10#2)
with the hypovirulent Pn117##3##4##(2008-10#3)
with the idea of##2##4##(2008-10#1)(2012-2#1)
with the idea that the##5##5##(1990-10#1)(1990-5#1)(1995-11#1)(2009-10#1)(2010-2#1)
with the idea that##13##4##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#1)(1991-9#2)(1995-11#1)(1995-3#1)(1997-4#1)(2008-10#1)(2009-10#1)(2009-11#1)(2010-2#1)
with the idea##15##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#1)(1991-9#2)(1995-11#1)(1995-3#1)(1997-4#1)(2008-10#2)(2009-10#1)(2009-11#1)(2010-2#1)(2012-2#1)
with the identical##3##3##(1992-8#1)(2008-11#1)(2008-7#1)
with the identification of the##3##5##(2006-5#1)(2007-12#1)(2013-7#1)
with the identification of##16##4##(1992-9#1)(1993-12#1)(1996-10#1)(2006-5#1)(2007-12#1)(2008-10#3)(2008-5#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-12#3)(2013-7#1)
with the identification##17##3##(1992-9#1)(1993-12#1)(1996-10#1)(2006-5#1)(2007-12#1)(2008-10#3)(2008-5#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-12#3)(2013-7#1)(2013-8#1)
with the image##2##3##(2007-11#1)(2010-12#1)
with the iminoether ligands##2##4##(2008-5#2)
with the immobilized##4##3##(1996-3#1)(2007-8#1)(2008-10#2)
with the immune response##2##4##(2007-7#1)(2013-1#1)
with the immune system##6##4##(1993-3#1)(2007-11#2)(2008-7#1)(2010-12#2)
with the immune##8##3##(1993-3#1)(2007-11#2)(2007-7#1)(2008-7#1)(2010-12#2)(2013-1#1)
with the immunohistochemical##2##3##(1996-5#1)(1997-6#1)
with the immunosuppressive##2##3##(1990-12#1)(2008-10#1)
with the impact of##5##4##(1997-2#1)(2006-10#1)(2006-11#1)(2007-8#1)(2010-2#1)
with the impact##7##3##(1997-2#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-8#1)(2008-12#1)(2010-2#1)
with the implant were##2##4##(2008-9#1)(2011-1#1)
with the implant##3##3##(2004-9#1)(2008-9#1)(2011-1#1)
with the implementation of##9##4##(1995-12#1)(1996-1#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-6#1)(2010-2#1)
with the implied##2##3##(1990-7#1)(2008-11#1)
with the importance of##3##4##(2008-8#1)(2009-8#1)(2011-1#1)
with the importance##4##3##(1995-1#1)(2008-8#1)(2009-8#1)(2011-1#1)
with the important##2##3##(2012-2#1)(2012-3#1)
with the improved Ronchi test##2##5##(2008-3#2)
with the improved##4##3##(2008-3#4)
with the improvement in##2##4##(2007-10#1)(2013-1#1)
with the improvement of the##2##5##(1991-6#1)(2007-2#1)
with the improvement of##5##4##(1991-6#1)(2007-2#1)(2007-6#1)(2013-8#2)
with the improvement##7##3##(1991-6#1)(2007-10#1)(2007-2#1)(2007-6#1)(2013-1#1)(2013-8#2)
with the in vitro##11##4##(1991-2#1)(1991-5#1)(1993-8#1)(1995-7#2)(1997-5#1)(2008-5#1)(2009-6#1)(2010-2#1)(2010-5#1)(2012-1#1)
with the in vivo data##2##5##(1993-3#1)(1995-5#1)
with the in vivo##8##4##(1993-12#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(2010-8#1)
with the in##22##3##(1990-2#1)(1991-2#1)(1991-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-5#1)(1995-7#2)(1995-8#1)(1996-12#1)(1997-5#1)(2008-10#1)(2008-5#1)(2009-6#1)(2010-2#1)(2010-5#1)(2010-8#1)(2012-1#1)(2012-3#1)
with the in-vivo##2##3##(1997-3#1)(2008-3#1)
with the inability to##2##4##(1993-6#1)(2009-7#1)
with the inability##3##3##(1993-6#1)(2009-7#1)(2012-12#1)
with the inactivation##2##3##(1995-2#1)(2012-2#1)
with the inactive##3##3##(1991-9#1)(1994-11#1)(2013-8#1)
with the incidence and##3##4##(2005-7#1)(2007-8#1)(2012-2#1)
with the incidence of##15##4##(1990-5#1)(1993-12#1)(1993-8#1)(2006-4#1)(2007-4#1)(2008-10#2)(2008-5#2)(2008-8#1)(2009-3#1)(2009-8#1)(2010-5#1)(2012-1#1)(2013-1#1)
with the incidence##22##3##(1990-2#1)(1990-5#1)(1993-12#1)(1993-8#1)(2005-7#1)(2006-4#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-5#2)(2008-8#1)(2009-3#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
with the inclusion of the##2##5##(1990-11#1)(2012-12#1)
with the inclusion of##7##4##(1990-11#1)(1990-8#1)(2005-11#1)(2007-9#1)(2008-10#2)(2012-12#1)
with the inclusion##9##3##(1990-11#1)(1990-8#1)(2005-11#1)(2007-9#1)(2008-10#3)(2012-12#1)(2013-1#1)
with the incoherent##2##3##(2008-3#2)
with the incorporation of##5##4##(1992-1#1)(1992-6#1)(1996-3#1)(1997-4#1)(2008-4#1)
with the increase in pH##2##5##(2005-11#2)
with the increase in the##9##5##(1991-5#1)(1994-11#1)(1996-1#1)(2005-11#1)(2007-11#1)(2008-11#1)(2010-1#1)(2012-2#1)(2013-8#1)
with the increase in##34##4##(1990-12#1)(1990-4#1)(1991-5#1)(1993-3#1)(1994-11#1)(1994-9#2)(1995-8#1)(1996-1#1)(1997-5#1)(2005-11#4)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#4)(2008-5#1)(2009-11#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#5)
with the increase of age##2##5##(2011-1#1)(2012-2#1)
with the increase of blood##2##5##(2006-3#1)(2007-11#1)
with the increase of the##8##5##(2007-2#1)(2008-10#4)(2008-3#1)(2010-4#1)(2011-3#1)
with the increase of workload##2##5##(2011-2#2)
with the increase of##36##4##(1990-4#1)(1992-6#1)(1993-8#1)(1995-12#1)(2005-11#2)(2006-3#1)(2007-11#1)(2007-2#2)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-7#2)(2010-4#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-2#2)
with the increase##72##3##(1990-12#1)(1990-4#2)(1991-5#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-9#2)(1995-12#1)(1995-8#1)(1996-1#1)(1997-5#1)(1997-8#1)(2005-11#6)(2006-10#1)(2006-3#1)(2007-11#2)(2007-2#2)(2008-10#8)(2008-11#5)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#5)
with the increased number of##2##5##(2007-10#1)(2007-7#1)
with the increased production of##3##5##(1994-11#1)(1996-6#1)(2012-2#1)
with the increased##21##3##(1991-4#1)(1993-11#1)(1993-4#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-5#2)(1996-6#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-6#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-2#2)
with the increases in the##2##5##(1997-2#1)(2008-5#1)
with the increasing amount of##3##5##(2007-6#1)(2008-10#1)(2013-8#1)
with the increasing length of##2##5##(1992-6#1)(2007-8#1)
with the increasing number of##2##5##(1993-2#1)(2008-10#1)
with the increasing use of##2##5##(1990-12#1)(2008-7#1)
with the increasing use##3##4##(1990-12#1)(2008-7#1)(2010-12#1)
with the increasing##31##3##(1990-12#1)(1991-3#1)(1992-5#1)(1992-6#2)(1993-2#1)(1994-8#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#2)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#4)(2009-3#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#2)
with the increment##2##3##(1996-2#1)(2013-8#1)
with the incubation time##2##4##(1996-11#1)(2008-9#1)
with the incubation##3##3##(1996-11#1)(2008-10#1)(2008-9#1)
with the independently##4##3##(1990-7#1)(1997-2#1)(2006-5#1)(2008-10#1)
with the index of##2##4##(2008-10#2)
with the index##3##3##(2008-10#2)(2008-3#1)
with the indications for##2##4##(2008-7#1)(2012-12#1)
with the individual##5##3##(1990-5#1)(1993-12#1)(2008-10#1)(2008-2#1)(2009-8#1)
with the individual's##2##3##(1993-7#1)(2007-6#1)
with the induced##2##3##(2007-12#1)(2008-4#1)
with the inducer##2##3##(1996-8#1)(1997-7#1)
with the induction and##2##4##(1991-12#1)(2006-10#1)
with the induction of##16##4##(1990-5#1)(1991-3#1)(1992-8#1)(1993-11#1)(1993-4#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-8#1)(2004-11#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-8#1)
with the induction##19##3##(1990-5#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-8#1)(1993-11#1)(1993-4#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-8#1)(2004-11#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-8#1)
with the inevitable##2##3##(1993-12#1)(2007-4#1)
with the infection##2##3##(2006-8#1)(2007-8#1)
with the inflammatory##2##3##(1993-3#1)(2007-10#1)
with the influence##6##3##(1993-12#1)(1994-3#2)(2008-10#1)(2008-8#1)(2009-11#1)
with the influenza##3##3##(1995-5#1)(2009-4#1)(2010-5#1)
with the influx of##2##4##(1990-8#1)(1996-5#1)
with the information##11##3##(1993-12#1)(1995-9#1)(2005-5#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)(2009-8#1)(2010-5#1)(2011-2#1)
with the inherent##2##3##(2004-9#1)(2008-2#1)
with the inheritance of##2##4##(2008-12#1)(2013-1#1)
with the inhibition of##7##4##(1991-2#1)(1992-3#1)(1995-8#1)(1996-5#1)(2008-11#1)(2008-5#1)(2013-1#1)
with the inhibition##9##3##(1991-2#1)(1992-3#1)(1995-8#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-5#2)(2013-1#1)
with the inhibitor##10##3##(1990-12#1)(1992-2#1)(1992-6#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-2#1)(1997-7#1)(2008-4#1)(2010-10#1)
with the inhibitory##6##3##(1990-4#1)(1995-1#1)(1995-6#1)(1996-2#1)(2008-5#1)(2012-3#1)
with the initial##9##3##(1996-12#1)(2007-10#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-3#1)(2012-12#1)
with the initiation of##3##4##(2006-10#1)(2008-7#1)(2010-8#1)
with the initiation##5##3##(2006-10#1)(2007-10#1)(2008-7#2)(2010-8#1)
with the injected##2##3##(1991-9#1)(2010-1#1)
with the injury##4##3##(2006-3#1)(2007-7#1)(2007-8#1)(2011-2#1)
with the inner##6##3##(1990-5#1)(1997-4#1)(1997-6#1)(2005-8#1)(2008-10#2)
with the inorganic##3##3##(1990-5#1)(2008-10#1)(2010-4#1)
with the input##4##3##(1995-2#1)(2007-12#1)(2008-3#1)(2009-10#1)
with the insignificant biases##2##4##(2008-10#2)
with the instrument function##2##4##(2008-3#2)
with the instrument##3##3##(1992-6#1)(2008-3#2)
with the insulin receptor##5##4##(1990-8#2)(1994-12#1)(1995-6#1)(1996-5#1)
with the insulin##8##3##(1990-8#2)(1991-12#1)(1994-12#2)(1995-6#1)(1996-5#1)(2010-11#1)
with the intact##2##3##(1995-3#1)(1996-9#1)
with the intake of##4##4##(1991-2#1)(1991-5#3)
with the integrated##2##3##(2008-10#1)(2012-3#1)
with the intensity of##7##4##(1992-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-4#1)(2008-5#1)(2010-3#1)
with the intensity##8##3##(1992-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-3#1)
with the intent of##7##4##(1994-1#1)(1994-3#1)(1996-12#1)(2008-12#1)(2008-8#1)(2010-5#1)(2012-12#1)
with the intent to##4##4##(1993-2#1)(2006-10#1)(2009-2#1)(2010-9#1)
with the intent##11##3##(1993-2#1)(1994-1#1)(1994-3#1)(1996-12#1)(2006-10#1)(2008-12#1)(2008-8#1)(2009-2#1)(2010-5#1)(2010-9#1)(2012-12#1)
with the intention of##7##4##(1995-11#1)(1995-3#2)(2011-1#1)(2012-2#1)(2013-1#2)
with the intention to##3##4##(2006-8#1)(2011-1#1)(2013-8#1)
with the intention##10##3##(1995-11#1)(1995-3#2)(2006-8#1)(2011-1#2)(2012-2#1)(2013-1#2)(2013-8#1)
with the interaction between##4##4##(1993-8#1)(2006-6#1)(2008-11#1)(2008-2#1)
with the interaction of##2##4##(1996-7#1)(2008-2#1)
with the interaction##7##3##(1993-8#1)(1996-7#1)(2006-6#1)(2008-11#1)(2008-2#2)(2008-9#1)
with the interactions##2##3##(1993-1#1)(2008-9#1)
with the interactive##2##3##(1992-2#1)(2011-2#1)
with the interests of##2##4##(2010-2#1)(2012-12#1)
with the interface##2##3##(2011-1#1)(2012-12#1)
with the intermediate##3##3##(1992-11#1)(2007-11#1)(2012-11#1)
with the internal guide sequence##2##5##(1991-2#2)
with the internal standard##2##4##(1997-8#1)(2004-12#1)
with the internal##8##3##(1991-2#2)(1997-8#1)(2004-12#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-3#1)
with the international##2##3##(2008-1#1)(2008-7#1)
with the intracellular##4##3##(1992-6#1)(1994-3#1)(1996-12#1)(1997-8#1)
with the intramuscular##2##3##(1992-11#1)(1997-4#1)
with the intravenous injection of##2##5##(1992-3#2)
with the introduction of the##2##5##(2006-10#1)(2008-1#1)
with the introduction of##18##4##(1990-12#1)(1993-1#1)(1993-2#1)(1996-9#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-9#1)(2011-12#1)
with the introduction##19##3##(1990-12#1)(1993-1#1)(1993-2#1)(1996-9#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-9#1)(2011-12#1)(2012-2#1)
with the inverse##2##3##(1990-11#1)(2008-10#1)
with the investigation of##2##4##(2008-11#1)(2010-2#1)
with the involvement of##12##4##(1993-11#1)(1994-3#1)(1995-11#1)(1995-3#1)(1996-9#2)(2006-3#1)(2008-10#1)(2008-8#1)(2009-4#1)(2009-6#1)(2011-2#1)
with the involvement##13##3##(1993-11#1)(1994-3#1)(1995-11#1)(1995-3#1)(1996-9#2)(2006-3#1)(2008-10#2)(2008-8#1)(2009-4#1)(2009-6#1)(2011-2#1)
with the ion pair of 2-(5-bromo-2-pyridylazo)-5-diethylaminophenol and##2##7##(2008-10#2)
with the ion pair of##4##5##(2008-10#4)
with the ion##6##3##(2008-10#5)(2009-11#1)
with the iron##2##3##(1997-7#1)(2007-3#1)
with the irradiation##2##3##(2008-10#2)
with the isolated##4##3##(1990-10#1)(1990-5#1)(1995-2#1)(1997-7#1)
with the isotropic##2##3##(2008-3#1)(2009-11#1)
with the issue of the##2##5##(2007-11#1)(2008-12#1)
with the issue of##7##4##(1995-12#1)(2006-4#1)(2007-11#1)(2008-11#1)(2008-12#2)(2011-2#1)
with the issue##9##3##(1995-12#1)(2006-4#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2011-2#1)
with the iterative##2##3##(2008-10#1)(2008-2#1)
with the job##2##3##(1991-2#1)(1996-1#1)
with the judiciary##2##3##(2011-2#2)
with the jury##2##3##(1995-6#2)
with the kainate##2##3##(1995-11#1)(1995-5#1)
with the karyosome##2##3##(2007-12#1)(2008-7#1)
with the key##3##3##(2010-12#1)(2012-12#1)(2013-1#1)
with the kinase##2##3##(1996-5#1)(1997-4#1)
with the kinetic##5##3##(1992-1#1)(1992-3#1)(1997-4#1)(2006-12#1)(2008-5#1)
with the kinetically##2##3##(1990-8#1)(1997-2#1)
with the knee flexed##2##4##(2007-4#1)(2007-8#1)
with the knee##4##3##(2007-4#1)(2007-8#1)(2011-2#2)
with the knowledge and##3##4##(2005-10#1)(2008-1#1)(2008-10#1)
with the knowledge of##4##4##(2007-7#2)(2008-9#1)(2012-2#1)
with the knowledge##10##3##(2005-10#1)(2006-12#1)(2006-8#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-9#1)(2010-12#1)(2012-2#1)
with the known amino##2##4##(1990-3#1)(1991-2#1)
with the known compound##2##4##(2007-1#1)(2007-11#1)
with the known preference of##2##5##(1991-4#1)(1997-7#1)
with the known role of##2##5##(1991-5#1)(2007-12#1)
with the known##49##3##(1990-2#1)(1990-3#3)(1990-4#1)(1990-7#1)(1990-9#1)(1991-2#3)(1991-4#1)(1991-5#1)(1991-9#1)(1992-11#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-4#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-12#2)(2007-1#4)(2007-11#2)(2007-12#2)(2008-11#1)(2008-2#2)(2008-5#1)(2008-8#1)(2009-10#2)(2011-1#1)(2012-12#1)
with the label values##2##4##(2008-10#2)
with the labeled##2##3##(1992-7#1)(2008-4#1)
with the labelling of a##2##5##(1990-7#1)(1996-3#1)
with the lack of a##2##5##(1990-2#1)(1995-3#1)
with the lack of##12##4##(1990-2#1)(1991-2#1)(1992-3#1)(1992-5#3)(1993-12#1)(1995-3#1)(2006-4#1)(2008-10#1)(2008-7#1)(2008-9#1)
with the lag##2##3##(1992-11#1)(2008-11#1)
with the lamellar##3##3##(2006-10#2)(2008-5#1)
with the laparoscopic##3##3##(1995-3#1)(2006-6#1)(2013-1#1)
with the large Klenow fragment of Escherichia coli DNA polymerase I##2##11##(1993-3#2)
with the large subunit##2##4##(1993-8#1)(1995-12#1)
with the large##15##3##(1991-2#1)(1993-3#2)(1993-8#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-8#1)(1997-7#1)(2004-12#1)(2005-8#1)(2007-12#1)(2008-1#1)(2011-2#1)(2013-1#1)
with the larger of##2##4##(1990-3#1)(1994-12#1)
with the larger##9##3##(1990-3#1)(1991-6#1)(1994-12#1)(2008-10#1)(2008-2#1)(2009-10#1)(2010-11#1)(2010-2#1)(2010-5#1)
with the largest about##2##4##(1991-2#1)(2008-7#1)
with the largest##19##3##(1991-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-6#1)(1995-11#1)(1995-8#1)(1997-2#1)(2004-9#1)(2007-1#1)(2007-11#1)(2008-4#2)(2008-7#1)(2008-9#1)(2011-1#1)(2012-3#2)(2013-1#1)
with the laser beam##2##4##(2008-2#1)(2008-3#1)
with the laser##9##3##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#4)
with the last##2##3##(1996-5#1)(2008-2#1)
with the late##4##3##(1990-4#1)(1990-7#1)(1995-1#1)(2011-2#1)
with the latest research##2##4##(2008-11#1)(2008-2#1)
with the latest##5##3##(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#1)
with the latter being##5##4##(1990-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-4#1)
with the latter two##2##4##(1994-12#1)(2007-8#1)
with the latter##24##3##(1990-9#1)(1991-4#1)(1991-7#1)(1994-12#1)(1994-9#1)(1995-8#1)(2006-8#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-7#2)(2008-8#2)(2009-4#1)(2009-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
with the law##3##3##(2008-11#1)(2008-8#1)(2008-9#1)
with the lead##2##3##(2005-8#1)(2008-10#1)
with the leaf##4##3##(2004-4#1)(2006-12#1)(2008-10#2)
with the learning##2##3##(1993-12#1)(2008-11#1)
with the least##11##3##(1993-2#1)(2005-11#1)(2006-6#1)(2006-9#1)(2007-6#1)(2008-10#3)(2008-5#1)(2010-2#1)(2010-5#1)
with the lectin##3##3##(1992-9#1)(2005-11#1)(2008-4#1)
with the left##4##3##(1994-2#1)(2007-8#2)(2010-2#1)
with the length of the##4##5##(1991-5#1)(1994-9#1)(1995-5#1)(2008-3#1)
with the length of##10##4##(1991-5#1)(1994-9#1)(1995-5#1)(2006-1#1)(2006-4#1)(2007-9#1)(2008-3#1)(2012-12#2)(2013-1#1)
with the length##11##3##(1991-5#1)(1993-3#1)(1994-9#1)(1995-5#1)(2006-1#1)(2006-4#1)(2007-9#1)(2008-3#1)(2012-12#2)(2013-1#1)
with the less##2##3##(1996-2#1)(2008-5#1)
with the level of injury##2##5##(2006-11#1)(2007-8#1)
with the level of the##2##5##(1997-2#1)(2010-5#1)
with the level of##24##4##(1992-2#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-8#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-5#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#2)
with the level##25##3##(1992-2#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-8#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-5#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#2)
with the levels in##2##4##(1995-1#1)(1995-7#1)
with the levels of##2##4##(1995-10#1)(2007-1#1)
with the levels##5##3##(1993-7#1)(1995-1#1)(1995-10#1)(1995-7#1)(2007-1#1)
with the ligand##6##3##(1992-3#1)(1994-12#1)(1997-2#1)(2008-10#2)(2008-8#1)
with the light and##2##4##(1995-12#1)(2008-7#1)
with the light##8##3##(1995-12#1)(2007-12#1)(2008-2#3)(2008-3#1)(2008-7#1)(2012-3#1)
with the limbic##2##3##(1997-2#1)(2009-2#1)
with the limit of##4##4##(2008-10#4)
with the limitation of##2##4##(2008-10#2)
with the limited##7##3##(1992-3#1)(1994-12#1)(1997-7#1)(2008-2#1)(2008-8#1)(2009-6#1)(2009-8#1)
with the limits of##2##4##(2007-10#1)(2008-3#1)
with the linear range##3##4##(2008-10#3)
with the linear##6##3##(2007-12#1)(2008-10#3)(2009-2#1)(2013-1#1)
with the lipase##3##3##(1995-5#1)(2006-8#1)(2008-10#1)
with the lipid bilayers of##2##5##(1994-8#1)(2008-5#1)
with the lipid##11##3##(1990-2#1)(1992-7#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-8#1)(1996-7#1)(2008-10#1)(2008-5#1)
with the lipids of##2##4##(1991-8#1)(1996-1#1)
with the liposomal vaccine than with a subunit vaccine for##2##10##(2007-11#2)
with the liquid##2##3##(2008-10#1)(2010-4#1)
with the literature and##2##4##(2006-2#1)(2009-10#1)
with the literature data on##2##5##(1991-2#1)(2008-10#1)
with the literature data##3##4##(1991-2#1)(2008-10#1)(2010-4#1)
with the literature##14##3##(1990-2#1)(1990-3#1)(1991-2#1)(1993-3#1)(2006-2#1)(2008-10#4)(2009-10#1)(2010-4#1)(2012-2#2)(2012-3#1)
with the lithium solution##2##4##(1991-8#2)
with the lithium##3##3##(1991-8#2)(2008-10#1)
with the liver and##2##4##(2006-10#1)(2008-1#1)
with the liver disease phenotype##2##5##(1996-5#2)
with the liver##6##3##(1996-5#2)(2006-10#1)(2008-1#1)(2008-10#1)(2009-8#1)
with the local##12##3##(1990-10#1)(1990-2#2)(1992-5#1)(2006-9#1)(2007-12#1)(2008-11#1)(2008-3#2)(2009-5#1)(2010-8#1)(2011-2#1)
with the localized##3##3##(1993-10#1)(2007-12#2)
with the location of the##2##5##(1990-9#1)(2008-11#1)
with the location of##9##4##(1990-9#1)(1992-8#1)(1993-9#1)(1996-7#1)(2005-12#1)(2007-12#1)(2008-11#1)(2013-1#2)
with the location##10##3##(1990-9#1)(1992-8#1)(1993-9#1)(1996-7#1)(2005-12#1)(2007-12#1)(2008-11#1)(2012-2#1)(2013-1#2)
with the logarithm of the##2##5##(2006-5#1)(2008-10#1)
with the logarithm of##3##4##(2006-5#1)(2008-10#2)
with the long##5##3##(1990-5#1)(1993-6#1)(2007-11#1)(2011-2#1)(2013-8#1)
with the long-term##2##3##(2007-8#1)(2009-5#1)
with the longest##5##3##(1990-8#1)(1993-4#1)(2008-2#1)(2008-9#1)(2011-2#1)
with the longitudinal##2##3##(2007-11#1)(2008-7#1)
with the loss of the##2##5##(1994-8#1)(1995-5#1)
with the loss of##15##4##(1990-11#2)(1990-12#1)(1992-8#1)(1994-8#2)(1995-1#1)(1995-2#1)(1995-5#1)(2007-9#1)(2008-11#1)(2008-5#1)(2009-8#1)(2010-7#1)(2011-3#1)
with the low##12##3##(1990-8#1)(1991-5#1)(1991-7#1)(1995-1#1)(1995-5#1)(1996-12#2)(1996-7#1)(2007-12#1)(2007-3#1)(2008-9#1)(2011-2#1)
with the lower##7##3##(1991-4#1)(1992-9#1)(1995-3#1)(1997-1#1)(2006-10#1)(2007-10#1)(2007-4#1)
with the lowest friction##2##4##(1997-3#2)
with the lowest incidence##2##4##(2008-10#2)
with the lowest infection##2##4##(2008-10#2)
with the lowest mean##4##4##(1995-12#1)(2008-10#1)(2008-4#1)(2012-12#1)
with the lowest values##2##4##(2010-4#1)(2013-1#1)
with the lowest##46##3##(1991-5#1)(1993-12#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-3#2)(2006-10#1)(2006-2#1)(2007-1#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2009-9#1)(2010-4#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
with the lung##2##3##(1992-12#1)(2010-7#1)
with the lysosomal##2##3##(1990-11#1)(1991-6#1)
with the mRNA##3##3##(1990-7#1)(1994-12#1)(2008-8#1)
with the magnetic##4##3##(2008-10#3)(2008-6#1)
with the magnitude of the##2##5##(1996-6#1)(2008-3#1)
with the magnitude of##4##4##(1996-3#1)(1996-6#1)(1997-2#1)(2008-3#1)
with the magnitude##5##3##(1996-3#1)(1996-6#1)(1997-2#1)(2008-3#1)(2009-10#1)
with the main aim of##2##5##(1992-10#1)(2008-8#1)
with the main aim##3##4##(1992-10#1)(2008-8#1)(2013-8#1)
with the main emphasis on##2##5##(2008-8#2)
with the main focus on the##2##6##(2005-9#1)(2012-11#1)
with the main focus on##3##5##(2005-9#1)(2009-5#1)(2012-11#1)
with the main##23##3##(1990-7#1)(1992-10#1)(1993-11#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-8#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#3)(2009-5#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-11#1)(2013-8#1)
with the major##13##3##(1991-2#1)(1991-8#1)(1992-7#1)(1993-2#1)(1993-8#1)(1994-6#1)(1996-11#1)(2008-1#1)(2008-10#3)(2010-7#1)(2013-1#1)
with the majority in##3##4##(2005-11#1)(2007-11#1)(2009-4#1)
with the majority of patients##2##5##(2006-11#1)(2007-11#1)
with the majority of##15##4##(1991-7#1)(1993-8#1)(1994-6#1)(2006-11#1)(2007-11#2)(2008-10#5)(2011-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
with the majority##20##3##(1991-7#1)(1993-8#1)(1994-6#1)(2005-11#1)(2006-11#1)(2007-11#3)(2008-10#5)(2008-9#1)(2009-4#1)(2010-2#1)(2011-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
with the malarial parasite Plasmodium falciparum##2##6##(1997-1#1)(2008-1#1)
with the mammalian##6##3##(1990-12#1)(1990-2#1)(1993-12#1)(1993-3#1)(1995-11#1)(1997-3#1)
with the management of##6##4##(1993-5#1)(2006-12#1)(2008-3#1)(2008-9#1)(2010-9#1)(2012-3#1)
with the management##7##3##(1993-5#1)(2006-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-9#1)(2012-3#1)
with the manifestation of##2##4##(2008-11#1)(2011-2#1)
with the manifold##2##3##(1992-2#1)(1993-12#1)
with the manual##3##3##(2008-10#2)(2012-12#1)
with the manufacturer's##2##3##(2005-10#1)(2008-10#1)
with the many##2##3##(2006-9#1)(2010-3#1)
with the marker##4##3##(1995-11#1)(1996-5#2)(2009-2#1)
with the materials##3##3##(1996-2#1)(2008-10#1)(2008-5#1)
with the matrix##3##3##(2008-3#1)(2011-2#1)(2013-1#1)
with the mature##2##3##(1993-5#1)(2008-4#1)
with the maximal##6##3##(1990-7#1)(1997-2#2)(1997-7#1)(2005-1#1)(2006-11#1)
with the maximum at##3##4##(2006-10#1)(2008-10#1)(2013-8#1)
with the maximum scattering##2##4##(2007-12#1)(2008-10#1)
with the maximum temperature as##2##5##(2011-1#2)
with the maximum temperature of##2##5##(2011-1#2)
with the maximum temperature##4##4##(2011-1#4)
with the maximum##33##3##(1991-2#1)(1993-9#1)(2004-9#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-10#8)(2008-3#1)(2009-5#1)(2011-1#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
with the mean age of 26##2##6##(2007-4#1)(2007-9#1)
with the mean age of##4##5##(2007-4#1)(2007-9#1)(2008-7#1)(2012-2#1)
with the mean disease##3##4##(2008-10#1)(2008-4#1)(2012-2#1)
with the mean of##2##4##(1994-3#1)(2008-10#1)
with the mean##16##3##(1994-3#1)(2005-4#2)(2007-4#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-1#1)(2012-2#2)(2012-3#1)
with the measured values##3##4##(1994-11#1)(2008-2#1)(2008-3#1)
with the measured##16##3##(1994-11#1)(1996-12#1)(2005-11#1)(2007-12#2)(2008-2#4)(2008-3#6)(2012-2#1)
with the measurement of##4##4##(1990-2#1)(1997-6#1)(2007-8#1)(2008-3#1)
with the measurement##6##3##(1990-2#1)(1997-6#1)(2007-8#1)(2008-3#1)(2010-4#1)(2011-12#1)
with the measurements##7##3##(1990-4#1)(2005-11#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-5#1)
with the measures of##4##4##(2006-4#1)(2008-10#1)(2013-1#2)
with the mechanism of action of##2##6##(1990-11#1)(2007-11#1)
with the mechanism of##3##4##(1990-11#1)(2005-11#1)(2007-11#1)
with the medical##7##3##(1991-12#1)(1991-9#1)(1993-12#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-7#1)
with the medium##4##3##(2008-10#1)(2008-11#2)(2008-3#1)
with the melanoma##3##3##(1995-8#2)(2011-2#1)
with the membrane and##2##4##(1990-11#1)(2008-10#1)
with the membrane fraction##2##4##(1992-6#1)(1995-5#1)
with the membrane in##2##4##(1994-6#1)(2005-11#1)
with the membrane##20##3##(1990-11#1)(1990-3#1)(1991-5#1)(1991-7#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-3#1)(1995-5#1)(1997-4#1)(2005-11#3)(2008-10#3)(2009-3#1)(2009-9#1)
with the membrane-bound##3##3##(1990-5#1)(1997-4#2)
with the membranes##9##3##(1990-3#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-9#1)(1993-9#1)(1995-6#1)(1996-8#1)
with the mental health##2##4##(1997-3#1)(2008-12#1)
with the mental##3##3##(1997-3#1)(2008-12#1)(2012-3#1)
with the metabolic syndrome and##4##5##(2008-3#1)(2008-5#1)(2010-4#2)
with the metabolic syndrome##22##4##(2006-6#1)(2008-1#4)(2008-3#6)(2008-5#1)(2008-7#2)(2010-4#3)(2011-2#4)(2012-2#1)
with the metabolism of##2##4##(1990-11#1)(1993-2#1)
with the metacestode##2##3##(2005-12#1)(2012-2#1)
with the metal ion##2##4##(2008-5#1)(2010-5#1)
with the metal ions##4##4##(2008-10#1)(2008-3#1)(2008-5#2)
with the metal##9##3##(2008-10#3)(2008-3#1)(2008-5#4)(2010-5#1)
with the metastatic potential of##3##5##(1992-9#1)(1994-6#1)(2012-2#1)
with the metastatic potential##4##4##(1992-9#1)(1994-6#1)(1995-1#1)(2012-2#1)
with the metastatic##5##3##(1992-9#1)(1994-5#1)(1994-6#1)(1995-1#1)(2012-2#1)
with the method of##8##4##(1990-11#1)(1996-12#1)(2008-2#1)(2008-3#1)(2010-12#1)(2011-3#1)(2013-8#2)
with the method##14##3##(1990-11#1)(1996-12#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2010-12#1)(2011-3#1)(2013-8#2)
with the methods for##2##4##(2007-5#1)(2013-1#1)
with the methods##5##3##(1991-3#1)(2007-11#1)(2007-5#1)(2012-12#1)(2013-1#1)
with the methyl##2##3##(1990-7#1)(1991-5#1)
with the microbial##2##3##(1994-12#1)(2011-1#1)
with the microscope##2##3##(2006-5#1)(2008-2#1)
with the microscopic##3##3##(2008-10#2)(2008-3#1)
with the migratory##2##3##(2008-2#1)(2008-6#1)
with the mild form##2##4##(2006-6#1)(2008-4#1)
with the mild##3##3##(1991-11#1)(2006-6#1)(2008-4#1)
with the minimal##5##3##(1993-12#1)(1995-1#1)(1995-4#1)(2011-2#1)(2012-2#1)
with the minimum of##2##4##(2007-8#1)(2008-10#1)
with the minimum temperature##2##4##(2008-10#1)(2008-8#1)
with the minimum##15##3##(1996-1#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-2#1)(2013-8#1)
with the minor groove##2##4##(1996-2#1)(1996-8#1)
with the minor##4##3##(1996-2#1)(1996-8#1)(2007-8#1)(2011-2#1)
with the mitochondrial membrane##3##4##(1991-5#1)(2008-9#1)(2010-2#1)
with the mitochondrial##9##3##(1991-5#1)(1995-2#1)(1995-3#1)(1996-6#1)(1996-9#1)(1997-6#1)(2008-9#1)(2010-2#1)(2010-4#1)
with the mitotic##3##3##(2006-5#1)(2009-3#1)(2011-2#1)
with the mixed##6##3##(1990-4#1)(2005-11#1)(2007-1#1)(2007-5#1)(2008-10#1)(2009-6#1)
with the mixing##2##3##(2005-11#1)(2005-4#1)
with the mixture of##4##4##(1990-3#1)(2008-10#2)(2012-3#1)
with the mixture##6##3##(1990-3#1)(2007-5#1)(2008-10#3)(2012-3#1)
with the mobile phase for##2##5##(1990-8#2)
with the mobile phase of methanol-water##2##6##(2005-12#1)(2008-10#1)
with the mobile phase of##4##5##(2005-12#1)(2008-10#2)(2011-1#1)
with the mobile phase##11##4##(1990-8#2)(1997-8#1)(2005-12#1)(2008-10#4)(2011-1#2)(2011-3#1)
with the mobile##14##3##(1990-8#2)(1997-8#1)(2005-12#1)(2008-10#4)(2008-11#1)(2011-1#3)(2011-3#1)(2012-12#1)
with the mode of##2##4##(2007-11#2)
with the model and##3##4##(1991-1#1)(2007-12#2)
with the model of##2##4##(1991-4#1)(2008-10#1)
with the model##17##3##(1990-8#1)(1991-1#1)(1991-4#1)(1992-12#1)(1995-2#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-7#1)(2008-8#1)(2009-9#1)(2012-3#1)(2013-8#2)
with the modeling##2##3##(2008-10#1)(2010-9#1)
with the models##2##3##(2008-10#1)(2013-8#1)
with the modern##2##3##(2008-10#1)(2008-7#1)
with the modified##17##3##(1990-8#1)(1991-3#1)(1992-6#1)(1995-1#1)(2005-1#1)(2006-11#2)(2007-11#2)(2008-10#5)(2008-2#2)(2008-3#1)
with the modulation of##2##4##(2008-11#1)(2008-3#1)
with the modulation##4##3##(2007-12#2)(2008-11#1)(2008-3#1)
with the moiré##2##3##(2008-2#2)
with the mole##2##3##(1992-6#1)(2008-10#1)
with the molecular mass##2##4##(1990-3#1)(2005-11#1)
with the molecular weight of##2##5##(1993-11#1)(1997-7#1)
with the molecular weight##4##4##(1993-11#1)(1997-7#1)(2005-11#1)(2012-3#1)
with the molecular##12##3##(1990-3#1)(1991-11#1)(1993-11#1)(1995-8#1)(1997-7#1)(2005-11#2)(2006-8#1)(2007-12#1)(2007-6#1)(2008-11#1)(2012-3#1)
with the monoclonal antibody##5##4##(1990-7#1)(1992-12#1)(1994-12#1)(1994-3#1)(1997-7#1)
with the monoclonal##7##3##(1990-7#1)(1991-5#1)(1992-12#1)(1994-12#1)(1994-3#2)(1997-7#1)
with the morbidity##2##3##(2006-8#1)(2007-7#1)
with the more severe##3##4##(1995-4#1)(1997-3#1)(2012-2#1)
with the more##21##3##(1990-12#1)(1991-7#1)(1992-11#1)(1994-2#1)(1994-9#1)(1995-4#1)(1996-6#1)(1996-8#1)(1997-3#2)(2005-11#1)(2007-4#1)(2008-10#3)(2008-5#1)(2008-6#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
with the morphological##5##3##(1992-7#1)(1993-7#1)(2007-12#1)(2008-5#1)(2008-7#1)
with the morphology##4##3##(1991-11#1)(1992-9#1)(2005-11#1)(2008-10#1)
with the mortality##2##3##(2008-4#1)(2010-12#1)
with the most active##2##4##(1991-2#1)(2008-3#1)
with the most common##8##4##(2007-11#1)(2008-6#1)(2009-2#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)
with the most commonly##2##4##(2010-8#1)(2011-2#1)
with the most recent##3##4##(2010-12#1)(2011-2#1)(2012-3#1)
with the most severe##7##4##(1990-8#1)(1995-2#1)(1995-9#1)(2006-10#1)(2007-10#1)(2008-2#1)(2010-8#1)
with the most significant##2##4##(2006-8#1)(2013-7#1)
with the most##58##3##(1990-4#1)(1990-8#1)(1991-2#1)(1993-10#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-5#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#1)(2009-2#1)(2010-12#2)(2010-8#4)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
with the motion model##2##4##(2008-3#2)
with the motion##3##3##(2006-12#1)(2008-3#2)
with the motor##4##3##(1992-9#1)(1993-6#1)(2006-10#1)(2008-7#1)
with the mouse and human##3##5##(1992-4#1)(1997-2#1)(2008-4#1)
with the mouse and##4##4##(1990-8#1)(1992-4#1)(1997-2#1)(2008-4#1)
with the mouse sequence##2##4##(1990-3#1)(1992-11#1)
with the mouse##13##3##(1990-3#1)(1990-8#1)(1992-11#2)(1992-12#1)(1992-4#1)(1993-11#1)(1994-11#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-4#1)
with the much##3##3##(1992-3#1)(2008-7#1)(2012-10#1)
with the mucosa##2##3##(1992-5#1)(2005-7#1)
with the multidisciplinary##2##3##(1996-3#1)(2010-3#1)
with the multifactorial##2##3##(1990-6#1)(2006-10#1)
with the multiple##5##3##(2006-12#1)(2008-8#1)(2008-9#1)(2009-1#1)(2012-3#1)
with the murine##3##3##(1994-12#1)(1994-8#1)(1996-10#1)
with the muscle##3##3##(1990-3#1)(2008-7#1)(2009-3#1)
with the mutant##4##3##(1990-8#1)(1996-5#1)(2008-10#1)(2008-8#1)
with the mutation of##2##4##(1994-9#1)(1997-7#1)
with the mutation##4##3##(1994-9#1)(1997-7#2)(2012-12#1)
with the naked eye##5##4##(2008-10#2)(2008-3#1)(2008-5#2)
with the naked##6##3##(2008-10#2)(2008-3#1)(2008-5#2)(2011-2#1)
with the narrow##3##3##(1996-2#1)(2008-2#2)
with the narrow-linewidth##2##3##(2007-12#1)(2008-3#1)
with the national##3##3##(1997-1#1)(2008-10#1)(2012-3#1)
with the native human##2##4##(1992-11#1)(2006-9#1)
with the native##8##3##(1990-2#1)(1992-11#1)(1992-6#1)(1995-4#1)(1997-4#1)(2006-10#1)(2006-9#1)(2008-11#1)
with the natural history of##2##5##(2006-10#1)(2013-8#1)
with the natural##13##3##(1992-3#1)(1993-2#1)(1994-5#1)(1994-9#1)(1995-10#1)(1996-11#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#2)(2013-8#1)
with the naturally occurring##2##4##(1997-8#1)(2006-8#1)
with the naturally##3##3##(1997-8#1)(2006-8#1)(2013-8#1)
with the nature of the##4##5##(1997-5#1)(2008-10#1)(2009-3#1)(2010-9#1)
with the nature of##7##4##(1990-12#1)(1991-12#1)(1997-5#1)(2007-7#1)(2008-10#1)(2009-3#1)(2010-9#1)
with the nature##8##3##(1990-12#1)(1991-12#1)(1997-5#1)(2006-3#1)(2007-7#1)(2008-10#1)(2009-3#1)(2010-9#1)
with the necessary##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
with the neck##2##3##(2006-11#1)(2008-1#1)
with the need for##10##4##(1992-2#1)(1993-3#1)(1996-1#1)(1997-7#1)(2006-6#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)
with the need to##6##4##(1994-12#1)(1996-1#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-4#1)
with the need##16##3##(1992-2#1)(1993-3#1)(1994-12#1)(1996-1#2)(1997-1#1)(1997-7#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)
with the needs of##2##4##(1994-3#1)(2008-9#1)
with the negative##5##3##(1995-3#1)(1995-4#1)(1996-11#1)(2008-10#1)(2008-5#1)
with the neighboring##3##3##(1996-5#1)(2007-8#2)
with the nematode##4##3##(2008-10#3)(2009-3#1)
with the neonatal##2##3##(1995-7#1)(1996-10#1)
with the nephrotic syndrome##7##4##(1990-8#1)(2007-7#1)(2008-1#5)
with the nerve##3##3##(1997-5#1)(2008-11#1)(2008-5#1)
with the net##2##3##(2006-9#1)(2008-3#1)
with the neurochemical##2##3##(1996-10#1)(1997-5#1)
with the neuronal##3##3##(1994-9#2)(1996-9#1)
with the neurosurgeons##2##3##(2012-3#1)(2013-1#1)
with the neutral theory##2##4##(1994-8#1)(2008-8#1)
with the neutral##6##3##(1993-9#1)(1994-8#1)(1995-2#1)(2008-10#2)(2008-8#1)
with the new generation of##2##5##(2007-11#1)(2008-11#1)
with the new generation##3##4##(2007-11#1)(2008-11#1)(2012-12#1)
with the new method##3##4##(2006-2#1)(2008-2#1)(2009-2#1)
with the new##49##3##(1991-9#1)(1992-10#1)(1992-2#1)(1992-6#1)(1993-11#2)(1995-2#1)(1995-4#1)(1997-8#1)(2003-11#1)(2004-2#1)(2005-5#1)(2006-10#1)(2006-2#2)(2006-7#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#7)(2008-4#2)(2008-5#1)(2009-10#1)(2009-2#1)(2009-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)
with the newer##4##3##(1993-12#1)(2007-11#1)(2008-3#1)(2010-12#1)
with the newly developed##3##4##(1991-11#1)(1992-8#2)
with the newly##6##3##(1991-11#1)(1992-8#2)(2004-9#1)(2010-7#1)(2013-1#1)
with the next##2##3##(2008-1#1)(2008-6#1)
with the nitric oxide##2##4##(1995-12#1)(1996-12#1)
with the nitrogen##2##3##(1995-8#1)(1996-2#1)
with the nitroxide##2##3##(1991-10#1)(1993-8#1)
with the no##2##3##(1996-3#1)(2009-8#1)
with the non-competitive##3##3##(1993-7#1)(1994-5#1)(2006-5#1)
with the non-selective##3##3##(1991-5#1)(1994-8#1)(2005-9#1)
with the non-toxic##2##3##(2006-8#1)(2008-10#1)
with the noninvasive##2##3##(1997-4#1)(2007-3#1)
with the normal##26##3##(1990-11#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#1)(1994-5#1)(1995-11#1)(1995-12#1)(1996-2#1)(1997-4#1)(2004-11#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-6#2)(2009-4#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#2)
with the normalized##2##3##(2008-3#1)(2008-8#1)
with the notion that##14##4##(1990-11#1)(1990-7#1)(1990-8#1)(1991-2#1)(1992-3#1)(1995-3#2)(1997-5#1)(2007-8#1)(2009-5#1)(2011-2#2)(2012-1#2)
with the notion##15##3##(1990-11#1)(1990-7#1)(1990-8#1)(1991-2#1)(1992-3#1)(1995-3#2)(1997-5#1)(2005-8#1)(2007-8#1)(2009-5#1)(2011-2#2)(2012-1#2)
with the notions of##2##4##(2009-3#1)(2012-2#1)
with the novel##7##3##(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2012-1#1)
with the now##2##3##(2007-11#1)(2010-4#1)
with the nuclear matrix##3##4##(1992-12#3)
with the nuclear##10##3##(1990-6#1)(1992-12#4)(1992-2#1)(1994-11#1)(1996-5#1)(2008-10#1)(2008-5#1)
with the nucleic acid##2##4##(1994-8#1)(2008-5#1)
with the nucleotide sequence of the##2##6##(1990-12#1)(1996-8#1)
with the nucleotide##5##3##(1990-12#1)(1991-11#1)(1996-8#1)(2005-11#1)(2008-4#1)
with the nucleus##4##3##(1992-4#1)(1993-8#1)(1997-1#1)(2008-9#1)
with the number and##2##4##(2007-11#1)(2008-3#1)
with the number of naturalizations##2##5##(2008-8#2)
with the number of##50##4##(1990-11#1)(1990-2#1)(1990-6#1)(1991-12#1)(1992-6#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-4#1)(2004-11#1)(2005-11#3)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#7)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-1#2)(2013-7#1)
with the number##53##3##(1990-11#1)(1990-2#1)(1990-6#1)(1991-12#1)(1992-6#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-4#1)(2004-11#1)(2005-11#3)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-1#2)(2013-7#1)
with the numerical results##2##4##(2007-12#1)(2008-3#1)
with the numerical##8##3##(2006-2#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-11#1)
with the nurses##2##3##(2007-2#1)(2011-1#1)
with the nursing##2##3##(2011-2#2)
with the object of##6##4##(1990-12#1)(1990-4#1)(1991-9#1)(1992-3#1)(1996-12#1)(2011-2#1)
with the object##8##3##(1990-12#1)(1990-4#1)(1991-9#1)(1992-3#1)(1996-12#1)(2008-3#2)(2011-2#1)
with the objective of finding##2##5##(1995-3#1)(2008-7#1)
with the objective of##14##4##(1992-2#1)(1994-6#1)(1995-3#1)(1995-6#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-7#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
with the objective to##4##4##(2008-10#1)(2008-5#1)(2011-1#1)(2012-1#1)
with the objective##20##3##(1992-2#1)(1994-6#1)(1995-3#1)(1995-6#1)(1996-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2011-1#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
with the objectives of##3##4##(1994-6#1)(1997-6#1)(2011-2#1)
with the observation of##2##4##(2008-10#1)(2010-5#1)
with the observation that the##2##5##(1994-8#1)(1997-5#1)
with the observation that##12##4##(1992-1#1)(1993-4#1)(1994-6#1)(1994-8#1)(1995-8#1)(1997-5#1)(2004-12#1)(2005-8#1)(2008-10#3)(2011-2#1)
with the observation##15##3##(1990-8#1)(1992-1#1)(1993-4#1)(1994-6#1)(1994-8#1)(1995-8#1)(1997-5#1)(2004-12#1)(2005-8#1)(2008-10#4)(2010-5#1)(2011-2#1)
with the observations on the##2##5##(2007-3#1)(2008-9#1)
with the observations##5##3##(1994-1#1)(1995-6#1)(1995-8#1)(2007-3#1)(2008-9#1)
with the observed data##3##4##(1995-2#1)(2008-5#1)(2011-2#1)
with the observed relative##3##4##(2008-10#1)(2012-12#2)
with the observed##29##3##(1991-5#1)(1992-11#1)(1992-2#1)(1993-3#1)(1994-8#1)(1995-2#2)(1996-7#1)(2006-10#1)(2007-1#1)(2007-12#2)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#2)(2012-12#2)
with the obtained##3##3##(2008-10#2)(2009-4#1)
with the occurrence of adverse##2##5##(2008-8#1)(2009-5#1)
with the occurrence of the##2##5##(1996-10#1)(2007-4#1)
with the occurrence of##18##4##(1991-10#1)(1995-2#1)(1996-10#1)(2006-3#1)(2007-12#1)(2007-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-12#3)(2012-2#2)(2013-1#1)(2013-7#1)
with the occurrence##19##3##(1991-10#1)(1995-2#1)(1996-10#1)(2006-3#1)(2007-12#1)(2007-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-10#1)(2010-12#3)(2012-2#2)(2013-1#1)(2013-7#1)
with the official methods##2##4##(2008-10#2)
with the official##4##3##(1995-6#1)(2008-10#3)
with the oil##2##3##(2006-9#1)(2011-2#1)
with the oldest##2##3##(1991-6#1)(2006-7#1)
with the olfactory bulb##2##4##(1990-6#1)(1995-5#1)
with the olfactory##4##3##(1990-6#1)(1992-8#1)(1995-5#2)
with the oligonucleotide probe##2##4##(1992-9#1)(2008-10#1)
with the on-axis##2##3##(2008-2#1)(2008-3#1)
with the oncologist##2##3##(2008-11#1)(2008-6#1)
with the one##3##3##(2004-10#1)(2007-2#1)(2011-2#1)
with the ones that##3##4##(1990-2#1)(2008-2#2)
with the ones##9##3##(1990-2#1)(1997-2#1)(2005-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-6#1)(2011-1#1)
with the ongoing##2##3##(1994-1#1)(2008-10#1)
with the only exception of##2##5##(1990-2#1)(2007-8#1)
with the only significant##2##4##(1995-1#1)(2012-12#1)
with the only##10##3##(1990-2#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(2007-12#1)(2007-8#1)(2008-6#1)(2012-12#1)
with the onset of meiosis##2##5##(2012-2#2)
with the onset of the##2##5##(1995-12#1)(1995-8#1)
with the onset of##18##4##(1991-4#1)(1992-12#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(2006-10#1)(2007-5#1)(2007-6#1)(2008-2#1)(2008-7#1)(2009-6#1)(2012-2#4)
with the onset##19##3##(1991-4#1)(1991-8#1)(1992-12#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(2006-10#1)(2007-5#1)(2007-6#1)(2008-2#1)(2008-7#1)(2009-6#1)(2012-2#4)
with the ontogeny of##2##4##(1991-9#1)(2009-12#1)
with the open reading##2##4##(1992-8#1)(1997-6#1)
with the open##3##3##(1992-12#1)(1992-8#1)(1997-6#1)
with the opening##2##3##(2008-8#1)(2012-2#1)
with the operating##2##3##(2007-7#1)(2012-3#1)
with the operation of the##2##5##(2007-10#1)(2007-9#1)
with the operation of##3##4##(2006-8#1)(2007-10#1)(2007-9#1)
with the operation##4##3##(2006-10#1)(2006-8#1)(2007-10#1)(2007-9#1)
with the opiate##2##3##(1990-7#2)
with the opioid##2##3##(1991-1#1)(2007-2#1)
with the opportunity to develop##2##5##(2007-3#1)(2008-11#1)
with the opportunity to##6##4##(1993-9#1)(2007-3#1)(2008-11#1)(2008-5#1)(2009-4#1)(2013-8#1)
with the opportunity##7##3##(1993-9#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-4#1)(2013-8#1)
with the opposite##2##3##(1995-1#1)(2011-1#1)
with the optic##2##3##(1993-12#1)(2008-2#1)
with the optical depth##2##4##(2008-2#1)(2008-3#1)
with the optical##9##3##(1994-6#1)(2007-12#4)(2008-10#1)(2008-2#2)(2008-3#1)
with the optimal##5##3##(1996-8#1)(2008-2#1)(2008-6#1)(2010-10#1)(2012-3#1)
with the optimized medium##2##4##(2013-7#2)
with the optimized##4##3##(2008-3#2)(2013-7#2)
with the optimum at##2##4##(2008-10#2)
with the optimum##5##3##(2006-5#1)(2008-10#3)(2008-3#1)
with the option of##4##4##(1997-3#1)(2008-7#1)(2008-9#1)(2012-2#1)
with the oral##4##3##(1992-11#1)(1993-4#1)(2011-1#1)(2013-7#1)
with the orchid##3##3##(1997-4#3)
with the order of the polynomial##2##6##(2008-3#1)(2008-6#1)
with the order of the##3##5##(2008-10#1)(2008-3#1)(2008-6#1)
with the order of##6##4##(1991-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)
with the order##8##3##(1991-4#1)(1991-8#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)
with the ordinary##3##3##(2005-11#1)(2007-12#1)(2008-8#1)
with the organic##5##3##(2007-12#1)(2007-8#1)(2008-10#2)(2009-7#1)
with the organism##3##3##(2006-10#1)(2007-12#1)(2008-7#1)
with the organisms##2##3##(2008-12#1)(2008-9#1)
with the organization of##2##4##(1993-3#1)(2009-5#1)
with the organization's##2##3##(1993-1#1)(2011-2#1)
with the orientation of the##2##5##(1991-7#1)(2007-12#1)
with the original method##2##4##(1992-4#1)(2008-2#1)
with the original##19##3##(1991-6#1)(1992-4#1)(1993-5#1)(1994-12#1)(1995-3#1)(1995-5#1)(1997-6#1)(2006-3#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2012-1#1)
with the other three##3##4##(2008-10#2)(2012-3#1)
with the other two##6##4##(1995-2#1)(2008-10#2)(2010-6#1)(2011-1#1)(2012-3#1)
with the other##67##3##(1990-12#2)(1990-5#1)(1990-9#1)(1991-2#1)(1992-12#2)(1992-2#1)(1992-8#1)(1993-11#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-10#1)(1997-1#1)(1997-4#1)(1997-7#1)(2004-9#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-7#1)(2008-1#2)(2008-10#13)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#4)(2010-1#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#4)(2013-1#1)(2013-8#3)
with the others##4##3##(2008-10#2)(2008-4#1)(2013-1#1)
with the outcome of##4##4##(1990-9#1)(1995-9#1)(2008-7#1)(2009-5#1)
with the outcome##9##3##(1990-9#1)(1995-9#1)(2007-8#1)(2007-9#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-2#1)
with the outcomes of##3##4##(2005-5#1)(2008-5#1)(2009-3#1)
with the outcomes##5##3##(2005-5#1)(2008-5#1)(2009-3#2)(2012-3#1)
with the outer##3##3##(1992-3#1)(2005-8#2)
with the output##2##3##(2007-12#1)(2008-2#1)
with the overall##13##3##(1991-7#1)(1992-8#1)(1993-9#1)(1995-12#1)(1996-4#1)(2004-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-8#1)
with the ovipositor##2##3##(2007-12#2)
with the oxygen atoms##2##4##(2008-10#1)(2011-2#1)
with the oxygen##5##3##(1990-5#1)(1997-7#1)(2008-10#2)(2011-2#1)
with the pH of the##2##5##(2005-11#1)(2008-10#1)
with the pH##11##3##(1997-1#1)(2005-11#1)(2008-10#7)(2008-6#1)(2012-12#1)
with the parabolic##3##3##(2007-11#1)(2008-3#2)
with the parallel##2##3##(2009-3#1)(2013-7#1)
with the parameter##4##3##(2007-3#1)(2008-10#1)(2008-9#2)
with the parameters##3##3##(1990-2#1)(1995-4#1)(2008-10#1)
with the parasite##4##3##(2008-4#2)(2008-8#1)(2010-8#1)
with the parent compound##4##4##(1996-9#1)(2006-12#1)(2010-12#1)(2010-2#1)
with the parent##7##3##(1994-12#1)(1996-9#1)(2006-12#1)(2008-4#1)(2010-12#1)(2010-2#1)(2013-1#1)
with the parental##10##3##(1993-6#1)(1996-2#1)(2007-11#1)(2008-10#4)(2008-9#1)(2013-1#1)(2013-8#1)
with the parents##2##3##(2008-10#1)(2011-2#1)
with the partial##6##3##(1991-2#1)(1993-12#1)(1997-5#1)(2008-10#1)(2008-2#1)(2010-7#1)
with the partially##2##3##(1990-8#1)(2008-10#1)
with the participants from##2##4##(2006-8#1)(2010-7#1)
with the participants##3##3##(2006-8#1)(2008-3#1)(2010-7#1)
with the participation of the##2##5##(2008-8#1)(2012-12#1)
with the participation of##6##4##(2007-7#1)(2007-9#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-12#1)
with the particle size of 3##2##6##(2013-8#2)
with the particle size##4##4##(2007-11#1)(2008-3#1)(2013-8#2)
with the particle##8##3##(2007-11#1)(2007-9#1)(2008-3#4)(2013-8#2)
with the particles'##2##3##(2008-3#1)(2009-9#1)
with the particular##4##3##(2007-8#1)(2008-4#1)(2008-9#1)(2010-12#1)
with the particulate fraction##4##4##(1992-8#1)(1994-12#1)(1995-8#1)(1997-1#1)
with the passage of##3##4##(2006-10#1)(2008-10#1)(2012-1#1)
with the past##3##3##(1995-4#1)(2006-12#1)(2011-2#1)
with the pathogen##19##3##(1996-3#1)(2008-10#18)
with the pathogenesis of##6##4##(1996-9#1)(1997-3#1)(2007-9#1)(2010-12#1)(2012-12#1)(2012-2#1)
with the pathogenic##4##3##(1997-4#1)(1997-6#1)(2008-10#1)(2008-5#1)
with the pathogens##2##3##(2008-10#1)(2010-4#1)
with the pathophysiology of##2##4##(2006-10#1)(2007-11#1)
with the patient and##2##4##(1992-8#1)(1996-8#1)
with the patient during##2##4##(2009-8#1)(2010-9#1)
with the patient in##3##4##(1990-6#1)(2007-8#1)(2013-7#1)
with the patient##31##3##(1990-6#1)(1991-2#1)(1992-11#1)(1992-8#1)(1993-10#1)(1996-8#1)(1997-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-6#2)(2009-8#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
with the patient's##10##3##(1996-6#1)(2004-3#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-6#1)(2008-9#1)(2012-1#1)
with the patients##12##3##(1996-2#1)(2006-6#1)(2008-10#1)(2008-7#4)(2009-12#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
with the pattern of##5##4##(1992-4#1)(1993-2#1)(1995-12#1)(2008-8#1)(2012-2#1)
with the pattern##8##3##(1992-4#1)(1993-2#1)(1995-12#2)(1996-2#1)(2007-12#1)(2008-8#1)(2012-2#1)
with the patterns of##2##4##(2008-10#1)(2008-2#1)
with the peak heights##2##4##(2008-10#2)
with the peak of##3##4##(1995-3#1)(2007-11#1)(2007-9#1)
with the peak##10##3##(1995-3#1)(1996-12#1)(2006-1#1)(2007-1#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-5#1)(2013-8#1)
with the pediatric##2##3##(2007-8#1)(2012-2#1)
with the pendant##2##3##(2005-11#1)(2009-10#1)
with the penis##2##3##(1995-5#1)(2008-10#1)
with the peptide##11##3##(1990-12#2)(1991-1#1)(1993-11#1)(1994-5#1)(1996-5#1)(1997-4#1)(2008-10#2)(2012-11#2)
with the percentage of##6##4##(2008-8#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-8#2)
with the percentage##7##3##(1991-2#1)(2008-8#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-8#2)
with the perception of##3##4##(2006-10#1)(2008-2#1)(2012-2#1)
with the perception##4##3##(2006-10#1)(2008-11#1)(2008-2#1)(2012-2#1)
with the perceptual##2##3##(2007-8#2)
with the performance of the##3##5##(1991-1#1)(2006-10#1)(2008-3#1)
with the performance of##11##4##(1991-1#1)(1993-2#1)(1994-11#1)(1995-1#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#3)(2011-2#1)
with the performance##14##3##(1991-1#1)(1993-2#1)(1994-11#1)(1995-1#1)(2004-11#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)(2011-2#1)
with the period of##3##4##(1990-5#1)(2008-10#1)(2008-5#1)
with the period##6##3##(1990-5#1)(1991-1#1)(1993-9#1)(1995-5#1)(2008-10#1)(2008-5#1)
with the periodic##2##3##(2007-12#1)(2010-7#1)
with the permanent##2##3##(1993-11#1)(2007-10#1)
with the permeability##2##3##(1996-5#1)(1997-1#1)
with the persistence of##2##4##(1991-8#2)
with the personality##3##3##(1994-3#1)(2009-5#1)(2011-2#1)
with the phage##2##3##(1993-4#1)(1995-3#1)
with the pharmacological##2##3##(1993-7#1)(1996-10#1)
with the pharmacy was##2##4##(2010-3#2)
with the phase##5##3##(1991-6#1)(2006-12#1)(2007-12#1)(2008-3#1)(2011-2#1)
with the phenol group##2##4##(1994-5#2)
with the phenotype##3##3##(1991-4#1)(2008-10#1)(2012-3#1)
with the phorbol ester##2##4##(1993-9#1)(1995-3#1)
with the phorbol##3##3##(1990-11#1)(1993-9#1)(1995-3#1)
with the phosphate##4##3##(1990-4#1)(2004-9#1)(2006-10#1)(2008-10#1)
with the phospholipid##2##3##(1990-5#1)(1991-5#1)
with the phosphonate##2##3##(1991-2#2)
with the phosphorylated##3##3##(1990-5#1)(1990-7#1)(2012-2#1)
with the phosphorylation of##2##4##(1996-5#1)(1997-6#1)
with the phosphorylation##4##3##(1996-5#1)(1997-6#1)(2006-10#1)(2009-12#1)
with the phosphotyrosine binding##2##4##(1996-5#2)
with the physical##3##3##(2006-12#1)(2008-2#1)(2008-5#1)
with the physiological##6##3##(1993-11#1)(1994-6#1)(1996-7#1)(1996-9#1)(2009-2#1)(2012-1#1)
with the physiology of the##2##5##(2007-11#1)(2008-7#1)
with the physiology of##4##4##(2007-11#1)(2008-7#1)(2008-9#1)(2010-2#1)
with the phytoplankton##2##3##(2008-2#1)(2008-5#1)
with the placebo group##11##4##(1991-11#1)(2008-11#2)(2008-5#2)(2009-10#1)(2009-7#2)(2009-8#1)(2012-2#1)(2013-1#1)
with the placebo##12##3##(1991-11#1)(2008-10#1)(2008-11#2)(2008-5#2)(2009-10#1)(2009-7#2)(2009-8#1)(2012-2#1)(2013-1#1)
with the plane of incidence##2##5##(2008-2#2)
with the plane##3##3##(2006-3#1)(2008-2#2)
with the plant##8##3##(1994-6#1)(2006-11#1)(2008-10#3)(2008-2#1)(2009-8#1)(2012-2#1)
with the plasma membrane and##2##5##(1991-2#1)(1991-9#1)
with the plasma membrane##9##4##(1990-11#1)(1991-1#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-12#1)(1994-11#1)(2008-1#1)(2008-11#1)
with the plasma##12##3##(1990-11#1)(1991-1#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-12#1)(1994-11#1)(1994-9#2)(2007-8#1)(2008-1#1)(2008-11#1)
with the plasmid expressing##2##4##(2008-11#1)(2008-9#1)
with the plasmid##5##3##(1990-12#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)
with the plate##3##3##(2006-3#1)(2008-10#2)
with the platelet##3##3##(1991-10#1)(2006-6#1)(2008-10#1)
with the point-spread function##2##4##(2008-3#2)
with the point-spread##3##3##(2008-3#3)
with the polar head group##2##5##(1991-2#1)(1996-7#1)
with the polar##4##3##(1991-2#1)(1991-5#1)(1996-7#1)(2013-8#1)
with the polarization##2##3##(1995-5#1)(2007-12#1)
with the police##2##3##(1996-6#1)(2009-7#1)
with the pollution##2##3##(2007-10#1)(2008-11#1)
with the polyclonal antiserum##2##4##(2008-10#2)
with the polyclonal##5##3##(1990-12#1)(1990-8#1)(1994-3#1)(2008-10#2)
with the polycystic ovary syndrome##2##5##(1993-1#1)(2008-3#1)
with the polymer##5##3##(2008-10#4)(2010-7#1)
with the polymerase chain reaction (PCR)##2##6##(1992-10#1)(1993-11#1)
with the polymerase chain reaction and##2##6##(1990-8#1)(2008-11#1)
with the polymerase chain reaction##7##5##(1990-8#1)(1992-10#1)(1993-11#1)(1993-2#1)(2008-11#1)(2008-5#2)
with the polymerase chain##8##4##(1990-8#2)(1992-10#1)(1993-11#1)(1993-2#1)(2008-11#1)(2008-5#2)
with the polymerase##9##3##(1990-8#3)(1992-10#1)(1993-11#1)(1993-2#1)(2008-11#1)(2008-5#2)
with the polymers##2##3##(2008-10#1)(2008-4#1)
with the polymorphism of the##2##5##(1990-3#1)(2013-1#1)
with the polypeptide##2##3##(1990-2#1)(2010-2#1)
with the pooled##3##3##(1995-2#1)(2012-3#1)(2013-1#1)
with the poor##4##3##(1991-7#1)(1993-11#1)(1995-9#1)(2011-2#1)
with the poorly##2##3##(1991-8#1)(1993-9#1)
with the population of##2##4##(2011-2#1)(2012-2#1)
with the population##5##3##(2006-10#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-2#1)
with the porphyrin##2##3##(2008-10#1)(2010-5#1)
with the position of##2##4##(1997-7#1)(2008-2#1)
with the positive effects of##2##5##(2005-6#1)(2008-10#1)
with the positive##8##3##(1994-3#1)(1994-9#1)(2005-6#1)(2007-3#1)(2008-10#1)(2008-6#1)(2009-5#1)(2012-3#1)
with the possibility of##8##4##(1991-1#1)(1995-2#1)(2005-7#1)(2008-4#1)(2009-1#1)(2009-7#1)(2010-2#1)(2013-1#1)
with the possibility that##4##4##(1990-7#1)(1993-10#1)(1995-1#1)(1997-8#1)
with the possibility to prove a supposed reaction##2##8##(2008-10#2)
with the possibility to##5##4##(2005-11#1)(2008-10#2)(2010-3#1)(2011-1#1)
with the possibility##17##3##(1990-7#1)(1991-1#1)(1993-10#1)(1995-1#1)(1995-2#1)(1997-8#1)(2005-11#1)(2005-7#1)(2008-10#2)(2008-4#1)(2009-1#1)(2009-7#1)(2010-2#1)(2010-3#1)(2011-1#1)(2013-1#1)
with the possible exception of##5##5##(1990-9#1)(2006-10#1)(2008-4#1)(2009-4#1)(2012-3#1)
with the possible role of##2##5##(1995-1#1)(1995-6#1)
with the possible##12##3##(1990-9#1)(1995-1#1)(1995-2#1)(1995-6#1)(2006-10#1)(2008-4#1)(2009-4#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
with the posterior approach##3##4##(2006-8#1)(2007-7#1)(2007-8#1)
with the posterior##4##3##(2006-8#1)(2007-7#2)(2007-8#1)
with the postero-lateral spondylodesis##2##4##(2007-11#2)
with the potassium##2##3##(1996-2#1)(1997-2#1)
with the potency##3##3##(1991-8#1)(1993-8#1)(2008-8#1)
with the potential for the##2##5##(2005-8#1)(2008-1#1)
with the potential for##13##4##(1990-2#1)(1993-2#1)(1995-10#1)(1995-2#1)(1996-4#1)(1996-8#1)(2005-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-7#1)(2009-8#1)
with the potential of being##2##5##(2008-10#1)(2008-7#1)
with the potential of##5##4##(1991-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-4#1)
with the potential to encode a##2##6##(1994-12#1)(2008-10#1)
with the potential to encode##3##5##(1994-12#1)(2008-10#1)(2013-8#1)
with the potential to##13##4##(1990-7#1)(1994-12#1)(1997-1#1)(2005-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#2)(2012-1#1)(2013-1#2)(2013-8#1)
with the potential##40##3##(1990-2#1)(1990-7#1)(1991-11#1)(1991-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-1#1)(1995-10#1)(1995-2#1)(1996-4#1)(1996-8#1)(1997-1#1)(2005-10#1)(2005-8#1)(2005-9#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-8#1)(2010-12#2)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
with the potentially##2##3##(1995-11#1)(2008-4#1)
with the power##3##3##(1997-4#1)(2008-3#1)(2012-1#1)
with the powerful##2##3##(1990-5#1)(1994-4#1)
with the practical##6##3##(1993-2#1)(1993-5#1)(2007-4#1)(2008-11#1)(2008-8#1)(2009-7#1)
with the practice##2##3##(2008-2#1)(2008-8#1)
with the pre- and##2##4##(2006-12#1)(2008-1#1)
with the precision of##2##4##(2008-10#2)
with the precision##4##3##(1993-7#1)(2008-10#3)
with the preconcentration##5##3##(1997-1#1)(2008-10#4)
with the predicted##12##3##(1990-4#1)(1991-2#1)(1991-8#1)(1994-11#1)(1996-8#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-5#1)(2013-8#1)
with the prediction by##2##4##(2005-11#1)(2008-10#1)
with the prediction of##3##4##(1992-9#1)(2007-11#1)(2012-3#1)
with the prediction##9##3##(1992-9#1)(1993-12#2)(2005-11#1)(2005-12#1)(2007-11#1)(2008-10#1)(2012-3#1)(2013-1#1)
with the predictions of Mie theory##2##6##(2008-2#2)
with the predictions of a##4##5##(2007-11#1)(2007-12#2)(2008-3#1)
with the predictions of the##2##5##(1990-8#1)(2012-1#1)
with the predictions of##13##4##(1990-8#1)(1993-7#1)(2006-10#2)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#2)(2010-4#1)(2012-1#1)
with the predictions##16##3##(1990-8#2)(1993-7#1)(2006-10#2)(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#3)(2010-4#1)(2012-1#1)
with the predominance of##2##4##(2005-11#1)(2008-8#1)
with the predominant##3##3##(1991-8#1)(2005-7#1)(2008-10#1)
with the preoperative##2##3##(2007-5#1)(2013-7#1)
with the preparation of##2##4##(2008-10#1)(2009-7#1)
with the prescribed medication##2##4##(1993-11#1)(1995-2#1)
with the prescription of##2##4##(2008-8#1)(2010-4#1)
with the prescription##4##3##(2008-8#2)(2009-2#1)(2010-4#1)
with the prescriptions##2##3##(1995-11#1)(2008-10#1)
with the presence of a##13##5##(1990-12#1)(1990-4#1)(1991-4#1)(1993-11#1)(1996-2#1)(1996-9#1)(1997-2#1)(2008-10#2)(2008-5#2)(2008-6#1)(2011-1#1)
with the presence of the##5##5##(1995-5#1)(1997-4#1)(1997-5#1)(2007-11#1)(2008-10#1)
with the presence of two##2##5##(1993-1#1)(2007-11#1)
with the presence of##91##4##(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#2)(2006-10#1)(2006-11#1)(2006-2#2)(2006-9#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-10#14)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-2#1)(2013-1#3)(2013-8#2)
with the presence or absence of##3##6##(1996-9#1)(1997-4#1)(2008-11#1)
with the presence or##4##4##(1991-9#1)(1996-9#1)(1997-4#1)(2008-11#1)
with the presence##96##3##(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-11#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-9#2)(1997-2#1)(1997-4#2)(1997-5#2)(2006-10#1)(2006-11#1)(2006-2#2)(2006-9#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-10#14)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-2#1)(2013-1#3)(2013-8#2)
with the present chelating##2##4##(2008-10#2)
with the present method##2##4##(2008-10#2)
with the present results##2##4##(1990-9#1)(2008-7#1)
with the present##18##3##(1990-12#2)(1990-9#1)(1991-1#1)(1996-1#1)(1996-10#1)(1996-6#1)(1997-2#1)(2008-10#7)(2008-7#1)(2011-12#1)(2011-2#1)
with the presentation of##2##4##(1992-6#1)(2008-2#1)
with the preservation of##2##4##(1997-7#1)(2008-5#1)
with the pressure##2##3##(2010-8#1)(2013-8#1)
with the prevacuolar##2##3##(1997-6#2)
with the prevalence of##6##4##(1993-5#1)(1995-8#1)(2006-12#1)(2008-3#1)(2011-2#1)(2013-7#1)
with the prevalence##10##3##(1993-5#1)(1995-8#1)(2006-12#1)(2008-3#1)(2009-12#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)
with the prevalent##2##3##(2008-10#1)(2012-12#1)
with the prevention of##2##4##(2005-7#1)(2010-4#1)
with the previous introduction of##2##5##(2008-10#2)
with the previous##38##3##(1990-1#1)(1990-4#1)(1991-1#1)(1991-12#1)(1992-2#1)(1993-12#1)(1996-11#1)(1996-5#2)(1997-2#1)(2005-11#1)(2006-10#1)(2008-10#7)(2008-2#2)(2008-3#4)(2008-5#2)(2008-6#1)(2009-9#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
with the previously cloned rat##2##5##(1991-3#1)(1991-7#1)
with the previously cloned##3##4##(1991-3#1)(1991-7#1)(1991-9#1)
with the previously described##4##4##(1991-10#1)(2008-10#2)(2008-3#1)
with the previously determined##2##4##(1992-12#1)(1997-4#1)
with the previously reported structure of the##2##7##(1995-8#1)(1996-7#1)
with the previously reported##10##4##(1992-1#1)(1995-11#1)(1995-8#1)(1996-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-5#1)(2013-8#1)
with the previously##34##3##(1991-10#1)(1991-3#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1994-12#1)(1994-3#1)(1995-11#2)(1995-8#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-4#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#3)(2009-3#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-8#1)
with the prey##2##3##(2006-12#1)(2007-12#1)
with the primary amino group##2##5##(1996-8#1)(2008-10#1)
with the primary antibody##3##4##(2008-2#1)(2008-4#2)
with the primary objective of##2##5##(2008-9#1)(2012-12#1)
with the primary##21##3##(1990-7#1)(1994-12#1)(1995-9#1)(1996-8#1)(1997-1#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
with the prime##2##3##(2010-12#1)(2012-2#1)
with the principal##4##3##(2010-12#1)(2010-9#1)(2011-2#1)(2012-3#1)
with the principle##2##3##(2008-10#1)(2008-9#1)
with the principles and##2##4##(1993-11#1)(2008-11#1)
with the principles##3##3##(1993-11#1)(2008-11#1)(2008-2#1)
with the prior##2##3##(1992-3#1)(2008-2#1)
with the privacy##2##3##(1995-6#1)(2007-12#1)
with the private##3##3##(1994-1#1)(2013-1#2)
with the probability of##3##4##(2004-12#1)(2008-7#1)(2008-8#1)
with the probe##5##3##(1991-12#1)(1996-3#1)(2008-10#1)(2008-2#1)(2008-9#1)
with the problem of##7##4##(1993-2#1)(2007-11#1)(2007-5#1)(2010-8#1)(2013-7#1)(2013-8#2)
with the problem##13##3##(1992-1#1)(1993-2#1)(1994-6#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-8#1)(2012-3#1)(2013-7#1)(2013-8#2)
with the problems of##3##4##(1993-2#1)(1994-2#1)(2013-1#1)
with the problems##5##3##(1990-6#1)(1993-2#1)(1994-2#1)(1995-8#1)(2013-1#1)
with the procedure##4##3##(2004-2#1)(2008-1#1)(2008-9#1)(2012-1#1)
with the procedures##2##3##(2006-6#1)(2012-1#1)
with the process of##3##4##(2007-11#1)(2008-10#1)(2008-5#1)
with the process##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)
with the processes of##4##4##(2006-6#1)(2008-5#1)(2009-2#1)(2013-1#1)
with the processes##5##3##(1991-5#1)(2006-6#1)(2008-5#1)(2009-2#1)(2013-1#1)
with the processing of##3##4##(2006-8#1)(2008-3#1)(2010-5#1)
with the product of the##5##5##(1991-5#1)(1992-6#1)(1997-3#1)(2008-10#1)(2008-3#1)
with the product of##6##4##(1991-5#1)(1992-6#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-3#1)
with the product##7##3##(1991-5#1)(1992-6#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
with the production of##9##4##(1992-8#1)(1994-2#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-8#1)(2012-2#1)
with the production##10##3##(1992-5#1)(1992-8#1)(1994-2#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-8#1)(2012-2#1)
with the professional training##2##4##(1990-12#1)(2008-7#1)
with the prognosis##2##3##(2007-12#1)(2009-8#1)
with the program##5##3##(1995-1#1)(1997-2#2)(2007-9#1)(2008-8#1)
with the progress of the##2##5##(2005-11#1)(2008-5#1)
with the progress of##5##4##(1995-1#1)(1995-6#1)(2005-11#1)(2008-10#1)(2008-5#1)
with the progress##6##3##(1995-1#1)(1995-6#1)(2005-11#1)(2008-10#1)(2008-5#1)(2008-9#1)
with the progression of colorectal cancer##2##6##(2008-4#1)(2009-4#1)
with the progression of the##2##5##(1993-12#1)(2005-11#1)
with the progression of##9##4##(1990-4#1)(1993-12#1)(1997-1#1)(2005-11#1)(2008-1#1)(2008-3#1)(2008-4#1)(2009-4#1)(2011-12#1)
with the progressive##3##3##(1990-8#1)(2008-9#1)(2009-2#1)
with the project##3##3##(1992-1#1)(2005-10#1)(2011-2#1)
with the prokaryotic##2##3##(1990-11#1)(1993-11#1)
with the proliferation of##3##4##(1990-7#1)(2005-8#1)(2006-12#1)
with the proliferation##4##3##(1990-7#1)(2004-9#1)(2005-8#1)(2006-12#1)
with the promoter##8##3##(1990-4#1)(1990-5#1)(1993-3#1)(1994-9#1)(1995-3#2)(1997-2#1)(2008-5#1)
with the propagation axis of the##2##6##(2008-3#2)
with the propensity score##3##4##(2007-8#1)(2012-3#2)
with the propensity##4##3##(2007-8#1)(2012-2#1)(2012-3#2)
with the proper##4##3##(1994-9#1)(2007-12#1)(2008-3#1)(2008-5#1)
with the properties of##5##4##(1997-4#1)(2008-1#1)(2008-10#2)(2008-9#1)
with the proportion of total n-3 PUFA##2##7##(2007-8#2)
with the proportion of##8##4##(1990-4#1)(1992-9#1)(2007-8#4)(2008-10#1)(2008-7#1)
with the proportions##2##3##(2008-10#1)(2013-8#1)
with the proposal##3##3##(1994-6#1)(1994-8#1)(2009-8#1)
with the proposed flow##2##4##(2008-10#2)
with the proposed method and the##2##6##(2008-10#2)
with the proposed method was 0##2##6##(2005-4#1)(2008-10#1)
with the proposed method##13##4##(2005-4#1)(2008-10#10)(2009-5#2)
with the proposed technique##2##4##(2008-2#1)(2008-3#1)
with the proposed##33##3##(1990-9#1)(1993-9#1)(1994-5#1)(1995-3#1)(2005-4#1)(2007-1#1)(2007-12#2)(2008-10#17)(2008-11#1)(2008-2#2)(2008-3#1)(2009-5#3)(2012-12#1)
with the proteases##2##3##(1991-7#1)(2006-10#1)
with the protein kinase C##4##5##(1990-10#1)(1992-8#1)(1994-11#1)(1996-5#1)
with the protein kinase##7##4##(1990-10#1)(1991-4#1)(1992-3#1)(1992-8#1)(1994-11#1)(1996-5#1)(1996-9#1)
with the protein synthesis##3##4##(1994-12#1)(1996-4#1)(2007-2#1)
with the protein##34##3##(1990-10#1)(1991-11#1)(1991-4#1)(1992-1#1)(1992-12#3)(1992-3#3)(1992-8#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(2004-2#1)(2005-11#1)(2005-7#1)(2006-12#2)(2007-2#1)(2011-1#2)
with the proteins##2##3##(1997-6#1)(2010-12#1)
with the protocol##3##3##(2008-11#1)(2009-2#1)(2012-3#1)
with the proton##2##3##(1993-3#1)(1994-11#1)
with the prototype##2##3##(1995-6#1)(2008-5#1)
with the provider##2##3##(1994-12#1)(2004-3#1)
with the provision of##3##4##(1997-8#1)(2006-10#1)(2012-3#1)
with the proximal##7##3##(1991-2#1)(1993-12#1)(1993-8#1)(1994-9#1)(2008-11#2)(2008-7#1)
with the psychiatric outpatient##2##4##(1991-9#1)(1994-8#1)
with the psychiatric##3##3##(1991-9#1)(1994-8#1)(2008-6#1)
with the psychosocial##4##3##(1993-1#1)(1994-8#1)(1997-4#1)(2008-6#1)
with the published experimental##2##4##(2007-4#1)(2008-2#1)
with the published sequence##2##4##(1992-12#1)(1996-6#1)
with the published sequences##2##4##(1990-9#1)(2008-5#1)
with the published##14##3##(1990-9#1)(1992-12#1)(1993-12#1)(1994-3#1)(1995-11#1)(1996-6#1)(2005-5#1)(2007-4#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#2)
with the pulmonary##2##3##(1997-1#1)(2011-2#1)
with the pulse##3##3##(2007-11#1)(2008-3#1)(2011-1#1)
with the pump##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
with the pure##5##3##(1990-8#1)(1991-6#1)(2008-10#1)(2008-12#1)(2008-3#1)
with the purified##5##3##(1990-2#1)(1990-7#1)(1995-2#1)(1996-2#1)(2008-8#1)
with the purity of##3##4##(2011-1#3)
with the purpose of identifying##4##5##(2006-6#1)(2010-12#1)(2013-1#2)
with the purpose of providing##2##5##(2008-1#1)(2011-3#1)
with the purpose of##15##4##(1992-10#1)(1993-4#1)(1996-5#1)(2006-6#2)(2007-3#1)(2008-1#1)(2008-2#1)(2008-5#1)(2010-12#1)(2011-3#1)(2012-1#1)(2013-1#3)
with the purpose to##2##4##(2008-10#1)(2011-2#1)
with the purpose##17##3##(1992-10#1)(1993-4#1)(1996-5#1)(2006-6#2)(2007-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-1#1)(2013-1#3)
with the putative##2##3##(1995-10#1)(2012-2#1)
with the qualification##2##3##(2007-7#2)
with the quality of##7##4##(1994-12#1)(2008-9#1)(2009-9#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
with the quality##9##3##(1994-12#1)(2008-9#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-8#1)
with the quantification##2##3##(1990-12#1)(2012-12#1)
with the quantity of##2##4##(1990-4#1)(2004-4#1)
with the quaternary ammonium##2##4##(2005-11#2)
with the question of##3##4##(1996-12#1)(1997-1#1)(2007-2#1)
with the question##5##3##(1992-12#1)(1994-4#1)(1996-12#1)(1997-1#1)(2007-2#1)
with the questions##2##3##(1995-2#1)(2008-7#1)
with the rabbit##4##3##(1990-12#1)(1993-7#1)(1994-8#1)(1995-6#1)
with the radial##4##3##(2007-8#1)(2008-3#1)(2009-11#1)(2011-2#1)
with the radiation##7##3##(2007-10#2)(2008-10#1)(2008-7#3)(2009-11#1)
with the radical##2##3##(1995-10#1)(2006-10#1)
with the radioactive##2##3##(1990-2#1)(1993-8#1)
with the radiolabelled##2##3##(2006-10#1)(2008-8#1)
with the radius of##2##4##(1997-7#1)(2012-2#1)
with the radius##3##3##(1997-7#1)(2006-3#1)(2012-2#1)
with the range of##7##4##(2006-8#2)(2007-11#1)(2007-12#1)(2008-10#1)(2011-2#1)(2013-8#1)
with the range##8##3##(2006-8#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2011-2#1)(2013-8#1)
with the rank##3##3##(1994-11#1)(1995-11#1)(2008-10#1)
with the rapid development of##2##5##(2007-11#1)(2011-1#1)
with the rapid growth##2##4##(1994-3#1)(2008-5#1)
with the rapid##12##3##(1994-3#1)(1995-7#1)(1996-2#1)(2007-11#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-5#1)(2008-8#1)(2011-1#1)(2012-1#1)(2012-3#1)
with the rapidly##2##3##(1994-11#1)(2012-12#1)
with the rare##11##3##(1992-6#1)(1996-7#1)(2007-5#1)(2008-10#4)(2008-8#1)(2012-3#2)(2013-8#1)
with the rat FGF-2##2##4##(1996-12#2)
with the rat and##3##4##(1993-8#1)(1995-7#1)(1997-2#1)
with the rat##15##3##(1991-8#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-7#1)(1996-12#2)(1997-2#2)(1997-4#1)(2010-12#1)
with the rate of the##2##5##(1991-12#1)(2008-8#1)
with the rate of##11##4##(1990-7#1)(1991-12#1)(1993-8#1)(1994-11#1)(1995-5#1)(1996-3#1)(1996-5#1)(2008-8#1)(2010-11#1)(2010-8#1)(2013-1#1)
with the rate##12##3##(1990-7#1)(1991-12#1)(1993-8#1)(1994-11#1)(1995-5#1)(1996-3#1)(1996-5#1)(2008-10#1)(2008-8#1)(2010-11#1)(2010-8#1)(2013-1#1)
with the ratio of##9##4##(1991-12#1)(1993-12#1)(1995-5#1)(1995-8#1)(2008-2#1)(2008-3#2)(2010-6#1)(2013-8#1)
with the ratio##12##3##(1991-12#1)(1993-12#1)(1995-5#1)(1995-8#1)(2008-10#3)(2008-2#1)(2008-3#2)(2010-6#1)(2013-8#1)
with the reaction between##2##4##(2007-11#1)(2008-5#1)
with the reaction##5##3##(1995-6#1)(2007-11#1)(2008-10#1)(2008-5#1)(2010-4#1)
with the reactive##2##3##(1995-8#1)(1997-4#1)
with the reagent stream##3##4##(2008-10#3)
with the reagent##7##3##(2008-10#7)
with the real-time##3##3##(2005-11#1)(2008-2#1)(2008-4#1)
with the recent X-ray##2##4##(1991-4#1)(2009-2#1)
with the recent##17##3##(1991-4#1)(1991-6#1)(1993-11#1)(1995-3#1)(1995-6#1)(2005-7#1)(2007-1#1)(2008-10#3)(2008-4#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-3#1)(2013-1#1)(2013-7#1)
with the recently##11##3##(1990-5#1)(1995-6#2)(1997-9#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#2)
with the receptor##12##3##(1990-3#1)(1990-4#1)(1991-7#2)(1994-3#1)(1995-10#1)(1995-3#1)(1996-2#1)(1996-8#1)(2006-12#1)(2008-4#1)(2008-8#1)
with the recognition of##2##4##(2008-10#1)(2011-2#1)
with the recognition that##2##4##(1992-9#1)(2006-9#1)
with the recognition##5##3##(1992-9#1)(1995-6#1)(2006-9#1)(2008-10#1)(2011-2#1)
with the recombinant adenoviruses##2##4##(1994-9#2)
with the recombinant baculovirus##2##4##(1994-8#1)(1997-4#1)
with the recombinant vector##2##4##(1992-12#1)(1994-5#1)
with the recombinant virus##2##4##(1996-4#1)(2008-11#1)
with the recombinant##13##3##(1991-4#1)(1992-12#1)(1994-5#1)(1994-8#1)(1994-9#2)(1996-4#1)(1997-4#1)(1997-7#1)(2005-8#1)(2008-10#1)(2008-11#1)(2011-3#1)
with the recommendations##4##3##(1990-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
with the recommended chemical fungicide##2##5##(2011-12#2)
with the recommended##7##3##(1993-2#1)(2008-10#2)(2008-7#1)(2010-6#1)(2011-12#2)
with the reconstituted##4##3##(1992-1#1)(1992-9#1)(1995-6#1)(2008-8#1)
with the recorded treatments##4##4##(2013-1#4)
with the recoveries of##2##4##(2008-10#2)
with the recoveries##3##3##(2005-12#1)(2008-10#2)
with the recovery of##7##4##(2008-10#5)(2008-11#1)(2011-2#1)
with the recruitment of##3##4##(1993-8#1)(2009-6#1)(2011-1#1)
with the red cell##2##4##(1996-2#1)(2006-2#1)
with the red##4##3##(1996-2#1)(2006-2#1)(2008-2#2)
with the redox##3##3##(1990-8#1)(1996-2#1)(2008-10#1)
with the reduced subsets##2##4##(2007-8#2)
with the reduced##8##3##(1990-2#1)(1994-11#1)(1995-2#1)(2007-8#2)(2008-2#1)(2008-3#1)(2012-1#1)
with the reducing agents dithiothreitol and##2##6##(1992-6#2)
with the reducing##3##3##(1992-6#2)(2013-8#1)
with the reductase##3##3##(1994-8#2)(1995-2#1)
with the reduction in MC and##2##6##(2013-7#2)
with the reduction in##5##4##(2008-2#1)(2012-12#2)(2013-7#2)
with the reduction of the##3##5##(2008-10#1)(2008-11#1)(2011-1#1)
with the reduction of##10##4##(2006-8#1)(2008-10#5)(2008-11#1)(2008-8#1)(2010-5#1)(2011-1#1)
with the reduction##16##3##(2006-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-8#1)(2010-5#1)(2011-1#1)(2012-12#2)(2013-7#2)
with the reference method##2##4##(2008-10#2)
with the reference population##2##4##(2006-10#1)(2008-11#1)
with the reference standard##2##4##(2008-10#2)
with the reference strain##2##4##(2008-5#1)(2011-2#1)
with the reference values##4##4##(1995-2#1)(2008-10#3)
with the reference##27##3##(1993-6#1)(1995-2#1)(2006-10#1)(2006-12#1)(2008-10#13)(2008-11#1)(2008-3#2)(2008-5#1)(2009-10#1)(2009-6#1)(2011-1#1)(2011-2#2)(2013-8#1)
with the reflectance##2##3##(2008-10#1)(2008-3#1)
with the reflection##4##3##(2007-12#1)(2008-2#1)(2009-4#1)(2009-8#1)
with the refractive index of the##2##6##(2008-10#1)(2008-3#1)
with the region of##3##4##(2008-3#2)(2011-1#1)
with the region##4##3##(2008-3#2)(2008-6#1)(2011-1#1)
with the regional##3##3##(1995-7#1)(1997-3#1)(2008-5#1)
with the regression coefficient is 0##2##6##(2008-10#2)
with the regression coefficient##3##4##(2008-10#3)
with the regression##5##3##(2008-10#5)
with the regulation of##5##4##(1993-5#1)(1997-8#1)(2011-12#1)(2012-2#1)(2013-8#1)
with the regulations##3##3##(1993-3#1)(2006-8#1)(2013-8#1)
with the regulatory and##2##4##(1993-6#1)(2010-11#1)
with the regulatory domain of##2##5##(1994-12#1)(1994-2#1)
with the regulatory##10##3##(1990-7#1)(1993-6#1)(1994-12#1)(1994-2#1)(1996-2#1)(1997-1#1)(2009-10#1)(2009-6#1)(2010-11#1)(2012-1#1)
with the rehabilitation##2##3##(2006-5#1)(2007-7#1)
with the related##4##3##(2006-12#1)(2006-8#1)(2008-10#1)(2013-1#1)
with the relationship##3##3##(1992-3#1)(2010-3#1)(2011-2#1)
with the relative standard deviation of 3##2##7##(2008-10#2)
with the relative standard deviation of##3##6##(2008-10#2)(2011-1#1)
with the relative standard deviation##6##5##(2008-10#5)(2011-1#1)
with the relative standard deviations (RSDs) of##2##7##(2012-12#2)
with the relative standard deviations (RSDs)##3##6##(2012-12#3)
with the relative standard deviations##8##5##(2008-10#2)(2011-1#1)(2012-12#5)
with the relative standard##14##4##(2008-10#7)(2011-1#2)(2012-12#5)
with the relative##28##3##(1990-7#1)(1991-10#1)(1992-8#1)(1993-8#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#2)(2012-12#5)
with the relatively##5##3##(1994-2#1)(2007-12#1)(2008-3#2)(2008-7#1)
with the release of##6##4##(1990-2#1)(2005-7#1)(2006-2#1)(2008-10#1)(2009-4#1)(2011-2#1)
with the release##10##3##(1990-2#1)(2005-7#1)(2006-2#1)(2008-10#3)(2008-4#1)(2009-12#1)(2009-4#1)(2011-2#1)
with the relevant##5##3##(1995-12#1)(1996-3#1)(1997-1#1)(2008-6#1)(2008-7#1)
with the remainder##7##3##(1991-2#1)(1994-12#1)(1996-2#1)(2008-1#1)(2008-10#2)(2012-2#1)
with the remaining##12##3##(1993-11#1)(1993-6#1)(1995-6#1)(2004-9#1)(2005-11#1)(2007-3#1)(2007-5#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-2#1)(2011-2#1)
with the removal of##2##4##(1991-12#1)(2008-11#1)
with the repeated##2##3##(2008-11#1)(2009-8#1)
with the replication##2##3##(1992-3#1)(1994-9#1)
with the reported##20##3##(1990-2#1)(1994-12#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-6#1)(1997-5#1)(2008-10#9)(2008-11#1)(2008-12#1)(2009-4#1)(2013-1#1)
with the reporter##4##3##(1991-8#1)(1994-2#1)(2008-11#1)(2008-9#1)
with the reproductive##2##3##(2008-3#1)(2013-8#1)
with the required##4##3##(1994-8#1)(2005-5#1)(2008-10#1)(2008-3#1)
with the requirement for##2##4##(1997-8#1)(2005-7#1)
with the requirement##4##3##(1997-8#1)(2005-7#1)(2008-1#1)(2008-2#1)
with the requirements of the##2##5##(2006-8#1)(2013-8#1)
with the requirements of##5##4##(1990-9#1)(2005-5#1)(2006-8#1)(2010-3#1)(2013-8#1)
with the requirements##7##3##(1990-8#1)(1990-9#1)(1992-3#1)(2005-5#1)(2006-8#1)(2010-3#1)(2013-8#1)
with the research##6##3##(2006-12#1)(2007-8#1)(2008-11#1)(2008-9#1)(2010-9#1)(2011-2#1)
with the residence times##2##4##(2007-8#2)
with the residual##4##3##(2008-10#1)(2008-3#1)(2009-3#1)(2011-12#1)
with the resin##2##3##(2008-10#2)
with the resistance gene##3##4##(2008-10#2)(2008-5#1)
with the resistance##5##3##(2008-10#4)(2008-5#1)
with the resistant##2##3##(2008-10#1)(2012-11#1)
with the resolution of##5##4##(1997-7#1)(2007-12#1)(2008-8#1)(2010-1#1)(2011-2#1)
with the resonant##2##3##(2007-11#1)(2008-3#1)
with the resonator##2##3##(2007-11#1)(2009-5#1)
with the respective##10##3##(1993-5#1)(1994-11#1)(1997-7#1)(2007-12#1)(2008-4#1)(2008-5#2)(2009-6#1)(2011-1#1)(2013-1#1)
with the response of##3##4##(2008-10#1)(2010-2#1)(2013-1#1)
with the response##11##3##(1991-10#1)(2005-8#1)(2005-9#1)(2007-8#1)(2008-10#4)(2010-2#1)(2012-12#1)(2013-1#1)
with the responsibility of##2##4##(1993-1#1)(2009-10#1)
with the responsibility##3##3##(1993-1#1)(1994-12#1)(2009-10#1)
with the rest of the##10##5##(1991-1#1)(1992-11#1)(1992-4#1)(2008-10#1)(2008-3#1)(2009-2#1)(2010-10#1)(2011-2#2)(2013-1#1)
with the rest of##12##4##(1991-1#1)(1992-11#1)(1992-4#1)(2008-10#2)(2008-3#1)(2009-2#1)(2010-10#1)(2011-2#3)(2013-1#1)
with the restoration of##2##4##(2007-8#2)
with the restriction enzyme##2##4##(2006-8#1)(2008-10#1)
with the restriction##3##3##(2006-8#1)(2008-10#1)(2008-2#1)
with the result of the##3##5##(1990-2#1)(2008-5#2)
with the result of##6##4##(1990-2#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#2)
with the result that##5##4##(1991-12#1)(1992-2#1)(1997-7#1)(2006-1#1)(2008-10#1)
with the result##13##3##(1990-2#1)(1991-12#1)(1992-2#1)(1997-7#1)(2006-1#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2009-6#1)
with the resulting##3##3##(2008-2#1)(2008-7#1)(2009-2#1)
with the results for the##2##5##(1996-2#1)(2007-8#1)
with the results from the##3##5##(2008-10#2)(2008-2#1)
with the results from##8##4##(1996-7#1)(2007-2#1)(2008-10#2)(2008-2#3)(2012-12#1)
with the results given by##2##5##(2008-10#1)(2008-5#1)
with the results in##2##4##(2006-8#1)(2008-10#1)
with the results obtained by the##3##6##(2005-11#1)(2006-8#1)(2008-10#1)
with the results obtained by using##2##6##(2008-10#2)
with the results obtained by##10##5##(2005-11#1)(2006-8#1)(2008-10#7)(2009-4#1)
with the results obtained from##5##5##(1992-2#1)(2008-10#3)(2008-2#1)
with the results obtained using##3##5##(2008-10#3)
with the results obtained with the##2##6##(2008-10#1)(2008-9#1)
with the results obtained with##5##5##(1990-12#1)(2007-8#1)(2008-10#1)(2008-9#2)
with the results obtained##25##4##(1990-12#1)(1992-2#1)(2005-11#1)(2006-8#1)(2007-8#1)(2008-10#16)(2008-2#1)(2008-9#2)(2009-4#1)
with the results of a##7##5##(1992-2#1)(1996-1#1)(1996-11#1)(2006-2#1)(2007-1#1)(2007-12#1)(2008-7#1)
with the results of direct numerical simulation##2##7##(2007-11#1)(2008-3#1)
with the results of recent##3##5##(1996-11#1)(2006-10#1)(2008-10#1)
with the results of the proposed##2##6##(2008-10#1)(2012-1#1)
with the results of the##14##5##(1990-9#1)(1991-4#1)(1992-12#1)(1994-2#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#3)(2012-1#1)(2012-12#1)(2013-1#1)
with the results of##68##4##(1990-4#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-7#2)(1992-9#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-11#2)(1996-9#1)(1997-4#1)(1997-8#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-2#2)(2006-7#1)(2007-1#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#4)(2008-2#3)(2008-3#7)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
with the results reported##2##4##(1990-11#1)(1990-3#1)
with the results##129##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-5#1)(1992-7#2)(1992-9#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-2#2)(1996-1#1)(1996-11#2)(1996-2#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-4#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-7#1)(2006-8#3)(2007-1#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-8#2)(2008-1#1)(2008-10#26)(2008-11#1)(2008-2#10)(2008-3#9)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#4)(2009-4#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#3)
with the retrograde##2##3##(1990-7#1)(1993-7#1)
with the reverse##3##3##(1996-4#1)(2006-4#1)(2013-8#1)
with the rhoptry-associated protein-1##2##4##(1992-12#2)
with the ribose##2##3##(1995-8#2)
with the ribosomal A-site##3##4##(2009-4#3)
with the rich##2##3##(2006-12#1)(2008-10#1)
with the right gastroepiploic artery##3##5##(2007-8#3)
with the right##14##3##(1991-6#1)(1994-2#1)(2005-10#1)(2007-10#1)(2007-12#2)(2007-8#3)(2008-1#1)(2008-11#1)(2008-5#1)(2010-9#1)(2011-2#1)
with the rigid probe##3##4##(2007-10#3)
with the rigorous coupled-wave analysis##2##5##(2008-2#2)
with the rigorous##4##3##(1991-8#1)(2007-12#1)(2008-2#2)
with the rise##2##3##(2012-2#2)
with the risk factors##2##4##(2007-9#1)(2013-8#1)
with the risk of##22##4##(2005-10#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-12#3)(2010-12#2)(2010-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
with the risk##31##3##(2005-10#2)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-12#3)(2010-12#3)(2010-4#1)(2010-9#1)(2011-1#1)(2013-1#2)(2013-8#3)
with the robot##2##3##(2007-8#1)(2011-2#1)
with the role of##10##4##(1992-6#1)(1993-3#1)(1994-3#1)(1996-4#1)(2006-10#2)(2008-4#1)(2010-12#2)(2011-2#1)
with the role played by##2##5##(1997-1#1)(2010-10#1)
with the role##12##3##(1992-6#1)(1993-3#1)(1994-3#1)(1996-4#1)(1997-1#1)(2006-10#2)(2008-4#1)(2010-10#1)(2010-12#2)(2011-2#1)
with the root##3##3##(2007-2#1)(2008-10#2)
with the roots##2##3##(2011-2#2)
with the rough endoplasmic reticulum##2##5##(1992-3#1)(1992-6#1)
with the routine##2##3##(1993-2#1)(2006-7#1)
with the rule##2##3##(2006-7#1)(2006-8#1)
with the sag##2##3##(2008-5#2)
with the same DNA##3##4##(1993-12#1)(1994-8#1)(2009-10#1)
with the same accuracy as##2##5##(1995-11#1)(1997-6#1)
with the same affinity##2##4##(1991-7#1)(1996-5#1)
with the same amino acid sequence##4##6##(1995-3#1)(2013-8#3)
with the same amino##5##4##(1994-12#1)(1995-3#1)(2013-8#3)
with the same amount of##2##5##(1996-1#1)(2009-7#1)
with the same amount##3##4##(1992-1#1)(1996-1#1)(2009-7#1)
with the same antigen##2##4##(2008-10#2)
with the same cell line##2##5##(1992-9#1)(2013-1#1)
with the same concentration##3##4##(1991-3#1)(2007-11#1)(2008-11#1)
with the same conditions##2##4##(1996-7#1)(2008-3#1)
with the same degree of##2##5##(1993-11#1)(2008-2#1)
with the same density##2##4##(1994-11#1)(2011-12#1)
with the same diameter##2##4##(2008-3#1)(2010-8#1)
with the same disease##2##4##(1992-8#1)(2009-9#1)
with the same drugs##2##4##(1992-6#1)(2007-7#1)
with the same efficiency##3##4##(1990-5#1)(1997-4#1)(2008-10#1)
with the same flow rate##2##5##(2008-10#1)(2012-12#1)
with the same frequency and##2##5##(2008-10#1)(2008-6#1)
with the same frequency##4##4##(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)
with the same genetic background##2##5##(2011-2#1)(2012-3#1)
with the same genetic##3##4##(2008-9#1)(2011-2#1)(2012-3#1)
with the same high##2##4##(1995-10#1)(2008-3#1)
with the same level of##2##5##(1993-5#1)(2012-12#1)
with the same molecular weight as##2##6##(1992-3#1)(1994-9#1)
with the same molecular weight##3##5##(1992-3#1)(1994-9#1)(2007-11#1)
with the same number of##3##5##(2008-10#2)(2008-2#1)
with the same optical path##2##5##(2008-10#1)(2008-2#1)
with the same order##2##4##(1994-11#1)(1997-2#1)
with the same period##5##4##(1996-11#1)(2007-12#2)(2008-3#1)(2008-7#1)
with the same phenotype##2##4##(2007-11#1)(2012-12#1)
with the same polarization##2##4##(2008-2#2)
with the same properties as those##2##6##(1992-10#1)(2005-11#1)
with the same setup##2##4##(2008-2#1)(2008-3#1)
with the same strain##3##4##(1997-6#1)(2008-4#1)(2008-5#1)
with the same system##2##4##(2008-10#1)(2008-2#1)
with the same technique##2##4##(1992-8#1)(2009-3#1)
with the same treatment##2##4##(1994-6#1)(2008-5#1)
with the same volume##2##4##(2008-3#1)(2012-3#1)
with the same##252##3##(1990-10#2)(1990-12#1)(1990-2#2)(1990-5#1)(1990-9#3)(1991-10#1)(1991-3#4)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#2)(1992-3#1)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#2)(1993-4#1)(1993-5#1)(1993-8#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#3)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#2)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#1)(2004-11#1)(2004-9#2)(2005-10#2)(2005-11#3)(2005-12#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#8)(2007-12#5)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#36)(2008-11#5)(2008-12#1)(2008-2#12)(2008-3#20)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#1)(2008-8#6)(2008-9#3)(2009-10#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#3)(2012-12#7)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#4)
with the sample##6##3##(1990-12#1)(2008-10#4)(2012-1#1)
with the samples##5##3##(1996-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)
with the sampling##3##3##(2008-10#2)(2008-8#1)
with the sarcoplasmic reticulum##3##4##(1994-2#2)(1994-9#1)
with the satisfactory results##2##4##(2008-10#2)
with the scale##2##3##(1990-2#1)(2008-3#1)
with the scaling factor of the##2##6##(2005-11#2)
with the scene image##2##4##(2007-12#1)(2008-1#1)
with the scores##2##3##(2008-1#1)(2009-4#1)
with the search for##2##4##(2004-12#1)(2008-10#1)
with the seasonal##2##3##(2008-7#1)(2008-9#1)
with the second harmonic##2##4##(2007-11#1)(2007-12#1)
with the second##13##3##(1991-3#1)(1995-1#1)(1996-5#1)(1997-3#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-5#1)(2012-3#1)
with the secondary##3##3##(1996-5#1)(2008-1#1)(2008-10#1)
with the security rule##2##4##(2006-8#1)(2008-4#1)
with the security##3##3##(2006-8#1)(2007-12#1)(2008-4#1)
with the segmented##2##3##(1991-3#1)(2008-4#1)
with the selected ion monitoring##2##5##(2008-10#1)(2013-1#1)
with the selected##6##3##(1996-8#1)(2006-8#1)(2007-12#1)(2008-10#1)(2010-7#1)(2013-1#1)
with the selection of##3##4##(2008-10#2)(2010-11#1)
with the selection##4##3##(2008-10#2)(2010-11#1)(2012-2#1)
with the selective##14##3##(1991-2#1)(1991-8#1)(1993-11#1)(1995-12#1)(1996-2#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-4#3)(2008-6#2)
with the selectivity of##2##4##(2007-8#1)(2008-10#1)
with the selectivity##4##3##(2007-8#1)(2008-10#2)(2008-2#1)
with the semi-batch system##2##4##(2008-10#2)
with the seminal##2##3##(1997-8#1)(2010-8#1)
with the sensing phase##2##4##(2008-10#2)
with the sensing##3##3##(2008-10#2)(2008-2#1)
with the sensitivity of the##2##5##(2007-12#1)(2008-10#1)
with the sensitivity of##7##4##(1990-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-9#1)
with the sensitivity##10##3##(1990-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-8#1)(2008-9#1)
with the sensor##6##3##(1993-12#1)(1996-7#1)(2007-11#1)(2008-3#2)(2010-2#1)
with the separation and##2##4##(2008-12#2)
with the separation of##3##4##(1997-6#1)(2008-10#2)
with the separation##5##3##(1997-6#1)(2008-10#2)(2008-12#2)
with the sequence of##5##4##(1990-11#1)(1990-5#1)(1993-8#1)(1994-11#1)(1997-7#1)
with the sequence##16##3##(1990-11#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-3#2)(1997-7#1)(2006-10#1)
with the sequences##7##3##(1990-5#1)(1996-7#1)(1997-6#2)(1997-8#1)(2011-1#1)(2012-12#1)
with the sequential injection##2##4##(2008-10#1)(2008-5#1)
with the serine##2##3##(1993-11#1)(1995-8#1)
with the serine/threonine##3##3##(1991-2#1)(1996-2#1)(2006-5#1)
with the serotonin##4##3##(1991-1#1)(1993-12#1)(2005-11#1)(2010-12#1)
with the serpin##2##3##(1991-6#1)(1993-11#1)
with the serum##4##3##(1995-2#2)(2005-9#1)(2010-12#1)
with the service##8##3##(1992-1#1)(1994-8#1)(1995-9#1)(1997-2#1)(2011-2#1)(2012-3#3)
with the severe form of the disease##2##7##(2008-7#2)
with the severe##5##3##(2008-10#1)(2008-7#2)(2009-12#1)(2010-2#1)
with the severity of abdominal aortic calcification in Japanese postmenopausal women and men##2##13##(2010-10#2)
with the severity of abdominal aortic calcification##4##7##(2010-10#4)
with the severity of periodontal disease##2##6##(2010-4#1)(2012-2#1)
with the severity of the##6##5##(1993-9#1)(1995-7#1)(1997-6#1)(2005-1#1)(2008-3#1)(2008-7#1)
with the severity of##32##4##(1993-2#1)(1993-9#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-7#1)(1995-9#1)(1997-5#1)(1997-6#1)(1997-8#2)(2005-1#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-7#2)(2010-10#4)(2010-4#1)(2010-7#1)(2012-2#1)
with the severity##33##3##(1993-2#1)(1993-9#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-7#1)(1995-9#1)(1997-5#1)(1997-6#1)(1997-8#2)(2005-1#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-7#2)(2010-10#4)(2010-4#1)(2010-7#1)(2012-2#1)(2012-3#1)
with the sex chromosomes##2##4##(2005-10#1)(2010-3#1)
with the sex##3##3##(2005-10#1)(2008-5#1)(2010-3#1)
with the sexual##3##3##(2008-10#1)(2008-9#1)(2013-7#1)
with the shift to##2##4##(2008-11#2)
with the shift##4##3##(1993-12#1)(2008-11#2)(2008-5#1)
with the short bowel syndrome##2##5##(1991-12#1)(1994-3#1)
with the short##5##3##(1991-12#1)(1994-3#1)(2007-12#1)(2008-10#2)
with the shorter##2##3##(2008-2#1)(2008-7#1)
with the shortest##2##3##(1995-2#1)(1997-8#1)
with the side chain of##2##5##(1994-11#1)(1994-8#1)
with the side##3##3##(1994-11#1)(1994-8#1)(2007-1#1)
with the sign##2##3##(1996-11#1)(2008-1#1)
with the signal##7##3##(1996-2#2)(1997-8#1)(2007-12#2)(2008-2#1)(2011-1#1)
with the signals##3##3##(1990-3#1)(1996-4#1)(2008-2#1)
with the significant##2##3##(2008-10#1)(2013-8#1)
with the simple##3##3##(1991-2#1)(2007-12#1)(2008-2#1)
with the simpler##2##3##(2008-3#1)(2011-2#1)
with the simplicity of the##2##5##(2005-11#1)(2010-10#1)
with the simplicity of##3##4##(2005-11#1)(2007-12#1)(2010-10#1)
with the simplified##2##3##(2005-11#1)(2008-2#1)
with the simulated##5##3##(1994-3#1)(2008-10#2)(2008-3#1)(2008-5#1)
with the simulation##6##3##(2007-8#1)(2008-2#3)(2008-3#2)
with the simulations##2##3##(2007-12#1)(2008-2#1)
with the simultaneous determination of##2##5##(2008-10#2)
with the simultaneous formation of##2##5##(1991-7#1)(2008-6#1)
with the simultaneous##6##3##(1991-7#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)
with the single##12##3##(1991-3#1)(1997-4#1)(2007-4#2)(2008-10#2)(2008-4#1)(2008-5#2)(2008-8#1)(2011-2#2)
with the singular##2##3##(2004-8#1)(2007-12#1)
with the site##2##3##(1992-1#1)(1993-11#1)
with the situation##10##3##(1991-6#1)(1992-5#1)(1995-11#1)(2006-4#1)(2007-11#2)(2008-2#1)(2010-12#1)(2012-2#1)(2013-1#1)
with the six##3##3##(1993-3#1)(1993-6#1)(2008-10#1)
with the size of the##11##5##(1993-2#1)(1995-2#1)(1996-7#1)(2006-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-8#1)(2012-2#1)
with the size of##16##4##(1992-9#1)(1993-2#1)(1995-2#2)(1996-6#1)(1996-7#1)(2006-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-8#1)(2010-2#1)(2012-2#1)
with the size##20##3##(1990-3#1)(1990-9#1)(1992-9#1)(1993-2#1)(1995-2#2)(1996-6#1)(1996-7#1)(2006-1#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-8#1)(2010-2#1)(2012-2#1)
with the skeletal##2##3##(1995-11#1)(2007-11#1)
with the skills##2##3##(2008-11#1)(2011-1#1)
with the skin of##2##4##(1992-3#1)(2008-5#1)
with the skin##5##3##(1992-3#1)(2008-10#1)(2008-5#3)
with the slight##2##3##(2008-10#1)(2008-11#1)
with the slope##4##3##(1990-11#1)(2007-11#1)(2008-10#2)
with the slow##3##3##(1993-5#1)(2008-7#1)(2008-9#1)
with the small##6##3##(1996-2#1)(1996-9#1)(2005-11#1)(2008-10#1)(2008-3#1)(2010-2#1)
with the smaller##4##3##(1991-7#1)(2004-1#1)(2008-11#1)(2009-5#1)
with the smallest##7##3##(1990-7#1)(2007-4#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-10#1)(2011-2#1)
with the so-called &quot##2##4##(1990-1#1)(1993-3#1)
with the so-called##3##3##(1990-1#1)(1993-3#1)(1996-6#1)
with the social##2##3##(1993-3#1)(2013-1#1)
with the sodium##2##3##(2007-8#1)(2009-3#1)
with the software##2##3##(2012-1#1)(2013-1#1)
with the soil##3##3##(2008-5#1)(2010-5#1)(2013-8#1)
with the sole##3##3##(1990-9#1)(2008-10#1)(2013-8#1)
with the solid##4##3##(2005-4#1)(2006-3#1)(2008-10#2)
with the soluble##3##3##(1991-12#1)(1991-2#1)(1997-2#1)
with the solute##2##3##(1992-12#1)(2010-2#1)
with the solution of##4##4##(2007-12#1)(2008-3#1)(2008-7#1)(2012-3#1)
with the solution##7##3##(1995-1#1)(1996-7#1)(1997-7#1)(2007-12#1)(2008-3#1)(2008-7#1)(2012-3#1)
with the solvent molecules##2##4##(2006-10#1)(2008-10#1)
with the solvent##9##3##(1994-11#1)(1995-10#2)(1996-4#1)(1997-4#1)(2005-4#1)(2006-10#1)(2008-10#1)(2010-2#1)
with the somatic##2##3##(1990-6#1)(1994-10#1)
with the sorbent##2##3##(2008-10#2)
with the source##4##3##(2008-10#2)(2009-2#1)(2011-2#1)
with the spatial##3##3##(2008-1#2)(2011-1#1)
with the special##3##3##(1995-11#1)(1996-11#1)(2013-1#1)
with the species##4##3##(1996-11#1)(1996-12#1)(2010-6#1)(2010-8#1)
with the specific energy dissipation rate##2##6##(2008-7#2)
with the specific energy dissipation##3##5##(2008-7#3)
with the specific growth rate##3##5##(1996-2#3)
with the specific##25##3##(1991-8#1)(1994-8#1)(1996-2#4)(1996-7#1)(1997-3#1)(1997-8#1)(2003-11#1)(2004-9#1)(2005-8#1)(2006-12#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-7#4)(2008-8#1)(2008-9#2)
with the specificity##2##3##(1991-9#1)(2011-2#1)
with the specimen##2##3##(2008-10#1)(2010-2#1)
with the spectra of##2##4##(2008-10#1)(2010-5#1)
with the spectral response of##2##5##(2007-11#1)(2008-3#1)
with the spectral##8##3##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#2)(2012-12#1)
with the spectrophotometric##3##3##(2008-10#3)
with the spectrum of##3##4##(1990-2#1)(1996-2#1)(2008-10#1)
with the spectrum##4##3##(1990-2#1)(1996-2#1)(2008-10#1)(2008-3#1)
with the speed##2##3##(2012-1#1)(2012-2#1)
with the sperm##6##3##(1990-11#1)(1991-8#1)(2008-7#2)(2012-12#2)
with the spider##2##3##(2007-6#2)
with the spread of##3##4##(1990-3#1)(1997-8#1)(2008-4#1)
with the square root of the##3##6##(2007-12#1)(2008-10#1)(2013-7#1)
with the square root of##5##5##(2006-6#1)(2007-12#1)(2008-10#1)(2008-9#1)(2013-7#1)
with the square##7##3##(2006-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2013-7#1)
with the stabilizing##3##3##(1995-5#1)(2006-10#1)(2007-11#1)
with the stage of the disease##2##6##(1991-9#1)(1995-8#1)
with the stage of the##3##5##(1990-8#1)(1991-9#1)(1995-8#1)
with the stage of##4##4##(1990-8#1)(1991-9#1)(1995-8#1)(2007-12#1)
with the stage##6##3##(1990-8#1)(1991-9#1)(1992-9#1)(1995-8#1)(2007-12#1)(2010-12#1)
with the standard VAS##2##4##(2009-3#2)
with the standard addition method##2##5##(2008-10#2)
with the standard addition##4##4##(2008-10#4)
with the standard case##3##4##(2005-11#2)(2008-2#1)
with the standard protocol##2##4##(2008-6#1)(2012-3#1)
with the standard regimen##2##4##(2006-10#1)(2008-7#1)
with the standard##67##3##(1991-10#1)(1991-5#1)(1993-10#2)(1994-2#1)(1996-3#1)(2005-11#2)(2005-4#1)(2005-9#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#4)(2011-1#1)(2012-3#2)
with the standards##2##3##(2008-1#1)(2008-3#1)
with the start of##4##4##(1990-4#1)(1993-2#1)(2006-5#1)(2012-2#1)
with the starting##3##3##(2008-5#1)(2009-7#1)(2012-3#1)
with the state of##3##4##(1993-8#1)(2007-8#1)(2008-2#1)
with the static##3##3##(2008-10#2)(2008-5#1)
with the stationary##2##3##(2008-10#1)(2008-8#1)
with the statistical##2##3##(1992-2#1)(2008-10#1)
with the steady-state levels of##2##5##(1992-11#2)
with the steps##2##3##(1994-2#1)(2007-4#1)
with the sterically##2##3##(2008-11#1)(2010-5#1)
with the steroid##3##3##(1991-4#1)(1996-4#1)(2007-11#1)
with the sticks##2##3##(2009-2#2)
with the stimulation##2##3##(1991-8#1)(1991-9#1)
with the stimulus##4##3##(1993-7#1)(2008-4#1)(2008-7#1)(2010-4#1)
with the strain of##2##4##(2007-9#1)(2008-5#1)
with the strain##3##3##(2007-6#1)(2007-9#1)(2008-5#1)
with the stress##2##3##(2006-3#1)(2010-10#1)
with the stressed##2##3##(2008-11#1)(2013-1#1)
with the strong##5##3##(2006-7#1)(2008-10#2)(2008-3#1)(2010-5#1)
with the strongest##6##3##(2006-9#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-11#1)
with the structural##9##3##(1991-3#1)(1994-11#1)(1995-2#1)(2006-10#1)(2006-12#1)(2008-10#2)(2009-10#2)
with the structure and##2##4##(1990-2#1)(1996-8#1)
with the structure of the##7##5##(1991-5#1)(1996-7#1)(2005-11#2)(2008-10#2)(2010-12#1)
with the structure of##11##4##(1991-5#1)(1992-7#1)(1994-2#1)(1996-7#1)(2005-11#2)(2006-3#1)(2008-10#2)(2008-12#1)(2010-12#1)
with the structure##15##3##(1990-2#1)(1990-7#1)(1991-12#1)(1991-5#1)(1992-7#1)(1994-2#1)(1996-7#1)(1996-8#1)(2005-11#2)(2006-3#1)(2008-10#2)(2008-12#1)(2010-12#1)
with the structures of##3##4##(1990-7#1)(2007-1#1)(2012-2#1)
with the structures##6##3##(1990-7#1)(1994-8#1)(1994-9#2)(2007-1#1)(2012-2#1)
with the study of the##2##5##(2007-8#1)(2008-10#1)
with the study of##7##4##(2007-7#2)(2007-8#2)(2008-10#1)(2008-3#1)(2011-2#1)
with the study##13##3##(1996-3#1)(2007-12#1)(2007-7#3)(2007-8#2)(2008-10#2)(2008-3#1)(2008-8#1)(2010-10#1)(2011-2#1)
with the subject##2##3##(2009-6#1)(2009-7#1)
with the subjective##2##3##(1996-5#1)(2011-2#1)
with the subjects##4##3##(1996-2#1)(2007-1#1)(2008-7#2)
with the subsequent##7##3##(1990-12#1)(2007-2#1)(2008-1#1)(2008-11#2)(2011-1#1)(2013-1#1)
with the substitution##2##3##(1990-12#1)(2013-1#1)
with the substrate##11##3##(1990-7#1)(1994-12#1)(1995-8#1)(2008-10#2)(2008-4#1)(2008-5#2)(2012-12#2)(2013-8#1)
with the successful##3##3##(2008-10#1)(2010-2#1)(2011-1#1)
with the suggestion that##2##4##(1993-12#1)(2011-2#1)
with the sulfhydryl##2##3##(1993-11#1)(2008-7#1)
with the sulfur atom in even##2##6##(2007-8#2)
with the sulfur atom in##3##5##(2007-8#3)
with the sulfur atom##4##4##(2007-8#4)
with the sulfur##6##3##(1997-7#1)(2007-8#4)(2010-5#1)
with the superior vena cava##3##5##(2007-8#3)
with the superior##5##3##(1991-3#1)(2007-8#3)(2013-1#1)
with the superoxide##2##3##(1990-11#1)(1992-12#1)
with the supplement##3##3##(2013-8#3)
with the support of the##5##5##(1996-12#1)(1997-6#1)(2008-6#1)(2008-9#1)(2011-12#1)
with the support of##10##4##(1991-2#1)(1994-12#1)(1996-12#1)(1997-6#1)(2008-5#1)(2008-6#2)(2008-9#1)(2011-12#1)(2011-2#1)
with the support##13##3##(1991-2#1)(1994-12#1)(1996-12#1)(1997-6#1)(2007-8#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-8#1)(2011-12#1)(2011-2#2)
with the supporting##2##3##(1994-3#1)(2009-4#1)
with the surface of the##3##5##(1992-12#1)(2008-10#1)(2010-4#1)
with the surface of##5##4##(1990-5#1)(1992-12#1)(2006-1#1)(2008-10#1)(2010-4#1)
with the surface##15##3##(1990-5#1)(1992-12#1)(2005-11#2)(2006-1#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-4#2)
with the surfactant##4##3##(2005-11#2)(2008-10#1)(2008-5#1)
with the surfactants##2##3##(1992-11#1)(2008-5#1)
with the surgeon's##2##3##(2006-6#1)(2011-2#1)
with the surgery##3##3##(2007-11#1)(2008-8#1)(2008-9#1)
with the surgical procedures##2##4##(1996-9#1)(2012-2#1)
with the surgical##12##3##(1994-12#1)(1995-5#1)(1996-9#1)(2007-7#3)(2007-8#1)(2008-8#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-2#1)
with the surrounding##11##3##(1995-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-11#1)(2011-1#1)(2012-1#1)(2012-2#2)
with the surveillance##2##3##(2008-1#1)(2012-12#1)
with the survival##3##3##(1995-12#1)(2008-10#1)(2010-3#1)
with the susceptibility to##3##4##(2008-9#1)(2011-1#2)
with the susceptible##7##3##(2008-10#6)(2012-11#1)
with the suspected##2##3##(2008-4#1)(2009-1#1)
with the symptom##2##3##(2006-8#1)(2013-8#1)
with the symptoms of##2##4##(1992-11#1)(2011-1#1)
with the symptoms##4##3##(1992-11#1)(1994-3#1)(1997-3#1)(2011-1#1)
with the synaptic##2##3##(1997-6#1)(2008-8#1)
with the synchronous##2##3##(2008-11#1)(2008-3#1)
with the syndrome of##5##4##(1990-9#1)(1993-11#1)(1997-3#1)(2007-10#1)(2008-6#1)
with the syndrome##9##3##(1990-9#1)(1992-3#1)(1993-11#1)(1997-3#1)(2007-10#2)(2008-3#1)(2008-6#1)(2012-11#1)
with the synthesis of##13##4##(1994-8#1)(1994-9#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
with the synthesis##15##3##(1994-8#1)(1994-9#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
with the synthesized##2##3##(2007-1#1)(2013-7#1)
with the synthetic glucocorticoid dexamethasone##2##5##(1992-12#1)(1993-7#1)
with the synthetic glucocorticoid##3##4##(1992-12#1)(1993-7#1)(2011-2#1)
with the synthetic peptide##2##4##(1991-3#1)(1995-5#1)
with the synthetic##10##3##(1991-3#1)(1992-12#1)(1993-7#1)(1994-5#1)(1995-1#1)(1995-5#1)(1995-9#1)(2008-4#1)(2008-5#1)(2011-2#1)
with the system and##2##4##(1994-2#1)(2009-9#1)
with the system##10##3##(1991-5#1)(1993-3#1)(1994-2#1)(2008-10#4)(2008-3#1)(2009-9#1)(2012-1#1)
with the system's##2##3##(1991-8#1)(2010-8#1)
with the systemic##4##3##(2005-1#1)(2006-10#1)(2008-10#1)(2012-3#1)
with the tail##2##3##(1993-1#1)(1997-2#1)
with the target##24##3##(1991-2#1)(1991-4#1)(1996-8#1)(2005-7#1)(2008-1#3)(2008-10#5)(2008-2#2)(2008-9#1)(2009-11#1)(2009-8#1)(2010-11#1)(2012-1#1)(2012-12#1)(2013-1#3)(2013-8#1)
with the task to##2##4##(1995-5#1)(2010-12#1)
with the task##5##3##(1995-5#1)(2006-3#1)(2008-11#1)(2008-12#1)(2010-12#1)
with the technique in two steps##2##6##(2012-12#2)
with the technique of##7##4##(2005-4#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-3#1)
with the technique##13##3##(2005-4#1)(2006-10#1)(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-11#1)(2012-12#2)(2012-3#1)
with the technology##3##3##(2007-2#1)(2007-4#1)(2008-12#1)
with the teenage##2##3##(2006-7#1)(2009-7#1)
with the teeth##2##3##(1995-3#1)(2008-5#1)
with the teicoplanin chiral selector##2##5##(2008-10#2)
with the temperature of##2##4##(1996-1#1)(2012-12#1)
with the temperature##11##3##(1991-1#1)(1992-7#1)(1996-1#1)(1997-2#1)(2008-10#2)(2008-9#1)(2011-2#1)(2012-12#1)(2013-7#2)
with the temporal##5##3##(1992-11#1)(1995-2#1)(2007-1#1)(2007-12#1)(2007-3#1)
with the temporally##2##3##(2008-2#1)(2010-5#1)
with the terminal##2##3##(1993-6#1)(2008-10#1)
with the terms##3##3##(1993-12#1)(2013-1#2)
with the test SNP##2##4##(2012-3#2)
with the test##7##3##(1990-12#2)(1991-9#1)(1994-3#1)(2008-11#1)(2012-3#2)
with the tested##4##3##(1994-3#1)(2007-7#1)(2009-6#1)(2011-1#1)
with the theme##2##3##(1996-1#1)(2011-2#1)
with the themes of##2##4##(2005-8#1)(2010-9#1)
with the theoretical analysis##3##4##(2008-2#2)(2008-3#1)
with the theoretical calculations##2##4##(2008-2#1)(2008-3#1)
with the theoretical model##4##4##(2005-11#1)(2008-3#1)(2010-2#1)(2013-8#1)
with the theoretical prediction##6##4##(1996-11#1)(2007-11#1)(2008-2#2)(2008-3#2)
with the theoretical predictions##6##4##(2007-12#1)(2008-2#3)(2008-3#1)(2008-5#1)
with the theoretical results##2##4##(2007-11#1)(2008-2#1)
with the theoretical values##3##4##(2008-10#1)(2008-2#2)
with the theoretical##42##3##(1996-11#1)(2005-11#2)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#5)(2008-10#2)(2008-2#12)(2008-3#10)(2008-5#2)(2008-7#1)(2009-5#1)(2010-2#1)(2013-8#1)
with the theoretically calculated##4##4##(1995-2#1)(2007-12#1)(2008-2#1)(2008-3#1)
with the theoretically##5##3##(1995-2#1)(1997-3#1)(2007-12#1)(2008-2#1)(2008-3#1)
with the theory of##4##4##(1990-3#1)(2007-11#1)(2008-1#1)(2009-2#1)
with the theory##11##3##(1990-3#1)(2004-2#1)(2005-11#1)(2006-4#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-3#1)(2009-2#1)(2009-7#1)
with the therapeutic##4##3##(1992-2#1)(2007-5#1)(2008-8#1)(2012-2#1)
with the therapy##3##3##(2011-2#1)(2011-3#1)(2013-7#1)
with the thesis that##2##4##(2007-12#1)(2008-11#1)
with the thickness of ca##2##5##(2008-10#2)
with the thickness of##4##4##(2008-10#3)(2008-2#1)
with the thickness##7##3##(2007-12#1)(2008-10#4)(2008-2#2)
with the third##4##3##(1993-8#1)(1995-3#1)(2006-9#1)(2008-2#1)
with the threat of##2##4##(1997-5#1)(2010-8#1)
with the three methods##2##4##(1992-2#1)(1993-2#1)
with the three most##2##4##(2008-10#1)(2008-7#1)
with the three substrates##2##4##(1990-5#1)(1996-4#1)
with the three##21##3##(1990-5#1)(1990-7#1)(1992-2#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-6#1)(1996-2#1)(1996-4#1)(1996-5#1)(2005-11#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-9#1)(2012-1#1)(2013-8#1)
with the thromboxane##2##3##(1996-10#1)(2007-9#1)
with the thylakoid bioassay##2##4##(2008-11#2)
with the thylakoid##3##3##(1994-12#1)(2008-11#2)
with the thymidine##2##3##(1996-5#1)(2008-5#1)
with the tidal##2##3##(2007-5#1)(2010-8#1)
with the time of##5##4##(1990-1#1)(1996-3#1)(2005-11#1)(2013-1#2)
with the time##16##3##(1990-1#1)(1991-11#1)(1991-2#1)(1992-7#1)(1994-3#1)(1994-5#1)(1996-3#2)(2005-11#1)(2006-7#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-4#1)(2013-1#2)
with the time-dependent##2##3##(1992-11#1)(1997-7#1)
with the times##2##3##(1992-2#1)(1996-4#1)
with the timing of##2##4##(1993-11#1)(2006-10#1)
with the tip of the##2##5##(2007-7#1)(2008-5#1)
with the tip##3##3##(2007-7#2)(2008-5#1)
with the tissue##6##3##(1991-9#1)(2007-12#1)(2008-2#2)(2011-1#1)(2013-1#1)
with the titration##2##3##(1991-9#1)(2008-10#1)
with the tools##3##3##(2008-10#1)(2008-3#1)(2012-1#1)
with the total amount##2##4##(1996-11#1)(2010-2#1)
with the total protein##2##4##(1993-12#1)(2008-10#1)
with the total score##3##4##(1996-8#1)(2010-10#1)(2011-1#1)
with the total##22##3##(1992-3#1)(1993-12#1)(1994-3#1)(1996-11#1)(1996-8#1)(2004-2#1)(2007-11#2)(2008-10#5)(2008-3#2)(2010-10#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-1#1)(2013-8#2)
with the toxin##2##3##(1995-8#1)(2007-12#1)
with the traditional method##2##4##(2008-5#1)(2012-1#1)
with the traditional##15##3##(1992-1#1)(1993-7#1)(1996-12#1)(2005-11#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
with the training and##2##4##(1996-12#1)(2008-8#1)
with the training##4##3##(1996-12#1)(1996-2#1)(2008-10#1)(2008-8#1)
with the trait##3##3##(1996-3#1)(2008-11#1)(2012-3#1)
with the transcription##4##3##(1992-5#1)(1995-6#1)(1995-9#1)(1996-4#1)
with the transcriptional##5##3##(1990-11#1)(1997-4#1)(2010-12#1)(2013-1#2)
with the transfer##2##3##(1992-8#1)(2006-10#1)
with the transferrin receptor##2##4##(1990-8#1)(2006-10#1)
with the transform##2##3##(2007-12#1)(2008-3#1)
with the transformed##2##3##(1990-8#1)(2008-11#1)
with the transforming growth factor##2##5##(1994-10#1)(2008-5#1)
with the transient##5##3##(1993-11#1)(1994-12#1)(1996-1#1)(2008-10#1)(2008-7#1)
with the transition##6##3##(1997-7#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-9#1)
with the transmission##2##3##(2009-2#1)(2009-7#1)
with the transmitted##2##3##(2008-2#2)
with the transport of##3##4##(1992-3#2)(1995-6#1)
with the transport##4##3##(1992-3#2)(1995-6#1)(2008-3#1)
with the treating##2##3##(2007-12#1)(2009-4#1)
with the treatment and##2##4##(2007-11#1)(2013-1#1)
with the treatment of patients##2##5##(2006-8#1)(2011-1#1)
with the treatment of##9##4##(1991-2#1)(1993-10#1)(1995-5#1)(2006-8#1)(2007-11#1)(2007-8#1)(2010-6#1)(2011-1#1)(2012-2#1)
with the treatment##20##3##(1991-2#1)(1993-10#1)(1995-11#1)(1995-5#1)(1996-6#1)(2004-3#2)(2006-8#1)(2006-9#1)(2007-11#3)(2007-8#1)(2008-9#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
with the tridentate##2##3##(1997-7#2)
with the true##4##3##(1992-11#1)(2008-10#1)(2008-3#1)(2012-7#1)
with the tubular##2##3##(2008-5#1)(2008-7#1)
with the tumor##11##3##(1991-5#1)(1992-1#1)(1994-3#1)(1995-5#1)(1996-6#1)(2006-12#1)(2006-7#1)(2007-6#1)(2008-11#1)(2009-4#1)(2012-2#1)
with the tumor-type##2##3##(1990-11#1)(2012-12#1)
with the tumour##2##3##(1995-12#1)(2010-9#1)
with the two major##2##4##(1995-2#1)(2007-9#1)
with the two other##3##4##(1994-12#1)(1996-7#1)(2008-10#1)
with the two##53##3##(1990-2#1)(1990-4#2)(1990-5#1)(1991-2#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-11#1)(1995-2#2)(1995-8#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-9#2)(2008-10#12)(2008-3#1)(2008-5#2)(2008-8#1)(2010-5#1)(2011-1#1)(2012-11#1)(2012-12#1)(2013-1#1)
with the two-dimensional##2##3##(2007-12#1)(2008-3#1)
with the type II##2##4##(2008-3#1)(2008-9#1)
with the type of the##2##5##(1996-3#1)(2007-12#1)
with the type of##16##4##(1991-5#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-6#1)(2008-8#1)(2011-1#1)(2012-2#1)
with the type strain##3##4##(2008-10#2)(2012-2#1)
with the type##22##3##(1991-5#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#2)(2013-1#1)
with the typical clinical##2##4##(2007-7#1)(2008-7#1)
with the typical##7##3##(1994-10#1)(2006-10#1)(2006-4#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#1)
with the tyrosine kinase inhibitors##2##5##(1994-9#1)(2012-12#1)
with the tyrosine kinase##3##4##(1994-9#1)(1996-5#1)(2012-12#1)
with the tyrosine##5##3##(1994-12#1)(1994-9#1)(1995-5#1)(1996-5#1)(2012-12#1)
with the ultimate aim of##3##5##(1997-1#1)(2006-10#1)(2011-2#1)
with the ultimate goal of##3##5##(2006-2#1)(2011-12#1)(2012-1#1)
with the ultimate goal##5##4##(2006-2#1)(2008-7#1)(2009-9#1)(2011-12#1)(2012-1#1)
with the ultimate##12##3##(1997-1#1)(2005-9#1)(2006-10#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-1#1)
with the uncertainties##2##3##(2005-7#1)(2008-2#1)
with the uncorrected##2##3##(1993-4#1)(2008-3#1)
with the underlying##11##3##(1992-3#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-3#2)(2008-7#1)(2009-10#1)(2010-11#1)(2010-2#1)
with the understanding that##2##4##(1996-3#1)(2006-12#1)
with the uniform##2##3##(2007-12#1)(2009-9#1)
with the union##2##3##(1995-12#1)(1995-3#1)
with the unique##4##3##(1993-3#1)(2009-7#1)(2012-11#2)
with the unmodified##2##3##(2008-10#1)(2009-7#1)
with the unusual##4##3##(2008-11#1)(2008-5#1)(2009-3#1)(2009-5#1)
with the updated##2##3##(2006-10#1)(2012-3#1)
with the upper##4##3##(1992-4#1)(2007-11#1)(2009-11#1)(2009-9#1)
with the upregulation of##2##4##(2010-5#1)(2012-2#1)
with the uptake of##5##4##(1991-8#1)(1995-2#1)(2008-7#1)(2008-8#1)(2011-2#1)
with the uptake##6##3##(1991-8#1)(1993-11#1)(1995-2#1)(2008-7#1)(2008-8#1)(2011-2#1)
with the urinary##2##3##(1996-12#1)(2011-2#1)
with the use of a commercial##3##6##(2007-8#1)(2008-10#1)(2013-8#1)
with the use of a##29##5##(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-10#5)(2008-2#4)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#2)(2010-10#1)(2010-3#1)(2010-8#1)(2011-12#1)(2013-8#1)
with the use of an##9##5##(2006-4#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-12#1)(2011-2#1)(2012-2#1)
with the use of antibiotics##2##5##(2009-5#1)(2011-2#1)
with the use of both##2##5##(2008-8#1)(2009-8#1)
with the use of combined##2##5##(1993-6#1)(2008-10#1)
with the use of conventional##2##5##(2008-10#1)(2013-7#1)
with the use of drugs##2##5##(1993-5#1)(2006-10#1)
with the use of human##2##5##(2012-12#1)(2013-1#1)
with the use of implants##2##5##(2007-11#2)
with the use of more##2##5##(2008-3#1)(2013-1#1)
with the use of several##2##5##(1995-2#1)(2006-2#1)
with the use of the##28##5##(1990-12#1)(1990-8#1)(1992-1#1)(1992-2#1)(1995-6#1)(1997-3#1)(2004-12#1)(2006-10#1)(2007-11#2)(2007-2#1)(2007-8#2)(2008-10#4)(2008-3#1)(2008-5#1)(2009-10#1)(2009-2#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
with the use of thermal##2##5##(1992-7#1)(2008-10#1)
with the use of this##3##5##(1996-5#1)(2006-5#1)(2007-8#1)
with the use of two##2##5##(1997-6#1)(2008-10#1)
with the use of##268##4##(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#3)(1990-9#1)(1991-3#1)(1991-5#1)(1992-1#2)(1992-2#2)(1992-3#2)(1992-7#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#2)(1994-12#1)(1994-3#1)(1994-9#1)(1995-2#3)(1995-3#1)(1995-6#2)(1996-5#2)(1996-9#1)(1997-3#1)(1997-6#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-10#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-10#16)(2006-11#2)(2006-2#1)(2006-4#2)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#16)(2007-12#1)(2007-2#3)(2007-3#2)(2007-4#2)(2007-6#1)(2007-7#8)(2007-8#15)(2007-9#1)(2008-1#6)(2008-10#31)(2008-11#6)(2008-12#2)(2008-2#7)(2008-3#11)(2008-4#3)(2008-5#9)(2008-6#4)(2008-7#6)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#2)(2010-10#3)(2010-3#3)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-12#1)(2011-2#6)(2012-12#4)(2012-2#4)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#5)
with the use##271##3##(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-3#1)(1991-5#1)(1992-1#2)(1992-2#2)(1992-3#2)(1992-7#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#2)(1994-12#1)(1994-3#1)(1994-9#1)(1995-2#3)(1995-3#1)(1995-6#2)(1996-5#2)(1996-9#1)(1997-3#1)(1997-6#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-10#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-10#16)(2006-11#2)(2006-2#1)(2006-4#2)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#17)(2007-12#1)(2007-2#3)(2007-3#2)(2007-4#2)(2007-6#1)(2007-7#8)(2007-8#15)(2007-9#1)(2008-1#6)(2008-10#31)(2008-11#6)(2008-12#2)(2008-2#7)(2008-3#11)(2008-4#3)(2008-5#9)(2008-6#4)(2008-7#6)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#2)(2010-10#3)(2010-3#3)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-12#1)(2011-2#6)(2012-12#4)(2012-2#4)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#5)
with the user##2##3##(2007-4#1)(2008-3#1)
with the usual##13##3##(1990-11#1)(2005-10#1)(2007-11#2)(2008-10#2)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#1)
with the utilization of##2##4##(2008-11#1)(2010-11#1)
with the vaccine type##2##4##(1992-10#1)(2005-9#1)
with the vaccine##6##3##(1992-10#1)(2005-9#1)(2007-11#1)(2008-10#1)(2013-1#1)(2013-8#1)
with the vacuolar##2##3##(1991-12#1)(1991-2#1)
with the vaginal##2##3##(2008-10#1)(2008-8#1)
with the value obtained##3##4##(1995-6#1)(2008-10#1)(2008-11#1)
with the value of##4##4##(1994-11#1)(1995-11#1)(2007-12#1)(2009-12#1)
with the value##14##3##(1990-9#1)(1994-11#1)(1995-11#1)(1995-6#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-9#1)(2009-12#1)
with the values determined##2##4##(2008-3#1)(2008-5#1)
with the values from##3##4##(2008-10#1)(2008-3#1)(2011-2#1)
with the values obtained by##4##5##(2008-10#3)(2008-3#1)
with the values obtained from##3##5##(2008-10#2)(2008-3#1)
with the values obtained##9##4##(1996-7#1)(2008-10#6)(2008-3#2)
with the values of##5##4##(1991-12#1)(1991-2#1)(2008-10#1)(2008-12#1)(2008-4#1)
with the values##24##3##(1991-12#1)(1991-2#1)(1993-6#1)(1996-7#1)(1997-1#1)(2007-11#1)(2008-10#9)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2011-2#1)
with the variant##2##3##(1994-12#1)(2009-10#1)
with the variation in##3##4##(1995-11#1)(2008-12#1)(2008-8#1)
with the variation##6##3##(1995-11#1)(1995-3#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-8#1)
with the various##18##3##(1992-4#1)(1994-8#1)(1995-3#1)(1997-4#1)(2006-2#1)(2006-9#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-10#1)(2010-8#1)(2011-2#1)(2012-1#1)
with the vascular##5##3##(1991-6#1)(1993-8#1)(1996-11#1)(2008-10#2)
with the vast##4##3##(2006-10#1)(2006-12#1)(2008-11#1)(2008-7#1)
with the vector##3##3##(1991-9#1)(2008-10#2)
with the vehicle group##3##4##(2011-2#1)(2013-8#2)
with the vehicle##8##3##(1996-9#1)(2008-4#1)(2010-1#1)(2011-2#1)(2013-1#2)(2013-8#2)
with the ventral##2##3##(2007-12#1)(2008-5#1)
with the vertebrate##2##3##(1990-2#1)(1993-3#1)
with the very##7##3##(1990-5#1)(2006-12#1)(2006-5#1)(2008-5#1)(2008-6#1)(2008-8#1)(2013-8#1)
with the vessel##2##3##(2007-5#1)(2008-11#1)
with the view of##2##4##(1994-8#1)(2009-7#1)
with the view that##6##4##(1990-6#1)(1992-1#1)(1992-8#1)(1994-2#1)(1997-9#1)(2008-1#1)
with the view to##2##4##(2008-1#1)(2008-10#1)
with the view##10##3##(1990-6#1)(1992-1#1)(1992-8#1)(1994-2#1)(1994-8#1)(1997-9#1)(2008-1#2)(2008-10#1)(2009-7#1)
with the viral##7##3##(1990-7#1)(1994-8#2)(2008-8#1)(2009-8#1)(2013-8#2)
with the virulence of##2##4##(2008-10#1)(2009-2#1)
with the virulence##3##3##(2008-10#2)(2009-2#1)
with the virulent##4##3##(2008-10#2)(2008-8#1)(2008-9#1)
with the virus##9##3##(1991-2#1)(1994-3#1)(1994-8#1)(1996-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2010-12#1)
with the visible##2##3##(1994-7#1)(2008-2#1)
with the visual##5##3##(1991-2#1)(1992-9#1)(2007-2#1)(2008-2#1)(2008-3#1)
with the vital dye##3##4##(1995-8#1)(2008-11#1)(2008-9#1)
with the vocal folds atrophy##2##5##(2007-9#2)
with the vocal##3##3##(2007-9#2)(2009-9#1)
with the volume of the##4##5##(1993-2#1)(2007-10#1)(2008-10#1)(2012-12#1)
with the volume of##6##4##(1992-2#1)(1993-2#1)(2007-10#1)(2008-10#1)(2011-2#1)(2012-12#1)
with the volume##8##3##(1992-2#1)(1993-2#1)(2007-10#1)(2008-10#1)(2008-2#1)(2010-9#1)(2011-2#1)(2012-12#1)
with the walls of the##2##5##(2008-11#1)(2008-9#1)
with the water at##2##4##(2007-12#2)
with the water##7##3##(1993-11#1)(2007-12#2)(2008-10#2)(2010-4#1)(2012-9#1)
with the wavelength of the##2##5##(2007-11#1)(2008-2#1)
with the wavelength of##4##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
with the wavelength##8##3##(1997-3#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#3)
with the wavelengths##2##3##(2008-3#1)(2012-2#1)
with the way##2##3##(2007-11#1)(2012-3#1)
with the weight of##2##4##(2008-10#1)(2010-9#1)
with the weight##5##3##(2007-11#1)(2008-10#1)(2010-9#1)(2012-1#2)
with the well-characterized##2##3##(2006-12#1)(2009-8#1)
with the well-established##3##3##(2008-10#2)(2008-4#1)
with the well-known##6##3##(1990-7#1)(1991-8#1)(2005-11#1)(2007-12#1)(2009-8#1)(2013-1#1)
with the whole##7##3##(1990-11#1)(1993-12#1)(2007-11#1)(2007-6#1)(2008-10#1)(2010-9#1)(2012-2#1)
with the whole-cell##3##3##(1997-8#1)(2007-11#1)(2008-8#1)
with the widely used##4##4##(2008-5#1)(2010-4#1)(2011-1#1)(2013-1#1)
with the widely##5##3##(2008-2#1)(2008-5#1)(2010-4#1)(2011-1#1)(2013-1#1)
with the widespread distribution of##2##5##(2008-10#1)(2008-11#1)
with the widespread##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2009-11#1)
with the widest##2##3##(2008-10#1)(2008-5#1)
with the wild type##6##4##(1992-8#1)(1993-11#1)(1993-8#1)(1997-8#1)(2008-10#1)(2008-6#1)
with the wild##7##3##(1992-8#1)(1993-11#1)(1993-8#1)(1996-5#1)(1997-8#1)(2008-10#1)(2008-6#1)
with the wild-type enzyme##7##4##(1990-12#2)(1992-9#1)(1994-9#1)(1995-3#1)(1995-6#1)(1995-8#1)
with the wild-type strain##4##4##(2008-10#4)
with the wild-type##25##3##(1990-12#2)(1991-4#1)(1992-4#1)(1992-9#1)(1993-9#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-7#1)(2007-12#1)(2008-10#5)(2010-12#1)(2012-1#2)
with the work of##3##4##(2007-1#1)(2008-2#1)(2013-1#1)
with the working##2##3##(1992-3#1)(2011-2#1)
with the world##2##3##(2006-2#2)
with the worst##3##3##(1996-9#1)(2006-10#1)(2008-8#1)
with the wound##2##3##(2008-7#1)(2012-12#1)
with the writing##2##3##(2008-10#1)(2008-2#1)
with the year##2##3##(2006-8#1)(2013-8#1)
with the yeast##5##3##(1993-3#2)(1996-7#1)(2008-10#2)
with the yeast-phase##2##3##(2008-5#2)
with the young##7##3##(1991-12#1)(1993-2#3)(2008-4#1)(2011-2#1)(2012-2#1)
with the younger##5##3##(1994-4#1)(2006-8#1)(2008-5#1)(2012-1#1)(2013-1#1)
with the##16353##2##(1990-1#6)(1990-10#28)(1990-11#56)(1990-12#82)(1990-2#85)(1990-3#54)(1990-4#47)(1990-5#82)(1990-6#31)(1990-7#66)(1990-8#60)(1990-9#49)(1991-1#36)(1991-10#25)(1991-11#34)(1991-12#66)(1991-2#103)(1991-3#43)(1991-4#43)(1991-5#74)(1991-6#41)(1991-7#56)(1991-8#57)(1991-9#72)(1992-1#35)(1992-10#26)(1992-11#46)(1992-12#68)(1992-2#57)(1992-3#87)(1992-4#28)(1992-5#31)(1992-6#66)(1992-7#37)(1992-8#72)(1992-9#47)(1993-1#24)(1993-10#13)(1993-11#80)(1993-12#85)(1993-2#60)(1993-3#83)(1993-4#23)(1993-5#20)(1993-6#56)(1993-7#26)(1993-8#68)(1993-9#49)(1994-1#13)(1994-10#20)(1994-11#79)(1994-12#115)(1994-2#69)(1994-3#90)(1994-4#10)(1994-5#45)(1994-6#52)(1994-7#12)(1994-8#92)(1994-9#112)(1995-1#68)(1995-10#26)(1995-11#67)(1995-12#65)(1995-2#105)(1995-3#118)(1995-4#20)(1995-5#76)(1995-6#89)(1995-7#19)(1995-8#86)(1995-9#24)(1996-1#43)(1996-10#29)(1996-11#38)(1996-12#59)(1996-2#100)(1996-3#55)(1996-4#41)(1996-5#98)(1996-6#46)(1996-7#53)(1996-8#50)(1996-9#45)(1997-1#72)(1997-2#86)(1997-3#64)(1997-4#110)(1997-5#50)(1997-6#74)(1997-7#93)(1997-8#63)(1997-9#4)(2003-11#3)(2004-1#5)(2004-10#5)(2004-11#20)(2004-12#19)(2004-2#11)(2004-3#6)(2004-4#8)(2004-8#3)(2004-9#21)(2005-1#11)(2005-10#35)(2005-11#189)(2005-12#22)(2005-4#25)(2005-5#9)(2005-6#5)(2005-7#32)(2005-8#56)(2005-9#21)(2006-1#18)(2006-10#249)(2006-11#51)(2006-12#97)(2006-2#39)(2006-3#32)(2006-4#37)(2006-5#40)(2006-6#74)(2006-7#32)(2006-8#99)(2006-9#34)(2007-1#48)(2007-10#88)(2007-11#290)(2007-12#325)(2007-2#63)(2007-3#51)(2007-4#68)(2007-5#47)(2007-6#40)(2007-7#129)(2007-8#227)(2007-9#87)(2008-1#142)(2008-10#2037)(2008-11#297)(2008-12#92)(2008-2#490)(2008-3#616)(2008-4#191)(2008-5#396)(2008-6#115)(2008-7#272)(2008-8#255)(2008-9#201)(2009-1#6)(2009-10#49)(2009-11#39)(2009-12#29)(2009-2#70)(2009-3#51)(2009-4#57)(2009-5#57)(2009-6#48)(2009-7#58)(2009-8#69)(2009-9#46)(2010-1#15)(2010-10#37)(2010-11#28)(2010-12#102)(2010-2#89)(2010-3#41)(2010-4#77)(2010-5#66)(2010-6#21)(2010-7#35)(2010-8#76)(2010-9#44)(2011-1#177)(2011-10#2)(2011-12#36)(2011-2#377)(2011-3#15)(2011-7#3)(2011-8#1)(2012-1#118)(2012-10#1)(2012-11#34)(2012-12#192)(2012-2#230)(2012-3#168)(2012-5#3)(2012-7#2)(2012-9#1)(2013-1#333)(2013-7#62)(2013-8#285)
with their abilities to##2##4##(1990-3#1)(1994-3#1)
with their ability to produce##2##5##(1993-6#1)(2008-10#1)
with their ability to##14##4##(1991-1#1)(1991-8#1)(1992-12#2)(1993-6#1)(1993-8#1)(1994-6#2)(2005-7#1)(2008-10#2)(2010-12#1)(2010-2#1)(2010-3#1)
with their action on##2##4##(2004-12#1)(2008-7#1)
with their active##2##3##(1990-6#1)(1990-8#1)
with their actual##2##3##(2008-10#1)(2011-2#1)
with their age-matched controls##2##4##(1990-3#1)(2007-7#1)
with their age-matched##3##3##(1990-3#1)(2007-7#1)(2011-1#1)
with their associated##3##3##(2008-9#1)(2013-1#2)
with their being##3##3##(1991-9#1)(1995-3#1)(2008-4#1)
with their bodies than##3##4##(2008-9#2)(2010-10#1)
with their bodies##10##3##(2007-12#2)(2008-9#5)(2009-5#2)(2010-10#1)
with their body size##2##4##(2007-12#2)
with their body##4##3##(2007-12#3)(2012-2#1)
with their caregivers##2##3##(2008-8#1)(2013-1#1)
with their clients##2##3##(1992-1#1)(2006-11#1)
with their clinical##5##3##(1990-12#1)(1996-2#1)(2004-10#1)(2008-5#1)(2010-10#1)
with their cognate##2##3##(1991-4#1)(2008-4#1)
with their communities##2##3##(1994-1#1)(1995-3#1)
with their complementary##2##3##(2008-10#2)
with their condition##2##3##(2011-1#1)(2013-1#1)
with their conventional##2##3##(2007-12#1)(2012-2#1)
with their corresponding##7##3##(1996-9#1)(2005-10#1)(2007-12#1)(2008-10#3)(2008-4#1)
with their counterparts in##4##4##(1994-11#1)(1997-1#1)(2007-6#1)(2008-11#1)
with their counterparts##8##3##(1994-11#1)(1997-1#1)(2005-7#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)
with their dependence on##2##4##(2008-10#1)(2008-3#1)
with their effects on##2##4##(1995-6#1)(1997-7#1)
with their environment##4##3##(2008-11#1)(2008-2#1)(2008-4#1)(2012-2#1)
with their eyes##2##3##(1995-8#1)(2007-4#1)
with their first##2##3##(2007-9#1)(2009-9#1)
with their general##2##3##(2006-10#1)(2007-8#1)
with their growth##2##3##(1990-7#1)(1992-9#1)
with their health care##3##4##(1997-1#1)(2012-3#1)(2013-7#1)
with their health##6##3##(1997-1#1)(2010-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
with their high##3##3##(1991-12#1)(2006-3#1)(2008-5#1)
with their host##2##3##(2004-11#1)(2009-8#1)
with their hosts##2##3##(2008-8#1)(2010-12#1)
with their human##2##3##(1991-6#1)(1997-7#1)
with their implications##3##3##(1990-6#1)(1997-7#1)(2007-1#1)
with their infant##2##3##(2008-10#1)(2010-10#1)
with their intrinsic##2##3##(2006-2#1)(2006-7#1)
with their ligands##2##3##(2008-11#1)(2013-1#1)
with their low##2##3##(2008-5#1)(2010-6#1)
with their male##2##3##(2007-2#1)(2010-5#1)
with their mental##2##3##(2010-8#1)(2013-1#1)
with their mother##3##3##(2005-11#1)(2008-10#1)(2013-1#1)
with their mothers##2##3##(1994-3#1)(2007-2#1)
with their occurrence##2##3##(2005-8#1)(2009-5#1)
with their overall##3##3##(1996-3#1)(2007-8#1)(2008-10#1)
with their own##10##3##(1995-2#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
with their parents##5##3##(1990-12#1)(2008-1#1)(2009-7#2)(2012-12#1)
with their partner##3##3##(2007-12#1)(2010-5#1)(2010-9#1)
with their patients to##2##4##(2010-9#1)(2011-1#1)
with their patients##8##3##(1991-12#1)(1997-4#1)(2006-7#1)(2007-11#1)(2007-12#1)(2010-9#1)(2011-1#1)(2012-1#1)
with their peers outside the##2##5##(1990-5#1)(2008-9#1)
with their peers##4##3##(1990-5#1)(2008-9#1)(2012-1#1)(2013-8#1)
with their performance in##2##4##(2007-10#1)(2008-2#1)
with their performance##3##3##(2007-10#1)(2008-2#2)
with their personal##2##3##(1992-6#1)(1995-3#1)
with their physician##2##3##(2008-3#1)(2008-4#1)
with their physicians before##2##4##(2009-5#1)(2009-7#1)
with their physicians##4##3##(2009-5#2)(2009-7#2)
with their possible##2##3##(1991-4#1)(2007-12#1)
with their potencies##2##3##(1992-8#1)(1995-11#1)
with their potential to##2##4##(1993-6#1)(2008-10#1)
with their potential##6##3##(1993-6#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-12#1)(2012-4#1)
with their previous##2##3##(2008-11#1)(2011-10#1)
with their primary care physicians##2##5##(2010-3#2)
with their primary##3##3##(2008-9#1)(2010-3#2)
with their relative##3##3##(1992-6#1)(1993-4#1)(2011-1#1)
with their respective normal##2##4##(2008-7#1)(2011-12#1)
with their respective##14##3##(1994-9#1)(1995-6#1)(1997-1#1)(2006-6#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-12#1)(2013-1#2)
with their right##2##3##(2008-6#1)(2012-12#1)
with their risk status##2##4##(1995-9#2)
with their side effects##3##4##(2006-10#1)(2008-12#1)(2009-5#1)
with their size##2##3##(2008-10#1)(2013-1#1)
with their structural##2##3##(1996-2#1)(2007-8#1)
with their use##9##3##(1992-4#1)(2006-2#1)(2008-5#2)(2008-8#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
with their usual##2##3##(1991-3#1)(2008-3#1)
with their work performance under NLEP##2##6##(2012-12#2)
with their work##5##3##(2007-10#1)(2008-7#2)(2012-12#2)
with their##564##2##(1990-12#3)(1990-3#3)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#4)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#6)(1992-11#1)(1992-12#4)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-6#3)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#4)(1995-9#3)(1996-1#1)(1996-11#1)(1996-2#5)(1996-3#1)(1996-5#4)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#4)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#2)(2004-10#3)(2004-11#1)(2004-12#1)(2005-10#3)(2005-11#4)(2005-4#1)(2005-7#2)(2005-8#1)(2005-9#2)(2006-10#9)(2006-11#1)(2006-2#4)(2006-3#1)(2006-4#4)(2006-5#2)(2006-6#1)(2006-7#3)(2006-9#2)(2007-1#6)(2007-10#4)(2007-11#5)(2007-12#19)(2007-2#4)(2007-4#2)(2007-6#4)(2007-7#6)(2007-8#5)(2007-9#3)(2008-1#3)(2008-10#37)(2008-11#13)(2008-12#8)(2008-2#11)(2008-3#8)(2008-4#9)(2008-5#17)(2008-6#5)(2008-7#8)(2008-8#15)(2008-9#17)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#3)(2009-5#10)(2009-7#9)(2009-8#4)(2009-9#4)(2010-10#3)(2010-12#4)(2010-2#4)(2010-3#5)(2010-4#4)(2010-5#6)(2010-6#3)(2010-7#1)(2010-8#3)(2010-9#4)(2011-1#10)(2011-10#1)(2011-12#3)(2011-2#11)(2011-3#2)(2012-1#7)(2012-11#1)(2012-12#13)(2012-2#11)(2012-3#5)(2012-4#1)(2013-1#19)(2013-7#2)(2013-8#8)
with them a##2##3##(2008-12#1)(2012-12#1)
with them and##2##3##(2009-3#1)(2009-9#1)
with them as##2##3##(2008-4#1)(2012-12#1)
with them in##2##3##(2008-1#1)(2011-2#1)
with them showed##2##3##(1995-8#1)(2008-5#1)
with them##49##2##(1990-5#1)(1991-2#1)(1991-3#2)(1991-4#1)(1992-1#1)(1992-2#1)(1992-7#1)(1993-12#1)(1994-1#1)(1994-11#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-1#1)(1997-8#1)(2005-3#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-3#1)(2009-7#1)(2009-9#2)(2010-1#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)
with themselves##2##2##(1990-8#1)(2008-11#1)
with theophylline and##2##3##(1991-12#2)
with theophylline##5##2##(1990-6#1)(1991-12#4)
with theoretical and experimental##2##4##(2007-12#1)(2013-1#1)
with theoretical calculations##6##3##(2008-2#2)(2008-3#3)(2008-6#1)
with theoretical considerations##4##3##(1992-2#1)(1996-1#1)(2007-11#1)(2008-10#1)
with theoretical data##2##3##(2008-2#2)
with theoretical expectations##7##3##(2006-5#1)(2007-11#1)(2008-2#3)(2008-3#1)(2008-9#1)
with theoretical models that##2##4##(1996-4#1)(2009-2#1)
with theoretical ones##2##3##(2008-3#1)(2012-3#1)
with theoretical patterns derived from Mie theory##2##7##(2008-3#2)
with theoretical predictions for##3##4##(1991-9#1)(2007-12#2)
with theoretical predictions##31##3##(1991-9#1)(2005-11#2)(2007-11#3)(2007-12#11)(2008-1#2)(2008-2#4)(2008-3#5)(2008-7#1)(2008-8#1)(2012-3#1)
with theoretical results##5##3##(2007-11#1)(2007-12#1)(2008-3#3)
with theoretical values##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
with theoretical##82##2##(1991-9#1)(1992-2#1)(1996-1#1)(1996-3#1)(1996-4#1)(2005-11#3)(2006-12#1)(2006-5#1)(2007-11#10)(2007-12#14)(2008-1#2)(2008-10#3)(2008-2#12)(2008-3#19)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2011-1#1)(2012-3#2)(2013-1#1)
with theoretically calculated##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
with theoretically##5##2##(2005-11#1)(2007-12#1)(2008-10#1)(2008-3#2)
with theory and##7##3##(2007-12#1)(2008-2#2)(2008-3#1)(2008-9#1)(2010-7#1)(2012-2#1)
with theory##29##2##(2007-11#4)(2007-12#8)(2008-10#1)(2008-2#7)(2008-3#5)(2008-9#1)(2010-7#1)(2012-11#1)(2012-2#1)
with therapeutic potential for##2##4##(1991-2#1)(2006-10#1)
with therapeutic potential##3##3##(1991-2#1)(2006-10#1)(2009-8#1)
with therapeutic##18##2##(1991-2#1)(2006-10#1)(2006-12#1)(2007-7#1)(2008-10#1)(2008-12#2)(2008-5#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#3)
with therapeutically##2##2##(1990-9#1)(2005-8#1)
with therapy in the##2##4##(2007-10#1)(2009-6#1)
with therapy##12##2##(1993-9#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-7#1)(2009-12#1)(2009-6#1)
with thermal##14##2##(1991-2#1)(1995-11#1)(1996-5#1)(1996-8#1)(2007-11#2)(2008-10#3)(2008-3#1)(2008-4#1)(2010-8#1)(2013-1#1)(2013-8#1)
with thermally##2##2##(2007-12#1)(2008-10#1)
with thermodynamic calculations##2##3##(2008-10#2)
with thermodynamic##6##2##(1996-4#1)(2007-8#1)(2008-10#3)(2009-11#1)
with thermogravimetric##3##2##(2004-9#1)(2008-10#2)
with thermolysin##3##2##(1990-2#2)(1990-5#1)
with thermostability##2##2##(2008-10#2)
with these agents will##2##4##(2008-4#1)(2010-12#1)
with these agents##21##3##(1993-9#1)(2005-8#2)(2006-10#1)(2006-8#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-11#2)(2009-3#1)(2010-12#1)(2013-7#1)
with these antibodies##4##3##(1990-11#1)(1991-2#1)(1991-6#1)(1994-11#1)
with these changes##6##3##(1990-5#1)(1992-4#1)(1993-2#1)(2006-9#1)(2008-3#1)(2009-8#1)
with these characteristics##3##3##(1996-10#1)(2008-3#1)(2012-2#1)
with these compounds and##3##4##(1991-4#1)(2008-4#1)(2012-1#1)
with these compounds##8##3##(1991-4#1)(1993-12#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2012-1#1)
with these conditions##7##3##(1996-6#1)(2006-10#1)(2006-4#1)(2006-6#1)(2008-1#1)(2008-3#1)(2010-9#1)
with these data##3##3##(1990-7#1)(1990-8#1)(1992-10#1)
with these devices##2##3##(1990-3#1)(2011-2#1)
with these different##2##3##(2006-3#1)(2010-2#1)
with these diseases##3##3##(1990-11#1)(1995-5#1)(2009-7#1)
with these disorders##8##3##(1997-3#1)(1997-8#1)(2005-6#1)(2006-10#1)(2006-8#1)(2007-6#1)(2012-3#1)(2013-1#1)
with these drugs have##2##4##(2010-5#1)(2013-1#1)
with these drugs##9##3##(1991-1#1)(1994-5#2)(1996-9#1)(2008-11#1)(2010-5#2)(2012-2#1)(2013-1#1)
with these elements are##2##4##(1996-4#2)
with these factors##4##3##(1991-2#1)(2008-9#1)(2009-12#1)(2009-6#1)
with these families in##2##4##(2008-2#1)(2010-9#1)
with these findings##3##3##(1993-11#1)(2012-12#1)(2012-2#1)
with these groups##4##3##(1994-9#1)(2008-7#1)(2011-1#1)(2012-12#1)
with these implants##2##3##(2008-5#1)(2011-1#1)
with these increases##2##3##(1990-10#1)(1992-3#1)
with these injuries##2##3##(2006-10#1)(2006-11#1)
with these issues and##2##4##(2007-4#2)
with these lesions##4##3##(2006-8#1)(2008-10#1)(2008-7#1)(2012-2#1)
with these medical##2##3##(1990-11#1)(2006-2#1)
with these methods##6##3##(1997-3#1)(2008-3#2)(2008-4#1)(2008-8#1)(2010-10#1)
with these molecular markers##2##4##(1994-3#1)(2008-5#1)
with these molecular##3##3##(1994-3#1)(2007-8#1)(2008-5#1)
with these mutations##2##3##(1994-11#1)(2013-1#1)
with these neoplasms##2##3##(2007-11#1)(2010-8#1)
with these new##4##3##(2006-6#1)(2008-10#1)(2008-11#1)(2010-12#1)
with these observations##3##3##(1991-2#1)(2008-8#1)(2010-3#1)
with these parameters##2##3##(1995-2#1)(2008-5#1)
with these partners##2##3##(2012-3#2)
with these patients##3##3##(2004-3#1)(2006-10#1)(2007-7#1)
with these problems##5##3##(2006-10#1)(2008-2#1)(2008-8#1)(2010-10#2)
with these procedures##4##3##(1992-8#1)(1995-2#1)(2013-1#2)
with these properties##2##3##(1991-5#1)(1995-3#1)
with these radiations##2##3##(1991-2#2)
with these receptors##4##3##(1991-5#1)(1995-12#1)(1996-1#1)(1996-5#1)
with these results##8##3##(1994-5#1)(1995-3#1)(1997-2#1)(2005-8#1)(2008-10#1)(2008-11#1)(2009-12#1)(2010-1#1)
with these studies in##2##4##(1995-9#1)(2006-10#1)
with these substances##2##3##(2006-11#1)(2008-4#1)
with these substrate##2##3##(1995-6#1)(2005-11#1)
with these syndromes##3##3##(2005-7#1)(2010-12#1)(2012-2#1)
with these systems##2##3##(2008-11#1)(2008-7#1)
with these techniques##4##3##(2006-10#1)(2006-3#1)(2007-6#1)(2007-8#1)
with these therapies##2##3##(2005-8#1)(2008-10#1)
with these three##3##3##(1993-11#1)(1997-3#1)(2008-10#1)
with these two methods##3##4##(2008-10#1)(2008-3#1)(2011-1#1)
with these two##16##3##(1990-5#1)(1991-8#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-9#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-8#1)(2011-1#1)
with these variables##3##3##(1996-7#1)(2012-3#2)
with these##384##2##(1990-10#1)(1990-11#3)(1990-3#1)(1990-5#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#6)(1991-3#2)(1991-4#1)(1991-5#4)(1991-6#2)(1991-8#1)(1992-10#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#2)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#2)(1995-2#3)(1995-3#4)(1995-5#2)(1995-6#4)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#2)(1996-11#2)(1996-12#2)(1996-2#1)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#4)(1997-5#1)(1997-6#1)(1997-8#2)(2004-3#1)(2004-8#1)(2005-10#2)(2005-11#1)(2005-6#1)(2005-7#1)(2005-8#8)(2006-10#14)(2006-11#2)(2006-2#2)(2006-3#3)(2006-4#1)(2006-6#2)(2006-8#3)(2006-9#4)(2007-10#2)(2007-11#9)(2007-12#7)(2007-4#3)(2007-6#4)(2007-7#2)(2007-8#7)(2007-9#1)(2008-1#2)(2008-10#26)(2008-11#9)(2008-12#1)(2008-2#6)(2008-3#12)(2008-4#5)(2008-5#12)(2008-6#2)(2008-7#8)(2008-8#9)(2008-9#6)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#1)(2009-6#3)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#4)(2010-12#6)(2010-2#3)(2010-3#1)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#4)(2011-1#4)(2011-2#10)(2011-7#1)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#9)(2012-3#8)(2013-1#8)(2013-7#1)(2013-8#1)
with thiamin##2##2##(1990-2#1)(2005-10#1)
with thiamine and##2##3##(1995-1#1)(2008-1#1)
with thiamine##7##2##(1990-9#2)(1991-9#1)(1995-1#1)(2008-1#1)(2008-10#2)
with thick##12##2##(1996-9#1)(2006-5#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-8#1)(2011-2#1)
with thickening##2##2##(2007-7#1)(2010-10#1)
with thicker##2##2##(1995-6#1)(1996-5#1)
with thickness##2##2##(2008-3#1)(2013-1#1)
with thin and##2##3##(2008-2#1)(2008-5#1)
with thin##23##2##(1994-11#1)(1995-12#1)(1996-5#1)(2005-11#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#3)(2009-11#1)(2009-8#1)(2010-6#1)(2011-1#3)(2013-1#1)(2013-8#1)
with thiocyanate##3##2##(2008-10#3)
with thiocyanates##2##2##(2007-11#2)
with thioglycolic acid##2##3##(2008-10#1)(2012-12#1)
with thiol cotton##3##3##(2008-10#3)
with thiol groups##2##3##(2008-10#2)
with thiol##7##2##(1991-8#1)(2008-10#6)
with thiol-containing##2##2##(1991-9#1)(2008-4#1)
with thiolated oligonucleotides##2##3##(2008-10#2)
with thiols##4##2##(2008-10#1)(2008-11#2)(2008-3#1)
with thionyl chloride##2##3##(2007-11#1)(2010-3#1)
with thiopental##2##2##(1992-7#1)(1997-6#1)
with thiopentone and##2##3##(2010-7#1)(2012-2#1)
with thiopentone##3##2##(2008-10#1)(2010-7#1)(2012-2#1)
with thioridazine##2##2##(2008-10#1)(2008-7#1)
with thiosulfate or##2##3##(1993-3#1)(2006-8#1)
with thiosulfate##3##2##(1992-12#1)(1993-3#1)(2006-8#1)
with thiourea and##2##3##(2007-11#1)(2008-10#1)
with thiourea##3##2##(1996-8#1)(2007-11#1)(2008-10#1)
with third##5##2##(1992-12#1)(1994-5#1)(1996-11#1)(2006-6#1)(2013-1#1)
with third-order##2##2##(2008-3#2)
with third-party payers##3##3##(1994-2#1)(2005-10#1)(2007-4#1)
with third-party##4##2##(1994-2#1)(2005-10#1)(2007-4#1)(2008-9#1)
with this &quot##2##3##(1991-8#1)(1994-8#1)
with this abnormal##2##3##(1991-9#1)(2006-9#1)
with this agent##5##3##(1991-12#1)(1994-7#1)(1996-10#1)(2008-7#1)(2010-12#1)
with this algorithm##2##3##(2008-2#2)
with this analysis##2##3##(1996-7#1)(2008-10#1)
with this antibody##2##3##(1994-10#1)(1995-8#1)
with this approach##10##3##(2005-8#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-7#2)(2011-1#1)(2011-2#1)(2013-1#1)
with this assay##3##3##(1994-10#1)(2008-10#1)(2013-1#1)
with this assumption##2##3##(1997-6#1)(2008-2#1)
with this class of##2##4##(2007-9#1)(2008-10#1)
with this clone##2##3##(1991-3#2)
with this combination of##2##4##(1991-12#1)(2006-10#1)
with this combination##4##3##(1991-12#1)(2006-10#1)(2011-2#1)(2012-12#1)
with this common##2##3##(2005-10#1)(2008-6#1)
with this complication##2##3##(2007-8#1)(2008-12#1)
with this compound##2##3##(1990-5#1)(1993-11#1)
with this condition##26##3##(1991-7#1)(1994-9#1)(1996-12#1)(1997-1#1)(2006-10#1)(2006-9#2)(2007-10#1)(2007-11#3)(2007-6#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-8#1)(2009-6#1)(2009-9#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
with this construct##2##3##(1991-7#1)(1997-8#1)
with this cytokine##2##3##(1993-12#1)(2008-4#1)
with this debilitating disease##2##4##(2006-1#1)(2009-3#1)
with this deletion##2##3##(1991-10#2)
with this design##2##3##(1992-9#1)(2008-2#1)
with this device##2##3##(2006-3#1)(2008-3#1)
with this diagnosis##3##3##(1992-11#1)(2008-11#1)(2010-11#1)
with this difficult##2##3##(1990-8#1)(2008-5#1)
with this disabling##2##3##(2006-10#1)(2011-2#1)
with this disease are##2##4##(1992-2#1)(2008-1#1)
with this disease process##2##4##(2005-11#1)(2008-7#1)
with this disease##30##3##(1990-5#1)(1991-8#1)(1992-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1996-3#1)(2005-1#1)(2005-11#1)(2006-11#1)(2006-5#1)(2007-11#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-7#1)(2010-3#1)(2010-5#1)(2012-11#1)
with this disorder##9##3##(1993-11#1)(1996-12#1)(2006-10#1)(2006-5#1)(2007-4#1)(2008-6#1)(2010-11#1)(2013-1#2)
with this drug in##4##4##(1996-4#1)(2006-4#1)(2008-1#1)(2011-1#1)
with this drug##8##3##(1991-11#1)(1991-7#1)(1996-4#1)(2006-4#1)(2007-11#2)(2008-1#1)(2011-1#1)
with this effect##4##3##(1993-5#1)(2010-5#1)(2011-2#1)(2012-11#1)
with this enzyme##4##3##(1990-4#1)(1990-7#1)(1991-12#1)(1994-11#1)
with this equation##2##3##(1995-2#1)(2008-2#1)
with this experimental##2##3##(1994-2#1)(1997-8#1)
with this family of##2##4##(2008-4#1)(2008-8#1)
with this finding##2##3##(1990-2#1)(1993-9#1)
with this form of##2##4##(2006-6#1)(2009-11#1)
with this group of patients##2##5##(1996-9#1)(2007-7#1)
with this group of##3##4##(1996-9#1)(2007-2#1)(2007-7#1)
with this hypothesis##9##3##(1990-5#1)(1994-3#2)(1995-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-11#1)
with this illness##2##3##(2007-2#1)(2012-12#1)
with this imaging##2##3##(2008-2#1)(2010-8#1)
with this in##3##3##(2008-10#1)(2008-12#1)(2010-12#1)
with this increase in##2##4##(1990-10#1)(2009-7#1)
with this infection##2##3##(2006-10#1)(2008-1#1)
with this instrument##2##3##(2007-11#1)(2008-3#1)
with this interpretation##2##3##(1994-2#1)(1995-1#1)
with this issue##3##3##(1992-1#1)(1993-6#1)(2010-12#1)
with this kind of##2##4##(1996-9#1)(2008-10#1)
with this major##2##3##(2006-10#1)(2006-2#1)
with this mechanism##2##3##(2005-11#1)(2011-2#1)
with this method are##2##4##(2008-6#1)(2008-9#1)
with this method was##2##4##(1993-2#1)(2010-5#1)
with this method were##3##4##(2008-10#1)(2008-4#1)(2008-5#1)
with this method##28##3##(1990-9#1)(1991-5#1)(1993-2#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#7)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-9#1)(2010-12#2)(2010-5#1)(2012-12#2)
with this methodology##2##3##(2008-10#1)(2008-4#1)
with this modality##2##3##(2005-2#1)(2008-1#1)
with this mode of##2##4##(1996-2#1)(2008-5#1)
with this model##6##3##(1993-12#1)(2006-12#1)(2006-9#1)(2008-10#1)(2008-3#1)(2008-7#1)
with this modified##3##3##(1990-12#1)(1995-8#1)(1997-4#1)
with this mutation##2##3##(1994-3#1)(1995-2#1)
with this new technique##2##4##(1990-9#1)(2008-3#1)
with this new##14##3##(1990-9#1)(1992-11#1)(1994-5#1)(2004-1#1)(2005-7#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-8#1)(2009-10#1)(2011-12#1)
with this novel##3##3##(2008-3#1)(2008-5#1)(2008-8#1)
with this observation##6##3##(1993-7#1)(1996-3#1)(1996-9#1)(2006-9#1)(2007-8#1)(2012-2#1)
with this organism##8##3##(1992-10#1)(1995-5#1)(2005-12#1)(2006-10#2)(2006-8#1)(2007-12#1)(2008-1#1)
with this pathology##3##3##(1993-9#1)(2009-2#1)(2012-3#1)
with this phenomenon##3##3##(2007-8#1)(2010-5#1)(2013-1#1)
with this polymeric##2##3##(1990-8#1)(1991-11#1)
with this population##6##3##(1991-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2011-12#1)
with this potentially##2##3##(2006-10#1)(2009-12#1)
with this prediction##3##3##(1996-5#1)(2008-4#1)(2008-9#1)
with this problem##9##3##(1994-6#1)(1996-11#1)(2005-1#1)(2007-10#1)(2007-5#1)(2008-2#1)(2008-6#1)(2012-1#1)(2013-1#1)
with this procedure is##2##4##(2006-11#1)(2006-3#1)
with this procedure##12##3##(1991-9#1)(2006-10#1)(2006-11#2)(2006-3#2)(2006-7#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2009-11#1)
with this process##7##3##(1994-9#1)(2005-8#1)(2008-1#1)(2008-2#1)(2009-7#1)(2009-8#1)(2011-2#1)
with this property##2##3##(1996-8#1)(2008-10#1)
with this protocol##2##3##(1993-11#1)(1994-10#1)
with this rare syndrome##2##4##(2006-10#1)(2008-11#1)
with this rare##7##3##(1996-7#1)(2004-10#1)(2005-5#1)(2006-10#1)(2007-2#1)(2008-11#1)(2008-2#1)
with this regimen##4##3##(1991-10#1)(2007-11#1)(2007-8#1)(2013-1#1)
with this regulatory##2##3##(1992-12#1)(2008-8#1)
with this result##4##3##(1991-2#1)(1995-3#1)(1995-6#1)(1996-9#1)
with this scheme##3##3##(2007-11#1)(2007-12#2)
with this sensor##2##3##(2008-10#1)(2008-3#1)
with this site##2##3##(1992-9#1)(1995-3#1)
with this structure##2##3##(1991-7#1)(2007-12#1)
with this subtype of##2##4##(1991-5#1)(2006-10#1)
with this switch##2##3##(2008-10#1)(2008-3#1)
with this syndrome##12##3##(1991-4#1)(1991-5#1)(1997-6#1)(2005-12#1)(2006-10#1)(2007-8#2)(2008-12#1)(2008-3#1)(2011-12#1)(2011-2#1)(2012-12#1)
with this system##16##3##(1992-10#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#3)(2012-3#1)(2013-8#3)
with this tablet##2##3##(2008-10#2)
with this technique and##4##4##(1997-1#1)(2007-12#1)(2008-7#1)(2009-5#1)
with this technique are##3##4##(1991-3#1)(2007-12#1)(2008-2#1)
with this technique has##2##4##(1991-11#1)(2006-3#1)
with this technique in##2##4##(1993-11#1)(2007-8#1)
with this technique is##2##4##(2006-8#1)(2008-3#1)
with this technique with##2##4##(2008-2#1)(2008-7#1)
with this technique##40##3##(1991-11#1)(1991-3#1)(1993-11#1)(1997-1#1)(2006-2#1)(2006-3#1)(2006-8#2)(2007-11#1)(2007-12#9)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#5)(2008-5#2)(2008-7#2)(2009-5#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
with this theory##3##3##(2008-1#1)(2008-3#2)
with this therapy##3##3##(2006-10#1)(2007-12#1)(2010-10#1)
with this tumor##2##3##(2008-10#1)(2011-2#1)
with this type of##14##4##(1991-11#1)(1993-2#1)(1994-8#1)(1997-3#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-1#2)(2010-3#1)(2010-8#1)(2013-1#1)(2013-8#1)
with this vector##2##3##(1991-9#1)(1995-2#1)
with this virus##5##3##(1991-3#1)(1993-8#1)(2007-11#1)(2008-10#1)(2010-12#1)
with this##721##2##(1990-10#4)(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#4)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#2)(1991-1#2)(1991-10#5)(1991-11#6)(1991-12#5)(1991-2#2)(1991-3#4)(1991-4#1)(1991-5#3)(1991-7#5)(1991-8#4)(1991-9#3)(1992-1#1)(1992-10#3)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#2)(1992-7#1)(1992-8#2)(1992-9#5)(1993-11#5)(1993-12#3)(1993-2#2)(1993-3#3)(1993-4#1)(1993-5#3)(1993-6#4)(1993-7#3)(1993-8#1)(1993-9#3)(1994-10#3)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#5)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#6)(1994-9#4)(1995-1#1)(1995-2#4)(1995-3#3)(1995-5#1)(1995-6#3)(1995-7#2)(1995-8#4)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#2)(1996-6#4)(1996-7#2)(1996-8#1)(1996-9#4)(1997-1#5)(1997-2#2)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#4)(2004-1#1)(2004-10#1)(2005-1#4)(2005-10#2)(2005-11#3)(2005-12#2)(2005-2#1)(2005-4#1)(2005-5#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#21)(2006-11#4)(2006-12#4)(2006-2#2)(2006-3#4)(2006-4#1)(2006-5#3)(2006-6#2)(2006-7#3)(2006-8#6)(2006-9#5)(2007-1#1)(2007-10#4)(2007-11#16)(2007-12#28)(2007-2#3)(2007-3#3)(2007-4#4)(2007-5#2)(2007-6#2)(2007-7#5)(2007-8#13)(2007-9#3)(2008-1#13)(2008-10#59)(2008-11#9)(2008-12#13)(2008-2#28)(2008-3#30)(2008-4#17)(2008-5#17)(2008-6#8)(2008-7#18)(2008-8#10)(2008-9#5)(2009-1#3)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#4)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#4)(2010-12#6)(2010-2#1)(2010-3#2)(2010-5#6)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#6)(2011-12#5)(2011-2#16)(2012-1#2)(2012-11#2)(2012-12#9)(2012-2#9)(2012-3#5)(2013-1#11)(2013-7#1)(2013-8#9)
with thoracic osteochondrosis##2##3##(2008-7#2)
with thoracic pain##3##3##(1997-5#1)(2006-8#2)
with thoracic##20##2##(1991-4#1)(1997-5#1)(2006-12#1)(2006-7#1)(2006-8#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
with thoracotomy##3##2##(2007-5#1)(2007-8#1)(2010-3#1)
with those achieved by##3##4##(2008-10#3)
with those achieved using##2##4##(2007-8#1)(2008-10#1)
with those achieved with##2##4##(1991-3#1)(2007-12#1)
with those achieved##9##3##(1991-2#1)(1991-3#1)(1993-3#1)(2007-12#1)(2007-8#1)(2008-10#4)
with those associated with##2##4##(2006-10#1)(2008-7#1)
with those at##3##3##(1997-7#1)(2007-11#1)(2008-1#1)
with those available##2##3##(2008-10#1)(2008-11#1)
with those by the##4##4##(2005-4#1)(2008-10#3)
with those by##6##3##(2005-4#1)(2008-10#4)(2010-5#1)
with those calculated##5##3##(1991-9#1)(1992-12#1)(2005-11#1)(2006-12#1)(2008-2#1)
with those collected##2##3##(2006-4#1)(2008-10#1)
with those deduced from##2##4##(1990-4#1)(1994-2#1)
with those derived from##5##4##(1992-12#1)(2008-2#1)(2008-3#1)(2012-12#2)
with those described in the##2##5##(1995-11#1)(2012-3#1)
with those described in##4##4##(1992-12#1)(1995-11#1)(2008-2#1)(2012-3#1)
with those described##7##3##(1991-9#1)(1992-12#1)(1995-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-3#1)
with those determined by##6##4##(1990-4#1)(2008-10#3)(2008-3#1)(2011-2#1)
with those determined##9##3##(1990-4#1)(1990-9#1)(1993-9#1)(2008-10#4)(2008-3#1)(2011-2#1)
with those estimated##2##3##(2005-11#1)(2008-2#1)
with those for the##3##4##(1993-8#1)(1996-2#1)(2008-2#1)
with those for##22##3##(1993-8#1)(1994-11#1)(1995-7#1)(1996-2#1)(1997-7#1)(2005-11#2)(2005-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)
with those found after##2##4##(2007-12#1)(2008-10#1)
with those found by##6##4##(2008-10#6)
with those found in the##2##5##(2007-2#1)(2008-7#1)
with those found in##6##4##(1992-3#1)(1995-3#1)(2007-2#1)(2008-7#1)(2010-12#1)(2011-2#1)
with those found##15##3##(1992-3#1)(1995-3#1)(2007-12#1)(2007-2#1)(2008-10#7)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)
with those from a##7##4##(1992-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)
with those from other##5##4##(1993-9#1)(1994-8#1)(2007-11#1)(2008-10#1)(2008-2#1)
with those from the##12##4##(1990-7#1)(1995-11#1)(1996-4#1)(1997-8#1)(2006-8#1)(2008-10#3)(2008-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
with those from##52##3##(1990-12#1)(1990-2#1)(1990-4#2)(1990-6#2)(1990-7#1)(1991-4#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-9#1)(1993-5#1)(1993-9#1)(1994-8#1)(1995-11#1)(1996-4#1)(1997-8#1)(2005-11#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#12)(2008-11#1)(2008-2#3)(2008-3#2)(2008-7#2)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
with those furnished by the reference procedure##2##7##(2008-10#2)
with those given by the##2##5##(2008-10#1)(2008-3#1)
with those given by##8##4##(2008-10#4)(2008-2#1)(2008-3#3)
with those given##9##3##(1990-5#1)(2008-10#4)(2008-2#1)(2008-3#3)
with those in a##2##4##(2008-10#1)(2008-9#1)
with those in other##2##4##(2008-7#1)(2011-1#1)
with those in the##18##4##(1990-2#1)(1990-3#1)(1991-2#1)(1991-8#1)(1995-2#1)(1996-5#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2012-12#1)
with those in which##2##4##(2008-2#2)
with those in##53##3##(1990-2#1)(1990-3#1)(1991-12#2)(1991-2#1)(1991-7#1)(1991-8#1)(1992-5#1)(1992-7#1)(1993-1#1)(1994-11#2)(1994-3#1)(1994-4#1)(1995-11#1)(1995-2#1)(1996-3#2)(1996-5#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-2#1)(2007-10#1)(2007-2#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#4)(2008-7#3)(2008-9#1)(2009-3#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#2)(2013-1#1)
with those measured in##2##4##(1995-12#1)(2008-2#1)
with those measured##6##3##(1995-12#1)(2005-11#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)
with those not##3##3##(1995-5#1)(2008-10#1)(2013-1#1)
with those observed in##2##4##(2007-12#1)(2007-8#1)
with those observed##7##3##(1997-7#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-8#2)(2008-10#1)
with those obtained by HPLC##3##5##(2008-10#3)
with those obtained by ICP-AES##3##5##(2008-10#3)
with those obtained by ICP-MS##2##5##(2008-10#2)
with those obtained by a batch##2##6##(2008-10#2)
with those obtained by a conventional method##2##7##(2008-10#2)
with those obtained by a conventional##3##6##(2008-10#3)
with those obtained by a##16##5##(1996-1#1)(1997-2#1)(2007-10#1)(2007-8#1)(2008-10#11)(2008-2#1)
with those obtained by an##5##5##(2008-10#5)
with those obtained by conventional##6##5##(2006-2#1)(2007-1#1)(2008-10#3)(2008-3#1)
with those obtained by means of##4##6##(2008-10#4)
with those obtained by other##2##5##(2008-10#1)(2008-5#1)
with those obtained by the British Pharmacopoeia##2##7##(2008-10#2)
with those obtained by the British##3##6##(2008-10#3)
with those obtained by the conventional##2##6##(2008-10#2)
with those obtained by the official##2##6##(2008-10#1)(2008-11#1)
with those obtained by the reference##2##6##(2008-10#2)
with those obtained by the##31##5##(1993-1#1)(1997-7#1)(2008-10#28)(2008-11#1)
with those obtained by use of##2##6##(2008-2#1)(2008-3#1)
with those obtained by##115##4##(1991-8#1)(1993-1#1)(1996-1#1)(1997-2#1)(1997-7#2)(2005-11#1)(2005-4#1)(2006-2#1)(2007-1#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-10#87)(2008-11#2)(2008-2#4)(2008-3#5)(2008-5#1)(2009-12#1)(2009-4#1)(2010-2#1)
with those obtained for the same##2##6##(1993-12#1)(2008-10#1)
with those obtained for the##3##5##(1993-12#1)(2008-10#1)(2012-12#1)
with those obtained for##5##4##(1993-12#1)(2008-10#2)(2009-3#1)(2012-12#1)
with those obtained from a##2##5##(2008-10#2)
with those obtained from other##2##5##(2008-5#1)(2008-7#1)
with those obtained from the##2##5##(2008-1#1)(2008-10#1)
with those obtained from##19##4##(1990-12#1)(1995-8#1)(1996-4#1)(2007-11#1)(2008-1#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)
with those obtained in a group of##2##7##(1994-4#1)(2013-1#1)
with those obtained in a##3##5##(1994-4#1)(2006-10#1)(2013-1#1)
with those obtained in the##2##5##(2008-3#1)(2008-5#1)
with those obtained in##14##4##(1991-2#1)(1993-9#1)(1994-3#1)(1994-4#1)(1996-5#1)(1996-9#1)(1997-8#1)(2006-10#1)(2008-3#3)(2008-5#1)(2009-2#1)(2013-1#1)
with those obtained through##2##4##(2008-10#2)
with those obtained using a##5##5##(1990-8#1)(2008-10#4)
with those obtained using conventional##2##5##(2007-8#1)(2008-10#1)
with those obtained using the##4##5##(1997-2#1)(2008-10#3)
with those obtained using##20##4##(1990-8#1)(1992-8#1)(1995-2#1)(1995-6#1)(1997-2#1)(2007-8#1)(2008-10#13)(2008-7#1)
with those obtained with a commercially available##2##7##(1992-8#1)(2008-10#1)
with those obtained with a##10##5##(1992-8#1)(1993-4#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#1)
with those obtained with the standard##2##6##(2008-10#2)
with those obtained with the##6##5##(2008-10#5)(2008-2#1)
with those obtained with##30##4##(1992-8#1)(1993-4#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#17)(2008-2#4)(2008-3#2)(2008-6#1)
with those obtained##214##3##(1990-12#1)(1990-8#1)(1991-2#1)(1991-8#1)(1992-8#2)(1993-1#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-3#1)(1994-4#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-7#2)(1997-8#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-3#1)(2007-8#3)(2008-1#1)(2008-10#132)(2008-11#2)(2008-2#10)(2008-3#14)(2008-5#4)(2008-6#1)(2008-7#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-2#1)(2012-12#1)(2013-1#1)
with those of 30##2##4##(1990-4#1)(1992-8#1)
with those of 38##2##4##(2008-10#1)(2008-7#1)
with those of P##2##4##(2008-10#1)(2008-5#1)
with those of Western##2##4##(1995-4#1)(2008-8#1)
with those of a control group##2##6##(1990-6#1)(2004-10#1)
with those of a##26##4##(1990-12#1)(1990-6#1)(1991-3#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-7#1)(1997-2#2)(1997-7#1)(1997-8#1)(2004-10#1)(2005-7#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#1)(2012-1#1)(2012-3#1)
with those of age-matched##2##4##(2008-10#1)(2013-1#1)
with those of an##5##4##(1991-7#1)(2007-12#1)(2008-10#2)(2008-6#1)
with those of another##2##4##(1994-10#1)(1995-10#1)
with those of classic##2##4##(2004-3#1)(2008-8#1)
with those of control mice##2##5##(1991-6#1)(1992-4#1)
with those of control##6##4##(1991-6#1)(1992-4#1)(1995-3#1)(2007-10#1)(2008-10#1)(2008-7#1)
with those of conventional##5##4##(2006-2#1)(2007-12#1)(2008-2#1)(2008-3#2)
with those of corresponding##2##4##(1992-12#1)(2011-1#1)
with those of human##2##4##(1994-5#1)(2008-10#1)
with those of mammalian##2##4##(1992-12#1)(1993-6#1)
with those of natural##2##4##(2007-8#1)(2008-10#1)
with those of normal##4##4##(1994-2#1)(1996-3#1)(2008-3#1)(2009-9#1)
with those of other small##2##5##(1993-11#1)(1997-4#1)
with those of other tospoviruses##2##5##(2008-10#2)
with those of other treatment##2##5##(1991-4#1)(2006-12#1)
with those of other##31##4##(1990-11#1)(1990-2#1)(1990-3#1)(1991-4#1)(1992-11#1)(1993-11#1)(1995-3#1)(1995-8#1)(1997-2#1)(1997-4#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#1)(2008-10#8)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2012-1#1)
with those of parent##2##4##(1992-8#1)(2008-10#1)
with those of patients with##2##5##(1991-5#2)
with those of patients##6##4##(1991-5#2)(2004-1#1)(2004-11#1)(2007-10#1)(2007-9#1)
with those of previous studies##3##5##(2007-7#1)(2008-10#1)(2011-2#1)
with those of previous##8##4##(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#2)(2011-1#1)(2011-2#1)
with those of previously##4##4##(1993-11#1)(1996-10#1)(2005-7#1)(2008-5#1)
with those of rat##2##4##(1990-11#1)(1991-12#1)
with those of recent##2##4##(1997-6#1)(2008-7#1)
with those of reference##2##4##(2008-12#1)(2009-6#1)
with those of reported tospoviruses##2##5##(2008-10#2)
with those of the other##3##5##(1993-6#1)(1995-3#1)(2006-5#1)
with those of the standard##2##5##(2007-8#1)(2010-11#1)
with those of the wild-type##2##5##(1992-9#1)(2008-10#1)
with those of the##80##4##(1990-12#1)(1990-7#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-6#2)(1993-9#2)(1994-12#1)(1994-8#2)(1995-3#1)(1996-10#1)(1996-7#2)(1997-2#1)(1997-6#1)(1997-7#3)(2005-11#2)(2005-4#1)(2006-10#2)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#14)(2008-11#1)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
with those of##391##3##(1990-10#2)(1990-11#4)(1990-12#5)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#3)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#3)(1991-6#3)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#3)(1992-12#4)(1992-4#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#4)(1993-12#1)(1993-3#2)(1993-6#3)(1993-7#1)(1993-9#5)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#6)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#3)(1995-3#6)(1995-4#1)(1995-6#2)(1995-7#1)(1995-8#4)(1996-10#2)(1996-3#2)(1996-5#3)(1996-6#2)(1996-7#7)(1997-1#1)(1997-2#5)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#6)(1997-8#1)(2004-1#1)(2004-10#1)(2004-11#1)(2004-3#1)(2005-11#4)(2005-4#4)(2005-7#2)(2005-8#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-10#5)(2007-11#4)(2007-12#7)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#4)(2008-1#1)(2008-10#69)(2008-11#5)(2008-12#1)(2008-2#10)(2008-3#23)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#11)(2008-8#6)(2008-9#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#4)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#6)
with those on##6##3##(1996-12#1)(1997-1#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-6#1)
with those patients##2##3##(2005-11#1)(2006-10#1)
with those predicted by theory##2##5##(2007-12#2)
with those predicted by##5##4##(2007-11#1)(2007-12#4)
with those predicted##7##3##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#1)
with those previously reported##2##4##(1994-11#1)(1996-2#1)
with those previously##6##3##(1990-4#1)(1994-11#1)(1996-2#1)(2006-10#1)(2008-10#1)(2008-6#1)
with those provided by the##4##5##(2008-10#4)
with those provided by##5##4##(2008-10#5)
with those published##2##3##(1991-6#1)(2007-3#1)
with those recently##2##3##(1991-11#1)(2008-2#1)
with those recorded in##2##4##(1992-7#1)(2010-8#1)
with those regions##2##3##(1994-2#1)(2010-3#1)
with those reported by other authors##2##6##(1992-1#1)(2007-7#1)
with those reported by##6##4##(1992-1#1)(1996-7#1)(2007-7#1)(2007-8#1)(2008-10#2)
with those reported for##3##4##(1991-8#1)(2005-11#1)(2008-3#1)
with those reported in the literature##3##6##(2007-3#1)(2008-10#1)(2008-8#1)
with those reported in##6##4##(2004-11#1)(2007-3#1)(2008-10#2)(2008-8#1)(2012-1#1)
with those reported previously##5##4##(1990-3#1)(1993-9#1)(1996-4#1)(2006-10#1)(2008-10#1)
with those reported##21##3##(1990-3#1)(1991-8#1)(1992-1#1)(1993-9#1)(1996-4#1)(1996-7#1)(2004-11#1)(2005-11#1)(2006-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-8#1)(2012-1#1)(2013-1#1)
with those seen in##3##4##(1994-5#1)(2005-10#1)(2007-12#1)
with those seen##5##3##(1994-5#1)(2005-10#1)(2007-12#1)(2008-5#1)(2009-12#1)
with those that##7##3##(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-9#1)
with those used in##2##4##(2007-11#1)(2007-12#1)
with those using##5##3##(1992-1#1)(2008-10#1)(2008-5#1)(2010-8#1)(2011-2#1)
with those who had##4##4##(1995-9#1)(2007-3#1)(2009-4#1)(2012-12#1)
with those who##15##3##(1993-12#1)(1995-9#1)(1996-11#1)(2007-10#2)(2007-3#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-4#1)(2012-12#2)(2013-1#2)
with those with a##2##4##(2008-10#2)
with those with normal##2##4##(2005-9#1)(2012-3#1)
with those with##17##3##(1991-2#1)(1995-2#1)(1996-12#1)(2005-9#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-10#3)(2008-8#1)(2009-8#1)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
with those##1039##2##(1990-10#2)(1990-11#4)(1990-12#7)(1990-2#5)(1990-3#3)(1990-4#7)(1990-5#5)(1990-6#4)(1990-7#4)(1990-8#2)(1990-9#2)(1991-10#1)(1991-11#2)(1991-12#5)(1991-2#6)(1991-3#3)(1991-4#3)(1991-5#4)(1991-6#5)(1991-7#3)(1991-8#4)(1991-9#5)(1992-1#3)(1992-11#4)(1992-12#8)(1992-2#1)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#5)(1992-9#3)(1993-1#2)(1993-11#5)(1993-12#4)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#10)(1994-10#1)(1994-11#5)(1994-12#4)(1994-2#3)(1994-3#4)(1994-4#3)(1994-5#2)(1994-8#7)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#4)(1995-12#1)(1995-2#6)(1995-3#8)(1995-4#1)(1995-5#1)(1995-6#4)(1995-7#2)(1995-8#5)(1995-9#1)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#4)(1996-4#3)(1996-5#5)(1996-6#2)(1996-7#8)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#8)(1997-4#5)(1997-5#3)(1997-6#5)(1997-7#12)(1997-8#5)(2004-1#2)(2004-10#1)(2004-11#2)(2004-3#1)(2005-10#1)(2005-11#13)(2005-4#6)(2005-7#2)(2005-8#1)(2005-9#2)(2006-10#14)(2006-11#2)(2006-12#3)(2006-2#3)(2006-4#3)(2006-5#1)(2006-7#2)(2006-8#2)(2007-1#2)(2007-10#14)(2007-11#12)(2007-12#23)(2007-2#2)(2007-3#6)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#12)(2007-9#8)(2008-1#4)(2008-10#280)(2008-11#15)(2008-12#2)(2008-2#42)(2008-3#55)(2008-4#3)(2008-5#26)(2008-6#7)(2008-7#24)(2008-8#12)(2008-9#6)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#5)(2010-2#6)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#5)(2011-1#6)(2011-12#1)(2011-2#10)(2012-1#5)(2012-12#16)(2012-2#7)(2012-3#5)(2012-8#1)(2013-1#17)(2013-7#2)(2013-8#6)
with thousands of##3##3##(2008-2#1)(2010-10#1)(2012-3#1)
with threaded Kirschner wires##2##4##(2007-8#2)
with threatened##2##2##(1992-2#1)(2011-2#1)
with three clinical##2##3##(2009-8#1)(2013-8#1)
with three components##2##3##(2008-10#1)(2012-12#1)
with three coupling##2##3##(2013-8#2)
with three different##29##3##(1990-9#1)(1991-11#1)(1992-7#1)(1992-9#1)(1995-5#1)(1997-1#1)(2007-12#1)(2007-4#1)(2007-7#3)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-5#2)(2008-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2013-1#1)
with three diode##2##3##(2007-12#1)(2008-2#1)
with three distinct##2##3##(1990-12#1)(2009-9#1)
with three disulfide bridges##2##4##(1994-9#1)(2008-8#1)
with three doses##6##3##(1996-8#1)(2004-12#1)(2005-11#1)(2008-7#1)(2013-1#2)
with three enzymes##2##3##(2008-10#1)(2008-5#1)
with three equivalents of##2##4##(2007-3#1)(2010-6#1)
with three examples##2##3##(1994-9#1)(2008-3#1)
with three independent data sets##2##5##(2008-10#1)(2008-8#1)
with three independent##4##3##(1997-7#1)(2008-10#2)(2008-8#1)
with three known compounds##2##4##(2006-12#1)(2007-11#1)
with three known##5##3##(2006-12#3)(2007-1#1)(2007-11#1)
with three levels of##2##4##(2007-8#1)(2008-11#1)
with three nucleoside reverse transcriptase inhibitors##2##6##(2012-12#2)
with three open reading frames##2##5##(1997-2#1)(2008-10#1)
with three or more##5##4##(1995-4#1)(2008-10#1)(2009-5#2)(2011-2#1)
with three other##5##3##(1990-3#1)(1992-8#1)(2008-10#2)(2011-2#1)
with three pairs##2##3##(1991-1#1)(2007-12#1)
with three replicates##4##3##(2008-10#4)
with three replications##4##3##(2008-10#1)(2008-12#2)(2010-4#1)
with three sets of##2##4##(2008-2#1)(2008-7#1)
with three successive 28-day##2##4##(2008-10#2)
with three trophic levels##3##4##(2008-9#3)
with three types of##3##4##(1991-5#1)(2010-12#1)(2012-1#1)
with three##223##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-5#1)(1993-6#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-9#3)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#2)(1996-2#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-7#1)(2004-12#2)(2005-10#1)(2005-11#1)(2005-4#1)(2006-11#2)(2006-12#3)(2006-2#1)(2007-1#1)(2007-11#2)(2007-12#9)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#4)(2007-8#5)(2008-10#46)(2008-11#6)(2008-12#5)(2008-2#7)(2008-3#12)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#7)(2009-11#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-2#4)(2012-1#4)(2012-12#5)(2012-2#1)(2013-1#7)(2013-7#2)(2013-8#5)
with three-dimensional reconstruction##4##3##(2007-8#2)(2008-4#1)(2010-5#1)
with three-dimensional##13##2##(1990-5#1)(1997-6#1)(2004-1#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-5#1)(2013-1#1)
with three-wavelength digital phase demodulation##2##5##(2007-12#2)
with three-wavelength##3##2##(2007-12#3)
with threonine##3##2##(1994-9#1)(2008-10#1)(2008-11#1)
with threshold##6##2##(1994-5#1)(2008-3#1)(2008-7#2)(2011-1#1)(2013-1#1)
with thresholds##2##2##(2007-12#1)(2008-9#1)
with thrombin and then##2##4##(1991-7#1)(1992-6#1)
with thrombin and##4##3##(1991-7#1)(1992-6#1)(1994-12#1)(1996-5#1)
with thrombin or##2##3##(1991-7#1)(1997-7#1)
with thrombin##24##2##(1990-5#1)(1991-7#2)(1991-9#1)(1992-5#1)(1992-6#4)(1992-8#2)(1993-3#1)(1993-5#1)(1994-12#3)(1995-5#3)(1996-5#1)(1996-8#2)(1997-7#1)(2004-11#1)
with thrombocytopenia and##3##3##(2005-10#1)(2007-2#1)(2007-8#1)
with thrombocytopenia##7##2##(2005-10#1)(2006-10#1)(2007-2#2)(2007-8#1)(2008-11#1)(2013-7#1)
with thrombocytosis##2##2##(2006-6#1)(2011-2#1)
with thrombolysis##7##2##(2007-10#2)(2007-11#2)(2007-9#1)(2008-3#1)(2011-2#1)
with thrombolytic therapy for##2##4##(2007-9#1)(2008-3#1)
with thrombolytic therapy##7##3##(1994-5#1)(2007-11#1)(2007-9#2)(2008-3#2)(2010-8#1)
with thrombolytic##8##2##(1994-5#1)(2007-11#1)(2007-9#3)(2008-3#2)(2010-8#1)
with thrombolytics##3##2##(2005-8#1)(2007-10#1)(2008-2#1)
with thrombosis in##2##3##(2004-10#1)(2006-10#1)
with thrombosis of the##3##4##(1993-2#1)(2006-12#1)(2010-12#1)
with thrombosis##9##2##(1992-3#1)(1992-7#1)(1993-2#1)(1996-2#1)(2004-10#1)(2006-10#2)(2006-12#1)(2010-12#1)
with thrombospondin 1##2##3##(1994-5#1)(1996-7#1)
with thrombospondin##4##2##(1994-5#1)(1996-7#1)(2007-12#1)(2009-7#1)
with thrombotic disorders##2##3##(2004-10#1)(2005-12#1)
with thymic##2##2##(2008-4#1)(2008-7#1)
with thymine##3##2##(1992-6#1)(1993-11#1)(2006-10#1)
with thymoma##7##2##(1991-9#4)(2007-2#1)(2007-8#1)(2012-12#1)
with thymopentin##3##2##(1990-2#1)(1991-3#2)
with thymostimulin##4##2##(1990-2#2)(1991-5#1)(1992-5#1)
with thyroid carcinoma##3##3##(2006-1#1)(2009-2#1)(2011-12#1)
with thyroid disorders had##4##4##(2013-1#4)
with thyroid disorders##9##3##(2006-10#1)(2013-1#8)
with thyroid dysfunction##4##3##(2008-4#1)(2011-1#1)(2013-1#2)
with thyroid nodule##3##3##(2011-12#3)
with thyroid##36##2##(1990-12#1)(1990-6#2)(1992-10#1)(2006-1#1)(2006-10#1)(2006-11#1)(2007-5#1)(2008-4#1)(2009-2#1)(2010-9#1)(2011-1#2)(2011-12#5)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#10)
with thyropathies##2##2##(1992-1#2)
with thyrotropin##2##2##(1991-12#1)(2012-12#1)
with thyroxine and##2##3##(2007-1#1)(2007-8#1)
with thyroxine##5##2##(1990-8#1)(1991-5#1)(2006-11#1)(2007-1#1)(2007-8#1)
with tibia##2##2##(2007-1#1)(2007-11#1)
with tibial##2##2##(1997-3#1)(2007-7#1)
with tightly focused##2##3##(2007-12#1)(2008-3#1)
with tightly##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
with tilidine-naloxone##2##2##(1995-9#2)
with tilted##4##2##(2006-12#1)(2007-12#2)(2008-2#1)
with time after inoculation##3##4##(2008-10#3)
with time after##7##3##(1994-6#1)(2007-11#1)(2007-9#1)(2008-10#4)
with time and##10##3##(1990-2#1)(1990-5#1)(1992-6#1)(1996-9#1)(2006-10#1)(2007-2#1)(2008-10#2)(2010-8#1)(2012-12#1)
with time at##2##3##(2006-9#1)(2010-12#1)
with time delay and##2##4##(2008-1#1)(2013-8#1)
with time delays##3##3##(2006-6#1)(2008-2#2)
with time during##3##3##(2005-11#1)(2009-11#1)(2011-2#1)
with time for##2##3##(2007-7#1)(2008-3#1)
with time in culture##2##4##(1990-7#1)(1996-1#1)
with time in the##6##4##(1990-11#1)(1995-10#1)(1997-4#1)(2008-7#2)(2010-12#1)
with time in##10##3##(1990-11#1)(1990-7#1)(1995-10#1)(1996-1#1)(1997-4#1)(2006-4#1)(2008-7#2)(2010-12#2)
with time of storage at##2##5##(1994-12#1)(2008-10#1)
with time of##9##3##(1993-3#1)(1994-12#1)(1996-1#1)(1996-7#1)(2005-11#2)(2007-12#1)(2008-10#1)(2011-2#1)
with time since##3##3##(1993-9#1)(2006-1#1)(2008-10#1)
with time spent##2##3##(2006-10#1)(2008-10#1)
with time to##5##3##(1992-12#1)(1993-9#1)(2007-8#1)(2010-7#1)(2013-1#1)
with time until##2##3##(1990-4#1)(2008-11#1)
with time was observed##2##4##(1990-4#1)(2005-11#1)
with time was##4##3##(1990-4#1)(2005-11#2)(2007-2#1)
with time with##2##3##(1993-7#1)(2008-5#1)
with time##165##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#1)(1990-4#4)(1990-5#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-2#2)(1991-8#1)(1992-1#1)(1992-12#3)(1992-5#2)(1992-6#1)(1992-8#3)(1993-11#1)(1993-3#1)(1993-7#4)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-10#1)(1995-12#1)(1995-6#1)(1996-1#2)(1996-11#1)(1996-3#1)(1996-7#1)(1996-9#2)(1997-4#1)(1997-5#1)(1997-7#2)(2005-11#9)(2006-1#1)(2006-10#2)(2006-4#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-11#4)(2007-12#4)(2007-2#2)(2007-4#1)(2007-7#2)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#18)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#4)(2008-5#9)(2008-6#2)(2008-7#5)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-8#2)(2010-12#5)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
with time-dependent##2##2##(2006-10#1)(2007-6#1)
with time-lapse##2##2##(2008-8#1)(2009-12#1)
with time-of-flight mass spectrometry (GCxGC-TOFMS)##2##5##(2008-10#2)
with time-of-flight mass spectrometry##4##4##(2008-10#4)
with time-of-flight##7##2##(1995-7#1)(2007-11#1)(2008-10#4)(2009-10#1)
with time-resolved reflectance##2##3##(2008-2#2)
with time-resolved##10##2##(1992-6#1)(1997-4#1)(2007-12#1)(2008-2#5)(2008-3#2)
with time-varying##2##2##(1992-3#1)(2010-1#1)
with timely##3##2##(2010-12#2)(2010-3#1)
with timing##3##2##(2007-12#1)(2008-7#1)(2010-2#1)
with tin(II) chloride##3##3##(2008-10#3)
with tin(II)##4##2##(2008-10#4)
with tinea corporis##2##3##(2007-7#1)(2008-5#1)
with tinea versicolor##3##3##(2007-7#1)(2011-2#2)
with tinea##5##2##(2007-7#2)(2008-5#1)(2011-2#2)
with tinnitus and##2##3##(1995-6#1)(2008-7#1)
with tinnitus##3##2##(1995-6#1)(2008-4#1)(2008-7#1)
with tirapazamine##2##2##(1997-4#1)(2008-8#1)
with tirofiban##2##2##(2006-12#2)
with tissue biopsy##2##3##(2008-1#1)(2012-1#1)
with tissue phantoms##2##3##(2007-12#2)
with tissue plasminogen activator##8##4##(1990-12#1)(1994-5#1)(2007-10#1)(2007-5#1)(2007-9#2)(2008-7#2)
with tissue##32##2##(1990-12#1)(1990-7#1)(1991-3#1)(1992-6#1)(1992-8#1)(1994-11#1)(1994-5#1)(1995-1#1)(1996-1#2)(1997-8#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#3)(2007-5#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2011-1#1)(2012-1#1)
with tissue-specific##2##2##(1993-8#1)(2010-10#1)
with titanium elastic nail##2##4##(2012-2#2)
with titanium##11##2##(1997-3#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#2)(2011-1#1)(2012-2#2)(2013-1#1)
with tobacco##5##2##(1991-8#2)(2008-10#1)(2012-12#1)(2012-2#1)
with today's##2##2##(2006-6#1)(2008-1#1)
with tolerance##4##2##(2008-10#3)(2011-10#1)
with toluene and##2##3##(1996-8#1)(2008-10#1)
with toluene##11##2##(1990-10#1)(1991-12#1)(1994-8#1)(1996-8#1)(1997-8#2)(2008-10#3)(2008-7#1)(2011-2#1)
with toluidine blue and##2##4##(1992-12#1)(2008-10#1)
with toluidine blue##3##3##(1992-12#1)(2008-10#1)(2010-2#1)
with tone##3##2##(1995-12#1)(2006-12#1)(2012-1#1)
with too many##2##3##(1994-12#1)(2008-11#1)
with too##3##2##(1991-6#1)(1994-12#1)(2008-11#1)
with tools##3##2##(2006-9#1)(2008-11#1)(2008-4#1)
with tooth##4##2##(1996-3#1)(2008-12#1)(2013-1#2)
with topical application of##5##4##(1992-8#1)(1996-10#1)(2006-8#1)(2008-5#2)
with topical calcineurin inhibitors##3##4##(2008-3#1)(2010-8#2)
with topical imiquimod##2##3##(2012-3#2)
with topical retinoids##2##3##(2007-10#2)
with topical steroids##2##3##(2007-11#1)(2011-2#1)
with topical##35##2##(1990-11#1)(1991-3#1)(1992-11#1)(1992-8#2)(1994-5#1)(1996-10#1)(1996-8#1)(1997-5#1)(2004-3#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-8#3)(2008-10#1)(2008-3#1)(2008-5#3)(2009-8#1)(2010-8#3)(2011-2#2)(2012-11#1)(2012-2#3)(2012-3#2)
with topics##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
with topographic##2##2##(2006-7#1)(2008-2#1)
with topographical##2##2##(2008-3#1)(2009-9#1)
with topoisomerase II##3##3##(1995-1#2)(1996-7#1)
with topoisomerase##7##2##(1995-1#2)(1995-7#1)(1996-6#2)(1996-7#1)(2010-2#1)
with torsion of##2##3##(1992-10#1)(2010-2#1)
with torsional##2##2##(1993-6#1)(2009-3#1)
with total cell##2##3##(1995-11#1)(2008-11#1)
with total fertility##2##3##(2006-10#2)
with total hip replacement##2##4##(2007-7#1)(2008-8#1)
with total hip##4##3##(2007-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
with total internal##2##3##(2008-3#1)(2011-2#1)
with total laparoscopic##2##3##(2010-3#1)(2011-2#1)
with total occlusion of the##2##5##(2008-1#1)(2008-7#1)
with total##66##2##(1991-10#1)(1991-2#1)(1991-3#1)(1992-10#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-4#1)(2005-10#1)(2005-12#1)(2006-10#2)(2006-7#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-6#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
with totally incoherent light##2##4##(2007-12#2)
with totally incoherent##3##3##(2007-12#3)
with totally##4##2##(2005-11#1)(2007-12#3)
with toxic##9##2##(1992-1#1)(1997-3#1)(2006-11#2)(2006-6#1)(2007-8#1)(2008-10#1)(2009-2#1)(2009-6#1)
with toxicity and##2##3##(1997-3#1)(2012-3#1)
with toxicity##4##2##(1997-3#1)(2007-5#1)(2008-9#1)(2012-3#1)
with toxins##2##2##(2008-11#2)
with trace##2##2##(2008-10#2)
with tracer##2##2##(1995-10#1)(1997-2#1)
with traces of##2##3##(2008-10#1)(2010-8#1)
with tracheal intubation##2##3##(2009-2#1)(2012-12#1)
with tracheal##6##2##(1994-10#1)(2007-8#1)(2008-5#2)(2009-2#1)(2012-12#1)
with tracheostomy and##2##3##(2009-2#1)(2012-2#1)
with tracheostomy##7##2##(2008-8#1)(2008-9#1)(2009-2#1)(2011-2#1)(2012-2#3)
with tracking##2##2##(2008-10#1)(2013-1#1)
with traditional Chinese##3##3##(2008-12#1)(2008-4#1)(2012-3#1)
with traditional NSAIDs##2##3##(2007-7#1)(2008-3#1)
with traditional methods##2##3##(2007-12#1)(2008-3#1)
with traditional surgical##3##3##(1996-12#1)(2008-6#1)(2011-2#1)
with traditional treatments##2##3##(1991-2#1)(2008-5#1)
with traditional varieties##2##3##(2008-12#2)
with traditional##62##2##(1990-12#1)(1991-2#1)(1992-1#2)(1995-1#1)(1996-12#1)(1997-1#1)(1997-2#1)(2004-3#1)(2006-10#4)(2006-5#1)(2006-7#1)(2007-1#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#3)(2008-6#5)(2008-7#1)(2008-8#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#1)
with training and##2##3##(2007-7#1)(2008-1#1)
with training in##3##3##(1994-1#1)(2010-4#1)(2012-2#1)
with training##5##2##(1994-1#1)(2007-7#1)(2008-1#1)(2010-4#1)(2012-2#1)
with traits##2##2##(2008-7#1)(2008-9#1)
with tranexamic acid##5##3##(1993-9#3)(2007-8#2)
with trans##3##2##(1996-5#1)(1996-6#1)(2007-12#1)
with transcatheter##2##2##(2007-8#1)(2008-4#1)
with transcranial direct current stimulation##2##5##(2010-7#1)(2011-1#1)
with transcranial##4##2##(2007-12#1)(2007-9#1)(2010-7#1)(2011-1#1)
with transcription factor IIA##2##4##(1992-2#2)
with transcription factor##4##3##(1992-2#2)(1993-3#1)(1994-11#1)
with transcription##8##2##(1992-2#2)(1993-3#1)(1994-11#1)(1996-7#1)(1997-4#1)(2008-5#1)(2008-9#1)
with transcriptional factor##2##3##(2008-9#2)
with transcriptional##13##2##(1991-2#1)(1992-12#1)(1994-9#1)(1996-11#1)(1996-8#1)(2007-10#2)(2007-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2011-2#1)
with transfected##3##2##(1996-2#1)(2008-4#1)(2012-1#1)
with transfer of##2##3##(2008-10#1)(2012-3#1)
with transferrin##4##2##(1994-12#1)(1994-5#1)(2006-9#1)(2012-12#1)
with transformation##2##2##(1991-2#1)(2007-11#1)
with transforming growth factor##2##4##(1990-5#1)(1993-9#1)
with transforming growth##5##3##(1990-5#1)(1993-9#1)(1994-10#1)(2006-9#2)
with transfusion##2##2##(2005-12#1)(2007-2#1)
with transgenic mice##2##3##(2005-11#1)(2007-1#1)
with transgenic##6##2##(2005-11#1)(2006-12#2)(2007-1#1)(2007-11#1)(2008-9#1)
with transient CH##4##3##(2006-9#4)
with transient ischemic attack (TIA)##2##5##(2007-10#1)(2008-8#1)
with transient ischemic attack##5##4##(2007-10#2)(2007-9#2)(2008-8#1)
with transient ischemic attacks##2##4##(2006-11#1)(2007-10#1)
with transient ischemic##7##3##(2006-11#1)(2007-10#3)(2007-9#2)(2008-8#1)
with transient##22##2##(1991-1#1)(1995-12#1)(1996-3#1)(1997-4#1)(2006-10#1)(2006-11#1)(2006-9#4)(2007-1#1)(2007-10#3)(2007-7#1)(2007-9#3)(2008-7#1)(2008-8#1)(2010-6#1)(2012-1#1)
with transition to##3##3##(1993-7#1)(1996-3#1)(2009-5#1)
with transition##6##2##(1990-9#1)(1993-7#1)(1996-3#1)(2008-10#1)(2009-5#1)(2013-1#1)
with transitional cell##2##3##(2006-6#1)(2011-2#1)
with transitional##3##2##(2006-6#1)(2008-9#1)(2011-2#1)
with transitions##2##2##(1995-3#1)(2011-2#1)
with translation##2##2##(1996-2#1)(2007-11#1)
with translational##2##2##(1991-12#1)(2013-1#1)
with translocation of##2##3##(1997-1#1)(2010-11#1)
with translocation##3##2##(1992-11#1)(1997-1#1)(2010-11#1)
with translocations##2##2##(1991-11#1)(2012-1#1)
with transmission Mueller matrix T##2##5##(2008-2#2)
with transmission electron microscopy##5##4##(1997-6#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-2#1)
with transmission##14##2##(1995-12#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#2)(2008-5#1)(2009-2#1)
with transparent##2##2##(2008-3#1)(2009-10#1)
with transplantation of##2##3##(1992-6#1)(2008-9#1)
with transplantation##4##2##(1992-6#1)(1996-12#1)(2008-9#1)(2009-2#1)
with transplanted##5##2##(1990-12#1)(1995-8#1)(2011-2#1)(2012-1#1)(2012-12#1)
with transport##3##2##(2008-7#1)(2010-2#1)(2010-4#1)
with transposition of##3##3##(2006-8#1)(2008-4#1)(2009-10#1)
with transposition##4##2##(2006-8#1)(2008-4#1)(2008-9#1)(2009-10#1)
with transthyretin##2##2##(1994-10#1)(1994-8#1)
with transtibial prostheses##2##3##(2013-1#2)
with transtrapezium approach for##2##4##(2008-9#2)
with transvaginal##3##2##(1995-3#2)(2011-1#1)
with transverse##4##2##(2006-10#1)(2006-7#1)(2007-11#2)
with trapped##2##2##(2007-12#1)(2008-10#1)
with trastuzumab##6##2##(2007-11#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
with trauma##5##2##(2006-10#1)(2006-2#1)(2007-7#1)(2008-7#1)(2012-1#1)
with traumatic brain injury##8##4##(1991-12#1)(1994-12#1)(1995-4#1)(2006-10#2)(2007-8#1)(2008-7#1)(2011-1#1)
with traumatic diaphragmatic##2##3##(2007-3#1)(2009-2#1)
with traumatic injuries to the cervical spine##2##7##(2007-11#2)
with traumatic injuries##3##3##(2006-10#1)(2007-11#2)
with traumatic lung##2##3##(2006-10#1)(2013-1#1)
with traumatic reticuloperitonitis##2##3##(1993-1#2)
with traumatic##27##2##(1991-12#1)(1991-6#1)(1992-6#1)(1993-1#2)(1994-12#1)(1995-3#1)(1995-4#1)(2006-10#4)(2007-10#1)(2007-11#4)(2007-3#1)(2007-8#1)(2008-5#1)(2008-7#2)(2009-2#1)(2011-1#1)(2011-2#2)(2013-1#1)
with treated##4##2##(1996-10#1)(2008-12#1)(2010-5#1)(2013-1#1)
with treatment and##7##3##(1991-1#1)(2005-1#1)(2006-5#1)(2009-5#1)(2009-8#1)(2013-1#2)
with treatment of##8##3##(1991-12#1)(1994-11#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-4#1)(2009-2#1)(2012-2#1)
with treatment outcomes##2##3##(2006-7#2)
with treatment selection##2##3##(2012-2#2)
with treatment services##2##3##(2008-5#1)(2012-1#1)
with treatment was##2##3##(1996-9#1)(2008-4#1)
with treatment with##5##3##(1995-2#1)(1995-5#1)(2006-10#1)(2008-5#1)(2009-6#1)
with treatment##64##2##(1990-6#1)(1991-1#1)(1991-12#1)(1991-7#1)(1993-11#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-8#1)(2005-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#2)(2007-8#2)(2008-1#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-11#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#3)(2013-8#1)
with treatment-refractory##3##2##(1992-3#1)(2005-6#2)
with treatments##4##2##(2008-10#1)(2008-4#1)(2008-5#1)(2010-4#1)
with trees##3##2##(2008-10#1)(2008-9#1)(2011-12#1)
with trehalose##3##2##(2006-5#1)(2008-10#1)(2013-1#1)
with tremolite##3##2##(1991-12#3)
with trends##4##2##(1997-4#1)(2007-11#1)(2008-1#1)(2013-1#1)
with tri-axial##3##2##(2006-11#1)(2007-1#1)(2007-4#1)
with trial##3##2##(2007-7#1)(2008-10#1)(2013-1#1)
with tributyltin hydride##2##3##(1994-5#1)(2008-4#1)
with trichloroacetic acid (TCA)##3##4##(1995-6#1)(2007-8#1)(2009-5#1)
with trichloroacetic acid##5##3##(1995-6#1)(2007-8#1)(2008-10#1)(2009-5#1)(2010-4#1)
with trichloroacetic##6##2##(1995-6#1)(2007-8#1)(2008-10#2)(2009-5#1)(2010-4#1)
with tricyclic antidepressants##2##3##(1996-1#1)(1996-7#1)
with tricyclic##3##2##(1991-11#1)(1996-1#1)(1996-7#1)
with triethylamine##4##2##(1996-5#3)(2008-10#1)
with trifluoroacetic acid##3##3##(1994-9#1)(2007-11#1)(2007-8#1)
with trifluoroacetic##5##2##(1994-9#1)(1997-2#1)(2007-11#1)(2007-8#1)(2013-7#1)
with triglyceride##2##2##(1995-2#1)(2011-1#1)
with triiodothyronine##2##2##(1991-2#1)(1992-2#1)
with trimeperidine and##2##3##(2012-3#2)
with trimethyl orthoformate##2##3##(1996-5#2)
with trimethylamine##2##2##(1995-2#1)(2008-11#1)
with triple vessel##2##3##(2007-9#1)(2013-8#1)
with triple##4##2##(2007-8#1)(2007-9#1)(2008-4#1)(2013-8#1)
with tripod##2##2##(2008-10#1)(2008-5#1)
with tris(2##6##2##(2008-10#6)
with trisomy 21##3##3##(1995-8#1)(1997-4#1)(2007-2#1)
with trisomy##4##2##(1995-8#1)(1997-4#2)(2007-2#1)
with tritiated##8##2##(1990-4#1)(1991-12#1)(1991-9#1)(1992-8#1)(1994-3#1)(1994-6#1)(1996-5#1)(2006-5#1)
with tritium##2##2##(1990-12#1)(1994-5#1)
with tropical deciduous forest##2##4##(2008-5#2)
with tropical##3##2##(2006-5#1)(2008-5#2)
with tropomyosin##2##2##(1992-8#1)(1996-5#1)
with true values##2##3##(1995-4#2)
with true##6##2##(1995-4#2)(2008-10#1)(2008-3#2)(2008-8#1)
with truncated##2##2##(1997-7#1)(2006-8#1)
with trypan blue##2##3##(1997-6#1)(2008-10#1)
with trypsin and##5##3##(1990-5#1)(1994-11#1)(1996-8#1)(1997-2#1)(2008-4#1)
with trypsin of##2##3##(1990-7#1)(1993-8#1)
with trypsin or##3##3##(1992-6#1)(1994-5#1)(2008-10#1)
with trypsin plus##2##3##(1990-12#1)(1995-2#1)
with trypsin##42##2##(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#3)(1993-8#2)(1994-11#1)(1994-12#2)(1994-5#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(2004-9#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#2)(2008-9#1)(2009-4#1)
with tryptase TL2##2##3##(1994-6#2)
with tryptase##3##2##(1994-6#2)(1997-7#1)
with tryptophan##4##2##(1991-7#1)(2008-10#2)(2008-7#1)
with tubal disease##2##3##(1990-2#2)
with tubal infertility and##2##4##(1990-10#2)
with tubal##6##2##(1990-10#2)(1990-2#2)(1993-12#1)(1994-12#1)
with tuberculoid##2##2##(2007-7#1)(2011-2#1)
with tuberculosis##17##2##(1995-9#1)(1996-3#2)(2005-11#1)(2006-6#2)(2006-7#1)(2007-1#1)(2007-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#2)
with tuberculous##6##2##(1997-8#3)(2006-8#1)(2011-2#1)(2013-7#1)
with tubular atrophy##2##3##(1993-3#1)(1995-2#1)
with tubular##5##2##(1990-12#1)(1993-3#1)(1995-2#1)(2006-5#1)(2008-8#1)
with tubulin##9##2##(1992-8#1)(1992-9#4)(1993-6#2)(1997-4#1)(2009-7#1)
with tumor bleeding##3##3##(2007-12#3)
with tumor cells##5##3##(1993-6#1)(1995-8#1)(2008-4#1)(2008-5#1)(2008-8#1)
with tumor necrosis factor-alpha inhibitor##3##5##(2011-2#1)(2013-1#2)
with tumor necrosis factor-alpha##5##4##(1993-12#1)(2008-6#1)(2011-2#1)(2013-1#2)
with tumor necrosis##7##3##(1993-12#1)(2006-10#1)(2008-6#1)(2011-2#1)(2013-1#2)(2013-8#1)
with tumor of##2##3##(2008-7#1)(2012-2#1)
with tumor progression##4##3##(2005-10#1)(2010-12#1)(2010-7#1)(2013-1#1)
with tumor promoters##2##3##(1993-7#2)
with tumor regression##2##3##(1991-8#2)
with tumor##44##2##(1990-11#1)(1991-8#2)(1993-12#1)(1993-6#1)(1993-7#2)(1994-12#1)(1995-5#1)(1995-8#1)(1996-10#1)(2005-10#1)(2005-5#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#3)(2007-2#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2010-12#2)(2010-7#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
with tumoricidal activity##2##3##(1997-7#1)(2008-4#1)
with tumorigenicity##2##2##(1990-4#1)(1992-9#1)
with tumors and##3##3##(1992-7#2)(2007-8#1)
with tumors of different##2##4##(2012-1#1)(2013-1#1)
with tumors of the##2##4##(2005-9#1)(2009-2#1)
with tumors of##5##3##(1992-6#1)(2005-9#1)(2009-2#1)(2012-1#1)(2013-1#1)
with tumors##18##2##(1990-10#1)(1990-12#1)(1992-10#1)(1992-6#1)(1992-7#3)(1995-4#1)(2005-9#1)(2006-12#1)(2006-2#1)(2007-8#2)(2008-6#1)(2009-2#1)(2011-2#1)(2012-1#1)(2013-1#1)
with tumour necrosis##2##3##(2011-12#1)(2012-11#1)
with tumour##12##2##(1990-2#1)(1992-10#1)(1992-9#1)(1996-3#1)(2004-2#1)(2006-10#1)(2006-8#1)(2008-6#1)(2008-7#1)(2011-12#1)(2012-11#1)(2013-8#1)
with tunable##6##2##(2007-12#2)(2008-3#1)(2008-7#1)(2010-4#1)(2013-1#1)
with tungsten##3##2##(2007-11#1)(2008-10#1)(2009-2#1)
with tunicamycin##3##2##(1990-7#1)(1991-7#1)(1993-4#1)
with turkey rhinotracheitis##2##3##(1997-6#1)(2008-5#1)
with twice the##3##3##(1992-8#1)(2008-3#1)(2011-2#1)
with twice##4##2##(1991-7#1)(1992-8#1)(2008-3#1)(2011-2#1)
with twin##5##2##(1996-12#1)(2005-7#1)(2008-3#3)
with twins##2##2##(2009-9#1)(2010-10#1)
with two additional##3##3##(1991-2#1)(2006-8#1)(2009-5#1)
with two adjacent##2##3##(1996-8#1)(2008-2#1)
with two cascaded##2##3##(2008-2#1)(2008-3#1)
with two clinical##2##3##(2008-2#1)(2008-4#1)
with two commercial##3##3##(1991-10#1)(2006-7#1)(2010-4#1)
with two commonly used##2##4##(1992-8#1)(2008-10#1)
with two consecutive##2##3##(2009-5#1)(2012-12#1)
with two cycles of##3##4##(1996-9#1)(2008-10#2)
with two different levels of##2##5##(1990-2#1)(2008-10#1)
with two different types of##2##5##(2011-1#1)(2013-7#1)
with two different wavelengths##2##4##(2008-2#1)(2008-3#1)
with two different##50##3##(1990-11#1)(1990-2#2)(1994-11#1)(1995-1#1)(1995-5#1)(1995-8#1)(1997-1#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-8#1)(2005-11#1)(2006-7#1)(2007-11#1)(2008-10#9)(2008-2#5)(2008-3#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-3#2)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)
with two distinct##11##3##(1991-11#1)(1994-9#1)(1997-4#2)(2007-8#1)(2008-10#1)(2008-3#1)(2010-9#1)(2012-12#1)(2013-1#2)
with two doses##2##3##(2004-12#1)(2012-12#1)
with two existing##2##3##(1991-3#1)(2012-2#1)
with two experimental##2##3##(2008-10#1)(2013-8#1)
with two flow##2##3##(2008-10#2)
with two hidden layers##2##4##(1994-9#1)(2010-8#1)
with two isolates of##3##4##(2008-10#3)
with two isolates##5##3##(2008-10#5)
with two lower##2##3##(1993-9#1)(2005-8#1)
with two major##3##3##(1992-5#1)(2008-10#1)(2008-11#1)
with two new##6##3##(2008-10#4)(2008-2#1)(2011-2#1)
with two of##5##3##(2006-9#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-1#1)
with two open reading##2##4##(1994-9#1)(2008-10#1)
with two or more##7##4##(1997-2#1)(2005-12#1)(2006-10#1)(2006-4#1)(2007-7#1)(2012-12#1)(2013-8#1)
with two or##12##3##(1995-1#1)(1997-1#1)(1997-2#1)(2005-12#1)(2006-10#1)(2006-4#1)(2007-7#1)(2008-2#1)(2008-9#1)(2009-5#1)(2012-12#1)(2013-8#1)
with two orthogonal##2##3##(2007-11#1)(2008-1#1)
with two other##9##3##(1997-3#1)(1997-4#2)(2006-8#1)(2008-10#1)(2008-8#1)(2010-4#1)(2012-2#2)
with two pairs of##3##4##(1991-7#1)(2007-11#1)(2007-12#1)
with two parallel##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)
with two parameters##3##3##(2008-10#2)(2008-2#1)
with two patients##2##3##(1992-2#1)(2008-7#1)
with two peaks##2##3##(1992-12#1)(2010-12#1)
with two protein##2##3##(1990-4#1)(2008-4#1)
with two proteins##3##3##(1990-7#1)(1994-2#1)(1994-8#1)
with two putative##3##3##(1993-3#1)(1995-2#1)(1997-7#1)
with two sample##2##3##(2008-10#1)(2011-2#1)
with two separate##2##3##(1994-2#1)(2007-10#1)
with two sets of##2##4##(1991-12#1)(2008-4#1)
with two short##2##3##(1996-2#2)
with two shots to the head inflicted by a captive-bolt gun##2##11##(2012-1#2)
with two terminal##2##3##(1995-6#1)(1996-10#1)
with two to four##2##4##(2010-8#1)(2013-8#1)
with two to##3##3##(2007-4#1)(2010-8#1)(2013-8#1)
with two treatments##3##3##(1992-9#1)(2010-2#1)(2013-7#1)
with two types of##11##4##(1992-3#1)(1993-11#1)(1994-2#1)(1997-7#2)(2006-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-12#1)
with two vertical##2##3##(2007-12#1)(2008-10#1)
with two years of##3##4##(2008-8#1)(2013-1#2)
with two years##6##3##(2008-8#1)(2009-9#1)(2013-1#3)(2013-8#1)
with two##513##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#3)(1990-4#3)(1990-5#2)(1990-6#2)(1990-7#2)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#3)(1992-11#3)(1992-12#3)(1992-2#4)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#3)(1993-12#4)(1993-2#1)(1993-3#2)(1993-9#1)(1994-11#6)(1994-12#1)(1994-2#4)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#4)(1995-1#2)(1995-11#3)(1995-12#1)(1995-2#4)(1995-5#3)(1995-6#1)(1995-8#3)(1996-10#1)(1996-12#1)(1996-2#5)(1996-3#2)(1996-5#2)(1996-6#3)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#6)(1997-5#1)(1997-6#3)(1997-7#6)(1997-8#2)(2004-12#1)(2004-8#1)(2005-11#3)(2005-12#2)(2005-8#1)(2005-9#1)(2006-10#7)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#2)(2006-6#2)(2006-7#3)(2006-8#4)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#8)(2007-12#31)(2007-2#2)(2007-3#2)(2007-4#2)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#84)(2008-11#6)(2008-12#2)(2008-2#25)(2008-3#24)(2008-4#6)(2008-5#8)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#2)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#11)(2011-2#7)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#7)(2012-3#9)(2013-1#16)(2013-7#3)(2013-8#8)
with two-##2##2##(2007-11#1)(2008-3#1)
with two-color##2##2##(2008-3#2)
with two-dimensional and##2##3##(1995-6#1)(2008-2#1)
with two-dimensional geometry##4##3##(2008-11#4)
with two-dimensional##15##2##(1995-6#1)(2007-12#1)(2008-11#5)(2008-2#3)(2008-3#2)(2008-5#1)(2010-1#1)(2011-1#1)
with two-photon excitation##3##3##(1996-11#1)(2008-3#2)
with two-photon##6##2##(1996-11#2)(2008-3#4)
with two-stage##2##2##(2012-1#1)(2012-12#1)
with two-thirds of##2##3##(1994-9#1)(2007-10#1)
with two-wave mixing in##2##4##(2008-2#2)
with two-wavelength nonlinear prism coupling##2##5##(2008-1#2)
with two-wavelength##3##2##(2008-1#2)(2008-2#1)
with type 1 and 2 diabetes##2##6##(2007-8#1)(2012-12#1)
with type 1 and##7##4##(2007-8#1)(2008-7#1)(2012-12#3)(2012-4#2)
with type 1 diabetes and##4##5##(2008-3#1)(2009-9#2)(2012-2#1)
with type 1 diabetes mellitus##4##5##(2008-7#1)(2010-11#1)(2011-1#1)(2012-1#1)
with type 1 diabetes##24##4##(1990-10#1)(2006-1#1)(2007-5#2)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#2)(2009-4#1)(2009-9#2)(2010-11#1)(2010-12#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
with type 1##36##3##(1990-10#2)(1990-5#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-5#2)(2007-8#1)(2008-1#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-11#2)(2009-4#1)(2009-9#2)(2010-11#1)(2010-12#2)(2011-1#1)(2012-1#1)(2012-12#4)(2012-2#1)(2012-4#2)(2013-1#1)(2013-8#2)
with type 2 DM and##3##5##(2010-10#2)(2011-11#1)
with type 2 DM##9##4##(2007-1#1)(2008-3#2)(2008-8#1)(2010-10#2)(2011-11#2)(2012-2#1)
with type 2 diabetes (T2DM)##2##5##(2008-3#1)(2013-1#1)
with type 2 diabetes and##5##5##(2008-1#1)(2008-7#2)(2009-11#1)(2012-3#1)
with type 2 diabetes have##3##5##(2007-1#1)(2008-1#2)
with type 2 diabetes in##4##5##(2008-7#2)(2009-7#1)(2011-1#1)
with type 2 diabetes mellitus (T2DM)##4##6##(2008-1#1)(2012-1#1)(2013-1#2)
with type 2 diabetes mellitus or metabolic syndrome##3##8##(2009-11#3)
with type 2 diabetes mellitus##37##5##(1990-11#1)(2006-9#1)(2007-1#1)(2007-2#1)(2007-5#1)(2008-1#3)(2008-3#3)(2008-8#2)(2009-11#4)(2010-10#2)(2011-1#2)(2011-11#1)(2011-2#3)(2012-1#2)(2012-2#1)(2013-1#7)(2013-8#2)
with type 2 diabetes##111##4##(1990-11#1)(1996-11#1)(2005-10#3)(2006-2#1)(2006-9#2)(2007-1#2)(2007-2#1)(2007-4#1)(2007-5#2)(2007-8#2)(2008-1#14)(2008-11#1)(2008-3#16)(2008-7#5)(2008-8#2)(2009-1#1)(2009-11#8)(2009-7#1)(2010-10#3)(2010-12#1)(2010-4#2)(2011-1#3)(2011-11#1)(2011-2#8)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#2)(2012-5#2)(2013-1#8)(2013-7#2)(2013-8#3)
with type 2##128##3##(1990-11#1)(1993-4#1)(1996-11#1)(2005-10#3)(2006-10#2)(2006-2#1)(2006-9#2)(2007-1#4)(2007-2#1)(2007-4#1)(2007-5#2)(2007-8#2)(2008-1#14)(2008-11#1)(2008-3#18)(2008-7#5)(2008-8#3)(2009-1#1)(2009-11#8)(2009-7#1)(2010-10#5)(2010-12#2)(2010-4#2)(2011-1#3)(2011-11#3)(2011-2#8)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#2)(2012-5#3)(2013-1#8)(2013-7#3)(2013-8#3)
with type A##2##3##(1997-6#1)(2013-8#1)
with type I and II##2##5##(2008-1#1)(2008-6#1)
with type I and##4##4##(2007-9#1)(2008-1#1)(2008-6#1)(2008-9#1)
with type I autophagy##2##4##(2007-9#2)
with type I collagen##2##4##(1992-11#1)(2010-4#1)
with type I diabetes mellitus and##2##6##(2007-7#1)(2009-2#1)
with type I diabetes mellitus##3##5##(2007-7#1)(2009-2#1)(2011-2#1)
with type I diabetes##6##4##(1996-9#1)(2006-6#1)(2007-7#1)(2009-2#2)(2011-2#1)
with type I mucopolysaccharidosis##3##4##(2012-3#3)
with type I##25##3##(1991-1#1)(1992-11#1)(1993-3#1)(1995-2#1)(1996-9#1)(2006-6#1)(2007-11#2)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-6#1)(2008-9#1)(2009-2#2)(2010-4#1)(2011-2#1)(2012-3#4)
with type II DM##2##4##(2007-2#2)
with type II collagen##3##4##(1996-10#1)(2007-11#1)(2008-4#1)
with type II diabetes and##2##5##(1994-2#1)(2009-4#1)
with type II diabetes mellitus and##3##6##(1996-1#1)(2006-6#1)(2008-7#1)
with type II diabetes mellitus##7##5##(1993-12#2)(1996-1#2)(2006-6#2)(2008-7#1)
with type II diabetes##12##4##(1993-12#2)(1994-2#1)(1995-8#1)(1996-1#2)(1996-11#1)(2005-8#1)(2006-6#2)(2008-7#1)(2009-4#1)
with type II##22##3##(1991-11#1)(1993-12#2)(1994-2#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#1)(1997-2#1)(2005-8#1)(2006-10#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-4#1)(2008-7#1)(2009-4#1)
with type III##5##3##(2006-2#1)(2007-8#1)(2008-7#1)(2011-2#1)(2013-8#1)
with type IV Ehlers-Danlos syndrome##2##5##(2004-10#2)
with type IV##3##3##(2004-10#2)(2007-7#1)
with type V collagen in##2##5##(2007-9#2)
with type V##4##3##(2007-7#1)(2007-8#1)(2007-9#2)
with type of##2##3##(1996-7#1)(2011-2#1)
with type##238##2##(1990-10#2)(1990-11#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-9#1)(1992-11#2)(1992-3#1)(1993-12#2)(1993-3#1)(1993-4#1)(1994-2#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-6#1)(2004-10#2)(2005-10#3)(2005-12#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-2#2)(2006-6#3)(2006-9#2)(2007-1#4)(2007-11#4)(2007-12#1)(2007-2#3)(2007-4#1)(2007-5#4)(2007-7#3)(2007-8#8)(2007-9#5)(2008-1#17)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#19)(2008-4#2)(2008-6#1)(2008-7#9)(2008-8#4)(2008-9#1)(2009-1#1)(2009-11#11)(2009-2#2)(2009-4#2)(2009-7#1)(2009-9#2)(2010-10#5)(2010-11#1)(2010-12#4)(2010-4#3)(2011-1#4)(2011-11#3)(2011-2#12)(2012-1#4)(2012-11#1)(2012-12#8)(2012-2#7)(2012-3#6)(2012-4#2)(2012-5#3)(2013-1#9)(2013-7#3)(2013-8#7)
with type-2 diabetes mellitus##3##4##(2010-4#1)(2011-12#1)(2011-2#1)
with type-2 diabetes##7##3##(2008-7#3)(2010-3#1)(2010-4#1)(2011-12#1)(2011-2#1)
with type-specific##2##2##(1992-9#1)(2007-12#1)
with typical and atypical antipsychotics##2##5##(2008-8#1)(2009-12#1)
with typical and atypical##4##4##(1996-12#1)(2004-3#1)(2008-8#1)(2009-12#1)
with typical and##5##3##(1996-12#1)(2004-3#1)(2008-8#1)(2009-12#1)(2012-1#1)
with typical antipsychotics##2##3##(2010-6#1)(2012-1#1)
with typical clinical signs##2##4##(2008-5#1)(2011-2#1)
with typical clinical symptoms##2##4##(2008-1#1)(2013-1#1)
with typical clinical##5##3##(2008-1#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
with typical development##2##3##(2006-10#1)(2012-1#1)
with typical symptoms of##2##4##(2005-11#1)(2013-8#1)
with typical##48##2##(1990-12#1)(1995-1#1)(1996-12#1)(1997-2#1)(2004-12#1)(2004-3#1)(2005-1#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#3)(2008-6#1)(2008-8#1)(2009-12#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-12#2)(2012-2#1)(2013-1#5)(2013-8#1)
with typically##2##2##(2007-11#1)(2008-2#1)
with tyrosinase##3##2##(1995-8#1)(2008-10#2)
with tyrosine hydroxylase##2##3##(1996-5#1)(1997-5#1)
with tyrosine kinase inhibitors##2##4##(2009-3#1)(2012-12#1)
with tyrosine kinase##3##3##(2008-4#1)(2009-3#1)(2012-12#1)
with tyrosine phosphorylation##2##3##(1993-8#1)(1994-8#1)
with tyrosine##13##2##(1990-7#2)(1992-8#1)(1993-2#1)(1993-8#1)(1994-8#1)(1996-5#1)(1997-5#1)(1997-7#1)(2007-9#1)(2008-4#1)(2009-3#1)(2012-12#1)
with tyrosine-phosphorylated##2##2##(1995-1#1)(1997-6#1)
with ubiquitin##3##2##(1991-7#1)(2008-1#1)(2011-3#1)
with ulcer##2##2##(2007-7#1)(2010-11#1)
with ulceration##2##2##(2005-7#1)(2011-12#1)
with ulcerative colitis (UC)##4##4##(2007-4#1)(2010-12#1)(2011-2#1)(2012-3#1)
with ulcerative colitis##21##3##(1992-9#1)(1994-2#1)(2006-10#5)(2006-2#1)(2007-10#2)(2007-4#2)(2009-4#1)(2010-12#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
with ulcerative colitis]##2##3##(2012-11#2)
with ulcerative##25##2##(1992-9#1)(1994-2#1)(2006-10#5)(2006-2#1)(2007-10#2)(2007-4#2)(2009-4#1)(2010-12#5)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
with ulnar##3##2##(2006-3#1)(2008-4#1)(2013-7#1)
with ultimate##2##2##(2008-1#2)
with ultra##2##2##(1992-3#1)(2008-9#1)
with ultra-violet##2##2##(2008-5#1)(2010-4#1)
with ultrafiltration##3##2##(2011-2#1)(2012-12#1)(2013-8#1)
with ultrashort pulse##2##3##(2007-12#2)
with ultrashort##5##2##(2007-12#4)(2008-2#1)
with ultrasonic extraction##2##3##(2007-8#1)(2011-12#1)
with ultrasonic nebulization##4##3##(1991-1#1)(2008-10#2)(2008-3#1)
with ultrasonic scalpel##2##3##(2007-8#1)(2008-3#1)
with ultrasonic##15##2##(1991-1#1)(1991-12#1)(1992-8#1)(1996-5#1)(2007-8#3)(2008-10#3)(2008-3#2)(2009-2#1)(2011-12#1)(2012-3#1)
with ultrasonography##4##2##(2006-2#1)(2008-1#1)(2008-4#1)(2008-7#1)
with ultrasound and##2##3##(1995-3#1)(2006-10#1)
with ultrasound scanning##2##3##(1994-7#1)(2007-8#1)
with ultrasound##21##2##(1990-2#1)(1993-5#2)(1994-7#1)(1995-3#1)(2005-10#1)(2006-10#2)(2007-7#3)(2007-8#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2011-2#2)(2013-8#2)
with ultrastructural##2##2##(1990-11#1)(2008-10#1)
with ultraviolet (UV)##2##3##(1996-6#1)(2007-8#1)
with ultraviolet absorbance detection##3##4##(1996-3#1)(1997-8#1)(2008-10#1)
with ultraviolet absorbance##4##3##(1996-3#1)(1997-8#1)(2008-10#2)
with ultraviolet detection at##6##4##(1990-9#1)(1996-6#1)(1997-2#1)(1997-8#2)(2008-10#1)
with ultraviolet detection was##2##4##(1994-12#1)(2008-10#1)
with ultraviolet detection##18##3##(1990-11#1)(1990-6#1)(1990-9#1)(1993-2#1)(1994-12#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#2)(2008-10#5)(2012-12#2)
with ultraviolet light and##2##4##(1996-6#1)(2007-8#1)
with ultraviolet light##8##3##(1990-7#1)(1991-8#1)(1996-6#1)(2005-7#1)(2007-11#1)(2007-8#1)(2008-10#2)
with ultraviolet##41##2##(1990-11#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-8#1)(1993-2#1)(1994-12#1)(1994-3#1)(1996-3#1)(1996-6#3)(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#3)(2005-7#1)(2007-11#2)(2007-8#3)(2008-10#11)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#2)
with umbilical##2##2##(2008-10#1)(2008-9#1)
with un-treated larvae##2##3##(2008-12#2)
with unaffected##3##2##(2006-9#1)(2007-2#1)(2010-4#1)
with uncertain##4##2##(1993-10#1)(2005-3#1)(2010-12#1)(2012-3#1)
with uncertainties in##2##3##(2008-10#1)(2008-3#1)
with uncertainties##4##2##(2008-10#1)(2008-3#3)
with uncertainty##6##2##(1995-6#1)(1997-3#1)(2008-11#1)(2010-11#1)(2010-8#1)(2012-12#1)
with uncertified seeds##2##3##(2008-12#2)
with unclear##8##2##(1994-9#1)(1995-12#1)(1996-12#1)(2008-1#1)(2012-11#2)(2013-1#1)(2013-8#1)
with uncoated##2##2##(1991-8#1)(2008-2#1)
with uncommon##8##2##(1992-8#1)(1994-6#1)(2005-11#1)(2007-7#1)(2008-7#2)(2009-4#1)(2012-2#1)
with uncomplicated##10##2##(1990-8#1)(1992-2#2)(1993-1#1)(2005-12#1)(2005-8#1)(2006-10#1)(2007-8#1)(2008-3#2)
with unconstrained##2##2##(2008-6#1)(2010-8#1)
with uncontrollable##2##2##(2006-10#1)(2010-9#1)
with uncontrolled##4##2##(1992-6#1)(2007-7#1)(2008-4#1)(2012-1#1)
with uncorrected##2##2##(2009-4#2)
with undamaged##2##2##(2008-2#1)(2008-8#1)
with undergraduate education and current job##2##6##(1993-3#2)
with undergraduate education##4##3##(1993-3#4)
with undergraduate nursing students##2##4##(2006-12#1)(2008-12#1)
with undergraduate##6##2##(1993-3#4)(2006-12#1)(2008-12#1)
with underlying chronic##2##3##(2012-11#1)(2012-12#1)
with underlying medical conditions##2##4##(2005-8#1)(2011-2#1)
with underlying##18##2##(1990-3#1)(1992-11#1)(2004-10#1)(2005-8#1)(2006-10#2)(2007-3#1)(2007-7#1)(2008-6#1)(2009-3#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#2)(2013-7#1)
with undetectable##7##2##(1990-7#1)(1995-2#1)(1995-8#1)(1996-5#1)(2008-7#1)(2009-8#1)(2013-1#1)
with undiagnosed Marfan syndrome##3##4##(2007-8#1)(2013-1#2)
with undiagnosed##8##2##(2006-10#1)(2007-12#1)(2007-8#1)(2008-4#1)(2013-1#4)
with undifferentiated##5##2##(1991-9#2)(1994-6#1)(2010-12#1)(2011-2#1)
with undoped ends##3##3##(2008-2#3)
with undoped##4##2##(2007-12#1)(2008-2#3)
with unemployment##3##2##(1997-3#2)(2007-12#1)
with unequal variances##2##3##(1995-12#1)(2012-1#1)
with unequal##15##2##(1995-12#1)(1996-3#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2012-1#3)(2012-3#1)
with unequivocal##2##2##(1992-2#1)(1996-9#1)
with unexpected##4##2##(1994-9#1)(1996-3#1)(2009-10#1)(2009-7#1)
with unexplained medical symptoms##2##4##(2008-11#2)
with unexplained recurrent##3##3##(2008-4#1)(2012-3#1)(2013-1#1)
with unexplained##19##2##(1992-8#1)(1996-12#1)(2006-10#3)(2006-2#1)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-11#3)(2008-4#1)(2008-8#1)(2012-3#1)(2013-1#2)(2013-7#1)
with unfavorable##6##2##(1990-8#1)(2007-7#1)(2008-5#1)(2009-7#1)(2013-7#2)
with unfavourable##2##2##(1995-10#1)(2010-11#1)
with unidentified##4##2##(1993-3#1)(1993-4#1)(1997-2#1)(2008-10#1)
with unidirectional##2##2##(2007-12#1)(2008-4#1)
with uniform orientation##2##3##(1992-7#1)(2008-7#1)
with uniform##14##2##(1990-7#1)(1992-7#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-5#1)(2008-7#1)(2009-7#1)(2010-1#1)(2010-4#1)(2012-12#1)
with uniformly##3##2##(2008-4#1)(2009-7#2)
with unilamellar##2##2##(1990-2#1)(1996-9#1)
with unilateral Perthes disease##4##4##(2007-11#3)(2007-7#1)
with unilateral Perthes##5##3##(2007-11#4)(2007-7#1)
with unilateral disease##2##3##(2007-7#2)
with unilateral lesions##2##3##(1995-8#1)(2009-4#1)
with unilateral nasal symptomatology##2##4##(2009-2#2)
with unilateral or bilateral##3##4##(2006-9#1)(2008-12#1)(2012-1#1)
with unilateral single##2##3##(2007-10#2)
with unilateral##58##2##(1990-2#1)(1993-12#1)(1994-2#1)(1995-4#1)(1995-5#2)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-8#2)(2005-10#1)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#2)(2007-10#3)(2007-11#4)(2007-7#5)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-2#3)(2009-4#3)(2009-8#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
with unimpaired##2##2##(2012-1#2)
with unipolar major depression##3##4##(1996-7#2)(2005-6#1)
with unipolar##5##2##(1995-11#1)(1996-7#3)(2005-6#1)
with unique properties##2##3##(1996-4#1)(2012-2#1)
with unique##25##2##(1991-9#1)(1994-12#1)(1994-2#1)(1996-4#1)(1996-6#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-1#1)(2010-4#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-3#1)(2012-2#1)
with unit cell dimensions a =##4##6##(1991-12#2)(1996-2#2)
with unit cell dimensions of a =##2##7##(1991-4#1)(1991-7#1)
with unit cell dimensions of##3##5##(1991-4#1)(1991-7#1)(1997-7#1)
with unit cell dimensions##8##4##(1991-12#2)(1991-4#1)(1991-7#1)(1994-6#1)(1996-2#2)(1997-7#1)
with unit cell##9##3##(1991-12#2)(1991-4#1)(1991-7#1)(1994-6#1)(1996-2#2)(1997-7#1)(2008-8#1)
with unit##12##2##(1991-12#2)(1991-4#1)(1991-7#1)(1994-6#1)(1996-2#2)(1997-7#1)(2007-12#1)(2008-7#1)(2008-8#1)(2010-12#1)
with univentricular heart##3##3##(1996-12#1)(2009-4#1)(2012-3#1)
with universal##2##2##(1994-3#1)(1996-8#1)
with unknown function and no##2##5##(1990-9#1)(2008-7#1)
with unknown function##10##3##(1990-5#1)(1990-9#1)(1994-3#1)(2006-11#1)(2007-12#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-6#1)
with unknown functions##2##3##(1991-7#1)(2008-4#1)
with unknown primary##4##3##(1992-11#1)(1992-12#1)(2007-11#2)
with unknown##34##2##(1990-5#1)(1990-9#1)(1991-7#1)(1992-11#1)(1992-12#1)(1994-3#1)(2006-11#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-4#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-7#1)(2012-2#2)
with unlabeled##9##2##(1990-3#1)(1992-12#1)(1993-7#1)(1994-12#1)(1995-5#1)(1995-6#1)(1996-7#1)(2006-7#1)(2012-2#1)
with unlimited##9##2##(2007-2#3)(2008-10#2)(2008-3#1)(2008-6#1)(2008-9#2)
with unmodified##5##2##(1994-5#1)(2008-10#2)(2008-2#1)(2009-10#1)
with unoperated##3##2##(1992-9#1)(1993-2#1)(2009-8#1)
with unplanned##4##2##(2004-10#1)(2010-10#2)(2011-12#1)
with unpolarized##2##2##(2007-11#1)(2008-3#1)
with unprecedented##4##2##(2006-10#1)(2007-9#1)(2008-9#1)(2009-5#1)
with unprotected##3##2##(2008-3#1)(2011-2#1)(2013-7#1)
with unrelated##3##2##(2005-8#1)(2008-10#1)(2012-3#1)
with unresectable pancreatic adenocarcinoma##2##4##(1991-2#1)(2006-6#1)
with unresectable pancreatic##3##3##(1991-2#1)(2006-6#2)
with unresectable##11##2##(1991-2#1)(1995-4#1)(2006-6#3)(2008-3#1)(2008-6#1)(2012-2#2)(2013-1#2)
with unruptured##2##2##(2004-10#1)(2008-7#1)
with unsafe##2##2##(1994-9#1)(2008-11#1)
with unsaturated##2##2##(1992-8#1)(2005-11#1)
with unstable angina pectoris##5##4##(1990-12#3)(2006-6#1)(2007-11#1)
with unstable angina##24##3##(1990-12#3)(1991-9#1)(2005-10#2)(2005-12#2)(2005-7#1)(2006-10#1)(2006-6#1)(2007-11#4)(2007-7#1)(2008-10#1)(2008-5#1)(2012-1#2)(2013-1#2)(2013-8#2)
with unstable##37##2##(1990-12#3)(1990-4#1)(1991-9#1)(2005-10#2)(2005-12#2)(2005-7#1)(2006-10#1)(2006-6#1)(2006-8#3)(2007-11#4)(2007-7#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#1)(2012-1#2)(2013-1#2)(2013-7#2)(2013-8#3)
with unsuccessful##2##2##(2007-11#1)(2011-1#1)
with untransformed steroid receptors##2##4##(1990-5#1)(1997-4#1)
with untransformed##4##2##(1990-5#1)(1991-7#1)(1997-4#1)(2008-10#1)
with untreated control##2##3##(2008-7#1)(2011-2#1)
with untreated or##3##3##(1991-6#1)(1992-9#1)(2008-7#1)
with untreated##22##2##(1991-6#1)(1992-2#1)(1992-9#1)(1993-8#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-11#2)(2004-1#1)(2008-12#1)(2008-5#1)(2008-7#2)(2010-11#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#2)
with unusual presentation##2##3##(2009-8#1)(2010-11#1)
with unusual properties##2##3##(1991-3#1)(2007-9#1)
with unusual##28##2##(1990-5#1)(1991-3#1)(1993-4#1)(1995-8#1)(1996-7#1)(1997-4#1)(2006-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
with unusually##2##2##(1993-11#1)(2010-1#1)
with up to 1##4##4##(1991-12#1)(1997-2#1)(2010-2#1)(2011-2#1)
with up to 100##2##4##(1993-5#1)(2008-10#1)
with up to##27##3##(1991-12#1)(1993-2#2)(1993-5#1)(1994-11#1)(1995-9#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2010-2#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
with up##29##2##(1991-12#1)(1993-2#2)(1993-5#1)(1994-11#1)(1994-5#1)(1995-9#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2009-5#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
with up-regulation of##3##3##(1995-1#1)(2008-10#1)(2008-11#1)
with upper abdominal pain and##2##5##(2007-9#1)(2013-1#1)
with upper abdominal##3##3##(2007-3#1)(2007-9#1)(2013-1#1)
with upper aerodigestive##2##3##(2013-1#2)
with upper airway##2##3##(2008-9#1)(2011-2#1)
with upper body##2##3##(2008-4#1)(2012-1#1)
with upper gastrointestinal bleeding##2##4##(2006-10#1)(2013-1#1)
with upper gastrointestinal##3##3##(2006-10#1)(2011-2#1)(2013-1#1)
with upper limb##2##3##(2012-1#2)
with upper##28##2##(1990-8#1)(1991-11#1)(1993-7#1)(2006-10#2)(2006-12#1)(2006-9#2)(2007-3#1)(2007-9#1)(2008-4#1)(2008-8#1)(2008-9#2)(2010-3#1)(2011-12#1)(2011-2#3)(2012-1#3)(2012-3#1)(2013-1#5)
with uranium##2##2##(2008-10#1)(2013-1#1)
with urban##3##2##(2007-12#1)(2009-7#1)(2012-1#1)
with urea and##4##3##(1992-7#1)(1994-12#1)(1997-2#1)(2008-10#1)
with urea or##2##3##(2007-11#1)(2008-10#1)
with urea##8##2##(1990-5#1)(1991-7#1)(1992-7#1)(1994-12#1)(1997-2#1)(2007-11#1)(2008-10#2)
with uremia##2##2##(1990-11#1)(1997-4#1)
with uremic parathyroid hyperplasia##2##4##(2008-5#2)
with uremic##3##2##(2008-5#2)(2011-2#1)
with ureteral##3##2##(1994-4#1)(2007-2#1)(2013-1#1)
with urethane##6##2##(1992-9#1)(1993-2#1)(1993-4#1)(1997-7#1)(2008-10#1)(2011-2#1)
with urethral##6##2##(1992-1#1)(1992-12#1)(2006-9#1)(2013-1#2)(2013-8#1)
with urethritis and##3##3##(2012-2#1)(2013-1#2)
with urethritis##6##2##(2007-8#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#2)
with urgent##4##2##(2007-11#1)(2008-3#1)(2008-4#1)(2008-6#1)
with uricase##2##2##(1997-2#1)(2008-10#1)
with uridine##3##2##(1991-4#1)(1996-6#2)
with urinary FSH##2##3##(2007-11#2)
with urinary stress##2##3##(1995-5#1)(1996-12#1)
with urinary tract infection##6##4##(1993-1#1)(2007-7#2)(2008-4#3)
with urinary tract##8##3##(1992-12#1)(1993-1#1)(1996-12#1)(2007-7#2)(2008-4#3)
with urinary##39##2##(1990-2#2)(1992-12#1)(1993-1#1)(1993-2#1)(1995-12#2)(1995-5#1)(1996-12#5)(1997-3#1)(1997-4#1)(2006-10#1)(2006-9#1)(2007-11#3)(2007-2#1)(2007-3#2)(2007-7#3)(2007-9#1)(2008-10#3)(2008-2#1)(2008-4#3)(2009-3#1)(2009-4#1)(2011-12#1)(2012-1#1)(2013-8#1)
with urine##4##2##(1991-11#1)(1992-9#1)(2008-10#2)
with urogenital##3##2##(1990-6#1)(2007-9#1)(2008-5#1)
with urokinase##3##2##(1995-3#1)(1997-5#1)(2007-7#1)
with ursodeoxycholic acid##3##3##(1991-12#1)(1996-4#1)(2004-11#1)
with urticaria##3##2##(2007-2#1)(2010-12#1)(2013-1#1)
with us##5##2##(2007-12#1)(2008-11#1)(2009-3#1)(2010-2#1)(2012-2#1)
with usage of##2##3##(2008-12#1)(2009-5#1)
with use of a##12##4##(1991-7#1)(2008-10#1)(2008-2#6)(2008-3#2)(2008-6#1)(2011-2#1)
with use of an##2##4##(1993-2#1)(2008-10#1)
with use of implants##2##4##(2007-11#2)
with use of the##4##4##(1996-3#1)(2007-8#1)(2008-10#1)(2008-3#1)
with use of##69##3##(1990-9#1)(1991-7#1)(1991-8#1)(1992-9#1)(1993-2#1)(1993-9#2)(1996-3#1)(1996-8#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-7#1)(2006-9#2)(2007-11#5)(2007-12#1)(2007-6#1)(2007-8#2)(2008-10#7)(2008-11#1)(2008-2#12)(2008-3#6)(2008-6#2)(2010-12#1)(2010-3#3)(2011-2#4)(2012-2#3)(2013-1#3)(2013-8#1)
with use##72##2##(1990-9#1)(1991-7#1)(1991-8#1)(1992-9#1)(1993-2#1)(1993-9#2)(1996-3#1)(1996-8#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-7#1)(2006-9#2)(2007-11#5)(2007-12#1)(2007-6#1)(2007-8#2)(2008-10#7)(2008-11#1)(2008-2#12)(2008-3#6)(2008-4#2)(2008-6#2)(2010-12#1)(2010-3#3)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
with useful##6##2##(2008-1#1)(2008-2#1)(2008-4#2)(2008-5#1)(2013-7#1)
with user##5##2##(2008-10#1)(2013-1#4)
with users##2##2##(2008-7#1)(2011-2#1)
with using a##2##3##(2007-7#1)(2008-3#1)
with using the##4##3##(1995-4#1)(2007-7#1)(2008-10#1)(2008-11#1)
with using##20##2##(1993-2#1)(1993-3#1)(1995-4#2)(1996-7#1)(2007-7#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2009-5#1)(2010-4#1)(2011-1#1)(2012-3#1)
with usual##5##2##(2005-10#2)(2005-8#1)(2007-6#1)(2010-4#1)
with uterine atony##2##3##(1995-12#1)(2011-2#1)
with uterine##9##2##(1991-9#1)(1995-12#1)(2006-6#1)(2011-1#2)(2011-2#2)(2011-8#1)(2013-7#1)
with uveitis##5##2##(2006-10#4)(2009-2#1)
with vaccination against##3##3##(2006-10#1)(2012-2#1)(2013-8#1)
with vaccination of##2##3##(2011-1#1)(2011-2#1)
with vaccination##12##2##(1995-5#1)(1997-6#1)(2005-11#1)(2006-10#1)(2007-9#1)(2008-3#1)(2009-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#1)
with vaccine##4##2##(2006-10#1)(2007-8#1)(2008-4#1)(2011-2#1)
with vaccines##8##2##(1991-8#1)(1992-6#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-9#1)(2012-2#1)
with vacuoles and paired-helical filaments##2##5##(2008-7#2)
with vacuoles and##3##3##(2008-5#1)(2008-7#2)
with vacuum disc##2##3##(2008-12#2)
with vacuum##4##2##(2008-12#2)(2008-7#1)(2009-2#1)
with vacuum-assisted##2##2##(2007-8#2)
with vaginal bleeding##2##3##(2009-6#1)(2012-2#1)
with vaginal delivery##2##3##(2010-8#1)(2011-2#1)
with vaginal discharge##3##3##(2007-2#1)(2007-7#2)
with vaginal##12##2##(1995-1#1)(1996-1#1)(1996-12#1)(2007-2#1)(2007-7#2)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)
with vaginismus##2##2##(2004-10#2)
with vague##5##2##(2006-2#1)(2007-11#1)(2008-1#1)(2011-1#1)(2011-2#1)
with validated##2##2##(2010-3#1)(2012-12#1)
with validation##2##2##(2008-10#1)(2008-3#1)
with valine and##2##3##(1993-11#1)(1996-2#1)
with valine##5##2##(1993-11#1)(1995-2#1)(1996-2#2)(2006-10#1)
with valproate##2##2##(1995-7#1)(2008-7#1)
with valproic acid##4##3##(1996-5#1)(2007-10#1)(2011-12#2)
with valuable information##2##3##(1992-1#1)(2008-9#1)
with valuable##3##2##(1992-1#1)(2008-9#1)(2010-8#1)
with values between##2##3##(2008-5#2)
with values for##2##3##(1990-10#1)(1991-8#1)
with values obtained by##3##4##(1990-2#1)(2008-10#2)
with values obtained##6##3##(1990-2#1)(1993-3#1)(1997-2#1)(2007-12#1)(2008-10#2)
with values of 0##2##4##(2008-10#1)(2008-3#1)
with values of##8##3##(1992-5#1)(1993-2#1)(1993-8#1)(1996-10#1)(2005-11#1)(2007-6#1)(2008-10#1)(2008-3#1)
with values ranging from##4##4##(2008-10#3)(2008-3#1)
with values ranging##5##3##(2008-10#3)(2008-3#1)(2013-1#1)
with values##37##2##(1990-10#1)(1990-2#1)(1991-8#1)(1992-5#1)(1993-2#1)(1993-3#1)(1993-8#1)(1996-10#1)(1996-12#1)(1997-2#1)(2005-11#1)(2007-12#2)(2007-6#1)(2008-10#8)(2008-2#2)(2008-3#6)(2008-5#3)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
with valve repair##2##3##(2007-8#2)
with valve##5##2##(2007-8#3)(2008-10#1)(2008-4#1)
with valvular heart disease##7##4##(2005-12#1)(2011-2#5)(2012-2#1)
with valvular heart##9##3##(2005-12#1)(2011-2#5)(2012-2#1)(2013-1#2)
with valvular##13##2##(1990-6#1)(1995-8#1)(2005-12#1)(2006-10#1)(2006-6#1)(2011-2#5)(2012-2#1)(2013-1#2)
with van der Waals##2##4##(1991-5#1)(2008-5#1)
with van##3##2##(1991-5#1)(2005-12#1)(2008-5#1)
with vanadate##9##2##(1990-2#1)(1994-5#1)(1994-6#3)(1995-6#1)(1997-1#2)(2008-10#1)
with vanadium##2##2##(2008-10#2)
with vanadyl##2##2##(1990-2#1)(1993-12#1)
with vancomycin and##2##3##(2007-12#1)(2007-7#1)
with vancomycin##9##2##(2006-10#1)(2007-12#4)(2007-7#1)(2008-5#1)(2011-1#1)(2011-2#1)
with vapour##2##2##(2008-10#1)(2008-4#1)
with variability##2##2##(2007-3#1)(2008-5#1)
with variable cutaneous##2##3##(2005-11#1)(2010-6#1)
with variable results##4##3##(2007-11#1)(2008-9#1)(2009-5#1)(2012-3#1)
with variable success##2##3##(1991-6#1)(2010-5#1)
with variable##65##2##(1990-9#2)(1991-12#1)(1991-6#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1997-6#1)(2005-11#2)(2006-10#3)(2006-11#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#8)(2008-3#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#1)(2011-10#1)(2011-2#4)(2012-3#1)(2013-1#4)(2013-7#1)
with variance##2##2##(1992-2#1)(2008-3#1)
with variant angina##3##3##(1994-11#1)(2007-8#2)
with variant##8##2##(1990-8#1)(1992-11#1)(1994-11#1)(1995-1#1)(2007-8#2)(2011-2#2)
with variants##4##2##(1992-7#1)(2009-3#1)(2013-1#2)
with variation in##5##3##(1997-7#1)(2007-12#1)(2007-8#1)(2008-8#1)(2010-12#1)
with variation of##2##3##(2008-10#1)(2008-3#1)
with variation##9##2##(1997-7#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-12#1)
with variations in the##9##4##(1990-7#1)(2006-10#2)(2008-10#1)(2008-9#1)(2010-10#1)(2011-2#2)(2013-8#1)
with variations in##17##3##(1990-7#1)(2006-10#2)(2006-9#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-10#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-8#2)
with variations##19##2##(1990-7#1)(2005-10#1)(2006-10#2)(2006-9#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-8#2)
with varicella zoster virus (VZV)##2##5##(1996-12#1)(2008-5#1)
with varicella##4##2##(1996-12#1)(2006-10#1)(2008-5#2)
with varicocele##3##2##(1990-3#1)(2006-9#1)(2008-7#1)
with varied and inconsistent outcomes##2##5##(2013-1#2)
with varied lifestyles##2##3##(2013-1#2)
with varied##16##2##(1995-3#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2009-5#1)(2013-1#5)(2013-8#3)
with various amounts of##3##4##(1992-6#1)(2008-10#1)(2008-3#1)
with various anions have been screened against bacterial species Escherichia##2##10##(2008-5#2)
with various aromatic##2##3##(2007-11#1)(2010-12#1)
with various biomolecules##2##3##(1996-1#1)(2010-5#1)
with various chemical##3##3##(1992-2#1)(2007-9#1)(2008-10#1)
with various chronic##2##3##(1990-8#1)(2008-3#1)
with various clinical##4##3##(1993-2#1)(2007-5#1)(2008-11#1)(2008-7#1)
with various combinations of I and T durations##2##8##(2007-9#2)
with various combinations of##4##4##(1992-3#1)(1993-8#1)(2007-9#2)
with various compounds##2##3##(1992-5#1)(2013-1#1)
with various concentrations (0##2##4##(1992-8#1)(2008-10#1)
with various concentrations of##13##4##(1992-7#1)(1992-8#1)(1993-3#1)(1994-12#1)(1995-5#1)(1996-12#1)(2006-5#2)(2008-11#1)(2008-12#1)(2011-2#1)(2013-8#2)
with various concentrations##15##3##(1992-7#1)(1992-8#2)(1993-3#1)(1994-12#1)(1995-5#1)(1996-12#1)(2006-5#2)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-8#2)
with various degrees of##3##4##(2008-10#1)(2009-2#1)(2010-4#1)
with various demographic variables##2##4##(2012-2#2)
with various disease##2##3##(2007-9#1)(2008-8#1)
with various diseases##2##3##(1995-12#1)(2010-2#1)
with various doses of##6##4##(1991-10#1)(1996-6#1)(2006-4#1)(2008-11#1)(2008-5#2)
with various doses##7##3##(1991-10#1)(1996-6#1)(1997-8#1)(2006-4#1)(2008-11#1)(2008-5#2)
with various electron##2##3##(1995-3#1)(2009-11#1)
with various factors##2##3##(2013-8#2)
with various forms of##5##4##(1990-2#1)(1992-2#1)(1996-12#1)(2005-7#1)(2006-10#1)
with various functions##2##3##(2008-10#1)(2008-9#1)
with various health##3##3##(1993-2#1)(1995-8#1)(2008-8#1)
with various levels of##3##4##(2008-1#1)(2008-10#1)(2012-2#1)
with various malignancies##2##3##(1990-1#1)(2008-6#1)
with various methods##2##3##(1996-3#1)(2008-2#1)
with various neurological diseases##2##4##(1993-8#2)
with various normal##2##3##(1995-10#1)(1997-4#1)
with various pathologies##2##3##(2011-3#1)(2012-12#1)
with various reagent##2##3##(1996-2#1)(2008-10#1)
with various shapes##2##3##(2008-10#1)(2008-3#1)
with various structures##3##3##(1994-3#1)(2008-10#2)
with various types of##14##4##(1991-12#1)(1996-3#1)(1997-4#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-3#1)(2008-5#1)(2009-9#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
with various values##2##3##(2008-3#2)
with various##286##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-2#2)(1990-8#2)(1991-10#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-11#2)(1992-12#1)(1992-2#4)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#3)(1992-9#3)(1993-1#1)(1993-11#1)(1993-2#4)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#4)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#3)(1994-8#1)(1994-9#3)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#2)(1996-6#3)(1997-4#3)(1997-7#2)(1997-8#1)(2004-12#1)(2004-9#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-8#1)(2006-9#2)(2007-10#2)(2007-11#4)(2007-12#5)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#4)(2008-1#5)(2008-10#31)(2008-11#8)(2008-12#1)(2008-2#5)(2008-3#15)(2008-4#4)(2008-5#12)(2008-6#4)(2008-7#4)(2008-8#5)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-12#5)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#5)(2011-2#6)(2011-3#1)(2012-12#5)(2012-2#6)(2012-3#6)(2013-1#4)(2013-7#1)(2013-8#5)
with varus##2##2##(2008-4#1)(2009-4#1)
with varying amounts of##2##4##(1993-12#1)(2008-6#1)
with varying concentrations of##4##4##(2008-10#1)(2009-10#1)(2009-9#1)(2013-1#1)
with varying degrees of gastrointestinal##2##5##(1992-8#1)(1994-8#1)
with varying degrees of success##4##5##(2005-8#2)(2006-10#1)(2008-11#1)
with varying degrees of##24##4##(1990-4#1)(1992-8#1)(1994-2#1)(1994-8#1)(1997-2#1)(2005-8#2)(2006-10#2)(2006-2#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2012-2#1)
with varying doses of##2##4##(1994-11#1)(2007-2#1)
with varying levels of clinical##4##5##(2013-1#4)
with varying levels of##13##4##(1994-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-11#1)(2012-3#1)(2013-1#4)
with varying rates of##2##4##(2006-12#1)(2010-8#1)
with varying results##8##3##(1990-2#1)(2006-8#1)(2008-10#1)(2008-4#1)(2009-7#1)(2010-2#1)(2010-5#1)(2012-12#1)
with varying##115##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1991-2#1)(1992-12#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-2#2)(1994-8#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-8#2)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#12)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#4)(2008-5#4)(2008-6#4)(2008-7#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#3)(2009-7#2)(2009-9#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#7)
with vascular access##3##3##(2007-7#1)(2007-8#1)(2013-1#1)
with vascular dementia and##2##4##(2007-9#1)(2008-7#1)
with vascular dementia##6##3##(1996-5#2)(1997-7#1)(2007-9#1)(2008-7#2)
with vascular disease##7##3##(1993-2#1)(2005-10#1)(2006-10#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-1#1)
with vascular endothelial growth factor (VEGF)##2##6##(2007-8#1)(2008-10#1)
with vascular malformations##2##3##(2007-7#1)(2008-7#1)
with vascular proliferation and##2##4##(2008-9#1)(2009-3#1)
with vascular##43##2##(1992-4#1)(1992-6#1)(1993-2#1)(1996-10#1)(1996-5#2)(1997-7#1)(2005-10#1)(2006-10#1)(2007-10#2)(2007-12#1)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#4)(2008-9#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
with vascularized##6##2##(2007-11#1)(2008-1#2)(2010-10#1)(2012-2#2)
with vasoactive##4##2##(1990-7#1)(1995-9#1)(2006-10#1)(2011-1#1)
with vasodilators and##2##3##(2006-10#1)(2010-12#1)
with vasodilators##3##2##(1994-7#1)(2006-10#1)(2010-12#1)
with vasopressin##4##2##(1990-12#1)(1990-9#1)(1991-3#1)(1993-12#1)
with vastly##2##2##(2009-3#1)(2010-3#1)
with vector diffraction theory##2##4##(2007-11#1)(2008-3#1)
with vector##5##2##(1992-9#1)(2007-11#1)(2007-12#1)(2008-3#1)(2011-2#1)
with vectors for gene therapy##2##5##(1994-5#1)(2008-4#1)
with vectors##4##2##(1994-5#1)(1995-8#1)(2008-11#1)(2008-4#1)
with vecuronium##3##2##(1993-1#1)(2010-7#2)
with vegetative##2##2##(1991-11#1)(2008-10#1)
with vehicle or##2##3##(1995-2#1)(2012-11#1)
with vehicle##7##2##(1990-11#1)(1995-2#1)(2005-7#1)(2008-10#1)(2008-9#1)(2012-11#1)(2013-1#1)
with vein##3##2##(1991-3#1)(1996-9#1)(2008-10#1)
with velocity##2##2##(2007-11#1)(2007-4#1)
with vendors##2##2##(2006-8#1)(2007-12#1)
with venlafaxine##2##2##(2007-4#1)(2011-1#1)
with venous hemorrhagic infarction##2##4##(2007-9#2)
with venous leg ulcers##2##4##(1997-3#2)
with venous leg##3##3##(1997-3#3)
with venous sinus##2##3##(2006-4#1)(2007-9#1)
with venous##16##2##(1996-6#1)(1997-3#3)(2006-4#1)(2007-12#1)(2007-7#2)(2007-9#4)(2008-6#1)(2008-7#1)(2008-9#1)(2013-8#1)
with ventral##3##2##(2008-5#1)(2010-12#1)(2012-12#1)
with ventricular fibrillation##3##3##(1990-12#1)(1995-12#1)(2006-10#1)
with ventricular septal defect##2##4##(2012-2#2)
with ventricular septal##3##3##(2009-5#1)(2012-2#2)
with ventricular##16##2##(1990-12#1)(1993-8#1)(1995-12#2)(1995-6#1)(1996-3#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-11#1)(2011-1#1)(2012-2#2)(2012-3#1)
with ventriculostomy##2##2##(2006-11#1)(2007-10#1)
with verbal##3##2##(1993-1#1)(2008-11#1)(2013-1#1)
with verified##2##2##(1994-3#1)(2008-1#1)
with verrucous##2##2##(2005-11#1)(2010-6#1)
with versatile##2##2##(2008-10#1)(2011-2#1)
with vertebral artery##2##3##(2006-6#1)(2008-7#1)
with vertebral compression fractures##2##4##(2008-7#2)
with vertebral corpus##2##3##(2007-8#2)
with vertebral fractures##3##3##(2007-11#1)(2008-7#1)(2013-1#1)
with vertebral##15##2##(1991-11#1)(2005-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-8#2)(2008-7#4)(2009-9#1)(2012-2#2)(2013-1#1)
with vertebrate##4##2##(1990-8#1)(1995-2#1)(2006-10#1)(2007-12#1)
with vertical##7##2##(1991-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-11#1)(2011-2#1)(2012-2#1)
with vertical-cavity surface-emitting laser (VCSEL)##2##5##(2008-2#1)(2008-3#1)
with vertical-cavity surface-emitting##3##3##(2008-2#1)(2008-3#2)
with vertigo and dizziness##2##4##(2011-2#1)(2012-2#1)
with very active##2##3##(2013-8#2)
with very close##2##3##(2008-10#1)(2010-12#1)
with very complex##2##3##(2008-11#1)(2012-12#1)
with very different##7##3##(1991-12#1)(1992-3#1)(1995-2#1)(2008-10#2)(2008-8#1)(2011-2#1)
with very fast##3##3##(2007-12#3)
with very few##7##3##(1990-11#1)(1991-5#1)(2008-2#1)(2008-3#1)(2010-5#1)(2012-12#1)(2012-3#1)
with very good accuracy##2##4##(2008-10#1)(2013-8#1)
with very good results##4##4##(1993-3#1)(2006-3#1)(2008-10#1)(2008-11#1)
with very good##12##3##(1993-3#1)(1996-6#1)(2006-3#1)(2008-10#6)(2008-11#2)(2013-8#1)
with very high accuracy##2##4##(1997-7#1)(2011-2#1)
with very high affinity##2##4##(1992-11#1)(1994-2#1)
with very high hardness##2##4##(2007-12#1)(2012-2#1)
with very high mortality##4##4##(2008-5#1)(2010-5#1)(2013-1#2)
with very high risk of##2##5##(1996-5#1)(2008-3#1)
with very high##27##3##(1991-5#1)(1991-6#1)(1992-11#1)(1994-2#1)(1995-1#1)(1995-10#1)(1996-12#1)(1996-5#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#2)
with very large##5##3##(1996-1#1)(2007-12#1)(2007-4#1)(2008-2#1)(2008-3#1)
with very little##5##3##(1992-9#1)(2008-11#1)(2008-4#1)(2008-5#1)(2012-3#1)
with very low birth weight##5##5##(1993-5#1)(1995-6#1)(2006-10#1)(2011-1#1)(2012-1#1)
with very low birth##6##4##(1993-5#1)(1994-6#1)(1995-6#1)(2006-10#1)(2011-1#1)(2012-1#1)
with very low serum##2##4##(1993-3#1)(1995-5#1)
with very low##24##3##(1992-5#1)(1993-3#1)(1993-4#1)(1993-5#1)(1994-11#1)(1994-6#1)(1995-5#1)(1995-6#1)(2004-11#1)(2005-11#1)(2006-10#2)(2007-11#1)(2008-10#4)(2008-2#1)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
with very poor##2##3##(2008-10#1)(2010-1#1)
with very satisfactory results##2##4##(2008-10#1)(2009-10#1)
with very short##5##3##(2005-7#1)(2006-4#1)(2007-12#1)(2007-9#1)(2008-7#1)
with very small##4##3##(2006-3#2)(2011-2#1)(2012-2#1)
with very strong##2##3##(1990-7#1)(1994-12#1)
with very##139##2##(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#2)(1991-6#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-3#2)(1993-4#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-6#1)(1997-7#1)(2004-11#1)(2005-11#2)(2005-7#1)(2006-10#4)(2006-12#1)(2006-3#3)(2006-4#1)(2007-11#3)(2007-12#8)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#3)(2008-10#17)(2008-11#4)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#4)(2008-7#4)(2008-8#2)(2009-10#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#4)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#4)
with vesicle##2##2##(1991-2#1)(2009-8#1)
with vesicles and##2##3##(2007-10#1)(2008-8#1)
with vesicles##5##2##(1992-8#1)(1994-2#1)(2007-10#1)(2008-8#1)(2012-2#1)
with vesicular##3##2##(1994-9#1)(2004-2#1)(2008-4#1)
with vestibular##5##2##(2005-5#1)(2008-4#1)(2012-2#3)
with viable##4##2##(2006-8#1)(2008-10#1)(2008-7#1)(2013-7#1)
with vibrational##2##2##(1991-9#1)(2008-2#1)
with victimization##4##2##(2008-12#1)(2009-5#3)
with victims##2##2##(1993-7#1)(2008-2#1)
with video##4##2##(1990-12#1)(1996-11#1)(2008-3#2)
with video-assisted##2##2##(2007-8#2)
with view to##2##3##(2007-11#1)(2011-2#1)
with vigabatrin##3##2##(1992-3#2)(1996-8#1)
with vigorous##2##2##(2008-10#1)(2009-12#1)
with villous height##3##3##(2013-1#3)
with villous##8##2##(1992-10#1)(2007-2#1)(2010-2#1)(2010-3#1)(2011-2#1)(2013-1#3)
with vinblastine##2##2##(1990-2#1)(1991-6#1)
with vincristine##4##2##(1995-3#1)(1997-5#1)(2009-6#1)(2012-1#1)
with vinyl##3##2##(1990-6#1)(1993-9#1)(2007-6#1)
with violence##5##2##(1993-3#1)(1995-12#1)(1996-2#1)(2009-9#1)(2011-12#1)
with viral RNA##3##3##(1990-7#1)(1997-4#1)(2008-9#1)
with viral RNAs##2##3##(2008-10#1)(2008-9#1)
with viral load##2##3##(2010-11#1)(2013-8#1)
with viral##28##2##(1990-7#1)(1991-9#1)(1993-2#1)(1994-11#1)(1995-5#1)(1995-6#1)(1996-11#1)(1997-4#1)(2006-10#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#2)(2010-11#1)(2010-7#1)(2011-1#1)(2013-1#1)(2013-8#4)
with virgin##2##2##(1994-3#1)(2006-12#1)
with virions##2##2##(1997-3#1)(2008-10#1)
with virtual bronchoscopy##2##3##(2012-12#2)
with virtual##4##2##(2009-6#1)(2012-1#1)(2012-12#2)
with virtually all##2##3##(1994-9#1)(2008-7#1)
with virtually no##2##3##(2007-11#1)(2008-10#1)
with virtually##8##2##(1993-3#1)(1993-6#1)(1994-9#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-7#1)
with virulence of isolates to##2##5##(2008-10#2)
with virulence of##3##3##(2007-6#1)(2008-10#2)
with virulence on##2##3##(2008-10#2)
with virulence##13##2##(1992-12#2)(2005-7#1)(2007-6#1)(2008-10#9)
with virulent isolates##2##3##(2008-10#2)
with virulent viruses##2##3##(1990-11#1)(2009-9#1)
with virulent##12##2##(1990-11#1)(1995-2#1)(1996-12#1)(1997-6#1)(2006-12#1)(2008-10#3)(2008-4#1)(2008-5#2)(2009-9#1)
with viruliferous whiteflies##2##3##(2008-10#2)
with viruliferous##4##2##(2008-10#4)
with virus isolation##2##3##(1993-12#2)
with virus##8##2##(1993-12#2)(2005-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)
with virus-specific##2##2##(2008-10#2)
with viruses##4##2##(1996-11#1)(2008-10#1)(2008-11#1)(2013-1#1)
with visceral involvement##3##3##(2007-10#1)(2013-1#1)(2013-7#1)
with visceral metastases##2##3##(2012-2#1)(2013-7#1)
with visceral obesity##3##3##(2008-10#1)(2013-8#2)
with visceral pleural invasion##2##4##(2007-8#2)
with visceral##16##2##(1990-10#1)(1992-2#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-9#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#3)
with visible and##2##3##(2007-12#1)(2008-2#1)
with visible light##2##3##(1992-1#1)(2010-2#1)
with visible##13##2##(1992-1#2)(1997-3#1)(2007-12#3)(2008-10#1)(2008-2#1)(2010-2#1)(2012-11#2)(2013-1#2)
with vision##4##2##(1994-3#1)(2004-8#1)(2009-3#1)(2010-8#1)
with visits##2##2##(2008-7#1)(2011-2#1)
with visual form agnosia##2##4##(1997-8#1)(2008-9#1)
with visual loss##4##3##(2005-10#1)(2007-3#1)(2011-2#1)(2013-1#1)
with visual##29##2##(1991-3#1)(1993-2#1)(1996-3#1)(1997-8#1)(2005-10#1)(2007-10#1)(2007-3#1)(2008-1#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-9#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#1)
with vitamin A deficiency##3##4##(2008-1#1)(2008-7#2)
with vitamin A##11##3##(1996-5#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2013-1#2)
with vitamin B12 deficiency##2##4##(2007-9#1)(2013-8#1)
with vitamin B12##6##3##(1993-12#2)(2005-7#1)(2007-9#1)(2013-7#1)(2013-8#1)
with vitamin C##9##3##(1991-5#1)(2008-1#1)(2010-12#1)(2011-1#2)(2013-8#4)
with vitamin D deficiency##2##4##(2011-1#1)(2012-2#1)
with vitamin D##6##3##(2005-1#1)(2005-3#1)(2011-1#3)(2012-2#1)
with vitamin E##10##3##(1991-12#1)(1995-12#1)(1995-8#1)(1996-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#3)
with vitamin K deficiency##2##4##(1990-11#1)(2008-8#1)
with vitamin K##4##3##(1990-11#2)(2006-4#1)(2008-8#1)
with vitamin d##2##3##(2011-1#1)(2011-2#1)
with vitamin##57##2##(1990-11#2)(1991-12#1)(1991-2#1)(1991-5#1)(1993-11#1)(1993-12#2)(1995-1#1)(1995-12#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-5#1)(2005-1#1)(2005-3#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#3)(2010-12#1)(2011-1#6)(2011-2#1)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#5)
with vitamins E and C##2##5##(2008-6#2)
with vitamins##6##2##(2005-10#1)(2007-7#1)(2008-3#1)(2008-6#2)(2008-8#1)
with vitiligo who##2##3##(2007-7#1)(2007-8#1)
with vitiligo##9##2##(2006-12#1)(2007-7#2)(2007-8#1)(2009-6#1)(2010-12#1)(2010-6#1)(2013-1#2)
with voice##3##2##(2006-10#1)(2006-3#1)(2011-1#1)
with voltage-sensitive dyes##2##3##(1996-12#1)(2008-4#1)
with voltage-sensitive##3##2##(1995-11#1)(1996-12#1)(2008-4#1)
with voltammetric##2##2##(2008-10#2)
with volume##5##2##(1992-12#1)(2006-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
with voluntary##3##2##(1994-3#1)(2007-7#1)(2008-11#1)
with volunteers##2##2##(2007-10#1)(2007-2#1)
with vomiting and##2##3##(1996-9#1)(2008-12#1)
with vomiting of##2##3##(2006-2#1)(2007-12#1)
with vomiting##11##2##(1991-2#1)(1996-9#1)(2006-2#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-12#1)(2009-5#2)(2010-2#1)(2013-7#1)
with von Recklinghausen's neurofibromatosis##2##4##(2008-10#2)
with von##6##2##(1992-11#1)(2008-1#1)(2008-10#2)(2008-12#1)(2010-8#1)
with voriconazole##2##2##(2009-2#1)(2012-2#1)
with vs##3##2##(2007-8#3)
with vulvar##2##2##(1993-9#1)(2006-10#1)
with wall##3##2##(2007-12#2)(2008-9#1)
with wall-jet amperometric detection##3##4##(1997-1#1)(2008-10#2)
with wall-jet##4##2##(1997-1#1)(2008-10#3)
with warfarin or##2##3##(1992-3#1)(2008-3#1)
with warfarin##12##2##(1992-3#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-3#1)(2008-8#1)(2010-8#1)(2011-1#1)(2012-12#4)
with warm temperature##2##3##(2008-10#1)(2012-4#1)
with warm##3##2##(1990-2#1)(2008-10#1)(2012-4#1)
with washed##4##2##(1990-10#1)(1992-3#1)(1994-8#1)(2010-4#1)
with waste##2##2##(1995-12#1)(2008-5#1)
with water agar##2##3##(2008-10#2)
with water alone##2##3##(2008-10#1)(2008-5#1)
with water and##14##3##(1996-2#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-5#2)(2009-5#1)(2011-2#1)
with water as the##2##4##(1993-9#1)(2013-7#1)
with water as##3##3##(1993-9#1)(2011-2#1)(2013-7#1)
with water at##2##3##(2008-10#1)(2011-2#1)
with water followed by##2##4##(2008-9#1)(2011-1#1)
with water for##3##3##(2008-10#3)
with water from##3##3##(2011-12#2)(2012-3#1)
with water in the##2##4##(1992-12#1)(2008-10#1)
with water in##4##3##(1992-12#1)(2005-11#1)(2008-10#1)(2012-12#1)
with water or##2##3##(2008-10#1)(2008-7#1)
with water soluble##2##3##(1990-11#1)(1996-9#1)
with water to##3##3##(1991-2#1)(2007-8#1)(2008-8#1)
with water##108##2##(1990-11#1)(1990-5#2)(1991-2#2)(1992-12#2)(1993-7#1)(1993-9#2)(1996-2#1)(1996-8#1)(1996-9#1)(2005-11#3)(2005-12#1)(2006-12#2)(2006-2#1)(2007-11#1)(2007-5#1)(2007-8#3)(2008-10#43)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#9)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#4)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
with water)##2##2##(2008-10#2)
with water-soluble##4##2##(1990-4#1)(2008-10#2)(2009-3#1)
with waterborne##2##2##(1995-5#1)(2009-3#1)
with wavelength##14##2##(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#8)
with wavelength-division multiplexing##3##3##(2007-12#3)
with wavelength-division##4##2##(2007-12#4)
with wavelengths##6##2##(2006-12#1)(2007-12#1)(2008-3#4)
with wavelet##2##2##(2008-10#1)(2008-3#1)
with waves between volumes##2##4##(2007-12#1)(2008-3#1)
with wax##4##2##(2008-10#3)(2011-2#1)
with weak##14##2##(1990-3#1)(1991-11#1)(1991-12#1)(1994-11#1)(1996-2#1)(2007-11#2)(2007-12#2)(2008-9#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-7#1)
with weaker##4##2##(1997-4#1)(1997-5#1)(2008-10#1)(2008-11#1)
with weakly##2##2##(2007-12#1)(2008-10#1)
with weakness##4##2##(1994-5#1)(2006-10#2)(2008-12#1)
with wedge##5##2##(1992-9#1)(2007-10#3)(2009-9#1)
with week##2##2##(1992-6#1)(2008-7#1)
with weekly##6##2##(1990-11#1)(1990-12#1)(1992-10#1)(2006-10#1)(2007-8#1)(2011-2#1)
with weight and##5##3##(1995-4#1)(2007-12#2)(2011-2#2)
with weight bearing##2##3##(2007-7#1)(2012-1#1)
with weight concerns and##3##4##(2006-7#2)(2007-12#1)
with weight control##2##3##(2007-12#1)(2013-1#1)
with weight gain##7##3##(1997-7#1)(2004-3#1)(2006-1#2)(2006-10#1)(2007-12#2)
with weight loss in##2##4##(2008-3#2)
with weight loss##9##3##(2006-10#1)(2006-2#1)(2006-6#1)(2008-3#4)(2008-5#1)(2008-9#1)
with weight##32##2##(1991-12#1)(1991-7#1)(1995-4#1)(1997-7#1)(2004-3#1)(2006-1#2)(2006-10#3)(2006-2#1)(2006-6#1)(2006-7#2)(2007-12#6)(2007-7#1)(2008-3#4)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-1#1)(2013-1#1)
with weights##3##2##(2008-10#1)(2010-2#1)(2012-3#1)
with well defined##3##3##(2007-7#1)(2007-8#1)(2008-9#1)
with well established##2##3##(2007-8#1)(2010-5#1)
with well known##3##3##(2008-10#1)(2012-3#2)
with well##16##2##(1994-6#1)(1995-9#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-3#2)
with well-compensated chronic hepatitis C##2##5##(2007-11#2)
with well-compensated chronic hepatitis##3##4##(2007-11#3)
with well-compensated chronic##4##3##(2007-11#4)
with well-compensated##5##2##(2007-11#5)
with well-controlled##6##2##(2010-4#2)(2010-9#2)(2011-2#1)(2013-8#1)
with well-defined##9##2##(1990-9#1)(1992-8#1)(1996-4#1)(1997-4#1)(2007-9#1)(2008-10#2)(2008-11#1)(2010-10#1)
with well-developed##2##2##(2005-11#1)(2011-12#1)
with well-documented##3##2##(2004-10#1)(2007-5#1)(2009-6#1)
with well-established##2##2##(1991-3#1)(2007-12#1)
with well-known##5##2##(1995-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
with western medical injections##2##4##(2011-2#2)
with western##5##2##(2006-10#1)(2008-4#1)(2011-2#3)
with wet##2##2##(1992-2#1)(2008-8#1)
with what has been##2##4##(2007-12#1)(2008-5#1)
with what is##6##3##(1993-12#1)(1994-9#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-12#1)
with what they##3##3##(1995-5#1)(2007-7#1)(2008-12#1)
with what we know##3##4##(1996-2#1)(2010-10#2)
with what we##7##3##(1994-2#1)(1996-2#1)(2009-9#2)(2010-10#2)(2012-2#1)
with what would be expected##2##5##(1992-6#1)(2008-7#1)
with what##34##2##(1990-8#1)(1991-12#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-5#1)(1996-2#1)(1997-4#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-5#2)(2008-7#1)(2009-4#1)(2009-9#2)(2010-10#2)(2010-8#1)(2011-1#2)(2012-12#1)(2012-2#3)
with wheat germ agglutinin##2##4##(1992-6#1)(2008-11#1)
with wheat germ##3##3##(1992-6#1)(1994-12#1)(2008-11#1)
with wheat##11##2##(1992-6#1)(1994-12#1)(2007-7#1)(2008-10#6)(2008-11#2)
with wheezing##2##2##(2007-8#1)(2008-1#1)
with when the knee##2##4##(1997-8#2)
with when the##3##3##(1997-8#2)(2011-12#1)
with when##5##2##(1997-8#2)(2007-5#1)(2009-11#1)(2011-12#1)
with which a##8##3##(1992-2#1)(1992-5#1)(1993-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#1)
with which all##2##3##(1990-9#1)(2012-12#1)
with which it interacts##2##4##(1991-9#1)(1994-12#1)
with which it shares##2##4##(1994-12#1)(1995-6#1)
with which it##12##3##(1991-9#1)(1992-3#1)(1994-12#2)(1995-6#1)(1996-5#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2013-1#2)
with which one can##2##4##(2008-2#1)(2008-3#1)
with which one##3##3##(2008-2#2)(2008-3#1)
with which such##2##3##(2008-3#1)(2011-1#1)
with which the##28##3##(1991-10#1)(1992-12#1)(1992-2#1)(1993-2#2)(1994-8#2)(2006-8#1)(2007-12#1)(2007-2#1)(2007-6#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2009-11#1)(2010-5#2)(2010-9#1)(2012-2#1)
with which these##5##3##(2005-8#1)(2006-12#1)(2006-8#1)(2010-12#1)(2011-2#1)
with which they are##3##4##(1992-2#1)(2008-2#1)(2011-2#1)
with which they can be##2##5##(2008-2#1)(2008-7#1)
with which they##12##3##(1991-3#1)(1992-2#1)(1995-3#1)(2008-10#3)(2008-2#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)
with which this##2##3##(1991-1#1)(2012-12#1)
with which to calculate##2##4##(2007-12#2)
with which to compare##3##4##(1997-4#1)(2005-8#1)(2008-8#1)
with which to improve##2##4##(2008-1#1)(2008-3#1)
with which to investigate##2##4##(1996-2#1)(2008-7#1)
with which to measure the##2##5##(1990-11#1)(1994-3#1)
with which to measure##5##4##(1990-11#2)(1994-3#1)(2008-3#2)
with which to obtain##3##4##(2008-3#3)
with which to study##4##4##(1991-5#1)(1994-6#1)(2008-7#1)(2008-9#1)
with which to##52##3##(1990-11#2)(1991-3#1)(1991-5#1)(1994-10#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-2#1)(1997-4#1)(2005-7#1)(2005-8#1)(2006-3#1)(2007-11#2)(2007-12#6)(2008-1#2)(2008-12#1)(2008-2#1)(2008-3#13)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2010-5#1)(2012-12#3)(2013-8#1)
with which we##4##3##(2006-3#1)(2008-10#1)(2009-5#1)(2012-2#1)
with which##178##2##(1990-11#2)(1990-3#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-3#2)(1991-5#2)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#3)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-2#2)(1996-5#1)(1997-4#3)(1997-5#1)(1997-7#2)(2004-3#1)(2005-10#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#2)(2006-5#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-11#3)(2007-12#10)(2007-2#1)(2007-6#2)(2007-9#1)(2008-1#3)(2008-10#8)(2008-11#2)(2008-12#3)(2008-2#6)(2008-3#22)(2008-4#5)(2008-5#6)(2008-7#6)(2008-8#2)(2008-9#3)(2009-11#1)(2009-5#1)(2009-9#1)(2010-12#4)(2010-5#3)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#6)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
with whispering-gallery modes##2##3##(2007-11#1)(2007-12#1)
with white light##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
with white##16##2##(2007-10#1)(2007-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-11#1)(2013-1#2)(2013-7#2)
with white-light illumination##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
with white-light interferometry##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
with white-light##7##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)
with whites##3##2##(1994-6#1)(2006-10#1)(2011-2#1)
with whole blood##2##3##(1990-12#1)(2008-10#1)
with whole saliva##2##3##(2006-4#2)
with whole##11##2##(1990-12#1)(1996-5#1)(2006-4#2)(2007-2#1)(2008-10#1)(2008-12#1)(2010-2#3)(2010-8#1)
with whole-cell##4##2##(1994-8#1)(1995-11#1)(1996-12#1)(1996-5#1)
with whom family doctors participated in euthanasia or assisted suicide##2##10##(1991-8#2)
with whom patients had##2##4##(2010-4#2)
with whom the##3##3##(1990-11#1)(1993-6#1)(2012-3#1)
with whom##14##2##(1990-11#1)(1990-12#1)(1991-3#1)(1991-8#2)(1993-6#1)(1994-4#1)(1995-1#1)(2010-4#2)(2012-12#2)(2012-3#2)
with wide excision##2##3##(2008-6#1)(2010-11#1)
with wide local excision##3##4##(2006-10#2)(2009-5#1)
with wide range of##2##4##(2009-10#1)(2010-3#1)
with wide resection margins##2##4##(2011-2#2)
with wide spectrum##3##3##(1990-12#1)(2008-5#2)
with wide surgical##3##3##(2007-11#1)(2007-7#1)(2013-7#1)
with wide variation in##3##4##(2006-6#1)(2007-4#1)(2009-2#1)
with wide variations in##2##4##(2008-11#1)(2012-12#1)
with wide variations##3##3##(2008-11#1)(2012-12#1)(2013-1#1)
with wide##43##2##(1990-12#2)(2006-10#2)(2006-12#1)(2006-6#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-7#1)(2007-8#3)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#3)(2008-6#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-1#2)(2013-7#1)
with widely different##2##3##(1995-11#1)(2008-5#1)
with widely spaced##3##3##(2008-2#2)(2009-8#1)
with widely##13##2##(1990-8#1)(1995-11#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2009-8#1)(2013-1#1)
with wider##7##2##(2006-7#1)(2007-8#1)(2008-2#3)(2008-3#1)(2011-2#1)
with widespread##10##2##(1992-3#1)(1993-12#1)(1996-9#1)(1997-4#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-7#1)(2013-1#1)
with widths##3##2##(2008-2#1)(2008-7#2)
with wild type strain##2##4##(2008-12#1)(2008-8#1)
with wild type##13##3##(1991-5#1)(1991-7#2)(1995-10#2)(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-8#1)(2013-1#1)
with wild vegetation##3##3##(2013-1#3)
with wild##23##2##(1991-5#1)(1991-7#2)(1995-1#1)(1995-10#2)(1996-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-10#1)(2012-12#2)(2013-1#4)
with wild-caught##2##2##(2004-11#1)(2007-12#1)
with wild-type TR##2##3##(1995-10#1)(1995-8#1)
with wild-type and##2##3##(2008-10#1)(2008-11#1)
with wild-type or##3##3##(1997-1#1)(1997-7#1)(2010-2#1)
with wild-type p53##2##3##(2007-9#1)(2012-12#1)
with wild-type virus##2##3##(1993-6#1)(2011-3#1)
with wild-type##46##2##(1990-3#1)(1992-2#2)(1992-9#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-7#1)(2006-12#2)(2007-11#2)(2007-9#1)(2008-10#9)(2008-11#2)(2008-8#1)(2008-9#1)(2010-2#1)(2011-1#3)(2011-3#1)(2012-12#2)(2013-1#1)
with wind##6##2##(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)
with window##2##2##(2006-7#1)(2006-9#1)
with wireless##2##2##(2010-8#2)
with with##2##2##(2008-8#1)(2010-11#1)
with withdrawal##3##2##(2007-8#1)(2009-5#1)(2012-11#1)
with woman&quot##2##2##(2013-1#2)
with women who had##3##4##(1991-7#1)(1996-9#1)(2008-9#1)
with women who##5##3##(1991-7#1)(1992-3#1)(1996-9#1)(2008-9#1)(2009-12#1)
with women with##5##3##(1991-11#1)(2004-2#1)(2006-10#1)(2006-8#1)(2013-8#1)
with women##23##2##(1991-11#1)(1991-7#2)(1991-9#1)(1992-3#1)(1996-9#1)(1997-3#1)(2004-2#1)(2006-10#3)(2006-8#1)(2008-12#1)(2008-9#1)(2009-12#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
with women's##3##2##(2006-7#1)(2008-5#1)(2011-2#1)
with work##4##2##(1991-10#1)(2008-7#1)(2008-9#1)(2012-2#1)
with working memory##2##3##(1997-8#1)(2012-2#1)
with working##4##2##(1997-8#1)(2008-10#1)(2012-2#1)(2013-1#1)
with workplace##2##2##(2004-9#1)(2010-5#1)
with worse outcome##2##3##(2009-2#2)
with worse##7##2##(1996-3#1)(2005-10#1)(2006-8#1)(2009-2#2)(2010-6#1)(2011-2#1)
with worsening##6##2##(1994-12#1)(1995-8#1)(2006-9#1)(2010-10#1)(2010-2#1)(2010-7#1)
with wortmannin##3##2##(1992-6#1)(1994-11#1)(1997-3#1)
with wound##6##2##(2007-12#1)(2007-8#2)(2008-2#1)(2010-6#1)(2011-1#1)
with wrist##3##2##(1996-2#1)(2005-11#1)(2008-1#1)
with written##4##2##(2008-12#1)(2011-2#1)(2012-1#2)
with x =##2##3##(1996-2#1)(2006-4#1)
with x##4##2##(1996-2#1)(2006-4#1)(2008-2#1)(2010-4#1)
with x-ray diffraction##3##3##(1990-12#1)(2008-2#1)(2008-3#1)
with x-ray photoelectron spectroscopy##3##4##(2008-2#3)
with x-ray##9##2##(1990-12#1)(2007-12#1)(2008-2#4)(2008-3#2)(2010-5#1)
with xanthine##4##2##(1994-12#1)(1994-8#1)(1996-9#1)(2008-10#1)
with xanthogranulomatous pyelonephritis##2##3##(2008-1#1)(2013-1#1)
with xeroderma pigmentosum##3##3##(1991-6#1)(1997-4#1)(2005-11#1)
with xeroderma##4##2##(1991-6#1)(1997-4#1)(2005-11#1)(2007-7#1)
with xerostomia##4##2##(2007-9#3)(2011-12#1)
with xerotic skin##3##3##(2008-5#3)
with xylenol orange##3##3##(2008-10#3)
with year##2##2##(2009-12#1)(2011-2#1)
with years##3##2##(2004-10#1)(2007-11#1)(2013-8#1)
with yeast HAP2##2##3##(1995-2#1)(2008-9#1)
with yeast and mammalian cells##2##5##(2008-4#1)(2008-9#1)
with yeast and##3##3##(1992-8#1)(2008-4#1)(2008-9#1)
with yeast artificial##2##3##(1996-10#2)
with yeast two-hybrid system##2##4##(2008-8#2)
with yeast##26##2##(1990-10#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-11#2)(1994-9#1)(1995-2#1)(1996-10#2)(1996-6#1)(1997-2#1)(2005-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2012-3#1)
with yellow##5##2##(1995-2#1)(2005-7#1)(2008-10#2)(2012-11#1)
with yield##2##2##(2011-2#1)(2012-11#1)
with yields of##2##3##(1990-5#1)(2013-1#1)
with you##3##2##(1993-12#1)(1993-3#1)(1994-1#1)
with young adult##3##3##(1995-7#1)(1996-2#1)(2012-11#1)
with young adults##2##3##(2008-7#1)(2010-2#1)
with young children##5##3##(2007-2#1)(2008-12#1)(2009-11#1)(2009-4#1)(2013-1#1)
with young people##2##3##(2006-7#1)(2008-7#1)
with young##25##2##(1990-5#2)(1993-4#1)(1995-7#2)(1996-2#1)(2006-7#1)(2006-9#1)(2007-2#2)(2008-12#1)(2008-2#1)(2008-7#4)(2009-11#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
with younger subjects##2##3##(2007-9#1)(2008-5#1)
with younger##11##2##(2004-10#1)(2006-8#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-11#1)(2010-12#1)(2012-1#1)(2013-1#2)
with your##15##2##(1993-2#1)(1993-3#1)(1994-1#2)(1994-3#2)(1995-2#1)(2007-9#1)(2008-11#1)(2010-3#2)(2010-5#1)(2010-9#1)(2012-3#1)(2013-7#1)
with youth##5##2##(2008-11#1)(2008-2#1)(2008-7#1)(2010-2#1)(2012-1#1)
with yttrium phosphate##2##3##(2008-10#2)
with zaleplon##2##2##(2004-3#2)
with zeaxanthin##2##2##(2008-11#1)(2008-12#1)
with zero##17##2##(1992-7#1)(1994-4#1)(2006-10#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#2)(2009-6#1)(2012-12#2)(2013-8#1)
with zidovudine and##2##3##(1995-6#1)(2008-5#1)
with zidovudine##5##2##(1990-11#1)(1995-6#1)(2008-5#2)(2011-3#1)
with zinc and##2##3##(1992-1#1)(2008-11#1)
with zinc##21##2##(1990-11#1)(1991-1#1)(1991-9#1)(1992-1#1)(1992-9#1)(1993-2#1)(1994-11#1)(1995-11#1)(1996-11#1)(1997-3#1)(2004-11#1)(2004-9#1)(2005-7#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2012-2#1)
with ziprasidone##2##2##(2005-6#2)
with zirconium permanent##2##3##(2008-10#2)
with zirconium##10##2##(2005-11#1)(2008-10#9)
with zoledronate##2##2##(2007-12#1)(2013-8#1)
with zoledronic acid in##2##4##(2008-7#1)(2013-7#1)
with zolpidem##3##2##(2004-3#2)(2011-2#1)
with zona##2##2##(2006-5#1)(2008-4#1)
with zonisamide##2##2##(2006-12#2)
with zwitterionic##2##2##(1997-4#1)(2006-2#1)
with zymosan##4##2##(1991-5#1)(1992-1#1)(1992-3#1)(2008-12#1)
with Î-Cyclodextrin and##3##3##(2010-12#3)
with α2A##2##2##(2011-1#2)
with β-cyclodextrin##3##2##(2010-12#3)
with ≥50% stenotic CAD##2##4##(2011-1#2)
with##134690##1##(1990-1#48)(1990-10#282)(1990-11#467)(1990-12#653)(1990-2#524)(1990-3#417)(1990-4#288)(1990-5#484)(1990-6#338)(1990-7#387)(1990-8#429)(1990-9#337)(1991-1#214)(1991-10#257)(1991-11#292)(1991-12#521)(1991-2#579)(1991-3#386)(1991-4#340)(1991-5#464)(1991-6#318)(1991-7#375)(1991-8#463)(1991-9#465)(1992-1#282)(1992-10#197)(1992-11#356)(1992-12#485)(1992-2#433)(1992-3#527)(1992-4#220)(1992-5#252)(1992-6#435)(1992-7#229)(1992-8#527)(1992-9#408)(1993-1#226)(1993-10#120)(1993-11#518)(1993-12#525)(1993-2#421)(1993-3#487)(1993-4#176)(1993-5#196)(1993-6#394)(1993-7#203)(1993-8#430)(1993-9#457)(1994-1#77)(1994-10#150)(1994-11#484)(1994-12#655)(1994-2#482)(1994-3#569)(1994-4#86)(1994-5#359)(1994-6#441)(1994-7#98)(1994-8#578)(1994-9#605)(1995-1#426)(1995-10#211)(1995-11#462)(1995-12#576)(1995-2#627)(1995-3#689)(1995-4#152)(1995-5#471)(1995-6#503)(1995-7#160)(1995-8#480)(1995-9#190)(1996-1#354)(1996-10#226)(1996-11#331)(1996-12#592)(1996-2#615)(1996-3#447)(1996-4#260)(1996-5#676)(1996-6#389)(1996-7#335)(1996-8#409)(1996-9#403)(1997-1#496)(1997-2#650)(1997-3#541)(1997-4#600)(1997-5#361)(1997-6#474)(1997-7#605)(1997-8#576)(1997-9#16)(2003-11#11)(2004-1#91)(2004-10#89)(2004-11#176)(2004-12#98)(2004-2#75)(2004-3#81)(2004-4#60)(2004-5#1)(2004-7#9)(2004-8#21)(2004-9#135)(2005-1#109)(2005-10#494)(2005-11#965)(2005-12#255)(2005-2#7)(2005-3#23)(2005-4#151)(2005-5#60)(2005-6#50)(2005-7#288)(2005-8#429)(2005-9#168)(2006-1#150)(2006-10#2506)(2006-11#327)(2006-12#787)(2006-2#431)(2006-3#224)(2006-4#370)(2006-5#434)(2006-6#603)(2006-7#397)(2006-8#868)(2006-9#379)(2007-1#377)(2007-10#990)(2007-11#2991)(2007-12#3479)(2007-2#820)(2007-3#457)(2007-4#349)(2007-5#386)(2007-6#340)(2007-7#1451)(2007-8#2471)(2007-9#789)(2008-1#1368)(2008-10#14342)(2008-11#2336)(2008-12#1101)(2008-2#3199)(2008-3#4585)(2008-4#1819)(2008-5#3019)(2008-6#1308)(2008-7#2855)(2008-8#1793)(2008-9#1590)(2009-1#95)(2009-10#500)(2009-11#334)(2009-12#329)(2009-2#440)(2009-3#487)(2009-4#597)(2009-5#555)(2009-6#395)(2009-7#418)(2009-8#628)(2009-9#445)(2010-1#194)(2010-10#413)(2010-11#374)(2010-12#1360)(2010-2#678)(2010-3#422)(2010-4#717)(2010-5#603)(2010-6#353)(2010-7#470)(2010-8#662)(2010-9#352)(2011-1#1967)(2011-10#18)(2011-11#30)(2011-12#426)(2011-2#3808)(2011-3#126)(2011-5#2)(2011-7#19)(2011-8#4)(2011-9#2)(2012-1#1046)(2012-10#4)(2012-11#338)(2012-12#2067)(2012-2#2431)(2012-3#1700)(2012-4#16)(2012-5#23)(2012-6#14)(2012-7#19)(2012-8#12)(2012-9#7)(2013-1#3882)(2013-2#1)(2013-3#4)(2013-4#3)(2013-7#739)(2013-8#1905)
with)##2##1##(1994-3#1)(2008-7#1)
with-out##2##1##(1991-5#1)(2007-7#1)
with/without##12##1##(1997-6#1)(2005-11#1)(2007-5#1)(2007-6#1)(2008-2#1)(2008-7#2)(2010-1#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
withDrosophila GGPPS##2##2##(2008-8#2)
withanolide A and##3##3##(2007-1#1)(2012-2#2)
withanolide A##4##2##(2007-1#1)(2012-2#3)
withanolide##6##1##(2007-1#2)(2012-2#4)
withdraw##17##1##(1991-7#2)(1992-1#1)(1993-2#1)(1994-2#1)(1995-12#1)(1996-8#1)(2006-10#3)(2007-8#1)(2007-9#1)(2008-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2012-3#1)
withdrawal after##3##2##(2007-8#1)(2011-2#2)
withdrawal and detoxification##2##3##(1997-5#1)(2012-2#1)
withdrawal and##24##2##(1990-8#2)(1994-3#1)(1994-6#1)(1995-1#2)(1995-12#1)(1996-12#1)(1997-5#1)(2006-10#1)(2006-8#1)(2007-11#3)(2007-2#1)(2007-8#1)(2008-10#1)(2010-6#1)(2012-1#1)(2012-2#4)(2013-1#1)
withdrawal are##3##2##(1996-12#1)(2007-11#2)
withdrawal for##2##2##(1995-12#1)(2008-7#1)
withdrawal from a##2##3##(2005-11#1)(2008-4#1)
withdrawal from cocaine##3##3##(1991-1#1)(1992-11#1)(1994-12#1)
withdrawal from the arterial port (sample##2##6##(2007-7#2)
withdrawal from the##6##3##(1995-12#1)(1997-6#1)(2007-12#1)(2007-7#2)(2007-8#1)
withdrawal from treatment##2##3##(1993-3#1)(2007-11#1)
withdrawal from##25##2##(1991-1#1)(1992-11#3)(1992-12#1)(1992-3#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#2)(1996-10#1)(1997-6#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-2#1)(2008-4#1)(2011-2#2)(2012-12#1)
withdrawal in the##3##3##(1991-1#1)(1996-10#2)
withdrawal in##17##2##(1991-1#5)(1991-12#1)(1996-10#2)(2005-9#2)(2007-11#2)(2007-5#1)(2012-11#1)(2012-2#1)(2013-1#2)
withdrawal is##2##2##(2006-11#1)(2007-11#1)
withdrawal may##2##2##(1995-1#1)(2006-4#1)
withdrawal movement##2##2##(2011-2#2)
withdrawal of a##2##3##(1994-9#1)(1996-2#1)
withdrawal of drugs from the market##2##6##(2007-2#1)(2008-8#1)
withdrawal of drugs##3##3##(2007-2#1)(2008-8#1)(2012-2#1)
withdrawal of light exposure##2##4##(1996-2#2)
withdrawal of serum##3##3##(1994-11#1)(1996-2#2)
withdrawal of steroids##2##3##(2006-8#1)(2007-8#1)
withdrawal of the drug##3##4##(1990-6#1)(2006-10#1)(2006-6#1)
withdrawal of the offending##2##4##(2007-8#1)(2008-7#1)
withdrawal of the##18##3##(1990-6#1)(1992-11#1)(1992-3#1)(1992-6#1)(1997-1#1)(1997-6#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-8#3)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
withdrawal of therapy and##2##4##(2006-4#2)
withdrawal of therapy##3##3##(1991-4#1)(2006-4#2)
withdrawal of treatment##4##3##(1990-3#1)(1991-8#1)(1993-2#1)(2005-8#1)
withdrawal of##74##2##(1990-3#1)(1990-6#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-11#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-11#2)(1993-2#1)(1994-11#1)(1994-12#1)(1994-9#1)(1996-12#1)(1996-2#5)(1996-7#1)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-1#1)(2005-8#1)(2006-10#5)(2006-4#3)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#2)(2007-7#2)(2007-8#5)(2008-10#1)(2008-11#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#1)
withdrawal on##4##2##(2007-11#4)
withdrawal or##5##2##(1990-8#1)(2007-11#1)(2007-8#1)(2008-7#1)(2009-11#1)
withdrawal period##2##2##(1996-12#1)(2007-9#1)
withdrawal phenomena##3##2##(1991-12#1)(1991-4#1)(1993-5#1)
withdrawal reactions##2##2##(1991-12#1)(2008-6#1)
withdrawal resistance of##3##3##(2009-3#3)
withdrawal resistance##8##2##(2009-3#8)
withdrawal response##3##2##(2011-2#3)
withdrawal seizures##3##2##(1993-4#2)(2008-2#1)
withdrawal should be##2##3##(2006-10#1)(2009-6#1)
withdrawal signs##2##2##(2007-11#1)(2007-2#1)
withdrawal speed##2##2##(2008-3#2)
withdrawal symptoms##10##2##(1991-1#1)(1992-3#1)(1993-8#1)(1995-11#1)(2008-2#1)(2009-7#1)(2011-1#2)(2011-2#1)(2012-2#1)
withdrawal syndrome is##2##3##(1991-12#1)(2011-2#1)
withdrawal syndrome of##2##3##(1991-12#1)(1995-12#1)
withdrawal syndrome##16##2##(1991-12#4)(1991-4#1)(1995-12#2)(1996-10#1)(2007-11#1)(2009-5#1)(2010-2#1)(2011-2#3)(2013-1#2)
withdrawal syndromes##2##2##(1991-12#1)(2008-8#1)
withdrawal threshold to##2##3##(2009-12#2)
withdrawal threshold##6##2##(1993-12#2)(2009-12#3)(2013-7#1)
withdrawal thresholds##4##2##(1993-12#2)(1997-2#1)(2012-2#1)
withdrawal to##5##2##(1997-2#1)(1997-6#1)(2008-5#1)(2008-8#1)(2012-11#1)
withdrawal treatment##2##2##(1995-11#1)(2008-9#1)
withdrawal under##2##2##(1996-8#1)(2007-2#1)
withdrawal was##4##2##(2007-11#1)(2010-12#1)(2012-2#1)(2013-8#1)
withdrawal were##4##2##(1993-4#1)(1993-9#1)(2008-10#1)(2012-2#1)
withdrawal##402##1##(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#3)(1991-1#12)(1991-12#11)(1991-3#2)(1991-4#5)(1991-5#3)(1991-8#2)(1992-11#4)(1992-12#1)(1992-3#5)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#5)(1993-2#2)(1993-3#1)(1993-4#3)(1993-5#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-1#7)(1995-11#8)(1995-12#15)(1995-2#2)(1996-1#2)(1996-10#9)(1996-11#1)(1996-12#7)(1996-2#8)(1996-5#2)(1996-7#6)(1996-8#1)(1997-1#1)(1997-2#2)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#1)(2005-1#1)(2005-11#2)(2005-7#1)(2005-8#2)(2005-9#2)(2006-10#9)(2006-11#1)(2006-2#3)(2006-4#4)(2006-5#2)(2006-6#2)(2006-8#2)(2006-9#2)(2007-10#2)(2007-11#31)(2007-12#4)(2007-2#10)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#11)(2007-9#1)(2008-10#5)(2008-11#4)(2008-2#5)(2008-3#4)(2008-4#3)(2008-5#6)(2008-6#7)(2008-7#7)(2008-8#4)(2008-9#7)(2009-11#3)(2009-12#4)(2009-3#11)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#16)(2012-1#1)(2012-11#8)(2012-12#2)(2012-2#17)(2012-3#1)(2013-1#10)(2013-7#1)(2013-8#2)
withdrawal)##4##1##(1991-5#1)(1995-8#1)(2006-5#1)(2011-2#1)
withdrawal-induced##2##1##(2005-7#1)(2008-3#1)
withdrawal-related##2##1##(2012-2#2)
withdrawals in the United States##2##5##(2008-8#2)
withdrawals in the##3##3##(2008-8#2)(2011-1#1)
withdrawals##15##1##(2006-5#1)(2007-2#4)(2008-8#9)(2011-1#1)
withdrawing blood##2##2##(2007-8#2)
withdrawing substituents##2##2##(2009-9#1)(2010-5#1)
withdrawing the drug##2##3##(2006-10#1)(2011-2#1)
withdrawing the##4##2##(1992-3#1)(1996-9#1)(2006-10#1)(2011-2#1)
withdrawing##23##1##(1991-2#2)(1992-3#1)(1995-1#1)(1996-9#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-8#3)(2008-10#1)(2008-3#1)(2008-9#1)(2009-7#1)(2009-9#3)(2010-12#1)(2010-5#2)(2011-2#1)
withdrawn and##3##2##(2009-5#1)(2012-2#1)(2013-8#1)
withdrawn at the##4##3##(1996-12#1)(2012-11#3)
withdrawn at##5##2##(1996-12#1)(2008-4#1)(2012-11#3)
withdrawn because of##5##3##(1992-11#1)(2006-10#2)(2007-7#1)(2008-12#1)
withdrawn before##2##2##(1992-5#1)(2007-2#1)
withdrawn by##3##2##(2008-4#1)(2011-1#1)(2013-1#1)
withdrawn for##4##2##(1992-11#1)(1995-1#1)(1996-9#1)(2013-1#1)
withdrawn from cocaine##2##3##(2010-3#2)
withdrawn from the market##3##4##(2006-10#1)(2008-11#1)(2010-12#1)
withdrawn from the study##2##4##(1992-8#1)(2007-2#1)
withdrawn from the##8##3##(1992-11#1)(1992-8#1)(2005-9#1)(2006-10#2)(2007-2#1)(2008-11#1)(2010-12#1)
withdrawn from##14##2##(1992-11#1)(1992-8#1)(1993-2#1)(2005-9#1)(2006-10#2)(2007-2#1)(2008-11#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-3#2)(2012-2#1)
withdrawn in##2##2##(1993-1#1)(2007-2#1)
withdrawn since 1993##2##3##(2008-8#2)
withdrawn##89##1##(1990-7#3)(1991-4#1)(1992-11#3)(1992-5#1)(1992-8#2)(1993-1#1)(1993-2#1)(1993-3#2)(1994-3#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-9#2)(1997-5#1)(2004-11#1)(2005-11#1)(2005-12#1)(2005-9#1)(2006-10#5)(2007-2#3)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#14)(2008-12#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#4)(2009-5#2)(2010-12#1)(2010-3#3)(2011-1#1)(2011-2#1)(2012-11#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
withdrew from##3##2##(2007-2#1)(2008-7#1)(2013-1#1)
withdrew##8##1##(2007-11#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2013-1#1)
wither##2##1##(2008-10#1)(2008-7#1)
withered leaves##3##2##(2013-8#3)
withered##5##1##(2006-12#1)(2007-9#1)(2013-8#3)
withheld##7##1##(1996-5#1)(1997-2#1)(2005-10#1)(2007-11#1)(2007-9#1)(2010-8#1)(2012-3#1)
withhold a##3##2##(2008-10#1)(2010-12#1)(2011-2#1)
withhold##12##1##(1993-5#1)(1993-7#5)(2006-4#1)(2007-2#1)(2008-10#1)(2009-10#1)(2010-12#1)(2011-2#1)
withholding and withdrawing life-support##2##4##(1991-2#2)
withholding of##3##2##(2012-3#1)(2013-8#2)
withholding##11##1##(1990-7#1)(1991-2#2)(1996-8#1)(2007-8#1)(2008-12#1)(2008-7#1)(2012-11#1)(2012-3#1)(2013-8#2)
within &quot##2##2##(2008-10#1)(2012-2#1)
within +/-##3##2##(1993-11#1)(1997-3#1)(2009-5#1)
within +/-0##11##2##(2008-10#2)(2008-2#4)(2008-3#5)
within +/-10%##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
within +/-20%##3##2##(2008-10#3)
within 0##27##2##(1990-2#2)(1991-8#1)(1993-12#1)(1993-2#1)(1994-2#1)(1995-8#1)(2007-5#2)(2008-10#7)(2008-2#1)(2008-3#4)(2009-2#1)(2009-8#2)(2010-12#1)(2011-2#1)(2012-2#1)
within 1 day##4##3##(1991-7#2)(1992-6#1)(2008-10#1)
within 1 h after##5##4##(1991-11#1)(1995-8#1)(2008-10#1)(2010-11#2)
within 1 h in##2##4##(1996-11#1)(2010-8#1)
within 1 h of##4##4##(1992-8#1)(1993-3#1)(2004-11#1)(2010-8#1)
within 1 h##16##3##(1991-11#1)(1992-8#1)(1993-3#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-11#1)(2004-11#1)(2008-10#2)(2008-5#2)(2010-11#2)(2010-8#2)
within 1 hr of##2##4##(1994-3#2)
within 1 hr##4##3##(1994-3#2)(1995-1#1)(2007-9#1)
within 1 min##11##3##(1990-5#1)(1991-12#1)(1991-7#1)(1995-1#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-7#1)
within 1 month after##2##4##(2008-10#1)(2011-2#1)
within 1 month of##2##4##(1991-12#1)(2007-7#1)
within 1 month##10##3##(1991-12#1)(2006-10#1)(2006-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2011-1#1)(2011-2#1)(2013-7#1)
within 1 to##4##3##(1992-11#1)(1995-9#2)(2006-11#1)
within 1 week##8##3##(1994-12#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-4#1)
within 1 year after##3##4##(2008-6#1)(2012-1#2)
within 1 year of##2##4##(2007-11#1)(2007-8#1)
within 1 year##9##3##(1997-5#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-6#2)(2012-1#2)
within 1##89##2##(1990-5#1)(1991-11#1)(1991-12#2)(1991-7#3)(1992-11#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-3#3)(1994-5#1)(1995-1#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-5#2)(1997-8#2)(2004-11#1)(2006-10#4)(2006-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#11)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2009-12#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-7#1)
within 1% of##3##3##(2008-1#1)(2008-3#1)(2010-12#1)
within 1%##7##2##(2008-1#1)(2008-2#1)(2008-3#4)(2010-12#1)
within 1-2 h of##2##4##(1990-4#1)(1995-6#1)
within 1-2 h##3##3##(1990-4#1)(1995-6#1)(2012-12#1)
within 1-2 min##2##3##(1992-3#1)(1994-12#1)
within 1-2##7##2##(1990-10#1)(1990-4#1)(1992-3#1)(1994-12#1)(1995-6#1)(1997-7#1)(2012-12#1)
within 1-6##2##2##(1997-1#1)(2010-7#1)
within 10 days of##3##4##(1991-12#1)(2007-10#1)(2007-8#1)
within 10 h##2##3##(2008-10#1)(2008-11#1)
within 10 min of##3##4##(1991-11#1)(1991-2#1)(1996-12#1)
within 10 min##14##3##(1991-11#1)(1991-2#2)(1992-11#1)(1993-4#1)(1994-12#1)(1995-2#1)(1995-5#1)(1996-12#2)(1996-7#1)(2008-10#2)(2008-5#1)
within 10 minutes and##2##4##(2012-2#1)(2012-3#1)
within 10 minutes of##4##4##(2004-11#1)(2005-12#1)(2008-11#1)(2011-1#1)
within 10 minutes##6##3##(2004-11#1)(2005-12#1)(2008-11#1)(2011-1#1)(2012-2#1)(2012-3#1)
within 10 sec and##2##4##(1990-7#1)(1993-11#1)
within 10 sec##3##3##(1990-7#1)(1993-11#1)(1994-3#1)
within 10 years##3##3##(2007-7#1)(2008-1#1)(2010-12#1)
within 10##41##2##(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-9#1)(1992-11#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-12#2)(1996-5#1)(1996-6#1)(1996-7#1)(2004-11#1)(2005-12#2)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)
within 10% for##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
within 10% of the##2##4##(2007-12#1)(2008-10#1)
within 10% of##3##3##(2007-12#1)(2008-10#1)(2011-2#1)
within 10%##11##2##(1997-3#1)(2005-11#1)(2007-12#2)(2008-10#2)(2008-3#4)(2011-2#1)
within 10-20##2##2##(1991-4#1)(2012-2#1)
within 100##5##2##(1992-2#1)(2008-10#2)(2010-8#1)(2012-1#1)
within 10s##2##2##(2008-10#2)
within 11 days##2##3##(1996-12#1)(2012-12#1)
within 12 hours of##5##4##(1990-8#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-3#1)
within 12 hours##8##3##(1990-8#1)(2006-6#2)(2007-10#1)(2007-8#1)(2007-9#1)(2008-3#1)(2009-11#1)
within 12 min##4##3##(1990-11#1)(2008-10#3)
within 12 months##5##3##(1992-7#2)(2011-2#1)(2012-2#2)
within 12 weeks##2##3##(2008-7#1)(2011-2#1)
within 12##25##2##(1990-11#1)(1990-8#1)(1992-7#2)(1993-8#1)(1997-3#1)(1997-7#1)(2006-6#2)(2007-10#3)(2007-8#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-7#1)(2009-11#1)(2011-2#2)(2012-2#2)
within 13##2##2##(2008-10#1)(2008-3#1)
within 14##5##2##(1993-2#1)(2008-10#3)(2010-11#1)
within 15 days##3##3##(1993-11#1)(1995-2#1)(2008-11#1)
within 15 min of##4##4##(1990-10#1)(1993-9#1)(1994-3#1)(1995-3#1)
within 15 min##17##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1991-11#1)(1992-1#1)(1992-2#1)(1993-9#1)(1994-3#1)(1995-3#1)(1995-5#1)(2005-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-12#1)
within 15 minutes##2##3##(1995-9#1)(2007-9#1)
within 15##28##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1991-11#1)(1992-1#1)(1992-10#1)(1992-2#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(2005-12#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)
within 15% of##2##3##(2008-3#2)
within 16 h of##2##4##(1996-8#1)(2008-10#1)
within 16 h##3##3##(1996-8#1)(2008-10#2)
within 16##4##2##(1996-8#1)(2008-10#2)(2012-2#1)
within 17 min##2##3##(2008-3#1)(2008-5#1)
within 18 hours##2##3##(1992-10#1)(1993-3#1)
within 18 months after##2##4##(1995-2#1)(2007-7#1)
within 18 months##3##3##(1990-6#1)(1995-2#1)(2007-7#1)
within 18##6##2##(1990-6#1)(1992-10#1)(1993-3#1)(1995-2#1)(2005-12#1)(2007-7#1)
within 2 and##2##3##(1990-6#1)(1996-2#1)
within 2 days##4##3##(1990-10#1)(1996-2#1)(2006-10#1)(2013-8#1)
within 2 h after##2##4##(2008-10#1)(2008-8#1)
within 2 h and##5##4##(1990-5#1)(1993-4#1)(1994-2#1)(2008-10#1)(2011-2#1)
within 2 h of##5##4##(1996-12#1)(1996-6#1)(2008-10#1)(2008-5#1)(2012-12#1)
within 2 h##23##3##(1990-10#1)(1990-5#1)(1991-7#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-4#1)(1994-2#1)(1995-11#1)(1996-12#1)(1996-6#1)(1997-4#1)(1997-6#1)(2006-8#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#1)
within 2 hours##3##3##(1990-11#1)(2006-2#1)(2007-9#1)
within 2 kcal/mol of the benchmark results##2##7##(2012-12#2)
within 2 min of##2##4##(1992-11#1)(2009-12#1)
within 2 min##4##3##(1990-3#1)(1992-11#1)(1994-3#1)(2009-12#1)
within 2 months##5##3##(1990-12#1)(2006-12#1)(2007-11#1)(2008-10#1)(2012-2#1)
within 2 to 6##2##4##(1992-8#1)(2008-10#1)
within 2 weeks after##3##4##(1996-12#1)(2008-10#2)
within 2 weeks of##4##4##(1995-1#1)(1997-4#1)(2006-10#1)(2008-10#1)
within 2 weeks##16##3##(1994-2#1)(1995-1#1)(1995-2#1)(1996-12#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2008-10#6)(2008-11#1)
within 2 years of##3##4##(1995-2#1)(2011-2#1)(2012-12#1)
within 2 years##8##3##(1995-2#1)(2006-10#1)(2007-10#2)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)
within 2##84##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-7#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-3#1)(1993-4#1)(1994-12#1)(1994-2#2)(1994-3#2)(1995-1#1)(1995-11#1)(1995-2#2)(1995-5#1)(1996-12#2)(1996-2#2)(1996-6#1)(1997-3#1)(1997-4#2)(1997-6#1)(2005-11#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-8#1)(2007-9#1)(2008-10#12)(2008-11#2)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#2)(2012-6#1)(2013-8#1)
within 2%##4##2##(2008-2#1)(2008-3#3)
within 2-3##5##2##(1990-12#1)(1993-3#1)(1994-11#1)(1996-11#1)(2007-11#1)
within 2-3%##2##2##(2008-10#2)
within 2-4##2##2##(1996-2#1)(2007-9#1)
within 20 km##2##3##(2013-1#2)
within 20 min##6##3##(1993-2#1)(1994-2#1)(1996-9#1)(2007-8#1)(2008-10#1)(2008-6#1)
within 20##18##2##(1990-5#1)(1991-8#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-8#1)(1996-9#1)(2006-6#1)(2007-8#1)(2008-10#4)(2008-6#2)(2013-1#2)
within 20%##3##2##(1997-8#1)(2008-3#1)(2010-4#1)
within 20min##2##2##(2008-10#2)
within 21 days##2##3##(2008-11#1)(2011-2#1)
within 21##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
within 24 h after##5##4##(1997-7#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
within 24 h and##2##4##(2007-8#1)(2009-6#1)
within 24 h of##5##4##(1990-10#1)(1990-8#1)(2008-10#2)(2008-7#1)
within 24 h when##2##4##(2004-9#1)(2008-10#1)
within 24 h##30##3##(1990-10#1)(1990-8#1)(1991-5#1)(1992-2#1)(1994-11#1)(1994-5#1)(1996-9#1)(1997-7#1)(2004-9#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-6#1)(2011-2#4)(2012-3#1)(2013-1#1)
within 24 hours and the##2##5##(1992-9#1)(2005-11#1)
within 24 hours and##4##4##(1992-9#1)(2005-11#1)(2013-1#2)
within 24 hours of stroke onset##2##6##(2006-7#1)(2007-10#1)
within 24 hours of stroke##3##5##(2006-7#1)(2007-10#2)
within 24 hours of the onset of##3##7##(2006-12#1)(2007-9#1)(2011-2#1)
within 24 hours of the##5##5##(1996-2#1)(2006-12#1)(2007-10#1)(2007-9#1)(2011-2#1)
within 24 hours of##16##4##(1993-2#1)(1996-2#1)(2006-12#2)(2006-7#1)(2006-9#3)(2007-10#3)(2007-9#1)(2008-1#1)(2011-1#1)(2011-2#1)(2012-3#1)
within 24 hours##35##3##(1992-9#1)(1993-2#1)(1995-8#1)(1996-2#1)(1997-4#1)(2004-1#1)(2005-11#1)(2006-11#1)(2006-12#2)(2006-6#1)(2006-7#1)(2006-9#4)(2007-10#5)(2007-9#1)(2008-1#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#4)
within 24 hr of##2##4##(1993-12#1)(1996-4#1)
within 24 hr##4##3##(1993-12#1)(1993-4#1)(1995-3#1)(1996-4#1)
within 24 months##2##3##(1992-7#1)(2008-6#1)
within 24 to 48##2##4##(1993-9#1)(2008-10#1)
within 24##74##2##(1990-10#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-4#1)(1997-7#1)(2004-1#1)(2004-9#2)(2005-11#1)(2006-11#1)(2006-12#2)(2006-6#1)(2006-7#1)(2006-9#4)(2007-10#5)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-9#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#5)(2012-3#2)(2013-1#5)
within 25##2##2##(1992-11#1)(2008-10#1)
within 28 days##4##3##(2007-10#1)(2007-12#1)(2008-7#1)(2008-8#1)
within 28##6##2##(1996-6#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-7#1)(2008-8#1)
within 2min##2##2##(2008-10#2)
within 3 days of##3##4##(1993-7#1)(2006-7#1)(2007-9#1)
within 3 days##12##3##(1993-7#1)(1995-2#1)(1996-4#1)(2006-11#1)(2006-7#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-4#1)(2012-2#1)(2013-8#1)
within 3 h of##3##4##(1995-10#1)(2006-8#1)(2008-8#1)
within 3 h##11##3##(1992-1#1)(1993-12#1)(1995-10#1)(1996-5#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-6#1)(2011-2#1)
within 3 hours of onset of stroke##3##7##(2007-10#1)(2007-11#1)(2007-9#1)
within 3 hours of onset##5##5##(2007-10#1)(2007-11#1)(2007-9#1)(2010-12#2)
within 3 hours of##7##4##(2007-10#2)(2007-11#1)(2007-9#2)(2010-12#2)
within 3 hours##11##3##(2007-10#3)(2007-11#1)(2007-9#3)(2010-12#2)(2010-2#1)(2013-8#1)
within 3 min##3##3##(1990-12#1)(2007-8#1)(2008-10#1)
within 3 months of##3##4##(1991-8#1)(2008-3#1)(2008-6#1)
within 3 months##11##3##(1991-8#1)(2005-10#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-6#2)(2008-8#1)(2012-12#1)(2013-1#2)
within 3 to 4 months##2##5##(2008-10#1)(2008-8#1)
within 3 weeks##2##3##(2006-9#1)(2010-12#1)
within 3 years of diagnosis##2##5##(2008-11#1)(2008-5#1)
within 3 years of##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
within 3##72##2##(1990-12#1)(1990-6#1)(1991-8#1)(1992-1#1)(1993-12#1)(1993-7#1)(1995-10#1)(1995-2#1)(1995-7#1)(1996-4#1)(1996-5#1)(1996-6#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#4)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#4)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#3)(2010-12#5)(2010-2#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
within 3%##2##2##(2008-3#2)
within 3-4##2##2##(1993-12#1)(2010-1#1)
within 3-5 days##2##3##(1997-4#1)(2008-11#1)
within 3-5##5##2##(1993-4#1)(1997-4#1)(2008-11#1)(2008-9#1)(2009-9#1)
within 30 days after##2##4##(1996-2#1)(2007-7#1)
within 30 days in##2##4##(1993-11#1)(2008-11#1)
within 30 days##15##3##(1993-11#1)(1996-2#1)(2006-1#4)(2006-12#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-5#1)(2012-3#1)(2013-1#3)
within 30 min after##2##4##(1990-12#1)(2008-11#1)
within 30 min of##2##4##(1994-3#1)(1995-2#1)
within 30 min##14##3##(1990-12#1)(1992-7#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-5#1)(2012-11#2)
within 30 minutes of##2##4##(2008-8#2)
within 30 minutes##4##3##(2006-2#2)(2008-8#2)
within 30 s##2##3##(1992-8#1)(2008-10#1)
within 30##43##2##(1990-12#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-3#2)(1995-2#2)(1995-3#1)(1996-2#1)(2006-1#4)(2006-12#1)(2006-2#2)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-11#1)(2010-5#1)(2012-11#2)(2012-3#2)(2013-1#3)
within 36 h##3##3##(2008-10#3)
within 36##5##2##(2008-10#4)(2010-7#1)
within 38##2##2##(1996-2#1)(2008-10#1)
within 4 days after##3##4##(2006-3#1)(2008-10#1)(2012-12#1)
within 4 days and##3##4##(1996-2#1)(2012-12#2)
within 4 days##8##3##(1994-9#1)(1996-2#1)(2006-3#1)(2008-10#1)(2008-5#1)(2012-12#3)
within 4 h after##2##4##(1992-2#1)(1995-11#1)
within 4 h of##3##4##(1997-2#1)(2007-8#1)(2013-1#1)
within 4 h##8##3##(1992-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1997-2#1)(2005-11#1)(2007-8#1)(2013-1#1)
within 4 min##2##3##(1990-6#1)(1990-7#1)
within 4 months##6##3##(1992-5#1)(1996-12#1)(2004-12#1)(2008-5#1)(2008-6#1)(2013-1#1)
within 4 to 7##2##4##(1992-8#1)(1997-5#1)
within 4 to##3##3##(1992-8#1)(1997-5#1)(2007-8#1)
within 4 weeks of##3##4##(2004-3#1)(2006-10#1)(2007-5#1)
within 4 weeks##7##3##(1990-12#1)(2004-3#1)(2006-10#1)(2007-5#1)(2008-10#3)
within 4 years of the##2##5##(1990-9#1)(2013-8#1)
within 4 years##3##3##(1990-9#1)(2008-7#1)(2013-8#1)
within 4##44##2##(1990-12#1)(1990-6#1)(1990-7#1)(1990-9#1)(1992-2#2)(1992-5#1)(1992-8#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-5#1)(2004-12#1)(2004-3#1)(2005-11#1)(2006-10#1)(2006-3#1)(2007-5#1)(2007-8#2)(2008-10#7)(2008-5#2)(2008-6#1)(2008-7#1)(2012-11#2)(2012-12#3)(2013-1#2)(2013-8#1)
within 4% for##2##3##(2008-3#2)
within 4%##5##2##(2008-10#1)(2008-2#1)(2008-3#3)
within 40##3##2##(1992-1#1)(2008-12#1)(2009-3#1)
within 45 min##3##3##(1994-9#1)(2008-10#1)(2008-8#1)
within 48 h after removal of##2##6##(1990-6#1)(1993-11#1)
within 48 h after##4##4##(1990-6#1)(1992-3#1)(1993-11#1)(2008-10#1)
within 48 h of##6##4##(2006-5#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#1)
within 48 h##14##3##(1990-6#1)(1990-7#1)(1992-3#1)(1993-11#1)(1997-3#1)(2006-5#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-11#1)(2012-2#1)
within 48 hours from##2##4##(2007-10#1)(2007-7#1)
within 48 hours of admission##2##5##(2006-2#1)(2007-10#1)
within 48 hours of onset##2##5##(2007-10#1)(2007-11#1)
within 48 hours of stroke##2##5##(2007-10#2)
within 48 hours of##8##4##(2006-1#1)(2006-2#1)(2007-10#4)(2007-11#1)(2012-12#1)
within 48 hours##17##3##(2005-11#1)(2006-1#1)(2006-2#1)(2007-10#6)(2007-11#1)(2007-7#1)(2009-3#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#2)
within 48 hr##2##3##(2007-2#1)(2008-4#1)
within 48 hrs##2##3##(2010-12#1)(2012-3#1)
within 48##36##2##(1990-6#1)(1990-7#1)(1992-3#1)(1993-11#1)(1997-3#1)(2005-11#1)(2006-1#1)(2006-2#1)(2006-5#1)(2007-10#6)(2007-11#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2009-3#1)(2010-12#1)(2010-5#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
within 5 h##2##3##(2007-2#1)(2008-10#1)
within 5 min of##6##4##(1991-11#1)(1995-7#2)(1996-6#1)(2008-10#1)(2010-2#1)
within 5 min##23##3##(1990-2#1)(1991-10#1)(1991-11#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-4#1)(1994-6#1)(1995-3#1)(1995-7#2)(1996-6#1)(2007-8#1)(2008-10#5)(2008-4#1)(2010-2#1)(2012-2#2)
within 5 minutes##4##3##(1991-12#1)(1991-4#1)(1994-11#1)(1995-3#1)
within 5 mm from the##2##5##(1994-12#1)(2007-8#1)
within 5 mm##3##3##(1994-12#1)(2007-8#1)(2011-2#1)
within 5 s##3##3##(1997-1#1)(1997-2#1)(2008-2#1)
within 5 to##3##3##(1993-7#1)(2006-9#1)(2007-7#1)
within 5 weeks##2##3##(1992-8#1)(1995-2#1)
within 5 x##2##3##(2008-10#1)(2008-3#1)
within 5 years of diagnosis##2##5##(1990-6#1)(2008-10#1)
within 5 years of##3##4##(1990-6#1)(1996-11#1)(2008-10#1)
within 5 years##4##3##(1990-6#1)(1995-2#1)(1996-11#1)(2008-10#1)
within 5##54##2##(1990-2#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-4#2)(1992-12#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-4#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-2#2)(1995-3#2)(1995-7#2)(1996-11#1)(1996-6#1)(1997-1#1)(1997-2#1)(2006-9#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#12)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
within 5% of##4##3##(2008-10#1)(2008-3#3)
within 5%##5##2##(1997-4#1)(2008-10#1)(2008-3#3)
within 5-10 min##3##3##(1990-7#1)(1995-3#1)(1995-8#1)
within 50##3##2##(2006-2#1)(2008-1#1)(2008-10#1)
within 500 bp of##3##4##(1995-1#3)
within 500##5##2##(1995-1#3)(2008-10#1)(2012-12#1)
within 6 days after##2##4##(2008-10#2)
within 6 days##3##3##(1992-9#1)(2008-10#2)
within 6 h after##4##4##(1991-1#1)(2008-10#1)(2008-7#1)(2010-11#1)
within 6 h of##2##4##(1997-8#1)(2008-10#1)
within 6 h##10##3##(1991-1#1)(1997-8#1)(2006-8#1)(2008-10#4)(2008-7#1)(2010-11#1)(2011-2#1)
within 6 hours##2##3##(2007-9#2)
within 6 min##5##3##(1990-2#2)(2005-12#1)(2008-10#1)(2013-8#1)
within 6 months of the##3##5##(1995-11#1)(2007-7#1)(2011-2#1)
within 6 months of##7##4##(1995-11#1)(2007-7#1)(2008-6#2)(2010-2#1)(2011-12#1)(2011-2#1)
within 6 months##14##3##(1990-12#1)(1992-1#1)(1992-7#1)(1994-12#1)(1995-11#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-6#2)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#1)
within 6##41##2##(1990-12#1)(1990-2#2)(1991-1#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-7#1)(1992-9#1)(1994-12#1)(1995-11#1)(1995-2#1)(1997-8#1)(2005-12#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-7#2)(2007-9#2)(2008-10#7)(2008-6#2)(2008-7#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
within 6%##2##2##(2008-2#2)
within 60 days of##2##4##(2007-10#2)
within 60 days##3##3##(2006-10#1)(2007-10#2)
within 60 min##7##3##(1990-11#1)(1990-8#1)(1993-3#1)(1993-4#1)(1996-6#1)(1997-4#1)(1997-8#1)
within 60 minutes##2##3##(2006-4#1)(2007-1#1)
within 60##18##2##(1990-11#1)(1990-8#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1996-6#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-4#1)(2007-1#1)(2007-10#2)(2007-4#1)(2008-10#1)(2010-7#1)
within 7 days after the##2##5##(1995-8#1)(2006-3#1)
within 7 days after##4##4##(1995-8#1)(2006-3#1)(2007-7#1)(2008-10#1)
within 7 days of##4##4##(1992-2#1)(1993-7#1)(2007-10#1)(2008-10#1)
within 7 days##11##3##(1992-2#1)(1993-7#1)(1995-8#1)(2006-3#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#1)
within 7 min##2##3##(1997-3#1)(2008-10#1)
within 7##16##2##(1992-2#1)(1992-8#1)(1993-7#1)(1995-8#1)(1997-3#1)(2006-3#1)(2007-10#2)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#1)
within 72 h of##2##4##(1990-3#1)(2008-10#1)
within 72 h##7##3##(1990-3#1)(1993-12#1)(1996-1#1)(2008-10#4)
within 72 hours after##2##4##(1997-3#1)(2013-1#1)
within 72 hours of admission##2##5##(1993-5#1)(2013-1#1)
within 72 hours of##3##4##(1993-5#1)(2007-10#1)(2013-1#1)
within 72 hours##14##3##(1993-5#1)(1997-3#1)(2006-6#1)(2007-10#1)(2013-1#10)
within 72##23##2##(1990-3#1)(1993-12#1)(1993-5#1)(1996-1#1)(1997-3#1)(2006-6#1)(2007-10#1)(2008-10#4)(2013-1#12)
within 8 days after##2##4##(1991-10#1)(1996-2#1)
within 8 days##4##3##(1991-10#1)(1996-2#1)(2008-12#1)(2009-4#1)
within 8 h##4##3##(1994-9#1)(1995-3#1)(1997-8#1)(2006-10#1)
within 8 weeks of##2##4##(1991-4#1)(2009-3#1)
within 8##16##2##(1991-10#1)(1991-4#1)(1991-8#1)(1994-9#1)(1995-3#1)(1996-2#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#2)(2009-3#1)(2009-4#1)
within 8min##2##2##(2008-10#2)
within 9##2##2##(2007-11#1)(2007-6#1)
within 90 days of their##2##5##(2009-12#2)
within 90 days of##4##4##(2006-10#1)(2009-12#2)(2011-2#1)
within 90 days##7##3##(2006-10#1)(2009-12#2)(2011-2#4)
within 90##9##2##(2006-10#1)(2008-10#1)(2008-3#1)(2009-12#2)(2011-2#4)
within 96##2##2##(2005-8#1)(2008-10#1)
within AC##2##2##(1991-3#2)
within AG-2##3##2##(2008-10#3)
within Australia##5##2##(1992-1#1)(1994-12#2)(2008-12#1)(2013-1#1)
within C##3##2##(2008-10#3)
within CA3##2##2##(1991-6#1)(2008-11#1)
within CN##2##2##(1996-5#1)(2011-2#1)
within Caenorhabditis##2##2##(2007-12#2)
within Canada##2##2##(1995-12#1)(2008-11#1)
within Canadian##3##2##(1997-3#1)(2007-12#1)(2007-8#1)
within DNA##3##2##(1992-2#1)(2008-10#1)(2008-11#1)
within Europe##4##2##(2006-2#1)(2011-1#1)(2012-2#1)(2013-8#1)
within F##3##2##(2008-10#3)
within Gonyleptidae##2##2##(2007-12#2)
within Heliosperma (Sileneae##2##3##(2010-6#2)
within I##2##2##(2007-8#1)(2011-1#1)
within ICL3##2##2##(1996-5#2)
within LII##2##2##(1990-7#2)
within M##2##2##(2008-10#2)
within MPFC##2##2##(2008-11#2)
within P##4##2##(2008-10#3)(2008-12#1)
within Schwann cells##2##3##(1996-4#1)(2007-10#1)
within South##2##2##(2008-10#1)(2013-1#1)
within Spotfire##2##2##(2008-4#2)
within Switzerland##2##2##(1996-12#1)(2012-5#1)
within T##3##2##(1996-3#1)(2008-10#1)(2008-2#1)
within X##2##2##(2008-10#2)
within a 1##2##3##(1997-6#1)(2009-10#1)
within a 2##2##3##(2008-2#1)(2010-12#1)
within a 24-hour period##2##4##(1996-3#1)(1996-9#1)
within a 3##2##3##(1990-11#1)(2010-8#1)
within a 3-month##2##3##(1997-8#1)(2012-12#1)
within a 79##2##3##(2008-12#2)
within a biological##2##3##(1996-5#1)(2008-11#1)
within a broader##2##3##(2006-9#1)(2009-4#1)
within a cell##2##3##(2008-2#1)(2010-11#1)
within a certain##7##3##(1993-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-12#1)(2012-1#1)(2013-8#1)
within a clinical##3##3##(1994-12#1)(1995-3#1)(2008-9#1)
within a cluster of fatty acid biosynthetic genes##2##8##(1992-4#2)
within a cluster of##4##4##(1992-4#2)(2008-10#2)
within a cluster##5##3##(1992-4#2)(2008-10#3)
within a complex system##2##4##(2008-11#1)(2008-6#1)
within a complex##5##3##(2008-11#1)(2008-6#1)(2009-12#1)(2011-1#1)(2012-12#1)
within a concentration range of##2##5##(1996-6#1)(2008-10#1)
within a concentration range##4##4##(1996-6#1)(1997-4#1)(2007-8#1)(2008-10#1)
within a context##3##3##(2010-10#1)(2012-3#1)(2013-8#1)
within a country##4##3##(2008-10#1)(2010-3#1)(2011-2#1)(2012-12#1)
within a critical##2##3##(1993-2#1)(2008-11#1)
within a dance##4##3##(2012-12#4)
within a day##2##3##(2008-10#1)(2013-8#1)
within a defined##2##3##(1995-8#1)(1996-12#1)
within a detection##2##3##(1993-9#1)(2008-10#1)
within a dielectric##2##3##(1995-1#1)(2007-12#1)
within a discrete##3##3##(1992-5#1)(1994-9#1)(1997-6#1)
within a factor of 2##3##5##(2008-2#1)(2008-3#2)
within a factor of##4##4##(2005-11#1)(2008-2#1)(2008-3#2)
within a family##4##3##(1996-5#1)(2007-7#1)(2011-1#1)(2011-2#1)
within a few days##10##4##(1991-4#2)(1993-12#1)(2006-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-4#1)(2010-4#1)(2011-2#1)
within a few hours of##2##5##(1993-12#1)(2008-11#1)
within a few hours##7##4##(1990-8#1)(1990-9#1)(1993-12#1)(1994-3#1)(1995-2#1)(2008-11#1)(2011-2#1)
within a few microns of the##2##6##(2008-1#1)(2010-12#1)
within a few minutes after##2##5##(1990-11#1)(1997-4#1)
within a few minutes##9##4##(1990-11#1)(1990-8#1)(1992-2#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-4#1)(2012-12#1)
within a few months after##2##5##(2007-8#1)(2012-3#1)
within a few months of##2##5##(1992-6#1)(2011-1#1)
within a few months##7##4##(1992-6#1)(1992-8#1)(2006-11#1)(2007-8#1)(2010-3#1)(2011-1#1)(2012-3#1)
within a few percent##2##4##(2008-3#2)
within a few seconds##3##4##(1992-8#1)(2008-10#2)
within a few weeks after##2##5##(2005-11#1)(2007-10#1)
within a few weeks##7##4##(1993-11#1)(1996-11#1)(2005-11#1)(2006-12#1)(2007-10#1)(2008-10#1)(2012-2#1)
within a few years of##2##5##(2005-10#1)(2008-1#1)
within a few years##7##4##(1996-4#1)(2005-10#1)(2005-5#1)(2007-9#1)(2008-1#1)(2008-6#1)(2012-12#1)
within a few##62##3##(1990-11#1)(1990-4#1)(1990-8#2)(1990-9#1)(1991-4#2)(1992-2#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-12#2)(1994-11#1)(1994-3#1)(1995-2#1)(1996-11#1)(1996-4#1)(1997-4#2)(2005-10#1)(2005-11#1)(2005-5#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)
within a fiber##2##3##(2007-11#1)(2007-12#1)
within a field##7##3##(2008-10#6)(2012-12#1)
within a finite##3##3##(1995-7#1)(1996-4#1)(2008-2#1)
within a fully##2##3##(2004-10#1)(2008-8#1)
within a gene##2##3##(2012-3#2)
within a general##2##3##(2007-9#1)(2013-8#1)
within a genetic##2##3##(2006-12#1)(2008-10#1)
within a geographic##2##3##(2008-10#1)(2008-8#1)
within a given##14##3##(1990-7#1)(1991-7#1)(1994-5#1)(1995-11#1)(2004-11#1)(2007-9#1)(2008-10#1)(2008-4#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-7#1)(2013-1#2)
within a group of##6##4##(1995-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#2)
within a health care##2##4##(1994-1#1)(1995-1#1)
within a health##4##3##(1993-1#1)(1994-1#1)(1995-1#1)(2008-11#1)
within a healthcare##2##3##(2007-12#1)(2008-9#1)
within a hospital##3##3##(1991-5#1)(2007-2#1)(2008-2#1)
within a large##7##3##(1990-2#1)(1995-5#1)(1997-7#1)(2007-1#1)(2008-10#1)(2010-11#1)(2012-2#1)
within a larger##2##3##(1992-12#1)(2005-10#1)
within a layer##2##3##(1992-9#2)
within a leaf##2##3##(2008-10#2)
within a litter##3##3##(2013-8#3)
within a local area##3##4##(2008-10#3)
within a local##4##3##(2008-10#3)(2012-2#1)
within a longer##2##3##(1992-7#1)(2013-1#1)
within a matrix##3##3##(2006-11#1)(2008-11#1)(2012-11#1)
within a metapopulation##2##3##(2008-10#1)(2008-8#1)
within a month##2##3##(1990-12#1)(2013-8#1)
within a much broader##2##4##(2010-3#1)(2012-3#1)
within a multidisciplinary##2##3##(1996-1#1)(2008-8#1)
within a multilayer##3##3##(2007-12#1)(2008-3#2)
within a narrow range of##2##5##(1990-3#1)(1995-11#1)
within a narrow range##4##4##(1990-3#1)(1995-11#1)(2007-2#1)(2011-2#1)
within a narrow##7##3##(1990-3#1)(1995-11#1)(2007-11#1)(2007-2#1)(2008-1#2)(2011-2#1)
within a national##2##3##(2008-9#1)(2011-2#1)
within a neighborhood##2##3##(2008-2#1)(2008-6#1)
within a network structure##2##4##(2005-11#2)
within a network##3##3##(2005-11#2)(2008-11#1)
within a new##2##3##(1991-12#1)(2008-10#1)
within a number of##2##4##(2008-10#1)(2008-7#1)
within a pH range of 2-8##2##6##(2006-1#1)(2007-12#1)
within a patch##2##3##(2010-2#2)
within a period of##6##4##(1990-5#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-3#1)
within a polymer##2##3##(2008-10#1)(2008-3#1)
within a population of##5##4##(1991-12#1)(1995-5#1)(2008-10#1)(2008-5#1)(2008-9#1)
within a population##11##3##(1991-12#1)(1995-5#1)(2007-10#1)(2008-10#3)(2008-5#1)(2008-8#2)(2008-9#2)
within a precision of##2##4##(2008-2#1)(2008-3#1)
within a public health care##2##5##(1994-9#2)
within a radius of##2##4##(2008-10#1)(2010-10#1)
within a range of 0##2##5##(2007-11#1)(2011-2#1)
within a range of##12##4##(1993-12#1)(1996-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-10#1)(2011-2#1)(2013-1#1)
within a range##18##3##(1993-12#1)(1993-5#1)(1996-1#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2010-10#1)(2010-12#1)(2011-2#1)(2013-1#2)
within a reasonable period of time##2##6##(1996-11#1)(2012-12#1)
within a reasonable time##3##4##(2007-10#1)(2008-11#1)(2008-4#1)
within a reasonable##6##3##(1996-11#1)(2006-5#1)(2007-10#1)(2008-11#1)(2008-4#1)(2012-12#1)
within a region of##3##4##(1992-5#1)(1997-4#1)(2011-2#1)
within a region##10##3##(1990-12#1)(1991-5#1)(1992-5#1)(1996-4#1)(1997-4#1)(2008-10#1)(2011-2#1)(2012-3#2)(2013-8#1)
within a regulated##2##3##(1990-8#1)(1997-5#1)
within a relatively short time period##2##6##(2006-2#1)(2007-7#1)
within a relatively short time##3##5##(2006-2#1)(2007-7#1)(2008-11#1)
within a relatively small range##2##5##(2005-11#1)(2006-6#1)
within a relatively small##3##4##(2005-11#1)(2006-6#1)(2009-7#1)
within a relatively##8##3##(1995-8#1)(2005-11#1)(2006-2#1)(2006-6#1)(2007-7#1)(2008-11#1)(2008-2#1)(2009-7#1)
within a restricted##2##3##(2008-8#1)(2008-9#1)
within a same##2##3##(2008-2#1)(2009-8#1)
within a sample of##3##4##(2007-12#1)(2008-10#1)(2012-3#1)
within a sample##4##3##(2007-12#1)(2008-10#1)(2011-2#1)(2012-3#1)
within a sequence##3##3##(1995-2#1)(1995-8#1)(1996-5#1)
within a series##2##3##(1992-12#1)(1993-2#1)
within a set of##5##4##(2008-10#1)(2008-2#2)(2008-3#1)(2012-12#1)
within a short period after##2##5##(1991-7#1)(2009-5#1)
within a short period of time##5##6##(1996-3#1)(2008-11#1)(2008-8#1)(2011-11#1)(2011-2#1)
within a short period##9##4##(1990-8#1)(1991-7#1)(1996-3#1)(2007-10#1)(2008-11#1)(2008-8#1)(2009-5#1)(2011-11#1)(2011-2#1)
within a short time##6##4##(1990-12#1)(1991-8#1)(2005-1#1)(2005-5#1)(2006-10#1)(2008-9#1)
within a short##19##3##(1990-12#1)(1990-8#1)(1991-7#1)(1991-8#1)(1996-3#1)(2005-1#1)(2005-5#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-11#1)(2011-2#1)(2012-11#1)
within a single cell##2##4##(1994-8#1)(2008-4#1)
within a single field##2##4##(2008-10#2)
within a single season##2##4##(2008-10#1)(2008-8#1)
within a single tree##2##4##(2008-10#2)
within a single##49##3##(1992-8#1)(1994-5#1)(1994-8#1)(1995-11#1)(1997-4#1)(2005-5#1)(2006-10#1)(2006-12#2)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#3)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-8#1)
within a small##5##3##(1997-5#1)(2007-12#2)(2008-3#1)(2008-9#1)
within a social##2##3##(2006-2#1)(2006-5#1)
within a spatially##2##3##(1995-5#1)(2008-3#1)
within a special##3##3##(2012-12#2)(2013-1#1)
within a species##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
within a specific##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
within a specified range of##2##5##(2007-12#1)(2008-3#1)
within a specified range##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
within a standard##2##3##(2009-11#1)(2011-2#1)
within a study##2##3##(1994-6#1)(2008-10#1)
within a thick##2##3##(2008-3#1)(2011-2#1)
within a tight##2##3##(2005-11#1)(2008-9#1)
within a time##3##3##(1993-8#1)(2008-3#1)(2013-1#1)
within a turbid medium##2##4##(2008-3#2)
within a unique##2##3##(2008-1#1)(2008-7#1)
within a unit##2##3##(2007-10#1)(2007-7#1)
within a variety of##2##4##(1991-12#1)(2008-11#1)
within a very##2##3##(1992-6#1)(2006-6#1)
within a wavelength range##2##4##(2007-12#1)(2008-3#1)
within a week of each other##2##6##(1991-11#1)(2008-5#1)
within a week of##4##4##(1991-11#1)(2007-8#1)(2008-11#1)(2008-5#1)
within a week##5##3##(1991-11#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-5#1)
within a whole##3##3##(2012-2#2)(2013-8#1)
within a wide##2##3##(1990-4#1)(2008-3#1)
within a wider##2##3##(2008-12#1)(2009-10#1)
within a year##7##3##(1992-5#1)(1993-7#1)(2007-2#1)(2008-8#1)(2009-5#1)(2010-12#1)(2013-1#1)
within a zone of##5##4##(1993-12#1)(2008-5#1)(2012-2#3)
within a##834##2##(1990-10#2)(1990-11#2)(1990-12#6)(1990-2#2)(1990-3#1)(1990-4#3)(1990-5#1)(1990-6#1)(1990-7#4)(1990-8#4)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#4)(1991-7#3)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-4#2)(1992-5#3)(1992-6#5)(1992-7#2)(1992-8#4)(1992-9#3)(1993-1#2)(1993-11#3)(1993-12#4)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-3#2)(1994-4#1)(1994-5#3)(1994-6#1)(1994-8#2)(1994-9#4)(1995-1#3)(1995-11#4)(1995-12#2)(1995-2#3)(1995-3#5)(1995-5#7)(1995-6#1)(1995-7#1)(1995-8#5)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#4)(1996-2#2)(1996-3#3)(1996-4#6)(1996-5#5)(1996-6#3)(1996-7#1)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#7)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#1)(2004-10#1)(2004-11#1)(2004-4#1)(2005-1#1)(2005-10#2)(2005-11#7)(2005-12#1)(2005-2#1)(2005-5#3)(2005-8#1)(2006-1#1)(2006-10#4)(2006-11#2)(2006-12#9)(2006-2#3)(2006-3#1)(2006-5#4)(2006-6#5)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#7)(2007-11#5)(2007-12#34)(2007-2#7)(2007-3#1)(2007-4#3)(2007-5#2)(2007-7#3)(2007-8#11)(2007-9#7)(2008-1#17)(2008-10#98)(2008-11#31)(2008-12#9)(2008-2#32)(2008-3#44)(2008-4#16)(2008-5#14)(2008-6#7)(2008-7#8)(2008-8#18)(2008-9#15)(2009-10#4)(2009-11#3)(2009-12#3)(2009-3#4)(2009-4#4)(2009-5#4)(2009-6#2)(2009-7#3)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#4)(2010-12#8)(2010-2#7)(2010-3#4)(2010-4#5)(2010-5#1)(2010-7#3)(2010-8#5)(2011-1#8)(2011-11#1)(2011-12#2)(2011-2#21)(2012-1#5)(2012-11#2)(2012-12#19)(2012-2#15)(2012-3#14)(2012-5#1)(2012-9#1)(2013-1#19)(2013-7#1)(2013-8#16)
within about 5##2##3##(1993-12#1)(2008-10#1)
within about##11##2##(1990-3#1)(1991-3#1)(1993-12#1)(1993-6#1)(2005-10#1)(2007-1#1)(2008-10#2)(2008-6#1)(2008-7#1)(2011-2#1)
within acceptable levels##2##3##(1992-10#1)(2008-3#1)
within acceptable limits##3##3##(2006-8#1)(2008-6#1)(2013-1#1)
within acceptable##7##2##(1992-10#1)(2004-12#1)(2006-8#1)(2008-3#1)(2008-6#1)(2010-3#1)(2013-1#1)
within adjacent##3##2##(1992-12#1)(2008-3#2)
within adult##2##2##(2007-11#1)(2008-11#1)
within all the##2##3##(1997-6#1)(2008-5#1)
within all##9##2##(1992-6#1)(1997-3#1)(1997-6#1)(2004-7#1)(2007-12#1)(2008-10#2)(2008-5#1)(2010-8#1)
within an acceptable range##3##4##(2006-4#1)(2008-10#2)
within an acute##3##3##(2007-10#1)(2008-5#1)(2013-8#1)
within an allozyme genotype##2##4##(2008-10#2)
within an amplified##2##3##(1990-7#1)(2008-10#1)
within an average##2##3##(2006-12#1)(2007-11#1)
within an environment##2##3##(2008-10#1)(2012-1#1)
within an error##2##3##(2007-11#1)(2008-10#1)
within an experimental##3##3##(2007-12#2)(2008-10#1)
within an hour##3##3##(1995-9#1)(2007-8#1)(2012-2#1)
within an individual plant##2##4##(2006-3#1)(2009-8#1)
within an individual##3##3##(2006-3#1)(2008-10#1)(2009-8#1)
within an open##2##3##(2007-3#1)(2008-10#1)
within an organization##2##3##(1995-3#1)(2008-9#1)
within an undergraduate dental curriculum##2##5##(2012-1#2)
within an undergraduate##3##3##(2008-11#1)(2012-1#2)
within an##112##2##(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1992-10#1)(1992-5#1)(1993-4#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-8#1)(1995-9#2)(1996-12#1)(1996-5#1)(1997-4#1)(1997-5#1)(2004-12#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2007-10#2)(2007-11#3)(2007-12#7)(2007-2#2)(2007-3#1)(2007-8#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#4)(2008-5#7)(2008-8#1)(2008-9#1)(2009-10#2)(2009-6#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-1#5)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
within and across the##2##4##(2008-10#1)(2009-7#1)
within and across##11##3##(2006-3#1)(2008-10#1)(2008-11#2)(2009-7#1)(2010-11#1)(2010-12#1)(2012-11#1)(2012-3#3)
within and adjacent to the##2##5##(2008-7#1)(2011-2#1)
within and adjacent to##4##4##(2008-10#2)(2008-7#1)(2011-2#1)
within and among populations was##2##5##(2005-10#1)(2008-10#1)
within and among populations##3##4##(2005-10#1)(2008-10#2)
within and among##19##3##(1994-3#1)(1996-2#1)(2005-10#1)(2006-3#1)(2008-10#11)(2008-8#1)(2008-9#1)(2010-3#2)
within and around the##4##4##(1993-4#1)(1996-9#1)(2009-5#1)(2010-10#1)
within and around##6##3##(1993-4#1)(1996-9#1)(1997-4#1)(2006-10#1)(2009-5#1)(2010-10#1)
within and between individuals##2##4##(1993-12#1)(2012-3#1)
within and between patches##3##4##(2008-8#3)
within and between species##6##4##(2006-5#1)(2009-6#1)(2009-8#2)(2012-3#2)
within and between the##5##4##(2008-10#2)(2008-7#1)(2010-3#1)(2010-7#1)
within and between two##2##4##(2008-8#1)(2008-9#1)
within and between##47##3##(1990-12#1)(1992-9#1)(1993-1#1)(1993-12#1)(1995-4#1)(1995-8#1)(1997-1#2)(1997-2#1)(2006-5#1)(2007-1#1)(2007-8#1)(2008-10#9)(2008-12#1)(2008-4#3)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#2)(2009-8#3)(2010-3#1)(2010-7#1)(2011-1#1)(2012-1#2)(2012-3#4)
within and beyond##2##3##(2006-9#1)(2012-12#1)
within and on the##2##4##(2007-7#1)(2008-10#1)
within and outside of the##2##5##(2008-10#1)(2008-12#1)
within and outside of##3##4##(1993-1#1)(2008-10#1)(2008-12#1)
within and outside the##6##4##(1991-2#1)(1991-4#1)(1995-11#1)(2007-6#1)(2007-7#1)(2013-1#1)
within and outside##11##3##(1991-2#1)(1991-4#1)(1993-1#1)(1995-11#1)(1995-5#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-12#1)(2013-1#1)(2013-7#1)
within and##111##2##(1990-12#1)(1991-1#1)(1991-2#1)(1991-4#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-4#1)(1994-3#1)(1995-11#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#2)(2005-10#1)(2006-10#1)(2006-3#2)(2006-5#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#27)(2008-11#2)(2008-12#2)(2008-4#3)(2008-7#2)(2008-8#5)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#3)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#7)(2013-1#2)(2013-7#1)
within animals##2##2##(1995-7#1)(2008-7#1)
within any given##2##3##(2010-11#1)(2012-2#1)
within any##8##2##(1991-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-11#1)(2012-2#1)
within approximately 1##3##3##(1997-2#2)(2006-6#1)
within approximately##12##2##(1991-2#1)(1994-12#1)(1997-2#2)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2010-12#1)
within as well as##2##4##(1991-4#1)(2008-2#1)
within axon terminals in##2##4##(1994-2#2)
within bedding##2##2##(2011-12#2)
within biofilms##4##2##(2006-11#1)(2008-10#1)(2008-9#1)(2013-8#1)
within biological systems##2##3##(2009-10#1)(2010-11#1)
within biological##5##2##(2009-10#1)(2009-12#1)(2010-11#1)(2010-5#1)(2011-1#1)
within both the##6##3##(1991-2#1)(1993-11#1)(1995-10#1)(1996-8#1)(2007-6#1)(2010-8#1)
within both##15##2##(1991-2#1)(1993-11#1)(1995-10#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(2006-7#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-10#3)(2010-8#1)
within ca##3##2##(1990-7#1)(1990-8#1)(2008-10#1)
within cankers##2##2##(2008-10#2)
within cell##2##2##(1991-8#1)(1997-4#1)
within cells of##4##3##(1992-3#1)(1995-11#1)(2008-10#1)(2013-8#1)
within cells##14##2##(1992-3#1)(1993-9#1)(1995-11#1)(1997-8#1)(2008-10#1)(2008-4#3)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
within certain##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
within children##2##2##(2009-12#1)(2009-8#1)
within clinical practice##3##3##(1996-3#1)(2008-11#2)
within clinical##6##2##(1994-12#1)(1996-3#1)(2008-11#2)(2013-1#2)
within clinically##3##2##(2006-12#1)(2008-1#1)(2013-8#1)
within cluster correlation##2##3##(2010-11#2)
within clusters##3##2##(2008-12#1)(2008-8#1)(2012-12#1)
within codons##3##2##(1993-9#1)(2008-7#2)
within collagen##2##2##(1990-12#1)(1991-2#1)
within companies##2##2##(2007-7#2)
within complex##2##2##(1997-5#1)(2008-2#1)
within contexts of##2##3##(1996-12#1)(2010-12#1)
within cortical##2##2##(1996-11#1)(2008-11#1)
within countries##9##2##(1991-5#1)(2005-11#1)(2007-7#1)(2008-10#1)(2009-7#1)(2010-5#3)(2011-1#1)
within current##4##2##(2008-11#1)(2008-3#1)(2008-9#1)(2012-12#1)
within cytoplasmic##3##2##(2006-10#1)(2008-9#1)(2009-2#1)
within day##4##2##(2008-10#1)(2010-12#3)
within days after##2##3##(1991-3#1)(2008-10#1)
within days of##2##3##(1995-6#1)(1996-9#1)
within days or weeks##2##4##(1995-2#1)(2008-7#1)
within days##10##2##(1991-3#1)(1992-12#1)(1993-2#1)(1995-2#1)(1995-6#1)(1996-9#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)
within defined##3##2##(1995-5#1)(2008-4#1)(2009-11#1)
within dendrites##2##2##(1997-4#1)(2009-2#1)
within different##12##2##(1990-4#1)(1992-3#1)(1997-5#1)(2005-10#1)(2006-7#1)(2007-2#1)(2008-10#1)(2008-4#1)(2011-12#1)(2013-1#3)
within distinct##2##2##(2009-2#2)
within domains##2##2##(1996-11#1)(1996-2#1)
within droplets##3##2##(2007-10#1)(2008-3#2)
within each block##2##3##(2008-11#1)(2012-2#1)
within each cell##2##3##(1997-5#1)(1997-8#1)
within each class##2##3##(1993-6#2)
within each community##3##3##(1993-1#1)(2008-10#1)(2008-8#1)
within each domain##3##3##(1992-7#1)(1995-1#1)(2008-8#1)
within each ethnic##2##3##(2008-5#1)(2009-7#1)
within each group##8##3##(1995-5#1)(1997-3#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-6#1)(2010-8#1)(2011-2#1)
within each layer##2##3##(2008-2#1)(2008-3#1)
within each of the##8##4##(1994-3#1)(1995-12#1)(2008-10#1)(2008-11#1)(2009-7#1)(2009-9#1)(2010-3#1)(2012-3#1)
within each of these##5##4##(2007-10#1)(2008-10#2)(2008-2#1)(2008-9#1)
within each of##15##3##(1993-1#1)(1994-3#1)(1995-12#1)(1996-2#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-3#1)(2012-3#1)
within each period##3##3##(2007-8#2)(2008-2#1)
within each population##3##3##(1997-7#1)(2008-10#2)
within each stage##2##3##(1995-1#1)(2008-10#1)
within each subgroup##2##3##(2007-4#1)(2008-10#1)
within each subpopulation##2##3##(2008-10#2)
within each tissue##2##3##(2007-11#2)
within each treatment##2##3##(1994-9#1)(2008-7#1)
within each##109##2##(1990-7#1)(1991-2#2)(1991-4#1)(1992-3#1)(1992-7#1)(1993-1#2)(1993-6#2)(1994-3#1)(1994-9#1)(1995-1#3)(1995-12#1)(1995-3#2)(1995-5#1)(1996-12#1)(1996-2#1)(1997-2#3)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#25)(2008-11#3)(2008-2#3)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#2)(2009-2#1)(2009-4#2)(2009-7#2)(2009-9#1)(2010-11#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
within either the##2##3##(1990-7#1)(2008-10#1)
within either##6##2##(1990-7#1)(1993-9#1)(1994-3#1)(1995-8#1)(1997-2#1)(2008-10#1)
within electronic##3##2##(2011-2#1)(2013-1#2)
within electropolymerized##2##2##(2008-10#2)
within elements of##2##3##(1993-6#1)(2013-1#1)
within eukaryotic##3##2##(2008-2#1)(2008-4#1)(2010-5#1)
within evolutionary biology##2##3##(2006-5#1)(2013-1#1)
within evolutionary##3##2##(1992-6#1)(2006-5#1)(2013-1#1)
within existing##3##2##(2011-1#1)(2013-1#2)
within exon 19##2##3##(1990-7#2)
within exon##3##2##(1990-7#2)(2012-12#1)
within experimental error##6##3##(1990-7#1)(1993-11#1)(1995-5#1)(2008-10#3)
within families##10##2##(1993-1#1)(1995-11#1)(1996-12#1)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#2)
within family##2##2##(1995-8#1)(2012-3#1)
within few##2##2##(1994-6#1)(2011-2#1)
within field##3##2##(2008-10#3)
within fields##8##2##(2008-10#8)
within fifteen##2##2##(1997-1#1)(2008-11#1)
within five to##2##3##(1992-5#1)(2006-6#1)
within five years##2##3##(2007-7#1)(2008-9#1)
within five##8##2##(1991-8#1)(1992-5#1)(1993-8#1)(2006-6#1)(2007-7#1)(2008-9#1)(2010-8#1)(2011-1#1)
within four to six weeks##2##5##(2006-9#1)(2007-8#1)
within four weeks of##2##4##(2005-12#1)(2010-8#1)
within four weeks##5##3##(2005-12#1)(2008-5#1)(2010-10#1)(2010-8#1)(2011-2#1)
within four years of implementation##2##5##(2012-3#2)
within four years##3##3##(1990-5#1)(2012-3#2)
within four##13##2##(1990-10#1)(1990-5#1)(2005-12#1)(2006-9#1)(2007-8#1)(2008-12#1)(2008-5#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-3#2)
within fungal##2##2##(1993-11#1)(2008-10#1)
within gene##2##2##(1997-7#1)(2012-3#1)
within genes and##2##3##(2012-3#2)
within genes##5##2##(2012-3#5)
within genotype##2##2##(2008-10#1)(2009-9#1)
within group##2##2##(1990-9#1)(1993-5#1)
within groups##14##2##(1996-6#3)(1997-8#1)(2005-8#1)(2007-12#1)(2008-10#2)(2008-8#2)(2008-9#2)(2010-3#1)(2012-2#1)
within guidelines##2##2##(2008-1#1)(2008-5#1)
within half an hour##2##4##(2007-7#1)(2012-12#1)
within half##4##2##(1992-8#1)(2005-11#1)(2007-7#1)(2012-12#1)
within health care organizations##5##4##(1991-12#1)(1993-3#1)(1995-12#1)(2008-1#1)(2008-12#1)
within health care systems##2##4##(2008-1#1)(2008-7#1)
within health care##13##3##(1991-12#1)(1992-2#1)(1993-3#1)(1995-12#1)(1996-1#1)(1996-12#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-7#1)(2011-1#1)
within health sectors##2##3##(2008-12#2)
within health##20##2##(1991-12#1)(1992-2#1)(1993-3#1)(1995-12#2)(1996-1#1)(1996-12#1)(2007-5#1)(2008-1#2)(2008-11#2)(2008-12#4)(2008-7#1)(2010-3#1)(2011-1#1)(2012-12#1)
within higher##2##2##(1993-6#1)(2008-1#1)
within highly scattering media##3##4##(2007-12#2)(2008-3#1)
within highly scattering##4##3##(2007-12#2)(2008-3#2)
within hip##2##2##(2007-11#1)(2007-8#1)
within his##2##2##(1990-8#1)(2007-6#1)
within hospitals##3##2##(2005-8#1)(2010-9#1)(2013-8#1)
within host cells##2##3##(2008-9#1)(2013-8#1)
within host##3##2##(2008-9#1)(2012-2#1)(2013-8#1)
within hours of##2##3##(1994-9#1)(2008-10#1)
within hours##9##2##(1991-9#1)(1992-12#1)(1994-9#1)(1995-3#1)(2006-8#1)(2007-11#1)(2008-10#1)(2009-4#1)(2013-1#1)
within households##2##2##(2010-8#1)(2012-2#1)
within human##2##2##(1997-8#1)(2011-2#1)
within humerus##3##2##(2007-11#3)
within hydrogen-bonding distance of##2##4##(1993-11#1)(1993-8#1)
within hydrogen-bonding distance##3##3##(1993-11#1)(1993-8#1)(1996-7#1)
within in##2##2##(2008-12#1)(2008-8#1)
within individual trees##2##3##(2008-10#2)
within individual##14##2##(1990-10#1)(1994-5#1)(1995-5#1)(1995-8#1)(2008-10#6)(2008-3#1)(2008-4#1)(2009-7#1)(2012-1#1)
within individuals and##2##3##(2008-5#1)(2012-2#1)
within individuals##7##2##(1993-10#1)(2006-5#1)(2008-5#1)(2008-6#1)(2012-2#2)(2012-3#1)
within industrial##2##2##(1996-5#1)(2008-10#1)
within infected cells##2##3##(2008-10#2)
within infected##5##2##(1993-8#1)(2008-10#3)(2008-9#1)
within intact cells##3##3##(1992-12#1)(2008-11#1)(2008-9#1)
within intact##4##2##(1992-12#1)(2008-11#1)(2008-9#1)(2011-1#1)
within integrated##3##2##(1992-3#1)(2007-12#1)(2012-2#1)
within interacting##2##2##(2008-8#2)
within internal##2##2##(1995-10#1)(1997-3#1)
within intron##4##2##(1991-1#1)(1993-9#1)(1995-5#1)(2008-9#1)
within isolates from##3##3##(2008-10#1)(2010-10#2)
within isolates of##3##3##(2008-10#3)
within isolates##6##2##(2008-10#4)(2010-10#2)
within it##9##2##(1990-6#1)(2007-12#2)(2007-5#1)(2008-12#2)(2008-8#1)(2010-10#1)(2010-11#1)
within its extracellular domain##2##4##(1991-6#1)(1996-9#1)
within its recognition sequence##2##4##(1990-3#1)(1994-12#1)
within its##29##2##(1990-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-6#1)(1995-8#1)(1996-9#1)(1997-4#1)(2003-11#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2012-2#1)(2013-7#1)
within just a few##2##4##(2008-10#1)(2008-3#1)
within laboratory##3##2##(2008-10#2)(2012-1#1)
within large##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2009-4#1)
within layers##3##2##(2005-11#1)(2008-11#1)(2008-2#1)
within less than##4##3##(2007-12#1)(2008-10#1)(2008-3#2)
within limits##2##2##(1997-4#1)(2006-6#1)
within living cells##3##3##(2006-6#1)(2007-11#1)(2008-1#1)
within living##6##2##(1995-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2012-2#1)
within local##2##2##(2008-10#1)(2008-8#1)
within lysosomes##2##2##(1992-2#1)(2007-7#1)
within mammalian##3##2##(1995-5#1)(2008-9#1)(2009-9#1)
within many##3##2##(1992-8#1)(2008-11#1)(2008-2#1)
within medical##3##2##(1996-8#1)(2008-12#1)(2009-4#1)
within mental health services##2##4##(2011-2#1)(2012-11#1)
within mental health##5##3##(1997-2#1)(2011-1#1)(2011-2#2)(2012-11#1)
within microbial##2##2##(2008-10#1)(2010-2#1)
within minutes after the##2##4##(1997-6#1)(2007-11#1)
within minutes at##2##3##(2008-7#1)(2010-5#1)
within minutes##14##2##(1991-6#1)(1995-12#1)(1995-6#1)(1997-6#2)(2006-3#1)(2007-10#1)(2007-11#2)(2008-7#1)(2009-8#1)(2010-5#1)(2011-12#1)(2012-12#1)
within months##2##2##(1990-12#1)(1997-2#1)
within most##2##2##(2008-10#1)(2008-11#1)
within muscle##4##2##(1997-9#1)(2008-1#1)(2010-4#1)(2010-9#1)
within nanoscale##2##2##(2006-12#1)(2008-7#1)
within narrow##3##2##(2008-1#1)(2008-5#1)(2012-2#1)
within natural##2##2##(1997-8#1)(2011-2#1)
within necrotic##2##2##(2008-10#2)
within neuronal##2##2##(2008-10#1)(2008-7#1)
within neurons in the##2##4##(1995-10#1)(1996-1#1)
within neurons##4##2##(1991-12#1)(1995-10#2)(1996-1#1)
within non-commercial partnerships##3##3##(2012-3#3)
within normal limits##11##3##(1990-8#1)(1997-7#1)(2006-5#1)(2007-2#1)(2007-9#1)(2008-1#2)(2008-7#1)(2008-9#1)(2010-7#1)(2011-12#1)
within normal range in##7##4##(2007-7#3)(2008-7#3)(2013-1#1)
within normal range##16##3##(1997-5#1)(2006-6#1)(2006-9#2)(2007-6#1)(2007-7#4)(2007-9#1)(2008-7#4)(2012-2#1)(2013-1#1)
within normal ranges##3##3##(2006-4#1)(2007-9#1)(2008-5#1)
within normal##33##2##(1990-8#1)(1993-2#1)(1997-5#1)(1997-7#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-9#2)(2007-2#1)(2007-6#1)(2007-7#4)(2007-9#3)(2008-1#2)(2008-5#1)(2008-7#5)(2008-9#1)(2010-7#1)(2011-12#1)(2012-2#2)(2013-1#2)
within nursing homes##2##3##(1995-2#1)(2010-8#1)
within nursing or##2##3##(1996-1#1)(2012-3#1)
within nursing##13##2##(1995-2#1)(1996-1#1)(1997-2#1)(2007-10#1)(2008-11#3)(2010-8#1)(2012-3#2)(2013-1#2)(2013-8#1)
within ocular##2##2##(2009-2#1)(2009-8#1)
within olive##2##2##(2008-10#1)(2013-8#1)
within one and a half##2##5##(2009-3#1)(2010-6#1)
within one and##3##3##(1992-2#1)(2009-3#1)(2010-6#1)
within one hour of##4##4##(1992-6#1)(1993-12#1)(1996-11#1)(2007-2#1)
within one hour##9##3##(1990-12#1)(1992-6#1)(1993-12#1)(1995-9#1)(1996-11#1)(2007-2#1)(2009-3#1)(2010-11#1)(2013-1#1)
within one month of##2##4##(1990-4#1)(2008-5#1)
within one month##5##3##(1990-4#1)(1996-8#1)(2008-11#1)(2008-5#1)(2013-1#1)
within one of the##3##4##(1991-8#1)(1992-5#1)(2005-8#1)
within one order of magnitude##2##5##(1991-5#1)(2012-3#1)
within one species##2##3##(1993-12#1)(2013-7#1)
within one to##2##3##(1993-11#1)(1995-11#1)
within one week of##2##4##(2007-10#1)(2010-10#1)
within one week##3##3##(2007-10#1)(2010-10#1)(2010-12#1)
within one year of##2##4##(1991-2#1)(2004-9#1)
within one year##8##3##(1991-2#1)(1992-5#1)(1995-11#1)(2004-9#1)(2005-10#1)(2006-4#1)(2006-8#1)(2009-10#1)
within one##68##2##(1990-12#1)(1990-4#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-5#2)(1992-6#1)(1993-11#1)(1993-12#3)(1993-9#1)(1995-11#2)(1995-9#1)(1996-11#1)(1996-8#1)(1997-1#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#2)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#8)(2008-2#2)(2008-3#2)(2008-5#3)(2009-10#1)(2009-3#2)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
within only one##2##3##(1992-1#1)(2008-10#1)
within only##5##2##(1992-1#1)(2008-10#2)(2008-3#1)(2013-8#1)
within optical tweezers##2##3##(2007-11#2)
within optical##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
within or adjacent to##2##4##(2008-4#1)(2009-12#1)
within or around##3##3##(1992-12#1)(1996-8#1)(2008-8#1)
within or between##3##3##(1997-2#1)(2009-7#1)(2012-2#1)
within or close to##3##4##(1992-6#1)(1996-8#1)(2007-11#1)
within or near the##3##4##(1991-5#1)(1995-8#1)(1996-7#1)
within or near##4##3##(1991-5#1)(1995-8#1)(1996-7#1)(1996-8#1)
within or on##2##3##(1991-11#1)(2008-10#1)
within or outside the##2##4##(1991-6#1)(2006-9#1)
within or outside##3##3##(1991-6#1)(1991-9#1)(2006-9#1)
within or##26##2##(1991-11#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-2#1)(1995-5#1)(1995-8#1)(1996-7#1)(1996-8#3)(1997-2#1)(2006-5#1)(2006-9#1)(2007-11#1)(2008-10#2)(2008-4#2)(2008-8#1)(2009-12#1)(2009-7#1)(2011-12#1)(2012-2#1)
within organisms##2##2##(1990-8#1)(2007-3#1)
within other##4##2##(1991-11#1)(1991-12#1)(1996-2#1)(1997-1#1)
within our discipline##2##3##(2008-12#2)
within our society##2##3##(1994-12#1)(1997-2#1)
within our##19##2##(1994-12#2)(1997-2#2)(1997-3#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-12#4)(2008-3#2)(2008-4#1)(2008-9#1)(2009-9#1)(2010-10#1)(2013-1#1)
within pH##2##2##(2008-10#2)
within participants##3##2##(2009-1#1)(2010-3#2)
within pathotypes##2##2##(2008-10#2)
within patient##4##2##(2005-10#2)(2013-1#2)
within pediatric##2##2##(2009-7#1)(2012-2#1)
within peripheral##2##2##(1990-2#1)(1992-12#1)
within persons##2##2##(1992-6#1)(2010-2#1)
within phonological words may##2##4##(2008-2#2)
within physiological ranges##2##3##(2008-6#1)(2011-2#1)
within physiological##5##2##(1990-11#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-12#1)
within plant tissue##2##3##(2008-10#1)(2012-1#1)
within plant tissues##3##3##(2008-2#2)(2009-10#1)
within plant##7##2##(2006-12#1)(2008-10#2)(2008-2#2)(2009-10#1)(2012-1#1)
within plots##3##2##(2008-10#3)
within polymer##2##2##(2008-10#1)(2010-4#1)
within population##3##2##(2008-10#2)(2012-1#1)
within populations and##2##3##(2008-10#1)(2008-8#1)
within populations of the##3##4##(2008-10#1)(2008-8#2)
within populations of##7##3##(1994-10#1)(2008-10#4)(2008-8#2)
within populations##28##2##(1994-10#1)(1997-7#1)(2008-10#18)(2008-8#4)(2008-9#1)(2009-4#1)(2011-2#1)(2012-7#1)
within possible##2##2##(2008-8#1)(2011-2#1)
within primary health care for older people##2##7##(2010-10#2)
within primary health care for##3##5##(2010-10#3)
within primary##5##2##(1991-11#1)(1996-12#1)(2010-10#3)
within professional##2##2##(1994-2#1)(2008-12#1)
within psychiatric healthcare services##3##4##(2011-2#3)
within quadrats##2##2##(2008-10#1)(2008-8#1)
within races##2##2##(2008-10#1)(2009-12#1)
within range of##3##3##(1997-4#1)(2013-1#2)
within range##4##2##(1997-4#1)(2008-9#1)(2013-1#2)
within rapidly##2##2##(2006-12#1)(2010-7#1)
within rat##2##2##(1991-11#1)(1992-7#1)
within reach##6##2##(1992-12#1)(1992-5#1)(2007-11#1)(2007-2#1)(2008-4#1)(2012-3#1)
within reasonable##2##2##(1994-3#1)(2008-3#1)
within reference intervals##2##3##(2012-3#2)
within region##2##2##(1990-3#2)
within regions##10##2##(1994-3#1)(1995-8#1)(2008-10#7)(2011-2#1)
within repeat##2##2##(1995-2#1)(2013-8#1)
within residues##4##2##(1991-12#2)(1994-5#1)(1995-1#1)
within restricted##4##2##(1991-9#1)(1992-12#1)(2011-2#1)(2012-2#1)
within root##2##2##(2008-10#2)
within rows##4##2##(2008-10#2)(2008-12#2)
within sampling units##2##3##(2008-10#2)
within sampling##5##2##(2008-10#5)
within schools of public health##2##5##(1997-2#2)
within schools of##3##3##(1994-3#1)(1997-2#2)
within secondary##2##2##(1995-6#1)(2012-1#1)
within seconds of##3##3##(1994-12#1)(1994-3#1)(2008-3#1)
within seconds##7##2##(1990-11#1)(1991-6#1)(1991-9#1)(1994-12#1)(1994-3#1)(2008-11#1)(2008-3#1)
within serotype e##2##3##(2006-8#2)
within seven##2##2##(1993-12#1)(2005-11#1)
within several hours##2##3##(1992-1#1)(1992-8#1)
within several##10##2##(1992-1#1)(1992-8#1)(1995-3#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
within similar##2##2##(1994-8#1)(2007-12#1)
within single##11##2##(1991-12#1)(1994-2#1)(1994-6#1)(1995-5#1)(1996-8#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-5#2)(2012-2#1)
within six hours of##2##4##(2007-10#1)(2007-2#1)
within six hours##3##3##(1991-6#1)(2007-10#1)(2007-2#1)
within six months of##2##4##(2006-9#1)(2010-8#1)
within six months##6##3##(1991-11#1)(1996-8#1)(2006-9#1)(2010-8#1)(2011-2#1)(2013-8#1)
within six weeks##2##3##(1991-10#1)(2007-12#1)
within six##13##2##(1991-10#2)(1991-11#1)(1991-6#1)(1996-8#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-12#1)(2010-8#1)(2011-2#1)(2013-8#1)
within skeletal muscle##2##3##(2008-11#1)(2012-3#1)
within skin##2##2##(1996-5#1)(2008-5#1)
within small regions##2##3##(2007-10#1)(2013-1#1)
within small##7##2##(1993-9#1)(1997-4#1)(2007-10#1)(2008-10#1)(2008-6#1)(2009-12#1)(2013-1#1)
within social##3##2##(2007-12#1)(2008-5#1)(2010-4#1)
within solid##2##2##(1991-7#1)(2008-5#1)
within some##13##2##(1991-4#1)(1994-4#2)(1995-3#1)(1997-3#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-1#1)
within species##7##2##(1995-11#2)(2008-10#1)(2008-11#1)(2008-9#2)(2009-5#1)
within specific##8##2##(1992-2#1)(1992-8#1)(1996-4#1)(2005-10#2)(2007-12#1)(2007-8#1)(2008-12#1)
within specified##4##2##(1992-9#1)(1995-12#1)(2007-11#1)(2010-2#1)
within standard##2##2##(2005-4#1)(2010-11#1)
within states##2##2##(1997-4#1)(2008-10#1)
within strong##2##2##(2008-2#1)(2009-11#1)
within subjects##6##2##(1992-2#1)(1993-5#1)(1993-6#1)(1994-3#1)(2007-7#1)(2008-10#1)
within sublineages##2##2##(1995-3#2)
within subpopulations##7##2##(2008-10#7)
within such a##2##3##(2008-1#1)(2008-11#1)
within such##8##2##(1990-11#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-12#1)
within tens of##2##3##(1994-5#1)(2008-10#1)
within that range of##2##4##(2007-12#1)(2008-5#1)
within that##9##2##(1996-11#1)(1996-12#1)(1997-1#1)(2005-8#1)(2007-12#1)(2008-5#1)(2008-6#1)(2010-10#1)(2010-11#1)
within the &quot##3##3##(1993-3#1)(1994-1#1)(2005-10#1)
within the 1##3##3##(2007-12#2)(2008-10#1)
within the 25S rDNA##2##4##(1996-9#2)
within the 3'##2##3##(1994-8#1)(2013-1#1)
within the 3-hour##2##3##(2007-10#1)(2007-9#1)
within the 5'##3##3##(1992-12#1)(1995-5#1)(1997-7#1)
within the 5'-flanking region of##2##5##(1993-8#1)(1997-2#1)
within the 5'-flanking##3##3##(1993-8#1)(1994-2#1)(1997-2#1)
within the 95% confidence##2##4##(2008-10#1)(2008-9#1)
within the A##2##3##(2008-10#1)(2008-3#1)
within the African##2##3##(2009-2#1)(2012-12#1)
within the B##4##3##(2006-8#3)(2011-2#1)
within the B5/FFM##2##3##(2008-5#2)
within the Bachelor of Nursing##2##5##(2007-8#1)(2010-3#1)
within the Branchiopoda##3##3##(2007-12#3)
within the C##2##3##(1995-3#1)(2008-10#1)
within the C-propeptide##2##3##(1994-9#2)
within the C-terminal##4##3##(1990-3#1)(1991-10#1)(1992-9#1)(1997-4#1)
within the CNS##3##3##(1991-12#1)(2007-11#1)(2012-3#1)
within the Central##2##3##(2008-11#1)(2013-7#1)
within the Csfm##2##3##(1990-5#2)
within the DNA region that##2##5##(1991-9#1)(1993-2#1)
within the ED##2##3##(2008-3#1)(2009-8#1)
within the ER##2##3##(1992-3#1)(1994-9#1)
within the European Union##2##4##(2006-2#1)(2008-10#1)
within the European##4##3##(1990-9#1)(1994-3#1)(2006-2#1)(2008-10#1)
within the F##2##3##(2008-10#2)
within the Health and##3##4##(1993-11#1)(1995-6#2)
within the ITS region##2##4##(2008-10#2)
within the Municipal##2##3##(2008-5#2)
within the N-terminal##6##3##(1990-7#1)(1993-8#1)(1994-9#1)(1996-3#1)(1997-4#1)(2008-5#1)
within the NAc##2##3##(2008-7#2)
within the National##3##3##(1997-1#1)(2012-12#1)(2012-3#1)
within the PVN may##2##4##(1993-7#1)(1994-2#1)
within the PVN##3##3##(1993-7#1)(1994-2#1)(2005-10#1)
within the SC##2##3##(2008-5#2)
within the STR pairs##2##4##(2008-12#2)
within the Singapore Chinese Health Study##2##6##(2010-6#2)
within the T##2##3##(1991-11#1)(1995-2#1)
within the U##7##3##(1991-8#1)(2007-8#1)(2008-10#3)(2009-8#1)(2012-2#1)
within the UK##4##3##(1992-6#1)(2006-5#1)(2008-10#1)(2010-4#1)
within the US##2##3##(2008-7#1)(2013-1#1)
within the USDA##2##3##(2008-7#2)
within the United States and##2##5##(2008-10#1)(2013-7#1)
within the United States##7##4##(2006-5#1)(2008-10#3)(2008-11#2)(2013-7#1)
within the United##8##3##(2006-5#1)(2008-10#4)(2008-11#2)(2013-7#1)
within the University of##3##4##(2008-1#1)(2008-12#2)
within the University##4##3##(2008-1#1)(2008-11#1)(2008-12#2)
within the Virtual##2##3##(2005-10#1)(2008-10#1)
within the abdomen and##2##4##(2006-10#1)(2012-2#1)
within the acceptable range##3##4##(2008-10#1)(2008-11#1)(2011-12#1)
within the acceptable##5##3##(1996-8#1)(2008-10#2)(2008-11#1)(2011-12#1)
within the active site##6##4##(1990-12#1)(1991-4#1)(1992-6#1)(1995-5#1)(1995-8#1)(2005-11#1)
within the active##7##3##(1990-12#1)(1991-4#1)(1992-6#1)(1995-5#1)(1995-8#1)(2005-11#1)(2007-12#1)
within the adult##2##3##(2008-6#1)(2008-9#1)
within the airways##3##3##(1997-1#1)(2005-11#1)(2007-11#1)
within the amino acid##2##4##(1991-1#1)(1994-6#1)
within the amygdala##3##3##(1992-8#1)(1994-2#1)(1994-8#1)
within the anterior##2##3##(1994-6#1)(1995-5#1)
within the aorta##2##3##(2007-4#1)(2007-8#1)
within the appropriate##2##3##(2008-3#1)(2012-3#1)
within the area of##4##4##(1997-2#1)(2006-10#1)(2008-10#1)(2013-1#1)
within the area##6##3##(1997-2#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
within the areas##2##3##(2006-8#1)(2013-1#1)
within the assigned##2##3##(1990-1#1)(2008-10#1)
within the bandgap##2##3##(2007-11#1)(2007-12#1)
within the beads##2##3##(2008-5#1)(2008-7#1)
within the beta##3##3##(1992-9#1)(1996-8#1)(2008-11#1)
within the biofilm##3##3##(1995-12#2)(2008-7#1)
within the biofilms##2##3##(2008-10#1)(2013-8#1)
within the biomass##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
within the black##2##3##(2006-4#1)(2010-10#1)
within the blood vessel##2##4##(1995-8#1)(2008-3#1)
within the blood##4##3##(1990-3#1)(1995-8#1)(2008-3#1)(2008-7#1)
within the body##10##3##(1994-1#1)(2007-10#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2012-12#1)(2013-7#1)
within the bone marrow##2##4##(2011-1#1)(2012-12#1)
within the bone##3##3##(1991-3#1)(2011-1#1)(2012-12#1)
within the borders of the##2##5##(1994-3#1)(2008-10#1)
within the borders of##3##4##(1994-3#1)(2008-10#1)(2009-9#1)
within the boundaries of the##2##5##(2006-5#1)(2008-9#1)
within the bovine##2##3##(1992-9#1)(2008-7#1)
within the bowel##2##3##(2006-8#2)
within the brain##13##3##(1991-2#1)(1993-11#1)(1993-2#1)(1995-1#1)(1995-10#1)(1995-5#1)(1997-8#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-5#1)(2013-7#2)
within the breast##3##3##(2008-2#1)(2009-5#1)(2011-2#1)
within the broad##3##3##(1994-12#1)(2005-7#1)(2007-12#1)
within the broader context of##2##5##(2007-12#1)(2008-8#1)
within the broader##7##3##(2007-12#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
within the cage##2##3##(2007-4#2)
within the cancer##2##3##(1994-3#1)(2010-4#1)
within the capability of##2##4##(2006-10#1)(2008-3#1)
within the catalytic##2##3##(1990-8#1)(2011-1#1)
within the cavity of a##2##5##(2008-2#1)(2008-3#1)
within the cavity##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
within the cell and##3##4##(1997-4#1)(2008-5#1)(2008-9#1)
within the cell cycle##2##4##(2007-8#1)(2011-1#1)
within the cell##29##3##(1990-6#1)(1991-6#1)(1993-2#1)(1994-11#1)(1994-9#1)(1995-10#1)(1995-11#3)(1995-2#1)(1996-8#1)(1997-4#1)(2005-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2011-1#1)(2012-1#1)(2012-12#1)
within the cells##6##3##(1990-3#1)(1993-9#1)(1996-11#1)(2006-12#1)(2008-11#1)(2011-2#1)
within the central metabolism##2##4##(2008-7#2)
within the central nervous system (CNS)##2##6##(2008-7#2)
within the central nervous system##10##5##(1991-7#1)(1993-2#1)(1995-2#1)(1996-6#1)(2008-1#1)(2008-7#4)(2013-1#1)
within the central##17##3##(1991-7#1)(1993-2#1)(1994-10#1)(1995-10#1)(1995-2#1)(1996-6#1)(1996-9#1)(2005-11#1)(2008-1#1)(2008-7#6)(2008-9#1)(2013-1#1)
within the channel##3##3##(1995-5#1)(2005-7#1)(2008-2#1)
within the chaotic region in##2##5##(2007-11#2)
within the chemosensory pathways of the male Syrian hamster brain##2##10##(1992-8#2)
within the cingulate##2##3##(1991-11#1)(2009-9#1)
within the city of##3##4##(1994-2#1)(2006-10#1)(2009-10#1)
within the city##4##3##(1992-6#1)(1994-2#1)(2006-10#1)(2009-10#1)
within the cladding of a straight optical fiber##2##8##(2007-12#2)
within the cladding##3##3##(2007-12#3)
within the class##3##3##(1991-12#1)(2008-10#1)(2011-2#1)
within the clear##2##3##(2007-12#1)(2008-3#1)
within the clinical##6##3##(1991-2#1)(2008-12#2)(2009-12#1)(2009-7#1)(2013-1#1)
within the cluster##2##3##(1996-8#1)(2008-10#1)
within the coding region and##2##5##(1990-6#1)(1993-6#1)
within the coding region##5##4##(1990-12#1)(1990-6#1)(1991-2#1)(1993-6#1)(2008-10#1)
within the coding##7##3##(1990-12#1)(1990-6#1)(1991-2#1)(1993-6#1)(1995-8#1)(1996-7#1)(2008-10#1)
within the colon##2##3##(1990-4#1)(2012-2#1)
within the colonies##2##3##(2008-10#1)(2008-9#1)
within the community##12##3##(1990-10#1)(1991-12#1)(1994-1#2)(2006-10#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-6#1)(2011-2#1)(2012-2#1)
within the company##2##3##(2008-11#1)(2012-3#1)
within the complex##6##3##(1993-3#1)(1994-9#1)(1997-1#1)(2008-1#1)(2009-10#1)(2010-2#1)
within the complexes##2##3##(2008-5#1)(2010-7#1)
within the concentration range of 0##2##6##(2008-10#2)
within the concentration range of##6##5##(1996-6#1)(2008-10#5)
within the concentration range##12##4##(1996-6#1)(2008-10#8)(2008-5#1)(2008-6#1)(2010-11#1)
within the concentration##14##3##(1996-6#1)(2008-10#10)(2008-5#1)(2008-6#1)(2010-11#1)
within the confines of##6##4##(2006-6#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-9#1)
within the constraints##2##3##(2007-10#1)(2007-2#1)
within the context of a##9##5##(1996-3#2)(2006-10#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-8#1)(2011-1#1)
within the context of current##2##5##(2007-3#1)(2008-11#1)
within the context of the new##2##6##(1991-3#1)(2011-1#1)
within the context of the##18##5##(1991-3#1)(1992-3#1)(1993-2#1)(1993-3#1)(1995-12#1)(2006-8#1)(2007-12#1)(2007-5#1)(2008-11#2)(2008-9#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-8#1)
within the context of their##2##5##(2007-11#1)(2010-10#1)
within the context of##64##4##(1991-3#1)(1992-3#1)(1993-2#2)(1993-3#1)(1994-1#1)(1994-12#1)(1995-12#1)(1995-8#1)(1996-3#2)(2005-10#1)(2005-2#1)(2006-10#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-3#1)(2007-5#1)(2008-10#1)(2008-11#7)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-11#1)(2009-4#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-2#3)(2010-8#2)(2011-1#2)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#2)
within the conventional##2##3##(1995-4#1)(2008-2#1)
within the core##6##3##(1996-2#1)(1997-2#1)(2007-11#1)(2008-8#1)(2012-2#1)(2013-1#1)
within the cortex in the##2##5##(2008-5#1)(2008-9#1)
within the cortex##5##3##(1992-7#1)(1995-6#1)(2008-5#1)(2008-9#2)
within the cortical##2##3##(2007-9#1)(2008-11#1)
within the country##3##3##(1994-9#1)(1997-8#1)(2008-10#1)
within the course of##2##4##(2004-1#1)(2005-10#1)
within the crystal##4##3##(1992-12#1)(1992-4#1)(1996-7#1)(2008-2#1)
within the current##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2010-11#1)
within the curriculum##2##3##(2008-11#1)(2008-12#1)
within the cuticle##2##3##(2008-10#1)(2008-5#1)
within the cyst##4##3##(1993-12#1)(1997-6#1)(2008-12#2)
within the cytoplasm of##3##4##(2006-6#1)(2008-10#1)(2011-2#1)
within the cytoplasm##7##3##(1991-5#1)(2006-6#2)(2007-10#1)(2008-10#2)(2011-2#1)
within the cytoplasmic##3##3##(1996-5#2)(1996-8#1)
within the cytosol of##2##4##(2008-9#1)(2011-1#1)
within the deduced##2##3##(1994-12#1)(1994-9#1)
within the department##3##3##(1996-3#1)(2008-11#1)(2010-4#1)
within the developing##5##3##(2007-12#2)(2008-10#1)(2008-12#1)(2008-5#1)
within the device##6##3##(1994-11#1)(1996-2#1)(2006-5#1)(2007-12#1)(2008-11#1)(2008-3#1)
within the different##2##3##(1992-8#1)(2008-7#1)
within the discipline##2##3##(1994-2#1)(2008-12#1)
within the diverse##2##3##(2007-1#1)(2008-5#1)
within the domains##2##3##(1996-10#1)(2007-5#1)
within the dorsal##3##3##(1993-12#1)(2012-12#2)
within the ear##2##3##(1996-11#1)(2008-4#1)
within the early##2##3##(1995-6#1)(2008-11#1)
within the embryo##3##3##(2006-12#1)(2007-12#1)(2008-5#1)
within the endoplasmic reticulum##2##4##(1994-9#1)(1996-5#1)
within the entire rostrocaudal extent of##2##6##(1991-5#2)
within the entire##6##3##(1991-5#2)(1994-3#1)(1995-5#1)(2008-10#1)(2010-7#1)
within the environment##4##3##(1992-6#1)(2006-7#1)(2007-12#1)(2008-1#1)
within the epidermis##2##3##(2007-8#1)(2010-6#1)
within the expected##2##3##(2008-3#1)(2013-1#1)
within the experimental error##2##4##(1996-4#1)(2008-3#1)
within the experimental group##2##4##(1994-3#1)(2009-6#1)
within the experimental limit of##2##5##(2007-12#2)
within the experimental##10##3##(1994-3#1)(1996-4#1)(2006-4#1)(2007-11#2)(2007-12#2)(2008-3#1)(2009-5#1)(2009-6#1)
within the facility##2##3##(1991-12#2)
within the family Cucurbitaceae##2##4##(2008-10#2)
within the family Reoviridae##2##4##(1997-4#1)(2008-10#1)
within the family of##2##4##(1990-8#1)(1992-11#1)
within the family##25##3##(1990-8#1)(1992-11#1)(1992-5#1)(1994-3#1)(1997-4#1)(2005-12#1)(2007-1#1)(2007-6#2)(2008-1#1)(2008-10#5)(2008-12#3)(2009-5#1)(2011-1#1)(2012-2#1)(2013-1#3)(2013-7#1)
within the female##2##3##(2006-11#1)(2007-11#1)
within the field of##6##4##(1993-8#1)(1996-5#1)(2005-6#1)(2008-10#1)(2008-12#1)(2008-3#1)
within the field##10##3##(1993-8#1)(1996-5#1)(2005-11#1)(2005-6#1)(2005-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2011-1#1)
within the fields of##2##4##(2009-4#1)(2010-8#1)
within the film##3##3##(2005-11#2)(2008-10#1)
within the first 12##3##4##(1993-7#1)(2006-2#1)(2011-2#1)
within the first 15 min of exposure to##2##8##(1990-10#1)(1993-6#1)
within the first 173##2##4##(1996-5#2)
within the first 2 weeks of treatment##2##7##(2008-6#2)
within the first 2##4##4##(2008-10#1)(2008-6#2)(2008-7#1)
within the first 20 min##2##5##(1995-5#1)(1995-6#1)
within the first 20##4##4##(1995-5#1)(1995-6#1)(2007-8#1)(2009-12#1)
within the first 24 h##2##5##(2008-4#1)(2012-3#1)
within the first 24 hours after ARR##2##7##(2007-9#2)
within the first 24 hours after##3##6##(2007-10#1)(2007-9#2)
within the first 24 hours##8##5##(2006-2#1)(2007-10#2)(2007-9#3)(2011-2#1)(2013-7#1)
within the first 24##11##4##(2006-10#1)(2006-2#1)(2007-10#2)(2007-9#3)(2008-4#1)(2011-2#1)(2012-3#1)(2013-7#1)
within the first 3 months##3##5##(2007-5#1)(2011-2#1)(2012-2#1)
within the first 3##8##4##(1994-10#1)(1996-3#1)(2007-5#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
within the first 30##2##4##(1992-2#1)(1994-2#1)
within the first 48 hours of##3##6##(2006-8#1)(2007-10#1)(2013-7#1)
within the first 48##4##4##(1991-4#1)(2006-8#1)(2007-10#1)(2013-7#1)
within the first 5##2##4##(1990-12#1)(1993-5#1)
within the first 6 months##2##5##(2007-9#2)
within the first 6##5##4##(1992-4#1)(2006-2#1)(2006-3#1)(2007-9#2)
within the first 60##2##4##(1992-12#1)(2006-11#1)
within the first 7 days##2##5##(1992-10#2)
within the first 8##2##4##(1992-1#1)(1994-9#1)
within the first exon##2##4##(1993-3#1)(1993-8#1)
within the first few days of##2##6##(1990-9#1)(2008-5#1)
within the first few days##3##5##(1990-9#1)(1995-11#1)(2008-5#1)
within the first few hours##2##5##(1995-5#1)(1996-8#1)
within the first few years of##2##6##(1990-1#1)(2008-9#1)
within the first few##9##4##(1990-1#1)(1990-9#1)(1995-11#1)(1995-5#1)(1996-1#1)(1996-8#1)(1997-2#1)(2008-5#1)(2008-9#1)
within the first month##2##4##(1997-8#1)(2007-9#1)
within the first second after stimulation##2##6##(2013-8#2)
within the first second after##3##5##(2013-8#3)
within the first six##2##4##(2008-2#1)(2011-1#1)
within the first three months##3##5##(1995-11#1)(2007-7#1)(2008-1#1)
within the first three##5##4##(1995-11#2)(2007-7#1)(2008-1#1)(2008-9#1)
within the first two weeks of##2##6##(2008-10#1)(2009-6#1)
within the first two weeks##3##5##(1991-9#1)(2008-10#1)(2009-6#1)
within the first two##8##4##(1991-9#1)(1996-2#1)(1996-6#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-6#1)
within the first week##4##4##(1994-2#1)(1996-9#1)(2007-9#1)(2010-3#1)
within the first year after##2##5##(2006-11#1)(2010-8#1)
within the first year of life##2##6##(2008-7#1)(2011-1#1)
within the first year of##4##5##(2008-4#1)(2008-7#1)(2011-1#1)(2012-3#1)
within the first year##11##4##(2005-7#1)(2006-11#1)(2007-11#1)(2007-9#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-8#1)
within the first##125##3##(1990-1#1)(1990-10#1)(1990-12#1)(1990-3#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-4#1)(1993-3#2)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-2#2)(1994-9#2)(1995-11#3)(1995-3#1)(1995-5#2)(1995-6#2)(1996-1#1)(1996-2#1)(1996-3#2)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2005-7#2)(2006-10#1)(2006-11#3)(2006-2#3)(2006-3#1)(2006-8#2)(2007-10#3)(2007-11#2)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#8)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#2)(2009-10#1)(2009-12#3)(2009-6#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-1#3)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#4)
within the five##2##3##(1992-9#1)(2011-1#1)
within the flexor##2##3##(2006-3#1)(2008-9#1)
within the focal##2##3##(2007-11#1)(2012-3#1)
within the fourth ventricle##4##4##(2006-5#4)
within the frame of a##2##5##(2006-12#1)(2011-2#1)
within the framework of a##9##5##(1990-8#1)(1992-1#1)(1995-5#1)(1997-8#1)(2007-11#1)(2008-2#2)(2008-3#2)
within the framework of our##2##5##(1993-6#1)(2007-10#1)
within the framework of the##15##5##(1990-6#2)(1994-6#1)(1996-8#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-2#2)(2008-3#5)
within the framework of##42##4##(1990-6#4)(1990-8#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-6#1)(1994-6#1)(1995-5#1)(1996-8#1)(1997-8#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-9#1)(2008-1#2)(2008-11#3)(2008-2#4)(2008-3#8)(2009-10#1)(2009-7#1)(2010-5#1)
within the framework##44##3##(1990-6#4)(1990-8#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-6#1)(1994-6#1)(1995-5#1)(1996-8#1)(1997-8#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-9#1)(2008-1#2)(2008-11#3)(2008-2#4)(2008-3#8)(2009-10#1)(2009-7#1)(2010-5#1)(2012-3#1)(2013-8#1)
within the ganglion##2##3##(1995-11#2)
within the gastrointestinal tract##2##4##(2006-10#1)(2011-2#1)
within the gel##3##3##(2008-10#1)(2008-4#2)
within the gene##5##3##(1992-9#1)(1996-7#1)(1997-4#1)(2008-10#1)(2013-8#1)
within the genes##3##3##(1997-5#1)(2011-1#1)(2013-7#1)
within the genome##2##3##(2007-3#1)(2008-10#1)
within the genomes of##2##4##(1991-8#1)(1994-8#1)
within the genomic##2##3##(1995-12#1)(2005-7#1)
within the genus##13##3##(1993-9#1)(1996-3#2)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-4#1)(2012-2#1)(2013-1#1)
within the given##2##3##(2008-10#1)(2008-7#1)
within the global##2##3##(2008-10#1)(2013-1#1)
within the graft##3##3##(1995-2#2)(2011-2#1)
within the group of##6##4##(1992-5#1)(1994-2#1)(2008-10#1)(2009-9#1)(2011-2#1)(2012-11#1)
within the group##10##3##(1990-6#1)(1992-5#1)(1994-2#1)(2008-10#2)(2009-9#1)(2010-3#1)(2011-2#1)(2012-11#1)(2013-8#1)
within the groups##4##3##(2007-11#1)(2008-10#1)(2008-5#2)
within the growing season##2##4##(2009-2#2)
within the growing##4##3##(2007-12#1)(2008-10#1)(2009-2#2)
within the hair##2##3##(2007-12#1)(2008-5#1)
within the health care industry##2##5##(1997-2#1)(2010-8#1)
within the health care system##2##5##(1991-1#1)(2011-1#1)
within the health care##13##4##(1990-12#1)(1991-1#2)(1991-2#1)(1991-4#1)(1993-12#1)(1996-12#1)(1997-2#1)(2008-11#2)(2008-7#1)(2010-8#1)(2011-1#1)
within the health##17##3##(1990-12#1)(1991-1#2)(1991-2#1)(1991-4#1)(1991-6#1)(1993-12#1)(1996-12#1)(1997-2#1)(2007-12#1)(2008-11#2)(2008-7#1)(2010-8#1)(2011-1#2)(2012-3#1)
within the heart conduction system##2##5##(2008-7#2)
within the heart##5##3##(2008-7#2)(2010-11#1)(2010-8#1)(2011-2#1)
within the high##2##3##(2008-11#1)(2012-2#1)
within the hippocampus##2##3##(1991-5#2)
within the home and##2##4##(2009-5#2)
within the homologous##2##3##(1990-5#1)(1996-7#1)
within the hospital setting##2##4##(1994-2#1)(2010-9#1)
within the hospital##7##3##(1990-3#1)(1994-2#1)(1995-1#1)(2010-9#2)(2013-8#2)
within the host##7##3##(1991-9#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-8#1)(2012-1#1)
within the household##2##3##(1993-5#1)(2011-2#1)
within the human genome##2##4##(1995-3#1)(2008-8#1)
within the human respiratory tract##2##5##(2011-2#1)(2013-1#1)
within the human##12##3##(1991-11#1)(1995-3#2)(1996-11#1)(1997-9#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-8#1)(2009-12#1)(2011-2#1)(2013-1#1)
within the hydrophobic core of##2##5##(1991-2#1)(1995-2#1)
within the hypothalamus##3##3##(1993-2#1)(1993-7#1)(1995-10#1)
within the immune##2##3##(2006-10#1)(2007-11#1)
within the individual##3##3##(2006-10#1)(2008-10#1)(2010-12#1)
within the industry##2##3##(1991-1#1)(1992-2#1)
within the inner cavity##2##4##(2008-8#2)
within the inner membrane##2##4##(1997-8#1)(2005-8#1)
within the inner##4##3##(1997-8#1)(2005-8#1)(2008-8#2)
within the institution##2##3##(2007-9#1)(2011-2#1)
within the instrument##3##3##(1992-6#1)(2008-3#2)
within the intact##4##3##(1990-8#1)(1991-10#1)(1996-1#1)(1997-4#1)
within the intermediate##2##3##(1990-9#1)(1995-11#1)
within the internal##3##3##(1995-8#1)(2006-5#1)(2008-10#1)
within the interval##5##3##(1994-11#1)(1995-6#1)(2008-2#1)(2008-5#1)(2013-8#1)
within the intestinal##3##3##(1996-6#1)(2006-10#1)(2008-7#1)
within the intracellular##3##3##(1996-5#1)(2008-5#1)(2008-7#1)
within the intranuclear inclusions##2##4##(2006-12#2)
within the joint##3##3##(2007-7#1)(2007-8#1)(2013-1#1)
within the large##2##3##(1995-8#1)(2008-2#1)
within the larger##3##3##(1993-5#1)(1995-3#1)(2012-12#1)
within the laser##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
within the last century##2##4##(2008-1#1)(2013-1#1)
within the last few years##2##5##(2008-5#1)(2012-12#1)
within the last##21##3##(1990-6#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-6#1)(2006-12#1)(2006-6#1)(2007-1#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-7#2)(2009-8#1)(2010-12#1)(2012-12#1)(2013-1#2)
within the lateral##3##3##(1991-12#1)(1995-5#1)(2006-5#1)
within the layer##2##3##(1990-2#1)(2008-10#1)
within the leading##2##3##(2008-10#2)
within the left##2##3##(1997-6#1)(2013-8#1)
within the legal##2##3##(2005-11#1)(2006-3#1)
within the lexical##2##3##(1991-2#1)(2010-2#1)
within the limits of##3##4##(2008-11#1)(2008-3#1)(2011-2#1)
within the limits##5##3##(2007-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
within the linear##5##3##(2008-10#2)(2008-2#1)(2008-5#1)(2010-4#1)
within the lipid##2##3##(1995-5#1)(2008-5#1)
within the literature##2##3##(2008-12#1)(2013-8#1)
within the lobe##2##3##(2007-12#2)
within the local##2##3##(2008-11#1)(2010-10#1)
within the locus##2##3##(1991-2#1)(1996-10#1)
within the loop##6##3##(1995-10#1)(1995-5#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-10#1)
within the lower##3##3##(1990-9#1)(2007-11#1)(2007-7#1)
within the lumen##3##3##(2006-10#2)(2007-12#1)
within the lymphatic##2##3##(2008-9#1)(2010-1#1)
within the lysosomes##2##3##(1992-10#1)(1996-3#1)
within the major##4##3##(1995-1#2)(2008-4#1)(2008-9#1)
within the material##2##3##(2008-7#1)(2010-10#1)
within the matrix##6##3##(1997-8#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-6#1)
within the maxillary sinus##2##4##(2012-1#1)(2013-1#1)
within the maxillary##3##3##(2007-12#1)(2012-1#1)(2013-1#1)
within the measurement##2##3##(2008-3#2)
within the median domain##2##4##(2007-12#2)
within the medical##3##3##(2007-11#1)(2008-12#2)
within the medium##3##3##(1994-3#1)(2007-12#1)(2011-1#1)
within the membrane##10##3##(1990-11#1)(1990-12#1)(1990-5#1)(1991-5#1)(1993-6#1)(1994-12#1)(1994-5#1)(1996-12#1)(1996-8#1)(1997-7#1)
within the mental health##2##4##(2008-11#1)(2008-2#1)
within the mental##3##3##(2008-11#1)(2008-2#1)(2010-9#1)
within the microenvironment##3##3##(1990-8#1)(2009-3#2)
within the middle ear cavity##2##5##(1991-3#1)(2013-7#1)
within the middle##4##3##(1991-3#1)(1991-9#1)(2007-1#1)(2013-7#1)
within the minimal##2##3##(1990-9#1)(2010-2#1)
within the minor groove##2##4##(1991-4#1)(1995-7#1)
within the mixing##2##3##(2008-2#1)(2011-12#1)
within the mosquito##2##3##(2008-11#1)(2011-3#1)
within the motif##2##3##(1994-3#1)(2010-12#1)
within the mouse myogenic gene##2##5##(1994-12#2)
within the mouse##5##3##(1992-7#1)(1994-12#2)(1997-9#1)(2008-9#1)
within the mucilage##2##3##(2011-1#2)
within the murine##2##3##(1994-12#1)(1995-1#1)
within the national##2##3##(2010-4#1)(2011-2#1)
within the necrotic##2##3##(2008-10#2)
within the next 10##2##4##(2008-1#1)(2010-8#1)
within the next 5 years##2##5##(1993-11#1)(2008-12#1)
within the next few years##3##5##(2006-10#1)(2008-12#1)(2011-2#1)
within the next year##2##4##(1994-1#1)(2008-11#1)
within the next##12##3##(1993-11#1)(1994-1#1)(2004-12#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2010-8#1)(2011-2#1)
within the normal range for##3##5##(2008-2#1)(2009-4#1)(2010-3#1)
within the normal range in##4##5##(1994-10#1)(1995-10#1)(2006-8#1)(2007-7#1)
within the normal range of##2##5##(2006-7#1)(2009-11#1)
within the normal range##34##4##(1990-12#1)(1993-9#1)(1994-10#1)(1995-10#1)(1995-2#1)(1995-7#2)(1996-12#1)(1997-5#2)(2005-12#1)(2006-10#1)(2006-2#1)(2006-7#3)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-11#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-11#1)(2011-12#2)(2011-2#1)
within the normal##41##3##(1990-12#1)(1993-9#2)(1994-10#1)(1994-6#1)(1995-10#1)(1995-2#1)(1995-7#2)(1996-12#1)(1997-5#2)(2005-12#1)(2006-10#1)(2006-2#1)(2006-5#2)(2006-7#3)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-11#1)(2009-4#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-11#1)(2011-12#2)(2011-2#1)(2012-3#1)
within the nucleus accumbens##2##4##(1993-6#1)(1996-10#1)
within the nucleus of##3##4##(1993-12#1)(1994-11#1)(1994-6#1)
within the nucleus##10##3##(1993-12#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-6#1)(1996-10#1)(2007-12#1)(2008-9#1)(2011-2#1)(2012-2#1)
within the nursing##3##3##(2008-11#2)(2008-12#1)
within the observed##2##3##(2007-11#1)(2008-10#1)
within the office##3##3##(2006-8#1)(2007-12#2)
within the one##2##3##(1995-12#1)(2008-11#1)
within the oocyte nucleus##2##4##(2007-12#2)
within the oocyte##5##3##(1994-9#1)(2007-12#2)(2007-8#1)(2008-10#1)
within the optical##3##3##(2008-3#2)(2010-2#1)
within the orchards##2##3##(2008-10#2)
within the order##2##3##(2010-10#1)(2013-8#1)
within the organism##4##3##(1995-2#1)(2006-10#1)(2006-12#1)(2010-11#1)
within the organization##9##3##(1993-2#2)(1995-1#1)(1995-3#2)(1997-1#1)(2004-12#1)(2006-10#1)(2006-7#1)
within the pH range##4##4##(1991-2#1)(1995-5#1)(2008-10#2)
within the pH##5##3##(1991-2#1)(1995-5#1)(2008-10#3)
within the pancreas##4##3##(1991-10#1)(1992-6#1)(2011-2#1)(2012-12#1)
within the parasite##2##3##(2006-10#1)(2012-2#1)
within the paraventricular nucleus of the hypothalamus##2##7##(1992-8#1)(1994-2#1)
within the particle##3##3##(2005-10#1)(2008-10#1)(2008-2#1)
within the past 100##2##4##(1994-3#1)(2013-8#1)
within the past year##4##4##(2006-10#2)(2007-9#1)(2009-5#1)
within the past##8##3##(1994-3#1)(2006-10#2)(2007-9#1)(2009-5#1)(2010-9#1)(2011-2#1)(2013-8#1)
within the patch##3##3##(2008-8#2)(2010-2#1)
within the pathogen##2##3##(2008-10#2)
within the pathways##3##3##(2012-2#1)(2013-1#2)
within the pentose phosphate pathway##2##5##(1991-5#1)(2008-7#1)
within the peritoneal cavity##3##4##(2006-6#1)(2008-1#1)(2008-6#1)
within the perspective of##2##4##(1991-6#1)(2004-11#1)
within the phantom##3##3##(2008-3#2)(2009-5#1)
within the pharmaceutical industry##3##4##(1996-12#1)(1997-5#1)(2008-11#1)
within the pharmaceutical##4##3##(1996-12#1)(1997-5#1)(2008-10#1)(2008-11#1)
within the phylum##3##3##(2011-2#3)
within the physiological range##4##4##(1990-3#1)(1995-5#1)(2008-10#2)
within the physiological##6##3##(1990-3#1)(1993-8#1)(1995-5#1)(1996-12#1)(2008-10#2)
within the plant##3##3##(2008-10#2)(2011-1#1)
within the plasma membrane##5##4##(1990-2#1)(1994-8#1)(2007-10#1)(2008-8#1)(2011-1#1)
within the polymer##4##3##(2005-11#1)(2007-12#1)(2008-2#1)(2009-2#1)
within the population and##2##4##(2008-10#1)(2011-2#1)
within the population##10##3##(1996-3#1)(2006-10#1)(2008-10#2)(2008-8#2)(2010-12#1)(2010-5#1)(2011-2#1)(2012-3#1)
within the populations##2##3##(2008-10#2)
within the pore##2##3##(2005-11#2)
within the pores of##2##4##(2008-10#2)
within the pores##3##3##(2008-10#2)(2010-12#1)
within the postero-medial NAS##2##4##(1993-6#2)
within the practice##2##3##(2008-4#1)(2008-9#1)
within the previous 12 months##2##5##(2009-5#1)(2010-10#1)
within the previous##7##3##(2006-12#1)(2008-12#1)(2008-4#1)(2009-5#1)(2010-10#1)(2012-12#1)(2012-3#1)
within the previously##2##3##(2008-10#1)(2012-3#1)
within the primary##5##3##(1991-11#1)(2007-12#1)(2008-1#1)(2011-2#1)(2012-12#1)
within the prior##2##3##(2007-10#1)(2010-12#1)
within the production##2##3##(2008-12#1)(2008-7#1)
within the profession##4##3##(1994-12#1)(1996-1#1)(2008-12#1)(2010-5#1)
within the professional##2##3##(2006-3#1)(2012-3#1)
within the program##3##3##(1994-5#1)(1995-1#1)(2007-1#1)
within the promoter of the##3##5##(1994-12#1)(1997-4#1)(2009-7#1)
within the promoter of##4##4##(1994-12#1)(1997-4#1)(2007-10#1)(2009-7#1)
within the promoter##6##3##(1994-12#1)(1994-6#1)(1996-10#1)(1997-4#1)(2007-10#1)(2009-7#1)
within the proposed##4##3##(1995-1#1)(2008-11#1)(2011-2#1)(2012-2#1)
within the protein##5##3##(1990-5#1)(1992-11#1)(1992-7#1)(1994-5#1)(1995-8#1)
within the public##3##3##(1997-3#1)(2007-7#1)(2008-12#1)
within the pulmonary arteries##2##4##(2008-7#1)(2010-6#1)
within the purview of##2##4##(2008-2#2)
within the putative##5##3##(1994-12#1)(1995-3#1)(1997-3#1)(1997-4#1)(2006-12#1)
within the pyramid and##2##4##(2008-6#2)
within the quadrat##3##3##(2008-10#3)
within the range 0##5##4##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
within the range 2##2##4##(2008-10#2)
within the range from##2##4##(2008-10#1)(2013-1#1)
within the range of 0##5##5##(1990-7#2)(2008-10#2)(2010-11#1)
within the range of 1##2##5##(1990-5#1)(2006-7#1)
within the range of 100 to##2##6##(2008-11#1)(2010-11#1)
within the range of the##2##5##(2008-4#1)(2009-2#1)
within the range of values##2##5##(2008-10#1)(2008-6#1)
within the range of##34##4##(1990-5#1)(1990-7#3)(1990-9#1)(1992-7#1)(1995-2#1)(1997-8#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-6#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-2#1)(2009-4#1)(2010-11#2)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
within the range##64##3##(1990-12#1)(1990-5#1)(1990-7#3)(1990-9#1)(1991-2#1)(1991-4#1)(1992-7#1)(1994-6#2)(1995-2#1)(1996-11#1)(1996-6#1)(1997-8#1)(2005-9#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#16)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#2)(2009-2#1)(2009-4#1)(2010-11#2)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-1#3)
within the ranges of##3##4##(2008-10#1)(2008-5#1)(2012-2#1)
within the ranges##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
within the rat##3##3##(1992-3#1)(1993-6#1)(2010-6#1)
within the reach of many##2##5##(1996-1#1)(2009-8#1)
within the reach of the##4##5##(2007-12#1)(2008-1#1)(2008-3#1)(2011-11#1)
within the reach of##8##4##(1996-1#1)(2007-12#1)(2008-1#1)(2008-3#1)(2009-8#1)(2010-11#1)(2010-2#1)(2011-11#1)
within the reaction##2##3##(1995-8#1)(2008-10#1)
within the realm of##3##4##(2007-8#1)(2010-7#1)(2010-8#1)
within the receiver##2##3##(2008-10#1)(2008-2#1)
within the recognition domain##2##4##(1997-2#2)
within the recommended##5##3##(1991-9#1)(2006-2#1)(2008-10#1)(2008-3#1)(2011-2#1)
within the reference range##3##4##(1991-2#1)(2006-6#2)
within the reference##4##3##(1991-2#1)(1994-6#1)(2006-6#2)
within the region of##2##4##(1995-3#1)(1996-12#1)
within the region##8##3##(1995-1#1)(1995-3#1)(1996-10#1)(1996-12#1)(2008-11#2)(2008-5#1)(2008-8#1)
within the regions##3##3##(1994-2#1)(2008-10#1)(2008-9#1)
within the regulatory##2##3##(1992-2#1)(1994-5#1)
within the renal##2##3##(1992-8#1)(2007-2#1)
within the research##3##3##(2007-12#1)(2008-7#1)(2009-4#1)
within the resonator##2##3##(2007-12#1)(2008-2#1)
within the respective##2##3##(1992-6#1)(2012-12#1)
within the respiratory tract##2##4##(1991-12#1)(1997-1#1)
within the ribosome##3##3##(1990-2#2)(1997-7#1)
within the right##3##3##(2006-4#1)(2007-8#1)(2008-11#1)
within the rubric of##2##4##(2010-1#1)(2012-12#1)
within the same organism##2##4##(2009-3#1)(2013-1#1)
within the same range##2##4##(1990-8#1)(2013-1#1)
within the same species##2##4##(2008-10#1)(2012-12#1)
within the same tissue##2##4##(1995-11#1)(2008-7#1)
within the same##51##3##(1990-3#1)(1990-8#2)(1991-12#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-7#1)(1997-1#1)(1997-8#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-12#2)(2009-3#1)(2009-7#1)(2010-11#1)(2010-2#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
within the sample##9##3##(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)(2010-2#1)
within the sat-RNA##2##3##(2008-10#2)
within the scientific community##2##4##(2007-7#1)(2007-8#1)
within the scientific##3##3##(2007-7#1)(2007-8#1)(2012-2#1)
within the scope of the##2##5##(2005-7#1)(2008-11#1)
within the scope of this##2##5##(2007-10#1)(2010-6#1)
within the scope of##6##4##(1992-10#1)(2005-7#1)(2007-10#1)(2008-11#1)(2008-7#1)(2010-6#1)
within the second##4##3##(1996-10#1)(1996-7#1)(1996-9#1)(2008-10#1)
within the seed##2##3##(2008-10#1)(2011-12#1)
within the sensor##2##3##(2008-3#1)(2010-2#1)
within the sequence##7##3##(1990-2#1)(1991-2#1)(1992-11#1)(1992-8#1)(1995-1#1)(1997-6#1)(2008-10#1)
within the sequences##2##3##(1997-2#2)
within the sinus##2##3##(2008-7#1)(2013-1#1)
within the skin##3##3##(2008-3#1)(2008-5#1)(2010-5#1)
within the small##2##3##(2006-10#1)(2008-10#1)
within the soft tissue##2##4##(2010-2#1)(2012-2#1)
within the soft##3##3##(2010-2#1)(2010-5#1)(2012-2#1)
within the space##3##3##(2004-3#1)(2008-3#1)(2013-8#1)
within the species##6##3##(2004-4#1)(2006-8#1)(2007-3#1)(2008-10#3)
within the spectral##3##3##(2007-12#1)(2008-2#2)
within the spectrum of##3##4##(1997-8#1)(2006-12#1)(2011-1#1)
within the sperm##2##3##(1990-11#1)(1993-6#1)
within the spinal canal##2##4##(2006-12#1)(2008-12#1)
within the spinal cord##5##4##(1991-5#1)(1993-7#2)(1995-1#1)(1995-11#1)
within the spinal##8##3##(1991-5#1)(1993-7#2)(1995-1#1)(1995-11#1)(2006-10#1)(2006-12#1)(2008-12#1)
within the state of##2##4##(1994-2#1)(2012-3#1)
within the stop band##2##4##(2007-12#2)
within the striatum##3##3##(1991-6#1)(1995-11#2)
within the studied##2##3##(2005-11#1)(2006-10#1)
within the study##3##3##(2004-11#1)(2007-12#1)(2008-5#1)
within the subfamily##2##3##(1997-4#1)(2013-7#1)
within the subgroup##2##3##(2008-10#2)
within the superficial##2##3##(2009-8#1)(2011-3#1)
within the surrounding##2##3##(2008-2#1)(2011-1#1)
within the sympathetic preganglionic neuropils of##2##6##(1992-1#2)
within the system##7##3##(1996-2#1)(2006-3#1)(2007-11#1)(2007-2#1)(2008-3#1)(2008-8#1)(2012-2#1)
within the target##2##3##(1993-4#2)
within the temporal##2##3##(1996-9#1)(2006-12#1)
within the tertiary structure of the Ca-ATPase of sarcoplasmic reticulum##2##10##(1991-2#2)
within the test##2##3##(2005-9#1)(2008-3#1)
within the testis##2##3##(2012-2#2)
within the theoretical##3##3##(2008-5#1)(2010-8#1)(2013-7#1)
within the therapeutic range##2##4##(1992-8#1)(1997-5#1)
within the therapeutic##4##3##(1991-9#1)(1992-8#1)(1997-5#1)(2008-11#1)
within the three##7##3##(1996-10#1)(1997-6#1)(2004-1#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-7#1)
within the thymic microenvironment##2##4##(1992-12#1)(1995-6#1)
within the thymus and##2##4##(1997-9#1)(2008-4#1)
within the thymus##5##3##(1991-11#1)(1996-4#1)(1997-9#1)(2008-4#1)(2013-7#1)
within the tissue##7##3##(1994-3#1)(2006-6#1)(2006-8#1)(2008-2#2)(2009-8#1)(2010-6#1)
within the top##3##3##(2005-11#1)(2008-10#1)(2010-12#1)
within the total##2##3##(1991-8#1)(2008-4#1)
within the transmembrane##3##3##(1994-9#1)(1996-5#1)(2008-4#1)
within the treated areas##2##4##(1993-9#1)(2006-12#1)
within the trigeminal subnucleus caudalis##2##5##(1991-8#2)
within the trigeminal##4##3##(1991-8#2)(1997-3#1)(2010-12#1)
within the tumor mass##2##4##(1993-11#1)(2007-10#1)
within the tumor microenvironment##5##4##(1997-7#1)(2009-3#1)(2010-12#1)(2013-1#2)
within the tumor##14##3##(1991-6#1)(1993-11#1)(1997-7#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-4#1)(2009-3#2)(2010-12#1)(2010-3#1)(2012-2#1)(2013-1#2)
within the tumour##2##3##(1990-8#1)(2006-6#1)
within the two##7##3##(1991-6#1)(1993-12#1)(1994-3#1)(2006-11#1)(2006-8#1)(2009-7#1)(2013-1#1)
within the tyrosine kinase domain##3##5##(1997-6#1)(2008-5#1)(2010-4#1)
within the uncertainty of##2##4##(1992-5#1)(2006-10#1)
within the unit##2##3##(1996-11#1)(2007-3#1)
within the uterine##3##3##(1993-12#3)
within the uterus##4##3##(1993-1#2)(2006-10#1)(2007-9#1)
within the various##3##3##(1995-5#1)(1997-1#1)(2009-5#1)
within the vascular##2##3##(1991-9#1)(2008-10#1)
within the vasculature##2##3##(1994-2#1)(2008-4#1)
within the vector##2##3##(2008-10#1)(2011-3#1)
within the ventral##2##3##(1992-7#1)(1997-3#1)
within the ventrolateral hypothalamus##2##4##(1995-5#2)
within the vertebral##2##3##(2008-12#1)(2011-2#1)
within the vesicle##2##3##(1991-10#1)(2007-10#1)
within the vesicles and##2##4##(1992-6#1)(2008-8#1)
within the vesicles##4##3##(1991-9#1)(1992-6#1)(1994-8#1)(2008-8#1)
within the vessel##2##3##(2006-10#1)(2011-1#1)
within the vicinity##2##3##(2006-12#1)(2008-10#1)
within the viral genome##2##4##(1994-12#1)(2013-8#1)
within the viral##3##3##(1994-12#1)(1995-2#1)(2013-8#1)
within the visible##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
within the visual##6##3##(1991-8#1)(1992-9#2)(2008-11#1)(2012-11#2)
within the whole##4##3##(1994-5#1)(2010-9#1)(2012-1#2)
within the wing##2##3##(2007-12#1)(2012-12#1)
within the work-family##2##3##(2009-10#2)
within the working range of the##2##6##(2008-10#2)
within the##2946##2##(1990-1#3)(1990-10#7)(1990-11#8)(1990-12#11)(1990-2#8)(1990-3#11)(1990-4#4)(1990-5#11)(1990-6#11)(1990-7#7)(1990-8#10)(1990-9#8)(1991-1#5)(1991-10#6)(1991-11#9)(1991-12#16)(1991-2#21)(1991-3#9)(1991-4#8)(1991-5#12)(1991-6#9)(1991-7#7)(1991-8#12)(1991-9#13)(1992-1#7)(1992-10#4)(1992-11#5)(1992-12#10)(1992-2#9)(1992-3#11)(1992-4#7)(1992-5#3)(1992-6#16)(1992-7#9)(1992-8#14)(1992-9#8)(1993-1#4)(1993-11#10)(1993-12#17)(1993-2#11)(1993-3#11)(1993-4#4)(1993-5#5)(1993-6#12)(1993-7#7)(1993-8#10)(1993-9#8)(1994-1#7)(1994-10#7)(1994-11#6)(1994-12#20)(1994-2#18)(1994-3#19)(1994-5#10)(1994-6#9)(1994-7#2)(1994-8#17)(1994-9#22)(1995-1#16)(1995-10#7)(1995-11#18)(1995-12#15)(1995-2#17)(1995-3#19)(1995-4#1)(1995-5#27)(1995-6#18)(1995-7#4)(1995-8#13)(1995-9#1)(1996-1#7)(1996-10#8)(1996-11#7)(1996-12#11)(1996-2#8)(1996-3#16)(1996-4#10)(1996-5#16)(1996-6#7)(1996-7#14)(1996-8#11)(1996-9#6)(1997-1#9)(1997-2#22)(1997-3#10)(1997-4#24)(1997-5#7)(1997-6#12)(1997-7#12)(1997-8#12)(1997-9#4)(2003-11#1)(2004-1#2)(2004-11#2)(2004-12#6)(2004-3#2)(2004-4#2)(2005-10#9)(2005-11#20)(2005-12#4)(2005-2#1)(2005-5#4)(2005-6#2)(2005-7#11)(2005-8#4)(2005-9#2)(2006-1#1)(2006-10#43)(2006-11#8)(2006-12#30)(2006-2#7)(2006-3#8)(2006-4#5)(2006-5#22)(2006-6#14)(2006-7#11)(2006-8#23)(2006-9#1)(2007-1#11)(2007-10#20)(2007-11#40)(2007-12#98)(2007-2#10)(2007-3#7)(2007-4#8)(2007-5#12)(2007-6#6)(2007-7#20)(2007-8#24)(2007-9#18)(2008-1#27)(2008-10#289)(2008-11#91)(2008-12#39)(2008-2#61)(2008-3#81)(2008-4#33)(2008-5#70)(2008-6#23)(2008-7#72)(2008-8#28)(2008-9#40)(2009-10#13)(2009-11#3)(2009-12#13)(2009-2#11)(2009-3#11)(2009-4#11)(2009-5#19)(2009-6#6)(2009-7#13)(2009-8#12)(2009-9#8)(2010-1#6)(2010-10#14)(2010-11#14)(2010-12#17)(2010-2#18)(2010-3#9)(2010-4#14)(2010-5#8)(2010-6#9)(2010-7#6)(2010-8#24)(2010-9#10)(2011-1#37)(2011-11#2)(2011-12#5)(2011-2#71)(2011-3#3)(2012-1#10)(2012-11#3)(2012-12#35)(2012-2#42)(2012-3#25)(2012-6#1)(2013-1#62)(2013-7#20)(2013-8#34)
within their classical receptive field##2##5##(1995-11#2)
within their own##6##3##(1991-3#1)(1994-3#1)(2005-8#1)(2007-4#1)(2008-1#1)(2008-11#1)
within their##41##2##(1990-12#1)(1991-12#1)(1991-3#1)(1992-6#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-11#2)(1997-5#1)(2005-8#2)(2006-2#1)(2006-8#1)(2007-12#1)(2007-4#2)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
within them##12##2##(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#2)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
within therapeutic##2##2##(2008-12#1)(2008-3#1)
within these cells##2##3##(1991-5#1)(2008-10#1)
within these networks##3##3##(2008-7#1)(2009-4#1)(2009-9#1)
within these regions##2##3##(1996-4#1)(1997-4#1)
within these sequences##2##3##(1996-4#1)(2010-12#1)
within these two##4##3##(1994-9#1)(2008-10#1)(2009-3#1)(2012-3#1)
within these##45##2##(1990-2#1)(1991-5#1)(1992-1#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-2#1)(1994-11#1)(1994-8#1)(1994-9#2)(1996-4#2)(1997-4#3)(2005-11#1)(2006-2#1)(2006-5#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#3)(2012-3#2)
within this age range##3##4##(2007-2#1)(2010-3#2)
within this cluster##2##3##(1994-3#1)(2013-1#1)
within this complex##2##3##(1991-5#1)(2011-2#1)
within this context##3##3##(1995-12#1)(2008-2#1)(2009-10#1)
within this domain##5##3##(1995-2#1)(1995-3#1)(1996-5#1)(1997-4#1)(2008-8#1)
within this family of##2##4##(1990-4#1)(2010-5#1)
within this family##3##3##(1990-4#1)(2010-5#1)(2011-2#1)
within this field##2##3##(1995-11#1)(2007-1#1)
within this framework##5##3##(1995-4#1)(2005-10#1)(2008-2#1)(2009-6#1)(2012-1#1)
within this genus##2##3##(2008-9#1)(2010-10#1)
within this group##9##3##(1993-5#1)(2004-2#2)(2005-10#1)(2007-12#1)(2008-10#1)(2008-12#1)(2013-7#2)
within this paper##3##3##(2006-3#1)(2007-11#1)(2008-11#1)
within this population##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2012-12#1)
within this range##3##3##(2008-10#2)(2012-1#1)
within this region of##2##4##(1995-10#1)(1997-4#1)
within this region##8##3##(1991-11#1)(1994-6#1)(1995-10#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-7#1)
within this sequence##2##3##(1993-3#1)(2011-2#1)
within this species##2##3##(2008-10#2)
within this##122##2##(1990-2#1)(1990-4#1)(1990-9#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-9#2)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-4#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#3)(1997-7#3)(1997-8#1)(2004-2#2)(2005-10#2)(2005-7#2)(2006-1#1)(2006-3#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#1)(2008-1#2)(2008-10#11)(2008-11#4)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-5#1)(2010-8#2)(2011-2#3)(2012-1#4)(2012-12#1)(2013-1#3)(2013-7#3)
within those##9##2##(1996-3#1)(2008-10#1)(2008-5#1)(2009-5#1)(2009-7#1)(2010-4#1)(2011-1#1)(2013-1#2)
within three hours##2##3##(2012-2#1)(2013-1#1)
within three months after##2##4##(2007-7#1)(2008-1#1)
within three months and##2##4##(2008-11#1)(2008-2#1)
within three months of##2##4##(1993-7#1)(2013-1#1)
within three months##11##3##(1991-9#1)(1993-7#1)(1996-8#1)(1997-8#1)(2005-1#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2013-1#2)
within three##26##2##(1991-9#1)(1992-5#1)(1993-6#1)(1993-7#1)(1995-11#1)(1996-8#1)(1997-8#1)(2005-1#1)(2006-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#2)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#6)
within tissue##4##2##(1997-6#1)(2008-10#1)(2008-3#2)
within tissuelike##2##2##(2007-12#1)(2008-3#1)
within today's##2##2##(1990-10#1)(1997-1#1)
within trials##2##2##(2008-10#1)(2008-12#1)
within twenty-four hours of##2##4##(1993-12#1)(2007-8#1)
within twenty-four hours##3##3##(1993-12#1)(2007-8#1)(2008-9#1)
within two days##3##3##(1991-9#1)(2005-3#1)(2008-11#1)
within two hours##3##3##(1990-9#1)(1992-3#1)(2010-6#1)
within two months after the##2##5##(1995-9#1)(2008-8#1)
within two months after##3##4##(1995-9#1)(2008-8#2)
within two months of##3##4##(1992-11#1)(2007-7#1)(2008-8#1)
within two months##6##3##(1992-11#1)(1995-9#1)(2007-7#1)(2008-8#3)
within two weeks##6##3##(1993-7#1)(1996-3#1)(2004-9#1)(2008-2#1)(2009-6#1)(2010-12#1)
within two years##3##3##(1990-12#1)(2007-11#1)(2011-2#1)
within two##38##2##(1990-12#2)(1990-9#1)(1991-11#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-3#1)(1993-7#1)(1995-9#1)(1996-3#2)(2004-9#1)(2005-3#1)(2005-8#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#3)(2008-9#2)(2009-4#1)(2009-6#1)(2010-12#1)(2010-6#1)(2011-2#1)(2013-1#2)
within various##2##2##(1991-1#1)(2007-6#1)
within vessels of##2##3##(2008-10#2)
within wards that used measurement tools##2##6##(2013-1#2)
within weeks or##2##3##(2008-5#1)(2008-7#1)
within weeks##6##2##(1991-8#2)(2008-5#2)(2008-7#1)(2008-9#1)
within which a##3##3##(1992-12#1)(1997-1#1)(2007-12#1)
within which the##8##3##(1995-8#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-2#1)(2008-5#1)(2011-1#1)
within which##33##2##(1991-2#1)(1992-12#1)(1993-2#1)(1994-2#2)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-1#1)(1997-8#1)(2007-12#2)(2007-5#1)(2008-1#3)(2008-10#2)(2008-2#1)(2008-5#2)(2008-7#1)(2009-9#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
within years##3##2##(2008-10#3)
within your##3##2##(1991-2#1)(1993-12#1)(1993-2#1)
within##7286##1##(1990-1#3)(1990-10#17)(1990-11#20)(1990-12#38)(1990-2#22)(1990-3#21)(1990-4#14)(1990-5#20)(1990-6#21)(1990-7#24)(1990-8#25)(1990-9#17)(1991-1#11)(1991-10#13)(1991-11#22)(1991-12#35)(1991-2#38)(1991-3#20)(1991-4#19)(1991-5#26)(1991-6#16)(1991-7#17)(1991-8#25)(1991-9#25)(1992-1#19)(1992-10#9)(1992-11#13)(1992-12#29)(1992-2#28)(1992-3#23)(1992-4#14)(1992-5#14)(1992-6#33)(1992-7#20)(1992-8#32)(1992-9#17)(1993-1#13)(1993-10#1)(1993-11#25)(1993-12#41)(1993-2#30)(1993-3#23)(1993-4#12)(1993-5#11)(1993-6#30)(1993-7#16)(1993-8#16)(1993-9#21)(1994-1#8)(1994-10#8)(1994-11#16)(1994-12#45)(1994-2#34)(1994-3#50)(1994-4#4)(1994-5#20)(1994-6#19)(1994-7#2)(1994-8#26)(1994-9#42)(1995-1#34)(1995-10#16)(1995-11#36)(1995-12#30)(1995-2#42)(1995-3#53)(1995-4#3)(1995-5#51)(1995-6#28)(1995-7#10)(1995-8#35)(1995-9#9)(1996-1#13)(1996-10#10)(1996-11#17)(1996-12#36)(1996-2#26)(1996-3#30)(1996-4#23)(1996-5#34)(1996-6#26)(1996-7#26)(1996-8#23)(1996-9#20)(1997-1#24)(1997-2#44)(1997-3#29)(1997-4#65)(1997-5#20)(1997-6#22)(1997-7#26)(1997-8#28)(1997-9#5)(2003-11#3)(2004-1#3)(2004-10#1)(2004-11#5)(2004-12#9)(2004-2#2)(2004-3#3)(2004-4#3)(2004-7#1)(2004-9#5)(2005-1#2)(2005-10#28)(2005-11#44)(2005-12#14)(2005-2#2)(2005-3#1)(2005-4#1)(2005-5#7)(2005-6#2)(2005-7#14)(2005-8#16)(2005-9#2)(2006-1#8)(2006-10#74)(2006-11#17)(2006-12#55)(2006-2#21)(2006-3#17)(2006-4#11)(2006-5#39)(2006-6#33)(2006-7#20)(2006-8#41)(2006-9#17)(2007-1#19)(2007-10#72)(2007-11#85)(2007-12#199)(2007-2#34)(2007-3#13)(2007-4#19)(2007-5#24)(2007-6#15)(2007-7#55)(2007-8#70)(2007-9#44)(2008-1#81)(2008-10#908)(2008-11#218)(2008-12#92)(2008-2#161)(2008-3#235)(2008-4#86)(2008-5#146)(2008-6#56)(2008-7#138)(2008-8#113)(2008-9#99)(2009-1#1)(2009-10#29)(2009-11#11)(2009-12#28)(2009-2#23)(2009-3#24)(2009-4#31)(2009-5#34)(2009-6#17)(2009-7#33)(2009-8#31)(2009-9#21)(2010-1#9)(2010-10#37)(2010-11#36)(2010-12#54)(2010-2#36)(2010-3#30)(2010-4#31)(2010-5#19)(2010-6#17)(2010-7#20)(2010-8#60)(2010-9#17)(2011-1#78)(2011-11#3)(2011-12#16)(2011-2#167)(2011-3#5)(2012-1#48)(2012-11#15)(2012-12#94)(2012-2#120)(2012-3#101)(2012-5#2)(2012-6#2)(2012-7#1)(2012-9#1)(2013-1#192)(2013-7#38)(2013-8#84)
within- and between-subject##2##3##(1993-5#1)(1996-12#1)
within- and##13##2##(1993-1#1)(1993-5#1)(1995-3#1)(1996-12#1)(2007-1#1)(2007-12#2)(2008-10#2)(2008-8#2)(2010-5#1)(2012-3#1)
within-brood##2##1##(2008-9#2)
within-campaign##2##1##(2010-5#2)
within-cohort##2##1##(2008-8#1)(2009-12#1)
within-day##10##1##(1991-2#1)(1996-6#1)(2008-10#6)(2012-1#1)(2013-7#1)
within-family##5##1##(2008-10#1)(2008-12#1)(2009-5#1)(2009-9#1)(2010-2#1)
within-field spread of##2##3##(2008-10#2)
within-field##9##1##(2008-10#9)
within-group analyses##2##2##(2008-10#1)(2008-5#1)
within-group##11##1##(2008-10#3)(2008-5#1)(2008-6#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
within-host competition##5##2##(2007-6#4)(2008-9#1)
within-host##6##1##(2007-6#4)(2008-9#1)(2013-1#1)
within-individual##3##1##(1994-8#1)(2009-7#1)(2009-8#1)
within-patient##3##1##(1994-4#1)(1997-3#1)(2009-8#1)
within-person variability##5##2##(1992-6#3)(2006-7#1)(2010-2#1)
within-person##10##1##(1992-6#3)(2006-7#3)(2010-2#2)(2010-4#1)(2013-8#1)
within-population variation in egg size##2##5##(2008-8#2)
within-population variation in##3##3##(2008-8#3)
within-population##8##1##(2005-10#3)(2008-8#4)(2013-1#1)
within-row##4##1##(2008-10#4)
within-run and between-run##8##3##(1990-2#1)(1991-10#1)(1997-2#1)(2007-8#1)(2008-10#2)(2010-4#2)
within-run##14##1##(1990-2#1)(1991-10#1)(1993-1#1)(1997-2#1)(2007-8#1)(2008-10#7)(2010-4#2)
within-season##2##1##(2007-6#1)(2008-10#1)
within-session##2##1##(2008-7#1)(2011-2#1)
within-state##2##1##(1997-1#2)
within-subject design##2##2##(1992-11#1)(2010-8#1)
within-subject variability##2##2##(1995-7#1)(2011-12#1)
within-subject variation##2##2##(1994-9#1)(2012-3#1)
within-subject##10##1##(1992-11#1)(1993-6#1)(1994-9#1)(1995-7#2)(2006-7#1)(2008-11#1)(2010-8#1)(2011-12#1)(2012-3#1)
within-subjects##3##1##(1992-6#2)(2012-12#1)
without (17##2##2##(1993-5#1)(1995-6#1)
without 2pi ambiguity##2##3##(2007-12#2)
without 2pi##3##2##(2007-11#1)(2007-12#2)
without A##5##2##(1997-5#3)(2008-5#1)(2012-2#1)
without ADHD##7##2##(2010-8#2)(2013-8#5)
without AF##2##2##(2007-10#2)
without AIDS##4##2##(1991-2#1)(2011-2#3)
without AN##3##2##(1993-5#2)(2005-11#1)
without ATP##2##2##(1994-8#1)(2011-2#1)
without BSA##4##2##(1991-5#3)(2013-1#1)
without CAD##2##2##(2008-4#2)
without CP##2##2##(2012-2#2)
without CVD##3##2##(1995-12#1)(2008-7#2)
without DP##3##2##(2013-1#3)
without E##2##2##(2008-5#2)
without EGF##3##2##(1992-9#1)(2006-5#1)(2008-6#1)
without EPS##4##2##(1994-7#2)(2011-2#2)
without GA##2##2##(2008-10#1)(2010-8#1)
without GH##2##2##(2006-1#1)(2007-11#1)
without HF##2##2##(2008-10#2)
without HIV##3##2##(1997-5#1)(2005-9#1)(2007-10#1)
without IL-1 beta##2##3##(1992-4#1)(1993-9#1)
without IL-3 stimulation##2##3##(1991-12#2)
without MPS (P&lt##2##3##(2007-8#2)
without MPS##5##2##(2007-8#5)
without MS##5##2##(2008-3#2)(2011-1#1)(2012-3#2)
without NPH##2##2##(2006-8#2)
without NaCl##2##2##(1995-11#1)(2007-12#1)
without OSMF and##2##3##(2013-8#2)
without OSMF##3##2##(2013-8#3)
without PCa##3##2##(2013-1#3)
without PD##2##2##(2009-10#1)(2013-1#1)
without PTE##2##2##(2007-7#2)
without PhosChol##2##2##(1990-11#2)
without RT##3##2##(1996-3#1)(2008-6#1)(2011-2#1)
without S9##3##2##(1992-5#1)(2008-8#1)(2008-9#1)
without SI##2##2##(2012-2#2)
without SOD##3##2##(2006-5#3)
without ST elevation##4##3##(2006-6#3)(2012-2#1)
without ST##5##2##(2006-6#3)(2007-5#1)(2012-2#1)
without UV##2##2##(2004-4#1)(2008-2#1)
without a blocking step##2##4##(2012-2#2)
without a change in Bmax##2##5##(1990-7#1)(1991-6#1)
without a change in##5##4##(1990-7#1)(1991-5#1)(1991-6#1)(1992-8#1)(2007-9#1)
without a change##6##3##(1990-7#1)(1991-5#1)(1991-6#1)(1992-8#1)(1997-3#1)(2007-9#1)
without a clear##2##3##(2008-7#1)(2012-1#1)
without a concomitant##2##3##(1995-2#2)
without a corresponding##2##3##(1991-5#1)(2008-12#1)
without a decrease in##4##4##(2004-9#1)(2008-10#1)(2010-4#1)(2012-12#1)
without a doubt##4##3##(2008-10#2)(2008-11#1)(2009-8#1)
without a family history of##5##5##(1991-1#1)(1994-2#1)(1996-8#1)(2008-3#2)
without a family##6##3##(1991-1#1)(1994-2#1)(1996-8#1)(2007-2#1)(2008-3#2)
without a high##4##3##(2006-6#1)(2008-1#1)(2010-8#1)(2011-2#1)
without a history of dysfunction##2##5##(2010-9#2)
without a history of##19##4##(1991-2#1)(1991-3#1)(1991-9#1)(1994-2#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-5#1)(2009-10#1)(2010-9#2)(2011-2#2)(2012-3#2)(2013-8#1)
without a known##2##3##(1992-12#1)(2011-2#1)
without a loss##2##3##(2008-10#1)(2008-3#1)
without a medical background##2##4##(1992-11#1)(1994-12#1)
without a need of sample filtration##2##6##(2007-8#2)
without a need##3##3##(2007-8#2)(2008-7#1)
without a phase mask##2##4##(2008-2#2)
without a previous##2##3##(2008-7#1)(2012-12#1)
without a priori knowledge##2##4##(2007-11#1)(2007-6#1)
without a priori##5##3##(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#1)(2009-6#1)
without a proper##2##3##(2008-7#1)(2008-8#1)
without a reduction in##2##4##(1996-11#1)(2006-12#1)
without a separate##2##3##(2006-10#1)(2007-12#1)
without a significant change in the##2##6##(1990-2#1)(2006-10#1)
without a significant change in##5##5##(1990-2#1)(2006-10#1)(2007-9#1)(2008-3#1)(2009-6#1)
without a significant##14##3##(1990-2#2)(1992-12#1)(1992-2#1)(2006-10#1)(2006-8#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-7#2)(2009-3#1)(2009-6#1)(2010-10#1)
without a specific plan##2##4##(2013-7#2)
without a uterus##2##3##(1993-11#1)(1995-11#1)
without a##241##2##(1990-10#1)(1990-11#1)(1990-2#3)(1990-3#2)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-8#2)(1993-11#2)(1993-9#2)(1994-12#1)(1994-2#3)(1994-7#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-4#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-4#2)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-8#2)(2004-1#1)(2004-9#2)(2006-10#5)(2006-11#2)(2006-12#2)(2006-6#3)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#13)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#2)(2007-8#4)(2007-9#5)(2008-1#4)(2008-10#16)(2008-11#7)(2008-12#2)(2008-2#4)(2008-3#13)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#3)(2009-6#2)(2009-8#2)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#8)(2012-1#3)(2012-12#7)(2012-2#6)(2012-3#3)(2013-1#6)(2013-7#2)(2013-8#3)
without access to a##2##4##(2008-4#1)(2009-5#1)
without access to##6##3##(1990-6#1)(2007-7#1)(2008-4#1)(2009-5#1)(2013-1#1)(2013-8#1)
without acetonitrile##2##2##(2008-10#2)
without achieving##2##2##(1991-4#1)(2011-1#1)
without acid treatment##2##3##(2004-9#1)(2008-10#1)
without acid##3##2##(2004-9#1)(2008-10#1)(2008-5#1)
without acids##2##2##(1995-3#2)
without activating##3##2##(1995-11#1)(2009-7#1)(2012-12#1)
without activation of##3##3##(1991-1#1)(1994-2#1)(1995-11#1)
without active##3##2##(1993-2#1)(2007-12#1)(2007-8#1)
without acute coronary syndrome##2##4##(2008-3#1)(2010-12#1)
without added##10##2##(1991-4#1)(1992-8#1)(1995-12#1)(1995-7#1)(1997-1#1)(1997-4#1)(2005-11#1)(2006-5#1)(2008-10#2)
without adding any##2##3##(2008-10#1)(2009-3#1)
without adding##4##2##(2008-10#1)(2008-5#1)(2009-3#1)(2013-1#1)
without addition of##8##3##(1992-2#1)(1993-9#1)(2008-10#5)(2008-11#1)
without additional therapy##2##3##(1990-11#1)(2008-6#1)
without additional##23##2##(1990-11#1)(1991-4#1)(1992-10#1)(1994-12#1)(1996-2#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2012-12#2)(2012-2#3)(2012-3#2)
without additives##3##2##(2008-10#1)(2012-2#1)(2012-3#1)
without addressing##2##2##(2010-5#1)(2012-2#1)
without adequate##3##2##(1997-7#1)(2008-4#1)(2012-12#1)
without adhesiolysis##2##2##(2006-8#2)
without adjunctive##3##2##(2006-12#1)(2007-11#1)(2007-9#1)
without adjusting##2##2##(1992-10#1)(2012-3#1)
without adjustment for##2##3##(1996-7#1)(1997-3#1)
without adjuvant##3##2##(2006-5#1)(2010-7#1)(2012-1#1)
without advanced##2##2##(2007-11#1)(2007-3#1)
without adverse effects##5##3##(1997-1#1)(2006-10#1)(2006-12#1)(2007-11#2)
without adverse events##2##3##(2006-8#1)(2010-12#1)
without adverse##10##2##(1997-1#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#2)(2007-8#1)(2010-12#1)(2010-4#1)(2013-7#1)
without adversely affecting##3##3##(1994-9#1)(1995-11#1)(1997-2#1)
without adversely##4##2##(1994-9#1)(1995-11#1)(1996-1#1)(1997-2#1)
without affecting basal##2##3##(1993-12#1)(2012-3#1)
without affecting either##2##3##(1994-3#1)(2008-5#1)
without affecting its##5##3##(1995-11#1)(1996-6#1)(2006-2#1)(2012-3#1)(2013-1#1)
without affecting neuronal##2##3##(2012-1#1)(2013-8#1)
without affecting other##3##3##(1992-8#1)(1996-9#1)(2012-2#1)
without affecting quality##2##3##(1992-1#1)(2011-2#1)
without affecting that of##4##4##(1993-3#1)(1994-12#1)(1994-2#1)(1994-9#1)
without affecting that##7##3##(1991-12#1)(1992-8#1)(1993-3#2)(1994-12#1)(1994-2#1)(1994-9#1)
without affecting the binding of##2##5##(1993-3#1)(1994-6#1)
without affecting the binding##3##4##(1993-3#1)(1994-6#1)(1996-5#1)
without affecting the##37##3##(1990-2#1)(1990-7#1)(1991-11#1)(1991-3#1)(1991-5#2)(1992-6#2)(1993-11#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-5#3)(1996-9#1)(1997-7#1)(2005-8#1)(2006-5#1)(2008-7#1)(2009-4#1)(2009-5#1)(2012-1#2)(2012-11#2)(2013-1#1)
without affecting voiding##2##3##(2010-8#2)
without affecting##106##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#2)(1992-1#1)(1992-11#2)(1992-6#2)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#2)(1993-3#4)(1993-6#3)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-5#4)(1996-6#1)(1996-9#3)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(2005-8#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-4#2)(2009-5#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#3)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
without agoraphobia##2##2##(1990-10#1)(2012-2#1)
without allergic##2##2##(2011-1#1)(2013-1#1)
without also##2##2##(1994-8#1)(1995-12#1)
without alterations##2##2##(1992-8#1)(1995-11#1)
without altering the##19##3##(1990-12#1)(1990-7#2)(1991-10#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-1#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-3#1)(2013-7#1)
without altering##28##2##(1990-12#1)(1990-7#2)(1991-10#1)(1991-9#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-7#1)(1997-2#1)(1997-3#1)(2005-3#1)(2006-12#2)(2007-11#1)(2007-12#1)(2008-11#2)(2008-3#1)(2011-2#1)(2013-7#1)
without ambiguity##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
without an additional##3##3##(2007-11#1)(2007-12#1)(2011-1#1)
without an adequate##2##3##(2005-11#1)(2006-3#1)
without an apparent##2##3##(2007-12#1)(2008-8#1)
without an appropriate##2##3##(2004-12#1)(2011-1#1)
without an associated##3##3##(2006-12#1)(2007-5#1)(2008-7#1)
without an effect on##3##4##(1991-3#1)(1992-1#1)(1997-5#1)
without an effect##4##3##(1991-3#1)(1992-1#1)(1996-2#1)(1997-5#1)
without an entrance##2##3##(2008-2#1)(2008-3#1)
without an increase in##5##4##(1994-12#1)(2006-5#1)(2007-8#1)(2008-6#1)(2012-2#1)
without an understanding of##2##4##(1991-2#1)(2005-10#1)
without an##68##2##(1990-3#1)(1991-2#1)(1991-3#2)(1991-6#1)(1992-1#1)(1992-7#1)(1992-8#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-4#1)(1996-2#1)(1997-3#1)(1997-5#1)(2004-12#1)(2005-10#1)(2005-11#2)(2006-12#3)(2006-3#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
without and with##13##3##(1990-11#1)(1990-6#1)(1997-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-3#1)(2010-8#1)(2011-12#2)(2011-2#2)
without and##15##2##(1990-11#1)(1990-6#1)(1997-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-3#1)(2010-8#1)(2011-12#2)(2011-2#2)
without antibiotics##5##2##(1994-3#1)(1997-4#1)(2006-5#1)(2012-2#1)(2013-8#1)
without antibody##3##2##(1996-11#1)(1996-9#1)(2007-11#1)
without anticoagulation##3##2##(1992-1#1)(2006-10#1)(2007-9#1)
without any a priori##2##4##(1997-6#1)(2008-3#1)
without any additional##7##3##(2005-10#1)(2007-6#1)(2007-8#2)(2008-3#1)(2008-5#1)(2011-1#1)
without any additives##2##3##(2008-10#1)(2009-11#1)
without any adverse effect on##2##5##(2007-8#1)(2008-3#1)
without any adverse effect##3##4##(2007-8#1)(2008-10#1)(2008-3#1)
without any adverse##5##3##(1997-2#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-3#1)
without any alteration##3##3##(1993-4#1)(1994-6#1)(2010-12#1)
without any apparent effect on##2##5##(1995-2#1)(1996-7#1)
without any apparent history of##2##5##(2007-10#2)
without any apparent##10##3##(1994-5#1)(1995-2#1)(1996-7#1)(2007-10#2)(2008-11#1)(2008-5#1)(2011-12#1)(2013-1#2)
without any appreciable##2##3##(2008-10#2)
without any association##2##3##(2007-7#1)(2007-8#1)
without any branch relation##2##4##(2005-5#2)
without any change in blood##2##5##(2007-11#1)(2009-6#1)
without any change in the##2##5##(1991-8#1)(1997-5#1)
without any change in##6##4##(1990-5#1)(1991-8#1)(1997-5#1)(2007-11#1)(2008-12#1)(2009-6#1)
without any change##7##3##(1990-5#1)(1991-8#1)(1993-12#1)(1997-5#1)(2007-11#1)(2008-12#1)(2009-6#1)
without any chemical##3##3##(2008-10#2)(2008-3#1)
without any clinical evidence of##2##5##(1991-2#1)(2006-4#1)
without any clinical##5##3##(1991-2#1)(1993-2#1)(2006-4#1)(2007-8#1)(2009-4#1)
without any comorbidities##2##3##(2009-3#1)(2011-2#1)
without any complication##4##3##(2008-7#2)(2012-2#1)(2013-8#1)
without any complications##5##3##(1991-12#1)(1994-9#1)(2007-7#1)(2012-2#1)(2012-3#1)
without any considerable divergence in potentials##2##6##(2008-10#2)
without any considerable divergence in##4##5##(2008-10#4)
without any considerable##6##3##(2008-10#6)
without any decrease in the##3##5##(1992-12#1)(2007-12#1)(2008-3#1)
without any decrease in##5##4##(1992-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
without any decrease##6##3##(1992-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
without any destructive##2##3##(1994-6#1)(2009-4#1)
without any disruption##2##3##(1993-3#1)(2008-11#1)
without any divergence in potential##2##5##(2008-10#2)
without any divergence in##3##4##(2008-10#3)
without any doubt##2##3##(1997-4#1)(2008-9#1)
without any effect on the##4##5##(1991-11#1)(1994-12#1)(1997-6#1)(2008-11#1)
without any effect on##9##4##(1990-3#1)(1990-7#1)(1991-11#1)(1994-12#1)(1995-2#1)(1995-3#1)(1997-6#1)(2008-11#1)(2012-2#1)
without any effect##10##3##(1990-3#1)(1990-7#1)(1991-11#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-3#1)(1997-6#1)(2008-11#1)(2012-2#1)
without any evidence of##11##4##(1990-7#1)(1992-1#1)(1992-10#1)(1997-6#1)(2005-12#1)(2006-10#1)(2007-3#1)(2008-5#1)(2008-9#1)(2010-12#1)(2013-8#1)
without any external##2##3##(1996-6#1)(2007-12#1)
without any further complications##3##4##(2012-1#1)(2012-12#2)
without any further sample##2##4##(2007-8#1)(2008-10#1)
without any further##10##3##(2006-7#1)(2007-12#1)(2007-8#2)(2008-10#3)(2012-1#1)(2012-12#2)
without any history of##2##4##(2007-11#1)(2010-6#1)
without any increase in##3##4##(2008-6#2)(2009-10#1)
without any influence##2##3##(1993-1#1)(2007-12#1)
without any interference from##2##4##(2008-10#2)
without any interference##4##3##(2008-10#3)(2010-12#1)
without any interferences##2##3##(1997-3#1)(2008-10#1)
without any known##4##3##(2007-7#1)(2008-10#1)(2011-1#1)(2012-2#1)
without any limitation##2##3##(1992-10#1)(2008-10#1)
without any loss of##3##4##(1997-4#1)(2007-12#1)(2011-1#1)
without any loss##4##3##(1997-4#1)(2007-12#1)(2007-8#1)(2011-1#1)
without any major##3##3##(1992-2#1)(2007-8#1)(2008-10#1)
without any marked##2##3##(1993-9#1)(2008-10#1)
without any mechanical##2##3##(1994-11#1)(2008-3#1)
without any modifications##2##3##(2007-11#1)(2008-2#1)
without any need##2##3##(2008-10#1)(2011-2#1)
without any negative##2##3##(2008-6#1)(2010-2#1)
without any observable##2##3##(1997-4#1)(2008-10#1)
without any obvious##3##3##(2007-7#1)(2008-10#1)(2013-8#1)
without any of the##2##4##(2006-8#1)(2008-3#1)
without any optical##2##3##(2007-11#1)(2007-12#1)
without any other##10##3##(2005-4#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)
without any pre-treatment##5##3##(1991-5#1)(2008-10#4)
without any preliminary treatment##2##4##(2008-10#2)
without any pretreatment##7##3##(2008-10#7)
without any previous##5##3##(2008-10#4)(2010-6#1)
without any prior separation##2##4##(2008-10#2)
without any prior##5##3##(1992-7#1)(2008-10#4)
without any purification##2##3##(2008-10#2)
without any reduction##2##3##(1994-2#1)(2008-10#1)
without any relapse##2##3##(2007-8#1)(2010-12#1)
without any response##2##3##(2007-7#1)(2008-10#1)
without any restrictions##2##3##(2007-5#1)(2008-9#1)
without any risk##4##3##(2006-10#1)(2007-8#1)(2008-5#2)
without any sample pretreatment##2##4##(1992-2#1)(1993-2#1)
without any sample##4##3##(1992-2#1)(1993-2#1)(2008-10#2)
without any serious interference##2##4##(2007-12#1)(2008-10#1)
without any serious##4##3##(1993-11#1)(2007-12#1)(2008-10#1)(2010-4#1)
without any severe##2##3##(2007-8#1)(2009-3#1)
without any side effects and##2##5##(2010-12#1)(2012-12#1)
without any side effects##5##4##(2005-7#1)(2008-10#1)(2010-12#1)(2012-12#1)(2013-8#1)
without any sign of##5##4##(1991-5#1)(2006-2#1)(2007-8#2)(2012-2#1)
without any significant change in##3##5##(1995-6#1)(1996-9#1)(2009-5#1)
without any significant change##4##4##(1995-6#1)(1996-9#1)(2008-10#1)(2009-5#1)
without any significant effect on the##2##6##(2011-2#1)(2013-1#1)
without any significant effect##3##4##(2008-5#1)(2011-2#1)(2013-1#1)
without any significant loss of##2##5##(1995-8#1)(2007-11#1)
without any significant##25##3##(1990-5#1)(1993-11#1)(1995-6#1)(1995-8#1)(1996-9#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2009-5#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#1)(2013-1#2)
without any signs of##4##4##(2006-8#1)(2007-8#1)(2008-11#1)(2009-2#1)
without any signs##6##3##(1990-8#1)(1996-9#1)(2006-8#1)(2007-8#1)(2008-11#1)(2009-2#1)
without any specific##2##3##(1993-3#1)(2009-8#1)
without any symptom of##2##4##(1994-7#1)(2006-4#1)
without any symptom##3##3##(1990-3#1)(1994-7#1)(2006-4#1)
without any symptoms of##3##4##(1991-5#1)(2008-12#1)(2008-7#1)
without any symptoms##5##3##(1991-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)
without any therapy##2##3##(1991-3#1)(1994-6#1)
without any treatment##5##3##(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2013-1#1)
without any##466##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#3)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#4)(1991-8#2)(1992-1#1)(1992-10#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#3)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#3)(1994-7#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-2#4)(1995-3#2)(1995-6#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-6#1)(1996-7#1)(1996-9#3)(1997-2#1)(1997-3#3)(1997-4#4)(1997-5#1)(1997-6#4)(1997-7#4)(2004-2#1)(2005-10#2)(2005-11#2)(2005-12#2)(2005-4#1)(2005-5#2)(2005-7#1)(2005-8#2)(2006-10#5)(2006-12#2)(2006-2#2)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#3)(2007-10#4)(2007-11#13)(2007-12#11)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#10)(2007-8#20)(2007-9#1)(2008-1#2)(2008-10#85)(2008-11#7)(2008-12#3)(2008-2#11)(2008-3#17)(2008-5#11)(2008-6#7)(2008-7#6)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#5)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#3)(2010-12#7)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#2)(2010-6#4)(2011-1#7)(2011-12#4)(2011-2#22)(2012-1#5)(2012-12#10)(2012-2#11)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#9)
without apparent association with##2##4##(1995-11#1)(1995-6#1)
without apparent##10##2##(1994-6#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-10#1)(1997-1#1)(1997-8#1)(2007-7#1)(2011-1#1)(2012-2#1)
without application of##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
without appreciable##3##2##(1990-12#1)(1991-5#1)(2012-2#1)
without appropriate##2##2##(2007-4#1)(2008-8#1)
without arterial##2##2##(2006-6#1)(2013-8#1)
without articular manifestations##3##3##(2006-10#3)
without artificial##4##2##(2007-10#1)(2007-12#1)(2008-10#1)(2012-1#1)
without associated changes in##2##4##(1997-1#1)(2005-10#1)
without associated##17##2##(1992-3#1)(1993-9#1)(1995-1#1)(1997-1#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2008-1#1)(2008-4#1)(2008-9#2)(2009-5#1)(2013-1#2)
without assuming##4##2##(2008-2#1)(2008-3#2)(2008-8#1)
without asthma##7##2##(2010-3#4)(2011-1#2)(2013-8#1)
without atherosclerotic##3##2##(2006-6#2)(2008-4#1)
without aura##8##2##(2004-12#2)(2007-11#1)(2007-2#1)(2008-9#4)
without base##5##2##(2008-4#4)(2008-8#1)
without being processed##2##3##(1990-8#1)(1991-9#1)
without being##19##2##(1990-8#1)(1991-1#1)(1991-9#1)(1992-12#1)(1996-12#1)(2005-11#1)(2005-9#1)(2006-7#1)(2007-1#1)(2007-3#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-6#1)(2010-7#1)(2011-2#1)(2012-12#1)
without benefit##4##2##(1997-7#1)(2004-9#1)(2008-10#1)(2008-2#1)
without bevacizumab##4##2##(2008-5#1)(2008-7#3)
without binding##2##2##(1995-6#1)(1997-5#1)
without blood transfusion]##2##3##(1990-2#2)
without blood##3##2##(1990-2#2)(1994-10#1)
without bone##7##2##(1993-11#1)(1994-12#2)(2007-12#1)(2007-7#1)(2011-2#2)
without bony##2##2##(1991-5#1)(2013-7#1)
without bound##2##2##(1992-12#1)(2007-4#1)
without brain##7##2##(1991-2#1)(1995-3#1)(2006-10#2)(2006-12#1)(2012-3#2)
without breaking##2##2##(2006-5#1)(2008-3#1)
without breast cancer##2##3##(2013-1#2)
without breast reconstruction##2##3##(1994-12#1)(2004-1#1)
without breast##4##2##(1994-12#1)(2004-1#1)(2013-1#2)
without broccoli##2##2##(2008-10#2)
without buildup cap was##2##4##(2007-11#2)
without cancer##6##2##(1991-7#3)(1994-12#1)(2004-2#2)
without cardiac##6##2##(1990-8#1)(2006-10#1)(2008-3#1)(2008-8#1)(2012-2#1)(2013-1#1)
without cardiopulmonary bypass##9##3##(2006-10#1)(2006-12#1)(2007-8#5)(2011-3#1)(2013-8#1)
without cardiopulmonary##11##2##(2006-10#2)(2006-12#1)(2007-5#1)(2007-8#5)(2011-3#1)(2013-8#1)
without cardiovascular disease##2##3##(2008-7#1)(2010-4#1)
without cardiovascular##3##2##(2008-7#1)(2010-4#1)(2013-3#1)
without carnitine##2##2##(1994-5#1)(2011-2#1)
without causing a release of##2##5##(1992-11#2)
without causing any##6##3##(1992-7#1)(1996-10#1)(1996-2#1)(2007-8#1)(2008-10#2)
without causing cytotoxicity##2##3##(1991-8#2)
without causing disease##2##3##(2008-10#1)(2010-6#1)
without causing significant##3##3##(2007-11#1)(2008-10#1)(2013-1#1)
without causing##29##2##(1991-8#2)(1992-11#2)(1992-7#1)(1994-2#2)(1996-10#1)(1996-2#2)(2006-2#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#2)(2010-6#1)(2011-2#1)(2013-1#2)(2013-7#1)
without cavity##4##2##(2007-11#1)(2007-12#1)(2013-1#2)
without cell##3##2##(2007-2#1)(2009-8#1)(2012-1#1)
without cellular##2##2##(2008-5#1)(2011-2#1)
without cervical##2##2##(1991-2#1)(1993-12#1)
without change in the##3##4##(1996-2#1)(1997-7#1)(2008-3#1)
without change in##4##3##(1996-2#1)(1997-7#1)(2008-1#1)(2008-3#1)
without change##5##2##(1996-2#1)(1997-7#1)(2008-1#1)(2008-2#1)(2008-3#1)
without changes in the##5##4##(1991-5#1)(2004-12#1)(2008-10#1)(2008-11#2)
without changes in##14##3##(1991-5#1)(1992-1#1)(1995-4#1)(1996-2#1)(1997-2#1)(2004-12#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-8#1)(2012-2#1)
without changing the##19##3##(1992-3#1)(1992-7#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-5#1)(1996-9#1)(1997-1#1)(1997-3#1)(2006-12#1)(2007-10#1)(2007-12#2)(2008-10#2)(2008-3#3)(2010-4#1)
without changing their##4##3##(1994-12#1)(2007-12#1)(2009-11#1)(2010-12#1)
without changing##26##2##(1990-6#1)(1992-3#1)(1992-7#1)(1993-3#1)(1993-9#1)(1994-12#2)(1994-5#1)(1995-5#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(2006-12#1)(2007-10#1)(2007-12#3)(2008-10#2)(2008-3#3)(2009-11#1)(2010-12#1)(2010-4#1)
without chemical suppression is##2##4##(2008-10#2)
without chemical##6##2##(1994-5#1)(2005-4#1)(2006-12#1)(2008-10#3)
without chirp control##2##3##(2007-11#2)
without chromatic##2##2##(2007-11#1)(2008-2#1)
without chronic##7##2##(1995-1#1)(1995-2#1)(2006-10#1)(2006-8#1)(2008-7#1)(2008-9#1)(2012-12#1)
without cirrhosis and##2##3##(2011-1#2)
without cirrhosis##11##2##(1993-2#1)(1994-7#3)(2006-10#1)(2006-2#1)(2007-11#1)(2011-1#4)
without citrate##2##2##(1992-11#2)
without clamping##3##2##(2007-8#1)(2010-12#1)(2013-1#1)
without clear##3##2##(2007-11#1)(2008-10#1)(2012-12#1)
without cleft palate##4##3##(1996-6#1)(2007-9#1)(2009-6#1)(2012-12#1)
without clinical evidence of##4##4##(2006-10#1)(2008-10#1)(2008-9#1)(2010-11#1)
without clinical involvement of##2##4##(1992-4#1)(2006-10#1)
without clinical or##2##3##(2005-7#1)(2011-1#1)
without clinical signs##2##3##(2006-12#1)(2008-5#1)
without clinical symptoms##2##3##(2007-7#1)(2007-9#1)
without clinical##20##2##(1992-4#1)(1992-5#1)(1997-6#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)
without committing##2##2##(1996-10#1)(2006-12#1)
without compensation##2##2##(2008-3#1)(2008-5#1)
without competition for##2##3##(1994-11#1)(2008-10#1)
without complete##3##2##(1994-6#1)(2008-10#1)(2012-12#1)
without complication##4##2##(2005-10#1)(2005-12#1)(2007-8#1)(2008-9#1)
without complications##21##2##(1990-6#1)(1990-9#1)(1996-8#1)(1997-2#1)(1997-4#1)(2005-4#1)(2006-12#1)(2007-1#1)(2007-2#1)(2008-9#2)(2009-8#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#2)(2013-1#4)
without compression##2##2##(1991-12#1)(2008-1#1)
without compromise of##2##3##(1995-12#1)(2008-10#1)
without compromise##3##2##(1995-12#1)(2008-10#1)(2011-2#1)
without compromising the quality##2##4##(2012-2#1)(2013-1#1)
without compromising the##15##3##(1992-2#1)(1996-5#1)(2006-6#1)(2006-8#1)(2008-2#1)(2009-6#1)(2009-8#1)(2010-4#1)(2011-1#2)(2012-12#1)(2012-2#2)(2013-1#2)
without compromising##29##2##(1992-2#1)(1996-5#1)(1997-3#1)(2005-9#1)(2006-10#3)(2006-6#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#2)
without concomitant##15##2##(1990-2#2)(1990-3#1)(1991-4#1)(1993-9#1)(1995-12#1)(1997-6#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-7#1)(2008-12#1)(2008-4#2)(2013-1#1)
without concurrent##2##2##(2007-2#1)(2012-3#1)
without congenital##2##2##(2008-11#2)
without consent##4##2##(1995-2#1)(1996-2#1)(1996-6#1)(1997-6#1)
without considerable##3##2##(1991-10#1)(1991-6#1)(2008-10#1)
without consideration of##3##3##(2006-8#2)(2010-6#1)
without considering##4##2##(1990-8#1)(1991-6#1)(2007-6#1)(2008-2#1)
without contamination by##3##3##(1995-11#1)(2007-11#1)(2013-1#1)
without contamination for a long time##2##6##(2008-10#2)
without contamination##5##2##(1995-11#1)(2007-11#1)(2008-10#2)(2013-1#1)
without controlled substance abuse in interventional pain management##2##8##(2006-8#2)
without cooperativity with##2##3##(1994-12#2)
without coronary artery disease##2##4##(1996-1#1)(2008-11#1)
without coronary artery##3##3##(1993-12#1)(1996-1#1)(2008-11#1)
without coronary heart disease##2##4##(1993-11#1)(1993-12#1)
without coronary##9##2##(1991-3#1)(1993-11#1)(1993-12#2)(1993-9#1)(1996-1#1)(1996-3#1)(2008-11#1)(2008-7#1)
without corresponding##2##2##(1996-5#1)(2011-10#1)
without creating##2##2##(2008-11#1)(2008-3#1)
without cross##2##2##(2008-11#1)(2009-8#1)
without culture##2##2##(2008-11#1)(2009-6#1)
without curing##2##2##(2008-4#2)
without cysts##2##2##(2007-12#1)(2008-4#1)
without cytoplasmic fusion##2##3##(1991-5#2)
without cytoplasmic##3##2##(1991-5#2)(1992-7#1)
without cytotoxic##2##2##(1993-1#1)(2006-10#1)
without cytotoxicity##3##2##(1992-5#1)(2008-7#1)(2009-10#1)
without damage to the##3##4##(2006-5#1)(2008-1#1)(2008-3#1)
without damage##6##2##(2006-5#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2009-2#1)
without damaging the##5##3##(2006-12#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-8#1)
without damaging##11##2##(1991-5#1)(1996-9#1)(2006-10#1)(2006-12#2)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)
without decomposition##2##2##(2008-10#1)(2008-7#1)
without decreasing the##4##3##(1990-10#1)(1996-10#1)(2007-12#1)(2008-2#1)
without decreasing##7##2##(1990-10#1)(1994-9#1)(1996-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
without deep##2##2##(1990-2#1)(2013-1#1)
without degradation of the##2##4##(2008-10#1)(2008-3#1)
without degradation of##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
without degradation##6##2##(2004-11#1)(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
without degrading##2##2##(1993-9#1)(2008-3#1)
without delay##12##2##(1990-4#1)(1993-10#2)(1996-6#1)(1996-8#1)(2006-10#1)(2009-12#1)(2010-12#1)(2012-12#1)(2012-2#2)(2013-1#1)
without delta##2##2##(1991-8#1)(1996-5#1)
without dementia##7##2##(2008-7#5)(2012-3#1)(2013-1#1)
without depression##4##2##(2006-8#3)(2007-9#1)
without derivatization##7##2##(1990-11#2)(2004-11#1)(2005-12#1)(2008-10#2)(2008-5#1)
without destroying the##2##3##(1994-3#1)(2010-12#1)
without destroying##4##2##(1994-3#1)(2007-3#1)(2008-2#1)(2010-12#1)
without destruction of##2##3##(2007-9#1)(2008-2#1)
without detectable##10##2##(1990-3#1)(1991-11#1)(1991-3#1)(1992-6#1)(1992-7#1)(1994-12#1)(1995-2#1)(1996-2#2)(2007-11#1)
without deterioration##2##2##(2006-7#1)(2008-3#1)
without dexamethasone##4##2##(1990-5#1)(1991-1#2)(2008-5#1)
without diabetes mellitus##3##3##(1992-5#1)(2008-11#1)(2011-1#1)
without diabetes##14##2##(1992-5#1)(1997-7#1)(2005-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#4)(2010-10#1)(2010-4#1)(2011-1#1)(2012-3#1)
without dialysis##5##2##(1990-12#1)(2004-8#2)(2008-4#2)
without difference##2##2##(2010-10#1)(2013-8#1)
without differences in##3##3##(1991-12#1)(1993-2#1)(2010-4#1)
without differences##5##2##(1991-12#1)(1993-2#1)(2010-4#1)(2011-2#1)(2013-8#1)
without difficulty##4##2##(2006-12#1)(2006-8#1)(2007-8#1)(2008-1#1)
without dilution##2##2##(2005-11#1)(2008-10#1)
without diminishing##2##2##(1991-4#1)(1993-3#1)
without direct##2##2##(1994-2#1)(1994-8#1)
without disabilities##3##2##(1996-5#1)(2012-1#1)(2013-7#1)
without disease progress##2##3##(2008-10#2)
without disease##5##2##(1991-10#2)(2008-10#2)(2012-12#1)
without dislocation##2##2##(2007-8#1)(2011-2#1)
without dispersion##2##2##(2008-10#1)(2008-3#1)
without disrupting the##2##3##(1995-1#1)(2008-1#1)
without disrupting##3##2##(1992-3#1)(1995-1#1)(2008-1#1)
without disruption of the##2##4##(1994-2#1)(2009-3#1)
without disruption##3##2##(1994-2#1)(2009-10#1)(2009-3#1)
without dissection##2##2##(1994-3#1)(2008-10#1)
without disturbance##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
without disturbing the##5##3##(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)
without disturbing##7##2##(2006-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-9#1)
without division##2##2##(2006-5#1)(2013-7#1)
without doing##2##2##(2011-2#1)(2012-3#1)
without doubt##3##2##(2006-12#1)(2006-5#1)(2006-6#1)
without drains##2##2##(2008-10#1)(2008-8#1)
without drug##2##2##(1996-5#1)(2008-9#1)
without dural attachment##3##3##(2005-10#1)(2008-7#2)
without eating concerns##3##3##(2007-12#3)
without editing##2##2##(2006-12#2)
without effect and##2##3##(1991-8#1)(1994-12#1)
without effect on the##7##4##(1990-5#1)(1990-8#1)(1991-6#1)(1993-6#1)(1994-12#1)(1995-12#1)(2008-10#1)
without effect on##19##3##(1990-2#2)(1990-5#1)(1990-8#1)(1991-5#1)(1991-6#2)(1992-11#1)(1992-5#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-9#2)(1995-12#1)(1995-8#1)(1997-8#1)(2008-10#1)(2010-3#1)
without effect##48##2##(1990-2#3)(1990-4#2)(1990-5#1)(1990-8#1)(1991-5#1)(1991-6#3)(1991-8#1)(1991-9#1)(1992-11#1)(1992-5#3)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-6#2)(1994-8#1)(1994-9#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-2#1)(1997-1#1)(1997-7#1)(1997-8#1)(2005-8#1)(2006-6#1)(2007-8#1)(2008-10#1)(2010-3#1)
without effects on##3##3##(1995-5#1)(2008-10#2)
without effects##4##2##(1993-11#1)(1995-5#1)(2008-10#2)
without elevated##4##2##(2006-9#1)(2007-11#1)(2008-6#1)(2009-5#1)
without elevation of##3##3##(2008-10#3)
without endocrine##2##2##(2008-3#1)(2013-1#1)
without endothelium##7##2##(1992-11#1)(1993-11#1)(1994-11#1)(1994-2#1)(1995-12#2)(1997-5#1)
without error##3##2##(2007-4#1)(2008-7#1)(2012-12#1)
without evidence for##2##3##(1995-12#1)(1997-5#1)
without evidence of NF2##2##4##(2008-8#1)(2010-11#1)
without evidence of disease##3##4##(1990-2#2)(2012-12#1)
without evidence of recurrence##2##4##(1990-8#1)(1992-4#1)
without evidence of##44##3##(1990-2#2)(1990-8#1)(1991-9#1)(1992-4#1)(1992-7#1)(1993-3#1)(1993-7#1)(1993-9#1)(1995-12#2)(1995-2#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-5#1)(1997-6#1)(2004-3#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-8#2)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
without evidence##46##2##(1990-2#2)(1990-8#1)(1991-9#1)(1992-4#1)(1992-7#1)(1993-3#1)(1993-7#1)(1993-9#1)(1995-12#3)(1995-2#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-5#2)(1997-6#1)(2004-3#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-8#2)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
without evident##3##2##(1993-12#1)(2007-8#1)(2013-1#1)
without examining##2##2##(1994-3#1)(2008-11#1)
without exceeding the##2##3##(1990-12#1)(2013-1#1)
without exceeding##3##2##(1990-12#1)(2008-7#1)(2013-1#1)
without exception##5##2##(1995-12#1)(1995-3#1)(1997-4#1)(2008-8#1)(2011-2#1)
without excessive##4##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)
without exogenous##5##2##(2007-11#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-5#1)
without expertise##3##2##(2011-2#3)
without explicit##2##2##(1993-7#1)(2007-12#1)
without exposure to##6##3##(1993-2#1)(1994-6#1)(2007-6#1)(2008-11#1)(2008-6#1)(2011-2#1)
without exposure##7##2##(1993-2#1)(1994-6#1)(2007-6#1)(2008-11#1)(2008-6#1)(2011-2#2)
without extended##4##2##(2008-7#2)(2012-12#2)
without extensive##6##2##(1996-6#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-7#1)(2010-6#1)
without external##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-5#1)
without extraction##5##2##(2005-4#2)(2008-10#3)
without family history of##2##4##(2006-10#1)(2012-1#1)
without family history##3##3##(2006-10#1)(2008-7#1)(2012-1#1)
without family##4##2##(2006-10#1)(2008-3#1)(2008-7#1)(2012-1#1)
without fear of##4##3##(1996-5#1)(2008-10#1)(2012-12#1)(2013-8#1)
without fear##5##2##(1996-5#1)(1997-3#1)(2008-10#1)(2012-12#1)(2013-8#1)
without feedback##3##2##(1990-3#1)(2007-11#1)(2009-10#1)
without feeding problems##2##3##(2013-8#2)
without fetal##2##2##(1992-11#1)(2006-12#1)
without fever##6##2##(2007-12#2)(2007-8#1)(2008-7#1)(2009-10#1)(2012-12#1)
without filters##2##2##(2007-12#2)
without first having to isolate the protein##3##7##(2008-2#1)(2008-4#2)
without first##7##2##(1995-12#1)(2006-12#1)(2006-3#1)(2008-2#1)(2008-4#2)(2009-6#1)
without fish##2##2##(2008-5#1)(2008-9#1)
without fixation##2##2##(2008-4#1)(2013-1#1)
without focal##2##2##(1997-3#1)(2007-11#1)
without formal##2##2##(1996-12#1)(2009-4#1)
without forming##4##2##(1994-5#1)(2008-10#1)(2008-4#1)(2010-7#1)
without fracture##2##2##(1991-11#1)(2012-3#1)
without free##3##2##(1994-9#1)(1997-3#1)(2007-11#1)
without functional##2##2##(2005-10#1)(2011-1#1)
without fundamental##2##2##(2007-1#1)(2008-3#1)
without further incident##2##3##(1994-9#1)(2007-8#1)
without further treatment##2##3##(2008-10#1)(2012-2#1)
without further##28##2##(1990-12#1)(1991-12#1)(1991-3#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#1)(1997-2#1)(1997-4#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-4#1)(2012-2#1)
without gas##3##2##(2008-11#1)(2012-12#2)
without gelatin##2##2##(2013-1#2)
without gene amplification##3##3##(1992-12#2)(2008-11#1)
without gene##4##2##(1992-12#2)(2008-11#1)(2012-2#1)
without general##2##2##(2007-2#1)(2011-2#1)
without genetic alteration of p53##2##5##(1994-12#2)
without genetic##4##2##(1994-12#2)(1994-3#1)(1995-5#1)
without giving##2##2##(2007-5#1)(2008-7#1)
without glucose##4##2##(2007-1#1)(2008-11#1)(2008-7#1)(2010-2#1)
without glutamine##2##2##(2008-11#2)
without gluteal##2##2##(2012-2#2)
without glycerol##2##2##(1990-10#1)(2008-11#1)
without growth##4##2##(1995-2#1)(2007-11#1)(2008-11#2)
without having any##3##3##(1991-9#1)(1993-8#1)(2008-9#1)
without having prior##3##3##(1995-12#1)(2013-1#2)
without having to increase the##2##5##(2008-3#1)(2008-5#1)
without having to resort to##3##5##(1990-5#1)(1996-8#1)(2009-12#1)
without having to sacrifice##2##4##(2006-3#1)(2008-2#1)
without having to##17##3##(1990-5#1)(1993-1#1)(1994-12#1)(1994-5#1)(1996-8#1)(2006-3#1)(2007-7#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-12#1)(2010-8#1)
without having##32##2##(1990-5#1)(1990-9#1)(1991-9#1)(1993-1#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-3#1)(1996-8#1)(1997-6#1)(2005-9#1)(2006-3#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2010-8#1)(2013-1#2)
without health insurance##3##3##(2005-10#1)(2011-2#1)(2013-1#1)
without help##2##2##(2006-4#1)(2008-11#1)
without hepatic dysfunction##5##3##(2005-8#4)(2012-3#1)
without hepatic##6##2##(2005-8#4)(2012-3#1)(2013-1#1)
without history of##11##3##(1990-9#1)(1992-6#1)(2006-8#2)(2007-12#1)(2007-3#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-9#2)
without hormonal##6##2##(1992-2#1)(1994-4#1)(2006-9#1)(2007-12#1)(2010-6#1)(2011-2#1)
without hospitalization##3##2##(1992-10#1)(2008-5#1)(2010-8#1)
without hydrogen##2##2##(1995-3#1)(2007-12#1)
without hyperandrogenism##2##2##(2011-2#2)
without hypertension were##2##3##(2007-10#1)(2013-1#1)
without hypertension##7##2##(1990-9#1)(2007-10#3)(2010-12#1)(2012-2#1)(2013-1#1)
without identification##4##2##(2006-10#1)(2009-10#3)
without immigration##3##2##(2008-8#3)
without impairing##2##2##(1994-12#1)(1995-8#1)
without important##2##2##(1992-11#1)(2007-8#1)
without imposing##3##2##(1997-5#1)(2007-10#1)(2011-2#1)
without improvement##5##2##(1995-9#1)(2005-8#1)(2009-3#1)(2012-3#1)(2013-8#1)
without incident##3##2##(2007-8#1)(2008-11#1)(2008-6#1)
without incidents##2##2##(2009-8#1)(2011-2#1)
without increase in##2##3##(2008-7#1)(2012-3#1)
without increase##4##2##(2008-10#1)(2008-3#1)(2008-7#1)(2012-3#1)
without increased##3##2##(2006-12#1)(2008-7#1)(2011-12#1)
without increasing the risk of##5##5##(2006-2#1)(2006-6#1)(2008-1#1)(2008-9#1)(2011-2#1)
without increasing the risk##6##4##(1997-3#1)(2006-2#1)(2006-6#1)(2008-1#1)(2008-9#1)(2011-2#1)
without increasing the##14##3##(1994-5#1)(1996-9#1)(1997-3#1)(2006-2#1)(2006-6#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-12#1)(2011-2#1)
without increasing##29##2##(1990-12#1)(1990-2#1)(1994-5#1)(1996-9#1)(1997-3#1)(1997-4#1)(2006-2#2)(2006-6#1)(2007-10#1)(2007-3#1)(2007-8#4)(2008-1#3)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#1)
without inducing any##2##3##(2007-11#1)(2008-10#1)
without inducing##17##2##(1991-9#1)(1994-4#1)(1995-12#1)(1995-3#1)(1996-8#1)(1997-4#1)(1997-6#1)(2007-11#3)(2008-10#2)(2008-11#1)(2008-5#2)(2012-12#1)(2013-8#1)
without infection had##2##3##(2008-10#2)
without infection##7##2##(2006-10#1)(2007-11#1)(2008-10#3)(2008-5#1)(2012-3#1)
without influencing the##2##3##(1995-11#1)(2008-10#1)
without influencing##6##2##(1992-8#1)(1993-12#1)(1995-11#1)(2008-10#1)(2008-7#1)(2012-1#1)
without inhibition##3##2##(1995-1#1)(1997-5#1)(2006-5#1)
without inhibitor##3##2##(2008-4#2)(2010-10#1)
without initial##5##2##(2007-12#1)(2007-7#1)(2008-2#1)(2010-1#1)(2013-8#1)
without insulin##2##2##(1990-2#1)(2012-7#1)
without interaction##2##2##(2007-10#1)(2007-12#1)
without intercurrences##2##2##(2009-4#2)
without interference from the##2##4##(1996-6#1)(2007-12#1)
without interference from##7##3##(1992-1#1)(1992-5#1)(1996-6#1)(2007-12#1)(2008-10#3)
without interference of the matrix##3##5##(2008-10#3)
without interference of##5##3##(2008-10#5)
without interference##16##2##(1990-12#1)(1992-1#1)(1992-5#1)(1996-6#1)(2007-12#1)(2008-10#10)(2012-12#1)
without interferences##2##2##(2008-10#2)
without interfering with the##2##4##(1990-3#1)(1996-10#1)
without interfering with##6##3##(1990-11#1)(1990-3#1)(1996-10#1)(2007-11#1)(2008-5#1)(2009-2#1)
without interfering##8##2##(1990-11#1)(1990-2#1)(1990-3#1)(1996-10#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-2#1)
without intermediate##3##2##(2007-12#1)(2008-3#1)(2008-7#1)
without internal##5##2##(1996-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)
without interrupting##2##2##(1992-10#1)(2007-12#1)
without interruption of the##2##4##(2008-10#1)(2008-11#1)
without intervening##2##2##(1996-9#1)(2011-2#1)
without intervention##4##2##(1996-8#1)(2007-2#1)(2007-7#1)(2009-12#1)
without intrauterine##2##2##(1994-9#1)(2006-11#1)
without intravenous##2##2##(1992-12#1)(2008-5#1)
without introducing additional##2##3##(2012-2#1)(2013-8#1)
without introducing##5##2##(2008-3#1)(2010-12#1)(2010-2#1)(2012-2#1)(2013-8#1)
without invasive##3##2##(1993-2#1)(1993-4#1)(1997-8#1)
without involvement of the##3##4##(1990-2#1)(2007-2#1)(2007-9#1)
without involvement of##9##3##(1990-2#1)(1996-6#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-9#1)(2010-11#1)(2011-2#1)(2013-7#1)
without involving##3##2##(2006-10#1)(2006-9#1)(2008-10#1)
without irradiation##2##2##(1995-11#1)(2008-10#1)
without it##3##2##(1994-7#1)(2008-3#1)(2013-1#1)
without its##9##2##(1991-5#1)(1992-9#1)(1993-12#1)(2006-12#2)(2008-12#2)(2008-4#1)(2010-11#1)
without jaundice##2##2##(1990-8#1)(2007-3#1)
without jeopardizing the##2##3##(1994-12#1)(1997-6#1)
without jeopardizing##5##2##(1992-4#1)(1994-12#1)(1997-6#1)(2010-8#1)(2013-8#1)
without joining##3##2##(2007-2#1)(2008-8#1)(2012-12#1)
without knowing the##2##3##(2007-12#1)(2010-8#1)
without knowing##3##2##(2007-12#1)(2010-11#1)(2010-8#1)
without knowledge of the original##2##5##(2008-3#2)
without knowledge of the simulation model##2##6##(2012-3#2)
without knowledge of the##10##4##(2008-10#1)(2008-3#3)(2012-3#6)
without knowledge##11##2##(1997-8#1)(2008-10#1)(2008-3#3)(2012-3#6)
without known risk factors##2##4##(1997-5#1)(2006-10#1)
without known##10##2##(1996-12#1)(1997-5#1)(2006-10#3)(2006-9#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)
without laser##2##2##(2007-12#1)(2008-2#1)
without leaving##3##2##(2006-6#1)(2009-6#1)(2011-2#1)
without left ventricular##3##3##(1991-6#1)(2008-3#1)(2008-4#1)
without leg##5##2##(2006-8#4)(2008-7#1)
without limitations##2##2##(2006-12#1)(2010-10#1)
without liver disease##2##3##(1996-5#1)(2010-2#1)
without liver##4##2##(1993-7#1)(1996-5#1)(2008-1#1)(2010-2#1)
without loading##2##2##(2007-8#2)
without local relapse##2##3##(1994-6#1)(2008-6#1)
without local##3##2##(1994-6#1)(2008-6#1)(2013-1#1)
without losing any##2##3##(2006-3#1)(2007-8#1)
without losing the##4##3##(1994-9#1)(2005-7#1)(2008-5#2)
without losing##10##2##(1994-6#1)(1994-9#1)(2004-9#1)(2005-7#1)(2006-3#1)(2007-8#1)(2008-5#2)(2008-7#1)(2013-1#1)
without loss of consciousness##2##4##(1990-4#1)(2008-1#1)
without loss of function##2##4##(1997-2#1)(2008-10#1)
without loss of prediction capacity using spectrophotometric method##2##8##(2008-10#2)
without loss of##26##3##(1990-11#1)(1990-4#1)(1991-4#1)(1992-3#1)(1993-8#1)(1997-2#2)(2006-10#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-4#1)(2009-3#1)(2011-2#1)(2012-2#1)
without luminal##2##2##(2007-9#1)(2012-2#1)
without magnifying endoscopy##2##3##(2012-2#2)
without major complications##3##3##(1992-5#1)(2011-2#1)(2012-2#1)
without major##10##2##(1992-5#1)(1993-5#1)(1996-3#1)(2005-5#1)(2006-8#1)(2007-2#1)(2007-8#1)(2009-12#1)(2011-2#1)(2012-2#1)
without making##3##2##(2009-6#1)(2010-8#1)(2011-2#1)
without manifold##2##2##(2008-10#2)
without many##2##2##(2006-3#1)(2008-9#1)
without marked ramification##2##3##(1994-5#2)
without marked##4##2##(1994-5#2)(2011-2#1)(2012-2#1)
without marrow##2##2##(1992-6#1)(2009-3#1)
without matrix matching##2##3##(2008-10#2)
without matrix##6##2##(2008-10#5)(2009-10#1)
without measurable##3##2##(2007-11#1)(2007-5#1)(2008-3#1)
without mechanical movement##2##3##(2007-12#1)(2008-3#1)
without mechanical##7##2##(2007-11#1)(2007-12#2)(2007-8#1)(2008-3#2)(2009-8#1)
without mediation##2##2##(1990-2#1)(2006-10#1)
without medical treatment##2##3##(1994-7#1)(2008-4#1)
without medical##5##2##(1994-7#1)(2007-2#2)(2008-4#1)(2010-8#1)
without medication##4##2##(1992-9#1)(1993-10#1)(2008-3#1)(2008-5#1)
without metabolic activation##2##3##(1992-8#1)(1996-2#1)
without metabolic##5##2##(1992-8#1)(1996-2#1)(1997-6#1)(2008-3#1)(2009-4#1)
without metal##3##2##(2008-10#1)(2008-2#1)(2009-3#1)
without metastases##3##2##(1990-2#1)(2005-12#1)(2008-6#1)
without metastasis##4##2##(1992-5#1)(1993-3#1)(2008-5#1)(2012-3#1)
without microelectrode recording for##2##4##(2008-7#2)
without microelectrode recording##3##3##(2008-7#3)
without mishap##2##2##(1997-6#1)(2008-7#1)
without mixing##2##2##(2008-10#1)(2013-8#1)
without mode hopping##2##3##(2007-12#1)(2008-3#1)
without mode##5##2##(2007-12#2)(2008-1#1)(2008-3#2)
without modification##2##2##(1994-11#1)(2008-3#1)
without modifications##2##2##(2008-4#1)(2008-7#1)
without modifier##7##2##(2008-10#7)
without modifying the##2##3##(1992-11#1)(2010-7#1)
without morbidity and##2##3##(2007-1#1)(2008-7#1)
without morbidity##3##2##(2007-1#1)(2007-8#1)(2008-7#1)
without morphine##2##2##(1993-9#1)(2013-7#1)
without motor##2##2##(2006-10#1)(2011-2#1)
without moving the##2##3##(2007-8#1)(2008-1#1)
without moving##3##2##(2007-8#1)(2008-1#1)(2008-3#1)
without much##8##2##(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-9#1)
without mucous involvement##2##3##(2013-8#2)
without multiple##3##2##(1991-9#1)(2008-10#1)(2008-3#1)
without muscle##3##2##(2006-10#2)(2008-8#1)
without necessarily##3##2##(1992-12#1)(2008-3#1)(2008-5#1)
without need for##2##3##(2008-10#1)(2008-11#1)
without need##3##2##(1994-2#1)(2008-10#1)(2008-11#1)
without needing##2##2##(1996-9#1)(2008-2#1)
without neglect##2##2##(1996-1#1)(2009-10#1)
without neurological deficit##2##3##(1997-6#1)(2005-10#1)
without neurological##4##2##(1997-6#1)(2005-10#1)(2008-7#1)(2009-4#1)
without neuropathy##2##2##(1990-9#1)(2012-12#1)
without noticeable##3##2##(2008-10#3)
without objective##2##2##(1993-3#1)(2008-3#1)
without observing any deviation##2##4##(2008-10#2)
without observing any##5##3##(2008-10#5)
without observing##7##2##(2008-10#5)(2008-3#1)(2012-1#1)
without obtaining##2##2##(2010-10#1)(2012-3#1)
without obvious##11##2##(1993-4#1)(1994-9#1)(1995-6#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2009-1#1)(2010-3#1)(2013-8#1)
without occupational##2##2##(1991-12#1)(2009-7#1)
without opening the##3##3##(1995-4#1)(2006-12#1)(2007-8#1)
without opening##4##2##(1995-4#1)(2006-12#1)(2007-11#1)(2007-8#1)
without or with##5##3##(2008-10#1)(2008-12#1)(2008-5#1)(2010-2#2)
without oral candidosis##2##3##(2008-5#2)
without oral##5##2##(1991-2#1)(2008-5#2)(2009-4#1)(2013-8#1)
without organic##2##2##(1996-1#1)(2008-10#1)
without osteonecrosis##2##2##(1994-7#2)
without other anomalies##2##3##(2006-8#1)(2007-11#1)
without other cause##2##3##(1996-6#1)(2013-1#1)
without other##11##2##(1996-6#1)(1997-2#1)(2004-11#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-3#1)(2008-5#1)(2013-1#1)
without oversampling##2##2##(2008-3#2)
without overt##3##2##(2011-2#3)
without pH##3##2##(2008-10#1)(2008-5#1)(2010-5#1)
without pain##7##2##(1995-4#1)(2006-8#2)(2008-1#1)(2008-4#1)(2011-1#1)(2013-1#1)
without palpable##2##2##(1995-9#1)(2006-10#1)
without panic disorder##2##3##(1995-1#2)
without panic##3##2##(1995-1#3)
without parental##4##2##(1997-6#1)(2008-4#1)(2008-9#1)(2011-1#1)
without particular##3##2##(1991-3#1)(1993-6#1)(2007-8#1)
without passing##2##2##(1991-3#1)(1992-11#1)
without pathological fractures##2##3##(2007-7#2)
without pathological##4##2##(2007-11#1)(2007-7#2)(2008-5#1)
without pathology##2##2##(2008-12#1)(2013-1#1)
without paying attention to##2##4##(2006-8#1)(2008-8#1)
without perceptible##2##2##(2009-12#1)(2010-8#1)
without perforation##2##2##(1993-6#2)
without performing any##2##3##(2008-11#1)(2010-12#1)
without performing##4##2##(2007-12#1)(2008-11#1)(2008-3#1)(2010-12#1)
without permanent##2##2##(1990-8#1)(2011-1#1)
without pharmacological##2##2##(2007-7#1)(2013-8#1)
without phase##5##2##(2007-11#1)(2007-12#3)(2008-12#1)
without photoradiation##2##2##(1990-6#2)
without physical##2##2##(1994-9#1)(2010-8#1)
without placing a##2##3##(1997-5#1)(2009-2#1)
without placing##3##2##(1997-5#1)(1997-6#1)(2009-2#1)
without plasma##2##2##(2008-11#1)(2008-5#1)
without polyps##2##2##(2008-3#1)(2013-1#1)
without portal hypertension##2##3##(2006-10#1)(2013-8#1)
without positive##2##2##(2006-12#1)(2006-6#1)
without post-translational proteolysis##2##3##(1993-5#2)
without postoperative##3##2##(1993-8#1)(2008-7#1)(2011-1#1)
without potential##2##2##(2008-10#1)(2013-1#1)
without pre-treatment of the##2##4##(2008-10#2)
without pre-treatment##3##2##(2008-10#3)
without prebinding##2##2##(1990-2#2)
without precautionary measures##2##3##(2007-1#2)
without precipitation##2##2##(2008-10#1)(2009-4#1)
without preconcentration and##2##3##(2008-10#2)
without preconcentration##3##2##(2008-10#3)
without preconstriction##2##2##(2007-9#2)
without premolar extractions##2##3##(2013-8#2)
without prescription##2##2##(2010-12#1)(2011-1#1)
without pretreatment##10##2##(1990-3#1)(1990-8#2)(1993-2#2)(1995-6#1)(2007-8#1)(2008-10#3)
without previous extraction##2##3##(2008-10#2)
without previous myocardial infarction##3##4##(2005-1#1)(2005-8#1)(2010-11#1)
without previous separation##5##3##(2005-4#1)(2008-10#4)
without previous separations##2##3##(2008-10#2)
without previous treatment##3##3##(2008-10#2)(2013-8#1)
without previous##32##2##(1992-10#1)(1992-2#1)(1992-3#1)(1994-5#1)(1996-12#1)(2005-1#2)(2005-4#1)(2005-8#1)(2006-6#1)(2007-7#1)(2007-8#4)(2008-10#11)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
without primary##5##2##(1991-12#1)(1991-3#1)(1996-3#1)(2004-11#1)(2008-12#1)
without prior administration of##2##4##(1992-6#1)(2007-7#1)
without prior extraction##2##3##(1990-8#1)(1996-9#1)
without prior knowledge about##2##4##(2007-7#1)(2012-1#1)
without prior knowledge##3##3##(2007-7#1)(2008-3#1)(2012-1#1)
without prior sample treatment##3##4##(1996-5#1)(2008-10#2)
without prior sample##4##3##(1996-5#1)(2008-10#3)
without prior separation steps##3##4##(2008-10#3)
without prior separation##4##3##(2008-10#4)
without prior treatment##4##3##(1991-2#1)(2007-8#1)(2008-10#2)
without prior##44##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-2#2)(1991-3#1)(1992-10#1)(1992-3#1)(1992-6#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-9#1)(2005-1#1)(2006-10#2)(2006-11#1)(2006-5#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#11)(2008-3#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2012-1#1)(2012-12#1)(2013-7#1)
without problems##4##2##(1991-12#1)(1991-5#1)(1993-8#1)(2008-6#1)
without producing##7##2##(1994-2#1)(1997-2#1)(2005-8#1)(2008-5#1)(2009-11#1)(2010-7#1)(2013-1#1)
without progression##2##2##(1995-12#1)(2008-6#1)
without prosthetic##2##2##(2011-1#2)
without pulmonary hypertension##2##3##(2007-8#1)(2008-7#1)
without pulmonary##4##2##(1994-6#1)(2007-8#1)(2008-7#1)(2011-2#1)
without purification##4##2##(1995-1#1)(2008-5#1)(2012-2#1)(2013-1#1)
without quality##2##2##(2008-3#1)(2013-1#1)
without radiation##3##2##(1994-3#1)(2007-2#1)(2008-6#1)
without radical##3##2##(1997-7#1)(2007-11#1)(2008-9#1)
without radiotherapy##4##2##(2006-10#1)(2008-1#1)(2008-7#1)(2008-8#1)
without recirculation##2##2##(1995-12#1)(2007-7#1)
without recognizable##2##2##(1996-2#1)(2009-3#1)
without recourse to##9##3##(1990-8#1)(1996-8#1)(2007-11#3)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)
without recurrence##11##2##(1995-10#2)(1995-4#1)(1996-6#2)(2006-12#1)(2007-8#1)(2008-5#1)(2008-7#2)(2012-3#1)
without reducing its##2##3##(1994-6#1)(1995-11#1)
without reducing the##7##3##(1991-3#1)(1994-2#1)(1996-11#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)
without reducing##19##2##(1990-12#1)(1991-3#1)(1994-2#1)(1994-6#1)(1995-11#1)(1996-11#1)(2005-7#1)(2005-8#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#2)(2010-5#1)(2012-2#1)
without reduction of##3##3##(2008-10#1)(2008-12#1)(2009-11#1)
without reduction##6##2##(2005-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2009-11#1)(2012-2#1)
without reference to the##2##4##(1997-5#1)(2012-3#1)
without reference to##4##3##(1997-5#1)(2008-1#1)(2010-12#1)(2012-3#1)
without regard to the##4##4##(1992-8#1)(1996-3#1)(2008-9#1)(2011-1#1)
without regard to##8##3##(1992-8#1)(1995-11#1)(1996-3#1)(2004-4#1)(2008-10#1)(2008-9#1)(2011-1#1)(2011-2#1)
without relapse##3##2##(1993-2#1)(2008-1#1)(2009-4#1)
without relation to##2##3##(1993-4#1)(2012-12#1)
without relief##2##2##(1995-10#1)(2008-9#1)
without relying on##2##3##(1997-7#1)(2008-5#1)
without removing the##4##3##(2007-7#1)(2008-10#1)(2008-2#1)(2008-9#1)
without removing##5##2##(2007-7#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-3#1)
without remuneration##2##2##(2008-1#2)
without renal failure##3##3##(1996-6#1)(1996-8#1)(2008-5#1)
without renal##11##2##(1990-3#1)(1991-4#1)(1993-8#1)(1996-6#1)(1996-8#1)(2005-10#1)(2008-5#2)(2010-12#1)(2012-3#2)
without replacement##2##2##(2009-3#1)(2013-1#1)
without requirement##2##2##(1990-7#1)(2010-1#1)
without requiring any##4##3##(2008-2#2)(2010-5#1)(2012-12#1)
without requiring prior##2##3##(2007-12#1)(2008-11#1)
without requiring the##2##3##(1993-6#1)(2010-4#1)
without requiring##20##2##(1993-6#1)(1995-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-7#1)(2009-4#1)(2010-4#1)(2010-5#1)(2012-1#2)(2012-12#2)(2012-3#1)(2013-1#2)
without residents to##3##3##(2008-11#3)
without residual##2##2##(1990-11#1)(2007-11#1)
without resorting to##5##3##(1992-7#1)(2007-12#1)(2008-10#1)(2008-6#1)(2010-6#1)
without restriction##5##2##(2005-1#1)(2007-8#1)(2008-3#1)(2010-2#1)(2013-8#1)
without restrictions##3##2##(1992-1#1)(1996-11#1)(2008-10#1)
without resulting##2##2##(2008-3#1)(2008-7#1)
without revascularization##5##2##(2005-1#5)
without risk factors##2##3##(2006-8#1)(2009-5#1)
without risk for##2##3##(2007-8#1)(2013-8#1)
without risk##9##2##(1993-9#1)(1996-2#1)(2005-10#1)(2006-8#1)(2007-8#1)(2008-7#1)(2009-5#1)(2010-5#1)(2013-8#1)
without risking##4##2##(1990-8#1)(2008-10#1)(2011-2#1)(2012-12#1)
without rupture##2##2##(1990-6#1)(2005-8#1)
without sacrificing quality of##2##4##(1992-12#2)
without sacrificing quality##3##3##(1992-12#2)(2008-10#1)
without sacrificing the##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
without sacrificing##19##2##(1992-12#2)(2006-3#2)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-11#1)(2013-1#2)(2013-7#1)
without sample pre-treatment##2##3##(2008-10#2)
without sample pretreatment##2##3##(2008-10#2)
without sample##7##2##(1990-12#1)(2007-11#1)(2008-10#5)
without scanning##5##2##(2007-11#2)(2007-12#2)(2008-2#1)
without scoliosis##2##2##(2007-7#2)
without scrototomy##2##2##(1997-8#2)
without secondary##2##2##(1996-11#1)(2008-5#1)
without selection##6##2##(1990-3#1)(1993-9#1)(2008-10#2)(2008-11#1)(2008-9#1)
without separation##3##2##(2008-10#3)
without sequelae##6##2##(1994-4#1)(1997-6#1)(2005-10#1)(2009-6#1)(2010-12#1)(2011-2#1)
without serious side##2##3##(2010-11#1)(2011-2#1)
without serious##7##2##(1990-5#1)(1996-1#1)(2008-3#2)(2010-11#1)(2011-2#1)(2013-1#1)
without serum##6##2##(1996-2#1)(2007-6#1)(2008-11#4)
without severe##4##2##(1993-5#1)(2006-12#1)(2007-12#1)(2013-8#1)
without sexual##2##2##(1991-3#1)(1994-2#1)
without showing any##2##3##(2008-1#1)(2008-10#1)
without showing the##2##3##(1990-7#1)(2010-6#1)
without showing##6##2##(1990-7#1)(2008-1#2)(2008-10#1)(2008-5#1)(2010-6#1)
without shunt##2##2##(1992-6#1)(2009-3#1)
without siblings##3##2##(2011-12#3)
without side effects and##3##4##(2005-10#1)(2010-1#1)(2013-8#1)
without side##4##2##(1997-3#1)(2005-10#1)(2010-1#1)(2013-8#1)
without significant change in the##2##5##(1996-5#1)(2008-3#1)
without significant change in##5##4##(1991-1#1)(1993-12#1)(1996-5#1)(2008-3#1)(2008-7#1)
without significant changes in##4##4##(1991-12#1)(1992-11#1)(1993-5#1)(2008-7#1)
without significant changes##5##3##(1991-12#1)(1992-11#1)(1993-5#1)(2008-7#1)(2010-10#1)
without significant coronary artery stenosis##2##5##(2009-10#1)(2013-1#1)
without significant degradation##2##3##(2005-7#1)(2008-2#1)
without significant difference##2##3##(2008-3#1)(2013-1#1)
without significant differences in##2##4##(2008-11#1)(2013-1#1)
without significant differences##3##3##(2008-11#1)(2008-9#1)(2013-1#1)
without significant effect on##3##4##(1995-1#1)(1995-6#1)(2007-10#1)
without significant effects##2##3##(1990-10#1)(1992-11#1)
without significant loss of##4##4##(1990-12#1)(1994-2#1)(2006-12#1)(2008-10#1)
without significant##60##2##(1990-10#1)(1990-12#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-11#2)(1992-4#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-7#1)(1994-2#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-3#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#3)
without significantly affecting the##3##4##(2008-5#1)(2010-3#1)(2012-12#1)
without significantly altering the##2##4##(1994-11#1)(1995-5#1)
without significantly changing##2##3##(1993-2#1)(2009-4#1)
without significantly decreasing the##2##4##(1993-9#1)(1995-3#1)
without significantly increasing##3##3##(1991-4#1)(1997-8#1)(2010-9#1)
without significantly##14##2##(1991-4#1)(1993-2#1)(1993-9#1)(1994-11#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-5#1)(1997-8#1)(2008-5#1)(2009-4#1)(2010-3#1)(2010-9#1)(2012-12#1)
without signs of recurrence##2##4##(2008-6#1)(2012-12#1)
without signs of##13##3##(1991-11#1)(1993-1#1)(1993-8#1)(1994-6#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-5#1)(2008-6#1)(2008-8#1)(2012-1#1)(2012-12#1)(2013-1#1)
without simultaneous##2##2##(1993-9#1)(2010-8#1)
without skeletal##2##2##(2008-3#1)(2008-7#1)
without social##2##2##(2008-2#1)(2010-2#1)
without somatization disorder##2##3##(2006-8#2)
without somatization##3##2##(2006-8#3)
without some form of##3##4##(1990-12#1)(1992-12#1)(1996-6#1)
without some##8##2##(1990-12#1)(1992-12#1)(1995-5#1)(1996-10#1)(1996-6#1)(2008-11#1)(2013-1#2)
without special##2##2##(2006-5#1)(2008-10#1)
without specific##4##2##(1997-1#1)(2006-8#2)(2010-12#1)
without spinal cord injury in a##2##6##(2007-11#2)
without spontaneous##2##2##(1996-6#1)(2007-12#1)
without staining or##2##3##(1997-4#1)(2008-11#1)
without statistical significance##4##3##(1990-7#1)(2007-9#1)(2008-12#1)(2008-5#1)
without statistical##6##2##(1990-7#1)(2006-8#1)(2007-9#1)(2008-12#1)(2008-5#1)(2009-12#1)
without statistically significant##2##3##(2008-10#2)
without stenosis##3##2##(1993-12#1)(1993-8#1)(2013-1#1)
without steroid administration##2##3##(2006-8#1)(2007-8#1)
without steroids##3##2##(2006-8#1)(2007-12#1)(2007-2#1)
without stroke##4##2##(2007-10#4)
without structural##4##2##(2006-9#1)(2011-2#1)(2012-2#1)(2013-7#1)
without subcloning##2##2##(1990-9#1)(1994-6#1)
without substantial##3##2##(2006-10#1)(2008-10#1)(2010-10#1)
without substrate##2##2##(1993-8#1)(2008-5#1)
without success to##2##3##(2005-11#1)(2008-4#1)
without success##8##2##(1990-11#1)(1991-4#1)(2005-11#1)(2007-4#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-2#1)
without such a history##2##4##(1993-7#1)(2007-10#1)
without such a##4##3##(1993-7#1)(2007-10#1)(2008-3#2)
without such an adjuvant therapy##2##5##(1990-10#2)
without such an##3##3##(1990-10#2)(1991-10#1)
without such##17##2##(1990-10#2)(1990-8#1)(1991-10#1)(1991-2#1)(1993-7#1)(1994-2#1)(1996-11#1)(2006-10#1)(2007-10#1)(2008-3#4)(2008-7#1)(2012-3#1)(2013-8#1)
without sudden##2##2##(2008-7#1)(2009-11#1)
without suffering##2##2##(1990-7#1)(2007-2#1)
without sufficient##5##2##(1990-12#1)(1990-6#1)(2007-12#1)(2010-12#1)(2011-12#1)
without sugar##2##2##(1997-2#1)(2011-2#1)
without sun##2##2##(1993-3#1)(2008-3#1)
without supplementary##2##2##(1993-2#1)(1996-2#1)
without supplementation of##2##3##(2009-4#2)
without support and##2##3##(1995-12#1)(1995-8#1)
without support##9##2##(1995-12#1)(1995-8#3)(2007-11#1)(2008-6#1)(2011-1#1)(2012-12#2)
without surface##4##2##(2006-3#1)(2007-12#1)(2010-12#1)(2012-2#1)
without surfactant##2##2##(2008-5#2)
without surgery##9##2##(1990-10#1)(1992-9#1)(1993-2#1)(1993-8#1)(2006-10#2)(2007-11#1)(2011-2#1)(2013-8#1)
without surgical##4##2##(1990-2#1)(2008-1#1)(2008-7#1)(2009-3#1)
without symptoms of##7##3##(1991-11#1)(1995-8#1)(2007-11#1)(2007-7#1)(2009-3#1)(2009-4#1)(2009-6#1)
without symptoms##19##2##(1990-4#1)(1990-6#1)(1991-11#1)(1991-5#1)(1993-12#1)(1995-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)
without synthetic##2##2##(1991-8#1)(1992-9#1)
without syringomyelia##5##2##(2006-5#5)
without syrinx##2##2##(2006-5#2)
without systemic##8##2##(1994-8#1)(2006-10#1)(2008-7#1)(2010-2#2)(2011-2#1)(2013-7#1)(2013-8#1)
without taking into account##3##4##(1990-11#1)(2009-1#1)(2012-12#1)
without taking the##2##3##(2007-11#1)(2007-12#1)
without taking##7##2##(1990-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-3#1)(2009-1#1)(2012-12#1)
without tedious sample##2##3##(1992-12#1)(2008-10#1)
without tedious##4##2##(1992-12#1)(2007-8#1)(2008-10#1)(2009-3#1)
without temperature##2##2##(2008-10#1)(2008-2#1)
without tenotomy##2##2##(2011-1#2)
without that##2##2##(1993-12#1)(2006-8#1)
without thawing the##2##3##(2006-2#2)
without the Disc Unloader brace##2##5##(2006-7#2)
without the added##2##3##(1992-11#1)(2008-8#1)
without the addition of other##2##5##(2008-5#1)(2008-6#1)
without the addition of##19##4##(1990-6#1)(1995-2#1)(2004-9#1)(2005-11#1)(2008-10#4)(2008-11#1)(2008-5#3)(2008-6#1)(2009-6#1)(2010-4#2)(2011-2#1)(2013-7#2)
without the additional##3##3##(2007-10#1)(2007-12#1)(2011-2#1)
without the adsorptive accumulation##2##4##(2008-10#2)
without the aid of any##2##5##(2008-10#1)(2012-2#1)
without the aid of special##2##5##(2008-2#1)(2008-7#1)
without the aid of##7##4##(1995-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-2#1)
without the application of##2##4##(2008-2#1)(2008-5#1)
without the benefit of##3##4##(2006-10#1)(2010-12#2)
without the clinical##2##3##(2005-11#1)(2011-2#1)
without the complication##3##3##(1995-8#1)(2010-8#1)(2013-8#1)
without the complications of##2##4##(2008-7#1)(2011-2#1)
without the contribution of##2##4##(2008-6#1)(2011-2#1)
without the development of##2##4##(1994-12#1)(2009-11#1)
without the influence of##2##4##(2008-3#1)(2011-2#1)
without the initiating methionine residue)##2##5##(1990-7#2)
without the interference of##3##4##(2008-10#3)
without the interference##4##3##(2008-10#4)
without the knowledge of##2##4##(2005-12#1)(2011-12#1)
without the metabolic syndrome##4##4##(2008-3#3)(2010-4#1)
without the necessity for##2##4##(1995-8#1)(2007-12#1)
without the necessity of##3##4##(2007-11#1)(2008-7#1)(2008-9#1)
without the necessity##5##3##(1995-8#1)(2007-11#1)(2007-12#1)(2008-7#1)(2008-9#1)
without the need for a##9##5##(1997-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-7#1)
without the need for an##2##5##(2007-12#1)(2008-3#1)
without the need for any##3##5##(2007-12#2)(2008-10#1)
without the need for further##3##5##(1992-11#1)(1993-6#1)(2008-4#1)
without the need for mechanical##2##5##(1990-4#1)(2007-12#1)
without the need for separation##2##5##(2008-10#1)(2008-4#1)
without the need for tedious##2##5##(2008-10#2)
without the need for the##2##5##(1994-3#1)(2008-7#1)
without the need for##70##4##(1990-4#1)(1991-5#1)(1992-11#1)(1993-6#1)(1994-3#1)(1995-3#1)(1995-7#1)(1997-4#1)(1997-6#1)(2005-7#1)(2006-12#2)(2006-5#1)(2007-11#8)(2007-12#8)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#3)(2008-7#3)(2008-8#2)(2008-9#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
without the need of a##2##5##(2008-10#1)(2008-11#1)
without the need of##10##4##(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2010-5#1)(2010-7#1)
without the need to resort to##2##6##(1993-12#1)(2007-12#1)
without the need to##10##4##(1993-12#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-9#1)(2011-1#1)
without the need##90##3##(1990-4#1)(1991-5#1)(1992-11#1)(1993-12#1)(1993-6#1)(1994-3#1)(1995-3#1)(1995-7#1)(1997-4#1)(1997-6#1)(2005-7#1)(2006-12#2)(2006-5#1)(2007-11#11)(2007-12#9)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-9#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
without the possibility of##2##4##(1993-11#1)(2007-11#1)
without the potential##2##3##(2010-8#1)(2013-1#1)
without the presence of##11##4##(1990-4#1)(1996-7#1)(1996-9#1)(2006-4#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-8#1)(2011-2#1)
without the previous accumulation##2##4##(2008-10#2)
without the previous##3##3##(2006-10#1)(2008-10#2)
without the requirement of##2##4##(2007-12#1)(2008-10#1)
without the routine use of ultrasonography##2##6##(2011-2#2)
without the routine use of##3##5##(2011-2#3)
without the standard##3##3##(1996-1#1)(2008-2#1)(2013-8#1)
without the support of##2##4##(2007-8#1)(2008-3#1)
without the syndrome##2##3##(2008-3#2)
without the toxin##2##3##(1995-7#2)
without the traditional##2##3##(1993-2#1)(2013-1#1)
without the use of a##7##5##(2006-10#1)(2007-11#1)(2008-2#1)(2009-10#1)(2012-12#1)(2012-2#1)(2012-3#1)
without the use of an##3##5##(2007-12#1)(2008-10#1)(2008-3#1)
without the use of labels##2##5##(2008-4#2)
without the use of##41##4##(1991-10#1)(1992-3#1)(1992-4#1)(1994-6#1)(1996-1#1)(1996-6#1)(1997-4#1)(2006-10#2)(2007-11#2)(2007-12#3)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#2)(2008-4#4)(2008-7#1)(2009-10#1)(2009-12#1)(2009-5#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
without the##401##2##(1990-12#1)(1990-2#1)(1990-4#3)(1990-6#1)(1990-7#4)(1990-9#1)(1991-10#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-10#2)(1992-11#3)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#2)(1995-7#3)(1995-8#3)(1996-1#3)(1996-12#1)(1996-2#2)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#2)(2004-4#1)(2004-9#2)(2005-10#1)(2005-11#3)(2005-12#3)(2005-7#1)(2006-10#7)(2006-12#3)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-7#3)(2006-8#1)(2007-10#3)(2007-11#20)(2007-12#18)(2007-2#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#3)(2008-1#2)(2008-10#46)(2008-11#10)(2008-12#1)(2008-2#17)(2008-3#24)(2008-4#8)(2008-5#10)(2008-6#4)(2008-7#8)(2008-8#7)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#4)(2009-9#1)(2010-10#1)(2010-12#3)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#13)(2012-1#2)(2012-12#6)(2012-2#6)(2012-3#2)(2013-1#12)(2013-7#6)(2013-8#10)
without their consent##4##3##(1991-6#1)(1994-4#1)(1995-12#1)(2009-6#1)
without their##6##2##(1991-6#1)(1994-4#1)(1995-12#1)(2008-7#1)(2009-6#1)(2011-1#1)
without these##6##2##(1994-12#1)(1994-6#1)(2006-6#1)(2007-10#1)(2008-4#1)(2008-9#1)
without this##11##2##(1990-12#1)(1990-5#1)(1993-1#1)(1995-12#1)(1997-3#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-3#1)(2011-2#1)
without those##2##2##(2008-10#1)(2011-1#1)
without thymoma##2##2##(2007-8#1)(2012-12#1)
without thyroid##5##2##(2008-6#1)(2013-1#4)
without time##2##2##(1995-5#1)(2007-7#1)
without time-consuming##2##2##(2007-8#1)(2008-10#1)
without titration has been developed##2##5##(2008-10#2)
without titration##8##2##(2008-10#8)
without toxicity##2##2##(1992-10#1)(2005-7#1)
without transfer##2##2##(1993-5#1)(2008-10#1)
without transient##2##2##(1994-12#1)(2007-2#1)
without trauma to the##2##4##(2007-5#1)(2012-2#1)
without trauma##3##2##(2007-5#1)(2009-4#1)(2012-2#1)
without treatment##15##2##(1990-11#1)(1991-11#1)(1992-10#1)(2007-3#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-7#1)(2009-10#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
without tumor##2##2##(2008-6#1)(2012-2#1)
without type 2 diabetes mellitus##2##5##(2008-3#1)(2011-11#1)
without typical##4##2##(1993-12#1)(1997-8#1)(2007-8#1)(2010-10#1)
without undergoing##2##2##(1994-11#1)(2008-10#1)
without undue##2##2##(2008-11#1)(2008-6#1)
without urinary##3##2##(2008-10#1)(2012-12#1)(2012-2#1)
without use of##6##3##(1990-11#1)(2006-10#1)(2006-7#1)(2007-12#1)(2008-3#1)(2011-2#1)
without using a##4##3##(1991-6#1)(2007-12#1)(2008-10#1)(2008-2#1)
without using an##4##3##(1997-2#1)(2008-3#1)(2012-12#1)(2012-3#1)
without using any##8##3##(2008-10#2)(2008-2#1)(2008-3#2)(2010-4#1)(2010-5#2)
without using internal##2##3##(1997-2#1)(2008-10#1)
without using of##2##3##(2008-10#2)
without using the##7##3##(2007-2#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-6#1)(2010-8#1)
without using##43##2##(1990-2#1)(1991-12#1)(1991-6#1)(1992-9#1)(1996-12#1)(1996-6#1)(1997-2#2)(2006-10#1)(2006-4#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#11)(2008-2#2)(2008-3#4)(2008-7#2)(2009-6#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2012-12#1)(2012-3#1)
without vascular##3##2##(1997-2#1)(2008-12#1)(2008-8#1)
without visceral##2##2##(2012-2#1)(2013-8#1)
without vision of##2##3##(1993-7#1)(2008-4#1)
without visual##4##2##(1990-10#1)(1991-12#1)(1993-2#1)(2008-10#1)
without vitamin C##3##3##(1997-3#1)(2011-1#1)(2013-7#1)
without vitamin##5##2##(1993-12#1)(1997-3#1)(2011-1#1)(2013-1#1)(2013-7#1)
without vitamins##2##2##(2008-10#1)(2008-4#1)
without vomiting##2##2##(1993-6#1)(2009-4#1)
without waiting for##3##3##(1996-4#1)(1997-2#1)(2009-12#1)
without waiting##4##2##(1996-4#1)(1997-2#1)(2007-8#1)(2009-12#1)
without wavelength##2##2##(2007-11#1)(2007-12#1)
without wetness##3##2##(2008-10#3)
without which##2##2##(1992-9#1)(2006-7#1)
without white##2##2##(2008-10#1)(2008-2#1)
without yeast##2##2##(2008-10#1)(2008-12#1)
without zinc##2##2##(2008-10#1)(2010-3#1)
without##5590##1##(1990-10#10)(1990-11#23)(1990-12#22)(1990-2#32)(1990-3#18)(1990-4#10)(1990-5#19)(1990-6#14)(1990-7#16)(1990-8#17)(1990-9#14)(1991-1#12)(1991-10#15)(1991-11#13)(1991-12#18)(1991-2#16)(1991-3#21)(1991-4#15)(1991-5#26)(1991-6#13)(1991-7#8)(1991-8#14)(1991-9#15)(1992-1#11)(1992-10#15)(1992-11#22)(1992-12#19)(1992-2#13)(1992-3#23)(1992-4#8)(1992-5#16)(1992-6#10)(1992-7#13)(1992-8#18)(1992-9#10)(1993-1#11)(1993-10#3)(1993-11#19)(1993-12#26)(1993-2#24)(1993-3#20)(1993-4#8)(1993-5#14)(1993-6#14)(1993-7#9)(1993-8#14)(1993-9#24)(1994-10#3)(1994-11#16)(1994-12#35)(1994-2#25)(1994-3#20)(1994-4#5)(1994-5#21)(1994-6#28)(1994-7#13)(1994-8#14)(1994-9#26)(1995-1#14)(1995-10#8)(1995-11#19)(1995-12#32)(1995-2#22)(1995-3#18)(1995-4#6)(1995-5#8)(1995-6#15)(1995-7#8)(1995-8#23)(1995-9#2)(1996-1#21)(1996-10#10)(1996-11#14)(1996-12#17)(1996-2#25)(1996-3#11)(1996-4#4)(1996-5#15)(1996-6#27)(1996-7#6)(1996-8#19)(1996-9#18)(1997-1#19)(1997-2#29)(1997-3#22)(1997-4#20)(1997-5#20)(1997-6#27)(1997-7#23)(1997-8#20)(2004-1#2)(2004-11#6)(2004-12#5)(2004-2#6)(2004-3#1)(2004-4#4)(2004-8#3)(2004-9#10)(2005-1#9)(2005-10#23)(2005-11#21)(2005-12#13)(2005-3#1)(2005-4#8)(2005-5#4)(2005-7#8)(2005-8#16)(2005-9#6)(2006-1#1)(2006-10#95)(2006-11#11)(2006-12#49)(2006-2#16)(2006-3#12)(2006-4#12)(2006-5#34)(2006-6#30)(2006-7#13)(2006-8#66)(2006-9#13)(2007-1#13)(2007-10#54)(2007-11#133)(2007-12#145)(2007-2#33)(2007-3#17)(2007-4#17)(2007-5#14)(2007-6#15)(2007-7#61)(2007-8#160)(2007-9#41)(2008-1#61)(2008-10#532)(2008-11#116)(2008-12#31)(2008-2#98)(2008-3#198)(2008-4#74)(2008-5#119)(2008-6#44)(2008-7#134)(2008-8#54)(2008-9#76)(2009-1#3)(2009-10#24)(2009-11#12)(2009-12#13)(2009-2#15)(2009-3#34)(2009-4#29)(2009-5#16)(2009-6#27)(2009-7#3)(2009-8#27)(2009-9#10)(2010-1#6)(2010-10#21)(2010-11#11)(2010-12#57)(2010-2#16)(2010-3#26)(2010-4#32)(2010-5#17)(2010-6#18)(2010-7#19)(2010-8#30)(2010-9#8)(2011-1#69)(2011-10#1)(2011-11#2)(2011-12#21)(2011-2#165)(2011-3#2)(2012-1#40)(2012-11#4)(2012-12#99)(2012-2#109)(2012-3#68)(2012-4#1)(2012-7#1)(2013-1#180)(2013-3#1)(2013-7#30)(2013-8#92)
withstand a##3##2##(2008-2#1)(2008-7#1)(2012-3#1)
withstand the##4##2##(2006-12#1)(2008-11#1)(2009-2#1)(2010-12#1)
withstand##29##1##(1993-12#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-5#1)(2008-7#3)(2009-2#2)(2009-4#1)(2010-12#1)(2010-4#2)(2010-7#1)(2010-8#1)(2012-1#1)(2012-11#1)(2012-3#2)
withstanding the##3##2##(2008-10#1)(2010-12#1)(2012-2#1)
withstanding##5##1##(1997-4#1)(2007-9#1)(2008-10#1)(2010-12#1)(2012-2#1)
withstands##4##1##(1992-9#1)(1997-2#1)(2007-11#1)(2008-9#1)
withstood the##2##2##(2006-8#1)(2008-2#1)
withstood##4##1##(1997-5#1)(2006-8#1)(2008-2#1)(2010-2#1)
withthe##2##1##(2008-11#1)(2013-7#1)
witness and##2##2##(1994-3#1)(2010-6#1)
witness to conjugal violence##2##4##(2008-2#2)
witness to##3##2##(2008-2#2)(2008-8#1)
witness##19##1##(1993-12#1)(1994-3#1)(2007-4#4)(2007-6#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-4#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-6#1)(2012-2#1)(2013-8#1)
witnessed a resurgence##2##3##(2009-12#1)(2011-2#1)
witnessed a##5##2##(1992-6#1)(2007-7#1)(2008-11#1)(2009-12#1)(2011-2#1)
witnessed an alarming##2##3##(1990-7#1)(2009-10#1)
witnessed an##6##2##(1990-7#1)(2006-2#1)(2009-10#1)(2010-10#1)(2012-1#1)(2012-2#1)
witnessed by##5##2##(2008-7#1)(2010-3#1)(2010-4#2)(2013-1#1)
witnessed in the##4##3##(2006-12#2)(2010-4#1)(2011-1#1)
witnessed in##7##2##(1993-8#1)(2006-12#2)(2009-7#1)(2010-4#1)(2011-1#1)(2012-2#1)
witnessed the introduction of##2##4##(2006-10#1)(2012-1#1)
witnessed the##7##2##(1997-2#1)(2006-10#2)(2008-7#2)(2010-11#1)(2012-1#1)
witnessed tremendous##3##2##(2006-10#1)(2007-6#1)(2008-8#1)
witnessed##55##1##(1990-4#1)(1990-7#1)(1991-2#1)(1992-6#1)(1993-8#1)(1994-12#1)(1996-1#1)(1997-2#2)(2006-10#5)(2006-12#2)(2006-2#1)(2006-5#1)(2006-9#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#3)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
witnesses to##2##2##(2006-10#1)(2007-4#1)
witnesses##12##1##(1990-5#1)(1994-2#1)(1994-4#1)(1995-12#2)(1996-2#1)(1997-3#1)(2006-10#1)(2007-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
witnessing a##4##2##(1990-9#1)(2008-6#1)(2010-8#1)(2011-1#1)
witnessing##13##1##(1990-9#1)(2004-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-4#2)(2009-7#3)(2010-8#1)(2011-1#1)
wives had titre##2##3##(2007-7#2)
wives or##2##2##(2008-5#1)(2011-2#1)
wives##13##1##(1996-6#1)(2007-7#3)(2008-5#1)(2008-9#2)(2009-4#2)(2010-12#1)(2011-12#1)(2011-2#2)
wives'##4##1##(2007-12#1)(2008-9#3)
wk PI##2##2##(2013-8#2)
wk after surgery##4##3##(2007-2#2)(2013-1#2)
wk after treatment##2##3##(1991-3#1)(2011-12#1)
wk after##11##2##(1991-3#1)(1995-2#1)(2005-10#1)(2007-2#3)(2009-3#1)(2011-12#1)(2013-1#2)(2013-8#1)
wk for##2##2##(2009-3#1)(2013-1#1)
wk of age##3##3##(1991-3#1)(2007-5#2)
wk of##8##2##(1991-3#1)(2007-2#1)(2007-5#3)(2007-8#3)
wk##54##1##(1991-3#3)(1993-1#1)(1995-2#6)(1996-10#2)(2004-11#1)(2005-10#1)(2006-5#2)(2007-2#7)(2007-5#3)(2007-8#9)(2008-10#2)(2008-12#1)(2008-8#1)(2009-3#3)(2010-12#1)(2011-12#1)(2013-1#5)(2013-8#5)
wk) and##2##2##(1995-2#1)(1997-6#1)
wk)##8##1##(1994-11#1)(1994-2#1)(1994-6#1)(1995-2#1)(1997-6#2)(2008-9#1)(2009-3#1)
wks##10##1##(1990-4#2)(1992-7#1)(1995-2#1)(2012-3#4)(2013-1#2)
wo##3##1##(1994-7#1)(2008-11#2)
wobble in##2##2##(1994-12#1)(2007-10#1)
wobble modification deficiency##3##3##(2006-11#3)
wobble modification##5##2##(2006-11#5)
wobble##16##1##(1992-9#1)(1994-12#2)(1995-1#1)(1997-1#1)(2005-11#1)(2006-11#6)(2007-10#1)(2007-9#1)(2008-3#1)(2008-9#1)
wobbler mouse##2##2##(1996-12#1)(1997-5#1)
wobbler##8##1##(1996-12#2)(1997-5#5)(2006-11#1)
wobbling##3##1##(1997-1#1)(2007-12#1)(2007-9#1)
wobenzyme##2##1##(2006-6#2)
woc##2##1##(2012-3#2)
woefully##2##1##(1992-3#1)(2008-12#1)
woes##4##1##(1992-3#1)(1994-5#1)(1995-5#1)(2009-9#1)
woesei##6##1##(1993-9#1)(2011-2#4)(2012-2#1)
wogonin##5##1##(2007-1#2)(2013-7#3)
wolf predation##2##2##(2007-2#2)
wolf##9##1##(1992-2#1)(1996-12#2)(2007-12#2)(2007-2#2)(2009-6#2)
wolfberry fruit of different geographic regions##2##6##(2013-8#2)
wolfberry fruit##3##2##(2013-8#3)
woluwensis##3##1##(2007-12#3)
wolves (Chrysocyon brachyurus)##2##3##(2007-2#2)
wolves in##2##2##(1996-12#1)(2007-2#1)
wolves##17##1##(1993-7#1)(1996-12#10)(2007-2#6)
woman admitted to##5##3##(2005-12#1)(2006-4#3)(2011-2#1)
woman admitted with##2##3##(2005-1#1)(2005-12#1)
woman admitted##8##2##(2005-1#1)(2005-12#2)(2006-4#3)(2011-2#1)(2012-2#1)
woman affected##3##2##(1991-10#1)(2013-1#2)
woman aged##7##2##(1990-6#1)(1991-3#1)(1991-9#1)(1995-12#1)(1997-8#1)(2007-8#1)(2011-2#1)
woman and her##4##3##(1992-9#1)(2007-2#2)(2013-1#1)
woman and the##2##3##(1993-6#1)(2006-7#1)
woman and##14##2##(1990-2#1)(1992-9#1)(1993-6#1)(1995-6#1)(2006-7#1)(2007-2#3)(2009-1#1)(2009-10#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
woman at##3##2##(2012-8#1)(2013-1#2)
woman can##2##2##(1996-11#1)(1997-7#1)
woman complained of##3##3##(1990-3#1)(1996-3#1)(2008-1#1)
woman consulted##2##2##(2009-8#1)(2012-2#1)
woman developed a##4##3##(1993-8#1)(2005-5#1)(2013-1#2)
woman developed##12##2##(1990-6#1)(1991-9#1)(1993-8#1)(1994-7#1)(1995-11#1)(2005-11#4)(2005-5#1)(2013-1#2)
woman diagnosed with##4##3##(1997-7#1)(2006-10#1)(2010-12#1)(2011-1#1)
woman diagnosed##5##2##(1997-7#1)(2006-10#1)(2010-12#1)(2011-1#1)(2013-7#1)
woman experienced##3##2##(1997-6#1)(2008-6#1)(2009-6#1)
woman following##2##2##(2006-7#1)(2007-8#1)
woman for##2##2##(1993-8#1)(2011-2#1)
woman from##2##2##(2007-7#1)(2007-8#1)
woman had a##4##3##(1992-3#1)(1997-7#1)(2008-3#1)(2013-8#1)
woman had##14##2##(1990-6#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-8#1)(1995-4#1)(1997-5#1)(1997-7#1)(2007-5#1)(2008-3#2)(2010-6#1)(2013-8#1)
woman has##6##2##(1990-6#1)(1990-9#1)(1994-4#1)(2007-8#1)(2010-12#1)(2010-8#1)
woman in her##2##3##(1993-7#1)(2013-8#1)
woman in whom##5##3##(1996-3#1)(2006-10#1)(2007-8#1)(2009-3#1)(2010-12#1)
woman in##18##2##(1991-12#1)(1993-12#1)(1993-3#1)(1993-7#1)(1996-12#1)(1996-3#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
woman is presented##4##3##(1990-6#1)(1991-5#1)(2007-8#1)(2008-6#1)
woman is reported##2##3##(1992-4#1)(2008-9#1)
woman is##11##2##(1990-6#1)(1991-5#1)(1992-1#1)(1992-4#1)(1995-11#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-6#1)(2008-9#1)(2013-8#1)
woman of##7##2##(1990-12#1)(1995-11#1)(1995-4#1)(2007-7#1)(2008-3#2)(2008-7#1)
woman or##2##2##(2007-2#2)
woman presented to##2##3##(2006-10#1)(2010-2#1)
woman presented with a left##2##5##(2007-9#1)(2010-12#1)
woman presented with a##14##4##(1992-3#1)(2005-11#1)(2006-10#1)(2007-7#1)(2007-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-6#2)(2012-12#1)(2012-3#1)(2013-7#1)
woman presented with an##3##4##(2007-8#1)(2012-12#1)(2012-2#1)
woman presented with chest pain and##2##6##(2006-12#1)(2007-8#1)
woman presented with increased##2##4##(2008-5#1)(2011-2#1)
woman presented with severe##2##4##(2007-7#1)(2009-3#1)
woman presented with##48##3##(1990-6#1)(1992-3#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#3)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-6#3)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
woman presented##52##2##(1990-6#1)(1992-3#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-3#3)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#3)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
woman presenting a##2##3##(1993-2#1)(2007-8#1)
woman presenting with a##4##4##(2006-10#1)(2008-5#1)(2013-1#2)
woman presenting with##8##3##(2006-10#2)(2008-4#1)(2008-5#1)(2010-5#1)(2013-1#2)(2013-7#1)
woman presenting##10##2##(1993-2#1)(2006-10#2)(2007-8#1)(2008-4#1)(2008-5#1)(2010-5#1)(2013-1#2)(2013-7#1)
woman previously##2##2##(2006-10#1)(2008-3#1)
woman received##3##2##(1995-8#1)(2006-8#1)(2008-5#1)
woman receiving##2##2##(1991-8#1)(2007-10#1)
woman referred##4##2##(2008-12#1)(2009-8#1)(2010-12#1)(2012-12#1)
woman suffering from##2##3##(2012-2#1)(2013-1#1)
woman to##2##2##(1995-1#1)(1996-12#1)
woman treated with##4##3##(2005-1#1)(2010-2#1)(2013-1#1)(2013-8#1)
woman under##2##2##(1997-1#1)(2013-8#1)
woman underwent a##2##3##(2004-2#1)(2008-7#1)
woman underwent##4##2##(1992-2#1)(2004-2#1)(2008-7#1)(2012-12#1)
woman visited our##2##3##(1996-6#1)(2007-8#1)
woman visited##3##2##(1996-6#1)(2007-8#1)(2010-5#1)
woman was admitted for##2##4##(2011-2#1)(2013-8#1)
woman was admitted to hospital##3##5##(1990-8#1)(2005-12#1)(2010-2#1)
woman was admitted to our hospital for##2##7##(1991-12#1)(2008-1#1)
woman was admitted to our hospital##3##6##(1991-12#1)(2008-1#1)(2008-7#1)
woman was admitted to our##4##5##(1991-12#1)(2006-9#1)(2008-1#1)(2008-7#1)
woman was admitted to the##3##5##(2006-2#1)(2006-4#1)(2007-8#1)
woman was admitted to##11##4##(1990-8#1)(1991-12#1)(2005-12#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-7#1)(2010-2#1)(2011-2#1)
woman was admitted with a##2##5##(2007-8#1)(2012-3#1)
woman was admitted with##5##4##(2007-8#1)(2008-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
woman was admitted##18##3##(1990-8#1)(1991-12#1)(2005-12#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-7#1)(2010-2#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
woman was diagnosed##2##3##(1995-2#1)(2012-2#1)
woman was hospitalized##2##3##(1993-6#1)(2007-8#1)
woman was referred because of an##2##6##(2012-3#1)(2013-1#1)
woman was referred because of##3##5##(2006-10#1)(2012-3#1)(2013-1#1)
woman was referred##4##3##(2006-10#1)(2012-3#1)(2013-1#1)(2013-7#1)
woman was##37##2##(1990-8#1)(1991-12#1)(1993-6#1)(1994-4#1)(1995-2#1)(1995-8#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-7#1)(2010-2#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#3)
woman who developed##7##3##(1992-2#1)(2006-10#1)(2007-8#1)(2008-6#1)(2008-7#1)(2010-3#1)(2010-4#1)
woman who experienced##2##3##(2006-3#1)(2007-5#1)
woman who had a##4##4##(1996-12#1)(2010-12#1)(2010-6#1)(2011-2#1)
woman who had##9##3##(1996-12#1)(2007-7#1)(2008-10#1)(2009-3#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
woman who has##2##3##(2008-1#2)
woman who is##2##3##(2008-11#1)(2012-2#1)
woman who presented with a##6##5##(2006-2#1)(2007-12#1)(2007-5#1)(2008-10#1)(2013-1#1)(2013-8#1)
woman who presented with bilateral##2##5##(2008-8#1)(2013-8#1)
woman who presented with##22##4##(1994-12#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-12#2)(2007-5#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
woman who presented##25##3##(1994-12#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-12#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
woman who suffered from##2##4##(2007-10#1)(2009-4#1)
woman who suffered##3##3##(1997-3#1)(2007-10#1)(2009-4#1)
woman who underwent##2##3##(2008-5#1)(2010-7#1)
woman who was admitted to our department with a##2##9##(2011-2#2)
woman who was admitted to our##3##6##(2011-2#2)(2012-2#1)
woman who was admitted to##4##5##(2011-2#2)(2012-1#1)(2012-2#1)
woman who was admitted##6##4##(2007-8#2)(2011-2#2)(2012-1#1)(2012-2#1)
woman who was diagnosed##2##4##(2011-1#1)(2012-2#1)
woman who was##17##3##(1992-2#1)(1996-12#1)(2004-12#1)(2006-10#1)(2006-11#1)(2007-4#1)(2007-8#3)(2008-6#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)
woman who##86##2##(1990-6#1)(1992-2#2)(1994-12#2)(1995-12#1)(1996-12#2)(1996-6#2)(1997-3#1)(1997-6#1)(2004-12#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-2#1)(2006-3#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#5)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-3#2)(2009-4#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#6)(2013-1#4)(2013-7#1)(2013-8#4)
woman whose##6##2##(1997-7#1)(2007-10#1)(2009-5#1)(2010-2#1)(2010-9#1)(2012-12#1)
woman with a history of##8##5##(1993-10#1)(2006-10#1)(2006-5#1)(2007-4#1)(2010-7#1)(2011-12#1)(2012-12#1)(2012-3#1)
woman with a##48##3##(1990-5#1)(1990-6#1)(1991-6#1)(1992-10#1)(1993-10#1)(1994-6#1)(1996-3#1)(1997-3#1)(2005-11#1)(2005-12#1)(2006-10#4)(2006-2#1)(2006-4#4)(2006-5#1)(2007-10#1)(2007-12#1)(2007-3#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-1#1)(2009-5#1)(2009-7#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#1)(2013-7#1)
woman with abdominal##2##3##(1995-3#1)(2008-11#1)
woman with an isolated##2##4##(2006-12#1)(2013-7#1)
woman with an##11##3##(1991-1#1)(1991-11#1)(1992-8#1)(1993-11#1)(1993-12#1)(2006-12#1)(2007-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
woman with bilateral##2##3##(2007-10#1)(2008-7#1)
woman with chronic##5##3##(1991-5#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-7#1)
woman with coronary artery disease##3##5##(1997-7#1)(2007-8#2)
woman with early##2##3##(2008-8#1)(2012-3#1)
woman with hypertension##2##3##(1992-5#1)(1993-9#1)
woman with known##2##3##(1990-12#1)(2011-2#1)
woman with metastatic##2##3##(2012-12#1)(2012-2#1)
woman with multiple##3##3##(1992-5#1)(2008-5#1)(2013-1#1)
woman with myasthenia gravis##2##4##(2006-10#1)(2007-8#1)
woman with no##2##3##(1992-3#1)(2010-9#1)
woman with previous##2##3##(1992-8#1)(2006-10#1)
woman with progressive##2##3##(2008-1#1)(2013-1#1)
woman with recurrent##4##3##(1990-8#1)(1991-2#1)(2007-5#1)(2012-12#1)
woman with right##2##3##(2010-7#2)
woman with severe##5##3##(2006-10#2)(2012-2#3)
woman with systemic lupus erythematosus##2##5##(2006-10#1)(2013-8#1)
woman with type##2##3##(2004-10#1)(2012-3#1)
woman with##195##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-8#2)(1993-10#2)(1993-11#1)(1993-12#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-3#3)(1996-6#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-10#2)(2005-11#1)(2005-12#1)(2005-5#1)(2006-10#16)(2006-12#3)(2006-2#1)(2006-4#5)(2006-5#1)(2006-8#2)(2006-9#2)(2007-10#5)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#2)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#7)(2007-9#3)(2008-1#3)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#3)(2009-1#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-12#4)(2010-3#2)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#1)(2010-9#4)(2011-1#4)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#7)(2012-2#4)(2012-3#5)(2013-1#13)(2013-7#3)(2013-8#4)
woman without##5##2##(1991-3#1)(1993-11#1)(2007-8#1)(2008-1#1)(2013-8#1)
woman##729##1##(1990-10#2)(1990-12#3)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#9)(1990-8#2)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#4)(1991-5#3)(1991-6#7)(1991-8#2)(1991-9#5)(1992-1#1)(1992-10#2)(1992-12#5)(1992-2#5)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#3)(1992-9#1)(1993-10#2)(1993-11#4)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#3)(1993-7#2)(1993-8#5)(1993-9#3)(1994-12#3)(1994-2#2)(1994-4#6)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#3)(1995-12#3)(1995-2#2)(1995-3#2)(1995-4#2)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#8)(1996-3#5)(1996-6#11)(1996-8#1)(1997-1#3)(1997-3#2)(1997-5#2)(1997-6#2)(1997-7#5)(1997-8#4)(2004-10#2)(2004-12#1)(2004-2#1)(2005-1#2)(2005-11#6)(2005-12#6)(2005-5#2)(2005-8#1)(2006-1#1)(2006-10#39)(2006-11#1)(2006-12#7)(2006-2#3)(2006-3#1)(2006-4#11)(2006-5#1)(2006-6#1)(2006-7#4)(2006-8#4)(2006-9#6)(2007-10#10)(2007-11#2)(2007-12#7)(2007-2#11)(2007-3#3)(2007-4#3)(2007-5#4)(2007-6#1)(2007-7#15)(2007-8#37)(2007-9#7)(2008-1#10)(2008-10#6)(2008-11#6)(2008-12#5)(2008-3#7)(2008-4#5)(2008-5#11)(2008-6#7)(2008-7#14)(2008-8#4)(2008-9#3)(2009-1#5)(2009-10#2)(2009-3#8)(2009-4#2)(2009-5#6)(2009-6#3)(2009-7#1)(2009-8#4)(2010-11#3)(2010-12#13)(2010-2#5)(2010-3#5)(2010-4#1)(2010-5#7)(2010-6#7)(2010-7#4)(2010-8#4)(2010-9#6)(2011-1#9)(2011-12#2)(2011-2#34)(2012-1#3)(2012-12#19)(2012-2#23)(2012-3#15)(2012-8#1)(2013-1#40)(2013-7#9)(2013-8#23)
woman&quot##3##1##(1997-3#1)(2013-1#2)
woman's ability to##2##3##(2007-2#1)(2010-2#1)
woman's body##2##2##(2007-12#1)(2007-2#1)
woman's health##4##2##(1992-6#1)(1996-8#1)(2007-7#1)(2011-2#1)
woman's own##3##2##(1991-4#1)(1997-2#1)(2008-1#1)
woman's##54##1##(1991-4#1)(1991-9#1)(1992-6#1)(1994-7#1)(1995-1#1)(1995-9#1)(1996-6#2)(1996-8#2)(1997-1#1)(1997-2#1)(1997-7#1)(2004-12#1)(2006-4#2)(2006-7#1)(2006-9#1)(2007-12#1)(2007-2#6)(2007-7#2)(2007-9#3)(2008-1#2)(2008-11#2)(2008-2#2)(2008-4#1)(2008-6#1)(2008-9#2)(2009-3#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#4)
woman)##4##1##(1991-8#1)(2007-8#1)(2008-1#1)(2011-2#1)
woman?##2##1##(2006-9#1)(2008-10#1)
woman]##5##1##(1993-10#1)(1995-12#1)(2005-11#1)(2006-2#1)(2010-12#1)
womb##4##1##(1992-6#1)(1997-6#1)(1997-7#1)(2006-12#1)
women &gt##4##2##(1994-9#1)(1997-8#1)(2004-2#1)(2009-11#1)
women &lt##2##2##(2004-2#1)(2011-1#1)
women &quot##3##2##(2006-7#1)(2008-12#1)(2009-4#1)
women (1##4##2##(2006-10#1)(2008-8#1)(2010-9#1)(2011-2#1)
women (14%)##2##2##(1995-8#1)(1997-2#1)
women (22%)##2##2##(1991-12#1)(2007-7#1)
women (36##2##2##(1994-2#1)(2008-5#1)
women (37##2##2##(2013-1#1)(2013-8#1)
women (5##2##2##(1994-12#1)(2010-12#1)
women (56##2##2##(1992-5#1)(2008-3#1)
women (6##2##2##(2006-10#1)(2011-2#1)
women (62%)##3##2##(2007-3#1)(2008-1#1)(2013-1#1)
women (8##2##2##(1991-9#1)(2008-5#1)
women (92##2##2##(2006-10#1)(2013-1#1)
women (95% CI##2##3##(1991-9#1)(2006-4#1)
women (95%##3##2##(1990-6#1)(1991-9#1)(2006-4#1)
women (BMIs##2##2##(2007-12#2)
women (M##3##2##(2007-12#1)(2008-11#1)(2010-2#1)
women (N =##4##3##(2006-1#2)(2006-7#1)(2007-7#1)
women (ORa##2##2##(2012-3#2)
women (P &lt##2##3##(2011-1#1)(2013-1#1)
women (P from 0##2##4##(2011-1#2)
women (P##6##2##(1996-7#1)(2011-1#3)(2013-1#1)(2013-8#1)
women (RR 1##2##3##(1997-8#1)(2007-3#1)
women (RR = 1##2##4##(1993-8#2)
women (RR##4##2##(1993-8#2)(1997-8#1)(2007-3#1)
women (age##2##2##(2008-7#1)(2012-2#1)
women (average age##3##3##(2007-11#1)(2007-9#1)(2010-9#1)
women (mean age 20##2##4##(1994-4#1)(2005-8#1)
women (mean age##12##3##(1992-2#1)(1994-4#1)(1996-2#1)(2004-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#2)(2008-3#1)(2008-5#1)
women (mean##14##2##(1992-2#1)(1994-4#1)(1996-2#1)(1996-9#1)(2004-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#2)(2008-3#1)(2008-5#1)(2013-8#1)
women (n =##8##3##(1990-11#1)(1991-2#1)(1992-9#1)(1995-11#2)(2007-8#1)(2008-11#1)(2011-2#1)
women (n##9##2##(1990-11#1)(1991-2#1)(1992-9#1)(1995-11#2)(2006-6#1)(2007-8#1)(2008-11#1)(2011-2#1)
women (p&lt##3##2##(2006-10#2)(2012-1#1)
women -##2##2##(2010-5#1)(2011-2#1)
women 40##2##2##(1995-9#1)(2011-2#1)
women 49 years or older##2##5##(1992-9#2)
women 50##2##2##(1990-6#1)(1997-1#1)
women 55##2##2##(2006-10#1)(2008-3#1)
women Veterans##3##2##(2012-12#3)
women a##3##2##(1990-9#2)(2007-2#1)
women about the##2##3##(1995-6#1)(2006-2#1)
women about their##3##3##(1992-4#1)(2008-3#1)(2008-9#1)
women about##9##2##(1990-6#1)(1992-4#1)(1995-6#1)(2006-10#1)(2006-2#1)(2008-3#1)(2008-9#1)(2011-2#2)
women across##3##2##(2007-12#1)(2010-5#1)(2013-1#1)
women admitted for##3##3##(1990-12#1)(2006-7#1)(2007-7#1)
women admitted to##2##3##(2004-10#1)(2007-2#1)
women admitted##6##2##(1990-12#1)(2004-10#1)(2006-7#1)(2007-2#2)(2007-7#1)
women affected by##6##3##(1991-2#1)(1991-4#1)(1994-5#2)(2011-2#1)(2013-1#1)
women after menopause##2##3##(1991-5#1)(2008-4#1)
women after##13##2##(1991-5#1)(2005-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-7#1)(2008-4#1)(2009-12#2)(2011-1#1)(2011-2#1)(2012-3#1)
women age 50 and older##2##5##(1995-2#2)
women age##6##2##(1990-6#1)(1995-2#2)(1995-4#1)(2007-10#1)(2009-12#1)
women aged &gt##3##3##(2004-1#1)(2008-3#1)(2008-7#1)
women aged &lt##2##3##(2008-7#2)
women aged 15-44##4##3##(1991-11#1)(1991-8#1)(2012-11#2)
women aged 15-49 years##3##4##(2009-7#1)(2012-3#2)
women aged 18 to 27##2##5##(1992-1#2)
women aged 18 to##4##4##(1992-1#2)(2008-1#1)(2012-11#1)
women aged 18##5##3##(1992-1#2)(2008-1#1)(2008-3#1)(2012-11#1)
women aged 18-44 years##2##4##(1996-8#2)
women aged 18-44##3##3##(1996-8#3)
women aged 20 to##3##4##(1991-4#1)(2013-8#2)
women aged 20##4##3##(1991-4#1)(2006-4#1)(2013-8#2)
women aged 20-64##2##3##(1992-4#1)(2005-10#1)
women aged 25 - 54 years in##4##7##(2011-1#4)
women aged 25##5##3##(1991-7#1)(2011-1#4)
women aged 35 to##2##4##(1992-2#1)(2008-7#1)
women aged 35##4##3##(1992-2#1)(2004-10#2)(2008-7#1)
women aged 45##2##3##(2008-1#1)(2013-1#1)
women aged 50##3##3##(2007-11#1)(2012-12#2)
women aged 50-69 years##2##4##(2004-2#2)
women aged 50-70##2##3##(2004-2#1)(2008-5#1)
women aged 60 or older##3##5##(2011-1#2)(2011-2#1)
women aged 60##4##3##(1996-6#1)(2011-1#2)(2011-2#1)
women aged between##8##3##(1990-9#1)(1992-10#1)(1996-4#1)(2008-5#1)(2010-3#1)(2011-2#2)(2013-8#1)
women aged over 50 years##2##5##(1993-2#1)(1995-4#1)
women aged over##6##3##(1993-2#1)(1994-2#1)(1995-4#1)(2007-10#1)(2008-7#1)(2011-2#1)
women aged##103##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-10#2)(1992-2#3)(1992-4#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-7#1)(1994-11#2)(1994-2#2)(1994-9#1)(1995-12#1)(1995-4#1)(1996-4#3)(1996-6#1)(1996-8#5)(2004-1#1)(2004-10#2)(2004-2#3)(2005-10#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-11#1)(2008-3#3)(2008-5#3)(2008-7#5)(2008-9#1)(2009-5#2)(2009-7#1)(2010-3#2)(2011-1#9)(2011-2#7)(2012-11#3)(2012-12#2)(2012-3#3)(2013-1#4)(2013-8#3)
women also##3##2##(2007-12#1)(2007-3#1)(2008-7#1)
women among##3##2##(1993-6#1)(2007-3#1)(2008-10#1)
women and 10##2##3##(2007-7#1)(2008-1#1)
women and 10%##2##3##(1991-11#1)(2010-11#1)
women and 13 men aged##2##5##(2007-11#1)(2008-7#1)
women and 13##3##3##(2007-11#1)(2008-3#1)(2008-7#1)
women and 15##4##3##(1996-1#1)(2008-3#1)(2008-4#1)(2009-10#1)
women and 19##2##3##(2011-2#1)(2013-1#1)
women and 2##3##3##(1994-5#1)(2006-2#1)(2007-8#1)
women and 5 men)##3##4##(2007-11#2)(2007-7#1)
women and 5##5##3##(1990-6#1)(1992-10#1)(2007-11#2)(2007-7#1)
women and 6 men##3##4##(1990-12#1)(2007-7#1)(2007-8#1)
women and 6 men)##2##4##(2007-11#1)(2007-8#1)
women and 6##5##3##(1990-12#1)(2007-11#1)(2007-7#1)(2007-8#2)
women and AIDS##2##3##(1996-12#2)
women and a##3##3##(2007-8#1)(2009-10#1)(2011-1#1)
women and among##2##3##(2006-10#1)(2007-7#1)
women and children in##3##4##(1990-2#1)(1996-8#1)(2009-9#1)
women and children##14##3##(1990-2#3)(1995-6#1)(1996-8#2)(1997-2#1)(2006-4#1)(2006-8#1)(2008-7#2)(2009-9#1)(2011-2#2)
women and cord blood##2##4##(2007-2#1)(2010-5#1)
women and female##2##3##(1995-9#1)(2012-3#1)
women and four##2##3##(1993-5#1)(2008-10#1)
women and girls##2##3##(1995-9#1)(2007-8#1)
women and had##2##3##(1997-7#1)(2013-1#1)
women and health##2##3##(1995-6#1)(2012-2#1)
women and in##5##3##(1991-3#1)(2005-7#1)(2006-10#1)(2007-4#1)(2013-8#1)
women and is characterized##2##4##(2006-10#1)(2011-1#1)
women and is##5##3##(2006-10#1)(2007-10#1)(2010-12#1)(2011-1#1)(2013-8#1)
women and its##3##3##(1990-9#1)(2008-11#1)(2012-12#1)
women and may be##2##4##(2008-3#1)(2013-1#1)
women and may##3##3##(2008-3#1)(2011-2#1)(2013-1#1)
women and men aged##3##4##(1991-6#2)(2009-10#1)
women and men from##2##4##(2011-2#1)(2012-2#1)
women and men were##2##4##(2008-5#1)(2013-1#1)
women and men##29##3##(1991-6#2)(1991-8#1)(1994-2#1)(1996-1#1)(1996-3#1)(1996-9#1)(2005-3#1)(2006-7#2)(2006-8#2)(2007-12#1)(2008-5#1)(2009-10#2)(2009-11#1)(2009-7#2)(2010-1#1)(2010-10#3)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
women and nine men##2##4##(1993-3#1)(2008-9#1)
women and seven men##2##4##(2006-11#1)(2012-3#1)
women and that##4##3##(2007-10#1)(2007-2#1)(2009-5#1)(2011-2#1)
women and the##17##3##(1992-2#1)(1994-6#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-5#1)(2006-10#2)(2007-12#1)(2007-7#1)(2008-12#1)(2008-9#3)(2011-1#2)(2012-12#1)
women and their families##13##4##(2007-2#8)(2010-9#1)(2012-2#1)(2012-3#3)
women and their infants##2##4##(1992-12#1)(2009-9#1)
women and their offspring##2##4##(2011-2#1)(2012-2#1)
women and their partners##2##4##(2005-10#1)(2013-1#1)
women and their##36##3##(1992-12#1)(1994-6#1)(1996-12#1)(2005-10#1)(2006-7#2)(2007-12#1)(2007-2#8)(2007-8#4)(2008-10#1)(2008-12#1)(2008-6#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#1)
women and three men##2##4##(2011-2#1)(2013-1#1)
women and to##6##3##(2005-7#1)(2006-10#1)(2007-12#1)(2008-5#1)(2011-2#1)(2012-3#1)
women and two men##2##4##(2008-10#1)(2010-7#1)
women and women with##4##4##(1992-12#1)(1992-9#1)(2010-6#1)(2013-1#1)
women and women##5##3##(1990-12#1)(1992-12#1)(1992-9#1)(2010-6#1)(2013-1#1)
women and young##5##3##(2007-7#4)(2012-3#1)
women and##304##2##(1990-11#2)(1990-12#2)(1990-2#3)(1990-4#1)(1990-6#2)(1990-9#1)(1991-11#2)(1991-3#1)(1991-6#6)(1991-8#5)(1992-10#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-3#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-5#1)(1995-6#3)(1995-9#5)(1996-1#3)(1996-12#4)(1996-2#1)(1996-3#3)(1996-8#2)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#3)(2005-10#2)(2005-3#1)(2005-7#2)(2006-10#14)(2006-11#1)(2006-12#1)(2006-2#3)(2006-4#1)(2006-7#7)(2006-8#6)(2007-10#4)(2007-11#10)(2007-12#9)(2007-2#14)(2007-4#1)(2007-7#13)(2007-8#11)(2007-9#2)(2008-1#5)(2008-10#3)(2008-11#1)(2008-12#4)(2008-3#5)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#6)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#2)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#4)(2010-9#4)(2011-1#7)(2011-2#11)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#8)(2013-1#14)(2013-8#3)
women are affected by##2##4##(1990-6#1)(2012-3#1)
women are at a##2##4##(2008-4#1)(2012-12#1)
women are at greater risk##3##5##(2007-10#1)(2007-7#1)(2010-6#1)
women are at##7##3##(2004-3#1)(2007-10#1)(2007-7#1)(2008-4#1)(2009-3#1)(2010-6#1)(2012-12#1)
women are exposed##2##3##(1991-6#1)(2012-3#1)
women are less likely to##2##5##(1991-11#1)(2011-2#1)
women are less likely##3##4##(1991-11#1)(2008-3#1)(2011-2#1)
women are more##2##3##(2008-4#1)(2012-2#1)
women are most##2##3##(2008-1#1)(2012-3#1)
women are not##2##3##(1994-12#1)(2013-1#1)
women are relatively##2##3##(1991-5#1)(2006-4#1)
women are systematically##2##3##(2008-11#1)(2008-8#1)
women are the##2##3##(2006-1#1)(2011-2#1)
women are##65##2##(1990-6#1)(1991-11#1)(1991-5#1)(1991-6#2)(1992-10#1)(1993-3#2)(1993-5#1)(1994-12#2)(1994-2#1)(1994-7#1)(1995-12#2)(1995-5#1)(1996-11#1)(2004-3#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#2)(2007-7#2)(2007-9#2)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-3#1)(2009-4#2)(2009-7#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#2)
women around the##2##3##(2008-5#1)(2009-10#1)
women as compared with##2##4##(1993-11#1)(1993-7#1)
women as compared##3##3##(1990-10#1)(1993-11#1)(1993-7#1)
women as well as women##2##5##(2005-3#1)(2011-2#1)
women as well as##4##4##(1992-12#2)(2005-3#1)(2011-2#1)
women as##19##2##(1990-10#1)(1990-4#1)(1991-6#1)(1992-12#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-7#1)(2005-3#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-3#1)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#2)
women at high risk for HIV infection##2##7##(1992-2#2)
women at high risk for HIV##3##6##(1992-2#3)
women at high risk for##6##5##(1991-8#1)(1992-2#3)(1993-11#1)(2010-7#1)
women at high risk##11##4##(1991-8#1)(1992-2#3)(1993-11#2)(2006-10#1)(2007-2#3)(2010-7#1)
women at increased risk##2##4##(1991-5#1)(2008-11#1)
women at risk for##4##4##(2004-3#1)(2008-4#1)(2009-6#1)(2011-2#1)
women at risk of##4##4##(1994-6#1)(1994-7#1)(1997-1#1)(2012-2#1)
women at risk##10##3##(1990-9#1)(1992-8#1)(1994-6#1)(1994-7#1)(1997-1#1)(2004-3#1)(2008-4#1)(2009-6#1)(2011-2#1)(2012-2#1)
women at the##7##3##(1996-3#1)(2004-2#1)(2006-2#1)(2008-7#2)(2011-2#2)
women at##52##2##(1990-3#1)(1990-9#1)(1991-5#1)(1991-8#1)(1992-2#3)(1992-8#1)(1993-11#3)(1994-12#1)(1994-6#1)(1994-7#1)(1996-3#1)(1997-1#1)(2004-2#1)(2004-3#1)(2006-10#4)(2006-2#1)(2006-7#2)(2007-12#2)(2007-2#3)(2007-7#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-3#1)(2009-6#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#4)(2012-2#1)(2013-1#1)
women attended##2##2##(2011-1#2)
women attending a##4##3##(1993-2#1)(1996-6#1)(2006-8#1)(2010-3#1)
women attending an##3##3##(2007-12#1)(2007-2#1)(2008-3#1)
women attending antenatal##3##3##(2009-5#1)(2011-2#1)(2013-8#1)
women attending obstetrics and##2##4##(2008-12#1)(2011-2#1)
women attending the##3##3##(2006-7#1)(2011-2#1)(2013-1#1)
women attending##26##2##(1993-2#1)(1994-6#1)(1996-6#1)(2004-10#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-8#2)(2009-5#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#3)(2013-1#1)(2013-8#1)
women awaiting##2##2##(2006-10#2)
women became pregnant##2##3##(1991-10#1)(1991-4#1)
women before##4##2##(1991-6#1)(1997-4#1)(1997-8#1)(2006-8#1)
women being##2##2##(2005-12#1)(2011-2#1)
women better##3##2##(1994-2#1)(2011-1#1)(2011-2#1)
women between the ages of##5##5##(1992-2#1)(2006-10#1)(2006-7#1)(2007-12#1)(2012-2#1)
women between the##6##3##(1992-2#1)(2006-10#1)(2006-7#1)(2007-12#1)(2011-1#1)(2012-2#1)
women between##16##2##(1990-9#1)(1991-5#1)(1991-6#1)(1992-2#1)(1995-8#1)(1996-3#2)(2006-10#1)(2006-7#1)(2007-12#1)(2008-10#1)(2011-1#1)(2012-2#3)(2012-3#1)
women beyond##2##2##(2011-1#1)(2013-7#1)
women born between##3##3##(1991-7#1)(1994-5#1)(1997-7#1)
women born##9##2##(1991-7#1)(1994-5#4)(1994-6#1)(1997-7#1)(2006-7#1)(2008-10#1)
women both##2##2##(2009-10#1)(2013-1#1)
women breast feed##2##3##(1994-4#2)
women but not##2##3##(2007-12#1)(2007-2#1)
women but##8##2##(1991-12#1)(1994-10#1)(2007-12#2)(2007-2#1)(2009-8#1)(2010-12#1)(2012-12#1)
women by means of##2##4##(1990-6#1)(1993-6#1)
women by##11##2##(1990-11#1)(1990-6#1)(1993-6#1)(2004-2#1)(2006-1#1)(2006-4#1)(2007-3#1)(2007-7#1)(2008-7#2)(2009-2#1)
women can##6##2##(2006-5#1)(2007-2#2)(2007-7#1)(2009-9#1)(2012-3#1)
women characterized by##2##3##(2008-3#2)
women clients##2##2##(1991-6#1)(2008-6#1)
women compared to##2##3##(1993-12#1)(2011-1#1)
women compared with##5##3##(2006-8#1)(2008-4#1)(2009-11#1)(2010-3#1)(2013-1#1)
women compared##9##2##(1992-4#1)(1993-12#1)(2006-8#1)(2007-12#1)(2008-4#1)(2009-11#1)(2010-3#1)(2011-1#1)(2013-1#1)
women complained of##2##3##(1992-3#1)(2008-3#1)
women complaining of##2##3##(2004-10#1)(2004-2#1)
women completed self-report##2##3##(2006-10#1)(2007-12#1)
women completed##6##2##(2006-10#1)(2007-12#2)(2011-1#1)(2012-11#1)(2012-2#1)
women complied with##2##3##(2011-2#2)
women considered##3##2##(2007-7#1)(2009-3#1)(2009-4#1)
women continue to##3##3##(1995-12#1)(2007-4#1)(2008-11#1)
women decreased##2##2##(1991-8#1)(1997-7#1)
women delivered##3##2##(1994-12#1)(2004-10#1)(2007-9#1)
women delivering in Tijuana##2##4##(2005-10#2)
women delivering in##4##3##(2005-10#3)(2006-2#1)
women delivering##5##2##(2005-10#3)(2006-2#1)(2007-9#1)
women demonstrated##2##2##(2011-2#1)(2013-1#1)
women described their##2##3##(1996-12#1)(2007-12#1)
women described##4##2##(1996-12#2)(2004-3#1)(2007-12#1)
women diagnosed as having##2##4##(2006-6#1)(2008-3#1)
women diagnosed with##4##3##(1993-2#1)(2006-10#1)(2006-7#1)(2010-12#1)
women diagnosed##8##2##(1991-7#2)(1993-2#1)(2006-10#1)(2006-6#1)(2006-7#1)(2008-3#1)(2010-12#1)
women did not differ##2##4##(2004-11#1)(2007-11#1)
women did not show##2##4##(2010-6#1)(2011-1#1)
women did not##9##3##(1991-10#1)(1991-4#1)(1996-1#1)(2004-11#1)(2007-11#1)(2008-5#1)(2010-6#1)(2011-1#1)(2013-8#1)
women did##10##2##(1991-10#1)(1991-4#1)(1996-1#1)(1996-6#1)(2004-11#1)(2007-11#1)(2008-5#1)(2010-6#1)(2011-1#1)(2013-8#1)
women divided into##2##3##(2004-10#1)(2008-8#1)
women do not##3##3##(1990-9#1)(2006-10#1)(2007-4#1)
women do##4##2##(1990-9#1)(2006-10#1)(2007-2#1)(2007-4#1)
women during pregnancy##2##3##(2008-4#1)(2009-9#1)
women during the##11##3##(1992-10#1)(1992-3#1)(1995-12#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-4#3)(2010-12#1)(2013-8#1)
women during their##2##3##(2006-6#1)(2010-7#1)
women during##19##2##(1992-10#1)(1992-3#1)(1995-12#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-8#1)(2008-4#4)(2009-9#1)(2010-12#2)(2010-7#1)(2010-9#1)(2013-8#1)
women each year##2##3##(1996-8#1)(2010-8#1)
women each##3##2##(1996-8#1)(2008-5#1)(2010-8#1)
women enrolled in the##2##4##(1995-8#1)(2008-12#1)
women enrolled in##3##3##(1995-8#1)(2007-12#1)(2008-12#1)
women enrolled##4##2##(1995-8#1)(2007-12#1)(2008-12#1)(2011-1#1)
women evaluated##3##2##(2007-12#1)(2010-3#1)(2011-2#1)
women examined##2##2##(1990-2#1)(1997-3#1)
women experience more##2##3##(2008-7#2)
women experience##8##2##(2004-1#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-7#2)(2012-3#1)
women experienced##3##2##(1995-6#1)(2007-10#1)(2007-3#1)
women experiencing##3##2##(1991-2#1)(2007-12#1)(2010-3#1)
women exposed to##3##3##(1993-4#1)(1994-8#1)(2011-1#1)
women felt##2##2##(1991-8#1)(2007-12#1)
women find##2##2##(2007-12#1)(2008-5#1)
women for prenatal##2##3##(1996-12#1)(1996-2#1)
women for##15##2##(1990-2#1)(1996-12#1)(1996-2#1)(1997-7#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-3#1)(2010-7#1)(2011-2#2)(2012-2#1)
women from the##8##3##(1994-5#1)(1995-12#1)(2006-4#2)(2007-12#1)(2007-2#1)(2008-4#1)(2010-6#1)
women from##42##2##(1992-2#1)(1993-1#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-12#2)(1996-7#1)(2004-10#1)(2006-4#3)(2006-8#1)(2006-9#1)(2007-12#2)(2007-2#2)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-4#1)(2009-9#1)(2010-6#2)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
women get##3##2##(1993-3#1)(1996-6#1)(2012-2#1)
women group##2##2##(2007-11#1)(2008-4#1)
women had a##5##3##(1990-12#1)(1991-2#1)(1992-2#1)(2004-10#1)(2008-11#1)
women had an overall survival##2##5##(2004-1#2)
women had an##4##3##(2004-1#2)(2007-3#2)
women had been##4##3##(1990-5#1)(2007-2#1)(2007-7#1)(2008-4#1)
women had better##2##3##(2008-3#1)(2011-2#1)
women had had at least##2##5##(1990-8#1)(1992-2#1)
women had had##3##3##(1990-6#1)(1990-8#1)(1992-2#1)
women had higher##3##3##(2006-10#1)(2007-3#1)(2013-1#1)
women had lower##3##3##(2006-12#1)(2008-1#1)(2011-2#1)
women had normal##2##3##(1993-12#1)(2012-12#1)
women had significantly##2##3##(2006-10#1)(2013-1#1)
women had##63##2##(1990-12#1)(1990-5#1)(1990-6#3)(1990-8#2)(1990-9#2)(1991-2#1)(1992-2#2)(1993-1#1)(1993-12#3)(1994-12#1)(1995-8#1)(1996-12#2)(1997-4#1)(2004-1#2)(2004-10#3)(2006-10#4)(2006-12#1)(2006-7#1)(2006-8#1)(2007-2#1)(2007-3#4)(2007-7#3)(2008-1#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2011-1#1)(2011-2#5)(2012-12#2)(2013-1#6)
women has been##2##3##(1994-6#1)(2009-5#1)
women has##10##2##(1990-6#1)(1991-11#1)(1991-6#1)(1994-6#1)(2006-4#1)(2007-6#1)(2009-5#1)(2009-9#1)(2011-1#1)(2013-1#1)
women have a##4##3##(2006-10#1)(2010-12#1)(2010-6#1)(2012-2#1)
women have been##5##3##(2006-10#1)(2006-8#1)(2008-11#1)(2011-2#2)
women have not##2##3##(1994-6#1)(2009-4#1)
women have##31##2##(1991-2#1)(1992-2#1)(1994-6#1)(2004-3#1)(2006-10#3)(2006-8#1)(2007-12#1)(2007-2#2)(2007-3#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-4#3)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
women having##4##2##(2007-7#1)(2008-3#1)(2009-6#1)(2013-8#1)
women high##3##2##(2007-12#1)(2010-3#2)
women identified as having##2##4##(2008-3#2)
women identified##5##2##(2007-12#1)(2008-3#2)(2012-11#1)(2013-1#1)
women in India##2##3##(1995-12#1)(1996-8#1)
women in Japan##3##3##(1994-6#1)(1997-8#1)(2011-2#1)
women in Korea##2##3##(2011-2#2)
women in Malawi##2##3##(1996-12#1)(2007-7#1)
women in New##3##3##(1994-9#1)(2008-1#2)
women in Norway##2##3##(1992-2#1)(2012-3#1)
women in South Africa##2##4##(2007-12#1)(2007-7#1)
women in a rural community in##2##6##(2007-3#1)(2010-6#1)
women in a rural##4##4##(2007-3#1)(2010-4#1)(2010-6#1)(2013-1#1)
women in a##12##3##(1996-12#1)(1997-7#1)(2006-10#1)(2007-3#1)(2008-12#1)(2009-5#1)(2010-4#1)(2010-6#1)(2010-9#1)(2012-3#1)(2013-1#2)
women in academic##2##3##(1993-6#1)(2007-4#1)
women in an urban slum##2##5##(2011-12#2)
women in an urban##4##4##(2007-4#1)(2011-1#1)(2011-12#2)
women in an##7##3##(2004-10#1)(2007-4#2)(2009-9#1)(2011-1#1)(2011-12#2)
women in both##2##3##(2007-7#1)(2009-11#1)
women in clinical##2##3##(1994-12#1)(2009-9#1)
women in developed countries##2##4##(2006-10#1)(2007-2#1)
women in different##2##3##(2006-10#1)(2007-12#1)
women in each group##4##4##(1993-4#3)(2006-8#1)
women in each##7##3##(1993-4#3)(1994-12#1)(2004-10#1)(2006-8#1)(2008-5#1)
women in early pregnancy##2##4##(1990-8#1)(2007-5#1)
women in early##3##3##(1990-8#1)(2007-5#1)(2008-10#1)
women in general##2##3##(1996-4#1)(2006-10#1)
women in group A##4##4##(2006-4#1)(2008-3#3)
women in group##7##3##(2006-4#1)(2008-3#6)
women in labor##3##3##(1993-1#1)(1993-2#1)(2007-2#1)
women in labour##2##3##(1993-7#1)(2012-12#1)
women in most##2##3##(2009-10#1)(2012-3#1)
women in research##2##3##(2009-9#2)
women in rural##4##3##(1996-12#1)(2006-10#1)(2011-2#1)(2012-2#1)
women in six##2##3##(1995-2#1)(2013-1#1)
women in southern##4##3##(2011-1#3)(2011-2#1)
women in the United States##4##5##(1991-3#1)(1996-8#1)(2007-2#1)(2007-9#1)
women in the analysis##2##4##(1996-7#1)(2009-5#1)
women in the community##2##4##(2008-11#1)(2010-8#1)
women in the control group##2##5##(2007-2#1)(2008-1#1)
women in the experimental##3##4##(2007-2#1)(2010-2#2)
women in the first trimester##3##5##(1992-2#1)(1996-12#1)(2012-12#1)
women in the normal##2##4##(1992-5#1)(1992-6#1)
women in the same##2##4##(1990-4#1)(2006-4#1)
women in the second##2##4##(1994-12#1)(2012-2#1)
women in the study##2##4##(2007-12#1)(2007-7#1)
women in the##72##3##(1990-4#1)(1991-3#1)(1991-6#3)(1991-8#1)(1992-1#1)(1992-2#1)(1992-4#3)(1992-5#1)(1992-6#1)(1993-3#1)(1993-6#3)(1994-12#1)(1994-6#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-3#1)(2004-1#1)(2004-2#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-8#3)(2006-9#1)(2007-12#1)(2007-2#4)(2007-3#2)(2007-7#3)(2007-9#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-4#2)(2009-5#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#2)
women in their first##2##4##(1990-12#1)(2007-7#1)
women in their##8##3##(1990-12#1)(1991-3#1)(1993-8#1)(2007-7#1)(2007-9#1)(2008-3#1)(2008-5#1)(2012-12#1)
women in this age group##2##5##(1996-8#1)(2008-3#1)
women in this group had##2##5##(2008-11#1)(2012-3#1)
women in this study##2##4##(1994-2#1)(2008-3#1)
women in this##8##3##(1994-2#1)(1996-8#1)(2008-11#1)(2008-3#2)(2010-6#1)(2012-3#1)(2013-1#1)
women in treatment for##2##4##(2004-3#1)(2013-8#1)
women in treatment##3##3##(1990-12#1)(2004-3#1)(2013-8#1)
women in urban##2##3##(2007-3#1)(2007-5#1)
women in whom##6##3##(1990-12#2)(1991-11#1)(1994-6#1)(2007-8#1)(2008-6#1)
women in##307##2##(1990-12#6)(1990-2#1)(1990-4#1)(1990-6#3)(1990-8#1)(1991-11#1)(1991-3#2)(1991-6#6)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#3)(1992-4#3)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-4#3)(1993-6#6)(1993-7#1)(1993-8#1)(1994-12#3)(1994-2#2)(1994-6#4)(1994-9#2)(1995-12#1)(1995-2#2)(1995-5#1)(1996-12#5)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-1#1)(2004-10#3)(2004-2#1)(2004-3#1)(2005-10#1)(2006-1#1)(2006-10#12)(2006-12#1)(2006-4#3)(2006-7#10)(2006-8#4)(2006-9#3)(2007-1#1)(2007-10#1)(2007-12#4)(2007-2#9)(2007-3#6)(2007-4#5)(2007-5#2)(2007-7#11)(2007-8#2)(2007-9#4)(2008-1#3)(2008-10#1)(2008-11#4)(2008-12#3)(2008-3#9)(2008-4#2)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#1)(2009-4#3)(2009-5#5)(2009-7#1)(2009-8#1)(2009-9#5)(2010-12#1)(2010-2#6)(2010-3#3)(2010-4#1)(2010-6#3)(2010-8#4)(2010-9#1)(2011-1#11)(2011-12#3)(2011-2#12)(2012-1#1)(2012-11#2)(2012-12#8)(2012-2#4)(2012-3#10)(2013-1#15)(2013-7#2)(2013-8#3)
women include##2##2##(2008-1#1)(2013-1#1)
women indicated##2##2##(2007-2#1)(2007-3#1)
women infected with##3##3##(1996-12#1)(2006-10#2)
women infected##4##2##(1996-12#1)(2006-10#2)(2012-3#1)
women interviewed were##2##3##(1995-6#1)(1997-7#1)
women into##4##2##(1991-6#1)(2009-4#1)(2011-2#1)(2012-12#1)
women invited##2##2##(2004-2#1)(2011-1#1)
women involved with##2##3##(2005-7#1)(2012-3#1)
women involved##3##2##(2005-7#1)(2007-2#1)(2012-3#1)
women is a##2##3##(2005-11#1)(2007-3#1)
women is not##2##3##(2006-10#1)(2012-2#1)
women is##36##2##(1991-2#1)(1991-8#1)(1992-11#1)(1992-2#1)(1993-5#1)(1994-12#2)(1994-4#1)(1995-9#1)(1996-3#1)(2005-11#1)(2005-3#2)(2006-10#1)(2006-8#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-3#3)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
women less than 35 years of age##2##7##(2008-7#2)
women less than##5##3##(1991-5#1)(2004-2#1)(2008-5#1)(2008-7#2)
women less##6##2##(1991-5#1)(2004-2#1)(2006-8#1)(2008-5#1)(2008-7#2)
women living in the##4##4##(2007-2#1)(2007-9#1)(2008-5#1)(2012-3#1)
women living in urban areas##2##5##(2008-10#1)(2012-12#1)
women living in urban##3##4##(2008-10#1)(2012-12#1)(2012-3#1)
women living in##16##3##(1990-2#1)(1991-8#1)(1993-11#1)(1996-3#1)(1996-7#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-5#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-7#1)(2013-8#1)
women living with##4##3##(1996-3#1)(2008-1#1)(2011-1#1)(2012-3#1)
women living##21##2##(1990-2#1)(1991-8#1)(1993-11#1)(1996-3#2)(1996-7#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#3)(2013-7#1)(2013-8#1)
women make##2##2##(2005-11#1)(2010-9#1)
women may be##6##3##(1996-11#1)(2005-10#1)(2006-10#1)(2007-2#1)(2008-12#2)
women may have##5##3##(2005-10#3)(2011-2#1)(2012-12#1)
women may##17##2##(1991-5#1)(1996-11#1)(2004-11#1)(2005-10#4)(2006-10#1)(2007-2#3)(2008-11#1)(2008-12#2)(2011-2#1)(2012-12#1)(2013-7#1)
women met##2##2##(1994-2#1)(2007-7#1)
women more than 5 years##2##5##(1995-2#1)(2007-11#1)
women more than##4##3##(1990-12#2)(1995-2#1)(2007-11#1)
women more##6##2##(1990-12#2)(1995-2#1)(2006-8#1)(2007-11#1)(2008-3#1)
women need##2##2##(2007-2#1)(2012-2#1)
women no##2##2##(1996-12#1)(2009-12#1)
women not taking##4##3##(1990-11#4)
women not##8##2##(1990-11#4)(1990-12#1)(2004-2#1)(2007-2#1)(2011-1#1)
women of age 35##2##4##(2004-10#1)(2011-1#1)
women of age##3##3##(2004-10#1)(2011-1#2)
women of all ages##2##4##(2007-10#1)(2011-1#1)
women of child-bearing age##4##4##(1996-12#1)(2006-10#1)(2007-11#1)(2009-7#1)
women of childbearing age (15-45 years)##2##6##(2009-4#2)
women of childbearing age at##2##5##(2010-8#1)(2013-1#1)
women of childbearing age##17##4##(2006-10#2)(2007-2#2)(2007-9#1)(2008-3#2)(2009-4#3)(2010-12#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#1)
women of childbearing##21##3##(1990-2#1)(1996-4#1)(2006-10#2)(2007-2#2)(2007-9#2)(2008-3#2)(2009-4#3)(2010-12#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
women of fertile age##3##4##(1996-12#2)(2008-1#1)
women of lower socioeconomic status##2##5##(2011-2#2)
women of reproductive age##14##4##(1994-9#1)(1995-5#1)(2006-4#1)(2008-3#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#1)(2012-3#1)(2013-7#1)
women of similar##2##3##(2006-4#1)(2007-11#1)
women of the Malwa region of Punjab##3##7##(2013-8#3)
women of the childbearing ages in Gorgan##2##7##(2013-8#2)
women of the childbearing ages##3##5##(2013-8#3)
women of the##14##3##(1990-2#1)(1993-2#1)(1996-6#1)(2008-9#2)(2013-1#1)(2013-8#8)
women of##91##2##(1990-2#2)(1990-6#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-9#1)(1993-2#1)(1994-9#1)(1995-5#1)(1996-12#3)(1996-4#1)(1996-5#1)(1996-6#1)(2004-10#1)(2006-10#3)(2006-4#3)(2006-6#2)(2007-10#2)(2007-11#2)(2007-2#2)(2007-7#2)(2007-9#2)(2008-1#2)(2008-11#1)(2008-3#5)(2008-9#2)(2009-4#4)(2009-7#1)(2010-12#3)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#6)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#12)
women older than 30##2##4##(2006-10#1)(2008-7#1)
women older than##3##3##(2006-10#1)(2008-7#1)(2013-1#1)
women on the day##2##4##(1994-6#1)(2004-2#1)
women on the##4##3##(1994-6#1)(2004-2#1)(2008-2#1)(2011-1#1)
women on##17##2##(1992-2#3)(1994-6#1)(2004-2#1)(2006-10#2)(2006-4#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-6#1)(2011-1#3)(2012-1#1)
women or##9##2##(1993-11#1)(2005-7#1)(2006-10#1)(2008-2#1)(2009-12#1)(2012-12#1)(2013-1#3)
women out of 100##2##4##(1992-2#1)(2008-11#1)
women ova##2##2##(1996-12#2)
women over 30 years##2##4##(1990-10#1)(1992-8#1)
women over 50 years of age##3##6##(1993-2#1)(1995-4#1)(2004-2#1)
women over 50##4##3##(1990-6#1)(1993-2#1)(1995-4#1)(2004-2#1)
women over the age of##2##5##(2004-2#1)(2007-8#1)
women over the##3##3##(2004-2#1)(2007-8#1)(2008-3#1)
women over##16##2##(1990-10#1)(1990-6#1)(1990-8#1)(1991-3#1)(1992-8#1)(1993-2#1)(1995-4#1)(1996-3#1)(1996-9#1)(2004-2#2)(2007-8#1)(2008-3#1)(2008-5#1)(2009-2#1)(2012-3#1)
women participated in the study##2##5##(2007-10#1)(2011-1#1)
women participated in the##3##4##(2007-10#1)(2011-1#1)(2012-3#1)
women participated in##5##3##(2007-10#1)(2007-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
women participated##6##2##(1992-12#1)(2007-10#1)(2007-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
women participating in a##2##4##(2007-12#2)
women participating in##4##3##(2004-2#1)(2007-12#2)(2007-7#1)
women patients with anorexia##2##4##(2006-6#2)
women patients##3##2##(1992-8#1)(2006-6#2)
women per##2##2##(1992-2#1)(2007-2#1)
women physicians##4##2##(1993-6#2)(2006-10#1)(2007-9#1)
women preferred##2##2##(1995-5#1)(2007-7#1)
women presenting for##6##3##(2006-10#1)(2007-2#2)(2008-6#1)(2012-3#1)(2013-1#1)
women presenting to##2##3##(2006-10#1)(2007-12#1)
women presenting with a##2##4##(2006-10#1)(2011-2#1)
women presenting with##5##3##(2006-10#1)(2006-8#1)(2007-3#1)(2008-3#1)(2011-2#1)
women presenting##13##2##(2006-10#3)(2006-8#1)(2007-12#1)(2007-2#2)(2007-3#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
women rated##2##2##(2010-2#1)(2010-3#1)
women receive##2##2##(1995-1#1)(2008-6#1)
women received a##2##3##(1996-12#1)(2008-5#1)
women received##7##2##(1992-12#1)(1996-12#1)(2006-7#1)(2008-5#1)(2010-8#1)(2011-1#1)(2012-11#1)
women receiving##8##2##(1990-12#1)(1991-8#1)(2007-11#1)(2008-7#1)(2011-1#3)(2013-1#1)
women recruited from##3##3##(1995-1#1)(2006-7#1)(2011-1#1)
women referred for##2##3##(1992-6#1)(2008-11#1)
women referred to##3##3##(1994-1#1)(2006-10#1)(2013-7#1)
women referred##6##2##(1992-6#1)(1994-1#1)(2006-10#1)(2008-11#1)(2011-1#1)(2013-7#1)
women reported more##3##3##(2007-12#2)(2008-5#1)
women reported that##2##3##(1990-8#1)(2007-3#1)
women reported##14##2##(1990-12#1)(1990-6#1)(1990-8#1)(1992-2#1)(1997-3#1)(2007-12#4)(2007-2#1)(2007-3#1)(2008-12#1)(2008-5#1)(2011-1#1)
women reporting no##2##3##(1991-7#2)
women reporting##5##2##(1990-12#2)(1991-7#2)(1992-9#1)
women required##2##2##(1993-4#1)(2004-10#1)
women resident##2##2##(1990-2#1)(2008-1#1)
women residents##2##2##(1991-8#1)(1993-9#1)
women residing in##3##3##(2007-8#2)(2008-7#1)
women residing to##2##3##(2007-8#2)
women residing##5##2##(2007-8#4)(2008-7#1)
women s##5##2##(2006-10#5)
women scheduled for a primary care appointment##2##7##(2006-10#2)
women scheduled for##4##3##(2006-10#2)(2010-3#1)(2010-8#1)
women screened##4##2##(2004-2#1)(2007-8#1)(2010-2#1)(2011-1#1)
women seek##2##2##(1992-2#1)(2006-10#1)
women seeking abortion##4##3##(1991-10#1)(1994-2#1)(2007-3#1)(2008-11#1)
women seeking##8##2##(1991-10#1)(1994-2#1)(1997-1#1)(2006-2#1)(2007-12#1)(2007-3#1)(2008-11#1)(2013-8#1)
women selected##4##2##(1991-10#1)(1991-9#1)(2006-8#1)(2007-3#1)
women sexual##2##2##(2008-1#1)(2009-11#1)
women should be##8##3##(1992-8#2)(1994-12#1)(2005-3#1)(2007-2#1)(2010-6#1)(2013-1#1)(2013-8#1)
women should##11##2##(1992-8#2)(1994-12#1)(1995-4#1)(2005-3#1)(2007-2#2)(2010-6#1)(2013-1#2)(2013-8#1)
women show##2##2##(2006-4#1)(2010-5#1)
women showed##2##2##(1994-6#1)(2013-8#1)
women significantly##2##2##(1996-12#1)(2012-3#1)
women since##3##2##(1994-9#1)(2008-4#1)(2010-12#1)
women still smoke##2##3##(1991-11#2)
women still##6##2##(1991-11#2)(1995-6#1)(1996-4#1)(2007-11#1)(2007-4#1)
women studied##4##2##(1994-3#1)(2006-10#1)(2007-11#1)(2009-5#1)
women such as##2##3##(2008-1#1)(2010-3#1)
women suffer##3##2##(1990-6#1)(2007-10#1)(2011-2#1)
women suffered from##2##3##(1991-2#1)(2011-1#1)
women suffering from chronic##2##4##(1996-4#1)(2008-11#1)
women suffering from osteoarthritis##2##4##(2011-1#1)(2013-1#1)
women suffering from##8##3##(1996-4#1)(2006-7#1)(2008-11#1)(2008-4#1)(2011-1#1)(2013-1#3)
women taking OC##2##3##(1990-11#1)(2008-11#1)
women taking OCs##2##3##(1990-11#2)
women taking oral contraceptives##3##4##(1990-11#1)(2007-8#1)(2009-8#1)
women taking##12##2##(1990-11#7)(2007-8#1)(2008-11#3)(2009-8#1)
women tend to be##2##4##(1995-2#1)(2012-12#1)
women tend to##3##3##(1995-2#1)(2011-2#1)(2012-12#1)
women tended to##2##3##(2011-2#2)
women than among##3##3##(1990-6#1)(1995-5#1)(2009-4#1)
women than for##2##3##(2008-12#1)(2011-2#1)
women than men##10##3##(1995-12#1)(1995-2#1)(2008-5#1)(2009-11#1)(2009-4#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
women than##31##2##(1990-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1997-6#2)(2005-3#1)(2007-11#2)(2007-8#2)(2008-10#1)(2008-12#2)(2008-3#2)(2008-5#2)(2009-11#2)(2009-4#2)(2010-4#1)(2010-6#1)(2011-2#3)(2012-3#1)(2013-8#3)
women that##8##2##(1995-9#1)(2006-8#1)(2007-10#1)(2007-3#1)(2010-9#1)(2012-11#1)(2012-12#1)(2013-8#1)
women the rate##2##3##(1991-8#1)(2011-2#1)
women the##14##2##(1990-9#1)(1991-8#2)(1992-3#1)(1992-7#1)(1994-2#1)(1994-9#1)(1995-4#1)(2006-7#1)(2007-12#1)(2008-5#1)(2011-12#1)(2011-2#2)
women through##2##2##(2007-9#1)(2008-9#1)
women to cope with##2##4##(2007-2#1)(2007-7#1)
women to determine##2##3##(1996-1#1)(2007-7#1)
women to develop##2##3##(1995-9#1)(2007-12#1)
women to give birth##2##4##(2007-2#1)(2010-2#1)
women to report##2##3##(2006-6#1)(2009-7#1)
women to use##2##3##(2007-2#1)(2008-3#1)
women to##56##2##(1990-12#1)(1990-2#1)(1991-12#1)(1992-4#1)(1994-12#2)(1994-4#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-7#1)(1996-8#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-12#4)(2007-2#7)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-7#3)(2010-10#1)(2010-12#1)(2010-2#1)(2010-9#1)(2012-1#1)(2012-11#1)(2012-3#2)(2013-1#2)
women treated by##2##3##(1992-3#1)(2004-1#1)
women treated for##3##3##(1996-9#1)(2011-2#1)(2012-11#1)
women treated with##3##3##(1993-2#1)(2004-1#1)(2008-5#1)
women treated##11##2##(1991-2#1)(1992-3#1)(1993-2#1)(1994-12#1)(1996-9#1)(2004-1#2)(2008-5#1)(2010-9#1)(2011-2#1)(2012-11#1)
women turn##2##2##(2008-9#2)
women under 25##2##3##(1991-8#1)(2006-1#1)
women under##10##2##(1991-6#1)(1991-8#1)(1992-2#2)(1997-2#1)(2006-1#1)(2007-5#1)(2007-8#1)(2010-12#2)
women undergoing IVF-ET##3##3##(1994-9#1)(2007-11#2)
women undergoing elective##2##3##(2004-1#1)(2011-2#1)
women undergoing in vitro##2##4##(2007-11#1)(2013-7#1)
women undergoing##19##2##(1992-1#1)(1993-12#1)(1994-9#1)(1995-12#1)(1996-12#2)(2004-1#1)(2006-2#1)(2007-11#3)(2007-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
women underwent a##2##3##(2006-10#1)(2010-3#1)
women underwent##6##2##(1991-11#1)(1994-2#1)(2006-10#1)(2010-3#1)(2011-2#1)(2012-12#1)
women used##4##2##(1992-2#3)(2008-4#1)
women using##7##2##(1990-6#1)(1992-2#1)(1995-8#1)(2005-10#1)(2011-1#2)(2011-2#1)
women versus##3##2##(2008-12#1)(2013-1#2)
women visiting##2##2##(2012-3#2)
women volunteers##6##2##(1990-3#1)(1994-2#1)(2008-3#1)(2008-5#1)(2009-6#1)(2013-8#1)
women was also##2##3##(2007-2#1)(2009-4#1)
women was not##2##3##(2010-3#1)(2013-8#1)
women was obtained##2##3##(2011-1#1)(2012-12#1)
women was##39##2##(1990-4#1)(1991-11#1)(1991-6#1)(1992-9#1)(1994-5#1)(1994-6#1)(1994-9#1)(1997-4#1)(1997-8#1)(2004-11#2)(2004-2#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-4#1)(2009-9#1)(2010-3#3)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
women wearing##2##2##(2007-7#1)(2011-1#1)
women were also##3##3##(1991-6#1)(1992-10#1)(2007-2#1)
women were at##2##3##(1997-7#1)(2007-2#1)
women were compared##3##3##(1994-12#1)(2007-3#1)(2009-5#1)
women were diagnosed with##2##4##(2011-2#2)
women were divided into##2##4##(1995-3#1)(2010-3#1)
women were examined##4##3##(2006-5#1)(2006-7#1)(2008-1#1)(2011-2#1)
women were having##2##3##(2006-4#2)
women were in##2##3##(2007-2#1)(2011-2#1)
women were included in the study##2##6##(2006-8#1)(2011-2#1)
women were included in the##3##5##(2006-8#1)(2007-2#1)(2011-2#1)
women were included##4##3##(2006-8#1)(2007-2#1)(2011-2#1)(2012-3#1)
women were interviewed##3##3##(2007-2#1)(2007-3#1)(2011-1#1)
women were less likely to##2##5##(1996-12#1)(2007-3#1)
women were less##3##3##(1996-12#1)(2007-3#1)(2010-5#1)
women were more likely to##2##5##(2008-1#1)(2013-1#1)
women were more likely##3##4##(2008-1#1)(2008-12#1)(2013-1#1)
women were more##8##3##(1990-12#1)(2006-7#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2013-1#1)
women were most##2##3##(2006-7#1)(2007-12#1)
women were positive##2##3##(1996-6#1)(2008-3#1)
women were randomized to receive##2##5##(2011-2#2)
women were randomized to##3##4##(2011-2#2)(2012-12#1)
women were randomly allocated to##2##5##(1990-6#1)(1995-5#1)
women were randomly##3##3##(1990-6#1)(1994-2#1)(1995-5#1)
women were recruited from##2##4##(2013-1#2)
women were recruited##3##3##(2007-10#1)(2013-1#2)
women were referred##2##3##(2007-3#1)(2011-1#1)
women were significantly##2##3##(1994-12#1)(2011-1#1)
women were studied##7##3##(1990-12#1)(2004-10#1)(2006-10#1)(2007-2#1)(2007-8#1)(2012-12#1)(2012-3#1)
women were surveyed##2##3##(2006-10#1)(2007-3#1)
women were treated with the##2##5##(1992-10#1)(1996-2#1)
women were treated with##3##4##(1992-10#1)(1996-2#1)(2008-5#1)
women were used##2##3##(2007-3#1)(2009-5#1)
women were##144##2##(1990-12#2)(1990-6#5)(1990-8#1)(1991-12#1)(1991-3#1)(1991-4#2)(1991-6#2)(1992-1#1)(1992-10#3)(1992-3#1)(1992-4#1)(1992-5#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-3#2)(1995-5#1)(1996-12#3)(1996-2#1)(1996-6#1)(1997-7#1)(2004-10#1)(2004-2#3)(2005-10#2)(2006-10#3)(2006-12#1)(2006-4#4)(2006-5#1)(2006-7#5)(2006-8#3)(2007-10#3)(2007-11#1)(2007-12#6)(2007-2#6)(2007-3#11)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#2)(2010-3#2)(2010-5#1)(2010-8#3)(2011-1#11)(2011-12#1)(2011-2#10)(2012-12#3)(2012-3#3)(2013-1#5)(2013-8#3)
women who are at##2##4##(1990-9#1)(1993-9#1)
women who are medically underserved##2##5##(1997-1#2)
women who are not##4##4##(1995-9#1)(2006-10#1)(2007-2#1)(2008-5#1)
women who are obese##2##4##(2008-3#1)(2011-1#1)
women who are##29##3##(1990-9#1)(1992-10#1)(1992-3#1)(1993-9#1)(1995-6#1)(1995-9#1)(1997-1#2)(2004-10#1)(2004-3#1)(2005-10#1)(2006-10#2)(2006-8#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#2)(2008-3#1)(2008-5#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
women who attended##2##3##(2006-10#1)(2007-7#1)
women who breast feed##2##4##(1994-4#2)
women who completed the screening##2##5##(2013-1#2)
women who completed the##3##4##(2006-10#1)(2013-1#2)
women who completed##5##3##(2006-10#1)(2007-3#1)(2011-2#1)(2013-1#2)
women who crossed##2##3##(1992-5#2)
women who delivered##2##3##(1992-2#1)(2011-1#1)
women who did not##5##4##(1990-6#1)(1992-5#1)(2007-12#1)(2007-2#1)(2010-2#1)
women who did##6##3##(1990-6#1)(1992-5#1)(2007-12#1)(2007-2#1)(2010-2#2)
women who felt##2##3##(1997-1#1)(2009-4#1)
women who got##3##3##(1993-8#1)(2007-2#2)
women who had a##3##4##(1991-11#1)(1996-9#1)(2011-2#1)
women who had been##3##4##(1996-6#1)(2007-12#1)(2011-1#1)
women who had had##4##4##(1991-7#1)(1993-10#1)(1993-2#1)(2011-2#1)
women who had received##3##4##(2007-12#2)(2008-7#1)
women who had##36##3##(1990-12#1)(1991-11#1)(1991-7#2)(1992-12#2)(1993-1#1)(1993-10#1)(1993-2#1)(1994-2#1)(1995-12#1)(1996-3#1)(1996-6#1)(1996-9#1)(2006-10#3)(2006-4#1)(2006-5#1)(2006-8#2)(2007-12#3)(2007-2#1)(2008-7#3)(2008-9#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)
women who have been##3##4##(2008-3#1)(2010-3#2)
women who have had##2##4##(2006-10#2)
women who have##14##3##(1994-9#1)(2006-10#3)(2007-2#1)(2008-2#1)(2008-3#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-3#2)(2010-8#1)(2011-2#1)
women who may##2##3##(2004-10#1)(2008-3#1)
women who never##2##3##(2009-5#1)(2011-2#1)
women who participated in the##2##5##(1996-1#1)(2007-2#1)
women who participated in##3##4##(1996-1#1)(2006-7#1)(2007-2#1)
women who participated##5##3##(1996-1#1)(2006-7#1)(2007-2#1)(2007-9#1)(2009-12#1)
women who plan##2##3##(2007-2#2)
women who presented##2##3##(2008-3#1)(2010-6#1)
women who received##4##3##(1991-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
women who required##2##3##(1993-1#1)(1995-8#1)
women who stalk##2##3##(2009-9#2)
women who started##2##3##(1996-4#1)(2006-8#1)
women who subsequently##2##3##(1994-3#1)(1996-8#1)
women who suffer##3##3##(2004-3#1)(2005-8#1)(2013-1#1)
women who took##2##3##(2008-3#2)
women who underwent##3##3##(2008-10#1)(2010-3#1)(2011-2#1)
women who used the low-dose##2##5##(1994-5#2)
women who used##4##3##(1994-5#2)(2010-11#1)(2013-1#1)
women who were diagnosed with##2##5##(1994-2#1)(2007-10#1)
women who were##18##3##(1990-6#1)(1991-10#1)(1991-8#1)(1994-2#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
women who##221##2##(1990-12#2)(1990-6#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#2)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#3)(1993-1#2)(1993-10#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#4)(1994-3#2)(1994-4#2)(1994-5#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-4#1)(2004-10#2)(2004-2#1)(2004-3#4)(2005-10#3)(2005-11#1)(2005-8#1)(2006-10#13)(2006-4#1)(2006-5#2)(2006-7#2)(2006-8#5)(2006-9#1)(2007-10#2)(2007-12#10)(2007-2#19)(2007-3#2)(2007-6#1)(2007-7#5)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#8)(2008-5#4)(2008-7#4)(2008-9#3)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#2)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#3)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#12)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#11)(2013-8#2)
women whose##10##2##(1991-7#1)(1991-9#2)(1993-11#1)(1994-7#1)(2006-10#1)(2006-4#1)(2008-10#1)(2010-4#1)(2011-1#1)
women will have##2##3##(2007-4#1)(2011-12#1)
women will##6##2##(1996-2#1)(2007-4#1)(2007-8#2)(2008-1#1)(2011-12#1)
women wished to##2##3##(1993-9#1)(2011-2#1)
women with 10 &lt##2##4##(2008-7#2)
women with Alzheimer's##2##3##(1995-11#2)
women with CTTH##2##3##(2010-9#2)
women with Down syndrome##4##4##(2013-1#4)
women with FGS##3##3##(1996-12#3)
women with GDM##2##3##(2009-3#2)
women with HIV##3##3##(1996-12#1)(2006-10#1)(2011-1#1)
women with HIV/AIDS##3##3##(2007-1#2)(2008-12#1)
women with MetS##2##3##(2011-1#2)
women with PCOS and##3##4##(2008-3#2)(2010-10#1)
women with PCOS##23##3##(2008-3#8)(2008-4#2)(2010-10#4)(2010-11#1)(2010-4#5)(2011-1#2)(2012-11#1)
women with PMS##2##3##(2009-6#2)
women with PPH##2##3##(2011-2#1)(2013-8#1)
women with SLE##4##3##(2006-10#4)
women with SUI##2##3##(2008-3#2)
women with WHO group##2##4##(2007-11#2)
women with a history of##9##5##(2004-3#1)(2007-12#2)(2008-4#1)(2010-12#2)(2012-3#2)(2013-1#1)
women with a multiple pregnancy##4##5##(2007-2#4)
women with a previous history of##2##6##(2006-10#1)(2008-7#1)
women with a##31##3##(1990-12#1)(1990-9#1)(1991-5#1)(1994-7#1)(2004-3#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#4)(2007-4#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#2)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
women with abnormal##5##3##(1990-6#1)(1995-3#1)(2006-10#1)(2011-1#1)(2011-2#1)
women with advanced ovarian cancer##2##5##(1992-2#2)
women with advanced##5##3##(1991-6#1)(1992-2#2)(1992-5#1)(2010-12#1)
women with age average##2##4##(2011-2#2)
women with an average age of##3##6##(1994-12#1)(2007-8#1)(2008-9#1)
women with an##8##3##(1992-1#2)(1994-12#1)(2007-8#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-2#1)
women with and without eating concerns##2##6##(2007-12#2)
women with and without##8##4##(1990-3#1)(1991-1#1)(1996-12#1)(2007-12#2)(2010-3#1)(2012-1#1)(2013-1#1)
women with apocrine##3##3##(1993-1#1)(2008-12#1)(2008-4#1)
women with average age##2##4##(2008-9#1)(2011-2#1)
women with benign##2##3##(1992-12#1)(1992-9#1)
women with breast cancer and their##2##6##(1994-3#1)(2013-1#1)
women with breast cancer and##5##5##(1990-12#1)(1994-3#1)(1994-4#1)(2008-7#1)(2013-1#1)
women with breast cancer##34##4##(1990-12#2)(1992-2#1)(1992-4#1)(1993-12#1)(1994-12#1)(1994-3#2)(1994-4#1)(2004-2#1)(2008-10#1)(2008-4#2)(2008-7#2)(2009-12#1)(2009-2#1)(2011-1#2)(2011-2#3)(2012-12#3)(2012-3#1)(2013-1#8)
women with breast##38##3##(1990-12#2)(1992-2#1)(1992-4#1)(1993-12#1)(1994-12#1)(1994-3#2)(1994-4#1)(2004-2#2)(2008-10#1)(2008-12#1)(2008-4#2)(2008-7#2)(2009-12#1)(2009-2#1)(2011-1#2)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#8)
women with breech presentation##2##4##(2011-12#2)
women with bulimia nervosa##5##4##(1995-11#1)(2006-7#3)(2007-12#1)
women with bulimia who##4##4##(2006-7#4)
women with bulimia##12##3##(1991-1#1)(1995-11#1)(2006-7#9)(2007-12#1)
women with cancer##2##3##(1991-2#1)(1994-4#1)
women with cervical intraepithelial neoplasia##3##5##(2006-10#1)(2011-2#2)
women with cervical##7##3##(2006-10#2)(2007-10#1)(2007-12#1)(2007-8#1)(2011-2#2)
women with children##2##3##(1991-7#1)(2008-6#1)
women with chronic##6##3##(1991-2#1)(1994-12#1)(2008-4#1)(2008-7#1)(2010-12#2)
women with climacteric##2##3##(1991-8#1)(2008-11#1)
women with coronary artery disease##2##5##(1995-3#1)(2010-6#1)
women with coronary##3##3##(1995-3#1)(2005-12#1)(2010-6#1)
women with cystic##3##3##(1993-7#1)(1994-3#1)(1995-9#1)
women with diabetes##3##3##(2008-3#2)(2010-10#1)
women with different##3##3##(2007-8#1)(2010-12#1)(2012-3#1)
women with disabilities##2##3##(2008-8#1)(2010-2#1)
women with endometriosis##7##3##(1992-9#4)(2007-10#3)
women with epilepsy##4##3##(2008-11#3)(2013-8#1)
women with fibromyalgia##2##3##(2006-10#1)(2006-8#1)
women with fistulas##2##3##(1996-12#2)
women with frequent##2##3##(2008-6#1)(2011-1#1)
women with genital prolapse##3##4##(2006-4#2)(2007-4#1)
women with genital##5##3##(1990-12#1)(1996-12#1)(2006-4#2)(2007-4#1)
women with gestational diabetes mellitus##4##5##(1992-12#3)(2011-2#1)
women with higher##2##3##(2006-10#1)(2013-1#1)
women with histologically confirmed##2##4##(1992-9#1)(1993-9#1)
women with histologically##4##3##(1992-9#2)(1993-9#1)(1994-1#1)
women with history##2##3##(2006-10#1)(2007-7#1)
women with hormone##2##3##(1991-4#1)(2013-1#1)
women with invasive##2##3##(2004-2#1)(2011-1#1)
women with large##2##3##(1994-2#1)(2007-7#1)
women with low bone##2##4##(2011-1#1)(2012-2#1)
women with low obstetric risk##3##5##(2013-1#3)
women with low##7##3##(1990-12#1)(2011-1#1)(2012-2#2)(2013-1#3)
women with lower##3##3##(1991-11#1)(2005-3#1)(2007-12#1)
women with metabolic##3##3##(2011-1#1)(2013-1#2)
women with migraine with aura##2##5##(2008-9#1)(2011-2#1)
women with mild##4##3##(2008-3#1)(2011-1#1)(2012-12#2)
women with no risk##2##4##(1990-6#1)(2010-9#1)
women with no##7##3##(1990-6#1)(2007-3#1)(2009-2#1)(2010-9#1)(2011-2#1)(2012-3#2)
women with normal##11##3##(1990-6#1)(2004-2#1)(2007-2#1)(2007-8#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
women with or without##3##4##(1994-9#1)(2011-2#2)
women with osteoporosis##4##3##(2008-8#2)(2010-3#2)
women with ovarian##3##3##(2005-11#1)(2007-10#1)(2008-1#1)
women with pelvic floor dysfunction##2##5##(2007-8#1)(2011-12#1)
women with pelvic floor##3##4##(2007-8#1)(2011-12#2)
women with pelvic##4##3##(1991-2#1)(2007-8#1)(2011-12#2)
women with polycystic ovarian syndrome##3##5##(2008-1#1)(2008-3#1)(2013-8#1)
women with polycystic ovarian syndrome]##2##5##(2008-11#1)(2013-1#1)
women with polycystic ovarian##5##4##(2008-1#1)(2008-11#1)(2008-3#1)(2013-1#1)(2013-8#1)
women with polycystic ovary syndrome (PCOS)##3##6##(2008-3#1)(2010-10#1)(2011-1#1)
women with polycystic ovary syndrome##7##5##(2008-3#2)(2010-10#2)(2011-1#1)(2012-3#1)(2013-8#1)
women with polycystic ovary##8##4##(2005-8#1)(2008-3#2)(2010-10#2)(2011-1#1)(2012-3#1)(2013-8#1)
women with polycystic##13##3##(2005-8#1)(2008-1#1)(2008-11#1)(2008-3#3)(2010-10#2)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
women with postmenopausal##2##3##(1990-6#1)(2007-9#1)
women with preeclampsia##2##3##(2008-3#1)(2011-2#1)
women with preterm delivery##2##4##(2012-12#1)(2013-1#1)
women with preterm##3##3##(2012-12#1)(2013-1#2)
women with previous##7##3##(2007-7#1)(2008-3#2)(2008-4#1)(2009-1#1)(2011-1#2)
women with primary heterosexual partners##2##5##(2011-1#2)
women with primary##4##3##(1991-8#1)(2009-10#1)(2011-1#2)
women with recurrent##3##3##(1990-11#1)(2007-10#1)(2008-5#1)
women with relative body weights##3##5##(1992-4#3)
women with risk factors for##2##5##(2012-2#1)(2013-8#1)
women with risk factors##3##4##(2012-2#2)(2013-8#1)
women with risk##4##3##(1996-6#1)(2012-2#2)(2013-8#1)
women with severe##3##3##(1996-8#1)(2008-11#1)(2011-1#1)
women with stress##2##3##(1995-5#1)(2013-1#1)
women with suspicious primary breast lesions##2##6##(2007-4#2)
women with symptoms of##3##4##(1996-12#1)(2008-11#2)
women with symptoms##5##3##(1990-8#1)(1996-12#1)(2004-2#1)(2008-11#2)
women with the##9##3##(1992-1#1)(1993-1#1)(1994-5#1)(1995-9#1)(2006-10#2)(2008-3#2)(2008-5#1)
women with this condition##2##4##(1994-9#1)(2008-10#1)
women with type 2 diabetes##4##5##(2008-1#2)(2008-3#1)(2012-2#1)
women with type##6##3##(2008-1#2)(2008-3#2)(2009-2#1)(2012-2#1)
women with urinary schistosomiasis##2##4##(1996-12#2)
women with urinary tract##2##4##(1992-12#1)(1993-1#1)
women with urinary##5##3##(1992-12#1)(1993-1#1)(1995-5#1)(1996-12#2)
women with##571##2##(1990-10#1)(1990-11#3)(1990-12#5)(1990-2#1)(1990-3#1)(1990-4#2)(1990-6#5)(1990-8#1)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#1)(1991-2#4)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#3)(1992-10#1)(1992-12#5)(1992-2#5)(1992-3#2)(1992-4#4)(1992-5#1)(1992-9#8)(1993-1#7)(1993-12#1)(1993-2#2)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-1#1)(1994-12#4)(1994-2#2)(1994-3#4)(1994-4#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#2)(1995-11#3)(1995-12#1)(1995-3#3)(1995-5#3)(1995-9#3)(1996-1#1)(1996-11#2)(1996-12#15)(1996-6#2)(1996-8#2)(1996-9#3)(1997-3#1)(1997-4#2)(1997-7#2)(2004-1#1)(2004-10#2)(2004-12#1)(2004-2#8)(2004-3#1)(2005-11#1)(2005-12#1)(2005-3#1)(2005-8#1)(2006-10#19)(2006-4#3)(2006-6#1)(2006-7#12)(2006-8#3)(2006-9#3)(2007-1#2)(2007-10#7)(2007-11#7)(2007-12#10)(2007-2#8)(2007-3#2)(2007-4#4)(2007-7#6)(2007-8#7)(2007-9#5)(2008-1#5)(2008-10#4)(2008-11#13)(2008-12#4)(2008-3#30)(2008-4#13)(2008-5#5)(2008-6#5)(2008-7#8)(2008-8#6)(2008-9#5)(2009-1#3)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#1)(2010-10#7)(2010-11#1)(2010-12#8)(2010-2#6)(2010-3#4)(2010-4#5)(2010-6#2)(2010-9#3)(2011-1#30)(2011-12#8)(2011-2#34)(2011-8#1)(2012-1#2)(2012-11#4)(2012-12#12)(2012-2#13)(2012-3#12)(2013-1#34)(2013-7#1)(2013-8#13)
women without a##2##3##(2007-6#1)(2008-7#1)
women without##18##2##(1990-6#2)(1991-3#1)(1993-9#1)(2004-2#1)(2006-10#2)(2007-6#1)(2008-3#2)(2008-7#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2011-1#2)(2013-1#1)
women working in##3##3##(2006-7#1)(2009-7#1)(2013-1#1)
women working##5##2##(2006-10#1)(2006-7#1)(2007-3#1)(2009-7#1)(2013-1#1)
women worldwide##8##2##(1995-9#1)(2005-10#1)(2007-10#1)(2008-11#1)(2011-2#2)(2012-2#1)(2013-1#1)
women would##4##2##(2006-8#1)(2007-7#1)(2007-8#1)(2009-1#1)
women younger than 49 years##3##5##(1992-9#3)
women younger than##4##3##(1991-12#1)(1992-9#3)
women##4641##1##(1990-10#5)(1990-11#21)(1990-12#40)(1990-2#22)(1990-3#6)(1990-4#9)(1990-5#5)(1990-6#45)(1990-8#13)(1990-9#18)(1991-1#5)(1991-10#7)(1991-11#22)(1991-12#10)(1991-2#15)(1991-3#11)(1991-4#9)(1991-5#13)(1991-6#38)(1991-7#11)(1991-8#38)(1991-9#12)(1992-1#20)(1992-10#13)(1992-11#2)(1992-12#17)(1992-2#45)(1992-3#15)(1992-4#24)(1992-5#12)(1992-6#3)(1992-7#3)(1992-8#11)(1992-9#25)(1993-1#15)(1993-10#7)(1993-11#11)(1993-12#10)(1993-2#14)(1993-3#6)(1993-4#6)(1993-5#3)(1993-6#17)(1993-7#7)(1993-8#12)(1993-9#14)(1994-1#2)(1994-10#3)(1994-11#6)(1994-12#32)(1994-2#31)(1994-3#12)(1994-4#10)(1994-5#19)(1994-6#24)(1994-7#7)(1994-8#3)(1994-9#23)(1995-1#4)(1995-10#1)(1995-11#6)(1995-12#18)(1995-2#12)(1995-3#6)(1995-4#6)(1995-5#12)(1995-6#15)(1995-8#12)(1995-9#16)(1996-1#9)(1996-11#11)(1996-12#59)(1996-2#10)(1996-3#21)(1996-4#10)(1996-5#5)(1996-6#14)(1996-7#10)(1996-8#20)(1996-9#18)(1997-1#8)(1997-2#9)(1997-3#10)(1997-4#10)(1997-5#11)(1997-6#4)(1997-7#17)(1997-8#17)(2003-11#1)(2004-1#16)(2004-10#31)(2004-11#6)(2004-12#2)(2004-2#36)(2004-3#11)(2005-1#5)(2005-10#24)(2005-11#5)(2005-12#4)(2005-3#9)(2005-7#6)(2005-8#4)(2005-9#1)(2006-1#9)(2006-10#169)(2006-11#2)(2006-12#13)(2006-2#19)(2006-3#5)(2006-4#32)(2006-5#9)(2006-6#14)(2006-7#67)(2006-8#57)(2006-9#12)(2007-1#8)(2007-10#35)(2007-11#59)(2007-12#162)(2007-2#145)(2007-3#60)(2007-4#24)(2007-5#4)(2007-6#6)(2007-7#97)(2007-8#54)(2007-9#52)(2008-1#54)(2008-10#30)(2008-11#57)(2008-12#55)(2008-2#7)(2008-3#136)(2008-4#55)(2008-5#65)(2008-6#15)(2008-7#74)(2008-8#23)(2008-9#37)(2009-1#11)(2009-10#21)(2009-11#18)(2009-12#16)(2009-2#9)(2009-3#12)(2009-4#39)(2009-5#31)(2009-6#10)(2009-7#17)(2009-8#6)(2009-9#17)(2010-1#3)(2010-10#19)(2010-11#4)(2010-12#50)(2010-2#27)(2010-3#45)(2010-4#16)(2010-5#11)(2010-6#25)(2010-7#7)(2010-8#32)(2010-9#26)(2011-1#179)(2011-12#22)(2011-2#257)(2011-3#1)(2011-7#2)(2011-8#1)(2011-9#1)(2012-1#15)(2012-11#23)(2012-12#81)(2012-2#59)(2012-3#98)(2013-1#212)(2013-3#1)(2013-7#19)(2013-8#75)
women's ability to##3##3##(2008-12#1)(2008-6#1)(2009-12#1)
women's access to##3##3##(2008-11#1)(2009-4#1)(2011-2#1)
women's age##2##2##(2007-7#1)(2011-3#1)
women's beauty and fashion magazines##2##5##(2006-7#2)
women's behavior##2##2##(1997-1#1)(2007-3#1)
women's body dissatisfaction##4##3##(2007-12#4)
women's body##8##2##(2007-12#6)(2008-9#1)(2011-2#1)
women's choice##2##2##(1996-11#1)(2007-7#1)
women's employment status##2##3##(2008-5#1)(2009-3#1)
women's employment##4##2##(2008-5#3)(2009-3#1)
women's experiences##4##2##(2008-12#1)(2009-4#1)(2012-1#1)(2013-8#1)
women's health and##5##3##(2008-10#1)(2008-11#2)(2008-9#1)(2009-10#1)
women's health care##3##3##(1996-3#1)(1997-1#1)(2008-10#1)
women's health in##2##3##(1991-6#1)(2010-6#1)
women's health##37##2##(1991-6#1)(1994-12#3)(1994-3#8)(1994-9#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(2005-10#1)(2006-8#1)(2007-3#1)(2008-10#2)(2008-11#4)(2008-9#1)(2009-10#1)(2009-11#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-3#1)
women's health]##3##2##(1990-5#1)(1997-4#1)(2005-3#1)
women's issues##2##2##(1994-3#1)(2012-3#1)
women's journey of recovery from sexual assault##2##7##(2010-3#2)
women's journey of recovery##3##4##(2010-3#3)
women's lives##7##2##(1996-1#1)(1997-5#1)(2006-7#1)(2007-7#1)(2008-3#1)(2012-12#2)
women's mental health##2##3##(2006-4#1)(2011-2#1)
women's mental##3##2##(2006-4#1)(2008-11#1)(2011-2#1)
women's movement##2##2##(1996-5#1)(1997-3#1)
women's needs##2##2##(2007-2#1)(2012-3#1)
women's perceptions of##2##3##(2007-12#1)(2007-2#1)
women's perceptions##4##2##(2006-7#1)(2007-12#1)(2007-2#1)(2012-12#1)
women's personal##3##2##(1994-12#1)(1996-1#1)(2012-12#1)
women's political participation##2##3##(2011-2#2)
women's preferences and##2##3##(2010-9#1)(2013-1#1)
women's preferences##3##2##(2010-3#1)(2010-9#1)(2013-1#1)
women's reports##2##2##(1995-8#1)(2009-5#1)
women's right to##2##3##(1996-8#1)(1997-1#1)
women's right##3##2##(1996-8#1)(1997-1#1)(2009-4#1)
women's rights##2##2##(1994-8#1)(2007-12#1)
women's satisfaction##2##2##(2006-1#1)(2006-4#1)
women's self-perception##2##2##(2008-5#2)
women's social##2##2##(1991-6#1)(2006-1#1)
women's views##2##2##(2008-3#1)(2010-9#1)
women's walking behaviour##3##3##(2010-2#3)
women's weight##2##2##(2008-9#1)(2009-5#1)
women's##239##1##(1990-10#1)(1990-5#1)(1990-8#2)(1991-4#1)(1991-6#5)(1991-7#1)(1993-6#1)(1994-12#5)(1994-3#12)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#2)(1995-4#1)(1995-6#3)(1995-8#1)(1996-1#4)(1996-11#2)(1996-3#3)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#1)(2005-10#2)(2005-3#1)(2006-1#2)(2006-4#2)(2006-7#5)(2006-8#3)(2007-12#15)(2007-2#10)(2007-3#3)(2007-4#1)(2007-7#6)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#12)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#8)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#5)(2009-4#7)(2009-5#2)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#4)(2010-3#4)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#4)(2011-1#2)(2011-12#1)(2011-2#15)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#9)(2012-3#7)(2013-1#4)(2013-8#1)
women) aged##2##2##(2007-9#1)(2013-1#1)
women) and##5##2##(1993-11#1)(1996-7#1)(2008-7#1)(2009-2#1)(2010-9#1)
women) for##2##2##(1996-12#1)(2007-7#1)
women) on##2##2##(2007-8#1)(2012-11#1)
women) were##7##2##(1991-9#1)(1996-6#1)(2008-11#1)(2008-9#2)(2013-1#1)(2013-8#1)
women) who##3##2##(1990-10#1)(2007-8#1)(2008-1#1)
women) with##6##2##(1993-8#1)(2006-6#1)(2007-12#1)(2008-9#1)(2010-9#1)(2013-8#1)
women)##90##1##(1990-10#1)(1990-4#1)(1990-5#2)(1991-10#3)(1991-4#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-6#2)(1996-7#3)(1997-8#1)(2005-1#4)(2005-10#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-7#2)(2007-8#3)(2007-9#3)(2008-1#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#5)(2008-9#4)(2009-10#1)(2009-2#1)(2010-9#4)(2011-1#1)(2012-11#1)(2012-12#3)(2012-2#3)(2013-1#7)(2013-8#3)
women--and##2##1##(1990-6#1)(1993-11#1)
women?##5##1##(1996-9#1)(2006-6#1)(2007-12#1)(2008-3#1)(2013-1#1)
women?]##2##1##(2006-2#1)(2007-9#1)
women]##32##1##(1990-10#1)(1991-11#1)(1991-2#1)(1991-6#2)(1991-9#2)(1992-4#1)(1993-2#1)(1993-3#1)(1995-4#1)(1996-3#1)(1996-8#1)(1997-3#1)(2005-10#2)(2005-11#1)(2006-6#2)(2007-10#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-1#2)(2009-5#1)(2010-6#1)(2012-3#2)
won the##4##2##(1994-2#1)(1994-3#1)(1996-12#1)(2007-8#1)
won##14##1##(1992-2#1)(1994-2#1)(1994-3#1)(1996-11#1)(1996-12#2)(1996-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-2#1)(2010-1#1)(2012-1#1)
won't be##2##2##(1994-3#1)(1995-12#1)
won't find##2##2##(1990-5#1)(2006-4#1)
won't go##2##2##(1993-12#1)(2007-8#1)
won't help##4##2##(1994-1#1)(1997-3#1)(2004-9#1)(2008-11#1)
won't##27##1##(1990-5#1)(1990-7#1)(1991-1#1)(1991-3#1)(1993-12#1)(1993-2#1)(1993-5#2)(1994-1#1)(1994-3#2)(1995-10#1)(1995-12#1)(1995-7#1)(1996-1#1)(1996-11#1)(1997-3#1)(2004-9#1)(2006-4#1)(2007-8#3)(2007-9#1)(2008-11#1)(2008-2#1)(2010-9#1)(2013-8#1)
wonder that##3##2##(1991-5#1)(1996-12#1)(2012-2#1)
wonder##6##1##(1991-5#1)(1996-12#1)(2007-10#1)(2008-7#1)(2009-1#1)(2012-2#1)
wondered if##2##2##(1994-2#1)(2011-2#1)
wondered##3##1##(1994-2#1)(2011-2#1)(2013-1#1)
wonderful##4##1##(1991-2#1)(2007-2#1)(2008-10#1)(2013-8#1)
wondering##2##1##(2007-8#1)(2010-12#1)
wonders##5##1##(1991-6#1)(1996-5#1)(2007-10#1)(2007-2#1)(2008-4#1)
wood and##12##2##(1990-10#1)(1992-10#2)(2005-8#1)(2007-9#1)(2008-10#4)(2008-5#1)(2011-2#1)(2013-8#1)
wood as##2##2##(1997-6#1)(2007-6#1)
wood ashes##2##2##(2008-10#2)
wood at##2##2##(2008-7#1)(2010-10#1)
wood boards to which the scent of##2##7##(2008-5#2)
wood by##2##2##(2013-1#1)(2013-8#1)
wood chips##2##2##(2005-11#1)(2011-12#1)
wood decay##3##2##(2008-10#3)
wood fiber##2##2##(2008-3#2)
wood fibers were##2##3##(2009-11#2)
wood fibers##7##2##(2008-3#4)(2009-11#3)
wood foreign bodies##2##3##(2011-1#2)
wood frogs##3##2##(2008-8#3)
wood in##2##2##(2008-10#2)
wood is##3##2##(2010-4#1)(2012-9#1)(2013-1#1)
wood origin##2##2##(2005-11#2)
wood products##2##2##(2006-12#1)(2008-10#1)
wood properties##2##2##(1993-4#1)(2008-5#1)
wood residue##3##2##(2009-3#3)
wood samples##4##2##(2007-6#1)(2008-10#3)
wood species##3##2##(2008-5#1)(2009-3#1)(2013-8#1)
wood surfaces##2##2##(2010-4#2)
wood that##3##2##(2008-4#1)(2012-12#1)(2013-1#1)
wood to##2##2##(2007-12#1)(2008-10#1)
wood were##4##2##(2008-10#2)(2008-5#1)(2009-3#1)
wood##154##1##(1990-10#1)(1990-6#1)(1992-10#2)(1993-4#1)(1994-6#2)(1995-3#1)(1996-8#1)(1997-6#1)(2004-8#2)(2005-10#3)(2005-11#7)(2005-8#1)(2006-12#1)(2007-1#3)(2007-12#1)(2007-3#1)(2007-6#5)(2007-9#1)(2008-10#29)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#13)(2008-6#4)(2008-7#2)(2008-8#3)(2008-9#4)(2009-11#3)(2009-3#7)(2009-8#2)(2010-10#1)(2010-4#13)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-5#1)(2012-9#1)(2013-1#7)(2013-8#6)
wood)##2##1##(2005-8#1)(2008-10#1)
wood-feeding termites##2##2##(2013-7#2)
wood-feeding##4##1##(2007-12#1)(2013-7#3)
wood-fiber##2##1##(2008-3#2)
wood-inhabiting##2##1##(2010-10#1)(2013-7#1)
wood-preserving sites##2##2##(2008-4#2)
wood-preserving##3##1##(2008-4#3)
wood-rotting##3##1##(2008-10#2)(2013-1#1)
woodborer##3##1##(2007-12#1)(2013-8#2)
wooden art objects##2##3##(2007-10#2)
wooden object##2##2##(2013-1#2)
wooden platform##2##2##(1993-9#2)
wooden##23##1##(1993-9#2)(2006-10#1)(2007-10#3)(2008-10#6)(2008-2#3)(2008-3#1)(2010-5#3)(2011-2#2)(2013-1#2)
woodland songbirds##2##2##(2008-9#2)
woodland##6##1##(2008-5#2)(2008-9#2)(2010-3#1)(2010-6#1)
woodlands##8##1##(2008-10#1)(2008-5#1)(2010-6#6)
woodpecker##3##1##(2008-9#2)(2013-1#1)
woodpeckers##2##1##(2008-9#1)(2013-1#1)
woodpile lattices##2##2##(2007-12#2)
woodrats##4##1##(2010-6#4)
woodwasp##2##1##(2011-2#2)
woody and ambery notes##2##4##(2006-12#2)
woody and ambery##3##3##(2006-12#3)
woody and##4##2##(2006-12#3)(2012-6#1)
woody hosts##4##2##(2008-10#4)
woody ornamental##2##2##(2008-10#2)
woody plant##2##2##(2006-12#1)(2008-8#1)
woody plants in##2##3##(2008-9#1)(2012-5#1)
woody plants##14##2##(2008-10#4)(2008-8#2)(2008-9#6)(2009-8#1)(2012-5#1)
woody species##6##2##(2008-10#2)(2008-8#1)(2011-10#1)(2012-5#1)(2013-7#1)
woody##44##1##(2006-12#5)(2007-3#1)(2008-10#17)(2008-8#4)(2008-9#6)(2009-8#1)(2010-8#2)(2011-10#1)(2012-5#2)(2012-6#1)(2012-7#1)(2013-7#1)(2013-8#2)
wool and##6##2##(2008-11#1)(2008-5#1)(2010-8#3)(2012-1#1)
wool fast blue BL (lambda(max)=540##2##5##(2008-10#2)
wool fast blue BL##3##4##(2008-10#3)
wool fiber##3##2##(2008-10#1)(2010-8#2)
wool fibers##4##2##(2008-2#1)(2010-8#3)
wool fibre##3##2##(2008-10#1)(2008-5#2)
wool is##2##2##(2008-4#1)(2010-8#1)
wool##57##1##(1992-2#1)(1992-8#2)(2008-10#13)(2008-11#1)(2008-2#1)(2008-4#4)(2008-5#3)(2008-6#5)(2008-8#1)(2010-5#1)(2010-8#23)(2012-1#1)(2013-1#1)
woolly monkeys##4##2##(2009-4#4)
woolly##7##1##(2007-7#2)(2009-4#5)
wools##2##1##(2010-8#2)
word &quot##5##2##(2004-10#1)(2006-3#1)(2007-10#1)(2007-12#1)(2008-1#1)
word and nonword##2##3##(2009-7#1)(2012-2#1)
word and text reading##3##4##(2007-9#2)(2008-11#1)
word and##14##2##(1994-1#2)(1995-12#1)(2005-7#1)(2007-9#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)(2009-7#1)(2012-2#1)
word as the nucleus##2##4##(2008-2#2)
word as##3##2##(2008-2#3)
word association##2##2##(2007-12#2)
word class deficits##2##3##(2012-11#2)
word class##4##2##(2012-11#4)
word classes##3##2##(2008-2#1)(2008-4#1)(2012-11#1)
word for##2##2##(1991-3#1)(2012-2#1)
word identification and##2##3##(2007-9#1)(2008-12#1)
word identification##4##2##(2004-10#1)(2007-9#1)(2008-12#1)(2008-2#1)
word in##7##2##(2005-10#1)(2006-3#1)(2007-5#1)(2008-2#1)(2008-5#1)(2009-5#1)(2013-8#1)
word learning##3##2##(2012-1#3)
word length##3##2##(2008-11#1)(2008-4#1)(2009-2#1)
word lists##3##2##(1997-7#1)(2008-4#1)(2009-7#1)
word n + 1##3##4##(2009-5#3)
word n +##4##3##(2009-5#4)
word network##2##2##(2012-2#2)
word nuclei##2##2##(2008-2#2)
word of##5##2##(2007-8#1)(2008-11#1)(2008-4#1)(2009-4#1)(2011-1#1)
word on##7##2##(1993-12#1)(1994-2#1)(2008-10#1)(2011-1#1)(2011-2#2)(2013-8#1)
word order##4##2##(2008-11#4)
word pairs##2##2##(2008-9#2)
word problem##3##2##(2009-12#3)
word problems##3##2##(2009-11#2)(2009-12#1)
word processing and##2##3##(2008-11#2)
word processing##10##2##(1992-12#1)(1993-6#1)(2007-4#1)(2008-11#6)(2008-12#1)
word production##4##2##(2007-10#1)(2007-7#1)(2008-9#2)
word reading and##2##3##(2007-9#1)(2008-12#1)
word reading efficiency in##2##4##(2012-2#2)
word reading skills##2##3##(2008-12#2)
word reading##12##2##(2004-10#1)(2007-9#5)(2008-12#3)(2008-9#1)(2012-2#2)
word recall##5##2##(2006-4#1)(2008-5#1)(2008-7#2)(2012-3#1)
word recognition research##2##3##(2008-4#2)
word recognition##12##2##(2007-3#1)(2007-9#1)(2008-11#3)(2008-4#3)(2009-2#1)(2010-2#2)(2011-2#1)
word sense disambiguation##4##3##(2013-1#4)
word size##2##2##(2007-12#1)(2008-3#1)
word type##4##2##(2007-9#1)(2008-2#1)(2009-11#2)
word was##2##2##(2012-2#2)
word with all digits restricted to the set##2##8##(2008-3#2)
word with##4##2##(2008-3#2)(2008-4#1)(2009-8#1)
word##255##1##(1990-8#1)(1991-3#1)(1992-12#1)(1992-8#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#3)(1994-2#1)(1995-1#2)(1995-11#3)(1995-12#1)(1995-2#2)(1995-5#2)(1995-8#1)(1996-1#1)(1996-2#3)(1997-6#1)(1997-7#2)(2004-10#5)(2005-10#4)(2005-7#2)(2005-8#1)(2006-12#1)(2006-3#2)(2006-4#2)(2006-7#2)(2007-10#3)(2007-11#1)(2007-12#7)(2007-3#2)(2007-4#3)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#14)(2008-1#2)(2008-10#6)(2008-11#18)(2008-12#6)(2008-2#19)(2008-3#8)(2008-4#13)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#10)(2009-11#4)(2009-12#4)(2009-2#5)(2009-4#2)(2009-5#5)(2009-7#3)(2009-8#3)(2010-12#2)(2010-2#2)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#6)(2011-3#1)(2012-1#5)(2012-11#6)(2012-2#16)(2012-3#1)(2013-1#8)(2013-8#4)
word's##2##1##(2008-4#1)(2010-2#1)
word)##2##1##(2007-8#1)(2010-10#1)
word- and bit-parallel##2##3##(2007-12#2)
word-learning##5##1##(2011-1#5)
word-problem measures##2##2##(2009-11#2)
word-problem##5##1##(2009-11#5)
wording##5##1##(1993-12#1)(2006-8#1)(2008-7#1)(2012-1#2)
words &quot##6##2##(1997-6#1)(2006-12#1)(2007-3#1)(2008-1#1)(2008-6#1)(2010-8#1)
words (with##2##2##(2009-10#1)(2013-8#1)
words and non-words were##2##4##(1995-12#1)(1996-2#1)
words and nonwords##3##3##(1990-8#1)(2004-10#1)(2009-7#1)
words and phrases##5##3##(2011-2#1)(2013-1#4)
words and the##2##3##(1994-4#1)(2007-3#1)
words and##33##2##(1990-8#3)(1993-9#2)(1994-4#1)(1995-1#2)(1995-12#1)(1996-2#1)(2004-10#1)(2006-3#1)(2007-12#4)(2007-3#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2011-2#1)(2013-1#4)
words are##5##2##(1991-6#1)(2008-2#2)(2008-3#1)(2010-7#1)
words as##2##2##(2008-2#2)
words associated with##2##3##(2007-12#1)(2008-9#1)
words at##3##2##(2007-12#1)(2010-6#1)(2012-12#1)
words by##2##2##(1996-2#1)(2010-2#1)
words can be##2##3##(2008-11#1)(2009-7#1)
words carry##2##2##(2007-12#1)(2008-2#1)
words for##3##2##(1995-3#1)(2008-2#1)(2011-1#1)
words from##2##2##(2012-3#2)
words in a##2##3##(2008-4#1)(2012-2#1)
words in the##3##3##(2008-6#1)(2009-1#1)(2011-2#1)
words in##17##2##(2006-3#2)(2007-12#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-6#1)(2009-1#1)(2009-11#1)(2009-8#1)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#1)
words into##4##2##(2007-9#1)(2009-11#2)(2012-3#1)
words is##3##2##(2008-4#1)(2010-7#1)(2012-1#1)
words may##3##2##(2008-2#2)(2009-7#1)
words more##3##2##(2007-12#2)(2010-2#1)
words of##5##2##(1994-1#1)(1994-3#1)(2008-9#1)(2012-12#1)(2013-1#1)
words or##3##2##(2007-12#1)(2008-2#2)
words over other linguistic stimuli in an associative##2##8##(2012-1#2)
words over other linguistic##3##4##(2012-1#3)
words than##2##2##(2007-12#1)(2008-4#1)
words that##10##2##(1995-12#1)(2007-10#1)(2007-12#1)(2008-2#4)(2008-4#1)(2012-2#1)(2012-3#1)
words to##2##2##(2008-3#1)(2009-5#1)
words used##2##2##(2007-12#1)(2008-2#1)
words using a##2##3##(2008-2#1)(2010-2#1)
words using##3##2##(2008-2#1)(2010-2#2)
words were found##2##3##(2009-11#1)(2011-1#1)
words were##7##2##(1995-11#1)(2007-10#1)(2008-2#1)(2009-11#1)(2011-1#1)(2012-2#1)(2013-1#1)
words with##3##2##(2008-9#2)(2009-10#1)
words##339##1##(1990-8#6)(1991-2#2)(1991-3#1)(1991-6#1)(1993-9#2)(1994-1#1)(1994-3#2)(1994-4#1)(1995-1#4)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#2)(1996-1#3)(1996-2#7)(1996-9#1)(1997-1#1)(1997-6#1)(1997-7#1)(2004-10#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-12#1)(2006-3#13)(2006-4#1)(2007-10#2)(2007-12#25)(2007-3#3)(2007-4#3)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#8)(2008-11#7)(2008-12#2)(2008-2#36)(2008-3#3)(2008-4#19)(2008-5#3)(2008-6#4)(2008-7#5)(2008-8#6)(2008-9#13)(2009-1#1)(2009-10#3)(2009-11#7)(2009-2#3)(2009-4#2)(2009-5#1)(2009-7#5)(2009-8#11)(2010-12#2)(2010-2#6)(2010-4#1)(2010-6#1)(2010-7#5)(2010-8#2)(2011-1#5)(2011-12#4)(2011-2#11)(2012-1#9)(2012-12#14)(2012-2#7)(2012-3#8)(2013-1#18)(2013-7#2)(2013-8#5)
words&quot##2##1##(1993-1#1)(2008-4#1)
words)##2##1##(2008-6#1)(2009-12#1)
wordt##2##1##(2012-12#2)
wore a##4##2##(2008-5#1)(2010-8#1)(2011-2#1)(2013-8#1)
wore##16##1##(2005-11#1)(2007-10#1)(2007-3#1)(2008-5#1)(2008-9#1)(2010-1#2)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
work (on##2##2##(2006-12#1)(2008-1#1)
work (p less than 0##2##5##(1991-12#2)
work (p##3##2##(1991-12#2)(2006-10#1)
work a##14##2##(2007-5#1)(2007-8#1)(2008-10#7)(2008-5#2)(2009-10#1)(2011-2#1)(2012-2#1)
work absenteeism##3##2##(2010-2#1)(2011-2#1)(2013-1#1)
work accidents##4##2##(1991-3#1)(2009-10#1)(2009-4#2)
work activities##3##2##(1996-6#2)(2012-3#1)
work addresses one##2##3##(1994-3#1)(2008-12#1)
work addresses##5##2##(1994-3#1)(2006-10#1)(2008-11#1)(2008-12#1)(2009-4#1)
work after##5##2##(1996-12#1)(2006-8#1)(2007-10#1)(2008-7#1)(2012-12#1)
work aimed at##3##3##(1997-4#1)(2008-2#1)(2012-1#1)
work aimed to identify##2##4##(2010-4#1)(2011-2#1)
work aimed to##4##3##(2008-6#1)(2008-8#1)(2010-4#1)(2011-2#1)
work aimed##7##2##(1997-4#1)(2008-2#1)(2008-6#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-1#1)
work aims at##3##3##(2009-5#1)(2009-7#1)(2013-1#1)
work aims to study##2##4##(2007-7#1)(2011-2#1)
work aims to##5##3##(2007-7#1)(2008-10#1)(2011-2#1)(2012-2#2)
work aims##8##2##(2007-7#1)(2008-10#1)(2009-5#1)(2009-7#1)(2011-2#1)(2012-2#2)(2013-1#1)
work also##5##2##(1992-8#1)(1996-2#1)(2005-11#1)(2008-10#1)(2011-1#1)
work among##4##2##(1992-5#1)(2008-12#1)(2008-8#1)(2012-3#1)
work an##4##2##(2007-10#1)(2008-10#1)(2009-4#1)(2011-2#1)
work and at##2##3##(2009-10#1)(2011-2#1)
work and cost##2##3##(2007-12#1)(2008-7#1)
work and for##4##3##(1995-5#1)(2008-3#1)(2013-1#2)
work and health conditions##2##4##(2011-2#1)(2013-1#1)
work and health##3##3##(2011-2#2)(2013-1#1)
work and its##3##3##(1994-6#1)(2004-10#1)(2008-1#1)
work and other##2##3##(2008-7#1)(2009-9#1)
work and productivity##2##3##(1993-3#1)(2008-6#1)
work and public##2##3##(2007-5#1)(2008-1#1)
work and sleep##2##3##(1997-6#1)(2010-7#1)
work and social##2##3##(2007-9#1)(2011-2#1)
work and that##2##3##(2008-2#1)(2011-1#1)
work and the##6##3##(1995-5#1)(1996-11#1)(1997-3#1)(2008-10#1)(2010-5#1)(2012-12#1)
work and##110##2##(1992-11#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#2)(1995-5#2)(1996-1#1)(1996-11#1)(1997-3#2)(1997-6#1)(2004-10#2)(2005-10#1)(2005-11#1)(2005-7#1)(2006-11#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-4#3)(2007-5#2)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#4)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#2)(2013-1#8)(2013-7#1)(2013-8#2)
work are discussed##2##3##(2008-2#1)(2008-7#1)
work are##16##2##(2005-10#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
work area##5##2##(1991-12#1)(2007-7#1)(2010-7#3)
work around##2##2##(2008-12#1)(2008-2#1)
work as a team##2##4##(2008-11#1)(2008-12#1)
work as a##15##3##(1993-12#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2009-2#1)(2010-8#1)(2011-3#1)(2013-1#1)
work as##34##2##(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-1#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-3#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2009-2#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-3#1)(2013-1#3)
work at all##2##3##(1995-6#1)(2008-4#1)
work at least##2##3##(2007-11#1)(2008-10#1)
work at the##3##3##(1993-7#1)(1996-4#1)(2008-8#1)
work at##15##2##(1993-7#1)(1995-6#1)(1996-12#1)(1996-4#1)(1997-6#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-11#1)(2010-12#1)
work because of##4##3##(1994-6#1)(1995-6#1)(2004-3#1)(2006-8#1)
work because##6##2##(1994-6#1)(1995-6#1)(1997-5#1)(2004-3#1)(2006-8#1)(2012-3#1)
work being done##3##3##(1997-3#1)(2013-1#2)
work being performed##2##3##(1997-2#1)(2010-5#1)
work being##6##2##(1997-2#1)(1997-3#1)(2008-4#1)(2010-5#1)(2013-1#2)
work best for##2##3##(2007-1#1)(2013-1#1)
work best##5##2##(2007-1#1)(2009-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
work better than##2##3##(2009-2#1)(2012-12#1)
work better##5##2##(2008-9#1)(2009-12#1)(2009-2#1)(2011-2#1)(2012-12#1)
work both##2##2##(1996-5#1)(2013-1#1)
work but##5##2##(2008-10#1)(2008-12#1)(2008-7#1)(2010-4#1)(2011-1#1)
work by determining##2##3##(2008-10#1)(2009-9#1)
work by using##2##3##(2008-6#1)(2012-3#1)
work by##29##2##(1991-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1996-4#1)(2006-10#2)(2007-11#1)(2007-12#2)(2007-8#2)(2007-9#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2011-2#2)(2012-1#1)(2012-3#1)
work can be##2##3##(1995-12#1)(2009-3#1)
work can##3##2##(1995-12#1)(2008-6#1)(2009-3#1)
work capacity##3##2##(1990-3#1)(2005-12#1)(2006-6#1)
work carried out at the##2##5##(1994-4#1)(2008-10#1)
work carried out in##2##4##(2008-10#1)(2008-5#1)
work carried out##8##3##(1994-2#1)(1994-4#1)(2008-10#3)(2008-5#2)(2011-2#1)
work closely##2##2##(2008-9#1)(2010-9#1)
work collaboratively with##5##3##(1995-3#1)(2006-5#1)(2007-12#1)(2008-12#1)(2011-1#1)
work collaboratively##7##2##(1995-3#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-12#1)(2011-1#1)(2013-1#1)
work combines##2##2##(2010-2#1)(2012-12#1)
work compares the##2##3##(1993-9#1)(2008-10#1)
work concerns##2##2##(1995-2#1)(2010-4#1)
work conditions for Colombian people##2##5##(2013-1#2)
work conditions##10##2##(1991-6#1)(1995-11#1)(2010-7#1)(2013-1#7)
work conducted in##2##3##(2005-10#1)(2010-11#1)
work conducted##5##2##(1995-11#1)(2005-10#1)(2005-5#1)(2009-4#1)(2010-11#1)
work continues to##2##3##(1997-4#1)(2012-3#1)
work could be##3##3##(2006-10#1)(2008-9#1)(2010-5#1)
work could lead to##2##4##(2008-7#1)(2012-2#1)
work could##7##2##(2006-10#1)(2007-8#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-5#1)(2012-2#1)
work crisis##2##2##(2013-1#2)
work deals with the application of##2##6##(2008-10#2)
work deals with the##6##4##(1997-1#1)(2007-11#1)(2008-10#2)(2009-7#1)(2013-1#1)
work deals with##8##3##(1997-1#1)(2005-11#1)(2007-11#1)(2007-5#1)(2008-10#2)(2009-7#1)(2013-1#1)
work defines##3##2##(2008-8#1)(2010-9#2)
work demonstrated that##2##3##(1996-10#1)(2008-10#1)
work demonstrates that##10##3##(1995-2#1)(1997-2#1)(2007-10#1)(2008-10#1)(2008-7#2)(2009-8#2)(2010-10#1)(2010-2#1)
work demonstrates the##7##3##(2008-7#1)(2009-12#1)(2009-6#1)(2010-1#1)(2010-5#1)(2012-11#1)(2013-7#1)
work demonstrates##20##2##(1995-2#1)(1997-2#1)(1997-7#1)(2007-10#1)(2008-10#2)(2008-7#3)(2009-12#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-2#1)(2010-5#1)(2012-11#1)(2013-7#2)
work demonstrating the##2##3##(2008-10#1)(2008-4#1)
work demonstrating##3##2##(2008-10#1)(2008-4#1)(2010-11#1)
work described here##4##3##(2008-10#1)(2009-3#1)(2013-1#2)
work described##8##2##(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2009-3#1)(2013-1#2)(2013-7#1)
work describes a new##4##4##(2008-10#1)(2008-12#1)(2013-1#2)
work describes a novel##2##4##(2008-10#1)(2008-11#1)
work describes a##8##3##(2008-10#4)(2008-11#1)(2008-12#1)(2013-1#2)
work describes an##2##3##(2007-8#1)(2008-10#1)
work describes the development and##2##5##(2008-10#1)(2010-5#1)
work describes the development##3##4##(2008-10#1)(2010-5#1)(2013-1#1)
work describes the##14##3##(1997-7#1)(2007-1#1)(2008-10#7)(2008-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2013-1#1)
work describes##30##2##(1990-12#1)(1997-7#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#13)(2008-11#2)(2008-12#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#2)(2013-1#3)
work design in##2##3##(1995-12#1)(2007-4#1)
work design##3##2##(1995-12#1)(2007-4#2)
work determined##2##2##(2004-9#1)(2008-10#1)
work differently##3##2##(1991-1#1)(1995-1#1)(2008-11#1)
work disability##4##2##(1991-11#1)(1995-5#1)(1996-9#1)(2010-9#1)
work discussed##2##2##(2008-7#1)(2013-1#1)
work done by##3##3##(2006-11#1)(2011-1#1)(2012-2#1)
work done in##2##3##(2008-8#1)(2009-11#1)
work done on the##2##4##(1995-3#1)(2008-3#1)
work done##9##2##(1995-3#1)(2006-11#1)(2008-1#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-1#1)(2012-2#1)
work due to##2##3##(1995-9#1)(2013-1#1)
work during a##2##3##(2007-7#1)(2008-2#1)
work during the##3##3##(2006-10#1)(2008-9#1)(2012-3#1)
work during##8##2##(2006-10#1)(2007-7#2)(2008-2#1)(2008-9#1)(2012-1#2)(2012-3#1)
work efficiently##2##2##(1990-5#1)(2007-12#1)
work either##2##2##(2008-10#1)(2008-3#1)
work elucidating the##2##3##(2006-10#1)(2007-12#1)
work emphasizes the##2##3##(1990-5#1)(2010-5#1)
work emphasizes##3##2##(1990-5#1)(2008-7#1)(2010-5#1)
work engagement##4##2##(2012-1#4)
work environment and health##2##4##(2012-12#2)
work environment and its##2##4##(2008-7#1)(2011-1#1)
work environment and the##3##4##(1993-6#1)(2009-7#1)(2012-12#1)
work environment and##11##3##(1993-6#1)(2008-7#1)(2009-10#1)(2009-7#1)(2011-1#3)(2012-12#3)(2012-3#1)
work environment for##3##3##(1992-12#1)(1994-6#1)(2013-7#1)
work environment is##2##3##(2010-2#1)(2012-3#1)
work environment##35##2##(1992-12#1)(1993-6#1)(1994-1#1)(1994-3#2)(1994-6#1)(1996-2#1)(1997-3#1)(2006-11#1)(2006-6#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#5)(2009-10#1)(2009-7#1)(2010-2#1)(2011-1#4)(2012-12#3)(2012-3#3)(2013-7#1)(2013-8#1)
work environment]##2##2##(1990-8#1)(1993-11#1)
work environments##2##2##(2006-6#1)(2010-5#1)
work established that##2##3##(1996-10#1)(2008-5#1)
work evaluated##3##2##(2006-4#1)(2011-1#1)(2013-1#1)
work examined the##2##3##(1994-5#1)(2008-11#1)
work examined##4##2##(1994-5#1)(2004-9#1)(2008-11#1)(2009-7#1)
work examines##3##2##(1995-8#1)(2005-11#1)(2009-8#1)
work examining the##3##3##(1994-11#1)(2008-11#1)(2008-7#1)
work experience and##3##3##(1997-6#1)(2007-4#1)(2010-10#1)
work experience of##2##3##(2007-4#1)(2012-12#1)
work experience##9##2##(1992-2#2)(1994-2#1)(1997-6#1)(2007-4#2)(2009-12#1)(2010-10#1)(2012-12#1)
work experiences##3##2##(1995-2#1)(2008-2#1)(2010-3#1)
work exposed##2##2##(1990-8#1)(2008-10#1)
work flow##3##2##(2008-10#1)(2008-5#1)(2012-3#1)
work focuses on##7##3##(1995-12#1)(2007-8#1)(2008-10#2)(2010-4#1)(2010-7#1)(2011-1#1)
work for more than##2##4##(1990-4#1)(1991-9#1)
work for the##8##3##(1992-11#1)(1992-5#1)(2008-1#1)(2008-10#3)(2011-2#1)(2012-1#1)
work for you##3##3##(1996-3#2)(2007-3#1)
work for##37##2##(1990-4#1)(1990-8#1)(1991-9#1)(1992-11#2)(1992-5#1)(1994-3#1)(1995-5#1)(1996-1#1)(1996-3#2)(1997-2#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-3#1)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#1)(2009-12#1)(2011-2#2)(2012-1#2)(2013-1#2)(2013-8#1)
work force planning in##2##4##(1994-1#1)(1994-2#1)
work force planning##3##3##(1994-1#1)(1994-2#2)
work force##25##2##(1991-7#1)(1991-9#1)(1992-12#2)(1993-3#1)(1994-1#2)(1994-2#4)(1995-2#1)(1996-3#1)(1997-2#6)(2006-2#1)(2007-12#1)(2008-1#2)(2008-11#2)
work from our lab##2##4##(2007-11#1)(2009-10#1)
work from our laboratory##2##4##(1996-11#1)(2006-6#1)
work from our##5##3##(1996-11#1)(1997-8#1)(2006-6#1)(2007-11#1)(2009-10#1)
work from the##2##3##(1991-2#1)(2011-3#1)
work from##16##2##(1990-4#1)(1991-2#1)(1996-11#1)(1997-8#1)(2006-6#1)(2007-11#1)(2008-10#1)(2009-10#1)(2009-6#1)(2009-8#1)(2011-3#1)(2013-1#4)(2013-7#1)
work functions##2##2##(2007-5#1)(2010-4#1)
work gives a##2##3##(2008-10#1)(2013-7#1)
work gives##5##2##(1992-7#1)(2008-10#1)(2011-3#1)(2013-7#1)(2013-8#1)
work group##3##2##(1996-2#1)(1997-4#1)(2007-10#1)
work groups in##2##3##(1993-12#1)(2009-9#1)
work had##3##2##(1991-8#1)(1995-1#1)(2006-8#1)
work has been carried out on the##2##7##(2012-2#1)(2013-8#1)
work has been carried out##5##5##(2008-10#1)(2008-5#1)(2010-8#1)(2012-2#1)(2013-8#1)
work has been done in the past year##2##8##(2006-10#2)
work has been done in the##3##6##(2006-10#2)(2008-5#1)
work has been done on##3##5##(2006-10#1)(2006-8#1)(2012-3#1)
work has been done##15##4##(1994-11#1)(1997-4#1)(2006-10#3)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-5#1)(2012-3#1)(2013-1#2)
work has been performed##2##4##(2006-10#1)(2008-10#1)
work has been##30##3##(1994-11#1)(1997-4#1)(2006-10#5)(2006-11#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-10#4)(2008-5#2)(2010-1#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
work has demonstrated that##6##4##(1991-3#1)(1993-6#1)(2008-10#1)(2008-4#1)(2009-4#1)(2010-8#1)
work has demonstrated the##2##4##(1997-6#1)(2009-10#1)
work has demonstrated##9##3##(1991-3#1)(1993-6#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-10#1)(2009-4#1)(2010-8#1)
work has examined##3##3##(2008-10#1)(2008-8#1)(2009-7#1)
work has focused on the##3##5##(1993-12#1)(1996-4#1)(2012-12#1)
work has focused on##5##4##(1993-12#1)(1996-4#1)(2006-10#1)(2008-6#1)(2012-12#1)
work has focused##6##3##(1993-12#1)(1996-4#1)(2006-10#1)(2008-6#1)(2012-1#1)(2012-12#1)
work has helped##2##3##(2007-11#1)(2010-4#1)
work has indicated that##2##4##(1990-10#1)(1991-9#1)
work has provided##2##3##(1997-7#1)(2008-11#1)
work has revealed##4##3##(2008-7#1)(2009-3#1)(2011-2#1)(2012-2#1)
work has shown that the##2##5##(1995-11#1)(2008-5#1)
work has shown that##17##4##(1990-6#1)(1992-11#1)(1993-7#1)(1994-3#1)(1994-8#1)(1995-11#1)(1996-2#1)(1996-5#1)(2006-10#2)(2006-7#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)
work has shown##21##3##(1990-6#1)(1992-11#1)(1993-7#1)(1994-3#1)(1994-8#1)(1995-11#1)(1996-2#1)(1996-5#1)(1997-6#1)(1997-7#1)(2006-10#2)(2006-7#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#1)(2011-2#1)
work has suggested that##3##4##(2005-11#1)(2007-8#1)(2012-11#1)
work has##121##2##(1990-10#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#2)(1991-9#1)(1992-1#1)(1992-11#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-11#2)(1995-12#2)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#1)(2005-11#3)(2006-10#10)(2006-11#1)(2006-12#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#5)(2008-2#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#3)
work have##6##2##(1994-3#1)(2005-11#1)(2007-4#1)(2008-11#1)(2008-5#1)(2009-3#1)
work here##3##2##(1993-2#1)(2008-11#1)(2010-7#1)
work hours and##2##3##(1991-2#1)(2011-2#1)
work hours or##2##3##(2010-9#1)(2011-1#1)
work hours##19##2##(1991-2#1)(1992-3#1)(1993-1#2)(1995-6#1)(1996-1#1)(2006-10#1)(2007-3#2)(2008-4#1)(2008-6#1)(2009-3#1)(2010-9#1)(2011-1#1)(2011-2#3)(2013-1#2)
work in a##6##3##(2005-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#2)
work in all##2##3##(1997-3#1)(2010-10#1)
work in an##4##3##(1990-5#1)(2008-7#1)(2012-11#1)(2013-1#1)
work in both##2##3##(1993-12#1)(2009-4#1)
work in experimental##2##3##(2007-4#1)(2007-9#1)
work in general##2##3##(1991-6#1)(2008-1#1)
work in health##2##3##(1993-3#1)(1995-1#1)
work in our##4##3##(1991-5#1)(1994-11#1)(2006-5#1)(2009-4#1)
work in partnership with##4##4##(1993-12#1)(2008-11#1)(2008-12#2)
work in partnership##6##3##(1993-12#1)(1996-2#1)(2008-11#2)(2008-12#2)
work in progress##5##3##(2008-7#1)(2011-1#2)(2012-12#2)
work in the area##2##4##(2008-11#1)(2008-12#1)
work in the context of##2##5##(2005-8#1)(2008-2#1)
work in the field##2##4##(2008-10#1)(2013-8#1)
work in the##29##3##(1990-4#1)(1991-11#1)(1994-12#1)(2005-10#2)(2005-4#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-10#2)(2007-3#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-6#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
work in their##2##3##(1993-3#1)(1995-9#1)
work in these##2##3##(2005-8#1)(2008-9#1)
work in this area##3##4##(1991-8#1)(1994-1#1)(2007-11#1)
work in this##8##3##(1990-2#1)(1991-8#1)(1994-1#1)(1996-4#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-6#1)
work in which##2##3##(1996-10#1)(2010-5#1)
work in##172##2##(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-6#4)(1991-8#1)(1992-12#1)(1993-10#1)(1993-12#3)(1993-2#1)(1993-3#3)(1994-1#2)(1994-11#1)(1994-12#1)(1994-6#1)(1995-1#2)(1995-11#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-3#2)(1997-5#1)(1997-8#3)(2004-10#1)(2004-9#1)(2005-10#2)(2005-4#1)(2005-7#2)(2005-8#3)(2005-9#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#1)(2007-3#2)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#7)(2008-11#5)(2008-12#6)(2008-2#3)(2008-3#1)(2008-5#5)(2008-6#2)(2008-7#7)(2008-9#2)(2009-10#2)(2009-11#2)(2009-2#1)(2009-4#4)(2009-5#1)(2009-6#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#6)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#4)
work incapacity##4##2##(1992-3#1)(1995-9#3)
work independently##2##2##(1991-3#1)(2012-12#1)
work indicated##3##2##(1990-7#1)(2004-4#1)(2004-9#1)
work indicates that the##2##4##(1991-6#1)(1996-8#1)
work indicates that##5##3##(1991-6#1)(1995-2#1)(1996-8#1)(2008-10#1)(2008-4#1)
work introduces##3##2##(2008-12#1)(2013-1#2)
work investigated the##2##3##(2008-4#1)(2010-4#1)
work investigates##3##2##(1997-4#1)(2008-12#1)(2008-5#1)
work investigating##2##2##(2008-11#1)(2009-12#1)
work involved##4##2##(1997-2#1)(2006-6#1)(2008-3#1)(2009-3#1)
work involves the##2##3##(2010-8#1)(2011-3#1)
work is a##9##3##(1996-12#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-2#1)(2009-4#1)(2010-12#1)(2011-1#1)
work is aimed at##2##4##(2004-2#1)(2013-8#1)
work is aimed to##3##4##(2005-11#1)(2008-5#1)(2013-7#1)
work is aimed##5##3##(2004-2#1)(2005-11#1)(2008-5#1)(2013-7#1)(2013-8#1)
work is associated with##3##4##(1990-6#1)(2008-8#1)(2011-2#1)
work is based on the##2##5##(2008-10#1)(2008-4#1)
work is done##2##3##(2013-1#1)(2013-7#1)
work is grounded in##3##4##(2011-2#1)(2013-1#2)
work is necessary to##3##4##(2007-8#1)(2010-9#1)(2013-7#1)
work is needed to identify##4##5##(1994-9#1)(2008-7#1)(2008-9#1)(2012-2#1)
work is needed to##11##4##(1994-9#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#1)
work is needed##14##3##(1994-9#1)(2006-2#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#1)
work is not##3##3##(2008-1#1)(2008-10#1)(2012-1#1)
work is related to##2##4##(2012-2#1)(2012-3#1)
work is required to establish##2##5##(2006-10#1)(2007-11#1)
work is required to##8##4##(1996-5#1)(2006-10#2)(2006-6#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-6#1)
work is required##9##3##(1996-5#1)(2006-10#2)(2006-6#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-6#1)(2010-4#1)
work is still required##2##4##(1997-1#1)(2007-10#1)
work is still##3##3##(1997-1#1)(2007-10#1)(2008-11#1)
work is that##6##3##(1990-7#1)(2008-5#1)(2008-7#1)(2010-2#1)(2013-1#2)
work is the study of##2##5##(2008-10#2)
work is the##13##3##(2006-6#1)(2007-4#1)(2008-10#6)(2008-4#1)(2008-5#1)(2009-3#1)(2011-1#1)(2012-1#1)
work is to apply##2##4##(1995-2#1)(2011-2#1)
work is to assess the##2##5##(1993-10#1)(2008-8#1)
work is to study the##3##5##(1997-2#1)(2008-10#1)(2009-3#1)
work is to##48##3##(1991-5#1)(1993-10#1)(1995-2#1)(1995-6#1)(1996-8#1)(1997-2#1)(2004-2#1)(2005-1#1)(2005-10#1)(2006-2#2)(2007-11#3)(2007-7#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-2#2)(2011-2#3)(2012-2#4)(2013-1#2)(2013-7#1)
work is##173##2##(1990-6#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1993-10#1)(1993-12#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(2004-2#2)(2005-1#1)(2005-10#2)(2005-11#2)(2006-10#4)(2006-2#3)(2006-3#1)(2006-6#2)(2007-1#1)(2007-10#1)(2007-11#10)(2007-12#1)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#22)(2008-11#3)(2008-12#2)(2008-2#3)(2008-4#4)(2008-5#8)(2008-6#4)(2008-7#4)(2008-8#6)(2008-9#2)(2009-12#1)(2009-3#3)(2009-4#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#8)(2012-1#2)(2012-2#6)(2012-3#2)(2013-1#7)(2013-7#5)(2013-8#2)
work it is##5##3##(1990-3#1)(2007-10#1)(2008-10#2)(2008-4#1)
work it##7##2##(1990-3#1)(1997-3#1)(2007-10#1)(2008-10#3)(2008-4#1)
work itself##2##2##(1994-2#1)(1997-3#1)
work life##2##2##(2007-9#1)(2010-7#1)
work load##7##2##(1990-4#1)(1994-6#1)(1995-9#1)(1996-9#1)(2008-7#2)(2011-2#1)
work mainly##3##2##(2008-10#1)(2008-4#1)(2013-1#1)
work makes##3##2##(2007-4#1)(2012-12#1)(2013-8#1)
work may##2##2##(2005-7#1)(2012-2#1)
work might##2##2##(2010-11#1)(2010-9#1)
work more closely with##2##4##(1991-12#1)(2008-12#1)
work more closely##3##3##(1991-12#1)(1996-1#1)(2008-12#1)
work must be##3##3##(2005-7#1)(2008-2#1)(2010-8#1)
work now##2##2##(1992-9#1)(2011-1#1)
work of Dr##3##3##(2008-1#1)(2008-11#1)(2010-5#1)
work of a##5##3##(1991-11#1)(1992-9#1)(1994-3#1)(2007-11#1)(2009-4#1)
work of adhesion for##2##4##(2006-7#2)
work of adhesion##8##3##(2005-11#3)(2006-7#2)(2008-7#3)
work of breathing in##2##4##(1997-4#2)
work of breathing##4##3##(1997-4#3)(2006-4#1)
work of each##2##3##(1991-12#1)(2009-4#1)
work of the nurse##2##4##(1991-11#1)(2011-2#1)
work of the##20##3##(1990-12#1)(1991-11#1)(1991-3#1)(1994-2#1)(1997-3#1)(2004-12#1)(2006-3#1)(2006-9#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-2#1)(2009-11#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#1)
work of this##2##3##(1992-12#1)(2008-10#1)
work of##117##2##(1990-12#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#2)(1992-9#2)(1994-1#1)(1994-2#1)(1994-3#2)(1995-2#1)(1995-3#1)(1996-1#3)(1996-3#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-7#1)(2004-12#1)(2005-11#4)(2005-5#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-4#1)(2006-7#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#4)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#6)(2008-12#2)(2008-2#5)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#3)(2009-5#1)(2009-7#3)(2009-9#1)(2010-11#1)(2010-3#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#3)
work on a##4##3##(2008-10#1)(2008-2#1)(2008-5#1)(2012-1#1)
work on nerve growth factor (NGF)##2##6##(1996-3#1)(2010-8#1)
work on normal##2##3##(1994-2#2)
work on the basis of##2##5##(1996-12#1)(2007-11#1)
work on the use of##2##5##(2007-5#1)(2008-10#1)
work on the##25##3##(1990-4#1)(1990-9#1)(1992-12#1)(1993-10#1)(1996-12#1)(2006-3#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-1#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)
work on this##3##3##(2007-3#1)(2008-11#1)(2008-2#1)
work on##107##2##(1990-4#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1992-12#1)(1993-10#1)(1993-12#1)(1993-2#1)(1994-2#2)(1995-3#3)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#2)(2004-12#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-4#2)(2006-6#2)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-3#2)(2007-4#2)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#2)(2008-2#8)(2008-5#3)(2008-7#2)(2008-9#1)(2009-2#2)(2009-5#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-6#2)(2010-7#3)(2010-8#1)(2011-1#4)(2011-2#6)(2011-3#1)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
work only##3##2##(2005-8#1)(2008-12#1)(2008-5#1)
work opens##2##2##(2008-7#1)(2012-2#1)
work or##9##2##(1994-11#2)(1995-2#1)(2007-2#1)(2009-9#1)(2010-9#2)(2011-12#1)(2013-1#1)
work organization##5##2##(2007-10#1)(2008-2#1)(2010-5#1)(2013-1#2)
work out##7##2##(1996-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-12#1)
work output##3##2##(2007-11#1)(2012-2#1)(2013-1#1)
work outside##2##2##(1991-5#1)(1994-4#1)
work overload##3##2##(2004-10#3)
work patterns##3##2##(1993-12#1)(2005-9#1)(2010-11#1)
work performance under NLEP##3##4##(2012-12#3)
work performance##14##2##(1994-1#1)(1994-2#1)(1995-1#1)(2009-7#1)(2011-2#3)(2012-12#7)
work performed##5##2##(1990-3#1)(2006-10#2)(2007-8#1)(2008-10#1)
work pertaining to##2##3##(1994-11#1)(1997-2#1)
work place##10##2##(1993-12#1)(1995-2#1)(1997-1#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-4#1)(2009-12#1)(2010-3#1)
work places##4##2##(2006-1#1)(2007-4#1)(2012-2#1)(2013-8#1)
work plan to##2##3##(2007-1#1)(2008-1#1)
work plan##3##2##(2007-1#1)(2008-1#2)
work practices##2##2##(2008-12#1)(2011-2#1)
work presented##10##2##(1991-12#1)(1991-8#1)(1992-8#1)(1997-3#1)(2005-9#1)(2008-10#3)(2008-7#1)(2012-1#1)
work presents a##10##3##(2007-6#1)(2008-10#5)(2009-12#1)(2009-5#1)(2009-7#1)(2012-3#1)
work presents an##3##3##(2008-10#1)(2009-2#1)(2010-12#1)
work presents the##6##3##(2007-11#1)(2008-12#1)(2008-3#1)(2010-10#1)(2011-2#2)
work presents##23##2##(2007-11#1)(2007-6#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-4#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-3#1)
work process##6##2##(1991-6#1)(1996-2#1)(2008-9#2)(2011-1#1)(2012-12#1)
work processes##6##2##(1990-12#1)(1997-1#1)(2008-9#1)(2011-1#2)(2012-12#1)
work productivity##3##2##(2006-10#1)(2008-3#1)(2013-1#1)
work provides a##3##3##(2008-10#2)(2012-3#1)
work provides the##2##3##(1994-8#1)(2008-10#1)
work provides##14##2##(1990-7#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-5#1)(2006-12#1)(2008-10#4)(2011-12#1)(2011-3#1)(2012-3#1)(2013-8#1)
work published##2##2##(2006-5#1)(2007-11#1)
work rather than##2##3##(2004-9#1)(2013-8#1)
work redesign##3##2##(1995-12#1)(2004-10#1)(2008-1#1)
work related disorders##2##3##(1996-8#1)(2008-11#1)
work related injury and ill-health##2##5##(2008-11#2)
work related to the##2##4##(2004-10#1)(2008-12#1)
work related to##3##3##(1994-6#1)(2004-10#1)(2008-12#1)
work related##13##2##(1994-6#1)(1996-8#1)(2004-10#1)(2006-10#1)(2007-9#1)(2008-11#3)(2008-12#1)(2010-5#1)(2011-1#3)
work relations##2##2##(2011-1#2)
work relationships##2##2##(2013-1#2)
work remains to be done in##2##6##(2008-8#1)(2009-7#1)
work remains to be done##3##5##(2007-4#1)(2008-8#1)(2009-7#1)
work remains to##4##3##(2007-4#1)(2008-8#1)(2009-7#1)(2012-3#1)
work remains##6##2##(2007-4#1)(2008-7#1)(2008-8#1)(2009-7#1)(2012-11#1)(2012-3#1)
work reported here##5##3##(1991-5#1)(1995-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
work reported##7##2##(1991-5#1)(1995-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-8#1)
work reports a##5##3##(2008-10#3)(2008-3#1)(2010-5#1)
work reports the development of a##2##6##(2008-10#1)(2008-5#1)
work reports the results##2##4##(2008-10#1)(2008-11#1)
work reports the##11##3##(1995-2#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-4#1)(2013-7#1)
work reports##20##2##(1995-2#1)(2006-8#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-4#1)(2010-5#1)(2013-7#1)
work represents a##2##3##(2007-8#1)(2008-11#1)
work represents the first##2##4##(1992-8#1)(2012-1#1)
work represents##9##2##(1992-8#1)(2006-10#1)(2007-8#1)(2008-11#1)(2010-4#1)(2012-1#1)(2012-2#1)(2013-1#2)
work required to##4##3##(1994-3#1)(2007-11#1)(2008-5#1)(2008-9#1)
work required##5##2##(1994-3#1)(2007-11#1)(2007-12#1)(2008-5#1)(2008-9#1)
work responsibilities##2##2##(2006-2#2)
work revealed an##2##3##(2008-7#1)(2009-8#1)
work revealed##5##2##(1995-2#1)(2007-2#1)(2008-7#1)(2008-9#1)(2009-8#1)
work reveals##2##2##(2009-8#1)(2011-1#1)
work reviews the##2##3##(2007-12#1)(2011-2#1)
work role##2##2##(1997-3#1)(2007-10#1)
work roles##2##2##(1995-12#1)(2007-9#1)
work sampling##2##2##(1996-3#2)
work satisfaction##5##2##(2010-10#1)(2010-11#3)(2013-1#1)
work schedules##3##2##(2005-9#1)(2011-2#2)
work setting##4##2##(1993-1#1)(1994-2#1)(1996-2#1)(2007-1#1)
work shift##4##2##(1994-6#1)(2005-11#1)(2010-7#1)(2012-12#1)
work should##7##2##(1996-10#1)(2006-10#1)(2007-12#1)(2009-5#1)(2010-2#2)(2010-7#1)
work show##3##2##(2008-12#1)(2008-7#1)(2010-8#1)
work showed a##2##3##(1992-11#1)(2011-2#1)
work showed that##6##3##(1992-9#1)(1996-1#1)(2006-10#1)(2008-10#2)(2011-1#1)
work showed##10##2##(1992-11#1)(1992-9#1)(1994-6#1)(1996-1#1)(2006-10#1)(2008-10#2)(2011-1#1)(2011-2#1)(2012-12#1)
work showing that##2##3##(2007-4#1)(2011-1#1)
work shows a##2##3##(2007-8#1)(2011-2#1)
work shows that a##2##4##(1996-11#1)(2006-12#1)
work shows that the##3##4##(2008-10#1)(2008-5#1)(2008-9#1)
work shows that##10##3##(1994-5#1)(1996-11#1)(2004-9#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-9#2)
work shows the importance of##3##5##(2006-10#1)(2013-1#2)
work shows the results##2##4##(1991-7#1)(2008-10#1)
work shows the##10##3##(1991-7#1)(1996-5#1)(2006-10#1)(2008-10#3)(2008-5#2)(2013-1#2)
work shows##23##2##(1991-7#1)(1994-5#1)(1996-11#1)(1996-5#1)(2004-9#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-5#4)(2008-9#2)(2011-2#1)(2012-11#1)(2013-1#2)
work sites##2##2##(2008-7#1)(2013-1#1)
work situation##5##2##(1996-5#1)(2006-10#1)(2007-9#1)(2008-6#1)(2010-10#1)
work so##2##2##(1990-9#1)(2008-2#1)
work sooner##2##2##(1992-3#1)(2012-12#1)
work status##4##2##(1997-3#1)(2006-8#2)(2012-12#1)
work students##2##2##(1994-3#1)(2010-3#1)
work studies the##6##3##(2008-10#1)(2008-5#1)(2009-8#1)(2012-1#1)(2012-11#2)
work successfully##2##2##(2007-11#1)(2008-2#1)
work suggested that##4##3##(1991-9#1)(1992-6#1)(2008-10#1)(2008-9#1)
work suggests that manipulating the##2##5##(2008-10#1)(2010-7#1)
work suggests that the##4##4##(1992-6#1)(2006-10#1)(2010-4#1)(2011-1#1)
work suggests that##10##3##(1992-6#1)(2006-10#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-4#1)(2010-7#1)(2011-1#1)
work suggests##13##2##(1992-6#1)(2006-10#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-2#1)
work supports the hypothesis that##2##5##(2008-10#1)(2011-1#1)
work supports the##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
work supports##4##2##(2008-10#1)(2008-11#1)(2011-1#1)(2012-12#1)
work surface height of##2##4##(1995-1#2)
work surface height##3##3##(1995-1#3)
work synergistically##2##2##(2008-5#1)(2011-2#1)
work systematically##2##2##(2004-9#1)(2008-11#1)
work tasks##3##2##(2007-3#1)(2011-1#1)(2012-3#1)
work teams##9##2##(1993-12#5)(1994-1#1)(1994-3#1)(2006-2#1)(2010-3#1)
work technologies?##2##2##(2013-1#2)
work that has been##4##4##(2006-10#1)(2009-10#1)(2012-2#1)(2013-1#1)
work that the##2##3##(1996-3#1)(2008-11#1)
work that used##2##3##(2008-10#1)(2009-2#1)
work that##22##2##(1996-3#1)(2005-10#1)(2005-9#1)(2006-10#3)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-7#2)(2009-10#1)(2009-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
work the authors##3##3##(2005-1#2)(2007-8#1)
work the##23##2##(1990-1#1)(1990-3#1)(1992-5#1)(1993-8#1)(1995-5#1)(2005-1#2)(2005-8#1)(2006-10#1)(2006-2#1)(2007-8#1)(2008-10#7)(2008-5#2)(2008-7#1)(2009-9#1)(2013-1#1)
work therapy##2##2##(2007-5#1)(2009-7#1)
work they##2##2##(2007-10#1)(2008-5#1)
work this##2##2##(2012-2#1)(2013-1#1)
work through the##2##3##(1997-6#1)(2008-2#1)
work through##4##2##(1996-4#1)(1997-6#1)(2008-2#1)(2013-8#1)
work throughout##2##2##(1992-6#1)(2008-4#1)
work thus represents##2##3##(1994-11#1)(2007-9#1)
work time##3##2##(1992-12#1)(2006-2#1)(2007-7#1)
work to be##3##3##(1991-1#1)(1992-10#1)(2006-10#1)
work to date##2##3##(2005-7#1)(2007-8#1)
work to improve##3##3##(2007-12#1)(2010-10#1)(2011-2#1)
work to provide##2##3##(2007-2#1)(2010-8#1)
work to##45##2##(1990-5#1)(1991-1#1)(1991-12#1)(1991-9#1)(1992-10#1)(1993-6#1)(1996-11#1)(1996-2#1)(1996-5#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#4)(2008-7#2)(2008-8#1)(2009-11#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#1)(2013-8#1)
work together in a##3##4##(1993-12#1)(2008-7#1)(2013-1#1)
work together in##6##3##(1993-12#1)(1996-12#1)(2007-4#1)(2007-5#1)(2008-7#1)(2013-1#1)
work together to address the##2##5##(1991-3#1)(2006-1#1)
work together to develop##2##4##(2010-2#1)(2010-8#1)
work together to ensure that the##2##6##(1996-2#1)(2006-4#1)
work together to##19##3##(1991-3#1)(1993-1#1)(1995-1#1)(1995-2#3)(1996-2#1)(1996-3#1)(2006-1#1)(2006-4#1)(2007-1#1)(2008-12#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-8#1)(2012-2#1)(2013-8#1)
work together within the##2##4##(1990-12#1)(1991-12#1)
work together within##3##3##(1990-12#1)(1991-12#1)(2005-5#1)
work together##36##2##(1990-12#1)(1991-12#2)(1991-3#1)(1993-1#2)(1993-12#1)(1993-7#1)(1994-3#1)(1995-1#1)(1995-2#3)(1996-12#1)(1996-2#1)(1996-3#1)(2004-7#1)(2005-5#1)(2006-1#1)(2006-4#1)(2007-1#1)(2007-4#2)(2007-5#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#2)
work tolerance##3##2##(2008-1#1)(2011-2#2)
work took place##2##3##(1995-12#1)(2011-12#1)
work toward##5##2##(1994-2#1)(2006-9#1)(2007-2#1)(2007-8#1)(2008-11#1)
work towards##3##2##(2008-11#1)(2012-12#2)
work under difficult conditions##2##4##(1991-5#1)(2008-6#1)
work under##5##2##(1991-5#1)(2006-2#1)(2008-10#1)(2008-6#1)(2011-2#1)
work undertaken##2##2##(1993-11#1)(2012-11#1)
work up in##2##3##(1991-12#1)(2006-8#1)
work up of##3##3##(1992-6#1)(2008-10#1)(2008-7#1)
work up##16##2##(1991-12#1)(1992-6#1)(2006-8#2)(2007-11#1)(2008-1#2)(2008-10#2)(2008-7#3)(2011-1#2)(2012-12#1)(2012-3#1)
work using an##2##3##(2006-6#1)(2012-2#1)
work using##6##2##(2006-5#1)(2006-6#1)(2008-10#1)(2008-7#1)(2012-11#1)(2012-2#1)
work validates##2##2##(2008-10#1)(2008-7#1)
work values emerged -##2##4##(2010-10#2)
work values##8##2##(2010-10#8)
work was aimed##4##3##(1997-6#1)(2007-8#1)(2008-10#1)(2008-4#1)
work was carried out##5##4##(1994-3#1)(2008-12#1)(2011-12#1)(2012-2#1)(2013-7#1)
work was conducted to##2##4##(2007-3#1)(2008-2#1)
work was conducted##4##3##(1997-3#1)(2007-3#1)(2008-2#1)(2011-1#1)
work was designed to##2##4##(2012-1#1)(2013-1#1)
work was done##2##3##(1993-3#1)(2007-9#1)
work was initiated##4##3##(2010-12#4)
work was performed with##2##4##(1996-8#1)(2008-10#1)
work was the##5##3##(1996-1#1)(2005-9#1)(2007-11#1)(2008-1#1)(2008-10#1)
work was to assess the##3##5##(1993-12#1)(2005-1#1)(2006-6#1)
work was to assess##5##4##(1993-12#1)(2005-1#1)(2006-6#1)(2009-7#1)(2010-4#1)
work was to compare the##3##5##(2007-11#1)(2010-4#1)(2013-8#1)
work was to compare##5##4##(1993-12#1)(1996-5#1)(2007-11#1)(2010-4#1)(2013-8#1)
work was to develop a##4##5##(1997-2#1)(2007-4#1)(2011-1#1)(2013-7#1)
work was to develop and validate##2##6##(2008-10#1)(2012-2#1)
work was to develop##8##4##(1997-2#1)(2007-4#1)(2008-10#1)(2010-12#1)(2011-1#1)(2012-2#2)(2013-7#1)
work was to evaluate the##9##5##(1993-11#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-5#3)(2012-2#1)(2013-1#1)
work was to evaluate##12##4##(1993-11#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-5#4)(2012-2#1)(2013-1#1)(2013-8#1)
work was to examine the##2##5##(1995-5#1)(2008-3#1)
work was to find out##2##5##(1994-9#1)(2008-5#1)
work was to find##3##4##(1994-9#1)(2008-10#1)(2008-5#1)
work was to investigate the##4##5##(2007-12#1)(2010-7#1)(2012-11#1)(2012-12#1)
work was to investigate whether##2##5##(1992-12#1)(2008-5#1)
work was to investigate##7##4##(1990-12#1)(1992-12#1)(2007-12#1)(2008-5#1)(2010-7#1)(2012-11#1)(2012-12#1)
work was to study the##13##5##(1996-5#1)(1997-7#1)(2005-11#1)(2007-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-1#2)(2013-7#1)
work was to study##18##4##(1996-5#1)(1997-7#1)(2005-11#1)(2006-6#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-1#2)(2013-7#2)
work was to##101##3##(1990-12#1)(1991-11#1)(1992-12#1)(1993-11#2)(1993-12#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-1#1)(2005-10#2)(2005-11#2)(2006-10#2)(2006-6#2)(2007-1#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#15)(2008-6#1)(2008-7#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#3)(2010-7#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#5)(2013-7#4)(2013-8#2)
work was##167##2##(1990-12#1)(1991-11#1)(1992-12#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-2#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-3#2)(1997-6#2)(1997-7#1)(1997-8#3)(2005-1#1)(2005-10#2)(2005-11#4)(2005-9#1)(2006-10#4)(2006-3#1)(2006-6#2)(2007-1#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#16)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-2#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#6)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#3)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#8)(2013-7#5)(2013-8#2)
work we aim to##2##4##(2007-10#1)(2013-1#1)
work we demonstrate that##2##4##(1991-12#1)(1994-12#1)
work we demonstrate##3##3##(1991-12#1)(1994-12#1)(2011-2#1)
work we examine##2##3##(2008-7#1)(2011-12#1)
work we extended the study to##2##6##(2009-5#1)(2012-3#1)
work we have found that##2##5##(1990-8#1)(1992-8#1)
work we have##10##3##(1990-5#1)(1990-8#1)(1991-4#1)(1991-5#1)(1992-8#2)(1996-12#1)(2005-10#1)(2008-11#1)(2012-2#1)
work we present a review##2##5##(2007-7#1)(2009-5#1)
work we present a##4##4##(2007-7#1)(2009-5#1)(2010-2#2)
work we present##8##3##(1991-5#1)(2007-5#1)(2007-7#1)(2008-10#1)(2009-5#1)(2009-7#1)(2010-2#2)
work we show##4##3##(1990-5#1)(1991-1#1)(1994-9#1)(2007-5#1)
work we studied the effect of##2##6##(1997-4#1)(2004-12#1)
work we studied the##5##4##(1993-4#1)(1997-4#1)(2004-12#1)(2008-10#1)(2013-7#1)
work we study the##5##4##(1996-3#1)(1997-2#1)(2008-10#2)(2009-8#1)
work we study##6##3##(1991-6#1)(1996-3#1)(1997-2#1)(2008-10#2)(2009-8#1)
work we used##2##3##(1990-12#1)(2008-5#1)
work we##84##2##(1990-12#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#2)(1991-6#1)(1992-11#1)(1992-8#2)(1993-4#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-2#2)(1997-4#1)(1997-5#1)(2004-12#1)(2005-10#2)(2005-11#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-5#2)(2007-7#1)(2008-10#11)(2008-11#6)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#3)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
work well for##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
work well with##2##3##(2008-10#1)(2012-3#1)
work well##15##2##(1991-3#1)(1994-2#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-8#1)(2010-2#1)(2011-2#1)(2012-3#1)
work were to##6##3##(1992-4#1)(2005-10#1)(2008-10#3)(2008-5#1)
work were##13##2##(1992-3#1)(1992-4#1)(1994-6#1)(1995-2#1)(2005-10#1)(2007-10#1)(2007-2#1)(2008-10#3)(2008-5#1)(2010-4#1)(2011-1#1)
work when##2##2##(2006-8#1)(2007-11#1)
work which##6##2##(1991-1#1)(1997-8#1)(2006-10#1)(2007-7#1)(2009-6#1)(2012-3#1)
work will be##3##3##(2007-8#1)(2008-1#1)(2011-1#1)
work will have to##2##4##(1994-10#1)(1997-8#1)
work will##20##2##(1991-1#1)(1993-9#1)(1994-10#1)(1995-5#1)(1996-12#1)(1997-1#1)(1997-4#1)(1997-8#1)(2007-12#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-7#1)(2011-1#1)(2012-12#1)(2013-1#3)(2013-8#1)
work with a##6##3##(1996-12#1)(2006-6#1)(2008-12#1)(2008-4#2)(2009-6#1)
work with and##2##3##(2009-6#1)(2009-8#1)
work with both##4##3##(1990-6#1)(2006-8#1)(2008-11#1)(2008-7#1)
work with children and##2##4##(1995-6#2)
work with children##3##3##(1995-6#2)(2009-9#1)
work with each other##2##4##(1994-1#1)(2007-8#1)
work with patients##3##3##(2005-6#1)(2007-10#1)(2010-8#1)
work with people with a##2##5##(2006-9#1)(2008-11#1)
work with practitioners##2##3##(1996-3#1)(2008-12#1)
work with the##8##3##(1995-6#1)(1996-3#1)(1997-2#1)(2008-2#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#1)
work with this##2##3##(1993-11#1)(2009-10#1)
work with##108##2##(1990-11#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-1#3)(1994-4#1)(1995-5#3)(1995-6#3)(1996-1#1)(1996-12#2)(1996-3#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-6#2)(2006-10#3)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#2)(2009-3#2)(2009-4#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-10#4)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#3)(2013-8#2)
work within the##6##3##(2007-10#1)(2007-2#1)(2008-10#1)(2009-9#1)(2012-2#1)(2012-3#1)
work within##14##2##(1992-5#1)(2006-6#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
work world and##2##3##(2013-1#2)
work world is##2##3##(2013-1#2)
work world##6##2##(1995-12#1)(2013-1#5)
work would be##2##3##(1994-3#1)(2010-7#1)
work would##3##2##(1994-3#1)(2008-8#1)(2010-7#1)
work##3621##1##(1990-1#1)(1990-10#2)(1990-11#2)(1990-12#11)(1990-2#4)(1990-3#9)(1990-4#6)(1990-5#6)(1990-6#5)(1990-7#5)(1990-8#6)(1990-9#3)(1991-1#7)(1991-10#2)(1991-11#7)(1991-12#24)(1991-2#11)(1991-3#9)(1991-4#3)(1991-5#10)(1991-6#12)(1991-7#2)(1991-8#5)(1991-9#6)(1992-1#2)(1992-10#3)(1992-11#8)(1992-12#18)(1992-2#8)(1992-3#9)(1992-4#5)(1992-5#6)(1992-6#7)(1992-7#4)(1992-8#5)(1992-9#7)(1993-1#11)(1993-10#3)(1993-11#14)(1993-12#23)(1993-2#10)(1993-3#14)(1993-4#1)(1993-5#1)(1993-6#5)(1993-7#4)(1993-8#6)(1993-9#5)(1994-1#13)(1994-10#2)(1994-11#10)(1994-12#8)(1994-2#18)(1994-3#21)(1994-4#3)(1994-5#5)(1994-6#21)(1994-8#5)(1994-9#5)(1995-1#23)(1995-11#6)(1995-12#14)(1995-2#26)(1995-3#8)(1995-4#2)(1995-5#15)(1995-6#14)(1995-7#1)(1995-8#7)(1995-9#9)(1996-1#20)(1996-10#4)(1996-11#6)(1996-12#13)(1996-2#15)(1996-3#17)(1996-4#7)(1996-5#9)(1996-6#6)(1996-7#3)(1996-8#6)(1996-9#4)(1997-1#12)(1997-2#27)(1997-3#18)(1997-4#16)(1997-5#5)(1997-6#11)(1997-7#10)(1997-8#11)(2004-10#10)(2004-12#4)(2004-2#2)(2004-3#1)(2004-4#2)(2004-7#1)(2004-9#8)(2005-1#5)(2005-10#23)(2005-11#43)(2005-12#2)(2005-4#1)(2005-5#4)(2005-6#2)(2005-7#7)(2005-8#9)(2005-9#8)(2006-1#2)(2006-10#74)(2006-11#7)(2006-12#16)(2006-2#19)(2006-3#7)(2006-4#8)(2006-5#10)(2006-6#20)(2006-7#10)(2006-8#26)(2006-9#4)(2007-1#16)(2007-10#32)(2007-11#47)(2007-12#35)(2007-2#17)(2007-3#17)(2007-4#37)(2007-5#19)(2007-6#5)(2007-7#22)(2007-8#51)(2007-9#34)(2008-1#47)(2008-10#377)(2008-11#89)(2008-12#65)(2008-2#63)(2008-3#28)(2008-4#38)(2008-5#102)(2008-6#32)(2008-7#84)(2008-8#31)(2008-9#39)(2009-10#24)(2009-11#9)(2009-12#13)(2009-2#16)(2009-3#17)(2009-4#23)(2009-5#13)(2009-6#17)(2009-7#26)(2009-8#25)(2009-9#16)(2010-1#8)(2010-10#34)(2010-11#19)(2010-12#21)(2010-2#25)(2010-3#13)(2010-4#32)(2010-5#31)(2010-6#6)(2010-7#31)(2010-8#25)(2010-9#22)(2011-1#70)(2011-10#1)(2011-12#11)(2011-2#108)(2011-3#9)(2012-1#52)(2012-11#13)(2012-12#79)(2012-2#67)(2012-3#50)(2013-1#167)(2013-7#28)(2013-8#45)
work&quot##5##1##(2008-1#1)(2008-10#1)(2009-7#1)(2013-1#2)
work'##3##1##(2007-10#2)(2008-1#1)
work's##2##1##(1993-3#1)(2007-9#1)
work)##4##1##(1996-3#1)(2007-11#1)(2007-4#1)(2008-11#1)
work--and##2##1##(2007-9#1)(2010-9#1)
work-based learning approach##2##3##(2008-11#2)
work-based learning##10##2##(2008-11#10)
work-based##12##1##(1992-1#1)(2008-11#11)
work-family variables##2##2##(2010-6#2)
work-family##7##1##(2009-10#5)(2010-6#2)
work-flow##2##1##(1994-2#1)(2012-3#1)
work-life balance and##3##3##(2012-2#1)(2013-1#2)
work-life balance##6##2##(2009-11#1)(2010-9#1)(2012-2#1)(2013-1#3)
work-life##7##1##(2009-11#2)(2010-9#1)(2012-2#1)(2013-1#3)
work-place##2##1##(2007-11#1)(2008-1#1)
work-related MSDs##2##2##(2006-11#2)
work-related accidents##4##2##(1993-6#3)(2013-1#1)
work-related injuries##3##2##(2007-10#1)(2007-3#1)(2011-2#1)
work-related injury##4##2##(1994-3#1)(2008-7#3)
work-related pulmonary##3##2##(1996-2#3)
work-related##43##1##(1992-8#1)(1993-6#3)(1994-3#1)(1995-2#1)(1996-1#1)(1996-2#6)(1997-3#1)(2006-11#2)(2006-2#2)(2006-7#2)(2007-10#2)(2007-3#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-7#5)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
work-to-fracture##2##1##(2004-9#2)
work-up and management##2##3##(2007-12#1)(2011-2#1)
work-up and##6##2##(2007-11#1)(2007-12#1)(2007-8#1)(2011-2#2)(2013-8#1)
work-up for##4##2##(1996-12#1)(2008-4#1)(2010-10#1)(2013-8#1)
work-up in##5##2##(2006-10#1)(2007-11#1)(2008-7#1)(2013-8#2)
work-up of patients with##2##4##(2008-6#1)(2012-2#1)
work-up of suspected##2##3##(2010-10#1)(2011-1#1)
work-up of##17##2##(1992-10#1)(1992-9#1)(1996-3#1)(2006-10#1)(2006-12#1)(2007-3#2)(2008-10#2)(2008-6#1)(2008-7#3)(2010-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
work-up procedures##2##2##(2008-10#2)
work-up revealed##2##2##(1990-3#1)(1997-6#1)
work-up showed##2##2##(1993-2#1)(1997-3#1)
work-up were##2##2##(2008-10#1)(2013-8#1)
work-up##82##1##(1990-3#1)(1991-11#2)(1992-10#1)(1992-2#1)(1992-5#1)(1992-9#2)(1993-2#1)(1996-12#1)(1996-3#2)(1997-1#1)(1997-3#3)(1997-6#1)(2005-11#1)(2006-10#5)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#2)(2007-8#1)(2008-10#14)(2008-4#2)(2008-6#4)(2008-7#6)(2009-5#1)(2010-10#5)(2011-1#2)(2011-2#3)(2012-2#3)(2013-1#3)(2013-8#7)
work/school##3##1##(2010-5#2)(2012-12#1)
work?##23##1##(1991-11#1)(1993-1#1)(1993-3#1)(1994-3#1)(1995-2#1)(1996-6#1)(1997-3#1)(1997-6#1)(2005-12#1)(2005-7#1)(2006-12#1)(2007-1#2)(2007-11#2)(2007-7#1)(2007-8#1)(2008-11#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
work]##11##1##(1990-12#1)(1990-6#2)(1991-11#1)(1992-5#1)(1994-2#1)(1995-5#1)(2007-3#1)(2007-8#1)(2008-10#1)(2010-9#1)
workable##13##1##(1990-12#1)(1994-12#2)(1994-2#1)(1994-7#1)(2007-4#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-9#1)(2011-1#1)(2012-2#2)
workbench##2##1##(2008-9#1)(2009-7#1)
workbook##2##1##(2008-12#2)
workday##7##1##(1997-3#1)(2008-10#1)(2010-6#1)(2012-12#4)
worked as a##4##3##(1995-11#1)(2008-10#1)(2010-12#1)(2010-3#1)
worked as the##2##3##(2008-10#1)(2008-8#1)
worked as##8##2##(1995-11#1)(1997-5#1)(2007-7#1)(2008-10#2)(2008-8#1)(2010-12#1)(2010-3#1)
worked at##3##2##(1992-12#1)(2007-5#1)(2013-1#1)
worked closely with##2##3##(1996-2#1)(2007-6#1)
worked during##2##2##(1991-2#1)(2008-10#1)
worked efficiently##2##2##(1994-12#1)(2008-9#1)
worked for the##2##3##(2008-1#1)(2012-3#1)
worked for##7##2##(1991-2#1)(1992-3#1)(1993-3#1)(2004-9#1)(2008-1#1)(2012-3#2)
worked full-time##2##2##(1993-3#1)(2008-1#1)
worked in an##2##3##(1991-6#1)(2008-1#1)
worked in the##11##3##(1991-12#1)(1992-6#2)(1994-1#1)(2006-1#1)(2007-7#1)(2008-1#1)(2008-12#1)(2012-11#1)(2012-3#1)(2013-1#1)
worked in##34##2##(1991-12#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-6#2)(1993-1#3)(1993-3#1)(1994-1#1)(1996-3#1)(1997-1#1)(1997-5#1)(2006-1#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-12#2)(2008-5#1)(2009-4#1)(2010-11#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-3#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
worked on##6##2##(1990-9#1)(1997-2#1)(2004-11#1)(2009-4#1)(2010-1#1)(2012-3#1)
worked out by##2##3##(1990-2#1)(1996-2#1)
worked out in##2##3##(1991-2#1)(2008-3#1)
worked out the##3##3##(2010-1#1)(2011-1#1)(2012-2#1)
worked out##26##2##(1990-2#1)(1991-11#1)(1991-2#1)(1992-9#1)(1996-2#1)(2005-4#1)(2006-10#1)(2006-12#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#1)(2010-1#1)(2010-9#2)(2011-1#1)(2012-2#3)
worked to##4##2##(1996-3#1)(2006-5#1)(2007-2#1)(2008-10#1)
worked together##2##2##(2008-8#1)(2010-11#1)
worked very well##2##3##(2008-7#1)(2013-1#1)
worked well for the##2##4##(1993-2#1)(2006-8#1)
worked well for##5##3##(1993-2#1)(2006-8#1)(2008-10#1)(2008-2#1)(2012-3#1)
worked well##11##2##(1993-12#1)(1993-2#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2009-4#1)(2009-6#1)(2010-5#1)(2012-3#1)
worked with##12##2##(1992-11#1)(1994-9#1)(1995-8#1)(2005-7#1)(2006-5#1)(2008-12#2)(2008-5#1)(2008-7#1)(2010-12#1)(2012-12#1)(2013-1#1)
worked##167##1##(1990-2#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-6#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#3)(1992-9#1)(1993-1#4)(1993-12#1)(1993-2#1)(1993-3#4)(1994-1#2)(1994-12#2)(1994-3#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#2)(2004-11#1)(2004-9#2)(2005-4#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-5#3)(2006-8#1)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#1)(2008-1#6)(2008-10#19)(2008-11#3)(2008-12#4)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-4#3)(2009-6#1)(2009-7#1)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#2)(2010-3#1)(2010-5#2)(2010-9#3)(2011-1#5)(2011-2#2)(2011-3#1)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#6)(2013-1#6)
worker brood cells infested##2##4##(2008-6#2)
worker control##2##2##(2010-5#2)
worker for##2##2##(2006-8#1)(2013-1#1)
worker from##2##2##(1997-7#1)(2008-11#1)
worker in the##2##3##(1995-11#1)(2006-12#1)
worker in##5##2##(1995-11#1)(1997-5#1)(2006-12#1)(2007-8#1)(2010-12#1)
worker policing##4##2##(2008-8#4)
worker presented with a##2##4##(1997-7#1)(2007-7#1)
worker production##2##2##(2008-8#2)
worker productivity##2##2##(1993-2#1)(2008-11#1)
worker safety##2##2##(2008-10#1)(2008-11#1)
worker who##3##2##(1995-12#2)(2012-3#1)
worker with##3##2##(1992-5#1)(1994-6#1)(1996-5#1)
worker##110##1##(1990-10#1)(1991-12#2)(1991-2#2)(1991-6#1)(1992-5#1)(1992-8#2)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-1#2)(1994-6#3)(1995-1#1)(1995-11#2)(1995-12#3)(1995-6#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-5#3)(1997-7#2)(2006-10#1)(2006-12#2)(2006-4#2)(2006-8#1)(2007-10#1)(2007-12#2)(2007-3#4)(2007-4#1)(2007-7#2)(2007-8#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#6)(2008-7#1)(2008-8#8)(2009-5#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#5)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#7)(2013-1#5)(2013-8#1)
worker's compensation##4##2##(1996-11#2)(2006-8#1)(2008-8#1)
worker's##8##1##(1991-2#1)(1991-6#1)(1996-11#2)(2006-6#1)(2006-8#1)(2008-8#1)(2013-1#1)
workers (HCWs)##3##2##(2009-10#1)(2011-2#1)(2012-2#1)
workers (SIR=1##2##2##(2010-8#2)
workers a##2##2##(2004-9#1)(2012-12#1)
workers and clients##2##3##(2007-9#1)(2013-7#1)
workers and healthy##2##3##(2007-9#1)(2008-10#1)
workers and in##2##3##(1994-6#1)(2008-2#1)
workers and other##2##3##(2011-2#1)(2013-1#1)
workers and the public##3##4##(2008-12#2)(2009-12#1)
workers and the##10##3##(1992-3#1)(1996-11#2)(2008-12#2)(2008-2#1)(2008-7#1)(2008-9#1)(2009-12#1)(2013-1#1)
workers and their families##2##4##(2013-1#2)
workers and their##3##3##(2012-3#1)(2013-1#2)
workers and##64##2##(1992-2#1)(1992-3#2)(1993-7#1)(1994-3#1)(1994-6#2)(1994-8#1)(1996-11#2)(1996-3#1)(2004-10#1)(2004-9#1)(2006-12#1)(2006-2#2)(2007-1#2)(2007-12#2)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-2#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-6#1)(2010-2#4)(2011-1#1)(2011-12#1)(2011-2#5)(2012-11#1)(2012-12#1)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#1)
workers are frequently##2##3##(1995-5#1)(2008-3#1)
workers are##18##2##(1995-2#1)(1995-3#1)(1995-5#2)(2004-9#1)(2007-1#1)(2007-12#1)(2008-1#3)(2008-10#1)(2008-3#2)(2008-8#2)(2010-2#1)(2012-1#1)(2012-3#1)
workers as a##3##3##(1991-12#1)(2008-8#1)(2009-12#1)
workers as well as##4##4##(1995-5#1)(2011-1#1)(2012-1#1)(2012-3#1)
workers as##10##2##(1991-12#1)(1995-5#1)(2007-9#1)(2008-2#1)(2008-8#1)(2009-12#1)(2009-9#1)(2011-1#1)(2012-1#1)(2012-3#1)
workers at a##3##3##(1993-6#2)(1994-4#1)
workers at filling and distribution stations##2##6##(2013-7#2)
workers at risk##2##3##(1994-6#1)(2012-12#1)
workers at the##3##3##(1991-11#1)(2007-12#1)(2008-2#1)
workers at##17##2##(1991-11#1)(1993-6#2)(1994-4#1)(1994-6#1)(1997-2#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-2#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-7#3)
workers can be##3##3##(2008-10#1)(2010-2#1)(2010-9#1)
workers chronically exposed to##3##4##(2007-1#1)(2011-2#2)
workers compared to##2##3##(2008-8#1)(2009-5#1)
workers compared##3##2##(1994-6#1)(2008-8#1)(2009-5#1)
workers during##2##2##(2007-12#1)(2007-9#1)
workers employed in##4##3##(1994-6#2)(2009-12#1)(2013-1#1)
workers employed##6##2##(1991-11#1)(1994-5#1)(1994-6#2)(2009-12#1)(2013-1#1)
workers engaged in the##2##4##(2005-8#1)(2006-6#1)
workers engaged in##4##3##(2005-8#1)(2006-6#2)(2012-12#1)
workers exposed to a##2##4##(1994-6#1)(2011-2#1)
workers exposed to asbestos at##3##5##(2010-9#3)
workers exposed to asbestos##4##4##(2010-9#4)
workers exposed to cobalt##2##4##(1994-6#2)
workers exposed to different##2##4##(2006-1#1)(2007-12#1)
workers exposed to##26##3##(1992-3#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#6)(2006-1#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-4#1)(2008-6#1)(2010-9#4)(2011-2#1)(2012-2#2)(2013-1#2)(2013-7#1)
workers exposed##28##2##(1992-3#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#6)(2006-1#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-4#1)(2008-6#1)(2010-8#2)(2010-9#4)(2011-2#1)(2012-2#2)(2013-1#2)(2013-7#1)
workers face##2##2##(2007-12#1)(2009-12#1)
workers for##4##2##(1992-2#1)(2006-6#1)(2008-6#1)(2009-8#1)
workers from a##3##3##(1991-12#1)(2012-1#1)(2012-3#1)
workers from an##2##3##(2008-11#1)(2010-9#1)
workers from##14##2##(1991-12#1)(1994-6#2)(2006-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2010-9#3)(2012-1#1)(2012-3#1)(2013-1#1)
workers had a##2##3##(2008-12#1)(2011-2#1)
workers had significantly elevated mortality for##3##6##(2008-12#3)
workers had significantly##4##3##(2008-12#3)(2013-7#1)
workers had##13##2##(1991-11#1)(1994-6#1)(1995-2#1)(2006-12#1)(2007-2#1)(2008-12#4)(2011-2#3)(2013-7#1)
workers has##2##2##(2008-3#1)(2013-1#1)
workers have been##3##3##(1994-6#1)(2008-9#1)(2009-9#1)
workers have suggested##2##3##(2007-3#1)(2011-1#1)
workers have##15##2##(1991-1#1)(1993-11#1)(1994-6#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-9#1)(2011-1#1)
workers in Fiji##2##3##(2008-1#2)
workers in New##2##3##(1991-12#1)(2008-1#1)
workers in a##4##3##(2005-11#1)(2013-1#3)
workers in fish-fillet##2##3##(2006-10#2)
workers in health##2##3##(2010-2#1)(2012-3#1)
workers in one##2##3##(2006-12#1)(2013-7#1)
workers in other##2##3##(2006-2#1)(2008-5#1)
workers in southern##4##3##(2007-7#1)(2012-3#3)
workers in the United States and##2##6##(1991-12#1)(2010-8#1)
workers in the United States##4##5##(1991-12#2)(2010-8#2)
workers in the field##2##4##(1992-9#1)(2008-11#1)
workers in the study##2##4##(2007-9#1)(2012-12#1)
workers in the##27##3##(1990-10#1)(1991-11#2)(1991-12#3)(1992-9#1)(1995-1#1)(2006-6#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-8#4)(2011-2#2)(2012-12#3)(2012-3#1)
workers in these##3##3##(1994-6#1)(1996-12#1)(2010-2#1)
workers in##117##2##(1990-10#2)(1990-11#1)(1990-9#1)(1991-11#2)(1991-12#4)(1992-2#1)(1992-9#1)(1993-2#1)(1994-4#1)(1994-6#3)(1995-1#1)(1996-12#2)(1996-2#1)(1996-8#1)(2005-11#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-6#1)(2006-8#2)(2007-4#2)(2007-7#1)(2007-9#1)(2008-1#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#4)(2010-8#11)(2011-1#1)(2011-2#6)(2012-12#8)(2012-2#3)(2012-3#14)(2013-1#6)(2013-7#3)(2013-8#1)
workers including##2##2##(2010-3#1)(2010-8#1)
workers involved in##2##3##(2008-1#1)(2013-8#1)
workers is a##4##3##(1994-6#1)(1995-11#1)(1995-2#1)(2011-2#1)
workers is##7##2##(1992-4#1)(1994-6#2)(1995-11#1)(1995-2#1)(2008-8#1)(2011-2#1)
workers may##5##2##(2008-11#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
workers must be##2##3##(1996-12#1)(2010-2#1)
workers must##5##2##(1996-12#1)(2006-8#1)(2007-7#1)(2010-2#1)(2012-1#1)
workers occupationally exposed to asbestos##6##5##(2010-9#6)
workers occupationally exposed to cement dust##2##6##(2009-5#2)
workers occupationally exposed to##11##4##(1994-6#2)(2007-9#1)(2009-5#2)(2010-9#6)
workers of Solenopsis##2##3##(2006-12#1)(2007-12#1)
workers of a##2##3##(2009-12#1)(2011-2#1)
workers of the##10##3##(1991-3#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#2)(2008-10#1)(2011-1#1)(2013-1#2)
workers of##24##2##(1991-12#1)(1991-3#1)(1996-3#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-12#6)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)
workers on##7##2##(1992-2#1)(2006-1#1)(2006-12#1)(2007-1#1)(2008-7#1)(2008-8#1)(2010-4#1)
workers performing##2##2##(1991-12#1)(2008-12#1)
workers regarding##2##2##(1996-9#1)(2007-9#1)
workers remain##3##2##(2008-11#1)(2010-8#1)(2013-1#1)
workers should be##4##3##(1993-1#1)(1994-6#1)(2006-2#1)(2012-3#1)
workers should##7##2##(1993-1#1)(1994-6#1)(2006-2#1)(2006-6#1)(2008-4#1)(2008-8#1)(2012-3#1)
workers suffer##2##2##(2007-9#1)(2008-11#1)
workers that##4##2##(2008-10#1)(2008-6#1)(2008-8#1)(2011-2#1)
workers the##2##2##(1991-12#1)(2008-2#1)
workers to examine##2##3##(2008-2#1)(2009-6#1)
workers to##16##2##(1992-6#1)(2005-2#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-2#4)(2008-8#1)(2009-6#1)(2010-11#1)(2010-2#1)(2011-2#1)
workers took##2##2##(1993-6#1)(2007-10#1)
workers using##3##2##(1996-1#1)(2006-6#1)(2011-2#1)
workers was##6##2##(1992-1#1)(2007-12#1)(2007-4#2)(2008-12#1)(2012-3#1)
workers were identified##2##3##(1994-6#1)(2007-12#1)
workers were not##2##3##(2011-1#1)(2012-3#1)
workers were significantly##2##3##(1994-5#1)(2009-5#1)
workers were##21##2##(1991-12#1)(1992-3#2)(1994-5#1)(1994-6#1)(2006-10#2)(2007-12#1)(2007-4#1)(2007-9#1)(2008-6#2)(2009-5#1)(2009-6#1)(2010-8#1)(2011-1#2)(2011-12#1)(2012-12#1)(2012-3#2)
workers while##2##2##(2007-12#1)(2012-12#1)
workers who had ever smoked##2##5##(2008-12#2)
workers who have##2##3##(1995-12#1)(2013-1#1)
workers who were##2##3##(1994-6#1)(1995-12#1)
workers who##22##2##(1992-1#1)(1993-1#2)(1994-1#1)(1994-12#1)(1994-6#2)(1995-12#2)(2007-2#1)(2008-11#1)(2008-12#2)(2009-6#2)(2010-11#1)(2012-12#3)(2013-1#3)
workers with a##4##3##(1994-6#2)(2007-4#1)(2013-7#1)
workers with or without##2##4##(1994-6#1)(2011-11#1)
workers with the##2##3##(2006-8#1)(2010-7#1)
workers with##32##2##(1992-4#1)(1994-6#4)(1996-8#2)(2004-9#1)(2005-10#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-4#1)(2007-9#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-7#1)(2010-9#2)(2011-11#4)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
workers without##2##2##(1994-12#1)(2008-7#1)
workers working in##2##3##(2007-8#1)(2009-12#1)
workers##930##1##(1990-10#2)(1990-11#2)(1990-2#3)(1990-3#2)(1990-6#1)(1990-9#1)(1991-1#1)(1991-11#5)(1991-12#25)(1991-3#4)(1991-6#2)(1991-9#2)(1992-1#8)(1992-10#1)(1992-2#4)(1992-3#9)(1992-4#3)(1992-5#3)(1992-6#1)(1992-9#1)(1993-1#5)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-6#7)(1993-7#3)(1993-8#1)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#3)(1994-4#3)(1994-5#4)(1994-6#52)(1994-7#3)(1994-8#1)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#5)(1995-6#1)(1995-9#1)(1996-1#2)(1996-11#4)(1996-12#6)(1996-2#3)(1996-3#5)(1996-6#1)(1996-7#1)(1996-8#4)(1996-9#1)(1997-2#4)(1997-3#2)(1997-6#1)(2004-10#1)(2004-8#1)(2004-9#4)(2005-10#1)(2005-11#3)(2005-2#3)(2005-7#1)(2005-8#2)(2006-1#3)(2006-10#17)(2006-12#10)(2006-2#7)(2006-4#1)(2006-5#1)(2006-6#8)(2006-8#10)(2006-9#2)(2007-1#8)(2007-10#7)(2007-11#1)(2007-12#26)(2007-2#7)(2007-3#3)(2007-4#10)(2007-6#2)(2007-7#14)(2007-8#5)(2007-9#15)(2008-1#16)(2008-10#11)(2008-11#14)(2008-12#29)(2008-2#21)(2008-3#4)(2008-4#5)(2008-5#3)(2008-6#13)(2008-7#9)(2008-8#31)(2008-9#10)(2009-10#5)(2009-12#14)(2009-2#1)(2009-3#1)(2009-5#8)(2009-6#7)(2009-7#5)(2009-8#1)(2009-9#6)(2010-1#2)(2010-11#4)(2010-12#5)(2010-2#24)(2010-3#3)(2010-4#4)(2010-5#1)(2010-7#2)(2010-8#30)(2010-9#19)(2011-1#17)(2011-11#4)(2011-12#6)(2011-2#43)(2012-1#11)(2012-11#4)(2012-12#31)(2012-2#10)(2012-3#47)(2013-1#35)(2013-7#12)(2013-8#3)
workers' compensation cases##2##3##(1995-1#1)(1997-4#1)
workers' compensation##14##2##(1992-2#1)(1993-1#1)(1994-12#2)(1995-1#2)(1996-2#2)(1996-6#1)(1997-1#1)(1997-4#1)(2009-4#1)(2011-2#1)(2012-12#1)
workers' exposure##2##2##(2006-10#1)(2006-8#1)
workers' health##7##2##(1993-6#1)(2008-10#1)(2011-2#3)(2013-1#2)
workers' knowledge##2##2##(2007-7#1)(2007-9#1)
workers' perceptions of##3##3##(2009-9#1)(2010-5#1)(2013-8#1)
workers' rights##4##2##(2007-10#1)(2012-3#3)
workers' safety##2##2##(2013-1#2)
workers'##74##1##(1992-2#1)(1993-1#1)(1993-6#2)(1994-12#2)(1994-6#2)(1995-1#2)(1995-11#1)(1995-2#3)(1996-2#2)(1996-6#1)(1997-1#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-7#1)(2007-9#4)(2008-10#1)(2008-2#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-5#4)(2011-1#1)(2011-2#6)(2012-12#4)(2012-3#6)(2013-1#7)(2013-8#2)
workers)##7##1##(1994-4#1)(1994-6#1)(2008-10#1)(2008-8#1)(2010-4#1)(2010-8#1)(2011-11#1)
workers]##12##1##(1990-12#1)(1992-1#1)(1994-6#1)(2008-10#1)(2008-11#1)(2010-12#4)(2012-2#2)(2013-1#1)
workflow and##7##2##(2006-6#2)(2012-1#1)(2013-1#4)
workflow for the##2##3##(2010-3#1)(2012-3#1)
workflow for##5##2##(2008-9#1)(2009-12#1)(2010-3#1)(2012-3#2)
workflow in##4##2##(2006-6#1)(2008-3#1)(2013-1#2)
workflow of##3##2##(2007-6#1)(2013-1#2)
workflow##63##1##(2004-9#1)(2006-6#4)(2007-12#2)(2007-6#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-12#2)(2010-11#1)(2010-12#1)(2010-3#1)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#27)
workflows##10##1##(2012-2#2)(2013-1#8)
workforce and##4##2##(2004-3#1)(2007-4#1)(2008-6#1)(2013-7#1)
workforce data##5##2##(1992-1#1)(2011-1#3)(2012-3#1)
workforce for the##2##3##(2004-3#1)(2011-1#1)
workforce for##4##2##(1996-2#1)(2004-3#1)(2009-5#1)(2011-1#1)
workforce has##2##2##(2007-4#2)
workforce in##8##2##(2007-4#3)(2008-1#1)(2008-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
workforce is##3##2##(2011-1#2)(2011-2#1)
workforce of##4##2##(2008-1#1)(2008-11#1)(2010-11#2)
workforce planning and development##2##4##(2011-2#2)
workforce planning##6##2##(1992-1#1)(2010-10#1)(2011-12#1)(2011-2#3)
workforce policy##2##2##(2011-1#1)(2012-2#1)
workforce shortage and##2##3##(2007-4#1)(2008-4#1)
workforce shortage##5##2##(2007-4#3)(2008-4#1)(2013-1#1)
workforce shortages##5##2##(2007-4#4)(2010-9#1)
workforce strategy##2##2##(2012-3#2)
workforce to##3##2##(2010-11#2)(2011-1#1)
workforce##135##1##(1992-1#2)(1996-1#1)(1996-2#1)(1997-3#2)(2004-3#2)(2006-2#1)(2007-10#2)(2007-2#1)(2007-3#1)(2007-4#22)(2007-9#2)(2008-1#6)(2008-10#5)(2008-11#5)(2008-12#3)(2008-4#4)(2008-6#2)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-10#1)(2010-11#7)(2010-2#1)(2010-3#1)(2010-9#4)(2011-1#16)(2011-12#1)(2011-2#7)(2012-12#9)(2012-2#5)(2012-3#7)(2013-1#5)(2013-7#1)(2013-8#1)
workhorse flaps##3##2##(2012-2#3)
workhorse##6##1##(2008-4#1)(2011-2#1)(2012-2#3)(2013-8#1)
workhorses for##2##2##(2008-3#1)(2011-2#1)
workhorses##4##1##(1996-3#1)(2008-3#1)(2009-5#1)(2011-2#1)
working age##3##2##(1993-5#1)(1994-6#1)(2010-2#1)
working alliance##3##2##(2008-2#1)(2008-4#2)
working and learning##2##3##(2008-11#2)
working and living##2##3##(1990-9#1)(1996-9#1)
working and reference memory##4##4##(1992-9#3)(1993-12#1)
working and will##2##3##(2008-11#1)(2012-12#1)
working and##22##2##(1990-9#1)(1991-11#1)(1992-2#1)(1992-9#3)(1993-12#1)(1996-9#1)(2007-9#1)(2008-10#2)(2008-11#5)(2008-5#1)(2008-7#1)(2009-2#1)(2011-1#1)(2012-12#2)
working animals##2##2##(2007-8#2)
working as a##5##3##(1992-6#1)(1994-6#1)(2010-12#1)(2011-2#1)(2013-8#1)
working as##12##2##(1992-6#2)(1994-6#1)(2005-11#1)(2007-2#1)(2008-10#1)(2008-12#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-8#1)
working at a##2##3##(2004-3#1)(2007-12#1)
working at the flow-line##2##4##(2006-10#2)
working at the##12##3##(1994-10#1)(2006-10#2)(2007-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#2)(2009-7#1)(2011-1#1)(2012-12#1)
working at##22##2##(1994-10#1)(2004-3#2)(2005-11#1)(2006-10#2)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#2)(2009-10#1)(2009-7#2)(2011-1#1)(2012-12#1)(2013-1#1)
working calibration range##2##3##(2008-10#2)
working calibration##6##2##(1990-1#1)(2008-10#5)
working capacity##6##2##(1990-12#1)(1990-8#1)(2008-10#1)(2012-2#3)
working channel##2##2##(2008-3#1)(2010-12#1)
working characteristics##2##2##(2008-10#1)(2010-12#1)
working concentration range for##2##4##(2007-8#2)
working concentration range##8##3##(2007-8#2)(2008-10#6)
working concentration##10##2##(2007-8#2)(2008-10#8)
working conditions and##8##3##(1992-5#2)(2007-12#1)(2007-8#1)(2008-2#1)(2010-4#1)(2011-2#1)(2012-12#1)
working conditions are##3##3##(2008-10#1)(2008-2#2)
working conditions for##2##3##(1997-7#1)(2008-10#1)
working conditions in##3##3##(1997-7#1)(2006-6#1)(2008-10#1)
working conditions of the##2##4##(2008-6#1)(2010-4#1)
working conditions of##4##3##(1992-3#1)(2008-6#1)(2009-12#1)(2010-4#1)
working conditions were##3##3##(2008-10#3)
working conditions##52##2##(1992-3#1)(1992-5#2)(1992-6#1)(1993-2#1)(1993-6#2)(1994-6#1)(1996-1#1)(1997-7#2)(2006-10#1)(2006-6#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#19)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2009-12#1)(2010-10#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)
working curve##4##2##(2008-10#4)
working day##5##2##(1991-7#1)(2008-10#1)(2011-1#2)(2013-1#1)
working days lost##3##3##(1992-3#3)
working days##7##2##(1992-3#5)(2008-10#1)(2008-5#1)
working dilutions##2##2##(2007-8#2)
working distance of##2##3##(2007-11#1)(2011-2#1)
working distance##13##2##(2006-2#1)(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#3)(2011-1#1)(2011-2#1)(2012-2#1)
working distances##3##2##(2006-12#1)(2008-3#2)
working donkeys##3##2##(2011-1#3)
working electrode and the##3##4##(2008-10#3)
working electrode and##5##3##(2008-10#5)
working electrode by##2##3##(2008-10#2)
working electrode for##2##3##(2008-10#2)
working electrode in the##3##4##(2008-10#3)
working electrode in##6##3##(2008-10#6)
working electrode of##2##3##(2008-10#1)(2010-2#1)
working electrode surface##5##3##(2008-10#5)
working electrode was##8##3##(2007-8#2)(2008-10#6)
working electrode were##2##3##(2008-10#2)
working electrode##67##2##(1990-11#1)(1991-7#1)(1997-7#1)(2007-8#2)(2008-10#60)(2010-2#1)(2010-4#1)
working electrodes and##2##3##(2008-10#2)
working electrodes##8##2##(1990-8#1)(2008-10#6)(2010-2#1)
working environment and##2##3##(1994-4#1)(2007-5#1)
working environment for##2##3##(1994-1#1)(2010-10#1)
working environment of##2##3##(1995-8#1)(2007-10#1)
working environment##16##2##(1990-8#2)(1991-12#1)(1994-1#1)(1994-4#1)(1995-2#1)(1995-8#1)(1996-2#2)(2007-10#1)(2007-5#1)(2008-11#1)(2008-6#1)(2010-10#1)(2010-2#1)(2010-4#1)
working experience of##2##3##(2009-8#1)(2012-12#1)
working for pay##2##3##(1995-2#1)(2007-3#1)
working for##7##2##(1992-12#1)(1995-2#1)(1996-8#1)(2005-11#1)(2007-3#1)(2007-7#1)(2012-12#1)
working frequency##2##2##(2008-10#1)(2008-11#1)
working from##2##2##(2008-2#1)(2012-3#1)
working group on##3##3##(1993-2#1)(2008-12#1)(2008-2#1)
working group to##2##3##(1995-12#1)(1996-2#1)
working group##20##2##(1993-2#1)(1995-12#1)(1996-2#1)(2007-10#1)(2007-7#3)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2012-11#2)(2013-1#3)(2013-7#1)
working groups##6##2##(1995-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#2)
working hard to##2##3##(1992-3#1)(2008-4#1)
working hours##4##2##(1990-11#1)(1993-8#1)(1995-6#1)(1995-8#1)
working hypothesis is that##2##4##(1994-5#1)(1995-3#1)
working hypothesis##10##2##(1994-5#2)(1995-3#1)(1995-6#1)(2008-12#2)(2008-3#1)(2008-5#1)(2009-8#1)(2013-8#1)
working in a##12##3##(1997-5#1)(2004-4#1)(2005-7#1)(2007-10#1)(2007-6#1)(2008-10#1)(2008-11#2)(2010-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
working in academic##2##3##(2008-12#1)(2009-7#1)
working in acute##2##3##(1993-12#1)(2011-2#1)
working in an##6##3##(2009-5#1)(2010-10#2)(2010-12#1)(2012-3#1)(2013-1#1)
working in clinical##3##3##(2008-11#1)(2009-6#1)(2012-2#1)
working in concert with##3##4##(1996-6#1)(2012-2#2)
working in conjunction with##2##4##(2008-3#1)(2012-2#1)
working in operating##2##3##(1991-7#1)(2006-10#1)
working in primary##2##3##(2010-11#1)(2011-2#1)
working in the emergency department##2##5##(2011-1#2)
working in the emergency##5##4##(1992-6#1)(1994-4#1)(1996-6#1)(2011-1#2)
working in the market##2##4##(2012-12#2)
working in the oil##2##4##(2011-1#1)(2011-11#1)
working in the same##3##4##(1994-6#1)(2008-10#1)(2010-9#1)
working in the##55##3##(1991-12#1)(1991-2#1)(1992-6#1)(1994-4#1)(1994-6#1)(1995-6#1)(1996-6#1)(2006-1#2)(2006-2#2)(2006-8#1)(2007-10#1)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#6)(2008-7#3)(2009-11#1)(2009-7#1)(2010-1#1)(2010-9#1)(2011-1#4)(2011-11#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#1)(2013-8#2)
working in these##2##3##(2006-2#1)(2011-1#1)
working in this field##2##4##(1996-4#1)(2013-1#1)
working in this##3##3##(1996-4#1)(2008-1#1)(2013-1#1)
working in##168##2##(1990-6#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-6#1)(1993-1#2)(1993-12#2)(1994-4#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-2#1)(1996-4#1)(1996-6#2)(1997-4#1)(1997-5#2)(1997-6#1)(2004-3#1)(2004-4#1)(2005-7#1)(2006-1#2)(2006-10#2)(2006-11#1)(2006-2#3)(2006-4#1)(2006-7#1)(2006-8#1)(2007-10#3)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#5)(2008-10#7)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#8)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-1#3)(2010-10#3)(2010-11#2)(2010-12#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#8)(2011-11#1)(2011-2#6)(2012-1#3)(2012-11#2)(2012-12#6)(2012-2#7)(2012-3#4)(2013-1#6)(2013-8#6)
working knowledge of##3##3##(2004-2#1)(2007-12#1)(2011-2#1)
working knowledge##4##2##(2004-2#1)(2007-12#1)(2008-11#1)(2011-2#1)
working length##2##2##(2008-11#1)(2011-12#1)
working life##6##2##(1992-3#1)(2008-10#1)(2008-11#2)(2008-9#2)
working lives##2##2##(2008-9#1)(2013-1#1)
working medium##3##2##(2008-10#3)
working memory (WM)##3##3##(1994-8#2)(2010-2#1)
working memory and##4##3##(1993-12#1)(2007-8#1)(2008-11#1)(2008-3#1)
working memory at##2##3##(1993-11#1)(2012-3#1)
working memory capacity##4##3##(2012-2#1)(2012-3#3)
working memory deficit in##2##4##(1997-8#1)(2005-10#1)
working memory deficit##3##3##(1997-8#2)(2005-10#1)
working memory deficits##4##3##(1995-12#1)(2005-10#1)(2008-5#1)(2012-2#1)
working memory errors##4##3##(1993-12#1)(1993-3#1)(1996-12#2)
working memory function##2##3##(1994-8#1)(1996-12#1)
working memory in##5##3##(1993-12#1)(1995-12#1)(2007-9#1)(2009-9#1)(2012-1#1)
working memory is##2##3##(1992-9#1)(1995-12#1)
working memory performance##5##3##(1997-8#1)(2009-9#1)(2012-2#3)
working memory processes##3##3##(1992-8#1)(2007-8#1)(2008-11#1)
working memory task##11##3##(1993-12#2)(1994-8#4)(1996-12#1)(1997-8#2)(2005-10#1)(2012-3#1)
working memory tasks##5##3##(1993-3#1)(2012-1#1)(2012-3#3)
working memory##111##2##(1991-1#2)(1991-11#1)(1992-1#1)(1992-10#4)(1992-11#1)(1992-8#1)(1992-9#1)(1993-11#4)(1993-12#10)(1993-3#6)(1993-5#1)(1994-3#1)(1994-5#2)(1994-8#8)(1995-12#4)(1996-12#5)(1997-8#5)(2005-10#4)(2006-9#1)(2007-11#1)(2007-8#3)(2007-9#2)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-7#1)(2009-9#2)(2010-2#1)(2012-1#4)(2012-12#2)(2012-2#6)(2012-3#13)(2013-7#2)(2013-8#1)
working memory)##2##2##(2012-12#1)(2013-1#1)
working method##2##2##(1992-3#1)(2008-5#1)
working model for##3##3##(1993-6#1)(1993-8#1)(2009-8#1)
working model##9##2##(1993-6#1)(1993-8#1)(2006-12#1)(2008-12#1)(2009-12#1)(2009-8#1)(2011-1#1)(2012-2#2)
working models for##2##3##(1994-12#1)(1994-8#1)
working models##4##2##(1994-12#1)(1994-8#1)(2005-8#1)(2007-9#1)
working of the##7##3##(2008-10#3)(2008-3#1)(2012-2#3)
working of##10##2##(2007-10#1)(2008-10#5)(2008-3#1)(2012-2#3)
working on a##4##3##(1997-3#1)(2004-10#1)(2007-7#1)(2008-12#1)
working on farms##2##3##(2008-12#1)(2012-12#1)
working on the##8##3##(1990-12#1)(2005-10#1)(2005-7#1)(2007-8#1)(2007-9#1)(2008-3#1)(2009-6#1)(2012-12#1)
working on##26##2##(1990-12#2)(1991-2#1)(1993-8#1)(1997-3#1)(2004-10#1)(2005-10#1)(2005-7#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-6#1)(2008-8#2)(2009-6#1)(2010-8#1)(2011-12#1)(2012-12#2)
working out##4##2##(1990-3#1)(2006-10#1)(2007-9#1)(2008-6#1)
working outside##3##2##(1991-12#1)(1993-1#1)(2011-2#1)
working pH range of##2##4##(2008-10#2)
working pH range##7##3##(1992-4#1)(2008-10#6)
working pH##11##2##(1992-4#1)(2008-10#9)(2008-11#1)
working parameters of##2##3##(2008-3#1)(2013-8#1)
working parameters##4##2##(2008-10#2)(2008-3#1)(2013-8#1)
working party##2##2##(1991-9#1)(2008-11#1)
working place##2##2##(2004-8#1)(2011-2#1)
working point##3##2##(2008-2#2)(2009-2#1)
working population##2##2##(1996-6#1)(2006-8#1)
working potential##4##2##(1997-1#1)(2008-10#3)
working practice in##2##3##(2010-12#1)(2011-2#1)
working practice##4##2##(2008-10#1)(2010-12#1)(2011-2#1)(2013-7#1)
working principle of the##2##4##(2008-10#1)(2008-3#1)
working principle of##4##3##(2008-10#1)(2008-3#1)(2012-1#1)(2013-1#1)
working principle##7##2##(2008-10#2)(2008-3#1)(2009-5#1)(2012-1#1)(2013-1#2)
working properly##2##2##(2008-3#1)(2008-8#1)
working range 0##2##3##(2008-10#2)
working range for##3##3##(2008-10#2)(2012-1#1)
working range is##2##3##(2008-10#2)
working range of at least##2##5##(2008-3#2)
working range of the##5##4##(2008-10#3)(2008-3#2)
working range of##15##3##(2006-4#1)(2007-8#1)(2008-10#9)(2008-3#4)
working range were##2##3##(2008-10#1)(2008-3#1)
working range##42##2##(2006-4#1)(2007-8#2)(2008-10#33)(2008-3#5)(2012-1#1)
working ranges##3##2##(2008-10#3)
working relationship between##2##3##(1992-9#1)(1995-12#1)
working relationship##7##2##(1992-9#1)(1993-1#2)(1994-1#1)(1995-12#1)(2008-12#1)(2010-9#1)
working relationships between##2##3##(2008-2#1)(2012-12#1)
working relationships of public health nurses and high-priority families in##2##10##(2010-9#2)
working relationships##8##2##(1991-3#1)(1994-12#1)(1996-12#1)(2008-2#1)(2010-9#2)(2011-1#1)(2012-12#1)
working remote from##2##3##(1992-3#1)(2007-2#1)
working solution##2##2##(2008-10#2)
working space was##3##3##(2007-5#3)
working space##8##2##(2006-12#1)(2007-5#5)(2011-2#1)(2012-12#1)
working temperature of##2##3##(2005-4#1)(2008-2#1)
working temperature range##2##3##(2006-6#1)(2008-10#1)
working temperature##5##2##(2005-4#1)(2006-6#1)(2008-10#1)(2008-2#1)(2011-1#1)
working there##2##2##(1996-11#1)(2006-10#1)
working through##6##2##(1993-1#1)(2004-12#1)(2009-10#1)(2009-4#1)(2012-3#1)(2013-1#1)
working time##9##2##(1992-5#1)(1993-1#1)(1994-6#2)(1995-2#1)(2008-10#2)(2008-11#1)(2011-2#1)
working to address##2##3##(1993-2#1)(1995-12#1)
working to develop a##2##4##(1996-2#1)(2007-5#1)
working to develop##3##3##(1996-2#1)(2007-5#1)(2009-6#1)
working to improve care##2##4##(1996-1#1)(2013-8#1)
working to improve##3##3##(1996-1#1)(2013-8#2)
working to##18##2##(1993-2#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(2005-5#1)(2006-2#1)(2007-10#1)(2007-2#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-6#1)(2010-1#1)(2010-9#1)(2013-8#2)
working together with the##2##4##(1995-2#1)(2008-7#1)
working together##8##2##(1995-1#2)(1995-2#1)(2007-5#1)(2008-6#2)(2008-7#1)(2013-8#1)
working towards##3##2##(2008-5#1)(2010-3#1)(2010-4#1)
working under##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
working volume##3##2##(2008-11#1)(2008-5#1)(2013-1#1)
working waveband##2##2##(2013-8#2)
working wavelength##4##2##(2008-10#2)(2008-2#1)(2010-5#1)
working with a##3##3##(2006-2#1)(2008-10#1)(2012-3#1)
working with an##2##3##(1991-11#1)(2008-11#1)
working with clients##2##3##(2007-9#1)(2011-1#1)
working with families##2##3##(2010-9#1)(2013-1#1)
working with health care##2##4##(1994-1#1)(1994-2#1)
working with homeless people##2##4##(2008-2#1)(2012-12#1)
working with homeless##3##3##(2008-2#1)(2012-12#2)
working with patients with##2##4##(2008-12#1)(2012-12#1)
working with patients##5##3##(2008-12#1)(2008-6#1)(2010-3#1)(2012-12#2)
working with people with##2##4##(1995-12#1)(2007-9#1)
working with the##9##3##(1994-9#1)(1995-2#1)(2006-1#1)(2007-10#1)(2008-10#2)(2008-7#1)(2010-8#1)(2013-1#1)
working with this##2##3##(2008-10#1)(2008-3#1)
working with##105##2##(1991-11#1)(1991-12#1)(1991-8#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#2)(1995-2#2)(1996-8#1)(1997-1#2)(2004-12#2)(2005-10#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-2#2)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-4#1)(2007-9#2)(2008-10#10)(2008-11#5)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#8)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#6)(2009-6#1)(2010-1#1)(2010-3#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#5)(2012-3#3)(2013-1#6)
working within a##4##3##(1992-12#1)(1997-7#1)(2009-7#2)
working within##7##2##(1992-12#1)(1997-7#1)(2004-3#1)(2006-11#2)(2009-7#2)
working women##3##2##(1992-2#1)(2010-5#1)(2013-1#1)
working##1156##1##(1990-1#1)(1990-11#2)(1990-12#3)(1990-3#1)(1990-6#1)(1990-8#5)(1990-9#2)(1991-1#2)(1991-11#3)(1991-12#7)(1991-2#2)(1991-3#3)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#4)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#11)(1992-4#1)(1992-5#3)(1992-6#4)(1992-8#1)(1992-9#6)(1993-1#8)(1993-11#5)(1993-12#14)(1993-2#5)(1993-3#8)(1993-5#2)(1993-6#4)(1993-8#3)(1994-1#6)(1994-10#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-4#2)(1994-5#5)(1994-6#10)(1994-8#9)(1994-9#1)(1995-1#4)(1995-12#12)(1995-2#6)(1995-3#4)(1995-6#6)(1995-8#2)(1996-1#3)(1996-11#2)(1996-12#6)(1996-2#5)(1996-4#1)(1996-5#2)(1996-6#3)(1996-8#3)(1996-9#2)(1997-1#3)(1997-3#1)(1997-4#2)(1997-5#5)(1997-6#1)(1997-7#5)(1997-8#8)(2004-10#2)(2004-12#3)(2004-2#1)(2004-3#4)(2004-4#1)(2004-8#1)(2005-10#6)(2005-11#5)(2005-4#1)(2005-5#1)(2005-7#4)(2005-8#2)(2006-1#3)(2006-10#12)(2006-11#3)(2006-12#3)(2006-2#11)(2006-4#2)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#4)(2006-9#1)(2007-1#2)(2007-10#10)(2007-11#9)(2007-12#12)(2007-2#9)(2007-3#3)(2007-4#4)(2007-5#8)(2007-6#1)(2007-7#9)(2007-8#27)(2007-9#9)(2008-1#9)(2008-10#223)(2008-11#42)(2008-12#17)(2008-2#26)(2008-3#38)(2008-4#16)(2008-5#15)(2008-6#10)(2008-7#13)(2008-8#11)(2008-9#13)(2009-10#4)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#4)(2009-7#8)(2009-8#4)(2009-9#2)(2010-1#7)(2010-10#5)(2010-11#2)(2010-12#5)(2010-2#6)(2010-3#2)(2010-4#6)(2010-5#3)(2010-7#2)(2010-8#5)(2010-9#8)(2011-1#25)(2011-11#1)(2011-12#3)(2011-2#23)(2012-1#14)(2012-11#4)(2012-12#31)(2012-2#27)(2012-3#25)(2013-1#29)(2013-7#9)(2013-8#17)
working-age##5##1##(1997-6#1)(2008-1#2)(2012-2#1)(2013-1#1)
working-memory##4##1##(1991-2#1)(2008-4#3)
workings of##4##2##(2006-11#1)(2007-12#1)(2008-7#1)(2012-2#1)
workings##7##1##(2006-11#1)(2007-12#1)(2007-9#1)(2008-7#1)(2008-9#1)(2009-10#1)(2012-2#1)
workload and work##2##3##(2004-10#2)
workload and##13##2##(1991-12#1)(1994-3#2)(1996-1#1)(2004-10#4)(2007-7#1)(2008-12#1)(2009-7#1)(2010-8#1)(2011-1#1)
workload in##5##2##(1997-8#3)(2005-9#1)(2012-2#1)
workload measurement system##2##3##(1994-12#1)(1996-1#1)
workload measurement##3##2##(1994-12#1)(1996-1#2)
workload of##4##2##(2008-1#1)(2008-6#1)(2011-2#1)(2013-1#1)
workload survey##2##2##(2005-9#2)
workload that##2##2##(1996-1#1)(2006-7#1)
workload when##2##2##(2010-3#1)(2012-12#1)
workload##86##1##(1990-10#1)(1990-12#1)(1991-12#1)(1991-4#1)(1992-12#1)(1992-2#1)(1993-12#2)(1993-2#1)(1993-9#2)(1994-12#3)(1994-3#5)(1995-2#1)(1996-1#6)(1996-12#1)(1997-8#3)(2004-10#6)(2005-9#3)(2006-10#1)(2006-7#1)(2007-10#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2009-7#1)(2010-10#2)(2010-3#1)(2010-8#2)(2011-1#5)(2011-2#7)(2012-12#6)(2012-2#6)(2012-3#1)(2013-1#1)
workloads and##2##2##(2007-4#1)(2011-1#1)
workloads##9##1##(1993-2#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-1#3)
workpiece##6##1##(2008-2#3)(2008-3#3)
workpieces##2##1##(2008-2#2)
workplace accidents##2##2##(2010-4#1)(2011-2#1)
workplace accommodations##3##2##(2010-12#1)(2010-2#2)
workplace air##2##2##(1994-6#1)(2008-10#1)
workplace and##6##2##(2007-1#2)(2007-2#1)(2008-11#1)(2008-3#1)(2012-12#1)
workplace by##3##2##(2008-10#1)(2008-7#1)(2011-1#1)
workplace conversations##3##2##(2011-1#3)
workplace environment##2##2##(2007-10#1)(2008-12#1)
workplace flexibility and worker insecurity##2##5##(2010-5#2)
workplace flexibility measures##2##3##(2010-5#2)
workplace flexibility##4##2##(2010-5#4)
workplace of##3##2##(1994-6#1)(2008-10#1)(2013-8#1)
workplace or##2##2##(2008-12#1)(2010-9#1)
workplace productivity##2##2##(2004-3#2)
workplace provision##2##2##(2011-2#1)(2012-2#1)
workplace relationships##2##2##(2011-1#2)
workplace substance use##2##3##(2012-12#2)
workplace substance##3##2##(1992-1#1)(2012-12#2)
workplace violence##8##2##(1996-12#1)(1996-2#1)(1997-2#1)(2007-3#1)(2008-7#3)(2010-10#1)
workplace##175##1##(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#2)(1992-1#2)(1992-2#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#2)(1994-4#2)(1994-6#4)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-1#1)(1996-12#2)(1996-2#2)(1997-2#3)(1997-4#2)(2004-3#2)(2004-9#2)(2005-8#1)(2006-1#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-1#2)(2007-10#2)(2007-11#3)(2007-2#2)(2007-3#2)(2007-4#1)(2007-7#3)(2007-9#2)(2008-10#6)(2008-11#11)(2008-12#7)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#6)(2008-7#5)(2008-9#6)(2009-4#3)(2010-10#2)(2010-12#3)(2010-2#4)(2010-4#4)(2010-5#5)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#14)(2011-2#3)(2012-1#3)(2012-12#7)(2012-2#3)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#4)
workplace)##2##1##(2009-4#2)
workplaces in##2##2##(1993-6#1)(1995-6#1)
workplaces##16##1##(1992-5#1)(1993-6#1)(1994-6#2)(1995-6#1)(1997-6#1)(2004-9#1)(2005-8#1)(2006-6#1)(2008-3#1)(2008-9#1)(2010-5#2)(2011-1#1)(2012-2#2)
works and the##2##3##(1990-12#1)(2008-10#1)
works and##9##2##(1990-12#1)(1992-12#1)(2007-7#1)(2008-10#1)(2011-2#1)(2012-2#3)(2013-7#1)
works are##9##2##(2006-12#1)(2009-2#1)(2009-3#1)(2010-11#1)(2010-12#1)(2012-11#4)
works as a##6##3##(1991-4#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-3#1)(2010-12#1)
works as an agonist of this vitamin##2##7##(2007-7#2)
works as an##5##3##(1995-11#1)(2007-7#2)(2008-5#1)(2009-5#1)
works as##14##2##(1991-4#1)(1995-11#1)(2006-10#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-12#1)(2011-1#1)
works at the##2##3##(2008-2#1)(2012-11#1)
works at##4##2##(2008-10#1)(2008-2#1)(2012-11#1)(2012-2#1)
works best##2##2##(2008-2#1)(2011-1#1)
works by##11##2##(2005-10#1)(2006-10#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#2)
works dealing with##2##3##(2008-10#1)(2011-2#1)
works effectively##2##2##(2008-1#1)(2008-2#1)
works for the##2##3##(1990-5#1)(2008-2#1)
works for##3##2##(1990-5#1)(1991-3#1)(2008-2#1)
works have##10##2##(1997-7#1)(2007-12#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-12#1)(2012-1#1)(2012-12#2)(2012-3#1)
works in a##6##3##(2008-10#1)(2008-3#3)(2008-9#1)(2013-1#1)
works in healthcare establishments##4##4##(2012-11#4)
works in##24##2##(1994-1#1)(1994-5#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-9#1)(2012-1#1)(2012-11#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
works of art by##2##4##(2008-10#2)
works of art##11##3##(2007-11#1)(2008-10#9)(2008-2#1)
works of##17##2##(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-2#2)(2009-10#1)(2009-7#1)
works on the##3##3##(2006-11#1)(2008-10#1)(2008-2#1)
works on##8##2##(1993-12#1)(2006-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-2#1)(2010-4#1)(2011-2#1)
works satisfactorily in the##3##4##(2008-10#3)
works that##3##2##(1994-1#1)(2008-4#1)(2010-12#1)
works through##2##2##(1993-9#1)(2008-8#1)
works to##6##2##(1992-10#1)(2008-11#1)(2008-6#1)(2009-11#1)(2010-1#1)(2010-8#1)
works together with##3##3##(2008-3#1)(2012-2#2)
works under##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
works well for a##2##4##(2008-2#1)(2010-6#1)
works well for##5##3##(2008-2#3)(2010-5#1)(2010-6#1)
works well in##6##3##(2008-10#4)(2008-3#1)(2012-3#1)
works well on##3##3##(2008-11#1)(2013-1#2)
works well over a wide concentration range##2##7##(2008-10#2)
works well over a##4##4##(2008-10#4)
works well when##2##3##(2008-10#1)(2008-3#1)
works well with##3##3##(2008-2#1)(2012-1#1)(2012-2#1)
works well##27##2##(1997-4#1)(2008-10#9)(2008-11#1)(2008-2#6)(2008-3#2)(2010-5#1)(2010-6#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)
works with a##2##3##(1992-4#1)(2008-5#1)
works with##10##2##(1992-4#1)(1993-12#1)(1993-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)
works without##2##2##(2008-3#2)
works##274##1##(1990-12#1)(1990-5#2)(1991-3#1)(1991-4#1)(1991-9#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-4#1)(1993-12#2)(1993-5#1)(1993-9#1)(1994-1#3)(1994-3#1)(1994-5#1)(1995-11#1)(1995-6#1)(1996-10#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-10#2)(2005-11#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-5#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#5)(2007-7#3)(2007-8#6)(2007-9#4)(2008-1#6)(2008-10#37)(2008-11#6)(2008-12#3)(2008-2#19)(2008-3#14)(2008-4#7)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#6)(2009-10#2)(2009-11#1)(2009-2#4)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#4)(2011-12#1)(2011-2#6)(2012-1#5)(2012-11#9)(2012-12#2)(2012-2#15)(2012-3#6)(2012-7#1)(2013-1#7)(2013-7#3)(2013-8#1)
works?##3##1##(1995-2#1)(2006-10#1)(2007-1#1)
worksheets##4##1##(1993-12#1)(2007-2#2)(2008-1#1)
workshop at##2##2##(2008-3#1)(2008-7#1)
workshop convened##2##2##(1990-11#1)(2009-7#1)
workshop focused on##2##3##(2008-4#1)(2013-7#1)
workshop for##2##2##(1996-2#1)(2008-2#1)
workshop held at the##2##4##(2009-3#1)(2011-2#1)
workshop in##3##2##(2008-7#1)(2008-8#1)(2010-5#1)
workshop included##4##2##(1996-2#1)(2008-1#1)(2008-10#1)(2013-8#1)
workshop is##2##2##(2008-11#1)(2008-3#1)
workshop on &quot##3##3##(2007-10#1)(2008-10#1)(2008-5#1)
workshop on the##4##3##(2008-1#2)(2008-5#2)
workshop on##24##2##(1991-12#1)(1992-1#1)(1994-2#1)(1994-3#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-5#4)(2008-7#4)(2012-2#1)(2013-7#1)
workshop organized by the##2##4##(2007-11#1)(2013-1#1)
workshop participants##3##2##(1991-8#1)(2008-10#2)
workshop report##2##2##(2008-5#2)
workshop to##7##2##(1990-11#1)(1993-9#1)(1995-3#1)(1996-8#1)(2008-5#2)(2012-12#1)
workshop was convened##2##3##(2007-2#1)(2009-4#1)
workshop was organized##2##3##(2008-10#1)(2011-2#1)
workshop was to##2##3##(2008-10#1)(2008-4#1)
workshop was##18##2##(1996-4#1)(2007-2#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-4#1)(2011-2#2)(2012-2#1)(2013-8#2)
workshop were##2##2##(2008-7#1)(2013-1#1)
workshop with##2##2##(2009-4#1)(2011-2#1)
workshop##156##1##(1990-11#5)(1991-12#1)(1991-8#1)(1992-1#1)(1992-12#3)(1992-5#3)(1993-1#2)(1993-11#1)(1993-9#3)(1994-2#1)(1994-3#1)(1994-6#1)(1995-3#3)(1995-9#2)(1996-2#4)(1996-3#1)(1996-4#2)(1996-8#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-5#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#8)(2008-10#12)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#14)(2008-6#2)(2008-7#11)(2008-8#2)(2008-9#3)(2009-3#2)(2009-4#3)(2009-7#1)(2010-2#1)(2010-5#3)(2011-12#1)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#5)
workshops and the##2##3##(2008-12#1)(2008-7#1)
workshops and##10##2##(2006-4#1)(2007-8#1)(2008-12#1)(2008-5#2)(2008-7#1)(2010-2#1)(2011-2#1)(2013-7#1)(2013-8#1)
workshops held##2##2##(2005-8#1)(2009-5#1)
workshops in##4##2##(1996-4#1)(2008-11#1)(2009-7#1)(2011-2#1)
workshops on##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
workshops that##2##2##(2005-7#1)(2008-12#1)
workshops to##3##2##(2009-4#1)(2010-10#1)(2010-5#1)
workshops##65##1##(1991-12#1)(1996-4#1)(2005-7#1)(2005-8#3)(2005-9#3)(2006-4#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#4)(2008-12#10)(2008-2#4)(2008-4#1)(2008-5#5)(2008-7#2)(2008-8#1)(2009-4#3)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-5#1)(2011-2#4)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
worksite tenure##4##2##(2010-6#4)
worksite##8##1##(1997-1#1)(2007-10#1)(2010-6#5)(2011-2#1)
worksites##4##1##(2007-10#3)(2013-1#1)
workspace##4##1##(2012-1#4)
workstation and##2##2##(2006-2#1)(2007-4#1)
workstation with##2##2##(2008-7#1)(2009-6#1)
workstation##25##1##(1991-12#1)(1992-10#1)(1996-2#1)(1997-4#1)(2004-9#1)(2006-12#2)(2006-2#1)(2007-4#4)(2008-10#3)(2008-3#1)(2008-4#2)(2008-7#3)(2009-6#1)(2009-8#1)(2010-2#1)(2011-2#1)
workstations##14##1##(1991-12#1)(1993-12#1)(1993-2#1)(1996-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-2#2)
workup for##4##2##(2010-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
workup of patients##3##3##(1993-3#1)(2008-3#1)(2010-11#1)
workup of##8##2##(1992-1#1)(1993-3#1)(2006-10#1)(2007-12#1)(2008-3#1)(2010-11#1)(2012-12#1)(2012-2#1)
workup##34##1##(1990-10#1)(1990-3#1)(1991-6#1)(1992-1#1)(1993-3#1)(1994-9#1)(1996-3#1)(2005-8#1)(2006-10#2)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2010-11#1)(2010-2#2)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
world -##2##2##(2006-5#1)(2009-7#1)
world and across##2##3##(2010-12#1)(2012-2#1)
world and are##3##3##(2006-1#1)(2009-5#1)(2010-5#1)
world and is##2##3##(1994-9#1)(2009-6#1)
world and its##2##3##(1995-5#1)(2013-1#1)
world and the##3##3##(2007-11#1)(2010-10#1)(2013-1#1)
world and##42##2##(1991-6#1)(1994-6#1)(1994-9#1)(1995-5#1)(1996-3#1)(1997-6#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-11#4)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2009-5#4)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-11#1)(2012-2#2)(2013-1#4)(2013-8#1)
world are##16##2##(1991-11#1)(1993-4#1)(1995-3#1)(1996-8#1)(2005-10#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
world as##8##2##(1992-2#1)(2007-8#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
world average##4##2##(2010-12#1)(2011-2#2)(2013-1#1)
world because of the##2##4##(1997-7#1)(2006-10#1)
world because##3##2##(1997-7#1)(2006-10#1)(2008-5#1)
world by##4##2##(1994-9#2)(1996-4#1)(2006-10#1)
world class##2##2##(1992-3#1)(1994-1#1)
world congress of##2##3##(2006-9#2)
world congress##4##2##(2005-8#1)(2006-9#3)
world countries##3##2##(1991-5#1)(2006-8#1)(2008-1#1)
world free##2##2##(1997-3#1)(2007-2#1)
world have##7##2##(1993-10#1)(2006-8#1)(2008-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
world health##2##2##(2006-12#1)(2012-2#1)
world in which we##2##4##(1990-12#1)(2008-2#1)
world in which##5##3##(1990-12#1)(2007-3#1)(2008-11#1)(2008-2#1)(2011-2#1)
world in##22##2##(1990-12#1)(1996-7#1)(2006-5#1)(2006-9#1)(2007-12#1)(2007-3#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
world is in##2##3##(1991-11#1)(2007-7#1)
world is suggested##2##3##(2013-1#2)
world is##18##2##(1991-11#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-5#1)(2011-2#1)(2013-1#3)
world literature are##2##3##(2008-10#1)(2011-2#1)
world literature##94##2##(1992-2#2)(1994-10#1)(2006-10#61)(2007-12#1)(2007-6#8)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-5#2)(2008-6#7)(2008-8#2)(2009-4#2)(2011-2#1)(2012-2#1)(2012-3#1)
world medical##2##2##(2009-3#1)(2010-4#1)
world monkeys##3##2##(2008-1#2)(2011-2#1)
world of a##2##3##(2008-2#1)(2012-2#1)
world of medicine##2##3##(2008-10#1)(2008-4#1)
world of the##5##3##(1993-2#1)(2006-12#1)(2008-2#2)(2009-7#1)
world of##53##2##(1990-6#1)(1991-3#1)(1992-3#2)(1993-1#1)(1993-2#2)(1994-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#2)(2005-7#1)(2006-10#2)(2006-12#2)(2006-2#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-7#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
world on the##3##3##(1991-7#1)(1993-9#1)(2008-1#1)
world on##5##2##(1991-7#1)(1993-9#1)(2006-2#1)(2008-1#1)(2012-2#1)
world population is##2##3##(2006-2#1)(2012-2#1)
world population##14##2##(1992-10#1)(1994-9#2)(2005-3#1)(2006-10#1)(2006-2#1)(2006-4#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-2#1)
world requires##2##2##(1994-2#1)(2008-9#1)
world seems##2##2##(1992-10#1)(2013-1#1)
world standards##2##2##(2007-8#2)
world statistics##2##2##(2010-7#1)(2012-12#1)
world that##3##2##(1996-11#1)(2006-2#1)(2007-8#1)
world the##2##2##(2008-10#1)(2010-12#1)
world to the##3##3##(1997-7#1)(2008-6#1)(2010-9#1)
world to understand##2##3##(2007-1#1)(2007-8#1)
world to##18##2##(1991-11#1)(1994-2#1)(1994-6#1)(1997-2#1)(1997-7#1)(2007-1#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-12#2)(2010-9#1)(2012-1#1)(2012-12#1)
world total##2##2##(1991-6#2)
world view##3##2##(1993-2#2)(2008-12#1)
world war##4##2##(1997-6#2)(2008-4#1)(2012-2#1)
world wars##2##2##(2004-3#1)(2007-7#1)
world was##5##2##(1990-2#1)(2004-10#2)(2007-11#1)(2011-2#1)
world we##2##2##(1995-6#1)(1997-8#1)
world where it##2##3##(2007-4#1)(2007-7#1)
world where##9##2##(1996-1#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-11#1)(2012-12#1)
world wide##9##2##(1992-2#1)(1997-6#1)(2006-10#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-8#1)
world with a##2##3##(2007-2#1)(2010-5#1)
world with##7##2##(2007-2#1)(2007-7#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-5#1)(2010-8#1)
world##1028##1##(1990-11#1)(1990-12#3)(1990-2#3)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-11#4)(1991-3#2)(1991-4#1)(1991-5#4)(1991-6#4)(1991-7#1)(1991-9#1)(1992-10#2)(1992-2#6)(1992-3#4)(1992-5#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#6)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-1#7)(1994-10#1)(1994-12#2)(1994-2#4)(1994-3#1)(1994-6#3)(1994-9#9)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#4)(1995-8#3)(1995-9#1)(1996-1#5)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#4)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#5)(1997-3#3)(1997-4#2)(1997-6#6)(1997-7#5)(1997-8#5)(2004-10#3)(2004-11#3)(2004-3#2)(2004-8#2)(2004-9#1)(2005-10#3)(2005-11#5)(2005-12#1)(2005-3#1)(2005-6#1)(2005-7#9)(2005-8#4)(2006-1#1)(2006-10#85)(2006-11#1)(2006-12#8)(2006-2#10)(2006-4#8)(2006-5#5)(2006-7#3)(2006-8#3)(2006-9#8)(2007-1#3)(2007-10#5)(2007-11#13)(2007-12#10)(2007-2#19)(2007-3#8)(2007-4#11)(2007-5#4)(2007-6#8)(2007-7#15)(2007-8#22)(2007-9#11)(2008-1#35)(2008-10#71)(2008-11#27)(2008-12#17)(2008-2#16)(2008-3#9)(2008-4#6)(2008-5#26)(2008-6#13)(2008-7#17)(2008-8#15)(2008-9#10)(2009-10#7)(2009-11#1)(2009-12#2)(2009-2#7)(2009-3#4)(2009-4#6)(2009-5#5)(2009-6#10)(2009-7#3)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#8)(2010-11#3)(2010-12#21)(2010-2#8)(2010-3#1)(2010-4#7)(2010-5#10)(2010-6#1)(2010-7#5)(2010-8#11)(2010-9#6)(2011-1#17)(2011-11#2)(2011-12#7)(2011-2#41)(2012-1#4)(2012-11#3)(2012-12#13)(2012-2#28)(2012-3#11)(2012-6#1)(2013-1#36)(2013-7#4)(2013-8#20)
world&quot##7##1##(1994-11#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#2)(2009-4#1)
world's biodiversity##2##2##(2012-12#1)(2012-3#1)
world's major##2##2##(2006-12#2)
world's##63##1##(1990-2#1)(1991-7#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-3#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-12#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#5)(2006-12#2)(2006-4#1)(2006-5#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#2)(2009-6#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
world-wide and##2##2##(2007-7#1)(2008-11#1)
world-wide distribution##3##2##(2006-2#1)(2007-2#1)(2008-7#1)
world-wide have##2##2##(2008-10#1)(2010-10#1)
world-wide level##2##2##(2006-2#1)(2008-10#1)
world-wide##33##1##(1992-8#1)(2005-7#2)(2006-10#1)(2006-12#1)(2006-2#2)(2007-12#1)(2007-2#2)(2007-7#2)(2008-1#2)(2008-10#5)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-4#1)(2010-10#2)(2010-12#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-11#1)
world?##5##1##(1992-5#1)(1993-5#1)(1997-6#1)(2006-9#1)(2007-12#1)
world]##5##1##(1991-10#1)(1993-8#1)(2008-10#1)(2008-8#1)(2010-11#1)
worlds as##2##2##(2008-4#1)(2009-11#1)
worlds for##2##2##(2008-6#1)(2009-4#1)
worlds##22##1##(2006-5#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#1)(2009-11#4)(2009-4#3)(2009-5#1)(2010-2#1)(2010-3#1)(2012-10#1)(2012-2#1)(2013-1#1)
worldview##2##1##(2005-10#1)(2010-2#1)
worldviews##4##1##(2009-4#1)(2013-7#3)
worldwide airline network##2##3##(2010-3#2)
worldwide and has##2##3##(2006-10#1)(2009-5#1)
worldwide and in##2##3##(1996-7#1)(2008-10#1)
worldwide and is##5##3##(2006-2#1)(2007-6#1)(2008-1#3)
worldwide and its##2##3##(2007-11#1)(2008-8#1)
worldwide and the##3##3##(2008-10#1)(2012-2#1)(2013-1#1)
worldwide and##25##2##(1996-7#1)(2006-10#1)(2006-2#2)(2007-11#1)(2007-6#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-8#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
worldwide annually##2##2##(2008-1#1)(2008-10#1)
worldwide are affected by##2##4##(2009-11#1)(2013-1#1)
worldwide are affected##3##3##(2008-5#1)(2009-11#1)(2013-1#1)
worldwide are##10##2##(2006-7#1)(2008-1#1)(2008-12#1)(2008-5#2)(2009-11#1)(2011-2#1)(2012-3#1)(2013-1#2)
worldwide as a##5##3##(2008-10#2)(2008-6#1)(2010-5#1)(2013-1#1)
worldwide as##9##2##(2008-1#1)(2008-10#3)(2008-6#1)(2010-5#1)(2010-6#1)(2012-12#1)(2013-1#1)
worldwide because of##2##3##(2005-11#1)(2007-3#1)
worldwide because##3##2##(2005-11#1)(2007-3#1)(2013-8#1)
worldwide by##2##2##(2007-2#1)(2008-10#1)
worldwide collection of##7##3##(2008-10#7)
worldwide collection##9##2##(1996-7#1)(2008-10#8)
worldwide condemnation##2##2##(1992-12#2)
worldwide diffusion##2##2##(2007-12#1)(2013-1#1)
worldwide distribution and##2##3##(2009-12#1)(2013-1#1)
worldwide distribution of##3##3##(2008-10#2)(2013-8#1)
worldwide distribution##9##2##(2005-7#1)(2006-8#1)(2007-2#1)(2008-10#2)(2009-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
worldwide due to its##2##4##(2011-2#2)
worldwide endeavor##2##2##(2006-9#1)(2008-2#1)
worldwide epidemic##2##2##(2008-10#1)(2012-3#1)
worldwide experience with##2##3##(2006-10#1)(2010-11#1)
worldwide for the##2##3##(2008-8#1)(2013-8#1)
worldwide for##6##2##(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-8#1)
worldwide from##2##2##(1990-2#1)(1994-9#1)
worldwide had##2##2##(2008-10#2)
worldwide has increased dramatically##2##4##(2008-7#1)(2011-2#1)
worldwide have been treated with##2##5##(2011-1#1)(2011-2#1)
worldwide have been##4##3##(2006-2#1)(2008-4#1)(2011-1#1)(2011-2#1)
worldwide have##9##2##(2006-10#1)(2006-2#1)(2008-4#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
worldwide health problem##2##3##(2008-10#1)(2010-6#1)
worldwide health##3##2##(2008-10#1)(2008-7#1)(2010-6#1)
worldwide in##8##2##(2007-7#1)(2008-10#2)(2010-10#1)(2010-3#1)(2011-1#2)(2012-11#1)
worldwide increase in the incidence##2##5##(1994-3#1)(2010-12#1)
worldwide increase in the##3##4##(1994-3#1)(2006-10#1)(2010-12#1)
worldwide increase in##4##3##(1992-8#1)(1994-3#1)(2006-10#1)(2010-12#1)
worldwide is##4##2##(2006-8#1)(2007-8#1)(2011-2#1)(2012-2#1)
worldwide license to patents##2##4##(2005-8#1)(2008-5#1)
worldwide license##3##2##(2005-8#1)(2005-9#1)(2008-5#1)
worldwide market##2##2##(2005-7#1)(2008-5#1)
worldwide occurrence of##2##3##(2010-12#1)(2010-5#1)
worldwide perspective##3##2##(2006-9#1)(2008-11#1)(2013-8#1)
worldwide prevalence of ADHD##2##4##(2006-9#2)
worldwide prevalence of##8##3##(2006-10#1)(2006-9#2)(2008-3#2)(2012-12#2)(2013-1#1)
worldwide prevalence##9##2##(2006-10#1)(2006-9#2)(2008-1#1)(2008-3#2)(2012-12#2)(2013-1#1)
worldwide reports##2##2##(2007-7#1)(2008-4#1)
worldwide rights to##2##3##(2005-8#1)(2008-5#1)
worldwide sales of##2##3##(2005-8#1)(2005-9#1)
worldwide shortage of##2##3##(2005-7#1)(2009-4#1)
worldwide spread##2##2##(2006-10#1)(2011-2#1)
worldwide that##2##2##(2008-10#1)(2011-2#1)
worldwide to##5##2##(1991-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-3#1)
worldwide use of##3##3##(2007-11#1)(2008-10#1)(2010-11#1)
worldwide use##4##2##(2005-12#1)(2007-11#1)(2008-10#1)(2010-11#1)
worldwide were##3##2##(2008-10#2)(2012-2#1)
worldwide with a##2##3##(2009-5#1)(2012-12#1)
worldwide with##6##2##(1995-9#1)(2007-8#1)(2009-5#1)(2012-12#2)(2013-8#1)
worldwide##578##1##(1990-12#1)(1990-2#1)(1991-4#1)(1991-5#2)(1992-12#2)(1992-3#2)(1992-4#2)(1992-8#1)(1993-11#1)(1993-12#3)(1993-5#1)(1994-1#1)(1994-10#1)(1994-3#3)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-9#2)(1996-1#1)(1996-12#1)(1996-2#3)(1996-4#1)(1996-7#3)(1997-3#2)(1997-4#1)(1997-8#1)(2004-3#1)(2004-8#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-12#2)(2005-6#1)(2005-7#7)(2005-8#10)(2005-9#3)(2006-1#1)(2006-10#29)(2006-11#2)(2006-12#1)(2006-2#4)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#3)(2006-9#8)(2007-10#1)(2007-11#15)(2007-12#5)(2007-2#7)(2007-3#4)(2007-4#2)(2007-6#1)(2007-7#5)(2007-8#5)(2007-9#1)(2008-1#16)(2008-10#95)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#9)(2008-5#12)(2008-6#3)(2008-7#14)(2008-8#8)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#3)(2009-3#9)(2009-4#2)(2009-5#5)(2009-7#5)(2009-8#2)(2009-9#2)(2010-10#4)(2010-11#6)(2010-12#12)(2010-2#1)(2010-3#6)(2010-4#1)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#17)(2011-10#1)(2011-12#3)(2011-2#33)(2012-1#3)(2012-11#2)(2012-12#18)(2012-2#12)(2012-3#5)(2013-1#29)(2013-7#7)(2013-8#21)
worm burden##4##2##(1996-12#2)(2007-7#1)(2008-5#1)
worm burdens##6##2##(1996-12#4)(2008-5#2)
worm##46##1##(1990-5#1)(1991-8#1)(1991-9#1)(1992-8#1)(1993-10#1)(1994-10#1)(1994-2#1)(1995-8#1)(1996-12#8)(1996-2#1)(1997-6#1)(1997-7#1)(2005-7#1)(2006-10#2)(2006-11#1)(2007-12#5)(2007-6#1)(2007-7#2)(2007-8#2)(2008-5#4)(2008-9#2)(2009-5#1)(2009-7#2)(2010-2#2)(2011-1#1)(2012-1#1)
worm-like chain##2##2##(2008-7#1)(2009-10#1)
worm-like##3##1##(2008-12#1)(2008-7#1)(2009-10#1)
wormhole framework structures##2##3##(2010-2#2)
wormhole##3##1##(2010-2#3)
worms and##5##2##(2006-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-12#1)
worms from##2##2##(2004-4#1)(2010-8#1)
worms in##3##2##(1990-12#1)(2007-7#1)(2011-12#1)
worms per##2##2##(1996-12#2)
worms recovered##2##2##(1996-12#1)(2008-5#1)
worms##49##1##(1990-12#3)(1992-6#1)(1993-10#1)(1994-2#1)(1995-3#1)(1996-10#1)(1996-12#5)(2004-4#4)(2006-10#3)(2006-8#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-5#5)(2008-7#1)(2009-8#3)(2010-12#5)(2010-8#1)(2011-12#2)(2011-2#1)(2012-3#1)(2013-8#1)
worn by##2##2##(2006-8#1)(2012-1#1)
worn##16##1##(1995-6#1)(1996-2#1)(1997-4#1)(1997-6#2)(2004-9#1)(2006-8#2)(2007-3#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-1#2)
worried about##3##2##(2006-12#1)(2008-11#1)(2013-1#1)
worried##7##1##(1990-12#1)(1997-6#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-11#1)(2013-1#1)
worries about##3##2##(1991-11#1)(2006-11#1)(2013-1#1)
worries##8##1##(1991-11#1)(2006-10#1)(2006-11#1)(2006-2#1)(2009-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
worrisome##9##1##(2006-4#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-2#1)(2008-5#1)(2008-8#1)(2012-2#1)(2013-8#1)
worry about##6##2##(1990-6#1)(1994-3#1)(2006-12#1)(2008-4#1)(2008-5#1)(2012-1#1)
worry and##3##2##(2008-4#1)(2011-2#2)
worry by##2##2##(1994-12#1)(2012-12#1)
worry that##2##2##(2006-10#1)(2007-9#1)
worry##28##1##(1990-6#1)(1994-12#2)(1994-3#1)(1995-9#1)(1996-3#1)(2006-10#1)(2006-12#2)(2007-9#1)(2008-4#3)(2008-5#1)(2010-1#1)(2010-2#1)(2010-8#3)(2011-2#6)(2012-1#1)(2012-12#1)(2013-1#1)
worry?##4##1##(2006-4#1)(2007-9#1)(2008-11#1)(2011-2#1)
worrying##4##1##(2007-9#1)(2008-11#1)(2010-12#1)(2010-9#1)
worse QOL##2##2##(2008-7#2)
worse after##2##2##(2007-12#1)(2008-9#1)
worse at##2##2##(1994-2#1)(2012-11#1)
worse because##2##2##(1993-11#1)(2009-10#1)
worse clinical##5##2##(2005-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
worse for the##2##3##(2006-9#1)(2008-4#1)
worse for##5##2##(2006-9#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)
worse if##3##2##(2007-8#1)(2007-9#1)(2011-2#1)
worse in the##6##3##(1995-1#1)(1996-1#1)(1996-7#1)(1997-6#1)(2008-1#1)(2008-7#1)
worse in##16##2##(1990-12#1)(1991-2#1)(1992-7#1)(1993-2#1)(1995-1#1)(1996-1#1)(1996-7#1)(1997-6#1)(2006-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-4#1)(2013-8#1)
worse metabolic pattern than pNGT##2##5##(2008-3#2)
worse metabolic##3##2##(2008-3#3)
worse off than##2##3##(2006-4#1)(2006-8#1)
worse off##3##2##(2006-4#1)(2006-8#1)(2009-10#1)
worse on the##2##3##(2006-10#2)
worse on##5##2##(2006-10#2)(2008-9#1)(2009-5#1)(2009-7#1)
worse outcome in##2##3##(2009-2#1)(2011-2#1)
worse outcome##10##2##(2007-10#1)(2007-7#1)(2007-8#1)(2009-2#4)(2009-4#1)(2011-1#1)(2011-2#1)
worse outcomes##5##2##(2005-8#1)(2007-6#1)(2007-7#1)(2008-3#1)(2013-7#1)
worse performance##6##2##(1996-3#1)(1997-7#1)(2008-1#1)(2008-10#1)(2009-4#1)(2009-5#1)
worse prognosis in##4##3##(1990-8#1)(2009-10#1)(2011-2#1)(2012-12#1)
worse prognosis##22##2##(1990-12#1)(1990-8#2)(1991-8#1)(1995-5#1)(2006-10#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-7#2)(2009-10#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
worse quality of##2##3##(2010-12#1)(2012-3#1)
worse results##5##2##(2007-9#1)(2008-10#1)(2008-3#1)(2010-6#1)(2011-2#1)
worse than controls##2##3##(1996-5#1)(2009-4#1)
worse than that of##4##4##(1992-7#1)(2006-10#1)(2008-3#1)(2013-1#1)
worse than the##3##3##(1991-5#1)(1996-7#1)(2008-10#1)
worse than##29##2##(1991-5#1)(1992-6#1)(1992-7#1)(1993-10#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-5#1)(1996-7#1)(1997-8#1)(2005-10#1)(2006-10#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-4#1)(2011-1#1)(2011-2#2)(2013-1#2)
worse when##2##2##(2006-10#1)(2009-10#1)
worse with##3##2##(1997-7#1)(2006-10#1)(2009-5#1)
worse##190##1##(1990-12#2)(1990-8#2)(1990-9#1)(1991-11#2)(1991-2#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-7#2)(1993-10#1)(1993-11#1)(1993-2#2)(1993-8#1)(1994-2#3)(1995-1#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#2)(1997-6#1)(1997-7#2)(1997-8#1)(2004-1#1)(2005-10#4)(2005-8#1)(2006-10#8)(2006-4#2)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-4#1)(2007-6#2)(2007-7#5)(2007-8#4)(2007-9#4)(2008-1#3)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#8)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#10)(2008-9#4)(2009-10#4)(2009-2#4)(2009-4#5)(2009-5#3)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#5)(2011-2#11)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#3)
worsen symptoms in##2##3##(1995-2#1)(2013-7#1)
worsen symptoms##3##2##(1995-2#1)(2007-11#1)(2013-7#1)
worsen the##9##2##(1996-12#2)(1996-3#1)(2005-6#1)(2006-9#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)
worsen with##3##2##(2004-3#1)(2007-12#1)(2013-1#1)
worsen##30##1##(1992-12#1)(1993-12#1)(1995-2#2)(1996-12#2)(1996-3#1)(2004-3#1)(2005-1#2)(2005-6#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
worsened after##2##2##(2006-10#1)(2007-11#1)
worsened and##3##2##(1995-6#1)(2007-7#1)(2010-12#1)
worsened by##7##2##(1993-11#1)(1993-8#1)(2006-10#1)(2008-8#1)(2009-4#1)(2012-12#1)(2012-2#1)
worsened in##5##2##(2006-12#1)(2008-7#2)(2011-2#1)(2013-1#1)
worsened over the##2##3##(2006-4#1)(2012-3#1)
worsened significantly##2##2##(2008-10#1)(2008-7#1)
worsened the##3##2##(2007-2#1)(2008-10#1)(2008-4#1)
worsened with##2##2##(2006-10#1)(2008-7#1)
worsened##47##1##(1990-10#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-8#1)(1995-6#1)(1997-6#1)(2006-10#3)(2006-12#1)(2006-4#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-2#2)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
worsening asthma##2##2##(2008-10#1)(2012-12#1)
worsening clinical##2##2##(1994-12#1)(2013-1#1)
worsening disease##3##2##(2006-10#1)(2009-3#1)(2013-1#1)
worsening dyspnoea##2##2##(2010-10#2)
worsening headache##3##2##(2006-5#1)(2008-11#1)(2008-5#1)
worsening in##2##2##(2005-8#1)(2008-11#1)
worsening of pre-existing##2##3##(2007-9#1)(2008-10#1)
worsening of renal##2##3##(1992-8#2)
worsening of the##9##3##(1991-11#1)(1996-9#1)(2007-11#2)(2008-9#1)(2009-1#1)(2009-12#1)(2011-3#1)(2013-1#1)
worsening of their##2##3##(1997-6#1)(2006-10#1)
worsening of##43##2##(1991-11#1)(1991-7#1)(1992-12#1)(1992-8#2)(1995-6#1)(1996-9#2)(1997-3#1)(1997-6#1)(2004-3#2)(2005-10#1)(2006-10#2)(2006-2#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
worsening or onset of##2##4##(2007-11#1)(2008-7#1)
worsening renal##3##2##(2006-7#2)(2013-1#1)
worsening symptoms##4##2##(2005-5#1)(2007-10#1)(2009-1#1)(2012-2#1)
worsening the##2##2##(2008-10#1)(2013-1#1)
worsening##116##1##(1990-12#1)(1991-11#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-8#2)(1993-10#1)(1993-6#1)(1994-12#1)(1995-10#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-9#2)(1997-3#1)(1997-4#1)(1997-6#1)(2004-3#9)(2005-10#1)(2005-5#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-4#1)(2006-5#3)(2006-7#3)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#2)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-1#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-10#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#1)(2012-4#1)(2013-1#9)(2013-7#1)
worsens the prognosis of##2##4##(1993-2#1)(2005-6#1)
worsens the##4##2##(1993-2#1)(2005-11#1)(2005-6#1)(2006-10#1)
worsens with##2##2##(1993-8#1)(2010-6#1)
worsens##15##1##(1990-4#1)(1993-11#1)(1993-2#1)(1993-8#1)(2005-11#1)(2005-6#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-6#1)(2013-1#1)
worst affected states##2##3##(2008-1#1)(2012-2#1)
worst affected##3##2##(1993-3#1)(2008-1#1)(2012-2#1)
worst and##2##2##(2007-2#1)(2008-10#1)
worst case##5##2##(2007-12#2)(2007-7#1)(2008-2#1)(2008-3#1)
worst cases##3##2##(2007-11#1)(2007-2#1)(2013-1#1)
worst pain##5##2##(2007-2#1)(2008-7#3)(2010-4#1)
worst results##3##2##(2006-2#1)(2007-8#1)(2010-11#1)
worst survival##2##2##(1991-4#1)(2007-6#1)
worst with##2##2##(2007-6#1)(2008-12#1)
worst##75##1##(1990-6#1)(1991-10#1)(1991-11#1)(1991-4#1)(1991-6#1)(1993-3#2)(1994-12#1)(1994-5#1)(1995-12#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-4#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#2)(2007-10#2)(2007-11#6)(2007-12#2)(2007-2#3)(2007-6#2)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2010-11#1)(2010-4#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
worst-case##9##1##(2006-10#1)(2007-11#2)(2007-5#1)(2008-1#1)(2008-3#3)(2011-2#1)
worst-off##3##1##(1991-4#1)(2012-1#2)
worth a pound of##2##4##(1995-9#1)(2006-8#1)
worth a##4##2##(1995-9#1)(2006-8#1)(2008-3#1)(2010-9#1)
worth as##3##2##(1991-3#1)(2008-3#1)(2010-2#1)
worth being##2##2##(2008-10#1)(2008-8#1)
worth exploring##2##2##(2006-10#1)(2008-7#1)
worth further##3##2##(1996-12#1)(2010-12#1)(2012-2#1)
worth mentioning##2##2##(2008-10#1)(2011-2#1)
worth noting that##5##3##(1993-11#1)(1993-3#1)(1994-6#1)(2008-4#1)(2008-5#1)
worth of##5##2##(2006-12#1)(2008-10#1)(2012-2#2)(2013-1#1)
worth pursuing##2##2##(2009-10#1)(2010-4#1)
worth reading##2##2##(2005-7#1)(2012-3#1)
worth the##8##2##(1991-6#1)(1992-3#1)(2007-4#1)(2007-8#2)(2010-2#1)(2010-9#1)(2012-1#1)
worth to be##2##3##(1992-9#1)(2013-1#1)
worth to##5##2##(1992-9#1)(2006-12#1)(2008-5#1)(2013-1#1)(2013-7#1)
worth while##5##2##(1991-3#1)(1995-11#1)(1996-3#1)(1997-3#1)(2012-2#1)
worth##87##1##(1991-3#3)(1991-5#1)(1991-6#1)(1992-10#1)(1992-3#1)(1992-5#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(2005-10#1)(2005-12#2)(2005-7#1)(2006-10#3)(2006-12#2)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-4#3)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#2)(2013-7#1)
worth?##4##1##(1992-5#1)(2008-11#1)(2008-9#1)(2013-8#1)
worthwhile and##2##2##(2007-7#1)(2008-12#1)
worthwhile to investigate##3##3##(2006-11#1)(2010-2#1)(2012-2#1)
worthwhile to##9##2##(1992-10#1)(1992-5#1)(1996-4#1)(2006-11#1)(2006-2#1)(2007-7#1)(2008-4#1)(2010-2#1)(2012-2#1)
worthwhile##29##1##(1991-11#1)(1991-12#1)(1992-10#1)(1992-5#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-5#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2009-4#1)(2010-12#2)(2010-2#1)(2010-3#1)(2012-2#2)
worthwhile?##3##1##(1990-5#1)(2006-10#1)(2007-4#1)
worthy of further investigation##2##4##(2006-12#1)(2008-7#1)
worthy of further##5##3##(1991-3#1)(2006-12#1)(2007-9#1)(2008-11#1)(2008-7#1)
worthy of##18##2##(1991-3#1)(1993-9#1)(2004-12#1)(2006-10#2)(2006-12#2)(2006-7#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
worthy##22##1##(1991-3#1)(1993-9#1)(2004-12#1)(2006-10#2)(2006-12#2)(2006-7#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-1#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
wortmannin does not block the effect of these agents##2##9##(1995-6#1)(1996-2#1)
wortmannin##37##1##(1992-6#4)(1994-11#3)(1994-8#1)(1995-12#2)(1995-3#1)(1995-6#3)(1995-8#2)(1996-2#1)(1996-5#2)(1997-3#9)(1997-7#2)(2008-11#2)(2008-4#2)(2012-12#1)(2013-7#2)
wortmannin-sensitive pathway##2##2##(1994-11#2)
would abrade faster##2##3##(2008-7#2)
would account for the##2##4##(1990-3#1)(1990-7#1)
would achieve##3##2##(1991-6#1)(2008-3#1)(2010-5#1)
would act as##2##3##(1996-10#1)(2011-12#1)
would activate##2##2##(2008-10#1)(2012-2#1)
would add##2##2##(2009-8#1)(2011-1#1)
would address##2##2##(2010-10#1)(2012-3#1)
would administer##3##2##(1992-2#1)(2007-9#1)(2008-1#1)
would affect the##4##3##(1990-12#1)(1992-9#1)(1994-2#2)
would affect##9##2##(1990-12#1)(1992-11#1)(1992-9#1)(1994-2#2)(2007-8#2)(2008-10#2)
would agree##3##2##(1993-8#1)(1994-12#1)(2007-7#1)
would all##3##2##(2008-1#1)(2011-2#2)
would allow a better##2##4##(2007-12#1)(2007-8#1)
would allow a##5##3##(2007-12#1)(2007-8#1)(2008-9#1)(2009-5#1)(2013-1#1)
would allow for##4##3##(1990-8#1)(1995-6#1)(2008-10#1)(2008-11#1)
would allow it to##2##4##(2006-4#1)(2012-2#1)
would allow more##3##3##(2007-7#1)(2010-12#1)(2013-8#1)
would allow the##10##3##(1991-10#1)(1995-11#1)(1996-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-5#1)(2012-2#1)
would allow##44##2##(1990-8#1)(1991-10#1)(1992-6#1)(1995-11#1)(1995-2#1)(1995-6#2)(1996-10#2)(1996-3#1)(2004-3#1)(2005-9#1)(2006-4#1)(2006-5#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#3)(2013-1#2)(2013-8#2)
would also be##6##3##(1991-5#1)(2007-11#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
would also benefit from##2##4##(1994-11#1)(2008-7#1)
would also have##3##3##(1990-3#1)(2007-9#1)(2008-5#1)
would also help##2##3##(2009-10#1)(2012-2#1)
would also provide##2##3##(1993-3#1)(2009-8#1)
would also require##2##3##(2007-6#1)(2008-11#1)
would also##29##2##(1990-3#1)(1990-5#1)(1991-5#1)(1992-12#1)(1993-1#1)(1993-3#1)(1994-11#1)(1996-6#1)(1997-1#1)(2007-11#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
would appear that the##7##4##(1991-11#1)(1992-10#1)(1994-8#1)(1996-1#1)(1996-5#1)(1997-8#1)(2007-8#1)
would appear that##20##3##(1991-11#1)(1992-10#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-5#1)(1997-2#1)(1997-8#1)(2005-10#1)(2006-12#2)(2006-9#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-2#1)(2009-5#1)(2011-2#1)(2013-8#1)
would appear to be the##3##5##(1990-2#1)(2007-11#1)(2007-8#1)
would appear to be##8##4##(1990-2#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-3#1)(2011-1#1)(2012-1#1)
would appear to##12##3##(1990-2#2)(1991-2#1)(1996-6#1)(2005-7#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-3#1)(2010-1#1)(2011-1#1)(2012-1#1)
would appear##43##2##(1990-2#2)(1991-11#2)(1991-2#1)(1991-4#1)(1991-6#1)(1992-10#2)(1994-8#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-12#2)(2006-9#1)(2007-11#3)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-10#1)(2009-5#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
would argue that##2##3##(2006-10#1)(2009-4#1)
would argue##3##2##(2006-10#1)(2009-4#1)(2011-2#1)
would assist in##2##3##(2006-10#1)(2011-12#1)
would assist##3##2##(2006-10#1)(2007-4#1)(2011-12#1)
would augment##2##2##(2006-10#1)(2010-12#1)
would authorize##2##2##(1997-5#1)(2007-9#1)
would avoid##3##2##(1991-8#1)(2008-10#1)(2008-3#1)
would be a great##2##4##(1992-1#1)(1992-5#1)
would be a useful tool for##2##6##(2008-10#1)(2010-10#1)
would be a##32##3##(1990-8#2)(1992-1#1)(1992-11#1)(1992-5#1)(1994-6#1)(1995-2#1)(1997-8#1)(2005-12#1)(2006-12#2)(2006-2#1)(2006-8#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-9#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-7#1)
would be able to##5##4##(2006-10#1)(2007-8#1)(2008-8#1)(2013-1#2)
would be achieved##2##3##(2006-10#1)(2009-1#1)
would be adequate for##2##4##(1991-12#1)(2007-8#1)
would be adequate##4##3##(1991-12#1)(2007-12#1)(2007-8#1)(2012-3#1)
would be advisable to##2##4##(2006-6#1)(2013-1#1)
would be also##2##3##(2008-4#1)(2011-2#1)
would be an effective##3##4##(2007-9#1)(2008-10#1)(2011-2#1)
would be an##14##3##(1990-11#1)(1993-1#1)(1993-9#1)(1994-5#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-11#1)(2009-4#1)(2011-2#2)(2012-3#1)(2013-1#1)
would be anticipated##2##3##(1990-12#1)(1997-1#1)
would be applicable for predicting##2##5##(2008-3#1)(2010-7#1)
would be applicable##3##3##(2008-3#1)(2010-7#1)(2011-2#1)
would be appropriate for##2##4##(2010-11#1)(2010-7#1)
would be appropriate##6##3##(1991-12#1)(1997-8#1)(2004-10#1)(2010-11#1)(2010-7#1)(2013-8#1)
would be associated with##7##4##(1996-9#1)(2007-2#1)(2008-8#2)(2009-12#1)(2009-5#1)(2013-7#1)
would be at a##2##4##(1995-11#1)(1996-4#1)
would be at##3##3##(1995-11#1)(1996-4#1)(2005-9#1)
would be based on##2##4##(1993-3#1)(2009-4#1)
would be beneficial for##2##4##(2008-10#1)(2012-1#1)
would be beneficial to##4##4##(2008-9#1)(2010-9#1)(2012-11#1)(2012-12#1)
would be beneficial##10##3##(2008-10#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#1)(2013-8#1)
would be best##5##3##(1994-2#1)(1995-1#1)(2008-10#2)(2009-2#1)
would be better##7##3##(1991-12#1)(1995-3#1)(2007-8#1)(2008-10#1)(2010-3#1)(2011-2#1)(2013-8#1)
would be called##3##3##(1994-9#1)(1996-12#1)(2012-2#1)
would be characterized##2##3##(1992-12#1)(2008-10#1)
would be classified as##3##4##(1991-12#1)(1993-2#1)(2008-5#1)
would be considered##7##3##(2007-12#1)(2007-2#1)(2008-10#1)(2008-4#1)(2009-9#1)(2011-2#1)(2012-1#1)
would be consistent with##7##4##(1991-10#1)(2008-9#5)(2009-4#1)
would be consistent##8##3##(1991-10#1)(1994-8#1)(2008-9#5)(2009-4#1)
would be dependent##2##3##(1990-4#1)(2011-12#1)
would be desirable##10##3##(1992-4#1)(1993-11#1)(1997-4#1)(2004-9#1)(2005-11#1)(2006-11#1)(2006-7#1)(2007-11#1)(2008-3#1)(2013-1#1)
would be determined##2##3##(1995-6#1)(2008-7#1)
would be difficult to##2##4##(2008-11#1)(2008-7#1)
would be difficult##4##3##(1992-12#1)(2007-12#1)(2008-11#1)(2008-7#1)
would be diminished##2##3##(2007-4#1)(2012-12#1)
would be directly##2##3##(1993-7#1)(2013-7#1)
would be due to the##2##5##(2008-7#1)(2009-9#1)
would be effective##3##3##(1997-6#1)(2004-9#1)(2009-5#1)
would be essential for##2##4##(1991-2#1)(2011-2#1)
would be essential##4##3##(1991-2#1)(1992-5#1)(2011-2#1)(2012-3#1)
would be expected based##3##4##(1991-7#1)(1992-6#1)(2008-11#1)
would be expected for##3##4##(1991-6#1)(1992-11#1)(2007-12#1)
would be expected from the##5##5##(1991-4#1)(1992-9#1)(2008-6#1)(2008-7#1)(2011-1#1)
would be expected from##11##4##(1991-4#1)(1992-9#1)(1993-12#1)(1993-6#1)(2007-1#1)(2007-11#1)(2008-6#1)(2008-7#1)(2010-2#1)(2011-1#1)(2012-2#1)
would be expected in a##2##5##(2008-10#1)(2011-1#1)
would be expected in##5##4##(2005-7#1)(2005-8#1)(2008-10#2)(2011-1#1)
would be expected to have##2##5##(1997-4#1)(2008-7#1)
would be expected to##13##4##(1990-2#2)(1991-5#1)(1993-9#1)(1994-3#1)(1996-8#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-2#1)
would be expected##47##3##(1990-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-3#2)(1996-8#1)(1997-1#1)(1997-4#1)(2005-7#1)(2005-8#1)(2007-1#1)(2007-11#1)(2007-12#3)(2008-10#5)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#4)(2009-10#1)(2009-2#1)(2010-2#1)(2011-1#2)(2012-2#2)(2013-1#1)
would be extremely difficult##2##4##(1996-1#1)(2008-10#1)
would be extremely##3##3##(1994-5#1)(1996-1#1)(2008-10#1)
would be facilitated by##2##4##(1993-6#1)(1993-9#1)
would be facilitated##3##3##(1993-6#1)(1993-9#1)(2008-11#1)
would be feasible##3##3##(2006-12#1)(2008-10#1)(2013-7#1)
would be found##2##3##(1992-7#1)(2008-7#1)
would be funded on a##2##5##(1996-1#1)(1996-2#1)
would be further##2##3##(1990-12#1)(1995-4#1)
would be generated##2##3##(1995-8#1)(2012-3#1)
would be good##2##3##(2007-12#1)(2008-9#1)
would be greater in##2##4##(2012-2#1)(2013-1#1)
would be helpful in##3##4##(2006-2#1)(2008-10#1)(2009-8#1)
would be helpful to##5##4##(2007-12#1)(2009-4#1)(2011-1#1)(2013-8#2)
would be helpful##11##3##(2006-2#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-7#1)(2011-1#1)(2013-8#2)
would be highly useful for##2##5##(2005-12#1)(2008-10#1)
would be highly##3##3##(1991-7#1)(2005-12#1)(2008-10#1)
would be impaired##2##3##(1996-3#1)(2008-3#1)
would be important in##2##4##(1994-11#1)(2007-10#1)
would be important##4##3##(1994-11#1)(1996-10#1)(2007-10#1)(2008-12#1)
would be impractical##2##3##(1996-4#1)(2008-7#1)
would be improved##3##3##(1996-11#1)(2007-4#1)(2008-3#1)
would be in a##2##4##(2008-11#2)
would be in##5##3##(1990-4#1)(1993-2#1)(2007-9#1)(2008-11#2)
would be indicated##2##3##(2007-11#1)(2012-1#1)
would be interesting##2##3##(1994-5#1)(2008-6#1)
would be launched by##2##4##(2005-6#1)(2005-8#1)
would be launched in Japan##2##5##(2005-8#2)
would be launched##4##3##(2005-6#1)(2005-8#3)
would be less likely##2##4##(2007-10#1)(2007-4#1)
would be less than##3##4##(2005-3#1)(2005-8#1)(2008-10#1)
would be less##9##3##(2005-3#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-4#1)(2008-10#1)(2012-12#2)
would be likely##2##3##(1990-9#1)(2009-4#1)
would be limited by##2##4##(2008-3#1)(2008-5#1)
would be located##2##3##(1994-11#1)(2009-7#1)
would be lost##4##3##(1993-6#1)(2006-12#1)(2007-4#1)(2008-1#1)
would be made##2##3##(2009-7#1)(2011-1#1)
would be maintained##2##3##(2011-2#1)(2013-1#1)
would be more beneficial##3##4##(2008-4#1)(2010-8#1)(2012-12#1)
would be more effective##2##4##(1991-10#1)(2008-7#1)
would be more likely##2##4##(2009-5#1)(2009-7#1)
would be more sensitive to##2##5##(1996-1#1)(2009-4#1)
would be more sensitive##3##4##(1996-1#1)(2008-8#1)(2009-4#1)
would be more suitable##2##4##(2010-7#1)(2012-3#1)
would be more##30##3##(1990-9#1)(1991-10#1)(1991-12#1)(1993-2#1)(1994-1#2)(1996-1#1)(1996-3#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
would be most appropriate to##2##5##(1995-1#1)(2008-11#1)
would be most beneficial##2##4##(2008-7#1)(2010-2#1)
would be most##8##3##(1995-1#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-2#1)
would be much##6##3##(1991-7#1)(1996-3#1)(2006-10#1)(2007-7#1)(2008-11#1)(2012-2#1)
would be necessary for##2##4##(1993-9#1)(2007-12#1)
would be necessary##9##3##(1993-9#1)(1995-12#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-8#1)(2011-2#1)(2012-12#1)
would be needed for##2##4##(1994-3#1)(2009-7#1)
would be needed to##6##4##(1996-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)
would be needed##9##3##(1994-3#1)(1996-2#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-7#1)(2009-8#1)
would be negatively##2##3##(2010-7#1)(2011-2#1)
would be negligible##2##3##(1990-5#1)(2006-5#1)
would be observed##2##3##(2007-11#1)(2012-1#1)
would be obtained##4##3##(1994-5#1)(2007-12#1)(2008-10#1)(2008-2#1)
would be of great##3##4##(1991-12#1)(2005-10#1)(2011-1#1)
would be of interest##2##4##(2007-5#1)(2012-12#1)
would be of significant##4##4##(2007-2#1)(2008-3#1)(2013-1#2)
would be of value##2##4##(2008-5#1)(2013-8#1)
would be of##17##3##(1991-12#1)(1993-11#1)(1996-8#1)(1997-8#1)(2005-10#1)(2006-9#1)(2007-2#1)(2007-5#1)(2008-3#1)(2008-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
would be one of the##2##5##(1997-7#1)(2013-8#1)
would be particularly##3##3##(1996-12#1)(1997-8#1)(2008-7#1)
would be possible##11##3##(1992-12#1)(1996-3#1)(2006-5#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-12#1)(2011-3#1)(2012-12#1)
would be predicted##3##3##(1990-11#1)(1992-9#1)(2009-9#1)
would be present##2##3##(2008-10#1)(2008-8#1)
would be provided by##3##4##(1990-6#1)(1994-1#1)(2008-7#1)
would be provided##5##3##(1990-6#1)(1994-1#1)(2007-4#1)(2008-3#1)(2008-7#1)
would be prudent##5##3##(1991-12#1)(1995-1#1)(2005-12#1)(2007-9#1)(2009-10#1)
would be recommended##2##3##(2007-8#1)(2008-10#1)
would be reduced in##3##4##(2007-11#1)(2008-10#1)(2012-2#1)
would be reduced##7##3##(1994-6#1)(2006-9#1)(2007-11#1)(2008-10#1)(2009-1#1)(2012-2#1)(2013-8#1)
would be reflected in##2##4##(1993-6#1)(2004-3#1)
would be related to##3##4##(1995-3#1)(2008-1#1)(2008-5#1)
would be related##4##3##(1994-6#1)(1995-3#1)(2008-1#1)(2008-5#1)
would be released if##2##4##(1996-1#2)
would be required before##2##4##(1997-3#1)(2010-7#1)
would be required for##3##4##(1991-11#1)(1996-12#1)(2008-3#1)
would be required to##8##4##(1990-8#1)(1991-9#1)(1993-3#1)(1996-1#1)(2005-11#1)(2008-10#2)(2012-12#1)
would be required##15##3##(1990-8#1)(1991-11#1)(1991-9#1)(1993-3#1)(1996-1#1)(1996-12#1)(1997-3#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-7#1)(2012-12#2)
would be severely##2##3##(1990-4#1)(2011-1#1)
would be significant##3##3##(1993-3#1)(2007-8#1)(2013-1#1)
would be sufficient to##4##4##(1997-6#1)(2006-6#1)(2007-12#1)(2012-12#1)
would be sufficient##5##3##(1995-1#1)(1997-6#1)(2006-6#1)(2007-12#1)(2012-12#1)
would be suitable##5##3##(1994-3#1)(2005-12#1)(2008-10#1)(2008-7#1)(2012-2#1)
would be that##2##3##(2008-7#1)(2012-3#1)
would be the best##2##4##(2008-12#1)(2009-1#1)
would be the first##3##4##(1995-5#1)(1996-1#1)(2007-9#1)
would be the most##3##4##(2008-10#1)(2012-3#1)(2012-9#1)
would be the##22##3##(1992-3#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-5#1)(1997-1#1)(2006-9#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-1#1)(2009-9#2)(2011-1#1)(2012-3#1)(2012-9#1)(2013-1#3)
would be to##17##3##(1992-3#1)(1995-11#1)(1995-5#1)(1996-1#2)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-2#1)(2012-11#1)(2012-2#1)(2013-1#2)
would be unable to##2##4##(1996-9#1)(2007-11#1)
would be unlikely##4##3##(2008-10#1)(2008-6#1)(2013-1#2)
would be used##4##3##(1994-9#1)(2004-7#1)(2008-5#1)(2009-6#1)
would be useful as a##2##5##(2008-10#2)
would be useful as##3##4##(2008-10#2)(2008-5#1)
would be useful for##8##4##(1990-8#1)(1991-1#1)(1996-12#1)(2008-10#2)(2011-1#2)(2013-8#1)
would be useful in developing##2##5##(1994-11#1)(2011-3#1)
would be useful in the##2##5##(2007-2#1)(2011-12#1)
would be useful in##5##4##(1994-11#1)(2007-2#1)(2009-12#1)(2011-12#1)(2011-3#1)
would be useful to##6##4##(1994-11#1)(2008-11#1)(2008-12#1)(2008-2#1)(2010-12#1)(2013-8#1)
would be useful##25##3##(1990-8#1)(1991-1#1)(1994-11#2)(1994-7#1)(1996-12#1)(1996-8#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-12#1)(2010-12#1)(2011-1#2)(2011-12#1)(2011-3#1)(2012-11#1)(2013-8#2)
would be valuable##5##3##(1994-2#1)(1997-5#1)(2007-2#1)(2007-9#1)(2008-4#1)
would be very helpful##2##4##(2005-4#1)(2010-8#1)
would be very##4##3##(1996-4#1)(2005-4#1)(2010-4#1)(2010-8#1)
would be well advised to##2##5##(2006-8#1)(2011-2#1)
would be well##3##3##(2006-8#1)(2007-8#1)(2011-2#1)
would be widely##2##3##(2008-11#1)(2012-12#1)
would be willing to##5##4##(2006-10#1)(2007-12#1)(2007-7#1)(2007-9#1)(2012-2#1)
would be wise to##2##4##(1996-1#1)(2013-1#1)
would be worth##2##3##(1991-3#1)(2013-7#1)
would be##785##2##(1990-11#3)(1990-12#6)(1990-2#2)(1990-3#1)(1990-4#3)(1990-5#1)(1990-6#1)(1990-8#4)(1990-9#3)(1991-1#4)(1991-10#2)(1991-11#1)(1991-12#10)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#4)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#4)(1992-6#2)(1992-7#1)(1992-9#3)(1993-1#2)(1993-11#3)(1993-12#3)(1993-2#3)(1993-3#4)(1993-6#4)(1993-7#1)(1993-8#1)(1993-9#5)(1994-1#4)(1994-10#1)(1994-11#4)(1994-2#6)(1994-3#8)(1994-4#1)(1994-5#5)(1994-6#5)(1994-7#1)(1994-8#1)(1994-9#4)(1995-1#5)(1995-11#3)(1995-12#4)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#5)(1995-8#3)(1996-1#14)(1996-10#2)(1996-11#2)(1996-12#5)(1996-2#2)(1996-3#5)(1996-4#3)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#6)(1996-9#2)(1997-1#3)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#5)(2004-10#1)(2004-3#1)(2004-7#1)(2004-9#3)(2005-10#2)(2005-11#3)(2005-12#4)(2005-3#1)(2005-4#1)(2005-5#1)(2005-6#2)(2005-7#6)(2005-8#7)(2005-9#2)(2006-10#11)(2006-11#1)(2006-12#7)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#5)(2006-9#5)(2007-1#2)(2007-10#5)(2007-11#6)(2007-12#19)(2007-2#8)(2007-4#7)(2007-5#3)(2007-7#7)(2007-8#12)(2007-9#7)(2008-1#4)(2008-10#49)(2008-11#21)(2008-12#9)(2008-2#6)(2008-3#12)(2008-4#9)(2008-5#17)(2008-6#6)(2008-7#21)(2008-8#10)(2008-9#12)(2009-1#3)(2009-10#3)(2009-12#4)(2009-2#4)(2009-4#8)(2009-5#5)(2009-6#3)(2009-7#7)(2009-8#2)(2009-9#8)(2010-10#2)(2010-11#4)(2010-12#4)(2010-2#6)(2010-3#2)(2010-4#4)(2010-5#2)(2010-7#7)(2010-8#6)(2010-9#1)(2011-1#13)(2011-12#3)(2011-2#19)(2011-3#2)(2012-1#4)(2012-11#3)(2012-12#16)(2012-2#14)(2012-3#16)(2012-9#1)(2013-1#21)(2013-7#12)(2013-8#15)
would become##2##2##(2006-5#1)(2009-4#1)
would benefit from a##3##4##(1991-2#1)(2007-8#1)(2008-11#1)
would benefit from the##3##4##(2006-7#1)(2007-1#1)(2007-12#1)
would benefit from this##3##4##(1992-12#1)(2008-3#1)(2010-12#1)
would benefit from##24##3##(1991-2#1)(1992-12#1)(1997-3#1)(2004-10#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#1)(2008-11#2)(2008-3#1)(2010-12#1)(2010-3#1)(2010-9#1)(2012-12#2)(2013-7#2)
would benefit##28##2##(1991-2#1)(1992-12#1)(1994-12#1)(1997-3#1)(2004-10#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-8#2)(2008-10#1)(2008-11#2)(2008-3#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#2)(2013-7#2)
would best be##2##3##(1995-9#1)(2008-7#1)
would best fit##2##3##(1994-12#1)(2005-7#1)
would best##4##2##(1994-12#1)(1995-9#1)(2005-7#1)(2008-7#1)
would better##2##2##(2010-2#1)(2011-2#1)
would block##2##2##(1991-5#1)(1993-3#1)
would bring##3##2##(1992-12#1)(1993-6#1)(2006-12#1)
would catalyze the##2##3##(1991-10#1)(2008-10#1)
would cause##10##2##(1994-12#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#2)(2011-12#1)(2012-12#1)
would certainly##2##2##(2007-6#1)(2013-1#1)
would change the##2##3##(1996-1#1)(2004-11#1)
would change##4##2##(1990-6#1)(1996-1#1)(2004-11#1)(2006-10#1)
would choose##4##2##(1997-3#1)(2007-3#1)(2010-4#2)
would classify the##2##3##(2007-11#2)
would consent to##4##3##(1993-2#1)(1993-8#1)(2008-11#1)(2012-11#1)
would consent##5##2##(1993-2#1)(1993-8#2)(2008-11#1)(2012-11#1)
would consider an OAH##3##4##(2008-7#3)
would consider##6##2##(1995-12#1)(1996-12#1)(2008-7#4)
would consist of##2##3##(2008-3#1)(2008-5#1)
would contain##3##2##(1995-1#1)(2006-12#1)(2010-8#1)
would continue to##2##3##(1997-2#1)(2012-12#1)
would contribute greatly to##2##4##(2008-11#1)(2008-3#1)
would contribute to the##4##4##(2006-10#1)(2008-1#1)(2008-10#1)(2012-2#1)
would contribute to##10##3##(2006-10#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-2#2)(2012-2#1)
would contribute##13##2##(2006-10#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#1)(2010-3#1)(2011-2#2)(2012-2#1)
would convert##2##2##(2007-7#1)(2012-12#1)
would correspond to##4##3##(2007-12#1)(2008-11#1)(2008-2#1)(2008-8#1)
would cost##4##2##(1990-2#1)(1994-2#1)(1997-6#1)(2010-12#1)
would cover##4##2##(2009-3#2)(2013-1#2)
would create##4##2##(1995-1#1)(1995-6#1)(1996-5#1)(2008-8#1)
would decrease##4##2##(2006-10#1)(2006-7#1)(2011-1#1)(2013-7#1)
would depend##3##2##(1994-2#1)(2010-8#1)(2011-1#1)
would derive the##2##3##(2012-1#2)
would derive##3##2##(2011-12#1)(2012-1#2)
would describe##3##2##(1991-12#1)(2006-3#1)(2011-1#1)
would determine##3##2##(1994-9#1)(2008-11#1)(2010-12#1)
would develop a##2##3##(1993-1#1)(2008-7#1)
would develop##3##2##(1993-1#1)(1995-12#1)(2008-7#1)
would differentiate##2##2##(2008-5#1)(2008-8#1)
would directly##2##2##(2008-8#1)(2009-6#1)
would display##2##2##(1990-12#1)(2013-7#1)
would do well to##3##4##(2007-2#1)(2007-3#1)(2008-8#1)
would do##8##2##(1992-2#1)(1995-5#1)(1997-5#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-8#1)(2010-2#1)
would eliminate##4##2##(1991-4#1)(2008-7#1)(2010-7#1)(2013-1#1)
would enable the##6##3##(1992-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
would enable them to##2##4##(2004-9#1)(2007-9#1)
would enable##21##2##(1992-11#1)(1992-12#1)(1992-8#1)(1997-5#1)(2004-9#1)(2005-10#1)(2005-12#1)(2006-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#2)
would encode a##4##3##(1990-7#1)(1993-2#2)(1995-2#1)
would encourage##2##2##(1997-2#1)(2008-7#1)
would endanger##3##2##(1996-6#1)(2008-2#1)(2008-4#1)
would enhance the##2##3##(2006-12#1)(2008-8#1)
would enhance##5##2##(1992-5#1)(2006-12#1)(2006-5#1)(2007-7#1)(2008-8#1)
would ensure##2##2##(1996-2#1)(2013-1#1)
would enter##2##2##(1990-7#1)(2008-8#1)
would eventually##6##2##(2008-10#1)(2010-3#1)(2010-9#1)(2012-1#1)(2013-1#2)
would exacerbate##3##2##(1996-8#1)(2008-10#1)(2010-3#1)
would exist in##2##3##(1993-11#1)(2005-4#1)
would exist##3##2##(1993-11#1)(2005-4#1)(2007-9#1)
would expand##3##2##(1990-4#1)(1992-3#1)(1995-12#1)
would expect##7##2##(1990-4#1)(1993-6#1)(1995-12#1)(1995-4#1)(1997-8#1)(2008-11#1)(2012-3#1)
would explain the outcome##2##4##(2005-10#2)
would explain the##5##3##(1996-5#1)(2005-10#2)(2008-10#1)(2010-12#1)
would explain##9##2##(1996-5#1)(1997-8#1)(2005-10#2)(2007-9#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-12#1)
would extend the##2##3##(2008-7#1)(2009-10#1)
would extend##3##2##(2007-9#1)(2008-7#1)(2009-10#1)
would facilitate the development of##2##5##(1996-2#1)(2006-2#1)
would facilitate the##6##3##(1993-9#1)(1996-2#1)(2005-7#1)(2006-2#1)(2006-5#1)(2010-4#1)
would facilitate##10##2##(1993-11#1)(1993-9#1)(1996-2#1)(1997-7#1)(2005-7#1)(2006-2#1)(2006-5#1)(2008-6#1)(2010-4#1)(2012-3#1)
would fail##2##2##(1993-6#1)(1996-5#1)
would favor##5##2##(2007-7#1)(2008-7#1)(2008-9#2)(2009-10#1)
would find a##2##3##(1991-12#1)(1992-1#1)
would find##4##2##(1991-12#1)(1991-9#1)(1992-1#1)(2013-7#1)
would first appear##2##3##(2004-9#1)(2008-11#1)
would first##4##2##(1993-6#1)(2004-9#1)(2007-10#1)(2008-11#1)
would follow the##2##3##(2008-1#1)(2011-1#1)
would follow##4##2##(1994-8#1)(2008-1#1)(2008-10#1)(2011-1#1)
would form##2##2##(2008-10#2)
would further enhance##2##3##(2012-1#1)(2013-1#1)
would further##8##2##(1997-1#1)(2007-7#1)(2008-10#1)(2008-12#1)(2009-3#1)(2011-3#1)(2012-1#1)(2013-1#1)
would gain##2##2##(2008-11#1)(2012-2#1)
would generate##2##2##(1992-2#1)(2010-5#1)
would give a##2##3##(1994-12#1)(2009-12#1)
would give the##2##3##(1995-5#1)(2008-11#1)
would give##9##2##(1990-9#1)(1992-6#1)(1993-8#1)(1994-12#1)(1995-5#1)(1997-8#1)(2008-11#1)(2008-2#1)(2009-12#1)
would go##2##2##(1991-10#1)(2007-10#1)
would gradually##2##2##(2008-6#1)(2013-8#1)
would greatly##7##2##(1990-12#1)(1996-8#1)(2007-4#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-4#1)
would guarantee##2##2##(2007-8#1)(2009-2#1)
would have a##15##3##(1995-11#2)(1997-4#1)(1997-5#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#2)
would have be##3##3##(2008-10#1)(2013-1#2)
would have been missed##5##4##(1993-11#1)(1994-12#1)(1997-1#1)(2013-1#2)
would have been##34##3##(1990-11#1)(1991-10#1)(1991-6#2)(1993-11#1)(1994-12#1)(1995-12#1)(1997-1#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#6)(2008-8#1)(2010-2#2)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
would have clear advantages##2##4##(2006-10#1)(2008-5#1)
would have died if##2##4##(1992-9#1)(2008-10#1)
would have died##4##3##(1992-9#1)(1995-12#1)(2008-10#2)
would have given##3##3##(1996-5#1)(2007-9#1)(2008-5#1)
would have greater##2##3##(1997-8#1)(2012-11#1)
would have had##3##3##(1995-12#1)(2008-3#1)(2011-12#1)
would have higher##2##3##(2008-10#1)(2008-11#1)
would have increased##3##3##(1991-6#1)(1993-1#1)(2008-11#1)
would have lambda(i)##2##3##(1997-5#2)
would have multiple##2##3##(2007-11#1)(2012-2#1)
would have on##2##3##(1991-2#1)(2010-7#1)
would have potential##2##3##(2008-10#1)(2009-4#1)
would have reached##2##3##(1997-6#1)(2008-1#1)
would have resulted in##2##4##(1994-12#1)(2004-3#1)
would have resulted##4##3##(1994-12#1)(2004-3#1)(2008-6#1)(2008-9#1)
would have significant##2##3##(2008-7#1)(2011-1#1)
would have the potential to##2##5##(2007-9#1)(2008-3#1)
would have the##5##3##(1994-3#1)(1995-2#1)(2005-9#1)(2007-9#1)(2008-3#1)
would have to be##5##4##(1992-6#1)(1995-5#1)(2006-10#1)(2007-5#1)(2008-10#1)
would have to##12##3##(1992-6#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-12#1)(2006-10#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-2#1)
would have##150##2##(1990-11#1)(1990-3#2)(1990-5#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#3)(1991-9#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-3#1)(1994-12#3)(1994-3#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-12#1)(1996-5#3)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#4)(1997-6#2)(1997-7#1)(1997-8#1)(2004-3#1)(2004-9#1)(2005-12#1)(2005-9#1)(2006-10#4)(2006-7#2)(2007-10#1)(2007-11#2)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#5)(2008-1#4)(2008-10#13)(2008-11#7)(2008-2#3)(2008-3#3)(2008-5#6)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#3)
would help avoid##2##3##(2008-5#1)(2009-6#1)
would help in##4##3##(2009-10#1)(2010-3#1)(2010-9#1)(2011-1#1)
would help to##4##3##(2005-11#1)(2008-8#1)(2009-5#1)(2011-10#1)
would help##18##2##(1990-2#1)(1992-10#1)(1993-2#1)(1995-12#1)(1996-11#1)(2005-11#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-10#1)
would identify##2##2##(1993-5#1)(2006-10#1)
would impact##2##2##(2007-8#1)(2013-8#1)
would imply that##2##3##(1991-5#1)(2010-12#1)
would improve patient##3##3##(2011-1#1)(2013-1#2)
would improve the##6##3##(1991-3#1)(2004-9#1)(2006-6#1)(2006-9#1)(2009-4#1)(2012-2#1)
would improve##21##2##(1991-3#1)(1994-12#1)(1996-2#1)(2004-9#1)(2005-7#1)(2006-6#1)(2006-9#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2009-4#1)(2011-1#1)(2012-2#3)(2013-1#2)
would in##4##2##(1992-12#1)(1994-5#1)(1997-5#1)(2012-2#1)
would include##13##2##(1992-12#1)(1996-3#1)(2005-7#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#2)(2011-2#2)
would increase by##2##3##(1994-1#1)(2006-7#1)
would increase the##3##3##(1996-3#1)(2008-11#1)(2008-8#1)
would increase their##2##3##(2007-10#1)(2013-1#1)
would increase##24##2##(1990-12#1)(1992-8#2)(1994-1#3)(1995-9#1)(1996-1#1)(1996-3#1)(1997-1#1)(2006-7#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-8#2)(2009-4#1)(2009-5#1)(2010-12#1)(2013-1#2)
would indicate a##2##3##(2008-10#1)(2008-7#1)
would indicate that##6##3##(1990-2#1)(1990-7#1)(2007-2#1)(2008-5#1)(2013-1#2)
would indicate##13##2##(1990-2#1)(1990-7#1)(1996-4#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2013-1#2)
would induce the##2##3##(1993-11#1)(2010-12#1)
would induce##7##2##(1992-11#1)(1992-12#1)(1993-11#1)(2008-5#1)(2009-10#1)(2010-12#1)(2013-8#1)
would inevitably##2##2##(2006-4#1)(2009-2#1)
would influence##10##2##(1993-1#1)(1995-9#1)(1996-2#1)(2005-5#1)(2006-5#1)(2008-12#1)(2009-5#1)(2010-10#1)(2012-2#1)(2013-8#1)
would inhibit##2##2##(1992-10#1)(2009-7#1)
would initiate##2##2##(2008-1#1)(2013-1#1)
would involve a##2##3##(2005-7#1)(2008-9#1)
would involve##12##2##(1992-2#1)(1992-3#1)(2005-10#1)(2005-7#1)(2008-10#2)(2008-7#2)(2008-9#1)(2010-12#1)(2010-2#2)
would it##2##2##(1993-12#1)(2010-3#1)
would justify##2##2##(2007-5#1)(2008-6#1)
would lead to a##3##4##(1996-9#1)(2006-2#1)(2008-11#1)
would lead to the##4##4##(1993-2#1)(2006-10#1)(2008-7#1)(2013-8#1)
would lead to##21##3##(1991-12#1)(1993-2#1)(1995-6#1)(1996-9#1)(1997-1#1)(2005-7#1)(2006-10#1)(2006-2#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2013-1#1)(2013-8#1)
would lead##24##2##(1991-12#1)(1993-2#1)(1995-6#1)(1996-9#1)(1997-1#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2013-1#1)(2013-8#1)
would leave##3##2##(1990-3#1)(2006-3#1)(2010-3#1)
would like to be##2##4##(1992-12#1)(1992-2#1)
would like to emphasize the##2##5##(2008-12#1)(2013-1#1)
would like to present the##2##5##(2007-8#1)(2012-3#1)
would like to present##3##4##(2007-8#1)(2012-12#1)(2012-3#1)
would like to pursue##2##4##(2007-2#1)(2007-7#1)
would like to report a case##2##6##(2011-1#1)(2012-2#1)
would like to report a##3##5##(2007-8#1)(2011-1#1)(2012-2#1)
would like to see for##2##5##(1992-3#1)(2008-2#1)
would like to see the##2##5##(1992-3#1)(2008-5#1)
would like to see##6##4##(1992-3#3)(2008-2#1)(2008-3#1)(2008-5#1)
would like to##42##3##(1991-2#1)(1992-12#1)(1992-2#1)(1992-3#3)(1997-6#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
would like##47##2##(1991-2#1)(1992-12#1)(1992-2#1)(1992-3#3)(1997-6#2)(2006-12#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)
would likely be##2##3##(2008-10#1)(2008-8#1)
would likely lead to##2##4##(2008-5#2)
would likely volunteer to perform##2##5##(2006-10#2)
would likely##7##2##(2006-10#2)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#1)
would limit the##5##3##(1990-6#1)(1993-5#1)(1995-3#1)(2007-10#1)(2008-10#1)
would limit##6##2##(1990-6#1)(1993-5#1)(1995-3#1)(2007-10#1)(2008-10#1)(2008-8#1)
would look##2##2##(1991-8#1)(2008-12#1)
would lower##2##2##(1995-8#1)(2010-12#1)
would mainly##2##2##(2004-1#1)(2012-12#1)
would maintain##4##2##(1992-9#1)(1996-9#1)(2008-3#1)(2012-2#1)
would make it##4##3##(1994-11#1)(2007-10#1)(2008-9#1)(2009-5#1)
would make the##4##3##(1995-11#1)(1996-1#1)(2008-12#1)(2008-6#1)
would make##20##2##(1990-2#1)(1994-11#1)(1995-11#1)(1996-1#1)(2005-4#1)(2007-10#1)(2007-3#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-2#1)(2010-4#2)(2011-1#2)(2012-12#1)(2012-2#1)
would mean that standard protocols would have be flexible enough to &quot##2##12##(2013-1#2)
would mean that##3##3##(2007-9#1)(2013-1#2)
would mean##4##2##(2007-9#1)(2008-1#1)(2013-1#2)
would mediate the##3##3##(1994-9#1)(1997-4#1)(2008-3#1)
would meet the##2##3##(1993-6#1)(1996-12#1)
would meet##3##2##(1993-6#1)(1996-12#1)(2008-3#1)
would minimize their##2##3##(2004-3#1)(2008-8#1)
would minimize##4##2##(2004-3#1)(2008-8#1)(2013-1#2)
would more##2##2##(1996-12#1)(1997-4#1)
would most likely##2##3##(1993-12#1)(1997-5#1)
would most##3##2##(1993-12#1)(1997-5#1)(2011-2#1)
would necessarily##2##2##(1995-5#1)(2008-7#1)
would need to be##6##4##(1992-2#1)(1995-6#1)(2007-12#1)(2007-9#1)(2008-8#1)(2011-1#1)
would need to##7##3##(1992-2#1)(1995-6#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-8#1)(2011-1#1)
would need##10##2##(1992-2#1)(1995-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-8#1)(2011-1#1)
would never##3##2##(2007-2#1)(2008-3#1)(2010-4#1)
would normally be##3##3##(1991-12#1)(1993-8#1)(2012-3#1)
would normally have##2##3##(1993-3#1)(2008-5#1)
would normally##7##2##(1991-12#1)(1993-3#2)(1993-8#1)(1996-4#1)(2008-5#1)(2012-3#1)
would not be##23##3##(1990-2#1)(1990-7#1)(1991-1#1)(1993-7#1)(1994-10#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-7#1)(2006-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
would not benefit from##3##4##(2007-5#1)(2007-6#1)(2013-8#1)
would not have##6##3##(1994-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2013-8#1)
would not interfere with the##3##5##(2007-8#1)(2012-11#2)
would not occur##2##3##(2005-10#1)(2011-2#1)
would not only##5##3##(1991-9#1)(1995-1#1)(2006-10#1)(2006-9#1)(2007-11#1)
would not provide##3##3##(1991-6#1)(2007-8#1)(2008-11#1)
would not result in##3##4##(1993-6#1)(1996-7#1)(2008-10#1)
would not##83##2##(1990-2#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-6#1)(1993-7#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#2)(1996-7#2)(1997-8#1)(2005-10#1)(2006-10#5)(2006-11#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#3)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-6#1)(2010-2#1)(2010-8#1)(2011-2#3)(2012-11#2)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#2)
would occur in##5##3##(2005-8#1)(2008-4#1)(2008-5#1)(2013-1#2)
would occur##9##2##(1992-3#1)(2005-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2012-12#1)(2013-1#2)
would offer##3##2##(1994-1#1)(1996-3#1)(2010-10#1)
would offset##2##2##(1992-3#1)(2010-8#1)
would only be##3##3##(1995-6#1)(2008-9#1)(2009-3#1)
would only##7##2##(1991-11#1)(1995-6#1)(1996-9#1)(2005-7#1)(2008-9#1)(2009-3#1)(2009-9#1)
would open a##2##3##(1991-11#1)(2008-6#1)
would open##4##2##(1991-11#1)(1996-12#1)(2008-6#1)(2012-2#1)
would optimize the##2##3##(2008-2#1)(2013-1#1)
would otherwise be considered##2##4##(1994-11#1)(2007-7#1)
would otherwise be##6##3##(1994-11#1)(2005-7#1)(2007-4#1)(2007-7#1)(2008-8#1)(2011-1#1)
would otherwise have had##2##4##(1991-6#1)(2012-11#1)
would otherwise have##6##3##(1991-6#1)(1992-7#1)(1997-1#1)(2006-10#1)(2011-2#1)(2012-11#1)
would otherwise occur##2##3##(2008-8#1)(2012-12#1)
would otherwise##29##2##(1990-11#1)(1991-6#1)(1992-7#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#1)(1996-3#1)(1997-1#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-2#2)(2008-8#3)(2009-2#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)
would participate in##2##3##(2005-10#1)(2008-8#1)
would particularly benefit##2##3##(2008-10#1)(2012-2#1)
would permit the##2##3##(2006-12#1)(2008-10#1)
would permit##6##2##(1993-6#1)(2006-12#2)(2008-10#1)(2008-3#1)(2010-12#1)
would play##2##2##(1991-4#1)(1991-5#1)
would preclude##2##2##(2008-8#2)
would predict that##3##3##(1994-12#1)(2008-3#1)(2008-7#1)
would predict##9##2##(1994-12#1)(1995-1#1)(1996-8#1)(2007-12#2)(2008-3#1)(2008-7#2)(2011-2#1)
would present##2##2##(1992-4#1)(2013-8#1)
would prevent##4##2##(1992-9#1)(1996-12#1)(2007-12#1)(2012-3#1)
would probably be the##2##4##(1991-11#1)(1996-2#1)
would probably be##7##3##(1991-11#1)(1991-7#1)(1992-4#1)(1993-9#1)(1996-2#1)(1997-8#1)(2013-1#1)
would probably lead##3##3##(1992-5#1)(1994-3#1)(1996-3#1)
would probably##15##2##(1991-10#1)(1991-11#1)(1991-7#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-9#1)(1994-3#1)(1996-2#1)(1996-3#1)(1997-8#1)(2007-11#1)(2008-11#1)(2008-8#1)(2013-1#1)
would produce a##6##3##(1990-5#1)(1992-9#1)(2008-2#1)(2008-8#1)(2010-4#1)(2013-1#1)
would produce##16##2##(1990-2#1)(1990-5#1)(1992-8#1)(1992-9#1)(1993-9#1)(1995-5#1)(1995-8#1)(1997-9#1)(2008-12#1)(2008-2#1)(2008-8#1)(2010-4#1)(2012-12#1)(2012-3#1)(2013-1#2)
would profit from##2##3##(2006-6#1)(2008-1#1)
would promote##5##2##(2007-10#1)(2008-4#1)(2008-6#1)(2009-9#1)(2011-1#1)
would protect##2##2##(1990-11#1)(2008-1#1)
would provide a powerful tool##2##5##(2010-12#1)(2010-2#1)
would provide a##10##3##(1995-1#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2010-12#2)(2010-2#1)(2012-3#1)
would provide an##2##3##(2005-8#1)(2008-4#1)
would provide better##3##3##(1997-3#1)(2005-11#1)(2006-1#1)
would provide protection##2##3##(1995-12#1)(2013-1#1)
would provide the##5##3##(1994-8#1)(2008-11#1)(2008-8#1)(2011-1#1)(2012-3#1)
would provide valuable information##2##4##(1996-8#1)(2012-12#1)
would provide valuable##3##3##(1996-8#1)(2008-7#1)(2012-12#1)
would provide##53##2##(1992-1#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-5#1)(2005-11#1)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
would reach the##2##3##(2005-8#2)
would reach##4##2##(2005-8#2)(2010-8#1)(2011-2#1)
would receive##5##2##(1996-12#1)(1997-2#1)(2006-9#1)(2009-2#1)(2013-8#1)
would recommend a##2##3##(1996-8#1)(2009-10#1)
would recommend##10##2##(1993-3#1)(1996-12#1)(1996-8#1)(2004-2#1)(2006-8#1)(2007-7#1)(2007-8#1)(2009-10#1)(2012-12#1)(2013-7#1)
would reduce the##7##3##(1993-9#1)(1995-6#1)(2006-12#1)(2006-4#1)(2008-10#2)(2013-1#1)
would reduce##13##2##(1991-11#1)(1993-9#1)(1995-6#1)(2006-12#1)(2006-4#1)(2007-12#1)(2008-10#2)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
would refer##2##2##(2006-10#1)(2007-2#1)
would reflect##3##2##(2006-8#1)(2007-8#1)(2009-10#1)
would remain##5##2##(1992-12#1)(1996-1#1)(1996-12#1)(2009-10#1)(2013-1#1)
would render##3##2##(1991-12#1)(1996-7#1)(2010-7#1)
would represent a##2##3##(2009-3#1)(2011-2#1)
would represent##4##2##(1993-2#1)(2008-11#1)(2009-3#1)(2011-2#1)
would require a##5##3##(1996-12#1)(2007-12#1)(2009-12#1)(2009-2#1)(2012-1#1)
would require disclosure of##2##4##(1995-12#1)(2009-7#1)
would require##25##2##(1991-2#1)(1991-3#1)(1991-7#1)(1993-12#1)(1993-3#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-7#1)(2006-12#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-12#1)(2009-2#1)(2009-7#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-1#1)
would restore the##2##3##(2007-7#1)(2010-11#1)
would restrict##2##2##(1991-1#1)(2005-11#1)
would result in a##6##4##(1991-3#1)(1991-7#1)(1993-9#1)(1995-2#1)(2005-9#1)(2008-10#1)
would result in an##3##4##(1995-3#1)(2008-10#1)(2009-7#1)
would result in the##5##4##(1993-6#1)(1994-9#1)(1997-7#1)(2008-10#2)
would result in##27##3##(1991-3#1)(1991-7#1)(1992-9#1)(1993-6#1)(1993-9#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-3#1)(1997-7#1)(2005-9#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-6#1)(2008-7#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-8#1)(2011-1#2)
would result##31##2##(1991-3#1)(1991-7#1)(1992-9#1)(1993-6#1)(1993-9#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-7#1)(2005-9#1)(2006-4#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-8#1)(2011-1#2)(2012-12#1)
would return to##2##3##(2008-5#1)(2013-7#1)
would return##4##2##(2006-4#1)(2008-5#1)(2010-8#1)(2013-7#1)
would say##3##2##(1993-9#1)(2007-8#1)(2008-10#1)
would seek##2##2##(2012-2#1)(2013-1#1)
would seem pertinent to##2##4##(2008-11#1)(2013-7#1)
would seem that##2##3##(2005-11#1)(2008-11#1)
would seem to be a##3##5##(1995-1#1)(1996-2#1)(2008-11#1)
would seem to be the##2##5##(2007-8#2)
would seem to be##6##4##(1995-1#1)(1996-2#1)(2007-8#2)(2008-10#1)(2008-11#1)
would seem to##13##3##(1995-1#1)(1996-2#1)(1996-7#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-12#1)
would seem##25##2##(1991-2#1)(1992-4#1)(1995-1#1)(1996-2#1)(1996-7#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-11#3)(2008-2#1)(2008-5#1)(2008-7#2)(2009-1#1)(2011-12#1)(2013-7#1)
would seriously##2##2##(1996-4#1)(2010-8#1)
would serve as a##2##4##(1993-11#1)(2010-10#1)
would serve as##3##3##(1993-11#1)(2007-12#1)(2010-10#1)
would serve##5##2##(1993-11#1)(2007-12#1)(2008-5#1)(2009-8#1)(2010-10#1)
would show a##2##3##(2008-4#1)(2009-4#1)
would show##8##2##(1997-8#1)(2007-10#1)(2007-6#1)(2008-11#1)(2008-4#1)(2009-11#1)(2009-4#1)(2013-7#1)
would significantly##6##2##(1995-1#1)(2005-9#1)(2006-12#1)(2006-6#1)(2006-7#1)(2009-11#1)
would still##4##2##(1996-2#1)(2006-4#1)(2012-11#1)(2013-1#1)
would suffer the##2##3##(2008-8#2)
would suffer##3##2##(2007-1#1)(2008-8#2)
would suggest a##4##3##(1992-8#1)(2008-10#1)(2012-12#2)
would suggest that the##2##4##(2008-11#1)(2008-7#1)
would suggest that there##2##4##(1992-1#1)(2004-7#1)
would suggest that##19##3##(1990-11#1)(1990-2#2)(1991-3#1)(1992-1#1)(1993-9#1)(1994-8#1)(1995-9#1)(1997-5#1)(2004-10#1)(2004-7#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2011-7#1)
would suggest the##2##3##(1990-8#1)(2008-7#1)
would suggest##30##2##(1990-11#1)(1990-2#2)(1990-8#1)(1991-3#1)(1992-1#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-9#1)(1994-8#1)(1995-9#1)(1997-5#1)(2004-10#1)(2004-7#1)(2006-10#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#2)(2011-7#1)(2012-12#2)
would support a##2##3##(1993-3#1)(2007-12#1)
would support the##2##3##(1991-4#1)(2012-3#1)
would support##4##2##(1991-4#1)(1993-3#1)(2007-12#1)(2012-3#1)
would survive##2##2##(2006-8#1)(2008-1#1)
would take##8##2##(1990-2#1)(1996-1#1)(2005-11#1)(2007-10#1)(2007-9#1)(2008-1#2)(2009-7#1)
would the##3##2##(2007-9#1)(2008-6#1)(2012-1#1)
would then be##3##3##(1994-5#1)(1995-3#1)(2012-1#1)
would then serve##2##3##(1997-7#1)(2006-8#1)
would then##10##2##(1994-10#1)(1994-5#1)(1995-3#1)(1997-7#1)(2005-9#1)(2006-12#1)(2006-8#1)(2009-8#1)(2010-11#1)(2012-1#1)
would theoretically##2##2##(1992-8#1)(2013-1#1)
would therefore be##7##3##(1990-5#1)(1990-8#1)(1991-8#1)(1994-6#1)(1995-6#1)(2008-11#1)(2013-1#1)
would therefore##12##2##(1990-5#1)(1990-8#2)(1991-8#1)(1994-6#1)(1995-6#1)(2005-11#1)(2008-11#1)(2008-8#1)(2010-4#1)(2012-11#1)(2013-1#1)
would thus appear to##2##4##(1992-6#1)(1992-7#1)
would thus appear##3##3##(1992-6#1)(1992-7#1)(1994-3#1)
would thus##5##2##(1992-6#1)(1992-7#1)(1992-8#1)(1994-3#1)(2009-6#1)
would use the##2##3##(2007-12#1)(2007-7#1)
would use##6##2##(1992-12#1)(2007-12#1)(2007-7#2)(2007-9#1)(2008-1#1)
would vary##2##2##(2006-11#1)(2012-3#1)
would want to##2##3##(2008-5#1)(2011-1#1)
would want##3##2##(2005-4#1)(2008-5#1)(2011-1#1)
would work##2##2##(2005-9#1)(2011-2#1)
would yield the##4##3##(2008-10#1)(2010-2#2)(2012-1#1)
would yield##9##2##(1995-11#1)(1997-1#1)(1997-8#1)(2006-9#1)(2007-11#1)(2008-10#1)(2010-2#2)(2012-1#1)
would##2481##1##(1990-10#1)(1990-11#8)(1990-12#11)(1990-2#15)(1990-3#7)(1990-4#5)(1990-5#5)(1990-6#7)(1990-7#5)(1990-8#9)(1990-9#4)(1991-1#8)(1991-10#8)(1991-11#8)(1991-12#16)(1991-2#10)(1991-3#5)(1991-4#5)(1991-5#6)(1991-6#8)(1991-7#9)(1991-8#6)(1991-9#4)(1992-1#4)(1992-10#4)(1992-11#6)(1992-12#17)(1992-2#9)(1992-3#12)(1992-4#6)(1992-5#6)(1992-6#7)(1992-7#5)(1992-8#7)(1992-9#9)(1993-1#7)(1993-11#8)(1993-12#7)(1993-2#12)(1993-3#15)(1993-5#3)(1993-6#12)(1993-7#2)(1993-8#8)(1993-9#12)(1994-1#8)(1994-10#5)(1994-11#9)(1994-12#14)(1994-2#12)(1994-3#13)(1994-4#1)(1994-5#8)(1994-6#7)(1994-7#1)(1994-8#7)(1994-9#8)(1995-1#15)(1995-11#9)(1995-12#19)(1995-2#11)(1995-3#8)(1995-4#3)(1995-5#10)(1995-6#21)(1995-7#1)(1995-8#6)(1995-9#4)(1996-1#22)(1996-10#6)(1996-11#5)(1996-12#18)(1996-2#12)(1996-3#13)(1996-4#7)(1996-5#9)(1996-6#11)(1996-7#7)(1996-8#11)(1996-9#7)(1997-1#12)(1997-2#12)(1997-3#10)(1997-4#7)(1997-5#14)(1997-6#9)(1997-7#7)(1997-8#16)(1997-9#1)(2004-1#1)(2004-10#5)(2004-11#2)(2004-12#1)(2004-2#2)(2004-3#4)(2004-7#2)(2004-9#7)(2005-10#9)(2005-11#13)(2005-12#6)(2005-3#1)(2005-4#4)(2005-5#3)(2005-6#2)(2005-7#18)(2005-8#14)(2005-9#8)(2006-1#1)(2006-10#42)(2006-11#3)(2006-12#21)(2006-2#9)(2006-3#4)(2006-4#10)(2006-5#8)(2006-6#8)(2006-7#13)(2006-8#15)(2006-9#13)(2007-1#9)(2007-10#17)(2007-11#27)(2007-12#45)(2007-2#21)(2007-3#4)(2007-4#17)(2007-5#10)(2007-6#5)(2007-7#30)(2007-8#40)(2007-9#32)(2008-1#32)(2008-10#132)(2008-11#74)(2008-12#21)(2008-2#25)(2008-3#39)(2008-4#21)(2008-5#50)(2008-6#23)(2008-7#72)(2008-8#56)(2008-9#25)(2009-1#4)(2009-10#14)(2009-11#3)(2009-12#7)(2009-2#10)(2009-3#6)(2009-4#16)(2009-5#13)(2009-6#10)(2009-7#12)(2009-8#10)(2009-9#12)(2010-1#2)(2010-10#10)(2010-11#8)(2010-12#25)(2010-2#21)(2010-3#10)(2010-4#18)(2010-5#8)(2010-7#12)(2010-8#16)(2010-9#6)(2011-1#41)(2011-10#1)(2011-12#11)(2011-2#52)(2011-3#3)(2011-7#1)(2012-1#17)(2012-11#12)(2012-12#38)(2012-2#45)(2012-3#31)(2012-9#1)(2013-1#79)(2013-7#24)(2013-8#32)
would-be##4##1##(1990-7#1)(1995-12#1)(2012-2#1)(2013-8#1)
wound after##2##2##(2007-7#1)(2012-2#1)
wound and##15##2##(1991-6#1)(1994-5#1)(2005-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#2)
wound appearance##2##2##(2008-12#1)(2008-5#1)
wound area##4##2##(1996-7#1)(2008-10#1)(2008-11#2)
wound bed##3##2##(2010-2#1)(2011-2#1)(2012-10#1)
wound breaking strength##2##3##(2006-9#2)
wound care and##2##3##(2008-7#1)(2013-1#1)
wound care##18##2##(2005-7#1)(2006-9#1)(2007-11#2)(2007-12#2)(2008-7#2)(2009-4#1)(2010-12#1)(2010-4#1)(2011-2#5)(2012-10#1)(2013-1#1)
wound caused by##2##3##(1990-6#1)(2008-8#1)
wound closure and##4##3##(2006-9#1)(2008-7#1)(2011-2#2)
wound closure by##3##3##(2008-5#2)(2012-12#1)
wound closure in##2##3##(1992-2#1)(2012-12#1)
wound closure##27##2##(1992-2#1)(2006-9#2)(2008-10#2)(2008-4#1)(2008-5#3)(2008-7#5)(2008-9#1)(2009-8#1)(2010-2#2)(2011-12#1)(2011-2#4)(2012-10#1)(2012-12#3)
wound closure]##2##2##(1996-3#1)(2005-11#1)
wound complications and##2##3##(2008-2#2)
wound complications##12##2##(1992-1#1)(2007-7#1)(2007-8#4)(2008-2#2)(2008-8#2)(2011-2#1)(2012-2#1)
wound contraction##2##2##(2008-10#2)
wound creation##2##2##(2008-9#1)(2011-1#1)
wound dehiscence and##2##3##(2007-7#1)(2007-8#1)
wound dehiscence##10##2##(2007-7#1)(2007-8#4)(2008-7#3)(2009-6#1)(2011-2#1)
wound drainage was##2##3##(1996-9#2)
wound drainage##3##2##(1996-9#3)
wound dressing##10##2##(2008-5#2)(2009-3#1)(2011-2#5)(2013-7#2)
wound dressings##2##2##(2006-9#1)(2009-2#1)
wound edge protector##2##3##(2007-8#2)
wound edge##3##2##(1996-7#1)(2007-8#2)
wound fluid##4##2##(2006-9#4)
wound for##3##2##(2009-3#1)(2013-1#2)
wound healed##3##2##(2008-12#1)(2009-3#1)(2011-1#1)
wound healing after##3##3##(2004-10#1)(2007-8#1)(2012-12#1)
wound healing and##12##3##(1994-6#1)(2006-11#1)(2007-1#1)(2007-11#1)(2008-11#1)(2008-12#1)(2010-6#1)(2012-12#4)(2012-3#1)
wound healing are##4##3##(2008-10#1)(2008-7#1)(2008-8#1)(2010-9#1)
wound healing effect of##2##4##(2009-12#1)(2011-2#1)
wound healing in the##2##4##(2008-9#1)(2011-2#1)
wound healing in##14##3##(1996-7#1)(2005-12#1)(2006-8#1)(2006-9#1)(2007-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-9#1)(2011-12#1)(2011-2#1)
wound healing is##3##3##(2007-1#1)(2008-4#1)(2010-8#1)
wound healing process##5##3##(2006-11#1)(2007-4#1)(2011-1#2)(2011-2#1)
wound healing processes##2##3##(2008-5#1)(2009-12#1)
wound healing response##2##3##(2006-9#1)(2012-12#1)
wound healing was##6##3##(2007-8#1)(2008-11#1)(2008-7#1)(2010-12#1)(2012-12#1)(2013-1#1)
wound healing with##3##3##(2007-3#1)(2013-1#2)
wound healing##139##2##(1990-10#1)(1990-12#1)(1990-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-3#1)(1996-7#3)(1996-8#1)(1997-6#1)(2004-1#1)(2004-10#1)(2005-10#1)(2005-12#1)(2005-7#3)(2005-8#1)(2006-10#1)(2006-11#4)(2006-12#1)(2006-8#1)(2006-9#9)(2007-1#2)(2007-11#5)(2007-12#6)(2007-3#2)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#2)(2008-12#2)(2008-4#10)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#4)(2009-12#5)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#4)(2011-2#6)(2012-11#3)(2012-12#11)(2012-3#5)(2013-1#4)(2013-8#2)
wound in the##2##3##(2008-10#1)(2013-1#1)
wound in##5##2##(2008-10#2)(2011-12#1)(2011-2#1)(2013-1#1)
wound infection after median sternotomy##3##5##(2007-8#3)
wound infection after##9##3##(2006-10#1)(2006-2#1)(2007-8#6)(2013-1#1)
wound infection and##6##3##(1992-10#1)(2008-1#1)(2008-7#2)(2012-10#1)(2012-2#1)
wound infection in##4##3##(1995-12#1)(2006-12#1)(2006-6#1)(2007-7#1)
wound infection incidence##2##3##(1990-3#2)
wound infection of##2##3##(1994-2#1)(2008-5#1)
wound infection was##3##3##(1994-2#1)(2006-2#1)(2006-8#1)
wound infection##55##2##(1990-10#1)(1990-3#2)(1992-10#1)(1994-2#5)(1995-12#1)(2006-10#2)(2006-12#1)(2006-2#4)(2006-6#1)(2006-7#1)(2006-8#3)(2007-7#4)(2007-8#8)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2010-3#1)(2011-2#4)(2012-10#2)(2012-2#4)(2012-3#1)(2013-1#2)
wound infections after sternotomy##3##4##(2007-8#3)
wound infections and##2##3##(2012-12#1)(2012-2#1)
wound infections##19##2##(1990-3#2)(1992-12#1)(1996-8#1)(2006-6#1)(2006-8#2)(2007-8#6)(2010-12#2)(2010-2#1)(2012-12#1)(2012-2#2)
wound infiltration with bupivacaine##2##4##(2008-7#2)
wound infiltration##6##2##(1991-3#1)(1996-8#1)(2008-7#4)
wound inoculation##3##2##(2008-10#3)
wound leakage was##2##3##(2007-1#2)
wound leakage##4##2##(2007-1#4)
wound management##2##2##(2010-2#1)(2012-10#1)
wound model##5##2##(2007-8#1)(2010-12#1)(2012-11#2)(2012-12#1)
wound of the##4##3##(2004-8#1)(2010-3#1)(2011-2#1)(2012-12#1)
wound of##6##2##(2004-8#1)(2008-12#1)(2010-3#1)(2011-2#2)(2012-12#1)
wound pain##2##2##(1996-8#1)(2008-3#1)
wound problems##2##2##(2008-9#1)(2009-9#1)
wound repair and the##2##4##(2008-5#1)(2012-12#1)
wound repair and##4##3##(2006-9#1)(2008-1#1)(2008-5#1)(2012-12#1)
wound repair in##2##3##(1996-7#2)
wound repair process##2##3##(1994-3#1)(2012-12#1)
wound repair##18##2##(1990-12#1)(1994-3#3)(1996-7#3)(2006-9#1)(2008-1#1)(2008-4#2)(2008-5#1)(2011-2#1)(2012-12#5)
wound response##3##2##(2008-4#2)(2009-8#1)
wound should##3##2##(1990-2#1)(2007-5#1)(2009-3#1)
wound site pain##3##3##(2012-12#3)
wound site##11##2##(2006-9#1)(2007-9#1)(2008-10#4)(2008-9#1)(2012-12#3)(2012-3#1)
wound sites##3##2##(2008-10#2)(2012-2#1)
wound specimens##2##2##(1996-7#2)
wound surface##4##2##(2007-7#1)(2007-8#1)(2010-12#2)
wound swabs##2##2##(2007-7#2)
wound therapy##3##2##(2009-9#1)(2010-3#1)(2012-10#1)
wound to##2##2##(2006-12#1)(2011-2#1)
wound treatment##4##2##(2006-9#1)(2010-1#1)(2010-3#1)(2012-3#1)
wound under##2##2##(2009-6#1)(2010-3#1)
wound using##2##2##(2008-11#1)(2010-3#1)
wound was##13##2##(1991-6#1)(1994-3#1)(1996-8#1)(2007-8#1)(2008-11#2)(2010-3#2)(2011-1#3)(2013-1#2)
wound with##4##2##(1996-8#1)(2007-8#2)(2011-1#1)
wound##590##1##(1990-10#2)(1990-12#3)(1990-2#1)(1990-3#4)(1990-6#1)(1990-7#2)(1990-9#4)(1991-11#1)(1991-3#2)(1991-6#2)(1991-8#1)(1992-1#1)(1992-10#3)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#5)(1994-3#5)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-3#2)(1996-7#10)(1996-8#6)(1996-9#3)(1997-6#1)(2004-1#1)(2004-10#1)(2004-8#1)(2005-10#4)(2005-11#1)(2005-12#1)(2005-5#1)(2005-7#4)(2005-8#1)(2005-9#1)(2006-10#3)(2006-11#6)(2006-12#4)(2006-2#4)(2006-4#2)(2006-6#5)(2006-7#2)(2006-8#6)(2006-9#26)(2007-1#7)(2007-11#8)(2007-12#11)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#2)(2007-7#17)(2007-8#40)(2007-9#1)(2008-1#3)(2008-10#31)(2008-11#10)(2008-12#5)(2008-2#6)(2008-3#3)(2008-4#16)(2008-5#13)(2008-6#2)(2008-7#21)(2008-8#5)(2008-9#15)(2009-12#5)(2009-2#1)(2009-3#8)(2009-4#2)(2009-6#7)(2009-8#3)(2009-9#3)(2010-1#1)(2010-12#14)(2010-2#5)(2010-3#9)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#3)(2011-1#13)(2011-12#6)(2011-2#43)(2012-10#12)(2012-11#7)(2012-12#32)(2012-2#11)(2012-3#14)(2013-1#15)(2013-7#3)(2013-8#2)
wound-healing and##2##2##(1995-12#1)(2012-11#1)
wound-healing process##4##2##(2004-9#1)(2008-7#1)(2012-12#2)
wound-healing##14##1##(1995-12#1)(1995-3#1)(2004-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#3)(2012-11#2)(2012-12#2)
wound-induced##3##1##(2008-10#1)(2009-8#2)
wound-inducible promoter##2##2##(2008-10#2)
wound-inducible##7##1##(1997-2#2)(2006-12#2)(2008-10#2)(2008-9#1)
wound-related##2##1##(2011-12#1)(2012-3#1)
wounded in##3##2##(2010-12#1)(2011-1#1)(2012-2#1)
wounded maize##2##2##(2008-10#2)
wounded soldiers##2##2##(1990-12#1)(2007-12#1)
wounded tissues##2##2##(2008-10#2)
wounded##34##1##(1990-12#1)(1993-5#1)(1997-2#3)(2005-9#1)(2007-12#1)(2007-8#1)(2008-10#20)(2008-7#1)(2009-7#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-2#1)
wounding and##5##2##(2008-10#4)(2009-8#1)
wounding in##4##2##(1992-12#2)(1997-2#1)(2006-9#1)
wounding machine##2##2##(2008-7#2)
wounding of##4##2##(2008-10#3)(2008-7#1)
wounding##41##1##(1992-12#3)(1993-12#1)(1996-7#1)(1997-2#4)(2006-9#3)(2007-12#1)(2008-10#15)(2008-5#1)(2008-7#5)(2009-8#4)(2009-9#1)(2010-12#1)(2012-12#1)
wounds and the##2##3##(2010-3#1)(2011-2#1)
wounds and##22##2##(1990-6#1)(1991-7#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
wounds are##10##2##(1990-2#1)(1992-2#1)(2007-12#2)(2007-7#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
wounds below the fourth intercostal space##2##6##(1990-2#2)
wounds below##3##2##(1990-2#2)(2008-10#1)
wounds during the##2##3##(1990-2#1)(2011-2#1)
wounds had healed##2##3##(2007-11#1)(2008-9#1)
wounds had##3##2##(2006-2#1)(2007-11#1)(2008-9#1)
wounds has##2##2##(2008-5#1)(2008-9#1)
wounds have##3##2##(2006-9#1)(2008-9#2)
wounds in rats##3##3##(2008-11#2)(2010-12#1)
wounds in the##3##3##(1996-7#1)(2008-9#1)(2011-2#1)
wounds in##13##2##(1996-7#1)(2006-9#2)(2007-3#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-9#1)(2010-12#2)(2011-2#1)
wounds of the##7##3##(2007-8#1)(2008-9#1)(2011-2#2)(2012-10#1)(2012-12#2)
wounds of##15##2##(1994-3#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-9#2)(2010-6#1)(2011-2#2)(2012-10#1)(2012-12#2)
wounds on##3##2##(2008-10#2)(2012-3#1)
wounds or the##2##3##(2008-11#1)(2008-5#1)
wounds or##9##2##(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)(2010-3#1)(2013-1#1)
wounds that##4##2##(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)
wounds to the##4##3##(1995-11#2)(2011-2#2)
wounds to##7##2##(1995-11#2)(2007-8#1)(2008-9#1)(2011-2#2)(2012-3#1)
wounds was##3##2##(1996-7#1)(2008-5#1)(2010-12#1)
wounds were##21##2##(1990-7#2)(1992-10#1)(1992-2#1)(1996-7#2)(2005-10#1)(2006-2#2)(2007-1#3)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#1)(2010-12#1)
wounds with##6##2##(1991-8#1)(1992-6#1)(2008-4#1)(2008-5#1)(2008-9#1)(2013-8#1)
wounds##228##1##(1990-2#4)(1990-6#1)(1990-7#4)(1991-3#1)(1991-7#1)(1991-8#1)(1992-10#2)(1992-2#4)(1992-6#2)(1993-8#1)(1994-3#1)(1995-11#2)(1996-7#4)(2005-10#1)(2005-7#2)(2005-9#2)(2006-11#1)(2006-2#4)(2006-3#1)(2006-4#1)(2006-6#2)(2006-8#3)(2006-9#8)(2007-1#3)(2007-10#2)(2007-11#2)(2007-12#4)(2007-2#2)(2007-3#2)(2007-5#1)(2007-7#6)(2007-8#10)(2008-10#32)(2008-11#8)(2008-12#2)(2008-3#2)(2008-4#5)(2008-5#9)(2008-7#1)(2008-8#1)(2008-9#20)(2009-9#2)(2010-12#6)(2010-2#1)(2010-3#2)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#13)(2012-10#6)(2012-11#2)(2012-12#8)(2012-2#5)(2012-3#6)(2013-1#4)(2013-7#2)(2013-8#1)
wounds)##2##1##(2008-10#1)(2008-2#1)
woven bone##2##2##(2007-7#1)(2008-5#1)
woven into the##2##3##(1997-1#1)(2007-10#1)
woven structures##2##2##(2008-3#2)
woven##9##1##(1997-1#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-3#3)(2008-5#1)(2012-2#1)
wpk4 mRNA is##2##3##(1994-3#2)
wpk4 mRNA##5##2##(1994-3#5)
wpk4##6##1##(1994-3#6)
wrap around the##2##3##(1991-2#1)(1994-5#1)
wrap around##5##2##(1991-2#1)(1994-5#1)(2007-8#1)(2008-6#1)(2008-9#1)
wrap##8##1##(1991-2#1)(1994-5#1)(2007-1#1)(2007-8#1)(2008-6#2)(2008-9#2)
wrap-around flap##3##2##(2006-3#3)
wrapped around a##5##3##(2008-10#2)(2008-2#1)(2008-3#1)(2010-10#1)
wrapped around the##3##3##(1993-9#1)(2006-2#1)(2010-3#1)
wrapped around##8##2##(1993-9#1)(2006-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-10#1)(2010-3#1)
wrapped by##2##2##(2005-11#1)(2007-12#1)
wrapped in a##2##3##(2006-10#1)(2007-11#1)
wrapped in the somatic cytoplasm of pigmented##2##7##(1995-3#2)
wrapped in##7##2##(1995-3#2)(2006-10#1)(2007-11#1)(2008-7#1)(2011-12#1)(2011-2#1)
wrapped phase##10##2##(2007-12#1)(2008-2#6)(2008-3#3)
wrapped with##3##2##(2010-4#2)(2010-7#1)
wrapped##42##1##(1993-9#1)(1995-3#2)(2005-11#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#10)(2008-3#5)(2008-5#1)(2008-7#3)(2009-4#1)(2010-10#1)(2010-3#1)(2010-4#2)(2010-7#2)(2011-12#1)(2011-2#2)(2013-7#1)
wrapping of the##3##3##(1995-11#1)(2007-8#1)(2010-7#1)
wrapping##10##1##(1993-3#1)(1995-11#2)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-8#1)(2010-7#1)
wraps##2##1##(2008-10#1)(2010-5#1)
wrenching##2##1##(1992-3#1)(2007-8#1)
wrestler##3##1##(2010-1#2)(2012-3#1)
wrestlers##2##1##(2006-3#1)(2012-3#1)
wrestling##2##1##(2006-12#1)(2010-4#1)
wrightii##5##1##(2009-8#3)(2011-2#2)
wring mode##2##2##(1997-1#2)
wring##5##1##(1997-1#5)
wringing##8##1##(2008-2#3)(2008-3#5)
wrinkle depth##2##2##(2008-5#2)
wrinkle##10##1##(2007-12#1)(2008-5#6)(2010-4#3)
wrinkled##6##1##(1994-11#1)(2009-10#1)(2010-12#1)(2010-4#2)(2012-2#1)
wrinkles and##2##2##(2006-12#2)
wrinkles in##3##2##(2008-5#3)
wrinkles of##3##2##(2006-12#1)(2008-5#1)(2010-4#1)
wrinkles were##2##2##(2008-5#2)
wrinkles##38##1##(1991-6#1)(2005-11#1)(2006-12#3)(2007-12#1)(2008-5#30)(2010-4#1)(2011-2#1)
wrinkling and##4##2##(1994-11#1)(2007-7#1)(2008-5#1)(2010-8#1)
wrinkling##9##1##(1994-11#1)(2007-7#1)(2008-5#5)(2010-8#1)(2011-2#1)
wrist and finger extension##2##4##(2007-7#1)(2012-2#1)
wrist and finger##3##3##(2007-7#1)(2012-1#1)(2012-2#1)
wrist and hand##2##3##(2006-12#1)(2008-8#1)
wrist and##17##2##(1996-3#1)(2006-12#1)(2007-7#3)(2008-12#2)(2008-8#2)(2008-9#1)(2009-6#1)(2010-12#1)(2012-1#3)(2012-2#1)(2012-3#1)
wrist arthroscopy##4##2##(2008-10#3)(2008-9#1)
wrist by##2##2##(2006-3#1)(2012-1#1)
wrist deviation##4##2##(2013-7#4)
wrist flexion and extension##2##4##(1991-6#1)(2012-1#1)
wrist flexion-extension##2##2##(2006-3#1)(2012-1#1)
wrist flexion/extension##3##2##(1993-2#1)(2012-1#2)
wrist ganglion##3##2##(2008-9#3)
wrist instability##2##2##(2008-9#1)(2013-1#1)
wrist joint##6##2##(2012-1#3)(2012-2#3)
wrist joints##4##2##(1995-6#1)(2006-10#1)(2007-8#1)(2009-8#1)
wrist movements##2##2##(2012-1#1)(2012-2#1)
wrist pain##12##2##(2008-10#1)(2008-9#10)(2012-3#1)
wrist pulse signals##2##3##(2010-8#2)
wrist pulse##3##2##(2010-8#3)
wrist radiography is not##2##4##(2008-9#2)
wrist radiography##3##2##(2008-9#3)
wrist rehabilitation##2##2##(2012-1#2)
wrist to##3##2##(1991-1#1)(1996-3#1)(2012-1#1)
wrist were##2##2##(1996-1#1)(2008-7#1)
wrist##166##1##(1991-1#1)(1991-11#1)(1991-6#1)(1993-2#1)(1993-7#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#6)(1997-5#1)(2005-11#2)(2006-10#4)(2006-12#1)(2006-3#17)(2006-4#4)(2006-6#1)(2006-7#1)(2007-11#1)(2007-3#1)(2007-7#9)(2007-8#3)(2008-1#5)(2008-10#5)(2008-11#1)(2008-12#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#29)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-8#3)(2010-9#1)(2011-2#3)(2012-1#23)(2012-2#11)(2012-3#4)(2013-1#3)(2013-7#6)(2013-8#1)
wrists and##2##2##(2006-10#1)(2008-9#1)
wrists##13##1##(1995-6#1)(2006-10#5)(2006-3#2)(2008-9#2)(2009-3#2)(2009-6#1)
wrists)##2##1##(2006-3#1)(2008-9#1)
write a##4##2##(2008-1#1)(2008-3#1)(2008-9#1)(2010-7#1)
write about##2##2##(2007-9#1)(2008-2#1)
write and##2##2##(2008-2#1)(2008-6#1)
write beams##2##2##(2008-1#1)(2008-3#1)
write##45##1##(1995-3#1)(1996-2#1)(2004-3#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-9#3)(2008-1#3)(2008-11#1)(2008-2#5)(2008-3#7)(2008-4#3)(2008-6#2)(2008-7#2)(2008-9#1)(2009-4#2)(2010-7#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#3)
write-once##3##1##(2008-3#3)
write?##2##1##(2005-12#1)(2008-2#1)
writer data##2##2##(2008-6#2)
writer identification##2##2##(2008-6#2)
writer##13##1##(1995-2#1)(2007-9#1)(2008-6#6)(2009-3#1)(2010-12#2)(2010-7#1)(2011-2#1)
writers and##4##2##(1993-3#2)(2006-1#1)(2008-8#1)
writers##13##1##(1991-4#1)(1993-3#2)(2006-1#1)(2007-9#2)(2008-2#1)(2008-6#3)(2008-8#1)(2009-4#1)(2013-8#1)
writes##6##1##(1993-2#1)(1993-3#1)(1994-12#1)(2007-12#1)(2007-7#1)(2008-3#1)
writhes##3##1##(2008-12#1)(2013-7#2)
writhing method##2##2##(2011-1#1)(2013-7#1)
writhing tests##3##2##(1990-2#3)
writhing##15##1##(1990-2#3)(1992-3#1)(1996-2#1)(2008-6#2)(2011-1#2)(2013-7#6)
writing a successful##2##3##(2007-6#1)(2012-1#1)
writing a##5##2##(1996-6#1)(2007-12#1)(2007-6#1)(2009-4#1)(2012-1#1)
writing about the##2##3##(2008-4#1)(2011-2#1)
writing about##4##2##(2008-4#1)(2009-10#1)(2010-10#1)(2011-2#1)
writing an##3##2##(2008-11#1)(2008-12#1)(2011-2#1)
writing and reading##3##3##(2007-12#1)(2008-12#1)(2008-2#1)
writing and##14##2##(1997-7#1)(2005-12#1)(2007-12#4)(2008-1#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2009-9#1)(2013-1#1)
writing apprehension##3##2##(2006-12#3)
writing as##2##2##(2012-2#1)(2013-1#1)
writing at##2##2##(2007-12#2)
writing beams and##3##3##(2008-2#2)(2008-3#1)
writing beams##10##2##(2007-11#3)(2007-12#1)(2008-2#4)(2008-3#2)
writing for##2##2##(1996-2#1)(2008-11#1)
writing in the##2##3##(2008-7#1)(2010-6#1)
writing in##4##2##(2008-2#1)(2008-7#1)(2010-10#1)(2010-6#1)
writing intensity##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
writing letters##2##2##(2007-2#1)(2008-3#1)
writing light##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
writing of the##6##3##(1994-3#1)(2007-11#1)(2008-12#1)(2008-2#1)(2011-1#1)(2011-2#1)
writing of##17##2##(1991-1#1)(1994-3#1)(2007-11#3)(2007-12#2)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-1#1)(2011-2#2)(2013-7#1)
writing on##4##2##(1991-11#1)(2007-12#1)(2008-2#1)(2012-3#1)
writing power##4##2##(2008-3#4)
writing process##2##2##(2007-11#1)(2008-1#1)
writing skills##2##2##(2008-12#2)
writing the##5##2##(1991-10#1)(1996-11#1)(1997-4#1)(2008-1#1)(2008-3#1)
writing to##4##2##(2006-5#1)(2007-8#1)(2013-1#2)
writing with##5##2##(2007-12#1)(2008-7#1)(2010-9#1)(2011-1#1)(2013-1#1)
writing##190##1##(1991-1#1)(1991-10#1)(1991-11#1)(1992-9#1)(1993-2#2)(1993-3#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-4#1)(1997-7#1)(2005-12#3)(2006-10#1)(2006-12#5)(2006-5#1)(2007-10#1)(2007-11#8)(2007-12#23)(2007-2#1)(2007-4#1)(2007-5#2)(2007-6#2)(2007-8#2)(2007-9#1)(2008-1#7)(2008-10#1)(2008-11#7)(2008-12#9)(2008-2#13)(2008-3#20)(2008-4#6)(2008-5#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-9#3)(2010-10#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#7)(2012-1#4)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#8)(2013-7#10)
writing&quot##2##1##(2008-1#1)(2009-4#1)
writing-beam##3##1##(2007-11#2)(2008-2#1)
writing-to-learn activities##2##2##(2006-12#2)
writing-to-learn##3##1##(2006-12#3)
writings of##6##2##(2007-9#1)(2008-10#1)(2008-12#1)(2008-9#1)(2012-12#1)(2012-2#1)
writings on the subject##2##4##(2008-7#1)(2011-2#1)
writings on the##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
writings##19##1##(1994-3#1)(2007-5#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-7#2)(2008-9#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
written about the##10##3##(1992-1#1)(1994-8#1)(2006-3#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-10#1)
written about##23##2##(1991-3#1)(1992-1#1)(1994-8#1)(1995-3#1)(2005-2#1)(2006-3#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-11#3)(2008-12#1)(2009-4#2)(2010-10#1)(2011-1#1)(2012-2#2)(2013-8#1)
written after##2##2##(1996-1#1)(2009-4#1)
written and##8##2##(1992-12#1)(1994-12#1)(1996-11#1)(2007-4#1)(2008-2#1)(2008-8#1)(2010-3#1)(2012-2#1)
written as the##2##3##(2008-10#1)(2013-7#1)
written as##6##2##(2008-10#2)(2008-2#1)(2008-3#1)(2013-1#1)(2013-7#1)
written at a##4##3##(2008-12#1)(2008-2#1)(2013-7#2)
written at##7##2##(2008-12#3)(2008-2#1)(2008-8#1)(2013-7#2)
written by a##2##3##(1992-2#1)(2008-2#1)
written by exposure##2##3##(2007-12#2)
written by the##2##3##(2006-11#1)(2013-1#1)
written by two-wave mixing in a cerium-doped potassium sodium strontium barium niobate##2##12##(2008-3#2)
written by##25##2##(1992-2#1)(1992-6#1)(1996-5#1)(2006-11#1)(2006-9#1)(2007-10#1)(2007-12#3)(2007-5#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#1)
written compliance##2##2##(2006-8#1)(2007-1#1)
written composition##3##2##(2012-1#3)
written consent##2##2##(2006-9#1)(2013-1#1)
written directives for##2##3##(1992-3#1)(2009-4#1)
written directly##2##2##(2007-12#1)(2008-2#1)
written documentation##2##2##(2007-2#2)
written down##2##2##(1991-9#1)(1993-3#1)
written during##2##2##(2007-5#1)(2010-7#1)
written examination in##2##3##(2012-1#2)
written examination##5##2##(2011-2#1)(2012-1#4)
written for the##3##3##(2008-10#2)(2008-8#1)
written for##11##2##(1991-12#1)(2006-2#1)(2007-2#6)(2008-10#2)(2008-8#1)
written form##2##2##(2007-4#1)(2010-9#1)
written from##4##2##(1996-5#1)(2005-7#1)(2006-11#1)(2008-1#1)
written in English##3##3##(1993-6#1)(2008-6#1)(2013-1#1)
written in Visual Basic##2##4##(2008-10#2)
written in a##2##3##(1992-8#1)(2007-2#1)
written in an##3##3##(2007-12#1)(2008-3#2)
written in order to##3##4##(1994-3#2)(2008-11#1)
written in the##5##3##(1990-12#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-3#1)
written in this##3##3##(1991-2#1)(2007-11#2)
written in##65##2##(1990-12#1)(1991-2#1)(1992-8#1)(1993-6#1)(1994-3#2)(1996-11#1)(1996-12#1)(1997-3#1)(2007-11#7)(2007-12#9)(2007-2#1)(2007-4#1)(2007-5#2)(2007-6#1)(2008-1#5)(2008-10#10)(2008-11#1)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2010-5#1)(2011-2#1)(2011-7#1)(2013-1#3)
written information about the##2##4##(1990-8#1)(1992-8#1)
written information##3##2##(1990-2#1)(1990-8#1)(1992-8#1)
written informed consent##3##3##(2008-7#1)(2010-4#1)(2011-2#1)
written instructions in##2##3##(1991-9#1)(2011-2#1)
written instructions##3##2##(1991-9#1)(2004-10#1)(2011-2#1)
written into a##2##3##(2007-12#1)(2008-3#1)
written into##6##2##(2007-12#2)(2007-2#1)(2008-11#1)(2008-3#1)(2012-1#1)
written language##5##2##(2007-9#1)(2008-9#1)(2009-7#1)(2009-9#1)(2012-1#1)
written materials##2##2##(1996-5#1)(2008-4#1)
written on how##2##3##(2005-9#1)(2007-4#1)
written on the##4##3##(1994-2#1)(2008-1#1)(2008-5#1)(2010-2#1)
written on##10##2##(1994-2#1)(2005-9#1)(2007-12#3)(2007-4#1)(2008-1#1)(2008-5#1)(2010-2#1)(2013-7#1)
written onto##4##2##(2008-3#4)
written or##2##2##(1996-12#1)(2007-2#1)
written over##2##2##(2007-11#1)(2008-3#1)
written policies##2##2##(1991-4#1)(2007-9#1)
written policy##2##2##(2008-1#1)(2008-4#1)
written program##2##2##(2008-10#1)(2008-12#1)
written protocol for sedation##2##4##(2008-8#2)
written protocol for##3##3##(2007-7#1)(2008-8#2)
written questionnaire was##2##3##(2006-10#1)(2007-2#1)
written questionnaire##5##2##(2006-10#1)(2007-2#2)(2010-10#1)(2010-8#1)
written statements##2##2##(2005-7#1)(2006-7#1)
written summaries##2##2##(1992-12#1)(1993-2#1)
written survey##3##2##(1995-12#1)(1996-3#1)(2012-1#1)
written surveys##2##2##(2007-10#1)(2009-9#1)
written text##2##2##(2008-11#1)(2010-1#1)
written to##7##2##(1993-6#1)(2007-11#1)(2007-6#1)(2007-9#1)(2010-8#1)(2011-2#2)
written using##3##2##(2006-12#1)(2008-10#1)(2013-7#1)
written with the##2##3##(2006-5#1)(2013-8#1)
written with##7##2##(1996-12#1)(1997-6#1)(2005-4#1)(2006-5#1)(2008-10#1)(2008-3#1)(2013-8#1)
written works##2##2##(2007-5#2)
written##410##1##(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#2)(1991-9#2)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#3)(1993-12#1)(1993-2#4)(1993-3#2)(1993-5#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-1#4)(1996-11#2)(1996-12#3)(1996-3#1)(1996-5#5)(1997-3#1)(1997-5#1)(1997-6#2)(2004-10#2)(2005-11#1)(2005-2#1)(2005-4#1)(2005-7#2)(2005-9#1)(2006-10#1)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#11)(2007-12#20)(2007-2#15)(2007-3#1)(2007-4#6)(2007-5#6)(2007-6#6)(2007-7#1)(2007-8#64)(2007-9#7)(2008-1#12)(2008-10#23)(2008-11#9)(2008-12#7)(2008-2#11)(2008-3#20)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#2)(2009-12#1)(2009-2#1)(2009-4#5)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#5)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#12)(2011-7#1)(2012-1#12)(2012-12#1)(2012-2#3)(2013-1#6)(2013-7#7)(2013-8#3)
written/updated##3##1##(2012-12#3)
wrong about##2##2##(2006-4#1)(2012-2#1)
wrong and##3##2##(1991-4#1)(1996-11#1)(2008-1#1)
wrong in##4##2##(1992-10#2)(1997-1#1)(2008-4#1)
wrong results##2##2##(2007-12#1)(2008-10#1)
wrong to talk about##2##4##(2012-3#2)
wrong to##7##2##(1997-8#1)(2007-10#1)(2007-4#2)(2012-1#1)(2012-3#2)
wrong way to##2##3##(1991-3#1)(1991-5#1)
wrong with the##2##3##(1997-4#1)(2008-4#1)
wrong with##7##2##(1994-12#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-11#2)(2008-4#1)
wrong##79##1##(1991-3#2)(1991-4#2)(1991-5#2)(1992-10#2)(1992-11#1)(1993-5#1)(1994-1#2)(1994-12#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-8#2)(2005-10#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-4#3)(2007-6#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#3)(2008-4#3)(2008-5#3)(2009-10#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-8#1)(2011-2#3)(2012-1#3)(2012-12#1)(2012-2#3)(2012-3#4)(2013-8#2)
wrong&quot##2##1##(1993-3#1)(2010-7#1)
wrong?##3##1##(2004-12#1)(2009-12#1)(2011-2#1)
wrongdoing in##2##2##(2012-12#2)
wrongdoing##6##1##(1996-11#1)(2007-7#1)(2011-1#1)(2012-12#3)
wrongful birth and wrongful life##3##5##(2004-12#2)(2007-2#1)
wrongful birth##5##2##(2004-12#2)(2006-6#1)(2007-2#2)
wrongful conception##2##2##(2005-12#2)
wrongful termination##2##2##(1995-12#1)(1997-5#1)
wrongful##14##1##(1991-12#1)(1995-12#1)(1995-6#1)(1997-5#1)(2004-12#4)(2005-12#2)(2006-6#1)(2007-2#3)
wrongly attributed to##2##3##(1991-12#1)(1993-4#1)
wrongly##14##1##(1990-3#1)(1991-12#1)(1993-4#1)(1993-9#1)(1995-11#1)(1996-9#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-1#1)(2008-1#1)(2008-7#1)(2012-2#1)
wrongs##3##1##(1991-12#1)(2007-4#1)(2010-8#1)
wrote a##4##2##(1991-3#1)(1994-3#2)(2005-10#1)
wrote about##2##2##(1992-6#1)(2007-9#1)
wrote in##2##2##(2008-1#1)(2009-4#1)
wrote the##2##2##(2008-11#1)(2011-2#1)
wrote this##2##2##(2008-1#1)(2011-2#1)
wrote##24##1##(1991-3#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-3#3)(2005-10#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-7#1)(2009-4#2)(2011-2#3)(2012-10#1)(2012-12#1)(2013-1#1)
wrought##4##1##(2009-7#2)(2012-1#1)(2012-2#1)
ws##2##1##(2008-11#2)
wt % Pd##2##3##(2004-9#2)
wt %##12##2##(2004-9#6)(2008-10#1)(2008-12#1)(2010-4#4)
wt %)##4##2##(1991-4#1)(2004-9#1)(2009-2#1)(2010-9#1)
wt and##3##2##(1990-5#1)(1995-5#1)(2007-1#1)
wt of##7##2##(1995-12#1)(2007-1#2)(2008-10#2)(2008-5#1)(2008-6#1)
wt per##2##2##(1996-2#1)(2007-8#1)
wt##154##1##(1990-11#1)(1990-3#2)(1990-5#3)(1991-1#1)(1991-3#5)(1991-4#3)(1992-10#2)(1992-2#1)(1992-4#2)(1992-5#4)(1992-7#1)(1992-8#3)(1993-11#1)(1993-12#1)(1993-4#4)(1993-6#1)(1993-7#2)(1994-11#2)(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#4)(1995-6#1)(1996-2#1)(1996-5#1)(1997-3#1)(2004-4#2)(2004-9#7)(2005-11#3)(2007-1#4)(2007-12#2)(2007-5#10)(2007-8#3)(2008-10#22)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#7)(2008-6#5)(2008-9#1)(2009-12#3)(2009-2#1)(2009-8#1)(2010-1#2)(2010-4#4)(2010-9#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#10)(2013-8#2)
wt% and##2##2##(2008-5#1)(2009-7#1)
wt% of##4##2##(1990-2#1)(1997-5#1)(2005-11#1)(2008-5#1)
wt%##34##1##(1990-2#1)(1997-5#1)(2004-8#2)(2004-9#1)(2005-11#9)(2008-10#3)(2008-5#6)(2009-10#1)(2009-11#2)(2009-7#2)(2010-8#1)(2012-2#1)(2013-8#4)
wt%) and##2##2##(2005-11#1)(2012-1#1)
wt%) for##2##2##(1997-8#2)
wt%) in##2##2##(2008-5#1)(2010-8#1)
wt%)##20##1##(1997-8#2)(2005-11#1)(2007-5#1)(2008-10#1)(2008-5#5)(2010-8#1)(2012-1#7)(2012-2#1)(2013-8#1)
wt) for##3##2##(2007-5#1)(2008-10#1)(2008-11#1)
wt)##11##1##(1991-11#1)(1991-3#1)(1993-4#1)(1996-9#2)(2007-5#1)(2008-10#1)(2008-11#3)(2013-1#1)
wt-p53 in##2##2##(1997-7#2)
wt-p53##7##1##(1993-11#2)(1997-7#5)
wt/wt##3##1##(2008-10#1)(2008-5#2)
wt/wt)##2##1##(2008-10#2)
wt/wt/wt##3##1##(2008-10#3)
wtSSB##2##1##(1997-2#2)
wtih##2##1##(1994-6#2)
wtip##3##1##(2012-12#3)
wurtzite structure with##2##3##(2009-2#1)(2010-4#1)
wurtzite structure##3##2##(2007-12#1)(2009-2#1)(2010-4#1)
wv/wv mice##4##2##(1996-12#4)
www##28##1##(2005-7#1)(2005-9#1)(2006-6#3)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-3#1)(2008-7#7)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-3#1)
x &lt##12##2##(1990-4#1)(1996-5#1)(2008-2#1)(2008-3#1)(2008-5#6)(2010-4#2)
x (1 -##2##3##(2008-10#1)(2011-2#1)
x )##2##2##(1992-5#1)(2008-11#1)
x +/-##3##2##(1993-5#1)(1995-1#1)(2009-4#1)
x 0##32##2##(1990-8#1)(1996-3#1)(1996-6#2)(1997-7#1)(1997-8#1)(2005-12#4)(2006-5#4)(2006-8#1)(2007-11#3)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2011-1#2)(2012-12#1)
x 1 m##2##3##(2007-5#1)(2011-2#1)
x 1##22##2##(1991-12#1)(1997-8#2)(2005-11#1)(2006-12#1)(2006-5#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
x 1)##2##2##(1993-3#1)(1996-7#1)
x 10 mg/kg##4##3##(1996-10#4)
x 10##33##2##(1990-12#1)(1990-7#1)(1992-3#1)(1993-10#1)(1993-2#1)(1993-9#1)(1994-6#1)(1995-12#1)(1996-10#4)(1997-7#1)(2004-4#1)(2006-4#1)(2007-1#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#1)(2010-4#1)(2010-5#2)
x 10(-)(3) M)##2##3##(1997-7#2)
x 10(-)(3)##4##2##(1997-7#4)
x 10(-1) mol 1(-1)##3##4##(2008-10#3)
x 10(-1) mol##4##3##(2008-10#4)
x 10(-1)##9##2##(1992-12#1)(1993-3#1)(2008-10#6)(2008-4#1)
x 10(-10) M##10##3##(1990-8#1)(1991-12#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-11#1)(1995-12#1)(1996-3#1)(2008-10#2)
x 10(-10) M)##2##3##(1991-5#1)(1995-5#1)
x 10(-10) and##2##3##(1995-11#1)(2008-3#1)
x 10(-10) cm(-1) Hz(-1/2)##2##4##(2008-3#2)
x 10(-10) mol l(-1)##2##4##(2008-10#2)
x 10(-10) mol##3##3##(2008-10#2)(2013-8#1)
x 10(-10) to##3##3##(2005-11#2)(2008-10#1)
x 10(-10)##35##2##(1990-8#1)(1991-12#1)(1991-5#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-11#3)(1995-12#1)(1995-5#1)(1996-3#1)(2005-11#4)(2005-4#1)(2007-12#2)(2008-10#6)(2008-2#6)(2008-3#3)(2013-8#1)
x 10(-10)M##2##2##(1994-6#1)(2008-10#1)
x 10(-10)mol##2##2##(2008-10#2)
x 10(-11) M##3##3##(1991-9#1)(2008-10#1)(2008-11#1)
x 10(-11) mol 1(-1) (AdS-DPV)##2##5##(2008-10#2)
x 10(-11) to 1 x##2##5##(2008-10#1)(2008-2#1)
x 10(-11) to 1##3##4##(2008-10#1)(2008-2#1)(2010-7#1)
x 10(-11) to##5##3##(1990-2#1)(2008-10#2)(2008-2#1)(2010-7#1)
x 10(-11)##15##2##(1990-2#1)(1990-3#1)(1991-9#1)(1995-11#1)(2005-12#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#2)(2010-7#1)
x 10(-12) to##2##3##(2008-10#1)(2008-2#1)
x 10(-12)##8##2##(1991-5#1)(1991-9#1)(1995-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)
x 10(-13)##3##2##(1990-12#1)(1997-3#1)(2008-3#1)
x 10(-14)##3##2##(2008-2#1)(2008-3#2)
x 10(-15)##4##2##(1997-3#1)(1997-5#1)(2007-12#2)
x 10(-16)##4##2##(2007-12#2)(2008-3#2)
x 10(-17) W/ radicalHz##2##4##(2008-2#1)(2008-3#1)
x 10(-17) mol##2##3##(1995-1#1)(1997-3#1)
x 10(-17)##5##2##(1995-1#1)(1997-3#1)(2007-12#1)(2008-2#1)(2008-3#1)
x 10(-18) mole of##2##4##(1996-8#2)
x 10(-18) moles of InsP3##2##5##(1990-10#2)
x 10(-18) moles##3##3##(1990-10#3)
x 10(-18)##8##2##(1990-10#3)(1996-8#3)(2008-11#1)(2008-12#1)
x 10(-19) cm(2)##2##3##(2008-3#2)
x 10(-19) mol##2##3##(1992-1#1)(1997-3#1)
x 10(-19)##6##2##(1990-10#1)(1992-1#1)(1997-3#1)(2008-3#3)
x 10(-2) M##3##3##(2007-8#1)(2008-10#2)
x 10(-2) and##2##3##(1991-2#1)(2008-5#1)
x 10(-2) mol##3##3##(1993-8#2)(2008-10#1)
x 10(-2) per Sv for the##2##6##(1996-6#2)
x 10(-2) per Sv##4##4##(1996-6#4)
x 10(-2)##26##2##(1991-2#2)(1992-9#2)(1993-3#2)(1993-8#2)(1995-10#2)(1996-6#4)(1997-2#1)(1997-8#1)(2004-12#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-5#1)(2009-6#1)(2010-4#1)
x 10(-2))##5##2##(2005-11#2)(2008-10#3)
x 10(-2)M)##2##2##(1991-7#1)(2008-10#1)
x 10(-2)mol##2##2##(2008-10#2)
x 10(-20) cm(2)##5##3##(2008-2#3)(2008-3#2)
x 10(-20)##6##2##(2008-2#3)(2008-3#2)(2009-5#1)
x 10(-23)##2##2##(2007-8#1)(2008-3#1)
x 10(-24)##3##2##(2005-11#3)
x 10(-3 )mm2/s##2##3##(2006-1#2)
x 10(-3) (Q##3##3##(1990-2#3)
x 10(-3) M##2##3##(1992-6#1)(2004-9#1)
x 10(-3) cm(-1)##4##3##(2005-4#2)(2008-3#2)
x 10(-3) for##3##3##(1993-3#2)(2008-10#1)
x 10(-3) in##3##3##(2006-12#1)(2008-2#1)(2008-3#1)
x 10(-3) kg m(-1) s(-1)##2##5##(2008-7#2)
x 10(-3) mg/L for##4##4##(2008-10#4)
x 10(-3) min-1##2##3##(1990-7#2)
x 10(-3) mol l(-1)##4##4##(2008-10#4)
x 10(-3) mol##5##3##(2007-8#1)(2008-10#4)
x 10(-3) s-1##4##3##(1992-6#1)(1994-5#1)(1995-11#2)
x 10(-3) sr(-1) for the##2##5##(2008-3#2)
x 10(-3) sr(-1)##3##3##(2008-3#3)
x 10(-3)##60##2##(1990-2#3)(1990-7#2)(1990-8#1)(1991-12#1)(1992-6#2)(1993-3#2)(1993-8#1)(1994-5#1)(1995-1#1)(1995-11#2)(1996-2#1)(1997-2#1)(2004-12#1)(2004-9#1)(2005-4#3)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#11)(2008-2#8)(2008-3#12)(2008-7#3)
x 10(-3)) was##3##3##(1993-8#1)(2006-12#1)(2008-4#1)
x 10(-3))##4##2##(1993-8#1)(2006-12#2)(2008-4#1)
x 10(-3)M##2##2##(2008-10#2)
x 10(-3)mol##2##2##(2008-10#2)
x 10(-4 )pg/cell##2##3##(2008-11#2)
x 10(-4) M and##2##4##(1991-8#1)(2008-2#1)
x 10(-4) M for the##2##5##(1990-11#2)
x 10(-4) M##15##3##(1990-11#2)(1991-12#1)(1991-8#1)(1992-8#2)(1995-3#1)(2005-11#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)
x 10(-4) M)##3##3##(1993-11#1)(2011-2#2)
x 10(-4) and 1##2##4##(2006-12#1)(2008-11#1)
x 10(-4) and##9##3##(1996-5#1)(2006-12#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)
x 10(-4) cm(-1) at##2##4##(2008-2#2)
x 10(-4) cm-1##2##3##(1996-7#2)
x 10(-4) days l-1 (S##2##5##(1993-8#2)
x 10(-4) for##5##3##(1993-3#2)(2008-10#1)(2008-3#2)
x 10(-4) m(-1) [Appl##2##4##(2008-2#2)
x 10(-4) m(-1)##3##3##(2008-2#3)
x 10(-4) mg aragonite per mm(2) of pellet at##2##9##(2008-10#2)
x 10(-4) mg##4##3##(2008-10#4)
x 10(-4) mol##4##3##(2005-11#1)(2007-8#1)(2008-10#2)
x 10(-4) mol/l##2##3##(1997-8#1)(2008-10#1)
x 10(-4) molL(-1)##2##3##(2007-10#2)
x 10(-4) rad##2##3##(2008-3#2)
x 10(-4) s(-1)##3##3##(2008-2#2)(2010-7#1)
x 10(-4) s-1 for##2##4##(1992-6#2)
x 10(-4) s-1##3##3##(1992-6#2)(1993-3#1)
x 10(-4) standard liters/s##2##4##(2008-2#2)
x 10(-4) with##2##3##(2008-3#2)
x 10(-4)##96##2##(1990-11#2)(1990-8#1)(1991-12#1)(1991-8#1)(1992-6#2)(1992-8#2)(1993-11#1)(1993-3#4)(1993-8#2)(1994-3#1)(1994-5#1)(1995-1#1)(1995-11#2)(1995-3#1)(1996-12#2)(1996-4#2)(1996-5#1)(1996-7#2)(1997-2#1)(1997-8#1)(2005-11#3)(2006-12#1)(2006-5#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-8#3)(2008-1#1)(2008-10#13)(2008-11#3)(2008-2#16)(2008-3#13)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#2)
x 10(-4))##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
x 10(-4)M range in##3##4##(2008-10#3)
x 10(-4)M##7##2##(2008-10#7)
x 10(-4)molL(-1)##2##2##(2007-10#1)(2008-10#1)
x 10(-4)moll(-1)##5##2##(2008-10#5)
x 10(-40) cm6/s##2##3##(2008-3#2)
x 10(-5) M and##3##4##(1992-6#1)(1994-3#1)(2008-10#1)
x 10(-5) M or greater##2##5##(1994-5#2)
x 10(-5) M##13##3##(1991-2#1)(1991-8#1)(1992-6#2)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#2)(1997-1#1)(2007-8#1)(2008-10#2)
x 10(-5) M)##8##3##(1995-10#1)(1995-11#1)(1995-6#1)(1996-10#2)(1997-5#2)(2004-12#1)
x 10(-5) and##3##3##(1996-3#1)(2008-10#1)(2008-3#1)
x 10(-5) days l-1)##2##4##(1993-8#2)
x 10(-5) ml/s/g dry wt##2##5##(1993-7#2)
x 10(-5) mol l(-1)##3##4##(2007-8#1)(2008-10#2)
x 10(-5) mol##6##3##(1996-5#1)(2007-8#2)(2008-10#3)
x 10(-5) s-1##2##3##(1995-5#2)
x 10(-5) to 1##4##4##(2008-10#4)
x 10(-5) to 2##4##4##(2005-4#1)(2008-10#3)
x 10(-5) to 5##2##4##(2007-8#1)(2008-10#1)
x 10(-5) to##11##3##(2005-4#1)(2007-8#1)(2008-10#9)
x 10(-5) with a##2##4##(2008-3#1)(2010-1#1)
x 10(-5)##81##2##(1990-8#1)(1991-2#1)(1991-8#1)(1992-6#2)(1993-7#4)(1993-8#3)(1994-11#1)(1994-3#1)(1994-5#2)(1995-10#1)(1995-11#1)(1995-5#2)(1995-6#1)(1996-10#2)(1996-3#2)(1996-5#2)(1997-1#1)(1997-2#1)(1997-5#2)(2004-12#1)(2005-4#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-8#5)(2008-10#17)(2008-2#8)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#2)(2010-1#1)(2010-4#1)
x 10(-5))##3##2##(2008-2#1)(2008-3#1)(2008-4#1)
x 10(-5))-(1##3##2##(2008-10#3)
x 10(-5)-1##2##2##(2008-10#1)(2009-4#1)
x 10(-5)M##5##2##(1995-8#1)(2008-10#4)
x 10(-5)mol l(-1)##2##3##(2008-10#2)
x 10(-5)mol##3##2##(2008-10#3)
x 10(-5)moll(-1)##2##2##(2008-10#2)
x 10(-6) K(-1) and##2##4##(2008-3#2)
x 10(-6) K(-1)##4##3##(2008-3#4)
x 10(-6) M with a detection limit of##2##8##(2007-8#1)(2008-10#1)
x 10(-6) M with##3##4##(1991-5#1)(2007-8#1)(2008-10#1)
x 10(-6) M##15##3##(1990-9#1)(1991-4#1)(1991-5#3)(1991-8#1)(1992-3#1)(1994-3#1)(1994-5#1)(1995-11#1)(1996-12#1)(2007-8#2)(2008-10#2)
x 10(-6) M) and##2##4##(1990-9#1)(1991-5#1)
x 10(-6) M)##11##3##(1990-11#1)(1990-9#3)(1991-5#1)(1992-5#1)(1992-7#1)(1993-11#1)(2004-12#1)(2007-8#1)(2008-10#1)
x 10(-6) and 1##5##4##(1995-11#2)(2008-10#3)
x 10(-6) and 5##2##4##(1993-11#1)(2008-3#1)
x 10(-6) and##8##3##(1993-11#1)(1995-11#2)(2008-10#4)(2008-3#1)
x 10(-6) cm(2) s(-1)##2##4##(2005-11#1)(2010-4#1)
x 10(-6) cm/s for##2##4##(1992-3#2)
x 10(-6) for 10a/b##2##4##(2009-12#2)
x 10(-6) for##5##3##(1993-3#1)(2004-9#1)(2008-3#1)(2009-12#2)
x 10(-6) mol l(-1) for##2##5##(2008-10#2)
x 10(-6) mol l(-1)##5##4##(2008-10#5)
x 10(-6) mol##9##3##(2007-8#1)(2008-10#7)(2013-8#1)
x 10(-6) to 1##5##4##(2007-8#1)(2008-10#4)
x 10(-6) to 4##2##4##(2007-8#1)(2008-10#1)
x 10(-6) to##8##3##(2007-8#2)(2008-10#6)
x 10(-6) was##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
x 10(-6)##88##2##(1990-11#1)(1990-3#1)(1990-8#2)(1990-9#4)(1991-4#1)(1991-5#4)(1991-8#1)(1992-3#3)(1992-5#1)(1992-7#1)(1993-11#2)(1993-3#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-11#3)(1996-12#1)(1996-5#1)(1997-2#1)(1997-8#1)(2004-12#2)(2004-9#1)(2005-11#1)(2006-5#1)(2007-12#1)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#22)(2008-2#2)(2008-3#9)(2008-5#1)(2009-11#1)(2009-12#4)(2010-4#1)(2013-8#1)
x 10(-6)-1 x 10(-4)M##2##4##(2008-10#2)
x 10(-6)-1 x##4##3##(2008-10#4)
x 10(-6)-1##6##2##(2008-10#6)
x 10(-6)-2 x 10(-4)M range in##2##6##(2008-10#2)
x 10(-6)-2 x 10(-4)M##3##4##(2008-10#3)
x 10(-6)M for##2##3##(2008-10#2)
x 10(-6)M with##2##3##(2008-10#2)
x 10(-6)M##10##2##(1996-1#2)(2008-10#7)(2008-4#1)
x 10(-6)M)##2##2##(1991-7#1)(2008-10#1)
x 10(-6)mol L(-1)##3##3##(2008-10#3)
x 10(-6)mol l(-1)##3##3##(2008-10#3)
x 10(-6)mol##6##2##(2008-10#6)
x 10(-6)mug ml(-1) for##2##4##(2008-10#2)
x 10(-7) - 5 x 10(-6) M)##2##7##(1990-9#1)(2004-12#1)
x 10(-7) -##3##3##(1990-9#2)(2004-12#1)
x 10(-7) M##10##3##(1990-10#1)(1990-11#2)(1990-2#1)(1993-8#1)(1995-11#1)(1995-6#1)(2008-10#3)
x 10(-7) M)##11##3##(1992-5#1)(1992-7#2)(1993-11#2)(1994-12#2)(1994-2#1)(1995-10#1)(2008-4#1)(2011-2#1)
x 10(-7) Torr##2##3##(2008-9#2)
x 10(-7) and##2##3##(2007-8#1)(2008-10#1)
x 10(-7) cm x s(-1)##2##5##(2010-1#2)
x 10(-7) cm(-1)##2##3##(2008-3#1)(2013-8#1)
x 10(-7) cm(2)/V##3##3##(2010-4#3)
x 10(-7) mol L(-1)##2##4##(2007-8#1)(2008-10#1)
x 10(-7) mol l(-1) for##3##5##(2008-10#3)
x 10(-7) mol l(-1)##7##4##(2008-10#7)
x 10(-7) mol##12##3##(2007-8#1)(2008-10#11)
x 10(-7) to 2##2##4##(2008-10#1)(2010-1#1)
x 10(-7) to##15##3##(2004-9#1)(2007-8#1)(2008-10#11)(2008-3#1)(2010-1#1)
x 10(-7)##73##2##(1990-10#1)(1990-11#2)(1990-2#1)(1990-8#1)(1990-9#2)(1992-5#1)(1992-7#2)(1993-11#2)(1993-8#1)(1994-12#2)(1994-2#1)(1995-10#1)(1995-11#1)(1995-6#1)(1997-5#1)(2004-12#1)(2004-9#2)(2007-8#3)(2008-10#27)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-9#3)(2010-1#3)(2010-4#3)(2011-2#1)(2013-8#1)
x 10(-7))##2##2##(2008-4#2)
x 10(-7)M for##4##3##(2008-10#4)
x 10(-7)M##9##2##(1990-11#1)(2008-10#8)
x 10(-7)mol L(-1) and##3##4##(2008-10#3)
x 10(-7)mol l(-1)##2##3##(2008-10#2)
x 10(-7)mol##5##2##(2008-10#5)
x 10(-8) M CXB##2##4##(2008-10#2)
x 10(-8) M and##3##4##(1992-5#1)(1995-1#1)(2008-10#1)
x 10(-8) M##17##3##(1991-5#1)(1992-5#2)(1992-8#1)(1993-11#1)(1993-2#1)(1995-1#2)(1995-5#1)(1997-4#1)(2007-8#1)(2008-10#6)
x 10(-8) M) but##2##4##(1993-4#2)
x 10(-8) M)##6##3##(1991-7#1)(1992-7#1)(1993-4#2)(2007-8#1)(2008-10#1)
x 10(-8) cm(2)/W##2##3##(2008-3#2)
x 10(-8) g ml(-1)##3##4##(2008-10#3)
x 10(-8) mol L(-1) for Pb##2##6##(2007-8#2)
x 10(-8) mol L(-1) for##3##5##(2007-8#3)
x 10(-8) mol##6##3##(2005-4#1)(2007-8#3)(2008-10#2)
x 10(-8) to 1##3##4##(2008-10#2)(2013-8#1)
x 10(-8) to 2##5##4##(1994-12#1)(2007-8#2)(2008-10#2)
x 10(-8) to##11##3##(1994-12#1)(2007-8#3)(2008-10#6)(2013-8#1)
x 10(-8)##59##2##(1991-5#1)(1991-7#1)(1992-5#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-4#2)(1994-12#1)(1995-1#2)(1995-11#1)(1995-5#1)(1997-4#1)(2004-12#1)(2005-4#2)(2006-12#1)(2007-8#8)(2008-10#20)(2008-3#6)(2008-4#1)(2009-11#1)(2010-4#1)(2010-7#1)(2013-8#1)
x 10(-8)M##3##2##(2008-10#3)
x 10(-8)mol L(-1)##3##3##(2007-8#1)(2008-10#2)
x 10(-8)mol/L##2##2##(2008-10#2)
x 10(-9) M and##3##4##(1992-3#1)(1993-2#1)(1995-1#1)
x 10(-9) M for##3##4##(1993-11#1)(1996-11#2)
x 10(-9) M##19##3##(1990-2#1)(1991-5#1)(1992-3#2)(1993-11#2)(1993-2#1)(1994-2#1)(1995-1#2)(1995-11#1)(1995-3#1)(1996-11#2)(1996-5#1)(2008-10#4)
x 10(-9) M)##2##3##(1991-4#1)(1995-3#1)
x 10(-9) and 4##2##4##(2008-10#2)
x 10(-9) and 5##2##4##(1995-11#1)(2008-10#1)
x 10(-9) and##5##3##(1995-11#1)(2008-10#3)(2008-3#1)
x 10(-9) cm(-1)##2##3##(2008-3#2)
x 10(-9) mol/L##2##3##(2007-8#1)(2008-8#1)
x 10(-9) to##3##3##(2008-10#3)
x 10(-9)##47##2##(1990-2#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-3#2)(1992-5#1)(1993-11#2)(1993-2#1)(1994-2#1)(1995-1#3)(1995-11#3)(1995-3#2)(1996-11#2)(1996-5#1)(1997-5#1)(2007-8#1)(2008-10#14)(2008-2#1)(2008-3#5)(2008-8#1)
x 10(-9)/cm##2##2##(2007-12#1)(2008-2#1)
x 10(-9)M##10##2##(1990-10#1)(1990-11#1)(1992-7#1)(1994-6#1)(1996-7#1)(2008-10#5)
x 10(-9)mol##2##2##(2008-10#2)
x 10(-9)molL(-1)##2##2##(2008-10#2)
x 10(1) TCID(50)##3##3##(2009-6#3)
x 10(10) M-1##2##3##(1994-11#1)(1995-8#1)
x 10(10)##13##2##(1991-8#1)(1994-11#1)(1994-12#1)(1995-8#1)(2006-12#1)(2006-5#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-6#1)(2012-3#1)
x 10(11)##6##2##(1997-1#1)(2008-3#1)(2008-8#2)(2010-1#1)(2012-3#1)
x 10(12)##3##2##(2008-3#1)(2008-7#1)(2008-9#1)
x 10(12)/L##2##2##(2006-4#2)
x 10(13)##2##2##(2007-12#1)(2008-2#1)
x 10(16)##3##2##(2004-9#2)(2005-11#1)
x 10(18) cm(-3)##2##3##(2008-3#2)
x 10(2) to##2##3##(2007-8#1)(2009-7#1)
x 10(2)##11##2##(1992-7#1)(1992-9#1)(1996-9#1)(2007-8#3)(2008-10#1)(2008-2#1)(2009-2#1)(2009-3#1)(2009-7#1)
x 10(21)##2##2##(1990-8#1)(1995-11#1)
x 10(3) J/mol)##2##3##(2005-11#2)
x 10(3) M-1 s-1)##2##4##(1995-1#2)
x 10(3) M-1##6##3##(1991-1#1)(1994-12#1)(1994-8#1)(1995-1#2)(1996-5#1)
x 10(3) Pa##6##3##(2008-10#6)
x 10(3) Pa)##2##3##(2008-10#2)
x 10(3) and##3##3##(1996-2#1)(2008-10#2)
x 10(3) cm(-)(1) (epsilon =##2##5##(1997-7#2)
x 10(3) cm(-)(1) )##2##4##(1997-7#2)
x 10(3) cm(-)(1)##5##3##(1997-7#5)
x 10(3) mol##2##3##(2008-5#2)
x 10(3) to##4##3##(1996-2#2)(2008-10#2)
x 10(3)##59##2##(1991-1#1)(1992-12#1)(1992-9#1)(1993-2#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-1#2)(1995-10#1)(1996-12#3)(1996-2#5)(1996-5#2)(1996-8#1)(1997-7#7)(2005-11#2)(2007-12#1)(2007-8#1)(2008-10#20)(2008-3#1)(2008-5#3)(2009-7#1)(2010-4#1)(2012-3#1)
x 10(3)/L)##3##2##(2008-5#3)
x 10(4) 1 mol(-1)##2##4##(2008-10#2)
x 10(4) CFU##2##3##(2008-10#1)(2008-5#1)
x 10(4) L##2##3##(2005-4#1)(2008-10#1)
x 10(4) M(-1) s(-1)##3##4##(2005-8#1)(2008-10#1)(2010-5#1)
x 10(4) M(-1)##4##3##(2005-8#1)(2008-10#1)(2008-8#1)(2010-5#1)
x 10(4) M-1 and##3##4##(1994-12#1)(1994-5#2)
x 10(4) M-1 s-1##2##4##(1994-8#2)
x 10(4) M-1##10##3##(1993-1#1)(1993-8#1)(1994-12#1)(1994-5#2)(1994-8#4)(1995-2#1)
x 10(4) M-1s-1##2##3##(1991-4#2)
x 10(4) and 1##2##4##(1994-12#1)(2010-4#1)
x 10(4) cells##2##3##(1994-3#1)(2008-11#1)
x 10(4) cm(-1)##2##3##(2008-2#2)
x 10(4) cm2 x ml(-1))##2##5##(2010-1#2)
x 10(4) l mol(-1) cm(-1) and##3##6##(2008-10#3)
x 10(4) l mol(-1) cm(-1)##5##5##(2008-10#5)
x 10(4) to 1##2##4##(2010-1#2)
x 10(4) to##3##3##(2008-10#1)(2010-1#2)
x 10(4)##64##2##(1990-4#1)(1990-9#1)(1991-1#1)(1991-4#2)(1992-3#1)(1993-1#1)(1993-2#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-8#4)(1995-1#1)(1995-2#2)(1995-3#1)(1996-11#1)(1997-3#1)(2005-4#3)(2005-8#1)(2007-11#1)(2008-10#18)(2008-11#1)(2008-2#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-1#4)(2010-4#1)(2010-5#1)(2010-6#1)
x 10(4))##6##2##(1991-9#1)(1993-5#1)(1995-2#1)(2006-8#1)(2008-5#2)
x 10(5) 1##2##3##(2008-10#1)(2008-5#1)
x 10(5) CFU/mL##2##3##(2005-11#2)
x 10(5) J mol(-1)##2##4##(2008-3#2)
x 10(5) L x mol(-1) x cm(-1)##3##7##(2005-4#3)
x 10(5) L##4##3##(2005-4#3)(2008-10#1)
x 10(5) M(-1) s(-1)##3##4##(1996-9#1)(2005-8#1)(2009-4#1)
x 10(5) M(-1)##5##3##(1996-9#1)(1997-4#1)(2005-8#1)(2007-8#1)(2009-4#1)
x 10(5) M-1##6##3##(1992-10#1)(1994-11#1)(1995-1#1)(1995-2#1)(1995-5#2)
x 10(5) and 1##2##4##(1994-8#1)(2008-10#1)
x 10(5) and##5##3##(1994-5#1)(1994-8#2)(2008-10#2)
x 10(5) cells ml(-1)##2##4##(2008-10#1)(2008-11#1)
x 10(5) cells per##2##4##(1995-3#1)(2010-6#1)
x 10(5) cells##8##3##(1990-10#1)(1994-3#1)(1995-3#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-6#1)
x 10(5) conidia##2##3##(2008-10#2)
x 10(5) dynes/cm2##2##3##(1993-12#2)
x 10(5) l mol(-1)##2##4##(2006-12#1)(2008-10#1)
x 10(5) ml-1##2##3##(1994-5#2)
x 10(5) sites/cell)##2##3##(1994-8#1)(1996-11#1)
x 10(5) times##3##3##(1995-2#1)(2007-12#1)(2008-3#1)
x 10(5)##88##2##(1990-10#1)(1990-12#1)(1990-4#1)(1990-5#2)(1992-10#1)(1992-11#1)(1993-12#4)(1994-11#1)(1994-12#1)(1994-3#3)(1994-5#4)(1994-8#3)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-9#1)(1996-11#1)(1996-2#2)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#3)(2005-11#2)(2005-4#3)(2005-8#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#18)(2008-11#3)(2008-2#2)(2008-3#6)(2008-5#2)(2008-9#2)(2009-4#1)(2010-4#1)(2010-6#1)(2013-8#1)
x 10(5))##6##2##(1991-9#1)(2008-10#2)(2008-4#1)(2008-5#2)
x 10(5)CFU/ml##2##2##(2008-10#2)
x 10(6) CFU##3##3##(2008-10#3)
x 10(6) CFU/ml of##2##4##(2008-10#2)
x 10(6) IU##3##3##(1990-12#1)(1992-2#1)(2006-6#1)
x 10(6) M(-1)##2##3##(2008-10#1)(2009-4#1)
x 10(6) M(-1)s(-1) and##2##4##(1996-2#2)
x 10(6) M-1 s-1##3##4##(1993-8#1)(1994-5#2)
x 10(6) M-1##11##3##(1991-7#1)(1992-10#1)(1993-1#1)(1993-8#1)(1994-12#1)(1994-5#2)(1994-8#1)(1995-2#3)
x 10(6) M-1)##3##3##(1992-4#3)
x 10(6) U in the##3##5##(1990-8#3)
x 10(6) and 1##4##4##(1994-5#1)(2008-10#1)(2012-2#2)
x 10(6) and##8##3##(1991-1#1)(1991-12#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#2)
x 10(6) c/ml##2##3##(2008-11#2)
x 10(6) cells ml(-1)##8##4##(2008-10#1)(2008-11#5)(2012-2#2)
x 10(6) cells ml(-1))##4##4##(2008-11#3)(2012-2#1)
x 10(6) cells##15##3##(1991-12#1)(1991-8#1)(2008-10#1)(2008-11#9)(2012-2#3)
x 10(6) cells/ml##5##3##(1993-3#1)(2008-11#2)(2008-7#2)
x 10(6) cells/ml)##2##3##(1992-12#1)(1993-3#1)
x 10(6) conidia per##3##4##(2008-10#3)
x 10(6) conidia##4##3##(2008-10#4)
x 10(6) ml(-1)##3##3##(2008-11#3)
x 10(6) ml-1##2##3##(1994-5#2)
x 10(6) to 4##2##4##(1994-5#1)(1994-8#1)
x 10(6) to##4##3##(1994-5#1)(1994-8#1)(1995-11#1)(2008-10#1)
x 10(6) vs##2##3##(1991-12#1)(2008-11#1)
x 10(6)##127##2##(1990-12#2)(1990-8#4)(1990-9#1)(1991-1#3)(1991-12#5)(1991-7#1)(1991-8#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-4#3)(1993-1#1)(1993-12#1)(1993-3#2)(1993-8#1)(1993-9#2)(1994-12#2)(1994-5#6)(1994-8#2)(1995-11#1)(1995-2#3)(1995-9#1)(1996-2#2)(1996-5#1)(1997-6#1)(1997-8#1)(2005-11#2)(2006-10#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#22)(2008-11#19)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#2)(2009-4#1)(2010-4#1)(2010-5#1)(2012-2#8)
x 10(6))##3##2##(2006-10#1)(2008-10#1)(2008-11#1)
x 10(6)/ml##2##2##(1994-12#1)(2006-5#1)
x 10(6)/ml)##2##2##(1992-8#2)
x 10(7) M-1##9##3##(1991-8#1)(1992-11#1)(1992-9#1)(1994-11#1)(1994-8#1)(1995-2#4)
x 10(7) and 3##2##4##(1994-8#2)
x 10(7) and##5##3##(1994-8#2)(2007-12#1)(2007-8#1)(2008-10#1)
x 10(7) cells ml(-1)##6##4##(2008-10#1)(2008-11#5)
x 10(7) cells per ml##2##5##(1994-5#1)(2008-10#1)
x 10(7) cells##9##3##(1994-5#1)(2008-10#2)(2008-11#6)
x 10(7) cells)##2##3##(1991-5#1)(1995-9#1)
x 10(7) cells/g##2##3##(2008-10#2)
x 10(7) conidia per ml)##2##5##(2008-10#2)
x 10(7)##56##2##(1990-8#1)(1991-1#2)(1991-5#1)(1991-8#1)(1992-11#1)(1992-9#1)(1994-11#1)(1994-5#2)(1994-8#3)(1995-1#1)(1995-2#4)(1995-3#1)(1995-9#1)(1996-9#2)(2005-7#1)(2006-4#1)(2007-12#3)(2007-8#1)(2008-10#15)(2008-11#9)(2008-2#1)(2008-7#1)(2008-9#1)(2012-3#1)
x 10(7))##2##2##(1990-12#1)(1995-2#1)
x 10(8) CFU/g of##2##4##(2008-10#2)
x 10(8) CFU/g##3##3##(2007-3#1)(2008-10#2)
x 10(8) M(-1)##2##3##(2008-8#2)
x 10(8) M-1##3##3##(1991-12#1)(1993-1#1)(1994-12#1)
x 10(8) U/mg##2##3##(1990-12#2)
x 10(8) and##2##3##(1990-12#1)(1997-5#1)
x 10(8)##32##2##(1990-12#3)(1990-5#1)(1991-1#1)(1991-12#1)(1991-5#1)(1993-1#1)(1994-12#1)(1994-9#1)(1995-2#1)(1996-2#1)(1997-4#1)(1997-5#1)(2006-5#1)(2007-11#2)(2007-12#2)(2007-3#1)(2008-10#7)(2008-11#1)(2008-8#3)(2008-9#1)
x 10(9) M-1 s-1##3##4##(1992-7#2)(1995-8#1)
x 10(9) M-1##4##3##(1992-7#2)(1995-2#1)(1995-8#1)
x 10(9) cells in the##2##5##(2008-11#2)
x 10(9) cells##4##3##(2008-10#1)(2008-11#3)
x 10(9) dm(3) mol(-1) s(-1)##2##5##(2006-10#1)(2010-5#1)
x 10(9) s(-1)##2##3##(2008-8#2)
x 10(9)##25##2##(1990-11#2)(1992-7#2)(1995-2#1)(1995-8#1)(1997-5#1)(2006-10#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-2#1)(2010-4#1)(2010-5#1)
x 10(9)/L or more##2##4##(1992-8#1)(2011-2#1)
x 10(9)/L##5##2##(1992-8#1)(2007-10#1)(2011-12#1)(2011-2#2)
x 10(9)/L)##2##2##(2007-2#1)(2011-2#1)
x 10(9)/l##2##2##(1993-1#1)(2010-3#1)
x 10(9)/l)##3##2##(1990-9#2)(2007-12#1)
x 10(9)mol(-1)##2##2##(2008-10#2)
x 10(9)mol(-1))##2##2##(2008-10#2)
x 10-10##2##2##(1995-10#1)(2008-11#1)
x 10-4##2##2##(2010-2#2)
x 10-5##2##2##(1996-3#1)(2008-10#1)
x 100##8##2##(1990-12#1)(1992-12#1)(1992-8#1)(2007-11#1)(2009-11#2)(2011-1#1)(2011-2#1)
x 104 cell/well##2##3##(2007-11#2)
x 105##3##2##(2008-10#1)(2008-11#2)
x 106##2##2##(2007-5#1)(2008-7#1)
x 108##3##2##(2008-10#2)(2008-5#1)
x 109/l##4##2##(2008-10#4)
x 12##5##2##(1994-11#1)(2008-1#1)(2008-10#1)(2010-5#1)(2012-3#1)
x 128##7##2##(1991-2#1)(1997-8#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-7#1)
x 14##2##2##(1996-12#1)(2007-11#1)
x 15 cm##4##3##(2005-12#1)(2008-5#1)(2012-2#2)
x 15##7##2##(2005-12#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-11#1)(2012-2#2)
x 150 mm##2##3##(2005-12#1)(2012-3#1)
x 150##4##2##(2005-12#1)(2007-8#1)(2008-3#1)(2012-3#1)
x 17##2##2##(2006-10#1)(2008-2#1)
x 18##6##2##(1997-1#1)(2008-2#2)(2009-5#1)(2010-6#2)
x 2 cm in size##2##5##(2008-6#1)(2010-6#1)
x 2 cm##10##3##(1994-6#1)(1994-7#1)(2006-10#1)(2008-3#2)(2008-6#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#1)
x 2 m##2##3##(2008-5#2)
x 2 m)##2##3##(2007-3#1)(2007-5#1)
x 2 mm##2##3##(1997-2#1)(2008-3#1)
x 2##66##2##(1993-2#1)(1994-3#1)(1994-6#2)(1994-7#1)(1995-2#1)(1995-4#2)(1995-9#2)(1996-7#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-11#2)(2006-10#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-5#3)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#9)(2008-3#9)(2008-5#2)(2008-6#1)(2010-2#2)(2010-3#2)(2010-5#3)(2010-6#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#3)(2012-2#1)(2013-1#1)
x 20##8##2##(1996-10#1)(2006-5#2)(2006-6#1)(2008-12#1)(2008-8#1)(2012-2#2)
x 200##4##2##(1991-7#1)(1995-8#1)(2008-12#1)(2008-2#1)
x 21##3##2##(2008-3#3)
x 24##3##2##(2008-2#2)(2008-3#1)
x 25##5##2##(2005-4#1)(2008-11#2)(2008-2#1)(2008-3#1)
x 250##2##2##(1993-1#1)(2005-12#1)
x 3 cm##2##3##(2008-12#1)(2009-5#1)
x 3 mm I##3##4##(1991-5#2)(1996-11#1)
x 3 mm##8##3##(1991-5#2)(1996-11#1)(2008-3#3)(2008-5#2)
x 3##32##2##(1990-12#2)(1991-5#2)(1994-2#2)(1996-11#2)(1996-6#1)(1997-3#1)(2005-12#1)(2006-4#1)(2006-5#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-2#3)(2008-3#5)(2008-5#3)(2009-5#1)(2012-12#1)
x 3)##2##2##(1991-2#1)(2006-2#1)
x 30 cm##3##3##(1991-6#1)(2012-2#2)
x 30##4##2##(1990-5#1)(1991-6#1)(2012-2#2)
x 300##2##2##(1995-1#1)(2008-7#1)
x 35##2##2##(2008-5#1)(2011-2#1)
x 4 array of##2##4##(2008-3#2)
x 4 cm##3##3##(2007-11#1)(2008-3#1)(2011-12#1)
x 4 mm##6##3##(1993-2#1)(2007-12#4)(2009-7#1)
x 4##69##2##(1990-12#1)(1990-8#1)(1990-9#1)(1991-5#1)(1992-2#1)(1993-2#2)(1993-9#1)(1994-6#1)(1996-5#2)(1996-6#5)(1996-8#1)(1997-2#1)(1997-3#4)(1997-8#1)(2005-3#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-8#2)(2008-10#8)(2008-2#10)(2008-3#6)(2008-5#1)(2008-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-12#1)(2012-12#1)(2013-8#1)
x 4)##2##2##(1997-8#1)(2008-3#1)
x 40 cm)##2##3##(2008-3#1)(2008-6#1)
x 40##8##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-6#1)(2009-8#1)
x 480##2##2##(2007-12#1)(2008-3#1)
x 4mm##3##2##(2007-12#1)(2008-10#2)
x 5 cm##3##3##(1991-11#1)(2008-12#1)(2008-9#1)
x 5 days) +##2##4##(1992-2#2)
x 5 mm##3##3##(2008-10#1)(2010-4#1)(2013-8#1)
x 5##20##2##(1991-11#1)(1992-2#2)(1994-6#1)(2005-10#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-9#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
x 50 microns##2##3##(1996-5#2)
x 50##4##2##(1996-5#2)(2004-4#1)(2008-12#1)
x 500 mg##4##3##(2006-6#2)(2008-5#2)
x 500##5##2##(1991-7#1)(2006-6#2)(2008-5#2)
x 512##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
x 6##7##2##(2007-12#1)(2008-2#2)(2008-3#2)(2010-5#1)(2011-2#1)
x 63##2##2##(1994-11#2)
x 7##6##2##(1990-2#1)(1993-9#1)(1995-5#1)(2008-3#1)(2010-11#1)(2011-1#1)
x 70##2##2##(2008-12#1)(2009-4#1)
x 75##4##2##(1994-9#2)(2007-8#2)
x 75mum capillary using a nonaqueous solution##2##7##(2008-10#2)
x 8 cm##3##3##(1994-7#1)(2006-10#1)(2012-3#1)
x 8 x##2##3##(2008-3#1)(2011-2#1)
x 8##25##2##(1992-8#1)(1993-9#2)(1994-7#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-2#8)(2008-3#5)(2010-5#2)(2011-2#2)(2012-3#1)
x 8)##2##2##(1991-12#1)(2008-2#1)
x 800 microm##2##3##(2006-5#1)(2008-3#1)
x 800##3##2##(2006-5#1)(2008-2#1)(2008-3#1)
x 9##2##2##(2008-3#1)(2010-5#1)
x 90##3##2##(1990-5#1)(1991-10#1)(2008-3#1)
x = 0##3##3##(2006-4#1)(2007-11#1)(2010-4#1)
x = 2##2##3##(1996-2#2)
x =##12##2##(1995-12#1)(1996-2#5)(2006-4#1)(2007-11#1)(2008-5#1)(2010-4#1)(2010-5#2)
x A##8##2##(1993-11#5)(2008-10#3)
x ADP x Pi##3##4##(1997-4#3)
x ADP##4##2##(1997-4#4)
x AlF4-##3##2##(1997-4#3)
x B37HtN##2##2##(2008-10#2)
x BMR##3##2##(2008-9#3)
x BeFx and##2##3##(1997-4#2)
x BeFx##3##2##(1997-4#3)
x C##6##2##(1993-11#2)(2008-10#2)(2008-12#1)(2008-6#1)
x CO(2)##4##2##(2004-4#4)
x Co##2##2##(2010-5#2)
x Co)##2##2##(2010-5#2)
x D##4##2##(2008-10#3)(2010-2#1)
x G##2##2##(2008-10#1)(2008-9#1)
x H2O##2##2##(2005-4#2)
x HCl##5##2##(2007-11#2)(2008-4#3)
x Hor2596##3##2##(2008-10#3)
x L##3##2##(2008-10#2)(2013-8#1)
x L(-1) and##2##3##(2005-4#1)(2007-5#1)
x L(-1) was##2##3##(2005-11#1)(2013-8#1)
x L(-1)##35##2##(2005-11#1)(2005-12#2)(2005-4#9)(2007-5#14)(2008-6#1)(2011-3#4)(2013-8#4)
x L(-1))##7##2##(2007-10#2)(2011-3#5)
x Landrace##2##2##(2008-9#1)(2010-4#1)
x MIC##3##2##(2012-2#3)
x MX169##3##2##(2008-10#3)
x Mn)##2##2##(2010-5#2)
x N##6##2##(2008-2#3)(2008-3#3)
x O(3))##2##2##(2004-4#2)
x P##11##2##(2008-10#9)(2008-5#2)
x Pi##4##2##(1997-4#4)
x SP##5##2##(2008-10#5)
x Self-Portrait Display##2##3##(2008-7#2)
x TBE##2##2##(2006-12#2)
x Tex6##6##2##(2008-10#6)
x age +##2##3##(2008-3#2)
x age##4##2##(1991-10#1)(1997-5#1)(2008-3#2)
x age-0##2##2##(2007-8#2)
x ananassa##3##2##(2008-10#3)
x and y##9##3##(2007-11#1)(2007-12#1)(2007-4#1)(2008-2#3)(2008-3#2)(2008-5#1)
x and##14##2##(1992-8#1)(2007-11#1)(2007-12#3)(2007-4#1)(2008-2#3)(2008-3#4)(2008-5#1)
x beta hCG##2##3##(1994-12#2)
x beta pLH##2##3##(1994-12#2)
x beta##4##2##(1994-12#4)
x cardiac##2##2##(2007-8#2)
x cerebrovascular co-morbidity (c-index=0##2##4##(2007-8#2)
x cm(-2)##2##2##(2011-3#2)
x cultivar interaction##2##3##(2008-10#2)
x cultivar##3##2##(2008-10#3)
x day##7##2##(2006-8#3)(2008-11#4)
x domestica##2##2##(2008-10#2)
x environment##2##2##(2008-10#2)
x extended resection+1##2##3##(2007-8#2)
x extended##3##2##(2007-8#3)
x g supernatant##2##3##(1992-2#1)(1994-11#1)
x g##8##2##(1990-5#1)(1991-1#1)(1991-3#1)(1992-2#1)(1992-8#1)(1993-7#1)(1994-11#1)(1994-12#1)
x g(-1)##2##2##(2005-4#1)(2013-8#1)
x g(av) pellet##2##3##(1992-11#2)
x h(-1) x##2##3##(2005-11#1)(2011-3#1)
x h(-1)##3##2##(2005-11#1)(2008-5#1)(2011-3#1)
x h)##3##2##(2008-5#1)(2008-6#2)
x human##3##2##(1991-12#1)(1994-3#2)
x in##2##2##(1993-12#1)(2010-2#1)
x is a##2##3##(1992-9#1)(1997-2#1)
x is the##2##3##(2008-10#1)(2008-2#1)
x is##7##2##(1992-9#1)(1997-2#2)(2008-10#2)(2008-2#2)
x kg(-1) and##5##3##(2011-3#1)(2013-8#4)
x kg(-1)##13##2##(2006-10#1)(2011-3#2)(2013-8#10)
x mL(-1) for ethinylestradiol##2##4##(2011-3#2)
x mL(-1) for gestodene and etonogestrel and##2##7##(2011-3#2)
x mL(-1) for##4##3##(2011-3#4)
x mL(-1)##8##2##(2005-4#3)(2011-3#4)(2013-8#1)
x mL(-1))##2##2##(2007-10#1)(2011-3#1)
x mg##3##2##(1992-1#1)(1996-5#2)
x min##2##2##(2008-5#1)(2011-3#1)
x min(-1) and##2##3##(1997-5#1)(2013-8#1)
x min(-1) could##2##3##(2008-3#1)(2013-8#1)
x min(-1) x mg protein(-1)##2##5##(1996-5#2)
x min(-1) x##4##3##(1996-5#2)(2011-3#2)
x min(-1)##15##2##(1996-5#2)(1997-5#1)(2008-3#4)(2008-6#1)(2011-3#4)(2012-3#1)(2013-8#2)
x mol(-1)##6##2##(2005-4#4)(2006-10#2)
x p##2##2##(1995-12#1)(2008-3#1)
x rat##2##2##(1997-2#1)(2008-4#1)
x ray##2##2##(2008-2#2)
x rays are##2##3##(2008-3#2)
x rays in the##3##4##(2007-12#1)(2008-3#2)
x rays in##5##3##(2007-12#1)(2008-3#4)
x rays##23##2##(2007-11#3)(2007-12#4)(2008-2#4)(2008-3#12)
x s-1##4##2##(1991-7#1)(1993-8#3)
x shift##2##2##(2008-10#1)(2008-2#1)
x susceptible##2##2##(2008-10#2)
x time##2##2##(1996-6#1)(2013-1#1)
x time)##2##2##(1996-6#1)(2008-5#1)
x to##2##2##(1992-2#1)(1995-1#1)
x tremuloides Michx##2##3##(2006-11#2)
x##2613##1##(1990-10#9)(1990-11#10)(1990-12#16)(1990-2#8)(1990-3#5)(1990-4#3)(1990-5#6)(1990-6#1)(1990-7#3)(1990-8#18)(1990-9#11)(1991-1#9)(1991-10#4)(1991-11#2)(1991-12#13)(1991-2#6)(1991-3#1)(1991-4#4)(1991-5#14)(1991-6#2)(1991-7#9)(1991-8#9)(1991-9#5)(1992-1#2)(1992-10#2)(1992-11#5)(1992-12#4)(1992-2#7)(1992-3#10)(1992-4#3)(1992-5#6)(1992-6#6)(1992-7#8)(1992-8#12)(1992-9#6)(1993-1#5)(1993-10#1)(1993-11#15)(1993-12#6)(1993-2#8)(1993-3#14)(1993-4#2)(1993-5#2)(1993-7#7)(1993-8#16)(1993-9#12)(1994-11#9)(1994-12#19)(1994-2#4)(1994-3#12)(1994-5#25)(1994-6#8)(1994-7#2)(1994-8#16)(1994-9#5)(1995-1#17)(1995-10#6)(1995-11#22)(1995-12#7)(1995-2#25)(1995-3#6)(1995-4#2)(1995-5#8)(1995-6#3)(1995-8#5)(1995-9#5)(1996-1#2)(1996-10#7)(1996-11#6)(1996-12#9)(1996-2#19)(1996-3#7)(1996-4#2)(1996-5#19)(1996-6#14)(1996-7#5)(1996-8#7)(1996-9#4)(1997-1#4)(1997-2#13)(1997-3#12)(1997-4#25)(1997-5#11)(1997-6#3)(1997-7#15)(1997-8#10)(2004-1#1)(2004-12#10)(2004-4#13)(2004-8#4)(2004-9#8)(2005-10#1)(2005-11#31)(2005-12#12)(2005-3#1)(2005-4#49)(2005-7#2)(2005-8#2)(2006-1#2)(2006-10#13)(2006-11#2)(2006-12#12)(2006-2#1)(2006-3#2)(2006-4#6)(2006-5#21)(2006-6#5)(2006-8#8)(2007-1#4)(2007-10#24)(2007-11#34)(2007-12#58)(2007-2#2)(2007-3#6)(2007-4#3)(2007-5#20)(2007-8#64)(2007-9#2)(2008-1#11)(2008-10#588)(2008-11#64)(2008-12#15)(2008-2#146)(2008-3#212)(2008-4#24)(2008-5#54)(2008-6#14)(2008-7#27)(2008-8#16)(2008-9#20)(2009-10#2)(2009-11#6)(2009-12#8)(2009-2#11)(2009-3#2)(2009-4#7)(2009-5#3)(2009-6#6)(2009-7#3)(2009-8#2)(2010-1#13)(2010-11#1)(2010-12#2)(2010-2#7)(2010-3#3)(2010-4#19)(2010-5#26)(2010-6#5)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#9)(2011-12#2)(2011-2#23)(2011-3#26)(2012-12#9)(2012-2#19)(2012-3#13)(2013-1#3)(2013-7#2)(2013-8#33)
x((3))##4##1##(2007-12#4)
x(-)##3##1##(2008-11#3)
x(EtOH) = 0##2##3##(2005-11#2)
x(EtOH)##3##1##(2005-11#3)
x)##7##1##(1992-5#1)(1994-11#1)(1996-5#1)(2008-10#1)(2009-10#2)(2011-2#1)
x-##3##1##(2008-10#1)(2010-5#1)(2012-3#1)
x-axis##3##1##(2010-12#2)(2013-8#1)
x-irradiation##2##1##(1991-8#1)(1994-8#1)
x-linked##5##1##(1992-4#1)(2007-10#1)(2007-2#1)(2010-12#1)(2012-12#1)
x-p correlation##2##2##(2007-12#2)
x-p##3##1##(2007-12#3)
x-ray CT##2##2##(2007-11#1)(2012-1#1)
x-ray absorptiometry (DXA)##3##3##(2005-7#1)(2006-10#1)(2010-1#1)
x-ray absorptiometry in the##2##4##(2008-4#1)(2008-8#1)
x-ray absorptiometry##11##2##(2005-7#1)(2006-10#2)(2006-9#1)(2007-3#1)(2007-4#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-1#1)
x-ray absorption##6##2##(1993-3#1)(2008-3#1)(2010-4#1)(2012-2#3)
x-ray analysis##4##2##(2008-2#2)(2008-3#1)(2010-4#1)
x-ray and optical##2##3##(2008-2#1)(2012-12#1)
x-ray and##6##2##(2008-1#1)(2008-2#1)(2008-9#1)(2011-12#1)(2011-2#1)(2012-12#1)
x-ray beam##2##2##(2005-7#1)(2008-3#1)
x-ray beams##4##2##(1993-9#1)(2007-11#1)(2008-2#1)(2012-12#1)
x-ray computed##2##2##(1997-5#1)(2011-1#1)
x-ray contrast##3##2##(1994-3#1)(2007-8#1)(2008-10#1)
x-ray crystal structure of the##2##5##(1996-5#1)(1997-4#1)
x-ray crystal structure##3##3##(1996-5#1)(1997-4#1)(2008-5#1)
x-ray crystallographic##4##2##(1991-12#1)(1991-3#1)(1992-4#1)(1994-8#1)
x-ray crystallography##9##2##(1991-6#1)(1992-12#1)(1992-7#1)(1993-11#1)(1994-3#1)(1994-8#1)(1995-8#1)(2008-1#1)(2009-10#1)
x-ray data##2##2##(2008-2#1)(2012-1#1)
x-ray diagnosis of##2##3##(2007-11#1)(2012-12#1)
x-ray diffraction (XRD)##5##3##(2008-10#1)(2008-5#3)(2010-4#1)
x-ray diffraction analysis##3##3##(2008-2#3)
x-ray diffraction and##2##3##(2008-2#1)(2008-5#1)
x-ray diffraction measurements##2##3##(1995-6#1)(2008-3#1)
x-ray diffraction studies##2##3##(1991-7#1)(2007-11#1)
x-ray diffraction##30##2##(1990-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-8#1)(1994-9#1)(1995-6#1)(1997-4#1)(2007-11#4)(2007-12#1)(2008-10#1)(2008-2#5)(2008-3#3)(2008-5#7)(2010-4#1)
x-ray emission##3##2##(2008-2#1)(2010-1#1)(2012-2#1)
x-ray energies##2##2##(2008-3#2)
x-ray energy##3##2##(2008-3#3)
x-ray examination##4##2##(1990-2#1)(1990-9#1)(1996-6#1)(2007-8#1)
x-ray films##4##2##(1990-2#1)(1992-11#1)(2006-8#2)
x-ray findings##3##2##(1992-9#1)(2006-10#1)(2007-11#1)
x-ray fluorescence##2##2##(2008-3#2)
x-ray had##2##2##(1991-4#1)(2013-1#1)
x-ray image##6##2##(2007-11#1)(2008-10#2)(2008-3#1)(2009-5#1)(2010-12#1)
x-ray images were##2##3##(2007-11#1)(2007-4#1)
x-ray images##8##2##(2007-1#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-2#1)(2008-3#3)
x-ray imaging system based on spherically##2##6##(2008-2#2)
x-ray imaging system##3##3##(2008-2#3)
x-ray imaging##11##2##(2008-2#6)(2008-3#1)(2008-8#1)(2010-2#2)(2010-4#1)
x-ray in##3##2##(2007-11#1)(2008-8#1)(2012-3#1)
x-ray laser##9##2##(1990-3#2)(1990-7#1)(1993-5#1)(2007-11#3)(2007-12#1)(2012-2#1)
x-ray lasers##4##2##(1990-3#3)(2007-12#1)
x-ray microanalysis##2##2##(2008-2#2)
x-ray microscope designs##2##3##(2008-3#2)
x-ray microscope##3##2##(2008-3#3)
x-ray microscopy will be##2##4##(2008-2#2)
x-ray microscopy##3##2##(2008-2#3)
x-ray of the##4##3##(1991-6#1)(1993-8#1)(2007-3#1)(2012-12#1)
x-ray optical##5##2##(2007-11#1)(2007-12#2)(2008-2#1)(2012-2#1)
x-ray optics##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
x-ray pencil beam##2##3##(2008-3#1)(2012-12#1)
x-ray photoelectron spectroscopy (XPS)##2##4##(2008-2#1)(2008-5#1)
x-ray photoelectron spectroscopy##7##3##(2007-12#1)(2008-2#5)(2008-5#1)
x-ray photoelectron##9##2##(1993-4#1)(2007-12#1)(2008-2#5)(2008-5#1)(2009-11#1)
x-ray pulse##2##2##(2008-3#2)
x-ray pulses##3##2##(2007-11#3)
x-ray quiz##3##2##(2006-9#1)(2007-11#2)
x-ray radiation##2##2##(2007-11#1)(2008-3#1)
x-ray revealed##5##2##(2007-12#1)(2007-3#1)(2007-8#1)(2010-12#1)(2012-12#1)
x-ray scattering and##2##3##(2008-2#1)(2008-3#1)
x-ray scattering studies##2##3##(1993-7#1)(1995-3#1)
x-ray scattering##11##2##(1993-7#1)(1994-5#1)(1995-3#1)(2008-2#3)(2008-3#1)(2008-5#2)(2009-6#1)(2010-2#1)
x-ray should be##2##3##(1991-4#1)(2007-3#1)
x-ray source and##3##3##(2007-12#1)(2009-5#1)(2012-1#1)
x-ray source##7##2##(2007-11#1)(2007-12#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-1#1)(2012-1#1)
x-ray sources##4##2##(2008-3#3)(2010-1#1)
x-ray spectrometer for laser-fusion experiments##2##5##(2008-2#2)
x-ray spectrometer##4##2##(2008-2#2)(2008-3#1)(2008-5#1)
x-ray specular reflectance##2##3##(2008-2#2)
x-ray streak camera##2##3##(2007-11#2)
x-ray streak##3##2##(2007-11#3)
x-ray structure of##2##3##(1994-3#1)(1995-1#1)
x-ray structure##3##2##(1994-3#1)(1995-1#1)(1997-4#1)
x-ray studies##5##2##(1992-6#1)(2006-8#2)(2007-4#1)(2012-12#1)
x-ray system##2##2##(2007-1#1)(2007-4#1)
x-ray telescope##2##2##(2008-2#1)(2008-3#1)
x-ray##353##1##(1990-12#2)(1990-2#2)(1990-3#5)(1990-7#2)(1990-9#1)(1991-11#1)(1991-12#3)(1991-3#1)(1991-4#3)(1991-5#1)(1991-6#5)(1991-7#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-3#3)(1994-5#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-4#3)(1997-5#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-10#8)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#2)(2007-1#2)(2007-11#37)(2007-12#13)(2007-3#5)(2007-4#4)(2007-8#11)(2007-9#3)(2008-1#2)(2008-10#6)(2008-12#1)(2008-2#42)(2008-3#46)(2008-4#1)(2008-5#14)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#8)(2010-12#6)(2010-2#6)(2010-4#5)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#2)(2012-1#7)(2012-12#10)(2012-2#9)(2012-3#1)(2013-1#2)
x-rayed##3##1##(1992-9#1)(2007-11#1)(2012-2#1)
x-rays and MRI images##2##4##(2007-8#2)
x-rays and##6##2##(1992-6#1)(2007-8#2)(2008-9#1)(2011-1#1)(2012-12#1)
x-rays from##3##2##(2007-7#1)(2007-8#1)(2007-9#1)
x-rays in##3##2##(2007-7#1)(2013-1#2)
x-rays of the##3##3##(2007-11#3)
x-rays were##2##2##(2007-4#1)(2007-7#1)
x-rays##37##1##(1992-6#1)(1995-6#1)(1995-8#1)(1997-4#1)(2005-8#1)(2007-11#7)(2007-12#2)(2007-4#1)(2007-7#6)(2007-8#6)(2007-9#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#3)(2013-1#3)
x-y##3##1##(2006-12#1)(2008-2#2)
x// 1##3##2##(2009-1#3)
x1##2##1##(1995-12#1)(2007-11#1)
x10&amp##3##1##(1996-6#3)
x10(-5)##3##1##(2005-4#1)(2008-2#2)
x10(4) cfu/g##3##2##(2007-2#3)
x10(4) cfu/ml##2##2##(2007-2#2)
x10(4)##6##1##(2007-2#5)(2008-9#1)
x2##2##1##(1995-12#1)(2008-10#1)
x3##4##1##(2007-12#1)(2008-10#2)(2008-11#1)
x4##6##1##(2008-10#4)(2008-4#1)(2013-1#1)
x=0##4##1##(2007-12#1)(2008-10#3)
xa5##5##1##(2008-10#5)
xagP##2##1##(2008-10#2)
xanthan gum##3##2##(2011-1#1)(2012-2#1)(2013-7#1)
xanthan##5##1##(2008-10#2)(2011-1#1)(2012-2#1)(2013-7#1)
xanthanolide##7##1##(2007-1#7)
xanthate##8##1##(2008-10#6)(2008-3#2)
xanthene dye##2##2##(2008-10#2)
xanthene dyes##4##2##(2008-10#1)(2008-3#2)(2010-2#1)
xanthene##7##1##(1993-12#1)(2008-10#3)(2008-3#2)(2010-2#1)
xanthenone##3##1##(1993-12#1)(2008-11#2)
xanthii##3##1##(2008-10#3)
xanthine (IBMX)##2##2##(1993-6#1)(2008-11#1)
xanthine amine congener##2##3##(2007-8#2)
xanthine and hypoxanthine concentrations were##2##5##(1990-4#2)
xanthine and hypoxanthine##4##3##(1990-4#2)(1991-9#1)(2008-5#1)
xanthine and##5##2##(1990-4#2)(1991-9#1)(1997-8#1)(2008-5#1)
xanthine dehydrogenase##5##2##(1991-9#2)(1994-12#2)(1997-4#1)
xanthine derivatives##2##2##(1997-3#1)(2011-2#1)
xanthine oxidase (XO)##4##3##(1996-6#1)(2008-10#1)(2008-11#1)(2010-8#1)
xanthine oxidase activities##2##3##(1990-4#1)(1996-6#1)
xanthine oxidase activity##4##3##(1990-4#2)(1994-9#1)(2007-11#1)
xanthine oxidase and##4##3##(1990-5#1)(1992-12#1)(2008-1#1)(2008-11#1)
xanthine oxidase levels##2##3##(1990-4#2)
xanthine oxidase##43##2##(1990-4#7)(1990-5#1)(1991-12#2)(1991-9#4)(1992-12#1)(1992-3#2)(1992-5#1)(1993-12#2)(1993-6#1)(1994-3#1)(1994-8#3)(1994-9#2)(1996-6#2)(1996-9#2)(2007-1#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-11#3)(2010-11#1)(2010-8#2)
xanthine##81##1##(1990-11#5)(1990-4#10)(1990-5#1)(1991-12#2)(1991-9#8)(1992-12#1)(1992-3#3)(1992-5#1)(1992-8#1)(1993-12#4)(1993-6#2)(1994-12#2)(1994-3#2)(1994-8#5)(1994-9#3)(1995-12#1)(1996-6#2)(1996-9#3)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#3)(2007-1#1)(2007-11#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#4)(2008-5#2)(2010-11#1)(2010-8#2)(2011-1#1)(2011-2#1)
xanthines##5##1##(1990-10#1)(1990-5#2)(1992-2#1)(2008-4#1)
xanthoastrocytoma##8##1##(2007-12#2)(2008-12#2)(2008-7#3)(2013-8#1)
xanthobilirubin methyl ester##3##3##(1997-8#3)
xanthobilirubin##4##1##(1997-8#4)
xanthogranuloma##4##1##(2009-9#4)
xanthogranulomatous pyelonephritis##3##2##(2008-1#1)(2013-1#2)
xanthogranulomatous##5##1##(1991-8#2)(2008-1#1)(2013-1#2)
xanthoma##7##1##(1993-8#1)(1996-3#1)(2007-7#1)(2012-2#1)(2012-3#3)
xanthomas##6##1##(1993-10#1)(1997-8#3)(2007-7#1)(2013-8#1)
xanthomatosis and##2##2##(2007-8#2)
xanthomatosis##6##1##(1991-5#1)(2006-10#1)(2007-7#2)(2007-8#2)
xanthomatous changes##2##2##(2007-12#1)(2012-3#1)
xanthomonads##6##1##(1990-3#1)(2008-10#5)
xanthomonas strains##2##2##(2008-10#2)
xanthomonas##4##1##(2008-10#4)
xanthone##5##1##(2006-12#3)(2010-2#1)(2010-5#1)
xanthones from##2##2##(2009-3#2)
xanthones##15##1##(2006-12#5)(2007-1#1)(2008-11#1)(2009-3#8)
xanthophores##3##1##(2008-5#3)
xanthophyll carotenoids##2##2##(2008-12#2)
xanthophyll##7##1##(1995-2#1)(2008-12#5)(2008-9#1)
xanthophylls in##2##2##(1990-4#1)(2008-12#1)
xanthophylls##6##1##(1990-4#2)(2008-12#4)
xanthorrhiza##2##1##(1996-9#2)
xanthosine 5'-monophosphate##2##2##(1994-11#1)(1995-3#1)
xanthosine 5'-triphosphate##2##2##(1994-9#2)
xanthosine##9##1##(1994-11#1)(1994-9#2)(1995-3#1)(1997-2#2)(2009-12#3)
xanthus##2##1##(1991-11#2)
xc- activity##3##2##(1992-6#3)
xc-##4##1##(1992-6#4)
xcFGFR-1 from tryptic cleavage##2##4##(1994-8#2)
xcFGFR-1##4##1##(1994-8#4)
xcmc##2##1##(2005-11#2)
xcolumbiana##5##1##(2008-10#5)
xemilofiban##3##1##(2008-5#3)
xeno-endothelial cells##2##2##(2008-8#2)
xenobiotic compounds##3##2##(2005-11#1)(2005-12#2)
xenobiotic metabolism##4##2##(1990-3#1)(1996-3#1)(2010-5#1)(2013-1#1)
xenobiotic metabolizing enzymes##2##3##(1993-11#1)(2008-10#1)
xenobiotic metabolizing##3##2##(1993-11#1)(2008-10#1)(2010-12#1)
xenobiotic##27##1##(1990-3#2)(1991-8#1)(1993-11#1)(1993-2#1)(1996-3#1)(1997-2#1)(1997-8#1)(2005-11#1)(2005-12#2)(2006-12#1)(2007-6#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
xenobiotic-metabolizing enzymes##2##2##(1995-9#1)(2010-2#1)
xenobiotic-metabolizing##7##1##(1990-5#1)(1990-7#1)(1991-9#1)(1995-3#2)(1995-9#1)(2010-2#1)
xenobiotics and##7##2##(1992-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#1)
xenobiotics for##2##2##(2006-12#1)(2008-10#1)
xenobiotics in the##6##3##(1990-6#1)(2008-10#1)(2008-11#3)(2010-9#1)
xenobiotics in##11##2##(1990-6#1)(1993-2#2)(1994-3#1)(2008-10#1)(2008-11#5)(2010-9#1)
xenobiotics##48##1##(1990-3#1)(1990-6#1)(1992-12#2)(1993-2#3)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1996-3#1)(1997-8#1)(2006-12#1)(2008-10#6)(2008-11#11)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#5)(2010-9#2)(2012-2#2)
xenodontics##2##1##(2008-6#2)
xenogeneic##10##1##(1995-11#1)(2005-8#1)(2007-11#1)(2011-2#3)(2012-3#3)(2013-7#1)
xenogenic##4##1##(2008-12#1)(2008-4#2)(2012-1#1)
xenograft MGMT activity##2##3##(1994-11#2)
xenograft in nude mice##5##4##(1993-9#1)(1995-4#2)(1997-7#1)(2010-12#1)
xenograft in##9##2##(1993-9#1)(1995-4#2)(1997-7#1)(2007-8#3)(2008-6#1)(2010-12#1)
xenograft model of##2##3##(2008-8#1)(2010-3#1)
xenograft model##4##2##(1993-7#1)(1995-8#1)(2008-8#1)(2010-3#1)
xenograft models##6##2##(2009-4#1)(2011-1#3)(2011-2#1)(2012-2#1)
xenograft rejection##6##2##(2005-7#1)(2007-11#5)
xenograft with##2##2##(1996-4#1)(2007-8#1)
xenograft##55##1##(1992-1#1)(1993-11#2)(1993-7#1)(1993-9#6)(1994-11#2)(1995-4#2)(1995-8#1)(1996-4#1)(1997-7#1)(2005-7#1)(2007-11#5)(2007-8#11)(2008-6#2)(2008-8#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#3)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-8#1)
xenografted##7##1##(1993-9#1)(2008-11#3)(2012-12#1)(2013-1#2)
xenografting##2##1##(2008-6#1)(2008-9#1)
xenografts expressing##2##2##(2004-1#1)(2009-9#1)
xenografts following##2##2##(1994-11#1)(1997-7#1)
xenografts in athymic mice##2##4##(1993-9#1)(1997-7#1)
xenografts in mice##3##3##(2012-12#2)(2013-1#1)
xenografts in nude mice##4##4##(1993-7#1)(2008-6#1)(2008-8#1)(2011-11#1)
xenografts in##13##2##(1993-7#1)(1993-9#1)(1997-7#1)(2005-7#1)(2008-6#3)(2008-8#1)(2011-11#1)(2012-12#2)(2013-1#1)(2013-7#1)
xenografts of##2##2##(2008-4#1)(2008-5#1)
xenografts was##2##2##(1993-7#1)(1994-11#1)
xenografts were##4##2##(1993-11#1)(1997-7#2)(2009-3#1)
xenografts with##2##2##(1994-11#1)(1997-7#1)
xenografts##55##1##(1991-6#2)(1993-11#2)(1993-4#1)(1993-7#2)(1993-9#1)(1994-11#4)(1994-3#1)(1994-6#2)(1995-2#1)(1995-3#2)(1995-4#1)(1997-7#8)(2004-1#2)(2005-7#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-8#1)(2009-3#3)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-11#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
xenon capillary discharge##2##3##(2007-12#2)
xenon gas##2##2##(2007-12#1)(2008-3#1)
xenon ions##2##2##(2006-2#1)(2007-11#1)
xenon lamp##3##2##(2007-11#1)(2008-10#2)
xenon plasma##2##2##(2008-3#2)
xenon##31##1##(1991-9#1)(1995-3#2)(2006-1#1)(2006-2#1)(2007-11#3)(2007-12#3)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#2)(2010-12#4)(2011-12#1)(2012-1#2)
xenon-129##2##1##(1995-3#1)(2006-1#1)
xenotransplant##2##1##(1997-7#1)(2007-11#1)
xenotransplantation##10##1##(1995-11#3)(2005-7#2)(2007-11#2)(2008-1#1)(2008-7#1)(2011-2#1)
xenotransplants##2##1##(1992-9#2)
xenotropic##3##1##(1990-5#1)(1992-9#1)(2011-2#1)
xenovorans LB400 in##2##3##(2011-12#2)
xenovorans LB400##6##2##(2011-12#6)
xenovorans##7##1##(2011-12#7)
xeroderma pigmentosa##3##2##(2007-7#3)
xeroderma pigmentosum (XP) group A##2##5##(1993-8#1)(1997-4#1)
xeroderma pigmentosum (XP)##3##3##(1993-8#1)(1997-4#1)(2008-8#1)
xeroderma pigmentosum complementation group E##2##5##(1991-3#2)
xeroderma pigmentosum group##2##3##(1994-7#1)(2009-3#1)
xeroderma pigmentosum##16##2##(1991-3#2)(1991-6#1)(1993-8#1)(1994-7#1)(1997-4#1)(2005-11#6)(2007-8#2)(2008-8#1)(2009-3#1)
xeroderma##19##1##(1991-3#2)(1991-6#1)(1993-8#1)(1994-7#1)(1997-4#1)(2005-11#6)(2007-7#3)(2007-8#2)(2008-8#1)(2009-3#1)
xerodermoid##2##1##(2007-7#2)
xerogel##3##1##(1990-3#1)(2007-8#2)
xerogels as##3##2##(1990-3#1)(2010-5#2)
xerogels##12##1##(1990-3#2)(2005-11#5)(2007-8#1)(2008-2#2)(2010-5#2)
xeromorphic##2##1##(2012-9#1)(2013-7#1)
xerophthalmia and##2##2##(2006-10#1)(2007-7#1)
xerophthalmia##7##1##(1991-8#3)(2006-10#3)(2007-7#1)
xerosis and##2##2##(2008-5#2)
xerosis##19##1##(1991-12#3)(1991-8#1)(2008-5#14)(2010-9#1)
xerostomia and##2##2##(2007-9#1)(2013-1#1)
xerostomia##13##1##(1993-9#1)(2006-10#2)(2007-7#1)(2007-9#6)(2008-5#1)(2011-12#1)(2013-1#1)
xerotic skin##7##2##(2008-5#7)
xerotic##8##1##(2008-5#8)
xi##6##1##(2007-12#1)(2008-3#5)
xii##2##1##(1990-11#1)(1990-8#1)
ximelagatran##5##1##(2007-10#3)(2008-1#2)
xipamide##3##1##(1990-11#1)(1991-8#1)(1992-11#1)
xis and int##2##3##(1990-9#1)(1997-1#1)
xis##3##1##(1990-9#1)(1997-1#2)
xiv##3##1##(1990-11#1)(1990-3#1)(1990-8#1)
xlcaax-1 protein##3##2##(1991-9#3)
xlcaax-1##5##1##(1991-9#5)
xor##2##1##(2008-2#1)(2008-3#1)
xorIIM homolog##2##2##(2008-10#2)
xpolyantha##2##1##(2008-10#2)
xrFNDI##2##1##(2008-4#2)
xrs-6##3##1##(1995-1#1)(1996-2#2)
xth nth nfo##2##3##(1991-10#2)
xuefu zhuyu##3##2##(2012-3#1)(2013-8#2)
xvi##4##1##(1990-11#1)(1990-6#1)(1990-9#2)
xviii##3##1##(1990-11#1)(1990-3#1)(1990-6#1)
xylE and lacZ reporter genes##2##5##(1993-11#2)
xylE and lacZ##3##3##(1990-5#1)(1993-11#2)
xylE and##4##2##(1990-5#1)(1993-11#2)(1994-12#1)
xylE gene##2##2##(1990-5#1)(1994-12#1)
xylE##14##1##(1990-5#2)(1990-9#5)(1993-11#2)(1994-12#5)
xylan and##5##2##(1990-3#1)(2008-5#2)(2011-1#1)(2013-1#1)
xylan fragments##2##2##(2006-8#1)(2008-5#1)
xylan hydrolysis in##3##3##(2013-1#3)
xylan hydrolysis##4##2##(2013-1#4)
xylan##35##1##(1990-3#1)(1990-4#1)(2006-8#7)(2008-5#9)(2008-8#2)(2011-1#6)(2013-1#9)
xylanase activity##5##2##(2006-8#3)(2008-10#1)(2008-6#1)
xylanase and endoglucanase##2##3##(2005-12#2)
xylanase and##5##2##(1990-1#1)(2005-12#2)(2008-6#2)
xylanase cDNA##3##2##(1995-1#3)
xylanase from C##2##3##(1990-4#1)(1991-7#1)
xylanase from alkalothermophilic Bacillus sp##2##5##(1993-3#2)
xylanase from##7##2##(1990-4#1)(1991-7#1)(1993-3#2)(2006-8#1)(2008-10#1)(2008-5#1)
xylanase genes##2##2##(2008-10#1)(2013-1#1)
xylanase partition coefficient##2##3##(2008-6#2)
xylanase produced##2##2##(1995-1#1)(2008-6#1)
xylanase productivity##3##2##(2008-6#3)
xylanase titers were##2##3##(2008-5#2)
xylanase##55##1##(1990-1#4)(1990-4#1)(1991-7#1)(1993-3#3)(1995-1#7)(2005-12#5)(2006-8#6)(2008-10#4)(2008-5#6)(2008-6#14)(2011-2#1)(2013-1#1)(2013-8#2)
xylanases and##2##2##(2011-2#1)(2013-1#1)
xylanases from##3##2##(2006-8#1)(2008-6#1)(2013-1#1)
xylanases were##2##2##(1995-1#1)(2008-6#1)
xylanases##11##1##(1995-1#1)(2006-8#2)(2008-10#1)(2008-6#3)(2011-2#1)(2013-1#3)
xylanolytic bacterium##2##2##(2008-8#2)
xylanolytic##8##1##(2006-8#2)(2008-10#1)(2008-8#2)(2012-2#3)
xylariaceous##2##1##(2008-11#2)
xylazine##11##1##(1993-12#1)(2007-2#1)(2012-3#7)(2013-1#2)
xylem and phloem##4##3##(2008-10#1)(2012-8#3)
xylem and##6##2##(2008-10#2)(2008-11#1)(2012-8#3)
xylem elements##2##2##(2007-12#1)(2008-10#1)
xylem flow##2##2##(2008-11#2)
xylem fluid##2##2##(2008-10#1)(2011-12#1)
xylem of##6##2##(1993-4#1)(2008-10#1)(2008-7#1)(2012-8#3)
xylem parenchyma cells##3##3##(2008-10#1)(2008-11#2)
xylem structure##2##2##(2012-5#2)
xylem vessels and##2##3##(2007-12#1)(2008-10#1)
xylem vessels of##3##3##(2007-12#1)(2008-10#2)
xylem vessels##12##2##(2007-12#2)(2008-10#10)
xylem##58##1##(1993-4#2)(2007-12#3)(2008-10#32)(2008-11#6)(2008-5#1)(2008-7#1)(2009-8#1)(2011-12#1)(2012-5#4)(2012-8#7)
xylem-limited##3##1##(2008-10#3)
xylene and##3##2##(1994-8#1)(2008-10#1)(2010-4#1)
xylene as##3##2##(2008-10#3)
xylene in##2##2##(2008-10#2)
xylene##33##1##(1994-8#1)(2007-11#1)(2008-10#27)(2008-8#3)(2010-4#1)
xylenes and##3##2##(2005-11#1)(2007-10#1)(2008-4#1)
xylenes##8##1##(2005-11#1)(2007-10#2)(2007-8#1)(2008-10#3)(2008-4#1)
xylenol isomers##2##2##(1996-6#2)
xylenol orange (XO)##2##3##(2008-10#2)
xylenol orange##8##2##(2008-10#8)
xylenol##10##1##(1996-6#2)(2008-10#8)
xylitol from##3##2##(2004-8#1)(2008-6#2)
xylitol production by biotechnological##2##4##(2008-6#2)
xylitol production##4##2##(2005-11#2)(2008-6#2)
xylitol was##2##2##(2005-11#1)(2008-5#1)
xylitol##18##1##(1994-8#1)(2004-8#1)(2005-11#6)(2006-2#1)(2008-5#1)(2008-6#7)(2012-2#1)
xylo-oligosaccharides##4##1##(2006-5#2)(2006-8#2)
xyloglucan##11##1##(1996-10#3)(1996-2#1)(1996-4#3)(2006-12#2)(2008-9#1)(2010-5#1)
xylonic acid##3##2##(2008-6#3)
xylophilus##8##1##(2008-10#8)
xyloporosis##4##1##(2008-10#4)
xylose and arabinose##4##3##(2006-8#1)(2008-5#1)(2008-6#1)(2011-1#1)
xylose and##9##2##(2006-8#1)(2008-5#2)(2008-6#4)(2011-1#1)(2012-3#1)
xylose as a sole##2##4##(2008-10#1)(2012-3#1)
xylose fermentation##8##2##(2005-11#3)(2008-5#1)(2008-6#2)(2012-3#2)
xylose recovery##2##2##(2008-5#2)
xylose reductase from##3##3##(1995-8#1)(2008-6#2)
xylose reductase##8##2##(1995-8#2)(2008-6#6)
xylose residues##3##2##(1992-3#3)
xylose strain##2##2##(2008-6#2)
xylose utilization of##2##3##(2012-3#2)
xylose utilization##7##2##(2005-11#1)(2008-5#1)(2008-6#2)(2012-3#3)
xylose was##3##2##(1990-5#1)(2008-6#2)
xylose##94##1##(1990-5#1)(1991-7#2)(1992-3#4)(1993-11#2)(1995-8#3)(1996-4#1)(1996-6#2)(2005-11#5)(2006-12#1)(2006-8#3)(2007-1#1)(2008-10#5)(2008-11#1)(2008-5#13)(2008-6#34)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#11)(2013-1#2)
xylose)##2##1##(2008-5#2)
xylose-fermenting##3##1##(2008-6#3)
xylose-grown cells##2##2##(2006-8#2)
xylosides##2##1##(1996-6#1)(2008-10#1)
xylostella on##2##2##(2011-2#2)
xylostella ranged##2##2##(2007-6#1)(2011-2#1)
xylostella##17##1##(2005-11#1)(2007-6#3)(2010-4#4)(2011-2#9)
xylosyltransferase##3##1##(1991-7#3)
y = 0##5##3##(1993-8#1)(1995-2#3)(2008-10#1)
y =##7##2##(1993-8#1)(1995-2#3)(1995-6#1)(2007-11#1)(2008-10#1)
y and##2##2##(1995-12#1)(2007-4#1)
y axis##2##2##(1993-7#1)(2007-12#1)
y directions##2##2##(2008-2#1)(2008-3#1)
y is##5##2##(1993-9#1)(1995-12#1)(2008-10#2)(2008-11#1)
y##88##1##(1990-12#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-4#1)(1995-12#2)(1995-2#3)(1995-6#1)(1995-7#1)(1997-3#1)(2004-9#1)(2005-1#1)(2006-9#2)(2007-10#1)(2007-11#4)(2007-12#2)(2007-3#2)(2007-4#3)(2007-5#4)(2008-10#9)(2008-11#1)(2008-2#5)(2008-3#8)(2008-5#8)(2008-7#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-5#2)(2011-2#3)(2011-3#1)(2012-12#5)(2012-2#2)(2013-1#2)
y)##9##1##(2008-10#1)(2008-3#1)(2008-6#3)(2008-7#1)(2009-10#2)(2012-2#1)
y-axis##8##1##(1992-12#1)(1995-1#1)(2006-11#2)(2008-10#1)(2010-12#2)(2013-8#1)
y/h in females##2##3##(1990-10#2)
y/h in##3##2##(1990-10#3)
y/o)##4##1##(2011-2#4)
y=1##2##1##(2008-10#2)
yClC-1##2##1##(1994-9#2)
yTAFII145##2##1##(1997-3#2)
yagouaroundi##2##1##(1996-12#1)(2008-5#1)
yak meat##3##2##(2010-4#3)
yak##6##1##(2010-4#6)
yaks (Bos grunniens) with keratoconjunctivitis##2##5##(2011-2#2)
yaks with keratoconjunctivitis##2##3##(2011-2#2)
yaks##11##1##(2011-2#11)
yallundae and T##5##3##(2008-10#5)
yallundae and##6##2##(2008-10#6)
yallundae##13##1##(2008-10#13)
yam##10##1##(1992-1#1)(2008-4#5)(2008-5#4)
yang##4##1##(2008-10#2)(2008-4#1)(2011-1#1)
yanguifella n##2##2##(2013-8#2)
yard waste##5##2##(2008-5#5)
yard##12##1##(2008-10#6)(2008-5#6)
yards##3##1##(2008-10#2)(2013-1#1)
yardstick for##2##2##(1990-12#1)(2007-9#1)
yardstick##4##1##(1990-12#1)(1992-6#1)(2007-9#2)
yaw is unimportant##2##3##(2012-11#2)
yaw##5##1##(2008-2#1)(2008-3#1)(2010-8#1)(2012-11#2)
yawning behavior##2##2##(1993-9#2)
yawning frequency##4##2##(1990-10#3)(1993-9#1)
yawning##9##1##(1990-10#4)(1993-9#3)(2011-12#1)(2011-2#1)
yawning-inducing##2##1##(1993-9#2)
yb##2##1##(2008-3#2)
ybdr##3##1##(2013-1#3)
year (2##2##2##(2007-2#1)(2008-7#1)
year (P &lt##2##3##(2004-11#1)(2004-2#1)
year (P##6##2##(2004-11#1)(2004-2#1)(2010-8#1)(2013-1#3)
year (n =##2##3##(2010-2#1)(2012-12#1)
year (range##2##2##(2006-7#2)
year 1##3##2##(1991-8#2)(2013-1#1)
year 1900##2##2##(1993-3#1)(2007-3#1)
year 1987##2##2##(1991-2#1)(1993-3#1)
year 1991##4##2##(1992-1#1)(1995-12#1)(1997-1#1)(2007-11#1)
year 1994##2##2##(1996-1#1)(1997-3#1)
year 1996##5##2##(1995-6#1)(2006-8#3)(2007-8#1)
year 1997##2##2##(1997-2#1)(2006-10#1)
year 1999##2##2##(2005-7#1)(2012-12#1)
year 2##2##2##(2008-3#1)(2013-1#1)
year 2000##54##2##(1990-2#1)(1991-5#1)(1991-9#1)(1992-3#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-3#3)(1994-9#3)(1995-6#1)(1996-11#1)(1996-2#1)(1997-2#3)(1997-3#3)(1997-6#4)(1997-7#1)(2006-10#3)(2006-4#1)(2006-8#3)(2007-12#1)(2007-3#1)(2007-8#2)(2008-1#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-5#2)(2010-7#1)(2011-1#3)(2012-2#1)(2013-1#1)
year 2000]##2##2##(1993-2#1)(1996-11#1)
year 2001##8##2##(2006-10#1)(2007-6#2)(2007-9#1)(2008-1#1)(2008-5#2)(2008-8#1)
year 2002##5##2##(2006-2#1)(2008-1#1)(2008-10#1)(2008-12#2)
year 2003##4##2##(1990-12#1)(2008-8#1)(2011-1#1)(2011-2#1)
year 2004##6##2##(1990-6#1)(1996-2#2)(2005-11#1)(2010-8#1)(2011-2#1)
year 2005##6##2##(1996-2#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-11#1)(2009-6#1)
year 2007##5##2##(2008-12#1)(2008-9#1)(2009-2#1)(2010-9#1)(2011-2#1)
year 2008##3##2##(2010-3#1)(2010-9#1)(2011-2#1)
year 3##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
year 4##2##2##(2007-4#1)(2013-1#1)
year a##3##2##(1992-6#1)(2005-7#1)(2006-10#1)
year actuarial survival##2##3##(2006-10#1)(2011-2#1)
year actuarial##3##2##(2006-10#1)(2008-8#1)(2011-2#1)
year after a##5##3##(1994-12#1)(2007-10#2)(2010-3#1)(2012-12#1)
year after discharge##4##3##(1993-7#1)(2007-1#1)(2007-9#1)(2008-3#1)
year after drug withdrawal##2##4##(2013-1#2)
year after his##2##3##(1997-6#1)(2010-1#1)
year after initial##2##3##(1997-1#1)(2004-1#1)
year after stroke##2##3##(2007-9#1)(2010-12#1)
year after surgery##12##3##(1990-10#1)(2005-5#3)(2006-11#1)(2007-8#2)(2008-8#2)(2009-1#1)(2010-4#1)(2012-12#1)
year after the initial##2##4##(2013-1#2)
year after the operation##5##4##(1993-2#1)(1994-3#1)(2007-7#1)(2007-8#2)
year after the procedure##2##4##(2008-11#1)(2010-10#1)
year after the second##3##4##(1994-7#1)(2008-6#1)(2009-5#1)
year after the##36##3##(1993-2#1)(1993-9#1)(1994-3#1)(1994-7#1)(1995-4#1)(1996-1#1)(1996-6#1)(1997-1#1)(2005-11#1)(2006-1#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-10#1)(2011-2#2)(2012-1#3)(2012-11#1)(2013-1#4)
year after transplantation##7##3##(2007-11#2)(2007-8#1)(2010-8#1)(2011-2#2)(2012-3#1)
year after treatment##2##3##(2004-1#1)(2008-10#1)
year after year##4##3##(2006-4#1)(2007-2#1)(2008-11#1)(2011-2#1)
year after##118##2##(1990-10#1)(1991-8#1)(1992-10#1)(1992-4#1)(1992-8#1)(1993-2#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-7#1)(1995-10#1)(1995-2#1)(1995-4#1)(1996-1#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-6#1)(2004-1#2)(2005-11#1)(2005-5#3)(2006-1#1)(2006-11#3)(2006-2#1)(2006-4#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#5)(2007-11#4)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#8)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#2)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#3)(2009-5#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#7)(2012-1#4)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#11)
year age group##2##3##(2008-12#2)
year age##3##2##(2007-2#1)(2008-12#2)
year ago##5##2##(1993-3#1)(2006-12#1)(2007-7#2)(2007-8#1)
year among##5##2##(1990-11#2)(2007-2#1)(2007-8#1)(2012-12#1)
year and a half##2##4##(2006-10#1)(2007-3#1)
year and a##3##3##(2006-10#1)(2006-7#1)(2007-3#1)
year and at##2##3##(2008-1#1)(2008-10#1)
year and finally##2##3##(1990-10#1)(2011-2#1)
year and had##2##3##(2007-3#1)(2008-8#1)
year and in##5##3##(2007-11#1)(2007-3#1)(2008-10#1)(2009-9#1)(2010-12#1)
year and location##2##3##(2008-10#2)
year and preferably indefinitely##2##4##(2009-12#2)
year and showed##2##3##(2006-10#1)(2008-10#1)
year and the other##2##4##(1990-12#1)(2008-8#1)
year and the##8##3##(1990-12#1)(1994-7#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-5#2)(2008-8#1)
year and then##3##3##(1995-8#1)(2008-12#1)(2008-8#1)
year and those##2##3##(2006-4#1)(2013-1#1)
year and to##2##3##(1994-7#1)(2006-2#1)
year and were##2##3##(1997-8#1)(2008-12#1)
year and##78##2##(1990-10#1)(1990-12#1)(1990-6#1)(1990-9#1)(1991-2#1)(1992-1#1)(1993-9#2)(1994-3#1)(1994-7#3)(1995-2#2)(1995-8#1)(1997-1#1)(1997-8#1)(2004-11#1)(2005-8#2)(2006-10#4)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#3)(2008-1#3)(2008-10#11)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#2)(2009-6#1)(2009-9#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
year apart##4##2##(1994-12#1)(2008-3#1)(2008-7#1)(2011-1#1)
year are##7##2##(2005-7#1)(2006-10#3)(2007-11#1)(2008-10#1)(2008-8#1)
year as well as##3##4##(2006-10#1)(2008-1#1)(2008-10#1)
year as well##4##3##(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)
year as##6##2##(1992-12#1)(2005-10#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)
year at the##5##3##(2008-1#1)(2008-2#1)(2009-4#1)(2011-2#1)(2013-7#1)
year at##14##2##(1990-11#1)(1997-5#1)(1997-6#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-4#1)(2011-2#1)(2013-1#2)(2013-7#1)
year before the##5##3##(1990-12#1)(1990-2#1)(1994-4#1)(2010-12#1)(2010-8#1)
year before##8##2##(1990-12#1)(1990-2#1)(1991-3#1)(1994-4#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-8#1)
year but##3##2##(1996-12#1)(2006-8#1)(2008-3#1)
year by year##2##3##(2012-3#1)(2013-7#1)
year by##10##2##(1992-3#1)(1994-2#1)(1994-7#1)(1995-11#1)(1996-5#1)(2006-10#1)(2007-5#1)(2012-3#1)(2013-1#1)(2013-7#1)
year compared##3##2##(2007-10#1)(2011-1#1)(2012-12#1)
year duration##3##2##(2007-7#1)(2010-2#1)(2012-2#1)
year during the##5##3##(2006-10#1)(2007-3#1)(2008-1#1)(2008-10#1)(2010-8#1)
year during##9##2##(1992-5#1)(1994-1#1)(2006-10#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#2)(2010-8#1)
year earlier##3##2##(1996-12#1)(2008-11#1)(2011-2#1)
year experience in##2##3##(2006-9#1)(2007-4#1)
year experience##5##2##(2006-9#1)(2007-4#2)(2008-6#1)(2011-2#1)
year follow up##9##3##(1990-9#1)(1991-2#1)(1991-6#1)(1996-6#1)(2006-8#1)(2007-2#1)(2007-8#1)(2013-1#2)
year follow-up of##2##3##(1994-2#1)(2009-7#1)
year follow-up study##2##3##(1995-6#1)(2013-8#1)
year follow-up##21##2##(1991-2#1)(1994-2#1)(1995-6#1)(1997-8#1)(2004-10#1)(2006-2#1)(2006-6#1)(2007-8#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-3#1)(2012-12#3)(2013-1#1)(2013-8#2)
year follow-up]##2##2##(2009-5#1)(2013-1#1)
year following##9##2##(2004-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-6#2)(2008-9#1)(2010-3#1)
year for##21##2##(1991-6#1)(1992-7#1)(1994-12#1)(1996-9#1)(2005-7#1)(2006-8#1)(2007-9#3)(2008-1#2)(2008-10#4)(2008-7#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-7#1)
year from a##2##3##(1993-5#1)(2008-8#1)
year from the##3##3##(1990-7#1)(2007-11#1)(2008-8#1)
year from##15##2##(1990-7#1)(1992-12#1)(1993-5#1)(1996-6#1)(2006-12#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#2)(2009-4#1)(2010-8#1)(2013-8#1)
year groups##2##2##(2006-8#2)
year had a##3##3##(1993-9#2)(2008-10#1)
year had##7##2##(1992-6#1)(1993-9#2)(2008-10#2)(2008-11#1)(2012-12#1)
year has been##2##3##(2008-12#1)(2010-7#1)
year has##16##2##(1996-6#1)(2005-8#1)(2006-10#9)(2006-8#2)(2008-12#1)(2010-5#1)(2010-7#1)
year have been##2##3##(2006-10#1)(2008-8#1)
year have##8##2##(1996-2#1)(2006-10#4)(2008-7#1)(2008-8#1)(2013-8#1)
year history of##10##3##(1994-6#1)(2005-12#2)(2006-12#1)(2007-8#1)(2008-12#1)(2008-7#2)(2010-12#1)(2012-12#1)
year in France##2##3##(1991-11#1)(2012-2#1)
year in a##4##3##(2007-10#1)(2008-10#1)(2008-3#1)(2008-9#1)
year in all##2##3##(2005-7#1)(2006-8#1)
year in operation##2##3##(1994-12#2)
year in review##4##3##(2006-10#1)(2007-12#1)(2007-3#1)(2008-12#1)
year in the US##3##4##(2006-11#1)(2009-8#1)(2010-8#1)
year in the United States##3##5##(2006-11#1)(2008-6#1)(2010-3#1)
year in the area of##2##5##(1993-12#1)(2006-10#1)
year in the##23##3##(1993-10#1)(1993-12#1)(1993-3#1)(1994-7#1)(1995-5#1)(2006-10#4)(2006-11#2)(2006-7#1)(2007-7#3)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-3#1)(2010-8#1)
year in##74##2##(1990-12#2)(1991-11#1)(1991-6#1)(1993-10#1)(1993-12#1)(1993-3#1)(1994-12#2)(1994-3#2)(1994-6#1)(1994-7#1)(1995-1#1)(1995-5#1)(1997-5#1)(1997-8#1)(2005-7#1)(2006-10#9)(2006-11#2)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#2)(2008-10#7)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-3#2)(2010-8#1)(2011-2#4)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
year interval from##2##3##(2010-7#1)(2013-1#1)
year is##7##2##(1993-10#1)(2006-2#1)(2007-10#3)(2007-5#1)(2008-7#1)
year it was##2##3##(2007-7#1)(2008-7#1)
year it##4##2##(1992-12#1)(2007-7#1)(2008-10#1)(2008-7#1)
year later##28##2##(1993-7#1)(1994-12#1)(1996-11#1)(1997-6#1)(1997-7#2)(2005-5#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-12#2)(2007-6#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
year local##2##2##(1996-3#1)(2012-2#1)
year male##3##2##(2008-7#1)(2010-11#1)(2013-8#1)
year medical students at the##3##5##(2008-10#1)(2008-4#2)
year medical students in##2##4##(2009-4#1)(2013-8#1)
year medical students##9##3##(2008-10#1)(2008-11#1)(2008-4#3)(2009-4#1)(2011-1#1)(2013-8#2)
year might##2##2##(1992-8#1)(2010-7#1)
year nursing##3##2##(2007-8#1)(2008-11#1)(2008-12#1)
year of a##4##3##(1995-3#1)(2007-11#1)(2008-11#1)(2008-12#1)
year of age##20##3##(1991-11#1)(1991-6#2)(1992-7#1)(1993-12#1)(1993-5#1)(1995-8#1)(1996-3#1)(2006-7#1)(2008-1#1)(2008-10#1)(2009-4#1)(2010-4#1)(2011-2#5)(2013-1#2)
year of basic##2##3##(1993-11#1)(2006-8#1)
year of birth##9##3##(1991-2#1)(1991-7#1)(1994-5#2)(1996-2#1)(2004-10#1)(2008-3#1)(2008-7#1)(2011-1#1)
year of diagnosis##5##3##(2006-8#1)(2011-1#2)(2011-2#1)(2012-3#1)
year of disease##2##3##(2011-1#2)
year of follow-up##9##3##(1990-5#1)(1995-2#1)(1997-4#1)(2006-9#1)(2007-2#2)(2008-3#1)(2008-8#1)(2013-1#1)
year of life and##5##4##(1992-7#1)(2006-7#1)(2008-1#1)(2008-7#1)(2012-2#1)
year of life in##2##4##(1992-7#1)(2009-4#1)
year of life##54##3##(1991-8#2)(1992-1#1)(1992-7#2)(1993-1#3)(1993-9#2)(1994-2#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#2)(1997-2#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-8#2)(2008-1#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#3)(2009-4#2)(2011-1#2)(2011-12#1)(2012-1#2)(2012-12#3)(2012-2#5)(2013-1#2)
year of operation##3##3##(2006-5#2)(2008-2#1)
year of publication##3##3##(1991-3#1)(2013-1#2)
year of study##3##3##(2005-12#1)(2008-12#1)(2009-7#1)
year of surgery##2##3##(2007-7#1)(2008-9#1)
year of the prospective payment system##2##6##(1991-2#1)(1992-12#1)
year of the##31##3##(1991-2#3)(1991-3#1)(1992-12#2)(1993-11#1)(1993-3#1)(1995-5#1)(1996-12#1)(1996-7#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-2#2)(2013-8#1)
year of their##2##3##(1993-3#1)(2008-11#1)
year of transplantation##3##3##(1995-2#1)(2008-1#1)(2008-4#1)
year of treatment##12##3##(1991-11#1)(2006-6#1)(2007-11#2)(2008-5#1)(2008-8#1)(2009-1#1)(2010-6#1)(2012-3#1)(2013-1#3)
year of##244##2##(1990-11#1)(1990-5#1)(1991-11#2)(1991-2#4)(1991-3#2)(1991-6#2)(1991-7#1)(1991-8#2)(1992-1#2)(1992-12#3)(1992-6#1)(1992-7#4)(1993-1#4)(1993-11#2)(1993-12#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-7#1)(1993-9#3)(1994-12#2)(1994-2#2)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#2)(1996-1#3)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#2)(2004-10#1)(2004-11#1)(2004-9#1)(2005-1#1)(2005-12#1)(2006-10#1)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#6)(2006-9#1)(2007-10#2)(2007-11#5)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#4)(2008-1#5)(2008-10#12)(2008-11#4)(2008-12#5)(2008-2#4)(2008-3#3)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#5)(2009-1#1)(2009-12#1)(2009-3#1)(2009-4#3)(2009-7#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#12)(2011-12#1)(2011-2#12)(2012-1#2)(2012-12#4)(2012-2#7)(2012-3#3)(2012-5#1)(2013-1#15)(2013-8#3)
year offollow up##4##3##(2013-8#4)
year old Caucasian##2##3##(2007-8#1)(2010-2#1)
year old Chinese##2##3##(2008-8#1)(2012-2#1)
year old DS cases##2##4##(1991-1#2)
year old and##2##3##(2007-11#1)(2007-4#1)
year old boy presented with##2##5##(2009-7#1)(2013-8#1)
year old boy with##3##4##(1991-11#1)(2010-8#1)(2012-1#1)
year old boy##12##3##(1991-11#1)(1993-6#1)(1996-6#1)(2005-12#1)(2009-7#1)(2010-10#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-8#1)
year old child who presented with##2##6##(2007-7#1)(2010-5#1)
year old child##8##3##(1993-9#1)(1995-11#1)(2007-4#1)(2007-7#2)(2007-8#1)(2010-5#1)(2012-12#1)
year old children in##2##4##(1992-10#1)(2008-1#1)
year old children##7##3##(1992-1#1)(1992-10#2)(2006-10#2)(2006-8#1)(2008-1#1)
year old female patient who##2##5##(2005-12#1)(2013-8#1)
year old female patient##4##4##(1993-1#1)(2005-12#1)(2010-9#1)(2013-8#1)
year old female presented with##2##5##(2007-7#1)(2012-3#1)
year old female presented##3##4##(2007-7#2)(2012-3#1)
year old female who presented with##2##6##(2007-2#1)(2011-1#1)
year old female with a##3##5##(1993-11#1)(2010-12#1)(2011-2#1)
year old female with##6##4##(1993-11#1)(2006-6#1)(2010-12#2)(2011-2#1)(2012-2#1)
year old female##23##3##(1993-1#1)(1993-11#1)(1993-5#1)(1997-6#1)(2005-12#1)(2006-11#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#2)(2010-12#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
year old gentleman##2##3##(2006-8#1)(2007-8#1)
year old girl who##2##4##(2006-8#1)(2011-12#1)
year old girl##5##3##(2006-8#1)(2007-2#1)(2007-8#1)(2008-7#1)(2011-12#1)
year old lady who##4##4##(2005-1#1)(2007-2#1)(2011-12#1)(2012-2#1)
year old lady with##2##4##(2008-6#1)(2010-12#1)
year old lady##9##3##(2005-1#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-6#1)(2010-12#1)(2011-12#1)(2012-2#1)
year old male child##3##4##(2010-4#1)(2012-2#1)(2013-1#1)
year old male patient##4##4##(1993-8#1)(2005-12#1)(2009-9#1)(2012-2#1)
year old male presented with a##2##6##(2007-11#1)(2008-7#1)
year old male was##2##4##(2011-1#1)(2013-1#1)
year old male who had##2##5##(1994-4#1)(2008-7#1)
year old male who##4##4##(1994-4#1)(2008-7#1)(2012-12#1)(2012-2#1)
year old male with##2##4##(2007-7#1)(2012-3#1)
year old male##25##3##(1993-8#1)(1994-4#1)(1997-6#2)(2005-12#1)(2006-4#2)(2007-11#1)(2007-7#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)
year old man admitted to intensive care with##2##8##(2006-4#2)
year old man admitted to##3##5##(2006-4#3)
year old man presented with##5##5##(1995-6#1)(2006-12#2)(2007-7#1)(2008-7#1)
year old man presented##6##4##(1995-6#1)(2006-12#2)(2007-7#1)(2008-7#1)(2012-2#1)
year old man was##3##4##(2006-12#1)(2013-1#2)
year old man with a##3##5##(1997-6#1)(2006-4#1)(2008-6#1)
year old man with##10##4##(1997-6#1)(2006-4#5)(2007-6#1)(2008-6#1)(2009-8#1)(2013-1#1)
year old man##33##3##(1990-9#1)(1992-9#1)(1993-10#2)(1994-8#1)(1995-6#1)(1997-6#1)(2006-12#3)(2006-4#9)(2006-8#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)
year old patient who presented with##2##6##(2011-1#1)(2012-2#1)
year old patient with##5##4##(1994-5#1)(2010-12#1)(2010-3#1)(2012-12#1)(2012-2#1)
year old patient##11##3##(1994-5#1)(1996-12#1)(2006-12#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
year old population##3##3##(2007-1#1)(2008-4#2)
year old school children##2##4##(2007-2#1)(2012-12#1)
year old subjects##3##3##(1994-6#1)(1996-2#1)(2006-9#1)
year old woman admitted to the##2##6##(2006-4#2)
year old woman admitted to##4##5##(2005-12#1)(2006-4#3)
year old woman is presented##2##5##(1991-5#1)(2007-8#1)
year old woman presented with##3##5##(1990-6#1)(2007-7#1)(2012-3#1)
year old woman was##2##4##(1993-6#1)(2005-12#1)
year old woman with a six##2##6##(2006-4#2)
year old woman with a##4##5##(2006-4#4)
year old woman##30##3##(1990-12#1)(1990-2#2)(1990-6#1)(1991-5#2)(1991-8#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-8#1)(1997-6#1)(2005-11#1)(2005-12#2)(2006-10#1)(2006-4#8)(2007-12#1)(2007-7#1)(2007-8#3)(2012-3#1)
year old women##2##3##(1992-2#1)(1997-4#1)
year old##221##2##(1990-12#1)(1990-2#2)(1990-6#1)(1990-9#2)(1991-1#3)(1991-10#1)(1991-11#2)(1991-12#1)(1991-4#1)(1991-5#2)(1991-8#1)(1992-1#1)(1992-10#2)(1992-2#1)(1992-9#1)(1993-1#1)(1993-10#2)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-6#1)(1997-4#1)(1997-6#5)(2005-1#1)(2005-11#1)(2005-12#5)(2006-10#5)(2006-11#2)(2006-12#5)(2006-4#20)(2006-6#1)(2006-7#1)(2006-8#5)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#1)(2007-2#5)(2007-4#3)(2007-6#1)(2007-7#9)(2007-8#12)(2008-1#2)(2008-10#1)(2008-4#2)(2008-6#2)(2008-7#5)(2008-8#3)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#3)(2011-2#7)(2012-1#2)(2012-12#5)(2012-2#14)(2012-3#5)(2013-1#8)(2013-8#7)
year olds and##3##3##(2006-10#1)(2007-2#2)
year olds was##2##3##(2006-8#1)(2013-8#1)
year olds with##2##3##(1997-6#1)(2006-10#1)
year olds##18##2##(1997-6#1)(1997-8#1)(2006-10#2)(2006-8#1)(2007-2#7)(2009-10#1)(2010-3#1)(2011-2#2)(2013-1#1)(2013-8#1)
year olds)##2##2##(2006-1#1)(2007-12#1)
year on the##2##3##(1991-4#1)(2010-3#1)
year on##13##2##(1991-4#1)(2004-11#1)(2005-10#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-9#1)(2008-10#2)(2009-5#1)(2009-7#1)(2010-3#1)
year or more##4##3##(1990-8#1)(2007-11#1)(2008-9#1)(2012-12#1)
year or##13##2##(1990-10#1)(1990-6#1)(1990-8#1)(1994-3#1)(1995-2#1)(1997-3#1)(2007-11#1)(2007-7#2)(2008-10#2)(2008-9#1)(2012-12#1)
year patient##3##2##(2008-1#1)(2008-8#2)
year period between##2##3##(2007-7#1)(2008-10#1)
year period from##6##3##(2004-10#1)(2006-10#2)(2006-8#1)(2008-1#1)(2010-7#1)
year period of time##2##4##(2008-8#1)(2012-2#1)
year period of##3##3##(2007-2#1)(2008-8#1)(2012-2#1)
year period were##2##3##(1996-12#1)(2007-1#1)
year period##67##2##(1990-2#1)(1990-3#1)(1990-6#1)(1991-3#1)(1991-9#1)(1992-11#2)(1992-9#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-10#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-2#1)(2007-3#1)(2007-7#5)(2007-8#2)(2008-1#2)(2008-10#1)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-7#1)(2010-2#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)
year period]##2##2##(1993-9#1)(2008-10#1)
year population##2##2##(1993-10#1)(2007-7#1)
year post-treatment##2##2##(2008-6#1)(2010-8#1)
year postoperatively##3##2##(1993-2#1)(2009-10#1)(2013-8#1)
year preceding breast cancer diagnosis to##2##6##(2011-2#2)
year preceding##5##2##(2011-2#4)(2013-8#1)
year prior to##5##3##(1990-6#1)(1997-8#1)(2007-10#1)(2007-6#1)(2007-8#1)
year project##2##2##(2007-7#1)(2008-12#1)
year prospective##2##2##(2007-7#1)(2010-7#1)
year regarding##2##2##(2006-10#2)
year results##3##2##(1991-4#1)(2008-3#2)
year retrospective study##2##3##(2008-8#1)(2011-1#1)
year retrospective##3##2##(2008-8#1)(2011-1#2)
year review##3##2##(2007-7#1)(2008-7#1)(2009-10#1)
year risk##2##2##(2008-1#1)(2013-7#1)
year round##5##2##(2005-8#1)(2007-2#1)(2008-5#1)(2009-4#1)(2013-7#1)
year several##2##2##(2006-10#2)
year should##2##2##(2006-3#1)(2008-7#1)
year since the##4##3##(2004-2#1)(2006-8#1)(2007-8#1)(2008-2#1)
year since##8##2##(1993-9#1)(1994-9#1)(2004-2#1)(2006-8#1)(2007-8#1)(2008-2#1)(2010-10#1)(2011-2#1)
year students of##2##3##(1997-3#1)(2013-1#1)
year students##4##2##(1997-3#1)(2008-12#2)(2013-1#1)
year study was conducted##2##4##(2008-5#1)(2011-2#1)
year study was##3##3##(2008-5#1)(2011-1#1)(2011-2#1)
year study##7##2##(2007-7#1)(2008-10#1)(2008-5#2)(2011-1#1)(2011-2#2)
year survival is##2##3##(2007-2#1)(2012-2#1)
year survival rate##5##3##(1990-6#2)(2008-6#2)(2011-2#1)
year survival##11##2##(1990-10#1)(1990-6#2)(1993-1#1)(2007-2#1)(2008-10#1)(2008-6#2)(2011-2#2)(2012-2#1)
year than##5##2##(1996-2#1)(1996-3#1)(2005-10#1)(2006-10#1)(2008-4#1)
year that is##2##3##(2011-2#1)(2012-1#1)
year that##10##2##(1991-4#1)(2006-10#3)(2007-9#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
year the patient##2##3##(1990-10#1)(1993-8#1)
year the##12##2##(1990-10#1)(1990-4#1)(1991-4#1)(1993-8#1)(1996-1#1)(1997-3#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-11#1)(2012-12#1)
year there was a##2##4##(2005-7#1)(2008-10#1)
year there was##3##3##(2005-7#1)(2008-10#1)(2008-12#1)
year there were##2##3##(2006-10#1)(2008-7#1)
year there##6##2##(2005-7#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)
year time##3##2##(2006-8#2)(2012-3#1)
year to year##12##3##(2008-10#4)(2008-12#1)(2008-8#3)(2010-9#1)(2011-2#2)(2013-1#1)
year to##29##2##(1991-12#1)(1992-10#1)(1995-3#1)(1995-6#1)(1996-8#1)(2004-2#1)(2006-2#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#3)(2009-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#1)
year two##2##2##(1997-2#1)(2008-11#1)
year undergraduate students##2##3##(2008-11#1)(2008-12#1)
year use of##3##3##(2008-5#1)(2009-7#1)(2010-2#1)
year using##2##2##(2007-7#1)(2008-3#1)
year was the##2##3##(1991-4#1)(1993-12#1)
year was##25##2##(1991-4#1)(1993-12#1)(1994-5#1)(1996-6#1)(1997-1#1)(1997-4#1)(2005-5#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-2#2)(2007-6#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-8#2)(2011-2#1)(2012-2#1)
year we##3##2##(1997-6#1)(2005-11#1)(2008-10#1)
year were evaluated##2##3##(2008-1#1)(2012-12#1)
year were##17##2##(1990-11#1)(1991-1#1)(1994-2#1)(1994-8#1)(2006-10#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#2)(2009-3#1)(2011-2#1)(2012-12#2)
year when the##2##3##(2005-10#1)(2007-8#1)
year when##8##2##(2005-10#1)(2007-8#1)(2008-10#2)(2008-8#2)(2011-2#1)(2013-7#1)
year with a##4##3##(1994-9#1)(2008-10#2)(2011-1#1)
year with##13##2##(1994-2#1)(1994-3#1)(1994-9#1)(2006-10#1)(2006-2#1)(2007-10#1)(2008-10#4)(2008-5#1)(2011-1#1)(2012-3#1)
year within##3##2##(2008-10#1)(2008-8#1)(2012-11#1)
year without##3##2##(2008-1#1)(2008-10#1)(2012-2#1)
year##2475##1##(1990-10#5)(1990-11#5)(1990-12#11)(1990-2#7)(1990-3#2)(1990-4#1)(1990-5#5)(1990-6#9)(1990-7#1)(1990-8#3)(1990-9#5)(1991-1#7)(1991-10#2)(1991-11#9)(1991-12#5)(1991-2#17)(1991-3#5)(1991-4#10)(1991-5#6)(1991-6#11)(1991-7#1)(1991-8#9)(1991-9#4)(1992-1#8)(1992-10#6)(1992-11#2)(1992-12#12)(1992-2#4)(1992-3#4)(1992-4#1)(1992-5#6)(1992-6#4)(1992-7#7)(1992-8#2)(1992-9#6)(1993-1#8)(1993-10#6)(1993-11#4)(1993-12#9)(1993-2#11)(1993-3#10)(1993-4#1)(1993-5#7)(1993-6#5)(1993-7#3)(1993-8#5)(1993-9#14)(1994-1#3)(1994-12#11)(1994-2#8)(1994-3#19)(1994-4#4)(1994-5#5)(1994-6#6)(1994-7#7)(1994-8#3)(1994-9#8)(1995-1#6)(1995-10#2)(1995-11#2)(1995-12#2)(1995-2#14)(1995-3#4)(1995-4#1)(1995-5#5)(1995-6#11)(1995-7#1)(1995-8#6)(1995-9#2)(1996-1#11)(1996-11#6)(1996-12#19)(1996-2#13)(1996-3#10)(1996-5#6)(1996-6#6)(1996-7#2)(1996-8#6)(1996-9#2)(1997-1#6)(1997-2#9)(1997-3#14)(1997-4#8)(1997-5#6)(1997-6#14)(1997-7#3)(1997-8#7)(2004-1#2)(2004-10#4)(2004-11#8)(2004-12#1)(2004-2#6)(2004-3#2)(2004-8#1)(2004-9#1)(2005-1#2)(2005-10#7)(2005-11#5)(2005-12#9)(2005-5#5)(2005-6#1)(2005-7#14)(2005-8#11)(2005-9#3)(2006-1#4)(2006-10#127)(2006-11#8)(2006-12#9)(2006-2#11)(2006-3#3)(2006-4#31)(2006-5#5)(2006-6#8)(2006-7#13)(2006-8#55)(2006-9#3)(2007-1#6)(2007-10#30)(2007-11#30)(2007-12#16)(2007-2#41)(2007-3#19)(2007-4#15)(2007-5#6)(2007-6#15)(2007-7#62)(2007-8#79)(2007-9#28)(2008-1#41)(2008-10#145)(2008-11#47)(2008-12#49)(2008-2#15)(2008-3#24)(2008-4#23)(2008-5#50)(2008-6#31)(2008-7#53)(2008-8#49)(2008-9#20)(2009-1#2)(2009-10#12)(2009-11#3)(2009-12#4)(2009-2#4)(2009-3#2)(2009-4#19)(2009-5#10)(2009-6#4)(2009-7#11)(2009-8#4)(2009-9#7)(2010-1#7)(2010-10#7)(2010-11#4)(2010-12#19)(2010-2#8)(2010-3#18)(2010-4#7)(2010-5#8)(2010-6#3)(2010-7#11)(2010-8#23)(2010-9#9)(2011-1#52)(2011-12#7)(2011-2#101)(2011-7#1)(2012-1#17)(2012-11#3)(2012-12#48)(2012-2#45)(2012-3#27)(2012-5#1)(2012-6#1)(2013-1#95)(2013-7#10)(2013-8#45)
year's conference##2##2##(2005-9#1)(2008-10#1)
year's literature##2##2##(2006-10#2)
year's meeting##5##2##(2005-6#1)(2005-8#1)(2008-5#1)(2008-7#2)
year's##49##1##(1990-11#2)(1990-2#1)(1991-2#1)(1992-3#1)(1995-2#1)(1995-3#3)(1996-6#1)(2004-12#1)(2005-6#2)(2005-8#2)(2005-9#1)(2006-10#7)(2006-6#2)(2007-6#1)(2007-9#6)(2008-10#6)(2008-5#1)(2008-7#4)(2009-5#1)(2009-6#1)(2010-11#2)(2011-2#2)
year(-1)##2##1##(2008-5#2)
year) and##7##2##(1991-8#1)(2006-7#1)(2007-8#1)(2008-8#1)(2010-3#1)(2011-2#1)(2012-3#1)
year)##34##1##(1991-8#1)(1992-2#1)(1992-7#1)(1992-9#1)(1997-4#1)(1997-8#1)(2004-9#1)(2006-1#1)(2006-7#4)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#2)(2008-7#3)(2008-8#3)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#1)
year- old##4##2##(2007-2#1)(2007-8#2)(2013-1#1)
year-end 2009##7##2##(2011-2#7)
year-end##14##1##(1993-6#1)(2008-12#2)(2011-2#11)
year-old boy with##3##3##(1990-8#1)(2010-10#1)(2011-2#1)
year-old boy##8##2##(1990-8#1)(1992-8#1)(1996-9#1)(2007-8#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-12#1)
year-old child##2##2##(2007-7#1)(2007-8#1)
year-old children##6##2##(1995-8#1)(2009-8#1)(2011-2#3)(2012-12#1)
year-old female patient##2##3##(2005-12#1)(2010-6#1)
year-old female with a##2##4##(1990-5#1)(2007-4#1)
year-old female with##3##3##(1990-5#1)(2007-4#1)(2008-7#1)
year-old female##7##2##(1990-5#1)(2005-12#1)(2006-7#1)(2007-4#1)(2008-7#1)(2010-6#1)(2011-2#1)
year-old group##3##2##(2006-2#1)(2008-7#2)
year-old male patient##2##3##(2007-8#1)(2010-4#1)
year-old male##5##2##(1992-11#1)(2007-8#1)(2010-4#1)(2010-9#2)
year-old man presented##2##3##(2008-4#1)(2008-8#1)
year-old man who presented##2##4##(2008-8#1)(2011-1#1)
year-old man who was##2##4##(2009-8#1)(2011-2#1)
year-old man who##4##3##(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#1)
year-old man with a##2##4##(1992-6#1)(2006-2#1)
year-old man with##6##3##(1990-4#1)(1992-6#1)(2005-11#1)(2006-2#1)(2007-7#1)(2008-7#1)
year-old man##22##2##(1990-4#1)(1990-8#1)(1991-12#1)(1992-6#1)(2005-11#1)(2006-2#1)(2006-8#2)(2007-7#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-7#1)(2009-8#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
year-old patient##4##2##(2007-11#1)(2010-12#2)(2013-1#1)
year-old woman was##2##3##(1990-8#1)(1995-2#1)
year-old woman with##2##3##(2006-2#1)(2007-2#1)
year-old woman##8##2##(1990-8#1)(1995-2#1)(2006-2#1)(2006-7#1)(2007-2#1)(2007-8#1)(2008-5#1)(2011-2#1)
year-old##87##1##(1990-4#1)(1990-5#1)(1990-8#4)(1991-12#1)(1992-11#1)(1992-4#1)(1992-6#1)(1992-8#1)(1995-2#1)(1995-8#1)(1996-9#1)(2005-11#3)(2005-12#1)(2006-2#4)(2006-7#2)(2006-8#2)(2007-11#2)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#4)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2009-11#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-4#2)(2010-6#1)(2010-9#2)(2011-1#2)(2011-2#7)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)
year-olds##4##1##(2010-2#1)(2011-12#1)(2012-12#1)(2013-1#1)
year-round residency in##2##3##(2008-8#2)
year-round##8##1##(2005-8#1)(2007-3#1)(2008-10#1)(2008-8#2)(2011-2#1)(2011-9#1)(2013-7#1)
year-to-year##2##1##(1991-3#1)(2008-10#1)
year?##3##1##(2008-2#1)(2009-12#2)
year]##6##1##(1990-10#1)(1991-11#1)(1992-3#1)(1993-11#1)(1993-5#1)(1994-3#1)
yearling sows and##2##3##(1992-12#2)
yearling##5##1##(1992-12#2)(1993-2#1)(2008-8#1)(2009-10#1)
yearlings##3##1##(1993-1#1)(2010-4#2)
yearly and##4##2##(2006-10#1)(2007-3#1)(2008-10#1)(2013-1#1)
yearly applications of Pseudomonas putida 06909-rif/nal##2##6##(2008-10#2)
yearly applications of##3##3##(2008-10#3)
yearly at##2##2##(1991-8#1)(2006-7#1)
yearly endoscopy##2##2##(2006-2#1)(2008-5#1)
yearly follow-up##3##2##(2006-2#1)(2008-5#1)(2013-1#1)
yearly in the United States##2##5##(2010-12#1)(2010-4#1)
yearly in the##3##3##(2010-12#2)(2010-4#1)
yearly mean values##2##3##(1995-7#2)
yearly to##2##2##(2007-11#1)(2008-10#1)
yearly##54##1##(1991-6#1)(1991-8#1)(1992-2#1)(1993-7#1)(1994-12#1)(1995-7#2)(1996-2#1)(1996-3#1)(1996-7#1)(1997-8#1)(2006-10#2)(2006-2#2)(2006-7#1)(2006-8#1)(2007-11#2)(2007-3#1)(2008-10#10)(2008-5#3)(2008-7#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-7#2)(2010-9#2)(2011-1#1)(2011-2#3)(2012-11#1)(2013-1#2)(2013-8#2)
yearly-averaged##2##1##(1990-8#2)
yearning for##3##2##(2006-4#1)(2007-12#1)(2007-9#1)
years (1##2##2##(2013-1#2)
years (12##2##2##(2011-2#1)(2013-1#1)
years (2##2##2##(2007-2#1)(2011-2#1)
years (20##2##2##(1995-9#1)(2008-5#1)
years (22##2##2##(2008-12#1)(2013-1#1)
years (27##2##2##(1991-2#1)(2006-2#1)
years (30##2##2##(2007-7#1)(2011-2#1)
years (9##2##2##(2007-11#1)(2013-1#1)
years (OR = 3##2##4##(2011-2#2)
years (OR =##4##3##(2011-2#4)
years (OR##5##2##(2010-8#1)(2011-2#4)
years (P &lt##5##3##(1995-2#1)(1996-12#1)(2004-11#1)(2007-10#2)
years (P =##4##3##(2010-2#1)(2013-1#3)
years (P##11##2##(1995-2#1)(1996-12#1)(2004-11#1)(2007-10#2)(2008-1#2)(2010-2#1)(2013-1#3)
years (S##2##2##(1994-6#1)(2008-7#1)
years (SD 1##4##3##(2006-10#4)
years (SD =##4##3##(2011-1#2)(2013-8#2)
years (SD##9##2##(2006-10#4)(2011-1#2)(2011-2#1)(2013-8#2)
years (average 3##2##3##(2007-8#1)(2008-7#1)
years (average age##5##3##(1992-9#1)(1996-4#1)(2007-11#1)(2010-3#1)(2011-2#1)
years (average##15##2##(1992-9#1)(1996-4#1)(2006-11#2)(2007-11#3)(2007-7#2)(2007-8#2)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#1)
years (from##2##2##(2007-2#1)(2013-8#1)
years (i##2##2##(2004-11#1)(2007-12#1)
years (mean 11##2##3##(2007-8#1)(2012-12#1)
years (mean 2##2##3##(2007-8#1)(2013-1#1)
years (mean 3##2##3##(1997-3#1)(2013-1#1)
years (mean 4##2##3##(1990-8#1)(2007-11#1)
years (mean 45##3##3##(2007-9#2)(2008-1#1)
years (mean 5##2##3##(1996-11#1)(2007-11#1)
years (mean =##5##3##(2005-12#2)(2005-8#1)(2009-8#2)
years (mean age##8##3##(1990-5#1)(1993-1#1)(2007-10#1)(2007-11#1)(2007-7#3)(2007-8#1)
years (mean##60##2##(1990-5#1)(1990-6#1)(1990-8#2)(1992-9#1)(1993-1#1)(1996-11#1)(1997-3#1)(1997-8#1)(2005-1#1)(2005-12#2)(2005-8#1)(2006-11#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#5)(2007-8#6)(2007-9#6)(2008-1#2)(2008-3#2)(2008-9#1)(2009-8#2)(2011-2#1)(2012-12#1)(2013-1#4)
years (median##9##2##(1992-4#1)(1995-9#1)(2004-11#1)(2007-2#2)(2008-10#1)(2008-6#1)(2012-1#1)(2013-1#1)
years (n =##4##3##(1995-6#1)(1997-2#1)(2007-10#1)(2007-11#1)
years (odds ratio [OR]##3##4##(2007-10#2)(2008-3#1)
years (p &lt##3##3##(2006-10#1)(2006-12#1)(2008-1#1)
years (p&lt##2##2##(2006-7#1)(2010-5#1)
years (r =##2##3##(1992-4#1)(2008-10#1)
years (range 1 month##2##4##(2008-6#1)(2011-2#1)
years (range 1##5##3##(2007-3#2)(2007-6#1)(2008-6#1)(2011-2#1)
years (range 2 months##2##4##(2006-5#1)(2007-2#1)
years (range 2##7##3##(2006-5#1)(2007-2#1)(2007-3#2)(2008-8#1)(2008-9#1)(2012-12#1)
years (range 20 to##2##4##(2006-10#1)(2011-2#1)
years (range 3##2##3##(2008-1#1)(2011-2#1)
years (range from##2##3##(2007-7#1)(2008-1#1)
years (range##114##2##(1990-11#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-2#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#2)(1993-2#1)(1994-6#1)(1995-2#1)(2006-10#2)(2006-11#1)(2006-3#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#3)(2007-2#1)(2007-3#4)(2007-6#1)(2007-7#15)(2007-8#4)(2007-9#1)(2008-1#6)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#6)(2008-7#2)(2008-8#3)(2008-9#6)(2009-10#2)(2009-3#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-11#1)(2011-2#9)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#5)
years (standard deviation##4##3##(2006-10#1)(2007-10#1)(2008-9#1)(2013-8#1)
years )##2##2##(2006-8#1)(2007-2#1)
years 1##2##2##(2007-3#1)(2007-7#1)
years 11 months##2##3##(2006-3#1)(2007-8#1)
years 1960##2##2##(1991-2#1)(2012-12#1)
years 1970##2##2##(1997-8#1)(2006-8#1)
years 1984##3##2##(1990-3#1)(1990-5#1)(1992-12#1)
years 1991##6##2##(2007-11#5)(2007-9#1)
years 1994##2##2##(1997-3#1)(2008-8#1)
years 1995 and##2##3##(2007-11#2)
years 1995##3##2##(1996-1#1)(2007-11#2)
years 1995-1999##2##2##(2006-2#1)(2007-11#1)
years 2##2##2##(2006-3#1)(2008-12#1)
years 2005##2##2##(2008-12#1)(2012-3#1)
years 4 months##3##3##(1991-11#1)(1991-8#1)(2007-8#1)
years 4##5##2##(1991-11#1)(1991-8#1)(2006-6#1)(2007-7#1)(2007-8#1)
years 42%##2##2##(2006-5#1)(2007-7#1)
years 6 months##3##3##(2007-7#1)(2008-7#1)(2008-9#1)
years 7 months##2##3##(2007-2#1)(2007-7#1)
years a large##2##3##(2010-11#1)(2012-3#1)
years a number of##6##4##(1997-6#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-6#1)(2007-11#1)
years a##17##2##(1991-8#1)(1992-7#1)(1992-8#1)(1993-5#1)(1997-6#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-8#1)(2008-2#1)(2008-6#1)(2010-11#1)(2012-2#1)(2012-3#1)
years about##3##2##(1993-11#1)(2007-11#1)(2007-5#1)
years admitted to##2##3##(2006-10#1)(2006-8#1)
years after a##5##3##(1991-11#1)(2007-10#1)(2008-6#1)(2008-7#1)(2012-2#1)
years after an##4##3##(1990-12#1)(1996-6#1)(2009-3#1)(2013-1#1)
years after coronary artery bypass##2##5##(2007-8#1)(2008-12#1)
years after coronary##3##3##(1997-3#1)(2007-8#1)(2008-12#1)
years after development of##2##4##(2010-11#1)(2012-2#1)
years after diagnosis of##3##4##(1997-3#1)(2009-4#1)(2011-2#1)
years after diagnosis##8##3##(1991-3#1)(1997-3#1)(2005-10#1)(2008-7#2)(2009-4#1)(2011-2#2)
years after discharge from##2##4##(2007-9#2)
years after discharge##4##3##(2007-9#4)
years after he had##2##4##(2007-5#1)(2008-12#1)
years after her##2##3##(2011-2#1)(2013-1#1)
years after his##2##3##(1997-8#1)(2010-12#1)
years after initial presentation##2##4##(2007-2#1)(2012-2#1)
years after initial##6##3##(2004-1#1)(2007-2#1)(2010-9#1)(2012-2#1)(2013-1#2)
years after it was##2##4##(2008-10#1)(2011-1#1)
years after it##4##3##(1996-12#1)(2006-10#1)(2008-10#1)(2011-1#1)
years after its##6##3##(1997-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-12#1)(2012-12#1)
years after mastectomy##3##3##(1996-3#2)(2011-2#1)
years after nephrectomy##3##3##(2008-1#1)(2013-1#2)
years after onset##3##3##(1990-10#1)(1992-11#1)(2007-7#1)
years after operation##6##3##(1990-2#1)(1993-11#1)(1995-9#1)(2007-11#1)(2008-6#1)(2011-2#1)
years after radiation therapy##3##4##(2008-7#1)(2013-8#2)
years after radiation##5##3##(2005-9#1)(2008-6#1)(2008-7#1)(2013-8#2)
years after receiving##2##3##(2008-7#1)(2013-8#1)
years after resection of the##2##5##(2007-8#1)(2011-3#1)
years after resection##4##3##(2007-8#2)(2008-8#1)(2011-3#1)
years after starting##2##3##(2007-12#1)(2013-8#1)
years after stroke##2##3##(2007-10#1)(2013-1#1)
years after successful##3##3##(2007-3#1)(2009-3#1)(2011-3#1)
years after surgery and##2##4##(1991-6#1)(2006-6#1)
years after surgery##25##3##(1991-2#1)(1991-6#1)(1993-7#1)(1994-5#1)(2006-6#1)(2006-8#1)(2007-7#1)(2007-8#4)(2008-10#2)(2008-7#1)(2009-2#1)(2009-3#1)(2010-8#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)
years after surgical resection##2##4##(1991-12#1)(2011-2#1)
years after surgical##6##3##(1991-12#1)(1991-6#1)(1992-6#1)(1994-3#1)(2008-6#1)(2011-2#1)
years after termination of##2##4##(2006-6#1)(2008-1#1)
years after the diagnosis##3##4##(1992-8#1)(1994-6#1)(2008-6#1)
years after the discovery of##2##5##(1997-7#1)(2008-12#1)
years after the end of##2##5##(2007-8#1)(2008-10#1)
years after the first##7##4##(1994-9#1)(1996-6#1)(2007-2#2)(2008-4#1)(2008-5#1)(2013-1#1)
years after the initial diagnosis##6##5##(1993-7#1)(2005-10#1)(2006-1#1)(2007-10#1)(2007-8#1)(2013-8#1)
years after the initial operation##5##5##(1994-5#1)(2008-7#1)(2011-2#2)(2012-3#1)
years after the initial##14##4##(1993-7#1)(1994-5#1)(1995-7#1)(2005-10#1)(2006-1#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-2#2)(2012-3#1)(2013-8#1)
years after the introduction of##3##5##(1997-4#1)(2006-10#1)(2007-12#1)
years after the onset of the##2##6##(2011-2#1)(2012-2#1)
years after the onset of##3##5##(2008-1#1)(2011-2#1)(2012-2#1)
years after the operation##5##4##(1991-9#1)(1993-3#1)(2007-7#1)(2007-8#1)(2008-6#1)
years after the original##3##4##(2008-6#2)(2010-12#1)
years after the procedure##2##4##(1993-11#1)(2012-12#1)
years after the surgery##3##4##(2007-3#1)(2007-8#1)(2013-8#1)
years after the surgical##2##4##(2007-11#1)(2012-12#1)
years after the use of##2##5##(2007-8#1)(2008-4#1)
years after the##95##3##(1990-12#1)(1991-9#1)(1992-2#2)(1992-8#1)(1993-11#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-4#1)(1995-7#1)(1996-11#2)(1996-6#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#1)(2006-1#1)(2006-10#2)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-5#2)(2007-7#4)(2007-8#5)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#5)(2008-7#2)(2008-8#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
years after their##4##3##(1996-3#1)(2008-7#1)(2010-9#1)(2013-1#1)
years after they##2##3##(1990-12#1)(2006-5#1)
years after tonsillectomy##2##3##(1996-12#2)
years after total hip##2##4##(2009-3#1)(2013-7#1)
years after total##3##3##(2009-3#1)(2009-5#1)(2013-7#1)
years after transplant##2##3##(2013-8#2)
years after transplantation##3##3##(1995-2#1)(2007-7#1)(2011-2#1)
years after treatment of##3##4##(1990-12#1)(1990-9#1)(1997-5#1)
years after treatment##9##3##(1990-12#1)(1990-9#1)(1995-11#1)(1995-12#1)(1997-5#1)(2006-10#1)(2006-12#1)(2007-7#1)(2009-5#1)
years after wide##3##3##(1992-2#1)(2013-1#2)
years after##346##2##(1990-10#1)(1990-12#4)(1990-2#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#3)(1993-3#1)(1993-7#2)(1994-12#1)(1994-3#2)(1994-5#3)(1994-6#1)(1994-7#1)(1994-9#2)(1995-11#2)(1995-12#2)(1995-2#2)(1995-4#2)(1995-7#1)(1995-9#4)(1996-11#2)(1996-12#5)(1996-3#3)(1996-6#3)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-1#1)(2004-10#1)(2004-11#2)(2004-7#1)(2005-10#3)(2005-9#1)(2006-1#1)(2006-10#8)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#6)(2007-12#4)(2007-2#3)(2007-3#4)(2007-4#1)(2007-5#3)(2007-7#11)(2007-8#25)(2007-9#6)(2008-1#3)(2008-10#10)(2008-11#2)(2008-12#8)(2008-2#3)(2008-4#2)(2008-5#1)(2008-6#9)(2008-7#11)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#7)(2009-4#1)(2009-5#3)(2009-7#1)(2009-9#1)(2010-11#3)(2010-12#5)(2010-2#2)(2010-3#4)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#3)(2011-1#4)(2011-2#16)(2011-3#2)(2012-1#1)(2012-12#8)(2012-2#7)(2012-3#3)(2013-1#21)(2013-7#5)(2013-8#8)
years age and##2##3##(2008-1#1)(2012-2#1)
years age group (z= -2##2##5##(2007-2#2)
years age group (z=##3##4##(2007-2#3)
years age group and##3##4##(2007-7#2)(2011-12#1)
years age group##12##3##(2006-4#1)(2007-2#4)(2007-7#4)(2011-12#1)(2013-8#2)
years age groups##2##3##(2006-10#1)(2007-2#1)
years age having##2##3##(2007-8#1)(2008-7#1)
years age##21##2##(2006-10#1)(2006-4#1)(2007-2#5)(2007-7#5)(2007-8#1)(2008-1#1)(2008-7#2)(2010-7#1)(2011-12#1)(2012-2#1)(2013-8#2)
years ago and##14##3##(1993-4#1)(1995-1#1)(1996-9#1)(2005-7#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-5#1)(2010-11#1)(2010-3#1)(2010-8#1)(2012-3#1)(2013-1#1)
years ago but##5##3##(2007-12#1)(2007-5#1)(2008-10#1)(2012-3#1)(2013-8#1)
years ago by##3##3##(1993-4#1)(2008-11#1)(2010-11#1)
years ago for##3##3##(2009-12#1)(2010-12#2)
years ago from##2##3##(2008-4#1)(2011-2#1)
years ago has##3##3##(1991-2#1)(1995-4#1)(2007-1#1)
years ago he##2##3##(1997-5#1)(2007-8#1)
years ago in the##2##4##(2006-12#1)(2006-4#1)
years ago in##5##3##(2005-9#1)(2006-12#1)(2006-4#1)(2007-4#1)(2008-8#1)
years ago is##2##3##(1992-2#1)(2011-2#1)
years ago it##2##3##(2007-11#1)(2008-8#1)
years ago that##2##3##(2009-8#1)(2012-2#1)
years ago the##2##3##(1994-12#1)(2012-2#1)
years ago to##4##3##(2008-10#1)(2008-7#1)(2009-4#1)(2011-12#1)
years ago was##4##3##(2008-1#1)(2008-10#1)(2008-4#1)(2012-12#1)
years ago when##2##3##(2007-9#1)(2008-10#1)
years ago with##4##3##(1997-3#1)(2008-8#1)(2013-1#2)
years ago##222##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-11#3)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-2#2)(1992-5#1)(1992-7#2)(1992-9#1)(1993-12#1)(1993-4#2)(1993-5#2)(1994-12#1)(1994-3#3)(1994-7#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(2004-12#1)(2004-3#2)(2005-12#2)(2005-7#2)(2005-9#2)(2006-1#1)(2006-10#2)(2006-11#2)(2006-12#2)(2006-4#2)(2006-5#2)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#10)(2008-1#6)(2008-10#15)(2008-11#4)(2008-12#5)(2008-2#4)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#7)(2009-10#2)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#4)(2010-1#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#9)(2011-7#1)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#7)(2012-3#3)(2013-1#6)(2013-8#2)
years ago)##4##2##(1992-5#2)(2006-10#1)(2008-10#1)
years ahead##6##2##(1992-2#1)(1994-3#1)(1995-1#1)(1996-9#1)(2007-8#1)(2008-10#1)
years alternative##2##2##(1997-4#1)(2007-11#1)
years although##2##2##(1996-4#1)(2007-6#1)
years among##5##2##(1993-1#1)(1994-6#1)(2007-2#1)(2007-8#1)(2010-4#1)
years an##5##2##(1996-11#1)(2006-10#1)(2006-2#1)(2006-6#1)(2008-5#1)
years and &gt##3##3##(2007-2#1)(2008-4#1)(2012-12#1)
years and 10 months##3##4##(1992-4#1)(2007-7#1)(2010-1#1)
years and 10##4##3##(1992-4#1)(2007-7#1)(2010-1#1)(2013-1#1)
years and 2 months##4##4##(2007-7#1)(2008-6#1)(2009-3#2)
years and 2 months)##2##4##(2007-7#1)(2009-3#1)
years and 2##8##3##(2006-8#1)(2007-7#2)(2008-6#1)(2009-3#3)(2012-2#1)
years and 27##2##3##(2010-12#1)(2011-1#1)
years and 3 months##2##4##(2007-7#1)(2007-8#1)
years and 3##3##3##(2007-7#1)(2007-8#1)(2011-2#1)
years and 34%##2##3##(2005-10#1)(2006-10#1)
years and 40##2##3##(2006-10#1)(2007-12#1)
years and 5##3##3##(2007-7#1)(2010-3#1)(2012-2#1)
years and 52##2##3##(2009-10#1)(2012-2#1)
years and 53%##2##3##(2008-7#1)(2013-1#1)
years and 58##2##3##(1994-6#1)(2011-2#1)
years and 6##3##3##(2011-2#1)(2012-3#1)(2013-8#1)
years and 7##2##3##(2008-10#1)(2013-8#1)
years and 8##2##3##(2007-7#1)(2013-8#1)
years and 9##4##3##(1997-7#1)(2008-11#1)(2008-3#1)(2012-3#1)
years and a mean##4##4##(1991-4#1)(1994-12#1)(2007-10#1)(2011-1#1)
years and a##6##3##(1991-4#1)(1994-12#1)(2006-10#1)(2007-10#1)(2008-7#1)(2011-1#1)
years and above##11##3##(2004-10#2)(2006-8#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-4#1)(2011-1#1)(2011-11#1)(2012-2#2)
years and above)##4##3##(1992-6#1)(2006-4#1)(2007-6#1)(2008-8#1)
years and an##2##3##(2007-2#1)(2007-6#1)
years and at##2##3##(2008-10#1)(2013-8#1)
years and compared with##2##4##(1992-12#1)(2012-12#1)
years and compared##3##3##(1991-1#1)(1992-12#1)(2012-12#1)
years and controls##2##3##(1996-1#2)
years and every##2##3##(2007-3#1)(2013-1#1)
years and for women##2##4##(2006-7#2)
years and had##3##3##(1995-4#1)(2005-11#1)(2006-2#1)
years and has##4##3##(2006-10#1)(2006-2#1)(2006-8#1)(2010-12#1)
years and in##6##3##(1990-9#3)(1992-7#1)(2006-2#1)(2007-6#1)
years and is now##3##4##(1991-4#1)(2006-10#1)(2007-12#1)
years and is##5##3##(1991-4#1)(2005-7#1)(2006-10#1)(2007-12#2)
years and less##2##3##(2008-10#1)(2008-3#1)
years and may##2##3##(2005-8#1)(2011-7#1)
years and mean##5##3##(1993-8#1)(2007-4#1)(2008-1#1)(2012-12#1)(2012-2#1)
years and more##3##3##(2007-7#1)(2012-12#1)(2013-8#1)
years and older were##2##4##(2006-8#1)(2009-4#1)
years and older##29##3##(1990-12#3)(1992-4#1)(1993-10#1)(1993-12#1)(1994-6#1)(2004-10#1)(2006-10#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-11#2)(2007-2#1)(2007-4#1)(2008-5#1)(2009-4#1)(2009-5#1)(2011-1#1)(2011-11#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
years and older) and##2##4##(1992-1#1)(2010-12#1)
years and older)##4##3##(1992-1#1)(1993-2#1)(2006-10#1)(2010-12#1)
years and one for##2##4##(1993-10#1)(2008-10#1)
years and one##3##3##(1993-10#1)(2008-10#2)
years and over were##2##4##(2008-7#1)(2011-1#1)
years and over##14##3##(1990-3#1)(1992-2#1)(1993-12#1)(1994-5#1)(2006-2#1)(2006-4#1)(2006-6#2)(2008-7#3)(2011-1#2)(2011-2#1)
years and showed##2##3##(2006-10#1)(2008-7#1)
years and sites##2##3##(2008-10#2)
years and ten##2##3##(2006-4#1)(2007-4#1)
years and that##2##3##(1995-8#1)(2008-12#1)
years and the duration##2##4##(2007-7#1)(2008-1#1)
years and the first##2##4##(2005-8#1)(2007-8#1)
years and the mean##2##4##(2008-1#1)(2009-10#1)
years and the##19##3##(1996-8#1)(2005-8#1)(2006-10#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-3#1)(2008-4#1)(2009-10#1)(2009-9#2)(2011-1#1)(2011-2#2)(2012-3#1)
years and then##2##3##(1997-8#1)(2007-12#1)
years and they##2##3##(2008-11#1)(2013-8#1)
years and those##5##3##(2006-10#1)(2006-6#1)(2007-7#1)(2011-11#1)(2013-1#1)
years and to##4##3##(1990-6#1)(2012-1#1)(2012-2#1)(2013-1#1)
years and two##3##3##(2007-9#1)(2008-10#1)(2012-12#1)
years and under##2##3##(1997-3#1)(2005-9#1)
years and was##3##3##(2006-8#1)(2008-4#1)(2010-3#1)
years and were##2##3##(2007-10#1)(2007-2#1)
years and with##3##3##(2008-10#1)(2012-2#2)
years and younger##5##3##(1993-10#1)(1996-3#1)(2006-10#1)(2008-3#1)(2011-1#1)
years and##350##2##(1990-12#5)(1990-3#1)(1990-6#2)(1990-9#3)(1991-1#1)(1991-12#2)(1991-4#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-4#2)(1992-5#2)(1992-6#3)(1992-7#2)(1993-1#1)(1993-10#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-2#1)(1995-4#1)(1995-8#1)(1995-9#2)(1996-1#2)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#4)(1997-6#1)(1997-7#1)(1997-8#1)(2004-10#3)(2005-10#3)(2005-11#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#15)(2006-12#4)(2006-2#5)(2006-3#1)(2006-4#4)(2006-6#4)(2006-7#4)(2006-8#9)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#3)(2007-12#7)(2007-2#9)(2007-3#1)(2007-4#3)(2007-6#3)(2007-7#13)(2007-8#7)(2007-9#3)(2008-1#6)(2008-10#20)(2008-11#4)(2008-12#1)(2008-3#5)(2008-4#5)(2008-5#2)(2008-6#3)(2008-7#8)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-3#3)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#6)(2010-3#2)(2011-1#10)(2011-11#5)(2011-12#2)(2011-2#15)(2011-7#1)(2012-1#3)(2012-12#7)(2012-2#15)(2012-3#7)(2013-1#16)(2013-7#2)(2013-8#10)
years are documented##2##3##(1997-8#1)(2007-8#1)
years are##19##2##(1996-1#1)(1996-4#1)(1997-3#1)(1997-6#2)(1997-8#1)(2006-3#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-2#3)(2012-12#3)
years as a means of##2##5##(1996-1#1)(2012-2#1)
years as a##10##3##(1996-1#1)(1997-5#1)(2005-9#1)(2006-11#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-9#1)(2010-8#1)(2012-2#1)
years as an##8##3##(1992-11#1)(1995-12#1)(1996-12#1)(1997-2#1)(2006-6#1)(2008-10#1)(2010-12#1)(2011-1#1)
years as the##2##3##(2008-10#1)(2009-8#1)
years as well as the##2##5##(2008-5#1)(2010-3#1)
years as well as##6##4##(2006-10#1)(2006-8#1)(2007-6#1)(2008-5#1)(2010-3#1)(2012-3#1)
years as well##7##3##(2006-10#1)(2006-8#1)(2007-6#1)(2007-7#1)(2008-5#1)(2010-3#1)(2012-3#1)
years as##38##2##(1990-3#1)(1992-11#1)(1993-12#1)(1995-1#3)(1995-12#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-5#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
years at diagnosis##2##3##(2008-7#1)(2012-3#1)
years at the beginning of##2##5##(2008-7#1)(2011-2#1)
years at the time of##4##5##(1995-6#1)(2007-7#1)(2008-4#2)
years at the##17##3##(1995-6#1)(1996-4#1)(1997-1#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-4#3)(2008-7#1)(2010-12#1)(2011-2#2)(2012-2#2)
years at various##2##3##(1990-3#1)(2008-10#1)
years at##41##2##(1990-3#1)(1992-8#1)(1993-2#1)(1993-8#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-4#1)(1997-1#1)(2004-2#1)(2005-8#1)(2007-11#2)(2007-12#1)(2007-3#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-4#3)(2008-6#1)(2008-7#2)(2010-12#1)(2011-2#2)(2012-2#2)(2012-3#1)
years back##3##2##(2007-11#1)(2007-7#1)(2010-7#1)
years based on##2##3##(1990-8#1)(1996-8#1)
years based##3##2##(1990-8#1)(1996-8#1)(2006-11#1)
years because of##2##3##(1991-9#1)(1993-1#1)
years been##2##2##(2008-11#1)(2009-6#1)
years before and##2##3##(2004-11#1)(2010-12#1)
years before clinical##2##3##(1997-5#1)(1997-6#1)
years before the##9##3##(1990-12#1)(1990-8#1)(1991-7#1)(1995-11#1)(1996-4#1)(2004-12#1)(2006-10#1)(2010-9#1)(2012-12#1)
years before##46##2##(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-7#2)(1993-10#1)(1993-3#1)(1994-10#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1996-4#1)(1997-5#1)(1997-6#1)(2004-11#1)(2004-12#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#2)(2009-11#1)(2009-2#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
years behind##3##2##(2006-9#1)(2008-11#1)(2013-7#1)
years between##6##2##(1996-11#1)(2004-10#1)(2007-4#1)(2008-2#1)(2009-10#1)(2012-12#1)
years but##3##2##(2007-11#1)(2008-10#1)(2009-3#1)
years by a##2##3##(1994-3#1)(2012-3#1)
years by the##6##3##(1997-6#1)(2005-7#1)(2005-8#1)(2009-7#1)(2013-1#1)(2013-8#1)
years by##23##2##(1990-10#1)(1993-11#1)(1994-3#2)(1996-4#1)(1997-6#1)(2005-7#1)(2005-8#1)(2007-1#1)(2008-1#1)(2008-10#6)(2008-8#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
years compared to##3##3##(1995-5#1)(2004-1#1)(2013-1#1)
years constituted##2##2##(1991-8#1)(2007-3#1)
years could##2##2##(2012-2#2)
years demonstrated##2##2##(2009-3#1)(2010-4#1)
years developed##2##2##(2005-7#1)(2008-5#1)
years due to a##3##4##(2004-4#1)(2008-12#1)(2008-9#1)
years due to##10##3##(1994-10#1)(2004-4#1)(2006-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-9#1)(2013-1#1)(2013-8#2)
years duration and##2##3##(1994-12#1)(2010-11#1)
years duration associated with##2##4##(2007-7#2)
years duration##14##2##(1994-12#2)(2006-10#1)(2007-11#2)(2007-7#5)(2007-8#1)(2009-3#1)(2010-11#1)(2012-2#1)
years during the##2##3##(1997-7#1)(2011-12#1)
years during which##2##3##(2006-9#1)(2008-10#1)
years during##5##2##(1997-7#1)(2006-9#1)(2008-10#1)(2011-12#1)(2012-12#1)
years earlier than the##2##4##(2006-10#1)(2009-6#1)
years earlier##27##2##(1991-12#1)(1991-6#1)(1993-12#1)(1994-7#2)(1995-12#1)(1995-8#1)(2005-9#1)(2006-10#3)(2006-2#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-7#2)(2009-6#1)(2010-10#1)(2010-6#1)(2011-2#2)(2013-8#2)
years evidence##2##2##(2005-1#1)(2009-8#1)
years experience at the##2##4##(1991-2#1)(1994-10#1)
years experience at##4##3##(1991-2#1)(1994-10#1)(2007-11#1)(2010-11#1)
years experience in the##2##4##(1990-3#1)(2008-8#1)
years experience in##4##3##(1990-3#1)(1994-12#1)(2006-12#1)(2008-8#1)
years experience of##4##3##(1990-6#1)(2007-11#1)(2007-7#1)(2011-2#1)
years experience with##3##3##(1997-2#1)(1997-3#1)(2010-4#1)
years experience##20##2##(1990-3#1)(1990-6#1)(1991-2#1)(1994-10#1)(1994-12#1)(1997-2#1)(1997-3#1)(2006-12#1)(2007-11#2)(2007-7#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-2#2)(2013-8#1)
years experience]##2##2##(2011-3#1)(2013-1#1)
years experienced##4##2##(1991-4#1)(2006-11#2)(2008-7#1)
years follow up##4##3##(2004-2#1)(2006-10#1)(2007-7#1)(2012-12#1)
years follow-up period##3##3##(1993-10#1)(2012-12#1)(2013-1#1)
years follow-up study##2##3##(1990-6#1)(1997-8#1)
years follow-up##14##2##(1990-6#1)(1993-10#1)(1997-8#1)(2008-4#2)(2008-7#1)(2009-9#2)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
years following acute##2##3##(2006-7#1)(2009-10#1)
years following the##4##3##(2004-10#1)(2008-10#1)(2008-12#1)(2008-2#1)
years following##30##2##(1990-10#1)(1993-10#1)(1993-9#1)(1994-2#1)(2004-10#1)(2004-2#1)(2005-12#1)(2005-8#1)(2006-3#1)(2006-7#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-12#1)(2010-5#1)(2012-1#2)(2012-12#1)(2013-1#2)(2013-7#1)
years for all##2##3##(1995-12#1)(2007-8#1)
years for both##2##3##(1997-4#1)(2008-5#1)
years for boys##2##3##(1990-9#1)(2013-1#1)
years for females##3##3##(2006-1#1)(2013-1#1)(2013-7#1)
years for males and##2##4##(2013-1#1)(2013-7#1)
years for men and##3##4##(1991-6#1)(2011-1#1)(2013-1#1)
years for men##4##3##(1991-6#1)(1997-4#1)(2011-1#1)(2013-1#1)
years for patients##2##3##(2007-7#1)(2008-1#1)
years for the##12##3##(1993-6#1)(2005-8#1)(2007-10#1)(2007-11#2)(2008-10#1)(2010-10#1)(2012-11#2)(2012-12#1)(2013-1#2)
years for women and##2##4##(1991-6#1)(1997-4#1)
years for women##3##3##(1991-6#1)(1997-4#1)(2013-1#1)
years for##61##2##(1990-12#2)(1990-9#2)(1991-6#2)(1992-2#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-6#1)(1995-12#1)(1995-8#1)(1996-3#1)(1997-1#1)(1997-4#3)(2005-10#1)(2005-12#1)(2005-8#1)(2006-1#1)(2007-10#1)(2007-11#2)(2007-7#4)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-12#1)(2013-1#8)(2013-7#2)(2013-8#1)
years from 1982##2##3##(1995-3#1)(2007-3#1)
years from a##3##3##(1994-6#1)(2008-12#1)(2010-5#1)
years from now##2##3##(2008-1#1)(2008-3#1)
years from the##9##3##(1991-2#1)(1995-12#1)(1996-3#1)(2006-2#1)(2007-5#1)(2008-3#1)(2008-4#1)(2009-7#1)(2011-2#1)
years from##51##2##(1991-12#1)(1991-2#1)(1993-3#2)(1994-4#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-3#1)(2005-10#1)(2006-2#1)(2006-7#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#2)(2008-7#3)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
years had had##2##3##(1990-6#1)(1994-4#1)
years had##10##2##(1990-12#1)(1990-6#1)(1991-10#1)(1992-12#1)(1992-5#1)(1992-9#1)(1994-4#1)(2006-8#1)(2007-8#2)
years has been##7##3##(1996-11#1)(1997-4#1)(2006-10#1)(2007-1#1)(2010-6#1)(2011-12#1)(2013-7#1)
years has clearly##2##3##(1990-5#1)(2010-12#1)
years has focused on##2##4##(2006-10#1)(2011-2#1)
years has resulted in##2##4##(1991-12#1)(2008-4#1)
years has##33##2##(1990-5#1)(1991-10#1)(1991-12#1)(1992-11#1)(1992-8#1)(1996-11#2)(1996-7#1)(1997-4#1)(2005-10#1)(2005-5#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-9#1)(2007-1#1)(2007-2#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
years have been##8##3##(1996-8#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)
years have brought##4##3##(1992-12#1)(1994-3#1)(2007-4#1)(2008-11#1)
years have demonstrated that##2##4##(2008-1#1)(2008-3#1)
years have elapsed##2##3##(1990-3#1)(1994-2#1)
years have passed since the##4##5##(2004-1#1)(2008-10#1)(2008-8#1)(2013-1#1)
years have provided##3##3##(2010-1#1)(2011-2#1)(2012-3#1)
years have seen a significant increase in##2##7##(2008-5#1)(2009-12#1)
years have seen a##6##4##(2006-10#1)(2006-12#1)(2008-5#1)(2008-7#1)(2009-12#1)(2012-12#1)
years have seen##16##3##(1997-8#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-5#1)(2010-7#1)(2012-12#1)
years have shown##3##3##(1993-9#1)(1995-4#1)(2008-3#1)
years have witnessed an##2##4##(1990-7#1)(2012-2#1)
years have witnessed tremendous##2##4##(2006-10#1)(2007-6#1)
years have witnessed##9##3##(1990-7#1)(1996-1#1)(2006-10#1)(2007-6#1)(2007-8#1)(2009-12#1)(2010-12#1)(2012-1#1)(2012-2#1)
years have##64##2##(1990-3#1)(1990-7#1)(1991-12#1)(1992-12#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-4#1)(1996-1#1)(1996-8#1)(1997-8#1)(2004-1#1)(2006-10#4)(2006-12#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-4#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#2)(2009-3#1)(2009-5#1)(2010-1#1)(2010-12#3)(2010-3#2)(2010-5#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
years having##2##2##(2007-7#1)(2012-2#1)
years he##2##2##(2007-8#1)(2008-6#1)
years hospitalized##3##2##(1992-5#1)(2010-12#1)(2012-2#1)
years however##2##2##(1991-4#1)(2008-7#1)
years if##2##2##(1995-6#1)(1996-6#1)
years in Europe and##2##4##(1996-7#1)(2008-10#1)
years in Norway##2##3##(1990-6#1)(1997-5#1)
years in Parkinson's disease (PD)##2##5##(2008-11#1)(2008-7#1)
years in St##2##3##(1995-12#1)(2008-10#1)
years in Yemen##2##3##(2007-2#1)(2010-6#1)
years in a##12##3##(1990-6#1)(1997-2#1)(1997-8#2)(2005-7#1)(2007-7#1)(2008-8#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
years in age##6##3##(1994-3#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-12#2)
years in an##3##3##(1997-6#1)(2007-10#1)(2013-8#1)
years in both##3##3##(1990-12#1)(2005-9#1)(2008-9#1)
years in clinical##2##3##(1994-12#1)(2008-8#1)
years in duration##2##3##(2006-6#1)(2008-3#1)
years in four##2##3##(1991-6#1)(2008-1#1)
years in its##2##3##(1992-1#1)(2011-2#1)
years in men##2##3##(2008-7#1)(2012-12#1)
years in order to##4##4##(1992-2#1)(2005-9#1)(2007-5#1)(2010-4#1)
years in our##4##3##(1996-12#1)(2005-10#1)(2008-10#1)(2011-2#1)
years in patients with##2##4##(2004-1#1)(2006-6#1)
years in prison for##2##4##(1996-5#1)(1997-5#1)
years in prison##5##3##(1996-5#4)(1997-5#1)
years in some##2##3##(1993-11#1)(2011-2#1)
years in the field of##2##5##(2006-10#1)(2008-5#1)
years in the other##2##4##(1992-4#1)(1994-7#1)
years in the study##2##4##(1994-6#1)(2007-8#1)
years in the##34##3##(1992-1#1)(1992-4#1)(1992-5#1)(1993-11#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-6#1)(1994-7#1)(1996-5#1)(1997-2#2)(2004-12#1)(2005-4#1)(2006-10#2)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-7#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#3)
years in this study##3##4##(2007-12#1)(2007-2#1)(2013-8#1)
years in two##3##3##(1992-3#1)(2008-5#1)(2012-12#1)
years in western##2##3##(2008-10#2)
years in##197##2##(1990-12#2)(1990-3#1)(1990-4#1)(1990-6#2)(1990-8#1)(1991-4#1)(1991-6#2)(1991-9#1)(1992-1#3)(1992-10#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1993-11#2)(1993-12#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-5#6)(1996-7#1)(1997-1#1)(1997-2#3)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#3)(2004-1#2)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-4#1)(2005-7#1)(2005-9#2)(2006-10#2)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#2)(2007-1#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#4)(2007-3#1)(2007-5#1)(2007-7#4)(2007-8#3)(2008-1#2)(2008-10#14)(2008-11#1)(2008-12#4)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#1)(2009-1#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-7#2)(2009-9#1)(2010-4#3)(2010-6#1)(2010-8#3)(2011-1#4)(2011-12#1)(2011-2#12)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#9)(2013-7#2)(2013-8#6)
years increased##3##2##(1991-8#1)(2007-8#1)(2008-11#1)
years indicated that the##2##4##(2007-7#1)(2008-10#1)
years into the##3##3##(2007-10#1)(2007-7#1)(2008-11#1)
years into##6##2##(1990-12#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-6#1)
years is presented##6##3##(1990-9#1)(1991-9#1)(1992-6#1)(2006-2#1)(2008-10#1)(2008-7#1)
years is to##3##3##(2008-4#1)(2010-5#1)(2012-12#1)
years is##28##2##(1990-9#1)(1991-8#1)(1991-9#1)(1992-6#1)(1994-12#1)(1995-2#1)(1995-5#1)(1997-6#1)(2005-7#1)(2006-1#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-7#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)
years it has been shown that##4##6##(1990-11#1)(1995-9#1)(1997-4#1)(2013-7#1)
years it has been##9##4##(1990-11#1)(1990-8#1)(1994-11#1)(1995-6#1)(1995-9#1)(1997-4#1)(2006-1#1)(2008-12#1)(2013-7#1)
years it has##10##3##(1990-11#1)(1990-8#1)(1994-11#1)(1995-6#1)(1995-9#1)(1997-4#1)(2006-1#1)(2008-12#1)(2008-7#1)(2013-7#1)
years it##13##2##(1990-11#1)(1990-8#1)(1993-8#1)(1994-11#1)(1995-6#1)(1995-9#1)(1996-3#1)(1997-4#1)(2006-1#1)(2008-12#1)(2008-7#1)(2009-1#1)(2013-7#1)
years later a##3##3##(1991-10#1)(1992-2#1)(2008-9#1)
years later he##2##3##(1991-3#1)(1993-5#1)
years later she##3##3##(2008-1#2)(2008-7#1)
years later than##3##3##(1991-9#1)(1996-3#1)(2011-2#1)
years later the##2##3##(2007-4#1)(2008-10#1)
years later to##2##3##(1994-3#1)(2006-8#1)
years later when##2##3##(1992-11#1)(2011-1#1)
years later with##3##3##(2007-8#2)(2008-1#1)
years later##104##2##(1990-6#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-6#3)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-4#1)(1996-3#2)(1997-5#1)(1997-7#1)(2004-2#1)(2005-8#1)(2006-10#5)(2006-12#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-8#5)(2007-9#2)(2008-1#4)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-3#1)(2009-4#2)(2009-7#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#5)(2013-1#7)(2013-8#1)
years later]##2##2##(1997-2#1)(2012-2#1)
years led to##2##3##(2010-2#1)(2012-12#1)
years living in##6##3##(1992-4#1)(1993-12#1)(2007-12#1)(2011-2#3)
years long##3##2##(1990-9#1)(1997-6#2)
years lost##3##2##(2006-10#2)(2010-10#1)
years male##4##2##(2006-1#1)(2008-7#1)(2010-11#1)(2011-1#1)
years many##7##2##(1990-9#1)(2006-10#1)(2006-2#1)(2008-10#1)(2009-2#1)(2012-3#1)(2013-1#1)
years may##3##2##(2004-11#1)(2008-8#1)(2010-12#1)
years much has been learned about##2##6##(1990-10#1)(2008-4#1)
years much##3##2##(1990-10#1)(1993-7#1)(2008-4#1)
years now##5##2##(1991-8#1)(2006-11#1)(2007-11#1)(2007-9#2)
years numerous##2##2##(2008-7#1)(2009-5#1)
years of &quot##4##3##(1994-7#1)(2006-3#1)(2007-12#1)(2008-9#1)
years of Polish##2##3##(2007-8#2)
years of a##4##3##(1992-2#1)(1994-5#1)(1995-6#1)(2005-10#1)
years of age (mean##2##4##(2007-7#1)(2009-7#1)
years of age and 78##2##5##(2011-1#1)(2012-12#1)
years of age and had##2##5##(2007-7#1)(2008-8#1)
years of age and older and##2##6##(2006-12#1)(2009-4#1)
years of age and older##6##5##(2005-10#1)(2006-12#1)(2009-4#3)(2013-8#1)
years of age and those##2##5##(2008-3#1)(2011-1#1)
years of age and##37##4##(1990-4#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#2)(2006-4#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#3)(2009-7#1)(2011-1#2)(2012-12#4)(2012-3#1)(2013-1#1)(2013-8#4)
years of age at##5##4##(2007-5#1)(2008-11#1)(2009-10#2)(2010-10#1)
years of age but##2##4##(2006-10#1)(2007-7#1)
years of age for##3##4##(1993-2#1)(2006-3#1)(2008-7#1)
years of age from##4##4##(1991-12#1)(2010-4#1)(2012-12#1)(2013-1#1)
years of age group##2##4##(1997-3#1)(2012-3#1)
years of age had##2##4##(1995-2#1)(2006-12#1)
years of age has##4##4##(1991-8#2)(1992-5#1)(2013-7#1)
years of age in 1996-2001##2##5##(2006-7#1)(2006-8#1)
years of age in the##4##5##(1992-7#1)(2012-2#3)
years of age in##12##4##(1992-7#1)(1995-4#1)(2005-11#1)(2006-7#1)(2006-8#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#4)
years of age is##2##4##(1990-6#1)(2008-7#1)
years of age living in##2##5##(2011-1#2)
years of age living##3##4##(1995-2#1)(2011-1#2)
years of age or older##6##5##(1990-5#1)(2006-12#1)(2008-11#1)(2010-10#2)(2011-2#1)
years of age or younger##5##5##(1995-8#1)(2006-12#2)(2008-5#2)
years of age or##18##4##(1990-5#1)(1991-12#1)(1991-3#1)(1992-1#1)(1993-12#1)(1993-6#1)(1995-8#1)(2006-12#3)(2007-12#1)(2008-11#1)(2008-5#2)(2010-10#2)(2011-2#1)(2013-8#1)
years of age participated##2##4##(2011-2#2)
years of age showed##2##4##(2007-7#1)(2010-11#1)
years of age to##2##4##(2007-12#1)(2009-11#1)
years of age was##7##4##(1992-4#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-1#1)(2008-11#1)(2008-9#1)
years of age were 2##2##5##(2006-4#1)(2007-6#1)
years of age were##14##4##(1990-10#1)(1993-5#1)(1993-8#1)(1995-12#1)(1996-1#1)(2006-4#1)(2007-1#1)(2007-6#1)(2008-10#2)(2008-5#1)(2009-6#1)(2013-1#1)(2013-8#1)
years of age when their##2##5##(2006-4#1)(2013-1#1)
years of age when##5##4##(2006-4#1)(2007-7#1)(2010-1#1)(2010-4#1)(2013-1#1)
years of age who were##4##5##(1993-1#1)(2008-2#1)(2008-3#1)(2011-2#1)
years of age who##7##4##(1993-1#1)(2007-3#1)(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#2)
years of age with a##3##5##(1990-9#1)(1996-11#1)(2008-4#1)
years of age with##12##4##(1990-9#1)(1992-8#2)(1996-11#1)(2006-8#1)(2007-11#1)(2007-6#2)(2008-4#1)(2008-7#1)(2013-1#2)
years of age##379##3##(1990-10#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-9#3)(1991-12#2)(1991-2#1)(1991-3#3)(1991-6#3)(1991-7#1)(1991-8#5)(1992-1#2)(1992-2#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#2)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#2)(1993-5#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-4#2)(1995-8#2)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#3)(1996-9#1)(1997-3#1)(1997-4#1)(2004-2#3)(2005-10#4)(2005-11#2)(2005-2#1)(2006-1#1)(2006-10#12)(2006-12#7)(2006-2#2)(2006-3#1)(2006-4#3)(2006-7#4)(2006-8#7)(2007-1#4)(2007-10#1)(2007-11#6)(2007-12#8)(2007-2#6)(2007-3#2)(2007-4#3)(2007-5#2)(2007-6#5)(2007-7#25)(2007-8#5)(2008-1#4)(2008-10#5)(2008-11#8)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#15)(2008-8#3)(2008-9#7)(2009-10#6)(2009-11#1)(2009-2#1)(2009-4#5)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#5)(2010-11#1)(2010-12#1)(2010-3#4)(2010-4#2)(2010-9#2)(2011-1#10)(2011-12#3)(2011-2#23)(2012-1#3)(2012-12#9)(2012-2#7)(2012-3#7)(2013-1#21)(2013-7#1)(2013-8#13)
years of age) using##2##4##(1996-5#1)(1996-6#1)
years of age)##17##3##(1993-10#2)(1996-3#1)(1996-5#3)(1996-6#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-3#1)(2008-10#1)(2008-7#2)(2008-9#1)(2012-12#1)(2012-2#1)
years of age]##4##3##(1991-8#2)(2008-1#1)(2012-3#1)
years of clinical and##2##4##(2005-8#1)(2013-8#1)
years of clinical experience##4##4##(1990-3#1)(2008-3#2)(2013-1#1)
years of clinical##9##3##(1990-3#1)(1996-4#1)(2005-8#1)(2008-3#2)(2010-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
years of cochlear implant##2##4##(2008-9#2)
years of continuous##3##3##(1996-6#1)(2009-8#1)(2011-2#1)
years of data##5##3##(1992-8#1)(1995-12#1)(2005-11#1)(2006-12#1)(2008-8#1)
years of development##2##3##(2008-3#1)(2013-8#1)
years of diagnosis##5##3##(1990-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)
years of duration##3##3##(2007-7#1)(2013-1#1)(2013-8#1)
years of education were more likely to##2##7##(2005-10#1)(2008-12#1)
years of education were##3##4##(2005-10#1)(2007-7#1)(2008-12#1)
years of education##10##3##(1995-11#1)(1996-8#1)(2005-10#2)(2007-7#2)(2008-12#2)(2010-6#1)(2011-2#1)
years of evolution##4##3##(1994-11#1)(2009-8#1)(2010-12#1)(2011-2#1)
years of experience and##2##4##(2007-8#1)(2008-1#1)
years of experience in the##2##5##(2007-7#2)
years of experience in##6##4##(1993-12#1)(1996-12#1)(2007-7#2)(2008-2#1)(2010-12#1)
years of experience with##3##4##(2006-7#1)(2007-8#1)(2008-6#1)
years of experience##27##3##(1993-12#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-12#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#5)(2007-8#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#2)
years of exposure was##2##4##(1994-6#1)(1994-7#1)
years of exposure##5##3##(1994-6#1)(1994-7#1)(1997-6#1)(2009-5#1)(2012-3#1)
years of field experiments##2##4##(2008-10#1)(2008-12#1)
years of field##4##3##(2008-10#3)(2008-12#1)
years of follow up##5##4##(1994-3#1)(2004-2#1)(2012-2#1)(2013-1#2)
years of follow-up in##3##4##(1993-1#1)(1995-11#1)(2007-8#1)
years of follow-up##30##3##(1990-3#1)(1991-8#1)(1992-6#1)(1993-1#1)(1993-9#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-11#1)(2004-10#1)(2006-2#1)(2007-12#1)(2007-8#4)(2008-1#1)(2008-11#1)(2008-6#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
years of funding##2##3##(2008-12#1)(2009-4#1)
years of hemodialysis##2##3##(2008-1#1)(2011-2#1)
years of human##2##3##(2012-3#1)(2013-7#1)
years of implementation##3##3##(2012-2#1)(2012-3#2)
years of intensive##2##3##(2006-10#1)(2012-2#1)
years of investigations into##2##4##(2007-9#1)(2008-10#1)
years of life and##4##4##(1996-9#1)(2006-8#1)(2011-2#1)(2012-12#1)
years of life lost##3##4##(1990-9#1)(2012-12#1)(2013-8#1)
years of life##30##3##(1990-9#1)(1991-2#1)(1992-6#1)(1993-1#1)(1993-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-7#1)(1996-9#1)(1997-2#1)(2006-1#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#1)
years of observation##2##3##(1990-5#1)(2012-12#1)
years of operation in##2##4##(2008-2#1)(2008-3#1)
years of operation of the##2##5##(1990-3#1)(2011-2#1)
years of operation##7##3##(1990-3#1)(1994-2#1)(2004-12#1)(2008-2#1)(2008-3#1)(2011-2#2)
years of practice##2##3##(1992-3#1)(2008-1#1)
years of quality##2##3##(2005-11#1)(2011-2#1)
years of research and development##2##5##(2006-7#1)(2012-11#1)
years of research##6##3##(2006-7#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-8#1)(2012-11#1)
years of schooling##2##3##(2007-7#2)
years of study##4##3##(1994-5#1)(2008-7#1)(2009-10#1)(2012-2#1)
years of the initial##2##4##(2011-2#1)(2013-8#1)
years of the study##11##4##(1996-3#1)(1997-8#1)(2006-10#1)(2008-10#6)(2009-4#1)(2012-3#1)
years of the##42##3##(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#1)(1993-12#1)(1994-2#1)(1995-4#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
years of their##4##3##(1996-2#1)(2006-10#1)(2007-12#1)(2008-11#1)
years of therapy##4##3##(2008-1#3)(2008-8#1)
years of this study##2##4##(2008-5#2)
years of this##4##3##(1990-1#1)(2008-1#1)(2008-5#2)
years of treatment with##2##4##(2008-4#1)(2009-8#1)
years of treatment##12##3##(1992-7#1)(1993-11#1)(1994-6#1)(2005-10#1)(2005-7#2)(2007-11#1)(2007-8#1)(2008-4#1)(2009-8#1)(2011-2#1)(2012-3#1)
years of use##5##3##(1994-2#1)(1997-5#1)(2006-2#1)(2009-6#1)(2012-12#1)
years of work in##2##4##(2009-6#2)
years of work##3##3##(2009-6#3)
years of##865##2##(1990-1#2)(1990-10#2)(1990-12#1)(1990-3#3)(1990-4#1)(1990-5#2)(1990-6#5)(1990-8#1)(1990-9#5)(1991-12#4)(1991-2#4)(1991-3#4)(1991-4#2)(1991-6#3)(1991-7#1)(1991-8#11)(1992-1#3)(1992-12#1)(1992-2#7)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#4)(1992-8#3)(1993-1#5)(1993-10#3)(1993-11#1)(1993-12#5)(1993-2#3)(1993-3#2)(1993-5#4)(1993-6#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#5)(1994-3#4)(1994-5#3)(1994-6#5)(1994-7#2)(1994-9#1)(1995-1#5)(1995-10#2)(1995-11#4)(1995-12#2)(1995-2#5)(1995-3#2)(1995-4#3)(1995-5#1)(1995-6#4)(1995-8#4)(1996-1#3)(1996-11#3)(1996-12#4)(1996-2#4)(1996-3#7)(1996-4#1)(1996-5#3)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#3)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-10#2)(2004-11#1)(2004-12#1)(2004-2#4)(2004-9#1)(2005-10#10)(2005-11#4)(2005-2#1)(2005-7#3)(2005-8#1)(2006-1#3)(2006-10#23)(2006-12#8)(2006-2#6)(2006-3#2)(2006-4#4)(2006-5#1)(2006-7#9)(2006-8#10)(2006-9#2)(2007-1#6)(2007-10#2)(2007-11#12)(2007-12#12)(2007-2#8)(2007-3#3)(2007-4#5)(2007-5#3)(2007-6#7)(2007-7#39)(2007-8#15)(2007-9#6)(2008-1#17)(2008-10#38)(2008-11#15)(2008-12#10)(2008-2#6)(2008-3#9)(2008-4#6)(2008-5#14)(2008-6#6)(2008-7#20)(2008-8#9)(2008-9#15)(2009-10#7)(2009-11#1)(2009-2#5)(2009-3#1)(2009-4#10)(2009-5#4)(2009-6#5)(2009-7#2)(2009-8#8)(2009-9#4)(2010-1#3)(2010-10#5)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#7)(2010-4#4)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#13)(2011-12#3)(2011-2#44)(2011-3#1)(2012-1#4)(2012-11#2)(2012-12#22)(2012-2#19)(2012-3#22)(2013-1#40)(2013-7#4)(2013-8#24)
years old and older##2##4##(2006-7#1)(2008-4#1)
years old and##24##3##(1990-4#1)(1991-9#1)(1997-4#1)(2005-7#1)(2006-1#1)(2006-7#2)(2006-9#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#3)
years old are##3##3##(2006-5#1)(2008-5#1)(2011-2#1)
years old at the##2##4##(2008-6#1)(2012-2#1)
years old at##4##3##(2007-10#1)(2008-6#1)(2011-1#1)(2012-2#1)
years old boy with##3##4##(2008-1#1)(2008-10#1)(2012-2#1)
years old boy##5##3##(2008-1#1)(2008-10#1)(2011-2#1)(2012-2#2)
years old female patient who##2##5##(2007-10#1)(2010-4#1)
years old female patient##5##4##(2007-10#1)(2009-4#1)(2010-12#1)(2010-4#1)(2013-8#1)
years old female##12##3##(1996-9#1)(2007-10#1)(2007-12#1)(2009-4#1)(2010-12#1)(2010-4#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
years old girl##3##3##(1994-2#1)(2009-4#1)(2012-2#1)
years old girls##2##3##(1996-9#1)(2007-2#1)
years old have a##2##4##(2007-7#1)(2011-1#1)
years old in##5##3##(1997-4#1)(1997-7#1)(2011-1#1)(2011-2#2)
years old lady##2##3##(2012-2#1)(2013-7#1)
years old male patient presented with##3##6##(2007-7#1)(2012-2#1)(2013-8#1)
years old male patient with##2##5##(2006-8#1)(2013-8#1)
years old male patient##5##4##(2006-8#1)(2007-7#1)(2012-2#1)(2013-8#2)
years old male##10##3##(2006-8#1)(2007-7#1)(2007-9#1)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#2)
years old man who##2##4##(1991-11#1)(2005-10#1)
years old man##6##3##(1991-11#1)(1993-2#1)(2005-10#1)(2010-6#1)(2011-1#1)(2012-3#1)
years old or more##2##4##(2008-3#1)(2011-2#1)
years old or older##3##4##(1991-9#1)(2011-1#1)(2011-2#1)
years old or##6##3##(1991-9#1)(2008-3#1)(2009-4#1)(2011-1#1)(2011-2#2)
years old patient with##2##4##(2009-11#1)(2010-12#1)
years old patient##6##3##(2007-8#1)(2008-7#1)(2009-11#1)(2010-12#1)(2011-2#1)(2012-12#1)
years old was##2##3##(1997-3#1)(1997-6#1)
years old were studied##3##4##(2007-12#1)(2011-2#1)(2012-12#1)
years old were##10##3##(2006-7#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-2#1)(2009-2#1)(2011-2#3)(2012-12#1)
years old who##3##3##(2007-2#1)(2008-7#1)(2008-8#1)
years old with##3##3##(1990-10#1)(2008-6#1)(2008-9#1)
years old woman who##2##4##(2011-2#1)(2013-8#1)
years old woman with##2##4##(1990-12#1)(2008-8#1)
years old woman##11##3##(1990-12#1)(1992-10#1)(2005-1#1)(2007-8#2)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
years old women##2##3##(2005-1#1)(2007-8#1)
years old##293##2##(1990-10#2)(1990-12#1)(1990-4#2)(1990-6#4)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-9#5)(1992-10#3)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-3#1)(1993-5#2)(1993-6#1)(1993-9#4)(1994-2#1)(1994-3#2)(1994-9#2)(1995-3#1)(1995-9#4)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#3)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#2)(1997-7#1)(2005-1#2)(2005-10#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#3)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#4)(2006-8#3)(2006-9#1)(2007-10#3)(2007-11#2)(2007-12#4)(2007-2#8)(2007-7#3)(2007-8#7)(2007-9#3)(2008-1#5)(2008-10#5)(2008-12#5)(2008-2#2)(2008-3#8)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#5)(2009-11#1)(2009-2#1)(2009-4#4)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#8)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#28)(2012-1#6)(2012-11#1)(2012-12#8)(2012-2#14)(2012-3#8)(2013-1#13)(2013-7#3)(2013-8#12)
years old) and##2##3##(2010-12#1)(2013-8#1)
years old) normal subjects##2##4##(2009-8#2)
years old) were##5##3##(2007-8#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-12#1)
years old) with##4##3##(2006-10#1)(2008-6#1)(2013-1#2)
years old)##41##2##(1990-10#1)(1990-5#1)(1992-2#1)(1996-8#1)(2004-3#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-8#4)(2008-10#1)(2008-12#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#3)(2009-8#2)(2010-12#3)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#4)(2013-8#4)
years old-group##2##2##(2008-4#2)
years old]##4##2##(1991-8#1)(1995-2#1)(2008-9#1)(2012-3#1)
years on PD##2##3##(2011-2#2)
years on average##2##3##(1992-2#1)(2013-8#1)
years on the##3##3##(2006-10#1)(2008-10#1)(2012-2#1)
years on##28##2##(1990-12#1)(1991-5#1)(1992-2#1)(1992-5#1)(1993-2#1)(1996-11#2)(1996-6#1)(1997-1#1)(2004-2#1)(2006-10#1)(2006-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2011-12#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
years only##2##2##(1994-12#1)(2008-7#1)
years or as##2##3##(2008-11#1)(2010-8#1)
years or decades##2##3##(1990-1#1)(2013-1#1)
years or greater##2##3##(2008-10#2)
years or less##4##3##(1990-12#1)(2006-12#1)(2012-3#1)(2013-1#1)
years or locations##2##3##(2008-10#2)
years or longer##2##3##(2006-7#1)(2010-12#1)
years or more##11##3##(1990-2#1)(1990-9#1)(1995-2#1)(1996-6#1)(2007-11#2)(2007-6#1)(2008-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
years or older were##2##4##(1992-5#1)(2009-8#1)
years or older with##3##4##(2007-10#1)(2010-8#1)(2012-2#1)
years or older##25##3##(1992-5#1)(1992-6#1)(1992-9#3)(1993-3#1)(1996-3#1)(1997-6#1)(2006-10#1)(2007-10#4)(2007-12#1)(2008-11#1)(2008-3#1)(2009-8#1)(2010-8#1)(2011-1#2)(2011-11#1)(2012-2#1)(2013-1#1)(2013-8#2)
years or over##5##3##(1994-6#2)(1997-8#2)(2011-1#1)
years or so##5##3##(1997-8#1)(2007-6#1)(2008-8#1)(2008-9#1)(2011-2#1)
years or##68##2##(1990-1#1)(1990-12#1)(1990-2#1)(1990-9#1)(1992-5#1)(1992-6#1)(1992-9#3)(1993-3#1)(1994-6#2)(1995-2#1)(1995-9#1)(1996-3#1)(1996-6#1)(1997-6#1)(1997-8#3)(2006-10#1)(2006-12#1)(2006-7#1)(2007-10#4)(2007-11#2)(2007-12#1)(2007-6#2)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-8#3)(2011-1#3)(2011-11#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#4)
years over the##2##3##(1992-1#1)(2006-6#1)
years over##3##2##(1992-1#1)(2006-6#1)(2007-8#1)
years owing to##2##3##(2010-2#1)(2012-1#1)
years participated in the study##2##5##(2008-12#1)(2008-9#1)
years participated in##3##3##(2007-2#1)(2008-12#1)(2008-9#1)
years per patient##3##3##(2007-11#2)(2008-8#1)
years per##5##2##(1993-7#1)(2007-11#2)(2008-8#1)(2010-3#1)
years period##13##2##(1991-5#1)(1997-2#1)(1997-8#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-9#1)(2011-2#2)(2012-2#1)
years post##7##2##(1996-9#1)(2004-10#1)(2007-7#2)(2008-6#1)(2010-10#1)(2010-9#1)
years post-implant##4##2##(2008-9#4)
years post-operatively##2##2##(2007-7#1)(2008-6#1)
years postoperatively##10##2##(2004-1#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2011-2#2)(2012-12#1)(2013-1#1)
years presenting with##2##3##(2007-7#1)(2013-8#1)
years presenting##5##2##(1991-11#1)(1992-5#1)(2007-7#1)(2013-1#1)(2013-8#1)
years previously and had##2##4##(1990-2#1)(2008-10#1)
years previously for##2##3##(1990-12#1)(1994-12#1)
years previously##21##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1994-12#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-4#1)(2007-8#2)(2008-10#2)(2008-3#1)(2008-6#1)(2009-2#1)(2010-12#1)(2010-6#1)
years prior to diagnosis##2##4##(1992-8#1)(2008-1#1)
years prior to the##3##4##(2011-1#2)(2011-12#1)
years prior to##13##3##(1992-10#1)(1992-6#1)(1992-8#1)(1993-11#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-6#1)(2011-1#2)(2011-12#1)(2013-1#2)
years ranging from##2##3##(2007-8#1)(2008-1#1)
years regarding the##2##3##(2005-8#1)(2006-10#1)
years regarding##4##2##(2005-8#1)(2006-10#1)(2010-12#1)(2012-12#1)
years respectively (p##4##3##(2005-10#3)(2007-3#1)
years respectively after##2##3##(1992-2#1)(2007-7#1)
years respectively##17##2##(1990-9#1)(1991-5#1)(1992-2#1)(1992-4#2)(1996-8#1)(2005-10#3)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-4#1)(2010-1#1)(2012-12#1)(2012-2#1)
years respectively)##3##2##(1992-9#1)(2007-7#1)(2008-4#1)
years revealed##2##2##(2006-5#1)(2007-8#1)
years reveals##2##2##(2008-11#1)(2009-4#1)
years several new##2##3##(2005-7#1)(2010-12#1)
years several##10##2##(1993-3#1)(1995-4#1)(2005-7#1)(2006-10#2)(2008-10#1)(2008-3#1)(2010-12#1)(2012-12#2)
years she##4##2##(2006-11#2)(2007-2#1)(2012-12#1)
years should be##2##3##(2010-8#1)(2013-1#1)
years should##6##2##(1995-10#1)(1996-6#1)(2010-8#1)(2012-12#1)(2013-1#2)
years showed##4##2##(1993-9#1)(2005-8#1)(2006-4#1)(2008-7#1)
years shows##2##2##(1990-6#1)(2008-10#1)
years since the first##3##4##(1996-4#1)(2013-1#1)(2013-8#1)
years since the##15##3##(1993-6#1)(1994-6#1)(1996-4#1)(1997-5#1)(2004-1#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
years since their##2##3##(2009-4#1)(2010-5#1)
years since##32##2##(1991-12#1)(1993-10#1)(1993-6#1)(1994-6#1)(1995-12#1)(1996-4#1)(1997-5#1)(2004-1#1)(2006-10#3)(2006-12#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
years so##3##2##(1997-6#1)(2012-12#1)(2012-3#1)
years some##3##2##(2006-10#1)(2008-1#1)(2008-11#1)
years study##4##2##(2009-7#1)(2010-4#1)(2011-2#1)(2012-3#1)
years suffering from##2##3##(1992-11#1)(2007-7#1)
years suggests that##3##3##(2005-8#1)(2008-1#1)(2008-10#1)
years survival##3##2##(2006-10#1)(2008-8#1)(2013-1#1)
years than in##2##3##(2008-10#1)(2008-7#1)
years than##8##2##(1992-1#1)(1997-3#1)(2008-10#2)(2008-7#1)(2010-12#1)(2011-1#1)(2013-8#1)
years thanks to the##4##4##(2005-10#1)(2008-9#1)(2010-7#1)(2011-2#1)
years that##13##2##(1993-6#1)(1994-6#1)(1996-4#1)(2005-7#1)(2006-1#1)(2006-12#1)(2008-1#2)(2008-11#1)(2008-2#2)(2008-3#1)(2010-12#1)
years the increase in##2##4##(1991-8#1)(1992-8#1)
years the##48##2##(1990-10#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-9#1)(1994-8#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-3#1)(1997-1#1)(2005-11#1)(2005-8#2)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-5#2)(2007-6#1)(2007-8#2)(2008-1#1)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#2)(2008-8#1)(2009-6#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)
years their##3##2##(1994-12#1)(2007-8#1)(2008-5#1)
years there has been a##8##5##(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-2#1)(2010-2#1)(2011-1#1)
years there has been an increase in##2##7##(2008-6#1)(2012-12#1)
years there has been an increasing interest in##2##8##(1992-8#1)(2008-10#1)
years there has been an increasing##3##6##(1992-8#1)(1993-5#1)(2008-10#1)
years there has been an##5##5##(1992-8#1)(1993-5#1)(2008-10#1)(2008-6#1)(2012-12#1)
years there has been##22##4##(1992-8#1)(1993-3#1)(1993-5#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#1)(2010-2#1)(2011-1#1)(2012-12#1)
years there have been##5##4##(1990-11#1)(1994-9#1)(2006-10#1)(2008-11#1)(2011-2#1)
years there was a##3##4##(1995-6#1)(2008-10#1)(2009-12#1)
years there were##2##3##(1994-11#1)(1995-12#1)
years there##34##2##(1990-11#1)(1992-8#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-6#1)(2006-10#3)(2006-7#1)(2006-8#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)
years thereafter##2##2##(2006-8#1)(2008-1#1)
years this##2##2##(2011-2#1)(2013-8#1)
years through##2##2##(1996-3#1)(2008-10#1)
years time##2##2##(2007-7#1)(2009-2#1)
years to 65 years##2##4##(2008-1#1)(2013-8#1)
years to a##3##3##(1995-12#1)(2007-9#1)(2008-10#1)
years to achieve##2##3##(1996-1#1)(1997-2#1)
years to an estimated##2##4##(2007-9#1)(2012-2#1)
years to assess the##2##4##(1997-2#1)(2007-11#1)
years to be##3##3##(1992-12#1)(2007-11#1)(2008-5#1)
years to come##14##3##(1993-2#1)(1994-6#1)(1996-3#2)(1997-1#1)(1997-8#1)(2006-10#2)(2007-8#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-6#1)(2011-1#1)
years to determine the##2##4##(2012-3#2)
years to determine##5##3##(2006-10#1)(2007-9#1)(2010-2#1)(2012-3#2)
years to develop##3##3##(2006-2#1)(2007-12#1)(2008-10#1)
years to have##2##3##(1994-8#1)(2006-1#1)
years to the##2##3##(2011-1#1)(2013-1#1)
years to##107##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-10#4)(1991-12#1)(1992-12#1)(1992-7#1)(1993-10#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-1#1)(1996-11#2)(1996-3#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-2#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-4#1)(2007-6#4)(2007-7#1)(2007-8#2)(2007-9#6)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#4)(2008-7#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-11#1)(2011-2#3)(2012-1#1)(2012-10#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
years two##3##2##(1996-6#1)(2008-11#1)(2010-7#1)
years under##2##2##(2008-10#1)(2013-7#1)
years underwent##3##2##(1994-12#1)(2006-6#1)(2008-4#1)
years using##7##2##(1992-10#1)(1993-2#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-5#1)
years various##2##2##(2011-1#1)(2011-12#1)
years versus##7##2##(1995-3#1)(1995-8#1)(2007-7#3)(2011-2#2)
years was 0##2##3##(1995-9#1)(2007-11#1)
years was carried out##3##4##(1990-12#1)(1996-12#1)(2011-2#1)
years was found to be##2##5##(2007-2#1)(2013-7#1)
years was higher##2##3##(1997-2#1)(2007-8#1)
years was presented##2##3##(2006-6#1)(2011-12#1)
years was significantly##2##3##(1991-8#1)(2007-8#1)
years was##61##2##(1990-12#2)(1990-2#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-5#2)(1993-9#1)(1995-9#2)(1996-12#1)(1997-2#1)(1997-6#1)(2004-1#2)(2004-11#1)(2006-10#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#4)(2007-2#1)(2007-8#11)(2008-1#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-9#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-3#2)(2013-1#2)(2013-7#1)
years we have treated##3##4##(1991-5#1)(1997-4#1)(2009-2#1)
years we have##4##3##(1991-5#1)(1997-4#1)(2006-9#1)(2009-2#1)
years we##8##2##(1991-5#1)(1995-5#1)(1997-4#1)(2006-9#1)(2007-5#1)(2009-2#2)(2011-2#1)
years were calculated##2##3##(1996-3#1)(2010-3#1)
years were defined as##2##4##(2004-11#2)
years were enrolled##2##3##(2013-1#1)(2013-8#1)
years were examined in##2##4##(1994-2#1)(1995-6#1)
years were examined##5##3##(1993-3#1)(1994-2#1)(1995-6#1)(2006-10#1)(2007-8#1)
years were highly Gompertzian for each and every year for both men and women##2##14##(1991-6#1)(1996-9#1)
years were identified##2##3##(2012-12#1)(2012-3#1)
years were included in the study##2##6##(2008-4#1)(2011-1#1)
years were included in the##3##5##(1990-10#1)(2008-4#1)(2011-1#1)
years were included in##4##4##(1990-10#1)(2008-1#1)(2008-4#1)(2011-1#1)
years were included##6##3##(1990-10#1)(2008-1#1)(2008-4#1)(2008-7#1)(2011-1#1)(2013-1#1)
years were interviewed##2##3##(1996-6#1)(2013-1#1)
years were operated##2##3##(2007-8#2)
years were selected from##2##4##(2011-1#1)(2013-8#1)
years were selected##4##3##(2005-8#1)(2011-1#1)(2011-12#1)(2013-8#1)
years were studied##8##3##(1994-3#1)(1997-2#1)(2007-7#1)(2008-6#1)(2010-12#1)(2011-1#1)(2013-1#2)
years were the##2##3##(2006-10#1)(2013-1#1)
years were treated with##2##4##(2007-8#2)
years were treated##4##3##(1991-12#1)(1992-3#1)(2007-8#2)
years were used##3##3##(2007-7#1)(2009-5#1)(2012-1#1)
years were##93##2##(1990-10#1)(1991-12#3)(1991-6#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-3#3)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#3)(2004-11#3)(2004-2#1)(2005-7#2)(2005-8#1)(2006-10#4)(2007-7#3)(2007-8#7)(2008-1#3)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#2)(2008-7#2)(2009-5#2)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#6)(2011-12#1)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#9)(2013-8#3)
years when##5##2##(1995-9#1)(1996-3#1)(2008-10#1)(2008-8#1)(2013-7#1)
years which##3##2##(2006-10#1)(2008-10#1)(2008-7#1)
years while the##2##3##(1993-9#1)(2007-3#1)
years while##7##2##(1991-3#1)(1993-9#1)(2007-12#1)(2007-3#1)(2008-5#1)(2010-7#1)(2013-1#1)
years who are at##2##4##(2010-10#1)(2013-1#1)
years who had##6##3##(1997-2#1)(2006-10#1)(2007-7#1)(2008-7#1)(2010-10#1)(2011-2#1)
years who were##8##3##(1991-9#1)(2006-2#1)(2007-1#1)(2008-9#1)(2010-12#1)(2012-12#1)(2013-1#2)
years who##22##2##(1990-9#1)(1991-9#1)(1996-4#1)(1997-2#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-10#2)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#4)
years will be##2##3##(2010-10#1)(2012-12#1)
years will##4##2##(1997-6#1)(2010-10#1)(2012-12#1)(2012-3#1)
years with a diagnosis of##2##5##(2007-12#1)(2008-6#1)
years with a mean age of##2##6##(2008-1#1)(2010-3#1)
years with a mean of##2##5##(2005-12#1)(2008-4#1)
years with a mean##6##4##(2005-12#1)(2006-5#1)(2008-1#1)(2008-4#1)(2010-3#1)(2012-12#1)
years with a##21##3##(1990-3#1)(1991-4#1)(1992-1#1)(2005-12#1)(2006-12#1)(2006-5#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-6#2)(2008-7#1)(2010-3#1)(2010-8#1)(2011-12#1)(2012-12#3)
years with an average##2##4##(1994-3#1)(2008-7#1)
years with an##3##3##(1994-3#1)(2007-9#1)(2008-7#1)
years with clinical conditions##2##4##(2009-12#2)
years with no##3##3##(1995-6#1)(2006-10#1)(2011-11#1)
years with severe##2##3##(1992-8#1)(2008-2#1)
years with the advent of##2##5##(2005-12#1)(2006-4#1)
years with the##9##3##(1992-10#1)(2005-12#1)(2005-7#1)(2006-4#1)(2007-4#1)(2007-8#1)(2008-5#1)(2008-8#1)(2010-3#1)
years with##103##2##(1990-3#1)(1991-12#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-8#1)(1993-11#1)(1993-3#2)(1993-9#3)(1994-3#1)(1995-6#3)(1995-9#1)(1997-6#1)(2005-12#2)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#8)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-4#4)(2008-5#2)(2008-6#4)(2008-7#2)(2008-8#1)(2009-12#3)(2009-3#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-3#2)(2010-8#1)(2011-1#2)(2011-11#1)(2011-12#3)(2011-2#2)(2012-1#1)(2012-12#6)(2012-2#3)(2013-1#2)(2013-7#1)
years within##3##2##(2006-8#1)(2008-10#1)(2011-1#1)
years without any##4##3##(1991-12#1)(1991-5#1)(2008-11#1)(2011-2#1)
years without##13##2##(1991-12#1)(1991-5#1)(1993-10#1)(1997-5#1)(2004-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-2#2)
years younger than##2##3##(1990-5#1)(1995-10#1)
years##7912##1##(1990-1#3)(1990-10#16)(1990-11#10)(1990-12#38)(1990-2#12)(1990-3#23)(1990-4#11)(1990-5#24)(1990-6#39)(1990-7#4)(1990-8#18)(1990-9#27)(1991-1#7)(1991-10#16)(1991-11#22)(1991-12#37)(1991-2#22)(1991-3#21)(1991-4#23)(1991-5#14)(1991-6#24)(1991-7#5)(1991-8#42)(1991-9#22)(1992-1#19)(1992-10#13)(1992-11#11)(1992-12#18)(1992-2#38)(1992-3#14)(1992-4#17)(1992-5#23)(1992-6#24)(1992-7#19)(1992-8#20)(1992-9#14)(1993-1#19)(1993-10#20)(1993-11#25)(1993-12#25)(1993-2#18)(1993-3#28)(1993-4#4)(1993-5#21)(1993-6#14)(1993-7#6)(1993-8#15)(1993-9#30)(1994-1#6)(1994-10#5)(1994-11#5)(1994-12#30)(1994-2#17)(1994-3#31)(1994-4#5)(1994-5#12)(1994-6#30)(1994-7#9)(1994-8#4)(1994-9#11)(1995-1#19)(1995-10#7)(1995-11#22)(1995-12#20)(1995-2#28)(1995-3#19)(1995-4#18)(1995-5#20)(1995-6#27)(1995-7#4)(1995-8#13)(1995-9#28)(1996-1#16)(1996-11#25)(1996-12#23)(1996-2#16)(1996-3#39)(1996-4#17)(1996-5#14)(1996-6#22)(1996-7#9)(1996-8#12)(1996-9#27)(1997-1#19)(1997-2#26)(1997-3#30)(1997-4#26)(1997-5#21)(1997-6#29)(1997-7#20)(1997-8#37)(2004-1#16)(2004-10#11)(2004-11#19)(2004-12#6)(2004-2#15)(2004-3#5)(2004-4#1)(2004-7#1)(2004-9#5)(2005-1#12)(2005-10#39)(2005-11#18)(2005-12#15)(2005-2#2)(2005-3#2)(2005-4#2)(2005-5#5)(2005-6#2)(2005-7#29)(2005-8#37)(2005-9#19)(2006-1#24)(2006-10#240)(2006-11#36)(2006-12#43)(2006-2#46)(2006-3#17)(2006-4#34)(2006-5#29)(2006-6#46)(2006-7#53)(2006-8#94)(2006-9#23)(2007-1#29)(2007-10#65)(2007-11#157)(2007-12#79)(2007-2#112)(2007-3#43)(2007-4#43)(2007-5#32)(2007-6#35)(2007-7#274)(2007-8#263)(2007-9#90)(2008-1#147)(2008-10#382)(2008-11#116)(2008-12#76)(2008-2#53)(2008-3#99)(2008-4#104)(2008-5#110)(2008-6#99)(2008-7#201)(2008-8#96)(2008-9#110)(2009-1#6)(2009-10#32)(2009-11#9)(2009-12#15)(2009-2#34)(2009-3#43)(2009-4#45)(2009-5#37)(2009-6#22)(2009-7#23)(2009-8#41)(2009-9#24)(2010-1#18)(2010-10#18)(2010-11#22)(2010-12#95)(2010-2#22)(2010-3#53)(2010-4#26)(2010-5#26)(2010-6#24)(2010-7#25)(2010-8#48)(2010-9#21)(2011-1#132)(2011-11#12)(2011-12#38)(2011-2#359)(2011-3#13)(2011-7#6)(2012-1#51)(2012-10#1)(2012-11#17)(2012-12#184)(2012-2#164)(2012-3#132)(2012-5#1)(2013-1#337)(2013-4#1)(2013-7#47)(2013-8#174)
years' duration##6##2##(1990-3#1)(2006-10#2)(2007-11#1)(2007-7#2)
years' experience of a##2##4##(1990-3#1)(2004-12#1)
years' experience of##3##3##(1990-3#1)(1991-2#1)(2004-12#1)
years' experience##13##2##(1990-2#1)(1990-3#1)(1991-2#1)(1994-4#1)(1994-9#1)(1995-11#1)(2004-12#1)(2006-10#1)(2007-2#1)(2007-7#2)(2010-11#1)(2012-12#1)
years' follow-up##3##2##(2008-11#1)(2008-7#1)(2012-11#1)
years'##43##1##(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1991-2#1)(1992-5#1)(1993-5#1)(1994-4#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-11#1)(1996-12#1)(2004-12#1)(2005-8#1)(2006-10#4)(2007-11#1)(2007-2#1)(2007-7#4)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-11#1)(2011-1#2)(2011-2#2)(2012-11#2)(2012-12#2)(2013-7#1)
years) admitted##4##2##(1990-8#1)(2005-6#1)(2007-7#1)(2008-5#1)
years) after the##2##3##(2008-3#1)(2008-8#1)
years) after##7##2##(1990-6#1)(1991-3#1)(1995-9#1)(2007-8#1)(2008-3#1)(2008-8#1)(2012-1#1)
years) and a##3##3##(1994-2#1)(2007-10#1)(2008-10#1)
years) and compared##2##3##(2007-5#1)(2008-7#1)
years) and elderly##2##3##(1991-6#1)(1996-11#1)
years) and older##2##3##(2007-9#1)(2010-2#1)
years) and the prevalence of##2##5##(2008-1#1)(2011-2#1)
years) and the##6##3##(1991-12#1)(2007-2#1)(2008-1#1)(2008-5#1)(2008-9#1)(2011-2#1)
years) and to have##2##4##(1996-2#1)(2007-10#1)
years) and##71##2##(1990-6#1)(1990-8#1)(1991-12#1)(1991-6#1)(1993-11#1)(1993-9#1)(1994-2#1)(1994-4#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-2#1)(2004-1#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#3)(2007-5#1)(2007-6#1)(2007-7#3)(2007-9#3)(2008-1#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#5)(2008-9#2)(2009-5#1)(2010-1#1)(2010-2#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)
years) are##3##2##(2008-10#1)(2009-4#1)(2011-2#1)
years) as##2##2##(2006-10#1)(2012-12#1)
years) at##2##2##(2006-2#1)(2010-9#1)
years) attending##3##2##(2007-7#1)(2008-7#1)(2010-6#1)
years) completed##2##2##(2007-12#1)(2012-12#1)
years) diagnosed##3##2##(2006-8#1)(2011-2#1)(2012-3#1)
years) for temporary vascular access for hemodialysis##2##7##(2007-7#2)
years) for##4##2##(1991-11#1)(2007-7#2)(2010-10#1)
years) from##2##2##(2008-10#1)(2008-3#1)
years) had##3##2##(1996-8#1)(2006-6#1)(2008-3#1)
years) have been##3##3##(1993-5#1)(2007-11#1)(2009-8#1)
years) have##6##2##(1993-5#1)(1997-1#1)(2007-11#1)(2009-8#1)(2011-2#2)
years) in a##2##3##(1990-6#1)(2008-5#1)
years) in the##3##3##(2007-7#1)(2008-5#1)(2012-12#1)
years) in##14##2##(1990-6#1)(1993-2#1)(2005-8#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#2)(2012-1#1)(2012-12#1)(2013-8#1)
years) living##2##2##(2006-4#1)(2010-12#1)
years) of the##2##3##(1991-3#1)(2006-2#1)
years) of##8##2##(1991-3#1)(1991-4#1)(2006-2#1)(2011-1#1)(2011-12#1)(2012-3#2)(2013-1#1)
years) participated in the##2##4##(1993-12#1)(2013-1#1)
years) participated in this study##2##5##(2007-6#1)(2013-1#1)
years) participated in##5##3##(1993-12#1)(2007-6#1)(2008-5#1)(2013-1#2)
years) participated##6##2##(1993-12#1)(2007-6#1)(2008-5#1)(2009-1#1)(2013-1#2)
years) patients##2##2##(2007-8#1)(2008-4#1)
years) received##4##2##(1997-2#2)(2010-1#1)(2013-1#1)
years) referred##2##2##(2008-12#1)(2008-7#1)
years) started##2##2##(2007-7#1)(2011-2#1)
years) suffering from##2##3##(1991-4#1)(2007-7#1)
years) than##4##2##(1992-5#1)(2007-9#1)(2008-10#1)(2011-2#1)
years) the##3##2##(1990-7#1)(1990-8#1)(1997-3#1)
years) to##4##2##(1990-3#1)(2006-2#1)(2008-11#1)(2012-3#1)
years) treated##6##2##(1990-10#1)(2007-8#1)(2008-2#1)(2008-7#1)(2009-3#1)(2011-2#1)
years) underwent##6##2##(2006-8#1)(2007-8#3)(2008-10#1)(2008-9#1)
years) using a##2##3##(2009-4#1)(2012-12#1)
years) was##5##2##(1992-12#1)(1995-5#1)(2007-2#1)(2007-7#1)(2009-4#1)
years) were classified as##2##4##(2004-2#2)
years) were collected##3##3##(1994-9#1)(2006-1#1)(2012-1#1)
years) were enrolled##3##3##(2007-8#1)(2010-12#1)(2013-8#1)
years) were examined##3##3##(2006-4#1)(2007-2#1)(2008-6#1)
years) were investigated##2##3##(1993-5#1)(2013-1#1)
years) were randomly assigned to##2##5##(2013-1#1)(2013-8#1)
years) were recruited##2##3##(2008-2#1)(2013-8#1)
years) were selected from##2##4##(2011-1#1)(2012-12#1)
years) were tested##2##3##(1992-4#1)(2011-1#1)
years) were treated for##2##4##(1992-1#1)(1996-2#1)
years) were treated##4##3##(1992-1#1)(1996-2#1)(2008-6#1)(2013-1#1)
years) were##48##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-4#1)(1993-10#1)(1993-11#1)(1993-5#1)(1994-9#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-7#1)(2004-2#2)(2006-1#1)(2006-11#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#1)(2009-6#1)(2010-12#1)(2010-9#1)(2011-1#4)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#3)
years) who had undergone##2##4##(1990-11#1)(2004-12#1)
years) who had##10##3##(1990-11#1)(1993-1#1)(1993-12#1)(1996-8#1)(2004-11#1)(2004-12#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-9#1)
years) who underwent coronary##2##4##(2007-8#2)
years) who underwent##4##3##(2004-1#1)(2006-8#1)(2007-8#2)
years) who were##5##3##(1990-5#1)(1993-10#1)(2007-10#1)(2007-12#1)(2008-11#1)
years) who##25##2##(1990-11#1)(1990-5#1)(1993-1#1)(1993-10#1)(1993-12#1)(1996-8#1)(2004-1#1)(2004-11#1)(2004-12#1)(2006-8#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-3#1)(2011-2#2)(2012-1#1)(2012-12#1)
years) with a##5##3##(1990-7#1)(1990-9#1)(2007-11#1)(2012-3#1)(2013-1#1)
years) with chronic pancreatitis##2##4##(1991-2#1)(1991-8#1)
years) with chronic##3##3##(1991-2#1)(1991-8#1)(1995-3#1)
years) with normal##2##3##(1996-8#1)(2008-3#1)
years) with severe##2##3##(2007-2#1)(2009-3#1)
years) with##59##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-8#1)(1992-5#1)(1992-7#1)(1992-9#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-8#2)(2004-10#1)(2004-3#1)(2006-10#1)(2006-2#1)(2006-8#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#4)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#1)(2008-3#2)(2008-5#1)(2008-6#2)(2009-3#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#5)(2013-4#1)
years) without##2##2##(1990-2#1)(1994-4#1)
years)##675##1##(1990-10#3)(1990-11#3)(1990-12#1)(1990-2#4)(1990-3#3)(1990-5#1)(1990-6#4)(1990-7#4)(1990-8#7)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#3)(1991-4#3)(1991-5#2)(1991-6#1)(1991-8#7)(1992-1#2)(1992-10#1)(1992-12#2)(1992-2#2)(1992-4#1)(1992-5#4)(1992-6#4)(1992-7#2)(1992-8#2)(1992-9#4)(1993-1#1)(1993-10#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-5#4)(1993-7#1)(1993-9#2)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-4#4)(1994-7#3)(1994-9#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#4)(1995-6#2)(1995-9#4)(1996-1#2)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#3)(1996-4#1)(1996-6#3)(1996-7#1)(1996-8#6)(1996-9#1)(1997-1#1)(1997-2#6)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#2)(2004-1#3)(2004-10#2)(2004-11#2)(2004-12#1)(2004-2#2)(2004-3#1)(2005-1#3)(2005-10#1)(2005-12#2)(2005-5#1)(2005-6#1)(2005-8#2)(2005-9#6)(2006-1#3)(2006-10#11)(2006-11#5)(2006-12#3)(2006-2#7)(2006-3#2)(2006-4#3)(2006-5#3)(2006-6#3)(2006-7#1)(2006-8#9)(2007-1#2)(2007-10#15)(2007-11#11)(2007-12#6)(2007-2#24)(2007-3#6)(2007-4#2)(2007-5#2)(2007-6#5)(2007-7#30)(2007-8#32)(2007-9#15)(2008-1#19)(2008-10#14)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#11)(2008-4#12)(2008-5#13)(2008-6#12)(2008-7#20)(2008-8#3)(2008-9#11)(2009-1#1)(2009-10#3)(2009-3#2)(2009-4#4)(2009-5#3)(2009-6#1)(2009-7#5)(2009-8#2)(2009-9#2)(2010-1#4)(2010-10#2)(2010-12#4)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#5)(2011-1#9)(2011-11#1)(2011-12#3)(2011-2#29)(2011-3#2)(2012-1#8)(2012-11#1)(2012-12#12)(2012-2#4)(2012-3#11)(2013-1#23)(2013-4#1)(2013-7#1)(2013-8#9)
years-old##10##1##(2006-7#1)(2008-1#1)(2011-2#1)(2012-12#4)(2012-2#2)(2013-8#1)
years?##2##1##(2006-10#1)(2006-8#1)
years]##32##1##(1990-10#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-10#1)(1994-10#1)(1994-7#1)(1996-2#1)(1997-6#1)(2004-10#2)(2007-8#1)(2008-11#1)(2008-9#1)(2009-10#1)(2010-3#1)(2011-11#1)(2011-2#4)(2012-12#1)(2013-1#6)(2013-8#1)
years])##3##1##(2010-12#1)(2011-2#1)(2013-1#1)
yeast (Saccharomyces cerevisiae)##5##3##(1990-8#1)(1993-3#1)(2008-10#1)(2008-12#1)(2008-4#1)
yeast (Saccharomyces##6##2##(1990-8#1)(1993-3#1)(2008-10#1)(2008-12#2)(2008-4#1)
yeast 2-hybrid##2##2##(2008-9#1)(2010-2#1)
yeast ARG-11##2##2##(1997-6#2)
yeast Arxula adeninivorans##4##3##(1996-9#4)
yeast Candida albicans##3##3##(1996-12#1)(2008-5#2)
yeast Candida oleophila##3##3##(2008-10#3)
yeast Candida tropicalis##4##3##(1990-5#1)(1991-8#2)(1991-9#1)
yeast Candida##14##2##(1990-5#1)(1991-8#2)(1991-9#1)(1995-8#1)(1996-12#1)(1996-9#2)(1997-2#1)(2008-10#3)(2008-5#2)
yeast DNA polymerase alpha complex##3##5##(1993-3#3)
yeast DNA polymerase alpha##4##4##(1993-3#4)
yeast DNA polymerase##5##3##(1990-5#1)(1993-3#4)
yeast DNA##9##2##(1990-5#1)(1993-11#1)(1993-2#1)(1993-3#4)(1994-9#1)(1997-6#1)
yeast GAL4##2##2##(1990-8#1)(1997-4#1)
yeast HAP2 and HAP3##2##4##(1995-2#2)
yeast HAP2##4##2##(1995-2#2)(2008-9#2)
yeast ISC##2##2##(2008-7#2)
yeast Kex2##3##2##(1992-12#2)(1992-5#1)
yeast Kluyveromyces lactis##3##3##(1995-4#1)(1995-8#1)(1996-7#1)
yeast L17A##2##2##(1991-6#2)
yeast P-450(14)DM##2##2##(1992-3#2)
yeast P450(14DM)##2##2##(1994-6#2)
yeast PFTase##2##2##(1993-9#1)(1997-7#1)
yeast Pichia pastoris as a##2##5##(1992-7#1)(2009-9#1)
yeast Pichia pastoris##13##3##(1992-7#1)(1994-11#1)(1994-3#2)(1996-11#1)(1996-9#1)(1997-4#2)(1997-7#1)(2007-11#1)(2008-7#1)(2009-9#1)(2010-5#1)
yeast Pichia##14##2##(1992-7#1)(1994-11#1)(1994-3#2)(1996-11#1)(1996-9#1)(1997-4#2)(1997-7#1)(2007-11#2)(2008-7#1)(2009-9#1)(2010-5#1)
yeast RNA and denatured DNA##2##5##(2008-10#2)
yeast RNA polymerase II##2##4##(1997-1#1)(1997-4#1)
yeast RNA polymerase##4##3##(1996-7#1)(1997-1#1)(1997-4#1)(1997-6#1)
yeast RNA##17##2##(1996-7#1)(1997-1#1)(1997-4#1)(1997-6#1)(2008-10#10)(2008-3#1)(2008-4#1)(2009-3#1)
yeast S##7##2##(1994-10#2)(1994-9#1)(2006-12#1)(2008-2#2)(2009-12#1)
yeast Saccharomyces cerevisiae and##3##4##(1991-12#1)(1994-9#1)(2008-2#1)
yeast Saccharomyces cerevisiae has become a##2##6##(1990-7#1)(2008-4#1)
yeast Saccharomyces cerevisiae has been##2##5##(1991-7#1)(2008-6#1)
yeast Saccharomyces cerevisiae has##4##4##(1990-7#1)(1991-7#1)(2008-4#1)(2008-6#1)
yeast Saccharomyces cerevisiae was##2##4##(1991-8#1)(1995-5#1)
yeast Saccharomyces cerevisiae##54##3##(1990-10#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#3)(1991-12#1)(1991-7#1)(1991-8#2)(1992-11#1)(1992-2#2)(1992-3#2)(1992-7#1)(1992-8#2)(1993-3#1)(1993-8#2)(1994-3#3)(1994-9#3)(1995-12#1)(1995-5#2)(1995-6#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#2)(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
yeast Saccharomyces##55##2##(1990-10#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#3)(1991-12#1)(1991-7#1)(1991-8#2)(1992-11#1)(1992-2#2)(1992-3#2)(1992-7#1)(1992-8#2)(1993-3#1)(1993-8#2)(1994-3#3)(1994-9#3)(1995-12#1)(1995-5#2)(1995-6#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#2)(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
yeast Schizosaccharomyces pombe##18##3##(1990-2#2)(1992-6#1)(1992-7#1)(1994-2#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-8#2)(1995-9#1)(1997-3#2)(2008-7#1)(2008-9#1)(2009-3#1)(2012-3#1)
yeast TATA##2##2##(1990-6#2)
yeast TATA-binding protein##2##3##(1992-5#1)(1995-8#1)
yeast TBP-TAFII complex##2##3##(1995-8#2)
yeast TFIID##2##2##(1990-2#1)(1990-6#1)
yeast Yarrowia lipolytica##3##3##(1995-4#1)(2011-1#2)
yeast alcohol dehydrogenase##3##3##(2005-11#1)(2005-4#1)(2008-6#1)
yeast and Escherichia coli##2##4##(1990-10#1)(1997-6#1)
yeast and bacteria##2##3##(1994-5#1)(2011-1#1)
yeast and bacterial##2##3##(1990-7#1)(1994-8#1)
yeast and higher##2##3##(1996-10#1)(2009-5#1)
yeast and human##2##3##(1996-5#1)(2008-9#1)
yeast and hyphal##2##3##(1991-9#1)(2007-7#1)
yeast and mammalian cells have##2##5##(2008-5#1)(2008-9#1)
yeast and mammalian cells##9##4##(1990-8#1)(1997-3#2)(1997-7#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-8#1)
yeast and mammalian##11##3##(1990-8#1)(1992-2#1)(1996-8#1)(1997-3#2)(1997-7#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-8#1)
yeast and mammals##2##3##(1996-11#1)(2012-2#1)
yeast and plant##3##3##(1992-3#1)(1992-8#1)(1993-6#1)
yeast and##51##2##(1990-10#1)(1990-11#1)(1990-7#2)(1990-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-6#2)(1993-8#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-10#2)(1996-11#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-8#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#2)(2009-12#2)(2009-5#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
yeast antioxidant protein##2##3##(1993-4#2)
yeast are##4##2##(1992-10#1)(1994-12#1)(1996-3#1)(2008-7#1)
yeast artificial chromosome (YAC) library##2##5##(1993-3#1)(2008-5#1)
yeast artificial chromosome (YAC)##7##4##(1993-3#1)(1994-12#1)(1996-10#1)(1997-1#1)(2008-4#2)(2008-5#1)
yeast artificial chromosome map covering##2##5##(1996-4#2)
yeast artificial chromosome##13##3##(1991-9#1)(1993-3#1)(1994-12#1)(1996-10#1)(1996-4#2)(1996-8#1)(1997-1#1)(1997-8#2)(2008-4#2)(2008-5#1)
yeast artificial chromosomes (YACs)##4##4##(1991-9#1)(1996-10#2)(1997-2#1)
yeast artificial chromosomes##6##3##(1991-9#1)(1995-6#1)(1996-10#2)(1996-4#1)(1997-2#1)
yeast artificial##19##2##(1991-9#2)(1993-3#1)(1994-12#1)(1995-6#1)(1996-10#3)(1996-4#3)(1996-8#1)(1997-1#1)(1997-2#1)(1997-8#2)(2008-4#2)(2008-5#1)
yeast as##4##2##(1993-6#1)(1996-7#1)(2008-5#1)(2008-7#1)
yeast autonomously##2##2##(1997-8#1)(2008-8#1)
yeast based##2##2##(1994-11#1)(2008-7#1)
yeast beta Tub##2##3##(1993-6#2)
yeast biomass##3##2##(2008-10#2)(2008-5#1)
yeast but##2##2##(2008-7#1)(2012-2#1)
yeast by##13##2##(1990-5#1)(1990-8#1)(1991-6#1)(1992-6#1)(1993-8#1)(1995-6#1)(1996-7#1)(1997-6#1)(2005-4#1)(2007-8#1)(2008-10#2)(2008-7#1)
yeast can be##2##3##(1993-8#1)(2008-2#1)
yeast casein##2##2##(1993-8#1)(1994-8#1)
yeast cell cycle##3##3##(1991-5#1)(2008-9#1)(2010-1#1)
yeast cell is##2##3##(2007-12#1)(2009-12#1)
yeast cell viability##2##3##(1995-8#1)(1997-5#1)
yeast cell##18##2##(1990-2#1)(1991-5#1)(1993-8#1)(1994-11#1)(1995-3#1)(1995-8#1)(1997-4#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-1#1)(2011-2#1)
yeast cells and##2##3##(2006-2#2)
yeast cells by##4##3##(1995-8#1)(1996-6#1)(2008-8#1)(2008-9#1)
yeast cells grown##2##3##(1997-6#1)(2007-12#1)
yeast cells in##3##3##(1994-11#1)(2008-10#1)(2011-1#1)
yeast cells were##4##3##(1990-2#2)(2008-5#2)
yeast cells with##2##3##(2007-7#1)(2008-10#1)
yeast cells##73##2##(1990-2#5)(1990-3#1)(1990-5#1)(1991-7#2)(1991-8#1)(1991-9#1)(1993-11#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-8#2)(1995-2#3)(1995-3#1)(1995-8#1)(1996-5#1)(1996-6#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-2#2)(2007-11#3)(2007-12#2)(2007-7#2)(2008-1#1)(2008-10#12)(2008-11#1)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#4)(2008-9#3)(2009-12#1)(2009-6#1)(2010-10#1)(2011-1#1)
yeast centromere##2##2##(1991-7#1)(1992-12#1)
yeast chromosomal##2##2##(1991-7#1)(1991-9#1)
yeast chromosome III##2##3##(1990-10#1)(1993-6#1)
yeast chromosome VII##2##3##(1997-3#2)
yeast chromosome XIV##3##3##(1995-9#1)(1996-3#1)(1996-6#1)
yeast chromosome##10##2##(1990-10#1)(1993-6#1)(1995-9#1)(1996-3#1)(1996-6#2)(1997-3#3)(1997-4#1)
yeast chromosomes##3##2##(1993-11#1)(1997-4#1)(2008-10#1)
yeast concentrations##2##2##(2008-10#1)(2008-5#1)
yeast containing human DDK##2##4##(2012-3#2)
yeast containing##3##2##(1991-9#1)(2012-3#2)
yeast could##2##2##(1996-3#1)(2011-2#1)
yeast cytochrome c peroxidase##2##4##(1994-12#1)(1995-11#1)
yeast cytochrome c##4##3##(1994-12#1)(1995-11#1)(1995-5#1)(1997-4#1)
yeast cytochrome oxidase##2##3##(1992-6#1)(1995-6#1)
yeast cytochrome##7##2##(1992-6#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-5#1)(1995-6#1)(1997-4#1)
yeast cytosol##3##2##(1996-9#3)
yeast cytosolic##4##2##(1991-2#1)(1996-8#1)(1997-6#2)
yeast did not have any##2##5##(2008-10#1)(2008-12#1)
yeast eEF1A##3##2##(1997-2#3)
yeast endogenous##2##2##(1990-12#2)
yeast enolase##2##2##(1994-8#1)(1995-1#1)
yeast enzyme##7##2##(1990-12#1)(1991-2#1)(1991-4#1)(1992-9#1)(1995-2#1)(1995-3#1)(1997-4#1)
yeast enzymes##2##2##(1996-5#1)(1997-6#1)
yeast expressed sequence tags##2##4##(1995-9#1)(1996-6#1)
yeast expression system##2##3##(1994-2#2)
yeast expression vectors##2##3##(1993-12#2)
yeast expression##8##2##(1993-12#2)(1993-9#1)(1994-2#2)(1995-2#1)(1997-6#1)(2008-9#1)
yeast extract (YE)##3##3##(2004-8#1)(2008-11#1)(2008-6#1)
yeast extract and 0##2##4##(2008-7#2)
yeast extract and##3##3##(2008-5#1)(2008-7#2)
yeast extract as##2##3##(2006-10#1)(2008-5#1)
yeast extract concentration##2##3##(2008-5#1)(2008-7#1)
yeast extract##27##2##(1990-3#1)(2004-8#2)(2005-11#1)(2006-10#1)(2006-8#3)(2006-9#1)(2008-10#1)(2008-11#2)(2008-5#6)(2008-6#3)(2008-7#3)(2012-3#1)(2013-7#2)
yeast extracts##4##2##(1990-12#1)(1990-8#1)(1996-2#1)(2012-3#1)
yeast fermentation##3##2##(2008-5#1)(2008-7#1)(2012-3#1)
yeast flocculation##4##2##(2008-10#1)(2008-7#3)
yeast for##2##2##(1997-4#1)(2008-10#1)
yeast forms##3##2##(2008-4#1)(2008-5#1)(2008-8#1)
yeast fragment##2##2##(1991-9#1)(1997-6#1)
yeast gene encoding a protein##2##5##(1990-5#1)(1993-11#1)
yeast gene encoding##3##3##(1990-5#1)(1991-6#1)(1993-11#1)
yeast gene required for##3##4##(1990-6#1)(1995-9#1)(1997-4#1)
yeast gene##12##2##(1990-4#1)(1990-5#1)(1990-6#1)(1991-6#1)(1991-7#1)(1993-11#1)(1995-8#1)(1995-9#1)(1996-7#1)(1997-4#1)(1997-6#1)(1997-8#1)
yeast general##2##2##(1995-6#1)(1996-7#1)
yeast genes##7##2##(1994-6#2)(1995-12#1)(1995-8#1)(1995-9#1)(1997-3#1)(2008-10#1)
yeast genome sequencing project##2##4##(1995-4#1)(1995-7#1)
yeast genome##12##2##(1990-5#1)(1991-7#1)(1993-9#1)(1995-4#1)(1995-7#1)(1995-8#1)(1996-3#1)(2006-10#1)(2008-11#1)(2008-7#2)(2012-3#1)
yeast genomic library##2##3##(1996-10#1)(1997-6#1)
yeast genomic##4##2##(1995-11#1)(1996-10#1)(1997-6#1)(1997-7#1)
yeast glutathione reductase##2##3##(1994-3#1)(1995-3#1)
yeast glutathione##3##2##(1990-10#1)(1994-3#1)(1995-3#1)
yeast glycolytic##2##2##(1990-4#1)(1996-7#1)
yeast grown on##2##3##(1996-11#1)(2008-4#1)
yeast had a##2##3##(1990-8#1)(2007-12#1)
yeast had##3##2##(1990-8#1)(2007-12#1)(2008-10#1)
yeast has##3##2##(1992-8#1)(1993-6#1)(1993-9#1)
yeast have been##4##3##(1991-12#1)(1995-9#1)(2008-4#1)(2008-5#1)
yeast have##5##2##(1991-12#1)(1995-9#1)(1996-7#1)(2008-4#1)(2008-5#1)
yeast hexokinase isoenzymes##2##3##(1991-11#2)
yeast hexokinase##3##2##(1991-11#2)(2008-10#1)
yeast homolog of##2##3##(1994-5#1)(2005-8#1)
yeast homologue##4##2##(1993-2#1)(1996-9#1)(1997-6#1)(2008-3#1)
yeast homologues##2##2##(1995-2#2)
yeast identification##4##2##(2007-7#4)
yeast in##8##2##(1995-8#1)(1995-9#1)(1996-12#1)(1996-7#1)(2008-10#1)(2008-8#1)(2011-1#2)
yeast indicates##2##2##(1990-7#1)(1992-9#1)
yeast initiator tRNA(Met)##2##3##(1990-4#2)
yeast interaction##2##2##(1995-6#1)(2009-10#1)
yeast invertase##5##2##(1994-5#1)(1996-3#1)(2008-7#3)
yeast is a##5##3##(1990-10#1)(2008-10#2)(2008-2#2)
yeast is##16##2##(1990-10#1)(1992-5#1)(1993-9#2)(1997-7#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-8#1)(2009-12#1)(2010-7#1)(2011-2#1)(2012-3#1)
yeast iso-1-cytochrome c##3##3##(1990-7#2)(1995-5#1)
yeast lacking##2##2##(1990-8#1)(1997-6#1)
yeast lanosterol 14##2##3##(1991-5#1)(1992-3#1)
yeast lanosterol##4##2##(1991-5#1)(1992-3#1)(1992-8#1)(1994-6#1)
yeast mannan##2##2##(1991-5#1)(1997-2#1)
yeast may##2##2##(1994-6#1)(2008-7#1)
yeast microsomes##5##2##(1990-11#1)(1990-12#4)
yeast mitochondria##5##2##(1992-6#1)(1994-5#2)(2012-2#1)(2013-8#1)
yeast mitochondrial##8##2##(1992-11#2)(1992-12#2)(1995-6#1)(1996-9#1)(1997-1#1)(1997-8#1)
yeast mutants##6##2##(1990-6#1)(1990-8#1)(1991-9#1)(1994-12#1)(1995-2#1)(2011-1#1)
yeast nitrogen##2##2##(2008-10#1)(2008-5#1)
yeast nuclear##3##2##(1994-12#2)(1995-2#1)
yeast of the##2##3##(1997-1#1)(2008-5#1)
yeast of##5##2##(1990-7#1)(1996-12#1)(1997-1#1)(2008-10#1)(2008-5#1)
yeast on##2##2##(2007-12#1)(2013-1#1)
yeast one-hybrid system##5##3##(1997-4#1)(2008-8#1)(2008-9#3)
yeast or##4##2##(1995-6#1)(1995-9#1)(2008-10#1)(2009-8#1)
yeast particles and associated respiratory burst##2##6##(1991-6#2)
yeast particles##4##2##(1991-6#3)(1994-6#1)
yeast phosphoglycerate kinase##4##3##(1990-5#2)(1991-2#2)
yeast phosphoglycerate##5##2##(1990-5#2)(1991-2#2)(1993-3#1)
yeast plasmid##2##2##(1991-8#1)(1996-7#1)
yeast plasmids##3##2##(1991-8#1)(1992-6#1)(1997-3#1)
yeast poly(A)-binding protein##2##3##(1997-5#2)
yeast polysaccharides##2##2##(2008-10#2)
yeast populations##5##2##(1995-9#1)(1997-7#1)(2007-3#1)(2008-8#1)(2010-10#1)
yeast product##2##2##(1992-6#1)(1996-9#1)
yeast promoter##5##2##(1991-7#1)(1991-8#1)(1991-9#1)(1994-5#1)(1995-6#1)
yeast propagated under##2##3##(2007-12#2)
yeast propagated##3##2##(2007-12#3)
yeast protein##9##2##(1991-1#1)(1993-11#1)(1996-9#1)(1997-2#1)(1997-3#2)(2008-11#1)(2009-7#1)(2012-3#1)
yeast proteome##3##2##(2006-12#2)(2008-4#1)
yeast pyruvate decarboxylase##3##3##(1990-3#1)(1995-10#2)
yeast reduced the##2##3##(1996-5#1)(2011-2#1)
yeast shuttle vector##2##3##(1995-6#1)(1997-2#1)
yeast species##6##2##(1995-6#1)(1996-6#2)(2008-4#1)(2008-5#1)(2012-2#1)
yeast strain##16##2##(1992-12#1)(1993-3#1)(1994-9#2)(1996-7#1)(1997-3#1)(2005-11#1)(2006-11#1)(2008-10#2)(2008-5#3)(2008-6#1)(2008-8#1)(2012-2#1)
yeast strains as##2##3##(2008-10#1)(2009-2#1)
yeast strains claimed##2##3##(2010-7#2)
yeast strains isolated from##3##4##(2009-2#2)(2013-1#1)
yeast strains were##2##3##(2008-10#1)(2010-7#1)
yeast strains with##3##3##(1993-8#1)(2008-4#1)(2008-8#1)
yeast strains##35##2##(1990-7#1)(1991-11#1)(1991-7#1)(1992-10#2)(1993-12#1)(1993-8#1)(1995-6#1)(1996-6#3)(2007-12#1)(2008-10#6)(2008-4#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#3)(2010-7#6)(2012-3#2)(2013-1#1)
yeast systems##2##2##(1997-4#1)(2008-11#1)
yeast tRNA##2##2##(2008-8#2)
yeast tRNA(Ala)##5##2##(2008-8#5)
yeast tRNA(Asp)##3##2##(1992-7#3)
yeast tRNA(Phe)##2##2##(1991-11#1)(2008-8#1)
yeast tRNA(phe)##3##2##(1993-3#2)(2008-3#1)
yeast temperature-sensitive##3##2##(1995-4#1)(1997-3#1)(1997-8#1)
yeast that##3##2##(1993-2#1)(1997-6#1)(2012-2#1)
yeast through##2##2##(1994-12#1)(2007-8#1)
yeast to##17##2##(1991-1#1)(1992-11#1)(1994-11#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-1#3)(2008-12#1)(2008-5#2)(2011-1#2)(2012-1#1)
yeast topoisomerase##2##2##(1995-1#1)(1995-6#1)
yeast transcription factor IIA##2##4##(1992-2#2)
yeast transcription factor##3##3##(1992-2#2)(1996-2#1)
yeast transcriptional activator##3##3##(1991-5#1)(1996-3#1)(2006-12#1)
yeast transformants##3##2##(1996-2#1)(1997-2#1)(1997-4#1)
yeast treatment##2##2##(2008-10#2)
yeast tubulin##3##2##(1993-8#3)
yeast two hybrid##2##3##(1994-2#1)(2008-7#1)
yeast two-hybrid assay##3##3##(1995-6#1)(2008-5#1)(2008-9#1)
yeast two-hybrid system##18##3##(1995-1#1)(1996-5#2)(1997-1#1)(1997-7#1)(2008-2#1)(2008-8#8)(2008-9#4)
yeast two-hybrid##31##2##(1995-1#1)(1995-6#1)(1996-5#3)(1997-1#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#8)(2008-9#6)(2009-10#1)(2011-2#1)
yeast using##2##2##(1990-4#1)(2008-9#1)
yeast vacuole##2##2##(1993-6#1)(2008-11#1)
yeast was##10##2##(1990-10#1)(1991-5#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-5#2)(2011-1#1)(2011-2#1)
yeast were##7##2##(1992-11#1)(1996-7#2)(2005-4#1)(2007-8#1)(2008-10#1)(2008-5#1)
yeast with##5##2##(1997-4#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-7#1)
yeast##1430##1##(1990-10#16)(1990-11#5)(1990-12#17)(1990-2#18)(1990-3#11)(1990-4#8)(1990-5#17)(1990-6#10)(1990-7#13)(1990-8#9)(1991-1#4)(1991-11#5)(1991-12#2)(1991-2#8)(1991-3#2)(1991-4#3)(1991-5#9)(1991-6#8)(1991-7#22)(1991-8#11)(1991-9#17)(1992-1#3)(1992-10#3)(1992-11#8)(1992-12#12)(1992-2#10)(1992-3#7)(1992-5#4)(1992-6#7)(1992-7#8)(1992-8#10)(1992-9#3)(1993-11#10)(1993-12#9)(1993-2#6)(1993-3#16)(1993-4#4)(1993-5#3)(1993-6#17)(1993-7#2)(1993-8#16)(1993-9#14)(1994-10#5)(1994-11#14)(1994-12#14)(1994-2#5)(1994-3#8)(1994-5#8)(1994-6#12)(1994-8#10)(1994-9#20)(1995-1#3)(1995-10#2)(1995-11#2)(1995-12#2)(1995-2#25)(1995-3#10)(1995-4#8)(1995-5#5)(1995-6#26)(1995-7#1)(1995-8#24)(1995-9#13)(1996-10#9)(1996-11#4)(1996-12#5)(1996-2#11)(1996-3#9)(1996-4#3)(1996-5#17)(1996-6#20)(1996-7#24)(1996-8#3)(1996-9#20)(1997-1#8)(1997-2#18)(1997-3#21)(1997-4#27)(1997-5#3)(1997-6#43)(1997-7#19)(1997-8#11)(2004-8#2)(2005-10#1)(2005-11#6)(2005-4#6)(2005-8#4)(2006-10#3)(2006-11#1)(2006-12#9)(2006-2#2)(2006-3#2)(2006-8#4)(2006-9#1)(2007-11#7)(2007-12#12)(2007-2#1)(2007-3#1)(2007-7#11)(2007-8#6)(2007-9#1)(2008-1#3)(2008-10#98)(2008-11#16)(2008-12#10)(2008-2#13)(2008-3#4)(2008-4#18)(2008-5#47)(2008-6#17)(2008-7#49)(2008-8#38)(2008-9#25)(2009-10#5)(2009-12#8)(2009-2#3)(2009-3#4)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#1)(2010-2#2)(2010-4#3)(2010-5#2)(2010-7#11)(2011-1#13)(2011-2#16)(2012-1#2)(2012-12#2)(2012-2#11)(2012-3#25)(2013-1#3)(2013-7#2)(2013-8#3)
yeast)##7##1##(1990-3#2)(2006-10#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)
yeast-derived##4##1##(1993-3#1)(2006-12#1)(2007-11#1)(2008-11#1)
yeast-expressed P450 NF25##2##3##(1990-12#2)
yeast-expressed##3##1##(1990-12#2)(1997-4#1)
yeast-phase exo-antigen of##2##3##(2008-5#2)
yeast-phase exo-antigen##3##2##(2008-5#3)
yeast-phase##6##1##(2008-5#6)
yeast]##2##1##(2010-11#2)
yeastlike##2##1##(2007-10#1)(2008-10#1)
yeastolate##3##1##(2008-11#3)
yeasts Candida albicans and##2##4##(1993-3#1)(2008-11#1)
yeasts Malassezia sp##2##3##(2007-9#2)
yeasts against##2##2##(2007-7#1)(2008-10#1)
yeasts and filamentous fungi##3##4##(2008-6#1)(2011-2#1)(2013-8#1)
yeasts and molds##2##3##(2010-11#1)(2011-2#1)
yeasts and##13##2##(1994-2#1)(1995-6#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-11#1)(2011-2#2)(2012-3#1)(2013-8#1)
yeasts as##2##2##(2009-2#2)
yeasts have been##2##3##(1997-4#1)(2009-2#1)
yeasts in##6##2##(1993-12#1)(1997-4#1)(2004-8#1)(2008-10#1)(2013-1#2)
yeasts may##2##2##(2007-9#1)(2012-3#1)
yeasts of##5##2##(2008-5#3)(2011-2#1)(2013-1#1)
yeasts should##2##2##(1991-7#1)(2009-9#1)
yeasts showed##2##2##(2013-1#2)
yeasts to##3##2##(2007-7#1)(2008-10#1)(2008-5#1)
yeasts were##2##2##(2007-7#1)(2008-5#1)
yeasts##110##1##(1990-2#1)(1990-4#1)(1991-7#1)(1991-8#1)(1993-12#3)(1993-3#1)(1994-2#2)(1994-5#1)(1995-6#2)(1997-2#1)(1997-4#4)(1997-6#1)(2004-8#2)(2006-12#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-7#12)(2007-9#3)(2008-1#1)(2008-10#9)(2008-11#1)(2008-3#2)(2008-5#19)(2008-6#6)(2008-7#1)(2008-9#5)(2009-2#3)(2009-6#1)(2009-9#1)(2010-11#1)(2011-2#3)(2012-11#1)(2012-3#3)(2013-1#9)(2013-8#1)
yellow (Ay)##2##2##(1994-3#2)
yellow alleles were##2##3##(2008-8#2)
yellow and##8##2##(1995-5#1)(2007-1#1)(2008-10#5)(2008-3#1)
yellow bands##2##2##(1992-2#1)(2009-2#1)
yellow color##3##2##(1994-11#1)(1997-4#1)(2008-10#1)
yellow colour##4##2##(2006-12#1)(2008-10#2)(2009-4#1)
yellow complex with##2##3##(2005-4#1)(2008-10#1)
yellow complex##5##2##(2005-4#1)(2008-10#3)(2010-5#1)
yellow component##2##2##(1995-2#2)
yellow compound##2##2##(1995-2#1)(2008-10#1)
yellow dwarf disease##3##3##(2008-10#3)
yellow dwarf virus (BYDV) resistance##2##5##(2008-5#1)(2008-8#1)
yellow dwarf virus (BYDV)##10##4##(2008-10#7)(2008-5#1)(2008-8#2)
yellow dwarf virus in##2##4##(2008-10#2)
yellow dwarf virus##26##3##(2008-10#23)(2008-5#1)(2008-8#2)
yellow dwarf viruses##3##3##(2008-10#2)(2008-9#1)
yellow dwarf##43##2##(2008-10#39)(2008-5#1)(2008-8#2)(2008-9#1)
yellow fever vaccination##2##3##(2007-2#2)
yellow fever##5##2##(2006-10#1)(2007-2#2)(2010-1#1)(2012-12#1)
yellow fluorescent proteins in##2##4##(2008-10#1)(2008-3#1)
yellow fluorescent proteins##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
yellow fluorescent##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)
yellow gene##4##2##(2008-8#4)
yellow laser##2##2##(2007-11#1)(2007-12#1)
yellow leaf curl virus##20##4##(2008-10#19)(2008-8#1)
yellow leaf curl##28##3##(2008-10#27)(2008-8#1)
yellow leaf syndrome##2##3##(2008-10#2)
yellow leaf##33##2##(2006-12#1)(2008-10#31)(2008-8#1)
yellow light for##2##3##(1991-2#1)(2007-11#1)
yellow light##3##2##(1991-2#1)(2007-11#1)(2007-8#1)
yellow mosaic virus (TYMV)##2##4##(1997-3#1)(2008-10#1)
yellow mosaic virus from Venezuela##2##5##(2008-10#2)
yellow mosaic virus from##3##4##(2008-10#3)
yellow mosaic virus##27##3##(1990-2#1)(1992-9#2)(1997-3#2)(2005-11#2)(2008-10#18)(2008-8#2)
yellow mosaic##29##2##(1990-2#1)(1992-9#2)(1997-3#2)(2005-11#2)(2008-10#20)(2008-8#2)
yellow mottle virus##4##3##(2008-10#3)(2008-9#1)
yellow mottle##5##2##(2008-10#4)(2008-9#1)
yellow nail syndrome##2##3##(2005-12#2)
yellow ochre##2##2##(2008-10#2)
yellow or##2##2##(1990-5#1)(2008-12#1)
yellow pages advertising##2##3##(1993-12#2)
yellow pages##4##2##(1993-12#2)(1997-1#2)
yellow pigment##6##2##(2006-11#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-5#1)
yellow preovulatory follicles##3##3##(2008-12#3)
yellow ring##2##2##(2008-10#2)
yellow rust##8##2##(2008-10#8)
yellow sac spider##3##3##(2010-8#3)
yellow seeds##2##2##(2006-12#1)(2012-11#1)
yellow spot virus##10##3##(2008-10#10)
yellow stripe virus##2##3##(2008-10#2)
yellow stripe##3##2##(2008-10#3)
yellow strips##2##2##(2008-10#2)
yellow stunt##4##2##(2008-10#2)(2008-8#2)
yellow stunting disorder virus##6##4##(2008-10#6)
yellow superimposed on both red and pink##2##7##(2008-10#2)
yellow vein virus##11##3##(2008-10#11)
yellow vein##17##2##(2008-10#17)
yellow vine disease##4##3##(2008-10#4)
yellow##343##1##(1990-10#1)(1990-2#1)(1990-5#2)(1990-7#1)(1991-2#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-9#2)(1993-12#3)(1994-11#3)(1994-2#1)(1994-3#3)(1995-2#5)(1995-5#2)(1995-6#1)(1995-8#1)(1996-11#1)(1997-1#2)(1997-3#2)(1997-4#1)(2005-11#2)(2005-12#2)(2005-4#1)(2005-7#2)(2006-10#2)(2006-11#2)(2006-12#5)(2007-1#2)(2007-10#1)(2007-11#7)(2007-12#7)(2007-2#2)(2007-3#1)(2007-8#5)(2008-10#192)(2008-11#3)(2008-12#8)(2008-2#2)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#14)(2008-9#5)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-1#1)(2010-5#2)(2010-8#4)(2011-1#2)(2011-12#1)(2011-2#5)(2012-11#6)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#1)
yellow-green##4##1##(2008-10#2)(2008-2#1)(2011-1#1)
yellow-necked mice##2##2##(2012-3#2)
yellow-necked##3##1##(2011-2#1)(2012-3#2)
yellow-pigmented##2##1##(2012-2#2)
yellowing and##5##2##(2008-10#4)(2012-11#1)
yellowing in##2##2##(2008-10#1)(2008-11#1)
yellowing or wilting##2##3##(2008-10#2)
yellowing symptoms##2##2##(2008-10#2)
yellowing##24##1##(2006-12#1)(2008-10#15)(2008-11#3)(2008-5#2)(2008-9#2)(2012-11#1)
yellowish color of##2##3##(1996-12#1)(2008-3#1)
yellowish##10##1##(1993-3#1)(1996-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-8#1)(2010-12#1)
yellows phytoplasma##7##2##(2005-11#1)(2008-10#6)
yellows virus##6##2##(2008-10#6)
yellows##47##1##(2005-11#3)(2008-10#44)
yen##4##1##(2005-8#1)(2008-3#1)(2008-5#2)
yersinia##2##1##(1990-6#1)(2008-7#1)
yes or no?]##2##3##(1994-6#1)(2006-6#1)
yes or##4##2##(1993-10#1)(1994-6#1)(2006-6#1)(2007-10#1)
yes to##2##2##(1990-5#1)(1991-12#1)
yes##15##1##(1990-5#1)(1991-11#1)(1991-12#1)(1992-1#1)(1993-10#1)(1993-5#1)(1994-6#1)(1995-12#1)(1996-3#1)(1996-8#1)(1997-3#1)(2006-6#1)(2006-8#1)(2007-10#1)(2008-4#1)
yes&quot##3##1##(1990-12#1)(2006-7#2)
yes/no##4##1##(1992-2#1)(2008-11#1)(2011-2#2)
yesterday##6##1##(1996-12#1)(2007-1#1)(2007-4#1)(2008-11#1)(2012-11#2)
yet a##7##2##(1993-2#1)(1997-5#1)(2006-8#1)(2007-12#2)(2011-1#1)(2012-1#1)
yet again##2##2##(1994-12#1)(2005-9#1)
yet allow for##2##3##(2006-10#1)(2010-12#1)
yet also##3##2##(2008-1#1)(2008-2#1)(2011-2#1)
yet another##10##2##(1993-7#1)(1996-4#1)(2005-7#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-6#1)(2012-3#1)(2013-8#1)
yet appear to##2##3##(1996-8#1)(2012-2#1)
yet appear##3##2##(1996-6#1)(1996-8#1)(2012-2#1)
yet appeared to##2##3##(1992-7#1)(2009-3#1)
yet appeared##3##2##(1992-7#1)(2005-7#1)(2009-3#1)
yet are##8##2##(1997-1#2)(2008-10#2)(2008-6#1)(2009-12#1)(2010-8#1)(2013-8#1)
yet as##2##2##(1990-10#1)(2008-2#1)
yet available for##4##3##(2007-11#1)(2008-9#1)(2010-1#1)(2011-2#1)
yet available##23##2##(1990-2#1)(1992-6#1)(1993-10#1)(1993-11#1)(1993-9#1)(1994-7#1)(1995-2#1)(1997-3#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-5#1)(2011-1#2)(2011-2#2)
yet be##8##2##(1991-11#2)(1996-11#1)(2007-12#1)(2008-10#1)(2010-9#2)(2011-7#1)
yet become##2##2##(2011-2#1)(2012-2#1)
yet been achieved##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
yet been demonstrated##4##3##(1990-1#1)(1991-6#1)(1992-12#1)(2004-1#1)
yet been described##3##3##(2008-5#1)(2010-4#1)(2013-7#1)
yet been developed##4##3##(1996-12#1)(2008-11#1)(2008-5#1)(2012-3#1)
yet been established##12##3##(1991-3#1)(1992-5#1)(1996-8#1)(2005-1#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-5#1)(2008-10#1)(2008-6#1)(2011-2#1)
yet been identified##12##3##(1990-11#1)(1994-3#1)(1994-6#1)(1996-6#1)(1997-4#1)(2006-8#1)(2008-10#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#1)
yet been reached##3##3##(2007-4#1)(2008-1#1)(2013-8#1)
yet been reported##9##3##(1995-1#1)(1995-4#1)(1995-8#1)(2006-11#1)(2006-7#1)(2008-10#1)(2008-3#1)(2010-7#1)(2013-8#1)
yet been shown to be of##2##6##(1991-12#1)(1994-3#1)
yet been shown to be##3##5##(1991-12#1)(1994-3#1)(2008-5#1)
yet been shown to##6##4##(1990-4#1)(1991-12#1)(1994-3#1)(2006-2#1)(2008-5#1)(2010-10#1)
yet been shown##7##3##(1990-11#1)(1990-4#1)(1991-12#1)(1994-3#1)(2006-2#1)(2008-5#1)(2010-10#1)
yet been##168##2##(1990-1#1)(1990-10#1)(1990-11#5)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-3#1)(1991-5#2)(1991-6#2)(1992-11#1)(1992-12#1)(1992-5#2)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#4)(1994-3#2)(1994-6#1)(1995-1#2)(1995-12#1)(1995-4#1)(1995-6#2)(1995-8#1)(1996-12#2)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(2004-1#1)(2005-1#1)(2005-10#1)(2005-11#2)(2005-7#2)(2006-10#5)(2006-11#1)(2006-12#3)(2006-2#4)(2006-7#2)(2006-8#2)(2007-10#1)(2007-11#4)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#6)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#1)(2009-4#2)(2009-5#2)(2009-8#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#4)
yet can##3##2##(2008-10#1)(2012-1#1)(2012-2#1)
yet complementary##2##2##(1991-8#1)(2009-8#1)
yet complex##2##2##(1992-8#1)(2008-10#1)
yet comprehensive pathway##2##3##(2008-3#2)
yet convinced##2##2##(1995-3#1)(2007-9#1)
yet current##2##2##(2005-7#1)(2010-5#1)
yet described in##2##3##(1995-6#1)(2012-2#1)
yet described##4##2##(1991-2#1)(1995-6#1)(2008-6#1)(2012-2#1)
yet despite##2##2##(2010-9#1)(2013-8#1)
yet determined##2##2##(1992-11#1)(2007-8#1)
yet did not##2##3##(1991-12#1)(2007-12#1)
yet did##3##2##(1991-12#1)(2007-12#1)(2010-6#1)
yet direct##2##2##(1995-12#1)(2008-5#1)
yet distinct##3##2##(1991-9#1)(1995-11#1)(2006-6#1)
yet effective##2##2##(2008-10#1)(2008-11#1)
yet efficient##5##2##(2007-12#1)(2007-8#1)(2008-2#1)(2009-12#1)(2012-3#1)
yet emerged##3##2##(2008-11#1)(2008-5#1)(2012-1#1)
yet established##6##2##(1993-12#1)(1994-12#1)(2006-10#1)(2007-1#1)(2008-1#1)(2008-5#1)
yet existing##2##2##(2008-3#1)(2008-5#1)
yet failed to##2##3##(1997-6#1)(2008-10#1)
yet flexible##2##2##(1994-3#1)(2006-12#1)
yet had##3##2##(1997-3#1)(2009-6#1)(2013-7#1)
yet have##5##2##(1995-3#1)(1997-8#1)(2007-11#1)(2011-2#1)(2012-1#1)
yet highly##3##2##(2006-7#1)(2008-2#1)(2008-8#1)
yet in##9##2##(1990-8#1)(1991-2#1)(1995-8#1)(1996-11#1)(2005-11#1)(2005-7#1)(2008-6#1)(2008-9#1)(2013-8#1)
yet increased##2##2##(2007-12#1)(2007-7#1)
yet investigated##2##2##(2013-1#1)(2013-8#1)
yet is##4##2##(1995-8#1)(2006-10#1)(2008-11#1)(2008-9#1)
yet it has##2##3##(2009-3#1)(2009-4#1)
yet it is##7##3##(1991-5#1)(1994-8#1)(2008-10#1)(2008-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
yet it remains##3##3##(1997-7#1)(2006-12#1)(2012-3#1)
yet it##18##2##(1991-5#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-7#1)(2006-12#1)(2007-7#1)(2008-10#3)(2008-12#1)(2009-3#1)(2009-4#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
yet its##4##2##(1996-2#1)(2010-8#1)(2010-9#1)(2013-1#1)
yet known##12##2##(1992-11#1)(1994-2#1)(1995-9#1)(1996-8#1)(2004-12#1)(2006-12#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-4#1)(2011-1#1)(2012-1#1)
yet largely##2##2##(1991-3#1)(1994-2#1)
yet less expensive##2##3##(2007-9#1)(2009-7#1)
yet little is known about the##2##6##(2008-12#1)(2008-5#1)
yet little is known##3##4##(1994-12#1)(2008-12#1)(2008-5#1)
yet little research has##2##4##(2007-12#2)
yet little##8##2##(1994-12#1)(2007-12#2)(2008-12#1)(2008-5#1)(2009-10#1)(2009-4#1)(2011-1#1)
yet low##2##2##(1997-3#1)(2011-1#1)
yet many##3##2##(2006-9#1)(2008-6#1)(2008-7#1)
yet may##2##2##(2008-3#1)(2008-5#1)
yet mice with genetically-ablated aggrecan-degrading activity have no defects in bone formation##2##12##(2012-12#2)
yet most electronic health records (EHRs) lack the functionality needed to facilitate and document care coordination activities##2##17##(2013-1#2)
yet most##5##2##(2008-9#1)(2010-10#1)(2013-1#3)
yet necessary##2##2##(1992-1#1)(2008-11#1)
yet no##10##2##(1991-11#1)(1995-2#1)(1995-5#1)(2006-2#1)(2006-8#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-7#1)
yet not##7##2##(1993-4#1)(2007-12#2)(2008-8#1)(2010-8#1)(2011-12#1)(2011-2#1)
yet novel##2##2##(2008-6#1)(2012-3#1)
yet on the##2##3##(1994-5#1)(2007-1#1)
yet on##3##2##(1994-5#1)(2007-1#1)(2007-7#1)
yet only##5##2##(1994-2#1)(2008-10#1)(2008-5#1)(2010-11#1)(2010-3#1)
yet powerful##5##2##(2008-1#1)(2008-2#1)(2008-7#1)(2012-1#2)
yet proved##3##2##(2006-10#1)(2009-6#1)(2012-12#1)
yet provide strong support for the trainees##2##7##(2013-1#2)
yet ready##3##2##(1995-5#1)(2006-10#1)(2008-6#1)
yet reasonably##2##2##(2011-1#1)(2013-1#1)
yet received##2##2##(2010-12#1)(2010-5#1)
yet reduced##2##2##(1992-8#1)(1994-9#1)
yet reported for##2##3##(1997-4#1)(2008-3#1)
yet reported in##3##3##(1991-3#1)(2009-6#1)(2012-2#1)
yet reported##10##2##(1990-5#1)(1991-3#1)(1997-4#1)(2007-8#1)(2008-3#1)(2009-6#1)(2009-9#1)(2010-12#1)(2012-2#2)
yet research##2##2##(2006-9#1)(2013-1#1)
yet retain the##2##3##(1990-6#1)(2010-8#1)
yet reviewing the protective role of sports and physical activity in his masterpiece##2##13##(2013-1#2)
yet robust##2##2##(2008-7#1)(2010-2#1)
yet say##2##2##(2007-9#1)(2010-2#1)
yet showed##2##2##(1995-12#1)(1997-3#1)
yet significant amounts of##2##4##(1992-12#1)(2012-3#1)
yet significant##3##2##(1992-12#1)(1996-12#1)(2012-3#1)
yet solved the##2##3##(1992-11#1)(2008-10#1)
yet solved##3##2##(1992-11#1)(1997-8#1)(2008-10#1)
yet some##2##2##(1997-7#1)(2008-10#1)
yet still##2##2##(1995-6#1)(2007-8#1)
yet sufficiently##2##2##(2008-10#1)(2009-7#1)
yet that##3##2##(1993-3#1)(2007-9#1)(2008-12#1)
yet the clinical##2##3##(2008-6#1)(2012-3#1)
yet the disease##2##3##(1997-7#1)(2008-10#1)
yet the number of##2##4##(1991-10#1)(2012-1#1)
yet the resulting##2##3##(1994-6#1)(2007-10#1)
yet the underlying genetic program remains largely unknown##2##8##(2012-12#2)
yet the##37##2##(1991-10#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-8#2)(2006-10#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-4#1)(2010-8#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
yet their reported satisfaction did not change##2##7##(2013-1#2)
yet their##6##2##(1995-5#1)(1996-12#1)(2009-5#1)(2010-5#1)(2013-1#2)
yet there has been little##2##5##(2006-2#1)(2012-12#1)
yet there has been##4##4##(2006-10#1)(2006-2#1)(2007-9#1)(2012-12#1)
yet there have been##2##4##(1996-6#1)(2008-7#1)
yet there is a##3##4##(2006-7#1)(2008-8#1)(2009-12#1)
yet there is little##2##4##(2008-7#1)(2009-7#1)
yet there is no##3##4##(2008-10#1)(2009-12#1)(2010-3#1)
yet there is##9##3##(2006-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-12#2)(2009-7#1)(2010-3#1)(2012-2#1)
yet there##17##2##(1990-8#1)(1996-6#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-9#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#2)(2009-7#1)(2010-3#1)(2012-12#1)(2012-2#1)
yet these##3##2##(1994-12#1)(2008-10#1)(2008-3#1)
yet they are##5##3##(1995-5#1)(2007-4#2)(2009-8#1)(2011-2#1)
yet they can##2##3##(1995-12#1)(2007-7#1)
yet they##10##2##(1995-12#1)(1995-5#1)(1997-4#1)(2007-4#2)(2007-7#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#1)
yet this##5##2##(1992-3#1)(1996-5#1)(2004-9#1)(2009-3#1)(2011-2#1)
yet to be completed##3##4##(2006-10#1)(2008-2#1)(2009-4#1)
yet to be defined##4##4##(1991-5#1)(2007-11#1)(2008-1#1)(2010-11#1)
yet to be demonstrated##3##4##(1997-5#1)(2005-7#1)(2007-8#1)
yet to be determined##19##4##(1994-8#1)(1995-2#2)(1997-1#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-5#2)(2008-6#1)(2009-12#1)(2010-12#2)(2013-1#1)
yet to be developed##2##4##(1994-3#1)(2007-9#1)
yet to be elucidated##8##4##(1993-5#1)(1995-6#1)(1996-6#1)(1997-6#1)(2008-10#1)(2008-4#1)(2009-9#1)(2013-1#1)
yet to be established##10##4##(1992-12#1)(1995-5#1)(2007-10#1)(2008-10#1)(2008-6#1)(2009-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)
yet to be evaluated in##2##5##(2006-6#1)(2007-8#1)
yet to be explored##2##4##(2007-12#1)(2007-7#1)
yet to be fully determined and##2##6##(2008-1#1)(2008-8#1)
yet to be fully determined##3##5##(2008-1#1)(2008-8#1)(2010-3#1)
yet to be fully##9##4##(1994-3#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-8#1)(2010-3#1)(2010-7#1)(2013-1#1)
yet to be identified##9##4##(1991-5#1)(1994-12#1)(1995-1#1)(1995-2#1)(1997-7#1)(2006-10#1)(2008-10#1)(2009-6#1)(2011-2#1)
yet to be investigated##2##4##(2008-8#1)(2010-5#1)
yet to be made##2##4##(2008-10#1)(2008-3#1)
yet to be overcome##2##4##(2010-7#1)(2012-12#1)
yet to be proved##3##4##(1990-11#1)(1993-5#1)(1994-5#1)
yet to be reported##3##4##(2008-10#1)(2008-12#1)(2012-2#1)
yet to be resolved##2##4##(1991-2#1)(2008-2#1)
yet to be shown##2##4##(1991-7#1)(1993-8#1)
yet to be solved##2##4##(1992-9#1)(2007-11#1)
yet to be tested##3##4##(1995-5#1)(2005-7#1)(2010-6#1)
yet to be##122##3##(1990-11#1)(1991-2#1)(1991-5#2)(1991-7#1)(1992-12#1)(1992-9#1)(1993-5#2)(1993-8#1)(1994-12#1)(1994-3#2)(1994-5#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#3)(1995-5#2)(1995-6#1)(1995-8#1)(1996-6#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-7#2)(2006-10#5)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#5)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#3)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#3)(2013-1#4)(2013-8#1)
yet to emerge##6##3##(1993-3#1)(2006-10#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)
yet to##145##2##(1990-11#1)(1990-12#2)(1991-2#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-12#1)(1992-9#1)(1993-3#1)(1993-5#2)(1993-8#1)(1994-10#1)(1994-12#1)(1994-3#2)(1994-5#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#3)(1995-5#2)(1995-6#1)(1995-8#1)(1996-6#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-7#3)(2005-8#1)(2006-10#6)(2006-12#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#5)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#4)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#3)(2013-1#4)(2013-8#1)
yet uncharacterized##2##2##(1994-12#1)(2008-5#1)
yet unclear##3##2##(1991-11#1)(2011-2#2)
yet undefined##4##2##(1992-4#1)(1993-9#1)(2008-10#2)
yet undescribed##3##2##(1996-5#1)(2008-10#2)
yet unidentified##21##2##(1990-3#2)(1991-12#1)(1992-2#1)(1992-4#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-6#1)(1995-9#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-9#1)(2009-9#1)
yet unknown mechanisms##2##3##(1990-11#1)(1993-9#1)
yet unknown structural##2##3##(1996-2#1)(2008-7#1)
yet unknown##22##2##(1990-1#1)(1990-11#1)(1990-12#1)(1993-9#2)(1994-6#1)(1996-2#2)(1997-8#1)(2004-11#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-2#1)(2009-4#1)(2009-8#2)(2010-10#1)(2012-2#1)
yet we##2##2##(2009-12#1)(2010-12#1)
yet well##11##2##(1997-7#1)(2006-10#3)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-11#1)(2012-12#1)(2013-1#1)
yet with##4##2##(1993-6#1)(2008-3#1)(2011-2#1)(2013-1#1)
yet##1215##1##(1990-1#3)(1990-10#2)(1990-11#8)(1990-12#6)(1990-2#3)(1990-3#3)(1990-4#2)(1990-5#2)(1990-6#2)(1990-7#3)(1990-8#5)(1990-9#1)(1991-10#1)(1991-11#5)(1991-12#8)(1991-2#6)(1991-3#5)(1991-4#1)(1991-5#7)(1991-6#4)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#3)(1992-11#4)(1992-12#8)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#3)(1992-6#3)(1992-7#1)(1992-8#3)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#6)(1993-2#5)(1993-3#5)(1993-4#1)(1993-5#4)(1993-6#1)(1993-7#3)(1993-8#3)(1993-9#9)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#9)(1994-2#7)(1994-3#9)(1994-5#7)(1994-6#7)(1994-7#1)(1994-8#8)(1994-9#6)(1995-1#4)(1995-10#1)(1995-11#3)(1995-12#6)(1995-2#8)(1995-3#5)(1995-4#2)(1995-5#7)(1995-6#7)(1995-8#6)(1995-9#4)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#5)(1996-2#8)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#4)(1996-7#1)(1996-8#6)(1996-9#8)(1997-1#5)(1997-2#4)(1997-3#9)(1997-4#6)(1997-5#3)(1997-6#5)(1997-7#5)(1997-8#6)(2004-1#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-1#2)(2005-10#7)(2005-11#6)(2005-7#11)(2005-8#6)(2005-9#2)(2006-1#1)(2006-10#39)(2006-11#4)(2006-12#12)(2006-2#9)(2006-6#9)(2006-7#6)(2006-8#7)(2006-9#5)(2007-1#4)(2007-10#7)(2007-11#20)(2007-12#20)(2007-2#2)(2007-4#4)(2007-5#2)(2007-6#4)(2007-7#10)(2007-8#17)(2007-9#12)(2008-1#22)(2008-10#65)(2008-11#27)(2008-12#10)(2008-2#18)(2008-3#21)(2008-4#13)(2008-5#30)(2008-6#12)(2008-7#27)(2008-8#15)(2008-9#12)(2009-10#3)(2009-11#3)(2009-12#7)(2009-2#3)(2009-3#8)(2009-4#9)(2009-5#6)(2009-6#7)(2009-7#10)(2009-8#12)(2009-9#6)(2010-1#3)(2010-10#7)(2010-11#4)(2010-12#17)(2010-2#7)(2010-3#7)(2010-4#4)(2010-5#9)(2010-6#4)(2010-7#6)(2010-8#7)(2010-9#9)(2011-1#17)(2011-12#4)(2011-2#34)(2011-7#1)(2012-1#12)(2012-11#2)(2012-12#22)(2012-2#28)(2012-3#15)(2013-1#40)(2013-7#7)(2013-8#17)
yet)##2##1##(1995-3#1)(2009-6#1)
yet?##3##1##(2007-11#1)(2008-3#1)(2008-8#1)
yew##6##1##(1994-11#2)(2007-1#3)(2008-7#1)
yield &quot##2##2##(2010-4#1)(2011-2#1)
yield (0##2##2##(2011-2#1)(2013-1#1)
yield 2##2##2##(2008-3#1)(2011-12#1)
yield Lp(a)##2##2##(1994-9#2)
yield a better##3##3##(2008-11#1)(2008-2#1)(2013-7#1)
yield a compact##2##3##(2007-11#1)(2008-3#1)
yield a constant##2##3##(2007-12#1)(2008-2#1)
yield a detection limit##3##4##(2007-12#1)(2008-10#2)
yield a positive##2##3##(2007-9#1)(2008-10#1)
yield a significant##3##3##(2008-4#1)(2010-10#1)(2010-4#1)
yield a##86##2##(1990-11#1)(1990-9#1)(1991-7#1)(1992-7#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-8#2)(1996-5#1)(1996-7#1)(1997-5#1)(2007-11#8)(2007-12#5)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#10)(2008-3#11)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2010-10#1)(2010-4#3)(2010-5#1)(2010-8#1)(2012-2#2)(2013-1#1)(2013-7#1)
yield accurate##2##2##(2006-10#1)(2008-9#1)
yield additional##3##2##(1997-6#1)(2006-6#1)(2008-10#1)
yield after##4##2##(2008-10#1)(2008-11#1)(2008-6#1)(2010-2#1)
yield an EC(50) value of##2##5##(2008-10#2)
yield an average##2##3##(2007-8#1)(2011-2#1)
yield an##20##2##(1993-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-4#2)(2011-2#1)(2012-1#1)
yield and LAI losses##3##4##(2008-12#3)
yield and grain##2##3##(2008-12#1)(2008-8#1)
yield and high##2##3##(1996-5#1)(2013-1#1)
yield and purity were##2##4##(2011-1#2)
yield and purity##4##3##(2007-11#1)(2008-2#1)(2011-1#2)
yield and quality in##3##4##(2008-10#1)(2008-12#2)
yield and quality reductions##2##4##(2008-10#2)
yield and quality##7##3##(2008-10#4)(2008-11#1)(2008-12#2)
yield and the##3##3##(1990-3#1)(2008-10#1)(2008-4#1)
yield and yield components in wheat cultivars (Triticum sp##2##9##(2008-12#2)
yield and yield components##3##4##(2008-12#2)(2008-4#1)
yield and##65##2##(1990-11#2)(1990-3#1)(1991-7#1)(1992-2#1)(1994-2#1)(1994-6#1)(1996-12#1)(1996-5#1)(1996-8#1)(2007-11#2)(2007-5#1)(2007-6#1)(2008-10#11)(2008-11#2)(2008-12#11)(2008-2#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#3)(2013-8#2)
yield are##4##2##(2008-10#2)(2008-11#1)(2009-6#1)
yield as##9##2##(2007-12#1)(2008-5#1)(2008-6#1)(2008-9#3)(2011-2#1)(2012-1#2)
yield at the##2##3##(2008-9#1)(2010-7#1)
yield at##5##2##(1994-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-7#1)
yield attributes of##3##3##(2011-12#3)
yield attributes##4##2##(2008-12#1)(2011-12#3)
yield based on##2##3##(2007-11#1)(2008-5#1)
yield benefits##3##2##(2007-11#1)(2008-10#1)(2008-9#1)
yield better efficiency##2##3##(2008-3#2)
yield better##5##2##(2006-10#1)(2008-3#3)(2008-7#1)
yield biased##2##2##(1997-8#1)(2009-10#1)
yield but##2##2##(2006-8#1)(2008-10#1)
yield by the##3##3##(2008-10#1)(2008-12#1)(2012-2#1)
yield by##19##2##(1990-5#1)(1991-9#1)(1992-6#1)(1997-7#1)(2007-11#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2012-2#1)
yield can be##2##3##(2007-12#1)(2011-2#1)
yield clinically##2##2##(2007-11#1)(2013-8#1)
yield components in##3##3##(2008-10#1)(2008-12#2)
yield components##9##2##(2008-10#1)(2008-12#6)(2008-4#1)(2011-2#1)
yield convergence to##2##3##(2008-10#1)(2008-3#1)
yield data##4##2##(1992-12#1)(2008-3#1)(2009-11#2)
yield decreased##6##2##(2008-10#1)(2008-11#3)(2008-6#1)(2013-1#1)
yield different##5##2##(1992-2#1)(2006-8#1)(2007-8#1)(2008-3#1)(2009-5#1)
yield essentially##2##2##(1997-5#1)(2008-10#1)
yield evidence##2##2##(1994-9#1)(2007-12#1)
yield expression of##2##3##(1996-2#1)(2008-11#1)
yield expression##3##2##(1994-8#1)(1996-2#1)(2008-11#1)
yield for##8##2##(1990-3#1)(1992-7#1)(2005-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-8#1)
yield four##2##2##(1997-8#1)(2006-5#1)
yield from the##4##3##(1995-3#1)(2008-10#2)(2013-1#1)
yield from##14##2##(1991-9#1)(1995-11#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-8#1)(2007-11#1)(2008-10#4)(2008-4#1)(2013-1#2)
yield functional##3##2##(1994-8#1)(2008-4#1)(2008-9#1)
yield gains##2##2##(2008-10#1)(2008-12#1)
yield good##6##2##(1991-7#1)(2006-10#1)(2006-9#1)(2007-8#1)(2007-9#1)(2008-2#1)
yield high##5##2##(1992-9#1)(2008-2#1)(2008-3#1)(2012-2#2)
yield higher##4##2##(2008-10#1)(2008-5#1)(2008-7#1)(2010-4#1)
yield highly##4##2##(2007-12#1)(2008-3#1)(2008-4#1)(2010-12#1)
yield identical##2##2##(1997-4#2)
yield important insights into the##2##5##(2008-4#1)(2011-1#1)
yield important##5##2##(2005-11#1)(2007-10#1)(2008-4#1)(2009-4#1)(2011-1#1)
yield improvement##2##2##(1997-3#1)(2012-11#1)
yield in a##3##3##(1996-2#1)(2007-11#1)(2013-1#1)
yield in farmer-managed plot##2##4##(2008-12#2)
yield in the presence of##2##5##(1996-5#1)(2008-11#1)
yield in the##5##3##(1996-5#1)(2008-10#2)(2008-11#1)(2008-5#1)
yield in##38##2##(1990-3#1)(1990-5#1)(1992-2#1)(1992-8#1)(1994-12#1)(1995-1#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#5)(2008-2#1)(2008-5#2)(2008-9#1)(2009-3#1)(2010-2#1)(2011-2#1)(2013-1#1)
yield increased##5##2##(2007-11#1)(2008-10#1)(2008-11#2)(2008-8#1)
yield increases##2##2##(2008-10#2)
yield information about the##2##4##(1996-3#1)(2008-4#1)
yield information on the##2##4##(2008-2#1)(2008-4#1)
yield information##5##2##(1996-12#1)(1996-3#1)(2008-2#1)(2008-4#2)
yield insight into the##2##4##(2008-6#1)(2013-1#1)
yield insight into##4##3##(1994-3#1)(2008-6#1)(2008-8#1)(2013-1#1)
yield insights into##2##3##(2006-12#1)(2010-1#1)
yield is##7##2##(1990-10#1)(1994-6#1)(1995-6#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#1)
yield less than##2##3##(1996-6#1)(2008-10#1)
yield less##3##2##(1996-6#1)(2008-10#2)
yield loss and##2##3##(2008-10#1)(2008-12#1)
yield loss models##3##3##(2008-10#1)(2008-12#2)
yield loss was##2##3##(2008-10#1)(2008-12#1)
yield loss##24##2##(2008-10#17)(2008-12#7)
yield losses and management efficiencies##2##5##(2008-10#2)
yield losses and##3##3##(2008-10#2)(2011-10#1)
yield losses for##2##3##(2008-10#1)(2012-2#1)
yield losses from##3##3##(2008-10#1)(2012-11#1)(2012-2#1)
yield losses in##4##3##(2008-10#3)(2012-11#1)
yield losses of up to##2##5##(2008-10#2)
yield losses##26##2##(2008-10#20)(2011-1#1)(2011-10#1)(2012-11#2)(2012-2#2)
yield measurement errors of roughly##2##5##(2008-10#2)
yield misleading inferences##2##3##(1993-9#1)(2009-9#1)
yield more than##2##3##(2008-10#1)(2008-3#1)
yield more##6##2##(1993-12#1)(1997-1#1)(2007-5#1)(2008-10#1)(2008-3#1)(2011-2#1)
yield multiple##2##2##(1997-2#1)(2008-4#1)
yield nearly##2##2##(1992-7#1)(2008-11#1)
yield new##5##2##(1993-6#1)(1994-6#1)(2007-8#1)(2009-5#1)(2012-2#1)
yield obtained##2##2##(2008-10#1)(2008-11#1)
yield of 0##5##3##(1995-8#1)(2007-12#1)(2008-5#1)(2008-6#1)(2013-1#1)
yield of 4##2##3##(2008-11#1)(2008-5#1)
yield of 80%##2##3##(2008-5#1)(2008-6#1)
yield of a##3##3##(1994-12#1)(1994-8#1)(2008-10#1)
yield of about##3##3##(1990-3#2)(1992-1#1)
yield of cells##3##3##(1994-2#1)(2008-7#1)(2011-2#1)
yield of each##2##3##(2008-2#1)(2013-1#1)
yield of fluorescence##2##3##(1991-9#1)(1994-12#1)
yield of plots planted with##2##5##(2008-10#2)
yield of processing##2##3##(2008-10#2)
yield of recombinant##4##3##(1990-3#1)(1993-2#1)(2008-8#1)(2011-2#1)
yield of singlet oxygen##2##4##(1992-12#1)(2008-8#1)
yield of soybean##2##3##(2008-12#1)(2012-11#1)
yield of the##25##3##(1992-11#2)(1993-6#1)(1994-12#1)(1994-3#1)(1994-8#2)(1996-3#1)(1997-1#1)(1997-3#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-12#1)(2011-12#1)(2012-1#1)(2012-12#1)(2013-1#1)
yield of##204##2##(1990-11#1)(1990-12#2)(1990-3#6)(1990-4#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-2#2)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-7#1)(1992-8#4)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-7#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-8#3)(1994-9#1)(1995-2#3)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-1#2)(1997-2#2)(1997-3#3)(1997-5#3)(1997-6#2)(1997-8#1)(2004-8#1)(2005-11#6)(2006-11#2)(2006-12#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#2)(2007-6#1)(2007-8#2)(2008-10#23)(2008-11#3)(2008-12#5)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#13)(2008-6#11)(2008-7#4)(2008-8#3)(2008-9#6)(2009-12#1)(2009-7#1)(2009-9#1)(2010-12#3)(2010-2#2)(2010-4#2)(2010-5#1)(2011-12#1)(2011-2#8)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#2)(2012-3#1)(2012-4#1)(2013-1#9)(2013-7#1)
yield on glucose##2##3##(1994-11#1)(1994-5#1)
yield on the##2##3##(2008-2#1)(2011-2#1)
yield on##8##2##(1994-11#1)(1994-5#2)(1996-5#1)(2008-10#1)(2008-2#1)(2008-6#1)(2011-2#1)
yield only##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
yield optimal##2##2##(1997-3#1)(2008-6#1)
yield or##3##2##(1990-11#1)(2007-11#1)(2008-10#1)
yield per plant##2##3##(2007-1#2)
yield per##5##2##(2007-1#2)(2008-12#3)
yield point (N)##2##3##(2013-1#2)
yield point##5##2##(2007-11#1)(2013-1#4)
yield potential##4##2##(2006-12#1)(2008-10#3)
yield promising##2##2##(2012-3#2)
yield quality##2##2##(2008-10#2)
yield quantity##2##2##(2008-10#2)
yield ranged from##2##3##(2007-5#1)(2008-12#1)
yield reached##2##2##(2008-4#1)(2008-5#1)
yield reduction##2##2##(1997-2#1)(2008-10#1)
yield reductions caused by##2##4##(2008-10#2)
yield reductions##4##2##(2008-10#4)
yield results that##2##3##(2006-10#1)(2009-5#1)
yield results##6##2##(1996-12#1)(2006-10#1)(2007-12#1)(2008-12#1)(2008-3#1)(2009-5#1)
yield satisfactory results##3##3##(1992-10#1)(2008-10#1)(2010-11#1)
yield significant##2##2##(2007-2#1)(2008-7#1)
yield significantly different##2##3##(1992-8#1)(1993-12#1)
yield significantly##4##2##(1992-8#1)(1993-12#1)(2008-2#1)(2010-2#1)
yield similar results for##3##4##(2008-1#1)(2008-2#2)
yield similar results##6##3##(1990-8#1)(1994-9#1)(2008-1#1)(2008-2#2)(2008-3#1)
yield similar##10##2##(1990-7#1)(1990-8#1)(1991-3#1)(1994-9#1)(2008-1#1)(2008-2#3)(2008-3#1)(2012-12#1)
yield smaller##2##2##(1992-9#1)(1995-2#1)
yield specific##3##2##(1997-3#1)(2012-2#2)
yield spurious##2##2##(1997-5#1)(2009-11#1)
yield strength of##3##3##(2009-7#2)(2012-12#1)
yield strength was##2##3##(2009-7#2)
yield strength##11##2##(2009-11#1)(2009-7#7)(2012-12#1)(2012-2#2)
yield stress##3##2##(2005-11#1)(2008-5#1)(2012-11#1)
yield sufficient##2##2##(1997-8#1)(2008-10#1)
yield than##3##2##(2008-10#1)(2008-12#1)(2008-3#1)
yield that##2##2##(1992-4#1)(2008-12#1)
yield the best##2##3##(2008-10#1)(2008-2#1)
yield the desired##4##3##(2007-12#2)(2010-2#2)
yield the same##3##3##(1996-2#1)(2008-10#1)(2009-5#1)
yield the##56##2##(1990-8#1)(1991-6#1)(1991-9#1)(1993-11#2)(1994-5#1)(1995-10#2)(1995-3#1)(1995-6#1)(1996-10#1)(1996-2#2)(1996-5#1)(1997-4#1)(2005-11#2)(2006-7#1)(2007-11#4)(2007-12#5)(2008-10#5)(2008-11#1)(2008-2#6)(2008-3#6)(2008-4#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#2)(2012-1#1)
yield three##2##2##(1991-4#1)(2010-5#1)
yield tip-displacement values that are##2##5##(2010-4#2)
yield to##6##2##(1993-11#1)(1994-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-7#1)
yield under winter##2##3##(2013-8#2)
yield under##9##2##(1995-8#1)(2005-11#1)(2008-10#1)(2008-12#1)(2009-8#1)(2013-8#4)
yield useful##4##2##(1991-12#1)(1992-5#1)(2004-4#1)(2008-8#1)
yield valid##2##2##(1997-4#1)(2012-3#1)
yield valuable##4##2##(2007-8#1)(2008-7#1)(2011-1#1)(2013-7#1)
yield was 0##2##3##(2007-11#1)(2008-6#1)
yield was 1##3##3##(1997-6#1)(2008-11#1)(2013-1#1)
yield was about##3##3##(1996-11#1)(2007-3#1)(2008-5#1)
yield was increased##2##3##(1990-11#1)(1995-1#1)
yield was lower##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
yield was not##4##3##(2008-10#4)
yield was observed##2##3##(2007-6#1)(2008-10#1)
yield was obtained##3##3##(2008-10#1)(2008-7#1)(2010-1#1)
yield was recorded##2##3##(2008-12#2)
yield was the##2##3##(2008-10#1)(2013-8#1)
yield was##52##2##(1990-11#1)(1990-5#1)(1990-7#1)(1995-1#1)(1995-12#1)(1996-11#1)(1996-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#1)(2008-10#12)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#3)(2008-7#4)(2010-1#1)(2011-1#1)(2011-10#1)(2011-2#3)(2013-1#2)(2013-8#1)
yield were##10##2##(1991-8#1)(2008-10#5)(2008-12#1)(2008-7#1)(2011-2#1)(2012-3#1)
yield with##7##2##(2005-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2013-1#1)
yield##1387##1##(1990-10#1)(1990-11#7)(1990-12#3)(1990-2#2)(1990-3#10)(1990-4#1)(1990-5#5)(1990-6#2)(1990-7#7)(1990-8#3)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#2)(1991-6#3)(1991-7#6)(1991-8#2)(1991-9#6)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#5)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#5)(1992-8#6)(1992-9#3)(1993-11#5)(1993-12#6)(1993-2#2)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#3)(1994-11#12)(1994-12#4)(1994-2#4)(1994-3#4)(1994-5#6)(1994-6#5)(1994-7#1)(1994-8#9)(1994-9#6)(1995-1#3)(1995-10#4)(1995-11#3)(1995-12#2)(1995-2#5)(1995-3#6)(1995-6#6)(1995-7#2)(1995-8#5)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#8)(1996-2#9)(1996-3#2)(1996-4#1)(1996-5#13)(1996-6#2)(1996-7#3)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#6)(1997-3#8)(1997-4#7)(1997-5#6)(1997-6#5)(1997-7#4)(1997-8#7)(2004-4#1)(2004-8#2)(2004-9#1)(2005-11#18)(2005-4#1)(2005-6#1)(2005-7#1)(2005-8#4)(2006-1#1)(2006-10#6)(2006-11#2)(2006-12#7)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#4)(2007-10#1)(2007-11#39)(2007-12#33)(2007-2#1)(2007-3#4)(2007-4#1)(2007-5#5)(2007-6#5)(2007-8#14)(2007-9#4)(2008-1#8)(2008-10#224)(2008-11#47)(2008-12#66)(2008-2#55)(2008-3#54)(2008-4#36)(2008-5#47)(2008-6#31)(2008-7#31)(2008-8#15)(2008-9#30)(2009-10#3)(2009-11#5)(2009-12#2)(2009-2#1)(2009-3#5)(2009-4#2)(2009-5#4)(2009-6#2)(2009-7#11)(2009-8#4)(2009-9#2)(2010-1#3)(2010-10#1)(2010-11#4)(2010-12#8)(2010-2#9)(2010-3#3)(2010-4#15)(2010-5#5)(2010-6#2)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#9)(2011-10#2)(2011-12#7)(2011-2#34)(2011-3#1)(2012-1#8)(2012-11#7)(2012-12#8)(2012-2#25)(2012-3#8)(2012-4#1)(2013-1#37)(2013-7#3)(2013-8#19)
yield) and##2##2##(2008-10#1)(2008-8#1)
yield)##10##1##(1994-11#1)(1994-9#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
yield-limiting##2##1##(2008-10#2)
yield-per-recruit##4##1##(2013-7#4)
yielded 11##2##2##(2008-9#1)(2010-2#1)
yielded M##2##2##(1996-12#1)(2011-2#1)
yielded Mycobacterium##2##2##(1997-4#1)(2008-1#1)
yielded a 1##2##3##(2008-10#1)(2012-1#1)
yielded a high##2##3##(1993-5#1)(2008-11#1)
yielded a linear##3##3##(1994-3#1)(2008-10#2)
yielded a new##4##3##(2007-1#2)(2007-11#1)(2007-12#1)
yielded a number of##2##4##(1992-3#1)(2009-2#1)
yielded a pA2 value of 7##2##6##(1996-2#2)
yielded a peak##3##3##(1992-1#2)(2008-10#1)
yielded a protein##2##3##(1990-6#1)(1994-9#1)
yielded a resolution##2##3##(2007-11#1)(2007-12#1)
yielded a response##2##3##(2005-7#1)(2008-2#1)
yielded a sensitivity and specificity of##2##6##(1992-6#1)(2007-7#1)
yielded a sensitivity##3##3##(1992-6#1)(2006-2#1)(2007-7#1)
yielded a single##7##3##(1990-2#1)(1990-7#2)(1991-12#1)(1992-12#1)(1992-5#1)(2008-10#1)
yielded a total of##2##4##(2009-6#1)(2013-1#1)
yielded a##113##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-7#2)(1991-8#1)(1992-1#2)(1992-10#1)(1992-12#2)(1992-3#3)(1992-5#1)(1992-6#2)(1993-12#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-10#2)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#3)(1996-11#1)(1996-12#1)(1996-2#2)(1996-4#2)(1996-7#1)(1996-8#1)(1997-5#1)(1997-7#2)(2005-7#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#2)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#4)(2007-7#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#3)(2008-6#2)(2008-7#3)(2009-10#1)(2009-2#1)(2009-6#1)(2010-2#2)(2010-4#1)(2012-1#1)(2012-3#1)(2013-1#3)
yielded additional##2##2##(2007-11#1)(2013-1#1)
yielded almost##2##2##(2008-10#1)(2008-5#1)
yielded an overall##2##3##(1996-7#1)(2007-7#1)
yielded an##16##2##(1993-8#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-2#1)
yielded as##2##2##(2008-10#1)(2008-2#1)
yielded better results than the##2##5##(1994-6#1)(2008-2#1)
yielded better results##3##3##(1994-6#1)(2008-10#1)(2008-2#1)
yielded better##4##2##(1994-6#1)(2008-10#1)(2008-2#1)(2008-6#1)
yielded by the##3##3##(2006-4#1)(2008-1#1)(2008-2#1)
yielded by##10##2##(1993-4#1)(1995-10#1)(2006-4#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)(2013-1#1)
yielded different##4##2##(1992-7#1)(1996-7#1)(2008-10#1)(2012-3#1)
yielded endocervical cells in##2##4##(1992-1#2)
yielded enzymes with##2##3##(1993-6#1)(2013-8#1)
yielded exclusively the##2##3##(1991-9#1)(2007-3#1)
yielded exclusively##3##2##(1991-9#1)(1995-6#1)(2007-3#1)
yielded five##3##2##(1994-2#1)(2006-10#1)(2008-10#1)
yielded four##5##2##(1995-6#1)(1997-3#1)(2009-10#1)(2009-7#1)(2011-3#1)
yielded fragments##2##2##(2008-10#1)(2008-6#1)
yielded good results##3##3##(1994-6#1)(2007-12#1)(2007-2#1)
yielded good##6##2##(1994-6#1)(1997-6#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-3#1)
yielded important##3##2##(2006-10#1)(2008-11#1)(2010-7#1)
yielded inconsistent##2##2##(2007-11#1)(2009-8#1)
yielded insights into##2##3##(2009-3#1)(2011-2#1)
yielded linear##2##2##(1990-11#1)(1991-7#1)
yielded log(10)CFU/mL reductions of##2##4##(2006-8#2)
yielded lower##2##2##(2008-10#1)(2013-8#1)
yielded mixed results##2##3##(2006-2#1)(2008-9#1)
yielded more##6##2##(1994-5#1)(1997-8#1)(2007-8#1)(2008-10#1)(2010-3#1)(2012-1#1)
yielded new insights into the##2##5##(2006-10#1)(2007-12#1)
yielded new##3##2##(2006-10#1)(2007-12#1)(2012-2#1)
yielded no improvement##2##3##(2008-3#1)(2008-6#1)
yielded no##11##2##(1993-7#1)(1995-2#1)(1997-3#1)(2007-10#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2009-4#1)(2011-2#1)
yielded one##3##2##(1992-11#1)(1994-11#1)(2008-10#1)
yielded only##8##2##(1990-8#1)(1992-12#1)(2006-5#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-6#1)
yielded positive##3##2##(1994-7#1)(2008-10#1)(2013-8#1)
yielded progressively higher##2##3##(1995-10#1)(1995-5#1)
yielded promising results##2##3##(2007-11#1)(2010-11#1)
yielded promising##5##2##(1990-3#1)(2006-10#1)(2007-11#2)(2010-11#1)
yielded responses##2##2##(1994-6#1)(2008-10#1)
yielded results##7##2##(1992-12#1)(1995-2#1)(2008-10#4)(2010-4#1)
yielded satisfactory##2##2##(2006-12#1)(2012-1#1)
yielded significant results only on##2##5##(1994-3#1)(2010-2#1)
yielded significant results##3##3##(1994-3#1)(2007-12#1)(2010-2#1)
yielded significant##5##2##(1994-3#1)(2006-7#1)(2007-12#1)(2008-6#1)(2010-2#1)
yielded significantly##2##2##(2005-11#1)(2013-8#1)
yielded similar results##2##3##(1991-6#1)(2008-10#1)
yielded similar##7##2##(1991-6#1)(1997-7#1)(2007-6#1)(2008-10#1)(2008-3#1)(2010-8#1)(2011-2#1)
yielded slightly higher##2##3##(1997-2#1)(2007-4#1)
yielded slightly##3##2##(1997-2#1)(1997-7#1)(2007-4#1)
yielded some##2##2##(2005-8#1)(2006-6#1)
yielded spurious evidence##2##3##(1997-5#2)
yielded the best results##2##4##(2008-5#1)(2010-2#1)
yielded the desired##2##3##(1993-11#1)(1995-3#1)
yielded the following##7##3##(1991-12#1)(1994-8#1)(1995-11#1)(1997-8#1)(2008-10#2)(2008-12#1)
yielded the highest##3##3##(2007-8#1)(2008-10#1)(2008-5#1)
yielded the maximum##3##3##(1990-10#1)(2008-12#1)(2009-3#1)
yielded the same##5##3##(1994-11#1)(2007-12#1)(2008-10#2)(2013-7#1)
yielded the##48##2##(1990-10#1)(1991-12#1)(1991-4#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-3#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-12#1)(2007-1#3)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#7)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#2)(2009-3#1)(2010-2#1)(2010-4#1)(2012-12#1)(2012-3#2)(2013-7#1)
yielded three##3##2##(2008-10#1)(2008-5#1)(2010-9#1)
yielded two##8##2##(1990-5#1)(1991-2#1)(1992-7#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-5#1)
yielded up to##2##3##(2007-12#1)(2008-5#1)
yielded values##3##2##(1995-2#1)(1997-1#1)(2008-10#1)
yielded very##3##2##(2008-12#1)(2008-6#1)(2010-2#1)
yielded well-defined##2##2##(1997-4#1)(2009-10#1)
yielded##571##1##(1990-10#2)(1990-11#3)(1990-12#4)(1990-2#4)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#2)(1991-11#2)(1991-12#5)(1991-2#5)(1991-3#1)(1991-4#3)(1991-6#2)(1991-7#7)(1991-8#2)(1991-9#1)(1992-1#4)(1992-10#2)(1992-11#3)(1992-12#6)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#3)(1992-6#3)(1992-7#4)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#5)(1993-9#3)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#4)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#4)(1995-11#2)(1995-2#6)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#5)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#4)(1996-3#1)(1996-4#3)(1996-5#1)(1996-7#3)(1996-8#3)(1996-9#2)(1997-1#4)(1997-2#5)(1997-3#2)(1997-4#4)(1997-5#3)(1997-6#3)(1997-7#7)(1997-8#4)(2004-11#1)(2004-12#1)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#11)(2006-11#2)(2006-12#6)(2006-2#2)(2006-4#2)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#6)(2006-9#2)(2007-1#6)(2007-10#3)(2007-11#18)(2007-12#16)(2007-2#2)(2007-3#2)(2007-4#1)(2007-6#2)(2007-7#6)(2007-8#6)(2007-9#1)(2008-1#3)(2008-10#74)(2008-11#9)(2008-12#6)(2008-2#14)(2008-3#17)(2008-4#1)(2008-5#12)(2008-6#7)(2008-7#6)(2008-8#2)(2008-9#3)(2009-10#4)(2009-11#2)(2009-2#3)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#7)(2010-3#1)(2010-4#4)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#5)(2011-12#2)(2011-2#10)(2011-3#1)(2012-1#5)(2012-11#2)(2012-12#3)(2012-2#10)(2012-3#5)(2013-1#10)(2013-7#1)(2013-8#6)
yielding 1##2##2##(1992-9#1)(2008-10#1)
yielding T beta##2##3##(1995-3#2)
yielding a detection limit##2##4##(1996-3#1)(2008-10#1)
yielding a maximum##2##3##(1991-8#1)(2008-7#1)
yielding a pink##2##3##(2008-10#2)
yielding a##55##2##(1990-2#2)(1991-8#2)(1992-10#2)(1992-3#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-12#1)(1996-12#1)(1996-3#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#3)(2007-12#5)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2009-12#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-7#1)(2012-2#1)(2013-1#2)
yielding an overall##2##3##(2008-10#1)(2012-2#1)
yielding an##12##2##(1991-4#1)(1994-3#1)(1995-2#1)(1995-6#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2012-2#1)
yielding and remarkably##2##3##(2009-12#1)(2010-7#1)
yielding and##4##2##(2006-4#1)(2008-10#1)(2009-12#1)(2010-7#1)
yielding good agreement with##2##4##(2008-2#1)(2012-2#1)
yielding good##3##2##(2008-2#1)(2008-3#1)(2012-2#1)
yielding improved##2##2##(2007-11#1)(2008-10#1)
yielding information##2##2##(2009-5#1)(2011-2#1)
yielding lower##2##2##(1995-8#1)(2008-2#1)
yielding of##2##2##(2007-5#1)(2008-10#1)
yielding one##4##2##(1991-12#1)(2008-10#2)(2009-12#1)
yielding optimum##2##2##(2008-10#1)(2008-11#1)
yielding period##3##2##(2008-6#3)
yielding several##3##2##(2006-12#1)(2008-4#2)
yielding similar##2##2##(2006-5#1)(2007-11#1)
yielding some##2##2##(2008-5#1)(2011-2#1)
yielding the best##2##3##(2008-10#1)(2012-3#1)
yielding the##14##2##(1994-3#1)(1996-2#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#2)(2010-5#1)(2011-3#1)(2012-3#1)(2013-8#2)
yielding two##2##2##(1993-11#1)(2008-3#1)
yielding very##2##2##(2007-12#1)(2008-2#1)
yielding##228##1##(1990-10#1)(1990-2#2)(1990-8#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-8#3)(1992-10#2)(1992-3#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#3)(1994-8#1)(1994-9#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-4#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#2)(1997-8#2)(2004-11#1)(2004-12#1)(2004-9#1)(2005-11#3)(2006-10#3)(2006-12#4)(2006-4#1)(2006-5#1)(2007-1#1)(2007-11#7)(2007-12#16)(2007-5#3)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#36)(2008-11#4)(2008-12#2)(2008-2#11)(2008-3#10)(2008-4#5)(2008-5#6)(2008-6#6)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#4)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#2)(2012-2#5)(2012-3#2)(2013-1#4)(2013-8#2)
yields a fringe pattern##2##4##(2008-2#1)(2008-3#1)
yields a global##2##3##(1991-4#1)(1997-5#1)
yields a good estimate of##2##5##(2008-2#2)
yields a good##3##3##(2008-2#2)(2008-3#1)
yields a high frequency of both stable transformation and transient gene expression##2##12##(2008-1#1)(2008-2#1)
yields a high frequency of##3##5##(2008-1#1)(2008-2#1)(2008-4#1)
yields a high##4##3##(2008-1#1)(2008-2#1)(2008-4#1)(2012-2#1)
yields a product with##2##4##(1990-12#1)(1995-8#1)
yields a protein##2##3##(1994-9#1)(1995-6#1)
yields a##85##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-8#3)(1991-10#1)(1991-4#3)(1993-12#1)(1994-10#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-4#1)(1995-6#1)(1995-8#3)(1996-12#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-9#1)(2008-1#1)(2008-10#10)(2008-12#1)(2008-2#14)(2008-3#11)(2008-4#1)(2008-7#2)(2009-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-2#1)
yields accurate##2##2##(1997-2#1)(2008-3#1)
yields after##2##2##(2007-11#1)(2013-1#1)
yields an effective##3##3##(2006-10#1)(2007-11#1)(2008-3#1)
yields an##18##2##(1990-11#1)(1991-4#1)(1993-11#1)(1994-11#2)(1994-9#1)(1996-12#1)(1996-3#2)(2006-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#5)
yields and high##2##3##(1996-5#1)(2008-9#1)
yields and##24##2##(1990-4#1)(1991-11#1)(1992-8#1)(1996-5#3)(2005-11#1)(2006-4#1)(2007-11#2)(2008-10#3)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-12#1)
yields are low##3##3##(2008-11#2)(2008-8#1)
yields are##12##2##(1990-11#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-1#1)
yields as##5##2##(2008-10#1)(2008-11#2)(2008-12#1)(2012-12#1)
yields at##4##2##(1996-5#1)(1996-8#1)(2011-2#1)(2013-1#1)
yields better results than##2##4##(2008-8#1)(2010-8#1)
yields better##4##2##(2008-2#1)(2008-8#1)(2010-8#1)(2011-2#1)
yields between##2##2##(2007-5#1)(2009-2#1)
yields by a##2##3##(2007-11#1)(2008-4#1)
yields by the##2##3##(1996-5#1)(2007-11#1)
yields by##13##2##(1990-3#1)(1996-5#2)(1996-7#1)(2007-10#1)(2007-11#2)(2008-10#2)(2008-4#1)(2008-5#3)
yields close##3##2##(2008-10#2)(2009-5#1)
yields could##2##2##(2007-11#1)(2008-10#1)
yields critical##2##2##(1997-3#1)(2008-3#1)
yields excellent##2##2##(1993-12#1)(2008-3#1)
yields for the##2##3##(2006-12#1)(2008-12#1)
yields for##9##2##(2005-8#1)(2006-12#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-2#1)(2013-1#1)
yields from the##2##3##(2008-11#1)(2010-5#1)
yields from##11##2##(1990-3#1)(2007-11#1)(2007-6#1)(2008-11#3)(2008-4#1)(2010-5#1)(2012-2#1)(2013-1#2)
yields good##2##2##(2012-2#1)(2012-3#1)
yields greater##2##2##(2005-8#1)(2007-12#1)
yields high##4##2##(2005-11#1)(2007-12#2)(2008-2#1)
yields highly##2##2##(1993-6#1)(1997-7#1)
yields improved##4##2##(2006-5#1)(2008-12#1)(2008-6#2)
yields in the##5##3##(2007-6#2)(2008-10#1)(2008-6#1)(2012-12#1)
yields in##18##2##(1990-2#1)(1994-12#1)(1997-3#1)(2007-1#1)(2007-11#2)(2007-6#2)(2008-10#5)(2008-3#1)(2008-6#2)(2011-2#1)(2012-12#1)
yields information##4##2##(2008-2#1)(2008-3#2)(2008-9#1)
yields is##2##2##(2007-10#1)(2010-6#1)
yields more##3##2##(2005-12#1)(2006-10#1)(2008-4#1)
yields no##2##2##(2008-4#1)(2010-8#1)
yields obtained in##2##3##(2008-11#2)
yields obtained##4##2##(2008-10#1)(2008-11#2)(2008-6#1)
yields of 0##2##3##(1990-5#1)(2008-12#1)
yields of permethylated##2##3##(1992-3#2)
yields of pure##2##3##(1991-7#1)(2008-4#1)
yields of the##11##3##(1990-8#1)(1991-3#1)(1996-8#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-4#1)(2011-1#1)
yields of up to##2##4##(2008-7#1)(2011-1#1)
yields of##69##2##(1990-5#1)(1990-8#2)(1990-9#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-3#3)(1992-7#1)(1993-6#1)(1994-1#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-4#2)(2005-11#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-3#1)(2007-6#1)(2007-8#3)(2008-1#2)(2008-10#5)(2008-11#5)(2008-12#1)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-2#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#2)
yields on##3##2##(1995-4#1)(2008-6#2)
yields one##2##2##(2007-11#1)(2009-4#1)
yields only##2##2##(2008-11#1)(2008-3#1)
yields over##2##2##(2008-10#1)(2013-1#1)
yields poor##2##2##(2011-1#1)(2012-3#1)
yields poorly##2##2##(1992-7#1)(1996-2#1)
yields reproducible##2##2##(1991-5#1)(2008-7#1)
yields results##3##2##(1997-2#1)(2008-2#1)(2008-5#1)
yields significant##3##2##(1997-2#1)(2008-2#2)
yields starting from##2##3##(2006-12#1)(2008-5#1)
yields substantially better##2##3##(2007-12#1)(2008-2#1)
yields sufficient##2##2##(1994-11#1)(2008-4#1)
yields than the##2##3##(2008-10#1)(2008-5#1)
yields than##7##2##(1996-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2011-2#1)
yields that were##2##3##(2008-10#1)(2013-1#1)
yields the best##3##3##(2007-11#1)(2008-10#1)(2008-11#1)
yields the corresponding##2##3##(2007-11#1)(2008-5#1)
yields the following results##2##4##(1992-6#1)(2008-7#1)
yields the same##2##3##(2008-2#1)(2008-3#1)
yields the##44##2##(1991-11#1)(1992-6#1)(1993-2#2)(1997-1#1)(1997-7#2)(2006-10#1)(2006-4#1)(2007-11#3)(2007-12#4)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#7)(2008-3#8)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-4#1)
yields to##6##2##(1991-11#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)
yields two##2##2##(2008-10#1)(2008-2#1)
yields under##5##2##(2007-10#1)(2007-11#1)(2008-2#1)(2008-4#2)
yields vary between##2##3##(2007-8#1)(2008-10#1)
yields via the##3##3##(2007-11#2)(2013-7#1)
yields via##5##2##(2007-11#2)(2009-5#1)(2010-6#1)(2013-7#1)
yields were calculated##2##3##(2008-10#2)
yields were increased##2##3##(1995-12#1)(2008-11#1)
yields were obtained##3##3##(2006-12#1)(2008-10#1)(2008-11#1)
yields were##29##2##(1993-4#1)(1995-12#1)(2006-12#1)(2007-1#1)(2007-11#3)(2007-5#1)(2007-6#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#2)(2009-2#1)(2009-5#1)(2011-2#1)(2012-11#1)(2012-12#1)
yields with##7##2##(2007-10#1)(2007-8#2)(2008-10#1)(2010-7#2)(2013-7#1)
yields##702##1##(1990-11#3)(1990-12#3)(1990-2#6)(1990-3#3)(1990-4#4)(1990-5#3)(1990-7#1)(1990-8#6)(1990-9#2)(1991-10#1)(1991-11#6)(1991-3#1)(1991-4#4)(1991-5#1)(1991-7#3)(1991-8#1)(1992-3#3)(1992-6#1)(1992-7#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#2)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#4)(1994-12#2)(1994-3#1)(1994-6#1)(1994-9#3)(1995-1#1)(1995-10#2)(1995-12#2)(1995-2#2)(1995-4#2)(1995-6#1)(1995-8#6)(1996-12#4)(1996-2#3)(1996-3#2)(1996-4#2)(1996-5#11)(1996-7#4)(1996-8#3)(1997-1#2)(1997-2#4)(1997-3#4)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#4)(2005-11#3)(2005-12#1)(2005-4#1)(2005-8#4)(2006-10#4)(2006-12#8)(2006-4#4)(2006-5#1)(2006-9#1)(2007-1#5)(2007-10#9)(2007-11#47)(2007-12#26)(2007-3#2)(2007-5#2)(2007-6#6)(2007-8#12)(2007-9#3)(2008-1#4)(2008-10#76)(2008-11#32)(2008-12#11)(2008-2#46)(2008-3#46)(2008-4#24)(2008-5#24)(2008-6#21)(2008-7#12)(2008-8#4)(2008-9#7)(2009-10#2)(2009-12#2)(2009-2#7)(2009-3#1)(2009-4#2)(2009-5#3)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-4#3)(2010-5#6)(2010-6#5)(2010-7#5)(2010-8#3)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#11)(2012-1#3)(2012-11#3)(2012-12#4)(2012-2#5)(2012-3#6)(2013-1#15)(2013-7#3)
yields)##4##1##(1990-4#2)(2008-11#1)(2008-5#1)
yin and yang##2##3##(2008-10#1)(2008-4#1)
yin and##3##2##(2006-10#1)(2008-10#1)(2008-4#1)
yin##4##1##(2006-10#1)(2008-10#2)(2008-4#1)
yl]carbamate##2##1##(1992-3#1)(1993-1#1)
ylide##8##1##(1997-4#1)(2007-11#2)(2009-3#1)(2009-5#2)(2010-6#1)(2010-7#1)
ylides##2##1##(1997-4#1)(2010-7#1)
yoctomole##2##1##(2007-8#2)
yoelii##7##1##(1994-12#4)(2008-3#1)(2008-4#1)(2012-2#1)
yoga and osteopathy##2##3##(2010-12#2)
yoga and tai chi##2##4##(2011-12#2)
yoga and##4##2##(2010-12#2)(2011-12#2)
yoga##25##1##(1990-3#2)(1991-10#1)(1991-12#1)(2004-8#1)(2007-2#1)(2008-10#1)(2008-3#2)(2009-1#1)(2010-12#6)(2011-12#4)(2013-1#5)
yoghurt##5##1##(1997-3#1)(2008-10#4)
yoghurt)##2##1##(1993-9#1)(2008-10#1)
yogic##5##1##(1991-10#1)(1991-12#1)(2008-3#1)(2009-6#1)(2011-12#1)
yogurt##6##1##(1990-8#1)(2011-1#2)(2012-1#1)(2012-11#1)(2012-2#1)
yohimbine##20##1##(1990-5#1)(1991-3#1)(1992-2#1)(1993-12#1)(1993-4#4)(1994-3#1)(1994-6#1)(1996-12#2)(1996-3#1)(1997-1#3)(2006-12#1)(2007-2#1)(2008-10#1)(2013-1#1)
yoked##3##1##(1993-6#2)(1994-12#1)
yolk DNA##4##2##(2008-4#4)
yolk by##2##2##(2008-10#2)
yolk granules##7##2##(2007-12#7)
yolk precursor##2##2##(1994-9#1)(2009-4#1)
yolk proteins##4##2##(1995-2#1)(2008-12#1)(2010-5#2)
yolk sac and paraaortic splanchnopleura##2##5##(1995-1#2)
yolk sac and##6##3##(1993-8#1)(1995-1#5)
yolk sac carcinoma##3##3##(2012-1#3)
yolk sac tumor##3##3##(2008-10#2)(2010-1#1)
yolk sac tumour##3##3##(2012-2#3)
yolk sac##37##2##(1993-12#1)(1993-8#1)(1994-3#1)(1995-1#8)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#9)(2008-5#1)(2008-9#2)(2010-1#1)(2010-8#1)(2012-1#4)(2012-2#3)
yolk sacs##3##2##(2007-12#3)
yolk##98##1##(1990-10#1)(1990-11#1)(1990-3#1)(1991-8#1)(1992-8#2)(1993-12#1)(1993-8#1)(1994-2#2)(1994-3#1)(1994-9#3)(1995-1#8)(1995-2#2)(1995-8#3)(1996-1#1)(1997-4#1)(2006-5#1)(2007-12#11)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#13)(2008-4#4)(2008-5#5)(2008-6#1)(2008-8#2)(2008-9#2)(2009-4#1)(2010-1#1)(2010-2#4)(2010-5#2)(2010-8#1)(2011-1#2)(2012-1#4)(2012-12#1)(2012-2#3)(2012-3#2)
yolk-sac membrane##8##2##(2008-5#8)
yolkless##2##1##(1995-2#2)
you a##5##2##(2007-10#3)(2007-7#1)(2012-12#1)
you and your##3##3##(1993-3#1)(1994-2#1)(1996-3#1)
you are called to##2##4##(2012-2#2)
you are##16##2##(1994-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(2006-10#1)(2007-11#1)(2007-9#2)(2008-11#1)(2008-2#1)(2010-4#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#2)
you at##2##2##(2009-12#1)(2013-7#1)
you be##2##2##(1994-1#1)(2006-5#1)
you can help##2##3##(1997-1#1)(2008-7#1)
you can##10##2##(1994-1#1)(1994-2#1)(1995-2#1)(1997-1#1)(1997-3#1)(2007-10#1)(2007-11#1)(2008-4#1)(2008-7#1)(2011-2#1)
you choose##2##2##(1995-1#1)(2011-2#1)
you could##2##2##(2011-1#1)(2012-2#1)
you do##7##2##(1993-3#1)(1994-2#1)(1995-2#1)(2007-4#3)(2008-11#1)
you don't##5##2##(1994-2#1)(1997-7#1)(2006-4#1)(2006-5#1)(2009-5#1)
you ever##3##2##(1992-1#1)(1994-2#1)(1995-12#1)
you feel##2##2##(2007-12#1)(2010-2#1)
you find##2##2##(1996-3#1)(2007-4#1)
you for the##2##3##(2010-2#1)(2013-1#1)
you for##3##2##(2008-11#1)(2010-2#1)(2013-1#1)
you get##5##2##(1994-3#1)(1996-3#1)(2007-4#1)(2009-5#1)(2010-12#1)
you have a##3##3##(1991-3#1)(1992-1#1)(2003-11#1)
you have to##2##3##(1991-1#1)(1994-2#1)
you have##9##2##(1991-1#1)(1991-3#1)(1992-1#2)(1994-2#1)(2003-11#1)(2008-10#1)(2008-11#1)(2011-1#1)
you know how##2##3##(1991-11#1)(1993-1#1)
you know##12##2##(1991-11#1)(1993-1#1)(2006-10#1)(2006-4#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-9#2)(2011-2#2)
you learned##2##2##(2006-5#2)
you like##2##2##(1990-5#1)(2006-10#1)
you make##2##2##(1996-3#1)(2007-9#1)
you may have##2##3##(1993-12#1)(2006-10#1)
you may not##2##3##(1994-2#1)(2006-10#1)
you may##5##2##(1993-12#1)(1994-2#1)(1994-3#1)(2006-10#2)
you measure##2##2##(1995-2#1)(2010-10#1)
you must##3##2##(1993-3#1)(1994-2#1)(2008-12#1)
you need to know about##4##5##(2008-10#1)(2010-4#1)(2010-5#1)(2010-8#1)
you need to know##7##4##(2007-4#1)(2007-9#1)(2008-10#1)(2008-9#1)(2010-4#1)(2010-5#1)(2010-8#1)
you need to##10##3##(1996-1#1)(1996-3#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-9#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)
you need##15##2##(1993-3#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-3#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-9#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#2)
you publish##2##2##(2006-5#1)(2012-2#1)
you read##2##2##(2007-2#1)(2008-11#1)
you ready for##2##3##(2012-3#2)
you see##4##2##(1997-7#1)(2009-12#1)(2011-1#1)(2012-1#1)
you should know about##2##4##(2012-12#1)(2013-7#1)
you should##7##2##(1991-11#1)(2005-8#1)(2006-8#1)(2009-2#1)(2010-11#1)(2012-12#1)(2013-7#1)
you take##3##2##(1993-2#1)(1995-11#1)(2008-11#1)
you tell me##3##3##(1992-3#1)(2008-1#1)(2012-12#1)
you the##3##2##(2005-8#1)(2006-9#1)(2008-7#1)
you think##11##2##(1993-5#1)(1996-2#1)(2006-12#1)(2006-4#1)(2008-8#3)(2009-6#1)(2012-12#1)(2012-2#1)(2013-7#1)
you to##7##2##(1993-1#1)(1995-2#1)(1996-3#1)(2007-1#1)(2008-10#1)(2008-3#1)(2009-4#1)
you treat your##2##3##(1996-6#1)(2008-4#1)
you want to##9##3##(1992-1#1)(1994-3#1)(1995-12#1)(2007-4#1)(2008-1#1)(2012-2#2)(2012-3#1)(2013-8#1)
you want##11##2##(1992-1#1)(1993-4#1)(1994-3#1)(1995-12#1)(2007-4#1)(2008-1#1)(2008-4#1)(2012-2#2)(2012-3#1)(2013-8#1)
you were##2##2##(2006-8#1)(2012-2#1)
you will be##2##3##(1996-4#1)(2011-12#1)
you will##5##2##(1993-12#1)(1996-4#1)(2007-8#1)(2010-5#1)(2011-12#1)
you wish to##3##3##(2008-4#2)(2008-9#1)
you wish##4##2##(2004-12#1)(2008-4#2)(2008-9#1)
you with##2##2##(2006-10#1)(2008-7#1)
you won't##2##2##(1994-3#1)(2006-4#1)
you!)##3##1##(2007-1#1)(2009-3#2)
you##338##1##(1990-5#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-3#11)(1992-1#5)(1992-10#1)(1992-3#2)(1992-4#1)(1993-1#4)(1993-12#3)(1993-2#1)(1993-3#7)(1993-4#2)(1993-5#1)(1993-8#1)(1994-1#3)(1994-12#1)(1994-2#10)(1994-3#12)(1995-1#2)(1995-11#1)(1995-12#10)(1995-2#9)(1995-3#3)(1996-1#3)(1996-2#5)(1996-3#11)(1996-4#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-6#1)(1997-7#2)(2003-11#2)(2004-12#1)(2005-8#2)(2006-1#1)(2006-10#7)(2006-12#3)(2006-4#7)(2006-5#6)(2006-8#4)(2006-9#2)(2007-1#3)(2007-10#5)(2007-11#3)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#13)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#1)(2007-9#8)(2008-1#4)(2008-10#5)(2008-11#12)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#8)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#4)(2009-10#1)(2009-12#2)(2009-2#1)(2009-4#2)(2009-5#2)(2009-6#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#2)(2010-4#3)(2010-5#3)(2010-8#3)(2010-9#1)(2011-1#4)(2011-12#3)(2011-2#11)(2012-1#4)(2012-12#8)(2012-2#9)(2012-3#4)(2013-1#5)(2013-7#5)(2013-8#5)
you&quot##2##1##(1992-2#1)(2008-12#1)
you'll##3##1##(1994-12#1)(2008-11#1)(2010-9#1)
you're##5##1##(1992-12#1)(1996-3#2)(2011-1#1)(2012-12#1)
you've seen one##2##3##(1996-3#2)
you've seen##3##2##(1996-3#2)(2008-11#1)
you?##8##1##(1992-9#1)(1994-10#1)(1996-2#1)(2006-11#1)(2007-10#1)(2007-7#1)(2008-4#1)(2012-12#1)
young (&lt##2##2##(2008-3#1)(2012-2#1)
young (1 and 3 months old) animals##2##7##(1993-12#2)
young (2##3##2##(2008-3#1)(2009-12#1)(2013-7#1)
young (3 months)##2##3##(1993-2#1)(2010-12#1)
young (3##5##2##(1991-12#1)(1993-2#1)(1994-6#1)(1997-9#1)(2010-12#1)
young (4-6##2##2##(1993-12#1)(1994-6#1)
young (aged##2##2##(2008-5#1)(2008-9#1)
young Black men are##2##4##(2009-9#2)
young Black##3##2##(2009-9#2)(2011-2#1)
young Icelandic female college students##2##5##(2006-7#2)
young Indian##2##2##(2011-2#1)(2012-2#1)
young Japanese##2##2##(2008-10#2)
young Korean##3##2##(2006-7#2)(2009-11#1)
young Scots pine seedlings##2##4##(2004-4#2)
young adolescent##4##2##(2006-1#1)(2006-6#1)(2007-12#1)(2009-7#1)
young adolescents##9##2##(2007-8#3)(2008-9#1)(2010-2#1)(2012-1#3)(2012-2#1)
young adolescents'##3##2##(2008-2#1)(2009-11#1)(2013-1#1)
young adult and##2##3##(1994-11#1)(2008-5#1)
young adult female##2##3##(2012-2#1)(2012-3#1)
young adult mice##2##3##(1990-5#2)
young adult patients##4##3##(1990-10#1)(2006-12#1)(2006-7#2)
young adult survivors of##2##4##(2008-6#1)(2008-7#1)
young adult with##4##3##(2008-12#1)(2010-12#1)(2010-7#1)(2012-2#1)
young adult women##2##3##(2011-1#1)(2012-11#1)
young adult##76##2##(1990-10#1)(1990-3#1)(1990-5#4)(1991-11#1)(1993-2#1)(1994-10#1)(1994-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-2#2)(1996-3#1)(1996-8#1)(1997-5#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-12#2)(2007-4#3)(2007-7#2)(2007-9#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#7)(2010-9#3)(2011-1#1)(2011-12#1)(2012-1#1)(2012-11#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
young adulthood##17##2##(1993-9#1)(1996-5#1)(2006-9#2)(2007-4#1)(2008-12#1)(2009-12#1)(2009-7#1)(2010-10#3)(2010-7#1)(2011-1#2)(2012-3#1)(2013-1#1)(2013-8#1)
young adults (aged##2##3##(1995-5#1)(2013-1#1)
young adults aged##2##3##(1990-4#1)(2011-2#1)
young adults and is##2##4##(2006-10#1)(2008-1#1)
young adults and##8##3##(1994-5#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-7#1)(2013-1#1)
young adults are##3##3##(2007-2#1)(2008-11#1)(2012-12#1)
young adults from##3##3##(2008-7#1)(2010-2#1)(2012-12#1)
young adults in a##3##4##(1995-9#2)(2008-7#1)
young adults in the##4##4##(1997-6#1)(2007-11#1)(2012-12#1)(2013-1#1)
young adults in##14##3##(1995-5#2)(1995-6#1)(1995-9#2)(1997-6#1)(2007-11#1)(2008-7#1)(2010-2#1)(2011-11#1)(2012-12#1)(2013-1#3)
young adults may be##2##4##(2007-1#1)(2007-12#1)
young adults may##3##3##(2007-1#1)(2007-12#1)(2011-2#1)
young adults of##4##3##(1991-11#1)(2008-3#1)(2011-12#1)(2012-12#1)
young adults who were##2##4##(2013-1#1)(2013-8#1)
young adults who##7##3##(2009-10#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
young adults with##13##3##(1990-10#1)(1990-3#1)(1996-2#1)(2006-2#1)(2007-8#1)(2008-11#1)(2008-8#1)(2009-7#1)(2010-12#1)(2011-1#1)(2012-2#2)(2013-1#1)
young adults##178##2##(1990-10#1)(1990-12#1)(1990-3#2)(1990-4#1)(1991-1#1)(1991-11#3)(1992-10#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-12#2)(1994-2#2)(1994-5#1)(1995-1#1)(1995-3#3)(1995-5#3)(1995-6#1)(1995-9#2)(1996-2#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-11#1)(2006-10#4)(2006-12#3)(2006-2#1)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#3)(2007-12#5)(2007-2#1)(2007-7#1)(2007-8#7)(2007-9#2)(2008-1#3)(2008-10#1)(2008-11#5)(2008-12#3)(2008-3#1)(2008-4#5)(2008-6#4)(2008-7#8)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#3)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#3)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-11#2)(2011-12#1)(2011-2#8)(2012-1#4)(2012-12#11)(2012-2#3)(2012-3#3)(2013-1#15)(2013-7#1)(2013-8#6)
young adults' current financial learning##2##5##(2010-10#2)
young adults'##6##2##(2008-12#1)(2009-12#1)(2010-10#3)(2010-3#1)
young adults)##2##2##(2010-4#1)(2012-12#1)
young adults]##2##2##(1993-5#1)(2007-3#1)
young age and##2##3##(2007-2#1)(2007-8#1)
young age at##2##3##(2009-12#1)(2013-8#1)
young age##35##2##(1990-5#1)(1990-9#1)(1991-2#1)(1992-2#1)(1994-12#1)(1994-4#2)(1994-8#1)(1994-9#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-2#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-7#1)(2010-12#2)(2010-2#2)(2011-2#4)(2012-2#3)(2013-8#2)
young and adult rats##6##4##(1992-3#1)(2008-8#3)(2013-7#2)
young and adult##15##3##(1991-11#1)(1992-11#1)(1992-3#1)(1995-2#1)(1997-6#1)(1997-9#1)(2008-7#1)(2008-8#3)(2011-2#1)(2012-3#2)(2013-7#2)
young and aged mice##6##4##(1994-6#1)(1995-12#2)(1995-9#2)(2006-10#1)
young and aged rats##6##4##(1990-5#1)(1990-7#1)(1993-7#1)(1994-10#2)(1996-11#1)
young and aged##17##3##(1990-5#1)(1990-7#1)(1993-11#1)(1993-7#2)(1994-10#2)(1994-6#1)(1995-12#2)(1995-5#1)(1995-9#2)(1996-11#1)(1997-6#1)(2006-10#1)(2008-5#1)
young and also##2##3##(1992-6#1)(2005-3#1)
young and elderly subjects##2##4##(1991-1#1)(1996-7#1)
young and elderly##8##3##(1991-1#1)(1992-6#1)(1995-3#1)(1996-11#1)(1996-7#2)(1996-9#2)
young and middle-aged adults##5##4##(1995-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2013-8#1)
young and middle-aged##8##3##(1995-6#1)(1996-4#1)(2005-1#1)(2008-7#2)(2008-9#1)(2009-12#1)(2013-8#1)
young and old adults##2##4##(2008-11#2)
young and old mice##4##4##(1990-5#1)(1994-5#1)(1996-9#1)(2013-1#1)
young and old rat##2##4##(1994-8#1)(2009-12#1)
young and old rats were##2##5##(1991-12#1)(2010-12#1)
young and old rats##17##4##(1990-3#1)(1991-12#3)(1994-6#3)(1994-8#1)(1995-12#1)(1995-9#1)(2008-7#4)(2009-12#1)(2010-12#2)
young and old##41##3##(1990-3#2)(1990-5#2)(1991-12#3)(1992-1#1)(1992-12#2)(1994-5#2)(1994-6#4)(1994-8#2)(1995-12#2)(1995-9#1)(1996-7#1)(1996-9#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-11#3)(2008-6#1)(2008-7#4)(2009-12#2)(2010-11#1)(2010-12#2)(2013-1#2)
young and older adults##3##4##(2008-11#1)(2008-3#1)(2009-10#1)
young and older women##2##4##(2008-3#2)
young and older##8##3##(1992-4#1)(2008-11#1)(2008-3#3)(2008-5#1)(2009-10#1)(2011-1#1)
young and##131##2##(1990-3#3)(1990-5#3)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#4)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#2)(1993-11#1)(1993-7#2)(1994-10#2)(1994-5#3)(1994-6#5)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#4)(1996-11#2)(1996-4#1)(1996-7#3)(1996-9#4)(1997-3#2)(1997-6#2)(1997-9#1)(2005-1#1)(2005-3#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-11#4)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#3)(2010-11#2)(2010-12#3)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#3)(2013-8#2)
young animals was##3##3##(1993-2#1)(1996-5#2)
young animals##26##2##(1990-10#1)(1990-3#1)(1990-5#1)(1990-7#3)(1991-12#2)(1993-2#1)(1994-2#1)(1995-6#1)(1996-5#2)(1996-9#1)(1997-5#1)(1997-7#1)(2008-3#3)(2008-7#2)(2009-12#2)(2009-5#1)(2011-1#1)(2011-2#1)
young athlete##3##2##(2008-7#1)(2012-3#1)(2013-1#1)
young athletes##14##2##(1995-6#1)(1996-6#1)(2008-7#2)(2008-9#1)(2010-1#4)(2010-10#1)(2012-3#4)
young babies##2##2##(1990-2#1)(2010-11#1)
young birds##3##2##(2007-2#1)(2008-5#1)(2008-9#1)
young black##4##2##(1992-5#1)(2011-2#2)(2013-1#1)
young bulls##3##2##(2013-1#3)
young but not##4##3##(1990-7#1)(1994-10#1)(1994-6#1)(1995-12#1)
young but##6##2##(1990-3#2)(1990-7#1)(1994-10#1)(1994-6#1)(1995-12#1)
young calves##4##2##(1992-1#1)(2005-7#1)(2008-11#1)(2008-7#1)
young cancer patients##2##3##(1992-5#1)(2011-2#1)
young cells##4##2##(1992-3#2)(1994-3#2)
young chickens and##2##3##(2005-9#1)(2012-1#1)
young chickens##4##2##(2005-9#1)(2008-5#2)(2012-1#1)
young chicks##4##2##(1990-3#1)(1992-10#1)(1994-2#1)(2007-6#1)
young child##19##2##(1993-3#1)(1996-2#2)(1996-3#1)(2007-9#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-7#1)(2010-4#1)(2010-5#5)(2011-1#1)(2012-2#1)
young children and the##2##4##(2005-7#1)(2009-4#1)
young children and##12##3##(1996-3#1)(1997-1#1)(2005-7#1)(2006-1#1)(2008-11#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-9#2)(2012-2#1)
young children are##4##3##(1994-11#1)(2006-2#1)(2009-2#1)(2013-8#1)
young children from##2##3##(1991-6#1)(2005-11#1)
young children in rural areas##2##5##(2007-2#1)(2013-1#1)
young children in the##2##4##(2008-9#1)(2009-11#1)
young children in##9##3##(2007-2#1)(2007-7#1)(2008-9#1)(2009-11#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#2)
young children is##2##3##(2008-9#1)(2010-6#1)
young children to##3##3##(1993-6#1)(2008-6#1)(2013-1#1)
young children using cochlear implants##2##5##(2008-9#2)
young children with##10##3##(1997-1#1)(2007-4#1)(2007-6#2)(2008-4#1)(2009-3#1)(2009-4#1)(2010-10#1)(2012-11#1)(2013-1#1)
young children##129##2##(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#4)(1997-3#1)(1997-8#1)(2005-10#1)(2005-11#4)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-2#3)(2006-8#2)(2007-10#1)(2007-12#1)(2007-2#2)(2007-4#2)(2007-6#2)(2007-7#2)(2008-1#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#11)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#2)(2009-4#3)(2009-6#1)(2009-9#2)(2010-10#2)(2010-12#1)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#2)(2010-9#4)(2011-2#5)(2012-1#4)(2012-11#1)(2012-12#2)(2012-2#4)(2013-1#7)(2013-8#5)
young cirrhotics##5##2##(2012-3#5)
young control##2##2##(1990-4#1)(1994-5#1)
young controls (YC)##2##3##(1995-11#1)(2008-7#1)
young controls##6##2##(1994-5#1)(1995-11#1)(1995-6#1)(1996-12#1)(1997-2#1)(2008-7#1)
young deaf##2##2##(2008-9#1)(2011-2#1)
young deer##3##2##(2005-7#3)
young dogs##2##2##(1991-6#1)(1993-7#1)
young donors##5##2##(1996-3#2)(1996-9#1)(2008-7#1)(2012-2#1)
young drug##2##2##(1997-6#1)(2005-8#1)
young enzyme##2##2##(1991-6#2)
young erythrocytes##2##2##(2008-9#2)
young female##24##2##(1992-10#1)(1994-6#1)(1995-9#1)(2006-7#1)(2006-9#1)(2007-7#1)(2008-12#3)(2008-6#2)(2008-7#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-8#1)
young females in##3##3##(2007-11#1)(2007-7#1)(2012-2#1)
young females##12##2##(1990-8#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-6#1)(2009-5#1)(2011-2#2)(2012-12#1)(2012-2#1)
young girl##6##2##(2007-8#1)(2007-9#2)(2008-10#1)(2011-2#1)(2012-1#1)
young girls with##2##3##(2007-12#1)(2007-8#1)
young girls##3##2##(2007-12#1)(2007-8#1)(2011-1#1)
young group of##3##3##(1992-10#1)(2007-7#1)(2008-4#1)
young group##7##2##(1991-12#1)(1992-10#1)(1996-8#1)(2007-7#1)(2007-9#1)(2008-4#1)(2013-1#1)
young growing##3##2##(1994-3#1)(2012-2#2)
young healthy##3##2##(2004-11#1)(2007-2#1)(2007-7#1)
young hogs##2##2##(2012-1#2)
young in##2##2##(2007-9#1)(2008-9#1)
young individuals were##2##3##(2007-3#1)(2008-7#1)
young individuals with##2##3##(2008-12#1)(2012-12#1)
young individuals##13##2##(1991-12#1)(1993-1#1)(1996-7#2)(2007-3#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2012-12#1)
young infant##2##2##(2007-2#1)(2007-3#1)
young infants and##3##3##(1996-12#1)(2006-7#1)(2010-10#1)
young infants##11##2##(1996-12#1)(2005-11#1)(2006-10#3)(2006-7#1)(2008-11#1)(2008-9#1)(2009-4#1)(2010-10#1)(2012-1#1)
young injection drug users##2##4##(2013-8#2)
young is##2##2##(2008-9#1)(2012-1#1)
young kittens (postnatal##2##3##(1993-12#2)
young lady##3##2##(2007-7#2)(2010-10#1)
young leaves##15##2##(2004-2#1)(2006-12#2)(2007-1#2)(2007-3#4)(2008-10#3)(2008-5#2)(2011-12#1)
young male buffalo meat##2##4##(2010-4#2)
young male patients##2##3##(1996-7#1)(2010-7#1)
young male rats##4##3##(1996-10#2)(2008-7#2)
young male with##3##3##(1996-3#1)(2011-2#1)(2012-2#1)
young male##36##2##(1990-6#2)(1991-1#1)(1991-3#1)(1993-4#1)(1996-10#2)(1996-3#2)(1996-7#1)(1996-8#1)(2006-10#2)(2006-4#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#5)(2010-4#3)(2010-5#1)(2010-7#2)(2010-9#1)(2011-2#1)(2012-2#2)(2012-3#2)
young males##12##2##(1991-6#1)(1996-6#1)(2007-7#2)(2008-6#1)(2009-5#2)(2010-3#1)(2011-12#1)(2011-2#2)(2013-7#1)
young man who presented with##4##5##(2007-11#1)(2008-8#1)(2013-1#2)
young man who presented##5##4##(2007-11#1)(2007-7#1)(2008-8#1)(2013-1#2)
young man who##8##3##(1995-12#1)(2007-11#1)(2007-7#2)(2008-8#1)(2010-9#1)(2013-1#2)
young man with##5##3##(2009-3#1)(2010-12#1)(2011-2#1)(2012-3#2)
young man##20##2##(1991-11#1)(1992-2#1)(1995-12#1)(2006-9#1)(2007-11#1)(2007-7#2)(2008-7#2)(2008-8#1)(2009-3#2)(2010-12#2)(2010-9#1)(2011-2#1)(2012-3#2)(2013-1#2)
young maternal age is##2##4##(2009-12#2)
young maternal age##3##3##(2009-12#2)(2012-12#1)
young medical##2##2##(2007-6#1)(2008-4#1)
young men and women##2##4##(2007-7#1)(2009-5#1)
young men and##3##3##(2007-7#2)(2009-5#1)
young men in##4##3##(1990-6#1)(1991-11#1)(2007-7#1)(2008-10#1)
young men were##2##3##(2007-7#1)(2009-5#1)
young men who have sex with men (YMSM)##5##8##(2007-12#1)(2010-9#1)(2012-11#1)(2013-1#2)
young men with##4##3##(1994-2#1)(2008-3#1)(2011-2#1)(2013-1#1)
young men##47##2##(1990-6#1)(1991-11#1)(1991-9#1)(1992-8#1)(1994-2#2)(1997-2#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-12#1)(2007-7#6)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2009-12#1)(2009-5#10)(2010-9#1)(2011-2#6)(2012-11#1)(2013-1#4)(2013-8#1)
young men's##4##2##(2007-12#2)(2009-5#2)
young mice##8##2##(1990-5#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-9#2)(1996-9#1)(2013-1#1)
young mothers##3##2##(1996-2#1)(1997-2#1)(2007-2#1)
young ones##6##2##(1990-5#1)(1992-12#1)(1994-6#2)(2008-7#1)(2012-2#1)
young or adult##2##3##(1997-6#1)(2013-7#1)
young or##9##2##(1995-12#1)(1996-5#1)(1997-6#1)(2007-8#1)(2008-7#1)(2008-9#1)(2012-3#2)(2013-7#1)
young parents##2##2##(2006-2#1)(2008-1#1)
young patient who##2##3##(2013-7#1)(2013-8#1)
young patient##22##2##(1990-12#1)(1991-5#1)(1992-10#1)(1992-6#1)(2005-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-6#2)(2011-12#1)(2011-2#5)(2013-1#2)(2013-7#1)(2013-8#1)
young patients and##5##3##(1992-6#2)(1993-8#1)(2006-10#1)(2007-8#1)
young patients are##2##3##(2010-7#1)(2011-2#1)
young patients who##3##3##(1992-6#1)(1993-5#1)(2007-7#1)
young patients with severe##2##4##(2009-3#2)
young patients with##15##3##(1993-7#1)(1996-7#3)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-3#2)(2010-12#1)(2011-2#1)(2013-1#1)
young patients without##2##3##(2010-7#1)(2013-1#1)
young patients##64##2##(1990-3#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-3#1)(1992-6#4)(1993-5#1)(1993-7#1)(1993-8#2)(1995-12#1)(1995-6#1)(1996-7#3)(2006-10#3)(2006-7#1)(2006-8#3)(2007-10#3)(2007-11#3)(2007-12#3)(2007-7#3)(2007-8#3)(2008-10#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-3#2)(2010-12#2)(2010-7#4)(2011-1#2)(2011-11#1)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
young people and##4##3##(2006-10#1)(2007-3#1)(2010-5#1)(2012-3#1)
young people are##2##3##(2007-12#1)(2010-12#1)
young people from##2##3##(2007-3#1)(2010-12#1)
young people in Maputo##3##4##(2006-7#3)
young people in Mozambique##2##4##(2006-7#2)
young people in##21##3##(1990-6#1)(1991-8#3)(1996-2#1)(2004-3#1)(2006-7#5)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-8#1)(2012-11#1)(2012-2#1)(2013-8#1)
young people is##3##3##(2006-1#1)(2009-5#1)(2013-1#1)
young people reported##2##3##(2012-12#1)(2012-3#1)
young people to##6##3##(2006-7#2)(2007-3#2)(2008-7#1)(2013-1#1)
young people who have a##2##5##(2008-7#1)(2012-2#1)
young people who##8##3##(1992-2#1)(1996-2#1)(2007-1#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
young people with##3##3##(2008-4#1)(2008-7#1)(2013-1#1)
young people##114##2##(1990-3#1)(1990-5#1)(1990-6#1)(1991-6#1)(1991-8#5)(1992-2#1)(1992-5#2)(1995-8#2)(1996-11#1)(1996-2#2)(1997-6#1)(2004-3#1)(2005-1#1)(2005-8#1)(2006-1#2)(2006-10#1)(2006-2#1)(2006-4#1)(2006-7#9)(2007-1#1)(2007-12#2)(2007-2#1)(2007-3#9)(2007-7#5)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#6)(2008-9#1)(2009-2#2)(2009-4#1)(2009-5#4)(2009-7#1)(2010-12#3)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#4)(2012-3#7)(2013-1#6)(2013-7#2)(2013-8#2)
young people's##2##2##(2006-7#1)(2006-8#1)
young person who##2##3##(1991-8#1)(1993-5#1)
young persons aged 15-24 years##3##5##(2012-12#3)
young persons##11##2##(1991-3#2)(1994-4#1)(1996-1#1)(1997-2#1)(2007-3#1)(2010-8#1)(2012-12#4)
young pigs##3##2##(1997-4#1)(2013-1#1)(2013-8#1)
young plants##4##2##(1997-6#1)(2007-1#1)(2010-10#2)
young population##6##2##(1992-12#1)(2007-11#1)(2007-9#1)(2008-11#1)(2009-7#1)(2012-2#1)
young rat##8##2##(1990-7#1)(1994-2#1)(1994-6#1)(1995-9#1)(1996-11#1)(1997-5#1)(1997-8#1)(2009-12#1)
young rats were##2##3##(1992-10#1)(1993-4#1)
young rats##38##2##(1990-3#2)(1990-5#1)(1990-7#1)(1991-12#2)(1992-1#1)(1992-10#2)(1992-11#2)(1993-4#2)(1993-7#1)(1994-10#1)(1994-6#1)(1995-11#1)(1995-12#4)(1995-3#1)(1995-7#1)(1995-9#1)(1996-11#2)(1996-5#2)(2008-7#3)(2009-8#1)(2010-12#2)(2011-1#1)(2013-7#3)
young ruminants##2##2##(1996-9#2)
young scientists and##2##3##(1990-9#1)(2012-2#1)
young scientists##7##2##(1990-9#1)(1997-2#1)(2007-6#1)(2007-9#1)(2008-5#1)(2009-2#1)(2012-2#1)
young seedlings##5##2##(2008-10#2)(2008-5#2)(2013-1#1)
young soccer##2##2##(2008-5#1)(2012-3#1)
young speakers##2##2##(2008-2#1)(2008-4#1)
young stems of##2##3##(2008-10#1)(2008-4#1)
young stems##3##2##(2008-10#2)(2008-4#1)
young stroke patients##2##3##(2007-10#1)(2007-9#1)
young stroke##3##2##(2007-10#1)(2007-9#2)
young subjects but##2##3##(1991-1#1)(2006-9#1)
young subjects##20##2##(1991-1#3)(1992-12#2)(1993-1#2)(1994-4#1)(1995-11#2)(1995-12#1)(1996-11#1)(2005-8#1)(2006-8#1)(2006-9#3)(2008-5#1)(2008-7#1)(2008-8#1)
young surgeons##5##2##(1993-2#1)(2007-3#1)(2008-4#2)(2013-7#1)
young volunteers##3##2##(2008-7#2)(2012-2#1)
young woman who##2##3##(2007-10#1)(2008-7#1)
young woman with##11##3##(1991-3#1)(2006-10#4)(2006-8#1)(2007-10#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-3#1)
young woman##26##2##(1990-2#1)(1991-3#1)(1992-12#2)(1996-6#1)(1997-1#1)(2006-10#5)(2006-8#1)(2007-10#2)(2007-7#2)(2008-4#1)(2008-7#1)(2009-5#1)(2010-12#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-3#1)
young women and young men##4##5##(2007-7#4)
young women and##10##3##(1993-8#1)(1996-12#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-7#4)
young women are##2##3##(2007-7#1)(2011-2#1)
young women at##2##3##(1997-1#1)(2007-7#1)
young women from##2##3##(1996-12#2)
young women in a##2##4##(1996-12#1)(2007-3#1)
young women in##11##3##(1996-12#2)(1997-8#1)(2006-10#1)(2007-2#2)(2007-3#2)(2007-8#1)(2007-9#1)(2011-2#1)
young women of##3##3##(1991-9#1)(2010-9#1)(2013-7#1)
young women to##3##3##(1996-12#1)(1997-7#1)(2007-12#1)
young women who##3##3##(1996-12#1)(2006-9#1)(2009-11#1)
young women with breast cancer##3##5##(2013-1#3)
young women with##13##3##(2007-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-2#2)(2010-3#1)(2011-2#1)(2013-1#5)
young women##104##2##(1990-3#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-10#1)(1993-8#1)(1994-4#1)(1994-5#4)(1996-12#8)(1996-3#1)(1996-4#1)(1997-1#2)(1997-7#1)(1997-8#2)(2005-8#1)(2006-10#4)(2006-12#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#2)(2007-3#4)(2007-4#1)(2007-7#6)(2007-8#2)(2007-9#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-9#1)(2009-10#1)(2009-11#1)(2010-2#2)(2010-3#3)(2010-7#1)(2010-9#3)(2011-2#6)(2012-2#2)(2012-3#2)(2013-1#8)(2013-7#1)
young women's##4##2##(1997-1#1)(2007-12#1)(2007-2#1)(2010-7#1)
young workers##2##2##(1997-2#1)(2008-6#1)
young##1819##1##(1990-10#3)(1990-12#3)(1990-2#2)(1990-3#19)(1990-4#2)(1990-5#17)(1990-6#4)(1990-7#8)(1990-8#2)(1990-9#3)(1991-1#6)(1991-11#9)(1991-12#15)(1991-2#4)(1991-3#4)(1991-5#4)(1991-6#8)(1991-8#9)(1991-9#2)(1992-1#4)(1992-10#9)(1992-11#3)(1992-12#11)(1992-2#5)(1992-3#5)(1992-4#2)(1992-5#10)(1992-6#7)(1992-7#3)(1992-8#2)(1992-9#1)(1993-1#3)(1993-10#2)(1993-11#1)(1993-12#10)(1993-2#8)(1993-3#3)(1993-4#3)(1993-5#3)(1993-6#1)(1993-7#6)(1993-8#3)(1993-9#1)(1994-10#6)(1994-11#3)(1994-12#3)(1994-2#8)(1994-3#4)(1994-4#6)(1994-5#13)(1994-6#13)(1994-7#1)(1994-8#4)(1994-9#2)(1995-1#1)(1995-11#8)(1995-12#15)(1995-2#3)(1995-3#6)(1995-5#7)(1995-6#9)(1995-7#2)(1995-8#3)(1995-9#14)(1996-1#4)(1996-10#4)(1996-11#8)(1996-12#13)(1996-2#11)(1996-3#10)(1996-4#3)(1996-5#7)(1996-6#5)(1996-7#10)(1996-8#5)(1996-9#13)(1997-1#9)(1997-2#7)(1997-3#8)(1997-4#2)(1997-5#5)(1997-6#12)(1997-7#2)(1997-8#7)(1997-9#2)(2004-11#5)(2004-12#1)(2004-2#1)(2004-3#1)(2004-4#2)(2005-1#2)(2005-10#4)(2005-11#6)(2005-3#1)(2005-7#5)(2005-8#5)(2005-9#1)(2006-1#8)(2006-10#36)(2006-12#13)(2006-2#6)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#2)(2006-7#23)(2006-8#14)(2006-9#12)(2007-1#8)(2007-10#14)(2007-11#14)(2007-12#30)(2007-2#16)(2007-3#25)(2007-4#11)(2007-6#6)(2007-7#39)(2007-8#22)(2007-9#18)(2008-1#16)(2008-10#37)(2008-11#24)(2008-12#17)(2008-2#8)(2008-3#21)(2008-4#25)(2008-5#30)(2008-6#18)(2008-7#68)(2008-8#18)(2008-9#39)(2009-10#8)(2009-11#5)(2009-12#16)(2009-2#7)(2009-3#6)(2009-4#8)(2009-5#29)(2009-6#3)(2009-7#11)(2009-8#3)(2009-9#6)(2010-1#6)(2010-10#16)(2010-11#3)(2010-12#29)(2010-2#14)(2010-3#10)(2010-4#11)(2010-5#11)(2010-6#4)(2010-7#26)(2010-8#5)(2010-9#15)(2011-1#18)(2011-11#4)(2011-12#6)(2011-2#77)(2012-1#27)(2012-11#7)(2012-12#36)(2012-2#49)(2012-3#42)(2012-9#1)(2013-1#67)(2013-7#19)(2013-8#30)
young-adult rats##2##2##(1997-1#2)
young-adult##6##1##(1990-12#1)(1997-1#2)(2008-7#2)(2012-12#1)
young/middle-aged##3##1##(2010-12#3)
younger (&lt##2##2##(2007-12#1)(2009-8#1)
younger (mean age##4##3##(1996-12#1)(2007-10#1)(2007-9#1)(2008-3#1)
younger adults##13##2##(2007-1#2)(2007-11#2)(2008-1#1)(2008-10#2)(2008-11#2)(2010-2#1)(2012-1#1)(2012-11#1)(2012-12#1)
younger age at##2##3##(2004-3#1)(2008-12#1)
younger age group##5##3##(1992-4#1)(1996-11#1)(2006-10#1)(2007-3#1)(2012-3#1)
younger age groups##10##3##(1991-2#1)(1996-4#1)(2005-10#1)(2005-11#1)(2007-10#1)(2009-4#1)(2012-12#1)(2013-1#2)(2013-8#1)
younger age in##2##3##(2008-7#1)(2009-4#1)
younger age of##5##3##(1991-2#1)(1996-12#1)(1996-7#1)(2008-6#1)(2008-9#1)
younger age##40##2##(1991-2#2)(1992-4#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-7#1)(2004-10#1)(2004-3#1)(2005-10#1)(2005-11#1)(2006-10#2)(2007-10#3)(2007-3#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-4#2)(2010-1#1)(2010-12#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#2)
younger ages in##2##3##(2008-8#1)(2013-8#1)
younger ages##6##2##(1991-6#1)(2006-7#1)(2007-10#1)(2008-3#1)(2008-8#1)(2013-8#1)
younger and older adults##2##4##(2008-1#1)(2012-1#1)
younger and older age groups##4##5##(2006-2#1)(2008-5#1)(2011-2#1)(2013-1#1)
younger and older groups##3##4##(2006-10#1)(2008-6#2)
younger and older##22##3##(1990-12#1)(2004-11#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-6#2)(2009-4#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
younger and smaller##2##3##(1995-3#1)(2006-10#1)
younger and##38##2##(1990-12#1)(1990-3#1)(1992-9#3)(1994-5#1)(1995-3#1)(1997-5#1)(2004-11#1)(2006-10#2)(2006-2#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-12#1)(2009-4#2)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
younger animals##6##2##(1995-3#1)(1996-3#1)(1997-7#1)(2008-3#2)(2009-12#1)
younger brother##3##2##(2004-11#2)(2011-2#1)
younger children##17##2##(1992-10#1)(1995-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-9#1)(2009-12#1)(2010-10#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-2#4)(2013-1#2)
younger colleagues##2##2##(1997-3#1)(2006-9#1)
younger controls##2##2##(1996-8#1)(2004-10#1)
younger donors##3##2##(2007-5#1)(2008-11#1)(2011-2#1)
younger generations##3##2##(1992-1#1)(1997-5#1)(2011-1#1)
younger group of##3##3##(2006-10#2)(2011-2#1)
younger group##10##2##(1994-4#1)(2006-10#2)(2006-8#1)(2007-12#1)(2008-3#1)(2008-6#1)(2010-2#1)(2011-2#1)(2012-12#1)
younger individuals##4##2##(2006-8#1)(2007-12#1)(2008-5#1)(2008-8#1)
younger leaves##4##2##(2006-12#1)(2008-10#3)
younger male##2##2##(2007-3#1)(2009-5#1)
younger mean##2##2##(1994-2#1)(2012-2#1)
younger men##7##2##(1990-9#1)(2008-3#1)(2008-4#1)(2009-5#3)(2011-1#1)
younger mothers##4##2##(1990-6#1)(1997-3#1)(2008-10#1)(2009-4#1)
younger ones##3##2##(2010-2#1)(2012-1#1)(2012-2#1)
younger participants##2##2##(2008-10#1)(2012-12#1)
younger patients and in##2##4##(2007-7#1)(2013-1#1)
younger patients and##4##3##(2007-7#1)(2012-1#1)(2012-12#1)(2013-1#1)
younger patients with##4##3##(1991-5#1)(2005-4#1)(2007-10#1)(2007-8#1)
younger patients##57##2##(1990-1#1)(1991-12#2)(1991-2#1)(1991-5#1)(1993-3#2)(1994-6#7)(1995-10#2)(1995-2#1)(1996-7#1)(1997-3#2)(1997-7#1)(2005-4#1)(2006-10#1)(2006-3#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-7#7)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#3)
younger persons##3##2##(1990-12#1)(2008-7#1)(2008-8#1)
younger population##3##2##(2006-12#1)(2007-9#1)(2012-12#1)
younger rats##5##2##(1990-5#1)(1991-12#2)(1992-8#1)(2012-1#1)
younger recipients##2##2##(2007-8#1)(2009-2#1)
younger schizophrenics##2##2##(1993-3#1)(2004-11#1)
younger sisters##4##2##(2004-11#1)(2006-7#3)
younger sows##2##2##(1992-12#2)
younger subjects##8##2##(1996-2#1)(2007-9#2)(2008-12#1)(2008-3#1)(2008-5#3)
younger than 10 years##2##4##(2007-7#1)(2008-11#1)
younger than 12##2##3##(1991-2#1)(1993-2#1)
younger than 2 months of age##2##6##(2006-5#2)
younger than 2##3##3##(2006-5#2)(2009-9#1)
younger than 3 years of age##2##6##(2005-10#1)(2008-10#1)
younger than 3 years##3##4##(1996-5#1)(2005-10#1)(2008-10#1)
younger than 3##4##3##(1996-5#1)(2005-10#1)(2008-10#1)(2013-1#1)
younger than 30 years##3##4##(1990-4#1)(1993-8#1)(2008-3#1)
younger than 40 years of age##2##6##(2010-12#1)(2012-12#1)
younger than 40 years##5##4##(1996-4#1)(2007-9#1)(2010-12#2)(2012-12#1)
younger than 40##9##3##(1991-12#1)(1991-4#1)(1996-4#1)(2007-4#1)(2007-9#1)(2010-12#2)(2012-12#1)(2013-1#1)
younger than 5 years##3##4##(2004-12#1)(2011-2#1)(2013-1#1)
younger than 50 years##3##4##(2007-10#2)(2007-12#1)
younger than 50##4##3##(1990-4#1)(2007-10#2)(2007-12#1)
younger than 6 months##4##4##(1996-12#1)(2006-5#3)
younger than 6##5##3##(1996-12#1)(2006-5#3)(2010-9#1)
younger than 65 years##5##4##(2007-8#1)(2009-8#3)(2011-2#1)
younger than in older##2##4##(2006-12#1)(2011-2#1)
younger than the##2##3##(1990-5#1)(1997-3#1)
younger than those##4##3##(1990-6#1)(2004-12#1)(2007-10#2)
younger than three months of age##2##6##(2008-11#1)(2012-2#1)
younger than three##4##3##(2008-11#2)(2010-9#1)(2012-2#1)
younger than##90##2##(1990-4#2)(1990-5#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-9#3)(1993-10#1)(1993-2#1)(1993-8#2)(1995-10#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-3#2)(2004-12#2)(2004-2#1)(2005-10#1)(2006-12#1)(2006-5#6)(2007-1#2)(2007-10#6)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#4)(2007-9#2)(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#1)(2008-9#3)(2009-2#1)(2009-8#3)(2009-9#1)(2010-12#2)(2010-3#4)(2010-9#2)(2011-11#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#5)(2013-7#2)
younger using##2##2##(2006-10#1)(2008-9#1)
younger versus older##3##3##(2006-6#2)(2010-12#1)
younger women who##2##3##(1994-4#1)(2011-1#1)
younger women##27##2##(1990-6#1)(1991-7#1)(1992-2#1)(1992-4#2)(1993-6#1)(1993-9#1)(1994-3#1)(1994-4#1)(1995-8#1)(1996-6#1)(1997-7#1)(2004-1#3)(2004-2#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-4#1)(2008-3#2)(2008-7#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-2#1)
younger workers##2##2##(2011-1#1)(2012-3#1)
younger##517##1##(1990-1#1)(1990-12#3)(1990-3#2)(1990-4#2)(1990-5#3)(1990-6#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#5)(1991-2#5)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#2)(1992-4#3)(1992-8#1)(1992-9#6)(1993-1#1)(1993-10#2)(1993-2#1)(1993-3#4)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#4)(1994-5#3)(1994-6#8)(1994-8#1)(1994-9#1)(1995-10#3)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#1)(1997-2#1)(1997-3#7)(1997-5#2)(1997-7#4)(2004-1#3)(2004-10#2)(2004-11#7)(2004-12#2)(2004-2#2)(2004-3#1)(2005-10#3)(2005-11#1)(2005-4#3)(2006-1#1)(2006-10#10)(2006-11#3)(2006-12#5)(2006-2#1)(2006-3#1)(2006-5#7)(2006-6#5)(2006-7#6)(2006-8#5)(2006-9#1)(2007-1#4)(2007-10#12)(2007-11#3)(2007-12#8)(2007-2#2)(2007-3#4)(2007-4#2)(2007-5#3)(2007-7#15)(2007-8#10)(2007-9#6)(2008-1#2)(2008-10#14)(2008-11#9)(2008-12#6)(2008-2#1)(2008-3#13)(2008-4#6)(2008-5#13)(2008-6#7)(2008-7#9)(2008-8#5)(2008-9#8)(2009-10#2)(2009-11#2)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#7)(2009-5#7)(2009-8#6)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#8)(2010-2#9)(2010-3#7)(2010-4#1)(2010-7#1)(2010-8#3)(2010-9#4)(2011-1#7)(2011-11#1)(2011-2#20)(2012-1#6)(2012-11#1)(2012-12#12)(2012-2#12)(2012-3#8)(2013-1#19)(2013-7#4)(2013-8#5)
youngest age group##2##3##(1992-3#1)(2006-8#1)
youngest children##2##2##(2010-3#1)(2013-8#1)
youngest##40##1##(1990-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1993-5#1)(1995-4#1)(1996-2#1)(1997-6#1)(2006-1#1)(2006-10#2)(2006-7#1)(2006-8#3)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-3#1)(2010-9#1)(2011-11#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
youngsters##10##1##(1993-10#1)(1993-2#1)(2005-3#1)(2005-9#1)(2007-8#1)(2009-10#1)(2011-2#1)(2012-12#2)(2013-8#1)
your Patient Focused Care program##3##5##(1994-1#1)(1994-2#2)
your Patient Focused Care program)!&quot##2##5##(1994-1#2)
your Patient Focused Care##5##4##(1994-1#3)(1994-2#2)
your Patient Focused communications##2##4##(1994-1#2)
your Patient Focused restructuring##2##4##(1994-2#1)(1994-3#1)
your Patient Focused##11##3##(1993-3#1)(1994-1#5)(1994-2#3)(1994-3#2)
your article##2##2##(2006-2#1)(2010-9#1)
your back##2##2##(1992-12#1)(1995-2#1)
your best##2##2##(1994-1#1)(2007-12#1)
your brain##3##2##(2007-9#1)(2008-10#1)(2013-7#1)
your child##3##2##(2007-12#1)(2008-12#1)(2013-8#1)
your children##2##2##(1992-4#1)(1997-3#1)
your clinical##3##2##(1997-2#1)(2008-11#1)(2011-2#1)
your community##2##2##(1995-2#2)
your company##2##2##(1996-12#1)(2005-7#1)
your company's##3##2##(1992-3#2)(1996-3#1)
your cultural##2##2##(1994-1#1)(2006-1#1)
your current##3##2##(1995-2#1)(1996-3#1)(2008-1#1)
your department's##2##2##(1992-1#1)(2011-12#1)
your diagnosis?##25##2##(1990-10#1)(1990-2#1)(1991-2#1)(1991-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-4#1)(2006-12#1)(2007-1#2)(2007-12#2)(2007-2#3)(2007-3#2)(2012-3#1)
your doctor##2##2##(2009-12#1)(2011-2#1)
your educational##4##2##(1994-1#1)(1995-12#3)
your efforts##2##2##(1992-1#1)(1996-1#1)
your employees##2##2##(1996-3#1)(2007-4#1)
your environment##2##2##(1992-2#1)(1995-2#1)
your eyes##2##2##(2007-8#1)(2007-9#1)
your facility##5##2##(2004-4#1)(2011-1#1)(2011-2#3)
your facility's fiscal integrity##2##4##(1992-1#2)
your facility's##7##2##(1992-1#2)(2004-4#2)(2007-10#1)(2007-4#1)(2011-2#1)
your feet##2##2##(2008-10#1)(2010-9#1)
your future##4##2##(1992-2#1)(1995-12#1)(2007-4#1)(2012-12#1)
your gift##2##2##(1994-12#1)(1997-1#1)
your head##2##2##(2005-8#1)(2011-2#1)
your health care facility##2##4##(1991-1#1)(1991-12#1)
your health care organization##2##4##(1996-1#2)
your health care##5##3##(1991-1#1)(1991-12#1)(1994-3#1)(1996-1#2)
your health##7##2##(1991-1#1)(1991-12#1)(1994-3#1)(1996-1#2)(1996-3#1)(2008-10#1)
your healthcare institution##2##3##(1993-2#2)
your heart##5##2##(2005-9#1)(2007-2#1)(2007-8#1)(2010-5#1)(2012-2#1)
your hospital##12##2##(1991-1#1)(1992-1#1)(1992-3#1)(1993-12#1)(1993-3#2)(1994-12#1)(1994-2#2)(1995-2#1)(1997-2#1)(2011-2#1)
your hospital's##3##2##(1992-1#1)(1993-2#1)(1994-12#1)
your institution##4##2##(1994-2#1)(1994-3#1)(1996-1#1)(2011-2#1)
your knowledge##6##2##(2004-4#1)(2006-2#4)(2012-12#1)
your medical##4##2##(1991-1#1)(1992-1#1)(2008-8#1)(2013-7#1)
your message across##2##3##(1996-3#1)(2013-1#1)
your mind##3##2##(2008-10#1)(2008-4#1)(2013-8#1)
your money##2##2##(1995-2#1)(2011-2#1)
your organization is##2##3##(1994-1#1)(1996-1#1)
your organization may##2##3##(1991-2#1)(1994-1#1)
your organization##17##2##(1991-2#1)(1992-12#1)(1993-1#2)(1994-1#3)(1996-1#2)(1996-2#2)(1997-2#1)(2007-4#1)(2008-1#1)(2008-8#2)(2013-7#1)
your organizational##2##2##(1994-3#1)(1996-1#1)
your own##10##2##(1993-12#1)(1994-2#2)(1995-2#1)(1996-3#1)(2008-1#1)(2008-11#1)(2009-3#1)(2013-1#1)(2013-8#1)
your particular##3##2##(1992-12#1)(1993-12#1)(2008-11#1)
your patient focused care program##2##5##(1993-2#2)
your patient focused##3##3##(1993-2#3)
your patient##8##2##(1992-1#1)(1993-2#3)(1994-3#1)(1995-2#1)(2008-10#1)(2011-2#1)
your patients and##3##3##(1997-3#1)(2011-2#2)
your patients##9##2##(1994-3#1)(1997-3#1)(2006-1#1)(2008-4#1)(2010-7#1)(2011-2#3)(2012-3#1)
your personal##2##2##(1995-3#1)(2009-9#1)
your practice##6##2##(2004-3#1)(2006-10#1)(2007-4#1)(2008-1#1)(2012-3#2)
your practice?##2##2##(2007-4#1)(2012-3#1)
your program##2##2##(1993-2#1)(1993-3#1)
your questions##2##2##(2008-6#1)(2011-12#1)
your research##2##2##(2008-11#1)(2013-7#1)
your restructuring initiative##4##3##(1994-12#1)(1994-3#1)(1996-1#2)
your restructuring##5##2##(1994-12#1)(1994-3#1)(1995-2#1)(1996-1#2)
your staff##3##2##(1991-3#1)(1997-2#1)(2011-12#1)
your strategic##2##2##(1994-3#1)(1996-3#1)
your top##2##2##(1991-1#1)(1997-1#1)
your treatment##2##2##(2011-1#1)(2011-2#1)
your views##2##2##(2008-6#2)
your way##2##2##(1996-2#1)(2004-9#1)
your##465##1##(1990-10#1)(1990-2#1)(1990-5#2)(1991-1#7)(1991-12#1)(1991-2#4)(1991-3#4)(1991-4#1)(1992-1#8)(1992-12#4)(1992-2#2)(1992-3#3)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#4)(1993-11#1)(1993-12#6)(1993-2#10)(1993-3#9)(1993-8#1)(1994-1#14)(1994-12#6)(1994-2#11)(1994-3#23)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#8)(1995-2#19)(1995-3#2)(1995-8#1)(1996-1#16)(1996-12#3)(1996-2#9)(1996-3#10)(1996-4#2)(1996-6#1)(1997-1#3)(1997-2#6)(1997-3#2)(1997-5#1)(2004-3#1)(2004-4#5)(2004-5#3)(2004-9#2)(2005-7#1)(2005-8#4)(2005-9#2)(2006-1#2)(2006-10#1)(2006-12#1)(2006-2#6)(2006-5#1)(2006-8#3)(2007-1#4)(2007-10#8)(2007-12#7)(2007-2#6)(2007-3#2)(2007-4#14)(2007-7#2)(2007-8#5)(2007-9#7)(2008-1#6)(2008-10#8)(2008-11#9)(2008-12#2)(2008-2#1)(2008-4#8)(2008-5#8)(2008-6#5)(2008-8#5)(2008-9#3)(2009-1#2)(2009-12#4)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-3#3)(2010-4#1)(2010-5#3)(2010-7#1)(2010-9#6)(2011-1#5)(2011-12#4)(2011-2#27)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#10)(2013-1#4)(2013-7#10)(2013-8#12)
yours##4##1##(1992-12#1)(1993-3#1)(2012-2#1)(2013-7#1)
yourself in your##2##3##(1994-3#1)(2013-8#1)
yourself##7##1##(1994-3#1)(2007-1#1)(2007-9#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
youth (N =##2##3##(2008-6#1)(2008-9#1)
youth aged##5##2##(2006-10#1)(2010-5#1)(2010-8#1)(2012-3#1)(2013-1#1)
youth and adults##2##3##(2008-11#1)(2008-7#1)
youth and their##3##3##(2008-7#2)(2012-2#1)
youth and young##4##3##(2009-5#1)(2012-12#1)(2013-8#2)
youth and##24##2##(1990-1#1)(1993-10#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-3#2)(2008-7#4)(2009-5#2)(2009-7#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
youth are##7##2##(2007-8#1)(2008-2#1)(2009-7#1)(2010-3#1)(2011-2#1)(2013-1#2)
youth as##2##2##(2008-12#1)(2008-9#1)
youth at risk for##2##4##(2009-2#1)(2009-7#1)
youth at risk##3##3##(2009-2#1)(2009-7#1)(2010-3#1)
youth at##5##2##(2007-2#1)(2007-7#1)(2009-2#1)(2009-7#1)(2010-3#1)
youth centre##5##2##(2007-3#5)
youth development programs##2##3##(2008-7#2)
youth development##10##2##(2008-7#5)(2009-7#2)(2009-8#1)(2013-1#2)
youth for##2##2##(2010-12#1)(2010-7#1)
youth from##2##2##(2007-1#1)(2009-7#1)
youth had reductions (p &lt##2##5##(2008-3#2)
youth had##3##2##(2007-3#1)(2008-3#2)
youth health##5##2##(2008-11#1)(2009-5#1)(2010-5#2)(2012-2#1)
youth in the##2##3##(2009-7#1)(2012-12#1)
youth in##23##2##(1996-12#1)(2006-7#1)(2007-3#2)(2008-11#1)(2008-4#1)(2008-7#4)(2008-8#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#2)(2012-12#1)(2013-1#1)
youth is##2##2##(2008-12#1)(2012-12#1)
youth may##4##2##(2007-12#1)(2007-7#1)(2010-4#1)(2013-1#1)
youth mental health##3##3##(2009-2#1)(2010-5#1)(2011-2#1)
youth mentoring##2##2##(2009-4#2)
youth problem##2##2##(2010-2#1)(2013-7#1)
youth protection##4##2##(2008-11#1)(2008-9#3)
youth reported##2##2##(2009-7#1)(2009-8#1)
youth residing##2##2##(2007-1#1)(2008-7#1)
youth spent more time##2##4##(2009-7#2)
youth to##5##2##(2007-10#1)(2008-12#1)(2009-7#1)(2009-8#1)(2012-12#1)
youth using##2##2##(2012-2#2)
youth were more likely to##2##5##(2007-1#1)(2009-7#1)
youth were##4##2##(2007-1#1)(2009-7#2)(2010-4#1)
youth who are##2##3##(2007-12#1)(2007-7#1)
youth who identify##2##3##(2008-12#1)(2010-8#1)
youth who spent more time##2##5##(2009-7#1)(2010-4#1)
youth who were aggressive##3##4##(2010-4#3)
youth who##16##2##(1994-2#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-4#4)(2010-8#1)(2012-12#1)
youth with a##2##3##(2008-12#1)(2010-1#1)
youth with disabilities or##3##4##(2010-11#3)
youth with##24##2##(1992-3#1)(2006-10#2)(2008-11#1)(2008-12#1)(2009-12#1)(2009-5#2)(2009-7#3)(2009-8#1)(2010-1#1)(2010-11#4)(2010-12#1)(2010-3#4)(2011-1#1)(2011-2#1)
youth##349##1##(1990-1#1)(1990-12#1)(1990-5#1)(1991-8#1)(1992-3#1)(1993-10#1)(1994-2#1)(1994-4#1)(1996-12#2)(1997-6#1)(2005-10#1)(2005-9#1)(2006-10#4)(2006-12#2)(2006-4#1)(2006-7#1)(2007-1#4)(2007-10#2)(2007-12#4)(2007-2#1)(2007-3#11)(2007-4#2)(2007-7#4)(2007-8#3)(2008-1#1)(2008-11#15)(2008-12#10)(2008-2#2)(2008-3#8)(2008-4#4)(2008-6#1)(2008-7#23)(2008-8#4)(2008-9#8)(2009-12#3)(2009-2#3)(2009-4#5)(2009-5#9)(2009-6#3)(2009-7#38)(2009-8#12)(2009-9#3)(2010-1#5)(2010-10#3)(2010-11#6)(2010-12#5)(2010-2#4)(2010-3#7)(2010-4#9)(2010-5#11)(2010-7#5)(2010-8#6)(2010-9#4)(2011-1#7)(2011-12#1)(2011-2#5)(2012-1#9)(2012-12#8)(2012-2#19)(2012-3#5)(2013-1#17)(2013-7#4)(2013-8#5)
youth's achievement##2##2##(2009-7#2)
youth's##13##1##(2008-9#1)(2009-7#10)(2010-7#2)
youth]##2##1##(1990-9#1)(2011-2#1)
youthful##4##1##(2009-8#1)(2010-11#1)(2010-2#1)(2011-2#1)
youths and##4##2##(1992-5#1)(2008-1#1)(2008-2#1)(2008-9#1)
youths in##2##2##(2009-7#1)(2012-12#1)
youths reported##3##2##(2008-9#3)
youths with selective mutism##2##4##(2009-11#2)
youths with##5##2##(2008-9#1)(2009-11#2)(2009-7#1)(2012-12#1)
youths##40##1##(1990-4#1)(1992-5#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#3)(2008-2#2)(2008-4#2)(2008-7#1)(2008-9#8)(2009-10#2)(2009-11#2)(2009-7#5)(2010-11#1)(2011-1#2)(2011-2#1)(2012-12#4)(2013-1#1)
youths' academic engagement##2##3##(2008-12#1)(2009-7#1)
youths' engagement##2##2##(2008-12#2)
youths'##8##1##(2008-12#4)(2008-7#1)(2009-7#2)(2010-4#1)
yperite##5##1##(2008-10#2)(2008-11#3)
yr after the##2##3##(2007-2#1)(2007-8#1)
yr after##6##2##(2007-2#2)(2007-8#2)(2009-9#1)(2013-8#1)
yr and##3##2##(2007-8#2)(2008-8#1)
yr earlier##2##2##(2007-2#1)(2007-8#1)
yr in##6##2##(1996-4#1)(2007-8#2)(2008-9#1)(2011-12#1)(2013-8#1)
yr of age##7##3##(1990-4#1)(2005-11#1)(2007-8#4)(2009-4#1)
yr of dialysis##2##3##(2007-8#2)
yr of field##2##3##(2008-8#1)(2011-2#1)
yr of##16##2##(1990-4#1)(2005-11#1)(2007-8#9)(2008-8#1)(2008-9#2)(2009-4#1)(2011-2#1)
yr old##2##2##(2012-2#2)
yr old)##2##2##(2007-8#2)
yr versus##2##2##(2008-7#2)
yr was##2##2##(2008-3#1)(2008-9#1)
yr##118##1##(1990-4#1)(1991-10#1)(1996-4#1)(2005-11#1)(2006-6#1)(2007-2#6)(2007-5#2)(2007-8#32)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#19)(2008-8#11)(2008-9#12)(2009-10#1)(2009-3#2)(2009-4#4)(2009-9#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-7#5)(2013-8#3)
yr(-1)##2##1##(2008-8#1)(2012-2#1)
yr(-2) for##3##2##(2012-2#3)
yr) after 4 yr##2##4##(2007-8#2)
yr) or##2##2##(2007-8#2)
yr) who##3##2##(1992-10#1)(2007-8#2)
yr)##23##1##(1990-1#1)(1992-10#1)(2005-8#1)(2007-8#13)(2008-9#2)(2009-11#2)(2009-3#1)(2009-4#2)
yr-1##4##1##(2008-9#2)(2011-12#2)
yrs and##2##2##(2010-10#1)(2012-3#1)
yrs old##4##2##(1993-10#1)(2007-2#1)(2008-7#1)(2011-2#1)
yrs with##2##2##(2008-12#1)(2010-10#1)
yrs##32##1##(1993-10#1)(1993-9#1)(1996-12#2)(2005-10#1)(2006-6#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#1)(2010-10#3)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#2)
yrs) were##3##2##(1991-5#1)(2007-11#1)(2011-1#1)
yrs)##10##1##(1991-5#1)(1997-3#1)(2007-11#1)(2007-7#1)(2008-12#1)(2008-3#1)(2009-6#1)(2011-1#1)(2012-3#2)
ys##3##1##(1997-3#1)(2007-3#2)
ytterbium codoping in heavily erbium-doped##2##5##(2007-12#2)
ytterbium codoping##3##2##(2007-12#3)
ytterbium fiber Fabry-Perot lasers##2##4##(2007-12#2)
ytterbium fiber laser##3##3##(2007-12#3)
ytterbium fiber##5##2##(2007-12#5)
ytterbium##21##1##(1997-8#1)(2007-11#1)(2007-12#14)(2008-10#5)
ytterbium(III)##3##1##(2007-11#1)(2008-10#2)
ytterbium-doped double-clad fiber##2##3##(2007-11#1)(2007-12#1)
ytterbium-doped fiber##3##2##(2007-12#1)(2008-3#2)
ytterbium-doped##13##1##(2007-11#2)(2007-12#6)(2008-2#1)(2008-3#4)
yttrium aluminum garnet (YAG)##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
yttrium aluminum garnet##6##3##(2007-11#2)(2007-12#1)(2008-2#2)(2010-8#1)
yttrium aluminum##8##2##(2007-11#2)(2007-12#1)(2008-2#4)(2010-8#1)
yttrium and the sodium##2##4##(1996-2#2)
yttrium and the##3##3##(1996-2#2)(2008-10#1)
yttrium and##9##2##(1992-11#1)(1996-2#2)(2005-11#2)(2006-5#1)(2008-10#3)
yttrium in##2##2##(2008-10#2)
yttrium##36##1##(1992-11#1)(1996-2#3)(1997-1#1)(2005-11#2)(2006-5#1)(2007-11#2)(2007-12#1)(2008-10#16)(2008-2#5)(2008-7#1)(2010-5#1)(2010-8#1)(2012-2#1)
yttrium(III)##5##1##(2007-8#1)(2008-10#4)
yttrium-90##4##1##(2007-1#2)(2013-1#2)
yttrium-aluminum-garnet laser##2##2##(2006-10#1)(2007-1#1)
yuan##2##1##(2008-9#1)(2013-1#1)
yunnanensis and##2##2##(2007-1#1)(2012-3#1)
yunnanensis##5##1##(2007-1#2)(2012-3#1)(2013-1#2)
z -dependent structures##3##3##(2007-12#3)
z = 2##2##3##(2008-10#1)(2010-2#1)
z =##7##2##(1995-8#2)(2005-11#1)(2005-12#1)(2008-10#1)(2008-5#1)(2010-2#1)
z and z'##3##3##(2005-11#3)
z is##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
z of##2##2##(2008-10#1)(2008-3#1)
z score and##4##3##(2008-7#2)(2011-1#1)(2013-1#1)
z score##10##2##(2008-7#3)(2011-1#6)(2013-1#1)
z scores##2##2##(2011-1#2)
z##51##1##(1992-12#2)(1995-8#2)(1996-2#3)(2005-11#4)(2005-12#1)(2006-10#1)(2007-12#5)(2007-4#1)(2008-1#2)(2008-10#5)(2008-2#2)(2008-3#6)(2008-5#1)(2008-7#3)(2008-8#1)(2009-11#1)(2010-2#1)(2011-1#9)(2013-1#1)
z'##4##1##(2005-11#4)
z(r)##2##1##(2008-10#2)
z-VAD-Fmk##2##1##(2011-2#2)
z-VAD-fmk##3##1##(2011-1#1)(2013-1#2)
z-axis##3##1##(1994-11#1)(2007-12#1)(2008-4#1)
z-cut##2##1##(2008-1#1)(2008-2#1)
z-scan technique##2##2##(2008-3#2)
z-scan##4##1##(2007-12#1)(2008-2#1)(2008-3#2)
z-score##5##1##(2007-2#1)(2008-10#1)(2010-4#2)(2011-1#1)
z-scores##5##1##(1993-2#1)(2007-12#1)(2008-10#1)(2011-1#2)
z-spectra##3##1##(2012-7#3)
z1##2##1##(2007-11#2)
zFP538##4##1##(2009-9#4)
zNosetrade mark##6##2##(2008-10#6)
zNosetrade##7##1##(2008-10#7)
zacopride##2##1##(1992-3#1)(1993-3#1)
zafirlukast##6##1##(2007-11#4)(2013-1#2)
zaleplon##5##1##(2004-3#4)(2013-1#1)
zanamivir##3##1##(2008-5#2)(2008-8#1)
zea cell##3##2##(2008-11#3)
zea cells showed a preference for##2##6##(2008-11#2)
zea cells##4##2##(2008-11#4)
zea##15##1##(1992-1#3)(1994-8#3)(2008-11#8)(2012-2#1)
zeae are##2##2##(2008-10#1)(2011-1#1)
zeae from##2##2##(2008-10#2)
zeae in##5##2##(2008-10#5)
zeae is the##2##3##(2008-10#2)
zeae is##3##2##(2005-11#1)(2008-10#2)
zeae were collected##3##3##(2008-10#3)
zeae were##5##2##(2005-11#1)(2008-10#4)
zeae with##2##2##(2005-11#1)(2008-10#1)
zeae##51##1##(2005-11#4)(2008-10#42)(2008-8#1)(2011-1#4)
zeae)##5##1##(2008-10#3)(2008-8#1)(2011-1#1)
zeae-infested maize kernels##2##3##(2008-10#2)
zeae-maydis##11##1##(2008-10#11)
zeamatin##2##1##(2008-10#2)
zearalenone (ZEN)##2##2##(2008-10#1)(2013-1#1)
zearalenone determination in##2##3##(2008-10#2)
zearalenone##8##1##(1997-6#2)(2008-10#3)(2010-7#1)(2013-1#2)
zeaxanthin and##4##2##(1992-9#1)(2008-11#1)(2008-12#2)
zeaxanthin dipalmitate##2##2##(2008-11#2)
zeaxanthin##17##1##(1990-4#1)(1992-9#1)(1993-12#1)(1997-1#2)(2008-11#3)(2008-12#8)(2012-12#1)
zeaxanthins##4##1##(2008-11#3)(2008-12#1)
zebra finch##2##2##(1997-2#1)(2013-8#1)
zebra finches##6##2##(1996-1#4)(1997-2#1)(2013-8#1)
zebra fish##3##2##(2008-4#1)(2010-1#2)
zebra presented with a##2##4##(2007-2#2)
zebra##16##1##(1996-1#4)(1997-2#2)(2005-7#1)(2007-2#3)(2007-3#1)(2008-4#1)(2010-1#2)(2013-8#2)
zebrafish (Danio rerio)##4##3##(2008-7#1)(2008-9#2)(2013-1#1)
zebrafish Danio rerio##2##3##(1997-4#1)(2012-12#1)
zebrafish FSH##3##2##(2010-5#3)
zebrafish and##4##2##(1997-7#1)(2008-1#1)(2008-9#1)(2012-11#1)
zebrafish by##2##2##(1997-2#1)(2008-7#1)
zebrafish embryos and adult tissues##2##5##(2012-12#2)
zebrafish embryos and##4##3##(1997-4#1)(2010-7#1)(2012-12#2)
zebrafish embryos##7##2##(1993-12#1)(1997-4#1)(2010-7#2)(2012-11#1)(2012-12#2)
zebrafish embryos/larvae##4##2##(2013-1#4)
zebrafish fibroblasts by nucleofection##2##4##(2008-11#2)
zebrafish genome##3##2##(1991-9#1)(2008-8#2)
zebrafish model##3##2##(2008-7#1)(2008-8#2)
zebrafish testis##3##2##(2008-7#3)
zebrafish were##2##2##(2008-8#1)(2008-9#1)
zebrafish##97##1##(1991-9#2)(1992-9#4)(1993-12#2)(1997-2#1)(1997-4#3)(1997-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#9)(2008-4#4)(2008-7#11)(2008-8#11)(2008-9#4)(2009-5#1)(2010-12#1)(2010-5#4)(2010-7#4)(2011-1#3)(2012-11#4)(2012-12#13)(2012-3#5)(2013-1#7)
zebras##4##1##(2007-2#4)
zebrin##6##1##(1992-9#3)(2010-12#3)
zebu##2##1##(1994-3#2)
zeeman##2##1##(2008-2#1)(2008-3#1)
zein signal sequence##2##3##(1991-10#2)
zein##3##1##(1991-10#2)(2009-10#1)
zenith angle of##3##3##(2008-2#2)(2008-3#1)
zenith angle##14##2##(2008-2#5)(2008-3#9)
zenith angles##14##2##(2008-2#7)(2008-3#7)
zenith of##2##2##(1990-7#1)(1994-3#1)
zenith radiance##2##2##(2008-3#2)
zenith##42##1##(1990-7#1)(1994-3#1)(2008-2#16)(2008-3#23)(2011-2#1)
zeolite has##2##2##(1992-3#2)
zeolite##19##1##(1992-3#6)(2008-10#11)(2008-3#1)(2010-12#1)
zeolite-like products##2##2##(2008-6#2)
zeolites##13##1##(2006-4#1)(2008-1#2)(2008-10#8)(2008-6#1)(2010-12#1)
zeolitic material##2##2##(2008-10#2)
zeolitic##3##1##(2008-10#3)
zephyrinid nudibranch##2##2##(2008-5#2)
zero after the##2##3##(1991-12#1)(1991-4#1)
zero after##4##2##(1991-12#1)(1991-4#1)(1993-2#1)(1994-5#1)
zero and the##2##3##(2008-7#1)(2010-1#1)
zero and##9##2##(1993-10#1)(2006-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-2#1)(2010-4#1)
zero as##4##2##(1993-12#1)(2008-10#2)(2011-2#1)
zero at##7##2##(1990-11#1)(1991-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2013-8#1)
zero axis of symmetry##2##4##(2008-10#2)
zero concentration##2##2##(2005-11#1)(2008-10#1)
zero contrast prediction is##2##4##(2008-2#2)
zero contrast##3##2##(2008-2#3)
zero crossing##3##2##(2008-10#3)
zero crossings##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
zero differential group delay##2##4##(2007-12#2)
zero dispersion##3##2##(2007-11#1)(2007-12#2)
zero for the##2##3##(1996-11#1)(2008-3#1)
zero for##8##2##(1996-11#1)(1996-7#1)(2008-10#2)(2008-2#2)(2008-3#2)
zero geometric loss##2##3##(2008-3#2)
zero in##11##2##(1992-6#1)(1995-8#1)(1997-2#1)(1997-6#1)(2005-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-5#1)
zero level##2##2##(2008-9#1)(2012-1#1)
zero net##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
zero of##2##2##(2007-11#1)(2007-12#1)
zero on##2##2##(1990-10#1)(2008-3#1)
zero or##7##2##(1990-8#1)(1995-6#1)(1997-7#1)(2008-2#2)(2008-9#1)(2010-12#1)
zero order and##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
zero order##19##2##(1992-6#1)(2007-12#1)(2008-10#2)(2008-2#6)(2008-3#3)(2008-5#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
zero point##3##2##(2008-2#3)
zero sodium##2##2##(1991-11#1)(2008-1#1)
zero the##2##2##(1996-12#1)(2008-3#1)
zero time##5##2##(1994-8#2)(1996-6#1)(2008-12#1)(2008-3#1)
zero to approximately##2##3##(1996-5#1)(2007-12#1)
zero to##14##2##(1990-5#1)(1996-10#1)(1996-5#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-12#1)
zero trans uptake##2##3##(1991-4#2)
zero trans##3##2##(1991-4#2)(1991-5#1)
zero ultraflattened##2##2##(2007-12#2)
zero value##2##2##(2008-10#1)(2010-1#1)
zero with##3##2##(1997-6#1)(2008-2#1)(2008-9#1)
zero##317##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#2)(1991-11#2)(1991-12#1)(1991-3#1)(1991-4#4)(1991-5#1)(1992-1#2)(1992-10#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#1)(1993-10#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-4#1)(1994-5#3)(1994-8#2)(1995-1#1)(1995-10#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#2)(1996-9#2)(1997-2#3)(1997-4#1)(1997-6#3)(1997-7#2)(2004-2#1)(2005-10#1)(2005-11#6)(2005-4#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#2)(2007-1#2)(2007-10#2)(2007-11#9)(2007-12#26)(2007-2#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#39)(2008-11#5)(2008-12#7)(2008-2#37)(2008-3#24)(2008-5#3)(2008-7#5)(2008-8#5)(2008-9#8)(2009-11#1)(2009-3#1)(2009-6#1)(2009-9#2)(2010-1#2)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#3)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#5)
zero)##2##1##(1995-10#1)(2008-10#1)
zero- and##2##2##(2007-11#1)(2008-7#1)
zero-background linkers##2##2##(1994-12#2)
zero-background##3##1##(1994-12#2)(2010-7#1)
zero-birefringence polymer was##2##3##(2008-3#2)
zero-birefringence polymer##4##2##(2008-3#4)
zero-birefringence##5##1##(2008-3#5)
zero-calcium Ringer##2##2##(1992-8#2)
zero-crossing first-order derivative UV-spectrophotometric technique##2##5##(2008-10#2)
zero-crossing points##2##2##(2008-10#2)
zero-crossing wavelengths##2##2##(2008-10#2)
zero-crossing##11##1##(2008-10#10)(2008-3#1)
zero-crossing' point of##2##3##(2008-10#2)
zero-current##2##1##(1991-9#1)(2008-10#1)
zero-dispersion wavelength##10##2##(2007-11#5)(2007-12#5)
zero-dispersion##14##1##(2007-11#6)(2007-12#6)(2008-2#2)
zero-field splitting##4##2##(1990-2#1)(1990-3#1)(1993-11#1)(1997-7#1)
zero-field##6##1##(1990-2#1)(1990-3#2)(1993-11#1)(1997-7#1)(2008-10#1)
zero-inflated##2##1##(2009-6#1)(2012-3#1)
zero-length##3##1##(1995-2#1)(1995-8#2)
zero-mean##4##1##(1997-4#1)(2008-2#3)
zero-order (on-axis)##2##2##(2008-2#2)
zero-order Bessel##2##2##(2008-2#2)
zero-order kinetics##2##2##(2008-11#1)(2008-6#1)
zero-order release##4##2##(2008-5#1)(2011-2#2)(2012-3#1)
zero-order##28##1##(2004-12#2)(2006-4#1)(2007-12#1)(2008-11#1)(2008-2#8)(2008-3#10)(2008-5#1)(2008-6#1)(2011-2#2)(2012-3#1)
zero-point energy##3##2##(1995-11#1)(2009-9#2)
zero-point fluctuations##2##2##(1993-3#1)(2010-12#1)
zero-point##5##1##(1993-3#1)(1995-11#1)(2009-9#2)(2010-12#1)
zero-pressure##2##1##(1996-7#1)(2007-12#1)
zero-sodium Ringer##2##2##(1992-8#2)
zero-temperature##2##1##(2009-9#2)
zero-time control##2##2##(2007-2#2)
zero-time##4##1##(1990-10#2)(2007-2#2)
zero-twist nematic liquid-crystal spatial light modulator##2##6##(2007-12#2)
zero-twist##3##1##(2007-12#3)
zeros in the##2##3##(2007-12#1)(2008-2#1)
zeros##7##1##(2007-12#2)(2008-2#3)(2008-3#1)(2012-3#1)
zeroth-order##2##1##(2007-12#1)(2008-3#1)
zerotree coding##3##2##(2008-2#2)(2008-3#1)
zerotree image##2##2##(2008-2#2)
zerotree quantization##2##2##(2008-2#2)
zerotree##10##1##(2008-2#9)(2008-3#1)
zeta -potential##3##2##(2005-11#3)
zeta PKC##16##2##(1994-12#3)(1995-6#13)
zeta and eta##2##3##(1991-10#1)(1994-12#1)
zeta and##4##2##(1991-10#1)(1994-12#3)
zeta chain##2##2##(1992-5#1)(1993-6#1)
zeta isoform##2##2##(1994-12#1)(1995-6#1)
zeta of##2##2##(1991-7#1)(1994-2#1)
zeta potential and##4##3##(2005-11#2)(2009-11#1)(2012-3#1)
zeta potential distribution measurement##2##4##(2005-11#2)
zeta potential distribution##7##3##(2005-11#7)
zeta potential is##2##3##(2005-11#2)
zeta potential measurements##2##3##(1990-3#1)(2005-11#1)
zeta potential of the##2##4##(2008-10#1)(2013-8#1)
zeta potential of##6##3##(2005-11#2)(2008-10#1)(2008-5#1)(2013-8#2)
zeta potential value##3##3##(2008-5#1)(2012-2#2)
zeta potential were##3##3##(2005-11#2)(2012-3#1)
zeta potential##59##2##(1990-3#1)(2005-11#35)(2008-10#2)(2008-5#8)(2009-11#1)(2009-12#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-7#2)(2013-8#3)
zeta potentials##7##2##(1990-3#1)(2005-11#3)(2008-6#2)(2013-8#1)
zeta to the##2##3##(1994-12#1)(1996-11#1)
zeta to##3##2##(1994-12#2)(1996-11#1)
zeta##144##1##(1990-3#3)(1991-10#1)(1991-7#1)(1992-3#1)(1992-5#2)(1993-3#2)(1993-6#1)(1994-11#2)(1994-12#17)(1994-2#1)(1994-9#3)(1995-11#1)(1995-3#3)(1995-5#2)(1995-6#16)(1996-11#5)(1996-5#2)(1996-8#1)(2005-11#47)(2008-10#4)(2008-5#8)(2008-6#2)(2009-11#1)(2009-12#1)(2011-2#1)(2012-12#2)(2012-2#6)(2012-3#2)(2013-7#2)(2013-8#4)
zeta(1)##4##1##(2009-12#4)
zeta(2)##4##1##(2007-12#1)(2009-12#3)
zeta(x(1))##3##1##(2008-2#3)
zeta-COP##3##1##(2009-7#3)
zeta-associated protein (ZAP-70) and CD38 expression in##2##7##(2008-8#2)
zeta-carotene##2##1##(1990-7#2)
zeta-chain##2##1##(1993-6#2)
zeta-crystallin##4##1##(1992-11#2)(1993-3#1)(1995-5#1)
zeta-potential measurements##4##2##(2005-11#2)(2010-7#1)(2012-12#1)
zeta-potential##10##1##(1992-7#3)(1996-1#1)(1997-6#1)(2005-11#2)(2009-11#1)(2010-7#1)(2012-12#1)
zeylanicum##3##1##(2013-7#3)
zhuyu##4##1##(2012-3#1)(2013-8#3)
ziconotide with the##2##3##(2005-7#2)
ziconotide##6##1##(2005-7#6)
zidovudine (AZT)##2##2##(1993-3#1)(2011-3#1)
zidovudine and IFNalpha##2##3##(2007-11#2)
zidovudine and lamivudine##2##3##(2008-5#2)
zidovudine and##9##2##(1995-6#1)(2006-11#1)(2007-11#3)(2007-12#1)(2008-5#2)(2008-7#1)
zidovudine in##3##2##(1990-10#1)(1995-7#1)(1995-9#1)
zidovudine therapy##2##2##(1992-3#1)(1992-6#1)
zidovudine##41##1##(1990-10#1)(1990-11#1)(1990-8#1)(1990-9#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-3#1)(1995-3#3)(1995-6#2)(1995-7#2)(1995-8#1)(1995-9#1)(1996-2#2)(2005-10#1)(2006-11#2)(2006-7#1)(2007-11#4)(2007-12#1)(2007-2#1)(2008-1#1)(2008-5#4)(2008-7#2)(2009-4#1)(2011-2#1)(2011-3#2)
zidovudine)##4##1##(1990-6#1)(1993-9#1)(2011-3#2)
zif 268 and c-fos##2##4##(1997-3#2)
zif/268 and CREM##2##3##(1995-12#2)
zif/268##3##1##(1995-12#2)(1996-8#1)
zig-zag##5##1##(1993-3#1)(2008-5#2)(2009-6#1)(2009-8#1)
zigzag configuration##2##2##(2005-11#1)(2008-3#1)
zigzag edges##3##2##(2012-2#3)
zigzag hexagonal graphene rings##2##4##(2010-7#2)
zigzag nanostructure##3##2##(2006-12#3)
zigzag path##2##2##(2007-11#1)(2008-3#1)
zigzag slab Nd##4##3##(2007-12#3)(2008-3#1)
zigzag slab##6##2##(2007-11#1)(2007-12#4)(2008-3#1)
zigzag##36##1##(2005-11#1)(2005-7#1)(2006-12#4)(2007-11#6)(2007-12#4)(2008-10#7)(2008-11#1)(2008-3#5)(2008-7#1)(2009-11#1)(2010-7#2)(2012-2#3)
zijn##4##1##(2012-12#4)
zileuton and A-78773##2##3##(1993-11#2)
zileuton and##4##2##(1993-11#3)(2007-11#1)
zileuton##7##1##(1993-11#5)(2007-11#2)
zimeldine##7##1##(1990-11#7)
zinc (II)##2##2##(2008-10#2)
zinc (P &lt##2##3##(1994-10#2)
zinc (Zn) and mercury (Hg)##2##5##(2007-5#1)(2007-8#1)
zinc (Zn) and##3##3##(2007-5#1)(2007-8#1)(2012-2#1)
zinc (Zn)##11##2##(1995-3#2)(1996-3#1)(1997-3#1)(1997-4#1)(2004-4#1)(2007-5#1)(2007-8#1)(2008-5#1)(2010-2#1)(2012-2#1)
zinc acetate and##2##3##(2008-4#1)(2010-10#1)
zinc acetate##7##2##(2007-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-10#3)
zinc administration##4##2##(2008-5#4)
zinc and 1##2##3##(1991-2#1)(2013-1#1)
zinc and cadmium##2##3##(1997-4#1)(2009-5#1)
zinc and calcium##5##3##(1995-8#1)(2013-7#4)
zinc and cobalt##4##3##(1992-1#1)(1993-3#1)(2008-10#1)(2008-5#1)
zinc and copper in##3##4##(1997-4#1)(2008-10#1)(2013-8#1)
zinc and copper##9##3##(1990-8#2)(1996-7#1)(1997-4#1)(2008-10#3)(2013-7#1)(2013-8#1)
zinc and iron##2##3##(2007-2#1)(2008-10#1)
zinc and lead##3##3##(2008-10#3)
zinc and magnesium##2##3##(2006-6#1)(2008-5#1)
zinc and manganese##4##3##(1991-12#1)(1992-6#1)(2005-4#1)(2008-10#1)
zinc and nickel in##3##4##(2008-10#3)
zinc and nickel##5##3##(2008-10#5)
zinc and##54##2##(1990-8#2)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-3#1)(1992-6#2)(1993-3#1)(1993-8#1)(1994-6#1)(1995-8#1)(1996-3#1)(1996-7#1)(1997-4#2)(2005-4#1)(2006-5#1)(2006-6#1)(2007-2#1)(2007-5#1)(2008-10#18)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-5#1)(2013-1#2)(2013-7#5)(2013-8#1)
zinc are##2##2##(1991-5#1)(2009-3#1)
zinc as##2##2##(1991-12#1)(1993-12#1)
zinc at##6##2##(1994-5#1)(1996-8#1)(2007-5#1)(2008-10#3)
zinc atom and##2##3##(1991-5#1)(2004-12#1)
zinc atom##7##2##(1990-11#1)(1991-5#1)(1992-1#1)(1992-3#1)(1994-11#1)(1997-7#1)(2004-12#1)
zinc atoms##4##2##(1992-12#1)(1994-11#1)(1995-8#1)(2010-5#1)
zinc binding to##2##3##(1994-12#1)(2012-11#1)
zinc binding##13##2##(1990-8#1)(1994-10#1)(1994-12#4)(1994-6#2)(2008-1#2)(2008-10#2)(2012-11#1)
zinc blocked##2##2##(1995-3#1)(2008-4#1)
zinc bound to##2##3##(1994-11#2)
zinc bound##4##2##(1991-9#2)(1994-11#2)
zinc but##2##2##(1994-5#1)(2008-10#1)
zinc by##6##2##(1997-4#1)(2008-1#1)(2008-10#4)
zinc can##3##2##(2008-10#1)(2008-7#1)(2009-3#1)
zinc chelate##2##2##(1990-9#1)(1997-4#1)
zinc chelates##2##2##(1990-5#1)(2008-10#1)
zinc chloride##5##2##(2006-8#1)(2008-10#2)(2012-1#1)(2012-2#1)
zinc complex##3##2##(1996-2#2)(2008-10#1)
zinc complexes and##2##3##(2008-5#2)
zinc complexes##3##2##(1996-2#1)(2008-5#2)
zinc compound##2##2##(1996-2#1)(2006-12#1)
zinc compounds##6##2##(1992-6#1)(2008-10#4)(2010-5#1)
zinc concentration##7##2##(1994-10#3)(2008-10#1)(2008-7#1)(2012-2#2)
zinc concentrations in##2##3##(1993-2#1)(2006-4#1)
zinc concentrations were##2##3##(2007-5#1)(2013-7#1)
zinc concentrations##8##2##(1990-5#1)(1993-2#1)(2006-4#2)(2007-5#1)(2012-2#2)(2013-7#1)
zinc content of##2##3##(2006-4#1)(2008-10#1)
zinc content##7##2##(2006-4#2)(2008-10#1)(2008-5#2)(2012-12#2)
zinc deficiency and##2##3##(2004-11#1)(2008-10#1)
zinc deficiency can##2##3##(2008-10#1)(2009-3#1)
zinc deficiency in##5##3##(2007-12#1)(2008-10#2)(2008-11#1)(2012-2#1)
zinc deficiency##24##2##(1992-4#1)(2004-11#2)(2007-12#1)(2008-10#10)(2008-11#1)(2009-3#3)(2010-2#1)(2012-2#5)
zinc deficient diet##2##3##(2010-2#2)
zinc determination##8##2##(2007-10#1)(2008-10#7)
zinc dimethyldithiocarbamate##2##2##(2005-11#1)(2008-10#1)
zinc dithizonate##3##2##(2008-10#3)
zinc excess##2##2##(2004-11#2)
zinc exposure##2##2##(1993-2#1)(2012-2#1)
zinc finger and##2##3##(1992-6#1)(1995-6#1)
zinc finger domain of##3##4##(1991-2#2)(2009-7#1)
zinc finger domain##10##3##(1991-2#3)(1994-9#4)(1996-6#1)(2009-7#1)(2012-2#1)
zinc finger domains of##2##4##(1991-9#1)(2008-8#1)
zinc finger domains with##2##4##(1991-4#2)
zinc finger domains##6##3##(1991-2#2)(1991-4#2)(1991-9#1)(2008-8#1)
zinc finger gene##5##3##(1990-6#1)(1991-11#1)(1991-5#2)(2007-12#1)
zinc finger motif##5##3##(1991-5#1)(1992-1#1)(1992-8#1)(1995-6#1)(1996-4#1)
zinc finger motifs##2##3##(1991-9#1)(1996-10#1)
zinc finger of##2##3##(1991-2#1)(1994-6#1)
zinc finger protein##8##3##(1990-11#1)(1991-11#1)(1991-4#1)(1992-7#2)(1994-9#1)(1996-6#1)(2007-12#1)
zinc finger proteins##6##3##(1991-4#2)(1992-8#1)(1994-6#1)(2008-7#1)(2010-4#1)
zinc finger region of the##3##5##(1990-11#1)(1994-3#2)
zinc finger region of##4##4##(1990-11#1)(1991-10#1)(1994-3#2)
zinc finger region##6##3##(1990-11#2)(1991-10#1)(1994-3#3)
zinc finger transcription factor##2##4##(2007-12#1)(2010-2#1)
zinc finger transcription##3##3##(2007-12#1)(2010-2#1)(2012-2#1)
zinc finger##76##2##(1990-11#3)(1990-6#2)(1991-10#2)(1991-11#2)(1991-2#10)(1991-4#5)(1991-5#3)(1991-9#2)(1992-1#1)(1992-6#1)(1992-7#2)(1992-8#3)(1994-3#3)(1994-6#2)(1994-9#7)(1995-11#3)(1995-3#1)(1995-6#2)(1996-10#1)(1996-4#1)(1996-6#2)(1997-1#2)(2006-10#1)(2007-12#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)
zinc finger-containing##5##2##(1990-11#2)(1991-10#1)(1994-9#1)(1996-5#1)
zinc finger-like motif##2##3##(1993-4#2)
zinc finger-like##3##2##(1992-3#1)(1993-4#2)
zinc fingers and##2##3##(1997-7#1)(2009-10#1)
zinc fingers of##2##3##(1995-11#1)(2008-10#1)
zinc fingers##16##2##(1990-11#1)(1991-10#1)(1991-6#1)(1992-8#2)(1993-3#1)(1994-2#1)(1994-7#1)(1995-11#2)(1996-10#1)(1996-5#1)(1997-7#2)(2008-10#1)(2009-10#1)
zinc from the##3##3##(2008-10#3)
zinc from##9##2##(1997-4#1)(2008-10#8)
zinc homeostasis##2##2##(2004-11#1)(2008-10#1)
zinc hydroxide##6##2##(1990-8#3)(1992-6#3)
zinc in a##2##3##(1994-6#1)(1995-10#1)
zinc in milkvetch##2##3##(2008-10#2)
zinc in plant samples by##2##5##(2008-10#2)
zinc in plant##3##3##(2008-10#3)
zinc in the##9##3##(1996-3#2)(2004-4#1)(2007-7#1)(2008-10#4)(2012-2#1)
zinc in##63##2##(1991-3#1)(1991-4#1)(1993-9#1)(1994-6#1)(1995-10#1)(1995-5#1)(1995-8#2)(1996-3#2)(1996-7#1)(2004-4#3)(2005-10#1)(2005-4#4)(2007-1#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-10#34)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
zinc into##3##2##(2008-10#3)
zinc ion binding##2##3##(1990-8#1)(1995-11#1)
zinc ion in the##2##4##(1993-11#1)(2009-3#1)
zinc ion in##3##3##(1993-11#1)(1995-5#1)(2009-3#1)
zinc ion##11##2##(1990-11#1)(1990-8#2)(1993-11#1)(1995-11#2)(1995-5#1)(1996-11#1)(2006-10#1)(2009-3#1)(2012-11#1)
zinc ions and##3##3##(2005-11#1)(2007-8#1)(2008-10#1)
zinc ions in the liquid phase##2##6##(2005-11#2)
zinc ions in##6##3##(2005-11#3)(2008-10#2)(2009-7#1)
zinc ions##25##2##(1991-10#1)(1991-3#1)(1992-6#1)(1992-9#1)(1995-11#1)(1997-7#1)(2005-11#4)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2009-7#1)(2010-11#2)(2013-7#2)
zinc is not##2##3##(1995-8#1)(2004-11#1)
zinc is##15##2##(1992-3#1)(1992-8#1)(1994-11#1)(1995-8#2)(1997-3#1)(2004-11#1)(2005-10#1)(2008-10#5)(2010-3#1)(2013-7#1)
zinc levels were##2##3##(1995-3#1)(2008-10#1)
zinc levels##5##2##(1995-3#1)(2008-10#1)(2008-5#1)(2010-5#1)(2013-8#1)
zinc ligand##5##2##(1994-10#2)(1994-12#1)(1995-5#2)
zinc ligands of##3##3##(1994-12#3)
zinc ligands##4##2##(1992-4#1)(1994-12#3)
zinc metalloprotease##2##2##(1994-12#1)(2008-7#1)
zinc metalloproteases##2##2##(1994-10#2)
zinc nanostructured films is##2##4##(2009-12#2)
zinc nanostructured films were##2##4##(2009-12#2)
zinc nanostructured films##5##3##(2009-12#5)
zinc of##2##2##(1990-9#1)(2007-10#1)
zinc on the##4##3##(1994-6#1)(1995-11#1)(1995-3#1)(2008-10#1)
zinc on##12##2##(1992-12#1)(1994-6#1)(1995-11#1)(1995-3#1)(1997-7#1)(2008-10#3)(2008-5#1)(2008-7#2)(2013-8#1)
zinc or cobalt##2##3##(2005-11#1)(2008-5#1)
zinc or##4##2##(2005-11#1)(2008-10#1)(2008-5#1)(2013-7#1)
zinc oxide (ZnO)##3##3##(2008-5#1)(2009-5#1)(2009-7#1)
zinc oxide nanoparticles##3##3##(2006-12#1)(2007-9#2)
zinc oxide particles##2##3##(2005-11#2)
zinc oxide single crystals##3##4##(2008-3#3)
zinc oxide##18##2##(2005-11#3)(2005-7#1)(2006-12#1)(2007-9#3)(2008-3#3)(2008-5#3)(2009-2#1)(2009-5#1)(2009-7#1)(2011-12#1)
zinc oxide-eugenol##3##2##(2006-8#2)(2013-1#1)
zinc per enzyme subunit##3##4##(1994-5#2)(1994-6#1)
zinc per##5##2##(1994-5#4)(1994-6#1)
zinc phosphate##6##2##(2004-9#6)
zinc pyrithione in##2##3##(2008-10#1)(2008-5#1)
zinc pyrithione##8##2##(2008-10#1)(2008-11#1)(2008-5#6)
zinc ratio##2##2##(2009-5#2)
zinc receptors as##2##3##(2008-4#2)
zinc salts##2##2##(2008-8#1)(2010-3#1)
zinc secretion in the##2##4##(2008-10#2)
zinc secretion##3##2##(2008-10#3)
zinc selenide##3##2##(1991-9#1)(2007-11#1)(2008-2#1)
zinc separation and##2##3##(2008-10#2)
zinc separation##3##2##(2008-10#3)
zinc signaling##2##2##(2008-4#1)(2013-1#1)
zinc status##4##2##(2004-11#2)(2005-10#1)(2013-7#1)
zinc sulfate##9##2##(1990-5#1)(1995-5#3)(1997-3#1)(2007-8#1)(2008-10#2)(2013-7#1)
zinc sulphate##2##2##(2011-12#1)(2012-12#1)
zinc superoxide dismutase##2##3##(1997-8#2)
zinc supplementation in##2##3##(1994-10#1)(2010-6#1)
zinc supplementation##6##2##(1994-10#1)(2009-3#1)(2010-6#1)(2013-7#3)
zinc to##3##2##(1994-6#2)(2008-10#1)
zinc traces##5##2##(2008-10#5)
zinc transporter##2##2##(2008-10#2)
zinc transporters##3##2##(2008-10#2)(2013-1#1)
zinc triad metal ion##2##4##(2009-4#2)
zinc uptake##6##2##(1994-10#1)(2004-11#5)
zinc using a##2##3##(2008-10#1)(2008-5#1)
zinc using##6##2##(1991-3#1)(2008-10#4)(2008-5#1)
zinc via##3##2##(1996-7#2)(1997-3#1)
zinc was also##2##3##(1991-9#1)(2008-10#1)
zinc was significantly##2##3##(1997-3#1)(2009-5#1)
zinc was##8##2##(1991-9#1)(1994-10#1)(1997-3#2)(2008-10#3)(2009-5#1)
zinc white##2##2##(2008-10#2)
zinc with##5##2##(1994-5#1)(2008-10#3)(2008-5#1)
zinc##891##1##(1990-10#1)(1990-11#10)(1990-3#1)(1990-5#7)(1990-6#2)(1990-8#12)(1990-9#3)(1991-1#1)(1991-10#5)(1991-11#2)(1991-12#2)(1991-2#12)(1991-3#3)(1991-4#10)(1991-5#7)(1991-6#1)(1991-9#7)(1992-1#4)(1992-12#2)(1992-3#9)(1992-4#2)(1992-6#14)(1992-7#2)(1992-8#6)(1992-9#4)(1993-11#1)(1993-12#3)(1993-2#4)(1993-3#3)(1993-4#3)(1993-5#1)(1993-8#1)(1993-9#3)(1994-10#19)(1994-11#7)(1994-12#9)(1994-2#1)(1994-3#3)(1994-5#10)(1994-6#12)(1994-7#1)(1994-9#8)(1995-10#2)(1995-11#9)(1995-3#7)(1995-5#9)(1995-6#2)(1995-8#11)(1996-10#2)(1996-11#1)(1996-2#4)(1996-3#6)(1996-4#1)(1996-5#3)(1996-6#2)(1996-7#8)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#10)(1997-4#9)(1997-7#8)(1997-8#2)(2004-11#28)(2004-12#1)(2004-4#8)(2004-9#10)(2005-10#3)(2005-11#9)(2005-4#10)(2005-7#1)(2006-10#5)(2006-12#2)(2006-4#6)(2006-5#3)(2006-6#1)(2006-8#4)(2007-1#1)(2007-10#7)(2007-11#3)(2007-12#4)(2007-2#3)(2007-5#9)(2007-7#2)(2007-8#3)(2007-9#4)(2008-1#5)(2008-10#237)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#9)(2008-5#32)(2008-7#8)(2008-8#2)(2008-9#1)(2009-10#3)(2009-12#5)(2009-2#2)(2009-3#8)(2009-4#2)(2009-5#5)(2009-7#3)(2009-8#1)(2010-10#6)(2010-11#5)(2010-2#6)(2010-3#2)(2010-4#2)(2010-5#4)(2010-6#3)(2011-12#3)(2011-2#4)(2012-1#3)(2012-11#2)(2012-12#9)(2012-2#16)(2012-3#2)(2013-1#11)(2013-7#20)(2013-8#10)
zinc's##3##1##(2008-10#1)(2012-12#1)(2013-1#1)
zinc(II) and cadmium(II)##2##3##(2008-10#2)
zinc(II) and lead(II)##2##3##(2008-10#2)
zinc(II) and##8##2##(1992-11#1)(2008-10#5)(2008-3#1)(2010-11#1)
zinc(II) by##3##2##(1991-4#1)(2008-10#2)
zinc(II) ion##2##2##(1997-7#1)(2010-5#1)
zinc(II) sulphate##2##2##(2008-10#2)
zinc(II)##40##1##(1990-2#1)(1991-4#1)(1991-5#4)(1992-11#1)(1997-7#1)(2005-11#1)(2007-11#1)(2008-10#23)(2008-3#2)(2008-5#1)(2010-11#1)(2010-12#1)(2010-5#2)
zinc)##6##1##(1993-9#1)(1995-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2013-7#1)
zinc-binding##10##1##(1990-11#1)(1992-6#1)(1994-10#1)(2006-5#1)(2007-3#1)(2008-1#3)(2010-8#1)(2013-7#1)
zinc-containing##12##1##(1995-5#3)(1995-6#2)(1997-2#1)(2005-7#1)(2006-8#1)(2008-5#3)(2012-3#1)
zinc-deficient##2##1##(2004-11#1)(2009-3#1)
zinc-dependent##4##1##(1993-12#1)(1994-9#1)(2007-11#1)(2010-11#1)
zinc-enriched##2##1##(1996-3#1)(2008-5#1)
zinc-finger domain##5##2##(1995-2#5)
zinc-finger genes related to##2##4##(1991-9#2)
zinc-finger protein##3##2##(1991-7#1)(1992-2#1)(2009-10#1)
zinc-finger##24##1##(1991-12#2)(1991-7#3)(1991-9#3)(1992-2#1)(1993-12#1)(1993-2#1)(1994-6#1)(1995-2#5)(1996-10#2)(1996-5#1)(1997-7#1)(2009-10#1)(2010-8#1)(2011-1#1)
zinc-induced##2##1##(1994-6#1)(1997-3#1)
zinc-selective sensor##2##2##(2008-10#1)(2012-11#1)
zinc-sulfide thin films##2##3##(2008-2#2)
zineb##11##1##(2008-10#11)
zip code##4##2##(2010-2#2)(2011-2#2)
zip##6##1##(2006-2#1)(2007-11#1)(2010-2#2)(2011-2#2)
zipper genes##4##2##(1994-8#4)
zipper motif##4##2##(1994-8#1)(1994-9#2)(2008-10#1)
zipper motifs##2##2##(1996-2#1)(1996-6#1)
zipper##31##1##(1992-3#4)(1992-8#3)(1993-12#2)(1993-3#1)(1994-3#3)(1994-8#7)(1994-9#2)(1996-2#2)(1996-6#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-4#2)(2013-8#1)
zipper-like silica cells##2##3##(2007-3#1)(2008-5#1)
zipper-like##5##1##(1997-4#2)(2007-3#1)(2007-7#1)(2008-5#1)
zippers##3##1##(1997-5#1)(2009-8#1)(2011-2#1)
ziprasidone##11##1##(2005-6#6)(2008-3#1)(2008-6#4)
ziram and zineb respectively##2##4##(2008-10#2)
ziram and zineb were##2##4##(2008-10#2)
ziram and zineb##8##3##(2008-10#8)
ziram and##9##2##(2008-10#9)
ziram##11##1##(2008-10#11)
ziram/zineb##2##1##(2008-10#2)
zircon##8##1##(2005-11#3)(2008-10#5)
zirconate acid##2##2##(2008-10#2)
zirconate##9##1##(2008-10#3)(2008-2#6)
zirconia and its##2##3##(1993-12#1)(2005-11#1)
zirconia and##6##2##(1993-12#1)(2005-11#1)(2008-10#1)(2009-8#1)(2010-12#1)(2011-1#1)
zirconia content of the fume##2##5##(2008-10#2)
zirconia framework##4##2##(2013-1#1)(2013-8#3)
zirconia implants##3##2##(2009-8#3)
zirconia precipitates##2##2##(2005-11#2)
zirconia specimens from##2##3##(2009-8#2)
zirconia stationary phase##4##3##(2008-10#4)
zirconia surface is##2##3##(1993-12#2)
zirconia surface##5##2##(1993-12#3)(2008-10#2)
zirconia##53##1##(1993-12#7)(2004-9#1)(2005-11#4)(2007-11#1)(2008-10#19)(2009-8#10)(2010-12#2)(2011-1#1)(2013-1#3)(2013-8#5)
zirconia-coated silica##2##2##(2008-10#2)
zirconium and hafnium##3##3##(2008-10#3)
zirconium and##6##2##(2008-10#5)(2010-4#1)
zirconium oxide##7##2##(2005-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)
zirconium oxychloride##2##2##(2008-10#2)
zirconium permanent##3##2##(2008-10#3)
zirconium phosphate##5##2##(2005-11#2)(2008-10#2)(2008-6#1)
zirconium with##2##2##(2005-4#1)(2008-10#1)
zirconium##58##1##(1990-5#5)(1993-12#1)(2005-11#9)(2005-4#2)(2007-12#2)(2008-10#30)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-4#1)(2011-2#2)
zirconium(IV) and##2##2##(2008-10#2)
zirconium(IV)##16##1##(2006-12#2)(2008-10#12)(2008-3#2)
zirconocene##2##1##(2006-4#2)
zmol##2##1##(1997-8#2)
zoisite##4##1##(2011-2#4)
zolantidine##3##1##(1993-3#1)(1994-2#2)
zoledronate##5##1##(2007-11#1)(2007-12#1)(2008-3#1)(2012-1#1)(2013-8#1)
zoledronic Acid on##3##3##(2008-7#1)(2013-1#2)
zoledronic Acid##4##2##(2008-7#2)(2013-1#2)
zoledronic acid (4 mg)##2##4##(2008-7#2)
zoledronic acid significantly reduced the cumulative incidence of SREs compared with##2##11##(2008-7#2)
zoledronic acid##14##2##(2008-1#1)(2008-7#9)(2009-6#1)(2013-1#2)(2013-7#1)
zoledronic##18##1##(2008-1#1)(2008-7#11)(2009-6#1)(2013-1#4)(2013-7#1)
zolpidem and zopiclone##3##3##(2004-11#2)(2013-8#1)
zolpidem and##7##2##(2004-11#2)(2011-2#4)(2013-8#1)
zolpidem is##2##2##(1993-8#1)(2008-8#1)
zolpidem##28##1##(1993-8#4)(1994-12#1)(1995-11#1)(2004-11#3)(2004-3#4)(2007-6#1)(2008-8#5)(2011-2#8)(2013-8#1)
zona fasciculata/reticularis cells##3##3##(1994-3#3)
zona glomerulosa of##2##3##(1995-10#1)(2008-4#1)
zona glomerulosa##10##2##(1990-10#1)(1990-11#1)(1990-5#1)(1994-2#1)(1995-10#2)(1996-5#1)(2006-10#1)(2008-4#2)
zona incerta (ZI)##2##3##(1996-12#1)(1996-6#1)
zona incerta##13##2##(1991-5#3)(1994-2#1)(1995-5#2)(1996-12#2)(1996-6#1)(2009-2#3)(2012-3#1)
zona pellucida and##2##3##(1997-4#1)(2008-4#1)
zona pellucida glycoproteins##4##3##(1991-2#3)(1995-5#1)
zona pellucida##12##2##(1991-2#3)(1995-5#2)(1996-9#1)(1997-4#1)(2008-12#1)(2008-4#2)(2008-9#1)(2013-1#1)
zona##45##1##(1990-10#1)(1990-11#1)(1990-5#3)(1991-2#3)(1991-5#3)(1994-2#2)(1994-3#3)(1995-10#3)(1995-12#1)(1995-5#4)(1996-12#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-4#1)(2006-10#1)(2006-5#1)(2008-12#1)(2008-4#4)(2008-8#1)(2008-9#1)(2009-2#3)(2012-3#1)(2013-1#2)
zonal crash prediction##2##3##(2012-12#2)
zonal##19##1##(1990-6#1)(1992-7#1)(1993-4#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#3)(2008-4#2)(2009-12#2)(2010-7#1)(2011-2#1)(2012-12#3)
zonation##2##1##(2008-3#1)(2013-7#1)
zonatus##3##1##(2004-8#3)
zone B-cell lymphoma##3##3##(2006-4#1)(2009-5#1)(2009-7#1)
zone II##2##2##(2006-4#1)(2008-7#1)
zone III##2##2##(2008-7#1)(2011-1#1)
zone and a##4##3##(2007-12#1)(2007-3#1)(2008-10#1)(2012-12#1)
zone and the##2##3##(1996-4#1)(2008-3#1)
zone and##22##2##(1996-4#2)(1996-5#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-10#6)(2008-3#2)(2009-8#1)(2010-12#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
zone are##4##2##(1996-4#1)(2008-10#1)(2008-7#1)(2010-12#1)
zone around##2##2##(1997-6#1)(2012-12#1)
zone as an##2##3##(2009-2#1)(2012-3#1)
zone as##3##2##(2006-4#1)(2009-2#1)(2012-3#1)
zone at the##3##3##(2007-12#2)(2008-10#1)
zone at##5##2##(1997-8#1)(2007-12#2)(2008-10#2)
zone becomes##2##2##(1995-8#1)(2007-11#1)
zone between the##4##3##(2006-4#1)(2008-10#1)(2008-11#1)(2008-2#1)
zone between##11##2##(1991-3#1)(1991-5#1)(1992-6#2)(2006-4#1)(2006-5#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-8#1)
zone by stopping##2##3##(1997-4#1)(2008-10#1)
zone by##5##2##(1997-4#1)(2008-10#2)(2008-8#2)
zone capillary electrophoresis##2##3##(1996-5#1)(2008-10#1)
zone compared with##2##3##(1996-4#1)(2012-12#1)
zone decomposition##2##2##(2008-3#2)
zone decreased from##4##3##(1991-10#4)
zone decreased##5##2##(1991-10#5)
zone diagrams for##2##3##(2008-10#2)
zone diagrams##4##2##(2008-10#4)
zone during##5##2##(2004-4#1)(2007-4#1)(2008-11#1)(2008-5#1)(2012-2#1)
zone electrophoresis (CZE) and micellar electrokinetic capillary chromatography##2##8##(1996-5#2)
zone electrophoresis (CZE) and micellar electrokinetic##3##6##(1996-5#3)
zone electrophoresis (CZE) was used##2##5##(1996-5#1)(2008-10#1)
zone electrophoresis (CZE) with##3##4##(2008-10#3)
zone electrophoresis (CZE)##29##3##(1992-1#1)(1994-9#1)(1996-5#6)(1997-3#1)(2005-12#1)(2007-8#1)(2008-10#17)(2012-12#1)
zone electrophoresis mode in phosphate buffer (pH 6##2##8##(1992-1#2)
zone electrophoresis of##2##3##(1996-5#1)(1997-3#1)
zone electrophoresis##96##2##(1990-8#1)(1992-1#4)(1992-12#2)(1994-9#3)(1996-5#13)(1997-3#3)(1997-8#4)(2005-12#1)(2007-8#3)(2008-1#1)(2008-10#59)(2008-4#1)(2012-12#1)
zone electrophoretic##3##2##(1994-12#1)(1994-9#1)(1996-5#1)
zone for##6##2##(1991-9#1)(1994-12#1)(2008-7#1)(2010-6#1)(2010-8#1)(2011-2#1)
zone formation##3##2##(2008-10#3)
zone from the##2##3##(2008-10#2)
zone from##3##2##(2008-10#2)(2008-8#1)
zone had##2##2##(2006-5#1)(2010-1#1)
zone in a##2##3##(2008-10#1)(2008-2#1)
zone in the##6##3##(1990-2#1)(1991-1#1)(1994-2#1)(2008-5#2)(2011-2#1)
zone in##14##2##(1990-2#1)(1990-6#1)(1991-1#1)(1994-2#1)(2005-9#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-5#2)(2011-2#2)(2013-8#1)
zone is##17##2##(1996-4#1)(2007-5#1)(2008-10#6)(2008-11#1)(2009-2#2)(2009-8#1)(2010-4#1)(2011-1#1)(2012-12#2)(2013-7#1)
zone lymphoma##6##2##(2006-4#1)(2009-8#3)(2011-2#2)
zone may##2##2##(2007-11#1)(2011-2#1)
zone of Nigeria##2##3##(2007-7#2)
zone of inhibition was##2##4##(2010-3#1)(2011-2#1)
zone of inhibition##3##3##(2010-12#1)(2010-3#1)(2011-2#1)
zone of polarizing activity##2##4##(1993-12#2)
zone of the ball##2##4##(2009-7#2)
zone of the brain##2##4##(2008-8#1)(2012-1#1)
zone of the spinal##2##4##(1995-5#1)(1996-11#1)
zone of the traumatic cavity##2##5##(2012-1#2)
zone of the##31##3##(1990-5#1)(1995-5#1)(1996-11#2)(1996-4#1)(1996-5#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-5#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2009-7#3)(2010-8#1)(2011-2#1)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#1)
zone of##97##2##(1990-5#1)(1990-9#1)(1992-12#2)(1993-12#3)(1993-5#1)(1994-3#1)(1995-5#1)(1996-11#2)(1996-4#1)(1996-5#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#3)(2008-10#12)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#5)(2008-8#2)(2008-9#5)(2009-10#3)(2009-12#1)(2009-6#1)(2009-7#3)(2009-8#2)(2010-12#2)(2010-3#1)(2010-8#1)(2011-2#2)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#4)
zone on##2##2##(2006-10#1)(2013-1#1)
zone plate##5##2##(2007-11#1)(2008-2#3)(2008-3#1)
zone plates by##2##3##(2007-11#1)(2008-2#1)
zone plates fabricated##2##3##(2007-11#1)(2008-2#1)
zone plates##15##2##(2007-11#4)(2007-12#1)(2008-2#5)(2008-3#3)(2012-2#2)
zone shows##2##2##(1995-8#1)(2008-10#1)
zone size##4##2##(1996-4#2)(2007-11#1)(2012-12#1)
zone surrounding##2##2##(2008-8#1)(2009-8#1)
zone to##3##2##(2007-5#1)(2008-3#1)(2008-4#1)
zone under##2##2##(1993-9#1)(2008-10#1)
zone was then##2##3##(2008-10#2)
zone was##20##2##(1990-2#1)(1991-2#1)(1992-12#1)(1996-4#1)(1997-3#1)(2006-12#2)(2008-10#9)(2008-5#1)(2010-4#2)(2012-12#1)
zone were##2##2##(2009-4#1)(2011-2#1)
zone where the##2##3##(2008-8#2)
zone where##3##2##(2008-8#2)(2011-2#1)
zone with higher##2##3##(2008-10#1)(2009-6#1)
zone with##6##2##(1990-11#1)(1996-4#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-6#1)
zone##648##1##(1990-11#4)(1990-12#1)(1990-2#5)(1990-4#2)(1990-5#2)(1990-6#4)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#6)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#5)(1991-5#1)(1991-9#1)(1992-1#5)(1992-12#5)(1992-6#3)(1993-12#3)(1993-2#2)(1993-4#2)(1993-5#1)(1993-9#1)(1994-12#2)(1994-2#4)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#4)(1995-1#1)(1995-11#1)(1995-5#1)(1995-8#2)(1996-11#3)(1996-12#3)(1996-2#3)(1996-4#22)(1996-5#24)(1997-1#1)(1997-3#6)(1997-4#4)(1997-5#3)(1997-6#1)(1997-7#3)(1997-8#6)(2004-4#3)(2005-10#2)(2005-11#1)(2005-12#2)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#2)(2006-12#3)(2006-3#1)(2006-4#6)(2006-5#4)(2006-8#1)(2007-1#1)(2007-10#8)(2007-11#10)(2007-12#13)(2007-2#2)(2007-3#6)(2007-4#1)(2007-5#8)(2007-7#6)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#139)(2008-11#5)(2008-12#1)(2008-2#16)(2008-3#20)(2008-4#6)(2008-5#13)(2008-7#25)(2008-8#13)(2008-9#6)(2009-10#5)(2009-12#1)(2009-2#3)(2009-4#2)(2009-5#3)(2009-6#3)(2009-7#8)(2009-8#16)(2009-9#1)(2010-1#1)(2010-12#9)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#6)(2011-1#3)(2011-12#2)(2011-2#19)(2012-1#4)(2012-11#1)(2012-12#22)(2012-2#12)(2012-3#5)(2013-1#4)(2013-7#5)(2013-8#6)
zone&quot##10##1##(1992-11#1)(1994-6#1)(1995-3#1)(1996-4#4)(2005-9#1)(2007-11#1)(2012-12#1)
zone) and##3##2##(2007-12#1)(2008-10#2)
zone)##7##1##(1996-4#1)(1997-3#1)(2007-12#1)(2008-10#3)(2012-1#1)
zone-plate array##2##2##(2008-3#2)
zone-plate arrays##2##2##(2007-12#2)
zone-plate##5##1##(2007-12#2)(2008-2#1)(2008-3#2)
zone]##4##1##(1996-3#1)(1997-3#1)(2007-2#1)(2011-1#1)
zones (the##2##2##(2006-4#1)(2007-7#1)
zones 1##3##2##(1997-8#2)(2007-7#1)
zones and##10##2##(1996-4#1)(1997-7#1)(2007-2#1)(2008-10#2)(2009-2#1)(2010-3#1)(2012-1#1)(2013-1#1)(2013-8#1)
zones appeared##2##2##(1994-2#1)(2008-5#1)
zones are##2##2##(2008-10#2)
zones as##2##2##(2008-10#1)(2008-8#1)
zones at high risk for##2##5##(2012-12#2)
zones at##5##2##(2007-9#1)(2008-10#2)(2012-12#2)
zones between##2##2##(2008-8#2)
zones for##2##2##(1991-3#1)(2008-12#1)
zones in the##5##3##(1992-2#1)(1996-4#1)(1997-7#1)(2007-11#1)(2011-2#1)
zones in##14##2##(1992-2#1)(1996-4#1)(1997-3#1)(1997-7#1)(2006-1#1)(2007-11#1)(2007-6#2)(2008-10#1)(2008-2#1)(2011-12#1)(2011-2#1)(2013-1#2)
zones is the main mechanism##2##5##(1996-4#1)(2008-3#1)
zones is##5##2##(1996-4#1)(1997-3#1)(2008-10#1)(2008-3#2)
zones of the face##2##4##(2008-5#2)
zones of the##18##3##(1991-10#3)(1993-7#1)(1994-9#1)(1997-8#1)(2007-3#1)(2007-5#3)(2008-10#1)(2008-11#1)(2008-5#2)(2011-2#2)(2012-1#1)(2013-8#1)
zones of##45##2##(1991-10#3)(1992-8#1)(1993-12#1)(1993-7#1)(1994-9#1)(1995-12#1)(1996-1#1)(1996-5#1)(1997-8#2)(2006-12#1)(2007-12#1)(2007-3#2)(2007-5#3)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#4)(2008-7#2)(2008-8#2)(2009-10#1)(2009-12#1)(2010-3#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
zones ranged from##2##3##(2011-12#1)(2012-2#1)
zones studied##2##2##(2008-9#1)(2012-2#1)
zones that are##2##3##(1996-4#1)(2007-12#1)
zones that##4##2##(1996-4#1)(2007-12#2)(2008-10#1)
zones to##2##2##(2008-3#1)(2010-10#1)
zones using##2##2##(2007-5#1)(2013-1#1)
zones was##9##2##(1990-2#1)(1991-5#1)(1995-11#1)(2007-5#1)(2008-10#2)(2008-12#2)(2009-2#1)
zones were##7##2##(1992-7#1)(1996-12#1)(2006-8#1)(2008-5#2)(2009-7#1)(2012-2#1)
zones where the##2##3##(2007-5#1)(2008-2#1)
zones where##4##2##(2006-3#1)(2007-5#1)(2008-10#1)(2008-2#1)
zones with different##2##3##(1997-4#1)(2008-3#1)
zones with##11##2##(1997-4#1)(2008-10#3)(2008-3#3)(2008-5#1)(2010-4#1)(2012-3#1)(2013-1#1)
zones within##2##2##(2008-10#1)(2008-5#1)
zones##275##1##(1990-2#3)(1991-10#3)(1991-12#1)(1991-3#1)(1991-5#1)(1992-2#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-7#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-8#1)(1996-1#2)(1996-12#1)(1996-4#6)(1996-5#3)(1997-3#2)(1997-4#2)(1997-7#3)(1997-8#5)(2003-11#2)(2004-2#1)(2005-11#2)(2005-5#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-3#3)(2006-4#3)(2006-5#2)(2006-7#1)(2006-8#1)(2007-11#4)(2007-12#6)(2007-2#2)(2007-3#6)(2007-5#10)(2007-6#2)(2007-7#4)(2007-8#3)(2007-9#1)(2008-10#46)(2008-11#3)(2008-12#6)(2008-2#6)(2008-3#11)(2008-4#1)(2008-5#15)(2008-7#3)(2008-8#16)(2008-9#3)(2009-10#1)(2009-12#2)(2009-2#2)(2009-4#1)(2009-7#2)(2009-8#2)(2010-10#1)(2010-12#1)(2010-3#3)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#5)(2011-2#8)(2012-1#3)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#9)(2013-7#2)(2013-8#4)
zones)##4##1##(1992-3#1)(2006-4#1)(2007-5#1)(2008-10#1)
zonisamide in##3##2##(2006-12#2)(2010-12#1)
zonisamide##11##1##(2006-12#8)(2008-8#1)(2010-12#2)
zonules##2##1##(2006-11#2)
zoo animals##2##2##(1990-3#1)(1996-12#1)
zoo population##2##2##(1996-12#2)
zoo##20##1##(1990-3#2)(1991-11#1)(1996-12#4)(2007-12#1)(2007-2#4)(2007-8#1)(2009-4#7)
zoological##7##1##(2007-2#1)(2007-6#1)(2009-4#2)(2010-3#1)(2011-1#2)
zoology##2##1##(1990-8#1)(1993-3#1)
zooming##4##1##(2008-5#1)(2008-6#2)(2013-1#1)
zoonoses in Colombia##2##3##(2012-12#2)
zoonoses in##4##2##(2011-2#1)(2012-12#3)
zoonoses##14##1##(2005-5#1)(2006-2#1)(2007-12#4)(2010-4#1)(2011-2#3)(2012-12#4)
zoonosis caused by##3##3##(2007-2#1)(2011-2#2)
zoonosis##13##1##(1997-6#1)(2007-2#3)(2008-1#1)(2008-5#1)(2010-12#1)(2011-2#3)(2012-12#2)(2013-1#1)
zoonotic cutaneous leishmaniasis##2##3##(2011-1#1)(2013-1#1)
zoonotic cutaneous##4##2##(2007-2#1)(2011-1#2)(2013-1#1)
zoonotic disease that##2##3##(2005-7#2)
zoonotic disease##6##2##(2005-7#2)(2007-12#2)(2013-7#1)(2013-8#1)
zoonotic diseases##5##2##(2005-7#1)(2007-6#2)(2011-1#1)(2011-2#1)
zoonotic infection##4##2##(2007-12#1)(2008-10#1)(2008-4#1)(2011-1#1)
zoonotic infections##3##2##(2006-10#1)(2008-12#1)(2010-4#1)
zoonotic parasites##3##2##(2011-1#1)(2011-2#2)
zoonotic potential##4##2##(2007-7#1)(2010-4#1)(2011-1#1)(2013-1#1)
zoonotic transmission##2##2##(2012-12#1)(2013-1#1)
zoonotic##58##1##(1993-7#1)(1997-3#1)(2005-5#1)(2005-7#3)(2006-10#1)(2007-12#5)(2007-2#3)(2007-6#2)(2007-7#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-8#1)(2010-10#1)(2010-4#4)(2011-1#12)(2011-2#5)(2012-12#2)(2012-2#3)(2013-1#5)(2013-7#1)(2013-8#1)
zoophilic##3##1##(2004-11#1)(2010-1#2)
zooplankton mortality##2##2##(2007-9#2)
zooplankton or##2##2##(2010-8#2)
zooplankton samples##3##2##(2012-2#3)
zooplankton##28##1##(2007-3#1)(2007-5#3)(2007-9#6)(2008-12#1)(2008-5#1)(2008-8#2)(2009-8#4)(2010-8#4)(2012-2#6)
zoos and aquariums##2##3##(2013-8#2)
zoos and##3##2##(2007-2#1)(2013-8#2)
zoos##4##1##(2007-2#1)(2009-4#1)(2013-8#2)
zoosporangia##9##1##(2008-10#9)
zoospore concentrations##3##2##(2008-10#3)
zoospore inoculation##2##2##(2008-10#2)
zoospore isolates##7##2##(2008-10#7)
zoospore##17##1##(2008-10#17)
zoospores of##7##2##(1991-8#1)(2008-10#5)(2010-4#1)
zoospores per ml##2##3##(2008-10#2)
zoospores per##3##2##(2008-10#3)
zoospores##35##1##(1991-8#1)(2008-10#33)(2010-4#1)
zooxanthellae##6##1##(2008-5#3)(2012-12#3)
zooxanthellal##2##1##(2012-12#2)
zopiclone##8##1##(1996-9#4)(2004-11#2)(2008-8#1)(2013-8#1)
zorgdiagnose##3##1##(2012-12#3)
zoster and##6##2##(1991-6#1)(1995-9#1)(2005-11#1)(2008-4#2)(2008-5#1)
zoster in##4##2##(2005-12#1)(2007-7#2)(2008-5#1)
zoster infection##6##2##(2008-7#3)(2010-8#2)(2012-2#1)
zoster neuralgia##2##2##(1993-9#1)(2008-4#1)
zoster ophthalmicus##2##2##(2008-7#1)(2009-6#1)
zoster or##2##2##(2006-12#1)(2007-7#1)
zoster pain##2##2##(2005-11#1)(2008-9#1)
zoster virus (VZV)##4##3##(1996-12#1)(2007-11#1)(2007-2#1)(2008-5#1)
zoster virus in##2##3##(1996-2#1)(2007-2#1)
zoster virus##10##2##(1992-11#1)(1994-2#1)(1996-12#1)(1996-2#1)(2007-11#1)(2007-2#2)(2008-5#1)(2008-7#1)(2013-1#1)
zoster was##3##2##(2005-12#2)(2007-7#1)
zoster##69##1##(1991-6#1)(1992-11#3)(1993-8#2)(1993-9#1)(1994-2#1)(1994-3#3)(1995-9#1)(1996-12#1)(1996-2#1)(2005-11#2)(2005-12#4)(2006-12#2)(2006-7#1)(2007-11#1)(2007-2#2)(2007-7#8)(2007-9#4)(2008-4#5)(2008-5#9)(2008-7#9)(2008-9#1)(2009-12#1)(2009-6#1)(2010-8#2)(2011-1#1)(2012-2#1)(2013-1#1)
zosteric acid##4##2##(2008-10#4)
zosteric##5##1##(2008-10#5)
zostericola##2##1##(1992-8#1)(1997-4#1)
zucchini squash##5##2##(2008-10#5)
zucchini##15##1##(2008-10#15)
zur Hausen##2##2##(1991-11#2)
zwitterion##4##1##(1996-7#1)(2006-2#3)
zwitterionic and##3##2##(1990-3#1)(1997-4#1)(2008-10#1)
zwitterionic detergent##4##2##(1990-5#1)(1994-9#3)
zwitterionic latex particles##2##3##(2005-11#2)
zwitterionic lipid##2##2##(1992-12#1)(1995-2#1)
zwitterionic membranes##3##2##(1997-7#3)
zwitterionic phospholipid##3##2##(1992-9#3)
zwitterionic phospholipids##3##2##(1990-2#1)(1992-9#1)(2006-2#1)
zwitterionic polymer electrolyte membranes##2##4##(2010-4#2)
zwitterionic surfactants##2##2##(2008-10#2)
zwitterionic##41##1##(1990-2#1)(1990-3#1)(1990-5#2)(1991-5#1)(1992-12#1)(1992-9#5)(1993-11#1)(1993-3#1)(1994-7#1)(1994-9#4)(1995-2#1)(1996-5#1)(1997-4#1)(1997-7#3)(2005-11#3)(2006-2#2)(2007-11#2)(2008-10#5)(2009-7#1)(2010-4#3)(2010-8#1)
zygapophyseal joint synovitis##4##3##(2006-8#4)
zygapophyseal joint##12##2##(2006-11#1)(2006-12#1)(2006-7#1)(2006-8#9)
zygapophyseal joints##2##2##(2006-8#2)
zygapophyseal##14##1##(2006-11#1)(2006-12#1)(2006-7#1)(2006-8#11)
zygapophysial (facet)##2##2##(2006-8#2)
zygapophysial##3##1##(2006-7#1)(2006-8#2)
zygoma##4##1##(1995-6#1)(2008-4#1)(2008-9#1)(2009-9#1)
zygomatic arch##4##2##(2007-12#2)(2008-3#2)
zygomatic##9##1##(1996-6#1)(2006-12#2)(2007-12#2)(2008-3#2)(2010-12#2)
zygomycosis caused by Rhizopus arrhizus in a surgical wound##2##9##(2007-7#2)
zygomycosis caused by##5##3##(2007-7#4)(2012-2#1)
zygomycosis in##3##2##(2008-5#2)(2011-12#1)
zygomycosis which##2##2##(2007-7#2)
zygomycosis##14##1##(1992-2#1)(1997-3#1)(2007-7#6)(2008-5#4)(2011-12#1)(2012-2#1)
zygosity##2##1##(1997-5#1)(2010-2#1)
zygote injection##2##2##(2008-2#2)
zygote##11##1##(1994-7#1)(1997-6#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-2#2)(2008-9#1)(2010-8#1)(2012-1#2)
zygotes and##2##2##(2009-12#2)
zygotes##10##1##(2005-8#1)(2006-5#2)(2008-2#1)(2008-8#1)(2009-12#4)(2009-8#1)
zygotic embryos##2##2##(2009-12#2)
zygotic expression of##2##3##(1996-7#2)
zygotic expression##4##2##(1996-7#3)(2008-5#1)
zygotic nucleus##2##2##(2008-9#2)
zygotic##12##1##(1992-12#3)(1996-7#3)(2008-5#1)(2008-9#2)(2009-12#3)
zymogen form##3##2##(1990-5#1)(1995-2#1)(2008-4#1)
zymogen granule membranes##4##3##(1991-1#1)(1991-5#2)(1994-9#1)
zymogen granule##6##2##(1991-1#1)(1991-5#2)(1992-4#1)(1994-9#1)(2006-10#1)
zymogen granules with##2##3##(1993-3#1)(2006-10#1)
zymogen granules##8##2##(1991-1#1)(1991-5#1)(1993-3#1)(1994-9#1)(2006-10#2)(2012-1#2)
zymogen##30##1##(1990-12#2)(1990-5#1)(1990-8#1)(1991-1#2)(1991-5#3)(1992-12#1)(1992-4#1)(1992-7#2)(1993-3#2)(1994-9#2)(1995-2#1)(1995-6#1)(1996-1#2)(1997-4#2)(2006-10#3)(2008-4#2)(2012-1#2)
zymogenic cells##3##2##(1995-6#3)
zymogenic##5##1##(1995-6#5)
zymogens##4##1##(1995-3#2)(1997-4#1)(2006-10#1)
zymogram analysis##2##2##(1995-2#1)(2009-6#1)
zymogram and##2##2##(2008-11#1)(2009-6#1)
zymogram##6##1##(1994-5#1)(1995-2#1)(2005-12#1)(2008-11#1)(2009-6#2)
zymograms##2##1##(1991-8#1)(2010-10#1)
zymography and##3##2##(1990-11#1)(2007-2#1)(2008-11#1)
zymography##22##1##(1990-11#1)(1994-8#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-9#1)(2007-10#1)(2007-2#4)(2008-1#1)(2008-11#1)(2008-4#1)(2010-3#2)(2011-2#2)(2012-3#3)(2013-8#1)
zymosan and##5##2##(1990-4#2)(1992-3#1)(1994-3#1)(1994-6#1)
zymosan particles##4##2##(1991-12#2)(1991-5#2)
zymosan with##3##2##(1994-6#1)(2008-12#2)
zymosan##31##1##(1990-4#6)(1991-12#2)(1991-2#1)(1991-5#3)(1991-9#1)(1992-1#2)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#1)(1994-11#1)(1994-3#2)(1994-6#3)(2004-12#1)(2005-9#1)(2008-12#3)
zymosan-activated serum##2##2##(1991-8#1)(2008-12#1)
zymosan-activated##3##1##(1991-8#1)(2008-10#1)(2008-12#1)
zymosan-induced peritonitis##2##2##(2008-12#2)
zymosan-induced##3##1##(1991-6#1)(2008-12#2)
{0##4##1##(2008-2#1)(2008-3#1)(2010-2#2)
{1 - exp[0##2##3##(2008-10#2)
{1##4##1##(2008-10#2)(2008-2#1)(2008-3#1)
{100}##5##1##(2007-5#2)(2009-2#1)(2013-1#2)
{104}##2##1##(2005-11#2)
{21-1}##2##1##(2005-11#2)
{Ru(NO)}(6)##4##1##(2008-5#4)
{[HC(3##6##1##(1996-2#6)
{[Ni(2)Cl(2)(bppz)(H(2)O)(2)(CH(3)OH)(2)]Cl(2)}(n)() (2)##2##2##(1997-7#2)
{precedes##2##1##(2006-10#2)
{where R = Ph##2##4##(2010-5#2)
{z(i)}##2##1##(2008-3#2)
|##3##1##(2007-12#1)(2010-12#1)(2012-2#1)
|Deltabeta|##2##1##(2008-3#2)
|beta|##3##1##(2008-8#3)
|j-z|##2##1##(2008-10#2)
|z|&lt##2##1##(2008-10#2)
|z|= 0##3##2##(2009-7#3)
~ 0##3##2##(2007-11#1)(2012-11#1)(2013-1#1)
~ 36 y/o)##2##3##(2011-2#2)
~##17##1##(1996-9#1)(2006-3#3)(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#1)(2008-4#1)(2010-2#1)(2011-2#4)(2012-11#1)(2013-1#1)
~0##55##1##(2007-11#4)(2007-12#24)(2008-2#18)(2008-3#4)(2010-4#4)(2012-12#1)
~1 cm##3##2##(2007-12#2)(2008-5#1)
~1 degrees##2##2##(2008-2#1)(2008-3#1)
~1 kHz##3##2##(2007-12#1)(2008-2#2)
~1##44##1##(2007-11#8)(2007-12#14)(2008-2#10)(2008-3#6)(2008-5#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
~1%##3##1##(2007-11#1)(2010-8#1)(2013-1#1)
~10 nm##3##2##(2007-11#2)(2008-1#1)
~10##13##1##(2007-11#2)(2007-12#3)(2008-1#1)(2008-2#3)(2008-3#3)(2012-12#1)
~10%##6##1##(2007-11#1)(2008-1#1)(2008-2#3)(2008-3#1)
~10(2)##2##1##(2007-12#2)
~10(5)##2##1##(2007-12#1)(2008-2#1)
~10-mum##2##1##(2007-12#2)
~100 MHz##3##2##(2007-11#1)(2007-12#2)
~100 nm##2##2##(2007-11#1)(2008-2#1)
~100 times##3##2##(2007-12#1)(2008-1#2)
~100##19##1##(2007-11#4)(2007-12#8)(2007-7#1)(2008-1#2)(2008-2#2)(2008-3#2)
~11##4##1##(2007-11#1)(2008-3#2)(2011-1#1)
~12##2##1##(2007-11#2)
~13##3##1##(2008-1#1)(2008-2#1)(2012-11#1)
~15##3##1##(2007-11#2)(2007-12#1)
~1mum##2##1##(2007-11#1)(2007-12#1)
~2 mm##2##2##(2008-1#1)(2008-2#1)
~2 mum##2##2##(2007-12#1)(2008-3#1)
~2##16##1##(2007-12#5)(2008-1#1)(2008-2#5)(2008-3#3)(2011-1#1)(2012-12#1)
~20##4##1##(2007-12#1)(2008-2#1)(2008-3#1)(2010-4#1)
~200##4##1##(2007-11#1)(2007-12#2)(2011-1#1)
~21##2##1##(2007-11#2)
~25%##2##1##(2008-1#1)(2008-2#1)
~250##2##1##(2008-3#1)(2012-2#1)
~3##8##1##(2007-11#2)(2007-12#1)(2008-3#5)
~30 dB##2##2##(2007-12#1)(2008-3#1)
~30 nm##4##2##(2007-11#1)(2008-2#1)(2009-2#1)(2011-1#1)
~30 ns##2##2##(2007-12#2)
~30##12##1##(2007-11#1)(2007-12#5)(2008-2#1)(2008-3#1)(2009-2#1)(2009-6#1)(2011-1#2)
~30%##2##1##(2009-10#1)(2012-3#1)
~33##2##1##(2007-11#1)(2008-2#1)
~35##2##1##(2007-12#1)(2009-8#1)
~4##9##1##(2007-11#3)(2007-12#1)(2008-2#2)(2008-7#1)(2011-1#1)(2012-12#1)
~4%##2##1##(2007-12#1)(2008-2#1)
~40##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
~400##4##1##(2007-12#1)(2008-2#1)(2008-3#1)(2013-8#1)
~42##2##1##(2008-2#1)(2011-2#1)
~5##12##1##(2007-11#1)(2007-12#4)(2008-2#3)(2008-3#2)(2008-5#1)(2011-1#1)
~5%##2##1##(2008-3#1)(2010-11#1)
~50 nm##2##2##(2008-2#2)
~50##8##1##(2007-12#2)(2008-2#2)(2008-3#3)(2009-5#1)
~50%##2##1##(2007-11#1)(2007-12#1)
~6##7##1##(2007-11#3)(2008-2#1)(2008-3#3)
~60##3##1##(2007-11#1)(2008-12#1)(2008-3#1)
~7##2##1##(2007-11#1)(2007-12#1)
~70##2##1##(2007-12#1)(2008-1#1)
~70%##3##1##(2007-11#1)(2008-11#1)(2011-1#1)
~860-nm output##2##2##(2008-1#1)(2008-2#1)
  Animals were##2##3##(2010-12#2)
  In##2##2##(2010-11#2)
  Paratuberculosis##2##2##(2010-12#2)
  The##2##2##(2010-12#2)
  Therefore##2##2##(2010-11#2)
  This##2##2##(2010-11#1)(2010-12#1)
  We##2##2##(2010-11#2)
 ##35##1##(2010-11#16)(2010-12#15)(2013-1#1)(2013-8#3)
 0##32##1##(2011-2#1)(2012-12#5)(2012-2#3)(2012-5#7)(2012-6#3)(2012-7#2)(2013-1#5)(2013-3#1)(2013-8#5)
 1##3##1##(2012-12#3)
 2##2##1##(2012-6#2)
 21##2##1##(2012-12#2)
 9##2##1##(2012-12#2)
 africana##2##1##(2012-5#2)
 alternifolia##2##1##(2012-8#2)
 aromatica rhizomes##2##2##(2012-11#2)
 aromatica##3##1##(2012-11#3)
 cereus##2##1##(2011-2#2)
 elegans##2##1##(2010-12#2)
 finmarchicus biomass##2##2##(2013-1#2)
 geophilum on##2##2##(2012-6#2)
 geophilum##8##1##(2012-6#8)
 graminearum##3##1##(2011-10#3)
 graminicola##3##1##(2011-10#3)
 hupehensis##3##1##(2011-10#3)
 ilex##2##1##(2011-10#2)
 jirovecii colonization##2##2##(2011-2#2)
 jirovecii##4##1##(2011-2#4)
 maculans##2##1##(2011-10#2)
 oceanica##2##1##(2013-1#2)
 petraea and Q##4##3##(2012-6#1)(2012-7#1)(2012-9#2)
 petraea with##2##2##(2012-5#2)
 petraea##14##1##(2012-5#6)(2012-6#3)(2012-7#2)(2012-9#3)
 petraea)##2##1##(2012-5#2)
 pubescens had##2##2##(2012-6#1)(2012-9#1)
 pubescens##10##1##(2012-5#2)(2012-6#6)(2012-7#1)(2012-9#1)
 pubescens)##5##1##(2012-5#1)(2012-6#2)(2012-7#1)(2012-9#1)
 rhamnoides and##2##2##(2012-8#2)
 robur and Q##5##3##(2012-5#4)(2012-6#1)
 robur than##2##2##(2012-5#1)(2012-7#1)
 robur##13##1##(2012-5#7)(2012-6#2)(2012-7#2)(2012-9#2)
 sylvestris##2##1##(2011-10#2)
© 2010 American Institute of Chemical Engineers Biotechnol##16##8##(2011-2#16)
© 2010 International Society for Advancement of Cytometry##10##8##(2011-2#10)
© 2010 Wiley Periodicals##5##4##(2011-2#5)
© 2010 Wiley-Liss##27##3##(2010-12#1)(2011-2#26)
© 2010##82##2##(2010-12#1)(2011-1#2)(2011-2#73)(2012-2#6)
© 2011 American Cancer Society##2##5##(2012-3#2)
© 2011 American Institute of Chemical Engineers Biotechnol##7##8##(2011-2#6)(2012-2#1)
© 2011 American##9##3##(2011-2#6)(2012-2#1)(2012-3#2)
© 2011 IUBMB IUBMB Life##2##5##(2012-3#2)
© 2011 John Wiley &amp##14##5##(2011-2#1)(2012-1#6)(2012-2#5)(2012-3#2)
© 2011 Wiley Periodicals##3##4##(2012-2#1)(2012-3#2)
© 2011 Wiley-Liss##3##3##(2011-2#2)(2012-1#1)
© 2011##33##2##(2011-2#9)(2012-1#9)(2012-2#7)(2012-3#8)
© 2012 Society of Chemical Industry##2##6##(2012-12#1)(2013-1#1)
© 2012##23##2##(2012-12#1)(2012-2#2)(2012-3#1)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#3)(2012-8#2)(2013-1#11)
©##138##1##(2010-12#1)(2011-1#2)(2011-2#82)(2012-1#9)(2012-12#1)(2012-2#15)(2012-3#9)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#3)(2012-8#2)(2013-1#11)
°C and##7##2##(2011-2#6)(2013-8#1)
°C for 1##3##3##(2011-12#1)(2012-11#2)
°C for##4##2##(2011-12#2)(2012-11#2)
°C to##7##2##(2011-12#4)(2011-2#2)(2012-12#1)
°C##40##1##(2009-3#1)(2010-12#2)(2011-1#4)(2011-12#13)(2011-2#13)(2012-11#3)(2012-12#2)(2012-2#1)(2013-8#1)
°C)##9##1##(2010-2#1)(2011-12#3)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
± 0##129##2##(2010-10#13)(2010-11#6)(2010-12#4)(2010-9#5)(2011-1#9)(2011-12#1)(2011-2#15)(2012-1#3)(2012-11#3)(2012-12#20)(2012-3#8)(2013-1#26)(2013-7#7)(2013-8#9)
± 1 °C##3##3##(2011-12#1)(2011-2#2)
± 1##39##2##(2010-9#3)(2011-12#6)(2011-2#10)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#8)
± 10##11##2##(2010-12#2)(2011-1#2)(2011-2#2)(2013-1#5)
± 11##11##2##(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#3)
± 12##7##2##(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
± 13##2##2##(2013-1#1)(2013-8#1)
± 14##7##2##(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
± 15##3##2##(2013-1#2)(2013-8#1)
± 17##4##2##(2011-2#1)(2013-1#3)
± 18##4##2##(2011-2#2)(2012-3#2)
± 19##2##2##(2011-2#1)(2013-8#1)
± 2##22##2##(2010-11#1)(2011-1#5)(2011-11#1)(2011-12#1)(2011-2#4)(2012-3#2)(2013-1#2)(2013-8#6)
± 20##4##2##(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
± 22##2##2##(2012-12#1)(2013-1#1)
± 27##2##2##(2013-1#1)(2013-8#1)
± 3##18##2##(2010-12#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-3#2)(2013-1#3)(2013-8#4)
± 3%##2##2##(2013-1#2)
± 36##2##2##(2011-2#1)(2012-12#1)
± 38##2##2##(2010-12#1)(2011-1#1)
± 4##25##2##(2010-11#3)(2010-12#1)(2010-9#1)(2011-1#2)(2011-11#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#6)
± 5##13##2##(2010-10#2)(2011-1#3)(2011-11#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
± 5%##2##2##(2011-12#1)(2013-1#1)
± 56##2##2##(2013-1#1)(2013-8#1)
± 6##7##2##(2010-9#1)(2011-1#1)(2013-1#4)(2013-8#1)
± 7##6##2##(2011-2#1)(2013-1#3)(2013-8#2)
± 8##10##2##(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#3)
± 9##9##2##(2011-2#1)(2012-3#3)(2013-1#5)
± SD##9##2##(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#2)
± standard deviation##5##3##(2012-12#1)(2012-2#2)(2013-1#2)
± standard##7##2##(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
±##412##1##(2007-9#1)(2010-10#15)(2010-11#10)(2010-12#10)(2010-9#11)(2011-1#35)(2011-11#4)(2011-12#10)(2011-2#62)(2012-1#5)(2012-11#4)(2012-12#31)(2012-2#7)(2012-3#30)(2013-1#105)(2013-7#8)(2013-8#64)
±0##3##1##(2011-1#1)(2011-11#1)(2012-12#1)
±1##3##1##(2012-1#1)(2013-1#2)
±3##2##1##(2011-11#2)
²⁺##4##1##(2013-1#4)
µ(E)##5##1##(2012-2#5)
µ/kg ± 2##3##3##(2013-8#3)
µ/kg ±##6##2##(2013-8#6)
µ/kg##10##1##(2013-8#10)
µ/kg)##2##1##(2013-8#2)
µM##7##1##(2011-2#3)(2012-12#2)(2012-2#1)(2013-7#1)
µSBS##5##1##(2013-1#5)
µg/##2##1##(2011-2#2)
µg/L##6##1##(2011-1#2)(2011-2#3)(2013-1#1)
µg/d)##2##1##(2013-1#2)
µg/dl##2##1##(2013-1#2)
µg/g)##2##1##(2011-1#2)
µg/mL##5##1##(2011-1#4)(2011-2#1)
µg/mL)##3##1##(2011-2#3)
µg/ml and##4##2##(2010-12#1)(2011-2#3)
µg/ml##17##1##(2010-10#1)(2010-12#4)(2011-2#7)(2012-2#5)
µg/ml)##3##1##(2011-1#1)(2012-12#1)(2012-2#1)
µm column##2##2##(2010-12#2)
µm median##2##2##(2013-1#2)
µm##10##1##(2010-12#2)(2011-1#3)(2011-2#1)(2013-1#4)
µm)##7##1##(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#3)(2013-1#1)
µmol/L)##2##1##(2011-2#1)(2012-2#1)
µmol/l])##2##1##(2012-2#2)
·##3##1##(2011-1#3)
Â##3##1##(2010-12#3)
Å (average = 2##2##4##(1996-2#2)
Å and##3##2##(1996-2#2)(2011-1#1)
Å at##3##2##(1996-2#3)
Å resolution crystal structure of##2##5##(2011-1#2)
Å resolution##9##2##(2007-5#1)(2011-1#6)(2012-2#1)(2012-3#1)
Å##206##1##(1996-2#130)(1996-5#3)(1997-7#56)(2007-5#1)(2009-11#1)(2011-1#10)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
Å(3)##25##1##(1996-2#20)(1997-7#5)
Å)##5##1##(1996-2#3)(1997-7#1)(2010-12#1)
Î-terpineol##2##1##(2010-12#2)
× 10##3##2##(2011-2#1)(2013-8#2)
× 10(-4)##4##2##(2010-12#1)(2011-2#1)(2013-1#2)
× 10(-7))##2##2##(2012-3#2)
× 10(3)##4##2##(2011-1#1)(2011-12#1)(2013-1#1)(2013-7#1)
× 10(6) cells##2##3##(2011-2#2)
× 10(6)##4##2##(2011-1#1)(2011-2#2)(2012-12#1)
× 10(8)##2##2##(2012-2#2)
× 10(9)##2##2##(2012-2#2)
× 10³##3##2##(2013-1#3)
× 10⁴##3##2##(2013-1#3)
× 10⁵##2##2##(2013-1#2)
× 11##2##2##(2011-2#1)(2013-7#1)
× 3 mm##2##3##(2010-11#1)(2012-12#1)
× 3##5##2##(2010-11#1)(2010-12#1)(2012-1#2)(2012-12#1)
× 4##9##2##(2010-12#1)(2011-1#1)(2012-12#3)(2013-1#2)(2013-7#2)
×##88##1##(2010-11#2)(2010-12#5)(2010-9#1)(2011-1#9)(2011-12#3)(2011-2#6)(2012-1#2)(2012-11#5)(2012-12#11)(2012-2#7)(2012-3#5)(2013-1#15)(2013-7#9)(2013-8#8)
ß-cell function##2##2##(2011-2#2)
ß-cell##3##1##(2011-2#3)
ß-cells##2##1##(2010-11#2)
à des##4##2##(2012-2#3)(2013-1#1)
à l'âge adulte##2##3##(2008-11#1)(2011-2#1)
à la nicotine##3##3##(2013-1#3)
à la##10##2##(2011-2#2)(2012-2#3)(2013-1#5)
à un##5##2##(2008-11#1)(2012-2#3)(2013-1#1)
à une##8##2##(2011-2#1)(2012-2#3)(2013-1#4)
à##68##1##(1996-11#1)(2008-11#4)(2008-2#1)(2008-3#3)(2008-5#2)(2009-4#2)(2011-2#9)(2012-1#1)(2012-2#18)(2013-1#27)
â##2##1##(2008-3#1)(2010-12#1)
âgé de##2##2##(2012-2#1)(2013-1#1)
âgé##4##1##(2012-2#1)(2013-1#3)
å##5##1##(2007-11#4)(2008-10#1)
échelette##2##1##(2007-12#2)
échographique a##2##2##(2012-2#2)
échographique##4##1##(2012-2#4)
économique##2##1##(2009-10#1)(2012-2#1)
également##2##1##(2012-2#1)(2013-1#1)
étaient##5##1##(2009-4#1)(2011-2#1)(2012-2#2)(2013-1#1)
était##6##1##(2011-2#3)(2012-2#1)(2013-1#2)
étude rétrospective##2##2##(2013-1#2)
étude##4##1##(2011-2#1)(2013-1#3)
été##25##1##(2011-2#3)(2012-2#11)(2013-1#11)
évoluant##2##1##(2012-2#2)
évolution##2##1##(2012-2#1)(2013-1#1)
évoluées##2##1##(2011-2#2)
évoquer##2##1##(2012-2#1)(2013-1#1)
évoqué##3##1##(2012-2#1)(2013-1#2)
être##13##1##(2011-2#1)(2012-2#9)(2013-1#3)
ó##4##1##(2007-11#1)(2012-2#3)
øg1e##5##1##(1997-1#5)
ďun##2##1##(2013-1#2)
ɛ##6##1##(2011-1#3)(2013-1#3)
ɳ(2)=0##4##1##(2013-8#4)
Δ(9)-tetrahydrocannabinol##2##1##(2013-1#2)
ΔE##2##1##(2013-1#2)
ΔK##2##1##(2012-1#2)
ΔluxS strain##2##2##(2010-12#2)
ΔluxS##3##1##(2010-12#3)
Σ(2) (m)##2##2##(2013-1#2)
Φ6 phage##2##2##(2013-1#2)
Φ6##3##1##(2013-1#3)
Ψ(PD)##3##1##(2012-7#3)
α and##4##2##(2012-1#1)(2012-12#2)(2012-2#1)
α##34##1##(2008-12#2)(2009-10#2)(2009-11#2)(2010-11#4)(2010-12#5)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#6)
α(4)β(2)##2##1##(2011-2#2)
α) and##3##2##(2011-1#1)(2012-3#1)(2013-1#1)
α+β-protein##2##1##(2008-9#2)
α- and##3##2##(2011-10#1)(2011-2#1)(2012-2#1)
α-2a##3##1##(2011-12#1)(2012-2#2)
α-B##2##1##(2012-2#2)
α-Fetoprotein##2##1##(2012-1#2)
α-Stx2##2##1##(2011-2#2)
α-actin##2##1##(2011-2#1)(2013-7#1)
α-amylase##5##1##(2010-12#1)(2011-2#1)(2013-8#3)
α-cell##2##1##(2010-11#2)
α-fetoprotein##2##1##(2012-1#2)
α-glucosidase activity in##3##3##(2010-11#3)
α-glucosidase##7##1##(2010-11#7)
α-helical##5##1##(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#2)
α-helix##3##1##(2010-10#1)(2011-1#2)
α-lactalbumin##3##1##(2012-2#3)
α-smooth muscle actin (α-SMA)##2##4##(2011-1#1)(2012-2#1)
α-smooth muscle actin##3##3##(2011-1#1)(2012-1#1)(2012-2#1)
α-subunit of##2##2##(2011-2#1)(2012-12#1)
α-subunit##4##1##(2011-2#1)(2012-1#1)(2012-12#2)
α-synuclein in##4##2##(2012-1#4)
α-synuclein level##3##2##(2012-1#3)
α-synuclein##13##1##(2012-1#12)(2012-2#1)
α-tocopherol##10##1##(2011-12#7)(2012-1#1)(2012-2#1)(2013-1#1)
α1-antitrypsin##2##1##(2012-1#1)(2012-3#1)
α2A##7##1##(2011-1#7)
α7 nAChR agonists##3##3##(2011-1#3)
α7 nAChRs##4##2##(2011-1#4)
α7 nicotinic##2##2##(2011-1#1)(2012-1#1)
α7##10##1##(2011-1#9)(2012-1#1)
α=0##3##1##(2011-2#1)(2012-12#1)(2013-1#1)
αNAC and βNAC##2##3##(2011-1#2)
αNAC##5##1##(2011-1#5)
αv##4##1##(2012-12#4)
αvβ3 was strongly expressed in some invasive NSCLC cohorts##2##9##(2012-12#2)
αvβ3##8##1##(2012-12#8)
αvβ5 (EM09902)##2##2##(2012-12#2)
αvβ6 (EM05201)##2##2##(2012-12#2)
αvβ6 and αvβ8##4##3##(2012-12#4)
αvβ6##8##1##(2012-12#8)
αvβ8 (EM13309)##2##2##(2012-12#2)
αvβ8 was rarely expressed in human tumor specimens##2##8##(2012-12#2)
αvβ8##12##1##(2012-12#12)
β =##2##2##(2012-12#1)(2013-1#1)
β III tubulin overexpression##2##4##(2011-12#2)
β and##2##2##(2013-1#2)
β cell##3##2##(2013-7#2)(2013-8#1)
β cells##6##2##(2010-11#1)(2011-1#2)(2011-2#1)(2013-7#2)
β##34##1##(2010-11#2)(2010-12#1)(2011-1#4)(2011-12#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#13)(2013-7#5)(2013-8#2)
β(1)-##2##1##(2010-12#2)
β(2)-##2##1##(2010-12#2)
β(2)-AR gene##2##2##(2009-9#2)
β(2)-AR##4##1##(2009-9#4)
β-##4##1##(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
β-1##3##1##(2010-12#2)(2011-2#1)
β-1a##4##1##(2013-8#4)
β-B##3##1##(2012-2#3)
β-acetyldigoxin##3##1##(2012-1#3)
β-actin mRNA##4##2##(2012-2#4)
β-actin##6##1##(2012-2#4)(2012-3#2)
β-adrenergic receptor##2##2##(2011-2#2)
β-adrenergic##3##1##(2011-2#2)(2012-12#1)
β-amyloid##2##1##(2013-1#2)
β-blocker therapy##2##2##(2009-9#1)(2011-2#1)
β-blocker##4##1##(2009-9#2)(2011-2#2)
β-carotene##3##1##(2011-1#1)(2013-8#2)
β-casein##3##1##(2012-2#3)
β-catenin in##3##2##(2012-2#1)(2013-1#2)
β-catenin is##2##2##(2012-2#2)
β-catenin##15##1##(2012-2#6)(2013-1#9)
β-cell K(ATP) channel openers##2##4##(2013-1#2)
β-cell damage##2##2##(2010-11#2)
β-cell destruction##2##2##(2010-11#2)
β-cell differentiation##2##2##(2012-12#2)
β-cell function##7##2##(2010-10#2)(2010-11#1)(2012-2#4)
β-cell line##2##2##(2010-11#1)(2012-2#1)
β-cell mass##7##2##(2010-11#5)(2012-12#2)
β-cell proliferation##5##2##(2010-11#5)
β-cell regeneration##3##2##(2010-11#3)
β-cell replication##2##2##(2010-11#2)
β-cell##51##1##(2010-10#5)(2010-11#32)(2012-12#5)(2012-2#6)(2013-1#2)(2013-7#1)
β-cells against apoptosis##3##3##(2010-11#3)
β-cells and##2##2##(2010-11#1)(2012-12#1)
β-cells in the##2##3##(2010-10#1)(2010-12#1)
β-cells in##3##2##(2010-10#1)(2010-12#2)
β-cells of##2##2##(2010-11#1)(2010-12#1)
β-cells or##2##2##(2010-11#2)
β-cells to##2##2##(2010-11#2)
β-cells##41##1##(2010-10#1)(2010-11#32)(2010-12#3)(2012-12#4)(2013-8#1)
β-cyclodextrin##9##1##(2010-12#4)(2011-2#3)(2013-1#2)
β-galactosidase##4##1##(2009-12#1)(2011-1#1)(2012-11#1)(2012-12#1)
β-globin##3##1##(2011-2#1)(2013-1#2)
β-glucosidase activity##2##2##(2013-7#2)
β-glucosidase##5##1##(2011-1#2)(2013-7#3)
β-glucosidases##2##1##(2011-1#2)
β-glucuronidase##2##1##(2010-12#1)(2012-2#1)
β-glycosidase##3##1##(2011-1#1)(2011-12#2)
β-lactam antibiotics##2##2##(2011-1#1)(2013-1#1)
β-lactam##6##1##(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#2)
β-lactamase##2##1##(2011-2#2)
β-lactamase-producing Escherichia coli and##2##4##(2011-2#1)(2013-8#1)
β-lactamases##2##1##(2012-2#1)(2013-8#1)
β-secretase and##2##2##(2012-12#1)(2012-3#1)
β-sheet nanocrystals##2##2##(2012-2#2)
β-sheet##8##1##(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#5)
β-thalassaemia mutations in##2##3##(2010-12#2)
β-thalassaemia##4##1##(2010-12#4)
β-tropomyosin##2##1##(2010-12#2)
β-turns##2##1##(2011-2#1)(2012-2#1)
β-unsaturated ketones##2##2##(2009-10#1)(2011-2#1)
β-unsaturated nitrone-aryne [3+2] cycloaddition##2##4##(2009-11#2)
β-unsaturated##4##1##(2009-10#1)(2009-11#2)(2011-2#1)
β1##3##1##(2012-1#1)(2012-12#2)
β1-integrin##5##1##(2010-11#2)(2012-2#3)
β2##3##1##(2013-1#3)
β4 expression##2##2##(2012-12#2)
β4##4##1##(2012-12#4)
β4-regulated mRNAs##2##2##(2012-12#2)
β4-regulated##3##1##(2012-12#3)
βNAC##3##1##(2011-1#3)
βPS integrin##2##2##(2012-12#2)
γ subunit##2##2##(2010-12#1)(2013-8#1)
γ##15##1##(2010-12#7)(2011-1#1)(2012-2#1)(2013-1#5)(2013-8#1)
γ-PGA##4##1##(2012-11#4)
γ-PGA's free carboxyl side groups allow for simple chemical functionalization##2##10##(2012-11#2)
γ-PGA-Bn scaffolds cultured in osteogenic media were also efficient in supporting hMSCs differentiation towards an osteogenic lineage as determined by alkaline phosphatase and Runx2 gene expression##2##26##(2012-11#2)
γ-PGA-Bn scaffolds##6##2##(2012-11#6)
γ-PGA-Bn showed##4##2##(2012-11#4)
γ-PGA-Bn##10##1##(2012-11#10)
γ-TuRC function##4##2##(2012-12#4)
γ-TuRC##10##1##(2012-12#10)
γ-aminobutyric acid aminotransferase##2##3##(2013-1#2)
γ-aminobutyric acid##6##2##(2012-12#2)(2012-2#2)(2013-1#2)
γ-casein##2##1##(2012-2#2)
γ-globulin fraction proteins##4##3##(2012-1#4)
γ-globulin##8##1##(2012-1#8)
γ-globulin-copper##2##1##(2012-1#2)
γ-glutamyl##2##1##(2011-2#1)(2012-12#1)
γ-radiation##4##1##(2011-2#1)(2013-1#3)
γ-ray##5##1##(2012-2#1)(2013-1#4)
γ-secretase cleavage of APP##2##4##(2012-12#2)
γ-secretase cleavage of##3##3##(2012-12#3)
γ-secretase inhibitor##2##2##(2012-12#2)
γ-secretase##9##1##(2012-12#9)
γ-tubulin to##6##2##(2012-12#6)
γ-tubulin##10##1##(2012-12#10)
γ2 chain##3##2##(2013-8#3)
γ2##4##1##(2010-10#1)(2013-8#3)
δ##4##1##(2010-11#1)(2011-1#1)(2012-11#1)(2012-2#1)
δ(1)- and##2##2##(2010-12#2)
δ(13)C value##3##2##(2012-2#3)
δ(13)C values of##2##3##(2012-2#2)
δ(13)C##5##1##(2012-2#5)
δ(15)N discrimination values##2##3##(2013-1#2)
δ(15)N##3##1##(2013-1#3)
δ₂-opioid receptor agonist deltorphin II##2##5##(2010-12#2)
δ₂-opioid receptor##3##2##(2010-12#3)
δ₂-opioid##4##1##(2010-12#4)
ε##2##1##(2010-12#1)(2013-8#1)
ε-supervenience##2##1##(2012-2#2)
εS278del##3##1##(2013-1#3)
η##3##1##(2007-12#1)(2010-12#1)(2013-7#1)
ι##5##1##(2012-12#2)(2013-1#3)
κ-opioid receptor##2##2##(2009-2#1)(2010-12#1)
λ(max)##3##1##(2011-1#1)(2012-2#2)
μ##5##1##(2013-8#5)
μ-opioid receptor##3##2##(2010-12#1)(2011-1#1)(2012-1#1)
μ-opioid receptors##2##2##(2012-1#2)
μ-opioid##7##1##(2010-12#1)(2011-1#3)(2012-1#3)
μL##2##1##(2010-11#1)(2013-8#1)
μM deltamethrin##2##2##(2013-1#2)
μM##11##1##(2010-11#3)(2012-11#2)(2012-2#1)(2013-1#5)
μM)##9##1##(2010-11#2)(2012-11#3)(2012-12#2)(2013-1#1)(2013-7#1)
μg Se/g##2##2##(2012-2#2)
μg bid##3##2##(2012-3#3)
μg mL(-1)##3##2##(2012-12#2)(2013-7#1)
μg##12##1##(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#1)(2013-7#1)
μg/ plate for##2##3##(2011-2#2)
μg/ plate)##3##2##(2011-2#3)
μg/##5##1##(2011-2#5)
μg/L##4##1##(2008-8#1)(2011-1#3)
μg/kg BW of##4##3##(2013-1#4)
μg/kg BW##5##2##(2010-4#1)(2013-1#4)
μg/kg##11##1##(2010-12#2)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#4)(2013-8#2)
μg/kg) to##2##2##(2011-1#1)(2012-1#1)
μg/kg)##3##1##(2011-1#1)(2012-1#1)(2012-2#1)
μg/mL##5##1##(2012-11#1)(2012-3#2)(2013-8#2)
μg/mL)##5##1##(2011-1#2)(2011-2#2)(2012-3#1)
μg/ml##8##1##(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#2)(2012-12#1)
μg/ml)##2##1##(2011-1#2)
μg/μl##3##1##(2012-1#3)
μg·l-1##3##1##(2013-1#3)
μl##2##1##(2011-2#1)(2012-12#1)
μm and##4##2##(2011-2#1)(2012-11#2)(2013-7#1)
μm based on##3##3##(2010-10#3)
μm in##2##2##(2013-1#1)(2013-7#1)
μm square pixels with 12 bit depth##2##7##(2011-1#2)
μm to 6##2##3##(2010-10#2)
μm to##4##2##(2010-10#4)
μm ×##3##2##(2012-2#1)(2013-7#2)
μm##51##1##(2008-12#5)(2009-12#1)(2009-6#1)(2010-10#8)(2011-1#6)(2011-2#3)(2012-11#10)(2012-12#2)(2012-2#2)(2013-1#5)(2013-7#7)(2013-8#1)
μm(2)##2##1##(2013-1#2)
μm)##8##1##(2008-12#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-7#2)
μmol/L##4##1##(2012-2#4)
π##4##1##(2010-11#1)(2010-12#1)(2012-3#1)(2013-1#1)
π-cations##2##1##(2009-5#2)
χ(2) =##6##2##(2010-10#1)(2011-1#5)
χ(2) rates between Aini and##2##5##(2011-1#2)
χ(2) rates##3##2##(2011-1#3)
χ(2)##13##1##(2007-12#1)(2010-10#1)(2011-1#9)(2013-1#2)
χ2##4##1##(2011-2#2)(2012-12#1)(2012-2#1)
ω3##3##1##(2010-10#1)(2011-2#1)(2013-1#1)
ϕ1402##3##1##(2011-12#3)
ϕTMA and ϕYS40##2##3##(2011-12#2)
ϕTMA##8##1##(2011-12#8)
ϕYS40##4##1##(2011-12#4)
  A cross-sectional##2##3##(2010-10#1)(2012-2#1)
  A descriptive##2##3##(2013-1#2)
  A survey was conducted to obtain feedback from registered nurses as end-users of standardized nursing terminology for care planning in an electronic health record##2##25##(2013-1#2)
  A total of 35##2##5##(2012-2#2)
  A total of##3##4##(2012-2#2)(2013-1#1)
  A##16##2##(2010-10#4)(2011-2#3)(2012-2#4)(2013-1#5)
  Acute pain occurs in over 50% of hospitalized children##2##10##(2013-1#2)
  All##3##2##(2011-2#2)(2012-12#1)
  An##2##2##(2010-10#1)(2013-1#1)
  Data were obtained through the author's clinical practice in emergency nursing and literature sources##2##15##(2013-1#2)
  Data were##3##3##(2012-12#1)(2013-1#2)
  Data##4##2##(2011-2#1)(2012-12#1)(2013-1#2)
  Despite the increasing demands for reliable nursing data as a basis for measuring nursing effects on nursing outcomes and safety##2##21##(2013-1#2)
  Despite the##3##3##(2010-10#1)(2013-1#2)
  Diagnosis of acute pain increased in the postimplementation period##2##10##(2013-1#2)
  Genetic##2##2##(2012-12#1)(2013-1#1)
  Given the centrality of CS to interpreting research findings and applying them to practice##2##15##(2013-1#2)
  Hepatitis B virus (HBV)##2##5##(2013-1#2)
  Hepatitis B##3##3##(2013-1#3)
  In the postimplementation##2##4##(2013-1#2)
  In this##3##3##(2011-2#1)(2012-12#1)(2012-2#1)
  In total##2##3##(2010-10#1)(2013-1#1)
  In##10##2##(2010-10#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)
  It is##2##3##(2010-10#1)(2011-2#1)
  It##4##2##(2010-10#2)(2011-2#1)(2013-1#1)
  NANDA International Classification##2##4##(2013-1#2)
  Nurses reported a more positive agreement with the changes at 6 months compared with baseline##2##16##(2013-1#2)
  Of##3##2##(2012-12#2)(2012-2#1)
  One##2##2##(2010-10#2)
  Oral##2##2##(2012-2#2)
  Our results##2##3##(2010-10#1)(2011-2#1)
  Our##4##2##(2010-10#1)(2011-2#2)(2012-2#1)
  Overall##4##2##(2012-12#1)(2013-1#3)
  Patients##3##2##(2010-10#1)(2011-2#1)(2012-12#1)
  Qualitative##3##2##(2010-10#3)
  Serum##2##2##(2012-12#1)(2013-1#1)
  Significant##2##2##(2010-10#1)(2012-2#1)
  Staying in the stream of life##2##7##(2010-10#2)
  Survey##2##2##(2010-10#1)(2011-2#1)
  The C1q-deficient SLE##2##4##(2011-2#2)
  The aim of the present study was to investigate##2##10##(2010-10#1)(2012-2#1)
  The aim of the present study was to##4##9##(2010-10#2)(2012-2#2)
  The aim of the study was to##2##8##(2010-10#2)
  The aim of the##6##5##(2010-10#4)(2012-2#2)
  The aim of this study was to##2##8##(2010-10#1)(2012-2#1)
  The aim of this##3##5##(2010-10#2)(2012-2#1)
  The aim of##9##4##(2010-10#6)(2012-2#3)
  The current literature and research studies##2##7##(2013-1#2)
  The current##3##3##(2011-2#1)(2013-1#2)
  The development of strategies for improvement of diagnostic accuracy is warranted##2##12##(2013-1#2)
  The disparate uses of CS negatively impact standardizing and quantifying research outcomes to discern EBPs##2##16##(2013-1#2)
  The focus of this study##2##6##(2010-10#1)(2012-2#1)
  The incidence##2##3##(2012-2#2)
  The introduction of nonvalidated instruments in Italian hospitals needs to be restricted because of the short- and long-term negative effects these nonvalidated instruments may have##2##26##(2013-1#2)
  The main##2##3##(2010-10#1)(2012-2#1)
  The most immediate and tangible advantages to a common conceptual definition and meaning of CS terminologies by nursing##2##19##(2013-1#2)
  The most##3##3##(2012-12#1)(2013-1#2)
  The patient plan of care in the electronic record is expected to offer nurses the ability to communicate the needs of the patient and assess outcomes of care##2##29##(2013-1#2)
  The purpose of this study was to describe the implementation strategies of measurement instruments and their validity as adopted in Italian hospital nursing practice##2##25##(2013-1#2)
  The purpose of this study was to##3##8##(2012-11#1)(2013-1#2)
  The purpose of this study##4##6##(2011-2#1)(2012-11#1)(2013-1#2)
  The purpose##5##3##(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#2)
  The results show that##2##5##(2010-10#2)
  The results##3##3##(2010-10#3)
  The sample was divided into##2##6##(2013-1#2)
  The sample##3##3##(2013-1#3)
  The scale##2##3##(2012-11#1)(2013-1#1)
  The study aims to##2##5##(2013-1#2)
  The study##6##3##(2010-10#1)(2012-2#2)(2013-1#3)
  The survey was conducted pre-##2##6##(2013-1#2)
  The##83##2##(2010-10#22)(2011-2#8)(2012-11#4)(2012-12#4)(2012-2#19)(2013-1#26)
  There##2##2##(2011-2#2)
  This case study focused on the emergency nursing care of a 32-year-old female##2##14##(2013-1#2)
  This case study provides emergency nurses and students with the pertinent nursing diagnoses##2##14##(2013-1#2)
  This case study##4##4##(2013-1#4)
  This paper analyzes the concept of clinical significance (CS) in relation to evidence-based practice (EBP)##2##16##(2013-1#2)
  This paper##5##3##(2010-10#2)(2010-9#1)(2013-1#2)
  This study##6##3##(2010-10#1)(2011-2#1)(2012-2#3)(2013-1#1)
  This##22##2##(2010-10#5)(2010-9#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#4)(2013-1#7)
  Three##2##2##(2010-10#2)
  To assess##3##3##(2011-2#1)(2012-12#1)(2012-2#1)
  To determine##3##3##(2010-10#1)(2011-2#1)(2012-2#1)
  To develop##2##3##(2012-2#2)
  To explore##2##3##(2010-10#1)(2012-12#1)
  To##19##2##(2010-10#4)(2011-2#5)(2012-11#1)(2012-12#4)(2012-2#4)(2013-1#1)
  Two##2##2##(2010-10#1)(2013-1#1)
  We analyzed##2##3##(2011-2#1)(2012-11#1)
  We##5##2##(2011-2#4)(2012-11#1)
  While##3##2##(2010-10#1)(2012-12#1)(2012-2#1)
  Within##2##2##(2012-12#1)(2012-2#1)
 ##333##1##(2010-10#83)(2010-9#1)(2011-2#70)(2012-11#8)(2012-12#31)(2012-2#66)(2013-1#74)
 P &lt##2##1##(2012-1#2)
 The##3##1##(2012-3#3)
 To##3##1##(2012-1#1)(2012-3#2)
  formosa##3##2##(2013-1#3)
 0##75##1##(2010-12#1)(2011-1#6)(2011-2#9)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#26)(2013-1#26)
 50)##2##1##(2012-2#2)
 A systematic review of the##2##5##(2012-12#2)
 A systematic review was undertaken for articles published up to October 2011##3##12##(2012-12#3)
 A systematic review##5##3##(2012-12#5)
 A systematic search##2##3##(2012-12#2)
 A systematic##7##2##(2012-12#7)
 A##16##1##(2012-11#1)(2012-12#14)(2013-1#1)
 Although##2##1##(2012-11#1)(2012-12#1)
 Articles published##2##2##(2012-12#2)
 From##5##1##(2012-12#5)
 In##2##1##(2012-12#2)
 Most##2##1##(2012-12#2)
 Our##2##1##(2012-1#1)(2012-12#1)
 Retrospective##6##1##(2012-12#6)
 Systematic review##8##2##(2012-12#8)
 Systematic##9##1##(2012-12#9)
 The overall strength of evidence evaluating the diagnostic characteristics was low due to inconsistent findings between studies and uncertainty of the impact of false-negatives##2##24##(2012-12#2)
 The##12##1##(2012-1#2)(2012-12#10)
 There is##2##2##(2012-12#2)
 There##3##1##(2012-12#3)
 To describe##2##2##(2012-12#2)
 To determine##2##2##(2012-12#2)
 To report##2##2##(2012-12#2)
 To##11##1##(2012-12#11)
 Two##4##1##(2012-12#4)
 What##3##1##(2012-12#3)
 spores/m(3)##2##1##(2011-1#2)
 ##4##1##(2012-2#1)(2013-1#3)
 0##42##1##(2010-11#9)(2010-8#2)(2011-12#4)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#12)(2013-7#6)
 1##3##1##(2010-11#1)(2013-1#2)
 100 fL)##2##1##(2013-1#2)
 60 mL/min/1##2##1##(2013-1#2)
–##3##1##(2011-2#1)(2013-1#1)(2013-8#1)
• The##2##2##(2011-2#1)(2012-12#1)
•##14##1##(2011-2#2)(2012-11#2)(2012-12#5)(2013-8#5)
•  An exploration of the##2##5##(2011-2#2)
•  An##3##2##(2011-2#3)
•  Mental health##3##3##(2011-2#3)
•  The##4##2##(2011-2#4)
• ##32##1##(2011-2#32)
••-••##2##1##(2012-12#2)
 Conclusion##2##1##(2013-7#2)
 Methods##2##1##(2013-7#2)
 Results##3##1##(2013-7#3)
₅##2##1##(2010-12#2)
∓ 9##2##2##(2011-2#2)
∓##5##1##(2011-2#5)
∗##2##1##(2013-1#1)(2013-8#1)
∞)##2##1##(2012-12#1)(2013-8#1)
∼##2##1##(2011-1#1)(2012-2#1)
∼10##3##1##(2008-12#1)(2011-2#2)
∼100##2##1##(2011-2#1)(2012-2#1)
∼15 degrees##2##2##(2012-12#2)
∼25%##2##1##(2012-3#1)(2013-8#1)
∼30##3##1##(2011-2#2)(2012-1#1)
∼30%##2##1##(2011-2#1)(2013-1#1)
∼4##3##1##(2011-2#1)(2012-2#1)(2012-3#1)
∼40%##2##1##(2011-1#1)(2012-2#1)
≈##3##1##(2012-2#1)(2013-1#2)
≤ 0##9##2##(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#3)
≤##14##1##(2010-12#3)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#3)
≤1##2##1##(2012-2#1)(2013-1#1)
≤10##2##1##(2011-12#1)(2012-2#1)
≤4##2##1##(2012-12#1)(2013-1#1)
≥ 0##5##2##(2012-12#1)(2013-1#2)(2013-8#2)
≥ 1##5##2##(2011-1#2)(2012-12#2)(2013-1#1)
≥ 4##2##2##(2011-1#1)(2012-12#1)
≥ 5##2##2##(2012-1#1)(2012-12#1)
≥ 65##2##2##(2010-4#1)(2013-1#1)
≥ 8##4##2##(2010-12#3)(2013-1#1)
≥ 9##3##2##(2010-12#1)(2013-1#2)
≥##47##1##(2010-12#8)(2010-4#1)(2011-1#5)(2011-2#3)(2012-1#2)(2012-12#8)(2012-3#4)(2013-1#14)(2013-8#2)
≥0##3##1##(2010-11#2)(2013-1#1)
≥1##4##1##(2011-1#1)(2011-2#1)(2013-1#2)
≥10##2##1##(2013-1#1)(2013-7#1)
≥2##4##1##(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
≥20##2##1##(2013-1#2)
≥3##7##1##(2011-1#1)(2011-11#1)(2011-2#2)(2013-1#3)
≥5##2##1##(2013-1#2)
≥50%##3##1##(2011-1#3)
≥65 years##2##2##(2012-12#2)
≥7 drinks/wk##2##2##(2013-1#2)
≥75 years##2##2##(2012-3#2)
・・0##7##1##(2011-2#7)
